id|nct_id|result_group_id|ctgov_group_code|classification|category|title|description|units|param_type|param_value|param_value_num|dispersion_type|dispersion_value|dispersion_value_num|dispersion_lower_limit|dispersion_upper_limit|explanation_of_na
3593125|NCT03704376|3447511|B3|United States||Region of Enrollment||Participants|Count of Participants|78|78.0||||||
3593126|NCT03704376|3447512|B2|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3593127|NCT03704376|3447513|B1|United States||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
3593128|NCT03704376|3447511|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3593129|NCT03704376|3447511|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3593130|NCT03704376|3447512|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3593131|NCT03704376|3447513|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3593132|NCT03704376|3447511|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3593133|NCT03704376|3447512|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3593134|NCT03704376|3447513|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3593135|NCT03704376|3447511|B3|||Age||years|Mean|22.7|22.7|Standard Deviation|8.1|8.1|||
3593136|NCT03704376|3447512|B2|||Age||years|Mean|21.0|21.0|Standard Deviation|7.3|7.3|||
3593137|NCT03704376|3447513|B1|||Age||years|Mean|24.4|24.4|Standard Deviation|8.8|8.8|||
3593138|NCT03670537|3447556|B1||Gravida 6 or more|Gravidity (number of pregnancies)||Participants|Count of Participants|2|2.0||||||
3593139|NCT03670537|3447556|B1||Gravida 5|Gravidity (number of pregnancies)||Participants|Count of Participants|6|6.0||||||
3593140|NCT03670537|3447556|B1||Gravida 4|Gravidity (number of pregnancies)||Participants|Count of Participants|11|11.0||||||
3593141|NCT03670537|3447556|B1||Gravida 3|Gravidity (number of pregnancies)||Participants|Count of Participants|23|23.0||||||
3593142|NCT03670537|3447556|B1||Gravida 2|Gravidity (number of pregnancies)||Participants|Count of Participants|30|30.0||||||
3593143|NCT03670537|3447556|B1||Gravida 1|Gravidity (number of pregnancies)||Participants|Count of Participants|29|29.0||||||
3593144|NCT03670537|3447556|B1|United States||Region of Enrollment||Participants|Count of Participants|101|101.0||||||
3593145|NCT03670537|3447556|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3593146|NCT03670537|3447556|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3593147|NCT03670537|3447556|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3593148|NCT03670537|3447556|B1||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
3593149|NCT03670537|3447556|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3593150|NCT03651856|3447560|B1|United States||Region of Enrollment||Count of Participants|Number|10|10.0||||||
3593151|NCT03651856|3447560|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3593152|NCT03651856|3447560|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3593153|NCT03651856|3447560|B1|||Age||years|Mean|67.1|67.1|Standard Deviation|3.5|3.5|||
3593154|NCT03647033|3447570|B3|Singapore||Region of Enrollment||participants|Number|32|32.0||||||
3593155|NCT03647033|3447571|B2|Singapore||Region of Enrollment||participants|Number|16|16.0||||||
3593156|NCT03647033|3447572|B1|Singapore||Region of Enrollment||participants|Number|16|16.0||||||
3593157|NCT03647033|3447570|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593158|NCT03647033|3447571|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593159|NCT03647033|3447572|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593160|NCT03647033|3447570|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593161|NCT03647033|3447571|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593162|NCT03647033|3447572|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593163|NCT03647033|3447570|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593164|NCT03647033|3447571|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593165|NCT03647033|3447572|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593166|NCT03647033|3447570|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593167|NCT03647033|3447571|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593168|NCT03647033|3447572|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593169|NCT03647033|3447570|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593170|NCT03647033|3447571|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593171|NCT03647033|3447572|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593172|NCT03647033|3447570|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3593173|NCT03647033|3447571|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3593174|NCT03647033|3447572|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3593175|NCT03647033|3447570|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593176|NCT03647033|3447571|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593177|NCT03647033|3447572|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593178|NCT03647033|3447570|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3593179|NCT03647033|3447571|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3593180|NCT03647033|3447572|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3593181|NCT03647033|3447570|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3593182|NCT03647033|3447571|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3593183|NCT03647033|3447572|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3593184|NCT03647033|3447570|B3|||Age||years|Median|67|67.0|Inter-Quartile Range|||63.0|72.0|
3593185|NCT03647033|3447571|B2|||Age||years|Median|65|65.0|Inter-Quartile Range|||62.0|67.0|
3593186|NCT03647033|3447572|B1|||Age||years|Median|69|69.0|Inter-Quartile Range|||64.3|76.8|
3593187|NCT03615534|3447581|B5|||Body Mass Index (BMI)|"Weight (in Kilograms) and Height (in Meters) were measured using a portable stadiometer with movable head piece typically mounted on balanced beam scale (Segma, Germany). Body mass index (BMI) is the relative weight for height and it was calculated according to formula bellow:~BMI=Weight (Kg) / Height2 (m)"|kg/m^2|Mean|40.6|40.6|Standard Deviation|1.8|1.8|||
3593188|NCT03615534|3447582|B4|||Body Mass Index (BMI)|"Weight (in Kilograms) and Height (in Meters) were measured using a portable stadiometer with movable head piece typically mounted on balanced beam scale (Segma, Germany). Body mass index (BMI) is the relative weight for height and it was calculated according to formula bellow:~BMI=Weight (Kg) / Height2 (m)"|kg/m^2|Mean|39.7|39.7|Standard Deviation|1.8|1.8|||
3593189|NCT03615534|3447583|B3|||Body Mass Index (BMI)|"Weight (in Kilograms) and Height (in Meters) were measured using a portable stadiometer with movable head piece typically mounted on balanced beam scale (Segma, Germany). Body mass index (BMI) is the relative weight for height and it was calculated according to formula bellow:~BMI=Weight (Kg) / Height2 (m)"|kg/m^2|Mean|42.0|42.0|Standard Deviation|1.7|1.7|||
3593190|NCT03615534|3447584|B2|||Body Mass Index (BMI)|"Weight (in Kilograms) and Height (in Meters) were measured using a portable stadiometer with movable head piece typically mounted on balanced beam scale (Segma, Germany). Body mass index (BMI) is the relative weight for height and it was calculated according to formula bellow:~BMI=Weight (Kg) / Height2 (m)"|kg/m^2|Mean|41.5|41.5|Standard Deviation|1.7|1.7|||
3593191|NCT03615534|3447585|B1|||Body Mass Index (BMI)|"Weight (in Kilograms) and Height (in Meters) were measured using a portable stadiometer with movable head piece typically mounted on balanced beam scale (Segma, Germany). Body mass index (BMI) is the relative weight for height and it was calculated according to formula bellow:~BMI=Weight (Kg) / Height2 (m)"|kg/m^2|Mean|38.9|38.9|Standard Deviation|2.1|2.1|||
3593192|NCT03615534|3447581|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3593193|NCT03615534|3447582|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3593194|NCT03615534|3447583|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3593195|NCT03615534|3447584|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3593196|NCT03615534|3447585|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3593197|NCT03615534|3447581|B5||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3593198|NCT03615534|3447582|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3593199|NCT03615534|3447583|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3593200|NCT03615534|3447584|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3593201|NCT03615534|3447585|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3593202|NCT03615534|3447581|B5|||Age||years|Mean|37.6|37.6|Standard Deviation|2.2|2.2|||
3593203|NCT03615534|3447582|B4|||Age||years|Mean|40.2|40.2|Standard Deviation|2.2|2.2|||
3593204|NCT03615534|3447583|B3|||Age||years|Mean|36.6|36.6|Standard Deviation|2.1|2.1|||
3593205|NCT03615534|3447584|B2|||Age||years|Mean|37.3|37.3|Standard Deviation|2.0|2.0|||
3593206|NCT03615534|3447585|B1|||Age||years|Mean|36.2|36.2|Standard Deviation|2.5|2.5|||
3593207|NCT03585504|3447630|B3|United States||Region of Enrollment||participants|Number|81|81.0||||||
3593208|NCT03585504|3447631|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
3593209|NCT03585504|3447632|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
3593210|NCT03585504|3447630|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3593211|NCT03585504|3447631|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3593212|NCT03585504|3447632|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3593213|NCT03585504|3447630|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593214|NCT03585504|3447631|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593215|NCT03585504|3447632|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593216|NCT03585504|3447630|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3593217|NCT03585504|3447631|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3593218|NCT03585504|3447632|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3593219|NCT03585504|3447630|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3593220|NCT03585504|3447631|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3593221|NCT03585504|3447632|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3593222|NCT03585504|3447630|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3593223|NCT03585504|3447631|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3593224|NCT03585504|3447632|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593225|NCT03585504|3447630|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3593226|NCT03585504|3447631|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593227|NCT03585504|3447632|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3593228|NCT03585504|3447630|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593229|NCT03585504|3447631|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593230|NCT03585504|3447632|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593231|NCT03585504|3447630|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3593232|NCT03585504|3447631|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3593233|NCT03585504|3447632|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3593234|NCT03585504|3447630|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3593235|NCT03585504|3447631|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3593236|NCT03585504|3447632|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3593237|NCT03585504|3447630|B3|||Age||years|Median|19.24|19.24|Standard Deviation|1.42|1.42|||
3593238|NCT03585504|3447631|B2|||Age||years|Median|19.64|19.64|Standard Deviation|1.03|1.03|||
3593239|NCT03585504|3447632|B1|||Age||years|Median|18.93|18.93|Standard Deviation|1.64|1.64|||
3593240|NCT03582943|3447643|B3|||Body mass index||kg/m^2|Mean|26.6|26.6|Standard Deviation|4.8|4.8|||
3593241|NCT03582943|3447644|B2|||Body mass index||kg/m^2|Mean|26.8|26.8|Standard Deviation|5.1|5.1|||
3593242|NCT03582943|3447645|B1|||Body mass index||kg/m^2|Mean|26.5|26.5|Standard Deviation|4.4|4.4|||
3593243|NCT03582943|3447643|B3|United States||Region of Enrollment||Participants|Count of Participants|69|69.0||||||
3593244|NCT03582943|3447644|B2|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3593245|NCT03582943|3447645|B1|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3593246|NCT03582943|3447643|B3|Race|African-American|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3593247|NCT03582943|3447644|B2|Race|African-American|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3593248|NCT03582943|3447645|B1|Race|African-American|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3593249|NCT03582943|3447643|B3|Race|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
3593250|NCT03582943|3447644|B2|Race|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3593251|NCT03582943|3447645|B1|Race|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3593252|NCT03582943|3447643|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3593253|NCT03582943|3447644|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3593254|NCT03582943|3447645|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3593255|NCT03582943|3447643|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3593256|NCT03582943|3447644|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3593257|NCT03582943|3447645|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3593258|NCT03582943|3447643|B3|||Age||years|Mean|61.2|61.2|Standard Deviation|10.0|10.0|||
3593259|NCT03582943|3447644|B2|||Age||years|Mean|61.8|61.8|Standard Deviation|9.0|9.0|||
3593260|NCT03582943|3447645|B1|||Age||years|Mean|60.4|60.4|Standard Deviation|10.5|10.5|||
3593261|NCT03578146|3447652|B7||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3593262|NCT03578146|3447653|B6||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3593263|NCT03578146|3447654|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3593264|NCT03578146|3447655|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3593265|NCT03578146|3447656|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3593266|NCT03578146|3447657|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3593267|NCT03578146|3447658|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3593268|NCT03578146|3447652|B7||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3593269|NCT03578146|3447653|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3593270|NCT03578146|3447654|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3593271|NCT03578146|3447655|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3593272|NCT03578146|3447656|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3593273|NCT03578146|3447657|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3593274|NCT03578146|3447658|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3593275|NCT03578146|3447652|B7|||Age||years|Mean|35.8|35.8|Standard Deviation|6.79|6.79|||
3593276|NCT03578146|3447653|B6|||Age||years|Mean|32.9|32.9|Standard Deviation|8.10|8.1|||
3593277|NCT03578146|3447654|B5|||Age||years|Mean|35.2|35.2|Standard Deviation|5.04|5.04|||
3593278|NCT03578146|3447655|B4|||Age||years|Mean|34.2|34.2|Standard Deviation|7.25|7.25|||
3593279|NCT03578146|3447656|B3|||Age||years|Mean|35.7|35.7|Standard Deviation|9.07|9.07|||
3593280|NCT03578146|3447657|B2|||Age||years|Mean|35.7|35.7|Standard Deviation|3.33|3.33|||
3593281|NCT03578146|3447658|B1|||Age||years|Mean|38.2|38.2|Standard Deviation|6.69|6.69|||
3593282|NCT03551743|3447725|B5||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3593283|NCT03551743|3447726|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3593284|NCT03551743|3447727|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3593285|NCT03551743|3447728|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3593286|NCT03551743|3447729|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3593287|NCT03551743|3447725|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3593288|NCT03551743|3447726|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3593289|NCT03551743|3447727|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3593290|NCT03551743|3447728|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3593291|NCT03551743|3447729|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3593292|NCT03551743|3447725|B5|||Age||years|Mean|33.4|33.4|Standard Deviation|8.79|8.79|||
3593293|NCT03551743|3447726|B4|||Age||years|Mean|35.5|35.5|Standard Deviation|8.55|8.55|||
3593294|NCT03551743|3447727|B3|||Age||years|Mean|31.3|31.3|Standard Deviation|8.82|8.82|||
3593295|NCT03551743|3447728|B2|||Age||years|Mean|38.8|38.8|Standard Deviation|8.61|8.61|||
3593296|NCT03551743|3447729|B1|||Age||years|Mean|30.2|30.2|Standard Deviation|8.35|8.35|||
3593297|NCT03551730|3447774|B5||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3593298|NCT03551730|3447775|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3593299|NCT03551730|3447776|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3593300|NCT03551730|3447777|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3593301|NCT03551730|3447778|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3593302|NCT03551730|3447774|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3593303|NCT03551730|3447775|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3593304|NCT03551730|3447776|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3593305|NCT03551730|3447777|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3593306|NCT03551730|3447778|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3593307|NCT03551730|3447774|B5|||Age||years|Mean|33.7|33.7|Standard Deviation|6.60|6.6|||
3593308|NCT03551730|3447775|B4|||Age||years|Mean|35.7|35.7|Standard Deviation|8.66|8.66|||
3593309|NCT03551730|3447776|B3|||Age||years|Mean|32.5|32.5|Standard Deviation|5.09|5.09|||
3593310|NCT03551730|3447777|B2|||Age||years|Mean|33.2|33.2|Standard Deviation|8.30|8.3|||
3593311|NCT03551730|3447778|B1|||Age||years|Mean|33.7|33.7|Standard Deviation|5.59|5.59|||
3593312|NCT03549130|3447819|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593313|NCT03549130|3447820|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593314|NCT03549130|3447821|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593315|NCT03549130|3447819|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3593316|NCT03549130|3447820|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3593317|NCT03549130|3447821|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3593318|NCT03549130|3447819|B3||White|Race (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
3593319|NCT03549130|3447820|B2||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3593320|NCT03549130|3447821|B1||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3593321|NCT03549130|3447819|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3593322|NCT03549130|3447820|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3593323|NCT03549130|3447821|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3593324|NCT03549130|3447819|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593325|NCT03549130|3447820|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593326|NCT03549130|3447821|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593327|NCT03549130|3447819|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3593328|NCT03549130|3447820|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3593329|NCT03549130|3447821|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593330|NCT03549130|3447819|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593331|NCT03549130|3447820|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593332|NCT03549130|3447821|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593333|NCT03549130|3447819|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3593334|NCT03549130|3447820|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3593335|NCT03549130|3447821|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3593336|NCT03549130|3447819|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3593337|NCT03549130|3447820|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3593338|NCT03549130|3447821|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3593339|NCT03549130|3447819|B3|||Age, Customized||Years|Mean|47.8|47.8|Standard Deviation|12.53|12.53|||
3593340|NCT03549130|3447820|B2|||Age, Customized||Years|Mean|48.4|48.4|Standard Deviation|13.74|13.74|||
3593341|NCT03549130|3447821|B1|||Age, Customized||Years|Mean|47.1|47.1|Standard Deviation|11.27|11.27|||
3593342|NCT03549117|3447838|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593343|NCT03549117|3447839|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593344|NCT03549117|3447840|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593345|NCT03549117|3447838|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593346|NCT03549117|3447839|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593347|NCT03549117|3447840|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593348|NCT03549117|3447838|B3||White|Race (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
3593349|NCT03549117|3447839|B2||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3593350|NCT03549117|3447840|B1||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3593351|NCT03549117|3447838|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3593352|NCT03549117|3447839|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3593353|NCT03549117|3447840|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3593354|NCT03549117|3447838|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593355|NCT03549117|3447839|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593356|NCT03549117|3447840|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593357|NCT03549117|3447838|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593358|NCT03549117|3447839|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593359|NCT03549117|3447840|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593360|NCT03549117|3447838|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593361|NCT03549117|3447839|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593362|NCT03549117|3447840|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593363|NCT03549117|3447838|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3593364|NCT03549117|3447839|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3593365|NCT03549117|3447840|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3593366|NCT03549117|3447838|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3593367|NCT03549117|3447839|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3593368|NCT03549117|3447840|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3593369|NCT03549117|3447838|B3|||Age, Customized||years|Mean|46.7|46.7|Standard Deviation|13.65|13.65|||
3593370|NCT03549117|3447839|B2|||Age, Customized||years|Mean|47.7|47.7|Standard Deviation|13.19|13.19|||
3593371|NCT03549117|3447840|B1|||Age, Customized||years|Mean|45.8|45.8|Standard Deviation|14.12|14.12|||
3593372|NCT03546192|3447867|B3|Philippines||Region of Enrollment||Participants|Count of Participants|120|120.0||||||
3593373|NCT03546192|3447868|B2|Philippines||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3593374|NCT03546192|3447869|B1|Philippines||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3593375|NCT03546192|3447867|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3593376|NCT03546192|3447868|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3593377|NCT03546192|3447869|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3593378|NCT03546192|3447867|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3593379|NCT03546192|3447868|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3593380|NCT03546192|3447869|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3593381|NCT03546192|3447867|B3|||Age||years|Mean|51.7|51.7|Standard Deviation|19.5|19.5|||
3593382|NCT03546192|3447868|B2|||Age||years|Mean|68.0|68.0|Standard Deviation|5.4|5.4|||
3593383|NCT03546192|3447869|B1|||Age||years|Mean|35.3|35.3|Standard Deviation|13.9|13.9|||
3593384|NCT03545412|3447886|B1||Skin Type VI|Fitzpatrick Skin Type|Skin type I = white; very fair, red or blonde hair blue eyes; freckles; always burns, never tans, skin type II = white, fair, red or blond hair; blue, hazel or green eyes; usually burns, tans with difficulty, skin type III = cream white; fair with any eye or hair color (common); sometimes mild burn, gradually tans, skin type IV = brown; typical Mediterranean Caucasian skin; rarely burns, tans with ease, skin type V = dark brown; mid-eastern skin types; very rarely burns, tans easily, and skin type VI = black; never burns, tans very easily|Participants|Count of Participants|0|0.0||||||
3593385|NCT03545412|3447886|B1||Skin Type V|Fitzpatrick Skin Type|Skin type I = white; very fair, red or blonde hair blue eyes; freckles; always burns, never tans, skin type II = white, fair, red or blond hair; blue, hazel or green eyes; usually burns, tans with difficulty, skin type III = cream white; fair with any eye or hair color (common); sometimes mild burn, gradually tans, skin type IV = brown; typical Mediterranean Caucasian skin; rarely burns, tans with ease, skin type V = dark brown; mid-eastern skin types; very rarely burns, tans easily, and skin type VI = black; never burns, tans very easily|Participants|Count of Participants|0|0.0||||||
3593386|NCT03545412|3447886|B1||Skin Type IV|Fitzpatrick Skin Type|Skin type I = white; very fair, red or blonde hair blue eyes; freckles; always burns, never tans, skin type II = white, fair, red or blond hair; blue, hazel or green eyes; usually burns, tans with difficulty, skin type III = cream white; fair with any eye or hair color (common); sometimes mild burn, gradually tans, skin type IV = brown; typical Mediterranean Caucasian skin; rarely burns, tans with ease, skin type V = dark brown; mid-eastern skin types; very rarely burns, tans easily, and skin type VI = black; never burns, tans very easily|Participants|Count of Participants|22|22.0||||||
3593387|NCT03545412|3447886|B1||Skin Type III|Fitzpatrick Skin Type|Skin type I = white; very fair, red or blonde hair blue eyes; freckles; always burns, never tans, skin type II = white, fair, red or blond hair; blue, hazel or green eyes; usually burns, tans with difficulty, skin type III = cream white; fair with any eye or hair color (common); sometimes mild burn, gradually tans, skin type IV = brown; typical Mediterranean Caucasian skin; rarely burns, tans with ease, skin type V = dark brown; mid-eastern skin types; very rarely burns, tans easily, and skin type VI = black; never burns, tans very easily|Participants|Count of Participants|3|3.0||||||
3593388|NCT03545412|3447886|B1||Skin Type II|Fitzpatrick Skin Type|Skin type I = white; very fair, red or blonde hair blue eyes; freckles; always burns, never tans, skin type II = white, fair, red or blond hair; blue, hazel or green eyes; usually burns, tans with difficulty, skin type III = cream white; fair with any eye or hair color (common); sometimes mild burn, gradually tans, skin type IV = brown; typical Mediterranean Caucasian skin; rarely burns, tans with ease, skin type V = dark brown; mid-eastern skin types; very rarely burns, tans easily, and skin type VI = black; never burns, tans very easily|Participants|Count of Participants|0|0.0||||||
3593562|NCT03493828|3448018|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3593389|NCT03545412|3447886|B1||Skin Type I|Fitzpatrick Skin Type|Skin type I = white; very fair, red or blonde hair blue eyes; freckles; always burns, never tans, skin type II = white, fair, red or blond hair; blue, hazel or green eyes; usually burns, tans with difficulty, skin type III = cream white; fair with any eye or hair color (common); sometimes mild burn, gradually tans, skin type IV = brown; typical Mediterranean Caucasian skin; rarely burns, tans with ease, skin type V = dark brown; mid-eastern skin types; very rarely burns, tans easily, and skin type VI = black; never burns, tans very easily|Participants|Count of Participants|0|0.0||||||
3593390|NCT03545412|3447886|B1|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|22.0|22.0|Full Range|||18.6|26.0|
3593391|NCT03545412|3447886|B1|Taiwan||Region of Enrollment||participants|Number|25|25.0||||||
3593392|NCT03545412|3447886|B1||Native Amer. Indian/ Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3593393|NCT03545412|3447886|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3593394|NCT03545412|3447886|B1||Hispanic/ Latino|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3593395|NCT03545412|3447886|B1||African American/ Black|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3593396|NCT03545412|3447886|B1||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3593397|NCT03545412|3447886|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3593398|NCT03545412|3447886|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3593399|NCT03545412|3447886|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3593400|NCT03545412|3447886|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3593401|NCT03545412|3447886|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3593402|NCT03536923|3447896|B1||Births=3|Parity||Participants|Count of Participants|2|2.0||||||
3593403|NCT03536923|3447896|B1||Births=2|Parity||Participants|Count of Participants|10|10.0||||||
3593404|NCT03536923|3447896|B1||Births=1|Parity||Participants|Count of Participants|5|5.0||||||
3593405|NCT03536923|3447896|B1||Births=0|Parity||Participants|Count of Participants|6|6.0||||||
3593406|NCT03536923|3447896|B1|||BMI||kg/m^2|Mean|26|26.0|Standard Deviation|4|4.0|||
3593407|NCT03536923|3447896|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
3593408|NCT03536923|3447896|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3593409|NCT03536923|3447896|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593410|NCT03536923|3447896|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3593411|NCT03536923|3447896|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3593412|NCT03536923|3447896|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593413|NCT03536923|3447896|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3593414|NCT03536923|3447896|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593415|NCT03536923|3447896|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3593416|NCT03536923|3447896|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3593417|NCT03536923|3447896|B1|||Age||years|Mean|42|42.0|Standard Deviation|10.7|10.7|||
3593418|NCT03536923|3447896|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3593419|NCT03536923|3447896|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3593420|NCT03536923|3447896|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3593421|NCT03534986|3447903|B4|United States||Region of Enrollment||participants|Number|32|32.0||||||
3593422|NCT03534986|3447904|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3593423|NCT03534986|3447905|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3593424|NCT03534986|3447906|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3593425|NCT03534986|3447903|B4|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3593426|NCT03534986|3447903|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3593427|NCT03534986|3447904|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3593428|NCT03534986|3447905|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3593429|NCT03534986|3447906|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3593430|NCT03534986|3447903|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3593431|NCT03534986|3447904|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3593432|NCT03534986|3447905|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3593433|NCT03534986|3447906|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3593434|NCT03534986|3447903|B4|||Age||years|Mean|31.7|31.7|Standard Deviation|11.7|11.7|||
3593435|NCT03534986|3447904|B3|||Age||years|Mean|34.7|34.7|Standard Deviation|10.2|10.2|||
3593436|NCT03534986|3447905|B2|||Age||years|Mean|30.6|30.6|Standard Deviation|13.3|13.3|||
3593437|NCT03534986|3447906|B1|||Age||years|Mean|28.4|28.4|Standard Deviation|11.9|11.9|||
3593438|NCT03534986|3447903|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3593439|NCT03534986|3447904|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3593440|NCT03534986|3447905|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3593441|NCT03534986|3447906|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3593442|NCT03534986|3447903|B4||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3593443|NCT03534986|3447904|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3593444|NCT03534986|3447905|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3650549|NCT02454283|3497012|B2|||Pacemaker||participants|Number|0|0.0||||||
3593445|NCT03534986|3447906|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3593446|NCT03534986|3447903|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3593447|NCT03534986|3447904|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3593448|NCT03534986|3447905|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3593449|NCT03534986|3447906|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3593450|NCT03523988|3447928|B4|United States||Region of Enrollment||participants|Number|22|22.0||||||
3593451|NCT03523988|3447929|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
3593452|NCT03523988|3447930|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3593453|NCT03523988|3447931|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3593454|NCT03523988|3447928|B4|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3593455|NCT03523988|3447928|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3593456|NCT03523988|3447929|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3593457|NCT03523988|3447930|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3593458|NCT03523988|3447931|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3593459|NCT03523988|3447928|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3593460|NCT03523988|3447929|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3593461|NCT03523988|3447930|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3593462|NCT03523988|3447931|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3593463|NCT03523988|3447928|B4|||Age||years|Mean|23.1|23.1|Standard Deviation|14.3|14.3|||
3593464|NCT03523988|3447929|B3|||Age||years|Mean|21.4|21.4|Standard Deviation|15.3|15.3|||
3593465|NCT03523988|3447930|B2|||Age||years|Mean|25.9|25.9|Standard Deviation|18.0|18.0|||
3593466|NCT03523988|3447931|B1|||Age||years|Mean|21.7|21.7|Standard Deviation|9.6|9.6|||
3593467|NCT03509766|3447947|B1|Female||Sex/Gender, Customized||Participants|Count of Participants|18|18.0||||||
3593468|NCT03509766|3447947|B1|Male||Sex/Gender, Customized||Participants|Count of Participants|6|6.0||||||
3593469|NCT03509766|3447947|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3593470|NCT03509766|3447947|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3593471|NCT03509766|3447947|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3593472|NCT03496987|3447953|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
3593473|NCT03496987|3447954|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
3593474|NCT03496987|3447955|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
3593475|NCT03496987|3447953|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3593476|NCT03496987|3447953|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3593477|NCT03496987|3447954|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3593478|NCT03496987|3447955|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3593479|NCT03496987|3447953|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3593480|NCT03496987|3447954|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3593481|NCT03496987|3447955|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3593482|NCT03496987|3447953|B3|||Age||years|Mean|67|67.0|Standard Deviation|15.8|15.8|||
3593483|NCT03496987|3447954|B2|||Age||years|Mean|65.6|65.6|Standard Deviation|15.5|15.5|||
3593484|NCT03496987|3447955|B1|||Age||years|Mean|68.5|68.5|Standard Deviation|16.2|16.2|||
3593485|NCT03494985|3447974|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593486|NCT03494985|3447975|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593487|NCT03494985|3447976|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593488|NCT03494985|3447977|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593489|NCT03494985|3447978|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593490|NCT03494985|3447974|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3593491|NCT03494985|3447975|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593492|NCT03494985|3447976|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593493|NCT03494985|3447977|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3593494|NCT03494985|3447978|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3593495|NCT03494985|3447974|B5||White|Race (NIH/OMB)||Participants|Count of Participants|326|326.0||||||
3593496|NCT03494985|3447975|B4||White|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3593497|NCT03494985|3447976|B3||White|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3593498|NCT03494985|3447977|B2||White|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3593499|NCT03494985|3447978|B1||White|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3593500|NCT03494985|3447974|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3593501|NCT03494985|3447975|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3593502|NCT03494985|3447976|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3593503|NCT03494985|3447977|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3593504|NCT03494985|3447978|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3751095|NCT01980589|3585202|B2|Asian||Race||participants|Number|0|0.0||||||
3593505|NCT03494985|3447974|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593506|NCT03494985|3447975|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593507|NCT03494985|3447976|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593508|NCT03494985|3447977|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593509|NCT03494985|3447978|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593510|NCT03494985|3447974|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3593511|NCT03494985|3447975|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3593512|NCT03494985|3447976|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3593513|NCT03494985|3447977|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3593514|NCT03494985|3447978|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3593515|NCT03494985|3447974|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3593516|NCT03494985|3447975|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593517|NCT03494985|3447976|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593518|NCT03494985|3447977|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3593519|NCT03494985|3447978|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593520|NCT03494985|3447974|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593521|NCT03494985|3447975|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593522|NCT03494985|3447976|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593523|NCT03494985|3447977|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593524|NCT03494985|3447978|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593525|NCT03494985|3447974|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|356|356.0||||||
3593526|NCT03494985|3447975|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3593527|NCT03494985|3447976|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3593528|NCT03494985|3447977|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3593529|NCT03494985|3447978|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3593530|NCT03494985|3447974|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3593531|NCT03494985|3447975|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3593532|NCT03494985|3447976|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3593533|NCT03494985|3447977|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3593534|NCT03494985|3447978|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3593535|NCT03494985|3447974|B5||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3593536|NCT03494985|3447975|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3593537|NCT03494985|3447976|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3593538|NCT03494985|3447977|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3593539|NCT03494985|3447978|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3593540|NCT03494985|3447974|B5||Female|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
3593541|NCT03494985|3447975|B4||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3593542|NCT03494985|3447976|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3593543|NCT03494985|3447977|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3593544|NCT03494985|3447978|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3593545|NCT03494985|3447974|B5|||Age||Years|Geometric Mean|53.9|53.9|Standard Deviation|10.20|10.2|||
3593546|NCT03494985|3447975|B4|||Age||Years|Geometric Mean|52.7|52.7|Standard Deviation|9.61|9.61|||
3593547|NCT03494985|3447976|B3|||Age||Years|Geometric Mean|54.0|54.0|Standard Deviation|9.80|9.8|||
3593548|NCT03494985|3447977|B2|||Age||Years|Geometric Mean|52.6|52.6|Standard Deviation|10.87|10.87|||
3593549|NCT03494985|3447978|B1|||Age||Years|Geometric Mean|56.2|56.2|Standard Deviation|10.19|10.19|||
3593550|NCT03493828|3448015|B4|North America||Region of Enrollment||participants|Number|60|60.0||||||
3593551|NCT03493828|3448016|B3|North America||Region of Enrollment||participants|Number|20|20.0||||||
3593552|NCT03493828|3448017|B2|North America||Region of Enrollment||participants|Number|20|20.0||||||
3593553|NCT03493828|3448018|B1|North America||Region of Enrollment||participants|Number|20|20.0||||||
3593554|NCT03493828|3448015|B4|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3593555|NCT03493828|3448015|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3593556|NCT03493828|3448016|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3593557|NCT03493828|3448017|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3593558|NCT03493828|3448018|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3593559|NCT03493828|3448015|B4||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3593560|NCT03493828|3448016|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3593561|NCT03493828|3448017|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3593563|NCT03493828|3448015|B4|||Age||years|Median|33|33.0|Full Range|||19.0|48.0|
3593564|NCT03493828|3448016|B3|||Age||years|Median|32.5|32.5|Full Range|||19.0|41.0|
3593565|NCT03493828|3448017|B2|||Age||years|Median|34.5|34.5|Full Range|||21.0|48.0|
3593566|NCT03493828|3448018|B1|||Age||years|Median|33|33.0|Full Range|||23.0|41.0|
3593567|NCT03493828|3448015|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3593568|NCT03493828|3448016|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3593569|NCT03493828|3448017|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3593570|NCT03493828|3448018|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3593571|NCT03493828|3448015|B4||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3593572|NCT03493828|3448016|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3593573|NCT03493828|3448017|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3593574|NCT03493828|3448018|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3593575|NCT03493828|3448015|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3593576|NCT03493828|3448016|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3593577|NCT03493828|3448017|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3593578|NCT03493828|3448018|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3593579|NCT03491228|3448028|B1|Infectious enterocolitis + amebic dysentery||Target Diseases|Target diseases for this study were anaerobic infection, infectious enterocolitis, amebic dysentery, and the infection with both infectious enterocolitis and amebic dysentery.|Participants|Number|3|3.0||||||
3593580|NCT03491228|3448028|B1|Amebic dysentery||Target Diseases|Target diseases for this study were anaerobic infection, infectious enterocolitis, amebic dysentery, and the infection with both infectious enterocolitis and amebic dysentery.|Participants|Number|7|7.0||||||
3593581|NCT03491228|3448028|B1|Infectious enterocolitis||Target Diseases|Target diseases for this study were anaerobic infection, infectious enterocolitis, amebic dysentery, and the infection with both infectious enterocolitis and amebic dysentery.|Participants|Number|23|23.0||||||
3593582|NCT03491228|3448028|B1|Anaerobic infection||Target Diseases|Target diseases for this study were anaerobic infection, infectious enterocolitis, amebic dysentery, and the infection with both infectious enterocolitis and amebic dysentery.|Participants|Number|74|74.0||||||
3593583|NCT03491228|3448028|B1|Female||Sex/Gender, Customized||Participants|Number|38|38.0||||||
3593584|NCT03491228|3448028|B1|Male||Sex/Gender, Customized||Participants|Number|69|69.0||||||
3593585|NCT03491228|3448028|B1|≥65 years||Age, Customized||Participants|Number|67|67.0||||||
3593586|NCT03491228|3448028|B1|≥15 and <65 years||Age, Customized||Participants|Number|40|40.0||||||
3593587|NCT03491228|3448028|B1|<15 years||Age, Customized||Participants|Number|0|0.0||||||
3593588|NCT03489551|3448034|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3593589|NCT03489551|3448034|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3593590|NCT03489551|3448034|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3593591|NCT03489551|3448034|B1|||Age||years|Mean|59.3|59.3|Full Range|||46.8|70.7|
3593592|NCT03489551|3448034|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3593593|NCT03489551|3448034|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3593594|NCT03489551|3448034|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3593595|NCT03489304|3448038|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3593596|NCT03489304|3448038|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593597|NCT03489304|3448038|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593598|NCT03489304|3448038|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3593599|NCT03489304|3448038|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3593600|NCT03489304|3448038|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593601|NCT03489304|3448038|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593602|NCT03489304|3448038|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593603|NCT03489304|3448038|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3593604|NCT03489304|3448038|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3593605|NCT03489304|3448038|B1|||Age||years|Mean|49|49.0|Standard Deviation|9|9.0|||
3593606|NCT03489304|3448038|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3593607|NCT03489304|3448038|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3593608|NCT03489304|3448038|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3593609|NCT03479216|3448044|B3|Turkey||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
3593610|NCT03479216|3448045|B2|Turkey||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3593611|NCT03479216|3448046|B1|Turkey||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3593612|NCT03479216|3448044|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3593613|NCT03479216|3448044|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3593614|NCT03479216|3448045|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3593615|NCT03479216|3448046|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3593616|NCT03479216|3448044|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3593617|NCT03479216|3448045|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3593618|NCT03479216|3448046|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3593619|NCT03479216|3448044|B3|||Age||years|Mean|42.18|42.18|Full Range|||18.0|65.0|
3593620|NCT03479216|3448045|B2|||Age||years|Mean|42.73|42.73|Full Range|||23.0|59.0|
3593621|NCT03479216|3448046|B1|||Age||years|Mean|41.62|41.62|Full Range|||18.0|65.0|
3593622|NCT03478891|3448065|B4|||Weight||kg|Mean|73.9|73.9|Standard Deviation|13.4|13.4|||
3593623|NCT03478891|3448066|B3|||Weight||kg|Mean|73.5|73.5|Standard Deviation|12.4|12.4|||
3593624|NCT03478891|3448067|B2|||Weight||kg|Mean|66.3|66.3|Standard Deviation|12.6|12.6|||
3593625|NCT03478891|3448068|B1|||Weight||kg|Mean|88|88.0|Standard Deviation|8.8|8.8|||
3593626|NCT03478891|3448065|B4|United States||Region of Enrollment||participants|Number|19|19.0||||||
3593627|NCT03478891|3448066|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3593628|NCT03478891|3448067|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3593629|NCT03478891|3448068|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3593630|NCT03478891|3448065|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593631|NCT03478891|3448066|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593632|NCT03478891|3448067|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593633|NCT03478891|3448068|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593634|NCT03478891|3448065|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3593635|NCT03478891|3448066|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3593636|NCT03478891|3448067|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593637|NCT03478891|3448068|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3593638|NCT03478891|3448065|B4||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3593639|NCT03478891|3448066|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3593640|NCT03478891|3448067|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3593641|NCT03478891|3448068|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3593642|NCT03478891|3448065|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3593643|NCT03478891|3448066|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3593644|NCT03478891|3448067|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593645|NCT03478891|3448068|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593646|NCT03478891|3448065|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593647|NCT03478891|3448066|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593648|NCT03478891|3448067|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593649|NCT03478891|3448068|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593650|NCT03478891|3448065|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3593651|NCT03478891|3448066|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3593652|NCT03478891|3448067|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593653|NCT03478891|3448068|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593654|NCT03478891|3448065|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593655|NCT03478891|3448066|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593656|NCT03478891|3448067|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593657|NCT03478891|3448068|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593658|NCT03478891|3448065|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3593659|NCT03478891|3448066|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3593660|NCT03478891|3448067|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3593661|NCT03478891|3448068|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3593662|NCT03478891|3448065|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3593663|NCT03478891|3448066|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3593664|NCT03478891|3448067|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3593665|NCT03478891|3448068|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3593666|NCT03478891|3448065|B4|51-60 years||Age, Customized||Participants|Count of Participants|4|4.0||||||
3593667|NCT03478891|3448066|B3|51-60 years||Age, Customized||Participants|Count of Participants|4|4.0||||||
3593668|NCT03478891|3448067|B2|51-60 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3593669|NCT03478891|3448068|B1|51-60 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3593670|NCT03478891|3448065|B4|41-50 years||Age, Customized||Participants|Count of Participants|4|4.0||||||
3593671|NCT03478891|3448066|B3|41-50 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3593672|NCT03478891|3448067|B2|41-50 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
3593673|NCT03478891|3448068|B1|41-50 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3593674|NCT03478891|3448065|B4|31-40 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
3593675|NCT03478891|3448066|B3|31-40 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
3593676|NCT03478891|3448067|B2|31-40 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
3593677|NCT03478891|3448068|B1|31-40 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
3593678|NCT03478891|3448065|B4|21-30 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
3593679|NCT03478891|3448066|B3|21-30 years||Age, Customized||Participants|Count of Participants|4|4.0||||||
3593680|NCT03478891|3448067|B2|21-30 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3593681|NCT03478891|3448068|B1|21-30 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3593682|NCT03478644|3448084|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593683|NCT03478644|3448085|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593684|NCT03478644|3448086|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593685|NCT03478644|3448084|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3593686|NCT03478644|3448085|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593687|NCT03478644|3448086|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3593688|NCT03478644|3448084|B3||White|Race (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
3593689|NCT03478644|3448085|B2||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3593690|NCT03478644|3448086|B1||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3593691|NCT03478644|3448084|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3593692|NCT03478644|3448085|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3593693|NCT03478644|3448086|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3593694|NCT03478644|3448084|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3593695|NCT03478644|3448085|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593696|NCT03478644|3448086|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3593697|NCT03478644|3448084|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3593698|NCT03478644|3448085|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3593699|NCT03478644|3448086|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593700|NCT03478644|3448084|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593701|NCT03478644|3448085|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593702|NCT03478644|3448086|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593703|NCT03478644|3448084|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3593704|NCT03478644|3448085|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3593705|NCT03478644|3448086|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3593706|NCT03478644|3448084|B3||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3593707|NCT03478644|3448085|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3593708|NCT03478644|3448086|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3593709|NCT03478644|3448084|B3|||Age||years|Mean|61.01|61.01|Standard Deviation|12.620|12.62|||
3593710|NCT03478644|3448085|B2|||Age||years|Mean|61.03|61.03|Standard Deviation|12.622|12.622|||
3593711|NCT03478644|3448086|B1|||Age||years|Mean|60.99|60.99|Standard Deviation|12.702|12.702|||
3593712|NCT03447821|3448099|B4|||Axillary Temperature (°C)||Degrees Celsius|Mean|36.8|36.8|Standard Deviation|0.4|0.4|||
3593713|NCT03447821|3448100|B3|||Axillary Temperature (°C)||Degrees Celsius|Mean|36.7|36.7|Standard Deviation|0.4|0.4|||
3593714|NCT03447821|3448101|B2|||Axillary Temperature (°C)||Degrees Celsius|Mean|36.8|36.8|Standard Deviation|0.4|0.4|||
3593715|NCT03447821|3448102|B1|||Axillary Temperature (°C)||Degrees Celsius|Mean|36.8|36.8|Standard Deviation|0.5|0.5|||
3593716|NCT03447821|3448099|B4|||Weight (kg)||kg|Mean|71.8|71.8|Standard Deviation|15|15.0|||
3593717|NCT03447821|3448100|B3|||Weight (kg)||kg|Mean|70.3|70.3|Standard Deviation|11.8|11.8|||
3593718|NCT03447821|3448101|B2|||Weight (kg)||kg|Mean|72.9|72.9|Standard Deviation|17|17.0|||
3593719|NCT03447821|3448102|B1|||Weight (kg)||kg|Mean|72.3|72.3|Standard Deviation|16.7|16.7|||
3593720|NCT03447821|3448099|B4|||Height (cm)||cm|Mean|161.8|161.8|Standard Deviation|8.9|8.9|||
3593721|NCT03447821|3448100|B3|||Height (cm)||cm|Mean|159.1|159.1|Standard Deviation|6.2|6.2|||
3593722|NCT03447821|3448101|B2|||Height (cm)||cm|Mean|160.8|160.8|Standard Deviation|9.7|9.7|||
3593723|NCT03447821|3448102|B1|||Height (cm)||cm|Mean|165.2|165.2|Standard Deviation|9.8|9.8|||
3593724|NCT03447821|3448099|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3593725|NCT03447821|3448100|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3593726|NCT03447821|3448101|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3593727|NCT03447821|3448102|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3593728|NCT03447821|3448099|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3593729|NCT03447821|3448100|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3593730|NCT03447821|3448101|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3593731|NCT03447821|3448102|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3593732|NCT03447821|3448099|B4|||Age||years|Mean|39.6|39.6|Standard Deviation|13.4|13.4|||
3593733|NCT03447821|3448100|B3|||Age||years|Mean|41.9|41.9|Standard Deviation|12.7|12.7|||
3593734|NCT03447821|3448101|B2|||Age||years|Mean|37.3|37.3|Standard Deviation|15.9|15.9|||
3593735|NCT03447821|3448102|B1|||Age||years|Mean|39.5|39.5|Standard Deviation|12.1|12.1|||
3593736|NCT03447353|3448127|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3593737|NCT03447353|3448127|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593738|NCT03447353|3448127|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593739|NCT03447353|3448127|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3593740|NCT03447353|3448127|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3593741|NCT03447353|3448127|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593742|NCT03447353|3448127|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593743|NCT03447353|3448127|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593744|NCT03447353|3448127|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593745|NCT03447353|3448127|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3593746|NCT03447353|3448127|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593747|NCT03447353|3448127|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3593748|NCT03447353|3448127|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3593749|NCT03447353|3448127|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3593750|NCT03447353|3448127|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3593751|NCT03447353|3448127|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3593752|NCT03446690|3448141|B3|China||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3593753|NCT03446690|3448142|B2|China||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3593754|NCT03446690|3448143|B1|China||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3593755|NCT03446690|3448141|B3|Africa||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3593756|NCT03446690|3448142|B2|Africa||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3593757|NCT03446690|3448143|B1|Africa||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3593758|NCT03446690|3448141|B3|Central America||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
3593759|NCT03446690|3448142|B2|Central America||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3593760|NCT03446690|3448143|B1|Central America||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3593761|NCT03446690|3448141|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3593762|NCT03446690|3448142|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3593763|NCT03446690|3448143|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3593764|NCT03446690|3448141|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3593765|NCT03446690|3448142|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3593766|NCT03446690|3448143|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3593767|NCT03446690|3448141|B3|||Age||years|Mean|29|29.0|Standard Deviation|5.94|5.94|||
3593768|NCT03446690|3448142|B2|||Age||years|Mean|28.5|28.5|Standard Deviation|5.2|5.2|||
3593769|NCT03446690|3448143|B1|||Age||years|Mean|29.5|29.5|Standard Deviation|6.7|6.7|||
3593770|NCT03417713|3448150|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3593771|NCT03417713|3448150|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3593772|NCT03417713|3448150|B1|||Age||Years|Mean|69.9|69.9|Full Range|||55.0|81.0|
3593773|NCT03410628|3448155|B1|South Africa||Region of Enrollment||participants|Number|21|21.0||||||
3593774|NCT03410628|3448155|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3593775|NCT03410628|3448155|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3593776|NCT03410628|3448155|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3593777|NCT03410628|3448155|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3593778|NCT03410628|3448155|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3593779|NCT03410628|3448155|B1|||Age||years|Mean|38.6|38.6|Full Range|||22.0|55.0|
3593780|NCT03407612|3448160|B3||Left Handed|Hand Dominance||Participants|Count of Participants|18|18.0||||||
3593781|NCT03407612|3448161|B2||Left Handed|Hand Dominance||Participants|Count of Participants|10|10.0||||||
3593782|NCT03407612|3448162|B1||Left Handed|Hand Dominance||Participants|Count of Participants|8|8.0||||||
3593783|NCT03407612|3448160|B3||Right Handed|Hand Dominance||Participants|Count of Participants|24|24.0||||||
3593784|NCT03407612|3448161|B2||Right Handed|Hand Dominance||Participants|Count of Participants|13|13.0||||||
3593785|NCT03407612|3448162|B1||Right Handed|Hand Dominance||Participants|Count of Participants|11|11.0||||||
3593786|NCT03407612|3448160|B3|||BMI||kg/m^2|Mean|26.2|26.2|Standard Deviation|5.8|5.8|||
3593787|NCT03407612|3448161|B2|||BMI||kg/m^2|Mean|25.1|25.1|Standard Deviation|4.6|4.6|||
3593788|NCT03407612|3448162|B1|||BMI||kg/m^2|Mean|27.5|27.5|Standard Deviation|7.0|7.0|||
3593789|NCT03407612|3448160|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
3593790|NCT03407612|3448161|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
3593791|NCT03407612|3448162|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3593792|NCT03407612|3448160|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3593793|NCT03407612|3448160|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3593794|NCT03407612|3448161|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3593795|NCT03407612|3448162|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3593796|NCT03407612|3448160|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3593797|NCT03407612|3448161|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3593798|NCT03407612|3448162|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3593799|NCT03407612|3448160|B3|||Age||years|Mean|32.5|32.5|Standard Deviation|11.3|11.3|||
3593800|NCT03407612|3448161|B2|||Age||years|Mean|29.5|29.5|Standard Deviation|11.1|11.1|||
3593801|NCT03407612|3448162|B1|||Age||years|Mean|36.2|36.2|Standard Deviation|10.7|10.7|||
3593802|NCT03407430|3448173|B3|||Baseline neuropathic pain scale|"The ID-Pain scale (i.e. neuropathic pain scale) is a 6-item, participant-completed screening tool to help differentiate nociceptive and neuropathic pain.~Did the pain feel like pins and needles?~Did the pain feel hot/burning?~Did the pain feel numb?~Did the pain feel like electrical shocks?~Is the pain made worse with the touch of clothing or bed sheets?~Is the pain limited to your joints?~A “yes” response to questions 1–5 are scored as 1; for question 6, is scored as −1. As such, higher scores (approaching 5) signify worse outcomes. Scale total range of -1 to 5."|units on a scale|Mean|0.1|0.1|Full Range|||0.0|1.0|
3593803|NCT03407430|3448174|B2|||Baseline neuropathic pain scale|"The ID-Pain scale (i.e. neuropathic pain scale) is a 6-item, participant-completed screening tool to help differentiate nociceptive and neuropathic pain.~Did the pain feel like pins and needles?~Did the pain feel hot/burning?~Did the pain feel numb?~Did the pain feel like electrical shocks?~Is the pain made worse with the touch of clothing or bed sheets?~Is the pain limited to your joints?~A “yes” response to questions 1–5 are scored as 1; for question 6, is scored as −1. As such, higher scores (approaching 5) signify worse outcomes. Scale total range of -1 to 5."|units on a scale|Mean|0.3|0.3|Full Range|||0.0|1.0|
3593804|NCT03407430|3448175|B1|||Baseline neuropathic pain scale|"The ID-Pain scale (i.e. neuropathic pain scale) is a 6-item, participant-completed screening tool to help differentiate nociceptive and neuropathic pain.~Did the pain feel like pins and needles?~Did the pain feel hot/burning?~Did the pain feel numb?~Did the pain feel like electrical shocks?~Is the pain made worse with the touch of clothing or bed sheets?~Is the pain limited to your joints?~A “yes” response to questions 1–5 are scored as 1; for question 6, is scored as −1. As such, higher scores (approaching 5) signify worse outcomes. Scale total range of -1 to 5."|units on a scale|Mean|0|0.0|Full Range|||0.0|0.0|
3593805|NCT03407430|3448173|B3|||Eastern Cooperative Oncology Group (ECOG) performance status|"Measure Description: A scale from 0-5 to describe a patient's level of functioning in terms of selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|units on a scale|Mean|0.4|0.4|Full Range|||0.0|1.0|
3593806|NCT03407430|3448174|B2|||Eastern Cooperative Oncology Group (ECOG) performance status|"Measure Description: A scale from 0-5 to describe a patient's level of functioning in terms of selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|units on a scale|Mean|0.3|0.3|Full Range|||0.0|1.0|
3593807|NCT03407430|3448175|B1|||Eastern Cooperative Oncology Group (ECOG) performance status|"Measure Description: A scale from 0-5 to describe a patient's level of functioning in terms of selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|units on a scale|Mean|0.4|0.4|Full Range|||0.0|1.0|
3593808|NCT03407430|3448173|B3|||Body Surface Area (BSA)||m^2|Mean|1.88|1.88|Full Range|||1.68|2.16|
3593809|NCT03407430|3448174|B2|||Body Surface Area (BSA)||m^2|Mean|1.86|1.86|Full Range|||1.82|1.91|
3593810|NCT03407430|3448175|B1|||Body Surface Area (BSA)||m^2|Mean|1.89|1.89|Full Range|||1.68|2.16|
3593811|NCT03407430|3448173|B3|||Body Mass Index (BMI)||kg/m^2|Mean|26.7|26.7|Full Range|||20.1|32.0|
3593812|NCT03407430|3448174|B2|||Body Mass Index (BMI)||kg/m^2|Mean|24.3|24.3|Full Range|||20.6|26.8|
3593813|NCT03407430|3448175|B1|||Body Mass Index (BMI)||kg/m^2|Mean|28.2|28.2|Full Range|||20.1|32.0|
3593814|NCT03407430|3448173|B3|||Baseline pain score|The ten-point numerical scale is scored as an integer from 0 to 10. Participants will use this scale to rate their pain (and separately bone/joint pain) with 0 signifying “no pain” and 10 signifying “the worst pain you can imagine.” As such, higher values (approaching 10) signify worse outcomes.|units on a scale|Mean|1.8|1.8|Full Range|||0.0|6.0|
3593815|NCT03407430|3448174|B2|||Baseline pain score|The ten-point numerical scale is scored as an integer from 0 to 10. Participants will use this scale to rate their pain (and separately bone/joint pain) with 0 signifying “no pain” and 10 signifying “the worst pain you can imagine.” As such, higher values (approaching 10) signify worse outcomes.|units on a scale|Mean|3.3|3.3|Full Range|||2.0|6.0|
3593816|NCT03407430|3448175|B1|||Baseline pain score|The ten-point numerical scale is scored as an integer from 0 to 10. Participants will use this scale to rate their pain (and separately bone/joint pain) with 0 signifying “no pain” and 10 signifying “the worst pain you can imagine.” As such, higher values (approaching 10) signify worse outcomes.|units on a scale|Mean|0.8|0.8|Full Range|||0.0|2.0|
3593817|NCT03407430|3448173|B3|||Serum creatinine (SCr)||mg/dL|Mean|0.7|0.7|Full Range|||0.5|0.9|
3593818|NCT03407430|3448174|B2|||Serum creatinine (SCr)||mg/dL|Mean|0.6|0.6|Full Range|||0.6|0.7|
3593819|NCT03407430|3448175|B1|||Serum creatinine (SCr)||mg/dL|Mean|0.7|0.7|Full Range|||0.5|0.9|
3593820|NCT03407430|3448173|B3|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3593821|NCT03407430|3448174|B2|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3593822|NCT03407430|3448175|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3593823|NCT03407430|3448173|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593824|NCT03407430|3448174|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593825|NCT03407430|3448175|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593826|NCT03407430|3448173|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593827|NCT03407430|3448174|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593828|NCT03407430|3448175|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593829|NCT03407430|3448173|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3593830|NCT03407430|3448174|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3593831|NCT03407430|3448175|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3593832|NCT03407430|3448173|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3593833|NCT03407430|3448174|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593834|NCT03407430|3448175|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3593835|NCT03407430|3448173|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593836|NCT03407430|3448174|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593837|NCT03407430|3448175|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593838|NCT03407430|3448173|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3593839|NCT03407430|3448174|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3593840|NCT03407430|3448175|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593841|NCT03407430|3448173|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593842|NCT03407430|3448174|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593843|NCT03407430|3448175|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593844|NCT03407430|3448173|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3593845|NCT03407430|3448174|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3593846|NCT03407430|3448175|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3593847|NCT03407430|3448173|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3593848|NCT03407430|3448174|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3593849|NCT03407430|3448175|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3593850|NCT03407430|3448173|B3|||Age||years|Mean|48.1|48.1|Full Range|||23.0|71.0|
3593851|NCT03407430|3448174|B2|||Age||years|Mean|51.3|51.3|Full Range|||33.0|62.0|
3593852|NCT03407430|3448175|B1|||Age||years|Mean|46.2|46.2|Full Range|||23.0|71.0|
3593853|NCT03407430|3448173|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3593854|NCT03407430|3448174|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3593855|NCT03407430|3448175|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3593856|NCT03407430|3448173|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3593857|NCT03407430|3448174|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3593858|NCT03407430|3448175|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3593859|NCT03407430|3448173|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3593860|NCT03407430|3448174|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3593861|NCT03407430|3448175|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3593862|NCT03405818|3448208|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593863|NCT03405818|3448208|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593864|NCT03405818|3448208|B1||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3593865|NCT03405818|3448208|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3593866|NCT03405818|3448208|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593867|NCT03405818|3448208|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593868|NCT03405818|3448208|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593869|NCT03405818|3448208|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593870|NCT03405818|3448208|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3593871|NCT03405818|3448208|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3593872|NCT03405818|3448208|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3593873|NCT03405818|3448208|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3593874|NCT03405818|3448208|B1|||Age||years|Mean|13.2|13.2|Standard Deviation|2.69|2.69|||
3593875|NCT03400475|3448249|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
3593876|NCT03400475|3448250|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
3593877|NCT03400475|3448251|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3593878|NCT03400475|3448249|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3593879|NCT03400475|3448250|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3593880|NCT03400475|3448251|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3593881|NCT03400475|3448249|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3593882|NCT03400475|3448250|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3593883|NCT03400475|3448251|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3593884|NCT03400475|3448249|B3|||Age||years|Mean|63.3|63.3|Standard Deviation|13.7|13.7|||
3593885|NCT03400475|3448250|B2|||Age||years|Mean|63.1|63.1|Standard Deviation|14.3|14.3|||
3593886|NCT03400475|3448251|B1|||Age||years|Mean|63.45|63.45|Standard Deviation|13.3|13.3|||
3593887|NCT03365011|3448292|B3||Extremely bothered|Global Bothersome Scale||Participants|Count of Participants|4|4.0||||||
3593888|NCT03365011|3448293|B2||Extremely bothered|Global Bothersome Scale||Participants|Count of Participants|3|3.0||||||
3593889|NCT03365011|3448294|B1||Extremely bothered|Global Bothersome Scale||Participants|Count of Participants|1|1.0||||||
3593890|NCT03365011|3448292|B3||Bothered a lot|Global Bothersome Scale||Participants|Count of Participants|12|12.0||||||
3593891|NCT03365011|3448293|B2||Bothered a lot|Global Bothersome Scale||Participants|Count of Participants|5|5.0||||||
3593892|NCT03365011|3448294|B1||Bothered a lot|Global Bothersome Scale||Participants|Count of Participants|7|7.0||||||
3593893|NCT03365011|3448292|B3||Bothered more than a little, but not a lot|Global Bothersome Scale||Participants|Count of Participants|24|24.0||||||
3593894|NCT03365011|3448293|B2||Bothered more than a little, but not a lot|Global Bothersome Scale||Participants|Count of Participants|12|12.0||||||
3593895|NCT03365011|3448294|B1||Bothered more than a little, but not a lot|Global Bothersome Scale||Participants|Count of Participants|12|12.0||||||
3593896|NCT03365011|3448292|B3||Bothered a little, but not much|Global Bothersome Scale||Participants|Count of Participants|0|0.0||||||
3593897|NCT03365011|3448293|B2||Bothered a little, but not much|Global Bothersome Scale||Participants|Count of Participants|0|0.0||||||
3593898|NCT03365011|3448294|B1||Bothered a little, but not much|Global Bothersome Scale||Participants|Count of Participants|0|0.0||||||
3593899|NCT03365011|3448292|B3||Not bothered|Global Bothersome Scale||Participants|Count of Participants|0|0.0||||||
3593900|NCT03365011|3448293|B2||Not bothered|Global Bothersome Scale||Participants|Count of Participants|0|0.0||||||
3593901|NCT03365011|3448294|B1||Not bothered|Global Bothersome Scale||Participants|Count of Participants|0|0.0||||||
3593902|NCT03365011|3448292|B3|||Tinnitus Functional Index|The Tinnitus Functional Index (TFI) is a 25-question survey assessing tinnitus impact on quality of life. Participants were asked to rate on a scale from 0-10 the degree of unpleasantness, cognitive interference, sleep disturbance, auditory difficulties, interference with relaxation, and emotional distress associated with their tinnitus. Subscores are summed and scaled to a score of 0-100. A score less than 25 indicates mild problems due to tinnitus and little need for intervention, while a score between 25-50 indicates significant problems due to tinnitus with potential need for intervention.|units on a scale|Median|41|41.0|Full Range|||6.0|92.0|
3593903|NCT03365011|3448293|B2|||Tinnitus Functional Index|The Tinnitus Functional Index (TFI) is a 25-question survey assessing tinnitus impact on quality of life. Participants were asked to rate on a scale from 0-10 the degree of unpleasantness, cognitive interference, sleep disturbance, auditory difficulties, interference with relaxation, and emotional distress associated with their tinnitus. Subscores are summed and scaled to a score of 0-100. A score less than 25 indicates mild problems due to tinnitus and little need for intervention, while a score between 25-50 indicates significant problems due to tinnitus with potential need for intervention.|units on a scale|Median|40|40.0|Full Range|||21.0|92.0|
3593904|NCT03365011|3448294|B1|||Tinnitus Functional Index|The Tinnitus Functional Index (TFI) is a 25-question survey assessing tinnitus impact on quality of life. Participants were asked to rate on a scale from 0-10 the degree of unpleasantness, cognitive interference, sleep disturbance, auditory difficulties, interference with relaxation, and emotional distress associated with their tinnitus. Subscores are summed and scaled to a score of 0-100. A score less than 25 indicates mild problems due to tinnitus and little need for intervention, while a score between 25-50 indicates significant problems due to tinnitus with potential need for intervention.|units on a scale|Median|42|42.0|Full Range|||6.0|82.0|
3593905|NCT03365011|3448292|B3|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3593906|NCT03365011|3448293|B2|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3593907|NCT03365011|3448294|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3593908|NCT03365011|3448292|B3|Race|Did not respond|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3593909|NCT03365011|3448293|B2|Race|Did not respond|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3593910|NCT03365011|3448294|B1|Race|Did not respond|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3593911|NCT03365011|3448292|B3|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3593912|NCT03365011|3448293|B2|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3593913|NCT03365011|3448294|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3593914|NCT03365011|3448292|B3|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3593915|NCT03365011|3448293|B2|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3593916|NCT03365011|3448294|B1|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3593917|NCT03365011|3448292|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3593918|NCT03365011|3448293|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3593919|NCT03365011|3448294|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3593920|NCT03365011|3448292|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3593921|NCT03365011|3448293|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3593922|NCT03365011|3448294|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3593923|NCT03365011|3448292|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3593924|NCT03365011|3448293|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3593925|NCT03365011|3448294|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3593926|NCT03365011|3448292|B3|||Age||years|Mean|52.9|52.9|Standard Deviation|11.1|11.1|||
3593927|NCT03365011|3448293|B2|||Age||years|Mean|52.8|52.8|Standard Deviation|11.1|11.1|||
3593928|NCT03365011|3448294|B1|||Age||years|Mean|53.5|53.5|Standard Deviation|9.4|9.4|||
3593929|NCT03364335|3448305|B6|||Waist Circumference||cm|Mean|112.71|112.71|Standard Deviation|12.39|12.39|||
3593930|NCT03364335|3448306|B5|||Waist Circumference||cm|Mean|112.93|112.93|Standard Deviation|13.311|13.311|||
3593931|NCT03364335|3448307|B4|||Waist Circumference||cm|Mean|111.17|111.17|Standard Deviation|13.291|13.291|||
3593932|NCT03364335|3448308|B3|||Waist Circumference||cm|Mean|116.02|116.02|Standard Deviation|12.411|12.411|||
3593933|NCT03364335|3448309|B2|||Waist Circumference||cm|Mean|112.91|112.91|Standard Deviation|11.466|11.466|||
3593934|NCT03364335|3448310|B1|||Waist Circumference||cm|Mean|110.40|110.4|Standard Deviation|10.998|10.998|||
3593935|NCT03364335|3448305|B6|||Body Mass Index (BMI)||kg/m^2|Mean|36.89|36.89|Standard Deviation|4.08|4.08|||
3593936|NCT03364335|3448306|B5|||Body Mass Index (BMI)||kg/m^2|Mean|37.152|37.152|Standard Deviation|4.23|4.23|||
3593937|NCT03364335|3448307|B4|||Body Mass Index (BMI)||kg/m^2|Mean|36.425|36.425|Standard Deviation|4.13|4.13|||
3593938|NCT03364335|3448308|B3|||Body Mass Index (BMI)||kg/m^2|Mean|37.9|37.9|Standard Deviation|4.20|4.2|||
3593939|NCT03364335|3448309|B2|||Body Mass Index (BMI)||kg/m^2|Mean|37.179|37.179|Standard Deviation|4.28|4.28|||
3593940|NCT03364335|3448310|B1|||Body Mass Index (BMI)||kg/m^2|Mean|35.773|35.773|Standard Deviation|3.31|3.31|||
3593941|NCT03364335|3448305|B6|||Weight (kg)||kg|Mean|103.74|103.74|Standard Deviation|16.49|16.49|||
3593942|NCT03364335|3448306|B5|||Weight (kg)||kg|Mean|104.50|104.5|Standard Deviation|17.405|17.405|||
3593943|NCT03364335|3448307|B4|||Weight (kg)||kg|Mean|100.18|100.18|Standard Deviation|16.991|16.991|||
3593944|NCT03364335|3448308|B3|||Weight (kg)||kg|Mean|107.16|107.16|Standard Deviation|17.962|17.962|||
3593945|NCT03364335|3448309|B2|||Weight (kg)||kg|Mean|105.05|105.05|Standard Deviation|15.568|15.568|||
3593946|NCT03364335|3448310|B1|||Weight (kg)||kg|Mean|101.67|101.67|Standard Deviation|13.856|13.856|||
3593947|NCT03364335|3448305|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3593948|NCT03364335|3448306|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593949|NCT03364335|3448307|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593950|NCT03364335|3448308|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593951|NCT03364335|3448309|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593952|NCT03364335|3448310|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3593953|NCT03364335|3448305|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593954|NCT03364335|3448306|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593955|NCT03364335|3448307|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593956|NCT03364335|3448308|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593957|NCT03364335|3448309|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593958|NCT03364335|3448310|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593959|NCT03364335|3448305|B6||White|Race (NIH/OMB)||Participants|Count of Participants|198|198.0||||||
3593960|NCT03364335|3448306|B5||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3593961|NCT03364335|3448307|B4||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3593962|NCT03364335|3448308|B3||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3593963|NCT03364335|3448309|B2||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3593964|NCT03364335|3448310|B1||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3593965|NCT03364335|3448305|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3593966|NCT03364335|3448306|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3593967|NCT03364335|3448307|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3593968|NCT03364335|3448308|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3593969|NCT03364335|3448309|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3593970|NCT03364335|3448310|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3593971|NCT03364335|3448305|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593972|NCT03364335|3448306|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593973|NCT03364335|3448307|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593974|NCT03364335|3448308|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593975|NCT03364335|3448309|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593976|NCT03364335|3448310|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593977|NCT03364335|3448305|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3593978|NCT03364335|3448306|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3593979|NCT03364335|3448307|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3593980|NCT03364335|3448308|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3593981|NCT03364335|3448309|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593982|NCT03364335|3448310|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593983|NCT03364335|3448305|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3593984|NCT03364335|3448306|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593985|NCT03364335|3448307|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593986|NCT03364335|3448308|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593987|NCT03364335|3448309|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593988|NCT03364335|3448310|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3593989|NCT03364335|3448305|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593990|NCT03364335|3448306|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593991|NCT03364335|3448307|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593992|NCT03364335|3448308|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593993|NCT03364335|3448309|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593994|NCT03364335|3448310|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3593995|NCT03364335|3448305|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|198|198.0||||||
3593996|NCT03364335|3448306|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3593997|NCT03364335|3448307|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3593998|NCT03364335|3448308|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3593999|NCT03364335|3448309|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3594000|NCT03364335|3448310|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3594001|NCT03364335|3448305|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3594002|NCT03364335|3448306|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3594003|NCT03364335|3448307|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3594004|NCT03364335|3448308|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3594005|NCT03364335|3448309|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3594006|NCT03364335|3448310|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3594007|NCT03364335|3448305|B6||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3594008|NCT03364335|3448306|B5||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3594009|NCT03364335|3448307|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3594010|NCT03364335|3448308|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3594011|NCT03364335|3448309|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3594012|NCT03364335|3448310|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3594013|NCT03364335|3448305|B6||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
3594014|NCT03364335|3448306|B5||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3594015|NCT03364335|3448307|B4||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3594016|NCT03364335|3448308|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3594017|NCT03364335|3448309|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3594018|NCT03364335|3448310|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3594019|NCT03364335|3448305|B6|||Age||years|Mean|41.20|41.2|Standard Deviation|11.36|11.36|||
3594020|NCT03364335|3448306|B5|||Age||years|Mean|42.89|42.89|Standard Deviation|10.70|10.7|||
3594021|NCT03364335|3448307|B4|||Age||years|Mean|41.36|41.36|Standard Deviation|12.66|12.66|||
3594022|NCT03364335|3448308|B3|||Age||years|Mean|39.55|39.55|Standard Deviation|11.14|11.14|||
3594023|NCT03364335|3448309|B2|||Age||years|Mean|40.94|40.94|Standard Deviation|11.14|11.14|||
3594024|NCT03364335|3448310|B1|||Age||years|Mean|41.29|41.29|Standard Deviation|11.30|11.3|||
3594025|NCT03364335|3448305|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3594026|NCT03364335|3448306|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3594027|NCT03364335|3448307|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3594028|NCT03364335|3448308|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3594029|NCT03364335|3448309|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3594030|NCT03364335|3448310|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3594031|NCT03364335|3448305|B6||Between 18 and 65 years|Age||Participants|Count of Participants|258|258.0||||||
3594032|NCT03364335|3448306|B5||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3594033|NCT03364335|3448307|B4||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3594034|NCT03364335|3448308|B3||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
3594035|NCT03364335|3448309|B2||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3594036|NCT03364335|3448310|B1||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3594037|NCT03364335|3448305|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3594038|NCT03364335|3448306|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3594039|NCT03364335|3448307|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3594040|NCT03364335|3448308|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3594041|NCT03364335|3448309|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3594042|NCT03364335|3448310|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3594043|NCT03350724|3448394|B3|United States||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3594044|NCT03350724|3448395|B2|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3594045|NCT03350724|3448396|B1|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3594046|NCT03350724|3448394|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594047|NCT03350724|3448395|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594048|NCT03350724|3448396|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594049|NCT03350724|3448394|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594050|NCT03350724|3448395|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594051|NCT03350724|3448396|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594052|NCT03350724|3448394|B3||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3594053|NCT03350724|3448395|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3594054|NCT03350724|3448396|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3594055|NCT03350724|3448394|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3594056|NCT03350724|3448395|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3594057|NCT03350724|3448396|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3594058|NCT03350724|3448394|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594059|NCT03350724|3448395|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594060|NCT03350724|3448396|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594061|NCT03350724|3448394|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3594062|NCT03350724|3448395|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594063|NCT03350724|3448396|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3594064|NCT03350724|3448394|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594065|NCT03350724|3448395|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594066|NCT03350724|3448396|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594067|NCT03350724|3448394|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3594068|NCT03350724|3448395|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3594069|NCT03350724|3448396|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3594070|NCT03350724|3448394|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3594071|NCT03350724|3448395|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3594072|NCT03350724|3448396|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3594073|NCT03350724|3448394|B3|||Age||years|Mean|46.8|46.8|Standard Deviation|16.4|16.4|||
3594074|NCT03350724|3448395|B2|||Age||years|Mean|47.1|47.1|Standard Deviation|15.5|15.5|||
3594075|NCT03350724|3448396|B1|||Age||years|Mean|46.5|46.5|Standard Deviation|17.2|17.2|||
3594076|NCT03349099|3448451|B3|United States||Region of Enrollment||participants|Number|95|95.0||||||
3594077|NCT03349099|3448452|B2|United States||Region of Enrollment||participants|Number|47|47.0||||||
3594078|NCT03349099|3448453|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
3594079|NCT03349099|3448451|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3594080|NCT03349099|3448451|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3594081|NCT03349099|3448452|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3594082|NCT03349099|3448453|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3594083|NCT03349099|3448451|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3594084|NCT03349099|3448452|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3594085|NCT03349099|3448453|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3594086|NCT03349099|3448451|B3|||Age||years|Mean|52.1|52.1|Standard Deviation|10|10.0|||
3594087|NCT03349099|3448452|B2|||Age||years|Mean|50.4|50.4|Standard Deviation|11|11.0|||
3594088|NCT03349099|3448453|B1|||Age||years|Mean|53.1|53.1|Standard Deviation|9|9.0|||
3594089|NCT03346902|3448464|B3|||Weight||kg|Mean|82.38|82.38|Standard Deviation|21.055|21.055|||
3594090|NCT03346902|3448465|B2|||Weight||kg|Mean|79.94|79.94|Standard Deviation|19.352|19.352|||
3594091|NCT03346902|3448466|B1|||Weight||kg|Mean|87.28|87.28|Standard Deviation|25.528|25.528|||
3594092|NCT03346902|3448464|B3|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3594093|NCT03346902|3448465|B2|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3594094|NCT03346902|3448466|B1|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3594095|NCT03346902|3448464|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594096|NCT03346902|3448465|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594097|NCT03346902|3448466|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594098|NCT03346902|3448464|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594099|NCT03346902|3448465|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594100|NCT03346902|3448466|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594101|NCT03346902|3448464|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3594102|NCT03346902|3448465|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3594103|NCT03346902|3448466|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3594104|NCT03346902|3448464|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594105|NCT03346902|3448465|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594106|NCT03346902|3448466|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594107|NCT03346902|3448464|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594108|NCT03346902|3448465|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594109|NCT03346902|3448466|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594110|NCT03346902|3448464|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594111|NCT03346902|3448465|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594112|NCT03346902|3448466|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594113|NCT03346902|3448464|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594114|NCT03346902|3448465|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594115|NCT03346902|3448466|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594116|NCT03346902|3448464|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3594117|NCT03346902|3448465|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3594118|NCT03346902|3448466|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3594119|NCT03346902|3448464|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3594120|NCT03346902|3448465|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3594121|NCT03346902|3448466|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3594122|NCT03346902|3448464|B3|||Age||years|Mean|62|62.0|Full Range|||34.0|75.0|
3594123|NCT03346902|3448465|B2|||Age||years|Mean|59|59.0|Full Range|||34.0|72.0|
3594124|NCT03346902|3448466|B1|||Age||years|Mean|67|67.0|Full Range|||60.0|75.0|
3594125|NCT03346759|3448473|B3|||Relative abundance of Gardnerella vaginalis|Relative abundance is defined as the proportion of total identified bacteria in a sample that are a given type of bacteria. Thus, a relative abundance of Gardnerella vaginalis equal to 0.9 would mean that 90% of the bacteria identified in a sample are Gardnerella vaginalis.|relative abundance|Median|.000045|0.000045|Inter-Quartile Range|||0.0|0.000499|
3594126|NCT03346759|3448474|B2|||Relative abundance of Gardnerella vaginalis|Relative abundance is defined as the proportion of total identified bacteria in a sample that are a given type of bacteria. Thus, a relative abundance of Gardnerella vaginalis equal to 0.9 would mean that 90% of the bacteria identified in a sample are Gardnerella vaginalis.|relative abundance|Median|.000019|0.000019|Inter-Quartile Range|||0.0|0.000136|
3594127|NCT03346759|3448475|B1|||Relative abundance of Gardnerella vaginalis|Relative abundance is defined as the proportion of total identified bacteria in a sample that are a given type of bacteria. Thus, a relative abundance of Gardnerella vaginalis equal to 0.9 would mean that 90% of the bacteria identified in a sample are Gardnerella vaginalis.|relative abundance|Median|.000091|0.000091|Inter-Quartile Range|||0.0|0.000094|
3594128|NCT03346759|3448473|B3|||Relative abundance of Lactobacillus species|Relative abundance is defined as the proportion of total identified bacteria in a sample that are a given type of bacteria. The Lactobacillus species included here are L. crispatus, L. iners, L. gasseri, and L. jensenii. Thus, a relative abundance of Lactobacillus species equal to 0.9 would mean that 90% of the bacteria identified in a sample are Lactobacillus species.|relative abundance|Median|.9705|0.9705|Inter-Quartile Range|||0.9301|0.9894|
3594129|NCT03346759|3448474|B2|||Relative abundance of Lactobacillus species|Relative abundance is defined as the proportion of total identified bacteria in a sample that are a given type of bacteria. The Lactobacillus species included here are L. crispatus, L. iners, L. gasseri, and L. jensenii. Thus, a relative abundance of Lactobacillus species equal to 0.9 would mean that 90% of the bacteria identified in a sample are Lactobacillus species.|relative abundance|Median|.9727|0.9727|Inter-Quartile Range|||0.9521|0.9877|
3594130|NCT03346759|3448475|B1|||Relative abundance of Lactobacillus species|Relative abundance is defined as the proportion of total identified bacteria in a sample that are a given type of bacteria. The Lactobacillus species included here are L. crispatus, L. iners, L. gasseri, and L. jensenii. Thus, a relative abundance of Lactobacillus species equal to 0.9 would mean that 90% of the bacteria identified in a sample are Lactobacillus species.|relative abundance|Median|.9667|0.9667|Inter-Quartile Range|||0.9192|0.9898|
3594131|NCT03346759|3448473|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3594132|NCT03346759|3448474|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3594133|NCT03346759|3448475|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3594134|NCT03346759|3448473|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3594135|NCT03346759|3448474|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3594136|NCT03346759|3448475|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3594137|NCT03346759|3448473|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3594138|NCT03346759|3448474|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3594139|NCT03346759|3448475|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3594140|NCT03346759|3448473|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3594370|NCT03295201|3448625|B2|Turkey||Region of Enrollment||participants|Number|9|9.0||||||
3594141|NCT03346759|3448474|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3594142|NCT03346759|3448475|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3594143|NCT03346759|3448473|B3|Non-Hispanic white||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3594144|NCT03346759|3448474|B2|Non-Hispanic white||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3594145|NCT03346759|3448475|B1|Non-Hispanic white||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3594146|NCT03346759|3448473|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3594147|NCT03346759|3448474|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3594148|NCT03346759|3448475|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3594149|NCT03346759|3448473|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3594150|NCT03346759|3448474|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3594151|NCT03346759|3448475|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3594152|NCT03346759|3448473|B3|||Age||years|Mean|26.1|26.1|Standard Deviation|4.9|4.9|||
3594153|NCT03346759|3448474|B2|||Age||years|Mean|24.3|24.3|Standard Deviation|4.0|4.0|||
3594154|NCT03346759|3448475|B1|||Age||years|Mean|27.6|27.6|Standard Deviation|5.0|5.0|||
3594155|NCT03338556|3448485|B5|United Kingdom||Region of Enrollment||participants|Number|102|102.0||||||
3594156|NCT03338556|3448486|B4|United Kingdom||Region of Enrollment||participants|Number|26|26.0||||||
3594157|NCT03338556|3448487|B3|United Kingdom||Region of Enrollment||participants|Number|24|24.0||||||
3594158|NCT03338556|3448488|B2|United Kingdom||Region of Enrollment||participants|Number|27|27.0||||||
3594159|NCT03338556|3448489|B1|United Kingdom||Region of Enrollment||participants|Number|25|25.0||||||
3594160|NCT03338556|3448485|B5||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3594161|NCT03338556|3448486|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3594162|NCT03338556|3448487|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3594163|NCT03338556|3448488|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3594164|NCT03338556|3448489|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3594165|NCT03338556|3448485|B5||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3594166|NCT03338556|3448486|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3594167|NCT03338556|3448487|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3594168|NCT03338556|3448488|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3594169|NCT03338556|3448489|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3594170|NCT03338556|3448485|B5|||Age||years|Mean|23.3|23.3|Standard Deviation|5.84|5.84|||
3594171|NCT03338556|3448486|B4|||Age||years|Mean|22.2|22.2|Standard Deviation|3.58|3.58|||
3594172|NCT03338556|3448487|B3|||Age||years|Mean|21.7|21.7|Standard Deviation|2.93|2.93|||
3594173|NCT03338556|3448488|B2|||Age||years|Mean|24.9|24.9|Standard Deviation|8.30|8.3|||
3594174|NCT03338556|3448489|B1|||Age||years|Mean|24.3|24.3|Standard Deviation|6.26|6.26|||
3594175|NCT03338556|3448485|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3594176|NCT03338556|3448486|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3594177|NCT03338556|3448487|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3594178|NCT03338556|3448488|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3594179|NCT03338556|3448489|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3594180|NCT03338556|3448485|B5||Between 18 and 65 years|Age||Participants|Count of Participants|102|102.0||||||
3594181|NCT03338556|3448486|B4||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3594182|NCT03338556|3448487|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3594183|NCT03338556|3448488|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3594184|NCT03338556|3448489|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3594185|NCT03338556|3448485|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3594186|NCT03338556|3448486|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3594187|NCT03338556|3448487|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3594188|NCT03338556|3448488|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3594189|NCT03338556|3448489|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3594190|NCT03335566|3448510|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594191|NCT03335566|3448511|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594192|NCT03335566|3448512|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594193|NCT03335566|3448510|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594194|NCT03335566|3448511|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594195|NCT03335566|3448512|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594196|NCT03335566|3448510|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594197|NCT03335566|3448511|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594198|NCT03335566|3448512|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594199|NCT03335566|3448510|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594200|NCT03335566|3448511|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594201|NCT03335566|3448512|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594202|NCT03335566|3448510|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594203|NCT03335566|3448511|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594204|NCT03335566|3448512|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594205|NCT03335566|3448510|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|424|424.0||||||
3594206|NCT03335566|3448511|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|206|206.0||||||
3594207|NCT03335566|3448512|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|218|218.0||||||
3594208|NCT03335566|3448510|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594209|NCT03335566|3448511|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594210|NCT03335566|3448512|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594211|NCT03335566|3448510|B3||Male|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
3594212|NCT03335566|3448511|B2||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3594213|NCT03335566|3448512|B1||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3594214|NCT03335566|3448510|B3||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3594215|NCT03335566|3448511|B2||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3594216|NCT03335566|3448512|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3594217|NCT03335566|3448510|B3|||Age||years|Mean|53.4|53.4|Standard Deviation|13.22|13.22|||
3594218|NCT03335566|3448511|B2|||Age||years|Mean|52.2|52.2|Standard Deviation|13.77|13.77|||
3594219|NCT03335566|3448512|B1|||Age||years|Mean|54.5|54.5|Standard Deviation|12.61|12.61|||
3594220|NCT03331315|3448525|B3||Genetic Predisposition to Malignancy|Preoperative Diagnosis||Participants|Count of Participants|7|7.0||||||
3594221|NCT03331315|3448526|B2||Genetic Predisposition to Malignancy|Preoperative Diagnosis||Participants|Count of Participants|4|4.0||||||
3594222|NCT03331315|3448527|B1||Genetic Predisposition to Malignancy|Preoperative Diagnosis||Participants|Count of Participants|3|3.0||||||
3594223|NCT03331315|3448525|B3||Adnexal Mass|Preoperative Diagnosis||Participants|Count of Participants|24|24.0||||||
3594224|NCT03331315|3448526|B2||Adnexal Mass|Preoperative Diagnosis||Participants|Count of Participants|14|14.0||||||
3594225|NCT03331315|3448527|B1||Adnexal Mass|Preoperative Diagnosis||Participants|Count of Participants|10|10.0||||||
3594226|NCT03331315|3448525|B3||Abnormal Uterine Bleeding|Preoperative Diagnosis||Participants|Count of Participants|11|11.0||||||
3594227|NCT03331315|3448526|B2||Abnormal Uterine Bleeding|Preoperative Diagnosis||Participants|Count of Participants|8|8.0||||||
3594228|NCT03331315|3448527|B1||Abnormal Uterine Bleeding|Preoperative Diagnosis||Participants|Count of Participants|3|3.0||||||
3594229|NCT03331315|3448525|B3||Pelvic Pain|Preoperative Diagnosis||Participants|Count of Participants|19|19.0||||||
3594230|NCT03331315|3448526|B2||Pelvic Pain|Preoperative Diagnosis||Participants|Count of Participants|8|8.0||||||
3594231|NCT03331315|3448527|B1||Pelvic Pain|Preoperative Diagnosis||Participants|Count of Participants|11|11.0||||||
3594232|NCT03331315|3448525|B3||Leiomyoma|Preoperative Diagnosis||Participants|Count of Participants|12|12.0||||||
3594233|NCT03331315|3448526|B2||Leiomyoma|Preoperative Diagnosis||Participants|Count of Participants|4|4.0||||||
3594234|NCT03331315|3448527|B1||Leiomyoma|Preoperative Diagnosis||Participants|Count of Participants|8|8.0||||||
3594235|NCT03331315|3448525|B3||Premalignancy|Preoperative Diagnosis||Participants|Count of Participants|29|29.0||||||
3594236|NCT03331315|3448526|B2||Premalignancy|Preoperative Diagnosis||Participants|Count of Participants|15|15.0||||||
3594237|NCT03331315|3448527|B1||Premalignancy|Preoperative Diagnosis||Participants|Count of Participants|14|14.0||||||
3594238|NCT03331315|3448525|B3||Malignancy|Preoperative Diagnosis||Participants|Count of Participants|36|36.0||||||
3594239|NCT03331315|3448526|B2||Malignancy|Preoperative Diagnosis||Participants|Count of Participants|15|15.0||||||
3594240|NCT03331315|3448527|B1||Malignancy|Preoperative Diagnosis||Participants|Count of Participants|21|21.0||||||
3594241|NCT03331315|3448525|B3|||Trochar Sites||Trochars|Mean|4.2|4.2|Standard Deviation|0.5|0.5|||
3594242|NCT03331315|3448526|B2|||Trochar Sites||Trochars|Mean|4.2|4.2|Standard Deviation|0.4|0.4|||
3594243|NCT03331315|3448527|B1|||Trochar Sites||Trochars|Mean|4.3|4.3|Standard Deviation|0.5|0.5|||
3594244|NCT03331315|3448525|B3|||Operative Time||Minutes|Mean|104|104.0|Standard Deviation|33|33.0|||
3594245|NCT03331315|3448526|B2|||Operative Time||Minutes|Mean|104|104.0|Standard Deviation|34|34.0|||
3594246|NCT03331315|3448527|B1|||Operative Time||Minutes|Mean|105|105.0|Standard Deviation|32|32.0|||
3594247|NCT03331315|3448525|B3||Robotic Assisted Hysterectomy, +/- BSO, LND, Cysto|Procedure|BSO - bilateral salpingo-oophorectomy LND - Lymph Node Dissection Cysto - diagnostic cystoscopy|Participants|Count of Participants|37|37.0||||||
3594248|NCT03331315|3448526|B2||Robotic Assisted Hysterectomy, +/- BSO, LND, Cysto|Procedure|BSO - bilateral salpingo-oophorectomy LND - Lymph Node Dissection Cysto - diagnostic cystoscopy|Participants|Count of Participants|15|15.0||||||
3594249|NCT03331315|3448527|B1||Robotic Assisted Hysterectomy, +/- BSO, LND, Cysto|Procedure|BSO - bilateral salpingo-oophorectomy LND - Lymph Node Dissection Cysto - diagnostic cystoscopy|Participants|Count of Participants|22|22.0||||||
3594250|NCT03331315|3448525|B3||Robotic Assisted Hysterectomy, +/- BSO, Cysto|Procedure|BSO - bilateral salpingo-oophorectomy LND - Lymph Node Dissection Cysto - diagnostic cystoscopy|Participants|Count of Participants|101|101.0||||||
3594251|NCT03331315|3448526|B2||Robotic Assisted Hysterectomy, +/- BSO, Cysto|Procedure|BSO - bilateral salpingo-oophorectomy LND - Lymph Node Dissection Cysto - diagnostic cystoscopy|Participants|Count of Participants|53|53.0||||||
3594252|NCT03331315|3448527|B1||Robotic Assisted Hysterectomy, +/- BSO, Cysto|Procedure|BSO - bilateral salpingo-oophorectomy LND - Lymph Node Dissection Cysto - diagnostic cystoscopy|Participants|Count of Participants|48|48.0||||||
3594253|NCT03331315|3448525|B3||Malignant|Surgical Pathology||Participants|Count of Participants|37|37.0||||||
3594254|NCT03331315|3448526|B2||Malignant|Surgical Pathology||Participants|Count of Participants|15|15.0||||||
3594255|NCT03331315|3448527|B1||Malignant|Surgical Pathology||Participants|Count of Participants|22|22.0||||||
3594256|NCT03331315|3448525|B3||Benign|Surgical Pathology||Participants|Count of Participants|101|101.0||||||
3594257|NCT03331315|3448526|B2||Benign|Surgical Pathology||Participants|Count of Participants|53|53.0||||||
3594258|NCT03331315|3448527|B1||Benign|Surgical Pathology||Participants|Count of Participants|48|48.0||||||
3594259|NCT03331315|3448525|B3|||Body Mass Index||Kg/m^2|Mean|31.7|31.7|Standard Deviation|8.3|8.3|||
3594260|NCT03331315|3448526|B2|||Body Mass Index||Kg/m^2|Mean|31.7|31.7|Standard Deviation|8.1|8.1|||
3594261|NCT03331315|3448527|B1|||Body Mass Index||Kg/m^2|Mean|31.8|31.8|Standard Deviation|8.6|8.6|||
3594262|NCT03331315|3448525|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3594263|NCT03331315|3448526|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3594264|NCT03331315|3448527|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3594265|NCT03331315|3448525|B3||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3594266|NCT03331315|3448526|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3594267|NCT03331315|3448527|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3594268|NCT03331315|3448525|B3|||Age||years|Mean|55.7|55.7|Standard Deviation|12.0|12.0|||
3594269|NCT03331315|3448526|B2|||Age||years|Mean|55.1|55.1|Standard Deviation|14.4|14.4|||
3594270|NCT03331315|3448527|B1|||Age||years|Mean|56.3|56.3|Standard Deviation|11.3|11.3|||
3594271|NCT03330275|3448548|B1|Australia||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3594272|NCT03330275|3448548|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3594273|NCT03330275|3448548|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3594274|NCT03330275|3448548|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3594275|NCT03330275|3448548|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3594276|NCT03330275|3448548|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3594277|NCT03330275|3448548|B1|||Age||Years|Mean|29.8|29.8|Standard Deviation|7.71|7.71|||
3594278|NCT03317431|3448583|B1|China||Region of Enrollment||participants|Number|46|46.0||||||
3594279|NCT03317431|3448583|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594280|NCT03317431|3448583|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594281|NCT03317431|3448583|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594282|NCT03317431|3448583|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594283|NCT03317431|3448583|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594284|NCT03317431|3448583|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3594285|NCT03317431|3448583|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594286|NCT03317431|3448583|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3594287|NCT03317431|3448583|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3594288|NCT03317431|3448583|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3594289|NCT03317431|3448583|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
3594290|NCT03317431|3448583|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3594291|NCT03308825|3448591|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594292|NCT03308825|3448592|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594293|NCT03308825|3448593|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594294|NCT03308825|3448594|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594295|NCT03308825|3448595|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594296|NCT03308825|3448591|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3594297|NCT03308825|3448592|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3594298|NCT03308825|3448593|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3594299|NCT03308825|3448594|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3594300|NCT03308825|3448595|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3594301|NCT03308825|3448591|B5||White|Race (NIH/OMB)||Participants|Count of Participants|150|150.0||||||
3594302|NCT03308825|3448592|B4||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3594303|NCT03308825|3448593|B3||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3594304|NCT03308825|3448594|B2||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3594305|NCT03308825|3448595|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3594306|NCT03308825|3448591|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3594307|NCT03308825|3448592|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3594308|NCT03308825|3448593|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3594309|NCT03308825|3448594|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3594310|NCT03308825|3448595|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3594311|NCT03308825|3448591|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594312|NCT03308825|3448592|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594313|NCT03308825|3448593|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594314|NCT03308825|3448594|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594315|NCT03308825|3448595|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594316|NCT03308825|3448591|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3594317|NCT03308825|3448592|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3594318|NCT03308825|3448593|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594319|NCT03308825|3448594|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594320|NCT03308825|3448595|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594321|NCT03308825|3448591|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594322|NCT03308825|3448592|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594323|NCT03308825|3448593|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594324|NCT03308825|3448594|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594325|NCT03308825|3448595|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594326|NCT03308825|3448591|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594327|NCT03308825|3448592|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594328|NCT03308825|3448593|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594329|NCT03308825|3448594|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594330|NCT03308825|3448595|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594331|NCT03308825|3448591|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|230|230.0||||||
3594332|NCT03308825|3448592|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3594333|NCT03308825|3448593|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3594334|NCT03308825|3448594|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3594335|NCT03308825|3448595|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3594336|NCT03308825|3448591|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3594337|NCT03308825|3448592|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3594338|NCT03308825|3448593|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594339|NCT03308825|3448594|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3594340|NCT03308825|3448595|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3594341|NCT03308825|3448591|B5||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3594342|NCT03308825|3448592|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3594343|NCT03308825|3448593|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3594344|NCT03308825|3448594|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3594345|NCT03308825|3448595|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3594346|NCT03308825|3448591|B5||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3594347|NCT03308825|3448592|B4||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3594348|NCT03308825|3448593|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3594349|NCT03308825|3448594|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3594350|NCT03308825|3448595|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3594351|NCT03308825|3448591|B5||>=65 years|Age||Participants|Count of Participants|60|60.0||||||
3594352|NCT03308825|3448592|B4||>=65 years|Age||Participants|Count of Participants|60|60.0||||||
3594353|NCT03308825|3448593|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3594354|NCT03308825|3448594|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3594355|NCT03308825|3448595|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3594356|NCT03308825|3448591|B5||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
3594357|NCT03308825|3448592|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3594358|NCT03308825|3448593|B3||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
3594359|NCT03308825|3448594|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3594360|NCT03308825|3448595|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3594361|NCT03308825|3448591|B5||<=18 years|Age||Participants|Count of Participants|121|121.0||||||
3594362|NCT03308825|3448592|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3594363|NCT03308825|3448593|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3594364|NCT03308825|3448594|B2||<=18 years|Age||Participants|Count of Participants|61|61.0||||||
3594365|NCT03308825|3448595|B1||<=18 years|Age||Participants|Count of Participants|59|59.0||||||
3594366|NCT03295201|3448624|B3|||Body Mass Index||kg/m^2|Mean|16|16.0|Standard Deviation|2|2.0|||
3594367|NCT03295201|3448625|B2|||Body Mass Index||kg/m^2|Mean|16|16.0|Standard Deviation|2|2.0|||
3594368|NCT03295201|3448626|B1|||Body Mass Index||kg/m^2|Mean|16|16.0|Standard Deviation|2|2.0|||
3594369|NCT03295201|3448624|B3|Turkey||Region of Enrollment||participants|Number|19|19.0||||||
3594371|NCT03295201|3448626|B1|Turkey||Region of Enrollment||participants|Number|10|10.0||||||
3594372|NCT03295201|3448624|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3594373|NCT03295201|3448624|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3594374|NCT03295201|3448625|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3594375|NCT03295201|3448626|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3594376|NCT03295201|3448624|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3594377|NCT03295201|3448625|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3594378|NCT03295201|3448626|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3594379|NCT03295201|3448624|B3|||Age||years|Mean|9|9.0|Standard Deviation|2|2.0|||
3594380|NCT03295201|3448625|B2|||Age||years|Mean|10|10.0|Standard Deviation|3|3.0|||
3594381|NCT03295201|3448626|B1|||Age||years|Mean|9|9.0|Standard Deviation|2|2.0|||
3594382|NCT03294629|3448679|B3|||Nasal Obstruction Symptom Evaluation (NOSE)|The Nasal Obstruction Symptom Evaluation (NOSE) is a self-administered questionnaire with 11 questions. The NOSE score can range from 0 to 44, where higher scores denote a worse nasal obstruction.|units on a scale|Mean|14.6|14.6|Standard Deviation|7.6|7.6|||
3594383|NCT03294629|3448680|B2|||Nasal Obstruction Symptom Evaluation (NOSE)|The Nasal Obstruction Symptom Evaluation (NOSE) is a self-administered questionnaire with 11 questions. The NOSE score can range from 0 to 44, where higher scores denote a worse nasal obstruction.|units on a scale|Mean|15.6|15.6|Standard Deviation|8.4|8.4|||
3594384|NCT03294629|3448681|B1|||Nasal Obstruction Symptom Evaluation (NOSE)|The Nasal Obstruction Symptom Evaluation (NOSE) is a self-administered questionnaire with 11 questions. The NOSE score can range from 0 to 44, where higher scores denote a worse nasal obstruction.|units on a scale|Mean|13.5|13.5|Standard Deviation|6.8|6.8|||
3594385|NCT03294629|3448679|B3|||Epworth Sleepiness Scale (ESS)|The ESS is a self-administered questionnaire with 8 questions. The ESS score can range from 0 to 24, where higher scores denote a worse daytime sleepiness.|units on a scale|Mean|13.2|13.2|Standard Deviation|6.0|6.0|||
3594386|NCT03294629|3448680|B2|||Epworth Sleepiness Scale (ESS)|The ESS is a self-administered questionnaire with 8 questions. The ESS score can range from 0 to 24, where higher scores denote a worse daytime sleepiness.|units on a scale|Mean|13.1|13.1|Standard Deviation|6.7|6.7|||
3594387|NCT03294629|3448681|B1|||Epworth Sleepiness Scale (ESS)|The ESS is a self-administered questionnaire with 8 questions. The ESS score can range from 0 to 24, where higher scores denote a worse daytime sleepiness.|units on a scale|Mean|13.3|13.3|Standard Deviation|5.5|5.5|||
3594388|NCT03294629|3448679|B3|||Pittsburgh Sleep Quality Index (PSQI)|The Pittsburgh Sleep Quality Index (PSQI) is a self-report questionnaire that assesses sleep quality over a 1-month time interval. Overall score is ranging from 0 to 21, where lower scores denote a healthier sleep quality.|units on a scale|Mean|8.8|8.8|Standard Deviation|3.4|3.4|||
3594389|NCT03294629|3448680|B2|||Pittsburgh Sleep Quality Index (PSQI)|The Pittsburgh Sleep Quality Index (PSQI) is a self-report questionnaire that assesses sleep quality over a 1-month time interval. Overall score is ranging from 0 to 21, where lower scores denote a healthier sleep quality.|units on a scale|Mean|10.1|10.1|Standard Deviation|3.8|3.8|||
3594390|NCT03294629|3448681|B1|||Pittsburgh Sleep Quality Index (PSQI)|The Pittsburgh Sleep Quality Index (PSQI) is a self-report questionnaire that assesses sleep quality over a 1-month time interval. Overall score is ranging from 0 to 21, where lower scores denote a healthier sleep quality.|units on a scale|Mean|7.4|7.4|Standard Deviation|2.3|2.3|||
3594391|NCT03294629|3448679|B3|||Residual AHI under CPAP Tx|Apnea-hypopnea index (AHI) is an index used to indicate the severity of sleep apnea. It is represented by the number of apnea and hypopnea events per hour of sleep. Residual AHI is recorded by CPAP device.|events per hour|Mean|3.7|3.7|Standard Deviation|2.3|2.3|||
3594392|NCT03294629|3448680|B2|||Residual AHI under CPAP Tx|Apnea-hypopnea index (AHI) is an index used to indicate the severity of sleep apnea. It is represented by the number of apnea and hypopnea events per hour of sleep. Residual AHI is recorded by CPAP device.|events per hour|Mean|4.4|4.4|Standard Deviation|2.8|2.8|||
3594393|NCT03294629|3448681|B1|||Residual AHI under CPAP Tx|Apnea-hypopnea index (AHI) is an index used to indicate the severity of sleep apnea. It is represented by the number of apnea and hypopnea events per hour of sleep. Residual AHI is recorded by CPAP device.|events per hour|Mean|2.9|2.9|Standard Deviation|1.3|1.3|||
3594394|NCT03294629|3448679|B3|||Compliance of CPAP|CPAP compliance is defined as using the therapy for more than 4 hours a night of all the nights.|%|Mean|39.3|39.3|Standard Deviation|31.4|31.4|||
3594395|NCT03294629|3448680|B2|||Compliance of CPAP|CPAP compliance is defined as using the therapy for more than 4 hours a night of all the nights.|%|Mean|46.2|46.2|Standard Deviation|30.6|30.6|||
3594396|NCT03294629|3448681|B1|||Compliance of CPAP|CPAP compliance is defined as using the therapy for more than 4 hours a night of all the nights.|%|Mean|31.9|31.9|Standard Deviation|31.9|31.9|||
3594397|NCT03294629|3448679|B3|||Average used time of CPAP||minutes|Mean|208.5|208.5|Standard Deviation|104.2|104.2|||
3594398|NCT03294629|3448680|B2|||Average used time of CPAP||minutes|Mean|227.9|227.9|Standard Deviation|104.1|104.1|||
3594399|NCT03294629|3448681|B1|||Average used time of CPAP||minutes|Mean|187.4|187.4|Standard Deviation|104.6|104.6|||
3594400|NCT03294629|3448679|B3|||Deep sleep - Stage 3|Deep sleep is presented by percentage of minutes of stage 3 divided by the minutes of all sleep time.|% (percentage of minutes of stage 3)|Mean|5.2|5.2|Standard Deviation|8.0|8.0|||
3594401|NCT03294629|3448680|B2|||Deep sleep - Stage 3|Deep sleep is presented by percentage of minutes of stage 3 divided by the minutes of all sleep time.|% (percentage of minutes of stage 3)|Mean|4.4|4.4|Standard Deviation|5.6|5.6|||
3594402|NCT03294629|3448681|B1|||Deep sleep - Stage 3|Deep sleep is presented by percentage of minutes of stage 3 divided by the minutes of all sleep time.|% (percentage of minutes of stage 3)|Mean|6.1|6.1|Standard Deviation|10.4|10.4|||
3594403|NCT03294629|3448679|B3|||Total sleep time||minutes|Mean|287.6|287.6|Standard Deviation|62.8|62.8|||
3594404|NCT03294629|3448680|B2|||Total sleep time||minutes|Mean|276.2|276.2|Standard Deviation|79.2|79.2|||
3594405|NCT03294629|3448681|B1|||Total sleep time||minutes|Mean|301.0|301.0|Standard Deviation|34.2|34.2|||
3594406|NCT03294629|3448679|B3|||Sleep efficiency|Sleep efficiency is presented by percentage of minutes of sleep divided by the minutes in bed.|% (percentage of minutes slept)|Mean|77.1|77.1|Standard Deviation|17.1|17.1|||
3594407|NCT03294629|3448680|B2|||Sleep efficiency|Sleep efficiency is presented by percentage of minutes of sleep divided by the minutes in bed.|% (percentage of minutes slept)|Mean|73.0|73.0|Standard Deviation|21.3|21.3|||
3594408|NCT03294629|3448681|B1|||Sleep efficiency|Sleep efficiency is presented by percentage of minutes of sleep divided by the minutes in bed.|% (percentage of minutes slept)|Mean|82.0|82.0|Standard Deviation|8.9|8.9|||
3594409|NCT03294629|3448679|B3|||Apnea-hypopnea index (AHI)|Apnea-hypopnea index is an index used to indicate the severity of sleep apnea. It is represented by the number of apnea and hypopnea events per hour of sleep that recorded in polysomnography.|events per hour|Mean|54.6|54.6|Standard Deviation|32.5|32.5|||
3594410|NCT03294629|3448680|B2|||Apnea-hypopnea index (AHI)|Apnea-hypopnea index is an index used to indicate the severity of sleep apnea. It is represented by the number of apnea and hypopnea events per hour of sleep that recorded in polysomnography.|events per hour|Mean|54.0|54.0|Standard Deviation|35.3|35.3|||
3594411|NCT03294629|3448681|B1|||Apnea-hypopnea index (AHI)|Apnea-hypopnea index is an index used to indicate the severity of sleep apnea. It is represented by the number of apnea and hypopnea events per hour of sleep that recorded in polysomnography.|events per hour|Mean|55.3|55.3|Standard Deviation|30.8|30.8|||
3594412|NCT03294629|3448679|B3|||Neck Circumference (NC)||cm|Mean|41.6|41.6|Standard Deviation|2.2|2.2|||
3594413|NCT03294629|3448680|B2|||Neck Circumference (NC)||cm|Mean|41.0|41.0|Standard Deviation|2.2|2.2|||
3594414|NCT03294629|3448681|B1|||Neck Circumference (NC)||cm|Mean|42.3|42.3|Standard Deviation|2.1|2.1|||
3594415|NCT03294629|3448679|B3|||Body Mass Index (BMI)||kg/m2|Mean|32.4|32.4|Standard Deviation|5.7|5.7|||
3594416|NCT03294629|3448680|B2|||Body Mass Index (BMI)||kg/m2|Mean|32.9|32.9|Standard Deviation|6.9|6.9|||
3594417|NCT03294629|3448681|B1|||Body Mass Index (BMI)||kg/m2|Mean|31.8|31.8|Standard Deviation|4.3|4.3|||
3594418|NCT03294629|3448679|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3594419|NCT03294629|3448680|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3594420|NCT03294629|3448681|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3594421|NCT03294629|3448679|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3594422|NCT03294629|3448680|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3594423|NCT03294629|3448681|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3594424|NCT03294629|3448679|B3|||Age||years|Mean|44.0|44.0|Standard Deviation|11.7|11.7|||
3594425|NCT03294629|3448680|B2|||Age||years|Mean|41.5|41.5|Standard Deviation|12.0|12.0|||
3594426|NCT03294629|3448681|B1|||Age||years|Mean|47.6|47.6|Standard Deviation|10.9|10.9|||
3594427|NCT03292692|3448710|B3|United States||Region of Enrollment||Participants|Count of Participants|600|600.0||||||
3594428|NCT03292692|3448711|B2|United States||Region of Enrollment||Participants|Count of Participants|298|298.0||||||
3594429|NCT03292692|3448712|B1|United States||Region of Enrollment||Participants|Count of Participants|302|302.0||||||
3594430|NCT03292692|3448710|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594431|NCT03292692|3448711|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594432|NCT03292692|3448712|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594433|NCT03292692|3448710|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3594434|NCT03292692|3448711|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3594435|NCT03292692|3448712|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3594436|NCT03292692|3448710|B3||White|Race (NIH/OMB)||Participants|Count of Participants|421|421.0||||||
3594437|NCT03292692|3448711|B2||White|Race (NIH/OMB)||Participants|Count of Participants|212|212.0||||||
3594438|NCT03292692|3448712|B1||White|Race (NIH/OMB)||Participants|Count of Participants|209|209.0||||||
3594439|NCT03292692|3448710|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
3594440|NCT03292692|3448711|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3594441|NCT03292692|3448712|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3594442|NCT03292692|3448710|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3594443|NCT03292692|3448711|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3594444|NCT03292692|3448712|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3594445|NCT03292692|3448710|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3594446|NCT03292692|3448711|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3594447|NCT03292692|3448712|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3594448|NCT03292692|3448710|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3594449|NCT03292692|3448711|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3594450|NCT03292692|3448712|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3594451|NCT03292692|3448710|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594452|NCT03292692|3448711|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594453|NCT03292692|3448712|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594454|NCT03292692|3448710|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|541|541.0||||||
3594455|NCT03292692|3448711|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|269|269.0||||||
3594456|NCT03292692|3448712|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|272|272.0||||||
3594457|NCT03292692|3448710|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3594458|NCT03292692|3448711|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3594459|NCT03292692|3448712|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3594460|NCT03292692|3448710|B3||Male|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
3594461|NCT03292692|3448711|B2||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3594462|NCT03292692|3448712|B1||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3594463|NCT03292692|3448710|B3||Female|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
3594464|NCT03292692|3448711|B2||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3594465|NCT03292692|3448712|B1||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3594466|NCT03292692|3448710|B3|||Age||years|Mean|36.11|36.11|Standard Deviation|9.58|9.58|||
3594467|NCT03292692|3448711|B2|||Age||years|Mean|36.22|36.22|Standard Deviation|9.62|9.62|||
3594468|NCT03292692|3448712|B1|||Age||years|Mean|36.01|36.01|Standard Deviation|9.54|9.54|||
3594469|NCT03285984|3448725|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594470|NCT03285984|3448725|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594471|NCT03285984|3448725|B1||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3594472|NCT03285984|3448725|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3594473|NCT03285984|3448725|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594474|NCT03285984|3448725|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594475|NCT03285984|3448725|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594476|NCT03285984|3448725|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3594477|NCT03285984|3448725|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3594478|NCT03285984|3448725|B1|||Age||Years|Mean|44.1|44.1|Standard Deviation|11.87|11.87|||
3594479|NCT03279458|3448737|B1|||Number of participants||Participants|Count of Participants|40|40.0||||||
3594480|NCT03279458|3448737|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3594481|NCT03279458|3448737|B1|>= 18 years||Age, Customized||Participants|Count of Participants|40|40.0||||||
3594482|NCT03274453|3448743|B5|Sex|Female|Sex/Gender, Customized||Participants|Count of Participants|58|58.0||||||
3594483|NCT03274453|3448744|B4|Sex|Female|Sex/Gender, Customized||Participants|Count of Participants|12|12.0||||||
3594484|NCT03274453|3448745|B3|Sex|Female|Sex/Gender, Customized||Participants|Count of Participants|14|14.0||||||
3594485|NCT03274453|3448746|B2|Sex|Female|Sex/Gender, Customized||Participants|Count of Participants|13|13.0||||||
3594486|NCT03274453|3448747|B1|Sex|Female|Sex/Gender, Customized||Participants|Count of Participants|19|19.0||||||
3594487|NCT03274453|3448743|B5|Sex|Male|Sex/Gender, Customized||Participants|Count of Participants|53|53.0||||||
3594488|NCT03274453|3448744|B4|Sex|Male|Sex/Gender, Customized||Participants|Count of Participants|13|13.0||||||
3594489|NCT03274453|3448745|B3|Sex|Male|Sex/Gender, Customized||Participants|Count of Participants|14|14.0||||||
3594490|NCT03274453|3448746|B2|Sex|Male|Sex/Gender, Customized||Participants|Count of Participants|11|11.0||||||
3594491|NCT03274453|3448747|B1|Sex|Male|Sex/Gender, Customized||Participants|Count of Participants|15|15.0||||||
3594492|NCT03274453|3448743|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3594493|NCT03274453|3448744|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3594494|NCT03274453|3448745|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3594495|NCT03274453|3448746|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3594496|NCT03274453|3448747|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3594497|NCT03274453|3448743|B5||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
3594498|NCT03274453|3448744|B4||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3594499|NCT03274453|3448745|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3594500|NCT03274453|3448746|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3594501|NCT03274453|3448747|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3594502|NCT03274453|3448743|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3594503|NCT03274453|3448744|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3594504|NCT03274453|3448745|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3594505|NCT03274453|3448746|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3594506|NCT03274453|3448747|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3594507|NCT03271424|3448760|B4|South Africa||Region of Enrollment||Participants|Count of Participants|95|95.0||||||
3594508|NCT03271424|3448761|B3|South Africa||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3594509|NCT03271424|3448762|B2|South Africa||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3594510|NCT03271424|3448763|B1|South Africa||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3594511|NCT03271424|3448760|B4||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3594512|NCT03271424|3448761|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3594513|NCT03271424|3448762|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3594514|NCT03271424|3448763|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3594515|NCT03271424|3448760|B4||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3594516|NCT03271424|3448761|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3594517|NCT03271424|3448762|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3594518|NCT03271424|3448763|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3594519|NCT03271424|3448760|B4|||Age||years|Mean|20|20.0|Full Range|||18.0|24.0|
3594520|NCT03271424|3448761|B3|||Age||years|Mean|20|20.0|Full Range|||18.0|24.0|
3594521|NCT03271424|3448762|B2|||Age||years|Mean|20|20.0|Full Range|||18.0|24.0|
3594522|NCT03271424|3448763|B1|||Age||years|Mean|20|20.0|Full Range|||18.0|24.0|
3594523|NCT03271424|3448760|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3594524|NCT03271424|3448761|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3594525|NCT03271424|3448762|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3594526|NCT03271424|3448763|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3594527|NCT03271424|3448760|B4||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
3594528|NCT03271424|3448761|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3594529|NCT03271424|3448762|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3594530|NCT03271424|3448763|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3594531|NCT03271424|3448760|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3594532|NCT03271424|3448761|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3594533|NCT03271424|3448762|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3594534|NCT03271424|3448763|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3594535|NCT03263806|3448775|B3|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3594536|NCT03263806|3448776|B2|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3594537|NCT03263806|3448777|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3594538|NCT03263806|3448775|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3594539|NCT03263806|3448775|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3594540|NCT03263806|3448776|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3594541|NCT03263806|3448777|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3594542|NCT03263806|3448775|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3594543|NCT03263806|3448776|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3594544|NCT03263806|3448777|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3594545|NCT03263806|3448775|B3|||Age||years|Median|57|57.0|Full Range|||43.0|76.0|
3594546|NCT03263806|3448776|B2|||Age||years|Median|60.5|60.5|Full Range|||47.0|75.0|
3594547|NCT03263806|3448777|B1|||Age||years|Median|52|52.0|Full Range|||43.0|76.0|
3594548|NCT03256552|3448790|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3594549|NCT03256552|3448790|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3594550|NCT03256552|3448790|B1|||Age||Years|Mean|67.5|67.5|Standard Deviation|7.0|7.0|||
3594551|NCT03255733|3448812|B1|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3594552|NCT03255733|3448812|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3594553|NCT03255733|3448812|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3594554|NCT03255733|3448812|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3594555|NCT03255733|3448812|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3594556|NCT03255733|3448812|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3594557|NCT03255655|3448817|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
3594558|NCT03255655|3448818|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3594559|NCT03255655|3448819|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3594560|NCT03255655|3448817|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3594561|NCT03255655|3448817|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3594562|NCT03255655|3448818|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3594563|NCT03255655|3448819|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3594564|NCT03255655|3448817|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3594565|NCT03255655|3448818|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3594566|NCT03255655|3448819|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3594567|NCT03255655|3448817|B3|||Age||years|Mean|51|51.0|Full Range|||34.0|83.0|
3594568|NCT03255655|3448818|B2|||Age||years|Mean|47|47.0|Full Range|||34.0|83.0|
3594569|NCT03255655|3448819|B1|||Age||years|Mean|54|54.0|Full Range|||35.0|83.0|
3594570|NCT03255655|3448817|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3594571|NCT03255655|3448818|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3594572|NCT03255655|3448819|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3594573|NCT03255655|3448817|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3594574|NCT03255655|3448818|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3594575|NCT03255655|3448819|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3594576|NCT03255655|3448817|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3594577|NCT03255655|3448818|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3594578|NCT03255655|3448819|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3594579|NCT03254602|3448828|B1|||Patients with Chronic Plantar Fasciitis where Standard of Care Therapy failed to Reduce Pain||Participants|Count of Participants|33|33.0||||||
3594580|NCT03254602|3448828|B1|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3594581|NCT03254602|3448828|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3594582|NCT03254602|3448828|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3594583|NCT03254602|3448828|B1|||Age||years|Mean|56|56.0|Full Range|||31.0|73.0|
3594584|NCT03254602|3448828|B1||>=65 years|Age|Patient Age at time of first treatment|Participants|Count of Participants|3|3.0||||||
3594585|NCT03254602|3448828|B1||Between 18 and 65 years|Age|Patient Age at time of first treatment|Participants|Count of Participants|30|30.0||||||
3594586|NCT03254602|3448828|B1||<=18 years|Age|Patient Age at time of first treatment|Participants|Count of Participants|0|0.0||||||
3594587|NCT03254459|3448834|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594588|NCT03254459|3448835|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594589|NCT03254459|3448836|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594590|NCT03254459|3448834|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594591|NCT03254459|3448835|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594592|NCT03254459|3448836|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594593|NCT03254459|3448834|B3||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3594594|NCT03254459|3448835|B2||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3594595|NCT03254459|3448836|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3594596|NCT03254459|3448834|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3594597|NCT03254459|3448835|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3594598|NCT03254459|3448836|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3594599|NCT03254459|3448834|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3594600|NCT03254459|3448835|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3594601|NCT03254459|3448836|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594602|NCT03254459|3448834|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3594603|NCT03254459|3448835|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594604|NCT03254459|3448836|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3594605|NCT03254459|3448834|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3594606|NCT03254459|3448835|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594607|NCT03254459|3448836|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3594608|NCT03254459|3448834|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594609|NCT03254459|3448835|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594610|NCT03254459|3448836|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594611|NCT03254459|3448834|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3594612|NCT03254459|3448835|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3594613|NCT03254459|3448836|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3594614|NCT03254459|3448834|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3594615|NCT03254459|3448835|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3594616|NCT03254459|3448836|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3594617|NCT03254459|3448834|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3594618|NCT03254459|3448835|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3594619|NCT03254459|3448836|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3594620|NCT03254459|3448834|B3||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3594621|NCT03254459|3448835|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3594622|NCT03254459|3448836|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3594623|NCT03254459|3448834|B3|||Age||years|Mean|36.6|36.6|Standard Deviation|11.22|11.22|||
3594624|NCT03254459|3448835|B2|||Age||years|Mean|37.1|37.1|Standard Deviation|11.68|11.68|||
3594625|NCT03254459|3448836|B1|||Age||years|Mean|36.2|36.2|Standard Deviation|10.83|10.83|||
3594626|NCT03247985|3448855|B3|Bilateral||Site of Hernia||Participants|Count of Participants|27|27.0||||||
3594627|NCT03247985|3448856|B2|Bilateral||Site of Hernia||Participants|Count of Participants|11|11.0||||||
3594628|NCT03247985|3448857|B1|Bilateral||Site of Hernia||Participants|Count of Participants|16|16.0||||||
3594629|NCT03247985|3448855|B3|Unilateral||Site of Hernia||Participants|Count of Participants|11|11.0||||||
3594630|NCT03247985|3448856|B2|Unilateral||Site of Hernia||Participants|Count of Participants|8|8.0||||||
3594631|NCT03247985|3448857|B1|Unilateral||Site of Hernia||Participants|Count of Participants|3|3.0||||||
3594632|NCT03247985|3448855|B3|||Body Mass Index (BMI)||kg/m^2|Mean|30|30.0|Standard Deviation|9|9.0|||
3594633|NCT03247985|3448856|B2|||Body Mass Index (BMI)||kg/m^2|Mean|30|30.0|Standard Deviation|4|4.0|||
3594634|NCT03247985|3448857|B1|||Body Mass Index (BMI)||kg/m^2|Mean|30|30.0|Standard Deviation|10|10.0|||
3594635|NCT03247985|3448855|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
3594636|NCT03247985|3448856|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3594637|NCT03247985|3448857|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3594638|NCT03247985|3448855|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3594639|NCT03247985|3448855|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3594640|NCT03247985|3448856|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3594641|NCT03247985|3448857|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3594642|NCT03247985|3448855|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3594643|NCT03247985|3448856|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3594644|NCT03247985|3448857|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3594645|NCT03247985|3448855|B3|||Age||years|Mean|55|55.0|Standard Deviation|11|11.0|||
3594646|NCT03247985|3448856|B2|||Age||years|Mean|55|55.0|Standard Deviation|11|11.0|||
3594647|NCT03247985|3448857|B1|||Age||years|Mean|58|58.0|Standard Deviation|11|11.0|||
3594648|NCT03243084|3448872|B3|||Duration of Pain||years|Mean|7.1|7.1|Standard Deviation|6.0|6.0|||
3594649|NCT03243084|3448873|B2|||Duration of Pain||years|Mean|9.3|9.3|Standard Deviation|7.4|7.4|||
3594650|NCT03243084|3448874|B1|||Duration of Pain||years|Mean|4.8|4.8|Standard Deviation|3.0|3.0|||
3594651|NCT03243084|3448872|B3|||BMI||kg/m^2|Mean|25.94|25.94|Standard Deviation|4.5|4.5|||
3594652|NCT03243084|3448873|B2|||BMI||kg/m^2|Mean|25.92|25.92|Standard Deviation|5.1|5.1|||
3594653|NCT03243084|3448874|B1|||BMI||kg/m^2|Mean|25.98|25.98|Standard Deviation|4.1|4.1|||
3594654|NCT03243084|3448872|B3|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3594655|NCT03243084|3448873|B2|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3594656|NCT03243084|3448874|B1|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3594657|NCT03243084|3448872|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594658|NCT03243084|3448873|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594659|NCT03243084|3448874|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594660|NCT03243084|3448872|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594661|NCT03243084|3448873|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594662|NCT03243084|3448874|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594663|NCT03243084|3448872|B3||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3594664|NCT03243084|3448873|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3594665|NCT03243084|3448874|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3594666|NCT03243084|3448872|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3594667|NCT03243084|3448873|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3594668|NCT03243084|3448874|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594669|NCT03243084|3448872|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594670|NCT03243084|3448873|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594671|NCT03243084|3448874|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594672|NCT03243084|3448872|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594673|NCT03243084|3448873|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594674|NCT03243084|3448874|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594675|NCT03243084|3448872|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594676|NCT03243084|3448873|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594677|NCT03243084|3448874|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594678|NCT03243084|3448872|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3594679|NCT03243084|3448873|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3594680|NCT03243084|3448874|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594681|NCT03243084|3448872|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3594682|NCT03243084|3448873|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3594683|NCT03243084|3448874|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3594684|NCT03243084|3448872|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3594685|NCT03243084|3448873|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3594686|NCT03243084|3448874|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594687|NCT03243084|3448872|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3594688|NCT03243084|3448873|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3594689|NCT03243084|3448874|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3594690|NCT03243084|3448872|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3594691|NCT03243084|3448873|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3594692|NCT03243084|3448874|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3594693|NCT03243084|3448872|B3|||Age||years|Mean|43|43.0|Standard Deviation|13.4|13.4|||
3594694|NCT03243084|3448873|B2|||Age||years|Mean|43.4|43.4|Standard Deviation|13.6|13.6|||
3594695|NCT03243084|3448874|B1|||Age||years|Mean|42.6|42.6|Standard Deviation|13.8|13.8|||
3594696|NCT03238924|3448885|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
3594697|NCT03238924|3448886|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3594698|NCT03238924|3448887|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3594699|NCT03238924|3448885|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594700|NCT03238924|3448886|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594701|NCT03238924|3448887|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594702|NCT03238924|3448885|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3594703|NCT03238924|3448886|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3594704|NCT03238924|3448887|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3594705|NCT03238924|3448885|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3594706|NCT03238924|3448886|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3594707|NCT03238924|3448887|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3594708|NCT03238924|3448885|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3594709|NCT03238924|3448886|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3594710|NCT03238924|3448887|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3594711|NCT03238924|3448885|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3594712|NCT03238924|3448886|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3594713|NCT03238924|3448887|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594714|NCT03238924|3448885|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594715|NCT03238924|3448886|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594716|NCT03238924|3448887|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594717|NCT03238924|3448885|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3594718|NCT03238924|3448886|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3594719|NCT03238924|3448887|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594720|NCT03238924|3448885|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3594721|NCT03238924|3448886|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3594722|NCT03238924|3448887|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3594723|NCT03238924|3448885|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3594724|NCT03238924|3448886|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3594725|NCT03238924|3448887|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3594726|NCT03238924|3448885|B3|||Age||years|Mean|43.82|43.82|Standard Deviation|14.54|14.54|||
3594727|NCT03238924|3448886|B2|||Age||years|Mean|45.78|45.78|Standard Deviation|15.09|15.09|||
3594728|NCT03238924|3448887|B1|||Age||years|Mean|41.63|41.63|Standard Deviation|14.58|14.58|||
3594729|NCT03238352|3448898|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594730|NCT03238352|3448899|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594731|NCT03238352|3448900|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594732|NCT03238352|3448901|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594733|NCT03238352|3448898|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594734|NCT03238352|3448899|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594735|NCT03238352|3448900|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594736|NCT03238352|3448901|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594737|NCT03238352|3448898|B4||White|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3594738|NCT03238352|3448899|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3594739|NCT03238352|3448900|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3594740|NCT03238352|3448901|B1||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3594741|NCT03238352|3448898|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3594742|NCT03238352|3448899|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3594743|NCT03238352|3448900|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3594744|NCT03238352|3448901|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3594745|NCT03238352|3448898|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594746|NCT03238352|3448899|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594747|NCT03238352|3448900|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594748|NCT03238352|3448901|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594749|NCT03238352|3448898|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594750|NCT03238352|3448899|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594751|NCT03238352|3448900|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594752|NCT03238352|3448901|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594753|NCT03238352|3448898|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3594754|NCT03238352|3448899|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594755|NCT03238352|3448900|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3594756|NCT03238352|3448901|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594757|NCT03238352|3448898|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594758|NCT03238352|3448899|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594759|NCT03238352|3448900|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594760|NCT03238352|3448901|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594761|NCT03238352|3448898|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
3594762|NCT03238352|3448899|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3594763|NCT03238352|3448900|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3594764|NCT03238352|3448901|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3594765|NCT03238352|3448898|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3594766|NCT03238352|3448899|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3594767|NCT03238352|3448900|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594768|NCT03238352|3448901|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3594769|NCT03238352|3448898|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3594770|NCT03238352|3448899|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3594771|NCT03238352|3448900|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3594772|NCT03238352|3448901|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3594773|NCT03238352|3448898|B4||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3594774|NCT03238352|3448899|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3594775|NCT03238352|3448900|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3594776|NCT03238352|3448901|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3594777|NCT03238352|3448898|B4|||Age, Customized||Years|Mean|44.1|44.1|Standard Deviation|9.38|9.38|||
3594778|NCT03238352|3448899|B3|||Age, Customized||Years|Mean|43.0|43.0|Standard Deviation|8.75|8.75|||
3594779|NCT03238352|3448900|B2|||Age, Customized||Years|Mean|41.5|41.5|Standard Deviation|9.76|9.76|||
3594780|NCT03238352|3448901|B1|||Age, Customized||Years|Mean|46.0|46.0|Standard Deviation|9.27|9.27|||
3594781|NCT03238001|3448914|B1||Unknown|Highest education level attained||Participants|Count of Participants|10|10.0||||||
3594782|NCT03238001|3448914|B1||Less than high school|Highest education level attained||Participants|Count of Participants|45|45.0||||||
3594783|NCT03238001|3448914|B1||High school|Highest education level attained||Participants|Count of Participants|106|106.0||||||
3594784|NCT03238001|3448914|B1||High School and some college|Highest education level attained||Participants|Count of Participants|141|141.0||||||
3594785|NCT03238001|3448914|B1||College Degree +|Highest education level attained||Participants|Count of Participants|148|148.0||||||
3594786|NCT03238001|3448914|B1||Other or unknown|Handedness||Participants|Count of Participants|7|7.0||||||
3594787|NCT03238001|3448914|B1||Ambidextrous|Handedness||Participants|Count of Participants|13|13.0||||||
3594788|NCT03238001|3448914|B1||Left handed|Handedness||Participants|Count of Participants|34|34.0||||||
3594789|NCT03238001|3448914|B1||Right handed|Handedness||Participants|Count of Participants|396|396.0||||||
3594790|NCT03238001|3448914|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3594791|NCT03238001|3448914|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3594792|NCT03238001|3448914|B1||White|Race (NIH/OMB)||Participants|Count of Participants|329|329.0||||||
3594793|NCT03238001|3448914|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
3594794|NCT03238001|3448914|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594795|NCT03238001|3448914|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3594796|NCT03238001|3448914|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594797|NCT03238001|3448914|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3594798|NCT03238001|3448914|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|405|405.0||||||
3594799|NCT03238001|3448914|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3594800|NCT03238001|3448914|B1|Unknown or Other||Sex/Gender, Customized||Participants|Count of Participants|3|3.0||||||
3594801|NCT03238001|3448914|B1|Female||Sex/Gender, Customized||Participants|Count of Participants|333|333.0||||||
3594802|NCT03238001|3448914|B1|Male||Sex/Gender, Customized||Participants|Count of Participants|114|114.0||||||
3594803|NCT03238001|3448914|B1|||Age||years|Mean|68.94|68.94|Standard Deviation|8.78|8.78|||
3594804|NCT03235817|3448937|B4|||Induction Time||minutes|Mean|9.2|9.2|Standard Deviation|4.3|4.3|||
3594805|NCT03235817|3448938|B3|||Induction Time||minutes|Mean|9.6|9.6|Standard Deviation|3.1|3.1|||
3594806|NCT03235817|3448939|B2|||Induction Time||minutes|Mean|8.6|8.6|Standard Deviation|3.3|3.3|||
3594807|NCT03235817|3448940|B1|||Induction Time||minutes|Mean|9.5|9.5|Standard Deviation|5.9|5.9|||
3594808|NCT03235817|3448937|B4||Size 2|PLMA Size (ProSeal laryngeal mask airway)||Participants|Count of Participants|7|7.0||||||
3594809|NCT03235817|3448938|B3||Size 2|PLMA Size (ProSeal laryngeal mask airway)||Participants|Count of Participants|3|3.0||||||
3594810|NCT03235817|3448939|B2||Size 2|PLMA Size (ProSeal laryngeal mask airway)||Participants|Count of Participants|2|2.0||||||
3594811|NCT03235817|3448940|B1||Size 2|PLMA Size (ProSeal laryngeal mask airway)||Participants|Count of Participants|2|2.0||||||
3594812|NCT03235817|3448937|B4||Size 1.5|PLMA Size (ProSeal laryngeal mask airway)||Participants|Count of Participants|26|26.0||||||
3594813|NCT03235817|3448938|B3||Size 1.5|PLMA Size (ProSeal laryngeal mask airway)||Participants|Count of Participants|8|8.0||||||
3594814|NCT03235817|3448939|B2||Size 1.5|PLMA Size (ProSeal laryngeal mask airway)||Participants|Count of Participants|10|10.0||||||
3594815|NCT03235817|3448940|B1||Size 1.5|PLMA Size (ProSeal laryngeal mask airway)||Participants|Count of Participants|8|8.0||||||
3594816|NCT03235817|3448937|B4|||Weight||kg|Mean|8.2|8.2|Standard Deviation|1.4|1.4|||
3594817|NCT03235817|3448938|B3|||Weight||kg|Mean|8.2|8.2|Standard Deviation|1.3|1.3|||
3594818|NCT03235817|3448939|B2|||Weight||kg|Mean|8.5|8.5|Standard Deviation|.9|0.9|||
3594819|NCT03235817|3448940|B1|||Weight||kg|Mean|8|8.0|Standard Deviation|1.7|1.7|||
3594820|NCT03235817|3448937|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3594821|NCT03235817|3448938|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3594822|NCT03235817|3448939|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3594823|NCT03235817|3448940|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3594824|NCT03235817|3448937|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3594825|NCT03235817|3448938|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3594826|NCT03235817|3448939|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3594827|NCT03235817|3448940|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3594828|NCT03235817|3448937|B4|Age||Age, Customized||months|Mean|7.1|7.1|Standard Deviation|2|2.0|||
3594829|NCT03235817|3448938|B3|Age||Age, Customized||months|Mean|6.9|6.9|Standard Deviation|1.9|1.9|||
3594830|NCT03235817|3448939|B2|Age||Age, Customized||months|Mean|7.3|7.3|Standard Deviation|2|2.0|||
3594831|NCT03235817|3448940|B1|Age||Age, Customized||months|Mean|7.1|7.1|Standard Deviation|2|2.0|||
3594832|NCT03235115|3448959|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3594833|NCT03235115|3448959|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3594834|NCT03235115|3448959|B1|||Age||years|Mean|29.0|29.0|Standard Deviation|6.4|6.4|||
3594835|NCT03233009|3448984|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594836|NCT03233009|3448984|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594837|NCT03233009|3448984|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3594838|NCT03233009|3448984|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3594839|NCT03233009|3448984|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594840|NCT03233009|3448984|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594841|NCT03233009|3448984|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594842|NCT03233009|3448984|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3594843|NCT03233009|3448984|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3594844|NCT03233009|3448984|B1|||Age||Years|Mean|35.7|35.7|Standard Deviation|11.65|11.65|||
3594845|NCT03231371|3449027|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3594846|NCT03231371|3449027|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3594847|NCT03231371|3449027|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3594848|NCT03231371|3449027|B1|18 - 25 years||Age, Customized||Participants|Count of Participants|8|8.0||||||
3594849|NCT03231371|3449027|B1|1-18 years||Age, Customized||Participants|Count of Participants|14|14.0||||||
3594850|NCT03228212|3449032|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3594851|NCT03228212|3449032|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|111|111.0||||||
3594852|NCT03228212|3449032|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3594853|NCT03228212|3449032|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3594854|NCT03228212|3449032|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3594855|NCT03228212|3449032|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3594856|NCT03228212|3449032|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3594857|NCT03228212|3449032|B1|||Age||Years|Mean|31.6|31.6|Standard Deviation|7.69|7.69|||
3594858|NCT03225001|3449049|B1|||NYHA III/IV|New York Heart Association (NYHA), functional classification of heart failure based on how much a patient is limited during physical activity. The rating ranges from I - IV, with the lowest as no limitations and the highest unable to carry on any physical activity without discomfort.|Participants|Count of Participants|188|188.0||||||
3594859|NCT03225001|3449049|B1|||STS Score|The Society of Thoracic Surgeons (STS) score measures patient risk at the time of cardiovascular surgery on a scale that ranges from 0% to 100%, with higher numbers indicating greater risk.|units on a scale|Mean|9.7|9.7|Standard Deviation|5.1|5.1|||
3594860|NCT03225001|3449049|B1||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3594861|NCT03225001|3449049|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3594862|NCT03225001|3449049|B1|||Age||Years|Mean|78.5|78.5|Standard Deviation|11.0|11.0|||
3594863|NCT03223662|3449054|B1|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3594864|NCT03223662|3449054|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594865|NCT03223662|3449054|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594866|NCT03223662|3449054|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3594867|NCT03223662|3449054|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594868|NCT03223662|3449054|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594869|NCT03223662|3449054|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3594870|NCT03223662|3449054|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594871|NCT03223662|3449054|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594872|NCT03223662|3449054|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3594873|NCT03223662|3449054|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594874|NCT03223662|3449054|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3594875|NCT03223662|3449054|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3594876|NCT03223662|3449054|B1|||Age||years|Mean|58.55|58.55|Standard Deviation|5.3|5.3|||
3594877|NCT03223662|3449054|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3594878|NCT03223662|3449054|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3594879|NCT03223662|3449054|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3594880|NCT03222141|3449064|B1|||Coronary artery disease||Participants|Count of Participants|444|444.0||||||
3594881|NCT03222141|3449064|B1|||NYHA III/IV|New York Heart Association (NYHA), functional classification of heart failure based on how much a patient is limited during physical activity. The rating ranges from I-IV, with the lowest as no limitations and the highest unable to carry on any physical activity without discomfort.|Participants|Count of Participants|525|525.0||||||
3594882|NCT03222141|3449064|B1|||STS score|The Society of Thoracic Surgeons (STS) Score measures patient risk of mortality or morbidity at the time of cardiovascular surgery on a scale that ranges from 0% to 100%, with higher numbers indicating greater risk.|units on a scale|Mean|8.6|8.6|Standard Deviation|3.7|3.7|||
3594883|NCT03222141|3449064|B1||Male|Sex: Female, Male||Participants|Count of Participants|338|338.0||||||
3594884|NCT03222141|3449064|B1||Female|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
3594885|NCT03222141|3449064|B1|||Age||years|Mean|82.6|82.6|Standard Deviation|8.1|8.1|||
3594886|NCT03222128|3449070|B1|||NYHA Classification III/IV|New York Heart Association (NYHA), functional classification of heart failure based on how much a patient is limited during physical activity. The rating ranges from I-V, with the lowest as no limitations and highest unable to carry on any physical activity without discomfort.|Participants|Count of Participants|780|780.0||||||
3594887|NCT03222128|3449070|B1|||STS Score|The Society of Thoracic Surgeons (STS) Score measures patient risk of mortality or morbidity at the time of cardiovascular surgery on a scale that ranges from 0% to 100%, with higher numbers indicating greater risk.|units on a scale|Mean|5.3|5.3|Standard Deviation|1.29|1.29|||
3594888|NCT03222128|3449070|B1||Male|Sex: Female, Male||Participants|Count of Participants|662|662.0||||||
3594889|NCT03222128|3449070|B1||Female|Sex: Female, Male||Participants|Count of Participants|412|412.0||||||
3594890|NCT03222128|3449070|B1|||Age||years|Mean|81.9|81.9|Standard Deviation|6.6|6.6|||
3594891|NCT03222037|3449075|B1|United States||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
3594892|NCT03222037|3449075|B1|White||Race/Ethnicity, Customized||Count of Participants|Number|29|29.0||||||
3594893|NCT03222037|3449075|B1|Black or African American||Race/Ethnicity, Customized||Count of Participants|Number|6|6.0||||||
3594894|NCT03222037|3449075|B1|Asian||Race/Ethnicity, Customized||Count of Participants|Number|8|8.0||||||
3594895|NCT03222037|3449075|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3594896|NCT03222037|3449075|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3594897|NCT03222037|3449075|B1|||Age||Years|Mean|26.8|26.8|Standard Deviation|4.65|4.65|||
3594898|NCT03218163|3449084|B1|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3594899|NCT03218163|3449084|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594900|NCT03218163|3449084|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594901|NCT03218163|3449084|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3594902|NCT03218163|3449084|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594903|NCT03218163|3449084|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594904|NCT03218163|3449084|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594905|NCT03218163|3449084|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594906|NCT03218163|3449084|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3594907|NCT03218163|3449084|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3594908|NCT03218163|3449084|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3594909|NCT03218163|3449084|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3594910|NCT03218163|3449084|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3594911|NCT03217968|3449088|B1|Sensitivity to sound||Most bothersome syndrome||Participants|Count of Participants|9|9.0||||||
3594912|NCT03217968|3449088|B1|Sensitivity to light||Most bothersome syndrome||Participants|Count of Participants|27|27.0||||||
3594913|NCT03217968|3449088|B1|Vomiting||Most bothersome syndrome||Participants|Count of Participants|1|1.0||||||
3594914|NCT03217968|3449088|B1|Nausea||Most bothersome syndrome||Participants|Count of Participants|11|11.0||||||
3594915|NCT03217968|3449088|B1|Severe intensity at baseline||Migraine intensity||Participants|Count of Participants|15|15.0||||||
3594916|NCT03217968|3449088|B1|Moderate intensity at baseline||Migraine intensity||Participants|Count of Participants|33|33.0||||||
3594917|NCT03217968|3449088|B1|Migraine without aura||Migraine type||Participants|Count of Participants|33|33.0||||||
3594918|NCT03217968|3449088|B1|Migraine with aura||Migraine type||Participants|Count of Participants|15|15.0||||||
3594919|NCT03217968|3449088|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3594920|NCT03217968|3449088|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3594921|NCT03217968|3449088|B1|||Age||years|Mean|46.85|46.85|Standard Deviation|10.2|10.2|||
3594922|NCT03206216|3449097|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3594923|NCT03206216|3449098|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3594924|NCT03206216|3449097|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594925|NCT03206216|3449098|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594926|NCT03206216|3449099|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594927|NCT03206216|3449097|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594928|NCT03206216|3449098|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594929|NCT03206216|3449099|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594930|NCT03206216|3449097|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3594931|NCT03206216|3449098|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3594932|NCT03206216|3449099|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594933|NCT03206216|3449097|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594934|NCT03206216|3449098|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594935|NCT03206216|3449099|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594936|NCT03206216|3449097|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594937|NCT03206216|3449098|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594938|NCT03206216|3449099|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594939|NCT03206216|3449097|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594940|NCT03206216|3449098|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594941|NCT03206216|3449099|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594942|NCT03206216|3449097|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594943|NCT03206216|3449098|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594944|NCT03206216|3449099|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594945|NCT03206216|3449097|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594946|NCT03206216|3449098|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594947|NCT03206216|3449099|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594948|NCT03206216|3449097|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3594949|NCT03206216|3449098|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3594950|NCT03206216|3449099|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594951|NCT03206216|3449097|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594952|NCT03206216|3449098|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594953|NCT03206216|3449099|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594954|NCT03206216|3449097|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3594955|NCT03206216|3449098|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3594956|NCT03206216|3449099|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3594957|NCT03206216|3449097|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3594958|NCT03206216|3449098|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3594959|NCT03206216|3449099|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3594960|NCT03206216|3449097|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3594961|NCT03206216|3449098|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3594962|NCT03206216|3449099|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3594963|NCT03206216|3449097|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3594964|NCT03206216|3449098|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3594965|NCT03206216|3449099|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3594966|NCT03206216|3449097|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3594967|NCT03206216|3449098|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3594968|NCT03206216|3449099|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3594969|NCT03198767|3449108|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594970|NCT03198767|3449109|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594971|NCT03198767|3449110|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594972|NCT03198767|3449111|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594973|NCT03198767|3449112|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594974|NCT03198767|3449113|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594975|NCT03198767|3449114|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594976|NCT03198767|3449115|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594977|NCT03198767|3449108|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3594978|NCT03198767|3449109|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3594979|NCT03198767|3449110|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3594980|NCT03198767|3449111|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3594981|NCT03198767|3449112|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3594982|NCT03198767|3449113|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3594983|NCT03198767|3449114|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3594984|NCT03198767|3449115|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3594985|NCT03198767|3449108|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3594986|NCT03198767|3449109|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594987|NCT03198767|3449110|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3594988|NCT03198767|3449111|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3594989|NCT03198767|3449112|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3594990|NCT03198767|3449113|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3594991|NCT03198767|3449114|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3594992|NCT03198767|3449115|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3594993|NCT03198767|3449108|B8||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3594994|NCT03198767|3449109|B7||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3594995|NCT03198767|3449110|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3594996|NCT03198767|3449111|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3594997|NCT03198767|3449112|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3594998|NCT03198767|3449113|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3594999|NCT03198767|3449114|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3595000|NCT03198767|3449115|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3595001|NCT03198767|3449108|B8||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3595002|NCT03198767|3449109|B7||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3595003|NCT03198767|3449110|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3595004|NCT03198767|3449111|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3595005|NCT03198767|3449112|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3595006|NCT03198767|3449113|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3595007|NCT03198767|3449114|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3595008|NCT03198767|3449115|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3595009|NCT03198767|3449108|B8|||Age||Years|Mean|44.3|44.3|Full Range|||21.0|63.0|
3595010|NCT03198767|3449109|B7|||Age||Years|Mean|43.3|43.3|Full Range|||29.0|58.0|
3595011|NCT03198767|3449110|B6|||Age||Years|Mean|50.1|50.1|Full Range|||36.0|62.0|
3595012|NCT03198767|3449111|B5|||Age||Years|Mean|43.8|43.8|Full Range|||27.0|56.0|
3595013|NCT03198767|3449112|B4|||Age||Years|Mean|53.3|53.3|Full Range|||51.0|57.0|
3595014|NCT03198767|3449113|B3|||Age||Years|Mean|43.9|43.9|Full Range|||26.0|63.0|
3595015|NCT03198767|3449114|B2|||Age||Years|Mean|45.5|45.5|Full Range|||27.0|61.0|
3595016|NCT03198767|3449115|B1|||Age||Years|Mean|32.1|32.1|Full Range|||21.0|46.0|
3595017|NCT03198000|3449154|B4|United States||Region of Enrollment||Participants|Count of Participants|120|120.0||||||
3595018|NCT03198000|3449155|B3|United States||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3595019|NCT03198000|3449156|B2|United States||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
3595020|NCT03198000|3449157|B1|United States||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3595021|NCT03198000|3449154|B4||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|109|109.0||||||
3595022|NCT03198000|3449155|B3||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3595023|NCT03198000|3449156|B2||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
3595024|NCT03198000|3449157|B1||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3595025|NCT03198000|3449154|B4||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3595026|NCT03198000|3449155|B3||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3595027|NCT03198000|3449156|B2||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3595028|NCT03198000|3449157|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3595029|NCT03198000|3449154|B4||Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3595030|NCT03198000|3449155|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3595031|NCT03198000|3449156|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3595032|NCT03198000|3449157|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3595033|NCT03198000|3449154|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3595034|NCT03198000|3449155|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3595035|NCT03198000|3449156|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3595036|NCT03198000|3449157|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3595037|NCT03198000|3449154|B4||Black or African-American|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3595038|NCT03198000|3449155|B3||Black or African-American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3595039|NCT03198000|3449156|B2||Black or African-American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3595040|NCT03198000|3449157|B1||Black or African-American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3595041|NCT03198000|3449154|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|111|111.0||||||
3595042|NCT03198000|3449155|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
3595043|NCT03198000|3449156|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3595044|NCT03198000|3449157|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3595045|NCT03198000|3449154|B4||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3595046|NCT03198000|3449155|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3595047|NCT03198000|3449156|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3595048|NCT03198000|3449157|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3595049|NCT03198000|3449154|B4||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3595050|NCT03198000|3449155|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3595051|NCT03198000|3449156|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3595052|NCT03198000|3449157|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3595053|NCT03198000|3449154|B4|||Age||Years|Mean|56.4|56.4|Standard Deviation|14.03|14.03|||
3595054|NCT03198000|3449155|B3|||Age||Years|Mean|54.9|54.9|Standard Deviation|12.47|12.47|||
3595055|NCT03198000|3449156|B2|||Age||Years|Mean|59.1|59.1|Standard Deviation|13.85|13.85|||
3595056|NCT03198000|3449157|B1|||Age||Years|Mean|55.4|55.4|Standard Deviation|15.58|15.58|||
3595057|NCT03196635|3449266|B1||Withdrawn subject|Breast of Interest|One breast per eligible subject was randomly assigned as her 'breast of interest' which underwent study-specific procedures and image evaluations. Randomization of breast of interest was performed so that approximately half the subjects were assigned to the first breast imaged and the other half was assigned to the second breast imaged. The laterality of the breast of interest depended on which breast (left or right) the technologist imaged first and second in standard practice.|Participants|Count of Participants|1|1.0||||||
3595058|NCT03196635|3449266|B1||Second breast of interest|Breast of Interest|One breast per eligible subject was randomly assigned as her 'breast of interest' which underwent study-specific procedures and image evaluations. Randomization of breast of interest was performed so that approximately half the subjects were assigned to the first breast imaged and the other half was assigned to the second breast imaged. The laterality of the breast of interest depended on which breast (left or right) the technologist imaged first and second in standard practice.|Participants|Count of Participants|14|14.0||||||
3595059|NCT03196635|3449266|B1||First breast of interest|Breast of Interest|One breast per eligible subject was randomly assigned as her 'breast of interest' which underwent study-specific procedures and image evaluations. Randomization of breast of interest was performed so that approximately half the subjects were assigned to the first breast imaged and the other half was assigned to the second breast imaged. The laterality of the breast of interest depended on which breast (left or right) the technologist imaged first and second in standard practice.|Participants|Count of Participants|16|16.0||||||
3595060|NCT03196635|3449266|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3595061|NCT03196635|3449266|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3595062|NCT03196635|3449266|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3595063|NCT03196635|3449266|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3595064|NCT03196635|3449266|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3595065|NCT03196635|3449266|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3595066|NCT03196635|3449266|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3595067|NCT03196635|3449266|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3595068|NCT03192306|3449284|B3|United States||Region of Enrollment||participants|Number|156|156.0||||||
3595069|NCT03192306|3449285|B2|United States||Region of Enrollment||participants|Number|80|80.0||||||
3595070|NCT03192306|3449286|B1|United States||Region of Enrollment||participants|Number|76|76.0||||||
3595071|NCT03192306|3449284|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3595072|NCT03192306|3449285|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3595073|NCT03192306|3449286|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595074|NCT03192306|3449284|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3595075|NCT03192306|3449285|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3595076|NCT03192306|3449286|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3595077|NCT03192306|3449284|B3||White|Race (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
3595078|NCT03192306|3449285|B2||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3595079|NCT03192306|3449286|B1||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3595080|NCT03192306|3449284|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3595081|NCT03192306|3449285|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3595082|NCT03192306|3449286|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3595083|NCT03192306|3449284|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595084|NCT03192306|3449285|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595085|NCT03192306|3449286|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595086|NCT03192306|3449284|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3595087|NCT03192306|3449285|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3595088|NCT03192306|3449286|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3595089|NCT03192306|3449284|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3595090|NCT03192306|3449285|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3595091|NCT03192306|3449286|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595092|NCT03192306|3449284|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3595093|NCT03192306|3449285|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3595094|NCT03192306|3449286|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3595095|NCT03192306|3449284|B3||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3595096|NCT03192306|3449285|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3595097|NCT03192306|3449286|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3595098|NCT03192306|3449284|B3|||Age||Years|Mean|42.1|42.1|Standard Deviation|12.32|12.32|||
3595099|NCT03192306|3449285|B2|||Age||Years|Mean|42.7|42.7|Standard Deviation|12.8|12.8|||
3595100|NCT03192306|3449286|B1|||Age||Years|Mean|41.4|41.4|Standard Deviation|11.84|11.84|||
3595101|NCT03192306|3449284|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3595102|NCT03192306|3449285|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3595103|NCT03192306|3449286|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3595104|NCT03192306|3449284|B3||Between 18 and 65 years|Age||Participants|Count of Participants|150|150.0||||||
3595105|NCT03192306|3449285|B2||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
3595106|NCT03192306|3449286|B1||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
3595107|NCT03192306|3449284|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3595108|NCT03192306|3449285|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3595109|NCT03192306|3449286|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3595110|NCT03191552|3449305|B4|GMFCS level 4||GMFCS Level|"GMFCS© Robert Palisano, Peter Rosenbaum, Stephen Walter, Dianne Russell, Ellen Wood, Barbara Galuppi, 1997. CanChild Centre for Childhood Disability Research, McMaster University. (Reference: Dev Med Child Neurol 1997;39:214-223).~Levels I-V based on self-initiated movement, with emphasis on sitting, transfers, and mobility. Level I is highest functioning, level V is lowest~General:~I: walks without limitations II: walks with limitations III: walks using hand-held mobility device IV: self-mobility with limitations; may use powered mobility V: transported in manual wheelchair"|Participants|Count of Participants|19|19.0||||||
3595111|NCT03191552|3449306|B3|GMFCS level 4||GMFCS Level|"GMFCS© Robert Palisano, Peter Rosenbaum, Stephen Walter, Dianne Russell, Ellen Wood, Barbara Galuppi, 1997. CanChild Centre for Childhood Disability Research, McMaster University. (Reference: Dev Med Child Neurol 1997;39:214-223).~Levels I-V based on self-initiated movement, with emphasis on sitting, transfers, and mobility. Level I is highest functioning, level V is lowest~General:~I: walks without limitations II: walks with limitations III: walks using hand-held mobility device IV: self-mobility with limitations; may use powered mobility V: transported in manual wheelchair"|Participants|Count of Participants|7|7.0||||||
3595112|NCT03191552|3449307|B2|GMFCS level 4||GMFCS Level|"GMFCS© Robert Palisano, Peter Rosenbaum, Stephen Walter, Dianne Russell, Ellen Wood, Barbara Galuppi, 1997. CanChild Centre for Childhood Disability Research, McMaster University. (Reference: Dev Med Child Neurol 1997;39:214-223).~Levels I-V based on self-initiated movement, with emphasis on sitting, transfers, and mobility. Level I is highest functioning, level V is lowest~General:~I: walks without limitations II: walks with limitations III: walks using hand-held mobility device IV: self-mobility with limitations; may use powered mobility V: transported in manual wheelchair"|Participants|Count of Participants|6|6.0||||||
3595113|NCT03191552|3449308|B1|GMFCS level 4||GMFCS Level|"GMFCS© Robert Palisano, Peter Rosenbaum, Stephen Walter, Dianne Russell, Ellen Wood, Barbara Galuppi, 1997. CanChild Centre for Childhood Disability Research, McMaster University. (Reference: Dev Med Child Neurol 1997;39:214-223).~Levels I-V based on self-initiated movement, with emphasis on sitting, transfers, and mobility. Level I is highest functioning, level V is lowest~General:~I: walks without limitations II: walks with limitations III: walks using hand-held mobility device IV: self-mobility with limitations; may use powered mobility V: transported in manual wheelchair"|Participants|Count of Participants|6|6.0||||||
3595114|NCT03191552|3449305|B4|GMFCS level 3||GMFCS Level|"GMFCS© Robert Palisano, Peter Rosenbaum, Stephen Walter, Dianne Russell, Ellen Wood, Barbara Galuppi, 1997. CanChild Centre for Childhood Disability Research, McMaster University. (Reference: Dev Med Child Neurol 1997;39:214-223).~Levels I-V based on self-initiated movement, with emphasis on sitting, transfers, and mobility. Level I is highest functioning, level V is lowest~General:~I: walks without limitations II: walks with limitations III: walks using hand-held mobility device IV: self-mobility with limitations; may use powered mobility V: transported in manual wheelchair"|Participants|Count of Participants|5|5.0||||||
3595281|NCT03161327|3449497|B1|ABI severe risk||diabetic||Participants|Count of Participants|6|6.0||||||
3595115|NCT03191552|3449306|B3|GMFCS level 3||GMFCS Level|"GMFCS© Robert Palisano, Peter Rosenbaum, Stephen Walter, Dianne Russell, Ellen Wood, Barbara Galuppi, 1997. CanChild Centre for Childhood Disability Research, McMaster University. (Reference: Dev Med Child Neurol 1997;39:214-223).~Levels I-V based on self-initiated movement, with emphasis on sitting, transfers, and mobility. Level I is highest functioning, level V is lowest~General:~I: walks without limitations II: walks with limitations III: walks using hand-held mobility device IV: self-mobility with limitations; may use powered mobility V: transported in manual wheelchair"|Participants|Count of Participants|1|1.0||||||
3595116|NCT03191552|3449307|B2|GMFCS level 3||GMFCS Level|"GMFCS© Robert Palisano, Peter Rosenbaum, Stephen Walter, Dianne Russell, Ellen Wood, Barbara Galuppi, 1997. CanChild Centre for Childhood Disability Research, McMaster University. (Reference: Dev Med Child Neurol 1997;39:214-223).~Levels I-V based on self-initiated movement, with emphasis on sitting, transfers, and mobility. Level I is highest functioning, level V is lowest~General:~I: walks without limitations II: walks with limitations III: walks using hand-held mobility device IV: self-mobility with limitations; may use powered mobility V: transported in manual wheelchair"|Participants|Count of Participants|2|2.0||||||
3595117|NCT03191552|3449308|B1|GMFCS level 3||GMFCS Level|"GMFCS© Robert Palisano, Peter Rosenbaum, Stephen Walter, Dianne Russell, Ellen Wood, Barbara Galuppi, 1997. CanChild Centre for Childhood Disability Research, McMaster University. (Reference: Dev Med Child Neurol 1997;39:214-223).~Levels I-V based on self-initiated movement, with emphasis on sitting, transfers, and mobility. Level I is highest functioning, level V is lowest~General:~I: walks without limitations II: walks with limitations III: walks using hand-held mobility device IV: self-mobility with limitations; may use powered mobility V: transported in manual wheelchair"|Participants|Count of Participants|2|2.0||||||
3595118|NCT03191552|3449305|B4|Tetraplegic||Cerebral palsy (CP) type||Participants|Count of Participants|22|22.0||||||
3595119|NCT03191552|3449306|B3|Tetraplegic||Cerebral palsy (CP) type||Participants|Count of Participants|7|7.0||||||
3595120|NCT03191552|3449307|B2|Tetraplegic||Cerebral palsy (CP) type||Participants|Count of Participants|8|8.0||||||
3595121|NCT03191552|3449308|B1|Tetraplegic||Cerebral palsy (CP) type||Participants|Count of Participants|7|7.0||||||
3595122|NCT03191552|3449305|B4|Diplegic||Cerebral palsy (CP) type||Participants|Count of Participants|2|2.0||||||
3595123|NCT03191552|3449306|B3|Diplegic||Cerebral palsy (CP) type||Participants|Count of Participants|1|1.0||||||
3595124|NCT03191552|3449307|B2|Diplegic||Cerebral palsy (CP) type||Participants|Count of Participants|0|0.0||||||
3595125|NCT03191552|3449308|B1|Diplegic||Cerebral palsy (CP) type||Participants|Count of Participants|1|1.0||||||
3595126|NCT03191552|3449305|B4|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3595127|NCT03191552|3449305|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3595128|NCT03191552|3449306|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3595129|NCT03191552|3449307|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3595130|NCT03191552|3449308|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3595131|NCT03191552|3449305|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3595132|NCT03191552|3449306|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3595133|NCT03191552|3449307|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3595134|NCT03191552|3449308|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3595135|NCT03191552|3449305|B4|||Age||months|Mean|61|61.0|Standard Deviation|18|18.0|||
3595136|NCT03191552|3449306|B3|||Age||months|Mean|55.63|55.63|Standard Deviation|18.11|18.11|||
3595137|NCT03191552|3449307|B2|||Age||months|Mean|60.5|60.5|Standard Deviation|19.57|19.57|||
3595138|NCT03191552|3449308|B1|||Age||months|Mean|64.29|64.29|Standard Deviation|18.09|18.09|||
3595139|NCT03191552|3449305|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3595140|NCT03191552|3449306|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3595141|NCT03191552|3449307|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3595142|NCT03191552|3449308|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3595143|NCT03191552|3449305|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3595144|NCT03191552|3449306|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3595145|NCT03191552|3449307|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3595146|NCT03191552|3449308|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3595147|NCT03191552|3449305|B4||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
3595148|NCT03191552|3449306|B3||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
3595149|NCT03191552|3449307|B2||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
3595150|NCT03191552|3449308|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
3595151|NCT03184441|3449361|B1|||Cranial Abnormalities Were Measured at Enrollment||participants|Number|10|10.0||||||
3595152|NCT03184441|3449361|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3595153|NCT03184441|3449361|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3595154|NCT03184441|3449361|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3595155|NCT03184441|3449361|B1|||Age||days|Mean|17.9|17.9|Full Range|||5.0|38.0|
3595156|NCT03184441|3449361|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3595157|NCT03184441|3449361|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3595158|NCT03184441|3449361|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
3595159|NCT03184077|3449369|B3|United States||Region of Enrollment||participants|Number|318|318.0||||||
3595160|NCT03184077|3449370|B2|United States||Region of Enrollment||participants|Number|131|131.0||||||
3595161|NCT03184077|3449371|B1|United States||Region of Enrollment||participants|Number|145|145.0||||||
3595162|NCT03184077|3449369|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3595163|NCT03184077|3449370|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3595164|NCT03184077|3449371|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3595165|NCT03184077|3449369|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3595166|NCT03184077|3449370|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3595167|NCT03184077|3449371|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3595168|NCT03184077|3449369|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3595169|NCT03184077|3449370|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3595170|NCT03184077|3449371|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3595171|NCT03184077|3449369|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|122|122.0||||||
3595172|NCT03184077|3449370|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|62|62.0||||||
3595173|NCT03184077|3449371|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|60|60.0||||||
3595174|NCT03184077|3449369|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|114|114.0||||||
3595175|NCT03184077|3449370|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
3595176|NCT03184077|3449371|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|63|63.0||||||
3595177|NCT03184077|3449369|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3595178|NCT03184077|3449370|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3595179|NCT03184077|3449371|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3595180|NCT03184077|3449369|B3||Female|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
3595181|NCT03184077|3449370|B2||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3595182|NCT03184077|3449371|B1||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3595183|NCT03184077|3449369|B3|||Age||years|Mean|27.4|27.4|Full Range|||18.0|42.0|
3595184|NCT03184077|3449370|B2|||Age||years|Mean|27.6|27.6|Full Range|||18.0|40.0|
3595185|NCT03184077|3449371|B1|||Age||years|Mean|27.4|27.4|Full Range|||19.0|42.0|
3595186|NCT03182582|3449382|B1|||Wound size||cm|Mean|3.6|3.6|Standard Deviation|5.6|5.6|||
3595187|NCT03182582|3449382|B1||Other|Wound Etiology||Participants|Count of Participants|7|7.0||||||
3595188|NCT03182582|3449382|B1||Venous|Wound Etiology||Participants|Count of Participants|11|11.0||||||
3595189|NCT03182582|3449382|B1||Diabetic|Wound Etiology||Participants|Count of Participants|4|4.0||||||
3595190|NCT03182582|3449382|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3595191|NCT03182582|3449382|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3595192|NCT03182582|3449382|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3595193|NCT03182582|3449382|B1|||Age||years|Mean|68.2|68.2|Standard Deviation|16.8|16.8|||
3595194|NCT03182582|3449382|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3595195|NCT03182582|3449382|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3595196|NCT03182582|3449382|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3595197|NCT03180138|3449398|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595198|NCT03180138|3449399|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595199|NCT03180138|3449400|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595200|NCT03180138|3449401|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595201|NCT03180138|3449398|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595202|NCT03180138|3449399|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595203|NCT03180138|3449400|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595204|NCT03180138|3449401|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595205|NCT03180138|3449398|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595206|NCT03180138|3449399|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595207|NCT03180138|3449400|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595208|NCT03180138|3449401|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595209|NCT03180138|3449398|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595210|NCT03180138|3449399|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595211|NCT03180138|3449400|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595212|NCT03180138|3449401|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595213|NCT03180138|3449398|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595214|NCT03180138|3449399|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595215|NCT03180138|3449400|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595216|NCT03180138|3449401|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595217|NCT03180138|3449398|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|549|549.0||||||
3595218|NCT03180138|3449399|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|179|179.0||||||
3595219|NCT03180138|3449400|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|188|188.0||||||
3595220|NCT03180138|3449401|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|182|182.0||||||
3595221|NCT03180138|3449398|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595222|NCT03180138|3449399|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595223|NCT03180138|3449400|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595224|NCT03180138|3449401|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595225|NCT03180138|3449398|B4||Male|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
3595226|NCT03180138|3449399|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3595227|NCT03180138|3449400|B2||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3595228|NCT03180138|3449401|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3595229|NCT03180138|3449398|B4||Female|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
3595230|NCT03180138|3449399|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3595231|NCT03180138|3449400|B2||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3595232|NCT03180138|3449401|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3595233|NCT03180138|3449398|B4|||Age||Months|Median|5|5.0|Inter-Quartile Range|||1.0|11.0|
3595234|NCT03180138|3449399|B3|||Age||Months|Median|4|4.0|Inter-Quartile Range|||1.0|11.0|
3595235|NCT03180138|3449400|B2|||Age||Months|Median|5|5.0|Inter-Quartile Range|||1.0|11.0|
3595236|NCT03180138|3449401|B1|||Age||Months|Median|5|5.0|Inter-Quartile Range|||1.0|11.0|
3595237|NCT03178344|3449414|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595238|NCT03178344|3449414|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3595239|NCT03178344|3449414|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3595240|NCT03178344|3449414|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3595241|NCT03178344|3449414|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595242|NCT03178344|3449414|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3595243|NCT03178344|3449414|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595244|NCT03178344|3449414|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3595245|NCT03178344|3449414|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3595246|NCT03178344|3449414|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3595247|NCT03178344|3449414|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3595248|NCT03178344|3449414|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3595249|NCT03168542|3449429|B1|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3595250|NCT03168542|3449429|B1|White||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
3595251|NCT03168542|3449429|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3595252|NCT03168542|3449429|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3595253|NCT03168542|3449429|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3595254|NCT03168542|3449429|B1|||Age||Years|Mean|57.0|57.0|Standard Deviation|6.05|6.05|||
3595255|NCT03163134|3449459|B3|United States||Region of Enrollment||Participants|Count of Participants|170|170.0||||||
3595256|NCT03163134|3449460|B2|United States||Region of Enrollment||Participants|Count of Participants|85|85.0||||||
3595257|NCT03163134|3449461|B1|United States||Region of Enrollment||Participants|Count of Participants|85|85.0||||||
3595258|NCT03163134|3449459|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3595259|NCT03163134|3449460|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3595260|NCT03163134|3449461|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3595261|NCT03163134|3449459|B3||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3595262|NCT03163134|3449460|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3595263|NCT03163134|3449461|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3595264|NCT03163134|3449459|B3|||Age||years|Mean|52|52.0|Standard Deviation|15.30|15.3|||
3595265|NCT03163134|3449460|B2|||Age||years|Mean|51|51.0|Standard Deviation|15.49|15.49|||
3595266|NCT03163134|3449461|B1|||Age||years|Mean|52|52.0|Standard Deviation|15.11|15.11|||
3595267|NCT03162458|3449470|B3|Russia||Region of Enrollment||Participants|Count of Participants|142|142.0||||||
3595268|NCT03162458|3449471|B2|Russia||Region of Enrollment||Participants|Count of Participants|71|71.0||||||
3595269|NCT03162458|3449472|B1|Russia||Region of Enrollment||Participants|Count of Participants|71|71.0||||||
3595270|NCT03162458|3449470|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3595271|NCT03162458|3449471|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3595272|NCT03162458|3449472|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3595273|NCT03162458|3449470|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3595274|NCT03162458|3449471|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3595275|NCT03162458|3449472|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3595276|NCT03162458|3449470|B3|||Age||years|Mean|1.9|1.9|Standard Deviation|1.0|1.0|||
3595277|NCT03162458|3449471|B2|||Age||years|Mean|1.9|1.9|Standard Deviation|1.0|1.0|||
3595278|NCT03162458|3449472|B1|||Age||years|Mean|1.8|1.8|Standard Deviation|1.0|1.0|||
3595279|NCT03161327|3449497|B1|ABI mild risk||diabetic||Participants|Count of Participants|11|11.0||||||
3595280|NCT03161327|3449497|B1|ABI moderate risk||diabetic||Participants|Count of Participants|11|11.0||||||
3595282|NCT03161327|3449497|B1|Pateients at risk for PAD||diabetic||Participants|Count of Participants|100|100.0||||||
3595283|NCT03161327|3449497|B1|All patients at risk for PAD|Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3595284|NCT03161327|3449497|B1|All patients at risk for PAD|Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3595285|NCT03161327|3449497|B1|ABI mild risk|Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3595286|NCT03161327|3449497|B1|ABI mild risk|Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3595287|NCT03161327|3449497|B1|ABI moderate risk|Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3595288|NCT03161327|3449497|B1|ABI moderate risk|Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3595289|NCT03161327|3449497|B1|ABI severe risk|Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3595290|NCT03161327|3449497|B1|ABI severe risk|Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3595291|NCT03161327|3449497|B1|ABI mild risk||Age||years|Mean|67.1|67.1|Standard Deviation|15.5|15.5|||
3595292|NCT03161327|3449497|B1|ABI moderate risk||Age||years|Mean|65.6|65.6|Standard Deviation|9.2|9.2|||
3595293|NCT03161327|3449497|B1|ABI severe risk||Age||years|Mean|68.2|68.2|Standard Deviation|8.5|8.5|||
3595294|NCT03161327|3449497|B1|All patients at risk for PAD||Age||years|Mean|59.9|59.9|Standard Deviation|13.1|13.1|||
3595295|NCT03161327|3449497|B1||>=65 years|Age||Participants|Count of Participants|81|81.0||||||
3595296|NCT03161327|3449497|B1||Between 18 and 65 years|Age||Participants|Count of Participants|125|125.0||||||
3595297|NCT03161327|3449497|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3595298|NCT03159143|3449502|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3595299|NCT03159143|3449502|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3595300|NCT03159143|3449502|B1|||Age||years|Median|66.4|66.4|Full Range|||39.9|83.2|
3595301|NCT03157232|3449509|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3595302|NCT03157232|3449509|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3595303|NCT03157232|3449509|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3595304|NCT03157232|3449509|B1|26-65 years||Age, Customized||participants|Number|18|18.0||||||
3595305|NCT03154047|3449513|B1|Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3595306|NCT03154047|3449513|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|79|79.0||||||
3595307|NCT03154047|3449513|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3595308|NCT03154047|3449513|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|74|74.0||||||
3595309|NCT03154047|3449513|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3595310|NCT03154047|3449513|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3595311|NCT03154047|3449513|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3595312|NCT03154047|3449513|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3595313|NCT03154047|3449513|B1|||Age||years|Mean|64.5|64.5|Standard Deviation|8.62|8.62|||
3595314|NCT03154047|3449513|B1||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
3595315|NCT03154047|3449513|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3595316|NCT03154047|3449513|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3595317|NCT03151226|3449517|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3595318|NCT03151226|3449517|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595319|NCT03151226|3449517|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595320|NCT03151226|3449517|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3595321|NCT03151226|3449517|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3595322|NCT03151226|3449517|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595323|NCT03151226|3449517|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595324|NCT03151226|3449517|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595325|NCT03151226|3449517|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3595326|NCT03151226|3449517|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3595327|NCT03151226|3449517|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3595328|NCT03151226|3449517|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3595329|NCT03151226|3449517|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3595330|NCT03150485|3449521|B1|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3595331|NCT03150485|3449521|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595332|NCT03150485|3449521|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595333|NCT03150485|3449521|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3595334|NCT03150485|3449521|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3595335|NCT03150485|3449521|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595336|NCT03150485|3449521|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3595337|NCT03150485|3449521|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595338|NCT03150485|3449521|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3595339|NCT03150485|3449521|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3595340|NCT03150485|3449521|B1|||Age||Years|Mean|55.7|55.7|Standard Deviation|5.08|5.08|||
3595341|NCT03150082|3449541|B1||Other-Mixed Race|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3595342|NCT03150082|3449541|B1||White -White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3595343|NCT03150082|3449541|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3595344|NCT03150082|3449541|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3595345|NCT03150082|3449541|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3595346|NCT03150082|3449541|B1|||Age||Years|Mean|23.5|23.5|Standard Deviation|5.62|5.62|||
3595347|NCT03148756|3449596|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3595348|NCT03148756|3449597|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3595349|NCT03148756|3449598|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3595350|NCT03148756|3449596|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3595351|NCT03148756|3449596|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3595352|NCT03148756|3449596|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3595353|NCT03148756|3449596|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3595354|NCT03148756|3449596|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3595355|NCT03148262|3449629|B3|||Body Mass Index||kg/m^2|Mean|49|49.0|Standard Deviation|8.5|8.5|||
3595356|NCT03148262|3449630|B2|||Body Mass Index||kg/m^2|Mean|49|49.0|Standard Deviation|10|10.0|||
3595357|NCT03148262|3449631|B1|||Body Mass Index||kg/m^2|Mean|48|48.0|Standard Deviation|7|7.0|||
3595358|NCT03148262|3449629|B3|United States||Region of Enrollment||participants|Number|59|59.0||||||
3595359|NCT03148262|3449630|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
3595360|NCT03148262|3449631|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
3595361|NCT03148262|3449629|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595362|NCT03148262|3449630|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595363|NCT03148262|3449631|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595364|NCT03148262|3449629|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3595365|NCT03148262|3449630|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3595366|NCT03148262|3449631|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3595367|NCT03148262|3449629|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3595368|NCT03148262|3449630|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3595369|NCT03148262|3449631|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3595370|NCT03148262|3449629|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3595371|NCT03148262|3449630|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3595372|NCT03148262|3449631|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3595373|NCT03148262|3449629|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3595374|NCT03148262|3449630|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3595375|NCT03148262|3449631|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3595376|NCT03148262|3449629|B3|||Age||years|Mean|57|57.0|Standard Deviation|7.5|7.5|||
3595377|NCT03148262|3449630|B2|||Age||years|Mean|59|59.0|Standard Deviation|6.5|6.5|||
3595378|NCT03148262|3449631|B1|||Age||years|Mean|54|54.0|Standard Deviation|7.9|7.9|||
3595379|NCT03143101|3449638|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3595380|NCT03143101|3449639|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3595381|NCT03143101|3449640|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595382|NCT03143101|3449641|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595383|NCT03143101|3449638|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3595384|NCT03143101|3449639|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3595385|NCT03143101|3449640|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3595386|NCT03143101|3449641|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3595387|NCT03143101|3449638|B4||White|Race (NIH/OMB)||Participants|Count of Participants|156|156.0||||||
3595388|NCT03143101|3449639|B3||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3595389|NCT03143101|3449640|B2||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3595390|NCT03143101|3449641|B1||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3595391|NCT03143101|3449638|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3595392|NCT03143101|3449639|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3595393|NCT03143101|3449640|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3595394|NCT03143101|3449641|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3595395|NCT03143101|3449638|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3595396|NCT03143101|3449639|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3595397|NCT03143101|3449640|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595398|NCT03143101|3449641|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3595399|NCT03143101|3449638|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3595400|NCT03143101|3449639|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595401|NCT03143101|3449640|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595402|NCT03143101|3449641|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3595403|NCT03143101|3449638|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3595404|NCT03143101|3449639|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595405|NCT03143101|3449640|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3595406|NCT03143101|3449641|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595407|NCT03143101|3449638|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595408|NCT03143101|3449639|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595409|NCT03143101|3449640|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595410|NCT03143101|3449641|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595411|NCT03143101|3449638|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|166|166.0||||||
3595412|NCT03143101|3449639|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3595413|NCT03143101|3449640|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3595414|NCT03143101|3449641|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3595415|NCT03143101|3449638|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3595416|NCT03143101|3449639|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3595417|NCT03143101|3449640|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3595418|NCT03143101|3449641|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3595419|NCT03143101|3449638|B4||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3595420|NCT03143101|3449639|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3595421|NCT03143101|3449640|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3595422|NCT03143101|3449641|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3595423|NCT03143101|3449638|B4||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3595424|NCT03143101|3449639|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3595425|NCT03143101|3449640|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3595426|NCT03143101|3449641|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3595427|NCT03143101|3449638|B4|||Age||months|Mean|35.29|35.29|Standard Deviation|6.65|6.65|||
3595428|NCT03143101|3449639|B3|||Age||months|Mean|34.94|34.94|Standard Deviation|6.80|6.8|||
3595429|NCT03143101|3449640|B2|||Age||months|Mean|34.96|34.96|Standard Deviation|6.78|6.78|||
3595430|NCT03143101|3449641|B1|||Age||months|Mean|35.96|35.96|Standard Deviation|6.41|6.41|||
3595431|NCT03142932|3449696|B3|||Fagerström Test for Nicotine Dependence|"We used the Fagerstrom Test for Nicotine Dependence (FTND) to measure nicotine dependence.~The measure consists of 6 Questions. Each question has multiple response options out of which one option must be selected. Each option carries a corresponding numerical score. The scores for each question are summed to obtain a total score. The range of possible scores is 1 to 10, with a higher value indicating greater nicotine dependence (worse outcome).~The interpretation of scores is as follows:~1-2: low dependence 3-4: low to moderate dependence 5-7: moderate dependence 8+: high dependence"|score|Mean|2.69|2.69|Standard Deviation|1.47|1.47|||
3595432|NCT03142932|3449697|B2|||Fagerström Test for Nicotine Dependence|"We used the Fagerstrom Test for Nicotine Dependence (FTND) to measure nicotine dependence.~The measure consists of 6 Questions. Each question has multiple response options out of which one option must be selected. Each option carries a corresponding numerical score. The scores for each question are summed to obtain a total score. The range of possible scores is 1 to 10, with a higher value indicating greater nicotine dependence (worse outcome).~The interpretation of scores is as follows:~1-2: low dependence 3-4: low to moderate dependence 5-7: moderate dependence 8+: high dependence"|score|Mean|2.54|2.54|Standard Deviation|1.43|1.43|||
3595433|NCT03142932|3449698|B1|||Fagerström Test for Nicotine Dependence|"We used the Fagerstrom Test for Nicotine Dependence (FTND) to measure nicotine dependence.~The measure consists of 6 Questions. Each question has multiple response options out of which one option must be selected. Each option carries a corresponding numerical score. The scores for each question are summed to obtain a total score. The range of possible scores is 1 to 10, with a higher value indicating greater nicotine dependence (worse outcome).~The interpretation of scores is as follows:~1-2: low dependence 3-4: low to moderate dependence 5-7: moderate dependence 8+: high dependence"|score|Mean|2.85|2.85|Standard Deviation|1.51|1.51|||
3595434|NCT03142932|3449696|B3|||Quit attempts in past 12 months||attempts|Median|2|2.0|Inter-Quartile Range|||1.0|2.0|
3595435|NCT03142932|3449697|B2|||Quit attempts in past 12 months||attempts|Median|2|2.0|Inter-Quartile Range|||2.0|2.0|
3595436|NCT03142932|3449698|B1|||Quit attempts in past 12 months||attempts|Median|2|2.0|Inter-Quartile Range|||1.0|2.0|
3595437|NCT03142932|3449696|B3|||Cigarettes smoked per day||cigarettes|Median|10|10.0|Inter-Quartile Range|||8.0|20.0|
3595438|NCT03142932|3449697|B2|||Cigarettes smoked per day||cigarettes|Median|10|10.0|Inter-Quartile Range|||7.0|20.0|
3595439|NCT03142932|3449698|B1|||Cigarettes smoked per day||cigarettes|Median|10|10.0|Inter-Quartile Range|||9.0|20.0|
3595440|NCT03142932|3449696|B3|Unemployed/don’t work||Employment||Participants|Count of Participants|83|83.0||||||
3595441|NCT03142932|3449697|B2|Unemployed/don’t work||Employment||Participants|Count of Participants|44|44.0||||||
3595442|NCT03142932|3449698|B1|Unemployed/don’t work||Employment||Participants|Count of Participants|39|39.0||||||
3595443|NCT03142932|3449696|B3|Employed (full/part time)||Employment||Participants|Count of Participants|19|19.0||||||
3595444|NCT03142932|3449697|B2|Employed (full/part time)||Employment||Participants|Count of Participants|6|6.0||||||
3595445|NCT03142932|3449698|B1|Employed (full/part time)||Employment||Participants|Count of Participants|13|13.0||||||
3595446|NCT03142932|3449696|B3|High school or more||Education||Participants|Count of Participants|68|68.0||||||
3595447|NCT03142932|3449697|B2|High school or more||Education||Participants|Count of Participants|30|30.0||||||
3595448|NCT03142932|3449698|B1|High school or more||Education||Participants|Count of Participants|38|38.0||||||
3595449|NCT03142932|3449696|B3|Less than high school||Education||Participants|Count of Participants|34|34.0||||||
3595450|NCT03142932|3449697|B2|Less than high school||Education||Participants|Count of Participants|20|20.0||||||
3595451|NCT03142932|3449698|B1|Less than high school||Education||Participants|Count of Participants|14|14.0||||||
3595452|NCT03142932|3449696|B3|United States||Region of Enrollment||participants|Number|102|102.0||||||
3595453|NCT03142932|3449697|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
3595454|NCT03142932|3449698|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
3595455|NCT03142932|3449696|B3|Mixed Race/Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3595456|NCT03142932|3449697|B2|Mixed Race/Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3595457|NCT03142932|3449698|B1|Mixed Race/Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3595458|NCT03142932|3449696|B3|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|81|81.0||||||
3595459|NCT03142932|3449697|B2|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3595460|NCT03142932|3449698|B1|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
3595461|NCT03142932|3449696|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3595462|NCT03142932|3449697|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3595463|NCT03142932|3449698|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3595464|NCT03142932|3449696|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3595465|NCT03142932|3449697|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3595466|NCT03142932|3449698|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3595467|NCT03142932|3449696|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3595468|NCT03142932|3449697|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3595469|NCT03142932|3449698|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3595470|NCT03142932|3449696|B3|||Age||years|Median|52|52.0|Inter-Quartile Range|||45.0|56.0|
3595471|NCT03142932|3449697|B2|||Age||years|Median|52|52.0|Inter-Quartile Range|||47.0|56.0|
3595472|NCT03142932|3449698|B1|||Age||years|Median|51|51.0|Inter-Quartile Range|||41.0|55.0|
3595473|NCT03141372|3449713|B3|||BMI||kg/m^2|Median|30.2|30.2|Inter-Quartile Range|||25.8|35.2|
3595474|NCT03141372|3449714|B2|||BMI||kg/m^2|Median|28.8|28.8|Inter-Quartile Range|||25.8|33.9|
3595475|NCT03141372|3449715|B1|||BMI||kg/m^2|Median|32.4|32.4|Inter-Quartile Range|||25.5|35.9|
3595476|NCT03141372|3449713|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595477|NCT03141372|3449714|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595478|NCT03141372|3449715|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595479|NCT03141372|3449713|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595480|NCT03141372|3449714|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595481|NCT03141372|3449715|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595482|NCT03141372|3449713|B3||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3595483|NCT03141372|3449714|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3595484|NCT03141372|3449715|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3595485|NCT03141372|3449713|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3595486|NCT03141372|3449714|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3595487|NCT03141372|3449715|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3595488|NCT03141372|3449713|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595489|NCT03141372|3449714|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595490|NCT03141372|3449715|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595491|NCT03141372|3449713|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3595492|NCT03141372|3449714|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3595493|NCT03141372|3449715|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595494|NCT03141372|3449713|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595495|NCT03141372|3449714|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595496|NCT03141372|3449715|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595497|NCT03141372|3449713|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3595498|NCT03141372|3449714|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3595499|NCT03141372|3449715|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3595500|NCT03141372|3449713|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3595501|NCT03141372|3449714|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3595502|NCT03141372|3449715|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3595503|NCT03141372|3449713|B3|||Age||years|Median|46|46.0|Inter-Quartile Range|||42.0|50.0|
3595504|NCT03141372|3449714|B2|||Age||years|Median|46|46.0|Inter-Quartile Range|||42.8|50.0|
3595505|NCT03141372|3449715|B1|||Age||years|Median|46|46.0|Inter-Quartile Range|||41.3|50.0|
3595506|NCT03140631|3449734|B3|||Creatinine||mg/dl|Mean|1.0|1.0|Standard Deviation|0.6|0.6|||
3595507|NCT03140631|3449735|B2|||Creatinine||mg/dl|Mean|1.0|1.0|Standard Deviation|0.3|0.3|||
3595508|NCT03140631|3449736|B1|||Creatinine||mg/dl|Mean|1.0|1.0|Standard Deviation|0.8|0.8|||
3595509|NCT03140631|3449734|B3|||INR||ratio|Mean|1.4|1.4|Standard Deviation|0.6|0.6|||
3595510|NCT03140631|3449735|B2|||INR||ratio|Mean|1.3|1.3|Standard Deviation|0.5|0.5|||
3595511|NCT03140631|3449736|B1|||INR||ratio|Mean|1.4|1.4|Standard Deviation|0.6|0.6|||
3595512|NCT03140631|3449734|B3|||Platelets||10^3 platelets/mm^3|Mean|188|188.0|Standard Deviation|70|70.0|||
3595513|NCT03140631|3449735|B2|||Platelets||10^3 platelets/mm^3|Mean|182|182.0|Standard Deviation|72|72.0|||
3595514|NCT03140631|3449736|B1|||Platelets||10^3 platelets/mm^3|Mean|194|194.0|Standard Deviation|67|67.0|||
3595515|NCT03140631|3449734|B3|||Hemoglobin||g/dl|Mean|14.1|14.1|Standard Deviation|1.4|1.4|||
3595516|NCT03140631|3449735|B2|||Hemoglobin||g/dl|Mean|14.4|14.4|Standard Deviation|1.2|1.2|||
3595517|NCT03140631|3449736|B1|||Hemoglobin||g/dl|Mean|13.7|13.7|Standard Deviation|1.6|1.6|||
3595518|NCT03140631|3449734|B3|||NOAC use|this is a count of the number of participants taking a medication in the class of NOAC (novel oral anticoagulants) at the time of study enrollment|Participants|Count of Participants|122|122.0||||||
3595519|NCT03140631|3449735|B2|||NOAC use|this is a count of the number of participants taking a medication in the class of NOAC (novel oral anticoagulants) at the time of study enrollment|Participants|Count of Participants|63|63.0||||||
3595520|NCT03140631|3449736|B1|||NOAC use|this is a count of the number of participants taking a medication in the class of NOAC (novel oral anticoagulants) at the time of study enrollment|Participants|Count of Participants|59|59.0||||||
3595521|NCT03140631|3449734|B3|||Warfarin use|this is a count of the number of participants taking the medication warfarin during study enrollment|Participants|Count of Participants|28|28.0||||||
3595522|NCT03140631|3449735|B2|||Warfarin use|this is a count of the number of participants taking the medication warfarin during study enrollment|Participants|Count of Participants|14|14.0||||||
3595523|NCT03140631|3449736|B1|||Warfarin use|this is a count of the number of participants taking the medication warfarin during study enrollment|Participants|Count of Participants|14|14.0||||||
3595524|NCT03140631|3449734|B3|||CHAD2Ds2-VASc Score|Summation of weighted risk factor points: Congestive Heart Failure (1), Hypertension (1), Age 75 years or older (2), Diabetes Mellitus (1), Stroke/Transient Ischemic Attack/Thromboembolic Event (2), Vascular Disease (1), Age 65 to 74 Years (1), Female Sex (1). The minimum score is 0 and represents the lowest risk of thromboembolic events and 9 is the maximum score and represents the highest risk.|scores on a scale|Mean|2.1|2.1|Standard Deviation|1.2|1.2|||
3595525|NCT03140631|3449735|B2|||CHAD2Ds2-VASc Score|Summation of weighted risk factor points: Congestive Heart Failure (1), Hypertension (1), Age 75 years or older (2), Diabetes Mellitus (1), Stroke/Transient Ischemic Attack/Thromboembolic Event (2), Vascular Disease (1), Age 65 to 74 Years (1), Female Sex (1). The minimum score is 0 and represents the lowest risk of thromboembolic events and 9 is the maximum score and represents the highest risk.|scores on a scale|Mean|2.1|2.1|Standard Deviation|1.2|1.2|||
3595526|NCT03140631|3449736|B1|||CHAD2Ds2-VASc Score|Summation of weighted risk factor points: Congestive Heart Failure (1), Hypertension (1), Age 75 years or older (2), Diabetes Mellitus (1), Stroke/Transient Ischemic Attack/Thromboembolic Event (2), Vascular Disease (1), Age 65 to 74 Years (1), Female Sex (1). The minimum score is 0 and represents the lowest risk of thromboembolic events and 9 is the maximum score and represents the highest risk.|scores on a scale|Mean|2.2|2.2|Standard Deviation|1.2|1.2|||
3595527|NCT03140631|3449734|B3|||BMI||kilograms/(meter squared)|Mean|32|32.0|Standard Deviation|6|6.0|||
3595528|NCT03140631|3449735|B2|||BMI||kilograms/(meter squared)|Mean|32|32.0|Standard Deviation|6|6.0|||
3595529|NCT03140631|3449736|B1|||BMI||kilograms/(meter squared)|Mean|31|31.0|Standard Deviation|7|7.0|||
3595530|NCT03140631|3449734|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3595531|NCT03140631|3449734|B3||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3595532|NCT03140631|3449735|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3595533|NCT03140631|3449736|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3595534|NCT03140631|3449734|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3595535|NCT03140631|3449735|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3595536|NCT03140631|3449736|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3595537|NCT03140631|3449734|B3|||Age||years|Mean|63|63.0|Standard Deviation|11|11.0|||
3595538|NCT03140631|3449735|B2|||Age||years|Mean|63|63.0|Standard Deviation|12|12.0|||
3595539|NCT03140631|3449736|B1|||Age||years|Mean|66|66.0|Standard Deviation|9|9.0|||
3595540|NCT03139578|3449745|B1|United Kingdom||Region of Enrollment||Participants|Number|50|50.0||||||
3595541|NCT03139578|3449745|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595542|NCT03139578|3449745|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3595543|NCT03139578|3449745|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3595544|NCT03139578|3449745|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3595545|NCT03139578|3449745|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595546|NCT03139578|3449745|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3595547|NCT03139578|3449745|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595548|NCT03139578|3449745|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595549|NCT03139578|3449745|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3595550|NCT03139578|3449745|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3595551|NCT03139578|3449745|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3595552|NCT03139578|3449745|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3595553|NCT03139578|3449745|B1|||Age||years|Mean|30.3|30.3|Standard Deviation|13.61|13.61|||
3595554|NCT03139552|3449782|B1|United States||Region of Enrollment||participants|Number|150|150.0||||||
3595555|NCT03139552|3449782|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3595556|NCT03139552|3449782|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595557|NCT03139552|3449782|B1||White|Race (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
3595558|NCT03139552|3449782|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3595559|NCT03139552|3449782|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3595560|NCT03139552|3449782|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3595561|NCT03139552|3449782|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3595562|NCT03139552|3449782|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3595563|NCT03139552|3449782|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|114|114.0||||||
3595564|NCT03139552|3449782|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3595565|NCT03139552|3449782|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3595566|NCT03139552|3449782|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3595567|NCT03139552|3449782|B1|||Age||years|Mean|32.9|32.9|Standard Deviation|10.6|10.6|||
3595568|NCT03138798|3449823|B3||3|Number anesthetic boluses administered in 2nd stage||Participants|Count of Participants|6|6.0||||||
3595569|NCT03138798|3449824|B2||3|Number anesthetic boluses administered in 2nd stage||Participants|Count of Participants|2|2.0||||||
3595570|NCT03138798|3449825|B1||3|Number anesthetic boluses administered in 2nd stage||Participants|Count of Participants|4|4.0||||||
3595571|NCT03138798|3449823|B3||2|Number anesthetic boluses administered in 2nd stage||Participants|Count of Participants|7|7.0||||||
3595572|NCT03138798|3449824|B2||2|Number anesthetic boluses administered in 2nd stage||Participants|Count of Participants|4|4.0||||||
3595573|NCT03138798|3449825|B1||2|Number anesthetic boluses administered in 2nd stage||Participants|Count of Participants|3|3.0||||||
3595574|NCT03138798|3449823|B3||1|Number anesthetic boluses administered in 2nd stage||Participants|Count of Participants|29|29.0||||||
3595575|NCT03138798|3449824|B2||1|Number anesthetic boluses administered in 2nd stage||Participants|Count of Participants|10|10.0||||||
3595576|NCT03138798|3449825|B1||1|Number anesthetic boluses administered in 2nd stage||Participants|Count of Participants|19|19.0||||||
3595577|NCT03138798|3449823|B3||0|Number anesthetic boluses administered in 2nd stage||Participants|Count of Participants|260|260.0||||||
3595578|NCT03138798|3449824|B2||0|Number anesthetic boluses administered in 2nd stage||Participants|Count of Participants|138|138.0||||||
3595579|NCT03138798|3449825|B1||0|Number anesthetic boluses administered in 2nd stage||Participants|Count of Participants|122|122.0||||||
3595580|NCT03138798|3449823|B3|||Epidural||Participants|Count of Participants|302|302.0||||||
3595581|NCT03138798|3449824|B2|||Epidural||Participants|Count of Participants|154|154.0||||||
3595582|NCT03138798|3449825|B1|||Epidural||Participants|Count of Participants|148|148.0||||||
3595583|NCT03138798|3449823|B3|||Number of patients on pitocin in labor||Participants|Count of Participants|232|232.0||||||
3595584|NCT03138798|3449824|B2|||Number of patients on pitocin in labor||Participants|Count of Participants|122|122.0||||||
3595585|NCT03138798|3449825|B1|||Number of patients on pitocin in labor||Participants|Count of Participants|110|110.0||||||
3595586|NCT03138798|3449823|B3|||Cervical dilation at admission >= 6 cm||Participants|Count of Participants|19|19.0||||||
3595587|NCT03138798|3449824|B2|||Cervical dilation at admission >= 6 cm||Participants|Count of Participants|7|7.0||||||
3595588|NCT03138798|3449825|B1|||Cervical dilation at admission >= 6 cm||Participants|Count of Participants|12|12.0||||||
3595589|NCT03138798|3449823|B3|||Meconium at ROM|Meconium at Rupture of Membranes (ROM)|Participants|Count of Participants|50|50.0||||||
3595590|NCT03138798|3449824|B2|||Meconium at ROM|Meconium at Rupture of Membranes (ROM)|Participants|Count of Participants|30|30.0||||||
3595591|NCT03138798|3449825|B1|||Meconium at ROM|Meconium at Rupture of Membranes (ROM)|Participants|Count of Participants|20|20.0||||||
3595592|NCT03138798|3449823|B3|||Membrane Status|Rupture of membranes (ROM) prior to admission|Participants|Count of Participants|71|71.0||||||
3595593|NCT03138798|3449824|B2|||Membrane Status|Rupture of membranes (ROM) prior to admission|Participants|Count of Participants|29|29.0||||||
3595594|NCT03138798|3449825|B1|||Membrane Status|Rupture of membranes (ROM) prior to admission|Participants|Count of Participants|42|42.0||||||
3595595|NCT03138798|3449823|B3||Spontaneous Labor|Indications for Admission||Participants|Count of Participants|191|191.0||||||
3595596|NCT03138798|3449824|B2||Spontaneous Labor|Indications for Admission||Participants|Count of Participants|97|97.0||||||
3595597|NCT03138798|3449825|B1||Spontaneous Labor|Indications for Admission||Participants|Count of Participants|94|94.0||||||
3595598|NCT03138798|3449823|B3||Premature rupture of membranes (PROM)|Indications for Admission||Participants|Count of Participants|62|62.0||||||
3595651|NCT03138798|3449825|B1|Maternal Age|35-39 years|Age, Customized||Participants|Count of Participants|32|32.0||||||
3595599|NCT03138798|3449824|B2||Premature rupture of membranes (PROM)|Indications for Admission||Participants|Count of Participants|31|31.0||||||
3595600|NCT03138798|3449825|B1||Premature rupture of membranes (PROM)|Indications for Admission||Participants|Count of Participants|31|31.0||||||
3595601|NCT03138798|3449823|B3||Labor induction (intact membranes)|Indications for Admission||Participants|Count of Participants|85|85.0||||||
3595602|NCT03138798|3449824|B2||Labor induction (intact membranes)|Indications for Admission||Participants|Count of Participants|43|43.0||||||
3595603|NCT03138798|3449825|B1||Labor induction (intact membranes)|Indications for Admission||Participants|Count of Participants|42|42.0||||||
3595604|NCT03138798|3449823|B3|||Preeclampsia with severe features on Magnesium||Participants|Count of Participants|5|5.0||||||
3595605|NCT03138798|3449824|B2|||Preeclampsia with severe features on Magnesium||Participants|Count of Participants|2|2.0||||||
3595606|NCT03138798|3449825|B1|||Preeclampsia with severe features on Magnesium||Participants|Count of Participants|3|3.0||||||
3595607|NCT03138798|3449823|B3||40+ kg/m2|BMI at delivery|Body Mass Index (BMI) at delivery|Participants|Count of Participants|7|7.0||||||
3595608|NCT03138798|3449824|B2||40+ kg/m2|BMI at delivery|Body Mass Index (BMI) at delivery|Participants|Count of Participants|1|1.0||||||
3595609|NCT03138798|3449825|B1||40+ kg/m2|BMI at delivery|Body Mass Index (BMI) at delivery|Participants|Count of Participants|6|6.0||||||
3595610|NCT03138798|3449823|B3||30-39 kg/m2|BMI at delivery|Body Mass Index (BMI) at delivery|Participants|Count of Participants|78|78.0||||||
3595611|NCT03138798|3449824|B2||30-39 kg/m2|BMI at delivery|Body Mass Index (BMI) at delivery|Participants|Count of Participants|43|43.0||||||
3595612|NCT03138798|3449825|B1||30-39 kg/m2|BMI at delivery|Body Mass Index (BMI) at delivery|Participants|Count of Participants|35|35.0||||||
3595613|NCT03138798|3449823|B3||18-29 kg/m2|BMI at delivery|Body Mass Index (BMI) at delivery|Participants|Count of Participants|253|253.0||||||
3595614|NCT03138798|3449824|B2||18-29 kg/m2|BMI at delivery|Body Mass Index (BMI) at delivery|Participants|Count of Participants|127|127.0||||||
3595615|NCT03138798|3449825|B1||18-29 kg/m2|BMI at delivery|Body Mass Index (BMI) at delivery|Participants|Count of Participants|126|126.0||||||
3595616|NCT03138798|3449823|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3595617|NCT03138798|3449824|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3595618|NCT03138798|3449825|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3595619|NCT03138798|3449823|B3||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
3595620|NCT03138798|3449824|B2||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3595621|NCT03138798|3449825|B1||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3595622|NCT03138798|3449823|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3595623|NCT03138798|3449824|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3595624|NCT03138798|3449825|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3595625|NCT03138798|3449823|B3||African American|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3595626|NCT03138798|3449824|B2||African American|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3595627|NCT03138798|3449825|B1||African American|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3595628|NCT03138798|3449823|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|249|249.0||||||
3595629|NCT03138798|3449824|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|128|128.0||||||
3595630|NCT03138798|3449825|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|121|121.0||||||
3595631|NCT03138798|3449823|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3595632|NCT03138798|3449824|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3595633|NCT03138798|3449825|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3595634|NCT03138798|3449823|B3||Female|Sex: Female, Male||Participants|Count of Participants|338|338.0||||||
3595635|NCT03138798|3449824|B2||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3595636|NCT03138798|3449825|B1||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3595637|NCT03138798|3449823|B3|Gestational Age at procedure|41.0 - 41.9 weeks|Age, Customized||Participants|Count of Participants|49|49.0||||||
3595638|NCT03138798|3449824|B2|Gestational Age at procedure|41.0 - 41.9 weeks|Age, Customized||Participants|Count of Participants|25|25.0||||||
3595639|NCT03138798|3449825|B1|Gestational Age at procedure|41.0 - 41.9 weeks|Age, Customized||Participants|Count of Participants|24|24.0||||||
3595640|NCT03138798|3449823|B3|Gestational Age at procedure|39.0 - 40.9 weeks|Age, Customized||Participants|Count of Participants|224|224.0||||||
3595641|NCT03138798|3449824|B2|Gestational Age at procedure|39.0 - 40.9 weeks|Age, Customized||Participants|Count of Participants|112|112.0||||||
3595642|NCT03138798|3449825|B1|Gestational Age at procedure|39.0 - 40.9 weeks|Age, Customized||Participants|Count of Participants|112|112.0||||||
3595643|NCT03138798|3449823|B3|Gestational Age at procedure|37.0 - 38.9 weeks|Age, Customized||Participants|Count of Participants|65|65.0||||||
3595644|NCT03138798|3449824|B2|Gestational Age at procedure|37.0 - 38.9 weeks|Age, Customized||Participants|Count of Participants|34|34.0||||||
3595645|NCT03138798|3449825|B1|Gestational Age at procedure|37.0 - 38.9 weeks|Age, Customized||Participants|Count of Participants|31|31.0||||||
3595646|NCT03138798|3449823|B3|Maternal Age|40+ years|Age, Customized||Participants|Count of Participants|9|9.0||||||
3595647|NCT03138798|3449824|B2|Maternal Age|40+ years|Age, Customized||Participants|Count of Participants|5|5.0||||||
3595648|NCT03138798|3449825|B1|Maternal Age|40+ years|Age, Customized||Participants|Count of Participants|4|4.0||||||
3595649|NCT03138798|3449823|B3|Maternal Age|35-39 years|Age, Customized||Participants|Count of Participants|59|59.0||||||
3595650|NCT03138798|3449824|B2|Maternal Age|35-39 years|Age, Customized||Participants|Count of Participants|27|27.0||||||
3595652|NCT03138798|3449823|B3|Maternal Age|30-34 years|Age, Customized||Participants|Count of Participants|156|156.0||||||
3595653|NCT03138798|3449824|B2|Maternal Age|30-34 years|Age, Customized||Participants|Count of Participants|83|83.0||||||
3595654|NCT03138798|3449825|B1|Maternal Age|30-34 years|Age, Customized||Participants|Count of Participants|73|73.0||||||
3595655|NCT03138798|3449823|B3|Maternal Age|18-29 years|Age, Customized||Participants|Count of Participants|114|114.0||||||
3595656|NCT03138798|3449824|B2|Maternal Age|18-29 years|Age, Customized||Participants|Count of Participants|56|56.0||||||
3595657|NCT03138798|3449825|B1|Maternal Age|18-29 years|Age, Customized||Participants|Count of Participants|58|58.0||||||
3595658|NCT03135379|3449849|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3595659|NCT03135379|3449849|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3595660|NCT03135379|3449850|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3595661|NCT03135379|3449851|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3595662|NCT03135379|3449849|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3595663|NCT03135379|3449850|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3595664|NCT03135379|3449851|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3595665|NCT03135379|3449849|B3|||Age||years|Mean|41.7|41.7|Standard Deviation|18.0|18.0|||
3595666|NCT03135379|3449850|B2|||Age||years|Mean|42.0|42.0|Standard Deviation|18.5|18.5|||
3595667|NCT03135379|3449851|B1|||Age||years|Mean|41.5|41.5|Standard Deviation|17.6|17.6|||
3595668|NCT03134326|3449860|B1|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3595669|NCT03134326|3449860|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3595670|NCT03134326|3449860|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3595671|NCT03134326|3449860|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3595672|NCT03134326|3449860|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3595673|NCT03134326|3449860|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3595674|NCT03134313|3449864|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3595675|NCT03134313|3449864|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3595676|NCT03134313|3449864|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3595677|NCT03134313|3449864|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3595678|NCT03134313|3449864|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3595679|NCT03134313|3449864|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3595680|NCT03134248|3449868|B1|Canada||Region of Enrollment||Participants|Count of Participants|49|49.0||||||
3595681|NCT03134248|3449868|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3595682|NCT03134248|3449868|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3595683|NCT03134248|3449868|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3595684|NCT03134248|3449868|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3595685|NCT03134248|3449868|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3595686|NCT03134183|3449889|B3|United States||Region of Enrollment||Participants|Count of Participants|68|68.0||||||
3595687|NCT03134183|3449890|B2|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3595688|NCT03134183|3449891|B1|United States||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3595689|NCT03134183|3449889|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3595690|NCT03134183|3449889|B3||Male|Sex: Female, Male|Men not eligible for study. N/A|Participants|Count of Participants|0|0.0||||||
3595691|NCT03134183|3449890|B2||Male|Sex: Female, Male|Men not eligible for study. N/A|Participants|Count of Participants|0|0.0||||||
3595692|NCT03134183|3449891|B1||Male|Sex: Female, Male|Men not eligible for study. N/A|Participants|Count of Participants|0|0.0||||||
3595693|NCT03134183|3449889|B3||Female|Sex: Female, Male|Men not eligible for study. N/A|Participants|Count of Participants|68|68.0||||||
3595694|NCT03134183|3449890|B2||Female|Sex: Female, Male|Men not eligible for study. N/A|Participants|Count of Participants|33|33.0||||||
3595695|NCT03134183|3449891|B1||Female|Sex: Female, Male|Men not eligible for study. N/A|Participants|Count of Participants|35|35.0||||||
3595696|NCT03134183|3449889|B3|35+||Age, Customized||Participants|Count of Participants|15|15.0||||||
3595697|NCT03134183|3449890|B2|35+||Age, Customized||Participants|Count of Participants|5|5.0||||||
3595698|NCT03134183|3449891|B1|35+||Age, Customized||Participants|Count of Participants|10|10.0||||||
3595699|NCT03134183|3449889|B3|30-34||Age, Customized||Participants|Count of Participants|11|11.0||||||
3595700|NCT03134183|3449890|B2|30-34||Age, Customized||Participants|Count of Participants|7|7.0||||||
3595701|NCT03134183|3449891|B1|30-34||Age, Customized||Participants|Count of Participants|4|4.0||||||
3595702|NCT03134183|3449889|B3|25-29||Age, Customized||Participants|Count of Participants|15|15.0||||||
3595703|NCT03134183|3449890|B2|25-29||Age, Customized||Participants|Count of Participants|6|6.0||||||
3595704|NCT03134183|3449891|B1|25-29||Age, Customized||Participants|Count of Participants|9|9.0||||||
3595705|NCT03134183|3449889|B3|18-24||Age, Customized||Participants|Count of Participants|29|29.0||||||
3595706|NCT03134183|3449890|B2|18-24||Age, Customized||Participants|Count of Participants|16|16.0||||||
3595707|NCT03134183|3449891|B1|18-24||Age, Customized||Participants|Count of Participants|13|13.0||||||
3595708|NCT03133767|3449900|B3|United States||Region of Enrollment||participants|Number|94|94.0||||||
3595709|NCT03133767|3449901|B2|United States||Region of Enrollment||participants|Number|53|53.0||||||
3595710|NCT03133767|3449902|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
3595711|NCT03133767|3449900|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3595712|NCT03133767|3449901|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3595713|NCT03133767|3449902|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3595714|NCT03133767|3449900|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595715|NCT03133767|3449901|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595716|NCT03133767|3449902|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595717|NCT03133767|3449900|B3||White|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3595718|NCT03133767|3449901|B2||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3595719|NCT03133767|3449902|B1||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3595720|NCT03133767|3449900|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3595721|NCT03133767|3449901|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3595722|NCT03133767|3449902|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3595723|NCT03133767|3449900|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595724|NCT03133767|3449901|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595725|NCT03133767|3449902|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595726|NCT03133767|3449900|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3595727|NCT03133767|3449901|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595728|NCT03133767|3449902|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3595729|NCT03133767|3449900|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595730|NCT03133767|3449901|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595731|NCT03133767|3449902|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595732|NCT03133767|3449900|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3595733|NCT03133767|3449901|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3595734|NCT03133767|3449902|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3595735|NCT03133767|3449900|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3595736|NCT03133767|3449901|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3595737|NCT03133767|3449902|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3595738|NCT03133767|3449900|B3|||Age||years|Median|35|35.0|Inter-Quartile Range|||23.0|44.0|
3595739|NCT03133767|3449901|B2|||Age||years|Median|39|39.0|Inter-Quartile Range|||25.0|45.0|
3595740|NCT03133767|3449902|B1|||Age||years|Median|29|29.0|Inter-Quartile Range|||22.0|41.0|
3595741|NCT03129321|3449917|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3595742|NCT03129321|3449918|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3595743|NCT03129321|3449919|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3595744|NCT03129321|3449920|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3595745|NCT03129321|3449917|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3595746|NCT03129321|3449918|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3595747|NCT03129321|3449919|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3595748|NCT03129321|3449920|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3595749|NCT03129321|3449917|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3595750|NCT03129321|3449918|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3595751|NCT03129321|3449919|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3595752|NCT03129321|3449920|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3595753|NCT03129321|3449917|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3595754|NCT03129321|3449918|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3595755|NCT03129321|3449919|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3595756|NCT03129321|3449920|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3595757|NCT03129321|3449917|B4|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|365|365.0||||||
3595758|NCT03129321|3449918|B3|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|74|74.0||||||
3595759|NCT03129321|3449919|B2|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|142|142.0||||||
3595760|NCT03129321|3449920|B1|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|149|149.0||||||
3595761|NCT03129321|3449917|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|481|481.0||||||
3595762|NCT03129321|3449918|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|93|93.0||||||
3595763|NCT03129321|3449919|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|197|197.0||||||
3595764|NCT03129321|3449920|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|191|191.0||||||
3595765|NCT03129321|3449917|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595766|NCT03129321|3449918|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595767|NCT03129321|3449919|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595768|NCT03129321|3449920|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595769|NCT03129321|3449917|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|462|462.0||||||
3595770|NCT03129321|3449918|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3595771|NCT03129321|3449919|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|185|185.0||||||
3595772|NCT03129321|3449920|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|183|183.0||||||
3595773|NCT03129321|3449917|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|414|414.0||||||
3595774|NCT03129321|3449918|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
3595775|NCT03129321|3449919|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|165|165.0||||||
3595776|NCT03129321|3449920|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|168|168.0||||||
3595777|NCT03129321|3449917|B4||Male|Sex: Female, Male||Participants|Count of Participants|575|575.0||||||
3595778|NCT03129321|3449918|B3||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3595779|NCT03129321|3449919|B2||Male|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
3595780|NCT03129321|3449920|B1||Male|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
3595781|NCT03129321|3449917|B4||Female|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
3595782|NCT03129321|3449918|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3595783|NCT03129321|3449919|B2||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3595784|NCT03129321|3449920|B1||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3595785|NCT03129321|3449917|B4|||Age||years|Mean|47.0|47.0|Standard Deviation|13.7|13.7|||
3595786|NCT03129321|3449918|B3|||Age||years|Mean|46.1|46.1|Standard Deviation|13.3|13.3|||
3595787|NCT03129321|3449919|B2|||Age||years|Mean|47.1|47.1|Standard Deviation|14.6|14.6|||
3595788|NCT03129321|3449920|B1|||Age||years|Mean|47.3|47.3|Standard Deviation|12.9|12.9|||
3595789|NCT03128723|3449942|B1||No|When purchasing skincare products, do you look for products labeled “for sensitive skin” or similar?||Participants|Count of Participants|3|3.0||||||
3595790|NCT03128723|3449942|B1||Yes|When purchasing skincare products, do you look for products labeled “for sensitive skin” or similar?||Participants|Count of Participants|42|42.0||||||
3595791|NCT03128723|3449942|B1||No|Have you ever been told by a skin care professional that you have sensitive skin on your face?||Participants|Count of Participants|30|30.0||||||
3595792|NCT03128723|3449942|B1||Yes|Have you ever been told by a skin care professional that you have sensitive skin on your face?||Participants|Count of Participants|15|15.0||||||
3595793|NCT03128723|3449942|B1||No|In the past, have you ever stopped using a topical acne treatment due to skin irritation||Participants|Count of Participants|20|20.0||||||
3595794|NCT03128723|3449942|B1||Yes|In the past, have you ever stopped using a topical acne treatment due to skin irritation||Participants|Count of Participants|25|25.0||||||
3595795|NCT03128723|3449942|B1||No|In the past, have you ever experienced skin irritation when using topical acne treatments?||Participants|Count of Participants|7|7.0||||||
3595796|NCT03128723|3449942|B1||Yes|In the past, have you ever experienced skin irritation when using topical acne treatments?||Participants|Count of Participants|38|38.0||||||
3595797|NCT03128723|3449942|B1||All of the time|Do you consider your facial skin to be sensitive?||Participants|Count of Participants|19|19.0||||||
3595798|NCT03128723|3449942|B1||Most of the time|Do you consider your facial skin to be sensitive?||Participants|Count of Participants|26|26.0||||||
3595799|NCT03128723|3449942|B1||Some of the time|Do you consider your facial skin to be sensitive?||Participants|Count of Participants|0|0.0||||||
3595800|NCT03128723|3449942|B1||None of the time|Do you consider your facial skin to be sensitive?||Participants|Count of Participants|0|0.0||||||
3595801|NCT03128723|3449942|B1||4 (severe)|Investigator's global acne assessment|Investigator's global acne assessment score 0-4|Participants|Count of Participants|0|0.0||||||
3595802|NCT03128723|3449942|B1||3 (moderate)|Investigator's global acne assessment|Investigator's global acne assessment score 0-4|Participants|Count of Participants|17|17.0||||||
3595803|NCT03128723|3449942|B1||2 (mild)|Investigator's global acne assessment|Investigator's global acne assessment score 0-4|Participants|Count of Participants|28|28.0||||||
3595804|NCT03128723|3449942|B1||1 (Almost clear)|Investigator's global acne assessment|Investigator's global acne assessment score 0-4|Participants|Count of Participants|0|0.0||||||
3595805|NCT03128723|3449942|B1||0 (clear)|Investigator's global acne assessment|Investigator's global acne assessment score 0-4|Participants|Count of Participants|0|0.0||||||
3595806|NCT03128723|3449942|B1||VI|Fitzpatrick skin type|"Fitzpatrick skin type range I to VI:~I: White; very fair; red or blonde hair; blue eyes; freckles; Always burns easily; never tans II: White; fair; red or blonde hair; blue hazel, or green eyes; Always burns easily; tans minimally III: Cream white; fair with any eye or hair color; very common; Burns moderately; tans gradually IV: Brown; typical Mediterranean white skin; Burns minimally; always tans well V: Dark brown; mid-eastern skin types, black hair, olive skin; Rarely burns; tans profusely VI: Black; black hair, black eyes, black skin; Never burns; deeply pigmented"|Participants|Count of Participants|9|9.0||||||
3595807|NCT03128723|3449942|B1||V|Fitzpatrick skin type|"Fitzpatrick skin type range I to VI:~I: White; very fair; red or blonde hair; blue eyes; freckles; Always burns easily; never tans II: White; fair; red or blonde hair; blue hazel, or green eyes; Always burns easily; tans minimally III: Cream white; fair with any eye or hair color; very common; Burns moderately; tans gradually IV: Brown; typical Mediterranean white skin; Burns minimally; always tans well V: Dark brown; mid-eastern skin types, black hair, olive skin; Rarely burns; tans profusely VI: Black; black hair, black eyes, black skin; Never burns; deeply pigmented"|Participants|Count of Participants|4|4.0||||||
3595901|NCT03124771|3450012|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3595808|NCT03128723|3449942|B1||IV|Fitzpatrick skin type|"Fitzpatrick skin type range I to VI:~I: White; very fair; red or blonde hair; blue eyes; freckles; Always burns easily; never tans II: White; fair; red or blonde hair; blue hazel, or green eyes; Always burns easily; tans minimally III: Cream white; fair with any eye or hair color; very common; Burns moderately; tans gradually IV: Brown; typical Mediterranean white skin; Burns minimally; always tans well V: Dark brown; mid-eastern skin types, black hair, olive skin; Rarely burns; tans profusely VI: Black; black hair, black eyes, black skin; Never burns; deeply pigmented"|Participants|Count of Participants|6|6.0||||||
3595809|NCT03128723|3449942|B1||III|Fitzpatrick skin type|"Fitzpatrick skin type range I to VI:~I: White; very fair; red or blonde hair; blue eyes; freckles; Always burns easily; never tans II: White; fair; red or blonde hair; blue hazel, or green eyes; Always burns easily; tans minimally III: Cream white; fair with any eye or hair color; very common; Burns moderately; tans gradually IV: Brown; typical Mediterranean white skin; Burns minimally; always tans well V: Dark brown; mid-eastern skin types, black hair, olive skin; Rarely burns; tans profusely VI: Black; black hair, black eyes, black skin; Never burns; deeply pigmented"|Participants|Count of Participants|11|11.0||||||
3595810|NCT03128723|3449942|B1||II|Fitzpatrick skin type|"Fitzpatrick skin type range I to VI:~I: White; very fair; red or blonde hair; blue eyes; freckles; Always burns easily; never tans II: White; fair; red or blonde hair; blue hazel, or green eyes; Always burns easily; tans minimally III: Cream white; fair with any eye or hair color; very common; Burns moderately; tans gradually IV: Brown; typical Mediterranean white skin; Burns minimally; always tans well V: Dark brown; mid-eastern skin types, black hair, olive skin; Rarely burns; tans profusely VI: Black; black hair, black eyes, black skin; Never burns; deeply pigmented"|Participants|Count of Participants|15|15.0||||||
3595811|NCT03128723|3449942|B1||I|Fitzpatrick skin type|"Fitzpatrick skin type range I to VI:~I: White; very fair; red or blonde hair; blue eyes; freckles; Always burns easily; never tans II: White; fair; red or blonde hair; blue hazel, or green eyes; Always burns easily; tans minimally III: Cream white; fair with any eye or hair color; very common; Burns moderately; tans gradually IV: Brown; typical Mediterranean white skin; Burns minimally; always tans well V: Dark brown; mid-eastern skin types, black hair, olive skin; Rarely burns; tans profusely VI: Black; black hair, black eyes, black skin; Never burns; deeply pigmented"|Participants|Count of Participants|0|0.0||||||
3595812|NCT03128723|3449942|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3595813|NCT03128723|3449942|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3595814|NCT03128723|3449942|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3595815|NCT03128723|3449942|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3595816|NCT03128723|3449942|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595817|NCT03128723|3449942|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3595818|NCT03128723|3449942|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595819|NCT03128723|3449942|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595820|NCT03128723|3449942|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3595821|NCT03128723|3449942|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3595822|NCT03128723|3449942|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3595823|NCT03128723|3449942|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3595824|NCT03128723|3449942|B1|||Age||Years|Mean|24|24.0|Standard Deviation|8.4|8.4|||
3595825|NCT03128372|3449957|B1|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3595826|NCT03128372|3449957|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595827|NCT03128372|3449957|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3595828|NCT03128372|3449957|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3595829|NCT03128372|3449957|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3595830|NCT03128372|3449957|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595831|NCT03128372|3449957|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3595832|NCT03128372|3449957|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595833|NCT03128372|3449957|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3595834|NCT03128372|3449957|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3595835|NCT03128372|3449957|B1|||Age||years|Mean|31.4|31.4|Standard Deviation|6.66|6.66|||
3595836|NCT03128372|3449957|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3595837|NCT03128372|3449957|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3595838|NCT03128372|3449957|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3595839|NCT03128307|3449961|B1|||How Frequently Do you Snore: VAS (1-10)|A visual-analogue scale (VAS) was used to measure how frequently the subject snored. A score of '0' would indicate the subject never snored, while a score of '10' would indicate the subject snores every single night.|units on a scale|Mean|8.94|8.94|Standard Deviation|2.83|2.83|||
3595840|NCT03128307|3449961|B1|||How Much Does your Snoring bother YOUR PARTNER: VAS (1-10)|A visual-analogue scale (VAS) was used to measure how much snoring bothered the subject's partner (if applicable). A score of '0' was not bothersome at all, while a score of '10' would indicate it is extremely bothersome.|units on a scale|Mean|8.92|8.92|Standard Deviation|1.98|1.98|||
3595841|NCT03128307|3449961|B1|||How Much Does your Snoring bother YOU: VAS (1-10)|A visual-analogue scale (VAS) was used to measure how much snoring bothered the individual user. A score of '0' was not bothersome at all, while a score of '10' would indicate it is extremely bothersome.|units on a scale|Mean|5.08|5.08|Standard Deviation|2.91|2.91|||
3595899|NCT03124784|3450008|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3595900|NCT03124784|3450008|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3595842|NCT03128307|3449961|B1|||Snoring Severity Scale (1-9)|"The Snoring Severity Scale (SSS) is a 9-point, validated scale to measure the severity of snoring. A total of three questions are asked: 1) How often do you snore, 2) How long do you snore, and 3) How audible is your snoring. Answers for each of these questions are summed for a total SSS score. A score of '0' would indicate no snoring at all, while a score of '9' would indicate the most severe snoring as measured by the SSS."|units on a scale|Mean|6.2|6.2|Standard Deviation|1.57|1.57|||
3595843|NCT03128307|3449961|B1||Male|Sex: Female, Male||Participants|Count of Participants|465|465.0||||||
3595844|NCT03128307|3449961|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3595845|NCT03128307|3449961|B1|||Age||years|Mean|48|48.0|Standard Deviation|11|11.0|||
3595846|NCT03125031|3449966|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3595847|NCT03125031|3449966|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3595848|NCT03125031|3449966|B1|18-38 years||Age, Customized||Participants|Count of Participants|44|44.0||||||
3595849|NCT03125018|3449972|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3595850|NCT03125018|3449972|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3595851|NCT03125018|3449972|B1|20-37 years||Age, Customized||Participants|Count of Participants|13|13.0||||||
3595852|NCT03125005|3449976|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
3595853|NCT03125005|3449976|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3595854|NCT03125005|3449976|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3595855|NCT03125005|3449976|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3595856|NCT03125005|3449976|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3595857|NCT03125005|3449976|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3595858|NCT03124979|3449980|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3595859|NCT03124979|3449980|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3595860|NCT03124979|3449980|B1|20-32 years||Age, Customized||Participants|Count of Participants|13|13.0||||||
3595861|NCT03124966|3449984|B1|United States||Region of Enrollment||participants|Number|118|118.0||||||
3595862|NCT03124966|3449984|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3595863|NCT03124966|3449984|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3595864|NCT03124966|3449984|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3595865|NCT03124966|3449984|B1||Between 18 and 65 years|Age||Participants|Count of Participants|118|118.0||||||
3595866|NCT03124966|3449984|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3595867|NCT03124927|3449988|B1|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3595868|NCT03124927|3449988|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3595869|NCT03124927|3449988|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3595870|NCT03124927|3449988|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3595871|NCT03124927|3449988|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3595872|NCT03124927|3449988|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3595873|NCT03124901|3449992|B1|United States||Region of Enrollment||participants|Number|147|147.0||||||
3595874|NCT03124901|3449992|B1||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3595875|NCT03124901|3449992|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3595876|NCT03124901|3449992|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3595877|NCT03124901|3449992|B1||Between 18 and 65 years|Age||Participants|Count of Participants|147|147.0||||||
3595878|NCT03124901|3449992|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3595879|NCT03124836|3449996|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
3595880|NCT03124836|3449996|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3595881|NCT03124836|3449996|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3595882|NCT03124836|3449996|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3595883|NCT03124836|3449996|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3595884|NCT03124836|3449996|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3595885|NCT03124823|3450000|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3595886|NCT03124823|3450000|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3595887|NCT03124823|3450000|B1|24-43 years||Age, Customized||Participants|Count of Participants|11|11.0||||||
3595888|NCT03124797|3450004|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3595889|NCT03124797|3450004|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3595890|NCT03124797|3450004|B1|22-43 years||Age, Customized||Participants|Count of Participants|18|18.0||||||
3595891|NCT03124784|3450008|B1|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3595892|NCT03124784|3450008|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3595893|NCT03124784|3450008|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3595894|NCT03124784|3450008|B1|Asian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3595895|NCT03124784|3450008|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3595896|NCT03124784|3450008|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3595897|NCT03124784|3450008|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3595898|NCT03124784|3450008|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3595902|NCT03124771|3450012|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3595903|NCT03124771|3450012|B1|18-40 years||Age, Customized||Participants|Count of Participants|132|132.0||||||
3595904|NCT03124758|3450016|B1||Male|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
3595905|NCT03124758|3450016|B1||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3595906|NCT03124758|3450016|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3595907|NCT03124758|3450016|B1||Between 18 and 65 years|Age||Participants|Count of Participants|354|354.0||||||
3595908|NCT03124758|3450016|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3595909|NCT03124693|3450020|B1|United States||Region of Enrollment||participants|Number|90|90.0||||||
3595910|NCT03124693|3450020|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3595911|NCT03124693|3450020|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3595912|NCT03124693|3450020|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3595913|NCT03124693|3450020|B1||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
3595914|NCT03124693|3450020|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3595915|NCT03124381|3450024|B3||VI|Fitzpatrick Skin Type|Description:Measure of skin type characteristics, including sensitivity to burning/tanning. Ranging from I to VI, where I = White; very fair; red or blonde hair; blue eyes; freckles; Always burns easily; never tans and VI = Black; black hair, black eyes, black skin; Never burns; deeply pigmented|Participants|Count of Participants|4|4.0||||||
3595916|NCT03124381|3450025|B2||VI|Fitzpatrick Skin Type|Description:Measure of skin type characteristics, including sensitivity to burning/tanning. Ranging from I to VI, where I = White; very fair; red or blonde hair; blue eyes; freckles; Always burns easily; never tans and VI = Black; black hair, black eyes, black skin; Never burns; deeply pigmented|Participants|Count of Participants|3|3.0||||||
3595917|NCT03124381|3450026|B1||VI|Fitzpatrick Skin Type|Description:Measure of skin type characteristics, including sensitivity to burning/tanning. Ranging from I to VI, where I = White; very fair; red or blonde hair; blue eyes; freckles; Always burns easily; never tans and VI = Black; black hair, black eyes, black skin; Never burns; deeply pigmented|Participants|Count of Participants|1|1.0||||||
3595918|NCT03124381|3450024|B3||V|Fitzpatrick Skin Type|Description:Measure of skin type characteristics, including sensitivity to burning/tanning. Ranging from I to VI, where I = White; very fair; red or blonde hair; blue eyes; freckles; Always burns easily; never tans and VI = Black; black hair, black eyes, black skin; Never burns; deeply pigmented|Participants|Count of Participants|16|16.0||||||
3595919|NCT03124381|3450025|B2||V|Fitzpatrick Skin Type|Description:Measure of skin type characteristics, including sensitivity to burning/tanning. Ranging from I to VI, where I = White; very fair; red or blonde hair; blue eyes; freckles; Always burns easily; never tans and VI = Black; black hair, black eyes, black skin; Never burns; deeply pigmented|Participants|Count of Participants|6|6.0||||||
3595920|NCT03124381|3450026|B1||V|Fitzpatrick Skin Type|Description:Measure of skin type characteristics, including sensitivity to burning/tanning. Ranging from I to VI, where I = White; very fair; red or blonde hair; blue eyes; freckles; Always burns easily; never tans and VI = Black; black hair, black eyes, black skin; Never burns; deeply pigmented|Participants|Count of Participants|10|10.0||||||
3595921|NCT03124381|3450024|B3||IV|Fitzpatrick Skin Type|Description:Measure of skin type characteristics, including sensitivity to burning/tanning. Ranging from I to VI, where I = White; very fair; red or blonde hair; blue eyes; freckles; Always burns easily; never tans and VI = Black; black hair, black eyes, black skin; Never burns; deeply pigmented|Participants|Count of Participants|22|22.0||||||
3595922|NCT03124381|3450025|B2||IV|Fitzpatrick Skin Type|Description:Measure of skin type characteristics, including sensitivity to burning/tanning. Ranging from I to VI, where I = White; very fair; red or blonde hair; blue eyes; freckles; Always burns easily; never tans and VI = Black; black hair, black eyes, black skin; Never burns; deeply pigmented|Participants|Count of Participants|10|10.0||||||
3595923|NCT03124381|3450026|B1||IV|Fitzpatrick Skin Type|Description:Measure of skin type characteristics, including sensitivity to burning/tanning. Ranging from I to VI, where I = White; very fair; red or blonde hair; blue eyes; freckles; Always burns easily; never tans and VI = Black; black hair, black eyes, black skin; Never burns; deeply pigmented|Participants|Count of Participants|12|12.0||||||
3595924|NCT03124381|3450024|B3||III|Fitzpatrick Skin Type|Description:Measure of skin type characteristics, including sensitivity to burning/tanning. Ranging from I to VI, where I = White; very fair; red or blonde hair; blue eyes; freckles; Always burns easily; never tans and VI = Black; black hair, black eyes, black skin; Never burns; deeply pigmented|Participants|Count of Participants|32|32.0||||||
3595925|NCT03124381|3450025|B2||III|Fitzpatrick Skin Type|Description:Measure of skin type characteristics, including sensitivity to burning/tanning. Ranging from I to VI, where I = White; very fair; red or blonde hair; blue eyes; freckles; Always burns easily; never tans and VI = Black; black hair, black eyes, black skin; Never burns; deeply pigmented|Participants|Count of Participants|14|14.0||||||
3595926|NCT03124381|3450026|B1||III|Fitzpatrick Skin Type|Description:Measure of skin type characteristics, including sensitivity to burning/tanning. Ranging from I to VI, where I = White; very fair; red or blonde hair; blue eyes; freckles; Always burns easily; never tans and VI = Black; black hair, black eyes, black skin; Never burns; deeply pigmented|Participants|Count of Participants|18|18.0||||||
3595927|NCT03124381|3450024|B3||II|Fitzpatrick Skin Type|Description:Measure of skin type characteristics, including sensitivity to burning/tanning. Ranging from I to VI, where I = White; very fair; red or blonde hair; blue eyes; freckles; Always burns easily; never tans and VI = Black; black hair, black eyes, black skin; Never burns; deeply pigmented|Participants|Count of Participants|52|52.0||||||
3595928|NCT03124381|3450025|B2||II|Fitzpatrick Skin Type|Description:Measure of skin type characteristics, including sensitivity to burning/tanning. Ranging from I to VI, where I = White; very fair; red or blonde hair; blue eyes; freckles; Always burns easily; never tans and VI = Black; black hair, black eyes, black skin; Never burns; deeply pigmented|Participants|Count of Participants|28|28.0||||||
3595965|NCT03124381|3450026|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3595966|NCT03124381|3450024|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595929|NCT03124381|3450026|B1||II|Fitzpatrick Skin Type|Description:Measure of skin type characteristics, including sensitivity to burning/tanning. Ranging from I to VI, where I = White; very fair; red or blonde hair; blue eyes; freckles; Always burns easily; never tans and VI = Black; black hair, black eyes, black skin; Never burns; deeply pigmented|Participants|Count of Participants|24|24.0||||||
3595930|NCT03124381|3450024|B3||I|Fitzpatrick Skin Type|Description:Measure of skin type characteristics, including sensitivity to burning/tanning. Ranging from I to VI, where I = White; very fair; red or blonde hair; blue eyes; freckles; Always burns easily; never tans and VI = Black; black hair, black eyes, black skin; Never burns; deeply pigmented|Participants|Count of Participants|0|0.0||||||
3595931|NCT03124381|3450025|B2||I|Fitzpatrick Skin Type|Description:Measure of skin type characteristics, including sensitivity to burning/tanning. Ranging from I to VI, where I = White; very fair; red or blonde hair; blue eyes; freckles; Always burns easily; never tans and VI = Black; black hair, black eyes, black skin; Never burns; deeply pigmented|Participants|Count of Participants|0|0.0||||||
3595932|NCT03124381|3450026|B1||I|Fitzpatrick Skin Type|Description:Measure of skin type characteristics, including sensitivity to burning/tanning. Ranging from I to VI, where I = White; very fair; red or blonde hair; blue eyes; freckles; Always burns easily; never tans and VI = Black; black hair, black eyes, black skin; Never burns; deeply pigmented|Participants|Count of Participants|0|0.0||||||
3595933|NCT03124381|3450024|B3||All of the Time|Skin Sensitivity|Self-perceived skin sensitivity. Do you consider your skin to be sensitive...none of the time, some of the time, most of the time, all of the time|Participants|Count of Participants|2|2.0||||||
3595934|NCT03124381|3450025|B2||All of the Time|Skin Sensitivity|Self-perceived skin sensitivity. Do you consider your skin to be sensitive...none of the time, some of the time, most of the time, all of the time|Participants|Count of Participants|2|2.0||||||
3595935|NCT03124381|3450026|B1||All of the Time|Skin Sensitivity|Self-perceived skin sensitivity. Do you consider your skin to be sensitive...none of the time, some of the time, most of the time, all of the time|Participants|Count of Participants|0|0.0||||||
3595936|NCT03124381|3450024|B3||Most of the Time|Skin Sensitivity|Self-perceived skin sensitivity. Do you consider your skin to be sensitive...none of the time, some of the time, most of the time, all of the time|Participants|Count of Participants|7|7.0||||||
3595937|NCT03124381|3450025|B2||Most of the Time|Skin Sensitivity|Self-perceived skin sensitivity. Do you consider your skin to be sensitive...none of the time, some of the time, most of the time, all of the time|Participants|Count of Participants|1|1.0||||||
3595938|NCT03124381|3450026|B1||Most of the Time|Skin Sensitivity|Self-perceived skin sensitivity. Do you consider your skin to be sensitive...none of the time, some of the time, most of the time, all of the time|Participants|Count of Participants|6|6.0||||||
3595939|NCT03124381|3450024|B3||Some of the Time|Skin Sensitivity|Self-perceived skin sensitivity. Do you consider your skin to be sensitive...none of the time, some of the time, most of the time, all of the time|Participants|Count of Participants|39|39.0||||||
3595940|NCT03124381|3450025|B2||Some of the Time|Skin Sensitivity|Self-perceived skin sensitivity. Do you consider your skin to be sensitive...none of the time, some of the time, most of the time, all of the time|Participants|Count of Participants|18|18.0||||||
3595941|NCT03124381|3450026|B1||Some of the Time|Skin Sensitivity|Self-perceived skin sensitivity. Do you consider your skin to be sensitive...none of the time, some of the time, most of the time, all of the time|Participants|Count of Participants|21|21.0||||||
3595942|NCT03124381|3450024|B3||None of the Time|Skin Sensitivity|Self-perceived skin sensitivity. Do you consider your skin to be sensitive...none of the time, some of the time, most of the time, all of the time|Participants|Count of Participants|78|78.0||||||
3595943|NCT03124381|3450025|B2||None of the Time|Skin Sensitivity|Self-perceived skin sensitivity. Do you consider your skin to be sensitive...none of the time, some of the time, most of the time, all of the time|Participants|Count of Participants|40|40.0||||||
3595944|NCT03124381|3450026|B1||None of the Time|Skin Sensitivity|Self-perceived skin sensitivity. Do you consider your skin to be sensitive...none of the time, some of the time, most of the time, all of the time|Participants|Count of Participants|38|38.0||||||
3595945|NCT03124381|3450024|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3595946|NCT03124381|3450025|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3595947|NCT03124381|3450026|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3595948|NCT03124381|3450024|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595949|NCT03124381|3450025|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595950|NCT03124381|3450026|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595951|NCT03124381|3450024|B3||White|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3595952|NCT03124381|3450025|B2||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3595953|NCT03124381|3450026|B1||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3595954|NCT03124381|3450024|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3595955|NCT03124381|3450025|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3595956|NCT03124381|3450026|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3595957|NCT03124381|3450024|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595958|NCT03124381|3450025|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595959|NCT03124381|3450026|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595960|NCT03124381|3450024|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3595961|NCT03124381|3450025|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3595962|NCT03124381|3450026|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3595963|NCT03124381|3450024|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3595964|NCT03124381|3450025|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3595967|NCT03124381|3450025|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595968|NCT03124381|3450026|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595969|NCT03124381|3450024|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3595970|NCT03124381|3450025|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3595971|NCT03124381|3450026|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3595972|NCT03124381|3450024|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3595973|NCT03124381|3450025|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3595974|NCT03124381|3450026|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3595975|NCT03124381|3450024|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3595976|NCT03124381|3450025|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3595977|NCT03124381|3450026|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3595978|NCT03124381|3450024|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3595979|NCT03124381|3450025|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3595980|NCT03124381|3450026|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3595981|NCT03124381|3450024|B3|||Age||Years|Mean|19.4|19.4|Standard Deviation|6.86|6.86|||
3595982|NCT03124381|3450025|B2|||Age||Years|Mean|20.0|20.0|Standard Deviation|7.65|7.65|||
3595983|NCT03124381|3450026|B1|||Age||Years|Mean|18.8|18.8|Standard Deviation|6.03|6.03|||
3595984|NCT03124199|3450117|B1|Spain||Region of Enrollment||participants|Number|40|40.0||||||
3595985|NCT03124199|3450117|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3595986|NCT03124199|3450117|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3595987|NCT03124199|3450117|B1|||Age||years|Mean|44|44.0|Standard Deviation|15|15.0|||
3595988|NCT03124199|3450117|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3595989|NCT03124199|3450117|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3595990|NCT03124199|3450117|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3595991|NCT03123848|3450123|B1|JAPAN||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3595992|NCT03123848|3450123|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3595993|NCT03123848|3450123|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595994|NCT03123848|3450123|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3595995|NCT03123848|3450123|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3595996|NCT03123848|3450123|B1|Male||Sex/Gender, Customized||Participants|Count of Participants|8|8.0||||||
3595997|NCT03123848|3450123|B1|||Age||years|Mean|33.1|33.1|Standard Deviation|6.10|6.1|||
3595998|NCT03123354|3450145|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
3595999|NCT03123354|3450145|B1|Ethnicity|Not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3596000|NCT03123354|3450145|B1|Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3596001|NCT03123354|3450145|B1|Ethnicity|Hispanic/Latino|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3596002|NCT03123354|3450145|B1|Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3596003|NCT03123354|3450145|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3596004|NCT03123354|3450145|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3596005|NCT03123354|3450145|B1|2-12 years||Age, Customized||Participants|Count of Participants|19|19.0||||||
3596006|NCT03123354|3450145|B1|0-23 months||Age, Customized||Participants|Count of Participants|14|14.0||||||
3596007|NCT03121820|3450149|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3596008|NCT03121820|3450150|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3596009|NCT03121820|3450151|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3596010|NCT03121820|3450149|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3596011|NCT03121820|3450150|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3596012|NCT03121820|3450151|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3596013|NCT03121820|3450149|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3596014|NCT03121820|3450150|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3596015|NCT03121820|3450151|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3596016|NCT03121820|3450149|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3596017|NCT03121820|3450150|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3596018|NCT03121820|3450151|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3596019|NCT03121820|3450149|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3596020|NCT03121820|3450150|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3596021|NCT03121820|3450151|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3596022|NCT03119831|3450160|B4||Mandible|Jaw||Participants|Count of Participants|19|19.0||||||
3596023|NCT03119831|3450161|B3||Mandible|Jaw||Participants|Count of Participants|5|5.0||||||
3596024|NCT03119831|3450162|B2||Mandible|Jaw||Participants|Count of Participants|8|8.0||||||
3596025|NCT03119831|3450163|B1||Mandible|Jaw||Participants|Count of Participants|6|6.0||||||
3596026|NCT03119831|3450160|B4||Maxilla|Jaw||Participants|Count of Participants|23|23.0||||||
3596027|NCT03119831|3450161|B3||Maxilla|Jaw||Participants|Count of Participants|9|9.0||||||
3596028|NCT03119831|3450162|B2||Maxilla|Jaw||Participants|Count of Participants|6|6.0||||||
3596029|NCT03119831|3450163|B1||Maxilla|Jaw||Participants|Count of Participants|8|8.0||||||
3596030|NCT03119831|3450160|B4||Area #43-47|Tooth area scheduled for surgery|"According to FDI World Dental Federation enumeration system:~Area #13-17: Maxillary right canine - maxillary right second molar~Area #23-27: Maxillary left canine - maxillary left second molar~Area #33-37: Mandibular left canine - mandibular left second molar~Area #43-47: Mandibular right canine - mandibular right second molar"|Participants|Count of Participants|12|12.0||||||
3596031|NCT03119831|3450161|B3||Area #43-47|Tooth area scheduled for surgery|"According to FDI World Dental Federation enumeration system:~Area #13-17: Maxillary right canine - maxillary right second molar~Area #23-27: Maxillary left canine - maxillary left second molar~Area #33-37: Mandibular left canine - mandibular left second molar~Area #43-47: Mandibular right canine - mandibular right second molar"|Participants|Count of Participants|3|3.0||||||
3596032|NCT03119831|3450162|B2||Area #43-47|Tooth area scheduled for surgery|"According to FDI World Dental Federation enumeration system:~Area #13-17: Maxillary right canine - maxillary right second molar~Area #23-27: Maxillary left canine - maxillary left second molar~Area #33-37: Mandibular left canine - mandibular left second molar~Area #43-47: Mandibular right canine - mandibular right second molar"|Participants|Count of Participants|5|5.0||||||
3596033|NCT03119831|3450163|B1||Area #43-47|Tooth area scheduled for surgery|"According to FDI World Dental Federation enumeration system:~Area #13-17: Maxillary right canine - maxillary right second molar~Area #23-27: Maxillary left canine - maxillary left second molar~Area #33-37: Mandibular left canine - mandibular left second molar~Area #43-47: Mandibular right canine - mandibular right second molar"|Participants|Count of Participants|4|4.0||||||
3596034|NCT03119831|3450160|B4||Area #33-37|Tooth area scheduled for surgery|"According to FDI World Dental Federation enumeration system:~Area #13-17: Maxillary right canine - maxillary right second molar~Area #23-27: Maxillary left canine - maxillary left second molar~Area #33-37: Mandibular left canine - mandibular left second molar~Area #43-47: Mandibular right canine - mandibular right second molar"|Participants|Count of Participants|7|7.0||||||
3596035|NCT03119831|3450161|B3||Area #33-37|Tooth area scheduled for surgery|"According to FDI World Dental Federation enumeration system:~Area #13-17: Maxillary right canine - maxillary right second molar~Area #23-27: Maxillary left canine - maxillary left second molar~Area #33-37: Mandibular left canine - mandibular left second molar~Area #43-47: Mandibular right canine - mandibular right second molar"|Participants|Count of Participants|2|2.0||||||
3596036|NCT03119831|3450162|B2||Area #33-37|Tooth area scheduled for surgery|"According to FDI World Dental Federation enumeration system:~Area #13-17: Maxillary right canine - maxillary right second molar~Area #23-27: Maxillary left canine - maxillary left second molar~Area #33-37: Mandibular left canine - mandibular left second molar~Area #43-47: Mandibular right canine - mandibular right second molar"|Participants|Count of Participants|3|3.0||||||
3596037|NCT03119831|3450163|B1||Area #33-37|Tooth area scheduled for surgery|"According to FDI World Dental Federation enumeration system:~Area #13-17: Maxillary right canine - maxillary right second molar~Area #23-27: Maxillary left canine - maxillary left second molar~Area #33-37: Mandibular left canine - mandibular left second molar~Area #43-47: Mandibular right canine - mandibular right second molar"|Participants|Count of Participants|2|2.0||||||
3596038|NCT03119831|3450160|B4||Area #23-27|Tooth area scheduled for surgery|"According to FDI World Dental Federation enumeration system:~Area #13-17: Maxillary right canine - maxillary right second molar~Area #23-27: Maxillary left canine - maxillary left second molar~Area #33-37: Mandibular left canine - mandibular left second molar~Area #43-47: Mandibular right canine - mandibular right second molar"|Participants|Count of Participants|9|9.0||||||
3596039|NCT03119831|3450161|B3||Area #23-27|Tooth area scheduled for surgery|"According to FDI World Dental Federation enumeration system:~Area #13-17: Maxillary right canine - maxillary right second molar~Area #23-27: Maxillary left canine - maxillary left second molar~Area #33-37: Mandibular left canine - mandibular left second molar~Area #43-47: Mandibular right canine - mandibular right second molar"|Participants|Count of Participants|4|4.0||||||
3596040|NCT03119831|3450162|B2||Area #23-27|Tooth area scheduled for surgery|"According to FDI World Dental Federation enumeration system:~Area #13-17: Maxillary right canine - maxillary right second molar~Area #23-27: Maxillary left canine - maxillary left second molar~Area #33-37: Mandibular left canine - mandibular left second molar~Area #43-47: Mandibular right canine - mandibular right second molar"|Participants|Count of Participants|2|2.0||||||
3596041|NCT03119831|3450163|B1||Area #23-27|Tooth area scheduled for surgery|"According to FDI World Dental Federation enumeration system:~Area #13-17: Maxillary right canine - maxillary right second molar~Area #23-27: Maxillary left canine - maxillary left second molar~Area #33-37: Mandibular left canine - mandibular left second molar~Area #43-47: Mandibular right canine - mandibular right second molar"|Participants|Count of Participants|3|3.0||||||
3596042|NCT03119831|3450160|B4||Area #13-17|Tooth area scheduled for surgery|"According to FDI World Dental Federation enumeration system:~Area #13-17: Maxillary right canine - maxillary right second molar~Area #23-27: Maxillary left canine - maxillary left second molar~Area #33-37: Mandibular left canine - mandibular left second molar~Area #43-47: Mandibular right canine - mandibular right second molar"|Participants|Count of Participants|14|14.0||||||
3596043|NCT03119831|3450161|B3||Area #13-17|Tooth area scheduled for surgery|"According to FDI World Dental Federation enumeration system:~Area #13-17: Maxillary right canine - maxillary right second molar~Area #23-27: Maxillary left canine - maxillary left second molar~Area #33-37: Mandibular left canine - mandibular left second molar~Area #43-47: Mandibular right canine - mandibular right second molar"|Participants|Count of Participants|5|5.0||||||
3596044|NCT03119831|3450162|B2||Area #13-17|Tooth area scheduled for surgery|"According to FDI World Dental Federation enumeration system:~Area #13-17: Maxillary right canine - maxillary right second molar~Area #23-27: Maxillary left canine - maxillary left second molar~Area #33-37: Mandibular left canine - mandibular left second molar~Area #43-47: Mandibular right canine - mandibular right second molar"|Participants|Count of Participants|4|4.0||||||
3596045|NCT03119831|3450163|B1||Area #13-17|Tooth area scheduled for surgery|"According to FDI World Dental Federation enumeration system:~Area #13-17: Maxillary right canine - maxillary right second molar~Area #23-27: Maxillary left canine - maxillary left second molar~Area #33-37: Mandibular left canine - mandibular left second molar~Area #43-47: Mandibular right canine - mandibular right second molar"|Participants|Count of Participants|5|5.0||||||
3596046|NCT03119831|3450160|B4||Combination|Type of periodontal surgical intervention||Participants|Count of Participants|2|2.0||||||
3596047|NCT03119831|3450161|B3||Combination|Type of periodontal surgical intervention||Participants|Count of Participants|1|1.0||||||
3596048|NCT03119831|3450162|B2||Combination|Type of periodontal surgical intervention||Participants|Count of Participants|1|1.0||||||
3596049|NCT03119831|3450163|B1||Combination|Type of periodontal surgical intervention||Participants|Count of Participants|0|0.0||||||
3596050|NCT03119831|3450160|B4||Crown lengthening|Type of periodontal surgical intervention||Participants|Count of Participants|10|10.0||||||
3596051|NCT03119831|3450161|B3||Crown lengthening|Type of periodontal surgical intervention||Participants|Count of Participants|5|5.0||||||
3596052|NCT03119831|3450162|B2||Crown lengthening|Type of periodontal surgical intervention||Participants|Count of Participants|1|1.0||||||
3596053|NCT03119831|3450163|B1||Crown lengthening|Type of periodontal surgical intervention||Participants|Count of Participants|4|4.0||||||
3596054|NCT03119831|3450160|B4||Periodontal flap surgery|Type of periodontal surgical intervention||Participants|Count of Participants|30|30.0||||||
3596055|NCT03119831|3450161|B3||Periodontal flap surgery|Type of periodontal surgical intervention||Participants|Count of Participants|8|8.0||||||
3596056|NCT03119831|3450162|B2||Periodontal flap surgery|Type of periodontal surgical intervention||Participants|Count of Participants|12|12.0||||||
3596057|NCT03119831|3450163|B1||Periodontal flap surgery|Type of periodontal surgical intervention||Participants|Count of Participants|10|10.0||||||
3596058|NCT03119831|3450160|B4||First year postgraduate residents|Surgeon's experience||Participants|Count of Participants|9|9.0||||||
3596059|NCT03119831|3450161|B3||First year postgraduate residents|Surgeon's experience||Participants|Count of Participants|4|4.0||||||
3596060|NCT03119831|3450162|B2||First year postgraduate residents|Surgeon's experience||Participants|Count of Participants|2|2.0||||||
3596061|NCT03119831|3450163|B1||First year postgraduate residents|Surgeon's experience||Participants|Count of Participants|3|3.0||||||
3596062|NCT03119831|3450160|B4||Third year postgraduate residents|Surgeon's experience||Participants|Count of Participants|33|33.0||||||
3596063|NCT03119831|3450161|B3||Third year postgraduate residents|Surgeon's experience||Participants|Count of Participants|10|10.0||||||
3596064|NCT03119831|3450162|B2||Third year postgraduate residents|Surgeon's experience||Participants|Count of Participants|12|12.0||||||
3596065|NCT03119831|3450163|B1||Third year postgraduate residents|Surgeon's experience||Participants|Count of Participants|11|11.0||||||
3596066|NCT03119831|3450160|B4||Ex - smoker|Smoking status||Participants|Count of Participants|3|3.0||||||
3596067|NCT03119831|3450161|B3||Ex - smoker|Smoking status||Participants|Count of Participants|1|1.0||||||
3596068|NCT03119831|3450162|B2||Ex - smoker|Smoking status||Participants|Count of Participants|1|1.0||||||
3596069|NCT03119831|3450163|B1||Ex - smoker|Smoking status||Participants|Count of Participants|1|1.0||||||
3596070|NCT03119831|3450160|B4||Non - smoker|Smoking status||Participants|Count of Participants|23|23.0||||||
3596071|NCT03119831|3450161|B3||Non - smoker|Smoking status||Participants|Count of Participants|8|8.0||||||
3596072|NCT03119831|3450162|B2||Non - smoker|Smoking status||Participants|Count of Participants|7|7.0||||||
3596073|NCT03119831|3450163|B1||Non - smoker|Smoking status||Participants|Count of Participants|8|8.0||||||
3596074|NCT03119831|3450160|B4||Smoker|Smoking status||Participants|Count of Participants|16|16.0||||||
3596075|NCT03119831|3450161|B3||Smoker|Smoking status||Participants|Count of Participants|5|5.0||||||
3596076|NCT03119831|3450162|B2||Smoker|Smoking status||Participants|Count of Participants|6|6.0||||||
3596077|NCT03119831|3450163|B1||Smoker|Smoking status||Participants|Count of Participants|5|5.0||||||
3596078|NCT03119831|3450160|B4|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3596079|NCT03119831|3450160|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3596080|NCT03119831|3450161|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3596081|NCT03119831|3450162|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3596082|NCT03119831|3450163|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3596083|NCT03119831|3450160|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3596084|NCT03119831|3450161|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3596085|NCT03119831|3450162|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3596086|NCT03119831|3450163|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3596087|NCT03119831|3450160|B4|||Age||years|Median|51|51.0|Inter-Quartile Range|||45.0|58.0|
3596088|NCT03119831|3450161|B3|||Age||years|Median|49|49.0|Inter-Quartile Range|||43.0|55.0|
3596089|NCT03119831|3450162|B2|||Age||years|Median|52|52.0|Inter-Quartile Range|||49.0|59.0|
3596090|NCT03119831|3450163|B1|||Age||years|Median|53|53.0|Inter-Quartile Range|||43.0|58.0|
3596091|NCT03119649|3450182|B6||Unknown or Not Reported|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|3|3.0||||||
3596092|NCT03119649|3450183|B5||Unknown or Not Reported|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|1|1.0||||||
3596093|NCT03119649|3450184|B4||Unknown or Not Reported|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|1|1.0||||||
3596094|NCT03119649|3450185|B3||Unknown or Not Reported|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|0|0.0||||||
3596095|NCT03119649|3450186|B2||Unknown or Not Reported|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|1|1.0||||||
3596181|NCT03118934|3450236|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3596096|NCT03119649|3450187|B1||Unknown or Not Reported|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|0|0.0||||||
3596097|NCT03119649|3450182|B6||More than one race|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|0|0.0||||||
3596098|NCT03119649|3450183|B5||More than one race|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|0|0.0||||||
3596099|NCT03119649|3450184|B4||More than one race|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|0|0.0||||||
3596100|NCT03119649|3450185|B3||More than one race|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|0|0.0||||||
3596101|NCT03119649|3450186|B2||More than one race|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|0|0.0||||||
3596102|NCT03119649|3450187|B1||More than one race|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|0|0.0||||||
3596103|NCT03119649|3450182|B6||White|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|56|56.0||||||
3596104|NCT03119649|3450183|B5||White|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|13|13.0||||||
3596105|NCT03119649|3450184|B4||White|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|13|13.0||||||
3596106|NCT03119649|3450185|B3||White|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|10|10.0||||||
3596107|NCT03119649|3450186|B2||White|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|9|9.0||||||
3596108|NCT03119649|3450187|B1||White|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|11|11.0||||||
3596109|NCT03119649|3450182|B6||Black or African American|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|0|0.0||||||
3596110|NCT03119649|3450183|B5||Black or African American|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|0|0.0||||||
3596111|NCT03119649|3450184|B4||Black or African American|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|0|0.0||||||
3596112|NCT03119649|3450185|B3||Black or African American|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|0|0.0||||||
3596113|NCT03119649|3450186|B2||Black or African American|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|0|0.0||||||
3596114|NCT03119649|3450187|B1||Black or African American|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|0|0.0||||||
3596115|NCT03119649|3450182|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|0|0.0||||||
3596116|NCT03119649|3450183|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|0|0.0||||||
3596117|NCT03119649|3450184|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|0|0.0||||||
3596118|NCT03119649|3450185|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|0|0.0||||||
3596119|NCT03119649|3450186|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|0|0.0||||||
3596120|NCT03119649|3450187|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|0|0.0||||||
3596121|NCT03119649|3450182|B6||Asian|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|0|0.0||||||
3596122|NCT03119649|3450183|B5||Asian|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|0|0.0||||||
3596123|NCT03119649|3450184|B4||Asian|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|0|0.0||||||
3596124|NCT03119649|3450185|B3||Asian|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|0|0.0||||||
3596125|NCT03119649|3450186|B2||Asian|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|0|0.0||||||
3596126|NCT03119649|3450187|B1||Asian|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|0|0.0||||||
3596127|NCT03119649|3450182|B6||American Indian or Alaska Native|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|0|0.0||||||
3596128|NCT03119649|3450183|B5||American Indian or Alaska Native|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|0|0.0||||||
3596129|NCT03119649|3450184|B4||American Indian or Alaska Native|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|0|0.0||||||
3596130|NCT03119649|3450185|B3||American Indian or Alaska Native|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|0|0.0||||||
3596131|NCT03119649|3450186|B2||American Indian or Alaska Native|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|0|0.0||||||
3596132|NCT03119649|3450187|B1||American Indian or Alaska Native|Race (NIH/OMB)|Unknown data were not reported because local regulations did not allow the Sponsor to ask for the information.|Participants|Count of Participants|0|0.0||||||
3596133|NCT03119649|3450182|B6||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3596134|NCT03119649|3450183|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3596135|NCT03119649|3450184|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3596136|NCT03119649|3450185|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3596137|NCT03119649|3450186|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3596138|NCT03119649|3450187|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3596139|NCT03119649|3450182|B6||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3596140|NCT03119649|3450183|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3596141|NCT03119649|3450184|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3596142|NCT03119649|3450185|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3596143|NCT03119649|3450186|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3596144|NCT03119649|3450187|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3596145|NCT03119649|3450182|B6|||Age||years|Median|27.0|27.0|Full Range|||18.0|59.0|
3596146|NCT03119649|3450183|B5|||Age||years|Median|26.0|26.0|Full Range|||19.0|59.0|
3596147|NCT03119649|3450184|B4|||Age||years|Median|32.0|32.0|Full Range|||19.0|47.0|
3596148|NCT03119649|3450185|B3|||Age||years|Median|24.0|24.0|Full Range|||18.0|35.0|
3596149|NCT03119649|3450186|B2|||Age||years|Median|26.0|26.0|Full Range|||20.0|37.0|
3596150|NCT03119649|3450187|B1|||Age||years|Median|27.0|27.0|Full Range|||21.0|58.0|
3596151|NCT03118934|3450234|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3596152|NCT03118934|3450235|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3596153|NCT03118934|3450236|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3596154|NCT03118934|3450237|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3596155|NCT03118934|3450234|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3596156|NCT03118934|3450235|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3596157|NCT03118934|3450236|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3596158|NCT03118934|3450237|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3596159|NCT03118934|3450234|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3596160|NCT03118934|3450235|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3596161|NCT03118934|3450236|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3596162|NCT03118934|3450237|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3596163|NCT03118934|3450234|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3596164|NCT03118934|3450235|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3596165|NCT03118934|3450236|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3596166|NCT03118934|3450237|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3596167|NCT03118934|3450234|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3596168|NCT03118934|3450235|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3596169|NCT03118934|3450236|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3596170|NCT03118934|3450237|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3596171|NCT03118934|3450234|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|154|154.0||||||
3596172|NCT03118934|3450235|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
3596173|NCT03118934|3450236|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
3596174|NCT03118934|3450237|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|55|55.0||||||
3596175|NCT03118934|3450234|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3596176|NCT03118934|3450235|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3596177|NCT03118934|3450236|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3596178|NCT03118934|3450237|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3596179|NCT03118934|3450234|B4||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3596180|NCT03118934|3450235|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3596182|NCT03118934|3450237|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3596183|NCT03118934|3450234|B4|||Age||years|Mean|50.3|50.3|Standard Deviation|6.7|6.7|||
3596184|NCT03118934|3450235|B3|||Age||years|Mean|50.1|50.1|Standard Deviation|6.7|6.7|||
3596185|NCT03118934|3450236|B2|||Age||years|Mean|50.1|50.1|Standard Deviation|6.7|6.7|||
3596186|NCT03118934|3450237|B1|||Age||years|Mean|50.6|50.6|Standard Deviation|6.9|6.9|||
3596187|NCT03118297|3450252|B3|||Days of bleeding in 30 days prior to enrollment||days|Median|20.3|20.3|Inter-Quartile Range|||13.3|28.8|
3596188|NCT03118297|3450253|B2|||Days of bleeding in 30 days prior to enrollment||days|Median|20.0|20.0|Inter-Quartile Range|||14.0|28.0|
3596189|NCT03118297|3450254|B1|||Days of bleeding in 30 days prior to enrollment||days|Median|20.5|20.5|Inter-Quartile Range|||12.5|29.5|
3596190|NCT03118297|3450252|B3|||Duration of implant use||months|Median|10.1|10.1|Inter-Quartile Range|||5.7|18.7|
3596191|NCT03118297|3450253|B2|||Duration of implant use||months|Median|9.2|9.2|Inter-Quartile Range|||5.9|19.3|
3596192|NCT03118297|3450254|B1|||Duration of implant use||months|Median|10.9|10.9|Inter-Quartile Range|||5.5|18.1|
3596193|NCT03118297|3450252|B3|||BMI||kg/m^2|Mean|28.7|28.7|Standard Deviation|7.6|7.6|||
3596194|NCT03118297|3450253|B2|||BMI||kg/m^2|Mean|27.8|27.8|Standard Deviation|7.0|7.0|||
3596195|NCT03118297|3450254|B1|||BMI||kg/m^2|Mean|29.6|29.6|Standard Deviation|8.2|8.2|||
3596196|NCT03118297|3450252|B3|United States||Region of Enrollment||participants|Number|63|63.0||||||
3596197|NCT03118297|3450253|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
3596198|NCT03118297|3450254|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
3596199|NCT03118297|3450252|B3|Race|Other or multiracial|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3596200|NCT03118297|3450253|B2|Race|Other or multiracial|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3596201|NCT03118297|3450254|B1|Race|Other or multiracial|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3596202|NCT03118297|3450252|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3596203|NCT03118297|3450253|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3596204|NCT03118297|3450254|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3596205|NCT03118297|3450252|B3|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
3596206|NCT03118297|3450253|B2|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3596207|NCT03118297|3450254|B1|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3596208|NCT03118297|3450252|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596209|NCT03118297|3450253|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596210|NCT03118297|3450254|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596211|NCT03118297|3450252|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3596212|NCT03118297|3450253|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3596213|NCT03118297|3450254|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3596214|NCT03118297|3450252|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3596215|NCT03118297|3450253|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3596216|NCT03118297|3450254|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596217|NCT03118297|3450252|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3596218|NCT03118297|3450253|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3596219|NCT03118297|3450254|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3596220|NCT03118297|3450252|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3596221|NCT03118297|3450253|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3596222|NCT03118297|3450254|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3596223|NCT03118297|3450252|B3|||Age||years|Mean|26.0|26.0|Standard Deviation|6.2|6.2|||
3596224|NCT03118297|3450253|B2|||Age||years|Mean|25.5|25.5|Standard Deviation|6.3|6.3|||
3596225|NCT03118297|3450254|B1|||Age||years|Mean|26.4|26.4|Standard Deviation|6.2|6.2|||
3596226|NCT03117140|3450269|B5|||Weight||kilograms|Mean|98.09|98.09|Standard Deviation|22.79|22.79|||
3596227|NCT03117140|3450270|B4|||Weight||kilograms|Mean|95.63|95.63|Standard Deviation|21.41|21.41|||
3596228|NCT03117140|3450271|B3|||Weight||kilograms|Mean|99.78|99.78|Standard Deviation|25.95|25.95|||
3596229|NCT03117140|3450272|B2|||Weight||kilograms|Mean|98.13|98.13|Standard Deviation|21.47|21.47|||
3596230|NCT03117140|3450273|B1|||Weight||kilograms|Mean|98.82|98.82|Standard Deviation|22.71|22.71|||
3596231|NCT03117140|3450269|B5|ASA classification III||ASA (American Society of Anesthesiolgy) Classification system|I-a normal healthy patient II- a patient with mild systemic disease III-a patient with severe systemic disease|Participants|Count of Participants|15|15.0||||||
3596232|NCT03117140|3450270|B4|ASA classification III||ASA (American Society of Anesthesiolgy) Classification system|I-a normal healthy patient II- a patient with mild systemic disease III-a patient with severe systemic disease|Participants|Count of Participants|2|2.0||||||
3596233|NCT03117140|3450271|B3|ASA classification III||ASA (American Society of Anesthesiolgy) Classification system|I-a normal healthy patient II- a patient with mild systemic disease III-a patient with severe systemic disease|Participants|Count of Participants|7|7.0||||||
3596234|NCT03117140|3450272|B2|ASA classification III||ASA (American Society of Anesthesiolgy) Classification system|I-a normal healthy patient II- a patient with mild systemic disease III-a patient with severe systemic disease|Participants|Count of Participants|2|2.0||||||
3596235|NCT03117140|3450273|B1|ASA classification III||ASA (American Society of Anesthesiolgy) Classification system|I-a normal healthy patient II- a patient with mild systemic disease III-a patient with severe systemic disease|Participants|Count of Participants|4|4.0||||||
3596236|NCT03117140|3450269|B5|ASA classification II||ASA (American Society of Anesthesiolgy) Classification system|I-a normal healthy patient II- a patient with mild systemic disease III-a patient with severe systemic disease|Participants|Count of Participants|86|86.0||||||
3596237|NCT03117140|3450270|B4|ASA classification II||ASA (American Society of Anesthesiolgy) Classification system|I-a normal healthy patient II- a patient with mild systemic disease III-a patient with severe systemic disease|Participants|Count of Participants|21|21.0||||||
3596238|NCT03117140|3450271|B3|ASA classification II||ASA (American Society of Anesthesiolgy) Classification system|I-a normal healthy patient II- a patient with mild systemic disease III-a patient with severe systemic disease|Participants|Count of Participants|18|18.0||||||
3596239|NCT03117140|3450272|B2|ASA classification II||ASA (American Society of Anesthesiolgy) Classification system|I-a normal healthy patient II- a patient with mild systemic disease III-a patient with severe systemic disease|Participants|Count of Participants|24|24.0||||||
3596240|NCT03117140|3450273|B1|ASA classification II||ASA (American Society of Anesthesiolgy) Classification system|I-a normal healthy patient II- a patient with mild systemic disease III-a patient with severe systemic disease|Participants|Count of Participants|23|23.0||||||
3596241|NCT03117140|3450269|B5|ASA classification I||ASA (American Society of Anesthesiolgy) Classification system|I-a normal healthy patient II- a patient with mild systemic disease III-a patient with severe systemic disease|Participants|Count of Participants|59|59.0||||||
3596242|NCT03117140|3450270|B4|ASA classification I||ASA (American Society of Anesthesiolgy) Classification system|I-a normal healthy patient II- a patient with mild systemic disease III-a patient with severe systemic disease|Participants|Count of Participants|17|17.0||||||
3596243|NCT03117140|3450271|B3|ASA classification I||ASA (American Society of Anesthesiolgy) Classification system|I-a normal healthy patient II- a patient with mild systemic disease III-a patient with severe systemic disease|Participants|Count of Participants|15|15.0||||||
3596244|NCT03117140|3450272|B2|ASA classification I||ASA (American Society of Anesthesiolgy) Classification system|I-a normal healthy patient II- a patient with mild systemic disease III-a patient with severe systemic disease|Participants|Count of Participants|14|14.0||||||
3596245|NCT03117140|3450273|B1|ASA classification I||ASA (American Society of Anesthesiolgy) Classification system|I-a normal healthy patient II- a patient with mild systemic disease III-a patient with severe systemic disease|Participants|Count of Participants|13|13.0||||||
3596246|NCT03117140|3450269|B5|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3596247|NCT03117140|3450269|B5||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3596248|NCT03117140|3450270|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3596249|NCT03117140|3450271|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3596250|NCT03117140|3450272|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3596251|NCT03117140|3450273|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3596252|NCT03117140|3450269|B5||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3596253|NCT03117140|3450270|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3596254|NCT03117140|3450271|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3596255|NCT03117140|3450272|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3596256|NCT03117140|3450273|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3596257|NCT03117140|3450269|B5|||Age||years|Mean|43.89|43.89|Standard Deviation|14.19|14.19|||
3596258|NCT03117140|3450270|B4|||Age||years|Mean|42.3|42.3|Standard Deviation|13.71|13.71|||
3596259|NCT03117140|3450271|B3|||Age||years|Mean|43.1|43.1|Standard Deviation|14.74|14.74|||
3596260|NCT03117140|3450272|B2|||Age||years|Mean|44.8|44.8|Standard Deviation|14.2|14.2|||
3596261|NCT03117140|3450273|B1|||Age||years|Mean|45.38|45.38|Standard Deviation|14.39|14.39|||
3596262|NCT03117140|3450269|B5||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3596263|NCT03117140|3450270|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3596264|NCT03117140|3450271|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3596265|NCT03117140|3450272|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3596266|NCT03117140|3450273|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3596267|NCT03117140|3450269|B5||Between 18 and 65 years|Age||Participants|Count of Participants|154|154.0||||||
3596268|NCT03117140|3450270|B4||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3596269|NCT03117140|3450271|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3596270|NCT03117140|3450272|B2||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3596271|NCT03117140|3450273|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3596272|NCT03117140|3450269|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3596273|NCT03117140|3450270|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3596274|NCT03117140|3450271|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3596275|NCT03117140|3450272|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3596276|NCT03117140|3450273|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3596277|NCT03115853|3450342|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
3596278|NCT03115853|3450342|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3596279|NCT03115853|3450342|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3596280|NCT03115853|3450342|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3596281|NCT03115177|3450360|B3|||Body Mass Index||kg/m^2|Mean|30|30.0|Standard Deviation|6|6.0|||
3596282|NCT03115177|3450361|B2|||Body Mass Index||kg/m^2|Mean|30|30.0|Standard Deviation|6|6.0|||
3596283|NCT03115177|3450362|B1|||Body Mass Index||kg/m^2|Mean|30|30.0|Standard Deviation|6|6.0|||
3596284|NCT03115177|3450360|B3|United States||Region of Enrollment||participants|Number|56|56.0||||||
3596285|NCT03115177|3450361|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
3596286|NCT03115177|3450362|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3596287|NCT03115177|3450360|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3596288|NCT03115177|3450360|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3596289|NCT03115177|3450361|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3596290|NCT03115177|3450362|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3596291|NCT03115177|3450360|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3596292|NCT03115177|3450361|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3596293|NCT03115177|3450362|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3596294|NCT03115177|3450360|B3|||Age||years|Mean|68|68.0|Standard Deviation|8|8.0|||
3596295|NCT03115177|3450361|B2|||Age||years|Mean|67|67.0|Standard Deviation|8|8.0|||
3596296|NCT03115177|3450362|B1|||Age||years|Mean|69|69.0|Standard Deviation|8|8.0|||
3596297|NCT03115177|3450360|B3||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
3596298|NCT03115177|3450361|B2||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3596299|NCT03115177|3450362|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3596300|NCT03115177|3450360|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3596301|NCT03115177|3450361|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3596302|NCT03115177|3450362|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3596303|NCT03115177|3450360|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3596304|NCT03115177|3450361|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3596305|NCT03115177|3450362|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3596306|NCT03114995|3450369|B4||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3596307|NCT03114995|3450370|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3596308|NCT03114995|3450371|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3596309|NCT03114995|3450372|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3596310|NCT03114995|3450369|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3596311|NCT03114995|3450370|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3596312|NCT03114995|3450371|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3596313|NCT03114995|3450372|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3596314|NCT03114995|3450369|B4|||Age||years|Mean|64.8|64.8|Standard Deviation|11.4|11.4|||
3596315|NCT03114995|3450370|B3|||Age||years|Mean|62.9|62.9|Standard Deviation|10.1|10.1|||
3596316|NCT03114995|3450371|B2|||Age||years|Mean|64.5|64.5|Standard Deviation|12.0|12.0|||
3596317|NCT03114995|3450372|B1|||Age||years|Mean|70.0|70.0|Standard Deviation|12.8|12.8|||
3596318|NCT03110900|3450385|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3596319|NCT03110900|3450386|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3596320|NCT03110900|3450387|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3596321|NCT03110900|3450385|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596322|NCT03110900|3450386|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596323|NCT03110900|3450387|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596324|NCT03110900|3450385|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596325|NCT03110900|3450386|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596326|NCT03110900|3450387|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596327|NCT03110900|3450385|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596328|NCT03110900|3450386|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596329|NCT03110900|3450387|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596330|NCT03110900|3450385|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596331|NCT03110900|3450386|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596332|NCT03110900|3450387|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596333|NCT03110900|3450385|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596334|NCT03110900|3450386|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596335|NCT03110900|3450387|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596336|NCT03110900|3450385|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596337|NCT03110900|3450386|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596338|NCT03110900|3450387|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596339|NCT03110900|3450385|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3596340|NCT03110900|3450386|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3596341|NCT03110900|3450387|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3596342|NCT03110900|3450385|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3596343|NCT03110900|3450386|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3596344|NCT03110900|3450387|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3596345|NCT03110900|3450385|B3|>18 years <99||Age, Customized||Participants|Count of Participants|2|2.0||||||
3596346|NCT03110900|3450386|B2|>18 years <99||Age, Customized||Participants|Count of Participants|1|1.0||||||
3596347|NCT03110900|3450387|B1|>18 years <99||Age, Customized||Participants|Count of Participants|1|1.0||||||
3596348|NCT03110003|3450394|B3|United States||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3596349|NCT03110003|3450395|B2|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3596350|NCT03110003|3450396|B1|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3596351|NCT03110003|3450394|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3596352|NCT03110003|3450394|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3596353|NCT03110003|3450395|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3596354|NCT03110003|3450396|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3596355|NCT03110003|3450394|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3596356|NCT03110003|3450395|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3596357|NCT03110003|3450396|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3596358|NCT03110003|3450394|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3596359|NCT03110003|3450395|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3596360|NCT03110003|3450396|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3596361|NCT03110003|3450394|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3596362|NCT03110003|3450395|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3596363|NCT03110003|3450396|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3596364|NCT03110003|3450394|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3596365|NCT03110003|3450395|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3596366|NCT03110003|3450396|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3596367|NCT03109769|3450413|B3|Saudi Arabia||Region of Enrollment||participants|Number|44|44.0||||||
3596368|NCT03109769|3450414|B2|Saudi Arabia||Region of Enrollment||participants|Number|22|22.0||||||
3596369|NCT03109769|3450415|B1|Saudi Arabia||Region of Enrollment||participants|Number|22|22.0||||||
3596370|NCT03109769|3450413|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3596371|NCT03109769|3450413|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3596372|NCT03109769|3450414|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3596373|NCT03109769|3450415|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3596374|NCT03109769|3450413|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3596375|NCT03109769|3450414|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3596376|NCT03109769|3450415|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3596377|NCT03109769|3450413|B3|||Age||years|Mean|16.9|16.9|Standard Deviation|4.4|4.4|||
3596378|NCT03109769|3450414|B2|||Age||years|Mean|17.2|17.2|Standard Deviation|5.2|5.2|||
3596379|NCT03109769|3450415|B1|||Age||years|Mean|16.6|16.6|Standard Deviation|3.2|3.2|||
3596380|NCT03106870|3450424|B3|Egypt||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
3596381|NCT03106870|3450425|B2|Egypt||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3596382|NCT03106870|3450426|B1|Egypt||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3596383|NCT03106870|3450424|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3596384|NCT03106870|3450425|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3596385|NCT03106870|3450426|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3596386|NCT03106870|3450424|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3596387|NCT03106870|3450425|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3596388|NCT03106870|3450426|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3596389|NCT03106870|3450424|B3|||Age||years|Mean|29.3|29.3|Standard Deviation|3.7|3.7|||
3596390|NCT03106870|3450425|B2|||Age||years|Mean|29.7|29.7|Standard Deviation|3.5|3.5|||
3596391|NCT03106870|3450426|B1|||Age||years|Mean|28.9|28.9|Standard Deviation|3.9|3.9|||
3596392|NCT03106870|3450424|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3596393|NCT03106870|3450425|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3596394|NCT03106870|3450426|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3596395|NCT03106870|3450424|B3||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
3596396|NCT03106870|3450425|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3596397|NCT03106870|3450426|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3596398|NCT03106870|3450424|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3596399|NCT03106870|3450425|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3596400|NCT03106870|3450426|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3596401|NCT03106337|3450437|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3596402|NCT03106337|3450437|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3596403|NCT03106337|3450437|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3596404|NCT03106337|3450437|B1|||Age||years|Mean|55|55.0|Standard Deviation|16.1|16.1|||
3596405|NCT03105518|3450442|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596406|NCT03105518|3450442|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596407|NCT03105518|3450442|B1||White|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
3596408|NCT03105518|3450442|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3596409|NCT03105518|3450442|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596410|NCT03105518|3450442|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3596411|NCT03105518|3450442|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596412|NCT03105518|3450442|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596413|NCT03105518|3450442|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3596414|NCT03105518|3450442|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3596415|NCT03105518|3450442|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3596416|NCT03105518|3450442|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3596417|NCT03105518|3450442|B1|||Age||years|Mean|35.54|35.54|Standard Deviation|4.61|4.61|||
3596418|NCT03104985|3450447|B3|Russia||Region of Enrollment||Participants|Count of Participants|68|68.0||||||
3596419|NCT03104985|3450448|B2|Russia||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3596420|NCT03104985|3450449|B1|Russia||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3596421|NCT03104985|3450447|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3596422|NCT03104985|3450447|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3596423|NCT03104985|3450448|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3596424|NCT03104985|3450449|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3596425|NCT03104985|3450447|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3596426|NCT03104985|3450448|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3596427|NCT03104985|3450449|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3596428|NCT03104985|3450447|B3|||Age||years|Mean|57.2|57.2|Full Range|||39.0|78.0|
3596429|NCT03104985|3450448|B2|||Age||years|Mean|57.5|57.5|Full Range|||40.0|78.0|
3596430|NCT03104985|3450449|B1|||Age||years|Mean|56.9|56.9|Full Range|||39.0|77.0|
3596431|NCT03104738|3450456|B3|||BMI||Kg/m2|Mean|37.8|37.8|Standard Deviation|9.6|9.6|||
3596432|NCT03104738|3450457|B2|||BMI||Kg/m2|Mean|39.9|39.9|Standard Deviation|8.7|8.7|||
3596433|NCT03104738|3450458|B1|||BMI||Kg/m2|Mean|35.8|35.8|Standard Deviation|10.2|10.2|||
3596434|NCT03104738|3450456|B3|||Height||cm|Mean|169.3|169.3|Standard Deviation|11.2|11.2|||
3596435|NCT03104738|3450457|B2|||Height||cm|Mean|166.4|166.4|Standard Deviation|10.1|10.1|||
3596436|NCT03104738|3450458|B1|||Height||cm|Mean|172.1|172.1|Standard Deviation|11.7|11.7|||
3596437|NCT03104738|3450456|B3|||Weight||Kg|Mean|108.0|108.0|Standard Deviation|26.9|26.9|||
3596438|NCT03104738|3450457|B2|||Weight||Kg|Mean|110.0|110.0|Standard Deviation|23.3|23.3|||
3596439|NCT03104738|3450458|B1|||Weight||Kg|Mean|105.9|105.9|Standard Deviation|30.5|30.5|||
3596440|NCT03104738|3450456|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596441|NCT03104738|3450457|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596442|NCT03104738|3450458|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596443|NCT03104738|3450456|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596444|NCT03104738|3450457|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596445|NCT03104738|3450458|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596446|NCT03104738|3450456|B3||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3596447|NCT03104738|3450457|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3596448|NCT03104738|3450458|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3596449|NCT03104738|3450456|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3596450|NCT03104738|3450457|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3596451|NCT03104738|3450458|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3596452|NCT03104738|3450456|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596453|NCT03104738|3450457|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596454|NCT03104738|3450458|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596455|NCT03104738|3450456|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3596456|NCT03104738|3450457|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596457|NCT03104738|3450458|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3596458|NCT03104738|3450456|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596459|NCT03104738|3450457|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596460|NCT03104738|3450458|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596461|NCT03104738|3450456|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3596462|NCT03104738|3450457|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3596463|NCT03104738|3450458|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3596464|NCT03104738|3450456|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3596465|NCT03104738|3450457|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3596466|NCT03104738|3450458|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3596467|NCT03104738|3450456|B3|||Age||years|Mean|59.2|59.2|Standard Deviation|11|11.0|||
3596468|NCT03104738|3450457|B2|||Age||years|Mean|57.9|57.9|Standard Deviation|11.4|11.4|||
3596469|NCT03104738|3450458|B1|||Age||years|Mean|60.6|60.6|Standard Deviation|11.4|11.4|||
3596470|NCT03104647|3450485|B1|Israel||Region of Enrollment||participants|Number|20|20.0||||||
3596471|NCT03104647|3450485|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3596472|NCT03104647|3450485|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3596473|NCT03104647|3450485|B1|||Age||years|Mean|38|38.0|Standard Deviation|14|14.0|||
3596474|NCT03104647|3450485|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3596475|NCT03104647|3450485|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3596476|NCT03104647|3450485|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3596477|NCT03101150|3450490|B3|||Primiparity||Participants|Count of Participants|64|64.0||||||
3596478|NCT03101150|3450491|B2|||Primiparity||Participants|Count of Participants|33|33.0||||||
3596479|NCT03101150|3450492|B1|||Primiparity||Participants|Count of Participants|31|31.0||||||
3596480|NCT03101150|3450490|B3|||Body Mass Index (BMI)||Kg/m2|Mean|28.4|28.4|Standard Deviation|7.2|7.2|||
3596481|NCT03101150|3450491|B2|||Body Mass Index (BMI)||Kg/m2|Mean|28.1|28.1|Standard Deviation|7.2|7.2|||
3596482|NCT03101150|3450492|B1|||Body Mass Index (BMI)||Kg/m2|Mean|28.8|28.8|Standard Deviation|7.3|7.3|||
3596483|NCT03101150|3450490|B3|Africa||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3596484|NCT03101150|3450491|B2|Africa||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3596485|NCT03101150|3450492|B1|Africa||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3596486|NCT03101150|3450490|B3|Philippines||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3596487|NCT03101150|3450491|B2|Philippines||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3596488|NCT03101150|3450492|B1|Philippines||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3596489|NCT03101150|3450490|B3|India||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3596490|NCT03101150|3450491|B2|India||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3596491|NCT03101150|3450492|B1|India||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3596492|NCT03101150|3450490|B3|Saudi Arabia||Region of Enrollment||Participants|Count of Participants|160|160.0||||||
3596493|NCT03101150|3450491|B2|Saudi Arabia||Region of Enrollment||Participants|Count of Participants|80|80.0||||||
3596494|NCT03101150|3450492|B1|Saudi Arabia||Region of Enrollment||Participants|Count of Participants|80|80.0||||||
3596495|NCT03101150|3450490|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3596496|NCT03101150|3450491|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3596497|NCT03101150|3450492|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3596498|NCT03101150|3450490|B3||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
3596499|NCT03101150|3450491|B2||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3596500|NCT03101150|3450492|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3596501|NCT03101150|3450490|B3|||Age||years|Mean|29.3|29.3|Standard Deviation|5.2|5.2|||
3596502|NCT03101150|3450491|B2|||Age||years|Mean|29.4|29.4|Standard Deviation|4.8|4.8|||
3596503|NCT03101150|3450492|B1|||Age||years|Mean|29.3|29.3|Standard Deviation|5.3|5.3|||
3596504|NCT03101033|3450503|B3|||Duration of pain||months|Mean|9.08|9.08|Standard Deviation|4.97|4.97|||
3596505|NCT03101033|3450504|B2|||Duration of pain||months|Mean|8.84|8.84|Standard Deviation|4.61|4.61|||
3596506|NCT03101033|3450505|B1|||Duration of pain||months|Mean|9.52|9.52|Standard Deviation|5.65|5.65|||
3596507|NCT03101033|3450503|B3|||BMI||kg/mʌ2|Mean|23.17|23.17|Standard Deviation|1.60|1.6|||
3596508|NCT03101033|3450504|B2|||BMI||kg/mʌ2|Mean|23.37|23.37|Standard Deviation|1.66|1.66|||
3596509|NCT03101033|3450505|B1|||BMI||kg/mʌ2|Mean|22.50|22.5|Standard Deviation|2.24|2.24|||
3596510|NCT03101033|3450503|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3596511|NCT03101033|3450504|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3596512|NCT03101033|3450505|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3596513|NCT03101033|3450503|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3596514|NCT03101033|3450504|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3596515|NCT03101033|3450505|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3596516|NCT03101033|3450503|B3|||Age||years|Mean|48.83|48.83|Standard Deviation|15.07|15.07|||
3596517|NCT03101033|3450504|B2|||Age||years|Mean|47.67|47.67|Standard Deviation|15.34|15.34|||
3596518|NCT03101033|3450505|B1|||Age||years|Mean|51.04|51.04|Standard Deviation|14.56|14.56|||
3596519|NCT03099096|3450526|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3596520|NCT03099096|3450526|B1||White - White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|126|126.0||||||
3596521|NCT03099096|3450526|B1||White - Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3596522|NCT03099096|3450526|B1||Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3596753|NCT03090958|3450802|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3596523|NCT03099096|3450526|B1||Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3596524|NCT03099096|3450526|B1||Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3596525|NCT03099096|3450526|B1||African American/African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3596526|NCT03099096|3450526|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3596527|NCT03099096|3450526|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3596528|NCT03099096|3450526|B1|||Age||Years|Mean|49.3|49.3|Standard Deviation|16.18|16.18|||
3596529|NCT03098966|3450533|B1|Egypt||Region of Enrollment||Participants|Count of Participants|368|368.0||||||
3596530|NCT03098966|3450533|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3596531|NCT03098966|3450533|B1||Female|Sex: Female, Male||Participants|Count of Participants|368|368.0||||||
3596532|NCT03098966|3450533|B1|||Age||years|Mean|28.6|28.6|Standard Deviation|4.6|4.6|||
3596533|NCT03098966|3450533|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3596534|NCT03098966|3450533|B1||Between 18 and 65 years|Age||Participants|Count of Participants|368|368.0||||||
3596535|NCT03098966|3450533|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3596536|NCT03097614|3450539|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596537|NCT03097614|3450539|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596538|NCT03097614|3450539|B1||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3596539|NCT03097614|3450539|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596540|NCT03097614|3450539|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596541|NCT03097614|3450539|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596542|NCT03097614|3450539|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596543|NCT03097614|3450539|B1|Male||Sex/Gender, Customized||Participants|Number|14|14.0||||||
3596544|NCT03097614|3450539|B1|Female||Sex/Gender, Customized||Participants|Number|43|43.0||||||
3596545|NCT03097614|3450539|B1|||Age||Years|Mean|60.3|60.3|Standard Deviation|9.6|9.6|||
3596546|NCT03097289|3450543|B1|||Weight||pounds|Mean|196.5|196.5|Standard Deviation|48.27|48.27|||
3596547|NCT03097289|3450543|B1|||Height||inches|Mean|68.3|68.3|Standard Deviation|3.24|3.24|||
3596548|NCT03097289|3450543|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
3596549|NCT03097289|3450543|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3596550|NCT03097289|3450543|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3596551|NCT03097289|3450543|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3596552|NCT03097289|3450543|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3596553|NCT03097289|3450543|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3596554|NCT03097289|3450543|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3596555|NCT03097289|3450543|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3596556|NCT03097289|3450543|B1|Age ≥ 18 years||Age, Customized||Participants|Count of Participants|32|32.0||||||
3596557|NCT03095638|3450550|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3596558|NCT03095638|3450551|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3596559|NCT03095638|3450552|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3596560|NCT03095638|3450550|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3596561|NCT03095638|3450551|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3596562|NCT03095638|3450552|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3596563|NCT03095638|3450550|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3596564|NCT03095638|3450551|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3596565|NCT03095638|3450552|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3596566|NCT03095638|3450550|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3596567|NCT03095638|3450551|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3596568|NCT03095638|3450552|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3596569|NCT03095638|3450550|B3|||Age||Years|Mean|34.9|34.9|Standard Deviation|9.355|9.355|||
3596570|NCT03095638|3450551|B2|||Age||Years|Mean|35.7|35.7|Standard Deviation|9.71|9.71|||
3596571|NCT03095638|3450552|B1|||Age||Years|Mean|34.1|34.1|Standard Deviation|9.00|9.0|||
3596572|NCT03095456|3450705|B3|Former Smoker||Smoking history||Participants|Count of Participants|110|110.0||||||
3596573|NCT03095456|3450706|B2|Former Smoker||Smoking history||Participants|Count of Participants|54|54.0||||||
3596574|NCT03095456|3450707|B1|Former Smoker||Smoking history||Participants|Count of Participants|56|56.0||||||
3596575|NCT03095456|3450705|B3|Current Smoker||Smoking history||Participants|Count of Participants|96|96.0||||||
3596576|NCT03095456|3450706|B2|Current Smoker||Smoking history||Participants|Count of Participants|50|50.0||||||
3596577|NCT03095456|3450707|B1|Current Smoker||Smoking history||Participants|Count of Participants|46|46.0||||||
3596578|NCT03095456|3450705|B3|United States||Region of Enrollment||Participants|Count of Participants|206|206.0||||||
3596579|NCT03095456|3450706|B2|United States||Region of Enrollment||Participants|Count of Participants|104|104.0||||||
3596580|NCT03095456|3450707|B1|United States||Region of Enrollment||Participants|Count of Participants|102|102.0||||||
3596581|NCT03095456|3450705|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596582|NCT03095456|3450706|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596583|NCT03095456|3450707|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596584|NCT03095456|3450705|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596585|NCT03095456|3450706|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596586|NCT03095456|3450707|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596587|NCT03095456|3450705|B3||White|Race (NIH/OMB)||Participants|Count of Participants|185|185.0||||||
3596588|NCT03095456|3450706|B2||White|Race (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3596589|NCT03095456|3450707|B1||White|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
3596590|NCT03095456|3450705|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3596591|NCT03095456|3450706|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3596592|NCT03095456|3450707|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3596593|NCT03095456|3450705|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596594|NCT03095456|3450706|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596595|NCT03095456|3450707|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596596|NCT03095456|3450705|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596597|NCT03095456|3450706|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596598|NCT03095456|3450707|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596599|NCT03095456|3450705|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596600|NCT03095456|3450706|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596601|NCT03095456|3450707|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596602|NCT03095456|3450705|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3596603|NCT03095456|3450706|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596604|NCT03095456|3450707|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3596605|NCT03095456|3450705|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|197|197.0||||||
3596606|NCT03095456|3450706|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
3596607|NCT03095456|3450707|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3596608|NCT03095456|3450705|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3596609|NCT03095456|3450706|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3596610|NCT03095456|3450707|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3596611|NCT03095456|3450705|B3||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3596612|NCT03095456|3450706|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3596613|NCT03095456|3450707|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3596614|NCT03095456|3450705|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3596615|NCT03095456|3450706|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3596616|NCT03095456|3450707|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3596617|NCT03095456|3450705|B3|||Age||years|Mean|65.1|65.1|Standard Deviation|8.13|8.13|||
3596618|NCT03095456|3450706|B2|||Age||years|Mean|65.1|65.1|Standard Deviation|8.36|8.36|||
3596619|NCT03095456|3450707|B1|||Age||years|Mean|65.1|65.1|Standard Deviation|7.94|7.94|||
3596620|NCT03095456|3450705|B3||>=65 years|Age||Participants|Count of Participants|102|102.0||||||
3596621|NCT03095456|3450706|B2||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
3596622|NCT03095456|3450707|B1||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
3596623|NCT03095456|3450705|B3||Between 18 and 65 years|Age||Participants|Count of Participants|104|104.0||||||
3596624|NCT03095456|3450706|B2||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
3596625|NCT03095456|3450707|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3596626|NCT03095456|3450705|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3596627|NCT03095456|3450706|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3596628|NCT03095456|3450707|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3596629|NCT03094806|3450724|B3|||Body Mass Index (BMI)||kg/m^2|Mean|32.6|32.6|Standard Deviation|10.3|10.3|||
3596630|NCT03094806|3450725|B2|||Body Mass Index (BMI)||kg/m^2|Mean|30.7|30.7|Standard Deviation|8.2|8.2|||
3596631|NCT03094806|3450726|B1|||Body Mass Index (BMI)||kg/m^2|Mean|34.6|34.6|Standard Deviation|11.9|11.9|||
3596632|NCT03094806|3450724|B3|United States||Region of Enrollment||participants|Number|91|91.0||||||
3596633|NCT03094806|3450725|B2|United States||Region of Enrollment||participants|Number|47|47.0||||||
3596634|NCT03094806|3450726|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
3596635|NCT03094806|3450724|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3596636|NCT03094806|3450725|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||not measured
3596637|NCT03094806|3450726|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||not measured
3596638|NCT03094806|3450724|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3596639|NCT03094806|3450725|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||not measured
3596640|NCT03094806|3450726|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||not measured
3596641|NCT03094806|3450724|B3||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3596642|NCT03094806|3450725|B2||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3596643|NCT03094806|3450726|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3596644|NCT03094806|3450724|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3596645|NCT03094806|3450725|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3596646|NCT03094806|3450726|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3596647|NCT03094806|3450724|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596648|NCT03094806|3450725|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596649|NCT03094806|3450726|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596650|NCT03094806|3450724|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596651|NCT03094806|3450725|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596652|NCT03094806|3450726|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596653|NCT03094806|3450724|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596654|NCT03094806|3450725|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596655|NCT03094806|3450726|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596656|NCT03094806|3450724|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3596657|NCT03094806|3450725|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3596658|NCT03094806|3450726|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3596659|NCT03094806|3450724|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3596660|NCT03094806|3450725|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3596661|NCT03094806|3450726|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3596662|NCT03094806|3450724|B3|||Age||years|Mean|64.0|64.0|Standard Deviation|11.6|11.6|||
3596663|NCT03094806|3450725|B2|||Age||years|Mean|65.9|65.9|Standard Deviation|12.2|12.2|||
3596664|NCT03094806|3450726|B1|||Age||years|Mean|61.8|61.8|Standard Deviation|10.6|10.6|||
3596665|NCT03094806|3450724|B3||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
3596666|NCT03094806|3450725|B2||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
3596667|NCT03094806|3450726|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3596668|NCT03094806|3450724|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
3596669|NCT03094806|3450725|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3596670|NCT03094806|3450726|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3596671|NCT03094806|3450724|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3596672|NCT03094806|3450725|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3596673|NCT03094806|3450726|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3596674|NCT03091751|3450745|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596675|NCT03091751|3450745|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596676|NCT03091751|3450745|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3596677|NCT03091751|3450745|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596678|NCT03091751|3450745|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596679|NCT03091751|3450745|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596680|NCT03091751|3450745|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596681|NCT03091751|3450745|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3596682|NCT03091751|3450745|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3596683|NCT03091751|3450745|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3596684|NCT03091751|3450745|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3596685|NCT03091751|3450745|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3596686|NCT03091673|3450753|B4|United States||Region of Enrollment||participants|Number|31|31.0||||||
3596687|NCT03091673|3450754|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3596688|NCT03091673|3450755|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3596689|NCT03091673|3450756|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3596690|NCT03091673|3450753|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596691|NCT03091673|3450754|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596692|NCT03091673|3450755|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596693|NCT03091673|3450756|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596694|NCT03091673|3450753|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596695|NCT03091673|3450754|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596696|NCT03091673|3450755|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596697|NCT03091673|3450756|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596698|NCT03091673|3450753|B4||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3596699|NCT03091673|3450754|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3596700|NCT03091673|3450755|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3596701|NCT03091673|3450756|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3596702|NCT03091673|3450753|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3596703|NCT03091673|3450754|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596704|NCT03091673|3450755|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3596705|NCT03091673|3450756|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3596706|NCT03091673|3450753|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596707|NCT03091673|3450754|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596708|NCT03091673|3450755|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596709|NCT03091673|3450756|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596710|NCT03091673|3450753|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596711|NCT03091673|3450754|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596712|NCT03091673|3450755|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596713|NCT03091673|3450756|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596714|NCT03091673|3450753|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596715|NCT03091673|3450754|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596716|NCT03091673|3450755|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596717|NCT03091673|3450756|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596718|NCT03091673|3450753|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596719|NCT03091673|3450754|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596720|NCT03091673|3450755|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596721|NCT03091673|3450756|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596722|NCT03091673|3450753|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3596723|NCT03091673|3450754|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3596724|NCT03091673|3450755|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3596725|NCT03091673|3450756|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3596726|NCT03091673|3450753|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596727|NCT03091673|3450754|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596728|NCT03091673|3450755|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596729|NCT03091673|3450756|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596730|NCT03091673|3450753|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3596731|NCT03091673|3450754|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3596732|NCT03091673|3450755|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3596733|NCT03091673|3450756|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3596734|NCT03091673|3450753|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3596735|NCT03091673|3450754|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3596736|NCT03091673|3450755|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3596737|NCT03091673|3450756|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3596738|NCT03091673|3450753|B4|||Age||years|Mean|10.79|10.79|Standard Deviation|4.41|4.41|||
3596739|NCT03091673|3450754|B3|||Age||years|Mean|15.48|15.48|Standard Deviation|1.58|1.58|||
3596740|NCT03091673|3450755|B2|||Age||years|Mean|9.95|9.95|Standard Deviation|2.25|2.25|||
3596741|NCT03091673|3450756|B1|||Age||years|Mean|4.96|4.96|Standard Deviation|1.1|1.1|||
3596742|NCT03090958|3450802|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3596743|NCT03090958|3450802|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596744|NCT03090958|3450802|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3596745|NCT03090958|3450802|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3596746|NCT03090958|3450802|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3596747|NCT03090958|3450802|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596748|NCT03090958|3450802|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596749|NCT03090958|3450802|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3596750|NCT03090958|3450802|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596751|NCT03090958|3450802|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3596752|NCT03090958|3450802|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3596754|NCT03090958|3450802|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3596755|NCT03090958|3450802|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3596756|NCT03090958|3450802|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3596757|NCT03090958|3450802|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3596758|NCT03087604|3450814|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596759|NCT03087604|3450815|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596760|NCT03087604|3450816|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596761|NCT03087604|3450814|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3596762|NCT03087604|3450815|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596763|NCT03087604|3450816|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3596764|NCT03087604|3450814|B3||White|Race (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3596765|NCT03087604|3450815|B2||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3596766|NCT03087604|3450816|B1||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3596767|NCT03087604|3450814|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3596768|NCT03087604|3450815|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3596769|NCT03087604|3450816|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3596770|NCT03087604|3450814|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596771|NCT03087604|3450815|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596772|NCT03087604|3450816|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596773|NCT03087604|3450814|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3596774|NCT03087604|3450815|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596775|NCT03087604|3450816|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3596776|NCT03087604|3450814|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596777|NCT03087604|3450815|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596778|NCT03087604|3450816|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596779|NCT03087604|3450814|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3596780|NCT03087604|3450815|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3596781|NCT03087604|3450816|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3596782|NCT03087604|3450814|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3596783|NCT03087604|3450815|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3596784|NCT03087604|3450816|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3596785|NCT03087604|3450814|B3|||Age||years|Mean|61.8|61.8|Standard Deviation|14.2|14.2|||
3596786|NCT03087604|3450815|B2|||Age||years|Mean|60.4|60.4|Standard Deviation|15.4|15.4|||
3596787|NCT03087604|3450816|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|12.6|12.6|||
3596788|NCT03086447|3450827|B3|United States||Region of Enrollment||Participants|Count of Participants|262|262.0||||||
3596789|NCT03086447|3450828|B2|United States||Region of Enrollment||Participants|Count of Participants|130|130.0||||||
3596790|NCT03086447|3450829|B1|United States||Region of Enrollment||Participants|Count of Participants|132|132.0||||||
3596791|NCT03086447|3450827|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3596792|NCT03086447|3450828|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3596793|NCT03086447|3450829|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3596794|NCT03086447|3450827|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|221|221.0||||||
3596795|NCT03086447|3450828|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|111|111.0||||||
3596796|NCT03086447|3450829|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|110|110.0||||||
3596797|NCT03086447|3450827|B3|Native Hawaiian or Other Pacific||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3596798|NCT03086447|3450828|B2|Native Hawaiian or Other Pacific||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3596799|NCT03086447|3450829|B1|Native Hawaiian or Other Pacific||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3596800|NCT03086447|3450827|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3596801|NCT03086447|3450828|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3596802|NCT03086447|3450829|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3596803|NCT03086447|3450827|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3596804|NCT03086447|3450828|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3596805|NCT03086447|3450829|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3596806|NCT03086447|3450827|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3596807|NCT03086447|3450828|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3596808|NCT03086447|3450829|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3596809|NCT03086447|3450827|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3596810|NCT03086447|3450828|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3596811|NCT03086447|3450829|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3596812|NCT03086447|3450827|B3||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3596813|NCT03086447|3450828|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3596814|NCT03086447|3450829|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3596815|NCT03086447|3450827|B3|||Age||Years|Mean|29.4|29.4|Standard Deviation|6.16|6.16|||
3596816|NCT03086447|3450828|B2|||Age||Years|Mean|29.4|29.4|Standard Deviation|5.81|5.81|||
3596817|NCT03086447|3450829|B1|||Age||Years|Mean|29.3|29.3|Standard Deviation|6.50|6.5|||
3596818|NCT03083483|3450850|B4|United States||Region of Enrollment||participants|Number|60|60.0||||||
3596819|NCT03083483|3450851|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3596820|NCT03083483|3450852|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3596821|NCT03083483|3450853|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3596822|NCT03083483|3450850|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3596823|NCT03083483|3450851|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3596824|NCT03083483|3450852|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596825|NCT03083483|3450853|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3596826|NCT03083483|3450850|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3596827|NCT03083483|3450851|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3596828|NCT03083483|3450852|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3596829|NCT03083483|3450853|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3596830|NCT03083483|3450850|B4||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3596831|NCT03083483|3450851|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3596832|NCT03083483|3450852|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3596833|NCT03083483|3450853|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3596834|NCT03083483|3450850|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3596835|NCT03083483|3450851|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3596836|NCT03083483|3450852|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3596837|NCT03083483|3450853|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3596838|NCT03083483|3450850|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3596839|NCT03083483|3450851|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3596840|NCT03083483|3450852|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596841|NCT03083483|3450853|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596842|NCT03083483|3450850|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3596843|NCT03083483|3450851|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3596844|NCT03083483|3450852|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3596845|NCT03083483|3450853|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3596846|NCT03083483|3450850|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596847|NCT03083483|3450851|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596848|NCT03083483|3450852|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596849|NCT03083483|3450853|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596850|NCT03083483|3450850|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596851|NCT03083483|3450851|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596852|NCT03083483|3450852|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596853|NCT03083483|3450853|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596854|NCT03083483|3450850|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3596855|NCT03083483|3450851|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3596856|NCT03083483|3450852|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3596857|NCT03083483|3450853|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3596858|NCT03083483|3450850|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3596859|NCT03083483|3450851|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3596860|NCT03083483|3450852|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3596861|NCT03083483|3450853|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3596862|NCT03083483|3450850|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3596863|NCT03083483|3450851|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3596864|NCT03083483|3450852|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3596865|NCT03083483|3450853|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3596866|NCT03083483|3450850|B4||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3596867|NCT03083483|3450851|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3596868|NCT03083483|3450852|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3596869|NCT03083483|3450853|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3596870|NCT03083483|3450850|B4|||Age||years|Mean|22.7|22.7|Standard Deviation|4.8|4.8|||
3596871|NCT03083483|3450851|B3|||Age||years|Mean|22.7|22.7|Standard Deviation|3.7|3.7|||
3596872|NCT03083483|3450852|B2|||Age||years|Mean|23.5|23.5|Standard Deviation|5.4|5.4|||
3596873|NCT03083483|3450853|B1|||Age||years|Mean|21.9|21.9|Standard Deviation|5.2|5.2|||
3596874|NCT03083379|3450869|B3|||Change in dorsal regional distribution of ventilation||Percent|Median|2.8|2.8|Inter-Quartile Range|||-0.78|6.4|
3596875|NCT03083379|3450870|B2|||Change in dorsal regional distribution of ventilation||Percent|Median|2.8|2.8|Inter-Quartile Range|||-0.3|4.6|
3596876|NCT03083379|3450871|B1|||Change in dorsal regional distribution of ventilation||Percent|Median|2.9|2.9|Inter-Quartile Range|||-2.6|9.4|
3596877|NCT03083379|3450869|B3|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3596878|NCT03083379|3450870|B2|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3596879|NCT03083379|3450871|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3596880|NCT03083379|3450869|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596881|NCT03083379|3450870|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596882|NCT03083379|3450871|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596883|NCT03083379|3450869|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596884|NCT03083379|3450870|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596885|NCT03083379|3450871|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596886|NCT03083379|3450869|B3||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3596887|NCT03083379|3450870|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3596888|NCT03083379|3450871|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3596889|NCT03083379|3450869|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3596890|NCT03083379|3450870|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3596891|NCT03083379|3450871|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596892|NCT03083379|3450869|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596893|NCT03083379|3450870|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596894|NCT03083379|3450871|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596895|NCT03083379|3450869|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3596896|NCT03083379|3450870|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3596897|NCT03083379|3450871|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3596898|NCT03083379|3450869|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3596899|NCT03083379|3450870|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596900|NCT03083379|3450871|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3596901|NCT03083379|3450869|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3596902|NCT03083379|3450870|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3596903|NCT03083379|3450871|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3596904|NCT03083379|3450869|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3596905|NCT03083379|3450870|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3596906|NCT03083379|3450871|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3596907|NCT03083379|3450869|B3|||Age||years|Median|35|35.0|Inter-Quartile Range|||28.0|49.0|
3596908|NCT03083379|3450870|B2|||Age||years|Median|31|31.0|Inter-Quartile Range|||27.0|45.0|
3596909|NCT03083379|3450871|B1|||Age||years|Median|37|37.0|Inter-Quartile Range|||28.0|55.0|
3596910|NCT03073798|3450878|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596911|NCT03073798|3450878|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596912|NCT03073798|3450878|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3596913|NCT03073798|3450878|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3596914|NCT03073798|3450878|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596915|NCT03073798|3450878|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596916|NCT03073798|3450878|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3596917|NCT03073798|3450878|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3596918|NCT03073798|3450878|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3596919|NCT03073798|3450878|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3596920|NCT03073798|3450878|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3596921|NCT03073798|3450878|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3596922|NCT03072875|3450889|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3596923|NCT03072875|3450889|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3596924|NCT03072875|3450889|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3596925|NCT03072875|3450889|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3596926|NCT03072875|3450889|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596927|NCT03072875|3450889|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3596928|NCT03072875|3450889|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596929|NCT03072875|3450889|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3596930|NCT03072875|3450889|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3596931|NCT03072875|3450889|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3596932|NCT03072875|3450889|B1|Unknown||Sex/Gender, Customized||Participants|Count of Participants|3|3.0||||||
3596933|NCT03072875|3450889|B1|Other||Sex/Gender, Customized||Participants|Count of Participants|1|1.0||||||
3596934|NCT03072875|3450889|B1|Female||Sex/Gender, Customized||Participants|Count of Participants|16|16.0||||||
3596935|NCT03072875|3450889|B1|Male||Sex/Gender, Customized||Participants|Count of Participants|6|6.0||||||
3596936|NCT03072875|3450889|B1|||Age||Years|Mean|39.38|39.38|Standard Deviation|12.76|12.76|||
3596937|NCT03072719|3450894|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596938|NCT03072719|3450895|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596939|NCT03072719|3450896|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596940|NCT03072719|3450894|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596941|NCT03072719|3450895|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596942|NCT03072719|3450896|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596943|NCT03072719|3450894|B3||White|Race (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
3596944|NCT03072719|3450895|B2||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3596945|NCT03072719|3450896|B1||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3596946|NCT03072719|3450894|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3596947|NCT03072719|3450895|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3596948|NCT03072719|3450896|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596949|NCT03072719|3450894|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596950|NCT03072719|3450895|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596951|NCT03072719|3450896|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596952|NCT03072719|3450894|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596953|NCT03072719|3450895|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596954|NCT03072719|3450896|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596955|NCT03072719|3450894|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596956|NCT03072719|3450895|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596957|NCT03072719|3450896|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596958|NCT03072719|3450894|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596959|NCT03072719|3450895|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596960|NCT03072719|3450896|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3596961|NCT03072719|3450894|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|118|118.0||||||
3596962|NCT03072719|3450895|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3596963|NCT03072719|3450896|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3596964|NCT03072719|3450894|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3596965|NCT03072719|3450895|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3596966|NCT03072719|3450896|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3596967|NCT03072719|3450894|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3596968|NCT03072719|3450895|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3596969|NCT03072719|3450896|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3596970|NCT03072719|3450894|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3596971|NCT03072719|3450895|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3596972|NCT03072719|3450896|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3596973|NCT03072719|3450894|B3|||Age||Years|Mean|29.5|29.5|Standard Deviation|12.27|12.27|||
3596974|NCT03072719|3450895|B2|||Age||Years|Mean|30.7|30.7|Standard Deviation|11.66|11.66|||
3596975|NCT03072719|3450896|B1|||Age||Years|Mean|28.4|28.4|Standard Deviation|12.85|12.85|||
3596976|NCT03070730|3450907|B4||Unknown or Not Reported|Race (NIH/OMB)||||0|0.0||||||
3596977|NCT03070730|3450908|B3||Unknown or Not Reported|Race (NIH/OMB)||||0|0.0||||||
3596978|NCT03070730|3450909|B2||Unknown or Not Reported|Race (NIH/OMB)||||0|0.0||||||
3596979|NCT03070730|3450910|B1||Unknown or Not Reported|Race (NIH/OMB)||||0|0.0||||||
3596980|NCT03070730|3450907|B4||More than one race|Race (NIH/OMB)||||0|0.0||||||
3596981|NCT03070730|3450908|B3||More than one race|Race (NIH/OMB)||||0|0.0||||||
3596982|NCT03070730|3450909|B2||More than one race|Race (NIH/OMB)||||0|0.0||||||
3596983|NCT03070730|3450910|B1||More than one race|Race (NIH/OMB)||||0|0.0||||||
3596984|NCT03070730|3450907|B4||White|Race (NIH/OMB)||||0|0.0||||||
3596985|NCT03070730|3450908|B3||White|Race (NIH/OMB)||||0|0.0||||||
3596986|NCT03070730|3450909|B2||White|Race (NIH/OMB)||||0|0.0||||||
3596987|NCT03070730|3450910|B1||White|Race (NIH/OMB)||||0|0.0||||||
3596988|NCT03070730|3450907|B4||Black or African American|Race (NIH/OMB)||||0|0.0||||||
3596989|NCT03070730|3450908|B3||Black or African American|Race (NIH/OMB)||||0|0.0||||||
3596990|NCT03070730|3450909|B2||Black or African American|Race (NIH/OMB)||||0|0.0||||||
3596991|NCT03070730|3450910|B1||Black or African American|Race (NIH/OMB)||||0|0.0||||||
3596992|NCT03070730|3450907|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||||0|0.0||||||
3596993|NCT03070730|3450908|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||||0|0.0||||||
3596994|NCT03070730|3450909|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||||0|0.0||||||
3596995|NCT03070730|3450910|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||||0|0.0||||||
3596996|NCT03070730|3450907|B4||Asian|Race (NIH/OMB)||||0|0.0||||||
3596997|NCT03070730|3450908|B3||Asian|Race (NIH/OMB)||||0|0.0||||||
3596998|NCT03070730|3450909|B2||Asian|Race (NIH/OMB)||||0|0.0||||||
3596999|NCT03070730|3450910|B1||Asian|Race (NIH/OMB)||||0|0.0||||||
3597000|NCT03070730|3450907|B4||American Indian or Alaska Native|Race (NIH/OMB)||||0|0.0||||||
3597001|NCT03070730|3450908|B3||American Indian or Alaska Native|Race (NIH/OMB)||||0|0.0||||||
3597002|NCT03070730|3450909|B2||American Indian or Alaska Native|Race (NIH/OMB)||||0|0.0||||||
3597003|NCT03070730|3450910|B1||American Indian or Alaska Native|Race (NIH/OMB)||||0|0.0||||||
3597004|NCT03070730|3450908|B3||Male|Sex: Female, Male||||0|0.0||||||
3597005|NCT03070730|3450909|B2||Male|Sex: Female, Male||||0|0.0||||||
3597006|NCT03070730|3450910|B1||Male|Sex: Female, Male||||0|0.0||||||
3597007|NCT03070730|3450908|B3||Female|Sex: Female, Male||||0|0.0||||||
3597008|NCT03070730|3450909|B2||Female|Sex: Female, Male||||0|0.0||||||
3597009|NCT03070730|3450910|B1||Female|Sex: Female, Male||||0|0.0||||||
3597010|NCT03070730|3450908|B3|||Age, Customized||||0|0.0||||||
3597011|NCT03070730|3450909|B2|||Age, Customized||||0|0.0||||||
3597012|NCT03070730|3450910|B1|||Age, Customized||||0|0.0||||||
3597013|NCT03070548|3451043|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597014|NCT03070548|3451043|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597015|NCT03070548|3451043|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3597016|NCT03070548|3451043|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597017|NCT03070548|3451043|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597018|NCT03070548|3451043|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597019|NCT03070548|3451043|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597020|NCT03070548|3451043|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597021|NCT03070548|3451043|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3597022|NCT03070548|3451043|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597023|NCT03070548|3451043|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3597024|NCT03070548|3451043|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3597025|NCT03070548|3451043|B1|||Age||years|Mean|50.2|50.2|Standard Deviation|17.61|17.61|||
3597026|NCT03070002|3451079|B1|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3597027|NCT03070002|3451079|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597028|NCT03070002|3451079|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597029|NCT03070002|3451079|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3597030|NCT03070002|3451079|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597031|NCT03070002|3451079|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597032|NCT03070002|3451079|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597033|NCT03070002|3451079|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597034|NCT03070002|3451079|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597035|NCT03070002|3451079|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3597036|NCT03070002|3451079|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597037|NCT03070002|3451079|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3597038|NCT03070002|3451079|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3597039|NCT03070002|3451079|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3597040|NCT03070002|3451079|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3597041|NCT03070002|3451079|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597042|NCT03069313|3451085|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
3597043|NCT03069313|3451085|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597044|NCT03069313|3451085|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597045|NCT03069313|3451085|B1||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3597046|NCT03069313|3451085|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597047|NCT03069313|3451085|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597048|NCT03069313|3451085|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597049|NCT03069313|3451085|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597050|NCT03069313|3451085|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3597051|NCT03069313|3451085|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3597052|NCT03069313|3451085|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3597053|NCT03069313|3451085|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3597054|NCT03069313|3451085|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597055|NCT03067948|3451092|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3597056|NCT03067948|3451092|B1|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3597057|NCT03067948|3451092|B1|Black||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3597058|NCT03067948|3451092|B1|Female||Sex/Gender, Customized||participants|Number|11|11.0||||||
3597059|NCT03067948|3451092|B1|Male||Sex/Gender, Customized||participants|Number|21|21.0||||||
3597060|NCT03067948|3451092|B1|||Age||years|Mean|51.6|51.6|Standard Deviation|8.9|8.9|||
3597061|NCT03065933|3451097|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3597062|NCT03063476|3451101|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3597063|NCT03063476|3451101|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597064|NCT03063476|3451101|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597065|NCT03063476|3451101|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3597066|NCT03063476|3451101|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3597067|NCT03063476|3451101|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597068|NCT03063476|3451101|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597069|NCT03063476|3451101|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597070|NCT03063476|3451101|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3597071|NCT03063476|3451101|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3597072|NCT03063476|3451101|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3597073|NCT03063476|3451101|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3597074|NCT03063476|3451101|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597075|NCT03061513|3451106|B3|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3597076|NCT03061513|3451107|B2|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3597077|NCT03061513|3451108|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3597078|NCT03061513|3451106|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3597079|NCT03061513|3451107|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3597080|NCT03061513|3451108|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3597081|NCT03061513|3451106|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3597082|NCT03061513|3451107|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3597083|NCT03061513|3451108|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3597084|NCT03061513|3451106|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3597085|NCT03061513|3451107|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3597086|NCT03061513|3451108|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3597087|NCT03061513|3451106|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3597088|NCT03061513|3451107|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3597089|NCT03061513|3451108|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3597090|NCT03061513|3451106|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597091|NCT03061513|3451107|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597092|NCT03061513|3451108|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597093|NCT03061331|3451117|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597094|NCT03061331|3451118|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597095|NCT03061331|3451119|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597096|NCT03061331|3451117|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597097|NCT03061331|3451118|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597098|NCT03061331|3451119|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597099|NCT03061331|3451117|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3597100|NCT03061331|3451118|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3597101|NCT03061331|3451119|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3597102|NCT03061331|3451117|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597103|NCT03061331|3451118|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597104|NCT03061331|3451119|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597105|NCT03061331|3451117|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597162|NCT03060512|3451126|B3||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3597106|NCT03061331|3451118|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597107|NCT03061331|3451119|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597108|NCT03061331|3451117|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597109|NCT03061331|3451118|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597110|NCT03061331|3451119|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597111|NCT03061331|3451117|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597112|NCT03061331|3451118|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597113|NCT03061331|3451119|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597114|NCT03061331|3451117|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597115|NCT03061331|3451118|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597116|NCT03061331|3451119|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597117|NCT03061331|3451117|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3597118|NCT03061331|3451118|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3597119|NCT03061331|3451119|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3597120|NCT03061331|3451117|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597121|NCT03061331|3451118|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597122|NCT03061331|3451119|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597123|NCT03061331|3451117|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3597124|NCT03061331|3451118|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3597125|NCT03061331|3451119|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3597126|NCT03061331|3451117|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3597127|NCT03061331|3451118|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3597128|NCT03061331|3451119|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3597129|NCT03061331|3451117|B3|||Age||years|Mean|38.0|38.0|Standard Deviation|13.6|13.6|||
3597130|NCT03061331|3451118|B2|||Age||years|Mean|34.7|34.7|Standard Deviation|11.8|11.8|||
3597131|NCT03061331|3451119|B1|||Age||years|Mean|41.2|41.2|Standard Deviation|15.1|15.1|||
3597132|NCT03060512|3451126|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597133|NCT03060512|3451127|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597134|NCT03060512|3451128|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597135|NCT03060512|3451126|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597136|NCT03060512|3451127|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597137|NCT03060512|3451128|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597138|NCT03060512|3451126|B3||White|Race (NIH/OMB)||Participants|Count of Participants|214|214.0||||||
3597139|NCT03060512|3451127|B2||White|Race (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
3597140|NCT03060512|3451128|B1||White|Race (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
3597141|NCT03060512|3451126|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3597142|NCT03060512|3451127|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3597143|NCT03060512|3451128|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3597144|NCT03060512|3451126|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597145|NCT03060512|3451127|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597146|NCT03060512|3451128|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597147|NCT03060512|3451126|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3597148|NCT03060512|3451127|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3597149|NCT03060512|3451128|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597150|NCT03060512|3451126|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3597151|NCT03060512|3451127|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3597152|NCT03060512|3451128|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597153|NCT03060512|3451126|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3597154|NCT03060512|3451127|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597155|NCT03060512|3451128|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3597156|NCT03060512|3451126|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|232|232.0||||||
3597157|NCT03060512|3451127|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|117|117.0||||||
3597158|NCT03060512|3451128|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
3597159|NCT03060512|3451126|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3597160|NCT03060512|3451127|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3597161|NCT03060512|3451128|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3597163|NCT03060512|3451127|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3597164|NCT03060512|3451128|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3597165|NCT03060512|3451126|B3||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
3597166|NCT03060512|3451127|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3597167|NCT03060512|3451128|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3597168|NCT03060512|3451126|B3|||Age||Years|Mean|56.4|56.4|Standard Deviation|9.52|9.52|||
3597169|NCT03060512|3451127|B2|||Age||Years|Mean|56.9|56.9|Standard Deviation|9.65|9.65|||
3597170|NCT03060512|3451128|B1|||Age||Years|Mean|55.9|55.9|Standard Deviation|9.38|9.38|||
3597171|NCT03060486|3451146|B1|Italy||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3597172|NCT03060486|3451146|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3597173|NCT03060486|3451146|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3597174|NCT03060486|3451146|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3597175|NCT03060486|3451146|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3597176|NCT03060486|3451146|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597177|NCT03059901|3451150|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
3597178|NCT03059901|3451151|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3597179|NCT03059901|3451152|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3597180|NCT03059901|3451150|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3597181|NCT03059901|3451151|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3597182|NCT03059901|3451152|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3597183|NCT03059901|3451150|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3597184|NCT03059901|3451151|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3597185|NCT03059901|3451152|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3597186|NCT03059901|3451150|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3597187|NCT03059901|3451151|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3597188|NCT03059901|3451152|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3597189|NCT03059901|3451150|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597190|NCT03059901|3451151|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597191|NCT03059901|3451152|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597192|NCT03059901|3451150|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597193|NCT03059901|3451151|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597194|NCT03059901|3451152|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597195|NCT03059901|3451150|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597196|NCT03059901|3451151|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597197|NCT03059901|3451152|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597198|NCT03059901|3451150|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3597199|NCT03059901|3451151|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3597200|NCT03059901|3451152|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3597201|NCT03059901|3451150|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3597202|NCT03059901|3451151|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3597203|NCT03059901|3451152|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3597204|NCT03059901|3451150|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3597205|NCT03059901|3451151|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3597206|NCT03059901|3451152|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3597207|NCT03059901|3451150|B3|||Age||years|Mean|33.28|33.28|Standard Deviation|9.34|9.34|||
3597208|NCT03059901|3451151|B2|||Age||years|Mean|33.0|33.0|Standard Deviation|10.75|10.75|||
3597209|NCT03059901|3451152|B1|||Age||years|Mean|33.57|33.57|Standard Deviation|7.86|7.86|||
3597210|NCT03057704|3451159|B3||IV pain score of 1-3|Pain score at IV prior to procedure||Participants|Count of Participants|0|0.0||||||
3597211|NCT03057704|3451160|B2||IV pain score of 1-3|Pain score at IV prior to procedure||Participants|Count of Participants|0|0.0||||||
3597212|NCT03057704|3451161|B1||IV pain score of 1-3|Pain score at IV prior to procedure||Participants|Count of Participants|0|0.0||||||
3597213|NCT03057704|3451159|B3||IV pain score of 0|Pain score at IV prior to procedure||Participants|Count of Participants|50|50.0||||||
3597214|NCT03057704|3451160|B2||IV pain score of 0|Pain score at IV prior to procedure||Participants|Count of Participants|25|25.0||||||
3597215|NCT03057704|3451161|B1||IV pain score of 0|Pain score at IV prior to procedure||Participants|Count of Participants|25|25.0||||||
3597216|NCT03057704|3451159|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3597217|NCT03057704|3451160|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3597218|NCT03057704|3451161|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3597219|NCT03057704|3451159|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597220|NCT03057704|3451160|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597221|NCT03057704|3451161|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597222|NCT03057704|3451159|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597223|NCT03057704|3451160|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597224|NCT03057704|3451161|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597225|NCT03057704|3451159|B3||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3597226|NCT03057704|3451160|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3597227|NCT03057704|3451161|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3597228|NCT03057704|3451159|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3597229|NCT03057704|3451160|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3597230|NCT03057704|3451161|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3597231|NCT03057704|3451159|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597232|NCT03057704|3451160|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597233|NCT03057704|3451161|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597234|NCT03057704|3451159|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3597235|NCT03057704|3451160|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3597236|NCT03057704|3451161|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3597237|NCT03057704|3451159|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3597238|NCT03057704|3451160|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597239|NCT03057704|3451161|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3597240|NCT03057704|3451159|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3597241|NCT03057704|3451160|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3597242|NCT03057704|3451161|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3597243|NCT03057704|3451159|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3597244|NCT03057704|3451160|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3597245|NCT03057704|3451161|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3597246|NCT03057704|3451159|B3|||Age||years|Mean|53|53.0|Standard Deviation|7.1|7.1|||
3597247|NCT03057704|3451160|B2|||Age||years|Mean|54|54.0|Standard Deviation|7.3|7.3|||
3597248|NCT03057704|3451161|B1|||Age||years|Mean|52|52.0|Standard Deviation|6.9|6.9|||
3597249|NCT03057704|3451159|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3597250|NCT03057704|3451160|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3597251|NCT03057704|3451161|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3597252|NCT03057704|3451159|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3597253|NCT03057704|3451160|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3597254|NCT03057704|3451161|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3597255|NCT03057704|3451159|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597256|NCT03057704|3451160|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597257|NCT03057704|3451161|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597258|NCT03056352|3451172|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3597259|NCT03056352|3451172|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3597260|NCT03056352|3451172|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3597261|NCT03056352|3451172|B1|||Age||years|Mean|45|45.0|Standard Deviation|18|18.0|||
3597262|NCT03056300|3451178|B1|China||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3597263|NCT03056300|3451178|B1|50|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597264|NCT03056300|3451178|B1|50|More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597265|NCT03056300|3451178|B1|50|White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597266|NCT03056300|3451178|B1|50|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597267|NCT03056300|3451178|B1|50|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597268|NCT03056300|3451178|B1|50|Asian|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3597269|NCT03056300|3451178|B1|50|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597270|NCT03056300|3451178|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3597271|NCT03056300|3451178|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3597272|NCT03056300|3451178|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|8.2|8.2|||
3597273|NCT03055338|3451183|B4||> 10 Years|Duration of Illness||Participants|Count of Participants|143|143.0||||||
3597274|NCT03055338|3451184|B3||> 10 Years|Duration of Illness||Participants|Count of Participants|57|57.0||||||
3597275|NCT03055338|3451185|B2||> 10 Years|Duration of Illness||Participants|Count of Participants|27|27.0||||||
3597276|NCT03055338|3451186|B1||> 10 Years|Duration of Illness||Participants|Count of Participants|59|59.0||||||
3597277|NCT03055338|3451183|B4||<= 10 Years|Duration of Illness||Participants|Count of Participants|81|81.0||||||
3597278|NCT03055338|3451184|B3||<= 10 Years|Duration of Illness||Participants|Count of Participants|32|32.0||||||
3597279|NCT03055338|3451185|B2||<= 10 Years|Duration of Illness||Participants|Count of Participants|18|18.0||||||
3597280|NCT03055338|3451186|B1||<= 10 Years|Duration of Illness||Participants|Count of Participants|31|31.0||||||
3597281|NCT03055338|3451183|B4|||Clinical Global Impression Severity of Illness (CGI-S) Score|The CGI-S is a 7-point clinician-rated scale for assessing the global severity of the participant’s illness. Possible CGI-S scores range from 1 (participant normal, not ill) to 7 (participant extremely ill).|Score on a Scale|Mean|4.9|4.9|Standard Deviation|0.57|0.57|||
3597282|NCT03055338|3451184|B3|||Clinical Global Impression Severity of Illness (CGI-S) Score|The CGI-S is a 7-point clinician-rated scale for assessing the global severity of the participant’s illness. Possible CGI-S scores range from 1 (participant normal, not ill) to 7 (participant extremely ill).|Score on a Scale|Mean|5.0|5.0|Standard Deviation|0.4|0.4|||
3597283|NCT03055338|3451185|B2|||Clinical Global Impression Severity of Illness (CGI-S) Score|The CGI-S is a 7-point clinician-rated scale for assessing the global severity of the participant’s illness. Possible CGI-S scores range from 1 (participant normal, not ill) to 7 (participant extremely ill).|Score on a Scale|Mean|5.0|5.0|Standard Deviation|0.7|0.7|||
3597284|NCT03055338|3451186|B1|||Clinical Global Impression Severity of Illness (CGI-S) Score|The CGI-S is a 7-point clinician-rated scale for assessing the global severity of the participant’s illness. Possible CGI-S scores range from 1 (participant normal, not ill) to 7 (participant extremely ill).|Score on a Scale|Mean|4.9|4.9|Standard Deviation|0.6|0.6|||
3597285|NCT03055338|3451183|B4|||Positive and Negative Syndrome Scale (PANSS) Total Score|The PANSS assesses the severity of schizophrenia symptoms through a clinician-rated inventory of 30 items organized in 3 subscales: 1) positive subscale (7 items); 2) negative subscale (7 items); and 3) general psychopathology subscale (16 items). For each item, symptoms are scored from 1 (absent) to 7 (extreme) and sum to a total PANSS score (range: 30-210). Higher scores reflect more severe symptoms of schizophrenia.|Score on a Scale|Mean|95.6|95.6|Standard Deviation|10.45|10.45|||
3597286|NCT03055338|3451184|B3|||Positive and Negative Syndrome Scale (PANSS) Total Score|The PANSS assesses the severity of schizophrenia symptoms through a clinician-rated inventory of 30 items organized in 3 subscales: 1) positive subscale (7 items); 2) negative subscale (7 items); and 3) general psychopathology subscale (16 items). For each item, symptoms are scored from 1 (absent) to 7 (extreme) and sum to a total PANSS score (range: 30-210). Higher scores reflect more severe symptoms of schizophrenia.|Score on a Scale|Mean|96.2|96.2|Standard Deviation|9.6|9.6|||
3597287|NCT03055338|3451185|B2|||Positive and Negative Syndrome Scale (PANSS) Total Score|The PANSS assesses the severity of schizophrenia symptoms through a clinician-rated inventory of 30 items organized in 3 subscales: 1) positive subscale (7 items); 2) negative subscale (7 items); and 3) general psychopathology subscale (16 items). For each item, symptoms are scored from 1 (absent) to 7 (extreme) and sum to a total PANSS score (range: 30-210). Higher scores reflect more severe symptoms of schizophrenia.|Score on a Scale|Mean|95.3|95.3|Standard Deviation|12.4|12.4|||
3597288|NCT03055338|3451186|B1|||Positive and Negative Syndrome Scale (PANSS) Total Score|The PANSS assesses the severity of schizophrenia symptoms through a clinician-rated inventory of 30 items organized in 3 subscales: 1) positive subscale (7 items); 2) negative subscale (7 items); and 3) general psychopathology subscale (16 items). For each item, symptoms are scored from 1 (absent) to 7 (extreme) and sum to a total PANSS score (range: 30-210). Higher scores reflect more severe symptoms of schizophrenia.|Score on a Scale|Mean|95.1|95.1|Standard Deviation|10.4|10.4|||
3597289|NCT03055338|3451183|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597290|NCT03055338|3451184|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597291|NCT03055338|3451185|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597292|NCT03055338|3451186|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597293|NCT03055338|3451183|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3597294|NCT03055338|3451184|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3597295|NCT03055338|3451185|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597296|NCT03055338|3451186|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597297|NCT03055338|3451183|B4||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3597298|NCT03055338|3451184|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3597299|NCT03055338|3451185|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3597300|NCT03055338|3451186|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3597301|NCT03055338|3451183|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
3597302|NCT03055338|3451184|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3597303|NCT03055338|3451185|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3597304|NCT03055338|3451186|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3597305|NCT03055338|3451183|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3597306|NCT03055338|3451184|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3597307|NCT03055338|3451185|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597308|NCT03055338|3451186|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597309|NCT03055338|3451183|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3597310|NCT03055338|3451184|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3597311|NCT03055338|3451185|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597312|NCT03055338|3451186|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3597313|NCT03055338|3451183|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3597314|NCT03055338|3451184|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597315|NCT03055338|3451185|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597316|NCT03055338|3451186|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3597317|NCT03055338|3451183|B4||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
3597318|NCT03055338|3451184|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3597319|NCT03055338|3451185|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3597320|NCT03055338|3451186|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3597321|NCT03055338|3451183|B4||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3597322|NCT03055338|3451184|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3597323|NCT03055338|3451185|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3597324|NCT03055338|3451186|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3597325|NCT03055338|3451183|B4|||Age||Years|Mean|37.1|37.1|Standard Deviation|7.7|7.7|||
3597326|NCT03055338|3451184|B3|||Age||Years|Mean|35.6|35.6|Standard Deviation|7.6|7.6|||
3597327|NCT03055338|3451185|B2|||Age||Years|Mean|37.3|37.3|Standard Deviation|8.0|8.0|||
3597328|NCT03055338|3451186|B1|||Age||Years|Mean|38.4|38.4|Standard Deviation|7.4|7.4|||
3597329|NCT03055221|3451205|B1|India||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3597330|NCT03055221|3451205|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597331|NCT03055221|3451205|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597332|NCT03055221|3451205|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597333|NCT03055221|3451205|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597334|NCT03055221|3451205|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597335|NCT03055221|3451205|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3597336|NCT03055221|3451205|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597337|NCT03055221|3451205|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597338|NCT03055221|3451205|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3597339|NCT03055221|3451205|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597340|NCT03055221|3451205|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3597341|NCT03055221|3451205|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3597342|NCT03055221|3451205|B1|||Age||years|Mean|30.1|30.1|Standard Deviation|10.0|10.0|||
3597343|NCT03055195|3451210|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3597344|NCT03055195|3451211|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3597345|NCT03055195|3451212|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3597346|NCT03055195|3451210|B3|Black Or African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3597347|NCT03055195|3451211|B2|Black Or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3597348|NCT03055195|3451212|B1|Black Or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3597349|NCT03055195|3451210|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3597350|NCT03055195|3451211|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3597351|NCT03055195|3451212|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3597352|NCT03055195|3451210|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3597353|NCT03055195|3451211|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3597354|NCT03055195|3451212|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3597355|NCT03055195|3451210|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3597356|NCT03055195|3451211|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3597357|NCT03055195|3451212|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3597358|NCT03055195|3451210|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3597359|NCT03055195|3451211|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3597360|NCT03055195|3451212|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3597361|NCT03055195|3451210|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3597362|NCT03055195|3451211|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3597363|NCT03055195|3451212|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3597364|NCT03055195|3451210|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3597365|NCT03055195|3451211|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3597366|NCT03055195|3451212|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3597367|NCT03055195|3451210|B3|||Age||Years|Mean|32.8|32.8|Standard Deviation|12.23|12.23|||
3597368|NCT03055195|3451211|B2|||Age||Years|Mean|34.6|34.6|Standard Deviation|13.99|13.99|||
3597369|NCT03055195|3451212|B1|||Age||Years|Mean|30.8|30.8|Standard Deviation|9.95|9.95|||
3597413|NCT03054857|3451266|B2|||BMI||Kilograms per metre square|Mean|26.19|26.19|Standard Deviation|19.21|19.21|||
3597370|NCT03054857|3451265|B3|||Baseline Short Blessed Test score (0-28 points)|Short Blessed Test (SBT) is a screening test for detecting cognitive change in the aspects of memory and concentration. SBT score ranges from 0 to 28. Score less than 4 will be defined as normal cognitive function.|points|Mean|5.14|5.14|Standard Deviation|5.334|5.334|||
3597371|NCT03054857|3451266|B2|||Baseline Short Blessed Test score (0-28 points)|Short Blessed Test (SBT) is a screening test for detecting cognitive change in the aspects of memory and concentration. SBT score ranges from 0 to 28. Score less than 4 will be defined as normal cognitive function.|points|Mean|5.30|5.3|Standard Deviation|5.754|5.754|||
3597372|NCT03054857|3451267|B1|||Baseline Short Blessed Test score (0-28 points)|Short Blessed Test (SBT) is a screening test for detecting cognitive change in the aspects of memory and concentration. SBT score ranges from 0 to 28. Score less than 4 will be defined as normal cognitive function.|points|Mean|4.98|4.98|Standard Deviation|4.922|4.922|||
3597373|NCT03054857|3451265|B3|||Baseline Montreal Cognitive Assessment scores (0-30 points)|Montreal Cognitive Assessment (MoCA) is a screening test for assessment of multiple aspects of cognitive function including, attention, concentration, executive function, memory, language, calculation, visuospatial ability and orientation. MoCA score ranges from 0 to 30. Score more than 25 will be defined as normal cognitive function.|points|Mean|22.86|22.86|Standard Deviation|4.078|4.078|||
3597374|NCT03054857|3451266|B2|||Baseline Montreal Cognitive Assessment scores (0-30 points)|Montreal Cognitive Assessment (MoCA) is a screening test for assessment of multiple aspects of cognitive function including, attention, concentration, executive function, memory, language, calculation, visuospatial ability and orientation. MoCA score ranges from 0 to 30. Score more than 25 will be defined as normal cognitive function.|points|Mean|22.88|22.88|Standard Deviation|3.707|3.707|||
3597375|NCT03054857|3451267|B1|||Baseline Montreal Cognitive Assessment scores (0-30 points)|Montreal Cognitive Assessment (MoCA) is a screening test for assessment of multiple aspects of cognitive function including, attention, concentration, executive function, memory, language, calculation, visuospatial ability and orientation. MoCA score ranges from 0 to 30. Score more than 25 will be defined as normal cognitive function.|points|Mean|22.84|22.84|Standard Deviation|4.464|4.464|||
3597376|NCT03054857|3451265|B3|||Atrial fibrillation||Participants|Count of Participants|25|25.0||||||
3597377|NCT03054857|3451266|B2|||Atrial fibrillation||Participants|Count of Participants|13|13.0||||||
3597378|NCT03054857|3451267|B1|||Atrial fibrillation||Participants|Count of Participants|12|12.0||||||
3597379|NCT03054857|3451265|B3|||Hypertension||Participants|Count of Participants|50|50.0||||||
3597380|NCT03054857|3451266|B2|||Hypertension||Participants|Count of Participants|28|28.0||||||
3597381|NCT03054857|3451267|B1|||Hypertension||Participants|Count of Participants|22|22.0||||||
3597382|NCT03054857|3451265|B3|||Diabetes Mellitus||Participants|Count of Participants|16|16.0||||||
3597383|NCT03054857|3451266|B2|||Diabetes Mellitus||Participants|Count of Participants|10|10.0||||||
3597384|NCT03054857|3451267|B1|||Diabetes Mellitus||Participants|Count of Participants|6|6.0||||||
3597385|NCT03054857|3451265|B3|||Aortic Cross-clamp Time||minutes|Mean|96.32|96.32|Standard Deviation|36.287|36.287|||
3597386|NCT03054857|3451266|B2|||Aortic Cross-clamp Time||minutes|Mean|99.88|99.88|Standard Deviation|38.38|38.38|||
3597387|NCT03054857|3451267|B1|||Aortic Cross-clamp Time||minutes|Mean|92.69|92.69|Standard Deviation|34.03|34.03|||
3597388|NCT03054857|3451265|B3|||Cardiopulmonary Bypass Time||minutes|Mean|126.53|126.53|Standard Deviation|44.299|44.299|||
3597389|NCT03054857|3451266|B2|||Cardiopulmonary Bypass Time||minutes|Mean|132.34|132.34|Standard Deviation|46.55|46.55|||
3597390|NCT03054857|3451267|B1|||Cardiopulmonary Bypass Time||minutes|Mean|120.59|120.59|Standard Deviation|41.52|41.52|||
3597391|NCT03054857|3451265|B3|||Operative Time||minutes|Mean|305.55|305.55|Standard Deviation|83.541|83.541|||
3597392|NCT03054857|3451266|B2|||Operative Time||minutes|Mean|309.28|309.28|Standard Deviation|79.97|79.97|||
3597393|NCT03054857|3451267|B1|||Operative Time||minutes|Mean|301.73|301.73|Standard Deviation|87.70|87.7|||
3597394|NCT03054857|3451265|B3||CABG with valve surgery|Operation type||Participants|Count of Participants|6|6.0||||||
3597395|NCT03054857|3451266|B2||CABG with valve surgery|Operation type||Participants|Count of Participants|1|1.0||||||
3597396|NCT03054857|3451267|B1||CABG with valve surgery|Operation type||Participants|Count of Participants|5|5.0||||||
3597397|NCT03054857|3451265|B3||Multiple valve surgery|Operation type||Participants|Count of Participants|18|18.0||||||
3597398|NCT03054857|3451266|B2||Multiple valve surgery|Operation type||Participants|Count of Participants|12|12.0||||||
3597399|NCT03054857|3451267|B1||Multiple valve surgery|Operation type||Participants|Count of Participants|6|6.0||||||
3597400|NCT03054857|3451265|B3||Single valve surgery|Operation type||Participants|Count of Participants|44|44.0||||||
3597401|NCT03054857|3451266|B2||Single valve surgery|Operation type||Participants|Count of Participants|19|19.0||||||
3597402|NCT03054857|3451267|B1||Single valve surgery|Operation type||Participants|Count of Participants|25|25.0||||||
3597403|NCT03054857|3451265|B3||CABG|Operation type||Participants|Count of Participants|31|31.0||||||
3597404|NCT03054857|3451266|B2||CABG|Operation type||Participants|Count of Participants|18|18.0||||||
3597405|NCT03054857|3451267|B1||CABG|Operation type||Participants|Count of Participants|13|13.0||||||
3597406|NCT03054857|3451265|B3|||Serum Creatinine||miligram per decilitre|Mean|0.9445|0.9445|Standard Deviation|0.25329|0.25329|||
3597407|NCT03054857|3451266|B2|||Serum Creatinine||miligram per decilitre|Mean|0.95|0.95|Standard Deviation|0.27|0.27|||
3597408|NCT03054857|3451267|B1|||Serum Creatinine||miligram per decilitre|Mean|0.94|0.94|Standard Deviation|0.24|0.24|||
3597409|NCT03054857|3451265|B3|||Left Ventricular Ejection Fraction||percentage of left ventricular ejection|Mean|62.7717|62.7717|Standard Deviation|11.48959|11.48959|||
3597410|NCT03054857|3451266|B2|||Left Ventricular Ejection Fraction||percentage of left ventricular ejection|Mean|63.27|63.27|Standard Deviation|11.55|11.55|||
3597411|NCT03054857|3451267|B1|||Left Ventricular Ejection Fraction||percentage of left ventricular ejection|Mean|62.26|62.26|Standard Deviation|11.53|11.53|||
3597412|NCT03054857|3451265|B3|||BMI||Kilograms per metre square|Mean|24.65|24.65|Standard Deviation|13.8424|13.8424|||
3597414|NCT03054857|3451267|B1|||BMI||Kilograms per metre square|Mean|23.08|23.08|Standard Deviation|3.09|3.09|||
3597415|NCT03054857|3451265|B3|||Weight||kilograms|Mean|61.794|61.794|Standard Deviation|12.128|12.128|||
3597416|NCT03054857|3451266|B2|||Weight||kilograms|Mean|62.69|62.69|Standard Deviation|11.81|11.81|||
3597417|NCT03054857|3451267|B1|||Weight||kilograms|Mean|60.88|60.88|Standard Deviation|12.5|12.5|||
3597418|NCT03054857|3451265|B3|Thailand||Region of Enrollment||Participants|Count of Participants|99|99.0||||||
3597419|NCT03054857|3451266|B2|Thailand||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3597420|NCT03054857|3451267|B1|Thailand||Region of Enrollment||Participants|Count of Participants|49|49.0||||||
3597421|NCT03054857|3451265|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3597422|NCT03054857|3451266|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3597423|NCT03054857|3451267|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3597424|NCT03054857|3451265|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3597425|NCT03054857|3451266|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3597426|NCT03054857|3451267|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3597427|NCT03054857|3451265|B3|||Age||years|Mean|52.08|52.08|Standard Deviation|12.017|12.017|||
3597428|NCT03054857|3451266|B2|||Age||years|Mean|52.72|52.72|Standard Deviation|10.975|10.975|||
3597429|NCT03054857|3451267|B1|||Age||years|Mean|51.43|51.43|Standard Deviation|13.077|13.077|||
3597430|NCT03054740|3451282|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3597431|NCT03054740|3451282|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3597432|NCT03054740|3451283|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3597433|NCT03054740|3451284|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3597434|NCT03054740|3451282|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3597435|NCT03054740|3451283|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3597436|NCT03054740|3451284|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3597437|NCT03054740|3451282|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3597438|NCT03054740|3451283|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3597439|NCT03054740|3451284|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3597440|NCT03054740|3451282|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3597441|NCT03054740|3451283|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3597442|NCT03054740|3451284|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3597443|NCT03054740|3451282|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597444|NCT03054740|3451283|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597445|NCT03054740|3451284|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597446|NCT03054103|3451299|B4|United States||Region of Enrollment||Participants|Count of Participants|105|105.0||||||
3597447|NCT03054103|3451300|B3|United States||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3597448|NCT03054103|3451301|B2|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3597449|NCT03054103|3451302|B1|United States||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3597450|NCT03054103|3451299|B4||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3597451|NCT03054103|3451300|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3597452|NCT03054103|3451301|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3597453|NCT03054103|3451302|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3597454|NCT03054103|3451299|B4||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3597455|NCT03054103|3451300|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3597456|NCT03054103|3451301|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3597457|NCT03054103|3451302|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3597458|NCT03054103|3451299|B4|||Age||years|Mean|68|68.0|Standard Deviation|9.1|9.1|||
3597459|NCT03054103|3451300|B3|||Age||years|Mean|65.6|65.6|Standard Deviation|9.8|9.8|||
3597460|NCT03054103|3451301|B2|||Age||years|Mean|69.1|69.1|Standard Deviation|8.1|8.1|||
3597461|NCT03054103|3451302|B1|||Age||years|Mean|70.4|70.4|Standard Deviation|8.8|8.8|||
3597462|NCT03054103|3451299|B4||>=65 years|Age||Participants|Count of Participants|80|80.0||||||
3597463|NCT03054103|3451300|B3||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
3597464|NCT03054103|3451301|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3597465|NCT03054103|3451302|B1||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
3597466|NCT03054103|3451299|B4||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3597467|NCT03054103|3451300|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3597468|NCT03054103|3451301|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3597469|NCT03054103|3451302|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3597470|NCT03054103|3451299|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597471|NCT03054103|3451300|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597472|NCT03054103|3451301|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597473|NCT03054103|3451302|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597474|NCT03054077|3451321|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
3597475|NCT03054077|3451322|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3597476|NCT03054077|3451323|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3597477|NCT03054077|3451321|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3597478|NCT03054077|3451322|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597479|NCT03054077|3451323|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3597480|NCT03054077|3451321|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597481|NCT03054077|3451322|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597482|NCT03054077|3451323|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597483|NCT03054077|3451321|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3597484|NCT03054077|3451322|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3597485|NCT03054077|3451323|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3597486|NCT03054077|3451321|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3597487|NCT03054077|3451322|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3597488|NCT03054077|3451323|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3597489|NCT03054077|3451321|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597490|NCT03054077|3451322|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597491|NCT03054077|3451323|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597492|NCT03054077|3451321|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3597493|NCT03054077|3451322|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3597494|NCT03054077|3451323|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597495|NCT03054077|3451321|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597496|NCT03054077|3451322|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597497|NCT03054077|3451323|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597498|NCT03054077|3451321|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3597499|NCT03054077|3451322|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3597500|NCT03054077|3451323|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3597501|NCT03054077|3451321|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597502|NCT03054077|3451322|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597503|NCT03054077|3451323|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597504|NCT03054077|3451321|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597505|NCT03054077|3451322|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597506|NCT03054077|3451323|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597507|NCT03054077|3451321|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3597508|NCT03054077|3451322|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3597509|NCT03054077|3451323|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3597510|NCT03054077|3451321|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3597511|NCT03054077|3451322|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3597512|NCT03054077|3451323|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3597513|NCT03054077|3451321|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3597514|NCT03054077|3451322|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3597515|NCT03054077|3451323|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3597516|NCT03054077|3451321|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3597517|NCT03054077|3451322|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3597518|NCT03054077|3451323|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3597519|NCT03054077|3451321|B3||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
3597520|NCT03054077|3451322|B2||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
3597521|NCT03054077|3451323|B1||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
3597522|NCT03052530|3451330|B1|3 (complete perfusion)||Lesion Characteristics: Pre-Procedure Thrombolysis in Myocardial Infarction (TIMI) Flow|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|50|50.0||||||
3597523|NCT03052530|3451330|B1|2 (partial perfusion)||Lesion Characteristics: Pre-Procedure Thrombolysis in Myocardial Infarction (TIMI) Flow|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|4|4.0||||||
3597524|NCT03052530|3451330|B1|1 (penetration with minimal perfusion)||Lesion Characteristics: Pre-Procedure Thrombolysis in Myocardial Infarction (TIMI) Flow|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|4|4.0||||||
3597525|NCT03052530|3451330|B1|0 (no perfusion)||Lesion Characteristics: Pre-Procedure Thrombolysis in Myocardial Infarction (TIMI) Flow|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|9|9.0||||||
3597526|NCT03052530|3451330|B1|Total Occlusion||Lesion Characteristics|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|9|9.0||||||
3597527|NCT03052530|3451330|B1|Aneurysm||Lesion Characteristics|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|0|0.0||||||
3597528|NCT03052530|3451330|B1|Ulceration||Lesion Characteristics|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|4|4.0||||||
3597529|NCT03052530|3451330|B1|Calcification||Lesion Characteristics|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|34|34.0||||||
3597530|NCT03052530|3451330|B1|Tortuosity||Lesion Characteristics|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|0|0.0||||||
3597531|NCT03052530|3451330|B1|Thrombus||Lesion Characteristics|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|1|1.0||||||
3597532|NCT03052530|3451330|B1|Minimum Lumen Diameter||Lesion Characteristics|Analysis is based on the number of intent-to-treat lesions (n=67).|Millimeters|Mean|.52|0.52|Standard Deviation|.35|0.35|||
3597533|NCT03052530|3451330|B1|Lesion Length||Lesion Characteristics|Analysis is based on the number of intent-to-treat lesions (n=67).|Millimeters|Mean|18.42|18.42|Standard Deviation|12.25|12.25|||
3597534|NCT03052530|3451330|B1|Prox||Lesion Characteristics: Lesion Location|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|26|26.0||||||
3597535|NCT03052530|3451330|B1|Ostial||Lesion Characteristics: Lesion Location|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|3|3.0||||||
3597536|NCT03052530|3451330|B1|Mid||Lesion Characteristics: Lesion Location|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|27|27.0||||||
3597537|NCT03052530|3451330|B1|Distal||Lesion Characteristics: Lesion Location|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|11|11.0||||||
3597538|NCT03052530|3451330|B1|Right Coronary Artery||Lesion Characteristics: Vessel Treated|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|16|16.0||||||
3597539|NCT03052530|3451330|B1|Posterior Descending Branch-Right Coronary Artery||Lesion Characteristics: Vessel Treated|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|2|2.0||||||
3597540|NCT03052530|3451330|B1|Marginal Branch of Left Circumflex Artery||Lesion Characteristics: Vessel Treated|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|1|1.0||||||
3597541|NCT03052530|3451330|B1|Left Circumflex Artery||Lesion Characteristics: Vessel Treated|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|12|12.0||||||
3597542|NCT03052530|3451330|B1|Left Anterior Descending Artery||Lesion Characteristics: Vessel Treated|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|22|22.0||||||
3597543|NCT03052530|3451330|B1|Diagonol Branch-Left Anterior Descending Artery||Lesion Characteristics: Vessel Treated|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|10|10.0||||||
3597544|NCT03052530|3451330|B1|Bypass Graft||Lesion Characteristics: Vessel Treated|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|4|4.0||||||
3597545|NCT03052530|3451330|B1|Hypertension Requiring Treatment||Cardiac Risk Factors|More than one Cardiac Risk Factor may be reported for each participant.|Participants|Count of Participants|51|51.0||||||
3597546|NCT03052530|3451330|B1|Hypercholesterolemia Requiring Treatment||Cardiac Risk Factors|More than one Cardiac Risk Factor may be reported for each participant.|Participants|Count of Participants|55|55.0||||||
3597547|NCT03052530|3451330|B1|Medically Treated Diabetes||Cardiac Risk Factors|More than one Cardiac Risk Factor may be reported for each participant.|Participants|Count of Participants|16|16.0||||||
3597548|NCT03052530|3451330|B1|Current Cigarette Smoking (within 30 days)||Cardiac Risk Factors|More than one Cardiac Risk Factor may be reported for each participant.|Participants|Count of Participants|10|10.0||||||
3597549|NCT03052530|3451330|B1|Unstable Angina||Cardiac History|More than one Cardiac History measure may be reported for each participant.|Participants|Count of Participants|21|21.0||||||
3597550|NCT03052530|3451330|B1|Stable Angina||Cardiac History|More than one Cardiac History measure may be reported for each participant.|Participants|Count of Participants|31|31.0||||||
3597551|NCT03052530|3451330|B1|Previous Myocardial Infarction||Cardiac History|More than one Cardiac History measure may be reported for each participant.|Participants|Count of Participants|25|25.0||||||
3597552|NCT03052530|3451330|B1|Previous Coronary Artery Bypass Graft||Cardiac History|More than one Cardiac History measure may be reported for each participant.|Participants|Count of Participants|18|18.0||||||
3597553|NCT03052530|3451330|B1|Previous Percutaneous Coronary Intervention||Cardiac History|More than one Cardiac History measure may be reported for each participant.|Participants|Count of Participants|31|31.0||||||
3597554|NCT03052530|3451330|B1|United States||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
3597555|NCT03052530|3451330|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|57|57.0||||||
3597556|NCT03052530|3451330|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3597557|NCT03052530|3451330|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3597558|NCT03052530|3451330|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3597559|NCT03052530|3451330|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3597560|NCT03052530|3451330|B1|||Age||Years|Mean|67.26|67.26|Standard Deviation|9.35|9.35|||
3597561|NCT03051646|3451337|B3|||Self-report heat-sensitivity during exercise||Participants|Count of Participants|8|8.0||||||
3597562|NCT03051646|3451338|B2|||Self-report heat-sensitivity during exercise||Participants|Count of Participants|3|3.0||||||
3597563|NCT03051646|3451339|B1|||Self-report heat-sensitivity during exercise||Participants|Count of Participants|5|5.0||||||
3597564|NCT03051646|3451337|B3|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3597565|NCT03051646|3451338|B2|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3597566|NCT03051646|3451339|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3597567|NCT03051646|3451337|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3597568|NCT03051646|3451337|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3597569|NCT03051646|3451338|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3597570|NCT03051646|3451339|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3597571|NCT03051646|3451337|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3597572|NCT03051646|3451338|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3597573|NCT03051646|3451339|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3597574|NCT03051646|3451337|B3|Overall Participants|>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3597575|NCT03051646|3451338|B2|Overall Participants|>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3597576|NCT03051646|3451339|B1|Overall Participants|>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3597577|NCT03051646|3451337|B3|Overall Participants|Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3597578|NCT03051646|3451338|B2|Overall Participants|Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3597579|NCT03051646|3451339|B1|Overall Participants|Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3597580|NCT03051646|3451337|B3|Overall Participants|<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597581|NCT03051646|3451338|B2|Overall Participants|<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597582|NCT03051646|3451339|B1|Overall Participants|<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597583|NCT03051165|3451348|B1|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3597584|NCT03051165|3451348|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597585|NCT03051165|3451348|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597586|NCT03051165|3451348|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3597587|NCT03051165|3451348|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3597588|NCT03051165|3451348|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597589|NCT03051165|3451348|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597590|NCT03051165|3451348|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597591|NCT03051165|3451348|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3597592|NCT03051165|3451348|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3597593|NCT03051165|3451348|B1|||Age||years|Mean|67|67.0|Standard Deviation|10.5|10.5|||
3597594|NCT03051165|3451348|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3597595|NCT03051165|3451348|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3597596|NCT03051165|3451348|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597597|NCT03050775|3451360|B3|ASA III||American Society of Anesthesiologists (ASA) Status|The ASA physical status classification system is a system for assessing the fitness of patients before surgery. There are six categories in the classification system, the higher the number, the more severe illness is indicated. I=normal healthy patient, II=patient with mild systemic disease, III=a patient with severe systemic disease, IV=a patient with severe systemic disease that is a constant threat to life, V=a moribund patient who is not expected to survive without the operation, VI=a declared brain-dead patient whose organs are being removed for donor purposes.|Participants|Count of Participants|26|26.0||||||
3597598|NCT03050775|3451361|B2|ASA III||American Society of Anesthesiologists (ASA) Status|The ASA physical status classification system is a system for assessing the fitness of patients before surgery. There are six categories in the classification system, the higher the number, the more severe illness is indicated. I=normal healthy patient, II=patient with mild systemic disease, III=a patient with severe systemic disease, IV=a patient with severe systemic disease that is a constant threat to life, V=a moribund patient who is not expected to survive without the operation, VI=a declared brain-dead patient whose organs are being removed for donor purposes.|Participants|Count of Participants|13|13.0||||||
3597599|NCT03050775|3451362|B1|ASA III||American Society of Anesthesiologists (ASA) Status|The ASA physical status classification system is a system for assessing the fitness of patients before surgery. There are six categories in the classification system, the higher the number, the more severe illness is indicated. I=normal healthy patient, II=patient with mild systemic disease, III=a patient with severe systemic disease, IV=a patient with severe systemic disease that is a constant threat to life, V=a moribund patient who is not expected to survive without the operation, VI=a declared brain-dead patient whose organs are being removed for donor purposes.|Participants|Count of Participants|13|13.0||||||
3597600|NCT03050775|3451360|B3|ASA I or II||American Society of Anesthesiologists (ASA) Status|The ASA physical status classification system is a system for assessing the fitness of patients before surgery. There are six categories in the classification system, the higher the number, the more severe illness is indicated. I=normal healthy patient, II=patient with mild systemic disease, III=a patient with severe systemic disease, IV=a patient with severe systemic disease that is a constant threat to life, V=a moribund patient who is not expected to survive without the operation, VI=a declared brain-dead patient whose organs are being removed for donor purposes.|Participants|Count of Participants|43|43.0||||||
3597601|NCT03050775|3451361|B2|ASA I or II||American Society of Anesthesiologists (ASA) Status|The ASA physical status classification system is a system for assessing the fitness of patients before surgery. There are six categories in the classification system, the higher the number, the more severe illness is indicated. I=normal healthy patient, II=patient with mild systemic disease, III=a patient with severe systemic disease, IV=a patient with severe systemic disease that is a constant threat to life, V=a moribund patient who is not expected to survive without the operation, VI=a declared brain-dead patient whose organs are being removed for donor purposes.|Participants|Count of Participants|21|21.0||||||
3597602|NCT03050775|3451362|B1|ASA I or II||American Society of Anesthesiologists (ASA) Status|The ASA physical status classification system is a system for assessing the fitness of patients before surgery. There are six categories in the classification system, the higher the number, the more severe illness is indicated. I=normal healthy patient, II=patient with mild systemic disease, III=a patient with severe systemic disease, IV=a patient with severe systemic disease that is a constant threat to life, V=a moribund patient who is not expected to survive without the operation, VI=a declared brain-dead patient whose organs are being removed for donor purposes.|Participants|Count of Participants|22|22.0||||||
3597603|NCT03050775|3451360|B3|||BMI||kg/m^2|Mean|28.69|28.69|Standard Deviation|5.25|5.25|||
3597604|NCT03050775|3451361|B2|||BMI||kg/m^2|Mean|29.17|29.17|Standard Deviation|5.90|5.9|||
3597605|NCT03050775|3451362|B1|||BMI||kg/m^2|Mean|28.21|28.21|Standard Deviation|4.61|4.61|||
3597606|NCT03050775|3451360|B3|United States||Region of Enrollment||Participants|Count of Participants|69|69.0||||||
3597607|NCT03050775|3451361|B2|United States||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3597608|NCT03050775|3451362|B1|United States||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3597609|NCT03050775|3451360|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3597610|NCT03050775|3451361|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3597611|NCT03050775|3451362|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3597612|NCT03050775|3451360|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597613|NCT03050775|3451361|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597614|NCT03050775|3451362|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597615|NCT03050775|3451360|B3||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3597616|NCT03050775|3451361|B2||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3597617|NCT03050775|3451362|B1||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3597618|NCT03050775|3451360|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597619|NCT03050775|3451361|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597620|NCT03050775|3451362|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597621|NCT03050775|3451360|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597622|NCT03050775|3451361|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597623|NCT03050775|3451362|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597624|NCT03050775|3451360|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597625|NCT03050775|3451361|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597626|NCT03050775|3451362|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597627|NCT03050775|3451360|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597628|NCT03050775|3451361|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597629|NCT03050775|3451362|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597630|NCT03050775|3451360|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3597631|NCT03050775|3451361|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3597632|NCT03050775|3451362|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3597633|NCT03050775|3451360|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3597634|NCT03050775|3451361|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3597635|NCT03050775|3451362|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3597636|NCT03050775|3451360|B3|||Age||years|Mean|62|62.0|Standard Deviation|11|11.0|||
3597637|NCT03050775|3451361|B2|||Age||years|Mean|61|61.0|Standard Deviation|12|12.0|||
3597638|NCT03050775|3451362|B1|||Age||years|Mean|63|63.0|Standard Deviation|11|11.0|||
3597639|NCT03050541|3451381|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3597640|NCT03050541|3451382|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3597641|NCT03050541|3451383|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3597642|NCT03050541|3451384|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3597643|NCT03050541|3451381|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3597644|NCT03050541|3451382|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3597645|NCT03050541|3451383|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3597646|NCT03050541|3451384|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3597647|NCT03050541|3451381|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3597648|NCT03050541|3451382|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3597649|NCT03050541|3451383|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3597650|NCT03050541|3451384|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3597651|NCT03050541|3451381|B4||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3597652|NCT03050541|3451382|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3597653|NCT03050541|3451383|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3597654|NCT03050541|3451384|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3597655|NCT03050541|3451381|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597656|NCT03050541|3451382|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597657|NCT03050541|3451383|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597658|NCT03050541|3451384|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597659|NCT03050320|3451397|B3||No Osteoarthritis|Type of Osteoarthritis||Participants|Count of Participants|37|37.0||||||
3597660|NCT03050320|3451398|B2||No Osteoarthritis|Type of Osteoarthritis||Participants|Count of Participants|19|19.0||||||
3597661|NCT03050320|3451399|B1||No Osteoarthritis|Type of Osteoarthritis||Participants|Count of Participants|18|18.0||||||
3597662|NCT03050320|3451397|B3||Knee Osteoarthritis|Type of Osteoarthritis||Participants|Count of Participants|5|5.0||||||
3597663|NCT03050320|3451398|B2||Knee Osteoarthritis|Type of Osteoarthritis||Participants|Count of Participants|3|3.0||||||
3597664|NCT03050320|3451399|B1||Knee Osteoarthritis|Type of Osteoarthritis||Participants|Count of Participants|2|2.0||||||
3597665|NCT03050320|3451397|B3||Hip Osteoarthritis|Type of Osteoarthritis||Participants|Count of Participants|1|1.0||||||
3597666|NCT03050320|3451398|B2||Hip Osteoarthritis|Type of Osteoarthritis||Participants|Count of Participants|0|0.0||||||
3597667|NCT03050320|3451399|B1||Hip Osteoarthritis|Type of Osteoarthritis||Participants|Count of Participants|1|1.0||||||
3597668|NCT03050320|3451397|B3|Canada||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
3597669|NCT03050320|3451398|B2|Canada||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3597670|NCT03050320|3451399|B1|Canada||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3597671|NCT03050320|3451397|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3597672|NCT03050320|3451397|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3597673|NCT03050320|3451398|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3597674|NCT03050320|3451399|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3597675|NCT03050320|3451397|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3597676|NCT03050320|3451398|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3597677|NCT03050320|3451399|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3597678|NCT03050320|3451397|B3|||Age||years|Mean|43.6|43.6|Standard Deviation|10.3|10.3|||
3597679|NCT03050320|3451398|B2|||Age||years|Mean|43.3|43.3|Standard Deviation|10.4|10.4|||
3597680|NCT03050320|3451399|B1|||Age||years|Mean|44.1|44.1|Standard Deviation|10.5|10.5|||
3597681|NCT03050294|3451430|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3597682|NCT03050294|3451431|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597683|NCT03050294|3451432|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597684|NCT03050294|3451433|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3597685|NCT03050294|3451434|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597686|NCT03050294|3451430|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3597687|NCT03050294|3451431|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597688|NCT03050294|3451432|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597689|NCT03050294|3451433|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597690|NCT03050294|3451434|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3597691|NCT03050294|3451430|B5||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3597692|NCT03050294|3451431|B4||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3597693|NCT03050294|3451432|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3597694|NCT03050294|3451433|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3597695|NCT03050294|3451434|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3597696|NCT03050294|3451430|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3597697|NCT03050294|3451431|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597698|NCT03050294|3451432|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3597699|NCT03050294|3451433|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3597700|NCT03050294|3451434|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3597701|NCT03050294|3451430|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597702|NCT03050294|3451431|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597703|NCT03050294|3451432|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597704|NCT03050294|3451433|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597705|NCT03050294|3451434|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597706|NCT03050294|3451430|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3597707|NCT03050294|3451431|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597708|NCT03050294|3451432|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597709|NCT03050294|3451433|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3597710|NCT03050294|3451434|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597711|NCT03050294|3451430|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597712|NCT03050294|3451431|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597713|NCT03050294|3451432|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597714|NCT03050294|3451433|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597715|NCT03050294|3451434|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597716|NCT03050294|3451430|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3597717|NCT03050294|3451431|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3597718|NCT03050294|3451432|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3597719|NCT03050294|3451433|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3597720|NCT03050294|3451434|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3597721|NCT03050294|3451430|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3597722|NCT03050294|3451431|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3597723|NCT03050294|3451432|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3597724|NCT03050294|3451433|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3597725|NCT03050294|3451434|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3597726|NCT03050294|3451430|B5|||Age||years|Mean|55.23|55.23|Full Range|||22.0|73.0|
3597727|NCT03050294|3451431|B4|||Age||years|Mean|61.8|61.8|Full Range|||48.0|73.0|
3597728|NCT03050294|3451432|B3|||Age||years|Mean|58.3|58.3|Full Range|||40.0|68.0|
3597729|NCT03050294|3451433|B2|||Age||years|Mean|48|48.0|Full Range|||22.0|67.0|
3597730|NCT03050294|3451434|B1|||Age||years|Mean|52.8|52.8|Full Range|||27.0|70.0|
3597731|NCT03048383|3451459|B4|||Pre-treatment SAQ score|The Synkinesis Assessment Questionnaire (SAQ) was used to assess severity of facial synkinesis in this study. SAQ scores are calculated as the sum of scores for 9 questions, which each is scored from 1 to 5, divided by 45 and multiplied by 100. The total score therefore can range from 20 to 100. Lower SAQ scores represent less severe facial synkinesis, and higher scores more severe. We report here the mean total SAQ score each group. For additional information on the SAQ for facial synkinesis see Mehta et al. published in Laryngoscope in May 2007 (PMID: 17473697).|units on a scale|Mean|73.7|73.7|Standard Deviation|14.4|14.4|||
3597732|NCT03048383|3451460|B3|||Pre-treatment SAQ score|The Synkinesis Assessment Questionnaire (SAQ) was used to assess severity of facial synkinesis in this study. SAQ scores are calculated as the sum of scores for 9 questions, which each is scored from 1 to 5, divided by 45 and multiplied by 100. The total score therefore can range from 20 to 100. Lower SAQ scores represent less severe facial synkinesis, and higher scores more severe. We report here the mean total SAQ score each group. For additional information on the SAQ for facial synkinesis see Mehta et al. published in Laryngoscope in May 2007 (PMID: 17473697).|units on a scale|Mean|69.6|69.6|Standard Deviation|9.7|9.7|||
3597733|NCT03048383|3451461|B2|||Pre-treatment SAQ score|The Synkinesis Assessment Questionnaire (SAQ) was used to assess severity of facial synkinesis in this study. SAQ scores are calculated as the sum of scores for 9 questions, which each is scored from 1 to 5, divided by 45 and multiplied by 100. The total score therefore can range from 20 to 100. Lower SAQ scores represent less severe facial synkinesis, and higher scores more severe. We report here the mean total SAQ score each group. For additional information on the SAQ for facial synkinesis see Mehta et al. published in Laryngoscope in May 2007 (PMID: 17473697).|units on a scale|Mean|70.1|70.1|Standard Deviation|15.3|15.3|||
3597734|NCT03048383|3451462|B1|||Pre-treatment SAQ score|The Synkinesis Assessment Questionnaire (SAQ) was used to assess severity of facial synkinesis in this study. SAQ scores are calculated as the sum of scores for 9 questions, which each is scored from 1 to 5, divided by 45 and multiplied by 100. The total score therefore can range from 20 to 100. Lower SAQ scores represent less severe facial synkinesis, and higher scores more severe. We report here the mean total SAQ score each group. For additional information on the SAQ for facial synkinesis see Mehta et al. published in Laryngoscope in May 2007 (PMID: 17473697).|units on a scale|Mean|79.6|79.6|Standard Deviation|15.1|15.1|||
3597735|NCT03048383|3451459|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3597736|NCT03048383|3451460|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3597737|NCT03048383|3451461|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3597738|NCT03048383|3451462|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3597739|NCT03048383|3451459|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3597740|NCT03048383|3451460|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3597741|NCT03048383|3451461|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3597742|NCT03048383|3451462|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3597743|NCT03048383|3451459|B4|||Age||years|Mean|49.1|49.1|Full Range|||21.0|83.0|
3597744|NCT03048383|3451460|B3|||Age||years|Mean|53.2|53.2|Full Range|||32.0|73.0|
3597745|NCT03048383|3451461|B2|||Age||years|Mean|52.1|52.1|Full Range|||21.0|83.0|
3597746|NCT03048383|3451462|B1|||Age||years|Mean|43.9|43.9|Full Range|||24.0|76.0|
3597747|NCT03048058|3451475|B3|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3597748|NCT03048058|3451476|B2|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3597749|NCT03048058|3451477|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3597750|NCT03048058|3451475|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597751|NCT03048058|3451476|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597752|NCT03048058|3451477|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597753|NCT03048058|3451475|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597754|NCT03048058|3451476|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597755|NCT03048058|3451477|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597756|NCT03048058|3451475|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3597757|NCT03048058|3451476|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3597758|NCT03048058|3451477|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3597759|NCT03048058|3451475|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597760|NCT03048058|3451476|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597761|NCT03048058|3451477|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597762|NCT03048058|3451475|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597763|NCT03048058|3451476|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597764|NCT03048058|3451477|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597765|NCT03048058|3451475|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597766|NCT03048058|3451476|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597767|NCT03048058|3451477|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597768|NCT03048058|3451475|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597769|NCT03048058|3451476|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597770|NCT03048058|3451477|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597771|NCT03048058|3451475|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3597772|NCT03048058|3451476|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3597773|NCT03048058|3451477|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3597774|NCT03048058|3451475|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3597775|NCT03048058|3451476|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3597776|NCT03048058|3451477|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3597777|NCT03048058|3451475|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3597778|NCT03048058|3451476|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3597779|NCT03048058|3451477|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3597780|NCT03048058|3451475|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3597781|NCT03048058|3451476|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3597782|NCT03048058|3451477|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3597783|NCT03048058|3451475|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597784|NCT03048058|3451476|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597785|NCT03048058|3451477|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597786|NCT03048006|3451496|B1|Other||Risk factors|Risk factors were recorded before the MRI examination|Participants|Count of Participants|858|858.0||||||
3597787|NCT03048006|3451496|B1|Central nervous system disorders||Risk factors|Risk factors were recorded before the MRI examination|Participants|Count of Participants|560|560.0||||||
3597788|NCT03048006|3451496|B1|Liver dysfunction||Risk factors|Risk factors were recorded before the MRI examination|Participants|Count of Participants|121|121.0||||||
3597789|NCT03048006|3451496|B1|Hypertension||Risk factors|Risk factors were recorded before the MRI examination|Participants|Count of Participants|2479|2479.0||||||
3597790|NCT03048006|3451496|B1|Heart failure||Risk factors|Risk factors were recorded before the MRI examination|Participants|Count of Participants|413|413.0||||||
3597791|NCT03048006|3451496|B1|Coronary heart disease||Risk factors|Risk factors were recorded before the MRI examination|Participants|Count of Participants|824|824.0||||||
3597792|NCT03048006|3451496|B1|Beta-blocker treatment||Risk factors|Risk factors were recorded before the MRI examination|Participants|Count of Participants|648|648.0||||||
3597793|NCT03048006|3451496|B1|Bronchial asthma||Risk factors|Risk factors were recorded before the MRI examination|Participants|Count of Participants|630|630.0||||||
3597794|NCT03048006|3451496|B1|History of a reaction to a contrast agent||Risk factors|Risk factors were recorded before the MRI examination|Participants|Count of Participants|176|176.0||||||
3597795|NCT03048006|3451496|B1|Known allergies||Risk factors|Risk factors were recorded before the MRI examination|Participants|Count of Participants|6871|6871.0||||||
3597796|NCT03048006|3451496|B1||Male|Sex: Female, Male||Participants|Count of Participants|19515|19515.0||||||
3597797|NCT03048006|3451496|B1||Female|Sex: Female, Male||Participants|Count of Participants|24254|24254.0||||||
3597798|NCT03048006|3451496|B1|≥18 years||Age, Customized||Participants|Count of Participants|43590|43590.0||||||
3597799|NCT03048006|3451496|B1|between 12 and 17 years||Age, Customized||Participants|Count of Participants|617|617.0||||||
3597800|NCT03048006|3451496|B1|between 2 and 11 years||Age, Customized||Participants|Count of Participants|81|81.0||||||
3597801|NCT03048006|3451496|B1|<2 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3597802|NCT03048006|3451496|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|16.9|16.9|||
3597803|NCT03047447|3451502|B4|United States||Region of Enrollment||participants|Number|30|30.0||||||
3597804|NCT03047447|3451503|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3597805|NCT03047447|3451504|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3597806|NCT03047447|3451505|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3597807|NCT03047447|3451502|B4|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3597808|NCT03047447|3451502|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3597809|NCT03047447|3451503|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3597810|NCT03047447|3451504|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3597811|NCT03047447|3451505|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3597812|NCT03047447|3451502|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3597813|NCT03047447|3451503|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3597814|NCT03047447|3451504|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3597815|NCT03047447|3451505|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3597816|NCT03047447|3451502|B4|||Age||Age|Mean|48.70|48.7|Standard Deviation|8.55|8.55|||
3597817|NCT03047447|3451503|B3|||Age||Age|Mean|50.20|50.2|Standard Deviation|6.75|6.75|||
3597818|NCT03047447|3451504|B2|||Age||Age|Mean|48.20|48.2|Standard Deviation|9.77|9.77|||
3597819|NCT03047447|3451505|B1|||Age||Age|Mean|47.70|47.7|Standard Deviation|9.51|9.51|||
3597820|NCT03047447|3451502|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3597821|NCT03047447|3451503|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3597822|NCT03047447|3451504|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3597823|NCT03047447|3451505|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3597824|NCT03047447|3451502|B4||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3597825|NCT03047447|3451503|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3597826|NCT03047447|3451504|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3597827|NCT03047447|3451505|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3597828|NCT03047447|3451502|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597829|NCT03047447|3451503|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597830|NCT03047447|3451504|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597831|NCT03047447|3451505|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597832|NCT03046225|3451527|B3|||Femoral nerve block||Participants|Count of Participants|9|9.0||||||
3597833|NCT03046225|3451528|B2|||Femoral nerve block||Participants|Count of Participants|4|4.0||||||
3597834|NCT03046225|3451529|B1|||Femoral nerve block||Participants|Count of Participants|5|5.0||||||
3597835|NCT03046225|3451527|B3|||Body Mass Index (BMI)||kg/m²|Mean|31.3|31.3|Standard Deviation|4|4.0|||
3597836|NCT03046225|3451528|B2|||Body Mass Index (BMI)||kg/m²|Mean|32|32.0|Standard Deviation|4.3|4.3|||
3597837|NCT03046225|3451529|B1|||Body Mass Index (BMI)||kg/m²|Mean|30.7|30.7|Standard Deviation|3.7|3.7|||
3597838|NCT03046225|3451527|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3597839|NCT03046225|3451528|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3597840|NCT03046225|3451529|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3597841|NCT03046225|3451527|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3597842|NCT03046225|3451528|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3597843|NCT03046225|3451529|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3597844|NCT03046225|3451527|B3|||Age||Years|Mean|67.1|67.1|Standard Deviation|7.3|7.3|||
3597845|NCT03046225|3451528|B2|||Age||Years|Mean|66.5|66.5|Standard Deviation|7.4|7.4|||
3597846|NCT03046225|3451529|B1|||Age||Years|Mean|67.8|67.8|Standard Deviation|7.4|7.4|||
3597847|NCT03046212|3451540|B3|||Body mass index (BMI)||kg/m²|Mean|29.06|29.06|Standard Deviation|4.8|4.8|||
3597848|NCT03046212|3451541|B2|||Body mass index (BMI)||kg/m²|Mean|28.6|28.6|Standard Deviation|5.9|5.9|||
3597849|NCT03046212|3451542|B1|||Body mass index (BMI)||kg/m²|Mean|29.5|29.5|Standard Deviation|3.4|3.4|||
3597850|NCT03046212|3451540|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3597851|NCT03046212|3451541|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3597852|NCT03046212|3451542|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3597853|NCT03046212|3451540|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3597854|NCT03046212|3451541|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3597855|NCT03046212|3451542|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3597856|NCT03046212|3451540|B3|||Age||years|Mean|63.3|63.3|Standard Deviation|11.8|11.8|||
3597857|NCT03046212|3451541|B2|||Age||years|Mean|66.9|66.9|Standard Deviation|12.8|12.8|||
3597858|NCT03046212|3451542|B1|||Age||years|Mean|59.8|59.8|Standard Deviation|9.9|9.9|||
3597859|NCT03044431|3451553|B1|||ILD Participant Baseline QOL score based on Clinical COPD Questionnaire (CCQ)|The Clinical COPD Questionnaire (CCQ) is a 10-item scale where the participant chooses responses on a 0-6 scale for each item. 0 represents no symptoms and 6 represents severe symptoms. The mean of the responses is the final score and ranges from 0-6, 0 is least severe symptoms and 6 is most severe symptoms.|units on a scale|Mean|3.3|3.3|Inter-Quartile Range|||0.8|5.6|
3597860|NCT03044431|3451553|B1|||COPD Participant Baseline QOL (quality of life) score based on the Clinical COPD Questionnaire (CCQ)|The Clinical COPD Questionnaire (CCQ) is a 10-item scale where the participant chooses responses on a 0-6 scale for each item. 0 represents no symptoms and 6 represents severe symptoms. The mean of the responses is the final score and ranges from 0-6, 0 is least severe symptoms and 6 is most severe symptoms.|units on a scale|Mean|3.6|3.6|Full Range|||1.0|6.0|
3597861|NCT03044431|3451553|B1|||Baseline Clinical COPD Questionnaire Score All Participants|The Clinical COPD Questionnaire (CCQ) is a 10-item scale where the participant chooses responses on a 0-6 scale for each item. 0 represents no symptoms and 6 represents severe symptoms. The mean of the responses is the final score and ranges from 0-6, 0 is least severe symptoms and 6 is most severe symptoms.|units on a scale|Mean|3.6|3.6|Full Range|||0.8|6.0|
3597862|NCT03044431|3451553|B1|||Baseline FEV1 if participant has COPD||FEV1 Percentage (%)|Mean|36.9|36.9|Full Range|||9.0|85.0|
3597863|NCT03044431|3451553|B1|Bone Marrow Protocol||Treatment Type||Participants|Count of Participants|22|22.0||||||
3597864|NCT03044431|3451553|B1|Double Venous Protocol||Treatment Type||Participants|Count of Participants|26|26.0||||||
3597865|NCT03044431|3451553|B1|Venous Protocol||Treatment Type||Participants|Count of Participants|159|159.0||||||
3597866|NCT03044431|3451553|B1|||Number of Participants with Interstitial Lung Disease (ILD)||Participants|Count of Participants|40|40.0||||||
3597867|NCT03044431|3451553|B1|||Number of Participants with Chronic Obstructive Pulmonary Disease (COPD)||Participants|Count of Participants|167|167.0||||||
3597868|NCT03044431|3451553|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3597869|NCT03044431|3451553|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3597870|NCT03044431|3451553|B1||>=65 years|Age||Participants|Count of Participants|165|165.0||||||
3597871|NCT03044431|3451553|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3597872|NCT03044431|3451553|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597873|NCT03043885|3451563|B5|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3597874|NCT03043885|3451564|B4|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3597875|NCT03043885|3451565|B3|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3597876|NCT03043885|3451566|B2|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3597877|NCT03043885|3451567|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3597878|NCT03043885|3451563|B5|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3597879|NCT03043885|3451563|B5||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3597880|NCT03043885|3451564|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3597881|NCT03043885|3451565|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3597882|NCT03043885|3451566|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3597883|NCT03043885|3451567|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3597884|NCT03043885|3451563|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3597885|NCT03043885|3451564|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3597886|NCT03043885|3451565|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3597887|NCT03043885|3451566|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3597888|NCT03043885|3451567|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3597889|NCT03043885|3451563|B5||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3597890|NCT03043885|3451564|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3597891|NCT03043885|3451565|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3597892|NCT03043885|3451566|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3597893|NCT03043885|3451567|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3597894|NCT03043885|3451563|B5||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3597895|NCT03043885|3451564|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3597896|NCT03043885|3451565|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3597897|NCT03043885|3451566|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3597898|NCT03043885|3451567|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3597899|NCT03043885|3451563|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597900|NCT03043885|3451564|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597901|NCT03043885|3451565|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597902|NCT03043885|3451566|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597903|NCT03043885|3451567|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597904|NCT03043534|3451584|B3|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3597905|NCT03043534|3451585|B2|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3597906|NCT03043534|3451586|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3597907|NCT03043534|3451584|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3597908|NCT03043534|3451585|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3597909|NCT03043534|3451586|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3597910|NCT03043534|3451584|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3597911|NCT03043534|3451585|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3597912|NCT03043534|3451586|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3597913|NCT03043534|3451584|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3597914|NCT03043534|3451585|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3597915|NCT03043534|3451586|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3597916|NCT03043534|3451584|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3597917|NCT03043534|3451585|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3597918|NCT03043534|3451586|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3597919|NCT03043534|3451584|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597920|NCT03043534|3451585|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597921|NCT03043534|3451586|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597922|NCT03042780|3451601|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3597923|NCT03042780|3451601|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597924|NCT03042780|3451601|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597925|NCT03042780|3451601|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3597926|NCT03042780|3451601|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597927|NCT03042780|3451601|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597928|NCT03042780|3451601|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597929|NCT03042780|3451601|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597930|NCT03042780|3451601|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597931|NCT03042780|3451601|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3597932|NCT03042780|3451601|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597933|NCT03042780|3451601|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3597934|NCT03042780|3451601|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3597935|NCT03042780|3451601|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3597936|NCT03042780|3451601|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3597937|NCT03042780|3451601|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3597938|NCT03042702|3451607|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3597939|NCT03042702|3451607|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597940|NCT03042702|3451607|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597941|NCT03042702|3451607|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3597942|NCT03042702|3451607|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597943|NCT03042702|3451607|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597944|NCT03042702|3451607|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597945|NCT03042702|3451607|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597946|NCT03042702|3451607|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597947|NCT03042702|3451607|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3597948|NCT03042702|3451607|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3597949|NCT03042702|3451607|B1|Female||Sex/Gender, Customized||Participants|Count of Participants|2|2.0||||||
3597950|NCT03042702|3451607|B1|71 years old||Age, Customized||Participants|Count of Participants|1|1.0||||||
3597951|NCT03042702|3451607|B1|54 years old||Age, Customized||Participants|Count of Participants|1|1.0||||||
3597952|NCT03042299|3451616|B3|Had no caffeine consumption||Caffeine classification||Participants|Count of Participants|11|11.0||||||
3597953|NCT03042299|3451617|B2|Had no caffeine consumption||Caffeine classification||Participants|Count of Participants|5|5.0||||||
3597954|NCT03042299|3451618|B1|Had no caffeine consumption||Caffeine classification||Participants|Count of Participants|6|6.0||||||
3597955|NCT03042299|3451616|B3|Had caffeine consumption||Caffeine classification||Participants|Count of Participants|3|3.0||||||
3597956|NCT03042299|3451617|B2|Had caffeine consumption||Caffeine classification||Participants|Count of Participants|2|2.0||||||
3597957|NCT03042299|3451618|B1|Had caffeine consumption||Caffeine classification||Participants|Count of Participants|1|1.0||||||
3597958|NCT03042299|3451616|B3|Never drank||Alcohol classification||Participants|Count of Participants|4|4.0||||||
3597959|NCT03042299|3451617|B2|Never drank||Alcohol classification||Participants|Count of Participants|2|2.0||||||
3597960|NCT03042299|3451618|B1|Never drank||Alcohol classification||Participants|Count of Participants|2|2.0||||||
3597961|NCT03042299|3451616|B3|Drank a few times per month||Alcohol classification||Participants|Count of Participants|7|7.0||||||
3597962|NCT03042299|3451617|B2|Drank a few times per month||Alcohol classification||Participants|Count of Participants|3|3.0||||||
3597963|NCT03042299|3451618|B1|Drank a few times per month||Alcohol classification||Participants|Count of Participants|4|4.0||||||
3597964|NCT03042299|3451616|B3|Drank a few times per week||Alcohol classification||Participants|Count of Participants|3|3.0||||||
3597965|NCT03042299|3451617|B2|Drank a few times per week||Alcohol classification||Participants|Count of Participants|2|2.0||||||
3597966|NCT03042299|3451618|B1|Drank a few times per week||Alcohol classification||Participants|Count of Participants|1|1.0||||||
3597967|NCT03042299|3451616|B3|Ex-smoker||Smoking classification||Participants|Count of Participants|1|1.0||||||
3597968|NCT03042299|3451617|B2|Ex-smoker||Smoking classification||Participants|Count of Participants|0|0.0||||||
3597969|NCT03042299|3451618|B1|Ex-smoker||Smoking classification||Participants|Count of Participants|1|1.0||||||
3597970|NCT03042299|3451616|B3|Current smoker||Smoking classification||Participants|Count of Participants|4|4.0||||||
3597971|NCT03042299|3451617|B2|Current smoker||Smoking classification||Participants|Count of Participants|3|3.0||||||
3597972|NCT03042299|3451618|B1|Current smoker||Smoking classification||Participants|Count of Participants|1|1.0||||||
3597973|NCT03042299|3451616|B3|Never smoked||Smoking classification||Participants|Count of Participants|9|9.0||||||
3597974|NCT03042299|3451617|B2|Never smoked||Smoking classification||Participants|Count of Participants|4|4.0||||||
3597975|NCT03042299|3451618|B1|Never smoked||Smoking classification||Participants|Count of Participants|5|5.0||||||
3597976|NCT03042299|3451616|B3|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|20.97|20.97|Standard Deviation|2.060|2.06|||
3597977|NCT03042299|3451617|B2|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|20.61|20.61|Standard Deviation|2.143|2.143|||
3597978|NCT03042299|3451618|B1|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|21.33|21.33|Standard Deviation|2.072|2.072|||
3597979|NCT03042299|3451616|B3|||Weight||kilogram (kg)|Mean|60.23|60.23|Standard Deviation|6.005|6.005|||
3597980|NCT03042299|3451617|B2|||Weight||kilogram (kg)|Mean|60.49|60.49|Standard Deviation|6.838|6.838|||
3597981|NCT03042299|3451618|B1|||Weight||kilogram (kg)|Mean|59.97|59.97|Standard Deviation|5.586|5.586|||
3597982|NCT03042299|3451616|B3|||Height||centimeter (cm)|Mean|169.5|169.5|Standard Deviation|4.31|4.31|||
3597983|NCT03042299|3451617|B2|||Height||centimeter (cm)|Mean|171.3|171.3|Standard Deviation|4.42|4.42|||
3597984|NCT03042299|3451618|B1|||Height||centimeter (cm)|Mean|167.7|167.7|Standard Deviation|3.64|3.64|||
3597985|NCT03042299|3451616|B3|Japan||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3597986|NCT03042299|3451617|B2|Japan||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3597987|NCT03042299|3451618|B1|Japan||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3597988|NCT03042299|3451616|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3597989|NCT03042299|3451616|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3597990|NCT03042299|3451617|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3597991|NCT03042299|3451618|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3597992|NCT03042299|3451616|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3597993|NCT03042299|3451617|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3597994|NCT03042299|3451618|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3597995|NCT03042299|3451616|B3|||Age||years|Mean|21.3|21.3|Standard Deviation|1.14|1.14|||
3597996|NCT03042299|3451617|B2|||Age||years|Mean|21.3|21.3|Standard Deviation|1.38|1.38|||
3597997|NCT03042299|3451618|B1|||Age||years|Mean|21.3|21.3|Standard Deviation|0.95|0.95|||
3597998|NCT03041298|3451645|B1|Other||Risk factors|Risk factors were recorded before MR mammography.|Participants|Count of Participants|14|14.0||||||
3597999|NCT03041298|3451645|B1|Family and personal history||Risk factors|Risk factors were recorded before MR mammography.|Participants|Count of Participants|300|300.0||||||
3598000|NCT03041298|3451645|B1|Personal history||Risk factors|Risk factors were recorded before MR mammography.|Participants|Count of Participants|525|525.0||||||
3598001|NCT03041298|3451645|B1|Family history||Risk factors|Risk factors were recorded before MR mammography.|Participants|Count of Participants|428|428.0||||||
3598002|NCT03041298|3451645|B1|Postmenopausal||Menopausal status|Menopausal status was recorded before MR mammography.|Participants|Count of Participants|826|826.0||||||
3598003|NCT03041298|3451645|B1|Perimenopausal||Menopausal status|Menopausal status was recorded before MR mammography.|Participants|Count of Participants|174|174.0||||||
3598004|NCT03041298|3451645|B1|Premenopausal||Menopausal status|Menopausal status was recorded before MR mammography.|Participants|Count of Participants|506|506.0||||||
3598005|NCT03041298|3451645|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3598006|NCT03041298|3451645|B1||Female|Sex: Female, Male||Participants|Count of Participants|1491|1491.0||||||
3598007|NCT03041298|3451645|B1|>55 years||Age, Customized||Participants|Count of Participants|504|504.0||||||
3598008|NCT03041298|3451645|B1|between 25 and 55 years||Age, Customized||Participants|Count of Participants|1025|1025.0||||||
3598009|NCT03041298|3451645|B1|<25 years||Age, Customized||Participants|Count of Participants|8|8.0||||||
3598010|NCT03041298|3451645|B1|||Age||years|Mean|51.4|51.4|Standard Deviation|12.3|12.3|||
3598011|NCT03039543|3451653|B3|||operation time||min|Mean|23|23.0|Standard Deviation|13|13.0|||
3598012|NCT03039543|3451654|B2|||operation time||min|Mean|22|22.0|Standard Deviation|13|13.0|||
3598013|NCT03039543|3451655|B1|||operation time||min|Mean|23|23.0|Standard Deviation|13|13.0|||
3598014|NCT03039543|3451653|B3|South Korea||Region of Enrollment||Participants|Count of Participants|104|104.0||||||
3598015|NCT03039543|3451654|B2|South Korea||Region of Enrollment||Participants|Count of Participants|51|51.0||||||
3598016|NCT03039543|3451655|B1|South Korea||Region of Enrollment||Participants|Count of Participants|53|53.0||||||
3598017|NCT03039543|3451653|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3598018|NCT03039543|3451653|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3598019|NCT03039543|3451654|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3598020|NCT03039543|3451655|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3598021|NCT03039543|3451653|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3598022|NCT03039543|3451654|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3598023|NCT03039543|3451655|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3598024|NCT03039543|3451653|B3|||Age||years|Mean|69|69.0|Standard Deviation|11|11.0|||
3598025|NCT03039543|3451654|B2|||Age||years|Mean|68|68.0|Standard Deviation|10|10.0|||
3598026|NCT03039543|3451655|B1|||Age||years|Mean|70|70.0|Standard Deviation|11|11.0|||
3598027|NCT03039543|3451653|B3||>=65 years|Age||Participants|Count of Participants|95|95.0||||||
3598028|NCT03039543|3451654|B2||>=65 years|Age||Participants|Count of Participants|47|47.0||||||
3598029|NCT03039543|3451655|B1||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
3598030|NCT03039543|3451653|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3598031|NCT03039543|3451654|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3598032|NCT03039543|3451655|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3598033|NCT03039543|3451653|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598034|NCT03039543|3451654|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598035|NCT03039543|3451655|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598036|NCT03039179|3451670|B3|||type of analgesia:peripheral nerve blocks analgesia||Participants|Count of Participants|23|23.0||||||
3598037|NCT03039179|3451671|B2|||type of analgesia:peripheral nerve blocks analgesia||Participants|Count of Participants|13|13.0||||||
3598038|NCT03039179|3451672|B1|||type of analgesia:peripheral nerve blocks analgesia||Participants|Count of Participants|10|10.0||||||
3598039|NCT03039179|3451670|B3|||type of surgery:Calcaneal Osteotomy||Participants|Count of Participants|76|76.0||||||
3598040|NCT03039179|3451671|B2|||type of surgery:Calcaneal Osteotomy||Participants|Count of Participants|39|39.0||||||
3598132|NCT03037905|3451690|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3598041|NCT03039179|3451672|B1|||type of surgery:Calcaneal Osteotomy||Participants|Count of Participants|37|37.0||||||
3598042|NCT03039179|3451670|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3598043|NCT03039179|3451671|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3598044|NCT03039179|3451672|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3598045|NCT03039179|3451670|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3598046|NCT03039179|3451671|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3598047|NCT03039179|3451672|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3598048|NCT03039179|3451670|B3|||Age||years|Mean|11.71|11.71|Standard Deviation|1.35|1.35|||
3598049|NCT03039179|3451671|B2|||Age||years|Mean|11.64|11.64|Standard Deviation|1.44|1.44|||
3598050|NCT03039179|3451672|B1|||Age||years|Mean|11.79|11.79|Standard Deviation|1.27|1.27|||
3598051|NCT03039088|3451681|B3||Male|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
3598052|NCT03039088|3451682|B2||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
3598053|NCT03039088|3451683|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3598054|NCT03039088|3451681|B3||Female|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
3598055|NCT03039088|3451682|B2||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3598056|NCT03039088|3451683|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3598057|NCT03039088|3451681|B3|||Age||years|Mean|41.3|41.3|Standard Deviation|11.6|11.6|||
3598058|NCT03039088|3451682|B2|||Age||years|Mean|41.1|41.1|Standard Deviation|12.1|12.1|||
3598059|NCT03039088|3451683|B1|||Age||years|Mean|41.6|41.6|Standard Deviation|10.7|10.7|||
3598060|NCT03039088|3451681|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3598061|NCT03039088|3451682|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3598062|NCT03039088|3451683|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3598063|NCT03039088|3451681|B3||Between 18 and 65 years|Age||Participants|Count of Participants|526|526.0||||||
3598064|NCT03039088|3451682|B2||Between 18 and 65 years|Age||Participants|Count of Participants|324|324.0||||||
3598065|NCT03039088|3451683|B1||Between 18 and 65 years|Age||Participants|Count of Participants|202|202.0||||||
3598066|NCT03039088|3451681|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598067|NCT03039088|3451682|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598068|NCT03039088|3451683|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598069|NCT03037905|3451690|B3|||Preoperative heart rate||beats per minute|Mean|78.4|78.4|Standard Deviation|14.0|14.0|||
3598070|NCT03037905|3451691|B2|||Preoperative heart rate||beats per minute|Mean|78.8|78.8|Standard Deviation|15.3|15.3|||
3598071|NCT03037905|3451692|B1|||Preoperative heart rate||beats per minute|Mean|77.9|77.9|Standard Deviation|12.7|12.7|||
3598072|NCT03037905|3451690|B3|||Preoperative systolic blood pressure||mm Hg|Mean|140.0|140.0|Standard Deviation|18.7|18.7|||
3598073|NCT03037905|3451691|B2|||Preoperative systolic blood pressure||mm Hg|Mean|142.6|142.6|Standard Deviation|19.8|19.8|||
3598074|NCT03037905|3451692|B1|||Preoperative systolic blood pressure||mm Hg|Mean|137.50|137.5|Standard Deviation|17.4|17.4|||
3598075|NCT03037905|3451690|B3|||Preoperative anxiety visual analog scale|"The preoperative anxiety scale quantifies preoperative anxiety. It is measured on a 100 millimeter line with anchors No anxiety to The most anxiety I can imagine. Participants make a mark across the line to represent their current state of preoperative anxiety. A millimeter ruler is used to measure from left to right with the number of millimeters recorded where the mark crosses the line, minimum score is 0 and maximum score is 100. Higher number means more anxiety."|units on a scale|Mean|34.13|34.13|Standard Deviation|28.4|28.4|||
3598076|NCT03037905|3451691|B2|||Preoperative anxiety visual analog scale|"The preoperative anxiety scale quantifies preoperative anxiety. It is measured on a 100 millimeter line with anchors No anxiety to The most anxiety I can imagine. Participants make a mark across the line to represent their current state of preoperative anxiety. A millimeter ruler is used to measure from left to right with the number of millimeters recorded where the mark crosses the line, minimum score is 0 and maximum score is 100. Higher number means more anxiety."|units on a scale|Mean|32.0|32.0|Standard Deviation|28.9|28.9|||
3598077|NCT03037905|3451692|B1|||Preoperative anxiety visual analog scale|"The preoperative anxiety scale quantifies preoperative anxiety. It is measured on a 100 millimeter line with anchors No anxiety to The most anxiety I can imagine. Participants make a mark across the line to represent their current state of preoperative anxiety. A millimeter ruler is used to measure from left to right with the number of millimeters recorded where the mark crosses the line, minimum score is 0 and maximum score is 100. Higher number means more anxiety."|units on a scale|Mean|36.3|36.3|Standard Deviation|27.9|27.9|||
3598078|NCT03037905|3451690|B3|neuromuscular||Past medical history diagnosis groups||participants|Number|41|41.0||||||
3598079|NCT03037905|3451691|B2|neuromuscular||Past medical history diagnosis groups||participants|Number|25|25.0||||||
3598080|NCT03037905|3451692|B1|neuromuscular||Past medical history diagnosis groups||participants|Number|16|16.0||||||
3598081|NCT03037905|3451690|B3|gastrointestinal/genitourinary||Past medical history diagnosis groups||participants|Number|38|38.0||||||
3598082|NCT03037905|3451691|B2|gastrointestinal/genitourinary||Past medical history diagnosis groups||participants|Number|18|18.0||||||
3598083|NCT03037905|3451692|B1|gastrointestinal/genitourinary||Past medical history diagnosis groups||participants|Number|20|20.0||||||
3598084|NCT03037905|3451690|B3|endocrine||Past medical history diagnosis groups||participants|Number|97|97.0||||||
3598085|NCT03037905|3451691|B2|endocrine||Past medical history diagnosis groups||participants|Number|48|48.0||||||
3598086|NCT03037905|3451692|B1|endocrine||Past medical history diagnosis groups||participants|Number|49|49.0||||||
3598087|NCT03037905|3451690|B3|Other||Past medical history diagnosis groups||participants|Number|34|34.0||||||
3598088|NCT03037905|3451691|B2|Other||Past medical history diagnosis groups||participants|Number|19|19.0||||||
3598089|NCT03037905|3451692|B1|Other||Past medical history diagnosis groups||participants|Number|15|15.0||||||
3598090|NCT03037905|3451690|B3|cardiovascular/respiratory||Past medical history diagnosis groups||participants|Number|32|32.0||||||
3598091|NCT03037905|3451691|B2|cardiovascular/respiratory||Past medical history diagnosis groups||participants|Number|19|19.0||||||
3598092|NCT03037905|3451692|B1|cardiovascular/respiratory||Past medical history diagnosis groups||participants|Number|13|13.0||||||
3598093|NCT03037905|3451690|B3|||Kindler Preoperative Anxiety Scale Total Score|"The Kindler preoperative anxiety scale quantifies 10 factors that cause preoperative anxiety. Each factor is measured on a 100 millimeter line with anchors No anxiety to The most anxiety I can imagine. Participants make a mark across the line to represent their current state on each factor. A millimeter ruler is used to measure from left to right with the number of millimeters recorded where the mark crosses the line, minimum score is 0 and maximum score is 100. Higher number means more anxiety. The average of the scores represents the total preoperative anxiety score."|units on a scale|Median|28.9|28.9|Inter-Quartile Range|||10.3|47.9|
3598094|NCT03037905|3451691|B2|||Kindler Preoperative Anxiety Scale Total Score|"The Kindler preoperative anxiety scale quantifies 10 factors that cause preoperative anxiety. Each factor is measured on a 100 millimeter line with anchors No anxiety to The most anxiety I can imagine. Participants make a mark across the line to represent their current state on each factor. A millimeter ruler is used to measure from left to right with the number of millimeters recorded where the mark crosses the line, minimum score is 0 and maximum score is 100. Higher number means more anxiety. The average of the scores represents the total preoperative anxiety score."|units on a scale|Median|26.6|26.6|Inter-Quartile Range|||8.6|44.1|
3598095|NCT03037905|3451692|B1|||Kindler Preoperative Anxiety Scale Total Score|"The Kindler preoperative anxiety scale quantifies 10 factors that cause preoperative anxiety. Each factor is measured on a 100 millimeter line with anchors No anxiety to The most anxiety I can imagine. Participants make a mark across the line to represent their current state on each factor. A millimeter ruler is used to measure from left to right with the number of millimeters recorded where the mark crosses the line, minimum score is 0 and maximum score is 100. Higher number means more anxiety. The average of the scores represents the total preoperative anxiety score."|units on a scale|Median|29.8|29.8|Inter-Quartile Range|||15.8|55.2|
3598096|NCT03037905|3451690|B3||Thyroid|Surgical site||Participants|Count of Participants|62|62.0||||||
3598097|NCT03037905|3451691|B2||Thyroid|Surgical site||Participants|Count of Participants|28|28.0||||||
3598098|NCT03037905|3451692|B1||Thyroid|Surgical site||Participants|Count of Participants|34|34.0||||||
3598099|NCT03037905|3451690|B3||Parathyroid|Surgical site||Participants|Count of Participants|38|38.0||||||
3598100|NCT03037905|3451691|B2||Parathyroid|Surgical site||Participants|Count of Participants|22|22.0||||||
3598101|NCT03037905|3451692|B1||Parathyroid|Surgical site||Participants|Count of Participants|16|16.0||||||
3598102|NCT03037905|3451690|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3598103|NCT03037905|3451691|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598104|NCT03037905|3451692|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3598105|NCT03037905|3451690|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3598106|NCT03037905|3451691|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3598107|NCT03037905|3451692|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598108|NCT03037905|3451690|B3||White|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3598109|NCT03037905|3451691|B2||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3598110|NCT03037905|3451692|B1||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3598111|NCT03037905|3451690|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3598112|NCT03037905|3451691|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3598113|NCT03037905|3451692|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3598114|NCT03037905|3451690|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598115|NCT03037905|3451691|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598116|NCT03037905|3451692|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598117|NCT03037905|3451690|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3598118|NCT03037905|3451691|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598119|NCT03037905|3451692|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3598120|NCT03037905|3451690|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598121|NCT03037905|3451691|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598122|NCT03037905|3451692|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598123|NCT03037905|3451690|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3598124|NCT03037905|3451691|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598125|NCT03037905|3451692|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598126|NCT03037905|3451690|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
3598127|NCT03037905|3451691|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3598128|NCT03037905|3451692|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3598129|NCT03037905|3451690|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598130|NCT03037905|3451691|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598131|NCT03037905|3451692|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598133|NCT03037905|3451691|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3598134|NCT03037905|3451692|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3598135|NCT03037905|3451690|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3598136|NCT03037905|3451691|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3598137|NCT03037905|3451692|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3598138|NCT03037905|3451690|B3|||Age||years|Mean|52.5|52.5|Standard Deviation|14.2|14.2|||
3598139|NCT03037905|3451691|B2|||Age||years|Mean|53.3|53.3|Standard Deviation|14.3|14.3|||
3598140|NCT03037905|3451692|B1|||Age||years|Mean|51.7|51.7|Standard Deviation|14.3|14.3|||
3598141|NCT03037541|3451705|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
3598142|NCT03037541|3451706|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3598143|NCT03037541|3451707|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3598144|NCT03037541|3451705|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598145|NCT03037541|3451706|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598146|NCT03037541|3451707|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598147|NCT03037541|3451705|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598148|NCT03037541|3451706|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598149|NCT03037541|3451707|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598150|NCT03037541|3451705|B3||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3598151|NCT03037541|3451706|B2||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3598152|NCT03037541|3451707|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3598153|NCT03037541|3451705|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598154|NCT03037541|3451706|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598155|NCT03037541|3451707|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598156|NCT03037541|3451705|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598157|NCT03037541|3451706|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598158|NCT03037541|3451707|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598159|NCT03037541|3451705|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598160|NCT03037541|3451706|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598161|NCT03037541|3451707|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598162|NCT03037541|3451705|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598163|NCT03037541|3451706|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598164|NCT03037541|3451707|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598165|NCT03037541|3451705|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598166|NCT03037541|3451706|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598167|NCT03037541|3451707|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598168|NCT03037541|3451705|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3598169|NCT03037541|3451706|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3598170|NCT03037541|3451707|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3598171|NCT03037541|3451705|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598172|NCT03037541|3451706|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598173|NCT03037541|3451707|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598174|NCT03037541|3451705|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3598175|NCT03037541|3451706|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3598176|NCT03037541|3451707|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3598177|NCT03037541|3451705|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3598178|NCT03037541|3451706|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3598179|NCT03037541|3451707|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3598180|NCT03037541|3451705|B3||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
3598181|NCT03037541|3451706|B2||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3598182|NCT03037541|3451707|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3598183|NCT03037541|3451705|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3598184|NCT03037541|3451706|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3598185|NCT03037541|3451707|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3598186|NCT03037541|3451705|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598187|NCT03037541|3451706|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598188|NCT03037541|3451707|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598189|NCT03037307|3451716|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598190|NCT03037307|3451716|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598191|NCT03037307|3451716|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3598192|NCT03037307|3451716|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3598193|NCT03037307|3451716|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598194|NCT03037307|3451716|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598195|NCT03037307|3451716|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598196|NCT03037307|3451716|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3598197|NCT03037307|3451716|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3598198|NCT03037307|3451716|B1|||Age||years|Mean|67.0|67.0|Standard Deviation|9.39|9.39|||
3598199|NCT03036735|3451731|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3598200|NCT03036735|3451731|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3598201|NCT03036735|3451731|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3598202|NCT03036735|3451731|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3598203|NCT03036735|3451731|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3598204|NCT03036735|3451731|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598205|NCT03036215|3451735|B3|||Jaw Functioning|Level of limitation during the last 30 days. Scale 0-10 of drink, Soft food, Swallow, Talk, Smile, Chew, Yawn, Hard food. JAW FUNCTIONING 8 items R:0-80; Item scale: 0 = No limitation up to 10=Severe limitation|units on a scale|Mean|22|22.0|Standard Deviation|16.8|16.8|||
3598206|NCT03036215|3451736|B2|||Jaw Functioning|Level of limitation during the last 30 days. Scale 0-10 of drink, Soft food, Swallow, Talk, Smile, Chew, Yawn, Hard food. JAW FUNCTIONING 8 items R:0-80; Item scale: 0 = No limitation up to 10=Severe limitation|units on a scale|Mean|19.4|19.4|Standard Deviation|14|14.0|||
3598207|NCT03036215|3451737|B1|||Jaw Functioning|Level of limitation during the last 30 days. Scale 0-10 of drink, Soft food, Swallow, Talk, Smile, Chew, Yawn, Hard food. JAW FUNCTIONING 8 items R:0-80; Item scale: 0 = No limitation up to 10=Severe limitation|units on a scale|Mean|24.5|24.5|Standard Deviation|18.9|18.9|||
3598208|NCT03036215|3451735|B3|||Graded Chronic Pain interference|"Graded Chronic Pain Interference subscale:~Interference Score is a O-100 score derived from 3 questions:~Mean (Daily Activities, Social Activities, Work Activities) x 10; Scale 0=no interference up to 10=unable to carry on activities"|units on a scale|Mean|24.9|24.9|Standard Deviation|22.5|22.5|||
3598209|NCT03036215|3451736|B2|||Graded Chronic Pain interference|"Graded Chronic Pain Interference subscale:~Interference Score is a O-100 score derived from 3 questions:~Mean (Daily Activities, Social Activities, Work Activities) x 10; Scale 0=no interference up to 10=unable to carry on activities"|units on a scale|Mean|23|23.0|Standard Deviation|21.3|21.3|||
3598210|NCT03036215|3451737|B1|||Graded Chronic Pain interference|"Graded Chronic Pain Interference subscale:~Interference Score is a O-100 score derived from 3 questions:~Mean (Daily Activities, Social Activities, Work Activities) x 10; Scale 0=no interference up to 10=unable to carry on activities"|units on a scale|Mean|26.6|26.6|Standard Deviation|23.7|23.7|||
3598211|NCT03036215|3451735|B3|||Graded Chronic Pain Severity|"Pain Intensity is a O-100 score derived from questions 1-3:~Mean (Pain Right Now, Worst Pain, Average Pain) x 10; Item Scale is from 0=No pain to 10=Pain as bad as it could be"|units on a scale|Mean|50|50.0|Standard Deviation|16|16.0|||
3598212|NCT03036215|3451736|B2|||Graded Chronic Pain Severity|"Pain Intensity is a O-100 score derived from questions 1-3:~Mean (Pain Right Now, Worst Pain, Average Pain) x 10; Item Scale is from 0=No pain to 10=Pain as bad as it could be"|units on a scale|Mean|50|50.0|Standard Deviation|17.6|17.6|||
3598213|NCT03036215|3451737|B1|||Graded Chronic Pain Severity|"Pain Intensity is a O-100 score derived from questions 1-3:~Mean (Pain Right Now, Worst Pain, Average Pain) x 10; Item Scale is from 0=No pain to 10=Pain as bad as it could be"|units on a scale|Mean|50|50.0|Standard Deviation|15|15.0|||
3598214|NCT03036215|3451735|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
3598215|NCT03036215|3451736|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
3598216|NCT03036215|3451737|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
3598217|NCT03036215|3451735|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3598218|NCT03036215|3451736|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3598219|NCT03036215|3451737|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3598220|NCT03036215|3451735|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598221|NCT03036215|3451736|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598222|NCT03036215|3451737|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598223|NCT03036215|3451735|B3||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3598224|NCT03036215|3451736|B2||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3598225|NCT03036215|3451737|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3598226|NCT03036215|3451735|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3598227|NCT03036215|3451736|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3598228|NCT03036215|3451737|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3598229|NCT03036215|3451735|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598230|NCT03036215|3451736|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598231|NCT03036215|3451737|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598232|NCT03036215|3451735|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598233|NCT03036215|3451736|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598234|NCT03036215|3451737|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598235|NCT03036215|3451735|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598236|NCT03036215|3451736|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598237|NCT03036215|3451737|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598238|NCT03036215|3451735|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598239|NCT03036215|3451736|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598240|NCT03036215|3451737|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598241|NCT03036215|3451735|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
3598242|NCT03036215|3451736|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3598243|NCT03036215|3451737|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3598244|NCT03036215|3451735|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3598245|NCT03036215|3451736|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598246|NCT03036215|3451737|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3598247|NCT03036215|3451735|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3598248|NCT03036215|3451736|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3598249|NCT03036215|3451737|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3598250|NCT03036215|3451735|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3598251|NCT03036215|3451736|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3598252|NCT03036215|3451737|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3598253|NCT03036215|3451735|B3|||Age||years|Mean|47.5|47.5|Standard Deviation|16.1|16.1|||
3598254|NCT03036215|3451736|B2|||Age||years|Mean|46|46.0|Standard Deviation|17.1|17.1|||
3598255|NCT03036215|3451737|B1|||Age||years|Mean|49|49.0|Standard Deviation|15.1|15.1|||
3598256|NCT03035955|3451748|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3598257|NCT03035955|3451749|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3598258|NCT03035955|3451750|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3598259|NCT03035955|3451748|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3598260|NCT03035955|3451749|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3598261|NCT03035955|3451750|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3598262|NCT03035955|3451748|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3598263|NCT03035955|3451749|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3598264|NCT03035955|3451750|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3598265|NCT03035955|3451748|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3598266|NCT03035955|3451749|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3598267|NCT03035955|3451750|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3598268|NCT03035955|3451748|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598269|NCT03035955|3451749|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598270|NCT03035955|3451750|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598271|NCT03035916|3451757|B4||III|ASA physical status|ASA I: No organic, physiologic, biochemical or psychiatric disturbance; ASA II: A patient with mild systemic disease that results in no functional limitation; ASA III: A patient with severe systemic disease that results in functional impairment; ASA IV: Severe systemic disease that is a constant threat to life; ASA V: Moribund condition in a patient who is not expected to survive with or without the operation; ASA VI: Declared brain death patient whose organs are being harvested for transplantation; E: Emergency operation is required.|Participants|Count of Participants|19|19.0||||||
3598272|NCT03035916|3451758|B3||III|ASA physical status|ASA I: No organic, physiologic, biochemical or psychiatric disturbance; ASA II: A patient with mild systemic disease that results in no functional limitation; ASA III: A patient with severe systemic disease that results in functional impairment; ASA IV: Severe systemic disease that is a constant threat to life; ASA V: Moribund condition in a patient who is not expected to survive with or without the operation; ASA VI: Declared brain death patient whose organs are being harvested for transplantation; E: Emergency operation is required.|Participants|Count of Participants|7|7.0||||||
3598273|NCT03035916|3451759|B2||III|ASA physical status|ASA I: No organic, physiologic, biochemical or psychiatric disturbance; ASA II: A patient with mild systemic disease that results in no functional limitation; ASA III: A patient with severe systemic disease that results in functional impairment; ASA IV: Severe systemic disease that is a constant threat to life; ASA V: Moribund condition in a patient who is not expected to survive with or without the operation; ASA VI: Declared brain death patient whose organs are being harvested for transplantation; E: Emergency operation is required.|Participants|Count of Participants|6|6.0||||||
3598274|NCT03035916|3451760|B1||III|ASA physical status|ASA I: No organic, physiologic, biochemical or psychiatric disturbance; ASA II: A patient with mild systemic disease that results in no functional limitation; ASA III: A patient with severe systemic disease that results in functional impairment; ASA IV: Severe systemic disease that is a constant threat to life; ASA V: Moribund condition in a patient who is not expected to survive with or without the operation; ASA VI: Declared brain death patient whose organs are being harvested for transplantation; E: Emergency operation is required.|Participants|Count of Participants|6|6.0||||||
3598304|NCT03035916|3451758|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3598305|NCT03035916|3451759|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3598306|NCT03035916|3451760|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3598275|NCT03035916|3451757|B4||II|ASA physical status|ASA I: No organic, physiologic, biochemical or psychiatric disturbance; ASA II: A patient with mild systemic disease that results in no functional limitation; ASA III: A patient with severe systemic disease that results in functional impairment; ASA IV: Severe systemic disease that is a constant threat to life; ASA V: Moribund condition in a patient who is not expected to survive with or without the operation; ASA VI: Declared brain death patient whose organs are being harvested for transplantation; E: Emergency operation is required.|Participants|Count of Participants|57|57.0||||||
3598276|NCT03035916|3451758|B3||II|ASA physical status|ASA I: No organic, physiologic, biochemical or psychiatric disturbance; ASA II: A patient with mild systemic disease that results in no functional limitation; ASA III: A patient with severe systemic disease that results in functional impairment; ASA IV: Severe systemic disease that is a constant threat to life; ASA V: Moribund condition in a patient who is not expected to survive with or without the operation; ASA VI: Declared brain death patient whose organs are being harvested for transplantation; E: Emergency operation is required.|Participants|Count of Participants|20|20.0||||||
3598277|NCT03035916|3451759|B2||II|ASA physical status|ASA I: No organic, physiologic, biochemical or psychiatric disturbance; ASA II: A patient with mild systemic disease that results in no functional limitation; ASA III: A patient with severe systemic disease that results in functional impairment; ASA IV: Severe systemic disease that is a constant threat to life; ASA V: Moribund condition in a patient who is not expected to survive with or without the operation; ASA VI: Declared brain death patient whose organs are being harvested for transplantation; E: Emergency operation is required.|Participants|Count of Participants|18|18.0||||||
3598278|NCT03035916|3451760|B1||II|ASA physical status|ASA I: No organic, physiologic, biochemical or psychiatric disturbance; ASA II: A patient with mild systemic disease that results in no functional limitation; ASA III: A patient with severe systemic disease that results in functional impairment; ASA IV: Severe systemic disease that is a constant threat to life; ASA V: Moribund condition in a patient who is not expected to survive with or without the operation; ASA VI: Declared brain death patient whose organs are being harvested for transplantation; E: Emergency operation is required.|Participants|Count of Participants|19|19.0||||||
3598279|NCT03035916|3451757|B4||I|ASA physical status|ASA I: No organic, physiologic, biochemical or psychiatric disturbance; ASA II: A patient with mild systemic disease that results in no functional limitation; ASA III: A patient with severe systemic disease that results in functional impairment; ASA IV: Severe systemic disease that is a constant threat to life; ASA V: Moribund condition in a patient who is not expected to survive with or without the operation; ASA VI: Declared brain death patient whose organs are being harvested for transplantation; E: Emergency operation is required.|Participants|Count of Participants|13|13.0||||||
3598280|NCT03035916|3451758|B3||I|ASA physical status|ASA I: No organic, physiologic, biochemical or psychiatric disturbance; ASA II: A patient with mild systemic disease that results in no functional limitation; ASA III: A patient with severe systemic disease that results in functional impairment; ASA IV: Severe systemic disease that is a constant threat to life; ASA V: Moribund condition in a patient who is not expected to survive with or without the operation; ASA VI: Declared brain death patient whose organs are being harvested for transplantation; E: Emergency operation is required.|Participants|Count of Participants|4|4.0||||||
3598281|NCT03035916|3451759|B2||I|ASA physical status|ASA I: No organic, physiologic, biochemical or psychiatric disturbance; ASA II: A patient with mild systemic disease that results in no functional limitation; ASA III: A patient with severe systemic disease that results in functional impairment; ASA IV: Severe systemic disease that is a constant threat to life; ASA V: Moribund condition in a patient who is not expected to survive with or without the operation; ASA VI: Declared brain death patient whose organs are being harvested for transplantation; E: Emergency operation is required.|Participants|Count of Participants|4|4.0||||||
3598282|NCT03035916|3451760|B1||I|ASA physical status|ASA I: No organic, physiologic, biochemical or psychiatric disturbance; ASA II: A patient with mild systemic disease that results in no functional limitation; ASA III: A patient with severe systemic disease that results in functional impairment; ASA IV: Severe systemic disease that is a constant threat to life; ASA V: Moribund condition in a patient who is not expected to survive with or without the operation; ASA VI: Declared brain death patient whose organs are being harvested for transplantation; E: Emergency operation is required.|Participants|Count of Participants|5|5.0||||||
3598283|NCT03035916|3451757|B4|Asian||Race/Ethnicity, Customized||participants|Number|89|89.0||||||
3598284|NCT03035916|3451758|B3|Asian||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3598285|NCT03035916|3451759|B2|Asian||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3598286|NCT03035916|3451760|B1|Asian||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3598287|NCT03035916|3451757|B4||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3598288|NCT03035916|3451758|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3598289|NCT03035916|3451759|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3598290|NCT03035916|3451760|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3598291|NCT03035916|3451757|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3598292|NCT03035916|3451758|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3598293|NCT03035916|3451759|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3598294|NCT03035916|3451760|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3598295|NCT03035916|3451757|B4|||Age||years|Mean|59.18|59.18|Standard Deviation|9.02|9.02|||
3598296|NCT03035916|3451758|B3|||Age||years|Mean|60.20|60.2|Standard Deviation|9.43|9.43|||
3598297|NCT03035916|3451759|B2|||Age||years|Mean|58.60|58.6|Standard Deviation|8.72|8.72|||
3598298|NCT03035916|3451760|B1|||Age||years|Mean|56.75|56.75|Standard Deviation|8.24|8.24|||
3598299|NCT03035916|3451757|B4||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
3598300|NCT03035916|3451758|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3598301|NCT03035916|3451759|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3598302|NCT03035916|3451760|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3598303|NCT03035916|3451757|B4||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
3598307|NCT03035916|3451757|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598308|NCT03035916|3451758|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598309|NCT03035916|3451759|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598310|NCT03035916|3451760|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598311|NCT03034954|3451809|B3|||Object Location Touchscreen Task (Version B) Recognition Average Time to Respond|The OLTT requires participants to learn and recall the location of 15 object-location associations. Memory is evaluated using a touchscreen monitor, which allows for the continuous measurement of memory accuracy (i.e., distance from targeted location). During the Recognition, participants are asked to select the correct location of an object from three options on the screen. Recognition Average Response Time is the average latency to respond across all 15 trials. Lower scores represent faster responses.|milliseconds|Mean|2716.853|2716.853|Standard Deviation|1510.062|1510.062|||
3598312|NCT03034954|3451810|B2|||Object Location Touchscreen Task (Version B) Recognition Average Time to Respond|The OLTT requires participants to learn and recall the location of 15 object-location associations. Memory is evaluated using a touchscreen monitor, which allows for the continuous measurement of memory accuracy (i.e., distance from targeted location). During the Recognition, participants are asked to select the correct location of an object from three options on the screen. Recognition Average Response Time is the average latency to respond across all 15 trials. Lower scores represent faster responses.|milliseconds|Mean|2456.063|2456.063|Standard Deviation|1164.46|1164.46|||
3598313|NCT03034954|3451811|B1|||Object Location Touchscreen Task (Version B) Recognition Average Time to Respond|The OLTT requires participants to learn and recall the location of 15 object-location associations. Memory is evaluated using a touchscreen monitor, which allows for the continuous measurement of memory accuracy (i.e., distance from targeted location). During the Recognition, participants are asked to select the correct location of an object from three options on the screen. Recognition Average Response Time is the average latency to respond across all 15 trials. Lower scores represent faster responses.|milliseconds|Mean|3005.095|3005.095|Standard Deviation|1807.47|1807.47|||
3598314|NCT03034954|3451809|B3|||Object Location Touchscreen Task (Version B) Recognition Total Correct|The OLTT requires participants to learn and recall the location of 15 object-location associations. Memory is evaluated using a touchscreen monitor, which allows for the continuous measurement of memory accuracy (i.e., distance from targeted location). During the Recognition, participants are asked to select the correct location of an object from three options on the screen. Recognition total is the number of correct selections on all 15 trials. Higher scores represent better performance.|number of correct answers|Mean|13.6|13.6|Standard Deviation|1.692|1.692|||
3598315|NCT03034954|3451810|B2|||Object Location Touchscreen Task (Version B) Recognition Total Correct|The OLTT requires participants to learn and recall the location of 15 object-location associations. Memory is evaluated using a touchscreen monitor, which allows for the continuous measurement of memory accuracy (i.e., distance from targeted location). During the Recognition, participants are asked to select the correct location of an object from three options on the screen. Recognition total is the number of correct selections on all 15 trials. Higher scores represent better performance.|number of correct answers|Mean|14.05|14.05|Standard Deviation|1.322|1.322|||
3598316|NCT03034954|3451811|B1|||Object Location Touchscreen Task (Version B) Recognition Total Correct|The OLTT requires participants to learn and recall the location of 15 object-location associations. Memory is evaluated using a touchscreen monitor, which allows for the continuous measurement of memory accuracy (i.e., distance from targeted location). During the Recognition, participants are asked to select the correct location of an object from three options on the screen. Recognition total is the number of correct selections on all 15 trials. Higher scores represent better performance.|number of correct answers|Mean|13.11|13.11|Standard Deviation|1.941|1.941|||
3598317|NCT03034954|3451809|B3|||Object Location Touchscreen Task (Version B) Cued Recall Average Time to Respond|"The OLTT requires participants to learn and recall the location of 15 object-location associations. Memory is evaluated using a touchscreen monitor, which allows for the continuous measurement of memory accuracy (i.e., distance from targeted location). During the Cued Recall, participants are shown the room or environment on the screen and asked to touch the area of the screen an object was located. Average Time is the average latency to respond across all 15 trials. Lower scores represent faster responses."|milliseconds|Mean|3568.155|3568.155|Standard Deviation|2043.063|2043.063|||
3598318|NCT03034954|3451810|B2|||Object Location Touchscreen Task (Version B) Cued Recall Average Time to Respond|"The OLTT requires participants to learn and recall the location of 15 object-location associations. Memory is evaluated using a touchscreen monitor, which allows for the continuous measurement of memory accuracy (i.e., distance from targeted location). During the Cued Recall, participants are shown the room or environment on the screen and asked to touch the area of the screen an object was located. Average Time is the average latency to respond across all 15 trials. Lower scores represent faster responses."|milliseconds|Mean|3307.879|3307.879|Standard Deviation|1605.689|1605.689|||
3598319|NCT03034954|3451811|B1|||Object Location Touchscreen Task (Version B) Cued Recall Average Time to Respond|"The OLTT requires participants to learn and recall the location of 15 object-location associations. Memory is evaluated using a touchscreen monitor, which allows for the continuous measurement of memory accuracy (i.e., distance from targeted location). During the Cued Recall, participants are shown the room or environment on the screen and asked to touch the area of the screen an object was located. Average Time is the average latency to respond across all 15 trials. Lower scores represent faster responses."|milliseconds|Mean|3855.83|3855.83|Standard Deviation|2452.1|2452.1|||
3598320|NCT03034954|3451809|B3|||Object Location Touchscreen Task (Version B) Cued Recall Average Error|"The OLTT requires participants to learn and recall the location of 15 object-location associations. Memory is evaluated using a touchscreen monitor, which allows for the continuous measurement of memory accuracy (i.e., distance from targeted location). During the Cued Recall, participants are shown the room or environment on the screen and asked to touch the area of the screen an object was located. Average Score is the average error across all 15 trials. Lower scores represent better performance."|centimeters|Mean|3.937|3.937|Standard Deviation|3.129|3.129|||
3598359|NCT03034954|3451809|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598360|NCT03034954|3451810|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598321|NCT03034954|3451810|B2|||Object Location Touchscreen Task (Version B) Cued Recall Average Error|"The OLTT requires participants to learn and recall the location of 15 object-location associations. Memory is evaluated using a touchscreen monitor, which allows for the continuous measurement of memory accuracy (i.e., distance from targeted location). During the Cued Recall, participants are shown the room or environment on the screen and asked to touch the area of the screen an object was located. Average Score is the average error across all 15 trials. Lower scores represent better performance."|centimeters|Mean|3.002|3.002|Standard Deviation|2.574|2.574|||
3598322|NCT03034954|3451811|B1|||Object Location Touchscreen Task (Version B) Cued Recall Average Error|"The OLTT requires participants to learn and recall the location of 15 object-location associations. Memory is evaluated using a touchscreen monitor, which allows for the continuous measurement of memory accuracy (i.e., distance from targeted location). During the Cued Recall, participants are shown the room or environment on the screen and asked to touch the area of the screen an object was located. Average Score is the average error across all 15 trials. Lower scores represent better performance."|centimeters|Mean|4.971|4.971|Standard Deviation|3.422|3.422|||
3598323|NCT03034954|3451809|B3|||Object Location Touchscreen Task (Version B) Cued Recall Total Error|"The OLTT requires participants to learn and recall the location of 15 object-location associations. Memory is evaluated using a touchscreen monitor, which allows for the continuous measurement of memory accuracy (i.e., distance from targeted location). During the Cued Recall, participants are shown the room or environment on the screen and asked to touch the area of the screen an object was located. Total Score is the sum of error for all 15 trials. Lower scores represent better performance."|centimeters|Mean|59.048|59.048|Standard Deviation|46.958|46.958|||
3598324|NCT03034954|3451810|B2|||Object Location Touchscreen Task (Version B) Cued Recall Total Error|"The OLTT requires participants to learn and recall the location of 15 object-location associations. Memory is evaluated using a touchscreen monitor, which allows for the continuous measurement of memory accuracy (i.e., distance from targeted location). During the Cued Recall, participants are shown the room or environment on the screen and asked to touch the area of the screen an object was located. Total Score is the sum of error for all 15 trials. Lower scores represent better performance."|centimeters|Mean|45.055|45.055|Standard Deviation|38.61|38.61|||
3598325|NCT03034954|3451811|B1|||Object Location Touchscreen Task (Version B) Cued Recall Total Error|"The OLTT requires participants to learn and recall the location of 15 object-location associations. Memory is evaluated using a touchscreen monitor, which allows for the continuous measurement of memory accuracy (i.e., distance from targeted location). During the Cued Recall, participants are shown the room or environment on the screen and asked to touch the area of the screen an object was located. Total Score is the sum of error for all 15 trials. Lower scores represent better performance."|centimeters|Mean|74.513|74.513|Standard Deviation|51.385|51.385|||
3598326|NCT03034954|3451809|B3|||Object Location Touchscreen Task (Version B) Free Recall Average Time to Respond|The Object Location Touchscreen Task (OLTT) is a measure of object location association memory. The OLTT requires participants to learn and recall the location of 15 object-location associations. Memory is evaluated using a touchscreen monitor, which allows for the continuous measurement of memory accuracy (i.e., distance from targeted location). During the Free Recall, participants are given a blank screen and asked to touch the area of the screen an object was located. Average Time is the average latency to respond across all 15 trials. Lower scores represent faster responses.|milliseconds|Mean|4387.09|4387.09|Standard Deviation|1924.503|1924.503|||
3598327|NCT03034954|3451810|B2|||Object Location Touchscreen Task (Version B) Free Recall Average Time to Respond|The Object Location Touchscreen Task (OLTT) is a measure of object location association memory. The OLTT requires participants to learn and recall the location of 15 object-location associations. Memory is evaluated using a touchscreen monitor, which allows for the continuous measurement of memory accuracy (i.e., distance from targeted location). During the Free Recall, participants are given a blank screen and asked to touch the area of the screen an object was located. Average Time is the average latency to respond across all 15 trials. Lower scores represent faster responses.|milliseconds|Mean|4921.558|4921.558|Standard Deviation|2306.631|2306.631|||
3598328|NCT03034954|3451811|B1|||Object Location Touchscreen Task (Version B) Free Recall Average Time to Respond|The Object Location Touchscreen Task (OLTT) is a measure of object location association memory. The OLTT requires participants to learn and recall the location of 15 object-location associations. Memory is evaluated using a touchscreen monitor, which allows for the continuous measurement of memory accuracy (i.e., distance from targeted location). During the Free Recall, participants are given a blank screen and asked to touch the area of the screen an object was located. Average Time is the average latency to respond across all 15 trials. Lower scores represent faster responses.|milliseconds|Mean|3796.361|3796.361|Standard Deviation|1188.015|1188.015|||
3598329|NCT03034954|3451809|B3|||Object Location Touchscreen Task (Version B) Free Recall Average Error|The Object Location Touchscreen Task (OLTT) is a measure of object location association memory. The OLTT requires participants to learn and recall the location of 15 object-location associations. Memory is evaluated using a touchscreen monitor, which allows for the continuous measurement of memory accuracy (i.e., distance from targeted location). During the Free Recall, participants are given a blank screen and asked to touch the area of the screen an object was located. Average Score is the average error across all 15 trials. Lower scores represent better performance.|centimeters|Mean|7.239|7.239|Standard Deviation|2.96|2.96|||
3598330|NCT03034954|3451810|B2|||Object Location Touchscreen Task (Version B) Free Recall Average Error|The Object Location Touchscreen Task (OLTT) is a measure of object location association memory. The OLTT requires participants to learn and recall the location of 15 object-location associations. Memory is evaluated using a touchscreen monitor, which allows for the continuous measurement of memory accuracy (i.e., distance from targeted location). During the Free Recall, participants are given a blank screen and asked to touch the area of the screen an object was located. Average Score is the average error across all 15 trials. Lower scores represent better performance.|centimeters|Mean|6.835|6.835|Standard Deviation|2.97|2.97|||
3598361|NCT03034954|3451811|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598362|NCT03034954|3451809|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598363|NCT03034954|3451810|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598364|NCT03034954|3451811|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598331|NCT03034954|3451811|B1|||Object Location Touchscreen Task (Version B) Free Recall Average Error|The Object Location Touchscreen Task (OLTT) is a measure of object location association memory. The OLTT requires participants to learn and recall the location of 15 object-location associations. Memory is evaluated using a touchscreen monitor, which allows for the continuous measurement of memory accuracy (i.e., distance from targeted location). During the Free Recall, participants are given a blank screen and asked to touch the area of the screen an object was located. Average Score is the average error across all 15 trials. Lower scores represent better performance.|centimeters|Mean|7.685|7.685|Standard Deviation|2.963|2.963|||
3598332|NCT03034954|3451809|B3|||Object Location Touchscreen Task (Version B) Free Recall Total Error|The Object Location Touchscreen Task (OLTT) is an ecologically relevant measure of object location association memory. The OLTT requires participants to learn and recall the location of 15 object-location associations. Memory is evaluated using a touchscreen monitor, which allows for the continuous measurement of memory accuracy (i.e., distance from targeted location). During the Free Recall, participants are given a black screen and asked to touch the area of the screen an object was located. Total Score is the sum of error for all 15 trials. Lower scores represent better performance.|centimeters|Mean|108.583|108.583|Standard Deviation|7.239|7.239|||
3598333|NCT03034954|3451810|B2|||Object Location Touchscreen Task (Version B) Free Recall Total Error|The Object Location Touchscreen Task (OLTT) is an ecologically relevant measure of object location association memory. The OLTT requires participants to learn and recall the location of 15 object-location associations. Memory is evaluated using a touchscreen monitor, which allows for the continuous measurement of memory accuracy (i.e., distance from targeted location). During the Free Recall, participants are given a black screen and asked to touch the area of the screen an object was located. Total Score is the sum of error for all 15 trials. Lower scores represent better performance.|centimeters|Mean|102.534|102.534|Standard Deviation|6.835|6.835|||
3598334|NCT03034954|3451811|B1|||Object Location Touchscreen Task (Version B) Free Recall Total Error|The Object Location Touchscreen Task (OLTT) is an ecologically relevant measure of object location association memory. The OLTT requires participants to learn and recall the location of 15 object-location associations. Memory is evaluated using a touchscreen monitor, which allows for the continuous measurement of memory accuracy (i.e., distance from targeted location). During the Free Recall, participants are given a black screen and asked to touch the area of the screen an object was located. Total Score is the sum of error for all 15 trials. Lower scores represent better performance.|centimeters|Mean|115.27|115.27|Standard Deviation|44.445|44.445|||
3598335|NCT03034954|3451809|B3|||Impedance|"The first impedance reading averaged across all five electrodes. The unit measured is in Quality Units as produced by the Soterix transcranial direct current stimulation machine, which is a proprietary measurement of impedance. Lower values represent less impedance."|quality units|Mean|0.921|0.921|Standard Deviation|0.528|0.528|||
3598336|NCT03034954|3451810|B2|||Impedance|"The first impedance reading averaged across all five electrodes. The unit measured is in Quality Units as produced by the Soterix transcranial direct current stimulation machine, which is a proprietary measurement of impedance. Lower values represent less impedance."|quality units|Mean|0.8939|0.8939|Standard Deviation|.06314|0.06314|||
3598337|NCT03034954|3451811|B1|||Impedance|"The first impedance reading averaged across all five electrodes. The unit measured is in Quality Units as produced by the Soterix transcranial direct current stimulation machine, which is a proprietary measurement of impedance. Lower values represent less impedance."|quality units|Mean|0.9512|0.9512|Standard Deviation|0.4004|0.4004|||
3598338|NCT03034954|3451809|B3|||Education||years|Mean|16.63|16.63|Standard Deviation|1.866|1.866|||
3598339|NCT03034954|3451810|B2|||Education||years|Mean|16.48|16.48|Standard Deviation|2.089|2.089|||
3598340|NCT03034954|3451811|B1|||Education||years|Mean|16.82|16.82|Standard Deviation|1.59|1.59|||
3598341|NCT03034954|3451809|B3|||Mini-Mental State Examination|The Mini Mental-State Examination is a 30-item global cognitive screen. Scores range from 0-30 with higher scores represent better performances and scores 23 and below are suggestive of cognitive impairment.|units on a scale|Mean|28.47|28.47|Standard Deviation|1.202|1.202|||
3598342|NCT03034954|3451810|B2|||Mini-Mental State Examination|The Mini Mental-State Examination is a 30-item global cognitive screen. Scores range from 0-30 with higher scores represent better performances and scores 23 and below are suggestive of cognitive impairment.|units on a scale|Mean|28.37|28.37|Standard Deviation|1.212|1.212|||
3598343|NCT03034954|3451811|B1|||Mini-Mental State Examination|The Mini Mental-State Examination is a 30-item global cognitive screen. Scores range from 0-30 with higher scores represent better performances and scores 23 and below are suggestive of cognitive impairment.|units on a scale|Mean|28.58|28.58|Standard Deviation|1.216|1.216|||
3598344|NCT03034954|3451809|B3|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3598345|NCT03034954|3451810|B2|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3598346|NCT03034954|3451811|B1|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3598347|NCT03034954|3451809|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598348|NCT03034954|3451810|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598349|NCT03034954|3451811|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598350|NCT03034954|3451809|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598351|NCT03034954|3451810|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598352|NCT03034954|3451811|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598353|NCT03034954|3451809|B3||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3598354|NCT03034954|3451810|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3598355|NCT03034954|3451811|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3598356|NCT03034954|3451809|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598357|NCT03034954|3451810|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598358|NCT03034954|3451811|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598365|NCT03034954|3451809|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598366|NCT03034954|3451810|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598367|NCT03034954|3451811|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598368|NCT03034954|3451809|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598369|NCT03034954|3451810|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598370|NCT03034954|3451811|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598371|NCT03034954|3451809|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3598372|NCT03034954|3451810|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3598373|NCT03034954|3451811|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3598374|NCT03034954|3451809|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598375|NCT03034954|3451810|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598376|NCT03034954|3451811|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598377|NCT03034954|3451809|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3598378|NCT03034954|3451810|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3598379|NCT03034954|3451811|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3598380|NCT03034954|3451809|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3598381|NCT03034954|3451810|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3598382|NCT03034954|3451811|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3598383|NCT03034954|3451809|B3|||Age||years|Mean|65.88|65.88|Standard Deviation|9.573|9.573|||
3598384|NCT03034954|3451810|B2|||Age||years|Mean|65.38|65.38|Standard Deviation|10.604|10.604|||
3598385|NCT03034954|3451811|B1|||Age||years|Mean|66.42|66.42|Standard Deviation|8.546|8.546|||
3598386|NCT03032965|3451864|B3|||CHADS2 Score ( Congestive heart failure, Hypertension, Age > 75 years, Diabetes Mellitus, Stroke|Each of these five variables is given 1 point for its presence, except stroke is given 2 points. Each individual point is added, so the score ranges possible are 0 to 6 where 0 represents no risk factors and 6 represents highest number of risk factors.|units on a scale|Mean|0.75|0.75|Standard Deviation|0.9|0.9|||
3598387|NCT03032965|3451865|B2|||CHADS2 Score ( Congestive heart failure, Hypertension, Age > 75 years, Diabetes Mellitus, Stroke|Each of these five variables is given 1 point for its presence, except stroke is given 2 points. Each individual point is added, so the score ranges possible are 0 to 6 where 0 represents no risk factors and 6 represents highest number of risk factors.|units on a scale|Mean|0.7|0.7|Standard Deviation|0.7|0.7|||
3598388|NCT03032965|3451866|B1|||CHADS2 Score ( Congestive heart failure, Hypertension, Age > 75 years, Diabetes Mellitus, Stroke|Each of these five variables is given 1 point for its presence, except stroke is given 2 points. Each individual point is added, so the score ranges possible are 0 to 6 where 0 represents no risk factors and 6 represents highest number of risk factors.|units on a scale|Mean|0.8|0.8|Standard Deviation|0.7|0.7|||
3598389|NCT03032965|3451864|B3|||Repeat procedure|These are patients who had a previous ablation prior to entering the study|Participants|Count of Participants|43|43.0||||||
3598390|NCT03032965|3451865|B2|||Repeat procedure|These are patients who had a previous ablation prior to entering the study|Participants|Count of Participants|23|23.0||||||
3598391|NCT03032965|3451866|B1|||Repeat procedure|These are patients who had a previous ablation prior to entering the study|Participants|Count of Participants|20|20.0||||||
3598392|NCT03032965|3451864|B3|||Cerebrovascular accident|participants with a history of cerebrovascular accident|Participants|Count of Participants|6|6.0||||||
3598393|NCT03032965|3451865|B2|||Cerebrovascular accident|participants with a history of cerebrovascular accident|Participants|Count of Participants|4|4.0||||||
3598394|NCT03032965|3451866|B1|||Cerebrovascular accident|participants with a history of cerebrovascular accident|Participants|Count of Participants|2|2.0||||||
3598395|NCT03032965|3451864|B3|||Obstructive sleep apnea|participants with a history of obstructive sleep apnea|Participants|Count of Participants|34|34.0||||||
3598396|NCT03032965|3451865|B2|||Obstructive sleep apnea|participants with a history of obstructive sleep apnea|Participants|Count of Participants|19|19.0||||||
3598397|NCT03032965|3451866|B1|||Obstructive sleep apnea|participants with a history of obstructive sleep apnea|Participants|Count of Participants|15|15.0||||||
3598398|NCT03032965|3451864|B3|||Diabetes Mellitus|participants with a history of diabetes mellitus or current treatment for diabetes|Participants|Count of Participants|14|14.0||||||
3598399|NCT03032965|3451865|B2|||Diabetes Mellitus|participants with a history of diabetes mellitus or current treatment for diabetes|Participants|Count of Participants|8|8.0||||||
3598400|NCT03032965|3451866|B1|||Diabetes Mellitus|participants with a history of diabetes mellitus or current treatment for diabetes|Participants|Count of Participants|6|6.0||||||
3598401|NCT03032965|3451864|B3|||Hypertension|Participants with a documented history of hypertension or being treated for hypertension with medications|Participants|Count of Participants|61|61.0||||||
3598402|NCT03032965|3451865|B2|||Hypertension|Participants with a documented history of hypertension or being treated for hypertension with medications|Participants|Count of Participants|28|28.0||||||
3598403|NCT03032965|3451866|B1|||Hypertension|Participants with a documented history of hypertension or being treated for hypertension with medications|Participants|Count of Participants|33|33.0||||||
3598404|NCT03032965|3451864|B3|||left atrial diameter||milli meters|Mean|41.1|41.1|Standard Deviation|8.3|8.3|||
3598405|NCT03032965|3451865|B2|||left atrial diameter||milli meters|Mean|41.2|41.2|Standard Deviation|6.4|6.4|||
3598406|NCT03032965|3451866|B1|||left atrial diameter||milli meters|Mean|41.0|41.0|Standard Deviation|5.3|5.3|||
3598407|NCT03032965|3451864|B3|||Left ventricular ejection fraction||Percentage|Mean|59.5|59.5|Standard Deviation|7.8|7.8|||
3598408|NCT03032965|3451865|B2|||Left ventricular ejection fraction||Percentage|Mean|59.3|59.3|Standard Deviation|5.6|5.6|||
3598409|NCT03032965|3451866|B1|||Left ventricular ejection fraction||Percentage|Mean|59.7|59.7|Standard Deviation|5.4|5.4|||
3598410|NCT03032965|3451864|B3|United States||Region of Enrollment||Participants|Count of Participants|129|129.0||||||
3598411|NCT03032965|3451865|B2|United States||Region of Enrollment||Participants|Count of Participants|68|68.0||||||
3598412|NCT03032965|3451866|B1|United States||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
3598413|NCT03032965|3451864|B3||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3598414|NCT03032965|3451865|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3598415|NCT03032965|3451866|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3598416|NCT03032965|3451864|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3598417|NCT03032965|3451865|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3598418|NCT03032965|3451866|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3598419|NCT03032965|3451864|B3|||Age||years|Mean|59.3|59.3|Standard Deviation|13.8|13.8|||
3598420|NCT03032965|3451865|B2|||Age||years|Mean|58.9|58.9|Standard Deviation|10.7|10.7|||
3598421|NCT03032965|3451866|B1|||Age||years|Mean|59.7|59.7|Standard Deviation|8.7|8.7|||
3598422|NCT03032263|3451889|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598423|NCT03032263|3451890|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598424|NCT03032263|3451891|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598425|NCT03032263|3451889|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3598426|NCT03032263|3451890|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3598427|NCT03032263|3451891|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3598428|NCT03032263|3451889|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598429|NCT03032263|3451890|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598430|NCT03032263|3451891|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598431|NCT03032263|3451889|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3598432|NCT03032263|3451890|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3598433|NCT03032263|3451891|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3598434|NCT03032263|3451889|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3598435|NCT03032263|3451890|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3598436|NCT03032263|3451891|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3598437|NCT03032263|3451889|B3|||Age||years|Mean|6.83|6.83|Standard Deviation|3.43|3.43|||
3598438|NCT03032263|3451890|B2|||Age||years|Mean|7.33|7.33|Standard Deviation|4.55|4.55|||
3598439|NCT03032263|3451891|B1|||Age||years|Mean|6.33|6.33|Standard Deviation|2.16|2.16|||
3598440|NCT03031899|3451906|B1||gingiva|location of the lesion||lesions|Count of Units|1|1.0||||||
3598441|NCT03031899|3451906|B1||tongue|location of the lesion||lesions|Count of Units|1|1.0||||||
3598442|NCT03031899|3451906|B1||labial mucosa|location of the lesion||lesions|Count of Units|5|5.0||||||
3598443|NCT03031899|3451906|B1||buccal mucosa|location of the lesion||lesions|Count of Units|31|31.0||||||
3598444|NCT03031899|3451906|B1|||tobacco habit|patients were asked regarding the usage of tobacco products and was recorded in proforma by investigator|lesions|Count of Units|36|36.0||||||
3598445|NCT03031899|3451906|B1||Male|Sex: Female, Male||lesions|Count of Units|32|32.0||||||
3598446|NCT03031899|3451906|B1||Female|Sex: Female, Male||lesions|Count of Units|6|6.0||||||
3598447|NCT03031899|3451906|B1|||Age||years|Mean|38.16|38.16|Standard Deviation|9.6|9.6|||
3598448|NCT03031899|3451906|B1||>=65 years|Age|a proforma was used to record the baseline details|lesions|Count of Units|0|0.0||||||
3598449|NCT03031899|3451906|B1||Between 18 and 65 years|Age|a proforma was used to record the baseline details|lesions|Count of Units|38|38.0||||||
3598450|NCT03031899|3451906|B1||<=18 years|Age|a proforma was used to record the baseline details|lesions|Count of Units|0|0.0||||||
3598451|NCT03031795|3451914|B3|United States||Region of Enrollment||Participants|Count of Participants|71|71.0||||||
3598452|NCT03031795|3451915|B2|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3598453|NCT03031795|3451916|B1|United States||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3598454|NCT03031795|3451914|B3|Race/ethnicity|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3598455|NCT03031795|3451915|B2|Race/ethnicity|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3598456|NCT03031795|3451916|B1|Race/ethnicity|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3598457|NCT03031795|3451914|B3|Race/ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3598458|NCT03031795|3451915|B2|Race/ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3598459|NCT03031795|3451916|B1|Race/ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3598460|NCT03031795|3451914|B3|Race/ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3598461|NCT03031795|3451915|B2|Race/ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3598462|NCT03031795|3451916|B1|Race/ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3598463|NCT03031795|3451914|B3|Race/ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3598523|NCT03029819|3451979|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3598464|NCT03031795|3451915|B2|Race/ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3598465|NCT03031795|3451916|B1|Race/ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3598466|NCT03031795|3451914|B3|Race/ethnicity|Black|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3598467|NCT03031795|3451915|B2|Race/ethnicity|Black|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3598468|NCT03031795|3451916|B1|Race/ethnicity|Black|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3598469|NCT03031795|3451914|B3|Race/ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|49|49.0||||||
3598470|NCT03031795|3451915|B2|Race/ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3598471|NCT03031795|3451916|B1|Race/ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3598472|NCT03031795|3451914|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3598473|NCT03031795|3451915|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3598474|NCT03031795|3451916|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3598475|NCT03031795|3451914|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3598476|NCT03031795|3451915|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3598477|NCT03031795|3451916|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3598478|NCT03031795|3451914|B3|||Age||years|Mean|31.3|31.3|Standard Deviation|7.9|7.9|||
3598479|NCT03031795|3451915|B2|||Age||years|Mean|30.7|30.7|Standard Deviation|8.9|8.9|||
3598480|NCT03031795|3451916|B1|||Age||years|Mean|31.9|31.9|Standard Deviation|6.7|6.7|||
3598481|NCT03031795|3451914|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3598482|NCT03031795|3451915|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3598483|NCT03031795|3451916|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3598484|NCT03031795|3451914|B3||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
3598485|NCT03031795|3451915|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3598486|NCT03031795|3451916|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3598487|NCT03031795|3451914|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598488|NCT03031795|3451915|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598489|NCT03031795|3451916|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598490|NCT03031496|3451923|B1|Mixed Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3598491|NCT03031496|3451923|B1|White Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3598492|NCT03031496|3451923|B1|Black or African American Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3598493|NCT03031496|3451923|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3598494|NCT03031496|3451923|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3598495|NCT03031496|3451923|B1|||Age||Years|Mean|24.1|24.1|Standard Deviation|4.13|4.13|||
3598496|NCT03031340|3451960|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3598497|NCT03031340|3451961|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3598498|NCT03031340|3451962|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3598499|NCT03031340|3451960|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3598500|NCT03031340|3451961|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3598501|NCT03031340|3451962|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3598502|NCT03031340|3451960|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3598503|NCT03031340|3451961|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3598504|NCT03031340|3451962|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3598505|NCT03031340|3451960|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3598506|NCT03031340|3451961|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3598507|NCT03031340|3451962|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3598508|NCT03031340|3451960|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3598509|NCT03031340|3451961|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3598510|NCT03031340|3451962|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3598511|NCT03031340|3451960|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598512|NCT03031340|3451961|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598513|NCT03031340|3451962|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598514|NCT03029819|3451979|B3|||Baseline cigarettes per day||Cigarettes per day|Mean|16.5|16.5|Standard Deviation|9.6|9.6|||
3598515|NCT03029819|3451980|B2|||Baseline cigarettes per day||Cigarettes per day|Mean|14.4|14.4|Standard Deviation|9.4|9.4|||
3598516|NCT03029819|3451981|B1|||Baseline cigarettes per day||Cigarettes per day|Mean|18.8|18.8|Standard Deviation|9.3|9.3|||
3598517|NCT03029819|3451979|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598518|NCT03029819|3451980|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598519|NCT03029819|3451981|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598520|NCT03029819|3451979|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3598521|NCT03029819|3451980|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598522|NCT03029819|3451981|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3598524|NCT03029819|3451980|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3598525|NCT03029819|3451981|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3598526|NCT03029819|3451979|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3598527|NCT03029819|3451980|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3598528|NCT03029819|3451981|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3598529|NCT03029819|3451979|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598530|NCT03029819|3451980|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598531|NCT03029819|3451981|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598532|NCT03029819|3451979|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598533|NCT03029819|3451980|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598534|NCT03029819|3451981|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598535|NCT03029819|3451979|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598536|NCT03029819|3451980|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598537|NCT03029819|3451981|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598538|NCT03029819|3451979|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598539|NCT03029819|3451980|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598540|NCT03029819|3451981|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598541|NCT03029819|3451979|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3598542|NCT03029819|3451980|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3598543|NCT03029819|3451981|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3598544|NCT03029819|3451979|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3598545|NCT03029819|3451980|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598546|NCT03029819|3451981|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3598547|NCT03029819|3451979|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3598548|NCT03029819|3451980|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3598549|NCT03029819|3451981|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3598550|NCT03029819|3451979|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3598551|NCT03029819|3451980|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3598552|NCT03029819|3451981|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3598553|NCT03029819|3451979|B3|||Age||Years|Mean|45.6|45.6|Standard Deviation|12.0|12.0|||
3598554|NCT03029819|3451980|B2|||Age||Years|Mean|45.6|45.6|Standard Deviation|12.4|12.4|||
3598555|NCT03029819|3451981|B1|||Age||Years|Mean|45.6|45.6|Standard Deviation|12.0|12.0|||
3598556|NCT03029780|3451994|B3|Other||Race/Ethnicity, Customized||Count of participants|Number|2|2.0||||||
3598557|NCT03029780|3451995|B2|Other||Race/Ethnicity, Customized||Count of participants|Number|1|1.0||||||
3598558|NCT03029780|3451996|B1|Other||Race/Ethnicity, Customized||Count of participants|Number|1|1.0||||||
3598559|NCT03029780|3451994|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Count of participants|Number|1|1.0||||||
3598560|NCT03029780|3451995|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Count of participants|Number|0|0.0||||||
3598561|NCT03029780|3451996|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Count of participants|Number|1|1.0||||||
3598562|NCT03029780|3451994|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Count of participants|Number|0|0.0||||||
3598563|NCT03029780|3451995|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Count of participants|Number|0|0.0||||||
3598564|NCT03029780|3451996|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Count of participants|Number|0|0.0||||||
3598565|NCT03029780|3451994|B3|Asian||Race/Ethnicity, Customized||Count of participants|Number|3|3.0||||||
3598566|NCT03029780|3451995|B2|Asian||Race/Ethnicity, Customized||Count of participants|Number|0|0.0||||||
3598567|NCT03029780|3451996|B1|Asian||Race/Ethnicity, Customized||Count of participants|Number|3|3.0||||||
3598568|NCT03029780|3451994|B3|Black or African American||Race/Ethnicity, Customized||Count of participants|Number|1|1.0||||||
3598569|NCT03029780|3451995|B2|Black or African American||Race/Ethnicity, Customized||Count of participants|Number|0|0.0||||||
3598570|NCT03029780|3451996|B1|Black or African American||Race/Ethnicity, Customized||Count of participants|Number|1|1.0||||||
3598571|NCT03029780|3451994|B3|White||Race/Ethnicity, Customized||Count of participants|Number|97|97.0||||||
3598572|NCT03029780|3451995|B2|White||Race/Ethnicity, Customized||Count of participants|Number|51|51.0||||||
3598573|NCT03029780|3451996|B1|White||Race/Ethnicity, Customized||Count of participants|Number|46|46.0||||||
3598574|NCT03029780|3451994|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3598575|NCT03029780|3451995|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3598576|NCT03029780|3451996|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3598577|NCT03029780|3451994|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3598578|NCT03029780|3451995|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3598579|NCT03029780|3451996|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3598580|NCT03029780|3451994|B3|||Age||Years|Mean|62.4|62.4|Standard Deviation|10.4|10.4|||
3598581|NCT03029780|3451995|B2|||Age||Years|Mean|62.6|62.6|Standard Deviation|9.9|9.9|||
3598582|NCT03029780|3451996|B1|||Age||Years|Mean|62.2|62.2|Standard Deviation|10.9|10.9|||
3598583|NCT03029650|3452009|B1|||Body Mass Index||kg/m^2|Mean|23.3|23.3|Standard Deviation|2.88|2.88|||
3598584|NCT03029650|3452009|B1|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3598585|NCT03029650|3452009|B1|Other/Chose not to answer||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3598586|NCT03029650|3452009|B1|Bi-/Multiracial||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3598587|NCT03029650|3452009|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3598588|NCT03029650|3452009|B1|African American/Black||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3598589|NCT03029650|3452009|B1|Caucasian/White||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3598590|NCT03029650|3452009|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3598591|NCT03029650|3452009|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3598592|NCT03029650|3452009|B1|||Age||years|Mean|24.32|24.32|Standard Deviation|6.32|6.32|||
3598593|NCT03029650|3452009|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3598594|NCT03029650|3452009|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3598595|NCT03029650|3452009|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598596|NCT03029000|3452025|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598597|NCT03029000|3452025|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598598|NCT03029000|3452025|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598599|NCT03029000|3452025|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598600|NCT03029000|3452025|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598601|NCT03029000|3452025|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598602|NCT03029000|3452025|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598603|NCT03029000|3452025|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3598604|NCT03029000|3452025|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3598605|NCT03029000|3452025|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3598606|NCT03029000|3452025|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3598607|NCT03029000|3452025|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598608|NCT03028987|3452036|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3598609|NCT03028987|3452037|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3598610|NCT03028987|3452038|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3598611|NCT03028987|3452036|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3598612|NCT03028987|3452037|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3598613|NCT03028987|3452038|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3598614|NCT03028987|3452036|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3598615|NCT03028987|3452037|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3598616|NCT03028987|3452038|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3598617|NCT03028987|3452036|B3|||Age||years|Median|46|46.0|Standard Deviation|9.23|9.23|||
3598618|NCT03028987|3452037|B2|||Age||years|Median|46|46.0|Standard Deviation|9.79|9.79|||
3598619|NCT03028987|3452038|B1|||Age||years|Median|46|46.0|Standard Deviation|9.79|9.79|||
3598620|NCT03028987|3452036|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3598621|NCT03028987|3452037|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3598622|NCT03028987|3452038|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3598623|NCT03028987|3452036|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3598624|NCT03028987|3452037|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3598625|NCT03028987|3452038|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3598626|NCT03028987|3452036|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598627|NCT03028987|3452037|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598628|NCT03028987|3452038|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598629|NCT03028974|3452047|B6|United States||Region of Enrollment||participants|Number|77|77.0||||||
3598630|NCT03028974|3452048|B5|United States||Region of Enrollment||participants|Number|47|47.0||||||
3598631|NCT03028974|3452049|B4|United States||Region of Enrollment||participants|Number|21|21.0||||||
3598632|NCT03028974|3452050|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3598633|NCT03028974|3452051|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3598634|NCT03028974|3452052|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3598635|NCT03028974|3452047|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598636|NCT03028974|3452048|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598637|NCT03028974|3452049|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598638|NCT03028974|3452050|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598639|NCT03028974|3452051|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598640|NCT03028974|3452052|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598641|NCT03028974|3452047|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3598642|NCT03028974|3452048|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3598643|NCT03028974|3452049|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3598644|NCT03028974|3452050|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598645|NCT03028974|3452051|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598646|NCT03028974|3452052|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598647|NCT03028974|3452047|B6||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3598648|NCT03028974|3452048|B5||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3598649|NCT03028974|3452049|B4||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3598650|NCT03028974|3452050|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598651|NCT03028974|3452051|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3598652|NCT03028974|3452052|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598653|NCT03028974|3452047|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3598654|NCT03028974|3452048|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598655|NCT03028974|3452049|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598656|NCT03028974|3452050|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598657|NCT03028974|3452051|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598658|NCT03028974|3452052|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598659|NCT03028974|3452047|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598660|NCT03028974|3452048|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598661|NCT03028974|3452049|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598662|NCT03028974|3452050|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598663|NCT03028974|3452051|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598664|NCT03028974|3452052|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598665|NCT03028974|3452047|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3598666|NCT03028974|3452048|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3598667|NCT03028974|3452049|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3598668|NCT03028974|3452050|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3598669|NCT03028974|3452051|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598670|NCT03028974|3452052|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598671|NCT03028974|3452047|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598672|NCT03028974|3452048|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598673|NCT03028974|3452049|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598674|NCT03028974|3452050|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598675|NCT03028974|3452051|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598676|NCT03028974|3452052|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598677|NCT03028974|3452047|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598678|NCT03028974|3452048|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598679|NCT03028974|3452049|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598680|NCT03028974|3452050|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598681|NCT03028974|3452051|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598682|NCT03028974|3452052|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598683|NCT03028974|3452047|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3598684|NCT03028974|3452048|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3598685|NCT03028974|3452049|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3598686|NCT03028974|3452050|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3598687|NCT03028974|3452051|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3598688|NCT03028974|3452052|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598689|NCT03028974|3452047|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3598690|NCT03028974|3452048|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3598691|NCT03028974|3452049|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598692|NCT03028974|3452050|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598693|NCT03028974|3452051|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598694|NCT03028974|3452052|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598695|NCT03028974|3452047|B6||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3598696|NCT03028974|3452048|B5||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3598697|NCT03028974|3452049|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3598698|NCT03028974|3452050|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3598699|NCT03028974|3452051|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3598700|NCT03028974|3452052|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3598701|NCT03028974|3452047|B6||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3598702|NCT03028974|3452048|B5||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3598703|NCT03028974|3452049|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3598704|NCT03028974|3452050|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3598705|NCT03028974|3452051|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3598706|NCT03028974|3452052|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3598707|NCT03028974|3452047|B6|||Age||years|Median|21.1|21.1|Standard Deviation|1.64|1.64|||
3598708|NCT03028974|3452048|B5|||Age||years|Median|33.5|33.5|Standard Deviation|1.48|1.48|||
3598709|NCT03028974|3452049|B4|||Age||years|Median|20|20.0|Standard Deviation|13.05|13.05|||
3598710|NCT03028974|3452050|B3|||Age||years|Median|1|1.0|Standard Deviation|0|0.0|||
3598711|NCT03028974|3452051|B2|||Age||years|Median|1.5|1.5|Standard Deviation|00.187|0.187|||
3598712|NCT03028974|3452052|B1|||Age||years|Median|2|2.0|Standard Deviation|0|0.0|||
3598713|NCT03028896|3452075|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3598714|NCT03028896|3452076|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3598715|NCT03028896|3452077|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3598716|NCT03028896|3452075|B3||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3598717|NCT03028896|3452076|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3598718|NCT03028896|3452077|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3598719|NCT03028896|3452075|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3598720|NCT03028896|3452076|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3598721|NCT03028896|3452077|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3598722|NCT03028896|3452075|B3||Between 18 and 65 years|Age||Participants|Count of Participants|124|124.0||||||
3598723|NCT03028896|3452076|B2||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
3598724|NCT03028896|3452077|B1||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
3598725|NCT03028896|3452075|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3598726|NCT03028896|3452076|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598727|NCT03028896|3452077|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3598728|NCT03028870|3452084|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3598729|NCT03028870|3452085|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3598730|NCT03028870|3452086|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3598731|NCT03028870|3452087|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3598732|NCT03028870|3452088|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3598733|NCT03028870|3452084|B5|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3598734|NCT03028870|3452085|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3598735|NCT03028870|3452086|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3598736|NCT03028870|3452087|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3598737|NCT03028870|3452088|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3598738|NCT03028870|3452084|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3598739|NCT03028870|3452085|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3598740|NCT03028870|3452086|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3598741|NCT03028870|3452087|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3598742|NCT03028870|3452088|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3598743|NCT03028870|3452084|B5|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|70|70.0||||||
3598744|NCT03028870|3452085|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3598745|NCT03028870|3452086|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3598746|NCT03028870|3452087|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3598747|NCT03028870|3452088|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3598748|NCT03028870|3452084|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|214|214.0||||||
3598749|NCT03028870|3452085|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|54|54.0||||||
3598750|NCT03028870|3452086|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|61|61.0||||||
3598751|NCT03028870|3452087|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
3598752|NCT03028870|3452088|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
3598753|NCT03028870|3452084|B5||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3598754|NCT03028870|3452085|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3598755|NCT03028870|3452086|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3598756|NCT03028870|3452087|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3598757|NCT03028870|3452088|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3598758|NCT03028870|3452084|B5||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3598759|NCT03028870|3452085|B4||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3598760|NCT03028870|3452086|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3598761|NCT03028870|3452087|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3598762|NCT03028870|3452088|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3598763|NCT03028870|3452084|B5|||Age||years|Mean|60.1|60.1|Standard Deviation|8.79|8.79|||
3598764|NCT03028870|3452085|B4|||Age||years|Mean|59.0|59.0|Standard Deviation|8.97|8.97|||
3598765|NCT03028870|3452086|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|8.94|8.94|||
3598766|NCT03028870|3452087|B2|||Age||years|Mean|60.7|60.7|Standard Deviation|8.62|8.62|||
3598767|NCT03028870|3452088|B1|||Age||years|Mean|60.9|60.9|Standard Deviation|8.66|8.66|||
3598768|NCT03028025|3452169|B3|||Barbeau Class A|A Barbeau test is performed to evaluate the patency of the radiopalmar arch. This is performed by compressing the radial artery for up to 2 minutes and observing the resulting waveform changes. The procedure can be performed in patients with Barbeau classification waveform A, B, or C. All patients received baseline assessment of the hand circulation using the Barbeau’s test on a scale A-D, A being patent radial artery. Patients who exhibit a type D waveform indicates an incomplete palmar arch.|Participants|Count of Participants|155|155.0||||||
3598769|NCT03028025|3452170|B2|||Barbeau Class A|A Barbeau test is performed to evaluate the patency of the radiopalmar arch. This is performed by compressing the radial artery for up to 2 minutes and observing the resulting waveform changes. The procedure can be performed in patients with Barbeau classification waveform A, B, or C. All patients received baseline assessment of the hand circulation using the Barbeau’s test on a scale A-D, A being patent radial artery. Patients who exhibit a type D waveform indicates an incomplete palmar arch.|Participants|Count of Participants|79|79.0||||||
3598770|NCT03028025|3452171|B1|||Barbeau Class A|A Barbeau test is performed to evaluate the patency of the radiopalmar arch. This is performed by compressing the radial artery for up to 2 minutes and observing the resulting waveform changes. The procedure can be performed in patients with Barbeau classification waveform A, B, or C. All patients received baseline assessment of the hand circulation using the Barbeau’s test on a scale A-D, A being patent radial artery. Patients who exhibit a type D waveform indicates an incomplete palmar arch.|Participants|Count of Participants|76|76.0||||||
3598771|NCT03028025|3452169|B3|United States||Region of Enrollment||participants|Number|180|180.0||||||
3598772|NCT03028025|3452170|B2|United States||Region of Enrollment||participants|Number|93|93.0||||||
3598773|NCT03028025|3452171|B1|United States||Region of Enrollment||participants|Number|87|87.0||||||
3598774|NCT03028025|3452169|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3598775|NCT03028025|3452169|B3||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3598776|NCT03028025|3452170|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3598777|NCT03028025|3452171|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3598778|NCT03028025|3452169|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3598779|NCT03028025|3452170|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3598780|NCT03028025|3452171|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3598781|NCT03028025|3452169|B3|||Age||years|Mean|66.15|66.15|Standard Deviation|10.8|10.8|||
3598782|NCT03028025|3452170|B2|||Age||years|Mean|65.8|65.8|Standard Deviation|11.8|11.8|||
3598783|NCT03028025|3452171|B1|||Age||years|Mean|66.5|66.5|Standard Deviation|9.8|9.8|||
3598784|NCT03028025|3452169|B3||>=65 years|Age||Participants|Count of Participants|107|107.0||||||
3598785|NCT03028025|3452170|B2||>=65 years|Age||Participants|Count of Participants|55|55.0||||||
3598786|NCT03028025|3452171|B1||>=65 years|Age||Participants|Count of Participants|52|52.0||||||
3598787|NCT03028025|3452169|B3||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
3598788|NCT03028025|3452170|B2||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3598789|NCT03028025|3452171|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3598790|NCT03028025|3452169|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598791|NCT03028025|3452170|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598792|NCT03028025|3452171|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598793|NCT03027661|3452180|B3|||history of csection||Participants|Count of Participants|19|19.0||||||
3598794|NCT03027661|3452181|B2|||history of csection||Participants|Count of Participants|8|8.0||||||
3598795|NCT03027661|3452182|B1|||history of csection||Participants|Count of Participants|11|11.0||||||
3598796|NCT03027661|3452180|B3|||BMI||kg/m^2|Mean|33.87|33.87|Standard Deviation|9.7|9.7|||
3598797|NCT03027661|3452181|B2|||BMI||kg/m^2|Mean|32.75|32.75|Standard Deviation|9.8|9.8|||
3598798|NCT03027661|3452182|B1|||BMI||kg/m^2|Mean|35.05|35.05|Standard Deviation|9.8|9.8|||
3598799|NCT03027661|3452180|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
3598800|NCT03027661|3452181|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
3598801|NCT03027661|3452182|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3598802|NCT03027661|3452180|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3598803|NCT03027661|3452180|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3598804|NCT03027661|3452181|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3598805|NCT03027661|3452182|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3598806|NCT03027661|3452180|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3598807|NCT03027661|3452181|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3598808|NCT03027661|3452182|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3598809|NCT03027661|3452180|B3|||Age||years|Mean|46.24|46.24|Standard Deviation|10.0|10.0|||
3598810|NCT03027661|3452181|B2|||Age||years|Mean|46|46.0|Standard Deviation|10.4|10.4|||
3598811|NCT03027661|3452182|B1|||Age||years|Mean|46.50|46.5|Standard Deviation|9.8|9.8|||
3598812|NCT03027661|3452180|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3598813|NCT03027661|3452181|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3598814|NCT03027661|3452182|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3598815|NCT03027661|3452180|B3||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3598816|NCT03027661|3452181|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3598817|NCT03027661|3452182|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3598818|NCT03027661|3452180|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598819|NCT03027661|3452181|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598820|NCT03027661|3452182|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598821|NCT03026803|3452191|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3598822|NCT03026803|3452191|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3598823|NCT03026803|3452191|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3598824|NCT03026803|3452191|B1|||Age||years|Median|71|71.0|Full Range|||65.0|74.0|
3598825|NCT03026530|3452195|B3|||BMI||kg/m2|Median|38|38.0|Inter-Quartile Range|||36.0|42.0|
3598826|NCT03026530|3452196|B2|||BMI||kg/m2|Median|38|38.0|Inter-Quartile Range|||36.0|42.0|
3598827|NCT03026530|3452197|B1|||BMI||kg/m2|Median|38|38.0|Inter-Quartile Range|||36.0|42.0|
3598828|NCT03026530|3452195|B3|Sweden||Region of Enrollment||participants|Number|150|150.0||||||
3598829|NCT03026530|3452196|B2|Sweden||Region of Enrollment||participants|Number|71|71.0||||||
3598830|NCT03026530|3452197|B1|Sweden||Region of Enrollment||participants|Number|79|79.0||||||
3598831|NCT03026530|3452195|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3598832|NCT03026530|3452195|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3598833|NCT03026530|3452196|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3598834|NCT03026530|3452197|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3598835|NCT03026530|3452195|B3||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3598836|NCT03026530|3452196|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3598837|NCT03026530|3452197|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3598838|NCT03026530|3452195|B3|||Age||years|Median|46|46.0|Inter-Quartile Range|||33.0|52.0|
3598839|NCT03026530|3452196|B2|||Age||years|Median|44|44.0|Inter-Quartile Range|||32.0|51.0|
3598840|NCT03026530|3452197|B1|||Age||years|Median|47|47.0|Inter-Quartile Range|||34.0|53.0|
3598841|NCT03026257|3452206|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3598842|NCT03026257|3452207|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598843|NCT03026257|3452208|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598844|NCT03026257|3452209|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598845|NCT03026257|3452210|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598846|NCT03026257|3452211|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598847|NCT03026257|3452212|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598848|NCT03026257|3452206|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|238|238.0||||||
3598849|NCT03026257|3452207|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3598850|NCT03026257|3452208|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3598851|NCT03026257|3452209|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3598852|NCT03026257|3452210|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3598853|NCT03026257|3452211|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3598854|NCT03026257|3452212|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3598855|NCT03026257|3452206|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3598856|NCT03026257|3452207|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3598857|NCT03026257|3452208|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598858|NCT03026257|3452209|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598859|NCT03026257|3452210|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598860|NCT03026257|3452211|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598861|NCT03026257|3452212|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3598862|NCT03026257|3452206|B7||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3598863|NCT03026257|3452207|B6||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3598864|NCT03026257|3452208|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3598865|NCT03026257|3452209|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3598866|NCT03026257|3452210|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3598867|NCT03026257|3452211|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3598868|NCT03026257|3452212|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3598869|NCT03026257|3452206|B7||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
3598870|NCT03026257|3452207|B6||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3598871|NCT03026257|3452208|B5||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3598872|NCT03026257|3452209|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3598873|NCT03026257|3452210|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3598874|NCT03026257|3452211|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3598875|NCT03026257|3452212|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3598876|NCT03026257|3452206|B7|||Age||years|Mean|28.4|28.4|Standard Deviation|6.8|6.8|||
3598877|NCT03026257|3452207|B6|||Age||years|Mean|30.4|30.4|Standard Deviation|8.2|8.2|||
3598878|NCT03026257|3452208|B5|||Age||years|Mean|28.8|28.8|Standard Deviation|7.2|7.2|||
3598879|NCT03026257|3452209|B4|||Age||years|Mean|28.2|28.2|Standard Deviation|5.7|5.7|||
3598880|NCT03026257|3452210|B3|||Age||years|Mean|28.2|28.2|Standard Deviation|5.9|5.9|||
3598881|NCT03026257|3452211|B2|||Age||years|Mean|27.8|27.8|Standard Deviation|6.0|6.0|||
3598882|NCT03026257|3452212|B1|||Age||years|Mean|27.7|27.7|Standard Deviation|7.0|7.0|||
3598883|NCT03025945|3452231|B3|||Macular volume||mm|Mean|8.72|8.72|Standard Deviation|0.15|0.15|||
3598884|NCT03025945|3452232|B2|||Macular volume||mm|Mean|8.75|8.75|Standard Deviation|0.15|0.15|||
3598885|NCT03025945|3452233|B1|||Macular volume||mm|Mean|8.7|8.7|Standard Deviation|0.15|0.15|||
3598886|NCT03025945|3452231|B3||Male|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
3598887|NCT03025945|3452232|B2||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3598888|NCT03025945|3452233|B1||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3598889|NCT03025945|3452231|B3||Female|Sex: Female, Male||Participants|Count of Participants|364|364.0||||||
3598890|NCT03025945|3452232|B2||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3598891|NCT03025945|3452233|B1||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3598892|NCT03025945|3452231|B3|||Age||years|Mean|68.3|68.3|Full Range|||31.0|96.0|
3598893|NCT03025945|3452232|B2|||Age||years|Mean|67.9|67.9|Full Range|||39.0|96.0|
3598894|NCT03025945|3452233|B1|||Age||years|Mean|68.8|68.8|Full Range|||31.0|94.0|
3598895|NCT03024606|3452240|B3|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3598896|NCT03024606|3452241|B2|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3598897|NCT03024606|3452242|B1|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3598898|NCT03024606|3452240|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598899|NCT03024606|3452241|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598900|NCT03024606|3452242|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598901|NCT03024606|3452240|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598902|NCT03024606|3452241|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598903|NCT03024606|3452242|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598904|NCT03024606|3452240|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3598905|NCT03024606|3452241|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3598906|NCT03024606|3452242|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3598907|NCT03024606|3452240|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3598908|NCT03024606|3452241|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3598909|NCT03024606|3452242|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3598910|NCT03024606|3452240|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598911|NCT03024606|3452241|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598912|NCT03024606|3452242|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598913|NCT03024606|3452240|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598914|NCT03024606|3452241|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598915|NCT03024606|3452242|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598916|NCT03024606|3452240|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598917|NCT03024606|3452241|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598918|NCT03024606|3452242|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598919|NCT03024606|3452240|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3598920|NCT03024606|3452241|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3598921|NCT03024606|3452242|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3598922|NCT03024606|3452240|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3598923|NCT03024606|3452241|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3598924|NCT03024606|3452242|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3598925|NCT03024606|3452240|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3598926|NCT03024606|3452241|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3598927|NCT03024606|3452242|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3598928|NCT03024606|3452240|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3598929|NCT03024606|3452241|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3598930|NCT03024606|3452242|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3598931|NCT03024606|3452240|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598932|NCT03024606|3452241|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598933|NCT03024606|3452242|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598934|NCT03024112|3452249|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
3598935|NCT03024112|3452250|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
3598936|NCT03024112|3452251|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3598937|NCT03024112|3452249|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3598938|NCT03024112|3452250|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3598939|NCT03024112|3452251|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3598940|NCT03024112|3452249|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3598941|NCT03024112|3452250|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3598942|NCT03024112|3452251|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3598943|NCT03024112|3452249|B3|||Age||years|Mean|58|58.0|Full Range|||18.0|100.0|
3598944|NCT03024112|3452250|B2|||Age||years|Mean|59|59.0|Full Range|||18.0|100.0|
3598945|NCT03024112|3452251|B1|||Age||years|Mean|57|57.0|Full Range|||18.0|100.0|
3598946|NCT03024112|3452249|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3598947|NCT03024112|3452250|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3598948|NCT03024112|3452251|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3598949|NCT03024112|3452249|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3598950|NCT03024112|3452250|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3598951|NCT03024112|3452251|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3598952|NCT03024112|3452249|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598953|NCT03024112|3452250|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598954|NCT03024112|3452251|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3598955|NCT03023709|3452264|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3598956|NCT03023709|3452266|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3598957|NCT03023709|3452264|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598958|NCT03023709|3452266|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598959|NCT03023709|3452264|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598960|NCT03023709|3452266|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598961|NCT03023709|3452264|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3598962|NCT03023709|3452266|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3598963|NCT03023709|3452264|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598964|NCT03023709|3452266|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598965|NCT03023709|3452264|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598966|NCT03023709|3452266|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598967|NCT03023709|3452264|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598968|NCT03023709|3452266|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3598969|NCT03023709|3452264|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598970|NCT03023709|3452266|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598971|NCT03023709|3452264|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598972|NCT03023709|3452266|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598973|NCT03023709|3452264|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3598974|NCT03023709|3452266|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3598975|NCT03023709|3452264|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598976|NCT03023709|3452266|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598977|NCT03023709|3452264|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3598978|NCT03023709|3452266|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3598979|NCT03023709|3452264|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3598980|NCT03023709|3452266|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3598981|NCT03023709|3452264|B3|||Age||years|Mean|32|32.0|Standard Deviation|7.93|7.93|||
3598982|NCT03023709|3452266|B1|||Age||years|Mean|32|32.0|Standard Deviation|7.93|7.93|||
3598983|NCT03023683|3452275|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
3598984|NCT03023683|3452276|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
3598985|NCT03023683|3452275|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598986|NCT03023683|3452276|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598987|NCT03023683|3452275|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3598988|NCT03023683|3452276|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3598989|NCT03023683|3452275|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3598990|NCT03023683|3452276|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3598991|NCT03023683|3452275|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598992|NCT03023683|3452276|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598993|NCT03023683|3452275|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598994|NCT03023683|3452276|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598995|NCT03023683|3452275|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3598996|NCT03023683|3452276|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3598997|NCT03023683|3452275|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598998|NCT03023683|3452276|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3598999|NCT03023683|3452275|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599000|NCT03023683|3452276|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599001|NCT03023683|3452275|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3599002|NCT03023683|3452276|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3599003|NCT03023683|3452275|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599004|NCT03023683|3452276|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599005|NCT03023683|3452275|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3599006|NCT03023683|3452276|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3599007|NCT03023683|3452275|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3599008|NCT03023683|3452276|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3599009|NCT03023683|3452275|B3|||Age||years|Mean|28.07|28.07|Standard Deviation|8.09|8.09|||
3599010|NCT03023683|3452276|B2|||Age||years|Mean|28.07|28.07|Standard Deviation|8.09|8.09|||
3599011|NCT03023553|3452286|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3599012|NCT03023553|3452287|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3599013|NCT03023553|3452288|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3599014|NCT03023553|3452286|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599015|NCT03023553|3452287|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599016|NCT03023553|3452288|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599017|NCT03023553|3452286|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3599018|NCT03023553|3452287|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3599019|NCT03023553|3452288|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3599020|NCT03023553|3452286|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3599021|NCT03023553|3452287|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3599022|NCT03023553|3452288|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3599023|NCT03023553|3452286|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599024|NCT03023553|3452287|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599025|NCT03023553|3452288|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599026|NCT03023553|3452286|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599027|NCT03023553|3452287|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599028|NCT03023553|3452288|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599029|NCT03023553|3452286|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599030|NCT03023553|3452287|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599031|NCT03023553|3452288|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599032|NCT03023553|3452286|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599033|NCT03023553|3452287|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599034|NCT03023553|3452288|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599035|NCT03023553|3452286|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599036|NCT03023553|3452287|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599037|NCT03023553|3452288|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599038|NCT03023553|3452286|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3599039|NCT03023553|3452287|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3599101|NCT03023137|3452317|B1||White|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
3599040|NCT03023553|3452288|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3599041|NCT03023553|3452286|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599042|NCT03023553|3452287|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599043|NCT03023553|3452288|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599044|NCT03023553|3452286|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3599045|NCT03023553|3452287|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3599046|NCT03023553|3452288|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3599047|NCT03023553|3452286|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3599048|NCT03023553|3452287|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3599049|NCT03023553|3452288|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3599050|NCT03023553|3452286|B3|||Age||years|Mean|24.40|24.4|Standard Deviation|4.45|4.45|||
3599051|NCT03023553|3452287|B2|||Age||years|Mean|24.60|24.6|Standard Deviation|5.22|5.22|||
3599052|NCT03023553|3452288|B1|||Age||years|Mean|23.99|23.99|Standard Deviation|2.955|2.955|||
3599053|NCT03023488|3452297|B1|||Stone volume||mm3|Mean|1685|1685.0|Full Range|||150.0|5868.0|
3599054|NCT03023488|3452297|B1|||Body Mass Index (BMI) units: kg/m2||kg/m2|Mean|26.49|26.49|Standard Deviation|4.97|4.97|||
3599055|NCT03023488|3452297|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3599056|NCT03023488|3452297|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3599057|NCT03023488|3452297|B1|||Age||years|Mean|41.24|41.24|Full Range|||17.0|83.0|
3599058|NCT03023176|3452310|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3599059|NCT03023176|3452310|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599060|NCT03023176|3452310|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3599061|NCT03023176|3452310|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3599062|NCT03023176|3452310|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599063|NCT03023176|3452310|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599064|NCT03023176|3452310|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599065|NCT03023176|3452310|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599066|NCT03023176|3452310|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599067|NCT03023176|3452310|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3599068|NCT03023176|3452310|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3599069|NCT03023176|3452310|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3599070|NCT03023176|3452310|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3599071|NCT03023176|3452310|B1|||Age||years|Mean|4.06|4.06|Standard Deviation|1.46|1.46|||
3599072|NCT03023137|3452315|B3|||Women with live offspring||participants|Number|64|64.0||||||
3599073|NCT03023137|3452316|B2|||Women with live offspring||participants|Number|28|28.0||||||
3599074|NCT03023137|3452317|B1|||Women with live offspring||participants|Number|36|36.0||||||
3599075|NCT03023137|3452315|B3|||Chronic hypertension||participants|Number|12|12.0||||||
3599076|NCT03023137|3452316|B2|||Chronic hypertension||participants|Number|4|4.0||||||
3599077|NCT03023137|3452317|B1|||Chronic hypertension||participants|Number|8|8.0||||||
3599078|NCT03023137|3452315|B3|||Type 1 diabetes mellitus||participants|Number|2|2.0||||||
3599079|NCT03023137|3452316|B2|||Type 1 diabetes mellitus||participants|Number|2|2.0||||||
3599080|NCT03023137|3452317|B1|||Type 1 diabetes mellitus||participants|Number|0|0.0||||||
3599081|NCT03023137|3452315|B3|||Obese (BMI > 30 kg/m2)||participants|Number|35|35.0||||||
3599082|NCT03023137|3452316|B2|||Obese (BMI > 30 kg/m2)||participants|Number|19|19.0||||||
3599083|NCT03023137|3452317|B1|||Obese (BMI > 30 kg/m2)||participants|Number|16|16.0||||||
3599084|NCT03023137|3452315|B3|||Owerweight (BMI 25–30 kg/m2)||participants|Number|101|101.0||||||
3599085|NCT03023137|3452316|B2|||Owerweight (BMI 25–30 kg/m2)||participants|Number|48|48.0||||||
3599086|NCT03023137|3452317|B1|||Owerweight (BMI 25–30 kg/m2)||participants|Number|53|53.0||||||
3599087|NCT03023137|3452315|B3|||Normal or underweight (BMI <25 kg/m2)||participants|Number|200|200.0||||||
3599088|NCT03023137|3452316|B2|||Normal or underweight (BMI <25 kg/m2)||participants|Number|95|95.0||||||
3599089|NCT03023137|3452317|B1|||Normal or underweight (BMI <25 kg/m2)||participants|Number|105|105.0||||||
3599090|NCT03023137|3452315|B3|Brazil||Region of Enrollment||participants|Number|336|336.0||||||
3599091|NCT03023137|3452316|B2|Brazil||Region of Enrollment||participants|Number|162|162.0||||||
3599092|NCT03023137|3452317|B1|Brazil||Region of Enrollment||participants|Number|174|174.0||||||
3599093|NCT03023137|3452315|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599094|NCT03023137|3452316|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599095|NCT03023137|3452317|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599096|NCT03023137|3452315|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599097|NCT03023137|3452316|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599098|NCT03023137|3452317|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599099|NCT03023137|3452315|B3||White|Race (NIH/OMB)||Participants|Count of Participants|168|168.0||||||
3599100|NCT03023137|3452316|B2||White|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3599102|NCT03023137|3452315|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
3599103|NCT03023137|3452316|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3599104|NCT03023137|3452317|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3599105|NCT03023137|3452315|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599106|NCT03023137|3452316|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599107|NCT03023137|3452317|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599108|NCT03023137|3452315|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599109|NCT03023137|3452316|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599110|NCT03023137|3452317|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599111|NCT03023137|3452315|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3599112|NCT03023137|3452316|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3599113|NCT03023137|3452317|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3599114|NCT03023137|3452315|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3599115|NCT03023137|3452316|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3599116|NCT03023137|3452317|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3599117|NCT03023137|3452315|B3||Female|Sex: Female, Male||Participants|Count of Participants|336|336.0||||||
3599118|NCT03023137|3452316|B2||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3599119|NCT03023137|3452317|B1||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3599120|NCT03023137|3452315|B3|||Age||years|Mean|30|30.0|Standard Deviation|8|8.0|||
3599121|NCT03023137|3452316|B2|||Age||years|Mean|30|30.0|Standard Deviation|8|8.0|||
3599122|NCT03023137|3452317|B1|||Age||years|Mean|31|31.0|Standard Deviation|7|7.0|||
3599123|NCT03022435|3452344|B6|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3599124|NCT03022435|3452345|B5|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3599125|NCT03022435|3452346|B4|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3599126|NCT03022435|3452347|B3|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3599127|NCT03022435|3452348|B2|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3599128|NCT03022435|3452349|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3599129|NCT03022435|3452344|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599130|NCT03022435|3452345|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599131|NCT03022435|3452346|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599132|NCT03022435|3452347|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599133|NCT03022435|3452348|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599134|NCT03022435|3452349|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599135|NCT03022435|3452344|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3599136|NCT03022435|3452345|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599137|NCT03022435|3452346|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599138|NCT03022435|3452347|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599139|NCT03022435|3452348|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3599140|NCT03022435|3452349|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3599141|NCT03022435|3452344|B6||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3599142|NCT03022435|3452345|B5||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3599143|NCT03022435|3452346|B4||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3599144|NCT03022435|3452347|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3599145|NCT03022435|3452348|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3599146|NCT03022435|3452349|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3599147|NCT03022435|3452344|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599148|NCT03022435|3452345|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599149|NCT03022435|3452346|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599150|NCT03022435|3452347|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599151|NCT03022435|3452348|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599152|NCT03022435|3452349|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599153|NCT03022435|3452344|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3599154|NCT03022435|3452345|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599155|NCT03022435|3452346|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599156|NCT03022435|3452347|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599157|NCT03022435|3452348|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3599158|NCT03022435|3452349|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3599159|NCT03022435|3452344|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3599160|NCT03022435|3452345|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599161|NCT03022435|3452346|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599162|NCT03022435|3452347|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599163|NCT03022435|3452348|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3599164|NCT03022435|3452349|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3599165|NCT03022435|3452344|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599166|NCT03022435|3452345|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599167|NCT03022435|3452346|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599168|NCT03022435|3452347|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599169|NCT03022435|3452348|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599170|NCT03022435|3452349|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599171|NCT03022435|3452344|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599172|NCT03022435|3452345|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599173|NCT03022435|3452346|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599174|NCT03022435|3452347|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599175|NCT03022435|3452348|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599176|NCT03022435|3452349|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599177|NCT03022435|3452344|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3599178|NCT03022435|3452345|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3599179|NCT03022435|3452346|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3599180|NCT03022435|3452347|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3599181|NCT03022435|3452348|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3599182|NCT03022435|3452349|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3599183|NCT03022435|3452344|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3599184|NCT03022435|3452345|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599185|NCT03022435|3452346|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599186|NCT03022435|3452347|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599187|NCT03022435|3452348|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3599188|NCT03022435|3452349|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3599189|NCT03022435|3452344|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3599190|NCT03022435|3452345|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3599191|NCT03022435|3452346|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3599192|NCT03022435|3452347|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3599193|NCT03022435|3452348|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3599194|NCT03022435|3452349|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3599195|NCT03022435|3452344|B6||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3599196|NCT03022435|3452345|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3599197|NCT03022435|3452346|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3599198|NCT03022435|3452347|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3599199|NCT03022435|3452348|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3599200|NCT03022435|3452349|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3599201|NCT03022435|3452344|B6|||Age||years|Mean|42.14|42.14|Standard Deviation|21.63|21.63|||
3599202|NCT03022435|3452345|B5|||Age||years|Mean|73.45|73.45|Standard Deviation|4.20|4.2|||
3599203|NCT03022435|3452346|B4|||Age||years|Mean|73.45|73.45|Standard Deviation|4.20|4.2|||
3599204|NCT03022435|3452347|B3|||Age||years|Mean|42.76|42.76|Standard Deviation|1.93|1.93|||
3599205|NCT03022435|3452348|B2|||Age||years|Mean|22.98|22.98|Standard Deviation|4.26|4.26|||
3599206|NCT03022435|3452349|B1|||Age||years|Mean|22.98|22.98|Standard Deviation|4.26|4.26|||
3599207|NCT03022422|3452370|B7|United States||Region of Enrollment||participants|Number|63|63.0||||||
3599208|NCT03022422|3452371|B6|United States||Region of Enrollment||participants|Number|5|5.0||||||
3599209|NCT03022422|3452372|B5|United States||Region of Enrollment||participants|Number|5|5.0||||||
3599210|NCT03022422|3452373|B4|United States||Region of Enrollment||participants|Number|12|12.0||||||
3599211|NCT03022422|3452374|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
3599212|NCT03022422|3452375|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3599213|NCT03022422|3452376|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3599214|NCT03022422|3452370|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3599215|NCT03022422|3452371|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599216|NCT03022422|3452372|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599217|NCT03022422|3452373|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3599218|NCT03022422|3452374|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599219|NCT03022422|3452375|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599220|NCT03022422|3452376|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599221|NCT03022422|3452370|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3599222|NCT03022422|3452371|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599223|NCT03022422|3452372|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599224|NCT03022422|3452373|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3599225|NCT03022422|3452374|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599226|NCT03022422|3452375|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3599227|NCT03022422|3452376|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3599228|NCT03022422|3452370|B7||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3599229|NCT03022422|3452371|B6||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3599230|NCT03022422|3452372|B5||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3599231|NCT03022422|3452373|B4||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3599232|NCT03022422|3452374|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3599233|NCT03022422|3452375|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3599234|NCT03022422|3452376|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3599235|NCT03022422|3452370|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599236|NCT03022422|3452371|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599237|NCT03022422|3452372|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599238|NCT03022422|3452373|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599239|NCT03022422|3452374|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599240|NCT03022422|3452375|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599241|NCT03022422|3452376|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599242|NCT03022422|3452370|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599243|NCT03022422|3452371|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599244|NCT03022422|3452372|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599245|NCT03022422|3452373|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599246|NCT03022422|3452374|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599247|NCT03022422|3452375|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599248|NCT03022422|3452376|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599249|NCT03022422|3452370|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3599250|NCT03022422|3452371|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599251|NCT03022422|3452372|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599252|NCT03022422|3452373|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599253|NCT03022422|3452374|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3599254|NCT03022422|3452375|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599255|NCT03022422|3452376|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599256|NCT03022422|3452370|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599257|NCT03022422|3452371|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599258|NCT03022422|3452372|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599259|NCT03022422|3452373|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599260|NCT03022422|3452374|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599261|NCT03022422|3452375|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599262|NCT03022422|3452376|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599263|NCT03022422|3452370|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)|Ethnicity is reported as self-identified; identical twins could have provided different responses.|Participants|Count of Participants|1|1.0||||||
3599264|NCT03022422|3452371|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)|Ethnicity is reported as self-identified; identical twins could have provided different responses.|Participants|Count of Participants|0|0.0||||||
3599265|NCT03022422|3452372|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)|Ethnicity is reported as self-identified; identical twins could have provided different responses.|Participants|Count of Participants|0|0.0||||||
3599266|NCT03022422|3452373|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)|Ethnicity is reported as self-identified; identical twins could have provided different responses.|Participants|Count of Participants|0|0.0||||||
3599267|NCT03022422|3452374|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)|Ethnicity is reported as self-identified; identical twins could have provided different responses.|Participants|Count of Participants|0|0.0||||||
3599268|NCT03022422|3452375|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)|Ethnicity is reported as self-identified; identical twins could have provided different responses.|Participants|Count of Participants|1|1.0||||||
3599269|NCT03022422|3452376|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|Ethnicity is reported as self-identified; identical twins could have provided different responses.|Participants|Count of Participants|0|0.0||||||
3599270|NCT03022422|3452370|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity is reported as self-identified; identical twins could have provided different responses.|Participants|Count of Participants|53|53.0||||||
3599271|NCT03022422|3452371|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity is reported as self-identified; identical twins could have provided different responses.|Participants|Count of Participants|5|5.0||||||
3599272|NCT03022422|3452372|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity is reported as self-identified; identical twins could have provided different responses.|Participants|Count of Participants|5|5.0||||||
3599273|NCT03022422|3452373|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity is reported as self-identified; identical twins could have provided different responses.|Participants|Count of Participants|10|10.0||||||
3599274|NCT03022422|3452374|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity is reported as self-identified; identical twins could have provided different responses.|Participants|Count of Participants|20|20.0||||||
3599275|NCT03022422|3452375|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity is reported as self-identified; identical twins could have provided different responses.|Participants|Count of Participants|8|8.0||||||
3599276|NCT03022422|3452376|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity is reported as self-identified; identical twins could have provided different responses.|Participants|Count of Participants|5|5.0||||||
3599277|NCT03022422|3452370|B7||Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity is reported as self-identified; identical twins could have provided different responses.|Participants|Count of Participants|9|9.0||||||
3599278|NCT03022422|3452371|B6||Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity is reported as self-identified; identical twins could have provided different responses.|Participants|Count of Participants|0|0.0||||||
3599279|NCT03022422|3452372|B5||Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity is reported as self-identified; identical twins could have provided different responses.|Participants|Count of Participants|0|0.0||||||
3599280|NCT03022422|3452373|B4||Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity is reported as self-identified; identical twins could have provided different responses.|Participants|Count of Participants|2|2.0||||||
3599281|NCT03022422|3452374|B3||Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity is reported as self-identified; identical twins could have provided different responses.|Participants|Count of Participants|3|3.0||||||
3599282|NCT03022422|3452375|B2||Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity is reported as self-identified; identical twins could have provided different responses.|Participants|Count of Participants|1|1.0||||||
3599283|NCT03022422|3452376|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity is reported as self-identified; identical twins could have provided different responses.|Participants|Count of Participants|3|3.0||||||
3599284|NCT03022422|3452370|B7||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3599285|NCT03022422|3452371|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3599286|NCT03022422|3452372|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3599287|NCT03022422|3452373|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3599288|NCT03022422|3452374|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3599289|NCT03022422|3452375|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3599290|NCT03022422|3452376|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3599291|NCT03022422|3452370|B7||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3599292|NCT03022422|3452371|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3599293|NCT03022422|3452372|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3599294|NCT03022422|3452373|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3599295|NCT03022422|3452374|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3599296|NCT03022422|3452375|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3599297|NCT03022422|3452376|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3599298|NCT03022422|3452370|B7|||Age||years|Mean|47.55|47.55|Standard Deviation|16.46|16.46|||
3599299|NCT03022422|3452371|B6|||Age||years|Mean|70.08|70.08|Standard Deviation|3.83|3.83|||
3599300|NCT03022422|3452372|B5|||Age||years|Mean|70.08|70.08|Standard Deviation|3.83|3.83|||
3599301|NCT03022422|3452373|B4|||Age||years|Mean|55.86|55.86|Standard Deviation|7.10|7.1|||
3599302|NCT03022422|3452374|B3|||Age||years|Mean|50.55|50.55|Standard Deviation|7.03|7.03|||
3599303|NCT03022422|3452375|B2|||Age||years|Mean|26.37|26.37|Standard Deviation|3.11|3.11|||
3599304|NCT03022422|3452376|B1|||Age||years|Mean|24.79|24.79|Standard Deviation|4.18|4.18|||
3599305|NCT03022396|3452401|B7|United States||Region of Enrollment||Participants|Count of Participants|82|82.0||||||
3599306|NCT03022396|3452402|B6|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3599307|NCT03022396|3452403|B5|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3599308|NCT03022396|3452404|B4|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3599309|NCT03022396|3452405|B3|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3599310|NCT03022396|3452406|B2|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3599311|NCT03022396|3452407|B1|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3599312|NCT03022396|3452401|B7||Unknown or Not Reported|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|1|1.0||||||
3599409|NCT03021343|3452434|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3599410|NCT03021343|3452432|B3|||Age||years|Mean|60.6|60.6|Full Range|||20.0|98.0|
3599313|NCT03022396|3452402|B6||Unknown or Not Reported|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|0|0.0||||||
3599314|NCT03022396|3452403|B5||Unknown or Not Reported|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|0|0.0||||||
3599315|NCT03022396|3452404|B4||Unknown or Not Reported|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|0|0.0||||||
3599316|NCT03022396|3452405|B3||Unknown or Not Reported|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|0|0.0||||||
3599317|NCT03022396|3452406|B2||Unknown or Not Reported|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|1|1.0||||||
3599318|NCT03022396|3452407|B1||Unknown or Not Reported|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|0|0.0||||||
3599319|NCT03022396|3452401|B7||More than one race|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|10|10.0||||||
3599320|NCT03022396|3452402|B6||More than one race|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|0|0.0||||||
3599321|NCT03022396|3452403|B5||More than one race|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|1|1.0||||||
3599322|NCT03022396|3452404|B4||More than one race|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|0|0.0||||||
3599323|NCT03022396|3452405|B3||More than one race|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|1|1.0||||||
3599324|NCT03022396|3452406|B2||More than one race|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|2|2.0||||||
3599325|NCT03022396|3452407|B1||More than one race|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|6|6.0||||||
3599326|NCT03022396|3452401|B7||White|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|60|60.0||||||
3599327|NCT03022396|3452402|B6||White|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|8|8.0||||||
3599328|NCT03022396|3452403|B5||White|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|8|8.0||||||
3599329|NCT03022396|3452404|B4||White|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|19|19.0||||||
3599330|NCT03022396|3452405|B3||White|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|6|6.0||||||
3599331|NCT03022396|3452406|B2||White|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|9|9.0||||||
3599332|NCT03022396|3452407|B1||White|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|10|10.0||||||
3599333|NCT03022396|3452401|B7||Black or African American|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|4|4.0||||||
3599334|NCT03022396|3452402|B6||Black or African American|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|0|0.0||||||
3599411|NCT03021343|3452433|B2|||Age||years|Mean|60.5|60.5|Full Range|||23.0|98.0|
3599335|NCT03022396|3452403|B5||Black or African American|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|4|4.0||||||
3599336|NCT03022396|3452404|B4||Black or African American|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|0|0.0||||||
3599337|NCT03022396|3452405|B3||Black or African American|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|0|0.0||||||
3599338|NCT03022396|3452406|B2||Black or African American|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|0|0.0||||||
3599339|NCT03022396|3452407|B1||Black or African American|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|0|0.0||||||
3599340|NCT03022396|3452401|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|0|0.0||||||
3599341|NCT03022396|3452402|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|0|0.0||||||
3599342|NCT03022396|3452403|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|0|0.0||||||
3599343|NCT03022396|3452404|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|0|0.0||||||
3599344|NCT03022396|3452405|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|0|0.0||||||
3599345|NCT03022396|3452406|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|0|0.0||||||
3599346|NCT03022396|3452407|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|0|0.0||||||
3599347|NCT03022396|3452401|B7||Asian|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|6|6.0||||||
3599348|NCT03022396|3452402|B6||Asian|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|0|0.0||||||
3599349|NCT03022396|3452403|B5||Asian|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|1|1.0||||||
3599350|NCT03022396|3452404|B4||Asian|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|0|0.0||||||
3599351|NCT03022396|3452405|B3||Asian|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|3|3.0||||||
3599352|NCT03022396|3452406|B2||Asian|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|2|2.0||||||
3599353|NCT03022396|3452407|B1||Asian|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|0|0.0||||||
3599354|NCT03022396|3452401|B7||American Indian or Alaska Native|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|1|1.0||||||
3599355|NCT03022396|3452402|B6||American Indian or Alaska Native|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|0|0.0||||||
3599356|NCT03022396|3452403|B5||American Indian or Alaska Native|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|0|0.0||||||
3599357|NCT03022396|3452404|B4||American Indian or Alaska Native|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|1|1.0||||||
3599358|NCT03022396|3452405|B3||American Indian or Alaska Native|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|0|0.0||||||
3599359|NCT03022396|3452406|B2||American Indian or Alaska Native|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|0|0.0||||||
3599360|NCT03022396|3452407|B1||American Indian or Alaska Native|Race (NIH/OMB)|The Race is inconsistent in Group D because identical twins self reported differently from each other. One identical twin reported Hispanic and American Indian and the other identical twin said Hispanic and Caucasian.|Participants|Count of Participants|0|0.0||||||
3599361|NCT03022396|3452401|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599362|NCT03022396|3452402|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599363|NCT03022396|3452403|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599364|NCT03022396|3452404|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599365|NCT03022396|3452405|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599366|NCT03022396|3452406|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599367|NCT03022396|3452407|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599368|NCT03022396|3452401|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
3599369|NCT03022396|3452402|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3599370|NCT03022396|3452403|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3599371|NCT03022396|3452404|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3599372|NCT03022396|3452405|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3599373|NCT03022396|3452406|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3599374|NCT03022396|3452407|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3599375|NCT03022396|3452401|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3599376|NCT03022396|3452402|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599377|NCT03022396|3452403|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599378|NCT03022396|3452404|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3599379|NCT03022396|3452405|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3599380|NCT03022396|3452406|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3599381|NCT03022396|3452407|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599382|NCT03022396|3452401|B7||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3599383|NCT03022396|3452402|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3599384|NCT03022396|3452403|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3599385|NCT03022396|3452404|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3599386|NCT03022396|3452405|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3599387|NCT03022396|3452406|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3599388|NCT03022396|3452407|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3599389|NCT03022396|3452401|B7||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3599390|NCT03022396|3452402|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3599391|NCT03022396|3452403|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3599392|NCT03022396|3452404|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3599393|NCT03022396|3452405|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3599394|NCT03022396|3452406|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3599395|NCT03022396|3452407|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3599396|NCT03022396|3452401|B7|||Age||years|Mean|37.70|37.7|Standard Deviation|19.94|19.94|||
3599397|NCT03022396|3452402|B6|||Age||years|Mean|75.51|75.51|Standard Deviation|4.50|4.5|||
3599398|NCT03022396|3452403|B5|||Age||years|Mean|44.52|44.52|Standard Deviation|1.68|1.68|||
3599399|NCT03022396|3452404|B4|||Age||years|Mean|53.44|53.44|Standard Deviation|2.25|2.25|||
3599400|NCT03022396|3452405|B3|||Age||years|Mean|22.65|22.65|Standard Deviation|2.99|2.99|||
3599401|NCT03022396|3452406|B2|||Age||years|Mean|23.71|23.71|Standard Deviation|3.33|3.33|||
3599402|NCT03022396|3452407|B1|||Age||years|Mean|13.69|13.69|Standard Deviation|1.88|1.88|||
3599403|NCT03021343|3452432|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3599404|NCT03021343|3452432|B3||Male|Sex: Female, Male||Participants|Count of Participants|284|284.0||||||
3599405|NCT03021343|3452433|B2||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3599406|NCT03021343|3452434|B1||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3599407|NCT03021343|3452432|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3599408|NCT03021343|3452433|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3599412|NCT03021343|3452434|B1|||Age||years|Mean|60.8|60.8|Full Range|||20.0|82.0|
3599413|NCT03021304|3452443|B1|White Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
3599414|NCT03021304|3452443|B1|Black Or African American Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3599415|NCT03021304|3452443|B1|Asian- Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3599416|NCT03021304|3452443|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3599417|NCT03021304|3452443|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3599418|NCT03021304|3452443|B1|||Age||Years|Mean|50.8|50.8|Standard Deviation|12.98|12.98|||
3599419|NCT03020576|3452448|B3|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3599420|NCT03020576|3452449|B2|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3599421|NCT03020576|3452450|B1|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3599422|NCT03020576|3452448|B3|Austria||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3599423|NCT03020576|3452449|B2|Austria||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3599424|NCT03020576|3452450|B1|Austria||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3599425|NCT03020576|3452448|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3599426|NCT03020576|3452449|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3599427|NCT03020576|3452450|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3599428|NCT03020576|3452448|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3599429|NCT03020576|3452449|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3599430|NCT03020576|3452450|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3599431|NCT03020576|3452448|B3|||Age||years|Mean|57.13|57.13|Standard Deviation|15.10|15.1|||
3599432|NCT03020576|3452449|B2|||Age||years|Mean|54.57|54.57|Standard Deviation|13.8|13.8|||
3599433|NCT03020576|3452450|B1|||Age||years|Mean|58.14|58.14|Standard Deviation|17.9|17.9|||
3599434|NCT03020537|3452471|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3599435|NCT03020537|3452472|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3599436|NCT03020537|3452473|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3599437|NCT03020537|3452471|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599438|NCT03020537|3452472|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599439|NCT03020537|3452473|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599440|NCT03020537|3452471|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3599441|NCT03020537|3452472|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3599442|NCT03020537|3452473|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3599443|NCT03020537|3452471|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3599444|NCT03020537|3452472|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3599445|NCT03020537|3452473|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599446|NCT03020537|3452471|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599447|NCT03020537|3452472|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599448|NCT03020537|3452473|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599449|NCT03020537|3452471|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599450|NCT03020537|3452472|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599451|NCT03020537|3452473|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599452|NCT03020537|3452471|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3599453|NCT03020537|3452472|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3599454|NCT03020537|3452473|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599455|NCT03020537|3452471|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599456|NCT03020537|3452472|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599457|NCT03020537|3452473|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599458|NCT03020537|3452471|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599459|NCT03020537|3452472|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599460|NCT03020537|3452473|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599461|NCT03020537|3452471|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3599462|NCT03020537|3452472|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3599463|NCT03020537|3452473|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3599464|NCT03020537|3452471|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3599465|NCT03020537|3452472|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3599466|NCT03020537|3452473|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599467|NCT03020537|3452471|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3599468|NCT03020537|3452472|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3599469|NCT03020537|3452473|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3599470|NCT03020537|3452471|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3599471|NCT03020537|3452472|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3599472|NCT03020537|3452473|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3599473|NCT03020537|3452471|B3|||Age||years|Mean|24.025|24.025|Standard Deviation|9.98|9.98|||
3599474|NCT03020537|3452472|B2|||Age||years|Mean|27.29|27.29|Standard Deviation|4.066|4.066|||
3599475|NCT03020537|3452473|B1|||Age||years|Mean|1.128|1.128|Standard Deviation|0|0.0|||
3599476|NCT03020498|3452482|B4|United States||Region of Enrollment||participants|Number|91|91.0||||||
3599477|NCT03020498|3452483|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
3599478|NCT03020498|3452484|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
3599479|NCT03020498|3452485|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3599480|NCT03020498|3452482|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3599481|NCT03020498|3452483|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599482|NCT03020498|3452484|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3599483|NCT03020498|3452485|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599484|NCT03020498|3452482|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3599485|NCT03020498|3452483|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599486|NCT03020498|3452484|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3599487|NCT03020498|3452485|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3599488|NCT03020498|3452482|B4||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3599489|NCT03020498|3452483|B3||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3599490|NCT03020498|3452484|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3599491|NCT03020498|3452485|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3599492|NCT03020498|3452482|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3599493|NCT03020498|3452483|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599494|NCT03020498|3452484|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3599495|NCT03020498|3452485|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599496|NCT03020498|3452482|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599497|NCT03020498|3452483|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599498|NCT03020498|3452484|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599499|NCT03020498|3452485|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599500|NCT03020498|3452482|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3599501|NCT03020498|3452483|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599502|NCT03020498|3452484|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3599503|NCT03020498|3452485|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599504|NCT03020498|3452482|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599505|NCT03020498|3452483|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599506|NCT03020498|3452484|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599507|NCT03020498|3452485|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599508|NCT03020498|3452482|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599509|NCT03020498|3452483|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599510|NCT03020498|3452484|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599511|NCT03020498|3452485|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599512|NCT03020498|3452482|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3599513|NCT03020498|3452483|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3599514|NCT03020498|3452484|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3599515|NCT03020498|3452485|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3599516|NCT03020498|3452482|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3599517|NCT03020498|3452483|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599518|NCT03020498|3452484|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3599519|NCT03020498|3452485|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3599520|NCT03020498|3452482|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3599521|NCT03020498|3452483|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3599522|NCT03020498|3452484|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3599523|NCT03020498|3452485|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3599524|NCT03020498|3452482|B4||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3599525|NCT03020498|3452483|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3599526|NCT03020498|3452484|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3599527|NCT03020498|3452485|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3599528|NCT03020498|3452482|B4|||Age||years|Mean|42.27|42.27|Standard Deviation|28.86|28.86|||
3599529|NCT03020498|3452483|B3|||Age||years|Mean|77.00|77.0|Standard Deviation|5.313|5.313|||
3599530|NCT03020498|3452484|B2|||Age||years|Mean|21.82|21.82|Standard Deviation|5.32|5.32|||
3599531|NCT03020498|3452485|B1|||Age||years|Mean|12.84|12.84|Standard Deviation|3.53|3.53|||
3599532|NCT03020472|3452498|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3599533|NCT03020472|3452498|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3599534|NCT03020472|3452498|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599535|NCT03020472|3452498|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3599536|NCT03020472|3452498|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599537|NCT03020472|3452498|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599538|NCT03020472|3452498|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599539|NCT03020472|3452498|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599540|NCT03020472|3452498|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599541|NCT03020472|3452498|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3599542|NCT03020472|3452498|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3599543|NCT03020472|3452498|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3599544|NCT03020472|3452498|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3599545|NCT03020472|3452498|B1|||Age||years|Mean|2.4|2.4|Standard Deviation|0.1|0.1|||
3599546|NCT03020160|3452504|B3||>1 Target Joints|Number of Participants with 0, 1, or >1 Target Joints in the Last 24 Weeks Prior to Study Entry|A target joint was defined as a a joint location where at least 3 bleeds have occurred over the last 24 weeks prior to study entry.|Participants|Count of Participants|21|21.0||||||
3599547|NCT03020160|3452505|B2||>1 Target Joints|Number of Participants with 0, 1, or >1 Target Joints in the Last 24 Weeks Prior to Study Entry|A target joint was defined as a a joint location where at least 3 bleeds have occurred over the last 24 weeks prior to study entry.|Participants|Count of Participants|17|17.0||||||
3599548|NCT03020160|3452506|B1||>1 Target Joints|Number of Participants with 0, 1, or >1 Target Joints in the Last 24 Weeks Prior to Study Entry|A target joint was defined as a a joint location where at least 3 bleeds have occurred over the last 24 weeks prior to study entry.|Participants|Count of Participants|4|4.0||||||
3599549|NCT03020160|3452504|B3||1 Target Joint|Number of Participants with 0, 1, or >1 Target Joints in the Last 24 Weeks Prior to Study Entry|A target joint was defined as a a joint location where at least 3 bleeds have occurred over the last 24 weeks prior to study entry.|Participants|Count of Participants|10|10.0||||||
3599550|NCT03020160|3452505|B2||1 Target Joint|Number of Participants with 0, 1, or >1 Target Joints in the Last 24 Weeks Prior to Study Entry|A target joint was defined as a a joint location where at least 3 bleeds have occurred over the last 24 weeks prior to study entry.|Participants|Count of Participants|8|8.0||||||
3599551|NCT03020160|3452506|B1||1 Target Joint|Number of Participants with 0, 1, or >1 Target Joints in the Last 24 Weeks Prior to Study Entry|A target joint was defined as a a joint location where at least 3 bleeds have occurred over the last 24 weeks prior to study entry.|Participants|Count of Participants|2|2.0||||||
3599552|NCT03020160|3452504|B3||0 Target Joints|Number of Participants with 0, 1, or >1 Target Joints in the Last 24 Weeks Prior to Study Entry|A target joint was defined as a a joint location where at least 3 bleeds have occurred over the last 24 weeks prior to study entry.|Participants|Count of Participants|17|17.0||||||
3599553|NCT03020160|3452505|B2||0 Target Joints|Number of Participants with 0, 1, or >1 Target Joints in the Last 24 Weeks Prior to Study Entry|A target joint was defined as a a joint location where at least 3 bleeds have occurred over the last 24 weeks prior to study entry.|Participants|Count of Participants|16|16.0||||||
3599554|NCT03020160|3452506|B1||0 Target Joints|Number of Participants with 0, 1, or >1 Target Joints in the Last 24 Weeks Prior to Study Entry|A target joint was defined as a a joint location where at least 3 bleeds have occurred over the last 24 weeks prior to study entry.|Participants|Count of Participants|1|1.0||||||
3599555|NCT03020160|3452504|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3599556|NCT03020160|3452505|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3599557|NCT03020160|3452506|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599558|NCT03020160|3452504|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599559|NCT03020160|3452505|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599560|NCT03020160|3452506|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599561|NCT03020160|3452504|B3||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3599562|NCT03020160|3452505|B2||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3599563|NCT03020160|3452506|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3599564|NCT03020160|3452504|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3599565|NCT03020160|3452505|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3599566|NCT03020160|3452506|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599567|NCT03020160|3452504|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599568|NCT03020160|3452505|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599569|NCT03020160|3452506|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599570|NCT03020160|3452504|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3599571|NCT03020160|3452505|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3599572|NCT03020160|3452506|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3599573|NCT03020160|3452504|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599574|NCT03020160|3452505|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599575|NCT03020160|3452506|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599576|NCT03020160|3452504|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3599577|NCT03020160|3452505|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3599578|NCT03020160|3452506|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599579|NCT03020160|3452504|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3599580|NCT03020160|3452505|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3599581|NCT03020160|3452506|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3599582|NCT03020160|3452504|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3599583|NCT03020160|3452505|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3599584|NCT03020160|3452506|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3599585|NCT03020160|3452504|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3599586|NCT03020160|3452505|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3599587|NCT03020160|3452506|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3599588|NCT03020160|3452504|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3599589|NCT03020160|3452505|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3599590|NCT03020160|3452506|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3599591|NCT03020160|3452504|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3599592|NCT03020160|3452505|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3599593|NCT03020160|3452506|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3599594|NCT03020160|3452504|B3||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3599595|NCT03020160|3452505|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3599596|NCT03020160|3452506|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3599597|NCT03020160|3452504|B3||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3599598|NCT03020160|3452505|B2||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3599599|NCT03020160|3452506|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3599600|NCT03020004|3452560|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599601|NCT03020004|3452560|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599602|NCT03020004|3452560|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599603|NCT03020004|3452560|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599604|NCT03020004|3452560|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599605|NCT03020004|3452560|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3599606|NCT03020004|3452560|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599607|NCT03020004|3452560|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3599608|NCT03020004|3452560|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3599609|NCT03020004|3452560|B1|||Age||years|Mean|41.2|41.2|Standard Deviation|12.4|12.4|||
3599610|NCT03019783|3452564|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
3599611|NCT03019783|3452565|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
3599612|NCT03019783|3452566|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3599613|NCT03019783|3452564|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599614|NCT03019783|3452565|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599615|NCT03019783|3452566|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599616|NCT03019783|3452564|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599617|NCT03019783|3452565|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599618|NCT03019783|3452566|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599619|NCT03019783|3452564|B3||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3599620|NCT03019783|3452565|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3599621|NCT03019783|3452566|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3599622|NCT03019783|3452564|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3599623|NCT03019783|3452565|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3599624|NCT03019783|3452566|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3599625|NCT03019783|3452564|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599626|NCT03019783|3452565|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599744|NCT03017235|3452613|B1|||Age||Years|Mean|57.2|57.2|Standard Deviation|11.04|11.04|||
3599627|NCT03019783|3452566|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599628|NCT03019783|3452564|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599629|NCT03019783|3452565|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599630|NCT03019783|3452566|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599631|NCT03019783|3452564|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599632|NCT03019783|3452565|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599633|NCT03019783|3452566|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599634|NCT03019783|3452564|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3599635|NCT03019783|3452565|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3599636|NCT03019783|3452566|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3599637|NCT03019783|3452564|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3599638|NCT03019783|3452565|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3599639|NCT03019783|3452566|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3599640|NCT03019783|3452564|B3|||Age||years|Mean|53|53.0|Standard Deviation|6|6.0|||
3599641|NCT03019783|3452565|B2|||Age||years|Mean|53|53.0|Standard Deviation|6|6.0|||
3599642|NCT03019783|3452566|B1|||Age||years|Mean|53|53.0|Standard Deviation|6|6.0|||
3599643|NCT03019744|3452575|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3599644|NCT03019744|3452576|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3599645|NCT03019744|3452577|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3599646|NCT03019744|3452575|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3599647|NCT03019744|3452576|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3599648|NCT03019744|3452577|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3599649|NCT03019744|3452575|B3|||Age||years|Mean|66.6|66.6|Standard Deviation|13.3|13.3|||
3599650|NCT03019744|3452576|B2|||Age||years|Mean|67.1|67.1|Standard Deviation|13.8|13.8|||
3599651|NCT03019744|3452577|B1|||Age||years|Mean|66.2|66.2|Standard Deviation|12.9|12.9|||
3599652|NCT03018106|3452592|B3|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3599653|NCT03018106|3452593|B2|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3599654|NCT03018106|3452592|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599655|NCT03018106|3452593|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599656|NCT03018106|3452592|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599657|NCT03018106|3452593|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599658|NCT03018106|3452592|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599659|NCT03018106|3452593|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599660|NCT03018106|3452592|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599661|NCT03018106|3452593|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599662|NCT03018106|3452592|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599663|NCT03018106|3452593|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599664|NCT03018106|3452592|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3599665|NCT03018106|3452593|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3599666|NCT03018106|3452592|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599667|NCT03018106|3452593|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599668|NCT03018106|3452592|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599669|NCT03018106|3452593|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599670|NCT03018106|3452592|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3599671|NCT03018106|3452593|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3599672|NCT03018106|3452592|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599673|NCT03018106|3452593|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599674|NCT03018106|3452592|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3599675|NCT03018106|3452593|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3599676|NCT03018106|3452592|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3599677|NCT03018106|3452593|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3599678|NCT03018106|3452592|B3|||Age||years|Mean|51|51.0|Standard Deviation|0.0|0.0|||
3599679|NCT03018106|3452593|B2|||Age||years|Mean|51|51.0|Standard Deviation|0.0|0.0|||
3599680|NCT03018106|3452592|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3599681|NCT03018106|3452593|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3599682|NCT03018106|3452592|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3599683|NCT03018106|3452593|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3599684|NCT03018106|3452592|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3599685|NCT03018106|3452593|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3599745|NCT03017040|3452664|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3599686|NCT03017612|3452603|B1|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3599687|NCT03017612|3452603|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3599688|NCT03017612|3452603|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3599689|NCT03017612|3452603|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3599690|NCT03017612|3452603|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3599691|NCT03017612|3452603|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3599692|NCT03017612|3452603|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3599693|NCT03017612|3452603|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3599694|NCT03017612|3452603|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3599695|NCT03017612|3452603|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3599696|NCT03017612|3452603|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3599697|NCT03017235|3452611|B3|No||Child-bearing potential||Participants|Number|406|406.0||||||
3599698|NCT03017235|3452612|B2|No||Child-bearing potential||Participants|Number|203|203.0||||||
3599699|NCT03017235|3452613|B1|No||Child-bearing potential||Participants|Number|203|203.0||||||
3599700|NCT03017235|3452611|B3|Yes||Child-bearing potential||Participants|Number|96|96.0||||||
3599701|NCT03017235|3452612|B2|Yes||Child-bearing potential||Participants|Number|47|47.0||||||
3599702|NCT03017235|3452613|B1|Yes||Child-bearing potential||Participants|Number|49|49.0||||||
3599703|NCT03017235|3452611|B3|Child bearing potential||Child-bearing potential||Participants|Number|502|502.0||||||
3599704|NCT03017235|3452612|B2|Child bearing potential||Child-bearing potential||Participants|Number|250|250.0||||||
3599705|NCT03017235|3452613|B1|Child bearing potential||Child-bearing potential||Participants|Number|252|252.0||||||
3599706|NCT03017235|3452611|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3599707|NCT03017235|3452612|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3599708|NCT03017235|3452613|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3599709|NCT03017235|3452611|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3599710|NCT03017235|3452612|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3599711|NCT03017235|3452613|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3599712|NCT03017235|3452611|B3||White|Race (NIH/OMB)||Participants|Count of Participants|770|770.0||||||
3599713|NCT03017235|3452612|B2||White|Race (NIH/OMB)||Participants|Count of Participants|394|394.0||||||
3599714|NCT03017235|3452613|B1||White|Race (NIH/OMB)||Participants|Count of Participants|376|376.0||||||
3599715|NCT03017235|3452611|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
3599716|NCT03017235|3452612|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3599717|NCT03017235|3452613|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3599718|NCT03017235|3452611|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3599719|NCT03017235|3452612|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3599720|NCT03017235|3452613|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3599721|NCT03017235|3452611|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3599722|NCT03017235|3452612|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3599723|NCT03017235|3452613|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3599724|NCT03017235|3452611|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3599725|NCT03017235|3452612|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3599726|NCT03017235|3452613|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599727|NCT03017235|3452611|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3599728|NCT03017235|3452612|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3599729|NCT03017235|3452613|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599730|NCT03017235|3452611|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|761|761.0||||||
3599731|NCT03017235|3452612|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|381|381.0||||||
3599732|NCT03017235|3452613|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|380|380.0||||||
3599733|NCT03017235|3452611|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|139|139.0||||||
3599734|NCT03017235|3452612|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3599735|NCT03017235|3452613|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3599736|NCT03017235|3452611|B3||Male|Sex: Female, Male||Participants|Count of Participants|399|399.0||||||
3599737|NCT03017235|3452612|B2||Male|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
3599738|NCT03017235|3452613|B1||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
3599739|NCT03017235|3452611|B3||Female|Sex: Female, Male||Participants|Count of Participants|502|502.0||||||
3599740|NCT03017235|3452612|B2||Female|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
3599741|NCT03017235|3452613|B1||Female|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
3599742|NCT03017235|3452611|B3|||Age||Years|Mean|57.2|57.2|Standard Deviation|10.94|10.94|||
3599743|NCT03017235|3452612|B2|||Age||Years|Mean|57.1|57.1|Standard Deviation|10.85|10.85|||
3599746|NCT03017040|3452664|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599747|NCT03017040|3452664|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599748|NCT03017040|3452664|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3599749|NCT03017040|3452664|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599750|NCT03017040|3452664|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599751|NCT03017040|3452664|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599752|NCT03017040|3452664|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599753|NCT03017040|3452664|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599754|NCT03017040|3452664|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3599755|NCT03017040|3452664|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599756|NCT03017040|3452664|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3599757|NCT03017040|3452664|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3599758|NCT03017040|3452664|B1|||Age||years|Mean|47|47.0|Full Range|||47.0|47.0|
3599759|NCT03016078|3452675|B1|||Blistering||Number of blisters|Number|0|0.0||||||
3599760|NCT03016078|3452675|B1|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3599761|NCT03016078|3452675|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3599762|NCT03016078|3452675|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3599763|NCT03016078|3452675|B1|||Age||years|Mean|68.4|68.4|Standard Deviation|5.8|5.8|||
3599764|NCT03014674|3452686|B4||Black or African American and White|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3599765|NCT03014674|3452687|B3||Black or African American and White|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3599766|NCT03014674|3452688|B2||Black or African American and White|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3599767|NCT03014674|3452689|B1||Black or African American and White|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3599768|NCT03014674|3452686|B4||Asian and White|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3599769|NCT03014674|3452687|B3||Asian and White|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3599770|NCT03014674|3452688|B2||Asian and White|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3599771|NCT03014674|3452689|B1||Asian and White|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3599772|NCT03014674|3452686|B4||White/Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|186|186.0||||||
3599773|NCT03014674|3452687|B3||White/Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|61|61.0||||||
3599774|NCT03014674|3452688|B2||White/Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|61|61.0||||||
3599775|NCT03014674|3452689|B1||White/Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|64|64.0||||||
3599776|NCT03014674|3452686|B4||Arabic/ North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3599777|NCT03014674|3452687|B3||Arabic/ North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3599778|NCT03014674|3452688|B2||Arabic/ North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3599779|NCT03014674|3452689|B1||Arabic/ North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3599780|NCT03014674|3452686|B4||Native Hawaiian or other pacific islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3599781|NCT03014674|3452687|B3||Native Hawaiian or other pacific islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3599782|NCT03014674|3452688|B2||Native Hawaiian or other pacific islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3599783|NCT03014674|3452689|B1||Native Hawaiian or other pacific islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3599784|NCT03014674|3452686|B4||East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3599785|NCT03014674|3452687|B3||East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3599786|NCT03014674|3452688|B2||East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3599787|NCT03014674|3452689|B1||East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3599788|NCT03014674|3452686|B4||Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3599789|NCT03014674|3452687|B3||Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3599790|NCT03014674|3452688|B2||Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3599791|NCT03014674|3452689|B1||Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3599792|NCT03014674|3452686|B4||American Indian or Alaska native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3599793|NCT03014674|3452687|B3||American Indian or Alaska native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3599794|NCT03014674|3452688|B2||American Indian or Alaska native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3599795|NCT03014674|3452689|B1||American Indian or Alaska native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3599796|NCT03014674|3452686|B4||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
3599797|NCT03014674|3452687|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3599798|NCT03014674|3452688|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3599799|NCT03014674|3452689|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3599800|NCT03014674|3452686|B4||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3599801|NCT03014674|3452687|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3599802|NCT03014674|3452688|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3599803|NCT03014674|3452689|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3599804|NCT03014674|3452686|B4||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3599805|NCT03014674|3452687|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3599806|NCT03014674|3452688|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3599807|NCT03014674|3452689|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3599808|NCT03014674|3452686|B4|||Age||Years|Mean|46.7|46.7|Standard Deviation|14.95|14.95|||
3599809|NCT03014674|3452687|B3|||Age||Years|Mean|47.5|47.5|Standard Deviation|14.94|14.94|||
3599810|NCT03014674|3452688|B2|||Age||Years|Mean|46.5|46.5|Standard Deviation|15.00|15.0|||
3599811|NCT03014674|3452689|B1|||Age||Years|Mean|46.1|46.1|Standard Deviation|15.06|15.06|||
3599812|NCT03011099|3452753|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
3599813|NCT03011099|3452754|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3599814|NCT03011099|3452755|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3599815|NCT03011099|3452753|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3599816|NCT03011099|3452754|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3599817|NCT03011099|3452755|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3599818|NCT03011099|3452753|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3599819|NCT03011099|3452754|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3599820|NCT03011099|3452755|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3599821|NCT03011099|3452753|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3599822|NCT03011099|3452754|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3599823|NCT03011099|3452755|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3599824|NCT03011099|3452753|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3599825|NCT03011099|3452754|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3599826|NCT03011099|3452755|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3599827|NCT03011099|3452753|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3599828|NCT03011099|3452754|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3599829|NCT03011099|3452755|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3599830|NCT03010800|3452780|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3599831|NCT03010800|3452780|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3599832|NCT03010800|3452781|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3599833|NCT03010800|3452782|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3599834|NCT03010800|3452780|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3599835|NCT03010800|3452781|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3599836|NCT03010800|3452782|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3599837|NCT03010800|3452780|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3599838|NCT03010800|3452781|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3599839|NCT03010800|3452782|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3599840|NCT03010800|3452780|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3599841|NCT03010800|3452781|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3599842|NCT03010800|3452782|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3599843|NCT03010800|3452780|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3599844|NCT03010800|3452781|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3599845|NCT03010800|3452782|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3599846|NCT03005067|3452789|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599847|NCT03005067|3452790|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599848|NCT03005067|3452791|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599849|NCT03005067|3452789|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599850|NCT03005067|3452790|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599851|NCT03005067|3452791|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599852|NCT03005067|3452789|B3||White|Race (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
3599853|NCT03005067|3452790|B2||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3599854|NCT03005067|3452791|B1||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3599855|NCT03005067|3452789|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3599856|NCT03005067|3452790|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3599857|NCT03005067|3452791|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3599914|NCT03004638|3452822|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3599858|NCT03005067|3452789|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599859|NCT03005067|3452790|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599860|NCT03005067|3452791|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599861|NCT03005067|3452789|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3599862|NCT03005067|3452790|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599863|NCT03005067|3452791|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3599864|NCT03005067|3452789|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599865|NCT03005067|3452790|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599866|NCT03005067|3452791|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599867|NCT03005067|3452789|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3599868|NCT03005067|3452790|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3599869|NCT03005067|3452791|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3599870|NCT03005067|3452789|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3599871|NCT03005067|3452790|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3599872|NCT03005067|3452791|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3599873|NCT03005067|3452789|B3|||Age||Years|Mean|50.1|50.1|Standard Deviation|13.30|13.3|||
3599874|NCT03005067|3452790|B2|||Age||Years|Mean|50.3|50.3|Standard Deviation|12.60|12.6|||
3599875|NCT03005067|3452791|B1|||Age||Years|Mean|49.8|49.8|Standard Deviation|13.99|13.99|||
3599876|NCT03005041|3452804|B1||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
3599877|NCT03005041|3452804|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3599878|NCT03005041|3452804|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3599879|NCT03005041|3452804|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3599880|NCT03005041|3452804|B1|||Age||years|Mean|54.2|54.2|Standard Deviation|14.53|14.53|||
3599881|NCT03004638|3452817|B7||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3599882|NCT03004638|3452818|B6||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3599883|NCT03004638|3452819|B5||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3599884|NCT03004638|3452820|B4||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3599885|NCT03004638|3452821|B3||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3599886|NCT03004638|3452822|B2||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3599887|NCT03004638|3452823|B1||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3599888|NCT03004638|3452817|B7||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3599889|NCT03004638|3452818|B6||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3599890|NCT03004638|3452819|B5||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3599891|NCT03004638|3452820|B4||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3599892|NCT03004638|3452821|B3||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3599893|NCT03004638|3452822|B2||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3599894|NCT03004638|3452823|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3599895|NCT03004638|3452817|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599896|NCT03004638|3452818|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599897|NCT03004638|3452819|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599898|NCT03004638|3452820|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599899|NCT03004638|3452821|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599900|NCT03004638|3452822|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599901|NCT03004638|3452823|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599902|NCT03004638|3452817|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599903|NCT03004638|3452818|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599904|NCT03004638|3452819|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599905|NCT03004638|3452820|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599906|NCT03004638|3452821|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599907|NCT03004638|3452822|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599908|NCT03004638|3452823|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599909|NCT03004638|3452817|B7||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3599910|NCT03004638|3452818|B6||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3599911|NCT03004638|3452819|B5||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599912|NCT03004638|3452820|B4||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3599913|NCT03004638|3452821|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3599915|NCT03004638|3452823|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3599916|NCT03004638|3452817|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3599917|NCT03004638|3452818|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599918|NCT03004638|3452819|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3599919|NCT03004638|3452820|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3599920|NCT03004638|3452821|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599921|NCT03004638|3452822|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599922|NCT03004638|3452823|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3599923|NCT03004638|3452817|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599924|NCT03004638|3452818|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599925|NCT03004638|3452819|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599926|NCT03004638|3452820|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599927|NCT03004638|3452821|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599928|NCT03004638|3452822|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599929|NCT03004638|3452823|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599930|NCT03004638|3452817|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599931|NCT03004638|3452818|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599932|NCT03004638|3452819|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599933|NCT03004638|3452820|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599934|NCT03004638|3452821|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599935|NCT03004638|3452822|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599936|NCT03004638|3452823|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599937|NCT03004638|3452817|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599938|NCT03004638|3452818|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599939|NCT03004638|3452819|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599940|NCT03004638|3452820|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599941|NCT03004638|3452821|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599942|NCT03004638|3452822|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599943|NCT03004638|3452823|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599944|NCT03004638|3452817|B7||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3599945|NCT03004638|3452818|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3599946|NCT03004638|3452819|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3599947|NCT03004638|3452820|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3599948|NCT03004638|3452821|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3599949|NCT03004638|3452822|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3599950|NCT03004638|3452823|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3599951|NCT03004638|3452817|B7||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3599952|NCT03004638|3452818|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3599953|NCT03004638|3452819|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3599954|NCT03004638|3452820|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3599955|NCT03004638|3452821|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3599956|NCT03004638|3452822|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3599957|NCT03004638|3452823|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3599958|NCT03004638|3452817|B7|||Age||Years|Mean|68.2|68.2|Standard Deviation|3.9|3.9|||
3599959|NCT03004638|3452818|B6|||Age||Years|Mean|71.4|71.4|Standard Deviation|4.2|4.2|||
3599960|NCT03004638|3452819|B5|||Age||Years|Mean|65.0|65.0|Standard Deviation|NA||||Standard deviation was not applicable as only one participant was evaluable for this reporting group.
3599961|NCT03004638|3452820|B4|||Age||Years|Mean|66.2|66.2|Standard Deviation|2.6|2.6|||
3599962|NCT03004638|3452821|B3|||Age||Years|Mean|68.8|68.8|Standard Deviation|2.8|2.8|||
3599963|NCT03004638|3452822|B2|||Age||Years|Mean|66.7|66.7|Standard Deviation|3.3|3.3|||
3599964|NCT03004638|3452823|B1|||Age||Years|Mean|67.8|67.8|Standard Deviation|4.8|4.8|||
3599965|NCT03002623|3452934|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
3599966|NCT03002623|3452935|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3599967|NCT03002623|3452936|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3599968|NCT03002623|3452934|B3|Not meeting definition for Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3599969|NCT03002623|3452935|B2|Not meeting definition for Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3599970|NCT03002623|3452936|B1|Not meeting definition for Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3600029|NCT03001778|3452956|B3||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3599971|NCT03002623|3452934|B3|Mexican, Puerto Rican, Cuban, Central/So American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3599972|NCT03002623|3452935|B2|Mexican, Puerto Rican, Cuban, Central/So American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3599973|NCT03002623|3452936|B1|Mexican, Puerto Rican, Cuban, Central/So American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3599974|NCT03002623|3452934|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3599975|NCT03002623|3452935|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599976|NCT03002623|3452936|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3599977|NCT03002623|3452934|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599978|NCT03002623|3452935|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599979|NCT03002623|3452936|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599980|NCT03002623|3452934|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3599981|NCT03002623|3452935|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3599982|NCT03002623|3452936|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3599983|NCT03002623|3452934|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599984|NCT03002623|3452935|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599985|NCT03002623|3452936|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599986|NCT03002623|3452934|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599987|NCT03002623|3452935|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599988|NCT03002623|3452936|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599989|NCT03002623|3452934|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599990|NCT03002623|3452935|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599991|NCT03002623|3452936|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599992|NCT03002623|3452934|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599993|NCT03002623|3452935|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599994|NCT03002623|3452936|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3599995|NCT03002623|3452934|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3599996|NCT03002623|3452935|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3599997|NCT03002623|3452936|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3599998|NCT03002623|3452934|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3599999|NCT03002623|3452935|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3600000|NCT03002623|3452936|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3600001|NCT03002623|3452934|B3|||Age||years|Mean|62.5|62.5|Standard Deviation|16.15|16.15|||
3600002|NCT03002623|3452935|B2|||Age||years|Mean|66.6|66.6|Standard Deviation|1.39|1.39|||
3600003|NCT03002623|3452936|B1|||Age||years|Mean|59.5|59.5|Standard Deviation|19.18|19.18|||
3600004|NCT03002623|3452934|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3600005|NCT03002623|3452935|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3600006|NCT03002623|3452936|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3600007|NCT03002623|3452934|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3600008|NCT03002623|3452935|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3600009|NCT03002623|3452936|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3600010|NCT03002623|3452934|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3600011|NCT03002623|3452935|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3600012|NCT03002623|3452936|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3600013|NCT03002454|3452951|B1|Canada||Region of Enrollment||participants|Number|4|4.0||||||
3600014|NCT03002454|3452951|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3600015|NCT03002454|3452951|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3600016|NCT03002454|3452951|B1|||Age||years|Mean|61.5|61.5|Full Range|||44.0|75.0|
3600017|NCT03002454|3452951|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3600018|NCT03002454|3452951|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3600019|NCT03002454|3452951|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3600020|NCT03001778|3452956|B3|United States||Region of Enrollment||participants|Number|67|67.0||||||
3600021|NCT03001778|3452957|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
3600022|NCT03001778|3452958|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3600023|NCT03001778|3452956|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3600024|NCT03001778|3452957|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3600025|NCT03001778|3452958|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600026|NCT03001778|3452956|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600027|NCT03001778|3452957|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600028|NCT03001778|3452958|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600030|NCT03001778|3452957|B2||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3600031|NCT03001778|3452958|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3600032|NCT03001778|3452956|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3600033|NCT03001778|3452957|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600034|NCT03001778|3452958|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3600035|NCT03001778|3452956|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600036|NCT03001778|3452957|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600037|NCT03001778|3452958|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600038|NCT03001778|3452956|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600039|NCT03001778|3452957|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600040|NCT03001778|3452958|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600041|NCT03001778|3452956|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3600042|NCT03001778|3452957|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600043|NCT03001778|3452958|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3600044|NCT03001778|3452956|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3600045|NCT03001778|3452957|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3600046|NCT03001778|3452958|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3600047|NCT03001778|3452956|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3600048|NCT03001778|3452957|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3600049|NCT03001778|3452958|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3600050|NCT03001778|3452956|B3|||Age||years|Mean|NA||Standard Deviation|NA||||Data not collected
3600051|NCT03001778|3452957|B2|||Age||years|Mean|NA||Standard Deviation|NA||||Data not collected
3600052|NCT03001778|3452958|B1|||Age||years|Mean|NA||Standard Deviation|NA||||Data not collected
3600053|NCT03001674|3452965|B3|||Body Surface Area (BSA)||m^2|Mean|2.12|2.12|Standard Deviation|0.28|0.28|||
3600054|NCT03001674|3452966|B2|||Body Surface Area (BSA)||m^2|Mean|2.22|2.22|Standard Deviation|0.15|0.15|||
3600055|NCT03001674|3452967|B1|||Body Surface Area (BSA)||m^2|Mean|2.07|2.07|Standard Deviation|0.33|0.33|||
3600056|NCT03001674|3452965|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
3600057|NCT03001674|3452966|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3600058|NCT03001674|3452967|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3600059|NCT03001674|3452965|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3600060|NCT03001674|3452966|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3600061|NCT03001674|3452967|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3600062|NCT03001674|3452965|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3600063|NCT03001674|3452966|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3600064|NCT03001674|3452967|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3600065|NCT03001674|3452965|B3|||Age||years|Mean|56|56.0|Standard Deviation|13|13.0|||
3600066|NCT03001674|3452966|B2|||Age||years|Mean|54|54.0|Standard Deviation|13|13.0|||
3600067|NCT03001674|3452967|B1|||Age||years|Mean|57|57.0|Standard Deviation|14|14.0|||
3600068|NCT03001453|3452974|B3|||Exercise regularly||Participants|Count of Participants|30|30.0||||||
3600069|NCT03001453|3452975|B2|||Exercise regularly||Participants|Count of Participants|16|16.0||||||
3600070|NCT03001453|3452976|B1|||Exercise regularly||Participants|Count of Participants|14|14.0||||||
3600071|NCT03001453|3452974|B3|4||American Society of Anesthesiologists Grade|Patients were graded based on the American Society of Anesthesiologists Physical Status Classification System. 1 indicates a normal healthy patient, 2 is a patient with a mild systemic disease, 3 is a patient with a severe systemic disease, and 4 is a patient with a severe systemic disease that is a constant threat to life. Grade 1 is considered to be a better outcome while Grade 4 is considered to be a worse outcome.|Participants|Count of Participants|1|1.0||||||
3600072|NCT03001453|3452975|B2|4||American Society of Anesthesiologists Grade|Patients were graded based on the American Society of Anesthesiologists Physical Status Classification System. 1 indicates a normal healthy patient, 2 is a patient with a mild systemic disease, 3 is a patient with a severe systemic disease, and 4 is a patient with a severe systemic disease that is a constant threat to life. Grade 1 is considered to be a better outcome while Grade 4 is considered to be a worse outcome.|Participants|Count of Participants|1|1.0||||||
3600073|NCT03001453|3452976|B1|4||American Society of Anesthesiologists Grade|Patients were graded based on the American Society of Anesthesiologists Physical Status Classification System. 1 indicates a normal healthy patient, 2 is a patient with a mild systemic disease, 3 is a patient with a severe systemic disease, and 4 is a patient with a severe systemic disease that is a constant threat to life. Grade 1 is considered to be a better outcome while Grade 4 is considered to be a worse outcome.|Participants|Count of Participants|0|0.0||||||
3600074|NCT03001453|3452974|B3|3||American Society of Anesthesiologists Grade|Patients were graded based on the American Society of Anesthesiologists Physical Status Classification System. 1 indicates a normal healthy patient, 2 is a patient with a mild systemic disease, 3 is a patient with a severe systemic disease, and 4 is a patient with a severe systemic disease that is a constant threat to life. Grade 1 is considered to be a better outcome while Grade 4 is considered to be a worse outcome.|Participants|Count of Participants|37|37.0||||||
3600109|NCT03001453|3452975|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3600110|NCT03001453|3452976|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3600075|NCT03001453|3452975|B2|3||American Society of Anesthesiologists Grade|Patients were graded based on the American Society of Anesthesiologists Physical Status Classification System. 1 indicates a normal healthy patient, 2 is a patient with a mild systemic disease, 3 is a patient with a severe systemic disease, and 4 is a patient with a severe systemic disease that is a constant threat to life. Grade 1 is considered to be a better outcome while Grade 4 is considered to be a worse outcome.|Participants|Count of Participants|21|21.0||||||
3600076|NCT03001453|3452976|B1|3||American Society of Anesthesiologists Grade|Patients were graded based on the American Society of Anesthesiologists Physical Status Classification System. 1 indicates a normal healthy patient, 2 is a patient with a mild systemic disease, 3 is a patient with a severe systemic disease, and 4 is a patient with a severe systemic disease that is a constant threat to life. Grade 1 is considered to be a better outcome while Grade 4 is considered to be a worse outcome.|Participants|Count of Participants|16|16.0||||||
3600077|NCT03001453|3452974|B3|2||American Society of Anesthesiologists Grade|Patients were graded based on the American Society of Anesthesiologists Physical Status Classification System. 1 indicates a normal healthy patient, 2 is a patient with a mild systemic disease, 3 is a patient with a severe systemic disease, and 4 is a patient with a severe systemic disease that is a constant threat to life. Grade 1 is considered to be a better outcome while Grade 4 is considered to be a worse outcome.|Participants|Count of Participants|57|57.0||||||
3600078|NCT03001453|3452975|B2|2||American Society of Anesthesiologists Grade|Patients were graded based on the American Society of Anesthesiologists Physical Status Classification System. 1 indicates a normal healthy patient, 2 is a patient with a mild systemic disease, 3 is a patient with a severe systemic disease, and 4 is a patient with a severe systemic disease that is a constant threat to life. Grade 1 is considered to be a better outcome while Grade 4 is considered to be a worse outcome.|Participants|Count of Participants|31|31.0||||||
3600079|NCT03001453|3452976|B1|2||American Society of Anesthesiologists Grade|Patients were graded based on the American Society of Anesthesiologists Physical Status Classification System. 1 indicates a normal healthy patient, 2 is a patient with a mild systemic disease, 3 is a patient with a severe systemic disease, and 4 is a patient with a severe systemic disease that is a constant threat to life. Grade 1 is considered to be a better outcome while Grade 4 is considered to be a worse outcome.|Participants|Count of Participants|26|26.0||||||
3600080|NCT03001453|3452974|B3|1||American Society of Anesthesiologists Grade|Patients were graded based on the American Society of Anesthesiologists Physical Status Classification System. 1 indicates a normal healthy patient, 2 is a patient with a mild systemic disease, 3 is a patient with a severe systemic disease, and 4 is a patient with a severe systemic disease that is a constant threat to life. Grade 1 is considered to be a better outcome while Grade 4 is considered to be a worse outcome.|Participants|Count of Participants|12|12.0||||||
3600081|NCT03001453|3452975|B2|1||American Society of Anesthesiologists Grade|Patients were graded based on the American Society of Anesthesiologists Physical Status Classification System. 1 indicates a normal healthy patient, 2 is a patient with a mild systemic disease, 3 is a patient with a severe systemic disease, and 4 is a patient with a severe systemic disease that is a constant threat to life. Grade 1 is considered to be a better outcome while Grade 4 is considered to be a worse outcome.|Participants|Count of Participants|4|4.0||||||
3600082|NCT03001453|3452976|B1|1||American Society of Anesthesiologists Grade|Patients were graded based on the American Society of Anesthesiologists Physical Status Classification System. 1 indicates a normal healthy patient, 2 is a patient with a mild systemic disease, 3 is a patient with a severe systemic disease, and 4 is a patient with a severe systemic disease that is a constant threat to life. Grade 1 is considered to be a better outcome while Grade 4 is considered to be a worse outcome.|Participants|Count of Participants|8|8.0||||||
3600083|NCT03001453|3452974|B3|Oxycodone||Preoperative opioid prescription||Participants|Count of Participants|3|3.0||||||
3600084|NCT03001453|3452975|B2|Oxycodone||Preoperative opioid prescription||Participants|Count of Participants|2|2.0||||||
3600085|NCT03001453|3452976|B1|Oxycodone||Preoperative opioid prescription||Participants|Count of Participants|1|1.0||||||
3600086|NCT03001453|3452974|B3|Hydromorphine||Preoperative opioid prescription||Participants|Count of Participants|1|1.0||||||
3600087|NCT03001453|3452975|B2|Hydromorphine||Preoperative opioid prescription||Participants|Count of Participants|1|1.0||||||
3600088|NCT03001453|3452976|B1|Hydromorphine||Preoperative opioid prescription||Participants|Count of Participants|0|0.0||||||
3600089|NCT03001453|3452974|B3|Hydrocodone||Preoperative opioid prescription||Participants|Count of Participants|12|12.0||||||
3600090|NCT03001453|3452975|B2|Hydrocodone||Preoperative opioid prescription||Participants|Count of Participants|7|7.0||||||
3600091|NCT03001453|3452976|B1|Hydrocodone||Preoperative opioid prescription||Participants|Count of Participants|5|5.0||||||
3600092|NCT03001453|3452974|B3|Codeine||Preoperative opioid prescription||Participants|Count of Participants|1|1.0||||||
3600093|NCT03001453|3452975|B2|Codeine||Preoperative opioid prescription||Participants|Count of Participants|0|0.0||||||
3600094|NCT03001453|3452976|B1|Codeine||Preoperative opioid prescription||Participants|Count of Participants|1|1.0||||||
3600095|NCT03001453|3452974|B3|||Robotic assistance||Participants|Count of Participants|86|86.0||||||
3600096|NCT03001453|3452975|B2|||Robotic assistance||Participants|Count of Participants|44|44.0||||||
3600097|NCT03001453|3452976|B1|||Robotic assistance||Participants|Count of Participants|42|42.0||||||
3600098|NCT03001453|3452974|B3|Right||Laterality||hips|Number|58|58.0||||||
3600099|NCT03001453|3452975|B2|Right||Laterality||hips|Number|27|27.0||||||
3600100|NCT03001453|3452976|B1|Right||Laterality||hips|Number|31|31.0||||||
3600101|NCT03001453|3452974|B3|Left||Laterality||hips|Number|49|49.0||||||
3600102|NCT03001453|3452975|B2|Left||Laterality||hips|Number|30|30.0||||||
3600103|NCT03001453|3452976|B1|Left||Laterality||hips|Number|19|19.0||||||
3600104|NCT03001453|3452974|B3|||Body Mass Index||kg/m^2|Mean|30.1|30.1|Full Range|||18.6|55.4|
3600105|NCT03001453|3452975|B2|||Body Mass Index||kg/m^2|Mean|31|31.0|Full Range|||19.5|55.4|
3600106|NCT03001453|3452976|B1|||Body Mass Index||kg/m^2|Mean|29.2|29.2|Full Range|||18.6|46.0|
3600107|NCT03001453|3452974|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3600108|NCT03001453|3452974|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3600111|NCT03001453|3452974|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3600112|NCT03001453|3452975|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3600113|NCT03001453|3452976|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3600114|NCT03001453|3452974|B3|||Age||years|Mean|62.1|62.1|Full Range|||33.7|82.1|
3600115|NCT03001453|3452975|B2|||Age||years|Mean|62.4|62.4|Full Range|||33.7|82.1|
3600116|NCT03001453|3452976|B1|||Age||years|Mean|61.9|61.9|Full Range|||41.8|80.0|
3600117|NCT03001258|3452991|B4||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
3600118|NCT03001258|3452992|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3600119|NCT03001258|3452993|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3600120|NCT03001258|3452994|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3600121|NCT03001258|3452991|B4||Female|Sex: Female, Male||Participants|Count of Participants|913|913.0||||||
3600122|NCT03001258|3452992|B3||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
3600123|NCT03001258|3452993|B2||Female|Sex: Female, Male||Participants|Count of Participants|385|385.0||||||
3600124|NCT03001258|3452994|B1||Female|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
3600125|NCT03001258|3452991|B4|≥ 55||Age, Customized||participants|Number|162|162.0||||||
3600126|NCT03001258|3452992|B3|≥ 55||Age, Customized||participants|Number|41|41.0||||||
3600127|NCT03001258|3452993|B2|≥ 55||Age, Customized||participants|Number|62|62.0||||||
3600128|NCT03001258|3452994|B1|≥ 55||Age, Customized||participants|Number|59|59.0||||||
3600129|NCT03001258|3452991|B4|50-54||Age, Customized||participants|Number|178|178.0||||||
3600130|NCT03001258|3452992|B3|50-54||Age, Customized||participants|Number|47|47.0||||||
3600131|NCT03001258|3452993|B2|50-54||Age, Customized||participants|Number|64|64.0||||||
3600132|NCT03001258|3452994|B1|50-54||Age, Customized||participants|Number|67|67.0||||||
3600133|NCT03001258|3452991|B4|45-49||Age, Customized||participants|Number|261|261.0||||||
3600134|NCT03001258|3452992|B3|45-49||Age, Customized||participants|Number|65|65.0||||||
3600135|NCT03001258|3452993|B2|45-49||Age, Customized||participants|Number|108|108.0||||||
3600136|NCT03001258|3452994|B1|45-49||Age, Customized||participants|Number|88|88.0||||||
3600137|NCT03001258|3452991|B4|40-44||Age, Customized||participants|Number|324|324.0||||||
3600138|NCT03001258|3452992|B3|40-44||Age, Customized||participants|Number|52|52.0||||||
3600139|NCT03001258|3452993|B2|40-44||Age, Customized||participants|Number|146|146.0||||||
3600140|NCT03001258|3452994|B1|40-44||Age, Customized||participants|Number|126|126.0||||||
3600141|NCT03001258|3452991|B4|<40||Age, Customized||participants|Number|169|169.0||||||
3600142|NCT03001258|3452992|B3|<40||Age, Customized||participants|Number|45|45.0||||||
3600143|NCT03001258|3452993|B2|<40||Age, Customized||participants|Number|64|64.0||||||
3600144|NCT03001258|3452994|B1|<40||Age, Customized||participants|Number|60|60.0||||||
3600145|NCT03000452|3453004|B1|||Number of Prior Regimens||Regimens|Median|4.5|4.5|Full Range|||3.0|16.0|
3600146|NCT03000452|3453004|B1||Missing|International Staging System Multiple Myeloma Stage at Entry|The International Staging System divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels. Stage I: Serum beta-2 microglobulin is less than 3.5 (mg/L) and the albumin level is above 3.5 (g/L); Stage II: Neither stage I or III, meaning that either: # The beta-2 microglobulin level is between 3.5 and 5.5 (with any albumin level), OR # The albumin is below 3.5 while the beta-2 microglobulin is less than 3.5 Stage III: Serum beta-2 microglobulin is greater than 5.5.|Participants|Count of Participants|0|0.0||||||
3600147|NCT03000452|3453004|B1||Stage III|International Staging System Multiple Myeloma Stage at Entry|The International Staging System divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels. Stage I: Serum beta-2 microglobulin is less than 3.5 (mg/L) and the albumin level is above 3.5 (g/L); Stage II: Neither stage I or III, meaning that either: # The beta-2 microglobulin level is between 3.5 and 5.5 (with any albumin level), OR # The albumin is below 3.5 while the beta-2 microglobulin is less than 3.5 Stage III: Serum beta-2 microglobulin is greater than 5.5.|Participants|Count of Participants|9|9.0||||||
3600148|NCT03000452|3453004|B1||Stage II|International Staging System Multiple Myeloma Stage at Entry|The International Staging System divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels. Stage I: Serum beta-2 microglobulin is less than 3.5 (mg/L) and the albumin level is above 3.5 (g/L); Stage II: Neither stage I or III, meaning that either: # The beta-2 microglobulin level is between 3.5 and 5.5 (with any albumin level), OR # The albumin is below 3.5 while the beta-2 microglobulin is less than 3.5 Stage III: Serum beta-2 microglobulin is greater than 5.5.|Participants|Count of Participants|4|4.0||||||
3600149|NCT03000452|3453004|B1||Stage I|International Staging System Multiple Myeloma Stage at Entry|The International Staging System divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels. Stage I: Serum beta-2 microglobulin is less than 3.5 (mg/L) and the albumin level is above 3.5 (g/L); Stage II: Neither stage I or III, meaning that either: # The beta-2 microglobulin level is between 3.5 and 5.5 (with any albumin level), OR # The albumin is below 3.5 while the beta-2 microglobulin is less than 3.5 Stage III: Serum beta-2 microglobulin is greater than 5.5.|Participants|Count of Participants|5|5.0||||||
3600150|NCT03000452|3453004|B1||3 = Limited Self-Care|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG PS is used by physicians and researchers to assess how a subject's disease is progressing, and how the disease affects the daily living activities and determine appropriate treatment and prognosis. 0 = Fully Active, able to carry on all pre-disease performance without restriction; 1 = Restricted, in physically strenuous activity but ambulatory; 2 = Ambulatory and capable of all self-care; unable to carry out work activities. 3 = Capable of only limited self-care, confined to bed or chair >50% of waking hours 4 = Completely Disabled, cannot carry on any self-care 5 = Dead|Participants|Count of Participants|0|0.0||||||
3600189|NCT03000088|3453020|B3|||Mouth opening||cm|Median|5.3|5.3|Standard Deviation|1.0|1.0|||
3600190|NCT03000088|3453021|B2|||Mouth opening||cm|Median|5.2|5.2|Standard Deviation|0.9|0.9|||
3600151|NCT03000452|3453004|B1||2 = Ambulatory but unable to work|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG PS is used by physicians and researchers to assess how a subject's disease is progressing, and how the disease affects the daily living activities and determine appropriate treatment and prognosis. 0 = Fully Active, able to carry on all pre-disease performance without restriction; 1 = Restricted, in physically strenuous activity but ambulatory; 2 = Ambulatory and capable of all self-care; unable to carry out work activities. 3 = Capable of only limited self-care, confined to bed or chair >50% of waking hours 4 = Completely Disabled, cannot carry on any self-care 5 = Dead|Participants|Count of Participants|1|1.0||||||
3600152|NCT03000452|3453004|B1||1 = Restrictive but ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG PS is used by physicians and researchers to assess how a subject's disease is progressing, and how the disease affects the daily living activities and determine appropriate treatment and prognosis. 0 = Fully Active, able to carry on all pre-disease performance without restriction; 1 = Restricted, in physically strenuous activity but ambulatory; 2 = Ambulatory and capable of all self-care; unable to carry out work activities. 3 = Capable of only limited self-care, confined to bed or chair >50% of waking hours 4 = Completely Disabled, cannot carry on any self-care 5 = Dead|Participants|Count of Participants|5|5.0||||||
3600153|NCT03000452|3453004|B1||0 = Fully Active|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG PS is used by physicians and researchers to assess how a subject's disease is progressing, and how the disease affects the daily living activities and determine appropriate treatment and prognosis. 0 = Fully Active, able to carry on all pre-disease performance without restriction; 1 = Restricted, in physically strenuous activity but ambulatory; 2 = Ambulatory and capable of all self-care; unable to carry out work activities. 3 = Capable of only limited self-care, confined to bed or chair >50% of waking hours 4 = Completely Disabled, cannot carry on any self-care 5 = Dead|Participants|Count of Participants|12|12.0||||||
3600154|NCT03000452|3453004|B1||Not Collected or Reported|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3600155|NCT03000452|3453004|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3600156|NCT03000452|3453004|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3600157|NCT03000452|3453004|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3600158|NCT03000452|3453004|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3600159|NCT03000452|3453004|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3600160|NCT03000452|3453004|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3600161|NCT03000452|3453004|B1|||Age||Years|Mean|62.8|62.8|Standard Deviation|11.41|11.41|||
3600162|NCT03000088|3453020|B3|Mallampati score 3||Mallampati score|Lower Mallamlapti score predicts easier intubation than did higher Mallampati score.|Participants|Count of Participants|16|16.0||||||
3600163|NCT03000088|3453021|B2|Mallampati score 3||Mallampati score|Lower Mallamlapti score predicts easier intubation than did higher Mallampati score.|Participants|Count of Participants|9|9.0||||||
3600164|NCT03000088|3453022|B1|Mallampati score 3||Mallampati score|Lower Mallamlapti score predicts easier intubation than did higher Mallampati score.|Participants|Count of Participants|7|7.0||||||
3600165|NCT03000088|3453020|B3|Mallampati score 2||Mallampati score|Lower Mallamlapti score predicts easier intubation than did higher Mallampati score.|Participants|Count of Participants|42|42.0||||||
3600166|NCT03000088|3453021|B2|Mallampati score 2||Mallampati score|Lower Mallamlapti score predicts easier intubation than did higher Mallampati score.|Participants|Count of Participants|20|20.0||||||
3600167|NCT03000088|3453022|B1|Mallampati score 2||Mallampati score|Lower Mallamlapti score predicts easier intubation than did higher Mallampati score.|Participants|Count of Participants|22|22.0||||||
3600168|NCT03000088|3453020|B3|Mallampati score 1||Mallampati score|Lower Mallamlapti score predicts easier intubation than did higher Mallampati score.|Participants|Count of Participants|82|82.0||||||
3600169|NCT03000088|3453021|B2|Mallampati score 1||Mallampati score|Lower Mallamlapti score predicts easier intubation than did higher Mallampati score.|Participants|Count of Participants|41|41.0||||||
3600170|NCT03000088|3453022|B1|Mallampati score 1||Mallampati score|Lower Mallamlapti score predicts easier intubation than did higher Mallampati score.|Participants|Count of Participants|41|41.0||||||
3600171|NCT03000088|3453020|B3||fixed|upper incisors status||Participants|Count of Participants|1|1.0||||||
3600172|NCT03000088|3453021|B2||fixed|upper incisors status||Participants|Count of Participants|0|0.0||||||
3600173|NCT03000088|3453022|B1||fixed|upper incisors status||Participants|Count of Participants|1|1.0||||||
3600174|NCT03000088|3453020|B3||absent|upper incisors status||Participants|Count of Participants|1|1.0||||||
3600175|NCT03000088|3453021|B2||absent|upper incisors status||Participants|Count of Participants|0|0.0||||||
3600176|NCT03000088|3453022|B1||absent|upper incisors status||Participants|Count of Participants|1|1.0||||||
3600177|NCT03000088|3453020|B3||normal|upper incisors status||Participants|Count of Participants|138|138.0||||||
3600178|NCT03000088|3453021|B2||normal|upper incisors status||Participants|Count of Participants|70|70.0||||||
3600179|NCT03000088|3453022|B1||normal|upper incisors status||Participants|Count of Participants|68|68.0||||||
3600180|NCT03000088|3453020|B3||fixed|range of motion of cervical spine||Participants|Count of Participants|0|0.0||||||
3600181|NCT03000088|3453021|B2||fixed|range of motion of cervical spine||Participants|Count of Participants|0|0.0||||||
3600182|NCT03000088|3453022|B1||fixed|range of motion of cervical spine||Participants|Count of Participants|0|0.0||||||
3600183|NCT03000088|3453020|B3||reduced|range of motion of cervical spine||Participants|Count of Participants|1|1.0||||||
3600184|NCT03000088|3453021|B2||reduced|range of motion of cervical spine||Participants|Count of Participants|0|0.0||||||
3600185|NCT03000088|3453022|B1||reduced|range of motion of cervical spine||Participants|Count of Participants|1|1.0||||||
3600186|NCT03000088|3453020|B3||normal|range of motion of cervical spine||Participants|Count of Participants|139|139.0||||||
3600187|NCT03000088|3453021|B2||normal|range of motion of cervical spine||Participants|Count of Participants|70|70.0||||||
3600188|NCT03000088|3453022|B1||normal|range of motion of cervical spine||Participants|Count of Participants|69|69.0||||||
3600191|NCT03000088|3453022|B1|||Mouth opening||cm|Median|5.4|5.4|Standard Deviation|1.1|1.1|||
3600192|NCT03000088|3453020|B3|||Thyromental distance||cm|Mean|9.2|9.2|Standard Deviation|1.3|1.3|||
3600193|NCT03000088|3453021|B2|||Thyromental distance||cm|Mean|9.2|9.2|Standard Deviation|1.4|1.4|||
3600194|NCT03000088|3453022|B1|||Thyromental distance||cm|Mean|9.2|9.2|Standard Deviation|1.3|1.3|||
3600195|NCT03000088|3453020|B3||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3600196|NCT03000088|3453021|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3600197|NCT03000088|3453022|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3600198|NCT03000088|3453020|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3600199|NCT03000088|3453021|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3600200|NCT03000088|3453022|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3600201|NCT03000088|3453020|B3|||Age||years|Mean|41|41.0|Standard Deviation|14|14.0|||
3600202|NCT03000088|3453021|B2|||Age||years|Mean|41|41.0|Standard Deviation|14|14.0|||
3600203|NCT03000088|3453022|B1|||Age||years|Mean|41|41.0|Standard Deviation|14|14.0|||
3600204|NCT02998684|3453029|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
3600205|NCT02998684|3453030|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3600206|NCT02998684|3453031|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3600207|NCT02998684|3453029|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3600208|NCT02998684|3453030|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3600209|NCT02998684|3453031|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3600210|NCT02998684|3453029|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3600211|NCT02998684|3453030|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3600212|NCT02998684|3453031|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3600213|NCT02998684|3453029|B3|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3600214|NCT02998684|3453030|B2|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3600215|NCT02998684|3453031|B1|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3600216|NCT02998684|3453029|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3600217|NCT02998684|3453030|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3600218|NCT02998684|3453031|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3600219|NCT02998684|3453029|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3600220|NCT02998684|3453030|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3600221|NCT02998684|3453031|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3600222|NCT02998684|3453029|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3600223|NCT02998684|3453030|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3600224|NCT02998684|3453031|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3600225|NCT02998684|3453029|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3600226|NCT02998684|3453030|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3600227|NCT02998684|3453031|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3600228|NCT02998684|3453029|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3600229|NCT02998684|3453030|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3600230|NCT02998684|3453031|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3600231|NCT02998684|3453029|B3||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
3600232|NCT02998684|3453030|B2||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
3600233|NCT02998684|3453031|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3600234|NCT02997904|3453040|B3|United States||Region of Enrollment||Participants|Count of Participants|100|100.0||||||
3600235|NCT02997904|3453041|B2|United States||Region of Enrollment||Participants|Count of Participants|49|49.0||||||
3600236|NCT02997904|3453042|B1|United States||Region of Enrollment||Participants|Count of Participants|51|51.0||||||
3600237|NCT02997904|3453040|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600238|NCT02997904|3453041|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600239|NCT02997904|3453042|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600240|NCT02997904|3453040|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3600241|NCT02997904|3453041|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3600242|NCT02997904|3453042|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3600243|NCT02997904|3453040|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3600244|NCT02997904|3453041|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3600245|NCT02997904|3453042|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3600246|NCT02997904|3453040|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3600247|NCT02997904|3453041|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3600248|NCT02997904|3453042|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3600249|NCT02997904|3453040|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3600250|NCT02997904|3453041|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3600251|NCT02997904|3453042|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3600252|NCT02997904|3453040|B3|||Age||years|Mean|16.9|16.9|Standard Deviation|12.9|12.9|||
3600253|NCT02997904|3453041|B2|||Age||years|Mean|17.8|17.8|Standard Deviation|12.1|12.1|||
3600254|NCT02997904|3453042|B1|||Age||years|Mean|16.3|16.3|Standard Deviation|13.5|13.5|||
3600255|NCT02995967|3453053|B3|More than one race||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3600256|NCT02995967|3453054|B2|More than one race||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3600257|NCT02995967|3453055|B1|More than one race||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3600258|NCT02995967|3453053|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3600259|NCT02995967|3453054|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3600260|NCT02995967|3453055|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3600261|NCT02995967|3453053|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3600262|NCT02995967|3453054|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3600263|NCT02995967|3453055|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3600264|NCT02995967|3453053|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3600265|NCT02995967|3453054|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3600266|NCT02995967|3453055|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3600267|NCT02995967|3453053|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3600268|NCT02995967|3453054|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3600269|NCT02995967|3453055|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3600270|NCT02995967|3453053|B3|American Indian or AlaskaNative||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3600271|NCT02995967|3453054|B2|American Indian or AlaskaNative||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3600272|NCT02995967|3453055|B1|American Indian or AlaskaNative||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3600273|NCT02995967|3453053|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3600274|NCT02995967|3453054|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3600275|NCT02995967|3453055|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3600276|NCT02995967|3453053|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3600277|NCT02995967|3453054|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3600278|NCT02995967|3453055|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3600279|NCT02995967|3453053|B3|age uner 50 yrs||Age, Customized||Participants|Count of Participants|0|0.0||||||
3600280|NCT02995967|3453054|B2|age uner 50 yrs||Age, Customized||Participants|Count of Participants|0|0.0||||||
3600281|NCT02995967|3453055|B1|age uner 50 yrs||Age, Customized||Participants|Count of Participants|0|0.0||||||
3600282|NCT02995967|3453053|B3|age over 50 yrs||Age, Customized||Participants|Count of Participants|3|3.0||||||
3600283|NCT02995967|3453054|B2|age over 50 yrs||Age, Customized||Participants|Count of Participants|2|2.0||||||
3600284|NCT02995967|3453055|B1|age over 50 yrs||Age, Customized||Participants|Count of Participants|1|1.0||||||
3600285|NCT02992691|3453064|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600286|NCT02992691|3453064|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600287|NCT02992691|3453064|B1||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3600288|NCT02992691|3453064|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600289|NCT02992691|3453064|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600290|NCT02992691|3453064|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600291|NCT02992691|3453064|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600292|NCT02992691|3453064|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3600293|NCT02992691|3453064|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3600294|NCT02992691|3453064|B1|||Age||Years|Mean|42.3|42.3|Standard Deviation|10.59|10.59|||
3600295|NCT02991820|3453081|B3|United States||Region of Enrollment||participants|Number|43|43.0||||||
3600296|NCT02991820|3453082|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
3600297|NCT02991820|3453083|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3600298|NCT02991820|3453081|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3600299|NCT02991820|3453081|B3||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3600300|NCT02991820|3453082|B2||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||was not assessed
3600301|NCT02991820|3453083|B1||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||was not assessed
3600302|NCT02991820|3453081|B3||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3600303|NCT02991820|3453082|B2||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||was not assessed
3600304|NCT02991820|3453083|B1||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||was not assessed
3600305|NCT02991820|3453081|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3600306|NCT02991820|3453082|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3600307|NCT02991820|3453083|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3600308|NCT02991820|3453081|B3||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
3600309|NCT02991820|3453082|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3600310|NCT02991820|3453083|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3600311|NCT02991820|3453081|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3600312|NCT02991820|3453082|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3600313|NCT02991820|3453083|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3600314|NCT02990910|3453092|B3|||BMI||kg / m^2|Median|18|18.0|Inter-Quartile Range|||16.0|19.0|
3600315|NCT02990910|3453093|B2|||BMI||kg / m^2|Median|18|18.0|Inter-Quartile Range|||16.0|19.0|
3600316|NCT02990910|3453094|B1|||BMI||kg / m^2|Median|18|18.0|Inter-Quartile Range|||17.0|20.0|
3600317|NCT02990910|3453092|B3|China||Region of Enrollment||participants|Number|280|280.0||||||
3600318|NCT02990910|3453093|B2|China||Region of Enrollment||participants|Number|140|140.0||||||
3600319|NCT02990910|3453094|B1|China||Region of Enrollment||participants|Number|140|140.0||||||
3600320|NCT02990910|3453092|B3|Chinese||Race/Ethnicity, Customized||Participants|Count of Participants|280|280.0||||||
3600321|NCT02990910|3453093|B2|Chinese||Race/Ethnicity, Customized||Participants|Count of Participants|140|140.0||||||
3600322|NCT02990910|3453094|B1|Chinese||Race/Ethnicity, Customized||Participants|Count of Participants|140|140.0||||||
3600323|NCT02990910|3453092|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600324|NCT02990910|3453093|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600325|NCT02990910|3453094|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600326|NCT02990910|3453092|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600327|NCT02990910|3453093|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600328|NCT02990910|3453094|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600329|NCT02990910|3453092|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600330|NCT02990910|3453093|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600331|NCT02990910|3453094|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600332|NCT02990910|3453092|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600333|NCT02990910|3453093|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600334|NCT02990910|3453094|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600335|NCT02990910|3453092|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600336|NCT02990910|3453093|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600337|NCT02990910|3453094|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600338|NCT02990910|3453092|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|280|280.0||||||
3600339|NCT02990910|3453093|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
3600340|NCT02990910|3453094|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
3600341|NCT02990910|3453092|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600342|NCT02990910|3453093|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600343|NCT02990910|3453094|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600344|NCT02990910|3453092|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600345|NCT02990910|3453093|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600346|NCT02990910|3453094|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600347|NCT02990910|3453092|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|280|280.0||||||
3600348|NCT02990910|3453093|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
3600349|NCT02990910|3453094|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
3600350|NCT02990910|3453092|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600351|NCT02990910|3453093|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600352|NCT02990910|3453094|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600353|NCT02990910|3453092|B3||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3600354|NCT02990910|3453093|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3600355|NCT02990910|3453094|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3600356|NCT02990910|3453092|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3600357|NCT02990910|3453093|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3600358|NCT02990910|3453094|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3600359|NCT02990910|3453092|B3|||Age||years|Median|6|6.0|Inter-Quartile Range|||4.0|8.0|
3600360|NCT02990910|3453093|B2|||Age||years|Median|5|5.0|Inter-Quartile Range|||4.0|6.0|
3600361|NCT02990910|3453094|B1|||Age||years|Median|6|6.0|Inter-Quartile Range|||4.0|8.0|
3600362|NCT02988882|3453103|B3||Green|Iris Color||Participants|Count of Participants|13|13.0||||||
3600363|NCT02988882|3453104|B2||Green|Iris Color||Participants|Count of Participants|5|5.0||||||
3600364|NCT02988882|3453105|B1||Green|Iris Color||Participants|Count of Participants|8|8.0||||||
3600365|NCT02988882|3453103|B3||Hazel|Iris Color||Participants|Count of Participants|8|8.0||||||
3600366|NCT02988882|3453104|B2||Hazel|Iris Color||Participants|Count of Participants|3|3.0||||||
3600367|NCT02988882|3453105|B1||Hazel|Iris Color||Participants|Count of Participants|5|5.0||||||
3600368|NCT02988882|3453103|B3||Brown|Iris Color||Participants|Count of Participants|43|43.0||||||
3600369|NCT02988882|3453104|B2||Brown|Iris Color||Participants|Count of Participants|19|19.0||||||
3600370|NCT02988882|3453105|B1||Brown|Iris Color||Participants|Count of Participants|24|24.0||||||
3600371|NCT02988882|3453103|B3||Blue|Iris Color||Participants|Count of Participants|21|21.0||||||
3600372|NCT02988882|3453104|B2||Blue|Iris Color||Participants|Count of Participants|15|15.0||||||
3600373|NCT02988882|3453105|B1||Blue|Iris Color||Participants|Count of Participants|6|6.0||||||
3600374|NCT02988882|3453103|B3||Black|Iris Color||Participants|Count of Participants|1|1.0||||||
3600375|NCT02988882|3453104|B2||Black|Iris Color||Participants|Count of Participants|0|0.0||||||
3600376|NCT02988882|3453105|B1||Black|Iris Color||Participants|Count of Participants|1|1.0||||||
3600377|NCT02988882|3453103|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600378|NCT02988882|3453104|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600379|NCT02988882|3453105|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600380|NCT02988882|3453103|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600381|NCT02988882|3453104|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600382|NCT02988882|3453105|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600383|NCT02988882|3453103|B3||White|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3600384|NCT02988882|3453104|B2||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3600385|NCT02988882|3453105|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3600386|NCT02988882|3453103|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3600387|NCT02988882|3453104|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3600388|NCT02988882|3453105|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3600389|NCT02988882|3453103|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600390|NCT02988882|3453104|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600391|NCT02988882|3453105|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600392|NCT02988882|3453103|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3600393|NCT02988882|3453104|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600394|NCT02988882|3453105|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3600395|NCT02988882|3453103|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600396|NCT02988882|3453104|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600397|NCT02988882|3453105|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600398|NCT02988882|3453103|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600399|NCT02988882|3453104|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600400|NCT02988882|3453105|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600401|NCT02988882|3453103|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3600402|NCT02988882|3453104|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3600403|NCT02988882|3453105|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3600404|NCT02988882|3453103|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3600405|NCT02988882|3453104|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3600406|NCT02988882|3453105|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3600407|NCT02988882|3453103|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3600408|NCT02988882|3453104|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3600409|NCT02988882|3453105|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3600410|NCT02988882|3453103|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3600411|NCT02988882|3453104|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3600412|NCT02988882|3453105|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3600413|NCT02988882|3453103|B3|||Age||years|Mean|40|40.0|Full Range|||18.0|70.0|
3600414|NCT02988882|3453104|B2|||Age||years|Mean|42.2|42.2|Full Range|||18.0|70.0|
3600415|NCT02988882|3453105|B1|||Age||years|Mean|39.1|39.1|Full Range|||20.0|68.0|
3600416|NCT02988622|3453116|B1|||Scar length||Centimeters|Mean|12.1|12.1|Standard Deviation|9.1|9.1|||
3600417|NCT02988622|3453116|B1|||Scar age||years|Mean|11.7|11.7|Standard Deviation|13.7|13.7|||
3600418|NCT02988622|3453116|B1|United States||Region of Enrollment||Participants|Count of Participants|100|100.0||||||
3600419|NCT02988622|3453116|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3600420|NCT02988622|3453116|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3600421|NCT02988622|3453116|B1|||Age||years|Mean|43.8|43.8|Standard Deviation|13.0|13.0|||
3600422|NCT02988622|3453116|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3600423|NCT02988622|3453116|B1||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
3600424|NCT02988622|3453116|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3600425|NCT02988349|3453138|B3|China||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3600426|NCT02988349|3453139|B2|China||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3600427|NCT02988349|3453140|B1|China||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3600428|NCT02988349|3453138|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3600429|NCT02988349|3453139|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3600430|NCT02988349|3453140|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3600431|NCT02988349|3453138|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3600432|NCT02988349|3453139|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3600433|NCT02988349|3453140|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3600434|NCT02988349|3453138|B3|||Age||years|Median|23|23.0|Full Range|||19.0|31.0|
3600435|NCT02988349|3453139|B2|||Age||years|Median|23|23.0|Full Range|||19.0|28.0|
3600436|NCT02988349|3453140|B1|||Age||years|Median|23|23.0|Full Range|||19.0|31.0|
3600437|NCT02988349|3453138|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3600438|NCT02988349|3453139|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3600439|NCT02988349|3453140|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3600440|NCT02988349|3453138|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3600441|NCT02988349|3453139|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3600442|NCT02988349|3453140|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3600443|NCT02988349|3453138|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3600444|NCT02988349|3453139|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3600445|NCT02988349|3453140|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3600446|NCT02988219|3453149|B3||Nefrectomy|Type of Surgery||Participants|Count of Participants|17|17.0||||||
3600447|NCT02988219|3453150|B2||Nefrectomy|Type of Surgery||Participants|Count of Participants|5|5.0||||||
3600448|NCT02988219|3453151|B1||Nefrectomy|Type of Surgery||Participants|Count of Participants|12|12.0||||||
3600449|NCT02988219|3453149|B3||NSS|Type of Surgery||Participants|Count of Participants|29|29.0||||||
3600450|NCT02988219|3453150|B2||NSS|Type of Surgery||Participants|Count of Participants|17|17.0||||||
3600451|NCT02988219|3453151|B1||NSS|Type of Surgery||Participants|Count of Participants|12|12.0||||||
3600452|NCT02988219|3453149|B3|||ASA|"AMERICAN SOCIETY OF ANESTHESIOLOGISTASA (ASA) PHYSICAL STATUS CLASSIFICATION SYSTEM~ASA I A normal healthy patient ASA II A patient with mild systemic disease ASA III A patient with severe systemic disease ASA IV A patient with severe systemic disease that is a constant threat to life ASA V A moribund patient who is not expected to survive without the operation ASA VI A declared brain-dead patient whose organs are being removed for donor purposes~*The addition of “E” denotes Emergency surgery"|scores on a scale|Median|2|2.0|Full Range|||1.0|3.0|
3600453|NCT02988219|3453150|B2|||ASA|"AMERICAN SOCIETY OF ANESTHESIOLOGISTASA (ASA) PHYSICAL STATUS CLASSIFICATION SYSTEM~ASA I A normal healthy patient ASA II A patient with mild systemic disease ASA III A patient with severe systemic disease ASA IV A patient with severe systemic disease that is a constant threat to life ASA V A moribund patient who is not expected to survive without the operation ASA VI A declared brain-dead patient whose organs are being removed for donor purposes~*The addition of “E” denotes Emergency surgery"|scores on a scale|Median|2|2.0|Full Range|||1.0|3.0|
3600454|NCT02988219|3453151|B1|||ASA|"AMERICAN SOCIETY OF ANESTHESIOLOGISTASA (ASA) PHYSICAL STATUS CLASSIFICATION SYSTEM~ASA I A normal healthy patient ASA II A patient with mild systemic disease ASA III A patient with severe systemic disease ASA IV A patient with severe systemic disease that is a constant threat to life ASA V A moribund patient who is not expected to survive without the operation ASA VI A declared brain-dead patient whose organs are being removed for donor purposes~*The addition of “E” denotes Emergency surgery"|scores on a scale|Median|2|2.0|Full Range|||1.0|3.0|
3600455|NCT02988219|3453149|B3|||BMI|Body Mass Index|kg/m^2|Mean|29.29|29.29|Standard Deviation|5.99|5.99|||
3600456|NCT02988219|3453150|B2|||BMI|Body Mass Index|kg/m^2|Mean|30.04|30.04|Standard Deviation|7.01|7.01|||
3600457|NCT02988219|3453151|B1|||BMI|Body Mass Index|kg/m^2|Mean|28.14|28.14|Standard Deviation|4.84|4.84|||
3600458|NCT02988219|3453149|B3|Poland||Region of Enrollment||participants|Number|46|46.0||||||
3600459|NCT02988219|3453150|B2|Poland||Region of Enrollment||participants|Number|22|22.0||||||
3600460|NCT02988219|3453151|B1|Poland||Region of Enrollment||participants|Number|24|24.0||||||
3600461|NCT02988219|3453149|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3600462|NCT02988219|3453150|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3600463|NCT02988219|3453151|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3600464|NCT02988219|3453149|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3600465|NCT02988219|3453150|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3600466|NCT02988219|3453151|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3600467|NCT02988219|3453149|B3|||Age||years|Median|59|59.0|Standard Deviation|8.58|8.58|||
3600468|NCT02988219|3453150|B2|||Age||years|Median|57|57.0|Standard Deviation|9.04|9.04|||
3600469|NCT02988219|3453151|B1|||Age||years|Median|61|61.0|Standard Deviation|8.50|8.5|||
3600470|NCT02988219|3453149|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3600471|NCT02988219|3453150|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3600472|NCT02988219|3453151|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3600473|NCT02988219|3453149|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3600474|NCT02988219|3453150|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3600475|NCT02988219|3453151|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3600476|NCT02988219|3453149|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3600477|NCT02988219|3453150|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3600478|NCT02988219|3453151|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3600479|NCT02987868|3453160|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3600480|NCT02987868|3453160|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600481|NCT02987868|3453160|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3600482|NCT02987868|3453160|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3600483|NCT02987868|3453160|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3600484|NCT02987868|3453160|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600485|NCT02987868|3453160|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600486|NCT02987868|3453160|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600487|NCT02987868|3453160|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3600488|NCT02987868|3453160|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3600489|NCT02987868|3453160|B1|||Age||years|Mean|23|23.0|Standard Deviation|14|14.0|||
3600490|NCT02987868|3453160|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3600491|NCT02987868|3453160|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3600492|NCT02987868|3453160|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3600493|NCT02987374|3453167|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3600494|NCT02987374|3453167|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600495|NCT02987374|3453167|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3600496|NCT02987374|3453167|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3600497|NCT02987374|3453167|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600498|NCT02987374|3453167|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600499|NCT02987374|3453167|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3600500|NCT02987374|3453167|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600501|NCT02987374|3453167|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600502|NCT02987374|3453167|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3600503|NCT02987374|3453167|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600504|NCT02987374|3453167|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3600505|NCT02987374|3453167|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3600506|NCT02987374|3453167|B1|Between 18 and 30 years old||Age, Customized||Participants|Count of Participants|10|10.0||||||
3600507|NCT02987205|3453172|B1|||Body Mass Index (BMI)|BMI is the body mass divided by the square of the body height, and is universally expressed in units of kg/m^2|kg/m^2|Mean|26.27|26.27|Standard Deviation|5.374|5.374|||
3600508|NCT02987205|3453172|B1||FST VI|Fitzpatrick Skin Type (FST) Classification|FST Type I skin always burns, never tans (pale white; blond or red hair; blue, gray eyes; freckles) FST Type II skin usually burns, tans minimally (white; blond, brown or red hair; blue, green, or hazel eyes) FST Type III skin sometimes has a mild burn, tans uniformly (cream white; yellowish; any hair color or brown eyes) FST Type IV skin burns minimally, always tans well (light brown; olive; dark brown to black hair) FST Type V skin very rarely burns, tans very easily (brown) FST Type VI skin never burns, always tans (deeply pigmented dark brown to darkest brown, black in complexion)|Participants|Count of Participants|7|7.0||||||
3600509|NCT02987205|3453172|B1||FST V|Fitzpatrick Skin Type (FST) Classification|FST Type I skin always burns, never tans (pale white; blond or red hair; blue, gray eyes; freckles) FST Type II skin usually burns, tans minimally (white; blond, brown or red hair; blue, green, or hazel eyes) FST Type III skin sometimes has a mild burn, tans uniformly (cream white; yellowish; any hair color or brown eyes) FST Type IV skin burns minimally, always tans well (light brown; olive; dark brown to black hair) FST Type V skin very rarely burns, tans very easily (brown) FST Type VI skin never burns, always tans (deeply pigmented dark brown to darkest brown, black in complexion)|Participants|Count of Participants|4|4.0||||||
3600510|NCT02987205|3453172|B1||FST IV|Fitzpatrick Skin Type (FST) Classification|FST Type I skin always burns, never tans (pale white; blond or red hair; blue, gray eyes; freckles) FST Type II skin usually burns, tans minimally (white; blond, brown or red hair; blue, green, or hazel eyes) FST Type III skin sometimes has a mild burn, tans uniformly (cream white; yellowish; any hair color or brown eyes) FST Type IV skin burns minimally, always tans well (light brown; olive; dark brown to black hair) FST Type V skin very rarely burns, tans very easily (brown) FST Type VI skin never burns, always tans (deeply pigmented dark brown to darkest brown, black in complexion)|Participants|Count of Participants|16|16.0||||||
3600511|NCT02987205|3453172|B1||FST III|Fitzpatrick Skin Type (FST) Classification|FST Type I skin always burns, never tans (pale white; blond or red hair; blue, gray eyes; freckles) FST Type II skin usually burns, tans minimally (white; blond, brown or red hair; blue, green, or hazel eyes) FST Type III skin sometimes has a mild burn, tans uniformly (cream white; yellowish; any hair color or brown eyes) FST Type IV skin burns minimally, always tans well (light brown; olive; dark brown to black hair) FST Type V skin very rarely burns, tans very easily (brown) FST Type VI skin never burns, always tans (deeply pigmented dark brown to darkest brown, black in complexion)|Participants|Count of Participants|83|83.0||||||
3600555|NCT02986854|3453204|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3600556|NCT02986854|3453205|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3600512|NCT02987205|3453172|B1||FST II|Fitzpatrick Skin Type (FST) Classification|FST Type I skin always burns, never tans (pale white; blond or red hair; blue, gray eyes; freckles) FST Type II skin usually burns, tans minimally (white; blond, brown or red hair; blue, green, or hazel eyes) FST Type III skin sometimes has a mild burn, tans uniformly (cream white; yellowish; any hair color or brown eyes) FST Type IV skin burns minimally, always tans well (light brown; olive; dark brown to black hair) FST Type V skin very rarely burns, tans very easily (brown) FST Type VI skin never burns, always tans (deeply pigmented dark brown to darkest brown, black in complexion)|Participants|Count of Participants|50|50.0||||||
3600513|NCT02987205|3453172|B1||FST I|Fitzpatrick Skin Type (FST) Classification|FST Type I skin always burns, never tans (pale white; blond or red hair; blue, gray eyes; freckles) FST Type II skin usually burns, tans minimally (white; blond, brown or red hair; blue, green, or hazel eyes) FST Type III skin sometimes has a mild burn, tans uniformly (cream white; yellowish; any hair color or brown eyes) FST Type IV skin burns minimally, always tans well (light brown; olive; dark brown to black hair) FST Type V skin very rarely burns, tans very easily (brown) FST Type VI skin never burns, always tans (deeply pigmented dark brown to darkest brown, black in complexion)|Participants|Count of Participants|3|3.0||||||
3600514|NCT02987205|3453172|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600515|NCT02987205|3453172|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3600516|NCT02987205|3453172|B1||White|Race (NIH/OMB)||Participants|Count of Participants|154|154.0||||||
3600517|NCT02987205|3453172|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3600518|NCT02987205|3453172|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600519|NCT02987205|3453172|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3600520|NCT02987205|3453172|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600521|NCT02987205|3453172|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600522|NCT02987205|3453172|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
3600523|NCT02987205|3453172|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3600524|NCT02987205|3453172|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3600525|NCT02987205|3453172|B1||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3600526|NCT02987205|3453172|B1|= or >75 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
3600527|NCT02987205|3453172|B1|64 to <75 years||Age, Customized||Participants|Count of Participants|35|35.0||||||
3600528|NCT02987205|3453172|B1|40 to <64 years||Age, Customized||Participants|Count of Participants|110|110.0||||||
3600529|NCT02987205|3453172|B1|22 to <40 years||Age, Customized||Participants|Count of Participants|15|15.0||||||
3600530|NCT02987205|3453172|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|10.16|10.16|||
3600531|NCT02986958|3453180|B3|||Mean Mini-Mental State Examination (MMSE)|The Mini-Mental State Examination (MMSE) is a 30-item questionnaire used to measure cognitive impairment in clinical and research settings. MMSE scores range from 0-30, with higher values indicating less impairment.|units on a scale|Mean|21.6|21.6|Standard Deviation|6.8|6.8|||
3600532|NCT02986958|3453181|B2|||Mean Mini-Mental State Examination (MMSE)|The Mini-Mental State Examination (MMSE) is a 30-item questionnaire used to measure cognitive impairment in clinical and research settings. MMSE scores range from 0-30, with higher values indicating less impairment.|units on a scale|Mean|22.5|22.5|Standard Deviation|5.5|5.5|||
3600533|NCT02986958|3453182|B1|||Mean Mini-Mental State Examination (MMSE)|The Mini-Mental State Examination (MMSE) is a 30-item questionnaire used to measure cognitive impairment in clinical and research settings. MMSE scores range from 0-30, with higher values indicating less impairment.|units on a scale|Mean|20.8|20.8|Standard Deviation|7.8|7.8|||
3600534|NCT02986958|3453180|B3|Nonwhite race or Hispanic ethnicity||Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
3600535|NCT02986958|3453181|B2|Nonwhite race or Hispanic ethnicity||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3600536|NCT02986958|3453182|B1|Nonwhite race or Hispanic ethnicity||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3600537|NCT02986958|3453180|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3600538|NCT02986958|3453181|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3600539|NCT02986958|3453182|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3600540|NCT02986958|3453180|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3600541|NCT02986958|3453181|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3600542|NCT02986958|3453182|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3600543|NCT02986958|3453180|B3|||Age||years|Mean|79.9|79.9|Standard Deviation|7.6|7.6|||
3600544|NCT02986958|3453181|B2|||Age||years|Mean|78.8|78.8|Standard Deviation|7.1|7.1|||
3600545|NCT02986958|3453182|B1|||Age||years|Mean|80.9|80.9|Standard Deviation|8.0|8.0|||
3600546|NCT02986854|3453203|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|563|563.0||||||
3600547|NCT02986854|3453204|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|79|79.0||||||
3600548|NCT02986854|3453205|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|233|233.0||||||
3600549|NCT02986854|3453206|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|251|251.0||||||
3600550|NCT02986854|3453203|B4|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|45|45.0||||||
3600551|NCT02986854|3453204|B3|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3600552|NCT02986854|3453205|B2|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3600553|NCT02986854|3453206|B1|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3600554|NCT02986854|3453203|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3600557|NCT02986854|3453206|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3600558|NCT02986854|3453203|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|59|59.0||||||
3600559|NCT02986854|3453204|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3600560|NCT02986854|3453205|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3600561|NCT02986854|3453206|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3600562|NCT02986854|3453203|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3600563|NCT02986854|3453204|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3600564|NCT02986854|3453205|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3600565|NCT02986854|3453206|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3600566|NCT02986854|3453203|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3600567|NCT02986854|3453204|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3600568|NCT02986854|3453205|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3600569|NCT02986854|3453206|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3600570|NCT02986854|3453203|B4||Male|Sex: Female, Male||Participants|Count of Participants|333|333.0||||||
3600571|NCT02986854|3453204|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3600572|NCT02986854|3453205|B2||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3600573|NCT02986854|3453206|B1||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3600574|NCT02986854|3453203|B4||Female|Sex: Female, Male||Participants|Count of Participants|368|368.0||||||
3600575|NCT02986854|3453204|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3600576|NCT02986854|3453205|B2||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3600577|NCT02986854|3453206|B1||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3600578|NCT02986854|3453203|B4|||Age||Years|Mean|20.5|20.5|Standard Deviation|9.25|9.25|||
3600579|NCT02986854|3453204|B3|||Age||Years|Mean|38.8|38.8|Standard Deviation|10.47|10.47|||
3600580|NCT02986854|3453205|B2|||Age||Years|Mean|17.9|17.9|Standard Deviation|4.54|4.54|||
3600581|NCT02986854|3453206|B1|||Age||Years|Mean|17.1|17.1|Standard Deviation|3.66|3.66|||
3600582|NCT02986711|3453281|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3600583|NCT02986711|3453282|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3600584|NCT02986711|3453283|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3600585|NCT02986711|3453281|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3600586|NCT02986711|3453282|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3600587|NCT02986711|3453283|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3600588|NCT02986711|3453281|B3|||Age||years|Mean|41.8|41.8|Standard Deviation|13.2|13.2|||
3600589|NCT02986711|3453282|B2|||Age||years|Mean|42.5|42.5|Standard Deviation|13.3|13.3|||
3600590|NCT02986711|3453283|B1|||Age||years|Mean|41.1|41.1|Standard Deviation|13.3|13.3|||
3600591|NCT02986282|3453292|B1|Poland||Region of Enrollment||participants|Number|99|99.0||||||
3600592|NCT02986282|3453292|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600593|NCT02986282|3453292|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600594|NCT02986282|3453292|B1||White|Race (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3600595|NCT02986282|3453292|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600596|NCT02986282|3453292|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600597|NCT02986282|3453292|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600598|NCT02986282|3453292|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600599|NCT02986282|3453292|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3600600|NCT02986282|3453292|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3600601|NCT02986282|3453292|B1|||Age||years|Mean|66.5|66.5|Standard Deviation|11|11.0|||
3600602|NCT02986282|3453292|B1||>=65 years|Age||Participants|Count of Participants|61|61.0||||||
3600603|NCT02986282|3453292|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3600604|NCT02986282|3453292|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3600605|NCT02986139|3453297|B3||Psoriatic Arthritis|Actual Indication||Participants|Count of Participants|25|25.0||||||
3600606|NCT02986139|3453298|B2||Psoriatic Arthritis|Actual Indication||Participants|Count of Participants|10|10.0||||||
3600607|NCT02986139|3453299|B1||Psoriatic Arthritis|Actual Indication||Participants|Count of Participants|15|15.0||||||
3600608|NCT02986139|3453297|B3||Rheumatoid Arthritis|Actual Indication||Participants|Count of Participants|86|86.0||||||
3600609|NCT02986139|3453298|B2||Rheumatoid Arthritis|Actual Indication||Participants|Count of Participants|45|45.0||||||
3600610|NCT02986139|3453299|B1||Rheumatoid Arthritis|Actual Indication||Participants|Count of Participants|41|41.0||||||
3600611|NCT02986139|3453297|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|100|100.0||||||
3600612|NCT02986139|3453298|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
3600613|NCT02986139|3453299|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
3600614|NCT02986139|3453297|B3||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3600615|NCT02986139|3453298|B2||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3600616|NCT02986139|3453299|B1||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3600617|NCT02986139|3453297|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3600618|NCT02986139|3453298|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3600619|NCT02986139|3453299|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3600620|NCT02986139|3453297|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3600621|NCT02986139|3453298|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3600622|NCT02986139|3453299|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3600623|NCT02986139|3453297|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3600624|NCT02986139|3453298|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3600625|NCT02986139|3453299|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3600626|NCT02986139|3453297|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600627|NCT02986139|3453298|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600628|NCT02986139|3453299|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600629|NCT02986139|3453297|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3600630|NCT02986139|3453298|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3600631|NCT02986139|3453299|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3600632|NCT02986139|3453297|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3600633|NCT02986139|3453298|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3600634|NCT02986139|3453299|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3600635|NCT02986139|3453297|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3600636|NCT02986139|3453298|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3600637|NCT02986139|3453299|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3600638|NCT02986139|3453297|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3600639|NCT02986139|3453298|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3600640|NCT02986139|3453299|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3600641|NCT02986139|3453297|B3|||Age||years|Mean|55.3|55.3|Standard Deviation|13.7|13.7|||
3600642|NCT02986139|3453298|B2|||Age||years|Mean|55.9|55.9|Standard Deviation|13.7|13.7|||
3600643|NCT02986139|3453299|B1|||Age||years|Mean|54.7|54.7|Standard Deviation|13.9|13.9|||
3600644|NCT02985840|3453312|B3|United States||Region of Enrollment||Participants|Count of Participants|127|127.0||||||
3600645|NCT02985840|3453313|B2|United States||Region of Enrollment||Participants|Count of Participants|63|63.0||||||
3600646|NCT02985840|3453314|B1|United States||Region of Enrollment||Participants|Count of Participants|64|64.0||||||
3600647|NCT02985840|3453312|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3600648|NCT02985840|3453312|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3600649|NCT02985840|3453313|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3600650|NCT02985840|3453314|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3600651|NCT02985840|3453312|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3600652|NCT02985840|3453313|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3600653|NCT02985840|3453314|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3600654|NCT02985840|3453312|B3|||Age||years|Mean|35.21|35.21|Standard Deviation|12.08|12.08|||
3600655|NCT02985840|3453313|B2|||Age||years|Mean|34.65|34.65|Standard Deviation|12.75|12.75|||
3600656|NCT02985840|3453314|B1|||Age||years|Mean|35.77|35.77|Standard Deviation|11.46|11.46|||
3600657|NCT02985827|3453323|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600658|NCT02985827|3453324|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600659|NCT02985827|3453325|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600660|NCT02985827|3453323|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3600661|NCT02985827|3453324|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3600662|NCT02985827|3453325|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3600663|NCT02985827|3453323|B3||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3600664|NCT02985827|3453324|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3600665|NCT02985827|3453325|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3600666|NCT02985827|3453323|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3600667|NCT02985827|3453324|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600668|NCT02985827|3453325|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3600669|NCT02985827|3453323|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600670|NCT02985827|3453324|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600824|NCT02984267|3453349|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600671|NCT02985827|3453325|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600672|NCT02985827|3453323|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3600673|NCT02985827|3453324|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600674|NCT02985827|3453325|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3600675|NCT02985827|3453323|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600676|NCT02985827|3453324|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600677|NCT02985827|3453325|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600678|NCT02985827|3453323|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3600679|NCT02985827|3453324|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3600680|NCT02985827|3453325|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3600681|NCT02985827|3453323|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3600682|NCT02985827|3453324|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3600683|NCT02985827|3453325|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3600684|NCT02985827|3453323|B3|||Age||years|Mean|58.4|58.4|Standard Deviation|9.6|9.6|||
3600685|NCT02985827|3453324|B2|||Age||years|Mean|53.5|53.5|Standard Deviation|7.6|7.6|||
3600686|NCT02985827|3453325|B1|||Age||years|Mean|62.2|62.2|Standard Deviation|8.6|8.6|||
3600687|NCT02985827|3453323|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3600688|NCT02985827|3453324|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3600689|NCT02985827|3453325|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3600690|NCT02985827|3453323|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3600691|NCT02985827|3453324|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3600692|NCT02985827|3453325|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3600693|NCT02985827|3453323|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3600694|NCT02985827|3453324|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3600695|NCT02985827|3453325|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3600696|NCT02984878|3453334|B3|FST VI||Fitzpatrick Skin Type (FST) Classification|FST Type I skin always burns, never tans (pale white; blond or red hair; blue, gray eyes; freckles), FST Type II skin usually burns, tans minimally (white; blond, brown or red hair; blue, green, or hazel eyes), FST Type III skin sometimes has a mild burn, tans uniformly (cream white; yellowish; any hair color or brown eyes), FST Type IV skin burns minimally, always tans well (light brown; olive; dark brown to black hair), FST Type V skin very rarely burns, tans very easily (brown), FST Type VI skin never burns, always tans (deeply pigmented dark brown to darkest brown, black in complexion)|Participants|Count of Participants|5|5.0||||||
3600697|NCT02984878|3453335|B2|FST VI||Fitzpatrick Skin Type (FST) Classification|FST Type I skin always burns, never tans (pale white; blond or red hair; blue, gray eyes; freckles), FST Type II skin usually burns, tans minimally (white; blond, brown or red hair; blue, green, or hazel eyes), FST Type III skin sometimes has a mild burn, tans uniformly (cream white; yellowish; any hair color or brown eyes), FST Type IV skin burns minimally, always tans well (light brown; olive; dark brown to black hair), FST Type V skin very rarely burns, tans very easily (brown), FST Type VI skin never burns, always tans (deeply pigmented dark brown to darkest brown, black in complexion)|Participants|Count of Participants|4|4.0||||||
3600698|NCT02984878|3453336|B1|FST VI||Fitzpatrick Skin Type (FST) Classification|FST Type I skin always burns, never tans (pale white; blond or red hair; blue, gray eyes; freckles), FST Type II skin usually burns, tans minimally (white; blond, brown or red hair; blue, green, or hazel eyes), FST Type III skin sometimes has a mild burn, tans uniformly (cream white; yellowish; any hair color or brown eyes), FST Type IV skin burns minimally, always tans well (light brown; olive; dark brown to black hair), FST Type V skin very rarely burns, tans very easily (brown), FST Type VI skin never burns, always tans (deeply pigmented dark brown to darkest brown, black in complexion)|Participants|Count of Participants|1|1.0||||||
3600699|NCT02984878|3453334|B3|FST V||Fitzpatrick Skin Type (FST) Classification|FST Type I skin always burns, never tans (pale white; blond or red hair; blue, gray eyes; freckles), FST Type II skin usually burns, tans minimally (white; blond, brown or red hair; blue, green, or hazel eyes), FST Type III skin sometimes has a mild burn, tans uniformly (cream white; yellowish; any hair color or brown eyes), FST Type IV skin burns minimally, always tans well (light brown; olive; dark brown to black hair), FST Type V skin very rarely burns, tans very easily (brown), FST Type VI skin never burns, always tans (deeply pigmented dark brown to darkest brown, black in complexion)|Participants|Count of Participants|3|3.0||||||
3600700|NCT02984878|3453335|B2|FST V||Fitzpatrick Skin Type (FST) Classification|FST Type I skin always burns, never tans (pale white; blond or red hair; blue, gray eyes; freckles), FST Type II skin usually burns, tans minimally (white; blond, brown or red hair; blue, green, or hazel eyes), FST Type III skin sometimes has a mild burn, tans uniformly (cream white; yellowish; any hair color or brown eyes), FST Type IV skin burns minimally, always tans well (light brown; olive; dark brown to black hair), FST Type V skin very rarely burns, tans very easily (brown), FST Type VI skin never burns, always tans (deeply pigmented dark brown to darkest brown, black in complexion)|Participants|Count of Participants|2|2.0||||||
3600701|NCT02984878|3453336|B1|FST V||Fitzpatrick Skin Type (FST) Classification|FST Type I skin always burns, never tans (pale white; blond or red hair; blue, gray eyes; freckles), FST Type II skin usually burns, tans minimally (white; blond, brown or red hair; blue, green, or hazel eyes), FST Type III skin sometimes has a mild burn, tans uniformly (cream white; yellowish; any hair color or brown eyes), FST Type IV skin burns minimally, always tans well (light brown; olive; dark brown to black hair), FST Type V skin very rarely burns, tans very easily (brown), FST Type VI skin never burns, always tans (deeply pigmented dark brown to darkest brown, black in complexion)|Participants|Count of Participants|1|1.0||||||
3600759|NCT02984878|3453334|B3|40 to <64 years||Age, Customized|participants in each age group|Participants|Count of Participants|48|48.0||||||
3600702|NCT02984878|3453334|B3|FST IV||Fitzpatrick Skin Type (FST) Classification|FST Type I skin always burns, never tans (pale white; blond or red hair; blue, gray eyes; freckles), FST Type II skin usually burns, tans minimally (white; blond, brown or red hair; blue, green, or hazel eyes), FST Type III skin sometimes has a mild burn, tans uniformly (cream white; yellowish; any hair color or brown eyes), FST Type IV skin burns minimally, always tans well (light brown; olive; dark brown to black hair), FST Type V skin very rarely burns, tans very easily (brown), FST Type VI skin never burns, always tans (deeply pigmented dark brown to darkest brown, black in complexion)|Participants|Count of Participants|6|6.0||||||
3600703|NCT02984878|3453335|B2|FST IV||Fitzpatrick Skin Type (FST) Classification|FST Type I skin always burns, never tans (pale white; blond or red hair; blue, gray eyes; freckles), FST Type II skin usually burns, tans minimally (white; blond, brown or red hair; blue, green, or hazel eyes), FST Type III skin sometimes has a mild burn, tans uniformly (cream white; yellowish; any hair color or brown eyes), FST Type IV skin burns minimally, always tans well (light brown; olive; dark brown to black hair), FST Type V skin very rarely burns, tans very easily (brown), FST Type VI skin never burns, always tans (deeply pigmented dark brown to darkest brown, black in complexion)|Participants|Count of Participants|3|3.0||||||
3600704|NCT02984878|3453336|B1|FST IV||Fitzpatrick Skin Type (FST) Classification|FST Type I skin always burns, never tans (pale white; blond or red hair; blue, gray eyes; freckles), FST Type II skin usually burns, tans minimally (white; blond, brown or red hair; blue, green, or hazel eyes), FST Type III skin sometimes has a mild burn, tans uniformly (cream white; yellowish; any hair color or brown eyes), FST Type IV skin burns minimally, always tans well (light brown; olive; dark brown to black hair), FST Type V skin very rarely burns, tans very easily (brown), FST Type VI skin never burns, always tans (deeply pigmented dark brown to darkest brown, black in complexion)|Participants|Count of Participants|3|3.0||||||
3600705|NCT02984878|3453334|B3|FST III||Fitzpatrick Skin Type (FST) Classification|FST Type I skin always burns, never tans (pale white; blond or red hair; blue, gray eyes; freckles), FST Type II skin usually burns, tans minimally (white; blond, brown or red hair; blue, green, or hazel eyes), FST Type III skin sometimes has a mild burn, tans uniformly (cream white; yellowish; any hair color or brown eyes), FST Type IV skin burns minimally, always tans well (light brown; olive; dark brown to black hair), FST Type V skin very rarely burns, tans very easily (brown), FST Type VI skin never burns, always tans (deeply pigmented dark brown to darkest brown, black in complexion)|Participants|Count of Participants|30|30.0||||||
3600706|NCT02984878|3453335|B2|FST III||Fitzpatrick Skin Type (FST) Classification|FST Type I skin always burns, never tans (pale white; blond or red hair; blue, gray eyes; freckles), FST Type II skin usually burns, tans minimally (white; blond, brown or red hair; blue, green, or hazel eyes), FST Type III skin sometimes has a mild burn, tans uniformly (cream white; yellowish; any hair color or brown eyes), FST Type IV skin burns minimally, always tans well (light brown; olive; dark brown to black hair), FST Type V skin very rarely burns, tans very easily (brown), FST Type VI skin never burns, always tans (deeply pigmented dark brown to darkest brown, black in complexion)|Participants|Count of Participants|15|15.0||||||
3600707|NCT02984878|3453336|B1|FST III||Fitzpatrick Skin Type (FST) Classification|FST Type I skin always burns, never tans (pale white; blond or red hair; blue, gray eyes; freckles), FST Type II skin usually burns, tans minimally (white; blond, brown or red hair; blue, green, or hazel eyes), FST Type III skin sometimes has a mild burn, tans uniformly (cream white; yellowish; any hair color or brown eyes), FST Type IV skin burns minimally, always tans well (light brown; olive; dark brown to black hair), FST Type V skin very rarely burns, tans very easily (brown), FST Type VI skin never burns, always tans (deeply pigmented dark brown to darkest brown, black in complexion)|Participants|Count of Participants|15|15.0||||||
3600708|NCT02984878|3453334|B3|FST II||Fitzpatrick Skin Type (FST) Classification|FST Type I skin always burns, never tans (pale white; blond or red hair; blue, gray eyes; freckles), FST Type II skin usually burns, tans minimally (white; blond, brown or red hair; blue, green, or hazel eyes), FST Type III skin sometimes has a mild burn, tans uniformly (cream white; yellowish; any hair color or brown eyes), FST Type IV skin burns minimally, always tans well (light brown; olive; dark brown to black hair), FST Type V skin very rarely burns, tans very easily (brown), FST Type VI skin never burns, always tans (deeply pigmented dark brown to darkest brown, black in complexion)|Participants|Count of Participants|27|27.0||||||
3600709|NCT02984878|3453335|B2|FST II||Fitzpatrick Skin Type (FST) Classification|FST Type I skin always burns, never tans (pale white; blond or red hair; blue, gray eyes; freckles), FST Type II skin usually burns, tans minimally (white; blond, brown or red hair; blue, green, or hazel eyes), FST Type III skin sometimes has a mild burn, tans uniformly (cream white; yellowish; any hair color or brown eyes), FST Type IV skin burns minimally, always tans well (light brown; olive; dark brown to black hair), FST Type V skin very rarely burns, tans very easily (brown), FST Type VI skin never burns, always tans (deeply pigmented dark brown to darkest brown, black in complexion)|Participants|Count of Participants|17|17.0||||||
3600710|NCT02984878|3453336|B1|FST II||Fitzpatrick Skin Type (FST) Classification|FST Type I skin always burns, never tans (pale white; blond or red hair; blue, gray eyes; freckles), FST Type II skin usually burns, tans minimally (white; blond, brown or red hair; blue, green, or hazel eyes), FST Type III skin sometimes has a mild burn, tans uniformly (cream white; yellowish; any hair color or brown eyes), FST Type IV skin burns minimally, always tans well (light brown; olive; dark brown to black hair), FST Type V skin very rarely burns, tans very easily (brown), FST Type VI skin never burns, always tans (deeply pigmented dark brown to darkest brown, black in complexion)|Participants|Count of Participants|10|10.0||||||
3600711|NCT02984878|3453334|B3|FST I||Fitzpatrick Skin Type (FST) Classification|FST Type I skin always burns, never tans (pale white; blond or red hair; blue, gray eyes; freckles), FST Type II skin usually burns, tans minimally (white; blond, brown or red hair; blue, green, or hazel eyes), FST Type III skin sometimes has a mild burn, tans uniformly (cream white; yellowish; any hair color or brown eyes), FST Type IV skin burns minimally, always tans well (light brown; olive; dark brown to black hair), FST Type V skin very rarely burns, tans very easily (brown), FST Type VI skin never burns, always tans (deeply pigmented dark brown to darkest brown, black in complexion)|Participants|Count of Participants|0|0.0||||||
3600760|NCT02984878|3453335|B2|40 to <64 years||Age, Customized|participants in each age group|Participants|Count of Participants|27|27.0||||||
3600761|NCT02984878|3453336|B1|40 to <64 years||Age, Customized|participants in each age group|Participants|Count of Participants|21|21.0||||||
3600762|NCT02984878|3453334|B3|22 to <40 years||Age, Customized|participants in each age group|Participants|Count of Participants|6|6.0||||||
3600712|NCT02984878|3453335|B2|FST I||Fitzpatrick Skin Type (FST) Classification|FST Type I skin always burns, never tans (pale white; blond or red hair; blue, gray eyes; freckles), FST Type II skin usually burns, tans minimally (white; blond, brown or red hair; blue, green, or hazel eyes), FST Type III skin sometimes has a mild burn, tans uniformly (cream white; yellowish; any hair color or brown eyes), FST Type IV skin burns minimally, always tans well (light brown; olive; dark brown to black hair), FST Type V skin very rarely burns, tans very easily (brown), FST Type VI skin never burns, always tans (deeply pigmented dark brown to darkest brown, black in complexion)|Participants|Count of Participants|0|0.0||||||
3600713|NCT02984878|3453336|B1|FST I||Fitzpatrick Skin Type (FST) Classification|FST Type I skin always burns, never tans (pale white; blond or red hair; blue, gray eyes; freckles), FST Type II skin usually burns, tans minimally (white; blond, brown or red hair; blue, green, or hazel eyes), FST Type III skin sometimes has a mild burn, tans uniformly (cream white; yellowish; any hair color or brown eyes), FST Type IV skin burns minimally, always tans well (light brown; olive; dark brown to black hair), FST Type V skin very rarely burns, tans very easily (brown), FST Type VI skin never burns, always tans (deeply pigmented dark brown to darkest brown, black in complexion)|Participants|Count of Participants|0|0.0||||||
3600714|NCT02984878|3453334|B3|United States||Region of Enrollment||Participants|Count of Participants|71|71.0||||||
3600715|NCT02984878|3453335|B2|United States||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3600716|NCT02984878|3453336|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3600717|NCT02984878|3453334|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600718|NCT02984878|3453335|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600719|NCT02984878|3453336|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600720|NCT02984878|3453334|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600721|NCT02984878|3453335|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600722|NCT02984878|3453336|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600723|NCT02984878|3453334|B3||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3600724|NCT02984878|3453335|B2||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3600725|NCT02984878|3453336|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3600726|NCT02984878|3453334|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3600727|NCT02984878|3453335|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3600728|NCT02984878|3453336|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3600729|NCT02984878|3453334|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600730|NCT02984878|3453335|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600731|NCT02984878|3453336|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600732|NCT02984878|3453334|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600733|NCT02984878|3453335|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600734|NCT02984878|3453336|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600735|NCT02984878|3453334|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600736|NCT02984878|3453335|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600737|NCT02984878|3453336|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600738|NCT02984878|3453334|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600739|NCT02984878|3453335|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600740|NCT02984878|3453336|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600741|NCT02984878|3453334|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3600742|NCT02984878|3453335|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3600743|NCT02984878|3453336|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3600744|NCT02984878|3453334|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3600745|NCT02984878|3453335|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3600746|NCT02984878|3453336|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3600747|NCT02984878|3453334|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3600748|NCT02984878|3453335|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3600749|NCT02984878|3453336|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3600750|NCT02984878|3453334|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3600751|NCT02984878|3453335|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3600752|NCT02984878|3453336|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3600753|NCT02984878|3453334|B3|> = 75 years||Age, Customized|participants in each age group|Participants|Count of Participants|2|2.0||||||
3600754|NCT02984878|3453335|B2|> = 75 years||Age, Customized|participants in each age group|Participants|Count of Participants|0|0.0||||||
3600755|NCT02984878|3453336|B1|> = 75 years||Age, Customized|participants in each age group|Participants|Count of Participants|2|2.0||||||
3600756|NCT02984878|3453334|B3|64 to <75 years||Age, Customized|participants in each age group|Participants|Count of Participants|15|15.0||||||
3600757|NCT02984878|3453335|B2|64 to <75 years||Age, Customized|participants in each age group|Participants|Count of Participants|9|9.0||||||
3600758|NCT02984878|3453336|B1|64 to <75 years||Age, Customized|participants in each age group|Participants|Count of Participants|6|6.0||||||
3600763|NCT02984878|3453335|B2|22 to <40 years||Age, Customized|participants in each age group|Participants|Count of Participants|5|5.0||||||
3600764|NCT02984878|3453336|B1|22 to <40 years||Age, Customized|participants in each age group|Participants|Count of Participants|1|1.0||||||
3600765|NCT02984878|3453334|B3|||Age||years|Mean|56.1|56.1|Standard Deviation|10.05|10.05|||
3600766|NCT02984878|3453335|B2|||Age||years|Mean|54.5|54.5|Standard Deviation|10.44|10.44|||
3600767|NCT02984878|3453336|B1|||Age||years|Mean|58.3|58.3|Standard Deviation|9.19|9.19|||
3600768|NCT02984267|3453347|B3||No|Palpable interspace|"A patient has palpable interspaces when the spinous processes of the vertebrae, and thus the interspaces between them, can easily be physically felt by the provider through the patient's skin."|Participants|Count of Participants|4|4.0||||||
3600769|NCT02984267|3453348|B2||No|Palpable interspace|"A patient has palpable interspaces when the spinous processes of the vertebrae, and thus the interspaces between them, can easily be physically felt by the provider through the patient's skin."|Participants|Count of Participants|4|4.0||||||
3600770|NCT02984267|3453349|B1||No|Palpable interspace|"A patient has palpable interspaces when the spinous processes of the vertebrae, and thus the interspaces between them, can easily be physically felt by the provider through the patient's skin."|Participants|Count of Participants|0|0.0||||||
3600771|NCT02984267|3453347|B3||Yes|Palpable interspace|"A patient has palpable interspaces when the spinous processes of the vertebrae, and thus the interspaces between them, can easily be physically felt by the provider through the patient's skin."|Participants|Count of Participants|5|5.0||||||
3600772|NCT02984267|3453348|B2||Yes|Palpable interspace|"A patient has palpable interspaces when the spinous processes of the vertebrae, and thus the interspaces between them, can easily be physically felt by the provider through the patient's skin."|Participants|Count of Participants|5|5.0||||||
3600773|NCT02984267|3453349|B1||Yes|Palpable interspace|"A patient has palpable interspaces when the spinous processes of the vertebrae, and thus the interspaces between them, can easily be physically felt by the provider through the patient's skin."|Participants|Count of Participants|0|0.0||||||
3600774|NCT02984267|3453347|B3||No|External landmarks visible|The back of the patient is visually examined to determine if the outline of the spinous processes of the vertebrae can be seen through the skin.|Participants|Count of Participants|16|16.0||||||
3600775|NCT02984267|3453348|B2||No|External landmarks visible|The back of the patient is visually examined to determine if the outline of the spinous processes of the vertebrae can be seen through the skin.|Participants|Count of Participants|9|9.0||||||
3600776|NCT02984267|3453349|B1||No|External landmarks visible|The back of the patient is visually examined to determine if the outline of the spinous processes of the vertebrae can be seen through the skin.|Participants|Count of Participants|7|7.0||||||
3600777|NCT02984267|3453347|B3||Yes|External landmarks visible|The back of the patient is visually examined to determine if the outline of the spinous processes of the vertebrae can be seen through the skin.|Participants|Count of Participants|0|0.0||||||
3600778|NCT02984267|3453348|B2||Yes|External landmarks visible|The back of the patient is visually examined to determine if the outline of the spinous processes of the vertebrae can be seen through the skin.|Participants|Count of Participants|0|0.0||||||
3600779|NCT02984267|3453349|B1||Yes|External landmarks visible|The back of the patient is visually examined to determine if the outline of the spinous processes of the vertebrae can be seen through the skin.|Participants|Count of Participants|0|0.0||||||
3600780|NCT02984267|3453347|B3||ASA3|American Society of Anesthesiologists (ASA) physical status|ASA1, ASA2, and ASA3 are all categories that participants could fall into based on the status of their overall health. ASA1 indicates a normal, healthy patient. ASA2 indicates a patient with mild systemic disease (examples include but are not limited to pregnancy, current smoker, obesity with a BMI >30 but <40, and well controlled diabetes or hypertension). ASA3 indicates a patient with severe systemic disease (examples include but are not limited to poorly controlled diabetes or hypertension, chronic obstructive pulmonary disorder, morbid obesity with a BMI greater than or equal to 40).|Participants|Count of Participants|16|16.0||||||
3600781|NCT02984267|3453348|B2||ASA3|American Society of Anesthesiologists (ASA) physical status|ASA1, ASA2, and ASA3 are all categories that participants could fall into based on the status of their overall health. ASA1 indicates a normal, healthy patient. ASA2 indicates a patient with mild systemic disease (examples include but are not limited to pregnancy, current smoker, obesity with a BMI >30 but <40, and well controlled diabetes or hypertension). ASA3 indicates a patient with severe systemic disease (examples include but are not limited to poorly controlled diabetes or hypertension, chronic obstructive pulmonary disorder, morbid obesity with a BMI greater than or equal to 40).|Participants|Count of Participants|9|9.0||||||
3600782|NCT02984267|3453349|B1||ASA3|American Society of Anesthesiologists (ASA) physical status|ASA1, ASA2, and ASA3 are all categories that participants could fall into based on the status of their overall health. ASA1 indicates a normal, healthy patient. ASA2 indicates a patient with mild systemic disease (examples include but are not limited to pregnancy, current smoker, obesity with a BMI >30 but <40, and well controlled diabetes or hypertension). ASA3 indicates a patient with severe systemic disease (examples include but are not limited to poorly controlled diabetes or hypertension, chronic obstructive pulmonary disorder, morbid obesity with a BMI greater than or equal to 40).|Participants|Count of Participants|7|7.0||||||
3600783|NCT02984267|3453347|B3||ASA2|American Society of Anesthesiologists (ASA) physical status|ASA1, ASA2, and ASA3 are all categories that participants could fall into based on the status of their overall health. ASA1 indicates a normal, healthy patient. ASA2 indicates a patient with mild systemic disease (examples include but are not limited to pregnancy, current smoker, obesity with a BMI >30 but <40, and well controlled diabetes or hypertension). ASA3 indicates a patient with severe systemic disease (examples include but are not limited to poorly controlled diabetes or hypertension, chronic obstructive pulmonary disorder, morbid obesity with a BMI greater than or equal to 40).|Participants|Count of Participants|0|0.0||||||
3600820|NCT02984267|3453348|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600821|NCT02984267|3453349|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600822|NCT02984267|3453347|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600823|NCT02984267|3453348|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600784|NCT02984267|3453348|B2||ASA2|American Society of Anesthesiologists (ASA) physical status|ASA1, ASA2, and ASA3 are all categories that participants could fall into based on the status of their overall health. ASA1 indicates a normal, healthy patient. ASA2 indicates a patient with mild systemic disease (examples include but are not limited to pregnancy, current smoker, obesity with a BMI >30 but <40, and well controlled diabetes or hypertension). ASA3 indicates a patient with severe systemic disease (examples include but are not limited to poorly controlled diabetes or hypertension, chronic obstructive pulmonary disorder, morbid obesity with a BMI greater than or equal to 40).|Participants|Count of Participants|0|0.0||||||
3600785|NCT02984267|3453349|B1||ASA2|American Society of Anesthesiologists (ASA) physical status|ASA1, ASA2, and ASA3 are all categories that participants could fall into based on the status of their overall health. ASA1 indicates a normal, healthy patient. ASA2 indicates a patient with mild systemic disease (examples include but are not limited to pregnancy, current smoker, obesity with a BMI >30 but <40, and well controlled diabetes or hypertension). ASA3 indicates a patient with severe systemic disease (examples include but are not limited to poorly controlled diabetes or hypertension, chronic obstructive pulmonary disorder, morbid obesity with a BMI greater than or equal to 40).|Participants|Count of Participants|0|0.0||||||
3600786|NCT02984267|3453347|B3||ASA1|American Society of Anesthesiologists (ASA) physical status|ASA1, ASA2, and ASA3 are all categories that participants could fall into based on the status of their overall health. ASA1 indicates a normal, healthy patient. ASA2 indicates a patient with mild systemic disease (examples include but are not limited to pregnancy, current smoker, obesity with a BMI >30 but <40, and well controlled diabetes or hypertension). ASA3 indicates a patient with severe systemic disease (examples include but are not limited to poorly controlled diabetes or hypertension, chronic obstructive pulmonary disorder, morbid obesity with a BMI greater than or equal to 40).|Participants|Count of Participants|0|0.0||||||
3600787|NCT02984267|3453348|B2||ASA1|American Society of Anesthesiologists (ASA) physical status|ASA1, ASA2, and ASA3 are all categories that participants could fall into based on the status of their overall health. ASA1 indicates a normal, healthy patient. ASA2 indicates a patient with mild systemic disease (examples include but are not limited to pregnancy, current smoker, obesity with a BMI >30 but <40, and well controlled diabetes or hypertension). ASA3 indicates a patient with severe systemic disease (examples include but are not limited to poorly controlled diabetes or hypertension, chronic obstructive pulmonary disorder, morbid obesity with a BMI greater than or equal to 40).|Participants|Count of Participants|0|0.0||||||
3600788|NCT02984267|3453349|B1||ASA1|American Society of Anesthesiologists (ASA) physical status|ASA1, ASA2, and ASA3 are all categories that participants could fall into based on the status of their overall health. ASA1 indicates a normal, healthy patient. ASA2 indicates a patient with mild systemic disease (examples include but are not limited to pregnancy, current smoker, obesity with a BMI >30 but <40, and well controlled diabetes or hypertension). ASA3 indicates a patient with severe systemic disease (examples include but are not limited to poorly controlled diabetes or hypertension, chronic obstructive pulmonary disorder, morbid obesity with a BMI greater than or equal to 40).|Participants|Count of Participants|0|0.0||||||
3600789|NCT02984267|3453347|B3|||Body mass index||kg/m^2|Mean|45.8|45.8|Standard Deviation|6.6|6.6|||
3600790|NCT02984267|3453348|B2|||Body mass index||kg/m^2|Mean|45.9|45.9|Standard Deviation|6.3|6.3|||
3600791|NCT02984267|3453349|B1|||Body mass index||kg/m^2|Mean|45.6|45.6|Standard Deviation|7.4|7.4|||
3600792|NCT02984267|3453347|B3|||Height||cm|Mean|162.8|162.8|Standard Deviation|5.2|5.2|||
3600793|NCT02984267|3453348|B2|||Height||cm|Mean|162.1|162.1|Standard Deviation|5.3|5.3|||
3600794|NCT02984267|3453349|B1|||Height||cm|Mean|163.7|163.7|Standard Deviation|5.3|5.3|||
3600795|NCT02984267|3453347|B3|||Weight||kg|Mean|121.2|121.2|Standard Deviation|15.8|15.8|||
3600796|NCT02984267|3453348|B2|||Weight||kg|Mean|120.6|120.6|Standard Deviation|15.8|15.8|||
3600797|NCT02984267|3453349|B1|||Weight||kg|Mean|122.0|122.0|Standard Deviation|17.1|17.1|||
3600798|NCT02984267|3453347|B3|||Estimated gestational age||Weeks|Mean|38.7|38.7|Standard Deviation|1.1|1.1|||
3600799|NCT02984267|3453348|B2|||Estimated gestational age||Weeks|Mean|38.1|38.1|Standard Deviation|1.1|1.1|||
3600800|NCT02984267|3453349|B1|||Estimated gestational age||Weeks|Mean|39.6|39.6|Standard Deviation|0.8|0.8|||
3600801|NCT02984267|3453347|B3|||Parity||Number of children born|Median|0|0.0|Inter-Quartile Range|||0.0|1.0|
3600802|NCT02984267|3453348|B2|||Parity||Number of children born|Median|0|0.0|Inter-Quartile Range|||0.0|1.0|
3600803|NCT02984267|3453349|B1|||Parity||Number of children born|Median|0|0.0|Inter-Quartile Range|||0.0|1.0|
3600804|NCT02984267|3453347|B3|||Gravidity||Number of pregnancies|Median|2|2.0|Inter-Quartile Range|||1.0|3.0|
3600805|NCT02984267|3453348|B2|||Gravidity||Number of pregnancies|Median|2|2.0|Inter-Quartile Range|||1.0|3.0|
3600806|NCT02984267|3453349|B1|||Gravidity||Number of pregnancies|Median|1|1.0|Inter-Quartile Range|||1.0|2.0|
3600807|NCT02984267|3453347|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600808|NCT02984267|3453348|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600809|NCT02984267|3453349|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600810|NCT02984267|3453347|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600811|NCT02984267|3453348|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600812|NCT02984267|3453349|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600813|NCT02984267|3453347|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3600814|NCT02984267|3453348|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3600815|NCT02984267|3453349|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3600816|NCT02984267|3453347|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3600817|NCT02984267|3453348|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3600818|NCT02984267|3453349|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3600819|NCT02984267|3453347|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600825|NCT02984267|3453347|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600826|NCT02984267|3453348|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600827|NCT02984267|3453349|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600828|NCT02984267|3453347|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3600829|NCT02984267|3453348|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3600830|NCT02984267|3453349|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3600831|NCT02984267|3453347|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3600832|NCT02984267|3453348|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3600833|NCT02984267|3453349|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3600834|NCT02984267|3453347|B3|||Age||years|Mean|27.9|27.9|Standard Deviation|5.4|5.4|||
3600835|NCT02984267|3453348|B2|||Age||years|Mean|29.9|29.9|Standard Deviation|5.5|5.5|||
3600836|NCT02984267|3453349|B1|||Age||years|Mean|25.3|25.3|Standard Deviation|4.7|4.7|||
3600837|NCT02983981|3453374|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3600838|NCT02983981|3453374|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3600839|NCT02983981|3453374|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3600840|NCT02983981|3453374|B1|||Age||years|Mean|53.33|53.33|Standard Deviation|7.92|7.92|||
3600841|NCT02982863|3453381|B6||Male|Sex: Female, Male||Participants|Count of Participants|24089|24089.0||||||
3600842|NCT02982863|3453382|B5||Male|Sex: Female, Male||Participants|Count of Participants|1138|1138.0||||||
3600843|NCT02982863|3453383|B4||Male|Sex: Female, Male||Participants|Count of Participants|5575|5575.0||||||
3600844|NCT02982863|3453384|B3||Male|Sex: Female, Male||Participants|Count of Participants|6649|6649.0||||||
3600845|NCT02982863|3453385|B2||Male|Sex: Female, Male||Participants|Count of Participants|7416|7416.0||||||
3600846|NCT02982863|3453386|B1||Male|Sex: Female, Male||Participants|Count of Participants|3311|3311.0||||||
3600847|NCT02982863|3453381|B6||Female|Sex: Female, Male||Participants|Count of Participants|15743|15743.0||||||
3600848|NCT02982863|3453382|B5||Female|Sex: Female, Male||Participants|Count of Participants|1130|1130.0||||||
3600849|NCT02982863|3453383|B4||Female|Sex: Female, Male||Participants|Count of Participants|3183|3183.0||||||
3600850|NCT02982863|3453384|B3||Female|Sex: Female, Male||Participants|Count of Participants|4737|4737.0||||||
3600851|NCT02982863|3453385|B2||Female|Sex: Female, Male||Participants|Count of Participants|5068|5068.0||||||
3600852|NCT02982863|3453386|B1||Female|Sex: Female, Male||Participants|Count of Participants|1625|1625.0||||||
3600853|NCT02982863|3453381|B6|||Age||Years|Mean|76|76.0|Standard Deviation|10|10.0|||
3600854|NCT02982863|3453382|B5|||Age||Years|Mean|77|77.0|Standard Deviation|10|10.0|||
3600855|NCT02982863|3453383|B4|||Age||Years|Mean|74|74.0|Standard Deviation|11|11.0|||
3600856|NCT02982863|3453384|B3|||Age||Years|Mean|77|77.0|Standard Deviation|10|10.0|||
3600857|NCT02982863|3453385|B2|||Age||Years|Mean|78|78.0|Standard Deviation|10|10.0|||
3600858|NCT02982863|3453386|B1|||Age||Years|Mean|72|72.0|Standard Deviation|10|10.0|||
3600859|NCT02982018|3453447|B3|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3600860|NCT02982018|3453448|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3600861|NCT02982018|3453449|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3600862|NCT02982018|3453447|B3|White||Race/Ethnicity, Customized||Participants|Number|118|118.0||||||
3600863|NCT02982018|3453448|B2|White||Race/Ethnicity, Customized||Participants|Number|62|62.0||||||
3600864|NCT02982018|3453449|B1|White||Race/Ethnicity, Customized||Participants|Number|56|56.0||||||
3600865|NCT02982018|3453447|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3600866|NCT02982018|3453448|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3600867|NCT02982018|3453449|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3600868|NCT02982018|3453447|B3|Asian||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3600869|NCT02982018|3453448|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3600870|NCT02982018|3453449|B1|Asian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3600871|NCT02982018|3453447|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3600872|NCT02982018|3453448|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3600873|NCT02982018|3453449|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3600874|NCT02982018|3453447|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3600875|NCT02982018|3453448|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3600876|NCT02982018|3453449|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3600877|NCT02982018|3453447|B3|||Age||Years|Mean|31.6|31.6|Standard Deviation|8.02|8.02|||
3600878|NCT02982018|3453448|B2|||Age||Years|Mean|32.1|32.1|Standard Deviation|7.99|7.99|||
3600879|NCT02982018|3453449|B1|||Age||Years|Mean|31.2|31.2|Standard Deviation|8.15|8.15|||
3600880|NCT02979639|3453464|B1|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Number|332|332.0||||||
3600881|NCT02979639|3453464|B1|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3600882|NCT02979639|3453464|B1|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3600883|NCT02979639|3453464|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3600884|NCT02979639|3453464|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3600885|NCT02979639|3453464|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3600886|NCT02979639|3453464|B1|African Heritage/African American||Race/Ethnicity, Customized||Participants|Number|48|48.0||||||
3600887|NCT02979639|3453464|B1||Male|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3600888|NCT02979639|3453464|B1||Female|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
3600889|NCT02979639|3453464|B1|||Age||Years|Mean|64.6|64.6|Standard Deviation|8.8|8.8|||
3600890|NCT02978833|3453480|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3600891|NCT02978833|3453481|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3600892|NCT02978833|3453482|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3600893|NCT02978833|3453480|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600894|NCT02978833|3453481|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600895|NCT02978833|3453482|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600896|NCT02978833|3453480|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600897|NCT02978833|3453481|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600898|NCT02978833|3453482|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600899|NCT02978833|3453480|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3600900|NCT02978833|3453481|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3600901|NCT02978833|3453482|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3600902|NCT02978833|3453480|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600903|NCT02978833|3453481|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600904|NCT02978833|3453482|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600905|NCT02978833|3453480|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600906|NCT02978833|3453481|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600907|NCT02978833|3453482|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600908|NCT02978833|3453480|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600909|NCT02978833|3453481|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600910|NCT02978833|3453482|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600911|NCT02978833|3453480|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600912|NCT02978833|3453481|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600913|NCT02978833|3453482|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600914|NCT02978833|3453480|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3600915|NCT02978833|3453481|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3600916|NCT02978833|3453482|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3600917|NCT02978833|3453480|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3600918|NCT02978833|3453481|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3600919|NCT02978833|3453482|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3600920|NCT02978833|3453480|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3600921|NCT02978833|3453481|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3600922|NCT02978833|3453482|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3600923|NCT02978833|3453480|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3600924|NCT02978833|3453481|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3600925|NCT02978833|3453482|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3600926|NCT02978833|3453480|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3600927|NCT02978833|3453481|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3600928|NCT02978833|3453482|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3600929|NCT02977572|3453499|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3600930|NCT02977572|3453500|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3600931|NCT02977572|3453501|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3600932|NCT02977572|3453499|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3600933|NCT02977572|3453500|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3600934|NCT02977572|3453501|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3600935|NCT02977572|3453499|B3||>=65 years|Age||Participants|Count of Participants|78|78.0||||||
3600936|NCT02977572|3453500|B2||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
3600937|NCT02977572|3453501|B1||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
3600938|NCT02977572|3453499|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3600939|NCT02977572|3453500|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3600940|NCT02977572|3453501|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3600941|NCT02977572|3453499|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3600942|NCT02977572|3453500|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3600943|NCT02977572|3453501|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3600944|NCT02977507|3453524|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3601189|NCT02972515|3453692|B1||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3600945|NCT02977507|3453524|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3600946|NCT02977507|3453524|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3600947|NCT02977507|3453524|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3600948|NCT02977507|3453524|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3600949|NCT02977507|3453524|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3600950|NCT02977507|3453524|B1|||Age||years|Mean|53|53.0|Standard Deviation|10.1|10.1|||
3600951|NCT02974543|3453548|B3|||Tinnitus Loudness|Tinnitus matching loudness score at baseline assessment. Subjects are guided through a self-directed computerized assessment software that estimates how loud (in decibels/dB) they perceive their tinnitus to be (TinnTester). This measure will be performed at baseline, as well as time points following active, washout, or sham periods.|dB|Mean|54.42|54.42|Standard Deviation|14.77|14.77|||
3600952|NCT02974543|3453549|B2|||Tinnitus Loudness|Tinnitus matching loudness score at baseline assessment. Subjects are guided through a self-directed computerized assessment software that estimates how loud (in decibels/dB) they perceive their tinnitus to be (TinnTester). This measure will be performed at baseline, as well as time points following active, washout, or sham periods.|dB|Mean|49.85|49.85|Standard Deviation|18.25|18.25|||
3600953|NCT02974543|3453550|B1|||Tinnitus Loudness|Tinnitus matching loudness score at baseline assessment. Subjects are guided through a self-directed computerized assessment software that estimates how loud (in decibels/dB) they perceive their tinnitus to be (TinnTester). This measure will be performed at baseline, as well as time points following active, washout, or sham periods.|dB|Mean|58.99|58.99|Standard Deviation|14.77|14.77|||
3600954|NCT02974543|3453548|B3|||Tinnitus Functional Index (TFI)|Baseline measure of TFI score. TFI is a clinical questionnaire that assesses tinnitus impact on a subject's quality of life. It uses a scale of 0 - 100 where 0 means no negative impact on quality of life from tinnitus and 100 is devastating impact. This measure will be performed at baseline, as well as time points following active, washout, or sham periods.|units on a scale|Mean|31.78|31.78|Standard Deviation|16.70|16.7|||
3600955|NCT02974543|3453549|B2|||Tinnitus Functional Index (TFI)|Baseline measure of TFI score. TFI is a clinical questionnaire that assesses tinnitus impact on a subject's quality of life. It uses a scale of 0 - 100 where 0 means no negative impact on quality of life from tinnitus and 100 is devastating impact. This measure will be performed at baseline, as well as time points following active, washout, or sham periods.|units on a scale|Mean|26.66|26.66|Standard Deviation|14.78|14.78|||
3600956|NCT02974543|3453550|B1|||Tinnitus Functional Index (TFI)|Baseline measure of TFI score. TFI is a clinical questionnaire that assesses tinnitus impact on a subject's quality of life. It uses a scale of 0 - 100 where 0 means no negative impact on quality of life from tinnitus and 100 is devastating impact. This measure will be performed at baseline, as well as time points following active, washout, or sham periods.|units on a scale|Mean|34.88|34.88|Standard Deviation|16.70|16.7|||
3600957|NCT02974543|3453548|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3600958|NCT02974543|3453549|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3600959|NCT02974543|3453550|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3600960|NCT02974543|3453548|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3600961|NCT02974543|3453549|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3600962|NCT02974543|3453550|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3600963|NCT02974543|3453548|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3600964|NCT02974543|3453549|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3600965|NCT02974543|3453550|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3600966|NCT02974543|3453548|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3600967|NCT02974543|3453549|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3600968|NCT02974543|3453550|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3600969|NCT02974543|3453548|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3600970|NCT02974543|3453549|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3600971|NCT02974543|3453550|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3600972|NCT02974543|3453548|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3600973|NCT02974543|3453549|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3600974|NCT02974543|3453550|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3600975|NCT02974140|3453571|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600976|NCT02974140|3453571|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600977|NCT02974140|3453571|B1||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3600978|NCT02974140|3453571|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3600979|NCT02974140|3453571|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600980|NCT02974140|3453571|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600981|NCT02974140|3453571|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600982|NCT02974140|3453571|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3600983|NCT02974140|3453571|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3600984|NCT02974140|3453571|B1|||Age||years|Mean|67.7|67.7|Standard Deviation|7.8|7.8|||
3600985|NCT02974114|3453584|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600986|NCT02974114|3453585|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600987|NCT02974114|3453586|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600988|NCT02974114|3453587|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600989|NCT02974114|3453584|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3600990|NCT02974114|3453585|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3600991|NCT02974114|3453586|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600992|NCT02974114|3453587|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3600993|NCT02974114|3453584|B4||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3600994|NCT02974114|3453585|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3600995|NCT02974114|3453586|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3600996|NCT02974114|3453587|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3600997|NCT02974114|3453584|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3600998|NCT02974114|3453585|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3600999|NCT02974114|3453586|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601000|NCT02974114|3453587|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3601001|NCT02974114|3453584|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601002|NCT02974114|3453585|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601003|NCT02974114|3453586|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601004|NCT02974114|3453587|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601005|NCT02974114|3453584|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3601006|NCT02974114|3453585|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3601007|NCT02974114|3453586|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3601008|NCT02974114|3453587|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3601009|NCT02974114|3453584|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601010|NCT02974114|3453585|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601011|NCT02974114|3453586|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601012|NCT02974114|3453587|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601013|NCT02974114|3453584|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3601014|NCT02974114|3453585|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3601015|NCT02974114|3453586|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3601016|NCT02974114|3453587|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3601017|NCT02974114|3453584|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3601018|NCT02974114|3453585|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3601019|NCT02974114|3453586|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3601020|NCT02974114|3453587|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3601021|NCT02974114|3453584|B4|||Age||Years|Mean|33.2|33.2|Standard Deviation|12.31|12.31|||
3601022|NCT02974114|3453585|B3|||Age||Years|Mean|40.0|40.0|Standard Deviation|15.87|15.87|||
3601023|NCT02974114|3453586|B2|||Age||Years|Mean|30.0|30.0|Standard Deviation|9.45|9.45|||
3601024|NCT02974114|3453587|B1|||Age||Years|Mean|27.8|27.8|Standard Deviation|4.83|4.83|||
3601025|NCT02973100|3453630|B5|||Baseline Hemoglobin A1c (HbA1c)|HbA1c is the glycosylated fraction of hemoglobin A. HbA1c is measured primarily to identify average plasma glucose concentration over prolonged periods of time.|Percentage of glycosylated hemoglobin|Mean|8.09|8.09|Standard Deviation|0.83|0.83|||
3601026|NCT02973100|3453631|B4|||Baseline Hemoglobin A1c (HbA1c)|HbA1c is the glycosylated fraction of hemoglobin A. HbA1c is measured primarily to identify average plasma glucose concentration over prolonged periods of time.|Percentage of glycosylated hemoglobin|Mean|8.12|8.12|Standard Deviation|0.81|0.81|||
3601027|NCT02973100|3453632|B3|||Baseline Hemoglobin A1c (HbA1c)|HbA1c is the glycosylated fraction of hemoglobin A. HbA1c is measured primarily to identify average plasma glucose concentration over prolonged periods of time.|Percentage of glycosylated hemoglobin|Mean|8.16|8.16|Standard Deviation|0.92|0.92|||
3601028|NCT02973100|3453633|B2|||Baseline Hemoglobin A1c (HbA1c)|HbA1c is the glycosylated fraction of hemoglobin A. HbA1c is measured primarily to identify average plasma glucose concentration over prolonged periods of time.|Percentage of glycosylated hemoglobin|Mean|8.02|8.02|Standard Deviation|0.80|0.8|||
3601029|NCT02973100|3453634|B1|||Baseline Hemoglobin A1c (HbA1c)|HbA1c is the glycosylated fraction of hemoglobin A. HbA1c is measured primarily to identify average plasma glucose concentration over prolonged periods of time.|Percentage of glycosylated hemoglobin|Mean|8.08|8.08|Standard Deviation|0.79|0.79|||
3601030|NCT02973100|3453630|B5|Mexico||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3601031|NCT02973100|3453631|B4|Mexico||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3601032|NCT02973100|3453632|B3|Mexico||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3601033|NCT02973100|3453633|B2|Mexico||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3601034|NCT02973100|3453634|B1|Mexico||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3601035|NCT02973100|3453630|B5|Poland||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3601036|NCT02973100|3453631|B4|Poland||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3601037|NCT02973100|3453632|B3|Poland||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3601038|NCT02973100|3453633|B2|Poland||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3601039|NCT02973100|3453634|B1|Poland||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3601040|NCT02973100|3453630|B5|Czechia||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3601041|NCT02973100|3453631|B4|Czechia||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3601042|NCT02973100|3453632|B3|Czechia||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3601043|NCT02973100|3453633|B2|Czechia||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3601044|NCT02973100|3453634|B1|Czechia||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3601045|NCT02973100|3453630|B5|United States||Region of Enrollment||Participants|Count of Participants|174|174.0||||||
3601046|NCT02973100|3453631|B4|United States||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
3601047|NCT02973100|3453632|B3|United States||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3601048|NCT02973100|3453633|B2|United States||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3601049|NCT02973100|3453634|B1|United States||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3601050|NCT02973100|3453630|B5|Romania||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3601051|NCT02973100|3453631|B4|Romania||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3601052|NCT02973100|3453632|B3|Romania||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3601053|NCT02973100|3453633|B2|Romania||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3601054|NCT02973100|3453634|B1|Romania||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3601055|NCT02973100|3453630|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3601056|NCT02973100|3453631|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601057|NCT02973100|3453632|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3601058|NCT02973100|3453633|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601059|NCT02973100|3453634|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601060|NCT02973100|3453630|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3601061|NCT02973100|3453631|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3601062|NCT02973100|3453632|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3601063|NCT02973100|3453633|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3601064|NCT02973100|3453634|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3601065|NCT02973100|3453630|B5||White|Race (NIH/OMB)||Participants|Count of Participants|244|244.0||||||
3601066|NCT02973100|3453631|B4||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3601067|NCT02973100|3453632|B3||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3601068|NCT02973100|3453633|B2||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3601069|NCT02973100|3453634|B1||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3601070|NCT02973100|3453630|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3601071|NCT02973100|3453631|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3601072|NCT02973100|3453632|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3601073|NCT02973100|3453633|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3601074|NCT02973100|3453634|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3601075|NCT02973100|3453630|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3601076|NCT02973100|3453631|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601077|NCT02973100|3453632|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601078|NCT02973100|3453633|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601079|NCT02973100|3453634|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3601080|NCT02973100|3453630|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3601081|NCT02973100|3453631|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3601082|NCT02973100|3453632|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3601083|NCT02973100|3453633|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601084|NCT02973100|3453634|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601085|NCT02973100|3453630|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3601086|NCT02973100|3453631|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3601087|NCT02973100|3453632|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3601088|NCT02973100|3453633|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3601089|NCT02973100|3453634|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3601090|NCT02973100|3453630|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3601091|NCT02973100|3453631|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3601092|NCT02973100|3453632|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3601093|NCT02973100|3453633|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601094|NCT02973100|3453634|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601095|NCT02973100|3453630|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|180|180.0||||||
3601096|NCT02973100|3453631|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3601097|NCT02973100|3453632|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3601098|NCT02973100|3453633|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3601099|NCT02973100|3453634|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3601100|NCT02973100|3453630|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|135|135.0||||||
3601101|NCT02973100|3453631|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3601102|NCT02973100|3453632|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3601103|NCT02973100|3453633|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3601104|NCT02973100|3453634|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3601105|NCT02973100|3453630|B5||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3601106|NCT02973100|3453631|B4||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3601107|NCT02973100|3453632|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3601108|NCT02973100|3453633|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3601109|NCT02973100|3453634|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3601110|NCT02973100|3453630|B5||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
3601111|NCT02973100|3453631|B4||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3601112|NCT02973100|3453632|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3601113|NCT02973100|3453633|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3601114|NCT02973100|3453634|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3601115|NCT02973100|3453630|B5|||Age||Years|Mean|56.80|56.8|Standard Deviation|9.77|9.77|||
3601116|NCT02973100|3453631|B4|||Age||Years|Mean|57.13|57.13|Standard Deviation|9.63|9.63|||
3601117|NCT02973100|3453632|B3|||Age||Years|Mean|55.90|55.9|Standard Deviation|10.74|10.74|||
3601118|NCT02973100|3453633|B2|||Age||Years|Mean|57.65|57.65|Standard Deviation|9.79|9.79|||
3601119|NCT02973100|3453634|B1|||Age||Years|Mean|56.52|56.52|Standard Deviation|8.93|8.93|||
3601120|NCT02972554|3453673|B3|||Negative, High Arousal Emotion|"Self-report measure of affect (emotion) state using the Positive and Negative Affect Schedule (PANAS). Answered on a Likert scale from 0 (not at all) - 6 (very much). Mean score range is from 0-6. Higher numbers indicate more negative, high arousal emotions; low numbers indicate less negative, high arousal emotions."|scores on a scale|Mean|1.23|1.23|Standard Deviation|.26|0.26|||
3601121|NCT02972554|3453674|B2|||Negative, High Arousal Emotion|"Self-report measure of affect (emotion) state using the Positive and Negative Affect Schedule (PANAS). Answered on a Likert scale from 0 (not at all) - 6 (very much). Mean score range is from 0-6. Higher numbers indicate more negative, high arousal emotions; low numbers indicate less negative, high arousal emotions."|scores on a scale|Mean|1.25|1.25|Standard Deviation|.33|0.33|||
3601122|NCT02972554|3453675|B1|||Negative, High Arousal Emotion|"Self-report measure of affect (emotion) state using the Positive and Negative Affect Schedule (PANAS). Answered on a Likert scale from 0 (not at all) - 6 (very much). Mean score range is from 0-6. Higher numbers indicate more negative, high arousal emotions; low numbers indicate less negative, high arousal emotions."|scores on a scale|Mean|1.20|1.2|Standard Deviation|.19|0.19|||
3601123|NCT02972554|3453673|B3|||Respiratory Sinus Arrhythmia|Derived from electrocardiogram; measure of heart rate variability assessed as the ratio of low frequency/high frequency in the respiratory/cardiac power spectrum.|ratio|Mean|6.94|6.94|Standard Deviation|1.10|1.1|||
3601124|NCT02972554|3453674|B2|||Respiratory Sinus Arrhythmia|Derived from electrocardiogram; measure of heart rate variability assessed as the ratio of low frequency/high frequency in the respiratory/cardiac power spectrum.|ratio|Mean|7.02|7.02|Standard Deviation|1.02|1.02|||
3601125|NCT02972554|3453675|B1|||Respiratory Sinus Arrhythmia|Derived from electrocardiogram; measure of heart rate variability assessed as the ratio of low frequency/high frequency in the respiratory/cardiac power spectrum.|ratio|Mean|6.86|6.86|Standard Deviation|1.18|1.18|||
3601126|NCT02972554|3453673|B3|||Pre-Ejection Period|Derived from impedance cardiography and electrocardiogram.|milliseconds|Mean|118.32|118.32|Standard Deviation|15.99|15.99|||
3601127|NCT02972554|3453674|B2|||Pre-Ejection Period|Derived from impedance cardiography and electrocardiogram.|milliseconds|Mean|116.66|116.66|Standard Deviation|13.49|13.49|||
3601128|NCT02972554|3453675|B1|||Pre-Ejection Period|Derived from impedance cardiography and electrocardiogram.|milliseconds|Mean|119.97|119.97|Standard Deviation|18.48|18.48|||
3601129|NCT02972554|3453673|B3|||Salivary Alpha-Amylase|Concentration of alpha-amylase in saliva quantified by enzyme kinetic method.|picograms/mL|Mean|49.91|49.91|Standard Deviation|43.01|43.01|||
3601130|NCT02972554|3453674|B2|||Salivary Alpha-Amylase|Concentration of alpha-amylase in saliva quantified by enzyme kinetic method.|picograms/mL|Mean|55.13|55.13|Standard Deviation|47.17|47.17|||
3601131|NCT02972554|3453675|B1|||Salivary Alpha-Amylase|Concentration of alpha-amylase in saliva quantified by enzyme kinetic method.|picograms/mL|Mean|44.68|44.68|Standard Deviation|38.85|38.85|||
3601132|NCT02972554|3453673|B3|||Salivary Cortisol|Concentration of cortisol in saliva quantified quantified by chemiluminescence immunoassay with high sensitivity.|nanomole/L|Mean|10.07|10.07|Standard Deviation|12.55|12.55|||
3601133|NCT02972554|3453674|B2|||Salivary Cortisol|Concentration of cortisol in saliva quantified quantified by chemiluminescence immunoassay with high sensitivity.|nanomole/L|Mean|8.62|8.62|Standard Deviation|12.05|12.05|||
3601134|NCT02972554|3453675|B1|||Salivary Cortisol|Concentration of cortisol in saliva quantified quantified by chemiluminescence immunoassay with high sensitivity.|nanomole/L|Mean|11.51|11.51|Standard Deviation|13.04|13.04|||
3601135|NCT02972554|3453673|B3|||Interleukin-6 (IL-6)|Measured in blood plasma using enzyme-linked immunosorbent assay. All units are log transformed prior to analysis to correct for skew in data.|log(picograms/mL)|Mean|-.99|-0.99|Standard Deviation|.88|0.88|||
3601136|NCT02972554|3453674|B2|||Interleukin-6 (IL-6)|Measured in blood plasma using enzyme-linked immunosorbent assay. All units are log transformed prior to analysis to correct for skew in data.|log(picograms/mL)|Mean|-.98|-0.98|Standard Deviation|.86|0.86|||
3601137|NCT02972554|3453675|B1|||Interleukin-6 (IL-6)|Measured in blood plasma using enzyme-linked immunosorbent assay. All units are log transformed prior to analysis to correct for skew in data.|log(picograms/mL)|Mean|-1.00|-1.0|Standard Deviation|.90|0.9|||
3601138|NCT02972554|3453673|B3|United States||Region of Enrollment||Participants|Count of Participants|92|92.0||||||
3601139|NCT02972554|3453674|B2|United States||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
3601140|NCT02972554|3453675|B1|United States||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3601141|NCT02972554|3453673|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601142|NCT02972554|3453674|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601143|NCT02972554|3453675|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601144|NCT02972554|3453673|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3601145|NCT02972554|3453674|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3601146|NCT02972554|3453675|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3601147|NCT02972554|3453673|B3||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3601148|NCT02972554|3453674|B2||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3601149|NCT02972554|3453675|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3601150|NCT02972554|3453673|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3601151|NCT02972554|3453674|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3601152|NCT02972554|3453675|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3601153|NCT02972554|3453673|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601154|NCT02972554|3453674|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601155|NCT02972554|3453675|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601156|NCT02972554|3453673|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3601157|NCT02972554|3453674|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3601158|NCT02972554|3453675|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3601159|NCT02972554|3453673|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3601160|NCT02972554|3453674|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3601161|NCT02972554|3453675|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3601162|NCT02972554|3453673|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3601163|NCT02972554|3453674|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3601164|NCT02972554|3453675|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3601165|NCT02972554|3453673|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3601166|NCT02972554|3453674|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3601167|NCT02972554|3453675|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3601168|NCT02972554|3453673|B3|||Age||Years|Mean|20.28|20.28|Standard Deviation|1.42|1.42|||
3601169|NCT02972554|3453674|B2|||Age||Years|Mean|20.49|20.49|Standard Deviation|1.56|1.56|||
3601170|NCT02972554|3453675|B1|||Age||Years|Mean|20.07|20.07|Standard Deviation|1.28|1.28|||
3601171|NCT02972554|3453673|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3601172|NCT02972554|3453674|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3601173|NCT02972554|3453675|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3601174|NCT02972554|3453673|B3||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
3601175|NCT02972554|3453674|B2||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
3601176|NCT02972554|3453675|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3601177|NCT02972554|3453673|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3601178|NCT02972554|3453674|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3601179|NCT02972554|3453675|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3601180|NCT02972515|3453692|B1|||Use of any guided imagery||minutes of any guided imagery daily|Mean|1.77|1.77|Standard Deviation|1.19|1.19|||
3601181|NCT02972515|3453692|B1|||Minutes of Exercise per Day||Minutes of exercise per day|Mean|25.48|25.48|Standard Deviation|23.75|23.75|||
3601182|NCT02972515|3453692|B1|||Frequency of fruit intake||servings of fruit per day|Mean|3.70|3.7|Standard Deviation|1.91|1.91|||
3601183|NCT02972515|3453692|B1|||Weight||pounds|Mean|169.8|169.8|Standard Deviation|43.0|43.0|||
3601184|NCT02972515|3453692|B1|||Cigarettes per day||Cigarettes per Day|Mean|16.0|16.0|Standard Deviation|13.2|13.2|||
3601185|NCT02972515|3453692|B1|||Smoked last 30 days||Participants|Count of Participants|73|73.0||||||
3601186|NCT02972515|3453692|B1|United States||Region of Enrollment||participants|Number|73|73.0||||||
3601187|NCT02972515|3453692|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3601188|NCT02972515|3453692|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3601190|NCT02972515|3453692|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3601191|NCT02972515|3453692|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601192|NCT02972515|3453692|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3601193|NCT02972515|3453692|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601194|NCT02972515|3453692|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3601195|NCT02972515|3453692|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3601196|NCT02972515|3453692|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3601197|NCT02972515|3453692|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3601198|NCT02972515|3453692|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3601199|NCT02972515|3453692|B1|||Age||years|Mean|39.1|39.1|Standard Deviation|13.1|13.1|||
3601200|NCT02972502|3453699|B3|||Baseline Pain Score|Baseline Pain Score derived from Numeric Pain Intensity Scale. This scale is a patient-reported numeric measure of pain, from 0 [no pain] to 10 [worst pain imaginable.]|units on a scale|Mean|8.35|8.35|Standard Deviation|1.38|1.38|||
3601201|NCT02972502|3453700|B2|||Baseline Pain Score|Baseline Pain Score derived from Numeric Pain Intensity Scale. This scale is a patient-reported numeric measure of pain, from 0 [no pain] to 10 [worst pain imaginable.]|units on a scale|Mean|8.54|8.54|Standard Deviation|1.34|1.34|||
3601202|NCT02972502|3453701|B1|||Baseline Pain Score|Baseline Pain Score derived from Numeric Pain Intensity Scale. This scale is a patient-reported numeric measure of pain, from 0 [no pain] to 10 [worst pain imaginable.]|units on a scale|Mean|8.13|8.13|Standard Deviation|1.36|1.36|||
3601203|NCT02972502|3453699|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
3601204|NCT02972502|3453700|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
3601205|NCT02972502|3453701|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
3601206|NCT02972502|3453699|B3|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3601207|NCT02972502|3453700|B2|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3601208|NCT02972502|3453701|B1|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3601209|NCT02972502|3453699|B3|Race/Ethnicity|Somali|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3601210|NCT02972502|3453700|B2|Race/Ethnicity|Somali|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3601211|NCT02972502|3453701|B1|Race/Ethnicity|Somali|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3601212|NCT02972502|3453699|B3|Race/Ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3601213|NCT02972502|3453700|B2|Race/Ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3601214|NCT02972502|3453701|B1|Race/Ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3601215|NCT02972502|3453699|B3|Race/Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
3601216|NCT02972502|3453700|B2|Race/Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3601217|NCT02972502|3453701|B1|Race/Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3601218|NCT02972502|3453699|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3601219|NCT02972502|3453700|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3601220|NCT02972502|3453701|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3601221|NCT02972502|3453699|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3601222|NCT02972502|3453700|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3601223|NCT02972502|3453701|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3601224|NCT02972502|3453699|B3|||Age||years|Mean|35.7|35.7|Standard Deviation|10.0|10.0|||
3601225|NCT02972502|3453700|B2|||Age||years|Mean|36.9|36.9|Standard Deviation|10.0|10.0|||
3601226|NCT02972502|3453701|B1|||Age||years|Mean|34.5|34.5|Standard Deviation|9.9|9.9|||
3601227|NCT02971670|3453712|B5|Austria||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3601228|NCT02971670|3453713|B4|Austria||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3601229|NCT02971670|3453714|B3|Austria||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3601230|NCT02971670|3453715|B2|Austria||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3601231|NCT02971670|3453716|B1|Austria||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3601232|NCT02971670|3453712|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3601233|NCT02971670|3453713|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3601234|NCT02971670|3453714|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3601235|NCT02971670|3453715|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3601236|NCT02971670|3453716|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3601237|NCT02971670|3453712|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3601238|NCT02971670|3453713|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3601239|NCT02971670|3453714|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3601240|NCT02971670|3453715|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3601241|NCT02971670|3453716|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3601242|NCT02971670|3453712|B5|||Age||years|Mean|35.9|35.9|Standard Deviation|10.9|10.9|||
3601243|NCT02971670|3453713|B4|||Age||years|Mean|31.3|31.3|Standard Deviation|10.7|10.7|||
3601244|NCT02971670|3453714|B3|||Age||years|Mean|28.6|28.6|Standard Deviation|7.9|7.9|||
3601245|NCT02971670|3453715|B2|||Age||years|Mean|45|45.0|Standard Deviation|18.4|18.4|||
3601246|NCT02971670|3453716|B1|||Age||years|Mean|38.5|38.5|Standard Deviation|10.1|10.1|||
3601247|NCT02971670|3453712|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3601248|NCT02971670|3453713|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3601249|NCT02971670|3453714|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3601250|NCT02971670|3453715|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3601251|NCT02971670|3453716|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3601252|NCT02971670|3453712|B5||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3601253|NCT02971670|3453713|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3601254|NCT02971670|3453714|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3601255|NCT02971670|3453715|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3601256|NCT02971670|3453716|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3601257|NCT02971670|3453712|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3601258|NCT02971670|3453713|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3601259|NCT02971670|3453714|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3601260|NCT02971670|3453715|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3601261|NCT02971670|3453716|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3601262|NCT02971007|3453737|B4|||Body Mass Index (BMI)||kg/m2|Mean|30.21|30.21|Standard Deviation|7.819|7.819|||
3601263|NCT02971007|3453738|B3|||Body Mass Index (BMI)||kg/m2|Mean|29.50|29.5|Standard Deviation|6.973|6.973|||
3601264|NCT02971007|3453739|B2|||Body Mass Index (BMI)||kg/m2|Mean|30.64|30.64|Standard Deviation|8.411|8.411|||
3601265|NCT02971007|3453740|B1|||Body Mass Index (BMI)||kg/m2|Mean|30.49|30.49|Standard Deviation|8.136|8.136|||
3601266|NCT02971007|3453737|B4|United States||Region of Enrollment||participants|Number|137|137.0||||||
3601267|NCT02971007|3453738|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
3601268|NCT02971007|3453739|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
3601269|NCT02971007|3453740|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
3601270|NCT02971007|3453737|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601271|NCT02971007|3453738|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601272|NCT02971007|3453739|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601273|NCT02971007|3453740|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601274|NCT02971007|3453737|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601275|NCT02971007|3453738|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601276|NCT02971007|3453739|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601277|NCT02971007|3453740|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601278|NCT02971007|3453737|B4||White|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3601279|NCT02971007|3453738|B3||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3601280|NCT02971007|3453739|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3601281|NCT02971007|3453740|B1||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3601282|NCT02971007|3453737|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3601283|NCT02971007|3453738|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3601284|NCT02971007|3453739|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3601285|NCT02971007|3453740|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3601286|NCT02971007|3453737|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601287|NCT02971007|3453738|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601288|NCT02971007|3453739|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601289|NCT02971007|3453740|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601290|NCT02971007|3453737|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601291|NCT02971007|3453738|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601292|NCT02971007|3453739|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601293|NCT02971007|3453740|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601294|NCT02971007|3453737|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601295|NCT02971007|3453738|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601296|NCT02971007|3453739|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601297|NCT02971007|3453740|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601298|NCT02971007|3453737|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601299|NCT02971007|3453738|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601300|NCT02971007|3453739|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601301|NCT02971007|3453740|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601302|NCT02971007|3453737|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3601303|NCT02971007|3453738|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3601304|NCT02971007|3453739|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3601305|NCT02971007|3453740|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3601306|NCT02971007|3453737|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3601307|NCT02971007|3453738|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3601308|NCT02971007|3453739|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3601309|NCT02971007|3453740|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3601310|NCT02971007|3453737|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3601311|NCT02971007|3453738|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3601312|NCT02971007|3453739|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3601313|NCT02971007|3453740|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3601314|NCT02971007|3453737|B4||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3601315|NCT02971007|3453738|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3601316|NCT02971007|3453739|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3601317|NCT02971007|3453740|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3601318|NCT02971007|3453737|B4|||Age||years|Mean|35.4|35.4|Standard Deviation|11.24|11.24|||
3601319|NCT02971007|3453738|B3|||Age||years|Mean|34.3|34.3|Standard Deviation|11.25|11.25|||
3601320|NCT02971007|3453739|B2|||Age||years|Mean|36.2|36.2|Standard Deviation|9.77|9.77|||
3601321|NCT02971007|3453740|B1|||Age||years|Mean|35.7|35.7|Standard Deviation|12.63|12.63|||
3601322|NCT02970812|3453759|B3|||CT visceral fat||cm^2|Mean|95.2|95.2|Standard Deviation|58.1|58.1|||
3601323|NCT02970812|3453760|B2|||CT visceral fat||cm^2|Mean|91.0|91.0|Standard Deviation|48.3|48.3|||
3601324|NCT02970812|3453761|B1|||CT visceral fat||cm^2|Mean|105.7|105.7|Standard Deviation|66.3|66.3|||
3601325|NCT02970812|3453759|B3|||Waist circumference||cm|Mean|92.2|92.2|Standard Deviation|9.6|9.6|||
3601326|NCT02970812|3453760|B2|||Waist circumference||cm|Mean|92.3|92.3|Standard Deviation|7.2|7.2|||
3601327|NCT02970812|3453761|B1|||Waist circumference||cm|Mean|92.2|92.2|Standard Deviation|11.6|11.6|||
3601328|NCT02970812|3453759|B3|South Korea||Region of Enrollment||participants|Number|60|60.0||||||
3601329|NCT02970812|3453760|B2|South Korea||Region of Enrollment||participants|Number|30|30.0||||||
3601330|NCT02970812|3453761|B1|South Korea||Region of Enrollment||participants|Number|30|30.0||||||
3601331|NCT02970812|3453759|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3601332|NCT02970812|3453760|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3601333|NCT02970812|3453761|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3601334|NCT02970812|3453759|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3601335|NCT02970812|3453760|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3601336|NCT02970812|3453761|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3601337|NCT02970812|3453759|B3|||Age||years|Mean|39|39.0|Standard Deviation|11|11.0|||
3601338|NCT02970812|3453760|B2|||Age||years|Mean|38.5|38.5|Standard Deviation|10.6|10.6|||
3601339|NCT02970812|3453761|B1|||Age||years|Mean|40|40.0|Standard Deviation|12.9|12.9|||
3601340|NCT02970812|3453759|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3601341|NCT02970812|3453760|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3601342|NCT02970812|3453761|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3601343|NCT02970812|3453759|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3601344|NCT02970812|3453760|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3601345|NCT02970812|3453761|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3601346|NCT02970812|3453759|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3601347|NCT02970812|3453760|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3601348|NCT02970812|3453761|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3601349|NCT02970162|3453768|B3|||Weight||kg|Mean|85.78|85.78|Standard Deviation|19.545|19.545|||
3601350|NCT02970162|3453769|B2|||Weight||kg|Mean|93.95|93.95|Standard Deviation|15.449|15.449|||
3601351|NCT02970162|3453770|B1|||Weight||kg|Mean|77.62|77.62|Standard Deviation|20.312|20.312|||
3601352|NCT02970162|3453768|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601353|NCT02970162|3453769|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601354|NCT02970162|3453770|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601355|NCT02970162|3453768|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3601356|NCT02970162|3453769|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3601357|NCT02970162|3453770|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3601358|NCT02970162|3453768|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3601359|NCT02970162|3453769|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3601360|NCT02970162|3453770|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3601361|NCT02970162|3453768|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3601362|NCT02970162|3453769|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3601363|NCT02970162|3453770|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3601364|NCT02970162|3453768|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3601365|NCT02970162|3453769|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3601366|NCT02970162|3453770|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3601367|NCT02970162|3453768|B3|||Age||years|Mean|54.2|54.2|Standard Deviation|12.30|12.3|||
3601368|NCT02970162|3453769|B2|||Age||years|Mean|53.4|53.4|Standard Deviation|13.46|13.46|||
3601369|NCT02970162|3453770|B1|||Age||years|Mean|54.9|54.9|Standard Deviation|11.51|11.51|||
3601370|NCT02969863|3453783|B1|||Hemoglobin A1c||percent|Mean|7.2|7.2|Standard Deviation|1.0|1.0|||
3601371|NCT02969863|3453783|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3601372|NCT02969863|3453783|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601373|NCT02969863|3453783|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3601374|NCT02969863|3453783|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601375|NCT02969863|3453783|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601376|NCT02969863|3453783|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601377|NCT02969863|3453783|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601378|NCT02969863|3453783|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3601379|NCT02969863|3453783|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3601380|NCT02969863|3453783|B1|||Age||years|Mean|37.5|37.5|Standard Deviation|13.5|13.5|||
3601381|NCT02969044|3453802|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601382|NCT02969044|3453803|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601383|NCT02969044|3453804|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601384|NCT02969044|3453802|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601385|NCT02969044|3453803|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601386|NCT02969044|3453804|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601387|NCT02969044|3453802|B3||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3601388|NCT02969044|3453803|B2||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3601389|NCT02969044|3453804|B1||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3601390|NCT02969044|3453802|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601391|NCT02969044|3453803|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601392|NCT02969044|3453804|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601393|NCT02969044|3453802|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601394|NCT02969044|3453803|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601395|NCT02969044|3453804|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601396|NCT02969044|3453802|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3601397|NCT02969044|3453803|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601398|NCT02969044|3453804|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3601399|NCT02969044|3453802|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601400|NCT02969044|3453803|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601401|NCT02969044|3453804|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601402|NCT02969044|3453802|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601403|NCT02969044|3453803|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601404|NCT02969044|3453804|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601405|NCT02969044|3453802|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3601406|NCT02969044|3453803|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3601407|NCT02969044|3453804|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3601408|NCT02969044|3453802|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3601409|NCT02969044|3453803|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3601410|NCT02969044|3453804|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3601411|NCT02969044|3453802|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3601412|NCT02969044|3453803|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3601413|NCT02969044|3453804|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3601414|NCT02969044|3453802|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3601415|NCT02969044|3453803|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3601416|NCT02969044|3453804|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3601417|NCT02969044|3453802|B3|||Age||years|Mean|54.9|54.9|Standard Deviation|11.67|11.67|||
3601418|NCT02969044|3453803|B2|||Age||years|Mean|54.2|54.2|Standard Deviation|11.78|11.78|||
3601419|NCT02969044|3453804|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|11.72|11.72|||
3601420|NCT02968173|3453845|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601421|NCT02968173|3453845|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601422|NCT02968173|3453845|B1||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3601423|NCT02968173|3453845|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601424|NCT02968173|3453845|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601425|NCT02968173|3453845|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601426|NCT02968173|3453845|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601427|NCT02968173|3453845|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601428|NCT02968173|3453845|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3601429|NCT02968173|3453845|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601430|NCT02968173|3453845|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3601431|NCT02968173|3453845|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3601432|NCT02968173|3453845|B1|||Age||months|Mean|6.22|6.22|Standard Deviation|4.428|4.428|||
3601433|NCT02968134|3453857|B1|||INR|International normalized ratio|ratio|Median|1.3|1.3|Inter-Quartile Range|||1.3|1.4|
3601434|NCT02968134|3453857|B1|||Total bilirubin||umol/L|Median|11|11.0|Inter-Quartile Range|||10.0|20.0|
3601435|NCT02968134|3453857|B1|||ALP|Alkaline phosphatase|IU/mL|Median|75|75.0|Inter-Quartile Range|||63.0|108.0|
3601436|NCT02968134|3453857|B1|||AST|Aspartate transaminase|IU/mL|Median|47|47.0|Inter-Quartile Range|||38.0|130.0|
3601437|NCT02968134|3453857|B1|||ALT|Alanine transaminase|IU/mL|Median|53|53.0|Inter-Quartile Range|||28.0|60.0|
3601438|NCT02968134|3453857|B1|||Serum albumin||g/L|Median|20|20.0|Inter-Quartile Range|||18.0|20.0|
3601439|NCT02968134|3453857|B1|||Urinary creatinine clearance||mL/min|Median|74|74.0|Inter-Quartile Range|||53.0|109.0|
3601440|NCT02968134|3453857|B1|||Serum creatinine||umol/L|Median|106|106.0|Inter-Quartile Range|||78.0|179.0|
3601441|NCT02968134|3453857|B1|||Acute Physiology and Chronic Health Evaluation II Score|Acute Physiology and Chronic Health Evaluation II [APACHE II] score on ICU admission was calculated from 12 routine physiologic measurements using standard approach. APACHE II score ranges from 1 to 71, with higher scores correlating with increased risk of mortality. For a detailed description, please refer to Crit Care Med. 1985 Oct;13(10):818-29.|units on a scale|Median|17|17.0|Inter-Quartile Range|||17.0|24.0|
3601442|NCT02968134|3453857|B1|||BMI|Body mass index calculated in kg/m2|kg/m^2|Median|22.6|22.6|Inter-Quartile Range|||20.2|29.7|
3601443|NCT02968134|3453857|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3601444|NCT02968134|3453857|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3601445|NCT02968134|3453857|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3601446|NCT02968134|3453857|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3601447|NCT02968134|3453857|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3601448|NCT02967393|3453862|B3|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3601449|NCT02967393|3453863|B2|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3601450|NCT02967393|3453864|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3601451|NCT02967393|3453862|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601452|NCT02967393|3453863|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601453|NCT02967393|3453864|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601454|NCT02967393|3453862|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3601455|NCT02967393|3453863|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3601456|NCT02967393|3453864|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3601457|NCT02967393|3453862|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3601458|NCT02967393|3453863|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3601459|NCT02967393|3453864|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3601460|NCT02967393|3453862|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3601461|NCT02967393|3453863|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3601462|NCT02967393|3453864|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3601463|NCT02967393|3453862|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601464|NCT02967393|3453863|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601465|NCT02967393|3453864|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601466|NCT02967393|3453862|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601467|NCT02967393|3453863|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601468|NCT02967393|3453864|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601469|NCT02967393|3453862|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601470|NCT02967393|3453863|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601471|NCT02967393|3453864|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601472|NCT02967393|3453862|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601473|NCT02967393|3453863|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601474|NCT02967393|3453864|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601475|NCT02967393|3453862|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3601476|NCT02967393|3453863|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3601477|NCT02967393|3453864|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3601478|NCT02967393|3453862|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3601479|NCT02967393|3453863|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3601480|NCT02967393|3453864|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601481|NCT02967393|3453862|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3601482|NCT02967393|3453863|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3601483|NCT02967393|3453864|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3601484|NCT02967393|3453862|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3601485|NCT02967393|3453863|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3601486|NCT02967393|3453864|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3601487|NCT02967393|3453862|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3601488|NCT02967393|3453863|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3601489|NCT02967393|3453864|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3601490|NCT02967393|3453862|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3601491|NCT02967393|3453863|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3601492|NCT02967393|3453864|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3601493|NCT02967393|3453862|B3||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
3601494|NCT02967393|3453863|B2||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
3601495|NCT02967393|3453864|B1||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
3601496|NCT02967354|3453890|B6|||Body mass index||kg/m^2|Mean|29.2|29.2|Standard Deviation|2.7|2.7|||
3601497|NCT02967354|3453891|B5|||Body mass index||kg/m^2|Mean|25.8|25.8|Standard Deviation|1.4|1.4|||
3601498|NCT02967354|3453892|B4|||Body mass index||kg/m^2|Mean|25.1|25.1|Standard Deviation|2.4|2.4|||
3601499|NCT02967354|3453893|B3|||Body mass index||kg/m^2|Mean|33.2|33.2|Standard Deviation|3.6|3.6|||
3601500|NCT02967354|3453894|B2|||Body mass index||kg/m^2|Mean|33.3|33.3|Standard Deviation|2.6|2.6|||
3601501|NCT02967354|3453895|B1|||Body mass index||kg/m^2|Mean|28.1|28.1|Standard Deviation|3.4|3.4|||
3601502|NCT02967354|3453890|B6|Sweden||Region of Enrollment||participants|Number|39|39.0||||||
3601503|NCT02967354|3453891|B5|Sweden||Region of Enrollment||participants|Number|8|8.0||||||
3601504|NCT02967354|3453892|B4|Sweden||Region of Enrollment||participants|Number|7|7.0||||||
3601505|NCT02967354|3453893|B3|Sweden||Region of Enrollment||participants|Number|9|9.0||||||
3601506|NCT02967354|3453894|B2|Sweden||Region of Enrollment||participants|Number|7|7.0||||||
3601507|NCT02967354|3453895|B1|Sweden||Region of Enrollment||participants|Number|8|8.0||||||
3601508|NCT02967354|3453890|B6|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3601509|NCT02967354|3453890|B6||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3601510|NCT02967354|3453891|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3601511|NCT02967354|3453892|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3601512|NCT02967354|3453893|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3601513|NCT02967354|3453894|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3601514|NCT02967354|3453895|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3601515|NCT02967354|3453890|B6||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3601516|NCT02967354|3453891|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3601517|NCT02967354|3453892|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3601518|NCT02967354|3453893|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3601519|NCT02967354|3453894|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3601520|NCT02967354|3453895|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3601521|NCT02967354|3453890|B6|||Age||years|Mean|61.8|61.8|Standard Deviation|7.8|7.8|||
3601522|NCT02967354|3453891|B5|||Age||years|Mean|66.3|66.3|Standard Deviation|5.4|5.4|||
3601523|NCT02967354|3453892|B4|||Age||years|Mean|60.3|60.3|Standard Deviation|10.8|10.8|||
3601524|NCT02967354|3453893|B3|||Age||years|Mean|61.8|61.8|Standard Deviation|7.2|7.2|||
3601525|NCT02967354|3453894|B2|||Age||years|Mean|56.7|56.7|Standard Deviation|10.1|10.1|||
3601526|NCT02967354|3453895|B1|||Age||years|Mean|63.3|63.3|Standard Deviation|6.2|6.2|||
3601527|NCT02966509|3453931|B3|||Total Baseline Health Care Costs||US Dollars|Median|13090|13090.0|Inter-Quartile Range|||4091.0|29729.0|
3601528|NCT02966509|3453932|B2|||Total Baseline Health Care Costs||US Dollars|Median|11455|11455.0|Inter-Quartile Range|||3567.0|29085.0|
3601529|NCT02966509|3453933|B1|||Total Baseline Health Care Costs||US Dollars|Median|14052|14052.0|Inter-Quartile Range|||4613.0|35684.0|
3601530|NCT02966509|3453931|B3||Unmarried|Marital Status||Participants|Count of Participants|138|138.0||||||
3601531|NCT02966509|3453932|B2||Unmarried|Marital Status||Participants|Count of Participants|68|68.0||||||
3601532|NCT02966509|3453933|B1||Unmarried|Marital Status||Participants|Count of Participants|70|70.0||||||
3601533|NCT02966509|3453931|B3||Married|Marital Status||Participants|Count of Participants|75|75.0||||||
3601534|NCT02966509|3453932|B2||Married|Marital Status||Participants|Count of Participants|40|40.0||||||
3601535|NCT02966509|3453933|B1||Married|Marital Status||Participants|Count of Participants|35|35.0||||||
3601536|NCT02966509|3453931|B3||IV|Cancer Stage at Diagnosis||Participants|Count of Participants|118|118.0||||||
3601537|NCT02966509|3453932|B2||IV|Cancer Stage at Diagnosis||Participants|Count of Participants|59|59.0||||||
3601538|NCT02966509|3453933|B1||IV|Cancer Stage at Diagnosis||Participants|Count of Participants|59|59.0||||||
3601539|NCT02966509|3453931|B3||III|Cancer Stage at Diagnosis||Participants|Count of Participants|59|59.0||||||
3601540|NCT02966509|3453932|B2||III|Cancer Stage at Diagnosis||Participants|Count of Participants|29|29.0||||||
3601541|NCT02966509|3453933|B1||III|Cancer Stage at Diagnosis||Participants|Count of Participants|30|30.0||||||
3601542|NCT02966509|3453931|B3||II|Cancer Stage at Diagnosis||Participants|Count of Participants|29|29.0||||||
3601543|NCT02966509|3453932|B2||II|Cancer Stage at Diagnosis||Participants|Count of Participants|17|17.0||||||
3601544|NCT02966509|3453933|B1||II|Cancer Stage at Diagnosis||Participants|Count of Participants|12|12.0||||||
3601545|NCT02966509|3453931|B3||I|Cancer Stage at Diagnosis||Participants|Count of Participants|7|7.0||||||
3601546|NCT02966509|3453932|B2||I|Cancer Stage at Diagnosis||Participants|Count of Participants|3|3.0||||||
3601547|NCT02966509|3453933|B1||I|Cancer Stage at Diagnosis||Participants|Count of Participants|4|4.0||||||
3601548|NCT02966509|3453931|B3||Other|Cancer Diagnosis||Participants|Count of Participants|18|18.0||||||
3601549|NCT02966509|3453932|B2||Other|Cancer Diagnosis||Participants|Count of Participants|11|11.0||||||
3601550|NCT02966509|3453933|B1||Other|Cancer Diagnosis||Participants|Count of Participants|7|7.0||||||
3601551|NCT02966509|3453931|B3||Skin|Cancer Diagnosis||Participants|Count of Participants|14|14.0||||||
3601552|NCT02966509|3453932|B2||Skin|Cancer Diagnosis||Participants|Count of Participants|7|7.0||||||
3601553|NCT02966509|3453933|B1||Skin|Cancer Diagnosis||Participants|Count of Participants|7|7.0||||||
3601554|NCT02966509|3453931|B3||Head and Neck|Cancer Diagnosis||Participants|Count of Participants|31|31.0||||||
3601555|NCT02966509|3453932|B2||Head and Neck|Cancer Diagnosis||Participants|Count of Participants|15|15.0||||||
3601556|NCT02966509|3453933|B1||Head and Neck|Cancer Diagnosis||Participants|Count of Participants|16|16.0||||||
3601557|NCT02966509|3453931|B3||Genitourinary|Cancer Diagnosis||Participants|Count of Participants|17|17.0||||||
3601558|NCT02966509|3453932|B2||Genitourinary|Cancer Diagnosis||Participants|Count of Participants|9|9.0||||||
3601559|NCT02966509|3453933|B1||Genitourinary|Cancer Diagnosis||Participants|Count of Participants|8|8.0||||||
3601560|NCT02966509|3453931|B3||Gastrointestinal|Cancer Diagnosis||Participants|Count of Participants|53|53.0||||||
3601561|NCT02966509|3453932|B2||Gastrointestinal|Cancer Diagnosis||Participants|Count of Participants|27|27.0||||||
3601562|NCT02966509|3453933|B1||Gastrointestinal|Cancer Diagnosis||Participants|Count of Participants|26|26.0||||||
3601563|NCT02966509|3453931|B3||Thoracic|Cancer Diagnosis||Participants|Count of Participants|80|80.0||||||
3601564|NCT02966509|3453932|B2||Thoracic|Cancer Diagnosis||Participants|Count of Participants|39|39.0||||||
3601565|NCT02966509|3453933|B1||Thoracic|Cancer Diagnosis||Participants|Count of Participants|41|41.0||||||
3601566|NCT02966509|3453931|B3|United States||Region of Enrollment|Country|participants|Number|213|213.0||||||
3601567|NCT02966509|3453932|B2|United States||Region of Enrollment|Country|participants|Number|108|108.0||||||
3601568|NCT02966509|3453933|B1|United States||Region of Enrollment|Country|participants|Number|105|105.0||||||
3601569|NCT02966509|3453931|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3601570|NCT02966509|3453932|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3601571|NCT02966509|3453933|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3601572|NCT02966509|3453931|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3601573|NCT02966509|3453932|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3601574|NCT02966509|3453933|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3601575|NCT02966509|3453931|B3||White|Race (NIH/OMB)||Participants|Count of Participants|165|165.0||||||
3601576|NCT02966509|3453932|B2||White|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3601577|NCT02966509|3453933|B1||White|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3601578|NCT02966509|3453931|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3601579|NCT02966509|3453932|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3601580|NCT02966509|3453933|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3601581|NCT02966509|3453931|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3601582|NCT02966509|3453932|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3601583|NCT02966509|3453933|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3601584|NCT02966509|3453931|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3601585|NCT02966509|3453932|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3601586|NCT02966509|3453933|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3601587|NCT02966509|3453931|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3601588|NCT02966509|3453932|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3601589|NCT02966509|3453933|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3601590|NCT02966509|3453931|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3601702|NCT02965846|3454010|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3601591|NCT02966509|3453932|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3601592|NCT02966509|3453933|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3601593|NCT02966509|3453931|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|196|196.0||||||
3601594|NCT02966509|3453932|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
3601595|NCT02966509|3453933|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3601596|NCT02966509|3453931|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3601597|NCT02966509|3453932|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3601598|NCT02966509|3453933|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3601599|NCT02966509|3453931|B3||Male|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
3601600|NCT02966509|3453932|B2||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3601601|NCT02966509|3453933|B1||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3601602|NCT02966509|3453931|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3601603|NCT02966509|3453932|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3601604|NCT02966509|3453933|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3601605|NCT02966509|3453931|B3|||Age||years|Mean|69.3|69.3|Standard Deviation|9.10|9.1|||
3601606|NCT02966509|3453932|B2|||Age||years|Mean|69.4|69.4|Standard Deviation|9.05|9.05|||
3601607|NCT02966509|3453933|B1|||Age||years|Mean|69.2|69.2|Standard Deviation|9.20|9.2|||
3601608|NCT02966509|3453931|B3||>=65 years|Age||Participants|Count of Participants|150|150.0||||||
3601609|NCT02966509|3453932|B2||>=65 years|Age||Participants|Count of Participants|72|72.0||||||
3601610|NCT02966509|3453933|B1||>=65 years|Age||Participants|Count of Participants|78|78.0||||||
3601611|NCT02966509|3453931|B3||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
3601612|NCT02966509|3453932|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3601613|NCT02966509|3453933|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3601614|NCT02966509|3453931|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3601615|NCT02966509|3453932|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3601616|NCT02966509|3453933|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3601617|NCT02966275|3453958|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3601618|NCT02966275|3453958|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601619|NCT02966275|3453958|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3601620|NCT02966275|3453958|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3601621|NCT02966275|3453958|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601622|NCT02966275|3453958|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601623|NCT02966275|3453958|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601624|NCT02966275|3453958|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601625|NCT02966275|3453958|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3601626|NCT02966275|3453958|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3601627|NCT02966275|3453958|B1|||Age||years|Mean|56.2|56.2|Standard Deviation|7.1|7.1|||
3601628|NCT02966015|3453993|B3||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3601629|NCT02966015|3453994|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3601630|NCT02966015|3453995|B1||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3601631|NCT02966015|3453993|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3601632|NCT02966015|3453994|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3601633|NCT02966015|3453995|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3601634|NCT02966015|3453993|B3|Participants older than 18 years||Age, Customized||participants|Number|153|153.0||||||
3601635|NCT02966015|3453994|B2|Participants older than 18 years||Age, Customized||participants|Number|58|58.0||||||
3601636|NCT02966015|3453995|B1|Participants older than 18 years||Age, Customized||participants|Number|95|95.0||||||
3601637|NCT02966002|3454002|B1|||Quality of Life|The Medical Outcomes Short-Form 36-Item Health Survey (SF-36) is a standardized health survey consisting of 36 questions that measure 8 dimensions of general health-related quality of life: physical functioning, role limitation due to physical health problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and general mental health. The score is represented as an average of the individual question scores, and ranges from 0 (not functioning) to 100 (highest functioning). Higher scores indicate a better health status.|units on a scale|Mean|82.4|82.4|Standard Deviation|7.0|7.0|||
3601638|NCT02966002|3454002|B1|||High Sensitivity C-Reactive Protein||mg/dL|Mean|0.24|0.24|Standard Deviation|0.10|0.1|||
3601639|NCT02966002|3454002|B1|||HDL Cholesterol||mg/dL|Mean|47.6|47.6|Standard Deviation|15.1|15.1|||
3601640|NCT02966002|3454002|B1|||Total Cholesterol||mg/dL|Mean|138.6|138.6|Standard Deviation|16.6|16.6|||
3601641|NCT02966002|3454002|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601642|NCT02966002|3454002|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601643|NCT02966002|3454002|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3601644|NCT02966002|3454002|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601645|NCT02966002|3454002|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601646|NCT02966002|3454002|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601647|NCT02966002|3454002|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601648|NCT02966002|3454002|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3601649|NCT02966002|3454002|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3601650|NCT02966002|3454002|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3601651|NCT02966002|3454002|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3601652|NCT02966002|3454002|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3601653|NCT02965846|3454009|B4|||Height||cm|Mean|170.026|170.026|Standard Deviation|1.6317762147419|1.6317762147419|||
3601654|NCT02965846|3454010|B3|||Height||cm|Mean|163.74|163.74|Standard Deviation|9.2099077085495|9.2099077085495|||
3601655|NCT02965846|3454011|B2|||Height||cm|Mean|172.9|172.9|Standard Deviation|5.8343808583259|5.8343808583259|||
3601656|NCT02965846|3454012|B1|||Height||cm|Mean|173.44|173.44|Standard Deviation|5.6683683719391|5.6683683719391|||
3601657|NCT02965846|3454009|B4|||Weight||kg|Mean|97.2893|97.2893|Standard Deviation|2.0238704230461|2.0238704230461|||
3601658|NCT02965846|3454010|B3|||Weight||kg|Mean|87.868|87.868|Standard Deviation|25.016006395906|25.016006395906|||
3601659|NCT02965846|3454011|B2|||Weight||kg|Mean|102.56|102.56|Standard Deviation|20.180247768548|20.180247768548|||
3601660|NCT02965846|3454012|B1|||Weight||kg|Mean|101.44|101.44|Standard Deviation|23.543542639119|23.543542639119|||
3601661|NCT02965846|3454009|B4|||BMI|Body Mass Index|kg/m^2|Mean|33.996|33.996|Standard Deviation|.65464394984732|0.65464394984732|||
3601662|NCT02965846|3454010|B3|||BMI|Body Mass Index|kg/m^2|Mean|32.788|32.788|Standard Deviation|9.4405643899081|9.4405643899081|||
3601663|NCT02965846|3454011|B2|||BMI|Body Mass Index|kg/m^2|Mean|34.86|34.86|Standard Deviation|9.1331484166195|9.1331484166195|||
3601664|NCT02965846|3454012|B1|||BMI|Body Mass Index|kg/m^2|Mean|34.34|34.34|Standard Deviation|10.649807509998|10.649807509998|||
3601665|NCT02965846|3454009|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601666|NCT02965846|3454010|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601667|NCT02965846|3454011|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601668|NCT02965846|3454012|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601669|NCT02965846|3454009|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601670|NCT02965846|3454010|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601671|NCT02965846|3454011|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601672|NCT02965846|3454012|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601673|NCT02965846|3454009|B4||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3601674|NCT02965846|3454010|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3601675|NCT02965846|3454011|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3601676|NCT02965846|3454012|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3601677|NCT02965846|3454009|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3601678|NCT02965846|3454010|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3601679|NCT02965846|3454011|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3601680|NCT02965846|3454012|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3601681|NCT02965846|3454009|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3601682|NCT02965846|3454010|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3601683|NCT02965846|3454011|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601684|NCT02965846|3454012|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601685|NCT02965846|3454009|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3601686|NCT02965846|3454010|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3601687|NCT02965846|3454011|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601688|NCT02965846|3454012|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601689|NCT02965846|3454009|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601690|NCT02965846|3454010|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601691|NCT02965846|3454011|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601692|NCT02965846|3454012|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601693|NCT02965846|3454009|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3601694|NCT02965846|3454010|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3601695|NCT02965846|3454011|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3601696|NCT02965846|3454012|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3601697|NCT02965846|3454009|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3601698|NCT02965846|3454010|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3601699|NCT02965846|3454011|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3601700|NCT02965846|3454012|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3601701|NCT02965846|3454009|B4||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3601703|NCT02965846|3454011|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3601704|NCT02965846|3454012|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3601705|NCT02965846|3454009|B4||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3601706|NCT02965846|3454010|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3601707|NCT02965846|3454011|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3601708|NCT02965846|3454012|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3601709|NCT02965846|3454009|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3601710|NCT02965846|3454010|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3601711|NCT02965846|3454011|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3601712|NCT02965846|3454012|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3601713|NCT02965833|3454022|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601714|NCT02965833|3454022|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601715|NCT02965833|3454022|B1||White|Race (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
3601716|NCT02965833|3454022|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3601717|NCT02965833|3454022|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601718|NCT02965833|3454022|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3601719|NCT02965833|3454022|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601720|NCT02965833|3454022|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601721|NCT02965833|3454022|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
3601722|NCT02965833|3454022|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3601723|NCT02965833|3454022|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3601724|NCT02965833|3454022|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3601725|NCT02965833|3454022|B1|||Age||years|Mean|52.5|52.5|Standard Deviation|5.54|5.54|||
3601726|NCT02965820|3454029|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601727|NCT02965820|3454029|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601728|NCT02965820|3454029|B1||White|Race (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
3601729|NCT02965820|3454029|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3601730|NCT02965820|3454029|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601731|NCT02965820|3454029|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601732|NCT02965820|3454029|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601733|NCT02965820|3454029|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601734|NCT02965820|3454029|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
3601735|NCT02965820|3454029|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3601736|NCT02965820|3454029|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3601737|NCT02965820|3454029|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3601738|NCT02965820|3454029|B1|||Age||years|Mean|52.7|52.7|Standard Deviation|5.32|5.32|||
3601739|NCT02964767|3454036|B3||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3601740|NCT02964767|3454037|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3601741|NCT02964767|3454038|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3601742|NCT02964767|3454036|B3||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3601743|NCT02964767|3454037|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3601744|NCT02964767|3454038|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3601745|NCT02964767|3454036|B3|||Age||years|Mean|33.63|33.63|Standard Deviation|11.20|11.2|||
3601746|NCT02964767|3454037|B2|||Age||years|Mean|34.97|34.97|Standard Deviation|11.21|11.21|||
3601747|NCT02964767|3454038|B1|||Age||years|Mean|33.26|33.26|Standard Deviation|12.77|12.77|||
3601748|NCT02963701|3454046|B3|Other||Race/Ethnicity, Customized|Ethnicity data was not collected as per protocol.|Participants|Number|2|2.0||||||
3601749|NCT02963701|3454047|B2|Other||Race/Ethnicity, Customized|Ethnicity data was not collected as per protocol.|Participants|Number|1|1.0||||||
3601750|NCT02963701|3454048|B1|Other||Race/Ethnicity, Customized|Ethnicity data was not collected as per protocol.|Participants|Number|1|1.0||||||
3601751|NCT02963701|3454046|B3|More than one race||Race/Ethnicity, Customized|Ethnicity data was not collected as per protocol.|Participants|Number|0|0.0||||||
3601752|NCT02963701|3454047|B2|More than one race||Race/Ethnicity, Customized|Ethnicity data was not collected as per protocol.|Participants|Number|0|0.0||||||
3601753|NCT02963701|3454048|B1|More than one race||Race/Ethnicity, Customized|Ethnicity data was not collected as per protocol.|Participants|Number|0|0.0||||||
3601754|NCT02963701|3454046|B3|White||Race/Ethnicity, Customized|Ethnicity data was not collected as per protocol.|Participants|Number|13|13.0||||||
3601755|NCT02963701|3454047|B2|White||Race/Ethnicity, Customized|Ethnicity data was not collected as per protocol.|Participants|Number|6|6.0||||||
3601756|NCT02963701|3454048|B1|White||Race/Ethnicity, Customized|Ethnicity data was not collected as per protocol.|Participants|Number|7|7.0||||||
3601757|NCT02963701|3454046|B3|Black or African American||Race/Ethnicity, Customized|Ethnicity data was not collected as per protocol.|Participants|Number|41|41.0||||||
3602067|NCT02959996|3454099|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3601758|NCT02963701|3454047|B2|Black or African American||Race/Ethnicity, Customized|Ethnicity data was not collected as per protocol.|Participants|Number|21|21.0||||||
3601759|NCT02963701|3454048|B1|Black or African American||Race/Ethnicity, Customized|Ethnicity data was not collected as per protocol.|Participants|Number|20|20.0||||||
3601760|NCT02963701|3454046|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Ethnicity data was not collected as per protocol.|Participants|Number|0|0.0||||||
3601761|NCT02963701|3454047|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Ethnicity data was not collected as per protocol.|Participants|Number|0|0.0||||||
3601762|NCT02963701|3454048|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Ethnicity data was not collected as per protocol.|Participants|Number|0|0.0||||||
3601763|NCT02963701|3454046|B3|Asian||Race/Ethnicity, Customized|Ethnicity data was not collected as per protocol.|Participants|Number|0|0.0||||||
3601764|NCT02963701|3454047|B2|Asian||Race/Ethnicity, Customized|Ethnicity data was not collected as per protocol.|Participants|Number|0|0.0||||||
3601765|NCT02963701|3454048|B1|Asian||Race/Ethnicity, Customized|Ethnicity data was not collected as per protocol.|Participants|Number|0|0.0||||||
3601766|NCT02963701|3454046|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|Ethnicity data was not collected as per protocol.|Participants|Number|0|0.0||||||
3601767|NCT02963701|3454047|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|Ethnicity data was not collected as per protocol.|Participants|Number|0|0.0||||||
3601768|NCT02963701|3454048|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Ethnicity data was not collected as per protocol.|Participants|Number|0|0.0||||||
3601769|NCT02963701|3454046|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3601770|NCT02963701|3454047|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3601771|NCT02963701|3454048|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3601772|NCT02963701|3454046|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3601773|NCT02963701|3454047|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3601774|NCT02963701|3454048|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3601775|NCT02963701|3454046|B3|||Age||Years|Mean|28.8|28.8|Standard Deviation|7.37|7.37|||
3601776|NCT02963701|3454047|B2|||Age||Years|Mean|29.2|29.2|Standard Deviation|8.03|8.03|||
3601777|NCT02963701|3454048|B1|||Age||Years|Mean|28.5|28.5|Standard Deviation|6.77|6.77|||
3601778|NCT02962882|3454079|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3601779|NCT02962882|3454079|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3601780|NCT02962882|3454079|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3601781|NCT02962882|3454079|B1|||Age||years|Mean|66.9|66.9|Standard Deviation|15.7|15.7|||
3601782|NCT02961244|3454088|B3|||ASEPSIS Total Scores|ASEPSIS Wound Scoring System used in our study. ASEPSIS postoperative total Points (p=0.029) was different between two groups. Simply points are given for the need for Additional treatment, the presence of Serous discharge, Erythema, Purulent exudate, and Separation of the deep tissues, the Isolation of bacteria, and the duration of inpatient Stay (ASEPSIS). (min. is 0 points and max. doesn't have any limit but 0-10 points is succesful, 11-20 points is impaired healing and 21-30 points is mild, 31-40 is moderate, >41 points is severe SSI.)|points|Mean|15.41|15.41|Standard Deviation|12.67|12.67|||
3601783|NCT02961244|3454089|B2|||ASEPSIS Total Scores|ASEPSIS Wound Scoring System used in our study. ASEPSIS postoperative total Points (p=0.029) was different between two groups. Simply points are given for the need for Additional treatment, the presence of Serous discharge, Erythema, Purulent exudate, and Separation of the deep tissues, the Isolation of bacteria, and the duration of inpatient Stay (ASEPSIS). (min. is 0 points and max. doesn't have any limit but 0-10 points is succesful, 11-20 points is impaired healing and 21-30 points is mild, 31-40 is moderate, >41 points is severe SSI.)|points|Mean|12.64|12.64|Standard Deviation|10.6|10.6|||
3601784|NCT02961244|3454090|B1|||ASEPSIS Total Scores|ASEPSIS Wound Scoring System used in our study. ASEPSIS postoperative total Points (p=0.029) was different between two groups. Simply points are given for the need for Additional treatment, the presence of Serous discharge, Erythema, Purulent exudate, and Separation of the deep tissues, the Isolation of bacteria, and the duration of inpatient Stay (ASEPSIS). (min. is 0 points and max. doesn't have any limit but 0-10 points is succesful, 11-20 points is impaired healing and 21-30 points is mild, 31-40 is moderate, >41 points is severe SSI.)|points|Mean|17.83|17.83|Standard Deviation|13.83|13.83|||
3601785|NCT02961244|3454088|B3|Organ-Space||SSI Classification||Participants|Count of Participants|7|7.0||||||
3601786|NCT02961244|3454089|B2|Organ-Space||SSI Classification||Participants|Count of Participants|2|2.0||||||
3601787|NCT02961244|3454090|B1|Organ-Space||SSI Classification||Participants|Count of Participants|5|5.0||||||
3601788|NCT02961244|3454088|B3|Deep Incisional||SSI Classification||Participants|Count of Participants|4|4.0||||||
3601789|NCT02961244|3454089|B2|Deep Incisional||SSI Classification||Participants|Count of Participants|1|1.0||||||
3601790|NCT02961244|3454090|B1|Deep Incisional||SSI Classification||Participants|Count of Participants|3|3.0||||||
3601791|NCT02961244|3454088|B3|Superficial Incisional||SSI Classification||Participants|Count of Participants|16|16.0||||||
3601792|NCT02961244|3454089|B2|Superficial Incisional||SSI Classification||Participants|Count of Participants|6|6.0||||||
3601793|NCT02961244|3454090|B1|Superficial Incisional||SSI Classification||Participants|Count of Participants|10|10.0||||||
3601794|NCT02961244|3454088|B3|SSI||Infectious Complications|Our study's main outcome which is SSI is significiantly different between two groups.(p=0.044)|Participants|Count of Participants|27|27.0||||||
3601795|NCT02961244|3454089|B2|SSI||Infectious Complications|Our study's main outcome which is SSI is significiantly different between two groups.(p=0.044)|Participants|Count of Participants|9|9.0||||||
3601796|NCT02961244|3454090|B1|SSI||Infectious Complications|Our study's main outcome which is SSI is significiantly different between two groups.(p=0.044)|Participants|Count of Participants|18|18.0||||||
3601797|NCT02961244|3454088|B3|Bacteriemia||Infectious Complications|Our study's main outcome which is SSI is significiantly different between two groups.(p=0.044)|Participants|Count of Participants|4|4.0||||||
3601798|NCT02961244|3454089|B2|Bacteriemia||Infectious Complications|Our study's main outcome which is SSI is significiantly different between two groups.(p=0.044)|Participants|Count of Participants|1|1.0||||||
3601799|NCT02961244|3454090|B1|Bacteriemia||Infectious Complications|Our study's main outcome which is SSI is significiantly different between two groups.(p=0.044)|Participants|Count of Participants|3|3.0||||||
3601800|NCT02961244|3454088|B3|Urinary||Infectious Complications|Our study's main outcome which is SSI is significiantly different between two groups.(p=0.044)|Participants|Count of Participants|4|4.0||||||
3601801|NCT02961244|3454089|B2|Urinary||Infectious Complications|Our study's main outcome which is SSI is significiantly different between two groups.(p=0.044)|Participants|Count of Participants|2|2.0||||||
3601802|NCT02961244|3454090|B1|Urinary||Infectious Complications|Our study's main outcome which is SSI is significiantly different between two groups.(p=0.044)|Participants|Count of Participants|2|2.0||||||
3601803|NCT02961244|3454088|B3|Pulmonary||Infectious Complications|Our study's main outcome which is SSI is significiantly different between two groups.(p=0.044)|Participants|Count of Participants|5|5.0||||||
3601804|NCT02961244|3454089|B2|Pulmonary||Infectious Complications|Our study's main outcome which is SSI is significiantly different between two groups.(p=0.044)|Participants|Count of Participants|1|1.0||||||
3601805|NCT02961244|3454090|B1|Pulmonary||Infectious Complications|Our study's main outcome which is SSI is significiantly different between two groups.(p=0.044)|Participants|Count of Participants|4|4.0||||||
3601806|NCT02961244|3454088|B3|No İnfectious Complications||Infectious Complications|Our study's main outcome which is SSI is significiantly different between two groups.(p=0.044)|Participants|Count of Participants|85|85.0||||||
3601807|NCT02961244|3454089|B2|No İnfectious Complications||Infectious Complications|Our study's main outcome which is SSI is significiantly different between two groups.(p=0.044)|Participants|Count of Participants|43|43.0||||||
3601808|NCT02961244|3454090|B1|No İnfectious Complications||Infectious Complications|Our study's main outcome which is SSI is significiantly different between two groups.(p=0.044)|Participants|Count of Participants|42|42.0||||||
3601809|NCT02961244|3454088|B3|ICU Enterance Temperature (ICU patients)||Perioperative Temperature Measurements|Perioperative Minimum Measurement p<0.001 Preoperative Room Enterance Temperature p=0.980 Preoperative Room Exit Temperature p=0.094 After Entubation Temperature p=0.011 Postentubation 60. minutes Temperature p<0.001 Postentubation 120. minutes Temperature p<0.001 Postentubation 180. minutes Temperature p=0.001 Postentubation 240. minutes Temperature p=0.001 After Extubation Temperature p<0.001 Recovery Room Enterance Temperature p<0.001 Recovery Room ExitTemperature p=0.094 Service Enterance Temperature p=0.716|ºC degrees|Mean|35.89|35.89|Standard Deviation|0.85|0.85|||
3601810|NCT02961244|3454089|B2|ICU Enterance Temperature (ICU patients)||Perioperative Temperature Measurements|Perioperative Minimum Measurement p<0.001 Preoperative Room Enterance Temperature p=0.980 Preoperative Room Exit Temperature p=0.094 After Entubation Temperature p=0.011 Postentubation 60. minutes Temperature p<0.001 Postentubation 120. minutes Temperature p<0.001 Postentubation 180. minutes Temperature p=0.001 Postentubation 240. minutes Temperature p=0.001 After Extubation Temperature p<0.001 Recovery Room Enterance Temperature p<0.001 Recovery Room ExitTemperature p=0.094 Service Enterance Temperature p=0.716|ºC degrees|Mean|36.08|36.08|Standard Deviation|0.64|0.64|||
3601811|NCT02961244|3454090|B1|ICU Enterance Temperature (ICU patients)||Perioperative Temperature Measurements|Perioperative Minimum Measurement p<0.001 Preoperative Room Enterance Temperature p=0.980 Preoperative Room Exit Temperature p=0.094 After Entubation Temperature p=0.011 Postentubation 60. minutes Temperature p<0.001 Postentubation 120. minutes Temperature p<0.001 Postentubation 180. minutes Temperature p=0.001 Postentubation 240. minutes Temperature p=0.001 After Extubation Temperature p<0.001 Recovery Room Enterance Temperature p<0.001 Recovery Room ExitTemperature p=0.094 Service Enterance Temperature p=0.716|ºC degrees|Mean|35.78|35.78|Standard Deviation|0.95|0.95|||
3601812|NCT02961244|3454088|B3|Service Enterance Temperature||Perioperative Temperature Measurements|Perioperative Minimum Measurement p<0.001 Preoperative Room Enterance Temperature p=0.980 Preoperative Room Exit Temperature p=0.094 After Entubation Temperature p=0.011 Postentubation 60. minutes Temperature p<0.001 Postentubation 120. minutes Temperature p<0.001 Postentubation 180. minutes Temperature p=0.001 Postentubation 240. minutes Temperature p=0.001 After Extubation Temperature p<0.001 Recovery Room Enterance Temperature p<0.001 Recovery Room ExitTemperature p=0.094 Service Enterance Temperature p=0.716|ºC degrees|Mean|36.33|36.33|Standard Deviation|0.4|0.4|||
3601813|NCT02961244|3454089|B2|Service Enterance Temperature||Perioperative Temperature Measurements|Perioperative Minimum Measurement p<0.001 Preoperative Room Enterance Temperature p=0.980 Preoperative Room Exit Temperature p=0.094 After Entubation Temperature p=0.011 Postentubation 60. minutes Temperature p<0.001 Postentubation 120. minutes Temperature p<0.001 Postentubation 180. minutes Temperature p=0.001 Postentubation 240. minutes Temperature p=0.001 After Extubation Temperature p<0.001 Recovery Room Enterance Temperature p<0.001 Recovery Room ExitTemperature p=0.094 Service Enterance Temperature p=0.716|ºC degrees|Mean|36.35|36.35|Standard Deviation|0.38|0.38|||
3601814|NCT02961244|3454090|B1|Service Enterance Temperature||Perioperative Temperature Measurements|Perioperative Minimum Measurement p<0.001 Preoperative Room Enterance Temperature p=0.980 Preoperative Room Exit Temperature p=0.094 After Entubation Temperature p=0.011 Postentubation 60. minutes Temperature p<0.001 Postentubation 120. minutes Temperature p<0.001 Postentubation 180. minutes Temperature p=0.001 Postentubation 240. minutes Temperature p=0.001 After Extubation Temperature p<0.001 Recovery Room Enterance Temperature p<0.001 Recovery Room ExitTemperature p=0.094 Service Enterance Temperature p=0.716|ºC degrees|Mean|36.31|36.31|Standard Deviation|0.42|0.42|||
3601815|NCT02961244|3454088|B3|Recovery Room ExitTemperature||Perioperative Temperature Measurements|Perioperative Minimum Measurement p<0.001 Preoperative Room Enterance Temperature p=0.980 Preoperative Room Exit Temperature p=0.094 After Entubation Temperature p=0.011 Postentubation 60. minutes Temperature p<0.001 Postentubation 120. minutes Temperature p<0.001 Postentubation 180. minutes Temperature p=0.001 Postentubation 240. minutes Temperature p=0.001 After Extubation Temperature p<0.001 Recovery Room Enterance Temperature p<0.001 Recovery Room ExitTemperature p=0.094 Service Enterance Temperature p=0.716|ºC degrees|Mean|36.59|36.59|Standard Deviation|0.62|0.62|||
3601850|NCT02961244|3454090|B1|Other(Valvuler, collagen tissue, etc diseases)||Comorbidities|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title. Buy for classifaciton of the comobidities, Elixhauser Classification used for standart data presentation.|Participants|Count of Participants|4|4.0||||||
3601816|NCT02961244|3454089|B2|Recovery Room ExitTemperature||Perioperative Temperature Measurements|Perioperative Minimum Measurement p<0.001 Preoperative Room Enterance Temperature p=0.980 Preoperative Room Exit Temperature p=0.094 After Entubation Temperature p=0.011 Postentubation 60. minutes Temperature p<0.001 Postentubation 120. minutes Temperature p<0.001 Postentubation 180. minutes Temperature p=0.001 Postentubation 240. minutes Temperature p=0.001 After Extubation Temperature p<0.001 Recovery Room Enterance Temperature p<0.001 Recovery Room ExitTemperature p=0.094 Service Enterance Temperature p=0.716|ºC degrees|Mean|36.7|36.7|Standard Deviation|0.61|0.61|||
3601817|NCT02961244|3454090|B1|Recovery Room ExitTemperature||Perioperative Temperature Measurements|Perioperative Minimum Measurement p<0.001 Preoperative Room Enterance Temperature p=0.980 Preoperative Room Exit Temperature p=0.094 After Entubation Temperature p=0.011 Postentubation 60. minutes Temperature p<0.001 Postentubation 120. minutes Temperature p<0.001 Postentubation 180. minutes Temperature p=0.001 Postentubation 240. minutes Temperature p=0.001 After Extubation Temperature p<0.001 Recovery Room Enterance Temperature p<0.001 Recovery Room ExitTemperature p=0.094 Service Enterance Temperature p=0.716|ºC degrees|Mean|36.48|36.48|Standard Deviation|0.62|0.62|||
3601818|NCT02961244|3454088|B3|Recovery Room Enterance Temperature||Perioperative Temperature Measurements|Perioperative Minimum Measurement p<0.001 Preoperative Room Enterance Temperature p=0.980 Preoperative Room Exit Temperature p=0.094 After Entubation Temperature p=0.011 Postentubation 60. minutes Temperature p<0.001 Postentubation 120. minutes Temperature p<0.001 Postentubation 180. minutes Temperature p=0.001 Postentubation 240. minutes Temperature p=0.001 After Extubation Temperature p<0.001 Recovery Room Enterance Temperature p<0.001 Recovery Room ExitTemperature p=0.094 Service Enterance Temperature p=0.716|ºC degrees|Mean|36.12|36.12|Standard Deviation|0.75|0.75|||
3601819|NCT02961244|3454089|B2|Recovery Room Enterance Temperature||Perioperative Temperature Measurements|Perioperative Minimum Measurement p<0.001 Preoperative Room Enterance Temperature p=0.980 Preoperative Room Exit Temperature p=0.094 After Entubation Temperature p=0.011 Postentubation 60. minutes Temperature p<0.001 Postentubation 120. minutes Temperature p<0.001 Postentubation 180. minutes Temperature p=0.001 Postentubation 240. minutes Temperature p=0.001 After Extubation Temperature p<0.001 Recovery Room Enterance Temperature p<0.001 Recovery Room ExitTemperature p=0.094 Service Enterance Temperature p=0.716|ºC degrees|Mean|36.41|36.41|Standard Deviation|0.64|0.64|||
3601820|NCT02961244|3454090|B1|Recovery Room Enterance Temperature||Perioperative Temperature Measurements|Perioperative Minimum Measurement p<0.001 Preoperative Room Enterance Temperature p=0.980 Preoperative Room Exit Temperature p=0.094 After Entubation Temperature p=0.011 Postentubation 60. minutes Temperature p<0.001 Postentubation 120. minutes Temperature p<0.001 Postentubation 180. minutes Temperature p=0.001 Postentubation 240. minutes Temperature p=0.001 After Extubation Temperature p<0.001 Recovery Room Enterance Temperature p<0.001 Recovery Room ExitTemperature p=0.094 Service Enterance Temperature p=0.716|ºC degrees|Mean|35.84|35.84|Standard Deviation|0.75|0.75|||
3601821|NCT02961244|3454088|B3|After Extubation Temperature||Perioperative Temperature Measurements|Perioperative Minimum Measurement p<0.001 Preoperative Room Enterance Temperature p=0.980 Preoperative Room Exit Temperature p=0.094 After Entubation Temperature p=0.011 Postentubation 60. minutes Temperature p<0.001 Postentubation 120. minutes Temperature p<0.001 Postentubation 180. minutes Temperature p=0.001 Postentubation 240. minutes Temperature p=0.001 After Extubation Temperature p<0.001 Recovery Room Enterance Temperature p<0.001 Recovery Room ExitTemperature p=0.094 Service Enterance Temperature p=0.716|ºC degrees|Mean|36.21|36.21|Standard Deviation|0.77|0.77|||
3601822|NCT02961244|3454089|B2|After Extubation Temperature||Perioperative Temperature Measurements|Perioperative Minimum Measurement p<0.001 Preoperative Room Enterance Temperature p=0.980 Preoperative Room Exit Temperature p=0.094 After Entubation Temperature p=0.011 Postentubation 60. minutes Temperature p<0.001 Postentubation 120. minutes Temperature p<0.001 Postentubation 180. minutes Temperature p=0.001 Postentubation 240. minutes Temperature p=0.001 After Extubation Temperature p<0.001 Recovery Room Enterance Temperature p<0.001 Recovery Room ExitTemperature p=0.094 Service Enterance Temperature p=0.716|ºC degrees|Mean|36.54|36.54|Standard Deviation|0.67|0.67|||
3601823|NCT02961244|3454090|B1|After Extubation Temperature||Perioperative Temperature Measurements|Perioperative Minimum Measurement p<0.001 Preoperative Room Enterance Temperature p=0.980 Preoperative Room Exit Temperature p=0.094 After Entubation Temperature p=0.011 Postentubation 60. minutes Temperature p<0.001 Postentubation 120. minutes Temperature p<0.001 Postentubation 180. minutes Temperature p=0.001 Postentubation 240. minutes Temperature p=0.001 After Extubation Temperature p<0.001 Recovery Room Enterance Temperature p<0.001 Recovery Room ExitTemperature p=0.094 Service Enterance Temperature p=0.716|ºC degrees|Mean|35.88|35.88|Standard Deviation|0.74|0.74|||
3601824|NCT02961244|3454088|B3|Postentubation 240. minutes Temperature||Perioperative Temperature Measurements|Perioperative Minimum Measurement p<0.001 Preoperative Room Enterance Temperature p=0.980 Preoperative Room Exit Temperature p=0.094 After Entubation Temperature p=0.011 Postentubation 60. minutes Temperature p<0.001 Postentubation 120. minutes Temperature p<0.001 Postentubation 180. minutes Temperature p=0.001 Postentubation 240. minutes Temperature p=0.001 After Extubation Temperature p<0.001 Recovery Room Enterance Temperature p<0.001 Recovery Room ExitTemperature p=0.094 Service Enterance Temperature p=0.716|ºC degrees|Mean|35.85|35.85|Standard Deviation|0.95|0.95|||
3601825|NCT02961244|3454089|B2|Postentubation 240. minutes Temperature||Perioperative Temperature Measurements|Perioperative Minimum Measurement p<0.001 Preoperative Room Enterance Temperature p=0.980 Preoperative Room Exit Temperature p=0.094 After Entubation Temperature p=0.011 Postentubation 60. minutes Temperature p<0.001 Postentubation 120. minutes Temperature p<0.001 Postentubation 180. minutes Temperature p=0.001 Postentubation 240. minutes Temperature p=0.001 After Extubation Temperature p<0.001 Recovery Room Enterance Temperature p<0.001 Recovery Room ExitTemperature p=0.094 Service Enterance Temperature p=0.716|ºC degrees|Mean|36.45|36.45|Standard Deviation|0.87|0.87|||
3601826|NCT02961244|3454090|B1|Postentubation 240. minutes Temperature||Perioperative Temperature Measurements|Perioperative Minimum Measurement p<0.001 Preoperative Room Enterance Temperature p=0.980 Preoperative Room Exit Temperature p=0.094 After Entubation Temperature p=0.011 Postentubation 60. minutes Temperature p<0.001 Postentubation 120. minutes Temperature p<0.001 Postentubation 180. minutes Temperature p=0.001 Postentubation 240. minutes Temperature p=0.001 After Extubation Temperature p<0.001 Recovery Room Enterance Temperature p<0.001 Recovery Room ExitTemperature p=0.094 Service Enterance Temperature p=0.716|ºC degrees|Mean|35.5|35.5|Standard Deviation|0.82|0.82|||
3601985|NCT02961244|3454090|B1|||Intraoperative cristalloid fluid|For cristalloid fluid infusement amounts, groups were homogeneous. (p=0.855)|liters|Mean|3.06|3.06|Standard Deviation|1.38|1.38|||
3601827|NCT02961244|3454088|B3|Postentubation 180. minutes Temperature||Perioperative Temperature Measurements|Perioperative Minimum Measurement p<0.001 Preoperative Room Enterance Temperature p=0.980 Preoperative Room Exit Temperature p=0.094 After Entubation Temperature p=0.011 Postentubation 60. minutes Temperature p<0.001 Postentubation 120. minutes Temperature p<0.001 Postentubation 180. minutes Temperature p=0.001 Postentubation 240. minutes Temperature p=0.001 After Extubation Temperature p<0.001 Recovery Room Enterance Temperature p<0.001 Recovery Room ExitTemperature p=0.094 Service Enterance Temperature p=0.716|ºC degrees|Mean|35.88|35.88|Standard Deviation|0.86|0.86|||
3601828|NCT02961244|3454089|B2|Postentubation 180. minutes Temperature||Perioperative Temperature Measurements|Perioperative Minimum Measurement p<0.001 Preoperative Room Enterance Temperature p=0.980 Preoperative Room Exit Temperature p=0.094 After Entubation Temperature p=0.011 Postentubation 60. minutes Temperature p<0.001 Postentubation 120. minutes Temperature p<0.001 Postentubation 180. minutes Temperature p=0.001 Postentubation 240. minutes Temperature p=0.001 After Extubation Temperature p<0.001 Recovery Room Enterance Temperature p<0.001 Recovery Room ExitTemperature p=0.094 Service Enterance Temperature p=0.716|ºC degrees|Mean|36.25|36.25|Standard Deviation|0.72|0.72|||
3601829|NCT02961244|3454090|B1|Postentubation 180. minutes Temperature||Perioperative Temperature Measurements|Perioperative Minimum Measurement p<0.001 Preoperative Room Enterance Temperature p=0.980 Preoperative Room Exit Temperature p=0.094 After Entubation Temperature p=0.011 Postentubation 60. minutes Temperature p<0.001 Postentubation 120. minutes Temperature p<0.001 Postentubation 180. minutes Temperature p=0.001 Postentubation 240. minutes Temperature p=0.001 After Extubation Temperature p<0.001 Recovery Room Enterance Temperature p<0.001 Recovery Room ExitTemperature p=0.094 Service Enterance Temperature p=0.716|ºC degrees|Mean|35.63|35.63|Standard Deviation|0.86|0.86|||
3601830|NCT02961244|3454088|B3|Postentubation 120. minutes Temperature||Perioperative Temperature Measurements|Perioperative Minimum Measurement p<0.001 Preoperative Room Enterance Temperature p=0.980 Preoperative Room Exit Temperature p=0.094 After Entubation Temperature p=0.011 Postentubation 60. minutes Temperature p<0.001 Postentubation 120. minutes Temperature p<0.001 Postentubation 180. minutes Temperature p=0.001 Postentubation 240. minutes Temperature p=0.001 After Extubation Temperature p<0.001 Recovery Room Enterance Temperature p<0.001 Recovery Room ExitTemperature p=0.094 Service Enterance Temperature p=0.716|ºC degrees|Mean|35.9|35.9|Standard Deviation|0.76|0.76|||
3601831|NCT02961244|3454089|B2|Postentubation 120. minutes Temperature||Perioperative Temperature Measurements|Perioperative Minimum Measurement p<0.001 Preoperative Room Enterance Temperature p=0.980 Preoperative Room Exit Temperature p=0.094 After Entubation Temperature p=0.011 Postentubation 60. minutes Temperature p<0.001 Postentubation 120. minutes Temperature p<0.001 Postentubation 180. minutes Temperature p=0.001 Postentubation 240. minutes Temperature p=0.001 After Extubation Temperature p<0.001 Recovery Room Enterance Temperature p<0.001 Recovery Room ExitTemperature p=0.094 Service Enterance Temperature p=0.716|ºC degrees|Mean|36.28|36.28|Standard Deviation|0.6|0.6|||
3601832|NCT02961244|3454090|B1|Postentubation 120. minutes Temperature||Perioperative Temperature Measurements|Perioperative Minimum Measurement p<0.001 Preoperative Room Enterance Temperature p=0.980 Preoperative Room Exit Temperature p=0.094 After Entubation Temperature p=0.011 Postentubation 60. minutes Temperature p<0.001 Postentubation 120. minutes Temperature p<0.001 Postentubation 180. minutes Temperature p=0.001 Postentubation 240. minutes Temperature p=0.001 After Extubation Temperature p<0.001 Recovery Room Enterance Temperature p<0.001 Recovery Room ExitTemperature p=0.094 Service Enterance Temperature p=0.716|ºC degrees|Mean|35.8|35.8|Standard Deviation|0.73|0.73|||
3601833|NCT02961244|3454088|B3|Postentubation 60. minutes Temperature||Perioperative Temperature Measurements|Perioperative Minimum Measurement p<0.001 Preoperative Room Enterance Temperature p=0.980 Preoperative Room Exit Temperature p=0.094 After Entubation Temperature p=0.011 Postentubation 60. minutes Temperature p<0.001 Postentubation 120. minutes Temperature p<0.001 Postentubation 180. minutes Temperature p=0.001 Postentubation 240. minutes Temperature p=0.001 After Extubation Temperature p<0.001 Recovery Room Enterance Temperature p<0.001 Recovery Room ExitTemperature p=0.094 Service Enterance Temperature p=0.716|ºC degrees|Mean|35.9|35.9|Standard Deviation|0.62|0.62|||
3601834|NCT02961244|3454089|B2|Postentubation 60. minutes Temperature||Perioperative Temperature Measurements|Perioperative Minimum Measurement p<0.001 Preoperative Room Enterance Temperature p=0.980 Preoperative Room Exit Temperature p=0.094 After Entubation Temperature p=0.011 Postentubation 60. minutes Temperature p<0.001 Postentubation 120. minutes Temperature p<0.001 Postentubation 180. minutes Temperature p=0.001 Postentubation 240. minutes Temperature p=0.001 After Extubation Temperature p<0.001 Recovery Room Enterance Temperature p<0.001 Recovery Room ExitTemperature p=0.094 Service Enterance Temperature p=0.716|ºC degrees|Mean|36.16|36.16|Standard Deviation|0.56|0.56|||
3601835|NCT02961244|3454090|B1|Postentubation 60. minutes Temperature||Perioperative Temperature Measurements|Perioperative Minimum Measurement p<0.001 Preoperative Room Enterance Temperature p=0.980 Preoperative Room Exit Temperature p=0.094 After Entubation Temperature p=0.011 Postentubation 60. minutes Temperature p<0.001 Postentubation 120. minutes Temperature p<0.001 Postentubation 180. minutes Temperature p=0.001 Postentubation 240. minutes Temperature p=0.001 After Extubation Temperature p<0.001 Recovery Room Enterance Temperature p<0.001 Recovery Room ExitTemperature p=0.094 Service Enterance Temperature p=0.716|ºC degrees|Mean|35.74|35.74|Standard Deviation|0.62|0.62|||
3601836|NCT02961244|3454088|B3|After Entubation Temperature||Perioperative Temperature Measurements|Perioperative Minimum Measurement p<0.001 Preoperative Room Enterance Temperature p=0.980 Preoperative Room Exit Temperature p=0.094 After Entubation Temperature p=0.011 Postentubation 60. minutes Temperature p<0.001 Postentubation 120. minutes Temperature p<0.001 Postentubation 180. minutes Temperature p=0.001 Postentubation 240. minutes Temperature p=0.001 After Extubation Temperature p<0.001 Recovery Room Enterance Temperature p<0.001 Recovery Room ExitTemperature p=0.094 Service Enterance Temperature p=0.716|ºC degrees|Mean|36.5|36.5|Standard Deviation|0.56|0.56|||
3601837|NCT02961244|3454089|B2|After Entubation Temperature||Perioperative Temperature Measurements|Perioperative Minimum Measurement p<0.001 Preoperative Room Enterance Temperature p=0.980 Preoperative Room Exit Temperature p=0.094 After Entubation Temperature p=0.011 Postentubation 60. minutes Temperature p<0.001 Postentubation 120. minutes Temperature p<0.001 Postentubation 180. minutes Temperature p=0.001 Postentubation 240. minutes Temperature p=0.001 After Extubation Temperature p<0.001 Recovery Room Enterance Temperature p<0.001 Recovery Room ExitTemperature p=0.094 Service Enterance Temperature p=0.716|ºC degrees|Mean|36.66|36.66|Standard Deviation|0.46|0.46|||
3601986|NCT02961244|3454088|B3|||Intraoperative fresh frozen plasma transfusion||units|Mean|0.008|0.008|Standard Deviation|0.009|0.009|||
3601838|NCT02961244|3454090|B1|After Entubation Temperature||Perioperative Temperature Measurements|Perioperative Minimum Measurement p<0.001 Preoperative Room Enterance Temperature p=0.980 Preoperative Room Exit Temperature p=0.094 After Entubation Temperature p=0.011 Postentubation 60. minutes Temperature p<0.001 Postentubation 120. minutes Temperature p<0.001 Postentubation 180. minutes Temperature p=0.001 Postentubation 240. minutes Temperature p=0.001 After Extubation Temperature p<0.001 Recovery Room Enterance Temperature p<0.001 Recovery Room ExitTemperature p=0.094 Service Enterance Temperature p=0.716|ºC degrees|Mean|36.36|36.36|Standard Deviation|0.6|0.6|||
3601839|NCT02961244|3454088|B3|Preoperative Room Exit Temperature||Perioperative Temperature Measurements|Perioperative Minimum Measurement p<0.001 Preoperative Room Enterance Temperature p=0.980 Preoperative Room Exit Temperature p=0.094 After Entubation Temperature p=0.011 Postentubation 60. minutes Temperature p<0.001 Postentubation 120. minutes Temperature p<0.001 Postentubation 180. minutes Temperature p=0.001 Postentubation 240. minutes Temperature p=0.001 After Extubation Temperature p<0.001 Recovery Room Enterance Temperature p<0.001 Recovery Room ExitTemperature p=0.094 Service Enterance Temperature p=0.716|ºC degrees|Mean|36.96|36.96|Standard Deviation|0.46|0.46|||
3601840|NCT02961244|3454089|B2|Preoperative Room Exit Temperature||Perioperative Temperature Measurements|Perioperative Minimum Measurement p<0.001 Preoperative Room Enterance Temperature p=0.980 Preoperative Room Exit Temperature p=0.094 After Entubation Temperature p=0.011 Postentubation 60. minutes Temperature p<0.001 Postentubation 120. minutes Temperature p<0.001 Postentubation 180. minutes Temperature p=0.001 Postentubation 240. minutes Temperature p=0.001 After Extubation Temperature p<0.001 Recovery Room Enterance Temperature p<0.001 Recovery Room ExitTemperature p=0.094 Service Enterance Temperature p=0.716|ºC degrees|Mean|36.89|36.89|Standard Deviation|0.5|0.5|||
3601841|NCT02961244|3454090|B1|Preoperative Room Exit Temperature||Perioperative Temperature Measurements|Perioperative Minimum Measurement p<0.001 Preoperative Room Enterance Temperature p=0.980 Preoperative Room Exit Temperature p=0.094 After Entubation Temperature p=0.011 Postentubation 60. minutes Temperature p<0.001 Postentubation 120. minutes Temperature p<0.001 Postentubation 180. minutes Temperature p=0.001 Postentubation 240. minutes Temperature p=0.001 After Extubation Temperature p<0.001 Recovery Room Enterance Temperature p<0.001 Recovery Room ExitTemperature p=0.094 Service Enterance Temperature p=0.716|ºC degrees|Mean|37.03|37.03|Standard Deviation|0.4|0.4|||
3601842|NCT02961244|3454088|B3|Preoperative Room Enterance Temperature||Perioperative Temperature Measurements|Perioperative Minimum Measurement p<0.001 Preoperative Room Enterance Temperature p=0.980 Preoperative Room Exit Temperature p=0.094 After Entubation Temperature p=0.011 Postentubation 60. minutes Temperature p<0.001 Postentubation 120. minutes Temperature p<0.001 Postentubation 180. minutes Temperature p=0.001 Postentubation 240. minutes Temperature p=0.001 After Extubation Temperature p<0.001 Recovery Room Enterance Temperature p<0.001 Recovery Room ExitTemperature p=0.094 Service Enterance Temperature p=0.716|ºC degrees|Mean|36.94|36.94|Standard Deviation|0.46|0.46|||
3601843|NCT02961244|3454089|B2|Preoperative Room Enterance Temperature||Perioperative Temperature Measurements|Perioperative Minimum Measurement p<0.001 Preoperative Room Enterance Temperature p=0.980 Preoperative Room Exit Temperature p=0.094 After Entubation Temperature p=0.011 Postentubation 60. minutes Temperature p<0.001 Postentubation 120. minutes Temperature p<0.001 Postentubation 180. minutes Temperature p=0.001 Postentubation 240. minutes Temperature p=0.001 After Extubation Temperature p<0.001 Recovery Room Enterance Temperature p<0.001 Recovery Room ExitTemperature p=0.094 Service Enterance Temperature p=0.716|ºC degrees|Mean|36.94|36.94|Standard Deviation|0.46|0.46|||
3601844|NCT02961244|3454090|B1|Preoperative Room Enterance Temperature||Perioperative Temperature Measurements|Perioperative Minimum Measurement p<0.001 Preoperative Room Enterance Temperature p=0.980 Preoperative Room Exit Temperature p=0.094 After Entubation Temperature p=0.011 Postentubation 60. minutes Temperature p<0.001 Postentubation 120. minutes Temperature p<0.001 Postentubation 180. minutes Temperature p=0.001 Postentubation 240. minutes Temperature p=0.001 After Extubation Temperature p<0.001 Recovery Room Enterance Temperature p<0.001 Recovery Room ExitTemperature p=0.094 Service Enterance Temperature p=0.716|ºC degrees|Mean|36.94|36.94|Standard Deviation|0.47|0.47|||
3601845|NCT02961244|3454088|B3|Perioperative Minimum Measurement||Perioperative Temperature Measurements|Perioperative Minimum Measurement p<0.001 Preoperative Room Enterance Temperature p=0.980 Preoperative Room Exit Temperature p=0.094 After Entubation Temperature p=0.011 Postentubation 60. minutes Temperature p<0.001 Postentubation 120. minutes Temperature p<0.001 Postentubation 180. minutes Temperature p=0.001 Postentubation 240. minutes Temperature p=0.001 After Extubation Temperature p<0.001 Recovery Room Enterance Temperature p<0.001 Recovery Room ExitTemperature p=0.094 Service Enterance Temperature p=0.716|ºC degrees|Mean|35.44|35.44|Standard Deviation|0.63|0.63|||
3601846|NCT02961244|3454089|B2|Perioperative Minimum Measurement||Perioperative Temperature Measurements|Perioperative Minimum Measurement p<0.001 Preoperative Room Enterance Temperature p=0.980 Preoperative Room Exit Temperature p=0.094 After Entubation Temperature p=0.011 Postentubation 60. minutes Temperature p<0.001 Postentubation 120. minutes Temperature p<0.001 Postentubation 180. minutes Temperature p=0.001 Postentubation 240. minutes Temperature p=0.001 After Extubation Temperature p<0.001 Recovery Room Enterance Temperature p<0.001 Recovery Room ExitTemperature p=0.094 Service Enterance Temperature p=0.716|ºC degrees|Mean|35.76|35.76|Standard Deviation|0.52|0.52|||
3601847|NCT02961244|3454090|B1|Perioperative Minimum Measurement||Perioperative Temperature Measurements|Perioperative Minimum Measurement p<0.001 Preoperative Room Enterance Temperature p=0.980 Preoperative Room Exit Temperature p=0.094 After Entubation Temperature p=0.011 Postentubation 60. minutes Temperature p<0.001 Postentubation 120. minutes Temperature p<0.001 Postentubation 180. minutes Temperature p=0.001 Postentubation 240. minutes Temperature p=0.001 After Extubation Temperature p<0.001 Recovery Room Enterance Temperature p<0.001 Recovery Room ExitTemperature p=0.094 Service Enterance Temperature p=0.716|ºC degrees|Mean|35.17|35.17|Standard Deviation|0.59|0.59|||
3601848|NCT02961244|3454088|B3|Other(Valvuler, collagen tissue, etc diseases)||Comorbidities|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title. Buy for classifaciton of the comobidities, Elixhauser Classification used for standart data presentation.|Participants|Count of Participants|5|5.0||||||
3601849|NCT02961244|3454089|B2|Other(Valvuler, collagen tissue, etc diseases)||Comorbidities|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title. Buy for classifaciton of the comobidities, Elixhauser Classification used for standart data presentation.|Participants|Count of Participants|1|1.0||||||
3601987|NCT02961244|3454089|B2|||Intraoperative fresh frozen plasma transfusion||units|Mean|0.018|0.018|Standard Deviation|0.134|0.134|||
3601851|NCT02961244|3454088|B3|Non-metastatic Solid Tumor||Comorbidities|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title. Buy for classifaciton of the comobidities, Elixhauser Classification used for standart data presentation.|Participants|Count of Participants|88|88.0||||||
3601852|NCT02961244|3454089|B2|Non-metastatic Solid Tumor||Comorbidities|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title. Buy for classifaciton of the comobidities, Elixhauser Classification used for standart data presentation.|Participants|Count of Participants|43|43.0||||||
3601853|NCT02961244|3454090|B1|Non-metastatic Solid Tumor||Comorbidities|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title. Buy for classifaciton of the comobidities, Elixhauser Classification used for standart data presentation.|Participants|Count of Participants|45|45.0||||||
3601854|NCT02961244|3454088|B3|Metastatic Cancer||Comorbidities|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title. Buy for classifaciton of the comobidities, Elixhauser Classification used for standart data presentation.|Participants|Count of Participants|27|27.0||||||
3601855|NCT02961244|3454089|B2|Metastatic Cancer||Comorbidities|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title. Buy for classifaciton of the comobidities, Elixhauser Classification used for standart data presentation.|Participants|Count of Participants|11|11.0||||||
3601856|NCT02961244|3454090|B1|Metastatic Cancer||Comorbidities|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title. Buy for classifaciton of the comobidities, Elixhauser Classification used for standart data presentation.|Participants|Count of Participants|16|16.0||||||
3601857|NCT02961244|3454088|B3|Lymphoma||Comorbidities|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title. Buy for classifaciton of the comobidities, Elixhauser Classification used for standart data presentation.|Participants|Count of Participants|2|2.0||||||
3601858|NCT02961244|3454089|B2|Lymphoma||Comorbidities|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title. Buy for classifaciton of the comobidities, Elixhauser Classification used for standart data presentation.|Participants|Count of Participants|1|1.0||||||
3601859|NCT02961244|3454090|B1|Lymphoma||Comorbidities|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title. Buy for classifaciton of the comobidities, Elixhauser Classification used for standart data presentation.|Participants|Count of Participants|1|1.0||||||
3601860|NCT02961244|3454088|B3|Hypothyroidism||Comorbidities|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title. Buy for classifaciton of the comobidities, Elixhauser Classification used for standart data presentation.|Participants|Count of Participants|11|11.0||||||
3601861|NCT02961244|3454089|B2|Hypothyroidism||Comorbidities|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title. Buy for classifaciton of the comobidities, Elixhauser Classification used for standart data presentation.|Participants|Count of Participants|3|3.0||||||
3601862|NCT02961244|3454090|B1|Hypothyroidism||Comorbidities|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title. Buy for classifaciton of the comobidities, Elixhauser Classification used for standart data presentation.|Participants|Count of Participants|8|8.0||||||
3601863|NCT02961244|3454088|B3|Complicated Diabetes||Comorbidities|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title. Buy for classifaciton of the comobidities, Elixhauser Classification used for standart data presentation.|Participants|Count of Participants|3|3.0||||||
3601864|NCT02961244|3454089|B2|Complicated Diabetes||Comorbidities|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title. Buy for classifaciton of the comobidities, Elixhauser Classification used for standart data presentation.|Participants|Count of Participants|3|3.0||||||
3601865|NCT02961244|3454090|B1|Complicated Diabetes||Comorbidities|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title. Buy for classifaciton of the comobidities, Elixhauser Classification used for standart data presentation.|Participants|Count of Participants|0|0.0||||||
3601866|NCT02961244|3454088|B3|Uncomplicated Diabetes||Comorbidities|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title. Buy for classifaciton of the comobidities, Elixhauser Classification used for standart data presentation.|Participants|Count of Participants|21|21.0||||||
3601867|NCT02961244|3454089|B2|Uncomplicated Diabetes||Comorbidities|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title. Buy for classifaciton of the comobidities, Elixhauser Classification used for standart data presentation.|Participants|Count of Participants|10|10.0||||||
3601868|NCT02961244|3454090|B1|Uncomplicated Diabetes||Comorbidities|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title. Buy for classifaciton of the comobidities, Elixhauser Classification used for standart data presentation.|Participants|Count of Participants|11|11.0||||||
3601869|NCT02961244|3454088|B3|Chronic Respiratory Diseases||Comorbidities|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title. Buy for classifaciton of the comobidities, Elixhauser Classification used for standart data presentation.|Participants|Count of Participants|6|6.0||||||
3601870|NCT02961244|3454089|B2|Chronic Respiratory Diseases||Comorbidities|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title. Buy for classifaciton of the comobidities, Elixhauser Classification used for standart data presentation.|Participants|Count of Participants|4|4.0||||||
3601871|NCT02961244|3454090|B1|Chronic Respiratory Diseases||Comorbidities|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title. Buy for classifaciton of the comobidities, Elixhauser Classification used for standart data presentation.|Participants|Count of Participants|2|2.0||||||
3601872|NCT02961244|3454088|B3|Uncomplicated Hypertension||Comorbidities|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title. Buy for classifaciton of the comobidities, Elixhauser Classification used for standart data presentation.|Participants|Count of Participants|38|38.0||||||
3601988|NCT02961244|3454090|B1|||Intraoperative fresh frozen plasma transfusion||units|Mean|0|0.0|Standard Deviation|0|0.0|||
3601873|NCT02961244|3454089|B2|Uncomplicated Hypertension||Comorbidities|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title. Buy for classifaciton of the comobidities, Elixhauser Classification used for standart data presentation.|Participants|Count of Participants|19|19.0||||||
3601874|NCT02961244|3454090|B1|Uncomplicated Hypertension||Comorbidities|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title. Buy for classifaciton of the comobidities, Elixhauser Classification used for standart data presentation.|Participants|Count of Participants|19|19.0||||||
3601875|NCT02961244|3454088|B3|Complicated Hypertension||Comorbidities|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title. Buy for classifaciton of the comobidities, Elixhauser Classification used for standart data presentation.|Participants|Count of Participants|6|6.0||||||
3601876|NCT02961244|3454089|B2|Complicated Hypertension||Comorbidities|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title. Buy for classifaciton of the comobidities, Elixhauser Classification used for standart data presentation.|Participants|Count of Participants|4|4.0||||||
3601877|NCT02961244|3454090|B1|Complicated Hypertension||Comorbidities|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title. Buy for classifaciton of the comobidities, Elixhauser Classification used for standart data presentation.|Participants|Count of Participants|2|2.0||||||
3601878|NCT02961244|3454088|B3|Pulmonary Circulation Disorders||Comorbidities|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title. Buy for classifaciton of the comobidities, Elixhauser Classification used for standart data presentation.|Participants|Count of Participants|5|5.0||||||
3601879|NCT02961244|3454089|B2|Pulmonary Circulation Disorders||Comorbidities|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title. Buy for classifaciton of the comobidities, Elixhauser Classification used for standart data presentation.|Participants|Count of Participants|5|5.0||||||
3601880|NCT02961244|3454090|B1|Pulmonary Circulation Disorders||Comorbidities|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title. Buy for classifaciton of the comobidities, Elixhauser Classification used for standart data presentation.|Participants|Count of Participants|0|0.0||||||
3601881|NCT02961244|3454088|B3|Congestive Heart Failure||Comorbidities|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title. Buy for classifaciton of the comobidities, Elixhauser Classification used for standart data presentation.|Participants|Count of Participants|3|3.0||||||
3601882|NCT02961244|3454089|B2|Congestive Heart Failure||Comorbidities|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title. Buy for classifaciton of the comobidities, Elixhauser Classification used for standart data presentation.|Participants|Count of Participants|2|2.0||||||
3601883|NCT02961244|3454090|B1|Congestive Heart Failure||Comorbidities|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title. Buy for classifaciton of the comobidities, Elixhauser Classification used for standart data presentation.|Participants|Count of Participants|1|1.0||||||
3601884|NCT02961244|3454088|B3|≥3||SENIC Score|"For SENIC scores groups were homogeneous. (0.581) This Scoring system has known as Study on Efficacy of Nosocomial Infection Control (SENIC) project's SSI Risk Scoring System (Min. 0 to max. 4 points may be calculated , risk of SSI incerases by score ). 4 criterias include duration of surgery (>2 hours), abdominal surgery, wound class( contaminated or dirty takes one point) and comorbidities (>2) which is any of them is one points.~Because of the participants who in each score (0-4) was not enough to analyse statisticaly, participants divided into two groups. (<3 and ≥3)"|Participants|Count of Participants|13|13.0||||||
3601885|NCT02961244|3454089|B2|≥3||SENIC Score|"For SENIC scores groups were homogeneous. (0.581) This Scoring system has known as Study on Efficacy of Nosocomial Infection Control (SENIC) project's SSI Risk Scoring System (Min. 0 to max. 4 points may be calculated , risk of SSI incerases by score ). 4 criterias include duration of surgery (>2 hours), abdominal surgery, wound class( contaminated or dirty takes one point) and comorbidities (>2) which is any of them is one points.~Because of the participants who in each score (0-4) was not enough to analyse statisticaly, participants divided into two groups. (<3 and ≥3)"|Participants|Count of Participants|7|7.0||||||
3601886|NCT02961244|3454090|B1|≥3||SENIC Score|"For SENIC scores groups were homogeneous. (0.581) This Scoring system has known as Study on Efficacy of Nosocomial Infection Control (SENIC) project's SSI Risk Scoring System (Min. 0 to max. 4 points may be calculated , risk of SSI incerases by score ). 4 criterias include duration of surgery (>2 hours), abdominal surgery, wound class( contaminated or dirty takes one point) and comorbidities (>2) which is any of them is one points.~Because of the participants who in each score (0-4) was not enough to analyse statisticaly, participants divided into two groups. (<3 and ≥3)"|Participants|Count of Participants|6|6.0||||||
3601887|NCT02961244|3454088|B3|<3||SENIC Score|"For SENIC scores groups were homogeneous. (0.581) This Scoring system has known as Study on Efficacy of Nosocomial Infection Control (SENIC) project's SSI Risk Scoring System (Min. 0 to max. 4 points may be calculated , risk of SSI incerases by score ). 4 criterias include duration of surgery (>2 hours), abdominal surgery, wound class( contaminated or dirty takes one point) and comorbidities (>2) which is any of them is one points.~Because of the participants who in each score (0-4) was not enough to analyse statisticaly, participants divided into two groups. (<3 and ≥3)"|Participants|Count of Participants|105|105.0||||||
3601888|NCT02961244|3454089|B2|<3||SENIC Score|"For SENIC scores groups were homogeneous. (0.581) This Scoring system has known as Study on Efficacy of Nosocomial Infection Control (SENIC) project's SSI Risk Scoring System (Min. 0 to max. 4 points may be calculated , risk of SSI incerases by score ). 4 criterias include duration of surgery (>2 hours), abdominal surgery, wound class( contaminated or dirty takes one point) and comorbidities (>2) which is any of them is one points.~Because of the participants who in each score (0-4) was not enough to analyse statisticaly, participants divided into two groups. (<3 and ≥3)"|Participants|Count of Participants|48|48.0||||||
3601927|NCT02961244|3454089|B2|Postoperative Duration of Hospitalization||Duration of Hospitalization Parameters|Between two groups duration of hospitalizations were not statistically different including parameters of Total Duration of Hospitalization (p=0.879), Preoperative Duration of Hospitalization (p=0.601), Postoperative Duration of Hospitalization (0.995) and Duration of ICU Hospitalization (0.346).|days|Mean|12.1|12.1|Standard Deviation|9.07|9.07|||
3601889|NCT02961244|3454090|B1|<3||SENIC Score|"For SENIC scores groups were homogeneous. (0.581) This Scoring system has known as Study on Efficacy of Nosocomial Infection Control (SENIC) project's SSI Risk Scoring System (Min. 0 to max. 4 points may be calculated , risk of SSI incerases by score ). 4 criterias include duration of surgery (>2 hours), abdominal surgery, wound class( contaminated or dirty takes one point) and comorbidities (>2) which is any of them is one points.~Because of the participants who in each score (0-4) was not enough to analyse statisticaly, participants divided into two groups. (<3 and ≥3)"|Participants|Count of Participants|57|57.0||||||
3601890|NCT02961244|3454088|B3|≥2||NNISS Score|For NNISS scores groups were homogeneous. (p=0.875) NNISS Score which has known as The National Nosocomial Infections Surveillance System Scoring System used for prediction of the risk of Surgical Site İnfections (SSI).The NNIS basic SSI risk index is composed of the following criteria: American Society of Anesthesiologists score of 3, 4, or 5 (>2 takes one score; wound class( contaminated or dirty takes one point; and duration of surgery (There are percantile times defined and above 75 percantile, score takes one point) NNISS Score may be 0 to 3, and SSI risks were increased by score.|Participants|Count of Participants|20|20.0||||||
3601891|NCT02961244|3454089|B2|≥2||NNISS Score|For NNISS scores groups were homogeneous. (p=0.875) NNISS Score which has known as The National Nosocomial Infections Surveillance System Scoring System used for prediction of the risk of Surgical Site İnfections (SSI).The NNIS basic SSI risk index is composed of the following criteria: American Society of Anesthesiologists score of 3, 4, or 5 (>2 takes one score; wound class( contaminated or dirty takes one point; and duration of surgery (There are percantile times defined and above 75 percantile, score takes one point) NNISS Score may be 0 to 3, and SSI risks were increased by score.|Participants|Count of Participants|9|9.0||||||
3601892|NCT02961244|3454090|B1|≥2||NNISS Score|For NNISS scores groups were homogeneous. (p=0.875) NNISS Score which has known as The National Nosocomial Infections Surveillance System Scoring System used for prediction of the risk of Surgical Site İnfections (SSI).The NNIS basic SSI risk index is composed of the following criteria: American Society of Anesthesiologists score of 3, 4, or 5 (>2 takes one score; wound class( contaminated or dirty takes one point; and duration of surgery (There are percantile times defined and above 75 percantile, score takes one point) NNISS Score may be 0 to 3, and SSI risks were increased by score.|Participants|Count of Participants|11|11.0||||||
3601893|NCT02961244|3454088|B3|<2||NNISS Score|For NNISS scores groups were homogeneous. (p=0.875) NNISS Score which has known as The National Nosocomial Infections Surveillance System Scoring System used for prediction of the risk of Surgical Site İnfections (SSI).The NNIS basic SSI risk index is composed of the following criteria: American Society of Anesthesiologists score of 3, 4, or 5 (>2 takes one score; wound class( contaminated or dirty takes one point; and duration of surgery (There are percantile times defined and above 75 percantile, score takes one point) NNISS Score may be 0 to 3, and SSI risks were increased by score.|Participants|Count of Participants|98|98.0||||||
3601894|NCT02961244|3454089|B2|<2||NNISS Score|For NNISS scores groups were homogeneous. (p=0.875) NNISS Score which has known as The National Nosocomial Infections Surveillance System Scoring System used for prediction of the risk of Surgical Site İnfections (SSI).The NNIS basic SSI risk index is composed of the following criteria: American Society of Anesthesiologists score of 3, 4, or 5 (>2 takes one score; wound class( contaminated or dirty takes one point; and duration of surgery (There are percantile times defined and above 75 percantile, score takes one point) NNISS Score may be 0 to 3, and SSI risks were increased by score.|Participants|Count of Participants|46|46.0||||||
3601895|NCT02961244|3454090|B1|<2||NNISS Score|For NNISS scores groups were homogeneous. (p=0.875) NNISS Score which has known as The National Nosocomial Infections Surveillance System Scoring System used for prediction of the risk of Surgical Site İnfections (SSI).The NNIS basic SSI risk index is composed of the following criteria: American Society of Anesthesiologists score of 3, 4, or 5 (>2 takes one score; wound class( contaminated or dirty takes one point; and duration of surgery (There are percantile times defined and above 75 percantile, score takes one point) NNISS Score may be 0 to 3, and SSI risks were increased by score.|Participants|Count of Participants|52|52.0||||||
3601896|NCT02961244|3454088|B3||ASA 3|ASA Score|For ASA scores groups were homogeneous. (p=0.943) ASA 4,5,6 is not shown because of the study inclusion criterias. (ASA which has known as American Society of Anesthesiologists Physical Status, min. 1 and max. 6). Definitions: ASA 1-Normal healthy patients, ASA 2-A patient with mild systemic disease. ASA 3-A Patient with severe systemic disease, ASA4-A patient with severe systemic disease that is a constant threat to life, ASA5-A moribund patient who is not expected to survive without the operation, ASA6-A declared brain-dead patient whose organs are being removed for donor purposes)|Participants|Count of Participants|16|16.0||||||
3601897|NCT02961244|3454089|B2||ASA 3|ASA Score|For ASA scores groups were homogeneous. (p=0.943) ASA 4,5,6 is not shown because of the study inclusion criterias. (ASA which has known as American Society of Anesthesiologists Physical Status, min. 1 and max. 6). Definitions: ASA 1-Normal healthy patients, ASA 2-A patient with mild systemic disease. ASA 3-A Patient with severe systemic disease, ASA4-A patient with severe systemic disease that is a constant threat to life, ASA5-A moribund patient who is not expected to survive without the operation, ASA6-A declared brain-dead patient whose organs are being removed for donor purposes)|Participants|Count of Participants|7|7.0||||||
3601898|NCT02961244|3454090|B1||ASA 3|ASA Score|For ASA scores groups were homogeneous. (p=0.943) ASA 4,5,6 is not shown because of the study inclusion criterias. (ASA which has known as American Society of Anesthesiologists Physical Status, min. 1 and max. 6). Definitions: ASA 1-Normal healthy patients, ASA 2-A patient with mild systemic disease. ASA 3-A Patient with severe systemic disease, ASA4-A patient with severe systemic disease that is a constant threat to life, ASA5-A moribund patient who is not expected to survive without the operation, ASA6-A declared brain-dead patient whose organs are being removed for donor purposes)|Participants|Count of Participants|9|9.0||||||
3601899|NCT02961244|3454088|B3||ASA 2|ASA Score|For ASA scores groups were homogeneous. (p=0.943) ASA 4,5,6 is not shown because of the study inclusion criterias. (ASA which has known as American Society of Anesthesiologists Physical Status, min. 1 and max. 6). Definitions: ASA 1-Normal healthy patients, ASA 2-A patient with mild systemic disease. ASA 3-A Patient with severe systemic disease, ASA4-A patient with severe systemic disease that is a constant threat to life, ASA5-A moribund patient who is not expected to survive without the operation, ASA6-A declared brain-dead patient whose organs are being removed for donor purposes)|Participants|Count of Participants|61|61.0||||||
3602025|NCT02961244|3454088|B3||Alcohol use (<2 glass)|Alcohol Use|For alcohol use, groups were homogeneous. (p=0.541)|Participants|Count of Participants|113|113.0||||||
3601900|NCT02961244|3454089|B2||ASA 2|ASA Score|For ASA scores groups were homogeneous. (p=0.943) ASA 4,5,6 is not shown because of the study inclusion criterias. (ASA which has known as American Society of Anesthesiologists Physical Status, min. 1 and max. 6). Definitions: ASA 1-Normal healthy patients, ASA 2-A patient with mild systemic disease. ASA 3-A Patient with severe systemic disease, ASA4-A patient with severe systemic disease that is a constant threat to life, ASA5-A moribund patient who is not expected to survive without the operation, ASA6-A declared brain-dead patient whose organs are being removed for donor purposes)|Participants|Count of Participants|29|29.0||||||
3601901|NCT02961244|3454090|B1||ASA 2|ASA Score|For ASA scores groups were homogeneous. (p=0.943) ASA 4,5,6 is not shown because of the study inclusion criterias. (ASA which has known as American Society of Anesthesiologists Physical Status, min. 1 and max. 6). Definitions: ASA 1-Normal healthy patients, ASA 2-A patient with mild systemic disease. ASA 3-A Patient with severe systemic disease, ASA4-A patient with severe systemic disease that is a constant threat to life, ASA5-A moribund patient who is not expected to survive without the operation, ASA6-A declared brain-dead patient whose organs are being removed for donor purposes)|Participants|Count of Participants|32|32.0||||||
3601902|NCT02961244|3454088|B3||ASA 1|ASA Score|For ASA scores groups were homogeneous. (p=0.943) ASA 4,5,6 is not shown because of the study inclusion criterias. (ASA which has known as American Society of Anesthesiologists Physical Status, min. 1 and max. 6). Definitions: ASA 1-Normal healthy patients, ASA 2-A patient with mild systemic disease. ASA 3-A Patient with severe systemic disease, ASA4-A patient with severe systemic disease that is a constant threat to life, ASA5-A moribund patient who is not expected to survive without the operation, ASA6-A declared brain-dead patient whose organs are being removed for donor purposes)|Participants|Count of Participants|41|41.0||||||
3601903|NCT02961244|3454089|B2||ASA 1|ASA Score|For ASA scores groups were homogeneous. (p=0.943) ASA 4,5,6 is not shown because of the study inclusion criterias. (ASA which has known as American Society of Anesthesiologists Physical Status, min. 1 and max. 6). Definitions: ASA 1-Normal healthy patients, ASA 2-A patient with mild systemic disease. ASA 3-A Patient with severe systemic disease, ASA4-A patient with severe systemic disease that is a constant threat to life, ASA5-A moribund patient who is not expected to survive without the operation, ASA6-A declared brain-dead patient whose organs are being removed for donor purposes)|Participants|Count of Participants|19|19.0||||||
3601904|NCT02961244|3454090|B1||ASA 1|ASA Score|For ASA scores groups were homogeneous. (p=0.943) ASA 4,5,6 is not shown because of the study inclusion criterias. (ASA which has known as American Society of Anesthesiologists Physical Status, min. 1 and max. 6). Definitions: ASA 1-Normal healthy patients, ASA 2-A patient with mild systemic disease. ASA 3-A Patient with severe systemic disease, ASA4-A patient with severe systemic disease that is a constant threat to life, ASA5-A moribund patient who is not expected to survive without the operation, ASA6-A declared brain-dead patient whose organs are being removed for donor purposes)|Participants|Count of Participants|22|22.0||||||
3601905|NCT02961244|3454088|B3|Contaminated||Surgical Site Classification|"During the preoperative patient's approval period, if surgical site is predicted as contaminated and dirty, these patients not appropriate for study. (preoperatively) In 2 patients preoperatively appropriate was found that peroperatively they had closed microperforation of tumor.Though minimal contamination detected perioperatively and there were not any clinical findings of infection, they accepted as contaminated.~There were not enough numbers in all boxes so statistical analyses not appropriate to assess."|Participants|Count of Participants|2|2.0||||||
3601906|NCT02961244|3454089|B2|Contaminated||Surgical Site Classification|"During the preoperative patient's approval period, if surgical site is predicted as contaminated and dirty, these patients not appropriate for study. (preoperatively) In 2 patients preoperatively appropriate was found that peroperatively they had closed microperforation of tumor.Though minimal contamination detected perioperatively and there were not any clinical findings of infection, they accepted as contaminated.~There were not enough numbers in all boxes so statistical analyses not appropriate to assess."|Participants|Count of Participants|1|1.0||||||
3601907|NCT02961244|3454090|B1|Contaminated||Surgical Site Classification|"During the preoperative patient's approval period, if surgical site is predicted as contaminated and dirty, these patients not appropriate for study. (preoperatively) In 2 patients preoperatively appropriate was found that peroperatively they had closed microperforation of tumor.Though minimal contamination detected perioperatively and there were not any clinical findings of infection, they accepted as contaminated.~There were not enough numbers in all boxes so statistical analyses not appropriate to assess."|Participants|Count of Participants|1|1.0||||||
3601908|NCT02961244|3454088|B3|Clean-Contaminated||Surgical Site Classification|"During the preoperative patient's approval period, if surgical site is predicted as contaminated and dirty, these patients not appropriate for study. (preoperatively) In 2 patients preoperatively appropriate was found that peroperatively they had closed microperforation of tumor.Though minimal contamination detected perioperatively and there were not any clinical findings of infection, they accepted as contaminated.~There were not enough numbers in all boxes so statistical analyses not appropriate to assess."|Participants|Count of Participants|110|110.0||||||
3601909|NCT02961244|3454089|B2|Clean-Contaminated||Surgical Site Classification|"During the preoperative patient's approval period, if surgical site is predicted as contaminated and dirty, these patients not appropriate for study. (preoperatively) In 2 patients preoperatively appropriate was found that peroperatively they had closed microperforation of tumor.Though minimal contamination detected perioperatively and there were not any clinical findings of infection, they accepted as contaminated.~There were not enough numbers in all boxes so statistical analyses not appropriate to assess."|Participants|Count of Participants|52|52.0||||||
3601910|NCT02961244|3454090|B1|Clean-Contaminated||Surgical Site Classification|"During the preoperative patient's approval period, if surgical site is predicted as contaminated and dirty, these patients not appropriate for study. (preoperatively) In 2 patients preoperatively appropriate was found that peroperatively they had closed microperforation of tumor.Though minimal contamination detected perioperatively and there were not any clinical findings of infection, they accepted as contaminated.~There were not enough numbers in all boxes so statistical analyses not appropriate to assess."|Participants|Count of Participants|58|58.0||||||
3601928|NCT02961244|3454090|B1|Postoperative Duration of Hospitalization||Duration of Hospitalization Parameters|Between two groups duration of hospitalizations were not statistically different including parameters of Total Duration of Hospitalization (p=0.879), Preoperative Duration of Hospitalization (p=0.601), Postoperative Duration of Hospitalization (0.995) and Duration of ICU Hospitalization (0.346).|days|Mean|12.09|12.09|Standard Deviation|15.54|15.54|||
3601911|NCT02961244|3454088|B3|Clean||Surgical Site Classification|"During the preoperative patient's approval period, if surgical site is predicted as contaminated and dirty, these patients not appropriate for study. (preoperatively) In 2 patients preoperatively appropriate was found that peroperatively they had closed microperforation of tumor.Though minimal contamination detected perioperatively and there were not any clinical findings of infection, they accepted as contaminated.~There were not enough numbers in all boxes so statistical analyses not appropriate to assess."|Participants|Count of Participants|6|6.0||||||
3601912|NCT02961244|3454089|B2|Clean||Surgical Site Classification|"During the preoperative patient's approval period, if surgical site is predicted as contaminated and dirty, these patients not appropriate for study. (preoperatively) In 2 patients preoperatively appropriate was found that peroperatively they had closed microperforation of tumor.Though minimal contamination detected perioperatively and there were not any clinical findings of infection, they accepted as contaminated.~There were not enough numbers in all boxes so statistical analyses not appropriate to assess."|Participants|Count of Participants|2|2.0||||||
3601913|NCT02961244|3454090|B1|Clean||Surgical Site Classification|"During the preoperative patient's approval period, if surgical site is predicted as contaminated and dirty, these patients not appropriate for study. (preoperatively) In 2 patients preoperatively appropriate was found that peroperatively they had closed microperforation of tumor.Though minimal contamination detected perioperatively and there were not any clinical findings of infection, they accepted as contaminated.~There were not enough numbers in all boxes so statistical analyses not appropriate to assess."|Participants|Count of Participants|4|4.0||||||
3601914|NCT02961244|3454088|B3|Postoperative Warming||Perioperative Warming|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for preoperative and peroperative warming. Postoperative warming choices were significiantly different between two groups as excepted because of study protocols contents.(p<0.001)|participants|Number|60|60.0||||||
3601915|NCT02961244|3454089|B2|Postoperative Warming||Perioperative Warming|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for preoperative and peroperative warming. Postoperative warming choices were significiantly different between two groups as excepted because of study protocols contents.(p<0.001)|participants|Number|47|47.0||||||
3601916|NCT02961244|3454090|B1|Postoperative Warming||Perioperative Warming|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for preoperative and peroperative warming. Postoperative warming choices were significiantly different between two groups as excepted because of study protocols contents.(p<0.001)|participants|Number|13|13.0||||||
3601917|NCT02961244|3454088|B3|Peroperatuar Warming||Perioperative Warming|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for preoperative and peroperative warming. Postoperative warming choices were significiantly different between two groups as excepted because of study protocols contents.(p<0.001)|participants|Number|118|118.0||||||
3601918|NCT02961244|3454089|B2|Peroperatuar Warming||Perioperative Warming|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for preoperative and peroperative warming. Postoperative warming choices were significiantly different between two groups as excepted because of study protocols contents.(p<0.001)|participants|Number|55|55.0||||||
3601919|NCT02961244|3454090|B1|Peroperatuar Warming||Perioperative Warming|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for preoperative and peroperative warming. Postoperative warming choices were significiantly different between two groups as excepted because of study protocols contents.(p<0.001)|participants|Number|63|63.0||||||
3601920|NCT02961244|3454088|B3|||Simple Hospitalization costs|These data is not result of standardized (like in the literature suggests) costs data.These data made by our patients data system which can calculate goverments payments fees, etc for any procedure performed to any patient. (intervention based data ) (p=0.524)|Thousand Turkish liras|Mean|12.2|12.2|Standard Deviation|8.3|8.3|||
3601921|NCT02961244|3454089|B2|||Simple Hospitalization costs|These data is not result of standardized (like in the literature suggests) costs data.These data made by our patients data system which can calculate goverments payments fees, etc for any procedure performed to any patient. (intervention based data ) (p=0.524)|Thousand Turkish liras|Mean|11.7|11.7|Standard Deviation|6.1|6.1|||
3601922|NCT02961244|3454090|B1|||Simple Hospitalization costs|These data is not result of standardized (like in the literature suggests) costs data.These data made by our patients data system which can calculate goverments payments fees, etc for any procedure performed to any patient. (intervention based data ) (p=0.524)|Thousand Turkish liras|Mean|12.6|12.6|Standard Deviation|9.8|9.8|||
3601923|NCT02961244|3454088|B3|Duration of ICU Hospitalization||Duration of Hospitalization Parameters|Between two groups duration of hospitalizations were not statistically different including parameters of Total Duration of Hospitalization (p=0.879), Preoperative Duration of Hospitalization (p=0.601), Postoperative Duration of Hospitalization (0.995) and Duration of ICU Hospitalization (0.346).|days|Mean|3.48|3.48|Standard Deviation|6.33|6.33|||
3601924|NCT02961244|3454089|B2|Duration of ICU Hospitalization||Duration of Hospitalization Parameters|Between two groups duration of hospitalizations were not statistically different including parameters of Total Duration of Hospitalization (p=0.879), Preoperative Duration of Hospitalization (p=0.601), Postoperative Duration of Hospitalization (0.995) and Duration of ICU Hospitalization (0.346).|days|Mean|3.45|3.45|Standard Deviation|7.48|7.48|||
3601925|NCT02961244|3454090|B1|Duration of ICU Hospitalization||Duration of Hospitalization Parameters|Between two groups duration of hospitalizations were not statistically different including parameters of Total Duration of Hospitalization (p=0.879), Preoperative Duration of Hospitalization (p=0.601), Postoperative Duration of Hospitalization (0.995) and Duration of ICU Hospitalization (0.346).|days|Mean|3.5|3.5|Standard Deviation|5.68|5.68|||
3601926|NCT02961244|3454088|B3|Postoperative Duration of Hospitalization||Duration of Hospitalization Parameters|Between two groups duration of hospitalizations were not statistically different including parameters of Total Duration of Hospitalization (p=0.879), Preoperative Duration of Hospitalization (p=0.601), Postoperative Duration of Hospitalization (0.995) and Duration of ICU Hospitalization (0.346).|days|Mean|12.1|12.1|Standard Deviation|12.88|12.88|||
3601953|NCT02961244|3454088|B3|Postoperative 1. Day||Perioperative albumin levels|Preoperative (p=0.359), postoperative first day (p=0.314) and ∆(Albumin)(the difference between preoperative and postoperative first day levels)(p=0.055)|g/dl|Mean|2.91|2.91|Standard Deviation|0.53|0.53|||
3602127|NCT02959840|3454127|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3601929|NCT02961244|3454088|B3|Preoperative Duration of Hospitalization||Duration of Hospitalization Parameters|Between two groups duration of hospitalizations were not statistically different including parameters of Total Duration of Hospitalization (p=0.879), Preoperative Duration of Hospitalization (p=0.601), Postoperative Duration of Hospitalization (0.995) and Duration of ICU Hospitalization (0.346).|days|Mean|7.15|7.15|Standard Deviation|6.17|6.17|||
3601930|NCT02961244|3454089|B2|Preoperative Duration of Hospitalization||Duration of Hospitalization Parameters|Between two groups duration of hospitalizations were not statistically different including parameters of Total Duration of Hospitalization (p=0.879), Preoperative Duration of Hospitalization (p=0.601), Postoperative Duration of Hospitalization (0.995) and Duration of ICU Hospitalization (0.346).|days|Mean|7.47|7.47|Standard Deviation|6.49|6.49|||
3601931|NCT02961244|3454090|B1|Preoperative Duration of Hospitalization||Duration of Hospitalization Parameters|Between two groups duration of hospitalizations were not statistically different including parameters of Total Duration of Hospitalization (p=0.879), Preoperative Duration of Hospitalization (p=0.601), Postoperative Duration of Hospitalization (0.995) and Duration of ICU Hospitalization (0.346).|days|Mean|6.87|6.87|Standard Deviation|5.91|5.91|||
3601932|NCT02961244|3454088|B3|Total Duration of Hospitalization||Duration of Hospitalization Parameters|Between two groups duration of hospitalizations were not statistically different including parameters of Total Duration of Hospitalization (p=0.879), Preoperative Duration of Hospitalization (p=0.601), Postoperative Duration of Hospitalization (0.995) and Duration of ICU Hospitalization (0.346).|days|Mean|19.25|19.25|Standard Deviation|15.28|15.28|||
3601933|NCT02961244|3454089|B2|Total Duration of Hospitalization||Duration of Hospitalization Parameters|Between two groups duration of hospitalizations were not statistically different including parameters of Total Duration of Hospitalization (p=0.879), Preoperative Duration of Hospitalization (p=0.601), Postoperative Duration of Hospitalization (0.995) and Duration of ICU Hospitalization (0.346).|days|Mean|19.4|19.4|Standard Deviation|10.49|10.49|||
3601934|NCT02961244|3454090|B1|Total Duration of Hospitalization||Duration of Hospitalization Parameters|Between two groups duration of hospitalizations were not statistically different including parameters of Total Duration of Hospitalization (p=0.879), Preoperative Duration of Hospitalization (p=0.601), Postoperative Duration of Hospitalization (0.995) and Duration of ICU Hospitalization (0.346).|days|Mean|18.96|18.96|Standard Deviation|18.62|18.62|||
3601935|NCT02961244|3454088|B3|Amoxicillin + clavulanate||Profilactic antibiotics|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title.|Participants|Count of Participants|1|1.0||||||
3601936|NCT02961244|3454089|B2|Amoxicillin + clavulanate||Profilactic antibiotics|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title.|Participants|Count of Participants|0|0.0||||||
3601937|NCT02961244|3454090|B1|Amoxicillin + clavulanate||Profilactic antibiotics|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title.|Participants|Count of Participants|1|1.0||||||
3601938|NCT02961244|3454088|B3|Ceftriaxone+ metronidazole||Profilactic antibiotics|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title.|Participants|Count of Participants|1|1.0||||||
3601939|NCT02961244|3454089|B2|Ceftriaxone+ metronidazole||Profilactic antibiotics|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title.|Participants|Count of Participants|0|0.0||||||
3601940|NCT02961244|3454090|B1|Ceftriaxone+ metronidazole||Profilactic antibiotics|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title.|Participants|Count of Participants|1|1.0||||||
3601941|NCT02961244|3454088|B3|Ceftriaxone||Profilactic antibiotics|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title.|Participants|Count of Participants|2|2.0||||||
3601942|NCT02961244|3454089|B2|Ceftriaxone||Profilactic antibiotics|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title.|Participants|Count of Participants|1|1.0||||||
3601943|NCT02961244|3454090|B1|Ceftriaxone||Profilactic antibiotics|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title.|Participants|Count of Participants|1|1.0||||||
3601944|NCT02961244|3454088|B3|Cefuroxime + metronidazole||Profilactic antibiotics|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title.|Participants|Count of Participants|62|62.0||||||
3601945|NCT02961244|3454089|B2|Cefuroxime + metronidazole||Profilactic antibiotics|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title.|Participants|Count of Participants|32|32.0||||||
3601946|NCT02961244|3454090|B1|Cefuroxime + metronidazole||Profilactic antibiotics|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title.|Participants|Count of Participants|30|30.0||||||
3601947|NCT02961244|3454088|B3|Cefazolin||Profilactic antibiotics|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title.|Participants|Count of Participants|52|52.0||||||
3601948|NCT02961244|3454089|B2|Cefazolin||Profilactic antibiotics|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title.|Participants|Count of Participants|22|22.0||||||
3601949|NCT02961244|3454090|B1|Cefazolin||Profilactic antibiotics|There were not enough numbers in all boxes so statistical analyses not appropriate to assess for this title.|Participants|Count of Participants|30|30.0||||||
3601950|NCT02961244|3454088|B3|∆(Albumin)||Perioperative albumin levels|Preoperative (p=0.359), postoperative first day (p=0.314) and ∆(Albumin)(the difference between preoperative and postoperative first day levels)(p=0.055)|g/dl|Mean|0.79|0.79|Standard Deviation|0.51|0.51|||
3601951|NCT02961244|3454089|B2|∆(Albumin)||Perioperative albumin levels|Preoperative (p=0.359), postoperative first day (p=0.314) and ∆(Albumin)(the difference between preoperative and postoperative first day levels)(p=0.055)|g/dl|Mean|0.69|0.69|Standard Deviation|0.5|0.5|||
3601952|NCT02961244|3454090|B1|∆(Albumin)||Perioperative albumin levels|Preoperative (p=0.359), postoperative first day (p=0.314) and ∆(Albumin)(the difference between preoperative and postoperative first day levels)(p=0.055)|g/dl|Mean|0.88|0.88|Standard Deviation|0.51|0.51|||
3601984|NCT02961244|3454089|B2|||Intraoperative cristalloid fluid|For cristalloid fluid infusement amounts, groups were homogeneous. (p=0.855)|liters|Mean|3.01|3.01|Standard Deviation|1.4|1.4|||
3601954|NCT02961244|3454089|B2|Postoperative 1. Day||Perioperative albumin levels|Preoperative (p=0.359), postoperative first day (p=0.314) and ∆(Albumin)(the difference between preoperative and postoperative first day levels)(p=0.055)|g/dl|Mean|2.96|2.96|Standard Deviation|0.5|0.5|||
3601955|NCT02961244|3454090|B1|Postoperative 1. Day||Perioperative albumin levels|Preoperative (p=0.359), postoperative first day (p=0.314) and ∆(Albumin)(the difference between preoperative and postoperative first day levels)(p=0.055)|g/dl|Mean|2.86|2.86|Standard Deviation|0.56|0.56|||
3601956|NCT02961244|3454088|B3|Preoperative||Perioperative albumin levels|Preoperative (p=0.359), postoperative first day (p=0.314) and ∆(Albumin)(the difference between preoperative and postoperative first day levels)(p=0.055)|g/dl|Mean|3.71|3.71|Standard Deviation|0.48|0.48|||
3601957|NCT02961244|3454089|B2|Preoperative||Perioperative albumin levels|Preoperative (p=0.359), postoperative first day (p=0.314) and ∆(Albumin)(the difference between preoperative and postoperative first day levels)(p=0.055)|g/dl|Mean|3.66|3.66|Standard Deviation|0.5|0.5|||
3601958|NCT02961244|3454090|B1|Preoperative||Perioperative albumin levels|Preoperative (p=0.359), postoperative first day (p=0.314) and ∆(Albumin)(the difference between preoperative and postoperative first day levels)(p=0.055)|g/dl|Mean|3.74|3.74|Standard Deviation|0.46|0.46|||
3601959|NCT02961244|3454088|B3|∆(Hemoglobin)||Perioperative hemoglobin levels|Preoperative (p=0.984), postoperative first day (p=0.526) and ∆(Hemoglobin)(the difference between preoperative and postoperative first day levels)(p=0.385)|g/dl|Mean|0.71|0.71|Standard Deviation|1.16|1.16|||
3601960|NCT02961244|3454089|B2|∆(Hemoglobin)||Perioperative hemoglobin levels|Preoperative (p=0.984), postoperative first day (p=0.526) and ∆(Hemoglobin)(the difference between preoperative and postoperative first day levels)(p=0.385)|g/dl|Mean|0.61|0.61|Standard Deviation|1.10|1.1|||
3601961|NCT02961244|3454090|B1|∆(Hemoglobin)||Perioperative hemoglobin levels|Preoperative (p=0.984), postoperative first day (p=0.526) and ∆(Hemoglobin)(the difference between preoperative and postoperative first day levels)(p=0.385)|g/dl|Mean|0.80|0.8|Standard Deviation|1.22|1.22|||
3601962|NCT02961244|3454088|B3|Postoperative 1. Day||Perioperative hemoglobin levels|Preoperative (p=0.984), postoperative first day (p=0.526) and ∆(Hemoglobin)(the difference between preoperative and postoperative first day levels)(p=0.385)|g/dl|Mean|11.09|11.09|Standard Deviation|1.55|1.55|||
3601963|NCT02961244|3454089|B2|Postoperative 1. Day||Perioperative hemoglobin levels|Preoperative (p=0.984), postoperative first day (p=0.526) and ∆(Hemoglobin)(the difference between preoperative and postoperative first day levels)(p=0.385)|g/dl|Mean|11.19|11.19|Standard Deviation|1.54|1.54|||
3601964|NCT02961244|3454090|B1|Postoperative 1. Day||Perioperative hemoglobin levels|Preoperative (p=0.984), postoperative first day (p=0.526) and ∆(Hemoglobin)(the difference between preoperative and postoperative first day levels)(p=0.385)|g/dl|Mean|11.0|11.0|Standard Deviation|1.58|1.58|||
3601965|NCT02961244|3454088|B3|Preoperative||Perioperative hemoglobin levels|Preoperative (p=0.984), postoperative first day (p=0.526) and ∆(Hemoglobin)(the difference between preoperative and postoperative first day levels)(p=0.385)|g/dl|Mean|11.81|11.81|Standard Deviation|1.42|1.42|||
3601966|NCT02961244|3454089|B2|Preoperative||Perioperative hemoglobin levels|Preoperative (p=0.984), postoperative first day (p=0.526) and ∆(Hemoglobin)(the difference between preoperative and postoperative first day levels)(p=0.385)|g/dl|Mean|11.8|11.8|Standard Deviation|1.35|1.35|||
3601967|NCT02961244|3454090|B1|Preoperative||Perioperative hemoglobin levels|Preoperative (p=0.984), postoperative first day (p=0.526) and ∆(Hemoglobin)(the difference between preoperative and postoperative first day levels)(p=0.385)|g/dl|Mean|11.81|11.81|Standard Deviation|1.49|1.49|||
3601968|NCT02961244|3454088|B3|||Operation duration|For operation duration , groups were homogeneous. (p=0.059)|minutes|Mean|221.1|221.1|Standard Deviation|114|114.0|||
3601969|NCT02961244|3454089|B2|||Operation duration|For operation duration , groups were homogeneous. (p=0.059)|minutes|Mean|199.9|199.9|Standard Deviation|106.3|106.3|||
3601970|NCT02961244|3454090|B1|||Operation duration|For operation duration , groups were homogeneous. (p=0.059)|minutes|Mean|239.6|239.6|Standard Deviation|118.3|118.3|||
3601971|NCT02961244|3454088|B3|||Intraoperative mean arterial blood pressure|For intraoperative mean arterial blood pressure levels, groups were homogeneous. (p=0.388)|mm Hg|Mean|88.1|88.1|Standard Deviation|13.4|13.4|||
3601972|NCT02961244|3454089|B2|||Intraoperative mean arterial blood pressure|For intraoperative mean arterial blood pressure levels, groups were homogeneous. (p=0.388)|mm Hg|Mean|87|87.0|Standard Deviation|7|7.0|||
3601973|NCT02961244|3454090|B1|||Intraoperative mean arterial blood pressure|For intraoperative mean arterial blood pressure levels, groups were homogeneous. (p=0.388)|mm Hg|Mean|89.1|89.1|Standard Deviation|13.2|13.2|||
3601974|NCT02961244|3454088|B3|||Mean heart rate|For mean heart rate amounts, groups were homogeneous. (p=0.390)|beats per minute|Mean|77|77.0|Standard Deviation|13.9|13.9|||
3601975|NCT02961244|3454089|B2|||Mean heart rate|For mean heart rate amounts, groups were homogeneous. (p=0.390)|beats per minute|Mean|75.8|75.8|Standard Deviation|14.5|14.5|||
3601976|NCT02961244|3454090|B1|||Mean heart rate|For mean heart rate amounts, groups were homogeneous. (p=0.390)|beats per minute|Mean|78|78.0|Standard Deviation|13.4|13.4|||
3601977|NCT02961244|3454088|B3|||Intraoperative urine output|For peroperative urine output, groups were homogeneous. (p=0.559)|liters|Mean|0.74|0.74|Standard Deviation|0.64|0.64|||
3601978|NCT02961244|3454089|B2|||Intraoperative urine output|For peroperative urine output, groups were homogeneous. (p=0.559)|liters|Mean|0.7|0.7|Standard Deviation|0.57|0.57|||
3601979|NCT02961244|3454090|B1|||Intraoperative urine output|For peroperative urine output, groups were homogeneous. (p=0.559)|liters|Mean|0.77|0.77|Standard Deviation|0.71|0.71|||
3601980|NCT02961244|3454088|B3|||Intraoperative colloid fluid|For colloid fluid infusement amounts, groups were homogeneous. (p=0.361)|liters|Mean|0.38|0.38|Standard Deviation|0.5|0.5|||
3601981|NCT02961244|3454089|B2|||Intraoperative colloid fluid|For colloid fluid infusement amounts, groups were homogeneous. (p=0.361)|liters|Mean|0.33|0.33|Standard Deviation|0.42|0.42|||
3601982|NCT02961244|3454090|B1|||Intraoperative colloid fluid|For colloid fluid infusement amounts, groups were homogeneous. (p=0.361)|liters|Mean|0.42|0.42|Standard Deviation|0.57|0.57|||
3601983|NCT02961244|3454088|B3|||Intraoperative cristalloid fluid|For cristalloid fluid infusement amounts, groups were homogeneous. (p=0.855)|liters|Mean|3.04|3.04|Standard Deviation|1.38|1.38|||
3601989|NCT02961244|3454088|B3|||İntraoperative red cell transfusion|For intraoperative red cell transfusion variable, groups were homogeneous. (p=0.470)|units|Mean|0.25|0.25|Standard Deviation|0.6|0.6|||
3601990|NCT02961244|3454089|B2|||İntraoperative red cell transfusion|For intraoperative red cell transfusion variable, groups were homogeneous. (p=0.470)|units|Mean|0.33|0.33|Standard Deviation|0.74|0.74|||
3601991|NCT02961244|3454090|B1|||İntraoperative red cell transfusion|For intraoperative red cell transfusion variable, groups were homogeneous. (p=0.470)|units|Mean|0.24|0.24|Standard Deviation|0.58|0.58|||
3601992|NCT02961244|3454088|B3|||İntraoperative blood loss|For intraoperative blood loss data, groups were homogeneous. (p=0.614)|liters|Mean|0.24|0.24|Standard Deviation|0.33|0.33|||
3601993|NCT02961244|3454089|B2|||İntraoperative blood loss|For intraoperative blood loss data, groups were homogeneous. (p=0.614)|liters|Mean|0.26|0.26|Standard Deviation|0.36|0.36|||
3601994|NCT02961244|3454090|B1|||İntraoperative blood loss|For intraoperative blood loss data, groups were homogeneous. (p=0.614)|liters|Mean|0.23|0.23|Standard Deviation|0.3|0.3|||
3601995|NCT02961244|3454088|B3|||Operating Room Temperature|For operating room temperature variable, groups were homogeneous. (p=0.059)|ºC degrees|Mean|21.4|21.4|Standard Deviation|2|2.0|||
3601996|NCT02961244|3454089|B2|||Operating Room Temperature|For operating room temperature variable, groups were homogeneous. (p=0.059)|ºC degrees|Mean|21.5|21.5|Standard Deviation|2|2.0|||
3601997|NCT02961244|3454090|B1|||Operating Room Temperature|For operating room temperature variable, groups were homogeneous. (p=0.059)|ºC degrees|Mean|21.3|21.3|Standard Deviation|2|2.0|||
3601998|NCT02961244|3454088|B3|||If only temporary, removal time of central venous catheter|For temporary central venous catheter removing time both groups were homogenous. (p=0.259)|days|Mean|6.5|6.5|Standard Deviation|3.4|3.4|||
3601999|NCT02961244|3454089|B2|||If only temporary, removal time of central venous catheter|For temporary central venous catheter removing time both groups were homogenous. (p=0.259)|days|Mean|7.2|7.2|Standard Deviation|2.6|2.6|||
3602000|NCT02961244|3454090|B1|||If only temporary, removal time of central venous catheter|For temporary central venous catheter removing time both groups were homogenous. (p=0.259)|days|Mean|6.09|6.09|Standard Deviation|3.7|3.7|||
3602001|NCT02961244|3454088|B3||Permenant central venous port previously inserted|Central venous access|For cetral venous access choice groups were homogeneous. (p=0.107)|Participants|Count of Participants|26|26.0||||||
3602002|NCT02961244|3454089|B2||Permenant central venous port previously inserted|Central venous access|For cetral venous access choice groups were homogeneous. (p=0.107)|Participants|Count of Participants|14|14.0||||||
3602003|NCT02961244|3454090|B1||Permenant central venous port previously inserted|Central venous access|For cetral venous access choice groups were homogeneous. (p=0.107)|Participants|Count of Participants|12|12.0||||||
3602004|NCT02961244|3454088|B3||Used temporary methods|Central venous access|For cetral venous access choice groups were homogeneous. (p=0.107)|Participants|Count of Participants|53|53.0||||||
3602005|NCT02961244|3454089|B2||Used temporary methods|Central venous access|For cetral venous access choice groups were homogeneous. (p=0.107)|Participants|Count of Participants|20|20.0||||||
3602006|NCT02961244|3454090|B1||Used temporary methods|Central venous access|For cetral venous access choice groups were homogeneous. (p=0.107)|Participants|Count of Participants|33|33.0||||||
3602007|NCT02961244|3454088|B3||Not used|Central venous access|For cetral venous access choice groups were homogeneous. (p=0.107)|Participants|Count of Participants|39|39.0||||||
3602008|NCT02961244|3454089|B2||Not used|Central venous access|For cetral venous access choice groups were homogeneous. (p=0.107)|Participants|Count of Participants|21|21.0||||||
3602009|NCT02961244|3454090|B1||Not used|Central venous access|For cetral venous access choice groups were homogeneous. (p=0.107)|Participants|Count of Participants|18|18.0||||||
3602010|NCT02961244|3454088|B3|||Epidural catheter removal time if any inserted|For epidural catheher removal time, groups were homogeneous. (p=0.973)|days|Mean|5.08|5.08|Standard Deviation|2.2|2.2|||
3602011|NCT02961244|3454089|B2|||Epidural catheter removal time if any inserted|For epidural catheher removal time, groups were homogeneous. (p=0.973)|days|Mean|5.09|5.09|Standard Deviation|2|2.0|||
3602012|NCT02961244|3454090|B1|||Epidural catheter removal time if any inserted|For epidural catheher removal time, groups were homogeneous. (p=0.973)|days|Mean|5.07|5.07|Standard Deviation|2.3|2.3|||
3602013|NCT02961244|3454088|B3||General and intrathecal anesthesia|Type of anesthesia|For anesthesia choice, groups were homogeneous. (p=0.655)|Participants|Count of Participants|38|38.0||||||
3602014|NCT02961244|3454089|B2||General and intrathecal anesthesia|Type of anesthesia|For anesthesia choice, groups were homogeneous. (p=0.655)|Participants|Count of Participants|20|20.0||||||
3602015|NCT02961244|3454090|B1||General and intrathecal anesthesia|Type of anesthesia|For anesthesia choice, groups were homogeneous. (p=0.655)|Participants|Count of Participants|18|18.0||||||
3602016|NCT02961244|3454088|B3||General and epidural anesthesia|Type of anesthesia|For anesthesia choice, groups were homogeneous. (p=0.655)|Participants|Count of Participants|49|49.0||||||
3602017|NCT02961244|3454089|B2||General and epidural anesthesia|Type of anesthesia|For anesthesia choice, groups were homogeneous. (p=0.655)|Participants|Count of Participants|20|20.0||||||
3602018|NCT02961244|3454090|B1||General and epidural anesthesia|Type of anesthesia|For anesthesia choice, groups were homogeneous. (p=0.655)|Participants|Count of Participants|29|29.0||||||
3602019|NCT02961244|3454088|B3||General anesthesia|Type of anesthesia|For anesthesia choice, groups were homogeneous. (p=0.655)|Participants|Count of Participants|31|31.0||||||
3602020|NCT02961244|3454089|B2||General anesthesia|Type of anesthesia|For anesthesia choice, groups were homogeneous. (p=0.655)|Participants|Count of Participants|15|15.0||||||
3602021|NCT02961244|3454090|B1||General anesthesia|Type of anesthesia|For anesthesia choice, groups were homogeneous. (p=0.655)|Participants|Count of Participants|16|16.0||||||
3602022|NCT02961244|3454088|B3||Alcohol use (≥2 glass)|Alcohol Use|For alcohol use, groups were homogeneous. (p=0.541)|Participants|Count of Participants|5|5.0||||||
3602023|NCT02961244|3454089|B2||Alcohol use (≥2 glass)|Alcohol Use|For alcohol use, groups were homogeneous. (p=0.541)|Participants|Count of Participants|3|3.0||||||
3602024|NCT02961244|3454090|B1||Alcohol use (≥2 glass)|Alcohol Use|For alcohol use, groups were homogeneous. (p=0.541)|Participants|Count of Participants|2|2.0||||||
3602128|NCT02958995|3454170|B3|Unknown||Race/Ethnicity, Customized||Participants|Number|397964|397964.0||||||
3602026|NCT02961244|3454089|B2||Alcohol use (<2 glass)|Alcohol Use|For alcohol use, groups were homogeneous. (p=0.541)|Participants|Count of Participants|52|52.0||||||
3602027|NCT02961244|3454090|B1||Alcohol use (<2 glass)|Alcohol Use|For alcohol use, groups were homogeneous. (p=0.541)|Participants|Count of Participants|61|61.0||||||
3602028|NCT02961244|3454088|B3||Smoking History|Smoking habit|For smoking habit both groups were homogenous.(p=0.893)|Participants|Count of Participants|62|62.0||||||
3602029|NCT02961244|3454089|B2||Smoking History|Smoking habit|For smoking habit both groups were homogenous.(p=0.893)|Participants|Count of Participants|29|29.0||||||
3602030|NCT02961244|3454090|B1||Smoking History|Smoking habit|For smoking habit both groups were homogenous.(p=0.893)|Participants|Count of Participants|33|33.0||||||
3602031|NCT02961244|3454088|B3||Nonsmoker|Smoking habit|For smoking habit both groups were homogenous.(p=0.893)|Participants|Count of Participants|56|56.0||||||
3602032|NCT02961244|3454089|B2||Nonsmoker|Smoking habit|For smoking habit both groups were homogenous.(p=0.893)|Participants|Count of Participants|26|26.0||||||
3602033|NCT02961244|3454090|B1||Nonsmoker|Smoking habit|For smoking habit both groups were homogenous.(p=0.893)|Participants|Count of Participants|30|30.0||||||
3602034|NCT02961244|3454088|B3||Upper Gastointestinal Tract|Ethiology|Etiologies including hepatopancreaticobiliary, colorectal, upper gastrointestinal systems diseases .|Participants|Count of Participants|20|20.0||||||
3602035|NCT02961244|3454089|B2||Upper Gastointestinal Tract|Ethiology|Etiologies including hepatopancreaticobiliary, colorectal, upper gastrointestinal systems diseases .|Participants|Count of Participants|13|13.0||||||
3602036|NCT02961244|3454090|B1||Upper Gastointestinal Tract|Ethiology|Etiologies including hepatopancreaticobiliary, colorectal, upper gastrointestinal systems diseases .|Participants|Count of Participants|7|7.0||||||
3602037|NCT02961244|3454088|B3||Colorectal Tract Etiology|Ethiology|Etiologies including hepatopancreaticobiliary, colorectal, upper gastrointestinal systems diseases .|Participants|Count of Participants|64|64.0||||||
3602038|NCT02961244|3454089|B2||Colorectal Tract Etiology|Ethiology|Etiologies including hepatopancreaticobiliary, colorectal, upper gastrointestinal systems diseases .|Participants|Count of Participants|32|32.0||||||
3602039|NCT02961244|3454090|B1||Colorectal Tract Etiology|Ethiology|Etiologies including hepatopancreaticobiliary, colorectal, upper gastrointestinal systems diseases .|Participants|Count of Participants|32|32.0||||||
3602040|NCT02961244|3454088|B3||Hepatopancreaticobiliary System Etiology|Ethiology|Etiologies including hepatopancreaticobiliary, colorectal, upper gastrointestinal systems diseases .|Participants|Count of Participants|34|34.0||||||
3602041|NCT02961244|3454089|B2||Hepatopancreaticobiliary System Etiology|Ethiology|Etiologies including hepatopancreaticobiliary, colorectal, upper gastrointestinal systems diseases .|Participants|Count of Participants|10|10.0||||||
3602042|NCT02961244|3454090|B1||Hepatopancreaticobiliary System Etiology|Ethiology|Etiologies including hepatopancreaticobiliary, colorectal, upper gastrointestinal systems diseases .|Participants|Count of Participants|24|24.0||||||
3602043|NCT02961244|3454088|B3|||Height|For height variable, groups were homogeneous. (p=0.166)|centimeters|Mean|166.0|166.0|Standard Deviation|8.0|8.0|||
3602044|NCT02961244|3454089|B2|||Height|For height variable, groups were homogeneous. (p=0.166)|centimeters|Mean|167.3|167.3|Standard Deviation|8.7|8.7|||
3602045|NCT02961244|3454090|B1|||Height|For height variable, groups were homogeneous. (p=0.166)|centimeters|Mean|165.1|165.1|Standard Deviation|8.6|8.6|||
3602046|NCT02961244|3454088|B3|||Weight|For weight variable, groups were homogeneous. (p=0.346)|kilograms|Mean|74|74.0|Standard Deviation|14.7|14.7|||
3602047|NCT02961244|3454089|B2|||Weight|For weight variable, groups were homogeneous. (p=0.346)|kilograms|Mean|75.3|75.3|Standard Deviation|14.5|14.5|||
3602048|NCT02961244|3454090|B1|||Weight|For weight variable, groups were homogeneous. (p=0.346)|kilograms|Mean|72.8|72.8|Standard Deviation|14.9|14.9|||
3602049|NCT02961244|3454088|B3|||BMI|For BMI variable, groups were homogeneous. (p=0.836)|kilograms per square meter|Mean|26.7|26.7|Standard Deviation|4.7|4.7|||
3602050|NCT02961244|3454089|B2|||BMI|For BMI variable, groups were homogeneous. (p=0.836)|kilograms per square meter|Mean|26.8|26.8|Standard Deviation|4.4|4.4|||
3602051|NCT02961244|3454090|B1|||BMI|For BMI variable, groups were homogeneous. (p=0.836)|kilograms per square meter|Mean|26.6|26.6|Standard Deviation|4.9|4.9|||
3602052|NCT02961244|3454088|B3||Male|Sex: Female, Male|For gender variable, groups were homogeneous. (p=0.190)|Participants|Count of Participants|61|61.0||||||
3602053|NCT02961244|3454089|B2||Male|Sex: Female, Male|For gender variable, groups were homogeneous. (p=0.190)|Participants|Count of Participants|32|32.0||||||
3602054|NCT02961244|3454090|B1||Male|Sex: Female, Male|For gender variable, groups were homogeneous. (p=0.190)|Participants|Count of Participants|29|29.0||||||
3602055|NCT02961244|3454088|B3||Female|Sex: Female, Male|For gender variable, groups were homogeneous. (p=0.190)|Participants|Count of Participants|57|57.0||||||
3602056|NCT02961244|3454089|B2||Female|Sex: Female, Male|For gender variable, groups were homogeneous. (p=0.190)|Participants|Count of Participants|23|23.0||||||
3602057|NCT02961244|3454090|B1||Female|Sex: Female, Male|For gender variable, groups were homogeneous. (p=0.190)|Participants|Count of Participants|34|34.0||||||
3602058|NCT02961244|3454088|B3|||Age|For age variable, groups were homogeneous. (p=0.870)|years|Mean|57.8|57.8|Standard Deviation|13.6|13.6|||
3602059|NCT02961244|3454089|B2|||Age|For age variable, groups were homogeneous. (p=0.870)|years|Mean|57.6|57.6|Standard Deviation|12.9|12.9|||
3602060|NCT02961244|3454090|B1|||Age|For age variable, groups were homogeneous. (p=0.870)|years|Mean|58.0|58.0|Standard Deviation|14.3|14.3|||
3602061|NCT02959996|3454099|B3|||BMI, pre-pregnancy, kg/m2||kg/m2|Mean|26.9|26.9|Standard Deviation|0.7|0.7|||
3602062|NCT02959996|3454100|B2|||BMI, pre-pregnancy, kg/m2||kg/m2|Mean|26.2|26.2|Standard Deviation|5.3|5.3|||
3602063|NCT02959996|3454101|B1|||BMI, pre-pregnancy, kg/m2||kg/m2|Mean|27.6|27.6|Standard Deviation|6.4|6.4|||
3602064|NCT02959996|3454099|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3602065|NCT02959996|3454100|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3602066|NCT02959996|3454101|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3602129|NCT02958995|3454171|B2|Unknown||Race/Ethnicity, Customized||Participants|Number|1384|1384.0||||||
3602068|NCT02959996|3454100|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602069|NCT02959996|3454101|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602070|NCT02959996|3454099|B3||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3602071|NCT02959996|3454100|B2||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3602072|NCT02959996|3454101|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3602073|NCT02959996|3454099|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3602074|NCT02959996|3454100|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3602075|NCT02959996|3454101|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3602076|NCT02959996|3454099|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602077|NCT02959996|3454100|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602078|NCT02959996|3454101|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602079|NCT02959996|3454099|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602080|NCT02959996|3454100|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602081|NCT02959996|3454101|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602082|NCT02959996|3454099|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602083|NCT02959996|3454100|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602084|NCT02959996|3454101|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602085|NCT02959996|3454099|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602086|NCT02959996|3454100|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602087|NCT02959996|3454101|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602088|NCT02959996|3454099|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3602089|NCT02959996|3454100|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3602090|NCT02959996|3454101|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3602091|NCT02959996|3454099|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3602092|NCT02959996|3454100|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3602093|NCT02959996|3454101|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3602094|NCT02959996|3454099|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3602095|NCT02959996|3454100|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3602096|NCT02959996|3454101|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3602097|NCT02959996|3454099|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3602098|NCT02959996|3454100|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3602099|NCT02959996|3454101|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3602100|NCT02959996|3454099|B3|||Age||years|Mean|35.2|35.2|Standard Deviation|0.5|0.5|||
3602101|NCT02959996|3454100|B2|||Age||years|Mean|35.6|35.6|Standard Deviation|4.2|4.2|||
3602102|NCT02959996|3454101|B1|||Age||years|Mean|34.7|34.7|Standard Deviation|3.7|3.7|||
3602103|NCT02959840|3454124|B4|United States||Region of Enrollment||participants|Number|180|180.0||||||
3602104|NCT02959840|3454125|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
3602105|NCT02959840|3454126|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
3602106|NCT02959840|3454127|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
3602107|NCT02959840|3454124|B4|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3602108|NCT02959840|3454124|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3602109|NCT02959840|3454125|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3602110|NCT02959840|3454126|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3602111|NCT02959840|3454127|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3602112|NCT02959840|3454124|B4||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3602113|NCT02959840|3454125|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3602114|NCT02959840|3454126|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3602115|NCT02959840|3454127|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3602116|NCT02959840|3454124|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3602117|NCT02959840|3454125|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3602118|NCT02959840|3454126|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3602119|NCT02959840|3454127|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3602120|NCT02959840|3454124|B4||Between 18 and 65 years|Age||Participants|Count of Participants|180|180.0||||||
3602121|NCT02959840|3454125|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3602122|NCT02959840|3454126|B2||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3602123|NCT02959840|3454127|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3602124|NCT02959840|3454124|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3602125|NCT02959840|3454125|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3602126|NCT02959840|3454126|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3602130|NCT02958995|3454172|B1|Unknown||Race/Ethnicity, Customized||Participants|Number|396580|396580.0||||||
3602131|NCT02958995|3454170|B3|Other||Race/Ethnicity, Customized||Participants|Number|90629|90629.0||||||
3602132|NCT02958995|3454171|B2|Other||Race/Ethnicity, Customized||Participants|Number|2728|2728.0||||||
3602133|NCT02958995|3454172|B1|Other||Race/Ethnicity, Customized||Participants|Number|87901|87901.0||||||
3602134|NCT02958995|3454170|B3|Asian or Pacific Islander||Race/Ethnicity, Customized||Participants|Number|326238|326238.0||||||
3602135|NCT02958995|3454171|B2|Asian or Pacific Islander||Race/Ethnicity, Customized||Participants|Number|13508|13508.0||||||
3602136|NCT02958995|3454172|B1|Asian or Pacific Islander||Race/Ethnicity, Customized||Participants|Number|312730|312730.0||||||
3602137|NCT02958995|3454170|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|333917|333917.0||||||
3602138|NCT02958995|3454171|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|11871|11871.0||||||
3602139|NCT02958995|3454172|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|322046|322046.0||||||
3602140|NCT02958995|3454170|B3|Black||Race/Ethnicity, Customized||Participants|Number|181771|181771.0||||||
3602141|NCT02958995|3454171|B2|Black||Race/Ethnicity, Customized||Participants|Number|10167|10167.0||||||
3602142|NCT02958995|3454172|B1|Black||Race/Ethnicity, Customized||Participants|Number|171604|171604.0||||||
3602143|NCT02958995|3454170|B3|White||Race/Ethnicity, Customized||Participants|Number|1407642|1407642.0||||||
3602144|NCT02958995|3454171|B2|White||Race/Ethnicity, Customized||Participants|Number|67837|67837.0||||||
3602145|NCT02958995|3454172|B1|White||Race/Ethnicity, Customized||Participants|Number|1339805|1339805.0||||||
3602146|NCT02958995|3454170|B3||Male|Sex: Female, Male||Participants|Count of Participants|1329961|1329961.0||||||
3602147|NCT02958995|3454171|B2||Male|Sex: Female, Male||Participants|Count of Participants|53077|53077.0||||||
3602148|NCT02958995|3454172|B1||Male|Sex: Female, Male||Participants|Count of Participants|1276884|1276884.0||||||
3602149|NCT02958995|3454170|B3||Female|Sex: Female, Male||Participants|Count of Participants|1408200|1408200.0||||||
3602150|NCT02958995|3454171|B2||Female|Sex: Female, Male||Participants|Count of Participants|54418|54418.0||||||
3602151|NCT02958995|3454172|B1||Female|Sex: Female, Male||Participants|Count of Participants|1353782|1353782.0||||||
3602152|NCT02958995|3454170|B3|greater than or equal to (>=) 80 years||Age, Customized||participants|Number|71337|71337.0||||||
3602153|NCT02958995|3454171|B2|greater than or equal to (>=) 80 years||Age, Customized||participants|Number|5044|5044.0||||||
3602154|NCT02958995|3454172|B1|greater than or equal to (>=) 80 years||Age, Customized||participants|Number|66293|66293.0||||||
3602155|NCT02958995|3454170|B3|70 - 79 years||Age, Customized||participants|Number|192164|192164.0||||||
3602156|NCT02958995|3454171|B2|70 - 79 years||Age, Customized||participants|Number|22028|22028.0||||||
3602157|NCT02958995|3454172|B1|70 - 79 years||Age, Customized||participants|Number|170136|170136.0||||||
3602158|NCT02958995|3454170|B3|60 - 69 years||Age, Customized||participants|Number|348099|348099.0||||||
3602159|NCT02958995|3454171|B2|60 - 69 years||Age, Customized||participants|Number|25582|25582.0||||||
3602160|NCT02958995|3454172|B1|60 - 69 years||Age, Customized||participants|Number|322517|322517.0||||||
3602161|NCT02958995|3454170|B3|50 - 59 years||Age, Customized||participants|Number|595221|595221.0||||||
3602162|NCT02958995|3454171|B2|50 - 59 years||Age, Customized||participants|Number|24585|24585.0||||||
3602163|NCT02958995|3454172|B1|50 - 59 years||Age, Customized||participants|Number|570636|570636.0||||||
3602164|NCT02958995|3454170|B3|40 - 49 years||Age, Customized||participants|Number|1531340|1531340.0||||||
3602165|NCT02958995|3454171|B2|40 - 49 years||Age, Customized||participants|Number|30256|30256.0||12.9|12.9|||
3602166|NCT02958995|3454172|B1|40 - 49 years||Age, Customized||participants|Number|1501084|1501084.0||11.6|11.6|||
3602167|NCT02958956|3454181|B3|Missing||Time since diabetes diagnosis||Participants|Number|46468|46468.0||||||
3602168|NCT02958956|3454182|B2|Missing||Time since diabetes diagnosis||Participants|Number|37254|37254.0||||||
3602169|NCT02958956|3454183|B1|Missing||Time since diabetes diagnosis||Participants|Number|9214|9214.0||||||
3602170|NCT02958956|3454181|B3|>= 10 years||Time since diabetes diagnosis||Participants|Number|20293|20293.0||||||
3602171|NCT02958956|3454182|B2|>= 10 years||Time since diabetes diagnosis||Participants|Number|17300|17300.0||||||
3602172|NCT02958956|3454183|B1|>= 10 years||Time since diabetes diagnosis||Participants|Number|2993|2993.0||||||
3602173|NCT02958956|3454181|B3|5-9 years||Time since diabetes diagnosis||Participants|Number|12702|12702.0||||||
3602174|NCT02958956|3454182|B2|5-9 years||Time since diabetes diagnosis||Participants|Number|9554|9554.0||||||
3602175|NCT02958956|3454183|B1|5-9 years||Time since diabetes diagnosis||Participants|Number|3148|3148.0||||||
3602176|NCT02958956|3454181|B3|0-4 years||Time since diabetes diagnosis||Participants|Number|157044|157044.0||||||
3602177|NCT02958956|3454182|B2|0-4 years||Time since diabetes diagnosis||Participants|Number|134209|134209.0||||||
3602178|NCT02958956|3454183|B1|0-4 years||Time since diabetes diagnosis||Participants|Number|22835|22835.0||||||
3602179|NCT02958956|3454181|B3|Missing||Baseline Glycosylated Hemoglobin (HbA1c)||Participants|Number|48131|48131.0||||||
3602180|NCT02958956|3454182|B2|Missing||Baseline Glycosylated Hemoglobin (HbA1c)||Participants|Number|39722|39722.0||||||
3602181|NCT02958956|3454183|B1|Missing||Baseline Glycosylated Hemoglobin (HbA1c)||Participants|Number|8409|8409.0||||||
3602182|NCT02958956|3454181|B3|>=10.0%||Baseline Glycosylated Hemoglobin (HbA1c)||Participants|Number|38226|38226.0||||||
3602183|NCT02958956|3454182|B2|>=10.0%||Baseline Glycosylated Hemoglobin (HbA1c)||Participants|Number|29836|29836.0||||||
3602184|NCT02958956|3454183|B1|>=10.0%||Baseline Glycosylated Hemoglobin (HbA1c)||Participants|Number|8390|8390.0||||||
3602185|NCT02958956|3454181|B3|9.0-9.9%||Baseline Glycosylated Hemoglobin (HbA1c)||Participants|Number|15793|15793.0||||||
3602186|NCT02958956|3454182|B2|9.0-9.9%||Baseline Glycosylated Hemoglobin (HbA1c)||Participants|Number|12342|12342.0||||||
3602187|NCT02958956|3454183|B1|9.0-9.9%||Baseline Glycosylated Hemoglobin (HbA1c)||Participants|Number|3451|3451.0||||||
3602188|NCT02958956|3454181|B3|8.0-8.9%||Baseline Glycosylated Hemoglobin (HbA1c)||Participants|Number|22485|22485.0||||||
3602189|NCT02958956|3454182|B2|8.0-8.9%||Baseline Glycosylated Hemoglobin (HbA1c)||Participants|Number|17971|17971.0||||||
3602190|NCT02958956|3454183|B1|8.0-8.9%||Baseline Glycosylated Hemoglobin (HbA1c)||Participants|Number|4514|4514.0||||||
3602191|NCT02958956|3454181|B3|7.0-7.9%||Baseline Glycosylated Hemoglobin (HbA1c)||Participants|Number|41173|41173.0||||||
3602192|NCT02958956|3454182|B2|7.0-7.9%||Baseline Glycosylated Hemoglobin (HbA1c)||Participants|Number|34579|34579.0||||||
3602193|NCT02958956|3454183|B1|7.0-7.9%||Baseline Glycosylated Hemoglobin (HbA1c)||Participants|Number|6594|6594.0||||||
3602194|NCT02958956|3454181|B3|<7.0 percent (%)||Baseline Glycosylated Hemoglobin (HbA1c)||Participants|Number|70699|70699.0||||||
3602195|NCT02958956|3454182|B2|<7.0 percent (%)||Baseline Glycosylated Hemoglobin (HbA1c)||Participants|Number|63867|63867.0||||||
3602196|NCT02958956|3454183|B1|<7.0 percent (%)||Baseline Glycosylated Hemoglobin (HbA1c)||Participants|Number|6832|6832.0||||||
3602197|NCT02958956|3454181|B3|Missing||Congestive Heart Failure||Participants|Number|222835|222835.0||||||
3602198|NCT02958956|3454182|B2|Missing||Congestive Heart Failure||Participants|Number|185715|185715.0||||||
3602199|NCT02958956|3454183|B1|Missing||Congestive Heart Failure||Participants|Number|37120|37120.0||||||
3602200|NCT02958956|3454181|B3|Congestive Heart Failure||Congestive Heart Failure||Participants|Number|13672|13672.0||||||
3602201|NCT02958956|3454182|B2|Congestive Heart Failure||Congestive Heart Failure||Participants|Number|12602|12602.0||||||
3602202|NCT02958956|3454183|B1|Congestive Heart Failure||Congestive Heart Failure||Participants|Number|1070|1070.0||||||
3602203|NCT02958956|3454181|B3|Missing||Renal function|Renal function was measured based on the levels of creatinine: normal creatinine (less than [<] 1.5 milligram per deciliter [mg/dL] for males and <1.4 mg/dL for females) and elevated creatinine (greater than or equal to [>=] 1.5 mg/dL for males and >=1.4 mg/dL for females).|Participants|Number|32792|32792.0||||||
3602204|NCT02958956|3454182|B2|Missing||Renal function|Renal function was measured based on the levels of creatinine: normal creatinine (less than [<] 1.5 milligram per deciliter [mg/dL] for males and <1.4 mg/dL for females) and elevated creatinine (greater than or equal to [>=] 1.5 mg/dL for males and >=1.4 mg/dL for females).|Participants|Number|25573|25573.0||||||
3602205|NCT02958956|3454183|B1|Missing||Renal function|Renal function was measured based on the levels of creatinine: normal creatinine (less than [<] 1.5 milligram per deciliter [mg/dL] for males and <1.4 mg/dL for females) and elevated creatinine (greater than or equal to [>=] 1.5 mg/dL for males and >=1.4 mg/dL for females).|Participants|Number|7219|7219.0||||||
3602206|NCT02958956|3454181|B3|Elevated creatinine||Renal function|Renal function was measured based on the levels of creatinine: normal creatinine (less than [<] 1.5 milligram per deciliter [mg/dL] for males and <1.4 mg/dL for females) and elevated creatinine (greater than or equal to [>=] 1.5 mg/dL for males and >=1.4 mg/dL for females).|Participants|Number|17729|17729.0||||||
3602207|NCT02958956|3454182|B2|Elevated creatinine||Renal function|Renal function was measured based on the levels of creatinine: normal creatinine (less than [<] 1.5 milligram per deciliter [mg/dL] for males and <1.4 mg/dL for females) and elevated creatinine (greater than or equal to [>=] 1.5 mg/dL for males and >=1.4 mg/dL for females).|Participants|Number|16234|16234.0||||||
3602208|NCT02958956|3454183|B1|Elevated creatinine||Renal function|Renal function was measured based on the levels of creatinine: normal creatinine (less than [<] 1.5 milligram per deciliter [mg/dL] for males and <1.4 mg/dL for females) and elevated creatinine (greater than or equal to [>=] 1.5 mg/dL for males and >=1.4 mg/dL for females).|Participants|Number|1495|1495.0||||||
3602209|NCT02958956|3454181|B3|Normal creatinine||Renal function|Renal function was measured based on the levels of creatinine: normal creatinine (less than [<] 1.5 milligram per deciliter [mg/dL] for males and <1.4 mg/dL for females) and elevated creatinine (greater than or equal to [>=] 1.5 mg/dL for males and >=1.4 mg/dL for females).|Participants|Number|185986|185986.0||||||
3602210|NCT02958956|3454182|B2|Normal creatinine||Renal function|Renal function was measured based on the levels of creatinine: normal creatinine (less than [<] 1.5 milligram per deciliter [mg/dL] for males and <1.4 mg/dL for females) and elevated creatinine (greater than or equal to [>=] 1.5 mg/dL for males and >=1.4 mg/dL for females).|Participants|Number|156510|156510.0||||||
3602211|NCT02958956|3454183|B1|Normal creatinine||Renal function|Renal function was measured based on the levels of creatinine: normal creatinine (less than [<] 1.5 milligram per deciliter [mg/dL] for males and <1.4 mg/dL for females) and elevated creatinine (greater than or equal to [>=] 1.5 mg/dL for males and >=1.4 mg/dL for females).|Participants|Number|29476|29476.0||||||
3602212|NCT02958956|3454181|B3|Missing||Income|Income was categorized as high and low based on whether the annual household income lied above or below the average census block median income for the cohort (59,000 US Dollars).|Participants|Number|5612|5612.0||||||
3602213|NCT02958956|3454182|B2|Missing||Income|Income was categorized as high and low based on whether the annual household income lied above or below the average census block median income for the cohort (59,000 US Dollars).|Participants|Number|4926|4926.0||||||
3602214|NCT02958956|3454183|B1|Missing||Income|Income was categorized as high and low based on whether the annual household income lied above or below the average census block median income for the cohort (59,000 US Dollars).|Participants|Number|686|686.0||||||
3602215|NCT02958956|3454181|B3|High||Income|Income was categorized as high and low based on whether the annual household income lied above or below the average census block median income for the cohort (59,000 US Dollars).|Participants|Number|103509|103509.0||||||
3602216|NCT02958956|3454182|B2|High||Income|Income was categorized as high and low based on whether the annual household income lied above or below the average census block median income for the cohort (59,000 US Dollars).|Participants|Number|86384|86384.0||||||
3602217|NCT02958956|3454183|B1|High||Income|Income was categorized as high and low based on whether the annual household income lied above or below the average census block median income for the cohort (59,000 US Dollars).|Participants|Number|17125|17125.0||||||
3602218|NCT02958956|3454181|B3|Low||Income|Income was categorized as high and low based on whether the annual household income lied above or below the average census block median income for the cohort (59,000 US Dollars).|Participants|Number|127386|127386.0||||||
3602277|NCT02956837|3454214|B3|Geographic Ancestry|Unspecified|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3602219|NCT02958956|3454182|B2|Low||Income|Income was categorized as high and low based on whether the annual household income lied above or below the average census block median income for the cohort (59,000 US Dollars).|Participants|Number|107007|107007.0||||||
3602220|NCT02958956|3454183|B1|Low||Income|Income was categorized as high and low based on whether the annual household income lied above or below the average census block median income for the cohort (59,000 US Dollars).|Participants|Number|20379|20379.0||||||
3602221|NCT02958956|3454181|B3|Missing||Smoking||Participants|Number|191177|191177.0||||||
3602222|NCT02958956|3454182|B2|Missing||Smoking||Participants|Number|160916|160916.0||||||
3602223|NCT02958956|3454183|B1|Missing||Smoking||Participants|Number|30261|30261.0||||||
3602224|NCT02958956|3454181|B3|Current smoking||Smoking||Participants|Number|45330|45330.0||||||
3602225|NCT02958956|3454182|B2|Current smoking||Smoking||Participants|Number|37401|37401.0||||||
3602226|NCT02958956|3454183|B1|Current smoking||Smoking||Participants|Number|7929|7929.0||||||
3602227|NCT02958956|3454181|B3|Missing||Race/Ethnicity, Customized||Participants|Number|22843|22843.0||||||
3602228|NCT02958956|3454182|B2|Missing||Race/Ethnicity, Customized||Participants|Number|20005|20005.0||||||
3602229|NCT02958956|3454183|B1|Missing||Race/Ethnicity, Customized||Participants|Number|2838|2838.0||||||
3602230|NCT02958956|3454181|B3|Other||Race/Ethnicity, Customized||Participants|Number|12678|12678.0||||||
3602231|NCT02958956|3454182|B2|Other||Race/Ethnicity, Customized||Participants|Number|10549|10549.0||||||
3602232|NCT02958956|3454183|B1|Other||Race/Ethnicity, Customized||Participants|Number|2129|2129.0||||||
3602233|NCT02958956|3454181|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|26698|26698.0||||||
3602234|NCT02958956|3454182|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|21554|21554.0||||||
3602235|NCT02958956|3454183|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|5144|5144.0||||||
3602236|NCT02958956|3454181|B3|Asian or Pacific Islander||Race/Ethnicity, Customized||Participants|Number|32332|32332.0||||||
3602237|NCT02958956|3454182|B2|Asian or Pacific Islander||Race/Ethnicity, Customized||Participants|Number|26637|26637.0||||||
3602238|NCT02958956|3454183|B1|Asian or Pacific Islander||Race/Ethnicity, Customized||Participants|Number|5695|5695.0||||||
3602239|NCT02958956|3454181|B3|African American||Race/Ethnicity, Customized||Participants|Number|23598|23598.0||||||
3602240|NCT02958956|3454182|B2|African American||Race/Ethnicity, Customized||Participants|Number|19931|19931.0||||||
3602241|NCT02958956|3454183|B1|African American||Race/Ethnicity, Customized||Participants|Number|3667|3667.0||||||
3602242|NCT02958956|3454181|B3|Non-Hispanic white||Race/Ethnicity, Customized||Participants|Number|118358|118358.0||||||
3602243|NCT02958956|3454182|B2|Non-Hispanic white||Race/Ethnicity, Customized||Participants|Number|99641|99641.0||||||
3602244|NCT02958956|3454183|B1|Non-Hispanic white||Race/Ethnicity, Customized||Participants|Number|18717|18717.0||||||
3602245|NCT02958956|3454181|B3||Male|Sex: Female, Male||Participants|Count of Participants|126323|126323.0||||||
3602246|NCT02958956|3454182|B2||Male|Sex: Female, Male||Participants|Count of Participants|105765|105765.0||||||
3602247|NCT02958956|3454183|B1||Male|Sex: Female, Male||Participants|Count of Participants|20558|20558.0||||||
3602248|NCT02958956|3454181|B3||Female|Sex: Female, Male||Participants|Count of Participants|110184|110184.0||||||
3602249|NCT02958956|3454182|B2||Female|Sex: Female, Male||Participants|Count of Participants|92552|92552.0||||||
3602250|NCT02958956|3454183|B1||Female|Sex: Female, Male||Participants|Count of Participants|17632|17632.0||||||
3602251|NCT02958956|3454181|B3|||Age||Years|Mean|59.0|59.0|Standard Deviation|12.0|12.0|||
3602252|NCT02958956|3454182|B2|||Age||Years|Mean|59.7|59.7|Standard Deviation|12.2|12.2|||
3602253|NCT02958956|3454183|B1|||Age||Years|Mean|55.6|55.6|Standard Deviation|10.4|10.4|||
3602254|NCT02958787|3454197|B1||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3602255|NCT02958787|3454197|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3602256|NCT02958787|3454197|B1|||Age||years|Median|63|63.0|Full Range|||57.0|67.0|
3602257|NCT02958345|3454201|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
3602258|NCT02958345|3454202|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3602259|NCT02958345|3454203|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3602260|NCT02958345|3454201|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3602261|NCT02958345|3454202|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3602262|NCT02958345|3454203|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3602263|NCT02958345|3454201|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3602264|NCT02958345|3454202|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3602265|NCT02958345|3454203|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3602266|NCT02958345|3454201|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3602267|NCT02958345|3454202|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3602268|NCT02958345|3454203|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3602269|NCT02958345|3454201|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3602270|NCT02958345|3454202|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3602271|NCT02958345|3454203|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3602272|NCT02958345|3454201|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3602273|NCT02958345|3454202|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3602274|NCT02958345|3454203|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3602275|NCT02956837|3454212|B5|Geographic Ancestry|Unspecified|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3602276|NCT02956837|3454213|B4|Geographic Ancestry|Unspecified|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3602278|NCT02956837|3454215|B2|Geographic Ancestry|Unspecified|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3602279|NCT02956837|3454216|B1|Geographic Ancestry|Unspecified|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3602280|NCT02956837|3454212|B5|Geographic Ancestry|White - Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|384|384.0||||||
3602281|NCT02956837|3454213|B4|Geographic Ancestry|White - Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|98|98.0||||||
3602282|NCT02956837|3454214|B3|Geographic Ancestry|White - Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|93|93.0||||||
3602283|NCT02956837|3454215|B2|Geographic Ancestry|White - Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|97|97.0||||||
3602284|NCT02956837|3454216|B1|Geographic Ancestry|White - Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|96|96.0||||||
3602285|NCT02956837|3454212|B5|Geographic Ancestry|White - Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3602286|NCT02956837|3454213|B4|Geographic Ancestry|White - Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3602287|NCT02956837|3454214|B3|Geographic Ancestry|White - Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3602288|NCT02956837|3454215|B2|Geographic Ancestry|White - Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3602289|NCT02956837|3454216|B1|Geographic Ancestry|White - Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3602290|NCT02956837|3454212|B5|Geographic Ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3602291|NCT02956837|3454213|B4|Geographic Ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3602292|NCT02956837|3454214|B3|Geographic Ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3602293|NCT02956837|3454215|B2|Geographic Ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3602294|NCT02956837|3454216|B1|Geographic Ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3602295|NCT02956837|3454212|B5|Geographic Ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3602296|NCT02956837|3454213|B4|Geographic Ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3602297|NCT02956837|3454214|B3|Geographic Ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3602298|NCT02956837|3454215|B2|Geographic Ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3602299|NCT02956837|3454216|B1|Geographic Ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3602300|NCT02956837|3454212|B5|Geographic Ancestry|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3602301|NCT02956837|3454213|B4|Geographic Ancestry|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3602302|NCT02956837|3454214|B3|Geographic Ancestry|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3602303|NCT02956837|3454215|B2|Geographic Ancestry|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3602304|NCT02956837|3454216|B1|Geographic Ancestry|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3602305|NCT02956837|3454212|B5|Geographic Ancestry|African Heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3602306|NCT02956837|3454213|B4|Geographic Ancestry|African Heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3602307|NCT02956837|3454214|B3|Geographic Ancestry|African Heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3602308|NCT02956837|3454215|B2|Geographic Ancestry|African Heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3602309|NCT02956837|3454216|B1|Geographic Ancestry|African Heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3602310|NCT02956837|3454212|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3602311|NCT02956837|3454213|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3602312|NCT02956837|3454214|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3602313|NCT02956837|3454215|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3602314|NCT02956837|3454216|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3602315|NCT02956837|3454212|B5||Female|Sex: Female, Male||Participants|Count of Participants|400|400.0||||||
3602316|NCT02956837|3454213|B4||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3602317|NCT02956837|3454214|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3602318|NCT02956837|3454215|B2||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3602319|NCT02956837|3454216|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3602320|NCT02956837|3454212|B5|||Age||Years|Mean|29.7|29.7|Standard Deviation|7.0|7.0|||
3602321|NCT02956837|3454213|B4|||Age||Years|Mean|29.9|29.9|Standard Deviation|6.9|6.9|||
3602322|NCT02956837|3454214|B3|||Age||Years|Mean|29.6|29.6|Standard Deviation|7.1|7.1|||
3602323|NCT02956837|3454215|B2|||Age||Years|Mean|29.1|29.1|Standard Deviation|7.2|7.2|||
3602324|NCT02956837|3454216|B1|||Age||Years|Mean|30.2|30.2|Standard Deviation|6.7|6.7|||
3602325|NCT02956629|3454309|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602326|NCT02956629|3454310|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602327|NCT02956629|3454311|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602328|NCT02956629|3454312|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602329|NCT02956629|3454313|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602330|NCT02956629|3454314|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602331|NCT02956629|3454315|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602332|NCT02956629|3454309|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3602333|NCT02956629|3454310|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602334|NCT02956629|3454311|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3602335|NCT02956629|3454312|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602336|NCT02956629|3454313|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3602337|NCT02956629|3454314|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602338|NCT02956629|3454315|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3602339|NCT02956629|3454309|B7||White|Race (NIH/OMB)||Participants|Count of Participants|221|221.0||||||
3602340|NCT02956629|3454310|B6||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602341|NCT02956629|3454311|B5||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3602342|NCT02956629|3454312|B4||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3602343|NCT02956629|3454313|B3||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3602344|NCT02956629|3454314|B2||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3602345|NCT02956629|3454315|B1||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3602346|NCT02956629|3454309|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3602347|NCT02956629|3454310|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602348|NCT02956629|3454311|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3602349|NCT02956629|3454312|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3602350|NCT02956629|3454313|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3602351|NCT02956629|3454314|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602352|NCT02956629|3454315|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3602353|NCT02956629|3454309|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3602354|NCT02956629|3454310|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602355|NCT02956629|3454311|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602356|NCT02956629|3454312|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3602357|NCT02956629|3454313|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602358|NCT02956629|3454314|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3602359|NCT02956629|3454315|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3602360|NCT02956629|3454309|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3602361|NCT02956629|3454310|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3602362|NCT02956629|3454311|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3602363|NCT02956629|3454312|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602364|NCT02956629|3454313|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3602365|NCT02956629|3454314|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3602366|NCT02956629|3454315|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3602367|NCT02956629|3454309|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602368|NCT02956629|3454310|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602369|NCT02956629|3454311|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602370|NCT02956629|3454312|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602371|NCT02956629|3454313|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602372|NCT02956629|3454314|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602373|NCT02956629|3454315|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602374|NCT02956629|3454309|B7||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3602375|NCT02956629|3454310|B6||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3602376|NCT02956629|3454311|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3602377|NCT02956629|3454312|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3602378|NCT02956629|3454313|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3602379|NCT02956629|3454314|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3602380|NCT02956629|3454315|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3602381|NCT02956629|3454309|B7||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3602382|NCT02956629|3454310|B6||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3602383|NCT02956629|3454311|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3602384|NCT02956629|3454312|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3602385|NCT02956629|3454313|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3602386|NCT02956629|3454314|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3602387|NCT02956629|3454315|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3602388|NCT02956629|3454309|B7|||Age||Years|Mean|49.5|49.5|Standard Deviation|12.2|12.2|||
3602389|NCT02956629|3454310|B6|||Age||Years|Mean|53.3|53.3|Standard Deviation|11.0|11.0|||
3602390|NCT02956629|3454311|B5|||Age||Years|Mean|57.4|57.4|Standard Deviation|12.4|12.4|||
3602391|NCT02956629|3454312|B4|||Age||Years|Mean|46.4|46.4|Standard Deviation|13.0|13.0|||
3602392|NCT02956629|3454313|B3|||Age||Years|Mean|48.4|48.4|Standard Deviation|10.1|10.1|||
3602393|NCT02956629|3454314|B2|||Age||Years|Mean|52.7|52.7|Standard Deviation|11.9|11.9|||
3602394|NCT02956629|3454315|B1|||Age||Years|Mean|47.9|47.9|Standard Deviation|12.6|12.6|||
3602395|NCT02956460|3454382|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3602396|NCT02956460|3454383|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3602397|NCT02956460|3454384|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3602398|NCT02956460|3454382|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3602399|NCT02956460|3454383|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3602400|NCT02956460|3454384|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3602401|NCT02956460|3454382|B3|||Age||years|Mean|30.5|30.5|Standard Deviation|5.9|5.9|||
3602402|NCT02956460|3454383|B2|||Age||years|Mean|29.6|29.6|Standard Deviation|5.6|5.6|||
3602403|NCT02956460|3454384|B1|||Age||years|Mean|31.6|31.6|Standard Deviation|6.1|6.1|||
3602404|NCT02954601|3454411|B5||Former|Caffiene History||Participants|Count of Participants|1|1.0||||||
3602405|NCT02954601|3454412|B4||Former|Caffiene History||Participants|Count of Participants|1|1.0||||||
3602406|NCT02954601|3454413|B3||Former|Caffiene History||Participants|Count of Participants|0|0.0||||||
3602407|NCT02954601|3454414|B2||Former|Caffiene History||Participants|Count of Participants|0|0.0||||||
3602408|NCT02954601|3454415|B1||Former|Caffiene History||Participants|Count of Participants|0|0.0||||||
3602409|NCT02954601|3454411|B5||Current|Caffiene History||Participants|Count of Participants|26|26.0||||||
3602410|NCT02954601|3454412|B4||Current|Caffiene History||Participants|Count of Participants|5|5.0||||||
3602411|NCT02954601|3454413|B3||Current|Caffiene History||Participants|Count of Participants|6|6.0||||||
3602412|NCT02954601|3454414|B2||Current|Caffiene History||Participants|Count of Participants|5|5.0||||||
3602413|NCT02954601|3454415|B1||Current|Caffiene History||Participants|Count of Participants|10|10.0||||||
3602414|NCT02954601|3454411|B5||Never|Caffiene History||Participants|Count of Participants|4|4.0||||||
3602415|NCT02954601|3454412|B4||Never|Caffiene History||Participants|Count of Participants|1|1.0||||||
3602416|NCT02954601|3454413|B3||Never|Caffiene History||Participants|Count of Participants|1|1.0||||||
3602417|NCT02954601|3454414|B2||Never|Caffiene History||Participants|Count of Participants|1|1.0||||||
3602418|NCT02954601|3454415|B1||Never|Caffiene History||Participants|Count of Participants|1|1.0||||||
3602419|NCT02954601|3454411|B5||Former|Tobacco History||Participants|Count of Participants|6|6.0||||||
3602420|NCT02954601|3454412|B4||Former|Tobacco History||Participants|Count of Participants|1|1.0||||||
3602421|NCT02954601|3454413|B3||Former|Tobacco History||Participants|Count of Participants|2|2.0||||||
3602422|NCT02954601|3454414|B2||Former|Tobacco History||Participants|Count of Participants|1|1.0||||||
3602423|NCT02954601|3454415|B1||Former|Tobacco History||Participants|Count of Participants|2|2.0||||||
3602424|NCT02954601|3454411|B5||Current|Tobacco History||Participants|Count of Participants|2|2.0||||||
3602425|NCT02954601|3454412|B4||Current|Tobacco History||Participants|Count of Participants|1|1.0||||||
3602426|NCT02954601|3454413|B3||Current|Tobacco History||Participants|Count of Participants|0|0.0||||||
3602427|NCT02954601|3454414|B2||Current|Tobacco History||Participants|Count of Participants|0|0.0||||||
3602428|NCT02954601|3454415|B1||Current|Tobacco History||Participants|Count of Participants|1|1.0||||||
3602429|NCT02954601|3454411|B5||Never|Tobacco History||Participants|Count of Participants|23|23.0||||||
3602430|NCT02954601|3454412|B4||Never|Tobacco History||Participants|Count of Participants|5|5.0||||||
3602431|NCT02954601|3454413|B3||Never|Tobacco History||Participants|Count of Participants|5|5.0||||||
3602432|NCT02954601|3454414|B2||Never|Tobacco History||Participants|Count of Participants|5|5.0||||||
3602433|NCT02954601|3454415|B1||Never|Tobacco History||Participants|Count of Participants|8|8.0||||||
3602434|NCT02954601|3454411|B5||Former|Alcohol History||Participants|Count of Participants|1|1.0||||||
3602435|NCT02954601|3454412|B4||Former|Alcohol History||Participants|Count of Participants|0|0.0||||||
3602436|NCT02954601|3454413|B3||Former|Alcohol History||Participants|Count of Participants|1|1.0||||||
3602437|NCT02954601|3454414|B2||Former|Alcohol History||Participants|Count of Participants|0|0.0||||||
3602438|NCT02954601|3454415|B1||Former|Alcohol History||Participants|Count of Participants|0|0.0||||||
3602439|NCT02954601|3454411|B5||Current|Alcohol History||Participants|Count of Participants|14|14.0||||||
3602440|NCT02954601|3454412|B4||Current|Alcohol History||Participants|Count of Participants|2|2.0||||||
3602441|NCT02954601|3454413|B3||Current|Alcohol History||Participants|Count of Participants|4|4.0||||||
3602442|NCT02954601|3454414|B2||Current|Alcohol History||Participants|Count of Participants|3|3.0||||||
3602443|NCT02954601|3454415|B1||Current|Alcohol History||Participants|Count of Participants|5|5.0||||||
3602444|NCT02954601|3454411|B5||Never|Alcohol History||Participants|Count of Participants|16|16.0||||||
3602445|NCT02954601|3454412|B4||Never|Alcohol History||Participants|Count of Participants|5|5.0||||||
3602446|NCT02954601|3454413|B3||Never|Alcohol History||Participants|Count of Participants|2|2.0||||||
3602447|NCT02954601|3454414|B2||Never|Alcohol History||Participants|Count of Participants|3|3.0||||||
3602448|NCT02954601|3454415|B1||Never|Alcohol History||Participants|Count of Participants|6|6.0||||||
3602449|NCT02954601|3454411|B5||At least 1 year Post-Menopausal|Child-Bearing Status||Participants|Count of Participants|6|6.0||||||
3602450|NCT02954601|3454412|B4||At least 1 year Post-Menopausal|Child-Bearing Status||Participants|Count of Participants|1|1.0||||||
3602451|NCT02954601|3454413|B3||At least 1 year Post-Menopausal|Child-Bearing Status||Participants|Count of Participants|1|1.0||||||
3602452|NCT02954601|3454414|B2||At least 1 year Post-Menopausal|Child-Bearing Status||Participants|Count of Participants|2|2.0||||||
3602453|NCT02954601|3454415|B1||At least 1 year Post-Menopausal|Child-Bearing Status||Participants|Count of Participants|2|2.0||||||
3602454|NCT02954601|3454411|B5||Surgically Sterilized|Child-Bearing Status||Participants|Count of Participants|2|2.0||||||
3602455|NCT02954601|3454412|B4||Surgically Sterilized|Child-Bearing Status||Participants|Count of Participants|0|0.0||||||
3602456|NCT02954601|3454413|B3||Surgically Sterilized|Child-Bearing Status||Participants|Count of Participants|0|0.0||||||
3602457|NCT02954601|3454414|B2||Surgically Sterilized|Child-Bearing Status||Participants|Count of Participants|2|2.0||||||
3602458|NCT02954601|3454415|B1||Surgically Sterilized|Child-Bearing Status||Participants|Count of Participants|0|0.0||||||
3602459|NCT02954601|3454411|B5||Post Hysterectomy|Child-Bearing Status||Participants|Count of Participants|4|4.0||||||
3602460|NCT02954601|3454412|B4||Post Hysterectomy|Child-Bearing Status||Participants|Count of Participants|2|2.0||||||
3602461|NCT02954601|3454413|B3||Post Hysterectomy|Child-Bearing Status||Participants|Count of Participants|0|0.0||||||
3602462|NCT02954601|3454414|B2||Post Hysterectomy|Child-Bearing Status||Participants|Count of Participants|1|1.0||||||
3602463|NCT02954601|3454415|B1||Post Hysterectomy|Child-Bearing Status||Participants|Count of Participants|1|1.0||||||
3602464|NCT02954601|3454411|B5||Of Childbearing Potential|Child-Bearing Status||Participants|Count of Participants|0|0.0||||||
3602465|NCT02954601|3454412|B4||Of Childbearing Potential|Child-Bearing Status||Participants|Count of Participants|0|0.0||||||
3602466|NCT02954601|3454413|B3||Of Childbearing Potential|Child-Bearing Status||Participants|Count of Participants|0|0.0||||||
3602467|NCT02954601|3454414|B2||Of Childbearing Potential|Child-Bearing Status||Participants|Count of Participants|0|0.0||||||
3602468|NCT02954601|3454415|B1||Of Childbearing Potential|Child-Bearing Status||Participants|Count of Participants|0|0.0||||||
3602469|NCT02954601|3454411|B5||Not Applicable (Male)|Child-Bearing Status||Participants|Count of Participants|19|19.0||||||
3602470|NCT02954601|3454412|B4||Not Applicable (Male)|Child-Bearing Status||Participants|Count of Participants|4|4.0||||||
3602471|NCT02954601|3454413|B3||Not Applicable (Male)|Child-Bearing Status||Participants|Count of Participants|6|6.0||||||
3602472|NCT02954601|3454414|B2||Not Applicable (Male)|Child-Bearing Status||Participants|Count of Participants|1|1.0||||||
3602473|NCT02954601|3454415|B1||Not Applicable (Male)|Child-Bearing Status||Participants|Count of Participants|8|8.0||||||
3602474|NCT02954601|3454411|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602475|NCT02954601|3454412|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602476|NCT02954601|3454413|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602477|NCT02954601|3454414|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602478|NCT02954601|3454415|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602479|NCT02954601|3454411|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602480|NCT02954601|3454412|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602481|NCT02954601|3454413|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602482|NCT02954601|3454414|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602483|NCT02954601|3454415|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602484|NCT02954601|3454411|B5||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3602485|NCT02954601|3454412|B4||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3602486|NCT02954601|3454413|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3602487|NCT02954601|3454414|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3602488|NCT02954601|3454415|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3602489|NCT02954601|3454411|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3602490|NCT02954601|3454412|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602491|NCT02954601|3454413|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3602492|NCT02954601|3454414|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3602493|NCT02954601|3454415|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3602494|NCT02954601|3454411|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602495|NCT02954601|3454412|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602496|NCT02954601|3454413|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602497|NCT02954601|3454414|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602498|NCT02954601|3454415|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602499|NCT02954601|3454411|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3602500|NCT02954601|3454412|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3602501|NCT02954601|3454413|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3602502|NCT02954601|3454414|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602503|NCT02954601|3454415|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602504|NCT02954601|3454411|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602505|NCT02954601|3454412|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602506|NCT02954601|3454413|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602507|NCT02954601|3454414|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602508|NCT02954601|3454415|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602509|NCT02954601|3454411|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602510|NCT02954601|3454412|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602511|NCT02954601|3454413|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602512|NCT02954601|3454414|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602513|NCT02954601|3454415|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602514|NCT02954601|3454411|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3602515|NCT02954601|3454412|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3602516|NCT02954601|3454413|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3602517|NCT02954601|3454414|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3602518|NCT02954601|3454415|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3602519|NCT02954601|3454411|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3602520|NCT02954601|3454412|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3602521|NCT02954601|3454413|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3602522|NCT02954601|3454414|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3602523|NCT02954601|3454415|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3602524|NCT02954601|3454411|B5||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3602525|NCT02954601|3454412|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3602526|NCT02954601|3454413|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3602527|NCT02954601|3454414|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3602528|NCT02954601|3454415|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3602529|NCT02954601|3454411|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3602530|NCT02954601|3454412|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3602531|NCT02954601|3454413|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3602532|NCT02954601|3454414|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3602533|NCT02954601|3454415|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3602534|NCT02954601|3454411|B5|||Age||years|Mean|57.72|57.72|Standard Deviation|7.77|7.77|||
3602535|NCT02954601|3454412|B4|||Age||years|Mean|58.71|58.71|Standard Deviation|7.54|7.54|||
3602536|NCT02954601|3454413|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|7.03|7.03|||
3602537|NCT02954601|3454414|B2|||Age||years|Mean|57.17|57.17|Standard Deviation|11.37|11.37|||
3602538|NCT02954601|3454415|B1|||Age||years|Mean|57.27|57.27|Standard Deviation|7.00|7.0|||
3602539|NCT02954354|3454440|B4||≥ 12|Composite Symptom Score|Participants assessed the severity of seven influenza-associated symptoms (cough, sore throat, headache, nasal congestion, feverishness or chills, muscle or joint pain, and fatigue) on a 4-point scale (with 0 indicating no symptoms, 1 mild symptoms, 2 moderate symptoms, and 3 severe symptoms). The composite symptom score is the total score of the 7 influenza symptoms as assessed by the participant.|Participants|Count of Participants|729|729.0||||||
3602540|NCT02954354|3454441|B3||≥ 12|Composite Symptom Score|Participants assessed the severity of seven influenza-associated symptoms (cough, sore throat, headache, nasal congestion, feverishness or chills, muscle or joint pain, and fatigue) on a 4-point scale (with 0 indicating no symptoms, 1 mild symptoms, 2 moderate symptoms, and 3 severe symptoms). The composite symptom score is the total score of the 7 influenza symptoms as assessed by the participant.|Participants|Count of Participants|258|258.0||||||
3602541|NCT02954354|3454442|B2||≥ 12|Composite Symptom Score|Participants assessed the severity of seven influenza-associated symptoms (cough, sore throat, headache, nasal congestion, feverishness or chills, muscle or joint pain, and fatigue) on a 4-point scale (with 0 indicating no symptoms, 1 mild symptoms, 2 moderate symptoms, and 3 severe symptoms). The composite symptom score is the total score of the 7 influenza symptoms as assessed by the participant.|Participants|Count of Participants|159|159.0||||||
3602542|NCT02954354|3454443|B1||≥ 12|Composite Symptom Score|Participants assessed the severity of seven influenza-associated symptoms (cough, sore throat, headache, nasal congestion, feverishness or chills, muscle or joint pain, and fatigue) on a 4-point scale (with 0 indicating no symptoms, 1 mild symptoms, 2 moderate symptoms, and 3 severe symptoms). The composite symptom score is the total score of the 7 influenza symptoms as assessed by the participant.|Participants|Count of Participants|312|312.0||||||
3602582|NCT02954354|3454443|B1||> 24 to ≤ 36 hours|Time From Symptom Onset to Initiation of the Trial Regimen||Participants|Count of Participants|139|139.0||||||
3602583|NCT02954354|3454440|B4||> 12 to ≤ 24 hours|Time From Symptom Onset to Initiation of the Trial Regimen||Participants|Count of Participants|428|428.0||||||
3602866|NCT02949674|3454738|B4||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3602543|NCT02954354|3454440|B4||≤ 11|Composite Symptom Score|Participants assessed the severity of seven influenza-associated symptoms (cough, sore throat, headache, nasal congestion, feverishness or chills, muscle or joint pain, and fatigue) on a 4-point scale (with 0 indicating no symptoms, 1 mild symptoms, 2 moderate symptoms, and 3 severe symptoms). The composite symptom score is the total score of the 7 influenza symptoms as assessed by the participant.|Participants|Count of Participants|335|335.0||||||
3602544|NCT02954354|3454441|B3||≤ 11|Composite Symptom Score|Participants assessed the severity of seven influenza-associated symptoms (cough, sore throat, headache, nasal congestion, feverishness or chills, muscle or joint pain, and fatigue) on a 4-point scale (with 0 indicating no symptoms, 1 mild symptoms, 2 moderate symptoms, and 3 severe symptoms). The composite symptom score is the total score of the 7 influenza symptoms as assessed by the participant.|Participants|Count of Participants|119|119.0||||||
3602545|NCT02954354|3454442|B2||≤ 11|Composite Symptom Score|Participants assessed the severity of seven influenza-associated symptoms (cough, sore throat, headache, nasal congestion, feverishness or chills, muscle or joint pain, and fatigue) on a 4-point scale (with 0 indicating no symptoms, 1 mild symptoms, 2 moderate symptoms, and 3 severe symptoms). The composite symptom score is the total score of the 7 influenza symptoms as assessed by the participant.|Participants|Count of Participants|72|72.0||||||
3602546|NCT02954354|3454443|B1||≤ 11|Composite Symptom Score|Participants assessed the severity of seven influenza-associated symptoms (cough, sore throat, headache, nasal congestion, feverishness or chills, muscle or joint pain, and fatigue) on a 4-point scale (with 0 indicating no symptoms, 1 mild symptoms, 2 moderate symptoms, and 3 severe symptoms). The composite symptom score is the total score of the 7 influenza symptoms as assessed by the participant.|Participants|Count of Participants|144|144.0||||||
3602547|NCT02954354|3454440|B4||Rest of the world|Region||Participants|Count of Participants|243|243.0||||||
3602548|NCT02954354|3454441|B3||Rest of the world|Region||Participants|Count of Participants|74|74.0||||||
3602549|NCT02954354|3454442|B2||Rest of the world|Region||Participants|Count of Participants|56|56.0||||||
3602550|NCT02954354|3454443|B1||Rest of the world|Region||Participants|Count of Participants|113|113.0||||||
3602551|NCT02954354|3454440|B4||Japan/Asia|Region||Participants|Count of Participants|821|821.0||||||
3602552|NCT02954354|3454441|B3||Japan/Asia|Region||Participants|Count of Participants|303|303.0||||||
3602553|NCT02954354|3454442|B2||Japan/Asia|Region||Participants|Count of Participants|175|175.0||||||
3602554|NCT02954354|3454443|B1||Japan/Asia|Region||Participants|Count of Participants|343|343.0||||||
3602555|NCT02954354|3454440|B4||Other|Influenza Virus Type or Subtype on RT-PCR Assay at Enrollment||Participants|Count of Participants|18|18.0||||||
3602556|NCT02954354|3454441|B3||Other|Influenza Virus Type or Subtype on RT-PCR Assay at Enrollment||Participants|Count of Participants|3|3.0||||||
3602557|NCT02954354|3454442|B2||Other|Influenza Virus Type or Subtype on RT-PCR Assay at Enrollment||Participants|Count of Participants|5|5.0||||||
3602558|NCT02954354|3454443|B1||Other|Influenza Virus Type or Subtype on RT-PCR Assay at Enrollment||Participants|Count of Participants|10|10.0||||||
3602559|NCT02954354|3454440|B4||Mixed infection|Influenza Virus Type or Subtype on RT-PCR Assay at Enrollment||Participants|Count of Participants|17|17.0||||||
3602560|NCT02954354|3454441|B3||Mixed infection|Influenza Virus Type or Subtype on RT-PCR Assay at Enrollment||Participants|Count of Participants|6|6.0||||||
3602561|NCT02954354|3454442|B2||Mixed infection|Influenza Virus Type or Subtype on RT-PCR Assay at Enrollment||Participants|Count of Participants|3|3.0||||||
3602562|NCT02954354|3454443|B1||Mixed infection|Influenza Virus Type or Subtype on RT-PCR Assay at Enrollment||Participants|Count of Participants|8|8.0||||||
3602563|NCT02954354|3454440|B4||B|Influenza Virus Type or Subtype on RT-PCR Assay at Enrollment||Participants|Count of Participants|92|92.0||||||
3602564|NCT02954354|3454441|B3||B|Influenza Virus Type or Subtype on RT-PCR Assay at Enrollment||Participants|Count of Participants|34|34.0||||||
3602565|NCT02954354|3454442|B2||B|Influenza Virus Type or Subtype on RT-PCR Assay at Enrollment||Participants|Count of Participants|20|20.0||||||
3602566|NCT02954354|3454443|B1||B|Influenza Virus Type or Subtype on RT-PCR Assay at Enrollment||Participants|Count of Participants|38|38.0||||||
3602567|NCT02954354|3454440|B4||A/H3|Influenza Virus Type or Subtype on RT-PCR Assay at Enrollment||Participants|Count of Participants|921|921.0||||||
3602568|NCT02954354|3454441|B3||A/H3|Influenza Virus Type or Subtype on RT-PCR Assay at Enrollment||Participants|Count of Participants|332|332.0||||||
3602569|NCT02954354|3454442|B2||A/H3|Influenza Virus Type or Subtype on RT-PCR Assay at Enrollment||Participants|Count of Participants|196|196.0||||||
3602570|NCT02954354|3454443|B1||A/H3|Influenza Virus Type or Subtype on RT-PCR Assay at Enrollment||Participants|Count of Participants|393|393.0||||||
3602571|NCT02954354|3454440|B4||A/H1N1pdm|Influenza Virus Type or Subtype on RT-PCR Assay at Enrollment||Participants|Count of Participants|16|16.0||||||
3602572|NCT02954354|3454441|B3||A/H1N1pdm|Influenza Virus Type or Subtype on RT-PCR Assay at Enrollment||Participants|Count of Participants|2|2.0||||||
3602573|NCT02954354|3454442|B2||A/H1N1pdm|Influenza Virus Type or Subtype on RT-PCR Assay at Enrollment||Participants|Count of Participants|7|7.0||||||
3602574|NCT02954354|3454443|B1||A/H1N1pdm|Influenza Virus Type or Subtype on RT-PCR Assay at Enrollment||Participants|Count of Participants|7|7.0||||||
3602575|NCT02954354|3454440|B4||> 36 to ≤ 48 hours|Time From Symptom Onset to Initiation of the Trial Regimen||Participants|Count of Participants|201|201.0||||||
3602576|NCT02954354|3454441|B3||> 36 to ≤ 48 hours|Time From Symptom Onset to Initiation of the Trial Regimen||Participants|Count of Participants|79|79.0||||||
3602577|NCT02954354|3454442|B2||> 36 to ≤ 48 hours|Time From Symptom Onset to Initiation of the Trial Regimen||Participants|Count of Participants|43|43.0||||||
3602578|NCT02954354|3454443|B1||> 36 to ≤ 48 hours|Time From Symptom Onset to Initiation of the Trial Regimen||Participants|Count of Participants|79|79.0||||||
3602579|NCT02954354|3454440|B4||> 24 to ≤ 36 hours|Time From Symptom Onset to Initiation of the Trial Regimen||Participants|Count of Participants|300|300.0||||||
3602580|NCT02954354|3454441|B3||> 24 to ≤ 36 hours|Time From Symptom Onset to Initiation of the Trial Regimen||Participants|Count of Participants|94|94.0||||||
3602581|NCT02954354|3454442|B2||> 24 to ≤ 36 hours|Time From Symptom Onset to Initiation of the Trial Regimen||Participants|Count of Participants|67|67.0||||||
3602584|NCT02954354|3454441|B3||> 12 to ≤ 24 hours|Time From Symptom Onset to Initiation of the Trial Regimen||Participants|Count of Participants|163|163.0||||||
3602585|NCT02954354|3454442|B2||> 12 to ≤ 24 hours|Time From Symptom Onset to Initiation of the Trial Regimen||Participants|Count of Participants|87|87.0||||||
3602586|NCT02954354|3454443|B1||> 12 to ≤ 24 hours|Time From Symptom Onset to Initiation of the Trial Regimen||Participants|Count of Participants|178|178.0||||||
3602587|NCT02954354|3454440|B4||≥ 0 to ≤ 12 hours|Time From Symptom Onset to Initiation of the Trial Regimen||Participants|Count of Participants|135|135.0||||||
3602588|NCT02954354|3454441|B3||≥ 0 to ≤ 12 hours|Time From Symptom Onset to Initiation of the Trial Regimen||Participants|Count of Participants|41|41.0||||||
3602589|NCT02954354|3454442|B2||≥ 0 to ≤ 12 hours|Time From Symptom Onset to Initiation of the Trial Regimen||Participants|Count of Participants|34|34.0||||||
3602590|NCT02954354|3454443|B1||≥ 0 to ≤ 12 hours|Time From Symptom Onset to Initiation of the Trial Regimen||Participants|Count of Participants|60|60.0||||||
3602591|NCT02954354|3454440|B4||Other|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3602592|NCT02954354|3454441|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3602593|NCT02954354|3454442|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3602594|NCT02954354|3454443|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3602595|NCT02954354|3454440|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|185|185.0||||||
3602596|NCT02954354|3454441|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|60|60.0||||||
3602597|NCT02954354|3454442|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3602598|NCT02954354|3454443|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|85|85.0||||||
3602599|NCT02954354|3454440|B4||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3602600|NCT02954354|3454441|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3602601|NCT02954354|3454442|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3602602|NCT02954354|3454443|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3602603|NCT02954354|3454440|B4||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
3602604|NCT02954354|3454441|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3602605|NCT02954354|3454442|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3602606|NCT02954354|3454443|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3602607|NCT02954354|3454440|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|832|832.0||||||
3602608|NCT02954354|3454441|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|305|305.0||||||
3602609|NCT02954354|3454442|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|178|178.0||||||
3602610|NCT02954354|3454443|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|349|349.0||||||
3602611|NCT02954354|3454440|B4||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3602612|NCT02954354|3454441|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3602613|NCT02954354|3454442|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3602614|NCT02954354|3454443|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3602615|NCT02954354|3454440|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602616|NCT02954354|3454441|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602617|NCT02954354|3454442|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602618|NCT02954354|3454443|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602619|NCT02954354|3454440|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|996|996.0||||||
3602620|NCT02954354|3454441|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|352|352.0||||||
3602621|NCT02954354|3454442|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|220|220.0||||||
3602622|NCT02954354|3454443|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|424|424.0||||||
3602623|NCT02954354|3454440|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3602624|NCT02954354|3454441|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3602625|NCT02954354|3454442|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3602626|NCT02954354|3454443|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3602627|NCT02954354|3454440|B4||Male|Sex: Female, Male||Participants|Count of Participants|570|570.0||||||
3602628|NCT02954354|3454441|B3||Male|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
3602629|NCT02954354|3454442|B2||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3602630|NCT02954354|3454443|B1||Male|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
3602631|NCT02954354|3454440|B4||Female|Sex: Female, Male||Participants|Count of Participants|494|494.0||||||
3602632|NCT02954354|3454441|B3||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
3602633|NCT02954354|3454442|B2||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3602634|NCT02954354|3454443|B1||Female|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
3602635|NCT02954354|3454440|B4||≥ 60 to ≤ 64 years|Age, Customized||Participants|Count of Participants|32|32.0||||||
3602864|NCT02949674|3454740|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3602636|NCT02954354|3454441|B3||≥ 60 to ≤ 64 years|Age, Customized||Participants|Count of Participants|11|11.0||||||
3602637|NCT02954354|3454442|B2||≥ 60 to ≤ 64 years|Age, Customized||Participants|Count of Participants|7|7.0||||||
3602638|NCT02954354|3454443|B1||≥ 60 to ≤ 64 years|Age, Customized||Participants|Count of Participants|14|14.0||||||
3602639|NCT02954354|3454440|B4||≥ 50 to ≤ 59 years|Age, Customized||Participants|Count of Participants|133|133.0||||||
3602640|NCT02954354|3454441|B3||≥ 50 to ≤ 59 years|Age, Customized||Participants|Count of Participants|51|51.0||||||
3602641|NCT02954354|3454442|B2||≥ 50 to ≤ 59 years|Age, Customized||Participants|Count of Participants|30|30.0||||||
3602642|NCT02954354|3454443|B1||≥ 50 to ≤ 59 years|Age, Customized||Participants|Count of Participants|52|52.0||||||
3602643|NCT02954354|3454440|B4||≥ 40 to ≤ 49 years|Age, Customized||Participants|Count of Participants|222|222.0||||||
3602644|NCT02954354|3454441|B3||≥ 40 to ≤ 49 years|Age, Customized||Participants|Count of Participants|77|77.0||||||
3602645|NCT02954354|3454442|B2||≥ 40 to ≤ 49 years|Age, Customized||Participants|Count of Participants|48|48.0||||||
3602646|NCT02954354|3454443|B1||≥ 40 to ≤ 49 years|Age, Customized||Participants|Count of Participants|97|97.0||||||
3602647|NCT02954354|3454440|B4||≥ 30 to ≤ 39 years|Age, Customized||Participants|Count of Participants|243|243.0||||||
3602648|NCT02954354|3454441|B3||≥ 30 to ≤ 39 years|Age, Customized||Participants|Count of Participants|104|104.0||||||
3602649|NCT02954354|3454442|B2||≥ 30 to ≤ 39 years|Age, Customized||Participants|Count of Participants|47|47.0||||||
3602650|NCT02954354|3454443|B1||≥ 30 to ≤ 39 years|Age, Customized||Participants|Count of Participants|92|92.0||||||
3602651|NCT02954354|3454440|B4||≥ 20 to ≤ 29 years|Age, Customized||Participants|Count of Participants|316|316.0||||||
3602652|NCT02954354|3454441|B3||≥ 20 to ≤ 29 years|Age, Customized||Participants|Count of Participants|134|134.0||||||
3602653|NCT02954354|3454442|B2||≥ 20 to ≤ 29 years|Age, Customized||Participants|Count of Participants|61|61.0||||||
3602654|NCT02954354|3454443|B1||≥ 20 to ≤ 29 years|Age, Customized||Participants|Count of Participants|121|121.0||||||
3602655|NCT02954354|3454440|B4||≥ 12 to ≤ 19 years|Age, Customized||Participants|Count of Participants|118|118.0||||||
3602656|NCT02954354|3454441|B3||≥ 12 to ≤ 19 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3602657|NCT02954354|3454442|B2||≥ 12 to ≤ 19 years|Age, Customized||Participants|Count of Participants|38|38.0||||||
3602658|NCT02954354|3454443|B1||≥ 12 to ≤ 19 years|Age, Customized||Participants|Count of Participants|80|80.0||||||
3602659|NCT02954354|3454440|B4|||Age|Note that the baloxavir and placebo groups included participants from 12 to 64 years of age whereas the oseltamivir group only included participants from 20 to 64 years of age.|Years|Mean|34.5|34.5|Standard Deviation|13.0|13.0|||
3602660|NCT02954354|3454441|B3|||Age|Note that the baloxavir and placebo groups included participants from 12 to 64 years of age whereas the oseltamivir group only included participants from 20 to 64 years of age.|Years|Mean|36.0|36.0|Standard Deviation|11.8|11.8|||
3602661|NCT02954354|3454442|B2|||Age|Note that the baloxavir and placebo groups included participants from 12 to 64 years of age whereas the oseltamivir group only included participants from 20 to 64 years of age.|Years|Mean|33.9|33.9|Standard Deviation|13.7|13.7|||
3602662|NCT02954354|3454443|B1|||Age|Note that the baloxavir and placebo groups included participants from 12 to 64 years of age whereas the oseltamivir group only included participants from 20 to 64 years of age.|Years|Mean|33.5|33.5|Standard Deviation|13.5|13.5|||
3602663|NCT02953886|3454529|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3602664|NCT02953886|3454529|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3602665|NCT02953886|3454529|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602666|NCT02953886|3454529|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3602667|NCT02953886|3454529|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3602668|NCT02953886|3454529|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602669|NCT02953886|3454529|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602670|NCT02953886|3454529|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602671|NCT02953886|3454529|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3602672|NCT02953886|3454529|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3602673|NCT02953886|3454529|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3602674|NCT02953886|3454529|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3602675|NCT02953886|3454529|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3602676|NCT02952261|3454535|B3|||Distance from pleura||mm|Median|7.8|7.8|Full Range|||0.0|43.9|
3602677|NCT02952261|3454536|B2|||Distance from pleura||mm|Median|8.5|8.5|Full Range|||0.0|43.9|
3602678|NCT02952261|3454537|B1|||Distance from pleura||mm|Median|6.5|6.5|Full Range|||0.0|35.9|
3602679|NCT02952261|3454535|B3|Solid||Nodule type||Participants|Count of Participants|19|19.0||||||
3602680|NCT02952261|3454536|B2|Solid||Nodule type||Participants|Count of Participants|9|9.0||||||
3602681|NCT02952261|3454537|B1|Solid||Nodule type||Participants|Count of Participants|10|10.0||||||
3602682|NCT02952261|3454535|B3|Mixed ground glass opacity(GGO)||Nodule type||Participants|Count of Participants|85|85.0||||||
3602683|NCT02952261|3454536|B2|Mixed ground glass opacity(GGO)||Nodule type||Participants|Count of Participants|50|50.0||||||
3602684|NCT02952261|3454537|B1|Mixed ground glass opacity(GGO)||Nodule type||Participants|Count of Participants|35|35.0||||||
3602685|NCT02952261|3454535|B3|pure ground glass opacity(GGO)||Nodule type||Participants|Count of Participants|96|96.0||||||
3602686|NCT02952261|3454536|B2|pure ground glass opacity(GGO)||Nodule type||Participants|Count of Participants|41|41.0||||||
3602687|NCT02952261|3454537|B1|pure ground glass opacity(GGO)||Nodule type||Participants|Count of Participants|55|55.0||||||
3602688|NCT02952261|3454535|B3|left lower lobe(LLL)||Nodule location||Participants|Count of Participants|32|32.0||||||
3602689|NCT02952261|3454536|B2|left lower lobe(LLL)||Nodule location||Participants|Count of Participants|15|15.0||||||
3602690|NCT02952261|3454537|B1|left lower lobe(LLL)||Nodule location||Participants|Count of Participants|17|17.0||||||
3602691|NCT02952261|3454535|B3|left upper lobe(LUL)||Nodule location||Participants|Count of Participants|47|47.0||||||
3602692|NCT02952261|3454536|B2|left upper lobe(LUL)||Nodule location||Participants|Count of Participants|25|25.0||||||
3602693|NCT02952261|3454537|B1|left upper lobe(LUL)||Nodule location||Participants|Count of Participants|22|22.0||||||
3602694|NCT02952261|3454535|B3|right lower lobe(RLL)||Nodule location||Participants|Count of Participants|43|43.0||||||
3602695|NCT02952261|3454536|B2|right lower lobe(RLL)||Nodule location||Participants|Count of Participants|17|17.0||||||
3602696|NCT02952261|3454537|B1|right lower lobe(RLL)||Nodule location||Participants|Count of Participants|26|26.0||||||
3602697|NCT02952261|3454535|B3|right middle lobe(RML)||Nodule location||Participants|Count of Participants|14|14.0||||||
3602698|NCT02952261|3454536|B2|right middle lobe(RML)||Nodule location||Participants|Count of Participants|5|5.0||||||
3602699|NCT02952261|3454537|B1|right middle lobe(RML)||Nodule location||Participants|Count of Participants|9|9.0||||||
3602700|NCT02952261|3454535|B3|right upper lobe(RUL)||Nodule location||Participants|Count of Participants|64|64.0||||||
3602701|NCT02952261|3454536|B2|right upper lobe(RUL)||Nodule location||Participants|Count of Participants|38|38.0||||||
3602702|NCT02952261|3454537|B1|right upper lobe(RUL)||Nodule location||Participants|Count of Participants|26|26.0||||||
3602703|NCT02952261|3454535|B3|||Nodule size|nodule size measured by long-axis diameter|mm|Mean|9.7|9.7|Standard Deviation|2.9|2.9|||
3602704|NCT02952261|3454536|B2|||Nodule size|nodule size measured by long-axis diameter|mm|Mean|10.1|10.1|Standard Deviation|3.0|3.0|||
3602705|NCT02952261|3454537|B1|||Nodule size|nodule size measured by long-axis diameter|mm|Mean|9.2|9.2|Standard Deviation|2.7|2.7|||
3602706|NCT02952261|3454535|B3|||FEV1（of percentage predicted）||Percentage predicted FEV1|Mean|94.0|94.0|Standard Deviation|13.8|13.8|||
3602707|NCT02952261|3454536|B2|||FEV1（of percentage predicted）||Percentage predicted FEV1|Mean|94.3|94.3|Standard Deviation|14.6|14.6|||
3602708|NCT02952261|3454537|B1|||FEV1（of percentage predicted）||Percentage predicted FEV1|Mean|93.6|93.6|Standard Deviation|13.0|13.0|||
3602709|NCT02952261|3454535|B3|||BMI(body mass index)||Kg/m^2|Mean|22.9|22.9|Standard Deviation|2.8|2.8|||
3602710|NCT02952261|3454536|B2|||BMI(body mass index)||Kg/m^2|Mean|22.8|22.8|Standard Deviation|2.8|2.8|||
3602711|NCT02952261|3454537|B1|||BMI(body mass index)||Kg/m^2|Mean|22.9|22.9|Standard Deviation|2.9|2.9|||
3602712|NCT02952261|3454535|B3||NO|Smoking history||Participants|Count of Participants|142|142.0||||||
3602713|NCT02952261|3454536|B2||NO|Smoking history||Participants|Count of Participants|70|70.0||||||
3602714|NCT02952261|3454537|B1||NO|Smoking history||Participants|Count of Participants|72|72.0||||||
3602715|NCT02952261|3454535|B3||YES|Smoking history||Participants|Count of Participants|58|58.0||||||
3602716|NCT02952261|3454536|B2||YES|Smoking history||Participants|Count of Participants|30|30.0||||||
3602717|NCT02952261|3454537|B1||YES|Smoking history||Participants|Count of Participants|28|28.0||||||
3602718|NCT02952261|3454535|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3602719|NCT02952261|3454535|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3602720|NCT02952261|3454536|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3602721|NCT02952261|3454537|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3602722|NCT02952261|3454535|B3||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3602723|NCT02952261|3454536|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3602724|NCT02952261|3454537|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3602725|NCT02952261|3454535|B3|||Age||years|Mean|53|53.0|Standard Deviation|13|13.0|||
3602726|NCT02952261|3454536|B2|||Age||years|Mean|54|54.0|Standard Deviation|15|15.0|||
3602727|NCT02952261|3454537|B1|||Age||years|Mean|52|52.0|Standard Deviation|11|11.0|||
3602728|NCT02951884|3454550|B4|United States||Region of Enrollment||participants|Number|2|2.0||||||
3602729|NCT02951884|3454551|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3602730|NCT02951884|3454552|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3602731|NCT02951884|3454550|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602732|NCT02951884|3454551|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602733|NCT02951884|3454552|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602734|NCT02951884|3454550|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602735|NCT02951884|3454551|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602736|NCT02951884|3454552|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602737|NCT02951884|3454550|B4||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3602738|NCT02951884|3454551|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3602739|NCT02951884|3454552|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3602740|NCT02951884|3454550|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602741|NCT02951884|3454551|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602742|NCT02951884|3454552|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602743|NCT02951884|3454550|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602865|NCT02949674|3454741|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3602744|NCT02951884|3454551|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602745|NCT02951884|3454552|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602746|NCT02951884|3454550|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602747|NCT02951884|3454551|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602748|NCT02951884|3454552|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602749|NCT02951884|3454550|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602750|NCT02951884|3454551|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602751|NCT02951884|3454552|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602752|NCT02951884|3454550|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602753|NCT02951884|3454551|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602754|NCT02951884|3454552|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602755|NCT02951884|3454550|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3602756|NCT02951884|3454551|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3602757|NCT02951884|3454552|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3602758|NCT02951884|3454550|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602759|NCT02951884|3454551|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602760|NCT02951884|3454552|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602761|NCT02951884|3454550|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3602762|NCT02951884|3454551|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3602763|NCT02951884|3454552|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3602764|NCT02951884|3454550|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3602765|NCT02951884|3454551|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3602766|NCT02951884|3454552|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3602767|NCT02951884|3454550|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3602768|NCT02951884|3454551|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3602769|NCT02951884|3454552|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3602770|NCT02951884|3454550|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3602771|NCT02951884|3454551|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3602772|NCT02951884|3454552|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3602773|NCT02951884|3454550|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3602774|NCT02951884|3454551|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3602775|NCT02951884|3454552|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3602776|NCT02951767|3454566|B1||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3602777|NCT02951767|3454566|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3602778|NCT02951767|3454566|B1|||Age||years|Mean|71.8|71.8|Standard Deviation|8.9|8.9|||
3602779|NCT02951702|3454583|B3|United States||Region of Enrollment||Participants|Count of Participants|51|51.0||||||
3602780|NCT02951702|3454584|B2|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3602781|NCT02951702|3454585|B1|United States||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3602782|NCT02951702|3454583|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602783|NCT02951702|3454584|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602784|NCT02951702|3454585|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602785|NCT02951702|3454583|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602786|NCT02951702|3454584|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602787|NCT02951702|3454585|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602788|NCT02951702|3454583|B3||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3602789|NCT02951702|3454584|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3602790|NCT02951702|3454585|B1||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3602791|NCT02951702|3454583|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602792|NCT02951702|3454584|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602793|NCT02951702|3454585|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602794|NCT02951702|3454583|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602795|NCT02951702|3454584|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602796|NCT02951702|3454585|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602797|NCT02951702|3454583|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602798|NCT02951702|3454584|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602799|NCT02951702|3454585|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602800|NCT02951702|3454583|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602801|NCT02951702|3454584|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602802|NCT02951702|3454585|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602803|NCT02951702|3454583|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3602804|NCT02951702|3454584|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3602805|NCT02951702|3454585|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3602806|NCT02951702|3454583|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3602807|NCT02951702|3454584|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3602808|NCT02951702|3454585|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3602809|NCT02951702|3454583|B3|||Age||years|Mean|75|75.0|Full Range|||65.0|90.0|
3602810|NCT02951702|3454584|B2|||Age||years|Mean|75|75.0|Full Range|||65.0|86.0|
3602811|NCT02951702|3454585|B1|||Age||years|Mean|76|76.0|Full Range|||65.0|90.0|
3602812|NCT02951702|3454583|B3||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
3602813|NCT02951702|3454584|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3602814|NCT02951702|3454585|B1||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
3602815|NCT02951702|3454583|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3602816|NCT02951702|3454584|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3602817|NCT02951702|3454585|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3602818|NCT02951702|3454583|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3602819|NCT02951702|3454584|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3602820|NCT02951702|3454585|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3602821|NCT02951312|3454596|B5|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
3602822|NCT02951312|3454599|B2|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3602823|NCT02951312|3454600|B1|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3602824|NCT02951312|3454596|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3602825|NCT02951312|3454599|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3602826|NCT02951312|3454600|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3602827|NCT02951312|3454596|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3602828|NCT02951312|3454599|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3602829|NCT02951312|3454600|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3602830|NCT02951312|3454596|B5|||Age||years|Mean|41.67|41.67|Standard Deviation|58.33|58.33|||
3602831|NCT02951312|3454599|B2|||Age||years|Mean|63.5|63.5|Standard Deviation|8.89|8.89|||
3602832|NCT02951312|3454600|B1|||Age||years|Mean|66.2|66.2|Standard Deviation|3.82|3.82|||
3602833|NCT02951312|3454596|B5||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3602834|NCT02951312|3454599|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3602835|NCT02951312|3454600|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3602836|NCT02951312|3454596|B5||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3602837|NCT02951312|3454599|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3602838|NCT02951312|3454600|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3602839|NCT02951312|3454596|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3602840|NCT02951312|3454599|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3602841|NCT02951312|3454600|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3602842|NCT02951273|3454723|B1|||Internal carotid artery blood flow during anesthesia-induced hypotension||ml/min|Mean|193|193.0|Standard Deviation|41|41.0|||
3602843|NCT02951273|3454723|B1|Denmark||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3602844|NCT02951273|3454723|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602845|NCT02951273|3454723|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602846|NCT02951273|3454723|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3602847|NCT02951273|3454723|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602848|NCT02951273|3454723|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602849|NCT02951273|3454723|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602850|NCT02951273|3454723|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602851|NCT02951273|3454723|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3602852|NCT02951273|3454723|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3602853|NCT02951273|3454723|B1|||Age||years|Mean|65|65.0|Standard Deviation|11|11.0|||
3602854|NCT02951273|3454723|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3602855|NCT02951273|3454723|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3602856|NCT02951273|3454723|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3602857|NCT02949674|3454738|B4|Mexico||Region of Enrollment||participants|Number|93|93.0||||||
3602858|NCT02949674|3454739|B3|Mexico||Region of Enrollment||participants|Number|31|31.0||||||
3602859|NCT02949674|3454740|B2|Mexico||Region of Enrollment||participants|Number|31|31.0||||||
3602860|NCT02949674|3454741|B1|Mexico||Region of Enrollment||participants|Number|31|31.0||||||
3602861|NCT02949674|3454738|B4|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3602862|NCT02949674|3454738|B4||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3602863|NCT02949674|3454739|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3602867|NCT02949674|3454739|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3602868|NCT02949674|3454740|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3602869|NCT02949674|3454741|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3602870|NCT02949674|3454738|B4|||Age||years|Mean|37.7|37.7|Full Range|||18.0|71.0|
3602871|NCT02949674|3454739|B3|||Age||years|Mean|33.71|33.71|Full Range|||18.0|67.0|
3602872|NCT02949674|3454740|B2|||Age||years|Mean|37.16|37.16|Full Range|||18.0|71.0|
3602873|NCT02949674|3454741|B1|||Age||years|Mean|42.3|42.3|Full Range|||18.0|67.0|
3602874|NCT02949141|3454751|B1|Nepal||Region of Enrollment||participants|Number|62|62.0||||||
3602875|NCT02949141|3454751|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3602876|NCT02949141|3454751|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3602877|NCT02949141|3454751|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|14.5|14.5|||
3602878|NCT02949141|3454751|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3602879|NCT02949141|3454751|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3602880|NCT02949141|3454751|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3602881|NCT02948582|3454758|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3602882|NCT02948582|3454758|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602883|NCT02948582|3454758|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3602884|NCT02948582|3454758|B1||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3602885|NCT02948582|3454758|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602886|NCT02948582|3454758|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602887|NCT02948582|3454758|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602888|NCT02948582|3454758|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602889|NCT02948582|3454758|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602890|NCT02948582|3454758|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3602891|NCT02948582|3454758|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602892|NCT02948582|3454758|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3602893|NCT02948582|3454758|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3602894|NCT02948582|3454758|B1|||Age||years|Mean|62.0|62.0|Standard Deviation|6.99|6.99|||
3602895|NCT02948582|3454758|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3602896|NCT02948582|3454758|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3602897|NCT02948582|3454758|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3602898|NCT02947984|3454856|B3|||Clinical Target Volume||Cubic Centimeters|Median|38.5|38.5|Full Range|||6.5|464.0|
3602899|NCT02947984|3454857|B2|||Clinical Target Volume||Cubic Centimeters|Median|28|28.0|Full Range|||6.5|150.7|
3602900|NCT02947984|3454858|B1|||Clinical Target Volume||Cubic Centimeters|Median|49|49.0|Full Range|||9.0|464.0|
3602901|NCT02947984|3454856|B3|||Gross Tumor Volume||Cubic Centimeters|Median|26.5|26.5|Full Range|||3.0|313.0|
3602902|NCT02947984|3454857|B2|||Gross Tumor Volume||Cubic Centimeters|Median|13.2|13.2|Full Range|||3.0|313.0|
3602903|NCT02947984|3454858|B1|||Gross Tumor Volume||Cubic Centimeters|Median|39.7|39.7|Full Range|||5.6|243.0|
3602904|NCT02947984|3454856|B3|Recurrent Disease||Radiation Indication||Participants|Count of Participants|21|21.0||||||
3602905|NCT02947984|3454857|B2|Recurrent Disease||Radiation Indication||Participants|Count of Participants|10|10.0||||||
3602906|NCT02947984|3454858|B1|Recurrent Disease||Radiation Indication||Participants|Count of Participants|11|11.0||||||
3602907|NCT02947984|3454856|B3|Sub-Total Resection, postoperative||Radiation Indication||Participants|Count of Participants|23|23.0||||||
3602908|NCT02947984|3454857|B2|Sub-Total Resection, postoperative||Radiation Indication||Participants|Count of Participants|12|12.0||||||
3602909|NCT02947984|3454858|B1|Sub-Total Resection, postoperative||Radiation Indication||Participants|Count of Participants|11|11.0||||||
3602910|NCT02947984|3454856|B3|One or more of the above||Co-morbidities||participants|Number|10|10.0||||||
3602911|NCT02947984|3454857|B2|One or more of the above||Co-morbidities||participants|Number|6|6.0||||||
3602912|NCT02947984|3454858|B1|One or more of the above||Co-morbidities||participants|Number|4|4.0||||||
3602913|NCT02947984|3454856|B3|Coronary artery disease||Co-morbidities||participants|Number|1|1.0||||||
3602914|NCT02947984|3454857|B2|Coronary artery disease||Co-morbidities||participants|Number|0|0.0||||||
3602915|NCT02947984|3454858|B1|Coronary artery disease||Co-morbidities||participants|Number|1|1.0||||||
3602916|NCT02947984|3454856|B3|Hyperlipidemia||Co-morbidities||participants|Number|1|1.0||||||
3602917|NCT02947984|3454857|B2|Hyperlipidemia||Co-morbidities||participants|Number|0|0.0||||||
3602918|NCT02947984|3454858|B1|Hyperlipidemia||Co-morbidities||participants|Number|1|1.0||||||
3602919|NCT02947984|3454856|B3|Diabetes mellitus||Co-morbidities||participants|Number|4|4.0||||||
3602920|NCT02947984|3454857|B2|Diabetes mellitus||Co-morbidities||participants|Number|4|4.0||||||
3602921|NCT02947984|3454858|B1|Diabetes mellitus||Co-morbidities||participants|Number|0|0.0||||||
3602922|NCT02947984|3454856|B3|Hypertension||Co-morbidities||participants|Number|9|9.0||||||
3602923|NCT02947984|3454857|B2|Hypertension||Co-morbidities||participants|Number|6|6.0||||||
3602924|NCT02947984|3454858|B1|Hypertension||Co-morbidities||participants|Number|3|3.0||||||
3602925|NCT02947984|3454856|B3|Unknown||Smoking Status||Participants|Count of Participants|5|5.0||||||
3602926|NCT02947984|3454857|B2|Unknown||Smoking Status||Participants|Count of Participants|3|3.0||||||
3602927|NCT02947984|3454858|B1|Unknown||Smoking Status||Participants|Count of Participants|2|2.0||||||
3602928|NCT02947984|3454856|B3|Non-smoker||Smoking Status||Participants|Count of Participants|17|17.0||||||
3602929|NCT02947984|3454857|B2|Non-smoker||Smoking Status||Participants|Count of Participants|6|6.0||||||
3602930|NCT02947984|3454858|B1|Non-smoker||Smoking Status||Participants|Count of Participants|11|11.0||||||
3602931|NCT02947984|3454856|B3|Smoker||Smoking Status||Participants|Count of Participants|22|22.0||||||
3602932|NCT02947984|3454857|B2|Smoker||Smoking Status||Participants|Count of Participants|13|13.0||||||
3602933|NCT02947984|3454858|B1|Smoker||Smoking Status||Participants|Count of Participants|9|9.0||||||
3602934|NCT02947984|3454856|B3|Tentorium||Tumor Location|Count of tumors by location|Tumors|Number|1|1.0||||||
3602935|NCT02947984|3454857|B2|Tentorium||Tumor Location|Count of tumors by location|Tumors|Number|1|1.0||||||
3602936|NCT02947984|3454858|B1|Tentorium||Tumor Location|Count of tumors by location|Tumors|Number|0|0.0||||||
3602937|NCT02947984|3454856|B3|Optic canal||Tumor Location|Count of tumors by location|Tumors|Number|1|1.0||||||
3602938|NCT02947984|3454857|B2|Optic canal||Tumor Location|Count of tumors by location|Tumors|Number|1|1.0||||||
3602939|NCT02947984|3454858|B1|Optic canal||Tumor Location|Count of tumors by location|Tumors|Number|0|0.0||||||
3602940|NCT02947984|3454856|B3|Olfactory groove||Tumor Location|Count of tumors by location|Tumors|Number|1|1.0||||||
3602941|NCT02947984|3454857|B2|Olfactory groove||Tumor Location|Count of tumors by location|Tumors|Number|0|0.0||||||
3602942|NCT02947984|3454858|B1|Olfactory groove||Tumor Location|Count of tumors by location|Tumors|Number|1|1.0||||||
3602943|NCT02947984|3454856|B3|Clival/prepontine space||Tumor Location|Count of tumors by location|Tumors|Number|4|4.0||||||
3602944|NCT02947984|3454857|B2|Clival/prepontine space||Tumor Location|Count of tumors by location|Tumors|Number|1|1.0||||||
3602945|NCT02947984|3454858|B1|Clival/prepontine space||Tumor Location|Count of tumors by location|Tumors|Number|3|3.0||||||
3602946|NCT02947984|3454856|B3|Cerebellar pontine angle||Tumor Location|Count of tumors by location|Tumors|Number|4|4.0||||||
3602947|NCT02947984|3454857|B2|Cerebellar pontine angle||Tumor Location|Count of tumors by location|Tumors|Number|1|1.0||||||
3602948|NCT02947984|3454858|B1|Cerebellar pontine angle||Tumor Location|Count of tumors by location|Tumors|Number|3|3.0||||||
3602949|NCT02947984|3454856|B3|Sella/Parasella||Tumor Location|Count of tumors by location|Tumors|Number|8|8.0||||||
3602950|NCT02947984|3454857|B2|Sella/Parasella||Tumor Location|Count of tumors by location|Tumors|Number|2|2.0||||||
3602951|NCT02947984|3454858|B1|Sella/Parasella||Tumor Location|Count of tumors by location|Tumors|Number|6|6.0||||||
3602952|NCT02947984|3454856|B3|Cavernous sinus||Tumor Location|Count of tumors by location|Tumors|Number|11|11.0||||||
3602953|NCT02947984|3454857|B2|Cavernous sinus||Tumor Location|Count of tumors by location|Tumors|Number|8|8.0||||||
3602954|NCT02947984|3454858|B1|Cavernous sinus||Tumor Location|Count of tumors by location|Tumors|Number|3|3.0||||||
3602955|NCT02947984|3454856|B3|Sphenoid wing||Tumor Location|Count of tumors by location|Tumors|Number|15|15.0||||||
3602956|NCT02947984|3454857|B2|Sphenoid wing||Tumor Location|Count of tumors by location|Tumors|Number|8|8.0||||||
3602957|NCT02947984|3454858|B1|Sphenoid wing||Tumor Location|Count of tumors by location|Tumors|Number|7|7.0||||||
3602958|NCT02947984|3454856|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
3602959|NCT02947984|3454857|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
3602960|NCT02947984|3454858|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3602961|NCT02947984|3454856|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3602962|NCT02947984|3454857|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3602963|NCT02947984|3454858|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3602964|NCT02947984|3454856|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3602965|NCT02947984|3454857|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3602966|NCT02947984|3454858|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3602967|NCT02947984|3454856|B3|||Age||years|Median|55.5|55.5|Full Range|||31.0|76.0|
3602968|NCT02947984|3454857|B2|||Age||years|Median|50.5|50.5|Full Range|||38.0|76.0|
3602969|NCT02947984|3454858|B1|||Age||years|Median|61|61.0|Full Range|||31.0|77.0|
3602970|NCT02947022|3454871|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3602971|NCT02947022|3454871|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602972|NCT02947022|3454871|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602973|NCT02947022|3454871|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3602974|NCT02947022|3454871|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602975|NCT02947022|3454871|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602976|NCT02947022|3454871|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602977|NCT02947022|3454871|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602978|NCT02947022|3454871|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602979|NCT02947022|3454871|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3602980|NCT02947022|3454871|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602981|NCT02947022|3454871|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3602982|NCT02947022|3454871|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3602983|NCT02947022|3454871|B1|||Age||years|Mean|49|49.0|Standard Deviation|0|0.0|||
3602984|NCT02947022|3454871|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3602985|NCT02947022|3454871|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3602986|NCT02947022|3454871|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3602987|NCT02946229|3454890|B1|Male or Female||Sex/Gender, Customized|Gender information not collected|Participants|Count of Participants|142|142.0||||||
3602988|NCT02946229|3454890|B1|>=18 years||Age, Customized||Participants|Count of Participants|142|142.0||||||
3602989|NCT02945657|3454894|B1|||Percentage of Body Surface Area (BSA) Involved||%|Mean|43.7|43.7|Standard Deviation|13.25|13.25|||
3602990|NCT02945657|3454894|B1|Honduras||Region of Enrollment||participants|Number|6|6.0||||||
3602991|NCT02945657|3454894|B1|Panama||Region of Enrollment||participants|Number|11|11.0||||||
3602992|NCT02945657|3454894|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3602993|NCT02945657|3454894|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602994|NCT02945657|3454894|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3602995|NCT02945657|3454894|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3602996|NCT02945657|3454894|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3602997|NCT02945657|3454894|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3602998|NCT02945657|3454894|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3602999|NCT02945657|3454894|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3603000|NCT02945657|3454894|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603001|NCT02945657|3454894|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3603002|NCT02945657|3454894|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3603003|NCT02945657|3454894|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3603004|NCT02945657|3454894|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3603005|NCT02945657|3454894|B1|||Age||years|Mean|7.9|7.9|Standard Deviation|4.33|4.33|||
3603006|NCT02945657|3454894|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3603007|NCT02945657|3454894|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3603008|NCT02945657|3454894|B1||<=18 years|Age||Participants|Count of Participants|32|32.0||||||
3603009|NCT02945254|3454911|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603010|NCT02945254|3454912|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603011|NCT02945254|3454913|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603012|NCT02945254|3454911|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603013|NCT02945254|3454912|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603014|NCT02945254|3454913|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603015|NCT02945254|3454911|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3603016|NCT02945254|3454912|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3603017|NCT02945254|3454913|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3603018|NCT02945254|3454911|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3603019|NCT02945254|3454912|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3603020|NCT02945254|3454913|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3603021|NCT02945254|3454911|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603022|NCT02945254|3454912|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603023|NCT02945254|3454913|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603024|NCT02945254|3454911|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3603025|NCT02945254|3454912|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3603026|NCT02945254|3454913|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603027|NCT02945254|3454911|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603028|NCT02945254|3454912|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603029|NCT02945254|3454913|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603030|NCT02945254|3454911|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3603031|NCT02945254|3454912|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3603032|NCT02945254|3454913|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3603033|NCT02945254|3454911|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3603034|NCT02945254|3454912|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3603035|NCT02945254|3454913|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3603036|NCT02945254|3454911|B3|||Age||years|Mean|30.2|30.2|Standard Deviation|9.7|9.7|||
3603037|NCT02945254|3454912|B2|||Age||years|Mean|31.6|31.6|Standard Deviation|10.4|10.4|||
3603038|NCT02945254|3454913|B1|||Age||years|Mean|28.5|28.5|Standard Deviation|9.1|9.1|||
3603039|NCT02943226|3454922|B3|||Abdominal transverse (left-right) diameter at lower kidneys||centimeters|Mean|37.1|37.1|Standard Deviation|6.1|6.1|||
3603040|NCT02943226|3454923|B2|||Abdominal transverse (left-right) diameter at lower kidneys||centimeters|Mean|37.0|37.0|Standard Deviation|5.7|5.7|||
3603041|NCT02943226|3454924|B1|||Abdominal transverse (left-right) diameter at lower kidneys||centimeters|Mean|38.7|38.7|Standard Deviation|7.9|7.9|||
3603042|NCT02943226|3454922|B3|||Abdominal anterioposterior diameter at lower kidneys||centimeters|Mean|26.8|26.8|Standard Deviation|4.7|4.7|||
3603043|NCT02943226|3454923|B2|||Abdominal anterioposterior diameter at lower kidneys||centimeters|Mean|26.6|26.6|Standard Deviation|4.4|4.4|||
3603044|NCT02943226|3454924|B1|||Abdominal anterioposterior diameter at lower kidneys||centimeters|Mean|27.0|27.0|Standard Deviation|5.1|5.1|||
3603045|NCT02943226|3454922|B3|United States||Region of Enrollment||participants|Number|61|61.0||||||
3603046|NCT02943226|3454923|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3603047|NCT02943226|3454924|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
3603048|NCT02943226|3454922|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3603049|NCT02943226|3454922|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3603050|NCT02943226|3454923|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3603051|NCT02943226|3454924|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3603052|NCT02943226|3454922|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3603053|NCT02943226|3454923|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3603054|NCT02943226|3454924|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3603055|NCT02943226|3454922|B3|||Age||years|Mean|51.9|51.9|Standard Deviation|12.5|12.5|||
3603056|NCT02943226|3454923|B2|||Age||years|Mean|52.9|52.9|Standard Deviation|13.8|13.8|||
3603057|NCT02943226|3454924|B1|||Age||years|Mean|50.8|50.8|Standard Deviation|11.2|11.2|||
3603058|NCT02943213|3454941|B1|South Africa||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3603059|NCT02943213|3454941|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3603060|NCT02943213|3454941|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3603061|NCT02943213|3454941|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3603062|NCT02943213|3454941|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3603063|NCT02943213|3454941|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3603064|NCT02943213|3454941|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3603065|NCT02943213|3454941|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3603066|NCT02941692|3454969|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603067|NCT02941692|3454970|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603068|NCT02941692|3454971|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603069|NCT02941692|3454969|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3603070|NCT02941692|3454970|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3603071|NCT02941692|3454971|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603072|NCT02941692|3454969|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3603073|NCT02941692|3454970|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3603074|NCT02941692|3454971|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3603075|NCT02941692|3454969|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3603076|NCT02941692|3454970|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3603077|NCT02941692|3454971|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3603078|NCT02941692|3454969|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603079|NCT02941692|3454970|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603080|NCT02941692|3454971|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603081|NCT02941692|3454969|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3603082|NCT02941692|3454970|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603083|NCT02941692|3454971|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3603084|NCT02941692|3454969|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3603085|NCT02941692|3454970|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3603086|NCT02941692|3454971|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3603087|NCT02941692|3454969|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3603088|NCT02941692|3454970|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3603089|NCT02941692|3454971|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3603090|NCT02941692|3454969|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3603091|NCT02941692|3454970|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3603092|NCT02941692|3454971|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3603093|NCT02941692|3454969|B3|||Age||years|Mean|32.08|32.08|Standard Deviation|9.88|9.88|||
3603094|NCT02941692|3454970|B2|||Age||years|Mean|32.21|32.21|Standard Deviation|9.73|9.73|||
3603095|NCT02941692|3454971|B1|||Age||years|Mean|31.97|31.97|Standard Deviation|10.17|10.17|||
3603096|NCT02941640|3454980|B5||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3603097|NCT02941640|3454981|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3603098|NCT02941640|3454982|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3603099|NCT02941640|3454983|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3603100|NCT02941640|3454984|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3603101|NCT02941640|3454980|B5||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3603102|NCT02941640|3454981|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3603103|NCT02941640|3454982|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3603104|NCT02941640|3454983|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3603105|NCT02941640|3454984|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3603106|NCT02941640|3454980|B5|||Age||years|Mean|31.07|31.07|Standard Deviation|13.50|13.5|||
3603107|NCT02941640|3454981|B4|||Age||years|Mean|29.53|29.53|Standard Deviation|14.65|14.65|||
3603108|NCT02941640|3454982|B3|||Age||years|Mean|32.63|32.63|Standard Deviation|13.97|13.97|||
3603109|NCT02941640|3454983|B2|||Age||years|Mean|30.93|30.93|Standard Deviation|12.34|12.34|||
3603110|NCT02941640|3454984|B1|||Age||years|Mean|31.17|31.17|Standard Deviation|13.45|13.45|||
3603111|NCT02940522|3455017|B3|United States||Region of Enrollment||participants|Number|120|120.0||||||
3603112|NCT02940522|3455018|B2|United States||Region of Enrollment||participants|Number|61|61.0||||||
3603113|NCT02940522|3455019|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
3603114|NCT02940522|3455017|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3603115|NCT02940522|3455018|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3603116|NCT02940522|3455019|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3603117|NCT02940522|3455017|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3603118|NCT02940522|3455018|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3603119|NCT02940522|3455019|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3603120|NCT02940522|3455017|B3|||Age||years|Mean|58.4|58.4|Standard Deviation|6.05|6.05|||
3603121|NCT02940522|3455018|B2|||Age||years|Mean|57.0|57.0|Standard Deviation|5.68|5.68|||
3603122|NCT02940522|3455019|B1|||Age||years|Mean|59.7|59.7|Standard Deviation|6.16|6.16|||
3603123|NCT02940522|3455017|B3||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3603124|NCT02940522|3455018|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3603125|NCT02940522|3455019|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3603126|NCT02940522|3455017|B3||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
3603127|NCT02940522|3455018|B2||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
3603128|NCT02940522|3455019|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3603129|NCT02940522|3455017|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3603130|NCT02940522|3455018|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3603131|NCT02940522|3455019|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3603132|NCT02939170|3455036|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3603133|NCT02939170|3455037|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3603134|NCT02939170|3455038|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3603135|NCT02939170|3455036|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3603136|NCT02939170|3455037|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3603137|NCT02939170|3455038|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3603138|NCT02939170|3455036|B3|||Age||years|Mean|36.2|36.2|Standard Deviation|9.71|9.71|||
3603139|NCT02939170|3455037|B2|||Age||years|Mean|36.1|36.1|Standard Deviation|10.07|10.07|||
3603140|NCT02939170|3455038|B1|||Age||years|Mean|36.2|36.2|Standard Deviation|9.47|9.47|||
3603141|NCT02938052|3455050|B1|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3603142|NCT02938052|3455050|B1|Race|Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3603143|NCT02938052|3455050|B1|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3603144|NCT02938052|3455050|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3603145|NCT02938052|3455050|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3603146|NCT02938052|3455050|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3603147|NCT02938052|3455050|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3603148|NCT02938052|3455050|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3603149|NCT02938052|3455050|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3603150|NCT02937870|3455069|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603151|NCT02937870|3455069|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3603152|NCT02937870|3455069|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3603153|NCT02937870|3455069|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3603154|NCT02937870|3455069|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603155|NCT02937870|3455069|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603156|NCT02937870|3455069|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603157|NCT02937870|3455069|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3603158|NCT02937870|3455069|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3603159|NCT02937870|3455069|B1|||Age||years|Mean|64.9|64.9|Standard Deviation|5.90|5.9|||
3603160|NCT02937766|3455085|B3|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3603161|NCT02937766|3455086|B2|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3603162|NCT02937766|3455087|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3603163|NCT02937766|3455085|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3603164|NCT02937766|3455086|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3603165|NCT02937766|3455087|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3603166|NCT02937766|3455085|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3603167|NCT02937766|3455086|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3603168|NCT02937766|3455087|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3603169|NCT02937766|3455085|B3|||Age||years|Mean|57.9|57.9|Standard Deviation|5.55|5.55|||
3603170|NCT02937766|3455086|B2|||Age||years|Mean|56.5|56.5|Standard Deviation|4.23|4.23|||
3603171|NCT02937766|3455087|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|6.39|6.39|||
3603172|NCT02937766|3455085|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3603173|NCT02937766|3455086|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3603174|NCT02937766|3455087|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3603175|NCT02937766|3455085|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3603176|NCT02937766|3455086|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3603177|NCT02937766|3455087|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3603178|NCT02937766|3455085|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3603179|NCT02937766|3455086|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3603180|NCT02937766|3455087|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3603181|NCT02937623|3455098|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603182|NCT02937623|3455099|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603183|NCT02937623|3455100|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603184|NCT02937623|3455098|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3603185|NCT02937623|3455099|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3603186|NCT02937623|3455100|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3603187|NCT02937623|3455098|B3||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3603188|NCT02937623|3455099|B2||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3603189|NCT02937623|3455100|B1||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3603190|NCT02937623|3455098|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3603191|NCT02937623|3455099|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3603192|NCT02937623|3455100|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3603193|NCT02937623|3455098|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3603194|NCT02937623|3455099|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3603195|NCT02937623|3455100|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3603196|NCT02937623|3455098|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3603197|NCT02937623|3455099|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603198|NCT02937623|3455100|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3603199|NCT02937623|3455098|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603200|NCT02937623|3455099|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603201|NCT02937623|3455100|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603202|NCT02937623|3455098|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3603203|NCT02937623|3455099|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3603204|NCT02937623|3455100|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3603205|NCT02937623|3455098|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3603206|NCT02937623|3455099|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3603207|NCT02937623|3455100|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3603208|NCT02937623|3455098|B3|||Age||years|Mean|38.2|38.2|Standard Deviation|11.52|11.52|||
3603209|NCT02937623|3455099|B2|||Age||years|Mean|38.8|38.8|Standard Deviation|11.36|11.36|||
3603210|NCT02937623|3455100|B1|||Age||years|Mean|37.6|37.6|Standard Deviation|11.75|11.75|||
3603211|NCT02937506|3455113|B3||Male|Sex: Female, Male||Participants|Count of Participants|315|315.0||||||
3603212|NCT02937506|3455114|B2||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3603213|NCT02937506|3455115|B1||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3603214|NCT02937506|3455113|B3||Female|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
3603215|NCT02937506|3455114|B2||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3603216|NCT02937506|3455115|B1||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3603217|NCT02937506|3455113|B3|||Age|The age of the participant in completed years.|Years|Mean|61.2|61.2|Standard Deviation|9.6|9.6|||
3603218|NCT02937506|3455114|B2|||Age|The age of the participant in completed years.|Years|Mean|61.0|61.0|Standard Deviation|9.4|9.4|||
3603219|NCT02937506|3455115|B1|||Age|The age of the participant in completed years.|Years|Mean|61.4|61.4|Standard Deviation|9.8|9.8|||
3603220|NCT02936648|3455122|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|683|683.0||||||
3603221|NCT02936648|3455122|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603222|NCT02936648|3455122|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1470|1470.0||||||
3603223|NCT02936648|3455122|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3603224|NCT02936648|3455122|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603225|NCT02936648|3455122|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603226|NCT02936648|3455122|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603227|NCT02936648|3455122|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|654|654.0||||||
3603228|NCT02936648|3455122|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1526|1526.0||||||
3603229|NCT02936648|3455122|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3603230|NCT02936648|3455122|B1||Male|Sex: Female, Male||Participants|Count of Participants|2073|2073.0||||||
3603231|NCT02936648|3455122|B1||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3603232|NCT02936648|3455122|B1|Age|>60|Age, Customized||Participants|Count of Participants|1704|1704.0||||||
3603233|NCT02936648|3455122|B1|Age|<60|Age, Customized||Participants|Count of Participants|505|505.0||||||
3603234|NCT02935894|3455126|B1|||Perceived Exercise Intensity|Based on Physical Activity Intensity guidelines published by the Centers for Disease Control and Prevention. Intensity is based on an arbitrary scale where 0 = Sedentary, 1 = Light, 2 = Moderate, 3 = Strenuous|units on a scale|Mean|1.6|1.6|Standard Deviation|0.5|0.5|||
3603235|NCT02935894|3455126|B1|||Body Mass Index||kilograms per square meter|Mean|25.8|25.8|Standard Deviation|5.0|5.0|||
3603236|NCT02935894|3455126|B1|||Weight||kilograms|Mean|82.6|82.6|Standard Deviation|15.9|15.9|||
3603237|NCT02935894|3455126|B1|||Height||centimeters|Mean|179.2|179.2|Standard Deviation|6.2|6.2|||
3603238|NCT02935894|3455126|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3603239|NCT02935894|3455126|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3603240|NCT02935894|3455126|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3603241|NCT02935894|3455126|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3603242|NCT02935894|3455126|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3603243|NCT02935894|3455126|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3603244|NCT02935036|3455137|B3|||Body Mass Index (BMI)||kg/m^2|Mean|25.676|25.676|Standard Deviation|6.7730|6.773|||
3603245|NCT02935036|3455138|B2|||Body Mass Index (BMI)||kg/m^2|Mean|26.157|26.157|Standard Deviation|6.8472|6.8472|||
3603246|NCT02935036|3455139|B1|||Body Mass Index (BMI)||kg/m^2|Mean|25.210|25.21|Standard Deviation|6.6911|6.6911|||
3603247|NCT02935036|3455137|B3|United States||Region of Enrollment||participants|Number|294|294.0||||||
3603248|NCT02935036|3455138|B2|United States||Region of Enrollment||participants|Number|147|147.0||||||
3603249|NCT02935036|3455139|B1|United States||Region of Enrollment||participants|Number|147|147.0||||||
3603250|NCT02935036|3455137|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603251|NCT02935036|3455138|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603252|NCT02935036|3455139|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603253|NCT02935036|3455137|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3603254|NCT02935036|3455138|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3603255|NCT02935036|3455139|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3603256|NCT02935036|3455137|B3||White|Race (NIH/OMB)||Participants|Count of Participants|194|194.0||||||
3603257|NCT02935036|3455138|B2||White|Race (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
3603258|NCT02935036|3455139|B1||White|Race (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
3603259|NCT02935036|3455137|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
3603260|NCT02935036|3455138|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3603261|NCT02935036|3455139|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3603262|NCT02935036|3455137|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603263|NCT02935036|3455138|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603264|NCT02935036|3455139|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603265|NCT02935036|3455137|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3603266|NCT02935036|3455138|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3603267|NCT02935036|3455139|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3603268|NCT02935036|3455137|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603269|NCT02935036|3455138|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603270|NCT02935036|3455139|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603271|NCT02935036|3455137|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603272|NCT02935036|3455138|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603273|NCT02935036|3455139|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603274|NCT02935036|3455137|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|143|143.0||||||
3603275|NCT02935036|3455138|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3603276|NCT02935036|3455139|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3603277|NCT02935036|3455137|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
3603278|NCT02935036|3455138|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3603279|NCT02935036|3455139|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3603280|NCT02935036|3455137|B3||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3603281|NCT02935036|3455138|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3603282|NCT02935036|3455139|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3603283|NCT02935036|3455137|B3||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
3603284|NCT02935036|3455138|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3603285|NCT02935036|3455139|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3603286|NCT02935036|3455137|B3|||Age||years|Mean|22.2|22.2|Standard Deviation|8.48|8.48|||
3603287|NCT02935036|3455138|B2|||Age||years|Mean|22.4|22.4|Standard Deviation|8.7|8.7|||
3603288|NCT02935036|3455139|B1|||Age||years|Mean|22.1|22.1|Standard Deviation|8.29|8.29|||
3603289|NCT02935036|3455137|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3603290|NCT02935036|3455138|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3603291|NCT02935036|3455139|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3603292|NCT02935036|3455137|B3||Between 18 and 65 years|Age||Participants|Count of Participants|172|172.0||||||
3603293|NCT02935036|3455138|B2||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
3603294|NCT02935036|3455139|B1||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
3603295|NCT02935036|3455137|B3||<=18 years|Age||Participants|Count of Participants|115|115.0||||||
3603296|NCT02935036|3455138|B2||<=18 years|Age||Participants|Count of Participants|58|58.0||||||
3603297|NCT02935036|3455139|B1||<=18 years|Age||Participants|Count of Participants|57|57.0||||||
3603298|NCT02934698|3455150|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3603299|NCT02934698|3455150|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603300|NCT02934698|3455150|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603301|NCT02934698|3455150|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3603302|NCT02934698|3455150|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603303|NCT02934698|3455150|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603304|NCT02934698|3455150|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603305|NCT02934698|3455150|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603306|NCT02934698|3455150|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603307|NCT02934698|3455150|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3603308|NCT02934698|3455150|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603309|NCT02934698|3455150|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3603310|NCT02934698|3455150|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3603311|NCT02934698|3455150|B1|||Age||years|Mean|37|37.0|Full Range|||36.0|38.0|
3603312|NCT02934347|3455156|B3|Trainee||Grade of intubating anaesthetist|"Senior anaesthetists were permanent fulled trained members of staff capable of independent practice.~Trainee anaesthetists were on approved training programmes, required supervision by a nominated senior anaesthetist and rotated to Glan Clwyd Hospital for a fixed period of training."|participants|Number|244|244.0||||||
3603313|NCT02934347|3455157|B2|Trainee||Grade of intubating anaesthetist|"Senior anaesthetists were permanent fulled trained members of staff capable of independent practice.~Trainee anaesthetists were on approved training programmes, required supervision by a nominated senior anaesthetist and rotated to Glan Clwyd Hospital for a fixed period of training."|participants|Number|143|143.0||||||
3603314|NCT02934347|3455158|B1|Trainee||Grade of intubating anaesthetist|"Senior anaesthetists were permanent fulled trained members of staff capable of independent practice.~Trainee anaesthetists were on approved training programmes, required supervision by a nominated senior anaesthetist and rotated to Glan Clwyd Hospital for a fixed period of training."|participants|Number|101|101.0||||||
3603315|NCT02934347|3455156|B3|Not recorded||Grade of intubating anaesthetist|"Senior anaesthetists were permanent fulled trained members of staff capable of independent practice.~Trainee anaesthetists were on approved training programmes, required supervision by a nominated senior anaesthetist and rotated to Glan Clwyd Hospital for a fixed period of training."|participants|Number|1|1.0||||||
3603316|NCT02934347|3455157|B2|Not recorded||Grade of intubating anaesthetist|"Senior anaesthetists were permanent fulled trained members of staff capable of independent practice.~Trainee anaesthetists were on approved training programmes, required supervision by a nominated senior anaesthetist and rotated to Glan Clwyd Hospital for a fixed period of training."|participants|Number|0|0.0||||||
3603317|NCT02934347|3455158|B1|Not recorded||Grade of intubating anaesthetist|"Senior anaesthetists were permanent fulled trained members of staff capable of independent practice.~Trainee anaesthetists were on approved training programmes, required supervision by a nominated senior anaesthetist and rotated to Glan Clwyd Hospital for a fixed period of training."|participants|Number|1|1.0||||||
3603318|NCT02934347|3455156|B3|Senior||Grade of intubating anaesthetist|"Senior anaesthetists were permanent fulled trained members of staff capable of independent practice.~Trainee anaesthetists were on approved training programmes, required supervision by a nominated senior anaesthetist and rotated to Glan Clwyd Hospital for a fixed period of training."|participants|Number|536|536.0||||||
3603480|NCT02933866|3455212|B1|||Age||years|Mean|50.9|50.9|Standard Deviation|15.9|15.9|||
3603319|NCT02934347|3455157|B2|Senior||Grade of intubating anaesthetist|"Senior anaesthetists were permanent fulled trained members of staff capable of independent practice.~Trainee anaesthetists were on approved training programmes, required supervision by a nominated senior anaesthetist and rotated to Glan Clwyd Hospital for a fixed period of training."|participants|Number|264|264.0||||||
3603320|NCT02934347|3455158|B1|Senior||Grade of intubating anaesthetist|"Senior anaesthetists were permanent fulled trained members of staff capable of independent practice.~Trainee anaesthetists were on approved training programmes, required supervision by a nominated senior anaesthetist and rotated to Glan Clwyd Hospital for a fixed period of training."|participants|Number|272|272.0||||||
3603321|NCT02934347|3455156|B3|Not recorded||Type of surgery||participants|Number|1|1.0||||||
3603322|NCT02934347|3455157|B2|Not recorded||Type of surgery||participants|Number|0|0.0||||||
3603323|NCT02934347|3455158|B1|Not recorded||Type of surgery||participants|Number|1|1.0||||||
3603324|NCT02934347|3455156|B3|Vascular||Type of surgery||participants|Number|6|6.0||||||
3603325|NCT02934347|3455157|B2|Vascular||Type of surgery||participants|Number|4|4.0||||||
3603326|NCT02934347|3455158|B1|Vascular||Type of surgery||participants|Number|2|2.0||||||
3603327|NCT02934347|3455156|B3|Trauma||Type of surgery||participants|Number|22|22.0||||||
3603328|NCT02934347|3455157|B2|Trauma||Type of surgery||participants|Number|18|18.0||||||
3603329|NCT02934347|3455158|B1|Trauma||Type of surgery||participants|Number|4|4.0||||||
3603330|NCT02934347|3455156|B3|Facio-Maxillary||Type of surgery||participants|Number|72|72.0||||||
3603331|NCT02934347|3455157|B2|Facio-Maxillary||Type of surgery||participants|Number|62|62.0||||||
3603332|NCT02934347|3455158|B1|Facio-Maxillary||Type of surgery||participants|Number|10|10.0||||||
3603333|NCT02934347|3455156|B3|Orthopaedics||Type of surgery||participants|Number|15|15.0||||||
3603334|NCT02934347|3455157|B2|Orthopaedics||Type of surgery||participants|Number|3|3.0||||||
3603335|NCT02934347|3455158|B1|Orthopaedics||Type of surgery||participants|Number|12|12.0||||||
3603336|NCT02934347|3455156|B3|Ophthalmology||Type of surgery||participants|Number|1|1.0||||||
3603337|NCT02934347|3455157|B2|Ophthalmology||Type of surgery||participants|Number|1|1.0||||||
3603338|NCT02934347|3455158|B1|Ophthalmology||Type of surgery||participants|Number|0|0.0||||||
3603339|NCT02934347|3455156|B3|ENT||Type of surgery||participants|Number|67|67.0||||||
3603340|NCT02934347|3455157|B2|ENT||Type of surgery||participants|Number|43|43.0||||||
3603341|NCT02934347|3455158|B1|ENT||Type of surgery||participants|Number|24|24.0||||||
3603342|NCT02934347|3455156|B3|Urology||Type of surgery||participants|Number|48|48.0||||||
3603343|NCT02934347|3455157|B2|Urology||Type of surgery||participants|Number|19|19.0||||||
3603344|NCT02934347|3455158|B1|Urology||Type of surgery||participants|Number|29|29.0||||||
3603345|NCT02934347|3455156|B3|Gynaecology||Type of surgery||participants|Number|68|68.0||||||
3603346|NCT02934347|3455157|B2|Gynaecology||Type of surgery||participants|Number|24|24.0||||||
3603347|NCT02934347|3455158|B1|Gynaecology||Type of surgery||participants|Number|44|44.0||||||
3603348|NCT02934347|3455156|B3|General||Type of surgery||participants|Number|481|481.0||||||
3603349|NCT02934347|3455157|B2|General||Type of surgery||participants|Number|233|233.0||||||
3603350|NCT02934347|3455158|B1|General||Type of surgery||participants|Number|248|248.0||||||
3603351|NCT02934347|3455156|B3|||BMI||Kg/m^2|Mean|28.2|28.2|Standard Deviation|5.6|5.6|||
3603352|NCT02934347|3455157|B2|||BMI||Kg/m^2|Mean|28|28.0|Standard Deviation|5.8|5.8|||
3603353|NCT02934347|3455158|B1|||BMI||Kg/m^2|Mean|28.5|28.5|Standard Deviation|5.5|5.5|||
3603354|NCT02934347|3455156|B3|United Kingdom||Region of Enrollment||participants|Number|781|781.0||||||
3603355|NCT02934347|3455157|B2|United Kingdom||Region of Enrollment||participants|Number|407|407.0||||||
3603356|NCT02934347|3455158|B1|United Kingdom||Region of Enrollment||participants|Number|374|374.0||||||
3603357|NCT02934347|3455156|B3||Male|Sex: Female, Male||Participants|Count of Participants|374|374.0||||||
3603358|NCT02934347|3455157|B2||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3603359|NCT02934347|3455158|B1||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
3603360|NCT02934347|3455156|B3||Female|Sex: Female, Male||Participants|Count of Participants|406|406.0||||||
3603361|NCT02934347|3455157|B2||Female|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
3603362|NCT02934347|3455158|B1||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3603363|NCT02934347|3455156|B3|||Age||years|Mean|56.6|56.6|Standard Deviation|17.2|17.2|||
3603364|NCT02934347|3455157|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|16.9|16.9|||
3603365|NCT02934347|3455158|B1|||Age||years|Mean|57.4|57.4|Standard Deviation|17.6|17.6|||
3603366|NCT02933879|3455171|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603367|NCT02933879|3455172|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603368|NCT02933879|3455173|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603369|NCT02933879|3455174|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603370|NCT02933879|3455171|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603371|NCT02933879|3455172|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603372|NCT02933879|3455173|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603373|NCT02933879|3455174|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603374|NCT02933879|3455171|B4||White|Race (NIH/OMB)||Participants|Count of Participants|157|157.0||||||
3603375|NCT02933879|3455172|B3||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3603376|NCT02933879|3455173|B2||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3603377|NCT02933879|3455174|B1||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3603378|NCT02933879|3455171|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3603379|NCT02933879|3455172|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3603380|NCT02933879|3455173|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3603381|NCT02933879|3455174|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3603382|NCT02933879|3455171|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603383|NCT02933879|3455172|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603384|NCT02933879|3455173|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603385|NCT02933879|3455174|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603386|NCT02933879|3455171|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603387|NCT02933879|3455172|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603388|NCT02933879|3455173|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603389|NCT02933879|3455174|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603390|NCT02933879|3455171|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603391|NCT02933879|3455172|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603392|NCT02933879|3455173|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603393|NCT02933879|3455174|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603394|NCT02933879|3455171|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603395|NCT02933879|3455172|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603396|NCT02933879|3455173|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603397|NCT02933879|3455174|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603398|NCT02933879|3455171|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3603399|NCT02933879|3455172|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3603400|NCT02933879|3455173|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3603401|NCT02933879|3455174|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3603402|NCT02933879|3455171|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|118|118.0||||||
3603403|NCT02933879|3455172|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3603404|NCT02933879|3455173|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3603405|NCT02933879|3455174|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3603406|NCT02933879|3455171|B4||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3603407|NCT02933879|3455172|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3603408|NCT02933879|3455173|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3603409|NCT02933879|3455174|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3603410|NCT02933879|3455171|B4||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3603411|NCT02933879|3455172|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3603412|NCT02933879|3455173|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3603413|NCT02933879|3455174|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3603414|NCT02933879|3455171|B4|||Age||years|Mean|51.8|51.8|Standard Deviation|14.2|14.2|||
3603415|NCT02933879|3455172|B3|||Age||years|Mean|50.8|50.8|Standard Deviation|12.6|12.6|||
3603416|NCT02933879|3455173|B2|||Age||years|Mean|53.1|53.1|Standard Deviation|14.7|14.7|||
3603417|NCT02933879|3455174|B1|||Age||years|Mean|51.6|51.6|Standard Deviation|15.0|15.0|||
3603418|NCT02933866|3455210|B3||> 5 Years|Number of months and/or years patient has suffered from symptoms caused by scalp psoriasis||Participants|Count of Participants|194|194.0||||||
3603419|NCT02933866|3455211|B2||> 5 Years|Number of months and/or years patient has suffered from symptoms caused by scalp psoriasis||Participants|Count of Participants|92|92.0||||||
3603420|NCT02933866|3455212|B1||> 5 Years|Number of months and/or years patient has suffered from symptoms caused by scalp psoriasis||Participants|Count of Participants|102|102.0||||||
3603421|NCT02933866|3455210|B3||> 3 Years And <= 5 Years|Number of months and/or years patient has suffered from symptoms caused by scalp psoriasis||Participants|Count of Participants|50|50.0||||||
3603422|NCT02933866|3455211|B2||> 3 Years And <= 5 Years|Number of months and/or years patient has suffered from symptoms caused by scalp psoriasis||Participants|Count of Participants|31|31.0||||||
3603423|NCT02933866|3455212|B1||> 3 Years And <= 5 Years|Number of months and/or years patient has suffered from symptoms caused by scalp psoriasis||Participants|Count of Participants|19|19.0||||||
3603424|NCT02933866|3455210|B3||> 1 Year And <= 3 Years|Number of months and/or years patient has suffered from symptoms caused by scalp psoriasis||Participants|Count of Participants|71|71.0||||||
3603425|NCT02933866|3455211|B2||> 1 Year And <= 3 Years|Number of months and/or years patient has suffered from symptoms caused by scalp psoriasis||Participants|Count of Participants|33|33.0||||||
3603426|NCT02933866|3455212|B1||> 1 Year And <= 3 Years|Number of months and/or years patient has suffered from symptoms caused by scalp psoriasis||Participants|Count of Participants|38|38.0||||||
3603427|NCT02933866|3455210|B3||> 6 Months And <= 1 Year|Number of months and/or years patient has suffered from symptoms caused by scalp psoriasis||Participants|Count of Participants|14|14.0||||||
3603481|NCT02933528|3455219|B1|||Percent Scalp Affected with Plaque Psoriasis||percent of scalp|Mean|42.2|42.2|Standard Deviation|22.6|22.6|||
3603428|NCT02933866|3455211|B2||> 6 Months And <= 1 Year|Number of months and/or years patient has suffered from symptoms caused by scalp psoriasis||Participants|Count of Participants|6|6.0||||||
3603429|NCT02933866|3455212|B1||> 6 Months And <= 1 Year|Number of months and/or years patient has suffered from symptoms caused by scalp psoriasis||Participants|Count of Participants|8|8.0||||||
3603430|NCT02933866|3455210|B3||> 3 Months And <= 6 Months|Number of months and/or years patient has suffered from symptoms caused by scalp psoriasis||Participants|Count of Participants|4|4.0||||||
3603431|NCT02933866|3455211|B2||> 3 Months And <= 6 Months|Number of months and/or years patient has suffered from symptoms caused by scalp psoriasis||Participants|Count of Participants|3|3.0||||||
3603432|NCT02933866|3455212|B1||> 3 Months And <= 6 Months|Number of months and/or years patient has suffered from symptoms caused by scalp psoriasis||Participants|Count of Participants|1|1.0||||||
3603433|NCT02933866|3455210|B3||<= 3 Months|Number of months and/or years patient has suffered from symptoms caused by scalp psoriasis||Participants|Count of Participants|37|37.0||||||
3603434|NCT02933866|3455211|B2||<= 3 Months|Number of months and/or years patient has suffered from symptoms caused by scalp psoriasis||Participants|Count of Participants|19|19.0||||||
3603435|NCT02933866|3455212|B1||<= 3 Months|Number of months and/or years patient has suffered from symptoms caused by scalp psoriasis||Participants|Count of Participants|18|18.0||||||
3603436|NCT02933866|3455210|B3|||Percent Scalp Affected||percent|Mean|31.4|31.4|Standard Deviation|25.0|25.0|||
3603437|NCT02933866|3455211|B2|||Percent Scalp Affected||percent|Mean|29.2|29.2|Standard Deviation|23.8|23.8|||
3603438|NCT02933866|3455212|B1|||Percent Scalp Affected||percent|Mean|33.7|33.7|Standard Deviation|26.0|26.0|||
3603439|NCT02933866|3455210|B3|United States||Region of Enrollment||participants|Number|370|370.0||||||
3603440|NCT02933866|3455211|B2|United States||Region of Enrollment||participants|Number|184|184.0||||||
3603441|NCT02933866|3455212|B1|United States||Region of Enrollment||participants|Number|186|186.0||||||
3603442|NCT02933866|3455210|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3603443|NCT02933866|3455211|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3603444|NCT02933866|3455212|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3603445|NCT02933866|3455210|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603446|NCT02933866|3455211|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603447|NCT02933866|3455212|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603448|NCT02933866|3455210|B3||White|Race (NIH/OMB)||Participants|Count of Participants|338|338.0||||||
3603449|NCT02933866|3455211|B2||White|Race (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
3603450|NCT02933866|3455212|B1||White|Race (NIH/OMB)||Participants|Count of Participants|171|171.0||||||
3603451|NCT02933866|3455210|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3603452|NCT02933866|3455211|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3603453|NCT02933866|3455212|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3603454|NCT02933866|3455210|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3603455|NCT02933866|3455211|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3603456|NCT02933866|3455212|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3603457|NCT02933866|3455210|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3603458|NCT02933866|3455211|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3603459|NCT02933866|3455212|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3603460|NCT02933866|3455210|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603461|NCT02933866|3455211|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603462|NCT02933866|3455212|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603463|NCT02933866|3455210|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603464|NCT02933866|3455211|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603465|NCT02933866|3455212|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603466|NCT02933866|3455210|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|203|203.0||||||
3603467|NCT02933866|3455211|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
3603468|NCT02933866|3455212|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
3603469|NCT02933866|3455210|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
3603470|NCT02933866|3455211|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3603471|NCT02933866|3455212|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3603472|NCT02933866|3455210|B3||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3603473|NCT02933866|3455211|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3603474|NCT02933866|3455212|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3603475|NCT02933866|3455210|B3||Female|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
3603476|NCT02933866|3455211|B2||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3603477|NCT02933866|3455212|B1||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3603478|NCT02933866|3455210|B3|||Age||years|Mean|50.1|50.1|Standard Deviation|16.3|16.3|||
3603479|NCT02933866|3455211|B2|||Age||years|Mean|49.3|49.3|Standard Deviation|16.7|16.7|||
3603482|NCT02933528|3455219|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603483|NCT02933528|3455219|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603484|NCT02933528|3455219|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3603485|NCT02933528|3455219|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3603486|NCT02933528|3455219|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3603487|NCT02933528|3455219|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603488|NCT02933528|3455219|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603489|NCT02933528|3455219|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603490|NCT02933528|3455219|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3603491|NCT02933528|3455219|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3603492|NCT02933528|3455219|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3603493|NCT02933528|3455219|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3603494|NCT02933528|3455219|B1|||Age||years|Mean|48.8|48.8|Standard Deviation|17.9|17.9|||
3603495|NCT02933502|3455223|B1|||Percent Scalp Affected with Plaque Psoriasis||percent of scalp|Mean|28.3|28.3|Standard Deviation|2.9|2.9|||
3603496|NCT02933502|3455223|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603497|NCT02933502|3455223|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603498|NCT02933502|3455223|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3603499|NCT02933502|3455223|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3603500|NCT02933502|3455223|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603501|NCT02933502|3455223|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603502|NCT02933502|3455223|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603503|NCT02933502|3455223|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603504|NCT02933502|3455223|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3603505|NCT02933502|3455223|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3603506|NCT02933502|3455223|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3603507|NCT02933502|3455223|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3603508|NCT02933502|3455223|B1|||Age||years|Mean|15.0|15.0|Standard Deviation|1.7|1.7|||
3603509|NCT02933476|3455227|B1|||Disease Duration||years|Mean|5.718|5.718|Standard Deviation|2.694|2.694|||
3603510|NCT02933476|3455227|B1|||Unified Parkinson's disease Rating Scale, Part III|The Unified Parkinson's disease Rating Scale (UPDRS) has a total of four parts. We have used Part III which is the motor examination portion, excluding rigidity and speech. The total score ranges from 0 to 108. 108 represents the worst disability and 0 no disability|units on a scale|Mean|21|21.0|Standard Deviation|12.8|12.8|||
3603511|NCT02933476|3455227|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3603512|NCT02933476|3455227|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3603513|NCT02933476|3455227|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3603514|NCT02933476|3455227|B1|||Age||years|Mean|66|66.0|Standard Deviation|6.7|6.7|||
3603515|NCT02933476|3455227|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3603516|NCT02933476|3455227|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3603517|NCT02933476|3455227|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3603518|NCT02932904|3455234|B5|||Duration of Menstrual Cycle||days|Mean|28.4|28.4|Standard Deviation|5.75|5.75|||
3603519|NCT02932904|3455235|B4|||Duration of Menstrual Cycle||days|Mean|28.0|28.0|Standard Deviation|6.94|6.94|||
3603520|NCT02932904|3455236|B3|||Duration of Menstrual Cycle||days|Mean|28.2|28.2|Standard Deviation|7.07|7.07|||
3603521|NCT02932904|3455237|B2|||Duration of Menstrual Cycle||days|Mean|28.3|28.3|Standard Deviation|2.56|2.56|||
3603522|NCT02932904|3455238|B1|||Duration of Menstrual Cycle||days|Mean|28.9|28.9|Standard Deviation|5.35|5.35|||
3603523|NCT02932904|3455234|B5|||Duration of Menstruation||days|Mean|4.5|4.5|Standard Deviation|1.33|1.33|||
3603524|NCT02932904|3455235|B4|||Duration of Menstruation||days|Mean|4.6|4.6|Standard Deviation|1.37|1.37|||
3603525|NCT02932904|3455236|B3|||Duration of Menstruation||days|Mean|4.2|4.2|Standard Deviation|1.27|1.27|||
3603526|NCT02932904|3455237|B2|||Duration of Menstruation||days|Mean|4.4|4.4|Standard Deviation|1.27|1.27|||
3603527|NCT02932904|3455238|B1|||Duration of Menstruation||days|Mean|4.9|4.9|Standard Deviation|1.36|1.36|||
3603528|NCT02932904|3455234|B5|NA/Participant is male||Female Reproductive Status||Participants|Count of Participants|185|185.0||||||
3603529|NCT02932904|3455235|B4|NA/Participant is male||Female Reproductive Status||Participants|Count of Participants|49|49.0||||||
3603530|NCT02932904|3455236|B3|NA/Participant is male||Female Reproductive Status||Participants|Count of Participants|47|47.0||||||
3603531|NCT02932904|3455237|B2|NA/Participant is male||Female Reproductive Status||Participants|Count of Participants|43|43.0||||||
3603532|NCT02932904|3455238|B1|NA/Participant is male||Female Reproductive Status||Participants|Count of Participants|46|46.0||||||
3603533|NCT02932904|3455234|B5|Female of childbearing potential||Female Reproductive Status||Participants|Count of Participants|164|164.0||||||
3603534|NCT02932904|3455235|B4|Female of childbearing potential||Female Reproductive Status||Participants|Count of Participants|41|41.0||||||
3603535|NCT02932904|3455236|B3|Female of childbearing potential||Female Reproductive Status||Participants|Count of Participants|42|42.0||||||
3603536|NCT02932904|3455237|B2|Female of childbearing potential||Female Reproductive Status||Participants|Count of Participants|38|38.0||||||
3603537|NCT02932904|3455238|B1|Female of childbearing potential||Female Reproductive Status||Participants|Count of Participants|43|43.0||||||
3603538|NCT02932904|3455234|B5|Surgically sterile||Female Reproductive Status||Participants|Count of Participants|12|12.0||||||
3603539|NCT02932904|3455235|B4|Surgically sterile||Female Reproductive Status||Participants|Count of Participants|3|3.0||||||
3603540|NCT02932904|3455236|B3|Surgically sterile||Female Reproductive Status||Participants|Count of Participants|2|2.0||||||
3603541|NCT02932904|3455237|B2|Surgically sterile||Female Reproductive Status||Participants|Count of Participants|4|4.0||||||
3603542|NCT02932904|3455238|B1|Surgically sterile||Female Reproductive Status||Participants|Count of Participants|3|3.0||||||
3603543|NCT02932904|3455234|B5|Participant is an ex-smoker||Smoking Classification||Participants|Count of Participants|51|51.0||||||
3603544|NCT02932904|3455235|B4|Participant is an ex-smoker||Smoking Classification||Participants|Count of Participants|9|9.0||||||
3603545|NCT02932904|3455236|B3|Participant is an ex-smoker||Smoking Classification||Participants|Count of Participants|17|17.0||||||
3603546|NCT02932904|3455237|B2|Participant is an ex-smoker||Smoking Classification||Participants|Count of Participants|13|13.0||||||
3603547|NCT02932904|3455238|B1|Participant is an ex-smoker||Smoking Classification||Participants|Count of Participants|12|12.0||||||
3603548|NCT02932904|3455234|B5|Participant is a current smoker||Smoking Classification||Participants|Count of Participants|20|20.0||||||
3603549|NCT02932904|3455235|B4|Participant is a current smoker||Smoking Classification||Participants|Count of Participants|7|7.0||||||
3603550|NCT02932904|3455236|B3|Participant is a current smoker||Smoking Classification||Participants|Count of Participants|4|4.0||||||
3603551|NCT02932904|3455237|B2|Participant is a current smoker||Smoking Classification||Participants|Count of Participants|2|2.0||||||
3603552|NCT02932904|3455238|B1|Participant is a current smoker||Smoking Classification||Participants|Count of Participants|7|7.0||||||
3603553|NCT02932904|3455234|B5|Participant has never smoked||Smoking Classification||Participants|Count of Participants|290|290.0||||||
3603554|NCT02932904|3455235|B4|Participant has never smoked||Smoking Classification||Participants|Count of Participants|77|77.0||||||
3603555|NCT02932904|3455236|B3|Participant has never smoked||Smoking Classification||Participants|Count of Participants|70|70.0||||||
3603556|NCT02932904|3455237|B2|Participant has never smoked||Smoking Classification||Participants|Count of Participants|70|70.0||||||
3603557|NCT02932904|3455238|B1|Participant has never smoked||Smoking Classification||Participants|Count of Participants|73|73.0||||||
3603558|NCT02932904|3455234|B5|||Body Mass Index (BMI)|Body Mass Index = weight (kg)/[height (m)^2]|kg/m^2|Mean|26.26|26.26|Standard Deviation|4.062|4.062|||
3603559|NCT02932904|3455235|B4|||Body Mass Index (BMI)|Body Mass Index = weight (kg)/[height (m)^2]|kg/m^2|Mean|25.70|25.7|Standard Deviation|3.668|3.668|||
3603560|NCT02932904|3455236|B3|||Body Mass Index (BMI)|Body Mass Index = weight (kg)/[height (m)^2]|kg/m^2|Mean|26.77|26.77|Standard Deviation|4.306|4.306|||
3603561|NCT02932904|3455237|B2|||Body Mass Index (BMI)|Body Mass Index = weight (kg)/[height (m)^2]|kg/m^2|Mean|26.91|26.91|Standard Deviation|4.245|4.245|||
3603562|NCT02932904|3455238|B1|||Body Mass Index (BMI)|Body Mass Index = weight (kg)/[height (m)^2]|kg/m^2|Mean|25.72|25.72|Standard Deviation|3.925|3.925|||
3603563|NCT02932904|3455234|B5|||Weight||kg|Mean|77.56|77.56|Standard Deviation|15.192|15.192|||
3603564|NCT02932904|3455235|B4|||Weight||kg|Mean|75.12|75.12|Standard Deviation|13.282|13.282|||
3603565|NCT02932904|3455236|B3|||Weight||kg|Mean|78.67|78.67|Standard Deviation|14.850|14.85|||
3603566|NCT02932904|3455237|B2|||Weight||kg|Mean|80.19|80.19|Standard Deviation|16.808|16.808|||
3603567|NCT02932904|3455238|B1|||Weight||kg|Mean|76.49|76.49|Standard Deviation|15.523|15.523|||
3603568|NCT02932904|3455234|B5|||Height||cm|Mean|171.5|171.5|Standard Deviation|10.12|10.12|||
3603569|NCT02932904|3455235|B4|||Height||cm|Mean|170.8|170.8|Standard Deviation|10.04|10.04|||
3603570|NCT02932904|3455236|B3|||Height||cm|Mean|171.3|171.3|Standard Deviation|9.14|9.14|||
3603571|NCT02932904|3455237|B2|||Height||cm|Mean|172.1|172.1|Standard Deviation|10.59|10.59|||
3603572|NCT02932904|3455238|B1|||Height||cm|Mean|172.0|172.0|Standard Deviation|10.75|10.75|||
3603573|NCT02932904|3455234|B5|Non-white||Race Categories||Participants|Count of Participants|154|154.0||||||
3603574|NCT02932904|3455235|B4|Non-white||Race Categories||Participants|Count of Participants|38|38.0||||||
3603575|NCT02932904|3455236|B3|Non-white||Race Categories||Participants|Count of Participants|39|39.0||||||
3603576|NCT02932904|3455237|B2|Non-white||Race Categories||Participants|Count of Participants|36|36.0||||||
3603577|NCT02932904|3455238|B1|Non-white||Race Categories||Participants|Count of Participants|41|41.0||||||
3603578|NCT02932904|3455234|B5|White||Race Categories||Participants|Count of Participants|207|207.0||||||
3603579|NCT02932904|3455235|B4|White||Race Categories||Participants|Count of Participants|55|55.0||||||
3603580|NCT02932904|3455236|B3|White||Race Categories||Participants|Count of Participants|52|52.0||||||
3603581|NCT02932904|3455237|B2|White||Race Categories||Participants|Count of Participants|49|49.0||||||
3603582|NCT02932904|3455238|B1|White||Race Categories||Participants|Count of Participants|51|51.0||||||
3603583|NCT02932904|3455234|B5|> 28 Years||Median Age Categories||Participants|Count of Participants|168|168.0||||||
3603584|NCT02932904|3455235|B4|> 28 Years||Median Age Categories||Participants|Count of Participants|46|46.0||||||
3603585|NCT02932904|3455236|B3|> 28 Years||Median Age Categories||Participants|Count of Participants|39|39.0||||||
3603586|NCT02932904|3455237|B2|> 28 Years||Median Age Categories||Participants|Count of Participants|42|42.0||||||
3603587|NCT02932904|3455238|B1|> 28 Years||Median Age Categories||Participants|Count of Participants|41|41.0||||||
3603588|NCT02932904|3455234|B5|≤ 28 Years||Median Age Categories||Participants|Count of Participants|193|193.0||||||
3603589|NCT02932904|3455235|B4|≤ 28 Years||Median Age Categories||Participants|Count of Participants|47|47.0||||||
3603590|NCT02932904|3455236|B3|≤ 28 Years||Median Age Categories||Participants|Count of Participants|52|52.0||||||
3603591|NCT02932904|3455237|B2|≤ 28 Years||Median Age Categories||Participants|Count of Participants|43|43.0||||||
3603592|NCT02932904|3455238|B1|≤ 28 Years||Median Age Categories||Participants|Count of Participants|51|51.0||||||
3603593|NCT02932904|3455234|B5|United States||Region of Enrollment||Participants|Count of Participants|361|361.0||||||
3603594|NCT02932904|3455235|B4|United States||Region of Enrollment||Participants|Count of Participants|93|93.0||||||
3603595|NCT02932904|3455236|B3|United States||Region of Enrollment||Participants|Count of Participants|91|91.0||||||
3603596|NCT02932904|3455237|B2|United States||Region of Enrollment||Participants|Count of Participants|85|85.0||||||
3603597|NCT02932904|3455238|B1|United States||Region of Enrollment||Participants|Count of Participants|92|92.0||||||
3603598|NCT02932904|3455234|B5|Multiracial||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3603599|NCT02932904|3455235|B4|Multiracial||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3603600|NCT02932904|3455236|B3|Multiracial||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3603601|NCT02932904|3455237|B2|Multiracial||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3603602|NCT02932904|3455238|B1|Multiracial||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3603603|NCT02932904|3455234|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|207|207.0||||||
3603604|NCT02932904|3455235|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|55|55.0||||||
3603605|NCT02932904|3455236|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|52|52.0||||||
3603606|NCT02932904|3455237|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|49|49.0||||||
3603607|NCT02932904|3455238|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
3603608|NCT02932904|3455234|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3603609|NCT02932904|3455235|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3603610|NCT02932904|3455236|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3603611|NCT02932904|3455237|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3603612|NCT02932904|3455238|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3603613|NCT02932904|3455234|B5|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|124|124.0||||||
3603614|NCT02932904|3455235|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3603615|NCT02932904|3455236|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3603616|NCT02932904|3455237|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3603617|NCT02932904|3455238|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3603618|NCT02932904|3455234|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3603619|NCT02932904|3455235|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3603620|NCT02932904|3455236|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3603621|NCT02932904|3455237|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3603622|NCT02932904|3455238|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3603623|NCT02932904|3455234|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3603624|NCT02932904|3455235|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3603625|NCT02932904|3455236|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3603626|NCT02932904|3455237|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3603627|NCT02932904|3455238|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3603628|NCT02932904|3455234|B5|Non-Hispanic and Latino||Race/Ethnicity, Customized||Participants|Count of Participants|277|277.0||||||
3603629|NCT02932904|3455235|B4|Non-Hispanic and Latino||Race/Ethnicity, Customized||Participants|Count of Participants|75|75.0||||||
3603630|NCT02932904|3455236|B3|Non-Hispanic and Latino||Race/Ethnicity, Customized||Participants|Count of Participants|66|66.0||||||
3603631|NCT02932904|3455237|B2|Non-Hispanic and Latino||Race/Ethnicity, Customized||Participants|Count of Participants|65|65.0||||||
3603632|NCT02932904|3455238|B1|Non-Hispanic and Latino||Race/Ethnicity, Customized||Participants|Count of Participants|71|71.0||||||
3603633|NCT02932904|3455234|B5|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|84|84.0||||||
3603634|NCT02932904|3455235|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3603635|NCT02932904|3455236|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3603636|NCT02932904|3455237|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3603637|NCT02932904|3455238|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3603638|NCT02932904|3455234|B5||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
3603639|NCT02932904|3455235|B4||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3603640|NCT02932904|3455236|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3603641|NCT02932904|3455237|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3603642|NCT02932904|3455238|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3603643|NCT02932904|3455234|B5||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
3603644|NCT02932904|3455235|B4||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3603645|NCT02932904|3455236|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3603646|NCT02932904|3455237|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3603647|NCT02932904|3455238|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3603648|NCT02932904|3455234|B5|||Age||years|Mean|28.4|28.4|Standard Deviation|5.72|5.72|||
3603649|NCT02932904|3455235|B4|||Age||years|Mean|28.8|28.8|Standard Deviation|5.91|5.91|||
3603650|NCT02932904|3455236|B3|||Age||years|Mean|28.1|28.1|Standard Deviation|5.56|5.56|||
3603651|NCT02932904|3455237|B2|||Age||years|Mean|28.9|28.9|Standard Deviation|5.96|5.96|||
3603652|NCT02932904|3455238|B1|||Age||years|Mean|27.8|27.8|Standard Deviation|5.45|5.45|||
3603653|NCT02932891|3455276|B1|||Eczema Area and Severity Index (EASI) Score|The EASI is a composite score based on the severity of four different signs of atopic dermatitis (Erythema, Induration/Papulation/Edema, Lichenification, and Excoriation rated 0 to 3 in severity) in four different areas of the body (Head/Neck, Upper Limbs, Trunk, Lower Limbs) multiplied by the percent of that specific body area affected multiplied by a weighting factor. The minimum score would be 0 and the maximum score would be 72. To be eligible for participation in this study a patient must have an EASI of at least 15 at baseline. A higher EASI value represents a more severe case of eczema.|units on a scale|Mean|17.64|17.64|Standard Deviation|2.69|2.69|||
3603654|NCT02932891|3455276|B1||Severe Disease|Baseline IGA||Participants|Count of Participants|11|11.0||||||
3603655|NCT02932891|3455276|B1||Moderate Disease|Baseline IGA||Participants|Count of Participants|17|17.0||||||
3603656|NCT02932891|3455276|B1||Mild|Baseline IGA||Participants|Count of Participants|0|0.0||||||
3603657|NCT02932891|3455276|B1||Minimal|Baseline IGA||Participants|Count of Participants|0|0.0||||||
3603658|NCT02932891|3455276|B1||Clear|Baseline IGA||Participants|Count of Participants|0|0.0||||||
3603659|NCT02932891|3455276|B1|||Baseline Total BSA||meters squared|Mean|1.61|1.61|Standard Deviation|0.24|0.24|||
3603660|NCT02932891|3455276|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603661|NCT02932891|3455276|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603662|NCT02932891|3455276|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3603663|NCT02932891|3455276|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3603664|NCT02932891|3455276|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603665|NCT02932891|3455276|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603666|NCT02932891|3455276|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603667|NCT02932891|3455276|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603668|NCT02932891|3455276|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3603669|NCT02932891|3455276|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3603670|NCT02932891|3455276|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3603671|NCT02932891|3455276|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3603672|NCT02932891|3455276|B1|||Age||years|Mean|14.36|14.36|Standard Deviation|1.64|1.64|||
3603673|NCT02932878|3455280|B3||Severe|Baseline IGA||Participants|Count of Participants|0|0.0||||||
3603674|NCT02932878|3455281|B2||Severe|Baseline IGA||Participants|Count of Participants|0|0.0||||||
3603675|NCT02932878|3455282|B1||Severe|Baseline IGA||Participants|Count of Participants|0|0.0||||||
3603676|NCT02932878|3455280|B3||Moderate|Baseline IGA||Participants|Count of Participants|8|8.0||||||
3603677|NCT02932878|3455281|B2||Moderate|Baseline IGA||Participants|Count of Participants|0|0.0||||||
3603678|NCT02932878|3455282|B1||Moderate|Baseline IGA||Participants|Count of Participants|8|8.0||||||
3603679|NCT02932878|3455280|B3||Mild|Baseline IGA||Participants|Count of Participants|8|8.0||||||
3603680|NCT02932878|3455281|B2||Mild|Baseline IGA||Participants|Count of Participants|1|1.0||||||
3603681|NCT02932878|3455282|B1||Mild|Baseline IGA||Participants|Count of Participants|7|7.0||||||
3603682|NCT02932878|3455280|B3||Minimal|Baseline IGA||Participants|Count of Participants|0|0.0||||||
3603683|NCT02932878|3455281|B2||Minimal|Baseline IGA||Participants|Count of Participants|0|0.0||||||
3603684|NCT02932878|3455282|B1||Minimal|Baseline IGA||Participants|Count of Participants|0|0.0||||||
3603685|NCT02932878|3455280|B3||Clear|Baseline IGA||Participants|Count of Participants|0|0.0||||||
3603686|NCT02932878|3455281|B2||Clear|Baseline IGA||Participants|Count of Participants|0|0.0||||||
3603687|NCT02932878|3455282|B1||Clear|Baseline IGA||Participants|Count of Participants|0|0.0||||||
3603688|NCT02932878|3455280|B3|||Baseline Total BSA||meters squared|Mean|1.83|1.83|Standard Deviation|0.37|0.37|||
3603689|NCT02932878|3455281|B2|||Baseline Total BSA||meters squared|Mean|1.31|1.31|Standard Deviation|||||
3603690|NCT02932878|3455282|B1|||Baseline Total BSA||meters squared|Mean|1.86|1.86|Standard Deviation|0.35|0.35|||
3603691|NCT02932878|3455280|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603692|NCT02932878|3455281|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603693|NCT02932878|3455282|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603694|NCT02932878|3455280|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603695|NCT02932878|3455281|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603696|NCT02932878|3455282|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603697|NCT02932878|3455280|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3603698|NCT02932878|3455281|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3603699|NCT02932878|3455282|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3603700|NCT02932878|3455280|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3603701|NCT02932878|3455281|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603702|NCT02932878|3455282|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3603703|NCT02932878|3455280|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603704|NCT02932878|3455281|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603705|NCT02932878|3455282|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603706|NCT02932878|3455280|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603707|NCT02932878|3455281|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603708|NCT02932878|3455282|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603709|NCT02932878|3455280|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603710|NCT02932878|3455281|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603711|NCT02932878|3455282|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603712|NCT02932878|3455280|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603713|NCT02932878|3455281|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603714|NCT02932878|3455282|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603715|NCT02932878|3455280|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3603716|NCT02932878|3455281|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603717|NCT02932878|3455282|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3603718|NCT02932878|3455280|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3603719|NCT02932878|3455281|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3603720|NCT02932878|3455282|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3603721|NCT02932878|3455280|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3603722|NCT02932878|3455281|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3603723|NCT02932878|3455282|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3603724|NCT02932878|3455280|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3603725|NCT02932878|3455281|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3603726|NCT02932878|3455282|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3603727|NCT02932878|3455280|B3|||Age||years|Mean|14.69|14.69|Standard Deviation|2.55|2.55|||
3603728|NCT02932878|3455281|B2|||Age||years|Mean|8.00|8.0|Standard Deviation|||||
3603729|NCT02932878|3455282|B1|||Age||years|Mean|15.13|15.13|Standard Deviation|1.88|1.88|||
3603730|NCT02932462|3455289|B3|> 5 Years||Number of months and/or years patient has suffered from symptoms caused by scalp psoriasis||Participants|Count of Participants|234|234.0||||||
3603731|NCT02932462|3455290|B2|> 5 Years||Number of months and/or years patient has suffered from symptoms caused by scalp psoriasis||Participants|Count of Participants|118|118.0||||||
3603732|NCT02932462|3455291|B1|> 5 Years||Number of months and/or years patient has suffered from symptoms caused by scalp psoriasis||Participants|Count of Participants|116|116.0||||||
3603733|NCT02932462|3455289|B3|> 3 Years And <= 5 Years||Number of months and/or years patient has suffered from symptoms caused by scalp psoriasis||Participants|Count of Participants|57|57.0||||||
3603734|NCT02932462|3455290|B2|> 3 Years And <= 5 Years||Number of months and/or years patient has suffered from symptoms caused by scalp psoriasis||Participants|Count of Participants|28|28.0||||||
3603735|NCT02932462|3455291|B1|> 3 Years And <= 5 Years||Number of months and/or years patient has suffered from symptoms caused by scalp psoriasis||Participants|Count of Participants|29|29.0||||||
3603736|NCT02932462|3455289|B3|> 1 Year And <= 3 Years||Number of months and/or years patient has suffered from symptoms caused by scalp psoriasis||Participants|Count of Participants|56|56.0||||||
3603737|NCT02932462|3455290|B2|> 1 Year And <= 3 Years||Number of months and/or years patient has suffered from symptoms caused by scalp psoriasis||Participants|Count of Participants|29|29.0||||||
3603738|NCT02932462|3455291|B1|> 1 Year And <= 3 Years||Number of months and/or years patient has suffered from symptoms caused by scalp psoriasis||Participants|Count of Participants|27|27.0||||||
3603739|NCT02932462|3455289|B3|> 6 Months And <= 1 Year||Number of months and/or years patient has suffered from symptoms caused by scalp psoriasis||Participants|Count of Participants|19|19.0||||||
3603740|NCT02932462|3455290|B2|> 6 Months And <= 1 Year||Number of months and/or years patient has suffered from symptoms caused by scalp psoriasis||Participants|Count of Participants|11|11.0||||||
3603741|NCT02932462|3455291|B1|> 6 Months And <= 1 Year||Number of months and/or years patient has suffered from symptoms caused by scalp psoriasis||Participants|Count of Participants|8|8.0||||||
3603742|NCT02932462|3455289|B3|>3 Months And <= 6 Months||Number of months and/or years patient has suffered from symptoms caused by scalp psoriasis||Participants|Count of Participants|2|2.0||||||
3603743|NCT02932462|3455290|B2|>3 Months And <= 6 Months||Number of months and/or years patient has suffered from symptoms caused by scalp psoriasis||Participants|Count of Participants|1|1.0||||||
3603744|NCT02932462|3455291|B1|>3 Months And <= 6 Months||Number of months and/or years patient has suffered from symptoms caused by scalp psoriasis||Participants|Count of Participants|1|1.0||||||
3603745|NCT02932462|3455289|B3|<= 3 Months||Number of months and/or years patient has suffered from symptoms caused by scalp psoriasis||Participants|Count of Participants|4|4.0||||||
3603843|NCT02929823|3455583|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3603746|NCT02932462|3455290|B2|<= 3 Months||Number of months and/or years patient has suffered from symptoms caused by scalp psoriasis||Participants|Count of Participants|2|2.0||||||
3603747|NCT02932462|3455291|B1|<= 3 Months||Number of months and/or years patient has suffered from symptoms caused by scalp psoriasis||Participants|Count of Participants|2|2.0||||||
3603748|NCT02932462|3455289|B3|||Percent Scalp Affected||percent|Mean|33.0|33.0|Standard Deviation|25.9|25.9|||
3603749|NCT02932462|3455290|B2|||Percent Scalp Affected||percent|Mean|33.5|33.5|Standard Deviation|25.3|25.3|||
3603750|NCT02932462|3455291|B1|||Percent Scalp Affected||percent|Mean|32.4|32.4|Standard Deviation|26.6|26.6|||
3603751|NCT02932462|3455289|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3603752|NCT02932462|3455290|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3603753|NCT02932462|3455291|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3603754|NCT02932462|3455289|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603755|NCT02932462|3455290|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603756|NCT02932462|3455291|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603757|NCT02932462|3455289|B3||White|Race (NIH/OMB)||Participants|Count of Participants|324|324.0||||||
3603758|NCT02932462|3455290|B2||White|Race (NIH/OMB)||Participants|Count of Participants|165|165.0||||||
3603759|NCT02932462|3455291|B1||White|Race (NIH/OMB)||Participants|Count of Participants|159|159.0||||||
3603760|NCT02932462|3455289|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3603761|NCT02932462|3455290|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3603762|NCT02932462|3455291|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3603763|NCT02932462|3455289|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3603764|NCT02932462|3455290|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3603765|NCT02932462|3455291|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603766|NCT02932462|3455289|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3603767|NCT02932462|3455290|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3603768|NCT02932462|3455291|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3603769|NCT02932462|3455289|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3603770|NCT02932462|3455290|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3603771|NCT02932462|3455291|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3603772|NCT02932462|3455289|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603773|NCT02932462|3455290|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603774|NCT02932462|3455291|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603775|NCT02932462|3455289|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|210|210.0||||||
3603776|NCT02932462|3455290|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
3603777|NCT02932462|3455291|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
3603778|NCT02932462|3455289|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|162|162.0||||||
3603779|NCT02932462|3455290|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3603780|NCT02932462|3455291|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3603781|NCT02932462|3455289|B3||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3603782|NCT02932462|3455290|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3603783|NCT02932462|3455291|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3603784|NCT02932462|3455289|B3||Female|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
3603785|NCT02932462|3455290|B2||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3603786|NCT02932462|3455291|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3603787|NCT02932462|3455289|B3|||Age||years|Mean|48.1|48.1|Standard Deviation|17.2|17.2|||
3603788|NCT02932462|3455290|B2|||Age||years|Mean|48.1|48.1|Standard Deviation|17.3|17.3|||
3603789|NCT02932462|3455291|B1|||Age||years|Mean|48.1|48.1|Standard Deviation|17.2|17.2|||
3603790|NCT02930590|3455302|B1||Skin phototype III|Skin phototype|"Assessment of the participants' skin phototype according Fitzpatrick classification with six categories. Participants with the skin phototype I (celtic type: fair ivory skin, red or blond hair, blue eyes and freckles; tans never, burns always), II (fair caucasian: white skin, blond hair, blue or green eyes; tans a little, burns easily) and III (dark caucasian: white skin, brown hair, gray or brown eyes; tans moderately, burns moderately) have been included in this study."|Participants|Count of Participants|3|3.0||||||
3603791|NCT02930590|3455302|B1||Skin phototype II|Skin phototype|"Assessment of the participants' skin phototype according Fitzpatrick classification with six categories. Participants with the skin phototype I (celtic type: fair ivory skin, red or blond hair, blue eyes and freckles; tans never, burns always), II (fair caucasian: white skin, blond hair, blue or green eyes; tans a little, burns easily) and III (dark caucasian: white skin, brown hair, gray or brown eyes; tans moderately, burns moderately) have been included in this study."|Participants|Count of Participants|9|9.0||||||
3603844|NCT02929823|3455584|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3603845|NCT02929823|3455585|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3603846|NCT02929823|3455582|B4|||Age||years|Mean|61.6|61.6|Standard Deviation|10.39|10.39|||
3603792|NCT02930590|3455302|B1||Skin phototype I|Skin phototype|"Assessment of the participants' skin phototype according Fitzpatrick classification with six categories. Participants with the skin phototype I (celtic type: fair ivory skin, red or blond hair, blue eyes and freckles; tans never, burns always), II (fair caucasian: white skin, blond hair, blue or green eyes; tans a little, burns easily) and III (dark caucasian: white skin, brown hair, gray or brown eyes; tans moderately, burns moderately) have been included in this study."|Participants|Count of Participants|3|3.0||||||
3603793|NCT02930590|3455302|B1|||Diastolic blood pressure||mmHg|Median|75|75.0|Inter-Quartile Range|||70.0|85.0|
3603794|NCT02930590|3455302|B1|||Systolic blood pressure||mmHg|Median|125|125.0|Inter-Quartile Range|||115.0|140.0|
3603795|NCT02930590|3455302|B1|||Heart rate||beats per minute|Median|78|78.0|Inter-Quartile Range|||66.0|80.0|
3603796|NCT02930590|3455302|B1|||Body temperature||°C|Median|36.3|36.3|Inter-Quartile Range|||36.3|36.6|
3603797|NCT02930590|3455302|B1|||Body Mass Index (BMI)||kg/m2|Median|24.5|24.5|Inter-Quartile Range|||23.7|26.0|
3603798|NCT02930590|3455302|B1|Germany||Region of Enrollment||participants|Number|15|15.0||||||
3603799|NCT02930590|3455302|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3603800|NCT02930590|3455302|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3603801|NCT02930590|3455302|B1|||Age||years|Median|66|66.0|Inter-Quartile Range|||63.0|69.0|
3603802|NCT02929823|3455582|B4|United States||Region of Enrollment||Participants|Count of Participants|130|130.0||||||
3603803|NCT02929823|3455583|B3|United States||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3603804|NCT02929823|3455584|B2|United States||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
3603805|NCT02929823|3455585|B1|United States||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3603806|NCT02929823|3455582|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|102|102.0||||||
3603807|NCT02929823|3455583|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3603808|NCT02929823|3455584|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3603809|NCT02929823|3455585|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
3603810|NCT02929823|3455582|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3603811|NCT02929823|3455583|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3603812|NCT02929823|3455584|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3603813|NCT02929823|3455585|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3603814|NCT02929823|3455582|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3603815|NCT02929823|3455583|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3603816|NCT02929823|3455584|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3603817|NCT02929823|3455585|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3603818|NCT02929823|3455582|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3603819|NCT02929823|3455583|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3603820|NCT02929823|3455584|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3603821|NCT02929823|3455585|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3603822|NCT02929823|3455582|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3603823|NCT02929823|3455583|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3603824|NCT02929823|3455584|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3603825|NCT02929823|3455585|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3603826|NCT02929823|3455582|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3603827|NCT02929823|3455583|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3603828|NCT02929823|3455584|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3603829|NCT02929823|3455585|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3603830|NCT02929823|3455582|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3603831|NCT02929823|3455583|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3603832|NCT02929823|3455584|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3603833|NCT02929823|3455585|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3603834|NCT02929823|3455582|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|115|115.0||||||
3603835|NCT02929823|3455583|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
3603836|NCT02929823|3455584|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
3603837|NCT02929823|3455585|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
3603838|NCT02929823|3455582|B4||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3603839|NCT02929823|3455583|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3603840|NCT02929823|3455584|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3603841|NCT02929823|3455585|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3603842|NCT02929823|3455582|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3603847|NCT02929823|3455583|B3|||Age||years|Mean|60.7|60.7|Standard Deviation|11.91|11.91|||
3603848|NCT02929823|3455584|B2|||Age||years|Mean|61.7|61.7|Standard Deviation|9.13|9.13|||
3603849|NCT02929823|3455585|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|10.22|10.22|||
3603850|NCT02928380|3455595|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603851|NCT02928380|3455595|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603852|NCT02928380|3455595|B1||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3603853|NCT02928380|3455595|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3603854|NCT02928380|3455595|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3603855|NCT02928380|3455595|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603856|NCT02928380|3455595|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603857|NCT02928380|3455595|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603858|NCT02928380|3455595|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3603859|NCT02928380|3455595|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3603860|NCT02928380|3455595|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3603861|NCT02928380|3455595|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3603862|NCT02928380|3455595|B1|||Age||Years|Mean|63.4|63.4|Standard Deviation|12.99|12.99|||
3603863|NCT02927431|3455620|B4|Race/ Ethnicity|White-White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3603864|NCT02927431|3455621|B3|Race/ Ethnicity|White-White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3603865|NCT02927431|3455622|B2|Race/ Ethnicity|White-White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3603866|NCT02927431|3455623|B1|Race/ Ethnicity|White-White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3603867|NCT02927431|3455620|B4|Race/ Ethnicity|Asian-Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3603868|NCT02927431|3455621|B3|Race/ Ethnicity|Asian-Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3603869|NCT02927431|3455622|B2|Race/ Ethnicity|Asian-Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3603870|NCT02927431|3455623|B1|Race/ Ethnicity|Asian-Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3603871|NCT02927431|3455620|B4|Race/ Ethnicity|African American/African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3603872|NCT02927431|3455621|B3|Race/ Ethnicity|African American/African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3603873|NCT02927431|3455622|B2|Race/ Ethnicity|African American/African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3603874|NCT02927431|3455623|B1|Race/ Ethnicity|African American/African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3603875|NCT02927431|3455620|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3603876|NCT02927431|3455621|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3603877|NCT02927431|3455622|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3603878|NCT02927431|3455623|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3603879|NCT02927431|3455620|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3603880|NCT02927431|3455621|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3603881|NCT02927431|3455622|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3603882|NCT02927431|3455623|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3603883|NCT02927431|3455620|B4|||Age||Years|Mean|63.8|63.8|Standard Deviation|17.34|17.34|||
3603884|NCT02927431|3455621|B3|||Age||Years|Mean|63.0|63.0|Standard Deviation|24.90|24.9|||
3603885|NCT02927431|3455622|B2|||Age||Years|Mean|66.0|66.0|Standard Deviation|8.76|8.76|||
3603886|NCT02927431|3455623|B1|||Age||Years|Mean|61.0|61.0|Standard Deviation|24.04|24.04|||
3603887|NCT02927327|3455701|B3|United States||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
3603888|NCT02927327|3455702|B2|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3603889|NCT02927327|3455703|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3603890|NCT02927327|3455701|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3603891|NCT02927327|3455701|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3603892|NCT02927327|3455702|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3603893|NCT02927327|3455703|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3603894|NCT02927327|3455701|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3603895|NCT02927327|3455702|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3603896|NCT02927327|3455703|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3603897|NCT02927327|3455701|B3|||Age||years|Mean|64.0|64.0|Standard Deviation|12.21|12.21|||
3603898|NCT02927327|3455702|B2|||Age||years|Mean|67.3|67.3|Standard Deviation|10.76|10.76|||
3603899|NCT02927327|3455703|B1|||Age||years|Mean|60.6|60.6|Standard Deviation|12.86|12.86|||
3603900|NCT02927327|3455701|B3||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
3603901|NCT02927327|3455702|B2||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3603902|NCT02927327|3455703|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3603903|NCT02927327|3455701|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3603904|NCT02927327|3455702|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3603905|NCT02927327|3455703|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3603906|NCT02927327|3455701|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3603907|NCT02927327|3455702|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3603908|NCT02927327|3455703|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3603909|NCT02926573|3455716|B3||Daily pain|Participant's experience with significant amount of daily pain|Participants were asked about daily pain aside from the pain due to the current head and neck condition.|Participants|Count of Participants|11|11.0||||||
3603910|NCT02926573|3455717|B2||Daily pain|Participant's experience with significant amount of daily pain|Participants were asked about daily pain aside from the pain due to the current head and neck condition.|Participants|Count of Participants|8|8.0||||||
3603911|NCT02926573|3455718|B1||Daily pain|Participant's experience with significant amount of daily pain|Participants were asked about daily pain aside from the pain due to the current head and neck condition.|Participants|Count of Participants|3|3.0||||||
3603912|NCT02926573|3455716|B3||No daily pain|Participant's experience with significant amount of daily pain|Participants were asked about daily pain aside from the pain due to the current head and neck condition.|Participants|Count of Participants|76|76.0||||||
3603913|NCT02926573|3455717|B2||No daily pain|Participant's experience with significant amount of daily pain|Participants were asked about daily pain aside from the pain due to the current head and neck condition.|Participants|Count of Participants|36|36.0||||||
3603914|NCT02926573|3455718|B1||No daily pain|Participant's experience with significant amount of daily pain|Participants were asked about daily pain aside from the pain due to the current head and neck condition.|Participants|Count of Participants|40|40.0||||||
3603915|NCT02926573|3455716|B3|High effectiveness||Participant's opinion on effectiveness of narcotic pain medication||Participants|Count of Participants|61|61.0||||||
3603916|NCT02926573|3455717|B2|High effectiveness||Participant's opinion on effectiveness of narcotic pain medication||Participants|Count of Participants|32|32.0||||||
3603917|NCT02926573|3455718|B1|High effectiveness||Participant's opinion on effectiveness of narcotic pain medication||Participants|Count of Participants|29|29.0||||||
3603918|NCT02926573|3455716|B3|Low effectiveness||Participant's opinion on effectiveness of narcotic pain medication||Participants|Count of Participants|18|18.0||||||
3603919|NCT02926573|3455717|B2|Low effectiveness||Participant's opinion on effectiveness of narcotic pain medication||Participants|Count of Participants|10|10.0||||||
3603920|NCT02926573|3455718|B1|Low effectiveness||Participant's opinion on effectiveness of narcotic pain medication||Participants|Count of Participants|8|8.0||||||
3603921|NCT02926573|3455716|B3|United States||Region of Enrollment||participants|Number|90|90.0||||||
3603922|NCT02926573|3455717|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
3603923|NCT02926573|3455718|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
3603924|NCT02926573|3455716|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3603925|NCT02926573|3455716|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3603926|NCT02926573|3455717|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3603927|NCT02926573|3455718|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3603928|NCT02926573|3455716|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3603929|NCT02926573|3455717|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3603930|NCT02926573|3455718|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3603931|NCT02926573|3455716|B3|||Age||years|Mean|61.0|61.0|Standard Deviation|10.6|10.6|||
3603932|NCT02926573|3455717|B2|||Age||years|Mean|60.9|60.9|Standard Deviation|10.0|10.0|||
3603933|NCT02926573|3455718|B1|||Age||years|Mean|61.1|61.1|Standard Deviation|11.3|11.3|||
3603934|NCT02924350|3455737|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603935|NCT02924350|3455738|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603936|NCT02924350|3455739|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603937|NCT02924350|3455737|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3603938|NCT02924350|3455738|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3603939|NCT02924350|3455739|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3603940|NCT02924350|3455737|B3||White|Race (NIH/OMB)||Participants|Count of Participants|175|175.0||||||
3603941|NCT02924350|3455738|B2||White|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
3603942|NCT02924350|3455739|B1||White|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3603943|NCT02924350|3455737|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3603944|NCT02924350|3455738|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3603945|NCT02924350|3455739|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3603946|NCT02924350|3455737|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603947|NCT02924350|3455738|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603948|NCT02924350|3455739|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603949|NCT02924350|3455737|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3603950|NCT02924350|3455738|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3603951|NCT02924350|3455739|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3603952|NCT02924350|3455737|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603953|NCT02924350|3455738|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603954|NCT02924350|3455739|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603955|NCT02924350|3455737|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3603956|NCT02924350|3455738|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3603957|NCT02924350|3455739|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3603958|NCT02924350|3455737|B3||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3603959|NCT02924350|3455738|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3603960|NCT02924350|3455739|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3603961|NCT02924350|3455737|B3|||Age||years|Mean|22.5|22.5|Standard Deviation|5.91|5.91|||
3603962|NCT02924350|3455738|B2|||Age||years|Mean|22.2|22.2|Standard Deviation|5.12|5.12|||
3603963|NCT02924350|3455739|B1|||Age||years|Mean|22.8|22.8|Standard Deviation|6.61|6.61|||
3603964|NCT02923895|3455750|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603965|NCT02923895|3455751|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603966|NCT02923895|3455752|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603967|NCT02923895|3455750|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3603968|NCT02923895|3455751|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3603969|NCT02923895|3455752|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3603970|NCT02923895|3455750|B3||White|Race (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
3603971|NCT02923895|3455751|B2||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3603972|NCT02923895|3455752|B1||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3603973|NCT02923895|3455750|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3603974|NCT02923895|3455751|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3603975|NCT02923895|3455752|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3603976|NCT02923895|3455750|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603977|NCT02923895|3455751|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603978|NCT02923895|3455752|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603979|NCT02923895|3455750|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3603980|NCT02923895|3455751|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3603981|NCT02923895|3455752|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3603982|NCT02923895|3455750|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603983|NCT02923895|3455751|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603984|NCT02923895|3455752|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3603985|NCT02923895|3455750|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3603986|NCT02923895|3455751|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3603987|NCT02923895|3455752|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3603988|NCT02923895|3455750|B3||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3603989|NCT02923895|3455751|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3603990|NCT02923895|3455752|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3603991|NCT02923895|3455750|B3|||Age||Years|Mean|46.9|46.9|Standard Deviation|11.79|11.79|||
3603992|NCT02923895|3455751|B2|||Age||Years|Mean|46.9|46.9|Standard Deviation|10.53|10.53|||
3603993|NCT02923895|3455752|B1|||Age||Years|Mean|46.8|46.8|Standard Deviation|12.95|12.95|||
3603994|NCT02923245|3455765|B3|Other||Chief Complaint||Participants|Count of Participants|3|3.0||||||
3603995|NCT02923245|3455766|B2|Other||Chief Complaint||Participants|Count of Participants|3|3.0||||||
3603996|NCT02923245|3455767|B1|Other||Chief Complaint||Participants|Count of Participants|0|0.0||||||
3603997|NCT02923245|3455765|B3|Dysuria/flank pain/hematuria||Chief Complaint||Participants|Count of Participants|10|10.0||||||
3603998|NCT02923245|3455766|B2|Dysuria/flank pain/hematuria||Chief Complaint||Participants|Count of Participants|5|5.0||||||
3603999|NCT02923245|3455767|B1|Dysuria/flank pain/hematuria||Chief Complaint||Participants|Count of Participants|5|5.0||||||
3604000|NCT02923245|3455765|B3|Vomiting||Chief Complaint||Participants|Count of Participants|6|6.0||||||
3604001|NCT02923245|3455766|B2|Vomiting||Chief Complaint||Participants|Count of Participants|3|3.0||||||
3604002|NCT02923245|3455767|B1|Vomiting||Chief Complaint||Participants|Count of Participants|3|3.0||||||
3604003|NCT02923245|3455765|B3|Abdominal Pain||Chief Complaint||Participants|Count of Participants|106|106.0||||||
3604004|NCT02923245|3455766|B2|Abdominal Pain||Chief Complaint||Participants|Count of Participants|50|50.0||||||
3604005|NCT02923245|3455767|B1|Abdominal Pain||Chief Complaint||Participants|Count of Participants|56|56.0||||||
3604006|NCT02923245|3455765|B3|||Time from TAPUS order by physician to study enrollment||minutes|Median|32.5|32.5|Inter-Quartile Range|||21.0|49.3|
3604007|NCT02923245|3455766|B2|||Time from TAPUS order by physician to study enrollment||minutes|Median|34.5|34.5|Inter-Quartile Range|||23.5|51.0|
3604008|NCT02923245|3455767|B1|||Time from TAPUS order by physician to study enrollment||minutes|Median|32.0|32.0|Inter-Quartile Range|||21.0|49.5|
3604009|NCT02923245|3455765|B3|||Time since last void||minutes|Median|125|125.0|Inter-Quartile Range|||65.0|190.0|
3604010|NCT02923245|3455766|B2|||Time since last void||minutes|Median|120.5|120.5|Inter-Quartile Range|||65.0|200.0|
3604011|NCT02923245|3455767|B1|||Time since last void||minutes|Median|126.5|126.5|Inter-Quartile Range|||65.0|189.0|
3604012|NCT02923245|3455765|B3|||Body Mass Index (BMI)||kg/m2|Mean|24.2|24.2|Standard Deviation|5.86|5.86|||
3604013|NCT02923245|3455766|B2|||Body Mass Index (BMI)||kg/m2|Mean|25.4|25.4|Standard Deviation|6.57|6.57|||
3604014|NCT02923245|3455767|B1|||Body Mass Index (BMI)||kg/m2|Mean|23.0|23.0|Standard Deviation|4.81|4.81|||
3604015|NCT02923245|3455765|B3|United States||Region of Enrollment||Participants|Count of Participants|120|120.0||||||
3604016|NCT02923245|3455766|B2|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3604017|NCT02923245|3455767|B1|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3604018|NCT02923245|3455765|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3604019|NCT02923245|3455766|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3604020|NCT02923245|3455767|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3604021|NCT02923245|3455765|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3604022|NCT02923245|3455766|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3604023|NCT02923245|3455767|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3604024|NCT02923245|3455765|B3|Non-Hispanic Black||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3604025|NCT02923245|3455766|B2|Non-Hispanic Black||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3604026|NCT02923245|3455767|B1|Non-Hispanic Black||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3604027|NCT02923245|3455765|B3|Non-Hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|68|68.0||||||
3604028|NCT02923245|3455766|B2|Non-Hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
3604029|NCT02923245|3455767|B1|Non-Hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3604030|NCT02923245|3455765|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3604031|NCT02923245|3455766|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3604032|NCT02923245|3455767|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3604033|NCT02923245|3455765|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3604034|NCT02923245|3455766|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3604035|NCT02923245|3455767|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3604036|NCT02923245|3455765|B3|||Age||years|Mean|14.4|14.4|Standard Deviation|2.39|2.39|||
3604037|NCT02923245|3455766|B2|||Age||years|Mean|14.7|14.7|Standard Deviation|2.34|2.34|||
3604038|NCT02923245|3455767|B1|||Age||years|Mean|14.1|14.1|Standard Deviation|2.43|2.43|||
3604039|NCT02922985|3455785|B3|United States||Region of Enrollment||participants|Number|120|120.0||||||
3604040|NCT02922985|3455786|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
3604041|NCT02922985|3455787|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
3604042|NCT02922985|3455785|B3|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3604043|NCT02922985|3455786|B2|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3604044|NCT02922985|3455787|B1|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3604045|NCT02922985|3455785|B3|Race|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3604046|NCT02922985|3455786|B2|Race|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3604047|NCT02922985|3455787|B1|Race|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3604048|NCT02922985|3455785|B3|Race|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|79|79.0||||||
3604049|NCT02922985|3455786|B2|Race|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3604050|NCT02922985|3455787|B1|Race|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
3604051|NCT02922985|3455785|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3604052|NCT02922985|3455786|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3604053|NCT02922985|3455787|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3604054|NCT02922985|3455785|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3604055|NCT02922985|3455786|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3604056|NCT02922985|3455787|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3604057|NCT02922985|3455785|B3|||Age||years|Mean|29.5|29.5|Standard Deviation|5.1|5.1|||
3604058|NCT02922985|3455786|B2|||Age||years|Mean|29.6|29.6|Standard Deviation|5.1|5.1|||
3604059|NCT02922985|3455787|B1|||Age||years|Mean|29.4|29.4|Standard Deviation|5.2|5.2|||
3604060|NCT02922985|3455785|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3604061|NCT02922985|3455786|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3604062|NCT02922985|3455787|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3604063|NCT02922985|3455785|B3||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
3604064|NCT02922985|3455786|B2||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3604065|NCT02922985|3455787|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3604066|NCT02922985|3455785|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3604067|NCT02922985|3455786|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3604068|NCT02922985|3455787|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3604069|NCT02922868|3455798|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3604070|NCT02922868|3455799|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3604071|NCT02922868|3455800|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3604072|NCT02922868|3455798|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3604073|NCT02922868|3455799|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3604074|NCT02922868|3455800|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3604075|NCT02922868|3455798|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3604076|NCT02922868|3455799|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3604077|NCT02922868|3455800|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3604078|NCT02922868|3455798|B3||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3604079|NCT02922868|3455799|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3604080|NCT02922868|3455800|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3604081|NCT02922868|3455798|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3604082|NCT02922868|3455799|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3604083|NCT02922868|3455800|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3604084|NCT02921425|3455819|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
3604085|NCT02921425|3455819|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3604086|NCT02921425|3455819|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3604087|NCT02921425|3455819|B1|||Age||years|Mean|57.7|57.7|Standard Deviation|7.7|7.7|||
3604088|NCT02921412|3455833|B1|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3604089|NCT02921412|3455833|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3604090|NCT02921412|3455833|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3604091|NCT02921412|3455833|B1|||Age||years|Mean|29.4|29.4|Standard Deviation|6.7|6.7|||
3604092|NCT02921386|3455856|B1|||Serum testosterone at screening (ng/dL)||ng/dL|Mean|109.7|109.7|Standard Deviation|85.98|85.98|||
3604093|NCT02921386|3455856|B1|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3604094|NCT02921386|3455856|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604095|NCT02921386|3455856|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604096|NCT02921386|3455856|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3604097|NCT02921386|3455856|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3604098|NCT02921386|3455856|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604099|NCT02921386|3455856|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604100|NCT02921386|3455856|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604101|NCT02921386|3455856|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604102|NCT02921386|3455856|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3604103|NCT02921386|3455856|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3604104|NCT02921386|3455856|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3604105|NCT02921386|3455856|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3604106|NCT02921386|3455856|B1|||Age||years|Mean|46.2|46.2|Standard Deviation|11.12|11.12|||
3604107|NCT02921386|3455856|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3604108|NCT02921386|3455856|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3604109|NCT02921386|3455856|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3604110|NCT02921295|3455879|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3604111|NCT02921295|3455879|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3604112|NCT02921295|3455879|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3604113|NCT02921295|3455879|B1|||Age||years|Mean|41|41.0|Standard Deviation|0|0.0|||
3604114|NCT02921295|3455879|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3604115|NCT02921295|3455879|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3604116|NCT02921295|3455879|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3604117|NCT02920957|3455889|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3604118|NCT02920957|3455889|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3604119|NCT02920957|3455889|B1|Age||Age||years|Mean|27.9|27.9|Standard Deviation|4.3|4.3|||
3604120|NCT02920749|3455942|B5|Hungary||Region of Enrollment||participants|Number|120|120.0||||||
3604121|NCT02920749|3455943|B4|Hungary||Region of Enrollment||participants|Number|30|30.0||||||
3604122|NCT02920749|3455944|B3|Hungary||Region of Enrollment||participants|Number|30|30.0||||||
3604123|NCT02920749|3455945|B2|Hungary||Region of Enrollment||participants|Number|30|30.0||||||
3604124|NCT02920749|3455946|B1|Hungary||Region of Enrollment||participants|Number|30|30.0||||||
3604125|NCT02920749|3455942|B5||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3604126|NCT02920749|3455943|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3604127|NCT02920749|3455944|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3604128|NCT02920749|3455945|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3604129|NCT02920749|3455946|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3604130|NCT02920749|3455942|B5||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3604131|NCT02920749|3455943|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3604132|NCT02920749|3455944|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3604133|NCT02920749|3455945|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3604134|NCT02920749|3455946|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3604135|NCT02920749|3455942|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3604136|NCT02920749|3455943|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3604137|NCT02920749|3455944|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3604138|NCT02920749|3455945|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3604139|NCT02920749|3455946|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3604140|NCT02920749|3455942|B5||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
3604141|NCT02920749|3455943|B4||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3604142|NCT02920749|3455944|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3604143|NCT02920749|3455945|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3604144|NCT02920749|3455946|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3604145|NCT02920749|3455942|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3604146|NCT02920749|3455943|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3604147|NCT02920749|3455944|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3604148|NCT02920749|3455945|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3604149|NCT02920749|3455946|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3604150|NCT02919657|3455963|B1|All Participants||Protein blood levels||g/dl|Mean|7.0|7.0|Standard Deviation|.4|0.4|||
3604151|NCT02919657|3455963|B1|Whey Isolate first||Protein blood levels||g/dl|Mean|6.9|6.9|Standard Deviation|.4|0.4|||
3604152|NCT02919657|3455963|B1|Genepro Gen2 first||Protein blood levels||g/dl|Mean|7.1|7.1|Standard Deviation|.4|0.4|||
3604153|NCT02919657|3455963|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3604154|NCT02919657|3455963|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3604155|NCT02919657|3455963|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3604156|NCT02919657|3455963|B1|||Age||years|Mean|39|39.0|Standard Deviation|1|1.0|||
3604157|NCT02919657|3455963|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3604158|NCT02919657|3455963|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3604159|NCT02919657|3455963|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3604160|NCT02919007|3455970|B1|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3604161|NCT02919007|3455970|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3604162|NCT02919007|3455970|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3604163|NCT02919007|3455970|B1|||Age||years|Mean|49.2|49.2|Standard Deviation|15.9|15.9|||
3604164|NCT02919007|3455970|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3604165|NCT02919007|3455970|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3604166|NCT02919007|3455970|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3604167|NCT02918773|3455974|B3|Other||Reason for clinic visit|A child could have multiple symptoms documented as the reason for the emergency department visit.|Emergency department encounters|Number|655|655.0||||||
3604168|NCT02918773|3455975|B2|Other||Reason for clinic visit|A child could have multiple symptoms documented as the reason for the emergency department visit.|Emergency department encounters|Number|317|317.0||||||
3604169|NCT02918773|3455976|B1|Other||Reason for clinic visit|A child could have multiple symptoms documented as the reason for the emergency department visit.|Emergency department encounters|Number|338|338.0||||||
3604170|NCT02918773|3455974|B3|Cough||Reason for clinic visit|A child could have multiple symptoms documented as the reason for the emergency department visit.|Emergency department encounters|Number|639|639.0||||||
3604171|NCT02918773|3455975|B2|Cough||Reason for clinic visit|A child could have multiple symptoms documented as the reason for the emergency department visit.|Emergency department encounters|Number|274|274.0||||||
3604172|NCT02918773|3455976|B1|Cough||Reason for clinic visit|A child could have multiple symptoms documented as the reason for the emergency department visit.|Emergency department encounters|Number|365|365.0||||||
3604173|NCT02918773|3455974|B3|Congestion/runny nose||Reason for clinic visit|A child could have multiple symptoms documented as the reason for the emergency department visit.|Emergency department encounters|Number|452|452.0||||||
3604174|NCT02918773|3455975|B2|Congestion/runny nose||Reason for clinic visit|A child could have multiple symptoms documented as the reason for the emergency department visit.|Emergency department encounters|Number|182|182.0||||||
3604175|NCT02918773|3455976|B1|Congestion/runny nose||Reason for clinic visit|A child could have multiple symptoms documented as the reason for the emergency department visit.|Emergency department encounters|Number|270|270.0||||||
3604176|NCT02918773|3455974|B3|Ear pain||Reason for clinic visit|A child could have multiple symptoms documented as the reason for the emergency department visit.|Emergency department encounters|Number|202|202.0||||||
3604177|NCT02918773|3455975|B2|Ear pain||Reason for clinic visit|A child could have multiple symptoms documented as the reason for the emergency department visit.|Emergency department encounters|Number|96|96.0||||||
3604178|NCT02918773|3455976|B1|Ear pain||Reason for clinic visit|A child could have multiple symptoms documented as the reason for the emergency department visit.|Emergency department encounters|Number|106|106.0||||||
3604343|NCT02918396|3456070|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604179|NCT02918773|3455974|B3|Fever||Reason for clinic visit|A child could have multiple symptoms documented as the reason for the emergency department visit.|Emergency department encounters|Number|946|946.0||||||
3604180|NCT02918773|3455975|B2|Fever||Reason for clinic visit|A child could have multiple symptoms documented as the reason for the emergency department visit.|Emergency department encounters|Number|424|424.0||||||
3604181|NCT02918773|3455976|B1|Fever||Reason for clinic visit|A child could have multiple symptoms documented as the reason for the emergency department visit.|Emergency department encounters|Number|522|522.0||||||
3604182|NCT02918773|3455974|B3|United States||Region of Enrollment||Emergency department encounters|Number|1390|1390.0||||||
3604183|NCT02918773|3455975|B2|United States||Region of Enrollment||Emergency department encounters|Number|614|614.0||||||
3604184|NCT02918773|3455976|B1|United States||Region of Enrollment||Emergency department encounters|Number|776|776.0||||||
3604185|NCT02918773|3455974|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3604186|NCT02918773|3455974|B3|Not collected||Sex/Gender, Customized||Emergency department encounters|Number|1390|1390.0||||||
3604187|NCT02918773|3455975|B2|Not collected||Sex/Gender, Customized||Emergency department encounters|Number|614|614.0||||||
3604188|NCT02918773|3455976|B1|Not collected||Sex/Gender, Customized||Emergency department encounters|Number|776|776.0||||||
3604189|NCT02918773|3455974|B3|||Age||age in months of encounter subjects|Mean|45.90|45.9|Standard Deviation|40.34|40.34|||
3604190|NCT02918773|3455975|B2|||Age||age in months of encounter subjects|Mean|49.0|49.0|Standard Deviation|42.0|42.0|||
3604191|NCT02918773|3455976|B1|||Age||age in months of encounter subjects|Mean|43.5|43.5|Standard Deviation|38.8|38.8|||
3604192|NCT02918630|3455988|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
3604193|NCT02918630|3455989|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3604194|NCT02918630|3455990|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3604195|NCT02918630|3455988|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604196|NCT02918630|3455989|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604197|NCT02918630|3455990|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604198|NCT02918630|3455988|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604199|NCT02918630|3455989|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604200|NCT02918630|3455990|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604201|NCT02918630|3455988|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3604202|NCT02918630|3455989|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3604203|NCT02918630|3455990|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3604204|NCT02918630|3455988|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3604205|NCT02918630|3455989|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3604206|NCT02918630|3455990|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3604207|NCT02918630|3455988|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604208|NCT02918630|3455989|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604209|NCT02918630|3455990|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604210|NCT02918630|3455988|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604211|NCT02918630|3455989|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604212|NCT02918630|3455990|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604213|NCT02918630|3455988|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604214|NCT02918630|3455989|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604215|NCT02918630|3455990|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604216|NCT02918630|3455988|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604217|NCT02918630|3455989|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604218|NCT02918630|3455990|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604219|NCT02918630|3455988|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3604220|NCT02918630|3455989|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3604221|NCT02918630|3455990|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3604222|NCT02918630|3455988|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604223|NCT02918630|3455989|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604224|NCT02918630|3455990|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604225|NCT02918630|3455988|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3604226|NCT02918630|3455989|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3604227|NCT02918630|3455990|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3604228|NCT02918630|3455988|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3604229|NCT02918630|3455989|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3604230|NCT02918630|3455990|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3604231|NCT02918630|3455988|B3|||Age||years|Mean|48.3|48.3|Standard Deviation|2.7|2.7|||
3604232|NCT02918630|3455989|B2|||Age||years|Mean|44.6|44.6|Standard Deviation|1.2|1.2|||
3604233|NCT02918630|3455990|B1|||Age||years|Mean|51|51.0|Standard Deviation|4.377|4.377|||
3604234|NCT02918617|3456005|B10|Race Ethnicity|White not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
3604235|NCT02918617|3456006|B9|Race Ethnicity|White not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3604236|NCT02918617|3456007|B8|Race Ethnicity|White not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3604237|NCT02918617|3456008|B7|Race Ethnicity|White not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3604238|NCT02918617|3456009|B6|Race Ethnicity|White not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3604239|NCT02918617|3456010|B5|Race Ethnicity|White not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3604240|NCT02918617|3456011|B4|Race Ethnicity|White not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3604241|NCT02918617|3456012|B3|Race Ethnicity|White not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3604242|NCT02918617|3456013|B2|Race Ethnicity|White not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3604243|NCT02918617|3456014|B1|Race Ethnicity|White not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3604244|NCT02918617|3456005|B10|Race Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3604245|NCT02918617|3456006|B9|Race Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3604246|NCT02918617|3456007|B8|Race Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3604247|NCT02918617|3456008|B7|Race Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3604248|NCT02918617|3456009|B6|Race Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3604249|NCT02918617|3456010|B5|Race Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3604250|NCT02918617|3456011|B4|Race Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3604251|NCT02918617|3456012|B3|Race Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3604252|NCT02918617|3456013|B2|Race Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3604253|NCT02918617|3456014|B1|Race Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3604254|NCT02918617|3456005|B10|Race Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|111|111.0||||||
3604255|NCT02918617|3456006|B9|Race Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3604256|NCT02918617|3456007|B8|Race Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3604257|NCT02918617|3456008|B7|Race Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3604258|NCT02918617|3456009|B6|Race Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3604259|NCT02918617|3456010|B5|Race Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3604260|NCT02918617|3456011|B4|Race Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3604261|NCT02918617|3456012|B3|Race Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3604262|NCT02918617|3456013|B2|Race Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3604263|NCT02918617|3456014|B1|Race Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3604264|NCT02918617|3456005|B10|Race Ethnicity|Black not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3604265|NCT02918617|3456006|B9|Race Ethnicity|Black not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3604266|NCT02918617|3456007|B8|Race Ethnicity|Black not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3604267|NCT02918617|3456008|B7|Race Ethnicity|Black not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3604268|NCT02918617|3456009|B6|Race Ethnicity|Black not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3604269|NCT02918617|3456010|B5|Race Ethnicity|Black not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3604270|NCT02918617|3456011|B4|Race Ethnicity|Black not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3604271|NCT02918617|3456012|B3|Race Ethnicity|Black not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3604272|NCT02918617|3456013|B2|Race Ethnicity|Black not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3604273|NCT02918617|3456014|B1|Race Ethnicity|Black not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3604274|NCT02918617|3456005|B10|Race Ethnicity|Asian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3604275|NCT02918617|3456006|B9|Race Ethnicity|Asian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3604276|NCT02918617|3456007|B8|Race Ethnicity|Asian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3604277|NCT02918617|3456008|B7|Race Ethnicity|Asian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3604278|NCT02918617|3456009|B6|Race Ethnicity|Asian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3604279|NCT02918617|3456010|B5|Race Ethnicity|Asian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3604280|NCT02918617|3456011|B4|Race Ethnicity|Asian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3604281|NCT02918617|3456012|B3|Race Ethnicity|Asian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3604282|NCT02918617|3456013|B2|Race Ethnicity|Asian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3604283|NCT02918617|3456014|B1|Race Ethnicity|Asian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3604284|NCT02918617|3456005|B10||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3604285|NCT02918617|3456006|B9||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3604286|NCT02918617|3456007|B8||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3604287|NCT02918617|3456008|B7||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3604288|NCT02918617|3456009|B6||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3604289|NCT02918617|3456010|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3604290|NCT02918617|3456011|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3604291|NCT02918617|3456012|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3604292|NCT02918617|3456013|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3604293|NCT02918617|3456014|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3604294|NCT02918617|3456005|B10||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3604295|NCT02918617|3456006|B9||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3604296|NCT02918617|3456007|B8||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3604297|NCT02918617|3456008|B7||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3604298|NCT02918617|3456009|B6||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3604299|NCT02918617|3456010|B5||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3604300|NCT02918617|3456011|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3604301|NCT02918617|3456012|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3604302|NCT02918617|3456013|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3604303|NCT02918617|3456014|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3604304|NCT02918617|3456005|B10|||Age||Years|Mean|47.61|47.61|Standard Deviation|12.44|12.44|||
3604305|NCT02918617|3456006|B9|||Age||Years|Mean|49.38|49.38|Standard Deviation|10.62|10.62|||
3604306|NCT02918617|3456007|B8|||Age||Years|Mean|41.4|41.4|Standard Deviation|14.14|14.14|||
3604307|NCT02918617|3456008|B7|||Age||Years|Mean|47.14|47.14|Standard Deviation|14.54|14.54|||
3604308|NCT02918617|3456009|B6|||Age||Years|Mean|45.35|45.35|Standard Deviation|11.37|11.37|||
3604309|NCT02918617|3456010|B5|||Age||Years|Mean|43.7|43.7|Standard Deviation|12.8|12.8|||
3604310|NCT02918617|3456011|B4|||Age||Years|Mean|52.8|52.8|Standard Deviation|11.2|11.2|||
3604311|NCT02918617|3456012|B3|||Age||Years|Mean|53.6|53.6|Standard Deviation|11.0|11.0|||
3604312|NCT02918617|3456013|B2|||Age||Years|Mean|45.85|45.85|Standard Deviation|15.76|15.76|||
3604313|NCT02918617|3456014|B1|||Age||Years|Mean|49.3|49.3|Standard Deviation|10.5|10.5|||
3604314|NCT02918396|3456069|B4|United States||Region of Enrollment||Participants|Number|5|5.0||||||
3604315|NCT02918396|3456070|B3|United States||Region of Enrollment||Participants|Number|2|2.0||||||
3604316|NCT02918396|3456071|B2|United States||Region of Enrollment||Participants|Number|1|1.0||||||
3604317|NCT02918396|3456072|B1|United States||Region of Enrollment||Participants|Number|2|2.0||||||
3604318|NCT02918396|3456069|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604319|NCT02918396|3456070|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604320|NCT02918396|3456071|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604321|NCT02918396|3456072|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604322|NCT02918396|3456069|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604323|NCT02918396|3456070|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604324|NCT02918396|3456071|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604325|NCT02918396|3456072|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604326|NCT02918396|3456069|B4||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3604327|NCT02918396|3456070|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3604328|NCT02918396|3456071|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604329|NCT02918396|3456072|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3604330|NCT02918396|3456069|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3604331|NCT02918396|3456070|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604332|NCT02918396|3456071|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3604333|NCT02918396|3456072|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604334|NCT02918396|3456069|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604335|NCT02918396|3456070|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604336|NCT02918396|3456071|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604337|NCT02918396|3456072|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604338|NCT02918396|3456069|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604339|NCT02918396|3456070|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604340|NCT02918396|3456071|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604341|NCT02918396|3456072|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604342|NCT02918396|3456069|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604344|NCT02918396|3456071|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604345|NCT02918396|3456072|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604346|NCT02918396|3456069|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3604347|NCT02918396|3456070|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3604348|NCT02918396|3456071|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3604349|NCT02918396|3456072|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3604350|NCT02918396|3456069|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3604351|NCT02918396|3456070|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3604352|NCT02918396|3456071|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3604353|NCT02918396|3456072|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3604354|NCT02918396|3456069|B4|||Age||years|Mean|65.6|65.6|Full Range|||58.0|74.0|
3604355|NCT02918396|3456070|B3|||Age||years|Mean|65|65.0|Full Range|||60.0|70.0|
3604356|NCT02918396|3456071|B2|||Age||years|Mean|74|74.0|Full Range|||74.0|74.0|
3604357|NCT02918396|3456072|B1|||Age||years|Mean|62|62.0|Full Range|||58.0|66.0|
3604358|NCT02918071|3456082|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3604359|NCT02918071|3456082|B1|Asian||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3604360|NCT02918071|3456082|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3604361|NCT02918071|3456082|B1|White||Race/Ethnicity, Customized||Participants|Number|97|97.0||||||
3604362|NCT02918071|3456082|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3604363|NCT02918071|3456082|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3604364|NCT02918071|3456082|B1|||Age||Years|Mean|48.5|48.5|Standard Deviation|14.95|14.95|||
3604365|NCT02917642|3456092|B3|Brazil||Region of Enrollment||participants|Number|50|50.0||||||
3604366|NCT02917642|3456093|B2|Brazil||Region of Enrollment||participants|Number|25|25.0||||||
3604367|NCT02917642|3456094|B1|Brazil||Region of Enrollment||participants|Number|25|25.0||||||
3604368|NCT02917642|3456092|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3604369|NCT02917642|3456092|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3604370|NCT02917642|3456093|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3604371|NCT02917642|3456094|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3604372|NCT02917642|3456092|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3604373|NCT02917642|3456093|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3604374|NCT02917642|3456094|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3604375|NCT02917642|3456092|B3|||Age||years|Median|34|34.0|Full Range|||18.0|63.0|
3604376|NCT02917642|3456093|B2|||Age||years|Median|34|34.0|Full Range|||18.0|58.0|
3604377|NCT02917642|3456094|B1|||Age||years|Median|38|38.0|Full Range|||18.0|63.0|
3604378|NCT02917642|3456092|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3604379|NCT02917642|3456093|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3604380|NCT02917642|3456094|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3604381|NCT02917642|3456092|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3604382|NCT02917642|3456093|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3604383|NCT02917642|3456094|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3604384|NCT02917642|3456092|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3604385|NCT02917642|3456093|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3604386|NCT02917642|3456094|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3604387|NCT02915978|3456103|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604388|NCT02915978|3456104|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604389|NCT02915978|3456105|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604390|NCT02915978|3456106|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604391|NCT02915978|3456103|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604392|NCT02915978|3456104|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604393|NCT02915978|3456105|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604394|NCT02915978|3456106|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604395|NCT02915978|3456103|B4||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3604396|NCT02915978|3456104|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3604397|NCT02915978|3456105|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3604398|NCT02915978|3456106|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3604399|NCT02915978|3456103|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3604400|NCT02915978|3456104|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3604401|NCT02915978|3456105|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3604402|NCT02915978|3456106|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3604403|NCT02915978|3456103|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604404|NCT02915978|3456104|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604405|NCT02915978|3456105|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604406|NCT02915978|3456106|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604407|NCT02915978|3456103|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3604408|NCT02915978|3456104|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3604409|NCT02915978|3456105|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604410|NCT02915978|3456106|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604411|NCT02915978|3456103|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604412|NCT02915978|3456104|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604413|NCT02915978|3456105|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604414|NCT02915978|3456106|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604415|NCT02915978|3456103|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604416|NCT02915978|3456104|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604417|NCT02915978|3456105|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604418|NCT02915978|3456106|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604419|NCT02915978|3456103|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3604420|NCT02915978|3456104|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3604421|NCT02915978|3456105|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3604422|NCT02915978|3456106|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3604423|NCT02915978|3456103|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3604424|NCT02915978|3456104|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3604425|NCT02915978|3456105|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3604426|NCT02915978|3456106|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3604427|NCT02915978|3456103|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3604428|NCT02915978|3456104|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3604429|NCT02915978|3456105|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3604430|NCT02915978|3456106|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3604431|NCT02915978|3456103|B4||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3604432|NCT02915978|3456104|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3604433|NCT02915978|3456105|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3604434|NCT02915978|3456106|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3604435|NCT02915978|3456103|B4|||Age||years|Mean|46.4|46.4|Standard Deviation|12.2|12.2|||
3604436|NCT02915978|3456104|B3|||Age||years|Mean|45.5|45.5|Standard Deviation|11.4|11.4|||
3604437|NCT02915978|3456105|B2|||Age||years|Mean|50.0|50.0|Standard Deviation|10.6|10.6|||
3604438|NCT02915978|3456106|B1|||Age||years|Mean|43.8|43.8|Standard Deviation|14.3|14.3|||
3604439|NCT02915302|3456158|B3|United States||Region of Enrollment||participants|Number|1941|1941.0||||||
3604440|NCT02915302|3456159|B2|United States||Region of Enrollment||participants|Number|992|992.0||||||
3604441|NCT02915302|3456160|B1|United States||Region of Enrollment||participants|Number|949|949.0||||||
3604442|NCT02915302|3456158|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3604443|NCT02915302|3456159|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3604444|NCT02915302|3456160|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3604445|NCT02915302|3456158|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3604446|NCT02915302|3456159|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3604447|NCT02915302|3456160|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3604448|NCT02915302|3456158|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1442|1442.0||||||
3604449|NCT02915302|3456159|B2||White|Race (NIH/OMB)||Participants|Count of Participants|725|725.0||||||
3604450|NCT02915302|3456160|B1||White|Race (NIH/OMB)||Participants|Count of Participants|717|717.0||||||
3604451|NCT02915302|3456158|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|373|373.0||||||
3604452|NCT02915302|3456159|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|195|195.0||||||
3604453|NCT02915302|3456160|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|178|178.0||||||
3604454|NCT02915302|3456158|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3604455|NCT02915302|3456159|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3604456|NCT02915302|3456160|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3604457|NCT02915302|3456158|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3604458|NCT02915302|3456159|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3604459|NCT02915302|3456160|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3604460|NCT02915302|3456158|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3604461|NCT02915302|3456159|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3604462|NCT02915302|3456160|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3604463|NCT02915302|3456158|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3604464|NCT02915302|3456159|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3604465|NCT02915302|3456160|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3604466|NCT02915302|3456158|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1494|1494.0||||||
3604467|NCT02915302|3456159|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|763|763.0||||||
3604468|NCT02915302|3456160|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|731|731.0||||||
3604469|NCT02915302|3456158|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|427|427.0||||||
3604470|NCT02915302|3456159|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|221|221.0||||||
3604471|NCT02915302|3456160|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|206|206.0||||||
3604472|NCT02915302|3456158|B3||Male|Sex: Female, Male||Participants|Count of Participants|977|977.0||||||
3604473|NCT02915302|3456159|B2||Male|Sex: Female, Male||Participants|Count of Participants|497|497.0||||||
3604474|NCT02915302|3456160|B1||Male|Sex: Female, Male||Participants|Count of Participants|480|480.0||||||
3604475|NCT02915302|3456158|B3||Female|Sex: Female, Male||Participants|Count of Participants|964|964.0||||||
3604476|NCT02915302|3456159|B2||Female|Sex: Female, Male||Participants|Count of Participants|495|495.0||||||
3604477|NCT02915302|3456160|B1||Female|Sex: Female, Male||Participants|Count of Participants|469|469.0||||||
3604478|NCT02915302|3456158|B3|||Age||Months|Mean|20.5|20.5|Standard Deviation|8.65|8.65|||
3604479|NCT02915302|3456159|B2|||Age||Months|Mean|20.5|20.5|Standard Deviation|8.55|8.55|||
3604480|NCT02915302|3456160|B1|||Age||Months|Mean|20.4|20.4|Standard Deviation|8.75|8.75|||
3604481|NCT02914236|3456171|B1|||Nasal Obstruction Symptom Evaluation (NOSE) score|The Nasal Obstruction Symptom Evaluation (NOSE) scale is a validated disease-specific health status outcomes instrument, used to assess severity of nasal obstruction symptoms. Score ranges from 0 to 100. Higher scores indicate increased symptoms/symptom severity.|units on a scale|Mean|79.9|79.9|Standard Deviation|10.8|10.8|||
3604482|NCT02914236|3456171|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3604483|NCT02914236|3456171|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3604484|NCT02914236|3456171|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604485|NCT02914236|3456171|B1||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3604486|NCT02914236|3456171|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604487|NCT02914236|3456171|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604488|NCT02914236|3456171|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604489|NCT02914236|3456171|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604490|NCT02914236|3456171|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604491|NCT02914236|3456171|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3604492|NCT02914236|3456171|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3604493|NCT02914236|3456171|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3604494|NCT02914236|3456171|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3604495|NCT02914236|3456171|B1|||Age||years|Mean|50.9|50.9|Standard Deviation|12.6|12.6|||
3604496|NCT02912650|3456179|B5||Male|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
3604497|NCT02912650|3456180|B4||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3604498|NCT02912650|3456181|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3604499|NCT02912650|3456182|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3604500|NCT02912650|3456183|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3604501|NCT02912650|3456179|B5||Female|Sex: Female, Male||Participants|Count of Participants|335|335.0||||||
3604502|NCT02912650|3456180|B4||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3604503|NCT02912650|3456181|B3||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3604504|NCT02912650|3456182|B2||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3604505|NCT02912650|3456183|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3604506|NCT02912650|3456179|B5|||Age||years|Mean|19.5|19.5|Standard Deviation|2.3|2.3|||
3604507|NCT02912650|3456180|B4|||Age||years|Mean|19.4|19.4|Standard Deviation|2.1|2.1|||
3604508|NCT02912650|3456181|B3|||Age||years|Mean|19.7|19.7|Standard Deviation|2.7|2.7|||
3604509|NCT02912650|3456182|B2|||Age||years|Mean|19.3|19.3|Standard Deviation|1.8|1.8|||
3604510|NCT02912650|3456183|B1|||Age||years|Mean|19.6|19.6|Standard Deviation|3.0|3.0|||
3604511|NCT02911857|3456268|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604512|NCT02911857|3456269|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604513|NCT02911857|3456270|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604514|NCT02911857|3456271|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604515|NCT02911857|3456268|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604516|NCT02911857|3456269|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604517|NCT02911857|3456270|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604518|NCT02911857|3456271|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604519|NCT02911857|3456268|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604520|NCT02911857|3456269|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604521|NCT02911857|3456270|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604522|NCT02911857|3456271|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604523|NCT02911857|3456268|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604524|NCT02911857|3456269|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604525|NCT02911857|3456270|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604526|NCT02911857|3456271|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604527|NCT02911857|3456268|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604528|NCT02911857|3456269|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604529|NCT02911857|3456270|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604530|NCT02911857|3456271|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604531|NCT02911857|3456268|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3604532|NCT02911857|3456269|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3604533|NCT02911857|3456270|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3604534|NCT02911857|3456271|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3604535|NCT02911857|3456268|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604536|NCT02911857|3456269|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604537|NCT02911857|3456270|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604538|NCT02911857|3456271|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604539|NCT02911857|3456268|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3604540|NCT02911857|3456269|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3604541|NCT02911857|3456270|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3604542|NCT02911857|3456271|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3604543|NCT02911857|3456268|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3604544|NCT02911857|3456269|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3604545|NCT02911857|3456270|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3604546|NCT02911857|3456271|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3604547|NCT02911857|3456268|B4|||Age||Years|Mean|18.5|18.5|Standard Deviation|3.42|3.42|||
3604548|NCT02911857|3456269|B3|||Age||Years|Mean|20|20.0|Standard Deviation|NA||||There is only 1 participant in the cfFMF group. Therefore, standard deviation does not apply.
3604549|NCT02911857|3456270|B2|||Age||Years|Mean|14|14.0|Standard Deviation|NA||||There is only 1 participant in the HIDS/MKD group. Therefore, standard deviation does not apply.
3604550|NCT02911857|3456271|B1|||Age||Years|Mean|20.0|20.0|Standard Deviation|2.83|2.83|||
3604551|NCT02910739|3456281|B3|||Body Mass Index (BMI)||kg/m^2|Mean|30.000|30.0|Full Range|||20.4|36.1|
3604552|NCT02910739|3456282|B2|||Body Mass Index (BMI)||kg/m^2|Mean|30.313|30.313|Full Range|||27.5|32.6|
3604553|NCT02910739|3456283|B1|||Body Mass Index (BMI)||kg/m^2|Mean|29.688|29.688|Full Range|||20.4|36.1|
3604554|NCT02910739|3456281|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604555|NCT02910739|3456282|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604556|NCT02910739|3456283|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604557|NCT02910739|3456281|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604558|NCT02910739|3456282|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604559|NCT02910739|3456283|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604560|NCT02910739|3456281|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3604561|NCT02910739|3456282|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3604562|NCT02910739|3456283|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3604563|NCT02910739|3456281|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3604564|NCT02910739|3456282|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3604565|NCT02910739|3456283|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3604566|NCT02910739|3456281|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604567|NCT02910739|3456282|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604568|NCT02910739|3456283|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604569|NCT02910739|3456281|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604570|NCT02910739|3456282|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604571|NCT02910739|3456283|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604572|NCT02910739|3456281|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604573|NCT02910739|3456282|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604574|NCT02910739|3456283|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604575|NCT02910739|3456281|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3604576|NCT02910739|3456282|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3604577|NCT02910739|3456283|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3604578|NCT02910739|3456281|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3604579|NCT02910739|3456282|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3604580|NCT02910739|3456283|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3604581|NCT02910739|3456281|B3|||Age||years|Mean|61.2|61.2|Standard Deviation|5.3|5.3|||
3604582|NCT02910739|3456282|B2|||Age||years|Mean|61.4|61.4|Standard Deviation|4.8|4.8|||
3604583|NCT02910739|3456283|B1|||Age||years|Mean|61.0|61.0|Standard Deviation|6.1|6.1|||
3604584|NCT02910362|3456312|B3|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3604585|NCT02910362|3456313|B2|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3604586|NCT02910362|3456314|B1|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3604587|NCT02910362|3456312|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3604588|NCT02910362|3456313|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3604589|NCT02910362|3456314|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3604590|NCT02910362|3456312|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3604591|NCT02910362|3456313|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3604592|NCT02910362|3456314|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3604593|NCT02910362|3456312|B3|||Age||years|Mean|66|66.0|Standard Deviation|8|8.0|||
3604594|NCT02910362|3456313|B2|||Age||years|Mean|66|66.0|Standard Deviation|8|8.0|||
3604595|NCT02910362|3456314|B1|||Age||years|Mean|66|66.0|Standard Deviation|8|8.0|||
3604596|NCT02908269|3456321|B4|United States||Region of Enrollment||participants|Number|180|180.0||||||
3604597|NCT02908269|3456322|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
3604598|NCT02908269|3456323|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
3604599|NCT02908269|3456324|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
3604600|NCT02908269|3456321|B4||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3604601|NCT02908269|3456322|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3604602|NCT02908269|3456323|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3604603|NCT02908269|3456324|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3604604|NCT02908269|3456321|B4||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3604605|NCT02908269|3456322|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3604606|NCT02908269|3456323|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3604607|NCT02908269|3456324|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3604608|NCT02908269|3456321|B4|||Age||years|Mean|40.3|40.3|Standard Deviation|28.5|28.5|||
3604609|NCT02908269|3456322|B3|||Age||years|Mean|72.6|72.6|Standard Deviation|6.19|6.19|||
3604610|NCT02908269|3456323|B2|||Age||years|Mean|42.2|42.2|Standard Deviation|12.9|12.9|||
3604611|NCT02908269|3456324|B1|||Age||years|Mean|6.03|6.03|Standard Deviation|1.61|1.61|||
3604612|NCT02907892|3456340|B3|United States||Region of Enrollment||participants|Number|553|553.0||||||
3604613|NCT02907892|3456341|B2|United States||Region of Enrollment||participants|Number|276|276.0||||||
3604614|NCT02907892|3456342|B1|United States||Region of Enrollment||participants|Number|277|277.0||||||
3604615|NCT02907892|3456340|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3604616|NCT02907892|3456340|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3604617|NCT02907892|3456341|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3604618|NCT02907892|3456342|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3604619|NCT02907892|3456340|B3||Female|Sex: Female, Male||Participants|Count of Participants|553|553.0||||||
3604620|NCT02907892|3456341|B2||Female|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
3604621|NCT02907892|3456342|B1||Female|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
3604622|NCT02907892|3456340|B3|||Age||Years|Mean|30.6|30.6|Standard Deviation|5.3|5.3|||
3604623|NCT02907892|3456341|B2|||Age||Years|Mean|30.6|30.6|Standard Deviation|5.4|5.4|||
3604624|NCT02907892|3456342|B1|||Age||Years|Mean|30.7|30.7|Standard Deviation|5.3|5.3|||
3604625|NCT02907268|3456349|B3|||Blinded assessment of facial rhytids|5 point scale. 0=Wrinkles absent (minimum), 1=shallow but visible wrinkles, 2=fine lines slight indentation, 3=clear indentation(0-1mm deep), 4=moderate(1-2mm), 5=deep(>2mm) (maximum). Higher value means a worse outcome (more severe wrinkles). 9 subscales used to obtain 1 score for each patient. Same 5 point scale used for all subscales. Subscales assess different areas of the face. The 9 scales include assessments of the left & right forehead, glabella, around eyes on left & right, left & right cheek, left & right upper lip. Total per patient achieved by taking average of all 9 subscales.|units on a scale|Mean|2.7|2.7|Full Range|||1.6|3.0|
3604675|NCT02906917|3456361|B1|||Age||Years|Mean|58.2|58.2|Standard Deviation|8.9|8.9|||
3604676|NCT02906813|3456390|B4|Not applicable||Female Reproductive Status||Participants|Count of Participants|7|7.0||||||
3604677|NCT02906813|3456391|B3|Not applicable||Female Reproductive Status||Participants|Count of Participants|2|2.0||||||
3604678|NCT02906813|3456392|B2|Not applicable||Female Reproductive Status||Participants|Count of Participants|3|3.0||||||
3604679|NCT02906813|3456393|B1|Not applicable||Female Reproductive Status||Participants|Count of Participants|2|2.0||||||
3604626|NCT02907268|3456350|B2|||Blinded assessment of facial rhytids|5 point scale. 0=Wrinkles absent (minimum), 1=shallow but visible wrinkles, 2=fine lines slight indentation, 3=clear indentation(0-1mm deep), 4=moderate(1-2mm), 5=deep(>2mm) (maximum). Higher value means a worse outcome (more severe wrinkles). 9 subscales used to obtain 1 score for each patient. Same 5 point scale used for all subscales. Subscales assess different areas of the face. The 9 scales include assessments of the left & right forehead, glabella, around eyes on left & right, left & right cheek, left & right upper lip. Total per patient achieved by taking average of all 9 subscales.|units on a scale|Mean|2.8|2.8|Full Range|||2.4|3.0|
3604627|NCT02907268|3456351|B1|||Blinded assessment of facial rhytids|5 point scale. 0=Wrinkles absent (minimum), 1=shallow but visible wrinkles, 2=fine lines slight indentation, 3=clear indentation(0-1mm deep), 4=moderate(1-2mm), 5=deep(>2mm) (maximum). Higher value means a worse outcome (more severe wrinkles). 9 subscales used to obtain 1 score for each patient. Same 5 point scale used for all subscales. Subscales assess different areas of the face. The 9 scales include assessments of the left & right forehead, glabella, around eyes on left & right, left & right cheek, left & right upper lip. Total per patient achieved by taking average of all 9 subscales.|units on a scale|Mean|2.5|2.5|Full Range|||1.6|3.0|
3604628|NCT02907268|3456349|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3604629|NCT02907268|3456350|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3604630|NCT02907268|3456351|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3604631|NCT02907268|3456349|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3604632|NCT02907268|3456350|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3604633|NCT02907268|3456351|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3604634|NCT02907268|3456349|B3|||Age||years|Mean|51.1|51.1|Full Range|||51.1|60.0|
3604635|NCT02907268|3456350|B2|||Age||years|Mean|51.1|51.1|Full Range|||51.1|60.0|
3604636|NCT02907268|3456351|B1|||Age||years|Mean|51.1|51.1|Full Range|||44.0|60.0|
3604637|NCT02906917|3456359|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3604638|NCT02906917|3456360|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3604639|NCT02906917|3456361|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3604640|NCT02906917|3456359|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604641|NCT02906917|3456360|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604642|NCT02906917|3456361|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604643|NCT02906917|3456359|B3||White|Race (NIH/OMB)||Participants|Count of Participants|441|441.0||||||
3604644|NCT02906917|3456360|B2||White|Race (NIH/OMB)||Participants|Count of Participants|220|220.0||||||
3604645|NCT02906917|3456361|B1||White|Race (NIH/OMB)||Participants|Count of Participants|221|221.0||||||
3604646|NCT02906917|3456359|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3604647|NCT02906917|3456360|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3604648|NCT02906917|3456361|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3604649|NCT02906917|3456359|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604650|NCT02906917|3456360|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604651|NCT02906917|3456361|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604652|NCT02906917|3456359|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3604653|NCT02906917|3456360|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3604654|NCT02906917|3456361|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3604655|NCT02906917|3456359|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3604656|NCT02906917|3456360|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604657|NCT02906917|3456361|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3604658|NCT02906917|3456359|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604659|NCT02906917|3456360|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604660|NCT02906917|3456361|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604661|NCT02906917|3456359|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|491|491.0||||||
3604662|NCT02906917|3456360|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|245|245.0||||||
3604663|NCT02906917|3456361|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|246|246.0||||||
3604664|NCT02906917|3456359|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3604665|NCT02906917|3456360|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3604666|NCT02906917|3456361|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3604667|NCT02906917|3456359|B3||Male|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
3604668|NCT02906917|3456360|B2||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3604669|NCT02906917|3456361|B1||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3604670|NCT02906917|3456359|B3||Female|Sex: Female, Male||Participants|Count of Participants|270|270.0||||||
3604671|NCT02906917|3456360|B2||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3604672|NCT02906917|3456361|B1||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3604673|NCT02906917|3456359|B3|||Age||Years|Mean|58.7|58.7|Standard Deviation|9.0|9.0|||
3604674|NCT02906917|3456360|B2|||Age||Years|Mean|59.2|59.2|Standard Deviation|9.1|9.1|||
3604680|NCT02906813|3456390|B4|Having childbearing potential||Female Reproductive Status||Participants|Count of Participants|1|1.0||||||
3604681|NCT02906813|3456391|B3|Having childbearing potential||Female Reproductive Status||Participants|Count of Participants|0|0.0||||||
3604682|NCT02906813|3456392|B2|Having childbearing potential||Female Reproductive Status||Participants|Count of Participants|0|0.0||||||
3604683|NCT02906813|3456393|B1|Having childbearing potential||Female Reproductive Status||Participants|Count of Participants|1|1.0||||||
3604684|NCT02906813|3456390|B4|Postmenopausal||Female Reproductive Status||Participants|Count of Participants|1|1.0||||||
3604685|NCT02906813|3456391|B3|Postmenopausal||Female Reproductive Status||Participants|Count of Participants|1|1.0||||||
3604686|NCT02906813|3456392|B2|Postmenopausal||Female Reproductive Status||Participants|Count of Participants|0|0.0||||||
3604687|NCT02906813|3456393|B1|Postmenopausal||Female Reproductive Status||Participants|Count of Participants|0|0.0||||||
3604688|NCT02906813|3456390|B4|||No Xanthine/Caffeine Consumption||Participants|Count of Participants|9|9.0||||||
3604689|NCT02906813|3456391|B3|||No Xanthine/Caffeine Consumption||Participants|Count of Participants|3|3.0||||||
3604690|NCT02906813|3456392|B2|||No Xanthine/Caffeine Consumption||Participants|Count of Participants|3|3.0||||||
3604691|NCT02906813|3456393|B1|||No Xanthine/Caffeine Consumption||Participants|Count of Participants|3|3.0||||||
3604692|NCT02906813|3456390|B4|||No Alcohol Consumption||Participants|Count of Participants|9|9.0||||||
3604693|NCT02906813|3456391|B3|||No Alcohol Consumption||Participants|Count of Participants|3|3.0||||||
3604694|NCT02906813|3456392|B2|||No Alcohol Consumption||Participants|Count of Participants|3|3.0||||||
3604695|NCT02906813|3456393|B1|||No Alcohol Consumption||Participants|Count of Participants|3|3.0||||||
3604696|NCT02906813|3456390|B4|Ex-smoker||Smoking Classification||Participants|Count of Participants|2|2.0||||||
3604697|NCT02906813|3456391|B3|Ex-smoker||Smoking Classification||Participants|Count of Participants|0|0.0||||||
3604698|NCT02906813|3456392|B2|Ex-smoker||Smoking Classification||Participants|Count of Participants|1|1.0||||||
3604699|NCT02906813|3456393|B1|Ex-smoker||Smoking Classification||Participants|Count of Participants|1|1.0||||||
3604700|NCT02906813|3456390|B4|Never smoked||Smoking Classification||Participants|Count of Participants|7|7.0||||||
3604701|NCT02906813|3456391|B3|Never smoked||Smoking Classification||Participants|Count of Participants|3|3.0||||||
3604702|NCT02906813|3456392|B2|Never smoked||Smoking Classification||Participants|Count of Participants|2|2.0||||||
3604703|NCT02906813|3456393|B1|Never smoked||Smoking Classification||Participants|Count of Participants|2|2.0||||||
3604704|NCT02906813|3456390|B4|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|26.46|26.46|Standard Deviation|2.430|2.43|||
3604705|NCT02906813|3456391|B3|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|24.62|24.62|Standard Deviation|3.295|3.295|||
3604706|NCT02906813|3456392|B2|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|26.75|26.75|Standard Deviation|0.889|0.889|||
3604707|NCT02906813|3456393|B1|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|28.01|28.01|Standard Deviation|1.784|1.784|||
3604708|NCT02906813|3456390|B4|||Weight||kilogram (kg)|Mean|77.62|77.62|Standard Deviation|9.039|9.039|||
3604709|NCT02906813|3456391|B3|||Weight||kilogram (kg)|Mean|71.50|71.5|Standard Deviation|10.096|10.096|||
3604710|NCT02906813|3456392|B2|||Weight||kilogram (kg)|Mean|78.20|78.2|Standard Deviation|1.311|1.311|||
3604711|NCT02906813|3456393|B1|||Weight||kilogram (kg)|Mean|83.17|83.17|Standard Deviation|10.970|10.97|||
3604712|NCT02906813|3456390|B4|||Height||centimeter (cm)|Mean|171.1|171.1|Standard Deviation|3.44|3.44|||
3604713|NCT02906813|3456391|B3|||Height||centimeter (cm)|Mean|170.3|170.3|Standard Deviation|1.53|1.53|||
3604714|NCT02906813|3456392|B2|||Height||centimeter (cm)|Mean|171.0|171.0|Standard Deviation|2.00|2.0|||
3604715|NCT02906813|3456393|B1|||Height||centimeter (cm)|Mean|172.0|172.0|Standard Deviation|6.24|6.24|||
3604716|NCT02906813|3456390|B4|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3604717|NCT02906813|3456391|B3|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3604718|NCT02906813|3456392|B2|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3604719|NCT02906813|3456393|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3604720|NCT02906813|3456390|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604721|NCT02906813|3456391|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604722|NCT02906813|3456392|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604723|NCT02906813|3456393|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604724|NCT02906813|3456390|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3604725|NCT02906813|3456391|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3604726|NCT02906813|3456392|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604727|NCT02906813|3456393|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604728|NCT02906813|3456390|B4||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3604729|NCT02906813|3456391|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3604730|NCT02906813|3456392|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3604731|NCT02906813|3456393|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604732|NCT02906813|3456390|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3604733|NCT02906813|3456391|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604734|NCT02906813|3456392|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3604735|NCT02906813|3456393|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3604736|NCT02906813|3456390|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604737|NCT02906813|3456391|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604738|NCT02906813|3456392|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604739|NCT02906813|3456393|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604740|NCT02906813|3456390|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604741|NCT02906813|3456391|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604742|NCT02906813|3456392|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604743|NCT02906813|3456393|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604744|NCT02906813|3456390|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604745|NCT02906813|3456391|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604746|NCT02906813|3456392|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604747|NCT02906813|3456393|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604748|NCT02906813|3456390|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3604749|NCT02906813|3456391|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3604750|NCT02906813|3456392|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3604751|NCT02906813|3456393|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3604752|NCT02906813|3456390|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3604753|NCT02906813|3456391|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3604754|NCT02906813|3456392|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3604755|NCT02906813|3456393|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3604756|NCT02906813|3456390|B4|||Age||years|Mean|36.7|36.7|Standard Deviation|8.00|8.0|||
3604757|NCT02906813|3456391|B3|||Age||years|Mean|35.7|35.7|Standard Deviation|13.58|13.58|||
3604758|NCT02906813|3456392|B2|||Age||years|Mean|37.0|37.0|Standard Deviation|3.00|3.0|||
3604759|NCT02906813|3456393|B1|||Age||years|Mean|37.3|37.3|Standard Deviation|7.77|7.77|||
3604760|NCT02906358|3456421|B3||Multiple areas|Pain Location||Participants|Count of Participants|62|62.0||||||
3604761|NCT02906358|3456422|B2||Multiple areas|Pain Location||Participants|Count of Participants|32|32.0||||||
3604762|NCT02906358|3456423|B1||Multiple areas|Pain Location||Participants|Count of Participants|30|30.0||||||
3604763|NCT02906358|3456421|B3||Lower Extremity|Pain Location||Participants|Count of Participants|9|9.0||||||
3604764|NCT02906358|3456422|B2||Lower Extremity|Pain Location||Participants|Count of Participants|4|4.0||||||
3604765|NCT02906358|3456423|B1||Lower Extremity|Pain Location||Participants|Count of Participants|5|5.0||||||
3604766|NCT02906358|3456421|B3||Abdomen|Pain Location||Participants|Count of Participants|1|1.0||||||
3604767|NCT02906358|3456422|B2||Abdomen|Pain Location||Participants|Count of Participants|0|0.0||||||
3604768|NCT02906358|3456423|B1||Abdomen|Pain Location||Participants|Count of Participants|1|1.0||||||
3604769|NCT02906358|3456421|B3||Back|Pain Location||Participants|Count of Participants|32|32.0||||||
3604770|NCT02906358|3456422|B2||Back|Pain Location||Participants|Count of Participants|13|13.0||||||
3604771|NCT02906358|3456423|B1||Back|Pain Location||Participants|Count of Participants|19|19.0||||||
3604772|NCT02906358|3456421|B3||Upper Extremity|Pain Location||Participants|Count of Participants|4|4.0||||||
3604773|NCT02906358|3456422|B2||Upper Extremity|Pain Location||Participants|Count of Participants|1|1.0||||||
3604774|NCT02906358|3456423|B1||Upper Extremity|Pain Location||Participants|Count of Participants|3|3.0||||||
3604775|NCT02906358|3456421|B3||Neck|Pain Location||Participants|Count of Participants|3|3.0||||||
3604776|NCT02906358|3456422|B2||Neck|Pain Location||Participants|Count of Participants|3|3.0||||||
3604777|NCT02906358|3456423|B1||Neck|Pain Location||Participants|Count of Participants|0|0.0||||||
3604778|NCT02906358|3456421|B3|||BMI||kg/m^2|Mean|34.5|34.5|Standard Deviation|8.4|8.4|||
3604779|NCT02906358|3456422|B2|||BMI||kg/m^2|Mean|33.3|33.3|Standard Deviation|8.8|8.8|||
3604780|NCT02906358|3456423|B1|||BMI||kg/m^2|Mean|35.5|35.5|Standard Deviation|8.0|8.0|||
3604781|NCT02906358|3456421|B3||Unisured|Insurance Type||Participants|Count of Participants|39|39.0||||||
3604782|NCT02906358|3456422|B2||Unisured|Insurance Type||Participants|Count of Participants|19|19.0||||||
3604783|NCT02906358|3456423|B1||Unisured|Insurance Type||Participants|Count of Participants|20|20.0||||||
3604784|NCT02906358|3456421|B3||Medicaid|Insurance Type||Participants|Count of Participants|24|24.0||||||
3604785|NCT02906358|3456422|B2||Medicaid|Insurance Type||Participants|Count of Participants|11|11.0||||||
3604786|NCT02906358|3456423|B1||Medicaid|Insurance Type||Participants|Count of Participants|13|13.0||||||
3604787|NCT02906358|3456421|B3||Medicare|Insurance Type||Participants|Count of Participants|38|38.0||||||
3604788|NCT02906358|3456422|B2||Medicare|Insurance Type||Participants|Count of Participants|17|17.0||||||
3604789|NCT02906358|3456423|B1||Medicare|Insurance Type||Participants|Count of Participants|21|21.0||||||
3604790|NCT02906358|3456421|B3||Private Insurance|Insurance Type||Participants|Count of Participants|10|10.0||||||
3604791|NCT02906358|3456422|B2||Private Insurance|Insurance Type||Participants|Count of Participants|6|6.0||||||
3604792|NCT02906358|3456423|B1||Private Insurance|Insurance Type||Participants|Count of Participants|4|4.0||||||
3604793|NCT02906358|3456421|B3||Unemployed (retired, disabled, unemployed)|Employment Status||Participants|Count of Participants|104|104.0||||||
3604794|NCT02906358|3456422|B2||Unemployed (retired, disabled, unemployed)|Employment Status||Participants|Count of Participants|52|52.0||||||
3604795|NCT02906358|3456423|B1||Unemployed (retired, disabled, unemployed)|Employment Status||Participants|Count of Participants|52|52.0||||||
3604796|NCT02906358|3456421|B3||Employed|Employment Status||Participants|Count of Participants|7|7.0||||||
3604797|NCT02906358|3456422|B2||Employed|Employment Status||Participants|Count of Participants|1|1.0||||||
3604798|NCT02906358|3456423|B1||Employed|Employment Status||Participants|Count of Participants|6|6.0||||||
3604799|NCT02906358|3456421|B3||Other (single, divorced, separated, widowed)|Marital Status||Participants|Count of Participants|77|77.0||||||
3604800|NCT02906358|3456422|B2||Other (single, divorced, separated, widowed)|Marital Status||Participants|Count of Participants|37|37.0||||||
3604801|NCT02906358|3456423|B1||Other (single, divorced, separated, widowed)|Marital Status||Participants|Count of Participants|40|40.0||||||
3604802|NCT02906358|3456421|B3||Married|Marital Status||Participants|Count of Participants|34|34.0||||||
3604803|NCT02906358|3456422|B2||Married|Marital Status||Participants|Count of Participants|16|16.0||||||
3604804|NCT02906358|3456423|B1||Married|Marital Status||Participants|Count of Participants|18|18.0||||||
3604805|NCT02906358|3456421|B3||Spanish|Primary Language||Participants|Count of Participants|30|30.0||||||
3604806|NCT02906358|3456422|B2||Spanish|Primary Language||Participants|Count of Participants|17|17.0||||||
3604807|NCT02906358|3456423|B1||Spanish|Primary Language||Participants|Count of Participants|13|13.0||||||
3604808|NCT02906358|3456421|B3||English|Primary Language||Participants|Count of Participants|81|81.0||||||
3604809|NCT02906358|3456422|B2||English|Primary Language||Participants|Count of Participants|36|36.0||||||
3604810|NCT02906358|3456423|B1||English|Primary Language||Participants|Count of Participants|45|45.0||||||
3604811|NCT02906358|3456421|B3||Non-Hispanic Black|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3604812|NCT02906358|3456422|B2||Non-Hispanic Black|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3604813|NCT02906358|3456423|B1||Non-Hispanic Black|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3604814|NCT02906358|3456421|B3||Non-Hispanic White|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3604815|NCT02906358|3456422|B2||Non-Hispanic White|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3604816|NCT02906358|3456423|B1||Non-Hispanic White|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3604817|NCT02906358|3456421|B3||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|87|87.0||||||
3604818|NCT02906358|3456422|B2||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3604819|NCT02906358|3456423|B1||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|45|45.0||||||
3604820|NCT02906358|3456421|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3604821|NCT02906358|3456422|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3604822|NCT02906358|3456423|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3604823|NCT02906358|3456421|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3604824|NCT02906358|3456422|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3604825|NCT02906358|3456423|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3604826|NCT02906358|3456421|B3|||Age||years|Mean|56.5|56.5|Standard Deviation|9.0|9.0|||
3604827|NCT02906358|3456422|B2|||Age||years|Mean|56.2|56.2|Standard Deviation|9.4|9.4|||
3604828|NCT02906358|3456423|B1|||Age||years|Mean|56.9|56.9|Standard Deviation|8.7|8.7|||
3604829|NCT02905825|3456452|B1|Israel||Region of Enrollment||participants|Number|16|16.0||||||
3604830|NCT02905825|3456452|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
3604831|NCT02905825|3456452|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3604832|NCT02905825|3456452|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3604833|NCT02905825|3456452|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3604834|NCT02905825|3456452|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3604835|NCT02905825|3456452|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3604836|NCT02905825|3456452|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3604837|NCT02905825|3456452|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3604838|NCT02905825|3456452|B1||<=18 years|Age||Participants|Count of Participants|53|53.0||||||
3604839|NCT02905331|3456458|B3|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3604840|NCT02905331|3456459|B2|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3604841|NCT02905331|3456460|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3604842|NCT02905331|3456458|B3|Poland||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3604843|NCT02905331|3456459|B2|Poland||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3604844|NCT02905331|3456460|B1|Poland||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3604845|NCT02905331|3456458|B3|Canada||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3604846|NCT02905331|3456459|B2|Canada||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3604847|NCT02905331|3456460|B1|Canada||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3604848|NCT02905331|3456458|B3|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|68|68.0||||||
3604849|NCT02905331|3456459|B2|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|55|55.0||||||
3604850|NCT02905331|3456460|B1|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3604851|NCT02905331|3456458|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3604852|NCT02905331|3456459|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3604853|NCT02905331|3456460|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3604854|NCT02905331|3456458|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3604855|NCT02905331|3456459|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3604856|NCT02905331|3456460|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3604857|NCT02905331|3456458|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3604858|NCT02905331|3456459|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3604859|NCT02905331|3456460|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3604860|NCT02905331|3456458|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3604861|NCT02905331|3456459|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3604862|NCT02905331|3456460|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3604863|NCT02905331|3456458|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604864|NCT02905331|3456459|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604865|NCT02905331|3456460|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604866|NCT02905331|3456458|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3604867|NCT02905331|3456459|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3604868|NCT02905331|3456460|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604869|NCT02905331|3456458|B3||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3604870|NCT02905331|3456459|B2||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3604871|NCT02905331|3456460|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3604872|NCT02905331|3456458|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3604873|NCT02905331|3456459|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3604874|NCT02905331|3456460|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3604875|NCT02905331|3456458|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604876|NCT02905331|3456459|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604877|NCT02905331|3456460|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604878|NCT02905331|3456458|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3604879|NCT02905331|3456459|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3604880|NCT02905331|3456460|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3604881|NCT02905331|3456458|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604882|NCT02905331|3456459|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604883|NCT02905331|3456460|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604884|NCT02905331|3456458|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604885|NCT02905331|3456459|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604886|NCT02905331|3456460|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604887|NCT02905331|3456458|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3604888|NCT02905331|3456459|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3604889|NCT02905331|3456460|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3604890|NCT02905331|3456458|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3604891|NCT02905331|3456459|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3604892|NCT02905331|3456460|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3604893|NCT02905331|3456458|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3604894|NCT02905331|3456459|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3604895|NCT02905331|3456460|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3604896|NCT02905331|3456458|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3604897|NCT02905331|3456459|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3604898|NCT02905331|3456460|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3604899|NCT02905331|3456458|B3|>=65 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
3604900|NCT02905331|3456459|B2|>=65 years||Age, Customized||Participants|Count of Participants|4|4.0||||||
3604901|NCT02905331|3456460|B1|>=65 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
3604902|NCT02905331|3456458|B3|>=18 to 65 years||Age, Customized||Participants|Count of Participants|72|72.0||||||
3604903|NCT02905331|3456459|B2|>=18 to 65 years||Age, Customized||Participants|Count of Participants|58|58.0||||||
3604904|NCT02905331|3456460|B1|>=18 to 65 years||Age, Customized||Participants|Count of Participants|14|14.0||||||
3604905|NCT02905331|3456458|B3|||Age||years|Mean|46|46.0|Standard Deviation|13.43|13.43|||
3604906|NCT02905331|3456459|B2|||Age||years|Mean|46.2|46.2|Standard Deviation|12.92|12.92|||
3604907|NCT02905331|3456460|B1|||Age||years|Mean|45.4|45.4|Standard Deviation|15.7|15.7|||
3604908|NCT02904915|3456488|B3|||Take pain medication||Participants|Count of Participants|4|4.0||||||
3604909|NCT02904915|3456489|B2|||Take pain medication||Participants|Count of Participants|2|2.0||||||
3604910|NCT02904915|3456490|B1|||Take pain medication||Participants|Count of Participants|2|2.0||||||
3604911|NCT02904915|3456488|B3|None||History of Infection||Participants|Count of Participants|10|10.0||||||
3604912|NCT02904915|3456489|B2|None||History of Infection||Participants|Count of Participants|3|3.0||||||
3604913|NCT02904915|3456490|B1|None||History of Infection||Participants|Count of Participants|7|7.0||||||
3604914|NCT02904915|3456488|B3|Human papillomavirus (HPV)||History of Infection||Participants|Count of Participants|10|10.0||||||
3604915|NCT02904915|3456489|B2|Human papillomavirus (HPV)||History of Infection||Participants|Count of Participants|4|4.0||||||
3604916|NCT02904915|3456490|B1|Human papillomavirus (HPV)||History of Infection||Participants|Count of Participants|6|6.0||||||
3604917|NCT02904915|3456488|B3|Yeast||History of Infection||Participants|Count of Participants|7|7.0||||||
3604918|NCT02904915|3456489|B2|Yeast||History of Infection||Participants|Count of Participants|3|3.0||||||
3604919|NCT02904915|3456490|B1|Yeast||History of Infection||Participants|Count of Participants|4|4.0||||||
3604920|NCT02904915|3456488|B3|Bacterial vaginosis (BV)||History of Infection||Participants|Count of Participants|21|21.0||||||
3604921|NCT02904915|3456489|B2|Bacterial vaginosis (BV)||History of Infection||Participants|Count of Participants|13|13.0||||||
3604922|NCT02904915|3456490|B1|Bacterial vaginosis (BV)||History of Infection||Participants|Count of Participants|8|8.0||||||
3604923|NCT02904915|3456488|B3|Chlamydia||History of Infection||Participants|Count of Participants|2|2.0||||||
3604924|NCT02904915|3456489|B2|Chlamydia||History of Infection||Participants|Count of Participants|2|2.0||||||
3604925|NCT02904915|3456490|B1|Chlamydia||History of Infection||Participants|Count of Participants|0|0.0||||||
3604926|NCT02904915|3456488|B3|Unknown||Contraception History||Participants|Count of Participants|6|6.0||||||
3604927|NCT02904915|3456489|B2|Unknown||Contraception History||Participants|Count of Participants|3|3.0||||||
3604928|NCT02904915|3456490|B1|Unknown||Contraception History||Participants|Count of Participants|3|3.0||||||
3604929|NCT02904915|3456488|B3|None||Contraception History||Participants|Count of Participants|7|7.0||||||
3604930|NCT02904915|3456489|B2|None||Contraception History||Participants|Count of Participants|4|4.0||||||
3604931|NCT02904915|3456490|B1|None||Contraception History||Participants|Count of Participants|3|3.0||||||
3604932|NCT02904915|3456488|B3|Nuvaring||Contraception History||Participants|Count of Participants|7|7.0||||||
3604933|NCT02904915|3456489|B2|Nuvaring||Contraception History||Participants|Count of Participants|6|6.0||||||
3604934|NCT02904915|3456490|B1|Nuvaring||Contraception History||Participants|Count of Participants|1|1.0||||||
3604935|NCT02904915|3456488|B3|Condoms (female and male)||Contraception History||Participants|Count of Participants|5|5.0||||||
3604936|NCT02904915|3456489|B2|Condoms (female and male)||Contraception History||Participants|Count of Participants|2|2.0||||||
3604937|NCT02904915|3456490|B1|Condoms (female and male)||Contraception History||Participants|Count of Participants|3|3.0||||||
3604938|NCT02904915|3456488|B3|Depo Provera/injections||Contraception History||Participants|Count of Participants|10|10.0||||||
3604939|NCT02904915|3456489|B2|Depo Provera/injections||Contraception History||Participants|Count of Participants|3|3.0||||||
3604940|NCT02904915|3456490|B1|Depo Provera/injections||Contraception History||Participants|Count of Participants|7|7.0||||||
3604941|NCT02904915|3456488|B3|Nexplanon/injectables||Contraception History||Participants|Count of Participants|1|1.0||||||
3604942|NCT02904915|3456489|B2|Nexplanon/injectables||Contraception History||Participants|Count of Participants|0|0.0||||||
3604943|NCT02904915|3456490|B1|Nexplanon/injectables||Contraception History||Participants|Count of Participants|1|1.0||||||
3604944|NCT02904915|3456488|B3|Intrauterine device (IUD)||Contraception History||Participants|Count of Participants|6|6.0||||||
3604945|NCT02904915|3456489|B2|Intrauterine device (IUD)||Contraception History||Participants|Count of Participants|5|5.0||||||
3604946|NCT02904915|3456490|B1|Intrauterine device (IUD)||Contraception History||Participants|Count of Participants|1|1.0||||||
3604947|NCT02904915|3456488|B3|Oral contraceptive pill||Contraception History||Participants|Count of Participants|8|8.0||||||
3604948|NCT02904915|3456489|B2|Oral contraceptive pill||Contraception History||Participants|Count of Participants|2|2.0||||||
3604949|NCT02904915|3456490|B1|Oral contraceptive pill||Contraception History||Participants|Count of Participants|6|6.0||||||
3604950|NCT02904915|3456488|B3|None||Prior delivery type||Participants|Count of Participants|3|3.0||||||
3604951|NCT02904915|3456489|B2|None||Prior delivery type||Participants|Count of Participants|0|0.0||||||
3604952|NCT02904915|3456490|B1|None||Prior delivery type||Participants|Count of Participants|3|3.0||||||
3604953|NCT02904915|3456488|B3|Vaginal||Prior delivery type||Participants|Count of Participants|36|36.0||||||
3604954|NCT02904915|3456489|B2|Vaginal||Prior delivery type||Participants|Count of Participants|21|21.0||||||
3604955|NCT02904915|3456490|B1|Vaginal||Prior delivery type||Participants|Count of Participants|15|15.0||||||
3604956|NCT02904915|3456488|B3|Cesarean Section||Prior delivery type||Participants|Count of Participants|11|11.0||||||
3604957|NCT02904915|3456489|B2|Cesarean Section||Prior delivery type||Participants|Count of Participants|4|4.0||||||
3604958|NCT02904915|3456490|B1|Cesarean Section||Prior delivery type||Participants|Count of Participants|7|7.0||||||
3604959|NCT02904915|3456488|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3604960|NCT02904915|3456489|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3604961|NCT02904915|3456490|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3604962|NCT02904915|3456488|B3|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3604963|NCT02904915|3456489|B2|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3604964|NCT02904915|3456490|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3604965|NCT02904915|3456488|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3604966|NCT02904915|3456489|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3604967|NCT02904915|3456490|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3604968|NCT02904915|3456488|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3604969|NCT02904915|3456489|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3604970|NCT02904915|3456490|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3604971|NCT02904915|3456488|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3604972|NCT02904915|3456489|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3604973|NCT02904915|3456490|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3604974|NCT02904915|3456488|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3604975|NCT02904915|3456489|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3604976|NCT02904915|3456490|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3604977|NCT02904915|3456488|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3604978|NCT02904915|3456489|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3604979|NCT02904915|3456490|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3604980|NCT02904915|3456488|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3604981|NCT02904915|3456489|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3604982|NCT02904915|3456490|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3604983|NCT02904915|3456488|B3|||Age||years|Mean|25.6|25.6|Standard Deviation|5.4|5.4|||
3604984|NCT02904915|3456489|B2|||Age||years|Mean|26.6|26.6|Standard Deviation|5.9|5.9|||
3604985|NCT02904915|3456490|B1|||Age||years|Mean|24.6|24.6|Standard Deviation|4.6|4.6|||
3604986|NCT02903394|3456501|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3604987|NCT02903394|3456502|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3604988|NCT02903394|3456503|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604989|NCT02903394|3456501|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604990|NCT02903394|3456502|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604991|NCT02903394|3456503|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604992|NCT02903394|3456501|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3604993|NCT02903394|3456502|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3604994|NCT02903394|3456503|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3604995|NCT02903394|3456501|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3604996|NCT02903394|3456502|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3604997|NCT02903394|3456503|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3604998|NCT02903394|3456501|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3604999|NCT02903394|3456502|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605000|NCT02903394|3456503|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605001|NCT02903394|3456501|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3605002|NCT02903394|3456502|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3605003|NCT02903394|3456503|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605004|NCT02903394|3456501|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3605005|NCT02903394|3456502|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3605006|NCT02903394|3456503|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605007|NCT02903394|3456501|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605008|NCT02903394|3456502|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605009|NCT02903394|3456503|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605010|NCT02903394|3456501|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3605011|NCT02903394|3456502|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3605012|NCT02903394|3456503|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3605013|NCT02903394|3456501|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3605014|NCT02903394|3456502|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3605015|NCT02903394|3456503|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605016|NCT02903394|3456501|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3605017|NCT02903394|3456502|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3605018|NCT02903394|3456503|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3605019|NCT02903394|3456501|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3605020|NCT02903394|3456502|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3605021|NCT02903394|3456503|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3605022|NCT02903394|3456501|B3|||Age||years|Mean|29.4|29.4|Full Range|||18.0|42.0|
3605023|NCT02903394|3456502|B2|||Age||years|Mean|29.4|29.4|Full Range|||18.0|42.0|
3605024|NCT02903394|3456503|B1|||Age||years|Mean|29.8|29.8|Full Range|||24.0|34.0|
3605025|NCT02903238|3456514|B1|||Pain (Visual Analogue Score, VAS)|0 to 10 (0=no pain, 10=worst pain)|units on a scale|Mean|7.03|7.03|Standard Deviation|1.08|1.08|||
3605026|NCT02903238|3456514|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3605027|NCT02903238|3456514|B1||Male|Gender||Participants|Count of Participants|8|8.0||||||
3605028|NCT02903238|3456514|B1||Female|Gender||Participants|Count of Participants|9|9.0||||||
3605029|NCT02903238|3456514|B1|||Age||years|Mean|56.88|56.88|Standard Deviation|5.68|5.68|||
3605030|NCT02903238|3456514|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3605031|NCT02903238|3456514|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3605032|NCT02903238|3456514|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3605033|NCT02902172|3456523|B3|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3605034|NCT02902172|3456524|B2|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3605035|NCT02902172|3456525|B1|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3605036|NCT02902172|3456523|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605037|NCT02902172|3456524|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605038|NCT02902172|3456525|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605039|NCT02902172|3456523|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3605040|NCT02902172|3456524|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3605041|NCT02902172|3456525|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3605042|NCT02902172|3456523|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605043|NCT02902172|3456524|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605044|NCT02902172|3456525|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605045|NCT02902172|3456523|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3605046|NCT02902172|3456524|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3605047|NCT02902172|3456525|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3605048|NCT02902172|3456523|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3605049|NCT02902172|3456524|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3605050|NCT02902172|3456525|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3605051|NCT02902172|3456523|B3|||Age||years|Mean|27|27.0|Full Range|||16.0|44.0|
3605052|NCT02902172|3456524|B2|||Age||years|Mean|25|25.0|Full Range|||18.0|35.0|
3605053|NCT02902172|3456525|B1|||Age||years|Mean|28|28.0|Full Range|||16.0|44.0|
3605054|NCT02901951|3456534|B1|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|103|103.0||||||
3605055|NCT02901951|3456534|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3605056|NCT02901951|3456534|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3605057|NCT02901951|3456534|B1|||Age||Years|Mean|48.6|48.6|Standard Deviation|5.9|5.9|||
3605058|NCT02901054|3456545|B1|United States||Region of Enrollment|Washington University|participants|Number|15|15.0||||||
3605059|NCT02901054|3456545|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605060|NCT02901054|3456545|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605061|NCT02901054|3456545|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3605062|NCT02901054|3456545|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3605063|NCT02901054|3456545|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605064|NCT02901054|3456545|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605065|NCT02901054|3456545|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605066|NCT02901054|3456545|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3605067|NCT02901054|3456545|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3605068|NCT02901054|3456545|B1|||Age||years|Mean|58.0|58.0|Standard Deviation|6.9|6.9|||
3605069|NCT02899338|3456549|B3|||Body weight at baseline|Body weight at baseline is presented.|Kilogram (kg)|Mean|75.04|75.04|Standard Deviation|15.122|15.122|||
3605070|NCT02899338|3456550|B2|||Body weight at baseline|Body weight at baseline is presented.|Kilogram (kg)|Mean|75.25|75.25|Standard Deviation|14.909|14.909|||
3605071|NCT02899338|3456551|B1|||Body weight at baseline|Body weight at baseline is presented.|Kilogram (kg)|Mean|74.84|74.84|Standard Deviation|15.421|15.421|||
3605072|NCT02899338|3456549|B3||Unknown or Not Reported|Race (NIH/OMB)|Number of subjects belonging to different races are presented.|Participants|Count of Participants|1|1.0||||||
3605073|NCT02899338|3456550|B2||Unknown or Not Reported|Race (NIH/OMB)|Number of subjects belonging to different races are presented.|Participants|Count of Participants|1|1.0||||||
3605074|NCT02899338|3456551|B1||Unknown or Not Reported|Race (NIH/OMB)|Number of subjects belonging to different races are presented.|Participants|Count of Participants|0|0.0||||||
3605075|NCT02899338|3456549|B3||More than one race|Race (NIH/OMB)|Number of subjects belonging to different races are presented.|Participants|Count of Participants|0|0.0||||||
3605397|NCT02887989|3456676|B1|||Age||years|Mean|51.00|51.0|Standard Deviation|15.09|15.09|||
3605076|NCT02899338|3456550|B2||More than one race|Race (NIH/OMB)|Number of subjects belonging to different races are presented.|Participants|Count of Participants|0|0.0||||||
3605077|NCT02899338|3456551|B1||More than one race|Race (NIH/OMB)|Number of subjects belonging to different races are presented.|Participants|Count of Participants|0|0.0||||||
3605078|NCT02899338|3456549|B3||White|Race (NIH/OMB)|Number of subjects belonging to different races are presented.|Participants|Count of Participants|155|155.0||||||
3605079|NCT02899338|3456550|B2||White|Race (NIH/OMB)|Number of subjects belonging to different races are presented.|Participants|Count of Participants|77|77.0||||||
3605080|NCT02899338|3456551|B1||White|Race (NIH/OMB)|Number of subjects belonging to different races are presented.|Participants|Count of Participants|78|78.0||||||
3605081|NCT02899338|3456549|B3||Black or African American|Race (NIH/OMB)|Number of subjects belonging to different races are presented.|Participants|Count of Participants|4|4.0||||||
3605082|NCT02899338|3456550|B2||Black or African American|Race (NIH/OMB)|Number of subjects belonging to different races are presented.|Participants|Count of Participants|1|1.0||||||
3605083|NCT02899338|3456551|B1||Black or African American|Race (NIH/OMB)|Number of subjects belonging to different races are presented.|Participants|Count of Participants|3|3.0||||||
3605084|NCT02899338|3456549|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Number of subjects belonging to different races are presented.|Participants|Count of Participants|0|0.0||||||
3605085|NCT02899338|3456550|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Number of subjects belonging to different races are presented.|Participants|Count of Participants|0|0.0||||||
3605086|NCT02899338|3456551|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Number of subjects belonging to different races are presented.|Participants|Count of Participants|0|0.0||||||
3605087|NCT02899338|3456549|B3||Asian|Race (NIH/OMB)|Number of subjects belonging to different races are presented.|Participants|Count of Participants|2|2.0||||||
3605088|NCT02899338|3456550|B2||Asian|Race (NIH/OMB)|Number of subjects belonging to different races are presented.|Participants|Count of Participants|2|2.0||||||
3605089|NCT02899338|3456551|B1||Asian|Race (NIH/OMB)|Number of subjects belonging to different races are presented.|Participants|Count of Participants|0|0.0||||||
3605090|NCT02899338|3456549|B3||American Indian or Alaska Native|Race (NIH/OMB)|Number of subjects belonging to different races are presented.|Participants|Count of Participants|0|0.0||||||
3605091|NCT02899338|3456550|B2||American Indian or Alaska Native|Race (NIH/OMB)|Number of subjects belonging to different races are presented.|Participants|Count of Participants|0|0.0||||||
3605092|NCT02899338|3456551|B1||American Indian or Alaska Native|Race (NIH/OMB)|Number of subjects belonging to different races are presented.|Participants|Count of Participants|0|0.0||||||
3605093|NCT02899338|3456549|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)|Number of subjects having different ethnicities are presented.|Participants|Count of Participants|0|0.0||||||
3605094|NCT02899338|3456550|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)|Number of subjects having different ethnicities are presented.|Participants|Count of Participants|0|0.0||||||
3605095|NCT02899338|3456551|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|Number of subjects having different ethnicities are presented.|Participants|Count of Participants|0|0.0||||||
3605096|NCT02899338|3456549|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Number of subjects having different ethnicities are presented.|Participants|Count of Participants|162|162.0||||||
3605097|NCT02899338|3456550|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Number of subjects having different ethnicities are presented.|Participants|Count of Participants|81|81.0||||||
3605098|NCT02899338|3456551|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Number of subjects having different ethnicities are presented.|Participants|Count of Participants|81|81.0||||||
3605099|NCT02899338|3456549|B3||Hispanic or Latino|Ethnicity (NIH/OMB)|Number of subjects having different ethnicities are presented.|Participants|Count of Participants|0|0.0||||||
3605100|NCT02899338|3456550|B2||Hispanic or Latino|Ethnicity (NIH/OMB)|Number of subjects having different ethnicities are presented.|Participants|Count of Participants|0|0.0||||||
3605101|NCT02899338|3456551|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|Number of subjects having different ethnicities are presented.|Participants|Count of Participants|0|0.0||||||
3605102|NCT02899338|3456549|B3||Male|Sex: Female, Male|Number of subjects are presented as male/female in each treatment group.|Participants|Count of Participants|75|75.0||||||
3605103|NCT02899338|3456550|B2||Male|Sex: Female, Male|Number of subjects are presented as male/female in each treatment group.|Participants|Count of Participants|38|38.0||||||
3605104|NCT02899338|3456551|B1||Male|Sex: Female, Male|Number of subjects are presented as male/female in each treatment group.|Participants|Count of Participants|37|37.0||||||
3605105|NCT02899338|3456549|B3||Female|Sex: Female, Male|Number of subjects are presented as male/female in each treatment group.|Participants|Count of Participants|87|87.0||||||
3605106|NCT02899338|3456550|B2||Female|Sex: Female, Male|Number of subjects are presented as male/female in each treatment group.|Participants|Count of Participants|43|43.0||||||
3605107|NCT02899338|3456551|B1||Female|Sex: Female, Male|Number of subjects are presented as male/female in each treatment group.|Participants|Count of Participants|44|44.0||||||
3605108|NCT02899338|3456549|B3|||Age|Mean (SD) of age at enrollment is presented.|Years|Mean|43.0|43.0|Standard Deviation|14.62|14.62|||
3605109|NCT02899338|3456550|B2|||Age|Mean (SD) of age at enrollment is presented.|Years|Mean|41.5|41.5|Standard Deviation|14.44|14.44|||
3605110|NCT02899338|3456551|B1|||Age|Mean (SD) of age at enrollment is presented.|Years|Mean|44.5|44.5|Standard Deviation|14.74|14.74|||
3605111|NCT02898116|3456564|B1|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3605112|NCT02898116|3456564|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3605113|NCT02898116|3456564|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605114|NCT02898116|3456564|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3605115|NCT02898116|3456564|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605116|NCT02898116|3456564|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605117|NCT02898116|3456564|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605118|NCT02898116|3456564|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605119|NCT02898116|3456564|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605120|NCT02898116|3456564|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3605121|NCT02898116|3456564|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605122|NCT02898116|3456564|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3605123|NCT02898116|3456564|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3605124|NCT02898116|3456564|B1|||Age||years|Mean|57|57.0|Full Range|||48.0|66.0|
3605125|NCT02897141|3456570|B3|||Substance use weekly or more often||Participants|Count of Participants|24|24.0||||||
3605126|NCT02897141|3456571|B2|||Substance use weekly or more often||Participants|Count of Participants|9|9.0||||||
3605127|NCT02897141|3456572|B1|||Substance use weekly or more often||Participants|Count of Participants|15|15.0||||||
3605128|NCT02897141|3456570|B3|||Possible alcohol use disorder||Participants|Count of Participants|25|25.0||||||
3605129|NCT02897141|3456571|B2|||Possible alcohol use disorder||Participants|Count of Participants|10|10.0||||||
3605130|NCT02897141|3456572|B1|||Possible alcohol use disorder||Participants|Count of Participants|15|15.0||||||
3605131|NCT02897141|3456570|B3|||CD4 count greater than 500||Participants|Count of Participants|42|42.0||||||
3605132|NCT02897141|3456571|B2|||CD4 count greater than 500||Participants|Count of Participants|20|20.0||||||
3605133|NCT02897141|3456572|B1|||CD4 count greater than 500||Participants|Count of Participants|22|22.0||||||
3605134|NCT02897141|3456570|B3|||Ever diagnosed with AIDS||Participants|Count of Participants|41|41.0||||||
3605135|NCT02897141|3456571|B2|||Ever diagnosed with AIDS||Participants|Count of Participants|24|24.0||||||
3605136|NCT02897141|3456572|B1|||Ever diagnosed with AIDS||Participants|Count of Participants|17|17.0||||||
3605137|NCT02897141|3456570|B3|||Virologically suppressed||Participants|Count of Participants|68|68.0||||||
3605138|NCT02897141|3456571|B2|||Virologically suppressed||Participants|Count of Participants|34|34.0||||||
3605139|NCT02897141|3456572|B1|||Virologically suppressed||Participants|Count of Participants|34|34.0||||||
3605140|NCT02897141|3456570|B3||Prefer not to answer|ART use||Participants|Count of Participants|1|1.0||||||
3605141|NCT02897141|3456571|B2||Prefer not to answer|ART use||Participants|Count of Participants|0|0.0||||||
3605142|NCT02897141|3456572|B1||Prefer not to answer|ART use||Participants|Count of Participants|1|1.0||||||
3605143|NCT02897141|3456570|B3||1 pill per day|ART use||Participants|Count of Participants|41|41.0||||||
3605144|NCT02897141|3456571|B2||1 pill per day|ART use||Participants|Count of Participants|20|20.0||||||
3605145|NCT02897141|3456572|B1||1 pill per day|ART use||Participants|Count of Participants|21|21.0||||||
3605146|NCT02897141|3456570|B3||2+ pills per day|ART use||Participants|Count of Participants|34|34.0||||||
3605147|NCT02897141|3456571|B2||2+ pills per day|ART use||Participants|Count of Participants|19|19.0||||||
3605148|NCT02897141|3456572|B1||2+ pills per day|ART use||Participants|Count of Participants|15|15.0||||||
3605149|NCT02897141|3456570|B3||None|ART use||Participants|Count of Participants|4|4.0||||||
3605150|NCT02897141|3456571|B2||None|ART use||Participants|Count of Participants|1|1.0||||||
3605151|NCT02897141|3456572|B1||None|ART use||Participants|Count of Participants|3|3.0||||||
3605152|NCT02897141|3456570|B3||Unspecified|Employment||Participants|Count of Participants|4|4.0||||||
3605153|NCT02897141|3456571|B2||Unspecified|Employment||Participants|Count of Participants|2|2.0||||||
3605154|NCT02897141|3456572|B1||Unspecified|Employment||Participants|Count of Participants|2|2.0||||||
3605155|NCT02897141|3456570|B3||Disabled|Employment||Participants|Count of Participants|27|27.0||||||
3605156|NCT02897141|3456571|B2||Disabled|Employment||Participants|Count of Participants|16|16.0||||||
3605157|NCT02897141|3456572|B1||Disabled|Employment||Participants|Count of Participants|11|11.0||||||
3605158|NCT02897141|3456570|B3||Student|Employment||Participants|Count of Participants|4|4.0||||||
3605159|NCT02897141|3456571|B2||Student|Employment||Participants|Count of Participants|2|2.0||||||
3605160|NCT02897141|3456572|B1||Student|Employment||Participants|Count of Participants|2|2.0||||||
3605161|NCT02897141|3456570|B3||Retired|Employment||Participants|Count of Participants|4|4.0||||||
3605162|NCT02897141|3456571|B2||Retired|Employment||Participants|Count of Participants|1|1.0||||||
3605163|NCT02897141|3456572|B1||Retired|Employment||Participants|Count of Participants|3|3.0||||||
3605164|NCT02897141|3456570|B3||Unemployed (looking, not looking)|Employment||Participants|Count of Participants|26|26.0||||||
3605165|NCT02897141|3456571|B2||Unemployed (looking, not looking)|Employment||Participants|Count of Participants|11|11.0||||||
3605166|NCT02897141|3456572|B1||Unemployed (looking, not looking)|Employment||Participants|Count of Participants|15|15.0||||||
3605167|NCT02897141|3456570|B3||Working (full, part, off-books)|Employment||Participants|Count of Participants|15|15.0||||||
3605168|NCT02897141|3456571|B2||Working (full, part, off-books)|Employment||Participants|Count of Participants|8|8.0||||||
3605169|NCT02897141|3456572|B1||Working (full, part, off-books)|Employment||Participants|Count of Participants|7|7.0||||||
3605170|NCT02897141|3456570|B3||Don't know or prefer not to answer|Annual income||Participants|Count of Participants|11|11.0||||||
3605171|NCT02897141|3456571|B2||Don't know or prefer not to answer|Annual income||Participants|Count of Participants|5|5.0||||||
3605172|NCT02897141|3456572|B1||Don't know or prefer not to answer|Annual income||Participants|Count of Participants|6|6.0||||||
3605173|NCT02897141|3456570|B3||$20,000-$59,999/year|Annual income||Participants|Count of Participants|11|11.0||||||
3605174|NCT02897141|3456571|B2||$20,000-$59,999/year|Annual income||Participants|Count of Participants|8|8.0||||||
3605175|NCT02897141|3456572|B1||$20,000-$59,999/year|Annual income||Participants|Count of Participants|3|3.0||||||
3605176|NCT02897141|3456570|B3||$10,000-$19,999/year|Annual income||Participants|Count of Participants|19|19.0||||||
3605177|NCT02897141|3456571|B2||$10,000-$19,999/year|Annual income||Participants|Count of Participants|10|10.0||||||
3605178|NCT02897141|3456572|B1||$10,000-$19,999/year|Annual income||Participants|Count of Participants|9|9.0||||||
3605179|NCT02897141|3456570|B3||Less than $10,000/year|Annual income||Participants|Count of Participants|39|39.0||||||
3605180|NCT02897141|3456571|B2||Less than $10,000/year|Annual income||Participants|Count of Participants|17|17.0||||||
3605181|NCT02897141|3456572|B1||Less than $10,000/year|Annual income||Participants|Count of Participants|22|22.0||||||
3605182|NCT02897141|3456570|B3||Bachelors or advanced degree|Education||Participants|Count of Participants|13|13.0||||||
3605183|NCT02897141|3456571|B2||Bachelors or advanced degree|Education||Participants|Count of Participants|8|8.0||||||
3605184|NCT02897141|3456572|B1||Bachelors or advanced degree|Education||Participants|Count of Participants|5|5.0||||||
3605185|NCT02897141|3456570|B3||Some college or associates degree|Education||Participants|Count of Participants|28|28.0||||||
3605186|NCT02897141|3456571|B2||Some college or associates degree|Education||Participants|Count of Participants|13|13.0||||||
3605187|NCT02897141|3456572|B1||Some college or associates degree|Education||Participants|Count of Participants|15|15.0||||||
3605188|NCT02897141|3456570|B3||High school|Education||Participants|Count of Participants|25|25.0||||||
3605189|NCT02897141|3456571|B2||High school|Education||Participants|Count of Participants|14|14.0||||||
3605190|NCT02897141|3456572|B1||High school|Education||Participants|Count of Participants|11|11.0||||||
3605191|NCT02897141|3456570|B3||Less than high school|Education||Participants|Count of Participants|14|14.0||||||
3605192|NCT02897141|3456571|B2||Less than high school|Education||Participants|Count of Participants|5|5.0||||||
3605193|NCT02897141|3456572|B1||Less than high school|Education||Participants|Count of Participants|9|9.0||||||
3605194|NCT02897141|3456570|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
3605195|NCT02897141|3456571|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
3605196|NCT02897141|3456572|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3605197|NCT02897141|3456570|B3|Race|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3605198|NCT02897141|3456571|B2|Race|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3605199|NCT02897141|3456572|B1|Race|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3605200|NCT02897141|3456570|B3|Race|Black, non-hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|55|55.0||||||
3605201|NCT02897141|3456571|B2|Race|Black, non-hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3605202|NCT02897141|3456572|B1|Race|Black, non-hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3605203|NCT02897141|3456570|B3|Race|White, non-hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3605204|NCT02897141|3456571|B2|Race|White, non-hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3605205|NCT02897141|3456572|B1|Race|White, non-hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3605206|NCT02897141|3456570|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3605207|NCT02897141|3456571|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3605208|NCT02897141|3456572|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3605209|NCT02897141|3456570|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3605210|NCT02897141|3456571|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3605211|NCT02897141|3456572|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3605212|NCT02897141|3456570|B3|||Age||years|Mean|50.4|50.4|Standard Deviation|10.4|10.4|||
3605213|NCT02897141|3456571|B2|||Age||years|Mean|50.8|50.8|Standard Deviation|9|9.0|||
3605214|NCT02897141|3456572|B1|||Age||years|Mean|50|50.0|Standard Deviation|11.7|11.7|||
3605215|NCT02896296|3456580|B1|||Females of Childbearing Potential||Participants|Count of Participants|40|40.0||||||
3605216|NCT02896296|3456580|B1|||Waist-to-Hip Ratio|Waist-to-hip ratio is the ratio of the waist circumference to hip circumference (calculated by dividing the waist circumference by the hip circumference). It is a measurement of abdominal fat distribution.|ratio|Mean|0.925|0.925|Standard Deviation|0.0878|0.0878|||
3605217|NCT02896296|3456580|B1|||Body Mass Index||kg/m^2|Mean|26.12|26.12|Standard Deviation|5.031|5.031|||
3605218|NCT02896296|3456580|B1|||Weight||kg|Mean|78.41|78.41|Standard Deviation|16.949|16.949|||
3605219|NCT02896296|3456580|B1|||Height||cm|Mean|173.26|173.26|Standard Deviation|9.788|9.788|||
3605220|NCT02896296|3456580|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605221|NCT02896296|3456580|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605222|NCT02896296|3456580|B1||White|Race (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
3605223|NCT02896296|3456580|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3605224|NCT02896296|3456580|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605225|NCT02896296|3456580|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605226|NCT02896296|3456580|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3605227|NCT02896296|3456580|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605228|NCT02896296|3456580|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|198|198.0||||||
3605229|NCT02896296|3456580|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3605230|NCT02896296|3456580|B1||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3605231|NCT02896296|3456580|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3605232|NCT02896296|3456580|B1||>= 60 years|Age, Customized||Participants|Count of Participants|17|17.0||||||
3605233|NCT02896296|3456580|B1||>=45 and < 60 years|Age, Customized||Participants|Count of Participants|71|71.0||||||
3605234|NCT02896296|3456580|B1||>= 30 and < 45 years|Age, Customized||Participants|Count of Participants|88|88.0||||||
3605235|NCT02896296|3456580|B1||>=18 and <30 years|Age, Customized||Participants|Count of Participants|32|32.0||||||
3605236|NCT02896296|3456580|B1|||Age||years|Mean|42.1|42.1|Standard Deviation|11.47|11.47|||
3605237|NCT02895347|3456586|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3605238|NCT02895347|3456587|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3605239|NCT02895347|3456588|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3605240|NCT02895347|3456586|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3605241|NCT02895347|3456587|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3605242|NCT02895347|3456588|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3605243|NCT02895347|3456586|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3605244|NCT02895347|3456587|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3605245|NCT02895347|3456588|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3605246|NCT02895347|3456586|B3|||Age||years|Mean|25|25.0|Full Range|||22.0|40.0|
3605247|NCT02895347|3456587|B2|||Age||years|Mean|25|25.0|Full Range|||22.0|40.0|
3605248|NCT02895347|3456588|B1|||Age||years|Mean|25|25.0|Full Range|||22.0|40.0|
3605249|NCT02894840|3456598|B5|Thailand||Region of Enrollment|Phase I: N=40 participants, Phase II: N = 300 participants|Participants|Count of Participants|340|340.0||||||
3605250|NCT02894840|3456599|B4|Thailand||Region of Enrollment|Phase I: N=40 participants, Phase II: N = 300 participants|Participants|Count of Participants|100|100.0||||||
3605251|NCT02894840|3456600|B3|Thailand||Region of Enrollment|Phase I: N=40 participants, Phase II: N = 300 participants|Participants|Count of Participants|200|200.0||||||
3605252|NCT02894840|3456601|B2|Thailand||Region of Enrollment|Phase I: N=40 participants, Phase II: N = 300 participants|Participants|Count of Participants|20|20.0||||||
3605253|NCT02894840|3456602|B1|Thailand||Region of Enrollment|Phase I: N=40 participants, Phase II: N = 300 participants|Participants|Count of Participants|20|20.0||||||
3605254|NCT02894840|3456598|B5||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3605255|NCT02894840|3456599|B4||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3605256|NCT02894840|3456600|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3605257|NCT02894840|3456601|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3605258|NCT02894840|3456602|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3605259|NCT02894840|3456598|B5||Female|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
3605260|NCT02894840|3456599|B4||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3605261|NCT02894840|3456600|B3||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3605262|NCT02894840|3456601|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3605263|NCT02894840|3456602|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3605264|NCT02894840|3456598|B5|||Age||years|Mean|31.22|31.22|Standard Deviation|8.43|8.43|||
3605265|NCT02894840|3456599|B4|||Age||years|Mean|32.2|32.2|Standard Deviation|7.96|7.96|||
3605266|NCT02894840|3456600|B3|||Age||years|Mean|32.28|32.28|Standard Deviation|8.19|8.19|||
3605267|NCT02894840|3456601|B2|||Age||years|Mean|28.15|28.15|Standard Deviation|6.72|6.72|||
3605268|NCT02894840|3456602|B1|||Age||years|Mean|32.25|32.25|Standard Deviation|9.45|9.45|||
3605269|NCT02894840|3456598|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3605270|NCT02894840|3456599|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3605271|NCT02894840|3456600|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3605272|NCT02894840|3456601|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3605273|NCT02894840|3456602|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3605274|NCT02894840|3456598|B5||Between 18 and 65 years|Age||Participants|Count of Participants|340|340.0||||||
3605275|NCT02894840|3456599|B4||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
3605276|NCT02894840|3456600|B3||Between 18 and 65 years|Age||Participants|Count of Participants|200|200.0||||||
3605277|NCT02894840|3456601|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3605278|NCT02894840|3456602|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3605279|NCT02894840|3456598|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3605280|NCT02894840|3456599|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3605281|NCT02894840|3456600|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3605282|NCT02894840|3456601|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3605283|NCT02894840|3456602|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3605284|NCT02891863|3456627|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3605285|NCT02891863|3456627|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3605286|NCT02891863|3456627|B1|||Age||years|Mean|57|57.0|Standard Deviation|10|10.0|||
3605287|NCT02890381|3456632|B3|||Serum RSV-neutralizing antibody titers|Data values are presented as log 2 titers.|log 2 titers|Median|2.3|2.3|Inter-Quartile Range|||2.3|3.6|
3605288|NCT02890381|3456633|B2|||Serum RSV-neutralizing antibody titers|Data values are presented as log 2 titers.|log 2 titers|Median|2.3|2.3|Inter-Quartile Range|||2.3|3.7|
3605289|NCT02890381|3456634|B1|||Serum RSV-neutralizing antibody titers|Data values are presented as log 2 titers.|log 2 titers|Median|2.3|2.3|Inter-Quartile Range|||2.3|3.6|
3605290|NCT02890381|3456632|B3|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3605291|NCT02890381|3456633|B2|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3605292|NCT02890381|3456634|B1|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3605293|NCT02890381|3456632|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3605294|NCT02890381|3456633|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3605295|NCT02890381|3456634|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3605296|NCT02890381|3456632|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3605297|NCT02890381|3456633|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3605298|NCT02890381|3456634|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3605299|NCT02890381|3456632|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3605300|NCT02890381|3456633|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3605301|NCT02890381|3456634|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3605302|NCT02890381|3456632|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3605303|NCT02890381|3456633|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3605304|NCT02890381|3456634|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3605305|NCT02890381|3456632|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605306|NCT02890381|3456633|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605307|NCT02890381|3456634|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605308|NCT02890381|3456632|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605309|NCT02890381|3456633|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605310|NCT02890381|3456634|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605311|NCT02890381|3456632|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605312|NCT02890381|3456633|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605313|NCT02890381|3456634|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605314|NCT02890381|3456632|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3605315|NCT02890381|3456633|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605316|NCT02890381|3456634|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3605317|NCT02890381|3456632|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3605318|NCT02890381|3456633|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3605319|NCT02890381|3456634|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3605320|NCT02890381|3456632|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3605321|NCT02890381|3456633|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605322|NCT02890381|3456634|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3605323|NCT02890381|3456632|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3605324|NCT02890381|3456633|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3605325|NCT02890381|3456634|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3605326|NCT02890381|3456632|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3605327|NCT02890381|3456633|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3605328|NCT02890381|3456634|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3605329|NCT02890381|3456632|B3|||Age||months|Median|10|10.0|Inter-Quartile Range|||8.0|14.0|
3605330|NCT02890381|3456633|B2|||Age||months|Median|9|9.0|Inter-Quartile Range|||6.0|12.0|
3605331|NCT02890381|3456634|B1|||Age||months|Median|12|12.0|Inter-Quartile Range|||8.0|15.0|
3605332|NCT02890303|3456661|B1|||Dilated Pupil Size||mm|Mean|8|8.0|Full Range|||6.0|9.5|
3605333|NCT02890303|3456661|B1|% with a tilted disc||Fundus Examination||percentage of participants|Number|1|1.0||||||
3605334|NCT02890303|3456661|B1|% with post vitreous degeneration||Fundus Examination||percentage of participants|Number|1|1.0||||||
3605335|NCT02890303|3456661|B1|% with choroidal nevus||Fundus Examination||percentage of participants|Number|1|1.0||||||
3605336|NCT02890303|3456661|B1|% with mild epiretinal membrane||Fundus Examination||percentage of participants|Number|1|1.0||||||
3605337|NCT02890303|3456661|B1|% with peripheral drusen||Fundus Examination||percentage of participants|Number|1|1.0||||||
3605338|NCT02890303|3456661|B1|% with mild macular drusen||Fundus Examination||percentage of participants|Number|1|1.0||||||
3605339|NCT02890303|3456661|B1|% presented with posterior vitreous detachment||Fundus Examination||percentage of participants|Number|7|7.0||||||
3605340|NCT02890303|3456661|B1|% with normal findings||Fundus Examination||percentage of participants|Number|87|87.0||||||
3605341|NCT02890303|3456661|B1|% with faint stromal scarring||Slit Lamp||percentage of participants|Number|1|1.0||||||
3605342|NCT02890303|3456661|B1|% with Waite Beecham Lines - mild||Slit Lamp||percentage of participants|Number|1|1.0||||||
3605343|NCT02890303|3456661|B1|% 1 + punctuate epithelial keratitis/ keratopathy||Slit Lamp||percentage of participants|Number|1|1.0||||||
3605344|NCT02890303|3456661|B1|% of Normal cornea||Slit Lamp||percentage of participants|Number|97|97.0||||||
3605345|NCT02890303|3456661|B1|% presenting with 1 + Meibomian gland dysfunction||Slit Lamp||percentage of participants|Number|7|7.0||||||
3605346|NCT02890303|3456661|B1|% of Normal treatment lids||Slit Lamp||percentage of participants|Number|97|97.0||||||
3605347|NCT02890303|3456661|B1|||Best spectacle corrected distance visual acuity (BSCVA)||ft|Mean|40|40.0|Full Range|||20.0|400.0|
3605348|NCT02890303|3456661|B1|||Uncorrected distance visual acuity (UCVA)||ft|Mean|138|138.0|Full Range|||25.0|800.0|
3605349|NCT02890303|3456661|B1|||Manifest Refraction||Participants|Count of Participants|96|96.0||||||
3605350|NCT02890303|3456661|B1|||Intraocular Pressure||mm Hg|Mean|16|16.0|Full Range|||7.0|35.0|
3605351|NCT02890303|3456661|B1|United States||Region of Enrollment||Participants|Count of Participants|100|100.0||||||
3605352|NCT02890303|3456661|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3605353|NCT02890303|3456661|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605354|NCT02890303|3456661|B1||White|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
3605355|NCT02890303|3456661|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3605356|NCT02890303|3456661|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605357|NCT02890303|3456661|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3605358|NCT02890303|3456661|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3605359|NCT02890303|3456661|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3605360|NCT02890303|3456661|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3605361|NCT02890303|3456661|B1|||Age, Customized||years|Mean|69.4|69.4|Full Range|||46.0|89.0|
3605362|NCT02889289|3456665|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3605363|NCT02889289|3456665|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3605364|NCT02889289|3456665|B1|||Age||years|Mean|37|37.0|Standard Deviation|0|0.0|||
3605365|NCT02889289|3456665|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3605366|NCT02889289|3456665|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3605367|NCT02889289|3456665|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3605368|NCT02887989|3456674|B3|||Last pain score pre-intervention|The primary outcome was pain intensity collected via ecological momentary assessment in the course of usual care by hospital staff. At three-to-four hour intervals during waking hours, subjects were asked by their assigned nurse to rate their pain using a standard 11-point numeric rating scale (NRS), where 0 is “no pain” and 10 is “worst imaginable pain.”|units on a scale|Mean|3.63|3.63|Standard Deviation|2.99|2.99|||
3605369|NCT02887989|3456675|B2|||Last pain score pre-intervention|The primary outcome was pain intensity collected via ecological momentary assessment in the course of usual care by hospital staff. At three-to-four hour intervals during waking hours, subjects were asked by their assigned nurse to rate their pain using a standard 11-point numeric rating scale (NRS), where 0 is “no pain” and 10 is “worst imaginable pain.”|units on a scale|Mean|3.97|3.97|Standard Deviation|3.13|3.13|||
3605370|NCT02887989|3456676|B1|||Last pain score pre-intervention|The primary outcome was pain intensity collected via ecological momentary assessment in the course of usual care by hospital staff. At three-to-four hour intervals during waking hours, subjects were asked by their assigned nurse to rate their pain using a standard 11-point numeric rating scale (NRS), where 0 is “no pain” and 10 is “worst imaginable pain.”|units on a scale|Mean|3.31|3.31|Standard Deviation|2.83|2.83|||
3605371|NCT02887989|3456674|B3||Somatic|Pain Type||Participants|Count of Participants|77|77.0||||||
3605372|NCT02887989|3456675|B2||Somatic|Pain Type||Participants|Count of Participants|39|39.0||||||
3605373|NCT02887989|3456676|B1||Somatic|Pain Type||Participants|Count of Participants|38|38.0||||||
3605374|NCT02887989|3456674|B3||Visceral|Pain Type||Participants|Count of Participants|43|43.0||||||
3605375|NCT02887989|3456675|B2||Visceral|Pain Type||Participants|Count of Participants|20|20.0||||||
3605376|NCT02887989|3456676|B1||Visceral|Pain Type||Participants|Count of Participants|23|23.0||||||
3605377|NCT02887989|3456674|B3|United States||Region of Enrollment|Rows differ due to uneven withdrawal and death|participants|Number|120|120.0||||||
3605378|NCT02887989|3456675|B2|United States||Region of Enrollment|Rows differ due to uneven withdrawal and death|participants|Number|59|59.0||||||
3605379|NCT02887989|3456676|B1|United States||Region of Enrollment|Rows differ due to uneven withdrawal and death|participants|Number|61|61.0||||||
3605380|NCT02887989|3456674|B3|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3605381|NCT02887989|3456675|B2|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3605382|NCT02887989|3456676|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3605383|NCT02887989|3456674|B3|Race|African-American|Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3605384|NCT02887989|3456675|B2|Race|African-American|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3605385|NCT02887989|3456676|B1|Race|African-American|Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3605386|NCT02887989|3456674|B3|Race|white|Race/Ethnicity, Customized||Participants|Count of Participants|77|77.0||||||
3605387|NCT02887989|3456675|B2|Race|white|Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
3605388|NCT02887989|3456676|B1|Race|white|Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
3605389|NCT02887989|3456674|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3605390|NCT02887989|3456675|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3605391|NCT02887989|3456676|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3605392|NCT02887989|3456674|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3605393|NCT02887989|3456675|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3605394|NCT02887989|3456676|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3605395|NCT02887989|3456674|B3|||Age||years|Mean|50.8|50.8|Standard Deviation|15.48|15.48|||
3605396|NCT02887989|3456675|B2|||Age||years|Mean|50.02|50.02|Standard Deviation|15.92|15.92|||
3605398|NCT02887989|3456674|B3||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
3605399|NCT02887989|3456675|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3605400|NCT02887989|3456676|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3605401|NCT02887989|3456674|B3||Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
3605402|NCT02887989|3456675|B2||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3605403|NCT02887989|3456676|B1||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
3605404|NCT02887989|3456674|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3605405|NCT02887989|3456675|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3605406|NCT02887989|3456676|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3605407|NCT02886715|3456687|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|463|463.0||||||
3605408|NCT02886715|3456688|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|93|93.0||||||
3605409|NCT02886715|3456689|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|193|193.0||||||
3605410|NCT02886715|3456690|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|177|177.0||||||
3605411|NCT02886715|3456687|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|647|647.0||||||
3605412|NCT02886715|3456688|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|130|130.0||||||
3605413|NCT02886715|3456689|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|252|252.0||||||
3605414|NCT02886715|3456690|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|265|265.0||||||
3605415|NCT02886715|3456687|B4||Male|Sex: Female, Male||Participants|Count of Participants|563|563.0||||||
3605416|NCT02886715|3456688|B3||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3605417|NCT02886715|3456689|B2||Male|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
3605418|NCT02886715|3456690|B1||Male|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
3605419|NCT02886715|3456687|B4||Female|Sex: Female, Male||Participants|Count of Participants|547|547.0||||||
3605420|NCT02886715|3456688|B3||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3605421|NCT02886715|3456689|B2||Female|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
3605422|NCT02886715|3456690|B1||Female|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
3605423|NCT02886715|3456687|B4|||Age||Years|Mean|22.6|22.6|Standard Deviation|7.0|7.0|||
3605424|NCT02886715|3456688|B3|||Age||Years|Mean|22.5|22.5|Standard Deviation|7.0|7.0|||
3605425|NCT02886715|3456689|B2|||Age||Years|Mean|22.7|22.7|Standard Deviation|7.0|7.0|||
3605426|NCT02886715|3456690|B1|||Age||Years|Mean|22.5|22.5|Standard Deviation|7.0|7.0|||
3605427|NCT02886702|3456706|B4||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|341|341.0||||||
3605428|NCT02886702|3456707|B3||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|111|111.0||||||
3605429|NCT02886702|3456708|B2||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|118|118.0||||||
3605430|NCT02886702|3456709|B1||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|112|112.0||||||
3605431|NCT02886702|3456706|B4||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|514|514.0||||||
3605432|NCT02886702|3456707|B3||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|174|174.0||||||
3605433|NCT02886702|3456708|B2||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|168|168.0||||||
3605434|NCT02886702|3456709|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|172|172.0||||||
3605435|NCT02886702|3456706|B4||Male|Sex: Female, Male||Participants|Count of Participants|429|429.0||||||
3605436|NCT02886702|3456707|B3||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3605437|NCT02886702|3456708|B2||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3605438|NCT02886702|3456709|B1||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3605439|NCT02886702|3456706|B4||Female|Sex: Female, Male||Participants|Count of Participants|426|426.0||||||
3605440|NCT02886702|3456707|B3||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3605441|NCT02886702|3456708|B2||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3605442|NCT02886702|3456709|B1||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3605443|NCT02886702|3456706|B4|||Age||Years|Mean|53.3|53.3|Standard Deviation|14.2|14.2|||
3605444|NCT02886702|3456707|B3|||Age||Years|Mean|52.7|52.7|Standard Deviation|14.2|14.2|||
3605445|NCT02886702|3456708|B2|||Age||Years|Mean|53.7|53.7|Standard Deviation|14.2|14.2|||
3605446|NCT02886702|3456709|B1|||Age||Years|Mean|53.5|53.5|Standard Deviation|14.4|14.4|||
3605447|NCT02886338|3456725|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3605448|NCT02886338|3456725|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3605449|NCT02886338|3456725|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3605450|NCT02886338|3456725|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3605451|NCT02886338|3456725|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3605452|NCT02886338|3456725|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3605475|NCT02885181|3456731|B3|Moldova||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3605476|NCT02885181|3456732|B2|Moldova||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3605477|NCT02885181|3456733|B1|Moldova||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3605478|NCT02885181|3456729|B5|Poland||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3605453|NCT02885181|3456729|B5|||Health Assessment Questionnaire Disease Index (HAQ-DI)|The Health Assessment Questionnaire – Disability Index (HAQ-DI) is a self-reported tool used to assess the ability to perform tasks in 8 functional categories: dressing and grooming, arising, eating, walking, hygiene, reach, grip, and common daily activities. Responses in each functional category were collected as 0 (without any difficulty) to 3 (unable to do a task in that area). The HAQ-DI score ranges from 0 (no disability) to 3 (completely disabled), when 6 or more categories are non-missing.|units on a scale|Mean|1.49|1.49|Standard Deviation|0.563|0.563|||
3605454|NCT02885181|3456730|B4|||Health Assessment Questionnaire Disease Index (HAQ-DI)|The Health Assessment Questionnaire – Disability Index (HAQ-DI) is a self-reported tool used to assess the ability to perform tasks in 8 functional categories: dressing and grooming, arising, eating, walking, hygiene, reach, grip, and common daily activities. Responses in each functional category were collected as 0 (without any difficulty) to 3 (unable to do a task in that area). The HAQ-DI score ranges from 0 (no disability) to 3 (completely disabled), when 6 or more categories are non-missing.|units on a scale|Mean|1.51|1.51|Standard Deviation|0.577|0.577|||
3605455|NCT02885181|3456731|B3|||Health Assessment Questionnaire Disease Index (HAQ-DI)|The Health Assessment Questionnaire – Disability Index (HAQ-DI) is a self-reported tool used to assess the ability to perform tasks in 8 functional categories: dressing and grooming, arising, eating, walking, hygiene, reach, grip, and common daily activities. Responses in each functional category were collected as 0 (without any difficulty) to 3 (unable to do a task in that area). The HAQ-DI score ranges from 0 (no disability) to 3 (completely disabled), when 6 or more categories are non-missing.|units on a scale|Mean|1.61|1.61|Standard Deviation|0.591|0.591|||
3605456|NCT02885181|3456732|B2|||Health Assessment Questionnaire Disease Index (HAQ-DI)|The Health Assessment Questionnaire – Disability Index (HAQ-DI) is a self-reported tool used to assess the ability to perform tasks in 8 functional categories: dressing and grooming, arising, eating, walking, hygiene, reach, grip, and common daily activities. Responses in each functional category were collected as 0 (without any difficulty) to 3 (unable to do a task in that area). The HAQ-DI score ranges from 0 (no disability) to 3 (completely disabled), when 6 or more categories are non-missing.|units on a scale|Mean|1.47|1.47|Standard Deviation|0.425|0.425|||
3605457|NCT02885181|3456733|B1|||Health Assessment Questionnaire Disease Index (HAQ-DI)|The Health Assessment Questionnaire – Disability Index (HAQ-DI) is a self-reported tool used to assess the ability to perform tasks in 8 functional categories: dressing and grooming, arising, eating, walking, hygiene, reach, grip, and common daily activities. Responses in each functional category were collected as 0 (without any difficulty) to 3 (unable to do a task in that area). The HAQ-DI score ranges from 0 (no disability) to 3 (completely disabled), when 6 or more categories are non-missing.|units on a scale|Mean|1.38|1.38|Standard Deviation|0.650|0.65|||
3605458|NCT02885181|3456729|B5|||Disease Activity Score 28 C-Reactive Protein (DAS28 CRP)|Disease Activity Score 28 C-Reactive Protein (DAS28 (CRP)) is a measure of the participant's disease activity calculated using the tender joint counts (28 joints), swollen joint counts (28 joints), participant's global assessment of disease activity (visual analog scale: 0 = no disease activity to 100 = maximum disease activity) and C-Reactive Protein (CRP) for a total possible score of 1 to 9.4.|units on a scale|Mean|5.75|5.75|Standard Deviation|0.961|0.961|||
3605459|NCT02885181|3456730|B4|||Disease Activity Score 28 C-Reactive Protein (DAS28 CRP)|Disease Activity Score 28 C-Reactive Protein (DAS28 (CRP)) is a measure of the participant's disease activity calculated using the tender joint counts (28 joints), swollen joint counts (28 joints), participant's global assessment of disease activity (visual analog scale: 0 = no disease activity to 100 = maximum disease activity) and C-Reactive Protein (CRP) for a total possible score of 1 to 9.4.|units on a scale|Mean|5.51|5.51|Standard Deviation|1.003|1.003|||
3605460|NCT02885181|3456731|B3|||Disease Activity Score 28 C-Reactive Protein (DAS28 CRP)|Disease Activity Score 28 C-Reactive Protein (DAS28 (CRP)) is a measure of the participant's disease activity calculated using the tender joint counts (28 joints), swollen joint counts (28 joints), participant's global assessment of disease activity (visual analog scale: 0 = no disease activity to 100 = maximum disease activity) and C-Reactive Protein (CRP) for a total possible score of 1 to 9.4.|units on a scale|Mean|6.09|6.09|Standard Deviation|1.112|1.112|||
3605461|NCT02885181|3456732|B2|||Disease Activity Score 28 C-Reactive Protein (DAS28 CRP)|Disease Activity Score 28 C-Reactive Protein (DAS28 (CRP)) is a measure of the participant's disease activity calculated using the tender joint counts (28 joints), swollen joint counts (28 joints), participant's global assessment of disease activity (visual analog scale: 0 = no disease activity to 100 = maximum disease activity) and C-Reactive Protein (CRP) for a total possible score of 1 to 9.4.|units on a scale|Mean|5.65|5.65|Standard Deviation|0.941|0.941|||
3605462|NCT02885181|3456733|B1|||Disease Activity Score 28 C-Reactive Protein (DAS28 CRP)|Disease Activity Score 28 C-Reactive Protein (DAS28 (CRP)) is a measure of the participant's disease activity calculated using the tender joint counts (28 joints), swollen joint counts (28 joints), participant's global assessment of disease activity (visual analog scale: 0 = no disease activity to 100 = maximum disease activity) and C-Reactive Protein (CRP) for a total possible score of 1 to 9.4.|units on a scale|Mean|5.78|5.78|Standard Deviation|0.691|0.691|||
3605463|NCT02885181|3456729|B5|Bulgaria||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3605464|NCT02885181|3456730|B4|Bulgaria||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3605465|NCT02885181|3456731|B3|Bulgaria||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3605466|NCT02885181|3456732|B2|Bulgaria||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3605467|NCT02885181|3456733|B1|Bulgaria||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3605468|NCT02885181|3456729|B5|Georgia||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3605469|NCT02885181|3456730|B4|Georgia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3605470|NCT02885181|3456731|B3|Georgia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3605471|NCT02885181|3456732|B2|Georgia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3605472|NCT02885181|3456733|B1|Georgia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3605473|NCT02885181|3456729|B5|Moldova||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3605474|NCT02885181|3456730|B4|Moldova||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3605479|NCT02885181|3456730|B4|Poland||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3605480|NCT02885181|3456731|B3|Poland||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3605481|NCT02885181|3456732|B2|Poland||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3605482|NCT02885181|3456733|B1|Poland||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3605483|NCT02885181|3456729|B5|Ukraine||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3605484|NCT02885181|3456730|B4|Ukraine||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3605485|NCT02885181|3456731|B3|Ukraine||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3605486|NCT02885181|3456732|B2|Ukraine||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3605487|NCT02885181|3456733|B1|Ukraine||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3605488|NCT02885181|3456729|B5|Czechia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3605489|NCT02885181|3456730|B4|Czechia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3605490|NCT02885181|3456731|B3|Czechia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3605491|NCT02885181|3456732|B2|Czechia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3605492|NCT02885181|3456733|B1|Czechia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3605493|NCT02885181|3456729|B5|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3605494|NCT02885181|3456730|B4|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3605495|NCT02885181|3456731|B3|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3605496|NCT02885181|3456732|B2|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3605497|NCT02885181|3456733|B1|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3605498|NCT02885181|3456729|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605499|NCT02885181|3456730|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605500|NCT02885181|3456731|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|00|0.0||||||
3605501|NCT02885181|3456732|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605502|NCT02885181|3456733|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605503|NCT02885181|3456729|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605504|NCT02885181|3456730|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605505|NCT02885181|3456731|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605506|NCT02885181|3456732|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605507|NCT02885181|3456733|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605508|NCT02885181|3456729|B5||White|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3605509|NCT02885181|3456730|B4||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3605510|NCT02885181|3456731|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3605511|NCT02885181|3456732|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3605512|NCT02885181|3456733|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3605513|NCT02885181|3456729|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3605514|NCT02885181|3456730|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3605515|NCT02885181|3456731|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605516|NCT02885181|3456732|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3605517|NCT02885181|3456733|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605518|NCT02885181|3456729|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605519|NCT02885181|3456730|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605520|NCT02885181|3456731|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605521|NCT02885181|3456732|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605522|NCT02885181|3456733|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605523|NCT02885181|3456729|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3605524|NCT02885181|3456730|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3605525|NCT02885181|3456731|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605526|NCT02885181|3456732|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605527|NCT02885181|3456733|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605528|NCT02885181|3456729|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3605529|NCT02885181|3456730|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605530|NCT02885181|3456731|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605531|NCT02885181|3456732|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3605532|NCT02885181|3456733|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605533|NCT02885181|3456729|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605534|NCT02885181|3456730|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605593|NCT02884492|3456762|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3605535|NCT02885181|3456731|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605536|NCT02885181|3456732|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605537|NCT02885181|3456733|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605538|NCT02885181|3456729|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3605539|NCT02885181|3456730|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3605540|NCT02885181|3456731|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3605541|NCT02885181|3456732|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3605542|NCT02885181|3456733|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3605543|NCT02885181|3456729|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3605544|NCT02885181|3456730|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605545|NCT02885181|3456731|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3605546|NCT02885181|3456732|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3605547|NCT02885181|3456733|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3605548|NCT02885181|3456729|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3605549|NCT02885181|3456730|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3605550|NCT02885181|3456731|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3605551|NCT02885181|3456732|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3605552|NCT02885181|3456733|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3605553|NCT02885181|3456729|B5||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3605554|NCT02885181|3456730|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3605555|NCT02885181|3456731|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3605556|NCT02885181|3456732|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3605557|NCT02885181|3456733|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3605558|NCT02885181|3456729|B5|||Age||years|Mean|55|55.0|Standard Deviation|11.5|11.5|||
3605559|NCT02885181|3456730|B4|||Age||years|Mean|54|54.0|Standard Deviation|10.9|10.9|||
3605560|NCT02885181|3456731|B3|||Age||years|Mean|53|53.0|Standard Deviation|15.4|15.4|||
3605561|NCT02885181|3456732|B2|||Age||years|Mean|56|56.0|Standard Deviation|11.4|11.4|||
3605562|NCT02885181|3456733|B1|||Age||years|Mean|58|58.0|Standard Deviation|7.0|7.0|||
3605563|NCT02884492|3456762|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
3605564|NCT02884492|3456763|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3605565|NCT02884492|3456764|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3605566|NCT02884492|3456762|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605567|NCT02884492|3456763|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605568|NCT02884492|3456764|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605569|NCT02884492|3456762|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605570|NCT02884492|3456763|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605571|NCT02884492|3456764|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605572|NCT02884492|3456762|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3605573|NCT02884492|3456763|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3605574|NCT02884492|3456764|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3605575|NCT02884492|3456762|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3605576|NCT02884492|3456763|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3605577|NCT02884492|3456764|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605578|NCT02884492|3456762|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605579|NCT02884492|3456763|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605580|NCT02884492|3456764|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605581|NCT02884492|3456762|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605582|NCT02884492|3456763|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605583|NCT02884492|3456764|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605584|NCT02884492|3456762|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605585|NCT02884492|3456763|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605586|NCT02884492|3456764|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605587|NCT02884492|3456762|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3605588|NCT02884492|3456763|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3605589|NCT02884492|3456764|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3605590|NCT02884492|3456762|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3605591|NCT02884492|3456763|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3605592|NCT02884492|3456764|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3605594|NCT02884492|3456763|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3605595|NCT02884492|3456764|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3605596|NCT02884492|3456762|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3605597|NCT02884492|3456763|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3605598|NCT02884492|3456764|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3605599|NCT02884492|3456762|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3605600|NCT02884492|3456763|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3605601|NCT02884492|3456764|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3605602|NCT02884427|3456771|B4|||Body Mass Index (BMI)||kg/m^2|Mean|24|24.0|Standard Deviation|3|3.0|||
3605603|NCT02884427|3456772|B3|||Body Mass Index (BMI)||kg/m^2|Mean|25|25.0|Standard Deviation|5|5.0|||
3605604|NCT02884427|3456773|B2|||Body Mass Index (BMI)||kg/m^2|Mean|24|24.0|Standard Deviation|3|3.0|||
3605605|NCT02884427|3456774|B1|||Body Mass Index (BMI)||kg/m^2|Mean|24|24.0|Standard Deviation|3|3.0|||
3605606|NCT02884427|3456771|B4|Chile||Region of Enrollment||participants|Number|150|150.0||||||
3605607|NCT02884427|3456772|B3|Chile||Region of Enrollment||participants|Number|50|50.0||||||
3605608|NCT02884427|3456773|B2|Chile||Region of Enrollment||participants|Number|52|52.0||||||
3605609|NCT02884427|3456774|B1|Chile||Region of Enrollment||participants|Number|48|48.0||||||
3605610|NCT02884427|3456771|B4||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3605611|NCT02884427|3456772|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3605612|NCT02884427|3456773|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3605613|NCT02884427|3456774|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3605614|NCT02884427|3456771|B4||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3605615|NCT02884427|3456772|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3605616|NCT02884427|3456773|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3605617|NCT02884427|3456774|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3605618|NCT02884427|3456771|B4|||Age||years|Mean|23|23.0|Standard Deviation|3|3.0|||
3605619|NCT02884427|3456772|B3|||Age||years|Mean|22|22.0|Standard Deviation|3|3.0|||
3605620|NCT02884427|3456773|B2|||Age||years|Mean|23|23.0|Standard Deviation|2|2.0|||
3605621|NCT02884427|3456774|B1|||Age||years|Mean|23|23.0|Standard Deviation|3|3.0|||
3605622|NCT02884427|3456771|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3605623|NCT02884427|3456772|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3605624|NCT02884427|3456773|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3605625|NCT02884427|3456774|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3605626|NCT02884427|3456771|B4||Between 18 and 65 years|Age||Participants|Count of Participants|126|126.0||||||
3605627|NCT02884427|3456772|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3605628|NCT02884427|3456773|B2||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
3605629|NCT02884427|3456774|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3605630|NCT02884427|3456771|B4||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
3605631|NCT02884427|3456772|B3||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
3605632|NCT02884427|3456773|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3605633|NCT02884427|3456774|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
3605634|NCT02884089|3456790|B1|||Body Mass Index (BMI)||Kilogram per square meter (kg/m^2)|Mean|27.25|27.25|Standard Deviation|3.06|3.06|||
3605635|NCT02884089|3456790|B1|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3605636|NCT02884089|3456790|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605637|NCT02884089|3456790|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605638|NCT02884089|3456790|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3605639|NCT02884089|3456790|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3605640|NCT02884089|3456790|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605641|NCT02884089|3456790|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3605642|NCT02884089|3456790|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605643|NCT02884089|3456790|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605644|NCT02884089|3456790|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3605645|NCT02884089|3456790|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3605646|NCT02884089|3456790|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3605647|NCT02884089|3456790|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3605648|NCT02884089|3456790|B1|||Age||years|Mean|50.4|50.4|Standard Deviation|10.6|10.6|||
3605649|NCT02883244|3456807|B3|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3605650|NCT02883244|3456808|B2|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3605651|NCT02883244|3456809|B1|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3605652|NCT02883244|3456807|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3605653|NCT02883244|3456808|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3605654|NCT02883244|3456809|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3605655|NCT02883244|3456807|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
3605656|NCT02883244|3456808|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3605657|NCT02883244|3456809|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3605658|NCT02883244|3456807|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3605659|NCT02883244|3456808|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3605660|NCT02883244|3456809|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3605661|NCT02883244|3456807|B3|American Indian/Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3605662|NCT02883244|3456808|B2|American Indian/Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3605663|NCT02883244|3456809|B1|American Indian/Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3605664|NCT02883244|3456807|B3|African American, Asian, Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3605665|NCT02883244|3456808|B2|African American, Asian, Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3605666|NCT02883244|3456809|B1|African American, Asian, Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3605667|NCT02883244|3456807|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3605668|NCT02883244|3456808|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3605669|NCT02883244|3456809|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3605670|NCT02883244|3456807|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3605671|NCT02883244|3456808|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3605672|NCT02883244|3456809|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3605673|NCT02883244|3456807|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3605674|NCT02883244|3456808|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3605675|NCT02883244|3456809|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3605676|NCT02883244|3456807|B3|||Age||years|Mean|26.6|26.6|Standard Deviation|7.7|7.7|||
3605677|NCT02883244|3456808|B2|||Age||years|Mean|26.9|26.9|Standard Deviation|8.5|8.5|||
3605678|NCT02883244|3456809|B1|||Age||years|Mean|26.3|26.3|Standard Deviation|6.9|6.9|||
3605679|NCT02882152|3456826|B3|||Weight||kg|Mean|76.6|76.6|Standard Deviation|14.3|14.3|||
3605680|NCT02882152|3456827|B2|||Weight||kg|Mean|77.5|77.5|Standard Deviation|16.9|16.9|||
3605681|NCT02882152|3456828|B1|||Weight||kg|Mean|70.7|70.7|Standard Deviation|20.0|20.0|||
3605682|NCT02882152|3456826|B3||Male|Gender||Participants|Count of Participants|9|9.0||||||
3605683|NCT02882152|3456827|B2||Male|Gender||Participants|Count of Participants|6|6.0||||||
3605684|NCT02882152|3456828|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
3605685|NCT02882152|3456826|B3||Female|Gender||Participants|Count of Participants|30|30.0||||||
3605686|NCT02882152|3456827|B2||Female|Gender||Participants|Count of Participants|14|14.0||||||
3605687|NCT02882152|3456828|B1||Female|Gender||Participants|Count of Participants|16|16.0||||||
3605688|NCT02882152|3456826|B3|||Age||years|Mean|62.5|62.5|Standard Deviation|10.3|10.3|||
3605689|NCT02882152|3456827|B2|||Age||years|Mean|58.3|58.3|Standard Deviation|10.5|10.5|||
3605690|NCT02882152|3456828|B1|||Age||years|Mean|67.3|67.3|Standard Deviation|8.3|8.3|||
3605691|NCT02881658|3456837|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3605692|NCT02881658|3456837|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3605693|NCT02881658|3456838|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3605694|NCT02881658|3456839|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3605695|NCT02881658|3456837|B3||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3605696|NCT02881658|3456838|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3605697|NCT02881658|3456839|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3605698|NCT02881658|3456837|B3|||Age||years|Mean|45|45.0|Standard Deviation|16.6|16.6|||
3605699|NCT02881658|3456838|B2|||Age||years|Mean|44|44.0|Standard Deviation|16.7|16.7|||
3605700|NCT02881658|3456839|B1|||Age||years|Mean|46|46.0|Standard Deviation|16.5|16.5|||
3605701|NCT02881008|3456874|B7|Russia||Region of Enrollment||participants|Number|48|48.0||||||
3605702|NCT02881008|3456875|B6|Russia||Region of Enrollment||participants|Number|8|8.0||||||
3605703|NCT02881008|3456876|B5|Russia||Region of Enrollment||participants|Number|8|8.0||||||
3605704|NCT02881008|3456877|B4|Russia||Region of Enrollment||participants|Number|8|8.0||||||
3605705|NCT02881008|3456878|B3|Russia||Region of Enrollment||participants|Number|8|8.0||||||
3605706|NCT02881008|3456879|B2|Russia||Region of Enrollment||participants|Number|8|8.0||||||
3605707|NCT02881008|3456880|B1|Russia||Region of Enrollment||participants|Number|8|8.0||||||
3605708|NCT02881008|3456874|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605709|NCT02881008|3456875|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605710|NCT02881008|3456876|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605711|NCT02881008|3456877|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605712|NCT02881008|3456878|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605770|NCT02881008|3456880|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3605713|NCT02881008|3456879|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605714|NCT02881008|3456880|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605715|NCT02881008|3456874|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605716|NCT02881008|3456875|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605717|NCT02881008|3456876|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605718|NCT02881008|3456877|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605719|NCT02881008|3456878|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605720|NCT02881008|3456879|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605721|NCT02881008|3456880|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605722|NCT02881008|3456874|B7||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3605723|NCT02881008|3456875|B6||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3605724|NCT02881008|3456876|B5||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3605725|NCT02881008|3456877|B4||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3605726|NCT02881008|3456878|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3605727|NCT02881008|3456879|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3605728|NCT02881008|3456880|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3605729|NCT02881008|3456874|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605730|NCT02881008|3456875|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605731|NCT02881008|3456876|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605732|NCT02881008|3456877|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605733|NCT02881008|3456878|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605734|NCT02881008|3456879|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605735|NCT02881008|3456880|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605736|NCT02881008|3456874|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605737|NCT02881008|3456875|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605738|NCT02881008|3456876|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605739|NCT02881008|3456877|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605740|NCT02881008|3456878|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605741|NCT02881008|3456879|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605742|NCT02881008|3456880|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605743|NCT02881008|3456874|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3605744|NCT02881008|3456875|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605745|NCT02881008|3456876|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3605746|NCT02881008|3456877|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605747|NCT02881008|3456878|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605748|NCT02881008|3456879|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605749|NCT02881008|3456880|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3605750|NCT02881008|3456874|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605751|NCT02881008|3456875|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605752|NCT02881008|3456876|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605753|NCT02881008|3456877|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605754|NCT02881008|3456878|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605755|NCT02881008|3456879|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605756|NCT02881008|3456880|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605757|NCT02881008|3456874|B7||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3605758|NCT02881008|3456875|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3605759|NCT02881008|3456876|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3605760|NCT02881008|3456877|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3605761|NCT02881008|3456878|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3605762|NCT02881008|3456879|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3605763|NCT02881008|3456880|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3605764|NCT02881008|3456874|B7||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3605765|NCT02881008|3456875|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3605766|NCT02881008|3456876|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3605767|NCT02881008|3456877|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3605768|NCT02881008|3456878|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3605769|NCT02881008|3456879|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3605771|NCT02881008|3456874|B7|||Age||years|Mean|37.4|37.4|Standard Deviation|8.9|8.9|||
3605772|NCT02881008|3456875|B6|||Age||years|Mean|34.5|34.5|Standard Deviation|6.7|6.7|||
3605773|NCT02881008|3456876|B5|||Age||years|Mean|36.4|36.4|Standard Deviation|9.5|9.5|||
3605774|NCT02881008|3456877|B4|||Age||years|Mean|40.2|40.2|Standard Deviation|13.0|13.0|||
3605775|NCT02881008|3456878|B3|||Age||years|Mean|42.4|42.4|Standard Deviation|11.1|11.1|||
3605776|NCT02881008|3456879|B2|||Age||years|Mean|32.9|32.9|Standard Deviation|10.6|10.6|||
3605777|NCT02881008|3456880|B1|||Age||years|Mean|38.3|38.3|Standard Deviation|8.5|8.5|||
3605778|NCT02880852|3456918|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3605779|NCT02880852|3456918|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3605780|NCT02880852|3456918|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3605781|NCT02880852|3456918|B1|||Age||Years|Mean|37.4|37.4|Standard Deviation|14.07|14.07|||
3605782|NCT02880514|3456944|B1|||Lund-MacKay Frontal Score|The Lund-Mackay Frontal score is determined based on computed tomography (CT) of the frontal sinus on a 0 to 2 scale where 0 = no abnormality, 1 = partial opacification, and 2 = complete opacification. The frontal score is the sum of scores on the left and right side and ranges from 0 to 4 with higher score indicating greater disease burden.|units on a scale|Mean|1.2|1.2|Standard Deviation|0.40|0.4|||
3605783|NCT02880514|3456944|B1|||Lund-Mackay Total Score|The Lund-Mackay score is a method of radiologic staging of chronic rhinosinusitis based on computed tomography (CT) where each sinus is assigned a score of 0 (no abnormality), 1 (partial opacification), or 2 (complete opacification). The overall total score is the sum of scores from 6 sinuses on each side and ranges from 0 to 24 with higher score indicating greater disease burden.|units on a scale|Mean|10.8|10.8|Standard Deviation|3.67|3.67|||
3605784|NCT02880514|3456944|B1|Race|Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3605785|NCT02880514|3456944|B1|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3605786|NCT02880514|3456944|B1|Race|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3605787|NCT02880514|3456944|B1|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3605788|NCT02880514|3456944|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3605789|NCT02880514|3456944|B1|Race|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3605790|NCT02880514|3456944|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|49|49.0||||||
3605791|NCT02880514|3456944|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3605792|NCT02880514|3456944|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3605793|NCT02880514|3456944|B1|||Age||years|Mean|56.3|56.3|Standard Deviation|13.76|13.76|||
3605794|NCT02878590|3456952|B1|||Body Mass Index (BMI)||kg/m^2|Mean|31.6|31.6|Standard Deviation|5.5|5.5|||
3605795|NCT02878590|3456952|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3605796|NCT02878590|3456952|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605797|NCT02878590|3456952|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3605798|NCT02878590|3456952|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3605799|NCT02878590|3456952|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3605800|NCT02878590|3456952|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3605801|NCT02878590|3456952|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605802|NCT02878590|3456952|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3605803|NCT02878590|3456952|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3605804|NCT02878590|3456952|B1|||Age||years|Mean|52.7|52.7|Standard Deviation|12.8|12.8|||
3605805|NCT02877927|3456956|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3605806|NCT02877927|3456957|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3605807|NCT02877927|3456958|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3605808|NCT02877927|3456956|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605809|NCT02877927|3456957|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605810|NCT02877927|3456958|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605811|NCT02877927|3456956|B3||White|Race (NIH/OMB)||Participants|Count of Participants|668|668.0||||||
3605812|NCT02877927|3456957|B2||White|Race (NIH/OMB)||Participants|Count of Participants|341|341.0||||||
3605813|NCT02877927|3456958|B1||White|Race (NIH/OMB)||Participants|Count of Participants|327|327.0||||||
3605814|NCT02877927|3456956|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3605815|NCT02877927|3456957|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3605816|NCT02877927|3456958|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3605817|NCT02877927|3456956|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3605818|NCT02877927|3456957|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605819|NCT02877927|3456958|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3605820|NCT02877927|3456956|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3605821|NCT02877927|3456957|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3605822|NCT02877927|3456958|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3605823|NCT02877927|3456956|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3605824|NCT02877927|3456957|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3605825|NCT02877927|3456958|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3605826|NCT02877927|3456956|B3||Male|Sex: Female, Male||Participants|Count of Participants|462|462.0||||||
3605827|NCT02877927|3456957|B2||Male|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
3605828|NCT02877927|3456958|B1||Male|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
3605829|NCT02877927|3456956|B3||Female|Sex: Female, Male||Participants|Count of Participants|273|273.0||||||
3605830|NCT02877927|3456957|B2||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3605831|NCT02877927|3456958|B1||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3605832|NCT02877927|3456956|B3|||Age||years|Mean|43.7|43.7|Standard Deviation|12.94|12.94|||
3605833|NCT02877927|3456957|B2|||Age||years|Mean|44.5|44.5|Standard Deviation|13.11|13.11|||
3605834|NCT02877927|3456958|B1|||Age||years|Mean|42.8|42.8|Standard Deviation|12.72|12.72|||
3605835|NCT02877732|3456969|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3605836|NCT02877732|3456969|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3605837|NCT02877732|3456970|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3605838|NCT02877732|3456971|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3605839|NCT02877732|3456969|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3605840|NCT02877732|3456970|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3605841|NCT02877732|3456971|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3605842|NCT02877732|3456969|B3|||Age||years|Mean|20|20.0|Full Range|||18.0|23.0|
3605843|NCT02877732|3456970|B2|||Age||years|Mean|20|20.0|Full Range|||18.0|23.0|
3605844|NCT02877732|3456971|B1|||Age||years|Mean|20|20.0|Full Range|||18.0|23.0|
3605845|NCT02877082|3456988|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3605846|NCT02877082|3456988|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3605847|NCT02877082|3456988|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605848|NCT02877082|3456988|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3605849|NCT02877082|3456988|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605850|NCT02877082|3456988|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605851|NCT02877082|3456988|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605852|NCT02877082|3456988|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605853|NCT02877082|3456988|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3605854|NCT02877082|3456988|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3605855|NCT02877082|3456988|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605856|NCT02877082|3456988|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3605857|NCT02877082|3456988|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3605858|NCT02877082|3456988|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3605859|NCT02877082|3456988|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3605860|NCT02877082|3456988|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3605861|NCT02876757|3456996|B3|||Prior depression||Participants|Count of Participants|6706|6706.0||||||
3605862|NCT02876757|3456997|B2|||Prior depression||Participants|Count of Participants|3353|3353.0||||||
3605863|NCT02876757|3456998|B1|||Prior depression||Participants|Count of Participants|3353|3353.0||||||
3605864|NCT02876757|3456996|B3|Canada||Region of Enrollment||participants|Number|186394|186394.0||||||
3605865|NCT02876757|3456997|B2|Canada||Region of Enrollment||participants|Number|93197|93197.0||||||
3605866|NCT02876757|3456998|B1|Canada||Region of Enrollment||participants|Number|93197|93197.0||||||
3605867|NCT02876757|3456996|B3||Male|Sex: Female, Male||Participants|Count of Participants|186394|186394.0||||||
3605868|NCT02876757|3456997|B2||Male|Sex: Female, Male||Participants|Count of Participants|93197|93197.0||||||
3605869|NCT02876757|3456998|B1||Male|Sex: Female, Male||Participants|Count of Participants|93197|93197.0||||||
3605870|NCT02876757|3456996|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3605871|NCT02876757|3456997|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3605872|NCT02876757|3456998|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3605873|NCT02876757|3456996|B3|||Age||years|Mean|75.5|75.5|Standard Deviation|6.8|6.8|||
3605874|NCT02876757|3456997|B2|||Age||years|Mean|75.5|75.5|Standard Deviation|6.9|6.9|||
3605875|NCT02876757|3456998|B1|||Age||years|Mean|75.6|75.6|Standard Deviation|6.7|6.7|||
3605876|NCT02876159|3457009|B3|||BMI||kg/m^2|Mean|24.3|24.3|Standard Deviation|5.3|5.3|||
3605877|NCT02876159|3457010|B2|||BMI||kg/m^2|Mean|22.8|22.8|Standard Deviation|2.77|2.77|||
3605878|NCT02876159|3457011|B1|||BMI||kg/m^2|Mean|25.7|25.7|Standard Deviation|8|8.0|||
3605879|NCT02876159|3457009|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3605880|NCT02876159|3457010|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3605881|NCT02876159|3457011|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3605882|NCT02876159|3457009|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606105|NCT02874846|3457093|B2|||Age||years|Mean|64.5|64.5|Standard Deviation|5.07|5.07|||
3605883|NCT02876159|3457010|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605884|NCT02876159|3457011|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605885|NCT02876159|3457009|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3605886|NCT02876159|3457010|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605887|NCT02876159|3457011|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3605888|NCT02876159|3457009|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3605889|NCT02876159|3457010|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3605890|NCT02876159|3457011|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3605891|NCT02876159|3457009|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3605892|NCT02876159|3457010|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605893|NCT02876159|3457011|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3605894|NCT02876159|3457009|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605895|NCT02876159|3457010|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605896|NCT02876159|3457011|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605897|NCT02876159|3457009|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3605898|NCT02876159|3457010|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3605899|NCT02876159|3457011|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3605900|NCT02876159|3457009|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605901|NCT02876159|3457010|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605902|NCT02876159|3457011|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605903|NCT02876159|3457009|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605904|NCT02876159|3457010|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605905|NCT02876159|3457011|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605906|NCT02876159|3457009|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3605907|NCT02876159|3457010|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3605908|NCT02876159|3457011|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3605909|NCT02876159|3457009|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3605910|NCT02876159|3457010|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605911|NCT02876159|3457011|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3605912|NCT02876159|3457009|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3605913|NCT02876159|3457010|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3605914|NCT02876159|3457011|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3605915|NCT02876159|3457009|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3605916|NCT02876159|3457010|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3605917|NCT02876159|3457011|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3605918|NCT02876159|3457009|B3|||Age||years|Mean|24.0|24.0|Standard Deviation|2.1|2.1|||
3605919|NCT02876159|3457010|B2|||Age||years|Mean|24.6|24.6|Standard Deviation|2.2|2.2|||
3605920|NCT02876159|3457011|B1|||Age||years|Mean|23.4|23.4|Standard Deviation|1.9|1.9|||
3605921|NCT02875977|3457028|B3|Other Urogynecologic Diagnosis||Urogynecologic diagnosis||Participants|Count of Participants|4|4.0||||||
3605922|NCT02875977|3457029|B2|Other Urogynecologic Diagnosis||Urogynecologic diagnosis||Participants|Count of Participants|2|2.0||||||
3605923|NCT02875977|3457030|B1|Other Urogynecologic Diagnosis||Urogynecologic diagnosis||Participants|Count of Participants|2|2.0||||||
3605924|NCT02875977|3457028|B3|Myofascial Pain||Urogynecologic diagnosis||Participants|Count of Participants|76|76.0||||||
3605925|NCT02875977|3457029|B2|Myofascial Pain||Urogynecologic diagnosis||Participants|Count of Participants|36|36.0||||||
3605926|NCT02875977|3457030|B1|Myofascial Pain||Urogynecologic diagnosis||Participants|Count of Participants|40|40.0||||||
3605927|NCT02875977|3457028|B3|Pelvic Organ Prolapse (POP)||Urogynecologic diagnosis||Participants|Count of Participants|22|22.0||||||
3605928|NCT02875977|3457029|B2|Pelvic Organ Prolapse (POP)||Urogynecologic diagnosis||Participants|Count of Participants|12|12.0||||||
3605929|NCT02875977|3457030|B1|Pelvic Organ Prolapse (POP)||Urogynecologic diagnosis||Participants|Count of Participants|10|10.0||||||
3605930|NCT02875977|3457028|B3|Defecatory dysfunction||Urogynecologic diagnosis||Participants|Count of Participants|12|12.0||||||
3605931|NCT02875977|3457029|B2|Defecatory dysfunction||Urogynecologic diagnosis||Participants|Count of Participants|6|6.0||||||
3605932|NCT02875977|3457030|B1|Defecatory dysfunction||Urogynecologic diagnosis||Participants|Count of Participants|6|6.0||||||
3605933|NCT02875977|3457028|B3|Weak Pelvic Floor||Urogynecologic diagnosis||Participants|Count of Participants|22|22.0||||||
3605934|NCT02875977|3457029|B2|Weak Pelvic Floor||Urogynecologic diagnosis||Participants|Count of Participants|14|14.0||||||
3605935|NCT02875977|3457030|B1|Weak Pelvic Floor||Urogynecologic diagnosis||Participants|Count of Participants|8|8.0||||||
3605936|NCT02875977|3457028|B3|Urgency-frequency syndrome||Urogynecologic diagnosis||Participants|Count of Participants|47|47.0||||||
3605937|NCT02875977|3457029|B2|Urgency-frequency syndrome||Urogynecologic diagnosis||Participants|Count of Participants|20|20.0||||||
3605938|NCT02875977|3457030|B1|Urgency-frequency syndrome||Urogynecologic diagnosis||Participants|Count of Participants|27|27.0||||||
3605939|NCT02875977|3457028|B3|Mixed Urinary Incontinence (MUI)||Urogynecologic diagnosis||Participants|Count of Participants|55|55.0||||||
3605940|NCT02875977|3457029|B2|Mixed Urinary Incontinence (MUI)||Urogynecologic diagnosis||Participants|Count of Participants|21|21.0||||||
3605941|NCT02875977|3457030|B1|Mixed Urinary Incontinence (MUI)||Urogynecologic diagnosis||Participants|Count of Participants|34|34.0||||||
3605942|NCT02875977|3457028|B3|Urgency Urinary Incontinence (UUI)||Urogynecologic diagnosis||Participants|Count of Participants|49|49.0||||||
3605943|NCT02875977|3457029|B2|Urgency Urinary Incontinence (UUI)||Urogynecologic diagnosis||Participants|Count of Participants|24|24.0||||||
3605944|NCT02875977|3457030|B1|Urgency Urinary Incontinence (UUI)||Urogynecologic diagnosis||Participants|Count of Participants|25|25.0||||||
3605945|NCT02875977|3457028|B3|Stress Urinary Incontinence (SUI)||Urogynecologic diagnosis||Participants|Count of Participants|34|34.0||||||
3605946|NCT02875977|3457029|B2|Stress Urinary Incontinence (SUI)||Urogynecologic diagnosis||Participants|Count of Participants|25|25.0||||||
3605947|NCT02875977|3457030|B1|Stress Urinary Incontinence (SUI)||Urogynecologic diagnosis||Participants|Count of Participants|9|9.0||||||
3605948|NCT02875977|3457028|B3|||Vaginal Parity||Pregnancies to a viable gestational age|Median|2|2.0|Inter-Quartile Range|||1.0|3.0|
3605949|NCT02875977|3457029|B2|||Vaginal Parity||Pregnancies to a viable gestational age|Median|2|2.0|Inter-Quartile Range|||1.0|3.0|
3605950|NCT02875977|3457030|B1|||Vaginal Parity||Pregnancies to a viable gestational age|Median|2|2.0|Inter-Quartile Range|||1.0|3.0|
3605951|NCT02875977|3457028|B3||Spanish|Primary Language||Participants|Count of Participants|11|11.0||||||
3605952|NCT02875977|3457029|B2||Spanish|Primary Language||Participants|Count of Participants|6|6.0||||||
3605953|NCT02875977|3457030|B1||Spanish|Primary Language||Participants|Count of Participants|5|5.0||||||
3605954|NCT02875977|3457028|B3||English|Primary Language||Participants|Count of Participants|189|189.0||||||
3605955|NCT02875977|3457029|B2||English|Primary Language||Participants|Count of Participants|94|94.0||||||
3605956|NCT02875977|3457030|B1||English|Primary Language||Participants|Count of Participants|95|95.0||||||
3605957|NCT02875977|3457028|B3|||Body Mass Index||kg/m^2|Mean|31.21|31.21|Standard Deviation|7.62|7.62|||
3605958|NCT02875977|3457029|B2|||Body Mass Index||kg/m^2|Mean|29.94|29.94|Standard Deviation|6.74|6.74|||
3605959|NCT02875977|3457030|B1|||Body Mass Index||kg/m^2|Mean|32.48|32.48|Standard Deviation|8.24|8.24|||
3605960|NCT02875977|3457028|B3|United States||Region of Enrollment||participants|Number|200|200.0||||||
3605961|NCT02875977|3457029|B2|United States||Region of Enrollment||participants|Number|100|100.0||||||
3605962|NCT02875977|3457030|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
3605963|NCT02875977|3457028|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3605964|NCT02875977|3457029|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3605965|NCT02875977|3457030|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3605966|NCT02875977|3457028|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3605967|NCT02875977|3457029|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605968|NCT02875977|3457030|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3605969|NCT02875977|3457028|B3||White|Race (NIH/OMB)||Participants|Count of Participants|159|159.0||||||
3605970|NCT02875977|3457029|B2||White|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3605971|NCT02875977|3457030|B1||White|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
3605972|NCT02875977|3457028|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3605973|NCT02875977|3457029|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3605974|NCT02875977|3457030|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3605975|NCT02875977|3457028|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605976|NCT02875977|3457029|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605977|NCT02875977|3457030|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605978|NCT02875977|3457028|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3605979|NCT02875977|3457029|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3605980|NCT02875977|3457030|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3605981|NCT02875977|3457028|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605982|NCT02875977|3457029|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605983|NCT02875977|3457030|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605984|NCT02875977|3457028|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3605985|NCT02875977|3457029|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3605986|NCT02875977|3457030|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3605987|NCT02875977|3457028|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|151|151.0||||||
3605988|NCT02875977|3457029|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3605989|NCT02875977|3457030|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
3605990|NCT02875977|3457028|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3605991|NCT02875977|3457029|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3605992|NCT02875977|3457030|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3605993|NCT02875977|3457028|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3605994|NCT02875977|3457029|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3605995|NCT02875977|3457030|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3605996|NCT02875977|3457028|B3||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
3605997|NCT02875977|3457029|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3605998|NCT02875977|3457030|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3605999|NCT02875977|3457028|B3|||Age||years|Mean|57.05|57.05|Standard Deviation|16.52|16.52|||
3606000|NCT02875977|3457029|B2|||Age||years|Mean|56.77|56.77|Standard Deviation|17.00|17.0|||
3606001|NCT02875977|3457030|B1|||Age||years|Mean|57.32|57.32|Standard Deviation|16.12|16.12|||
3606002|NCT02875340|3457045|B1||Never-smokers|Smokers||Participants|Count of Participants|4|4.0||||||
3606003|NCT02875340|3457045|B1||Ex-smokers|Smokers||Participants|Count of Participants|4|4.0||||||
3606004|NCT02875340|3457045|B1||Smokers|Smokers||Participants|Count of Participants|0|0.0||||||
3606005|NCT02875340|3457045|B1|Georgia||Region of Enrollment||participants|Number|8|8.0||||||
3606006|NCT02875340|3457045|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606007|NCT02875340|3457045|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3606008|NCT02875340|3457045|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606009|NCT02875340|3457045|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3606010|NCT02875340|3457045|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3606011|NCT02875340|3457045|B1|||Age||years|Mean|65.8|65.8|Full Range|||54.0|76.0|
3606012|NCT02874924|3457067|B4|United States||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3606013|NCT02874924|3457068|B3|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3606014|NCT02874924|3457069|B2|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3606015|NCT02874924|3457070|B1|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3606016|NCT02874924|3457067|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606017|NCT02874924|3457068|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606018|NCT02874924|3457069|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606019|NCT02874924|3457070|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606020|NCT02874924|3457067|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606021|NCT02874924|3457068|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606022|NCT02874924|3457069|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606023|NCT02874924|3457070|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606024|NCT02874924|3457067|B4||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3606025|NCT02874924|3457068|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3606026|NCT02874924|3457069|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3606027|NCT02874924|3457070|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3606028|NCT02874924|3457067|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606029|NCT02874924|3457068|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606030|NCT02874924|3457069|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606031|NCT02874924|3457070|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606032|NCT02874924|3457067|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606033|NCT02874924|3457068|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606034|NCT02874924|3457069|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606035|NCT02874924|3457070|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606036|NCT02874924|3457067|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606037|NCT02874924|3457068|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606038|NCT02874924|3457069|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606039|NCT02874924|3457070|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606040|NCT02874924|3457067|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606041|NCT02874924|3457068|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606042|NCT02874924|3457069|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606043|NCT02874924|3457070|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606044|NCT02874924|3457067|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606045|NCT02874924|3457068|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606046|NCT02874924|3457069|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606047|NCT02874924|3457070|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606048|NCT02874924|3457067|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3606049|NCT02874924|3457068|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3606050|NCT02874924|3457069|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3606051|NCT02874924|3457070|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3606052|NCT02874924|3457067|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3606053|NCT02874924|3457068|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606054|NCT02874924|3457069|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3606055|NCT02874924|3457070|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3606056|NCT02874924|3457067|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3606057|NCT02874924|3457068|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3606058|NCT02874924|3457069|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3606059|NCT02874924|3457070|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3606060|NCT02874924|3457067|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3606061|NCT02874924|3457068|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3606062|NCT02874924|3457069|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3606063|NCT02874924|3457070|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3606064|NCT02874924|3457067|B4|Age, 70 years and older||Age, Customized|Only participants age 70 years or older were eligible|Participants|Count of Participants|34|34.0||||||
3606065|NCT02874924|3457068|B3|Age, 70 years and older||Age, Customized|Only participants age 70 years or older were eligible|Participants|Count of Participants|6|6.0||||||
3606066|NCT02874924|3457069|B2|Age, 70 years and older||Age, Customized|Only participants age 70 years or older were eligible|Participants|Count of Participants|14|14.0||||||
3606067|NCT02874924|3457070|B1|Age, 70 years and older||Age, Customized|Only participants age 70 years or older were eligible|Participants|Count of Participants|14|14.0||||||
3606068|NCT02874846|3457092|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606069|NCT02874846|3457093|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606070|NCT02874846|3457094|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606071|NCT02874846|3457092|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606072|NCT02874846|3457093|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606073|NCT02874846|3457094|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606074|NCT02874846|3457092|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3606075|NCT02874846|3457093|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606076|NCT02874846|3457094|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3606077|NCT02874846|3457092|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3606078|NCT02874846|3457093|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3606079|NCT02874846|3457094|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3606080|NCT02874846|3457092|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606081|NCT02874846|3457093|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606082|NCT02874846|3457094|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606083|NCT02874846|3457092|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606084|NCT02874846|3457093|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606085|NCT02874846|3457094|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606086|NCT02874846|3457092|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606087|NCT02874846|3457093|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606088|NCT02874846|3457094|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606089|NCT02874846|3457092|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606090|NCT02874846|3457093|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606091|NCT02874846|3457094|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606092|NCT02874846|3457092|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3606093|NCT02874846|3457093|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3606094|NCT02874846|3457094|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3606095|NCT02874846|3457092|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3606096|NCT02874846|3457093|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606097|NCT02874846|3457094|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606098|NCT02874846|3457092|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3606099|NCT02874846|3457093|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3606100|NCT02874846|3457094|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3606101|NCT02874846|3457092|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3606102|NCT02874846|3457093|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3606103|NCT02874846|3457094|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3606104|NCT02874846|3457092|B3|||Age||years|Mean|64.4|64.4|Standard Deviation|8.58|8.58|||
3606106|NCT02874846|3457094|B1|||Age||years|Mean|64.4|64.4|Standard Deviation|10.23|10.23|||
3606107|NCT02873754|3457103|B1|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3606108|NCT02873754|3457103|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606109|NCT02873754|3457103|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606110|NCT02873754|3457103|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3606111|NCT02873754|3457103|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3606112|NCT02873754|3457103|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606113|NCT02873754|3457103|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606114|NCT02873754|3457103|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606115|NCT02873754|3457103|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606116|NCT02873754|3457103|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3606117|NCT02873754|3457103|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606118|NCT02873754|3457103|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3606119|NCT02873754|3457103|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3606120|NCT02873754|3457103|B1|||Age||years|Mean|43.45|43.45|Standard Deviation|10.04|10.04|||
3606121|NCT02873481|3457118|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
3606122|NCT02873481|3457119|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3606123|NCT02873481|3457120|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3606124|NCT02873481|3457118|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606125|NCT02873481|3457119|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606126|NCT02873481|3457120|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606127|NCT02873481|3457118|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606128|NCT02873481|3457119|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606129|NCT02873481|3457120|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606130|NCT02873481|3457118|B3||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3606131|NCT02873481|3457119|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3606132|NCT02873481|3457120|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3606133|NCT02873481|3457118|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3606134|NCT02873481|3457119|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3606135|NCT02873481|3457120|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3606136|NCT02873481|3457118|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606137|NCT02873481|3457119|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606138|NCT02873481|3457120|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606139|NCT02873481|3457118|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606140|NCT02873481|3457119|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606141|NCT02873481|3457120|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606142|NCT02873481|3457118|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606143|NCT02873481|3457119|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606144|NCT02873481|3457120|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606145|NCT02873481|3457118|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3606146|NCT02873481|3457119|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3606147|NCT02873481|3457120|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3606148|NCT02873481|3457118|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3606149|NCT02873481|3457119|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3606150|NCT02873481|3457120|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3606151|NCT02873481|3457118|B3|||Age||years|Mean|26.6|26.6|Standard Deviation|6.4|6.4|||
3606152|NCT02873481|3457119|B2|||Age||years|Mean|24.4|24.4|Standard Deviation|5.6|5.6|||
3606153|NCT02873481|3457120|B1|||Age||years|Mean|29.3|29.3|Standard Deviation|6.5|6.5|||
3606154|NCT02873429|3457136|B3||Missing|Education||Participants|Count of Participants|1|1.0||||||
3606155|NCT02873429|3457137|B2||Missing|Education||Participants|Count of Participants|0|0.0||||||
3606156|NCT02873429|3457138|B1||Missing|Education||Participants|Count of Participants|1|1.0||||||
3606157|NCT02873429|3457136|B3||Greater than or equal to 4-year degree|Education||Participants|Count of Participants|108|108.0||||||
3606158|NCT02873429|3457137|B2||Greater than or equal to 4-year degree|Education||Participants|Count of Participants|53|53.0||||||
3606159|NCT02873429|3457138|B1||Greater than or equal to 4-year degree|Education||Participants|Count of Participants|55|55.0||||||
3606160|NCT02873429|3457136|B3||Less than 4-year degree|Education||Participants|Count of Participants|100|100.0||||||
3606161|NCT02873429|3457137|B2||Less than 4-year degree|Education||Participants|Count of Participants|47|47.0||||||
3606162|NCT02873429|3457138|B1||Less than 4-year degree|Education||Participants|Count of Participants|53|53.0||||||
3606163|NCT02873429|3457136|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3606164|NCT02873429|3457137|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606165|NCT02873429|3457138|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3606166|NCT02873429|3457136|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3606167|NCT02873429|3457137|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3606168|NCT02873429|3457138|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3606169|NCT02873429|3457136|B3||White|Race (NIH/OMB)||Participants|Count of Participants|159|159.0||||||
3606170|NCT02873429|3457137|B2||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3606171|NCT02873429|3457138|B1||White|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3606172|NCT02873429|3457136|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3606173|NCT02873429|3457137|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3606174|NCT02873429|3457138|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3606175|NCT02873429|3457136|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606176|NCT02873429|3457137|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606177|NCT02873429|3457138|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606178|NCT02873429|3457136|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3606179|NCT02873429|3457137|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606180|NCT02873429|3457138|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3606181|NCT02873429|3457136|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606182|NCT02873429|3457137|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606183|NCT02873429|3457138|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606184|NCT02873429|3457136|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606185|NCT02873429|3457137|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606186|NCT02873429|3457138|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606187|NCT02873429|3457136|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|194|194.0||||||
3606188|NCT02873429|3457137|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
3606189|NCT02873429|3457138|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
3606190|NCT02873429|3457136|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3606191|NCT02873429|3457137|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3606192|NCT02873429|3457138|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3606193|NCT02873429|3457136|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3606194|NCT02873429|3457137|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3606195|NCT02873429|3457138|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3606196|NCT02873429|3457136|B3||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3606197|NCT02873429|3457137|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3606198|NCT02873429|3457138|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3606199|NCT02873429|3457136|B3|||Age||years|Mean|47.5|47.5|Standard Deviation|14.9|14.9|||
3606200|NCT02873429|3457137|B2|||Age||years|Mean|49.5|49.5|Standard Deviation|15.0|15.0|||
3606201|NCT02873429|3457138|B1|||Age||years|Mean|45.6|45.6|Standard Deviation|14.5|14.5|||
3606202|NCT02873104|3457149|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3606203|NCT02873104|3457150|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3606204|NCT02873104|3457151|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3606205|NCT02873104|3457149|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3606206|NCT02873104|3457150|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3606207|NCT02873104|3457151|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3606208|NCT02873104|3457149|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3606209|NCT02873104|3457150|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3606210|NCT02873104|3457151|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3606211|NCT02873104|3457149|B3||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
3606212|NCT02873104|3457150|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3606213|NCT02873104|3457151|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3606214|NCT02873104|3457149|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3606215|NCT02873104|3457150|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3606216|NCT02873104|3457151|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3606217|NCT02871570|3457164|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606218|NCT02871570|3457165|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606219|NCT02871570|3457166|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606220|NCT02871570|3457164|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606221|NCT02871570|3457165|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606222|NCT02871570|3457166|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606223|NCT02871570|3457164|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3606224|NCT02871570|3457165|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3606225|NCT02871570|3457166|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3606226|NCT02871570|3457164|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606227|NCT02871570|3457165|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606228|NCT02871570|3457166|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606229|NCT02871570|3457164|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606230|NCT02871570|3457165|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606231|NCT02871570|3457166|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606232|NCT02871570|3457164|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606233|NCT02871570|3457165|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606234|NCT02871570|3457166|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606235|NCT02871570|3457164|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606236|NCT02871570|3457165|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606237|NCT02871570|3457166|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606238|NCT02871570|3457164|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3606239|NCT02871570|3457165|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3606240|NCT02871570|3457166|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3606241|NCT02871570|3457164|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3606242|NCT02871570|3457165|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3606243|NCT02871570|3457166|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3606244|NCT02871570|3457164|B3|||Age||years|Mean|58.38|58.38|Standard Deviation|4.03|4.03|||
3606245|NCT02871570|3457165|B2|||Age||years|Mean|58.75|58.75|Standard Deviation|4.43|4.43|||
3606246|NCT02871570|3457166|B1|||Age||years|Mean|58.00|58.0|Standard Deviation|3.85|3.85|||
3606247|NCT02871375|3457195|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3606248|NCT02871375|3457195|B1||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3606249|NCT02871375|3457195|B1|||Age||years|Mean|52.0|52.0|Standard Deviation|5.14|5.14|||
3606250|NCT02870205|3457205|B5||Male|Sex: Female, Male||Participants|Count of Participants|435|435.0||||||
3606251|NCT02870205|3457206|B4||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3606252|NCT02870205|3457207|B3||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3606253|NCT02870205|3457208|B2||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3606254|NCT02870205|3457209|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3606255|NCT02870205|3457205|B5||Female|Sex: Female, Male||Participants|Count of Participants|737|737.0||||||
3606256|NCT02870205|3457206|B4||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
3606257|NCT02870205|3457207|B3||Female|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
3606258|NCT02870205|3457208|B2||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3606259|NCT02870205|3457209|B1||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
3606260|NCT02870205|3457205|B5|||Age||years|Mean|39.6|39.6|Standard Deviation|14.81|14.81|||
3606261|NCT02870205|3457206|B4|||Age||years|Mean|39.2|39.2|Standard Deviation|14.86|14.86|||
3606262|NCT02870205|3457207|B3|||Age||years|Mean|39.9|39.9|Standard Deviation|14.62|14.62|||
3606263|NCT02870205|3457208|B2|||Age||years|Mean|39.9|39.9|Standard Deviation|14.91|14.91|||
3606264|NCT02870205|3457209|B1|||Age||years|Mean|39.6|39.6|Standard Deviation|14.93|14.93|||
3606265|NCT02869451|3457222|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3606266|NCT02869451|3457222|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606267|NCT02869451|3457222|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606268|NCT02869451|3457222|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606269|NCT02869451|3457222|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3606270|NCT02869451|3457222|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606271|NCT02869451|3457222|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606272|NCT02869451|3457222|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606273|NCT02869451|3457222|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606274|NCT02869451|3457222|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3606275|NCT02869451|3457222|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606276|NCT02869451|3457222|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3606277|NCT02869451|3457222|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3606278|NCT02869451|3457222|B1|||Age||years|Mean|43.6|43.6|Standard Deviation|8.87|8.87|||
3606279|NCT02868892|3457244|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3606280|NCT02868892|3457244|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3606281|NCT02868892|3457244|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606282|NCT02868892|3457244|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3606283|NCT02868892|3457244|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3606284|NCT02868892|3457244|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3606285|NCT02868892|3457244|B1|||Age||years|Mean|54|54.0|Full Range|||37.0|58.0|
3606286|NCT02868892|3457244|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3606287|NCT02868892|3457244|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3606288|NCT02868892|3457244|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3606289|NCT02867150|3457250|B1|United States||Region of Enrollment|Multi-site U.S. Study|participants|Number|58|58.0||||||
3606290|NCT02867150|3457250|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3606291|NCT02867150|3457250|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3606292|NCT02867150|3457250|B1|||Age||Years|Mean|43.3|43.3|Full Range|||18.0|74.0|
3606293|NCT02867150|3457250|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3606294|NCT02867150|3457250|B1||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3606295|NCT02867150|3457250|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3606296|NCT02865720|3457254|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606297|NCT02865720|3457255|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606298|NCT02865720|3457254|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606299|NCT02865720|3457255|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606300|NCT02865720|3457254|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606301|NCT02865720|3457255|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606302|NCT02865720|3457254|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606303|NCT02865720|3457255|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606304|NCT02865720|3457254|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606305|NCT02865720|3457255|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606306|NCT02865720|3457254|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3606307|NCT02865720|3457255|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3606308|NCT02865720|3457254|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606309|NCT02865720|3457255|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606310|NCT02865720|3457254|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606311|NCT02865720|3457255|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606312|NCT02865720|3457254|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3606313|NCT02865720|3457255|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3606314|NCT02865720|3457254|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606315|NCT02865720|3457255|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606316|NCT02865720|3457254|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3606317|NCT02865720|3457255|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3606318|NCT02865720|3457254|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3606319|NCT02865720|3457255|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3606320|NCT02865720|3457254|B3|||Age||year|Mean|38.4|38.4|Standard Deviation|7.27|7.27|||
3606321|NCT02865720|3457255|B2|||Age||year|Mean|38.4|38.4|Standard Deviation|7.27|7.27|||
3606322|NCT02865083|3457280|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3606323|NCT02865083|3457281|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3606324|NCT02865083|3457282|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3606325|NCT02865083|3457280|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3606326|NCT02865083|3457281|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3606327|NCT02865083|3457282|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3606328|NCT02864732|3457301|B3|||BMI||kg/m^2|Mean|26.18|26.18|Standard Deviation|3.4|3.4|||
3606329|NCT02864732|3457302|B2|||BMI||kg/m^2|Mean|26.47|26.47|Standard Deviation|2.9|2.9|||
3606330|NCT02864732|3457303|B1|||BMI||kg/m^2|Mean|25.89|25.89|Standard Deviation|3.9|3.9|||
3606331|NCT02864732|3457301|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606332|NCT02864732|3457302|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606333|NCT02864732|3457303|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606334|NCT02864732|3457301|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606335|NCT02864732|3457302|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606336|NCT02864732|3457303|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606337|NCT02864732|3457301|B3||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3606338|NCT02864732|3457302|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3606339|NCT02864732|3457303|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3606340|NCT02864732|3457301|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3606341|NCT02864732|3457302|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606342|NCT02864732|3457303|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3606343|NCT02864732|3457301|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606344|NCT02864732|3457302|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606345|NCT02864732|3457303|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606346|NCT02864732|3457301|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3606347|NCT02864732|3457302|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606348|NCT02864732|3457303|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606349|NCT02864732|3457301|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606350|NCT02864732|3457302|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606351|NCT02864732|3457303|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606352|NCT02864732|3457301|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3606353|NCT02864732|3457302|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3606354|NCT02864732|3457303|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3606355|NCT02864732|3457301|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3606356|NCT02864732|3457302|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3606357|NCT02864732|3457303|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3606358|NCT02864732|3457301|B3|||Age||years|Mean|35.87|35.87|Standard Deviation|10.15|10.15|||
3606359|NCT02864732|3457302|B2|||Age||years|Mean|33.40|33.4|Standard Deviation|9.0|9.0|||
3606360|NCT02864732|3457303|B1|||Age||years|Mean|38.33|38.33|Standard Deviation|11.3|11.3|||
3606361|NCT02864342|3457319|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3606362|NCT02864342|3457320|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606363|NCT02864342|3457321|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3606364|NCT02864342|3457319|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606365|NCT02864342|3457320|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606366|NCT02864342|3457321|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606367|NCT02864342|3457319|B3||White|Race (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
3606368|NCT02864342|3457320|B2||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3606369|NCT02864342|3457321|B1||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3606370|NCT02864342|3457319|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3606371|NCT02864342|3457320|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3606372|NCT02864342|3457321|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3606373|NCT02864342|3457319|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606374|NCT02864342|3457320|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606375|NCT02864342|3457321|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606376|NCT02864342|3457319|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606377|NCT02864342|3457320|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606378|NCT02864342|3457321|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606379|NCT02864342|3457319|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606380|NCT02864342|3457320|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606381|NCT02864342|3457321|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606382|NCT02864342|3457319|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606383|NCT02864342|3457320|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606384|NCT02864342|3457321|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606385|NCT02864342|3457319|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|136|136.0||||||
3606386|NCT02864342|3457320|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3606387|NCT02864342|3457321|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3606388|NCT02864342|3457319|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606389|NCT02864342|3457320|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606390|NCT02864342|3457321|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606391|NCT02864342|3457319|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3606392|NCT02864342|3457320|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3606393|NCT02864342|3457321|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3606394|NCT02864342|3457319|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3606395|NCT02864342|3457320|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3606396|NCT02864342|3457321|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3606397|NCT02864342|3457319|B3|||Age||Years|Mean|66.7|66.7|Standard Deviation|8.43|8.43|||
3606398|NCT02864342|3457320|B2|||Age||Years|Mean|66.7|66.7|Standard Deviation|8.72|8.72|||
3606399|NCT02864342|3457321|B1|||Age||Years|Mean|66.6|66.6|Standard Deviation|8.21|8.21|||
3606400|NCT02863198|3457337|B3|Egypt||Region of Enrollment||participants|Number|120|120.0||||||
3606401|NCT02863198|3457338|B2|Egypt||Region of Enrollment||participants|Number|60|60.0||||||
3606402|NCT02863198|3457339|B1|Egypt||Region of Enrollment||participants|Number|60|60.0||||||
3606403|NCT02863198|3457337|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3606404|NCT02863198|3457338|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3606405|NCT02863198|3457339|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3606406|NCT02863198|3457337|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3606407|NCT02863198|3457338|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3606408|NCT02863198|3457339|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3606409|NCT02863198|3457337|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3606410|NCT02863198|3457338|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3606411|NCT02863198|3457339|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3606412|NCT02863198|3457337|B3||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
3606413|NCT02863198|3457338|B2||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3606414|NCT02863198|3457339|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3606415|NCT02863198|3457337|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3606416|NCT02863198|3457338|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3606417|NCT02863198|3457339|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3606418|NCT02862730|3457356|B1|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3606419|NCT02862730|3457356|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606420|NCT02862730|3457356|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3606421|NCT02862730|3457356|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3606422|NCT02862730|3457356|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3606423|NCT02862730|3457356|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3606424|NCT02862730|3457356|B1|||Age||years|Mean|35|35.0|Standard Deviation|5|5.0|||
3606425|NCT02862730|3457356|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3606426|NCT02862730|3457356|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3606427|NCT02862730|3457356|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3606428|NCT02862600|3457417|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3606429|NCT02862600|3457417|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606430|NCT02862600|3457417|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606431|NCT02862600|3457417|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3606432|NCT02862600|3457417|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3606433|NCT02862600|3457417|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606434|NCT02862600|3457417|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606435|NCT02862600|3457417|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606436|NCT02862600|3457417|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606437|NCT02862600|3457417|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3606438|NCT02862600|3457417|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3606439|NCT02862600|3457417|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3606440|NCT02862600|3457417|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3606441|NCT02862600|3457417|B1|||Age||years|Median|50|50.0|Full Range|||26.0|72.0|
3606442|NCT02862574|3457424|B4|||Disease Activity Score C-reactive Protein (DAS28(CRP))|The DAS28 score is a measure of the participant's disease activity calculated using the tender joint counts (28 joints), swollen joint counts (28 joints), Patient's Global Assessment of Disease Activity (visual analog scale: 0 = no disease activity to 100 = maximum disease activity), and C-Reactive Protein (CRP) for a total possible score of 2 to 10. Higher values indicate higher disease activity.|units on a scale|Mean|5.79|5.79|Standard Deviation|0.764|0.764|||
3606443|NCT02862574|3457425|B3|||Disease Activity Score C-reactive Protein (DAS28(CRP))|The DAS28 score is a measure of the participant's disease activity calculated using the tender joint counts (28 joints), swollen joint counts (28 joints), Patient's Global Assessment of Disease Activity (visual analog scale: 0 = no disease activity to 100 = maximum disease activity), and C-Reactive Protein (CRP) for a total possible score of 2 to 10. Higher values indicate higher disease activity.|units on a scale|Mean|5.69|5.69|Standard Deviation|0.887|0.887|||
3606444|NCT02862574|3457426|B2|||Disease Activity Score C-reactive Protein (DAS28(CRP))|The DAS28 score is a measure of the participant's disease activity calculated using the tender joint counts (28 joints), swollen joint counts (28 joints), Patient's Global Assessment of Disease Activity (visual analog scale: 0 = no disease activity to 100 = maximum disease activity), and C-Reactive Protein (CRP) for a total possible score of 2 to 10. Higher values indicate higher disease activity.|units on a scale|Mean|5.90|5.9|Standard Deviation|0.752|0.752|||
3606499|NCT02862106|3457448|B6|||BMI||kg/m^2|Mean|22.12|22.12|Standard Deviation|2.792|2.792|||
3606500|NCT02862106|3457449|B5|||BMI||kg/m^2|Mean|21.76|21.76|Standard Deviation|3.273|3.273|||
3606445|NCT02862574|3457427|B1|||Disease Activity Score C-reactive Protein (DAS28(CRP))|The DAS28 score is a measure of the participant's disease activity calculated using the tender joint counts (28 joints), swollen joint counts (28 joints), Patient's Global Assessment of Disease Activity (visual analog scale: 0 = no disease activity to 100 = maximum disease activity), and C-Reactive Protein (CRP) for a total possible score of 2 to 10. Higher values indicate higher disease activity.|units on a scale|Mean|5.79|5.79|Standard Deviation|0.814|0.814|||
3606446|NCT02862574|3457424|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606447|NCT02862574|3457425|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606448|NCT02862574|3457426|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606449|NCT02862574|3457427|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606450|NCT02862574|3457424|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606451|NCT02862574|3457425|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606452|NCT02862574|3457426|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606453|NCT02862574|3457427|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606454|NCT02862574|3457424|B4||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3606455|NCT02862574|3457425|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3606456|NCT02862574|3457426|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3606457|NCT02862574|3457427|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3606458|NCT02862574|3457424|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3606459|NCT02862574|3457425|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606460|NCT02862574|3457426|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606461|NCT02862574|3457427|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3606462|NCT02862574|3457424|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606463|NCT02862574|3457425|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606464|NCT02862574|3457426|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606465|NCT02862574|3457427|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606466|NCT02862574|3457424|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606467|NCT02862574|3457425|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606468|NCT02862574|3457426|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606469|NCT02862574|3457427|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606470|NCT02862574|3457424|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606471|NCT02862574|3457425|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606472|NCT02862574|3457426|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606473|NCT02862574|3457427|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606474|NCT02862574|3457424|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606475|NCT02862574|3457425|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606476|NCT02862574|3457426|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606477|NCT02862574|3457427|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606478|NCT02862574|3457424|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3606479|NCT02862574|3457425|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3606480|NCT02862574|3457426|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3606481|NCT02862574|3457427|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3606482|NCT02862574|3457424|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3606483|NCT02862574|3457425|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606484|NCT02862574|3457426|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3606485|NCT02862574|3457427|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606486|NCT02862574|3457424|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3606487|NCT02862574|3457425|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3606488|NCT02862574|3457426|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3606489|NCT02862574|3457427|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3606490|NCT02862574|3457424|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3606491|NCT02862574|3457425|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3606492|NCT02862574|3457426|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3606493|NCT02862574|3457427|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3606494|NCT02862574|3457424|B4|||Age||years|Mean|56|56.0|Standard Deviation|10.6|10.6|||
3606495|NCT02862574|3457425|B3|||Age||years|Mean|58|58.0|Standard Deviation|5.6|5.6|||
3606496|NCT02862574|3457426|B2|||Age||years|Mean|57|57.0|Standard Deviation|9.3|9.3|||
3606497|NCT02862574|3457427|B1|||Age||years|Mean|54|54.0|Standard Deviation|16.3|16.3|||
3606498|NCT02862106|3457447|B7|||BMI||kg/m^2|Mean|21.89|21.89|Standard Deviation|2.835|2.835|||
3606501|NCT02862106|3457450|B4|||BMI||kg/m^2|Mean|21.95|21.95|Standard Deviation|2.615|2.615|||
3606502|NCT02862106|3457451|B3|||BMI||kg/m^2|Mean|21.42|21.42|Standard Deviation|2.601|2.601|||
3606503|NCT02862106|3457452|B2|||BMI||kg/m^2|Mean|21.23|21.23|Standard Deviation|2.181|2.181|||
3606504|NCT02862106|3457453|B1|||BMI||kg/m^2|Mean|22.69|22.69|Standard Deviation|4.043|4.043|||
3606505|NCT02862106|3457447|B7||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3606506|NCT02862106|3457448|B6||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3606507|NCT02862106|3457449|B5||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3606508|NCT02862106|3457450|B4||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3606509|NCT02862106|3457451|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3606510|NCT02862106|3457452|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3606511|NCT02862106|3457453|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3606512|NCT02862106|3457447|B7||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3606513|NCT02862106|3457448|B6||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3606514|NCT02862106|3457449|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3606515|NCT02862106|3457450|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3606516|NCT02862106|3457451|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3606517|NCT02862106|3457452|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3606518|NCT02862106|3457453|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3606519|NCT02862106|3457447|B7|||Age||years|Mean|29.4|29.4|Standard Deviation|7.96|7.96|||
3606520|NCT02862106|3457448|B6|||Age||years|Mean|29.4|29.4|Standard Deviation|7.61|7.61|||
3606521|NCT02862106|3457449|B5|||Age||years|Mean|29.6|29.6|Standard Deviation|9.14|9.14|||
3606522|NCT02862106|3457450|B4|||Age||years|Mean|30.4|30.4|Standard Deviation|7.56|7.56|||
3606523|NCT02862106|3457451|B3|||Age||years|Mean|25.8|25.8|Standard Deviation|8.02|8.02|||
3606524|NCT02862106|3457452|B2|||Age||years|Mean|25.2|25.2|Standard Deviation|4.39|4.39|||
3606525|NCT02862106|3457453|B1|||Age||years|Mean|32.7|32.7|Standard Deviation|6.03|6.03|||
3606526|NCT02862106|3457447|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3606527|NCT02862106|3457448|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3606528|NCT02862106|3457449|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3606529|NCT02862106|3457450|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3606530|NCT02862106|3457451|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3606531|NCT02862106|3457452|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3606532|NCT02862106|3457453|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3606533|NCT02862106|3457447|B7||Between 18 and 65 years|Age||Participants|Count of Participants|203|203.0||||||
3606534|NCT02862106|3457448|B6||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3606535|NCT02862106|3457449|B5||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
3606536|NCT02862106|3457450|B4||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
3606537|NCT02862106|3457451|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3606538|NCT02862106|3457452|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3606539|NCT02862106|3457453|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3606540|NCT02862106|3457447|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3606541|NCT02862106|3457448|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3606542|NCT02862106|3457449|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3606543|NCT02862106|3457450|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3606544|NCT02862106|3457451|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3606545|NCT02862106|3457452|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3606546|NCT02862106|3457453|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3606547|NCT02861664|3457512|B3|||Tactile Threshold at Baseline|The examiner assessed the response to tactile sensitivity using a Yeaple probe which allowed application of a known force to the dentin surface, starting at 10g and rising in increments of 10g until the tactile threshold or maximum force has reached. The tactile threshold for each tooth was determined by asking the participant whether the sensation caused discomfort. The pressure setting at which participant gave two consecutive 'yes' responses was recorded as the tactile threshold. The higher the tactile threshold, the less sensitive the tooth. At baseline, the maximum force used was 20g.|gram (g)|Mean|11.0|11.0|Standard Deviation|2.19|2.19|||
3606548|NCT02861664|3457513|B2|||Tactile Threshold at Baseline|The examiner assessed the response to tactile sensitivity using a Yeaple probe which allowed application of a known force to the dentin surface, starting at 10g and rising in increments of 10g until the tactile threshold or maximum force has reached. The tactile threshold for each tooth was determined by asking the participant whether the sensation caused discomfort. The pressure setting at which participant gave two consecutive 'yes' responses was recorded as the tactile threshold. The higher the tactile threshold, the less sensitive the tooth. At baseline, the maximum force used was 20g.|gram (g)|Mean|10.9|10.9|Standard Deviation|2.29|2.29|||
3606589|NCT02858050|3457525|B3|Race|Non-Caucasion|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3606590|NCT02858050|3457526|B2|Race|Non-Caucasion|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3606591|NCT02858050|3457527|B1|Race|Non-Caucasion|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3606592|NCT02858050|3457525|B3|Race|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3606549|NCT02861664|3457514|B1|||Tactile Threshold at Baseline|The examiner assessed the response to tactile sensitivity using a Yeaple probe which allowed application of a known force to the dentin surface, starting at 10g and rising in increments of 10g until the tactile threshold or maximum force has reached. The tactile threshold for each tooth was determined by asking the participant whether the sensation caused discomfort. The pressure setting at which participant gave two consecutive 'yes' responses was recorded as the tactile threshold. The higher the tactile threshold, the less sensitive the tooth. At baseline, the maximum force used was 20g.|gram (g)|Mean|11.1|11.1|Standard Deviation|2.10|2.1|||
3606550|NCT02861664|3457512|B3|||Schiff Sensitivity Score at Baseline|The examiner assessed the participant's response to evaporative air stimulus, after the stimulation of each individual tooth, using the Schiff Sensitivity Scale as follows: 0 Participant does not respond to air stimulation, 1 Participant responds to air stimulus but does not request discontinuation of stimulus, 2 Participant responds to air stimulus and requests discontinuation or moves from stimulus, 3 Participant responds to stimulus, considers stimulus to be painful and requests discontinuation of the stimulus. A reduction in Schiff Sensitivity score indicate improvement in sensitivity.|score on a scale|Mean|2.25|2.25|Standard Deviation|0.372|0.372|||
3606551|NCT02861664|3457513|B2|||Schiff Sensitivity Score at Baseline|The examiner assessed the participant's response to evaporative air stimulus, after the stimulation of each individual tooth, using the Schiff Sensitivity Scale as follows: 0 Participant does not respond to air stimulation, 1 Participant responds to air stimulus but does not request discontinuation of stimulus, 2 Participant responds to air stimulus and requests discontinuation or moves from stimulus, 3 Participant responds to stimulus, considers stimulus to be painful and requests discontinuation of the stimulus. A reduction in Schiff Sensitivity score indicate improvement in sensitivity.|score on a scale|Mean|2.23|2.23|Standard Deviation|0.352|0.352|||
3606552|NCT02861664|3457514|B1|||Schiff Sensitivity Score at Baseline|The examiner assessed the participant's response to evaporative air stimulus, after the stimulation of each individual tooth, using the Schiff Sensitivity Scale as follows: 0 Participant does not respond to air stimulation, 1 Participant responds to air stimulus but does not request discontinuation of stimulus, 2 Participant responds to air stimulus and requests discontinuation or moves from stimulus, 3 Participant responds to stimulus, considers stimulus to be painful and requests discontinuation of the stimulus. A reduction in Schiff Sensitivity score indicate improvement in sensitivity.|score on a scale|Mean|2.26|2.26|Standard Deviation|0.393|0.393|||
3606553|NCT02861664|3457512|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606554|NCT02861664|3457513|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606555|NCT02861664|3457514|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606556|NCT02861664|3457512|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606557|NCT02861664|3457513|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606558|NCT02861664|3457514|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606559|NCT02861664|3457512|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606560|NCT02861664|3457513|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606561|NCT02861664|3457514|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606562|NCT02861664|3457512|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606563|NCT02861664|3457513|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606564|NCT02861664|3457514|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606565|NCT02861664|3457512|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606566|NCT02861664|3457513|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606567|NCT02861664|3457514|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606568|NCT02861664|3457512|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
3606569|NCT02861664|3457513|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3606570|NCT02861664|3457514|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3606571|NCT02861664|3457512|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606572|NCT02861664|3457513|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606573|NCT02861664|3457514|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606574|NCT02861664|3457512|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3606575|NCT02861664|3457513|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3606576|NCT02861664|3457514|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3606577|NCT02861664|3457512|B3||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3606578|NCT02861664|3457513|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3606579|NCT02861664|3457514|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3606580|NCT02861664|3457512|B3|||Age||years|Mean|41.0|41.0|Standard Deviation|8.55|8.55|||
3606581|NCT02861664|3457513|B2|||Age||years|Mean|41.9|41.9|Standard Deviation|8.83|8.83|||
3606582|NCT02861664|3457514|B1|||Age||years|Mean|40.0|40.0|Standard Deviation|8.21|8.21|||
3606583|NCT02858050|3457525|B3|||Treatment Naive||Participants|Count of Participants|37|37.0||||||
3606584|NCT02858050|3457526|B2|||Treatment Naive||Participants|Count of Participants|19|19.0||||||
3606585|NCT02858050|3457527|B1|||Treatment Naive||Participants|Count of Participants|18|18.0||||||
3606586|NCT02858050|3457525|B3|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3606587|NCT02858050|3457526|B2|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3606588|NCT02858050|3457527|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3606593|NCT02858050|3457526|B2|Race|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3606594|NCT02858050|3457527|B1|Race|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3606595|NCT02858050|3457525|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3606596|NCT02858050|3457526|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3606597|NCT02858050|3457527|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3606598|NCT02858050|3457525|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3606599|NCT02858050|3457526|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3606600|NCT02858050|3457527|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3606601|NCT02858050|3457525|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3606602|NCT02858050|3457526|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3606603|NCT02858050|3457527|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3606604|NCT02858050|3457525|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3606605|NCT02858050|3457526|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3606606|NCT02858050|3457527|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3606607|NCT02858050|3457525|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3606608|NCT02858050|3457526|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3606609|NCT02858050|3457527|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3606610|NCT02857816|3457534|B1|||Baseline voids/day||episodes|Mean|11.5|11.5|Standard Deviation|2.9|2.9|||
3606611|NCT02857816|3457534|B1|||Baseline UUI episodes/day||episodes|Mean|3.5|3.5|Standard Deviation|2.5|2.5|||
3606612|NCT02857816|3457534|B1|||Years since OAB diagnosis||years|Mean|3.4|3.4|Standard Deviation|5.1|5.1|||
3606613|NCT02857816|3457534|B1|United States||Region of Enrollment||participants|Number|120|120.0||||||
3606614|NCT02857816|3457534|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3606615|NCT02857816|3457534|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
3606616|NCT02857816|3457534|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3606617|NCT02857816|3457534|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3606618|NCT02857816|3457534|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3606619|NCT02857816|3457534|B1|||Age||years|Mean|64.8|64.8|Standard Deviation|11.6|11.6|||
3606620|NCT02856880|3457540|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3606621|NCT02856880|3457540|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3606622|NCT02856880|3457540|B1|||Age||Years|Mean|39.4|39.4|Standard Deviation|12.60|12.6|||
3606623|NCT02855541|3457564|B1|||Systolic Blood Pressure||mmHg|Mean|112.2|112.2|Standard Deviation|10.3|10.3|||
3606624|NCT02855541|3457564|B1|||Fat Mass||kg|Mean|28.5|28.5|Standard Deviation|13.0|13.0|||
3606625|NCT02855541|3457564|B1|||Lean Mass||kg|Mean|47.8|47.8|Standard Deviation|8.1|8.1|||
3606626|NCT02855541|3457564|B1|||Triglycerides||mmol/L|Mean|1.16|1.16|Standard Deviation|0.64|0.64|||
3606627|NCT02855541|3457564|B1|||LDL Cholesterol||mmol/L|Mean|2.50|2.5|Standard Deviation|0.67|0.67|||
3606628|NCT02855541|3457564|B1|||HDL Cholesterol||mmol/L|Mean|1.09|1.09|Standard Deviation|0.17|0.17|||
3606629|NCT02855541|3457564|B1|||Work Sitting||hours|Mean|7.04|7.04|Standard Deviation|0.78|0.78|||
3606630|NCT02855541|3457564|B1|||Blood Glucose|2-h Post Oral Glucose Tolerance Test Blood Glucose|mmol/L|Mean|5.41|5.41|Standard Deviation|1.21|1.21|||
3606631|NCT02855541|3457564|B1|||Maximum Oxygen Consumption (VO2max)||L/min|Mean|2.07|2.07|Standard Deviation|0.44|0.44|||
3606632|NCT02855541|3457564|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3606633|NCT02855541|3457564|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606634|NCT02855541|3457564|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3606635|NCT02855541|3457564|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3606636|NCT02855541|3457564|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3606637|NCT02855541|3457564|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3606638|NCT02855541|3457564|B1|||Age||years|Mean|34.8|34.8|Standard Deviation|9.9|9.9|||
3606639|NCT02855411|3457575|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3606640|NCT02855411|3457575|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3606641|NCT02855411|3457575|B1|||Age||years|Mean|41.4|41.4|Standard Deviation|6.8|6.8|||
3606642|NCT02855086|3457595|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3606643|NCT02855086|3457596|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3606644|NCT02855086|3457597|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3606645|NCT02855086|3457595|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606646|NCT02855086|3457596|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606647|NCT02855086|3457597|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606648|NCT02855086|3457595|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606649|NCT02855086|3457596|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606650|NCT02855086|3457597|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606651|NCT02855086|3457595|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606652|NCT02855086|3457596|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606653|NCT02855086|3457597|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606654|NCT02855086|3457595|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606655|NCT02855086|3457596|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606656|NCT02855086|3457597|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606657|NCT02855086|3457595|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606658|NCT02855086|3457596|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606659|NCT02855086|3457597|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606660|NCT02855086|3457595|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606661|NCT02855086|3457596|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606662|NCT02855086|3457597|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606663|NCT02855086|3457595|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606664|NCT02855086|3457596|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606665|NCT02855086|3457597|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606666|NCT02855086|3457595|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606667|NCT02855086|3457596|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606668|NCT02855086|3457597|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606669|NCT02855086|3457595|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3606670|NCT02855086|3457596|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606671|NCT02855086|3457597|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3606672|NCT02855086|3457595|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606673|NCT02855086|3457596|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606674|NCT02855086|3457597|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606675|NCT02855086|3457595|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3606676|NCT02855086|3457596|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3606677|NCT02855086|3457597|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3606678|NCT02855086|3457595|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3606679|NCT02855086|3457596|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3606680|NCT02855086|3457597|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3606681|NCT02855086|3457595|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3606682|NCT02855086|3457596|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3606683|NCT02855086|3457597|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3606684|NCT02855086|3457595|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3606685|NCT02855086|3457596|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3606686|NCT02855086|3457597|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3606687|NCT02855086|3457595|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3606688|NCT02855086|3457596|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3606689|NCT02855086|3457597|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3606690|NCT02854527|3457606|B11||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3606691|NCT02854527|3457607|B10||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3606692|NCT02854527|3457608|B9||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3606693|NCT02854527|3457609|B8||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3606694|NCT02854527|3457610|B7||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3606695|NCT02854527|3457611|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3606696|NCT02854527|3457612|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3606697|NCT02854527|3457613|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3606698|NCT02854527|3457614|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3606699|NCT02854527|3457615|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3606700|NCT02854527|3457616|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3606701|NCT02854527|3457606|B11||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3606702|NCT02854527|3457607|B10||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3606703|NCT02854527|3457608|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3606704|NCT02854527|3457609|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3606705|NCT02854527|3457610|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3606706|NCT02854527|3457611|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3606707|NCT02854527|3457612|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3606708|NCT02854527|3457613|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3606709|NCT02854527|3457614|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3606710|NCT02854527|3457615|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3606711|NCT02854527|3457616|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3606712|NCT02854527|3457606|B11|||Age||Years|Mean|35.5|35.5|Standard Deviation|9.4|9.4|||
3606713|NCT02854527|3457607|B10|||Age||Years|Mean|34.3|34.3|Standard Deviation|7.2|7.2|||
3606714|NCT02854527|3457608|B9|||Age||Years|Mean|40.3|40.3|Standard Deviation|7.5|7.5|||
3606715|NCT02854527|3457609|B8|||Age||Years|Mean|33.0|33.0|Standard Deviation|9.6|9.6|||
3606716|NCT02854527|3457610|B7|||Age||Years|Mean|30.3|30.3|Standard Deviation|6.4|6.4|||
3606717|NCT02854527|3457611|B6|||Age||Years|Mean|45.7|45.7|Standard Deviation|7.2|7.2|||
3606718|NCT02854527|3457612|B5|||Age||Years|Mean|32.3|32.3|Standard Deviation|9.0|9.0|||
3606719|NCT02854527|3457613|B4|||Age||Years|Mean|42.0|42.0|Standard Deviation|5.3|5.3|||
3606720|NCT02854527|3457614|B3|||Age||Years|Mean|41.3|41.3|Standard Deviation|15.8|15.8|||
3606721|NCT02854527|3457615|B2|||Age||Years|Mean|28.7|28.7|Standard Deviation|8.1|8.1|||
3606722|NCT02854527|3457616|B1|||Age||Years|Mean|26.7|26.7|Standard Deviation|2.5|2.5|||
3606723|NCT02853435|3457656|B4|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3606724|NCT02853435|3457657|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3606725|NCT02853435|3457658|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3606726|NCT02853435|3457659|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3606727|NCT02853435|3457656|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3606728|NCT02853435|3457657|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3606729|NCT02853435|3457658|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3606730|NCT02853435|3457659|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3606731|NCT02853435|3457656|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3606732|NCT02853435|3457657|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3606733|NCT02853435|3457658|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3606734|NCT02853435|3457659|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3606735|NCT02853435|3457656|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3606736|NCT02853435|3457657|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3606737|NCT02853435|3457658|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3606738|NCT02853435|3457659|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3606739|NCT02853435|3457656|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3606740|NCT02853435|3457657|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3606741|NCT02853435|3457658|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3606742|NCT02853435|3457659|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3606743|NCT02853435|3457656|B4|||Age||Years|Mean|42.5|42.5|Standard Deviation|11.39|11.39|||
3606744|NCT02853435|3457657|B3|||Age||Years|Mean|37.8|37.8|Standard Deviation|7.93|7.93|||
3606745|NCT02853435|3457658|B2|||Age||Years|Mean|55.6|55.6|Standard Deviation|6.43|6.43|||
3606746|NCT02853435|3457659|B1|||Age||Years|Mean|39.5|39.5|Standard Deviation|10.64|10.64|||
3606747|NCT02852434|3457972|B3|||Gestational Age||weeks|Median|19.2|19.2|Full Range|||16.0|24.0|
3606748|NCT02852434|3457973|B2|||Gestational Age||weeks|Median|19.4|19.4|Full Range|||16.0|24.0|
3606749|NCT02852434|3457974|B1|||Gestational Age||weeks|Median|19|19.0|Full Range|||16.0|23.4|
3606750|NCT02852434|3457972|B3|United States||Region of Enrollment||participants|Number|69|69.0||||||
3606751|NCT02852434|3457973|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
3606752|NCT02852434|3457974|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
3606753|NCT02852434|3457972|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3606754|NCT02852434|3457973|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3606755|NCT02852434|3457974|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3606756|NCT02852434|3457972|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606757|NCT02852434|3457973|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606758|NCT02852434|3457974|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606759|NCT02852434|3457972|B3||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3606760|NCT02852434|3457973|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3606761|NCT02852434|3457974|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3606762|NCT02852434|3457972|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3606763|NCT02852434|3457973|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3606764|NCT02852434|3457974|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3606765|NCT02852434|3457972|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606766|NCT02852434|3457973|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606767|NCT02852434|3457974|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606768|NCT02852434|3457972|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606769|NCT02852434|3457973|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606770|NCT02852434|3457974|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606771|NCT02852434|3457972|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606772|NCT02852434|3457973|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606773|NCT02852434|3457974|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606774|NCT02852434|3457972|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606775|NCT02852434|3457973|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606776|NCT02852434|3457974|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606777|NCT02852434|3457972|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3606778|NCT02852434|3457973|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3606779|NCT02852434|3457974|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3606780|NCT02852434|3457972|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3606781|NCT02852434|3457973|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3606782|NCT02852434|3457974|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3606783|NCT02852434|3457972|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3606784|NCT02852434|3457973|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3606785|NCT02852434|3457974|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3606786|NCT02852434|3457972|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3606787|NCT02852434|3457973|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3606788|NCT02852434|3457974|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3606789|NCT02852434|3457972|B3|||Age||years|Mean|27.9|27.9|Standard Deviation|7.5|7.5|||
3606790|NCT02852434|3457973|B2|||Age||years|Mean|27.2|27.2|Standard Deviation|7.14|7.14|||
3606791|NCT02852434|3457974|B1|||Age||years|Mean|28.7|28.7|Standard Deviation|7.87|7.87|||
3606792|NCT02852265|3457989|B3||Continuous dosing|Pill type||Participants|Count of Participants|4|4.0||||||
3606793|NCT02852265|3457990|B2||Continuous dosing|Pill type||Participants|Count of Participants|2|2.0||||||
3606794|NCT02852265|3457991|B1||Continuous dosing|Pill type||Participants|Count of Participants|2|2.0||||||
3606795|NCT02852265|3457989|B3||21/7 triphasic|Pill type||Participants|Count of Participants|3|3.0||||||
3606796|NCT02852265|3457990|B2||21/7 triphasic|Pill type||Participants|Count of Participants|2|2.0||||||
3606797|NCT02852265|3457991|B1||21/7 triphasic|Pill type||Participants|Count of Participants|1|1.0||||||
3606798|NCT02852265|3457989|B3||24/4 monophasic|Pill type||Participants|Count of Participants|1|1.0||||||
3606799|NCT02852265|3457990|B2||24/4 monophasic|Pill type||Participants|Count of Participants|1|1.0||||||
3606800|NCT02852265|3457991|B1||24/4 monophasic|Pill type||Participants|Count of Participants|0|0.0||||||
3606801|NCT02852265|3457989|B3||21/7 monophasic|Pill type||Participants|Count of Participants|12|12.0||||||
3606802|NCT02852265|3457990|B2||21/7 monophasic|Pill type||Participants|Count of Participants|5|5.0||||||
3606803|NCT02852265|3457991|B1||21/7 monophasic|Pill type||Participants|Count of Participants|7|7.0||||||
3606804|NCT02852265|3457989|B3|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3606805|NCT02852265|3457990|B2|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3606806|NCT02852265|3457991|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3606807|NCT02852265|3457989|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606808|NCT02852265|3457990|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606809|NCT02852265|3457991|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606810|NCT02852265|3457989|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606811|NCT02852265|3457990|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606812|NCT02852265|3457991|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606813|NCT02852265|3457989|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3606814|NCT02852265|3457990|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3606815|NCT02852265|3457991|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3606816|NCT02852265|3457989|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606817|NCT02852265|3457990|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606818|NCT02852265|3457991|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606819|NCT02852265|3457989|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606820|NCT02852265|3457990|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606821|NCT02852265|3457991|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606822|NCT02852265|3457989|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3606823|NCT02852265|3457990|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3606824|NCT02852265|3457991|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3606825|NCT02852265|3457989|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606826|NCT02852265|3457990|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3606827|NCT02852265|3457991|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606828|NCT02852265|3457989|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3606829|NCT02852265|3457990|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3606830|NCT02852265|3457991|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3606831|NCT02852265|3457989|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3606832|NCT02852265|3457990|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3606833|NCT02852265|3457991|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3606834|NCT02852265|3457989|B3|||Age||years|Median|23|23.0|Full Range|||16.0|34.0|
3606835|NCT02852265|3457990|B2|||Age||years|Median|20.5|20.5|Full Range|||16.0|34.0|
3606836|NCT02852265|3457991|B1|||Age||years|Median|25|25.0|Full Range|||20.0|34.0|
3606837|NCT02851823|3458008|B1|Turkey||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3606838|NCT02851823|3458008|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3606839|NCT02851823|3458008|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3606840|NCT02851823|3458008|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3606841|NCT02851823|3458008|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3606842|NCT02851823|3458008|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3606843|NCT02850159|3458016|B3|||Right Handedness||Participants|Count of Participants|32|32.0||||||
3606844|NCT02850159|3458017|B2|||Right Handedness||Participants|Count of Participants|16|16.0||||||
3606845|NCT02850159|3458018|B1|||Right Handedness||Participants|Count of Participants|16|16.0||||||
3606846|NCT02850159|3458016|B3|Korea, Republic of||Region of Enrollment||participants|Number|32|32.0||||||
3606847|NCT02850159|3458017|B2|Korea, Republic of||Region of Enrollment||participants|Number|16|16.0||||||
3606848|NCT02850159|3458018|B1|Korea, Republic of||Region of Enrollment||participants|Number|16|16.0||||||
3606849|NCT02850159|3458016|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606850|NCT02850159|3458017|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606851|NCT02850159|3458018|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606852|NCT02850159|3458016|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606853|NCT02850159|3458017|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606854|NCT02850159|3458018|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606855|NCT02850159|3458016|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606856|NCT02850159|3458017|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606857|NCT02850159|3458018|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606858|NCT02850159|3458016|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606859|NCT02850159|3458017|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606860|NCT02850159|3458018|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606861|NCT02850159|3458016|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606862|NCT02850159|3458017|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606863|NCT02850159|3458018|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606864|NCT02850159|3458016|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3606865|NCT02850159|3458017|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3606866|NCT02850159|3458018|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3606867|NCT02850159|3458016|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606868|NCT02850159|3458017|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606869|NCT02850159|3458018|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3606870|NCT02850159|3458016|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3606871|NCT02850159|3458017|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3606872|NCT02850159|3458018|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3606873|NCT02850159|3458016|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3606874|NCT02850159|3458017|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3606875|NCT02850159|3458018|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3606876|NCT02850159|3458016|B3|||Age||years|Mean|63.7|63.7|Standard Deviation|7.8|7.8|||
3606877|NCT02850159|3458017|B2|||Age||years|Mean|63.8|63.8|Standard Deviation|8.3|8.3|||
3606878|NCT02850159|3458018|B1|||Age||years|Mean|63.6|63.6|Standard Deviation|7.5|7.5|||
3606879|NCT02849678|3458025|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
3606880|NCT02849678|3458026|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
3606881|NCT02849678|3458027|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3606882|NCT02849678|3458025|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3606883|NCT02849678|3458026|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3606884|NCT02849678|3458027|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3606885|NCT02849678|3458025|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3606886|NCT02849678|3458026|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3606887|NCT02849678|3458027|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3606888|NCT02849678|3458025|B3|Age over 18 years||Age, Customized||participants|Number|35|35.0||||||
3606889|NCT02849678|3458026|B2|Age over 18 years||Age, Customized||participants|Number|18|18.0||||||
3606890|NCT02849678|3458027|B1|Age over 18 years||Age, Customized||participants|Number|17|17.0||||||
3606891|NCT02848326|3458046|B7|||Migraine Days (Migraine/Probable Migraine Headache Days)|A migraine day was any calendar day on which the participant experienced a migraine headache qualified by duration and acute symptomatic medication use. The 4-week migraine days=total number of reported migraine days in diary divided by total number of days with diary records in each 4-week period multiplied by 28.|migraine days per month|Mean|7.67|7.67|Standard Deviation|2.49|2.49|||
3606892|NCT02848326|3458047|B6|||Migraine Days (Migraine/Probable Migraine Headache Days)|A migraine day was any calendar day on which the participant experienced a migraine headache qualified by duration and acute symptomatic medication use. The 4-week migraine days=total number of reported migraine days in diary divided by total number of days with diary records in each 4-week period multiplied by 28.|migraine days per month|Mean|7.62|7.62|Standard Deviation|2.56|2.56|||
3606893|NCT02848326|3458048|B5|||Migraine Days (Migraine/Probable Migraine Headache Days)|A migraine day was any calendar day on which the participant experienced a migraine headache qualified by duration and acute symptomatic medication use. The 4-week migraine days=total number of reported migraine days in diary divided by total number of days with diary records in each 4-week period multiplied by 28.|migraine days per month|Mean|7.38|7.38|Standard Deviation|2.43|2.43|||
3606894|NCT02848326|3458049|B4|||Migraine Days (Migraine/Probable Migraine Headache Days)|A migraine day was any calendar day on which the participant experienced a migraine headache qualified by duration and acute symptomatic medication use. The 4-week migraine days=total number of reported migraine days in diary divided by total number of days with diary records in each 4-week period multiplied by 28.|migraine days per month|Mean|7.74|7.74|Standard Deviation|2.59|2.59|||
3606895|NCT02848326|3458050|B3|||Migraine Days (Migraine/Probable Migraine Headache Days)|A migraine day was any calendar day on which the participant experienced a migraine headache qualified by duration and acute symptomatic medication use. The 4-week migraine days=total number of reported migraine days in diary divided by total number of days with diary records in each 4-week period multiplied by 28.|migraine days per month|Mean|7.64|7.64|Standard Deviation|2.37|2.37|||
3606896|NCT02848326|3458051|B2|||Migraine Days (Migraine/Probable Migraine Headache Days)|A migraine day was any calendar day on which the participant experienced a migraine headache qualified by duration and acute symptomatic medication use. The 4-week migraine days=total number of reported migraine days in diary divided by total number of days with diary records in each 4-week period multiplied by 28.|migraine days per month|Mean|7.63|7.63|Standard Deviation|2.51|2.51|||
3606897|NCT02848326|3458052|B1|||Migraine Days (Migraine/Probable Migraine Headache Days)|A migraine day was any calendar day on which the participant experienced a migraine headache qualified by duration and acute symptomatic medication use. The 4-week migraine days=total number of reported migraine days in diary divided by total number of days with diary records in each 4-week period multiplied by 28.|migraine days per month|Mean|7.81|7.81|Standard Deviation|2.51|2.51|||
3606898|NCT02848326|3458046|B7|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|698|698.0||||||
3606899|NCT02848326|3458047|B6|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|78|78.0||||||
3606900|NCT02848326|3458048|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|73|73.0||||||
3606901|NCT02848326|3458049|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|161|161.0||||||
3606902|NCT02848326|3458050|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|151|151.0||||||
3606903|NCT02848326|3458051|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|78|78.0||||||
3606904|NCT02848326|3458052|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|157|157.0||||||
3606905|NCT02848326|3458046|B7|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|127|127.0||||||
3606906|NCT02848326|3458047|B6|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3606907|NCT02848326|3458048|B5|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3606908|NCT02848326|3458049|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3606909|NCT02848326|3458050|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3606910|NCT02848326|3458051|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3606911|NCT02848326|3458052|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3606912|NCT02848326|3458046|B7|Multiple Races||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3606913|NCT02848326|3458047|B6|Multiple Races||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3606914|NCT02848326|3458048|B5|Multiple Races||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3606915|NCT02848326|3458049|B4|Multiple Races||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3606916|NCT02848326|3458050|B3|Multiple Races||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3606917|NCT02848326|3458051|B2|Multiple Races||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3606918|NCT02848326|3458052|B1|Multiple Races||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3606919|NCT02848326|3458046|B7|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3606920|NCT02848326|3458047|B6|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3606921|NCT02848326|3458048|B5|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3606922|NCT02848326|3458049|B4|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3606923|NCT02848326|3458050|B3|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3606924|NCT02848326|3458051|B2|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3606925|NCT02848326|3458052|B1|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3606926|NCT02848326|3458046|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3606927|NCT02848326|3458047|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3606928|NCT02848326|3458048|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3606929|NCT02848326|3458049|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3606930|NCT02848326|3458050|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3606931|NCT02848326|3458051|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3606932|NCT02848326|3458052|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3606933|NCT02848326|3458046|B7|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3606934|NCT02848326|3458047|B6|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3606935|NCT02848326|3458048|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3606936|NCT02848326|3458049|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3606937|NCT02848326|3458050|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3606938|NCT02848326|3458051|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3606939|NCT02848326|3458052|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3606940|NCT02848326|3458046|B7|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|168|168.0||||||
3606941|NCT02848326|3458047|B6|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3606942|NCT02848326|3458048|B5|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3606943|NCT02848326|3458049|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
3606944|NCT02848326|3458050|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3606945|NCT02848326|3458051|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3606946|NCT02848326|3458052|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|45|45.0||||||
3606947|NCT02848326|3458046|B7|White||Race/Ethnicity, Customized||Participants|Count of Participants|628|628.0||||||
3606948|NCT02848326|3458047|B6|White||Race/Ethnicity, Customized||Participants|Count of Participants|71|71.0||||||
3606949|NCT02848326|3458048|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|73|73.0||||||
3606950|NCT02848326|3458049|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|133|133.0||||||
3606951|NCT02848326|3458050|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|145|145.0||||||
3606952|NCT02848326|3458051|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|69|69.0||||||
3606953|NCT02848326|3458052|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|137|137.0||||||
3606954|NCT02848326|3458046|B7||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3606955|NCT02848326|3458047|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3606956|NCT02848326|3458048|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3606957|NCT02848326|3458049|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3606958|NCT02848326|3458050|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3606959|NCT02848326|3458051|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3606960|NCT02848326|3458052|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3606961|NCT02848326|3458046|B7||Female|Sex: Female, Male||Participants|Count of Participants|714|714.0||||||
3606962|NCT02848326|3458047|B6||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3606963|NCT02848326|3458048|B5||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3606964|NCT02848326|3458049|B4||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3606965|NCT02848326|3458050|B3||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3606966|NCT02848326|3458051|B2||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3606967|NCT02848326|3458052|B1||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3606968|NCT02848326|3458046|B7|||Age||years|Mean|40.1|40.1|Standard Deviation|12.2|12.2|||
3606969|NCT02848326|3458047|B6|||Age||years|Mean|39.7|39.7|Standard Deviation|11.9|11.9|||
3606970|NCT02848326|3458048|B5|||Age||years|Mean|38.5|38.5|Standard Deviation|11.2|11.2|||
3606971|NCT02848326|3458049|B4|||Age||years|Mean|40.4|40.4|Standard Deviation|11.7|11.7|||
3606972|NCT02848326|3458050|B3|||Age||years|Mean|41.0|41.0|Standard Deviation|13.6|13.6|||
3606973|NCT02848326|3458051|B2|||Age||years|Mean|39.4|39.4|Standard Deviation|12.4|12.4|||
3606974|NCT02848326|3458052|B1|||Age||years|Mean|40.5|40.5|Standard Deviation|11.7|11.7|||
3606975|NCT02848222|3458089|B4|||Comfortable Contact Lens Wear Time||hours per day|Mean|7.3|7.3|Standard Deviation|3.4|3.4|||
3606976|NCT02848222|3458090|B3|||Comfortable Contact Lens Wear Time||hours per day|Mean|5.9|5.9|Standard Deviation|3.2|3.2|||
3607076|NCT02847637|3458102|B5||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3606977|NCT02848222|3458091|B2|||Comfortable Contact Lens Wear Time||hours per day|Mean|8.0|8.0|Standard Deviation|3.9|3.9|||
3606978|NCT02848222|3458092|B1|||Comfortable Contact Lens Wear Time||hours per day|Mean|7.8|7.8|Standard Deviation|3.0|3.0|||
3606979|NCT02848222|3458089|B4|United States||Region of Enrollment||participants|Number|51|51.0||||||
3606980|NCT02848222|3458090|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
3606981|NCT02848222|3458091|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3606982|NCT02848222|3458092|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3606983|NCT02848222|3458089|B4|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3606984|NCT02848222|3458090|B3|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3606985|NCT02848222|3458091|B2|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3606986|NCT02848222|3458092|B1|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3606987|NCT02848222|3458089|B4|Race|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3606988|NCT02848222|3458090|B3|Race|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3606989|NCT02848222|3458091|B2|Race|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3606990|NCT02848222|3458092|B1|Race|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3606991|NCT02848222|3458089|B4|Race|Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3606992|NCT02848222|3458090|B3|Race|Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3606993|NCT02848222|3458091|B2|Race|Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3606994|NCT02848222|3458092|B1|Race|Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3606995|NCT02848222|3458089|B4|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3606996|NCT02848222|3458090|B3|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3606997|NCT02848222|3458091|B2|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3606998|NCT02848222|3458092|B1|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3606999|NCT02848222|3458089|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3607000|NCT02848222|3458090|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3607001|NCT02848222|3458091|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3607002|NCT02848222|3458092|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3607003|NCT02848222|3458089|B4||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3607004|NCT02848222|3458090|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3607005|NCT02848222|3458091|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3607006|NCT02848222|3458092|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3607007|NCT02848222|3458089|B4|||Age||years|Mean|33|33.0|Standard Deviation|10|10.0|||
3607008|NCT02848222|3458090|B3|||Age||years|Mean|36|36.0|Standard Deviation|11|11.0|||
3607009|NCT02848222|3458091|B2|||Age||years|Mean|32|32.0|Standard Deviation|12|12.0|||
3607010|NCT02848222|3458092|B1|||Age||years|Mean|32|32.0|Standard Deviation|8|8.0|||
3607011|NCT02847637|3458102|B5|||Number of Target Joints in the Last 24 Weeks Prior to Study Entry|A target joint was defined as at least 3 bleeds into the same joint over the last 24 weeks prior to study entry.|target joints|Mean|1.7|1.7|Standard Deviation|1.6|1.6|||
3607012|NCT02847637|3458103|B4|||Number of Target Joints in the Last 24 Weeks Prior to Study Entry|A target joint was defined as at least 3 bleeds into the same joint over the last 24 weeks prior to study entry.|target joints|Mean|1.0|1.0|Standard Deviation|1.6|1.6|||
3607013|NCT02847637|3458104|B3|||Number of Target Joints in the Last 24 Weeks Prior to Study Entry|A target joint was defined as at least 3 bleeds into the same joint over the last 24 weeks prior to study entry.|target joints|Mean|2.2|2.2|Standard Deviation|1.7|1.7|||
3607014|NCT02847637|3458105|B2|||Number of Target Joints in the Last 24 Weeks Prior to Study Entry|A target joint was defined as at least 3 bleeds into the same joint over the last 24 weeks prior to study entry.|target joints|Mean|2.1|2.1|Standard Deviation|1.4|1.4|||
3607015|NCT02847637|3458106|B1|||Number of Target Joints in the Last 24 Weeks Prior to Study Entry|A target joint was defined as at least 3 bleeds into the same joint over the last 24 weeks prior to study entry.|target joints|Mean|2.2|2.2|Standard Deviation|1.4|1.4|||
3607016|NCT02847637|3458102|B5|Greater Than or Equal To (≥) 9 Bleeds||Number of Participants with <9 or ≥9 Bleeds in the Last 24 Weeks Prior to Study Entry||Participants|Count of Participants|81|81.0||||||
3607017|NCT02847637|3458103|B4|Greater Than or Equal To (≥) 9 Bleeds||Number of Participants with <9 or ≥9 Bleeds in the Last 24 Weeks Prior to Study Entry||Participants|Count of Participants|10|10.0||||||
3607018|NCT02847637|3458104|B3|Greater Than or Equal To (≥) 9 Bleeds||Number of Participants with <9 or ≥9 Bleeds in the Last 24 Weeks Prior to Study Entry||Participants|Count of Participants|30|30.0||||||
3607019|NCT02847637|3458105|B2|Greater Than or Equal To (≥) 9 Bleeds||Number of Participants with <9 or ≥9 Bleeds in the Last 24 Weeks Prior to Study Entry||Participants|Count of Participants|27|27.0||||||
3607020|NCT02847637|3458106|B1|Greater Than or Equal To (≥) 9 Bleeds||Number of Participants with <9 or ≥9 Bleeds in the Last 24 Weeks Prior to Study Entry||Participants|Count of Participants|14|14.0||||||
3607021|NCT02847637|3458102|B5|Less Than (<) 9 Bleeds||Number of Participants with <9 or ≥9 Bleeds in the Last 24 Weeks Prior to Study Entry||Participants|Count of Participants|71|71.0||||||
3607022|NCT02847637|3458103|B4|Less Than (<) 9 Bleeds||Number of Participants with <9 or ≥9 Bleeds in the Last 24 Weeks Prior to Study Entry||Participants|Count of Participants|53|53.0||||||
3607077|NCT02847637|3458103|B4||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3607023|NCT02847637|3458104|B3|Less Than (<) 9 Bleeds||Number of Participants with <9 or ≥9 Bleeds in the Last 24 Weeks Prior to Study Entry||Participants|Count of Participants|5|5.0||||||
3607024|NCT02847637|3458105|B2|Less Than (<) 9 Bleeds||Number of Participants with <9 or ≥9 Bleeds in the Last 24 Weeks Prior to Study Entry||Participants|Count of Participants|9|9.0||||||
3607025|NCT02847637|3458106|B1|Less Than (<) 9 Bleeds||Number of Participants with <9 or ≥9 Bleeds in the Last 24 Weeks Prior to Study Entry||Participants|Count of Participants|4|4.0||||||
3607026|NCT02847637|3458102|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3607027|NCT02847637|3458103|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3607028|NCT02847637|3458104|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3607029|NCT02847637|3458105|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3607030|NCT02847637|3458106|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607031|NCT02847637|3458102|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607032|NCT02847637|3458103|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607033|NCT02847637|3458104|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607034|NCT02847637|3458105|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607035|NCT02847637|3458106|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607036|NCT02847637|3458102|B5||White|Race (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
3607037|NCT02847637|3458103|B4||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3607038|NCT02847637|3458104|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3607039|NCT02847637|3458105|B2||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3607040|NCT02847637|3458106|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3607041|NCT02847637|3458102|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3607042|NCT02847637|3458103|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3607043|NCT02847637|3458104|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3607044|NCT02847637|3458105|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3607045|NCT02847637|3458106|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3607046|NCT02847637|3458102|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3607047|NCT02847637|3458103|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607048|NCT02847637|3458104|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607049|NCT02847637|3458105|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3607050|NCT02847637|3458106|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607051|NCT02847637|3458102|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3607052|NCT02847637|3458103|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3607053|NCT02847637|3458104|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3607054|NCT02847637|3458105|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3607055|NCT02847637|3458106|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3607056|NCT02847637|3458102|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607057|NCT02847637|3458103|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607058|NCT02847637|3458104|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607059|NCT02847637|3458105|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607060|NCT02847637|3458106|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607061|NCT02847637|3458102|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3607062|NCT02847637|3458103|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3607063|NCT02847637|3458104|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607064|NCT02847637|3458105|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607065|NCT02847637|3458106|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3607066|NCT02847637|3458102|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
3607067|NCT02847637|3458103|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3607068|NCT02847637|3458104|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3607069|NCT02847637|3458105|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3607070|NCT02847637|3458106|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3607071|NCT02847637|3458102|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3607072|NCT02847637|3458103|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3607073|NCT02847637|3458104|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3607074|NCT02847637|3458105|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3607075|NCT02847637|3458106|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607078|NCT02847637|3458104|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3607079|NCT02847637|3458105|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3607080|NCT02847637|3458106|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3607081|NCT02847637|3458102|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3607082|NCT02847637|3458103|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3607083|NCT02847637|3458104|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3607084|NCT02847637|3458105|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3607085|NCT02847637|3458106|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3607086|NCT02847637|3458102|B5|||Age||years|Mean|38.3|38.3|Standard Deviation|13.5|13.5|||
3607087|NCT02847637|3458103|B4|||Age||years|Mean|36.4|36.4|Standard Deviation|14.4|14.4|||
3607088|NCT02847637|3458104|B3|||Age||years|Mean|40.4|40.4|Standard Deviation|11.4|11.4|||
3607089|NCT02847637|3458105|B2|||Age||years|Mean|39.8|39.8|Standard Deviation|14.0|14.0|||
3607090|NCT02847637|3458106|B1|||Age||years|Mean|37.8|37.8|Standard Deviation|12.9|12.9|||
3607091|NCT02847260|3458221|B1|Germany||Region of Enrollment||participants|Number|39|39.0||||||
3607092|NCT02847260|3458221|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3607093|NCT02847260|3458221|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3607094|NCT02847260|3458221|B1|||Age||years|Median|50|50.0|Full Range|||25.0|82.0|
3607095|NCT02847260|3458221|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3607096|NCT02847260|3458221|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3607097|NCT02847260|3458221|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3607098|NCT02847169|3458233|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3607099|NCT02847169|3458233|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3607100|NCT02847169|3458233|B1|||Age||years|Mean|27.7|27.7|Standard Deviation|5.8|5.8|||
3607101|NCT02846558|3458268|B5|||Rosenberg Self-Esteem Score|The Rosenberg Self-Esteem Scale (RSES) is a 10-item scale that measures global self-worth using a 4-point Likert scale to ask about negative and positive feelings about the self. Individual items are summed to calculate the total score. Minimum score is 0 and maximum score is 30. Higher scores indicate higher/better self-esteem. Scores between 15 and 25 are considered within the normal range, while scores below 15 indicates poor self-esteem. An increase in RSES score over 6 months indicates a better outcome, or improved self-esteem, among participants.|scores on a scale|Mean|23.83|23.83|Standard Deviation|4.31|4.31|||
3607102|NCT02846558|3458269|B4|||Rosenberg Self-Esteem Score|The Rosenberg Self-Esteem Scale (RSES) is a 10-item scale that measures global self-worth using a 4-point Likert scale to ask about negative and positive feelings about the self. Individual items are summed to calculate the total score. Minimum score is 0 and maximum score is 30. Higher scores indicate higher/better self-esteem. Scores between 15 and 25 are considered within the normal range, while scores below 15 indicates poor self-esteem. An increase in RSES score over 6 months indicates a better outcome, or improved self-esteem, among participants.|scores on a scale|Mean|24.17|24.17|Standard Deviation|2.69|2.69|||
3607103|NCT02846558|3458270|B3|||Rosenberg Self-Esteem Score|The Rosenberg Self-Esteem Scale (RSES) is a 10-item scale that measures global self-worth using a 4-point Likert scale to ask about negative and positive feelings about the self. Individual items are summed to calculate the total score. Minimum score is 0 and maximum score is 30. Higher scores indicate higher/better self-esteem. Scores between 15 and 25 are considered within the normal range, while scores below 15 indicates poor self-esteem. An increase in RSES score over 6 months indicates a better outcome, or improved self-esteem, among participants.|scores on a scale|Mean|24.33|24.33|Standard Deviation|1.56|1.56|||
3607104|NCT02846558|3458271|B2|||Rosenberg Self-Esteem Score|The Rosenberg Self-Esteem Scale (RSES) is a 10-item scale that measures global self-worth using a 4-point Likert scale to ask about negative and positive feelings about the self. Individual items are summed to calculate the total score. Minimum score is 0 and maximum score is 30. Higher scores indicate higher/better self-esteem. Scores between 15 and 25 are considered within the normal range, while scores below 15 indicates poor self-esteem. An increase in RSES score over 6 months indicates a better outcome, or improved self-esteem, among participants.|scores on a scale|Mean|25.11|25.11|Standard Deviation|2.42|2.42|||
3607105|NCT02846558|3458272|B1|||Rosenberg Self-Esteem Score|The Rosenberg Self-Esteem Scale (RSES) is a 10-item scale that measures global self-worth using a 4-point Likert scale to ask about negative and positive feelings about the self. Individual items are summed to calculate the total score. Minimum score is 0 and maximum score is 30. Higher scores indicate higher/better self-esteem. Scores between 15 and 25 are considered within the normal range, while scores below 15 indicates poor self-esteem. An increase in RSES score over 6 months indicates a better outcome, or improved self-esteem, among participants.|scores on a scale|Mean|21.65|21.65|Standard Deviation|7.89|7.89|||
3607106|NCT02846558|3458268|B5|||Quality of Life|The Functional Assessment in Multiple Sclerosis (FAMS) is an instrument that measures quality of life among people with MS. It contains 44 questions scored on a 5-point Likert scale in 6 areas: mobility, symptoms, emotional wellbeing, general contentment, thinking/fatigue, and family/social wellbeing. Subscores are the sum of responses in that section, and the total FAMS score is the sum of all subscores. Minimum total score is 0 and maximum total score is 176, where a higher score indicates better quality of life. Increase in score over the study period indicates a better outcome.|scores on a scale|Mean|156.02|156.02|Standard Deviation|40.72|40.72|||
3607107|NCT02846558|3458269|B4|||Quality of Life|The Functional Assessment in Multiple Sclerosis (FAMS) is an instrument that measures quality of life among people with MS. It contains 44 questions scored on a 5-point Likert scale in 6 areas: mobility, symptoms, emotional wellbeing, general contentment, thinking/fatigue, and family/social wellbeing. Subscores are the sum of responses in that section, and the total FAMS score is the sum of all subscores. Minimum total score is 0 and maximum total score is 176, where a higher score indicates better quality of life. Increase in score over the study period indicates a better outcome.|scores on a scale|Mean|144.86|144.86|Standard Deviation|49.44|49.44|||
3607108|NCT02846558|3458270|B3|||Quality of Life|The Functional Assessment in Multiple Sclerosis (FAMS) is an instrument that measures quality of life among people with MS. It contains 44 questions scored on a 5-point Likert scale in 6 areas: mobility, symptoms, emotional wellbeing, general contentment, thinking/fatigue, and family/social wellbeing. Subscores are the sum of responses in that section, and the total FAMS score is the sum of all subscores. Minimum total score is 0 and maximum total score is 176, where a higher score indicates better quality of life. Increase in score over the study period indicates a better outcome.|scores on a scale|Mean|145.81|145.81|Standard Deviation|36.48|36.48|||
3607109|NCT02846558|3458271|B2|||Quality of Life|The Functional Assessment in Multiple Sclerosis (FAMS) is an instrument that measures quality of life among people with MS. It contains 44 questions scored on a 5-point Likert scale in 6 areas: mobility, symptoms, emotional wellbeing, general contentment, thinking/fatigue, and family/social wellbeing. Subscores are the sum of responses in that section, and the total FAMS score is the sum of all subscores. Minimum total score is 0 and maximum total score is 176, where a higher score indicates better quality of life. Increase in score over the study period indicates a better outcome.|scores on a scale|Mean|162.49|162.49|Standard Deviation|34.24|34.24|||
3607110|NCT02846558|3458272|B1|||Quality of Life|The Functional Assessment in Multiple Sclerosis (FAMS) is an instrument that measures quality of life among people with MS. It contains 44 questions scored on a 5-point Likert scale in 6 areas: mobility, symptoms, emotional wellbeing, general contentment, thinking/fatigue, and family/social wellbeing. Subscores are the sum of responses in that section, and the total FAMS score is the sum of all subscores. Minimum total score is 0 and maximum total score is 176, where a higher score indicates better quality of life. Increase in score over the study period indicates a better outcome.|scores on a scale|Mean|174.73|174.73|Standard Deviation|38.05|38.05|||
3607111|NCT02846558|3458268|B5|||Pittsburgh Sleep Quality Index Score|The Pittsburgh Sleep Quality Index (PSQI) is an instrument used to measure the quality and sleeping pattern of adults. It differentiates “poor” from “good” sleep quality, and the total score is calculated from the sum of seven components, each scored from 0 to 3. The minimum total score is 0 and the maximum total score is 21. A total score equal to or greater than 5 units indicates “poor” quality sleep, while a score of 0-4 indicates “good” quality sleep; lower scores indicate better sleep quality.|scores on a scale|Mean|7.79|7.79|Standard Deviation|4.74|4.74|||
3607112|NCT02846558|3458269|B4|||Pittsburgh Sleep Quality Index Score|The Pittsburgh Sleep Quality Index (PSQI) is an instrument used to measure the quality and sleeping pattern of adults. It differentiates “poor” from “good” sleep quality, and the total score is calculated from the sum of seven components, each scored from 0 to 3. The minimum total score is 0 and the maximum total score is 21. A total score equal to or greater than 5 units indicates “poor” quality sleep, while a score of 0-4 indicates “good” quality sleep; lower scores indicate better sleep quality.|scores on a scale|Mean|8.17|8.17|Standard Deviation|4.76|4.76|||
3607113|NCT02846558|3458270|B3|||Pittsburgh Sleep Quality Index Score|The Pittsburgh Sleep Quality Index (PSQI) is an instrument used to measure the quality and sleeping pattern of adults. It differentiates “poor” from “good” sleep quality, and the total score is calculated from the sum of seven components, each scored from 0 to 3. The minimum total score is 0 and the maximum total score is 21. A total score equal to or greater than 5 units indicates “poor” quality sleep, while a score of 0-4 indicates “good” quality sleep; lower scores indicate better sleep quality.|scores on a scale|Mean|7.75|7.75|Standard Deviation|5.96|5.96|||
3607114|NCT02846558|3458271|B2|||Pittsburgh Sleep Quality Index Score|The Pittsburgh Sleep Quality Index (PSQI) is an instrument used to measure the quality and sleeping pattern of adults. It differentiates “poor” from “good” sleep quality, and the total score is calculated from the sum of seven components, each scored from 0 to 3. The minimum total score is 0 and the maximum total score is 21. A total score equal to or greater than 5 units indicates “poor” quality sleep, while a score of 0-4 indicates “good” quality sleep; lower scores indicate better sleep quality.|scores on a scale|Mean|6.56|6.56|Standard Deviation|4.22|4.22|||
3607115|NCT02846558|3458272|B1|||Pittsburgh Sleep Quality Index Score|The Pittsburgh Sleep Quality Index (PSQI) is an instrument used to measure the quality and sleeping pattern of adults. It differentiates “poor” from “good” sleep quality, and the total score is calculated from the sum of seven components, each scored from 0 to 3. The minimum total score is 0 and the maximum total score is 21. A total score equal to or greater than 5 units indicates “poor” quality sleep, while a score of 0-4 indicates “good” quality sleep; lower scores indicate better sleep quality.|scores on a scale|Mean|8.50|8.5|Standard Deviation|4.56|4.56|||
3607116|NCT02846558|3458268|B5|||Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue-MS Score|The Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue is a 95-item question bank to evaluate fatigue in a variety of chronic conditions. The PROMIS-FatigueMS is a subset of 8 questions from the question bank, which have been validated to measure fatigue specifically in people with multiple sclerosis. Individual items are scored on a 5-point Likert scale, and the total score is the sum of individual items, with a minimum score of 8 and maximum score of 40. Lower scores indicate less fatigue; reduction in score over 6 months indicates a better outcome.|scores on a scale|Mean|21.91|21.91|Standard Deviation|8.05|8.05|||
3607117|NCT02846558|3458269|B4|||Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue-MS Score|The Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue is a 95-item question bank to evaluate fatigue in a variety of chronic conditions. The PROMIS-FatigueMS is a subset of 8 questions from the question bank, which have been validated to measure fatigue specifically in people with multiple sclerosis. Individual items are scored on a 5-point Likert scale, and the total score is the sum of individual items, with a minimum score of 8 and maximum score of 40. Lower scores indicate less fatigue; reduction in score over 6 months indicates a better outcome.|scores on a scale|Mean|20.96|20.96|Standard Deviation|9.46|9.46|||
3607118|NCT02846558|3458270|B3|||Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue-MS Score|The Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue is a 95-item question bank to evaluate fatigue in a variety of chronic conditions. The PROMIS-FatigueMS is a subset of 8 questions from the question bank, which have been validated to measure fatigue specifically in people with multiple sclerosis. Individual items are scored on a 5-point Likert scale, and the total score is the sum of individual items, with a minimum score of 8 and maximum score of 40. Lower scores indicate less fatigue; reduction in score over 6 months indicates a better outcome.|scores on a scale|Mean|22.50|22.5|Standard Deviation|6.49|6.49|||
3607119|NCT02846558|3458271|B2|||Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue-MS Score|The Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue is a 95-item question bank to evaluate fatigue in a variety of chronic conditions. The PROMIS-FatigueMS is a subset of 8 questions from the question bank, which have been validated to measure fatigue specifically in people with multiple sclerosis. Individual items are scored on a 5-point Likert scale, and the total score is the sum of individual items, with a minimum score of 8 and maximum score of 40. Lower scores indicate less fatigue; reduction in score over 6 months indicates a better outcome.|scores on a scale|Mean|22.94|22.94|Standard Deviation|7.67|7.67|||
3607120|NCT02846558|3458272|B1|||Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue-MS Score|The Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue is a 95-item question bank to evaluate fatigue in a variety of chronic conditions. The PROMIS-FatigueMS is a subset of 8 questions from the question bank, which have been validated to measure fatigue specifically in people with multiple sclerosis. Individual items are scored on a 5-point Likert scale, and the total score is the sum of individual items, with a minimum score of 8 and maximum score of 40. Lower scores indicate less fatigue; reduction in score over 6 months indicates a better outcome.|scores on a scale|Mean|21.40|21.4|Standard Deviation|9.30|9.3|||
3607121|NCT02846558|3458268|B5|||Patient-Determined Disability Score|The Patient-Determine Disability Scale (PDDS) measures level of disability from multiple sclerosis as reported by the patient. The scale ranges from a minimum of 0 (No disability – “I may have some mild symptoms, mostly sensory due to MS, but they do not limit my activity”) to a maximum of 8 (Bedridden – “Unable to sit in a wheelchair for more than one hour”). Lower values on this scale indicate less disability from multiple sclerosis. A reduction in PDDS over the study period indicates a better outcome, or improvement in disability/symptoms from MS, among participants.|scores on a scale|Mean|2.21|2.21|Standard Deviation|1.82|1.82|||
3607122|NCT02846558|3458269|B4|||Patient-Determined Disability Score|The Patient-Determine Disability Scale (PDDS) measures level of disability from multiple sclerosis as reported by the patient. The scale ranges from a minimum of 0 (No disability – “I may have some mild symptoms, mostly sensory due to MS, but they do not limit my activity”) to a maximum of 8 (Bedridden – “Unable to sit in a wheelchair for more than one hour”). Lower values on this scale indicate less disability from multiple sclerosis. A reduction in PDDS over the study period indicates a better outcome, or improvement in disability/symptoms from MS, among participants.|scores on a scale|Mean|3.00|3.0|Standard Deviation|2.14|2.14|||
3607123|NCT02846558|3458270|B3|||Patient-Determined Disability Score|The Patient-Determine Disability Scale (PDDS) measures level of disability from multiple sclerosis as reported by the patient. The scale ranges from a minimum of 0 (No disability – “I may have some mild symptoms, mostly sensory due to MS, but they do not limit my activity”) to a maximum of 8 (Bedridden – “Unable to sit in a wheelchair for more than one hour”). Lower values on this scale indicate less disability from multiple sclerosis. A reduction in PDDS over the study period indicates a better outcome, or improvement in disability/symptoms from MS, among participants.|scores on a scale|Mean|2.58|2.58|Standard Deviation|1.56|1.56|||
3607124|NCT02846558|3458271|B2|||Patient-Determined Disability Score|The Patient-Determine Disability Scale (PDDS) measures level of disability from multiple sclerosis as reported by the patient. The scale ranges from a minimum of 0 (No disability – “I may have some mild symptoms, mostly sensory due to MS, but they do not limit my activity”) to a maximum of 8 (Bedridden – “Unable to sit in a wheelchair for more than one hour”). Lower values on this scale indicate less disability from multiple sclerosis. A reduction in PDDS over the study period indicates a better outcome, or improvement in disability/symptoms from MS, among participants.|scores on a scale|Mean|1.89|1.89|Standard Deviation|1.54|1.54|||
3607125|NCT02846558|3458272|B1|||Patient-Determined Disability Score|The Patient-Determine Disability Scale (PDDS) measures level of disability from multiple sclerosis as reported by the patient. The scale ranges from a minimum of 0 (No disability – “I may have some mild symptoms, mostly sensory due to MS, but they do not limit my activity”) to a maximum of 8 (Bedridden – “Unable to sit in a wheelchair for more than one hour”). Lower values on this scale indicate less disability from multiple sclerosis. A reduction in PDDS over the study period indicates a better outcome, or improvement in disability/symptoms from MS, among participants.|scores on a scale|Mean|1.09|1.09|Standard Deviation|1.62|1.62|||
3607126|NCT02846558|3458268|B5|||Hip Circumference||cm|Mean|106.14|106.14|Standard Deviation|12.84|12.84|||
3607127|NCT02846558|3458269|B4|||Hip Circumference||cm|Mean|100.26|100.26|Standard Deviation|11.01|11.01|||
3607128|NCT02846558|3458270|B3|||Hip Circumference||cm|Mean|99.08|99.08|Standard Deviation|7.24|7.24|||
3607129|NCT02846558|3458271|B2|||Hip Circumference||cm|Mean|109.80|109.8|Standard Deviation|7.15|7.15|||
3607130|NCT02846558|3458272|B1|||Hip Circumference||cm|Mean|118.36|118.36|Standard Deviation|14.85|14.85|||
3607131|NCT02846558|3458268|B5|||Waist Circumference||cm|Mean|96.4|96.4|Standard Deviation|16.68|16.68|||
3607132|NCT02846558|3458269|B4|||Waist Circumference||cm|Mean|89.38|89.38|Standard Deviation|12.58|12.58|||
3607133|NCT02846558|3458270|B3|||Waist Circumference||cm|Mean|87.58|87.58|Standard Deviation|11.63|11.63|||
3607134|NCT02846558|3458271|B2|||Waist Circumference||cm|Mean|102.16|102.16|Standard Deviation|13.05|13.05|||
3607135|NCT02846558|3458272|B1|||Waist Circumference||cm|Mean|110.22|110.22|Standard Deviation|19.31|19.31|||
3607136|NCT02846558|3458268|B5|||BMI||kg/m^2|Mean|28.00|28.0|Standard Deviation|6.21|6.21|||
3607137|NCT02846558|3458269|B4|||BMI||kg/m^2|Mean|25.86|25.86|Standard Deviation|6.22|6.22|||
3607138|NCT02846558|3458270|B3|||BMI||kg/m^2|Mean|24.28|24.28|Standard Deviation|3.16|3.16|||
3607139|NCT02846558|3458271|B2|||BMI||kg/m^2|Mean|30.22|30.22|Standard Deviation|4.78|4.78|||
3607140|NCT02846558|3458272|B1|||BMI||kg/m^2|Mean|30.04|30.04|Standard Deviation|6.52|6.52|||
3607141|NCT02846558|3458268|B5|||Weight||kg|Mean|76.91|76.91|Standard Deviation|17.73|17.73|||
3607142|NCT02846558|3458269|B4|||Weight||kg|Mean|70.13|70.13|Standard Deviation|16.06|16.06|||
3607143|NCT02846558|3458270|B3|||Weight||kg|Mean|66.25|66.25|Standard Deviation|8.12|8.12|||
3607144|NCT02846558|3458271|B2|||Weight||kg|Mean|82.76|82.76|Standard Deviation|16.89|16.89|||
3607145|NCT02846558|3458272|B1|||Weight||kg|Mean|92.58|92.58|Standard Deviation|17.26|17.26|||
3607146|NCT02846558|3458268|B5|United States||Region of Enrollment||participants|Number|43|43.0||||||
3607147|NCT02846558|3458269|B4|United States||Region of Enrollment||participants|Number|12|12.0||||||
3607148|NCT02846558|3458270|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3607149|NCT02846558|3458271|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3607150|NCT02846558|3458272|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3607151|NCT02846558|3458268|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3607152|NCT02846558|3458269|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3607153|NCT02846558|3458270|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3607154|NCT02846558|3458271|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3607155|NCT02846558|3458272|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3607156|NCT02846558|3458268|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3607157|NCT02846558|3458269|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3607158|NCT02846558|3458270|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3607159|NCT02846558|3458271|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3607160|NCT02846558|3458272|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3607161|NCT02846558|3458268|B5|Non-White Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3607162|NCT02846558|3458269|B4|Non-White Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3607163|NCT02846558|3458270|B3|Non-White Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3607164|NCT02846558|3458271|B2|Non-White Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3607165|NCT02846558|3458272|B1|Non-White Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3607166|NCT02846558|3458268|B5|African American||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3607167|NCT02846558|3458269|B4|African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3607168|NCT02846558|3458270|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3607169|NCT02846558|3458271|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3607170|NCT02846558|3458272|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3607171|NCT02846558|3458268|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3607172|NCT02846558|3458269|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3607173|NCT02846558|3458270|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3607174|NCT02846558|3458271|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3607175|NCT02846558|3458272|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3607176|NCT02846558|3458268|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3607177|NCT02846558|3458269|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3607178|NCT02846558|3458270|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3607179|NCT02846558|3458271|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3607180|NCT02846558|3458272|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3607181|NCT02846558|3458268|B5||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3607182|NCT02846558|3458269|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3607183|NCT02846558|3458270|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3607184|NCT02846558|3458271|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3607185|NCT02846558|3458272|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3607186|NCT02846558|3458268|B5|||Age||years|Mean|41.73|41.73|Standard Deviation|11.31|11.31|||
3607187|NCT02846558|3458269|B4|||Age||years|Mean|43.42|43.42|Standard Deviation|11.77|11.77|||
3607188|NCT02846558|3458270|B3|||Age||years|Mean|39.83|39.83|Standard Deviation|10.94|10.94|||
3607189|NCT02846558|3458271|B2|||Age||years|Mean|31.18|31.18|Standard Deviation|3.79|3.79|||
3607190|NCT02846558|3458272|B1|||Age||years|Mean|31.10|31.1|Standard Deviation|6.00|6.0|||
3607191|NCT02845674|3458311|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607192|NCT02845674|3458312|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607193|NCT02845674|3458313|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607194|NCT02845674|3458311|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3607195|NCT02845674|3458312|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3607196|NCT02845674|3458313|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3607197|NCT02845674|3458311|B3||White|Race (NIH/OMB)||Participants|Count of Participants|221|221.0||||||
3607198|NCT02845674|3458312|B2||White|Race (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
3607199|NCT02845674|3458313|B1||White|Race (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
3607200|NCT02845674|3458311|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3607201|NCT02845674|3458312|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3607202|NCT02845674|3458313|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3607203|NCT02845674|3458311|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3607204|NCT02845674|3458312|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3607205|NCT02845674|3458313|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607206|NCT02845674|3458311|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3607207|NCT02845674|3458312|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3607208|NCT02845674|3458313|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3607209|NCT02845674|3458311|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3607210|NCT02845674|3458312|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607211|NCT02845674|3458313|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3607212|NCT02845674|3458311|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607213|NCT02845674|3458312|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607214|NCT02845674|3458313|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607215|NCT02845674|3458311|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|232|232.0||||||
3607216|NCT02845674|3458312|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|121|121.0||||||
3607217|NCT02845674|3458313|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
3607218|NCT02845674|3458311|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3607219|NCT02845674|3458312|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3607220|NCT02845674|3458313|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3607221|NCT02845674|3458311|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3607222|NCT02845674|3458312|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3607223|NCT02845674|3458313|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3607224|NCT02845674|3458311|B3||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
3607225|NCT02845674|3458312|B2||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3607226|NCT02845674|3458313|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3607227|NCT02845674|3458311|B3|||Age||years|Mean|60.0|60.0|Standard Deviation|14.92|14.92|||
3607228|NCT02845674|3458312|B2|||Age||years|Mean|61.5|61.5|Standard Deviation|14.21|14.21|||
3607229|NCT02845674|3458313|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|15.51|15.51|||
3607230|NCT02844998|3458320|B4|Turkey||Region of Enrollment|All participitants are male|count of participants|Number|105|105.0||||||
3607231|NCT02844998|3458321|B3|Turkey||Region of Enrollment|All participitants are male|count of participants|Number|35|35.0||||||
3607232|NCT02844998|3458322|B2|Turkey||Region of Enrollment|All participitants are male|count of participants|Number|35|35.0||||||
3607233|NCT02844998|3458323|B1|Turkey||Region of Enrollment|All participitants are male|count of participants|Number|35|35.0||||||
3607234|NCT02844998|3458320|B4|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3607235|NCT02844998|3458320|B4|Male||Sex/Gender, Customized||Participants|Count of Participants|105|105.0||||||
3607236|NCT02844998|3458321|B3|Male||Sex/Gender, Customized||Participants|Count of Participants|35|35.0||||||
3607237|NCT02844998|3458322|B2|Male||Sex/Gender, Customized||Participants|Count of Participants|35|35.0||||||
3607238|NCT02844998|3458323|B1|Male||Sex/Gender, Customized||Participants|Count of Participants|35|35.0||||||
3607239|NCT02844998|3458320|B4|Male|>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3607240|NCT02844998|3458321|B3|Male|>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3607241|NCT02844998|3458322|B2|Male|>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3607242|NCT02844998|3458323|B1|Male|>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3607243|NCT02844998|3458320|B4|Male|Between 18 and 65 years|Age||Participants|Count of Participants|105|105.0||||||
3607244|NCT02844998|3458321|B3|Male|Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3607245|NCT02844998|3458322|B2|Male|Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3607246|NCT02844998|3458323|B1|Male|Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3607247|NCT02844998|3458320|B4|Male|<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3607248|NCT02844998|3458321|B3|Male|<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3607249|NCT02844998|3458322|B2|Male|<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3607250|NCT02844998|3458323|B1|Male|<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3607251|NCT02844543|3458336|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3607252|NCT02844543|3458336|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3607253|NCT02844543|3458336|B1|||Age||years|Mean|19.8|19.8|Standard Deviation|1.3|1.3|||
3607254|NCT02843659|3458343|B4|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3607255|NCT02843659|3458344|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3607256|NCT02843659|3458345|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3607257|NCT02843659|3458346|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3607258|NCT02843659|3458343|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3607259|NCT02843659|3458344|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3607260|NCT02843659|3458345|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3607261|NCT02843659|3458346|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3607262|NCT02843659|3458343|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3607263|NCT02843659|3458344|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3607264|NCT02843659|3458345|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3607265|NCT02843659|3458346|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3607266|NCT02843659|3458343|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3607267|NCT02843659|3458344|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3607268|NCT02843659|3458345|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3607269|NCT02843659|3458346|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3607270|NCT02843659|3458343|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3607271|NCT02843659|3458344|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3607272|NCT02843659|3458345|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3607273|NCT02843659|3458346|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3607274|NCT02843659|3458343|B4|White||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3607275|NCT02843659|3458344|B3|White||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3607276|NCT02843659|3458345|B2|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3607277|NCT02843659|3458346|B1|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3607278|NCT02843659|3458343|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3607279|NCT02843659|3458344|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3607280|NCT02843659|3458345|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3607281|NCT02843659|3458346|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3607282|NCT02843659|3458343|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3607283|NCT02843659|3458344|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3607284|NCT02843659|3458345|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3607285|NCT02843659|3458346|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3607286|NCT02843659|3458343|B4|||Age||Years|Mean|51.2|51.2|Standard Deviation|11.41|11.41|||
3607287|NCT02843659|3458344|B3|||Age||Years|Mean|52.6|52.6|Standard Deviation|13.30|13.3|||
3607288|NCT02843659|3458345|B2|||Age||Years|Mean|51.2|51.2|Standard Deviation|8.77|8.77|||
3607289|NCT02843659|3458346|B1|||Age||Years|Mean|49.2|49.2|Standard Deviation|11.34|11.34|||
3607290|NCT02842073|3458413|B1|||Craving for Alcohol|The PACS is a five-item self-administered instrument for assessing craving. Frequency, intensity, and duration of thoughts about drinking are assessed along with ability to resist drinking. The final item asks the responder to provide an average rating of his/her craving over the course of the past week. The questions on the PACS use descriptors coupled with numerical ratings ranging from 0 to 6 with the highest possible total score of 30. Higher scores reflect a higher level of craving.|units on a scale|Mean|11.25|11.25|Standard Deviation|7.1|7.1|||
3607291|NCT02842073|3458413|B1|||Intensity of Binge Drinking prior to Study|The mean number of drinks/binge drinking day in the 90 days prior to screening.|drinks/binge drinking day|Mean|8.4|8.4|Standard Deviation|1.0|1.0|||
3607292|NCT02842073|3458413|B1|||Number of Binge Drinking Days in 90 days prior to screening||days|Mean|17.3|17.3|Standard Deviation|7.8|7.8|||
3607293|NCT02842073|3458413|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3607294|NCT02842073|3458413|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607295|NCT02842073|3458413|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607296|NCT02842073|3458413|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3607297|NCT02842073|3458413|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3607298|NCT02842073|3458413|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607299|NCT02842073|3458413|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607300|NCT02842073|3458413|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607301|NCT02842073|3458413|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3607302|NCT02842073|3458413|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3607303|NCT02842073|3458413|B1|||Age||years|Mean|33.1|33.1|Standard Deviation|2.0|2.0|||
3607304|NCT02841787|3458421|B4||Yes|Taking antidepressant medication||Participants|Count of Participants|15|15.0||||||
3607305|NCT02841787|3458422|B3||Yes|Taking antidepressant medication||Participants|Count of Participants|5|5.0||||||
3607306|NCT02841787|3458423|B2||Yes|Taking antidepressant medication||Participants|Count of Participants|5|5.0||||||
3607307|NCT02841787|3458424|B1||Yes|Taking antidepressant medication||Participants|Count of Participants|5|5.0||||||
3607308|NCT02841787|3458421|B4||No|Taking antidepressant medication||Participants|Count of Participants|32|32.0||||||
3607309|NCT02841787|3458422|B3||No|Taking antidepressant medication||Participants|Count of Participants|7|7.0||||||
3607310|NCT02841787|3458423|B2||No|Taking antidepressant medication||Participants|Count of Participants|18|18.0||||||
3607311|NCT02841787|3458424|B1||No|Taking antidepressant medication||Participants|Count of Participants|7|7.0||||||
3607312|NCT02841787|3458421|B4|Medicaid||Health Insurance||Participants|Count of Participants|4|4.0||||||
3607313|NCT02841787|3458422|B3|Medicaid||Health Insurance||Participants|Count of Participants|0|0.0||||||
3607314|NCT02841787|3458423|B2|Medicaid||Health Insurance||Participants|Count of Participants|3|3.0||||||
3607315|NCT02841787|3458424|B1|Medicaid||Health Insurance||Participants|Count of Participants|1|1.0||||||
3607316|NCT02841787|3458421|B4|Medicare||Health Insurance||Participants|Count of Participants|40|40.0||||||
3607317|NCT02841787|3458422|B3|Medicare||Health Insurance||Participants|Count of Participants|11|11.0||||||
3607318|NCT02841787|3458423|B2|Medicare||Health Insurance||Participants|Count of Participants|19|19.0||||||
3607319|NCT02841787|3458424|B1|Medicare||Health Insurance||Participants|Count of Participants|10|10.0||||||
3607320|NCT02841787|3458421|B4|Insured||Health Insurance||Participants|Count of Participants|46|46.0||||||
3607321|NCT02841787|3458422|B3|Insured||Health Insurance||Participants|Count of Participants|12|12.0||||||
3607322|NCT02841787|3458423|B2|Insured||Health Insurance||Participants|Count of Participants|22|22.0||||||
3607323|NCT02841787|3458424|B1|Insured||Health Insurance||Participants|Count of Participants|12|12.0||||||
3607324|NCT02841787|3458421|B4||Unemployed/Disability|Employment Status||Participants|Count of Participants|3|3.0||||||
3607325|NCT02841787|3458422|B3||Unemployed/Disability|Employment Status||Participants|Count of Participants|2|2.0||||||
3607326|NCT02841787|3458423|B2||Unemployed/Disability|Employment Status||Participants|Count of Participants|1|1.0||||||
3607327|NCT02841787|3458424|B1||Unemployed/Disability|Employment Status||Participants|Count of Participants|0|0.0||||||
3607328|NCT02841787|3458421|B4||Retired|Employment Status||Participants|Count of Participants|34|34.0||||||
3607329|NCT02841787|3458422|B3||Retired|Employment Status||Participants|Count of Participants|7|7.0||||||
3607330|NCT02841787|3458423|B2||Retired|Employment Status||Participants|Count of Participants|18|18.0||||||
3607331|NCT02841787|3458424|B1||Retired|Employment Status||Participants|Count of Participants|9|9.0||||||
3607332|NCT02841787|3458421|B4||Employed|Employment Status||Participants|Count of Participants|10|10.0||||||
3607333|NCT02841787|3458422|B3||Employed|Employment Status||Participants|Count of Participants|3|3.0||||||
3607334|NCT02841787|3458423|B2||Employed|Employment Status||Participants|Count of Participants|4|4.0||||||
3607335|NCT02841787|3458424|B1||Employed|Employment Status||Participants|Count of Participants|3|3.0||||||
3607336|NCT02841787|3458421|B4||Doctoral Degree (PhD, MD, JD)|Education||Participants|Count of Participants|7|7.0||||||
3607337|NCT02841787|3458422|B3||Doctoral Degree (PhD, MD, JD)|Education||Participants|Count of Participants|2|2.0||||||
3607338|NCT02841787|3458423|B2||Doctoral Degree (PhD, MD, JD)|Education||Participants|Count of Participants|2|2.0||||||
3607339|NCT02841787|3458424|B1||Doctoral Degree (PhD, MD, JD)|Education||Participants|Count of Participants|3|3.0||||||
3607340|NCT02841787|3458421|B4||Master's Degree|Education||Participants|Count of Participants|12|12.0||||||
3607341|NCT02841787|3458422|B3||Master's Degree|Education||Participants|Count of Participants|2|2.0||||||
3607342|NCT02841787|3458423|B2||Master's Degree|Education||Participants|Count of Participants|5|5.0||||||
3607343|NCT02841787|3458424|B1||Master's Degree|Education||Participants|Count of Participants|5|5.0||||||
3607344|NCT02841787|3458421|B4||4-yr College (Bachelor's)|Education||Participants|Count of Participants|13|13.0||||||
3607345|NCT02841787|3458422|B3||4-yr College (Bachelor's)|Education||Participants|Count of Participants|4|4.0||||||
3607346|NCT02841787|3458423|B2||4-yr College (Bachelor's)|Education||Participants|Count of Participants|6|6.0||||||
3607347|NCT02841787|3458424|B1||4-yr College (Bachelor's)|Education||Participants|Count of Participants|3|3.0||||||
3607348|NCT02841787|3458421|B4||2-yr College (Associate's)|Education||Participants|Count of Participants|7|7.0||||||
3607349|NCT02841787|3458422|B3||2-yr College (Associate's)|Education||Participants|Count of Participants|2|2.0||||||
3607350|NCT02841787|3458423|B2||2-yr College (Associate's)|Education||Participants|Count of Participants|5|5.0||||||
3607351|NCT02841787|3458424|B1||2-yr College (Associate's)|Education||Participants|Count of Participants|0|0.0||||||
3607352|NCT02841787|3458421|B4||Some College|Education||Participants|Count of Participants|7|7.0||||||
3607353|NCT02841787|3458422|B3||Some College|Education||Participants|Count of Participants|1|1.0||||||
3607354|NCT02841787|3458423|B2||Some College|Education||Participants|Count of Participants|5|5.0||||||
3607355|NCT02841787|3458424|B1||Some College|Education||Participants|Count of Participants|1|1.0||||||
3607356|NCT02841787|3458421|B4||Some High School|Education||Participants|Count of Participants|1|1.0||||||
3607357|NCT02841787|3458422|B3||Some High School|Education||Participants|Count of Participants|1|1.0||||||
3607358|NCT02841787|3458423|B2||Some High School|Education||Participants|Count of Participants|0|0.0||||||
3607359|NCT02841787|3458424|B1||Some High School|Education||Participants|Count of Participants|0|0.0||||||
3607360|NCT02841787|3458421|B4||Partner|Marital Status||Participants|Count of Participants|18|18.0||||||
3607361|NCT02841787|3458422|B3||Partner|Marital Status||Participants|Count of Participants|7|7.0||||||
3607362|NCT02841787|3458423|B2||Partner|Marital Status||Participants|Count of Participants|7|7.0||||||
3607363|NCT02841787|3458424|B1||Partner|Marital Status||Participants|Count of Participants|4|4.0||||||
3607364|NCT02841787|3458421|B4||No Partner|Marital Status||Participants|Count of Participants|29|29.0||||||
3607365|NCT02841787|3458422|B3||No Partner|Marital Status||Participants|Count of Participants|5|5.0||||||
3607366|NCT02841787|3458423|B2||No Partner|Marital Status||Participants|Count of Participants|16|16.0||||||
3607367|NCT02841787|3458424|B1||No Partner|Marital Status||Participants|Count of Participants|8|8.0||||||
3607368|NCT02841787|3458421|B4|||Annual gross household income (x1000)||USD|Median|41|41.0|Inter-Quartile Range|||29.0|50.0|
3607369|NCT02841787|3458422|B3|||Annual gross household income (x1000)||USD|Median|50|50.0|Inter-Quartile Range|||34.0|115.0|
3607370|NCT02841787|3458423|B2|||Annual gross household income (x1000)||USD|Median|37|37.0|Inter-Quartile Range|||22.2|50.0|
3607371|NCT02841787|3458424|B1|||Annual gross household income (x1000)||USD|Median|37.5|37.5|Inter-Quartile Range|||33.0|45.0|
3607372|NCT02841787|3458421|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3607373|NCT02841787|3458422|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607374|NCT02841787|3458423|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3607375|NCT02841787|3458424|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607376|NCT02841787|3458421|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3607377|NCT02841787|3458422|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607378|NCT02841787|3458423|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3607379|NCT02841787|3458424|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3607380|NCT02841787|3458421|B4||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3607381|NCT02841787|3458422|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3607382|NCT02841787|3458423|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3607383|NCT02841787|3458424|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3607384|NCT02841787|3458421|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3607385|NCT02841787|3458422|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3607386|NCT02841787|3458423|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3607387|NCT02841787|3458424|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607388|NCT02841787|3458421|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607389|NCT02841787|3458422|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607390|NCT02841787|3458423|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607391|NCT02841787|3458424|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607392|NCT02841787|3458421|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607393|NCT02841787|3458422|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607394|NCT02841787|3458423|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607395|NCT02841787|3458424|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607396|NCT02841787|3458421|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607397|NCT02841787|3458422|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607398|NCT02841787|3458423|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607399|NCT02841787|3458424|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607400|NCT02841787|3458421|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607401|NCT02841787|3458422|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607402|NCT02841787|3458423|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607403|NCT02841787|3458424|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607404|NCT02841787|3458421|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3607405|NCT02841787|3458422|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3607406|NCT02841787|3458423|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3607407|NCT02841787|3458424|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3607408|NCT02841787|3458421|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3607409|NCT02841787|3458422|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607410|NCT02841787|3458423|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3607411|NCT02841787|3458424|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607412|NCT02841787|3458421|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3607413|NCT02841787|3458422|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3607414|NCT02841787|3458423|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3607415|NCT02841787|3458424|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3607416|NCT02841787|3458421|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3607417|NCT02841787|3458422|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3607418|NCT02841787|3458423|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3607419|NCT02841787|3458424|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3607420|NCT02841787|3458421|B4|||Age||years|Mean|69.6|69.6|Standard Deviation|4.1|4.1|||
3607421|NCT02841787|3458422|B3|||Age||years|Mean|70|70.0|Standard Deviation|4.7|4.7|||
3607422|NCT02841787|3458423|B2|||Age||years|Mean|69.5|69.5|Standard Deviation|4.3|4.3|||
3607423|NCT02841787|3458424|B1|||Age||years|Mean|69.2|69.2|Standard Deviation|3.4|3.4|||
3607424|NCT02840916|3458440|B3|Taiwan||Region of Enrollment||participants|Number|62|62.0||||||
3607425|NCT02840916|3458441|B2|Taiwan||Region of Enrollment||participants|Number|30|30.0||||||
3607426|NCT02840916|3458442|B1|Taiwan||Region of Enrollment||participants|Number|32|32.0||||||
3607427|NCT02840916|3458440|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3607428|NCT02840916|3458441|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3607429|NCT02840916|3458442|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3607430|NCT02840916|3458440|B3||Female|Gender||Participants|Count of Participants|62|62.0||||||
3607431|NCT02840916|3458441|B2||Female|Gender||Participants|Count of Participants|30|30.0||||||
3607432|NCT02840916|3458442|B1||Female|Gender||Participants|Count of Participants|32|32.0||||||
3607433|NCT02840916|3458440|B3|||Age||years|Mean|35.28|35.28|Standard Deviation|4.02|4.02|||
3607434|NCT02840916|3458441|B2|||Age||years|Mean|35.70|35.7|Standard Deviation|3.72|3.72|||
3607435|NCT02840916|3458442|B1|||Age||years|Mean|34.88|34.88|Standard Deviation|4.31|4.31|||
3607436|NCT02840916|3458440|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3607437|NCT02840916|3458441|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3607438|NCT02840916|3458442|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3607439|NCT02840916|3458440|B3||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
3607440|NCT02840916|3458441|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3607441|NCT02840916|3458442|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3607442|NCT02840916|3458440|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3607443|NCT02840916|3458441|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3607444|NCT02840916|3458442|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3607445|NCT02840253|3458453|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607446|NCT02840253|3458453|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607447|NCT02840253|3458453|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3607448|NCT02840253|3458453|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3607449|NCT02840253|3458453|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607450|NCT02840253|3458453|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607451|NCT02840253|3458453|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607452|NCT02840253|3458453|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607453|NCT02840253|3458453|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3607454|NCT02840253|3458453|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607455|NCT02840253|3458453|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3607456|NCT02840253|3458453|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3607457|NCT02840253|3458453|B1|||Age||months|Mean|7|7.0|Standard Deviation|3|3.0|||
3607458|NCT02839772|3458458|B3|Severe disease||Severity of podoconioisis based on a staging systeme|There are 5 stages with 5 being the most severe stage of podoconiosis.|participants|Number|100|100.0||||||
3607459|NCT02839772|3458459|B2|Severe disease||Severity of podoconioisis based on a staging systeme|There are 5 stages with 5 being the most severe stage of podoconiosis.|participants|Number|50|50.0||||||
3607460|NCT02839772|3458460|B1|Severe disease||Severity of podoconioisis based on a staging systeme|There are 5 stages with 5 being the most severe stage of podoconiosis.|participants|Number|50|50.0||||||
3607461|NCT02839772|3458458|B3|Less severe/moderate disease||Severity of podoconioisis based on a staging systeme|There are 5 stages with 5 being the most severe stage of podoconiosis.|participants|Number|93|93.0||||||
3607462|NCT02839772|3458459|B2|Less severe/moderate disease||Severity of podoconioisis based on a staging systeme|There are 5 stages with 5 being the most severe stage of podoconiosis.|participants|Number|46|46.0||||||
3607463|NCT02839772|3458460|B1|Less severe/moderate disease||Severity of podoconioisis based on a staging systeme|There are 5 stages with 5 being the most severe stage of podoconiosis.|participants|Number|47|47.0||||||
3607464|NCT02839772|3458458|B3|Ethiopia||Region of Enrollment|Data was collected from new patients attending two Action on Podoconiosis Clinics in south-central Ethiopia with similar graphical features. Clinical practice at both was the same.|participants|Number|193|193.0||||||
3607465|NCT02839772|3458459|B2|Ethiopia||Region of Enrollment|Data was collected from new patients attending two Action on Podoconiosis Clinics in south-central Ethiopia with similar graphical features. Clinical practice at both was the same.|participants|Number|96|96.0||||||
3607466|NCT02839772|3458460|B1|Ethiopia||Region of Enrollment|Data was collected from new patients attending two Action on Podoconiosis Clinics in south-central Ethiopia with similar graphical features. Clinical practice at both was the same.|participants|Number|97|97.0||||||
3607467|NCT02839772|3458458|B3||Male|Gender||Participants|Count of Participants|95|95.0||||||
3607468|NCT02839772|3458459|B2||Male|Gender||Participants|Count of Participants|47|47.0||||||
3607469|NCT02839772|3458460|B1||Male|Gender||Participants|Count of Participants|48|48.0||||||
3607470|NCT02839772|3458458|B3||Female|Gender||Participants|Count of Participants|98|98.0||||||
3607471|NCT02839772|3458459|B2||Female|Gender||Participants|Count of Participants|49|49.0||||||
3607472|NCT02839772|3458460|B1||Female|Gender||Participants|Count of Participants|49|49.0||||||
3607473|NCT02839772|3458458|B3||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
3607474|NCT02839772|3458459|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3607475|NCT02839772|3458460|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3607476|NCT02839772|3458458|B3||Between 18 and 65 years|Age||Participants|Count of Participants|166|166.0||||||
3607477|NCT02839772|3458459|B2||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
3607478|NCT02839772|3458460|B1||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
3607479|NCT02839772|3458458|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3607480|NCT02839772|3458459|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3607481|NCT02839772|3458460|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3607482|NCT02838901|3458498|B3|||gait speed||m/s|Mean|0.22|0.22|Full Range|||0.08|0.32|
3607483|NCT02838901|3458499|B2|||gait speed||m/s|Mean|0.22|0.22|Full Range|||0.08|0.23|
3607484|NCT02838901|3458500|B1|||gait speed||m/s|Mean|0.23|0.23|Full Range|||0.07|0.36|
3607485|NCT02838901|3458498|B3|Baseline Nitrite||nitrate and nitrite levels||micromoles/L|Mean|0.15|0.15|Standard Deviation|0.11|0.11|||
3607486|NCT02838901|3458499|B2|Baseline Nitrite||nitrate and nitrite levels||micromoles/L|Mean|0.13|0.13|Standard Deviation|0.08|0.08|||
3607487|NCT02838901|3458500|B1|Baseline Nitrite||nitrate and nitrite levels||micromoles/L|Mean|0.17|0.17|Standard Deviation|0.14|0.14|||
3607488|NCT02838901|3458498|B3|Baseline Nitrate||nitrate and nitrite levels||micromoles/L|Mean|45.5|45.5|Standard Deviation|57.3|57.3|||
3607489|NCT02838901|3458499|B2|Baseline Nitrate||nitrate and nitrite levels||micromoles/L|Mean|27.0|27.0|Standard Deviation|16.0|16.0|||
3607490|NCT02838901|3458500|B1|Baseline Nitrate||nitrate and nitrite levels||micromoles/L|Mean|63.9|63.9|Standard Deviation|77.2|77.2|||
3607491|NCT02838901|3458498|B3|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3607492|NCT02838901|3458499|B2|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3607493|NCT02838901|3458500|B1|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3607494|NCT02838901|3458498|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3607495|NCT02838901|3458499|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3607496|NCT02838901|3458500|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3607497|NCT02838901|3458498|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3607498|NCT02838901|3458499|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||more than one race reported as other/unknown
3607499|NCT02838901|3458500|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||more than one race reported as other/unknown
3607500|NCT02838901|3458498|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3607501|NCT02838901|3458499|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3607502|NCT02838901|3458500|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3607503|NCT02838901|3458498|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3607504|NCT02838901|3458499|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3607505|NCT02838901|3458500|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3607506|NCT02838901|3458498|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607507|NCT02838901|3458499|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607508|NCT02838901|3458500|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607509|NCT02838901|3458498|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607510|NCT02838901|3458499|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607511|NCT02838901|3458500|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607512|NCT02838901|3458498|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607513|NCT02838901|3458499|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607514|NCT02838901|3458500|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607515|NCT02838901|3458498|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3607516|NCT02838901|3458499|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3607517|NCT02838901|3458500|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3607518|NCT02838901|3458498|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3607519|NCT02838901|3458499|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3607520|NCT02838901|3458500|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3607521|NCT02838901|3458498|B3|||Age||Age (yrs)|Mean|64.9|64.9|Standard Deviation|8.8|8.8|||
3607522|NCT02838901|3458499|B2|||Age||Age (yrs)|Mean|66.3|66.3|Standard Deviation|9.2|9.2|||
3607523|NCT02838901|3458500|B1|||Age||Age (yrs)|Mean|63.5|63.5|Standard Deviation|8.6|8.6|||
3607524|NCT02838901|3458498|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3607525|NCT02838901|3458499|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3607526|NCT02838901|3458500|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3607527|NCT02838901|3458498|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3607528|NCT02838901|3458499|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3607529|NCT02838901|3458500|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3607530|NCT02838901|3458498|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3607531|NCT02838901|3458499|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3607532|NCT02838901|3458500|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3607533|NCT02837952|3458529|B3|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3607534|NCT02837952|3458530|B2|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3607535|NCT02837952|3458531|B1|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3607536|NCT02837952|3458529|B3|White||Race/Ethnicity, Customized||Participants|Number|112|112.0||||||
3607537|NCT02837952|3458530|B2|White||Race/Ethnicity, Customized||Participants|Number|77|77.0||||||
3607538|NCT02837952|3458531|B1|White||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
3607539|NCT02837952|3458529|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3607540|NCT02837952|3458530|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3607541|NCT02837952|3458531|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3607542|NCT02837952|3458529|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3607543|NCT02837952|3458530|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3607544|NCT02837952|3458531|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3607545|NCT02837952|3458529|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3607546|NCT02837952|3458530|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3607547|NCT02837952|3458531|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3607548|NCT02837952|3458529|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3607549|NCT02837952|3458530|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3607550|NCT02837952|3458531|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3607551|NCT02837952|3458529|B3|||Age||Years|Mean|21.8|21.8|Standard Deviation|3.84|3.84|||
3607552|NCT02837952|3458530|B2|||Age||Years|Mean|21.8|21.8|Standard Deviation|3.73|3.73|||
3607553|NCT02837952|3458531|B1|||Age||Years|Mean|21.8|21.8|Standard Deviation|4.09|4.09|||
3607554|NCT02837913|3458544|B3|||BMI||kg/m2|Mean|29.2|29.2|Standard Deviation|6.2|6.2|||
3607555|NCT02837913|3458545|B2|||BMI||kg/m2|Mean|31.5|31.5|Standard Deviation|7.4|7.4|||
3607556|NCT02837913|3458546|B1|||BMI||kg/m2|Mean|27.1|27.1|Standard Deviation|4.3|4.3|||
3607557|NCT02837913|3458544|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
3607558|NCT02837913|3458545|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3607559|NCT02837913|3458546|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3607560|NCT02837913|3458544|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3607561|NCT02837913|3458544|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3607562|NCT02837913|3458545|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3607563|NCT02837913|3458546|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3607564|NCT02837913|3458544|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3607565|NCT02837913|3458545|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3607566|NCT02837913|3458546|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3607567|NCT02837913|3458544|B3|||Age||years|Mean|34.6|34.6|Standard Deviation|4.5|4.5|||
3607568|NCT02837913|3458545|B2|||Age||years|Mean|33.2|33.2|Standard Deviation|5.6|5.6|||
3607569|NCT02837913|3458546|B1|||Age||years|Mean|35.8|35.8|Standard Deviation|3.1|3.1|||
3607570|NCT02836249|3458555|B3||Grade 3|Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|0|0.0||||||
3607571|NCT02836249|3458556|B2||Grade 3|Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|0|0.0||||||
3607572|NCT02836249|3458557|B1||Grade 3|Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|0|0.0||||||
3607573|NCT02836249|3458555|B3||Grade 2|Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|1|1.0||||||
3607574|NCT02836249|3458556|B2||Grade 2|Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|1|1.0||||||
3607575|NCT02836249|3458557|B1||Grade 2|Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|0|0.0||||||
3607576|NCT02836249|3458555|B3||Grade 1|Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|8|8.0||||||
3607577|NCT02836249|3458556|B2||Grade 1|Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|2|2.0||||||
3607578|NCT02836249|3458557|B1||Grade 1|Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|6|6.0||||||
3607579|NCT02836249|3458555|B3||Grade 0|Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|171|171.0||||||
3607580|NCT02836249|3458556|B2||Grade 0|Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|54|54.0||||||
3607581|NCT02836249|3458557|B1||Grade 0|Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|117|117.0||||||
3607582|NCT02836249|3458555|B3||Treatment Naive|Oral antiviral (OAV) Treatment Status||Participants|Count of Participants|117|117.0||||||
3607583|NCT02836249|3458556|B2||Treatment Naive|Oral antiviral (OAV) Treatment Status||Participants|Count of Participants|39|39.0||||||
3607584|NCT02836249|3458557|B1||Treatment Naive|Oral antiviral (OAV) Treatment Status||Participants|Count of Participants|78|78.0||||||
3607585|NCT02836249|3458555|B3||Treatment Experienced|Oral antiviral (OAV) Treatment Status||Participants|Count of Participants|63|63.0||||||
3607586|NCT02836249|3458556|B2||Treatment Experienced|Oral antiviral (OAV) Treatment Status||Participants|Count of Participants|18|18.0||||||
3607587|NCT02836249|3458557|B1||Treatment Experienced|Oral antiviral (OAV) Treatment Status||Participants|Count of Participants|45|45.0||||||
3607588|NCT02836249|3458555|B3||TT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|2|2.0||||||
3607589|NCT02836249|3458556|B2||TT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|0|0.0||||||
3607590|NCT02836249|3458557|B1||TT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|2|2.0||||||
3607591|NCT02836249|3458555|B3||CT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|17|17.0||||||
3607592|NCT02836249|3458556|B2||CT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|5|5.0||||||
3607593|NCT02836249|3458557|B1||CT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|12|12.0||||||
3607594|NCT02836249|3458555|B3||CC|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|161|161.0||||||
3607595|NCT02836249|3458556|B2||CC|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|52|52.0||||||
3607596|NCT02836249|3458557|B1||CC|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|109|109.0||||||
3607597|NCT02836249|3458555|B3||≥ 8 log10 IU/mL|Plasma HBV DNA Level||Participants|Count of Participants|70|70.0||||||
3607598|NCT02836249|3458556|B2||≥ 8 log10 IU/mL|Plasma HBV DNA Level||Participants|Count of Participants|21|21.0||||||
3607599|NCT02836249|3458557|B1||≥ 8 log10 IU/mL|Plasma HBV DNA Level||Participants|Count of Participants|49|49.0||||||
3607600|NCT02836249|3458555|B3||< 8 log10 IU/mL|Plasma HBV DNA Level||Participants|Count of Participants|110|110.0||||||
3607601|NCT02836249|3458556|B2||< 8 log10 IU/mL|Plasma HBV DNA Level||Participants|Count of Participants|36|36.0||||||
3607602|NCT02836249|3458557|B1||< 8 log10 IU/mL|Plasma HBV DNA Level||Participants|Count of Participants|74|74.0||||||
3607603|NCT02836249|3458555|B3|||HBV DNA||log10 IU/mL|Mean|7.2|7.2|Standard Deviation|1.59|1.59|||
3607604|NCT02836249|3458556|B2|||HBV DNA||log10 IU/mL|Mean|7.2|7.2|Standard Deviation|1.48|1.48|||
3607605|NCT02836249|3458557|B1|||HBV DNA||log10 IU/mL|Mean|7.2|7.2|Standard Deviation|1.65|1.65|||
3607606|NCT02836249|3458555|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|180|180.0||||||
3607607|NCT02836249|3458556|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|57|57.0||||||
3607608|NCT02836249|3458557|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|123|123.0||||||
3607609|NCT02836249|3458555|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607610|NCT02836249|3458556|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607611|NCT02836249|3458557|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607612|NCT02836249|3458555|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|180|180.0||||||
3607613|NCT02836249|3458556|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3607614|NCT02836249|3458557|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
3607615|NCT02836249|3458555|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607616|NCT02836249|3458556|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607617|NCT02836249|3458557|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607618|NCT02836249|3458555|B3||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3607619|NCT02836249|3458556|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3607620|NCT02836249|3458557|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3607621|NCT02836249|3458555|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3607622|NCT02836249|3458556|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3607623|NCT02836249|3458557|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3607624|NCT02836249|3458555|B3|||Age||years|Mean|34|34.0|Standard Deviation|9.4|9.4|||
3607625|NCT02836249|3458556|B2|||Age||years|Mean|36|36.0|Standard Deviation|9.5|9.5|||
3607626|NCT02836249|3458557|B1|||Age||years|Mean|34|34.0|Standard Deviation|9.4|9.4|||
3607627|NCT02836236|3458574|B3||Grade 3|Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|0|0.0||||||
3607628|NCT02836236|3458575|B2||Grade 3|Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|0|0.0||||||
3607629|NCT02836236|3458576|B1||Grade 3|Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|0|0.0||||||
3607630|NCT02836236|3458574|B3||Grade 2|Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|0|0.0||||||
3607631|NCT02836236|3458575|B2||Grade 2|Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|0|0.0||||||
3607632|NCT02836236|3458576|B1||Grade 2|Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|0|0.0||||||
3607633|NCT02836236|3458574|B3||Grade 1|Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|5|5.0||||||
3607634|NCT02836236|3458575|B2||Grade 1|Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|2|2.0||||||
3607635|NCT02836236|3458576|B1||Grade 1|Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|3|3.0||||||
3607636|NCT02836236|3458574|B3||Grade 0|Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|149|149.0||||||
3607637|NCT02836236|3458575|B2||Grade 0|Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|48|48.0||||||
3607638|NCT02836236|3458576|B1||Grade 0|Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|101|101.0||||||
3607639|NCT02836236|3458574|B3||Treatment Naive|Oral antiviral (OAV) Treatment Status||Participants|Count of Participants|93|93.0||||||
3607640|NCT02836236|3458575|B2||Treatment Naive|Oral antiviral (OAV) Treatment Status||Participants|Count of Participants|30|30.0||||||
3607641|NCT02836236|3458576|B1||Treatment Naive|Oral antiviral (OAV) Treatment Status||Participants|Count of Participants|63|63.0||||||
3607642|NCT02836236|3458574|B3||Treatment Experienced|Oral antiviral (OAV) Treatment Status||Participants|Count of Participants|61|61.0||||||
3607643|NCT02836236|3458575|B2||Treatment Experienced|Oral antiviral (OAV) Treatment Status||Participants|Count of Participants|20|20.0||||||
3607644|NCT02836236|3458576|B1||Treatment Experienced|Oral antiviral (OAV) Treatment Status||Participants|Count of Participants|41|41.0||||||
3607645|NCT02836236|3458574|B3||Missing|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|1|1.0||||||
3607646|NCT02836236|3458575|B2||Missing|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|0|0.0||||||
3607647|NCT02836236|3458576|B1||Missing|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|1|1.0||||||
3607648|NCT02836236|3458574|B3||TT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|2|2.0||||||
3607649|NCT02836236|3458575|B2||TT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|1|1.0||||||
3607650|NCT02836236|3458576|B1||TT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|1|1.0||||||
3607651|NCT02836236|3458574|B3||CT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|18|18.0||||||
3607652|NCT02836236|3458575|B2||CT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|10|10.0||||||
3607653|NCT02836236|3458576|B1||CT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|8|8.0||||||
3607654|NCT02836236|3458574|B3||CC|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|133|133.0||||||
3607655|NCT02836236|3458575|B2||CC|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|39|39.0||||||
3607656|NCT02836236|3458576|B1||CC|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|94|94.0||||||
3607657|NCT02836236|3458574|B3||≥ 8 log10 IU/mL|Plasma HBV DNA Level||Participants|Count of Participants|7|7.0||||||
3607658|NCT02836236|3458575|B2||≥ 8 log10 IU/mL|Plasma HBV DNA Level||Participants|Count of Participants|1|1.0||||||
3607659|NCT02836236|3458576|B1||≥ 8 log10 IU/mL|Plasma HBV DNA Level||Participants|Count of Participants|6|6.0||||||
3607660|NCT02836236|3458574|B3||≥ 7 log10 IU/mL to < 8 log10 IU/mL|Plasma HBV DNA Level||Participants|Count of Participants|31|31.0||||||
3607661|NCT02836236|3458575|B2||≥ 7 log10 IU/mL to < 8 log10 IU/mL|Plasma HBV DNA Level||Participants|Count of Participants|10|10.0||||||
3607662|NCT02836236|3458576|B1||≥ 7 log10 IU/mL to < 8 log10 IU/mL|Plasma HBV DNA Level||Participants|Count of Participants|21|21.0||||||
3607663|NCT02836236|3458574|B3||< 7 log10 IU/mL|Plasma HBV DNA Level||Participants|Count of Participants|116|116.0||||||
3607664|NCT02836236|3458575|B2||< 7 log10 IU/mL|Plasma HBV DNA Level||Participants|Count of Participants|39|39.0||||||
3607665|NCT02836236|3458576|B1||< 7 log10 IU/mL|Plasma HBV DNA Level||Participants|Count of Participants|77|77.0||||||
3607666|NCT02836236|3458574|B3|||HBV DNA||log10 IU/mL|Mean|5.5|5.5|Standard Deviation|1.70|1.7|||
3607667|NCT02836236|3458575|B2|||HBV DNA||log10 IU/mL|Mean|5.3|5.3|Standard Deviation|1.63|1.63|||
3607668|NCT02836236|3458576|B1|||HBV DNA||log10 IU/mL|Mean|5.5|5.5|Standard Deviation|1.73|1.73|||
3607669|NCT02836236|3458574|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|154|154.0||||||
3607670|NCT02836236|3458575|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
3607671|NCT02836236|3458576|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|104|104.0||||||
3607672|NCT02836236|3458574|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607673|NCT02836236|3458575|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607674|NCT02836236|3458576|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607675|NCT02836236|3458574|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|154|154.0||||||
3607676|NCT02836236|3458575|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3607677|NCT02836236|3458576|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
3607678|NCT02836236|3458574|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607679|NCT02836236|3458575|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607680|NCT02836236|3458576|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607681|NCT02836236|3458574|B3||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3607682|NCT02836236|3458575|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3607683|NCT02836236|3458576|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3607684|NCT02836236|3458574|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3607685|NCT02836236|3458575|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3607686|NCT02836236|3458576|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3607687|NCT02836236|3458574|B3|||Age||years|Mean|43|43.0|Standard Deviation|10.4|10.4|||
3607688|NCT02836236|3458575|B2|||Age||years|Mean|45|45.0|Standard Deviation|11.2|11.2|||
3607689|NCT02836236|3458576|B1|||Age||years|Mean|42|42.0|Standard Deviation|9.9|9.9|||
3607690|NCT02834624|3458591|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3607691|NCT02834624|3458592|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3607692|NCT02834624|3458593|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3607693|NCT02834624|3458591|B3|Unknown||Sex/Gender, Customized||Participants|Count of Participants|30|30.0||||||
3607694|NCT02834624|3458592|B2|Unknown||Sex/Gender, Customized||Participants|Count of Participants|15|15.0||||||
3607695|NCT02834624|3458593|B1|Unknown||Sex/Gender, Customized||Participants|Count of Participants|15|15.0||||||
3607696|NCT02834624|3458591|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3607697|NCT02834624|3458592|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3607698|NCT02834624|3458593|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3607699|NCT02834624|3458591|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3607700|NCT02834624|3458592|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3607701|NCT02834624|3458593|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3607702|NCT02834624|3458591|B3||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
3607703|NCT02834624|3458592|B2||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
3607704|NCT02834624|3458593|B1||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
3607705|NCT02832674|3458604|B1|||Body Mass Index||kg/m^2|Mean|26.1|26.1|Standard Deviation|2.9|2.9|||
3607706|NCT02832674|3458604|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3607707|NCT02832674|3458604|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3607708|NCT02832674|3458604|B1||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3607709|NCT02832674|3458604|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3607710|NCT02832674|3458604|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607711|NCT02832674|3458604|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607712|NCT02832674|3458604|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607713|NCT02832674|3458604|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3607714|NCT02832674|3458604|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3607715|NCT02832674|3458604|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3607716|NCT02832674|3458604|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3607717|NCT02832674|3458604|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3607718|NCT02832674|3458604|B1|||Age||years|Mean|52.9|52.9|Standard Deviation|7.0|7.0|||
3607719|NCT02832375|3458613|B3|||Tactile Threshold at Baseline|Tactile threshold was assessed by examiner using a constant pressure probe (Yeaple probe) which allowed application of a known force to the dentin surface from 10 g to an upper threshold of 80g in increments of 10 g. Tactile threshold is the maximum pressure applied at which participant do not report any pain or discomfort. Tactile threshold for each tooth was determined by asking participant whether sensation caused discomfort. The pressure setting at which participant gave two consecutive 'yes' responses was recorded as tactile threshold. Higher tactile threshold, less sensitive tooth.|gram (g)|Mean|10.00|10.0|Standard Deviation|0.000|0.0|||
3607720|NCT02832375|3458614|B2|||Tactile Threshold at Baseline|Tactile threshold was assessed by examiner using a constant pressure probe (Yeaple probe) which allowed application of a known force to the dentin surface from 10 g to an upper threshold of 80g in increments of 10 g. Tactile threshold is the maximum pressure applied at which participant do not report any pain or discomfort. Tactile threshold for each tooth was determined by asking participant whether sensation caused discomfort. The pressure setting at which participant gave two consecutive 'yes' responses was recorded as tactile threshold. Higher tactile threshold, less sensitive tooth.|gram (g)|Mean|10.00|10.0|Standard Deviation|0.000|0.0|||
3607721|NCT02832375|3458615|B1|||Tactile Threshold at Baseline|Tactile threshold was assessed by examiner using a constant pressure probe (Yeaple probe) which allowed application of a known force to the dentin surface from 10 g to an upper threshold of 80g in increments of 10 g. Tactile threshold is the maximum pressure applied at which participant do not report any pain or discomfort. Tactile threshold for each tooth was determined by asking participant whether sensation caused discomfort. The pressure setting at which participant gave two consecutive 'yes' responses was recorded as tactile threshold. Higher tactile threshold, less sensitive tooth.|gram (g)|Mean|10.00|10.0|Standard Deviation|0.000|0.0|||
3607722|NCT02832375|3458613|B3|||Shiff Sensitivity Score at Baseline|Assessed by examiner as participant's response to an evaporative (air) stimulus after stimulation of each individual tooth, scored using Schiff sensitivity scale range of 0-3; 0=Participant does not respond to air stimulation; 1=Participant responds to air stimulus but does not request discontinuation of stimulus; 2=Participant responds to air stimulus & requests discontinuation or moves from stimulus; 3=Participant responds to stimulus, considers stimulus to be painful, & requests discontinuation of stimulus. A reduction in Schiff Sensitivity score indicates improvement in sensitivity.|score on a scale|Mean|2.54|2.54|Standard Deviation|0.392|0.392|||
3607772|NCT02831569|3458638|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3607723|NCT02832375|3458614|B2|||Shiff Sensitivity Score at Baseline|Assessed by examiner as participant's response to an evaporative (air) stimulus after stimulation of each individual tooth, scored using Schiff sensitivity scale range of 0-3; 0=Participant does not respond to air stimulation; 1=Participant responds to air stimulus but does not request discontinuation of stimulus; 2=Participant responds to air stimulus & requests discontinuation or moves from stimulus; 3=Participant responds to stimulus, considers stimulus to be painful, & requests discontinuation of stimulus. A reduction in Schiff Sensitivity score indicates improvement in sensitivity.|score on a scale|Mean|2.55|2.55|Standard Deviation|0.397|0.397|||
3607724|NCT02832375|3458615|B1|||Shiff Sensitivity Score at Baseline|Assessed by examiner as participant's response to an evaporative (air) stimulus after stimulation of each individual tooth, scored using Schiff sensitivity scale range of 0-3; 0=Participant does not respond to air stimulation; 1=Participant responds to air stimulus but does not request discontinuation of stimulus; 2=Participant responds to air stimulus & requests discontinuation or moves from stimulus; 3=Participant responds to stimulus, considers stimulus to be painful, & requests discontinuation of stimulus. A reduction in Schiff Sensitivity score indicates improvement in sensitivity.|score on a scale|Mean|2.53|2.53|Standard Deviation|0.389|0.389|||
3607725|NCT02832375|3458613|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607726|NCT02832375|3458614|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607727|NCT02832375|3458615|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607728|NCT02832375|3458613|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3607729|NCT02832375|3458614|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3607730|NCT02832375|3458615|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3607731|NCT02832375|3458613|B3||White|Race (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
3607732|NCT02832375|3458614|B2||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3607733|NCT02832375|3458615|B1||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3607734|NCT02832375|3458613|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3607735|NCT02832375|3458614|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3607736|NCT02832375|3458615|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3607737|NCT02832375|3458613|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3607738|NCT02832375|3458614|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3607739|NCT02832375|3458615|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3607740|NCT02832375|3458613|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3607741|NCT02832375|3458614|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3607742|NCT02832375|3458615|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3607743|NCT02832375|3458613|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3607744|NCT02832375|3458614|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3607745|NCT02832375|3458615|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3607746|NCT02832375|3458613|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607747|NCT02832375|3458614|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607748|NCT02832375|3458615|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607749|NCT02832375|3458613|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|196|196.0||||||
3607750|NCT02832375|3458614|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
3607751|NCT02832375|3458615|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3607752|NCT02832375|3458613|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3607753|NCT02832375|3458614|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3607754|NCT02832375|3458615|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3607755|NCT02832375|3458613|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3607756|NCT02832375|3458614|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3607757|NCT02832375|3458615|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3607758|NCT02832375|3458613|B3||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3607759|NCT02832375|3458614|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3607760|NCT02832375|3458615|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3607761|NCT02832375|3458613|B3|||Age||Years|Mean|37.7|37.7|Standard Deviation|11.15|11.15|||
3607762|NCT02832375|3458614|B2|||Age||Years|Mean|37.4|37.4|Standard Deviation|11.01|11.01|||
3607763|NCT02832375|3458615|B1|||Age||Years|Mean|38.0|38.0|Standard Deviation|11.32|11.32|||
3607764|NCT02832284|3458626|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
3607765|NCT02832284|3458626|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3607766|NCT02832284|3458626|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3607767|NCT02832284|3458626|B1|||Age||years|Mean|68.0|68.0|Full Range|||48.0|89.0|
3607768|NCT02831660|3458634|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3607769|NCT02831660|3458634|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3607770|NCT02831660|3458634|B1|||Age||years|Mean|82|82.0|Standard Deviation|||||
3607771|NCT02831569|3458638|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3607773|NCT02831569|3458638|B1|||Age||Years|Mean|50.8|50.8|Standard Deviation|12.4|12.4|||
3607774|NCT02831387|3458643|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
3607775|NCT02831387|3458644|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
3607776|NCT02831387|3458645|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
3607777|NCT02831387|3458643|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607778|NCT02831387|3458644|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607779|NCT02831387|3458645|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607780|NCT02831387|3458643|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3607781|NCT02831387|3458644|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3607782|NCT02831387|3458645|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3607783|NCT02831387|3458643|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3607784|NCT02831387|3458644|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3607785|NCT02831387|3458645|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3607786|NCT02831387|3458643|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3607787|NCT02831387|3458644|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3607788|NCT02831387|3458645|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3607789|NCT02831387|3458643|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3607790|NCT02831387|3458644|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3607791|NCT02831387|3458645|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3607792|NCT02831387|3458643|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3607793|NCT02831387|3458644|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3607794|NCT02831387|3458645|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3607795|NCT02831387|3458643|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3607796|NCT02831387|3458644|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3607797|NCT02831387|3458645|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3607798|NCT02831387|3458643|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3607799|NCT02831387|3458644|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3607800|NCT02831387|3458645|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3607801|NCT02830087|3458664|B7|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3607802|NCT02830087|3458665|B6|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3607803|NCT02830087|3458666|B5|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3607804|NCT02830087|3458667|B4|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3607805|NCT02830087|3458668|B3|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3607806|NCT02830087|3458669|B2|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3607807|NCT02830087|3458670|B1|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3607808|NCT02830087|3458664|B7||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3607809|NCT02830087|3458665|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3607810|NCT02830087|3458666|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3607811|NCT02830087|3458667|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3607812|NCT02830087|3458668|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3607813|NCT02830087|3458669|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3607814|NCT02830087|3458670|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3607815|NCT02830087|3458664|B7||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3607816|NCT02830087|3458665|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3607817|NCT02830087|3458666|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3607818|NCT02830087|3458667|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3607819|NCT02830087|3458668|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3607820|NCT02830087|3458669|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3607821|NCT02830087|3458670|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3607822|NCT02830087|3458664|B7|||Age||years|Mean|61.3|61.3|Standard Deviation|9.6|9.6|||
3607823|NCT02830087|3458665|B6|||Age||years|Mean|73.7|73.7|Standard Deviation|2.1|2.1|||
3607824|NCT02830087|3458666|B5|||Age||years|Mean|50.7|50.7|Standard Deviation|7.2|7.2|||
3607825|NCT02830087|3458667|B4|||Age||years|Mean|63.7|63.7|Standard Deviation|13.2|13.2|||
3607826|NCT02830087|3458668|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|8.9|8.9|||
3607827|NCT02830087|3458669|B2|||Age||years|Mean|58.3|58.3|Standard Deviation|8.9|8.9|||
3607828|NCT02830087|3458670|B1|||Age||years|Mean|63|63.0|Standard Deviation|6.7|6.7|||
3607829|NCT02830087|3458664|B7||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3607830|NCT02830087|3458665|B6||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3607831|NCT02830087|3458666|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3607832|NCT02830087|3458667|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3607833|NCT02830087|3458668|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3607834|NCT02830087|3458669|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3607835|NCT02830087|3458670|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3607836|NCT02830087|3458664|B7||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3607837|NCT02830087|3458665|B6||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3607838|NCT02830087|3458666|B5||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3607839|NCT02830087|3458667|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3607840|NCT02830087|3458668|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3607841|NCT02830087|3458669|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3607842|NCT02830087|3458670|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3607843|NCT02830087|3458664|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3607844|NCT02830087|3458665|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3607845|NCT02830087|3458666|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3607846|NCT02830087|3458667|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3607847|NCT02830087|3458668|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3607848|NCT02830087|3458669|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3607849|NCT02830087|3458670|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3607850|NCT02829996|3458737|B6|||Baseline IOP|mm of mercury on Goldmann Applanation Tonometry|mm of mercury|Mean|27.38|27.38|Standard Deviation|2.323|2.323|||
3607851|NCT02829996|3458738|B5|||Baseline IOP|mm of mercury on Goldmann Applanation Tonometry|mm of mercury|Mean|27.31|27.31|Standard Deviation|2.276|2.276|||
3607852|NCT02829996|3458739|B4|||Baseline IOP|mm of mercury on Goldmann Applanation Tonometry|mm of mercury|Mean|27.48|27.48|Standard Deviation|2.627|2.627|||
3607853|NCT02829996|3458740|B3|||Baseline IOP|mm of mercury on Goldmann Applanation Tonometry|mm of mercury|Mean|27.28|27.28|Standard Deviation|2.155|2.155|||
3607854|NCT02829996|3458741|B2|||Baseline IOP|mm of mercury on Goldmann Applanation Tonometry|mm of mercury|Mean|27.17|27.17|Standard Deviation|2.278|2.278|||
3607855|NCT02829996|3458742|B1|||Baseline IOP|mm of mercury on Goldmann Applanation Tonometry|mm of mercury|Mean|27.67|27.67|Standard Deviation|2.329|2.329|||
3607856|NCT02829996|3458737|B6|United States||Region of Enrollment||participants|Number|201|201.0||||||
3607857|NCT02829996|3458738|B5|United States||Region of Enrollment||participants|Number|42|42.0||||||
3607858|NCT02829996|3458739|B4|United States||Region of Enrollment||participants|Number|41|41.0||||||
3607859|NCT02829996|3458740|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3607860|NCT02829996|3458741|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
3607861|NCT02829996|3458742|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
3607862|NCT02829996|3458737|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607863|NCT02829996|3458738|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607864|NCT02829996|3458739|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607865|NCT02829996|3458740|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607866|NCT02829996|3458741|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607867|NCT02829996|3458742|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607868|NCT02829996|3458737|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607869|NCT02829996|3458738|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607870|NCT02829996|3458739|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607871|NCT02829996|3458740|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607872|NCT02829996|3458741|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607873|NCT02829996|3458742|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607874|NCT02829996|3458737|B6||White|Race (NIH/OMB)||Participants|Count of Participants|152|152.0||||||
3607875|NCT02829996|3458738|B5||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3607876|NCT02829996|3458739|B4||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3607877|NCT02829996|3458740|B3||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3607878|NCT02829996|3458741|B2||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3607879|NCT02829996|3458742|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3607880|NCT02829996|3458737|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3607881|NCT02829996|3458738|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3607882|NCT02829996|3458739|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3607883|NCT02829996|3458740|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3607884|NCT02829996|3458741|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3607885|NCT02829996|3458742|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3607886|NCT02829996|3458737|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607887|NCT02829996|3458738|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607888|NCT02829996|3458739|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607889|NCT02829996|3458740|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607890|NCT02829996|3458741|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607891|NCT02829996|3458742|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607892|NCT02829996|3458737|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3607893|NCT02829996|3458738|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607894|NCT02829996|3458739|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607895|NCT02829996|3458740|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3607896|NCT02829996|3458741|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3607897|NCT02829996|3458742|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3607898|NCT02829996|3458737|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3607899|NCT02829996|3458738|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607900|NCT02829996|3458739|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607901|NCT02829996|3458740|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607902|NCT02829996|3458741|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3607903|NCT02829996|3458742|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3607904|NCT02829996|3458737|B6||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3607905|NCT02829996|3458738|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3607906|NCT02829996|3458739|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3607907|NCT02829996|3458740|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3607908|NCT02829996|3458741|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3607909|NCT02829996|3458742|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3607910|NCT02829996|3458737|B6||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3607911|NCT02829996|3458738|B5||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3607912|NCT02829996|3458739|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3607913|NCT02829996|3458740|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3607914|NCT02829996|3458741|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3607915|NCT02829996|3458742|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3607916|NCT02829996|3458737|B6|||Age||years|Mean|66.0|66.0|Standard Deviation|9.74|9.74|||
3607917|NCT02829996|3458738|B5|||Age||years|Mean|66.4|66.4|Standard Deviation|8.57|8.57|||
3607918|NCT02829996|3458739|B4|||Age||years|Mean|66.5|66.5|Standard Deviation|9.84|9.84|||
3607919|NCT02829996|3458740|B3|||Age||years|Mean|68.8|68.8|Standard Deviation|8.43|8.43|||
3607920|NCT02829996|3458741|B2|||Age||years|Mean|64.4|64.4|Standard Deviation|9.18|9.18|||
3607921|NCT02829996|3458742|B1|||Age||years|Mean|64.1|64.1|Standard Deviation|12.08|12.08|||
3607922|NCT02829983|3458758|B3|||plaque index|Plaque index is the relation between the sites with deposits of plaque and the sites of full mouth divided for 100.|percentage of sites|Mean|60.5|60.5|Standard Deviation|2.12|2.12|||
3607923|NCT02829983|3458759|B2|||plaque index|Plaque index is the relation between the sites with deposits of plaque and the sites of full mouth divided for 100.|percentage of sites|Mean|62|62.0|Standard Deviation|25|25.0|||
3607924|NCT02829983|3458760|B1|||plaque index|Plaque index is the relation between the sites with deposits of plaque and the sites of full mouth divided for 100.|percentage of sites|Mean|59|59.0|Standard Deviation|23|23.0|||
3607925|NCT02829983|3458758|B3|||gingival recession||milimeter|Mean|0.12|0.12|Standard Deviation|0.028|0.028|||
3607926|NCT02829983|3458759|B2|||gingival recession||milimeter|Mean|0.1|0.1|Standard Deviation|0.12|0.12|||
3607927|NCT02829983|3458760|B1|||gingival recession||milimeter|Mean|0.14|0.14|Standard Deviation|0.16|0.16|||
3607928|NCT02829983|3458758|B3|||bleeding on probing||percentage of sites|Mean|53.5|53.5|Standard Deviation|0.7|0.7|||
3607929|NCT02829983|3458759|B2|||bleeding on probing||percentage of sites|Mean|54|54.0|Standard Deviation|30|30.0|||
3607930|NCT02829983|3458760|B1|||bleeding on probing||percentage of sites|Mean|53|53.0|Standard Deviation|19|19.0|||
3607931|NCT02829983|3458758|B3|||clinical attachment level||milimeter|Mean|3.55|3.55|Standard Deviation|0.1|0.1|||
3607932|NCT02829983|3458759|B2|||clinical attachment level||milimeter|Mean|3.63|3.63|Standard Deviation|0.7|0.7|||
3607933|NCT02829983|3458760|B1|||clinical attachment level||milimeter|Mean|3.48|3.48|Standard Deviation|0.66|0.66|||
3607934|NCT02829983|3458758|B3|||Probing depht||milimeter|Mean|3.43|3.43|Standard Deviation|0.13|0.13|||
3607935|NCT02829983|3458759|B2|||Probing depht||milimeter|Mean|3.53|3.53|Standard Deviation|0.6|0.6|||
3607936|NCT02829983|3458760|B1|||Probing depht||milimeter|Mean|3.34|3.34|Standard Deviation|0.56|0.56|||
3607937|NCT02829983|3458758|B3|Brazil||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3607938|NCT02829983|3458759|B2|Brazil||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3607939|NCT02829983|3458760|B1|Brazil||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3607940|NCT02829983|3458758|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3607941|NCT02829983|3458758|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3607942|NCT02829983|3458759|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3607943|NCT02829983|3458760|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3607944|NCT02829983|3458758|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3607945|NCT02829983|3458759|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3607946|NCT02829983|3458760|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3607947|NCT02829983|3458758|B3|||Age||years|Mean|31.32|31.32|Standard Deviation|0.10|0.1|||
3607948|NCT02829983|3458759|B2|||Age||years|Mean|31.25|31.25|Standard Deviation|4.6|4.6|||
3607949|NCT02829983|3458760|B1|||Age||years|Mean|31.4|31.4|Standard Deviation|3.7|3.7|||
3607950|NCT02829983|3458758|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3607951|NCT02829983|3458759|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3607952|NCT02829983|3458760|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3607953|NCT02829983|3458758|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3607954|NCT02829983|3458759|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3607955|NCT02829983|3458760|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3607956|NCT02829983|3458758|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3607957|NCT02829983|3458759|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3607958|NCT02829983|3458760|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3607959|NCT02829775|3458769|B1||Male|Gender||Participants|Count of Participants|7|7.0||||||
3607960|NCT02829775|3458769|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
3607961|NCT02829775|3458769|B1|||Age||years|Mean|48.1|48.1|Standard Deviation|18.3|18.3|||
3607962|NCT02829463|3458774|B3|||BMI||kg/(m^2)|Median|23.6|23.6|Standard Deviation|4.1|4.1|||
3607963|NCT02829463|3458775|B2|||BMI||kg/(m^2)|Median|22.6|22.6|Standard Deviation|4.4|4.4|||
3607964|NCT02829463|3458776|B1|||BMI||kg/(m^2)|Median|24.7|24.7|Standard Deviation|3.5|3.5|||
3607965|NCT02829463|3458774|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3607966|NCT02829463|3458775|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3607967|NCT02829463|3458776|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3607968|NCT02829463|3458774|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3607969|NCT02829463|3458775|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3607970|NCT02829463|3458776|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3607971|NCT02829463|3458774|B3|||Age||years|Mean|49.9|49.9|Standard Deviation|15.6|15.6|||
3607972|NCT02829463|3458775|B2|||Age||years|Mean|38.8|38.8|Standard Deviation|13.6|13.6|||
3607973|NCT02829463|3458776|B1|||Age||years|Mean|59.6|59.6|Standard Deviation|9.2|9.2|||
3607974|NCT02829320|3458783|B1||Maintenance dialysis|Dialysis Status|Dialysis newly started < 12 weeks before screening was considered as Newly started dialysis. Dialysis started >= 12 weeks before screening was considered as Maintenance dialysis.|Participants|Count of Participants|17|17.0||||||
3607975|NCT02829320|3458783|B1||Newly started dialysis|Dialysis Status|Dialysis newly started < 12 weeks before screening was considered as Newly started dialysis. Dialysis started >= 12 weeks before screening was considered as Maintenance dialysis.|Participants|Count of Participants|11|11.0||||||
3607976|NCT02829320|3458783|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Count of Participants|Number|28|28.0||||||
3607977|NCT02829320|3458783|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3607978|NCT02829320|3458783|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3607979|NCT02829320|3458783|B1|||Age||Years|Mean|62.5|62.5|Standard Deviation|10.16|10.16|||
3607980|NCT02829307|3458820|B1|White- White/Caucasian/ European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3607981|NCT02829307|3458820|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3607982|NCT02829307|3458820|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3607983|NCT02829307|3458820|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3607984|NCT02829307|3458820|B1|||Age||Years|Mean|55.0|55.0|Standard Deviation|2.33|2.33|||
3607985|NCT02829138|3458843|B3|Canada||Region of Enrollment||participants|Number|57|57.0||||||
3607986|NCT02829138|3458844|B2|Canada||Region of Enrollment||participants|Number|28|28.0||||||
3607987|NCT02829138|3458845|B1|Canada||Region of Enrollment||participants|Number|29|29.0||||||
3607988|NCT02829138|3458843|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3607989|NCT02829138|3458844|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3607990|NCT02829138|3458845|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3607991|NCT02829138|3458843|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3607992|NCT02829138|3458844|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3607993|NCT02829138|3458845|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3607994|NCT02829138|3458843|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3607995|NCT02829138|3458844|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3607996|NCT02829138|3458845|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3607997|NCT02829138|3458843|B3||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
3607998|NCT02829138|3458844|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3607999|NCT02829138|3458845|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3608000|NCT02829138|3458843|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3608001|NCT02829138|3458844|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3608002|NCT02829138|3458845|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3608003|NCT02828137|3458856|B4|Korea, Republic of||Region of Enrollment|Incheon Province in the Western part of South Korea|participants|Number|123|123.0||||||
3608004|NCT02828137|3458857|B3|Korea, Republic of||Region of Enrollment|Incheon Province in the Western part of South Korea|participants|Number|41|41.0||||||
3608005|NCT02828137|3458858|B2|Korea, Republic of||Region of Enrollment|Incheon Province in the Western part of South Korea|participants|Number|41|41.0||||||
3608006|NCT02828137|3458859|B1|Korea, Republic of||Region of Enrollment|Incheon Province in the Western part of South Korea|participants|Number|41|41.0||||||
3608007|NCT02828137|3458856|B4||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3608008|NCT02828137|3458857|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3608009|NCT02828137|3458858|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3608010|NCT02828137|3458859|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3608011|NCT02828137|3458856|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3608012|NCT02828137|3458857|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3608013|NCT02828137|3458858|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3608014|NCT02828137|3458859|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3608015|NCT02828137|3458856|B4|||Age||YEARS|Mean|57|57.0|Standard Deviation|12|12.0|||
3608016|NCT02828137|3458857|B3|||Age||YEARS|Mean|58|58.0|Standard Deviation|12|12.0|||
3608017|NCT02828137|3458858|B2|||Age||YEARS|Mean|55|55.0|Standard Deviation|11|11.0|||
3608018|NCT02828137|3458859|B1|||Age||YEARS|Mean|55|55.0|Standard Deviation|10|10.0|||
3608019|NCT02828137|3458856|B4||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
3608020|NCT02828137|3458857|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3608021|NCT02828137|3458858|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3608022|NCT02828137|3458859|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3608023|NCT02828137|3458856|B4||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
3608024|NCT02828137|3458857|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3608025|NCT02828137|3458858|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3608026|NCT02828137|3458859|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3608027|NCT02828137|3458856|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3608028|NCT02828137|3458857|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3608029|NCT02828137|3458858|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3608030|NCT02828137|3458859|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3608031|NCT02826551|3458869|B3|||Subjects Injected or Not Injected||participants|Number|23|23.0||||||
3608032|NCT02826551|3458870|B2|||Subjects Injected or Not Injected||participants|Number|12|12.0||||||
3608033|NCT02826551|3458871|B1|||Subjects Injected or Not Injected||participants|Number|11|11.0||||||
3608034|NCT02826551|3458869|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3608035|NCT02826551|3458870|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3608036|NCT02826551|3458871|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3608037|NCT02826551|3458869|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608038|NCT02826551|3458870|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608039|NCT02826551|3458871|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608040|NCT02826551|3458869|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608041|NCT02826551|3458870|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608042|NCT02826551|3458871|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608043|NCT02826551|3458869|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608044|NCT02826551|3458870|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608045|NCT02826551|3458871|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608046|NCT02826551|3458869|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608047|NCT02826551|3458870|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608048|NCT02826551|3458871|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608049|NCT02826551|3458869|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608050|NCT02826551|3458870|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608051|NCT02826551|3458871|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608052|NCT02826551|3458869|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608053|NCT02826551|3458870|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608054|NCT02826551|3458871|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608055|NCT02826551|3458869|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3608056|NCT02826551|3458870|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3608057|NCT02826551|3458871|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3608058|NCT02826551|3458869|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3608059|NCT02826551|3458870|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3608060|NCT02826551|3458871|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3608061|NCT02826551|3458869|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3608062|NCT02826551|3458870|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3608063|NCT02826551|3458871|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3608064|NCT02826551|3458869|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3608065|NCT02826551|3458870|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3608066|NCT02826551|3458871|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3608067|NCT02826551|3458869|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3608068|NCT02826551|3458870|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3608069|NCT02826551|3458871|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3608070|NCT02826421|3458880|B5||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3608071|NCT02826421|3458881|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3608072|NCT02826421|3458882|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3608073|NCT02826421|3458883|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3608074|NCT02826421|3458884|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3608075|NCT02826421|3458880|B5||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3608076|NCT02826421|3458881|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3608077|NCT02826421|3458882|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3608078|NCT02826421|3458883|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3608079|NCT02826421|3458884|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3608080|NCT02826421|3458880|B5|||Age||years|Mean|71.9|71.9|Standard Deviation|7.73|7.73|||
3608081|NCT02826421|3458881|B4|||Age||years|Mean|72.5|72.5|Standard Deviation|7.10|7.1|||
3608082|NCT02826421|3458882|B3|||Age||years|Mean|73.0|73.0|Standard Deviation|7.27|7.27|||
3608083|NCT02826421|3458883|B2|||Age||years|Mean|70.7|70.7|Standard Deviation|8.31|8.31|||
3608084|NCT02826421|3458884|B1|||Age||years|Mean|71.4|71.4|Standard Deviation|8.71|8.71|||
3608085|NCT02825550|3458899|B1|Taiwan||Region of Enrollment||participants|Number|12|12.0||||||
3608086|NCT02825550|3458899|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3608087|NCT02825550|3458899|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3608088|NCT02825550|3458899|B1|||Age||years|Mean|71|71.0|Standard Deviation|8|8.0|||
3608089|NCT02825550|3458899|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3608090|NCT02825550|3458899|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3608091|NCT02825550|3458899|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3608092|NCT02825251|3458905|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3608093|NCT02825251|3458906|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3608094|NCT02825251|3458907|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3608095|NCT02825251|3458905|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608096|NCT02825251|3458906|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608097|NCT02825251|3458907|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608098|NCT02825251|3458905|B3||White|Race (NIH/OMB)||Participants|Count of Participants|419|419.0||||||
3608099|NCT02825251|3458906|B2||White|Race (NIH/OMB)||Participants|Count of Participants|210|210.0||||||
3608100|NCT02825251|3458907|B1||White|Race (NIH/OMB)||Participants|Count of Participants|209|209.0||||||
3608101|NCT02825251|3458905|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3608102|NCT02825251|3458906|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3608103|NCT02825251|3458907|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3608104|NCT02825251|3458905|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608105|NCT02825251|3458906|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608106|NCT02825251|3458907|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608107|NCT02825251|3458905|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3608108|NCT02825251|3458906|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3608109|NCT02825251|3458907|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3608110|NCT02825251|3458905|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3608111|NCT02825251|3458906|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3608112|NCT02825251|3458907|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608113|NCT02825251|3458905|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3608114|NCT02825251|3458906|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3608115|NCT02825251|3458907|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3608116|NCT02825251|3458905|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|425|425.0||||||
3608117|NCT02825251|3458906|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|215|215.0||||||
3608118|NCT02825251|3458907|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|210|210.0||||||
3608119|NCT02825251|3458905|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3608120|NCT02825251|3458906|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3608121|NCT02825251|3458907|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3608122|NCT02825251|3458905|B3||Male|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
3608123|NCT02825251|3458906|B2||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3608124|NCT02825251|3458907|B1||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3608125|NCT02825251|3458905|B3||Female|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
3608126|NCT02825251|3458906|B2||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3608127|NCT02825251|3458907|B1||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3608128|NCT02825251|3458905|B3|||Age||Years|Mean|43.5|43.5|Standard Deviation|14.7|14.7|||
3608129|NCT02825251|3458906|B2|||Age||Years|Mean|43.6|43.6|Standard Deviation|14.7|14.7|||
3608130|NCT02825251|3458907|B1|||Age||Years|Mean|43.3|43.3|Standard Deviation|14.8|14.8|||
3608131|NCT02824913|3459094|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3608132|NCT02824913|3459096|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3608133|NCT02824913|3459094|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608134|NCT02824913|3459095|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608135|NCT02824913|3459096|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608136|NCT02824913|3459094|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608137|NCT02824913|3459095|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608138|NCT02824913|3459096|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608139|NCT02824913|3459094|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3608140|NCT02824913|3459095|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608141|NCT02824913|3459096|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3608142|NCT02824913|3459094|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3608143|NCT02824913|3459095|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3608144|NCT02824913|3459096|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3608145|NCT02824913|3459094|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3608146|NCT02824913|3459095|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3608147|NCT02824913|3459096|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3608148|NCT02824913|3459094|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3608149|NCT02824913|3459095|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3608150|NCT02824913|3459096|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3608151|NCT02824913|3459094|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3608152|NCT02824913|3459095|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3608153|NCT02824913|3459096|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3608154|NCT02824913|3459094|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3608155|NCT02824913|3459095|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3608156|NCT02824913|3459096|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3608157|NCT02824562|3459109|B3|||Number of participants with undetectable viral load (blood test, measured in copies/mL)||Participants|Count of Participants|42|42.0||||||
3608158|NCT02824562|3459110|B2|||Number of participants with undetectable viral load (blood test, measured in copies/mL)||Participants|Count of Participants|21|21.0||||||
3608159|NCT02824562|3459111|B1|||Number of participants with undetectable viral load (blood test, measured in copies/mL)||Participants|Count of Participants|21|21.0||||||
3608160|NCT02824562|3459109|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3608161|NCT02824562|3459110|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3608162|NCT02824562|3459111|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608163|NCT02824562|3459109|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608164|NCT02824562|3459110|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608165|NCT02824562|3459111|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608166|NCT02824562|3459109|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3608167|NCT02824562|3459110|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3608168|NCT02824562|3459111|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3608169|NCT02824562|3459109|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3608170|NCT02824562|3459110|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3608171|NCT02824562|3459111|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3608172|NCT02824562|3459109|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608173|NCT02824562|3459110|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608174|NCT02824562|3459111|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608175|NCT02824562|3459109|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608176|NCT02824562|3459110|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608177|NCT02824562|3459111|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608178|NCT02824562|3459109|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608179|NCT02824562|3459110|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608180|NCT02824562|3459111|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608181|NCT02824562|3459109|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3608182|NCT02824562|3459110|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3608183|NCT02824562|3459111|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3608184|NCT02824562|3459109|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3608185|NCT02824562|3459110|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3608186|NCT02824562|3459111|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3608187|NCT02824562|3459109|B3|||Age||years|Median|51|51.0|Inter-Quartile Range|||46.0|57.0|
3608188|NCT02824562|3459110|B2|||Age||years|Median|51|51.0|Inter-Quartile Range|||46.0|57.0|
3608189|NCT02824562|3459111|B1|||Age||years|Median|51|51.0|Inter-Quartile Range|||48.0|55.0|
3608190|NCT02823964|3459119|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608191|NCT02823964|3459119|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608192|NCT02823964|3459119|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3608193|NCT02823964|3459119|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608194|NCT02823964|3459119|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608195|NCT02823964|3459119|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608196|NCT02823964|3459119|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608197|NCT02823964|3459119|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3608198|NCT02823964|3459119|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3608199|NCT02823964|3459119|B1|||Age||years|Mean|22.94|22.94|Standard Deviation|6.84|6.84|||
3608200|NCT02823600|3459123|B1|Diabetes: No||Diabetic dialysis population|Proportion of entire study population with a diabetes mellitus (DM) diagnosis.|Participants|Count of Participants|31|31.0||||||
3608201|NCT02823600|3459123|B1|Diabetes: Yes||Diabetic dialysis population|Proportion of entire study population with a diabetes mellitus (DM) diagnosis.|Participants|Count of Participants|37|37.0||||||
3608202|NCT02823600|3459123|B1|Data Missing||End-Stage Renal Disease Etiology|"This measure is divided into categories by referral status, which is used as a proxy for retinal disease severity. With no retinopathy as the least severe or no disease and retinopathy with referral as the most severe."|Participants|Count of Participants|7|7.0||||||
3608203|NCT02823600|3459123|B1|Other: Retinopathy with referral||End-Stage Renal Disease Etiology|"This measure is divided into categories by referral status, which is used as a proxy for retinal disease severity. With no retinopathy as the least severe or no disease and retinopathy with referral as the most severe."|Participants|Count of Participants|4|4.0||||||
3608204|NCT02823600|3459123|B1|Other: Retinopathy without referral||End-Stage Renal Disease Etiology|"This measure is divided into categories by referral status, which is used as a proxy for retinal disease severity. With no retinopathy as the least severe or no disease and retinopathy with referral as the most severe."|Participants|Count of Participants|2|2.0||||||
3608205|NCT02823600|3459123|B1|Other: No retinopathy||End-Stage Renal Disease Etiology|"This measure is divided into categories by referral status, which is used as a proxy for retinal disease severity. With no retinopathy as the least severe or no disease and retinopathy with referral as the most severe."|Participants|Count of Participants|13|13.0||||||
3608206|NCT02823600|3459123|B1|Hypertension: Retinopathy with referral||End-Stage Renal Disease Etiology|"This measure is divided into categories by referral status, which is used as a proxy for retinal disease severity. With no retinopathy as the least severe or no disease and retinopathy with referral as the most severe."|Participants|Count of Participants|7|7.0||||||
3608207|NCT02823600|3459123|B1|Hypertension: Retinopathy without referral||End-Stage Renal Disease Etiology|"This measure is divided into categories by referral status, which is used as a proxy for retinal disease severity. With no retinopathy as the least severe or no disease and retinopathy with referral as the most severe."|Participants|Count of Participants|1|1.0||||||
3608208|NCT02823600|3459123|B1|Hypertension: No retinopathy||End-Stage Renal Disease Etiology|"This measure is divided into categories by referral status, which is used as a proxy for retinal disease severity. With no retinopathy as the least severe or no disease and retinopathy with referral as the most severe."|Participants|Count of Participants|12|12.0||||||
3608209|NCT02823600|3459123|B1|Diabetes: Retinopathy with referral||End-Stage Renal Disease Etiology|"This measure is divided into categories by referral status, which is used as a proxy for retinal disease severity. With no retinopathy as the least severe or no disease and retinopathy with referral as the most severe."|Participants|Count of Participants|13|13.0||||||
3608210|NCT02823600|3459123|B1|Diabetes: Retinopathy without referral||End-Stage Renal Disease Etiology|"This measure is divided into categories by referral status, which is used as a proxy for retinal disease severity. With no retinopathy as the least severe or no disease and retinopathy with referral as the most severe."|Participants|Count of Participants|8|8.0||||||
3608211|NCT02823600|3459123|B1|Diabetes: No retinopathy||End-Stage Renal Disease Etiology|"This measure is divided into categories by referral status, which is used as a proxy for retinal disease severity. With no retinopathy as the least severe or no disease and retinopathy with referral as the most severe."|Participants|Count of Participants|7|7.0||||||
3608212|NCT02823600|3459123|B1|Data Missing||Race/Ethnicity, Customized|"This measure is divided into categories by referral status, which is used as a proxy for retinal disease severity. With no retinopathy as the least severe or no disease and retinopathy with referral as the most severe."|Participants|Count of Participants|1|1.0||||||
3608213|NCT02823600|3459123|B1|Hispanic: Retinopathy with referral||Race/Ethnicity, Customized|"This measure is divided into categories by referral status, which is used as a proxy for retinal disease severity. With no retinopathy as the least severe or no disease and retinopathy with referral as the most severe."|Participants|Count of Participants|4|4.0||||||
3608214|NCT02823600|3459123|B1|Hispanic: Retinopathy without referral||Race/Ethnicity, Customized|"This measure is divided into categories by referral status, which is used as a proxy for retinal disease severity. With no retinopathy as the least severe or no disease and retinopathy with referral as the most severe."|Participants|Count of Participants|2|2.0||||||
3608215|NCT02823600|3459123|B1|Hispanic: No retinopathy||Race/Ethnicity, Customized|"This measure is divided into categories by referral status, which is used as a proxy for retinal disease severity. With no retinopathy as the least severe or no disease and retinopathy with referral as the most severe."|Participants|Count of Participants|8|8.0||||||
3608216|NCT02823600|3459123|B1|Caucasian: Retinopathy with referral||Race/Ethnicity, Customized|"This measure is divided into categories by referral status, which is used as a proxy for retinal disease severity. With no retinopathy as the least severe or no disease and retinopathy with referral as the most severe."|Participants|Count of Participants|8|8.0||||||
3608217|NCT02823600|3459123|B1|Caucasian: Retinopathy without referral||Race/Ethnicity, Customized|"This measure is divided into categories by referral status, which is used as a proxy for retinal disease severity. With no retinopathy as the least severe or no disease and retinopathy with referral as the most severe."|Participants|Count of Participants|3|3.0||||||
3608218|NCT02823600|3459123|B1|Caucasian: No retinopathy||Race/Ethnicity, Customized|"This measure is divided into categories by referral status, which is used as a proxy for retinal disease severity. With no retinopathy as the least severe or no disease and retinopathy with referral as the most severe."|Participants|Count of Participants|11|11.0||||||
3608219|NCT02823600|3459123|B1|African American: Retinopathy with referral||Race/Ethnicity, Customized|"This measure is divided into categories by referral status, which is used as a proxy for retinal disease severity. With no retinopathy as the least severe or no disease and retinopathy with referral as the most severe."|Participants|Count of Participants|11|11.0||||||
3608220|NCT02823600|3459123|B1|African American: Retinopathy without referral||Race/Ethnicity, Customized|"This measure is divided into categories by referral status, which is used as a proxy for retinal disease severity. With no retinopathy as the least severe or no disease and retinopathy with referral as the most severe."|Participants|Count of Participants|6|6.0||||||
3608221|NCT02823600|3459123|B1|African American: No retinopathy||Race/Ethnicity, Customized|"This measure is divided into categories by referral status, which is used as a proxy for retinal disease severity. With no retinopathy as the least severe or no disease and retinopathy with referral as the most severe."|Participants|Count of Participants|14|14.0||||||
3608222|NCT02823600|3459123|B1|Male : Retinopathy with referral||Sex/Gender, Customized|"This measure is divided into categories by referral status, which is used as a proxy for retinal disease severity. With no retinopathy as the least severe or no disease and retinopathy with referral as the most severe."|Participants|Count of Participants|18|18.0||||||
3608223|NCT02823600|3459123|B1|Male : Retinopathy without referral||Sex/Gender, Customized|"This measure is divided into categories by referral status, which is used as a proxy for retinal disease severity. With no retinopathy as the least severe or no disease and retinopathy with referral as the most severe."|Participants|Count of Participants|5|5.0||||||
3608224|NCT02823600|3459123|B1|Male : No retinopathy||Sex/Gender, Customized|"This measure is divided into categories by referral status, which is used as a proxy for retinal disease severity. With no retinopathy as the least severe or no disease and retinopathy with referral as the most severe."|Participants|Count of Participants|16|16.0||||||
3608225|NCT02823600|3459123|B1|Female : Retinopathy with referral||Sex/Gender, Customized|"This measure is divided into categories by referral status, which is used as a proxy for retinal disease severity. With no retinopathy as the least severe or no disease and retinopathy with referral as the most severe."|Participants|Count of Participants|6|6.0||||||
3608226|NCT02823600|3459123|B1|Female : Retinopathy without referral||Sex/Gender, Customized|"This measure is divided into categories by referral status, which is used as a proxy for retinal disease severity. With no retinopathy as the least severe or no disease and retinopathy with referral as the most severe."|Participants|Count of Participants|6|6.0||||||
3608227|NCT02823600|3459123|B1|Female : No retinopathy||Sex/Gender, Customized|"This measure is divided into categories by referral status, which is used as a proxy for retinal disease severity. With no retinopathy as the least severe or no disease and retinopathy with referral as the most severe."|Participants|Count of Participants|17|17.0||||||
3608228|NCT02823600|3459123|B1|Retinopathy with referral||Age, Customized|"This measure is divided into categories by referral status, which is used as a proxy for retinal disease severity. With no retinopathy as the least severe or no disease and retinopathy with referral as the most severe."|years|Mean|57.1|57.1|Standard Deviation|11.6|11.6|||
3608229|NCT02823600|3459123|B1|Retinopathy without referral||Age, Customized|"This measure is divided into categories by referral status, which is used as a proxy for retinal disease severity. With no retinopathy as the least severe or no disease and retinopathy with referral as the most severe."|years|Mean|60.0|60.0|Standard Deviation|6.6|6.6|||
3608230|NCT02823600|3459123|B1|No retinopathy||Age, Customized|"This measure is divided into categories by referral status, which is used as a proxy for retinal disease severity. With no retinopathy as the least severe or no disease and retinopathy with referral as the most severe."|years|Mean|54.7|54.7|Standard Deviation|18.1|18.1|||
3608231|NCT02823470|3459131|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608232|NCT02823470|3459132|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608233|NCT02823470|3459133|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608234|NCT02823470|3459131|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608235|NCT02823470|3459132|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608236|NCT02823470|3459133|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608237|NCT02823470|3459131|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3608238|NCT02823470|3459132|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3608239|NCT02823470|3459133|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3608240|NCT02823470|3459131|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608241|NCT02823470|3459132|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608242|NCT02823470|3459133|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608243|NCT02823470|3459131|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608244|NCT02823470|3459132|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608245|NCT02823470|3459133|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608246|NCT02823470|3459131|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608247|NCT02823470|3459132|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608248|NCT02823470|3459133|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608249|NCT02823470|3459131|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608250|NCT02823470|3459132|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608251|NCT02823470|3459133|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608252|NCT02823470|3459131|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608253|NCT02823470|3459132|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608254|NCT02823470|3459133|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608255|NCT02823470|3459131|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3608256|NCT02823470|3459132|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3608257|NCT02823470|3459133|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3608258|NCT02823470|3459131|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608259|NCT02823470|3459132|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608260|NCT02823470|3459133|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608261|NCT02823470|3459131|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3608262|NCT02823470|3459132|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3608263|NCT02823470|3459133|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3608264|NCT02823470|3459131|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3608265|NCT02823470|3459132|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3608266|NCT02823470|3459133|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3608267|NCT02823470|3459131|B3|||Age||Years|Mean|23.5|23.5|Standard Deviation|8.6|8.6|||
3608268|NCT02823470|3459132|B2|||Age||Years|Mean|25.1|25.1|Standard Deviation|10.3|10.3|||
3608269|NCT02823470|3459133|B1|||Age||Years|Mean|20.8|20.8|Standard Deviation|4.0|4.0|||
3608270|NCT02823431|3459146|B3|||BMI||kg/m^2|Mean|24|24.0|Standard Deviation|4.5|4.5|||
3608271|NCT02823431|3459147|B2|||BMI||kg/m^2|Mean|25|25.0|Standard Deviation|5|5.0|||
3608272|NCT02823431|3459148|B1|||BMI||kg/m^2|Mean|23|23.0|Standard Deviation|3.7|3.7|||
3608273|NCT02823431|3459146|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
3608274|NCT02823431|3459147|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3608275|NCT02823431|3459148|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3608276|NCT02823431|3459146|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608277|NCT02823431|3459147|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608278|NCT02823431|3459148|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608279|NCT02823431|3459146|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608280|NCT02823431|3459147|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608281|NCT02823431|3459148|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608282|NCT02823431|3459146|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3608283|NCT02823431|3459147|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3608284|NCT02823431|3459148|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3608285|NCT02823431|3459146|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3608286|NCT02823431|3459147|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3608287|NCT02823431|3459148|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3608288|NCT02823431|3459146|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608289|NCT02823431|3459147|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608290|NCT02823431|3459148|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608291|NCT02823431|3459146|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3608292|NCT02823431|3459147|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608293|NCT02823431|3459148|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3608294|NCT02823431|3459146|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608295|NCT02823431|3459147|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608296|NCT02823431|3459148|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608297|NCT02823431|3459146|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3608298|NCT02823431|3459147|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3608299|NCT02823431|3459148|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3608300|NCT02823431|3459146|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3608301|NCT02823431|3459147|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3608302|NCT02823431|3459148|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3608303|NCT02823431|3459146|B3|||Age||years|Mean|31.7|31.7|Standard Deviation|9.4|9.4|||
3608304|NCT02823431|3459147|B2|||Age||years|Mean|33|33.0|Standard Deviation|9.2|9.2|||
3608305|NCT02823431|3459148|B1|||Age||years|Mean|30|30.0|Standard Deviation|9.6|9.6|||
3608306|NCT02823080|3459161|B3|Saudi Arabia||Region of Enrollment||participants|Number|24|24.0||||||
3608307|NCT02823080|3459162|B2|Saudi Arabia||Region of Enrollment||participants|Number|12|12.0||||||
3608308|NCT02823080|3459163|B1|Saudi Arabia||Region of Enrollment||participants|Number|12|12.0||||||
3608309|NCT02823080|3459161|B3|Egypt||Region of Enrollment||participants|Number|24|24.0||||||
3608310|NCT02823080|3459162|B2|Egypt||Region of Enrollment||participants|Number|12|12.0||||||
3608311|NCT02823080|3459163|B1|Egypt||Region of Enrollment||participants|Number|12|12.0||||||
3608312|NCT02823080|3459161|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608313|NCT02823080|3459162|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608314|NCT02823080|3459163|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608315|NCT02823080|3459161|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3608316|NCT02823080|3459162|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3608317|NCT02823080|3459163|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3608318|NCT02823080|3459161|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608319|NCT02823080|3459162|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608320|NCT02823080|3459163|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608321|NCT02823080|3459161|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608322|NCT02823080|3459162|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608323|NCT02823080|3459163|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608324|NCT02823080|3459161|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608325|NCT02823080|3459162|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608326|NCT02823080|3459163|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608327|NCT02823080|3459161|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608328|NCT02823080|3459162|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608329|NCT02823080|3459163|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608330|NCT02823080|3459161|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608331|NCT02823080|3459162|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608332|NCT02823080|3459163|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608333|NCT02823080|3459161|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3608334|NCT02823080|3459162|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3608335|NCT02823080|3459163|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3608336|NCT02823080|3459161|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3608337|NCT02823080|3459162|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3608338|NCT02823080|3459163|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3608339|NCT02823080|3459161|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3608340|NCT02823080|3459162|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3608341|NCT02823080|3459163|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3608342|NCT02823080|3459161|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
3608343|NCT02823080|3459162|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3608344|NCT02823080|3459163|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3608345|NCT02823080|3459161|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3608346|NCT02823080|3459162|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3608347|NCT02823080|3459163|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3608348|NCT02822885|3459182|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3608349|NCT02822885|3459182|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3608350|NCT02822885|3459182|B1|||Age, Customized||years|Mean|59.85|59.85|Standard Deviation|4|4.0|||
3608351|NCT02822794|3459190|B5||≥ 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|92|92.0||||||
3608352|NCT02822794|3459191|B4||≥ 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|8|8.0||||||
3608353|NCT02822794|3459192|B3||≥ 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|38|38.0||||||
3608354|NCT02822794|3459193|B2||≥ 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|9|9.0||||||
3608355|NCT02822794|3459194|B1||≥ 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|37|37.0||||||
3608356|NCT02822794|3459190|B5||< 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|25|25.0||||||
3608357|NCT02822794|3459191|B4||< 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|4|4.0||||||
3608358|NCT02822794|3459192|B3||< 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|10|10.0||||||
3608359|NCT02822794|3459193|B2||< 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|1|1.0||||||
3608360|NCT02822794|3459194|B1||< 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|10|10.0||||||
3608361|NCT02822794|3459190|B5|||HCV RNA (log10 IU/mL)||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|.54|0.54|||
3608362|NCT02822794|3459191|B4|||HCV RNA (log10 IU/mL)||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|.86|0.86|||
3608363|NCT02822794|3459192|B3|||HCV RNA (log10 IU/mL)||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|.51|0.51|||
3608364|NCT02822794|3459193|B2|||HCV RNA (log10 IU/mL)||log10 IU/mL|Mean|6.6|6.6|Standard Deviation|.46|0.46|||
3608365|NCT02822794|3459194|B1|||HCV RNA (log10 IU/mL)||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|.47|0.47|||
3608366|NCT02822794|3459190|B5||TT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|12|12.0||||||
3608367|NCT02822794|3459191|B4||TT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|0|0.0||||||
3608368|NCT02822794|3459192|B3||TT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|7|7.0||||||
3608369|NCT02822794|3459193|B2||TT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|1|1.0||||||
3608370|NCT02822794|3459194|B1||TT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|4|4.0||||||
3608371|NCT02822794|3459190|B5||CT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|55|55.0||||||
3608372|NCT02822794|3459191|B4||CT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|6|6.0||||||
3608373|NCT02822794|3459192|B3||CT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|20|20.0||||||
3608374|NCT02822794|3459193|B2||CT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|1|1.0||||||
3608375|NCT02822794|3459194|B1||CT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|28|28.0||||||
3608376|NCT02822794|3459190|B5||CC|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|50|50.0||||||
3608377|NCT02822794|3459191|B4||CC|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|6|6.0||||||
3608378|NCT02822794|3459192|B3||CC|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|21|21.0||||||
3608379|NCT02822794|3459193|B2||CC|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|8|8.0||||||
3608380|NCT02822794|3459194|B1||CC|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|15|15.0||||||
3608381|NCT02822794|3459190|B5||Genotype 2 (No Confirmed Subtype)|HCV genotype||Participants|Count of Participants|9|9.0||||||
3608382|NCT02822794|3459191|B4||Genotype 2 (No Confirmed Subtype)|HCV genotype||Participants|Count of Participants|4|4.0||||||
3608383|NCT02822794|3459192|B3||Genotype 2 (No Confirmed Subtype)|HCV genotype||Participants|Count of Participants|0|0.0||||||
3608384|NCT02822794|3459193|B2||Genotype 2 (No Confirmed Subtype)|HCV genotype||Participants|Count of Participants|5|5.0||||||
3608385|NCT02822794|3459194|B1||Genotype 2 (No Confirmed Subtype)|HCV genotype||Participants|Count of Participants|0|0.0||||||
3608386|NCT02822794|3459190|B5||Genotype 2b|HCV genotype||Participants|Count of Participants|6|6.0||||||
3608387|NCT02822794|3459191|B4||Genotype 2b|HCV genotype||Participants|Count of Participants|4|4.0||||||
3608388|NCT02822794|3459192|B3||Genotype 2b|HCV genotype||Participants|Count of Participants|0|0.0||||||
3608389|NCT02822794|3459193|B2||Genotype 2b|HCV genotype||Participants|Count of Participants|2|2.0||||||
3608390|NCT02822794|3459194|B1||Genotype 2b|HCV genotype||Participants|Count of Participants|0|0.0||||||
3608391|NCT02822794|3459190|B5||Genotype 2a/2c|HCV genotype||Participants|Count of Participants|7|7.0||||||
3608392|NCT02822794|3459191|B4||Genotype 2a/2c|HCV genotype||Participants|Count of Participants|4|4.0||||||
3608393|NCT02822794|3459192|B3||Genotype 2a/2c|HCV genotype||Participants|Count of Participants|0|0.0||||||
3608394|NCT02822794|3459193|B2||Genotype 2a/2c|HCV genotype||Participants|Count of Participants|3|3.0||||||
3608395|NCT02822794|3459194|B1||Genotype 2a/2c|HCV genotype||Participants|Count of Participants|0|0.0||||||
3608396|NCT02822794|3459190|B5||Genotype 1b|HCV genotype||Participants|Count of Participants|92|92.0||||||
3608397|NCT02822794|3459191|B4||Genotype 1b|HCV genotype||Participants|Count of Participants|0|0.0||||||
3608398|NCT02822794|3459192|B3||Genotype 1b|HCV genotype||Participants|Count of Participants|47|47.0||||||
3608399|NCT02822794|3459193|B2||Genotype 1b|HCV genotype||Participants|Count of Participants|0|0.0||||||
3608400|NCT02822794|3459194|B1||Genotype 1b|HCV genotype||Participants|Count of Participants|45|45.0||||||
3608401|NCT02822794|3459190|B5||Genotype 1a|HCV genotype||Participants|Count of Participants|3|3.0||||||
3608402|NCT02822794|3459191|B4||Genotype 1a|HCV genotype||Participants|Count of Participants|0|0.0||||||
3608403|NCT02822794|3459192|B3||Genotype 1a|HCV genotype||Participants|Count of Participants|1|1.0||||||
3608404|NCT02822794|3459193|B2||Genotype 1a|HCV genotype||Participants|Count of Participants|0|0.0||||||
3608405|NCT02822794|3459194|B1||Genotype 1a|HCV genotype||Participants|Count of Participants|2|2.0||||||
3608406|NCT02822794|3459190|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|117|117.0||||||
3608407|NCT02822794|3459191|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3608408|NCT02822794|3459192|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
3608409|NCT02822794|3459193|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3608410|NCT02822794|3459194|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
3608411|NCT02822794|3459190|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|117|117.0||||||
3608412|NCT02822794|3459191|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3608413|NCT02822794|3459192|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
3608414|NCT02822794|3459193|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3608415|NCT02822794|3459194|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
3608416|NCT02822794|3459190|B5||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3608417|NCT02822794|3459191|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3608418|NCT02822794|3459192|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3608419|NCT02822794|3459193|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3608420|NCT02822794|3459194|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3608421|NCT02822794|3459190|B5||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3608422|NCT02822794|3459191|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3608423|NCT02822794|3459192|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3608424|NCT02822794|3459193|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3608425|NCT02822794|3459194|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3608426|NCT02822794|3459190|B5|||Age||years|Mean|63|63.0|Standard Deviation|10.3|10.3|||
3608427|NCT02822794|3459191|B4|||Age||years|Mean|61|61.0|Standard Deviation|7.2|7.2|||
3608428|NCT02822794|3459192|B3|||Age||years|Mean|64|64.0|Standard Deviation|10.1|10.1|||
3608429|NCT02822794|3459193|B2|||Age||years|Mean|59|59.0|Standard Deviation|15.7|15.7|||
3608430|NCT02822794|3459194|B1|||Age||years|Mean|63|63.0|Standard Deviation|9.7|9.7|||
3608431|NCT02822287|3459253|B1||Male|Gender||Participants|Count of Participants|24|24.0||||||
3608432|NCT02822287|3459253|B1||Female|Gender||Participants|Count of Participants|33|33.0||||||
3608433|NCT02822287|3459253|B1|||Age||Years|Mean|38.7|38.7|Standard Deviation|13.88|13.88|||
3608434|NCT02821455|3459263|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3608435|NCT02821455|3459263|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3608436|NCT02821455|3459263|B1|||Age||years|Mean|67.2|67.2|Standard Deviation|9.8|9.8|||
3608437|NCT02821403|3459268|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3608438|NCT02821403|3459269|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3608439|NCT02821403|3459270|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3608440|NCT02821403|3459268|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3608441|NCT02821403|3459269|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3608442|NCT02821403|3459270|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3608443|NCT02821403|3459268|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3608444|NCT02821403|3459269|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3608445|NCT02821403|3459270|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3608446|NCT02821403|3459268|B3||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
3608447|NCT02821403|3459269|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3608448|NCT02821403|3459270|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3608449|NCT02821403|3459268|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3608450|NCT02821403|3459269|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3608451|NCT02821403|3459270|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3608452|NCT02818244|3459289|B5|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3608453|NCT02818244|3459289|B5||Male|Sex: Female, Male||Heart Rate|Count of Units|46|46.0||||||
3608454|NCT02818244|3459290|B4||Male|Sex: Female, Male||Heart Rate|Count of Units|12|12.0||||||
3608455|NCT02818244|3459291|B3||Male|Sex: Female, Male||Heart Rate|Count of Units|10|10.0||||||
3608456|NCT02818244|3459292|B2||Male|Sex: Female, Male||Heart Rate|Count of Units|13|13.0||||||
3608457|NCT02818244|3459293|B1||Male|Sex: Female, Male||Heart Rate|Count of Units|11|11.0||||||
3608458|NCT02818244|3459289|B5||Female|Sex: Female, Male||Heart Rate|Count of Units|54|54.0||||||
3608459|NCT02818244|3459290|B4||Female|Sex: Female, Male||Heart Rate|Count of Units|13|13.0||||||
3608460|NCT02818244|3459291|B3||Female|Sex: Female, Male||Heart Rate|Count of Units|15|15.0||||||
3608461|NCT02818244|3459292|B2||Female|Sex: Female, Male||Heart Rate|Count of Units|12|12.0||||||
3608462|NCT02818244|3459293|B1||Female|Sex: Female, Male||Heart Rate|Count of Units|14|14.0||||||
3608463|NCT02818244|3459289|B5||>=65 years|Age||Heart Rate|Count of Units|0|0.0||||||
3608464|NCT02818244|3459290|B4||>=65 years|Age||Heart Rate|Count of Units|0|0.0||||||
3608465|NCT02818244|3459291|B3||>=65 years|Age||Heart Rate|Count of Units|0|0.0||||||
3608466|NCT02818244|3459292|B2||>=65 years|Age||Heart Rate|Count of Units|0|0.0||||||
3608467|NCT02818244|3459293|B1||>=65 years|Age||Heart Rate|Count of Units|0|0.0||||||
3608468|NCT02818244|3459289|B5||Between 18 and 65 years|Age||Heart Rate|Count of Units|100|100.0||||||
3608469|NCT02818244|3459290|B4||Between 18 and 65 years|Age||Heart Rate|Count of Units|25|25.0||||||
3608470|NCT02818244|3459291|B3||Between 18 and 65 years|Age||Heart Rate|Count of Units|25|25.0||||||
3608471|NCT02818244|3459292|B2||Between 18 and 65 years|Age||Heart Rate|Count of Units|25|25.0||||||
3608472|NCT02818244|3459293|B1||Between 18 and 65 years|Age||Heart Rate|Count of Units|25|25.0||||||
3608473|NCT02818244|3459289|B5||<=18 years|Age||Heart Rate|Count of Units|0|0.0||||||
3608474|NCT02818244|3459290|B4||<=18 years|Age||Heart Rate|Count of Units|0|0.0||||||
3608475|NCT02818244|3459291|B3||<=18 years|Age||Heart Rate|Count of Units|0|0.0||||||
3608476|NCT02818244|3459292|B2||<=18 years|Age||Heart Rate|Count of Units|0|0.0||||||
3608477|NCT02818244|3459293|B1||<=18 years|Age||Heart Rate|Count of Units|0|0.0||||||
3608478|NCT02817763|3459306|B3|||Gingival recession depth||millimeters|Mean|3.31|3.31|Standard Deviation|0.03|0.03|||
3608479|NCT02817763|3459307|B2|||Gingival recession depth||millimeters|Mean|3.29|3.29|Standard Deviation|1.13|1.13|||
3608480|NCT02817763|3459308|B1|||Gingival recession depth||millimeters|Mean|3.34|3.34|Standard Deviation|0.7|0.7|||
3608481|NCT02817763|3459306|B3|Brazil||Region of Enrollment||participants|Number|40|40.0||||||
3608482|NCT02817763|3459307|B2|Brazil||Region of Enrollment||participants|Number|20|20.0||||||
3608483|NCT02817763|3459308|B1|Brazil||Region of Enrollment||participants|Number|20|20.0||||||
3608484|NCT02817763|3459306|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608485|NCT02817763|3459307|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608486|NCT02817763|3459308|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608487|NCT02817763|3459306|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608488|NCT02817763|3459307|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608489|NCT02817763|3459308|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608490|NCT02817763|3459306|B3||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3608491|NCT02817763|3459307|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3608492|NCT02817763|3459308|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3608493|NCT02817763|3459306|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3608494|NCT02817763|3459307|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3608495|NCT02817763|3459308|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3608496|NCT02817763|3459306|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608497|NCT02817763|3459307|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608498|NCT02817763|3459308|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608499|NCT02817763|3459306|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608500|NCT02817763|3459307|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608501|NCT02817763|3459308|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608502|NCT02817763|3459306|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608503|NCT02817763|3459307|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608504|NCT02817763|3459308|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608505|NCT02817763|3459306|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3608506|NCT02817763|3459307|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3608507|NCT02817763|3459308|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3608508|NCT02817763|3459306|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3608509|NCT02817763|3459307|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3608510|NCT02817763|3459308|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3608511|NCT02817763|3459306|B3|||Age||years|Mean|44.5|44.5|Standard Deviation|10.6|10.6|||
3608512|NCT02817763|3459307|B2|||Age||years|Mean|44.35|44.35|Standard Deviation|10.39|10.39|||
3608513|NCT02817763|3459308|B1|||Age||years|Mean|46.52|46.52|Standard Deviation|10.26|10.26|||
3608514|NCT02816138|3459317|B1|||Depression severity (measured by Montgomery Asberg Depression Rating Scale total score)|The Montgomery-Asberg Depression Rating Scale (MADRS) is a clinician-rated measure of depression severity with a total score ranging from 0 to 60, where higher scores indicate greater depression severity.|units on a scale|Mean|27.7|27.7|Standard Deviation|4.0|4.0|||
3608515|NCT02816138|3459317|B1|||Past smoker (defined as smoking at least 1 cigarette daily for at least 6 months over the lifetime)||Participants|Count of Participants|5|5.0||||||
3608516|NCT02816138|3459317|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3608517|NCT02816138|3459317|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608518|NCT02816138|3459317|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3608519|NCT02816138|3459317|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3608520|NCT02816138|3459317|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3608521|NCT02816138|3459317|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608522|NCT02816138|3459317|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608523|NCT02816138|3459317|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608524|NCT02816138|3459317|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608525|NCT02816138|3459317|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3608526|NCT02816138|3459317|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608527|NCT02816138|3459317|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3608528|NCT02816138|3459317|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3608529|NCT02816138|3459317|B1|||Age||years|Mean|64.9|64.9|Standard Deviation|4.6|4.6|||
3608530|NCT02816138|3459317|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3608531|NCT02816138|3459317|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3608532|NCT02816138|3459317|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3608533|NCT02815982|3459330|B5|United States||Region of Enrollment||participants|Number|106|106.0||||||
3608534|NCT02815982|3459331|B4|United States||Region of Enrollment||participants|Number|26|26.0||||||
3608535|NCT02815982|3459332|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
3608536|NCT02815982|3459333|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
3608537|NCT02815982|3459334|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3608538|NCT02815982|3459330|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3608539|NCT02815982|3459331|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3608540|NCT02815982|3459332|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3608541|NCT02815982|3459333|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3608542|NCT02815982|3459334|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3608543|NCT02815982|3459330|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608544|NCT02815982|3459331|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608545|NCT02815982|3459332|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608546|NCT02815982|3459333|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608547|NCT02815982|3459334|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608548|NCT02815982|3459330|B5||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3608549|NCT02815982|3459331|B4||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3608550|NCT02815982|3459332|B3||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3608551|NCT02815982|3459333|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3608552|NCT02815982|3459334|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3608553|NCT02815982|3459330|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3608554|NCT02815982|3459331|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608555|NCT02815982|3459332|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608556|NCT02815982|3459333|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3608557|NCT02815982|3459334|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3608558|NCT02815982|3459330|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3608559|NCT02815982|3459331|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3608560|NCT02815982|3459332|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3608561|NCT02815982|3459333|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608562|NCT02815982|3459334|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608563|NCT02815982|3459330|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608564|NCT02815982|3459331|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608565|NCT02815982|3459332|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608566|NCT02815982|3459333|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608567|NCT02815982|3459334|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608568|NCT02815982|3459330|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608569|NCT02815982|3459331|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608570|NCT02815982|3459332|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608571|NCT02815982|3459333|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608572|NCT02815982|3459334|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608573|NCT02815982|3459330|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3608574|NCT02815982|3459331|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3608575|NCT02815982|3459332|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3608576|NCT02815982|3459333|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3608577|NCT02815982|3459334|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3608578|NCT02815982|3459330|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3608579|NCT02815982|3459331|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3608580|NCT02815982|3459332|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3608581|NCT02815982|3459333|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3608582|NCT02815982|3459334|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3608583|NCT02815982|3459330|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3608584|NCT02815982|3459331|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3608585|NCT02815982|3459332|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3608586|NCT02815982|3459333|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3608587|NCT02815982|3459334|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3608588|NCT02815982|3459330|B5||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3608589|NCT02815982|3459331|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3608590|NCT02815982|3459332|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3608591|NCT02815982|3459333|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3608592|NCT02815982|3459334|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3608593|NCT02815982|3459330|B5||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3608594|NCT02815982|3459331|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3608595|NCT02815982|3459332|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3608596|NCT02815982|3459333|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3608597|NCT02815982|3459334|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3608598|NCT02815982|3459330|B5|all Participants||Age||years|Mean|24.87|24.87|Standard Deviation|5.80|5.8|||
3608599|NCT02815982|3459331|B4|all Participants||Age||years|Mean|10.48|10.48|Standard Deviation|2.79|2.79|||
3608600|NCT02815982|3459332|B3|all Participants||Age||years|Mean|41.5|41.5|Standard Deviation|9.2|9.2|||
3608601|NCT02815982|3459333|B2|all Participants||Age||years|Mean|9.48|9.48|Standard Deviation|2.8|2.8|||
3608602|NCT02815982|3459334|B1|all Participants||Age||years|Mean|38.0|38.0|Standard Deviation|8.4|8.4|||
3608603|NCT02815982|3459330|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3608604|NCT02815982|3459331|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3608605|NCT02815982|3459332|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3608606|NCT02815982|3459333|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3608607|NCT02815982|3459334|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3608608|NCT02815982|3459330|B5||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
3608609|NCT02815982|3459331|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3608610|NCT02815982|3459332|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3608611|NCT02815982|3459333|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3608612|NCT02815982|3459334|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3608613|NCT02815982|3459330|B5||<=18 years|Age||Participants|Count of Participants|53|53.0||||||
3608614|NCT02815982|3459331|B4||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
3608615|NCT02815982|3459332|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3608616|NCT02815982|3459333|B2||<=18 years|Age||Participants|Count of Participants|27|27.0||||||
3608617|NCT02815982|3459334|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3608618|NCT02815735|3459363|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3608619|NCT02815735|3459363|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3608620|NCT02815735|3459363|B1|||Age||years|Mean|26.5|26.5|Standard Deviation|4.5|4.5|||
3608621|NCT02815644|3459379|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3608622|NCT02815644|3459380|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3608623|NCT02815644|3459381|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3608624|NCT02815644|3459379|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3608625|NCT02815644|3459380|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3608626|NCT02815644|3459381|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3608627|NCT02815644|3459379|B3|||Age||Years|Mean|31.36|31.36|Standard Deviation|9.30|9.3|||
3608628|NCT02815644|3459380|B2|||Age||Years|Mean|33.73|33.73|Standard Deviation|9.55|9.55|||
3608629|NCT02815644|3459381|B1|||Age||Years|Mean|29.00|29.0|Standard Deviation|8.83|8.83|||
3608630|NCT02815397|3459400|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3608631|NCT02815397|3459400|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3608632|NCT02815397|3459400|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3608633|NCT02815397|3459400|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3608634|NCT02815397|3459400|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3608635|NCT02814643|3459407|B3|White||Race/Ethnicity, Customized||Participants|Number|74|74.0||||||
3608636|NCT02814643|3459408|B2|White||Race/Ethnicity, Customized||Participants|Number|36|36.0||||||
3608637|NCT02814643|3459409|B1|White||Race/Ethnicity, Customized||Participants|Number|38|38.0||||||
3608638|NCT02814643|3459407|B3|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3608639|NCT02814643|3459408|B2|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3608640|NCT02814643|3459409|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3608641|NCT02814643|3459407|B3|Black Or African American||Race/Ethnicity, Customized||Participants|Number|26|26.0||||||
3608642|NCT02814643|3459408|B2|Black Or African American||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
3608643|NCT02814643|3459409|B1|Black Or African American||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
3608644|NCT02814643|3459407|B3|American Indian Or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3608645|NCT02814643|3459408|B2|American Indian Or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3608646|NCT02814643|3459409|B1|American Indian Or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3608647|NCT02814643|3459407|B3|Male||Sex/Gender, Customized||Participants|Number|61|61.0||||||
3608648|NCT02814643|3459408|B2|Male||Sex/Gender, Customized||Participants|Number|31|31.0||||||
3608649|NCT02814643|3459409|B1|Male||Sex/Gender, Customized||Participants|Number|30|30.0||||||
3608650|NCT02814643|3459407|B3|Female||Sex/Gender, Customized||Participants|Number|42|42.0||||||
3608651|NCT02814643|3459408|B2|Female||Sex/Gender, Customized||Participants|Number|21|21.0||||||
3608652|NCT02814643|3459409|B1|Female||Sex/Gender, Customized||Participants|Number|21|21.0||||||
3608653|NCT02814643|3459407|B3|≥18 to ≤21||Age, Customized||Participants|Number|31|31.0||||||
3608654|NCT02814643|3459408|B2|≥18 to ≤21||Age, Customized||Participants|Number|16|16.0||||||
3608655|NCT02814643|3459409|B1|≥18 to ≤21||Age, Customized||Participants|Number|15|15.0||||||
3608656|NCT02814643|3459407|B3|≥12 to ≤17||Age, Customized||Participants|Number|72|72.0||||||
3608657|NCT02814643|3459408|B2|≥12 to ≤17||Age, Customized||Participants|Number|36|36.0||||||
3608658|NCT02814643|3459409|B1|≥12 to ≤17||Age, Customized||Participants|Number|36|36.0||||||
3608659|NCT02814643|3459407|B3|||Age||Years|Mean|15.9|15.9|Standard Deviation|2.82|2.82|12.0|21.0|
3608660|NCT02814643|3459408|B2|||Age||Years|Mean|15.7|15.7|Standard Deviation|2.99|2.99|12.0|21.0|
3608661|NCT02814643|3459409|B1|||Age||Years|Mean|16.0|16.0|Standard Deviation|2.65|2.65|12.0|21.0|
3608662|NCT02814448|3459432|B6|Peru||Region of Enrollment||Participants|Count of Participants|51|51.0||||||
3608663|NCT02814448|3459433|B5|Peru||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3608664|NCT02814448|3459434|B4|Peru||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3608665|NCT02814448|3459435|B3|Peru||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3608666|NCT02814448|3459436|B2|Peru||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3608667|NCT02814448|3459437|B1|Peru||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3608668|NCT02814448|3459432|B6|El Salvador||Region of Enrollment||Participants|Count of Participants|79|79.0||||||
3608669|NCT02814448|3459433|B5|El Salvador||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3608670|NCT02814448|3459434|B4|El Salvador||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3608671|NCT02814448|3459435|B3|El Salvador||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3608672|NCT02814448|3459436|B2|El Salvador||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3608673|NCT02814448|3459437|B1|El Salvador||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3608674|NCT02814448|3459432|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3608675|NCT02814448|3459433|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3608676|NCT02814448|3459434|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3608677|NCT02814448|3459435|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3608678|NCT02814448|3459436|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3608679|NCT02814448|3459437|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3608680|NCT02814448|3459432|B6||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3608681|NCT02814448|3459433|B5||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3608682|NCT02814448|3459434|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3608683|NCT02814448|3459435|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3608684|NCT02814448|3459436|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3608685|NCT02814448|3459437|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3608686|NCT02814448|3459432|B6|||Age||years|Mean|45.37|45.37|Standard Deviation|5.98|5.98|||
3608687|NCT02814448|3459433|B5|||Age||years|Mean|45.35|45.35|Standard Deviation|6.05|6.05|||
3608688|NCT02814448|3459434|B4|||Age||years|Mean|44.65|44.65|Standard Deviation|5.91|5.91|||
3608689|NCT02814448|3459435|B3|||Age||years|Mean|45.92|45.92|Standard Deviation|5.82|5.82|||
3608690|NCT02814448|3459436|B2|||Age||years|Mean|45.5|45.5|Standard Deviation|6.53|6.53|||
3608691|NCT02814448|3459437|B1|||Age||years|Mean|45.46|45.46|Standard Deviation|6.44|6.44|||
3608692|NCT02814448|3459432|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3608693|NCT02814448|3459433|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3608694|NCT02814448|3459434|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3608695|NCT02814448|3459435|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3608696|NCT02814448|3459436|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3608697|NCT02814448|3459437|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3608698|NCT02814448|3459432|B6||Between 18 and 65 years|Age||Participants|Count of Participants|130|130.0||||||
3608699|NCT02814448|3459433|B5||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3608700|NCT02814448|3459434|B4||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3608701|NCT02814448|3459435|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3608702|NCT02814448|3459436|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3608703|NCT02814448|3459437|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3608704|NCT02814448|3459432|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3608705|NCT02814448|3459433|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3608706|NCT02814448|3459434|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3608707|NCT02814448|3459435|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3608708|NCT02814448|3459436|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3608709|NCT02814448|3459437|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3608710|NCT02814279|3459458|B3|||Gingival recession depth||millimeters|Mean|3.0|3.0|Standard Deviation|0.7|0.7|||
3608711|NCT02814279|3459459|B2|||Gingival recession depth||millimeters|Mean|3.0|3.0|Standard Deviation|0.6|0.6|||
3608712|NCT02814279|3459460|B1|||Gingival recession depth||millimeters|Mean|3.2|3.2|Standard Deviation|0.7|0.7|||
3608713|NCT02814279|3459458|B3|Brazil||Region of Enrollment||participants|Number|42|42.0||||||
3608714|NCT02814279|3459459|B2|Brazil||Region of Enrollment||participants|Number|21|21.0||||||
3608715|NCT02814279|3459460|B1|Brazil||Region of Enrollment||participants|Number|21|21.0||||||
3608716|NCT02814279|3459458|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608717|NCT02814279|3459459|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608718|NCT02814279|3459460|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608719|NCT02814279|3459458|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608720|NCT02814279|3459459|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608721|NCT02814279|3459460|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608722|NCT02814279|3459458|B3||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3608723|NCT02814279|3459459|B2||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3608724|NCT02814279|3459460|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3608725|NCT02814279|3459458|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3608726|NCT02814279|3459459|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608727|NCT02814279|3459460|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3608728|NCT02814279|3459458|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608729|NCT02814279|3459459|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608730|NCT02814279|3459460|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608731|NCT02814279|3459458|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608732|NCT02814279|3459459|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608733|NCT02814279|3459460|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608734|NCT02814279|3459458|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608735|NCT02814279|3459459|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608736|NCT02814279|3459460|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608737|NCT02814279|3459458|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3608738|NCT02814279|3459459|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3608739|NCT02814279|3459460|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3608740|NCT02814279|3459458|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3608741|NCT02814279|3459459|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3608742|NCT02814279|3459460|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3608743|NCT02814279|3459458|B3|||Age||years|Mean|40.2|40.2|Standard Deviation|9.6|9.6|||
3608744|NCT02814279|3459459|B2|||Age||years|Mean|39.71|39.71|Standard Deviation|10.38|10.38|||
3608745|NCT02814279|3459460|B1|||Age||years|Mean|40.66|40.66|Standard Deviation|8.89|8.89|||
3608746|NCT02814227|3459469|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
3608747|NCT02814227|3459469|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3608748|NCT02814227|3459469|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3608749|NCT02814227|3459469|B1|||Age||years|Mean|47.8|47.8|Standard Deviation|13.3|13.3|||
3608750|NCT02813070|3459476|B4||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3608751|NCT02813070|3459477|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3608752|NCT02813070|3459478|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3608753|NCT02813070|3459479|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3608754|NCT02813070|3459476|B4||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3608755|NCT02813070|3459477|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3608756|NCT02813070|3459478|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3608757|NCT02813070|3459479|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3608758|NCT02813070|3459476|B4|||Age||years|Mean|67.5|67.5|Standard Deviation|10.82|10.82|||
3608759|NCT02813070|3459477|B3|||Age||years|Mean|57.4|57.4|Standard Deviation|9.24|9.24|||
3608760|NCT02813070|3459478|B2|||Age||years|Mean|71.2|71.2|Standard Deviation|7.28|7.28|||
3608761|NCT02813070|3459479|B1|||Age||years|Mean|74.8|74.8|Standard Deviation|6.04|6.04|||
3608762|NCT02812342|3459490|B1|||SALT score|SALT score range is from 0 (no hair loss) to 100 (100% hair loss)|units on a scale|Mean|77.7|77.7|Standard Deviation|32.3|32.3|||
3608763|NCT02812342|3459490|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3608764|NCT02812342|3459490|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608765|NCT02812342|3459490|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608766|NCT02812342|3459490|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3608767|NCT02812342|3459490|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608768|NCT02812342|3459490|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608769|NCT02812342|3459490|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3608770|NCT02812342|3459490|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608771|NCT02812342|3459490|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3608772|NCT02812342|3459490|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3608773|NCT02812342|3459490|B1|||Age||years|Mean|36.9|36.9|Standard Deviation|14.2|14.2|||
3608774|NCT02811965|3459495|B1||30 < BMI|BMI, Categorical||Participants|Count of Participants|6|6.0||||||
3608775|NCT02811965|3459495|B1||25 < BMI < 29.9|BMI, Categorical||Participants|Count of Participants|7|7.0||||||
3608776|NCT02811965|3459495|B1||18.5 < BMI < 24.9|BMI, Categorical||Participants|Count of Participants|8|8.0||||||
3608777|NCT02811965|3459495|B1|||Body Mass Index (BMI), Continuous||kg/m^2|Mean|27.3|27.3|Standard Deviation|5.7|5.7|||
3608778|NCT02811965|3459495|B1|||Height, Continuous||inches|Mean|65.7|65.7|Standard Deviation|4.2|4.2|||
3608779|NCT02811965|3459495|B1|||Weight, Continuous||lbs|Mean|168.6|168.6|Standard Deviation|43.5|43.5|||
3608780|NCT02811965|3459495|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3608781|NCT02811965|3459495|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3608782|NCT02811965|3459495|B1|||Age||years|Mean|36.5|36.5|Standard Deviation|14.1|14.1|||
3608783|NCT02811965|3459495|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3608784|NCT02811965|3459495|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3608785|NCT02811965|3459495|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3608786|NCT02810873|3459518|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
3608787|NCT02810873|3459519|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3608788|NCT02810873|3459520|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3608789|NCT02810873|3459518|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608790|NCT02810873|3459519|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608791|NCT02810873|3459520|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608792|NCT02810873|3459518|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608793|NCT02810873|3459519|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608794|NCT02810873|3459520|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608795|NCT02810873|3459518|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3608796|NCT02810873|3459519|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3608797|NCT02810873|3459520|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3608798|NCT02810873|3459518|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3608799|NCT02810873|3459519|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3608800|NCT02810873|3459520|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3608801|NCT02810873|3459518|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608802|NCT02810873|3459519|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608803|NCT02810873|3459520|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608804|NCT02810873|3459518|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608805|NCT02810873|3459519|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608806|NCT02810873|3459520|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608807|NCT02810873|3459518|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608808|NCT02810873|3459519|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608809|NCT02810873|3459520|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608810|NCT02810873|3459518|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608811|NCT02810873|3459519|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608812|NCT02810873|3459520|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608813|NCT02810873|3459518|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3608814|NCT02810873|3459519|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3608815|NCT02810873|3459520|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3608816|NCT02810873|3459518|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3608817|NCT02810873|3459519|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3608818|NCT02810873|3459520|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608819|NCT02810873|3459518|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3608820|NCT02810873|3459519|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3608821|NCT02810873|3459520|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3608822|NCT02810873|3459518|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3608823|NCT02810873|3459519|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3608824|NCT02810873|3459520|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3608825|NCT02810873|3459518|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3608826|NCT02810873|3459519|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3608827|NCT02810873|3459520|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3608828|NCT02810873|3459518|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3608829|NCT02810873|3459519|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3608830|NCT02810873|3459520|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3608831|NCT02810873|3459518|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3608832|NCT02810873|3459519|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3608833|NCT02810873|3459520|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3608834|NCT02809911|3459529|B3|||BMI||kg/m^2|Mean|30|30.0|Standard Deviation|5|5.0|||
3608835|NCT02809911|3459530|B2|||BMI||kg/m^2|Mean|29.4|29.4|Standard Deviation|5.17|5.17|||
3608836|NCT02809911|3459531|B1|||BMI||kg/m^2|Mean|30.6|30.6|Standard Deviation|4.89|4.89|||
3608837|NCT02809911|3459529|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
3608838|NCT02809911|3459530|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3608839|NCT02809911|3459531|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3608840|NCT02809911|3459529|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3608841|NCT02809911|3459530|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608842|NCT02809911|3459531|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3608843|NCT02809911|3459529|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608844|NCT02809911|3459530|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608845|NCT02809911|3459531|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608846|NCT02809911|3459529|B3||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3608847|NCT02809911|3459530|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3608848|NCT02809911|3459531|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3608849|NCT02809911|3459529|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3608850|NCT02809911|3459530|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3608851|NCT02809911|3459531|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3608852|NCT02809911|3459529|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608853|NCT02809911|3459530|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608854|NCT02809911|3459531|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608855|NCT02809911|3459529|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608856|NCT02809911|3459530|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608857|NCT02809911|3459531|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608858|NCT02809911|3459529|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608859|NCT02809911|3459530|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608860|NCT02809911|3459531|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608861|NCT02809911|3459529|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3608862|NCT02809911|3459530|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3608863|NCT02809911|3459531|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608864|NCT02809911|3459529|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3608865|NCT02809911|3459530|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3608866|NCT02809911|3459531|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3608867|NCT02809911|3459529|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3608868|NCT02809911|3459530|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3608869|NCT02809911|3459531|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3608870|NCT02809911|3459529|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3608871|NCT02809911|3459530|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3608872|NCT02809911|3459531|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3608873|NCT02809911|3459529|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3608874|NCT02809911|3459530|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3608875|NCT02809911|3459531|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3608876|NCT02809911|3459529|B3|||Age||years|Mean|63.4|63.4|Standard Deviation|12.10|12.1|||
3608877|NCT02809911|3459530|B2|||Age||years|Mean|63.8|63.8|Standard Deviation|12.38|12.38|||
3608878|NCT02809911|3459531|B1|||Age||years|Mean|63|63.0|Standard Deviation|12.14|12.14|||
3608879|NCT02809833|3459540|B1||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
3608880|NCT02809833|3459540|B1||Female|Sex: Female, Male||Participants|Count of Participants|640|640.0||||||
3608881|NCT02809833|3459540|B1|||Age||years|Mean|55.9|55.9|Standard Deviation|12.9|12.9|||
3608882|NCT02808390|3459614|B4|Not reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3608883|NCT02808390|3459615|B3|Not reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3608884|NCT02808390|3459616|B2|Not reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3608885|NCT02808390|3459617|B1|Not reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3608886|NCT02808390|3459614|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3608887|NCT02808390|3459615|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3608888|NCT02808390|3459616|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3608889|NCT02808390|3459617|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3608890|NCT02808390|3459614|B4|White||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3608891|NCT02808390|3459615|B3|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3608892|NCT02808390|3459616|B2|White||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3608893|NCT02808390|3459617|B1|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3608894|NCT02808390|3459614|B4|Male||Sex/Gender, Customized||participants|Number|9|9.0||||||
3608895|NCT02808390|3459615|B3|Male||Sex/Gender, Customized||participants|Number|2|2.0||||||
3608896|NCT02808390|3459616|B2|Male||Sex/Gender, Customized||participants|Number|5|5.0||||||
3608897|NCT02808390|3459617|B1|Male||Sex/Gender, Customized||participants|Number|2|2.0||||||
3608898|NCT02808390|3459614|B4|Female||Sex/Gender, Customized||participants|Number|10|10.0||||||
3608899|NCT02808390|3459615|B3|Female||Sex/Gender, Customized||participants|Number|5|5.0||||||
3608900|NCT02808390|3459616|B2|Female||Sex/Gender, Customized||participants|Number|3|3.0||||||
3608901|NCT02808390|3459617|B1|Female||Sex/Gender, Customized||participants|Number|2|2.0||||||
3608902|NCT02808390|3459614|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3608903|NCT02808390|3459615|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3608904|NCT02808390|3459616|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3608905|NCT02808390|3459617|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3608906|NCT02808390|3459614|B4||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3608907|NCT02808390|3459615|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3608908|NCT02808390|3459616|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3608909|NCT02808390|3459617|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3608910|NCT02808390|3459614|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3608911|NCT02808390|3459615|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3608912|NCT02808390|3459616|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3608913|NCT02808390|3459617|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3608914|NCT02808130|3459627|B7||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3608915|NCT02808130|3459628|B6||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3608916|NCT02808130|3459629|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3608917|NCT02808130|3459630|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3608918|NCT02808130|3459631|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3608919|NCT02808130|3459632|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3608920|NCT02808130|3459633|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3608921|NCT02808130|3459627|B7||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3608922|NCT02808130|3459628|B6||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3608923|NCT02808130|3459629|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3608924|NCT02808130|3459630|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3608925|NCT02808130|3459631|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3608926|NCT02808130|3459632|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3608927|NCT02808130|3459633|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3608928|NCT02808130|3459627|B7|age||Age||years|Mean|41.40|41.4|Standard Deviation|4.87|4.87|||
3608929|NCT02808130|3459628|B6|age||Age||years|Mean|41.45|41.45|Standard Deviation|4.81|4.81|||
3608930|NCT02808130|3459629|B5|age||Age||years|Mean|41|41.0|Standard Deviation|5.91|5.91|||
3608931|NCT02808130|3459630|B4|age||Age||years|Mean|45.47|45.47|Standard Deviation|6.66|6.66|||
3608932|NCT02808130|3459631|B3|age||Age||years|Mean|42.17|42.17|Standard Deviation|3.1|3.1|||
3608933|NCT02808130|3459632|B2|age||Age||years|Mean|40.04|40.04|Standard Deviation|3.93|3.93|||
3608934|NCT02808130|3459633|B1|age||Age||years|Mean|38.3|38.3|Standard Deviation|4.84|4.84|||
3608935|NCT02807376|3459664|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3608936|NCT02807376|3459665|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3608937|NCT02807376|3459666|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3608938|NCT02807376|3459664|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608939|NCT02807376|3459665|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608940|NCT02807376|3459666|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608941|NCT02807376|3459664|B3||White|Race (NIH/OMB)||Participants|Count of Participants|235|235.0||||||
3608942|NCT02807376|3459665|B2||White|Race (NIH/OMB)||Participants|Count of Participants|116|116.0||||||
3608943|NCT02807376|3459666|B1||White|Race (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
3609257|NCT02799082|3459887|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3608944|NCT02807376|3459664|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3608945|NCT02807376|3459665|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3608946|NCT02807376|3459666|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3608947|NCT02807376|3459664|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608948|NCT02807376|3459665|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608949|NCT02807376|3459666|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608950|NCT02807376|3459664|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3608951|NCT02807376|3459665|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3608952|NCT02807376|3459666|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3608953|NCT02807376|3459664|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608954|NCT02807376|3459665|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608955|NCT02807376|3459666|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608956|NCT02807376|3459664|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|186|186.0||||||
3608957|NCT02807376|3459665|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
3608958|NCT02807376|3459666|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3608959|NCT02807376|3459664|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3608960|NCT02807376|3459665|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3608961|NCT02807376|3459666|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3608962|NCT02807376|3459664|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3608963|NCT02807376|3459665|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3608964|NCT02807376|3459666|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3608965|NCT02807376|3459664|B3||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3608966|NCT02807376|3459665|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3608967|NCT02807376|3459666|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3608968|NCT02807376|3459664|B3||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3608969|NCT02807376|3459665|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3608970|NCT02807376|3459666|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3608971|NCT02807376|3459664|B3|||Age||Years|Mean|63.8|63.8|Standard Deviation|13.9|13.9|||
3608972|NCT02807376|3459665|B2|||Age||Years|Mean|63.6|63.6|Standard Deviation|13.8|13.8|||
3608973|NCT02807376|3459666|B1|||Age||Years|Mean|64.1|64.1|Standard Deviation|14.0|14.0|||
3608974|NCT02806869|3459675|B3|||Body Mass Index||kg/m^2|Mean|25.9|25.9|Standard Deviation|4.63|4.63|||
3608975|NCT02806869|3459676|B2|||Body Mass Index||kg/m^2|Mean|26.2|26.2|Standard Deviation|4.61|4.61|||
3608976|NCT02806869|3459677|B1|||Body Mass Index||kg/m^2|Mean|25.6|25.6|Standard Deviation|4.65|4.65|||
3608977|NCT02806869|3459675|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608978|NCT02806869|3459676|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608979|NCT02806869|3459677|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608980|NCT02806869|3459675|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608981|NCT02806869|3459676|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608982|NCT02806869|3459677|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608983|NCT02806869|3459675|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3608984|NCT02806869|3459676|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3608985|NCT02806869|3459677|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3608986|NCT02806869|3459675|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3608987|NCT02806869|3459676|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3608988|NCT02806869|3459677|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3608989|NCT02806869|3459675|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608990|NCT02806869|3459676|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608991|NCT02806869|3459677|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608992|NCT02806869|3459675|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3608993|NCT02806869|3459676|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608994|NCT02806869|3459677|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3608995|NCT02806869|3459675|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608996|NCT02806869|3459676|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608997|NCT02806869|3459677|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608998|NCT02806869|3459675|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3608999|NCT02806869|3459676|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609000|NCT02806869|3459677|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609001|NCT02806869|3459675|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3609002|NCT02806869|3459676|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3609003|NCT02806869|3459677|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3609004|NCT02806869|3459675|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3609005|NCT02806869|3459676|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3609006|NCT02806869|3459677|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609007|NCT02806869|3459675|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3609008|NCT02806869|3459676|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3609009|NCT02806869|3459677|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3609010|NCT02806869|3459675|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3609011|NCT02806869|3459676|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3609012|NCT02806869|3459677|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3609013|NCT02806869|3459675|B3|||Age||years|Mean|30.4|30.4|Standard Deviation|8.9|8.9|||
3609014|NCT02806869|3459676|B2|||Age||years|Mean|31.6|31.6|Standard Deviation|8.8|8.8|||
3609015|NCT02806869|3459677|B1|||Age||years|Mean|29.3|29.3|Standard Deviation|8.9|8.9|||
3609016|NCT02806544|3459688|B1|Guatemala||Region of Enrollment||participants|Number|35|35.0||||||
3609017|NCT02806544|3459688|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3609018|NCT02806544|3459688|B1||Female|Gender||Participants|Count of Participants|35|35.0||||||
3609019|NCT02806544|3459688|B1|||Age||years|Mean|59.1|59.1|Full Range|||35.0|78.0|
3609020|NCT02806544|3459688|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3609021|NCT02806544|3459688|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3609022|NCT02806544|3459688|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3609023|NCT02806505|3459697|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3609024|NCT02806505|3459698|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3609025|NCT02806505|3459699|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3609026|NCT02806505|3459697|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3609027|NCT02806505|3459698|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3609028|NCT02806505|3459699|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3609029|NCT02806505|3459697|B3|||Age||years|Mean|43.5|43.5|Standard Deviation|11.21|11.21|||
3609030|NCT02806505|3459698|B2|||Age||years|Mean|42.9|42.9|Standard Deviation|11.26|11.26|||
3609031|NCT02806505|3459699|B1|||Age||years|Mean|44.2|44.2|Standard Deviation|11.26|11.26|||
3609032|NCT02805907|3459710|B3|||Emergency care|Number of emergency care in the last 6 months|Emergency care in the last 6 months|Mean|0.52|0.52|Standard Deviation|1.08|1.08|||
3609033|NCT02805907|3459711|B2|||Emergency care|Number of emergency care in the last 6 months|Emergency care in the last 6 months|Mean|0.59|0.59|Standard Deviation|1.30|1.3|||
3609034|NCT02805907|3459712|B1|||Emergency care|Number of emergency care in the last 6 months|Emergency care in the last 6 months|Mean|0.45|0.45|Standard Deviation|0.81|0.81|||
3609035|NCT02805907|3459710|B3|||Hospitalizations|Number of hospitalizations in the last 6 months|Hospitalizations in the last 6 months|Mean|0.12|0.12|Standard Deviation|0.32|0.32|||
3609036|NCT02805907|3459711|B2|||Hospitalizations|Number of hospitalizations in the last 6 months|Hospitalizations in the last 6 months|Mean|0.13|0.13|Standard Deviation|0.33|0.33|||
3609037|NCT02805907|3459712|B1|||Hospitalizations|Number of hospitalizations in the last 6 months|Hospitalizations in the last 6 months|Mean|0.11|0.11|Standard Deviation|0.31|0.31|||
3609038|NCT02805907|3459710|B3|||Exacerbations|Number of exacerbations in the last 6 months|Exacerbations in the last 6 months|Mean|1.16|1.16|Standard Deviation|2.19|2.19|||
3609039|NCT02805907|3459711|B2|||Exacerbations|Number of exacerbations in the last 6 months|Exacerbations in the last 6 months|Mean|1.14|1.14|Standard Deviation|2.70|2.7|||
3609040|NCT02805907|3459712|B1|||Exacerbations|Number of exacerbations in the last 6 months|Exacerbations in the last 6 months|Mean|1.18|1.18|Standard Deviation|1.55|1.55|||
3609041|NCT02805907|3459710|B3||Severe Persistent|Asthma Severity||Participants|Count of Participants|19|19.0||||||
3609042|NCT02805907|3459711|B2||Severe Persistent|Asthma Severity||Participants|Count of Participants|6|6.0||||||
3609043|NCT02805907|3459712|B1||Severe Persistent|Asthma Severity||Participants|Count of Participants|13|13.0||||||
3609044|NCT02805907|3459710|B3||Moderate Persistent|Asthma Severity||Participants|Count of Participants|56|56.0||||||
3609045|NCT02805907|3459711|B2||Moderate Persistent|Asthma Severity||Participants|Count of Participants|27|27.0||||||
3609046|NCT02805907|3459712|B1||Moderate Persistent|Asthma Severity||Participants|Count of Participants|29|29.0||||||
3609047|NCT02805907|3459710|B3||Mild Persistent|Asthma Severity||Participants|Count of Participants|20|20.0||||||
3609048|NCT02805907|3459711|B2||Mild Persistent|Asthma Severity||Participants|Count of Participants|11|11.0||||||
3609049|NCT02805907|3459712|B1||Mild Persistent|Asthma Severity||Participants|Count of Participants|9|9.0||||||
3609050|NCT02805907|3459710|B3||Intermitent|Asthma Severity||Participants|Count of Participants|17|17.0||||||
3609051|NCT02805907|3459711|B2||Intermitent|Asthma Severity||Participants|Count of Participants|12|12.0||||||
3609052|NCT02805907|3459712|B1||Intermitent|Asthma Severity||Participants|Count of Participants|5|5.0||||||
3609135|NCT02802449|3459751|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609136|NCT02802449|3459752|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609053|NCT02805907|3459710|B3|||Initial Asthma Quality of Life Questionnaire|The response options for each item are placed on an equidistant 7-point scale, where 1 = maximum limitation and 7 = no limitation. The questionnaire Global score, which is the mean for all 15 items that make up the scale, and a score for each dimension, which is the average of the corresponding items for that dimension.|units on a scale|Mean|4.62|4.62|Standard Deviation|1.91|1.91|||
3609054|NCT02805907|3459711|B2|||Initial Asthma Quality of Life Questionnaire|The response options for each item are placed on an equidistant 7-point scale, where 1 = maximum limitation and 7 = no limitation. The questionnaire Global score, which is the mean for all 15 items that make up the scale, and a score for each dimension, which is the average of the corresponding items for that dimension.|units on a scale|Mean|4.85|4.85|Standard Deviation|1.96|1.96|||
3609055|NCT02805907|3459712|B1|||Initial Asthma Quality of Life Questionnaire|The response options for each item are placed on an equidistant 7-point scale, where 1 = maximum limitation and 7 = no limitation. The questionnaire Global score, which is the mean for all 15 items that make up the scale, and a score for each dimension, which is the average of the corresponding items for that dimension.|units on a scale|Mean|4.38|4.38|Standard Deviation|1.62|1.62|||
3609056|NCT02805907|3459710|B3|||Initial Asthma Control Test (ACT)|Interpretation of the ACT questionnaire: Score less than or equal to 15 points: poor control; Between 16 and 19 points: partially controlled; Greater or equal to 20 points: good control.|units on a scale|Mean|18.37|18.37|Standard Deviation|4.59|4.59|||
3609057|NCT02805907|3459711|B2|||Initial Asthma Control Test (ACT)|Interpretation of the ACT questionnaire: Score less than or equal to 15 points: poor control; Between 16 and 19 points: partially controlled; Greater or equal to 20 points: good control.|units on a scale|Mean|19.02|19.02|Standard Deviation|4.59|4.59|||
3609058|NCT02805907|3459712|B1|||Initial Asthma Control Test (ACT)|Interpretation of the ACT questionnaire: Score less than or equal to 15 points: poor control; Between 16 and 19 points: partially controlled; Greater or equal to 20 points: good control.|units on a scale|Mean|17.71|17.71|Standard Deviation|4.54|4.54|||
3609059|NCT02805907|3459710|B3|Spain||Region of Enrollment||participants|Number|112|112.0||||||
3609060|NCT02805907|3459711|B2|Spain||Region of Enrollment||participants|Number|56|56.0||||||
3609061|NCT02805907|3459712|B1|Spain||Region of Enrollment||participants|Number|56|56.0||||||
3609062|NCT02805907|3459710|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609063|NCT02805907|3459711|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609064|NCT02805907|3459712|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609065|NCT02805907|3459710|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609066|NCT02805907|3459711|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609067|NCT02805907|3459712|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609068|NCT02805907|3459710|B3||White|Race (NIH/OMB)||Participants|Count of Participants|112|112.0||||||
3609069|NCT02805907|3459711|B2||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3609070|NCT02805907|3459712|B1||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3609071|NCT02805907|3459710|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609072|NCT02805907|3459711|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609073|NCT02805907|3459712|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609074|NCT02805907|3459710|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609075|NCT02805907|3459711|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609076|NCT02805907|3459712|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609077|NCT02805907|3459710|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609078|NCT02805907|3459711|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609079|NCT02805907|3459712|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609080|NCT02805907|3459710|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609081|NCT02805907|3459711|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609082|NCT02805907|3459712|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609083|NCT02805907|3459710|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3609084|NCT02805907|3459711|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3609085|NCT02805907|3459712|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3609086|NCT02805907|3459710|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3609087|NCT02805907|3459711|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3609088|NCT02805907|3459712|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3609089|NCT02805907|3459710|B3|||Age||years|Mean|55.59|55.59|Standard Deviation|15.39|15.39|||
3609090|NCT02805907|3459711|B2|||Age||years|Mean|56.61|56.61|Standard Deviation|15.00|15.0|||
3609091|NCT02805907|3459712|B1|||Age||years|Mean|54.57|54.57|Standard Deviation|15.83|15.83|||
3609092|NCT02802878|3459725|B3|||Flexor Torque||Newton-meters|Mean|29.84|29.84|Standard Deviation|1.80|1.8|||
3609093|NCT02802878|3459726|B2|||Flexor Torque||Newton-meters|Mean|28.36|28.36|Standard Deviation|1.77|1.77|||
3609094|NCT02802878|3459727|B1|||Flexor Torque||Newton-meters|Mean|31.32|31.32|Standard Deviation|1.82|1.82|||
3609095|NCT02802878|3459725|B3|||Extensor Torque||Newton-meters|Mean|68.50|68.5|Standard Deviation|3.62|3.62|||
3609096|NCT02802878|3459726|B2|||Extensor Torque||Newton-meters|Mean|67.60|67.6|Standard Deviation|3.57|3.57|||
3609097|NCT02802878|3459727|B1|||Extensor Torque||Newton-meters|Mean|69.40|69.4|Standard Deviation|3.67|3.67|||
3609137|NCT02802449|3459753|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609098|NCT02802878|3459725|B3|||Knee Injury and Osteoarthritis Outcome Score (KOOS) Pain|The Knee Injury and Osteoarthritis Outcome Score (KOOS) Pain subscale was used at baseline and follow-up to assess participant outcomes. The pain subscale is made up of 9 questions and was scored from zero to 100, with zero corresponding to extreme knee problems and 100 corresponding to no knee problems.|units on a scale|Mean|57.9|57.9|Standard Deviation|15.07|15.07|||
3609099|NCT02802878|3459726|B2|||Knee Injury and Osteoarthritis Outcome Score (KOOS) Pain|The Knee Injury and Osteoarthritis Outcome Score (KOOS) Pain subscale was used at baseline and follow-up to assess participant outcomes. The pain subscale is made up of 9 questions and was scored from zero to 100, with zero corresponding to extreme knee problems and 100 corresponding to no knee problems.|units on a scale|Mean|54.86|54.86|Standard Deviation|14.55|14.55|||
3609100|NCT02802878|3459727|B1|||Knee Injury and Osteoarthritis Outcome Score (KOOS) Pain|The Knee Injury and Osteoarthritis Outcome Score (KOOS) Pain subscale was used at baseline and follow-up to assess participant outcomes. The pain subscale is made up of 9 questions and was scored from zero to 100, with zero corresponding to extreme knee problems and 100 corresponding to no knee problems.|units on a scale|Mean|60.85|60.85|Standard Deviation|15.47|15.47|||
3609101|NCT02802878|3459725|B3|||5-Chair Stand Time|The chair stand test is a validated measure of physical performance in adults with knee osteoarthritis. Participants were instructed to stand from a chair (seat height 44.45 cm) 5 times as quickly as they could without using their arms. Two trials were timed and averaged.|seconds|Mean|16.25|16.25|Standard Deviation|8.79|8.79|||
3609102|NCT02802878|3459726|B2|||5-Chair Stand Time|The chair stand test is a validated measure of physical performance in adults with knee osteoarthritis. Participants were instructed to stand from a chair (seat height 44.45 cm) 5 times as quickly as they could without using their arms. Two trials were timed and averaged.|seconds|Mean|15.36|15.36|Standard Deviation|4.35|4.35|||
3609103|NCT02802878|3459727|B1|||5-Chair Stand Time|The chair stand test is a validated measure of physical performance in adults with knee osteoarthritis. Participants were instructed to stand from a chair (seat height 44.45 cm) 5 times as quickly as they could without using their arms. Two trials were timed and averaged.|seconds|Mean|17.13|17.13|Standard Deviation|11.75|11.75|||
3609104|NCT02802878|3459725|B3|||20-Meter Walk Time|A timed 20-meter walk was completed as a measure of lower limb physical performance. Participants were instructed to walk along a 20-meters straight, uninterrupted course as quickly as they could. Timing started when the participant initiated foot movement and stopped when both feet crossed the 20-meter mark. Times for two trials were recorded and the averaged.|seconds|Mean|13.49|13.49|Standard Deviation|3.81|3.81|||
3609105|NCT02802878|3459726|B2|||20-Meter Walk Time|A timed 20-meter walk was completed as a measure of lower limb physical performance. Participants were instructed to walk along a 20-meters straight, uninterrupted course as quickly as they could. Timing started when the participant initiated foot movement and stopped when both feet crossed the 20-meter mark. Times for two trials were recorded and the averaged.|seconds|Mean|13.78|13.78|Standard Deviation|3.22|3.22|||
3609106|NCT02802878|3459727|B1|||20-Meter Walk Time|A timed 20-meter walk was completed as a measure of lower limb physical performance. Participants were instructed to walk along a 20-meters straight, uninterrupted course as quickly as they could. Timing started when the participant initiated foot movement and stopped when both feet crossed the 20-meter mark. Times for two trials were recorded and the averaged.|seconds|Mean|13.12|13.12|Standard Deviation|4.38|4.38|||
3609107|NCT02802878|3459725|B3|||Body Mass Index (BMI)||kg/m^2|Mean|27.87|27.87|Standard Deviation|5.64|5.64|||
3609108|NCT02802878|3459726|B2|||Body Mass Index (BMI)||kg/m^2|Mean|28.45|28.45|Standard Deviation|5.33|5.33|||
3609109|NCT02802878|3459727|B1|||Body Mass Index (BMI)||kg/m^2|Mean|27.29|27.29|Standard Deviation|5.99|5.99|||
3609110|NCT02802878|3459725|B3|||Body Mass||kilograms (kg)|Mean|75.31|75.31|Standard Deviation|15.44|15.44|||
3609111|NCT02802878|3459726|B2|||Body Mass||kilograms (kg)|Mean|76.14|76.14|Standard Deviation|15.56|15.56|||
3609112|NCT02802878|3459727|B1|||Body Mass||kilograms (kg)|Mean|74.49|74.49|Standard Deviation|15.66|15.66|||
3609113|NCT02802878|3459725|B3|||Height||centimeters (cm)|Mean|164.4|164.4|Standard Deviation|6.96|6.96|||
3609114|NCT02802878|3459726|B2|||Height||centimeters (cm)|Mean|163.38|163.38|Standard Deviation|8.53|8.53|||
3609115|NCT02802878|3459727|B1|||Height||centimeters (cm)|Mean|165.38|165.38|Standard Deviation|4.96|4.96|||
3609116|NCT02802878|3459725|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3609117|NCT02802878|3459725|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3609118|NCT02802878|3459726|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3609119|NCT02802878|3459727|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3609120|NCT02802878|3459725|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3609121|NCT02802878|3459726|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3609122|NCT02802878|3459727|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3609123|NCT02802878|3459725|B3|||Age||years|Mean|66.38|66.38|Standard Deviation|8.94|8.94|||
3609124|NCT02802878|3459726|B2|||Age||years|Mean|65.14|65.14|Standard Deviation|9.51|9.51|||
3609125|NCT02802878|3459727|B1|||Age||years|Mean|67.62|67.62|Standard Deviation|8.38|8.38|||
3609126|NCT02802592|3459742|B1|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3609127|NCT02802592|3459742|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3609128|NCT02802592|3459742|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3609129|NCT02802592|3459742|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3609130|NCT02802592|3459742|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3609131|NCT02802592|3459742|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3609132|NCT02802449|3459751|B3|United States||Region of Enrollment||participants|Number|330|330.0||||||
3609133|NCT02802449|3459752|B2|United States||Region of Enrollment||participants|Number|219|219.0||||||
3609134|NCT02802449|3459753|B1|United States||Region of Enrollment||participants|Number|111|111.0||||||
3609138|NCT02802449|3459751|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609139|NCT02802449|3459752|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609140|NCT02802449|3459753|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609141|NCT02802449|3459751|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609142|NCT02802449|3459752|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609143|NCT02802449|3459753|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609144|NCT02802449|3459751|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|330|330.0||||||
3609145|NCT02802449|3459752|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|219|219.0||||||
3609146|NCT02802449|3459753|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
3609147|NCT02802449|3459751|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609148|NCT02802449|3459752|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609149|NCT02802449|3459753|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609150|NCT02802449|3459751|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609151|NCT02802449|3459752|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609152|NCT02802449|3459753|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609153|NCT02802449|3459751|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609154|NCT02802449|3459752|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609155|NCT02802449|3459753|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609156|NCT02802449|3459751|B3||Male|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
3609157|NCT02802449|3459752|B2||Male|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
3609158|NCT02802449|3459753|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3609159|NCT02802449|3459751|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3609160|NCT02802449|3459752|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3609161|NCT02802449|3459753|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3609162|NCT02802449|3459751|B3|||Age||years|Mean|52.0|52.0|Standard Deviation|9.7|9.7|||
3609163|NCT02802449|3459752|B2|||Age||years|Mean|51.3|51.3|Standard Deviation|9.7|9.7|||
3609164|NCT02802449|3459753|B1|||Age||years|Mean|53.3|53.3|Standard Deviation|9.7|9.7|||
3609165|NCT02801396|3459770|B1|China||Region of Enrollment||Participants|Number|101|101.0||||||
3609166|NCT02801396|3459770|B1|Asian||Race/Ethnicity, Customized||Participants|Number|101|101.0||||||
3609167|NCT02801396|3459770|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3609168|NCT02801396|3459770|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3609169|NCT02801396|3459770|B1|||Age||Years|Mean|32.43|32.43|Standard Deviation|9.768|9.768|||
3609170|NCT02801006|3459792|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3609171|NCT02801006|3459792|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3609172|NCT02801006|3459792|B1|||Age||years|Mean|29|29.0|Standard Deviation|8|8.0|||
3609173|NCT02800213|3459809|B3|United States||Region of Enrollment||participants|Number|70|70.0||||||
3609174|NCT02800213|3459810|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
3609175|NCT02800213|3459811|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3609176|NCT02800213|3459809|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3609177|NCT02800213|3459810|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3609178|NCT02800213|3459811|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3609179|NCT02800213|3459809|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3609180|NCT02800213|3459810|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3609181|NCT02800213|3459811|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3609182|NCT02800213|3459809|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3609183|NCT02800213|3459810|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3609184|NCT02800213|3459811|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3609185|NCT02800213|3459809|B3||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
3609186|NCT02800213|3459810|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3609187|NCT02800213|3459811|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3609188|NCT02800213|3459809|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3609189|NCT02800213|3459810|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3609190|NCT02800213|3459811|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3609191|NCT02799784|3459818|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|223|223.0||||||
3609192|NCT02799784|3459818|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3609193|NCT02799784|3459818|B1||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3609194|NCT02799784|3459818|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3609195|NCT02799784|3459818|B1|||Age||Years|Mean|64.4|64.4|Standard Deviation|8.47|8.47|||
3609196|NCT02799472|3459825|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3609197|NCT02799472|3459826|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3609198|NCT02799472|3459827|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3609199|NCT02799472|3459825|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3609200|NCT02799472|3459826|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3609201|NCT02799472|3459827|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3609202|NCT02799472|3459825|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3609203|NCT02799472|3459826|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3609204|NCT02799472|3459827|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3609205|NCT02799472|3459825|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3609206|NCT02799472|3459826|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3609207|NCT02799472|3459827|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3609208|NCT02799472|3459825|B3|||Age||Years|Mean|56.6|56.6|Standard Deviation|10.73|10.73|||
3609209|NCT02799472|3459826|B2|||Age||Years|Mean|59.1|59.1|Standard Deviation|9.47|9.47|||
3609210|NCT02799472|3459827|B1|||Age||Years|Mean|50.3|50.3|Standard Deviation|11.57|11.57|||
3609211|NCT02799082|3459886|B3|moderate||Maximal severity of AK at baseline||participants|Number|90|90.0||||||
3609212|NCT02799082|3459887|B2|moderate||Maximal severity of AK at baseline||participants|Number|61|61.0||||||
3609213|NCT02799082|3459888|B1|moderate||Maximal severity of AK at baseline||participants|Number|29|29.0||||||
3609214|NCT02799082|3459886|B3|mild||Maximal severity of AK at baseline||participants|Number|30|30.0||||||
3609215|NCT02799082|3459887|B2|mild||Maximal severity of AK at baseline||participants|Number|19|19.0||||||
3609216|NCT02799082|3459888|B1|mild||Maximal severity of AK at baseline||participants|Number|11|11.0||||||
3609217|NCT02799082|3459886|B3|Germany||Region of Enrollment||participants|Number|120|120.0||||||
3609218|NCT02799082|3459887|B2|Germany||Region of Enrollment||participants|Number|80|80.0||||||
3609219|NCT02799082|3459888|B1|Germany||Region of Enrollment||participants|Number|40|40.0||||||
3609220|NCT02799082|3459886|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609221|NCT02799082|3459887|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609222|NCT02799082|3459888|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609223|NCT02799082|3459886|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609224|NCT02799082|3459887|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609225|NCT02799082|3459888|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609226|NCT02799082|3459886|B3||White|Race (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
3609227|NCT02799082|3459887|B2||White|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3609228|NCT02799082|3459888|B1||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3609229|NCT02799082|3459886|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609230|NCT02799082|3459887|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609231|NCT02799082|3459888|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609232|NCT02799082|3459886|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609233|NCT02799082|3459887|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609234|NCT02799082|3459888|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609235|NCT02799082|3459886|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609236|NCT02799082|3459887|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609237|NCT02799082|3459888|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609238|NCT02799082|3459886|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609239|NCT02799082|3459887|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609240|NCT02799082|3459888|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609241|NCT02799082|3459886|B3||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3609242|NCT02799082|3459887|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3609243|NCT02799082|3459888|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3609244|NCT02799082|3459886|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3609245|NCT02799082|3459887|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3609246|NCT02799082|3459888|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3609247|NCT02799082|3459886|B3|||Age||years|Mean|70.5|70.5|Standard Deviation|5.7|5.7|||
3609248|NCT02799082|3459887|B2|||Age||years|Mean|70.4|70.4|Standard Deviation|5.2|5.2|||
3609249|NCT02799082|3459888|B1|||Age||years|Mean|70.8|70.8|Standard Deviation|6.7|6.7|||
3609250|NCT02799082|3459886|B3||>=65 years|Age||Participants|Count of Participants|105|105.0||||||
3609251|NCT02799082|3459887|B2||>=65 years|Age||Participants|Count of Participants|70|70.0||||||
3609252|NCT02799082|3459888|B1||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
3609253|NCT02799082|3459886|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3609254|NCT02799082|3459887|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3609255|NCT02799082|3459888|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3609256|NCT02799082|3459886|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3609258|NCT02799082|3459888|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3609259|NCT02799069|3459923|B4|||Number of individual lesions||individual lesions|Number|3551|3551.0||||||
3609260|NCT02799069|3459924|B3|||Number of individual lesions||individual lesions|Number|1557|1557.0||||||
3609261|NCT02799069|3459925|B2|||Number of individual lesions||individual lesions|Number|1504|1504.0||||||
3609262|NCT02799069|3459926|B1|||Number of individual lesions||individual lesions|Number|490|490.0||||||
3609263|NCT02799069|3459923|B4|Europe||Region of Enrollment||participants|Number|570|570.0||||||
3609264|NCT02799069|3459924|B3|Europe||Region of Enrollment||participants|Number|246|246.0||||||
3609265|NCT02799069|3459925|B2|Europe||Region of Enrollment||participants|Number|248|248.0||||||
3609266|NCT02799069|3459926|B1|Europe||Region of Enrollment||participants|Number|76|76.0||||||
3609267|NCT02799069|3459923|B4||Male|Sex: Female, Male||Participants|Count of Participants|479|479.0||||||
3609268|NCT02799069|3459924|B3||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
3609269|NCT02799069|3459925|B2||Male|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
3609270|NCT02799069|3459926|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3609271|NCT02799069|3459923|B4||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3609272|NCT02799069|3459924|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3609273|NCT02799069|3459925|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3609274|NCT02799069|3459926|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3609275|NCT02799069|3459923|B4|||Age||years|Mean|70.7|70.7|Standard Deviation|7.01|7.01|||
3609276|NCT02799069|3459924|B3|||Age||years|Mean|71.0|71.0|Standard Deviation|6.93|6.93|||
3609277|NCT02799069|3459925|B2|||Age||years|Mean|70.2|70.2|Standard Deviation|7.18|7.18|||
3609278|NCT02799069|3459926|B1|||Age||years|Mean|71.5|71.5|Standard Deviation|6.68|6.68|||
3609279|NCT02799069|3459923|B4||>=65 years|Age||Participants|Count of Participants|476|476.0||||||
3609280|NCT02799069|3459924|B3||>=65 years|Age||Participants|Count of Participants|208|208.0||||||
3609281|NCT02799069|3459925|B2||>=65 years|Age||Participants|Count of Participants|201|201.0||||||
3609282|NCT02799069|3459926|B1||>=65 years|Age||Participants|Count of Participants|67|67.0||||||
3609283|NCT02799069|3459923|B4||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
3609284|NCT02799069|3459924|B3||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3609285|NCT02799069|3459925|B2||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3609286|NCT02799069|3459926|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3609287|NCT02799069|3459923|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3609288|NCT02799069|3459924|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3609289|NCT02799069|3459925|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3609290|NCT02799069|3459926|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3609291|NCT02798315|3460038|B1|||Patient Activation Measure 13 (PAM-13)|The PAM-13 item scale is a measure used to assess the patient knowledge, skill, and confidence for self-management. Based on responses to the 13-item measure, the score is calculated by adding up the raw scores (range of the sum: 13 – 52) and mapping up the value onto a scale of 0–100 indicating strength of agreement with the 13 items. A higher score indicates that the patient is likely to participate more actively in health care processes and takes more responsibility for his or her health.|units on a scale|Median|55.0|55.0|Inter-Quartile Range|||47.9|58.8|
3609292|NCT02798315|3460038|B1|Other (Not Specified)||Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3609293|NCT02798315|3460038|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3609294|NCT02798315|3460038|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3609295|NCT02798315|3460038|B1|||Age||years|Mean|49|49.0|Standard Deviation|13.9|13.9|||
3609296|NCT02798289|3460052|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
3609297|NCT02798289|3460052|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3609298|NCT02798289|3460052|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3609299|NCT02798289|3460052|B1|||Age||years|Mean|60.2|60.2|Standard Deviation|15.3|15.3|||
3609300|NCT02797821|3460056|B4|||Baseline Pyridoxal 5'-Phosphate (PLP)||nanogram (ng)/milliliter (mL)|Mean|309.7|309.7|Standard Deviation|346.99|346.99|||
3609301|NCT02797821|3460057|B3|||Baseline Pyridoxal 5'-Phosphate (PLP)||nanogram (ng)/milliliter (mL)|Mean|229.5|229.5|Standard Deviation|321.43|321.43|||
3609302|NCT02797821|3460058|B2|||Baseline Pyridoxal 5'-Phosphate (PLP)||nanogram (ng)/milliliter (mL)|Mean|382.1|382.1|Standard Deviation|385.89|385.89|||
3609303|NCT02797821|3460059|B1|||Baseline Pyridoxal 5'-Phosphate (PLP)||nanogram (ng)/milliliter (mL)|Mean|309.5|309.5|Standard Deviation|349.16|349.16|||
3609304|NCT02797821|3460056|B4|||Baseline Inorganic Pyrophosphate (PPi)||μM (micromolar)|Mean|5.2|5.2|Standard Deviation|1.23|1.23|||
3609305|NCT02797821|3460057|B3|||Baseline Inorganic Pyrophosphate (PPi)||μM (micromolar)|Mean|5|5.0|Standard Deviation|0.86|0.86|||
3609306|NCT02797821|3460058|B2|||Baseline Inorganic Pyrophosphate (PPi)||μM (micromolar)|Mean|5.3|5.3|Standard Deviation|1.22|1.22|||
3609307|NCT02797821|3460059|B1|||Baseline Inorganic Pyrophosphate (PPi)||μM (micromolar)|Mean|5.4|5.4|Standard Deviation|1.64|1.64|||
3609308|NCT02797821|3460056|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609309|NCT02797821|3460057|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609310|NCT02797821|3460058|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609311|NCT02797821|3460059|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609312|NCT02797821|3460056|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3609313|NCT02797821|3460057|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609314|NCT02797821|3460058|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609315|NCT02797821|3460059|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3609316|NCT02797821|3460056|B4||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3609317|NCT02797821|3460057|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3609318|NCT02797821|3460058|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3609319|NCT02797821|3460059|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3609320|NCT02797821|3460056|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609321|NCT02797821|3460057|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609322|NCT02797821|3460058|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609323|NCT02797821|3460059|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609324|NCT02797821|3460056|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609325|NCT02797821|3460057|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609326|NCT02797821|3460058|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609327|NCT02797821|3460059|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609328|NCT02797821|3460056|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609329|NCT02797821|3460057|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609330|NCT02797821|3460058|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609331|NCT02797821|3460059|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609332|NCT02797821|3460056|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609333|NCT02797821|3460057|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609334|NCT02797821|3460058|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609335|NCT02797821|3460059|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609336|NCT02797821|3460056|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609337|NCT02797821|3460057|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609338|NCT02797821|3460058|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609339|NCT02797821|3460059|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609340|NCT02797821|3460056|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3609341|NCT02797821|3460057|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3609342|NCT02797821|3460058|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3609343|NCT02797821|3460059|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3609344|NCT02797821|3460056|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609345|NCT02797821|3460057|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609346|NCT02797821|3460058|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609347|NCT02797821|3460059|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609348|NCT02797821|3460056|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3609349|NCT02797821|3460057|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3609350|NCT02797821|3460058|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3609351|NCT02797821|3460059|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3609352|NCT02797821|3460056|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3609353|NCT02797821|3460057|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3609354|NCT02797821|3460058|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3609355|NCT02797821|3460059|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3609356|NCT02797821|3460056|B4|||Age||years|Mean|44.8|44.8|Standard Deviation|16.94|16.94|||
3609357|NCT02797821|3460057|B3|||Age||years|Mean|50|50.0|Standard Deviation|17.01|17.01|||
3609358|NCT02797821|3460058|B2|||Age||years|Mean|42.7|42.7|Standard Deviation|16.77|16.77|||
3609359|NCT02797821|3460059|B1|||Age||years|Mean|41.5|41.5|Standard Deviation|17.90|17.9|||
3609360|NCT02797522|3460072|B12||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3609361|NCT02797522|3460073|B11||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3609362|NCT02797522|3460074|B10||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3609363|NCT02797522|3460075|B9||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3609364|NCT02797522|3460076|B8||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3609365|NCT02797522|3460077|B7||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3609366|NCT02797522|3460078|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3609367|NCT02797522|3460079|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3609368|NCT02797522|3460080|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3609369|NCT02797522|3460081|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3609370|NCT02797522|3460082|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3609371|NCT02797522|3460083|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3609372|NCT02797522|3460072|B12||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3609373|NCT02797522|3460073|B11||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3609374|NCT02797522|3460074|B10||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3609375|NCT02797522|3460075|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3609376|NCT02797522|3460076|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3609377|NCT02797522|3460077|B7||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3609378|NCT02797522|3460078|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3609379|NCT02797522|3460079|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3609380|NCT02797522|3460080|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3609381|NCT02797522|3460081|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3609382|NCT02797522|3460082|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3609383|NCT02797522|3460083|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3609384|NCT02797522|3460072|B12|||Age||years|Mean|30.0|30.0|Standard Deviation|8.49|8.49|||
3609385|NCT02797522|3460073|B11|||Age||years|Mean|36.0|36.0|Standard Deviation|NA||||1 participant in cohort
3609386|NCT02797522|3460074|B10|||Age||years|Mean|44.3|44.3|Standard Deviation|3.69|3.69|||
3609387|NCT02797522|3460075|B9|||Age||years|Mean|44.5|44.5|Standard Deviation|14.85|14.85|||
3609388|NCT02797522|3460076|B8|||Age||years|Mean|46.3|46.3|Standard Deviation|10.63|10.63|||
3609389|NCT02797522|3460077|B7|||Age||years|Mean|28.3|28.3|Standard Deviation|5.69|5.69|||
3609390|NCT02797522|3460078|B6|||Age||years|Mean|23.5|23.5|Standard Deviation|4.04|4.04|||
3609391|NCT02797522|3460079|B5|||Age||years|Mean|22.3|22.3|Standard Deviation|3.59|3.59|||
3609392|NCT02797522|3460080|B4|||Age||years|Mean|22.5|22.5|Standard Deviation|1.29|1.29|||
3609393|NCT02797522|3460081|B3|||Age||years|Mean|23.3|23.3|Standard Deviation|3.30|3.3|||
3609394|NCT02797522|3460082|B2|||Age||years|Mean|27.8|27.8|Standard Deviation|10.90|10.9|||
3609395|NCT02797522|3460083|B1|||Age||years|Mean|26.8|26.8|Standard Deviation|8.26|8.26|||
3609396|NCT02797132|3460199|B1|Part B (>=14 kg Weight)|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609397|NCT02797132|3460199|B1|Part B (>=14 kg Weight)|More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609398|NCT02797132|3460199|B1|Part B (>=14 kg Weight)|White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3609399|NCT02797132|3460199|B1|Part B (>=14 kg Weight)|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609400|NCT02797132|3460199|B1|Part B (>=14 kg Weight)|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609401|NCT02797132|3460199|B1|Part B (>=14 kg Weight)|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609402|NCT02797132|3460199|B1|Part B (>=14 kg Weight)|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609403|NCT02797132|3460199|B1|Part B (<14 kg Weight)|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3609404|NCT02797132|3460199|B1|Part B (<14 kg Weight)|More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609405|NCT02797132|3460199|B1|Part B (<14 kg Weight)|White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3609406|NCT02797132|3460199|B1|Part B (<14 kg Weight)|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609407|NCT02797132|3460199|B1|Part B (<14 kg Weight)|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609408|NCT02797132|3460199|B1|Part B (<14 kg Weight)|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609409|NCT02797132|3460199|B1|Part B (<14 kg Weight)|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609410|NCT02797132|3460199|B1|Part A (>=14 kg Weight)|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609411|NCT02797132|3460199|B1|Part A (>=14 kg Weight)|More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609412|NCT02797132|3460199|B1|Part A (>=14 kg Weight)|White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3609413|NCT02797132|3460199|B1|Part A (>=14 kg Weight)|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609414|NCT02797132|3460199|B1|Part A (>=14 kg Weight)|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609415|NCT02797132|3460199|B1|Part A (>=14 kg Weight)|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609416|NCT02797132|3460199|B1|Part A (>=14 kg Weight)|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609417|NCT02797132|3460199|B1|Part A (<14 kg Weight)|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609418|NCT02797132|3460199|B1|Part A (<14 kg Weight)|More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609419|NCT02797132|3460199|B1|Part A (<14 kg Weight)|White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3609420|NCT02797132|3460199|B1|Part A (<14 kg Weight)|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609421|NCT02797132|3460199|B1|Part A (<14 kg Weight)|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609422|NCT02797132|3460199|B1|Part A (<14 kg Weight)|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609423|NCT02797132|3460199|B1|Part A (<14 kg Weight)|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609424|NCT02797132|3460199|B1|Part B (>=14 kg Weight)|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609425|NCT02797132|3460199|B1|Part B (>=14 kg Weight)|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3609426|NCT02797132|3460199|B1|Part B (>=14 kg Weight)|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3609427|NCT02797132|3460199|B1|Part B (<14 kg Weight)|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609428|NCT02797132|3460199|B1|Part B (<14 kg Weight)|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3609429|NCT02797132|3460199|B1|Part B (<14 kg Weight)|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3609430|NCT02797132|3460199|B1|Part A (>=14 kg Weight)|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609431|NCT02797132|3460199|B1|Part A (>=14 kg Weight)|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3609432|NCT02797132|3460199|B1|Part A (>=14 kg Weight)|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609433|NCT02797132|3460199|B1|Part A (<14 kg Weight)|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609434|NCT02797132|3460199|B1|Part A (<14 kg Weight)|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3609435|NCT02797132|3460199|B1|Part A (<14 kg Weight)|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609436|NCT02797132|3460199|B1|Part B (>=14 kg Weight)|Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3609437|NCT02797132|3460199|B1|Part B (>=14 kg Weight)|Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3609438|NCT02797132|3460199|B1|Part B (<14 kg Weight)|Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3609439|NCT02797132|3460199|B1|Part B (<14 kg Weight)|Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3609440|NCT02797132|3460199|B1|Part A (>=14 kg Weight)|Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3609441|NCT02797132|3460199|B1|Part A (>=14 kg Weight)|Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3609442|NCT02797132|3460199|B1|Part A (<14 kg Weight)|Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3609443|NCT02797132|3460199|B1|Part A (<14 kg Weight)|Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3609444|NCT02797132|3460199|B1|Part B (>=14 kg Weight)||Age||months|Mean|49.9|49.9|Standard Deviation|10.63|10.63|||
3609445|NCT02797132|3460199|B1|Part B (<14 kg Weight)||Age||months|Mean|31.6|31.6|Standard Deviation|5.05|5.05|||
3609446|NCT02797132|3460199|B1|Part A (>=14 kg Weight)||Age||months|Mean|48.0|48.0|Standard Deviation|11.11|11.11|||
3609447|NCT02797132|3460199|B1|Part A (<14 kg Weight)||Age||months|Mean|27.0|27.0|Standard Deviation|6.00|6.0|||
3609448|NCT02797080|3460251|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3609449|NCT02797080|3460251|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609450|NCT02797080|3460251|B1||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3609451|NCT02797080|3460251|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609452|NCT02797080|3460251|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609453|NCT02797080|3460251|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609454|NCT02797080|3460251|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609455|NCT02797080|3460251|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609456|NCT02797080|3460251|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3609457|NCT02797080|3460251|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3609458|NCT02797080|3460251|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3609459|NCT02797080|3460251|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3609460|NCT02797080|3460251|B1|||Age||years|Mean|16.4|16.4|Standard Deviation|3.66|3.66|||
3609461|NCT02797054|3460255|B4|Race|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3609462|NCT02797054|3460256|B3|Race|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3609463|NCT02797054|3460257|B2|Race|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3609464|NCT02797054|3460258|B1|Race|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3609465|NCT02797054|3460255|B4|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|881|881.0||||||
3609466|NCT02797054|3460256|B3|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|319|319.0||||||
3609467|NCT02797054|3460257|B2|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|277|277.0||||||
3609468|NCT02797054|3460258|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|285|285.0||||||
3609469|NCT02797054|3460255|B4|Race|American Indian|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3609470|NCT02797054|3460256|B3|Race|American Indian|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3609471|NCT02797054|3460257|B2|Race|American Indian|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3609472|NCT02797054|3460258|B1|Race|American Indian|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3609473|NCT02797054|3460255|B4|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3609474|NCT02797054|3460256|B3|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3609475|NCT02797054|3460257|B2|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3609476|NCT02797054|3460258|B1|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3609477|NCT02797054|3460255|B4|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3609478|NCT02797054|3460256|B3|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3609479|NCT02797054|3460257|B2|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3609480|NCT02797054|3460258|B1|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3609481|NCT02797054|3460255|B4|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|291|291.0||||||
3609482|NCT02797054|3460256|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|105|105.0||||||
3609483|NCT02797054|3460257|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|98|98.0||||||
3609484|NCT02797054|3460258|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|88|88.0||||||
3609485|NCT02797054|3460255|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3609486|NCT02797054|3460256|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3609487|NCT02797054|3460257|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609488|NCT02797054|3460258|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3609489|NCT02797054|3460255|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|117|117.0||||||
3609490|NCT02797054|3460256|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3609491|NCT02797054|3460257|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3609492|NCT02797054|3460258|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3609493|NCT02797054|3460255|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1083|1083.0||||||
3609494|NCT02797054|3460256|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|392|392.0||||||
3609495|NCT02797054|3460257|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|342|342.0||||||
3609496|NCT02797054|3460258|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|349|349.0||||||
3609497|NCT02797054|3460255|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3609498|NCT02797054|3460256|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3609499|NCT02797054|3460257|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3609500|NCT02797054|3460258|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3609501|NCT02797054|3460255|B4||Female|Sex: Female, Male||Participants|Count of Participants|1202|1202.0||||||
3609502|NCT02797054|3460256|B3||Female|Sex: Female, Male||Participants|Count of Participants|434|434.0||||||
3609503|NCT02797054|3460257|B2||Female|Sex: Female, Male||Participants|Count of Participants|382|382.0||||||
3609504|NCT02797054|3460258|B1||Female|Sex: Female, Male||Participants|Count of Participants|386|386.0||||||
3609505|NCT02797054|3460255|B4|Age||Age, Customized||Years|Mean|31.60|31.6|Full Range|||17.0|60.0|
3609506|NCT02797054|3460256|B3|Age||Age, Customized||Years|Mean|31.60|31.6|Full Range|||17.0|60.0|
3609507|NCT02797054|3460257|B2|Age||Age, Customized||Years|Mean|31.18|31.18|Full Range|||17.0|55.0|
3609508|NCT02797054|3460258|B1|Age||Age, Customized||Years|Mean|32.01|32.01|Full Range|||18.0|59.0|
3609509|NCT02796963|3460289|B5||Yes|Syphilis testing|Had syphilis test in the past three months|Participants|Count of Participants|68|68.0||||||
3609510|NCT02796963|3460290|B4||Yes|Syphilis testing|Had syphilis test in the past three months|Participants|Count of Participants|19|19.0||||||
3609511|NCT02796963|3460291|B3||Yes|Syphilis testing|Had syphilis test in the past three months|Participants|Count of Participants|15|15.0||||||
3609512|NCT02796963|3460292|B2||Yes|Syphilis testing|Had syphilis test in the past three months|Participants|Count of Participants|11|11.0||||||
3609513|NCT02796963|3460293|B1||Yes|Syphilis testing|Had syphilis test in the past three months|Participants|Count of Participants|23|23.0||||||
3609514|NCT02796963|3460289|B5||No|Syphilis testing|Had syphilis test in the past three months|Participants|Count of Participants|1313|1313.0||||||
3609515|NCT02796963|3460290|B4||No|Syphilis testing|Had syphilis test in the past three months|Participants|Count of Participants|335|335.0||||||
3609516|NCT02796963|3460291|B3||No|Syphilis testing|Had syphilis test in the past three months|Participants|Count of Participants|301|301.0||||||
3609517|NCT02796963|3460292|B2||No|Syphilis testing|Had syphilis test in the past three months|Participants|Count of Participants|317|317.0||||||
3609518|NCT02796963|3460293|B1||No|Syphilis testing|Had syphilis test in the past three months|Participants|Count of Participants|360|360.0||||||
3609519|NCT02796963|3460289|B5||Yes|Condomless sex|Ever had condomless sex in the past three months|Participants|Count of Participants|1005|1005.0||||||
3609520|NCT02796963|3460290|B4||Yes|Condomless sex|Ever had condomless sex in the past three months|Participants|Count of Participants|256|256.0||||||
3609521|NCT02796963|3460291|B3||Yes|Condomless sex|Ever had condomless sex in the past three months|Participants|Count of Participants|231|231.0||||||
3609522|NCT02796963|3460292|B2||Yes|Condomless sex|Ever had condomless sex in the past three months|Participants|Count of Participants|236|236.0||||||
3609523|NCT02796963|3460293|B1||Yes|Condomless sex|Ever had condomless sex in the past three months|Participants|Count of Participants|282|282.0||||||
3609524|NCT02796963|3460289|B5||No|Condomless sex|Ever had condomless sex in the past three months|Participants|Count of Participants|376|376.0||||||
3609525|NCT02796963|3460290|B4||No|Condomless sex|Ever had condomless sex in the past three months|Participants|Count of Participants|98|98.0||||||
3609526|NCT02796963|3460291|B3||No|Condomless sex|Ever had condomless sex in the past three months|Participants|Count of Participants|85|85.0||||||
3609527|NCT02796963|3460292|B2||No|Condomless sex|Ever had condomless sex in the past three months|Participants|Count of Participants|92|92.0||||||
3609528|NCT02796963|3460293|B1||No|Condomless sex|Ever had condomless sex in the past three months|Participants|Count of Participants|101|101.0||||||
3609529|NCT02796963|3460289|B5||Not disclosed to others|Disclosure of sexual orientation||Participants|Count of Participants|483|483.0||||||
3609530|NCT02796963|3460290|B4||Not disclosed to others|Disclosure of sexual orientation||Participants|Count of Participants|132|132.0||||||
3609531|NCT02796963|3460291|B3||Not disclosed to others|Disclosure of sexual orientation||Participants|Count of Participants|107|107.0||||||
3609532|NCT02796963|3460292|B2||Not disclosed to others|Disclosure of sexual orientation||Participants|Count of Participants|123|123.0||||||
3609533|NCT02796963|3460293|B1||Not disclosed to others|Disclosure of sexual orientation||Participants|Count of Participants|121|121.0||||||
3609534|NCT02796963|3460289|B5||Disclosed to others|Disclosure of sexual orientation||Participants|Count of Participants|898|898.0||||||
3609535|NCT02796963|3460290|B4||Disclosed to others|Disclosure of sexual orientation||Participants|Count of Participants|222|222.0||||||
3609536|NCT02796963|3460291|B3||Disclosed to others|Disclosure of sexual orientation||Participants|Count of Participants|209|209.0||||||
3609537|NCT02796963|3460292|B2||Disclosed to others|Disclosure of sexual orientation||Participants|Count of Participants|205|205.0||||||
3609538|NCT02796963|3460293|B1||Disclosed to others|Disclosure of sexual orientation||Participants|Count of Participants|262|262.0||||||
3609539|NCT02796963|3460289|B5||Bisexual|Sexual orientation||Participants|Count of Participants|401|401.0||||||
3609540|NCT02796963|3460290|B4||Bisexual|Sexual orientation||Participants|Count of Participants|125|125.0||||||
3609541|NCT02796963|3460291|B3||Bisexual|Sexual orientation||Participants|Count of Participants|86|86.0||||||
3609542|NCT02796963|3460292|B2||Bisexual|Sexual orientation||Participants|Count of Participants|103|103.0||||||
3609543|NCT02796963|3460293|B1||Bisexual|Sexual orientation||Participants|Count of Participants|87|87.0||||||
3609544|NCT02796963|3460289|B5||Gay|Sexual orientation||Participants|Count of Participants|980|980.0||||||
3609545|NCT02796963|3460290|B4||Gay|Sexual orientation||Participants|Count of Participants|229|229.0||||||
3609546|NCT02796963|3460291|B3||Gay|Sexual orientation||Participants|Count of Participants|230|230.0||||||
3609547|NCT02796963|3460292|B2||Gay|Sexual orientation||Participants|Count of Participants|225|225.0||||||
3609548|NCT02796963|3460293|B1||Gay|Sexual orientation||Participants|Count of Participants|296|296.0||||||
3609549|NCT02796963|3460289|B5||College or beyond|Highest education||Participants|Count of Participants|898|898.0||||||
3609550|NCT02796963|3460290|B4||College or beyond|Highest education||Participants|Count of Participants|227|227.0||||||
3609551|NCT02796963|3460291|B3||College or beyond|Highest education||Participants|Count of Participants|198|198.0||||||
3609552|NCT02796963|3460292|B2||College or beyond|Highest education||Participants|Count of Participants|222|222.0||||||
3609553|NCT02796963|3460293|B1||College or beyond|Highest education||Participants|Count of Participants|251|251.0||||||
3609554|NCT02796963|3460289|B5||High school or below|Highest education||Participants|Count of Participants|483|483.0||||||
3609555|NCT02796963|3460290|B4||High school or below|Highest education||Participants|Count of Participants|127|127.0||||||
3609556|NCT02796963|3460291|B3||High school or below|Highest education||Participants|Count of Participants|118|118.0||||||
3609557|NCT02796963|3460292|B2||High school or below|Highest education||Participants|Count of Participants|106|106.0||||||
3609558|NCT02796963|3460293|B1||High school or below|Highest education||Participants|Count of Participants|132|132.0||||||
3609559|NCT02796963|3460289|B5||>12500|Annual income, US$||Participants|Count of Participants|129|129.0||||||
3609560|NCT02796963|3460290|B4||>12500|Annual income, US$||Participants|Count of Participants|36|36.0||||||
3609561|NCT02796963|3460291|B3||>12500|Annual income, US$||Participants|Count of Participants|36|36.0||||||
3609562|NCT02796963|3460292|B2||>12500|Annual income, US$||Participants|Count of Participants|22|22.0||||||
3609563|NCT02796963|3460293|B1||>12500|Annual income, US$||Participants|Count of Participants|35|35.0||||||
3609564|NCT02796963|3460289|B5||9501-12500|Annual income, US$||Participants|Count of Participants|234|234.0||||||
3609565|NCT02796963|3460290|B4||9501-12500|Annual income, US$||Participants|Count of Participants|67|67.0||||||
3609566|NCT02796963|3460291|B3||9501-12500|Annual income, US$||Participants|Count of Participants|52|52.0||||||
3609567|NCT02796963|3460292|B2||9501-12500|Annual income, US$||Participants|Count of Participants|50|50.0||||||
3609568|NCT02796963|3460293|B1||9501-12500|Annual income, US$||Participants|Count of Participants|65|65.0||||||
3609569|NCT02796963|3460289|B5||6001-9500|Annual income, US$||Participants|Count of Participants|434|434.0||||||
3609570|NCT02796963|3460290|B4||6001-9500|Annual income, US$||Participants|Count of Participants|120|120.0||||||
3609571|NCT02796963|3460291|B3||6001-9500|Annual income, US$||Participants|Count of Participants|93|93.0||||||
3609572|NCT02796963|3460292|B2||6001-9500|Annual income, US$||Participants|Count of Participants|88|88.0||||||
3609573|NCT02796963|3460293|B1||6001-9500|Annual income, US$||Participants|Count of Participants|133|133.0||||||
3609574|NCT02796963|3460289|B5||3000-6000|Annual income, US$||Participants|Count of Participants|299|299.0||||||
3609575|NCT02796963|3460290|B4||3000-6000|Annual income, US$||Participants|Count of Participants|67|67.0||||||
3609576|NCT02796963|3460291|B3||3000-6000|Annual income, US$||Participants|Count of Participants|71|71.0||||||
3609577|NCT02796963|3460292|B2||3000-6000|Annual income, US$||Participants|Count of Participants|86|86.0||||||
3609578|NCT02796963|3460293|B1||3000-6000|Annual income, US$||Participants|Count of Participants|75|75.0||||||
3609579|NCT02796963|3460289|B5||<3000|Annual income, US$||Participants|Count of Participants|285|285.0||||||
3609580|NCT02796963|3460290|B4||<3000|Annual income, US$||Participants|Count of Participants|64|64.0||||||
3609581|NCT02796963|3460291|B3||<3000|Annual income, US$||Participants|Count of Participants|64|64.0||||||
3609582|NCT02796963|3460292|B2||<3000|Annual income, US$||Participants|Count of Participants|82|82.0||||||
3609583|NCT02796963|3460293|B1||<3000|Annual income, US$||Participants|Count of Participants|75|75.0||||||
3609584|NCT02796963|3460289|B5||Married|Marital Status||Participants|Count of Participants|187|187.0||||||
3609585|NCT02796963|3460290|B4||Married|Marital Status||Participants|Count of Participants|55|55.0||||||
3609586|NCT02796963|3460291|B3||Married|Marital Status||Participants|Count of Participants|48|48.0||||||
3609587|NCT02796963|3460292|B2||Married|Marital Status||Participants|Count of Participants|38|38.0||||||
3609588|NCT02796963|3460293|B1||Married|Marital Status||Participants|Count of Participants|46|46.0||||||
3609589|NCT02796963|3460289|B5||Never married|Marital Status||Participants|Count of Participants|1194|1194.0||||||
3609590|NCT02796963|3460290|B4||Never married|Marital Status||Participants|Count of Participants|299|299.0||||||
3609591|NCT02796963|3460291|B3||Never married|Marital Status||Participants|Count of Participants|268|268.0||||||
3609592|NCT02796963|3460292|B2||Never married|Marital Status||Participants|Count of Participants|290|290.0||||||
3609593|NCT02796963|3460293|B1||Never married|Marital Status||Participants|Count of Participants|337|337.0||||||
3609594|NCT02796963|3460289|B5|China||Region of Enrollment||Participants|Count of Participants|1381|1381.0||||||
3609595|NCT02796963|3460290|B4|China||Region of Enrollment||Participants|Count of Participants|354|354.0||||||
3609596|NCT02796963|3460291|B3|China||Region of Enrollment||Participants|Count of Participants|316|316.0||||||
3609597|NCT02796963|3460292|B2|China||Region of Enrollment||Participants|Count of Participants|328|328.0||||||
3609598|NCT02796963|3460293|B1|China||Region of Enrollment||Participants|Count of Participants|383|383.0||||||
3609599|NCT02796963|3460289|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1381|1381.0||||||
3609600|NCT02796963|3460290|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|354|354.0||||||
3609601|NCT02796963|3460291|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|316|316.0||||||
3609602|NCT02796963|3460292|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|328|328.0||||||
3609603|NCT02796963|3460293|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|383|383.0||||||
3609604|NCT02796963|3460289|B5||Transgender individuals|Sex/Gender, Customized||Participants|Count of Participants|68|68.0||||||
3609605|NCT02796963|3460290|B4||Transgender individuals|Sex/Gender, Customized||Participants|Count of Participants|20|20.0||||||
3609606|NCT02796963|3460291|B3||Transgender individuals|Sex/Gender, Customized||Participants|Count of Participants|15|15.0||||||
3609607|NCT02796963|3460292|B2||Transgender individuals|Sex/Gender, Customized||Participants|Count of Participants|14|14.0||||||
3609608|NCT02796963|3460293|B1||Transgender individuals|Sex/Gender, Customized||Participants|Count of Participants|19|19.0||||||
3609609|NCT02796963|3460289|B5||Male|Sex/Gender, Customized||Participants|Count of Participants|1313|1313.0||||||
3609610|NCT02796963|3460290|B4||Male|Sex/Gender, Customized||Participants|Count of Participants|334|334.0||||||
3609611|NCT02796963|3460291|B3||Male|Sex/Gender, Customized||Participants|Count of Participants|301|301.0||||||
3609612|NCT02796963|3460292|B2||Male|Sex/Gender, Customized||Participants|Count of Participants|314|314.0||||||
3609613|NCT02796963|3460293|B1||Male|Sex/Gender, Customized||Participants|Count of Participants|364|364.0||||||
3609614|NCT02796963|3460289|B5||>30 years|Age, Customized||Participants|Count of Participants|246|246.0||||||
3609615|NCT02796963|3460290|B4||>30 years|Age, Customized||Participants|Count of Participants|61|61.0||||||
3609616|NCT02796963|3460291|B3||>30 years|Age, Customized||Participants|Count of Participants|61|61.0||||||
3609617|NCT02796963|3460292|B2||>30 years|Age, Customized||Participants|Count of Participants|52|52.0||||||
3609618|NCT02796963|3460293|B1||>30 years|Age, Customized||Participants|Count of Participants|72|72.0||||||
3609619|NCT02796963|3460289|B5||26-30 years|Age, Customized||Participants|Count of Participants|355|355.0||||||
3609620|NCT02796963|3460290|B4||26-30 years|Age, Customized||Participants|Count of Participants|95|95.0||||||
3609621|NCT02796963|3460291|B3||26-30 years|Age, Customized||Participants|Count of Participants|80|80.0||||||
3609622|NCT02796963|3460292|B2||26-30 years|Age, Customized||Participants|Count of Participants|80|80.0||||||
3609623|NCT02796963|3460293|B1||26-30 years|Age, Customized||Participants|Count of Participants|100|100.0||||||
3609624|NCT02796963|3460289|B5||21-25 years|Age, Customized||Participants|Count of Participants|469|469.0||||||
3609625|NCT02796963|3460290|B4||21-25 years|Age, Customized||Participants|Count of Participants|111|111.0||||||
3609626|NCT02796963|3460291|B3||21-25 years|Age, Customized||Participants|Count of Participants|94|94.0||||||
3609627|NCT02796963|3460292|B2||21-25 years|Age, Customized||Participants|Count of Participants|118|118.0||||||
3609628|NCT02796963|3460293|B1||21-25 years|Age, Customized||Participants|Count of Participants|146|146.0||||||
3609629|NCT02796963|3460289|B5||16-20 years|Age, Customized||Participants|Count of Participants|311|311.0||||||
3609630|NCT02796963|3460290|B4||16-20 years|Age, Customized||Participants|Count of Participants|87|87.0||||||
3609631|NCT02796963|3460291|B3||16-20 years|Age, Customized||Participants|Count of Participants|81|81.0||||||
3609632|NCT02796963|3460292|B2||16-20 years|Age, Customized||Participants|Count of Participants|78|78.0||||||
3609633|NCT02796963|3460293|B1||16-20 years|Age, Customized||Participants|Count of Participants|65|65.0||||||
3609634|NCT02796677|3460358|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609635|NCT02796677|3460359|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609636|NCT02796677|3460360|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609637|NCT02796677|3460361|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609638|NCT02796677|3460362|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609639|NCT02796677|3460358|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609640|NCT02796677|3460359|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609641|NCT02796677|3460360|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609642|NCT02796677|3460361|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609643|NCT02796677|3460362|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609644|NCT02796677|3460358|B5||White|Race (NIH/OMB)||Participants|Count of Participants|1501|1501.0||||||
3609645|NCT02796677|3460359|B4||White|Race (NIH/OMB)||Participants|Count of Participants|457|457.0||||||
3609646|NCT02796677|3460360|B3||White|Race (NIH/OMB)||Participants|Count of Participants|303|303.0||||||
3609647|NCT02796677|3460361|B2||White|Race (NIH/OMB)||Participants|Count of Participants|444|444.0||||||
3609648|NCT02796677|3460362|B1||White|Race (NIH/OMB)||Participants|Count of Participants|297|297.0||||||
3609649|NCT02796677|3460358|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3609650|NCT02796677|3460359|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3609651|NCT02796677|3460360|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3609652|NCT02796677|3460361|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3609653|NCT02796677|3460362|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3609654|NCT02796677|3460358|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609655|NCT02796677|3460359|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609656|NCT02796677|3460360|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609657|NCT02796677|3460361|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609658|NCT02796677|3460362|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609659|NCT02796677|3460358|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3609660|NCT02796677|3460359|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3609661|NCT02796677|3460360|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609662|NCT02796677|3460361|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3609663|NCT02796677|3460362|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609664|NCT02796677|3460358|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3609665|NCT02796677|3460359|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609666|NCT02796677|3460360|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609667|NCT02796677|3460361|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3609668|NCT02796677|3460362|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609669|NCT02796677|3460358|B5||Male|Sex: Female, Male||Participants|Count of Participants|963|963.0||||||
3609670|NCT02796677|3460359|B4||Male|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
3609671|NCT02796677|3460360|B3||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
3609672|NCT02796677|3460361|B2||Male|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
3609673|NCT02796677|3460362|B1||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
3609674|NCT02796677|3460358|B5||Female|Sex: Female, Male||Participants|Count of Participants|620|620.0||||||
3609675|NCT02796677|3460359|B4||Female|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
3609676|NCT02796677|3460360|B3||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3609677|NCT02796677|3460361|B2||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3609678|NCT02796677|3460362|B1||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3609679|NCT02796677|3460358|B5|||Age||Years|Mean|64.3|64.3|Standard Deviation|8.4|8.4|||
3609680|NCT02796677|3460359|B4|||Age||Years|Mean|64.0|64.0|Standard Deviation|8.6|8.6|||
3609681|NCT02796677|3460360|B3|||Age||Years|Mean|64.7|64.7|Standard Deviation|8.3|8.3|||
3609682|NCT02796677|3460361|B2|||Age||Years|Mean|64.4|64.4|Standard Deviation|8.1|8.1|||
3609683|NCT02796677|3460362|B1|||Age||Years|Mean|64.4|64.4|Standard Deviation|8.5|8.5|||
3609684|NCT02796651|3460389|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3609685|NCT02796651|3460389|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3609686|NCT02796651|3460389|B1|≥65 years||Age, Customized||Participants|Number|48|48.0||||||
3609687|NCT02796651|3460389|B1|≥50 to <65 years||Age, Customized||Participants|Number|78|78.0||||||
3609688|NCT02796651|3460389|B1|<50 years||Age, Customized||Participants|Number|5|5.0||||||
3609689|NCT02796651|3460389|B1|||Age||Years|Mean|62.3|62.3|Standard Deviation|7.5|7.5|||
3609690|NCT02796352|3460418|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609691|NCT02796352|3460418|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609692|NCT02796352|3460418|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3609693|NCT02796352|3460418|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609694|NCT02796352|3460418|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609695|NCT02796352|3460418|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609696|NCT02796352|3460418|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609697|NCT02796352|3460418|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3609698|NCT02796352|3460418|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3609699|NCT02796352|3460418|B1|||Age||years|Mean|63|63.0|Full Range|||63.0|63.0|
3609700|NCT02796092|3460425|B3|NO||Waveform change in Valsalva's maneuver||participants|Number|45|45.0||||||
3609701|NCT02796092|3460426|B2|NO||Waveform change in Valsalva's maneuver||participants|Number|20|20.0||||||
3609702|NCT02796092|3460427|B1|NO||Waveform change in Valsalva's maneuver||participants|Number|25|25.0||||||
3609703|NCT02796092|3460425|B3|YES||Waveform change in Valsalva's maneuver||participants|Number|55|55.0||||||
3609704|NCT02796092|3460426|B2|YES||Waveform change in Valsalva's maneuver||participants|Number|30|30.0||||||
3609705|NCT02796092|3460427|B1|YES||Waveform change in Valsalva's maneuver||participants|Number|25|25.0||||||
3609706|NCT02796092|3460425|B3|NO||Ovarian vein reflux||participants|Number|25|25.0||||||
3609707|NCT02796092|3460426|B2|NO||Ovarian vein reflux||participants|Number|15|15.0||||||
3609708|NCT02796092|3460427|B1|NO||Ovarian vein reflux||participants|Number|10|10.0||||||
3609709|NCT02796092|3460425|B3|YES||Ovarian vein reflux||participants|Number|75|75.0||||||
3609710|NCT02796092|3460426|B2|YES||Ovarian vein reflux||participants|Number|35|35.0||||||
3609711|NCT02796092|3460427|B1|YES||Ovarian vein reflux||participants|Number|40|40.0||||||
3609712|NCT02796092|3460425|B3|NO||Varicocele||participants|Number|14|14.0||||||
3609713|NCT02796092|3460426|B2|NO||Varicocele||participants|Number|5|5.0||||||
3609714|NCT02796092|3460427|B1|NO||Varicocele||participants|Number|9|9.0||||||
3609715|NCT02796092|3460425|B3|YES||Varicocele||participants|Number|86|86.0||||||
3609716|NCT02796092|3460426|B2|YES||Varicocele||participants|Number|45|45.0||||||
3609717|NCT02796092|3460427|B1|YES||Varicocele||participants|Number|41|41.0||||||
3609718|NCT02796092|3460425|B3|||Maximum left pelvic venous caliber||mm|Mean|6.72|6.72|Standard Deviation|1.76|1.76|||
3609719|NCT02796092|3460426|B2|||Maximum left pelvic venous caliber||mm|Mean|6.66|6.66|Standard Deviation|1.55|1.55|||
3609720|NCT02796092|3460427|B1|||Maximum left pelvic venous caliber||mm|Mean|6.78|6.78|Standard Deviation|1.96|1.96|||
3609721|NCT02796092|3460425|B3|||Maximum right pelvic venous caliber||mm|Mean|7.37|7.37|Standard Deviation|1.20|1.2|||
3609722|NCT02796092|3460426|B2|||Maximum right pelvic venous caliber||mm|Mean|7.36|7.36|Standard Deviation|1.22|1.22|||
3609723|NCT02796092|3460427|B1|||Maximum right pelvic venous caliber||mm|Mean|7.38|7.38|Standard Deviation|1.19|1.19|||
3609724|NCT02796092|3460425|B3|NO||History of lower limb varices surgery||participants|Number|80|80.0||||||
3609725|NCT02796092|3460426|B2|NO||History of lower limb varices surgery||participants|Number|40|40.0||||||
3609726|NCT02796092|3460427|B1|NO||History of lower limb varices surgery||participants|Number|40|40.0||||||
3609727|NCT02796092|3460425|B3|YES||History of lower limb varices surgery||participants|Number|20|20.0||||||
3609728|NCT02796092|3460426|B2|YES||History of lower limb varices surgery||participants|Number|10|10.0||||||
3609729|NCT02796092|3460427|B1|YES||History of lower limb varices surgery||participants|Number|10|10.0||||||
3609730|NCT02796092|3460425|B3|NO||History of lower limb varices||participants|Number|11|11.0||||||
3609731|NCT02796092|3460426|B2|NO||History of lower limb varices||participants|Number|6|6.0||||||
3609732|NCT02796092|3460427|B1|NO||History of lower limb varices||participants|Number|5|5.0||||||
3609733|NCT02796092|3460425|B3|YES||History of lower limb varices||participants|Number|89|89.0||||||
3609734|NCT02796092|3460426|B2|YES||History of lower limb varices||participants|Number|44|44.0||||||
3609735|NCT02796092|3460427|B1|YES||History of lower limb varices||participants|Number|45|45.0||||||
3609736|NCT02796092|3460425|B3|NO||History of vulvar varicosities||participants|Number|63|63.0||||||
3609737|NCT02796092|3460426|B2|NO||History of vulvar varicosities||participants|Number|31|31.0||||||
3609738|NCT02796092|3460427|B1|NO||History of vulvar varicosities||participants|Number|32|32.0||||||
3609739|NCT02796092|3460425|B3|YES||History of vulvar varicosities||participants|Number|37|37.0||||||
3609740|NCT02796092|3460426|B2|YES||History of vulvar varicosities||participants|Number|19|19.0||||||
3609741|NCT02796092|3460427|B1|YES||History of vulvar varicosities||participants|Number|18|18.0||||||
3609742|NCT02796092|3460425|B3|NO||History of vaginal varicosities||participants|Number|82|82.0||||||
3609743|NCT02796092|3460426|B2|NO||History of vaginal varicosities||participants|Number|42|42.0||||||
3609744|NCT02796092|3460427|B1|NO||History of vaginal varicosities||participants|Number|40|40.0||||||
3609745|NCT02796092|3460425|B3|YES||History of vaginal varicosities||participants|Number|18|18.0||||||
3609746|NCT02796092|3460426|B2|YES||History of vaginal varicosities||participants|Number|8|8.0||||||
3609747|NCT02796092|3460427|B1|YES||History of vaginal varicosities||participants|Number|10|10.0||||||
3609748|NCT02796092|3460425|B3|NO||History of ovarian cystic disease||participants|Number|57|57.0||||||
3609749|NCT02796092|3460426|B2|NO||History of ovarian cystic disease||participants|Number|29|29.0||||||
3609750|NCT02796092|3460427|B1|NO||History of ovarian cystic disease||participants|Number|28|28.0||||||
3609751|NCT02796092|3460425|B3|YES||History of ovarian cystic disease||participants|Number|43|43.0||||||
3609752|NCT02796092|3460426|B2|YES||History of ovarian cystic disease||participants|Number|21|21.0||||||
3609753|NCT02796092|3460427|B1|YES||History of ovarian cystic disease||participants|Number|22|22.0||||||
3609754|NCT02796092|3460425|B3|NO||Urinary urgency||participants|Number|87|87.0||||||
3609755|NCT02796092|3460426|B2|NO||Urinary urgency||participants|Number|44|44.0||||||
3609756|NCT02796092|3460427|B1|NO||Urinary urgency||participants|Number|43|43.0||||||
3609757|NCT02796092|3460425|B3|YES||Urinary urgency||participants|Number|13|13.0||||||
3609758|NCT02796092|3460426|B2|YES||Urinary urgency||participants|Number|6|6.0||||||
3609759|NCT02796092|3460427|B1|YES||Urinary urgency||participants|Number|7|7.0||||||
3609760|NCT02796092|3460425|B3|NO||Dysmenorrhea||participants|Number|38|38.0||||||
3609761|NCT02796092|3460426|B2|NO||Dysmenorrhea||participants|Number|15|15.0||||||
3609762|NCT02796092|3460427|B1|NO||Dysmenorrhea||participants|Number|23|23.0||||||
3609763|NCT02796092|3460425|B3|YES||Dysmenorrhea||participants|Number|62|62.0||||||
3609764|NCT02796092|3460426|B2|YES||Dysmenorrhea||participants|Number|35|35.0||||||
3609765|NCT02796092|3460427|B1|YES||Dysmenorrhea||participants|Number|27|27.0||||||
3609766|NCT02796092|3460425|B3|NO||Dyspareunia||participants|Number|46|46.0||||||
3609767|NCT02796092|3460426|B2|NO||Dyspareunia||participants|Number|23|23.0||||||
3609768|NCT02796092|3460427|B1|NO||Dyspareunia||participants|Number|23|23.0||||||
3609769|NCT02796092|3460425|B3|YES||Dyspareunia||participants|Number|54|54.0||||||
3609770|NCT02796092|3460426|B2|YES||Dyspareunia||participants|Number|27|27.0||||||
3609771|NCT02796092|3460427|B1|YES||Dyspareunia||participants|Number|27|27.0||||||
3609772|NCT02796092|3460425|B3|NO||Pain in supine position||participants|Number|87|87.0||||||
3609773|NCT02796092|3460426|B2|NO||Pain in supine position||participants|Number|44|44.0||||||
3609774|NCT02796092|3460427|B1|NO||Pain in supine position||participants|Number|43|43.0||||||
3609775|NCT02796092|3460425|B3|YES||Pain in supine position||participants|Number|13|13.0||||||
3609776|NCT02796092|3460426|B2|YES||Pain in supine position||participants|Number|6|6.0||||||
3609777|NCT02796092|3460427|B1|YES||Pain in supine position||participants|Number|7|7.0||||||
3609778|NCT02796092|3460425|B3|NO||Pain in orthostatic position||participants|Number|2|2.0||||||
3609779|NCT02796092|3460426|B2|NO||Pain in orthostatic position||participants|Number|0|0.0||||||
3609780|NCT02796092|3460427|B1|NO||Pain in orthostatic position||participants|Number|2|2.0||||||
3609781|NCT02796092|3460425|B3|YES||Pain in orthostatic position||participants|Number|98|98.0||||||
3609782|NCT02796092|3460426|B2|YES||Pain in orthostatic position||participants|Number|50|50.0||||||
3609783|NCT02796092|3460427|B1|YES||Pain in orthostatic position||participants|Number|48|48.0||||||
3609784|NCT02796092|3460425|B3|||Pre-treatment Visual Analogue Score|VAS is a subjective pain scale, scored from 1 to 10 (1 no pain; 10 worst pain possible)|units on a scale|Mean|7.51|7.51|Standard Deviation|1.36|1.36|||
3609785|NCT02796092|3460426|B2|||Pre-treatment Visual Analogue Score|VAS is a subjective pain scale, scored from 1 to 10 (1 no pain; 10 worst pain possible)|units on a scale|Mean|7.88|7.88|Standard Deviation|1.01|1.01|||
3609786|NCT02796092|3460427|B1|||Pre-treatment Visual Analogue Score|VAS is a subjective pain scale, scored from 1 to 10 (1 no pain; 10 worst pain possible)|units on a scale|Mean|7.14|7.14|Standard Deviation|1.55|1.55|||
3609787|NCT02796092|3460425|B3|||Living children||Children|Mean|1.82|1.82|Standard Deviation|0.8|0.8|||
3609788|NCT02796092|3460426|B2|||Living children||Children|Mean|1.78|1.78|Standard Deviation|0.71|0.71|||
3609789|NCT02796092|3460427|B1|||Living children||Children|Mean|1.86|1.86|Standard Deviation|0.96|0.96|||
3609790|NCT02796092|3460425|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3609791|NCT02796092|3460426|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3609792|NCT02796092|3460427|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3609793|NCT02796092|3460425|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3609794|NCT02796092|3460426|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3609795|NCT02796092|3460427|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3609796|NCT02796092|3460425|B3|||Age||years|Mean|42.67|42.67|Standard Deviation|7.59|7.59|||
3609797|NCT02796092|3460426|B2|||Age||years|Mean|44.34|44.34|Standard Deviation|8.45|8.45|||
3609798|NCT02796092|3460427|B1|||Age||years|Mean|41.00|41.0|Standard Deviation|6.26|6.26|||
3609799|NCT02794974|3460460|B3|Germany||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3609800|NCT02794974|3460461|B2|Germany||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3609801|NCT02794974|3460462|B1|Germany||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3609802|NCT02794974|3460460|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3609803|NCT02794974|3460460|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3609804|NCT02794974|3460461|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3609805|NCT02794974|3460462|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3609806|NCT02794974|3460460|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3609807|NCT02794974|3460461|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3609808|NCT02794974|3460462|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3609809|NCT02794974|3460460|B3|||Age||years|Mean|69|69.0|Standard Deviation|9.5|9.5|||
3609810|NCT02794974|3460461|B2|||Age||years|Mean|71|71.0|Standard Deviation|10|10.0|||
3609811|NCT02794974|3460462|B1|||Age||years|Mean|67|67.0|Standard Deviation|9|9.0|||
3609812|NCT02794870|3460477|B3|||Serum RSV-neutralizing antibody titers|Samples were obtained prior to inoculation. Data values are presented as log 2 titers.|log 2 titers|Median|2.3|2.3|Inter-Quartile Range|||2.3|2.3|
3609813|NCT02794870|3460478|B2|||Serum RSV-neutralizing antibody titers|Samples were obtained prior to inoculation. Data values are presented as log 2 titers.|log 2 titers|Median|2.3|2.3|Inter-Quartile Range|||2.3|2.3|
3609814|NCT02794870|3460479|B1|||Serum RSV-neutralizing antibody titers|Samples were obtained prior to inoculation. Data values are presented as log 2 titers.|log 2 titers|Median|2.3|2.3|Inter-Quartile Range|||2.3|2.3|
3609815|NCT02794870|3460477|B3|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3609816|NCT02794870|3460478|B2|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3609817|NCT02794870|3460479|B1|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3609818|NCT02794870|3460477|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3609819|NCT02794870|3460478|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609820|NCT02794870|3460479|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3609821|NCT02794870|3460477|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3609822|NCT02794870|3460478|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3609823|NCT02794870|3460479|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609824|NCT02794870|3460477|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3609825|NCT02794870|3460478|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3609826|NCT02794870|3460479|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3609827|NCT02794870|3460477|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3609828|NCT02794870|3460478|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3609829|NCT02794870|3460479|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3609830|NCT02794870|3460477|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609831|NCT02794870|3460478|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609832|NCT02794870|3460479|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609833|NCT02794870|3460477|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609834|NCT02794870|3460478|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609835|NCT02794870|3460479|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609836|NCT02794870|3460477|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3609837|NCT02794870|3460478|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609838|NCT02794870|3460479|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3609839|NCT02794870|3460477|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609840|NCT02794870|3460478|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609841|NCT02794870|3460479|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609842|NCT02794870|3460477|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3609843|NCT02794870|3460478|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3609844|NCT02794870|3460479|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3609845|NCT02794870|3460477|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3609846|NCT02794870|3460478|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3609847|NCT02794870|3460479|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3609848|NCT02794870|3460477|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3609849|NCT02794870|3460478|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3609850|NCT02794870|3460479|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3609851|NCT02794870|3460477|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3609852|NCT02794870|3460478|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3609853|NCT02794870|3460479|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3609854|NCT02794870|3460477|B3|||Age||months|Median|9|9.0|Inter-Quartile Range|||7.0|16.0|
3609855|NCT02794870|3460478|B2|||Age||months|Median|11|11.0|Inter-Quartile Range|||8.0|16.0|
3609856|NCT02794870|3460479|B1|||Age||months|Median|9|9.0|Inter-Quartile Range|||7.0|14.0|
3609857|NCT02794844|3460506|B1||Fast Metabolizers (EM and UM)|Metabolizer Phenotype Frequency|"Depending on the CYP2C19 genotype individuals are classified into different phenotypes: poor metabolizer (PM), intermediate metabolizers (IM), normal metabolizers (NM), rapid metabolizer (RM) and ultra-rapid metabolizers (UM).~Allele Genotype/Activity Phenotype~1/*1 -2 active alleles NM~1/n -1 active, 1 LOF allele IM~2/*2 or *n*n -2 LOF alleles PM~1/*17 -1 active, 1 GOF allele RM~17/*17 -2 GOF alleles UM"|Participants|Count of Participants|7|7.0||||||
3609858|NCT02794844|3460506|B1||Normal Metabolizers (NM)|Metabolizer Phenotype Frequency|"Depending on the CYP2C19 genotype individuals are classified into different phenotypes: poor metabolizer (PM), intermediate metabolizers (IM), normal metabolizers (NM), rapid metabolizer (RM) and ultra-rapid metabolizers (UM).~Allele Genotype/Activity Phenotype~1/*1 -2 active alleles NM~1/n -1 active, 1 LOF allele IM~2/*2 or *n*n -2 LOF alleles PM~1/*17 -1 active, 1 GOF allele RM~17/*17 -2 GOF alleles UM"|Participants|Count of Participants|11|11.0||||||
3609859|NCT02794844|3460506|B1||Slow Metabolizers (IM and PM)|Metabolizer Phenotype Frequency|"Depending on the CYP2C19 genotype individuals are classified into different phenotypes: poor metabolizer (PM), intermediate metabolizers (IM), normal metabolizers (NM), rapid metabolizer (RM) and ultra-rapid metabolizers (UM).~Allele Genotype/Activity Phenotype~1/*1 -2 active alleles NM~1/n -1 active, 1 LOF allele IM~2/*2 or *n*n -2 LOF alleles PM~1/*17 -1 active, 1 GOF allele RM~17/*17 -2 GOF alleles UM"|Participants|Count of Participants|5|5.0||||||
3609860|NCT02794844|3460506|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3609861|NCT02794844|3460506|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609862|NCT02794844|3460506|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3609863|NCT02794844|3460506|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3609864|NCT02794844|3460506|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609865|NCT02794844|3460506|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3609866|NCT02794844|3460506|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609867|NCT02794844|3460506|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3609868|NCT02794844|3460506|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3609869|NCT02794844|3460506|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3609870|NCT02794844|3460506|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3609871|NCT02794844|3460506|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3609872|NCT02794844|3460506|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3609873|NCT02794844|3460506|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3609874|NCT02794844|3460506|B1||<=18 years|Age||Participants|Count of Participants|28|28.0||||||
3609875|NCT02794480|3460514|B3|race customized|MULTIPLE|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3609876|NCT02794480|3460515|B2|race customized|MULTIPLE|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3609877|NCT02794480|3460516|B1|race customized|MULTIPLE|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3609878|NCT02794480|3460514|B3|race customized|WHITE - WHITE/CAUCASIAN/EUROPEAN HERITAGE|Race/Ethnicity, Customized||Participants|Count of Participants|228|228.0||||||
3609879|NCT02794480|3460515|B2|race customized|WHITE - WHITE/CAUCASIAN/EUROPEAN HERITAGE|Race/Ethnicity, Customized||Participants|Count of Participants|113|113.0||||||
3609880|NCT02794480|3460516|B1|race customized|WHITE - WHITE/CAUCASIAN/EUROPEAN HERITAGE|Race/Ethnicity, Customized||Participants|Count of Participants|115|115.0||||||
3609881|NCT02794480|3460514|B3|race customized|WHITE - ARABIC/NORTH AFRICAN HERITAGE|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3609882|NCT02794480|3460515|B2|race customized|WHITE - ARABIC/NORTH AFRICAN HERITAGE|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3609883|NCT02794480|3460516|B1|race customized|WHITE - ARABIC/NORTH AFRICAN HERITAGE|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3609884|NCT02794480|3460514|B3|race customized|BLACK OR AFRICAN AMERICAN|Race/Ethnicity, Customized||Participants|Count of Participants|69|69.0||||||
3609885|NCT02794480|3460515|B2|race customized|BLACK OR AFRICAN AMERICAN|Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3609886|NCT02794480|3460516|B1|race customized|BLACK OR AFRICAN AMERICAN|Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3609887|NCT02794480|3460514|B3|race customized|ASIAN - SOUTH EAST ASIAN HERITAGE|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3609888|NCT02794480|3460515|B2|race customized|ASIAN - SOUTH EAST ASIAN HERITAGE|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3609889|NCT02794480|3460516|B1|race customized|ASIAN - SOUTH EAST ASIAN HERITAGE|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3609890|NCT02794480|3460514|B3|race customized|ASIAN - JAPANESE HERITAGE|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3609891|NCT02794480|3460515|B2|race customized|ASIAN - JAPANESE HERITAGE|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3609892|NCT02794480|3460516|B1|race customized|ASIAN - JAPANESE HERITAGE|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3609893|NCT02794480|3460514|B3|race customized|ASIAN - EAST ASIAN HERITAGE|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3609894|NCT02794480|3460515|B2|race customized|ASIAN - EAST ASIAN HERITAGE|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3609895|NCT02794480|3460516|B1|race customized|ASIAN - EAST ASIAN HERITAGE|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3609896|NCT02794480|3460514|B3|race customized|ASIAN - CENTRAL/SOUTH ASIAN HERITAGE|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3609897|NCT02794480|3460515|B2|race customized|ASIAN - CENTRAL/SOUTH ASIAN HERITAGE|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3609898|NCT02794480|3460516|B1|race customized|ASIAN - CENTRAL/SOUTH ASIAN HERITAGE|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3609899|NCT02794480|3460514|B3|race customized|AMERICAN INDIAN OR ALASKA NATIVE|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3609900|NCT02794480|3460515|B2|race customized|AMERICAN INDIAN OR ALASKA NATIVE|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3609901|NCT02794480|3460516|B1|race customized|AMERICAN INDIAN OR ALASKA NATIVE|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3609902|NCT02794480|3460514|B3||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3609903|NCT02794480|3460515|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3609904|NCT02794480|3460516|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3609905|NCT02794480|3460514|B3||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
3609906|NCT02794480|3460515|B2||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3609907|NCT02794480|3460516|B1||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3609908|NCT02794480|3460514|B3|||Age||Years|Mean|51.1|51.1|Standard Deviation|15.46|15.46|||
3609909|NCT02794480|3460515|B2|||Age||Years|Mean|50.9|50.9|Standard Deviation|15.08|15.08|||
3609910|NCT02794480|3460516|B1|||Age||Years|Mean|51.4|51.4|Standard Deviation|15.87|15.87|||
3609911|NCT02793947|3460537|B3|United States||Region of Enrollment||participants|Number|102|102.0||||||
3609912|NCT02793947|3460538|B2|United States||Region of Enrollment||participants|Number|55|55.0||||||
3609913|NCT02793947|3460539|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
3609914|NCT02793947|3460537|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3609915|NCT02793947|3460538|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3609916|NCT02793947|3460539|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3609917|NCT02793947|3460537|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3609918|NCT02793947|3460538|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3609919|NCT02793947|3460539|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3609920|NCT02793947|3460537|B3|||Age||years|Mean|71.4|71.4|Standard Deviation|15.2|15.2|||
3609921|NCT02793947|3460538|B2|||Age||years|Mean|70.0|70.0|Standard Deviation|15.2|15.2|||
3609922|NCT02793947|3460539|B1|||Age||years|Mean|72.8|72.8|Standard Deviation|15.2|15.2|||
3609923|NCT02793947|3460537|B3||>=65 years|Age||Participants|Count of Participants|72|72.0||||||
3609924|NCT02793947|3460538|B2||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
3609925|NCT02793947|3460539|B1||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
3609926|NCT02793947|3460537|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3609927|NCT02793947|3460538|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3609928|NCT02793947|3460539|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3609929|NCT02793947|3460537|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3609930|NCT02793947|3460538|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3609931|NCT02793947|3460539|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3609932|NCT02793674|3460550|B3|Other||Respiratory Illness||participants|Number|6|6.0||||||
3609933|NCT02793674|3460551|B2|Other||Respiratory Illness||participants|Number|5|5.0||||||
3609934|NCT02793674|3460552|B1|Other||Respiratory Illness||participants|Number|1|1.0||||||
3609935|NCT02793674|3460550|B3|Pneumonia||Respiratory Illness||participants|Number|2|2.0||||||
3609936|NCT02793674|3460551|B2|Pneumonia||Respiratory Illness||participants|Number|0|0.0||||||
3609937|NCT02793674|3460552|B1|Pneumonia||Respiratory Illness||participants|Number|2|2.0||||||
3609938|NCT02793674|3460550|B3|Bronchiolitis||Respiratory Illness||participants|Number|13|13.0||||||
3609939|NCT02793674|3460551|B2|Bronchiolitis||Respiratory Illness||participants|Number|7|7.0||||||
3609940|NCT02793674|3460552|B1|Bronchiolitis||Respiratory Illness||participants|Number|6|6.0||||||
3609941|NCT02793674|3460550|B3|||Weight||kilograms|Median|6.5|6.5|Inter-Quartile Range|||5.0|9.0|
3609942|NCT02793674|3460551|B2|||Weight||kilograms|Median|6.5|6.5|Inter-Quartile Range|||4.8|7.0|
3609943|NCT02793674|3460552|B1|||Weight||kilograms|Median|9|9.0|Inter-Quartile Range|||6.4|11.0|
3609944|NCT02793674|3460550|B3|Ethnicity / Race|Not specified|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3609945|NCT02793674|3460551|B2|Ethnicity / Race|Not specified|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3609946|NCT02793674|3460552|B1|Ethnicity / Race|Not specified|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3609947|NCT02793674|3460550|B3|Ethnicity / Race|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3609948|NCT02793674|3460551|B2|Ethnicity / Race|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3609949|NCT02793674|3460552|B1|Ethnicity / Race|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3609950|NCT02793674|3460550|B3|Ethnicity / Race|African-American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3609951|NCT02793674|3460551|B2|Ethnicity / Race|African-American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3609952|NCT02793674|3460552|B1|Ethnicity / Race|African-American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3609953|NCT02793674|3460550|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3609954|NCT02793674|3460551|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3609955|NCT02793674|3460552|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3609956|NCT02793674|3460550|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3609957|NCT02793674|3460551|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3609958|NCT02793674|3460552|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3609959|NCT02793674|3460550|B3|||Age||months|Median|6|6.0|Inter-Quartile Range|||2.0|12.0|
3609960|NCT02793674|3460551|B2|||Age||months|Median|4|4.0|Inter-Quartile Range|||2.0|6.0|
3609961|NCT02793674|3460552|B1|||Age||months|Median|15|15.0|Inter-Quartile Range|||5.0|25.0|
3609962|NCT02793232|3460565|B10||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3609963|NCT02793232|3460566|B9||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3609964|NCT02793232|3460567|B8||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3609965|NCT02793232|3460568|B7||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3609966|NCT02793232|3460569|B6||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3609967|NCT02793232|3460570|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3609968|NCT02793232|3460571|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3609969|NCT02793232|3460572|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3609970|NCT02793232|3460573|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3609971|NCT02793232|3460574|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3609972|NCT02793232|3460565|B10||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3609973|NCT02793232|3460566|B9||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3609974|NCT02793232|3460567|B8||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3609975|NCT02793232|3460568|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3609976|NCT02793232|3460569|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3609977|NCT02793232|3460570|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3609978|NCT02793232|3460571|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3609979|NCT02793232|3460572|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3609980|NCT02793232|3460573|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3609981|NCT02793232|3460574|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3609982|NCT02793232|3460565|B10||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3609983|NCT02793232|3460566|B9||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3609984|NCT02793232|3460567|B8||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3609985|NCT02793232|3460568|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3609986|NCT02793232|3460569|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3609987|NCT02793232|3460570|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3609988|NCT02793232|3460571|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3609989|NCT02793232|3460572|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3609990|NCT02793232|3460573|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3609991|NCT02793232|3460574|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3609992|NCT02793232|3460565|B10||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3609993|NCT02793232|3460566|B9||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3609994|NCT02793232|3460567|B8||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3609995|NCT02793232|3460568|B7||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3609996|NCT02793232|3460569|B6||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3609997|NCT02793232|3460570|B5||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3609998|NCT02793232|3460571|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3609999|NCT02793232|3460572|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3610000|NCT02793232|3460573|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3610001|NCT02793232|3460574|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3610002|NCT02793232|3460565|B10||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610003|NCT02793232|3460566|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610004|NCT02793232|3460567|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610005|NCT02793232|3460568|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610006|NCT02793232|3460569|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610007|NCT02793232|3460570|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610008|NCT02793232|3460571|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610009|NCT02793232|3460572|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610010|NCT02793232|3460573|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610011|NCT02793232|3460574|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610012|NCT02793154|3460764|B4|White-White/Causasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3610013|NCT02793154|3460767|B1|White-White/Causasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3610014|NCT02793154|3460764|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3610015|NCT02793154|3460767|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3610016|NCT02793154|3460764|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3610017|NCT02793154|3460767|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3610018|NCT02793154|3460764|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3610019|NCT02793154|3460767|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3610020|NCT02793154|3460764|B4|||Age||Years|Mean|56.8|56.8|Standard Deviation|3.30|3.3|||
3610021|NCT02793154|3460767|B1|||Age||Years|Mean|56.8|56.8|Standard Deviation|3.30|3.3|||
3610022|NCT02792517|3460835|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3610023|NCT02792517|3460835|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3610024|NCT02792517|3460835|B1||Black (or African American)|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3610025|NCT02792517|3460835|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3610026|NCT02792517|3460835|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610027|NCT02792517|3460835|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3610028|NCT02792517|3460835|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3610029|NCT02792517|3460835|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3610030|NCT02792517|3460835|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3610031|NCT02792517|3460835|B1|||Age||years|Mean|33.4|33.4|Standard Deviation|6.9|6.9|||
3610032|NCT02792062|3460849|B7|No caffeine consumption||Caffeine Consumption||Participants|Count of Participants|7|7.0||||||
3610033|NCT02792062|3460850|B6|No caffeine consumption||Caffeine Consumption||Participants|Count of Participants|1|1.0||||||
3610034|NCT02792062|3460851|B5|No caffeine consumption||Caffeine Consumption||Participants|Count of Participants|1|1.0||||||
3610035|NCT02792062|3460852|B4|No caffeine consumption||Caffeine Consumption||Participants|Count of Participants|1|1.0||||||
3610036|NCT02792062|3460853|B3|No caffeine consumption||Caffeine Consumption||Participants|Count of Participants|1|1.0||||||
3610037|NCT02792062|3460854|B2|No caffeine consumption||Caffeine Consumption||Participants|Count of Participants|2|2.0||||||
3610038|NCT02792062|3460855|B1|No caffeine consumption||Caffeine Consumption||Participants|Count of Participants|1|1.0||||||
3610039|NCT02792062|3460849|B7|Caffeine consumption||Caffeine Consumption||Participants|Count of Participants|5|5.0||||||
3610040|NCT02792062|3460850|B6|Caffeine consumption||Caffeine Consumption||Participants|Count of Participants|1|1.0||||||
3610041|NCT02792062|3460851|B5|Caffeine consumption||Caffeine Consumption||Participants|Count of Participants|1|1.0||||||
3610042|NCT02792062|3460852|B4|Caffeine consumption||Caffeine Consumption||Participants|Count of Participants|1|1.0||||||
3610043|NCT02792062|3460853|B3|Caffeine consumption||Caffeine Consumption||Participants|Count of Participants|1|1.0||||||
3610044|NCT02792062|3460854|B2|Caffeine consumption||Caffeine Consumption||Participants|Count of Participants|0|0.0||||||
3610045|NCT02792062|3460855|B1|Caffeine consumption||Caffeine Consumption||Participants|Count of Participants|1|1.0||||||
3610046|NCT02792062|3460849|B7|Never drinks||Alcohol Classification||Participants|Count of Participants|1|1.0||||||
3610047|NCT02792062|3460850|B6|Never drinks||Alcohol Classification||Participants|Count of Participants|1|1.0||||||
3610048|NCT02792062|3460851|B5|Never drinks||Alcohol Classification||Participants|Count of Participants|0|0.0||||||
3610049|NCT02792062|3460852|B4|Never drinks||Alcohol Classification||Participants|Count of Participants|0|0.0||||||
3610050|NCT02792062|3460853|B3|Never drinks||Alcohol Classification||Participants|Count of Participants|0|0.0||||||
3610051|NCT02792062|3460854|B2|Never drinks||Alcohol Classification||Participants|Count of Participants|0|0.0||||||
3610052|NCT02792062|3460855|B1|Never drinks||Alcohol Classification||Participants|Count of Participants|0|0.0||||||
3610053|NCT02792062|3460849|B7|Drinks a few days per month||Alcohol Classification||Participants|Count of Participants|7|7.0||||||
3610054|NCT02792062|3460850|B6|Drinks a few days per month||Alcohol Classification||Participants|Count of Participants|0|0.0||||||
3610055|NCT02792062|3460851|B5|Drinks a few days per month||Alcohol Classification||Participants|Count of Participants|1|1.0||||||
3610056|NCT02792062|3460852|B4|Drinks a few days per month||Alcohol Classification||Participants|Count of Participants|2|2.0||||||
3610057|NCT02792062|3460853|B3|Drinks a few days per month||Alcohol Classification||Participants|Count of Participants|2|2.0||||||
3610058|NCT02792062|3460854|B2|Drinks a few days per month||Alcohol Classification||Participants|Count of Participants|2|2.0||||||
3610059|NCT02792062|3460855|B1|Drinks a few days per month||Alcohol Classification||Participants|Count of Participants|0|0.0||||||
3610060|NCT02792062|3460849|B7|Drinks a few days per week||Alcohol Classification||Participants|Count of Participants|4|4.0||||||
3610061|NCT02792062|3460850|B6|Drinks a few days per week||Alcohol Classification||Participants|Count of Participants|1|1.0||||||
3610062|NCT02792062|3460851|B5|Drinks a few days per week||Alcohol Classification||Participants|Count of Participants|1|1.0||||||
3610063|NCT02792062|3460852|B4|Drinks a few days per week||Alcohol Classification||Participants|Count of Participants|0|0.0||||||
3610064|NCT02792062|3460853|B3|Drinks a few days per week||Alcohol Classification||Participants|Count of Participants|0|0.0||||||
3610065|NCT02792062|3460854|B2|Drinks a few days per week||Alcohol Classification||Participants|Count of Participants|0|0.0||||||
3610066|NCT02792062|3460855|B1|Drinks a few days per week||Alcohol Classification||Participants|Count of Participants|2|2.0||||||
3610067|NCT02792062|3460849|B7|Ex-smoker||Smoking Classification||Participants|Count of Participants|2|2.0||||||
3610068|NCT02792062|3460850|B6|Ex-smoker||Smoking Classification||Participants|Count of Participants|0|0.0||||||
3610069|NCT02792062|3460851|B5|Ex-smoker||Smoking Classification||Participants|Count of Participants|1|1.0||||||
3610070|NCT02792062|3460852|B4|Ex-smoker||Smoking Classification||Participants|Count of Participants|0|0.0||||||
3610071|NCT02792062|3460853|B3|Ex-smoker||Smoking Classification||Participants|Count of Participants|0|0.0||||||
3610072|NCT02792062|3460854|B2|Ex-smoker||Smoking Classification||Participants|Count of Participants|0|0.0||||||
3610073|NCT02792062|3460855|B1|Ex-smoker||Smoking Classification||Participants|Count of Participants|1|1.0||||||
3610074|NCT02792062|3460849|B7|Never smoked||Smoking Classification||Participants|Count of Participants|10|10.0||||||
3610075|NCT02792062|3460850|B6|Never smoked||Smoking Classification||Participants|Count of Participants|2|2.0||||||
3610076|NCT02792062|3460851|B5|Never smoked||Smoking Classification||Participants|Count of Participants|1|1.0||||||
3610077|NCT02792062|3460852|B4|Never smoked||Smoking Classification||Participants|Count of Participants|2|2.0||||||
3610078|NCT02792062|3460853|B3|Never smoked||Smoking Classification||Participants|Count of Participants|2|2.0||||||
3610079|NCT02792062|3460854|B2|Never smoked||Smoking Classification||Participants|Count of Participants|2|2.0||||||
3610080|NCT02792062|3460855|B1|Never smoked||Smoking Classification||Participants|Count of Participants|1|1.0||||||
3610081|NCT02792062|3460849|B7|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|20.73|20.73|Standard Deviation|1.213|1.213|||
3610082|NCT02792062|3460850|B6|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|21.00|21.0|Standard Deviation|0.566|0.566|||
3610083|NCT02792062|3460851|B5|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|21.70|21.7|Standard Deviation|0.000|0.0|||
3610084|NCT02792062|3460852|B4|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|19.30|19.3|Standard Deviation|0.000|0.0|||
3610085|NCT02792062|3460853|B3|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|19.40|19.4|Standard Deviation|0.990|0.99|||
3610086|NCT02792062|3460854|B2|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|20.75|20.75|Standard Deviation|0.636|0.636|||
3610087|NCT02792062|3460855|B1|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|22.20|22.2|Standard Deviation|0.707|0.707|||
3610088|NCT02792062|3460849|B7|||Weight||kilogram (kg)|Mean|50.60|50.6|Standard Deviation|3.980|3.98|||
3610089|NCT02792062|3460850|B6|||Weight||kilogram (kg)|Mean|50.70|50.7|Standard Deviation|5.940|5.94|||
3610090|NCT02792062|3460851|B5|||Weight||kilogram (kg)|Mean|52.95|52.95|Standard Deviation|0.071|0.071|||
3610091|NCT02792062|3460852|B4|||Weight||kilogram (kg)|Mean|46.45|46.45|Standard Deviation|0.071|0.071|||
3610092|NCT02792062|3460853|B3|||Weight||kilogram (kg)|Mean|47.50|47.5|Standard Deviation|4.950|4.95|||
3610093|NCT02792062|3460854|B2|||Weight||kilogram (kg)|Mean|53.55|53.55|Standard Deviation|4.031|4.031|||
3610094|NCT02792062|3460855|B1|||Weight||kilogram (kg)|Mean|52.45|52.45|Standard Deviation|3.041|3.041|||
3610095|NCT02792062|3460849|B7|||Height||centimeter (cm)|Mean|156.0|156.0|Standard Deviation|3.59|3.59|||
3610096|NCT02792062|3460850|B6|||Height||centimeter (cm)|Mean|155.0|155.0|Standard Deviation|7.07|7.07|||
3610097|NCT02792062|3460851|B5|||Height||centimeter (cm)|Mean|156.0|156.0|Standard Deviation|0.00|0.0|||
3610098|NCT02792062|3460852|B4|||Height||centimeter (cm)|Mean|155.0|155.0|Standard Deviation|0.00|0.0|||
3610099|NCT02792062|3460853|B3|||Height||centimeter (cm)|Mean|156.0|156.0|Standard Deviation|4.24|4.24|||
3610100|NCT02792062|3460854|B2|||Height||centimeter (cm)|Mean|160.5|160.5|Standard Deviation|3.54|3.54|||
3610101|NCT02792062|3460855|B1|||Height||centimeter (cm)|Mean|153.5|153.5|Standard Deviation|2.12|2.12|||
3610102|NCT02792062|3460849|B7|Japan||Region of Enrollment||participants|Number|12|12.0||||||
3610103|NCT02792062|3460850|B6|Japan||Region of Enrollment||participants|Number|2|2.0||||||
3610104|NCT02792062|3460851|B5|Japan||Region of Enrollment||participants|Number|2|2.0||||||
3610105|NCT02792062|3460852|B4|Japan||Region of Enrollment||participants|Number|2|2.0||||||
3610106|NCT02792062|3460853|B3|Japan||Region of Enrollment||participants|Number|2|2.0||||||
3610107|NCT02792062|3460854|B2|Japan||Region of Enrollment||participants|Number|2|2.0||||||
3610108|NCT02792062|3460855|B1|Japan||Region of Enrollment||participants|Number|2|2.0||||||
3610109|NCT02792062|3460849|B7|Female||Sex/Gender, Customized||Participants|Count of Participants|12|12.0||||||
3610110|NCT02792062|3460850|B6|Female||Sex/Gender, Customized||Participants|Count of Participants|2|2.0||||||
3610111|NCT02792062|3460851|B5|Female||Sex/Gender, Customized||Participants|Count of Participants|2|2.0||||||
3610112|NCT02792062|3460852|B4|Female||Sex/Gender, Customized||Participants|Count of Participants|2|2.0||||||
3610113|NCT02792062|3460853|B3|Female||Sex/Gender, Customized||Participants|Count of Participants|2|2.0||||||
3610114|NCT02792062|3460854|B2|Female||Sex/Gender, Customized||Participants|Count of Participants|2|2.0||||||
3610115|NCT02792062|3460855|B1|Female||Sex/Gender, Customized||Participants|Count of Participants|2|2.0||||||
3610116|NCT02792062|3460849|B7|||Age||years|Mean|28.0|28.0|Standard Deviation|7.34|7.34|||
3610117|NCT02792062|3460850|B6|||Age||years|Mean|23.0|23.0|Standard Deviation|4.24|4.24|||
3610118|NCT02792062|3460851|B5|||Age||years|Mean|31.5|31.5|Standard Deviation|13.44|13.44|||
3610119|NCT02792062|3460852|B4|||Age||years|Mean|29.0|29.0|Standard Deviation|2.83|2.83|||
3610120|NCT02792062|3460853|B3|||Age||years|Mean|33.0|33.0|Standard Deviation|12.73|12.73|||
3610121|NCT02792062|3460854|B2|||Age||years|Mean|25.0|25.0|Standard Deviation|7.07|7.07|||
3610122|NCT02792062|3460855|B1|||Age||years|Mean|26.5|26.5|Standard Deviation|4.95|4.95|||
3610123|NCT02792049|3460892|B3|United States||Region of Enrollment||participants|Number|70|70.0||||||
3610124|NCT02792049|3460893|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
3610125|NCT02792049|3460894|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3610126|NCT02792049|3460892|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3610127|NCT02792049|3460893|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3610128|NCT02792049|3460894|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3610129|NCT02792049|3460892|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3610130|NCT02792049|3460893|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3610131|NCT02792049|3460894|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3610132|NCT02792049|3460892|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3610133|NCT02792049|3460893|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3610134|NCT02792049|3460894|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3610135|NCT02792049|3460892|B3||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
3610136|NCT02792049|3460893|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3610137|NCT02792049|3460894|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3610138|NCT02792049|3460892|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610139|NCT02792049|3460893|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610140|NCT02792049|3460894|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610141|NCT02791659|3460909|B3|||Patient entrance skin dose||mGy/min|Mean|5.6|5.6|Inter-Quartile Range|||4.86|6.72|
3610142|NCT02791659|3460910|B2|||Patient entrance skin dose||mGy/min|Mean|5.5|5.5|Inter-Quartile Range|||4.88|5.89|
3610143|NCT02791659|3460911|B1|||Patient entrance skin dose||mGy/min|Mean|5.7|5.7|Inter-Quartile Range|||4.76|7.56|
3610144|NCT02791659|3460909|B3|||Dose area product||Gy-cm2|Median|22.65|22.65|Inter-Quartile Range|||16.75|37.2|
3610145|NCT02791659|3460910|B2|||Dose area product||Gy-cm2|Median|23.2|23.2|Inter-Quartile Range|||16.25|32.1|
3610146|NCT02791659|3460911|B1|||Dose area product||Gy-cm2|Median|22.3|22.3|Inter-Quartile Range|||17.55|40.15|
3610147|NCT02791659|3460909|B3|||Fluoroscopy time||min|Median|4.11|4.11|Inter-Quartile Range|||2.58|6.03|
3610148|NCT02791659|3460910|B2|||Fluoroscopy time||min|Median|4.14|4.14|Inter-Quartile Range|||2.76|5.82|
3610149|NCT02791659|3460911|B1|||Fluoroscopy time||min|Median|4.06|4.06|Inter-Quartile Range|||2.58|6.1|
3610150|NCT02791659|3460909|B3|||Vertical thickness||cm|Mean|23.7|23.7|Standard Deviation|5.31|5.31|||
3610151|NCT02791659|3460910|B2|||Vertical thickness||cm|Mean|20.2|20.2|Standard Deviation|4.18|4.18|||
3610152|NCT02791659|3460911|B1|||Vertical thickness||cm|Mean|27.2|27.2|Standard Deviation|3.71|3.71|||
3610153|NCT02791659|3460909|B3||Benign biliary obstruction|Indication for ERCP||Participants|Count of Participants|5|5.0||||||
3610154|NCT02791659|3460910|B2||Benign biliary obstruction|Indication for ERCP||Participants|Count of Participants|2|2.0||||||
3610155|NCT02791659|3460911|B1||Benign biliary obstruction|Indication for ERCP||Participants|Count of Participants|3|3.0||||||
3610156|NCT02791659|3460909|B3||Malignant biliary obstruction|Indication for ERCP||Participants|Count of Participants|14|14.0||||||
3610157|NCT02791659|3460910|B2||Malignant biliary obstruction|Indication for ERCP||Participants|Count of Participants|8|8.0||||||
3610158|NCT02791659|3460911|B1||Malignant biliary obstruction|Indication for ERCP||Participants|Count of Participants|6|6.0||||||
3610159|NCT02791659|3460909|B3||Choledocholithiasis|Indication for ERCP||Participants|Count of Participants|35|35.0||||||
3610160|NCT02791659|3460910|B2||Choledocholithiasis|Indication for ERCP||Participants|Count of Participants|17|17.0||||||
3610161|NCT02791659|3460911|B1||Choledocholithiasis|Indication for ERCP||Participants|Count of Participants|18|18.0||||||
3610162|NCT02791659|3460909|B3|||BMI||kg/m2|Mean|22.5|22.5|Standard Deviation|3.77|3.77|||
3610163|NCT02791659|3460910|B2|||BMI||kg/m2|Mean|22.2|22.2|Standard Deviation|4.07|4.07|||
3610164|NCT02791659|3460911|B1|||BMI||kg/m2|Mean|22.9|22.9|Standard Deviation|3.45|3.45|||
3610165|NCT02791659|3460909|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3610166|NCT02791659|3460910|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3610167|NCT02791659|3460911|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3610168|NCT02791659|3460909|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3610169|NCT02791659|3460910|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3610170|NCT02791659|3460911|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3610171|NCT02791659|3460909|B3|||Age||years|Median|67|67.0|Inter-Quartile Range|||55.25|75.75|
3610172|NCT02791659|3460910|B2|||Age||years|Median|67|67.0|Inter-Quartile Range|||59.0|73.0|
3610173|NCT02791659|3460911|B1|||Age||years|Median|67|67.0|Inter-Quartile Range|||51.0|76.5|
3610174|NCT02791269|3460918|B3||Male|Gender||Participants|Count of Participants|17|17.0||||||
3610175|NCT02791269|3460919|B2||Male|Gender||Participants|Count of Participants|13|13.0||||||
3610176|NCT02791269|3460920|B1||Male|Gender||Participants|Count of Participants|4|4.0||||||
3610177|NCT02791269|3460918|B3||Female|Gender||Participants|Count of Participants|7|7.0||||||
3610178|NCT02791269|3460919|B2||Female|Gender||Participants|Count of Participants|7|7.0||||||
3610179|NCT02791269|3460920|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3610180|NCT02791269|3460918|B3|||Age||years|Mean|33.52|33.52|Standard Deviation|9.88|9.88|||
3610181|NCT02791269|3460919|B2|||Age||years|Mean|31.57|31.57|Standard Deviation|9.43|9.43|||
3610182|NCT02791269|3460920|B1|||Age||years|Mean|43.25|43.25|Standard Deviation|5.75|5.75|||
3610183|NCT02790736|3460935|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3610184|NCT02790736|3460936|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3610185|NCT02790736|3460937|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3610186|NCT02790736|3460935|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610187|NCT02790736|3460936|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610188|NCT02790736|3460937|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610189|NCT02790736|3460935|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610190|NCT02790736|3460936|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610191|NCT02790736|3460937|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610192|NCT02790736|3460935|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3610193|NCT02790736|3460936|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610194|NCT02790736|3460937|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3610195|NCT02790736|3460935|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3610196|NCT02790736|3460936|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610197|NCT02790736|3460937|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3610198|NCT02790736|3460935|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610199|NCT02790736|3460936|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610200|NCT02790736|3460937|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610201|NCT02790736|3460935|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3610202|NCT02790736|3460936|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3610203|NCT02790736|3460937|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610204|NCT02790736|3460935|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610205|NCT02790736|3460936|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610206|NCT02790736|3460937|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610207|NCT02790736|3460935|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3610208|NCT02790736|3460936|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3610209|NCT02790736|3460937|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3610210|NCT02790736|3460935|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3610211|NCT02790736|3460936|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3610212|NCT02790736|3460937|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3610213|NCT02790736|3460935|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3610214|NCT02790736|3460936|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3610215|NCT02790736|3460937|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3610216|NCT02790736|3460935|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3610217|NCT02790736|3460936|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3610218|NCT02790736|3460937|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3610219|NCT02790736|3460935|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610220|NCT02790736|3460936|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610221|NCT02790736|3460937|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610222|NCT02790281|3460946|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610223|NCT02790281|3460946|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610224|NCT02790281|3460946|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3610225|NCT02790281|3460946|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610226|NCT02790281|3460946|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610227|NCT02790281|3460946|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3610228|NCT02790281|3460946|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610229|NCT02790281|3460946|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610230|NCT02790281|3460946|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3610231|NCT02790281|3460946|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610232|NCT02790281|3460946|B1||Male|Gender||Participants|Count of Participants|17|17.0||||||
3610233|NCT02790281|3460946|B1||Female|Gender||Participants|Count of Participants|16|16.0||||||
3610234|NCT02790281|3460946|B1|||Age||years|Mean|43.6|43.6|Standard Deviation|16.41|16.41|||
3610235|NCT02788357|3460952|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3610236|NCT02788357|3460953|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3610237|NCT02788357|3460954|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3610238|NCT02788357|3460952|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3610239|NCT02788357|3460953|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3610240|NCT02788357|3460954|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3610241|NCT02788357|3460952|B3|||Age||years|Mean|55.6|55.6|Standard Deviation|10.4|10.4|||
3610242|NCT02788357|3460953|B2|||Age||years|Mean|59.8|59.8|Standard Deviation|5.2|5.2|||
3610243|NCT02788357|3460954|B1|||Age||years|Mean|50.5|50.5|Standard Deviation|12.6|12.6|||
3610244|NCT02788188|3460967|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3610245|NCT02788188|3460968|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3610246|NCT02788188|3460969|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610247|NCT02788188|3460970|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610248|NCT02788188|3460971|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610249|NCT02788188|3460972|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610250|NCT02788188|3460973|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610251|NCT02788188|3460974|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610252|NCT02788188|3460967|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3610253|NCT02788188|3460968|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610254|NCT02788188|3460969|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610255|NCT02788188|3460970|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3610256|NCT02788188|3460971|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610257|NCT02788188|3460972|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610258|NCT02788188|3460973|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610259|NCT02788188|3460974|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610260|NCT02788188|3460967|B8||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3610261|NCT02788188|3460968|B7||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3610262|NCT02788188|3460969|B6||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3610263|NCT02788188|3460970|B5||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3610264|NCT02788188|3460971|B4||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3610265|NCT02788188|3460972|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3610266|NCT02788188|3460973|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3610267|NCT02788188|3460974|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3610268|NCT02788188|3460967|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3610269|NCT02788188|3460968|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3610270|NCT02788188|3460969|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610271|NCT02788188|3460970|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3610272|NCT02788188|3460971|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610273|NCT02788188|3460972|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3610274|NCT02788188|3460973|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610275|NCT02788188|3460974|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610276|NCT02788188|3460967|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610277|NCT02788188|3460968|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610278|NCT02788188|3460969|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610279|NCT02788188|3460970|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610280|NCT02788188|3460971|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610281|NCT02788188|3460972|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610282|NCT02788188|3460973|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610283|NCT02788188|3460974|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610284|NCT02788188|3460967|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3610285|NCT02788188|3460968|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3610286|NCT02788188|3460969|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3610287|NCT02788188|3460970|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610288|NCT02788188|3460971|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610289|NCT02788188|3460972|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610290|NCT02788188|3460973|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610291|NCT02788188|3460974|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610292|NCT02788188|3460967|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610293|NCT02788188|3460968|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610294|NCT02788188|3460969|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610295|NCT02788188|3460970|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610296|NCT02788188|3460971|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610297|NCT02788188|3460972|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610298|NCT02788188|3460973|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610299|NCT02788188|3460974|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610300|NCT02788188|3460967|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610301|NCT02788188|3460968|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610302|NCT02788188|3460969|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610303|NCT02788188|3460970|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610304|NCT02788188|3460971|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610305|NCT02788188|3460972|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610306|NCT02788188|3460973|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610307|NCT02788188|3460974|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610308|NCT02788188|3460967|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3610309|NCT02788188|3460968|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3610310|NCT02788188|3460969|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3610311|NCT02788188|3460970|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3610312|NCT02788188|3460971|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3610313|NCT02788188|3460972|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3610314|NCT02788188|3460973|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3610315|NCT02788188|3460974|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3610316|NCT02788188|3460967|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3610317|NCT02788188|3460968|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610318|NCT02788188|3460969|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3610319|NCT02788188|3460970|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3610320|NCT02788188|3460971|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3610321|NCT02788188|3460972|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610322|NCT02788188|3460973|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610323|NCT02788188|3460974|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610324|NCT02788188|3460967|B8||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3610325|NCT02788188|3460968|B7||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3610326|NCT02788188|3460969|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3610327|NCT02788188|3460970|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3610328|NCT02788188|3460971|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3610329|NCT02788188|3460972|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3610330|NCT02788188|3460973|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3610331|NCT02788188|3460974|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3610332|NCT02788188|3460967|B8||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3610333|NCT02788188|3460968|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3610334|NCT02788188|3460969|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3610335|NCT02788188|3460970|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3610336|NCT02788188|3460971|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3610337|NCT02788188|3460972|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3610338|NCT02788188|3460973|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3610339|NCT02788188|3460974|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3610340|NCT02788188|3460967|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3610341|NCT02788188|3460968|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3610342|NCT02788188|3460969|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3610343|NCT02788188|3460970|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3610344|NCT02788188|3460971|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3610345|NCT02788188|3460972|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3610346|NCT02788188|3460973|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3610347|NCT02788188|3460974|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3610348|NCT02788188|3460967|B8||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3610349|NCT02788188|3460968|B7||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3610350|NCT02788188|3460969|B6||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3610351|NCT02788188|3460970|B5||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3610352|NCT02788188|3460971|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3610353|NCT02788188|3460972|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3610354|NCT02788188|3460973|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3610355|NCT02788188|3460974|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3610356|NCT02788188|3460967|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610357|NCT02788188|3460968|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610358|NCT02788188|3460969|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610359|NCT02788188|3460970|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610360|NCT02788188|3460971|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610361|NCT02788188|3460972|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610362|NCT02788188|3460973|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610363|NCT02788188|3460974|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610364|NCT02788097|3460996|B3|Turkey||Region of Enrollment||participants|Number|130|130.0||||||
3610365|NCT02788097|3460997|B2|Turkey||Region of Enrollment||participants|Number|69|69.0||||||
3610366|NCT02788097|3460998|B1|Turkey||Region of Enrollment||participants|Number|61|61.0||||||
3610367|NCT02788097|3460996|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3610368|NCT02788097|3460997|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3610369|NCT02788097|3460998|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3610370|NCT02788097|3460996|B3||Female|Gender||Participants|Count of Participants|130|130.0||||||
3610371|NCT02788097|3460997|B2||Female|Gender||Participants|Count of Participants|69|69.0||||||
3610372|NCT02788097|3460998|B1||Female|Gender||Participants|Count of Participants|61|61.0||||||
3610373|NCT02788097|3460996|B3|||Age||years|Mean|28.35|28.35|Standard Deviation|3.75|3.75|||
3610374|NCT02788097|3460997|B2|||Age||years|Mean|28.5|28.5|Standard Deviation|3.2|3.2|||
3610375|NCT02788097|3460998|B1|||Age||years|Mean|28.2|28.2|Standard Deviation|4.3|4.3|||
3610376|NCT02788097|3460996|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3610377|NCT02788097|3460997|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3610378|NCT02788097|3460998|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3610379|NCT02788097|3460996|B3||Between 18 and 65 years|Age||Participants|Count of Participants|130|130.0||||||
3610380|NCT02788097|3460997|B2||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
3610381|NCT02788097|3460998|B1||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
3610382|NCT02788097|3460996|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610383|NCT02788097|3460997|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610384|NCT02788097|3460998|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610385|NCT02787564|3461005|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3610386|NCT02787564|3461006|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3610387|NCT02787564|3461007|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3610388|NCT02787564|3461005|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3610389|NCT02787564|3461006|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3610390|NCT02787564|3461007|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3610391|NCT02787564|3461005|B3|||Age||years|Mean|54.9|54.9|Standard Deviation|10.2|10.2|||
3610392|NCT02787564|3461006|B2|||Age||years|Mean|54.9|54.9|Standard Deviation|8.5|8.5|||
3610393|NCT02787564|3461007|B1|||Age||years|Mean|55.0|55.0|Standard Deviation|11.9|11.9|||
3610394|NCT02786927|3461024|B1|Race/Ethnicity|White - White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|187|187.0||||||
3610395|NCT02786927|3461024|B1|Race/Ethnicity|White - Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3610396|NCT02786927|3461024|B1|Race/Ethnicity|Asian - Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3610397|NCT02786927|3461024|B1|Race/Ethnicity|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3610398|NCT02786927|3461024|B1|Race/Ethnicity|African American/African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3610399|NCT02786927|3461024|B1||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3610400|NCT02786927|3461024|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3610401|NCT02786927|3461024|B1|||Age||Years|Mean|65.1|65.1|Standard Deviation|9.15|9.15|||
3610402|NCT02786810|3461031|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610403|NCT02786810|3461031|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610404|NCT02786810|3461031|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3610405|NCT02786810|3461031|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3610406|NCT02786810|3461031|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610407|NCT02786810|3461031|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610408|NCT02786810|3461031|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610409|NCT02786810|3461031|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3610410|NCT02786810|3461031|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3610411|NCT02786810|3461031|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3610412|NCT02786810|3461031|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3610413|NCT02786810|3461031|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
3610414|NCT02786771|3461036|B3||Unknown|Employment Status||Participants|Count of Participants|6|6.0||||||
3610415|NCT02786771|3461037|B2||Unknown|Employment Status||Participants|Count of Participants|2|2.0||||||
3610416|NCT02786771|3461038|B1||Unknown|Employment Status||Participants|Count of Participants|4|4.0||||||
3610417|NCT02786771|3461036|B3||Retired|Employment Status||Participants|Count of Participants|1|1.0||||||
3610418|NCT02786771|3461037|B2||Retired|Employment Status||Participants|Count of Participants|1|1.0||||||
3610419|NCT02786771|3461038|B1||Retired|Employment Status||Participants|Count of Participants|0|0.0||||||
3610420|NCT02786771|3461036|B3||Student|Employment Status||Participants|Count of Participants|14|14.0||||||
3610421|NCT02786771|3461037|B2||Student|Employment Status||Participants|Count of Participants|7|7.0||||||
3610422|NCT02786771|3461038|B1||Student|Employment Status||Participants|Count of Participants|7|7.0||||||
3610423|NCT02786771|3461036|B3||Unemployed|Employment Status||Participants|Count of Participants|1|1.0||||||
3610424|NCT02786771|3461037|B2||Unemployed|Employment Status||Participants|Count of Participants|0|0.0||||||
3610425|NCT02786771|3461038|B1||Unemployed|Employment Status||Participants|Count of Participants|1|1.0||||||
3610426|NCT02786771|3461036|B3||Employed|Employment Status||Participants|Count of Participants|103|103.0||||||
3610427|NCT02786771|3461037|B2||Employed|Employment Status||Participants|Count of Participants|52|52.0||||||
3610428|NCT02786771|3461038|B1||Employed|Employment Status||Participants|Count of Participants|51|51.0||||||
3610429|NCT02786771|3461036|B3|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3610430|NCT02786771|3461037|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3610431|NCT02786771|3461038|B1|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3610432|NCT02786771|3461036|B3|Canada||Region of Enrollment||participants|Number|3|3.0||||||
3610433|NCT02786771|3461037|B2|Canada||Region of Enrollment||participants|Number|3|3.0||||||
3610434|NCT02786771|3461038|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
3610435|NCT02786771|3461036|B3|Australia||Region of Enrollment||participants|Number|2|2.0||||||
3610436|NCT02786771|3461037|B2|Australia||Region of Enrollment||participants|Number|1|1.0||||||
3610437|NCT02786771|3461038|B1|Australia||Region of Enrollment||participants|Number|1|1.0||||||
3610438|NCT02786771|3461036|B3|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3610439|NCT02786771|3461037|B2|Spain||Region of Enrollment||participants|Number|0|0.0||||||
3610440|NCT02786771|3461038|B1|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3610441|NCT02786771|3461036|B3|United States||Region of Enrollment||participants|Number|118|118.0||||||
3610442|NCT02786771|3461037|B2|United States||Region of Enrollment||participants|Number|57|57.0||||||
3610443|NCT02786771|3461038|B1|United States||Region of Enrollment||participants|Number|61|61.0||||||
3610444|NCT02786771|3461036|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3610445|NCT02786771|3461037|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3610446|NCT02786771|3461038|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3610447|NCT02786771|3461036|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610448|NCT02786771|3461037|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610449|NCT02786771|3461038|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610450|NCT02786771|3461036|B3||White|Race (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
3610451|NCT02786771|3461037|B2||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3610452|NCT02786771|3461038|B1||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3610453|NCT02786771|3461036|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3610454|NCT02786771|3461037|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3610455|NCT02786771|3461038|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3610456|NCT02786771|3461036|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610457|NCT02786771|3461037|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610458|NCT02786771|3461038|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610459|NCT02786771|3461036|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3610460|NCT02786771|3461037|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3610461|NCT02786771|3461038|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3610462|NCT02786771|3461036|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610463|NCT02786771|3461037|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610464|NCT02786771|3461038|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610465|NCT02786771|3461036|B3||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3610466|NCT02786771|3461037|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3610467|NCT02786771|3461038|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3610468|NCT02786771|3461036|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3610469|NCT02786771|3461037|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3610470|NCT02786771|3461038|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3610471|NCT02786771|3461036|B3|||Age||years|Mean|37.15|37.15|Standard Deviation|12.6|12.6|||
3610472|NCT02786771|3461037|B2|||Age||years|Mean|37.46|37.46|Standard Deviation|13.51|13.51|||
3610473|NCT02786771|3461038|B1|||Age||years|Mean|36.85|36.85|Standard Deviation|11.72|11.72|||
3610474|NCT02786355|3461045|B1|Canada||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3610475|NCT02786355|3461045|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3610476|NCT02786355|3461045|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3610477|NCT02786355|3461045|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3610478|NCT02786355|3461045|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3610479|NCT02786355|3461045|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610480|NCT02786004|3461052|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
3610481|NCT02786004|3461053|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3610482|NCT02786004|3461054|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3610483|NCT02786004|3461052|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3610484|NCT02786004|3461053|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3610485|NCT02786004|3461054|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3610486|NCT02786004|3461052|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3610487|NCT02786004|3461053|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3610488|NCT02786004|3461054|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3610489|NCT02786004|3461052|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3610490|NCT02786004|3461053|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3610491|NCT02786004|3461054|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3610492|NCT02786004|3461052|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3610493|NCT02786004|3461053|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3610494|NCT02786004|3461054|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3610495|NCT02786004|3461052|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610496|NCT02786004|3461053|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610497|NCT02786004|3461054|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610498|NCT02785900|3461063|B3||Grade 2: In bed less than 50% of the time|Eastern Cooperative Oncology Group (ECOG) Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed less than 50% of the time; 3= In bed more than 50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|36|36.0||||||
3610499|NCT02785900|3461064|B2||Grade 2: In bed less than 50% of the time|Eastern Cooperative Oncology Group (ECOG) Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed less than 50% of the time; 3= In bed more than 50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|20|20.0||||||
3610500|NCT02785900|3461065|B1||Grade 2: In bed less than 50% of the time|Eastern Cooperative Oncology Group (ECOG) Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed less than 50% of the time; 3= In bed more than 50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|16|16.0||||||
3610501|NCT02785900|3461063|B3||Grade 1: Symptoms but ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed less than 50% of the time; 3= In bed more than 50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|158|158.0||||||
3610502|NCT02785900|3461064|B2||Grade 1: Symptoms but ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed less than 50% of the time; 3= In bed more than 50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|80|80.0||||||
3610503|NCT02785900|3461065|B1||Grade 1: Symptoms but ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed less than 50% of the time; 3= In bed more than 50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|78|78.0||||||
3610504|NCT02785900|3461063|B3||Grade 0: Normal activity|Eastern Cooperative Oncology Group (ECOG) Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed less than 50% of the time; 3= In bed more than 50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|46|46.0||||||
3610505|NCT02785900|3461064|B2||Grade 0: Normal activity|Eastern Cooperative Oncology Group (ECOG) Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed less than 50% of the time; 3= In bed more than 50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|23|23.0||||||
3610506|NCT02785900|3461065|B1||Grade 0: Normal activity|Eastern Cooperative Oncology Group (ECOG) Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed less than 50% of the time; 3= In bed more than 50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|23|23.0||||||
3610507|NCT02785900|3461063|B3|Germany||Region of Enrollment||participants|Number|8|8.0||||||
3610508|NCT02785900|3461064|B2|Germany||Region of Enrollment||participants|Number|6|6.0||||||
3610509|NCT02785900|3461065|B1|Germany||Region of Enrollment||participants|Number|2|2.0||||||
3610510|NCT02785900|3461063|B3|Australia||Region of Enrollment||participants|Number|21|21.0||||||
3610511|NCT02785900|3461064|B2|Australia||Region of Enrollment||participants|Number|11|11.0||||||
3610512|NCT02785900|3461065|B1|Australia||Region of Enrollment||participants|Number|10|10.0||||||
3610513|NCT02785900|3461063|B3|France||Region of Enrollment||participants|Number|23|23.0||||||
3610514|NCT02785900|3461064|B2|France||Region of Enrollment||participants|Number|10|10.0||||||
3610515|NCT02785900|3461065|B1|France||Region of Enrollment||participants|Number|13|13.0||||||
3610516|NCT02785900|3461063|B3|Israel||Region of Enrollment||participants|Number|12|12.0||||||
3610517|NCT02785900|3461064|B2|Israel||Region of Enrollment||participants|Number|7|7.0||||||
3610518|NCT02785900|3461065|B1|Israel||Region of Enrollment||participants|Number|5|5.0||||||
3610519|NCT02785900|3461063|B3|Italy||Region of Enrollment||participants|Number|5|5.0||||||
3610520|NCT02785900|3461064|B2|Italy||Region of Enrollment||participants|Number|3|3.0||||||
3610521|NCT02785900|3461065|B1|Italy||Region of Enrollment||participants|Number|2|2.0||||||
3610522|NCT02785900|3461063|B3|Taiwan||Region of Enrollment||participants|Number|10|10.0||||||
3610523|NCT02785900|3461064|B2|Taiwan||Region of Enrollment||participants|Number|5|5.0||||||
3610524|NCT02785900|3461065|B1|Taiwan||Region of Enrollment||participants|Number|5|5.0||||||
3610525|NCT02785900|3461063|B3|Belgium||Region of Enrollment||participants|Number|12|12.0||||||
3610526|NCT02785900|3461064|B2|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
3610527|NCT02785900|3461065|B1|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
3610528|NCT02785900|3461063|B3|Austria||Region of Enrollment||participants|Number|3|3.0||||||
3610529|NCT02785900|3461064|B2|Austria||Region of Enrollment||participants|Number|0|0.0||||||
3610530|NCT02785900|3461065|B1|Austria||Region of Enrollment||participants|Number|3|3.0||||||
3610531|NCT02785900|3461063|B3|South Korea||Region of Enrollment||participants|Number|13|13.0||||||
3610532|NCT02785900|3461064|B2|South Korea||Region of Enrollment||participants|Number|7|7.0||||||
3610533|NCT02785900|3461065|B1|South Korea||Region of Enrollment||participants|Number|6|6.0||||||
3610534|NCT02785900|3461063|B3|Spain||Region of Enrollment||participants|Number|11|11.0||||||
3610535|NCT02785900|3461064|B2|Spain||Region of Enrollment||participants|Number|6|6.0||||||
3610536|NCT02785900|3461065|B1|Spain||Region of Enrollment||participants|Number|5|5.0||||||
3610537|NCT02785900|3461063|B3|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3610538|NCT02785900|3461064|B2|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3610539|NCT02785900|3461065|B1|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
3610540|NCT02785900|3461063|B3|Czechia||Region of Enrollment||participants|Number|9|9.0||||||
3610541|NCT02785900|3461064|B2|Czechia||Region of Enrollment||participants|Number|6|6.0||||||
3610542|NCT02785900|3461065|B1|Czechia||Region of Enrollment||participants|Number|3|3.0||||||
3610543|NCT02785900|3461063|B3|United States||Region of Enrollment||participants|Number|94|94.0||||||
3610544|NCT02785900|3461064|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
3610545|NCT02785900|3461065|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
3610546|NCT02785900|3461063|B3|Hungary||Region of Enrollment||participants|Number|11|11.0||||||
3610547|NCT02785900|3461064|B2|Hungary||Region of Enrollment||participants|Number|6|6.0||||||
3610548|NCT02785900|3461065|B1|Hungary||Region of Enrollment||participants|Number|5|5.0||||||
3610549|NCT02785900|3461063|B3|Race|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3610550|NCT02785900|3461064|B2|Race|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3610551|NCT02785900|3461065|B1|Race|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3610552|NCT02785900|3461063|B3|Race|Not Reportable|Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3610553|NCT02785900|3461064|B2|Race|Not Reportable|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3610554|NCT02785900|3461065|B1|Race|Not Reportable|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3610555|NCT02785900|3461063|B3|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3610556|NCT02785900|3461064|B2|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3610557|NCT02785900|3461065|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3610558|NCT02785900|3461063|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|179|179.0||||||
3610559|NCT02785900|3461064|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|94|94.0||||||
3610560|NCT02785900|3461065|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|85|85.0||||||
3610561|NCT02785900|3461063|B3|Race|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3610562|NCT02785900|3461064|B2|Race|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3610563|NCT02785900|3461065|B1|Race|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3610564|NCT02785900|3461063|B3|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3610565|NCT02785900|3461064|B2|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3610566|NCT02785900|3461065|B1|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3610567|NCT02785900|3461063|B3|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3610568|NCT02785900|3461064|B2|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3610569|NCT02785900|3461065|B1|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3610570|NCT02785900|3461063|B3|Race|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3610571|NCT02785900|3461064|B2|Race|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3610572|NCT02785900|3461065|B1|Race|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3610573|NCT02785900|3461063|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3610574|NCT02785900|3461064|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3610575|NCT02785900|3461065|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3610576|NCT02785900|3461063|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|209|209.0||||||
3610577|NCT02785900|3461064|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
3610578|NCT02785900|3461065|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3610579|NCT02785900|3461063|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3610580|NCT02785900|3461064|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3610581|NCT02785900|3461065|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3610582|NCT02785900|3461063|B3||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3610583|NCT02785900|3461064|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3610584|NCT02785900|3461065|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3610585|NCT02785900|3461063|B3||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3610586|NCT02785900|3461064|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3610587|NCT02785900|3461065|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3610588|NCT02785900|3461063|B3|Age Group|>= 80 years|Age, Customized||Participants|Count of Participants|50|50.0||||||
3610589|NCT02785900|3461064|B2|Age Group|>= 80 years|Age, Customized||Participants|Count of Participants|24|24.0||||||
3610590|NCT02785900|3461065|B1|Age Group|>= 80 years|Age, Customized||Participants|Count of Participants|26|26.0||||||
3610591|NCT02785900|3461063|B3|Age Group|75 - 79 years|Age, Customized||Participants|Count of Participants|74|74.0||||||
3610592|NCT02785900|3461064|B2|Age Group|75 - 79 years|Age, Customized||Participants|Count of Participants|41|41.0||||||
3610593|NCT02785900|3461065|B1|Age Group|75 - 79 years|Age, Customized||Participants|Count of Participants|33|33.0||||||
3610594|NCT02785900|3461063|B3|Age Group|65 - 74 years|Age, Customized||Participants|Count of Participants|110|110.0||||||
3610595|NCT02785900|3461064|B2|Age Group|65 - 74 years|Age, Customized||Participants|Count of Participants|55|55.0||||||
3610596|NCT02785900|3461065|B1|Age Group|65 - 74 years|Age, Customized||Participants|Count of Participants|55|55.0||||||
3610597|NCT02785900|3461063|B3|Age Group|>65 years|Age, Customized||Participants|Count of Participants|6|6.0||||||
3610598|NCT02785900|3461064|B2|Age Group|>65 years|Age, Customized||Participants|Count of Participants|3|3.0||||||
3610599|NCT02785900|3461065|B1|Age Group|>65 years|Age, Customized||Participants|Count of Participants|3|3.0||||||
3610600|NCT02785900|3461063|B3|||Age||years|Median|75.0|75.0|Full Range|||52.0|91.0|
3610601|NCT02785900|3461064|B2|||Age||years|Median|75.0|75.0|Full Range|||52.0|91.0|
3610602|NCT02785900|3461065|B1|||Age||years|Median|75.0|75.0|Full Range|||62.0|91.0|
3610603|NCT02785770|3461090|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3610604|NCT02785770|3461090|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3610605|NCT02785770|3461090|B1|||Age||years|Mean|36.3|36.3|Standard Deviation|8.8|8.8|||
3610606|NCT02785354|3461160|B4|Rivaroxaban vs VKA (matched pop)|Female|Sex/Gender, Customized||Participants|Count of Participants|20992|20992.0||||||
3610607|NCT02785354|3461161|B3|Rivaroxaban vs VKA (matched pop)|Female|Sex/Gender, Customized||Participants|Count of Participants|10496|10496.0||||||
3610608|NCT02785354|3461162|B2|Rivaroxaban vs VKA (matched pop)|Female|Sex/Gender, Customized||Participants|Count of Participants|10496|10496.0||||||
3610609|NCT02785354|3461160|B4|Rivaroxaban vs VKA (matched pop)|Male|Sex/Gender, Customized||Participants|Count of Participants|25114|25114.0||||||
3610610|NCT02785354|3461161|B3|Rivaroxaban vs VKA (matched pop)|Male|Sex/Gender, Customized||Participants|Count of Participants|12557|12557.0||||||
3610611|NCT02785354|3461162|B2|Rivaroxaban vs VKA (matched pop)|Male|Sex/Gender, Customized||Participants|Count of Participants|12557|12557.0||||||
3610667|NCT02784275|3461199|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3610612|NCT02785354|3461160|B4|Dabigatran vs VKA (matched pop)|Female|Sex/Gender, Customized||Participants|Count of Participants|18650|18650.0||||||
3610613|NCT02785354|3461161|B3|Dabigatran vs VKA (matched pop)|Female|Sex/Gender, Customized||Participants|Count of Participants|9325|9325.0||||||
3610614|NCT02785354|3461163|B1|Dabigatran vs VKA (matched pop)|Female|Sex/Gender, Customized||Participants|Count of Participants|9325|9325.0||||||
3610615|NCT02785354|3461160|B4|Dabigatran vs VKA (matched pop)|Male|Sex/Gender, Customized||Participants|Count of Participants|22328|22328.0||||||
3610616|NCT02785354|3461161|B3|Dabigatran vs VKA (matched pop)|Male|Sex/Gender, Customized||Participants|Count of Participants|11164|11164.0||||||
3610617|NCT02785354|3461163|B1|Dabigatran vs VKA (matched pop)|Male|Sex/Gender, Customized||Participants|Count of Participants|11164|11164.0||||||
3610618|NCT02785354|3461160|B4|Overall|Female|Sex/Gender, Customized||Participants|Count of Participants|47327|47327.0||||||
3610619|NCT02785354|3461161|B3|Overall|Female|Sex/Gender, Customized||Participants|Count of Participants|21785|21785.0||||||
3610620|NCT02785354|3461162|B2|Overall|Female|Sex/Gender, Customized||Participants|Count of Participants|13735|13735.0||||||
3610621|NCT02785354|3461163|B1|Overall|Female|Sex/Gender, Customized||Participants|Count of Participants|11807|11807.0||||||
3610622|NCT02785354|3461160|B4|Overall|Male|Sex/Gender, Customized||Participants|Count of Participants|55774|55774.0||||||
3610623|NCT02785354|3461161|B3|Overall|Male|Sex/Gender, Customized||Participants|Count of Participants|22868|22868.0||||||
3610624|NCT02785354|3461162|B2|Overall|Male|Sex/Gender, Customized||Participants|Count of Participants|17653|17653.0||||||
3610625|NCT02785354|3461163|B1|Overall|Male|Sex/Gender, Customized||Participants|Count of Participants|15253|15253.0||||||
3610626|NCT02785354|3461160|B4|Rivaroxaban vs VKA (matched pop)||Age, Customized||Years|Mean|75.4|75.4|Standard Deviation|10.7|10.7|||
3610627|NCT02785354|3461161|B3|Rivaroxaban vs VKA (matched pop)||Age, Customized||Years|Mean|75.4|75.4|Standard Deviation|10.7|10.7|||
3610628|NCT02785354|3461162|B2|Rivaroxaban vs VKA (matched pop)||Age, Customized||Years|Mean|75.3|75.3|Standard Deviation|10.7|10.7|||
3610629|NCT02785354|3461160|B4|Dabigatran vs VKA (matched pop)||Age, Customized||Years|Mean|75.4|75.4|Standard Deviation|10.7|10.7|||
3610630|NCT02785354|3461161|B3|Dabigatran vs VKA (matched pop)||Age, Customized||Years|Mean|75.4|75.4|Standard Deviation|10.7|10.7|||
3610631|NCT02785354|3461163|B1|Dabigatran vs VKA (matched pop)||Age, Customized||Years|Mean|75.3|75.3|Standard Deviation|10.7|10.7|||
3610632|NCT02785354|3461160|B4|Overall||Age, Customized||Years|Mean|75.2|75.2|Standard Deviation|11.7|11.7|||
3610633|NCT02785354|3461161|B3|Overall||Age, Customized||Years|Mean|77.9|77.9|Standard Deviation|11.1|11.1|||
3610634|NCT02785354|3461162|B2|Overall||Age, Customized||Years|Mean|73.2|73.2|Standard Deviation|11.8|11.8|||
3610635|NCT02785354|3461163|B1|Overall||Age, Customized||Years|Mean|73.2|73.2|Standard Deviation|11.8|11.8|||
3610636|NCT02784925|3461194|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3610637|NCT02784925|3461194|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3610638|NCT02784925|3461194|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3610639|NCT02784925|3461194|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3610640|NCT02784925|3461194|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610641|NCT02784275|3461198|B5|United States||Region of Enrollment||participants|Number|64|64.0||||||
3610642|NCT02784275|3461199|B4|United States||Region of Enrollment||participants|Number|15|15.0||||||
3610643|NCT02784275|3461200|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
3610644|NCT02784275|3461201|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3610645|NCT02784275|3461202|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3610646|NCT02784275|3461198|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3610647|NCT02784275|3461199|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3610648|NCT02784275|3461200|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610649|NCT02784275|3461201|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610650|NCT02784275|3461202|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610651|NCT02784275|3461198|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3610652|NCT02784275|3461199|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3610653|NCT02784275|3461200|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3610654|NCT02784275|3461201|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3610655|NCT02784275|3461202|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3610656|NCT02784275|3461198|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3610657|NCT02784275|3461199|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3610658|NCT02784275|3461200|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3610659|NCT02784275|3461201|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3610660|NCT02784275|3461202|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3610661|NCT02784275|3461198|B5||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3610662|NCT02784275|3461199|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3610663|NCT02784275|3461200|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3610664|NCT02784275|3461201|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3610665|NCT02784275|3461202|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3610666|NCT02784275|3461198|B5||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3610668|NCT02784275|3461200|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3610669|NCT02784275|3461201|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3610670|NCT02784275|3461202|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3610671|NCT02784275|3461198|B5|||Age|Age of the subjects at the time of study entry.|years|Mean|57.3|57.3|Standard Deviation|8.77|8.77|||
3610672|NCT02784275|3461199|B4|||Age|Age of the subjects at the time of study entry.|years|Mean|57.1|57.1|Standard Deviation|5.53|5.53|||
3610673|NCT02784275|3461200|B3|||Age|Age of the subjects at the time of study entry.|years|Mean|55.2|55.2|Standard Deviation|10.90|10.9|||
3610674|NCT02784275|3461201|B2|||Age|Age of the subjects at the time of study entry.|years|Mean|59.9|59.9|Standard Deviation|9.89|9.89|||
3610675|NCT02784275|3461202|B1|||Age|Age of the subjects at the time of study entry.|years|Mean|56.9|56.9|Standard Deviation|7.58|7.58|||
3610676|NCT02784275|3461198|B5||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3610677|NCT02784275|3461199|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3610678|NCT02784275|3461200|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3610679|NCT02784275|3461201|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3610680|NCT02784275|3461202|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3610681|NCT02784275|3461198|B5||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3610682|NCT02784275|3461199|B4||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3610683|NCT02784275|3461200|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3610684|NCT02784275|3461201|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3610685|NCT02784275|3461202|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3610686|NCT02784275|3461198|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610687|NCT02784275|3461199|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610688|NCT02784275|3461200|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610689|NCT02784275|3461201|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610690|NCT02784275|3461202|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610691|NCT02784106|3461247|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610692|NCT02784106|3461248|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610693|NCT02784106|3461249|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610694|NCT02784106|3461247|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610695|NCT02784106|3461248|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610696|NCT02784106|3461249|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610697|NCT02784106|3461247|B3||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3610698|NCT02784106|3461248|B2||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3610699|NCT02784106|3461249|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3610700|NCT02784106|3461247|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3610701|NCT02784106|3461248|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3610702|NCT02784106|3461249|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3610703|NCT02784106|3461247|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3610704|NCT02784106|3461248|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3610705|NCT02784106|3461249|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610706|NCT02784106|3461247|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610707|NCT02784106|3461248|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610708|NCT02784106|3461249|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610709|NCT02784106|3461247|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610710|NCT02784106|3461248|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610711|NCT02784106|3461249|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610712|NCT02784106|3461247|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610713|NCT02784106|3461248|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610714|NCT02784106|3461249|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610715|NCT02784106|3461247|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3610716|NCT02784106|3461248|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3610717|NCT02784106|3461249|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3610718|NCT02784106|3461247|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3610719|NCT02784106|3461248|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3610720|NCT02784106|3461249|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3610721|NCT02784106|3461247|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3610722|NCT02784106|3461248|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3610723|NCT02784106|3461249|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3610724|NCT02784106|3461247|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3610725|NCT02784106|3461248|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3610726|NCT02784106|3461249|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3610727|NCT02784106|3461247|B3|||Age||years|Mean|53.4|53.4|Standard Deviation|11.39|11.39|||
3610728|NCT02784106|3461248|B2|||Age||years|Mean|53.8|53.8|Standard Deviation|10.73|10.73|||
3610729|NCT02784106|3461249|B1|||Age||years|Mean|53.1|53.1|Standard Deviation|12.19|12.19|||
3610730|NCT02782676|3461313|B1|United States||Region of Enrollment||Participants|Count of Participants|213|213.0||||||
3610731|NCT02782676|3461313|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3610732|NCT02782676|3461313|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610733|NCT02782676|3461313|B1||White|Race (NIH/OMB)||Participants|Count of Participants|200|200.0||||||
3610734|NCT02782676|3461313|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3610735|NCT02782676|3461313|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3610736|NCT02782676|3461313|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3610737|NCT02782676|3461313|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3610738|NCT02782676|3461313|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3610739|NCT02782676|3461313|B1||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3610740|NCT02782676|3461313|B1|||Age||years|Mean|68.7|68.7|Standard Deviation|8|8.0|||
3610741|NCT02782169|3461342|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3610742|NCT02782169|3461343|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3610743|NCT02782169|3461344|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3610744|NCT02782169|3461342|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3610745|NCT02782169|3461343|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3610746|NCT02782169|3461344|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3610747|NCT02782169|3461342|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3610748|NCT02782169|3461343|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3610749|NCT02782169|3461344|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3610750|NCT02782169|3461342|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3610751|NCT02782169|3461343|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3610752|NCT02782169|3461344|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3610753|NCT02782169|3461342|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3610754|NCT02782169|3461343|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3610755|NCT02782169|3461344|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3610756|NCT02782169|3461342|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3610757|NCT02782169|3461343|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3610758|NCT02782169|3461344|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3610759|NCT02782169|3461342|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610760|NCT02782169|3461343|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610761|NCT02782169|3461344|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610762|NCT02782169|3461342|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3610763|NCT02782169|3461343|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3610764|NCT02782169|3461344|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3610765|NCT02782169|3461342|B3||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3610766|NCT02782169|3461343|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3610767|NCT02782169|3461344|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3610768|NCT02782169|3461342|B3|||Age||years|Mean|27.22|27.22|Standard Deviation|5.71|5.71|||
3610769|NCT02782169|3461343|B2|||Age||years|Mean|27.19|27.19|Standard Deviation|6.02|6.02|||
3610770|NCT02782169|3461344|B1|||Age||years|Mean|27.25|27.25|Standard Deviation|5.45|5.45|||
3610771|NCT02781818|3461359|B4|United States||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
3610772|NCT02781818|3461360|B3|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3610773|NCT02781818|3461361|B2|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3610774|NCT02781818|3461362|B1|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3610775|NCT02781818|3461359|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610776|NCT02781818|3461360|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610777|NCT02781818|3461361|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610778|NCT02781818|3461362|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610779|NCT02781818|3461359|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610780|NCT02781818|3461360|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610781|NCT02781818|3461361|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610782|NCT02781818|3461362|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610783|NCT02781818|3461359|B4||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3610784|NCT02781818|3461360|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3610785|NCT02781818|3461361|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3610786|NCT02781818|3461362|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3610787|NCT02781818|3461359|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3610788|NCT02781818|3461360|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3610789|NCT02781818|3461361|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3610790|NCT02781818|3461362|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3610791|NCT02781818|3461359|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610792|NCT02781818|3461360|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610793|NCT02781818|3461361|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610794|NCT02781818|3461362|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610795|NCT02781818|3461359|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610796|NCT02781818|3461360|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610797|NCT02781818|3461361|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610798|NCT02781818|3461362|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610799|NCT02781818|3461359|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610800|NCT02781818|3461360|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610801|NCT02781818|3461361|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610802|NCT02781818|3461362|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610803|NCT02781818|3461359|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3610804|NCT02781818|3461360|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3610805|NCT02781818|3461361|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3610806|NCT02781818|3461362|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3610807|NCT02781818|3461359|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3610808|NCT02781818|3461360|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3610809|NCT02781818|3461361|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3610810|NCT02781818|3461362|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3610811|NCT02781818|3461359|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3610812|NCT02781818|3461360|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3610813|NCT02781818|3461361|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3610814|NCT02781818|3461362|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3610815|NCT02781818|3461359|B4||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3610816|NCT02781818|3461360|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3610817|NCT02781818|3461361|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3610818|NCT02781818|3461362|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3610819|NCT02781818|3461359|B4||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3610820|NCT02781818|3461360|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3610821|NCT02781818|3461361|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3610822|NCT02781818|3461362|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610823|NCT02781649|3461378|B4|||Hepatitis C virus (HCV) antibody negative||Participants|Count of Participants|10|10.0||||||
3610824|NCT02781649|3461379|B3|||Hepatitis C virus (HCV) antibody negative||Participants|Count of Participants|3|3.0||||||
3610825|NCT02781649|3461380|B2|||Hepatitis C virus (HCV) antibody negative||Participants|Count of Participants|0|0.0||||||
3610826|NCT02781649|3461381|B1|||Hepatitis C virus (HCV) antibody negative||Participants|Count of Participants|7|7.0||||||
3610827|NCT02781649|3461378|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
3610828|NCT02781649|3461379|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3610829|NCT02781649|3461381|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3610830|NCT02781649|3461378|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610831|NCT02781649|3461379|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610832|NCT02781649|3461380|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610833|NCT02781649|3461381|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610834|NCT02781649|3461378|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610835|NCT02781649|3461379|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610836|NCT02781649|3461380|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610837|NCT02781649|3461381|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610838|NCT02781649|3461378|B4||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3610839|NCT02781649|3461379|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3610840|NCT02781649|3461380|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610841|NCT02781649|3461381|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3610842|NCT02781649|3461378|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3610843|NCT02781649|3461379|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3610844|NCT02781649|3461380|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610845|NCT02781649|3461381|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610846|NCT02781649|3461378|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610847|NCT02781649|3461379|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610848|NCT02781649|3461380|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610849|NCT02781649|3461381|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610850|NCT02781649|3461378|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3610851|NCT02781649|3461379|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610852|NCT02781649|3461380|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610853|NCT02781649|3461381|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3610854|NCT02781649|3461378|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610855|NCT02781649|3461379|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610856|NCT02781649|3461380|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610857|NCT02781649|3461381|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610858|NCT02781649|3461378|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3610859|NCT02781649|3461379|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3610860|NCT02781649|3461380|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3610861|NCT02781649|3461381|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3610862|NCT02781649|3461378|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3610863|NCT02781649|3461379|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3610864|NCT02781649|3461380|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3610865|NCT02781649|3461381|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3610866|NCT02781649|3461378|B4|||Age||years|Median|71|71.0|Full Range|||57.0|76.0|
3610867|NCT02781649|3461379|B3|||Age||years|Median|61|61.0|Full Range|||57.0|74.0|
3610868|NCT02781649|3461381|B1|||Age||years|Median|71|71.0|Full Range|||65.0|76.0|
3610869|NCT02781649|3461378|B4||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3610870|NCT02781649|3461379|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3610871|NCT02781649|3461380|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3610872|NCT02781649|3461381|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3610873|NCT02781649|3461378|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3610874|NCT02781649|3461379|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3610875|NCT02781649|3461380|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3610876|NCT02781649|3461381|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3610877|NCT02781649|3461378|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610878|NCT02781649|3461379|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610879|NCT02781649|3461380|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610880|NCT02781649|3461381|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3610881|NCT02781571|3461409|B1||Genotype 4|HCV genotype||Participants|Count of Participants|4|4.0||||||
3610882|NCT02781571|3461409|B1||Genotype 3|HCV genotype||Participants|Count of Participants|35|35.0||||||
3610883|NCT02781571|3461409|B1||Genotype 2|HCV genotype||Participants|Count of Participants|3|3.0||||||
3610884|NCT02781571|3461409|B1||Genotype 1|HCV genotype||Participants|Count of Participants|37|37.0||||||
3610885|NCT02781571|3461409|B1||≥ 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|61|61.0||||||
3610886|NCT02781571|3461409|B1||< 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|18|18.0||||||
3610887|NCT02781571|3461409|B1|||HCV RNA||log10 IU/mL|Mean|6.4|6.4|Standard Deviation|0.55|0.55|||
3610888|NCT02781571|3461409|B1||TT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|6|6.0||||||
3610889|NCT02781571|3461409|B1||CT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|34|34.0||||||
3610890|NCT02781571|3461409|B1||CC|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|39|39.0||||||
3610891|NCT02781571|3461409|B1|Spain||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3610892|NCT02781571|3461409|B1|Switzerland||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3610893|NCT02781571|3461409|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3610894|NCT02781571|3461409|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610895|NCT02781571|3461409|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610896|NCT02781571|3461409|B1||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3610897|NCT02781571|3461409|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3610898|NCT02781571|3461409|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610899|NCT02781571|3461409|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3610900|NCT02781571|3461409|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610901|NCT02781571|3461409|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610902|NCT02781571|3461409|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3610903|NCT02781571|3461409|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3610904|NCT02781571|3461409|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3610905|NCT02781571|3461409|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3610906|NCT02781571|3461409|B1|||Age||Years|Mean|62|62.0|Standard Deviation|8.7|8.7|||
3610907|NCT02781558|3461428|B3||≥ 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|148|148.0||||||
3610908|NCT02781558|3461429|B2||≥ 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|79|79.0||||||
3610909|NCT02781558|3461430|B1||≥ 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|69|69.0||||||
3610910|NCT02781558|3461428|B3||< 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|56|56.0||||||
3610911|NCT02781558|3461429|B2||< 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|24|24.0||||||
3610912|NCT02781558|3461430|B1||< 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|32|32.0||||||
3610913|NCT02781558|3461428|B3|||HCV RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.60|0.6|||
3610914|NCT02781558|3461429|B2|||HCV RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.56|0.56|||
3610915|NCT02781558|3461430|B1|||HCV RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.64|0.64|||
3610916|NCT02781558|3461428|B3||Missing|IL28B|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|1|1.0||||||
3610917|NCT02781558|3461429|B2||Missing|IL28B|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|0|0.0||||||
3610918|NCT02781558|3461430|B1||Missing|IL28B|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|1|1.0||||||
3610919|NCT02781558|3461428|B3||Non-CC|IL28B|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|86|86.0||||||
3610920|NCT02781558|3461429|B2||Non-CC|IL28B|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|50|50.0||||||
3610921|NCT02781558|3461430|B1||Non-CC|IL28B|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|36|36.0||||||
3610922|NCT02781558|3461428|B3||CC|IL28B|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|117|117.0||||||
3610923|NCT02781558|3461429|B2||CC|IL28B|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|53|53.0||||||
3610924|NCT02781558|3461430|B1||CC|IL28B|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|64|64.0||||||
3610925|NCT02781558|3461428|B3||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|185|185.0||||||
3610926|NCT02781558|3461429|B2||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|93|93.0||||||
3610927|NCT02781558|3461430|B1||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|92|92.0||||||
3610928|NCT02781558|3461428|B3||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3610929|NCT02781558|3461429|B2||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3610930|NCT02781558|3461430|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3610931|NCT02781558|3461428|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3610932|NCT02781558|3461429|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3610933|NCT02781558|3461430|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3610934|NCT02781558|3461428|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|179|179.0||||||
3610935|NCT02781558|3461429|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|95|95.0||||||
3610936|NCT02781558|3461430|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|84|84.0||||||
3610937|NCT02781558|3461428|B3||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3610938|NCT02781558|3461429|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3610939|NCT02781558|3461430|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3610940|NCT02781558|3461428|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3610941|NCT02781558|3461429|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3610942|NCT02781558|3461430|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3610943|NCT02781558|3461428|B3|||Age||years|Mean|51|51.0|Standard Deviation|7.4|7.4|||
3610944|NCT02781558|3461429|B2|||Age||years|Mean|51|51.0|Standard Deviation|7.6|7.6|||
3610945|NCT02781558|3461430|B1|||Age||years|Mean|51|51.0|Standard Deviation|7.3|7.3|||
3610946|NCT02780869|3461467|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610947|NCT02780869|3461468|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610948|NCT02780869|3461469|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610949|NCT02780869|3461467|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3610950|NCT02780869|3461468|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3610951|NCT02780869|3461469|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3610952|NCT02780869|3461467|B3||White|Race (NIH/OMB)||Participants|Count of Participants|180|180.0||||||
3610953|NCT02780869|3461468|B2||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3610954|NCT02780869|3461469|B1||White|Race (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
3610955|NCT02780869|3461467|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3610956|NCT02780869|3461468|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3610957|NCT02780869|3461469|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3610958|NCT02780869|3461467|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3610959|NCT02780869|3461468|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3610960|NCT02780869|3461469|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3610961|NCT02780869|3461467|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3610962|NCT02780869|3461468|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3610963|NCT02780869|3461469|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3610964|NCT02780869|3461467|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3610965|NCT02780869|3461468|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610966|NCT02780869|3461469|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3610967|NCT02780869|3461467|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3610968|NCT02780869|3461468|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3610969|NCT02780869|3461469|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3610970|NCT02780869|3461467|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|233|233.0||||||
3610971|NCT02780869|3461468|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
3610972|NCT02780869|3461469|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|157|157.0||||||
3610973|NCT02780869|3461467|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3610974|NCT02780869|3461468|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3610975|NCT02780869|3461469|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3610976|NCT02780869|3461467|B3||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3610977|NCT02780869|3461468|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3610978|NCT02780869|3461469|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3610979|NCT02780869|3461467|B3||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3610980|NCT02780869|3461468|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3610981|NCT02780869|3461469|B1||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3610982|NCT02780869|3461467|B3|||Age||years|Mean|56.7|56.7|Standard Deviation|14.71|14.71|||
3610983|NCT02780869|3461468|B2|||Age||years|Mean|56.2|56.2|Standard Deviation|14.62|14.62|||
3610984|NCT02780869|3461469|B1|||Age||years|Mean|56.9|56.9|Standard Deviation|14.79|14.79|||
3610985|NCT02780765|3461480|B3|India||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3610986|NCT02780765|3461481|B2|India||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3610987|NCT02780765|3461482|B1|India||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3610988|NCT02780765|3461480|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3610989|NCT02780765|3461480|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3610990|NCT02780765|3461481|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3610991|NCT02780765|3461482|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3610992|NCT02780765|3461480|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3610993|NCT02780765|3461481|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3610994|NCT02780765|3461482|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3610995|NCT02780765|3461480|B3|||Age||years|Mean|49.58|49.58|Standard Deviation|10.82|10.82|||
3610996|NCT02780765|3461481|B2|||Age||years|Mean|50.60|50.6|Standard Deviation|11.60|11.6|||
3610997|NCT02780765|3461482|B1|||Age||years|Mean|48.57|48.57|Standard Deviation|10.34|10.34|||
3610998|NCT02780765|3461480|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3610999|NCT02780765|3461481|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3611000|NCT02780765|3461482|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3611001|NCT02780765|3461480|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3611002|NCT02780765|3461481|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3611003|NCT02780765|3461482|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3611004|NCT02780765|3461480|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3611005|NCT02780765|3461481|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3611006|NCT02780765|3461482|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3611007|NCT02780700|3461491|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611008|NCT02780700|3461491|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611009|NCT02780700|3461491|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3611010|NCT02780700|3461491|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611011|NCT02780700|3461491|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611012|NCT02780700|3461491|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611013|NCT02780700|3461491|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611014|NCT02780700|3461491|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611015|NCT02780700|3461491|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611016|NCT02780700|3461491|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3611017|NCT02780700|3461491|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3611018|NCT02780700|3461491|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3611019|NCT02780700|3461491|B1|||Age||years|Mean|50|50.0|Standard Deviation|NA||||Not Applicable as only one patient was treated
3611020|NCT02780661|3461499|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611021|NCT02780661|3461499|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611022|NCT02780661|3461499|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611023|NCT02780661|3461499|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611024|NCT02780661|3461499|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3611025|NCT02780661|3461499|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611026|NCT02780661|3461499|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611027|NCT02780661|3461499|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3611028|NCT02780661|3461499|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3611029|NCT02780661|3461499|B1|||Age||years|Mean|68.7|68.7|Standard Deviation|5.10|5.1|||
3611030|NCT02780622|3461516|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3611031|NCT02780622|3461516|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3611032|NCT02780622|3461516|B1|||Age||years|Mean|62.4|62.4|Standard Deviation|8.82|8.82|||
3611033|NCT02780349|3461555|B1|Germany||Region of Enrollment||participants|Number|24|24.0||||||
3611034|NCT02780349|3461555|B1|United States||Region of Enrollment||participants|Number|79|79.0||||||
3611035|NCT02780349|3461555|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611036|NCT02780349|3461555|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
3611037|NCT02780349|3461555|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3611038|NCT02780349|3461555|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3611039|NCT02780349|3461555|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3611040|NCT02780349|3461555|B1|||Age||years|Mean|68.2|68.2|Standard Deviation|9.1|9.1|||
3611041|NCT02780167|3461559|B6||Other|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3611042|NCT02780167|3461560|B5||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3611043|NCT02780167|3461561|B4||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3611044|NCT02780167|3461562|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3611045|NCT02780167|3461563|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3611046|NCT02780167|3461564|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3611047|NCT02780167|3461559|B6||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3611048|NCT02780167|3461560|B5||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3611049|NCT02780167|3461561|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3611050|NCT02780167|3461562|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3611051|NCT02780167|3461563|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3611052|NCT02780167|3461564|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3611053|NCT02780167|3461559|B6||Black|Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
3611054|NCT02780167|3461560|B5||Black|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3611055|NCT02780167|3461561|B4||Black|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3611056|NCT02780167|3461562|B3||Black|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3611057|NCT02780167|3461563|B2||Black|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3611058|NCT02780167|3461564|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3611059|NCT02780167|3461559|B6||White|Race/Ethnicity, Customized||Participants|Count of Participants|194|194.0||||||
3611060|NCT02780167|3461560|B5||White|Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
3611061|NCT02780167|3461561|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3611062|NCT02780167|3461562|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
3611063|NCT02780167|3461563|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
3611064|NCT02780167|3461564|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3611065|NCT02780167|3461559|B6||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3611066|NCT02780167|3461560|B5||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3611067|NCT02780167|3461561|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3611068|NCT02780167|3461562|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3611069|NCT02780167|3461563|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3611070|NCT02780167|3461564|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3611071|NCT02780167|3461559|B6||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3611072|NCT02780167|3461560|B5||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3611073|NCT02780167|3461561|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3611074|NCT02780167|3461562|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3611075|NCT02780167|3461563|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3611076|NCT02780167|3461564|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3611077|NCT02780167|3461559|B6|||Age||years|Mean|40.8|40.8|Standard Deviation|16.1|16.1|||
3611078|NCT02780167|3461560|B5|||Age||years|Mean|38.7|38.7|Standard Deviation|17.6|17.6|||
3611079|NCT02780167|3461561|B4|||Age||years|Mean|41.1|41.1|Standard Deviation|15.6|15.6|||
3611080|NCT02780167|3461562|B3|||Age||years|Mean|37.6|37.6|Standard Deviation|15.9|15.9|||
3611081|NCT02780167|3461563|B2|||Age||years|Mean|44.3|44.3|Standard Deviation|15.9|15.9|||
3611082|NCT02780167|3461564|B1|||Age||years|Mean|42.6|42.6|Standard Deviation|15.1|15.1|||
3611083|NCT02777931|3461700|B3|United States||Region of Enrollment||Participants|Count of Participants|97|97.0||||||
3611084|NCT02777931|3461701|B2|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3611085|NCT02777931|3461702|B1|United States||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
3611086|NCT02777931|3461700|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3611087|NCT02777931|3461701|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3611088|NCT02777931|3461702|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611089|NCT02777931|3461700|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3611090|NCT02777931|3461701|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3611091|NCT02777931|3461702|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3611092|NCT02777931|3461700|B3||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3611093|NCT02777931|3461701|B2||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3611094|NCT02777931|3461702|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3611095|NCT02777931|3461700|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3611096|NCT02777931|3461701|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3611097|NCT02777931|3461702|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3611098|NCT02777931|3461700|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611099|NCT02777931|3461701|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611100|NCT02777931|3461702|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611101|NCT02777931|3461700|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3611102|NCT02777931|3461701|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3611103|NCT02777931|3461702|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611104|NCT02777931|3461700|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3611105|NCT02777931|3461701|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3611106|NCT02777931|3461702|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3611107|NCT02777931|3461700|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3611108|NCT02777931|3461701|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3611109|NCT02777931|3461702|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3611110|NCT02777931|3461700|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3611111|NCT02777931|3461701|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3611112|NCT02777931|3461702|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3611113|NCT02777931|3461700|B3|||Age||years|Mean|14.1|14.1|Standard Deviation|1.58|1.58|||
3611114|NCT02777931|3461701|B2|||Age||years|Mean|14.4|14.4|Standard Deviation|1.68|1.68|||
3611115|NCT02777931|3461702|B1|||Age||years|Mean|13.8|13.8|Standard Deviation|1.40|1.4|||
3611116|NCT02777268|3461711|B1|||Drug/Alcohol and HIV/Hepatitis Screening||Participants|Count of Participants|0|0.0||||||
3611117|NCT02777268|3461711|B1|||Medical History and Concurrent Conditions||Participants|Count of Participants|0|0.0||||||
3611118|NCT02777268|3461711|B1|||Weight (kg)||Kilograms (kg)|Mean|79.70|79.7|Standard Deviation|8.543|8.543|||
3611119|NCT02777268|3461711|B1|||Height (m)||Metres (m)|Mean|1.773|1.773|Standard Deviation|0.081|0.081|||
3611120|NCT02777268|3461711|B1|||Body Mass Index (BMI)||kg/m^2|Mean|25.34|25.34|Standard Deviation|2.085|2.085|||
3611121|NCT02777268|3461711|B1|United Kingdom||Region of Enrollment|United Kingdom|participants|Number|16|16.0||||||
3611122|NCT02777268|3461711|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611123|NCT02777268|3461711|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611124|NCT02777268|3461711|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3611125|NCT02777268|3461711|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3611126|NCT02777268|3461711|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611127|NCT02777268|3461711|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611128|NCT02777268|3461711|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611129|NCT02777268|3461711|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3611130|NCT02777268|3461711|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3611131|NCT02777268|3461711|B1|||Age||Years|Mean|40.70|40.7|Standard Deviation|14.370|14.37|||
3611132|NCT02777268|3461711|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3611133|NCT02777268|3461711|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3611134|NCT02777268|3461711|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3611135|NCT02777242|3461737|B1|United States||Region of Enrollment||Participants|Count of Participants|65|65.0||||||
3611136|NCT02777242|3461737|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611137|NCT02777242|3461737|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611138|NCT02777242|3461737|B1||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3611139|NCT02777242|3461737|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3611140|NCT02777242|3461737|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611141|NCT02777242|3461737|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611142|NCT02777242|3461737|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611143|NCT02777242|3461737|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611144|NCT02777242|3461737|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3611145|NCT02777242|3461737|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3611146|NCT02777242|3461737|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3611147|NCT02777242|3461737|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3611148|NCT02777242|3461737|B1|||Age||years|Mean|55.3|55.3|Standard Deviation|8.98|8.98|||
3611149|NCT02777125|3461741|B3|||Pediatric Asthma Score at Presentation|The Pediatric Asthma Severity Score is a composite score based upon the patient's respiratory rate, oxygen saturation, retractions, work of breathing and findings on auscultation. The score ranges from 5-15, with the higher score being associated with a more severe asthma exacerbation. A mild score ranges from 5-7, a moderate score of 8-11. The minimum score obtainable is 5, the maximum score is a 15. Any subject with a presenting score above 11 was not eligible for participation in this study as these would be classified as a severe exacerbation.|units on a scale|Mean|7.9|7.9|Standard Deviation|1.6|1.6|||
3611150|NCT02777125|3461742|B2|||Pediatric Asthma Score at Presentation|The Pediatric Asthma Severity Score is a composite score based upon the patient's respiratory rate, oxygen saturation, retractions, work of breathing and findings on auscultation. The score ranges from 5-15, with the higher score being associated with a more severe asthma exacerbation. A mild score ranges from 5-7, a moderate score of 8-11. The minimum score obtainable is 5, the maximum score is a 15. Any subject with a presenting score above 11 was not eligible for participation in this study as these would be classified as a severe exacerbation.|units on a scale|Mean|8.0|8.0|Standard Deviation|1.6|1.6|||
3611151|NCT02777125|3461743|B1|||Pediatric Asthma Score at Presentation|The Pediatric Asthma Severity Score is a composite score based upon the patient's respiratory rate, oxygen saturation, retractions, work of breathing and findings on auscultation. The score ranges from 5-15, with the higher score being associated with a more severe asthma exacerbation. A mild score ranges from 5-7, a moderate score of 8-11. The minimum score obtainable is 5, the maximum score is a 15. Any subject with a presenting score above 11 was not eligible for participation in this study as these would be classified as a severe exacerbation.|units on a scale|Mean|7.7|7.7|Standard Deviation|1.7|1.7|||
3611152|NCT02777125|3461741|B3|United States||Region of Enrollment||participants|Number|890|890.0||||||
3611153|NCT02777125|3461742|B2|United States||Region of Enrollment||participants|Number|445|445.0||||||
3611154|NCT02777125|3461743|B1|United States||Region of Enrollment||participants|Number|445|445.0||||||
3611155|NCT02777125|3461741|B3||Male|Sex: Female, Male||Participants|Count of Participants|577|577.0||||||
3611156|NCT02777125|3461742|B2||Male|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
3611157|NCT02777125|3461743|B1||Male|Sex: Female, Male||Participants|Count of Participants|279|279.0||||||
3611158|NCT02777125|3461741|B3||Female|Sex: Female, Male||Participants|Count of Participants|313|313.0||||||
3611159|NCT02777125|3461742|B2||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3611160|NCT02777125|3461743|B1||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3611161|NCT02777125|3461741|B3|||Age||years|Mean|6.37|6.37|Standard Deviation|3.93|3.93|||
3611162|NCT02777125|3461742|B2|||Age||years|Mean|6.38|6.38|Standard Deviation|4.0|4.0|||
3611163|NCT02777125|3461743|B1|||Age||years|Mean|6.37|6.37|Standard Deviation|3.9|3.9|||
3611164|NCT02777125|3461741|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3611165|NCT02777125|3461742|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3611166|NCT02777125|3461743|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3611167|NCT02777125|3461741|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3611168|NCT02777125|3461742|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3611169|NCT02777125|3461743|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3611170|NCT02777125|3461741|B3||<=18 years|Age||Participants|Count of Participants|890|890.0||||||
3611171|NCT02777125|3461742|B2||<=18 years|Age||Participants|Count of Participants|445|445.0||||||
3611172|NCT02777125|3461743|B1||<=18 years|Age||Participants|Count of Participants|445|445.0||||||
3611173|NCT02774343|3461758|B3|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3611174|NCT02774343|3461759|B2|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3611175|NCT02774343|3461760|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3611176|NCT02774343|3461758|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3611177|NCT02774343|3461759|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3611178|NCT02774343|3461760|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3611179|NCT02774343|3461758|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3611180|NCT02774343|3461759|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3611181|NCT02774343|3461760|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3611182|NCT02774343|3461758|B3|||Age||years|Mean|47.8|47.8|Standard Deviation|7.45|7.45|||
3611183|NCT02774343|3461759|B2|||Age||years|Mean|47.4|47.4|Standard Deviation|7.8|7.8|||
3611184|NCT02774343|3461760|B1|||Age||years|Mean|48.3|48.3|Standard Deviation|7.1|7.1|||
3611185|NCT02774278|3461797|B1||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3611186|NCT02774278|3461797|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3611187|NCT02774278|3461797|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|10.47|10.47|||
3611188|NCT02774265|3461805|B3|||Current smoker||Participants|Count of Participants|127|127.0||||||
3611189|NCT02774265|3461806|B2|||Current smoker||Participants|Count of Participants|65|65.0||||||
3611190|NCT02774265|3461807|B1|||Current smoker||Participants|Count of Participants|62|62.0||||||
3611191|NCT02774265|3461805|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3611192|NCT02774265|3461806|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3611193|NCT02774265|3461807|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3611194|NCT02774265|3461805|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3611195|NCT02774265|3461806|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3611196|NCT02774265|3461807|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3611197|NCT02774265|3461805|B3||White|Race (NIH/OMB)||Participants|Count of Participants|203|203.0||||||
3611198|NCT02774265|3461806|B2||White|Race (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
3611199|NCT02774265|3461807|B1||White|Race (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
3611200|NCT02774265|3461805|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3611201|NCT02774265|3461806|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3611202|NCT02774265|3461807|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3611203|NCT02774265|3461805|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611204|NCT02774265|3461806|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611205|NCT02774265|3461807|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611206|NCT02774265|3461805|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611207|NCT02774265|3461806|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611208|NCT02774265|3461807|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611209|NCT02774265|3461805|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611210|NCT02774265|3461806|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611211|NCT02774265|3461807|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611212|NCT02774265|3461805|B3||Male|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
3611213|NCT02774265|3461806|B2||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3611214|NCT02774265|3461807|B1||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3611215|NCT02774265|3461805|B3||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3611216|NCT02774265|3461806|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3611217|NCT02774265|3461807|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3611218|NCT02774265|3461805|B3|||Age||years|Mean|46.7|46.7|Standard Deviation|19.5|19.5|||
3611219|NCT02774265|3461806|B2|||Age||years|Mean|48|48.0|Standard Deviation|18.6|18.6|||
3611220|NCT02774265|3461807|B1|||Age||years|Mean|45.4|45.4|Standard Deviation|20.4|20.4|||
3611221|NCT02773758|3461835|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3611222|NCT02773758|3461836|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3611223|NCT02773758|3461837|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3611224|NCT02773758|3461835|B3||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3611225|NCT02773758|3461836|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3611226|NCT02773758|3461837|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3611227|NCT02773758|3461835|B3|||Age||Years|Mean|47.9|47.9|Standard Deviation|10.39|10.39|||
3611228|NCT02773758|3461836|B2|||Age||Years|Mean|48.0|48.0|Standard Deviation|10.58|10.58|||
3611229|NCT02773758|3461837|B1|||Age||Years|Mean|47.7|47.7|Standard Deviation|10.27|10.27|||
3611230|NCT02773446|3461848|B7|United States|Cohort 2|Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3611231|NCT02773446|3461849|B6|United States|Cohort 2|Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3611232|NCT02773446|3461850|B5|United States|Cohort 2|Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3611233|NCT02773446|3461851|B4|United States|Cohort 2|Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3611234|NCT02773446|3461852|B3|United States|Cohort 2|Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3611235|NCT02773446|3461853|B2|United States|Cohort 2|Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3611236|NCT02773446|3461854|B1|United States|Cohort 2|Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3611237|NCT02773446|3461848|B7|United States|Cohort 1|Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3611238|NCT02773446|3461849|B6|United States|Cohort 1|Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3611239|NCT02773446|3461850|B5|United States|Cohort 1|Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3611240|NCT02773446|3461851|B4|United States|Cohort 1|Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3611241|NCT02773446|3461852|B3|United States|Cohort 1|Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3611242|NCT02773446|3461853|B2|United States|Cohort 1|Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3611243|NCT02773446|3461854|B1|United States|Cohort 1|Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3611244|NCT02773446|3461848|B7|Cohort 2|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3611245|NCT02773446|3461849|B6|Cohort 2|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3611246|NCT02773446|3461850|B5|Cohort 2|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611247|NCT02773446|3461848|B7|Cohort 2|More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611248|NCT02773446|3461849|B6|Cohort 2|More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611249|NCT02773446|3461850|B5|Cohort 2|More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611250|NCT02773446|3461848|B7|Cohort 2|White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3611251|NCT02773446|3461849|B6|Cohort 2|White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3611252|NCT02773446|3461850|B5|Cohort 2|White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611253|NCT02773446|3461848|B7|Cohort 2|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3611254|NCT02773446|3461849|B6|Cohort 2|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3611255|NCT02773446|3461850|B5|Cohort 2|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3611256|NCT02773446|3461848|B7|Cohort 2|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611257|NCT02773446|3461849|B6|Cohort 2|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611258|NCT02773446|3461850|B5|Cohort 2|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611259|NCT02773446|3461848|B7|Cohort 2|Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3611260|NCT02773446|3461849|B6|Cohort 2|Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3611261|NCT02773446|3461850|B5|Cohort 2|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611262|NCT02773446|3461848|B7|Cohort 2|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611263|NCT02773446|3461849|B6|Cohort 2|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611264|NCT02773446|3461850|B5|Cohort 2|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611265|NCT02773446|3461848|B7|Cohort 1|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611266|NCT02773446|3461849|B6|Cohort 1|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611267|NCT02773446|3461850|B5|Cohort 1|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611268|NCT02773446|3461851|B4|Cohort 1|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611269|NCT02773446|3461852|B3|Cohort 1|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611270|NCT02773446|3461853|B2|Cohort 1|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611271|NCT02773446|3461854|B1|Cohort 1|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611272|NCT02773446|3461848|B7|Cohort 1|More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611273|NCT02773446|3461849|B6|Cohort 1|More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611274|NCT02773446|3461850|B5|Cohort 1|More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611275|NCT02773446|3461851|B4|Cohort 1|More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611276|NCT02773446|3461852|B3|Cohort 1|More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611277|NCT02773446|3461853|B2|Cohort 1|More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611278|NCT02773446|3461854|B1|Cohort 1|More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611279|NCT02773446|3461848|B7|Cohort 1|White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3611280|NCT02773446|3461849|B6|Cohort 1|White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611281|NCT02773446|3461850|B5|Cohort 1|White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611282|NCT02773446|3461851|B4|Cohort 1|White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3611283|NCT02773446|3461852|B3|Cohort 1|White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611284|NCT02773446|3461853|B2|Cohort 1|White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3611285|NCT02773446|3461854|B1|Cohort 1|White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3611286|NCT02773446|3461848|B7|Cohort 1|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3611287|NCT02773446|3461849|B6|Cohort 1|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611288|NCT02773446|3461850|B5|Cohort 1|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611289|NCT02773446|3461851|B4|Cohort 1|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3611290|NCT02773446|3461852|B3|Cohort 1|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3611291|NCT02773446|3461853|B2|Cohort 1|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3611292|NCT02773446|3461854|B1|Cohort 1|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3611293|NCT02773446|3461848|B7|Cohort 1|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611294|NCT02773446|3461849|B6|Cohort 1|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611295|NCT02773446|3461850|B5|Cohort 1|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611296|NCT02773446|3461851|B4|Cohort 1|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611297|NCT02773446|3461852|B3|Cohort 1|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611298|NCT02773446|3461853|B2|Cohort 1|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611299|NCT02773446|3461854|B1|Cohort 1|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611300|NCT02773446|3461848|B7|Cohort 1|Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3611301|NCT02773446|3461849|B6|Cohort 1|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611302|NCT02773446|3461850|B5|Cohort 1|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611303|NCT02773446|3461851|B4|Cohort 1|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611304|NCT02773446|3461852|B3|Cohort 1|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611305|NCT02773446|3461853|B2|Cohort 1|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611306|NCT02773446|3461854|B1|Cohort 1|Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3611307|NCT02773446|3461848|B7|Cohort 1|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611308|NCT02773446|3461849|B6|Cohort 1|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611309|NCT02773446|3461850|B5|Cohort 1|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611310|NCT02773446|3461851|B4|Cohort 1|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611311|NCT02773446|3461852|B3|Cohort 1|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611312|NCT02773446|3461853|B2|Cohort 1|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611313|NCT02773446|3461854|B1|Cohort 1|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611314|NCT02773446|3461848|B7|Cohort 2|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611315|NCT02773446|3461849|B6|Cohort 2|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611316|NCT02773446|3461850|B5|Cohort 2|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611317|NCT02773446|3461851|B4|Cohort 2|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611318|NCT02773446|3461852|B3|Cohort 2|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611319|NCT02773446|3461853|B2|Cohort 2|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611320|NCT02773446|3461854|B1|Cohort 2|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611321|NCT02773446|3461848|B7|Cohort 2|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3611322|NCT02773446|3461849|B6|Cohort 2|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3611323|NCT02773446|3461850|B5|Cohort 2|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3611324|NCT02773446|3461851|B4|Cohort 2|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611325|NCT02773446|3461852|B3|Cohort 2|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611326|NCT02773446|3461853|B2|Cohort 2|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611327|NCT02773446|3461854|B1|Cohort 2|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611328|NCT02773446|3461848|B7|Cohort 2|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3611329|NCT02773446|3461849|B6|Cohort 2|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3611330|NCT02773446|3461850|B5|Cohort 2|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611331|NCT02773446|3461851|B4|Cohort 2|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611332|NCT02773446|3461852|B3|Cohort 2|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611333|NCT02773446|3461853|B2|Cohort 2|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611334|NCT02773446|3461854|B1|Cohort 2|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611335|NCT02773446|3461848|B7|Cohort 1|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611336|NCT02773446|3461849|B6|Cohort 1|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611337|NCT02773446|3461850|B5|Cohort 1|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611338|NCT02773446|3461851|B4|Cohort 1|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611339|NCT02773446|3461852|B3|Cohort 1|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611340|NCT02773446|3461853|B2|Cohort 1|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611341|NCT02773446|3461854|B1|Cohort 1|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611342|NCT02773446|3461848|B7|Cohort 1|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3611343|NCT02773446|3461849|B6|Cohort 1|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611344|NCT02773446|3461850|B5|Cohort 1|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611345|NCT02773446|3461851|B4|Cohort 1|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3611346|NCT02773446|3461852|B3|Cohort 1|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3611347|NCT02773446|3461853|B2|Cohort 1|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3611348|NCT02773446|3461854|B1|Cohort 1|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3611349|NCT02773446|3461848|B7|Cohort 1|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3611350|NCT02773446|3461849|B6|Cohort 1|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611351|NCT02773446|3461850|B5|Cohort 1|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611352|NCT02773446|3461851|B4|Cohort 1|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611353|NCT02773446|3461852|B3|Cohort 1|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611354|NCT02773446|3461853|B2|Cohort 1|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3611355|NCT02773446|3461854|B1|Cohort 1|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611356|NCT02773446|3461848|B7|Cohort 2|Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3611357|NCT02773446|3461849|B6|Cohort 2|Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3611358|NCT02773446|3461850|B5|Cohort 2|Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3611359|NCT02773446|3461851|B4|Cohort 2|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3611360|NCT02773446|3461852|B3|Cohort 2|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3611361|NCT02773446|3461853|B2|Cohort 2|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3611362|NCT02773446|3461854|B1|Cohort 2|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3611363|NCT02773446|3461848|B7|Cohort 2|Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3611364|NCT02773446|3461849|B6|Cohort 2|Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3611365|NCT02773446|3461850|B5|Cohort 2|Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3611366|NCT02773446|3461851|B4|Cohort 2|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3611367|NCT02773446|3461852|B3|Cohort 2|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3611368|NCT02773446|3461853|B2|Cohort 2|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3611369|NCT02773446|3461854|B1|Cohort 2|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3611370|NCT02773446|3461848|B7|Cohort 1|Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3611371|NCT02773446|3461849|B6|Cohort 1|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3611372|NCT02773446|3461850|B5|Cohort 1|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3611373|NCT02773446|3461851|B4|Cohort 1|Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3611374|NCT02773446|3461852|B3|Cohort 1|Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3611375|NCT02773446|3461853|B2|Cohort 1|Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3611376|NCT02773446|3461854|B1|Cohort 1|Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3611377|NCT02773446|3461848|B7|Cohort 1|Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3611378|NCT02773446|3461849|B6|Cohort 1|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3611379|NCT02773446|3461850|B5|Cohort 1|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3611380|NCT02773446|3461851|B4|Cohort 1|Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3611381|NCT02773446|3461852|B3|Cohort 1|Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3611382|NCT02773446|3461853|B2|Cohort 1|Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3611383|NCT02773446|3461854|B1|Cohort 1|Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3611384|NCT02773446|3461848|B7|Cohort 2||Age||years|Median|36|36.0|Inter-Quartile Range|||30.0|41.5|
3611385|NCT02773446|3461849|B6|Cohort 2||Age||years|Median|35|35.0|Inter-Quartile Range|||30.0|42.0|
3611386|NCT02773446|3461850|B5|Cohort 2||Age||years|Median|39|39.0|Inter-Quartile Range|||32.0|41.0|
3611387|NCT02773446|3461848|B7|Cohort 1||Age||years|Median|34.5|34.5|Inter-Quartile Range|||32.0|40.0|
3611388|NCT02773446|3461851|B4|Cohort 1||Age||years|Median|35|35.0|Inter-Quartile Range|||33.0|40.5|
3611389|NCT02773446|3461852|B3|Cohort 1||Age||years|Median|39|39.0|Inter-Quartile Range|||31.0|40.5|
3611390|NCT02773446|3461853|B2|Cohort 1||Age||years|Median|34|34.0|Inter-Quartile Range|||31.5|37.0|
3611391|NCT02773446|3461854|B1|Cohort 1||Age||years|Median|36|36.0|Inter-Quartile Range|||29.5|39.0|
3611392|NCT02773368|3461898|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3611393|NCT02773368|3461899|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3611394|NCT02773368|3461900|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3611395|NCT02773368|3461898|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611396|NCT02773368|3461899|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611397|NCT02773368|3461900|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611398|NCT02773368|3461898|B3||White|Race (NIH/OMB)||Participants|Count of Participants|346|346.0||||||
3611399|NCT02773368|3461899|B2||White|Race (NIH/OMB)||Participants|Count of Participants|171|171.0||||||
3611400|NCT02773368|3461900|B1||White|Race (NIH/OMB)||Participants|Count of Participants|175|175.0||||||
3611401|NCT02773368|3461898|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3611402|NCT02773368|3461899|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3611403|NCT02773368|3461900|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3611404|NCT02773368|3461898|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611405|NCT02773368|3461899|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611406|NCT02773368|3461900|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611407|NCT02773368|3461898|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3611408|NCT02773368|3461899|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3611409|NCT02773368|3461900|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3611410|NCT02773368|3461898|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3611411|NCT02773368|3461899|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3611412|NCT02773368|3461900|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611413|NCT02773368|3461898|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611414|NCT02773368|3461899|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611415|NCT02773368|3461900|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611416|NCT02773368|3461898|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|352|352.0||||||
3611417|NCT02773368|3461899|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|173|173.0||||||
3611418|NCT02773368|3461900|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|179|179.0||||||
3611419|NCT02773368|3461898|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3611420|NCT02773368|3461899|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3611421|NCT02773368|3461900|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3611422|NCT02773368|3461898|B3||Male|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
3611423|NCT02773368|3461899|B2||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3611424|NCT02773368|3461900|B1||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3611425|NCT02773368|3461898|B3||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
3611426|NCT02773368|3461899|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3611427|NCT02773368|3461900|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3611428|NCT02773368|3461898|B3|||Age||years|Mean|56.7|56.7|Standard Deviation|10.3|10.3|||
3611429|NCT02773368|3461899|B2|||Age||years|Mean|57.2|57.2|Standard Deviation|10.2|10.2|||
3611430|NCT02773368|3461900|B1|||Age||years|Mean|56.1|56.1|Standard Deviation|10.4|10.4|||
3611431|NCT02772666|3461971|B1|Iran, Islamic Republic of||Region of Enrollment|Khatam Al-Anbia Eye Hospital, Mashhad, a city in north east of Iran.|participants|Number|44|44.0||||||
3611432|NCT02772666|3461971|B1||Male|Gender||Participants|Count of Participants|26|26.0||||||
3611433|NCT02772666|3461971|B1||Female|Gender||Participants|Count of Participants|18|18.0||||||
3611434|NCT02772666|3461971|B1|||Age||years|Mean|35|35.0|Full Range|||20.0|55.0|
3611435|NCT02771145|3461976|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3611436|NCT02771145|3461976|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3611437|NCT02771145|3461976|B1|||Age||years|Mean|32.1|32.1|Standard Deviation|9.05|9.05|||
3611438|NCT02771093|3462015|B3|||Dipeptidyl-peptidase (DPP)-4 activity||nmol/min/mL|Mean|10.9886|10.9886|Standard Deviation|2.74706|2.74706|||
3611439|NCT02771093|3462016|B2|||Dipeptidyl-peptidase (DPP)-4 activity||nmol/min/mL|Mean|10.9258|10.9258|Standard Deviation|3.25751|3.25751|||
3611440|NCT02771093|3462017|B1|||Dipeptidyl-peptidase (DPP)-4 activity||nmol/min/mL|Mean|11.0640|11.064|Standard Deviation|2.15107|2.15107|||
3611441|NCT02771093|3462015|B3|||Fasting Glucagon Like Peptide (GLP)-1||pmol/L|Mean|0.966|0.966|Standard Deviation|1.0994|1.0994|||
3611442|NCT02771093|3462016|B2|||Fasting Glucagon Like Peptide (GLP)-1||pmol/L|Mean|1.139|1.139|Standard Deviation|1.3195|1.3195|||
3611443|NCT02771093|3462017|B1|||Fasting Glucagon Like Peptide (GLP)-1||pmol/L|Mean|0.780|0.78|Standard Deviation|0.8125|0.8125|||
3611444|NCT02771093|3462015|B3|||Fasting Blood Glucose||mg/dL|Mean|144.8|144.8|Standard Deviation|18.06|18.06|||
3611445|NCT02771093|3462016|B2|||Fasting Blood Glucose||mg/dL|Mean|145.5|145.5|Standard Deviation|19.15|19.15|||
3611446|NCT02771093|3462017|B1|||Fasting Blood Glucose||mg/dL|Mean|144.0|144.0|Standard Deviation|17.57|17.57|||
3611447|NCT02771093|3462015|B3|||Fasting Insulin||uU/mL|Mean|9.09|9.09|Standard Deviation|4.221|4.221|||
3611448|NCT02771093|3462016|B2|||Fasting Insulin||uU/mL|Mean|8.79|8.79|Standard Deviation|4.395|4.395|||
3611449|NCT02771093|3462017|B1|||Fasting Insulin||uU/mL|Mean|9.42|9.42|Standard Deviation|4.177|4.177|||
3611450|NCT02771093|3462015|B3|||Area Under the Plasma Concentration-time Curve (AUC) of blood glucose||mg*min/dL|Mean|44242.3|44242.3|Standard Deviation|5553.22|5553.22|||
3611495|NCT02771093|3462017|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3611451|NCT02771093|3462016|B2|||Area Under the Plasma Concentration-time Curve (AUC) of blood glucose||mg*min/dL|Mean|46372.7|46372.7|Standard Deviation|5282.47|5282.47|||
3611452|NCT02771093|3462017|B1|||Area Under the Plasma Concentration-time Curve (AUC) of blood glucose||mg*min/dL|Mean|41947.9|41947.9|Standard Deviation|5058.50|5058.5|||
3611453|NCT02771093|3462015|B3|||Mean 24-hour Blood Glucose||mg/dL|Mean|153.62|153.62|Standard Deviation|19.287|19.287|||
3611454|NCT02771093|3462016|B2|||Mean 24-hour Blood Glucose||mg/dL|Mean|161.01|161.01|Standard Deviation|18.349|18.349|||
3611455|NCT02771093|3462017|B1|||Mean 24-hour Blood Glucose||mg/dL|Mean|145.65|145.65|Standard Deviation|17.570|17.57|||
3611456|NCT02771093|3462015|B3|||Mean Amplitude Glycemic Excursions (MAGE)|MAGE is used for measurement of the degree of glucose level fluctuations. MAGE is calculated from continuous glucose monitoring data.|millgrams per deciliter (mg/dL)|Mean|106.47|106.47|Standard Deviation|41.488|41.488|||
3611457|NCT02771093|3462016|B2|||Mean Amplitude Glycemic Excursions (MAGE)|MAGE is used for measurement of the degree of glucose level fluctuations. MAGE is calculated from continuous glucose monitoring data.|millgrams per deciliter (mg/dL)|Mean|114.91|114.91|Standard Deviation|38.454|38.454|||
3611458|NCT02771093|3462017|B1|||Mean Amplitude Glycemic Excursions (MAGE)|MAGE is used for measurement of the degree of glucose level fluctuations. MAGE is calculated from continuous glucose monitoring data.|millgrams per deciliter (mg/dL)|Mean|98.02|98.02|Standard Deviation|44.191|44.191|||
3611459|NCT02771093|3462015|B3|||Glycated hemoglobin A1c (HbA1c) [National Glycohemoglobin Standardization Program (NGSP)]||percent|Mean|7.24|7.24|Standard Deviation|0.485|0.485|||
3611460|NCT02771093|3462016|B2|||Glycated hemoglobin A1c (HbA1c) [National Glycohemoglobin Standardization Program (NGSP)]||percent|Mean|7.19|7.19|Standard Deviation|0.339|0.339|||
3611461|NCT02771093|3462017|B1|||Glycated hemoglobin A1c (HbA1c) [National Glycohemoglobin Standardization Program (NGSP)]||percent|Mean|7.29|7.29|Standard Deviation|0.616|0.616|||
3611462|NCT02771093|3462015|B3|||Duration of Diabetes Mellitus|Mean duration between start of study and first time of diagnosis of type 2 diabetes mellitus was reported.|years|Mean|5.89|5.89|Standard Deviation|4.500|4.5|||
3611463|NCT02771093|3462016|B2|||Duration of Diabetes Mellitus|Mean duration between start of study and first time of diagnosis of type 2 diabetes mellitus was reported.|years|Mean|6.15|6.15|Standard Deviation|4.679|4.679|||
3611464|NCT02771093|3462017|B1|||Duration of Diabetes Mellitus|Mean duration between start of study and first time of diagnosis of type 2 diabetes mellitus was reported.|years|Mean|5.62|5.62|Standard Deviation|4.471|4.471|||
3611465|NCT02771093|3462015|B3||No|Alcohol Classification|"Participants who answered Yes or No for a question “Drink Alcohol Almost Every Day? were reported."|Participants|Count of Participants|24|24.0||||||
3611466|NCT02771093|3462016|B2||No|Alcohol Classification|"Participants who answered Yes or No for a question “Drink Alcohol Almost Every Day? were reported."|Participants|Count of Participants|12|12.0||||||
3611467|NCT02771093|3462017|B1||No|Alcohol Classification|"Participants who answered Yes or No for a question “Drink Alcohol Almost Every Day? were reported."|Participants|Count of Participants|12|12.0||||||
3611468|NCT02771093|3462015|B3||Yes|Alcohol Classification|"Participants who answered Yes or No for a question “Drink Alcohol Almost Every Day? were reported."|Participants|Count of Participants|3|3.0||||||
3611469|NCT02771093|3462016|B2||Yes|Alcohol Classification|"Participants who answered Yes or No for a question “Drink Alcohol Almost Every Day? were reported."|Participants|Count of Participants|2|2.0||||||
3611470|NCT02771093|3462017|B1||Yes|Alcohol Classification|"Participants who answered Yes or No for a question “Drink Alcohol Almost Every Day? were reported."|Participants|Count of Participants|1|1.0||||||
3611471|NCT02771093|3462015|B3||Ex-Smoker|Smoking Classification||Participants|Count of Participants|6|6.0||||||
3611472|NCT02771093|3462016|B2||Ex-Smoker|Smoking Classification||Participants|Count of Participants|4|4.0||||||
3611473|NCT02771093|3462017|B1||Ex-Smoker|Smoking Classification||Participants|Count of Participants|2|2.0||||||
3611474|NCT02771093|3462015|B3||Current Smoker|Smoking Classification||Participants|Count of Participants|6|6.0||||||
3611475|NCT02771093|3462016|B2||Current Smoker|Smoking Classification||Participants|Count of Participants|3|3.0||||||
3611476|NCT02771093|3462017|B1||Current Smoker|Smoking Classification||Participants|Count of Participants|3|3.0||||||
3611477|NCT02771093|3462015|B3||Never Smoked|Smoking Classification||Participants|Count of Participants|15|15.0||||||
3611478|NCT02771093|3462016|B2||Never Smoked|Smoking Classification||Participants|Count of Participants|7|7.0||||||
3611479|NCT02771093|3462017|B1||Never Smoked|Smoking Classification||Participants|Count of Participants|8|8.0||||||
3611480|NCT02771093|3462015|B3|||Body Mass Index (BMI)|Body Mass Index = weght (kg)/[height (m)^2]|(kg/m^2)|Mean|24.52|24.52|Standard Deviation|2.783|2.783|||
3611481|NCT02771093|3462016|B2|||Body Mass Index (BMI)|Body Mass Index = weght (kg)/[height (m)^2]|(kg/m^2)|Mean|23.65|23.65|Standard Deviation|2.404|2.404|||
3611482|NCT02771093|3462017|B1|||Body Mass Index (BMI)|Body Mass Index = weght (kg)/[height (m)^2]|(kg/m^2)|Mean|25.45|25.45|Standard Deviation|2.948|2.948|||
3611483|NCT02771093|3462015|B3|||Weight||kilogram (kg)|Mean|65.26|65.26|Standard Deviation|11.796|11.796|||
3611484|NCT02771093|3462016|B2|||Weight||kilogram (kg)|Mean|64.15|64.15|Standard Deviation|9.585|9.585|||
3611485|NCT02771093|3462017|B1|||Weight||kilogram (kg)|Mean|66.45|66.45|Standard Deviation|14.107|14.107|||
3611486|NCT02771093|3462015|B3|||Height||centimeter (cm)|Mean|162.7|162.7|Standard Deviation|8.87|8.87|||
3611487|NCT02771093|3462016|B2|||Height||centimeter (cm)|Mean|164.4|164.4|Standard Deviation|7.17|7.17|||
3611488|NCT02771093|3462017|B1|||Height||centimeter (cm)|Mean|160.9|160.9|Standard Deviation|10.40|10.4|||
3611489|NCT02771093|3462015|B3|Japan||Region of Enrollment||Participants|Number|27|27.0||||||
3611490|NCT02771093|3462016|B2|Japan||Region of Enrollment||Participants|Number|14|14.0||||||
3611491|NCT02771093|3462017|B1|Japan||Region of Enrollment||Participants|Number|13|13.0||||||
3611492|NCT02771093|3462015|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3611493|NCT02771093|3462015|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3611494|NCT02771093|3462016|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3611496|NCT02771093|3462015|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3611497|NCT02771093|3462016|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3611498|NCT02771093|3462017|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3611499|NCT02771093|3462015|B3|||Age||years|Mean|62.7|62.7|Standard Deviation|8.76|8.76|||
3611500|NCT02771093|3462016|B2|||Age||years|Mean|62.7|62.7|Standard Deviation|7.64|7.64|||
3611501|NCT02771093|3462017|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|10.14|10.14|||
3611502|NCT02770625|3462070|B1|||Height||cm|Mean|100.40|100.4|Standard Deviation|22.852|22.852|||
3611503|NCT02770625|3462070|B1|||Weight||kg|Mean|17.9|17.9|Standard Deviation|7.64|7.64|||
3611504|NCT02770625|3462070|B1|||Body Mass Index (BMI)||Kilogram per square meter (kg/m^2)|Mean|17.244|17.244|Standard Deviation|1.9236|1.9236|||
3611505|NCT02770625|3462070|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611506|NCT02770625|3462070|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3611507|NCT02770625|3462070|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611508|NCT02770625|3462070|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611509|NCT02770625|3462070|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611510|NCT02770625|3462070|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611511|NCT02770625|3462070|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611512|NCT02770625|3462070|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3611513|NCT02770625|3462070|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3611514|NCT02770625|3462070|B1|||Age||years|Mean|5.8|5.8|Standard Deviation|4.74|4.74|||
3611515|NCT02770248|3462083|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3611516|NCT02770248|3462084|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3611517|NCT02770248|3462085|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3611518|NCT02770248|3462083|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3611519|NCT02770248|3462084|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3611520|NCT02770248|3462085|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3611521|NCT02770248|3462083|B3|||Age||years|Mean|65.5|65.5|Standard Deviation|10.10|10.1|||
3611522|NCT02770248|3462084|B2|||Age||years|Mean|63.6|63.6|Standard Deviation|11.22|11.22|||
3611523|NCT02770248|3462085|B1|||Age||years|Mean|67.5|67.5|Standard Deviation|8.52|8.52|||
3611524|NCT02769858|3462098|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611525|NCT02769858|3462098|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611526|NCT02769858|3462098|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3611527|NCT02769858|3462098|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3611528|NCT02769858|3462098|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611529|NCT02769858|3462098|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611530|NCT02769858|3462098|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611531|NCT02769858|3462098|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3611532|NCT02769858|3462098|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3611533|NCT02769858|3462098|B1|||Age||years|Mean|32|32.0|Standard Deviation|3|3.0|||
3611534|NCT02769702|3462104|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3611535|NCT02769702|3462104|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3611536|NCT02769702|3462104|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3611537|NCT02769702|3462104|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3611538|NCT02769702|3462104|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3611539|NCT02769442|3462109|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3611540|NCT02769442|3462109|B3||Male|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
3611541|NCT02769442|3462110|B2||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3611542|NCT02769442|3462111|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3611543|NCT02769442|3462109|B3||Female|Sex: Female, Male||Participants|Count of Participants|376|376.0||||||
3611544|NCT02769442|3462110|B2||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
3611545|NCT02769442|3462111|B1||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3611546|NCT02769442|3462109|B3|Patient Age Mean||Age, Customized||years|Mean|51|51.0|Standard Deviation|17.7|17.7|||
3611547|NCT02769442|3462110|B2|Patient Age Mean||Age, Customized||years|Mean|50.9|50.9|Standard Deviation|17.7|17.7|||
3611548|NCT02769442|3462111|B1|Patient Age Mean||Age, Customized||years|Mean|51.1|51.1|Standard Deviation|17.7|17.7|||
3611549|NCT02769247|3462120|B5|United States||Region of Enrollment||Participants|Count of Participants|157|157.0||||||
3611550|NCT02769247|3462121|B4|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3611551|NCT02769247|3462122|B3|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3611552|NCT02769247|3462123|B2|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3611553|NCT02769247|3462124|B1|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3611554|NCT02769247|3462120|B5|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3611555|NCT02769247|3462120|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3611556|NCT02769247|3462121|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3611557|NCT02769247|3462122|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3611558|NCT02769247|3462123|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3611559|NCT02769247|3462124|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3611560|NCT02769247|3462120|B5||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3611561|NCT02769247|3462121|B4||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3611562|NCT02769247|3462122|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3611563|NCT02769247|3462123|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3611564|NCT02769247|3462124|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3611565|NCT02769247|3462120|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3611566|NCT02769247|3462121|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3611567|NCT02769247|3462122|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3611568|NCT02769247|3462123|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3611569|NCT02769247|3462124|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3611570|NCT02769247|3462120|B5||Between 18 and 65 years|Age||Participants|Count of Participants|157|157.0||||||
3611571|NCT02769247|3462121|B4||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3611572|NCT02769247|3462122|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3611573|NCT02769247|3462123|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3611574|NCT02769247|3462124|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3611575|NCT02769247|3462120|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3611576|NCT02769247|3462121|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3611577|NCT02769247|3462122|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3611578|NCT02769247|3462123|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3611579|NCT02769247|3462124|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3611580|NCT02768194|3462165|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611581|NCT02768194|3462165|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3611582|NCT02768194|3462165|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3611583|NCT02768194|3462165|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611584|NCT02768194|3462165|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611585|NCT02768194|3462165|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3611586|NCT02768194|3462165|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611587|NCT02768194|3462165|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611588|NCT02768194|3462165|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3611589|NCT02768194|3462165|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611590|NCT02768194|3462165|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3611591|NCT02768194|3462165|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3611592|NCT02768194|3462165|B1|||Age||Years|Mean|41.4|41.4|Standard Deviation|13.31|13.31|||
3611593|NCT02767843|3462181|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3611594|NCT02767843|3462181|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3611595|NCT02767843|3462181|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3611596|NCT02767843|3462181|B1|||Age||years|Mean|42|42.0|Full Range|||33.0|57.0|
3611597|NCT02767843|3462181|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3611598|NCT02767843|3462181|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3611599|NCT02767843|3462181|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3611600|NCT02767765|3462187|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3611601|NCT02767765|3462187|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3611602|NCT02767765|3462187|B1|||Age||years|Mean|61.31|61.31|Standard Deviation|13.55|13.55|||
3611603|NCT02766400|3462196|B3|||Functional Independence Measure|The Functional Independence Measure contains 18 items composed of 13 motor tasks and 5 cognitive tasks. A total score of 18-126 is obtained where 18 represents complete dependence/total assistance and 126 represents complete independence with daily activities.|units on a scale|Mean|67.33|67.33|Standard Deviation|16.47|16.47|||
3611604|NCT02766400|3462197|B2|||Functional Independence Measure|The Functional Independence Measure contains 18 items composed of 13 motor tasks and 5 cognitive tasks. A total score of 18-126 is obtained where 18 represents complete dependence/total assistance and 126 represents complete independence with daily activities.|units on a scale|Mean|67.32|67.32|Standard Deviation|18.33|18.33|||
3611605|NCT02766400|3462198|B1|||Functional Independence Measure|The Functional Independence Measure contains 18 items composed of 13 motor tasks and 5 cognitive tasks. A total score of 18-126 is obtained where 18 represents complete dependence/total assistance and 126 represents complete independence with daily activities.|units on a scale|Mean|67.33|67.33|Standard Deviation|14.72|14.72|||
3611606|NCT02766400|3462196|B3|||Cognitive status, EXIT|The EXIT is composed of 14 items that are summed to yield a total score ranging from 0 to 28. A total score of 0 typically indicates no executive impairment, while a total score of 28 indicates severe executive impairment.|units on a scale|Mean|11.60|11.6|Standard Deviation|5.12|5.12|||
3611607|NCT02766400|3462197|B2|||Cognitive status, EXIT|The EXIT is composed of 14 items that are summed to yield a total score ranging from 0 to 28. A total score of 0 typically indicates no executive impairment, while a total score of 28 indicates severe executive impairment.|units on a scale|Mean|10.86|10.86|Standard Deviation|5.14|5.14|||
3611608|NCT02766400|3462198|B1|||Cognitive status, EXIT|The EXIT is composed of 14 items that are summed to yield a total score ranging from 0 to 28. A total score of 0 typically indicates no executive impairment, while a total score of 28 indicates severe executive impairment.|units on a scale|Mean|12.38|12.38|Standard Deviation|5.11|5.11|||
3611609|NCT02766400|3462196|B3|||Stroke severity, NIHSS|The NIHSS is composed of 11 items that are summed to yield a total score. Total scores range from 0 to 42, where 0=no neurological impairment, and 42=severe neurological impairment.|units on a scale|Mean|7.44|7.44|Standard Deviation|4.52|4.52|||
3611610|NCT02766400|3462197|B2|||Stroke severity, NIHSS|The NIHSS is composed of 11 items that are summed to yield a total score. Total scores range from 0 to 42, where 0=no neurological impairment, and 42=severe neurological impairment.|units on a scale|Mean|7.86|7.86|Standard Deviation|5.10|5.1|||
3611611|NCT02766400|3462198|B1|||Stroke severity, NIHSS|The NIHSS is composed of 11 items that are summed to yield a total score. Total scores range from 0 to 42, where 0=no neurological impairment, and 42=severe neurological impairment.|units on a scale|Mean|7.00|7.0|Standard Deviation|3.90|3.9|||
3611612|NCT02766400|3462196|B3|Right||Hemisphere||participants|Number|20|20.0||||||
3611613|NCT02766400|3462197|B2|Right||Hemisphere||participants|Number|9|9.0||||||
3611614|NCT02766400|3462198|B1|Right||Hemisphere||participants|Number|11|11.0||||||
3611615|NCT02766400|3462196|B3|Left||Hemisphere||participants|Number|23|23.0||||||
3611616|NCT02766400|3462197|B2|Left||Hemisphere||participants|Number|13|13.0||||||
3611617|NCT02766400|3462198|B1|Left||Hemisphere||participants|Number|10|10.0||||||
3611618|NCT02766400|3462196|B3|hemorrhagic||Stroke type||participants|Number|15|15.0||||||
3611619|NCT02766400|3462197|B2|hemorrhagic||Stroke type||participants|Number|8|8.0||||||
3611620|NCT02766400|3462198|B1|hemorrhagic||Stroke type||participants|Number|7|7.0||||||
3611621|NCT02766400|3462196|B3|ischemic||Stroke type||participants|Number|28|28.0||||||
3611622|NCT02766400|3462197|B2|ischemic||Stroke type||participants|Number|14|14.0||||||
3611623|NCT02766400|3462198|B1|ischemic||Stroke type||participants|Number|14|14.0||||||
3611624|NCT02766400|3462196|B3|||Stroke onset|Stroke onset is calculated from date of stroke to date of study admission.|days|Mean|19.40|19.4|Standard Deviation|25.46|25.46|||
3611625|NCT02766400|3462197|B2|||Stroke onset|Stroke onset is calculated from date of stroke to date of study admission.|days|Mean|22.36|22.36|Standard Deviation|30.97|30.97|||
3611626|NCT02766400|3462198|B1|||Stroke onset|Stroke onset is calculated from date of stroke to date of study admission.|days|Mean|16.29|16.29|Standard Deviation|18.24|18.24|||
3611627|NCT02766400|3462196|B3|United States||Region of Enrollment||participants|Number|43|43.0||||||
3611628|NCT02766400|3462197|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
3611629|NCT02766400|3462198|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3611630|NCT02766400|3462196|B3|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3611631|NCT02766400|3462197|B2|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3611632|NCT02766400|3462198|B1|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3611633|NCT02766400|3462196|B3|White||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
3611634|NCT02766400|3462197|B2|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3611635|NCT02766400|3462198|B1|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3611636|NCT02766400|3462196|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3611637|NCT02766400|3462197|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3611638|NCT02766400|3462198|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3611639|NCT02766400|3462196|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3611640|NCT02766400|3462197|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3611641|NCT02766400|3462198|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3611642|NCT02766400|3462196|B3|||Age||years|Mean|66.30|66.3|Standard Deviation|12.91|12.91|||
3611643|NCT02766400|3462197|B2|||Age||years|Mean|66.73|66.73|Standard Deviation|14.25|14.25|||
3611644|NCT02766400|3462198|B1|||Age||years|Mean|65.86|65.86|Standard Deviation|11.67|11.67|||
3611645|NCT02766283|3462205|B1|Amiodarone||Dispenses of hypothyroidism inducing drugs||Participants|Number|5|5.0||||||
3611646|NCT02766283|3462205|B1|Anticonvulsants||Dispenses of hypothyroidism inducing drugs||Participants|Number|21|21.0||||||
3611647|NCT02766283|3462205|B1|Third and fourth||Time between examinations||Days|Mean|212.00|212.0|Standard Deviation|196.28|196.28|||
3611648|NCT02766283|3462205|B1|Second and third||Time between examinations||Days|Mean|208.19|208.19|Standard Deviation|180.01|180.01|||
3611649|NCT02766283|3462205|B1|First and second||Time between examinations||Days|Mean|282.79|282.79|Standard Deviation|252.34|252.34|||
3611650|NCT02766283|3462205|B1||CT|Type of >=2nd examination||Participants|Count of Participants|21|21.0||||||
3611651|NCT02766283|3462205|B1||Cardio-angiography|Type of >=2nd examination||Participants|Count of Participants|47|47.0||||||
3611652|NCT02766283|3462205|B1||CT|Type of 1st examination||Participants|Count of Participants|362|362.0||||||
3611653|NCT02766283|3462205|B1||Cardio-angiography|Type of 1st examination||Participants|Count of Participants|481|481.0||||||
3611654|NCT02766283|3462205|B1||>= 2|Sum of Examinations||Participants|Count of Participants|68|68.0||||||
3611655|NCT02766283|3462205|B1||1|Sum of Examinations||Participants|Count of Participants|775|775.0||||||
3611656|NCT02766283|3462205|B1|Overweight||Comorbidity||Participants|Number|12|12.0||||||
3611657|NCT02766283|3462205|B1|Cancer||Comorbidity||Participants|Number|21|21.0||||||
3611658|NCT02766283|3462205|B1|Diabetes||Comorbidity||Participants|Number|1|1.0||||||
3611659|NCT02766283|3462205|B1|Cardio||Comorbidity||Participants|Number|495|495.0||||||
3611660|NCT02766283|3462205|B1|||Weight||Kilograms|Mean|8.80|8.8|Standard Deviation|3.39|3.39|||
3611661|NCT02766283|3462205|B1||Male|Sex: Female, Male||Participants|Count of Participants|461|461.0||||||
3611662|NCT02766283|3462205|B1||Female|Sex: Female, Male||Participants|Count of Participants|382|382.0||||||
3611663|NCT02766283|3462205|B1|||Age||Years|Mean|1.06|1.06|Standard Deviation|0.87|0.87|||
3611664|NCT02766244|3462229|B1|||Size of burn||% of body surface area|Median|7|7.0|Full Range|||7.0|10.0|
3611665|NCT02766244|3462229|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3611666|NCT02766244|3462229|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3611667|NCT02766244|3462229|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3611668|NCT02766244|3462229|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3611669|NCT02766244|3462229|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3611670|NCT02765269|3462238|B3|China||Region of Enrollment||participants|Number|46|46.0||||||
3611671|NCT02765269|3462239|B2|China||Region of Enrollment||participants|Number|21|21.0||||||
3611672|NCT02765269|3462240|B1|China||Region of Enrollment||participants|Number|25|25.0||||||
3611673|NCT02765269|3462238|B3||Male|Gender||Participants|Count of Participants|32|32.0||||||
3611674|NCT02765269|3462239|B2||Male|Gender||Participants|Count of Participants|13|13.0||||||
3611675|NCT02765269|3462240|B1||Male|Gender||Participants|Count of Participants|19|19.0||||||
3611676|NCT02765269|3462238|B3||Female|Gender||Participants|Count of Participants|14|14.0||||||
3611677|NCT02765269|3462239|B2||Female|Gender||Participants|Count of Participants|8|8.0||||||
3611678|NCT02765269|3462240|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
3611679|NCT02765269|3462238|B3||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
3611680|NCT02765269|3462239|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3611681|NCT02765269|3462240|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3611682|NCT02765269|3462238|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3611683|NCT02765269|3462239|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3611684|NCT02765269|3462240|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3611685|NCT02765269|3462238|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3611686|NCT02765269|3462239|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3611687|NCT02765269|3462240|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3611688|NCT02764970|3462253|B3|||heart rate||beats per minute|Mean|82.8|82.8|Standard Deviation|5.0|5.0|||
3611689|NCT02764970|3462254|B2|||heart rate||beats per minute|Mean|80.7|80.7|Standard Deviation|5.1|5.1|||
3611690|NCT02764970|3462255|B1|||heart rate||beats per minute|Mean|84.1|84.1|Standard Deviation|6.7|6.7|||
3611691|NCT02764970|3462253|B3|Austria||Region of Enrollment||participants|Number|112|112.0||||||
3611692|NCT02764970|3462254|B2|Austria||Region of Enrollment||participants|Number|47|47.0||||||
3611693|NCT02764970|3462255|B1|Austria||Region of Enrollment||participants|Number|65|65.0||||||
3611694|NCT02764970|3462253|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3611695|NCT02764970|3462253|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3611696|NCT02764970|3462254|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3611697|NCT02764970|3462255|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3611698|NCT02764970|3462253|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3611699|NCT02764970|3462254|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3611700|NCT02764970|3462255|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3611701|NCT02764970|3462253|B3|||Age||years|Mean|61|61.0|Standard Deviation|11|11.0|||
3611702|NCT02764970|3462254|B2|||Age||years|Mean|63|63.0|Standard Deviation|10|10.0|||
3611703|NCT02764970|3462255|B1|||Age||years|Mean|60|60.0|Standard Deviation|11|11.0|||
3611704|NCT02764970|3462253|B3||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
3611705|NCT02764970|3462254|B2||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3611706|NCT02764970|3462255|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3611707|NCT02764970|3462253|B3||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
3611708|NCT02764970|3462254|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3611709|NCT02764970|3462255|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3611710|NCT02764970|3462253|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3611711|NCT02764970|3462254|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3611712|NCT02764970|3462255|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3611713|NCT02764697|3462268|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3611714|NCT02764697|3462268|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611715|NCT02764697|3462268|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611716|NCT02764697|3462268|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3611717|NCT02764697|3462268|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3611718|NCT02764697|3462268|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611719|NCT02764697|3462268|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611720|NCT02764697|3462268|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611721|NCT02764697|3462268|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3611722|NCT02764697|3462268|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3611723|NCT02764697|3462268|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3611724|NCT02764697|3462268|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3611725|NCT02764697|3462268|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3611726|NCT02763189|3462273|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3611727|NCT02763189|3462274|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3611728|NCT02763189|3462275|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3611729|NCT02763189|3462273|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611730|NCT02763189|3462274|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611731|NCT02763189|3462275|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611732|NCT02763189|3462273|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611733|NCT02763189|3462274|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611734|NCT02763189|3462275|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611735|NCT02763189|3462273|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3611736|NCT02763189|3462274|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3611737|NCT02763189|3462275|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3611738|NCT02763189|3462273|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611739|NCT02763189|3462274|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611740|NCT02763189|3462275|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611741|NCT02763189|3462273|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611742|NCT02763189|3462274|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611743|NCT02763189|3462275|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611744|NCT02763189|3462273|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611745|NCT02763189|3462274|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611746|NCT02763189|3462275|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611747|NCT02763189|3462273|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611748|NCT02763189|3462274|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611749|NCT02763189|3462275|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611750|NCT02763189|3462273|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3611751|NCT02763189|3462274|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3611752|NCT02763189|3462275|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3611753|NCT02763189|3462273|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3611754|NCT02763189|3462274|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3611755|NCT02763189|3462275|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3611756|NCT02763189|3462273|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3611757|NCT02763189|3462274|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3611758|NCT02763189|3462275|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3611759|NCT02763189|3462273|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3611760|NCT02763189|3462274|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3611761|NCT02763189|3462275|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3611762|NCT02763189|3462273|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3611763|NCT02763189|3462274|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3611764|NCT02763189|3462275|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3611765|NCT02762799|3462284|B5|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3611766|NCT02762799|3462284|B5||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3611767|NCT02762799|3462285|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3611768|NCT02762799|3462286|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3611769|NCT02762799|3462287|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3611770|NCT02762799|3462288|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3611771|NCT02762799|3462284|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3611772|NCT02762799|3462285|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3611773|NCT02762799|3462286|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3611774|NCT02762799|3462287|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3611775|NCT02762799|3462288|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3611776|NCT02762799|3462284|B5|||Age||years|Median|24.63|24.63|Inter-Quartile Range|||22.35|27.41|
3611777|NCT02762799|3462285|B4|||Age||years|Median|27.30|27.3|Inter-Quartile Range|||24.61|27.78|
3611778|NCT02762799|3462286|B3|||Age||years|Median|23.48|23.48|Inter-Quartile Range|||21.81|26.97|
3611779|NCT02762799|3462287|B2|||Age||years|Median|25.41|25.41|Inter-Quartile Range|||22.45|29.58|
3611780|NCT02762799|3462288|B1|||Age||years|Median|22.94|22.94|Inter-Quartile Range|||21.79|26.49|
3611781|NCT02762578|3462361|B3|||Body weight||kg|Mean|68.80|68.8|Standard Deviation|11.88|11.88|||
3611782|NCT02762578|3462362|B2|||Body weight||kg|Mean|69.41|69.41|Standard Deviation|12.38|12.38|||
3611783|NCT02762578|3462363|B1|||Body weight||kg|Mean|68.50|68.5|Standard Deviation|11.63|11.63|||
3611784|NCT02762578|3462361|B3|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.07|9.07|Standard Deviation|2.31|2.31|||
3611785|NCT02762578|3462362|B2|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.07|9.07|Standard Deviation|2.49|2.49|||
3611786|NCT02762578|3462363|B1|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.07|9.07|Standard Deviation|2.21|2.21|||
3611787|NCT02762578|3462361|B3|||Glycosylated haemoglobin (HbA1c)||percentage of HbA1c|Mean|8.32|8.32|Standard Deviation|0.76|0.76|||
3611788|NCT02762578|3462362|B2|||Glycosylated haemoglobin (HbA1c)||percentage of HbA1c|Mean|8.33|8.33|Standard Deviation|0.77|0.77|||
3611789|NCT02762578|3462363|B1|||Glycosylated haemoglobin (HbA1c)||percentage of HbA1c|Mean|8.32|8.32|Standard Deviation|0.76|0.76|||
3611790|NCT02762578|3462361|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611791|NCT02762578|3462362|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611792|NCT02762578|3462363|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611793|NCT02762578|3462361|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611794|NCT02762578|3462362|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611795|NCT02762578|3462363|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611796|NCT02762578|3462361|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611797|NCT02762578|3462362|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611798|NCT02762578|3462363|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611799|NCT02762578|3462361|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611800|NCT02762578|3462362|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611801|NCT02762578|3462363|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611802|NCT02762578|3462361|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611803|NCT02762578|3462362|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611804|NCT02762578|3462363|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611805|NCT02762578|3462361|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|543|543.0||||||
3611806|NCT02762578|3462362|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|182|182.0||||||
3611807|NCT02762578|3462363|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|361|361.0||||||
3611808|NCT02762578|3462361|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611809|NCT02762578|3462362|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611810|NCT02762578|3462363|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611811|NCT02762578|3462361|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611812|NCT02762578|3462362|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611813|NCT02762578|3462363|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611814|NCT02762578|3462361|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|543|543.0||||||
3611815|NCT02762578|3462362|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|182|182.0||||||
3611816|NCT02762578|3462363|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|361|361.0||||||
3611817|NCT02762578|3462361|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611818|NCT02762578|3462362|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611819|NCT02762578|3462363|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611820|NCT02762578|3462361|B3||Male|Sex: Female, Male||Participants|Count of Participants|297|297.0||||||
3611821|NCT02762578|3462362|B2||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3611822|NCT02762578|3462363|B1||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
3611823|NCT02762578|3462361|B3||Female|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
3611824|NCT02762578|3462362|B2||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3611825|NCT02762578|3462363|B1||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3611826|NCT02762578|3462361|B3|||Age||years|Mean|59.35|59.35|Standard Deviation|9.16|9.16|||
3611827|NCT02762578|3462362|B2|||Age||years|Mean|58.78|58.78|Standard Deviation|9.41|9.41|||
3611828|NCT02762578|3462363|B1|||Age||years|Mean|59.64|59.64|Standard Deviation|9.04|9.04|||
3611829|NCT02762370|3462464|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3611830|NCT02762370|3462465|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3611831|NCT02762370|3462466|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3611832|NCT02762370|3462464|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3611833|NCT02762370|3462465|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3611834|NCT02762370|3462466|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3611835|NCT02762370|3462464|B3|||Age||years|Mean|61.2|61.2|Standard Deviation|8.08|8.08|||
3611836|NCT02762370|3462465|B2|||Age||years|Mean|60.3|60.3|Standard Deviation|10.38|10.38|||
3611837|NCT02762370|3462466|B1|||Age||years|Mean|61.8|61.8|Standard Deviation|5.76|5.76|||
3611838|NCT02761980|3462485|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3611839|NCT02761980|3462486|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3611840|NCT02761980|3462487|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3611841|NCT02761980|3462488|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3611842|NCT02761980|3462489|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3611843|NCT02761980|3462485|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611844|NCT02761980|3462486|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611845|NCT02761980|3462487|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611846|NCT02761980|3462488|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611847|NCT02761980|3462489|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611848|NCT02761980|3462485|B5||White|Race (NIH/OMB)||Participants|Count of Participants|227|227.0||||||
3611849|NCT02761980|3462486|B4||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3611850|NCT02761980|3462487|B3||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3611851|NCT02761980|3462488|B2||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3611852|NCT02761980|3462489|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3611853|NCT02761980|3462485|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3611854|NCT02761980|3462486|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3611855|NCT02761980|3462487|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3611856|NCT02761980|3462488|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3611857|NCT02761980|3462489|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3611858|NCT02761980|3462485|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611859|NCT02761980|3462486|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611860|NCT02761980|3462487|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611861|NCT02761980|3462488|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611862|NCT02761980|3462489|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611863|NCT02761980|3462485|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3611864|NCT02761980|3462486|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3611865|NCT02761980|3462487|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611866|NCT02761980|3462488|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3611867|NCT02761980|3462489|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3611868|NCT02761980|3462485|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611869|NCT02761980|3462486|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611870|NCT02761980|3462487|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611871|NCT02761980|3462488|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611872|NCT02761980|3462489|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611873|NCT02761980|3462485|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611874|NCT02761980|3462486|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611875|NCT02761980|3462487|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611876|NCT02761980|3462488|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611877|NCT02761980|3462489|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3611878|NCT02761980|3462485|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|277|277.0||||||
3611879|NCT02761980|3462486|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3611880|NCT02761980|3462487|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3611881|NCT02761980|3462488|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3611882|NCT02761980|3462489|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3611883|NCT02761980|3462485|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3611884|NCT02761980|3462486|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3611885|NCT02761980|3462487|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3611886|NCT02761980|3462488|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3611887|NCT02761980|3462489|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3611888|NCT02761980|3462485|B5||Male|Sex: Female, Male||Participants|Count of Participants|290|290.0||||||
3611889|NCT02761980|3462486|B4||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3611890|NCT02761980|3462487|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3611891|NCT02761980|3462488|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3611892|NCT02761980|3462489|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3611893|NCT02761980|3462485|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3611894|NCT02761980|3462486|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3611895|NCT02761980|3462487|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3611896|NCT02761980|3462488|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3611897|NCT02761980|3462489|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3611898|NCT02761980|3462485|B5|||Age||years|Mean|32.4|32.4|Standard Deviation|10.07|10.07|||
3611899|NCT02761980|3462486|B4|||Age||years|Mean|32.6|32.6|Standard Deviation|9.99|9.99|||
3611900|NCT02761980|3462487|B3|||Age||years|Mean|32.3|32.3|Standard Deviation|10.19|10.19|||
3611901|NCT02761980|3462488|B2|||Age||years|Mean|33.4|33.4|Standard Deviation|10.54|10.54|||
3611902|NCT02761980|3462489|B1|||Age||years|Mean|28.8|28.8|Standard Deviation|7.97|7.97|||
3611903|NCT02761733|3462522|B5|United States||Region of Enrollment||Participants|Count of Participants|240|240.0||||||
3611904|NCT02761733|3462523|B4|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3611905|NCT02761733|3462524|B3|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3611906|NCT02761733|3462525|B2|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3611907|NCT02761733|3462526|B1|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3611908|NCT02761733|3462522|B5|Race/Ethnicity|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3611909|NCT02761733|3462523|B4|Race/Ethnicity|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3611910|NCT02761733|3462524|B3|Race/Ethnicity|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3611911|NCT02761733|3462525|B2|Race/Ethnicity|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3611912|NCT02761733|3462526|B1|Race/Ethnicity|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3611913|NCT02761733|3462522|B5|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3611914|NCT02761733|3462523|B4|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3611915|NCT02761733|3462524|B3|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3611916|NCT02761733|3462525|B2|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3611917|NCT02761733|3462526|B1|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3611918|NCT02761733|3462522|B5|Race/Ethnicity|Mixed|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3611919|NCT02761733|3462523|B4|Race/Ethnicity|Mixed|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3611920|NCT02761733|3462524|B3|Race/Ethnicity|Mixed|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3611921|NCT02761733|3462525|B2|Race/Ethnicity|Mixed|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3611922|NCT02761733|3462526|B1|Race/Ethnicity|Mixed|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3611923|NCT02761733|3462522|B5|Race/Ethnicity|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3611924|NCT02761733|3462523|B4|Race/Ethnicity|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3611925|NCT02761733|3462524|B3|Race/Ethnicity|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3611926|NCT02761733|3462525|B2|Race/Ethnicity|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3611927|NCT02761733|3462526|B1|Race/Ethnicity|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3611928|NCT02761733|3462522|B5|Race/Ethnicity|Asian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3611929|NCT02761733|3462523|B4|Race/Ethnicity|Asian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3611930|NCT02761733|3462524|B3|Race/Ethnicity|Asian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3611931|NCT02761733|3462525|B2|Race/Ethnicity|Asian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3611932|NCT02761733|3462526|B1|Race/Ethnicity|Asian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3611933|NCT02761733|3462522|B5|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|61|61.0||||||
3611934|NCT02761733|3462523|B4|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3611935|NCT02761733|3462524|B3|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3611936|NCT02761733|3462525|B2|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3611937|NCT02761733|3462526|B1|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3611938|NCT02761733|3462522|B5|Race/Ethnicity|Black, not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3611939|NCT02761733|3462523|B4|Race/Ethnicity|Black, not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3611940|NCT02761733|3462524|B3|Race/Ethnicity|Black, not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3611941|NCT02761733|3462525|B2|Race/Ethnicity|Black, not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3611942|NCT02761733|3462526|B1|Race/Ethnicity|Black, not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3611943|NCT02761733|3462522|B5|Race/Ethnicity|White, not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|130|130.0||||||
3611944|NCT02761733|3462523|B4|Race/Ethnicity|White, not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
3611945|NCT02761733|3462524|B3|Race/Ethnicity|White, not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3611946|NCT02761733|3462525|B2|Race/Ethnicity|White, not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
3611947|NCT02761733|3462526|B1|Race/Ethnicity|White, not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3611948|NCT02761733|3462522|B5|Other||Sex/Gender, Customized||Participants|Count of Participants|1|1.0||||||
3611949|NCT02761733|3462523|B4|Other||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3611950|NCT02761733|3462524|B3|Other||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3611951|NCT02761733|3462525|B2|Other||Sex/Gender, Customized||Participants|Count of Participants|1|1.0||||||
3611952|NCT02761733|3462526|B1|Other||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3611953|NCT02761733|3462522|B5|Male||Sex/Gender, Customized||Participants|Count of Participants|112|112.0||||||
3611954|NCT02761733|3462523|B4|Male||Sex/Gender, Customized||Participants|Count of Participants|25|25.0||||||
3611955|NCT02761733|3462524|B3|Male||Sex/Gender, Customized||Participants|Count of Participants|32|32.0||||||
3611956|NCT02761733|3462525|B2|Male||Sex/Gender, Customized||Participants|Count of Participants|29|29.0||||||
3611957|NCT02761733|3462526|B1|Male||Sex/Gender, Customized||Participants|Count of Participants|26|26.0||||||
3611958|NCT02761733|3462522|B5|Female||Sex/Gender, Customized||Participants|Count of Participants|127|127.0||||||
3611959|NCT02761733|3462523|B4|Female||Sex/Gender, Customized||Participants|Count of Participants|35|35.0||||||
3611960|NCT02761733|3462524|B3|Female||Sex/Gender, Customized||Participants|Count of Participants|28|28.0||||||
3611961|NCT02761733|3462525|B2|Female||Sex/Gender, Customized||Participants|Count of Participants|30|30.0||||||
3611962|NCT02761733|3462526|B1|Female||Sex/Gender, Customized||Participants|Count of Participants|34|34.0||||||
3611963|NCT02761733|3462522|B5||>=65 years|Age||Participants|Count of Participants|102|102.0||||||
3611964|NCT02761733|3462523|B4||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3611965|NCT02761733|3462524|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3611966|NCT02761733|3462525|B2||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
3611967|NCT02761733|3462526|B1||>=65 years|Age||Participants|Count of Participants|47|47.0||||||
3611968|NCT02761733|3462522|B5||Between 18 and 65 years|Age||Participants|Count of Participants|136|136.0||||||
3611969|NCT02761733|3462523|B4||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3611970|NCT02761733|3462524|B3||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3611971|NCT02761733|3462525|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3611972|NCT02761733|3462526|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3611973|NCT02761733|3462522|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3611974|NCT02761733|3462523|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3611975|NCT02761733|3462524|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3611976|NCT02761733|3462525|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3611977|NCT02761733|3462526|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3611978|NCT02761642|3462559|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3611979|NCT02761642|3462559|B1||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
3611980|NCT02761642|3462559|B1|||Age||years|Mean|57.3|57.3|Standard Deviation|11.6|11.6|||
3611981|NCT02761629|3462570|B3||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3611982|NCT02761629|3462571|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3611983|NCT02761629|3462572|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3611984|NCT02761629|3462570|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3611985|NCT02761629|3462571|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3611986|NCT02761629|3462572|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3611987|NCT02761629|3462570|B3|||Age||years|Mean|42.3|42.3|Standard Deviation|8.2|8.2|||
3611988|NCT02761629|3462571|B2|||Age||years|Mean|42.2|42.2|Standard Deviation|8.4|8.4|||
3611989|NCT02761629|3462572|B1|||Age||years|Mean|42.3|42.3|Standard Deviation|7.9|7.9|||
3611990|NCT02760927|3462593|B1|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3611991|NCT02760927|3462593|B1|Race/Ethic Heritage|Asian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3611992|NCT02760927|3462593|B1|Race/Ethic Heritage|White (not of Hispanic origin)|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3611993|NCT02760927|3462593|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3611994|NCT02760927|3462593|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3611995|NCT02760927|3462593|B1|||Age||years|Mean|47|47.0|Standard Deviation|18|18.0|||
3611996|NCT02760810|3462601|B1|United Kingdom||Region of Enrollment||Participants|Number|30|30.0||||||
3611997|NCT02760810|3462601|B1|White||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3611998|NCT02760810|3462601|B1|Asian||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
3611999|NCT02760810|3462601|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3612000|NCT02760810|3462601|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3612001|NCT02760810|3462601|B1|||Age||Years|Mean|22.8|22.8|Standard Deviation|4.08|4.08|||
3612069|NCT02760654|3462608|B2||Unknown|Cancer Stage||Participants|Count of Participants|1|1.0||||||
3612070|NCT02760654|3462609|B1||Unknown|Cancer Stage||Participants|Count of Participants|1|1.0||||||
3612071|NCT02760654|3462607|B3||Metastatic (IV)|Cancer Stage||Participants|Count of Participants|15|15.0||||||
3612072|NCT02760654|3462608|B2||Metastatic (IV)|Cancer Stage||Participants|Count of Participants|9|9.0||||||
3612002|NCT02760654|3462607|B3|Sleep-related Impairment (30.0 - 80.1)||Pain-related Symptoms|Pain -related symptoms are measured from Patient Reported Outcome Measurement Information System surveys, and are measured along the following scales: Anxiety: 40.3 -81.6 where 40.3 means no anxiety to 81.6 as high anxiety. Depression: 41.0 -79.4 where 41 means no depression and 79.4 is ultimately high depression. Fatigue: 33.7 - 75.8 where 33.7 is no fatigue and 75.8 is extreme fatigue. Sleep related impairment: 30.0 - 80.1 where 30.0 is no impairment and 80.1 is high impairment in daily functioning due to poor sleep.|units on a scale|Mean|56.86|56.86|Standard Deviation|8.81|8.81|||
3612003|NCT02760654|3462608|B2|Sleep-related Impairment (30.0 - 80.1)||Pain-related Symptoms|Pain -related symptoms are measured from Patient Reported Outcome Measurement Information System surveys, and are measured along the following scales: Anxiety: 40.3 -81.6 where 40.3 means no anxiety to 81.6 as high anxiety. Depression: 41.0 -79.4 where 41 means no depression and 79.4 is ultimately high depression. Fatigue: 33.7 - 75.8 where 33.7 is no fatigue and 75.8 is extreme fatigue. Sleep related impairment: 30.0 - 80.1 where 30.0 is no impairment and 80.1 is high impairment in daily functioning due to poor sleep.|units on a scale|Mean|55.07|55.07|Standard Deviation|6.09|6.09|||
3612004|NCT02760654|3462609|B1|Sleep-related Impairment (30.0 - 80.1)||Pain-related Symptoms|Pain -related symptoms are measured from Patient Reported Outcome Measurement Information System surveys, and are measured along the following scales: Anxiety: 40.3 -81.6 where 40.3 means no anxiety to 81.6 as high anxiety. Depression: 41.0 -79.4 where 41 means no depression and 79.4 is ultimately high depression. Fatigue: 33.7 - 75.8 where 33.7 is no fatigue and 75.8 is extreme fatigue. Sleep related impairment: 30.0 - 80.1 where 30.0 is no impairment and 80.1 is high impairment in daily functioning due to poor sleep.|units on a scale|Mean|58.65|58.65|Standard Deviation|6.67|6.67|||
3612005|NCT02760654|3462607|B3|Fatigue (33.7 - 75.8)||Pain-related Symptoms|Pain -related symptoms are measured from Patient Reported Outcome Measurement Information System surveys, and are measured along the following scales: Anxiety: 40.3 -81.6 where 40.3 means no anxiety to 81.6 as high anxiety. Depression: 41.0 -79.4 where 41 means no depression and 79.4 is ultimately high depression. Fatigue: 33.7 - 75.8 where 33.7 is no fatigue and 75.8 is extreme fatigue. Sleep related impairment: 30.0 - 80.1 where 30.0 is no impairment and 80.1 is high impairment in daily functioning due to poor sleep.|units on a scale|Mean|55.95|55.95|Standard Deviation|7.71|7.71|||
3612006|NCT02760654|3462608|B2|Fatigue (33.7 - 75.8)||Pain-related Symptoms|Pain -related symptoms are measured from Patient Reported Outcome Measurement Information System surveys, and are measured along the following scales: Anxiety: 40.3 -81.6 where 40.3 means no anxiety to 81.6 as high anxiety. Depression: 41.0 -79.4 where 41 means no depression and 79.4 is ultimately high depression. Fatigue: 33.7 - 75.8 where 33.7 is no fatigue and 75.8 is extreme fatigue. Sleep related impairment: 30.0 - 80.1 where 30.0 is no impairment and 80.1 is high impairment in daily functioning due to poor sleep.|units on a scale|Mean|52.73|52.73|Standard Deviation|8.25|8.25|||
3612007|NCT02760654|3462609|B1|Fatigue (33.7 - 75.8)||Pain-related Symptoms|Pain -related symptoms are measured from Patient Reported Outcome Measurement Information System surveys, and are measured along the following scales: Anxiety: 40.3 -81.6 where 40.3 means no anxiety to 81.6 as high anxiety. Depression: 41.0 -79.4 where 41 means no depression and 79.4 is ultimately high depression. Fatigue: 33.7 - 75.8 where 33.7 is no fatigue and 75.8 is extreme fatigue. Sleep related impairment: 30.0 - 80.1 where 30.0 is no impairment and 80.1 is high impairment in daily functioning due to poor sleep.|units on a scale|Mean|59.18|59.18|Standard Deviation|8.26|8.26|||
3612008|NCT02760654|3462607|B3|Depression (41.0 -79.4)||Pain-related Symptoms|Pain -related symptoms are measured from Patient Reported Outcome Measurement Information System surveys, and are measured along the following scales: Anxiety: 40.3 -81.6 where 40.3 means no anxiety to 81.6 as high anxiety. Depression: 41.0 -79.4 where 41 means no depression and 79.4 is ultimately high depression. Fatigue: 33.7 - 75.8 where 33.7 is no fatigue and 75.8 is extreme fatigue. Sleep related impairment: 30.0 - 80.1 where 30.0 is no impairment and 80.1 is high impairment in daily functioning due to poor sleep.|units on a scale|Mean|51.22|51.22|Standard Deviation|8.74|8.74|||
3612009|NCT02760654|3462608|B2|Depression (41.0 -79.4)||Pain-related Symptoms|Pain -related symptoms are measured from Patient Reported Outcome Measurement Information System surveys, and are measured along the following scales: Anxiety: 40.3 -81.6 where 40.3 means no anxiety to 81.6 as high anxiety. Depression: 41.0 -79.4 where 41 means no depression and 79.4 is ultimately high depression. Fatigue: 33.7 - 75.8 where 33.7 is no fatigue and 75.8 is extreme fatigue. Sleep related impairment: 30.0 - 80.1 where 30.0 is no impairment and 80.1 is high impairment in daily functioning due to poor sleep.|units on a scale|Mean|49.51|49.51|Standard Deviation|7.17|7.17|||
3612010|NCT02760654|3462609|B1|Depression (41.0 -79.4)||Pain-related Symptoms|Pain -related symptoms are measured from Patient Reported Outcome Measurement Information System surveys, and are measured along the following scales: Anxiety: 40.3 -81.6 where 40.3 means no anxiety to 81.6 as high anxiety. Depression: 41.0 -79.4 where 41 means no depression and 79.4 is ultimately high depression. Fatigue: 33.7 - 75.8 where 33.7 is no fatigue and 75.8 is extreme fatigue. Sleep related impairment: 30.0 - 80.1 where 30.0 is no impairment and 80.1 is high impairment in daily functioning due to poor sleep.|units on a scale|Mean|52.92|52.92|Standard Deviation|7.98|7.98|||
3612011|NCT02760654|3462607|B3|Anxiety (40.3 -81.6)||Pain-related Symptoms|Pain -related symptoms are measured from Patient Reported Outcome Measurement Information System surveys, and are measured along the following scales: Anxiety: 40.3 -81.6 where 40.3 means no anxiety to 81.6 as high anxiety. Depression: 41.0 -79.4 where 41 means no depression and 79.4 is ultimately high depression. Fatigue: 33.7 - 75.8 where 33.7 is no fatigue and 75.8 is extreme fatigue. Sleep related impairment: 30.0 - 80.1 where 30.0 is no impairment and 80.1 is high impairment in daily functioning due to poor sleep.|units on a scale|Mean|53.18|53.18|Standard Deviation|6.58|6.58|||
3612012|NCT02760654|3462608|B2|Anxiety (40.3 -81.6)||Pain-related Symptoms|Pain -related symptoms are measured from Patient Reported Outcome Measurement Information System surveys, and are measured along the following scales: Anxiety: 40.3 -81.6 where 40.3 means no anxiety to 81.6 as high anxiety. Depression: 41.0 -79.4 where 41 means no depression and 79.4 is ultimately high depression. Fatigue: 33.7 - 75.8 where 33.7 is no fatigue and 75.8 is extreme fatigue. Sleep related impairment: 30.0 - 80.1 where 30.0 is no impairment and 80.1 is high impairment in daily functioning due to poor sleep.|units on a scale|Mean|51.58|51.58|Standard Deviation|7.83|7.83|||
3612073|NCT02760654|3462609|B1||Metastatic (IV)|Cancer Stage||Participants|Count of Participants|6|6.0||||||
3612074|NCT02760654|3462607|B3||III|Cancer Stage||Participants|Count of Participants|21|21.0||||||
3612013|NCT02760654|3462609|B1|Anxiety (40.3 -81.6)||Pain-related Symptoms|Pain -related symptoms are measured from Patient Reported Outcome Measurement Information System surveys, and are measured along the following scales: Anxiety: 40.3 -81.6 where 40.3 means no anxiety to 81.6 as high anxiety. Depression: 41.0 -79.4 where 41 means no depression and 79.4 is ultimately high depression. Fatigue: 33.7 - 75.8 where 33.7 is no fatigue and 75.8 is extreme fatigue. Sleep related impairment: 30.0 - 80.1 where 30.0 is no impairment and 80.1 is high impairment in daily functioning due to poor sleep.|units on a scale|Mean|54.79|54.79|Standard Deviation|9.42|9.42|||
3612014|NCT02760654|3462607|B3||Multiple|Chemotherapy Name||Participants|Count of Participants|12|12.0||||||
3612015|NCT02760654|3462608|B2||Multiple|Chemotherapy Name||Participants|Count of Participants|8|8.0||||||
3612016|NCT02760654|3462609|B1||Multiple|Chemotherapy Name||Participants|Count of Participants|4|4.0||||||
3612017|NCT02760654|3462607|B3||Bortezomib|Chemotherapy Name||Participants|Count of Participants|1|1.0||||||
3612018|NCT02760654|3462608|B2||Bortezomib|Chemotherapy Name||Participants|Count of Participants|0|0.0||||||
3612019|NCT02760654|3462609|B1||Bortezomib|Chemotherapy Name||Participants|Count of Participants|1|1.0||||||
3612020|NCT02760654|3462607|B3||Vincristine|Chemotherapy Name||Participants|Count of Participants|3|3.0||||||
3612021|NCT02760654|3462608|B2||Vincristine|Chemotherapy Name||Participants|Count of Participants|2|2.0||||||
3612022|NCT02760654|3462609|B1||Vincristine|Chemotherapy Name||Participants|Count of Participants|1|1.0||||||
3612023|NCT02760654|3462607|B3||Abraxane|Chemotherapy Name||Participants|Count of Participants|1|1.0||||||
3612024|NCT02760654|3462608|B2||Abraxane|Chemotherapy Name||Participants|Count of Participants|0|0.0||||||
3612025|NCT02760654|3462609|B1||Abraxane|Chemotherapy Name||Participants|Count of Participants|1|1.0||||||
3612026|NCT02760654|3462607|B3||Docetaxel|Chemotherapy Name||Participants|Count of Participants|4|4.0||||||
3612027|NCT02760654|3462608|B2||Docetaxel|Chemotherapy Name||Participants|Count of Participants|3|3.0||||||
3612028|NCT02760654|3462609|B1||Docetaxel|Chemotherapy Name||Participants|Count of Participants|1|1.0||||||
3612029|NCT02760654|3462607|B3||Paclitaxel|Chemotherapy Name||Participants|Count of Participants|13|13.0||||||
3612030|NCT02760654|3462608|B2||Paclitaxel|Chemotherapy Name||Participants|Count of Participants|4|4.0||||||
3612031|NCT02760654|3462609|B1||Paclitaxel|Chemotherapy Name||Participants|Count of Participants|9|9.0||||||
3612032|NCT02760654|3462607|B3||Oxaliplatin|Chemotherapy Name||Participants|Count of Participants|26|26.0||||||
3612033|NCT02760654|3462608|B2||Oxaliplatin|Chemotherapy Name||Participants|Count of Participants|13|13.0||||||
3612034|NCT02760654|3462609|B1||Oxaliplatin|Chemotherapy Name||Participants|Count of Participants|13|13.0||||||
3612035|NCT02760654|3462607|B3||Multiple|Chemotherapy Type||Participants|Count of Participants|10|10.0||||||
3612036|NCT02760654|3462608|B2||Multiple|Chemotherapy Type||Participants|Count of Participants|7|7.0||||||
3612037|NCT02760654|3462609|B1||Multiple|Chemotherapy Type||Participants|Count of Participants|3|3.0||||||
3612038|NCT02760654|3462607|B3||Vinca Alkaloids|Chemotherapy Type||Participants|Count of Participants|3|3.0||||||
3612039|NCT02760654|3462608|B2||Vinca Alkaloids|Chemotherapy Type||Participants|Count of Participants|2|2.0||||||
3612040|NCT02760654|3462609|B1||Vinca Alkaloids|Chemotherapy Type||Participants|Count of Participants|1|1.0||||||
3612041|NCT02760654|3462607|B3||Bortezomib|Chemotherapy Type||Participants|Count of Participants|1|1.0||||||
3612042|NCT02760654|3462608|B2||Bortezomib|Chemotherapy Type||Participants|Count of Participants|0|0.0||||||
3612043|NCT02760654|3462609|B1||Bortezomib|Chemotherapy Type||Participants|Count of Participants|1|1.0||||||
3612044|NCT02760654|3462607|B3||Taxanes|Chemotherapy Type||Participants|Count of Participants|20|20.0||||||
3612045|NCT02760654|3462608|B2||Taxanes|Chemotherapy Type||Participants|Count of Participants|8|8.0||||||
3612046|NCT02760654|3462609|B1||Taxanes|Chemotherapy Type||Participants|Count of Participants|12|12.0||||||
3612047|NCT02760654|3462607|B3||Platinums|Chemotherapy Type||Participants|Count of Participants|26|26.0||||||
3612048|NCT02760654|3462608|B2||Platinums|Chemotherapy Type||Participants|Count of Participants|13|13.0||||||
3612049|NCT02760654|3462609|B1||Platinums|Chemotherapy Type||Participants|Count of Participants|13|13.0||||||
3612050|NCT02760654|3462607|B3||Genitourinary|Cancer Type||Participants|Count of Participants|1|1.0||||||
3612051|NCT02760654|3462608|B2||Genitourinary|Cancer Type||Participants|Count of Participants|1|1.0||||||
3612052|NCT02760654|3462609|B1||Genitourinary|Cancer Type||Participants|Count of Participants|0|0.0||||||
3612053|NCT02760654|3462607|B3||Lymphoma|Cancer Type||Participants|Count of Participants|3|3.0||||||
3612054|NCT02760654|3462608|B2||Lymphoma|Cancer Type||Participants|Count of Participants|1|1.0||||||
3612055|NCT02760654|3462609|B1||Lymphoma|Cancer Type||Participants|Count of Participants|2|2.0||||||
3612056|NCT02760654|3462607|B3||Multiple|Cancer Type||Participants|Count of Participants|3|3.0||||||
3612057|NCT02760654|3462608|B2||Multiple|Cancer Type||Participants|Count of Participants|2|2.0||||||
3612058|NCT02760654|3462609|B1||Multiple|Cancer Type||Participants|Count of Participants|1|1.0||||||
3612059|NCT02760654|3462607|B3||Lung|Cancer Type||Participants|Count of Participants|4|4.0||||||
3612060|NCT02760654|3462608|B2||Lung|Cancer Type||Participants|Count of Participants|3|3.0||||||
3612061|NCT02760654|3462609|B1||Lung|Cancer Type||Participants|Count of Participants|1|1.0||||||
3612062|NCT02760654|3462607|B3||Gastrointestinal|Cancer Type||Participants|Count of Participants|26|26.0||||||
3612063|NCT02760654|3462608|B2||Gastrointestinal|Cancer Type||Participants|Count of Participants|13|13.0||||||
3612064|NCT02760654|3462609|B1||Gastrointestinal|Cancer Type||Participants|Count of Participants|13|13.0||||||
3612065|NCT02760654|3462607|B3||Breast|Cancer Type||Participants|Count of Participants|23|23.0||||||
3612066|NCT02760654|3462608|B2||Breast|Cancer Type||Participants|Count of Participants|10|10.0||||||
3612067|NCT02760654|3462609|B1||Breast|Cancer Type||Participants|Count of Participants|13|13.0||||||
3612068|NCT02760654|3462607|B3||Unknown|Cancer Stage||Participants|Count of Participants|2|2.0||||||
3612075|NCT02760654|3462608|B2||III|Cancer Stage||Participants|Count of Participants|11|11.0||||||
3612076|NCT02760654|3462609|B1||III|Cancer Stage||Participants|Count of Participants|10|10.0||||||
3612077|NCT02760654|3462607|B3||Early I-II|Cancer Stage||Participants|Count of Participants|22|22.0||||||
3612078|NCT02760654|3462608|B2||Early I-II|Cancer Stage||Participants|Count of Participants|9|9.0||||||
3612079|NCT02760654|3462609|B1||Early I-II|Cancer Stage||Participants|Count of Participants|13|13.0||||||
3612080|NCT02760654|3462607|B3||More than once a week|Amount of Computer Use||Participants|Count of Participants|51|51.0||||||
3612081|NCT02760654|3462608|B2||More than once a week|Amount of Computer Use||Participants|Count of Participants|23|23.0||||||
3612082|NCT02760654|3462609|B1||More than once a week|Amount of Computer Use||Participants|Count of Participants|28|28.0||||||
3612083|NCT02760654|3462607|B3||About once a week|Amount of Computer Use||Participants|Count of Participants|2|2.0||||||
3612084|NCT02760654|3462608|B2||About once a week|Amount of Computer Use||Participants|Count of Participants|1|1.0||||||
3612085|NCT02760654|3462609|B1||About once a week|Amount of Computer Use||Participants|Count of Participants|1|1.0||||||
3612086|NCT02760654|3462607|B3||Once a month|Amount of Computer Use||Participants|Count of Participants|7|7.0||||||
3612087|NCT02760654|3462608|B2||Once a month|Amount of Computer Use||Participants|Count of Participants|6|6.0||||||
3612088|NCT02760654|3462609|B1||Once a month|Amount of Computer Use||Participants|Count of Participants|1|1.0||||||
3612089|NCT02760654|3462607|B3||Widowed|Marital Status||Participants|Count of Participants|3|3.0||||||
3612090|NCT02760654|3462608|B2||Widowed|Marital Status||Participants|Count of Participants|1|1.0||||||
3612091|NCT02760654|3462609|B1||Widowed|Marital Status||Participants|Count of Participants|2|2.0||||||
3612092|NCT02760654|3462607|B3||Divorced|Marital Status||Participants|Count of Participants|9|9.0||||||
3612093|NCT02760654|3462608|B2||Divorced|Marital Status||Participants|Count of Participants|2|2.0||||||
3612094|NCT02760654|3462609|B1||Divorced|Marital Status||Participants|Count of Participants|7|7.0||||||
3612095|NCT02760654|3462607|B3||Separated|Marital Status||Participants|Count of Participants|2|2.0||||||
3612096|NCT02760654|3462608|B2||Separated|Marital Status||Participants|Count of Participants|1|1.0||||||
3612097|NCT02760654|3462609|B1||Separated|Marital Status||Participants|Count of Participants|1|1.0||||||
3612098|NCT02760654|3462607|B3||Married|Marital Status||Participants|Count of Participants|42|42.0||||||
3612099|NCT02760654|3462608|B2||Married|Marital Status||Participants|Count of Participants|24|24.0||||||
3612100|NCT02760654|3462609|B1||Married|Marital Status||Participants|Count of Participants|18|18.0||||||
3612101|NCT02760654|3462607|B3||Single|Marital Status||Participants|Count of Participants|4|4.0||||||
3612102|NCT02760654|3462608|B2||Single|Marital Status||Participants|Count of Participants|2|2.0||||||
3612103|NCT02760654|3462609|B1||Single|Marital Status||Participants|Count of Participants|2|2.0||||||
3612104|NCT02760654|3462607|B3||Unable to Work|Employment Status||Participants|Count of Participants|8|8.0||||||
3612105|NCT02760654|3462608|B2||Unable to Work|Employment Status||Participants|Count of Participants|3|3.0||||||
3612106|NCT02760654|3462609|B1||Unable to Work|Employment Status||Participants|Count of Participants|5|5.0||||||
3612107|NCT02760654|3462607|B3||Retired|Employment Status||Participants|Count of Participants|26|26.0||||||
3612108|NCT02760654|3462608|B2||Retired|Employment Status||Participants|Count of Participants|17|17.0||||||
3612109|NCT02760654|3462609|B1||Retired|Employment Status||Participants|Count of Participants|9|9.0||||||
3612110|NCT02760654|3462607|B3||Homemaker|Employment Status||Participants|Count of Participants|1|1.0||||||
3612111|NCT02760654|3462608|B2||Homemaker|Employment Status||Participants|Count of Participants|1|1.0||||||
3612112|NCT02760654|3462609|B1||Homemaker|Employment Status||Participants|Count of Participants|0|0.0||||||
3612113|NCT02760654|3462607|B3||Out of Work|Employment Status||Participants|Count of Participants|5|5.0||||||
3612114|NCT02760654|3462608|B2||Out of Work|Employment Status||Participants|Count of Participants|2|2.0||||||
3612115|NCT02760654|3462609|B1||Out of Work|Employment Status||Participants|Count of Participants|3|3.0||||||
3612116|NCT02760654|3462607|B3||Employed|Employment Status||Participants|Count of Participants|20|20.0||||||
3612117|NCT02760654|3462608|B2||Employed|Employment Status||Participants|Count of Participants|7|7.0||||||
3612118|NCT02760654|3462609|B1||Employed|Employment Status||Participants|Count of Participants|13|13.0||||||
3612119|NCT02760654|3462607|B3||Missing/Unknown|Education||Participants|Count of Participants|1|1.0||||||
3612120|NCT02760654|3462608|B2||Missing/Unknown|Education||Participants|Count of Participants|1|1.0||||||
3612121|NCT02760654|3462609|B1||Missing/Unknown|Education||Participants|Count of Participants|0|0.0||||||
3612122|NCT02760654|3462607|B3||Post Graduate Degree|Education||Participants|Count of Participants|10|10.0||||||
3612123|NCT02760654|3462608|B2||Post Graduate Degree|Education||Participants|Count of Participants|5|5.0||||||
3612124|NCT02760654|3462609|B1||Post Graduate Degree|Education||Participants|Count of Participants|5|5.0||||||
3612125|NCT02760654|3462607|B3||College Graduate|Education||Participants|Count of Participants|14|14.0||||||
3612126|NCT02760654|3462608|B2||College Graduate|Education||Participants|Count of Participants|6|6.0||||||
3612127|NCT02760654|3462609|B1||College Graduate|Education||Participants|Count of Participants|8|8.0||||||
3612128|NCT02760654|3462607|B3||Some College|Education||Participants|Count of Participants|25|25.0||||||
3612129|NCT02760654|3462608|B2||Some College|Education||Participants|Count of Participants|12|12.0||||||
3612130|NCT02760654|3462609|B1||Some College|Education||Participants|Count of Participants|13|13.0||||||
3612131|NCT02760654|3462607|B3||High School or less|Education||Participants|Count of Participants|10|10.0||||||
3612132|NCT02760654|3462608|B2||High School or less|Education||Participants|Count of Participants|6|6.0||||||
3612133|NCT02760654|3462609|B1||High School or less|Education||Participants|Count of Participants|4|4.0||||||
3612134|NCT02760654|3462607|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
3612135|NCT02760654|3462608|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3612136|NCT02760654|3462609|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3612137|NCT02760654|3462607|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3612138|NCT02760654|3462608|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3612139|NCT02760654|3462609|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3612140|NCT02760654|3462607|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612141|NCT02760654|3462608|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612142|NCT02760654|3462609|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612143|NCT02760654|3462607|B3||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3612144|NCT02760654|3462608|B2||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3612145|NCT02760654|3462609|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3612146|NCT02760654|3462607|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3612147|NCT02760654|3462608|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3612148|NCT02760654|3462609|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3612149|NCT02760654|3462607|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612150|NCT02760654|3462608|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612151|NCT02760654|3462609|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612152|NCT02760654|3462607|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612153|NCT02760654|3462608|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612154|NCT02760654|3462609|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612155|NCT02760654|3462607|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612156|NCT02760654|3462608|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612157|NCT02760654|3462609|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612158|NCT02760654|3462607|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3612159|NCT02760654|3462608|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3612160|NCT02760654|3462609|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3612161|NCT02760654|3462607|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3612162|NCT02760654|3462608|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3612163|NCT02760654|3462609|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3612164|NCT02760654|3462607|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3612165|NCT02760654|3462608|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3612166|NCT02760654|3462609|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612167|NCT02760654|3462607|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3612168|NCT02760654|3462608|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3612169|NCT02760654|3462609|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3612170|NCT02760654|3462607|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3612171|NCT02760654|3462608|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3612172|NCT02760654|3462609|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3612173|NCT02760654|3462607|B3|||Age||years|Mean|61.15|61.15|Standard Deviation|9.06|9.06|||
3612174|NCT02760654|3462608|B2|||Age||years|Mean|63.37|63.37|Standard Deviation|8.36|8.36|||
3612175|NCT02760654|3462609|B1|||Age||years|Mean|58.93|58.93|Standard Deviation|9.33|9.33|||
3612176|NCT02760602|3462634|B3|||ADAS-Cog14 at Baseline|ADAS-Cog14 is ADAS-Cog11 augmented with orientation, verbal memory, language, praxis, delayed free recall, digit cancellation, and maze-completion measures. The ADAS-Cog14 scale ranges from 0 to 90. Higher scores indicate greater disease severity.|units on a scale|Mean|25.92|25.92|Standard Deviation|6.37|6.37|||
3612177|NCT02760602|3462635|B2|||ADAS-Cog14 at Baseline|ADAS-Cog14 is ADAS-Cog11 augmented with orientation, verbal memory, language, praxis, delayed free recall, digit cancellation, and maze-completion measures. The ADAS-Cog14 scale ranges from 0 to 90. Higher scores indicate greater disease severity.|units on a scale|Mean|27.77|27.77|Standard Deviation|3.63|3.63|||
3612178|NCT02760602|3462636|B1|||ADAS-Cog14 at Baseline|ADAS-Cog14 is ADAS-Cog11 augmented with orientation, verbal memory, language, praxis, delayed free recall, digit cancellation, and maze-completion measures. The ADAS-Cog14 scale ranges from 0 to 90. Higher scores indicate greater disease severity.|units on a scale|Mean|24.08|24.08|Standard Deviation|8.00|8.0|||
3612179|NCT02760602|3462634|B3|Poland||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3612180|NCT02760602|3462635|B2|Poland||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3612181|NCT02760602|3462636|B1|Poland||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3612182|NCT02760602|3462634|B3|Canada||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3612183|NCT02760602|3462635|B2|Canada||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3612184|NCT02760602|3462636|B1|Canada||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3612185|NCT02760602|3462634|B3|Japan||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3612186|NCT02760602|3462635|B2|Japan||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3612187|NCT02760602|3462636|B1|Japan||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3612188|NCT02760602|3462634|B3|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3612189|NCT02760602|3462635|B2|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3612190|NCT02760602|3462636|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3612191|NCT02760602|3462634|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612192|NCT02760602|3462635|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612193|NCT02760602|3462636|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612194|NCT02760602|3462634|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612195|NCT02760602|3462635|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612196|NCT02760602|3462636|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612197|NCT02760602|3462634|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3612198|NCT02760602|3462635|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3612199|NCT02760602|3462636|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3612200|NCT02760602|3462634|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3612201|NCT02760602|3462635|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3612202|NCT02760602|3462636|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612203|NCT02760602|3462634|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3612204|NCT02760602|3462635|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612205|NCT02760602|3462636|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3612206|NCT02760602|3462634|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3612207|NCT02760602|3462635|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612208|NCT02760602|3462636|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3612209|NCT02760602|3462634|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612210|NCT02760602|3462635|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612211|NCT02760602|3462636|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612212|NCT02760602|3462634|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3612213|NCT02760602|3462635|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612214|NCT02760602|3462636|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3612215|NCT02760602|3462634|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3612216|NCT02760602|3462635|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3612217|NCT02760602|3462636|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3612218|NCT02760602|3462634|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612219|NCT02760602|3462635|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612220|NCT02760602|3462636|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612221|NCT02760602|3462634|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3612222|NCT02760602|3462635|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3612223|NCT02760602|3462636|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3612224|NCT02760602|3462634|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3612225|NCT02760602|3462635|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3612226|NCT02760602|3462636|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3612227|NCT02760602|3462634|B3|||Age||years|Mean|74.54|74.54|Standard Deviation|5.49|5.49|||
3612228|NCT02760602|3462635|B2|||Age||years|Mean|75.62|75.62|Standard Deviation|4.93|4.93|||
3612229|NCT02760602|3462636|B1|||Age||years|Mean|73.46|73.46|Standard Deviation|6.01|6.01|||
3612230|NCT02760056|3462675|B3|Secondary Progressive Multiple Sclerosis||MS Subtype||Participants|Count of Participants|1|1.0||||||
3612231|NCT02760056|3462676|B2|Secondary Progressive Multiple Sclerosis||MS Subtype||Participants|Count of Participants|0|0.0||||||
3612232|NCT02760056|3462677|B1|Secondary Progressive Multiple Sclerosis||MS Subtype||Participants|Count of Participants|1|1.0||||||
3612233|NCT02760056|3462675|B3|Relapsing Remitting Multiple Sclerosis||MS Subtype||Participants|Count of Participants|14|14.0||||||
3612234|NCT02760056|3462676|B2|Relapsing Remitting Multiple Sclerosis||MS Subtype||Participants|Count of Participants|5|5.0||||||
3612235|NCT02760056|3462677|B1|Relapsing Remitting Multiple Sclerosis||MS Subtype||Participants|Count of Participants|9|9.0||||||
3612236|NCT02760056|3462675|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612237|NCT02760056|3462676|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612238|NCT02760056|3462677|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612239|NCT02760056|3462675|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3612240|NCT02760056|3462676|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3612241|NCT02760056|3462677|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612242|NCT02760056|3462675|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3612243|NCT02760056|3462676|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3612244|NCT02760056|3462677|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3612245|NCT02760056|3462675|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3612246|NCT02760056|3462676|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612247|NCT02760056|3462677|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3612248|NCT02760056|3462675|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612249|NCT02760056|3462676|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612250|NCT02760056|3462677|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612251|NCT02760056|3462675|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612252|NCT02760056|3462676|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612253|NCT02760056|3462677|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612254|NCT02760056|3462675|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612255|NCT02760056|3462676|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612256|NCT02760056|3462677|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612257|NCT02760056|3462675|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3612258|NCT02760056|3462676|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3612259|NCT02760056|3462677|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3612260|NCT02760056|3462675|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3612261|NCT02760056|3462676|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3612262|NCT02760056|3462677|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3612263|NCT02760056|3462675|B3|||Age||years|Mean|38.8|38.8|Full Range|||21.0|49.0|
3612264|NCT02760056|3462676|B2|||Age||years|Mean|38.4|38.4|Full Range|||21.0|46.0|
3612265|NCT02760056|3462677|B1|||Age||years|Mean|39|39.0|Full Range|||30.0|49.0|
3612266|NCT02759692|3462686|B1|United States||Region of Enrollment||Participants|Number|276|276.0||||||
3612267|NCT02759692|3462686|B1|White||Race/Ethnicity, Customized||Participants|Number|237|237.0||||||
3612268|NCT02759692|3462686|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
3612269|NCT02759692|3462686|B1|Asian||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3612270|NCT02759692|3462686|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3612271|NCT02759692|3462686|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3612272|NCT02759692|3462686|B1||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3612273|NCT02759692|3462686|B1|||Age||Years|Mean|28.0|28.0|Standard Deviation|5.75|5.75|||
3612274|NCT02759562|3462703|B3|||Post-bronchodilator FEV1 % predicted||percent|Mean|58.3|58.3|Standard Deviation|15.17|15.17|||
3612275|NCT02759562|3462704|B2|||Post-bronchodilator FEV1 % predicted||percent|Mean|64.6|64.6|Standard Deviation|20.58|20.58|||
3612276|NCT02759562|3462705|B1|||Post-bronchodilator FEV1 % predicted||percent|Mean|52.1|52.1|Standard Deviation|5.90|5.9|||
3612277|NCT02759562|3462703|B3|||Pre-bronchodilator Forced expiratory volume in 1 second (FEV1) % predicted|FEV1 % predicted is defined as FEV1 of the patient divided by the average FEV1 in the population for any person of similar age, sex, race, and body composition.|percent|Mean|54.4|54.4|Standard Deviation|14.33|14.33|||
3612278|NCT02759562|3462704|B2|||Pre-bronchodilator Forced expiratory volume in 1 second (FEV1) % predicted|FEV1 % predicted is defined as FEV1 of the patient divided by the average FEV1 in the population for any person of similar age, sex, race, and body composition.|percent|Mean|59.1|59.1|Standard Deviation|19.26|19.26|||
3612279|NCT02759562|3462705|B1|||Pre-bronchodilator Forced expiratory volume in 1 second (FEV1) % predicted|FEV1 % predicted is defined as FEV1 of the patient divided by the average FEV1 in the population for any person of similar age, sex, race, and body composition.|percent|Mean|49.7|49.7|Standard Deviation|8.70|8.7|||
3612280|NCT02759562|3462703|B3|Spain||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3612281|NCT02759562|3462704|B2|Spain||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3612282|NCT02759562|3462705|B1|Spain||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3612283|NCT02759562|3462703|B3|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3612284|NCT02759562|3462704|B2|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3612285|NCT02759562|3462705|B1|Germany||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3612286|NCT02759562|3462703|B3|France||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3612287|NCT02759562|3462704|B2|France||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3612288|NCT02759562|3462705|B1|France||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3612289|NCT02759562|3462703|B3|Australia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3612290|NCT02759562|3462704|B2|Australia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3612291|NCT02759562|3462705|B1|Australia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3612292|NCT02759562|3462703|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3612293|NCT02759562|3462704|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3612294|NCT02759562|3462705|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3612295|NCT02759562|3462703|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3612296|NCT02759562|3462704|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3612297|NCT02759562|3462705|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3612298|NCT02759562|3462703|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3612299|NCT02759562|3462704|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3612300|NCT02759562|3462705|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3612301|NCT02759562|3462703|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3612302|NCT02759562|3462704|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3612303|NCT02759562|3462705|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3612304|NCT02759562|3462703|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3612305|NCT02759562|3462704|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3612306|NCT02759562|3462705|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3612307|NCT02759562|3462703|B3|||Age||years|Mean|44.7|44.7|Standard Deviation|14.46|14.46|||
3612308|NCT02759562|3462704|B2|||Age||years|Mean|43.3|43.3|Standard Deviation|10.02|10.02|||
3612309|NCT02759562|3462705|B1|||Age||years|Mean|46.0|46.0|Standard Deviation|20.42|20.42|||
3612310|NCT02759471|3462719|B1||Male|Gender||Participants|Count of Participants|19|19.0||||||
3612311|NCT02759471|3462719|B1||Female|Gender||Participants|Count of Participants|35|35.0||||||
3612312|NCT02759471|3462719|B1|||Age||years|Median|26|26.0|Full Range|||18.0|34.0|
3612313|NCT02759315|3462729|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612314|NCT02759315|3462730|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612315|NCT02759315|3462731|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612316|NCT02759315|3462732|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612317|NCT02759315|3462733|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612318|NCT02759315|3462734|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612319|NCT02759315|3462729|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3612320|NCT02759315|3462730|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612321|NCT02759315|3462731|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612322|NCT02759315|3462732|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612323|NCT02759315|3462733|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612324|NCT02759315|3462734|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3612325|NCT02759315|3462729|B6||White|Race (NIH/OMB)||Participants|Count of Participants|149|149.0||||||
3612326|NCT02759315|3462730|B5||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612327|NCT02759315|3462731|B4||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3612328|NCT02759315|3462732|B3||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3612329|NCT02759315|3462733|B2||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3612330|NCT02759315|3462734|B1||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3612331|NCT02759315|3462729|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3612332|NCT02759315|3462730|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612333|NCT02759315|3462731|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3612334|NCT02759315|3462732|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612335|NCT02759315|3462733|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3612336|NCT02759315|3462734|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3612337|NCT02759315|3462729|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612338|NCT02759315|3462730|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612339|NCT02759315|3462731|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612340|NCT02759315|3462732|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612341|NCT02759315|3462733|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612342|NCT02759315|3462734|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612343|NCT02759315|3462729|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3612344|NCT02759315|3462730|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3612345|NCT02759315|3462731|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612346|NCT02759315|3462732|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612347|NCT02759315|3462733|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612348|NCT02759315|3462734|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612349|NCT02759315|3462729|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612350|NCT02759315|3462730|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612351|NCT02759315|3462731|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612409|NCT02758613|3462783|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3612352|NCT02759315|3462732|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612353|NCT02759315|3462733|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612354|NCT02759315|3462734|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612355|NCT02759315|3462729|B6||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3612356|NCT02759315|3462730|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3612357|NCT02759315|3462731|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3612358|NCT02759315|3462732|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3612359|NCT02759315|3462733|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3612360|NCT02759315|3462734|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3612361|NCT02759315|3462729|B6||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3612362|NCT02759315|3462730|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3612363|NCT02759315|3462731|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3612364|NCT02759315|3462732|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3612365|NCT02759315|3462733|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3612366|NCT02759315|3462734|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3612367|NCT02759315|3462729|B6|||Age||Years|Mean|51.9|51.9|Standard Deviation|10.3|10.3|||
3612368|NCT02759315|3462730|B5|||Age||Years|Mean|61.3|61.3|Standard Deviation|1.5|1.5|||
3612369|NCT02759315|3462731|B4|||Age||Years|Mean|56.5|56.5|Standard Deviation|8.5|8.5|||
3612370|NCT02759315|3462732|B3|||Age||Years|Mean|48.7|48.7|Standard Deviation|10.3|10.3|||
3612371|NCT02759315|3462733|B2|||Age||Years|Mean|57.2|57.2|Standard Deviation|6.8|6.8|||
3612372|NCT02759315|3462734|B1|||Age||Years|Mean|49.8|49.8|Standard Deviation|10.7|10.7|||
3612373|NCT02758613|3462782|B5|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|22.01|22.01|Standard Deviation|1.38|1.38|||
3612374|NCT02758613|3462783|B4|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|21.68|21.68|Standard Deviation|1.39|1.39|||
3612375|NCT02758613|3462784|B3|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|21.87|21.87|Standard Deviation|1.28|1.28|||
3612376|NCT02758613|3462785|B2|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|22.15|22.15|Standard Deviation|1.75|1.75|||
3612377|NCT02758613|3462786|B1|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|22.34|22.34|Standard Deviation|1.21|1.21|||
3612378|NCT02758613|3462782|B5|China||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3612379|NCT02758613|3462783|B4|China||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3612380|NCT02758613|3462784|B3|China||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3612381|NCT02758613|3462785|B2|China||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3612382|NCT02758613|3462786|B1|China||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3612383|NCT02758613|3462782|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612384|NCT02758613|3462783|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612385|NCT02758613|3462784|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612386|NCT02758613|3462785|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612387|NCT02758613|3462786|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612388|NCT02758613|3462782|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612389|NCT02758613|3462783|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612390|NCT02758613|3462784|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612391|NCT02758613|3462785|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612392|NCT02758613|3462786|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612393|NCT02758613|3462782|B5||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612394|NCT02758613|3462783|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612395|NCT02758613|3462784|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612396|NCT02758613|3462785|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612397|NCT02758613|3462786|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612398|NCT02758613|3462782|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612399|NCT02758613|3462783|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612400|NCT02758613|3462784|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612401|NCT02758613|3462785|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612402|NCT02758613|3462786|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612403|NCT02758613|3462782|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612404|NCT02758613|3462783|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612405|NCT02758613|3462784|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612406|NCT02758613|3462785|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612407|NCT02758613|3462786|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612408|NCT02758613|3462782|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3612410|NCT02758613|3462784|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3612411|NCT02758613|3462785|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3612412|NCT02758613|3462786|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3612413|NCT02758613|3462782|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612414|NCT02758613|3462783|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612415|NCT02758613|3462784|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612416|NCT02758613|3462785|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612417|NCT02758613|3462786|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612418|NCT02758613|3462782|B5||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3612419|NCT02758613|3462783|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3612420|NCT02758613|3462784|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3612421|NCT02758613|3462785|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3612422|NCT02758613|3462786|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3612423|NCT02758613|3462782|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3612424|NCT02758613|3462783|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3612425|NCT02758613|3462784|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3612426|NCT02758613|3462785|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3612427|NCT02758613|3462786|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3612428|NCT02758613|3462782|B5|||Age||years|Mean|27.8|27.8|Standard Deviation|5.8|5.8|||
3612429|NCT02758613|3462783|B4|||Age||years|Mean|27.6|27.6|Standard Deviation|6.7|6.7|||
3612430|NCT02758613|3462784|B3|||Age||years|Mean|26.6|26.6|Standard Deviation|3.5|3.5|||
3612431|NCT02758613|3462785|B2|||Age||years|Mean|30.8|30.8|Standard Deviation|7.3|7.3|||
3612432|NCT02758613|3462786|B1|||Age||years|Mean|26.6|26.6|Standard Deviation|5.4|5.4|||
3612433|NCT02758210|3462805|B1|||Atrioventricular (AV) node ablation concomitantly with the MICRA procedure||Participants|Count of Participants|5|5.0||||||
3612434|NCT02758210|3462805|B1|||Pacing indication: permanent atrial fibrillation and high-grade AV block||Participants|Count of Participants|10|10.0||||||
3612435|NCT02758210|3462805|B1|||Congestive heart failure|Participants with a diagnosis of congestive heart failure|Participants|Count of Participants|6|6.0||||||
3612436|NCT02758210|3462805|B1|||Diabetes|Participants with a diagnosis of diabetes|Participants|Count of Participants|8|8.0||||||
3612437|NCT02758210|3462805|B1|||Hypertension|Participants with a diagnosis of hypertension|Participants|Count of Participants|17|17.0||||||
3612438|NCT02758210|3462805|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3612439|NCT02758210|3462805|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612440|NCT02758210|3462805|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612441|NCT02758210|3462805|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3612442|NCT02758210|3462805|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3612443|NCT02758210|3462805|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612444|NCT02758210|3462805|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612445|NCT02758210|3462805|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612446|NCT02758210|3462805|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612447|NCT02758210|3462805|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3612448|NCT02758210|3462805|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612449|NCT02758210|3462805|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3612450|NCT02758210|3462805|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3612451|NCT02758210|3462805|B1|||Age||years|Mean|78.9|78.9|Standard Deviation|9.4|9.4|||
3612452|NCT02758210|3462805|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3612453|NCT02758210|3462805|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3612454|NCT02758210|3462805|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3612455|NCT02758171|3462814|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3612456|NCT02758171|3462815|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3612457|NCT02758171|3462816|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3612458|NCT02758171|3462814|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3612459|NCT02758171|3462815|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3612460|NCT02758171|3462816|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3612461|NCT02758171|3462814|B3|||Age||Years|Mean|39.0|39.0|Standard Deviation|9.9|9.9|||
3612462|NCT02758171|3462815|B2|||Age||Years|Mean|38.9|38.9|Standard Deviation|10.2|10.2|||
3612463|NCT02758171|3462816|B1|||Age||Years|Mean|39.1|39.1|Standard Deviation|9.7|9.7|||
3612464|NCT02757625|3462833|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612465|NCT02757625|3462834|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612466|NCT02757625|3462835|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612467|NCT02757625|3462836|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612468|NCT02757625|3462837|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612469|NCT02757625|3462833|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612470|NCT02757625|3462834|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612471|NCT02757625|3462835|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612472|NCT02757625|3462836|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612473|NCT02757625|3462837|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612474|NCT02757625|3462833|B5||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612475|NCT02757625|3462834|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612476|NCT02757625|3462835|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612477|NCT02757625|3462836|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612478|NCT02757625|3462837|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612479|NCT02757625|3462833|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612480|NCT02757625|3462834|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612481|NCT02757625|3462835|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612482|NCT02757625|3462836|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612483|NCT02757625|3462837|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612484|NCT02757625|3462833|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612485|NCT02757625|3462834|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612486|NCT02757625|3462835|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612487|NCT02757625|3462836|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612488|NCT02757625|3462837|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612489|NCT02757625|3462833|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3612490|NCT02757625|3462834|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3612491|NCT02757625|3462835|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3612492|NCT02757625|3462836|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3612493|NCT02757625|3462837|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3612494|NCT02757625|3462833|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612495|NCT02757625|3462834|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612496|NCT02757625|3462835|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612497|NCT02757625|3462836|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612498|NCT02757625|3462837|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612499|NCT02757625|3462833|B5||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3612500|NCT02757625|3462834|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3612501|NCT02757625|3462835|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3612502|NCT02757625|3462836|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3612503|NCT02757625|3462837|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3612504|NCT02757625|3462833|B5||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3612505|NCT02757625|3462834|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3612506|NCT02757625|3462835|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3612507|NCT02757625|3462836|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3612508|NCT02757625|3462837|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3612509|NCT02757625|3462833|B5|||Age||months|Mean|41.3|41.3|Standard Deviation|41.8|41.8|||
3612510|NCT02757625|3462834|B4|||Age||months|Mean|112.1|112.1|Standard Deviation|37.9|37.9|||
3612511|NCT02757625|3462835|B3|||Age||months|Mean|45.7|45.7|Standard Deviation|14.6|14.6|||
3612512|NCT02757625|3462836|B2|||Age||months|Mean|16.9|16.9|Standard Deviation|3.6|3.6|||
3612513|NCT02757625|3462837|B1|||Age||months|Mean|6.1|6.1|Standard Deviation|2.1|2.1|||
3612514|NCT02757105|3462992|B3|||Median C-reactive protein (CRP)||mg/L|Number|2.09|2.09||||||
3612515|NCT02757105|3462993|B2|||Median C-reactive protein (CRP)||mg/L|Number|2.25|2.25||||||
3612516|NCT02757105|3462994|B1|||Median C-reactive protein (CRP)||mg/L|Number|2.07|2.07||||||
3612517|NCT02757105|3462992|B3|Not Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|113|113.0||||||
3612518|NCT02757105|3462993|B2|Not Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
3612519|NCT02757105|3462994|B1|Not Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|66|66.0||||||
3612520|NCT02757105|3462992|B3|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3612521|NCT02757105|3462993|B2|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3612522|NCT02757105|3462994|B1|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3612523|NCT02757105|3462992|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3612524|NCT02757105|3462993|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3612525|NCT02757105|3462994|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3612526|NCT02757105|3462992|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|100|100.0||||||
3612527|NCT02757105|3462993|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3612528|NCT02757105|3462994|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|58|58.0||||||
3612529|NCT02757105|3462992|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3612530|NCT02757105|3462993|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3612531|NCT02757105|3462994|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3612532|NCT02757105|3462992|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3612533|NCT02757105|3462993|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3612534|NCT02757105|3462994|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3612535|NCT02757105|3462992|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3612536|NCT02757105|3462993|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3612537|NCT02757105|3462994|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3612538|NCT02757105|3462992|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3612539|NCT02757105|3462993|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3612540|NCT02757105|3462994|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3612541|NCT02757105|3462992|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3612542|NCT02757105|3462993|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3612543|NCT02757105|3462994|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3612544|NCT02757105|3462992|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3612545|NCT02757105|3462993|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3612546|NCT02757105|3462994|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3612547|NCT02757105|3462992|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3612548|NCT02757105|3462993|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3612549|NCT02757105|3462994|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3612550|NCT02757105|3462992|B3||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
3612551|NCT02757105|3462993|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3612552|NCT02757105|3462994|B1||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
3612553|NCT02757105|3462992|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3612554|NCT02757105|3462993|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3612555|NCT02757105|3462994|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3612556|NCT02757053|3463015|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3612557|NCT02757053|3463016|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3612558|NCT02757053|3463017|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3612559|NCT02757053|3463015|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3612560|NCT02757053|3463016|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3612561|NCT02757053|3463017|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3612562|NCT02757053|3463015|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3612563|NCT02757053|3463016|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3612564|NCT02757053|3463017|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3612565|NCT02757053|3463015|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3612566|NCT02757053|3463016|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3612567|NCT02757053|3463017|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3612568|NCT02757053|3463015|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3612569|NCT02757053|3463016|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3612570|NCT02757053|3463017|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3612571|NCT02757053|3463015|B3||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
3612572|NCT02757053|3463016|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3612573|NCT02757053|3463017|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3612574|NCT02756637|3463030|B3|United States||Region of Enrollment||Participants|Count of Participants|493|493.0||||||
3612575|NCT02756637|3463031|B2|United States||Region of Enrollment||Participants|Count of Participants|263|263.0||||||
3612576|NCT02756637|3463032|B1|United States||Region of Enrollment||Participants|Count of Participants|230|230.0||||||
3612577|NCT02756637|3463030|B3||Male|Sex: Female, Male||Participants|Count of Participants|398|398.0||||||
3612578|NCT02756637|3463031|B2||Male|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
3612579|NCT02756637|3463032|B1||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
3612580|NCT02756637|3463030|B3||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3612581|NCT02756637|3463031|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3612582|NCT02756637|3463032|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3612583|NCT02756637|3463030|B3||>=65 years|Age||Participants|Count of Participants|216|216.0||||||
3612584|NCT02756637|3463031|B2||>=65 years|Age||Participants|Count of Participants|115|115.0||||||
3612585|NCT02756637|3463032|B1||>=65 years|Age||Participants|Count of Participants|101|101.0||||||
3612586|NCT02756637|3463030|B3||Between 18 and 65 years|Age||Participants|Count of Participants|277|277.0||||||
3612587|NCT02756637|3463031|B2||Between 18 and 65 years|Age||Participants|Count of Participants|148|148.0||||||
3612588|NCT02756637|3463032|B1||Between 18 and 65 years|Age||Participants|Count of Participants|129|129.0||||||
3612589|NCT02756637|3463030|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3612590|NCT02756637|3463031|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3612591|NCT02756637|3463032|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3612592|NCT02756624|3463039|B3|United States||Region of Enrollment||participants|Number|516|516.0||||||
3612593|NCT02756624|3463040|B2|United States||Region of Enrollment||participants|Number|173|173.0||||||
3612594|NCT02756624|3463041|B1|United States||Region of Enrollment||participants|Number|343|343.0||||||
3612595|NCT02756624|3463039|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3612596|NCT02756624|3463040|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3612597|NCT02756624|3463041|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3612598|NCT02756624|3463039|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3612599|NCT02756624|3463040|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612600|NCT02756624|3463041|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3612601|NCT02756624|3463039|B3||White|Race (NIH/OMB)||Participants|Count of Participants|396|396.0||||||
3612602|NCT02756624|3463040|B2||White|Race (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
3612603|NCT02756624|3463041|B1||White|Race (NIH/OMB)||Participants|Count of Participants|270|270.0||||||
3612604|NCT02756624|3463039|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3612605|NCT02756624|3463040|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3612606|NCT02756624|3463041|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3612607|NCT02756624|3463039|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3612608|NCT02756624|3463040|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3612609|NCT02756624|3463041|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3612610|NCT02756624|3463039|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3612611|NCT02756624|3463040|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3612612|NCT02756624|3463041|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3612613|NCT02756624|3463039|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3612614|NCT02756624|3463040|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3612615|NCT02756624|3463041|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612616|NCT02756624|3463039|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612617|NCT02756624|3463040|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612618|NCT02756624|3463041|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612619|NCT02756624|3463039|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|418|418.0||||||
3612620|NCT02756624|3463040|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|133|133.0||||||
3612621|NCT02756624|3463041|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|285|285.0||||||
3612622|NCT02756624|3463039|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3612623|NCT02756624|3463040|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3612624|NCT02756624|3463041|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3612625|NCT02756624|3463039|B3||Male|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
3612626|NCT02756624|3463040|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3612627|NCT02756624|3463041|B1||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3612628|NCT02756624|3463039|B3||Female|Sex: Female, Male||Participants|Count of Participants|299|299.0||||||
3612629|NCT02756624|3463040|B2||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3612630|NCT02756624|3463041|B1||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
3612631|NCT02756624|3463039|B3|>/= 18 years old||Age, Customized||participants|Number|388|388.0||||||
3612632|NCT02756624|3463040|B2|>/= 18 years old||Age, Customized||participants|Number|129|129.0||||||
3612633|NCT02756624|3463041|B1|>/= 18 years old||Age, Customized||participants|Number|259|259.0||||||
3612634|NCT02756624|3463039|B3|13-17 years old||Age, Customized||participants|Number|54|54.0||||||
3612635|NCT02756624|3463040|B2|13-17 years old||Age, Customized||participants|Number|17|17.0||||||
3612636|NCT02756624|3463041|B1|13-17 years old||Age, Customized||participants|Number|37|37.0||||||
3612637|NCT02756624|3463039|B3|4-12 years old||Age, Customized||participants|Number|53|53.0||||||
3612638|NCT02756624|3463040|B2|4-12 years old||Age, Customized||participants|Number|17|17.0||||||
3612639|NCT02756624|3463041|B1|4-12 years old||Age, Customized||participants|Number|36|36.0||||||
3612640|NCT02756624|3463039|B3|7-12 years old||Age, Customized||participants|Number|44|44.0||||||
3612641|NCT02756624|3463040|B2|7-12 years old||Age, Customized||participants|Number|15|15.0||||||
3612642|NCT02756624|3463041|B1|7-12 years old||Age, Customized||participants|Number|29|29.0||||||
3612643|NCT02756624|3463039|B3|3 years old||Age, Customized||participants|Number|7|7.0||||||
3612644|NCT02756624|3463040|B2|3 years old||Age, Customized||participants|Number|2|2.0||||||
3612645|NCT02756624|3463041|B1|3 years old||Age, Customized||participants|Number|5|5.0||||||
3612646|NCT02756624|3463039|B3|2 years old||Age, Customized||participants|Number|14|14.0||||||
3612647|NCT02756624|3463040|B2|2 years old||Age, Customized||participants|Number|8|8.0||||||
3612648|NCT02756624|3463041|B1|2 years old||Age, Customized||participants|Number|6|6.0||||||
3612649|NCT02756624|3463039|B3|2-6 years old||Age, Customized||participants|Number|31|31.0||||||
3612650|NCT02756624|3463040|B2|2-6 years old||Age, Customized||participants|Number|12|12.0||||||
3612651|NCT02756624|3463041|B1|2-6 years old||Age, Customized||participants|Number|18|18.0||||||
3612652|NCT02756624|3463039|B3|||Age||years|Mean|32.2|32.2|Standard Deviation|17.31|17.31|||
3612653|NCT02756624|3463040|B2|||Age||years|Mean|31.8|31.8|Standard Deviation|18.3|18.3|||
3612654|NCT02756624|3463041|B1|||Age||years|Mean|32.5|32.5|Standard Deviation|16.81|16.81|||
3612655|NCT02756351|3463054|B3|Sweden||Region of Enrollment||participants|Number|48|48.0||||||
3612656|NCT02756351|3463055|B2|Sweden||Region of Enrollment||participants|Number|24|24.0||||||
3612657|NCT02756351|3463056|B1|Sweden||Region of Enrollment||participants|Number|24|24.0||||||
3612658|NCT02756351|3463054|B3||Male|Gender||Participants|Count of Participants|9|9.0||||||
3612659|NCT02756351|3463055|B2||Male|Gender||Participants|Count of Participants|3|3.0||||||
3612660|NCT02756351|3463056|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
3612661|NCT02756351|3463054|B3||Female|Gender||Participants|Count of Participants|39|39.0||||||
3612662|NCT02756351|3463055|B2||Female|Gender||Participants|Count of Participants|21|21.0||||||
3612663|NCT02756351|3463056|B1||Female|Gender||Participants|Count of Participants|18|18.0||||||
3612664|NCT02756351|3463054|B3|||Age||years|Mean|32.77|32.77|Standard Deviation|13.74|13.74|||
3612665|NCT02756351|3463055|B2|||Age||years|Mean|31.58|31.58|Standard Deviation|13.44|13.44|||
3612666|NCT02756351|3463056|B1|||Age||years|Mean|33.96|33.96|Standard Deviation|14.22|14.22|||
3612667|NCT02756351|3463054|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3612668|NCT02756351|3463055|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3612669|NCT02756351|3463056|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3612670|NCT02756351|3463054|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
3612671|NCT02756351|3463055|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3612672|NCT02756351|3463056|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3612673|NCT02756351|3463054|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3612674|NCT02756351|3463055|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3612675|NCT02756351|3463056|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3612676|NCT02756338|3463065|B1|||Weight||pounds|Mean|205.6|205.6|Standard Deviation|47.93|47.93|||
3612677|NCT02756338|3463065|B1|||Height||inches|Mean|67.8|67.8|Standard Deviation|4.82|4.82|||
3612678|NCT02756338|3463065|B1|Ethnicity Not Specified||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3612679|NCT02756338|3463065|B1|Not Hispanic or Latino Ethnicity||Race/Ethnicity, Customized||Participants|Count of Participants|76|76.0||||||
3612680|NCT02756338|3463065|B1|Race Not Specified||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3612681|NCT02756338|3463065|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3612682|NCT02756338|3463065|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|71|71.0||||||
3612683|NCT02756338|3463065|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3612684|NCT02756338|3463065|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3612685|NCT02756338|3463065|B1|Age at Enrollment||Age, Customized||years|Mean|62.1|62.1|Standard Deviation|15.38|15.38|||
3612686|NCT02756078|3463074|B1|Canada||Region of Enrollment||Participants|Count of Participants|200|200.0||||||
3612687|NCT02756078|3463074|B1|Other||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3612688|NCT02756078|3463074|B1|White||Race/Ethnicity, Customized||Participants|Number|114|114.0||||||
3612689|NCT02756078|3463074|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3612690|NCT02756078|3463074|B1|Asian||Race/Ethnicity, Customized||Participants|Number|78|78.0||||||
3612691|NCT02756078|3463074|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3612692|NCT02756078|3463074|B1||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3612693|NCT02756078|3463074|B1|||Age||Years|Mean|23.9|23.9|Standard Deviation|4.92|4.92|||
3612694|NCT02755935|3463093|B1|||Speech understanding (% correct) on AzBio sentences in noise in the ear to be implanted||percent correct|Mean|5.3|5.3|Standard Deviation|12.8|12.8|||
3612695|NCT02755935|3463093|B1|||Speech understanding (% correct) on AzBio sentences in quiet in the ear to be implanted||percent correct|Mean|11.2|11.2|Standard Deviation|16.6|16.6|||
3612696|NCT02755935|3463093|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3612697|NCT02755935|3463093|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3612698|NCT02755935|3463093|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3612699|NCT02755935|3463093|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3612700|NCT02755935|3463093|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3612701|NCT02755805|3463098|B3|||Apathy, AES|The Apathy Evaluation Scale measures motivation or interest in goal-directed activities. The scale has 18 items with a total score of 18 (absence of apathy) to 72 (severe apathy).|units on a scale|Mean|25.52|25.52|Standard Deviation|6.29|6.29|||
3612767|NCT02755090|3463113|B3||13 weeks|Gestational Age||Participants|Count of Participants|7|7.0||||||
3612702|NCT02755805|3463099|B2|||Apathy, AES|The Apathy Evaluation Scale measures motivation or interest in goal-directed activities. The scale has 18 items with a total score of 18 (absence of apathy) to 72 (severe apathy).|units on a scale|Mean|25.18|25.18|Standard Deviation|4.40|4.4|||
3612703|NCT02755805|3463100|B1|||Apathy, AES|The Apathy Evaluation Scale measures motivation or interest in goal-directed activities. The scale has 18 items with a total score of 18 (absence of apathy) to 72 (severe apathy).|units on a scale|Mean|25.79|25.79|Standard Deviation|7.62|7.62|||
3612704|NCT02755805|3463098|B3|||Depressive symptoms, HamD (Hamilton Rating Scale for Depression)|The Hamilton Depression Rating Scale is composed of 17 items that are summed to yield a total score ranging from 0 to 52. A total score of 0 typically indicates no depressive symptoms; 52 indicates severe depressive symptoms.|units on a scale|Mean|6.73|6.73|Standard Deviation|4.35|4.35|||
3612705|NCT02755805|3463099|B2|||Depressive symptoms, HamD (Hamilton Rating Scale for Depression)|The Hamilton Depression Rating Scale is composed of 17 items that are summed to yield a total score ranging from 0 to 52. A total score of 0 typically indicates no depressive symptoms; 52 indicates severe depressive symptoms.|units on a scale|Mean|6.75|6.75|Standard Deviation|4.53|4.53|||
3612706|NCT02755805|3463100|B1|||Depressive symptoms, HamD (Hamilton Rating Scale for Depression)|The Hamilton Depression Rating Scale is composed of 17 items that are summed to yield a total score ranging from 0 to 52. A total score of 0 typically indicates no depressive symptoms; 52 indicates severe depressive symptoms.|units on a scale|Mean|6.71|6.71|Standard Deviation|4.36|4.36|||
3612707|NCT02755805|3463098|B3|||Cognitive flexibility, CWI (Color Word Interference)|The Cognitive Flexibility Scale raw scores are converted to norm-referenced scaled scores adjusted for age and education. These scores are aligned with a population mean of 10, and standard deviation of 3. Higher scores indicate better executive function.|units on a scale|Mean|3.18|3.18|Standard Deviation|2.36|2.36|||
3612708|NCT02755805|3463099|B2|||Cognitive flexibility, CWI (Color Word Interference)|The Cognitive Flexibility Scale raw scores are converted to norm-referenced scaled scores adjusted for age and education. These scores are aligned with a population mean of 10, and standard deviation of 3. Higher scores indicate better executive function.|units on a scale|Mean|2.73|2.73|Standard Deviation|2.34|2.34|||
3612709|NCT02755805|3463100|B1|||Cognitive flexibility, CWI (Color Word Interference)|The Cognitive Flexibility Scale raw scores are converted to norm-referenced scaled scores adjusted for age and education. These scores are aligned with a population mean of 10, and standard deviation of 3. Higher scores indicate better executive function.|units on a scale|Mean|3.69|3.69|Standard Deviation|2.36|2.36|||
3612710|NCT02755805|3463098|B3|||Inhibition, CWI (Color Word Interference)|The Inhibition Scale raw scores are converted to norm-referenced scaled scores adjusted for age and education. These scores are aligned with a population mean of 10, and standard deviation of 3. Higher scores indicate better executive function.|units on a scale|Mean|4.39|4.39|Standard Deviation|3.50|3.5|||
3612711|NCT02755805|3463099|B2|||Inhibition, CWI (Color Word Interference)|The Inhibition Scale raw scores are converted to norm-referenced scaled scores adjusted for age and education. These scores are aligned with a population mean of 10, and standard deviation of 3. Higher scores indicate better executive function.|units on a scale|Mean|4.00|4.0|Standard Deviation|2.98|2.98|||
3612712|NCT02755805|3463100|B1|||Inhibition, CWI (Color Word Interference)|The Inhibition Scale raw scores are converted to norm-referenced scaled scores adjusted for age and education. These scores are aligned with a population mean of 10, and standard deviation of 3. Higher scores indicate better executive function.|units on a scale|Mean|4.85|4.85|Standard Deviation|4.10|4.1|||
3612713|NCT02755805|3463098|B3|||Functional Independence Measure|The Functional Independence Measure contains 18 items composed of 13 motor tasks and 5 cognitive tasks. A total scores is obtained (18-126), 18 represents complete dependence/total assistance and 126 represents complete independence with daily activities.|units on a scale|Mean|63.93|63.93|Standard Deviation|13.82|13.82|||
3612714|NCT02755805|3463099|B2|||Functional Independence Measure|The Functional Independence Measure contains 18 items composed of 13 motor tasks and 5 cognitive tasks. A total scores is obtained (18-126), 18 represents complete dependence/total assistance and 126 represents complete independence with daily activities.|units on a scale|Mean|62.60|62.6|Standard Deviation|16.56|16.56|||
3612715|NCT02755805|3463100|B1|||Functional Independence Measure|The Functional Independence Measure contains 18 items composed of 13 motor tasks and 5 cognitive tasks. A total scores is obtained (18-126), 18 represents complete dependence/total assistance and 126 represents complete independence with daily activities.|units on a scale|Mean|65.27|65.27|Standard Deviation|10.85|10.85|||
3612716|NCT02755805|3463098|B3|||Communication status, BDAE (Boston Diagnositic Aphasia Examination Severity Index)|The Boston Diagnostic Aphasia Examination is an aphasia severity rating scale ranging from 0-5, with 0 representing no usable speech or auditory comprehension and 5 representing minimal discernible speech impairments.|units on a scale|Mean|4.47|4.47|Standard Deviation|0.86|0.86|||
3612717|NCT02755805|3463099|B2|||Communication status, BDAE (Boston Diagnositic Aphasia Examination Severity Index)|The Boston Diagnostic Aphasia Examination is an aphasia severity rating scale ranging from 0-5, with 0 representing no usable speech or auditory comprehension and 5 representing minimal discernible speech impairments.|units on a scale|Mean|4.67|4.67|Standard Deviation|.62|0.62|||
3612718|NCT02755805|3463100|B1|||Communication status, BDAE (Boston Diagnositic Aphasia Examination Severity Index)|The Boston Diagnostic Aphasia Examination is an aphasia severity rating scale ranging from 0-5, with 0 representing no usable speech or auditory comprehension and 5 representing minimal discernible speech impairments.|units on a scale|Mean|4.27|4.27|Standard Deviation|1.03|1.03|||
3612719|NCT02755805|3463098|B3|||Cognitive status, EXIT (Quick Executive Interview)|The EXIT is composed of 14 items that are summed to yield a total score ranging from 0 to 28. A total score of 0 typically indicates no executive impairment, while a total score of 28 indicates severe executive impairment.|units on a scale|Mean|8.72|8.72|Standard Deviation|3.28|3.28|||
3612720|NCT02755805|3463099|B2|||Cognitive status, EXIT (Quick Executive Interview)|The EXIT is composed of 14 items that are summed to yield a total score ranging from 0 to 28. A total score of 0 typically indicates no executive impairment, while a total score of 28 indicates severe executive impairment.|units on a scale|Mean|9.31|9.31|Standard Deviation|3.54|3.54|||
3612768|NCT02755090|3463114|B2||13 weeks|Gestational Age||Participants|Count of Participants|4|4.0||||||
3612721|NCT02755805|3463100|B1|||Cognitive status, EXIT (Quick Executive Interview)|The EXIT is composed of 14 items that are summed to yield a total score ranging from 0 to 28. A total score of 0 typically indicates no executive impairment, while a total score of 28 indicates severe executive impairment.|units on a scale|Mean|8.13|8.13|Standard Deviation|3.00|3.0|||
3612722|NCT02755805|3463098|B3|||Medical burden, CIRS (Cumulative Illness Rating Scale)|The Cumulative Illness Rating Scale records medical problems for 14 organ systems. The severity index is computed by averaging the impairment severity for each organ system (0=no impairment, 4=severe impairment), yielding an average severity index of 0 (no medical problems) to 4 (severe medical problems).|units on a scale|Mean|2.37|2.37|Standard Deviation|0.53|0.53|||
3612723|NCT02755805|3463099|B2|||Medical burden, CIRS (Cumulative Illness Rating Scale)|The Cumulative Illness Rating Scale records medical problems for 14 organ systems. The severity index is computed by averaging the impairment severity for each organ system (0=no impairment, 4=severe impairment), yielding an average severity index of 0 (no medical problems) to 4 (severe medical problems).|units on a scale|Mean|2.36|2.36|Standard Deviation|.57|0.57|||
3612724|NCT02755805|3463100|B1|||Medical burden, CIRS (Cumulative Illness Rating Scale)|The Cumulative Illness Rating Scale records medical problems for 14 organ systems. The severity index is computed by averaging the impairment severity for each organ system (0=no impairment, 4=severe impairment), yielding an average severity index of 0 (no medical problems) to 4 (severe medical problems).|units on a scale|Mean|2.37|2.37|Standard Deviation|.47|0.47|||
3612725|NCT02755805|3463098|B3|||Stroke severity, NIHSS (National Institutes of Health Stroke Scale)|The NIHSS is composed of 11 items that are summed to yield a total score. Total scores range from 0 to 42; 0=no neurological impairment, 42=severe neurological impairment.|units on a scale|Mean|7.37|7.37|Standard Deviation|3.10|3.1|||
3612726|NCT02755805|3463099|B2|||Stroke severity, NIHSS (National Institutes of Health Stroke Scale)|The NIHSS is composed of 11 items that are summed to yield a total score. Total scores range from 0 to 42; 0=no neurological impairment, 42=severe neurological impairment.|units on a scale|Mean|5.87|5.87|Standard Deviation|2.72|2.72|||
3612727|NCT02755805|3463100|B1|||Stroke severity, NIHSS (National Institutes of Health Stroke Scale)|The NIHSS is composed of 11 items that are summed to yield a total score. Total scores range from 0 to 42; 0=no neurological impairment, 42=severe neurological impairment.|units on a scale|Mean|8.87|8.87|Standard Deviation|2.77|2.77|||
3612728|NCT02755805|3463098|B3|left||Hemisphere||participants|Number|10|10.0||||||
3612729|NCT02755805|3463099|B2|left||Hemisphere||participants|Number|5|5.0||||||
3612730|NCT02755805|3463100|B1|left||Hemisphere||participants|Number|5|5.0||||||
3612731|NCT02755805|3463098|B3|right||Hemisphere||participants|Number|20|20.0||||||
3612732|NCT02755805|3463099|B2|right||Hemisphere||participants|Number|10|10.0||||||
3612733|NCT02755805|3463100|B1|right||Hemisphere||participants|Number|10|10.0||||||
3612734|NCT02755805|3463098|B3|hemorrhagic||Stroke type||participants|Number|9|9.0||||||
3612735|NCT02755805|3463099|B2|hemorrhagic||Stroke type||participants|Number|4|4.0||||||
3612736|NCT02755805|3463100|B1|hemorrhagic||Stroke type||participants|Number|5|5.0||||||
3612737|NCT02755805|3463098|B3|ischemic||Stroke type||participants|Number|21|21.0||||||
3612738|NCT02755805|3463099|B2|ischemic||Stroke type||participants|Number|11|11.0||||||
3612739|NCT02755805|3463100|B1|ischemic||Stroke type||participants|Number|10|10.0||||||
3612740|NCT02755805|3463098|B3|||Stroke onset|Stroke onset is calculated from date of stroke to date of study admission.|days|Mean|17.63|17.63|Standard Deviation|18.35|18.35|||
3612741|NCT02755805|3463099|B2|||Stroke onset|Stroke onset is calculated from date of stroke to date of study admission.|days|Mean|18.47|18.47|Standard Deviation|21.29|21.29|||
3612742|NCT02755805|3463100|B1|||Stroke onset|Stroke onset is calculated from date of stroke to date of study admission.|days|Mean|16.80|16.8|Standard Deviation|15.58|15.58|||
3612743|NCT02755805|3463098|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3612744|NCT02755805|3463099|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3612745|NCT02755805|3463100|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3612746|NCT02755805|3463098|B3|African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3612747|NCT02755805|3463099|B2|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3612748|NCT02755805|3463100|B1|African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3612749|NCT02755805|3463098|B3|White||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3612750|NCT02755805|3463099|B2|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3612751|NCT02755805|3463100|B1|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3612752|NCT02755805|3463098|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3612753|NCT02755805|3463099|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3612754|NCT02755805|3463100|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3612755|NCT02755805|3463098|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3612756|NCT02755805|3463099|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3612757|NCT02755805|3463100|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3612758|NCT02755805|3463098|B3|||Age||years|Mean|67.33|67.33|Standard Deviation|15.41|15.41|||
3612759|NCT02755805|3463099|B2|||Age||years|Mean|71.80|71.8|Standard Deviation|13.19|13.19|||
3612760|NCT02755805|3463100|B1|||Age||years|Mean|64.87|64.87|Standard Deviation|16.59|16.59|||
3612761|NCT02755090|3463113|B3||15 weeks|Gestational Age||Participants|Count of Participants|6|6.0||||||
3612762|NCT02755090|3463114|B2||15 weeks|Gestational Age||Participants|Count of Participants|3|3.0||||||
3612763|NCT02755090|3463115|B1||15 weeks|Gestational Age||Participants|Count of Participants|3|3.0||||||
3612764|NCT02755090|3463113|B3||14 weeks|Gestational Age||Participants|Count of Participants|10|10.0||||||
3612765|NCT02755090|3463114|B2||14 weeks|Gestational Age||Participants|Count of Participants|5|5.0||||||
3612766|NCT02755090|3463115|B1||14 weeks|Gestational Age||Participants|Count of Participants|5|5.0||||||
3612769|NCT02755090|3463115|B1||13 weeks|Gestational Age||Participants|Count of Participants|3|3.0||||||
3612770|NCT02755090|3463113|B3||12 weeks|Gestational Age||Participants|Count of Participants|16|16.0||||||
3612771|NCT02755090|3463114|B2||12 weeks|Gestational Age||Participants|Count of Participants|8|8.0||||||
3612772|NCT02755090|3463115|B1||12 weeks|Gestational Age||Participants|Count of Participants|8|8.0||||||
3612773|NCT02755090|3463113|B3||Bachelor's or graduate degree|Education||Participants|Count of Participants|6|6.0||||||
3612774|NCT02755090|3463114|B2||Bachelor's or graduate degree|Education||Participants|Count of Participants|3|3.0||||||
3612775|NCT02755090|3463115|B1||Bachelor's or graduate degree|Education||Participants|Count of Participants|3|3.0||||||
3612776|NCT02755090|3463113|B3||More than high school|Education||Participants|Count of Participants|17|17.0||||||
3612777|NCT02755090|3463114|B2||More than high school|Education||Participants|Count of Participants|9|9.0||||||
3612778|NCT02755090|3463115|B1||More than high school|Education||Participants|Count of Participants|8|8.0||||||
3612779|NCT02755090|3463113|B3||High school or equivalent|Education||Participants|Count of Participants|16|16.0||||||
3612780|NCT02755090|3463114|B2||High school or equivalent|Education||Participants|Count of Participants|8|8.0||||||
3612781|NCT02755090|3463115|B1||High school or equivalent|Education||Participants|Count of Participants|8|8.0||||||
3612782|NCT02755090|3463113|B3||Not in a committed relationship|Relationship Status||Participants|Count of Participants|13|13.0||||||
3612783|NCT02755090|3463114|B2||Not in a committed relationship|Relationship Status||Participants|Count of Participants|7|7.0||||||
3612784|NCT02755090|3463115|B1||Not in a committed relationship|Relationship Status||Participants|Count of Participants|6|6.0||||||
3612785|NCT02755090|3463113|B3||In a committed relationship|Relationship Status||Participants|Count of Participants|26|26.0||||||
3612786|NCT02755090|3463114|B2||In a committed relationship|Relationship Status||Participants|Count of Participants|13|13.0||||||
3612787|NCT02755090|3463115|B1||In a committed relationship|Relationship Status||Participants|Count of Participants|13|13.0||||||
3612788|NCT02755090|3463113|B3|Race|Other: including bi and mutiracial|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3612789|NCT02755090|3463114|B2|Race|Other: including bi and mutiracial|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3612790|NCT02755090|3463115|B1|Race|Other: including bi and mutiracial|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3612791|NCT02755090|3463113|B3|Race|American Indian/ Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3612792|NCT02755090|3463114|B2|Race|American Indian/ Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3612793|NCT02755090|3463115|B1|Race|American Indian/ Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3612794|NCT02755090|3463113|B3|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3612795|NCT02755090|3463114|B2|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3612796|NCT02755090|3463115|B1|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3612797|NCT02755090|3463113|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3612798|NCT02755090|3463114|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3612799|NCT02755090|3463115|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3612800|NCT02755090|3463113|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612801|NCT02755090|3463114|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612802|NCT02755090|3463115|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3612803|NCT02755090|3463113|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3612804|NCT02755090|3463114|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3612805|NCT02755090|3463115|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3612806|NCT02755090|3463113|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3612807|NCT02755090|3463114|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3612808|NCT02755090|3463115|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3612809|NCT02755090|3463113|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3612810|NCT02755090|3463114|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3612811|NCT02755090|3463115|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3612812|NCT02755090|3463113|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3612813|NCT02755090|3463114|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3612814|NCT02755090|3463115|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3612815|NCT02755090|3463113|B3|||Age||years|Mean|27.1|27.1|Full Range|||18.0|42.0|
3612816|NCT02755090|3463114|B2|||Age||years|Mean|26.8|26.8|Full Range|||18.0|42.0|
3612817|NCT02755090|3463115|B1|||Age||years|Mean|27.5|27.5|Full Range|||19.0|40.0|
3612818|NCT02754492|3463124|B5|||Weight||pounds|Mean|206.28|206.28|Standard Deviation|48.206|48.206|||
3612819|NCT02754492|3463125|B4|||Weight||pounds|Mean|196.00|196.0|Standard Deviation|39.852|39.852|||
3612820|NCT02754492|3463126|B3|||Weight||pounds|Mean|232.55|232.55|Standard Deviation|48.648|48.648|||
3612821|NCT02754492|3463127|B2|||Weight||pounds|Mean|202.00|202.0|Standard Deviation|44.835|44.835|||
3612822|NCT02754492|3463128|B1|||Weight||pounds|Mean|187.18|187.18|Standard Deviation|41.653|41.653|||
3612823|NCT02754492|3463124|B5|||Height||inches|Mean|68.5|68.5|Standard Deviation|3.87|3.87|||
3612824|NCT02754492|3463125|B4|||Height||inches|Mean|69.1|69.1|Standard Deviation|2.92|2.92|||
3612825|NCT02754492|3463126|B3|||Height||inches|Mean|69.1|69.1|Standard Deviation|3.80|3.8|||
3612826|NCT02754492|3463127|B2|||Height||inches|Mean|68.5|68.5|Standard Deviation|3.88|3.88|||
3612827|NCT02754492|3463128|B1|||Height||inches|Mean|67.8|67.8|Standard Deviation|4.06|4.06|||
3612828|NCT02754492|3463124|B5|United States||Region of Enrollment||participants|Number|310|310.0||||||
3612829|NCT02754492|3463125|B4|United States||Region of Enrollment||participants|Number|23|23.0||||||
3612830|NCT02754492|3463126|B3|United States||Region of Enrollment||participants|Number|95|95.0||||||
3612831|NCT02754492|3463127|B2|United States||Region of Enrollment||participants|Number|95|95.0||||||
3612832|NCT02754492|3463128|B1|United States||Region of Enrollment||participants|Number|97|97.0||||||
3612833|NCT02754492|3463124|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3612834|NCT02754492|3463125|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3612835|NCT02754492|3463126|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3612836|NCT02754492|3463127|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3612837|NCT02754492|3463128|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3612838|NCT02754492|3463124|B5|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3612839|NCT02754492|3463125|B4|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3612840|NCT02754492|3463126|B3|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3612841|NCT02754492|3463127|B2|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3612842|NCT02754492|3463128|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3612843|NCT02754492|3463124|B5|No Response||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3612844|NCT02754492|3463125|B4|No Response||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3612845|NCT02754492|3463126|B3|No Response||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3612846|NCT02754492|3463127|B2|No Response||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3612847|NCT02754492|3463128|B1|No Response||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3612848|NCT02754492|3463124|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|261|261.0||||||
3612849|NCT02754492|3463125|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3612850|NCT02754492|3463126|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|80|80.0||||||
3612851|NCT02754492|3463127|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|84|84.0||||||
3612852|NCT02754492|3463128|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|78|78.0||||||
3612853|NCT02754492|3463124|B5|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3612854|NCT02754492|3463125|B4|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3612855|NCT02754492|3463126|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3612856|NCT02754492|3463127|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3612857|NCT02754492|3463128|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3612858|NCT02754492|3463124|B5|Black||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3612859|NCT02754492|3463125|B4|Black||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3612860|NCT02754492|3463126|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3612861|NCT02754492|3463127|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3612862|NCT02754492|3463128|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3612863|NCT02754492|3463124|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3612864|NCT02754492|3463125|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3612865|NCT02754492|3463126|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3612866|NCT02754492|3463127|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3612867|NCT02754492|3463128|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3612868|NCT02754492|3463124|B5|American Indian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3612869|NCT02754492|3463125|B4|American Indian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3612870|NCT02754492|3463126|B3|American Indian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3612871|NCT02754492|3463127|B2|American Indian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3612872|NCT02754492|3463128|B1|American Indian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3612873|NCT02754492|3463124|B5||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3612874|NCT02754492|3463125|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3612875|NCT02754492|3463126|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3612876|NCT02754492|3463127|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3612877|NCT02754492|3463128|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3612878|NCT02754492|3463124|B5||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3612879|NCT02754492|3463125|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3612880|NCT02754492|3463126|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3612881|NCT02754492|3463127|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3612882|NCT02754492|3463128|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3612883|NCT02754492|3463124|B5|Age ≥ 18 years||Age, Customized||Participants|Count of Participants|310|310.0||||||
3612884|NCT02754492|3463125|B4|Age ≥ 18 years||Age, Customized||Participants|Count of Participants|23|23.0||||||
3612885|NCT02754492|3463126|B3|Age ≥ 18 years||Age, Customized||Participants|Count of Participants|95|95.0||||||
3612886|NCT02754492|3463127|B2|Age ≥ 18 years||Age, Customized||Participants|Count of Participants|95|95.0||||||
3612887|NCT02754492|3463128|B1|Age ≥ 18 years||Age, Customized||Participants|Count of Participants|97|97.0||||||
3612888|NCT02754440|3463143|B5|||Weight||pounds|Mean|210.44|210.44|Standard Deviation|48.18|48.18|||
3612889|NCT02754440|3463144|B4|||Weight||pounds|Mean|207.45|207.45|Standard Deviation|51.44|51.44|||
3612890|NCT02754440|3463145|B3|||Weight||pounds|Mean|225.01|225.01|Standard Deviation|51.3|51.3|||
3612891|NCT02754440|3463146|B2|||Weight||pounds|Mean|205.09|205.09|Standard Deviation|46.95|46.95|||
3612892|NCT02754440|3463147|B1|||Weight||pounds|Mean|202.25|202.25|Standard Deviation|42.04|42.04|||
3612893|NCT02754440|3463143|B5|||Height||inches|Mean|68.9|68.9|Standard Deviation|3.99|3.99|||
3612894|NCT02754440|3463144|B4|||Height||inches|Mean|69.5|69.5|Standard Deviation|4.28|4.28|||
3612895|NCT02754440|3463145|B3|||Height||inches|Mean|69.1|69.1|Standard Deviation|4.04|4.04|||
3612896|NCT02754440|3463146|B2|||Height||inches|Mean|68.7|68.7|Standard Deviation|3.95|3.95|||
3612897|NCT02754440|3463147|B1|||Height||inches|Mean|68.6|68.6|Standard Deviation|3.90|3.9|||
3612898|NCT02754440|3463143|B5|United States||Region of Enrollment||participants|Number|335|335.0||||||
3612899|NCT02754440|3463144|B4|United States||Region of Enrollment||participants|Number|35|35.0||||||
3612900|NCT02754440|3463145|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
3612901|NCT02754440|3463146|B2|United States||Region of Enrollment||participants|Number|101|101.0||||||
3612902|NCT02754440|3463147|B1|United States||Region of Enrollment||participants|Number|99|99.0||||||
3612903|NCT02754440|3463143|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3612904|NCT02754440|3463144|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3612905|NCT02754440|3463145|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3612906|NCT02754440|3463146|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3612907|NCT02754440|3463147|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3612908|NCT02754440|3463143|B5|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3612909|NCT02754440|3463144|B4|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3612910|NCT02754440|3463145|B3|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3612911|NCT02754440|3463146|B2|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3612912|NCT02754440|3463147|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3612913|NCT02754440|3463143|B5|No Response||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3612914|NCT02754440|3463144|B4|No Response||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3612915|NCT02754440|3463145|B3|No Response||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3612916|NCT02754440|3463146|B2|No Response||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3612917|NCT02754440|3463147|B1|No Response||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3612918|NCT02754440|3463143|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|291|291.0||||||
3612919|NCT02754440|3463144|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3612920|NCT02754440|3463145|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|84|84.0||||||
3612921|NCT02754440|3463146|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|86|86.0||||||
3612922|NCT02754440|3463147|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|93|93.0||||||
3612923|NCT02754440|3463143|B5|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3612924|NCT02754440|3463144|B4|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3612925|NCT02754440|3463145|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3612926|NCT02754440|3463146|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3612927|NCT02754440|3463147|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3612928|NCT02754440|3463143|B5|Black||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3612929|NCT02754440|3463144|B4|Black||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3612930|NCT02754440|3463145|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3612931|NCT02754440|3463146|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3612932|NCT02754440|3463147|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3612933|NCT02754440|3463143|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3612934|NCT02754440|3463144|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3612935|NCT02754440|3463145|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3612936|NCT02754440|3463146|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3612937|NCT02754440|3463147|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3612938|NCT02754440|3463143|B5|American Indian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3612939|NCT02754440|3463144|B4|American Indian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3612940|NCT02754440|3463145|B3|American Indian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3612941|NCT02754440|3463146|B2|American Indian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3612942|NCT02754440|3463147|B1|American Indian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3612943|NCT02754440|3463143|B5||Male|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
3612944|NCT02754440|3463144|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3612945|NCT02754440|3463145|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3612946|NCT02754440|3463146|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3612947|NCT02754440|3463147|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3612948|NCT02754440|3463143|B5||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3612949|NCT02754440|3463144|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3612950|NCT02754440|3463145|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3612951|NCT02754440|3463146|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3612952|NCT02754440|3463147|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3612953|NCT02754440|3463143|B5|Age ≥ 18 years||Age, Customized||Participants|Count of Participants|335|335.0||||||
3612954|NCT02754440|3463144|B4|Age ≥ 18 years||Age, Customized||Participants|Count of Participants|35|35.0||||||
3612955|NCT02754440|3463145|B3|Age ≥ 18 years||Age, Customized||Participants|Count of Participants|100|100.0||||||
3612956|NCT02754440|3463146|B2|Age ≥ 18 years||Age, Customized||Participants|Count of Participants|101|101.0||||||
3612957|NCT02754440|3463147|B1|Age ≥ 18 years||Age, Customized||Participants|Count of Participants|99|99.0||||||
3612958|NCT02753946|3463162|B3|> 50 mL/min||Screening Creatinine Clearance Group|Cockroft Gault Equation used|Participants|Count of Participants|405|405.0||||||
3612959|NCT02753946|3463163|B2|> 50 mL/min||Screening Creatinine Clearance Group|Cockroft Gault Equation used|Participants|Count of Participants|205|205.0||||||
3612960|NCT02753946|3463164|B1|> 50 mL/min||Screening Creatinine Clearance Group|Cockroft Gault Equation used|Participants|Count of Participants|200|200.0||||||
3612961|NCT02753946|3463162|B3|>40 to 50 mL/min||Screening Creatinine Clearance Group|Cockroft Gault Equation used|Participants|Count of Participants|35|35.0||||||
3612962|NCT02753946|3463163|B2|>40 to 50 mL/min||Screening Creatinine Clearance Group|Cockroft Gault Equation used|Participants|Count of Participants|19|19.0||||||
3612963|NCT02753946|3463164|B1|>40 to 50 mL/min||Screening Creatinine Clearance Group|Cockroft Gault Equation used|Participants|Count of Participants|16|16.0||||||
3612964|NCT02753946|3463162|B3|>30 to 40 mL/min||Screening Creatinine Clearance Group|Cockroft Gault Equation used|Participants|Count of Participants|19|19.0||||||
3612965|NCT02753946|3463163|B2|>30 to 40 mL/min||Screening Creatinine Clearance Group|Cockroft Gault Equation used|Participants|Count of Participants|7|7.0||||||
3612966|NCT02753946|3463164|B1|>30 to 40 mL/min||Screening Creatinine Clearance Group|Cockroft Gault Equation used|Participants|Count of Participants|12|12.0||||||
3612967|NCT02753946|3463162|B3|> or = 20 to 30 mL/min||Screening Creatinine Clearance Group|Cockroft Gault Equation used|Participants|Count of Participants|5|5.0||||||
3612968|NCT02753946|3463163|B2|> or = 20 to 30 mL/min||Screening Creatinine Clearance Group|Cockroft Gault Equation used|Participants|Count of Participants|1|1.0||||||
3612969|NCT02753946|3463164|B1|> or = 20 to 30 mL/min||Screening Creatinine Clearance Group|Cockroft Gault Equation used|Participants|Count of Participants|4|4.0||||||
3612970|NCT02753946|3463162|B3|<20 mL/min||Screening Creatinine Clearance Group|Cockroft Gault Equation used|Participants|Count of Participants|0|0.0||||||
3612971|NCT02753946|3463163|B2|<20 mL/min||Screening Creatinine Clearance Group|Cockroft Gault Equation used|Participants|Count of Participants|0|0.0||||||
3612972|NCT02753946|3463164|B1|<20 mL/min||Screening Creatinine Clearance Group|Cockroft Gault Equation used|Participants|Count of Participants|0|0.0||||||
3612973|NCT02753946|3463162|B3|||BMI (kg/m2)||kg/m2|Mean|26.12|26.12|Standard Deviation|5.776|5.776|||
3612974|NCT02753946|3463163|B2|||BMI (kg/m2)||kg/m2|Mean|26.44|26.44|Standard Deviation|6.167|6.167|||
3612975|NCT02753946|3463164|B1|||BMI (kg/m2)||kg/m2|Mean|25.81|25.81|Standard Deviation|5.355|5.355|||
3612976|NCT02753946|3463162|B3|Estonia||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3612977|NCT02753946|3463163|B2|Estonia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3612978|NCT02753946|3463164|B1|Estonia||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3612979|NCT02753946|3463162|B3|Croatia||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3612980|NCT02753946|3463163|B2|Croatia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3612981|NCT02753946|3463164|B1|Croatia||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3612982|NCT02753946|3463162|B3|Lithuania||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3612983|NCT02753946|3463163|B2|Lithuania||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3612984|NCT02753946|3463164|B1|Lithuania||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3612985|NCT02753946|3463162|B3|Bulgaria||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3612986|NCT02753946|3463163|B2|Bulgaria||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3612987|NCT02753946|3463164|B1|Bulgaria||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3612988|NCT02753946|3463162|B3|Slovakia||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3612989|NCT02753946|3463163|B2|Slovakia||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3612990|NCT02753946|3463164|B1|Slovakia||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3612991|NCT02753946|3463162|B3|Georgia||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3612992|NCT02753946|3463163|B2|Georgia||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3612993|NCT02753946|3463164|B1|Georgia||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3612994|NCT02753946|3463162|B3|Poland||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3612995|NCT02753946|3463163|B2|Poland||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3612996|NCT02753946|3463164|B1|Poland||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3612997|NCT02753946|3463162|B3|Latvia||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3612998|NCT02753946|3463163|B2|Latvia||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3612999|NCT02753946|3463164|B1|Latvia||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3613000|NCT02753946|3463162|B3|Russia||Region of Enrollment||Participants|Count of Participants|78|78.0||||||
3613001|NCT02753946|3463163|B2|Russia||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3613002|NCT02753946|3463164|B1|Russia||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3613003|NCT02753946|3463162|B3|Belarus||Region of Enrollment||Participants|Count of Participants|70|70.0||||||
3613004|NCT02753946|3463163|B2|Belarus||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3613005|NCT02753946|3463164|B1|Belarus||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3613006|NCT02753946|3463162|B3|Ukraine||Region of Enrollment||Participants|Count of Participants|144|144.0||||||
3613007|NCT02753946|3463163|B2|Ukraine||Region of Enrollment||Participants|Count of Participants|73|73.0||||||
3613008|NCT02753946|3463164|B1|Ukraine||Region of Enrollment||Participants|Count of Participants|71|71.0||||||
3613009|NCT02753946|3463162|B3|Czechia||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3613010|NCT02753946|3463163|B2|Czechia||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3613011|NCT02753946|3463164|B1|Czechia||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3613012|NCT02753946|3463162|B3|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3613013|NCT02753946|3463163|B2|United States||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3613014|NCT02753946|3463164|B1|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3613015|NCT02753946|3463162|B3|Hungary||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3613016|NCT02753946|3463163|B2|Hungary||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3613017|NCT02753946|3463164|B1|Hungary||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3613018|NCT02753946|3463162|B3|Romania||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3613019|NCT02753946|3463163|B2|Romania||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3613020|NCT02753946|3463164|B1|Romania||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3613021|NCT02753946|3463162|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613022|NCT02753946|3463163|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613023|NCT02753946|3463164|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613024|NCT02753946|3463162|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613025|NCT02753946|3463163|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613026|NCT02753946|3463164|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613027|NCT02753946|3463162|B3||White|Race (NIH/OMB)||Participants|Count of Participants|465|465.0||||||
3613028|NCT02753946|3463163|B2||White|Race (NIH/OMB)||Participants|Count of Participants|232|232.0||||||
3613029|NCT02753946|3463164|B1||White|Race (NIH/OMB)||Participants|Count of Participants|233|233.0||||||
3613030|NCT02753946|3463162|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613031|NCT02753946|3463163|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613032|NCT02753946|3463164|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613033|NCT02753946|3463162|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613034|NCT02753946|3463163|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613035|NCT02753946|3463164|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613036|NCT02753946|3463162|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613037|NCT02753946|3463163|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613038|NCT02753946|3463164|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613039|NCT02753946|3463162|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613040|NCT02753946|3463163|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613041|NCT02753946|3463164|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613042|NCT02753946|3463162|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613043|NCT02753946|3463163|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613044|NCT02753946|3463164|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613045|NCT02753946|3463162|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|465|465.0||||||
3613046|NCT02753946|3463163|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|232|232.0||||||
3613047|NCT02753946|3463164|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|233|233.0||||||
3613048|NCT02753946|3463162|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613049|NCT02753946|3463163|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613050|NCT02753946|3463164|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613051|NCT02753946|3463162|B3||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3613052|NCT02753946|3463163|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3613053|NCT02753946|3463164|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3613054|NCT02753946|3463162|B3||Female|Sex: Female, Male||Participants|Count of Participants|297|297.0||||||
3613055|NCT02753946|3463163|B2||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3613056|NCT02753946|3463164|B1||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3613057|NCT02753946|3463162|B3|> 75 years of age||Age, Customized||Participants|Count of Participants|57|57.0||||||
3613058|NCT02753946|3463163|B2|> 75 years of age||Age, Customized||Participants|Count of Participants|35|35.0||||||
3613059|NCT02753946|3463164|B1|> 75 years of age||Age, Customized||Participants|Count of Participants|22|22.0||||||
3613060|NCT02753946|3463162|B3|65 to 75 years of age||Age, Customized||Participants|Count of Participants|94|94.0||||||
3613061|NCT02753946|3463163|B2|65 to 75 years of age||Age, Customized||Participants|Count of Participants|42|42.0||||||
3613062|NCT02753946|3463164|B1|65 to 75 years of age||Age, Customized||Participants|Count of Participants|52|52.0||||||
3613063|NCT02753946|3463162|B3|< 65 years of age||Age, Customized||Participants|Count of Participants|314|314.0||||||
3613064|NCT02753946|3463163|B2|< 65 years of age||Age, Customized||Participants|Count of Participants|155|155.0||||||
3613065|NCT02753946|3463164|B1|< 65 years of age||Age, Customized||Participants|Count of Participants|159|159.0||||||
3613066|NCT02753920|3463175|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613067|NCT02753920|3463176|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613068|NCT02753920|3463177|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613069|NCT02753920|3463175|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|155|155.0||||||
3613070|NCT02753920|3463176|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3613071|NCT02753920|3463177|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3613072|NCT02753920|3463175|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3613073|NCT02753920|3463176|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3613074|NCT02753920|3463177|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3613075|NCT02753920|3463175|B3|female||Sex/Gender, Customized||Participants|Count of Participants|173|173.0||||||
3613076|NCT02753920|3463176|B2|female||Sex/Gender, Customized||Participants|Count of Participants|86|86.0||||||
3613077|NCT02753920|3463177|B1|female||Sex/Gender, Customized||Participants|Count of Participants|87|87.0||||||
3613078|NCT02753920|3463175|B3|||Age||years|Median|62.9|62.9|Standard Deviation|11.1|11.1|||
3613079|NCT02753920|3463176|B2|||Age||years|Median|62.7|62.7|Standard Deviation|10.5|10.5|||
3613080|NCT02753920|3463177|B1|||Age||years|Median|63.1|63.1|Standard Deviation|11.4|11.4|||
3613081|NCT02753699|3463188|B4||Male|Sex: Female, Male||Participants|Count of Participants|422|422.0||||||
3613082|NCT02753699|3463189|B3||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3613083|NCT02753699|3463190|B2||Male|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
3613084|NCT02753699|3463191|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3613085|NCT02753699|3463188|B4||Female|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
3613086|NCT02753699|3463189|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3613087|NCT02753699|3463190|B2||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3613088|NCT02753699|3463191|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3613089|NCT02753699|3463188|B4|||Age||years|Mean|47.2|47.2|Standard Deviation|11.53|11.53|||
3613090|NCT02753699|3463189|B3|||Age||years|Mean|43.7|43.7|Standard Deviation|10.89|10.89|||
3613091|NCT02753699|3463190|B2|||Age||years|Mean|46.4|46.4|Standard Deviation|11.70|11.7|||
3613092|NCT02753699|3463191|B1|||Age||years|Mean|52.5|52.5|Standard Deviation|9.89|9.89|||
3613093|NCT02753413|3463207|B3|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|100|100.0||||||
3613094|NCT02753413|3463208|B2|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
3613095|NCT02753413|3463209|B1|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|49|49.0||||||
3613096|NCT02753413|3463207|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3613097|NCT02753413|3463208|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3613098|NCT02753413|3463209|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3613099|NCT02753413|3463207|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3613100|NCT02753413|3463208|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3613101|NCT02753413|3463209|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3613102|NCT02753413|3463207|B3|||Age||Years|Mean|25.70|25.7|Standard Deviation|5.97|5.97|||
3613103|NCT02753413|3463208|B2|||Age||Years|Mean|25.60|25.6|Standard Deviation|6.10|6.1|||
3613104|NCT02753413|3463209|B1|||Age||Years|Mean|25.80|25.8|Standard Deviation|5.90|5.9|||
3613105|NCT02753075|3463242|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3613106|NCT02753075|3463243|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3613107|NCT02753075|3463244|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3613108|NCT02753075|3463245|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3613109|NCT02753075|3463242|B4||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
3613110|NCT02753075|3463243|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3613111|NCT02753075|3463244|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3613112|NCT02753075|3463245|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3613113|NCT02753075|3463242|B4|||Age||Years|Mean|40.3|40.3|Standard Deviation|9.15|9.15|||
3613114|NCT02753075|3463243|B3|||Age||Years|Mean|40.5|40.5|Standard Deviation|8.71|8.71|||
3613115|NCT02753075|3463244|B2|||Age||Years|Mean|40.0|40.0|Standard Deviation|9.81|9.81|||
3613116|NCT02753075|3463245|B1|||Age||Years|Mean|40.5|40.5|Standard Deviation|9.00|9.0|||
3613117|NCT02752958|3463272|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613118|NCT02752958|3463272|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613119|NCT02752958|3463272|B1||White|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3613120|NCT02752958|3463272|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613121|NCT02752958|3463272|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613122|NCT02752958|3463272|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613123|NCT02752958|3463272|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613124|NCT02752958|3463272|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3613125|NCT02752958|3463272|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3613126|NCT02752958|3463272|B1|||Age||Years|Mean|38.2|38.2|Standard Deviation|8.88|8.88|||
3613127|NCT02752802|3463341|B3||Male|Gender||Participants|Count of Participants|56|56.0||||||
3613128|NCT02752802|3463342|B2||Male|Gender||Participants|Count of Participants|28|28.0||||||
3613129|NCT02752802|3463343|B1||Male|Gender||Participants|Count of Participants|28|28.0||||||
3613130|NCT02752802|3463341|B3||Female|Gender||Participants|Count of Participants|40|40.0||||||
3613131|NCT02752802|3463342|B2||Female|Gender||Participants|Count of Participants|20|20.0||||||
3613132|NCT02752802|3463343|B1||Female|Gender||Participants|Count of Participants|20|20.0||||||
3613133|NCT02752802|3463341|B3|||Age||years|Mean|67.4|67.4|Standard Deviation|13.2|13.2|||
3613134|NCT02752802|3463342|B2|||Age||years|Mean|66.2|66.2|Standard Deviation|12.8|12.8|||
3613135|NCT02752802|3463343|B1|||Age||years|Mean|68.6|68.6|Standard Deviation|13.6|13.6|||
3613136|NCT02752633|3463353|B1|Iceland||Region of Enrollment||participants|Number|9|9.0||||||
3613137|NCT02752633|3463353|B1|Race|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613138|NCT02752633|3463353|B1|Race|More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613139|NCT02752633|3463353|B1|Race|White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3613140|NCT02752633|3463353|B1|Race|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613141|NCT02752633|3463353|B1|Race|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613142|NCT02752633|3463353|B1|Race|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613143|NCT02752633|3463353|B1|Race|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613144|NCT02752633|3463353|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3613145|NCT02752633|3463353|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3613146|NCT02752633|3463353|B1|||Age||years|Median|54|54.0|Full Range|||28.0|67.0|
3613147|NCT02752633|3463353|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3613148|NCT02752633|3463353|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3613149|NCT02752633|3463353|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3613150|NCT02752490|3463357|B3|United States||Region of Enrollment||Participants|Count of Participants|844|844.0||||||
3613151|NCT02752490|3463358|B2|United States||Region of Enrollment||Participants|Count of Participants|435|435.0||||||
3613152|NCT02752490|3463359|B1|United States||Region of Enrollment||Participants|Count of Participants|409|409.0||||||
3613153|NCT02752490|3463357|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3613154|NCT02752490|3463358|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3613155|NCT02752490|3463359|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3613156|NCT02752490|3463357|B3||Female|Sex: Female, Male||Participants|Count of Participants|844|844.0||||||
3613157|NCT02752490|3463358|B2||Female|Sex: Female, Male||Participants|Count of Participants|435|435.0||||||
3613158|NCT02752490|3463359|B1||Female|Sex: Female, Male||Participants|Count of Participants|409|409.0||||||
3613159|NCT02752490|3463357|B3|||Age||years|Mean|27.7|27.7|Standard Deviation|5.6|5.6|||
3613160|NCT02752490|3463358|B2|||Age||years|Mean|27.7|27.7|Standard Deviation|5.6|5.6|||
3613161|NCT02752490|3463359|B1|||Age||years|Mean|27.7|27.7|Standard Deviation|5.6|5.6|||
3613162|NCT02751450|3463380|B3|||Tactile Sensitivity - Tactile Threshold at Baseline||grams (g)|Mean|10.77|10.77|Standard Deviation|2.285|2.285|||
3613163|NCT02751450|3463381|B2|||Tactile Sensitivity - Tactile Threshold at Baseline||grams (g)|Mean|10.69|10.69|Standard Deviation|2.074|2.074|||
3613164|NCT02751450|3463382|B1|||Tactile Sensitivity - Tactile Threshold at Baseline||grams (g)|Mean|10.85|10.85|Standard Deviation|2.482|2.482|||
3613212|NCT02751424|3463400|B5|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3613213|NCT02751424|3463401|B4|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3613214|NCT02751424|3463402|B3|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3613215|NCT02751424|3463403|B2|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3613165|NCT02751450|3463380|B3|||Schiff Sensitivity Score at Baseline|Participant's response was scored using Schiff Sensitivity Scale of 0 to 3 (0-Participant does not respond to air stimulation, 1-Participant responded to air stimulus but does not request discontinuation of stimulus, 2-Participant responded to air stimulus and requests discontinuation or moves from stimulus, 3-Participant responded to stimulus, considered stimulus to be painful, and requested discontinuation of the stimulus).|Score on a scale|Mean|2.12|2.12|Standard Deviation|0.299|0.299|||
3613166|NCT02751450|3463381|B2|||Schiff Sensitivity Score at Baseline|Participant's response was scored using Schiff Sensitivity Scale of 0 to 3 (0-Participant does not respond to air stimulation, 1-Participant responded to air stimulus but does not request discontinuation of stimulus, 2-Participant responded to air stimulus and requests discontinuation or moves from stimulus, 3-Participant responded to stimulus, considered stimulus to be painful, and requested discontinuation of the stimulus).|Score on a scale|Mean|2.12|2.12|Standard Deviation|0.299|0.299|||
3613167|NCT02751450|3463382|B1|||Schiff Sensitivity Score at Baseline|Participant's response was scored using Schiff Sensitivity Scale of 0 to 3 (0-Participant does not respond to air stimulation, 1-Participant responded to air stimulus but does not request discontinuation of stimulus, 2-Participant responded to air stimulus and requests discontinuation or moves from stimulus, 3-Participant responded to stimulus, considered stimulus to be painful, and requested discontinuation of the stimulus).|Score on a scale|Mean|2.12|2.12|Standard Deviation|0.300|0.3|||
3613168|NCT02751450|3463380|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613169|NCT02751450|3463381|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613170|NCT02751450|3463382|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613171|NCT02751450|3463380|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3613172|NCT02751450|3463381|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3613173|NCT02751450|3463382|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613174|NCT02751450|3463380|B3||White|Race (NIH/OMB)||Participants|Count of Participants|195|195.0||||||
3613175|NCT02751450|3463381|B2||White|Race (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
3613176|NCT02751450|3463382|B1||White|Race (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
3613177|NCT02751450|3463380|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3613178|NCT02751450|3463381|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3613179|NCT02751450|3463382|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3613180|NCT02751450|3463380|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613181|NCT02751450|3463381|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613182|NCT02751450|3463382|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613183|NCT02751450|3463380|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3613184|NCT02751450|3463381|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3613185|NCT02751450|3463382|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3613186|NCT02751450|3463380|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3613187|NCT02751450|3463381|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3613188|NCT02751450|3463382|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613189|NCT02751450|3463380|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613190|NCT02751450|3463381|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613191|NCT02751450|3463382|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613192|NCT02751450|3463380|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|233|233.0||||||
3613193|NCT02751450|3463381|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|116|116.0||||||
3613194|NCT02751450|3463382|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|117|117.0||||||
3613195|NCT02751450|3463380|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613196|NCT02751450|3463381|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613197|NCT02751450|3463382|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613198|NCT02751450|3463380|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3613199|NCT02751450|3463381|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3613200|NCT02751450|3463382|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3613201|NCT02751450|3463380|B3||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3613202|NCT02751450|3463381|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3613203|NCT02751450|3463382|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3613204|NCT02751450|3463380|B3|||Age||Years|Mean|33.5|33.5|Standard Deviation|12.24|12.24|||
3613205|NCT02751450|3463381|B2|||Age||Years|Mean|32.8|32.8|Standard Deviation|11.52|11.52|||
3613206|NCT02751450|3463382|B1|||Age||Years|Mean|34.3|34.3|Standard Deviation|12.92|12.92|||
3613207|NCT02751424|3463395|B10|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3613208|NCT02751424|3463396|B9|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3613209|NCT02751424|3463397|B8|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3613210|NCT02751424|3463398|B7|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3613211|NCT02751424|3463399|B6|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3613216|NCT02751424|3463404|B1|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3613217|NCT02751424|3463395|B10|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3613218|NCT02751424|3463396|B9|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3613219|NCT02751424|3463397|B8|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3613220|NCT02751424|3463398|B7|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3613221|NCT02751424|3463399|B6|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3613222|NCT02751424|3463400|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3613223|NCT02751424|3463401|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3613224|NCT02751424|3463402|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3613225|NCT02751424|3463403|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3613226|NCT02751424|3463404|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3613227|NCT02751424|3463395|B10|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3613228|NCT02751424|3463396|B9|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3613229|NCT02751424|3463397|B8|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3613230|NCT02751424|3463398|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3613231|NCT02751424|3463399|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3613232|NCT02751424|3463400|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3613233|NCT02751424|3463401|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3613234|NCT02751424|3463402|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3613235|NCT02751424|3463403|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3613236|NCT02751424|3463404|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3613237|NCT02751424|3463395|B10|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3613238|NCT02751424|3463396|B9|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3613239|NCT02751424|3463397|B8|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3613240|NCT02751424|3463398|B7|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3613241|NCT02751424|3463399|B6|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3613242|NCT02751424|3463400|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3613243|NCT02751424|3463401|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3613244|NCT02751424|3463402|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3613245|NCT02751424|3463403|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3613246|NCT02751424|3463404|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3613247|NCT02751424|3463395|B10|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3613248|NCT02751424|3463396|B9|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3613249|NCT02751424|3463397|B8|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3613250|NCT02751424|3463398|B7|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3613251|NCT02751424|3463399|B6|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3613252|NCT02751424|3463400|B5|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3613253|NCT02751424|3463401|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3613254|NCT02751424|3463402|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3613255|NCT02751424|3463403|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3613256|NCT02751424|3463404|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3613257|NCT02751424|3463395|B10|White||Race/Ethnicity, Customized||Participants|Count of Participants|52|52.0||||||
3613258|NCT02751424|3463396|B9|White||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3613259|NCT02751424|3463397|B8|White||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3613260|NCT02751424|3463398|B7|White||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3613261|NCT02751424|3463399|B6|White||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3613262|NCT02751424|3463400|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3613263|NCT02751424|3463401|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3613264|NCT02751424|3463402|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3613265|NCT02751424|3463403|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3613266|NCT02751424|3463404|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3613267|NCT02751424|3463395|B10||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3613268|NCT02751424|3463396|B9||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3613269|NCT02751424|3463397|B8||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3613270|NCT02751424|3463398|B7||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3613271|NCT02751424|3463399|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3613272|NCT02751424|3463400|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3613273|NCT02751424|3463401|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3613274|NCT02751424|3463402|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3613275|NCT02751424|3463403|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3613276|NCT02751424|3463404|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3613277|NCT02751424|3463395|B10||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3613278|NCT02751424|3463396|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3613279|NCT02751424|3463397|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3613280|NCT02751424|3463398|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3613281|NCT02751424|3463399|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3613282|NCT02751424|3463400|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3613283|NCT02751424|3463401|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3613284|NCT02751424|3463402|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3613285|NCT02751424|3463403|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3613286|NCT02751424|3463404|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3613287|NCT02751424|3463395|B10|||Age||Years|Mean|26.4|26.4|Standard Deviation|6.08|6.08|||
3613288|NCT02751424|3463396|B9|||Age||Years|Mean|22.3|22.3|Standard Deviation|1.53|1.53|||
3613289|NCT02751424|3463397|B8|||Age||Years|Mean|27.1|27.1|Standard Deviation|3.99|3.99|||
3613290|NCT02751424|3463398|B7|||Age||Years|Mean|28.3|28.3|Standard Deviation|5.68|5.68|||
3613291|NCT02751424|3463399|B6|||Age||Years|Mean|21.0|21.0|Standard Deviation|1.10|1.1|||
3613292|NCT02751424|3463400|B5|||Age||Years|Mean|30.2|30.2|Standard Deviation|7.70|7.7|||
3613293|NCT02751424|3463401|B4|||Age||Years|Mean|25.5|25.5|Standard Deviation|3.78|3.78|||
3613294|NCT02751424|3463402|B3|||Age||Years|Mean|32.2|32.2|Standard Deviation|10.57|10.57|||
3613295|NCT02751424|3463403|B2|||Age||Years|Mean|22.8|22.8|Standard Deviation|2.64|2.64|||
3613296|NCT02751424|3463404|B1|||Age||Years|Mean|23.2|23.2|Standard Deviation|3.54|3.54|||
3613297|NCT02751320|3463555|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613298|NCT02751320|3463555|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3613299|NCT02751320|3463555|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3613300|NCT02751320|3463555|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3613301|NCT02751320|3463555|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613302|NCT02751320|3463555|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613303|NCT02751320|3463555|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613304|NCT02751320|3463555|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3613305|NCT02751320|3463555|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3613306|NCT02751320|3463555|B1|||Age||Years|Mean|64.3|64.3|Standard Deviation|9.69|9.69|||
3613307|NCT02750943|3463591|B3||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3613308|NCT02750943|3463592|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3613309|NCT02750943|3463593|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3613310|NCT02750943|3463591|B3||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3613311|NCT02750943|3463592|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3613312|NCT02750943|3463593|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3613313|NCT02750943|3463591|B3|||Age||Years|Mean|37.86|37.86|Standard Deviation|13.453|13.453|||
3613314|NCT02750943|3463592|B2|||Age||Years|Mean|36.37|36.37|Standard Deviation|13.179|13.179|||
3613315|NCT02750943|3463593|B1|||Age||Years|Mean|39.39|39.39|Standard Deviation|13.610|13.61|||
3613316|NCT02750930|3463608|B1|American Indian or Alaskan native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3613317|NCT02750930|3463608|B1|White||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3613318|NCT02750930|3463608|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3613319|NCT02750930|3463608|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3613320|NCT02750930|3463608|B1|||Age||Participants|Mean|53.1|53.1|Standard Deviation|7.86|7.86|||
3613321|NCT02750813|3463620|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3613322|NCT02750813|3463620|B1||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3613323|NCT02750813|3463620|B1|||Age||years|Mean|30.7|30.7|Standard Deviation|8.44|8.44|||
3613324|NCT02750709|3463630|B1|South Africa||Region of Enrollment||participants|Number|24|24.0||||||
3613325|NCT02750709|3463630|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3613326|NCT02750709|3463630|B1|Coloured||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3613327|NCT02750709|3463630|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3613328|NCT02750709|3463630|B1|Black||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
3613329|NCT02750709|3463630|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3613330|NCT02750709|3463630|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3613331|NCT02750709|3463630|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3613332|NCT02750709|3463630|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3613333|NCT02750709|3463630|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3613334|NCT02750618|3463661|B1|||Serum Alkaline Phosphatase (ALP)||U/L|Mean|548.5|548.5|Standard Deviation|193.80|193.8|||
3613335|NCT02750618|3463661|B1|||Recumbent length/Standing height (percentile)||percentile|Mean|18.044|18.044|Standard Deviation|25.2644|25.2644|||
3613336|NCT02750618|3463661|B1|||Recumbent length/Standing height (Z score)|Recumbent length/Standing height z scores are measures of height adjusted for a child's age and sex. The Z-score indicates the number of standard deviations away from a reference population (from the Centers for Disease Control [CDC] growth charts) in the same age range and with the same sex. A Z-score of 0 is equal to the mean with negative numbers indicating values lower than the mean and positive values higher. Higher Z-scores indicate a better outcome.|Z score|Mean|-1.378|-1.378|Standard Deviation|1.1947|1.1947|||
3613337|NCT02750618|3463661|B1|||Recumbent length/Standing height|Growth is measured by recumbent length for subjects < 2 years of age or those unable or unwilling to stand for the measurement.|cm|Mean|89.15|89.15|Standard Deviation|7.597|7.597|||
3613338|NCT02750618|3463661|B1|||Rickets Severity Score (RSS) Total Score|The RSS system is a 10-point radiographic scoring method that was developed to assess the severity of nutritional rickets in the wrists and knees based on the degree of metaphyseal fraying, cupping, and the proportion of the growth plate affected. Scores are assigned for the unilateral wrist and knee X-rays deemed by the rater to be the more severe of the bilateral images. The maximum total score on the RSS is 10 points and the minimum score is 0, with a total possible score of 4 points for the wrists and 6 points for the knees. Higher scores indicate greater rickets severity.|units on a scale|Mean|2.92|2.92|Standard Deviation|1.367|1.367|||
3613339|NCT02750618|3463661|B1|||Serum Phosphorus||mg/dL|Mean|2.51|2.51|Standard Deviation|0.284|0.284|||
3613340|NCT02750618|3463661|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3613341|NCT02750618|3463661|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3613342|NCT02750618|3463661|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613343|NCT02750618|3463661|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3613344|NCT02750618|3463661|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3613345|NCT02750618|3463661|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3613346|NCT02750618|3463661|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3613347|NCT02750618|3463661|B1|||Age||years|Mean|2.94|2.94|Standard Deviation|1.146|1.146|||
3613348|NCT02750501|3463677|B1||Non-cystic fibrosis related diabetes|Cystic fibrosis related diabetes||Participants|Count of Participants|30|30.0||||||
3613349|NCT02750501|3463677|B1||Cystic fibrosis related diabetes|Cystic fibrosis related diabetes||Participants|Count of Participants|9|9.0||||||
3613350|NCT02750501|3463677|B1|||BMI|BMI formula: weight (kg) / [height (m)]2|weight (kg) / [height (m)]2|Mean|17.7|17.7|Standard Deviation|1.8|1.8|||
3613351|NCT02750501|3463677|B1|||Erythrocyte omega-3 index %||% of omega-3 index of RBC membrane|Mean|4.43|4.43|Standard Deviation|2.05|2.05|||
3613352|NCT02750501|3463677|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613353|NCT02750501|3463677|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613354|NCT02750501|3463677|B1||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3613355|NCT02750501|3463677|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3613356|NCT02750501|3463677|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613357|NCT02750501|3463677|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613358|NCT02750501|3463677|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613359|NCT02750501|3463677|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3613360|NCT02750501|3463677|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3613361|NCT02750501|3463677|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3613362|NCT02750501|3463677|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3613363|NCT02750501|3463677|B1||<=18 years|Age||Participants|Count of Participants|34|34.0||||||
3613364|NCT02750345|3463689|B1|South Africa||Region of Enrollment||participants|Number|24|24.0||||||
3613365|NCT02750345|3463689|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3613366|NCT02750345|3463689|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3613367|NCT02750345|3463689|B1|Black||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
3613368|NCT02750345|3463689|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3613369|NCT02750345|3463689|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3613370|NCT02750345|3463689|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3613371|NCT02750345|3463689|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3613372|NCT02750345|3463689|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3613373|NCT02750332|3463720|B1|South Africa||Region of Enrollment||participants|Number|20|20.0||||||
3613374|NCT02750332|3463720|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3613375|NCT02750332|3463720|B1|Black||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
3613376|NCT02750332|3463720|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3613377|NCT02750332|3463720|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3613378|NCT02750332|3463720|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3613379|NCT02750332|3463720|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3613380|NCT02750332|3463720|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3613381|NCT02750267|3463739|B3|||Diabetes Duration||years|Median|3.7|3.7|Inter-Quartile Range|||2.9|5.7|
3613382|NCT02750267|3463740|B2|||Diabetes Duration||years|Median|3.3|3.3|Inter-Quartile Range|||3.2|5.0|
3613383|NCT02750267|3463741|B1|||Diabetes Duration||years|Median|4.9|4.9|Inter-Quartile Range|||2.2|6.1|
3613384|NCT02750267|3463739|B3|||HbA1c||percentage of HbA1C|Median|7.7|7.7|Inter-Quartile Range|||7.1|7.8|
3613385|NCT02750267|3463740|B2|||HbA1c||percentage of HbA1C|Median|7.6|7.6|Inter-Quartile Range|||7.1|7.8|
3613386|NCT02750267|3463741|B1|||HbA1c||percentage of HbA1C|Median|7.7|7.7|Inter-Quartile Range|||7.2|7.8|
3613387|NCT02750267|3463739|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3613388|NCT02750267|3463740|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3613389|NCT02750267|3463741|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3613390|NCT02750267|3463739|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3613391|NCT02750267|3463740|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3613392|NCT02750267|3463741|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3613393|NCT02750267|3463739|B3|||Age||years|Median|7|7.0|Inter-Quartile Range|||6.75|7.25|
3613394|NCT02750267|3463740|B2|||Age||years|Median|7|7.0|Inter-Quartile Range|||7.0|7.0|
3613395|NCT02750267|3463741|B1|||Age||years|Median|7|7.0|Inter-Quartile Range|||6.25|7.75|
3613396|NCT02749370|3463780|B1||Very satisfied|Patient Assessment of Treatment Satisfaction|Participants indicated their level of satisfaction with the medication’s control of psoriasis on a scale from “very dissatisfied” to “very satisfied”.|Participants|Count of Participants|0|0.0||||||
3613397|NCT02749370|3463780|B1||Satisfied|Patient Assessment of Treatment Satisfaction|Participants indicated their level of satisfaction with the medication’s control of psoriasis on a scale from “very dissatisfied” to “very satisfied”.|Participants|Count of Participants|4|4.0||||||
3613398|NCT02749370|3463780|B1||Neither satisfied nor dissatisfied|Patient Assessment of Treatment Satisfaction|Participants indicated their level of satisfaction with the medication’s control of psoriasis on a scale from “very dissatisfied” to “very satisfied”.|Participants|Count of Participants|30|30.0||||||
3613399|NCT02749370|3463780|B1||Dissatisfied|Patient Assessment of Treatment Satisfaction|Participants indicated their level of satisfaction with the medication’s control of psoriasis on a scale from “very dissatisfied” to “very satisfied”.|Participants|Count of Participants|13|13.0||||||
3613400|NCT02749370|3463780|B1||Very dissatisfied|Patient Assessment of Treatment Satisfaction|Participants indicated their level of satisfaction with the medication’s control of psoriasis on a scale from “very dissatisfied” to “very satisfied”.|Participants|Count of Participants|33|33.0||||||
3613401|NCT02749370|3463780|B1|Pain from skin lesions||Psoriasis Symptom Inventory (PSI)|Participants rated the severity of their psoriasis signs and symptoms on an 8-item questionnaire (itch, redness, scaling, burning, stinging, cracking, flaking, pain) based on the past 7 days. Each item was scored on a 5-point scale from 0 (not at all severe) to 4 (very severe). The total score was calculated as the sum of the 8 responses, and ranges from 0 to 32. Each component score ranges from 0 to 4. Higher total score and component scores indicate more severe psoriasis.|units on a scale|Mean|1.5|1.5|Standard Deviation|1.1|1.1|||
3613402|NCT02749370|3463780|B1|Flaking of skin lesions||Psoriasis Symptom Inventory (PSI)|Participants rated the severity of their psoriasis signs and symptoms on an 8-item questionnaire (itch, redness, scaling, burning, stinging, cracking, flaking, pain) based on the past 7 days. Each item was scored on a 5-point scale from 0 (not at all severe) to 4 (very severe). The total score was calculated as the sum of the 8 responses, and ranges from 0 to 32. Each component score ranges from 0 to 4. Higher total score and component scores indicate more severe psoriasis.|units on a scale|Mean|2.5|2.5|Standard Deviation|1.9|1.9|||
3613403|NCT02749370|3463780|B1|Cracking of skin lesions||Psoriasis Symptom Inventory (PSI)|Participants rated the severity of their psoriasis signs and symptoms on an 8-item questionnaire (itch, redness, scaling, burning, stinging, cracking, flaking, pain) based on the past 7 days. Each item was scored on a 5-point scale from 0 (not at all severe) to 4 (very severe). The total score was calculated as the sum of the 8 responses, and ranges from 0 to 32. Each component score ranges from 0 to 4. Higher total score and component scores indicate more severe psoriasis.|units on a scale|Mean|2.0|2.0|Standard Deviation|1.0|1.0|||
3613404|NCT02749370|3463780|B1|Stinging of skin lesions||Psoriasis Symptom Inventory (PSI)|Participants rated the severity of their psoriasis signs and symptoms on an 8-item questionnaire (itch, redness, scaling, burning, stinging, cracking, flaking, pain) based on the past 7 days. Each item was scored on a 5-point scale from 0 (not at all severe) to 4 (very severe). The total score was calculated as the sum of the 8 responses, and ranges from 0 to 32. Each component score ranges from 0 to 4. Higher total score and component scores indicate more severe psoriasis.|units on a scale|Mean|1.5|1.5|Standard Deviation|1.2|1.2|||
3613405|NCT02749370|3463780|B1|Burning of skin lesions||Psoriasis Symptom Inventory (PSI)|Participants rated the severity of their psoriasis signs and symptoms on an 8-item questionnaire (itch, redness, scaling, burning, stinging, cracking, flaking, pain) based on the past 7 days. Each item was scored on a 5-point scale from 0 (not at all severe) to 4 (very severe). The total score was calculated as the sum of the 8 responses, and ranges from 0 to 32. Each component score ranges from 0 to 4. Higher total score and component scores indicate more severe psoriasis.|units on a scale|Mean|1.4|1.4|Standard Deviation|1.2|1.2|||
3613406|NCT02749370|3463780|B1|Scaling of skin lesions||Psoriasis Symptom Inventory (PSI)|Participants rated the severity of their psoriasis signs and symptoms on an 8-item questionnaire (itch, redness, scaling, burning, stinging, cracking, flaking, pain) based on the past 7 days. Each item was scored on a 5-point scale from 0 (not at all severe) to 4 (very severe). The total score was calculated as the sum of the 8 responses, and ranges from 0 to 32. Each component score ranges from 0 to 4. Higher total score and component scores indicate more severe psoriasis.|units on a scale|Mean|2.6|2.6|Standard Deviation|0.8|0.8|||
3613434|NCT02748889|3463808|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3613407|NCT02749370|3463780|B1|Redness of skin lesions||Psoriasis Symptom Inventory (PSI)|Participants rated the severity of their psoriasis signs and symptoms on an 8-item questionnaire (itch, redness, scaling, burning, stinging, cracking, flaking, pain) based on the past 7 days. Each item was scored on a 5-point scale from 0 (not at all severe) to 4 (very severe). The total score was calculated as the sum of the 8 responses, and ranges from 0 to 32. Each component score ranges from 0 to 4. Higher total score and component scores indicate more severe psoriasis.|units on a scale|Mean|2.6|2.6|Standard Deviation|0.9|0.9|||
3613408|NCT02749370|3463780|B1|Itch from psoriasis||Psoriasis Symptom Inventory (PSI)|Participants rated the severity of their psoriasis signs and symptoms on an 8-item questionnaire (itch, redness, scaling, burning, stinging, cracking, flaking, pain) based on the past 7 days. Each item was scored on a 5-point scale from 0 (not at all severe) to 4 (very severe). The total score was calculated as the sum of the 8 responses, and ranges from 0 to 32. Each component score ranges from 0 to 4. Higher total score and component scores indicate more severe psoriasis.|units on a scale|Mean|2.5|2.5|Standard Deviation|1.0|1.0|||
3613409|NCT02749370|3463780|B1|Total score||Psoriasis Symptom Inventory (PSI)|Participants rated the severity of their psoriasis signs and symptoms on an 8-item questionnaire (itch, redness, scaling, burning, stinging, cracking, flaking, pain) based on the past 7 days. Each item was scored on a 5-point scale from 0 (not at all severe) to 4 (very severe). The total score was calculated as the sum of the 8 responses, and ranges from 0 to 32. Each component score ranges from 0 to 4. Higher total score and component scores indicate more severe psoriasis.|units on a scale|Mean|16.6|16.6|Standard Deviation|6.6|6.6|||
3613410|NCT02749370|3463780|B1|||Dermatology Life Quality Index (DLQI)|The DLQI is a 10-item skin disease-specific instrument to evaluate impact of skin disease on health-related quality of life. Items rated on a 4-point Likert scale were summed to create a DLQI total score ranging from 0 (best possible score) to 30 (worst possible score). Total scores of the DLQI are interpreted as 0 to 1 = no effect at all on patient’s life, 2 to 5 = small effect on patient’s life, 6 to 10 = moderate effect on patient’s life, 11 to 20 = very large effect on patient¡'s life, 21 to 30 = extremely large effect on patient¡'s life.|units on a scale|Mean|12.5|12.5|Standard Deviation|7.4|7.4|||
3613411|NCT02749370|3463780|B1||5 = Very Severe|Static Physician Global Assessment (sPGA) of Psoriasis|A physician’s global assessment of the participant's psoriasis based on the severity of induration, scaling, and erythema. The sPGA of psoriasis is a 6-point scale ranging from 0 (clear) to 5 (very severe).|Participants|Count of Participants|1|1.0||||||
3613412|NCT02749370|3463780|B1||4 = Severe|Static Physician Global Assessment (sPGA) of Psoriasis|A physician’s global assessment of the participant's psoriasis based on the severity of induration, scaling, and erythema. The sPGA of psoriasis is a 6-point scale ranging from 0 (clear) to 5 (very severe).|Participants|Count of Participants|28|28.0||||||
3613413|NCT02749370|3463780|B1||3 = Moderate|Static Physician Global Assessment (sPGA) of Psoriasis|A physician’s global assessment of the participant's psoriasis based on the severity of induration, scaling, and erythema. The sPGA of psoriasis is a 6-point scale ranging from 0 (clear) to 5 (very severe).|Participants|Count of Participants|51|51.0||||||
3613414|NCT02749370|3463780|B1||2 = Mild|Static Physician Global Assessment (sPGA) of Psoriasis|A physician’s global assessment of the participant's psoriasis based on the severity of induration, scaling, and erythema. The sPGA of psoriasis is a 6-point scale ranging from 0 (clear) to 5 (very severe).|Participants|Count of Participants|0|0.0||||||
3613415|NCT02749370|3463780|B1||1 = Almost clear|Static Physician Global Assessment (sPGA) of Psoriasis|A physician’s global assessment of the participant's psoriasis based on the severity of induration, scaling, and erythema. The sPGA of psoriasis is a 6-point scale ranging from 0 (clear) to 5 (very severe).|Participants|Count of Participants|0|0.0||||||
3613416|NCT02749370|3463780|B1||0 = Clear|Static Physician Global Assessment (sPGA) of Psoriasis|A physician’s global assessment of the participant's psoriasis based on the severity of induration, scaling, and erythema. The sPGA of psoriasis is a 6-point scale ranging from 0 (clear) to 5 (very severe).|Participants|Count of Participants|0|0.0||||||
3613417|NCT02749370|3463780|B1|||Percent of Body Surface Area (BSA) Involved in Psoriasis|A measurement of psoriasis involvement, given as the physician’s assessment of the percentage of the participant’s total body surface area involved with psoriasis.|Percentage of BSA|Mean|16.4|16.4|Standard Deviation|10.5|10.5|||
3613418|NCT02749370|3463780|B1|||Psoriasis Area Severity Index (PASI) Score|The PASI measures the average redness (erythema), thickness (induration), and scaliness (each graded on a 0 to 4 scale) of psoriasis lesions, weighted by the area of involvement in the four main body areas (i.e., head and neck, trunk, upper extremities, and lower extremities). PASI scores can range from 0 to 72, with higher scores indicating greater severity and/or more extensive psoriasis.|units on a scale|Mean|16.4|16.4|Standard Deviation|6.5|6.5|||
3613419|NCT02749370|3463780|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3613420|NCT02749370|3463780|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|60|60.0||||||
3613421|NCT02749370|3463780|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3613422|NCT02749370|3463780|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3613423|NCT02749370|3463780|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3613424|NCT02749370|3463780|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3613425|NCT02749370|3463780|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613426|NCT02749370|3463780|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3613427|NCT02749370|3463780|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3613428|NCT02749370|3463780|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3613429|NCT02749370|3463780|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3613430|NCT02749370|3463780|B1||≥ 65 years|Age, Customized||Participants|Count of Participants|17|17.0||||||
3613431|NCT02749370|3463780|B1||< 65 years|Age, Customized||Participants|Count of Participants|63|63.0||||||
3613432|NCT02749370|3463780|B1|||Age||years|Mean|50.4|50.4|Standard Deviation|14.8|14.8|||
3613433|NCT02748889|3463807|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3613435|NCT02748889|3463807|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613436|NCT02748889|3463808|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613437|NCT02748889|3463807|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613438|NCT02748889|3463808|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613439|NCT02748889|3463807|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613440|NCT02748889|3463808|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613441|NCT02748889|3463807|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3613442|NCT02748889|3463808|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3613443|NCT02748889|3463807|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613444|NCT02748889|3463808|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613445|NCT02748889|3463807|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613446|NCT02748889|3463808|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613447|NCT02748889|3463807|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613448|NCT02748889|3463808|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613449|NCT02748889|3463807|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3613450|NCT02748889|3463808|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3613451|NCT02748889|3463807|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3613452|NCT02748889|3463808|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3613453|NCT02748889|3463807|B3|||Age||years|Mean|58|58.0|Standard Deviation|0|0.0|||
3613454|NCT02748889|3463808|B2|||Age||years|Mean|58|58.0|Standard Deviation|0|0.0|||
3613455|NCT02748889|3463807|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3613456|NCT02748889|3463808|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3613457|NCT02748889|3463807|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3613458|NCT02748889|3463808|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3613459|NCT02748889|3463807|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3613460|NCT02748889|3463808|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3613461|NCT02748785|3463814|B5|||Disease Activity Score (DAS)-28|"The Disease Activity Score (DAS) is a combined index to measure the disease activity in patients with Rheumatoid Arthritis (RA).~The DAS will provide a number between 0 and 10, indicating how active the rheumatoid arthritis is at this moment, whereas a higher values represent a worse disease activity.~0.. minimum score 10..maximum score"|units on a scale (0-10)|Mean|2.6|2.6|Standard Deviation|1.1|1.1|||
3613462|NCT02748785|3463815|B4|||Disease Activity Score (DAS)-28|"The Disease Activity Score (DAS) is a combined index to measure the disease activity in patients with Rheumatoid Arthritis (RA).~The DAS will provide a number between 0 and 10, indicating how active the rheumatoid arthritis is at this moment, whereas a higher values represent a worse disease activity.~0.. minimum score 10..maximum score"|units on a scale (0-10)|Mean|2.6|2.6|Standard Deviation|1.0|1.0|||
3613463|NCT02748785|3463816|B3|||Disease Activity Score (DAS)-28|"The Disease Activity Score (DAS) is a combined index to measure the disease activity in patients with Rheumatoid Arthritis (RA).~The DAS will provide a number between 0 and 10, indicating how active the rheumatoid arthritis is at this moment, whereas a higher values represent a worse disease activity.~0.. minimum score 10..maximum score"|units on a scale (0-10)|Mean|2.6|2.6|Standard Deviation|1.0|1.0|||
3613464|NCT02748785|3463817|B2|||Disease Activity Score (DAS)-28|"The Disease Activity Score (DAS) is a combined index to measure the disease activity in patients with Rheumatoid Arthritis (RA).~The DAS will provide a number between 0 and 10, indicating how active the rheumatoid arthritis is at this moment, whereas a higher values represent a worse disease activity.~0.. minimum score 10..maximum score"|units on a scale (0-10)|Mean|2.8|2.8|Standard Deviation|1.2|1.2|||
3613465|NCT02748785|3463818|B1|||Disease Activity Score (DAS)-28|"The Disease Activity Score (DAS) is a combined index to measure the disease activity in patients with Rheumatoid Arthritis (RA).~The DAS will provide a number between 0 and 10, indicating how active the rheumatoid arthritis is at this moment, whereas a higher values represent a worse disease activity.~0.. minimum score 10..maximum score"|units on a scale (0-10)|Mean|2.5|2.5|Standard Deviation|1.1|1.1|||
3613466|NCT02748785|3463814|B5|||Disease duration||years|Mean|6.2|6.2|Standard Deviation|5.5|5.5|||
3613467|NCT02748785|3463815|B4|||Disease duration||years|Mean|6.2|6.2|Standard Deviation|5.5|5.5|||
3613468|NCT02748785|3463816|B3|||Disease duration||years|Mean|4.9|4.9|Standard Deviation|4.4|4.4|||
3613469|NCT02748785|3463817|B2|||Disease duration||years|Mean|6.1|6.1|Standard Deviation|4.9|4.9|||
3613470|NCT02748785|3463818|B1|||Disease duration||years|Mean|5.2|5.2|Standard Deviation|4.5|4.5|||
3613471|NCT02748785|3463814|B5||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3613472|NCT02748785|3463815|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3613473|NCT02748785|3463816|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3613474|NCT02748785|3463817|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3613475|NCT02748785|3463818|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3613476|NCT02748785|3463814|B5||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3613477|NCT02748785|3463815|B4||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3613478|NCT02748785|3463816|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3613479|NCT02748785|3463817|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3613480|NCT02748785|3463818|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3613481|NCT02748785|3463814|B5|||Age||years|Mean|58.5|58.5|Standard Deviation|11.7|11.7|||
3613482|NCT02748785|3463815|B4|||Age||years|Mean|58.1|58.1|Standard Deviation|11.7|11.7|||
3613483|NCT02748785|3463816|B3|||Age||years|Mean|58.1|58.1|Standard Deviation|10.9|10.9|||
3613484|NCT02748785|3463817|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|113.3|113.3|||
3613485|NCT02748785|3463818|B1|||Age||years|Mean|59.1|59.1|Standard Deviation|13.1|13.1|||
3613486|NCT02748213|3463867|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3613487|NCT02748213|3463868|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3613488|NCT02748213|3463869|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3613489|NCT02748213|3463867|B3||Female|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
3613490|NCT02748213|3463868|B2||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3613491|NCT02748213|3463869|B1||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3613492|NCT02748213|3463867|B3|||Age||years|Mean|52.1|52.1|Standard Deviation|10.95|10.95|||
3613493|NCT02748213|3463868|B2|||Age||years|Mean|51.6|51.6|Standard Deviation|10.74|10.74|||
3613494|NCT02748213|3463869|B1|||Age||years|Mean|52.7|52.7|Standard Deviation|11.18|11.18|||
3613495|NCT02748057|3463886|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613496|NCT02748057|3463887|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613497|NCT02748057|3463888|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613498|NCT02748057|3463886|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|135|135.0||||||
3613499|NCT02748057|3463887|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3613500|NCT02748057|3463888|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|114|114.0||||||
3613501|NCT02748057|3463886|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613502|NCT02748057|3463887|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613503|NCT02748057|3463888|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613504|NCT02748057|3463886|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3613505|NCT02748057|3463887|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3613506|NCT02748057|3463888|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3613507|NCT02748057|3463886|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3613508|NCT02748057|3463887|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3613509|NCT02748057|3463888|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3613510|NCT02748057|3463886|B3|||Age||Years|Mean|57.3|57.3|Standard Deviation|11.4|11.4|||
3613511|NCT02748057|3463887|B2|||Age||Years|Mean|52.4|52.4|Standard Deviation|13.3|13.3|||
3613512|NCT02748057|3463888|B1|||Age||Years|Mean|58.2|58.2|Standard Deviation|10.8|10.8|||
3613513|NCT02747186|3463899|B1|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3613514|NCT02747186|3463899|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613515|NCT02747186|3463899|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3613516|NCT02747186|3463899|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613517|NCT02747186|3463899|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3613518|NCT02747186|3463899|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3613519|NCT02747186|3463899|B1|||Age||Years|Median|24|24.0|Inter-Quartile Range|||21.0|26.0|
3613520|NCT02747186|3463899|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3613521|NCT02747186|3463899|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3613522|NCT02747186|3463899|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3613523|NCT02746809|3463908|B1|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3613524|NCT02746809|3463908|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3613525|NCT02746809|3463908|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3613526|NCT02746809|3463908|B1|||Age||years|Mean|81.8|81.8|Standard Deviation|8.2|8.2|||
3613527|NCT02746679|3463926|B3|> ¥ 5000||Salary per month||participants|Number|120|120.0||||||
3613528|NCT02746679|3463927|B2|> ¥ 5000||Salary per month||participants|Number|60|60.0||||||
3613529|NCT02746679|3463928|B1|> ¥ 5000||Salary per month||participants|Number|60|60.0||||||
3613530|NCT02746679|3463926|B3|< ¥ 5000||Salary per month||participants|Number|31|31.0||||||
3613531|NCT02746679|3463927|B2|< ¥ 5000||Salary per month||participants|Number|15|15.0||||||
3613532|NCT02746679|3463928|B1|< ¥ 5000||Salary per month||participants|Number|16|16.0||||||
3613533|NCT02746679|3463926|B3|Married||Marriage||participants|Number|132|132.0||||||
3613534|NCT02746679|3463927|B2|Married||Marriage||participants|Number|68|68.0||||||
3613535|NCT02746679|3463928|B1|Married||Marriage||participants|Number|64|64.0||||||
3613536|NCT02746679|3463926|B3|Single||Marriage||participants|Number|19|19.0||||||
3613537|NCT02746679|3463927|B2|Single||Marriage||participants|Number|7|7.0||||||
3613538|NCT02746679|3463928|B1|Single||Marriage||participants|Number|12|12.0||||||
3613539|NCT02746679|3463926|B3|< 9 years||Education||participants|Number|13|13.0||||||
3613540|NCT02746679|3463927|B2|< 9 years||Education||participants|Number|8|8.0||||||
3613541|NCT02746679|3463928|B1|< 9 years||Education||participants|Number|5|5.0||||||
3613542|NCT02746679|3463926|B3|≥9 years||Education||participants|Number|138|138.0||||||
3613543|NCT02746679|3463927|B2|≥9 years||Education||participants|Number|67|67.0||||||
3613544|NCT02746679|3463928|B1|≥9 years||Education||participants|Number|71|71.0||||||
3613545|NCT02746679|3463926|B3|female||Sex/Gender, Customized||participants|Number|151|151.0||||||
3613546|NCT02746679|3463927|B2|female||Sex/Gender, Customized||participants|Number|75|75.0||||||
3613547|NCT02746679|3463928|B1|female||Sex/Gender, Customized||participants|Number|76|76.0||||||
3613548|NCT02746679|3463926|B3|||Age||years|Mean|30.9|30.9|Standard Deviation|6.0|6.0|||
3613549|NCT02746679|3463927|B2|||Age||years|Mean|31.1|31.1|Standard Deviation|6.5|6.5|||
3613550|NCT02746679|3463928|B1|||Age||years|Mean|30.7|30.7|Standard Deviation|5.5|5.5|||
3613551|NCT02746406|3463959|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3613552|NCT02746406|3463959|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
3613553|NCT02746406|3463959|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
3613554|NCT02746406|3463959|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3613555|NCT02746406|3463959|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3613556|NCT02746406|3463959|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3613557|NCT02746107|3463963|B1|Romania||Region of Enrollment||participants|Number|968|968.0||||||
3613558|NCT02746107|3463963|B1||Male|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
3613559|NCT02746107|3463963|B1||Female|Sex: Female, Male||Participants|Count of Participants|704|704.0||||||
3613560|NCT02746107|3463963|B1|||Age||years|Median|39|39.0|Full Range|||25.0|83.0|
3613561|NCT02745626|3463978|B4|United States||Region of Enrollment||participants|Number|56|56.0||||||
3613562|NCT02745626|3463979|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
3613563|NCT02745626|3463980|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3613564|NCT02745626|3463981|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3613565|NCT02745626|3463978|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3613566|NCT02745626|3463979|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3613567|NCT02745626|3463980|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3613568|NCT02745626|3463981|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3613569|NCT02745626|3463978|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3613570|NCT02745626|3463979|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3613571|NCT02745626|3463980|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3613572|NCT02745626|3463981|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3613573|NCT02745626|3463978|B4|||Age||years|Mean|15.6|15.6|Standard Deviation|4.2|4.2|||
3613574|NCT02745626|3463979|B3|||Age||years|Mean|14.5|14.5|Standard Deviation|4|4.0|||
3613575|NCT02745626|3463980|B2|||Age||years|Mean|14.8|14.8|Standard Deviation|4.3|4.3|||
3613576|NCT02745626|3463981|B1|||Age||years|Mean|16.9|16.9|Standard Deviation|4.3|4.3|||
3613577|NCT02745392|3464009|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3613578|NCT02745392|3464010|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3613579|NCT02745392|3464011|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613580|NCT02745392|3464012|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613581|NCT02745392|3464013|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613582|NCT02745392|3464009|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3613583|NCT02745392|3464010|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3613584|NCT02745392|3464011|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3613585|NCT02745392|3464012|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3613586|NCT02745392|3464013|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3613587|NCT02745392|3464009|B5||White|Race (NIH/OMB)||Participants|Count of Participants|238|238.0||||||
3613588|NCT02745392|3464010|B4||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3613589|NCT02745392|3464011|B3||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3613590|NCT02745392|3464012|B2||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3613591|NCT02745392|3464013|B1||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3613592|NCT02745392|3464009|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3613593|NCT02745392|3464010|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3613594|NCT02745392|3464011|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3613595|NCT02745392|3464012|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3613596|NCT02745392|3464013|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3613597|NCT02745392|3464009|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3613598|NCT02745392|3464010|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3613599|NCT02745392|3464011|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3613600|NCT02745392|3464012|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613601|NCT02745392|3464013|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613602|NCT02745392|3464009|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3613603|NCT02745392|3464010|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3613604|NCT02745392|3464011|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3613605|NCT02745392|3464012|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3613606|NCT02745392|3464013|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3613607|NCT02745392|3464009|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3613608|NCT02745392|3464010|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613609|NCT02745392|3464011|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3613610|NCT02745392|3464012|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3613611|NCT02745392|3464013|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613612|NCT02745392|3464009|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613613|NCT02745392|3464010|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613614|NCT02745392|3464011|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613615|NCT02745392|3464012|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613616|NCT02745392|3464013|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613617|NCT02745392|3464009|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|268|268.0||||||
3613618|NCT02745392|3464010|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3613619|NCT02745392|3464011|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3613620|NCT02745392|3464012|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3613621|NCT02745392|3464013|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3613622|NCT02745392|3464009|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3613623|NCT02745392|3464010|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3613624|NCT02745392|3464011|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3613625|NCT02745392|3464012|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3613626|NCT02745392|3464013|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3613627|NCT02745392|3464009|B5||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3613628|NCT02745392|3464010|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3613629|NCT02745392|3464011|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3613630|NCT02745392|3464012|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3613631|NCT02745392|3464013|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3613632|NCT02745392|3464009|B5||Female|Sex: Female, Male||Participants|Count of Participants|280|280.0||||||
3613633|NCT02745392|3464010|B4||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3613634|NCT02745392|3464011|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3613635|NCT02745392|3464012|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3613636|NCT02745392|3464013|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3613637|NCT02745392|3464009|B5|||Age||years|Mean|41.3|41.3|Standard Deviation|11.34|11.34|||
3613638|NCT02745392|3464010|B4|||Age||years|Mean|41.0|41.0|Standard Deviation|11.39|11.39|||
3613639|NCT02745392|3464011|B3|||Age||years|Mean|40.1|40.1|Standard Deviation|10.92|10.92|||
3613640|NCT02745392|3464012|B2|||Age||years|Mean|41.7|41.7|Standard Deviation|11.58|11.58|||
3613641|NCT02745392|3464013|B1|||Age||years|Mean|42.7|42.7|Standard Deviation|11.53|11.53|||
3613642|NCT02744755|3464030|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3613643|NCT02744755|3464031|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3613644|NCT02744755|3464032|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3613645|NCT02744755|3464030|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3613646|NCT02744755|3464031|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3613647|NCT02744755|3464032|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3613648|NCT02744755|3464030|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3613649|NCT02744755|3464031|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3613650|NCT02744755|3464032|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3613651|NCT02744755|3464030|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3613652|NCT02744755|3464031|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3613653|NCT02744755|3464032|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3613654|NCT02744755|3464030|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|304|304.0||||||
3613655|NCT02744755|3464031|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|152|152.0||||||
3613656|NCT02744755|3464032|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|152|152.0||||||
3613657|NCT02744755|3464030|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3613658|NCT02744755|3464031|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3613659|NCT02744755|3464032|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3613660|NCT02744755|3464030|B3||Female|Sex: Female, Male||Participants|Count of Participants|295|295.0||||||
3613661|NCT02744755|3464031|B2||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3613662|NCT02744755|3464032|B1||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3613663|NCT02744755|3464030|B3|||Age||years|Mean|53.3|53.3|Standard Deviation|12.51|12.51|||
3613664|NCT02744755|3464031|B2|||Age||years|Mean|53.8|53.8|Standard Deviation|12.22|12.22|||
3613665|NCT02744755|3464032|B1|||Age||years|Mean|52.8|52.8|Standard Deviation|12.81|12.81|||
3613666|NCT02744066|3464087|B3|||Head Circumference|Occipital-Frontal Head Circumference at birth|centimeters|Mean|31.8|31.8|Standard Deviation|3.4|3.4|||
3613667|NCT02744066|3464088|B2|||Head Circumference|Occipital-Frontal Head Circumference at birth|centimeters|Mean|31.4|31.4|Standard Deviation|3.66|3.66|||
3613668|NCT02744066|3464089|B1|||Head Circumference|Occipital-Frontal Head Circumference at birth|centimeters|Mean|32.3|32.3|Standard Deviation|3.03|3.03|||
3613669|NCT02744066|3464087|B3|||Birth Weight|Birth Weight in kilograms|kilograms|Mean|2.5|2.5|Standard Deviation|0.9|0.9|||
3613670|NCT02744066|3464088|B2|||Birth Weight|Birth Weight in kilograms|kilograms|Mean|2.3|2.3|Standard Deviation|0.94|0.94|||
3613671|NCT02744066|3464089|B1|||Birth Weight|Birth Weight in kilograms|kilograms|Mean|2.6|2.6|Standard Deviation|0.84|0.84|||
3613672|NCT02744066|3464087|B3|||Gestational Age at Birth|Mean gestational age at birth in weeks|Weeks|Mean|35.7|35.7|Standard Deviation|3.7|3.7|||
3613673|NCT02744066|3464088|B2|||Gestational Age at Birth|Mean gestational age at birth in weeks|Weeks|Mean|34.8|34.8|Standard Deviation|3.87|3.87|||
3613674|NCT02744066|3464089|B1|||Gestational Age at Birth|Mean gestational age at birth in weeks|Weeks|Mean|36.6|36.6|Standard Deviation|3.29|3.29|||
3613675|NCT02744066|3464087|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3613676|NCT02744066|3464087|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3613677|NCT02744066|3464088|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3613678|NCT02744066|3464089|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3613679|NCT02744066|3464087|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3613680|NCT02744066|3464088|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3613681|NCT02744066|3464089|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3613682|NCT02744066|3464087|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3613683|NCT02744066|3464088|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3613684|NCT02744066|3464089|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3613685|NCT02744066|3464087|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3613686|NCT02744066|3464088|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3613687|NCT02744066|3464089|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3613688|NCT02744066|3464087|B3||<=18 years|Age||Participants|Count of Participants|50|50.0||||||
3613689|NCT02744066|3464088|B2||<=18 years|Age||Participants|Count of Participants|25|25.0||||||
3613690|NCT02744066|3464089|B1||<=18 years|Age||Participants|Count of Participants|25|25.0||||||
3613691|NCT02743962|3464098|B3|||Duration of BPS symptoms||Years|Mean|4.8|4.8|Standard Deviation|3.8|3.8|||
3613692|NCT02743962|3464099|B2|||Duration of BPS symptoms||Years|Mean|5.2|5.2|Standard Deviation|4.02|4.02|||
3613693|NCT02743962|3464100|B1|||Duration of BPS symptoms||Years|Mean|4.25|4.25|Standard Deviation|4.03|4.03|||
3613694|NCT02743962|3464098|B3|||Visual Analogue Scale of pain experienced on palpation of the pelvic floor muscles|This is a standard printed visual analogue scale with scores from 0 to 10. Higher scores denote higher pain on palpation of the pelvic floor muscles when tested.|units on a scale|Mean|7.6|7.6|Standard Deviation|1.1|1.1|||
3613695|NCT02743962|3464099|B2|||Visual Analogue Scale of pain experienced on palpation of the pelvic floor muscles|This is a standard printed visual analogue scale with scores from 0 to 10. Higher scores denote higher pain on palpation of the pelvic floor muscles when tested.|units on a scale|Mean|8|8.0|Standard Deviation|0.7|0.7|||
3613696|NCT02743962|3464100|B1|||Visual Analogue Scale of pain experienced on palpation of the pelvic floor muscles|This is a standard printed visual analogue scale with scores from 0 to 10. Higher scores denote higher pain on palpation of the pelvic floor muscles when tested.|units on a scale|Mean|7.25|7.25|Standard Deviation|1.5|1.5|||
3613697|NCT02743962|3464098|B3|||The Pelvic Pain and Urinary Frequency Patient Symptom Score|"This outcome measure has 11 questions and total scores range from 0 to 31. A higher score describes both worse symptoms and a greater burden on the individual.~Although a subscale exists, total scores were collected for analysis due to the small sample size of this small feasibility study."|units on a scale|Mean|15.2|15.2|Standard Deviation|2.7|2.7|||
3613698|NCT02743962|3464099|B2|||The Pelvic Pain and Urinary Frequency Patient Symptom Score|"This outcome measure has 11 questions and total scores range from 0 to 31. A higher score describes both worse symptoms and a greater burden on the individual.~Although a subscale exists, total scores were collected for analysis due to the small sample size of this small feasibility study."|units on a scale|Mean|16.2|16.2|Standard Deviation|1.6|1.6|||
3613699|NCT02743962|3464100|B1|||The Pelvic Pain and Urinary Frequency Patient Symptom Score|"This outcome measure has 11 questions and total scores range from 0 to 31. A higher score describes both worse symptoms and a greater burden on the individual.~Although a subscale exists, total scores were collected for analysis due to the small sample size of this small feasibility study."|units on a scale|Mean|14|14.0|Standard Deviation|3.6|3.6|||
3613700|NCT02743962|3464098|B3|||Genito-Urinary Pain Index|This outcome measure has 9 questions and the total achievable in this outcome measure is a score of between 0 to 45. A higher score describes worse genitourinary pain symptoms and a greater impact upon quality of life. Although subscales exist, total scores were used for analysis due to the small sample number of this small feasibility trial.|units on a scale|Mean|29.2|29.2|Standard Deviation|5.9|5.9|||
3613701|NCT02743962|3464099|B2|||Genito-Urinary Pain Index|This outcome measure has 9 questions and the total achievable in this outcome measure is a score of between 0 to 45. A higher score describes worse genitourinary pain symptoms and a greater impact upon quality of life. Although subscales exist, total scores were used for analysis due to the small sample number of this small feasibility trial.|units on a scale|Mean|31|31.0|Standard Deviation|4.9|4.9|||
3613702|NCT02743962|3464100|B1|||Genito-Urinary Pain Index|This outcome measure has 9 questions and the total achievable in this outcome measure is a score of between 0 to 45. A higher score describes worse genitourinary pain symptoms and a greater impact upon quality of life. Although subscales exist, total scores were used for analysis due to the small sample number of this small feasibility trial.|units on a scale|Mean|27|27.0|Standard Deviation|7.1|7.1|||
3613703|NCT02743962|3464098|B3|||O'Leary-Sant Interstitial Cystitis Problem Score|"This outcome measure has 4 questions and scores for each question range from 0 to 4. The total achievable in this outcome measure is a score of between 0 to 16. A higher score describes greater burden of Interstitial Cystitis symptoms on the individual.~Total scores were collected for analysis."|units on a scale|Mean|10.6|10.6|Standard Deviation|3.12|3.12|||
3613704|NCT02743962|3464099|B2|||O'Leary-Sant Interstitial Cystitis Problem Score|"This outcome measure has 4 questions and scores for each question range from 0 to 4. The total achievable in this outcome measure is a score of between 0 to 16. A higher score describes greater burden of Interstitial Cystitis symptoms on the individual.~Total scores were collected for analysis."|units on a scale|Mean|11.2|11.2|Standard Deviation|2.7|2.7|||
3613705|NCT02743962|3464100|B1|||O'Leary-Sant Interstitial Cystitis Problem Score|"This outcome measure has 4 questions and scores for each question range from 0 to 4. The total achievable in this outcome measure is a score of between 0 to 16. A higher score describes greater burden of Interstitial Cystitis symptoms on the individual.~Total scores were collected for analysis."|units on a scale|Mean|10|10.0|Standard Deviation|3.9|3.9|||
3613706|NCT02743962|3464098|B3|||O'Leary-Sant Interstitial Cystitis Symptom Score|"This outcome measure has 4 questions and scores for each question range from 0 to 4 or 5. The total achievable in this outcome measure is a score of between 0 to 19. A higher score describes worse Interstitial Cystitis symptoms.~Total scores were collected for analysis."|units on a scale|Mean|11.5|11.5|Standard Deviation|2.4|2.4|||
3613707|NCT02743962|3464099|B2|||O'Leary-Sant Interstitial Cystitis Symptom Score|"This outcome measure has 4 questions and scores for each question range from 0 to 4 or 5. The total achievable in this outcome measure is a score of between 0 to 19. A higher score describes worse Interstitial Cystitis symptoms.~Total scores were collected for analysis."|units on a scale|Mean|12.4|12.4|Standard Deviation|2.07|2.07|||
3613708|NCT02743962|3464100|B1|||O'Leary-Sant Interstitial Cystitis Symptom Score|"This outcome measure has 4 questions and scores for each question range from 0 to 4 or 5. The total achievable in this outcome measure is a score of between 0 to 19. A higher score describes worse Interstitial Cystitis symptoms.~Total scores were collected for analysis."|units on a scale|Mean|10.5|10.5|Standard Deviation|2.64|2.64|||
3613709|NCT02743962|3464098|B3|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
3613710|NCT02743962|3464099|B2|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
3613711|NCT02743962|3464100|B1|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3613712|NCT02743962|3464098|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3613713|NCT02743962|3464099|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3613714|NCT02743962|3464100|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3613715|NCT02743962|3464098|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3613716|NCT02743962|3464099|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3613717|NCT02743962|3464100|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3613718|NCT02743962|3464098|B3|||Age||years|Mean|34.4|34.4|Standard Deviation|12.2|12.2|||
3613719|NCT02743962|3464099|B2|||Age||years|Mean|32.6|32.6|Standard Deviation|7.2|7.2|||
3613720|NCT02743962|3464100|B1|||Age||years|Mean|36.3|36.3|Standard Deviation|17.9|17.9|||
3613721|NCT02743936|3464120|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3613722|NCT02743936|3464121|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3613723|NCT02743936|3464122|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3613724|NCT02743936|3464120|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3613725|NCT02743936|3464121|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3613726|NCT02743936|3464122|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3613727|NCT02743936|3464120|B3|||Age||years|Median|31|31.0|Inter-Quartile Range|||28.0|35.0|
3613728|NCT02743936|3464121|B2|||Age||years|Median|32|32.0|Inter-Quartile Range|||28.0|34.0|
3613729|NCT02743936|3464122|B1|||Age||years|Median|31|31.0|Inter-Quartile Range|||28.0|36.0|
3613730|NCT02743780|3464131|B6|8 PM IOP||Intraocular Pressure (IOP)|IOP (fluid pressure inside the eye) was assessed using Goldmann applanation tonometry and reported in millimeters mercury (mmHg). Only one eye (study eye) contributed to the analysis.|mmHg|Mean|22.98|22.98|Standard Deviation|2.680|2.68|||
3613731|NCT02743780|3464132|B5|8 PM IOP||Intraocular Pressure (IOP)|IOP (fluid pressure inside the eye) was assessed using Goldmann applanation tonometry and reported in millimeters mercury (mmHg). Only one eye (study eye) contributed to the analysis.|mmHg|Mean|22.64|22.64|Standard Deviation|2.344|2.344|||
3613732|NCT02743780|3464134|B3|8 PM IOP||Intraocular Pressure (IOP)|IOP (fluid pressure inside the eye) was assessed using Goldmann applanation tonometry and reported in millimeters mercury (mmHg). Only one eye (study eye) contributed to the analysis.|mmHg|Mean|23.34|23.34|Standard Deviation|2.998|2.998|||
3613733|NCT02743780|3464131|B6|4 PM IOP||Intraocular Pressure (IOP)|IOP (fluid pressure inside the eye) was assessed using Goldmann applanation tonometry and reported in millimeters mercury (mmHg). Only one eye (study eye) contributed to the analysis.|mmHg|Mean|24.30|24.3|Standard Deviation|2.221|2.221|||
3613773|NCT02743780|3464136|B1|Female, Part 1||Sex/Gender, Customized||participants|Number|0|0.0||||||
3613774|NCT02743780|3464131|B6|Part 3||Age, Customized||years|Mean|65.2|65.2|Standard Deviation|9.02|9.02|||
3613734|NCT02743780|3464132|B5|4 PM IOP||Intraocular Pressure (IOP)|IOP (fluid pressure inside the eye) was assessed using Goldmann applanation tonometry and reported in millimeters mercury (mmHg). Only one eye (study eye) contributed to the analysis.|mmHg|Mean|24.21|24.21|Standard Deviation|1.939|1.939|||
3613735|NCT02743780|3464134|B3|4 PM IOP||Intraocular Pressure (IOP)|IOP (fluid pressure inside the eye) was assessed using Goldmann applanation tonometry and reported in millimeters mercury (mmHg). Only one eye (study eye) contributed to the analysis.|mmHg|Mean|24.39|24.39|Standard Deviation|2.521|2.521|||
3613736|NCT02743780|3464131|B6|Noon IOP||Intraocular Pressure (IOP)|IOP (fluid pressure inside the eye) was assessed using Goldmann applanation tonometry and reported in millimeters mercury (mmHg). Only one eye (study eye) contributed to the analysis.|mmHg|Mean|24.33|24.33|Standard Deviation|2.445|2.445|||
3613737|NCT02743780|3464132|B5|Noon IOP||Intraocular Pressure (IOP)|IOP (fluid pressure inside the eye) was assessed using Goldmann applanation tonometry and reported in millimeters mercury (mmHg). Only one eye (study eye) contributed to the analysis.|mmHg|Mean|24.21|24.21|Standard Deviation|2.046|2.046|||
3613738|NCT02743780|3464134|B3|Noon IOP||Intraocular Pressure (IOP)|IOP (fluid pressure inside the eye) was assessed using Goldmann applanation tonometry and reported in millimeters mercury (mmHg). Only one eye (study eye) contributed to the analysis.|mmHg|Mean|24.46|24.46|Standard Deviation|2.842|2.842|||
3613739|NCT02743780|3464131|B6|10 AM IOP||Intraocular Pressure (IOP)|IOP (fluid pressure inside the eye) was assessed using Goldmann applanation tonometry and reported in millimeters mercury (mmHg). Only one eye (study eye) contributed to the analysis.|mmHg|Mean|24.72|24.72|Standard Deviation|2.263|2.263|||
3613740|NCT02743780|3464132|B5|10 AM IOP||Intraocular Pressure (IOP)|IOP (fluid pressure inside the eye) was assessed using Goldmann applanation tonometry and reported in millimeters mercury (mmHg). Only one eye (study eye) contributed to the analysis.|mmHg|Mean|24.77|24.77|Standard Deviation|1.976|1.976|||
3613741|NCT02743780|3464134|B3|10 AM IOP||Intraocular Pressure (IOP)|IOP (fluid pressure inside the eye) was assessed using Goldmann applanation tonometry and reported in millimeters mercury (mmHg). Only one eye (study eye) contributed to the analysis.|mmHg|Mean|24.68|24.68|Standard Deviation|2.571|2.571|||
3613742|NCT02743780|3464131|B6|8 AM IOP||Intraocular Pressure (IOP)|IOP (fluid pressure inside the eye) was assessed using Goldmann applanation tonometry and reported in millimeters mercury (mmHg). Only one eye (study eye) contributed to the analysis.|mmHg|Mean|26.97|26.97|Standard Deviation|2.844|2.844|||
3613743|NCT02743780|3464132|B5|8 AM IOP||Intraocular Pressure (IOP)|IOP (fluid pressure inside the eye) was assessed using Goldmann applanation tonometry and reported in millimeters mercury (mmHg). Only one eye (study eye) contributed to the analysis.|mmHg|Mean|27.33|27.33|Standard Deviation|3.300|3.3|||
3613744|NCT02743780|3464134|B3|8 AM IOP||Intraocular Pressure (IOP)|IOP (fluid pressure inside the eye) was assessed using Goldmann applanation tonometry and reported in millimeters mercury (mmHg). Only one eye (study eye) contributed to the analysis.|mmHg|Mean|26.60|26.6|Standard Deviation|2.289|2.289|||
3613745|NCT02743780|3464131|B6|Diurnal IOP||Intraocular Pressure (IOP)|IOP (fluid pressure inside the eye) was assessed using Goldmann applanation tonometry and reported in millimeters mercury (mmHg). Only one eye (study eye) contributed to the analysis.|mmHg|Mean|24.66|24.66|Standard Deviation|2.276|2.276|||
3613746|NCT02743780|3464132|B5|Diurnal IOP||Intraocular Pressure (IOP)|IOP (fluid pressure inside the eye) was assessed using Goldmann applanation tonometry and reported in millimeters mercury (mmHg). Only one eye (study eye) contributed to the analysis.|mmHg|Mean|24.63|24.63|Standard Deviation|2.119|2.119|||
3613747|NCT02743780|3464134|B3|Diurnal IOP||Intraocular Pressure (IOP)|IOP (fluid pressure inside the eye) was assessed using Goldmann applanation tonometry and reported in millimeters mercury (mmHg). Only one eye (study eye) contributed to the analysis.|mmHg|Mean|24.69|24.69|Standard Deviation|2.475|2.475|||
3613748|NCT02743780|3464131|B6|Male, Part 3||Sex/Gender, Customized||participants|Number|15|15.0||||||
3613749|NCT02743780|3464132|B5|Male, Part 3||Sex/Gender, Customized||participants|Number|8|8.0||||||
3613750|NCT02743780|3464134|B3|Male, Part 3||Sex/Gender, Customized||participants|Number|7|7.0||||||
3613751|NCT02743780|3464131|B6|Female, Part 3||Sex/Gender, Customized||participants|Number|34|34.0||||||
3613752|NCT02743780|3464132|B5|Female, Part 3||Sex/Gender, Customized||participants|Number|17|17.0||||||
3613753|NCT02743780|3464134|B3|Female, Part 3||Sex/Gender, Customized||participants|Number|17|17.0||||||
3613754|NCT02743780|3464131|B6|Male, Part 2||Sex/Gender, Customized||participants|Number|7|7.0||||||
3613755|NCT02743780|3464132|B5|Male, Part 2||Sex/Gender, Customized||participants|Number|2|2.0||||||
3613756|NCT02743780|3464134|B3|Male, Part 2||Sex/Gender, Customized||participants|Number|3|3.0||||||
3613757|NCT02743780|3464135|B2|Male, Part 2||Sex/Gender, Customized||participants|Number|2|2.0||||||
3613758|NCT02743780|3464131|B6|Female, Part 2||Sex/Gender, Customized||participants|Number|9|9.0||||||
3613759|NCT02743780|3464132|B5|Female, Part 2||Sex/Gender, Customized||participants|Number|2|2.0||||||
3613760|NCT02743780|3464134|B3|Female, Part 2||Sex/Gender, Customized||participants|Number|3|3.0||||||
3613761|NCT02743780|3464135|B2|Female, Part 2||Sex/Gender, Customized||participants|Number|4|4.0||||||
3613762|NCT02743780|3464131|B6|Male, Part 1||Sex/Gender, Customized||participants|Number|12|12.0||||||
3613763|NCT02743780|3464132|B5|Male, Part 1||Sex/Gender, Customized||participants|Number|3|3.0||||||
3613764|NCT02743780|3464133|B4|Male, Part 1||Sex/Gender, Customized||participants|Number|0|0.0||||||
3613765|NCT02743780|3464134|B3|Male, Part 1||Sex/Gender, Customized||participants|Number|2|2.0||||||
3613766|NCT02743780|3464135|B2|Male, Part 1||Sex/Gender, Customized||participants|Number|1|1.0||||||
3613767|NCT02743780|3464136|B1|Male, Part 1||Sex/Gender, Customized||participants|Number|6|6.0||||||
3613768|NCT02743780|3464131|B6|Female, Part 1||Sex/Gender, Customized||participants|Number|20|20.0||||||
3613769|NCT02743780|3464132|B5|Female, Part 1||Sex/Gender, Customized||participants|Number|5|5.0||||||
3613770|NCT02743780|3464133|B4|Female, Part 1||Sex/Gender, Customized||participants|Number|6|6.0||||||
3613771|NCT02743780|3464134|B3|Female, Part 1||Sex/Gender, Customized||participants|Number|4|4.0||||||
3613772|NCT02743780|3464135|B2|Female, Part 1||Sex/Gender, Customized||participants|Number|5|5.0||||||
3613775|NCT02743780|3464132|B5|Part 3||Age, Customized||years|Mean|64.8|64.8|Standard Deviation|9.92|9.92|||
3613776|NCT02743780|3464134|B3|Part 3||Age, Customized||years|Mean|65.5|65.5|Standard Deviation|8.17|8.17|||
3613777|NCT02743780|3464131|B6|Part 2||Age, Customized||years|Mean|61.8|61.8|Standard Deviation|7.23|7.23|||
3613778|NCT02743780|3464132|B5|Part 2||Age, Customized||years|Mean|63.3|63.3|Standard Deviation|6.70|6.7|||
3613779|NCT02743780|3464134|B3|Part 2||Age, Customized||years|Mean|63.3|63.3|Standard Deviation|7.79|7.79|||
3613780|NCT02743780|3464135|B2|Part 2||Age, Customized||years|Mean|59.2|59.2|Standard Deviation|7.52|7.52|||
3613781|NCT02743780|3464131|B6|Part 1||Age, Customized||years|Mean|48.9|48.9|Standard Deviation|15.54|15.54|||
3613782|NCT02743780|3464132|B5|Part 1||Age, Customized||years|Mean|50.1|50.1|Standard Deviation|7.51|7.51|||
3613783|NCT02743780|3464133|B4|Part 1||Age, Customized||years|Mean|62.7|62.7|Standard Deviation|7.74|7.74|||
3613784|NCT02743780|3464134|B3|Part 1||Age, Customized||years|Mean|48.5|48.5|Standard Deviation|17.55|17.55|||
3613785|NCT02743780|3464135|B2|Part 1||Age, Customized||years|Mean|51.7|51.7|Standard Deviation|15.77|15.77|||
3613786|NCT02743780|3464136|B1|Part 1||Age, Customized||years|Mean|31.2|31.2|Standard Deviation|13.61|13.61|||
3613787|NCT02743702|3464185|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3613788|NCT02743702|3464186|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3613789|NCT02743702|3464187|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3613790|NCT02743702|3464185|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3613791|NCT02743702|3464186|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3613792|NCT02743702|3464187|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3613793|NCT02743702|3464185|B3|||Age||years|Median|7|7.0|Inter-Quartile Range|||4.0|9.0|
3613794|NCT02743702|3464186|B2|||Age||years|Median|7.5|7.5|Inter-Quartile Range|||3.75|9.25|
3613795|NCT02743702|3464187|B1|||Age||years|Median|6|6.0|Inter-Quartile Range|||4.0|9.0|
3613796|NCT02743312|3464194|B3|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3613797|NCT02743312|3464195|B2|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3613798|NCT02743312|3464196|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3613799|NCT02743312|3464194|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3613800|NCT02743312|3464194|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3613801|NCT02743312|3464195|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3613802|NCT02743312|3464196|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3613803|NCT02743312|3464194|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3613804|NCT02743312|3464195|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3613805|NCT02743312|3464196|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3613806|NCT02743312|3464194|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3613807|NCT02743312|3464195|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3613808|NCT02743312|3464196|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3613809|NCT02743312|3464194|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3613810|NCT02743312|3464195|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3613811|NCT02743312|3464196|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3613812|NCT02743312|3464194|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3613813|NCT02743312|3464195|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3613814|NCT02743312|3464196|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3613815|NCT02743117|3464228|B3||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3613816|NCT02743117|3464229|B2||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3613817|NCT02743117|3464230|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3613818|NCT02743117|3464228|B3||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3613819|NCT02743117|3464229|B2||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3613820|NCT02743117|3464230|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3613821|NCT02743117|3464228|B3|||Age||Years|Mean|33.3|33.3|Standard Deviation|9.4|9.4|||
3613822|NCT02743117|3464229|B2|||Age||Years|Mean|33.3|33.3|Standard Deviation|9.5|9.5|||
3613823|NCT02743117|3464230|B1|||Age||Years|Mean|33.2|33.2|Standard Deviation|9.4|9.4|||
3613824|NCT02742987|3464245|B3|Italy||Region of Enrollment||participants|Number|42|42.0||||||
3613825|NCT02742987|3464246|B2|Italy||Region of Enrollment||participants|Number|21|21.0||||||
3613826|NCT02742987|3464247|B1|Italy||Region of Enrollment||participants|Number|21|21.0||||||
3613827|NCT02742987|3464245|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3613828|NCT02742987|3464246|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3613829|NCT02742987|3464247|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3613830|NCT02742987|3464245|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3613831|NCT02742987|3464246|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3613832|NCT02742987|3464247|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3613833|NCT02742987|3464245|B3|||Age||years|Mean|66.8|66.8|Standard Deviation|8.8|8.8|||
3613834|NCT02742987|3464246|B2|||Age||years|Mean|67.7|67.7|Standard Deviation|8.1|8.1|||
3613835|NCT02742987|3464247|B1|||Age||years|Mean|65.9|65.9|Standard Deviation|9.5|9.5|||
3613836|NCT02742818|3464254|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3613837|NCT02742818|3464255|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3613838|NCT02742818|3464256|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3613839|NCT02742818|3464254|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3613840|NCT02742818|3464255|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3613841|NCT02742818|3464256|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3613842|NCT02742818|3464254|B3|||Age||years|Median|70.5|70.5|Inter-Quartile Range|||60.25|74.75|
3613843|NCT02742818|3464255|B2|||Age||years|Median|70|70.0|Inter-Quartile Range|||62.0|73.0|
3613844|NCT02742818|3464256|B1|||Age||years|Median|71|71.0|Inter-Quartile Range|||60.5|76.5|
3613845|NCT02742649|3464271|B4|Randomization (T=8 hour)||Intraocular Pressure (IOP)|IOP is a measurement of the fluid pressure inside the eye. IOP was measured at the following three time points: 8 am (T=0 hour), 12 pm (T=4 hour) and 4 pm (T=8 hour). The IOP measured in the two eyes was averaged to compute a single IOP value for each timepoint.|mm Hg|Mean|22.78|22.78|Standard Deviation|2.77|2.77|||
3613846|NCT02742649|3464272|B3|Randomization (T=8 hour)||Intraocular Pressure (IOP)|IOP is a measurement of the fluid pressure inside the eye. IOP was measured at the following three time points: 8 am (T=0 hour), 12 pm (T=4 hour) and 4 pm (T=8 hour). The IOP measured in the two eyes was averaged to compute a single IOP value for each timepoint.|mm Hg|Mean|23.03|23.03|Standard Deviation|2.70|2.7|||
3613847|NCT02742649|3464273|B2|Randomization (T=8 hour)||Intraocular Pressure (IOP)|IOP is a measurement of the fluid pressure inside the eye. IOP was measured at the following three time points: 8 am (T=0 hour), 12 pm (T=4 hour) and 4 pm (T=8 hour). The IOP measured in the two eyes was averaged to compute a single IOP value for each timepoint.|mm Hg|Mean|22.90|22.9|Standard Deviation|3.13|3.13|||
3613848|NCT02742649|3464274|B1|Randomization (T=8 hour)||Intraocular Pressure (IOP)|IOP is a measurement of the fluid pressure inside the eye. IOP was measured at the following three time points: 8 am (T=0 hour), 12 pm (T=4 hour) and 4 pm (T=8 hour). The IOP measured in the two eyes was averaged to compute a single IOP value for each timepoint.|mm Hg|Mean|22.44|22.44|Standard Deviation|2.57|2.57|||
3613849|NCT02742649|3464271|B4|Randomization (T=4 hour)||Intraocular Pressure (IOP)|IOP is a measurement of the fluid pressure inside the eye. IOP was measured at the following three time points: 8 am (T=0 hour), 12 pm (T=4 hour) and 4 pm (T=8 hour). The IOP measured in the two eyes was averaged to compute a single IOP value for each timepoint.|mm Hg|Mean|23.07|23.07|Standard Deviation|2.87|2.87|||
3613850|NCT02742649|3464272|B3|Randomization (T=4 hour)||Intraocular Pressure (IOP)|IOP is a measurement of the fluid pressure inside the eye. IOP was measured at the following three time points: 8 am (T=0 hour), 12 pm (T=4 hour) and 4 pm (T=8 hour). The IOP measured in the two eyes was averaged to compute a single IOP value for each timepoint.|mm Hg|Mean|23.33|23.33|Standard Deviation|2.77|2.77|||
3613851|NCT02742649|3464273|B2|Randomization (T=4 hour)||Intraocular Pressure (IOP)|IOP is a measurement of the fluid pressure inside the eye. IOP was measured at the following three time points: 8 am (T=0 hour), 12 pm (T=4 hour) and 4 pm (T=8 hour). The IOP measured in the two eyes was averaged to compute a single IOP value for each timepoint.|mm Hg|Mean|22.93|22.93|Standard Deviation|3.06|3.06|||
3613852|NCT02742649|3464274|B1|Randomization (T=4 hour)||Intraocular Pressure (IOP)|IOP is a measurement of the fluid pressure inside the eye. IOP was measured at the following three time points: 8 am (T=0 hour), 12 pm (T=4 hour) and 4 pm (T=8 hour). The IOP measured in the two eyes was averaged to compute a single IOP value for each timepoint.|mm Hg|Mean|22.98|22.98|Standard Deviation|2.92|2.92|||
3613853|NCT02742649|3464271|B4|Randomization (T=0 hour)||Intraocular Pressure (IOP)|IOP is a measurement of the fluid pressure inside the eye. IOP was measured at the following three time points: 8 am (T=0 hour), 12 pm (T=4 hour) and 4 pm (T=8 hour). The IOP measured in the two eyes was averaged to compute a single IOP value for each timepoint.|mm Hg|Mean|24.27|24.27|Standard Deviation|1.88|1.88|||
3613854|NCT02742649|3464272|B3|Randomization (T=0 hour)||Intraocular Pressure (IOP)|IOP is a measurement of the fluid pressure inside the eye. IOP was measured at the following three time points: 8 am (T=0 hour), 12 pm (T=4 hour) and 4 pm (T=8 hour). The IOP measured in the two eyes was averaged to compute a single IOP value for each timepoint.|mm Hg|Mean|24.18|24.18|Standard Deviation|1.78|1.78|||
3613855|NCT02742649|3464273|B2|Randomization (T=0 hour)||Intraocular Pressure (IOP)|IOP is a measurement of the fluid pressure inside the eye. IOP was measured at the following three time points: 8 am (T=0 hour), 12 pm (T=4 hour) and 4 pm (T=8 hour). The IOP measured in the two eyes was averaged to compute a single IOP value for each timepoint.|mm Hg|Mean|24.30|24.3|Standard Deviation|1.89|1.89|||
3613856|NCT02742649|3464274|B1|Randomization (T=0 hour)||Intraocular Pressure (IOP)|IOP is a measurement of the fluid pressure inside the eye. IOP was measured at the following three time points: 8 am (T=0 hour), 12 pm (T=4 hour) and 4 pm (T=8 hour). The IOP measured in the two eyes was averaged to compute a single IOP value for each timepoint.|mm Hg|Mean|24.34|24.34|Standard Deviation|2.06|2.06|||
3613857|NCT02742649|3464271|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3613858|NCT02742649|3464272|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3613859|NCT02742649|3464273|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3613860|NCT02742649|3464274|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3613861|NCT02742649|3464271|B4||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3613862|NCT02742649|3464272|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3613863|NCT02742649|3464273|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3613864|NCT02742649|3464274|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3613865|NCT02742649|3464271|B4|||Age||years|Mean|67.92|67.92|Standard Deviation|9.61|9.61|||
3613866|NCT02742649|3464272|B3|||Age||years|Mean|67.56|67.56|Standard Deviation|9.27|9.27|||
3613867|NCT02742649|3464273|B2|||Age||years|Mean|68.94|68.94|Standard Deviation|5.75|5.75|||
3613868|NCT02742649|3464274|B1|||Age||years|Mean|67.24|67.24|Standard Deviation|12.94|12.94|||
3613869|NCT02742519|3464304|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613870|NCT02742519|3464305|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613871|NCT02742519|3464306|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613872|NCT02742519|3464304|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613873|NCT02742519|3464305|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613874|NCT02742519|3464306|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613875|NCT02742519|3464304|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3613876|NCT02742519|3464305|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3613877|NCT02742519|3464306|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3613878|NCT02742519|3464304|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613879|NCT02742519|3464305|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613880|NCT02742519|3464306|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613881|NCT02742519|3464304|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613882|NCT02742519|3464305|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613883|NCT02742519|3464306|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613884|NCT02742519|3464304|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613885|NCT02742519|3464305|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613886|NCT02742519|3464306|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613887|NCT02742519|3464304|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613888|NCT02742519|3464305|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613889|NCT02742519|3464306|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613890|NCT02742519|3464304|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3613891|NCT02742519|3464305|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3613892|NCT02742519|3464306|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3613893|NCT02742519|3464304|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3613894|NCT02742519|3464305|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3613895|NCT02742519|3464306|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3613896|NCT02742519|3464304|B3|||Age||years|Mean|3.9|3.9|Standard Deviation|0.9|0.9|||
3613897|NCT02742519|3464305|B2|||Age||years|Mean|4.2|4.2|Standard Deviation|1.0|1.0|||
3613898|NCT02742519|3464306|B1|||Age||years|Mean|3.6|3.6|Standard Deviation|0.7|0.7|||
3613899|NCT02742441|3464326|B3|United States||Region of Enrollment||participants|Number|409|409.0||||||
3613900|NCT02742441|3464327|B2|United States||Region of Enrollment||participants|Number|204|204.0||||||
3613901|NCT02742441|3464328|B1|United States||Region of Enrollment||participants|Number|205|205.0||||||
3613902|NCT02742441|3464326|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613903|NCT02742441|3464327|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613904|NCT02742441|3464328|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613905|NCT02742441|3464326|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3613906|NCT02742441|3464327|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3613907|NCT02742441|3464328|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3613908|NCT02742441|3464326|B3||White|Race (NIH/OMB)||Participants|Count of Participants|375|375.0||||||
3613909|NCT02742441|3464327|B2||White|Race (NIH/OMB)||Participants|Count of Participants|185|185.0||||||
3613910|NCT02742441|3464328|B1||White|Race (NIH/OMB)||Participants|Count of Participants|190|190.0||||||
3613911|NCT02742441|3464326|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3613912|NCT02742441|3464327|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3613913|NCT02742441|3464328|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3613914|NCT02742441|3464326|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3613915|NCT02742441|3464327|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3613916|NCT02742441|3464328|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613917|NCT02742441|3464326|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3613918|NCT02742441|3464327|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3613919|NCT02742441|3464328|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3613920|NCT02742441|3464326|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3613921|NCT02742441|3464327|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613922|NCT02742441|3464328|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3613923|NCT02742441|3464326|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613924|NCT02742441|3464327|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613925|NCT02742441|3464328|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613926|NCT02742441|3464326|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|301|301.0||||||
3613927|NCT02742441|3464327|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|150|150.0||||||
3613928|NCT02742441|3464328|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|151|151.0||||||
3613929|NCT02742441|3464326|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
3613930|NCT02742441|3464327|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3613931|NCT02742441|3464328|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3613932|NCT02742441|3464326|B3||Male|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
3613933|NCT02742441|3464327|B2||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3613934|NCT02742441|3464328|B1||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3613935|NCT02742441|3464326|B3||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
3613936|NCT02742441|3464327|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3613937|NCT02742441|3464328|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3613938|NCT02742441|3464326|B3|||Age||years|Mean|50.2|50.2|Standard Deviation|13.9|13.9|||
3613939|NCT02742441|3464327|B2|||Age||years|Mean|50.1|50.1|Standard Deviation|14.0|14.0|||
3613940|NCT02742441|3464328|B1|||Age||years|Mean|50.3|50.3|Standard Deviation|13.9|13.9|||
3613941|NCT02741713|3464345|B3||Right sided surgery|Surgical Side (L/R)||Participants|Count of Participants|17|17.0||||||
3613942|NCT02741713|3464346|B2||Right sided surgery|Surgical Side (L/R)||Participants|Count of Participants|9|9.0||||||
3613943|NCT02741713|3464347|B1||Right sided surgery|Surgical Side (L/R)||Participants|Count of Participants|8|8.0||||||
3613944|NCT02741713|3464345|B3||Left sided surgery|Surgical Side (L/R)||Participants|Count of Participants|20|20.0||||||
3613945|NCT02741713|3464346|B2||Left sided surgery|Surgical Side (L/R)||Participants|Count of Participants|10|10.0||||||
3613946|NCT02741713|3464347|B1||Left sided surgery|Surgical Side (L/R)||Participants|Count of Participants|10|10.0||||||
3613947|NCT02741713|3464345|B3|||BMI||kg/m^2|Mean|27.8|27.8|Standard Deviation|4.55|4.55|||
3613948|NCT02741713|3464346|B2|||BMI||kg/m^2|Mean|26.9|26.9|Standard Deviation|4.55|4.55|||
3613949|NCT02741713|3464347|B1|||BMI||kg/m^2|Mean|28.9|28.9|Standard Deviation|4.44|4.44|||
3613950|NCT02741713|3464345|B3|||Weight (kg)||kg|Mean|84.3|84.3|Standard Deviation|18.1|18.1|||
3613951|NCT02741713|3464346|B2|||Weight (kg)||kg|Mean|80.7|80.7|Standard Deviation|18.2|18.2|||
3613952|NCT02741713|3464347|B1|||Weight (kg)||kg|Mean|88.1|88.1|Standard Deviation|17.7|17.7|||
3613953|NCT02741713|3464345|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3613954|NCT02741713|3464346|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3613955|NCT02741713|3464347|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613956|NCT02741713|3464345|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613957|NCT02741713|3464346|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613958|NCT02741713|3464347|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613959|NCT02741713|3464345|B3||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3613960|NCT02741713|3464346|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3613961|NCT02741713|3464347|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3613962|NCT02741713|3464345|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3613963|NCT02741713|3464346|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3613964|NCT02741713|3464347|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3613965|NCT02741713|3464345|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613966|NCT02741713|3464346|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613967|NCT02741713|3464347|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613968|NCT02741713|3464345|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613969|NCT02741713|3464346|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613970|NCT02741713|3464347|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613971|NCT02741713|3464345|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613972|NCT02741713|3464346|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613973|NCT02741713|3464347|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3613974|NCT02741713|3464345|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3613975|NCT02741713|3464346|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3613976|NCT02741713|3464347|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3613977|NCT02741713|3464345|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3613978|NCT02741713|3464346|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3613979|NCT02741713|3464347|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3613980|NCT02741713|3464345|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3613981|NCT02741713|3464346|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3613982|NCT02741713|3464347|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3613983|NCT02741713|3464345|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3613984|NCT02741713|3464346|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3613985|NCT02741713|3464347|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3613986|NCT02741713|3464345|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3613987|NCT02741713|3464346|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3613988|NCT02741713|3464347|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3613989|NCT02741687|3464361|B3|||Admission blood glucose||mg/dl|Mean|103.6|103.6|Standard Deviation|23.4|23.4|||
3613990|NCT02741687|3464362|B2|||Admission blood glucose||mg/dl|Mean|107.6|107.6|Standard Deviation|25.3|25.3|||
3613991|NCT02741687|3464363|B1|||Admission blood glucose||mg/dl|Mean|98.5|98.5|Standard Deviation|20.0|20.0|||
3613992|NCT02741687|3464361|B3||Unknown|ASA Status|"The American Society of Anesthesiology (ASA) Physical Status Classification is a method of assessing patients prior to surgery. The following categories are used:~= Healthy person~= Mild systemic disease~= Severe systemic disease~= Severe systemic disease that is a constant threat to life~= A moribund person who is not expected to survive with the operation~= A declared brain-dead person whose organs are being removed for donor purposes"|Participants|Count of Participants|11|11.0||||||
3613993|NCT02741687|3464362|B2||Unknown|ASA Status|"The American Society of Anesthesiology (ASA) Physical Status Classification is a method of assessing patients prior to surgery. The following categories are used:~= Healthy person~= Mild systemic disease~= Severe systemic disease~= Severe systemic disease that is a constant threat to life~= A moribund person who is not expected to survive with the operation~= A declared brain-dead person whose organs are being removed for donor purposes"|Participants|Count of Participants|5|5.0||||||
3613994|NCT02741687|3464363|B1||Unknown|ASA Status|"The American Society of Anesthesiology (ASA) Physical Status Classification is a method of assessing patients prior to surgery. The following categories are used:~= Healthy person~= Mild systemic disease~= Severe systemic disease~= Severe systemic disease that is a constant threat to life~= A moribund person who is not expected to survive with the operation~= A declared brain-dead person whose organs are being removed for donor purposes"|Participants|Count of Participants|6|6.0||||||
3613995|NCT02741687|3464361|B3||ASA status = 3|ASA Status|"The American Society of Anesthesiology (ASA) Physical Status Classification is a method of assessing patients prior to surgery. The following categories are used:~= Healthy person~= Mild systemic disease~= Severe systemic disease~= Severe systemic disease that is a constant threat to life~= A moribund person who is not expected to survive with the operation~= A declared brain-dead person whose organs are being removed for donor purposes"|Participants|Count of Participants|22|22.0||||||
3613996|NCT02741687|3464362|B2||ASA status = 3|ASA Status|"The American Society of Anesthesiology (ASA) Physical Status Classification is a method of assessing patients prior to surgery. The following categories are used:~= Healthy person~= Mild systemic disease~= Severe systemic disease~= Severe systemic disease that is a constant threat to life~= A moribund person who is not expected to survive with the operation~= A declared brain-dead person whose organs are being removed for donor purposes"|Participants|Count of Participants|13|13.0||||||
3613997|NCT02741687|3464363|B1||ASA status = 3|ASA Status|"The American Society of Anesthesiology (ASA) Physical Status Classification is a method of assessing patients prior to surgery. The following categories are used:~= Healthy person~= Mild systemic disease~= Severe systemic disease~= Severe systemic disease that is a constant threat to life~= A moribund person who is not expected to survive with the operation~= A declared brain-dead person whose organs are being removed for donor purposes"|Participants|Count of Participants|9|9.0||||||
3613998|NCT02741687|3464361|B3||ASA status = 2|ASA Status|"The American Society of Anesthesiology (ASA) Physical Status Classification is a method of assessing patients prior to surgery. The following categories are used:~= Healthy person~= Mild systemic disease~= Severe systemic disease~= Severe systemic disease that is a constant threat to life~= A moribund person who is not expected to survive with the operation~= A declared brain-dead person whose organs are being removed for donor purposes"|Participants|Count of Participants|39|39.0||||||
3613999|NCT02741687|3464362|B2||ASA status = 2|ASA Status|"The American Society of Anesthesiology (ASA) Physical Status Classification is a method of assessing patients prior to surgery. The following categories are used:~= Healthy person~= Mild systemic disease~= Severe systemic disease~= Severe systemic disease that is a constant threat to life~= A moribund person who is not expected to survive with the operation~= A declared brain-dead person whose organs are being removed for donor purposes"|Participants|Count of Participants|22|22.0||||||
3614000|NCT02741687|3464363|B1||ASA status = 2|ASA Status|"The American Society of Anesthesiology (ASA) Physical Status Classification is a method of assessing patients prior to surgery. The following categories are used:~= Healthy person~= Mild systemic disease~= Severe systemic disease~= Severe systemic disease that is a constant threat to life~= A moribund person who is not expected to survive with the operation~= A declared brain-dead person whose organs are being removed for donor purposes"|Participants|Count of Participants|17|17.0||||||
3614001|NCT02741687|3464361|B3||ASA status = 1|ASA Status|"The American Society of Anesthesiology (ASA) Physical Status Classification is a method of assessing patients prior to surgery. The following categories are used:~= Healthy person~= Mild systemic disease~= Severe systemic disease~= Severe systemic disease that is a constant threat to life~= A moribund person who is not expected to survive with the operation~= A declared brain-dead person whose organs are being removed for donor purposes"|Participants|Count of Participants|8|8.0||||||
3614002|NCT02741687|3464362|B2||ASA status = 1|ASA Status|"The American Society of Anesthesiology (ASA) Physical Status Classification is a method of assessing patients prior to surgery. The following categories are used:~= Healthy person~= Mild systemic disease~= Severe systemic disease~= Severe systemic disease that is a constant threat to life~= A moribund person who is not expected to survive with the operation~= A declared brain-dead person whose organs are being removed for donor purposes"|Participants|Count of Participants|4|4.0||||||
3614003|NCT02741687|3464363|B1||ASA status = 1|ASA Status|"The American Society of Anesthesiology (ASA) Physical Status Classification is a method of assessing patients prior to surgery. The following categories are used:~= Healthy person~= Mild systemic disease~= Severe systemic disease~= Severe systemic disease that is a constant threat to life~= A moribund person who is not expected to survive with the operation~= A declared brain-dead person whose organs are being removed for donor purposes"|Participants|Count of Participants|4|4.0||||||
3614004|NCT02741687|3464361|B3||gynecologic|Surgery type||Participants|Count of Participants|10|10.0||||||
3614005|NCT02741687|3464362|B2||gynecologic|Surgery type||Participants|Count of Participants|3|3.0||||||
3614006|NCT02741687|3464363|B1||gynecologic|Surgery type||Participants|Count of Participants|7|7.0||||||
3614007|NCT02741687|3464361|B3||Vascular|Surgery type||Participants|Count of Participants|1|1.0||||||
3614008|NCT02741687|3464362|B2||Vascular|Surgery type||Participants|Count of Participants|1|1.0||||||
3614009|NCT02741687|3464363|B1||Vascular|Surgery type||Participants|Count of Participants|0|0.0||||||
3614010|NCT02741687|3464361|B3||Burn/Wound|Surgery type||Participants|Count of Participants|5|5.0||||||
3614011|NCT02741687|3464362|B2||Burn/Wound|Surgery type||Participants|Count of Participants|4|4.0||||||
3614012|NCT02741687|3464363|B1||Burn/Wound|Surgery type||Participants|Count of Participants|1|1.0||||||
3614013|NCT02741687|3464361|B3||Thoracic|Surgery type||Participants|Count of Participants|4|4.0||||||
3614014|NCT02741687|3464362|B2||Thoracic|Surgery type||Participants|Count of Participants|2|2.0||||||
3614015|NCT02741687|3464363|B1||Thoracic|Surgery type||Participants|Count of Participants|2|2.0||||||
3614016|NCT02741687|3464361|B3||Oral maxillofacial surgery|Surgery type||Participants|Count of Participants|5|5.0||||||
3614017|NCT02741687|3464362|B2||Oral maxillofacial surgery|Surgery type||Participants|Count of Participants|1|1.0||||||
3614018|NCT02741687|3464363|B1||Oral maxillofacial surgery|Surgery type||Participants|Count of Participants|4|4.0||||||
3614019|NCT02741687|3464361|B3||Neurologic|Surgery type||Participants|Count of Participants|9|9.0||||||
3614020|NCT02741687|3464362|B2||Neurologic|Surgery type||Participants|Count of Participants|5|5.0||||||
3614021|NCT02741687|3464363|B1||Neurologic|Surgery type||Participants|Count of Participants|4|4.0||||||
3614022|NCT02741687|3464361|B3||Gastrointestinal|Surgery type||Participants|Count of Participants|6|6.0||||||
3614023|NCT02741687|3464362|B2||Gastrointestinal|Surgery type||Participants|Count of Participants|3|3.0||||||
3614024|NCT02741687|3464363|B1||Gastrointestinal|Surgery type||Participants|Count of Participants|3|3.0||||||
3614025|NCT02741687|3464361|B3||Genitourinary|Surgery type||Participants|Count of Participants|23|23.0||||||
3614026|NCT02741687|3464362|B2||Genitourinary|Surgery type||Participants|Count of Participants|14|14.0||||||
3614027|NCT02741687|3464363|B1||Genitourinary|Surgery type||Participants|Count of Participants|9|9.0||||||
3614028|NCT02741687|3464361|B3||Orthopedic|Surgery type||Participants|Count of Participants|17|17.0||||||
3614029|NCT02741687|3464362|B2||Orthopedic|Surgery type||Participants|Count of Participants|11|11.0||||||
3614030|NCT02741687|3464363|B1||Orthopedic|Surgery type||Participants|Count of Participants|6|6.0||||||
3614031|NCT02741687|3464361|B3|United States||Region of Enrollment||Participants|Count of Participants|80|80.0||||||
3614032|NCT02741687|3464362|B2|United States||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3614033|NCT02741687|3464363|B1|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3614034|NCT02741687|3464361|B3|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3614035|NCT02741687|3464362|B2|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3614036|NCT02741687|3464363|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3614037|NCT02741687|3464361|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3614038|NCT02741687|3464362|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3614039|NCT02741687|3464363|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3614040|NCT02741687|3464361|B3|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|58|58.0||||||
3614041|NCT02741687|3464362|B2|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3614042|NCT02741687|3464363|B1|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3614043|NCT02741687|3464361|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3614044|NCT02741687|3464362|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3614045|NCT02741687|3464363|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3614046|NCT02741687|3464361|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3614047|NCT02741687|3464362|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3614048|NCT02741687|3464363|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3614049|NCT02741687|3464361|B3|||Age||years|Mean|48.8|48.8|Standard Deviation|13.8|13.8|||
3614050|NCT02741687|3464362|B2|||Age||years|Mean|51.1|51.1|Standard Deviation|12.8|12.8|||
3614051|NCT02741687|3464363|B1|||Age||years|Mean|45.9|45.9|Standard Deviation|14.5|14.5|||
3614052|NCT02741284|3464388|B3|||Hematocrit on admission||Percentage of red blood cells|Mean|32.6|32.6|Standard Deviation|3.3|3.3|||
3614053|NCT02741284|3464389|B2|||Hematocrit on admission||Percentage of red blood cells|Mean|32.8|32.8|Standard Deviation|3.5|3.5|||
3614054|NCT02741284|3464390|B1|||Hematocrit on admission||Percentage of red blood cells|Mean|32.5|32.5|Standard Deviation|3.2|3.2|||
3614055|NCT02741284|3464388|B3|||Epidural||Participants|Count of Participants|94|94.0||||||
3614056|NCT02741284|3464389|B2|||Epidural||Participants|Count of Participants|44|44.0||||||
3614057|NCT02741284|3464390|B1|||Epidural||Participants|Count of Participants|50|50.0||||||
3614058|NCT02741284|3464388|B3|||Chorioamnionitis||Participants|Count of Participants|0|0.0||||||
3614059|NCT02741284|3464389|B2|||Chorioamnionitis||Participants|Count of Participants|0|0.0||||||
3614060|NCT02741284|3464390|B1|||Chorioamnionitis||Participants|Count of Participants|0|0.0||||||
3614061|NCT02741284|3464388|B3|||Oxytocin||Participants|Count of Participants|88|88.0||||||
3614062|NCT02741284|3464389|B2|||Oxytocin||Participants|Count of Participants|43|43.0||||||
3614063|NCT02741284|3464390|B1|||Oxytocin||Participants|Count of Participants|45|45.0||||||
3614064|NCT02741284|3464388|B3|||Induction of labor||Participants|Count of Participants|70|70.0||||||
3614065|NCT02741284|3464389|B2|||Induction of labor||Participants|Count of Participants|34|34.0||||||
3614066|NCT02741284|3464390|B1|||Induction of labor||Participants|Count of Participants|36|36.0||||||
3614067|NCT02741284|3464388|B3|||Alcohol||Participants|Count of Participants|2|2.0||||||
3614068|NCT02741284|3464389|B2|||Alcohol||Participants|Count of Participants|0|0.0||||||
3614069|NCT02741284|3464390|B1|||Alcohol||Participants|Count of Participants|2|2.0||||||
3614070|NCT02741284|3464388|B3|||Illicit drug use||Participants|Count of Participants|20|20.0||||||
3614071|NCT02741284|3464389|B2|||Illicit drug use||Participants|Count of Participants|12|12.0||||||
3614072|NCT02741284|3464390|B1|||Illicit drug use||Participants|Count of Participants|8|8.0||||||
3614073|NCT02741284|3464388|B3|||Tobacco use||Participants|Count of Participants|14|14.0||||||
3614074|NCT02741284|3464389|B2|||Tobacco use||Participants|Count of Participants|6|6.0||||||
3614075|NCT02741284|3464390|B1|||Tobacco use||Participants|Count of Participants|8|8.0||||||
3614076|NCT02741284|3464388|B3|||Pregestational diabetes||Participants|Count of Participants|0|0.0||||||
3614077|NCT02741284|3464389|B2|||Pregestational diabetes||Participants|Count of Participants|0|0.0||||||
3614078|NCT02741284|3464390|B1|||Pregestational diabetes||Participants|Count of Participants|0|0.0||||||
3614079|NCT02741284|3464388|B3|||Preeclampsia||Participants|Count of Participants|3|3.0||||||
3614080|NCT02741284|3464389|B2|||Preeclampsia||Participants|Count of Participants|0|0.0||||||
3614081|NCT02741284|3464390|B1|||Preeclampsia||Participants|Count of Participants|3|3.0||||||
3614082|NCT02741284|3464388|B3|||Chronic hypertension||Participants|Count of Participants|9|9.0||||||
3614083|NCT02741284|3464389|B2|||Chronic hypertension||Participants|Count of Participants|3|3.0||||||
3614084|NCT02741284|3464390|B1|||Chronic hypertension||Participants|Count of Participants|6|6.0||||||
3614085|NCT02741284|3464388|B3|||Nulliparity||Participants|Count of Participants|11|11.0||||||
3614086|NCT02741284|3464389|B2|||Nulliparity||Participants|Count of Participants|5|5.0||||||
3614087|NCT02741284|3464390|B1|||Nulliparity||Participants|Count of Participants|6|6.0||||||
3614088|NCT02741284|3464388|B3|||Gestational age at delivery||weeks|Mean|39.1|39.1|Standard Deviation|1.1|1.1|||
3614089|NCT02741284|3464389|B2|||Gestational age at delivery||weeks|Mean|39.2|39.2|Standard Deviation|1.1|1.1|||
3614090|NCT02741284|3464390|B1|||Gestational age at delivery||weeks|Mean|39.1|39.1|Standard Deviation|1.1|1.1|||
3614091|NCT02741284|3464388|B3|||Body mass index||kg/m2|Mean|27.3|27.3|Standard Deviation|6.9|6.9|||
3614092|NCT02741284|3464389|B2|||Body mass index||kg/m2|Mean|26.9|26.9|Standard Deviation|6.5|6.5|||
3614093|NCT02741284|3464390|B1|||Body mass index||kg/m2|Mean|27.7|27.7|Standard Deviation|7.3|7.3|||
3614094|NCT02741284|3464388|B3||Unknown or Not Reported|Race (NIH/OMB)|Baseline characteristics were only compared in patients with paired umbilical cord gases (51 in room air group, and 48 in oxygen group)|Participants|Count of Participants|2|2.0||||||
3614095|NCT02741284|3464389|B2||Unknown or Not Reported|Race (NIH/OMB)|Baseline characteristics were only compared in patients with paired umbilical cord gases (51 in room air group, and 48 in oxygen group)|Participants|Count of Participants|1|1.0||||||
3614096|NCT02741284|3464390|B1||Unknown or Not Reported|Race (NIH/OMB)|Baseline characteristics were only compared in patients with paired umbilical cord gases (51 in room air group, and 48 in oxygen group)|Participants|Count of Participants|1|1.0||||||
3614097|NCT02741284|3464388|B3||More than one race|Race (NIH/OMB)|Baseline characteristics were only compared in patients with paired umbilical cord gases (51 in room air group, and 48 in oxygen group)|Participants|Count of Participants|0|0.0||||||
3614098|NCT02741284|3464389|B2||More than one race|Race (NIH/OMB)|Baseline characteristics were only compared in patients with paired umbilical cord gases (51 in room air group, and 48 in oxygen group)|Participants|Count of Participants|0|0.0||||||
3614099|NCT02741284|3464390|B1||More than one race|Race (NIH/OMB)|Baseline characteristics were only compared in patients with paired umbilical cord gases (51 in room air group, and 48 in oxygen group)|Participants|Count of Participants|0|0.0||||||
3614100|NCT02741284|3464388|B3||White|Race (NIH/OMB)|Baseline characteristics were only compared in patients with paired umbilical cord gases (51 in room air group, and 48 in oxygen group)|Participants|Count of Participants|18|18.0||||||
3614101|NCT02741284|3464389|B2||White|Race (NIH/OMB)|Baseline characteristics were only compared in patients with paired umbilical cord gases (51 in room air group, and 48 in oxygen group)|Participants|Count of Participants|8|8.0||||||
3614102|NCT02741284|3464390|B1||White|Race (NIH/OMB)|Baseline characteristics were only compared in patients with paired umbilical cord gases (51 in room air group, and 48 in oxygen group)|Participants|Count of Participants|10|10.0||||||
3614103|NCT02741284|3464388|B3||Black or African American|Race (NIH/OMB)|Baseline characteristics were only compared in patients with paired umbilical cord gases (51 in room air group, and 48 in oxygen group)|Participants|Count of Participants|76|76.0||||||
3614104|NCT02741284|3464389|B2||Black or African American|Race (NIH/OMB)|Baseline characteristics were only compared in patients with paired umbilical cord gases (51 in room air group, and 48 in oxygen group)|Participants|Count of Participants|36|36.0||||||
3614105|NCT02741284|3464390|B1||Black or African American|Race (NIH/OMB)|Baseline characteristics were only compared in patients with paired umbilical cord gases (51 in room air group, and 48 in oxygen group)|Participants|Count of Participants|40|40.0||||||
3614106|NCT02741284|3464388|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Baseline characteristics were only compared in patients with paired umbilical cord gases (51 in room air group, and 48 in oxygen group)|Participants|Count of Participants|0|0.0||||||
3614107|NCT02741284|3464389|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Baseline characteristics were only compared in patients with paired umbilical cord gases (51 in room air group, and 48 in oxygen group)|Participants|Count of Participants|0|0.0||||||
3614108|NCT02741284|3464390|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Baseline characteristics were only compared in patients with paired umbilical cord gases (51 in room air group, and 48 in oxygen group)|Participants|Count of Participants|0|0.0||||||
3614161|NCT02741245|3464408|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614109|NCT02741284|3464388|B3||Asian|Race (NIH/OMB)|Baseline characteristics were only compared in patients with paired umbilical cord gases (51 in room air group, and 48 in oxygen group)|Participants|Count of Participants|3|3.0||||||
3614110|NCT02741284|3464389|B2||Asian|Race (NIH/OMB)|Baseline characteristics were only compared in patients with paired umbilical cord gases (51 in room air group, and 48 in oxygen group)|Participants|Count of Participants|3|3.0||||||
3614111|NCT02741284|3464390|B1||Asian|Race (NIH/OMB)|Baseline characteristics were only compared in patients with paired umbilical cord gases (51 in room air group, and 48 in oxygen group)|Participants|Count of Participants|0|0.0||||||
3614112|NCT02741284|3464388|B3||American Indian or Alaska Native|Race (NIH/OMB)|Baseline characteristics were only compared in patients with paired umbilical cord gases (51 in room air group, and 48 in oxygen group)|Participants|Count of Participants|0|0.0||||||
3614113|NCT02741284|3464389|B2||American Indian or Alaska Native|Race (NIH/OMB)|Baseline characteristics were only compared in patients with paired umbilical cord gases (51 in room air group, and 48 in oxygen group)|Participants|Count of Participants|0|0.0||||||
3614114|NCT02741284|3464390|B1||American Indian or Alaska Native|Race (NIH/OMB)|Baseline characteristics were only compared in patients with paired umbilical cord gases (51 in room air group, and 48 in oxygen group)|Participants|Count of Participants|0|0.0||||||
3614115|NCT02741284|3464388|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3614116|NCT02741284|3464389|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3614117|NCT02741284|3464390|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3614118|NCT02741284|3464388|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3614119|NCT02741284|3464389|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3614120|NCT02741284|3464390|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3614121|NCT02741284|3464388|B3|||Age||years|Mean|27.5|27.5|Standard Deviation|5.8|5.8|||
3614122|NCT02741284|3464389|B2|||Age||years|Mean|27.3|27.3|Standard Deviation|6.3|6.3|||
3614123|NCT02741284|3464390|B1|||Age||years|Mean|27.8|27.8|Standard Deviation|5.3|5.3|||
3614124|NCT02741245|3464407|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614125|NCT02741245|3464408|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614126|NCT02741245|3464409|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614127|NCT02741245|3464410|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614128|NCT02741245|3464411|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614129|NCT02741245|3464412|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614130|NCT02741245|3464407|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614131|NCT02741245|3464408|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614132|NCT02741245|3464409|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614133|NCT02741245|3464410|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614134|NCT02741245|3464411|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614135|NCT02741245|3464412|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614136|NCT02741245|3464407|B6||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614137|NCT02741245|3464408|B5||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614138|NCT02741245|3464409|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614139|NCT02741245|3464410|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614140|NCT02741245|3464411|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614141|NCT02741245|3464412|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614142|NCT02741245|3464407|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614143|NCT02741245|3464408|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614144|NCT02741245|3464409|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614145|NCT02741245|3464410|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614146|NCT02741245|3464411|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614147|NCT02741245|3464412|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614148|NCT02741245|3464407|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614149|NCT02741245|3464408|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614150|NCT02741245|3464409|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614151|NCT02741245|3464410|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614152|NCT02741245|3464411|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614153|NCT02741245|3464412|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614154|NCT02741245|3464407|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|321|321.0||||||
3614155|NCT02741245|3464408|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3614156|NCT02741245|3464409|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3614157|NCT02741245|3464410|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3614158|NCT02741245|3464411|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3614159|NCT02741245|3464412|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3614160|NCT02741245|3464407|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614162|NCT02741245|3464409|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614163|NCT02741245|3464410|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614164|NCT02741245|3464411|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614165|NCT02741245|3464412|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614166|NCT02741245|3464407|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614167|NCT02741245|3464408|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614168|NCT02741245|3464409|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614169|NCT02741245|3464410|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614170|NCT02741245|3464411|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614171|NCT02741245|3464412|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614172|NCT02741245|3464407|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614173|NCT02741245|3464408|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614174|NCT02741245|3464409|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614175|NCT02741245|3464410|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614176|NCT02741245|3464411|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614177|NCT02741245|3464412|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614178|NCT02741245|3464407|B6||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614179|NCT02741245|3464408|B5||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614180|NCT02741245|3464409|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614181|NCT02741245|3464410|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614182|NCT02741245|3464411|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614183|NCT02741245|3464412|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614184|NCT02741245|3464407|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614185|NCT02741245|3464408|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614186|NCT02741245|3464409|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614187|NCT02741245|3464410|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614188|NCT02741245|3464411|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614189|NCT02741245|3464412|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614190|NCT02741245|3464407|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614191|NCT02741245|3464408|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614192|NCT02741245|3464409|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614193|NCT02741245|3464410|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614194|NCT02741245|3464411|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614195|NCT02741245|3464412|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614196|NCT02741245|3464407|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|321|321.0||||||
3614197|NCT02741245|3464408|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3614198|NCT02741245|3464409|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3614199|NCT02741245|3464410|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3614200|NCT02741245|3464411|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3614201|NCT02741245|3464412|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3614202|NCT02741245|3464407|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614203|NCT02741245|3464408|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614204|NCT02741245|3464409|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614205|NCT02741245|3464410|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614206|NCT02741245|3464411|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614207|NCT02741245|3464412|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614208|NCT02741245|3464407|B6||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3614209|NCT02741245|3464408|B5||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3614210|NCT02741245|3464409|B4||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3614211|NCT02741245|3464410|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3614212|NCT02741245|3464411|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3614213|NCT02741245|3464412|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3614214|NCT02741245|3464407|B6||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3614215|NCT02741245|3464408|B5||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3614216|NCT02741245|3464409|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3614217|NCT02741245|3464410|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3614218|NCT02741245|3464411|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3614219|NCT02741245|3464412|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3614220|NCT02741245|3464407|B6|||Age||Years|Mean|57.0|57.0|Standard Deviation|10.1|10.1|||
3614221|NCT02741245|3464408|B5|||Age||Years|Mean|58.2|58.2|Standard Deviation|10.6|10.6|||
3614222|NCT02741245|3464409|B4|||Age||Years|Mean|56.0|56.0|Standard Deviation|10.3|10.3|||
3614223|NCT02741245|3464410|B3|||Age||Years|Mean|58.9|58.9|Standard Deviation|9.0|9.0|||
3614224|NCT02741245|3464411|B2|||Age||Years|Mean|55.7|55.7|Standard Deviation|10.6|10.6|||
3614225|NCT02741245|3464412|B1|||Age||Years|Mean|56.0|56.0|Standard Deviation|8.9|8.9|||
3614226|NCT02739997|3464518|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614227|NCT02739997|3464518|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614228|NCT02739997|3464518|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614229|NCT02739997|3464518|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614230|NCT02739997|3464518|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614231|NCT02739997|3464518|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3614232|NCT02739997|3464518|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614233|NCT02739997|3464518|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3614234|NCT02739997|3464518|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3614235|NCT02739997|3464518|B1|||Age||Years|Mean|61.1|61.1|Standard Deviation|16.3|16.3|||
3614236|NCT02739984|3464530|B3|||Very Low-density Lipoprotein Cholesterol (VLDL-C) Concentration||mg/dL|Mean|34.4|34.4|Standard Deviation|15.0|15.0|||
3614237|NCT02739984|3464531|B2|||Very Low-density Lipoprotein Cholesterol (VLDL-C) Concentration||mg/dL|Mean|34.8|34.8|Standard Deviation|15.4|15.4|||
3614238|NCT02739984|3464532|B1|||Very Low-density Lipoprotein Cholesterol (VLDL-C) Concentration||mg/dL|Mean|33.6|33.6|Standard Deviation|14.3|14.3|||
3614239|NCT02739984|3464530|B3|||High-density Lipoprotein Cholesterol (HDL-C) Concentraion||mg/dL|Mean|44.2|44.2|Standard Deviation|12.7|12.7|||
3614240|NCT02739984|3464531|B2|||High-density Lipoprotein Cholesterol (HDL-C) Concentraion||mg/dL|Mean|43.6|43.6|Standard Deviation|12.9|12.9|||
3614241|NCT02739984|3464532|B1|||High-density Lipoprotein Cholesterol (HDL-C) Concentraion||mg/dL|Mean|45.2|45.2|Standard Deviation|12.2|12.2|||
3614242|NCT02739984|3464530|B3|||Triglycerides Concentration||mg/dL|Mean|181.9|181.9|Standard Deviation|98.0|98.0|||
3614243|NCT02739984|3464531|B2|||Triglycerides Concentration||mg/dL|Mean|184.2|184.2|Standard Deviation|102.2|102.2|||
3614244|NCT02739984|3464532|B1|||Triglycerides Concentration||mg/dL|Mean|177.3|177.3|Standard Deviation|89.2|89.2|||
3614245|NCT02739984|3464530|B3|||Lipoprotein(a) Concentration||nmol/L|Mean|91.8|91.8|Standard Deviation|115.4|115.4|||
3614246|NCT02739984|3464531|B2|||Lipoprotein(a) Concentration||nmol/L|Mean|88.0|88.0|Standard Deviation|111.5|111.5|||
3614247|NCT02739984|3464532|B1|||Lipoprotein(a) Concentration||nmol/L|Mean|99.4|99.4|Standard Deviation|122.8|122.8|||
3614248|NCT02739984|3464530|B3|||Total Cholesterol Concentration||mg/dL|Mean|189.1|189.1|Standard Deviation|36.2|36.2|||
3614249|NCT02739984|3464531|B2|||Total Cholesterol Concentration||mg/dL|Mean|188.2|188.2|Standard Deviation|36.8|36.8|||
3614250|NCT02739984|3464532|B1|||Total Cholesterol Concentration||mg/dL|Mean|190.7|190.7|Standard Deviation|35.0|35.0|||
3614251|NCT02739984|3464530|B3|||Apolipoprotein B Concentration||mg/dL|Mean|97.5|97.5|Standard Deviation|22.9|22.9|||
3614252|NCT02739984|3464531|B2|||Apolipoprotein B Concentration||mg/dL|Mean|97.1|97.1|Standard Deviation|23.3|23.3|||
3614253|NCT02739984|3464532|B1|||Apolipoprotein B Concentration||mg/dL|Mean|98.1|98.1|Standard Deviation|22.1|22.1|||
3614254|NCT02739984|3464530|B3|||Non-High-density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|144.9|144.9|Standard Deviation|34.5|34.5|||
3614255|NCT02739984|3464531|B2|||Non-High-density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|144.6|144.6|Standard Deviation|34.9|34.9|||
3614256|NCT02739984|3464532|B1|||Non-High-density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|145.5|145.5|Standard Deviation|33.9|33.9|||
3614257|NCT02739984|3464530|B3|||LDL-C Concentration||mg/dL|Mean|109.2|109.2|Standard Deviation|31.6|31.6|||
3614258|NCT02739984|3464531|B2|||LDL-C Concentration||mg/dL|Mean|108.6|108.6|Standard Deviation|31.0|31.0|||
3614259|NCT02739984|3464532|B1|||LDL-C Concentration||mg/dL|Mean|110.4|110.4|Standard Deviation|33.0|33.0|||
3614260|NCT02739984|3464530|B3||≥ 130 mg/dL|Stratification Factor: Low-density Lipoprotein Cholesterol (LDL-C) Level||Participants|Count of Participants|103|103.0||||||
3614261|NCT02739984|3464531|B2||≥ 130 mg/dL|Stratification Factor: Low-density Lipoprotein Cholesterol (LDL-C) Level||Participants|Count of Participants|68|68.0||||||
3614262|NCT02739984|3464532|B1||≥ 130 mg/dL|Stratification Factor: Low-density Lipoprotein Cholesterol (LDL-C) Level||Participants|Count of Participants|35|35.0||||||
3614263|NCT02739984|3464530|B3||< 130 mg/dL|Stratification Factor: Low-density Lipoprotein Cholesterol (LDL-C) Level||Participants|Count of Participants|321|321.0||||||
3614264|NCT02739984|3464531|B2||< 130 mg/dL|Stratification Factor: Low-density Lipoprotein Cholesterol (LDL-C) Level||Participants|Count of Participants|213|213.0||||||
3614265|NCT02739984|3464532|B1||< 130 mg/dL|Stratification Factor: Low-density Lipoprotein Cholesterol (LDL-C) Level||Participants|Count of Participants|108|108.0||||||
3614266|NCT02739984|3464530|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3614267|NCT02739984|3464531|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3614268|NCT02739984|3464532|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3614269|NCT02739984|3464530|B3||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3614270|NCT02739984|3464531|B2||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3614271|NCT02739984|3464532|B1||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3614272|NCT02739984|3464530|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|325|325.0||||||
3614273|NCT02739984|3464531|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|223|223.0||||||
3614274|NCT02739984|3464532|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|102|102.0||||||
3614275|NCT02739984|3464530|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3614276|NCT02739984|3464531|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3614277|NCT02739984|3464532|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3614278|NCT02739984|3464530|B3||Black (or African American)|Race/Ethnicity, Customized||Participants|Count of Participants|73|73.0||||||
3614279|NCT02739984|3464531|B2||Black (or African American)|Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
3614280|NCT02739984|3464532|B1||Black (or African American)|Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3614281|NCT02739984|3464530|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3614282|NCT02739984|3464531|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3614283|NCT02739984|3464532|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3614284|NCT02739984|3464530|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3614285|NCT02739984|3464531|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3614286|NCT02739984|3464532|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3614287|NCT02739984|3464530|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614288|NCT02739984|3464531|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614289|NCT02739984|3464532|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614290|NCT02739984|3464530|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|346|346.0||||||
3614291|NCT02739984|3464531|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|227|227.0||||||
3614292|NCT02739984|3464532|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
3614293|NCT02739984|3464530|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3614294|NCT02739984|3464531|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3614295|NCT02739984|3464532|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3614296|NCT02739984|3464530|B3||Male|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
3614297|NCT02739984|3464531|B2||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3614298|NCT02739984|3464532|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3614299|NCT02739984|3464530|B3||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
3614300|NCT02739984|3464531|B2||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3614301|NCT02739984|3464532|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3614302|NCT02739984|3464530|B3||≥ 85 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3614303|NCT02739984|3464531|B2||≥ 85 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3614304|NCT02739984|3464532|B1||≥ 85 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3614305|NCT02739984|3464530|B3||65 - < 85 years|Age, Customized||Participants|Count of Participants|179|179.0||||||
3614306|NCT02739984|3464531|B2||65 - < 85 years|Age, Customized||Participants|Count of Participants|122|122.0||||||
3614307|NCT02739984|3464532|B1||65 - < 85 years|Age, Customized||Participants|Count of Participants|57|57.0||||||
3614308|NCT02739984|3464530|B3||< 65 years|Age, Customized||Participants|Count of Participants|245|245.0||||||
3614309|NCT02739984|3464531|B2||< 65 years|Age, Customized||Participants|Count of Participants|159|159.0||||||
3614310|NCT02739984|3464532|B1||< 65 years|Age, Customized||Participants|Count of Participants|86|86.0||||||
3614311|NCT02739984|3464530|B3|||Age||years|Mean|62.5|62.5|Standard Deviation|8.5|8.5|||
3614312|NCT02739984|3464531|B2|||Age||years|Mean|62.5|62.5|Standard Deviation|8.5|8.5|||
3614313|NCT02739984|3464532|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|8.5|8.5|||
3614314|NCT02739698|3464581|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3614315|NCT02739698|3464582|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3614316|NCT02739698|3464583|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3614317|NCT02739698|3464581|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3614318|NCT02739698|3464582|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3614319|NCT02739698|3464583|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3614320|NCT02739698|3464581|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3614321|NCT02739698|3464582|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3614322|NCT02739698|3464583|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3614323|NCT02739698|3464581|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3614324|NCT02739698|3464582|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3614325|NCT02739698|3464583|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3614326|NCT02739698|3464581|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3614327|NCT02739698|3464582|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3614328|NCT02739698|3464583|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3614329|NCT02739594|3464590|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3614330|NCT02739594|3464591|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3614331|NCT02739594|3464592|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3614332|NCT02739594|3464590|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3614333|NCT02739594|3464591|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3614334|NCT02739594|3464592|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3614335|NCT02739594|3464590|B3|||Age||years|Mean|67.2|67.2|Standard Deviation|9.4|9.4|||
3614336|NCT02739594|3464591|B2|||Age||years|Mean|69.1|69.1|Standard Deviation|9.1|9.1|||
3614337|NCT02739594|3464592|B1|||Age||years|Mean|65.3|65.3|Standard Deviation|9.4|9.4|||
3614338|NCT02739321|3464623|B3|United States||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3614339|NCT02739321|3464624|B2|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3614340|NCT02739321|3464625|B1|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3614341|NCT02739321|3464623|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3614342|NCT02739321|3464624|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614343|NCT02739321|3464625|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3614344|NCT02739321|3464623|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3614345|NCT02739321|3464624|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3614346|NCT02739321|3464625|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3614347|NCT02739321|3464623|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3614348|NCT02739321|3464624|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3614349|NCT02739321|3464625|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614350|NCT02739321|3464623|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3614351|NCT02739321|3464624|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3614352|NCT02739321|3464625|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3614353|NCT02739321|3464623|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3614354|NCT02739321|3464624|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3614355|NCT02739321|3464625|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3614356|NCT02739321|3464623|B3|||Age||years|Mean|6.1|6.1|Standard Deviation|2.6|2.6|||
3614357|NCT02739321|3464624|B2|||Age||years|Mean|6.2|6.2|Standard Deviation|2.8|2.8|||
3614358|NCT02739321|3464625|B1|||Age||years|Mean|6.0|6.0|Standard Deviation|2.5|2.5|||
3614359|NCT02739321|3464623|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3614360|NCT02739321|3464624|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3614361|NCT02739321|3464625|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3614362|NCT02739321|3464623|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3614363|NCT02739321|3464624|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3614364|NCT02739321|3464625|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3614365|NCT02739321|3464623|B3||<=18 years|Age||Participants|Count of Participants|45|45.0||||||
3614366|NCT02739321|3464624|B2||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
3614367|NCT02739321|3464625|B1||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
3614368|NCT02738853|3464670|B1|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3614369|NCT02738853|3464670|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3614370|NCT02738853|3464670|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3614371|NCT02738853|3464670|B1|||Age||years|Mean|83.3|83.3|Standard Deviation|7.2|7.2|||
3614372|NCT02738333|3464686|B4||≥ 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|163|163.0||||||
3614373|NCT02738333|3464687|B3||≥ 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|15|15.0||||||
3614374|NCT02738333|3464688|B2||≥ 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|72|72.0||||||
3614375|NCT02738333|3464689|B1||≥ 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|76|76.0||||||
3614376|NCT02738333|3464686|B4||< 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|76|76.0||||||
3614377|NCT02738333|3464687|B3||< 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|10|10.0||||||
3614378|NCT02738333|3464688|B2||< 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|36|36.0||||||
3614379|NCT02738333|3464689|B1||< 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|30|30.0||||||
3614380|NCT02738333|3464686|B4|||HCV RNA (log10 IU/mL)||log10 IU/mL|Mean|6.0|6.0|Standard Deviation|0.78|0.78|||
3614381|NCT02738333|3464687|B3|||HCV RNA (log10 IU/mL)||log10 IU/mL|Mean|5.9|5.9|Standard Deviation|0.72|0.72|||
3614382|NCT02738333|3464688|B2|||HCV RNA (log10 IU/mL)||log10 IU/mL|Mean|6.1|6.1|Standard Deviation|0.79|0.79|||
3614383|NCT02738333|3464689|B1|||HCV RNA (log10 IU/mL)||log10 IU/mL|Mean|6.1|6.1|Standard Deviation|0.79|0.79|||
3614384|NCT02738333|3464686|B4||TT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|4|4.0||||||
3614385|NCT02738333|3464687|B3||TT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|0|0.0||||||
3614386|NCT02738333|3464688|B2||TT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|3|3.0||||||
3614387|NCT02738333|3464689|B1||TT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|1|1.0||||||
3614388|NCT02738333|3464686|B4||CT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|46|46.0||||||
3614389|NCT02738333|3464687|B3||CT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|10|10.0||||||
3614390|NCT02738333|3464688|B2||CT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|19|19.0||||||
3614391|NCT02738333|3464689|B1||CT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|17|17.0||||||
3614392|NCT02738333|3464686|B4||CC|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|189|189.0||||||
3614393|NCT02738333|3464687|B3||CC|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|15|15.0||||||
3614394|NCT02738333|3464688|B2||CC|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|86|86.0||||||
3614395|NCT02738333|3464689|B1||CC|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|88|88.0||||||
3614396|NCT02738333|3464686|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614397|NCT02738333|3464687|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614398|NCT02738333|3464688|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614399|NCT02738333|3464689|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614400|NCT02738333|3464686|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614401|NCT02738333|3464687|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614402|NCT02738333|3464688|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614403|NCT02738333|3464689|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614404|NCT02738333|3464686|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614405|NCT02738333|3464687|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614406|NCT02738333|3464688|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614407|NCT02738333|3464689|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614408|NCT02738333|3464686|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614409|NCT02738333|3464687|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614410|NCT02738333|3464688|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614411|NCT02738333|3464689|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614412|NCT02738333|3464686|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614413|NCT02738333|3464687|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614414|NCT02738333|3464688|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614415|NCT02738333|3464689|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614416|NCT02738333|3464686|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|239|239.0||||||
3614417|NCT02738333|3464687|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3614418|NCT02738333|3464688|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
3614419|NCT02738333|3464689|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
3614420|NCT02738333|3464686|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614421|NCT02738333|3464687|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614422|NCT02738333|3464688|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614423|NCT02738333|3464689|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614424|NCT02738333|3464686|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614425|NCT02738333|3464687|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614426|NCT02738333|3464688|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614427|NCT02738333|3464689|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614428|NCT02738333|3464686|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|239|239.0||||||
3614429|NCT02738333|3464687|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3614430|NCT02738333|3464688|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
3614431|NCT02738333|3464689|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
3614432|NCT02738333|3464686|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614433|NCT02738333|3464687|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614434|NCT02738333|3464688|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614435|NCT02738333|3464689|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614436|NCT02738333|3464686|B4||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3614437|NCT02738333|3464687|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3614438|NCT02738333|3464688|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3614439|NCT02738333|3464689|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3614440|NCT02738333|3464686|B4||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3614441|NCT02738333|3464687|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3614442|NCT02738333|3464688|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3614443|NCT02738333|3464689|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3614444|NCT02738333|3464686|B4|||Age||years|Mean|61|61.0|Standard Deviation|11.9|11.9|||
3614445|NCT02738333|3464687|B3|||Age||years|Mean|74|74.0|Standard Deviation|7.1|7.1|||
3614446|NCT02738333|3464688|B2|||Age||years|Mean|60|60.0|Standard Deviation|12.3|12.3|||
3614447|NCT02738333|3464689|B1|||Age||years|Mean|58|58.0|Standard Deviation|10.5|10.5|||
3614448|NCT02738255|3464765|B3|||Snoring Index|Snoring Index quantifies the number of breaths with snoring per hour of sleep. This was only measured in simple snorers who had an apnea-hypopnea index <10 events/hour|Events/hour|Mean|146.7|146.7|Standard Deviation|215.3|215.3|||
3614449|NCT02738255|3464766|B2|||Snoring Index|Snoring Index quantifies the number of breaths with snoring per hour of sleep. This was only measured in simple snorers who had an apnea-hypopnea index <10 events/hour|Events/hour|Mean|331.2|331.2|Standard Deviation|271.7|271.7|||
3614450|NCT02738255|3464767|B1|||Snoring Index|Snoring Index quantifies the number of breaths with snoring per hour of sleep. This was only measured in simple snorers who had an apnea-hypopnea index <10 events/hour|Events/hour|Mean|36.0|36.0|Standard Deviation|57.9|57.9|||
3614451|NCT02738255|3464765|B3|||Apnea-Hypopnea Index|Apnea-Hypopnea Index (AHI) is the metric used to diagnose and quantify the severity of sleep apnea. AHI measures the frequency of partial and complete airway obstructions during sleep.|Events/hour|Mean|21.9|21.9|Standard Deviation|16.8|16.8|||
3614452|NCT02738255|3464766|B2|||Apnea-Hypopnea Index|Apnea-Hypopnea Index (AHI) is the metric used to diagnose and quantify the severity of sleep apnea. AHI measures the frequency of partial and complete airway obstructions during sleep.|Events/hour|Mean|25.5|25.5|Standard Deviation|18.1|18.1|||
3614453|NCT02738255|3464767|B1|||Apnea-Hypopnea Index|Apnea-Hypopnea Index (AHI) is the metric used to diagnose and quantify the severity of sleep apnea. AHI measures the frequency of partial and complete airway obstructions during sleep.|Events/hour|Mean|17.0|17.0|Standard Deviation|14.3|14.3|||
3614454|NCT02738255|3464765|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
3614455|NCT02738255|3464766|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3614456|NCT02738255|3464767|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3614457|NCT02738255|3464765|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614458|NCT02738255|3464766|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614459|NCT02738255|3464767|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614460|NCT02738255|3464765|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614461|NCT02738255|3464766|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614462|NCT02738255|3464767|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614463|NCT02738255|3464765|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3614464|NCT02738255|3464766|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3614465|NCT02738255|3464767|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3614466|NCT02738255|3464765|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3614467|NCT02738255|3464766|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3614468|NCT02738255|3464767|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3614469|NCT02738255|3464765|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614470|NCT02738255|3464766|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614471|NCT02738255|3464767|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614472|NCT02738255|3464765|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3614473|NCT02738255|3464766|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614474|NCT02738255|3464767|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3614475|NCT02738255|3464765|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614476|NCT02738255|3464766|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614477|NCT02738255|3464767|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614478|NCT02738255|3464765|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3614479|NCT02738255|3464766|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3614480|NCT02738255|3464767|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3614481|NCT02738255|3464765|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3614482|NCT02738255|3464766|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3614483|NCT02738255|3464767|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3614484|NCT02738255|3464765|B3|||Age||years|Mean|54.8|54.8|Standard Deviation|10.4|10.4|||
3614485|NCT02738255|3464766|B2|||Age||years|Mean|55.3|55.3|Standard Deviation|8.1|8.1|||
3614486|NCT02738255|3464767|B1|||Age||years|Mean|54.2|54.2|Standard Deviation|13.4|13.4|||
3614487|NCT02738203|3464778|B3|||Previous Intrauterine Device Insertion|Participant had a previous intrauterine device insertion.|Participants|Count of Participants|70|70.0||||||
3614488|NCT02738203|3464779|B2|||Previous Intrauterine Device Insertion|Participant had a previous intrauterine device insertion.|Participants|Count of Participants|33|33.0||||||
3614489|NCT02738203|3464780|B1|||Previous Intrauterine Device Insertion|Participant had a previous intrauterine device insertion.|Participants|Count of Participants|37|37.0||||||
3614490|NCT02738203|3464778|B3|United States||Region of Enrollment||participants|Number|215|215.0||||||
3614491|NCT02738203|3464779|B2|United States||Region of Enrollment||participants|Number|107|107.0||||||
3614492|NCT02738203|3464780|B1|United States||Region of Enrollment||participants|Number|108|108.0||||||
3614493|NCT02738203|3464778|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3614494|NCT02738203|3464779|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3614495|NCT02738203|3464780|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3614496|NCT02738203|3464778|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3614497|NCT02738203|3464779|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3614498|NCT02738203|3464780|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3614499|NCT02738203|3464778|B3||White|Race (NIH/OMB)||Participants|Count of Participants|136|136.0||||||
3614500|NCT02738203|3464779|B2||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3614501|NCT02738203|3464780|B1||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3614502|NCT02738203|3464778|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3614503|NCT02738203|3464779|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3614504|NCT02738203|3464780|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3614505|NCT02738203|3464778|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3614506|NCT02738203|3464779|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3614507|NCT02738203|3464780|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3614508|NCT02738203|3464778|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3614509|NCT02738203|3464779|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3614510|NCT02738203|3464780|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3614511|NCT02738203|3464778|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3614512|NCT02738203|3464779|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614513|NCT02738203|3464780|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3614514|NCT02738203|3464778|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3614515|NCT02738203|3464779|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3614516|NCT02738203|3464780|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3614517|NCT02738203|3464778|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|183|183.0||||||
3614518|NCT02738203|3464779|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
3614519|NCT02738203|3464780|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
3614520|NCT02738203|3464778|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3614521|NCT02738203|3464779|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3614522|NCT02738203|3464780|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3614523|NCT02738203|3464778|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3614524|NCT02738203|3464779|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3614525|NCT02738203|3464780|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3614526|NCT02738203|3464778|B3||Female|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
3614527|NCT02738203|3464779|B2||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3614528|NCT02738203|3464780|B1||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3614529|NCT02738203|3464778|B3|||Age||years|Median|28|28.0|Full Range|||18.0|51.0|
3614530|NCT02738203|3464779|B2|||Age||years|Median|27|27.0|Full Range|||18.0|51.0|
3614531|NCT02738203|3464780|B1|||Age||years|Median|28.9|28.9|Full Range|||18.0|48.0|
3614532|NCT02738151|3464795|B3|||Basal Insulin Daily Dose||Units per kilogram (U/kg)|Mean|0.15|0.15|Standard Deviation|0.05|0.05|||
3614533|NCT02738151|3464796|B2|||Basal Insulin Daily Dose||Units per kilogram (U/kg)|Mean|0.12|0.12|Standard Deviation|0.03|0.03|||
3614534|NCT02738151|3464797|B1|||Basal Insulin Daily Dose||Units per kilogram (U/kg)|Mean|0.19|0.19|Standard Deviation|0.04|0.04|||
3614535|NCT02738151|3464795|B3|||Baseline HbA1c||Percentage of HbA1c|Mean|8.64|8.64|Standard Deviation|0.82|0.82|||
3614536|NCT02738151|3464796|B2|||Baseline HbA1c||Percentage of HbA1c|Mean|8.57|8.57|Standard Deviation|0.80|0.8|||
3614537|NCT02738151|3464797|B1|||Baseline HbA1c||Percentage of HbA1c|Mean|8.71|8.71|Standard Deviation|0.83|0.83|||
3614538|NCT02738151|3464795|B3|||Duration of Type 2 Diabetes Mellitus||years|Mean|10.6|10.6|Standard Deviation|6.3|6.3|||
3614539|NCT02738151|3464796|B2|||Duration of Type 2 Diabetes Mellitus||years|Mean|10.7|10.7|Standard Deviation|6.5|6.5|||
3614540|NCT02738151|3464797|B1|||Duration of Type 2 Diabetes Mellitus||years|Mean|10.5|10.5|Standard Deviation|6.1|6.1|||
3614541|NCT02738151|3464795|B3|||Body Mass Index (BMI)||Kg/m^2|Mean|31.5|31.5|Standard Deviation|4.4|4.4|||
3614542|NCT02738151|3464796|B2|||Body Mass Index (BMI)||Kg/m^2|Mean|31.3|31.3|Standard Deviation|4.4|4.4|||
3614543|NCT02738151|3464797|B1|||Body Mass Index (BMI)||Kg/m^2|Mean|31.7|31.7|Standard Deviation|4.3|4.3|||
3614544|NCT02738151|3464795|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3614545|NCT02738151|3464795|B3||Male|Sex: Female, Male||Participants|Count of Participants|499|499.0||||||
3614546|NCT02738151|3464796|B2||Male|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
3614547|NCT02738151|3464797|B1||Male|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
3614548|NCT02738151|3464795|B3||Female|Sex: Female, Male||Participants|Count of Participants|430|430.0||||||
3614549|NCT02738151|3464796|B2||Female|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
3614550|NCT02738151|3464797|B1||Female|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
3614551|NCT02738151|3464795|B3|||Age||years|Mean|60.5|60.5|Standard Deviation|9.7|9.7|||
3614552|NCT02738151|3464796|B2|||Age||years|Mean|60.5|60.5|Standard Deviation|9.8|9.8|||
3614553|NCT02738151|3464797|B1|||Age||years|Mean|60.6|60.6|Standard Deviation|9.6|9.6|||
3614554|NCT02738138|3464840|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614555|NCT02738138|3464841|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614556|NCT02738138|3464842|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614557|NCT02738138|3464840|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3614558|NCT02738138|3464841|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614559|NCT02738138|3464842|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3614560|NCT02738138|3464840|B3||White|Race (NIH/OMB)||Participants|Count of Participants|121|121.0||||||
3614561|NCT02738138|3464841|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3614562|NCT02738138|3464842|B1||White|Race (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
3614563|NCT02738138|3464840|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3614564|NCT02738138|3464841|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3614565|NCT02738138|3464842|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3614566|NCT02738138|3464840|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614567|NCT02738138|3464841|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614568|NCT02738138|3464842|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614569|NCT02738138|3464840|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3614570|NCT02738138|3464841|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614571|NCT02738138|3464842|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3614572|NCT02738138|3464840|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614573|NCT02738138|3464841|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614574|NCT02738138|3464842|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614575|NCT02738138|3464840|B3||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3614576|NCT02738138|3464841|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3614577|NCT02738138|3464842|B1||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3614578|NCT02738138|3464840|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3614579|NCT02738138|3464841|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3614580|NCT02738138|3464842|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3614581|NCT02738138|3464840|B3|||Age||years|Mean|45.00|45.0|Standard Deviation|10.16|10.16|||
3614582|NCT02738138|3464841|B2|||Age||years|Mean|50.00|50.0|Standard Deviation|8.36|8.36|||
3614583|NCT02738138|3464842|B1|||Age||years|Mean|45.00|45.0|Standard Deviation|10.22|10.22|||
3614584|NCT02737852|3464850|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3614585|NCT02737852|3464850|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3614586|NCT02737852|3464850|B1|Age 19-59||Age, Customized||Participants|Count of Participants|30|30.0||||||
3614587|NCT02737631|3464855|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3614588|NCT02737631|3464855|B1||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3614589|NCT02737631|3464855|B1|18-69||Age, Customized||Participants|Count of Participants|222|222.0||||||
3614590|NCT02737618|3464860|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3614591|NCT02737618|3464860|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3614592|NCT02737618|3464860|B1|18-69||Age, Customized||Participants|Count of Participants|34|34.0||||||
3614593|NCT02737592|3464865|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3614594|NCT02737592|3464865|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3614595|NCT02737592|3464865|B1|Age 20 - 60||Age, Customized||Participants|Count of Participants|33|33.0||||||
3614596|NCT02737397|3464870|B1|||Veisalgia with pre-determined consumption||Participants|Count of Participants|13|13.0||||||
3614597|NCT02737397|3464870|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3614598|NCT02737397|3464870|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3614599|NCT02737397|3464870|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3614600|NCT02737397|3464870|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3614601|NCT02737397|3464870|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3614625|NCT02736955|3464887|B1||Mood disorder|Primary Psychiatric Diagnosis||Participants|Count of Participants|12|12.0||||||
3614626|NCT02736955|3464884|B4||Schizophrenia/schizoaffective disorder|Primary Psychiatric Diagnosis||Participants|Count of Participants|104|104.0||||||
3614602|NCT02736955|3464884|B4|CGI-TD-Severity Score||Scales|"The Brief Psychiatric Rating Scale (BPRS) assesses the severity of psychopathology in patients with schizophrenia and other psychotic disorders by addressing 18 items. The severity of each item is rated on a scale of 1 (not present) to 7 (extremely severe) (total score range: 18 to 126). Higher scores represent greater symptom severity.~The Clinical Global Impression of Tardive Dyskinesia-Severity (CGI-TD-severity) scale assesses the overall global severity of TD. The scale has 7 points from 1=normal, not at all ill to 7=among the most extremely ill patient."|units on a scale|Mean|3.9|3.9|Standard Deviation|1.2|1.2|||
3614603|NCT02736955|3464885|B3|CGI-TD-Severity Score||Scales|"The Brief Psychiatric Rating Scale (BPRS) assesses the severity of psychopathology in patients with schizophrenia and other psychotic disorders by addressing 18 items. The severity of each item is rated on a scale of 1 (not present) to 7 (extremely severe) (total score range: 18 to 126). Higher scores represent greater symptom severity.~The Clinical Global Impression of Tardive Dyskinesia-Severity (CGI-TD-severity) scale assesses the overall global severity of TD. The scale has 7 points from 1=normal, not at all ill to 7=among the most extremely ill patient."|units on a scale|Mean|4.3|4.3|Standard Deviation|0.7|0.7|||
3614604|NCT02736955|3464886|B2|CGI-TD-Severity Score||Scales|"The Brief Psychiatric Rating Scale (BPRS) assesses the severity of psychopathology in patients with schizophrenia and other psychotic disorders by addressing 18 items. The severity of each item is rated on a scale of 1 (not present) to 7 (extremely severe) (total score range: 18 to 126). Higher scores represent greater symptom severity.~The Clinical Global Impression of Tardive Dyskinesia-Severity (CGI-TD-severity) scale assesses the overall global severity of TD. The scale has 7 points from 1=normal, not at all ill to 7=among the most extremely ill patient."|units on a scale|Mean|3.9|3.9|Standard Deviation|1.3|1.3|||
3614605|NCT02736955|3464887|B1|CGI-TD-Severity Score||Scales|"The Brief Psychiatric Rating Scale (BPRS) assesses the severity of psychopathology in patients with schizophrenia and other psychotic disorders by addressing 18 items. The severity of each item is rated on a scale of 1 (not present) to 7 (extremely severe) (total score range: 18 to 126). Higher scores represent greater symptom severity.~The Clinical Global Impression of Tardive Dyskinesia-Severity (CGI-TD-severity) scale assesses the overall global severity of TD. The scale has 7 points from 1=normal, not at all ill to 7=among the most extremely ill patient."|units on a scale|Mean|3.9|3.9|Standard Deviation|1.1|1.1|||
3614606|NCT02736955|3464884|B4|BPRS Score||Scales|"The Brief Psychiatric Rating Scale (BPRS) assesses the severity of psychopathology in patients with schizophrenia and other psychotic disorders by addressing 18 items. The severity of each item is rated on a scale of 1 (not present) to 7 (extremely severe) (total score range: 18 to 126). Higher scores represent greater symptom severity.~The Clinical Global Impression of Tardive Dyskinesia-Severity (CGI-TD-severity) scale assesses the overall global severity of TD. The scale has 7 points from 1=normal, not at all ill to 7=among the most extremely ill patient."|units on a scale|Mean|26.6|26.6|Standard Deviation|6.0|6.0|||
3614607|NCT02736955|3464885|B3|BPRS Score||Scales|"The Brief Psychiatric Rating Scale (BPRS) assesses the severity of psychopathology in patients with schizophrenia and other psychotic disorders by addressing 18 items. The severity of each item is rated on a scale of 1 (not present) to 7 (extremely severe) (total score range: 18 to 126). Higher scores represent greater symptom severity.~The Clinical Global Impression of Tardive Dyskinesia-Severity (CGI-TD-severity) scale assesses the overall global severity of TD. The scale has 7 points from 1=normal, not at all ill to 7=among the most extremely ill patient."|units on a scale|Mean|30.5|30.5|Standard Deviation|9.2|9.2|||
3614608|NCT02736955|3464886|B2|BPRS Score||Scales|"The Brief Psychiatric Rating Scale (BPRS) assesses the severity of psychopathology in patients with schizophrenia and other psychotic disorders by addressing 18 items. The severity of each item is rated on a scale of 1 (not present) to 7 (extremely severe) (total score range: 18 to 126). Higher scores represent greater symptom severity.~The Clinical Global Impression of Tardive Dyskinesia-Severity (CGI-TD-severity) scale assesses the overall global severity of TD. The scale has 7 points from 1=normal, not at all ill to 7=among the most extremely ill patient."|units on a scale|Mean|26.1|26.1|Standard Deviation|5.6|5.6|||
3614609|NCT02736955|3464887|B1|BPRS Score||Scales|"The Brief Psychiatric Rating Scale (BPRS) assesses the severity of psychopathology in patients with schizophrenia and other psychotic disorders by addressing 18 items. The severity of each item is rated on a scale of 1 (not present) to 7 (extremely severe) (total score range: 18 to 126). Higher scores represent greater symptom severity.~The Clinical Global Impression of Tardive Dyskinesia-Severity (CGI-TD-severity) scale assesses the overall global severity of TD. The scale has 7 points from 1=normal, not at all ill to 7=among the most extremely ill patient."|units on a scale|Mean|27.3|27.3|Standard Deviation|6.3|6.3|||
3614610|NCT02736955|3464884|B4|Tardive Dyskinesia||Age at Diagnosis||years|Mean|48.0|48.0|Standard Deviation|10.1|10.1|||
3614611|NCT02736955|3464885|B3|Tardive Dyskinesia||Age at Diagnosis||years|Mean|43.8|43.8|Standard Deviation|13.7|13.7|||
3614612|NCT02736955|3464886|B2|Tardive Dyskinesia||Age at Diagnosis||years|Mean|48.4|48.4|Standard Deviation|9.5|9.5|||
3614613|NCT02736955|3464887|B1|Tardive Dyskinesia||Age at Diagnosis||years|Mean|48.3|48.3|Standard Deviation|11.2|11.2|||
3614614|NCT02736955|3464884|B4|Mood Disorder||Age at Diagnosis||years|Mean|34.7|34.7|Standard Deviation|1.8|1.8|||
3614615|NCT02736955|3464885|B3|Mood Disorder||Age at Diagnosis||years|Mean|46.0|46.0|Standard Deviation|14.0|14.0|||
3614616|NCT02736955|3464886|B2|Mood Disorder||Age at Diagnosis||years|Mean|33.9|33.9|Standard Deviation|2.1|2.1|||
3614617|NCT02736955|3464887|B1|Mood Disorder||Age at Diagnosis||years|Mean|36.0|36.0|Standard Deviation|3.6|3.6|||
3614618|NCT02736955|3464884|B4|Schizophrenia/Schizoaffective Disorder||Age at Diagnosis||years|Mean|28.2|28.2|Standard Deviation|10.6|10.6|||
3614619|NCT02736955|3464885|B3|Schizophrenia/Schizoaffective Disorder||Age at Diagnosis||years|Mean|25.3|25.3|Standard Deviation|6.2|6.2|||
3614620|NCT02736955|3464886|B2|Schizophrenia/Schizoaffective Disorder||Age at Diagnosis||years|Mean|28.7|28.7|Standard Deviation|11.4|11.4|||
3614621|NCT02736955|3464887|B1|Schizophrenia/Schizoaffective Disorder||Age at Diagnosis||years|Mean|27.1|27.1|Standard Deviation|8.3|8.3|||
3614622|NCT02736955|3464884|B4||Mood disorder|Primary Psychiatric Diagnosis||Participants|Count of Participants|56|56.0||||||
3614623|NCT02736955|3464885|B3||Mood disorder|Primary Psychiatric Diagnosis||Participants|Count of Participants|2|2.0||||||
3614624|NCT02736955|3464886|B2||Mood disorder|Primary Psychiatric Diagnosis||Participants|Count of Participants|42|42.0||||||
3614627|NCT02736955|3464885|B3||Schizophrenia/schizoaffective disorder|Primary Psychiatric Diagnosis||Participants|Count of Participants|6|6.0||||||
3614628|NCT02736955|3464886|B2||Schizophrenia/schizoaffective disorder|Primary Psychiatric Diagnosis||Participants|Count of Participants|75|75.0||||||
3614629|NCT02736955|3464887|B1||Schizophrenia/schizoaffective disorder|Primary Psychiatric Diagnosis||Participants|Count of Participants|23|23.0||||||
3614630|NCT02736955|3464884|B4|||Body Mass Index (BMI) at Baseline||kg/m^2|Mean|28.77|28.77|Standard Deviation|5.46|5.46|||
3614631|NCT02736955|3464885|B3|||Body Mass Index (BMI) at Baseline||kg/m^2|Mean|30.55|30.55|Standard Deviation|5.29|5.29|||
3614632|NCT02736955|3464886|B2|||Body Mass Index (BMI) at Baseline||kg/m^2|Mean|28.54|28.54|Standard Deviation|5.48|5.48|||
3614633|NCT02736955|3464887|B1|||Body Mass Index (BMI) at Baseline||kg/m^2|Mean|29.15|29.15|Standard Deviation|5.52|5.52|||
3614634|NCT02736955|3464884|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614635|NCT02736955|3464885|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614636|NCT02736955|3464886|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614637|NCT02736955|3464887|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614638|NCT02736955|3464884|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614639|NCT02736955|3464885|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614640|NCT02736955|3464886|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614641|NCT02736955|3464887|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614642|NCT02736955|3464884|B4||White|Race (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
3614643|NCT02736955|3464885|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3614644|NCT02736955|3464886|B2||White|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
3614645|NCT02736955|3464887|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3614646|NCT02736955|3464884|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3614647|NCT02736955|3464885|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3614648|NCT02736955|3464886|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3614649|NCT02736955|3464887|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3614650|NCT02736955|3464884|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3614651|NCT02736955|3464885|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614652|NCT02736955|3464886|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3614653|NCT02736955|3464887|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614654|NCT02736955|3464884|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614655|NCT02736955|3464885|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614656|NCT02736955|3464886|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614657|NCT02736955|3464887|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614658|NCT02736955|3464884|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3614659|NCT02736955|3464885|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3614660|NCT02736955|3464886|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614661|NCT02736955|3464887|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614662|NCT02736955|3464884|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614663|NCT02736955|3464885|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614664|NCT02736955|3464886|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614665|NCT02736955|3464887|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614666|NCT02736955|3464884|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
3614667|NCT02736955|3464885|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3614668|NCT02736955|3464886|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3614669|NCT02736955|3464887|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3614670|NCT02736955|3464884|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3614671|NCT02736955|3464885|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3614672|NCT02736955|3464886|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3614673|NCT02736955|3464887|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3614674|NCT02736955|3464884|B4||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3614675|NCT02736955|3464885|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3614676|NCT02736955|3464886|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3614677|NCT02736955|3464887|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3614678|NCT02736955|3464884|B4||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3614679|NCT02736955|3464885|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3614680|NCT02736955|3464886|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3614681|NCT02736955|3464887|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3614682|NCT02736955|3464884|B4|||Age||years|Mean|57.9|57.9|Standard Deviation|8.8|8.8|||
3614683|NCT02736955|3464885|B3|||Age||years|Mean|59.3|59.3|Standard Deviation|9.0|9.0|||
3614684|NCT02736955|3464886|B2|||Age||years|Mean|57.9|57.9|Standard Deviation|8.8|8.8|||
3614685|NCT02736955|3464887|B1|||Age||years|Mean|57.3|57.3|Standard Deviation|8.9|8.9|||
3614686|NCT02736721|3464903|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3614687|NCT02736721|3464903|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3614688|NCT02736721|3464903|B1|||Age||years|Mean|48.5|48.5|Standard Deviation|14.1|14.1|||
3614689|NCT02736175|3464912|B3|Black||Iris Color||Participants|Count of Participants|2|2.0||||||
3614690|NCT02736175|3464913|B2|Black||Iris Color||Participants|Count of Participants|2|2.0||||||
3614691|NCT02736175|3464914|B1|Black||Iris Color||Participants|Count of Participants|0|0.0||||||
3614692|NCT02736175|3464912|B3|Gray||Iris Color||Participants|Count of Participants|2|2.0||||||
3614693|NCT02736175|3464913|B2|Gray||Iris Color||Participants|Count of Participants|0|0.0||||||
3614694|NCT02736175|3464914|B1|Gray||Iris Color||Participants|Count of Participants|2|2.0||||||
3614695|NCT02736175|3464912|B3|Green||Iris Color||Participants|Count of Participants|33|33.0||||||
3614696|NCT02736175|3464913|B2|Green||Iris Color||Participants|Count of Participants|18|18.0||||||
3614697|NCT02736175|3464914|B1|Green||Iris Color||Participants|Count of Participants|15|15.0||||||
3614698|NCT02736175|3464912|B3|Hazel||Iris Color||Participants|Count of Participants|69|69.0||||||
3614699|NCT02736175|3464913|B2|Hazel||Iris Color||Participants|Count of Participants|37|37.0||||||
3614700|NCT02736175|3464914|B1|Hazel||Iris Color||Participants|Count of Participants|32|32.0||||||
3614701|NCT02736175|3464912|B3|Blue||Iris Color||Participants|Count of Participants|125|125.0||||||
3614702|NCT02736175|3464913|B2|Blue||Iris Color||Participants|Count of Participants|64|64.0||||||
3614703|NCT02736175|3464914|B1|Blue||Iris Color||Participants|Count of Participants|61|61.0||||||
3614704|NCT02736175|3464912|B3|Brown||Iris Color||Participants|Count of Participants|207|207.0||||||
3614705|NCT02736175|3464913|B2|Brown||Iris Color||Participants|Count of Participants|101|101.0||||||
3614706|NCT02736175|3464914|B1|Brown||Iris Color||Participants|Count of Participants|106|106.0||||||
3614707|NCT02736175|3464912|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3614708|NCT02736175|3464913|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3614709|NCT02736175|3464914|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3614710|NCT02736175|3464912|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3614711|NCT02736175|3464913|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Not collected in this manner
3614712|NCT02736175|3464914|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Not collected in this manner
3614713|NCT02736175|3464912|B3||White|Race (NIH/OMB)||Participants|Count of Participants|363|363.0||||||
3614714|NCT02736175|3464913|B2||White|Race (NIH/OMB)||Participants|Count of Participants|189|189.0||||||
3614715|NCT02736175|3464914|B1||White|Race (NIH/OMB)||Participants|Count of Participants|174|174.0||||||
3614716|NCT02736175|3464912|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3614717|NCT02736175|3464913|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3614718|NCT02736175|3464914|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3614719|NCT02736175|3464912|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3614720|NCT02736175|3464913|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3614721|NCT02736175|3464914|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3614722|NCT02736175|3464912|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3614723|NCT02736175|3464913|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3614724|NCT02736175|3464914|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3614725|NCT02736175|3464912|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3614726|NCT02736175|3464913|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3614727|NCT02736175|3464914|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3614728|NCT02736175|3464912|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614729|NCT02736175|3464913|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614730|NCT02736175|3464914|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614731|NCT02736175|3464912|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|364|364.0||||||
3614732|NCT02736175|3464913|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|185|185.0||||||
3614733|NCT02736175|3464914|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|179|179.0||||||
3614734|NCT02736175|3464912|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3614735|NCT02736175|3464913|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3614736|NCT02736175|3464914|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3614737|NCT02736175|3464912|B3||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3614738|NCT02736175|3464913|B2||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3614739|NCT02736175|3464914|B1||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3614740|NCT02736175|3464912|B3||Female|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
3614741|NCT02736175|3464913|B2||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3614742|NCT02736175|3464914|B1||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3614743|NCT02736175|3464912|B3|||Age||years|Mean|68.0|68.0|Standard Deviation|8.75|8.75|||
3614744|NCT02736175|3464913|B2|||Age||years|Mean|68.6|68.6|Standard Deviation|8.37|8.37|||
3614745|NCT02736175|3464914|B1|||Age||years|Mean|67.3|67.3|Standard Deviation|9.09|9.09|||
3614746|NCT02735200|3464923|B3|Saudi Arabia||Region of Enrollment||participants|Number|550|550.0||||||
3614747|NCT02735200|3464924|B2|Saudi Arabia||Region of Enrollment||participants|Number|200|200.0||||||
3614748|NCT02735200|3464925|B1|Saudi Arabia||Region of Enrollment||participants|Number|350|350.0||||||
3614749|NCT02735200|3464923|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3614750|NCT02735200|3464923|B3||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3614751|NCT02735200|3464924|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3614752|NCT02735200|3464925|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3614753|NCT02735200|3464923|B3||Female|Sex: Female, Male||Participants|Count of Participants|422|422.0||||||
3614754|NCT02735200|3464924|B2||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3614755|NCT02735200|3464925|B1||Female|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
3614756|NCT02735200|3464923|B3|||Age||years|Mean|41.9|41.9|Standard Deviation|16.1|16.1|||
3614757|NCT02735200|3464924|B2|||Age||years|Mean|41.6|41.6|Standard Deviation|16.6|16.6|||
3614758|NCT02735200|3464925|B1|||Age||years|Mean|42.59|42.59|Standard Deviation|15.74|15.74|||
3614759|NCT02735200|3464923|B3||>=65 years|Age||Participants|Count of Participants|79|79.0||||||
3614760|NCT02735200|3464924|B2||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
3614761|NCT02735200|3464925|B1||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
3614762|NCT02735200|3464923|B3||Between 18 and 65 years|Age||Participants|Count of Participants|471|471.0||||||
3614763|NCT02735200|3464924|B2||Between 18 and 65 years|Age||Participants|Count of Participants|171|171.0||||||
3614764|NCT02735200|3464925|B1||Between 18 and 65 years|Age||Participants|Count of Participants|300|300.0||||||
3614765|NCT02735200|3464923|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3614766|NCT02735200|3464924|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3614767|NCT02735200|3464925|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3614768|NCT02734953|3464932|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3614769|NCT02734953|3464932|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3614770|NCT02734953|3464932|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3614771|NCT02734953|3464932|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3614772|NCT02734953|3464932|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3614773|NCT02734953|3464932|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3614774|NCT02734810|3464972|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
3614775|NCT02734810|3464974|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3614776|NCT02734810|3464972|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614777|NCT02734810|3464973|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614778|NCT02734810|3464974|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614779|NCT02734810|3464972|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614780|NCT02734810|3464973|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614781|NCT02734810|3464974|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614782|NCT02734810|3464972|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3614783|NCT02734810|3464973|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614784|NCT02734810|3464974|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3614785|NCT02734810|3464972|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614786|NCT02734810|3464973|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614787|NCT02734810|3464974|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614788|NCT02734810|3464972|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614789|NCT02734810|3464973|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614790|NCT02734810|3464974|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614791|NCT02734810|3464972|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614792|NCT02734810|3464973|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614793|NCT02734810|3464974|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614794|NCT02734810|3464972|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614795|NCT02734810|3464973|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614796|NCT02734810|3464974|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614797|NCT02734810|3464972|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3614798|NCT02734810|3464973|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3614799|NCT02734810|3464974|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3614800|NCT02734810|3464972|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3614801|NCT02734810|3464973|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3614802|NCT02734810|3464974|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3614803|NCT02734810|3464972|B3|||Age||years|Mean|24.1|24.1|Full Range|||8.0|52.0|
3614804|NCT02734810|3464974|B1|||Age||years|Mean|24.1|24.1|Full Range|||8.0|52.0|
3614805|NCT02734355|3464981|B3|Russian Federation||Region of Enrollment||Participants|Count of Participants|64|64.0||||||
3614806|NCT02734355|3464982|B2|Russian Federation||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3614807|NCT02734355|3464983|B1|Russian Federation||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3614808|NCT02734355|3464981|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3614809|NCT02734355|3464982|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3614810|NCT02734355|3464983|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3614811|NCT02734355|3464981|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3614812|NCT02734355|3464982|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3614813|NCT02734355|3464983|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3614814|NCT02734355|3464981|B3|||Age||years|Mean|53.1|53.1|Standard Deviation|6.7|6.7|||
3614815|NCT02734355|3464982|B2|||Age||years|Mean|54.1|54.1|Standard Deviation|6.2|6.2|||
3614816|NCT02734355|3464983|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|5.7|5.7|||
3614817|NCT02734212|3465014|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3614818|NCT02734212|3465015|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3614819|NCT02734212|3465016|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3614820|NCT02734212|3465014|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3614821|NCT02734212|3465015|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3614822|NCT02734212|3465016|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3614823|NCT02734212|3465014|B3|||Age||years|Mean|53.6|53.6|Standard Deviation|11.1|11.1|||
3614824|NCT02734212|3465015|B2|||Age||years|Mean|55.5|55.5|Standard Deviation|8.5|8.5|||
3614825|NCT02734212|3465016|B1|||Age||years|Mean|51.8|51.8|Standard Deviation|13.0|13.0|||
3614826|NCT02734056|3465027|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614827|NCT02734056|3465028|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614828|NCT02734056|3465029|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614829|NCT02734056|3465027|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3614830|NCT02734056|3465028|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3614831|NCT02734056|3465029|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3614832|NCT02734056|3465027|B3||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3614833|NCT02734056|3465028|B2||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3614834|NCT02734056|3465029|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3614835|NCT02734056|3465027|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3614836|NCT02734056|3465028|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3614837|NCT02734056|3465029|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3614838|NCT02734056|3465027|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614839|NCT02734056|3465028|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614840|NCT02734056|3465029|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614841|NCT02734056|3465027|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3614842|NCT02734056|3465028|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3614843|NCT02734056|3465029|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3614844|NCT02734056|3465027|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614845|NCT02734056|3465028|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614846|NCT02734056|3465029|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614847|NCT02734056|3465027|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3614848|NCT02734056|3465028|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3614849|NCT02734056|3465029|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3614850|NCT02734056|3465027|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3614851|NCT02734056|3465028|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3614852|NCT02734056|3465029|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3614853|NCT02734056|3465027|B3|||Age||years|Mean|32|32.0|Standard Deviation|6|6.0|||
3614854|NCT02734056|3465028|B2|||Age||years|Mean|32|32.0|Standard Deviation|6|6.0|||
3614855|NCT02734056|3465029|B1|||Age||years|Mean|31|31.0|Standard Deviation|6|6.0|||
3614856|NCT02733653|3465036|B1|Japan||Region of Enrollment||participants|Number|50|50.0||||||
3614857|NCT02733653|3465036|B1|Japanese||Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
3614858|NCT02733653|3465036|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3614859|NCT02733653|3465036|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3614860|NCT02733653|3465036|B1|||Age||years|Mean|72.3|72.3|Full Range|||50.0|90.0|
3614861|NCT02733588|3465042|B1|||Received nutritional counseling||Participants|Count of Participants|7|7.0||||||
3614862|NCT02733588|3465042|B1|||Prescribed glucose-modifying medications||Participants|Count of Participants|6|6.0||||||
3614863|NCT02733588|3465042|B1|||Delta BMI||kg/m2|Mean|-16.3|-16.3|Full Range|||-36.7|-5.2|
3614864|NCT02733588|3465042|B1|||Current BMI||kg/m2|Mean|30.1|30.1|Full Range|||24.3|36.8|
3614865|NCT02733588|3465042|B1|||Preoperative Body Mass Index (BMI)||kg/m2|Mean|46.4|46.4|Full Range|||37.8|61.0|
3614866|NCT02733588|3465042|B1|||Hemoglobin A1c||%|Mean|5.7|5.7|Full Range|||5.4|5.8|
3614867|NCT02733588|3465042|B1|||Months postop at study visit||months|Median|116|116.0|Full Range|||45.0|176.0|
3614868|NCT02733588|3465042|B1|||Months postop hypoglycemia diagnosed||months|Mean|41|41.0|Full Range|||12.0|150.0|
3614869|NCT02733588|3465042|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3614870|NCT02733588|3465042|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614871|NCT02733588|3465042|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614872|NCT02733588|3465042|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3614873|NCT02733588|3465042|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614874|NCT02733588|3465042|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614875|NCT02733588|3465042|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614876|NCT02733588|3465042|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614877|NCT02733588|3465042|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614878|NCT02733588|3465042|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3614879|NCT02733588|3465042|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3614880|NCT02733588|3465042|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3614881|NCT02733588|3465042|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3614882|NCT02733588|3465042|B1|||Age||years|Median|51|51.0|Full Range|||38.0|62.0|
3614883|NCT02732899|3465049|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3614884|NCT02732899|3465050|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3614885|NCT02732899|3465051|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3614886|NCT02732899|3465049|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614887|NCT02732899|3465050|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614888|NCT02732899|3465051|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614889|NCT02732899|3465049|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614890|NCT02732899|3465050|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614891|NCT02732899|3465051|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614892|NCT02732899|3465049|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3614893|NCT02732899|3465050|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3614894|NCT02732899|3465051|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3614895|NCT02732899|3465049|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614896|NCT02732899|3465050|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614897|NCT02732899|3465051|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614898|NCT02732899|3465049|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614899|NCT02732899|3465050|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614900|NCT02732899|3465051|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614901|NCT02732899|3465049|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614902|NCT02732899|3465050|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614903|NCT02732899|3465051|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614904|NCT02732899|3465049|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614905|NCT02732899|3465050|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614906|NCT02732899|3465051|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614907|NCT02732899|3465049|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3614908|NCT02732899|3465050|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3614909|NCT02732899|3465051|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3614910|NCT02732899|3465049|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3614911|NCT02732899|3465050|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3614912|NCT02732899|3465051|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3614913|NCT02732899|3465049|B3|||Age||years|Mean|74|74.0|Full Range|||63.0|91.0|
3614914|NCT02732899|3465050|B2|||Age||years|Mean|77|77.0|Full Range|||63.0|91.0|
3614915|NCT02732899|3465051|B1|||Age||years|Mean|71|71.0|Full Range|||69.0|90.0|
3614916|NCT02732639|3465060|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3614917|NCT02732639|3465060|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3614918|NCT02732639|3465060|B1|||Age||years|Mean|38|38.0|Standard Deviation|13.3|13.3|||
3614919|NCT02732561|3465071|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614920|NCT02732561|3465072|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614921|NCT02732561|3465073|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614922|NCT02732561|3465071|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614923|NCT02732561|3465072|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614924|NCT02732561|3465073|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614925|NCT02732561|3465071|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3614926|NCT02732561|3465072|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3614927|NCT02732561|3465073|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3614928|NCT02732561|3465071|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3614929|NCT02732561|3465072|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3614930|NCT02732561|3465073|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3614931|NCT02732561|3465071|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614932|NCT02732561|3465072|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614933|NCT02732561|3465073|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614934|NCT02732561|3465071|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614935|NCT02732561|3465072|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614936|NCT02732561|3465073|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614937|NCT02732561|3465071|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614938|NCT02732561|3465072|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614939|NCT02732561|3465073|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3614940|NCT02732561|3465071|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3614941|NCT02732561|3465072|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3614942|NCT02732561|3465073|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3614943|NCT02732561|3465071|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3614944|NCT02732561|3465072|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3614945|NCT02732561|3465073|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3614946|NCT02732561|3465071|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3614947|NCT02732561|3465072|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3614948|NCT02732561|3465073|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3614949|NCT02732561|3465071|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3614950|NCT02732561|3465072|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3614951|NCT02732561|3465073|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3614952|NCT02732561|3465071|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3614953|NCT02732561|3465072|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3614954|NCT02732561|3465073|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3614955|NCT02732327|3465082|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3614956|NCT02732327|3465083|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3614957|NCT02732327|3465082|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3614958|NCT02732327|3465083|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3614959|NCT02732327|3465082|B3|Between 18 and 65 years||Age, Customized||Participants|Number|0|0.0||||||
3614960|NCT02732327|3465083|B2|Between 18 and 65 years||Age, Customized||Participants|Number|2|2.0||||||
3614961|NCT02732210|3465091|B3|Not Hispanic or Latino||Ethnicity||participants|Number|888|888.0||||||
3614962|NCT02732210|3465092|B2|Not Hispanic or Latino||Ethnicity||participants|Number|587|587.0||||||
3614963|NCT02732210|3465093|B1|Not Hispanic or Latino||Ethnicity||participants|Number|301|301.0||||||
3614964|NCT02732210|3465091|B3|Hispanic or Latino||Ethnicity||participants|Number|47|47.0||||||
3614965|NCT02732210|3465092|B2|Hispanic or Latino||Ethnicity||participants|Number|45|45.0||||||
3614966|NCT02732210|3465093|B1|Hispanic or Latino||Ethnicity||participants|Number|2|2.0||||||
3614967|NCT02732210|3465091|B3|Mixed race||Race||participants|Number|2|2.0||||||
3614968|NCT02732210|3465092|B2|Mixed race||Race||participants|Number|2|2.0||||||
3614969|NCT02732210|3465093|B1|Mixed race||Race||participants|Number|0|0.0||||||
3614970|NCT02732210|3465091|B3|Other||Race||participants|Number|9|9.0||||||
3614971|NCT02732210|3465092|B2|Other||Race||participants|Number|8|8.0||||||
3614972|NCT02732210|3465093|B1|Other||Race||participants|Number|1|1.0||||||
3614973|NCT02732210|3465091|B3|White||Race||participants|Number|886|886.0||||||
3614974|NCT02732210|3465092|B2|White||Race||participants|Number|601|601.0||||||
3614975|NCT02732210|3465093|B1|White||Race||participants|Number|285|285.0||||||
3614976|NCT02732210|3465091|B3|Native Hawaiian or Other Pacific Islander||Race||participants|Number|2|2.0||||||
3614977|NCT02732210|3465092|B2|Native Hawaiian or Other Pacific Islander||Race||participants|Number|1|1.0||||||
3614978|NCT02732210|3465093|B1|Native Hawaiian or Other Pacific Islander||Race||participants|Number|1|1.0||||||
3614979|NCT02732210|3465091|B3|Black or African American||Race||participants|Number|9|9.0||||||
3614980|NCT02732210|3465092|B2|Black or African American||Race||participants|Number|9|9.0||||||
3614981|NCT02732210|3465093|B1|Black or African American||Race||participants|Number|0|0.0||||||
3614982|NCT02732210|3465091|B3|Asian||Race||participants|Number|25|25.0||||||
3614983|NCT02732210|3465092|B2|Asian||Race||participants|Number|9|9.0||||||
3614984|NCT02732210|3465093|B1|Asian||Race||participants|Number|16|16.0||||||
3614985|NCT02732210|3465091|B3|American Indian or Alaska Native||Race||participants|Number|2|2.0||||||
3614986|NCT02732210|3465092|B2|American Indian or Alaska Native||Race||participants|Number|2|2.0||||||
3614987|NCT02732210|3465093|B1|American Indian or Alaska Native||Race||participants|Number|0|0.0||||||
3614988|NCT02732210|3465091|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3614989|NCT02732210|3465092|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3614990|NCT02732210|3465093|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3614991|NCT02732210|3465091|B3||Female|Sex: Female, Male||Participants|Count of Participants|935|935.0||||||
3614992|NCT02732210|3465092|B2||Female|Sex: Female, Male||Participants|Count of Participants|632|632.0||||||
3614993|NCT02732210|3465093|B1||Female|Sex: Female, Male||Participants|Count of Participants|303|303.0||||||
3614994|NCT02732210|3465091|B3|≥ 75 years||Age, Customized||participants|Number|350|350.0||||||
3614995|NCT02732210|3465092|B2|≥ 75 years||Age, Customized||participants|Number|264|264.0||||||
3614996|NCT02732210|3465093|B1|≥ 75 years||Age, Customized||participants|Number|86|86.0||||||
3614997|NCT02732210|3465091|B3|≥ 65 to < 75 years||Age, Customized||participants|Number|318|318.0||||||
3614998|NCT02732210|3465092|B2|≥ 65 to < 75 years||Age, Customized||participants|Number|216|216.0||||||
3614999|NCT02732210|3465093|B1|≥ 65 to < 75 years||Age, Customized||participants|Number|102|102.0||||||
3615000|NCT02732210|3465091|B3|< 65 years||Age, Customized||participants|Number|267|267.0||||||
3615001|NCT02732210|3465092|B2|< 65 years||Age, Customized||participants|Number|152|152.0||||||
3615002|NCT02732210|3465093|B1|< 65 years||Age, Customized||participants|Number|115|115.0||||||
3615003|NCT02732210|3465091|B3|||Age||years|Mean|70.8|70.8|Standard Deviation|9.9|9.9|||
3615004|NCT02732210|3465092|B2|||Age||years|Mean|71.9|71.9|Standard Deviation|10.0|10.0|||
3615005|NCT02732210|3465093|B1|||Age||years|Mean|68.6|68.6|Standard Deviation|9.2|9.2|||
3615006|NCT02731833|3465110|B3|||Tactile Sensitivity - Tactile Threshold at Baseline|The examiner assessed the response to tactile sensitivity using a Yeaple probe which allowed application of a known force to the dentin surface, starting at 10g and rising in increments of 10g until the tactile threshold or maximum force was reached. The tactile threshold for each tooth was determined by asking the participant whether the sensation caused discomfort. The pressure setting at which the participant gives two consecutive 'yes' responses was recorded as the tactile threshold. The higher the tactile threshold, the less sensitive the tooth.|gram (g)|Mean|13.04|13.04|Standard Deviation|4.240|4.24|||
3615007|NCT02731833|3465111|B2|||Tactile Sensitivity - Tactile Threshold at Baseline|The examiner assessed the response to tactile sensitivity using a Yeaple probe which allowed application of a known force to the dentin surface, starting at 10g and rising in increments of 10g until the tactile threshold or maximum force was reached. The tactile threshold for each tooth was determined by asking the participant whether the sensation caused discomfort. The pressure setting at which the participant gives two consecutive 'yes' responses was recorded as the tactile threshold. The higher the tactile threshold, the less sensitive the tooth.|gram (g)|Mean|13.42|13.42|Standard Deviation|4.263|4.263|||
3615008|NCT02731833|3465112|B1|||Tactile Sensitivity - Tactile Threshold at Baseline|The examiner assessed the response to tactile sensitivity using a Yeaple probe which allowed application of a known force to the dentin surface, starting at 10g and rising in increments of 10g until the tactile threshold or maximum force was reached. The tactile threshold for each tooth was determined by asking the participant whether the sensation caused discomfort. The pressure setting at which the participant gives two consecutive 'yes' responses was recorded as the tactile threshold. The higher the tactile threshold, the less sensitive the tooth.|gram (g)|Mean|12.66|12.66|Standard Deviation|4.201|4.201|||
3615009|NCT02731833|3465110|B3|||Schiff Sensitivity Score at Baseline|Examiner assessed the participant's response to evaporative air stimulus for each tooth using the Schiff Sensitivity Scale which was scored as follows - 0: Participant does not respond to air stimulation; 1: Participant responded to air stimulus but does not request discontinuation of stimulus; 2: Participant responded to air stimulus and requests discontinuation or moves from stimulus; 3: Participant responded to stimulus, considered stimulus to be painful, and requested discontinuation of the stimulus. A reduction in Schiff Sensitivity score was indicative of an improvement in sensitivity.|Score on a Scale|Mean|2.48|2.48|Standard Deviation|0.472|0.472|||
3615010|NCT02731833|3465111|B2|||Schiff Sensitivity Score at Baseline|Examiner assessed the participant's response to evaporative air stimulus for each tooth using the Schiff Sensitivity Scale which was scored as follows - 0: Participant does not respond to air stimulation; 1: Participant responded to air stimulus but does not request discontinuation of stimulus; 2: Participant responded to air stimulus and requests discontinuation or moves from stimulus; 3: Participant responded to stimulus, considered stimulus to be painful, and requested discontinuation of the stimulus. A reduction in Schiff Sensitivity score was indicative of an improvement in sensitivity.|Score on a Scale|Mean|2.46|2.46|Standard Deviation|0.461|0.461|||
3615011|NCT02731833|3465112|B1|||Schiff Sensitivity Score at Baseline|Examiner assessed the participant's response to evaporative air stimulus for each tooth using the Schiff Sensitivity Scale which was scored as follows - 0: Participant does not respond to air stimulation; 1: Participant responded to air stimulus but does not request discontinuation of stimulus; 2: Participant responded to air stimulus and requests discontinuation or moves from stimulus; 3: Participant responded to stimulus, considered stimulus to be painful, and requested discontinuation of the stimulus. A reduction in Schiff Sensitivity score was indicative of an improvement in sensitivity.|Score on a Scale|Mean|2.50|2.5|Standard Deviation|0.484|0.484|||
3615012|NCT02731833|3465110|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615013|NCT02731833|3465111|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615014|NCT02731833|3465112|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615015|NCT02731833|3465110|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615016|NCT02731833|3465111|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615017|NCT02731833|3465112|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615018|NCT02731833|3465110|B3||White|Race (NIH/OMB)||Participants|Count of Participants|133|133.0||||||
3615019|NCT02731833|3465111|B2||White|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3615020|NCT02731833|3465112|B1||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3615021|NCT02731833|3465110|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3615022|NCT02731833|3465111|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3615023|NCT02731833|3465112|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3615024|NCT02731833|3465110|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615025|NCT02731833|3465111|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615026|NCT02731833|3465112|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615027|NCT02731833|3465110|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3615028|NCT02731833|3465111|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3615029|NCT02731833|3465112|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3615030|NCT02731833|3465110|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615031|NCT02731833|3465111|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615032|NCT02731833|3465112|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615033|NCT02731833|3465110|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615034|NCT02731833|3465111|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615035|NCT02731833|3465112|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615036|NCT02731833|3465110|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|219|219.0||||||
3615037|NCT02731833|3465111|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
3615038|NCT02731833|3465112|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|109|109.0||||||
3615039|NCT02731833|3465110|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3615040|NCT02731833|3465111|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3615041|NCT02731833|3465112|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3615042|NCT02731833|3465110|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3615043|NCT02731833|3465111|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3615044|NCT02731833|3465112|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3615045|NCT02731833|3465110|B3||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3615046|NCT02731833|3465111|B2||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3615047|NCT02731833|3465112|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3615048|NCT02731833|3465110|B3|||Age||Years|Mean|47.0|47.0|Standard Deviation|10.85|10.85|||
3615049|NCT02731833|3465111|B2|||Age||Years|Mean|47.6|47.6|Standard Deviation|10.95|10.95|||
3615050|NCT02731833|3465112|B1|||Age||Years|Mean|46.4|46.4|Standard Deviation|10.77|10.77|||
3615051|NCT02731313|3465125|B1||Male|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
3615052|NCT02731313|3465125|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3615053|NCT02731313|3465125|B1|||Age||years|Mean|66.4|66.4|Standard Deviation|13.2|13.2|||
3615054|NCT02731300|3465133|B3|5 drugs||Number of antiepileptic drugs used||participants|Number|4|4.0||||||
3615055|NCT02731300|3465134|B2|5 drugs||Number of antiepileptic drugs used||participants|Number|2|2.0||||||
3615056|NCT02731300|3465135|B1|5 drugs||Number of antiepileptic drugs used||participants|Number|2|2.0||||||
3615057|NCT02731300|3465133|B3|4 drugs||Number of antiepileptic drugs used||participants|Number|6|6.0||||||
3615058|NCT02731300|3465134|B2|4 drugs||Number of antiepileptic drugs used||participants|Number|2|2.0||||||
3615059|NCT02731300|3465135|B1|4 drugs||Number of antiepileptic drugs used||participants|Number|4|4.0||||||
3615060|NCT02731300|3465133|B3|3 drugs||Number of antiepileptic drugs used||participants|Number|12|12.0||||||
3615061|NCT02731300|3465134|B2|3 drugs||Number of antiepileptic drugs used||participants|Number|3|3.0||||||
3615062|NCT02731300|3465135|B1|3 drugs||Number of antiepileptic drugs used||participants|Number|9|9.0||||||
3615063|NCT02731300|3465133|B3|||Age at onset of seizures||years|Mean|2.08|2.08|Standard Deviation|2.18|2.18|||
3615064|NCT02731300|3465134|B2|||Age at onset of seizures||years|Mean|1.58|1.58|Standard Deviation|1.70|1.7|||
3615065|NCT02731300|3465135|B1|||Age at onset of seizures||years|Mean|2.32|2.32|Standard Deviation|2.39|2.39|||
3615066|NCT02731300|3465133|B3|||Baseline epileptic discharges per 30 minutes||epileptic discharges/30 mins|Mean|691.27|691.27|Standard Deviation|303.62|303.62|||
3615067|NCT02731300|3465134|B2|||Baseline epileptic discharges per 30 minutes||epileptic discharges/30 mins|Mean|800.86|800.86|Standard Deviation|374.62|374.62|||
3615068|NCT02731300|3465135|B1|||Baseline epileptic discharges per 30 minutes||epileptic discharges/30 mins|Mean|640.13|640.13|Standard Deviation|263.30|263.3|||
3615069|NCT02731300|3465133|B3|||Baseline seizure frequency per day||seizures per day|Mean|84.73|84.73|Standard Deviation|55.13|55.13|||
3615070|NCT02731300|3465134|B2|||Baseline seizure frequency per day||seizures per day|Mean|93.43|93.43|Standard Deviation|59.94|59.94|||
3615071|NCT02731300|3465135|B1|||Baseline seizure frequency per day||seizures per day|Mean|80.67|80.67|Standard Deviation|54.43|54.43|||
3615072|NCT02731300|3465133|B3|Preterm with history of intercerebral hemorrhage||Etiologies of epilepsy||participants|Number|3|3.0||||||
3615073|NCT02731300|3465134|B2|Preterm with history of intercerebral hemorrhage||Etiologies of epilepsy||participants|Number|1|1.0||||||
3615074|NCT02731300|3465135|B1|Preterm with history of intercerebral hemorrhage||Etiologies of epilepsy||participants|Number|2|2.0||||||
3615075|NCT02731300|3465133|B3|Preterm with severe birth asphyxia||Etiologies of epilepsy||participants|Number|2|2.0||||||
3615076|NCT02731300|3465134|B2|Preterm with severe birth asphyxia||Etiologies of epilepsy||participants|Number|0|0.0||||||
3615077|NCT02731300|3465135|B1|Preterm with severe birth asphyxia||Etiologies of epilepsy||participants|Number|2|2.0||||||
3615078|NCT02731300|3465133|B3|Neonatal hypoglycemia||Etiologies of epilepsy||participants|Number|7|7.0||||||
3615079|NCT02731300|3465134|B2|Neonatal hypoglycemia||Etiologies of epilepsy||participants|Number|3|3.0||||||
3615080|NCT02731300|3465135|B1|Neonatal hypoglycemia||Etiologies of epilepsy||participants|Number|4|4.0||||||
3615081|NCT02731300|3465133|B3|Infantile spasm||Etiologies of epilepsy||participants|Number|2|2.0||||||
3615082|NCT02731300|3465134|B2|Infantile spasm||Etiologies of epilepsy||participants|Number|1|1.0||||||
3615083|NCT02731300|3465135|B1|Infantile spasm||Etiologies of epilepsy||participants|Number|1|1.0||||||
3615084|NCT02731300|3465133|B3|Idiopathic||Etiologies of epilepsy||participants|Number|8|8.0||||||
3615085|NCT02731300|3465134|B2|Idiopathic||Etiologies of epilepsy||participants|Number|2|2.0||||||
3615086|NCT02731300|3465135|B1|Idiopathic||Etiologies of epilepsy||participants|Number|6|6.0||||||
3615087|NCT02731300|3465133|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3615088|NCT02731300|3465134|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3615089|NCT02731300|3465135|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3615090|NCT02731300|3465133|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3615091|NCT02731300|3465134|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3615092|NCT02731300|3465135|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3615093|NCT02731300|3465133|B3|||Age||years|Mean|6.55|6.55|Standard Deviation|1.65|1.65|||
3615094|NCT02731300|3465134|B2|||Age||years|Mean|6.29|6.29|Standard Deviation|1.98|1.98|||
3615095|NCT02731300|3465135|B1|||Age||years|Mean|6.67|6.67|Standard Deviation|1.54|1.54|||
3615096|NCT02731131|3465144|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3615097|NCT02731131|3465145|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3615098|NCT02731131|3465146|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3615099|NCT02731131|3465144|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3615100|NCT02731131|3465145|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3615101|NCT02731131|3465146|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3615102|NCT02731131|3465144|B3|||Age||years|Mean|48.2|48.2|Standard Deviation|8.0|8.0|||
3615103|NCT02731131|3465145|B2|||Age||years|Mean|49.2|49.2|Standard Deviation|7.4|7.4|||
3615104|NCT02731131|3465146|B1|||Age||years|Mean|47.2|47.2|Standard Deviation|9.2|9.2|||
3615105|NCT02730819|3465163|B1|||Received prior treatments for melasma||Participants|Count of Participants|12|12.0||||||
3615106|NCT02730819|3465163|B1|||Melasma started with pregnancy||Participants|Count of Participants|5|5.0||||||
3615107|NCT02730819|3465163|B1|||Use sunscreen daily||Participants|Count of Participants|11|11.0||||||
3615108|NCT02730819|3465163|B1|||Use oral contraceptives||Participants|Count of Participants|3|3.0||||||
3615109|NCT02730819|3465163|B1||Type 5|Fitzpatrick Skin Type|"The Fitzpatrick scale is a numerical classification schema for human skin color.~Type I (scores 0–6) always burns, never tans Type II (scores 7–13) usually burns, tans minimally Type III (scores 14–20) sometimes mild burn, tans uniformly Type IV (scores 21–27) burns minimally, always tans well Type V (scores 28–34) very rarely burns, tans very easily Type VI (scores 35–36) Never burns, never tans (deeply pigmented dark brown to darkest brown)"|Participants|Count of Participants|2|2.0||||||
3615110|NCT02730819|3465163|B1||Type 4|Fitzpatrick Skin Type|"The Fitzpatrick scale is a numerical classification schema for human skin color.~Type I (scores 0–6) always burns, never tans Type II (scores 7–13) usually burns, tans minimally Type III (scores 14–20) sometimes mild burn, tans uniformly Type IV (scores 21–27) burns minimally, always tans well Type V (scores 28–34) very rarely burns, tans very easily Type VI (scores 35–36) Never burns, never tans (deeply pigmented dark brown to darkest brown)"|Participants|Count of Participants|1|1.0||||||
3615111|NCT02730819|3465163|B1||Type 3|Fitzpatrick Skin Type|"The Fitzpatrick scale is a numerical classification schema for human skin color.~Type I (scores 0–6) always burns, never tans Type II (scores 7–13) usually burns, tans minimally Type III (scores 14–20) sometimes mild burn, tans uniformly Type IV (scores 21–27) burns minimally, always tans well Type V (scores 28–34) very rarely burns, tans very easily Type VI (scores 35–36) Never burns, never tans (deeply pigmented dark brown to darkest brown)"|Participants|Count of Participants|5|5.0||||||
3615112|NCT02730819|3465163|B1||Type 2|Fitzpatrick Skin Type|"The Fitzpatrick scale is a numerical classification schema for human skin color.~Type I (scores 0–6) always burns, never tans Type II (scores 7–13) usually burns, tans minimally Type III (scores 14–20) sometimes mild burn, tans uniformly Type IV (scores 21–27) burns minimally, always tans well Type V (scores 28–34) very rarely burns, tans very easily Type VI (scores 35–36) Never burns, never tans (deeply pigmented dark brown to darkest brown)"|Participants|Count of Participants|8|8.0||||||
3615143|NCT02730598|3465192|B2|||Knee Extension Torque|Maximum isokinetic torque measured on the HUMAC NORM (Model 502140, Computer Sports Medicine, Inc., Stoughton, MA).|Newton-meters (Nm)|Mean|71.7|71.7|Standard Deviation|42.2|42.2|||
3615354|NCT02726178|3465456|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3615113|NCT02730819|3465163|B1||Type 1|Fitzpatrick Skin Type|"The Fitzpatrick scale is a numerical classification schema for human skin color.~Type I (scores 0–6) always burns, never tans Type II (scores 7–13) usually burns, tans minimally Type III (scores 14–20) sometimes mild burn, tans uniformly Type IV (scores 21–27) burns minimally, always tans well Type V (scores 28–34) very rarely burns, tans very easily Type VI (scores 35–36) Never burns, never tans (deeply pigmented dark brown to darkest brown)"|Participants|Count of Participants|0|0.0||||||
3615114|NCT02730819|3465163|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3615115|NCT02730819|3465163|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3615116|NCT02730819|3465163|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3615117|NCT02730819|3465163|B1|||Age||years|Median|38|38.0|Full Range|||31.0|63.0|
3615118|NCT02730728|3465169|B4||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3615119|NCT02730728|3465170|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3615120|NCT02730728|3465171|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3615121|NCT02730728|3465172|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3615122|NCT02730728|3465169|B4||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3615123|NCT02730728|3465170|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3615124|NCT02730728|3465171|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3615125|NCT02730728|3465172|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3615126|NCT02730728|3465169|B4|||Age||years|Mean|64|64.0|Standard Deviation|9|9.0|||
3615127|NCT02730728|3465170|B3|||Age||years|Mean|62.2|62.2|Standard Deviation|8.7|8.7|||
3615128|NCT02730728|3465171|B2|||Age||years|Mean|66.5|66.5|Standard Deviation|8.5|8.5|||
3615129|NCT02730728|3465172|B1|||Age||years|Mean|63.9|63.9|Standard Deviation|9.6|9.6|||
3615130|NCT02730598|3465191|B3|||Knee Pain by Visual Analog Scale|Knee pain will be evaluated using a visual analog scale (VAS) of 100 mm from no pain (0 mm) to the worst imaginable pain (100 mm). Participants will be asked to record their pain levels of the one week prior to their baseline visit.|millimeters (mm)|Mean|37.6|37.6|Standard Deviation|22.8|22.8|||
3615131|NCT02730598|3465192|B2|||Knee Pain by Visual Analog Scale|Knee pain will be evaluated using a visual analog scale (VAS) of 100 mm from no pain (0 mm) to the worst imaginable pain (100 mm). Participants will be asked to record their pain levels of the one week prior to their baseline visit.|millimeters (mm)|Mean|43.6|43.6|Standard Deviation|22.2|22.2|||
3615132|NCT02730598|3465193|B1|||Knee Pain by Visual Analog Scale|Knee pain will be evaluated using a visual analog scale (VAS) of 100 mm from no pain (0 mm) to the worst imaginable pain (100 mm). Participants will be asked to record their pain levels of the one week prior to their baseline visit.|millimeters (mm)|Mean|31.6|31.6|Standard Deviation|23.4|23.4|||
3615133|NCT02730598|3465191|B3|||Knee Injury and Osteoarthritis Outcome Score (KOOS) Quality of Life (QOL) sub scale|The Knee Injury and Osteoarthritis Outcome Score (KOOS) Quality of Life (QOL) subscale was used at baseline and follow-up to assess participant outcomes. The QOL subscale is made up of 4 questions and was scored from zero to 100, with zero corresponding to extreme knee problems and 100 corresponding to no knee problems.|units on a scale|Mean|9.8|9.8|Standard Deviation|2.8|2.8|||
3615134|NCT02730598|3465192|B2|||Knee Injury and Osteoarthritis Outcome Score (KOOS) Quality of Life (QOL) sub scale|The Knee Injury and Osteoarthritis Outcome Score (KOOS) Quality of Life (QOL) subscale was used at baseline and follow-up to assess participant outcomes. The QOL subscale is made up of 4 questions and was scored from zero to 100, with zero corresponding to extreme knee problems and 100 corresponding to no knee problems.|units on a scale|Mean|10.4|10.4|Standard Deviation|3.0|3.0|||
3615135|NCT02730598|3465193|B1|||Knee Injury and Osteoarthritis Outcome Score (KOOS) Quality of Life (QOL) sub scale|The Knee Injury and Osteoarthritis Outcome Score (KOOS) Quality of Life (QOL) subscale was used at baseline and follow-up to assess participant outcomes. The QOL subscale is made up of 4 questions and was scored from zero to 100, with zero corresponding to extreme knee problems and 100 corresponding to no knee problems.|units on a scale|Mean|9.1|9.1|Standard Deviation|2.6|2.6|||
3615136|NCT02730598|3465191|B3|||Knee Injury and Osteoarthritis Outcome Score (KOOS) Pain Subscale|The Knee Injury and Osteoarthritis Outcome Score (KOOS) Pain subscale was used at baseline and follow-up to assess participant outcomes. The pain subscale is made up of 9 questions and was scored from zero to 100, with zero corresponding to extreme knee problems and 100 corresponding to no knee problems.|units on a scale|Mean|15.9|15.9|Standard Deviation|4.4|4.4|||
3615137|NCT02730598|3465192|B2|||Knee Injury and Osteoarthritis Outcome Score (KOOS) Pain Subscale|The Knee Injury and Osteoarthritis Outcome Score (KOOS) Pain subscale was used at baseline and follow-up to assess participant outcomes. The pain subscale is made up of 9 questions and was scored from zero to 100, with zero corresponding to extreme knee problems and 100 corresponding to no knee problems.|units on a scale|Mean|17.1|17.1|Standard Deviation|4.0|4.0|||
3615138|NCT02730598|3465193|B1|||Knee Injury and Osteoarthritis Outcome Score (KOOS) Pain Subscale|The Knee Injury and Osteoarthritis Outcome Score (KOOS) Pain subscale was used at baseline and follow-up to assess participant outcomes. The pain subscale is made up of 9 questions and was scored from zero to 100, with zero corresponding to extreme knee problems and 100 corresponding to no knee problems.|units on a scale|Mean|14.7|14.7|Standard Deviation|4.7|4.7|||
3615139|NCT02730598|3465191|B3|||Knee Flexion Torque|Maximum isokinetic torque measured on the HUMAC NORM (Model 502140, Computer Sports Medicine, Inc., Stoughton, MA).|Newton-meters (Nm)|Mean|31.6|31.6|Standard Deviation|20.6|20.6|||
3615140|NCT02730598|3465192|B2|||Knee Flexion Torque|Maximum isokinetic torque measured on the HUMAC NORM (Model 502140, Computer Sports Medicine, Inc., Stoughton, MA).|Newton-meters (Nm)|Mean|26.3|26.3|Standard Deviation|19.2|19.2|||
3615141|NCT02730598|3465193|B1|||Knee Flexion Torque|Maximum isokinetic torque measured on the HUMAC NORM (Model 502140, Computer Sports Medicine, Inc., Stoughton, MA).|Newton-meters (Nm)|Mean|36.8|36.8|Standard Deviation|22.0|22.0|||
3615142|NCT02730598|3465191|B3|||Knee Extension Torque|Maximum isokinetic torque measured on the HUMAC NORM (Model 502140, Computer Sports Medicine, Inc., Stoughton, MA).|Newton-meters (Nm)|Mean|75.6|75.6|Standard Deviation|39.1|39.1|||
3615144|NCT02730598|3465193|B1|||Knee Extension Torque|Maximum isokinetic torque measured on the HUMAC NORM (Model 502140, Computer Sports Medicine, Inc., Stoughton, MA).|Newton-meters (Nm)|Mean|79.6|79.6|Standard Deviation|35.9|35.9|||
3615145|NCT02730598|3465191|B3|||Stair Climb Time||seconds|Mean|6.5|6.5|Standard Deviation|1.9|1.9|||
3615146|NCT02730598|3465192|B2|||Stair Climb Time||seconds|Mean|6.7|6.7|Standard Deviation|2.5|2.5|||
3615147|NCT02730598|3465193|B1|||Stair Climb Time||seconds|Mean|6.4|6.4|Standard Deviation|1.3|1.3|||
3615148|NCT02730598|3465191|B3|||5-Chair Stand Time||seconds|Mean|13.6|13.6|Standard Deviation|3.8|3.8|||
3615149|NCT02730598|3465192|B2|||5-Chair Stand Time||seconds|Mean|15.2|15.2|Standard Deviation|4.6|4.6|||
3615150|NCT02730598|3465193|B1|||5-Chair Stand Time||seconds|Mean|11.9|11.9|Standard Deviation|3.1|3.1|||
3615151|NCT02730598|3465191|B3|||20-Meter Walk Time||seconds|Mean|12.7|12.7|Standard Deviation|2.0|2.0|||
3615152|NCT02730598|3465192|B2|||20-Meter Walk Time||seconds|Mean|12.9|12.9|Standard Deviation|2.0|2.0|||
3615153|NCT02730598|3465193|B1|||20-Meter Walk Time||seconds|Mean|12.5|12.5|Standard Deviation|2.0|2.0|||
3615154|NCT02730598|3465191|B3|||Body Mass Index (BMI)|BMI was calculated by dividing body mass by the square of the height.|kilograms per meters squared (kg/m2)|Mean|36.6|36.6|Standard Deviation|3.6|3.6|||
3615155|NCT02730598|3465192|B2|||Body Mass Index (BMI)|BMI was calculated by dividing body mass by the square of the height.|kilograms per meters squared (kg/m2)|Mean|35.8|35.8|Standard Deviation|2.9|2.9|||
3615156|NCT02730598|3465193|B1|||Body Mass Index (BMI)|BMI was calculated by dividing body mass by the square of the height.|kilograms per meters squared (kg/m2)|Mean|37.4|37.4|Standard Deviation|4.2|4.2|||
3615157|NCT02730598|3465191|B3|||Height|Wall mounted stadiometer (seca 216 Stadiometer, seca Corporation, Chino, CA)|centimeters (cm)|Mean|162.5|162.5|Standard Deviation|7.6|7.6|||
3615158|NCT02730598|3465192|B2|||Height|Wall mounted stadiometer (seca 216 Stadiometer, seca Corporation, Chino, CA)|centimeters (cm)|Mean|163.5|163.5|Standard Deviation|8.6|8.6|||
3615159|NCT02730598|3465193|B1|||Height|Wall mounted stadiometer (seca 216 Stadiometer, seca Corporation, Chino, CA)|centimeters (cm)|Mean|161.5|161.5|Standard Deviation|6.6|6.6|||
3615160|NCT02730598|3465191|B3|||Weight|Digital physicians scale (Detecto 6449 Digital Physician Scale, DETECTO Scale Company, Webb City, MO).|kilograms (kg)|Mean|96.4|96.4|Standard Deviation|11.1|11.1|||
3615161|NCT02730598|3465192|B2|||Weight|Digital physicians scale (Detecto 6449 Digital Physician Scale, DETECTO Scale Company, Webb City, MO).|kilograms (kg)|Mean|95.6|95.6|Standard Deviation|12.6|12.6|||
3615162|NCT02730598|3465193|B1|||Weight|Digital physicians scale (Detecto 6449 Digital Physician Scale, DETECTO Scale Company, Webb City, MO).|kilograms (kg)|Mean|97.1|97.1|Standard Deviation|9.6|9.6|||
3615163|NCT02730598|3465191|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3615164|NCT02730598|3465191|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3615165|NCT02730598|3465192|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3615166|NCT02730598|3465193|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3615167|NCT02730598|3465191|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3615168|NCT02730598|3465192|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3615169|NCT02730598|3465193|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3615170|NCT02730598|3465191|B3|||Age||years|Mean|58.75|58.75|Standard Deviation|8.19|8.19|||
3615171|NCT02730598|3465192|B2|||Age||years|Mean|58.29|58.29|Standard Deviation|6.35|6.35|||
3615172|NCT02730598|3465193|B1|||Age||years|Mean|59.21|59.21|Standard Deviation|10.02|10.02|||
3615173|NCT02730351|3465214|B1|Race, Customized|Mixed Race|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3615174|NCT02730351|3465214|B1|Race, Customized|White - White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3615175|NCT02730351|3465214|B1|Race, Customized|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3615176|NCT02730351|3465214|B1|Race, Customized|African American/African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3615177|NCT02730351|3465214|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3615178|NCT02730351|3465214|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3615179|NCT02730351|3465214|B1|||Age||Years|Mean|27.8|27.8|Standard Deviation|10.35|10.35|||
3615180|NCT02730260|3465227|B3|||Fagerström Test for Nicotine Dependence (FTND)|"Scores for 3 binary and 3 multiple choice items in the Fagerstrom Test for Nicotine Dependence are summed to yield a total score of 0-10.~Classification of dependence:~0-2 Very low; 3-4 Low; 5 Moderate; 6-7 High; 8-10 Very high."|units on a scale|Median|3|3.0|Inter-Quartile Range|||1.0|4.0|
3615181|NCT02730260|3465228|B2|||Fagerström Test for Nicotine Dependence (FTND)|"Scores for 3 binary and 3 multiple choice items in the Fagerstrom Test for Nicotine Dependence are summed to yield a total score of 0-10.~Classification of dependence:~0-2 Very low; 3-4 Low; 5 Moderate; 6-7 High; 8-10 Very high."|units on a scale|Median|3|3.0|Inter-Quartile Range|||1.0|4.0|
3615182|NCT02730260|3465229|B1|||Fagerström Test for Nicotine Dependence (FTND)|"Scores for 3 binary and 3 multiple choice items in the Fagerstrom Test for Nicotine Dependence are summed to yield a total score of 0-10.~Classification of dependence:~0-2 Very low; 3-4 Low; 5 Moderate; 6-7 High; 8-10 Very high."|units on a scale|Median|3|3.0|Inter-Quartile Range|||1.0|5.0|
3615183|NCT02730260|3465227|B3|||Education|"The education scale is:~Less than 9th grade~9th grade~10th grade~11th grade~High school graduate or General Educational Development (GED)~Some college or trade school~Bachelor's degree~Master's degree~Doctoral degree"|units on a scale|Median|6|6.0|Inter-Quartile Range|||5.0|7.0|
3615184|NCT02730260|3465228|B2|||Education|"The education scale is:~Less than 9th grade~9th grade~10th grade~11th grade~High school graduate or General Educational Development (GED)~Some college or trade school~Bachelor's degree~Master's degree~Doctoral degree"|units on a scale|Median|6|6.0|Inter-Quartile Range|||5.0|7.0|
3615239|NCT02730260|3465229|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3615185|NCT02730260|3465229|B1|||Education|"The education scale is:~Less than 9th grade~9th grade~10th grade~11th grade~High school graduate or General Educational Development (GED)~Some college or trade school~Bachelor's degree~Master's degree~Doctoral degree"|units on a scale|Median|6|6.0|Inter-Quartile Range|||5.0|7.0|
3615186|NCT02730260|3465227|B3|||Income|"Income levels are:~$0-$15,000~>$15,000-$30,000~>$30,000-$45,000~>$45,000-$60,000~>$60,000-$75,000~>$75,000-$90,000~>$90,000"|units on a scale|Median|3|3.0|Inter-Quartile Range|||2.0|4.0|
3615187|NCT02730260|3465228|B2|||Income|"Income levels are:~$0-$15,000~>$15,000-$30,000~>$30,000-$45,000~>$45,000-$60,000~>$60,000-$75,000~>$75,000-$90,000~>$90,000"|units on a scale|Median|3|3.0|Inter-Quartile Range|||2.0|4.0|
3615188|NCT02730260|3465229|B1|||Income|"Income levels are:~$0-$15,000~>$15,000-$30,000~>$30,000-$45,000~>$45,000-$60,000~>$60,000-$75,000~>$75,000-$90,000~>$90,000"|units on a scale|Median|3|3.0|Inter-Quartile Range|||2.0|4.0|
3615189|NCT02730260|3465227|B3|United States||Region of Enrollment||participants|Number|518|518.0||||||
3615190|NCT02730260|3465228|B2|United States||Region of Enrollment||participants|Number|260|260.0||||||
3615191|NCT02730260|3465229|B1|United States||Region of Enrollment||participants|Number|258|258.0||||||
3615192|NCT02730260|3465227|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3615193|NCT02730260|3465228|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3615194|NCT02730260|3465229|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3615195|NCT02730260|3465227|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3615196|NCT02730260|3465228|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3615197|NCT02730260|3465229|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3615198|NCT02730260|3465227|B3||White|Race (NIH/OMB)||Participants|Count of Participants|398|398.0||||||
3615199|NCT02730260|3465228|B2||White|Race (NIH/OMB)||Participants|Count of Participants|199|199.0||||||
3615200|NCT02730260|3465229|B1||White|Race (NIH/OMB)||Participants|Count of Participants|199|199.0||||||
3615201|NCT02730260|3465227|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
3615202|NCT02730260|3465228|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3615203|NCT02730260|3465229|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3615204|NCT02730260|3465227|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615205|NCT02730260|3465228|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615206|NCT02730260|3465229|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615207|NCT02730260|3465227|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3615208|NCT02730260|3465228|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3615209|NCT02730260|3465229|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3615210|NCT02730260|3465227|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615211|NCT02730260|3465228|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615212|NCT02730260|3465229|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615213|NCT02730260|3465227|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3615214|NCT02730260|3465228|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3615215|NCT02730260|3465229|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3615216|NCT02730260|3465227|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|502|502.0||||||
3615217|NCT02730260|3465228|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|252|252.0||||||
3615218|NCT02730260|3465229|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|250|250.0||||||
3615219|NCT02730260|3465227|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3615220|NCT02730260|3465228|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3615221|NCT02730260|3465229|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3615222|NCT02730260|3465227|B3||Male|Gender||Participants|Count of Participants|174|174.0||||||
3615223|NCT02730260|3465228|B2||Male|Gender||Participants|Count of Participants|88|88.0||||||
3615224|NCT02730260|3465229|B1||Male|Gender||Participants|Count of Participants|86|86.0||||||
3615225|NCT02730260|3465227|B3||Female|Gender||Participants|Count of Participants|344|344.0||||||
3615226|NCT02730260|3465228|B2||Female|Gender||Participants|Count of Participants|172|172.0||||||
3615227|NCT02730260|3465229|B1||Female|Gender||Participants|Count of Participants|172|172.0||||||
3615228|NCT02730260|3465227|B3|||Age||years|Mean|46.2|46.2|Standard Deviation|10.9|10.9|||
3615229|NCT02730260|3465228|B2|||Age||years|Mean|46.0|46.0|Standard Deviation|10.6|10.6|||
3615230|NCT02730260|3465229|B1|||Age||years|Mean|46.3|46.3|Standard Deviation|11.3|11.3|||
3615231|NCT02730260|3465227|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3615232|NCT02730260|3465228|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3615233|NCT02730260|3465229|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3615234|NCT02730260|3465227|B3||Between 18 and 65 years|Age||Participants|Count of Participants|506|506.0||||||
3615235|NCT02730260|3465228|B2||Between 18 and 65 years|Age||Participants|Count of Participants|254|254.0||||||
3615236|NCT02730260|3465229|B1||Between 18 and 65 years|Age||Participants|Count of Participants|252|252.0||||||
3615237|NCT02730260|3465227|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3615238|NCT02730260|3465228|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3615240|NCT02729753|3465236|B3|||History of Barrett's Esophagus||Participants|Count of Participants|4|4.0||||||
3615241|NCT02729753|3465237|B2|||History of Barrett's Esophagus||Participants|Count of Participants|0|0.0||||||
3615242|NCT02729753|3465238|B1|||History of Barrett's Esophagus||Participants|Count of Participants|4|4.0||||||
3615243|NCT02729753|3465236|B3|||History of GERD||Participants|Count of Participants|5|5.0||||||
3615244|NCT02729753|3465237|B2|||History of GERD||Participants|Count of Participants|1|1.0||||||
3615245|NCT02729753|3465238|B1|||History of GERD||Participants|Count of Participants|4|4.0||||||
3615246|NCT02729753|3465236|B3|||BMI||kg/m^2|Median|26|26.0|Inter-Quartile Range|||23.9|26.7|
3615247|NCT02729753|3465237|B2|||BMI||kg/m^2|Median|23.3|23.3|Inter-Quartile Range|||20.5|24.2|
3615248|NCT02729753|3465238|B1|||BMI||kg/m^2|Median|26.3|26.3|Inter-Quartile Range|||22.0|26.9|
3615249|NCT02729753|3465236|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3615250|NCT02729753|3465237|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3615251|NCT02729753|3465238|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3615252|NCT02729753|3465236|B3|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3615253|NCT02729753|3465237|B2|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3615254|NCT02729753|3465238|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3615255|NCT02729753|3465236|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3615256|NCT02729753|3465237|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3615257|NCT02729753|3465238|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615258|NCT02729753|3465236|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615259|NCT02729753|3465237|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615260|NCT02729753|3465238|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615261|NCT02729753|3465236|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3615262|NCT02729753|3465237|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3615263|NCT02729753|3465238|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3615264|NCT02729753|3465236|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615265|NCT02729753|3465237|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615266|NCT02729753|3465238|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615267|NCT02729753|3465236|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615268|NCT02729753|3465237|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615269|NCT02729753|3465238|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615270|NCT02729753|3465236|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615271|NCT02729753|3465237|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615272|NCT02729753|3465238|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615273|NCT02729753|3465236|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615274|NCT02729753|3465237|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615275|NCT02729753|3465238|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615276|NCT02729753|3465236|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3615277|NCT02729753|3465237|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3615278|NCT02729753|3465238|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3615279|NCT02729753|3465236|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3615280|NCT02729753|3465237|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3615281|NCT02729753|3465238|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3615282|NCT02729753|3465236|B3|||Age||years|Median|64|64.0|Inter-Quartile Range|||58.0|74.0|
3615283|NCT02729753|3465237|B2|||Age||years|Median|57|57.0|Inter-Quartile Range|||51.5|66.0|
3615284|NCT02729753|3465238|B1|||Age||years|Median|69|69.0|Inter-Quartile Range|||58.0|77.0|
3615285|NCT02729038|3465251|B5|Multiple: African American/African/White||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3615286|NCT02729038|3465252|B4|Multiple: African American/African/White||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3615287|NCT02729038|3465253|B3|Multiple: African American/African/White||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3615288|NCT02729038|3465254|B2|Multiple: African American/African/White||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3615289|NCT02729038|3465255|B1|Multiple: African American/African/White||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3615290|NCT02729038|3465251|B5|White: White/Caucasian/European||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3615291|NCT02729038|3465252|B4|White: White/Caucasian/European||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3615292|NCT02729038|3465253|B3|White: White/Caucasian/European||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3615293|NCT02729038|3465254|B2|White: White/Caucasian/European||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3615294|NCT02729038|3465255|B1|White: White/Caucasian/European||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3615295|NCT02729038|3465251|B5|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3615296|NCT02729038|3465252|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3615297|NCT02729038|3465253|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3615298|NCT02729038|3465254|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3615299|NCT02729038|3465255|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3615300|NCT02729038|3465251|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3615301|NCT02729038|3465252|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3615302|NCT02729038|3465253|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3615303|NCT02729038|3465254|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3615304|NCT02729038|3465255|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3615305|NCT02729038|3465251|B5||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3615306|NCT02729038|3465252|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3615307|NCT02729038|3465253|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3615308|NCT02729038|3465254|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3615309|NCT02729038|3465255|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3615310|NCT02729038|3465251|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3615311|NCT02729038|3465252|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3615312|NCT02729038|3465253|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3615313|NCT02729038|3465254|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3615314|NCT02729038|3465255|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3615315|NCT02729038|3465251|B5|||Age||Years|Mean|61.6|61.6|Standard Deviation|2.72|2.72|||
3615316|NCT02729038|3465252|B4|||Age||Years|Mean|51.8|51.8|Standard Deviation|7.09|7.09|||
3615317|NCT02729038|3465253|B3|||Age||Years|Mean|61.4|61.4|Standard Deviation|12.49|12.49|||
3615318|NCT02729038|3465254|B2|||Age||Years|Mean|72.0|72.0|Standard Deviation|7.05|7.05|||
3615319|NCT02729038|3465255|B1|||Age||Years|Mean|61.5|61.5|Standard Deviation|10.78|10.78|||
3615320|NCT02728089|3465377|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615321|NCT02728089|3465377|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615322|NCT02728089|3465377|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615323|NCT02728089|3465377|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615324|NCT02728089|3465377|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615325|NCT02728089|3465377|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
3615326|NCT02728089|3465377|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615327|NCT02728089|3465377|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3615328|NCT02728089|3465377|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3615329|NCT02728089|3465377|B1|||Age||Years|Mean|68.2|68.2|Standard Deviation|13.8|13.8|||
3615330|NCT02727842|3465392|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3615331|NCT02727842|3465392|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3615332|NCT02727842|3465392|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3615333|NCT02727842|3465392|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3615334|NCT02727842|3465392|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3615335|NCT02727842|3465392|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3615336|NCT02727816|3465396|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3615337|NCT02727816|3465396|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3615338|NCT02727816|3465396|B1|||Age||years|Mean|22.5|22.5|Standard Deviation|2.8|2.8|||
3615339|NCT02726971|3465443|B3|||Parity|Parity means the number of past deliveries.|times|Mean|0.2|0.2|Standard Deviation|0.4|0.4|||
3615340|NCT02726971|3465444|B2|||Parity|Parity means the number of past deliveries.|times|Mean|0.2|0.2|Standard Deviation|0.4|0.4|||
3615341|NCT02726971|3465445|B1|||Parity|Parity means the number of past deliveries.|times|Mean|0.2|0.2|Standard Deviation|0.4|0.4|||
3615342|NCT02726971|3465443|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3615343|NCT02726971|3465444|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3615344|NCT02726971|3465445|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3615345|NCT02726971|3465443|B3||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3615346|NCT02726971|3465444|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3615347|NCT02726971|3465445|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3615348|NCT02726971|3465443|B3|||Age||years|Mean|32.3|32.3|Standard Deviation|4.6|4.6|||
3615349|NCT02726971|3465444|B2|||Age||years|Mean|32.3|32.3|Standard Deviation|4.1|4.1|||
3615350|NCT02726971|3465445|B1|||Age||years|Mean|31.9|31.9|Standard Deviation|5.0|5.0|||
3615351|NCT02726178|3465456|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3615352|NCT02726178|3465457|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3615353|NCT02726178|3465458|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3615355|NCT02726178|3465457|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3615356|NCT02726178|3465458|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3615357|NCT02726178|3465456|B3|||Age||weeks|Mean|27.5|27.5|Standard Deviation|1.9|1.9|||
3615358|NCT02726178|3465457|B2|||Age||weeks|Mean|27.2|27.2|Standard Deviation|2|2.0|||
3615359|NCT02726178|3465458|B1|||Age||weeks|Mean|27.8|27.8|Standard Deviation|1.8|1.8|||
3615360|NCT02726022|3465467|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3615361|NCT02726022|3465467|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3615362|NCT02726022|3465467|B1|||Age|Number of participants analyzed for age were 113.|years|Mean|46.30|46.3|Standard Deviation|13.31|13.31|||
3615363|NCT02725788|3465476|B3||Upper Forearm|PIV catheter insertion location||Participants|Count of Participants|26|26.0||||||
3615364|NCT02725788|3465477|B2||Upper Forearm|PIV catheter insertion location||Participants|Count of Participants|16|16.0||||||
3615365|NCT02725788|3465478|B1||Upper Forearm|PIV catheter insertion location||Participants|Count of Participants|10|10.0||||||
3615366|NCT02725788|3465476|B3||Mid Forearm|PIV catheter insertion location||Participants|Count of Participants|31|31.0||||||
3615367|NCT02725788|3465477|B2||Mid Forearm|PIV catheter insertion location||Participants|Count of Participants|15|15.0||||||
3615368|NCT02725788|3465478|B1||Mid Forearm|PIV catheter insertion location||Participants|Count of Participants|16|16.0||||||
3615369|NCT02725788|3465476|B3||Lower Forearm|PIV catheter insertion location||Participants|Count of Participants|42|42.0||||||
3615370|NCT02725788|3465477|B2||Lower Forearm|PIV catheter insertion location||Participants|Count of Participants|20|20.0||||||
3615371|NCT02725788|3465478|B1||Lower Forearm|PIV catheter insertion location||Participants|Count of Participants|22|22.0||||||
3615372|NCT02725788|3465476|B3||Hand|PIV catheter insertion location||Participants|Count of Participants|145|145.0||||||
3615373|NCT02725788|3465477|B2||Hand|PIV catheter insertion location||Participants|Count of Participants|71|71.0||||||
3615374|NCT02725788|3465478|B1||Hand|PIV catheter insertion location||Participants|Count of Participants|74|74.0||||||
3615375|NCT02725788|3465476|B3|United States||Region of Enrollment||participants|Number|244|244.0||||||
3615376|NCT02725788|3465477|B2|United States||Region of Enrollment||participants|Number|122|122.0||||||
3615377|NCT02725788|3465478|B1|United States||Region of Enrollment||participants|Number|122|122.0||||||
3615378|NCT02725788|3465476|B3||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3615379|NCT02725788|3465477|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3615380|NCT02725788|3465478|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3615381|NCT02725788|3465476|B3||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3615382|NCT02725788|3465477|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3615383|NCT02725788|3465478|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3615384|NCT02725788|3465476|B3|||Age||years|Median|60|60.0|Full Range|||18.0|93.0|
3615385|NCT02725788|3465477|B2|||Age||years|Median|60|60.0|Full Range|||19.0|89.0|
3615386|NCT02725788|3465478|B1|||Age||years|Median|60|60.0|Full Range|||18.0|93.0|
3615387|NCT02725788|3465476|B3||>=65 years|Age||Participants|Count of Participants|89|89.0||||||
3615388|NCT02725788|3465477|B2||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
3615389|NCT02725788|3465478|B1||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
3615390|NCT02725788|3465476|B3||Between 18 and 65 years|Age||Participants|Count of Participants|155|155.0||||||
3615391|NCT02725788|3465477|B2||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
3615392|NCT02725788|3465478|B1||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
3615393|NCT02725788|3465476|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3615394|NCT02725788|3465477|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3615395|NCT02725788|3465478|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3615396|NCT02725476|3465485|B3|||Baseline IgG4-RD Responder Index Total Activity Score|The IgG4-RD Responder Index Total Activity Score ranges from 0 to a maximum of 162. Higher scores represent greater (i.e. worse) disease activity. A score of 0 represents no disease activity other than residual fibrosis.|Total Activity Score|Mean|11.8|11.8|Standard Deviation|6.45|6.45|||
3615397|NCT02725476|3465486|B2|||Baseline IgG4-RD Responder Index Total Activity Score|The IgG4-RD Responder Index Total Activity Score ranges from 0 to a maximum of 162. Higher scores represent greater (i.e. worse) disease activity. A score of 0 represents no disease activity other than residual fibrosis.|Total Activity Score|Mean|12.8|12.8|Standard Deviation|6.42|6.42|||
3615398|NCT02725476|3465487|B1|||Baseline IgG4-RD Responder Index Total Activity Score|The IgG4-RD Responder Index Total Activity Score ranges from 0 to a maximum of 162. Higher scores represent greater (i.e. worse) disease activity. A score of 0 represents no disease activity other than residual fibrosis.|Total Activity Score|Mean|11.5|11.5|Standard Deviation|6.65|6.65|||
3615399|NCT02725476|3465485|B3|Submandibular Glands||Involved Areas at Baseline||Participants|Count of Participants|12|12.0||||||
3615400|NCT02725476|3465486|B2|Submandibular Glands||Involved Areas at Baseline||Participants|Count of Participants|3|3.0||||||
3615401|NCT02725476|3465487|B1|Submandibular Glands||Involved Areas at Baseline||Participants|Count of Participants|9|9.0||||||
3615402|NCT02725476|3465485|B3|Skin||Involved Areas at Baseline||Participants|Count of Participants|1|1.0||||||
3615403|NCT02725476|3465486|B2|Skin||Involved Areas at Baseline||Participants|Count of Participants|1|1.0||||||
3615404|NCT02725476|3465487|B1|Skin||Involved Areas at Baseline||Participants|Count of Participants|0|0.0||||||
3615405|NCT02725476|3465485|B3|Sinusitis||Involved Areas at Baseline||Participants|Count of Participants|4|4.0||||||
3615406|NCT02725476|3465486|B2|Sinusitis||Involved Areas at Baseline||Participants|Count of Participants|2|2.0||||||
3615516|NCT02724644|3465496|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3615407|NCT02725476|3465487|B1|Sinusitis||Involved Areas at Baseline||Participants|Count of Participants|2|2.0||||||
3615408|NCT02725476|3465485|B3|Retroperitoneal Fibrosis||Involved Areas at Baseline||Participants|Count of Participants|2|2.0||||||
3615409|NCT02725476|3465486|B2|Retroperitoneal Fibrosis||Involved Areas at Baseline||Participants|Count of Participants|1|1.0||||||
3615410|NCT02725476|3465487|B1|Retroperitoneal Fibrosis||Involved Areas at Baseline||Participants|Count of Participants|1|1.0||||||
3615411|NCT02725476|3465485|B3|Parotid Glands||Involved Areas at Baseline||Participants|Count of Participants|10|10.0||||||
3615412|NCT02725476|3465486|B2|Parotid Glands||Involved Areas at Baseline||Participants|Count of Participants|2|2.0||||||
3615413|NCT02725476|3465487|B1|Parotid Glands||Involved Areas at Baseline||Participants|Count of Participants|8|8.0||||||
3615414|NCT02725476|3465485|B3|Pancreas||Involved Areas at Baseline||Participants|Count of Participants|4|4.0||||||
3615415|NCT02725476|3465486|B2|Pancreas||Involved Areas at Baseline||Participants|Count of Participants|3|3.0||||||
3615416|NCT02725476|3465487|B1|Pancreas||Involved Areas at Baseline||Participants|Count of Participants|1|1.0||||||
3615417|NCT02725476|3465485|B3|Other Salivary Glands||Involved Areas at Baseline||Participants|Count of Participants|1|1.0||||||
3615418|NCT02725476|3465486|B2|Other Salivary Glands||Involved Areas at Baseline||Participants|Count of Participants|0|0.0||||||
3615419|NCT02725476|3465487|B1|Other Salivary Glands||Involved Areas at Baseline||Participants|Count of Participants|1|1.0||||||
3615420|NCT02725476|3465485|B3|Other ENT Lesions, e.g. tonsillitis, pharyngitis||Involved Areas at Baseline||Participants|Count of Participants|2|2.0||||||
3615421|NCT02725476|3465486|B2|Other ENT Lesions, e.g. tonsillitis, pharyngitis||Involved Areas at Baseline||Participants|Count of Participants|0|0.0||||||
3615422|NCT02725476|3465487|B1|Other ENT Lesions, e.g. tonsillitis, pharyngitis||Involved Areas at Baseline||Participants|Count of Participants|2|2.0||||||
3615423|NCT02725476|3465485|B3|Other||Involved Areas at Baseline||Participants|Count of Participants|8|8.0||||||
3615424|NCT02725476|3465486|B2|Other||Involved Areas at Baseline||Participants|Count of Participants|4|4.0||||||
3615425|NCT02725476|3465487|B1|Other||Involved Areas at Baseline||Participants|Count of Participants|4|4.0||||||
3615426|NCT02725476|3465485|B3|Orbital Lesion||Involved Areas at Baseline||Participants|Count of Participants|3|3.0||||||
3615427|NCT02725476|3465486|B2|Orbital Lesion||Involved Areas at Baseline||Participants|Count of Participants|1|1.0||||||
3615428|NCT02725476|3465487|B1|Orbital Lesion||Involved Areas at Baseline||Participants|Count of Participants|2|2.0||||||
3615429|NCT02725476|3465485|B3|Nasal Cavity Lesion||Involved Areas at Baseline||Participants|Count of Participants|3|3.0||||||
3615430|NCT02725476|3465486|B2|Nasal Cavity Lesion||Involved Areas at Baseline||Participants|Count of Participants|0|0.0||||||
3615431|NCT02725476|3465487|B1|Nasal Cavity Lesion||Involved Areas at Baseline||Participants|Count of Participants|3|3.0||||||
3615432|NCT02725476|3465485|B3|Lymph Nodes||Involved Areas at Baseline||Participants|Count of Participants|14|14.0||||||
3615433|NCT02725476|3465486|B2|Lymph Nodes||Involved Areas at Baseline||Participants|Count of Participants|4|4.0||||||
3615434|NCT02725476|3465487|B1|Lymph Nodes||Involved Areas at Baseline||Participants|Count of Participants|10|10.0||||||
3615435|NCT02725476|3465485|B3|Lungs||Involved Areas at Baseline||Participants|Count of Participants|6|6.0||||||
3615436|NCT02725476|3465486|B2|Lungs||Involved Areas at Baseline||Participants|Count of Participants|2|2.0||||||
3615437|NCT02725476|3465487|B1|Lungs||Involved Areas at Baseline||Participants|Count of Participants|4|4.0||||||
3615438|NCT02725476|3465485|B3|Lacrimal Glands||Involved Areas at Baseline||Participants|Count of Participants|10|10.0||||||
3615439|NCT02725476|3465486|B2|Lacrimal Glands||Involved Areas at Baseline||Participants|Count of Participants|3|3.0||||||
3615440|NCT02725476|3465487|B1|Lacrimal Glands||Involved Areas at Baseline||Participants|Count of Participants|7|7.0||||||
3615441|NCT02725476|3465485|B3|Kidney||Involved Areas at Baseline||Participants|Count of Participants|6|6.0||||||
3615442|NCT02725476|3465486|B2|Kidney||Involved Areas at Baseline||Participants|Count of Participants|1|1.0||||||
3615443|NCT02725476|3465487|B1|Kidney||Involved Areas at Baseline||Participants|Count of Participants|5|5.0||||||
3615444|NCT02725476|3465485|B3|Heart / Pericardium||Involved Areas at Baseline||Participants|Count of Participants|3|3.0||||||
3615445|NCT02725476|3465486|B2|Heart / Pericardium||Involved Areas at Baseline||Participants|Count of Participants|0|0.0||||||
3615446|NCT02725476|3465487|B1|Heart / Pericardium||Involved Areas at Baseline||Participants|Count of Participants|3|3.0||||||
3615447|NCT02725476|3465485|B3|Constitutional Symptoms||Involved Areas at Baseline||Participants|Count of Participants|7|7.0||||||
3615448|NCT02725476|3465486|B2|Constitutional Symptoms||Involved Areas at Baseline||Participants|Count of Participants|1|1.0||||||
3615449|NCT02725476|3465487|B1|Constitutional Symptoms||Involved Areas at Baseline||Participants|Count of Participants|6|6.0||||||
3615450|NCT02725476|3465485|B3|Bile Ducts||Involved Areas at Baseline||Participants|Count of Participants|2|2.0||||||
3615451|NCT02725476|3465486|B2|Bile Ducts||Involved Areas at Baseline||Participants|Count of Participants|0|0.0||||||
3615452|NCT02725476|3465487|B1|Bile Ducts||Involved Areas at Baseline||Participants|Count of Participants|2|2.0||||||
3615453|NCT02725476|3465485|B3|||Serum IgG4 level at Baseline||mg/dL|Mean|544.90|544.9|Standard Deviation|588.674|588.674|||
3615454|NCT02725476|3465486|B2|||Serum IgG4 level at Baseline||mg/dL|Mean|858.60|858.6|Standard Deviation|351.608|351.608|||
3615455|NCT02725476|3465487|B1|||Serum IgG4 level at Baseline||mg/dL|Mean|440.33|440.33|Standard Deviation|622.990|622.99|||
3615456|NCT02725476|3465485|B3|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3615457|NCT02725476|3465486|B2|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3615458|NCT02725476|3465487|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3615459|NCT02725476|3465485|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615460|NCT02725476|3465486|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615461|NCT02725476|3465487|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615462|NCT02725476|3465485|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615463|NCT02725476|3465486|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615464|NCT02725476|3465487|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615465|NCT02725476|3465485|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3615466|NCT02725476|3465486|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3615467|NCT02725476|3465487|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3615468|NCT02725476|3465485|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3615469|NCT02725476|3465486|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3615470|NCT02725476|3465487|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3615471|NCT02725476|3465485|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615472|NCT02725476|3465486|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615473|NCT02725476|3465487|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615474|NCT02725476|3465485|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3615475|NCT02725476|3465486|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615476|NCT02725476|3465487|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3615477|NCT02725476|3465485|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615478|NCT02725476|3465486|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615479|NCT02725476|3465487|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615480|NCT02725476|3465485|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615481|NCT02725476|3465486|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615482|NCT02725476|3465487|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615483|NCT02725476|3465485|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3615484|NCT02725476|3465486|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3615485|NCT02725476|3465487|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3615486|NCT02725476|3465485|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615487|NCT02725476|3465486|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615488|NCT02725476|3465487|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615489|NCT02725476|3465485|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3615490|NCT02725476|3465486|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3615491|NCT02725476|3465487|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3615492|NCT02725476|3465485|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3615493|NCT02725476|3465486|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3615494|NCT02725476|3465487|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3615495|NCT02725476|3465485|B3|||Age||years|Mean|57.9|57.9|Standard Deviation|11.82|11.82|||
3615496|NCT02725476|3465486|B2|||Age||years|Mean|51.2|51.2|Standard Deviation|14.11|14.11|||
3615497|NCT02725476|3465487|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|10.57|10.57|||
3615498|NCT02724644|3465496|B3|United States||Region of Enrollment||Participants|Count of Participants|375|375.0||||||
3615499|NCT02724644|3465497|B2|United States||Region of Enrollment||Participants|Count of Participants|186|186.0||||||
3615500|NCT02724644|3465498|B1|United States||Region of Enrollment||Participants|Count of Participants|189|189.0||||||
3615501|NCT02724644|3465496|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615502|NCT02724644|3465497|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615503|NCT02724644|3465498|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615504|NCT02724644|3465496|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3615505|NCT02724644|3465497|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615506|NCT02724644|3465498|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3615507|NCT02724644|3465496|B3||White|Race (NIH/OMB)||Participants|Count of Participants|324|324.0||||||
3615508|NCT02724644|3465497|B2||White|Race (NIH/OMB)||Participants|Count of Participants|157|157.0||||||
3615509|NCT02724644|3465498|B1||White|Race (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
3615510|NCT02724644|3465496|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3615511|NCT02724644|3465497|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3615512|NCT02724644|3465498|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3615513|NCT02724644|3465496|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3615514|NCT02724644|3465497|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3615515|NCT02724644|3465498|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615517|NCT02724644|3465497|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3615518|NCT02724644|3465498|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3615519|NCT02724644|3465496|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3615520|NCT02724644|3465497|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3615521|NCT02724644|3465498|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3615522|NCT02724644|3465496|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615523|NCT02724644|3465497|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615524|NCT02724644|3465498|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615525|NCT02724644|3465496|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|297|297.0||||||
3615526|NCT02724644|3465497|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|145|145.0||||||
3615527|NCT02724644|3465498|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|152|152.0||||||
3615528|NCT02724644|3465496|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3615529|NCT02724644|3465497|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3615530|NCT02724644|3465498|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3615531|NCT02724644|3465496|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3615532|NCT02724644|3465497|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3615533|NCT02724644|3465498|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3615534|NCT02724644|3465496|B3||Female|Sex: Female, Male||Participants|Count of Participants|375|375.0||||||
3615535|NCT02724644|3465497|B2||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
3615536|NCT02724644|3465498|B1||Female|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
3615537|NCT02724644|3465496|B3||>=45 years|Age, Customized||Participants|Count of Participants|226|226.0||||||
3615538|NCT02724644|3465497|B2||>=45 years|Age, Customized||Participants|Count of Participants|109|109.0||||||
3615539|NCT02724644|3465498|B1||>=45 years|Age, Customized||Participants|Count of Participants|117|117.0||||||
3615540|NCT02724644|3465496|B3||35-44 years|Age, Customized||Participants|Count of Participants|93|93.0||||||
3615541|NCT02724644|3465497|B2||35-44 years|Age, Customized||Participants|Count of Participants|47|47.0||||||
3615542|NCT02724644|3465498|B1||35-44 years|Age, Customized||Participants|Count of Participants|46|46.0||||||
3615543|NCT02724644|3465496|B3||25-34 years|Age, Customized||Participants|Count of Participants|39|39.0||||||
3615544|NCT02724644|3465497|B2||25-34 years|Age, Customized||Participants|Count of Participants|21|21.0||||||
3615545|NCT02724644|3465498|B1||25-34 years|Age, Customized||Participants|Count of Participants|18|18.0||||||
3615546|NCT02724644|3465496|B3||18-<25 years|Age, Customized||Participants|Count of Participants|17|17.0||||||
3615547|NCT02724644|3465497|B2||18-<25 years|Age, Customized||Participants|Count of Participants|9|9.0||||||
3615548|NCT02724644|3465498|B1||18-<25 years|Age, Customized||Participants|Count of Participants|8|8.0||||||
3615549|NCT02724644|3465496|B3|||Age||Participants|Mean|46.5|46.5|Standard Deviation|11.13|11.13|||
3615550|NCT02724644|3465497|B2|||Age||Participants|Mean|45.8|45.8|Standard Deviation|11.02|11.02|||
3615551|NCT02724644|3465498|B1|||Age||Participants|Mean|47.2|47.2|Standard Deviation|11.21|11.21|||
3615552|NCT02724449|3465527|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3615553|NCT02724449|3465527|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3615554|NCT02724449|3465527|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615555|NCT02724449|3465527|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3615556|NCT02724449|3465527|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3615557|NCT02724449|3465527|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615558|NCT02724449|3465527|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3615559|NCT02724449|3465527|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615560|NCT02724449|3465527|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615561|NCT02724449|3465527|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3615562|NCT02724449|3465527|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3615563|NCT02724449|3465527|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3615564|NCT02724449|3465527|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3615565|NCT02724449|3465527|B1|||Age||years|Mean|70.9|70.9|Full Range|||19.0|92.0|
3615566|NCT02724449|3465527|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3615567|NCT02724449|3465527|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3615568|NCT02724449|3465527|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3615569|NCT02724111|3465531|B3|||Weight (kg)||kg|Mean|59.9|59.9|Standard Deviation|7.7|7.7|||
3615570|NCT02724111|3465532|B2|||Weight (kg)||kg|Mean|60|60.0|Standard Deviation|6.9|6.9|||
3615571|NCT02724111|3465533|B1|||Weight (kg)||kg|Mean|59.8|59.8|Standard Deviation|8.5|8.5|||
3615572|NCT02724111|3465531|B3|||Height (m)||meter|Mean|1.59|1.59|Standard Deviation|0.07|0.07|||
3615573|NCT02724111|3465532|B2|||Height (m)||meter|Mean|1.58|1.58|Standard Deviation|0.08|0.08|||
3615574|NCT02724111|3465533|B1|||Height (m)||meter|Mean|1.59|1.59|Standard Deviation|0.07|0.07|||
3615575|NCT02724111|3465531|B3|South Korea||Region of Enrollment||Participants|Count of Participants|83|83.0||||||
3615576|NCT02724111|3465532|B2|South Korea||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3615577|NCT02724111|3465533|B1|South Korea||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
3615578|NCT02724111|3465531|B3|Korean||Race/Ethnicity, Customized||Participants|Count of Participants|83|83.0||||||
3615579|NCT02724111|3465532|B2|Korean||Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3615580|NCT02724111|3465533|B1|Korean||Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
3615581|NCT02724111|3465531|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3615582|NCT02724111|3465532|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3615583|NCT02724111|3465533|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3615584|NCT02724111|3465531|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3615585|NCT02724111|3465532|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3615586|NCT02724111|3465533|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3615587|NCT02724111|3465531|B3|||Age||years|Median|60|60.0|Full Range|||30.0|75.0|
3615588|NCT02724111|3465532|B2|||Age||years|Median|60|60.0|Full Range|||30.0|75.0|
3615589|NCT02724111|3465533|B1|||Age||years|Median|61|61.0|Full Range|||37.0|75.0|
3615590|NCT02724111|3465531|B3||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3615591|NCT02724111|3465532|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3615592|NCT02724111|3465533|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3615593|NCT02724111|3465531|B3||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
3615594|NCT02724111|3465532|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3615595|NCT02724111|3465533|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3615596|NCT02724111|3465531|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3615597|NCT02724111|3465532|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3615598|NCT02724111|3465533|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3615599|NCT02723201|3465554|B4||4 or more drinks per day|Amount of Alcohol Consumed by Participant||Participants|Count of Participants|0|0.0||||||
3615600|NCT02723201|3465555|B3||4 or more drinks per day|Amount of Alcohol Consumed by Participant||Participants|Count of Participants|0|0.0||||||
3615601|NCT02723201|3465556|B2||4 or more drinks per day|Amount of Alcohol Consumed by Participant||Participants|Count of Participants|0|0.0||||||
3615602|NCT02723201|3465557|B1||4 or more drinks per day|Amount of Alcohol Consumed by Participant||Participants|Count of Participants|0|0.0||||||
3615603|NCT02723201|3465554|B4||Less than (<) 4 drinks per day|Amount of Alcohol Consumed by Participant||Participants|Count of Participants|22|22.0||||||
3615604|NCT02723201|3465555|B3||Less than (<) 4 drinks per day|Amount of Alcohol Consumed by Participant||Participants|Count of Participants|6|6.0||||||
3615605|NCT02723201|3465556|B2||Less than (<) 4 drinks per day|Amount of Alcohol Consumed by Participant||Participants|Count of Participants|6|6.0||||||
3615606|NCT02723201|3465557|B1||Less than (<) 4 drinks per day|Amount of Alcohol Consumed by Participant||Participants|Count of Participants|10|10.0||||||
3615607|NCT02723201|3465554|B4||Not applicable (male participants)|Female Reproductive Status||Participants|Count of Participants|17|17.0||||||
3615608|NCT02723201|3465555|B3||Not applicable (male participants)|Female Reproductive Status||Participants|Count of Participants|6|6.0||||||
3615609|NCT02723201|3465556|B2||Not applicable (male participants)|Female Reproductive Status||Participants|Count of Participants|4|4.0||||||
3615610|NCT02723201|3465557|B1||Not applicable (male participants)|Female Reproductive Status||Participants|Count of Participants|7|7.0||||||
3615611|NCT02723201|3465554|B4||Female of childbearing potential|Female Reproductive Status||Participants|Count of Participants|4|4.0||||||
3615612|NCT02723201|3465555|B3||Female of childbearing potential|Female Reproductive Status||Participants|Count of Participants|1|1.0||||||
3615613|NCT02723201|3465556|B2||Female of childbearing potential|Female Reproductive Status||Participants|Count of Participants|2|2.0||||||
3615614|NCT02723201|3465557|B1||Female of childbearing potential|Female Reproductive Status||Participants|Count of Participants|1|1.0||||||
3615615|NCT02723201|3465554|B4||Surgically sterile|Female Reproductive Status||Participants|Count of Participants|4|4.0||||||
3615616|NCT02723201|3465555|B3||Surgically sterile|Female Reproductive Status||Participants|Count of Participants|0|0.0||||||
3615617|NCT02723201|3465556|B2||Surgically sterile|Female Reproductive Status||Participants|Count of Participants|1|1.0||||||
3615618|NCT02723201|3465557|B1||Surgically sterile|Female Reproductive Status||Participants|Count of Participants|3|3.0||||||
3615619|NCT02723201|3465554|B4||No caffeine/xanthine consumption|Caffeine/Xanthine Classification||Participants|Count of Participants|1|1.0||||||
3615620|NCT02723201|3465555|B3||No caffeine/xanthine consumption|Caffeine/Xanthine Classification||Participants|Count of Participants|0|0.0||||||
3615621|NCT02723201|3465556|B2||No caffeine/xanthine consumption|Caffeine/Xanthine Classification||Participants|Count of Participants|0|0.0||||||
3615622|NCT02723201|3465557|B1||No caffeine/xanthine consumption|Caffeine/Xanthine Classification||Participants|Count of Participants|1|1.0||||||
3615623|NCT02723201|3465554|B4||Caffeine/xanthine consumption|Caffeine/Xanthine Classification||Participants|Count of Participants|24|24.0||||||
3615624|NCT02723201|3465555|B3||Caffeine/xanthine consumption|Caffeine/Xanthine Classification||Participants|Count of Participants|7|7.0||||||
3615625|NCT02723201|3465556|B2||Caffeine/xanthine consumption|Caffeine/Xanthine Classification||Participants|Count of Participants|7|7.0||||||
3615626|NCT02723201|3465557|B1||Caffeine/xanthine consumption|Caffeine/Xanthine Classification||Participants|Count of Participants|10|10.0||||||
3615627|NCT02723201|3465554|B4||Ex-drinker|Alcohol Classification||Participants|Count of Participants|2|2.0||||||
3615628|NCT02723201|3465555|B3||Ex-drinker|Alcohol Classification||Participants|Count of Participants|1|1.0||||||
3615629|NCT02723201|3465556|B2||Ex-drinker|Alcohol Classification||Participants|Count of Participants|0|0.0||||||
3615630|NCT02723201|3465557|B1||Ex-drinker|Alcohol Classification||Participants|Count of Participants|1|1.0||||||
3615631|NCT02723201|3465554|B4||Current drinker|Alcohol Classification||Participants|Count of Participants|22|22.0||||||
3615632|NCT02723201|3465555|B3||Current drinker|Alcohol Classification||Participants|Count of Participants|6|6.0||||||
3615633|NCT02723201|3465556|B2||Current drinker|Alcohol Classification||Participants|Count of Participants|6|6.0||||||
3615634|NCT02723201|3465557|B1||Current drinker|Alcohol Classification||Participants|Count of Participants|10|10.0||||||
3615635|NCT02723201|3465554|B4||Never drinks|Alcohol Classification||Participants|Count of Participants|1|1.0||||||
3615636|NCT02723201|3465555|B3||Never drinks|Alcohol Classification||Participants|Count of Participants|0|0.0||||||
3615637|NCT02723201|3465556|B2||Never drinks|Alcohol Classification||Participants|Count of Participants|1|1.0||||||
3615638|NCT02723201|3465557|B1||Never drinks|Alcohol Classification||Participants|Count of Participants|0|0.0||||||
3615639|NCT02723201|3465554|B4||Ex-smoker|Smoking Classification||Participants|Count of Participants|4|4.0||||||
3615640|NCT02723201|3465555|B3||Ex-smoker|Smoking Classification||Participants|Count of Participants|2|2.0||||||
3615641|NCT02723201|3465556|B2||Ex-smoker|Smoking Classification||Participants|Count of Participants|1|1.0||||||
3615642|NCT02723201|3465557|B1||Ex-smoker|Smoking Classification||Participants|Count of Participants|1|1.0||||||
3615643|NCT02723201|3465554|B4||Current smoker|Smoking Classification||Participants|Count of Participants|0|0.0||||||
3615644|NCT02723201|3465555|B3||Current smoker|Smoking Classification||Participants|Count of Participants|0|0.0||||||
3615645|NCT02723201|3465556|B2||Current smoker|Smoking Classification||Participants|Count of Participants|0|0.0||||||
3615646|NCT02723201|3465557|B1||Current smoker|Smoking Classification||Participants|Count of Participants|0|0.0||||||
3615647|NCT02723201|3465554|B4||Never smoked|Smoking Classification||Participants|Count of Participants|21|21.0||||||
3615648|NCT02723201|3465555|B3||Never smoked|Smoking Classification||Participants|Count of Participants|5|5.0||||||
3615649|NCT02723201|3465556|B2||Never smoked|Smoking Classification||Participants|Count of Participants|6|6.0||||||
3615650|NCT02723201|3465557|B1||Never smoked|Smoking Classification||Participants|Count of Participants|10|10.0||||||
3615651|NCT02723201|3465554|B4|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|25.57|25.57|Standard Deviation|2.900|2.9|||
3615652|NCT02723201|3465555|B3|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|25.19|25.19|Standard Deviation|2.884|2.884|||
3615653|NCT02723201|3465556|B2|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|24.91|24.91|Standard Deviation|2.724|2.724|||
3615654|NCT02723201|3465557|B1|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|26.23|26.23|Standard Deviation|3.140|3.14|||
3615655|NCT02723201|3465554|B4|||Weight||kilogram (kg)|Mean|76.32|76.32|Standard Deviation|13.212|13.212|||
3615656|NCT02723201|3465555|B3|||Weight||kilogram (kg)|Mean|75.50|75.5|Standard Deviation|10.207|10.207|||
3615657|NCT02723201|3465556|B2|||Weight||kilogram (kg)|Mean|74.26|74.26|Standard Deviation|11.454|11.454|||
3615658|NCT02723201|3465557|B1|||Weight||kilogram (kg)|Mean|78.16|78.16|Standard Deviation|16.448|16.448|||
3615659|NCT02723201|3465554|B4|||Height||centimeter (cm)|Mean|172.2|172.2|Standard Deviation|8.34|8.34|||
3615660|NCT02723201|3465555|B3|||Height||centimeter (cm)|Mean|173.0|173.0|Standard Deviation|6.51|6.51|||
3615661|NCT02723201|3465556|B2|||Height||centimeter (cm)|Mean|172.3|172.3|Standard Deviation|7.36|7.36|||
3615662|NCT02723201|3465557|B1|||Height||centimeter (cm)|Mean|171.7|171.7|Standard Deviation|10.40|10.4|||
3615663|NCT02723201|3465554|B4|United Kingdom||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3615664|NCT02723201|3465555|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3615665|NCT02723201|3465556|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3615666|NCT02723201|3465557|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3615667|NCT02723201|3465554|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615668|NCT02723201|3465555|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615669|NCT02723201|3465556|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615670|NCT02723201|3465557|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615671|NCT02723201|3465554|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3615672|NCT02723201|3465555|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615673|NCT02723201|3465556|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615674|NCT02723201|3465557|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3615675|NCT02723201|3465554|B4||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3615676|NCT02723201|3465555|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3615677|NCT02723201|3465556|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3615678|NCT02723201|3465557|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3615679|NCT02723201|3465554|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615680|NCT02723201|3465555|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615681|NCT02723201|3465556|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615682|NCT02723201|3465557|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615683|NCT02723201|3465554|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615684|NCT02723201|3465555|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615685|NCT02723201|3465556|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615686|NCT02723201|3465557|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615687|NCT02723201|3465554|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615688|NCT02723201|3465555|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615689|NCT02723201|3465556|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615690|NCT02723201|3465557|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615691|NCT02723201|3465554|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615692|NCT02723201|3465555|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615693|NCT02723201|3465556|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615694|NCT02723201|3465557|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615695|NCT02723201|3465554|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615696|NCT02723201|3465555|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615697|NCT02723201|3465556|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615698|NCT02723201|3465557|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615699|NCT02723201|3465554|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3615700|NCT02723201|3465555|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3615701|NCT02723201|3465556|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3615702|NCT02723201|3465557|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3615703|NCT02723201|3465554|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615704|NCT02723201|3465555|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615705|NCT02723201|3465556|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615706|NCT02723201|3465557|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615707|NCT02723201|3465554|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3615708|NCT02723201|3465555|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3615709|NCT02723201|3465556|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3615710|NCT02723201|3465557|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3615711|NCT02723201|3465554|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3615712|NCT02723201|3465555|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3615713|NCT02723201|3465556|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3615714|NCT02723201|3465557|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3615715|NCT02723201|3465554|B4|||Age||years|Mean|39.3|39.3|Standard Deviation|10.68|10.68|||
3615716|NCT02723201|3465555|B3|||Age||years|Mean|38.9|38.9|Standard Deviation|12.36|12.36|||
3615717|NCT02723201|3465556|B2|||Age||years|Mean|31.1|31.1|Standard Deviation|6.49|6.49|||
3615718|NCT02723201|3465557|B1|||Age||years|Mean|44.7|44.7|Standard Deviation|8.82|8.82|||
3615719|NCT02723188|3465615|B4|Israel||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3615720|NCT02723188|3465616|B3|Israel||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3615721|NCT02723188|3465617|B2|Israel||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3615722|NCT02723188|3465618|B1|Israel||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3615723|NCT02723188|3465615|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3615724|NCT02723188|3465616|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3615725|NCT02723188|3465617|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3615726|NCT02723188|3465618|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3615727|NCT02723188|3465615|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3615728|NCT02723188|3465616|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3615729|NCT02723188|3465617|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3615730|NCT02723188|3465618|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3615731|NCT02723188|3465615|B4|||Age||years|Mean|25|25.0|Standard Deviation|6|6.0|||
3615732|NCT02723188|3465616|B3|||Age||years|Mean|25|25.0|Standard Deviation|5|5.0|||
3615733|NCT02723188|3465617|B2|||Age||years|Mean|23|23.0|Standard Deviation|3|3.0|||
3615734|NCT02723188|3465618|B1|||Age||years|Mean|27|27.0|Standard Deviation|7|7.0|||
3615735|NCT02723188|3465615|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3615736|NCT02723188|3465616|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3615737|NCT02723188|3465617|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3615738|NCT02723188|3465618|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3615739|NCT02723188|3465615|B4||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3615740|NCT02723188|3465616|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3615741|NCT02723188|3465617|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3615742|NCT02723188|3465618|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3615743|NCT02723188|3465615|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3615744|NCT02723188|3465616|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3615745|NCT02723188|3465617|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3615746|NCT02723188|3465618|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3615747|NCT02723175|3465631|B3|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3615748|NCT02723175|3465632|B2|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3615749|NCT02723175|3465633|B1|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3615750|NCT02723175|3465631|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615751|NCT02723175|3465632|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615752|NCT02723175|3465633|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615753|NCT02723175|3465631|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615754|NCT02723175|3465632|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615755|NCT02723175|3465633|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615756|NCT02723175|3465631|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3615757|NCT02723175|3465632|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3615758|NCT02723175|3465633|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3615759|NCT02723175|3465631|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3615760|NCT02723175|3465632|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615761|NCT02723175|3465633|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3615762|NCT02723175|3465631|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615763|NCT02723175|3465632|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615764|NCT02723175|3465633|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615765|NCT02723175|3465631|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615766|NCT02723175|3465632|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615767|NCT02723175|3465633|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615768|NCT02723175|3465631|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615769|NCT02723175|3465632|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615770|NCT02723175|3465633|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615771|NCT02723175|3465631|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3615772|NCT02723175|3465632|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3615773|NCT02723175|3465633|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3615774|NCT02723175|3465631|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3615775|NCT02723175|3465632|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3615776|NCT02723175|3465633|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3615777|NCT02723175|3465631|B3|||Age||years|Mean|49.47|49.47|Standard Deviation|12.12|12.12|||
3615778|NCT02723175|3465632|B2|||Age||years|Mean|48|48.0|Standard Deviation|14.69|14.69|||
3615779|NCT02723175|3465633|B1|||Age||years|Mean|50.75|50.75|Standard Deviation|10.25|10.25|||
3615780|NCT02723175|3465631|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3615781|NCT02723175|3465632|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3615782|NCT02723175|3465633|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3615783|NCT02723175|3465631|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3615784|NCT02723175|3465632|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3615785|NCT02723175|3465633|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3615786|NCT02723175|3465631|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3615787|NCT02723175|3465632|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3615788|NCT02723175|3465633|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3615789|NCT02722967|3465674|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3615790|NCT02722967|3465675|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3615791|NCT02722967|3465676|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3615792|NCT02722967|3465677|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3615793|NCT02722967|3465674|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3615794|NCT02722967|3465675|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3615795|NCT02722967|3465676|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3615796|NCT02722967|3465677|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3615797|NCT02722967|3465674|B4|||Age||years|Mean|46.4|46.4|Standard Deviation|13.0|13.0|||
3615798|NCT02722967|3465675|B3|||Age||years|Mean|45.5|45.5|Standard Deviation|11.1|11.1|||
3615799|NCT02722967|3465676|B2|||Age||years|Mean|49.3|49.3|Standard Deviation|11.2|11.2|||
3615800|NCT02722967|3465677|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|15.2|15.2|||
3615801|NCT02722837|3465687|B1||≥ 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|81|81.0||||||
3615802|NCT02722837|3465687|B1||< 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|38|38.0||||||
3615803|NCT02722837|3465687|B1|||HCV RNA||log10 IU/mL|Mean|6.1|6.1|Standard Deviation|0.54|0.54|||
3615804|NCT02722837|3465687|B1||TT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|18|18.0||||||
3615805|NCT02722837|3465687|B1||CT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|72|72.0||||||
3615806|NCT02722837|3465687|B1||CC|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|29|29.0||||||
3615807|NCT02722837|3465687|B1|Russia||Region of Enrollment||Participants|Count of Participants|103|103.0||||||
3615808|NCT02722837|3465687|B1|Sweden||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3615809|NCT02722837|3465687|B1||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|119|119.0||||||
3615810|NCT02722837|3465687|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3615811|NCT02722837|3465687|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|117|117.0||||||
3615812|NCT02722837|3465687|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3615813|NCT02722837|3465687|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3615814|NCT02722837|3465687|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3615815|NCT02722837|3465687|B1|||Age||years|Mean|44|44.0|Standard Deviation|11.1|11.1|||
3615816|NCT02722564|3465705|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
3615817|NCT02722564|3465705|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3615818|NCT02722564|3465705|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3615819|NCT02722564|3465705|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3615820|NCT02722564|3465705|B1||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
3615821|NCT02722564|3465705|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3615822|NCT02722278|3465709|B3|United States||Region of Enrollment||Participants|Count of Participants|222|222.0||||||
3615823|NCT02722278|3465710|B2|United States||Region of Enrollment||Participants|Count of Participants|56|56.0||||||
3615824|NCT02722278|3465711|B1|United States||Region of Enrollment||Participants|Count of Participants|166|166.0||||||
3615825|NCT02722278|3465709|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615826|NCT02722278|3465710|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615827|NCT02722278|3465711|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615828|NCT02722278|3465709|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3615829|NCT02722278|3465710|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615830|NCT02722278|3465711|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3615831|NCT02722278|3465709|B3||White|Race (NIH/OMB)||Participants|Count of Participants|175|175.0||||||
3615832|NCT02722278|3465710|B2||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3615833|NCT02722278|3465711|B1||White|Race (NIH/OMB)||Participants|Count of Participants|133|133.0||||||
3615834|NCT02722278|3465709|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3615835|NCT02722278|3465710|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3615836|NCT02722278|3465711|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3615837|NCT02722278|3465709|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615838|NCT02722278|3465710|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615839|NCT02722278|3465711|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615840|NCT02722278|3465709|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3615841|NCT02722278|3465710|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3615842|NCT02722278|3465711|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3615843|NCT02722278|3465709|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3615844|NCT02722278|3465710|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3615845|NCT02722278|3465711|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615846|NCT02722278|3465709|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615847|NCT02722278|3465710|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615848|NCT02722278|3465711|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615849|NCT02722278|3465709|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|182|182.0||||||
3615850|NCT02722278|3465710|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3615851|NCT02722278|3465711|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|141|141.0||||||
3615852|NCT02722278|3465709|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3615853|NCT02722278|3465710|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3615854|NCT02722278|3465711|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3615855|NCT02722278|3465709|B3||Male|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
3615856|NCT02722278|3465710|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3615857|NCT02722278|3465711|B1||Male|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3615858|NCT02722278|3465709|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3615859|NCT02722278|3465710|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3615860|NCT02722278|3465711|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3615861|NCT02722278|3465709|B3|||Age||years|Mean|52|52.0|Standard Deviation|8.81|8.81|||
3615862|NCT02722278|3465710|B2|||Age||years|Mean|53.4|53.4|Standard Deviation|7.86|7.86|||
3615863|NCT02722278|3465711|B1|||Age||years|Mean|51.6|51.6|Standard Deviation|9.08|9.08|||
3615864|NCT02722278|3465709|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3615865|NCT02722278|3465710|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3615866|NCT02722278|3465711|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3615867|NCT02722278|3465709|B3||Between 18 and 65 years|Age||Participants|Count of Participants|214|214.0||||||
3615868|NCT02722278|3465710|B2||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3615869|NCT02722278|3465711|B1||Between 18 and 65 years|Age||Participants|Count of Participants|160|160.0||||||
3615870|NCT02722278|3465709|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3615871|NCT02722278|3465710|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3615872|NCT02722278|3465711|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3615873|NCT02722239|3465720|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615874|NCT02722239|3465721|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615875|NCT02722239|3465722|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615876|NCT02722239|3465720|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615877|NCT02722239|3465721|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615878|NCT02722239|3465722|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615879|NCT02722239|3465720|B3||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3615880|NCT02722239|3465721|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3615881|NCT02722239|3465722|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3615882|NCT02722239|3465720|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615883|NCT02722239|3465721|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615884|NCT02722239|3465722|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615885|NCT02722239|3465720|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615886|NCT02722239|3465721|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615887|NCT02722239|3465722|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615888|NCT02722239|3465720|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615889|NCT02722239|3465721|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615890|NCT02722239|3465722|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615891|NCT02722239|3465720|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615892|NCT02722239|3465721|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615893|NCT02722239|3465722|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615894|NCT02722239|3465720|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3615895|NCT02722239|3465721|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3615896|NCT02722239|3465722|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3615897|NCT02722239|3465720|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3615898|NCT02722239|3465721|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3615899|NCT02722239|3465722|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3615900|NCT02722239|3465720|B3|>45 years||Age, Customized||participants|Number|0|0.0||||||
3615901|NCT02722239|3465721|B2|>45 years||Age, Customized||participants|Number|0|0.0||||||
3615902|NCT02722239|3465722|B1|>45 years||Age, Customized||participants|Number|0|0.0||||||
3615903|NCT02722239|3465720|B3|between 18 and 45 years (inclusive)||Age, Customized||participants|Number|40|40.0||||||
3615904|NCT02722239|3465721|B2|between 18 and 45 years (inclusive)||Age, Customized||participants|Number|20|20.0||||||
3615905|NCT02722239|3465722|B1|between 18 and 45 years (inclusive)||Age, Customized||participants|Number|20|20.0||||||
3615906|NCT02722239|3465720|B3|<18 years||Age, Customized||participants|Number|0|0.0||||||
3615907|NCT02722239|3465721|B2|<18 years||Age, Customized||participants|Number|0|0.0||||||
3615908|NCT02722239|3465722|B1|<18 years||Age, Customized||participants|Number|0|0.0||||||
3615909|NCT02722239|3465720|B3|Age (years): Mean ± Standard Deviation||Age||years|Mean|30.2|30.2|Standard Deviation|8.1|8.1|||
3615910|NCT02722239|3465721|B2|Age (years): Mean ± Standard Deviation||Age||years|Mean|30.8|30.8|Standard Deviation|8.7|8.7|||
3615911|NCT02722239|3465722|B1|Age (years): Mean ± Standard Deviation||Age||years|Mean|29.6|29.6|Standard Deviation|7.7|7.7|||
3615912|NCT02722044|3465736|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615913|NCT02722044|3465736|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615914|NCT02722044|3465736|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3615915|NCT02722044|3465736|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3615916|NCT02722044|3465736|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615917|NCT02722044|3465736|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615918|NCT02722044|3465736|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615919|NCT02722044|3465736|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615920|NCT02722044|3465736|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3615921|NCT02722044|3465736|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3615922|NCT02722044|3465736|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3615923|NCT02722044|3465736|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3615924|NCT02722044|3465736|B1|||Age||years|Mean|58.2|58.2|Standard Deviation|9.82|9.82|||
3615925|NCT02721875|3465763|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3615926|NCT02721875|3465765|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3615927|NCT02721875|3465763|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3615928|NCT02721875|3465765|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3615929|NCT02721875|3465763|B3|||Age||Years|Mean|69|69.0|Standard Deviation|||||
3615930|NCT02721875|3465765|B1|||Age||Years|Mean|69|69.0|Standard Deviation|||||
3615931|NCT02721641|3465779|B1|||Age||years|Mean|58.0|58.0|Standard Deviation|11.00|11.0|||
3615932|NCT02721277|3465785|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3615933|NCT02721277|3465785|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3615934|NCT02721277|3465785|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3615935|NCT02721277|3465785|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3615936|NCT02721277|3465785|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3615937|NCT02721277|3465785|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3615938|NCT02721147|3465814|B4|United States||Region of Enrollment||Participants|Count of Participants|89|89.0||||||
3615939|NCT02721147|3465815|B3|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3615940|NCT02721147|3465816|B2|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3615941|NCT02721147|3465817|B1|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3615942|NCT02721147|3465814|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3615943|NCT02721147|3465815|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3615944|NCT02721147|3465816|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615945|NCT02721147|3465817|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3615946|NCT02721147|3465814|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3615947|NCT02721147|3465815|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615948|NCT02721147|3465816|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615949|NCT02721147|3465817|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3615950|NCT02721147|3465814|B4||White|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3615951|NCT02721147|3465815|B3||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3615952|NCT02721147|3465816|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3615953|NCT02721147|3465817|B1||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3615954|NCT02721147|3465814|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3615955|NCT02721147|3465815|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3615956|NCT02721147|3465816|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615957|NCT02721147|3465817|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3615958|NCT02721147|3465814|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615959|NCT02721147|3465815|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615960|NCT02721147|3465816|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615961|NCT02721147|3465817|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615962|NCT02721147|3465814|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3615963|NCT02721147|3465815|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615964|NCT02721147|3465816|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3615965|NCT02721147|3465817|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615966|NCT02721147|3465814|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615967|NCT02721147|3465815|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615968|NCT02721147|3465816|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615969|NCT02721147|3465817|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615970|NCT02721147|3465814|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615971|NCT02721147|3465815|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615972|NCT02721147|3465816|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615973|NCT02721147|3465817|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615974|NCT02721147|3465814|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3615975|NCT02721147|3465815|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3615976|NCT02721147|3465816|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3615977|NCT02721147|3465817|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3615978|NCT02721147|3465814|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3615979|NCT02721147|3465815|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3615980|NCT02721147|3465816|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615981|NCT02721147|3465817|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3615982|NCT02721147|3465814|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3615983|NCT02721147|3465815|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3615984|NCT02721147|3465816|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3615985|NCT02721147|3465817|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3615986|NCT02721147|3465814|B4||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3615987|NCT02721147|3465815|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3615988|NCT02721147|3465816|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3615989|NCT02721147|3465817|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3615990|NCT02721147|3465814|B4|||Age||years|Mean|54.92|54.92|Standard Deviation|9.73|9.73|||
3615991|NCT02721147|3465815|B3|||Age||years|Mean|55.77|55.77|Standard Deviation|8.65|8.65|||
3615992|NCT02721147|3465816|B2|||Age||years|Mean|53.33|53.33|Standard Deviation|10.69|10.69|||
3615993|NCT02721147|3465817|B1|||Age||years|Mean|54.68|54.68|Standard Deviation|10.08|10.08|||
3615994|NCT02720952|3465854|B1|Germany||Region of Enrollment||participants|Number|24|24.0||||||
3615995|NCT02720952|3465854|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615996|NCT02720952|3465854|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615997|NCT02720952|3465854|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3615998|NCT02720952|3465854|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3615999|NCT02720952|3465854|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616000|NCT02720952|3465854|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616001|NCT02720952|3465854|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616002|NCT02720952|3465854|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616003|NCT02720952|3465854|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3616004|NCT02720952|3465854|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616005|NCT02720952|3465854|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3616006|NCT02720952|3465854|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3616007|NCT02720952|3465854|B1|||Age||days|Mean|718.1|718.1|Full Range|||16.0|1708.0|
3616008|NCT02720952|3465854|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3616009|NCT02720952|3465854|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3616010|NCT02720952|3465854|B1||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
3616011|NCT02720510|3465863|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616012|NCT02720510|3465864|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616013|NCT02720510|3465865|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616014|NCT02720510|3465863|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616015|NCT02720510|3465864|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616016|NCT02720510|3465865|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616017|NCT02720510|3465863|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3616018|NCT02720510|3465864|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3616019|NCT02720510|3465865|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3616020|NCT02720510|3465863|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3616021|NCT02720510|3465864|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3616022|NCT02720510|3465865|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3616023|NCT02720510|3465863|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616024|NCT02720510|3465864|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616025|NCT02720510|3465865|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616026|NCT02720510|3465863|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616027|NCT02720510|3465864|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616028|NCT02720510|3465865|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616029|NCT02720510|3465863|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616030|NCT02720510|3465864|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616031|NCT02720510|3465865|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616032|NCT02720510|3465863|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3616033|NCT02720510|3465864|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3616034|NCT02720510|3465865|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3616035|NCT02720510|3465863|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3616036|NCT02720510|3465864|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3616037|NCT02720510|3465865|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3616038|NCT02720510|3465863|B3|||Age||Years|Mean|60.5|60.5|Standard Deviation|9.22|9.22|||
3616039|NCT02720510|3465864|B2|||Age||Years|Mean|58.3|58.3|Standard Deviation|3.51|3.51|||
3616040|NCT02720510|3465865|B1|||Age||Years|Mean|62.7|62.7|Standard Deviation|13.65|13.65|||
3616041|NCT02720224|3465884|B1|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3616042|NCT02720224|3465884|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3616043|NCT02720224|3465884|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3616044|NCT02720224|3465884|B1|||Age||years|Mean|57.8|57.8|Standard Deviation|3.5|3.5|||
3616045|NCT02720224|3465884|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3616046|NCT02720224|3465884|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3616047|NCT02720224|3465884|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3616048|NCT02720081|3465906|B3|No||Prior inhaled corticosteroid use||Participants|Count of Participants|36|36.0||||||
3616049|NCT02720081|3465907|B2|No||Prior inhaled corticosteroid use||Participants|Count of Participants|16|16.0||||||
3616050|NCT02720081|3465908|B1|No||Prior inhaled corticosteroid use||Participants|Count of Participants|20|20.0||||||
3616051|NCT02720081|3465906|B3|Yes||Prior inhaled corticosteroid use||Participants|Count of Participants|106|106.0||||||
3616052|NCT02720081|3465907|B2|Yes||Prior inhaled corticosteroid use||Participants|Count of Participants|54|54.0||||||
3616053|NCT02720081|3465908|B1|Yes||Prior inhaled corticosteroid use||Participants|Count of Participants|52|52.0||||||
3616054|NCT02720081|3465906|B3|2 copies||C Alleles at the pre-specified single nucleotide polymorphism (SNP)|Copies of C Alleles at the pre-specified SNP is the proposed genetic marker for response to MK-1029 for the treatment of asthma.|Participants|Count of Participants|47|47.0||||||
3616055|NCT02720081|3465907|B2|2 copies||C Alleles at the pre-specified single nucleotide polymorphism (SNP)|Copies of C Alleles at the pre-specified SNP is the proposed genetic marker for response to MK-1029 for the treatment of asthma.|Participants|Count of Participants|23|23.0||||||
3616056|NCT02720081|3465908|B1|2 copies||C Alleles at the pre-specified single nucleotide polymorphism (SNP)|Copies of C Alleles at the pre-specified SNP is the proposed genetic marker for response to MK-1029 for the treatment of asthma.|Participants|Count of Participants|24|24.0||||||
3616057|NCT02720081|3465906|B3|1 copy||C Alleles at the pre-specified single nucleotide polymorphism (SNP)|Copies of C Alleles at the pre-specified SNP is the proposed genetic marker for response to MK-1029 for the treatment of asthma.|Participants|Count of Participants|95|95.0||||||
3616058|NCT02720081|3465907|B2|1 copy||C Alleles at the pre-specified single nucleotide polymorphism (SNP)|Copies of C Alleles at the pre-specified SNP is the proposed genetic marker for response to MK-1029 for the treatment of asthma.|Participants|Count of Participants|47|47.0||||||
3616059|NCT02720081|3465908|B1|1 copy||C Alleles at the pre-specified single nucleotide polymorphism (SNP)|Copies of C Alleles at the pre-specified SNP is the proposed genetic marker for response to MK-1029 for the treatment of asthma.|Participants|Count of Participants|48|48.0||||||
3616060|NCT02720081|3465906|B3|||Pre beta-agonist (β-agonist) forced expiratory volume in one second (FEV1) Predicted|If Week 0 measurement was not available, the last non-missing value before treatment was used as Baseline.|Liter (L)|Mean|2.247|2.247|Standard Deviation|0.600|0.6|||
3616061|NCT02720081|3465907|B2|||Pre beta-agonist (β-agonist) forced expiratory volume in one second (FEV1) Predicted|If Week 0 measurement was not available, the last non-missing value before treatment was used as Baseline.|Liter (L)|Mean|2.243|2.243|Standard Deviation|0.631|0.631|||
3616062|NCT02720081|3465908|B1|||Pre beta-agonist (β-agonist) forced expiratory volume in one second (FEV1) Predicted|If Week 0 measurement was not available, the last non-missing value before treatment was used as Baseline.|Liter (L)|Mean|2.251|2.251|Standard Deviation|0.572|0.572|||
3616063|NCT02720081|3465906|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616064|NCT02720081|3465907|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616065|NCT02720081|3465908|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616066|NCT02720081|3465906|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3616067|NCT02720081|3465907|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3616068|NCT02720081|3465908|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3616069|NCT02720081|3465906|B3||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3616070|NCT02720081|3465907|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3616071|NCT02720081|3465908|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3616072|NCT02720081|3465906|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616073|NCT02720081|3465907|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616074|NCT02720081|3465908|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616075|NCT02720081|3465906|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616076|NCT02720081|3465907|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616077|NCT02720081|3465908|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616078|NCT02720081|3465906|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
3616079|NCT02720081|3465907|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3616080|NCT02720081|3465908|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3616081|NCT02720081|3465906|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3616082|NCT02720081|3465907|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3616083|NCT02720081|3465908|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3616084|NCT02720081|3465906|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3616085|NCT02720081|3465907|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3616086|NCT02720081|3465908|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3616087|NCT02720081|3465906|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3616088|NCT02720081|3465907|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3616089|NCT02720081|3465908|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3616090|NCT02720081|3465906|B3|||Age||Years|Mean|43.3|43.3|Standard Deviation|12.6|12.6|||
3616091|NCT02720081|3465907|B2|||Age||Years|Mean|42.2|42.2|Standard Deviation|13.0|13.0|||
3616092|NCT02720081|3465908|B1|||Age||Years|Mean|44.4|44.4|Standard Deviation|12.1|12.1|||
3616093|NCT02718898|3465965|B3|||sPGA of Genitalia|The Static Physician Global Assessment (sPGA) of Genitalia score is based on a combination of erythema and the secondary features (plaque elevation and/or scale). For the analysis of responses, the participant's psoriasis is assessed as follows: 0 = clear,1 = minimal,2 = mild,3 = moderate,4 = severe,5 = very severe.|units on a scale|Mean|3.4|3.4|Standard Deviation|0.57|0.57|||
3616094|NCT02718898|3465966|B2|||sPGA of Genitalia|The Static Physician Global Assessment (sPGA) of Genitalia score is based on a combination of erythema and the secondary features (plaque elevation and/or scale). For the analysis of responses, the participant's psoriasis is assessed as follows: 0 = clear,1 = minimal,2 = mild,3 = moderate,4 = severe,5 = very severe.|units on a scale|Mean|3.4|3.4|Standard Deviation|0.57|0.57|||
3616095|NCT02718898|3465967|B1|||sPGA of Genitalia|The Static Physician Global Assessment (sPGA) of Genitalia score is based on a combination of erythema and the secondary features (plaque elevation and/or scale). For the analysis of responses, the participant's psoriasis is assessed as follows: 0 = clear,1 = minimal,2 = mild,3 = moderate,4 = severe,5 = very severe.|units on a scale|Mean|3.5|3.5|Standard Deviation|0.53|0.53|||
3616096|NCT02718898|3465965|B3|Australia||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3616097|NCT02718898|3465966|B2|Australia||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3616098|NCT02718898|3465967|B1|Australia||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3616099|NCT02718898|3465965|B3|United States||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
3616100|NCT02718898|3465966|B2|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3616101|NCT02718898|3465967|B1|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3616102|NCT02718898|3465965|B3|Belgium||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3616103|NCT02718898|3465966|B2|Belgium||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3616104|NCT02718898|3465967|B1|Belgium||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3616105|NCT02718898|3465965|B3|Turkey||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3616106|NCT02718898|3465966|B2|Turkey||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3616107|NCT02718898|3465967|B1|Turkey||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3616108|NCT02718898|3465965|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3616109|NCT02718898|3465966|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3616110|NCT02718898|3465967|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3616111|NCT02718898|3465965|B3|Austria||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3616112|NCT02718898|3465966|B2|Austria||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3616113|NCT02718898|3465967|B1|Austria||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3616114|NCT02718898|3465965|B3|Puerto Rico||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3616115|NCT02718898|3465966|B2|Puerto Rico||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3616116|NCT02718898|3465967|B1|Puerto Rico||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3616117|NCT02718898|3465965|B3|Canada||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3616118|NCT02718898|3465966|B2|Canada||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3616119|NCT02718898|3465967|B1|Canada||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3616120|NCT02718898|3465965|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616121|NCT02718898|3465966|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616122|NCT02718898|3465967|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616123|NCT02718898|3465965|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3616124|NCT02718898|3465966|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3616125|NCT02718898|3465967|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3616126|NCT02718898|3465965|B3||White|Race (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
3616127|NCT02718898|3465966|B2||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3616128|NCT02718898|3465967|B1||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3616129|NCT02718898|3465965|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3616130|NCT02718898|3465966|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616131|NCT02718898|3465967|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3616132|NCT02718898|3465965|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616133|NCT02718898|3465966|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616134|NCT02718898|3465967|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616135|NCT02718898|3465965|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3616136|NCT02718898|3465966|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3616137|NCT02718898|3465967|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3616138|NCT02718898|3465965|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3616139|NCT02718898|3465966|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3616140|NCT02718898|3465967|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616141|NCT02718898|3465965|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3616142|NCT02718898|3465966|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3616143|NCT02718898|3465967|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3616144|NCT02718898|3465965|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|117|117.0||||||
3616145|NCT02718898|3465966|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3616146|NCT02718898|3465967|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3616147|NCT02718898|3465965|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3616148|NCT02718898|3465966|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3616149|NCT02718898|3465967|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3616150|NCT02718898|3465965|B3||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3616151|NCT02718898|3465966|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3616152|NCT02718898|3465967|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3616153|NCT02718898|3465965|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3616154|NCT02718898|3465966|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3616155|NCT02718898|3465967|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3616156|NCT02718898|3465965|B3|||Age||years|Mean|43.7|43.7|Standard Deviation|12.72|12.72|||
3616157|NCT02718898|3465966|B2|||Age||years|Mean|43.1|43.1|Standard Deviation|12.95|12.95|||
3616158|NCT02718898|3465967|B1|||Age||years|Mean|44.4|44.4|Standard Deviation|12.55|12.55|||
3616159|NCT02718248|3465996|B1|||EuroQol 5 Dimensions Visual Analytic Scale|Participants were asked to use the EuroQol 5 Dimensions Visual Analytic Scale to assess their overall health on a scale from 0 to 100, with 100 being the best possible health state.|units on a scale|Mean|47.57|47.57|Standard Deviation|11.530|11.53|||
3616160|NCT02718248|3465996|B1|||General Health Related Quality of Life|Generic health-related quality of life index. The total scores on this measure range from 11111 to 33333, with lower values indicating higher levels of health-related quality of life.|units on a scale|Median|11223|11223.0|Full Range|||11113.0|21223.0|
3616161|NCT02718248|3465996|B1|||Social Functioning|Social Functioning was measured using the Social Functioning subscale of the Medical Outcomes Survey Short Form 12 (SF-12). The SF-12 is a 12-item self-report survey that assesses general health and well-being using a total of 8 subscales. The Social Functioning Subscale is scored using a range of 0-100, with a higher score indicating higher social functioning.|units on a scale|Mean|28.57|28.57|Standard Deviation|22.493|22.493|||
3616162|NCT02718248|3465996|B1|||Bodily Pain|Bodily Pain was measured using the Bodily Pain subscale of the Medical Outcomes Survey Short Form 12 (SF-12). The SF-12 is a 12-item self-report survey that assesses general health and well-being using a total of 8 subscales. The Bodily Pain Subscale is scored using a range of 0-100, with a higher score indicating lower levels of bodily pain.|units on a scale|Mean|71.43|71.43|Standard Deviation|30.375|30.375|||
3616163|NCT02718248|3465996|B1|||Mental Health Functioning|Mental Health Functioning was measured using the Mental Health subscale of the Medical Outcomes Survey Short Form 12 (SF-12). The SF-12 is a 12-item self-report survey that assesses general health and well-being using a total of 8 subscales. The Mental Health Functioning Subscale is scored using a range of 0-100, with a higher score indicating better mental health functioning.|units on a scale|Mean|17.86|17.86|Standard Deviation|17.466|17.466|||
3616164|NCT02718248|3465996|B1|||General Health|General Health was measured using the General Health subscale of the Medical Outcomes Survey Short Form 12 (SF-12). The SF-12 is a 12-item self-report survey that assesses general health and well-being using a total of 8 subscales. The General Health Subscale is scored using a range of 0-100, with a higher score indicating higher levels of general health.|units on a scale|Mean|42.14|42.14|Standard Deviation|29.277|29.277|||
3616165|NCT02718248|3465996|B1|||Vitality|Vitality was measured using the Vitality subscale of the Medical Outcomes Survey Short Form 12 (SF-12). The SF-12 is a 12-item self-report survey that assesses general health and well-being using a total of 8 subscales. The Vitality subscale is scored using a range of 0-100, with a higher score indicating a higher degree of vitality.|units on a scale|Mean|25.0|25.0|Standard Deviation|20.412|20.412|||
3616166|NCT02718248|3465996|B1|||Emotional Role Limitations|Emotional Role Limitations was measured using the Emotional Role Limitations subscale of the Medical Outcomes Survey Short Form 12 (SF-12). The SF-12 is a 12-item self-report survey that assesses general health and well-being using a total of 8 subscales. The Emotional Role Limitations Subscale is scored using a range of 0-100, with a higher score indicating fewer role limitations due to emotional health difficulties.|units on a scale|Mean|26.79|26.79|Standard Deviation|26.446|26.446|||
3616216|NCT02718118|3466021|B1|||Age||years|Mean|45.1|45.1|Standard Deviation|10.93|10.93|||
3616217|NCT02718040|3466056|B1|Canada||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3616167|NCT02718248|3465996|B1|||Physical Role Limitations|Physical Role Limitations was measured using the Physical Role Limitations subscale of the Medical Outcomes Survey Short Form 12 (SF-12). The SF-12 is a 12-item self-report survey that assesses general health and well-being using a total of 8 subscales. The Physical Role Limitations Subscale is scored using a range of 0-100, with a higher score indicating fewer role limitations due to physical health difficulties.|units on a scale|Mean|75|75.0|Standard Deviation|23.936|23.936|||
3616168|NCT02718248|3465996|B1|||Physical Functioning|Physical Functioning was measured using the Physical Functioning subscale of the Medical Outcomes Survey Short Form 12 (SF-12). The SF-12 is a 12-item self-report survey that assesses general health and well-being using a total of 8 subscales. The Physical Functioning Subscale is scored using a range of 0-100, with a higher score indicating better physical functioning.|units on a scale|Mean|82.14|82.14|Standard Deviation|18.898|18.898|||
3616169|NCT02718248|3465996|B1|||Severity of Depression Symptoms|"Severity of depression symptoms was measured using the Patient Health Questionnaire (PHQ-9). This is a 9-item self-report scale which assessed the severity of depressive symptoms over the preceding 2 weeks. Total scores on this scale range from 0 to 27, with higher scores indicating more severe depression symptoms. The scores on the Patient Health Questionnaire (PHQ-9) scale should be interpreted as follows:~0-4: Minimal Depression; 5-9: Mild Depression 10-14: Moderate Depression; 15-19: Moderately Severe Depression; 20 and Above: Severe Depression."|units on a scale|Mean|18.29|18.29|Standard Deviation|5.529|5.529|||
3616170|NCT02718248|3465996|B1|Canada||Region of Enrollment||participants|Number|7|7.0||||||
3616171|NCT02718248|3465996|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3616172|NCT02718248|3465996|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3616173|NCT02718248|3465996|B1|||Age||years|Mean|27.43|27.43|Standard Deviation|8.142|8.142|||
3616174|NCT02718248|3465996|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3616175|NCT02718248|3465996|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3616176|NCT02718248|3465996|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3616177|NCT02718157|3466012|B1|United States||Region of Enrollment||participants|Number|533|533.0||||||
3616178|NCT02718157|3466012|B1|Canada||Region of Enrollment||participants|Number|238|238.0||||||
3616179|NCT02718157|3466012|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3616180|NCT02718157|3466012|B1||Female|Sex: Female, Male||Participants|Count of Participants|771|771.0||||||
3616181|NCT02718157|3466012|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3616182|NCT02718157|3466012|B1||Between 18 and 65 years|Age||Participants|Count of Participants|771|771.0||||||
3616183|NCT02718157|3466012|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3616184|NCT02718118|3466019|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3616185|NCT02718118|3466020|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3616186|NCT02718118|3466021|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3616187|NCT02718118|3466019|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616188|NCT02718118|3466020|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616189|NCT02718118|3466021|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616190|NCT02718118|3466019|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616191|NCT02718118|3466020|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616192|NCT02718118|3466021|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616193|NCT02718118|3466019|B3||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3616194|NCT02718118|3466020|B2||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3616195|NCT02718118|3466021|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3616196|NCT02718118|3466019|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3616197|NCT02718118|3466020|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3616198|NCT02718118|3466021|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3616199|NCT02718118|3466019|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616200|NCT02718118|3466020|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616201|NCT02718118|3466021|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616202|NCT02718118|3466019|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616203|NCT02718118|3466020|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616204|NCT02718118|3466021|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616205|NCT02718118|3466019|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616206|NCT02718118|3466020|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616207|NCT02718118|3466021|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616208|NCT02718118|3466019|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3616209|NCT02718118|3466020|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3616210|NCT02718118|3466021|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3616211|NCT02718118|3466019|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3616212|NCT02718118|3466020|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3616213|NCT02718118|3466021|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3616214|NCT02718118|3466019|B3|||Age||years|Mean|45.8|45.8|Standard Deviation|11.26|11.26|||
3616215|NCT02718118|3466020|B2|||Age||years|Mean|46.5|46.5|Standard Deviation|11.73|11.73|||
3616218|NCT02718040|3466056|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616219|NCT02718040|3466056|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616220|NCT02718040|3466056|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3616221|NCT02718040|3466056|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616222|NCT02718040|3466056|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616223|NCT02718040|3466056|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616224|NCT02718040|3466056|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616225|NCT02718040|3466056|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3616226|NCT02718040|3466056|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3616227|NCT02718040|3466056|B1|||Age||Years|Mean|55.0|55.0|Standard Deviation|6.01|6.01|||
3616228|NCT02717754|3466069|B7||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3616229|NCT02717754|3466070|B6||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3616230|NCT02717754|3466071|B5||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3616231|NCT02717754|3466072|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3616232|NCT02717754|3466073|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3616233|NCT02717754|3466074|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3616234|NCT02717754|3466075|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3616235|NCT02717754|3466069|B7||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3616236|NCT02717754|3466070|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3616237|NCT02717754|3466071|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3616238|NCT02717754|3466072|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3616239|NCT02717754|3466073|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3616240|NCT02717754|3466074|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3616241|NCT02717754|3466075|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3616242|NCT02717754|3466069|B7|||Age||years|Mean|29.4040|29.404|Standard Deviation|7.44904|7.44904|||
3616243|NCT02717754|3466070|B6|||Age||years|Mean|28.6|28.6|Standard Deviation|8.09|8.09|||
3616244|NCT02717754|3466071|B5|||Age||years|Mean|31.1|31.1|Standard Deviation|7.80|7.8|||
3616245|NCT02717754|3466072|B4|||Age||years|Mean|29.7|29.7|Standard Deviation|7.90|7.9|||
3616246|NCT02717754|3466073|B3|||Age||years|Mean|30.2|30.2|Standard Deviation|7.73|7.73|||
3616247|NCT02717754|3466074|B2|||Age||years|Mean|28.3|28.3|Standard Deviation|6.97|6.97|||
3616248|NCT02717754|3466075|B1|||Age||years|Mean|28.1|28.1|Standard Deviation|6.19|6.19|||
3616249|NCT02717273|3466108|B3|United States||Region of Enrollment||Participants|Count of Participants|102|102.0||||||
3616250|NCT02717273|3466109|B2|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3616251|NCT02717273|3466110|B1|United States||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
3616252|NCT02717273|3466108|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3616253|NCT02717273|3466109|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3616254|NCT02717273|3466110|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3616255|NCT02717273|3466108|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3616256|NCT02717273|3466109|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3616257|NCT02717273|3466110|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3616258|NCT02717273|3466108|B3|||Age||years|Median|57.5|57.5|Inter-Quartile Range|||52.0|60.0|
3616259|NCT02717273|3466109|B2|||Age||years|Median|58.5|58.5|Inter-Quartile Range|||55.0|61.0|
3616260|NCT02717273|3466110|B1|||Age||years|Median|56|56.0|Inter-Quartile Range|||51.0|58.0|
3616261|NCT02717273|3466108|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3616262|NCT02717273|3466109|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3616263|NCT02717273|3466110|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3616264|NCT02717273|3466108|B3||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
3616265|NCT02717273|3466109|B2||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3616266|NCT02717273|3466110|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
3616267|NCT02717273|3466108|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3616268|NCT02717273|3466109|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3616269|NCT02717273|3466110|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3616270|NCT02716779|3466129|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3616271|NCT02716779|3466130|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3616272|NCT02716779|3466131|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3616273|NCT02716779|3466132|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3616274|NCT02716779|3466129|B4||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3616275|NCT02716779|3466130|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3616276|NCT02716779|3466131|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3616277|NCT02716779|3466132|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3616278|NCT02716779|3466129|B4|||Age||years|Mean|48.5|48.5|Standard Deviation|14.1|14.1|||
3616279|NCT02716779|3466130|B3|||Age||years|Mean|50.2|50.2|Standard Deviation|12.9|12.9|||
3616280|NCT02716779|3466131|B2|||Age||years|Mean|48.2|48.2|Standard Deviation|15.4|15.4|||
3616281|NCT02716779|3466132|B1|||Age||years|Mean|45.8|45.8|Standard Deviation|14.4|14.4|||
3616282|NCT02716714|3466178|B3||No|Prior treatment history of actinic keratosis||Participants|Count of Participants|58|58.0||||||
3616283|NCT02716714|3466179|B2||No|Prior treatment history of actinic keratosis||Participants|Count of Participants|6|6.0||||||
3616284|NCT02716714|3466180|B1||No|Prior treatment history of actinic keratosis||Participants|Count of Participants|52|52.0||||||
3616285|NCT02716714|3466178|B3||Yes|Prior treatment history of actinic keratosis||Participants|Count of Participants|15|15.0||||||
3616286|NCT02716714|3466179|B2||Yes|Prior treatment history of actinic keratosis||Participants|Count of Participants|3|3.0||||||
3616287|NCT02716714|3466180|B1||Yes|Prior treatment history of actinic keratosis||Participants|Count of Participants|12|12.0||||||
3616288|NCT02716714|3466178|B3||AK III (Severe)|Severity of actinic keratosis||Participants|Count of Participants|14|14.0||||||
3616289|NCT02716714|3466179|B2||AK III (Severe)|Severity of actinic keratosis||Participants|Count of Participants|1|1.0||||||
3616290|NCT02716714|3466180|B1||AK III (Severe)|Severity of actinic keratosis||Participants|Count of Participants|13|13.0||||||
3616291|NCT02716714|3466178|B3||AK II (Moderate)|Severity of actinic keratosis||Participants|Count of Participants|47|47.0||||||
3616292|NCT02716714|3466179|B2||AK II (Moderate)|Severity of actinic keratosis||Participants|Count of Participants|5|5.0||||||
3616293|NCT02716714|3466180|B1||AK II (Moderate)|Severity of actinic keratosis||Participants|Count of Participants|42|42.0||||||
3616294|NCT02716714|3466178|B3||AK I (Mild)|Severity of actinic keratosis||Participants|Count of Participants|12|12.0||||||
3616295|NCT02716714|3466179|B2||AK I (Mild)|Severity of actinic keratosis||Participants|Count of Participants|3|3.0||||||
3616296|NCT02716714|3466180|B1||AK I (Mild)|Severity of actinic keratosis||Participants|Count of Participants|9|9.0||||||
3616297|NCT02716714|3466178|B3|||Actinic keratosis duration at the selected treatment area||months|Mean|1.91|1.91|Standard Deviation|8.14|8.14|||
3616298|NCT02716714|3466179|B2|||Actinic keratosis duration at the selected treatment area||months|Mean|1.03|1.03|Standard Deviation|1.78|1.78|||
3616299|NCT02716714|3466180|B1|||Actinic keratosis duration at the selected treatment area||months|Mean|2.03|2.03|Standard Deviation|8.67|8.67|||
3616300|NCT02716714|3466178|B3|||Actinic keratosis duration||months|Mean|9.74|9.74|Standard Deviation|30.72|30.72|||
3616301|NCT02716714|3466179|B2|||Actinic keratosis duration||months|Mean|19.10|19.1|Standard Deviation|52.48|52.48|||
3616302|NCT02716714|3466180|B1|||Actinic keratosis duration||months|Mean|8.43|8.43|Standard Deviation|26.73|26.73|||
3616303|NCT02716714|3466178|B3|||BMI||kg/m^2|Mean|22.73|22.73|Standard Deviation|2.60|2.6|||
3616304|NCT02716714|3466179|B2|||BMI||kg/m^2|Mean|23.49|23.49|Standard Deviation|2.63|2.63|||
3616305|NCT02716714|3466180|B1|||BMI||kg/m^2|Mean|22.62|22.62|Standard Deviation|2.59|2.59|||
3616306|NCT02716714|3466178|B3|||Weight||kg|Mean|56.89|56.89|Standard Deviation|8.93|8.93|||
3616307|NCT02716714|3466179|B2|||Weight||kg|Mean|60.24|60.24|Standard Deviation|8.98|8.98|||
3616308|NCT02716714|3466180|B1|||Weight||kg|Mean|56.42|56.42|Standard Deviation|8.89|8.89|||
3616309|NCT02716714|3466178|B3|||Height||cm|Mean|157.92|157.92|Standard Deviation|7.51|7.51|||
3616310|NCT02716714|3466179|B2|||Height||cm|Mean|159.89|159.89|Standard Deviation|5.75|5.75|||
3616311|NCT02716714|3466180|B1|||Height||cm|Mean|157.64|157.64|Standard Deviation|7.72|7.72|||
3616312|NCT02716714|3466178|B3||VI|Fitzpatrick skin type|Fitzpatrick skin type was described as following; Type I: Extremely fair skin, always burns, never tans Type II: Fair skin, always burns, sometimes tans Type III: Medium skin, sometimes burns, always tans Type IV: Olive skin, rarely burns, always tans Type V: Moderately pigmented brown skin, never burns, always tans Type VI: Markedly pigmented black skin, never burns, always tans and it was considered worse outcomes from type IV upto type VI.|Participants|Count of Participants|0|0.0||||||
3616313|NCT02716714|3466179|B2||VI|Fitzpatrick skin type|Fitzpatrick skin type was described as following; Type I: Extremely fair skin, always burns, never tans Type II: Fair skin, always burns, sometimes tans Type III: Medium skin, sometimes burns, always tans Type IV: Olive skin, rarely burns, always tans Type V: Moderately pigmented brown skin, never burns, always tans Type VI: Markedly pigmented black skin, never burns, always tans and it was considered worse outcomes from type IV upto type VI.|Participants|Count of Participants|0|0.0||||||
3616314|NCT02716714|3466180|B1||VI|Fitzpatrick skin type|Fitzpatrick skin type was described as following; Type I: Extremely fair skin, always burns, never tans Type II: Fair skin, always burns, sometimes tans Type III: Medium skin, sometimes burns, always tans Type IV: Olive skin, rarely burns, always tans Type V: Moderately pigmented brown skin, never burns, always tans Type VI: Markedly pigmented black skin, never burns, always tans and it was considered worse outcomes from type IV upto type VI.|Participants|Count of Participants|0|0.0||||||
3616315|NCT02716714|3466178|B3||V|Fitzpatrick skin type|Fitzpatrick skin type was described as following; Type I: Extremely fair skin, always burns, never tans Type II: Fair skin, always burns, sometimes tans Type III: Medium skin, sometimes burns, always tans Type IV: Olive skin, rarely burns, always tans Type V: Moderately pigmented brown skin, never burns, always tans Type VI: Markedly pigmented black skin, never burns, always tans and it was considered worse outcomes from type IV upto type VI.|Participants|Count of Participants|0|0.0||||||
3616316|NCT02716714|3466179|B2||V|Fitzpatrick skin type|Fitzpatrick skin type was described as following; Type I: Extremely fair skin, always burns, never tans Type II: Fair skin, always burns, sometimes tans Type III: Medium skin, sometimes burns, always tans Type IV: Olive skin, rarely burns, always tans Type V: Moderately pigmented brown skin, never burns, always tans Type VI: Markedly pigmented black skin, never burns, always tans and it was considered worse outcomes from type IV upto type VI.|Participants|Count of Participants|0|0.0||||||
3616334|NCT02716714|3466179|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3616335|NCT02716714|3466180|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3616336|NCT02716714|3466178|B3|||Age||years|Mean|72.36|72.36|Standard Deviation|8.47|8.47|||
3616317|NCT02716714|3466180|B1||V|Fitzpatrick skin type|Fitzpatrick skin type was described as following; Type I: Extremely fair skin, always burns, never tans Type II: Fair skin, always burns, sometimes tans Type III: Medium skin, sometimes burns, always tans Type IV: Olive skin, rarely burns, always tans Type V: Moderately pigmented brown skin, never burns, always tans Type VI: Markedly pigmented black skin, never burns, always tans and it was considered worse outcomes from type IV upto type VI.|Participants|Count of Participants|0|0.0||||||
3616318|NCT02716714|3466178|B3||IV|Fitzpatrick skin type|Fitzpatrick skin type was described as following; Type I: Extremely fair skin, always burns, never tans Type II: Fair skin, always burns, sometimes tans Type III: Medium skin, sometimes burns, always tans Type IV: Olive skin, rarely burns, always tans Type V: Moderately pigmented brown skin, never burns, always tans Type VI: Markedly pigmented black skin, never burns, always tans and it was considered worse outcomes from type IV upto type VI.|Participants|Count of Participants|17|17.0||||||
3616319|NCT02716714|3466179|B2||IV|Fitzpatrick skin type|Fitzpatrick skin type was described as following; Type I: Extremely fair skin, always burns, never tans Type II: Fair skin, always burns, sometimes tans Type III: Medium skin, sometimes burns, always tans Type IV: Olive skin, rarely burns, always tans Type V: Moderately pigmented brown skin, never burns, always tans Type VI: Markedly pigmented black skin, never burns, always tans and it was considered worse outcomes from type IV upto type VI.|Participants|Count of Participants|2|2.0||||||
3616320|NCT02716714|3466180|B1||IV|Fitzpatrick skin type|Fitzpatrick skin type was described as following; Type I: Extremely fair skin, always burns, never tans Type II: Fair skin, always burns, sometimes tans Type III: Medium skin, sometimes burns, always tans Type IV: Olive skin, rarely burns, always tans Type V: Moderately pigmented brown skin, never burns, always tans Type VI: Markedly pigmented black skin, never burns, always tans and it was considered worse outcomes from type IV upto type VI.|Participants|Count of Participants|15|15.0||||||
3616321|NCT02716714|3466178|B3||III|Fitzpatrick skin type|Fitzpatrick skin type was described as following; Type I: Extremely fair skin, always burns, never tans Type II: Fair skin, always burns, sometimes tans Type III: Medium skin, sometimes burns, always tans Type IV: Olive skin, rarely burns, always tans Type V: Moderately pigmented brown skin, never burns, always tans Type VI: Markedly pigmented black skin, never burns, always tans and it was considered worse outcomes from type IV upto type VI.|Participants|Count of Participants|48|48.0||||||
3616322|NCT02716714|3466179|B2||III|Fitzpatrick skin type|Fitzpatrick skin type was described as following; Type I: Extremely fair skin, always burns, never tans Type II: Fair skin, always burns, sometimes tans Type III: Medium skin, sometimes burns, always tans Type IV: Olive skin, rarely burns, always tans Type V: Moderately pigmented brown skin, never burns, always tans Type VI: Markedly pigmented black skin, never burns, always tans and it was considered worse outcomes from type IV upto type VI.|Participants|Count of Participants|6|6.0||||||
3616323|NCT02716714|3466180|B1||III|Fitzpatrick skin type|Fitzpatrick skin type was described as following; Type I: Extremely fair skin, always burns, never tans Type II: Fair skin, always burns, sometimes tans Type III: Medium skin, sometimes burns, always tans Type IV: Olive skin, rarely burns, always tans Type V: Moderately pigmented brown skin, never burns, always tans Type VI: Markedly pigmented black skin, never burns, always tans and it was considered worse outcomes from type IV upto type VI.|Participants|Count of Participants|42|42.0||||||
3616324|NCT02716714|3466178|B3||II|Fitzpatrick skin type|Fitzpatrick skin type was described as following; Type I: Extremely fair skin, always burns, never tans Type II: Fair skin, always burns, sometimes tans Type III: Medium skin, sometimes burns, always tans Type IV: Olive skin, rarely burns, always tans Type V: Moderately pigmented brown skin, never burns, always tans Type VI: Markedly pigmented black skin, never burns, always tans and it was considered worse outcomes from type IV upto type VI.|Participants|Count of Participants|8|8.0||||||
3616325|NCT02716714|3466179|B2||II|Fitzpatrick skin type|Fitzpatrick skin type was described as following; Type I: Extremely fair skin, always burns, never tans Type II: Fair skin, always burns, sometimes tans Type III: Medium skin, sometimes burns, always tans Type IV: Olive skin, rarely burns, always tans Type V: Moderately pigmented brown skin, never burns, always tans Type VI: Markedly pigmented black skin, never burns, always tans and it was considered worse outcomes from type IV upto type VI.|Participants|Count of Participants|1|1.0||||||
3616326|NCT02716714|3466180|B1||II|Fitzpatrick skin type|Fitzpatrick skin type was described as following; Type I: Extremely fair skin, always burns, never tans Type II: Fair skin, always burns, sometimes tans Type III: Medium skin, sometimes burns, always tans Type IV: Olive skin, rarely burns, always tans Type V: Moderately pigmented brown skin, never burns, always tans Type VI: Markedly pigmented black skin, never burns, always tans and it was considered worse outcomes from type IV upto type VI.|Participants|Count of Participants|7|7.0||||||
3616327|NCT02716714|3466178|B3||I|Fitzpatrick skin type|Fitzpatrick skin type was described as following; Type I: Extremely fair skin, always burns, never tans Type II: Fair skin, always burns, sometimes tans Type III: Medium skin, sometimes burns, always tans Type IV: Olive skin, rarely burns, always tans Type V: Moderately pigmented brown skin, never burns, always tans Type VI: Markedly pigmented black skin, never burns, always tans and it was considered worse outcomes from type IV upto type VI.|Participants|Count of Participants|0|0.0||||||
3616328|NCT02716714|3466179|B2||I|Fitzpatrick skin type|Fitzpatrick skin type was described as following; Type I: Extremely fair skin, always burns, never tans Type II: Fair skin, always burns, sometimes tans Type III: Medium skin, sometimes burns, always tans Type IV: Olive skin, rarely burns, always tans Type V: Moderately pigmented brown skin, never burns, always tans Type VI: Markedly pigmented black skin, never burns, always tans and it was considered worse outcomes from type IV upto type VI.|Participants|Count of Participants|0|0.0||||||
3616329|NCT02716714|3466180|B1||I|Fitzpatrick skin type|Fitzpatrick skin type was described as following; Type I: Extremely fair skin, always burns, never tans Type II: Fair skin, always burns, sometimes tans Type III: Medium skin, sometimes burns, always tans Type IV: Olive skin, rarely burns, always tans Type V: Moderately pigmented brown skin, never burns, always tans Type VI: Markedly pigmented black skin, never burns, always tans and it was considered worse outcomes from type IV upto type VI.|Participants|Count of Participants|0|0.0||||||
3616330|NCT02716714|3466178|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3616331|NCT02716714|3466179|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3616332|NCT02716714|3466180|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3616333|NCT02716714|3466178|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3616337|NCT02716714|3466179|B2|||Age||years|Mean|72.11|72.11|Standard Deviation|5.44|5.44|||
3616338|NCT02716714|3466180|B1|||Age||years|Mean|72.39|72.39|Standard Deviation|8.85|8.85|||
3616339|NCT02716298|3466207|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3616340|NCT02716298|3466207|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3616341|NCT02716298|3466207|B1|||Age||years|Mean|27.1|27.1|Full Range|||18.0|63.0|
3616342|NCT02716194|3466223|B4|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3616343|NCT02716194|3466224|B3|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3616344|NCT02716194|3466225|B2|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3616345|NCT02716194|3466226|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3616346|NCT02716194|3466223|B4|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
3616347|NCT02716194|3466224|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3616348|NCT02716194|3466225|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3616349|NCT02716194|3466226|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3616350|NCT02716194|3466223|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3616351|NCT02716194|3466224|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3616352|NCT02716194|3466225|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3616353|NCT02716194|3466226|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3616354|NCT02716194|3466223|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3616355|NCT02716194|3466224|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3616356|NCT02716194|3466225|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3616357|NCT02716194|3466226|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3616358|NCT02716194|3466223|B4|||Age||Years|Median|34.0|34.0|Full Range|||18.0|63.0|
3616359|NCT02716194|3466224|B3|||Age||Years|Median|36.0|36.0|Full Range|||18.0|63.0|
3616360|NCT02716194|3466225|B2|||Age||Years|Median|33.0|33.0|Full Range|||19.0|55.0|
3616361|NCT02716194|3466226|B1|||Age||Years|Median|34.0|34.0|Full Range|||20.0|59.0|
3616362|NCT02714504|3466306|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3616363|NCT02714504|3466307|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3616364|NCT02714504|3466308|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3616365|NCT02714504|3466306|B3||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3616366|NCT02714504|3466307|B2||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3616367|NCT02714504|3466308|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3616368|NCT02714504|3466306|B3|Age||Age||years|Median|48|48.0|Full Range|||13.0|72.0|
3616369|NCT02714504|3466307|B2|Age||Age||years|Median|50|50.0|Full Range|||13.0|72.0|
3616370|NCT02714504|3466308|B1|Age||Age||years|Median|44|44.0|Full Range|||14.0|66.0|
3616371|NCT02714062|3466315|B4|United States||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3616372|NCT02714062|3466316|B3|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3616373|NCT02714062|3466317|B2|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3616374|NCT02714062|3466318|B1|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3616375|NCT02714062|3466315|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616376|NCT02714062|3466316|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616377|NCT02714062|3466317|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616378|NCT02714062|3466318|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616379|NCT02714062|3466315|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3616380|NCT02714062|3466316|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3616381|NCT02714062|3466317|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3616382|NCT02714062|3466318|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616383|NCT02714062|3466315|B4||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3616384|NCT02714062|3466316|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3616385|NCT02714062|3466317|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3616386|NCT02714062|3466318|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3616387|NCT02714062|3466315|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3616388|NCT02714062|3466316|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3616389|NCT02714062|3466317|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3616390|NCT02714062|3466318|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3616391|NCT02714062|3466315|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616392|NCT02714062|3466316|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616393|NCT02714062|3466317|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616394|NCT02714062|3466318|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616395|NCT02714062|3466315|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616396|NCT02714062|3466316|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616397|NCT02714062|3466317|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616398|NCT02714062|3466318|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616399|NCT02714062|3466315|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3616400|NCT02714062|3466316|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616401|NCT02714062|3466317|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3616402|NCT02714062|3466318|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616403|NCT02714062|3466315|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3616404|NCT02714062|3466316|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3616405|NCT02714062|3466317|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3616406|NCT02714062|3466318|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3616407|NCT02714062|3466315|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3616408|NCT02714062|3466316|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3616409|NCT02714062|3466317|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3616410|NCT02714062|3466318|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3616411|NCT02714062|3466315|B4|||Age||years|Mean|14.3|14.3|Standard Deviation|1.44|1.44|||
3616412|NCT02714062|3466316|B3|||Age||years|Mean|14.3|14.3|Standard Deviation|1.55|1.55|||
3616413|NCT02714062|3466317|B2|||Age||years|Mean|14.4|14.4|Standard Deviation|1.30|1.3|||
3616414|NCT02714062|3466318|B1|||Age||years|Mean|14.1|14.1|Standard Deviation|1.56|1.56|||
3616415|NCT02713698|3466364|B4|Portugal||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3616416|NCT02713698|3466365|B3|Portugal||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3616417|NCT02713698|3466366|B2|Portugal||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3616418|NCT02713698|3466367|B1|Portugal||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3616419|NCT02713698|3466364|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616420|NCT02713698|3466365|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616421|NCT02713698|3466366|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616422|NCT02713698|3466367|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616423|NCT02713698|3466364|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616424|NCT02713698|3466365|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616425|NCT02713698|3466366|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616426|NCT02713698|3466367|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616427|NCT02713698|3466364|B4||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3616428|NCT02713698|3466365|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3616429|NCT02713698|3466366|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3616430|NCT02713698|3466367|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3616431|NCT02713698|3466364|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616432|NCT02713698|3466365|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616433|NCT02713698|3466366|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616434|NCT02713698|3466367|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616435|NCT02713698|3466364|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616436|NCT02713698|3466365|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616437|NCT02713698|3466366|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616438|NCT02713698|3466367|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616439|NCT02713698|3466364|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616440|NCT02713698|3466365|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616441|NCT02713698|3466366|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616442|NCT02713698|3466367|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616443|NCT02713698|3466364|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616444|NCT02713698|3466365|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616445|NCT02713698|3466366|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616446|NCT02713698|3466367|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616447|NCT02713698|3466364|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3616448|NCT02713698|3466365|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3616449|NCT02713698|3466366|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3616450|NCT02713698|3466367|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3616451|NCT02713698|3466364|B4||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3616452|NCT02713698|3466365|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3616453|NCT02713698|3466366|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3616454|NCT02713698|3466367|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3616455|NCT02713698|3466364|B4|||Age||years|Mean|56.4|56.4|Standard Deviation|18.3|18.3|||
3616456|NCT02713698|3466365|B3|||Age||years|Mean|77.7|77.7|Standard Deviation|8.6|8.6|||
3616457|NCT02713698|3466366|B2|||Age||years|Mean|47.9|47.9|Standard Deviation|9.4|9.4|||
3616458|NCT02713698|3466367|B1|||Age||years|Mean|43.7|43.7|Standard Deviation|12.5|12.5|||
3616459|NCT02713594|3466377|B3|United States||Region of Enrollment||Count of Participants|Number|1900|1900.0||||||
3616460|NCT02713594|3466378|B2|United States||Region of Enrollment||Count of Participants|Number|948|948.0||||||
3616461|NCT02713594|3466379|B1|United States||Region of Enrollment||Count of Participants|Number|952|952.0||||||
3616462|NCT02713594|3466377|B3||Refused/Do not know/Not collected|Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3616463|NCT02713594|3466378|B2||Refused/Do not know/Not collected|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3616464|NCT02713594|3466379|B1||Refused/Do not know/Not collected|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3616465|NCT02713594|3466377|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|74|74.0||||||
3616466|NCT02713594|3466378|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
3616467|NCT02713594|3466379|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3616468|NCT02713594|3466377|B3||American Indian/Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3616469|NCT02713594|3466378|B2||American Indian/Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3616470|NCT02713594|3466379|B1||American Indian/Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3616471|NCT02713594|3466377|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3616472|NCT02713594|3466378|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3616473|NCT02713594|3466379|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3616474|NCT02713594|3466377|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|972|972.0||||||
3616475|NCT02713594|3466378|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|485|485.0||||||
3616476|NCT02713594|3466379|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|487|487.0||||||
3616477|NCT02713594|3466377|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|783|783.0||||||
3616478|NCT02713594|3466378|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|393|393.0||||||
3616479|NCT02713594|3466379|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|390|390.0||||||
3616480|NCT02713594|3466377|B3||Male|Sex: Female, Male||Participants|Count of Participants|754|754.0||||||
3616481|NCT02713594|3466378|B2||Male|Sex: Female, Male||Participants|Count of Participants|379|379.0||||||
3616482|NCT02713594|3466379|B1||Male|Sex: Female, Male||Participants|Count of Participants|375|375.0||||||
3616483|NCT02713594|3466377|B3||Female|Sex: Female, Male||Participants|Count of Participants|1146|1146.0||||||
3616484|NCT02713594|3466378|B2||Female|Sex: Female, Male||Participants|Count of Participants|569|569.0||||||
3616485|NCT02713594|3466379|B1||Female|Sex: Female, Male||Participants|Count of Participants|577|577.0||||||
3616486|NCT02713594|3466377|B3|||Age||years|Mean|45.0|45.0|Standard Deviation|11.2|11.2|||
3616487|NCT02713594|3466378|B2|||Age||years|Mean|45.0|45.0|Standard Deviation|11.2|11.2|||
3616488|NCT02713594|3466379|B1|||Age||years|Mean|44.9|44.9|Standard Deviation|11.2|11.2|||
3616489|NCT02713256|3466390|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616490|NCT02713256|3466390|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616491|NCT02713256|3466390|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3616492|NCT02713256|3466390|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616493|NCT02713256|3466390|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616494|NCT02713256|3466390|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3616495|NCT02713256|3466390|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616496|NCT02713256|3466390|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3616497|NCT02713256|3466390|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3616498|NCT02713256|3466390|B1|||Age||years|Mean|44.3|44.3|Standard Deviation|12.9|12.9|||
3616499|NCT02712333|3466396|B3|||Body mass index||kg/m^2|Mean|21.1|21.1|Standard Deviation|2.6|2.6|||
3616500|NCT02712333|3466397|B2|||Body mass index||kg/m^2|Mean|20.6|20.6|Standard Deviation|2.5|2.5|||
3616501|NCT02712333|3466398|B1|||Body mass index||kg/m^2|Mean|21.6|21.6|Standard Deviation|2.9|2.9|||
3616502|NCT02712333|3466396|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3616503|NCT02712333|3466397|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3616504|NCT02712333|3466398|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3616505|NCT02712333|3466396|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3616506|NCT02712333|3466397|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3616507|NCT02712333|3466398|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3616508|NCT02712333|3466396|B3|||Age||years|Mean|20.2|20.2|Standard Deviation|1.3|1.3|||
3616509|NCT02712333|3466397|B2|||Age||years|Mean|20.6|20.6|Standard Deviation|1.4|1.4|||
3616510|NCT02712333|3466398|B1|||Age||years|Mean|20.0|20.0|Standard Deviation|1.3|1.3|||
3616511|NCT02712320|3466417|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3616512|NCT02712320|3466417|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616513|NCT02712320|3466417|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3616514|NCT02712320|3466417|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3616515|NCT02712320|3466417|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616516|NCT02712320|3466417|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3616517|NCT02712320|3466417|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616518|NCT02712320|3466417|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3616519|NCT02712320|3466417|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3616520|NCT02712320|3466417|B1|||Age||years|Mean|75.0|75.0|Standard Deviation|7.86|7.86|||
3616521|NCT02712099|3466425|B3|Egypt||Region of Enrollment||participants|Number|50|50.0||||||
3616522|NCT02712099|3466426|B2|Egypt||Region of Enrollment||participants|Number|20|20.0||||||
3616523|NCT02712099|3466427|B1|Egypt||Region of Enrollment||participants|Number|30|30.0||||||
3616524|NCT02712099|3466425|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3616525|NCT02712099|3466425|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3616526|NCT02712099|3466426|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3616527|NCT02712099|3466427|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3616528|NCT02712099|3466425|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3616529|NCT02712099|3466426|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3616530|NCT02712099|3466427|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3616531|NCT02712099|3466425|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3616532|NCT02712099|3466426|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3616533|NCT02712099|3466427|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3616534|NCT02712099|3466425|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3616535|NCT02712099|3466426|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3616536|NCT02712099|3466427|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3616537|NCT02712099|3466425|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3616538|NCT02712099|3466426|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3616539|NCT02712099|3466427|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3616540|NCT02712047|3466444|B1|Native Hawaiin or other Pacific Islander and White||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3616541|NCT02712047|3466444|B1|Asian and White||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3616542|NCT02712047|3466444|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3616543|NCT02712047|3466444|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3616544|NCT02712047|3466444|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3616545|NCT02712047|3466444|B1|||Age||Years|Mean|24.5|24.5|Standard Deviation|8.14|8.14|||
3616546|NCT02712008|3466457|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3616547|NCT02712008|3466458|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3616548|NCT02712008|3466459|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3616549|NCT02712008|3466460|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616550|NCT02712008|3466457|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616551|NCT02712008|3466458|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616552|NCT02712008|3466459|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616553|NCT02712008|3466460|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616554|NCT02712008|3466457|B4||White|Race (NIH/OMB)||Participants|Count of Participants|245|245.0||||||
3616555|NCT02712008|3466458|B3||White|Race (NIH/OMB)||Participants|Count of Participants|121|121.0||||||
3616556|NCT02712008|3466459|B2||White|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3616557|NCT02712008|3466460|B1||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3616558|NCT02712008|3466457|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3616559|NCT02712008|3466458|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3616560|NCT02712008|3466459|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3616561|NCT02712008|3466460|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3616562|NCT02712008|3466457|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3616563|NCT02712008|3466458|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616564|NCT02712008|3466459|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3616565|NCT02712008|3466460|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616566|NCT02712008|3466457|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3616567|NCT02712008|3466458|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3616568|NCT02712008|3466459|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3616569|NCT02712008|3466460|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3616570|NCT02712008|3466457|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3616571|NCT02712008|3466458|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3616572|NCT02712008|3466459|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616573|NCT02712008|3466460|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3616574|NCT02712008|3466457|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3616575|NCT02712008|3466458|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3616576|NCT02712008|3466459|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3616577|NCT02712008|3466460|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616578|NCT02712008|3466457|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|247|247.0||||||
3616579|NCT02712008|3466458|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
3616580|NCT02712008|3466459|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3616581|NCT02712008|3466460|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3616582|NCT02712008|3466457|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3616583|NCT02712008|3466458|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3616584|NCT02712008|3466459|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3616585|NCT02712008|3466460|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3616586|NCT02712008|3466457|B4||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3616587|NCT02712008|3466458|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3616588|NCT02712008|3466459|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3616589|NCT02712008|3466460|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3616590|NCT02712008|3466457|B4||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3616591|NCT02712008|3466458|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3616592|NCT02712008|3466459|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3616593|NCT02712008|3466460|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3616594|NCT02712008|3466457|B4|||Age||years|Mean|61.0|61.0|Standard Deviation|10.16|10.16|||
3616595|NCT02712008|3466458|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|10.20|10.2|||
3616596|NCT02712008|3466459|B2|||Age||years|Mean|62.5|62.5|Standard Deviation|10.36|10.36|||
3616597|NCT02712008|3466460|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|9.12|9.12|||
3616598|NCT02711995|3466499|B1|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3616599|NCT02711995|3466499|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3616600|NCT02711995|3466499|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3616601|NCT02711995|3466499|B1|||Age||years|Mean|62|62.0|Full Range|||46.0|82.0|
3616602|NCT02711995|3466499|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3616603|NCT02711995|3466499|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3616604|NCT02711995|3466499|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3616605|NCT02710630|3466521|B6||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3616606|NCT02710630|3466522|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3616607|NCT02710630|3466523|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3616608|NCT02710630|3466524|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3616609|NCT02710630|3466525|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3616610|NCT02710630|3466526|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3616611|NCT02710630|3466521|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3616612|NCT02710630|3466522|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3616613|NCT02710630|3466523|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3616614|NCT02710630|3466524|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3616615|NCT02710630|3466525|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3616616|NCT02710630|3466526|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3616617|NCT02710630|3466521|B6|||Age||Years|Mean|27.8|27.8|Standard Deviation|3.2|3.2|||
3616618|NCT02710630|3466522|B5|||Age||Years|Mean|27.4|27.4|Standard Deviation|3.4|3.4|||
3616619|NCT02710630|3466523|B4|||Age||Years|Mean|29.1|29.1|Standard Deviation|3.6|3.6|||
3616620|NCT02710630|3466524|B3|||Age||Years|Mean|27.3|27.3|Standard Deviation|3.4|3.4|||
3616621|NCT02710630|3466525|B2|||Age||Years|Mean|28.1|28.1|Standard Deviation|3.4|3.4|||
3616622|NCT02710630|3466526|B1|||Age||Years|Mean|26.9|26.9|Standard Deviation|2.4|2.4|||
3616623|NCT02710292|3466574|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3616624|NCT02710292|3466574|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3616625|NCT02710292|3466574|B1|||Age||years|Mean|39.9|39.9|Standard Deviation|9.7|9.7|||
3616626|NCT02710136|3466582|B3|||Log base 10 Albumin in Nasal Secretions|Albumin is a protein in the human body whose levels are hypothesized to be related to extent of allergic response. Baseline albumin scores were obtained after the nasal rinse administered prior to the Nasal Allergen Challenge. Higher scores indicate more allergic response.|mcg/L|Mean|5.67|5.67|Standard Deviation|0.55|0.55|||
3616627|NCT02710136|3466583|B2|||Log base 10 Albumin in Nasal Secretions|Albumin is a protein in the human body whose levels are hypothesized to be related to extent of allergic response. Baseline albumin scores were obtained after the nasal rinse administered prior to the Nasal Allergen Challenge. Higher scores indicate more allergic response.|mcg/L|Mean|5.80|5.8|Standard Deviation|0.44|0.44|||
3616628|NCT02710136|3466584|B1|||Log base 10 Albumin in Nasal Secretions|Albumin is a protein in the human body whose levels are hypothesized to be related to extent of allergic response. Baseline albumin scores were obtained after the nasal rinse administered prior to the Nasal Allergen Challenge. Higher scores indicate more allergic response.|mcg/L|Mean|5.39|5.39|Standard Deviation|0.69|0.69|||
3616629|NCT02710136|3466582|B3|||Log base 10 Tryptase in Nasal Secretions|Tryptase is a protein in the human body whose levels are hypothesized to be related to extent of allergic response. Baseline tryptase scores were obtained after the nasal rinse administered prior to the Nasal Allergen Challenge. Higher scores indicate more allergic response.|mcg/L|Mean|0.71|0.71|Standard Deviation|0.72|0.72|||
3616630|NCT02710136|3466583|B2|||Log base 10 Tryptase in Nasal Secretions|Tryptase is a protein in the human body whose levels are hypothesized to be related to extent of allergic response. Baseline tryptase scores were obtained after the nasal rinse administered prior to the Nasal Allergen Challenge. Higher scores indicate more allergic response.|mcg/L|Mean|0.84|0.84|Standard Deviation|0.73|0.73|||
3616631|NCT02710136|3466584|B1|||Log base 10 Tryptase in Nasal Secretions|Tryptase is a protein in the human body whose levels are hypothesized to be related to extent of allergic response. Baseline tryptase scores were obtained after the nasal rinse administered prior to the Nasal Allergen Challenge. Higher scores indicate more allergic response.|mcg/L|Mean|0.49|0.49|Standard Deviation|0.69|0.69|||
3616632|NCT02710136|3466582|B3|||Visual Analog Score (VAS)|Participants self-reported their score, reflecting the severity of their nasal symptoms-sneezing, runny nose, stuffy nose, itchy nose- on a Visual Analogue Scale (0 to 10 centimeters). The left-hand side of the scale (0) represents “No Symptoms,” and the right hand side of the scale (10) represents “As Bad as I Can Imagine.” Baseline VAS scores were obtained after the nasal rinse administered prior to the Nasal Allergen Challenge.|Centimeters|Mean|0.80|0.8|Standard Deviation|1.64|1.64|||
3616633|NCT02710136|3466583|B2|||Visual Analog Score (VAS)|Participants self-reported their score, reflecting the severity of their nasal symptoms-sneezing, runny nose, stuffy nose, itchy nose- on a Visual Analogue Scale (0 to 10 centimeters). The left-hand side of the scale (0) represents “No Symptoms,” and the right hand side of the scale (10) represents “As Bad as I Can Imagine.” Baseline VAS scores were obtained after the nasal rinse administered prior to the Nasal Allergen Challenge.|Centimeters|Mean|1.07|1.07|Standard Deviation|1.88|1.88|||
3616634|NCT02710136|3466584|B1|||Visual Analog Score (VAS)|Participants self-reported their score, reflecting the severity of their nasal symptoms-sneezing, runny nose, stuffy nose, itchy nose- on a Visual Analogue Scale (0 to 10 centimeters). The left-hand side of the scale (0) represents “No Symptoms,” and the right hand side of the scale (10) represents “As Bad as I Can Imagine.” Baseline VAS scores were obtained after the nasal rinse administered prior to the Nasal Allergen Challenge.|Centimeters|Mean|0.12|0.12|Standard Deviation|0.26|0.26|||
3616635|NCT02710136|3466582|B3|||Peak Expiratory Flow (PEF) L/min|PEF is defined as the speed of expiration of air in Liters per minute when breathing out of the lungs. Baseline PEF scores were obtained after the nasal rinse administered prior to the Nasal Allergen Challenge. Lower scores indicate less ability to expel air out of the lungs due to more severe nasal symptoms.|L/min|Mean|320.0|320.0|Standard Deviation|95.6|95.6|||
3616636|NCT02710136|3466583|B2|||Peak Expiratory Flow (PEF) L/min|PEF is defined as the speed of expiration of air in Liters per minute when breathing out of the lungs. Baseline PEF scores were obtained after the nasal rinse administered prior to the Nasal Allergen Challenge. Lower scores indicate less ability to expel air out of the lungs due to more severe nasal symptoms.|L/min|Mean|303.0|303.0|Standard Deviation|88.9|88.9|||
3616637|NCT02710136|3466584|B1|||Peak Expiratory Flow (PEF) L/min|PEF is defined as the speed of expiration of air in Liters per minute when breathing out of the lungs. Baseline PEF scores were obtained after the nasal rinse administered prior to the Nasal Allergen Challenge. Lower scores indicate less ability to expel air out of the lungs due to more severe nasal symptoms.|L/min|Mean|362.5|362.5|Standard Deviation|103.3|103.3|||
3616638|NCT02710136|3466582|B3|||Peak Nasal Inspiratory Flow (PNIF) L/min|PNIF is defined as the speed of inspiration of air in Liters per minute when breathing into the lungs. Baseline PNIF scores were obtained after the nasal rinse administered prior to the Nasal Allergen Challenge. Lower scores indicate less ability to breathe air into the lungs due to more severe nasal symptoms.|L/min|Mean|120.7|120.7|Standard Deviation|41.4|41.4|||
3616639|NCT02710136|3466583|B2|||Peak Nasal Inspiratory Flow (PNIF) L/min|PNIF is defined as the speed of inspiration of air in Liters per minute when breathing into the lungs. Baseline PNIF scores were obtained after the nasal rinse administered prior to the Nasal Allergen Challenge. Lower scores indicate less ability to breathe air into the lungs due to more severe nasal symptoms.|L/min|Mean|108.8|108.8|Standard Deviation|37.8|37.8|||
3616640|NCT02710136|3466584|B1|||Peak Nasal Inspiratory Flow (PNIF) L/min|PNIF is defined as the speed of inspiration of air in Liters per minute when breathing into the lungs. Baseline PNIF scores were obtained after the nasal rinse administered prior to the Nasal Allergen Challenge. Lower scores indicate less ability to breathe air into the lungs due to more severe nasal symptoms.|L/min|Mean|150.5|150.5|Standard Deviation|36.1|36.1|||
3616641|NCT02710136|3466582|B3|||Total Nasal Symptom Score (TNSS)|Total Nasal Symptom Score (TNSS) (0-12) is a participant rated score computed as the sum of four subscale scores (0-3) measuring sneezing, runny nose, stuffy nose, and itchy nose symptoms. Participants indicate a score on each subscale of 0, 1, 2, or 3, indicating none, mild, moderate, or severe symptoms, respectively. Baseline TNSS scores were obtained after the nasal rinse administered prior to the Nasal Allergen Challenge. Higher scores indicate more severe nasal symptoms.|Scores on a Scale|Mean|0.89|0.89|Standard Deviation|0.99|0.99|||
3616642|NCT02710136|3466583|B2|||Total Nasal Symptom Score (TNSS)|Total Nasal Symptom Score (TNSS) (0-12) is a participant rated score computed as the sum of four subscale scores (0-3) measuring sneezing, runny nose, stuffy nose, and itchy nose symptoms. Participants indicate a score on each subscale of 0, 1, 2, or 3, indicating none, mild, moderate, or severe symptoms, respectively. Baseline TNSS scores were obtained after the nasal rinse administered prior to the Nasal Allergen Challenge. Higher scores indicate more severe nasal symptoms.|Scores on a Scale|Mean|1.04|1.04|Standard Deviation|1.06|1.06|||
3616643|NCT02710136|3466584|B1|||Total Nasal Symptom Score (TNSS)|Total Nasal Symptom Score (TNSS) (0-12) is a participant rated score computed as the sum of four subscale scores (0-3) measuring sneezing, runny nose, stuffy nose, and itchy nose symptoms. Participants indicate a score on each subscale of 0, 1, 2, or 3, indicating none, mild, moderate, or severe symptoms, respectively. Baseline TNSS scores were obtained after the nasal rinse administered prior to the Nasal Allergen Challenge. Higher scores indicate more severe nasal symptoms.|Scores on a Scale|Mean|0.50|0.5|Standard Deviation|0.71|0.71|||
3616644|NCT02710136|3466582|B3|||German cockroach allergen IgE (kU/L)|Extent of allergy to German cockroach can be assessed using levels of German cockroach specific Immunoglobulin E (IgE). IgE are antibodies produced by the immune system, so that higher levels of IgE present indicate greater allergy to German cockroach. IgE levels are measured in the serum (blood test).|kU/L|Geometric Mean|3.52|3.52|Standard Deviation|4.50|4.5|||
3616645|NCT02710136|3466583|B2|||German cockroach allergen IgE (kU/L)|Extent of allergy to German cockroach can be assessed using levels of German cockroach specific Immunoglobulin E (IgE). IgE are antibodies produced by the immune system, so that higher levels of IgE present indicate greater allergy to German cockroach. IgE levels are measured in the serum (blood test).|kU/L|Geometric Mean|3.48|3.48|Standard Deviation|4.61|4.61|||
3616646|NCT02710136|3466584|B1|||German cockroach allergen IgE (kU/L)|Extent of allergy to German cockroach can be assessed using levels of German cockroach specific Immunoglobulin E (IgE). IgE are antibodies produced by the immune system, so that higher levels of IgE present indicate greater allergy to German cockroach. IgE levels are measured in the serum (blood test).|kU/L|Geometric Mean|3.61|3.61|Standard Deviation|4.60|4.6|||
3616647|NCT02710136|3466582|B3|||German cockroach allergen skin test wheal size (mm)|Extent of allergy to German cockroach can be assessed using a skin prick test. In this test, a small amount of allergen is introduced to the skin via a needle, and then the diameter of the resulting swelling, called a wheal, is measured. Larger wheal sizes indicate greater allergy to German cockroach.|mm|Geometric Mean|5.8|5.8|Standard Deviation|1.5|1.5|||
3616648|NCT02710136|3466583|B2|||German cockroach allergen skin test wheal size (mm)|Extent of allergy to German cockroach can be assessed using a skin prick test. In this test, a small amount of allergen is introduced to the skin via a needle, and then the diameter of the resulting swelling, called a wheal, is measured. Larger wheal sizes indicate greater allergy to German cockroach.|mm|Geometric Mean|5.6|5.6|Standard Deviation|1.5|1.5|||
3616649|NCT02710136|3466584|B1|||German cockroach allergen skin test wheal size (mm)|Extent of allergy to German cockroach can be assessed using a skin prick test. In this test, a small amount of allergen is introduced to the skin via a needle, and then the diameter of the resulting swelling, called a wheal, is measured. Larger wheal sizes indicate greater allergy to German cockroach.|mm|Geometric Mean|6.2|6.2|Standard Deviation|1.6|1.6|||
3616650|NCT02710136|3466582|B3|||German cockroach allergen Bla g 1, Bla g 2, or Bla g 5 ng/g levels in home dust above LLD (yes/no)|Blatella germanica 1 (Bla g 1), Blatella germanica 2 (Bla g 2), and Blatella germanica 5 (Bla g 5) are cockroach proteins that cause allergy to cockroach in humans. Levels above the lower limit of detection (LLD) indicate the presence of cockroaches in the home. LLD for Bla g 1, Bla g 2, and Bla g 5 were 120, 196, and 140 ng/g, respectively.|Participants|Count of Participants|10|10.0||||||
3616651|NCT02710136|3466583|B2|||German cockroach allergen Bla g 1, Bla g 2, or Bla g 5 ng/g levels in home dust above LLD (yes/no)|Blatella germanica 1 (Bla g 1), Blatella germanica 2 (Bla g 2), and Blatella germanica 5 (Bla g 5) are cockroach proteins that cause allergy to cockroach in humans. Levels above the lower limit of detection (LLD) indicate the presence of cockroaches in the home. LLD for Bla g 1, Bla g 2, and Bla g 5 were 120, 196, and 140 ng/g, respectively.|Participants|Count of Participants|9|9.0||||||
3616652|NCT02710136|3466584|B1|||German cockroach allergen Bla g 1, Bla g 2, or Bla g 5 ng/g levels in home dust above LLD (yes/no)|Blatella germanica 1 (Bla g 1), Blatella germanica 2 (Bla g 2), and Blatella germanica 5 (Bla g 5) are cockroach proteins that cause allergy to cockroach in humans. Levels above the lower limit of detection (LLD) indicate the presence of cockroaches in the home. LLD for Bla g 1, Bla g 2, and Bla g 5 were 120, 196, and 140 ng/g, respectively.|Participants|Count of Participants|1|1.0||||||
3616653|NCT02710136|3466582|B3|United States||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3616654|NCT02710136|3466583|B2|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3616655|NCT02710136|3466584|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3616656|NCT02710136|3466582|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3616657|NCT02710136|3466583|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3616658|NCT02710136|3466584|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616659|NCT02710136|3466582|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616660|NCT02710136|3466583|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616661|NCT02710136|3466584|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616662|NCT02710136|3466582|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3616663|NCT02710136|3466583|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3616664|NCT02710136|3466584|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616665|NCT02710136|3466582|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3616666|NCT02710136|3466583|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3616667|NCT02710136|3466584|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3616668|NCT02710136|3466582|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616669|NCT02710136|3466583|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616670|NCT02710136|3466584|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616671|NCT02710136|3466582|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616672|NCT02710136|3466583|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616673|NCT02710136|3466584|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616674|NCT02710136|3466582|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616675|NCT02710136|3466583|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616676|NCT02710136|3466584|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616677|NCT02710136|3466582|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616678|NCT02710136|3466583|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616679|NCT02710136|3466584|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616680|NCT02710136|3466582|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3616681|NCT02710136|3466583|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3616682|NCT02710136|3466584|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3616683|NCT02710136|3466582|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3616684|NCT02710136|3466583|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3616685|NCT02710136|3466584|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616686|NCT02710136|3466582|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3616687|NCT02710136|3466583|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3616688|NCT02710136|3466584|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3616689|NCT02710136|3466582|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3616690|NCT02710136|3466583|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3616691|NCT02710136|3466584|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3616692|NCT02710136|3466582|B3|||Age||years|Mean|15.5|15.5|Standard Deviation|8.0|8.0|||
3616693|NCT02710136|3466583|B2|||Age||years|Mean|11.2|11.2|Standard Deviation|1.9|1.9|||
3616694|NCT02710136|3466584|B1|||Age||years|Mean|26.0|26.0|Standard Deviation|7.5|7.5|||
3616695|NCT02710136|3466582|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3616696|NCT02710136|3466583|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3616697|NCT02710136|3466584|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3616698|NCT02710136|3466582|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3616699|NCT02710136|3466583|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3616700|NCT02710136|3466584|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3616701|NCT02710136|3466582|B3||<=18 years|Age||Participants|Count of Participants|25|25.0||||||
3616702|NCT02710136|3466583|B2||<=18 years|Age||Participants|Count of Participants|25|25.0||||||
3616703|NCT02710136|3466584|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3616704|NCT02709785|3466608|B4|||Calculus Index|Calculus Index scores the amount of calculus accumulation by adding surfaces from the lingual of the mandibular anterior teeth.|units on a scale|Median|9.000|9.0|Inter-Quartile Range|||3.5|15.5|
3616705|NCT02709785|3466609|B3|||Calculus Index|Calculus Index scores the amount of calculus accumulation by adding surfaces from the lingual of the mandibular anterior teeth.|units on a scale|Median|9.000|9.0|Inter-Quartile Range|||4.25|15.0|
3616706|NCT02709785|3466610|B2|||Calculus Index|Calculus Index scores the amount of calculus accumulation by adding surfaces from the lingual of the mandibular anterior teeth.|units on a scale|Median|9.500|9.5|Inter-Quartile Range|||4.0|17.0|
3616707|NCT02709785|3466611|B1|||Calculus Index|Calculus Index scores the amount of calculus accumulation by adding surfaces from the lingual of the mandibular anterior teeth.|units on a scale|Median|8.000|8.0|Inter-Quartile Range|||1.25|14.75|
3616708|NCT02709785|3466608|B4|||Tooth Stain Index|"Tooth Stain Index scores are taken on the facial surfaces of the 8 incisor teeth. Each incisor is scored for stain area on a scale of 0 (no stain) to 3 (greater than 2/3 of surface). The sum of the scores is used as the subject's stain score. The higher the score, the greater the amount of tooth stain (worse outcome). The minimum score for a subject is 0 and the maximum score for a subject is 24 (worse outcome)."|units on a scale|Median|2.000|2.0|Inter-Quartile Range|||0.0|4.0|
3616709|NCT02709785|3466609|B3|||Tooth Stain Index|"Tooth Stain Index scores are taken on the facial surfaces of the 8 incisor teeth. Each incisor is scored for stain area on a scale of 0 (no stain) to 3 (greater than 2/3 of surface). The sum of the scores is used as the subject's stain score. The higher the score, the greater the amount of tooth stain (worse outcome). The minimum score for a subject is 0 and the maximum score for a subject is 24 (worse outcome)."|units on a scale|Median|3.000|3.0|Inter-Quartile Range|||1.0|4.75|
3616710|NCT02709785|3466610|B2|||Tooth Stain Index|"Tooth Stain Index scores are taken on the facial surfaces of the 8 incisor teeth. Each incisor is scored for stain area on a scale of 0 (no stain) to 3 (greater than 2/3 of surface). The sum of the scores is used as the subject's stain score. The higher the score, the greater the amount of tooth stain (worse outcome). The minimum score for a subject is 0 and the maximum score for a subject is 24 (worse outcome)."|units on a scale|Median|3.000|3.0|Inter-Quartile Range|||0.0|4.0|
3616711|NCT02709785|3466611|B1|||Tooth Stain Index|"Tooth Stain Index scores are taken on the facial surfaces of the 8 incisor teeth. Each incisor is scored for stain area on a scale of 0 (no stain) to 3 (greater than 2/3 of surface). The sum of the scores is used as the subject's stain score. The higher the score, the greater the amount of tooth stain (worse outcome). The minimum score for a subject is 0 and the maximum score for a subject is 24 (worse outcome)."|units on a scale|Median|1.000|1.0|Inter-Quartile Range|||0.0|4.0|
3616712|NCT02709785|3466608|B4|||Plaque Index|Plaque Index scores plaque accumulation from 0 (no plaque) to 5 (plaque covering 2/3 of surface or more).|units on a scale|Median|1.745|1.745|Inter-Quartile Range|||1.55|2.29|
3616761|NCT02709577|3466633|B3|Cohort A||Age|Cohort A and Cohort B|years|Mean|46.9|46.9|Standard Deviation|10.75|10.75|||
3616713|NCT02709785|3466609|B3|||Plaque Index|Plaque Index scores plaque accumulation from 0 (no plaque) to 5 (plaque covering 2/3 of surface or more).|units on a scale|Median|1.680|1.68|Inter-Quartile Range|||1.498|2.112|
3616714|NCT02709785|3466610|B2|||Plaque Index|Plaque Index scores plaque accumulation from 0 (no plaque) to 5 (plaque covering 2/3 of surface or more).|units on a scale|Median|1.895|1.895|Inter-Quartile Range|||1.57|2.48|
3616715|NCT02709785|3466611|B1|||Plaque Index|Plaque Index scores plaque accumulation from 0 (no plaque) to 5 (plaque covering 2/3 of surface or more).|units on a scale|Median|1.740|1.74|Inter-Quartile Range|||1.562|2.21|
3616716|NCT02709785|3466608|B4|||Bleeding Score|Bleeding Score is determined by adding the number of bleeding sites and dividing by the number of teeth to assess gingival inflammation. A higher score indicates more bleeding and inflammation (worse outcome).|units on a scale|Median|0.645|0.645|Inter-Quartile Range|||0.46|1.065|
3616717|NCT02709785|3466609|B3|||Bleeding Score|Bleeding Score is determined by adding the number of bleeding sites and dividing by the number of teeth to assess gingival inflammation. A higher score indicates more bleeding and inflammation (worse outcome).|units on a scale|Median|0.860|0.86|Inter-Quartile Range|||0.558|1.335|
3616718|NCT02709785|3466610|B2|||Bleeding Score|Bleeding Score is determined by adding the number of bleeding sites and dividing by the number of teeth to assess gingival inflammation. A higher score indicates more bleeding and inflammation (worse outcome).|units on a scale|Median|0.640|0.64|Inter-Quartile Range|||0.54|1.08|
3616719|NCT02709785|3466611|B1|||Bleeding Score|Bleeding Score is determined by adding the number of bleeding sites and dividing by the number of teeth to assess gingival inflammation. A higher score indicates more bleeding and inflammation (worse outcome).|units on a scale|Median|0.540|0.54|Inter-Quartile Range|||0.26|0.818|
3616720|NCT02709785|3466608|B4|||Gingival Index|Gingival Index scores gingival inflammation from 0 (normal gingiva) to 3 (severe inflammation).|units on a scale|Median|0.965|0.965|Inter-Quartile Range|||0.72|1.09|
3616721|NCT02709785|3466609|B3|||Gingival Index|Gingival Index scores gingival inflammation from 0 (normal gingiva) to 3 (severe inflammation).|units on a scale|Median|1.010|1.01|Inter-Quartile Range|||0.738|1.168|
3616722|NCT02709785|3466610|B2|||Gingival Index|Gingival Index scores gingival inflammation from 0 (normal gingiva) to 3 (severe inflammation).|units on a scale|Median|0.970|0.97|Inter-Quartile Range|||0.72|1.07|
3616723|NCT02709785|3466611|B1|||Gingival Index|Gingival Index scores gingival inflammation from 0 (normal gingiva) to 3 (severe inflammation).|units on a scale|Median|0.890|0.89|Inter-Quartile Range|||0.653|1.03|
3616724|NCT02709785|3466608|B4|United States||Region of Enrollment||Participants|Count of Participants|80|80.0||||||
3616725|NCT02709785|3466609|B3|United States||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3616726|NCT02709785|3466610|B2|United States||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3616727|NCT02709785|3466611|B1|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3616728|NCT02709785|3466608|B4|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3616729|NCT02709785|3466608|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3616730|NCT02709785|3466609|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3616731|NCT02709785|3466610|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3616732|NCT02709785|3466611|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3616733|NCT02709785|3466608|B4||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3616734|NCT02709785|3466609|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3616735|NCT02709785|3466610|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3616736|NCT02709785|3466611|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3616737|NCT02709785|3466608|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3616738|NCT02709785|3466609|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3616739|NCT02709785|3466610|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3616740|NCT02709785|3466611|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3616741|NCT02709785|3466608|B4||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
3616742|NCT02709785|3466609|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3616743|NCT02709785|3466610|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3616744|NCT02709785|3466611|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3616745|NCT02709785|3466608|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3616746|NCT02709785|3466609|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3616747|NCT02709785|3466610|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3616748|NCT02709785|3466611|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3616749|NCT02709577|3466633|B3|Chile||Region of Enrollment||participants|Number|27|27.0||||||
3616750|NCT02709577|3466634|B2|Chile||Region of Enrollment||participants|Number|9|9.0||||||
3616751|NCT02709577|3466635|B1|Chile||Region of Enrollment||participants|Number|18|18.0||||||
3616752|NCT02709577|3466633|B3||Male|Gender||Participants|Count of Participants|7|7.0||||||
3616753|NCT02709577|3466634|B2||Male|Gender||Participants|Count of Participants|2|2.0||||||
3616754|NCT02709577|3466635|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
3616755|NCT02709577|3466633|B3||Female|Gender||Participants|Count of Participants|20|20.0||||||
3616756|NCT02709577|3466634|B2||Female|Gender||Participants|Count of Participants|7|7.0||||||
3616757|NCT02709577|3466635|B1||Female|Gender||Participants|Count of Participants|13|13.0||||||
3616758|NCT02709577|3466633|B3|Cohort B||Age|Cohort A and Cohort B|years|Mean|46.1|46.1|Standard Deviation|8.36|8.36|||
3616759|NCT02709577|3466634|B2|Cohort B||Age|Cohort A and Cohort B|years|Mean|46.3|46.3|Standard Deviation|6.25|6.25|||
3616760|NCT02709577|3466635|B1|Cohort B||Age|Cohort A and Cohort B|years|Mean|41.2|41.2|Standard Deviation|9.28|9.28|||
3616762|NCT02709577|3466634|B2|Cohort A||Age|Cohort A and Cohort B|years|Mean|52.1|52.1|Standard Deviation|16.14|16.14|||
3616763|NCT02709577|3466635|B1|Cohort A||Age|Cohort A and Cohort B|years|Mean|44.8|44.8|Standard Deviation|7.96|7.96|||
3616764|NCT02709538|3466650|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3616765|NCT02709538|3466651|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3616766|NCT02709538|3466652|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3616767|NCT02709538|3466653|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3616768|NCT02709538|3466650|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616769|NCT02709538|3466651|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616770|NCT02709538|3466652|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616771|NCT02709538|3466653|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616772|NCT02709538|3466650|B4||White|Race (NIH/OMB)||Participants|Count of Participants|436|436.0||||||
3616773|NCT02709538|3466651|B3||White|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
3616774|NCT02709538|3466652|B2||White|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3616775|NCT02709538|3466653|B1||White|Race (NIH/OMB)||Participants|Count of Participants|282|282.0||||||
3616776|NCT02709538|3466650|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
3616777|NCT02709538|3466651|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3616778|NCT02709538|3466652|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3616779|NCT02709538|3466653|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3616780|NCT02709538|3466650|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616781|NCT02709538|3466651|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616782|NCT02709538|3466652|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616783|NCT02709538|3466653|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616784|NCT02709538|3466650|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3616785|NCT02709538|3466651|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3616786|NCT02709538|3466652|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3616787|NCT02709538|3466653|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3616788|NCT02709538|3466650|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3616789|NCT02709538|3466651|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616790|NCT02709538|3466652|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3616791|NCT02709538|3466653|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3616792|NCT02709538|3466650|B4||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3616793|NCT02709538|3466651|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3616794|NCT02709538|3466652|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3616795|NCT02709538|3466653|B1||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3616796|NCT02709538|3466650|B4||Female|Sex: Female, Male||Participants|Count of Participants|405|405.0||||||
3616797|NCT02709538|3466651|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3616798|NCT02709538|3466652|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3616799|NCT02709538|3466653|B1||Female|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
3616800|NCT02709538|3466650|B4|||Age||years|Mean|40.8|40.8|Standard Deviation|14.7|14.7|||
3616801|NCT02709538|3466651|B3|||Age||years|Mean|41.2|41.2|Standard Deviation|13.5|13.5|||
3616802|NCT02709538|3466652|B2|||Age||years|Mean|42.1|42.1|Standard Deviation|15.4|15.4|||
3616803|NCT02709538|3466653|B1|||Age||years|Mean|40.4|40.4|Standard Deviation|14.8|14.8|||
3616804|NCT02709330|3466663|B1|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3616805|NCT02709330|3466663|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616806|NCT02709330|3466663|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616807|NCT02709330|3466663|B1||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3616808|NCT02709330|3466663|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3616809|NCT02709330|3466663|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616810|NCT02709330|3466663|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616811|NCT02709330|3466663|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616812|NCT02709330|3466663|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616813|NCT02709330|3466663|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3616814|NCT02709330|3466663|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3616815|NCT02709330|3466663|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3616816|NCT02709330|3466663|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3616817|NCT02709330|3466663|B1|||Age||years|Mean|60|60.0|Standard Deviation|7.8|7.8|||
3616818|NCT02709096|3466676|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
3616819|NCT02709096|3466677|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3616820|NCT02709096|3466678|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3616821|NCT02709096|3466676|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616822|NCT02709096|3466677|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616823|NCT02709096|3466678|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616824|NCT02709096|3466676|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616825|NCT02709096|3466677|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616826|NCT02709096|3466678|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616827|NCT02709096|3466676|B3||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3616828|NCT02709096|3466677|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3616829|NCT02709096|3466678|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3616830|NCT02709096|3466676|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3616831|NCT02709096|3466677|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3616832|NCT02709096|3466678|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3616833|NCT02709096|3466676|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616834|NCT02709096|3466677|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616835|NCT02709096|3466678|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616836|NCT02709096|3466676|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616837|NCT02709096|3466677|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616838|NCT02709096|3466678|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616839|NCT02709096|3466676|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616840|NCT02709096|3466677|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616841|NCT02709096|3466678|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616842|NCT02709096|3466676|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3616843|NCT02709096|3466677|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3616844|NCT02709096|3466678|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3616845|NCT02709096|3466676|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3616846|NCT02709096|3466677|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3616847|NCT02709096|3466678|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3616848|NCT02709096|3466676|B3|||Age||years|Mean|32|32.0|Full Range|||19.0|41.0|
3616849|NCT02709096|3466677|B2|||Age||years|Mean|34|34.0|Full Range|||24.0|40.0|
3616850|NCT02709096|3466678|B1|||Age||years|Mean|32|32.0|Full Range|||19.0|41.0|
3616851|NCT02709083|3466685|B1|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3616852|NCT02709083|3466685|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3616853|NCT02709083|3466685|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616854|NCT02709083|3466685|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3616855|NCT02709083|3466685|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3616856|NCT02709083|3466685|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616857|NCT02709083|3466685|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616858|NCT02709083|3466685|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616859|NCT02709083|3466685|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616860|NCT02709083|3466685|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3616861|NCT02709083|3466685|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616862|NCT02709083|3466685|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3616863|NCT02709083|3466685|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3616864|NCT02709083|3466685|B1|Age 70-79||Age, Customized||Participants|Count of Participants|1|1.0||||||
3616865|NCT02709083|3466685|B1|Age 60-69||Age, Customized||Participants|Count of Participants|1|1.0||||||
3616866|NCT02709083|3466685|B1|Age 50-59||Age, Customized||Participants|Count of Participants|0|0.0||||||
3616867|NCT02709083|3466685|B1|Age 40-49||Age, Customized||Participants|Count of Participants|0|0.0||||||
3616868|NCT02709083|3466685|B1|Age 30-39||Age, Customized||Participants|Count of Participants|3|3.0||||||
3616869|NCT02709083|3466685|B1|Age 20-29||Age, Customized||Participants|Count of Participants|2|2.0||||||
3616870|NCT02709005|3466696|B3|||Positive HIV, Chlamydia, or Neisseria gonorrhoeae test||Participants|Count of Participants|1|1.0||||||
3616871|NCT02709005|3466697|B2|||Positive HIV, Chlamydia, or Neisseria gonorrhoeae test||Participants|Count of Participants|0|0.0||||||
3616872|NCT02709005|3466698|B1|||Positive HIV, Chlamydia, or Neisseria gonorrhoeae test||Participants|Count of Participants|1|1.0||||||
3616873|NCT02709005|3466696|B3|||Nugent score <4|A vaginal swab for bacteriological assessment of BV by Nugent criteria was performed. The Nugent score utilizes a 10-point scale for evaluation of vaginal flora. The Nugent score can range from 0 to 10. A score of 7 to 10 is consistent with BV while 4-6 is considered intermediate and 0-3 is negative for BV.|Participants|Count of Participants|9|9.0||||||
3616928|NCT02708524|3466728|B4|United States||Region of Enrollment||participants|Number|136|136.0||||||
3616874|NCT02709005|3466697|B2|||Nugent score <4|A vaginal swab for bacteriological assessment of BV by Nugent criteria was performed. The Nugent score utilizes a 10-point scale for evaluation of vaginal flora. The Nugent score can range from 0 to 10. A score of 7 to 10 is consistent with BV while 4-6 is considered intermediate and 0-3 is negative for BV.|Participants|Count of Participants|2|2.0||||||
3616875|NCT02709005|3466698|B1|||Nugent score <4|A vaginal swab for bacteriological assessment of BV by Nugent criteria was performed. The Nugent score utilizes a 10-point scale for evaluation of vaginal flora. The Nugent score can range from 0 to 10. A score of 7 to 10 is consistent with BV while 4-6 is considered intermediate and 0-3 is negative for BV.|Participants|Count of Participants|7|7.0||||||
3616876|NCT02709005|3466696|B3|United States||Region of Enrollment||participants|Number|109|109.0||||||
3616877|NCT02709005|3466697|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
3616878|NCT02709005|3466698|B1|United States||Region of Enrollment||participants|Number|73|73.0||||||
3616879|NCT02709005|3466696|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616880|NCT02709005|3466697|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616881|NCT02709005|3466698|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616882|NCT02709005|3466696|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3616883|NCT02709005|3466697|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3616884|NCT02709005|3466698|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616885|NCT02709005|3466696|B3||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3616886|NCT02709005|3466697|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3616887|NCT02709005|3466698|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3616888|NCT02709005|3466696|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3616889|NCT02709005|3466697|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3616890|NCT02709005|3466698|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3616891|NCT02709005|3466696|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3616892|NCT02709005|3466697|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3616893|NCT02709005|3466698|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3616894|NCT02709005|3466696|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3616895|NCT02709005|3466697|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616896|NCT02709005|3466698|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3616897|NCT02709005|3466696|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616898|NCT02709005|3466697|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616899|NCT02709005|3466698|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616900|NCT02709005|3466696|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3616901|NCT02709005|3466697|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3616902|NCT02709005|3466698|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3616903|NCT02709005|3466696|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3616904|NCT02709005|3466697|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3616905|NCT02709005|3466698|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3616906|NCT02709005|3466696|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3616907|NCT02709005|3466697|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3616908|NCT02709005|3466698|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3616909|NCT02709005|3466696|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3616910|NCT02709005|3466697|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3616911|NCT02709005|3466698|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3616912|NCT02709005|3466696|B3||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3616913|NCT02709005|3466697|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3616914|NCT02709005|3466698|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3616915|NCT02709005|3466696|B3|||Age||years|Mean|30.2|30.2|Standard Deviation|8.4|8.4|||
3616916|NCT02709005|3466697|B2|||Age||years|Mean|31.3|31.3|Standard Deviation|8.4|8.4|||
3616917|NCT02709005|3466698|B1|||Age||years|Mean|29.7|29.7|Standard Deviation|8.4|8.4|||
3616918|NCT02709005|3466696|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3616919|NCT02709005|3466697|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3616920|NCT02709005|3466698|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3616921|NCT02709005|3466696|B3||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
3616922|NCT02709005|3466697|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3616923|NCT02709005|3466698|B1||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
3616924|NCT02709005|3466696|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3616925|NCT02709005|3466697|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3616926|NCT02709005|3466698|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3616927|NCT02708524|3466727|B5|United States||Region of Enrollment||participants|Number|548|548.0||||||
3616929|NCT02708524|3466729|B3|United States||Region of Enrollment||participants|Number|137|137.0||||||
3616930|NCT02708524|3466730|B2|United States||Region of Enrollment||participants|Number|136|136.0||||||
3616931|NCT02708524|3466731|B1|United States||Region of Enrollment||participants|Number|139|139.0||||||
3616932|NCT02708524|3466727|B5|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3616933|NCT02708524|3466728|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3616934|NCT02708524|3466729|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3616935|NCT02708524|3466730|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3616936|NCT02708524|3466731|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3616937|NCT02708524|3466727|B5|White||Race/Ethnicity, Customized||participants|Number|476|476.0||||||
3616938|NCT02708524|3466728|B4|White||Race/Ethnicity, Customized||participants|Number|113|113.0||||||
3616939|NCT02708524|3466729|B3|White||Race/Ethnicity, Customized||participants|Number|122|122.0||||||
3616940|NCT02708524|3466730|B2|White||Race/Ethnicity, Customized||participants|Number|122|122.0||||||
3616941|NCT02708524|3466731|B1|White||Race/Ethnicity, Customized||participants|Number|119|119.0||||||
3616942|NCT02708524|3466727|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3616943|NCT02708524|3466728|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3616944|NCT02708524|3466729|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3616945|NCT02708524|3466730|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3616946|NCT02708524|3466731|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3616947|NCT02708524|3466727|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
3616948|NCT02708524|3466728|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3616949|NCT02708524|3466729|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3616950|NCT02708524|3466730|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3616951|NCT02708524|3466731|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3616952|NCT02708524|3466727|B5|Asian||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3616953|NCT02708524|3466728|B4|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3616954|NCT02708524|3466729|B3|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3616955|NCT02708524|3466730|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3616956|NCT02708524|3466731|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3616957|NCT02708524|3466727|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3616958|NCT02708524|3466728|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3616959|NCT02708524|3466729|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3616960|NCT02708524|3466730|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3616961|NCT02708524|3466731|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3616962|NCT02708524|3466727|B5||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3616963|NCT02708524|3466728|B4||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3616964|NCT02708524|3466729|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3616965|NCT02708524|3466730|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3616966|NCT02708524|3466731|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3616967|NCT02708524|3466727|B5||Female|Sex: Female, Male||Participants|Count of Participants|364|364.0||||||
3616968|NCT02708524|3466728|B4||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3616969|NCT02708524|3466729|B3||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3616970|NCT02708524|3466730|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3616971|NCT02708524|3466731|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3616972|NCT02708524|3466727|B5|||Age||years|Mean|28.6|28.6|Standard Deviation|6.11|6.11|||
3616973|NCT02708524|3466728|B4|||Age||years|Mean|28.8|28.8|Standard Deviation|6.56|6.56|||
3616974|NCT02708524|3466729|B3|||Age||years|Mean|28.6|28.6|Standard Deviation|5.63|5.63|||
3616975|NCT02708524|3466730|B2|||Age||years|Mean|27.7|27.7|Standard Deviation|5.86|5.86|||
3616976|NCT02708524|3466731|B1|||Age||years|Mean|29.1|29.1|Standard Deviation|6.24|6.24|||
3616977|NCT02708485|3466780|B3|||Mini-Mental State Examination|The Mini–Mental State Examination (MMSE) is a 30-point questionnaire to measure cognitive impairment. A total score ≥26/30 indicates a normal cognition. Scores below this can indicate mild (20–25 points) , moderate (10–20 points) or severe (≤9 points) cognitive impairment.|points|Mean|26|26.0|Full Range|||23.0|29.0|
3616978|NCT02708485|3466781|B2|||Mini-Mental State Examination|The Mini–Mental State Examination (MMSE) is a 30-point questionnaire to measure cognitive impairment. A total score ≥26/30 indicates a normal cognition. Scores below this can indicate mild (20–25 points) , moderate (10–20 points) or severe (≤9 points) cognitive impairment.|points|Mean|26|26.0|Full Range|||23.0|29.0|
3616979|NCT02708485|3466782|B1|||Mini-Mental State Examination|The Mini–Mental State Examination (MMSE) is a 30-point questionnaire to measure cognitive impairment. A total score ≥26/30 indicates a normal cognition. Scores below this can indicate mild (20–25 points) , moderate (10–20 points) or severe (≤9 points) cognitive impairment.|points|Mean|26|26.0|Full Range|||23.0|27.0|
3616980|NCT02708485|3466780|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3616981|NCT02708485|3466780|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3616982|NCT02708485|3466781|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3616983|NCT02708485|3466782|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3616984|NCT02708485|3466780|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3616985|NCT02708485|3466781|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3616986|NCT02708485|3466782|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3616987|NCT02708485|3466780|B3|||Age||years|Mean|75|75.0|Standard Deviation|2|2.0|||
3616988|NCT02708485|3466781|B2|||Age||years|Mean|73|73.0|Standard Deviation|4|4.0|||
3616989|NCT02708485|3466782|B1|||Age||years|Mean|77|77.0|Standard Deviation|2|2.0|||
3616990|NCT02708433|3466791|B1|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3616991|NCT02708433|3466791|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3616992|NCT02708433|3466791|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3616993|NCT02708433|3466791|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3616994|NCT02708433|3466791|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3616995|NCT02708433|3466791|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3616996|NCT02708433|3466791|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3616997|NCT02708433|3466791|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3616998|NCT02708433|3466791|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3616999|NCT02708355|3466800|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3617000|NCT02708355|3466801|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3617001|NCT02708355|3466802|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3617002|NCT02708355|3466803|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3617003|NCT02708355|3466800|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3617004|NCT02708355|3466801|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3617005|NCT02708355|3466802|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3617006|NCT02708355|3466803|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3617007|NCT02708355|3466800|B4|||Age||years|Mean|41.9|41.9|Standard Deviation|10.49|10.49|||
3617008|NCT02708355|3466801|B3|||Age||years|Mean|44.7|44.7|Standard Deviation|10.50|10.5|||
3617009|NCT02708355|3466802|B2|||Age||years|Mean|40.8|40.8|Standard Deviation|10.95|10.95|||
3617010|NCT02708355|3466803|B1|||Age||years|Mean|41.6|41.6|Standard Deviation|10.23|10.23|||
3617011|NCT02708277|3466816|B3|China||Region of Enrollment||participants|Number|82|82.0||||||
3617012|NCT02708277|3466817|B2|China||Region of Enrollment||participants|Number|39|39.0||||||
3617013|NCT02708277|3466818|B1|China||Region of Enrollment||participants|Number|43|43.0||||||
3617014|NCT02708277|3466816|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3617015|NCT02708277|3466817|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3617016|NCT02708277|3466818|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3617017|NCT02708277|3466816|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3617018|NCT02708277|3466817|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3617019|NCT02708277|3466818|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3617020|NCT02708277|3466816|B3|||Age||years|Mean|31.9|31.9|Standard Deviation|4.3|4.3|||
3617021|NCT02708277|3466817|B2|||Age||years|Mean|31.6|31.6|Standard Deviation|4.3|4.3|||
3617022|NCT02708277|3466818|B1|||Age||years|Mean|32.3|32.3|Standard Deviation|4.3|4.3|||
3617023|NCT02708277|3466816|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3617024|NCT02708277|3466817|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3617025|NCT02708277|3466818|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3617026|NCT02708277|3466816|B3||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
3617027|NCT02708277|3466817|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3617028|NCT02708277|3466818|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
3617029|NCT02708277|3466816|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3617030|NCT02708277|3466817|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3617031|NCT02708277|3466818|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3617032|NCT02708238|3466831|B4|Italy||Region of Enrollment||participants|Number|176|176.0||||||
3617033|NCT02708238|3466832|B3|Italy||Region of Enrollment||participants|Number|57|57.0||||||
3617034|NCT02708238|3466833|B2|Italy||Region of Enrollment||participants|Number|59|59.0||||||
3617035|NCT02708238|3466834|B1|Italy||Region of Enrollment||participants|Number|60|60.0||||||
3617036|NCT02708238|3466831|B4||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3617037|NCT02708238|3466832|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3617038|NCT02708238|3466833|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3617039|NCT02708238|3466834|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3617040|NCT02708238|3466831|B4||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3617041|NCT02708238|3466832|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3617042|NCT02708238|3466833|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3617043|NCT02708238|3466834|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3617044|NCT02708238|3466831|B4|||Age||Days|Median|35|35.0|Full Range|||14.0|86.0|
3617045|NCT02708238|3466832|B3|||Age||Days|Median|30|30.0|Full Range|||14.0|62.0|
3617046|NCT02708238|3466833|B2|||Age||Days|Median|35|35.0|Full Range|||14.0|85.0|
3617047|NCT02708238|3466834|B1|||Age||Days|Median|38|38.0|Full Range|||14.0|86.0|
3617048|NCT02708238|3466831|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3617049|NCT02708238|3466832|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3617050|NCT02708238|3466833|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3617051|NCT02708238|3466834|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3617052|NCT02708238|3466831|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3617053|NCT02708238|3466832|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3617054|NCT02708238|3466833|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3617055|NCT02708238|3466834|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3617056|NCT02708238|3466831|B4||<=18 years|Age||Participants|Count of Participants|176|176.0||||||
3617057|NCT02708238|3466832|B3||<=18 years|Age||Participants|Count of Participants|57|57.0||||||
3617058|NCT02708238|3466833|B2||<=18 years|Age||Participants|Count of Participants|59|59.0||||||
3617059|NCT02708238|3466834|B1||<=18 years|Age||Participants|Count of Participants|60|60.0||||||
3617060|NCT02708212|3466847|B3|Taiwan||Region of Enrollment||participants|Number|120|120.0||||||
3617061|NCT02708212|3466848|B2|Taiwan||Region of Enrollment||participants|Number|60|60.0||||||
3617062|NCT02708212|3466849|B1|Taiwan||Region of Enrollment||participants|Number|60|60.0||||||
3617063|NCT02708212|3466847|B3||Male|Gender||Participants|Count of Participants|56|56.0||||||
3617064|NCT02708212|3466848|B2||Male|Gender||Participants|Count of Participants|30|30.0||||||
3617065|NCT02708212|3466849|B1||Male|Gender||Participants|Count of Participants|26|26.0||||||
3617066|NCT02708212|3466847|B3||Female|Gender||Participants|Count of Participants|64|64.0||||||
3617067|NCT02708212|3466848|B2||Female|Gender||Participants|Count of Participants|30|30.0||||||
3617068|NCT02708212|3466849|B1||Female|Gender||Participants|Count of Participants|34|34.0||||||
3617069|NCT02708212|3466847|B3|||Age||years|Mean|53.7|53.7|Standard Deviation|11.9|11.9|||
3617070|NCT02708212|3466848|B2|||Age||years|Mean|52.9|52.9|Standard Deviation|12.7|12.7|||
3617071|NCT02708212|3466849|B1|||Age||years|Mean|54.5|54.5|Standard Deviation|11.1|11.1|||
3617072|NCT02708095|3466860|B4|Spain||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3617073|NCT02708095|3466861|B3|Spain||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3617074|NCT02708095|3466862|B2|Spain||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3617075|NCT02708095|3466863|B1|Spain||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3617076|NCT02708095|3466860|B4|France||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3617077|NCT02708095|3466861|B3|France||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3617078|NCT02708095|3466862|B2|France||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3617079|NCT02708095|3466863|B1|France||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3617080|NCT02708095|3466860|B4|Mexico||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3617081|NCT02708095|3466861|B3|Mexico||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3617082|NCT02708095|3466862|B2|Mexico||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3617083|NCT02708095|3466863|B1|Mexico||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3617084|NCT02708095|3466860|B4|Poland||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3617085|NCT02708095|3466861|B3|Poland||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3617086|NCT02708095|3466862|B2|Poland||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3617087|NCT02708095|3466863|B1|Poland||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3617088|NCT02708095|3466860|B4|Taiwan||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3617089|NCT02708095|3466861|B3|Taiwan||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3617090|NCT02708095|3466862|B2|Taiwan||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3617091|NCT02708095|3466863|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3617092|NCT02708095|3466860|B4|Japan||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3617093|NCT02708095|3466861|B3|Japan||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3617094|NCT02708095|3466862|B2|Japan||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3617095|NCT02708095|3466863|B1|Japan||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3617096|NCT02708095|3466860|B4|United States||Region of Enrollment||Participants|Count of Participants|95|95.0||||||
3617097|NCT02708095|3466861|B3|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3617098|NCT02708095|3466862|B2|United States||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3617099|NCT02708095|3466863|B1|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3617100|NCT02708095|3466860|B4|Romania||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3617101|NCT02708095|3466861|B3|Romania||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3617102|NCT02708095|3466862|B2|Romania||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3617103|NCT02708095|3466863|B1|Romania||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3617104|NCT02708095|3466860|B4|South Korea||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3617105|NCT02708095|3466861|B3|South Korea||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3617106|NCT02708095|3466862|B2|South Korea||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3617107|NCT02708095|3466863|B1|South Korea||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3617108|NCT02708095|3466860|B4|Austria||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3617109|NCT02708095|3466861|B3|Austria||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3617110|NCT02708095|3466862|B2|Austria||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3617111|NCT02708095|3466863|B1|Austria||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3617112|NCT02708095|3466860|B4|Argentina||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3617113|NCT02708095|3466861|B3|Argentina||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3617114|NCT02708095|3466862|B2|Argentina||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3617115|NCT02708095|3466863|B1|Argentina||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3617116|NCT02708095|3466860|B4|Puerto Rico||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3617117|NCT02708095|3466861|B3|Puerto Rico||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3617118|NCT02708095|3466862|B2|Puerto Rico||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3617119|NCT02708095|3466863|B1|Puerto Rico||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3617120|NCT02708095|3466860|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3617121|NCT02708095|3466861|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3617122|NCT02708095|3466862|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3617123|NCT02708095|3466863|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617124|NCT02708095|3466860|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3617125|NCT02708095|3466861|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3617126|NCT02708095|3466862|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3617127|NCT02708095|3466863|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617128|NCT02708095|3466860|B4||White|Race (NIH/OMB)||Participants|Count of Participants|204|204.0||||||
3617129|NCT02708095|3466861|B3||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3617130|NCT02708095|3466862|B2||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3617131|NCT02708095|3466863|B1||White|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3617132|NCT02708095|3466860|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3617133|NCT02708095|3466861|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3617134|NCT02708095|3466862|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3617135|NCT02708095|3466863|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3617136|NCT02708095|3466860|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617137|NCT02708095|3466861|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617138|NCT02708095|3466862|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617139|NCT02708095|3466863|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617140|NCT02708095|3466860|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3617141|NCT02708095|3466861|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3617142|NCT02708095|3466862|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3617143|NCT02708095|3466863|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3617144|NCT02708095|3466860|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3617145|NCT02708095|3466861|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3617146|NCT02708095|3466862|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3617147|NCT02708095|3466863|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3617148|NCT02708095|3466860|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3617149|NCT02708095|3466861|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3617150|NCT02708095|3466862|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3617151|NCT02708095|3466863|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3617152|NCT02708095|3466860|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|174|174.0||||||
3617153|NCT02708095|3466861|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3617154|NCT02708095|3466862|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3617155|NCT02708095|3466863|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3617156|NCT02708095|3466860|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
3617157|NCT02708095|3466861|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3617158|NCT02708095|3466862|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3617159|NCT02708095|3466863|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3617160|NCT02708095|3466860|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3617161|NCT02708095|3466861|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3617162|NCT02708095|3466862|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3617163|NCT02708095|3466863|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3617164|NCT02708095|3466860|B4||Female|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
3617165|NCT02708095|3466861|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3617166|NCT02708095|3466862|B2||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3617167|NCT02708095|3466863|B1||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3617168|NCT02708095|3466860|B4|||Age||Years|Mean|44.3|44.3|Standard Deviation|12.1|12.1|||
3617169|NCT02708095|3466861|B3|||Age||Years|Mean|45.0|45.0|Standard Deviation|12.4|12.4|||
3617170|NCT02708095|3466862|B2|||Age||Years|Mean|43.2|43.2|Standard Deviation|11.0|11.0|||
3617171|NCT02708095|3466863|B1|||Age||Years|Mean|44.9|44.9|Standard Deviation|12.8|12.8|||
3617172|NCT02707952|3466886|B5||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3617173|NCT02707952|3466887|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3617174|NCT02707952|3466888|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3617175|NCT02707952|3466889|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3617176|NCT02707952|3466890|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3617177|NCT02707952|3466886|B5||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3617178|NCT02707952|3466887|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3617179|NCT02707952|3466888|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3617180|NCT02707952|3466889|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3617181|NCT02707952|3466890|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3617182|NCT02707952|3466886|B5|>= 75 years||Age, Customized||participants|Number|62|62.0||||||
3617183|NCT02707952|3466887|B4|>= 75 years||Age, Customized||participants|Number|2|2.0||||||
3617184|NCT02707952|3466888|B3|>= 75 years||Age, Customized||participants|Number|27|27.0||||||
3617185|NCT02707952|3466889|B2|>= 75 years||Age, Customized||participants|Number|7|7.0||||||
3617186|NCT02707952|3466890|B1|>= 75 years||Age, Customized||participants|Number|26|26.0||||||
3617187|NCT02707952|3466886|B5|>= 65 years to < 75 years||Age, Customized||participants|Number|107|107.0||||||
3617188|NCT02707952|3466887|B4|>= 65 years to < 75 years||Age, Customized||participants|Number|4|4.0||||||
3617189|NCT02707952|3466888|B3|>= 65 years to < 75 years||Age, Customized||participants|Number|43|43.0||||||
3617190|NCT02707952|3466889|B2|>= 65 years to < 75 years||Age, Customized||participants|Number|23|23.0||||||
3617191|NCT02707952|3466890|B1|>= 65 years to < 75 years||Age, Customized||participants|Number|37|37.0||||||
3617192|NCT02707952|3466886|B5|< 65 years||Age, Customized||participants|Number|125|125.0||||||
3617193|NCT02707952|3466887|B4|< 65 years||Age, Customized||participants|Number|4|4.0||||||
3617194|NCT02707952|3466888|B3|< 65 years||Age, Customized||participants|Number|33|33.0||||||
3617195|NCT02707952|3466889|B2|< 65 years||Age, Customized||participants|Number|22|22.0||||||
3617196|NCT02707952|3466890|B1|< 65 years||Age, Customized||participants|Number|66|66.0||||||
3617197|NCT02707640|3466912|B3||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3617198|NCT02707640|3466913|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3617199|NCT02707640|3466914|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3617200|NCT02707640|3466912|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3617201|NCT02707640|3466913|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3617202|NCT02707640|3466914|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3617203|NCT02707640|3466912|B3|||Age||years|Mean|67.1|67.1|Standard Deviation|7.13|7.13|||
3617204|NCT02707640|3466913|B2|||Age||years|Mean|67.5|67.5|Standard Deviation|6.22|6.22|||
3617205|NCT02707640|3466914|B1|||Age||years|Mean|66.7|66.7|Standard Deviation|7.99|7.99|||
3617206|NCT02707601|3466933|B3|||HCV RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.92|0.92|||
3617207|NCT02707601|3466934|B2|||HCV RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.74|0.74|||
3617208|NCT02707601|3466935|B1|||HCV RNA||log10 IU/mL|Mean|6.0|6.0|Standard Deviation|1.07|1.07|||
3617209|NCT02707601|3466933|B3||≥ 50 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|1|1.0||||||
3617210|NCT02707601|3466934|B2||≥ 50 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|0|0.0||||||
3617211|NCT02707601|3466935|B1||≥ 50 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|1|1.0||||||
3617212|NCT02707601|3466933|B3||< 50 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|147|147.0||||||
3617213|NCT02707601|3466934|B2||< 50 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|74|74.0||||||
3617214|NCT02707601|3466935|B1||< 50 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|73|73.0||||||
3617215|NCT02707601|3466933|B3||≥ 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|109|109.0||||||
3617216|NCT02707601|3466934|B2||≥ 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|60|60.0||||||
3617217|NCT02707601|3466935|B1||≥ 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|49|49.0||||||
3617218|NCT02707601|3466933|B3||< 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|39|39.0||||||
3617219|NCT02707601|3466934|B2||< 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|14|14.0||||||
3617220|NCT02707601|3466935|B1||< 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|25|25.0||||||
3617221|NCT02707601|3466933|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3617222|NCT02707601|3466934|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3617223|NCT02707601|3466935|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3617224|NCT02707601|3466933|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3617225|NCT02707601|3466934|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3617226|NCT02707601|3466935|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3617227|NCT02707601|3466933|B3||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3617228|NCT02707601|3466934|B2||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3617229|NCT02707601|3466935|B1||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3617230|NCT02707601|3466933|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|78|78.0||||||
3617231|NCT02707601|3466934|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
3617232|NCT02707601|3466935|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
3617233|NCT02707601|3466933|B3||Black|Race/Ethnicity, Customized||Participants|Count of Participants|61|61.0||||||
3617234|NCT02707601|3466934|B2||Black|Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3617235|NCT02707601|3466935|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3617236|NCT02707601|3466933|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3617237|NCT02707601|3466934|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3617238|NCT02707601|3466935|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3617239|NCT02707601|3466933|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3617240|NCT02707601|3466934|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3617241|NCT02707601|3466935|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617242|NCT02707601|3466933|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
3617243|NCT02707601|3466934|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3617244|NCT02707601|3466935|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3617245|NCT02707601|3466933|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3617246|NCT02707601|3466934|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3617247|NCT02707601|3466935|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3617248|NCT02707601|3466933|B3||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3617249|NCT02707601|3466934|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3617250|NCT02707601|3466935|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3617251|NCT02707601|3466933|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3617252|NCT02707601|3466934|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3617253|NCT02707601|3466935|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3617254|NCT02707601|3466933|B3|||Age||years|Mean|51|51.0|Standard Deviation|9.7|9.7|||
3617255|NCT02707601|3466934|B2|||Age||years|Mean|52|52.0|Standard Deviation|9.9|9.9|||
3617256|NCT02707601|3466935|B1|||Age||years|Mean|51|51.0|Standard Deviation|9.5|9.5|||
3617257|NCT02707172|3466950|B1|Taiwan||Region of Enrollment||participants|Number|28|28.0||||||
3617258|NCT02707172|3466950|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3617259|NCT02707172|3466950|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3617260|NCT02707172|3466950|B1|||Age||years|Mean|21.9|21.9|Standard Deviation|1.6|1.6|||
3617261|NCT02707172|3466950|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3617262|NCT02707172|3466950|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3617263|NCT02707172|3466950|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3617264|NCT02706899|3466955|B3||Grade 2: In bed less than 50% of the time|Eastern Cooperative Oncology Group (ECOG) Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed less than 50% of the time; 3= In bed more than 50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|1|1.0||||||
3617265|NCT02706899|3466956|B2||Grade 2: In bed less than 50% of the time|Eastern Cooperative Oncology Group (ECOG) Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed less than 50% of the time; 3= In bed more than 50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|0|0.0||||||
3617266|NCT02706899|3466957|B1||Grade 2: In bed less than 50% of the time|Eastern Cooperative Oncology Group (ECOG) Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed less than 50% of the time; 3= In bed more than 50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|1|1.0||||||
3617267|NCT02706899|3466955|B3||Grade 1: Symptoms but ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed less than 50% of the time; 3= In bed more than 50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|10|10.0||||||
3617268|NCT02706899|3466956|B2||Grade 1: Symptoms but ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed less than 50% of the time; 3= In bed more than 50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|4|4.0||||||
3617269|NCT02706899|3466957|B1||Grade 1: Symptoms but ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed less than 50% of the time; 3= In bed more than 50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|6|6.0||||||
3617270|NCT02706899|3466955|B3||Grade 0: Normal activity|Eastern Cooperative Oncology Group (ECOG) Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed less than 50% of the time; 3= In bed more than 50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|8|8.0||||||
3617271|NCT02706899|3466956|B2||Grade 0: Normal activity|Eastern Cooperative Oncology Group (ECOG) Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed less than 50% of the time; 3= In bed more than 50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|2|2.0||||||
3617272|NCT02706899|3466957|B1||Grade 0: Normal activity|Eastern Cooperative Oncology Group (ECOG) Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed less than 50% of the time; 3= In bed more than 50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|6|6.0||||||
3617273|NCT02706899|3466955|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
3617274|NCT02706899|3466956|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3617275|NCT02706899|3466957|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3617276|NCT02706899|3466955|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617277|NCT02706899|3466956|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617278|NCT02706899|3466957|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617279|NCT02706899|3466955|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617280|NCT02706899|3466956|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617281|NCT02706899|3466957|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617282|NCT02706899|3466955|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3617283|NCT02706899|3466956|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3617284|NCT02706899|3466957|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3617285|NCT02706899|3466955|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3617286|NCT02706899|3466956|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3617287|NCT02706899|3466957|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3617288|NCT02706899|3466955|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617289|NCT02706899|3466956|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617290|NCT02706899|3466957|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617291|NCT02706899|3466955|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617292|NCT02706899|3466956|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617293|NCT02706899|3466957|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617294|NCT02706899|3466955|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617295|NCT02706899|3466956|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617296|NCT02706899|3466957|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617297|NCT02706899|3466955|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617298|NCT02706899|3466956|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617299|NCT02706899|3466957|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617300|NCT02706899|3466955|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3617301|NCT02706899|3466956|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3617302|NCT02706899|3466957|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3617303|NCT02706899|3466955|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617304|NCT02706899|3466956|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617305|NCT02706899|3466957|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617306|NCT02706899|3466955|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3617307|NCT02706899|3466956|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3617308|NCT02706899|3466957|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3617309|NCT02706899|3466955|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3617310|NCT02706899|3466956|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3617311|NCT02706899|3466957|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3617312|NCT02706899|3466955|B3|||Age||years|Median|72|72.0|Full Range|||46.0|83.0|
3617313|NCT02706899|3466956|B2|||Age||years|Median|66|66.0|Full Range|||57.0|81.0|
3617314|NCT02706899|3466957|B1|||Age||years|Median|72|72.0|Full Range|||46.0|83.0|
3617315|NCT02706834|3466966|B12|N/A (Participant is Male)||Female Reproductive Status||participants|Number|34|34.0||||||
3617316|NCT02706834|3466967|B11|N/A (Participant is Male)||Female Reproductive Status||participants|Number|4|4.0||||||
3617317|NCT02706834|3466968|B10|N/A (Participant is Male)||Female Reproductive Status||participants|Number|4|4.0||||||
3617318|NCT02706834|3466969|B9|N/A (Participant is Male)||Female Reproductive Status||participants|Number|4|4.0||||||
3617319|NCT02706834|3466970|B8|N/A (Participant is Male)||Female Reproductive Status||participants|Number|3|3.0||||||
3617320|NCT02706834|3466971|B7|N/A (Participant is Male)||Female Reproductive Status||participants|Number|3|3.0||||||
3617321|NCT02706834|3466972|B6|N/A (Participant is Male)||Female Reproductive Status||participants|Number|2|2.0||||||
3617322|NCT02706834|3466973|B5|N/A (Participant is Male)||Female Reproductive Status||participants|Number|2|2.0||||||
3617323|NCT02706834|3466974|B4|N/A (Participant is Male)||Female Reproductive Status||participants|Number|3|3.0||||||
3617324|NCT02706834|3466975|B3|N/A (Participant is Male)||Female Reproductive Status||participants|Number|3|3.0||||||
3617325|NCT02706834|3466976|B2|N/A (Participant is Male)||Female Reproductive Status||participants|Number|3|3.0||||||
3617326|NCT02706834|3466977|B1|N/A (Participant is Male)||Female Reproductive Status||participants|Number|3|3.0||||||
3617327|NCT02706834|3466966|B12|Female of Childbearing Potential||Female Reproductive Status||participants|Number|0|0.0||||||
3617328|NCT02706834|3466967|B11|Female of Childbearing Potential||Female Reproductive Status||participants|Number|0|0.0||||||
3617329|NCT02706834|3466968|B10|Female of Childbearing Potential||Female Reproductive Status||participants|Number|0|0.0||||||
3617330|NCT02706834|3466969|B9|Female of Childbearing Potential||Female Reproductive Status||participants|Number|0|0.0||||||
3617331|NCT02706834|3466970|B8|Female of Childbearing Potential||Female Reproductive Status||participants|Number|0|0.0||||||
3617332|NCT02706834|3466971|B7|Female of Childbearing Potential||Female Reproductive Status||participants|Number|0|0.0||||||
3617333|NCT02706834|3466972|B6|Female of Childbearing Potential||Female Reproductive Status||participants|Number|0|0.0||||||
3617334|NCT02706834|3466973|B5|Female of Childbearing Potential||Female Reproductive Status||participants|Number|0|0.0||||||
3617335|NCT02706834|3466974|B4|Female of Childbearing Potential||Female Reproductive Status||participants|Number|0|0.0||||||
3617336|NCT02706834|3466975|B3|Female of Childbearing Potential||Female Reproductive Status||participants|Number|0|0.0||||||
3617337|NCT02706834|3466976|B2|Female of Childbearing Potential||Female Reproductive Status||participants|Number|0|0.0||||||
3617338|NCT02706834|3466977|B1|Female of Childbearing Potential||Female Reproductive Status||participants|Number|0|0.0||||||
3617339|NCT02706834|3466966|B12|Surgically Sterile||Female Reproductive Status||participants|Number|1|1.0||||||
3617340|NCT02706834|3466967|B11|Surgically Sterile||Female Reproductive Status||participants|Number|0|0.0||||||
3617341|NCT02706834|3466968|B10|Surgically Sterile||Female Reproductive Status||participants|Number|0|0.0||||||
3617342|NCT02706834|3466969|B9|Surgically Sterile||Female Reproductive Status||participants|Number|0|0.0||||||
3617343|NCT02706834|3466970|B8|Surgically Sterile||Female Reproductive Status||participants|Number|0|0.0||||||
3617344|NCT02706834|3466971|B7|Surgically Sterile||Female Reproductive Status||participants|Number|0|0.0||||||
3617345|NCT02706834|3466972|B6|Surgically Sterile||Female Reproductive Status||participants|Number|0|0.0||||||
3617346|NCT02706834|3466973|B5|Surgically Sterile||Female Reproductive Status||participants|Number|1|1.0||||||
3617347|NCT02706834|3466974|B4|Surgically Sterile||Female Reproductive Status||participants|Number|0|0.0||||||
3617348|NCT02706834|3466975|B3|Surgically Sterile||Female Reproductive Status||participants|Number|0|0.0||||||
3617349|NCT02706834|3466976|B2|Surgically Sterile||Female Reproductive Status||participants|Number|0|0.0||||||
3617350|NCT02706834|3466977|B1|Surgically Sterile||Female Reproductive Status||participants|Number|0|0.0||||||
3617351|NCT02706834|3466966|B12|Postmenopausal||Female Reproductive Status||participants|Number|1|1.0||||||
3617352|NCT02706834|3466967|B11|Postmenopausal||Female Reproductive Status||participants|Number|0|0.0||||||
3617353|NCT02706834|3466968|B10|Postmenopausal||Female Reproductive Status||participants|Number|0|0.0||||||
3617354|NCT02706834|3466969|B9|Postmenopausal||Female Reproductive Status||participants|Number|0|0.0||||||
3617355|NCT02706834|3466970|B8|Postmenopausal||Female Reproductive Status||participants|Number|0|0.0||||||
3617356|NCT02706834|3466971|B7|Postmenopausal||Female Reproductive Status||participants|Number|0|0.0||||||
3617357|NCT02706834|3466972|B6|Postmenopausal||Female Reproductive Status||participants|Number|1|1.0||||||
3617358|NCT02706834|3466973|B5|Postmenopausal||Female Reproductive Status||participants|Number|0|0.0||||||
3617359|NCT02706834|3466974|B4|Postmenopausal||Female Reproductive Status||participants|Number|0|0.0||||||
3617360|NCT02706834|3466975|B3|Postmenopausal||Female Reproductive Status||participants|Number|0|0.0||||||
3617361|NCT02706834|3466976|B2|Postmenopausal||Female Reproductive Status||participants|Number|0|0.0||||||
3617362|NCT02706834|3466977|B1|Postmenopausal||Female Reproductive Status||participants|Number|0|0.0||||||
3617363|NCT02706834|3466966|B12|No||Xanthine/Caffeine Consumption||participants|Number|11|11.0||||||
3617364|NCT02706834|3466967|B11|No||Xanthine/Caffeine Consumption||participants|Number|0|0.0||||||
3617365|NCT02706834|3466968|B10|No||Xanthine/Caffeine Consumption||participants|Number|2|2.0||||||
3617366|NCT02706834|3466969|B9|No||Xanthine/Caffeine Consumption||participants|Number|1|1.0||||||
3617367|NCT02706834|3466970|B8|No||Xanthine/Caffeine Consumption||participants|Number|2|2.0||||||
3617368|NCT02706834|3466971|B7|No||Xanthine/Caffeine Consumption||participants|Number|1|1.0||||||
3617369|NCT02706834|3466972|B6|No||Xanthine/Caffeine Consumption||participants|Number|1|1.0||||||
3617370|NCT02706834|3466973|B5|No||Xanthine/Caffeine Consumption||participants|Number|1|1.0||||||
3617371|NCT02706834|3466974|B4|No||Xanthine/Caffeine Consumption||participants|Number|1|1.0||||||
3617372|NCT02706834|3466975|B3|No||Xanthine/Caffeine Consumption||participants|Number|1|1.0||||||
3617373|NCT02706834|3466976|B2|No||Xanthine/Caffeine Consumption||participants|Number|1|1.0||||||
3617374|NCT02706834|3466977|B1|No||Xanthine/Caffeine Consumption||participants|Number|0|0.0||||||
3617375|NCT02706834|3466966|B12|Yes||Xanthine/Caffeine Consumption||participants|Number|25|25.0||||||
3617376|NCT02706834|3466967|B11|Yes||Xanthine/Caffeine Consumption||participants|Number|4|4.0||||||
3617377|NCT02706834|3466968|B10|Yes||Xanthine/Caffeine Consumption||participants|Number|2|2.0||||||
3617378|NCT02706834|3466969|B9|Yes||Xanthine/Caffeine Consumption||participants|Number|3|3.0||||||
3617379|NCT02706834|3466970|B8|Yes||Xanthine/Caffeine Consumption||participants|Number|1|1.0||||||
3617380|NCT02706834|3466971|B7|Yes||Xanthine/Caffeine Consumption||participants|Number|2|2.0||||||
3617381|NCT02706834|3466972|B6|Yes||Xanthine/Caffeine Consumption||participants|Number|2|2.0||||||
3617382|NCT02706834|3466973|B5|Yes||Xanthine/Caffeine Consumption||participants|Number|2|2.0||||||
3617383|NCT02706834|3466974|B4|Yes||Xanthine/Caffeine Consumption||participants|Number|2|2.0||||||
3617384|NCT02706834|3466975|B3|Yes||Xanthine/Caffeine Consumption||participants|Number|2|2.0||||||
3617385|NCT02706834|3466976|B2|Yes||Xanthine/Caffeine Consumption||participants|Number|2|2.0||||||
3617386|NCT02706834|3466977|B1|Yes||Xanthine/Caffeine Consumption||participants|Number|3|3.0||||||
3617387|NCT02706834|3466966|B12|Missing||Alcohol Classification||participants|Number|1|1.0||||||
3617388|NCT02706834|3466967|B11|Missing||Alcohol Classification||participants|Number|0|0.0||||||
3617389|NCT02706834|3466968|B10|Missing||Alcohol Classification||participants|Number|0|0.0||||||
3617390|NCT02706834|3466969|B9|Missing||Alcohol Classification||participants|Number|0|0.0||||||
3617391|NCT02706834|3466970|B8|Missing||Alcohol Classification||participants|Number|0|0.0||||||
3617392|NCT02706834|3466971|B7|Missing||Alcohol Classification||participants|Number|0|0.0||||||
3617393|NCT02706834|3466972|B6|Missing||Alcohol Classification||participants|Number|0|0.0||||||
3617394|NCT02706834|3466973|B5|Missing||Alcohol Classification||participants|Number|0|0.0||||||
3617395|NCT02706834|3466974|B4|Missing||Alcohol Classification||participants|Number|0|0.0||||||
3617396|NCT02706834|3466975|B3|Missing||Alcohol Classification||participants|Number|0|0.0||||||
3617397|NCT02706834|3466976|B2|Missing||Alcohol Classification||participants|Number|0|0.0||||||
3617398|NCT02706834|3466977|B1|Missing||Alcohol Classification||participants|Number|1|1.0||||||
3617399|NCT02706834|3466966|B12|Ex-drinker||Alcohol Classification||participants|Number|8|8.0||||||
3617400|NCT02706834|3466967|B11|Ex-drinker||Alcohol Classification||participants|Number|1|1.0||||||
3617401|NCT02706834|3466968|B10|Ex-drinker||Alcohol Classification||participants|Number|1|1.0||||||
3617402|NCT02706834|3466969|B9|Ex-drinker||Alcohol Classification||participants|Number|0|0.0||||||
3617403|NCT02706834|3466970|B8|Ex-drinker||Alcohol Classification||participants|Number|0|0.0||||||
3617404|NCT02706834|3466971|B7|Ex-drinker||Alcohol Classification||participants|Number|1|1.0||||||
3617405|NCT02706834|3466972|B6|Ex-drinker||Alcohol Classification||participants|Number|1|1.0||||||
3617406|NCT02706834|3466973|B5|Ex-drinker||Alcohol Classification||participants|Number|2|2.0||||||
3617407|NCT02706834|3466974|B4|Ex-drinker||Alcohol Classification||participants|Number|1|1.0||||||
3617408|NCT02706834|3466975|B3|Ex-drinker||Alcohol Classification||participants|Number|0|0.0||||||
3617409|NCT02706834|3466976|B2|Ex-drinker||Alcohol Classification||participants|Number|1|1.0||||||
3617410|NCT02706834|3466977|B1|Ex-drinker||Alcohol Classification||participants|Number|0|0.0||||||
3617411|NCT02706834|3466966|B12|Current Drinker||Alcohol Classification||participants|Number|11|11.0||||||
3617412|NCT02706834|3466967|B11|Current Drinker||Alcohol Classification||participants|Number|2|2.0||||||
3617413|NCT02706834|3466968|B10|Current Drinker||Alcohol Classification||participants|Number|0|0.0||||||
3617414|NCT02706834|3466969|B9|Current Drinker||Alcohol Classification||participants|Number|2|2.0||||||
3617415|NCT02706834|3466970|B8|Current Drinker||Alcohol Classification||participants|Number|0|0.0||||||
3617416|NCT02706834|3466971|B7|Current Drinker||Alcohol Classification||participants|Number|1|1.0||||||
3617417|NCT02706834|3466972|B6|Current Drinker||Alcohol Classification||participants|Number|1|1.0||||||
3617418|NCT02706834|3466973|B5|Current Drinker||Alcohol Classification||participants|Number|0|0.0||||||
3617419|NCT02706834|3466974|B4|Current Drinker||Alcohol Classification||participants|Number|2|2.0||||||
3617420|NCT02706834|3466975|B3|Current Drinker||Alcohol Classification||participants|Number|1|1.0||||||
3617421|NCT02706834|3466976|B2|Current Drinker||Alcohol Classification||participants|Number|0|0.0||||||
3617422|NCT02706834|3466977|B1|Current Drinker||Alcohol Classification||participants|Number|2|2.0||||||
3617423|NCT02706834|3466966|B12|Never Drunk||Alcohol Classification||participants|Number|16|16.0||||||
3617424|NCT02706834|3466967|B11|Never Drunk||Alcohol Classification||participants|Number|1|1.0||||||
3617425|NCT02706834|3466968|B10|Never Drunk||Alcohol Classification||participants|Number|3|3.0||||||
3617426|NCT02706834|3466969|B9|Never Drunk||Alcohol Classification||participants|Number|2|2.0||||||
3617427|NCT02706834|3466970|B8|Never Drunk||Alcohol Classification||participants|Number|3|3.0||||||
3617428|NCT02706834|3466971|B7|Never Drunk||Alcohol Classification||participants|Number|1|1.0||||||
3617429|NCT02706834|3466972|B6|Never Drunk||Alcohol Classification||participants|Number|1|1.0||||||
3617430|NCT02706834|3466973|B5|Never Drunk||Alcohol Classification||participants|Number|1|1.0||||||
3617431|NCT02706834|3466974|B4|Never Drunk||Alcohol Classification||participants|Number|0|0.0||||||
3617432|NCT02706834|3466975|B3|Never Drunk||Alcohol Classification||participants|Number|2|2.0||||||
3617433|NCT02706834|3466976|B2|Never Drunk||Alcohol Classification||participants|Number|2|2.0||||||
3617434|NCT02706834|3466977|B1|Never Drunk||Alcohol Classification||participants|Number|0|0.0||||||
3617435|NCT02706834|3466966|B12|Ex-smoker||Smoking Classification||participants|Number|3|3.0||||||
3617436|NCT02706834|3466967|B11|Ex-smoker||Smoking Classification||participants|Number|1|1.0||||||
3617437|NCT02706834|3466968|B10|Ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3617438|NCT02706834|3466969|B9|Ex-smoker||Smoking Classification||participants|Number|1|1.0||||||
3617439|NCT02706834|3466970|B8|Ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3617440|NCT02706834|3466971|B7|Ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3617441|NCT02706834|3466972|B6|Ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3617442|NCT02706834|3466973|B5|Ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3617443|NCT02706834|3466974|B4|Ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3617444|NCT02706834|3466975|B3|Ex-smoker||Smoking Classification||participants|Number|1|1.0||||||
3617445|NCT02706834|3466976|B2|Ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3617446|NCT02706834|3466977|B1|Ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3617447|NCT02706834|3466966|B12|Current Smoker||Smoking Classification||participants|Number|0|0.0||||||
3617448|NCT02706834|3466967|B11|Current Smoker||Smoking Classification||participants|Number|0|0.0||||||
3617449|NCT02706834|3466968|B10|Current Smoker||Smoking Classification||participants|Number|0|0.0||||||
3617450|NCT02706834|3466969|B9|Current Smoker||Smoking Classification||participants|Number|0|0.0||||||
3617451|NCT02706834|3466970|B8|Current Smoker||Smoking Classification||participants|Number|0|0.0||||||
3617452|NCT02706834|3466971|B7|Current Smoker||Smoking Classification||participants|Number|0|0.0||||||
3617453|NCT02706834|3466972|B6|Current Smoker||Smoking Classification||participants|Number|0|0.0||||||
3617454|NCT02706834|3466973|B5|Current Smoker||Smoking Classification||participants|Number|0|0.0||||||
3617455|NCT02706834|3466974|B4|Current Smoker||Smoking Classification||participants|Number|0|0.0||||||
3617456|NCT02706834|3466975|B3|Current Smoker||Smoking Classification||participants|Number|0|0.0||||||
3617457|NCT02706834|3466976|B2|Current Smoker||Smoking Classification||participants|Number|0|0.0||||||
3617458|NCT02706834|3466977|B1|Current Smoker||Smoking Classification||participants|Number|0|0.0||||||
3617459|NCT02706834|3466966|B12|Never Smoked||Smoking Classification||participants|Number|33|33.0||||||
3617460|NCT02706834|3466967|B11|Never Smoked||Smoking Classification||participants|Number|3|3.0||||||
3617461|NCT02706834|3466968|B10|Never Smoked||Smoking Classification||participants|Number|4|4.0||||||
3617462|NCT02706834|3466969|B9|Never Smoked||Smoking Classification||participants|Number|3|3.0||||||
3617463|NCT02706834|3466970|B8|Never Smoked||Smoking Classification||participants|Number|3|3.0||||||
3617464|NCT02706834|3466971|B7|Never Smoked||Smoking Classification||participants|Number|3|3.0||||||
3617465|NCT02706834|3466972|B6|Never Smoked||Smoking Classification||participants|Number|3|3.0||||||
3617466|NCT02706834|3466973|B5|Never Smoked||Smoking Classification||participants|Number|3|3.0||||||
3617467|NCT02706834|3466974|B4|Never Smoked||Smoking Classification||participants|Number|3|3.0||||||
3617468|NCT02706834|3466975|B3|Never Smoked||Smoking Classification||participants|Number|2|2.0||||||
3617469|NCT02706834|3466976|B2|Never Smoked||Smoking Classification||participants|Number|3|3.0||||||
3617470|NCT02706834|3466977|B1|Never Smoked||Smoking Classification||participants|Number|3|3.0||||||
3617471|NCT02706834|3466966|B12|||Body Mass Index (BMI)||kg/m^2|Mean|25.01|25.01|Standard Deviation|2.584|2.584|||
3617472|NCT02706834|3466967|B11|||Body Mass Index (BMI)||kg/m^2|Mean|23.20|23.2|Standard Deviation|1.622|1.622|||
3617473|NCT02706834|3466968|B10|||Body Mass Index (BMI)||kg/m^2|Mean|22.96|22.96|Standard Deviation|0.527|0.527|||
3617474|NCT02706834|3466969|B9|||Body Mass Index (BMI)||kg/m^2|Mean|22.05|22.05|Standard Deviation|1.864|1.864|||
3617475|NCT02706834|3466970|B8|||Body Mass Index (BMI)||kg/m^2|Mean|26.37|26.37|Standard Deviation|3.709|3.709|||
3617476|NCT02706834|3466971|B7|||Body Mass Index (BMI)||kg/m^2|Mean|25.73|25.73|Standard Deviation|3.170|3.17|||
3617477|NCT02706834|3466972|B6|||Body Mass Index (BMI)||kg/m^2|Mean|24.25|24.25|Standard Deviation|1.772|1.772|||
3617478|NCT02706834|3466973|B5|||Body Mass Index (BMI)||kg/m^2|Mean|26.34|26.34|Standard Deviation|3.071|3.071|||
3617479|NCT02706834|3466974|B4|||Body Mass Index (BMI)||kg/m^2|Mean|26.65|26.65|Standard Deviation|2.727|2.727|||
3617480|NCT02706834|3466975|B3|||Body Mass Index (BMI)||kg/m^2|Mean|26.08|26.08|Standard Deviation|1.765|1.765|||
3617481|NCT02706834|3466976|B2|||Body Mass Index (BMI)||kg/m^2|Mean|27.41|27.41|Standard Deviation|0.755|0.755|||
3617482|NCT02706834|3466977|B1|||Body Mass Index (BMI)||kg/m^2|Mean|26.28|26.28|Standard Deviation|1.828|1.828|||
3617483|NCT02706834|3466966|B12|||Weight||kg|Mean|74.93|74.93|Standard Deviation|10.416|10.416|||
3617484|NCT02706834|3466967|B11|||Weight||kg|Mean|69.88|69.88|Standard Deviation|10.806|10.806|||
3617485|NCT02706834|3466968|B10|||Weight||kg|Mean|65.18|65.18|Standard Deviation|3.149|3.149|||
3617486|NCT02706834|3466969|B9|||Weight||kg|Mean|66.73|66.73|Standard Deviation|1.563|1.563|||
3617487|NCT02706834|3466970|B8|||Weight||kg|Mean|77.13|77.13|Standard Deviation|16.354|16.354|||
3617488|NCT02706834|3466971|B7|||Weight||kg|Mean|81.63|81.63|Standard Deviation|11.946|11.946|||
3617489|NCT02706834|3466972|B6|||Weight||kg|Mean|66.87|66.87|Standard Deviation|8.135|8.135|||
3617490|NCT02706834|3466973|B5|||Weight||kg|Mean|75.53|75.53|Standard Deviation|8.173|8.173|||
3617491|NCT02706834|3466974|B4|||Weight||kg|Mean|83.23|83.23|Standard Deviation|9.160|9.16|||
3617492|NCT02706834|3466975|B3|||Weight||kg|Mean|78.60|78.6|Standard Deviation|9.569|9.569|||
3617493|NCT02706834|3466976|B2|||Weight||kg|Mean|85.23|85.23|Standard Deviation|2.686|2.686|||
3617494|NCT02706834|3466977|B1|||Weight||kg|Mean|81.87|81.87|Standard Deviation|8.686|8.686|||
3617495|NCT02706834|3466966|B12|||Height||cm|Mean|172.9|172.9|Standard Deviation|6.82|6.82|||
3617496|NCT02706834|3466967|B11|||Height||cm|Mean|173.0|173.0|Standard Deviation|8.64|8.64|||
3617497|NCT02706834|3466968|B10|||Height||cm|Mean|168.5|168.5|Standard Deviation|5.00|5.0|||
3617498|NCT02706834|3466969|B9|||Height||cm|Mean|174.3|174.3|Standard Deviation|6.24|6.24|||
3617499|NCT02706834|3466970|B8|||Height||cm|Mean|170.3|170.3|Standard Deviation|7.23|7.23|||
3617500|NCT02706834|3466971|B7|||Height||cm|Mean|178.0|178.0|Standard Deviation|4.36|4.36|||
3617501|NCT02706834|3466972|B6|||Height||cm|Mean|166.1|166.1|Standard Deviation|9.54|9.54|||
3617502|NCT02706834|3466973|B5|||Height||cm|Mean|169.7|169.7|Standard Deviation|12.50|12.5|||
3617503|NCT02706834|3466974|B4|||Height||cm|Mean|176.7|176.7|Standard Deviation|1.53|1.53|||
3617504|NCT02706834|3466975|B3|||Height||cm|Mean|173.3|173.3|Standard Deviation|5.69|5.69|||
3617505|NCT02706834|3466976|B2|||Height||cm|Mean|176.3|176.3|Standard Deviation|2.89|2.89|||
3617506|NCT02706834|3466977|B1|||Height||cm|Mean|176.3|176.3|Standard Deviation|3.21|3.21|||
3617507|NCT02706834|3466966|B12|United States||Region of Enrollment||participants|Number|36|36.0||||||
3617508|NCT02706834|3466967|B11|United States||Region of Enrollment||participants|Number|4|4.0||||||
3617509|NCT02706834|3466968|B10|United States||Region of Enrollment||participants|Number|4|4.0||||||
3617510|NCT02706834|3466969|B9|United States||Region of Enrollment||participants|Number|4|4.0||||||
3617511|NCT02706834|3466970|B8|United States||Region of Enrollment||participants|Number|3|3.0||||||
3617512|NCT02706834|3466971|B7|United States||Region of Enrollment||participants|Number|3|3.0||||||
3617513|NCT02706834|3466972|B6|United States||Region of Enrollment||participants|Number|3|3.0||||||
3617514|NCT02706834|3466973|B5|United States||Region of Enrollment||participants|Number|3|3.0||||||
3617515|NCT02706834|3466974|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
3617516|NCT02706834|3466975|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3617517|NCT02706834|3466976|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3617518|NCT02706834|3466977|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3617519|NCT02706834|3466966|B12|White||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3617520|NCT02706834|3466967|B11|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3617521|NCT02706834|3466968|B10|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3617522|NCT02706834|3466969|B9|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3617523|NCT02706834|3466970|B8|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3617524|NCT02706834|3466971|B7|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3617525|NCT02706834|3466972|B6|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3617526|NCT02706834|3466973|B5|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3617527|NCT02706834|3466974|B4|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3617528|NCT02706834|3466975|B3|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3617529|NCT02706834|3466976|B2|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3617530|NCT02706834|3466977|B1|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3617531|NCT02706834|3466966|B12|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3617532|NCT02706834|3466967|B11|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3617533|NCT02706834|3466968|B10|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3617534|NCT02706834|3466969|B9|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3617535|NCT02706834|3466970|B8|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3617536|NCT02706834|3466971|B7|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3617537|NCT02706834|3466972|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3617538|NCT02706834|3466973|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3617539|NCT02706834|3466974|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3617540|NCT02706834|3466975|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3617541|NCT02706834|3466976|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3617542|NCT02706834|3466977|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3617543|NCT02706834|3466966|B12|Asian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3617544|NCT02706834|3466967|B11|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3617545|NCT02706834|3466968|B10|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3617546|NCT02706834|3466969|B9|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3617547|NCT02706834|3466970|B8|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3617548|NCT02706834|3466971|B7|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3617549|NCT02706834|3466972|B6|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3617550|NCT02706834|3466973|B5|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3617551|NCT02706834|3466974|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3617552|NCT02706834|3466975|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3617553|NCT02706834|3466976|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3617554|NCT02706834|3466977|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3617555|NCT02706834|3466966|B12|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3617556|NCT02706834|3466967|B11|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3617557|NCT02706834|3466968|B10|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3617558|NCT02706834|3466969|B9|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3617559|NCT02706834|3466970|B8|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3617560|NCT02706834|3466971|B7|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3617561|NCT02706834|3466972|B6|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3617562|NCT02706834|3466973|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3617563|NCT02706834|3466974|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3617564|NCT02706834|3466975|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3617565|NCT02706834|3466976|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3617566|NCT02706834|3466977|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3617567|NCT02706834|3466966|B12|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3617568|NCT02706834|3466967|B11|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3617569|NCT02706834|3466968|B10|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3617570|NCT02706834|3466969|B9|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3617571|NCT02706834|3466970|B8|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3617572|NCT02706834|3466971|B7|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3617573|NCT02706834|3466972|B6|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3617574|NCT02706834|3466973|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3617575|NCT02706834|3466974|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3617576|NCT02706834|3466975|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3617577|NCT02706834|3466976|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3617578|NCT02706834|3466977|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3617579|NCT02706834|3466966|B12||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3617580|NCT02706834|3466967|B11||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3617581|NCT02706834|3466968|B10||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3617582|NCT02706834|3466969|B9||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3617583|NCT02706834|3466970|B8||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3617584|NCT02706834|3466971|B7||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3617585|NCT02706834|3466972|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3617586|NCT02706834|3466973|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3617587|NCT02706834|3466974|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3617588|NCT02706834|3466975|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3617589|NCT02706834|3466976|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3617590|NCT02706834|3466977|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3617591|NCT02706834|3466966|B12||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3617592|NCT02706834|3466967|B11||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3617593|NCT02706834|3466968|B10||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3617594|NCT02706834|3466969|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3617595|NCT02706834|3466970|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3617596|NCT02706834|3466971|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3617597|NCT02706834|3466972|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3617598|NCT02706834|3466973|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3617599|NCT02706834|3466974|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3617600|NCT02706834|3466975|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3617601|NCT02706834|3466976|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3617602|NCT02706834|3466977|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3617603|NCT02706834|3466966|B12|||Age||years|Mean|35.9|35.9|Standard Deviation|8.45|8.45|||
3617604|NCT02706834|3466967|B11|||Age||years|Mean|43.8|43.8|Standard Deviation|5.44|5.44|||
3617605|NCT02706834|3466968|B10|||Age||years|Mean|34.3|34.3|Standard Deviation|6.65|6.65|||
3617606|NCT02706834|3466969|B9|||Age||years|Mean|37.5|37.5|Standard Deviation|10.02|10.02|||
3617607|NCT02706834|3466970|B8|||Age||years|Mean|40.7|40.7|Standard Deviation|5.51|5.51|||
3617608|NCT02706834|3466971|B7|||Age||years|Mean|32.3|32.3|Standard Deviation|10.69|10.69|||
3617609|NCT02706834|3466972|B6|||Age||years|Mean|40.3|40.3|Standard Deviation|8.39|8.39|||
3617610|NCT02706834|3466973|B5|||Age||years|Mean|28.0|28.0|Standard Deviation|6.24|6.24|||
3617611|NCT02706834|3466974|B4|||Age||years|Mean|36.7|36.7|Standard Deviation|9.71|9.71|||
3617612|NCT02706834|3466975|B3|||Age||years|Mean|34.7|34.7|Standard Deviation|4.16|4.16|||
3617613|NCT02706834|3466976|B2|||Age||years|Mean|29.3|29.3|Standard Deviation|11.68|11.68|||
3617614|NCT02706834|3466977|B1|||Age||years|Mean|34.3|34.3|Standard Deviation|10.26|10.26|||
3617615|NCT02706717|3467129|B3|||sCD14||ug/L|Median|2255|2255.0|Inter-Quartile Range|||2036.0|2750.0|
3617616|NCT02706717|3467130|B2|||sCD14||ug/L|Median|2262|2262.0|Inter-Quartile Range|||2033.0|2643.0|
3617617|NCT02706717|3467131|B1|||sCD14||ug/L|Median|2249|2249.0|Inter-Quartile Range|||2106.0|2759.0|
3617618|NCT02706717|3467129|B3||>=40 copies/mL|HIV-1 RNA||Participants|Count of Participants|1|1.0||||||
3617619|NCT02706717|3467130|B2||>=40 copies/mL|HIV-1 RNA||Participants|Count of Participants|1|1.0||||||
3617620|NCT02706717|3467131|B1||>=40 copies/mL|HIV-1 RNA||Participants|Count of Participants|0|0.0||||||
3617621|NCT02706717|3467129|B3||<40 copies/mL|HIV-1 RNA||Participants|Count of Participants|92|92.0||||||
3617622|NCT02706717|3467130|B2||<40 copies/mL|HIV-1 RNA||Participants|Count of Participants|45|45.0||||||
3617623|NCT02706717|3467131|B1||<40 copies/mL|HIV-1 RNA||Participants|Count of Participants|47|47.0||||||
3617624|NCT02706717|3467129|B3|||CD4 Count||cells/mm^3|Median|712|712.0|Inter-Quartile Range|||542.0|893.0|
3617625|NCT02706717|3467130|B2|||CD4 Count||cells/mm^3|Median|714.5|714.5|Inter-Quartile Range|||546.0|897.0|
3617626|NCT02706717|3467131|B1|||CD4 Count||cells/mm^3|Median|702|702.0|Inter-Quartile Range|||483.0|866.0|
3617627|NCT02706717|3467129|B3|||BMI||kg/m^2|Median|27.1|27.1|Inter-Quartile Range|||24.2|30.7|
3617628|NCT02706717|3467130|B2|||BMI||kg/m^2|Median|26.2|26.2|Inter-Quartile Range|||23.6|30.1|
3617629|NCT02706717|3467131|B1|||BMI||kg/m^2|Median|27.3|27.3|Inter-Quartile Range|||25.1|31.0|
3617630|NCT02706717|3467129|B3|||Weight||kg|Median|83.1|83.1|Inter-Quartile Range|||74.2|94.1|
3617631|NCT02706717|3467130|B2|||Weight||kg|Median|81.3|81.3|Inter-Quartile Range|||71.7|94.1|
3617632|NCT02706717|3467131|B1|||Weight||kg|Median|87|87.0|Inter-Quartile Range|||75.3|96.6|
3617633|NCT02706717|3467129|B3||Unknown or Not Reported|Alcohol Status||Participants|Count of Participants|2|2.0||||||
3617634|NCT02706717|3467130|B2||Unknown or Not Reported|Alcohol Status||Participants|Count of Participants|2|2.0||||||
3617635|NCT02706717|3467131|B1||Unknown or Not Reported|Alcohol Status||Participants|Count of Participants|0|0.0||||||
3617636|NCT02706717|3467129|B3||Current|Alcohol Status||Participants|Count of Participants|60|60.0||||||
3617637|NCT02706717|3467130|B2||Current|Alcohol Status||Participants|Count of Participants|31|31.0||||||
3617638|NCT02706717|3467131|B1||Current|Alcohol Status||Participants|Count of Participants|29|29.0||||||
3617639|NCT02706717|3467129|B3||Former|Alcohol Status||Participants|Count of Participants|23|23.0||||||
3617640|NCT02706717|3467130|B2||Former|Alcohol Status||Participants|Count of Participants|8|8.0||||||
3617641|NCT02706717|3467131|B1||Former|Alcohol Status||Participants|Count of Participants|15|15.0||||||
3617642|NCT02706717|3467129|B3||Never|Alcohol Status||Participants|Count of Participants|8|8.0||||||
3617643|NCT02706717|3467130|B2||Never|Alcohol Status||Participants|Count of Participants|5|5.0||||||
3617644|NCT02706717|3467131|B1||Never|Alcohol Status||Participants|Count of Participants|3|3.0||||||
3617645|NCT02706717|3467129|B3||Unknown or Not Reported|Smoking Status||Participants|Count of Participants|2|2.0||||||
3617646|NCT02706717|3467130|B2||Unknown or Not Reported|Smoking Status||Participants|Count of Participants|2|2.0||||||
3617647|NCT02706717|3467131|B1||Unknown or Not Reported|Smoking Status||Participants|Count of Participants|0|0.0||||||
3617648|NCT02706717|3467129|B3||Current|Smoking Status||Participants|Count of Participants|19|19.0||||||
3617649|NCT02706717|3467130|B2||Current|Smoking Status||Participants|Count of Participants|10|10.0||||||
3617650|NCT02706717|3467131|B1||Current|Smoking Status||Participants|Count of Participants|9|9.0||||||
3617651|NCT02706717|3467129|B3||Former|Smoking Status||Participants|Count of Participants|38|38.0||||||
3617652|NCT02706717|3467130|B2||Former|Smoking Status||Participants|Count of Participants|15|15.0||||||
3617653|NCT02706717|3467131|B1||Former|Smoking Status||Participants|Count of Participants|23|23.0||||||
3617654|NCT02706717|3467129|B3||Never|Smoking Status||Participants|Count of Participants|34|34.0||||||
3617655|NCT02706717|3467130|B2||Never|Smoking Status||Participants|Count of Participants|19|19.0||||||
3617656|NCT02706717|3467131|B1||Never|Smoking Status||Participants|Count of Participants|15|15.0||||||
3617657|NCT02706717|3467129|B3|United States||Region of Enrollment||Participants|Count of Participants|92|92.0||||||
3617658|NCT02706717|3467130|B2|United States||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
3617659|NCT02706717|3467131|B1|United States||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
3617660|NCT02706717|3467129|B3|Puerto Rico||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3617661|NCT02706717|3467130|B2|Puerto Rico||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3617662|NCT02706717|3467131|B1|Puerto Rico||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3617663|NCT02706717|3467129|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3617664|NCT02706717|3467130|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617665|NCT02706717|3467131|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3617666|NCT02706717|3467129|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617667|NCT02706717|3467130|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617668|NCT02706717|3467131|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617669|NCT02706717|3467129|B3||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3617670|NCT02706717|3467130|B2||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3617671|NCT02706717|3467131|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3617672|NCT02706717|3467129|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3617673|NCT02706717|3467130|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3617674|NCT02706717|3467131|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3617675|NCT02706717|3467129|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617676|NCT02706717|3467130|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617677|NCT02706717|3467131|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617678|NCT02706717|3467129|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3617679|NCT02706717|3467130|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3617680|NCT02706717|3467131|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617681|NCT02706717|3467129|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3617682|NCT02706717|3467130|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3617683|NCT02706717|3467131|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617684|NCT02706717|3467129|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617685|NCT02706717|3467130|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617686|NCT02706717|3467131|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617687|NCT02706717|3467129|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3617688|NCT02706717|3467130|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3617689|NCT02706717|3467131|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3617690|NCT02706717|3467129|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3617691|NCT02706717|3467130|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3617692|NCT02706717|3467131|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3617693|NCT02706717|3467129|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3617694|NCT02706717|3467130|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3617695|NCT02706717|3467131|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3617696|NCT02706717|3467129|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3617697|NCT02706717|3467130|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3617698|NCT02706717|3467131|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3617699|NCT02706717|3467129|B3|||Age||years|Median|51|51.0|Inter-Quartile Range|||45.0|56.0|
3617700|NCT02706717|3467130|B2|||Age||years|Median|51.5|51.5|Inter-Quartile Range|||42.0|56.0|
3617701|NCT02706717|3467131|B1|||Age||years|Median|51|51.0|Inter-Quartile Range|||47.0|56.0|
3617702|NCT02706327|3467150|B4|||International Physical Activity Questionnaire Short Form||kcal/week|Mean|3688.98|3688.98|Standard Deviation|3389.92|3389.92|||
3617703|NCT02706327|3467151|B3|||International Physical Activity Questionnaire Short Form||kcal/week|Mean|2824.54|2824.54|Standard Deviation|2221.46|2221.46|||
3617704|NCT02706327|3467152|B2|||International Physical Activity Questionnaire Short Form||kcal/week|Mean|4731.27|4731.27|Standard Deviation|5392.45|5392.45|||
3617705|NCT02706327|3467153|B1|||International Physical Activity Questionnaire Short Form||kcal/week|Mean|3438.81|3438.81|Standard Deviation|3543.30|3543.3|||
3617706|NCT02706327|3467150|B4|||Calcaneal valgus angle||degree|Mean|6.42|6.42|Standard Deviation|1.65|1.65|||
3617707|NCT02706327|3467151|B3|||Calcaneal valgus angle||degree|Mean|6.22|6.22|Standard Deviation|1.67|1.67|||
3617708|NCT02706327|3467152|B2|||Calcaneal valgus angle||degree|Mean|6.68|6.68|Standard Deviation|1.67|1.67|||
3617709|NCT02706327|3467153|B1|||Calcaneal valgus angle||degree|Mean|6.36|6.36|Standard Deviation|1.64|1.64|||
3617710|NCT02706327|3467150|B4|||Foot Posture Index|"This index measures posture (normal, pronated or supinated) of foot. Minimum-maximum values are -12 and +12 for the scale that 0 to +5 means normal foot posture, +6 to +9 means pronated foot, +10 and more means highly pronated and -1 to -4 means supinated foot, -5 to -12 means highly supinated.~Subjects with +6 and more were participated in this study."|units on a scale|Mean|8.19|8.19|Standard Deviation|1.89|1.89|||
3617711|NCT02706327|3467151|B3|||Foot Posture Index|"This index measures posture (normal, pronated or supinated) of foot. Minimum-maximum values are -12 and +12 for the scale that 0 to +5 means normal foot posture, +6 to +9 means pronated foot, +10 and more means highly pronated and -1 to -4 means supinated foot, -5 to -12 means highly supinated.~Subjects with +6 and more were participated in this study."|units on a scale|Mean|8.48|8.48|Standard Deviation|2.04|2.04|||
3617712|NCT02706327|3467152|B2|||Foot Posture Index|"This index measures posture (normal, pronated or supinated) of foot. Minimum-maximum values are -12 and +12 for the scale that 0 to +5 means normal foot posture, +6 to +9 means pronated foot, +10 and more means highly pronated and -1 to -4 means supinated foot, -5 to -12 means highly supinated.~Subjects with +6 and more were participated in this study."|units on a scale|Mean|8.59|8.59|Standard Deviation|1.76|1.76|||
3617713|NCT02706327|3467153|B1|||Foot Posture Index|"This index measures posture (normal, pronated or supinated) of foot. Minimum-maximum values are -12 and +12 for the scale that 0 to +5 means normal foot posture, +6 to +9 means pronated foot, +10 and more means highly pronated and -1 to -4 means supinated foot, -5 to -12 means highly supinated.~Subjects with +6 and more were participated in this study."|units on a scale|Mean|7.50|7.5|Standard Deviation|1.73|1.73|||
3617714|NCT02706327|3467150|B4|||Body Mass Index||kg/m2|Mean|23.48|23.48|Standard Deviation|3.62|3.62|||
3617715|NCT02706327|3467151|B3|||Body Mass Index||kg/m2|Mean|23.32|23.32|Standard Deviation|3.28|3.28|||
3617716|NCT02706327|3467152|B2|||Body Mass Index||kg/m2|Mean|24.11|24.11|Standard Deviation|4.15|4.15|||
3617717|NCT02706327|3467153|B1|||Body Mass Index||kg/m2|Mean|23.03|23.03|Standard Deviation|3.48|3.48|||
3617718|NCT02706327|3467150|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3617719|NCT02706327|3467151|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3617720|NCT02706327|3467152|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3617721|NCT02706327|3467153|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3617722|NCT02706327|3467150|B4||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3617723|NCT02706327|3467151|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3617724|NCT02706327|3467152|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3617725|NCT02706327|3467153|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3617726|NCT02706327|3467150|B4|||Age||years|Mean|21.94|21.94|Standard Deviation|3.78|3.78|||
3617727|NCT02706327|3467151|B3|||Age||years|Mean|21.09|21.09|Standard Deviation|1.95|1.95|||
3617728|NCT02706327|3467152|B2|||Age||years|Mean|23.05|23.05|Standard Deviation|5.53|5.53|||
3617729|NCT02706327|3467153|B1|||Age||years|Mean|21.73|21.73|Standard Deviation|2.89|2.89|||
3617730|NCT02705807|3467175|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
3617731|NCT02705807|3467175|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3617732|NCT02705807|3467175|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3617733|NCT02705807|3467175|B1|||Age||Years|Mean|35.8|35.8|Standard Deviation|7.35|7.35|||
3617734|NCT02705716|3467205|B3|||Tactile Threshold at Baseline|Tactile threshold was assessed by examiner using a constant pressure probe (Yeaple probe) which allowed application of a known force to the dentin surface from 10 g to an upper threshold of 80g in increments of 10 g. Tactile threshold is the maximum pressure applied at which participant do not report any pain or discomfort. Tactile threshold for each tooth was determined by asking participant whether sensation caused discomfort. The pressure setting at which participant gave two consecutive 'yes' responses was recorded as tactile threshold. Higher tactile threshold, less sensitive tooth.|gram (g)|Mean|11.76|11.76|Standard Deviation|2.878|2.878|||
3617735|NCT02705716|3467206|B2|||Tactile Threshold at Baseline|Tactile threshold was assessed by examiner using a constant pressure probe (Yeaple probe) which allowed application of a known force to the dentin surface from 10 g to an upper threshold of 80g in increments of 10 g. Tactile threshold is the maximum pressure applied at which participant do not report any pain or discomfort. Tactile threshold for each tooth was determined by asking participant whether sensation caused discomfort. The pressure setting at which participant gave two consecutive 'yes' responses was recorded as tactile threshold. Higher tactile threshold, less sensitive tooth.|gram (g)|Mean|12.03|12.03|Standard Deviation|3.010|3.01|||
3617736|NCT02705716|3467207|B1|||Tactile Threshold at Baseline|Tactile threshold was assessed by examiner using a constant pressure probe (Yeaple probe) which allowed application of a known force to the dentin surface from 10 g to an upper threshold of 80g in increments of 10 g. Tactile threshold is the maximum pressure applied at which participant do not report any pain or discomfort. Tactile threshold for each tooth was determined by asking participant whether sensation caused discomfort. The pressure setting at which participant gave two consecutive 'yes' responses was recorded as tactile threshold. Higher tactile threshold, less sensitive tooth.|gram (g)|Mean|11.50|11.5|Standard Deviation|2.739|2.739|||
3617737|NCT02705716|3467205|B3|||Schiff Sensitivity Score at Baseline|Assessed by examiner as participant's response to an evaporative (air) stimulus after stimulation of each individual tooth, scored using Schiff sensitivity scale range of 0-3; 0=Participant does not respond to air stimulation; 1=Participant responds to air stimulus but does not request discontinuation of stimulus; 2=Participant responds to air stimulus & requests discontinuation or moves from stimulus; 3=Participant responds to stimulus, considers stimulus to be painful, & requests discontinuation of stimulus. A reduction in Schiff Sensitivity score indicates improvement in sensitivity.|score on a scale|Mean|2.81|2.81|Standard Deviation|0.314|0.314|||
3617738|NCT02705716|3467206|B2|||Schiff Sensitivity Score at Baseline|Assessed by examiner as participant's response to an evaporative (air) stimulus after stimulation of each individual tooth, scored using Schiff sensitivity scale range of 0-3; 0=Participant does not respond to air stimulation; 1=Participant responds to air stimulus but does not request discontinuation of stimulus; 2=Participant responds to air stimulus & requests discontinuation or moves from stimulus; 3=Participant responds to stimulus, considers stimulus to be painful, & requests discontinuation of stimulus. A reduction in Schiff Sensitivity score indicates improvement in sensitivity.|score on a scale|Mean|2.83|2.83|Standard Deviation|0.307|0.307|||
3617739|NCT02705716|3467207|B1|||Schiff Sensitivity Score at Baseline|Assessed by examiner as participant's response to an evaporative (air) stimulus after stimulation of each individual tooth, scored using Schiff sensitivity scale range of 0-3; 0=Participant does not respond to air stimulation; 1=Participant responds to air stimulus but does not request discontinuation of stimulus; 2=Participant responds to air stimulus & requests discontinuation or moves from stimulus; 3=Participant responds to stimulus, considers stimulus to be painful, & requests discontinuation of stimulus. A reduction in Schiff Sensitivity score indicates improvement in sensitivity.|score on a scale|Mean|2.80|2.8|Standard Deviation|0.323|0.323|||
3617740|NCT02705716|3467205|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617741|NCT02705716|3467206|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617742|NCT02705716|3467207|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617743|NCT02705716|3467205|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3617744|NCT02705716|3467206|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617745|NCT02705716|3467207|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3617746|NCT02705716|3467205|B3||White|Race (NIH/OMB)||Participants|Count of Participants|116|116.0||||||
3617747|NCT02705716|3467206|B2||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3617748|NCT02705716|3467207|B1||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3617749|NCT02705716|3467205|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3617750|NCT02705716|3467206|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3617751|NCT02705716|3467207|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3617752|NCT02705716|3467205|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617753|NCT02705716|3467206|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617754|NCT02705716|3467207|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617755|NCT02705716|3467205|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3617756|NCT02705716|3467206|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3617757|NCT02705716|3467207|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3617758|NCT02705716|3467205|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617759|NCT02705716|3467206|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617760|NCT02705716|3467207|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617761|NCT02705716|3467205|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617762|NCT02705716|3467206|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617763|NCT02705716|3467207|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617764|NCT02705716|3467205|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|137|137.0||||||
3617765|NCT02705716|3467206|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3617766|NCT02705716|3467207|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3617767|NCT02705716|3467205|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3617768|NCT02705716|3467206|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617769|NCT02705716|3467207|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3617770|NCT02705716|3467205|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3617771|NCT02705716|3467206|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3617772|NCT02705716|3467207|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3617773|NCT02705716|3467205|B3||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3617774|NCT02705716|3467206|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3617775|NCT02705716|3467207|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3617776|NCT02705716|3467205|B3|||Age||Years|Mean|39.9|39.9|Standard Deviation|10.11|10.11|||
3617777|NCT02705716|3467206|B2|||Age||Years|Mean|39.9|39.9|Standard Deviation|9.53|9.53|||
3617778|NCT02705716|3467207|B1|||Age||Years|Mean|39.9|39.9|Standard Deviation|10.72|10.72|||
3617779|NCT02705365|3467218|B3|||Clinic Visits Over 3 Years||visits|Mean|10.5|10.5|Standard Deviation|8.3|8.3|||
3617780|NCT02705365|3467219|B2|||Clinic Visits Over 3 Years||visits|Mean|10.7|10.7|Standard Deviation|8.4|8.4|||
3617781|NCT02705365|3467220|B1|||Clinic Visits Over 3 Years||visits|Mean|10.3|10.3|Standard Deviation|7.9|7.9|||
3617782|NCT02705365|3467218|B3||Self|Insurance||Participants|Count of Participants|1|1.0||||||
3617783|NCT02705365|3467219|B2||Self|Insurance||Participants|Count of Participants|0|0.0||||||
3617784|NCT02705365|3467220|B1||Self|Insurance||Participants|Count of Participants|1|1.0||||||
3617785|NCT02705365|3467218|B3||Dual Medicare/Medicaid|Insurance||Participants|Count of Participants|328|328.0||||||
3617786|NCT02705365|3467219|B2||Dual Medicare/Medicaid|Insurance||Participants|Count of Participants|225|225.0||||||
3617787|NCT02705365|3467220|B1||Dual Medicare/Medicaid|Insurance||Participants|Count of Participants|103|103.0||||||
3617788|NCT02705365|3467218|B3||Medicaid|Insurance||Participants|Count of Participants|332|332.0||||||
3617789|NCT02705365|3467219|B2||Medicaid|Insurance||Participants|Count of Participants|211|211.0||||||
3617790|NCT02705365|3467220|B1||Medicaid|Insurance||Participants|Count of Participants|121|121.0||||||
3617791|NCT02705365|3467218|B3||Medicare|Insurance||Participants|Count of Participants|131|131.0||||||
3617792|NCT02705365|3467219|B2||Medicare|Insurance||Participants|Count of Participants|84|84.0||||||
3617793|NCT02705365|3467220|B1||Medicare|Insurance||Participants|Count of Participants|47|47.0||||||
3617794|NCT02705365|3467218|B3||Commercial|Insurance||Participants|Count of Participants|408|408.0||||||
3617795|NCT02705365|3467219|B2||Commercial|Insurance||Participants|Count of Participants|280|280.0||||||
3617796|NCT02705365|3467220|B1||Commercial|Insurance||Participants|Count of Participants|128|128.0||||||
3617797|NCT02705365|3467218|B3||Non-English|Language||Participants|Count of Participants|134|134.0||||||
3617798|NCT02705365|3467219|B2||Non-English|Language||Participants|Count of Participants|86|86.0||||||
3617799|NCT02705365|3467220|B1||Non-English|Language||Participants|Count of Participants|48|48.0||||||
3617800|NCT02705365|3467218|B3||English|Language||Participants|Count of Participants|1066|1066.0||||||
3617801|NCT02705365|3467219|B2||English|Language||Participants|Count of Participants|714|714.0||||||
3617802|NCT02705365|3467220|B1||English|Language||Participants|Count of Participants|352|352.0||||||
3617803|NCT02705365|3467218|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|977|977.0||||||
3617804|NCT02705365|3467219|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|666|666.0||||||
3617805|NCT02705365|3467220|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|311|311.0||||||
3617806|NCT02705365|3467218|B3|Other/Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|73|73.0||||||
3617807|NCT02705365|3467219|B2|Other/Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
3617808|NCT02705365|3467220|B1|Other/Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3617809|NCT02705365|3467218|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|67|67.0||||||
3617810|NCT02705365|3467219|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
3617811|NCT02705365|3467220|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3617812|NCT02705365|3467218|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
3617813|NCT02705365|3467219|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3617814|NCT02705365|3467220|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3617815|NCT02705365|3467218|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3617816|NCT02705365|3467219|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3617817|NCT02705365|3467220|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3617818|NCT02705365|3467218|B3||Male|Sex: Female, Male||Participants|Count of Participants|570|570.0||||||
3617819|NCT02705365|3467219|B2||Male|Sex: Female, Male||Participants|Count of Participants|358|358.0||||||
3617820|NCT02705365|3467220|B1||Male|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
3617821|NCT02705365|3467218|B3||Female|Sex: Female, Male||Participants|Count of Participants|630|630.0||||||
3617822|NCT02705365|3467219|B2||Female|Sex: Female, Male||Participants|Count of Participants|442|442.0||||||
3617823|NCT02705365|3467220|B1||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3617824|NCT02705365|3467218|B3|||Age||years|Mean|62.2|62.2|Standard Deviation|5.6|5.6|||
3617825|NCT02705365|3467219|B2|||Age||years|Mean|62.4|62.4|Standard Deviation|5.7|5.7|||
3617826|NCT02705365|3467220|B1|||Age||years|Mean|61.8|61.8|Standard Deviation|5.4|5.4|||
3617827|NCT02704702|3467229|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617828|NCT02704702|3467230|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617829|NCT02704702|3467231|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617830|NCT02704702|3467232|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617831|NCT02704702|3467233|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617832|NCT02704702|3467234|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617833|NCT02704702|3467235|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617834|NCT02704702|3467229|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617835|NCT02704702|3467230|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617836|NCT02704702|3467231|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617837|NCT02704702|3467232|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617838|NCT02704702|3467233|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617839|NCT02704702|3467234|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617840|NCT02704702|3467235|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617841|NCT02704702|3467229|B7||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3617842|NCT02704702|3467230|B6||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3617843|NCT02704702|3467231|B5||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3617844|NCT02704702|3467232|B4||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3617845|NCT02704702|3467233|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3617846|NCT02704702|3467234|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3617847|NCT02704702|3467235|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3617848|NCT02704702|3467229|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617849|NCT02704702|3467230|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617850|NCT02704702|3467231|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617851|NCT02704702|3467232|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617852|NCT02704702|3467233|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617853|NCT02704702|3467234|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617854|NCT02704702|3467235|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617855|NCT02704702|3467229|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617856|NCT02704702|3467230|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617857|NCT02704702|3467231|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617858|NCT02704702|3467232|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617859|NCT02704702|3467233|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617860|NCT02704702|3467234|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617861|NCT02704702|3467235|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617862|NCT02704702|3467229|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617863|NCT02704702|3467230|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617864|NCT02704702|3467231|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617865|NCT02704702|3467232|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617866|NCT02704702|3467233|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617867|NCT02704702|3467234|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617868|NCT02704702|3467235|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617869|NCT02704702|3467229|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617870|NCT02704702|3467230|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617871|NCT02704702|3467231|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617872|NCT02704702|3467232|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617873|NCT02704702|3467233|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617874|NCT02704702|3467234|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617875|NCT02704702|3467235|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617876|NCT02704702|3467229|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617877|NCT02704702|3467230|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617878|NCT02704702|3467231|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617938|NCT02704689|3467272|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617879|NCT02704702|3467232|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617880|NCT02704702|3467233|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617881|NCT02704702|3467234|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617882|NCT02704702|3467235|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617883|NCT02704702|3467229|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3617884|NCT02704702|3467230|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3617885|NCT02704702|3467231|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3617886|NCT02704702|3467232|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3617887|NCT02704702|3467233|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3617888|NCT02704702|3467234|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3617889|NCT02704702|3467235|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3617890|NCT02704702|3467229|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3617891|NCT02704702|3467230|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617892|NCT02704702|3467231|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617893|NCT02704702|3467232|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3617894|NCT02704702|3467233|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617895|NCT02704702|3467234|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3617896|NCT02704702|3467235|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617897|NCT02704702|3467229|B7||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3617898|NCT02704702|3467230|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3617899|NCT02704702|3467231|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3617900|NCT02704702|3467232|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3617901|NCT02704702|3467233|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3617902|NCT02704702|3467234|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3617903|NCT02704702|3467235|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3617904|NCT02704702|3467229|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3617905|NCT02704702|3467230|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3617906|NCT02704702|3467231|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3617907|NCT02704702|3467232|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3617908|NCT02704702|3467233|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3617909|NCT02704702|3467234|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3617910|NCT02704702|3467235|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3617911|NCT02704702|3467229|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3617912|NCT02704702|3467230|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3617913|NCT02704702|3467231|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3617914|NCT02704702|3467232|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3617915|NCT02704702|3467233|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3617916|NCT02704702|3467234|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3617917|NCT02704702|3467235|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3617918|NCT02704702|3467229|B7||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3617919|NCT02704702|3467230|B6||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3617920|NCT02704702|3467231|B5||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3617921|NCT02704702|3467232|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3617922|NCT02704702|3467233|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3617923|NCT02704702|3467234|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3617924|NCT02704702|3467235|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3617925|NCT02704702|3467229|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3617926|NCT02704702|3467230|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3617927|NCT02704702|3467231|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3617928|NCT02704702|3467232|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3617929|NCT02704702|3467233|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3617930|NCT02704702|3467234|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3617931|NCT02704702|3467235|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3617932|NCT02704689|3467272|B1|||BMI||kg/m2|Mean|32|32.0|Standard Deviation|5.4|5.4|||
3617933|NCT02704689|3467272|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617934|NCT02704689|3467272|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617935|NCT02704689|3467272|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3617936|NCT02704689|3467272|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3617937|NCT02704689|3467272|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617939|NCT02704689|3467272|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617940|NCT02704689|3467272|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617941|NCT02704689|3467272|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3617942|NCT02704689|3467272|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3617943|NCT02704689|3467272|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3617944|NCT02704689|3467272|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3617945|NCT02704689|3467272|B1|||Age||years|Mean|55|55.0|Standard Deviation|12.1|12.1|||
3617946|NCT02704104|3467289|B1|||Antiplatelet therapy||Participants|Count of Participants|10|10.0||||||
3617947|NCT02704104|3467289|B1|Ireland||Region of Enrollment||participants|Number|46|46.0||||||
3617948|NCT02704104|3467289|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617949|NCT02704104|3467289|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617950|NCT02704104|3467289|B1||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3617951|NCT02704104|3467289|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3617952|NCT02704104|3467289|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617953|NCT02704104|3467289|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617954|NCT02704104|3467289|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617955|NCT02704104|3467289|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3617956|NCT02704104|3467289|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3617957|NCT02704104|3467289|B1|||Age||years|Mean|57|57.0|Standard Deviation|15.5|15.5|||
3617958|NCT02703948|3467303|B1|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3617959|NCT02703948|3467303|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3617960|NCT02703948|3467303|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617961|NCT02703948|3467303|B1||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3617962|NCT02703948|3467303|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3617963|NCT02703948|3467303|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3617964|NCT02703948|3467303|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3617965|NCT02703948|3467303|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3617966|NCT02703948|3467303|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617967|NCT02703948|3467303|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3617968|NCT02703948|3467303|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3617969|NCT02703948|3467303|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3617970|NCT02703948|3467303|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3617971|NCT02703948|3467303|B1|||Age||years|Mean|46.5|46.5|Standard Deviation|14.1|14.1|||
3617972|NCT02703909|3467307|B5|United States||Region of Enrollment||participants|Number|144|144.0||||||
3617973|NCT02703909|3467308|B4|United States||Region of Enrollment||participants|Number|35|35.0||||||
3617974|NCT02703909|3467309|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
3617975|NCT02703909|3467310|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
3617976|NCT02703909|3467311|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
3617977|NCT02703909|3467307|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617978|NCT02703909|3467308|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617979|NCT02703909|3467309|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617980|NCT02703909|3467310|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617981|NCT02703909|3467311|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617982|NCT02703909|3467307|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617983|NCT02703909|3467308|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617984|NCT02703909|3467309|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617985|NCT02703909|3467310|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617986|NCT02703909|3467311|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617987|NCT02703909|3467307|B5||White|Race (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
3617988|NCT02703909|3467308|B4||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3617989|NCT02703909|3467309|B3||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3617990|NCT02703909|3467310|B2||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3617991|NCT02703909|3467311|B1||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3617992|NCT02703909|3467307|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3617993|NCT02703909|3467308|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3617994|NCT02703909|3467309|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3617995|NCT02703909|3467310|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3617996|NCT02703909|3467311|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3617997|NCT02703909|3467307|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617998|NCT02703909|3467308|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3617999|NCT02703909|3467309|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618000|NCT02703909|3467310|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618001|NCT02703909|3467311|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618002|NCT02703909|3467307|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618003|NCT02703909|3467308|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618004|NCT02703909|3467309|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618005|NCT02703909|3467310|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618006|NCT02703909|3467311|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618007|NCT02703909|3467307|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618008|NCT02703909|3467308|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618009|NCT02703909|3467309|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618010|NCT02703909|3467310|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618011|NCT02703909|3467311|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618012|NCT02703909|3467307|B5||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3618013|NCT02703909|3467308|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3618014|NCT02703909|3467309|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3618015|NCT02703909|3467310|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3618016|NCT02703909|3467311|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3618017|NCT02703909|3467307|B5||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3618018|NCT02703909|3467308|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3618019|NCT02703909|3467309|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3618020|NCT02703909|3467310|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3618021|NCT02703909|3467311|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3618022|NCT02703909|3467307|B5|||Age||years|Mean|45|45.0|Standard Deviation|11|11.0|||
3618023|NCT02703909|3467308|B4|||Age||years|Mean|44|44.0|Standard Deviation|11|11.0|||
3618024|NCT02703909|3467309|B3|||Age||years|Mean|50|50.0|Standard Deviation|12|12.0|||
3618025|NCT02703909|3467310|B2|||Age||years|Mean|43|43.0|Standard Deviation|11|11.0|||
3618026|NCT02703909|3467311|B1|||Age||years|Mean|42|42.0|Standard Deviation|8|8.0|||
3618027|NCT02702999|3467330|B3|||Gestational Age at Randomization||weeks|Mean|29.1|29.1|Standard Deviation|1.1|1.1|||
3618028|NCT02702999|3467331|B2|||Gestational Age at Randomization||weeks|Mean|29.0|29.0|Standard Deviation|1.1|1.1|||
3618029|NCT02702999|3467332|B1|||Gestational Age at Randomization||weeks|Mean|29.2|29.2|Standard Deviation|1.0|1.0|||
3618030|NCT02702999|3467330|B3|||Time of first ultrasound exam||weeks|Mean|12.9|12.9|Standard Deviation|4.3|4.3|||
3618031|NCT02702999|3467331|B2|||Time of first ultrasound exam||weeks|Mean|12.9|12.9|Standard Deviation|4.3|4.3|||
3618032|NCT02702999|3467332|B1|||Time of first ultrasound exam||weeks|Mean|12.9|12.9|Standard Deviation|4.3|4.3|||
3618033|NCT02702999|3467330|B3||30 to 39.9 kg/m^2|Body Mass Index (BMI) at first prenatal visit||Participants|Count of Participants|55|55.0||||||
3618034|NCT02702999|3467331|B2||30 to 39.9 kg/m^2|Body Mass Index (BMI) at first prenatal visit||Participants|Count of Participants|27|27.0||||||
3618035|NCT02702999|3467332|B1||30 to 39.9 kg/m^2|Body Mass Index (BMI) at first prenatal visit||Participants|Count of Participants|28|28.0||||||
3618036|NCT02702999|3467330|B3||less than 30 kg/m^2|Body Mass Index (BMI) at first prenatal visit||Participants|Count of Participants|151|151.0||||||
3618037|NCT02702999|3467331|B2||less than 30 kg/m^2|Body Mass Index (BMI) at first prenatal visit||Participants|Count of Participants|77|77.0||||||
3618038|NCT02702999|3467332|B1||less than 30 kg/m^2|Body Mass Index (BMI) at first prenatal visit||Participants|Count of Participants|74|74.0||||||
3618039|NCT02702999|3467330|B3||Private Insurance|Insurance||Participants|Count of Participants|71|71.0||||||
3618040|NCT02702999|3467331|B2||Private Insurance|Insurance||Participants|Count of Participants|35|35.0||||||
3618041|NCT02702999|3467332|B1||Private Insurance|Insurance||Participants|Count of Participants|36|36.0||||||
3618042|NCT02702999|3467330|B3||Medicaid|Insurance||Participants|Count of Participants|135|135.0||||||
3618043|NCT02702999|3467331|B2||Medicaid|Insurance||Participants|Count of Participants|69|69.0||||||
3618044|NCT02702999|3467332|B1||Medicaid|Insurance||Participants|Count of Participants|66|66.0||||||
3618045|NCT02702999|3467330|B3|||Nulliparity (never given birth)||Participants|Count of Participants|82|82.0||||||
3618046|NCT02702999|3467331|B2|||Nulliparity (never given birth)||Participants|Count of Participants|39|39.0||||||
3618047|NCT02702999|3467332|B1|||Nulliparity (never given birth)||Participants|Count of Participants|43|43.0||||||
3618048|NCT02702999|3467330|B3|United States||Region of Enrollment||Participants|Count of Participants|206|206.0||||||
3618049|NCT02702999|3467331|B2|United States||Region of Enrollment||Participants|Count of Participants|104|104.0||||||
3618050|NCT02702999|3467332|B1|United States||Region of Enrollment||Participants|Count of Participants|102|102.0||||||
3618051|NCT02702999|3467330|B3|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
3618052|NCT02702999|3467331|B2|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3618053|NCT02702999|3467332|B1|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3618054|NCT02702999|3467330|B3|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3618055|NCT02702999|3467331|B2|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3618056|NCT02702999|3467332|B1|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3618057|NCT02702999|3467330|B3|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
3618058|NCT02702999|3467331|B2|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3618059|NCT02702999|3467332|B1|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3618060|NCT02702999|3467330|B3|Race/Ethnicity|Black|Race/Ethnicity, Customized||Participants|Count of Participants|66|66.0||||||
3618061|NCT02702999|3467331|B2|Race/Ethnicity|Black|Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3618062|NCT02702999|3467332|B1|Race/Ethnicity|Black|Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3618063|NCT02702999|3467330|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3618064|NCT02702999|3467331|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3618065|NCT02702999|3467332|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3618066|NCT02702999|3467330|B3||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
3618067|NCT02702999|3467331|B2||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3618068|NCT02702999|3467332|B1||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3618069|NCT02702999|3467330|B3||greater than or equal to 35 years old|Age, Customized||Participants|Count of Participants|22|22.0||||||
3618070|NCT02702999|3467331|B2||greater than or equal to 35 years old|Age, Customized||Participants|Count of Participants|12|12.0||||||
3618071|NCT02702999|3467332|B1||greater than or equal to 35 years old|Age, Customized||Participants|Count of Participants|10|10.0||||||
3618072|NCT02702999|3467330|B3||20 to 34 years old|Age, Customized||Participants|Count of Participants|169|169.0||||||
3618073|NCT02702999|3467331|B2||20 to 34 years old|Age, Customized||Participants|Count of Participants|82|82.0||||||
3618074|NCT02702999|3467332|B1||20 to 34 years old|Age, Customized||Participants|Count of Participants|87|87.0||||||
3618075|NCT02702999|3467330|B3||less than 20 years old|Age, Customized||Participants|Count of Participants|15|15.0||||||
3618076|NCT02702999|3467331|B2||less than 20 years old|Age, Customized||Participants|Count of Participants|10|10.0||||||
3618077|NCT02702999|3467332|B1||less than 20 years old|Age, Customized||Participants|Count of Participants|5|5.0||||||
3618078|NCT02702921|3467349|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3618079|NCT02702921|3467350|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618080|NCT02702921|3467351|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618081|NCT02702921|3467349|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618082|NCT02702921|3467350|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618083|NCT02702921|3467351|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618084|NCT02702921|3467349|B3||White|Race (NIH/OMB)||Participants|Count of Participants|192|192.0||||||
3618085|NCT02702921|3467350|B2||White|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3618086|NCT02702921|3467351|B1||White|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3618087|NCT02702921|3467349|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3618088|NCT02702921|3467350|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3618089|NCT02702921|3467351|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3618090|NCT02702921|3467349|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618091|NCT02702921|3467350|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618092|NCT02702921|3467351|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618093|NCT02702921|3467349|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618094|NCT02702921|3467350|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618095|NCT02702921|3467351|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618096|NCT02702921|3467349|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618097|NCT02702921|3467350|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618098|NCT02702921|3467351|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618099|NCT02702921|3467349|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3618100|NCT02702921|3467350|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3618101|NCT02702921|3467351|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3618102|NCT02702921|3467349|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|136|136.0||||||
3618103|NCT02702921|3467350|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3618104|NCT02702921|3467351|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3618105|NCT02702921|3467349|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3618106|NCT02702921|3467350|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3618107|NCT02702921|3467351|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3618108|NCT02702921|3467349|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3618109|NCT02702921|3467350|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3618110|NCT02702921|3467351|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3618111|NCT02702921|3467349|B3||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3618112|NCT02702921|3467350|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3618113|NCT02702921|3467351|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3618114|NCT02702921|3467349|B3|||Age|Participant Age in Years|Years|Mean|68.0|68.0|Standard Deviation|9.0|9.0|||
3618115|NCT02702921|3467350|B2|||Age|Participant Age in Years|Years|Mean|68.0|68.0|Standard Deviation|9.0|9.0|||
3618116|NCT02702921|3467351|B1|||Age|Participant Age in Years|Years|Mean|68.2|68.2|Standard Deviation|9.1|9.1|||
3618117|NCT02702193|3467360|B3|Race/Ethnicity|White Non Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3618118|NCT02702193|3467361|B2|Race/Ethnicity|White Non Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3618119|NCT02702193|3467362|B1|Race/Ethnicity|White Non Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3618120|NCT02702193|3467360|B3|Race/Ethnicity|Black|Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3618121|NCT02702193|3467361|B2|Race/Ethnicity|Black|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3618122|NCT02702193|3467362|B1|Race/Ethnicity|Black|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3618123|NCT02702193|3467360|B3|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|137|137.0||||||
3618124|NCT02702193|3467361|B2|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|72|72.0||||||
3618125|NCT02702193|3467362|B1|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|65|65.0||||||
3618126|NCT02702193|3467360|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3618127|NCT02702193|3467361|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3618128|NCT02702193|3467362|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3618129|NCT02702193|3467360|B3||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3618130|NCT02702193|3467361|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3618131|NCT02702193|3467362|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3618132|NCT02702193|3467360|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3618133|NCT02702193|3467361|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3618134|NCT02702193|3467362|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3618135|NCT02702193|3467360|B3||Between 18 and 65 years|Age||Participants|Count of Participants|172|172.0||||||
3618136|NCT02702193|3467361|B2||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
3618137|NCT02702193|3467362|B1||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
3618138|NCT02702193|3467360|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3618139|NCT02702193|3467361|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3618140|NCT02702193|3467362|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3618141|NCT02702011|3467387|B5||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3618142|NCT02702011|3467388|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3618143|NCT02702011|3467389|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3618144|NCT02702011|3467390|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3618145|NCT02702011|3467391|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3618146|NCT02702011|3467387|B5||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3618147|NCT02702011|3467388|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3618148|NCT02702011|3467389|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3618149|NCT02702011|3467390|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3618150|NCT02702011|3467391|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3618151|NCT02702011|3467387|B5|||Age||Years|Mean|44.8|44.8|Standard Deviation|11.4|11.4|||
3618152|NCT02702011|3467388|B4|||Age||Years|Mean|46.6|46.6|Standard Deviation|10.8|10.8|||
3618153|NCT02702011|3467389|B3|||Age||Years|Mean|44.5|44.5|Standard Deviation|11.8|11.8|||
3618154|NCT02702011|3467390|B2|||Age||Years|Mean|44.2|44.2|Standard Deviation|12.6|12.6|||
3618155|NCT02702011|3467391|B1|||Age||Years|Mean|43.9|43.9|Standard Deviation|11.7|11.7|||
3618156|NCT02701985|3467404|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618157|NCT02701985|3467405|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618158|NCT02701985|3467406|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618159|NCT02701985|3467404|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618160|NCT02701985|3467405|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618161|NCT02701985|3467406|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618162|NCT02701985|3467404|B3||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3618163|NCT02701985|3467405|B2||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3618164|NCT02701985|3467406|B1||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3618165|NCT02701985|3467404|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3618166|NCT02701985|3467405|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3618167|NCT02701985|3467406|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3618168|NCT02701985|3467404|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618169|NCT02701985|3467405|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618170|NCT02701985|3467406|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618171|NCT02701985|3467404|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3618172|NCT02701985|3467405|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618173|NCT02701985|3467406|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618174|NCT02701985|3467404|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618175|NCT02701985|3467405|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618176|NCT02701985|3467406|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618177|NCT02701985|3467404|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618178|NCT02701985|3467405|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618179|NCT02701985|3467406|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618180|NCT02701985|3467404|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3618181|NCT02701985|3467405|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3618182|NCT02701985|3467406|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3618183|NCT02701985|3467404|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3618184|NCT02701985|3467405|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618185|NCT02701985|3467406|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3618186|NCT02701985|3467404|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3618187|NCT02701985|3467405|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3618188|NCT02701985|3467406|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3618189|NCT02701985|3467404|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3618190|NCT02701985|3467405|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3618191|NCT02701985|3467406|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3618192|NCT02701985|3467404|B3|||Age||years|Mean|52.2|52.2|Standard Deviation|12.5|12.5|||
3618193|NCT02701985|3467405|B2|||Age||years|Mean|52.1|52.1|Standard Deviation|13.2|13.2|||
3618194|NCT02701985|3467406|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|11.8|11.8|||
3618195|NCT02701634|3467448|B3|Canada||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3618196|NCT02701634|3467449|B2|Canada||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3618197|NCT02701634|3467450|B1|Canada||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3618198|NCT02701634|3467448|B3|South Korea||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3618199|NCT02701634|3467449|B2|South Korea||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3618200|NCT02701634|3467450|B1|South Korea||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3618201|NCT02701634|3467448|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3618202|NCT02701634|3467449|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3618203|NCT02701634|3467450|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3618204|NCT02701634|3467448|B3|France||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3618205|NCT02701634|3467449|B2|France||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3618206|NCT02701634|3467450|B1|France||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3618207|NCT02701634|3467448|B3|Germany||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3618208|NCT02701634|3467449|B2|Germany||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3618209|NCT02701634|3467450|B1|Germany||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3618210|NCT02701634|3467448|B3|Spain||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3618211|NCT02701634|3467449|B2|Spain||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3618212|NCT02701634|3467450|B1|Spain||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3618213|NCT02701634|3467448|B3|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3618214|NCT02701634|3467449|B2|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3618215|NCT02701634|3467450|B1|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3618216|NCT02701634|3467448|B3|Race/Ethnicity, Customized|Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3618217|NCT02701634|3467449|B2|Race/Ethnicity, Customized|Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3618218|NCT02701634|3467450|B1|Race/Ethnicity, Customized|Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3618219|NCT02701634|3467448|B3|Race/Ethnicity, Customized|Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3618220|NCT02701634|3467449|B2|Race/Ethnicity, Customized|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3618221|NCT02701634|3467450|B1|Race/Ethnicity, Customized|Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3618279|NCT02701361|3467495|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3618222|NCT02701634|3467448|B3|Race/Ethnicity, Customized|White|Race/Ethnicity, Customized||Participants|Count of Participants|52|52.0||||||
3618223|NCT02701634|3467449|B2|Race/Ethnicity, Customized|White|Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3618224|NCT02701634|3467450|B1|Race/Ethnicity, Customized|White|Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3618225|NCT02701634|3467448|B3|Race/Ethnicity, Customized|Black|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3618226|NCT02701634|3467449|B2|Race/Ethnicity, Customized|Black|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3618227|NCT02701634|3467450|B1|Race/Ethnicity, Customized|Black|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3618228|NCT02701634|3467448|B3|Race/Ethnicity, Customized|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3618229|NCT02701634|3467449|B2|Race/Ethnicity, Customized|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3618230|NCT02701634|3467450|B1|Race/Ethnicity, Customized|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3618231|NCT02701634|3467448|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3618232|NCT02701634|3467449|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3618233|NCT02701634|3467450|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3618234|NCT02701634|3467448|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3618235|NCT02701634|3467449|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3618236|NCT02701634|3467450|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3618237|NCT02701634|3467448|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3618238|NCT02701634|3467449|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3618239|NCT02701634|3467450|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618240|NCT02701634|3467448|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3618241|NCT02701634|3467449|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3618242|NCT02701634|3467450|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3618243|NCT02701634|3467448|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3618244|NCT02701634|3467449|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3618245|NCT02701634|3467450|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3618246|NCT02701634|3467448|B3|||Age||years|Mean|54|54.0|Standard Deviation|12.2|12.2|||
3618247|NCT02701634|3467449|B2|||Age||years|Mean|58|58.0|Standard Deviation|11.4|11.4|||
3618248|NCT02701634|3467450|B1|||Age||years|Mean|51|51.0|Standard Deviation|11.9|11.9|||
3618249|NCT02701556|3467479|B3|United States||Region of Enrollment||participants|Number|792|792.0||||||
3618250|NCT02701556|3467480|B2|United States||Region of Enrollment||participants|Number|396|396.0||||||
3618251|NCT02701556|3467481|B1|United States||Region of Enrollment||participants|Number|396|396.0||||||
3618252|NCT02701556|3467479|B3||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3618253|NCT02701556|3467480|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3618254|NCT02701556|3467481|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3618255|NCT02701556|3467479|B3||Female|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
3618256|NCT02701556|3467480|B2||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3618257|NCT02701556|3467481|B1||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3618258|NCT02701556|3467479|B3|||Age||years|Mean|33.5|33.5|Standard Deviation|9.4|9.4|||
3618259|NCT02701556|3467480|B2|||Age||years|Mean|33.7|33.7|Standard Deviation|8.9|8.9|||
3618260|NCT02701556|3467481|B1|||Age||years|Mean|33.2|33.2|Standard Deviation|10|10.0|||
3618261|NCT02701387|3467488|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3618262|NCT02701387|3467488|B1||Male|Gender||Participants|Count of Participants|7|7.0||||||
3618263|NCT02701387|3467488|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3618264|NCT02701387|3467488|B1|||Age||years|Mean|60.4|60.4|Full Range|||47.0|72.0|
3618265|NCT02701361|3467493|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618266|NCT02701361|3467494|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618267|NCT02701361|3467495|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618268|NCT02701361|3467496|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618269|NCT02701361|3467493|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618270|NCT02701361|3467494|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618271|NCT02701361|3467495|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618272|NCT02701361|3467496|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618273|NCT02701361|3467493|B4||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3618274|NCT02701361|3467494|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3618275|NCT02701361|3467495|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3618276|NCT02701361|3467496|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3618277|NCT02701361|3467493|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3618278|NCT02701361|3467494|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3618280|NCT02701361|3467496|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3618281|NCT02701361|3467493|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3618282|NCT02701361|3467494|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618283|NCT02701361|3467495|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618284|NCT02701361|3467496|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618285|NCT02701361|3467493|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618286|NCT02701361|3467494|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618287|NCT02701361|3467495|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618288|NCT02701361|3467496|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618289|NCT02701361|3467493|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3618290|NCT02701361|3467494|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3618291|NCT02701361|3467495|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618292|NCT02701361|3467496|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3618293|NCT02701361|3467493|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618294|NCT02701361|3467494|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618295|NCT02701361|3467495|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618296|NCT02701361|3467496|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618297|NCT02701361|3467493|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3618298|NCT02701361|3467494|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3618299|NCT02701361|3467495|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3618300|NCT02701361|3467496|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3618301|NCT02701361|3467493|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618302|NCT02701361|3467494|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618303|NCT02701361|3467495|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618304|NCT02701361|3467496|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618305|NCT02701361|3467493|B4||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3618306|NCT02701361|3467494|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3618307|NCT02701361|3467495|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3618308|NCT02701361|3467496|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3618309|NCT02701361|3467493|B4||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3618310|NCT02701361|3467494|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3618311|NCT02701361|3467495|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3618312|NCT02701361|3467496|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3618313|NCT02701361|3467493|B4|||Age||years|Mean|49.5|49.5|Standard Deviation|15.1|15.1|||
3618314|NCT02701361|3467494|B3|||Age||years|Mean|53.3|53.3|Standard Deviation|12.6|12.6|||
3618315|NCT02701361|3467495|B2|||Age||years|Mean|48.1|48.1|Standard Deviation|16.1|16.1|||
3618316|NCT02701361|3467496|B1|||Age||years|Mean|48.7|48.7|Standard Deviation|15.3|15.3|||
3618317|NCT02701296|3467537|B3|United States||Region of Enrollment||participants|Number|78|78.0||||||
3618318|NCT02701296|3467538|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
3618319|NCT02701296|3467539|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
3618320|NCT02701296|3467537|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3618321|NCT02701296|3467538|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3618322|NCT02701296|3467539|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3618323|NCT02701296|3467537|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3618324|NCT02701296|3467538|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3618325|NCT02701296|3467539|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3618326|NCT02701296|3467537|B3|||Age||Years|Mean|64.8|64.8|Standard Deviation|8.43|8.43|||
3618327|NCT02701296|3467538|B2|||Age||Years|Mean|63.5|63.5|Standard Deviation|8.9|8.9|||
3618328|NCT02701296|3467539|B1|||Age||Years|Mean|65.9|65.9|Standard Deviation|8.0|8.0|||
3618329|NCT02701270|3467556|B1|||Body Mass Index||kg/m^2|Mean|23.8|23.8|Standard Deviation|0.62|0.62|||
3618330|NCT02701270|3467556|B1|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
3618331|NCT02701270|3467556|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3618332|NCT02701270|3467556|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3618333|NCT02701270|3467556|B1|||Age||years|Mean|44.09|44.09|Standard Deviation|2.56|2.56|||
3618334|NCT02701270|3467556|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3618335|NCT02701270|3467556|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3618336|NCT02701270|3467556|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3618337|NCT02701049|3467573|B4|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3618338|NCT02701049|3467574|B3|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3618339|NCT02701049|3467575|B2|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3618340|NCT02701049|3467576|B1|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3618341|NCT02701049|3467573|B4|Declined||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3618342|NCT02701049|3467574|B3|Declined||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3618343|NCT02701049|3467575|B2|Declined||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3618344|NCT02701049|3467576|B1|Declined||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3618345|NCT02701049|3467573|B4|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3618346|NCT02701049|3467574|B3|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3618347|NCT02701049|3467575|B2|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3618348|NCT02701049|3467576|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3618349|NCT02701049|3467573|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3618350|NCT02701049|3467574|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3618351|NCT02701049|3467575|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3618352|NCT02701049|3467576|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3618353|NCT02701049|3467573|B4|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|72|72.0||||||
3618354|NCT02701049|3467574|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3618355|NCT02701049|3467575|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3618356|NCT02701049|3467576|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3618357|NCT02701049|3467573|B4|Native Hawaiian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3618358|NCT02701049|3467574|B3|Native Hawaiian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3618359|NCT02701049|3467575|B2|Native Hawaiian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3618360|NCT02701049|3467576|B1|Native Hawaiian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3618361|NCT02701049|3467573|B4|American Indian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3618362|NCT02701049|3467574|B3|American Indian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3618363|NCT02701049|3467575|B2|American Indian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3618364|NCT02701049|3467576|B1|American Indian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3618365|NCT02701049|3467573|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3618366|NCT02701049|3467574|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3618367|NCT02701049|3467575|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3618368|NCT02701049|3467576|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3618369|NCT02701049|3467573|B4|Black||Race/Ethnicity, Customized||Participants|Count of Participants|341|341.0||||||
3618370|NCT02701049|3467574|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|85|85.0||||||
3618371|NCT02701049|3467575|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|178|178.0||||||
3618372|NCT02701049|3467576|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|78|78.0||||||
3618373|NCT02701049|3467573|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|269|269.0||||||
3618374|NCT02701049|3467574|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|77|77.0||||||
3618375|NCT02701049|3467575|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|123|123.0||||||
3618376|NCT02701049|3467576|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|69|69.0||||||
3618377|NCT02701049|3467573|B4|Unavailable/Not Asked||Sex/Gender, Customized||Participants|Count of Participants|193|193.0||||||
3618378|NCT02701049|3467574|B3|Unavailable/Not Asked||Sex/Gender, Customized||Participants|Count of Participants|74|74.0||||||
3618379|NCT02701049|3467575|B2|Unavailable/Not Asked||Sex/Gender, Customized||Participants|Count of Participants|114|114.0||||||
3618380|NCT02701049|3467576|B1|Unavailable/Not Asked||Sex/Gender, Customized||Participants|Count of Participants|5|5.0||||||
3618381|NCT02701049|3467573|B4|Other||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3618382|NCT02701049|3467574|B3|Other||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3618383|NCT02701049|3467575|B2|Other||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3618384|NCT02701049|3467576|B1|Other||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3618385|NCT02701049|3467573|B4|Declined to State||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3618386|NCT02701049|3467574|B3|Declined to State||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3618387|NCT02701049|3467575|B2|Declined to State||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3618388|NCT02701049|3467576|B1|Declined to State||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3618389|NCT02701049|3467573|B4|Questioning/Unsure||Sex/Gender, Customized||Participants|Count of Participants|1|1.0||||||
3618390|NCT02701049|3467574|B3|Questioning/Unsure||Sex/Gender, Customized||Participants|Count of Participants|1|1.0||||||
3618391|NCT02701049|3467575|B2|Questioning/Unsure||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3618392|NCT02701049|3467576|B1|Questioning/Unsure||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3618393|NCT02701049|3467573|B4|Queer/Genderqueer||Sex/Gender, Customized||Participants|Count of Participants|1|1.0||||||
3618394|NCT02701049|3467574|B3|Queer/Genderqueer||Sex/Gender, Customized||Participants|Count of Participants|1|1.0||||||
3618395|NCT02701049|3467575|B2|Queer/Genderqueer||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3618396|NCT02701049|3467576|B1|Queer/Genderqueer||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3618397|NCT02701049|3467573|B4|Transgender Female to Male||Sex/Gender, Customized||Participants|Count of Participants|5|5.0||||||
3618398|NCT02701049|3467574|B3|Transgender Female to Male||Sex/Gender, Customized||Participants|Count of Participants|2|2.0||||||
3618399|NCT02701049|3467575|B2|Transgender Female to Male||Sex/Gender, Customized||Participants|Count of Participants|3|3.0||||||
3618400|NCT02701049|3467576|B1|Transgender Female to Male||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3618401|NCT02701049|3467573|B4|Transgender Male to Female||Sex/Gender, Customized||Participants|Count of Participants|2|2.0||||||
3618402|NCT02701049|3467574|B3|Transgender Male to Female||Sex/Gender, Customized||Participants|Count of Participants|1|1.0||||||
3618403|NCT02701049|3467575|B2|Transgender Male to Female||Sex/Gender, Customized||Participants|Count of Participants|1|1.0||||||
3618404|NCT02701049|3467576|B1|Transgender Male to Female||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3618405|NCT02701049|3467573|B4|Female||Sex/Gender, Customized||Participants|Count of Participants|341|341.0||||||
3618406|NCT02701049|3467574|B3|Female||Sex/Gender, Customized||Participants|Count of Participants|85|85.0||||||
3618407|NCT02701049|3467575|B2|Female||Sex/Gender, Customized||Participants|Count of Participants|149|149.0||||||
3618408|NCT02701049|3467576|B1|Female||Sex/Gender, Customized||Participants|Count of Participants|107|107.0||||||
3618409|NCT02701049|3467573|B4|Male||Sex/Gender, Customized||Participants|Count of Participants|204|204.0||||||
3618410|NCT02701049|3467574|B3|Male||Sex/Gender, Customized||Participants|Count of Participants|32|32.0||||||
3618411|NCT02701049|3467575|B2|Male||Sex/Gender, Customized||Participants|Count of Participants|75|75.0||||||
3618412|NCT02701049|3467576|B1|Male||Sex/Gender, Customized||Participants|Count of Participants|97|97.0||||||
3618413|NCT02701049|3467573|B4|Age||Age, Customized||years|Mean|39.3|39.3|Standard Deviation|15.2|15.2|||
3618414|NCT02701049|3467574|B3|Age||Age, Customized||years|Mean|33|33.0|Standard Deviation|12.3|12.3|||
3618415|NCT02701049|3467575|B2|Age||Age, Customized||years|Mean|38.5|38.5|Standard Deviation|13.5|13.5|||
3618416|NCT02701049|3467576|B1|Age||Age, Customized||years|Mean|48|48.0|Standard Deviation|17.2|17.2|||
3618417|NCT02700997|3467590|B1|||BMI||kg/m^2|Median|28|28.0|Full Range|||21.8|43.9|
3618418|NCT02700997|3467590|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3618419|NCT02700997|3467590|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618420|NCT02700997|3467590|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618421|NCT02700997|3467590|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3618422|NCT02700997|3467590|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618423|NCT02700997|3467590|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618424|NCT02700997|3467590|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618425|NCT02700997|3467590|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618426|NCT02700997|3467590|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3618427|NCT02700997|3467590|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3618428|NCT02700997|3467590|B1|||Age||years|Mean|58.1|58.1|Standard Deviation|14.2|14.2|||
3618429|NCT02699892|3467594|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3618430|NCT02699892|3467594|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3618431|NCT02699892|3467594|B1|||Age||Years|Mean|51.28|51.28|Standard Deviation|11.75|11.75|||
3618432|NCT02699684|3467599|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3618433|NCT02699684|3467599|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3618434|NCT02699684|3467599|B1|||Age||years|Mean|35.7|35.7|Standard Deviation|10.30|10.3|||
3618435|NCT02699632|3467610|B1|United States||Region of Enrollment||Participants|Count of Participants|360|360.0||||||
3618436|NCT02699632|3467610|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3618437|NCT02699632|3467610|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3618438|NCT02699632|3467610|B1||White|Race (NIH/OMB)||Participants|Count of Participants|286|286.0||||||
3618439|NCT02699632|3467610|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3618440|NCT02699632|3467610|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618441|NCT02699632|3467610|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3618442|NCT02699632|3467610|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618443|NCT02699632|3467610|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3618444|NCT02699632|3467610|B1||Female|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
3618445|NCT02699632|3467610|B1|>45 years||Age, Customized||Participants|Count of Participants|8|8.0||||||
3618446|NCT02699632|3467610|B1|31-45 years||Age, Customized||Participants|Count of Participants|182|182.0||||||
3618447|NCT02699632|3467610|B1|26-30 years||Age, Customized||Participants|Count of Participants|123|123.0||||||
3618448|NCT02699632|3467610|B1|21-25 years||Age, Customized||Participants|Count of Participants|42|42.0||||||
3618449|NCT02699632|3467610|B1|18-20 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
3618450|NCT02699593|3467617|B1|North America||Region of Enrollment||Participants|Number|141|141.0||||||
3618451|NCT02699593|3467617|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3618452|NCT02699593|3467617|B1|White||Race/Ethnicity, Customized||Participants|Number|111|111.0||||||
3618453|NCT02699593|3467617|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3618454|NCT02699593|3467617|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
3618455|NCT02699593|3467617|B1|Asian||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3618456|NCT02699593|3467617|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3618457|NCT02699593|3467617|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3618458|NCT02699593|3467617|B1|||Age||Years|Mean|31.0|31.0|Standard Deviation|8.96|8.96|||
3618459|NCT02698566|3467626|B1|Unknown||Sex/Gender, Customized|Gender information was not collected for this study.|patients|Number|35|35.0||||||
3618460|NCT02698566|3467626|B1|Male||Sex/Gender, Customized|Gender information was not collected for this study.|patients|Number|0|0.0||||||
3618461|NCT02698566|3467626|B1|Female||Sex/Gender, Customized|Gender information was not collected for this study.|patients|Number|0|0.0||||||
3618462|NCT02698566|3467626|B1|||Age||years|Mean|78.3|78.3|Standard Deviation|6.8|6.8|||
3618463|NCT02698436|3467633|B3|USA||Region of Enrollment||participants|Number|117|117.0||||||
3618464|NCT02698436|3467634|B2|USA||Region of Enrollment||participants|Number|58|58.0||||||
3618465|NCT02698436|3467635|B1|USA||Region of Enrollment||participants|Number|59|59.0||||||
3618466|NCT02698436|3467633|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3618467|NCT02698436|3467634|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3618468|NCT02698436|3467635|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3618469|NCT02698436|3467633|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3618470|NCT02698436|3467634|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3618471|NCT02698436|3467635|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3618472|NCT02698436|3467633|B3|||Age||years|Mean|18.2|18.2|Standard Deviation|5.87|5.87|||
3618473|NCT02698436|3467634|B2|||Age||years|Mean|18.7|18.7|Standard Deviation|5.97|5.97|||
3618474|NCT02698436|3467635|B1|||Age||years|Mean|17.8|17.8|Standard Deviation|5.79|5.79|||
3618475|NCT02698423|3467674|B3||Single|Relationship Status||Participants|Count of Participants|352|352.0||||||
3618476|NCT02698423|3467675|B2||Single|Relationship Status||Participants|Count of Participants|177|177.0||||||
3618477|NCT02698423|3467676|B1||Single|Relationship Status||Participants|Count of Participants|175|175.0||||||
3618478|NCT02698423|3467674|B3||With a partner|Relationship Status||Participants|Count of Participants|315|315.0||||||
3618479|NCT02698423|3467675|B2||With a partner|Relationship Status||Participants|Count of Participants|154|154.0||||||
3618480|NCT02698423|3467676|B1||With a partner|Relationship Status||Participants|Count of Participants|161|161.0||||||
3618481|NCT02698423|3467674|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618482|NCT02698423|3467675|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618483|NCT02698423|3467676|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618484|NCT02698423|3467674|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|456|456.0||||||
3618485|NCT02698423|3467675|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|225|225.0||||||
3618486|NCT02698423|3467676|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|231|231.0||||||
3618487|NCT02698423|3467674|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|211|211.0||||||
3618488|NCT02698423|3467675|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
3618489|NCT02698423|3467676|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
3618490|NCT02698423|3467674|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3618491|NCT02698423|3467675|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3618492|NCT02698423|3467676|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3618493|NCT02698423|3467674|B3||Female|Sex: Female, Male||Participants|Count of Participants|667|667.0||||||
3618494|NCT02698423|3467675|B2||Female|Sex: Female, Male||Participants|Count of Participants|331|331.0||||||
3618495|NCT02698423|3467676|B1||Female|Sex: Female, Male||Participants|Count of Participants|336|336.0||||||
3618496|NCT02698423|3467674|B3|||Age||years|Mean|42.2|42.2|Standard Deviation|10.9|10.9|||
3618497|NCT02698423|3467675|B2|||Age||years|Mean|42.1|42.1|Standard Deviation|10.8|10.8|||
3618498|NCT02698423|3467676|B1|||Age||years|Mean|42.3|42.3|Standard Deviation|10.9|10.9|||
3618499|NCT02698176|3467685|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618500|NCT02698176|3467686|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618501|NCT02698176|3467687|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618502|NCT02698176|3467688|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618503|NCT02698176|3467685|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618504|NCT02698176|3467686|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618505|NCT02698176|3467687|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618506|NCT02698176|3467688|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618507|NCT02698176|3467685|B4||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3618508|NCT02698176|3467686|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618509|NCT02698176|3467687|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3618510|NCT02698176|3467688|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3618511|NCT02698176|3467685|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618512|NCT02698176|3467686|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618513|NCT02698176|3467687|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618514|NCT02698176|3467688|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618515|NCT02698176|3467685|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618516|NCT02698176|3467686|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618517|NCT02698176|3467687|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618518|NCT02698176|3467688|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618519|NCT02698176|3467685|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618520|NCT02698176|3467686|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618521|NCT02698176|3467687|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618522|NCT02698176|3467688|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618523|NCT02698176|3467685|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618524|NCT02698176|3467686|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618525|NCT02698176|3467687|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618526|NCT02698176|3467688|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618527|NCT02698176|3467685|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3618528|NCT02698176|3467686|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3618529|NCT02698176|3467687|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3618530|NCT02698176|3467688|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3618531|NCT02698176|3467685|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3618532|NCT02698176|3467686|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3618533|NCT02698176|3467687|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3618534|NCT02698176|3467688|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3618535|NCT02698176|3467685|B4|||Age||Years|Mean|64.2|64.2|Full Range|||30.0|81.0|
3618536|NCT02698176|3467686|B3|||Age||Years|Mean|66.0|66.0|Full Range|||66.0|66.0|
3618537|NCT02698176|3467687|B2|||Age||Years|Mean|42.7|42.7|Full Range|||30.0|67.0|
3618538|NCT02698176|3467688|B1|||Age||Years|Mean|71.2|71.2|Full Range|||67.0|81.0|
3618539|NCT02697890|3467726|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
3618540|NCT02697890|3467727|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3618541|NCT02697890|3467728|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3618542|NCT02697890|3467726|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3618543|NCT02697890|3467727|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3618544|NCT02697890|3467728|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3618545|NCT02697890|3467726|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3618546|NCT02697890|3467727|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3618547|NCT02697890|3467728|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3618548|NCT02697890|3467726|B3|||Age||years|Mean|55.4|55.4|Full Range|||25.0|80.0|
3618549|NCT02697890|3467727|B2|||Age||years|Mean|55.1|55.1|Full Range|||25.0|80.0|
3618550|NCT02697890|3467728|B1|||Age||years|Mean|55.6|55.6|Full Range|||30.0|74.0|
3618551|NCT02697188|3467741|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3618552|NCT02697188|3467741|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3618553|NCT02697188|3467741|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3618554|NCT02697188|3467741|B1|||Age||years|Mean|53|53.0|Full Range|||31.0|68.0|
3618555|NCT02697188|3467741|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3618556|NCT02697188|3467741|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3618557|NCT02697188|3467741|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3618558|NCT02696317|3467750|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3618559|NCT02696317|3467750|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3618560|NCT02696317|3467750|B1|||Age||years|Mean|35.3|35.3|Standard Deviation|11.93|11.93|||
3618561|NCT02696291|3467765|B3|||Body Mass Index||kg/m^2|Mean|26.7|26.7|Standard Deviation|1.7|1.7|||
3618562|NCT02696291|3467766|B2|||Body Mass Index||kg/m^2|Mean|28.4|28.4|Standard Deviation|2.3|2.3|||
3618563|NCT02696291|3467767|B1|||Body Mass Index||kg/m^2|Mean|26.0|26.0|Standard Deviation|1.0|1.0|||
3618564|NCT02696291|3467765|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618565|NCT02696291|3467766|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618566|NCT02696291|3467767|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618567|NCT02696291|3467765|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618568|NCT02696291|3467766|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618569|NCT02696291|3467767|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618570|NCT02696291|3467765|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3618571|NCT02696291|3467766|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3618572|NCT02696291|3467767|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3618573|NCT02696291|3467765|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618574|NCT02696291|3467766|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618575|NCT02696291|3467767|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618576|NCT02696291|3467765|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618577|NCT02696291|3467766|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618578|NCT02696291|3467767|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618579|NCT02696291|3467765|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618580|NCT02696291|3467766|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618581|NCT02696291|3467767|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618582|NCT02696291|3467765|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618583|NCT02696291|3467766|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618584|NCT02696291|3467767|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618585|NCT02696291|3467765|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618586|NCT02696291|3467766|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618587|NCT02696291|3467767|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618588|NCT02696291|3467765|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3618589|NCT02696291|3467766|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618590|NCT02696291|3467767|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3618591|NCT02696291|3467765|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3618592|NCT02696291|3467766|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618593|NCT02696291|3467767|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3618594|NCT02696291|3467765|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3618595|NCT02696291|3467766|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3618596|NCT02696291|3467767|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3618597|NCT02696291|3467765|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3618598|NCT02696291|3467766|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3618599|NCT02696291|3467767|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3618600|NCT02696291|3467765|B3|||Age||years|Mean|34.1|34.1|Standard Deviation|8.7|8.7|||
3618601|NCT02696291|3467766|B2|||Age||years|Mean|41.5|41.5|Standard Deviation|4.9|4.9|||
3618602|NCT02696291|3467767|B1|||Age||years|Mean|31.2|31.2|Standard Deviation|8.3|8.3|||
3618603|NCT02696226|3467791|B5|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3618604|NCT02696226|3467791|B5||Male|Sex: Female, Male|Data was not analyzed due to low enrollment|Participants|Count of Participants|2|2.0||||||
3618605|NCT02696226|3467792|B4||Male|Sex: Female, Male|Data was not analyzed due to low enrollment|Participants|Count of Participants|0|0.0||||||
3618606|NCT02696226|3467793|B3||Male|Sex: Female, Male|Data was not analyzed due to low enrollment|Participants|Count of Participants|1|1.0||||||
3618607|NCT02696226|3467794|B2||Male|Sex: Female, Male|Data was not analyzed due to low enrollment|Participants|Count of Participants|0|0.0||||||
3618608|NCT02696226|3467795|B1||Male|Sex: Female, Male|Data was not analyzed due to low enrollment|Participants|Count of Participants|1|1.0||||||
3618609|NCT02696226|3467791|B5||Female|Sex: Female, Male|Data was not analyzed due to low enrollment|Participants|Count of Participants|1|1.0||||||
3618610|NCT02696226|3467792|B4||Female|Sex: Female, Male|Data was not analyzed due to low enrollment|Participants|Count of Participants|0|0.0||||||
3618611|NCT02696226|3467793|B3||Female|Sex: Female, Male|Data was not analyzed due to low enrollment|Participants|Count of Participants|1|1.0||||||
3618612|NCT02696226|3467794|B2||Female|Sex: Female, Male|Data was not analyzed due to low enrollment|Participants|Count of Participants|0|0.0||||||
3618613|NCT02696226|3467795|B1||Female|Sex: Female, Male|Data was not analyzed due to low enrollment|Participants|Count of Participants|0|0.0||||||
3618614|NCT02696226|3467791|B5||>=65 years|Age|Study was terminated - low number of participants did not allow for data analysis|Participants|Count of Participants|1|1.0||||||
3618615|NCT02696226|3467792|B4||>=65 years|Age|Study was terminated - low number of participants did not allow for data analysis|Participants|Count of Participants|0|0.0||||||
3618616|NCT02696226|3467793|B3||>=65 years|Age|Study was terminated - low number of participants did not allow for data analysis|Participants|Count of Participants|0|0.0||||||
3618617|NCT02696226|3467794|B2||>=65 years|Age|Study was terminated - low number of participants did not allow for data analysis|Participants|Count of Participants|0|0.0||||||
3618618|NCT02696226|3467795|B1||>=65 years|Age|Study was terminated - low number of participants did not allow for data analysis|Participants|Count of Participants|1|1.0||||||
3618619|NCT02696226|3467791|B5||Between 18 and 65 years|Age|Study was terminated - low number of participants did not allow for data analysis|Participants|Count of Participants|2|2.0||||||
3618620|NCT02696226|3467792|B4||Between 18 and 65 years|Age|Study was terminated - low number of participants did not allow for data analysis|Participants|Count of Participants|0|0.0||||||
3618675|NCT02695719|3467828|B1|||Body Mass Index (BMI)||(kg/m^2)|Mean|22.531|22.531|Standard Deviation|2.5836|2.5836|17.89|28.41|
3618621|NCT02696226|3467793|B3||Between 18 and 65 years|Age|Study was terminated - low number of participants did not allow for data analysis|Participants|Count of Participants|2|2.0||||||
3618622|NCT02696226|3467794|B2||Between 18 and 65 years|Age|Study was terminated - low number of participants did not allow for data analysis|Participants|Count of Participants|0|0.0||||||
3618623|NCT02696226|3467795|B1||Between 18 and 65 years|Age|Study was terminated - low number of participants did not allow for data analysis|Participants|Count of Participants|0|0.0||||||
3618624|NCT02696226|3467791|B5||<=18 years|Age|Study was terminated - low number of participants did not allow for data analysis|Participants|Count of Participants|0|0.0||||||
3618625|NCT02696226|3467792|B4||<=18 years|Age|Study was terminated - low number of participants did not allow for data analysis|Participants|Count of Participants|0|0.0||||||
3618626|NCT02696226|3467793|B3||<=18 years|Age|Study was terminated - low number of participants did not allow for data analysis|Participants|Count of Participants|0|0.0||||||
3618627|NCT02696226|3467794|B2||<=18 years|Age|Study was terminated - low number of participants did not allow for data analysis|Participants|Count of Participants|0|0.0||||||
3618628|NCT02696226|3467795|B1||<=18 years|Age|Study was terminated - low number of participants did not allow for data analysis|Participants|Count of Participants|0|0.0||||||
3618629|NCT02696083|3467808|B1|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3618630|NCT02696083|3467808|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618631|NCT02696083|3467808|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618632|NCT02696083|3467808|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3618633|NCT02696083|3467808|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618634|NCT02696083|3467808|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618635|NCT02696083|3467808|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618636|NCT02696083|3467808|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618637|NCT02696083|3467808|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618638|NCT02696083|3467808|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3618639|NCT02696083|3467808|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618640|NCT02696083|3467808|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3618641|NCT02696083|3467808|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3618642|NCT02696083|3467808|B1|||Age||years|Mean|63.68|63.68|Full Range|||46.0|79.0|
3618643|NCT02696070|3467817|B3|United States||Region of Enrollment||Count of Participants|Number|22|22.0||||||
3618644|NCT02696070|3467818|B2|United States||Region of Enrollment||Count of Participants|Number|14|14.0||||||
3618645|NCT02696070|3467819|B1|United States||Region of Enrollment||Count of Participants|Number|8|8.0||||||
3618646|NCT02696070|3467817|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618647|NCT02696070|3467818|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618648|NCT02696070|3467819|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618649|NCT02696070|3467817|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3618650|NCT02696070|3467818|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3618651|NCT02696070|3467819|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3618652|NCT02696070|3467817|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3618653|NCT02696070|3467818|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3618654|NCT02696070|3467819|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618655|NCT02696070|3467817|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3618656|NCT02696070|3467818|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3618657|NCT02696070|3467819|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3618658|NCT02696070|3467817|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3618659|NCT02696070|3467818|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3618660|NCT02696070|3467819|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3618661|NCT02696070|3467817|B3|||Age||Years|Mean|60.14|60.14|Full Range|||46.0|76.0|
3618662|NCT02696070|3467818|B2|||Age||Years|Mean|59|59.0|Full Range|||46.0|74.0|
3618663|NCT02696070|3467819|B1|||Age||Years|Mean|62.14|62.14|Full Range|||56.0|76.0|
3618664|NCT02695719|3467826|B3|Participant is an ex-smoker||Smokers||participants|Number|12|12.0||||||
3618665|NCT02695719|3467827|B2|Participant is an ex-smoker||Smokers||participants|Number|6|6.0||||||
3618666|NCT02695719|3467828|B1|Participant is an ex-smoker||Smokers||participants|Number|6|6.0||||||
3618667|NCT02695719|3467826|B3|participant is a current smoker||Smokers||participants|Number|7|7.0||||||
3618668|NCT02695719|3467827|B2|participant is a current smoker||Smokers||participants|Number|3|3.0||||||
3618669|NCT02695719|3467828|B1|participant is a current smoker||Smokers||participants|Number|4|4.0||||||
3618670|NCT02695719|3467826|B3|Participant has never smoked||Smokers||participants|Number|137|137.0||||||
3618671|NCT02695719|3467827|B2|Participant has never smoked||Smokers||participants|Number|73|73.0||||||
3618672|NCT02695719|3467828|B1|Participant has never smoked||Smokers||participants|Number|64|64.0||||||
3618673|NCT02695719|3467826|B3|||Body Mass Index (BMI)||(kg/m^2)|Mean|22.579|22.579|Standard Deviation|2.8638|2.8638|15.68|30.18|
3618674|NCT02695719|3467827|B2|||Body Mass Index (BMI)||(kg/m^2)|Mean|22.623|22.623|Standard Deviation|3.1104|3.1104|15.68|30.18|
3618676|NCT02695719|3467826|B3|||Weight||kg|Mean|60.05|60.05|Standard Deviation|10.380|10.38|37.1|103.1|
3618677|NCT02695719|3467827|B2|||Weight||kg|Mean|59.78|59.78|Standard Deviation|11.218|11.218|37.1|103.1|
3618678|NCT02695719|3467828|B1|||Weight||kg|Mean|60.32|60.32|Standard Deviation|9.434|9.434|45.3|90.0|
3618679|NCT02695719|3467826|B3|||Height||cm|Mean|162.7|162.7|Standard Deviation|7.30|7.3|143.0|189.0|
3618680|NCT02695719|3467827|B2|||Height||cm|Mean|162.2|162.2|Standard Deviation|7.83|7.83|143.0|189.0|
3618681|NCT02695719|3467828|B1|||Height||cm|Mean|163.4|163.4|Standard Deviation|6.65|6.65|151.0|188.0|
3618682|NCT02695719|3467826|B3|Korea, Republic Of||Region of Enrollment||participants|Number|156|156.0||||||
3618683|NCT02695719|3467827|B2|Korea, Republic Of||Region of Enrollment||participants|Number|82|82.0||||||
3618684|NCT02695719|3467828|B1|Korea, Republic Of||Region of Enrollment||participants|Number|74|74.0||||||
3618685|NCT02695719|3467826|B3|Asian||Race/Ethnicity, Customized||participants|Number|156|156.0||||||
3618686|NCT02695719|3467827|B2|Asian||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
3618687|NCT02695719|3467828|B1|Asian||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
3618688|NCT02695719|3467826|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3618689|NCT02695719|3467827|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3618690|NCT02695719|3467828|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3618691|NCT02695719|3467826|B3||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3618692|NCT02695719|3467827|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3618693|NCT02695719|3467828|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3618694|NCT02695719|3467826|B3|||Age||years|Mean|44.3|44.3|Full Range|||19.0|80.0|
3618695|NCT02695719|3467827|B2|||Age||years|Mean|44.6|44.6|Full Range|16.88|16.88|19.0|80.0|
3618696|NCT02695719|3467828|B1|||Age||years|Mean|43.9|43.9|Full Range|15.95|15.95|20.0|76.0|
3618697|NCT02695446|3467847|B1|||Plasma Minocycline (ng/ml)||ng/ml|Mean|0|0.0|Full Range|||0.0|0.0|
3618698|NCT02695446|3467847|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3618699|NCT02695446|3467847|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3618700|NCT02695446|3467847|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3618701|NCT02695446|3467847|B1|||Age||years|Mean|17|17.0|Full Range|||14.0|40.0|
3618702|NCT02695290|3467852|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3618703|NCT02695290|3467852|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3618704|NCT02695290|3467852|B1|||Age||Years|Mean|62|62.0|Standard Deviation|NA||||Not Applicable as only one patient was treated
3618705|NCT02694978|3467858|B3||Male|Sex: Female, Male||Participants|Count of Participants|478|478.0||||||
3618706|NCT02694978|3467859|B2||Male|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
3618707|NCT02694978|3467860|B1||Male|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
3618708|NCT02694978|3467858|B3||Female|Sex: Female, Male||Participants|Count of Participants|1519|1519.0||||||
3618709|NCT02694978|3467859|B2||Female|Sex: Female, Male||Participants|Count of Participants|776|776.0||||||
3618710|NCT02694978|3467860|B1||Female|Sex: Female, Male||Participants|Count of Participants|743|743.0||||||
3618711|NCT02694978|3467858|B3|||Age||years|Mean|55.2|55.2|Standard Deviation|17.16|17.16|||
3618712|NCT02694978|3467859|B2|||Age||years|Mean|54.8|54.8|Standard Deviation|17.02|17.02|||
3618713|NCT02694978|3467860|B1|||Age||years|Mean|55.6|55.6|Standard Deviation|17.30|17.3|||
3618714|NCT02694744|3467873|B3|United States||Region of Enrollment||participants|Number|112|112.0||||||
3618715|NCT02694744|3467874|B2|United States||Region of Enrollment||participants|Number|55|55.0||||||
3618716|NCT02694744|3467875|B1|United States||Region of Enrollment||participants|Number|57|57.0||||||
3618717|NCT02694744|3467873|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3618718|NCT02694744|3467874|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618719|NCT02694744|3467875|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3618720|NCT02694744|3467873|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618721|NCT02694744|3467874|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618722|NCT02694744|3467875|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618723|NCT02694744|3467873|B3||White|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
3618724|NCT02694744|3467874|B2||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3618725|NCT02694744|3467875|B1||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3618726|NCT02694744|3467873|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3618727|NCT02694744|3467874|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3618728|NCT02694744|3467875|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3618729|NCT02694744|3467873|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618730|NCT02694744|3467874|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618731|NCT02694744|3467875|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618732|NCT02694744|3467873|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3618733|NCT02694744|3467874|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3618734|NCT02694744|3467875|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618735|NCT02694744|3467873|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618736|NCT02694744|3467874|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618737|NCT02694744|3467875|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618738|NCT02694744|3467873|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618739|NCT02694744|3467874|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618740|NCT02694744|3467875|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618741|NCT02694744|3467873|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3618742|NCT02694744|3467874|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3618743|NCT02694744|3467875|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3618744|NCT02694744|3467873|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3618745|NCT02694744|3467874|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3618746|NCT02694744|3467875|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3618747|NCT02694744|3467873|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3618748|NCT02694744|3467874|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3618749|NCT02694744|3467875|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3618750|NCT02694744|3467873|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3618751|NCT02694744|3467874|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3618752|NCT02694744|3467875|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3618753|NCT02694744|3467873|B3|||Age||years|Median|67|67.0|Full Range|||26.0|94.0|
3618754|NCT02694744|3467874|B2|||Age||years|Median|66|66.0|Full Range|||48.0|94.0|
3618755|NCT02694744|3467875|B1|||Age||years|Median|69|69.0|Full Range|||26.0|89.0|
3618756|NCT02694744|3467873|B3||>=65 years|Age||Participants|Count of Participants|73|73.0||||||
3618757|NCT02694744|3467874|B2||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
3618758|NCT02694744|3467875|B1||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
3618759|NCT02694744|3467873|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3618760|NCT02694744|3467874|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3618761|NCT02694744|3467875|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3618762|NCT02694744|3467873|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3618763|NCT02694744|3467874|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3618764|NCT02694744|3467875|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3618765|NCT02694718|3467884|B1||Male|Gender||Participants|Count of Participants|46|46.0||||||
3618766|NCT02694718|3467884|B1||Female|Gender||Participants|Count of Participants|14|14.0||||||
3618767|NCT02694718|3467884|B1|||Age||years|Median|61|61.0|Full Range|||35.0|77.0|
3618768|NCT02694601|3467894|B1|Canada||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3618769|NCT02694601|3467894|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3618770|NCT02694601|3467894|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3618771|NCT02694601|3467894|B1|||Age||years|Mean|33|33.0|Standard Deviation|19|19.0|||
3618772|NCT02694601|3467894|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3618773|NCT02694601|3467894|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3618774|NCT02694601|3467894|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3618775|NCT02694549|3467914|B1|Germany||Region of Enrollment||participants|Number|10|10.0||||||
3618776|NCT02694549|3467914|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3618777|NCT02694549|3467914|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3618778|NCT02694549|3467914|B1|||Age||years|Mean|58.1|58.1|Standard Deviation|11.7|11.7|||
3618779|NCT02694536|3467920|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3618780|NCT02694536|3467920|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3618781|NCT02694536|3467920|B1|||Age||years|Mean|62.45|62.45|Standard Deviation|10.299|10.299|||
3618782|NCT02694315|3467929|B1|need for cesarean section||Outcome of induction of labor||participants|Number|86|86.0||||||
3618783|NCT02694315|3467929|B1|successful vaginal delivery||Outcome of induction of labor||participants|Number|114|114.0||||||
3618784|NCT02694315|3467929|B1|did not need oxytocin||Need for oxytocin||participants|Number|84|84.0||||||
3618785|NCT02694315|3467929|B1|needed oxytocin||Need for oxytocin||participants|Number|116|116.0||||||
3618786|NCT02694315|3467929|B1|term rupture of membranes||Indication of induction of labor||participants|Number|72|72.0||||||
3618787|NCT02694315|3467929|B1|postdate||Indication of induction of labor||participants|Number|89|89.0||||||
3618788|NCT02694315|3467929|B1|oligohydramnios||Indication of induction of labor||participants|Number|17|17.0||||||
3618789|NCT02694315|3467929|B1|intrauterine growth restriction||Indication of induction of labor||participants|Number|3|3.0||||||
3618790|NCT02694315|3467929|B1|mild pre-eclampsia||Indication of induction of labor||participants|Number|11|11.0||||||
3618791|NCT02694315|3467929|B1|severe pre-eclampsia||Indication of induction of labor||participants|Number|8|8.0||||||
3618792|NCT02694315|3467929|B1|three abortions||Previous abortions||participants|Number|1|1.0||||||
3618793|NCT02694315|3467929|B1|two abortions||Previous abortions||participants|Number|4|4.0||||||
3618794|NCT02694315|3467929|B1|one abortion||Previous abortions||participants|Number|22|22.0||||||
3618795|NCT02694315|3467929|B1|no abortions||Previous abortions||participants|Number|173|173.0||||||
3618796|NCT02694315|3467929|B1|||Gestational age||weeks|Median|39.8|39.8|Inter-Quartile Range|||38.2|40.4|
3618797|NCT02694315|3467929|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3618798|NCT02694315|3467929|B1||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
3618799|NCT02694315|3467929|B1|||Age||years|Median|23.5|23.5|Inter-Quartile Range|||21.0|27.0|
3618800|NCT02694198|3467934|B1|failed induction||Outcome of induction of abortion||participants|Number|3|3.0||||||
3618801|NCT02694198|3467934|B1|abortion in more than 24 hours||Outcome of induction of abortion||participants|Number|13|13.0||||||
3618802|NCT02694198|3467934|B1|abortion in less than 24 hours||Outcome of induction of abortion||participants|Number|119|119.0||||||
3618803|NCT02694198|3467934|B1|||gestational age in weeks||weeks|Mean|19.32|19.32|Standard Deviation|1.91|1.91|||
3618804|NCT02694198|3467934|B1|||Body mass index||kilograms per squared meter|Mean|29.4|29.4|Standard Deviation|2.31|2.31|||
3618805|NCT02694198|3467934|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3618806|NCT02694198|3467934|B1||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3618807|NCT02694198|3467934|B1|||Age||years|Mean|28.4|28.4|Standard Deviation|4.02|4.02|||
3618808|NCT02693704|3467939|B5|Switzerland||Region of Enrollment||participants|Number|40|40.0||||||
3618809|NCT02693704|3467940|B4|Switzerland||Region of Enrollment||participants|Number|10|10.0||||||
3618810|NCT02693704|3467941|B3|Switzerland||Region of Enrollment||participants|Number|10|10.0||||||
3618811|NCT02693704|3467942|B2|Switzerland||Region of Enrollment||participants|Number|10|10.0||||||
3618812|NCT02693704|3467943|B1|Switzerland||Region of Enrollment||participants|Number|10|10.0||||||
3618813|NCT02693704|3467939|B5||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3618814|NCT02693704|3467940|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3618815|NCT02693704|3467941|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3618816|NCT02693704|3467942|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3618817|NCT02693704|3467943|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3618818|NCT02693704|3467939|B5||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3618819|NCT02693704|3467940|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3618820|NCT02693704|3467941|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3618821|NCT02693704|3467942|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3618822|NCT02693704|3467943|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3618823|NCT02693704|3467939|B5|||Age||years|Mean|43|43.0|Standard Deviation|23|23.0|||
3618824|NCT02693704|3467940|B4|||Age||years|Mean|38|38.0|Standard Deviation|18|18.0|||
3618825|NCT02693704|3467941|B3|||Age||years|Mean|63|63.0|Standard Deviation|20|20.0|||
3618826|NCT02693704|3467942|B2|||Age||years|Mean|51|51.0|Standard Deviation|24|24.0|||
3618827|NCT02693704|3467943|B1|||Age||years|Mean|21|21.0|Standard Deviation|2|2.0|||
3618828|NCT02693704|3467939|B5||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3618829|NCT02693704|3467940|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3618830|NCT02693704|3467941|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3618831|NCT02693704|3467942|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3618832|NCT02693704|3467943|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3618833|NCT02693704|3467939|B5||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3618834|NCT02693704|3467940|B4||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3618835|NCT02693704|3467941|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3618836|NCT02693704|3467942|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3618837|NCT02693704|3467943|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3618838|NCT02693704|3467939|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3618839|NCT02693704|3467940|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3618840|NCT02693704|3467941|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3618841|NCT02693704|3467942|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3618842|NCT02693704|3467943|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3618843|NCT02693132|3467964|B4|United States||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
3618844|NCT02693132|3467965|B3|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3618845|NCT02693132|3467966|B2|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3618846|NCT02693132|3467967|B1|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3618847|NCT02693132|3467964|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618848|NCT02693132|3467965|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618849|NCT02693132|3467966|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618850|NCT02693132|3467967|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618851|NCT02693132|3467964|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618852|NCT02693132|3467965|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618853|NCT02693132|3467966|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618854|NCT02693132|3467967|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618855|NCT02693132|3467964|B4||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3618856|NCT02693132|3467965|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3618857|NCT02693132|3467966|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3618858|NCT02693132|3467967|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3618859|NCT02693132|3467964|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3618860|NCT02693132|3467965|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3618861|NCT02693132|3467966|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3618862|NCT02693132|3467967|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3618863|NCT02693132|3467964|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618864|NCT02693132|3467965|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618865|NCT02693132|3467966|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618866|NCT02693132|3467967|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618867|NCT02693132|3467964|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3618868|NCT02693132|3467965|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3618869|NCT02693132|3467966|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618870|NCT02693132|3467967|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618871|NCT02693132|3467964|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618872|NCT02693132|3467965|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618873|NCT02693132|3467966|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618874|NCT02693132|3467967|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618875|NCT02693132|3467964|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3618876|NCT02693132|3467965|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3618877|NCT02693132|3467966|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3618878|NCT02693132|3467967|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3618879|NCT02693132|3467964|B4||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3618880|NCT02693132|3467965|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3618881|NCT02693132|3467966|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3618882|NCT02693132|3467967|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3618883|NCT02693132|3467964|B4|||Age||years|Mean|43.5|43.5|Standard Deviation|10.1|10.1|||
3618884|NCT02693132|3467965|B3|||Age||years|Mean|39.3|39.3|Standard Deviation|10.7|10.7|||
3618885|NCT02693132|3467966|B2|||Age||years|Mean|46.2|46.2|Standard Deviation|10.1|10.1|||
3618886|NCT02693132|3467967|B1|||Age||years|Mean|45.2|45.2|Standard Deviation|8.5|8.5|||
3618887|NCT02693002|3467989|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3618888|NCT02693002|3467990|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3618889|NCT02693002|3467991|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3618890|NCT02693002|3467989|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3618891|NCT02693002|3467990|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3618892|NCT02693002|3467991|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3618893|NCT02693002|3467989|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3618894|NCT02693002|3467990|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3618895|NCT02693002|3467991|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3618896|NCT02693002|3467989|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3618897|NCT02693002|3467990|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3618898|NCT02693002|3467991|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3618899|NCT02693002|3467989|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3618900|NCT02693002|3467990|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3618901|NCT02693002|3467991|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3618902|NCT02693002|3467989|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3618903|NCT02693002|3467990|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3618904|NCT02693002|3467991|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3618905|NCT02692859|3468004|B3|China||Region of Enrollment||participants|Number|1992|1992.0||||||
3618906|NCT02692859|3468005|B2|China||Region of Enrollment||participants|Number|996|996.0||||||
3618907|NCT02692859|3468006|B1|China||Region of Enrollment||participants|Number|996|996.0||||||
3618908|NCT02692859|3468004|B3||Male|Sex: Female, Male||Participants|Count of Participants|1047|1047.0||||||
3618909|NCT02692859|3468005|B2||Male|Sex: Female, Male||Participants|Count of Participants|532|532.0||||||
3618910|NCT02692859|3468006|B1||Male|Sex: Female, Male||Participants|Count of Participants|515|515.0||||||
3618911|NCT02692859|3468004|B3||Female|Sex: Female, Male||Participants|Count of Participants|945|945.0||||||
3618912|NCT02692859|3468005|B2||Female|Sex: Female, Male||Participants|Count of Participants|464|464.0||||||
3618913|NCT02692859|3468006|B1||Female|Sex: Female, Male||Participants|Count of Participants|481|481.0||||||
3618914|NCT02692859|3468004|B3|3-5 months||Age||months|Mean|4.27|4.27|Standard Deviation|0.83|0.83|||
3618915|NCT02692859|3468005|B2|3-5 months||Age||months|Mean|4.27|4.27|Standard Deviation|0.83|0.83|||
3618916|NCT02692859|3468006|B1|3-5 months||Age||months|Mean|4.26|4.26|Standard Deviation|0.82|0.82|||
3618917|NCT02692859|3468004|B3|6-11 months||Age||months|Mean|8.26|8.26|Standard Deviation|1.80|1.8|||
3618918|NCT02692859|3468005|B2|6-11 months||Age||months|Mean|8.20|8.2|Standard Deviation|1.80|1.8|||
3618919|NCT02692859|3468006|B1|6-11 months||Age||months|Mean|8.31|8.31|Standard Deviation|1.80|1.8|||
3618920|NCT02692859|3468004|B3|12-60 months||Age||months|Mean|37.92|37.92|Standard Deviation|13.44|13.44|||
3618921|NCT02692859|3468005|B2|12-60 months||Age||months|Mean|37.32|37.32|Standard Deviation|13.92|13.92|||
3618922|NCT02692859|3468006|B1|12-60 months||Age||months|Mean|38.52|38.52|Standard Deviation|12.84|12.84|||
3618923|NCT02692859|3468004|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3618924|NCT02692859|3468005|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3618925|NCT02692859|3468006|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3618926|NCT02692859|3468004|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3618927|NCT02692859|3468005|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3618928|NCT02692859|3468006|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3618929|NCT02692859|3468004|B3||<=18 years|Age||Participants|Count of Participants|1992|1992.0||||||
3618930|NCT02692859|3468005|B2||<=18 years|Age||Participants|Count of Participants|996|996.0||||||
3618931|NCT02692859|3468006|B1||<=18 years|Age||Participants|Count of Participants|996|996.0||||||
3618932|NCT02692703|3468013|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618933|NCT02692703|3468013|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618934|NCT02692703|3468013|B1||White|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3618935|NCT02692703|3468013|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3618936|NCT02692703|3468013|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3618937|NCT02692703|3468013|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3618938|NCT02692703|3468013|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618939|NCT02692703|3468013|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618940|NCT02692703|3468013|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3618941|NCT02692703|3468013|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3618942|NCT02692703|3468013|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3618943|NCT02692703|3468013|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3618944|NCT02692703|3468013|B1|||Age||years|Mean|59.19|59.19|Standard Deviation|7.68|7.68|||
3618945|NCT02692560|3468019|B3|||Body mass index||kg/m^2|Mean|36.3|36.3|Standard Deviation|5|5.0|||
3618946|NCT02692560|3468020|B2|||Body mass index||kg/m^2|Mean|36.0|36.0|Standard Deviation|3.8|3.8|||
3618947|NCT02692560|3468021|B1|||Body mass index||kg/m^2|Mean|36.6|36.6|Standard Deviation|6.1|6.1|||
3618948|NCT02692560|3468019|B3|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3618949|NCT02692560|3468020|B2|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3618950|NCT02692560|3468021|B1|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3618951|NCT02692560|3468019|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618952|NCT02692560|3468020|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618953|NCT02692560|3468021|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618954|NCT02692560|3468019|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618955|NCT02692560|3468020|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618956|NCT02692560|3468021|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618957|NCT02692560|3468019|B3||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3618958|NCT02692560|3468020|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3618959|NCT02692560|3468021|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3618960|NCT02692560|3468019|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3618961|NCT02692560|3468020|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3618962|NCT02692560|3468021|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618963|NCT02692560|3468019|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618964|NCT02692560|3468020|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618965|NCT02692560|3468021|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618966|NCT02692560|3468019|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618967|NCT02692560|3468020|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618968|NCT02692560|3468021|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618969|NCT02692560|3468019|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618970|NCT02692560|3468020|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618971|NCT02692560|3468021|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618972|NCT02692560|3468019|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3618973|NCT02692560|3468020|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3619032|NCT02691702|3468060|B12||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3618974|NCT02692560|3468021|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618975|NCT02692560|3468019|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3618976|NCT02692560|3468020|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3618977|NCT02692560|3468021|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3618978|NCT02692560|3468019|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618979|NCT02692560|3468020|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3618980|NCT02692560|3468021|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3618981|NCT02692560|3468019|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3618982|NCT02692560|3468020|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3618983|NCT02692560|3468021|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3618984|NCT02692560|3468019|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3618985|NCT02692560|3468020|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3618986|NCT02692560|3468021|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3618987|NCT02692560|3468019|B3|||Age||years|Mean|68.4|68.4|Standard Deviation|4.9|4.9|||
3618988|NCT02692560|3468020|B2|||Age||years|Mean|67.8|67.8|Standard Deviation|5.2|5.2|||
3618989|NCT02692560|3468021|B1|||Age||years|Mean|69.0|69.0|Standard Deviation|4.7|4.7|||
3618990|NCT02692495|3468042|B3|Duration of symptoms||Duration of condition||years|Mean|9|9.0|Standard Deviation|6|6.0|||
3618991|NCT02692495|3468043|B2|Duration of symptoms||Duration of condition||years|Mean|9|9.0|Standard Deviation|5|5.0|||
3618992|NCT02692495|3468044|B1|Duration of symptoms||Duration of condition||years|Mean|9|9.0|Standard Deviation|6|6.0|||
3618993|NCT02692495|3468042|B3|Age at onset of symptoms||Duration of condition||years|Mean|23|23.0|Standard Deviation|9|9.0|||
3618994|NCT02692495|3468043|B2|Age at onset of symptoms||Duration of condition||years|Mean|29|29.0|Standard Deviation|9|9.0|||
3618995|NCT02692495|3468044|B1|Age at onset of symptoms||Duration of condition||years|Mean|21|21.0|Standard Deviation|9|9.0|||
3618996|NCT02692495|3468042|B3|United Kingdom||Region of Enrollment||participants|Number|16|16.0||||||
3618997|NCT02692495|3468043|B2|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3618998|NCT02692495|3468044|B1|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
3618999|NCT02692495|3468042|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3619000|NCT02692495|3468043|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3619001|NCT02692495|3468044|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3619002|NCT02692495|3468042|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3619003|NCT02692495|3468043|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3619004|NCT02692495|3468044|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3619005|NCT02692495|3468042|B3|||Age||years|Mean|32.6|32.6|Standard Deviation|8.3|8.3|||
3619006|NCT02692495|3468043|B2|||Age||years|Mean|37.5|37.5|Standard Deviation|5.9|5.9|||
3619007|NCT02692495|3468044|B1|||Age||years|Mean|30.9|30.9|Standard Deviation|8.5|8.5|||
3619008|NCT02691702|3468060|B12||Black|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3619009|NCT02691702|3468061|B11||Black|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3619010|NCT02691702|3468062|B10||Black|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3619011|NCT02691702|3468063|B9||Black|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3619012|NCT02691702|3468064|B8||Black|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3619013|NCT02691702|3468065|B7||Black|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3619014|NCT02691702|3468066|B6||Black|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3619015|NCT02691702|3468067|B5||Black|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3619016|NCT02691702|3468068|B4||Black|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3619017|NCT02691702|3468069|B3||Black|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3619018|NCT02691702|3468070|B2||Black|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3619019|NCT02691702|3468071|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3619020|NCT02691702|3468060|B12||White|Race/Ethnicity, Customized||Participants|Count of Participants|82|82.0||||||
3619021|NCT02691702|3468061|B11||White|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3619022|NCT02691702|3468062|B10||White|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3619023|NCT02691702|3468063|B9||White|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3619024|NCT02691702|3468064|B8||White|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3619025|NCT02691702|3468065|B7||White|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3619026|NCT02691702|3468066|B6||White|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3619027|NCT02691702|3468067|B5||White|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3619028|NCT02691702|3468068|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3619029|NCT02691702|3468069|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3619030|NCT02691702|3468070|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3619031|NCT02691702|3468071|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3619033|NCT02691702|3468061|B11||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3619034|NCT02691702|3468062|B10||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3619035|NCT02691702|3468063|B9||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3619036|NCT02691702|3468064|B8||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3619037|NCT02691702|3468065|B7||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3619038|NCT02691702|3468066|B6||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3619039|NCT02691702|3468067|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3619040|NCT02691702|3468068|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3619041|NCT02691702|3468069|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3619042|NCT02691702|3468070|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3619043|NCT02691702|3468071|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3619044|NCT02691702|3468060|B12||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3619045|NCT02691702|3468061|B11||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3619046|NCT02691702|3468062|B10||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3619047|NCT02691702|3468063|B9||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3619048|NCT02691702|3468064|B8||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3619049|NCT02691702|3468065|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3619050|NCT02691702|3468066|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3619051|NCT02691702|3468067|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3619052|NCT02691702|3468068|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3619053|NCT02691702|3468069|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3619054|NCT02691702|3468070|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3619055|NCT02691702|3468071|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3619056|NCT02691702|3468060|B12|>= 65||Age, Customized||participants|Number|0|0.0||||||
3619057|NCT02691702|3468061|B11|>= 65||Age, Customized||participants|Number|0|0.0||||||
3619058|NCT02691702|3468062|B10|>= 65||Age, Customized||participants|Number|0|0.0||||||
3619059|NCT02691702|3468063|B9|>= 65||Age, Customized||participants|Number|0|0.0||||||
3619060|NCT02691702|3468064|B8|>= 65||Age, Customized||participants|Number|0|0.0||||||
3619061|NCT02691702|3468065|B7|>= 65||Age, Customized||participants|Number|0|0.0||||||
3619062|NCT02691702|3468066|B6|>= 65||Age, Customized||participants|Number|0|0.0||||||
3619063|NCT02691702|3468067|B5|>= 65||Age, Customized||participants|Number|0|0.0||||||
3619064|NCT02691702|3468068|B4|>= 65||Age, Customized||participants|Number|0|0.0||||||
3619065|NCT02691702|3468069|B3|>= 65||Age, Customized||participants|Number|0|0.0||||||
3619066|NCT02691702|3468070|B2|>= 65||Age, Customized||participants|Number|0|0.0||||||
3619067|NCT02691702|3468071|B1|>= 65||Age, Customized||participants|Number|0|0.0||||||
3619068|NCT02691702|3468060|B12|45-64 years||Age, Customized||participants|Number|51|51.0||||||
3619069|NCT02691702|3468061|B11|45-64 years||Age, Customized||participants|Number|4|4.0||||||
3619070|NCT02691702|3468062|B10|45-64 years||Age, Customized||participants|Number|2|2.0||||||
3619071|NCT02691702|3468063|B9|45-64 years||Age, Customized||participants|Number|5|5.0||||||
3619072|NCT02691702|3468064|B8|45-64 years||Age, Customized||participants|Number|5|5.0||||||
3619073|NCT02691702|3468065|B7|45-64 years||Age, Customized||participants|Number|4|4.0||||||
3619074|NCT02691702|3468066|B6|45-64 years||Age, Customized||participants|Number|5|5.0||||||
3619075|NCT02691702|3468067|B5|45-64 years||Age, Customized||participants|Number|8|8.0||||||
3619076|NCT02691702|3468068|B4|45-64 years||Age, Customized||participants|Number|3|3.0||||||
3619077|NCT02691702|3468069|B3|45-64 years||Age, Customized||participants|Number|7|7.0||||||
3619078|NCT02691702|3468070|B2|45-64 years||Age, Customized||participants|Number|4|4.0||||||
3619079|NCT02691702|3468071|B1|45-64 years||Age, Customized||participants|Number|4|4.0||||||
3619080|NCT02691702|3468060|B12|18-44 years||Age, Customized||participants|Number|46|46.0||||||
3619081|NCT02691702|3468061|B11|18-44 years||Age, Customized||participants|Number|4|4.0||||||
3619082|NCT02691702|3468062|B10|18-44 years||Age, Customized||participants|Number|6|6.0||||||
3619083|NCT02691702|3468063|B9|18-44 years||Age, Customized||participants|Number|3|3.0||||||
3619084|NCT02691702|3468064|B8|18-44 years||Age, Customized||participants|Number|7|7.0||||||
3619085|NCT02691702|3468065|B7|18-44 years||Age, Customized||participants|Number|4|4.0||||||
3619086|NCT02691702|3468066|B6|18-44 years||Age, Customized||participants|Number|3|3.0||||||
3619087|NCT02691702|3468067|B5|18-44 years||Age, Customized||participants|Number|0|0.0||||||
3619088|NCT02691702|3468068|B4|18-44 years||Age, Customized||participants|Number|5|5.0||||||
3619089|NCT02691702|3468069|B3|18-44 years||Age, Customized||participants|Number|1|1.0||||||
3619090|NCT02691702|3468070|B2|18-44 years||Age, Customized||participants|Number|7|7.0||||||
3619091|NCT02691702|3468071|B1|18-44 years||Age, Customized||participants|Number|6|6.0||||||
3619092|NCT02691702|3468060|B12|< 18 years||Age, Customized||participants|Number|0|0.0||||||
3619093|NCT02691702|3468061|B11|< 18 years||Age, Customized||participants|Number|0|0.0||||||
3619094|NCT02691702|3468062|B10|< 18 years||Age, Customized||participants|Number|0|0.0||||||
3619095|NCT02691702|3468063|B9|< 18 years||Age, Customized||participants|Number|0|0.0||||||
3619096|NCT02691702|3468064|B8|< 18 years||Age, Customized||participants|Number|0|0.0||||||
3619097|NCT02691702|3468065|B7|< 18 years||Age, Customized||participants|Number|0|0.0||||||
3619098|NCT02691702|3468066|B6|< 18 years||Age, Customized||participants|Number|0|0.0||||||
3619099|NCT02691702|3468067|B5|< 18 years||Age, Customized||participants|Number|0|0.0||||||
3619100|NCT02691702|3468068|B4|< 18 years||Age, Customized||participants|Number|0|0.0||||||
3619101|NCT02691702|3468069|B3|< 18 years||Age, Customized||participants|Number|0|0.0||||||
3619102|NCT02691702|3468070|B2|< 18 years||Age, Customized||participants|Number|0|0.0||||||
3619103|NCT02691702|3468071|B1|< 18 years||Age, Customized||participants|Number|0|0.0||||||
3619104|NCT02691572|3468365|B3|||Nulliparous||Participants|Count of Participants|17|17.0||||||
3619105|NCT02691572|3468366|B2|||Nulliparous||Participants|Count of Participants|9|9.0||||||
3619106|NCT02691572|3468367|B1|||Nulliparous||Participants|Count of Participants|8|8.0||||||
3619107|NCT02691572|3468365|B3|||Gestational age||weeks|Median|38|38.0|Full Range|||37.0|40.0|
3619108|NCT02691572|3468366|B2|||Gestational age||weeks|Median|38|38.0|Full Range|||37.0|40.0|
3619109|NCT02691572|3468367|B1|||Gestational age||weeks|Median|38|38.0|Full Range|||37.0|40.0|
3619110|NCT02691572|3468365|B3|||Body mass index||kg/m^2|Mean|31.7|31.7|Standard Deviation|3.6|3.6|||
3619111|NCT02691572|3468366|B2|||Body mass index||kg/m^2|Mean|31|31.0|Standard Deviation|3.3|3.3|||
3619112|NCT02691572|3468367|B1|||Body mass index||kg/m^2|Mean|32.3|32.3|Standard Deviation|3.7|3.7|||
3619113|NCT02691572|3468365|B3|||Weight||kg|Mean|83.9|83.9|Standard Deviation|11.4|11.4|||
3619114|NCT02691572|3468366|B2|||Weight||kg|Mean|81.8|81.8|Standard Deviation|9.2|9.2|||
3619115|NCT02691572|3468367|B1|||Weight||kg|Mean|86|86.0|Standard Deviation|13|13.0|||
3619116|NCT02691572|3468365|B3|||Height||cm|Mean|163|163.0|Standard Deviation|5|5.0|||
3619117|NCT02691572|3468366|B2|||Height||cm|Mean|162|162.0|Standard Deviation|4|4.0|||
3619118|NCT02691572|3468367|B1|||Height||cm|Mean|163|163.0|Standard Deviation|6|6.0|||
3619119|NCT02691572|3468365|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3619120|NCT02691572|3468366|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3619121|NCT02691572|3468367|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3619122|NCT02691572|3468365|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3619123|NCT02691572|3468366|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3619124|NCT02691572|3468367|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3619125|NCT02691572|3468365|B3|||Age||years|Mean|26.4|26.4|Standard Deviation|4.2|4.2|||
3619126|NCT02691572|3468366|B2|||Age||years|Mean|26.7|26.7|Standard Deviation|4.1|4.1|||
3619127|NCT02691572|3468367|B1|||Age||years|Mean|26.2|26.2|Standard Deviation|4.4|4.4|||
3619128|NCT02691507|3468374|B3|United States||Region of Enrollment||participants|Number|53|53.0||||||
3619129|NCT02691507|3468375|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3619130|NCT02691507|3468376|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3619131|NCT02691507|3468374|B3||Male|Gender||Participants|Count of Participants|19|19.0||||||
3619132|NCT02691507|3468375|B2||Male|Gender||Participants|Count of Participants|4|4.0||||||
3619133|NCT02691507|3468376|B1||Male|Gender||Participants|Count of Participants|15|15.0||||||
3619134|NCT02691507|3468374|B3||Female|Gender||Participants|Count of Participants|34|34.0||||||
3619135|NCT02691507|3468375|B2||Female|Gender||Participants|Count of Participants|9|9.0||||||
3619136|NCT02691507|3468376|B1||Female|Gender||Participants|Count of Participants|25|25.0||||||
3619137|NCT02691507|3468374|B3|||Age||years|Mean|43.6|43.6|Standard Deviation|17.55|17.55|||
3619138|NCT02691507|3468375|B2|||Age||years|Mean|45.5|45.5|Standard Deviation|18.51|18.51|||
3619139|NCT02691507|3468376|B1|||Age||years|Mean|43.0|43.0|Standard Deviation|17.43|17.43|||
3619140|NCT02691416|3468507|B3|China||Region of Enrollment||participants|Number|60|60.0||||||
3619141|NCT02691416|3468508|B2|China||Region of Enrollment||participants|Number|30|30.0||||||
3619142|NCT02691416|3468509|B1|China||Region of Enrollment||participants|Number|30|30.0||||||
3619143|NCT02691416|3468507|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3619144|NCT02691416|3468508|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3619145|NCT02691416|3468509|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3619146|NCT02691416|3468507|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3619147|NCT02691416|3468508|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3619148|NCT02691416|3468509|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3619149|NCT02691416|3468507|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3619150|NCT02691416|3468508|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3619151|NCT02691416|3468509|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3619152|NCT02691416|3468507|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3619153|NCT02691416|3468508|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3619154|NCT02691416|3468509|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3619155|NCT02691416|3468507|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3619156|NCT02691416|3468508|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3619157|NCT02691416|3468509|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3619158|NCT02691143|3468530|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3619159|NCT02691143|3468531|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3619160|NCT02691143|3468532|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3619161|NCT02691143|3468530|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3619162|NCT02691143|3468531|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3619163|NCT02691143|3468532|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3619164|NCT02691143|3468530|B3|||Age||years|Mean|36.7|36.7|Full Range|||20.0|61.0|
3619165|NCT02691143|3468531|B2|||Age||years|Mean|36.5|36.5|Full Range|||18.0|58.0|
3619166|NCT02691143|3468532|B1|||Age||years|Mean|36.9|36.9|Full Range|||20.0|61.0|
3619167|NCT02690935|3468541|B3|Belgium||Region of Enrollment||participants|Number|102|102.0||||||
3619168|NCT02690935|3468542|B2|Belgium||Region of Enrollment||participants|Number|51|51.0||||||
3619169|NCT02690935|3468543|B1|Belgium||Region of Enrollment||participants|Number|51|51.0||||||
3619170|NCT02690935|3468541|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619171|NCT02690935|3468542|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619172|NCT02690935|3468543|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619173|NCT02690935|3468541|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
3619174|NCT02690935|3468542|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3619175|NCT02690935|3468543|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3619176|NCT02690935|3468541|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619177|NCT02690935|3468542|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619178|NCT02690935|3468543|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619179|NCT02690935|3468541|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3619180|NCT02690935|3468542|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3619181|NCT02690935|3468543|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3619182|NCT02690935|3468541|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3619183|NCT02690935|3468542|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3619184|NCT02690935|3468543|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3619185|NCT02690935|3468541|B3|||Age||years|Mean|40.1|40.1|Standard Deviation|14.8|14.8|||
3619186|NCT02690935|3468542|B2|||Age||years|Mean|40.7|40.7|Standard Deviation|15.1|15.1|||
3619187|NCT02690935|3468543|B1|||Age||years|Mean|39.5|39.5|Standard Deviation|14.5|14.5|||
3619188|NCT02690727|3468552|B1|||Body Mass Index||kg/m^2|Mean|24.50|24.5|Standard Deviation|2.46|2.46|||
3619189|NCT02690727|3468552|B1|||Height||cm|Mean|173.7|173.7|Standard Deviation|7.2|7.2|||
3619190|NCT02690727|3468552|B1|||Weight||Kg|Mean|73.9|73.9|Standard Deviation|8.1|8.1|||
3619191|NCT02690727|3468552|B1|Canada||Region of Enrollment||participants|Number|18|18.0||||||
3619192|NCT02690727|3468552|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3619193|NCT02690727|3468552|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619194|NCT02690727|3468552|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3619195|NCT02690727|3468552|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619196|NCT02690727|3468552|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619197|NCT02690727|3468552|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|01|1.0||||||
3619198|NCT02690727|3468552|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619199|NCT02690727|3468552|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619200|NCT02690727|3468552|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3619201|NCT02690727|3468552|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3619202|NCT02690727|3468552|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3619203|NCT02690727|3468552|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3619204|NCT02690727|3468552|B1|||Age||Years|Mean|29|29.0|Standard Deviation|6|6.0|||
3619205|NCT02690194|3468563|B4|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3619206|NCT02690194|3468563|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3619207|NCT02690194|3468564|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3619208|NCT02690194|3468565|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3619209|NCT02690194|3468566|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3619210|NCT02690194|3468563|B4||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3619211|NCT02690194|3468564|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3619212|NCT02690194|3468565|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3619213|NCT02690194|3468566|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3619214|NCT02690194|3468563|B4|||Age||years|Mean|52.4|52.4|Standard Deviation|2.12|2.12|||
3619215|NCT02690194|3468564|B3|||Age||years|Mean|55.5|55.5|Standard Deviation|17.1|17.1|||
3619216|NCT02690194|3468565|B2|||Age||years|Mean|53.9|53.9|Standard Deviation|15.8|15.8|||
3619217|NCT02690194|3468566|B1|||Age||years|Mean|50.9|50.9|Standard Deviation|18.0|18.0|||
3619218|NCT02690194|3468563|B4||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3619219|NCT02690194|3468564|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3619220|NCT02690194|3468565|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3619221|NCT02690194|3468566|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3619222|NCT02690194|3468563|B4||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3619223|NCT02690194|3468564|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3619224|NCT02690194|3468565|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3619225|NCT02690194|3468566|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3619226|NCT02690194|3468563|B4||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3619227|NCT02690194|3468564|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3619228|NCT02690194|3468565|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3619229|NCT02690194|3468566|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3619230|NCT02690181|3468611|B7|White||Race/Ethnicity, Customized||Participants|Count of Participants|80|80.0||||||
3619231|NCT02690181|3468612|B6|White||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3619232|NCT02690181|3468613|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3619233|NCT02690181|3468614|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3619234|NCT02690181|3468615|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3619235|NCT02690181|3468616|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3619236|NCT02690181|3468617|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3619237|NCT02690181|3468611|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3619238|NCT02690181|3468612|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3619239|NCT02690181|3468613|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3619240|NCT02690181|3468614|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3619241|NCT02690181|3468615|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3619242|NCT02690181|3468616|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3619243|NCT02690181|3468617|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3619244|NCT02690181|3468611|B7||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3619245|NCT02690181|3468612|B6||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3619246|NCT02690181|3468613|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3619247|NCT02690181|3468614|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3619248|NCT02690181|3468615|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3619249|NCT02690181|3468616|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3619250|NCT02690181|3468617|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3619251|NCT02690181|3468611|B7|||Age||Years|Mean|30.1|30.1|Standard Deviation|6.19|6.19|||
3619252|NCT02690181|3468612|B6|||Age||Years|Mean|29.2|29.2|Standard Deviation|6.96|6.96|||
3619253|NCT02690181|3468613|B5|||Age||Years|Mean|28.3|28.3|Standard Deviation|5.39|5.39|||
3619254|NCT02690181|3468614|B4|||Age||Years|Mean|29.7|29.7|Standard Deviation|6.22|6.22|||
3619255|NCT02690181|3468615|B3|||Age||Years|Mean|28.9|28.9|Standard Deviation|4.68|4.68|||
3619256|NCT02690181|3468616|B2|||Age||Years|Mean|31.6|31.6|Standard Deviation|6.06|6.06|||
3619257|NCT02690181|3468617|B1|||Age||Years|Mean|32.4|32.4|Standard Deviation|6.91|6.91|||
3619258|NCT02689973|3468678|B5|||Categorical BMI: number of participants with overweight/obesity||Participants|Count of Participants|230|230.0||||||
3619259|NCT02689973|3468679|B4|||Categorical BMI: number of participants with overweight/obesity||Participants|Count of Participants|48|48.0||||||
3619260|NCT02689973|3468680|B3|||Categorical BMI: number of participants with overweight/obesity||Participants|Count of Participants|75|75.0||||||
3619261|NCT02689973|3468681|B2|||Categorical BMI: number of participants with overweight/obesity||Participants|Count of Participants|54|54.0||||||
3619262|NCT02689973|3468682|B1|||Categorical BMI: number of participants with overweight/obesity||Participants|Count of Participants|53|53.0||||||
3619263|NCT02689973|3468678|B5|Poland||Region of Enrollment||Participants|Count of Participants|1217|1217.0||||||
3619264|NCT02689973|3468679|B4|Poland||Region of Enrollment||Participants|Count of Participants|285|285.0||||||
3619265|NCT02689973|3468680|B3|Poland||Region of Enrollment||Participants|Count of Participants|351|351.0||||||
3619266|NCT02689973|3468681|B2|Poland||Region of Enrollment||Participants|Count of Participants|270|270.0||||||
3619267|NCT02689973|3468682|B1|Poland||Region of Enrollment||Participants|Count of Participants|311|311.0||||||
3619268|NCT02689973|3468678|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619269|NCT02689973|3468679|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619270|NCT02689973|3468680|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619271|NCT02689973|3468681|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619272|NCT02689973|3468682|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619273|NCT02689973|3468678|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619274|NCT02689973|3468679|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619275|NCT02689973|3468680|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619276|NCT02689973|3468681|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619277|NCT02689973|3468682|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619278|NCT02689973|3468678|B5||White|Race (NIH/OMB)||Participants|Count of Participants|1217|1217.0||||||
3619279|NCT02689973|3468679|B4||White|Race (NIH/OMB)||Participants|Count of Participants|285|285.0||||||
3619280|NCT02689973|3468680|B3||White|Race (NIH/OMB)||Participants|Count of Participants|351|351.0||||||
3619281|NCT02689973|3468681|B2||White|Race (NIH/OMB)||Participants|Count of Participants|270|270.0||||||
3619282|NCT02689973|3468682|B1||White|Race (NIH/OMB)||Participants|Count of Participants|311|311.0||||||
3619283|NCT02689973|3468678|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619284|NCT02689973|3468679|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619285|NCT02689973|3468680|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619286|NCT02689973|3468681|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619287|NCT02689973|3468682|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619288|NCT02689973|3468678|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619289|NCT02689973|3468679|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619290|NCT02689973|3468680|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619291|NCT02689973|3468681|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619292|NCT02689973|3468682|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619293|NCT02689973|3468678|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619294|NCT02689973|3468679|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619295|NCT02689973|3468680|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619296|NCT02689973|3468681|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619297|NCT02689973|3468682|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619298|NCT02689973|3468678|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619299|NCT02689973|3468679|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619300|NCT02689973|3468680|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619301|NCT02689973|3468681|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619302|NCT02689973|3468682|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619303|NCT02689973|3468678|B5||Male|Sex: Female, Male||Participants|Count of Participants|510|510.0||||||
3619304|NCT02689973|3468679|B4||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3619305|NCT02689973|3468680|B3||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3619306|NCT02689973|3468681|B2||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3619307|NCT02689973|3468682|B1||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3619308|NCT02689973|3468678|B5||Female|Sex: Female, Male||Participants|Count of Participants|707|707.0||||||
3619309|NCT02689973|3468679|B4||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3619310|NCT02689973|3468680|B3||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
3619311|NCT02689973|3468681|B2||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3619312|NCT02689973|3468682|B1||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3619313|NCT02689973|3468678|B5|||Age||years|Mean|16.44|16.44|Standard Deviation|0.70|0.7|||
3619314|NCT02689973|3468679|B4|||Age||years|Mean|16.48|16.48|Standard Deviation|0.63|0.63|||
3619315|NCT02689973|3468680|B3|||Age||years|Mean|16.40|16.4|Standard Deviation|0.68|0.68|||
3619316|NCT02689973|3468681|B2|||Age||years|Mean|16.49|16.49|Standard Deviation|0.59|0.59|||
3619317|NCT02689973|3468682|B1|||Age||years|Mean|16.42|16.42|Standard Deviation|0.84|0.84|||
3619318|NCT02689804|3468707|B3|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3619319|NCT02689804|3468708|B2|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3619320|NCT02689804|3468709|B1|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3619321|NCT02689804|3468707|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3619322|NCT02689804|3468708|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3619323|NCT02689804|3468709|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3619324|NCT02689804|3468707|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3619325|NCT02689804|3468708|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3619326|NCT02689804|3468709|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3619327|NCT02689804|3468707|B3|||Age||years|Mean|30|30.0|Full Range|||19.0|45.0|
3619328|NCT02689804|3468708|B2|||Age||years|Mean|32.3|32.3|Full Range|||21.0|45.0|
3619329|NCT02689804|3468709|B1|||Age||years|Mean|28.8|28.8|Full Range|||19.0|35.0|
3619330|NCT02689206|3468736|B6|Race customized|White-White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|67|67.0||||||
3619331|NCT02689206|3468737|B5|Race customized|White-White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3619332|NCT02689206|3468738|B4|Race customized|White-White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3619333|NCT02689206|3468739|B3|Race customized|White-White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3619334|NCT02689206|3468740|B2|Race customized|White-White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3619335|NCT02689206|3468741|B1|Race customized|White-White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3619336|NCT02689206|3468736|B6|Race customized|White- Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3619337|NCT02689206|3468737|B5|Race customized|White- Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3619338|NCT02689206|3468738|B4|Race customized|White- Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3619339|NCT02689206|3468739|B3|Race customized|White- Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3619340|NCT02689206|3468740|B2|Race customized|White- Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3619341|NCT02689206|3468741|B1|Race customized|White- Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3619342|NCT02689206|3468736|B6|Race customized|Native Hawaiian Or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3619343|NCT02689206|3468737|B5|Race customized|Native Hawaiian Or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3619344|NCT02689206|3468738|B4|Race customized|Native Hawaiian Or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3619345|NCT02689206|3468739|B3|Race customized|Native Hawaiian Or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3619346|NCT02689206|3468740|B2|Race customized|Native Hawaiian Or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3619347|NCT02689206|3468741|B1|Race customized|Native Hawaiian Or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3619348|NCT02689206|3468736|B6|Race customized|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3619349|NCT02689206|3468737|B5|Race customized|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3619350|NCT02689206|3468738|B4|Race customized|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3619351|NCT02689206|3468739|B3|Race customized|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3619352|NCT02689206|3468740|B2|Race customized|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3619353|NCT02689206|3468741|B1|Race customized|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3619354|NCT02689206|3468736|B6|Race customized|American Indian Or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3619355|NCT02689206|3468737|B5|Race customized|American Indian Or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3619356|NCT02689206|3468738|B4|Race customized|American Indian Or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3619357|NCT02689206|3468739|B3|Race customized|American Indian Or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3619358|NCT02689206|3468740|B2|Race customized|American Indian Or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3619359|NCT02689206|3468741|B1|Race customized|American Indian Or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3619360|NCT02689206|3468736|B6|Race customized|African American/African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3619361|NCT02689206|3468737|B5|Race customized|African American/African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3619362|NCT02689206|3468738|B4|Race customized|African American/African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3619363|NCT02689206|3468739|B3|Race customized|African American/African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3619364|NCT02689206|3468740|B2|Race customized|African American/African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3619365|NCT02689206|3468741|B1|Race customized|African American/African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3619366|NCT02689206|3468736|B6||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3619367|NCT02689206|3468737|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3619368|NCT02689206|3468738|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3619369|NCT02689206|3468739|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3619370|NCT02689206|3468740|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3619371|NCT02689206|3468741|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3619372|NCT02689206|3468736|B6||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3619373|NCT02689206|3468737|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3619374|NCT02689206|3468738|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3619375|NCT02689206|3468739|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3619376|NCT02689206|3468740|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3619377|NCT02689206|3468741|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3619378|NCT02689206|3468736|B6|||Age||Years|Mean|63.4|63.4|Standard Deviation|14.39|14.39|||
3619379|NCT02689206|3468737|B5|||Age||Years|Mean|65.4|65.4|Standard Deviation|13.97|13.97|||
3619380|NCT02689206|3468738|B4|||Age||Years|Mean|67.2|67.2|Standard Deviation|15.22|15.22|||
3619381|NCT02689206|3468739|B3|||Age||Years|Mean|59.5|59.5|Standard Deviation|12.26|12.26|||
3619382|NCT02689206|3468740|B2|||Age||Years|Mean|63.6|63.6|Standard Deviation|16.98|16.98|||
3619383|NCT02689206|3468741|B1|||Age||Years|Mean|61.0|61.0|Standard Deviation|13.06|13.06|||
3619384|NCT02688933|3468949|B3|||Body mass index||kg/m^2|Mean|27.57|27.57|Standard Deviation|4.90|4.9|||
3619385|NCT02688933|3468950|B2|||Body mass index||kg/m^2|Mean|27.65|27.65|Standard Deviation|4.92|4.92|||
3619386|NCT02688933|3468951|B1|||Body mass index||kg/m^2|Mean|27.50|27.5|Standard Deviation|4.88|4.88|||
3619387|NCT02688933|3468949|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3619388|NCT02688933|3468950|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3619389|NCT02688933|3468951|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3619390|NCT02688933|3468949|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619391|NCT02688933|3468950|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619392|NCT02688933|3468951|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619393|NCT02688933|3468949|B3||White|Race (NIH/OMB)||Participants|Count of Participants|563|563.0||||||
3619394|NCT02688933|3468950|B2||White|Race (NIH/OMB)||Participants|Count of Participants|282|282.0||||||
3619395|NCT02688933|3468951|B1||White|Race (NIH/OMB)||Participants|Count of Participants|281|281.0||||||
3619396|NCT02688933|3468949|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3619397|NCT02688933|3468950|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3619398|NCT02688933|3468951|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3619399|NCT02688933|3468949|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3619400|NCT02688933|3468950|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3619401|NCT02688933|3468951|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3619402|NCT02688933|3468949|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3619403|NCT02688933|3468950|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3619404|NCT02688933|3468951|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3619405|NCT02688933|3468949|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3619406|NCT02688933|3468950|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619407|NCT02688933|3468951|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3619408|NCT02688933|3468949|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619409|NCT02688933|3468950|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619410|NCT02688933|3468951|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619411|NCT02688933|3468949|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|553|553.0||||||
3619412|NCT02688933|3468950|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|276|276.0||||||
3619413|NCT02688933|3468951|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|277|277.0||||||
3619414|NCT02688933|3468949|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3619415|NCT02688933|3468950|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3619416|NCT02688933|3468951|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3619417|NCT02688933|3468949|B3||Male|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
3619418|NCT02688933|3468950|B2||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3619419|NCT02688933|3468951|B1||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3619420|NCT02688933|3468949|B3||Female|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
3619421|NCT02688933|3468950|B2||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3619422|NCT02688933|3468951|B1||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3619423|NCT02688933|3468949|B3|||Age||years|Mean|45.5|45.5|Standard Deviation|13.9|13.9|||
3619424|NCT02688933|3468950|B2|||Age||years|Mean|45.5|45.5|Standard Deviation|13.9|13.9|||
3619425|NCT02688933|3468951|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|14.0|14.0|||
3619426|NCT02688153|3468972|B3|Europe||Region of Enrollment||Participants|Number|120|120.0||||||
3619427|NCT02688153|3468973|B2|Europe||Region of Enrollment||Participants|Number|61|61.0||||||
3619428|NCT02688153|3468974|B1|Europe||Region of Enrollment||Participants|Number|59|59.0||||||
3619429|NCT02688153|3468972|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3619430|NCT02688153|3468973|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3619431|NCT02688153|3468974|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3619432|NCT02688153|3468972|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3619433|NCT02688153|3468973|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3619434|NCT02688153|3468974|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3619435|NCT02688153|3468972|B3|||Age||years|Mean|79.7|79.7|Standard Deviation|4.6|4.6|||
3619436|NCT02688153|3468973|B2|||Age||years|Mean|80.0|80.0|Standard Deviation|4.8|4.8|||
3619437|NCT02688153|3468974|B1|||Age||years|Mean|79.4|79.4|Standard Deviation|4.2|4.2|||
3619438|NCT02687542|3469033|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3619439|NCT02687542|3469034|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3619440|NCT02687542|3469035|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619441|NCT02687542|3469036|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3619442|NCT02687542|3469037|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619443|NCT02687542|3469038|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619444|NCT02687542|3469033|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619445|NCT02687542|3469034|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619446|NCT02687542|3469035|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619447|NCT02687542|3469036|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619448|NCT02687542|3469037|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619449|NCT02687542|3469038|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619450|NCT02687542|3469033|B6||White|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
3619451|NCT02687542|3469034|B5||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3619452|NCT02687542|3469035|B4||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3619453|NCT02687542|3469036|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3619454|NCT02687542|3469037|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3619455|NCT02687542|3469038|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3619456|NCT02687542|3469033|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3619457|NCT02687542|3469034|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3619458|NCT02687542|3469035|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3619459|NCT02687542|3469036|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619460|NCT02687542|3469037|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3619461|NCT02687542|3469038|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3619462|NCT02687542|3469033|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619463|NCT02687542|3469034|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619464|NCT02687542|3469035|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619465|NCT02687542|3469036|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619466|NCT02687542|3469037|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619467|NCT02687542|3469038|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619468|NCT02687542|3469033|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3619469|NCT02687542|3469034|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3619470|NCT02687542|3469035|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3619471|NCT02687542|3469036|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3619472|NCT02687542|3469037|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619473|NCT02687542|3469038|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3619474|NCT02687542|3469033|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3619475|NCT02687542|3469034|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619476|NCT02687542|3469035|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3619477|NCT02687542|3469036|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619478|NCT02687542|3469037|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619479|NCT02687542|3469038|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619480|NCT02687542|3469033|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3619481|NCT02687542|3469034|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3619482|NCT02687542|3469035|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619483|NCT02687542|3469036|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3619484|NCT02687542|3469037|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619485|NCT02687542|3469038|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619486|NCT02687542|3469033|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3619487|NCT02687542|3469034|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3619488|NCT02687542|3469035|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3619489|NCT02687542|3469036|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3619490|NCT02687542|3469037|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3619491|NCT02687542|3469038|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3619492|NCT02687542|3469033|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3619493|NCT02687542|3469034|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3619494|NCT02687542|3469035|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3619495|NCT02687542|3469036|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3619496|NCT02687542|3469037|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3619497|NCT02687542|3469038|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3619498|NCT02687542|3469033|B6||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3619499|NCT02687542|3469034|B5||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3619500|NCT02687542|3469035|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3619501|NCT02687542|3469036|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3619502|NCT02687542|3469037|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3619503|NCT02687542|3469038|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3619504|NCT02687542|3469033|B6||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3619505|NCT02687542|3469034|B5||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3619506|NCT02687542|3469035|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3619507|NCT02687542|3469036|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3619508|NCT02687542|3469037|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3619509|NCT02687542|3469038|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3619510|NCT02687542|3469033|B6|||Age||years|Mean|64.97|64.97|Standard Deviation|8.60|8.6|||
3619511|NCT02687542|3469034|B5|||Age||years|Mean|63.41|63.41|Standard Deviation|8.47|8.47|||
3619512|NCT02687542|3469035|B4|||Age||years|Mean|67.77|67.77|Standard Deviation|9.36|9.36|||
3619513|NCT02687542|3469036|B3|||Age||years|Mean|63.80|63.8|Standard Deviation|7.76|7.76|||
3619514|NCT02687542|3469037|B2|||Age||years|Mean|66.92|66.92|Standard Deviation|8.79|8.79|||
3619515|NCT02687542|3469038|B1|||Age||years|Mean|66.04|66.04|Standard Deviation|8.79|8.79|||
3619516|NCT02687217|3469114|B3|||length of hospital stay||days|Mean|3.87|3.87|Standard Deviation|1|1.0|||
3619517|NCT02687217|3469115|B2|||length of hospital stay||days|Mean|3.87|3.87|Standard Deviation|1|1.0|||
3619518|NCT02687217|3469116|B1|||length of hospital stay||days|Mean|3.87|3.87|Standard Deviation|1|1.0|||
3619519|NCT02687217|3469114|B3|||Use of antibiotics||days|Mean|5.43|5.43|Standard Deviation|1.19|1.19|||
3619520|NCT02687217|3469115|B2|||Use of antibiotics||days|Mean|5.60|5.6|Standard Deviation|1.27|1.27|||
3619521|NCT02687217|3469116|B1|||Use of antibiotics||days|Mean|5.26|5.26|Standard Deviation|1.11|1.11|||
3619522|NCT02687217|3469114|B3|||Postoperative Total leucocyte count||10^3 cells per mm^3|Mean|8.6|8.6|Standard Deviation|1.74|1.74|||
3619523|NCT02687217|3469115|B2|||Postoperative Total leucocyte count||10^3 cells per mm^3|Mean|9.03|9.03|Standard Deviation|2.10|2.1|||
3619524|NCT02687217|3469116|B1|||Postoperative Total leucocyte count||10^3 cells per mm^3|Mean|8.16|8.16|Standard Deviation|1.17|1.17|||
3619525|NCT02687217|3469114|B3|||Postoperative partial pressure of arterial oxygen||mmhg|Mean|119|119.0|Standard Deviation|3.13|3.13|||
3619526|NCT02687217|3469115|B2|||Postoperative partial pressure of arterial oxygen||mmhg|Mean|137.6|137.6|Standard Deviation|2.49|2.49|||
3619527|NCT02687217|3469116|B1|||Postoperative partial pressure of arterial oxygen||mmhg|Mean|86.21|86.21|Standard Deviation|3.85|3.85|||
3619528|NCT02687217|3469114|B3|||Duration of surgery||Hours|Mean|1.1|1.1|Standard Deviation|.23|0.23|||
3619529|NCT02687217|3469115|B2|||Duration of surgery||Hours|Mean|1.14|1.14|Standard Deviation|.29|0.29|||
3619530|NCT02687217|3469116|B1|||Duration of surgery||Hours|Mean|1.05|1.05|Standard Deviation|.15|0.15|||
3619531|NCT02687217|3469114|B3|Gangrenous Appendicitis||Intraoperative findings||participants|Number|5|5.0||||||
3619532|NCT02687217|3469115|B2|Gangrenous Appendicitis||Intraoperative findings||participants|Number|4|4.0||||||
3619533|NCT02687217|3469116|B1|Gangrenous Appendicitis||Intraoperative findings||participants|Number|1|1.0||||||
3619534|NCT02687217|3469114|B3|Acute Appendicitis||Intraoperative findings||participants|Number|55|55.0||||||
3619535|NCT02687217|3469115|B2|Acute Appendicitis||Intraoperative findings||participants|Number|26|26.0||||||
3619536|NCT02687217|3469116|B1|Acute Appendicitis||Intraoperative findings||participants|Number|29|29.0||||||
3619537|NCT02687217|3469114|B3|||Intraoperative oxygen saturation||percentage of oxygenated haemoglobin|Mean|97.76|97.76|Standard Deviation|3.80|3.8|||
3619538|NCT02687217|3469115|B2|||Intraoperative oxygen saturation||percentage of oxygenated haemoglobin|Mean|98.50|98.5|Standard Deviation|1.08|1.08|||
3619539|NCT02687217|3469116|B1|||Intraoperative oxygen saturation||percentage of oxygenated haemoglobin|Mean|97.01|97.01|Standard Deviation|5.20|5.2|||
3619540|NCT02687217|3469114|B3|||Intraoperative bicarbonate||mmol/L|Mean|23.36|23.36|Standard Deviation|2.53|2.53|||
3619541|NCT02687217|3469115|B2|||Intraoperative bicarbonate||mmol/L|Mean|23.60|23.6|Standard Deviation|3.39|3.39|||
3619542|NCT02687217|3469116|B1|||Intraoperative bicarbonate||mmol/L|Mean|23.12|23.12|Standard Deviation|1.2|1.2|||
3619543|NCT02687217|3469114|B3|||Intraoperative partial pressure of carbon dioxide||mmHg|Mean|36.49|36.49|Standard Deviation|4.94|4.94|||
3619544|NCT02687217|3469115|B2|||Intraoperative partial pressure of carbon dioxide||mmHg|Mean|36.16|36.16|Standard Deviation|6.46|6.46|||
3619545|NCT02687217|3469116|B1|||Intraoperative partial pressure of carbon dioxide||mmHg|Mean|36.82|36.82|Standard Deviation|2.78|2.78|||
3619546|NCT02687217|3469114|B3|||Intraoperative partial pressure of arterial oxygen||mmHg|Mean|119|119.0|Standard Deviation|3.86|3.86|||
3619547|NCT02687217|3469115|B2|||Intraoperative partial pressure of arterial oxygen||mmHg|Mean|151.67|151.67|Standard Deviation|2.88|2.88|||
3619548|NCT02687217|3469116|B1|||Intraoperative partial pressure of arterial oxygen||mmHg|Mean|86.53|86.53|Standard Deviation|3.52|3.52|||
3619549|NCT02687217|3469114|B3|||Intraoperative pH||pH|Mean|7.39|7.39|Standard Deviation|0.04|0.04|||
3619550|NCT02687217|3469115|B2|||Intraoperative pH||pH|Mean|7.40|7.4|Standard Deviation|0.05|0.05|||
3619551|NCT02687217|3469116|B1|||Intraoperative pH||pH|Mean|7.39|7.39|Standard Deviation|0.03|0.03|||
3619552|NCT02687217|3469114|B3|unstable||Haemodynamic parameter|Stable: With normal haemodynamic parameter. Unstable: With deranged hemodynamic parameter.|participants|Number|0|0.0||||||
3619611|NCT02686437|3469135|B2|||Age||years|Mean|37.75|37.75|Full Range|||19.0|64.0|
3619553|NCT02687217|3469115|B2|unstable||Haemodynamic parameter|Stable: With normal haemodynamic parameter. Unstable: With deranged hemodynamic parameter.|participants|Number|0|0.0||||||
3619554|NCT02687217|3469116|B1|unstable||Haemodynamic parameter|Stable: With normal haemodynamic parameter. Unstable: With deranged hemodynamic parameter.|participants|Number|0|0.0||||||
3619555|NCT02687217|3469114|B3|Stable||Haemodynamic parameter|Stable: With normal haemodynamic parameter. Unstable: With deranged hemodynamic parameter.|participants|Number|60|60.0||||||
3619556|NCT02687217|3469115|B2|Stable||Haemodynamic parameter|Stable: With normal haemodynamic parameter. Unstable: With deranged hemodynamic parameter.|participants|Number|30|30.0||||||
3619557|NCT02687217|3469116|B1|Stable||Haemodynamic parameter|Stable: With normal haemodynamic parameter. Unstable: With deranged hemodynamic parameter.|participants|Number|30|30.0||||||
3619558|NCT02687217|3469114|B3|||Preoperative Total leucocyte count||10^3 cells per mm^3|Mean|12.75|12.75|Standard Deviation|2.88|2.88|||
3619559|NCT02687217|3469115|B2|||Preoperative Total leucocyte count||10^3 cells per mm^3|Mean|13.30|13.3|Standard Deviation|3.65|3.65|||
3619560|NCT02687217|3469116|B1|||Preoperative Total leucocyte count||10^3 cells per mm^3|Mean|12.20|12.2|Standard Deviation|1.71|1.71|||
3619561|NCT02687217|3469114|B3|||Preoperative Haemoglobin||g/dL|Mean|12.97|12.97|Standard Deviation|1.38|1.38|||
3619562|NCT02687217|3469115|B2|||Preoperative Haemoglobin||g/dL|Mean|13.07|13.07|Standard Deviation|1.57|1.57|||
3619563|NCT02687217|3469116|B1|||Preoperative Haemoglobin||g/dL|Mean|12.87|12.87|Standard Deviation|1.17|1.17|||
3619564|NCT02687217|3469114|B3|||Abdominal pain duration||days|Mean|1.60|1.6|Standard Deviation|0.76|0.76|||
3619565|NCT02687217|3469115|B2|||Abdominal pain duration||days|Mean|1.87|1.87|Standard Deviation|0.86|0.86|||
3619566|NCT02687217|3469116|B1|||Abdominal pain duration||days|Mean|1.33|1.33|Standard Deviation|0.54|0.54|||
3619567|NCT02687217|3469114|B3|||Body temperature||degrees Fahrenheit|Mean|98.56|98.56|Standard Deviation|1.08|1.08|||
3619568|NCT02687217|3469115|B2|||Body temperature||degrees Fahrenheit|Mean|98.67|98.67|Standard Deviation|1.16|1.16|||
3619569|NCT02687217|3469116|B1|||Body temperature||degrees Fahrenheit|Mean|98.45|98.45|Standard Deviation|1.01|1.01|||
3619570|NCT02687217|3469114|B3|||Body Mass Index||Kg/m^2|Mean|22.81|22.81|Standard Deviation|3.7|3.7|||
3619571|NCT02687217|3469115|B2|||Body Mass Index||Kg/m^2|Mean|23.35|23.35|Standard Deviation|4.25|4.25|||
3619572|NCT02687217|3469116|B1|||Body Mass Index||Kg/m^2|Mean|22.71|22.71|Standard Deviation|3.17|3.17|||
3619573|NCT02687217|3469114|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3619574|NCT02687217|3469115|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3619575|NCT02687217|3469116|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3619576|NCT02687217|3469114|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3619577|NCT02687217|3469115|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3619578|NCT02687217|3469116|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3619579|NCT02687217|3469114|B3|41-45||Age, Customized||participants|Number|2|2.0||||||
3619580|NCT02687217|3469115|B2|41-45||Age, Customized||participants|Number|1|1.0||||||
3619581|NCT02687217|3469116|B1|41-45||Age, Customized||participants|Number|1|1.0||||||
3619582|NCT02687217|3469114|B3|36-40||Age, Customized||participants|Number|5|5.0||||||
3619583|NCT02687217|3469115|B2|36-40||Age, Customized||participants|Number|2|2.0||||||
3619584|NCT02687217|3469116|B1|36-40||Age, Customized||participants|Number|3|3.0||||||
3619585|NCT02687217|3469114|B3|31-35||Age, Customized||participants|Number|5|5.0||||||
3619586|NCT02687217|3469115|B2|31-35||Age, Customized||participants|Number|2|2.0||||||
3619587|NCT02687217|3469116|B1|31-35||Age, Customized||participants|Number|3|3.0||||||
3619588|NCT02687217|3469114|B3|26-30||Age, Customized||participants|Number|14|14.0||||||
3619589|NCT02687217|3469115|B2|26-30||Age, Customized||participants|Number|7|7.0||||||
3619590|NCT02687217|3469116|B1|26-30||Age, Customized||participants|Number|7|7.0||||||
3619591|NCT02687217|3469114|B3|21-25 years||Age, Customized||participants|Number|19|19.0||||||
3619592|NCT02687217|3469115|B2|21-25 years||Age, Customized||participants|Number|10|10.0||||||
3619593|NCT02687217|3469116|B1|21-25 years||Age, Customized||participants|Number|9|9.0||||||
3619594|NCT02687217|3469114|B3|15-20 years||Age, Customized||participants|Number|15|15.0||||||
3619595|NCT02687217|3469115|B2|15-20 years||Age, Customized||participants|Number|8|8.0||||||
3619596|NCT02687217|3469116|B1|15-20 years||Age, Customized||participants|Number|7|7.0||||||
3619597|NCT02687126|3469127|B1|||Cross sectional area of the Internal Jugular Vein||Square of centimeter|Median|0.775|0.775|Full Range|||0.12|2.01|
3619598|NCT02687126|3469127|B1|||Body surface area|Body surface area was calculated using Mosteller's formula|Square of meter|Median|0.655|0.655|Full Range|||0.22|1.52|
3619599|NCT02687126|3469127|B1|||Weight||Kilograms|Median|15|15.0|Full Range|||3.0|54.0|
3619600|NCT02687126|3469127|B1|||Height||Centimeters|Median|102|102.0|Full Range|||51.0|163.0|
3619601|NCT02687126|3469127|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3619602|NCT02687126|3469127|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3619603|NCT02687126|3469127|B1|||Age||Months|Median|60|60.0|Full Range|||1.5|180.0|
3619604|NCT02686437|3469134|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3619605|NCT02686437|3469135|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3619606|NCT02686437|3469136|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3619607|NCT02686437|3469134|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3619608|NCT02686437|3469135|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3619609|NCT02686437|3469136|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3619610|NCT02686437|3469134|B3|||Age||years|Mean|39.81|39.81|Full Range|||18.0|64.0|
3619612|NCT02686437|3469136|B1|||Age||years|Mean|42.38|42.38|Full Range|||18.0|63.0|
3619613|NCT02685488|3469145|B3|||Overall Anxiety Severity and Impairment Scale|The Overall Anxiety Severity and Impairment Scale (OASIS) assesses severity of anxiety symptoms across anxiety disorders and with subsyndromal symptoms. Participants rate five items on a scale from 0 (indicating no anxiety or impairment) to 4 (indicating severe or extreme anxiety or impairment). Scores range from 0 to 20, with higher scores indicating more severe anxiety and impairment from anxiety (Norman et al., 2006).|units on a scale|Mean|5.77|5.77|Standard Deviation|2.847|2.847|||
3619614|NCT02685488|3469146|B2|||Overall Anxiety Severity and Impairment Scale|The Overall Anxiety Severity and Impairment Scale (OASIS) assesses severity of anxiety symptoms across anxiety disorders and with subsyndromal symptoms. Participants rate five items on a scale from 0 (indicating no anxiety or impairment) to 4 (indicating severe or extreme anxiety or impairment). Scores range from 0 to 20, with higher scores indicating more severe anxiety and impairment from anxiety (Norman et al., 2006).|units on a scale|Mean|5.79|5.79|Standard Deviation|2.392|2.392|||
3619615|NCT02685488|3469147|B1|||Overall Anxiety Severity and Impairment Scale|The Overall Anxiety Severity and Impairment Scale (OASIS) assesses severity of anxiety symptoms across anxiety disorders and with subsyndromal symptoms. Participants rate five items on a scale from 0 (indicating no anxiety or impairment) to 4 (indicating severe or extreme anxiety or impairment). Scores range from 0 to 20, with higher scores indicating more severe anxiety and impairment from anxiety (Norman et al., 2006).|units on a scale|Mean|5.75|5.75|Standard Deviation|3.415|3.415|||
3619616|NCT02685488|3469145|B3|||Ruminative Responses Scale|The Ruminative Responses scale (RRS) consists of 22 statements. It measures rumination, past-focused repetitive thinking that causes and maintains depression. Participants are asked to rate on a scale of 1 (almost never) to 4 (almost always) how much they think about various things (e.g. “think about how alone you feel” and “think about all your shortcomings, failings, faults, mistakes”). Scores range from 22 to 88 with higher scores indicating more rumination.|units on a scale|Mean|46.35|46.35|Standard Deviation|9.847|9.847|||
3619617|NCT02685488|3469146|B2|||Ruminative Responses Scale|The Ruminative Responses scale (RRS) consists of 22 statements. It measures rumination, past-focused repetitive thinking that causes and maintains depression. Participants are asked to rate on a scale of 1 (almost never) to 4 (almost always) how much they think about various things (e.g. “think about how alone you feel” and “think about all your shortcomings, failings, faults, mistakes”). Scores range from 22 to 88 with higher scores indicating more rumination.|units on a scale|Mean|43.29|43.29|Standard Deviation|9.980|9.98|||
3619618|NCT02685488|3469147|B1|||Ruminative Responses Scale|The Ruminative Responses scale (RRS) consists of 22 statements. It measures rumination, past-focused repetitive thinking that causes and maintains depression. Participants are asked to rate on a scale of 1 (almost never) to 4 (almost always) how much they think about various things (e.g. “think about how alone you feel” and “think about all your shortcomings, failings, faults, mistakes”). Scores range from 22 to 88 with higher scores indicating more rumination.|units on a scale|Mean|49.92|49.92|Standard Deviation|8.764|8.764|||
3619619|NCT02685488|3469145|B3|||Penn State Worry Questionnaire|The PSWQ assesses trait worry, a key component of Generalized Anxiety Disorder. Participants rate themselves on a scale of 1 (“not at all typical of me”) to 5 (“very typical of me”) for sixteen different statements. Scores range from 16-80, and higher scores reflect higher levels of worry. This scale has been widely used to assess worry and will allow for assessment of worry in the present study (Brown et al., 1992).|units on a scale|Mean|53.96|53.96|Standard Deviation|10.611|10.611|||
3619620|NCT02685488|3469146|B2|||Penn State Worry Questionnaire|The PSWQ assesses trait worry, a key component of Generalized Anxiety Disorder. Participants rate themselves on a scale of 1 (“not at all typical of me”) to 5 (“very typical of me”) for sixteen different statements. Scores range from 16-80, and higher scores reflect higher levels of worry. This scale has been widely used to assess worry and will allow for assessment of worry in the present study (Brown et al., 1992).|units on a scale|Mean|50.71|50.71|Standard Deviation|10.709|10.709|||
3619621|NCT02685488|3469147|B1|||Penn State Worry Questionnaire|The PSWQ assesses trait worry, a key component of Generalized Anxiety Disorder. Participants rate themselves on a scale of 1 (“not at all typical of me”) to 5 (“very typical of me”) for sixteen different statements. Scores range from 16-80, and higher scores reflect higher levels of worry. This scale has been widely used to assess worry and will allow for assessment of worry in the present study (Brown et al., 1992).|units on a scale|Mean|57.75|57.75|Standard Deviation|9.555|9.555|||
3619622|NCT02685488|3469145|B3|||Beck Depression Inventory II|The Beck Depression Inventory-II (BDI-II) is one of the most widely used self-report measures for assessing depression. It includes 21 self-report items. Scores range from 0 to 63, and higher scores indicate higher levels of depressive symptoms.|units on a scale|Mean|16.92|16.92|Standard Deviation|4.783|4.783|||
3619623|NCT02685488|3469146|B2|||Beck Depression Inventory II|The Beck Depression Inventory-II (BDI-II) is one of the most widely used self-report measures for assessing depression. It includes 21 self-report items. Scores range from 0 to 63, and higher scores indicate higher levels of depressive symptoms.|units on a scale|Mean|16.57|16.57|Standard Deviation|5.36|5.36|||
3619624|NCT02685488|3469147|B1|||Beck Depression Inventory II|The Beck Depression Inventory-II (BDI-II) is one of the most widely used self-report measures for assessing depression. It includes 21 self-report items. Scores range from 0 to 63, and higher scores indicate higher levels of depressive symptoms.|units on a scale|Mean|17.33|17.33|Standard Deviation|4.207|4.207|||
3619625|NCT02685488|3469145|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
3619626|NCT02685488|3469146|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3619627|NCT02685488|3469147|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3619628|NCT02685488|3469145|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3619629|NCT02685488|3469146|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3619630|NCT02685488|3469147|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3619631|NCT02685488|3469145|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3619632|NCT02685488|3469146|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619633|NCT02685488|3469147|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3619634|NCT02685488|3469145|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3619635|NCT02685488|3469146|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3619636|NCT02685488|3469147|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3619637|NCT02685488|3469145|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3619638|NCT02685488|3469146|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3619639|NCT02685488|3469147|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619640|NCT02685488|3469145|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619641|NCT02685488|3469146|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619642|NCT02685488|3469147|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619643|NCT02685488|3469145|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3619644|NCT02685488|3469146|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3619645|NCT02685488|3469147|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3619646|NCT02685488|3469145|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619647|NCT02685488|3469146|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619648|NCT02685488|3469147|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619649|NCT02685488|3469145|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3619650|NCT02685488|3469146|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3619651|NCT02685488|3469147|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3619652|NCT02685488|3469145|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3619653|NCT02685488|3469146|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3619654|NCT02685488|3469147|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3619655|NCT02685488|3469145|B3|||Age||years|Mean|18.88|18.88|Standard Deviation|1.071|1.071|||
3619656|NCT02685488|3469146|B2|||Age||years|Mean|19.14|19.14|Standard Deviation|1.292|1.292|||
3619657|NCT02685488|3469147|B1|||Age||years|Mean|18.58|18.58|Standard Deviation|.669|0.669|||
3619658|NCT02685488|3469145|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3619659|NCT02685488|3469146|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3619660|NCT02685488|3469147|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3619661|NCT02685488|3469145|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3619662|NCT02685488|3469146|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3619663|NCT02685488|3469147|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3619664|NCT02685488|3469145|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3619665|NCT02685488|3469146|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3619666|NCT02685488|3469147|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3619667|NCT02685202|3469162|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3619668|NCT02685202|3469162|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619669|NCT02685202|3469162|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619670|NCT02685202|3469162|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3619671|NCT02685202|3469162|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619672|NCT02685202|3469162|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619673|NCT02685202|3469162|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619674|NCT02685202|3469162|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619675|NCT02685202|3469162|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3619676|NCT02685202|3469162|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3619677|NCT02685202|3469162|B1|||Age||years|Mean|53.|0.0|Standard Deviation|2.3|2.3|||
3619678|NCT02685202|3469162|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3619679|NCT02685202|3469162|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3619680|NCT02685202|3469162|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3619681|NCT02684942|3469168|B1|IVB||FIGO stage|"Cervical cancer staging at diagnosis was based on the International Federation of Gynecology and Obstetrics (FIGO).~Stage I is the least severe, where the tumor is confined to the cervix. Stage II Tumor invades beyond uterus but not to pelvic wall or lower third of vagina.~Stage III Extends to pelvic wall and/or lower 1/3 vagina and/or causes hydronephrosis or nonfunctional kidney.~Stage IV Is the most severe, Tumor invades mucosa of bladder or rectum and/or extends beyond true pelvis."|participants|Number|1|1.0||||||
3619682|NCT02684942|3469168|B1|IIIB||FIGO stage|"Cervical cancer staging at diagnosis was based on the International Federation of Gynecology and Obstetrics (FIGO).~Stage I is the least severe, where the tumor is confined to the cervix. Stage II Tumor invades beyond uterus but not to pelvic wall or lower third of vagina.~Stage III Extends to pelvic wall and/or lower 1/3 vagina and/or causes hydronephrosis or nonfunctional kidney.~Stage IV Is the most severe, Tumor invades mucosa of bladder or rectum and/or extends beyond true pelvis."|participants|Number|15|15.0||||||
3619724|NCT02684630|3469189|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3619725|NCT02684630|3469187|B3|Age ≥ 18 years||Age, Customized||Participants|Count of Participants|128|128.0||||||
3619726|NCT02684630|3469188|B2|Age ≥ 18 years||Age, Customized||Participants|Count of Participants|63|63.0||||||
3619683|NCT02684942|3469168|B1|IIB||FIGO stage|"Cervical cancer staging at diagnosis was based on the International Federation of Gynecology and Obstetrics (FIGO).~Stage I is the least severe, where the tumor is confined to the cervix. Stage II Tumor invades beyond uterus but not to pelvic wall or lower third of vagina.~Stage III Extends to pelvic wall and/or lower 1/3 vagina and/or causes hydronephrosis or nonfunctional kidney.~Stage IV Is the most severe, Tumor invades mucosa of bladder or rectum and/or extends beyond true pelvis."|participants|Number|16|16.0||||||
3619684|NCT02684942|3469168|B1|IIA2||FIGO stage|"Cervical cancer staging at diagnosis was based on the International Federation of Gynecology and Obstetrics (FIGO).~Stage I is the least severe, where the tumor is confined to the cervix. Stage II Tumor invades beyond uterus but not to pelvic wall or lower third of vagina.~Stage III Extends to pelvic wall and/or lower 1/3 vagina and/or causes hydronephrosis or nonfunctional kidney.~Stage IV Is the most severe, Tumor invades mucosa of bladder or rectum and/or extends beyond true pelvis."|participants|Number|1|1.0||||||
3619685|NCT02684942|3469168|B1|IIA1||FIGO stage|"Cervical cancer staging at diagnosis was based on the International Federation of Gynecology and Obstetrics (FIGO).~Stage I is the least severe, where the tumor is confined to the cervix. Stage II Tumor invades beyond uterus but not to pelvic wall or lower third of vagina.~Stage III Extends to pelvic wall and/or lower 1/3 vagina and/or causes hydronephrosis or nonfunctional kidney.~Stage IV Is the most severe, Tumor invades mucosa of bladder or rectum and/or extends beyond true pelvis."|participants|Number|2|2.0||||||
3619686|NCT02684942|3469168|B1|IB||FIGO stage|"Cervical cancer staging at diagnosis was based on the International Federation of Gynecology and Obstetrics (FIGO).~Stage I is the least severe, where the tumor is confined to the cervix. Stage II Tumor invades beyond uterus but not to pelvic wall or lower third of vagina.~Stage III Extends to pelvic wall and/or lower 1/3 vagina and/or causes hydronephrosis or nonfunctional kidney.~Stage IV Is the most severe, Tumor invades mucosa of bladder or rectum and/or extends beyond true pelvis."|participants|Number|5|5.0||||||
3619687|NCT02684942|3469168|B1|3D conformal||Radiation modality|Generally, the brachytherapy technique divided into two methods; 1.2D method is based on 2D imaging x-ray 2.3D method is based on 3D imaging which have been incorporated into treatment planning methods, allowing full 3D dose distributions to be computed.|participants|Number|10|10.0||||||
3619688|NCT02684942|3469168|B1|2D, two-dimensional||Radiation modality|Generally, the brachytherapy technique divided into two methods; 1.2D method is based on 2D imaging x-ray 2.3D method is based on 3D imaging which have been incorporated into treatment planning methods, allowing full 3D dose distributions to be computed.|participants|Number|30|30.0||||||
3619689|NCT02684942|3469168|B1||Male|Sex: Female, Male|Study in patients with cervical cancer.|Participants|Count of Participants|0|0.0||||||
3619690|NCT02684942|3469168|B1||Female|Sex: Female, Male|Study in patients with cervical cancer.|Participants|Count of Participants|40|40.0||||||
3619691|NCT02684942|3469168|B1|||Age||years|Mean|56.7|56.7|Standard Deviation|12.9|12.9|||
3619692|NCT02684630|3469187|B3|||Total Blood Volume (mL)||mililiters|Mean|5249.5|5249.5|Standard Deviation|824.15|824.15|||
3619693|NCT02684630|3469188|B2|||Total Blood Volume (mL)||mililiters|Mean|5285.7|5285.7|Standard Deviation|735.86|735.86|||
3619694|NCT02684630|3469189|B1|||Total Blood Volume (mL)||mililiters|Mean|5214.3|5214.3|Standard Deviation|905.93|905.93|||
3619695|NCT02684630|3469187|B3|||Weight (lbs)||pounds|Mean|191.0|191.0|Standard Deviation|34.47|34.47|||
3619696|NCT02684630|3469188|B2|||Weight (lbs)||pounds|Mean|191.6|191.6|Standard Deviation|31.23|31.23|||
3619697|NCT02684630|3469189|B1|||Weight (lbs)||pounds|Mean|190.3|190.3|Standard Deviation|37.59|37.59|||
3619698|NCT02684630|3469187|B3|||Height (in)||inches|Mean|69.0|69.0|Standard Deviation|3.69|3.69|||
3619699|NCT02684630|3469188|B2|||Height (in)||inches|Mean|69.0|69.0|Standard Deviation|3.43|3.43|||
3619700|NCT02684630|3469189|B1|||Height (in)||inches|Mean|68.9|68.9|Standard Deviation|3.95|3.95|||
3619701|NCT02684630|3469187|B3|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3619702|NCT02684630|3469188|B2|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3619703|NCT02684630|3469189|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3619704|NCT02684630|3469187|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3619705|NCT02684630|3469188|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3619706|NCT02684630|3469189|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3619707|NCT02684630|3469187|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|109|109.0||||||
3619708|NCT02684630|3469188|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|53|53.0||||||
3619709|NCT02684630|3469189|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|56|56.0||||||
3619710|NCT02684630|3469187|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3619711|NCT02684630|3469188|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3619712|NCT02684630|3469189|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3619713|NCT02684630|3469187|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3619714|NCT02684630|3469188|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3619715|NCT02684630|3469189|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3619716|NCT02684630|3469187|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3619717|NCT02684630|3469188|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3619718|NCT02684630|3469189|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3619719|NCT02684630|3469187|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3619720|NCT02684630|3469188|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3619721|NCT02684630|3469189|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3619722|NCT02684630|3469187|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3619723|NCT02684630|3469188|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3619727|NCT02684630|3469189|B1|Age ≥ 18 years||Age, Customized||Participants|Count of Participants|65|65.0||||||
3619728|NCT02684604|3469198|B3|||serum progesterone level||nanogram per millilitre|Mean|14.55|14.55|Standard Deviation|5.52|5.52|||
3619729|NCT02684604|3469199|B2|||serum progesterone level||nanogram per millilitre|Mean|15.01|15.01|Standard Deviation|5.21|5.21|||
3619730|NCT02684604|3469200|B1|||serum progesterone level||nanogram per millilitre|Mean|14.09|14.09|Standard Deviation|4.91|4.91|||
3619731|NCT02684604|3469198|B3|||serum estradiole level||picogram per millilitre|Mean|41.04|41.04|Standard Deviation|14.02|14.02|||
3619732|NCT02684604|3469199|B2|||serum estradiole level||picogram per millilitre|Mean|34.52|34.52|Standard Deviation|12.41|12.41|||
3619733|NCT02684604|3469200|B1|||serum estradiole level||picogram per millilitre|Mean|47.56|47.56|Standard Deviation|16.55|16.55|||
3619734|NCT02684604|3469198|B3|||serum prolactin level||nanogram per millilitre|Mean|8.72|8.72|Standard Deviation|3.45|3.45|||
3619735|NCT02684604|3469199|B2|||serum prolactin level||nanogram per millilitre|Mean|9.21|9.21|Standard Deviation|4.91|4.91|||
3619736|NCT02684604|3469200|B1|||serum prolactin level||nanogram per millilitre|Mean|8.23|8.23|Standard Deviation|3.39|3.39|||
3619737|NCT02684604|3469198|B3|||serum LH level||international unit per litre|Mean|4.92|4.92|Standard Deviation|2.11|2.11|||
3619738|NCT02684604|3469199|B2|||serum LH level||international unit per litre|Mean|4.41|4.41|Standard Deviation|3.21|3.21|||
3619739|NCT02684604|3469200|B1|||serum LH level||international unit per litre|Mean|5.43|5.43|Standard Deviation|2.69|2.69|||
3619740|NCT02684604|3469198|B3|||serum FSH level||international unit per litre|Mean|5.53|5.53|Standard Deviation|3.12|3.12|||
3619741|NCT02684604|3469199|B2|||serum FSH level||international unit per litre|Mean|4.21|4.21|Standard Deviation|1.85|1.85|||
3619742|NCT02684604|3469200|B1|||serum FSH level||international unit per litre|Mean|6.85|6.85|Standard Deviation|2.17|2.17|||
3619743|NCT02684604|3469198|B3|secondary infertility||type of infertility||participants|Number|3|3.0||||||
3619744|NCT02684604|3469199|B2|secondary infertility||type of infertility||participants|Number|0|0.0||||||
3619745|NCT02684604|3469200|B1|secondary infertility||type of infertility||participants|Number|3|3.0||||||
3619746|NCT02684604|3469198|B3|primary infertility||type of infertility||participants|Number|41|41.0||||||
3619747|NCT02684604|3469199|B2|primary infertility||type of infertility||participants|Number|0|0.0||||||
3619748|NCT02684604|3469200|B1|primary infertility||type of infertility||participants|Number|41|41.0||||||
3619749|NCT02684604|3469198|B3|no infertility||type of infertility||participants|Number|44|44.0||||||
3619750|NCT02684604|3469199|B2|no infertility||type of infertility||participants|Number|44|44.0||||||
3619751|NCT02684604|3469200|B1|no infertility||type of infertility||participants|Number|0|0.0||||||
3619752|NCT02684604|3469198|B3|para 4||parity||participants|Number|1|1.0||||||
3619753|NCT02684604|3469199|B2|para 4||parity||participants|Number|1|1.0||||||
3619754|NCT02684604|3469200|B1|para 4||parity||participants|Number|0|0.0||||||
3619755|NCT02684604|3469198|B3|para 3||parity||participants|Number|10|10.0||||||
3619756|NCT02684604|3469199|B2|para 3||parity||participants|Number|10|10.0||||||
3619757|NCT02684604|3469200|B1|para 3||parity||participants|Number|0|0.0||||||
3619758|NCT02684604|3469198|B3|para 2||parity||participants|Number|21|21.0||||||
3619759|NCT02684604|3469199|B2|para 2||parity||participants|Number|20|20.0||||||
3619760|NCT02684604|3469200|B1|para 2||parity||participants|Number|1|1.0||||||
3619761|NCT02684604|3469198|B3|para 1||parity||participants|Number|15|15.0||||||
3619762|NCT02684604|3469199|B2|para 1||parity||participants|Number|13|13.0||||||
3619763|NCT02684604|3469200|B1|para 1||parity||participants|Number|2|2.0||||||
3619764|NCT02684604|3469198|B3|nullipara||parity||participants|Number|41|41.0||||||
3619765|NCT02684604|3469199|B2|nullipara||parity||participants|Number|0|0.0||||||
3619766|NCT02684604|3469200|B1|nullipara||parity||participants|Number|41|41.0||||||
3619767|NCT02684604|3469198|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3619768|NCT02684604|3469199|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3619769|NCT02684604|3469200|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3619770|NCT02684604|3469198|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3619771|NCT02684604|3469199|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3619772|NCT02684604|3469200|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3619773|NCT02684604|3469198|B3|||Age||years|Mean|28.06|28.06|Standard Deviation|5.12|5.12|||
3619774|NCT02684604|3469199|B2|||Age||years|Mean|27.8|27.8|Standard Deviation|4.9|4.9|||
3619775|NCT02684604|3469200|B1|||Age||years|Mean|28.3|28.3|Standard Deviation|5.4|5.4|||
3619776|NCT02684396|3469207|B7|||Waist to Hip Ratio||ratio|Mean|0.88|0.88|Standard Deviation|0.061|0.061|||
3619777|NCT02684396|3469208|B6|||Waist to Hip Ratio||ratio|Mean|0.89|0.89|Standard Deviation|0.069|0.069|||
3619778|NCT02684396|3469209|B5|||Waist to Hip Ratio||ratio|Mean|0.93|0.93|Standard Deviation|0.034|0.034|||
3619779|NCT02684396|3469210|B4|||Waist to Hip Ratio||ratio|Mean|0.84|0.84|Standard Deviation|0.074|0.074|||
3619780|NCT02684396|3469211|B3|||Waist to Hip Ratio||ratio|Mean|0.92|0.92|Standard Deviation|0.038|0.038|||
3619781|NCT02684396|3469212|B2|||Waist to Hip Ratio||ratio|Mean|0.86|0.86|Standard Deviation|0.061|0.061|||
3619782|NCT02684396|3469213|B1|||Waist to Hip Ratio||ratio|Mean|0.87|0.87|Standard Deviation|0.037|0.037|||
3619783|NCT02684396|3469207|B7|||Waist Circumference||cm|Mean|87.91|87.91|Standard Deviation|8.420|8.42|||
3619784|NCT02684396|3469208|B6|||Waist Circumference||cm|Mean|88.06|88.06|Standard Deviation|10.865|10.865|||
3619785|NCT02684396|3469209|B5|||Waist Circumference||cm|Mean|95.00|95.0|Standard Deviation|3.391|3.391|||
3619786|NCT02684396|3469210|B4|||Waist Circumference||cm|Mean|86.17|86.17|Standard Deviation|7.548|7.548|||
3619787|NCT02684396|3469211|B3|||Waist Circumference||cm|Mean|90.00|90.0|Standard Deviation|5.762|5.762|||
3619788|NCT02684396|3469212|B2|||Waist Circumference||cm|Mean|82.50|82.5|Standard Deviation|6.863|6.863|||
3619789|NCT02684396|3469213|B1|||Waist Circumference||cm|Mean|86.83|86.83|Standard Deviation|9.174|9.174|||
3619790|NCT02684396|3469207|B7|||Hip Circumference||cm|Mean|99.47|99.47|Standard Deviation|6.180|6.18|||
3619791|NCT02684396|3469208|B6|||Hip Circumference||cm|Mean|98.63|98.63|Standard Deviation|7.121|7.121|||
3619792|NCT02684396|3469209|B5|||Hip Circumference||cm|Mean|102.20|102.2|Standard Deviation|4.207|4.207|||
3619793|NCT02684396|3469210|B4|||Hip Circumference||cm|Mean|102.83|102.83|Standard Deviation|4.956|4.956|||
3619794|NCT02684396|3469211|B3|||Hip Circumference||cm|Mean|98.50|98.5|Standard Deviation|8.385|8.385|||
3619795|NCT02684396|3469212|B2|||Hip Circumference||cm|Mean|96.33|96.33|Standard Deviation|3.141|3.141|||
3619796|NCT02684396|3469213|B1|||Hip Circumference||cm|Mean|99.33|99.33|Standard Deviation|6.683|6.683|||
3619797|NCT02684396|3469207|B7|||Body Mass Index (BMI)||kg/m^2|Mean|25.0|25.0|Standard Deviation|2.69|2.69|||
3619798|NCT02684396|3469208|B6|||Body Mass Index (BMI)||kg/m^2|Mean|24.8|24.8|Standard Deviation|3.03|3.03|||
3619799|NCT02684396|3469209|B5|||Body Mass Index (BMI)||kg/m^2|Mean|26.0|26.0|Standard Deviation|2.26|2.26|||
3619800|NCT02684396|3469210|B4|||Body Mass Index (BMI)||kg/m^2|Mean|25.3|25.3|Standard Deviation|2.73|2.73|||
3619801|NCT02684396|3469211|B3|||Body Mass Index (BMI)||kg/m^2|Mean|25.4|25.4|Standard Deviation|2.37|2.37|||
3619802|NCT02684396|3469212|B2|||Body Mass Index (BMI)||kg/m^2|Mean|24.5|24.5|Standard Deviation|2.42|2.42|||
3619803|NCT02684396|3469213|B1|||Body Mass Index (BMI)||kg/m^2|Mean|24.3|24.3|Standard Deviation|3.60|3.6|||
3619804|NCT02684396|3469207|B7|||Weight||kg|Mean|74.1|74.1|Standard Deviation|11.71|11.71|||
3619805|NCT02684396|3469208|B6|||Weight||kg|Mean|77.7|77.7|Standard Deviation|14.33|14.33|||
3619806|NCT02684396|3469209|B5|||Weight||kg|Mean|76.1|76.1|Standard Deviation|12.79|12.79|||
3619807|NCT02684396|3469210|B4|||Weight||kg|Mean|67.1|67.1|Standard Deviation|4.36|4.36|||
3619808|NCT02684396|3469211|B3|||Weight||kg|Mean|75.6|75.6|Standard Deviation|12.86|12.86|||
3619809|NCT02684396|3469212|B2|||Weight||kg|Mean|70.0|70.0|Standard Deviation|9.32|9.32|||
3619810|NCT02684396|3469213|B1|||Weight||kg|Mean|76.1|76.1|Standard Deviation|12.39|12.39|||
3619811|NCT02684396|3469207|B7|||Height||cm|Mean|172.0|172.0|Standard Deviation|10.19|10.19|||
3619812|NCT02684396|3469208|B6|||Height||cm|Mean|176.4|176.4|Standard Deviation|8.46|8.46|||
3619813|NCT02684396|3469209|B5|||Height||cm|Mean|170.6|170.6|Standard Deviation|12.26|12.26|||
3619814|NCT02684396|3469210|B4|||Height||cm|Mean|163.3|163.3|Standard Deviation|8.21|8.21|||
3619815|NCT02684396|3469211|B3|||Height||cm|Mean|172.2|172.2|Standard Deviation|11.82|11.82|||
3619816|NCT02684396|3469212|B2|||Height||cm|Mean|169.0|169.0|Standard Deviation|8.58|8.58|||
3619817|NCT02684396|3469213|B1|||Height||cm|Mean|177.2|177.2|Standard Deviation|9.24|9.24|||
3619818|NCT02684396|3469207|B7|United States||Region of Enrollment||participants|Number|39|39.0||||||
3619819|NCT02684396|3469208|B6|United States||Region of Enrollment||participants|Number|10|10.0||||||
3619820|NCT02684396|3469209|B5|United States||Region of Enrollment||participants|Number|5|5.0||||||
3619821|NCT02684396|3469210|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
3619822|NCT02684396|3469211|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3619823|NCT02684396|3469212|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3619824|NCT02684396|3469213|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3619825|NCT02684396|3469207|B7|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3619826|NCT02684396|3469208|B6|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3619827|NCT02684396|3469209|B5|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3619828|NCT02684396|3469210|B4|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3619829|NCT02684396|3469211|B3|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3619830|NCT02684396|3469212|B2|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3619831|NCT02684396|3469213|B1|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3619832|NCT02684396|3469207|B7|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3619833|NCT02684396|3469208|B6|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3619834|NCT02684396|3469209|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3619835|NCT02684396|3469210|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3619836|NCT02684396|3469211|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3619837|NCT02684396|3469212|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3619838|NCT02684396|3469213|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3619839|NCT02684396|3469207|B7|Black or African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3619840|NCT02684396|3469208|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3619841|NCT02684396|3469209|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3619842|NCT02684396|3469210|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3619843|NCT02684396|3469211|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3619844|NCT02684396|3469212|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3619845|NCT02684396|3469213|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3619846|NCT02684396|3469207|B7|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3619847|NCT02684396|3469208|B6|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3619848|NCT02684396|3469209|B5|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3619849|NCT02684396|3469210|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3619850|NCT02684396|3469211|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3619851|NCT02684396|3469212|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3619852|NCT02684396|3469213|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3619853|NCT02684396|3469207|B7|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3619854|NCT02684396|3469208|B6|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3619855|NCT02684396|3469209|B5|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3619856|NCT02684396|3469210|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3619857|NCT02684396|3469211|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3619858|NCT02684396|3469212|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3619859|NCT02684396|3469213|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3619860|NCT02684396|3469207|B7|Non-Hispanic and Latino||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
3619861|NCT02684396|3469208|B6|Non-Hispanic and Latino||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3619862|NCT02684396|3469209|B5|Non-Hispanic and Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3619863|NCT02684396|3469210|B4|Non-Hispanic and Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3619864|NCT02684396|3469211|B3|Non-Hispanic and Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3619865|NCT02684396|3469212|B2|Non-Hispanic and Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3619866|NCT02684396|3469213|B1|Non-Hispanic and Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3619867|NCT02684396|3469207|B7|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3619868|NCT02684396|3469208|B6|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3619869|NCT02684396|3469209|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3619870|NCT02684396|3469210|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3619871|NCT02684396|3469211|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3619872|NCT02684396|3469212|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3619873|NCT02684396|3469213|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3619874|NCT02684396|3469207|B7||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3619875|NCT02684396|3469208|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3619876|NCT02684396|3469209|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3619877|NCT02684396|3469210|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3619878|NCT02684396|3469211|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3619879|NCT02684396|3469212|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3619880|NCT02684396|3469213|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3619881|NCT02684396|3469207|B7||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3619882|NCT02684396|3469208|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3619883|NCT02684396|3469209|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3619884|NCT02684396|3469210|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3619885|NCT02684396|3469211|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3619886|NCT02684396|3469212|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3619887|NCT02684396|3469213|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3619888|NCT02684396|3469207|B7|||Age||years|Mean|37.5|37.5|Standard Deviation|10.86|10.86|||
3619889|NCT02684396|3469208|B6|||Age||years|Mean|36.2|36.2|Standard Deviation|11.10|11.1|||
3619890|NCT02684396|3469209|B5|||Age||years|Mean|45.0|45.0|Standard Deviation|11.51|11.51|||
3619891|NCT02684396|3469210|B4|||Age||years|Mean|37.0|37.0|Standard Deviation|9.78|9.78|||
3619892|NCT02684396|3469211|B3|||Age||years|Mean|37.5|37.5|Standard Deviation|9.07|9.07|||
3619893|NCT02684396|3469212|B2|||Age||years|Mean|32.5|32.5|Standard Deviation|11.08|11.08|||
3619894|NCT02684396|3469213|B1|||Age||years|Mean|39.0|39.0|Standard Deviation|13.21|13.21|||
3619895|NCT02684188|3469270|B3|||Length of Stay, Acuity, Co-morbidity, and Emergency Department Visits (LACE+)|The LACE+ uses a proprietary algorithm to calculate the likelihood of a patient's hospital readmission based on information derived from the patient's electronic medical record. Generally, higher scores reflect higher risk. Scores range from 0 to 100. A score of 28 or less is categorized as low risk. A score of 29 to 58 is categorized as medium risk. A score of 59 or higher is categorized as high risk.|units on a scale|Mean|46.3|46.3|Full Range|||13.0|84.0|
3619896|NCT02684188|3469271|B2|||Length of Stay, Acuity, Co-morbidity, and Emergency Department Visits (LACE+)|The LACE+ uses a proprietary algorithm to calculate the likelihood of a patient's hospital readmission based on information derived from the patient's electronic medical record. Generally, higher scores reflect higher risk. Scores range from 0 to 100. A score of 28 or less is categorized as low risk. A score of 29 to 58 is categorized as medium risk. A score of 59 or higher is categorized as high risk.|units on a scale|Mean|49.7|49.7|Full Range|||22.0|80.0|
3619934|NCT02684188|3469270|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3619897|NCT02684188|3469272|B1|||Length of Stay, Acuity, Co-morbidity, and Emergency Department Visits (LACE+)|The LACE+ uses a proprietary algorithm to calculate the likelihood of a patient's hospital readmission based on information derived from the patient's electronic medical record. Generally, higher scores reflect higher risk. Scores range from 0 to 100. A score of 28 or less is categorized as low risk. A score of 29 to 58 is categorized as medium risk. A score of 59 or higher is categorized as high risk.|units on a scale|Mean|42.2|42.2|Full Range|||13.0|84.0|
3619898|NCT02684188|3469270|B3|||Patient Activation Measure (PAM10)|Patients completed the 10-item Patient Activation Measure (PAM10) questionnaire measuring a patient's confidence in their knowledge, skills, and abilities to manage their health once they were discharged from a hospital. Patients indicated whether they strongly agreed, agreed, disagreed, or strongly disagreed with each statement. A patient could also indicate that a particular item was not applicable to their situation. Total scores ranged from 0.0 to 100.0. Higher scores indicated greater confidence in their capacity for self-management.|units on a scale|Mean|69.9|69.9|Full Range|||39.0|100.0|
3619899|NCT02684188|3469271|B2|||Patient Activation Measure (PAM10)|Patients completed the 10-item Patient Activation Measure (PAM10) questionnaire measuring a patient's confidence in their knowledge, skills, and abilities to manage their health once they were discharged from a hospital. Patients indicated whether they strongly agreed, agreed, disagreed, or strongly disagreed with each statement. A patient could also indicate that a particular item was not applicable to their situation. Total scores ranged from 0.0 to 100.0. Higher scores indicated greater confidence in their capacity for self-management.|units on a scale|Mean|73.8|73.8|Full Range|||45.0|100.0|
3619900|NCT02684188|3469272|B1|||Patient Activation Measure (PAM10)|Patients completed the 10-item Patient Activation Measure (PAM10) questionnaire measuring a patient's confidence in their knowledge, skills, and abilities to manage their health once they were discharged from a hospital. Patients indicated whether they strongly agreed, agreed, disagreed, or strongly disagreed with each statement. A patient could also indicate that a particular item was not applicable to their situation. Total scores ranged from 0.0 to 100.0. Higher scores indicated greater confidence in their capacity for self-management.|units on a scale|Mean|65.1|65.1|Full Range|||39.0|100.0|
3619901|NCT02684188|3469270|B3|United States||Region of Enrollment|Participants recruited from among patients from four rural counties in St. Patrick Hospital's the catchment area, including Beaverhead, Lake, Powell, and Sanders Counties Montana.|participants|Number|127|127.0||||||
3619902|NCT02684188|3469271|B2|United States||Region of Enrollment|Participants recruited from among patients from four rural counties in St. Patrick Hospital's the catchment area, including Beaverhead, Lake, Powell, and Sanders Counties Montana.|participants|Number|50|50.0||||||
3619903|NCT02684188|3469272|B1|United States||Region of Enrollment|Participants recruited from among patients from four rural counties in St. Patrick Hospital's the catchment area, including Beaverhead, Lake, Powell, and Sanders Counties Montana.|participants|Number|77|77.0||||||
3619904|NCT02684188|3469270|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3619905|NCT02684188|3469271|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3619906|NCT02684188|3469272|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3619907|NCT02684188|3469270|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619908|NCT02684188|3469271|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619909|NCT02684188|3469272|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619910|NCT02684188|3469270|B3||White|Race (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
3619911|NCT02684188|3469271|B2||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3619912|NCT02684188|3469272|B1||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3619913|NCT02684188|3469270|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619914|NCT02684188|3469271|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619915|NCT02684188|3469272|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619916|NCT02684188|3469270|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3619917|NCT02684188|3469271|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619918|NCT02684188|3469272|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3619919|NCT02684188|3469270|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619920|NCT02684188|3469271|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619921|NCT02684188|3469272|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619922|NCT02684188|3469270|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3619923|NCT02684188|3469271|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3619924|NCT02684188|3469272|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3619925|NCT02684188|3469270|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3619926|NCT02684188|3469271|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3619927|NCT02684188|3469272|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3619928|NCT02684188|3469270|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
3619929|NCT02684188|3469271|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3619930|NCT02684188|3469272|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3619931|NCT02684188|3469270|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619932|NCT02684188|3469271|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619933|NCT02684188|3469272|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3619935|NCT02684188|3469271|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3619936|NCT02684188|3469272|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3619937|NCT02684188|3469270|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3619938|NCT02684188|3469271|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3619939|NCT02684188|3469272|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3619940|NCT02684188|3469270|B3|||Age||years|Mean|61.2|61.2|Full Range|||30.0|74.0|
3619941|NCT02684188|3469271|B2|||Age||years|Mean|63.2|63.2|Full Range|||38.0|74.0|
3619942|NCT02684188|3469272|B1|||Age||years|Mean|59.9|59.9|Full Range|||30.0|74.0|
3619943|NCT02683954|3469297|B3|obese||categorization of participants according to body mass index||participants|Number|15|15.0||||||
3619944|NCT02683954|3469298|B2|obese||categorization of participants according to body mass index||participants|Number|14|14.0||||||
3619945|NCT02683954|3469299|B1|obese||categorization of participants according to body mass index||participants|Number|1|1.0||||||
3619946|NCT02683954|3469297|B3|overweight||categorization of participants according to body mass index||participants|Number|26|26.0||||||
3619947|NCT02683954|3469298|B2|overweight||categorization of participants according to body mass index||participants|Number|13|13.0||||||
3619948|NCT02683954|3469299|B1|overweight||categorization of participants according to body mass index||participants|Number|13|13.0||||||
3619949|NCT02683954|3469297|B3|lean||categorization of participants according to body mass index||participants|Number|19|19.0||||||
3619950|NCT02683954|3469298|B2|lean||categorization of participants according to body mass index||participants|Number|3|3.0||||||
3619951|NCT02683954|3469299|B1|lean||categorization of participants according to body mass index||participants|Number|16|16.0||||||
3619952|NCT02683954|3469297|B3|participants not having menorrhagia||Menorrhagia||participants|Number|51|51.0||||||
3619953|NCT02683954|3469298|B2|participants not having menorrhagia||Menorrhagia||participants|Number|27|27.0||||||
3619954|NCT02683954|3469299|B1|participants not having menorrhagia||Menorrhagia||participants|Number|24|24.0||||||
3619955|NCT02683954|3469297|B3|participants having menorrhagia||Menorrhagia||participants|Number|9|9.0||||||
3619956|NCT02683954|3469298|B2|participants having menorrhagia||Menorrhagia||participants|Number|3|3.0||||||
3619957|NCT02683954|3469299|B1|participants having menorrhagia||Menorrhagia||participants|Number|6|6.0||||||
3619958|NCT02683954|3469297|B3|participants not having dyspareunia||Dyspareunia||participants|Number|45|45.0||||||
3619959|NCT02683954|3469298|B2|participants not having dyspareunia||Dyspareunia||participants|Number|27|27.0||||||
3619960|NCT02683954|3469299|B1|participants not having dyspareunia||Dyspareunia||participants|Number|18|18.0||||||
3619961|NCT02683954|3469297|B3|participants having dyspareunia||Dyspareunia||participants|Number|15|15.0||||||
3619962|NCT02683954|3469298|B2|participants having dyspareunia||Dyspareunia||participants|Number|3|3.0||||||
3619963|NCT02683954|3469299|B1|participants having dyspareunia||Dyspareunia||participants|Number|12|12.0||||||
3619964|NCT02683954|3469297|B3|participants not having chronic pelvic pain||chronic pelvic pain||participants|Number|47|47.0||||||
3619965|NCT02683954|3469298|B2|participants not having chronic pelvic pain||chronic pelvic pain||participants|Number|26|26.0||||||
3619966|NCT02683954|3469299|B1|participants not having chronic pelvic pain||chronic pelvic pain||participants|Number|21|21.0||||||
3619967|NCT02683954|3469297|B3|participants having chronic pelvic pain||chronic pelvic pain||participants|Number|13|13.0||||||
3619968|NCT02683954|3469298|B2|participants having chronic pelvic pain||chronic pelvic pain||participants|Number|4|4.0||||||
3619969|NCT02683954|3469299|B1|participants having chronic pelvic pain||chronic pelvic pain||participants|Number|9|9.0||||||
3619970|NCT02683954|3469297|B3|participants not having dysmenorrhea||Dysmenorrhea||participants|Number|22|22.0||||||
3619971|NCT02683954|3469298|B2|participants not having dysmenorrhea||Dysmenorrhea||participants|Number|19|19.0||||||
3619972|NCT02683954|3469299|B1|participants not having dysmenorrhea||Dysmenorrhea||participants|Number|3|3.0||||||
3619973|NCT02683954|3469297|B3|participants having dysmenorrhea||Dysmenorrhea||participants|Number|38|38.0||||||
3619974|NCT02683954|3469298|B2|participants having dysmenorrhea||Dysmenorrhea||participants|Number|11|11.0||||||
3619975|NCT02683954|3469299|B1|participants having dysmenorrhea||Dysmenorrhea||participants|Number|27|27.0||||||
3619976|NCT02683954|3469297|B3|||duration of infertility||years|Median|2.5|2.5|Inter-Quartile Range|||2.0|3.0|
3619977|NCT02683954|3469298|B2|||duration of infertility||years|Median|3|3.0|Inter-Quartile Range|||2.0|4.0|
3619978|NCT02683954|3469299|B1|||duration of infertility||years|Median|2|2.0|Inter-Quartile Range|||2.0|3.0|
3619979|NCT02683954|3469297|B3|secondary infertility||infertility||participants|Number|22|22.0||||||
3619980|NCT02683954|3469298|B2|secondary infertility||infertility||participants|Number|12|12.0||||||
3619981|NCT02683954|3469299|B1|secondary infertility||infertility||participants|Number|10|10.0||||||
3619982|NCT02683954|3469297|B3|primary infertility||infertility||participants|Number|31|31.0||||||
3619983|NCT02683954|3469298|B2|primary infertility||infertility||participants|Number|12|12.0||||||
3619984|NCT02683954|3469299|B1|primary infertility||infertility||participants|Number|19|19.0||||||
3619985|NCT02683954|3469297|B3|no infertility||infertility||participants|Number|7|7.0||||||
3619986|NCT02683954|3469298|B2|no infertility||infertility||participants|Number|6|6.0||||||
3619987|NCT02683954|3469299|B1|no infertility||infertility||participants|Number|1|1.0||||||
3619988|NCT02683954|3469297|B3|previous vaginal deliveries||previous vaginal deliveries||participants|Number|6|6.0||||||
3619989|NCT02683954|3469298|B2|previous vaginal deliveries||previous vaginal deliveries||participants|Number|4|4.0||||||
3619990|NCT02683954|3469299|B1|previous vaginal deliveries||previous vaginal deliveries||participants|Number|2|2.0||||||
3619991|NCT02683954|3469297|B3|no vaginal deliveries||previous vaginal deliveries||participants|Number|54|54.0||||||
3619992|NCT02683954|3469298|B2|no vaginal deliveries||previous vaginal deliveries||participants|Number|26|26.0||||||
3619993|NCT02683954|3469299|B1|no vaginal deliveries||previous vaginal deliveries||participants|Number|28|28.0||||||
3619994|NCT02683954|3469297|B3|three||number of previous cesarean sections||participants|Number|1|1.0||||||
3619995|NCT02683954|3469298|B2|three||number of previous cesarean sections||participants|Number|1|1.0||||||
3619996|NCT02683954|3469299|B1|three||number of previous cesarean sections||participants|Number|0|0.0||||||
3619997|NCT02683954|3469297|B3|two||number of previous cesarean sections||participants|Number|7|7.0||||||
3619998|NCT02683954|3469298|B2|two||number of previous cesarean sections||participants|Number|7|7.0||||||
3619999|NCT02683954|3469299|B1|two||number of previous cesarean sections||participants|Number|0|0.0||||||
3620000|NCT02683954|3469297|B3|one||number of previous cesarean sections||participants|Number|16|16.0||||||
3620001|NCT02683954|3469298|B2|one||number of previous cesarean sections||participants|Number|8|8.0||||||
3620002|NCT02683954|3469299|B1|one||number of previous cesarean sections||participants|Number|8|8.0||||||
3620003|NCT02683954|3469297|B3|none||number of previous cesarean sections||participants|Number|36|36.0||||||
3620004|NCT02683954|3469298|B2|none||number of previous cesarean sections||participants|Number|14|14.0||||||
3620005|NCT02683954|3469299|B1|none||number of previous cesarean sections||participants|Number|22|22.0||||||
3620006|NCT02683954|3469297|B3|three livebirths||number of living children||participants|Number|1|1.0||||||
3620007|NCT02683954|3469298|B2|three livebirths||number of living children||participants|Number|1|1.0||||||
3620008|NCT02683954|3469299|B1|three livebirths||number of living children||participants|Number|0|0.0||||||
3620009|NCT02683954|3469297|B3|two livebirths||number of living children||participants|Number|9|9.0||||||
3620010|NCT02683954|3469298|B2|two livebirths||number of living children||participants|Number|9|9.0||||||
3620011|NCT02683954|3469299|B1|two livebirths||number of living children||participants|Number|0|0.0||||||
3620012|NCT02683954|3469297|B3|one livebirth||number of living children||participants|Number|14|14.0||||||
3620013|NCT02683954|3469298|B2|one livebirth||number of living children||participants|Number|7|7.0||||||
3620014|NCT02683954|3469299|B1|one livebirth||number of living children||participants|Number|7|7.0||||||
3620015|NCT02683954|3469297|B3|no children||number of living children||participants|Number|36|36.0||||||
3620016|NCT02683954|3469298|B2|no children||number of living children||participants|Number|13|13.0||||||
3620017|NCT02683954|3469299|B1|no children||number of living children||participants|Number|23|23.0||||||
3620018|NCT02683954|3469297|B3|previous ectopic||previous ectopic pregnancies||participants|Number|3|3.0||||||
3620019|NCT02683954|3469298|B2|previous ectopic||previous ectopic pregnancies||participants|Number|2|2.0||||||
3620020|NCT02683954|3469299|B1|previous ectopic||previous ectopic pregnancies||participants|Number|1|1.0||||||
3620021|NCT02683954|3469297|B3|no ectopic||previous ectopic pregnancies||participants|Number|57|57.0||||||
3620022|NCT02683954|3469298|B2|no ectopic||previous ectopic pregnancies||participants|Number|28|28.0||||||
3620023|NCT02683954|3469299|B1|no ectopic||previous ectopic pregnancies||participants|Number|29|29.0||||||
3620024|NCT02683954|3469297|B3|three abortions||number of abortions||participants|Number|1|1.0||||||
3620025|NCT02683954|3469298|B2|three abortions||number of abortions||participants|Number|0|0.0||||||
3620026|NCT02683954|3469299|B1|three abortions||number of abortions||participants|Number|1|1.0||||||
3620027|NCT02683954|3469297|B3|two abortions||number of abortions||participants|Number|0|0.0||||||
3620028|NCT02683954|3469298|B2|two abortions||number of abortions||participants|Number|0|0.0||||||
3620029|NCT02683954|3469299|B1|two abortions||number of abortions||participants|Number|0|0.0||||||
3620030|NCT02683954|3469297|B3|one abortion||number of abortions||participants|Number|9|9.0||||||
3620031|NCT02683954|3469298|B2|one abortion||number of abortions||participants|Number|5|5.0||||||
3620032|NCT02683954|3469299|B1|one abortion||number of abortions||participants|Number|4|4.0||||||
3620033|NCT02683954|3469297|B3|no abortions||number of abortions||participants|Number|50|50.0||||||
3620034|NCT02683954|3469298|B2|no abortions||number of abortions||participants|Number|25|25.0||||||
3620035|NCT02683954|3469299|B1|no abortions||number of abortions||participants|Number|25|25.0||||||
3620036|NCT02683954|3469297|B3|para 3||parity||participants|Number|2|2.0||||||
3620037|NCT02683954|3469298|B2|para 3||parity||participants|Number|2|2.0||||||
3620038|NCT02683954|3469299|B1|para 3||parity||participants|Number|0|0.0||||||
3620039|NCT02683954|3469297|B3|para 2||parity||participants|Number|8|8.0||||||
3620040|NCT02683954|3469298|B2|para 2||parity||participants|Number|8|8.0||||||
3620041|NCT02683954|3469299|B1|para 2||parity||participants|Number|0|0.0||||||
3620042|NCT02683954|3469297|B3|para 1||parity||participants|Number|17|17.0||||||
3620043|NCT02683954|3469298|B2|para 1||parity||participants|Number|7|7.0||||||
3620044|NCT02683954|3469299|B1|para 1||parity||participants|Number|10|10.0||||||
3620045|NCT02683954|3469297|B3|para 0||parity||participants|Number|33|33.0||||||
3620046|NCT02683954|3469298|B2|para 0||parity||participants|Number|13|13.0||||||
3620047|NCT02683954|3469299|B1|para 0||parity||participants|Number|20|20.0||||||
3620048|NCT02683954|3469297|B3|||body mass index||kilograms per squared meter|Mean|27.4|27.4|Standard Deviation|3.14|3.14|||
3620049|NCT02683954|3469298|B2|||body mass index||kilograms per squared meter|Mean|29.4|29.4|Standard Deviation|2.86|2.86|||
3620050|NCT02683954|3469299|B1|||body mass index||kilograms per squared meter|Mean|25.4|25.4|Standard Deviation|1.90|1.9|||
3620051|NCT02683954|3469297|B3|||height||centimeters|Mean|161.45|161.45|Standard Deviation|4.14|4.14|||
3620052|NCT02683954|3469298|B2|||height||centimeters|Mean|161.16|161.16|Standard Deviation|4.33|4.33|||
3620053|NCT02683954|3469299|B1|||height||centimeters|Mean|161.73|161.73|Standard Deviation|3.99|3.99|||
3620054|NCT02683954|3469297|B3|||weight||kilograms|Mean|71.34|71.34|Standard Deviation|8.80|8.8|||
3620055|NCT02683954|3469298|B2|||weight||kilograms|Mean|76.31|76.31|Standard Deviation|8.35|8.35|||
3620056|NCT02683954|3469299|B1|||weight||kilograms|Mean|66.36|66.36|Standard Deviation|6.04|6.04|||
3620057|NCT02683954|3469297|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3620058|NCT02683954|3469298|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3620059|NCT02683954|3469299|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3620060|NCT02683954|3469297|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3620061|NCT02683954|3469298|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3620062|NCT02683954|3469299|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3620063|NCT02683954|3469297|B3|||Age||years|Mean|27.95|27.95|Standard Deviation|4.20|4.2|||
3620064|NCT02683954|3469298|B2|||Age||years|Mean|29.06|29.06|Standard Deviation|4.25|4.25|||
3620065|NCT02683954|3469299|B1|||Age||years|Mean|26.83|26.83|Standard Deviation|3.89|3.89|||
3620066|NCT02683785|3469306|B3|White - White /Caucasian/European||Race/Ethnicity, Customized||Participants|Number|44|44.0||||||
3620067|NCT02683785|3469307|B2|White - White /Caucasian/European||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
3620068|NCT02683785|3469308|B1|White - White /Caucasian/European||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
3620069|NCT02683785|3469306|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3620070|NCT02683785|3469307|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3620071|NCT02683785|3469308|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3620072|NCT02683785|3469306|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3620073|NCT02683785|3469307|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3620074|NCT02683785|3469308|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3620075|NCT02683785|3469306|B3|||Age||Years|Mean|58.8|58.8|Standard Deviation|6.79|6.79|||
3620076|NCT02683785|3469307|B2|||Age||Years|Mean|60.9|60.9|Standard Deviation|6.25|6.25|||
3620077|NCT02683785|3469308|B1|||Age||Years|Mean|56.7|56.7|Standard Deviation|6.80|6.8|||
3620078|NCT02683746|3469346|B3|Race/ethnicity customized|Multiple- Black or AA and White Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3620079|NCT02683746|3469347|B2|Race/ethnicity customized|Multiple- Black or AA and White Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3620080|NCT02683746|3469348|B1|Race/ethnicity customized|Multiple- Black or AA and White Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3620081|NCT02683746|3469346|B3|Race/ethnicity customized|Multiple- AI or Alaska Native and White Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3620082|NCT02683746|3469347|B2|Race/ethnicity customized|Multiple- AI or Alaska Native and White Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3620083|NCT02683746|3469348|B1|Race/ethnicity customized|Multiple- AI or Alaska Native and White Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3620084|NCT02683746|3469346|B3|Race/ethnicity customized|White Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|251|251.0||||||
3620085|NCT02683746|3469347|B2|Race/ethnicity customized|White Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|122|122.0||||||
3620086|NCT02683746|3469348|B1|Race/ethnicity customized|White Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|129|129.0||||||
3620087|NCT02683746|3469346|B3|Race/ethnicity customized|Native Hawaiian or Other Pacific Islander Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3620088|NCT02683746|3469347|B2|Race/ethnicity customized|Native Hawaiian or Other Pacific Islander Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3620089|NCT02683746|3469348|B1|Race/ethnicity customized|Native Hawaiian or Other Pacific Islander Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3620090|NCT02683746|3469346|B3|Race/ethnicity customized|Black or African American (AA) Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
3620091|NCT02683746|3469347|B2|Race/ethnicity customized|Black or African American (AA) Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3620092|NCT02683746|3469348|B1|Race/ethnicity customized|Black or African American (AA) Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3620093|NCT02683746|3469346|B3|Race/ethnicity customized|Asian- Japanese/East Asian (EA)/South EA Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3620094|NCT02683746|3469347|B2|Race/ethnicity customized|Asian- Japanese/East Asian (EA)/South EA Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3620095|NCT02683746|3469348|B1|Race/ethnicity customized|Asian- Japanese/East Asian (EA)/South EA Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3620096|NCT02683746|3469346|B3|Race/ethnicity customized|Asian- Central/ South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3620097|NCT02683746|3469347|B2|Race/ethnicity customized|Asian- Central/ South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3620098|NCT02683746|3469348|B1|Race/ethnicity customized|Asian- Central/ South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3620099|NCT02683746|3469346|B3|Race/ethnicity customized|American Indian (AI) or Alaska native Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3620100|NCT02683746|3469347|B2|Race/ethnicity customized|American Indian (AI) or Alaska native Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3620101|NCT02683746|3469348|B1|Race/ethnicity customized|American Indian (AI) or Alaska native Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3620102|NCT02683746|3469346|B3||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3620103|NCT02683746|3469347|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3620104|NCT02683746|3469348|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3620105|NCT02683746|3469346|B3||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3620106|NCT02683746|3469347|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3620107|NCT02683746|3469348|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3620108|NCT02683746|3469346|B3|||Age||Years|Mean|57.1|57.1|Standard Deviation|9.67|9.67|||
3620109|NCT02683746|3469347|B2|||Age||Years|Mean|56.6|56.6|Standard Deviation|10.08|10.08|||
3620110|NCT02683746|3469348|B1|||Age||Years|Mean|57.6|57.6|Standard Deviation|9.25|9.25|||
3620111|NCT02683707|3469377|B3|||Platelet count||K/cu mm|Mean|226|226.0|Standard Deviation|65|65.0|||
3620112|NCT02683707|3469378|B2|||Platelet count||K/cu mm|Mean|223|223.0|Standard Deviation|71|71.0|||
3620113|NCT02683707|3469379|B1|||Platelet count||K/cu mm|Mean|230|230.0|Standard Deviation|59|59.0|||
3620114|NCT02683707|3469377|B3|United States||Region of Enrollment||Participants|Count of Participants|212|212.0||||||
3620115|NCT02683707|3469378|B2|United States||Region of Enrollment||Participants|Count of Participants|107|107.0||||||
3620116|NCT02683707|3469379|B1|United States||Region of Enrollment||Participants|Count of Participants|105|105.0||||||
3620117|NCT02683707|3469377|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620118|NCT02683707|3469378|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620119|NCT02683707|3469379|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620120|NCT02683707|3469377|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620121|NCT02683707|3469378|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620122|NCT02683707|3469379|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620123|NCT02683707|3469377|B3||White|Race (NIH/OMB)||Participants|Count of Participants|154|154.0||||||
3620124|NCT02683707|3469378|B2||White|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3620125|NCT02683707|3469379|B1||White|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3620126|NCT02683707|3469377|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3620127|NCT02683707|3469378|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3620128|NCT02683707|3469379|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3620129|NCT02683707|3469377|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620130|NCT02683707|3469378|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620131|NCT02683707|3469379|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620132|NCT02683707|3469377|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3620133|NCT02683707|3469378|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3620134|NCT02683707|3469379|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3620135|NCT02683707|3469377|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620136|NCT02683707|3469378|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620137|NCT02683707|3469379|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620138|NCT02683707|3469377|B3||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3620139|NCT02683707|3469378|B2||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3620140|NCT02683707|3469379|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3620141|NCT02683707|3469377|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3620142|NCT02683707|3469378|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3620143|NCT02683707|3469379|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3620144|NCT02683707|3469377|B3|||Age||years|Mean|64|64.0|Standard Deviation|10|10.0|||
3620145|NCT02683707|3469378|B2|||Age||years|Mean|63|63.0|Standard Deviation|10.2|10.2|||
3620146|NCT02683707|3469379|B1|||Age||years|Mean|65|65.0|Standard Deviation|9.3|9.3|||
3620147|NCT02683577|3469392|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3620148|NCT02683577|3469393|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3620149|NCT02683577|3469394|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3620150|NCT02683577|3469395|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3620151|NCT02683577|3469392|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3620152|NCT02683577|3469393|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3620153|NCT02683577|3469394|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3620154|NCT02683577|3469395|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3620155|NCT02683577|3469392|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3620156|NCT02683577|3469393|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3620157|NCT02683577|3469394|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3620158|NCT02683577|3469395|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3620159|NCT02683577|3469392|B4||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3620160|NCT02683577|3469393|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3620161|NCT02683577|3469394|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3620162|NCT02683577|3469395|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3620163|NCT02683577|3469392|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3620164|NCT02683577|3469393|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3620165|NCT02683577|3469394|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3620166|NCT02683577|3469395|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3620167|NCT02683161|3469443|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620168|NCT02683161|3469443|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620169|NCT02683161|3469443|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3620170|NCT02683161|3469443|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3620171|NCT02683161|3469443|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620172|NCT02683161|3469443|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620173|NCT02683161|3469443|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620174|NCT02683161|3469443|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3620175|NCT02683161|3469443|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3620176|NCT02683161|3469443|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3620177|NCT02683161|3469443|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3620178|NCT02683161|3469443|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3620179|NCT02683109|3469447|B3||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3620180|NCT02683109|3469448|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3620181|NCT02683109|3469449|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3620182|NCT02683109|3469447|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3620183|NCT02683109|3469448|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3620184|NCT02683109|3469449|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3620185|NCT02683109|3469447|B3|||Age||Years|Mean|66.5|66.5|Standard Deviation|6.8|6.8|||
3620186|NCT02683109|3469448|B2|||Age||Years|Mean|66.5|66.5|Standard Deviation|6.4|6.4|||
3620187|NCT02683109|3469449|B1|||Age||Years|Mean|66.5|66.5|Standard Deviation|7.1|7.1|||
3620188|NCT02682498|3469461|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3620189|NCT02682498|3469462|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3620190|NCT02682498|3469463|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3620191|NCT02682498|3469461|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3620192|NCT02682498|3469462|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3620193|NCT02682498|3469463|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3620194|NCT02682498|3469461|B3|||Age||years|Mean|60|60.0|Standard Deviation|11|11.0|||
3620195|NCT02682498|3469462|B2|||Age||years|Mean|60|60.0|Standard Deviation|12.83|12.83|||
3620196|NCT02682498|3469463|B1|||Age||years|Mean|64.14|64.14|Standard Deviation|10.18|10.18|||
3620197|NCT02682381|3469478|B4|Race Customized|Not allowed based on local regulations|Race/Ethnicity, Customized|Customized race population was reported here.|Participants|Count of Participants|7|7.0||||||
3620198|NCT02682381|3469479|B3|Race Customized|Not allowed based on local regulations|Race/Ethnicity, Customized|Customized race population was reported here.|Participants|Count of Participants|3|3.0||||||
3620199|NCT02682381|3469480|B2|Race Customized|Not allowed based on local regulations|Race/Ethnicity, Customized|Customized race population was reported here.|Participants|Count of Participants|1|1.0||||||
3620200|NCT02682381|3469481|B1|Race Customized|Not allowed based on local regulations|Race/Ethnicity, Customized|Customized race population was reported here.|Participants|Count of Participants|3|3.0||||||
3620201|NCT02682381|3469478|B4|Race Customized|Other|Race/Ethnicity, Customized|Customized race population was reported here.|Participants|Count of Participants|3|3.0||||||
3620202|NCT02682381|3469479|B3|Race Customized|Other|Race/Ethnicity, Customized|Customized race population was reported here.|Participants|Count of Participants|2|2.0||||||
3620203|NCT02682381|3469480|B2|Race Customized|Other|Race/Ethnicity, Customized|Customized race population was reported here.|Participants|Count of Participants|0|0.0||||||
3620204|NCT02682381|3469481|B1|Race Customized|Other|Race/Ethnicity, Customized|Customized race population was reported here.|Participants|Count of Participants|1|1.0||||||
3620205|NCT02682381|3469478|B4|Race Customized|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized|Customized race population was reported here.|Participants|Count of Participants|0|0.0||||||
3620206|NCT02682381|3469479|B3|Race Customized|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized|Customized race population was reported here.|Participants|Count of Participants|0|0.0||||||
3620207|NCT02682381|3469480|B2|Race Customized|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized|Customized race population was reported here.|Participants|Count of Participants|0|0.0||||||
3620208|NCT02682381|3469481|B1|Race Customized|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized|Customized race population was reported here.|Participants|Count of Participants|0|0.0||||||
3620209|NCT02682381|3469478|B4|Race Customized|American Indian or Alaska Native|Race/Ethnicity, Customized|Customized race population was reported here.|Participants|Count of Participants|0|0.0||||||
3620210|NCT02682381|3469479|B3|Race Customized|American Indian or Alaska Native|Race/Ethnicity, Customized|Customized race population was reported here.|Participants|Count of Participants|0|0.0||||||
3620211|NCT02682381|3469480|B2|Race Customized|American Indian or Alaska Native|Race/Ethnicity, Customized|Customized race population was reported here.|Participants|Count of Participants|0|0.0||||||
3620263|NCT02681458|3469555|B3||Female|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
3620212|NCT02682381|3469481|B1|Race Customized|American Indian or Alaska Native|Race/Ethnicity, Customized|Customized race population was reported here.|Participants|Count of Participants|0|0.0||||||
3620213|NCT02682381|3469478|B4|Race Customized|Asian|Race/Ethnicity, Customized|Customized race population was reported here.|Participants|Count of Participants|3|3.0||||||
3620214|NCT02682381|3469479|B3|Race Customized|Asian|Race/Ethnicity, Customized|Customized race population was reported here.|Participants|Count of Participants|1|1.0||||||
3620215|NCT02682381|3469480|B2|Race Customized|Asian|Race/Ethnicity, Customized|Customized race population was reported here.|Participants|Count of Participants|1|1.0||||||
3620216|NCT02682381|3469481|B1|Race Customized|Asian|Race/Ethnicity, Customized|Customized race population was reported here.|Participants|Count of Participants|1|1.0||||||
3620217|NCT02682381|3469478|B4|Race Customized|Black or African American|Race/Ethnicity, Customized|Customized race population was reported here.|Participants|Count of Participants|7|7.0||||||
3620218|NCT02682381|3469479|B3|Race Customized|Black or African American|Race/Ethnicity, Customized|Customized race population was reported here.|Participants|Count of Participants|1|1.0||||||
3620219|NCT02682381|3469480|B2|Race Customized|Black or African American|Race/Ethnicity, Customized|Customized race population was reported here.|Participants|Count of Participants|3|3.0||||||
3620220|NCT02682381|3469481|B1|Race Customized|Black or African American|Race/Ethnicity, Customized|Customized race population was reported here.|Participants|Count of Participants|3|3.0||||||
3620221|NCT02682381|3469478|B4|Race Customized|White|Race/Ethnicity, Customized|Customized race population was reported here.|Participants|Count of Participants|39|39.0||||||
3620222|NCT02682381|3469479|B3|Race Customized|White|Race/Ethnicity, Customized|Customized race population was reported here.|Participants|Count of Participants|2|2.0||||||
3620223|NCT02682381|3469480|B2|Race Customized|White|Race/Ethnicity, Customized|Customized race population was reported here.|Participants|Count of Participants|21|21.0||||||
3620224|NCT02682381|3469481|B1|Race Customized|White|Race/Ethnicity, Customized|Customized race population was reported here.|Participants|Count of Participants|16|16.0||||||
3620225|NCT02682381|3469478|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3620226|NCT02682381|3469479|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3620227|NCT02682381|3469480|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3620228|NCT02682381|3469481|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3620229|NCT02682381|3469478|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3620230|NCT02682381|3469479|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3620231|NCT02682381|3469480|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3620232|NCT02682381|3469481|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3620233|NCT02682381|3469478|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3620234|NCT02682381|3469479|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3620235|NCT02682381|3469480|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3620236|NCT02682381|3469481|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3620237|NCT02682381|3469478|B4||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3620238|NCT02682381|3469479|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3620239|NCT02682381|3469480|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3620240|NCT02682381|3469481|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3620241|NCT02682381|3469478|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3620242|NCT02682381|3469479|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3620243|NCT02682381|3469480|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3620244|NCT02682381|3469481|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3620245|NCT02682381|3469478|B4|||Age||Years|Mean|6.3|6.3|Standard Deviation|3.76|3.76|||
3620246|NCT02682381|3469479|B3|||Age||Years|Mean|5.7|5.7|Standard Deviation|4.72|4.72|||
3620247|NCT02682381|3469480|B2|||Age||Years|Mean|6.2|6.2|Standard Deviation|3.67|3.67|||
3620248|NCT02682381|3469481|B1|||Age||Years|Mean|6.6|6.6|Standard Deviation|3.61|3.61|||
3620249|NCT02681510|3469548|B1|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3620250|NCT02681510|3469548|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3620251|NCT02681510|3469548|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3620252|NCT02681510|3469548|B1|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3620253|NCT02681510|3469548|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3620254|NCT02681510|3469548|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3620255|NCT02681510|3469548|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3620256|NCT02681510|3469548|B1|||Age||years|Mean|44|44.0|Standard Deviation|12.8|12.8|||
3620257|NCT02681458|3469555|B3|Iran, Islamic Republic of||Region of Enrollment||participants|Number|1436|1436.0||||||
3620258|NCT02681458|3469556|B2|Iran, Islamic Republic of||Region of Enrollment||participants|Number|718|718.0||||||
3620259|NCT02681458|3469557|B1|Iran, Islamic Republic of||Region of Enrollment||participants|Number|718|718.0||||||
3620260|NCT02681458|3469555|B3||Male|Sex: Female, Male||Participants|Count of Participants|1183|1183.0||||||
3620261|NCT02681458|3469556|B2||Male|Sex: Female, Male||Participants|Count of Participants|581|581.0||||||
3620262|NCT02681458|3469557|B1||Male|Sex: Female, Male||Participants|Count of Participants|602|602.0||||||
3620264|NCT02681458|3469556|B2||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3620265|NCT02681458|3469557|B1||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3620266|NCT02681458|3469555|B3|||Age||years|Mean|37.55|37.55|Full Range|||9.0|90.0|
3620267|NCT02681458|3469556|B2|||Age||years|Mean|36.8|36.8|Full Range|||11.0|86.0|
3620268|NCT02681458|3469557|B1|||Age||years|Mean|38.3|38.3|Full Range|||9.0|90.0|
3620269|NCT02681172|3469564|B1||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3620270|NCT02681172|3469564|B1||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3620271|NCT02681172|3469564|B1|||Age||years|Mean|70.9|70.9|Standard Deviation|9.7|9.7|||
3620272|NCT02681094|3469575|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3620273|NCT02681094|3469576|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3620274|NCT02681094|3469577|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3620275|NCT02681094|3469578|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3620276|NCT02681094|3469575|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620277|NCT02681094|3469576|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620278|NCT02681094|3469577|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620279|NCT02681094|3469578|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620280|NCT02681094|3469575|B4||White|Race (NIH/OMB)||Participants|Count of Participants|780|780.0||||||
3620281|NCT02681094|3469576|B3||White|Race (NIH/OMB)||Participants|Count of Participants|258|258.0||||||
3620282|NCT02681094|3469577|B2||White|Race (NIH/OMB)||Participants|Count of Participants|257|257.0||||||
3620283|NCT02681094|3469578|B1||White|Race (NIH/OMB)||Participants|Count of Participants|265|265.0||||||
3620284|NCT02681094|3469575|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3620285|NCT02681094|3469576|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3620286|NCT02681094|3469577|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3620287|NCT02681094|3469578|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3620288|NCT02681094|3469575|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620289|NCT02681094|3469576|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620290|NCT02681094|3469577|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620291|NCT02681094|3469578|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620292|NCT02681094|3469575|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3620293|NCT02681094|3469576|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3620294|NCT02681094|3469577|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3620295|NCT02681094|3469578|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3620296|NCT02681094|3469575|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3620297|NCT02681094|3469576|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620298|NCT02681094|3469577|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3620299|NCT02681094|3469578|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3620300|NCT02681094|3469575|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620301|NCT02681094|3469576|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620302|NCT02681094|3469577|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620303|NCT02681094|3469578|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620304|NCT02681094|3469575|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|577|577.0||||||
3620305|NCT02681094|3469576|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|192|192.0||||||
3620306|NCT02681094|3469577|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|194|194.0||||||
3620307|NCT02681094|3469578|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|191|191.0||||||
3620308|NCT02681094|3469575|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|293|293.0||||||
3620309|NCT02681094|3469576|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3620310|NCT02681094|3469577|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3620311|NCT02681094|3469578|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3620312|NCT02681094|3469575|B4||Male|Sex: Female, Male||Participants|Count of Participants|451|451.0||||||
3620313|NCT02681094|3469576|B3||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3620314|NCT02681094|3469577|B2||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3620315|NCT02681094|3469578|B1||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3620316|NCT02681094|3469575|B4||Female|Sex: Female, Male||Participants|Count of Participants|419|419.0||||||
3620317|NCT02681094|3469576|B3||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3620318|NCT02681094|3469577|B2||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3620319|NCT02681094|3469578|B1||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3620320|NCT02681094|3469575|B4|||Age||Years|Mean|56.7|56.7|Standard Deviation|10.53|10.53|||
3620321|NCT02681094|3469576|B3|||Age||Years|Mean|57.0|57.0|Standard Deviation|9.94|9.94|||
3620322|NCT02681094|3469577|B2|||Age||Years|Mean|55.9|55.9|Standard Deviation|10.94|10.94|||
3620323|NCT02681094|3469578|B1|||Age||Years|Mean|57.2|57.2|Standard Deviation|10.68|10.68|||
3620324|NCT02680847|3469596|B4||Black|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3620325|NCT02680847|3469597|B3||Black|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3620326|NCT02680847|3469598|B2||Black|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3620327|NCT02680847|3469599|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3620328|NCT02680847|3469596|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3620329|NCT02680847|3469597|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3620330|NCT02680847|3469598|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3620331|NCT02680847|3469599|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3620332|NCT02680847|3469596|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3620333|NCT02680847|3469597|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3620334|NCT02680847|3469598|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3620335|NCT02680847|3469599|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3620336|NCT02680847|3469596|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3620337|NCT02680847|3469597|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3620338|NCT02680847|3469598|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3620339|NCT02680847|3469599|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3620340|NCT02680847|3469596|B4|||Age||years|Mean|14.0|14.0|Standard Deviation|2.0|2.0|||
3620341|NCT02680847|3469597|B3|||Age||years|Mean|15.3|15.3|Standard Deviation|1.1|1.1|||
3620342|NCT02680847|3469598|B2|||Age||years|Mean|15.2|15.2|Standard Deviation|1.3|1.3|||
3620343|NCT02680847|3469599|B1|||Age||years|Mean|13.4|13.4|Standard Deviation|2.0|2.0|||
3620344|NCT02680301|3469636|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
3620345|NCT02680301|3469637|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3620346|NCT02680301|3469638|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3620347|NCT02680301|3469636|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620348|NCT02680301|3469637|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620349|NCT02680301|3469638|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620350|NCT02680301|3469636|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3620351|NCT02680301|3469637|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620352|NCT02680301|3469638|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3620353|NCT02680301|3469636|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3620354|NCT02680301|3469637|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3620355|NCT02680301|3469638|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3620356|NCT02680301|3469636|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3620357|NCT02680301|3469637|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3620358|NCT02680301|3469638|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3620359|NCT02680301|3469636|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3620360|NCT02680301|3469637|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620361|NCT02680301|3469638|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3620362|NCT02680301|3469636|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3620363|NCT02680301|3469637|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620364|NCT02680301|3469638|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3620365|NCT02680301|3469636|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620366|NCT02680301|3469637|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620367|NCT02680301|3469638|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620368|NCT02680301|3469636|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620369|NCT02680301|3469637|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620370|NCT02680301|3469638|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620371|NCT02680301|3469636|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3620372|NCT02680301|3469637|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3620373|NCT02680301|3469638|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3620374|NCT02680301|3469636|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3620375|NCT02680301|3469637|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3620376|NCT02680301|3469638|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3620377|NCT02680301|3469636|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3620378|NCT02680301|3469637|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3620379|NCT02680301|3469638|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3620380|NCT02680301|3469636|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3620381|NCT02680301|3469637|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3620382|NCT02680301|3469638|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3620383|NCT02680301|3469636|B3|||Age||years|Mean|7.77|7.77|Standard Deviation|3.61|3.61|||
3620384|NCT02680301|3469637|B2|||Age||years|Mean|7.29|7.29|Standard Deviation|3.27|3.27|||
3620385|NCT02680301|3469638|B1|||Age||years|Mean|8.14|8.14|Standard Deviation|3.88|3.88|||
3620386|NCT02680301|3469636|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3620387|NCT02680301|3469637|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3620388|NCT02680301|3469638|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3620389|NCT02680301|3469636|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3620390|NCT02680301|3469637|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3620391|NCT02680301|3469638|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3620392|NCT02680301|3469636|B3||<=18 years|Age||Participants|Count of Participants|39|39.0||||||
3620393|NCT02680301|3469637|B2||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
3620394|NCT02680301|3469638|B1||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
3620395|NCT02679976|3469646|B1|United Kingdom||Region of Enrollment||participants|Number|30|30.0||||||
3620396|NCT02679976|3469646|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3620397|NCT02679976|3469646|B1|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3620398|NCT02679976|3469646|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3620399|NCT02679976|3469646|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3620400|NCT02679976|3469646|B1|American Indian Or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3620401|NCT02679976|3469646|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3620402|NCT02679976|3469646|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3620403|NCT02679976|3469646|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3620404|NCT02679976|3469646|B1|||Age||years|Mean|51.7|51.7|Standard Deviation|7.37|7.37|||
3620405|NCT02679911|3469655|B1|Germany||Region of Enrollment||participants|Number|20|20.0||||||
3620406|NCT02679911|3469655|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3620407|NCT02679911|3469655|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3620408|NCT02679911|3469655|B1|||Age||years|Mean|54.5|54.5|Standard Deviation|8.7|8.7|||
3620409|NCT02679911|3469655|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3620410|NCT02679911|3469655|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3620411|NCT02679911|3469655|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3620412|NCT02679729|3469662|B10||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3620413|NCT02679729|3469663|B9||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3620414|NCT02679729|3469664|B8||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3620415|NCT02679729|3469665|B7||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3620416|NCT02679729|3469666|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3620417|NCT02679729|3469667|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3620418|NCT02679729|3469668|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3620419|NCT02679729|3469669|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3620420|NCT02679729|3469670|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3620421|NCT02679729|3469671|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3620422|NCT02679729|3469662|B10||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3620423|NCT02679729|3469663|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3620424|NCT02679729|3469664|B8||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3620425|NCT02679729|3469665|B7||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3620426|NCT02679729|3469666|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3620427|NCT02679729|3469667|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3620428|NCT02679729|3469668|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3620429|NCT02679729|3469669|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3620430|NCT02679729|3469670|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3620431|NCT02679729|3469671|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3620432|NCT02679729|3469662|B10|Part B||Age||Years|Mean|32.0|32.0|Standard Deviation|7.9|7.9|||
3620433|NCT02679729|3469663|B9|Part B||Age||Years|Mean|32.0|32.0|Standard Deviation|7.9|7.9|||
3620434|NCT02679729|3469662|B10|Part A||Age||Years|Mean|34.0|34.0|Standard Deviation|8.3|8.3|||
3620435|NCT02679729|3469664|B8|Part A||Age||Years|Mean|32.6|32.6|Standard Deviation|8.9|8.9|||
3620436|NCT02679729|3469665|B7|Part A||Age||Years|Mean|35.2|35.2|Standard Deviation|10.6|10.6|||
3620437|NCT02679729|3469666|B6|Part A||Age||Years|Mean|31.7|31.7|Standard Deviation|5.2|5.2|||
3620438|NCT02679729|3469667|B5|Part A||Age||Years|Mean|37.7|37.7|Standard Deviation|9.1|9.1|||
3620439|NCT02679729|3469668|B4|Part A||Age||Years|Mean|32.0|32.0|Standard Deviation|6.9|6.9|||
3620440|NCT02679729|3469669|B3|Part A||Age||Years|Mean|31.8|31.8|Standard Deviation|3.4|3.4|||
3620441|NCT02679729|3469670|B2|Part A||Age||Years|Mean|33.3|33.3|Standard Deviation|9.3|9.3|||
3620442|NCT02679729|3469671|B1|Part A||Age||Years|Mean|36.5|36.5|Standard Deviation|12.2|12.2|||
3620443|NCT02679469|3469783|B1|Japan||Region of Enrollment||participants|Number|7|7.0||||||
3620444|NCT02679469|3469783|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3620445|NCT02679469|3469783|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3620446|NCT02679469|3469783|B1|||Age||years|Mean|21.6|21.6|Standard Deviation|0.8|0.8|||
3620447|NCT02679469|3469783|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3620448|NCT02679469|3469783|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3620449|NCT02679469|3469783|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3620450|NCT02678923|3469789|B3|Poland||Region of Enrollment||Participants|Count of Participants|81|81.0||||||
3620451|NCT02678923|3469790|B2|Poland||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
3620452|NCT02678923|3469791|B1|Poland||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
3620453|NCT02678923|3469789|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3620454|NCT02678923|3469790|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3620455|NCT02678923|3469791|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3620456|NCT02678923|3469789|B3|Hungary||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3620457|NCT02678923|3469790|B2|Hungary||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3620458|NCT02678923|3469791|B1|Hungary||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3620459|NCT02678923|3469789|B3|Czech Republic||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3620460|NCT02678923|3469790|B2|Czech Republic||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3620461|NCT02678923|3469791|B1|Czech Republic||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3620462|NCT02678923|3469789|B3|Canada||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3620463|NCT02678923|3469790|B2|Canada||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3620464|NCT02678923|3469791|B1|Canada||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3620465|NCT02678923|3469789|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620466|NCT02678923|3469790|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620467|NCT02678923|3469791|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620468|NCT02678923|3469789|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620469|NCT02678923|3469790|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620470|NCT02678923|3469791|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620471|NCT02678923|3469789|B3||White|Race (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
3620472|NCT02678923|3469790|B2||White|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3620473|NCT02678923|3469791|B1||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3620474|NCT02678923|3469789|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620475|NCT02678923|3469790|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620476|NCT02678923|3469791|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620477|NCT02678923|3469789|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3620478|NCT02678923|3469790|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620479|NCT02678923|3469791|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3620480|NCT02678923|3469789|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3620481|NCT02678923|3469790|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3620482|NCT02678923|3469791|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620483|NCT02678923|3469789|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3620484|NCT02678923|3469790|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620485|NCT02678923|3469791|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3620486|NCT02678923|3469789|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3620487|NCT02678923|3469790|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3620488|NCT02678923|3469791|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3620489|NCT02678923|3469789|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3620490|NCT02678923|3469790|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3620491|NCT02678923|3469791|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3620492|NCT02678923|3469789|B3|||Age||years|Mean|61.8|61.8|Standard Deviation|10.4|10.4|||
3620493|NCT02678923|3469790|B2|||Age||years|Mean|61.4|61.4|Standard Deviation|10.3|10.3|||
3620494|NCT02678923|3469791|B1|||Age||years|Mean|62.2|62.2|Standard Deviation|10.6|10.6|||
3620495|NCT02678676|3469806|B3|||Body mass index (BMI)||kilogram per square meter (kg/m^2)|Mean|30.955|30.955|Standard Deviation|4.7572|4.7572|||
3620496|NCT02678676|3469807|B2|||Body mass index (BMI)||kilogram per square meter (kg/m^2)|Mean|31.078|31.078|Standard Deviation|4.7135|4.7135|||
3620497|NCT02678676|3469808|B1|||Body mass index (BMI)||kilogram per square meter (kg/m^2)|Mean|30.834|30.834|Standard Deviation|4.7978|4.7978|||
3620498|NCT02678676|3469806|B3|||Weight||Kilograms (kg)|Mean|88.17|88.17|Standard Deviation|15.534|15.534|||
3620499|NCT02678676|3469807|B2|||Weight||Kilograms (kg)|Mean|88.62|88.62|Standard Deviation|15.451|15.451|||
3620500|NCT02678676|3469808|B1|||Weight||Kilograms (kg)|Mean|87.72|87.72|Standard Deviation|15.607|15.607|||
3620501|NCT02678676|3469806|B3|||Duration of T2DM||Years|Mean|9.3|9.3|Standard Deviation|6.88|6.88|||
3620502|NCT02678676|3469807|B2|||Duration of T2DM||Years|Mean|9.3|9.3|Standard Deviation|6.96|6.96|||
3620503|NCT02678676|3469808|B1|||Duration of T2DM||Years|Mean|9.3|9.3|Standard Deviation|6.81|6.81|||
3620504|NCT02678676|3469806|B3|United Kingdom||Region of Enrollment||Participants|Number|316|316.0||||||
3620505|NCT02678676|3469807|B2|United Kingdom||Region of Enrollment||Participants|Number|148|148.0||||||
3620506|NCT02678676|3469808|B1|United Kingdom||Region of Enrollment||Participants|Number|168|168.0||||||
3620507|NCT02678676|3469806|B3|Switzerland||Region of Enrollment||Participants|Number|18|18.0||||||
3620508|NCT02678676|3469807|B2|Switzerland||Region of Enrollment||Participants|Number|7|7.0||||||
3620509|NCT02678676|3469808|B1|Switzerland||Region of Enrollment||Participants|Number|11|11.0||||||
3620510|NCT02678676|3469806|B3|Sweden||Region of Enrollment||Participants|Number|114|114.0||||||
3620511|NCT02678676|3469807|B2|Sweden||Region of Enrollment||Participants|Number|58|58.0||||||
3620512|NCT02678676|3469808|B1|Sweden||Region of Enrollment||Participants|Number|56|56.0||||||
3620513|NCT02678676|3469806|B3|Slovakia||Region of Enrollment||Participants|Number|81|81.0||||||
3620514|NCT02678676|3469807|B2|Slovakia||Region of Enrollment||Participants|Number|42|42.0||||||
3620515|NCT02678676|3469808|B1|Slovakia||Region of Enrollment||Participants|Number|39|39.0||||||
3620516|NCT02678676|3469806|B3|Poland||Region of Enrollment||Participants|Number|740|740.0||||||
3620517|NCT02678676|3469807|B2|Poland||Region of Enrollment||Participants|Number|366|366.0||||||
3620518|NCT02678676|3469808|B1|Poland||Region of Enrollment||Participants|Number|374|374.0||||||
3620519|NCT02678676|3469806|B3|Norway||Region of Enrollment||Participants|Number|91|91.0||||||
3620520|NCT02678676|3469807|B2|Norway||Region of Enrollment||Participants|Number|47|47.0||||||
3620521|NCT02678676|3469808|B1|Norway||Region of Enrollment||Participants|Number|44|44.0||||||
3620522|NCT02678676|3469806|B3|Netherlands||Region of Enrollment||Participants|Number|34|34.0||||||
3620523|NCT02678676|3469807|B2|Netherlands||Region of Enrollment||Participants|Number|18|18.0||||||
3620524|NCT02678676|3469808|B1|Netherlands||Region of Enrollment||Participants|Number|16|16.0||||||
3620525|NCT02678676|3469806|B3|Lithuania||Region of Enrollment||Participants|Number|235|235.0||||||
3620526|NCT02678676|3469807|B2|Lithuania||Region of Enrollment||Participants|Number|115|115.0||||||
3620527|NCT02678676|3469808|B1|Lithuania||Region of Enrollment||Participants|Number|120|120.0||||||
3620528|NCT02678676|3469806|B3|Latvia||Region of Enrollment||Participants|Number|353|353.0||||||
3620529|NCT02678676|3469807|B2|Latvia||Region of Enrollment||Participants|Number|175|175.0||||||
3620530|NCT02678676|3469808|B1|Latvia||Region of Enrollment||Participants|Number|178|178.0||||||
3620531|NCT02678676|3469806|B3|Hungary||Region of Enrollment||Participants|Number|716|716.0||||||
3620532|NCT02678676|3469807|B2|Hungary||Region of Enrollment||Participants|Number|360|360.0||||||
3620533|NCT02678676|3469808|B1|Hungary||Region of Enrollment||Participants|Number|356|356.0||||||
3620534|NCT02678676|3469806|B3|Germany||Region of Enrollment||Participants|Number|208|208.0||||||
3620535|NCT02678676|3469807|B2|Germany||Region of Enrollment||Participants|Number|104|104.0||||||
3620536|NCT02678676|3469808|B1|Germany||Region of Enrollment||Participants|Number|104|104.0||||||
3620537|NCT02678676|3469806|B3|France||Region of Enrollment||Participants|Number|58|58.0||||||
3620538|NCT02678676|3469807|B2|France||Region of Enrollment||Participants|Number|30|30.0||||||
3620539|NCT02678676|3469808|B1|France||Region of Enrollment||Participants|Number|28|28.0||||||
3620540|NCT02678676|3469806|B3|Finland||Region of Enrollment||Participants|Number|262|262.0||||||
3620541|NCT02678676|3469807|B2|Finland||Region of Enrollment||Participants|Number|124|124.0||||||
3620542|NCT02678676|3469808|B1|Finland||Region of Enrollment||Participants|Number|138|138.0||||||
3620543|NCT02678676|3469806|B3|Estonia||Region of Enrollment||Participants|Number|103|103.0||||||
3620544|NCT02678676|3469807|B2|Estonia||Region of Enrollment||Participants|Number|53|53.0||||||
3620545|NCT02678676|3469808|B1|Estonia||Region of Enrollment||Participants|Number|50|50.0||||||
3620546|NCT02678676|3469806|B3|Denmark||Region of Enrollment||Participants|Number|59|59.0||||||
3620547|NCT02678676|3469807|B2|Denmark||Region of Enrollment||Participants|Number|27|27.0||||||
3620548|NCT02678676|3469808|B1|Denmark||Region of Enrollment||Participants|Number|32|32.0||||||
3620549|NCT02678676|3469806|B3|Czech Republic||Region of Enrollment||Participants|Number|80|80.0||||||
3620550|NCT02678676|3469807|B2|Czech Republic||Region of Enrollment||Participants|Number|40|40.0||||||
3620551|NCT02678676|3469808|B1|Czech Republic||Region of Enrollment||Participants|Number|40|40.0||||||
3620552|NCT02678676|3469806|B3|Belgium||Region of Enrollment||Participants|Number|39|39.0||||||
3620553|NCT02678676|3469807|B2|Belgium||Region of Enrollment||Participants|Number|18|18.0||||||
3620554|NCT02678676|3469808|B1|Belgium||Region of Enrollment||Participants|Number|21|21.0||||||
3620555|NCT02678676|3469806|B3|Austria||Region of Enrollment||Participants|Number|92|92.0||||||
3620556|NCT02678676|3469807|B2|Austria||Region of Enrollment||Participants|Number|47|47.0||||||
3620557|NCT02678676|3469808|B1|Austria||Region of Enrollment||Participants|Number|45|45.0||||||
3620558|NCT02678676|3469806|B3|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3620559|NCT02678676|3469807|B2|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3620560|NCT02678676|3469808|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3620561|NCT02678676|3469806|B3|Asian/Oriental||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
3620562|NCT02678676|3469807|B2|Asian/Oriental||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3620563|NCT02678676|3469808|B1|Asian/Oriental||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
3620564|NCT02678676|3469806|B3|Black||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
3620565|NCT02678676|3469807|B2|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3620566|NCT02678676|3469808|B1|Black||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3620567|NCT02678676|3469806|B3|White||Race/Ethnicity, Customized||Participants|Number|3554|3554.0||||||
3620568|NCT02678676|3469807|B2|White||Race/Ethnicity, Customized||Participants|Number|1760|1760.0||||||
3620569|NCT02678676|3469808|B1|White||Race/Ethnicity, Customized||Participants|Number|1794|1794.0||||||
3620570|NCT02678676|3469806|B3||Male|Sex: Female, Male||Participants|Count of Participants|2341|2341.0||||||
3620571|NCT02678676|3469807|B2||Male|Sex: Female, Male||Participants|Count of Participants|1153|1153.0||||||
3620572|NCT02678676|3469808|B1||Male|Sex: Female, Male||Participants|Count of Participants|1188|1188.0||||||
3620573|NCT02678676|3469806|B3||Female|Sex: Female, Male||Participants|Count of Participants|1258|1258.0||||||
3620574|NCT02678676|3469807|B2||Female|Sex: Female, Male||Participants|Count of Participants|626|626.0||||||
3620575|NCT02678676|3469808|B1||Female|Sex: Female, Male||Participants|Count of Participants|632|632.0||||||
3620576|NCT02678676|3469806|B3|||Age||years|Mean|61.6|61.6|Standard Deviation|7.66|7.66|||
3620577|NCT02678676|3469807|B2|||Age||years|Mean|61.4|61.4|Standard Deviation|7.80|7.8|||
3620578|NCT02678676|3469808|B1|||Age||years|Mean|61.8|61.8|Standard Deviation|7.51|7.51|||
3620579|NCT02678286|3469817|B3|||Baseline Pain Intensity|Pain Intensity was assessed using the 11-point Numeric Pain Rating Scale (NPRS; 0-10) where 0 equates to no pain (better), and 10 equates to the worst pain imaginable (worse). The baseline assessment was the NPRS score collected prior to the first study dose.|units on a scale|Mean|7.3|7.3|Standard Deviation|1.63|1.63|||
3620580|NCT02678286|3469818|B2|||Baseline Pain Intensity|Pain Intensity was assessed using the 11-point Numeric Pain Rating Scale (NPRS; 0-10) where 0 equates to no pain (better), and 10 equates to the worst pain imaginable (worse). The baseline assessment was the NPRS score collected prior to the first study dose.|units on a scale|Mean|7.4|7.4|Standard Deviation|1.68|1.68|||
3620581|NCT02678286|3469819|B1|||Baseline Pain Intensity|Pain Intensity was assessed using the 11-point Numeric Pain Rating Scale (NPRS; 0-10) where 0 equates to no pain (better), and 10 equates to the worst pain imaginable (worse). The baseline assessment was the NPRS score collected prior to the first study dose.|units on a scale|Mean|7.2|7.2|Standard Deviation|1.57|1.57|||
3620582|NCT02678286|3469817|B3|||Time from End of Surgery to First Dose||hours|Mean|0.854|0.854|Standard Deviation|0.5475|0.5475|||
3620583|NCT02678286|3469818|B2|||Time from End of Surgery to First Dose||hours|Mean|0.855|0.855|Standard Deviation|0.5256|0.5256|||
3620584|NCT02678286|3469819|B1|||Time from End of Surgery to First Dose||hours|Mean|0.853|0.853|Standard Deviation|0.5708|0.5708|||
3620585|NCT02678286|3469817|B3|||Body Mass Index (BMI)||kg/m^2|Mean|26.7|26.7|Standard Deviation|3.12|3.12|||
3620586|NCT02678286|3469818|B2|||Body Mass Index (BMI)||kg/m^2|Mean|26.9|26.9|Standard Deviation|3.16|3.16|||
3620587|NCT02678286|3469819|B1|||Body Mass Index (BMI)||kg/m^2|Mean|26.5|26.5|Standard Deviation|3.08|3.08|||
3620588|NCT02678286|3469817|B3|United States||Region of Enrollment||participants|Number|219|219.0||||||
3620589|NCT02678286|3469818|B2|United States||Region of Enrollment||participants|Number|109|109.0||||||
3620590|NCT02678286|3469819|B1|United States||Region of Enrollment||participants|Number|110|110.0||||||
3620591|NCT02678286|3469817|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3620592|NCT02678286|3469818|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3620593|NCT02678286|3469819|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3620594|NCT02678286|3469817|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620595|NCT02678286|3469818|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620596|NCT02678286|3469819|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620597|NCT02678286|3469817|B3||White|Race (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
3620598|NCT02678286|3469818|B2||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3620599|NCT02678286|3469819|B1||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3620600|NCT02678286|3469817|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3620601|NCT02678286|3469818|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3620602|NCT02678286|3469819|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3620603|NCT02678286|3469817|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620604|NCT02678286|3469818|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620605|NCT02678286|3469819|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620606|NCT02678286|3469817|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3620607|NCT02678286|3469818|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3620608|NCT02678286|3469819|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3620609|NCT02678286|3469817|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3620610|NCT02678286|3469818|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3620611|NCT02678286|3469819|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620612|NCT02678286|3469817|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620613|NCT02678286|3469818|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620614|NCT02678286|3469819|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620615|NCT02678286|3469817|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
3620616|NCT02678286|3469818|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3620617|NCT02678286|3469819|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3620618|NCT02678286|3469817|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3620619|NCT02678286|3469818|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3620620|NCT02678286|3469819|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3620621|NCT02678286|3469817|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3620622|NCT02678286|3469818|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3620623|NCT02678286|3469819|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3620624|NCT02678286|3469817|B3||Female|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
3620625|NCT02678286|3469818|B2||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3620626|NCT02678286|3469819|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3620627|NCT02678286|3469817|B3|||Age||years|Mean|40.0|40.0|Standard Deviation|9.08|9.08|||
3620628|NCT02678286|3469818|B2|||Age||years|Mean|41.0|41.0|Standard Deviation|9.63|9.63|||
3620629|NCT02678286|3469819|B1|||Age||years|Mean|38.9|38.9|Standard Deviation|8.40|8.4|||
3620630|NCT02678286|3469817|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3620631|NCT02678286|3469818|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3620632|NCT02678286|3469819|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3620633|NCT02678286|3469817|B3||Between 18 and 65 years|Age||Participants|Count of Participants|217|217.0||||||
3620634|NCT02678286|3469818|B2||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
3620635|NCT02678286|3469819|B1||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
3620636|NCT02678286|3469817|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3620637|NCT02678286|3469818|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3620638|NCT02678286|3469819|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3620639|NCT02678039|3469850|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
3620640|NCT02678039|3469851|B2|United States||Region of Enrollment||participants|Number|53|53.0||||||
3620641|NCT02678039|3469852|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
3620642|NCT02678039|3469850|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3620643|NCT02678039|3469851|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3620644|NCT02678039|3469852|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3620645|NCT02678039|3469850|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3620646|NCT02678039|3469851|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3620647|NCT02678039|3469852|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3620648|NCT02678039|3469850|B3|||Age||years|Mean|65.1|65.1|Standard Deviation|10.2|10.2|||
3620649|NCT02678039|3469851|B2|||Age||years|Mean|64.9|64.9|Standard Deviation|8.9|8.9|||
3620650|NCT02678039|3469852|B1|||Age||years|Mean|65.2|65.2|Standard Deviation|10.6|10.6|||
3620651|NCT02678039|3469850|B3||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
3620652|NCT02678039|3469851|B2||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3620653|NCT02678039|3469852|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3620654|NCT02678039|3469850|B3||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
3620655|NCT02678039|3469851|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3620656|NCT02678039|3469852|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3620657|NCT02678039|3469850|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3620658|NCT02678039|3469851|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3620659|NCT02678039|3469852|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3620660|NCT02677844|3469867|B3|||Body Mass Index (BMI)||Kilogram per square meter (Kg/m^2)|Mean|27.12|27.12|Standard Deviation|2.82|2.82|||
3620661|NCT02677844|3469868|B2|||Body Mass Index (BMI)||Kilogram per square meter (Kg/m^2)|Mean|27.55|27.55|Standard Deviation|2.35|2.35|||
3620662|NCT02677844|3469869|B1|||Body Mass Index (BMI)||Kilogram per square meter (Kg/m^2)|Mean|26.80|26.8|Standard Deviation|3.15|3.15|||
3620663|NCT02677844|3469867|B3||Not Hispanic or Latino|Ethnicity||Participants|Count of Participants|25|25.0||||||
3620664|NCT02677844|3469868|B2||Not Hispanic or Latino|Ethnicity||Participants|Count of Participants|15|15.0||||||
3620665|NCT02677844|3469869|B1||Not Hispanic or Latino|Ethnicity||Participants|Count of Participants|10|10.0||||||
3620666|NCT02677844|3469867|B3||Hispanic or Latino|Ethnicity||Participants|Count of Participants|10|10.0||||||
3620667|NCT02677844|3469868|B2||Hispanic or Latino|Ethnicity||Participants|Count of Participants|0|0.0||||||
3620668|NCT02677844|3469869|B1||Hispanic or Latino|Ethnicity||Participants|Count of Participants|10|10.0||||||
3620669|NCT02677844|3469867|B3|United States||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3620670|NCT02677844|3469868|B2|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3620671|NCT02677844|3469869|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3620672|NCT02677844|3469867|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620673|NCT02677844|3469868|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620674|NCT02677844|3469869|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620675|NCT02677844|3469867|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620676|NCT02677844|3469868|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620677|NCT02677844|3469869|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620678|NCT02677844|3469867|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620679|NCT02677844|3469868|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620680|NCT02677844|3469869|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620681|NCT02677844|3469867|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3620682|NCT02677844|3469868|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3620683|NCT02677844|3469869|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3620684|NCT02677844|3469867|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620685|NCT02677844|3469868|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620686|NCT02677844|3469869|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620687|NCT02677844|3469867|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620688|NCT02677844|3469868|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620689|NCT02677844|3469869|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620690|NCT02677844|3469867|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3620691|NCT02677844|3469868|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3620692|NCT02677844|3469869|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3620693|NCT02677844|3469867|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3620694|NCT02677844|3469868|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3620695|NCT02677844|3469869|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3620696|NCT02677844|3469867|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3620697|NCT02677844|3469868|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3620698|NCT02677844|3469869|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3620699|NCT02677844|3469867|B3|||Age||years|Mean|52.8|52.8|Standard Deviation|8.9|8.9|||
3620700|NCT02677844|3469868|B2|||Age||years|Mean|58|58.0|Standard Deviation|7.5|7.5|||
3620701|NCT02677844|3469869|B1|||Age||years|Mean|48.9|48.9|Standard Deviation|7.9|7.9|||
3620702|NCT02677779|3469903|B3|||Ulcer area||cm^2|Mean|2.3|2.3|Standard Deviation|2.2|2.2|||
3620703|NCT02677779|3469904|B2|||Ulcer area||cm^2|Mean|2.7|2.7|Standard Deviation|2.8|2.8|||
3620704|NCT02677779|3469905|B1|||Ulcer area||cm^2|Mean|2.0|2.0|Standard Deviation|1.7|1.7|||
3620705|NCT02677779|3469903|B3|||Duration of ulcer||months|Mean|4.6|4.6|Standard Deviation|4.3|4.3|||
3620706|NCT02677779|3469904|B2|||Duration of ulcer||months|Mean|3.3|3.3|Standard Deviation|3.4|3.4|||
3620707|NCT02677779|3469905|B1|||Duration of ulcer||months|Mean|5.6|5.6|Standard Deviation|5.3|5.3|||
3620708|NCT02677779|3469903|B3|||HbA1c||percentage of total hemoglobin|Mean|7.0|7.0|Standard Deviation|1.3|1.3|||
3620709|NCT02677779|3469904|B2|||HbA1c||percentage of total hemoglobin|Mean|7.4|7.4|Standard Deviation|1.4|1.4|||
3620710|NCT02677779|3469905|B1|||HbA1c||percentage of total hemoglobin|Mean|6.6|6.6|Standard Deviation|1.0|1.0|||
3620711|NCT02677779|3469903|B3|||Diabetes duration||years|Mean|17.1|17.1|Standard Deviation|11.2|11.2|||
3620712|NCT02677779|3469904|B2|||Diabetes duration||years|Mean|20.3|20.3|Standard Deviation|10.5|10.5|||
3620713|NCT02677779|3469905|B1|||Diabetes duration||years|Mean|13.7|13.7|Standard Deviation|12.1|12.1|||
3620714|NCT02677779|3469903|B3|||Body Mass Index||Kg/m^2|Mean|28.2|28.2|Standard Deviation|7.5|7.5|||
3620715|NCT02677779|3469904|B2|||Body Mass Index||Kg/m^2|Mean|30.8|30.8|Standard Deviation|8.2|8.2|||
3620716|NCT02677779|3469905|B1|||Body Mass Index||Kg/m^2|Mean|25.6|25.6|Standard Deviation|7.0|7.0|||
3620717|NCT02677779|3469903|B3|Italy||Region of Enrollment||participants|Number|20|20.0||||||
3620718|NCT02677779|3469904|B2|Italy||Region of Enrollment||participants|Number|10|10.0||||||
3620719|NCT02677779|3469905|B1|Italy||Region of Enrollment||participants|Number|10|10.0||||||
3620720|NCT02677779|3469903|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3620721|NCT02677779|3469904|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3620722|NCT02677779|3469905|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3620723|NCT02677779|3469903|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3620724|NCT02677779|3469904|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3620725|NCT02677779|3469905|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3620726|NCT02677779|3469903|B3|||Age||years|Mean|71.9|71.9|Standard Deviation|9.9|9.9|||
3620727|NCT02677779|3469904|B2|||Age||years|Mean|76.8|76.8|Standard Deviation|8.6|8.6|||
3620728|NCT02677779|3469905|B1|||Age||years|Mean|67.0|67.0|Standard Deviation|11.1|11.1|||
3620729|NCT02677493|3469920|B4||Male|Sex: Female, Male||Participants|Count of Participants|570|570.0||||||
3620730|NCT02677493|3469921|B3||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3620731|NCT02677493|3469922|B2||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3620732|NCT02677493|3469923|B1||Male|Sex: Female, Male||Participants|Count of Participants|385|385.0||||||
3620733|NCT02677493|3469920|B4||Female|Sex: Female, Male||Participants|Count of Participants|1224|1224.0||||||
3620734|NCT02677493|3469921|B3||Female|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
3620735|NCT02677493|3469922|B2||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
3620736|NCT02677493|3469923|B1||Female|Sex: Female, Male||Participants|Count of Participants|812|812.0||||||
3620737|NCT02677493|3469920|B4|||Age||years|Mean|44.8|44.8|Standard Deviation|14.6|14.6|||
3620738|NCT02677493|3469921|B3|||Age||years|Mean|45.7|45.7|Standard Deviation|14.6|14.6|||
3620739|NCT02677493|3469922|B2|||Age||years|Mean|44.5|44.5|Standard Deviation|14.7|14.7|||
3620740|NCT02677493|3469923|B1|||Age||years|Mean|44.7|44.7|Standard Deviation|14.5|14.5|||
3620741|NCT02677493|3469920|B4||>=65 years|Age||Participants|Count of Participants|272|272.0||||||
3620742|NCT02677493|3469921|B3||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
3620743|NCT02677493|3469922|B2||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
3620744|NCT02677493|3469923|B1||>=65 years|Age||Participants|Count of Participants|182|182.0||||||
3620745|NCT02677493|3469920|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1522|1522.0||||||
3620746|NCT02677493|3469921|B3||Between 18 and 65 years|Age||Participants|Count of Participants|253|253.0||||||
3620747|NCT02677493|3469922|B2||Between 18 and 65 years|Age||Participants|Count of Participants|254|254.0||||||
3620748|NCT02677493|3469923|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1015|1015.0||||||
3620749|NCT02677493|3469920|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3620750|NCT02677493|3469921|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3620751|NCT02677493|3469922|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3620752|NCT02677493|3469923|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3620753|NCT02675907|3469936|B3|||Baseline Pain Intensity|Pain Intensity was assessed using the 11-point Numeric Pain Rating Scale (NPRS; 0-10) with the baseline assessment being the NPRS score collection prior to the first study dose.|units on a scale|Mean|6.8|6.8|Standard Deviation|1.86|1.86|||
3620754|NCT02675907|3469937|B2|||Baseline Pain Intensity|Pain Intensity was assessed using the 11-point Numeric Pain Rating Scale (NPRS; 0-10) with the baseline assessment being the NPRS score collection prior to the first study dose.|units on a scale|Mean|7.0|7.0|Standard Deviation|1.82|1.82|||
3620755|NCT02675907|3469938|B1|||Baseline Pain Intensity|Pain Intensity was assessed using the 11-point Numeric Pain Rating Scale (NPRS; 0-10) with the baseline assessment being the NPRS score collection prior to the first study dose.|units on a scale|Mean|6.7|6.7|Standard Deviation|1.90|1.9|||
3620756|NCT02675907|3469936|B3|||Time from End of Surgery to First Dose||hours|Mean|0.500|0.5|Standard Deviation|0.2206|0.2206|||
3620757|NCT02675907|3469937|B2|||Time from End of Surgery to First Dose||hours|Mean|0.485|0.485|Standard Deviation|0.2001|0.2001|||
3620758|NCT02675907|3469938|B1|||Time from End of Surgery to First Dose||hours|Mean|0.514|0.514|Standard Deviation|0.2397|0.2397|||
3620759|NCT02675907|3469936|B3|||Body Mass Index (BMI)||kg/m^2|Mean|27.6|27.6|Standard Deviation|4.46|4.46|||
3620760|NCT02675907|3469937|B2|||Body Mass Index (BMI)||kg/m^2|Mean|28.3|28.3|Standard Deviation|4.02|4.02|||
3620761|NCT02675907|3469938|B1|||Body Mass Index (BMI)||kg/m^2|Mean|26.9|26.9|Standard Deviation|4.80|4.8|||
3620762|NCT02675907|3469936|B3|United States||Region of Enrollment||Participants|Count of Participants|201|201.0||||||
3620763|NCT02675907|3469937|B2|United States||Region of Enrollment||Participants|Count of Participants|101|101.0||||||
3620764|NCT02675907|3469938|B1|United States||Region of Enrollment||Participants|Count of Participants|100|100.0||||||
3620765|NCT02675907|3469936|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620766|NCT02675907|3469937|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620767|NCT02675907|3469938|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620768|NCT02675907|3469936|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3620769|NCT02675907|3469937|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3620770|NCT02675907|3469938|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3620771|NCT02675907|3469936|B3||White|Race (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
3620772|NCT02675907|3469937|B2||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3620773|NCT02675907|3469938|B1||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3620774|NCT02675907|3469936|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3620775|NCT02675907|3469937|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3620776|NCT02675907|3469938|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3620777|NCT02675907|3469936|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3620778|NCT02675907|3469937|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3620779|NCT02675907|3469938|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3620780|NCT02675907|3469936|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3620781|NCT02675907|3469937|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3620782|NCT02675907|3469938|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3620783|NCT02675907|3469936|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620784|NCT02675907|3469937|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620785|NCT02675907|3469938|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620786|NCT02675907|3469936|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620787|NCT02675907|3469937|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620788|NCT02675907|3469938|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620789|NCT02675907|3469936|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|137|137.0||||||
3620790|NCT02675907|3469937|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3620791|NCT02675907|3469938|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3620792|NCT02675907|3469936|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3620793|NCT02675907|3469937|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3620794|NCT02675907|3469938|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3620795|NCT02675907|3469936|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3620796|NCT02675907|3469937|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3620797|NCT02675907|3469938|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3620798|NCT02675907|3469936|B3||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3620799|NCT02675907|3469937|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3620800|NCT02675907|3469938|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3620801|NCT02675907|3469936|B3|||Age||years|Mean|47.6|47.6|Standard Deviation|12.48|12.48|||
3620802|NCT02675907|3469937|B2|||Age||years|Mean|48.4|48.4|Standard Deviation|12.17|12.17|||
3620803|NCT02675907|3469938|B1|||Age||years|Mean|46.7|46.7|Standard Deviation|12.79|12.79|||
3620804|NCT02675907|3469936|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3620805|NCT02675907|3469937|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3620806|NCT02675907|3469938|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3620807|NCT02675907|3469936|B3||Between 18 and 65 years|Age||Participants|Count of Participants|184|184.0||||||
3620808|NCT02675907|3469937|B2||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
3620809|NCT02675907|3469938|B1||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
3620810|NCT02675907|3469936|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3620811|NCT02675907|3469937|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3620812|NCT02675907|3469938|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3620813|NCT02675764|3469969|B3|||baseline hand motor function (Box and Block Test score)|This test measures the number of blocks that a participant moved in a minute. The scale ranges from 0 to a positive number. Higher numbers represent better outcomes.|blocks|Mean|29|29.0|Standard Deviation|12|12.0|||
3620814|NCT02675764|3469970|B2|||baseline hand motor function (Box and Block Test score)|This test measures the number of blocks that a participant moved in a minute. The scale ranges from 0 to a positive number. Higher numbers represent better outcomes.|blocks|Mean|28|28.0|Standard Deviation|11|11.0|||
3620815|NCT02675764|3469971|B1|||baseline hand motor function (Box and Block Test score)|This test measures the number of blocks that a participant moved in a minute. The scale ranges from 0 to a positive number. Higher numbers represent better outcomes.|blocks|Mean|29|29.0|Standard Deviation|15|15.0|||
3620816|NCT02675764|3469969|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3620817|NCT02675764|3469970|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3620818|NCT02675764|3469971|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3620819|NCT02675764|3469969|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620820|NCT02675764|3469970|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620821|NCT02675764|3469971|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620822|NCT02675764|3469969|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620823|NCT02675764|3469970|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620824|NCT02675764|3469971|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620825|NCT02675764|3469969|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3620826|NCT02675764|3469970|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3620827|NCT02675764|3469971|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3620828|NCT02675764|3469969|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3620829|NCT02675764|3469970|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620830|NCT02675764|3469971|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3620831|NCT02675764|3469969|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620832|NCT02675764|3469970|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620833|NCT02675764|3469971|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620834|NCT02675764|3469969|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620835|NCT02675764|3469970|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620836|NCT02675764|3469971|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620837|NCT02675764|3469969|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620838|NCT02675764|3469970|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620839|NCT02675764|3469971|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620840|NCT02675764|3469969|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3620841|NCT02675764|3469970|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3620842|NCT02675764|3469971|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3620843|NCT02675764|3469969|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3620844|NCT02675764|3469970|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3620845|NCT02675764|3469971|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3620846|NCT02675764|3469969|B3|||Age||years|Mean|63|63.0|Standard Deviation|9|9.0|||
3620847|NCT02675764|3469970|B2|||Age||years|Mean|64|64.0|Standard Deviation|8|8.0|||
3620848|NCT02675764|3469971|B1|||Age||years|Mean|61|61.0|Standard Deviation|10|10.0|||
3620849|NCT02675634|3469984|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3620850|NCT02675634|3469984|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3620851|NCT02675634|3469984|B1|||Age||years|Mean|69|69.0|Standard Deviation|11.2|11.2|||
3620852|NCT02675543|3469997|B3|Italy||Region of Enrollment||participants|Number|35|35.0||||||
3620853|NCT02675543|3469998|B2|Italy||Region of Enrollment||participants|Number|20|20.0||||||
3620854|NCT02675543|3469999|B1|Italy||Region of Enrollment||participants|Number|15|15.0||||||
3620855|NCT02675543|3469997|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3620856|NCT02675543|3469998|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3620857|NCT02675543|3469999|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3620858|NCT02675543|3469997|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3620859|NCT02675543|3469998|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3620860|NCT02675543|3469999|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3620861|NCT02675543|3469997|B3|||Age||years|Mean|60.4|60.4|Standard Deviation|14.6|14.6|||
3620862|NCT02675543|3469998|B2|||Age||years|Mean|62.3|62.3|Standard Deviation|16.7|16.7|||
3620863|NCT02675543|3469999|B1|||Age||years|Mean|58.9|58.9|Standard Deviation|12.8|12.8|||
3620864|NCT02675543|3469997|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3620865|NCT02675543|3469998|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3620866|NCT02675543|3469999|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3620867|NCT02675543|3469997|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3620868|NCT02675543|3469998|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3620869|NCT02675543|3469999|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3620870|NCT02675543|3469997|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3620871|NCT02675543|3469998|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3620872|NCT02675543|3469999|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3620873|NCT02675517|3470006|B1||Male|Sex: Female, Male||Participants|Count of Participants|990|990.0||||||
3620874|NCT02675517|3470006|B1||Female|Sex: Female, Male||Participants|Count of Participants|747|747.0||||||
3620875|NCT02675517|3470006|B1|||Age|Age at the time of registration was captured|Years|Mean|66.51|66.51|Standard Deviation|10.30|10.3|||
3620876|NCT02674412|3470015|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3620877|NCT02674412|3470015|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3620878|NCT02674412|3470015|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3620879|NCT02674412|3470015|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3620880|NCT02674412|3470015|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3620881|NCT02674334|3470026|B3|United States||Region of Enrollment||participants|Number|90|90.0||||||
3620882|NCT02674334|3470027|B2|United States||Region of Enrollment||participants|Number|43|43.0||||||
3620883|NCT02674334|3470028|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
3620884|NCT02674334|3470026|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3620885|NCT02674334|3470027|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3620886|NCT02674334|3470028|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3620887|NCT02674334|3470026|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3620888|NCT02674334|3470027|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3620889|NCT02674334|3470028|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3620890|NCT02674334|3470026|B3|>=18 years||Age, Customized|>=18 years|participants|Number|90|90.0||||||
3620891|NCT02674334|3470027|B2|>=18 years||Age, Customized|>=18 years|participants|Number|43|43.0||||||
3620892|NCT02674334|3470028|B1|>=18 years||Age, Customized|>=18 years|participants|Number|47|47.0||||||
3620893|NCT02673944|3470037|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3620894|NCT02673944|3470037|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3620895|NCT02673944|3470037|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3620896|NCT02673944|3470037|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3620897|NCT02673944|3470037|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3620898|NCT02673619|3470042|B5|Race customized|MULTIPLE-W-W/CAUCASIAN/EUR HER ASI - EAST ASI HER|Race/Ethnicity, Customized|One participant was randomized but did not receive treatment|Participants|Count of Participants|1|1.0||||||
3620899|NCT02673619|3470043|B4|Race customized|MULTIPLE-W-W/CAUCASIAN/EUR HER ASI - EAST ASI HER|Race/Ethnicity, Customized|One participant was randomized but did not receive treatment|Participants|Count of Participants|0|0.0||||||
3620900|NCT02673619|3470044|B3|Race customized|MULTIPLE-W-W/CAUCASIAN/EUR HER ASI - EAST ASI HER|Race/Ethnicity, Customized|One participant was randomized but did not receive treatment|Participants|Count of Participants|1|1.0||||||
3620901|NCT02673619|3470045|B2|Race customized|MULTIPLE-W-W/CAUCASIAN/EUR HER ASI - EAST ASI HER|Race/Ethnicity, Customized|One participant was randomized but did not receive treatment|Participants|Count of Participants|0|0.0||||||
3620902|NCT02673619|3470046|B1|Race customized|MULTIPLE-W-W/CAUCASIAN/EUR HER ASI - EAST ASI HER|Race/Ethnicity, Customized|One participant was randomized but did not receive treatment|Participants|Count of Participants|0|0.0||||||
3620903|NCT02673619|3470042|B5|Race customized|W-W/CAUCASIAN/EUROPEAN (EUR) HER|Race/Ethnicity, Customized|One participant was randomized but did not receive treatment|Participants|Count of Participants|33|33.0||||||
3620904|NCT02673619|3470043|B4|Race customized|W-W/CAUCASIAN/EUROPEAN (EUR) HER|Race/Ethnicity, Customized|One participant was randomized but did not receive treatment|Participants|Count of Participants|5|5.0||||||
3620905|NCT02673619|3470044|B3|Race customized|W-W/CAUCASIAN/EUROPEAN (EUR) HER|Race/Ethnicity, Customized|One participant was randomized but did not receive treatment|Participants|Count of Participants|16|16.0||||||
3620906|NCT02673619|3470045|B2|Race customized|W-W/CAUCASIAN/EUROPEAN (EUR) HER|Race/Ethnicity, Customized|One participant was randomized but did not receive treatment|Participants|Count of Participants|4|4.0||||||
3620907|NCT02673619|3470046|B1|Race customized|W-W/CAUCASIAN/EUROPEAN (EUR) HER|Race/Ethnicity, Customized|One participant was randomized but did not receive treatment|Participants|Count of Participants|8|8.0||||||
3620908|NCT02673619|3470042|B5|Race customized|WHITE (W) ARABIC/NORTH AFRICAN HER|Race/Ethnicity, Customized|One participant was randomized but did not receive treatment|Participants|Count of Participants|7|7.0||||||
3620909|NCT02673619|3470043|B4|Race customized|WHITE (W) ARABIC/NORTH AFRICAN HER|Race/Ethnicity, Customized|One participant was randomized but did not receive treatment|Participants|Count of Participants|0|0.0||||||
3620910|NCT02673619|3470044|B3|Race customized|WHITE (W) ARABIC/NORTH AFRICAN HER|Race/Ethnicity, Customized|One participant was randomized but did not receive treatment|Participants|Count of Participants|2|2.0||||||
3620911|NCT02673619|3470045|B2|Race customized|WHITE (W) ARABIC/NORTH AFRICAN HER|Race/Ethnicity, Customized|One participant was randomized but did not receive treatment|Participants|Count of Participants|1|1.0||||||
3620912|NCT02673619|3470046|B1|Race customized|WHITE (W) ARABIC/NORTH AFRICAN HER|Race/Ethnicity, Customized|One participant was randomized but did not receive treatment|Participants|Count of Participants|4|4.0||||||
3620913|NCT02673619|3470042|B5|Race customized|NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER|Race/Ethnicity, Customized|One participant was randomized but did not receive treatment|Participants|Count of Participants|1|1.0||||||
3620914|NCT02673619|3470043|B4|Race customized|NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER|Race/Ethnicity, Customized|One participant was randomized but did not receive treatment|Participants|Count of Participants|0|0.0||||||
3620915|NCT02673619|3470044|B3|Race customized|NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER|Race/Ethnicity, Customized|One participant was randomized but did not receive treatment|Participants|Count of Participants|1|1.0||||||
3620916|NCT02673619|3470045|B2|Race customized|NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER|Race/Ethnicity, Customized|One participant was randomized but did not receive treatment|Participants|Count of Participants|0|0.0||||||
3620917|NCT02673619|3470046|B1|Race customized|NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER|Race/Ethnicity, Customized|One participant was randomized but did not receive treatment|Participants|Count of Participants|0|0.0||||||
3620918|NCT02673619|3470042|B5|Race customized|BLACK OR AFRICAN AMERICAN|Race/Ethnicity, Customized|One participant was randomized but did not receive treatment|Participants|Count of Participants|12|12.0||||||
3620919|NCT02673619|3470043|B4|Race customized|BLACK OR AFRICAN AMERICAN|Race/Ethnicity, Customized|One participant was randomized but did not receive treatment|Participants|Count of Participants|2|2.0||||||
3620920|NCT02673619|3470044|B3|Race customized|BLACK OR AFRICAN AMERICAN|Race/Ethnicity, Customized|One participant was randomized but did not receive treatment|Participants|Count of Participants|5|5.0||||||
3620921|NCT02673619|3470045|B2|Race customized|BLACK OR AFRICAN AMERICAN|Race/Ethnicity, Customized|One participant was randomized but did not receive treatment|Participants|Count of Participants|0|0.0||||||
3620922|NCT02673619|3470046|B1|Race customized|BLACK OR AFRICAN AMERICAN|Race/Ethnicity, Customized|One participant was randomized but did not receive treatment|Participants|Count of Participants|5|5.0||||||
3620923|NCT02673619|3470042|B5|Race customized|ASIAN (ASI)-CENTRAL/SOUTH ASI HERITAGE (HER)|Race/Ethnicity, Customized|One participant was randomized but did not receive treatment|Participants|Count of Participants|2|2.0||||||
3620924|NCT02673619|3470043|B4|Race customized|ASIAN (ASI)-CENTRAL/SOUTH ASI HERITAGE (HER)|Race/Ethnicity, Customized|One participant was randomized but did not receive treatment|Participants|Count of Participants|0|0.0||||||
3620925|NCT02673619|3470044|B3|Race customized|ASIAN (ASI)-CENTRAL/SOUTH ASI HERITAGE (HER)|Race/Ethnicity, Customized|One participant was randomized but did not receive treatment|Participants|Count of Participants|1|1.0||||||
3620926|NCT02673619|3470045|B2|Race customized|ASIAN (ASI)-CENTRAL/SOUTH ASI HERITAGE (HER)|Race/Ethnicity, Customized|One participant was randomized but did not receive treatment|Participants|Count of Participants|0|0.0||||||
3620927|NCT02673619|3470046|B1|Race customized|ASIAN (ASI)-CENTRAL/SOUTH ASI HERITAGE (HER)|Race/Ethnicity, Customized|One participant was randomized but did not receive treatment|Participants|Count of Participants|1|1.0||||||
3620928|NCT02673619|3470042|B5|Race customized|AMERICAN INDIAN OR ALASKAN NATIVE|Race/Ethnicity, Customized|One participant was randomized but did not receive treatment|Participants|Count of Participants|1|1.0||||||
3620929|NCT02673619|3470043|B4|Race customized|AMERICAN INDIAN OR ALASKAN NATIVE|Race/Ethnicity, Customized|One participant was randomized but did not receive treatment|Participants|Count of Participants|0|0.0||||||
3620930|NCT02673619|3470044|B3|Race customized|AMERICAN INDIAN OR ALASKAN NATIVE|Race/Ethnicity, Customized|One participant was randomized but did not receive treatment|Participants|Count of Participants|0|0.0||||||
3620931|NCT02673619|3470045|B2|Race customized|AMERICAN INDIAN OR ALASKAN NATIVE|Race/Ethnicity, Customized|One participant was randomized but did not receive treatment|Participants|Count of Participants|0|0.0||||||
3620932|NCT02673619|3470046|B1|Race customized|AMERICAN INDIAN OR ALASKAN NATIVE|Race/Ethnicity, Customized|One participant was randomized but did not receive treatment|Participants|Count of Participants|1|1.0||||||
3620933|NCT02673619|3470042|B5||Male|Sex: Female, Male|One participant was randomized but did not receive treatment|Participants|Count of Participants|21|21.0||||||
3620934|NCT02673619|3470043|B4||Male|Sex: Female, Male|One participant was randomized but did not receive treatment|Participants|Count of Participants|2|2.0||||||
3620935|NCT02673619|3470044|B3||Male|Sex: Female, Male|One participant was randomized but did not receive treatment|Participants|Count of Participants|12|12.0||||||
3620936|NCT02673619|3470045|B2||Male|Sex: Female, Male|One participant was randomized but did not receive treatment|Participants|Count of Participants|2|2.0||||||
3620937|NCT02673619|3470046|B1||Male|Sex: Female, Male|One participant was randomized but did not receive treatment|Participants|Count of Participants|5|5.0||||||
3620938|NCT02673619|3470042|B5||Female|Sex: Female, Male|One participant was randomized but did not receive treatment|Participants|Count of Participants|36|36.0||||||
3620939|NCT02673619|3470043|B4||Female|Sex: Female, Male|One participant was randomized but did not receive treatment|Participants|Count of Participants|5|5.0||||||
3620940|NCT02673619|3470044|B3||Female|Sex: Female, Male|One participant was randomized but did not receive treatment|Participants|Count of Participants|14|14.0||||||
3620941|NCT02673619|3470045|B2||Female|Sex: Female, Male|One participant was randomized but did not receive treatment|Participants|Count of Participants|3|3.0||||||
3620942|NCT02673619|3470046|B1||Female|Sex: Female, Male|One participant was randomized but did not receive treatment|Participants|Count of Participants|14|14.0||||||
3620943|NCT02673619|3470042|B5|Cohort 1.15%||Age|One participant was randomized but did not receive treatment.|Years|Mean|32.0|32.0|Standard Deviation|10.72|10.72|||
3620944|NCT02673619|3470043|B4|Cohort 1.15%||Age|One participant was randomized but did not receive treatment.|Years|Mean|32.6|32.6|Standard Deviation|12.55|12.55|||
3620945|NCT02673619|3470044|B3|Cohort 1.15%||Age|One participant was randomized but did not receive treatment.|Years|Mean|31.8|31.8|Standard Deviation|10.45|10.45|||
3620946|NCT02673619|3470042|B5|Cohort 1.85%||Age|One participant was randomized but did not receive treatment.|Years|Mean|31.8|31.8|Standard Deviation|11.79|11.79|||
3620947|NCT02673619|3470045|B2|Cohort 1.85%||Age|One participant was randomized but did not receive treatment.|Years|Mean|23.8|23.8|Standard Deviation|4.09|4.09|||
3620948|NCT02673619|3470046|B1|Cohort 1.85%||Age|One participant was randomized but did not receive treatment.|Years|Mean|33.9|33.9|Standard Deviation|12.31|12.31|||
3620949|NCT02673489|3470139|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620950|NCT02673489|3470140|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620951|NCT02673489|3470141|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620952|NCT02673489|3470139|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620953|NCT02673489|3470140|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620954|NCT02673489|3470141|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620955|NCT02673489|3470139|B3||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3620956|NCT02673489|3470140|B2||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3620957|NCT02673489|3470141|B1||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3620958|NCT02673489|3470139|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620959|NCT02673489|3470140|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620960|NCT02673489|3470141|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620961|NCT02673489|3470139|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620962|NCT02673489|3470140|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620963|NCT02673489|3470141|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620964|NCT02673489|3470139|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3620965|NCT02673489|3470140|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3620966|NCT02673489|3470141|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3620967|NCT02673489|3470139|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3620968|NCT02673489|3470140|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3620969|NCT02673489|3470141|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3620970|NCT02673489|3470139|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3620971|NCT02673489|3470140|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3620972|NCT02673489|3470141|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3620973|NCT02673489|3470139|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3620974|NCT02673489|3470140|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3620975|NCT02673489|3470141|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3620976|NCT02673489|3470139|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3620977|NCT02673489|3470140|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3620978|NCT02673489|3470141|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3620979|NCT02673489|3470139|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3620980|NCT02673489|3470140|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3620981|NCT02673489|3470141|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3620982|NCT02673489|3470139|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3620983|NCT02673489|3470140|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3620984|NCT02673489|3470141|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3620985|NCT02673489|3470139|B3|||Age||Years|Mean|54.4|54.4|Standard Deviation|7.16|7.16|||
3620986|NCT02673489|3470140|B2|||Age||Years|Mean|55.3|55.3|Standard Deviation|4.90|4.9|||
3620987|NCT02673489|3470141|B1|||Age||Years|Mean|54|54.0|Standard Deviation|7.97|7.97|||
3620988|NCT02673138|3470155|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3620989|NCT02673138|3470155|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3620990|NCT02673138|3470155|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3620991|NCT02673138|3470155|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3620992|NCT02673138|3470155|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3620993|NCT02672514|3470167|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3620994|NCT02672514|3470168|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3620995|NCT02672514|3470169|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3620996|NCT02672514|3470167|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3620997|NCT02672514|3470168|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3620998|NCT02672514|3470169|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3620999|NCT02672514|3470167|B3|||Age||years|Mean|67.1|67.1|Standard Deviation|9|9.0|||
3621000|NCT02672514|3470168|B2|||Age||years|Mean|67.98|67.98|Standard Deviation|8.43|8.43|||
3621001|NCT02672514|3470169|B1|||Age||years|Mean|66.25|66.25|Standard Deviation|8.95|8.95|||
3621002|NCT02672514|3470167|B3||>=65 years|Age||Participants|Count of Participants|77|77.0||||||
3621003|NCT02672514|3470168|B2||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
3621004|NCT02672514|3470169|B1||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
3621005|NCT02672514|3470167|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3621006|NCT02672514|3470168|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3621007|NCT02672514|3470169|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3621008|NCT02672514|3470167|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3621009|NCT02672514|3470168|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3621010|NCT02672514|3470169|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3621011|NCT02672423|3470176|B4|United States||Region of Enrollment||Participants|Count of Participants|127|127.0||||||
3621012|NCT02672423|3470177|B3|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3621013|NCT02672423|3470178|B2|United States||Region of Enrollment||Participants|Count of Participants|89|89.0||||||
3621014|NCT02672423|3470179|B1|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3621015|NCT02672423|3470176|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621016|NCT02672423|3470177|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621017|NCT02672423|3470178|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621018|NCT02672423|3470179|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621019|NCT02672423|3470176|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3621020|NCT02672423|3470177|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621021|NCT02672423|3470178|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3621022|NCT02672423|3470179|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3621023|NCT02672423|3470176|B4||White|Race (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3621024|NCT02672423|3470177|B3||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3621025|NCT02672423|3470178|B2||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3621026|NCT02672423|3470179|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3621027|NCT02672423|3470176|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3621028|NCT02672423|3470177|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621029|NCT02672423|3470178|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3621030|NCT02672423|3470179|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3621031|NCT02672423|3470176|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621032|NCT02672423|3470177|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621033|NCT02672423|3470178|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621034|NCT02672423|3470179|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621035|NCT02672423|3470176|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621036|NCT02672423|3470177|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621037|NCT02672423|3470178|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621038|NCT02672423|3470179|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621039|NCT02672423|3470176|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3621040|NCT02672423|3470177|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621041|NCT02672423|3470178|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621042|NCT02672423|3470179|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621043|NCT02672423|3470176|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621044|NCT02672423|3470177|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621045|NCT02672423|3470178|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621046|NCT02672423|3470179|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621047|NCT02672423|3470176|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
3621048|NCT02672423|3470177|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3621049|NCT02672423|3470178|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3621050|NCT02672423|3470179|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3621051|NCT02672423|3470176|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3621052|NCT02672423|3470177|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3621053|NCT02672423|3470178|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3621054|NCT02672423|3470179|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3621055|NCT02672423|3470176|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3621056|NCT02672423|3470177|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3621057|NCT02672423|3470178|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3621058|NCT02672423|3470179|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3621059|NCT02672423|3470176|B4||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3621060|NCT02672423|3470177|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3621061|NCT02672423|3470178|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3621062|NCT02672423|3470179|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3621063|NCT02672423|3470176|B4|||Age||years|Mean|52.7|52.7|Standard Deviation|12|12.0|||
3621064|NCT02672423|3470177|B3|||Age||years|Mean|55.5|55.5|Standard Deviation|10.6|10.6|||
3621065|NCT02672423|3470178|B2|||Age||years|Mean|51.8|51.8|Standard Deviation|11.6|11.6|||
3621066|NCT02672423|3470179|B1|||Age||years|Mean|53.6|53.6|Standard Deviation|16.9|16.9|||
3621067|NCT02671760|3470211|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
3621068|NCT02671760|3470211|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621069|NCT02671760|3470211|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621070|NCT02671760|3470211|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3621071|NCT02671760|3470211|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3621072|NCT02671760|3470211|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621073|NCT02671760|3470211|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3621074|NCT02671760|3470211|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621075|NCT02671760|3470211|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621076|NCT02671760|3470211|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3621077|NCT02671760|3470211|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3621078|NCT02671760|3470211|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3621079|NCT02671760|3470211|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3621080|NCT02671760|3470211|B1|||Age||years|Mean|41.9|41.9|Standard Deviation|8.5|8.5|||
3621081|NCT02671461|3470239|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621082|NCT02671461|3470240|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621083|NCT02671461|3470241|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621084|NCT02671461|3470242|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621085|NCT02671461|3470239|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621086|NCT02671461|3470240|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621087|NCT02671461|3470241|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621088|NCT02671461|3470242|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621089|NCT02671461|3470239|B4||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3621090|NCT02671461|3470240|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3621091|NCT02671461|3470241|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3621092|NCT02671461|3470242|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3621093|NCT02671461|3470239|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3621094|NCT02671461|3470240|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621095|NCT02671461|3470241|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3621096|NCT02671461|3470242|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621097|NCT02671461|3470239|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621098|NCT02671461|3470240|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621099|NCT02671461|3470241|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621100|NCT02671461|3470242|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621101|NCT02671461|3470239|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621102|NCT02671461|3470240|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621103|NCT02671461|3470241|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621104|NCT02671461|3470242|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621105|NCT02671461|3470239|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621106|NCT02671461|3470240|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621107|NCT02671461|3470241|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621108|NCT02671461|3470242|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621109|NCT02671461|3470239|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621110|NCT02671461|3470240|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621111|NCT02671461|3470241|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621112|NCT02671461|3470242|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621113|NCT02671461|3470239|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3621114|NCT02671461|3470240|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3621115|NCT02671461|3470241|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3621116|NCT02671461|3470242|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3621117|NCT02671461|3470239|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621118|NCT02671461|3470240|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621119|NCT02671461|3470241|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621120|NCT02671461|3470242|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621121|NCT02671461|3470239|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3621122|NCT02671461|3470240|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3621123|NCT02671461|3470241|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3621124|NCT02671461|3470242|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3621125|NCT02671461|3470239|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3621126|NCT02671461|3470240|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3621127|NCT02671461|3470241|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3621128|NCT02671461|3470242|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3621129|NCT02671461|3470239|B4|||Age||years|Mean|65.4|65.4|Standard Deviation|9.0|9.0|||
3621130|NCT02671461|3470240|B3|||Age||years|Mean|66.7|66.7|Standard Deviation|7.6|7.6|||
3621131|NCT02671461|3470241|B2|||Age||years|Mean|64.8|64.8|Standard Deviation|12.2|12.2|||
3621132|NCT02671461|3470242|B1|||Age||years|Mean|63.3|63.3|Standard Deviation|9.2|9.2|||
3621133|NCT02671266|3470267|B3|||BABS|The Brown Assessment of Beliefs Scale (BABS) is a clinician-administered measure designed to assess degree of insight and conviction of beliefs. Total scores are reported. Total scores range from 0 (excellent insight) to 24 (lacks insight, delusional).|units on a scale|Mean|11.91|11.91|Standard Deviation|4.67|4.67|||
3621134|NCT02671266|3470268|B2|||BABS|The Brown Assessment of Beliefs Scale (BABS) is a clinician-administered measure designed to assess degree of insight and conviction of beliefs. Total scores are reported. Total scores range from 0 (excellent insight) to 24 (lacks insight, delusional).|units on a scale|Mean|11.17|11.17|Standard Deviation|3.41|3.41|||
3621135|NCT02671266|3470269|B1|||BABS|The Brown Assessment of Beliefs Scale (BABS) is a clinician-administered measure designed to assess degree of insight and conviction of beliefs. Total scores are reported. Total scores range from 0 (excellent insight) to 24 (lacks insight, delusional).|units on a scale|Mean|12.73|12.73|Standard Deviation|5.82|5.82|||
3621136|NCT02671266|3470267|B3|||BDD-YBOCS|The Yale-Brown Obsessive Compulsive Scale Modified for Body Dysmorphic Disorder (BDD-YBOCS) is a 12-item clinician administered measure that is designed to assess body dysmorphic disorder symptom severity. Total scores are reported. Total scores range from 0 (least severe) to 48 (most severe).|units on a scale|Mean|24.89|24.89|Standard Deviation|4.19|4.19|||
3621137|NCT02671266|3470268|B2|||BDD-YBOCS|The Yale-Brown Obsessive Compulsive Scale Modified for Body Dysmorphic Disorder (BDD-YBOCS) is a 12-item clinician administered measure that is designed to assess body dysmorphic disorder symptom severity. Total scores are reported. Total scores range from 0 (least severe) to 48 (most severe).|units on a scale|Mean|24.89|24.89|Standard Deviation|3.55|3.55|||
3621138|NCT02671266|3470269|B1|||BDD-YBOCS|The Yale-Brown Obsessive Compulsive Scale Modified for Body Dysmorphic Disorder (BDD-YBOCS) is a 12-item clinician administered measure that is designed to assess body dysmorphic disorder symptom severity. Total scores are reported. Total scores range from 0 (least severe) to 48 (most severe).|units on a scale|Mean|25.11|25.11|Standard Deviation|5.13|5.13|||
3621139|NCT02671266|3470267|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621140|NCT02671266|3470268|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621141|NCT02671266|3470269|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621142|NCT02671266|3470267|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3621143|NCT02671266|3470268|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621144|NCT02671266|3470269|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3621145|NCT02671266|3470267|B3||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3621146|NCT02671266|3470268|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3621147|NCT02671266|3470269|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3621148|NCT02671266|3470267|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621149|NCT02671266|3470268|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621150|NCT02671266|3470269|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621151|NCT02671266|3470267|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621152|NCT02671266|3470268|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621153|NCT02671266|3470269|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621154|NCT02671266|3470267|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3621155|NCT02671266|3470268|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3621156|NCT02671266|3470269|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621157|NCT02671266|3470267|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621158|NCT02671266|3470268|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621159|NCT02671266|3470269|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621160|NCT02671266|3470267|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621161|NCT02671266|3470268|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621162|NCT02671266|3470269|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621163|NCT02671266|3470267|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3621164|NCT02671266|3470268|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3621165|NCT02671266|3470269|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3621166|NCT02671266|3470267|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3621167|NCT02671266|3470268|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621168|NCT02671266|3470269|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3621169|NCT02671266|3470267|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3621170|NCT02671266|3470268|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3621171|NCT02671266|3470269|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3621172|NCT02671266|3470267|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3621173|NCT02671266|3470268|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3621174|NCT02671266|3470269|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3621175|NCT02671266|3470267|B3|||Age||years|Mean|27.12|27.12|Standard Deviation|7.88|7.88|||
3621176|NCT02671266|3470268|B2|||Age||years|Mean|27.05|27.05|Standard Deviation|7.00|7.0|||
3621177|NCT02671266|3470269|B1|||Age||years|Mean|27.20|27.2|Standard Deviation|8.90|8.9|||
3621178|NCT02670811|3470282|B3|||Triglycerides||mg/dL|Mean|141|141.0|Standard Deviation|53.3|53.3|||
3621179|NCT02670811|3470283|B2|||Triglycerides||mg/dL|Mean|144.3|144.3|Standard Deviation|63.5|63.5|||
3621180|NCT02670811|3470284|B1|||Triglycerides||mg/dL|Mean|137.5|137.5|Standard Deviation|42.3|42.3|||
3621181|NCT02670811|3470282|B3|||High density lipoprotein||mg/dL|Mean|37.9|37.9|Standard Deviation|7.6|7.6|||
3621182|NCT02670811|3470283|B2|||High density lipoprotein||mg/dL|Mean|37.8|37.8|Standard Deviation|6.5|6.5|||
3621183|NCT02670811|3470284|B1|||High density lipoprotein||mg/dL|Mean|37.9|37.9|Standard Deviation|8.7|8.7|||
3621184|NCT02670811|3470282|B3|||Low density lipoprotein||mg/dL|Mean|120.9|120.9|Standard Deviation|35.5|35.5|||
3621185|NCT02670811|3470283|B2|||Low density lipoprotein||mg/dL|Mean|114.7|114.7|Standard Deviation|26|26.0|||
3621186|NCT02670811|3470284|B1|||Low density lipoprotein||mg/dL|Mean|127.1|127.1|Standard Deviation|43|43.0|||
3621187|NCT02670811|3470282|B3|||Total cholesterol||mg/dL|Mean|184.1|184.1|Standard Deviation|35.9|35.9|||
3621188|NCT02670811|3470283|B2|||Total cholesterol||mg/dL|Mean|178.1|178.1|Standard Deviation|26|26.0|||
3621189|NCT02670811|3470284|B1|||Total cholesterol||mg/dL|Mean|190.1|190.1|Standard Deviation|43.6|43.6|||
3621190|NCT02670811|3470282|B3|||Height||meters|Mean|1.65|1.65|Standard Deviation|0.1|0.1|||
3621191|NCT02670811|3470283|B2|||Height||meters|Mean|1.67|1.67|Standard Deviation|0.1|0.1|||
3621192|NCT02670811|3470284|B1|||Height||meters|Mean|1.63|1.63|Standard Deviation|0.1|0.1|||
3621193|NCT02670811|3470282|B3|||Weight||kilograms|Mean|83.2|83.2|Standard Deviation|16.5|16.5|||
3621194|NCT02670811|3470283|B2|||Weight||kilograms|Mean|85.8|85.8|Standard Deviation|18.2|18.2|||
3621195|NCT02670811|3470284|B1|||Weight||kilograms|Mean|80.5|80.5|Standard Deviation|14.6|14.6|||
3621196|NCT02670811|3470282|B3|||Diastolic blood pressure||mmHg|Mean|88.6|88.6|Standard Deviation|5.4|5.4|||
3621197|NCT02670811|3470283|B2|||Diastolic blood pressure||mmHg|Mean|89.3|89.3|Standard Deviation|5.8|5.8|||
3621198|NCT02670811|3470284|B1|||Diastolic blood pressure||mmHg|Mean|87.7|87.7|Standard Deviation|5.1|5.1|||
3621199|NCT02670811|3470282|B3|||Systolic blood pressure||mmHg|Mean|133.1|133.1|Standard Deviation|6.4|6.4|||
3621200|NCT02670811|3470283|B2|||Systolic blood pressure||mmHg|Mean|134.3|134.3|Standard Deviation|7|7.0|||
3621201|NCT02670811|3470284|B1|||Systolic blood pressure||mmHg|Mean|131.8|131.8|Standard Deviation|5.6|5.6|||
3621202|NCT02670811|3470282|B3|Mexico||Region of Enrollment||Participants|Number|36|36.0||||||
3621203|NCT02670811|3470283|B2|Mexico||Region of Enrollment||Participants|Number|18|18.0||||||
3621204|NCT02670811|3470284|B1|Mexico||Region of Enrollment||Participants|Number|18|18.0||||||
3621205|NCT02670811|3470282|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3621206|NCT02670811|3470283|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3621207|NCT02670811|3470284|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3621208|NCT02670811|3470282|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3621209|NCT02670811|3470283|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3621210|NCT02670811|3470284|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3621211|NCT02670811|3470282|B3|||Age||Years|Mean|42.5|42.5|Standard Deviation|10.5|10.5|||
3621212|NCT02670811|3470283|B2|||Age||Years|Mean|44.6|44.6|Standard Deviation|9.2|9.2|||
3621213|NCT02670811|3470284|B1|||Age||Years|Mean|40.5|40.5|Standard Deviation|11.7|11.7|||
3621214|NCT02670473|3470301|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3621215|NCT02670473|3470301|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3621216|NCT02670473|3470301|B1|||Age||years|Mean|24.15|24.15|Standard Deviation|5.53|5.53|||
3621217|NCT02670343|3470354|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3621218|NCT02670343|3470354|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3621219|NCT02670343|3470354|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3621220|NCT02670343|3470354|B1|||Age||years|Mean|47.3|47.3|Standard Deviation|11.60|11.6|||
3621221|NCT02670343|3470354|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3621222|NCT02670343|3470354|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3621223|NCT02670343|3470354|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3621224|NCT02669940|3470358|B3|White/Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|154|154.0||||||
3621225|NCT02669940|3470359|B2|White/Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|92|92.0||||||
3621226|NCT02669940|3470360|B1|White/Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|62|62.0||||||
3621227|NCT02669940|3470358|B3|Asian/Oriental||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3621228|NCT02669940|3470359|B2|Asian/Oriental||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3621229|NCT02669940|3470360|B1|Asian/Oriental||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3621230|NCT02669940|3470358|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3621231|NCT02669940|3470359|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3621232|NCT02669940|3470360|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3621233|NCT02669940|3470358|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3621234|NCT02669940|3470359|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3621235|NCT02669940|3470360|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3621236|NCT02669940|3470358|B3|||Age||years|Mean|48.1|48.1|Standard Deviation|11.69|11.69|||
3621237|NCT02669940|3470359|B2|||Age||years|Mean|46.2|46.2|Standard Deviation|11.59|11.59|||
3621238|NCT02669940|3470360|B1|||Age||years|Mean|50.8|50.8|Standard Deviation|11.38|11.38|||
3621239|NCT02669914|3470414|B4|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3621240|NCT02669914|3470417|B1|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3621241|NCT02669914|3470414|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621242|NCT02669914|3470417|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621243|NCT02669914|3470414|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621244|NCT02669914|3470417|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621245|NCT02669914|3470414|B4||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3621246|NCT02669914|3470417|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3621247|NCT02669914|3470414|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621248|NCT02669914|3470417|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621249|NCT02669914|3470414|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621250|NCT02669914|3470417|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621251|NCT02669914|3470414|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621252|NCT02669914|3470417|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621253|NCT02669914|3470414|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621254|NCT02669914|3470417|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621255|NCT02669914|3470414|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621256|NCT02669914|3470417|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621257|NCT02669914|3470414|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3621258|NCT02669914|3470417|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3621259|NCT02669914|3470414|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621260|NCT02669914|3470417|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621261|NCT02669914|3470414|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3621262|NCT02669914|3470417|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3621263|NCT02669914|3470414|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3621264|NCT02669914|3470417|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3621265|NCT02669914|3470414|B4|||Age||years|Median|62|62.0|Full Range|||55.0|76.0|
3621266|NCT02669914|3470417|B1|||Age||years|Median|62|62.0|Full Range|||55.0|76.0|
3621267|NCT02669862|3470460|B4|United States||Region of Enrollment||participants|Number|98|98.0||||||
3621268|NCT02669862|3470461|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
3621269|NCT02669862|3470462|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
3621270|NCT02669862|3470463|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
3621271|NCT02669862|3470460|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621272|NCT02669862|3470461|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621273|NCT02669862|3470462|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621274|NCT02669862|3470463|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621275|NCT02669862|3470460|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621276|NCT02669862|3470461|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621277|NCT02669862|3470462|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621278|NCT02669862|3470463|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621279|NCT02669862|3470460|B4||White|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
3621280|NCT02669862|3470461|B3||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3621281|NCT02669862|3470462|B2||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3621282|NCT02669862|3470463|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3621283|NCT02669862|3470460|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3621284|NCT02669862|3470461|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3621285|NCT02669862|3470462|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3621286|NCT02669862|3470463|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3621287|NCT02669862|3470460|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621288|NCT02669862|3470461|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621289|NCT02669862|3470462|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621290|NCT02669862|3470463|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621291|NCT02669862|3470460|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621292|NCT02669862|3470461|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621293|NCT02669862|3470462|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621294|NCT02669862|3470463|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621295|NCT02669862|3470460|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621296|NCT02669862|3470461|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621297|NCT02669862|3470462|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621298|NCT02669862|3470463|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621299|NCT02669862|3470460|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3621300|NCT02669862|3470461|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3621301|NCT02669862|3470462|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621302|NCT02669862|3470463|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3621303|NCT02669862|3470460|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
3621304|NCT02669862|3470461|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3621305|NCT02669862|3470462|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3621306|NCT02669862|3470463|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3621307|NCT02669862|3470460|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3621308|NCT02669862|3470461|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3621309|NCT02669862|3470462|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3621310|NCT02669862|3470463|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3621311|NCT02669862|3470460|B4||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3621312|NCT02669862|3470461|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3621313|NCT02669862|3470462|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3621314|NCT02669862|3470463|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3621315|NCT02669862|3470460|B4||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3621316|NCT02669862|3470461|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3621317|NCT02669862|3470462|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3621318|NCT02669862|3470463|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3621319|NCT02669862|3470460|B4|||Age||years|Mean|40.7|40.7|Standard Deviation|14.57|14.57|||
3621320|NCT02669862|3470461|B3|||Age||years|Mean|39.5|39.5|Standard Deviation|13.37|13.37|||
3621321|NCT02669862|3470462|B2|||Age||years|Mean|41.2|41.2|Standard Deviation|14.11|14.11|||
3621322|NCT02669862|3470463|B1|||Age||years|Mean|41.3|41.3|Standard Deviation|16.40|16.4|||
3621323|NCT02669615|3470478|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621324|NCT02669615|3470478|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621325|NCT02669615|3470478|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3621326|NCT02669615|3470478|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3621327|NCT02669615|3470478|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621328|NCT02669615|3470478|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621329|NCT02669615|3470478|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621330|NCT02669615|3470478|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3621331|NCT02669615|3470478|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3621332|NCT02669615|3470478|B1|||Age||years|Median|67|67.0|Full Range|||46.0|72.0|
3621333|NCT02669615|3470478|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3621334|NCT02669615|3470478|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3621335|NCT02669615|3470478|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3621336|NCT02669095|3470484|B3|North America||Region of Enrollment||Participants|Number|150|150.0||||||
3621337|NCT02669095|3470485|B2|North America||Region of Enrollment||Participants|Number|75|75.0||||||
3621338|NCT02669095|3470486|B1|North America||Region of Enrollment||Participants|Number|75|75.0||||||
3621339|NCT02669095|3470484|B3|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3621340|NCT02669095|3470485|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3621341|NCT02669095|3470486|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3621342|NCT02669095|3470484|B3|White||Race/Ethnicity, Customized||Participants|Number|126|126.0||||||
3621343|NCT02669095|3470485|B2|White||Race/Ethnicity, Customized||Participants|Number|65|65.0||||||
3621344|NCT02669095|3470486|B1|White||Race/Ethnicity, Customized||Participants|Number|61|61.0||||||
3621345|NCT02669095|3470484|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
3621346|NCT02669095|3470485|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3621347|NCT02669095|3470486|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3621348|NCT02669095|3470484|B3|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3621349|NCT02669095|3470485|B2|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3621350|NCT02669095|3470486|B1|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3621351|NCT02669095|3470484|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3621352|NCT02669095|3470485|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3621353|NCT02669095|3470486|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3621354|NCT02669095|3470484|B3||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3621355|NCT02669095|3470485|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3621356|NCT02669095|3470486|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3621357|NCT02669095|3470484|B3|||Age||Years|Mean|29.2|29.2|Standard Deviation|5.91|5.91|||
3621358|NCT02669095|3470485|B2|||Age||Years|Mean|30.2|30.2|Standard Deviation|5.62|5.62|||
3621359|NCT02669095|3470486|B1|||Age||Years|Mean|28.2|28.2|Standard Deviation|6.05|6.05|||
3621360|NCT02669043|3470495|B1|||HAMD Total Score|Depression rating scale; possible scores range from 0 to 81 with higher scores indicating higher depression symptoms.|units on a scale|Mean|28.5|28.5|Full Range|||25.0|31.0|
3621361|NCT02669043|3470495|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3621362|NCT02669043|3470495|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621363|NCT02669043|3470495|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621364|NCT02669043|3470495|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3621365|NCT02669043|3470495|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621366|NCT02669043|3470495|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621367|NCT02669043|3470495|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621368|NCT02669043|3470495|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621369|NCT02669043|3470495|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3621370|NCT02669043|3470495|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3621371|NCT02669043|3470495|B1|||Age||years|Mean|48.3|48.3|Full Range|||34.0|64.0|
3621372|NCT02669043|3470495|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3621373|NCT02669043|3470495|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3621374|NCT02669043|3470495|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3621375|NCT02668952|3470499|B3|||Serum chloride||mmol/L|Mean|107|107.0|Standard Deviation|3.2|3.2|||
3621376|NCT02668952|3470500|B2|||Serum chloride||mmol/L|Mean|106|106.0|Standard Deviation|3.4|3.4|||
3621377|NCT02668952|3470501|B1|||Serum chloride||mmol/L|Mean|108|108.0|Standard Deviation|3.1|3.1|||
3621378|NCT02668952|3470499|B3|||Serum creatinine||mg/dL|Mean|0.91|0.91|Standard Deviation|0.16|0.16|||
3621379|NCT02668952|3470500|B2|||Serum creatinine||mg/dL|Mean|0.88|0.88|Standard Deviation|0.14|0.14|||
3621380|NCT02668952|3470501|B1|||Serum creatinine||mg/dL|Mean|0.93|0.93|Standard Deviation|0.18|0.18|||
3621381|NCT02668952|3470499|B3|||[TIMP2] x [IGFBP7]|This measure is an index consisting of the product of laboratory-derived serum concentrations of tissue inhibitor of metalloproteinase 2 and insulin-like growth factor binding protein 7.|(ng/mL)^2/1000|Mean|0.108|0.108|Standard Deviation|0.115|0.115|||
3621382|NCT02668952|3470500|B2|||[TIMP2] x [IGFBP7]|This measure is an index consisting of the product of laboratory-derived serum concentrations of tissue inhibitor of metalloproteinase 2 and insulin-like growth factor binding protein 7.|(ng/mL)^2/1000|Mean|0.116|0.116|Standard Deviation|0.138|0.138|||
3621383|NCT02668952|3470501|B1|||[TIMP2] x [IGFBP7]|This measure is an index consisting of the product of laboratory-derived serum concentrations of tissue inhibitor of metalloproteinase 2 and insulin-like growth factor binding protein 7.|(ng/mL)^2/1000|Mean|0.101|0.101|Standard Deviation|0.096|0.096|||
3621384|NCT02668952|3470499|B3|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3621385|NCT02668952|3470500|B2|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3621386|NCT02668952|3470501|B1|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3621387|NCT02668952|3470499|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3621388|NCT02668952|3470499|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3621389|NCT02668952|3470500|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3621390|NCT02668952|3470501|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3621391|NCT02668952|3470499|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3621392|NCT02668952|3470500|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3621393|NCT02668952|3470501|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3621394|NCT02668952|3470499|B3|||Age||years|Mean|64.1|64.1|Standard Deviation|10.2|10.2|||
3621395|NCT02668952|3470500|B2|||Age||years|Mean|62.8|62.8|Standard Deviation|9.4|9.4|||
3621396|NCT02668952|3470501|B1|||Age||years|Mean|65.3|65.3|Standard Deviation|11.0|11.0|||
3621397|NCT02668822|3470520|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3621398|NCT02668822|3470521|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3621399|NCT02668822|3470522|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3621400|NCT02668822|3470520|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3621401|NCT02668822|3470521|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3621402|NCT02668822|3470522|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3621403|NCT02668822|3470520|B3|||Age||Years|Mean|30|30.0|Standard Deviation|8|8.0|||
3621404|NCT02668822|3470521|B2|||Age||Years|Mean|28|28.0|Standard Deviation|5|5.0|||
3621405|NCT02668822|3470522|B1|||Age||Years|Mean|31|31.0|Standard Deviation|10|10.0|||
3621406|NCT02668783|3470543|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3621407|NCT02668783|3470544|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3621408|NCT02668783|3470545|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3621409|NCT02668783|3470543|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3621410|NCT02668783|3470544|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3621411|NCT02668783|3470545|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3621412|NCT02668783|3470543|B3|||Age||Years|Mean|28|28.0|Standard Deviation|6|6.0|||
3621413|NCT02668783|3470544|B2|||Age||Years|Mean|29|29.0|Standard Deviation|6|6.0|||
3621414|NCT02668783|3470545|B1|||Age||Years|Mean|27|27.0|Standard Deviation|7|7.0|||
3621415|NCT02668302|3470566|B3|Current smoker||History of smoking||Participants|Count of Participants|2|2.0||||||
3621416|NCT02668302|3470567|B2|Current smoker||History of smoking||Participants|Count of Participants|1|1.0||||||
3621417|NCT02668302|3470568|B1|Current smoker||History of smoking||Participants|Count of Participants|1|1.0||||||
3621418|NCT02668302|3470566|B3|Former smoker||History of smoking||Participants|Count of Participants|10|10.0||||||
3621419|NCT02668302|3470567|B2|Former smoker||History of smoking||Participants|Count of Participants|4|4.0||||||
3621420|NCT02668302|3470568|B1|Former smoker||History of smoking||Participants|Count of Participants|6|6.0||||||
3621421|NCT02668302|3470566|B3|Never smoked||History of smoking||Participants|Count of Participants|28|28.0||||||
3621422|NCT02668302|3470567|B2|Never smoked||History of smoking||Participants|Count of Participants|15|15.0||||||
3621423|NCT02668302|3470568|B1|Never smoked||History of smoking||Participants|Count of Participants|13|13.0||||||
3621424|NCT02668302|3470566|B3|||History of aspirin exacerbated respiratory disease (AERD)||Participants|Count of Participants|0|0.0||||||
3621425|NCT02668302|3470567|B2|||History of aspirin exacerbated respiratory disease (AERD)||Participants|Count of Participants|0|0.0||||||
3621426|NCT02668302|3470568|B1|||History of aspirin exacerbated respiratory disease (AERD)||Participants|Count of Participants|0|0.0||||||
3621427|NCT02668302|3470566|B3|Other||History of allergies||Participants|Count of Participants|16|16.0||||||
3621428|NCT02668302|3470567|B2|Other||History of allergies||Participants|Count of Participants|8|8.0||||||
3621429|NCT02668302|3470568|B1|Other||History of allergies||Participants|Count of Participants|8|8.0||||||
3621430|NCT02668302|3470566|B3|Food||History of allergies||Participants|Count of Participants|4|4.0||||||
3621431|NCT02668302|3470567|B2|Food||History of allergies||Participants|Count of Participants|2|2.0||||||
3621432|NCT02668302|3470568|B1|Food||History of allergies||Participants|Count of Participants|2|2.0||||||
3621433|NCT02668302|3470566|B3|Environmental||History of allergies||Participants|Count of Participants|13|13.0||||||
3621434|NCT02668302|3470567|B2|Environmental||History of allergies||Participants|Count of Participants|5|5.0||||||
3621435|NCT02668302|3470568|B1|Environmental||History of allergies||Participants|Count of Participants|8|8.0||||||
3621436|NCT02668302|3470566|B3|None||History of allergies||Participants|Count of Participants|15|15.0||||||
3621437|NCT02668302|3470567|B2|None||History of allergies||Participants|Count of Participants|8|8.0||||||
3621438|NCT02668302|3470568|B1|None||History of allergies||Participants|Count of Participants|7|7.0||||||
3621439|NCT02668302|3470566|B3|||History of allergic rhinitis diagnosed by physician||Participants|Count of Participants|19|19.0||||||
3621440|NCT02668302|3470567|B2|||History of allergic rhinitis diagnosed by physician||Participants|Count of Participants|9|9.0||||||
3621441|NCT02668302|3470568|B1|||History of allergic rhinitis diagnosed by physician||Participants|Count of Participants|10|10.0||||||
3621442|NCT02668302|3470566|B3|||History of asthma diagnosed by physician||Participants|Count of Participants|10|10.0||||||
3621443|NCT02668302|3470567|B2|||History of asthma diagnosed by physician||Participants|Count of Participants|4|4.0||||||
3621444|NCT02668302|3470568|B1|||History of asthma diagnosed by physician||Participants|Count of Participants|6|6.0||||||
3621445|NCT02668302|3470566|B3|4 ESS||Number of prior ESS|Prior endoscopic sinus surgery procedures|Participants|Count of Participants|2|2.0||||||
3621446|NCT02668302|3470567|B2|4 ESS||Number of prior ESS|Prior endoscopic sinus surgery procedures|Participants|Count of Participants|1|1.0||||||
3621447|NCT02668302|3470568|B1|4 ESS||Number of prior ESS|Prior endoscopic sinus surgery procedures|Participants|Count of Participants|1|1.0||||||
3621448|NCT02668302|3470566|B3|3 ESS||Number of prior ESS|Prior endoscopic sinus surgery procedures|Participants|Count of Participants|1|1.0||||||
3621449|NCT02668302|3470567|B2|3 ESS||Number of prior ESS|Prior endoscopic sinus surgery procedures|Participants|Count of Participants|0|0.0||||||
3621450|NCT02668302|3470568|B1|3 ESS||Number of prior ESS|Prior endoscopic sinus surgery procedures|Participants|Count of Participants|1|1.0||||||
3621451|NCT02668302|3470566|B3|2 ESS||Number of prior ESS|Prior endoscopic sinus surgery procedures|Participants|Count of Participants|1|1.0||||||
3621452|NCT02668302|3470567|B2|2 ESS||Number of prior ESS|Prior endoscopic sinus surgery procedures|Participants|Count of Participants|1|1.0||||||
3621453|NCT02668302|3470568|B1|2 ESS||Number of prior ESS|Prior endoscopic sinus surgery procedures|Participants|Count of Participants|0|0.0||||||
3621454|NCT02668302|3470566|B3|1 ESS||Number of prior ESS|Prior endoscopic sinus surgery procedures|Participants|Count of Participants|5|5.0||||||
3621455|NCT02668302|3470567|B2|1 ESS||Number of prior ESS|Prior endoscopic sinus surgery procedures|Participants|Count of Participants|4|4.0||||||
3621456|NCT02668302|3470568|B1|1 ESS||Number of prior ESS|Prior endoscopic sinus surgery procedures|Participants|Count of Participants|1|1.0||||||
3621457|NCT02668302|3470566|B3|None||Number of prior ESS|Prior endoscopic sinus surgery procedures|Participants|Count of Participants|31|31.0||||||
3621458|NCT02668302|3470567|B2|None||Number of prior ESS|Prior endoscopic sinus surgery procedures|Participants|Count of Participants|14|14.0||||||
3621459|NCT02668302|3470568|B1|None||Number of prior ESS|Prior endoscopic sinus surgery procedures|Participants|Count of Participants|17|17.0||||||
3621460|NCT02668302|3470566|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621461|NCT02668302|3470567|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621462|NCT02668302|3470568|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621463|NCT02668302|3470566|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621464|NCT02668302|3470567|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621465|NCT02668302|3470568|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621466|NCT02668302|3470566|B3||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3621467|NCT02668302|3470567|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3621468|NCT02668302|3470568|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3621469|NCT02668302|3470566|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3621470|NCT02668302|3470567|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621471|NCT02668302|3470568|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621472|NCT02668302|3470566|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621473|NCT02668302|3470567|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621474|NCT02668302|3470568|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621475|NCT02668302|3470566|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621476|NCT02668302|3470567|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621477|NCT02668302|3470568|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621478|NCT02668302|3470566|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621479|NCT02668302|3470567|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621480|NCT02668302|3470568|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621481|NCT02668302|3470566|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621482|NCT02668302|3470567|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621483|NCT02668302|3470568|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621484|NCT02668302|3470566|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3621485|NCT02668302|3470567|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3621486|NCT02668302|3470568|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3621487|NCT02668302|3470566|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3621488|NCT02668302|3470567|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621726|NCT02665260|3470779|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3621489|NCT02668302|3470568|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3621490|NCT02668302|3470566|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3621491|NCT02668302|3470567|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3621492|NCT02668302|3470568|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3621493|NCT02668302|3470566|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3621494|NCT02668302|3470567|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3621495|NCT02668302|3470568|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3621496|NCT02668302|3470566|B3|||Age||years|Mean|50.1|50.1|Standard Deviation|11.82|11.82|||
3621497|NCT02668302|3470567|B2|||Age||years|Mean|51.6|51.6|Standard Deviation|10.83|10.83|||
3621498|NCT02668302|3470568|B1|||Age||years|Mean|48.6|48.6|Standard Deviation|12.81|12.81|||
3621499|NCT02667821|3470575|B1|Canada||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3621500|NCT02667821|3470575|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3621501|NCT02667821|3470575|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621502|NCT02667821|3470575|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3621503|NCT02667821|3470575|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621504|NCT02667821|3470575|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621505|NCT02667821|3470575|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621506|NCT02667821|3470575|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621507|NCT02667821|3470575|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3621508|NCT02667821|3470575|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3621509|NCT02667821|3470575|B1|||Age||years|Mean|32|32.0|Standard Deviation|12.4|12.4|||
3621510|NCT02667821|3470575|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3621511|NCT02667821|3470575|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3621512|NCT02667821|3470575|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3621513|NCT02667704|3470581|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3621514|NCT02667704|3470581|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3621515|NCT02667704|3470581|B1|||Age||Years|Mean|35.0|35.0|Standard Deviation|9.8|9.8|||
3621516|NCT02667288|3470592|B1|United States||Region of Enrollment||participants|Number|147|147.0||||||
3621517|NCT02667288|3470592|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621518|NCT02667288|3470592|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621519|NCT02667288|3470592|B1||White|Race (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
3621520|NCT02667288|3470592|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3621521|NCT02667288|3470592|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621522|NCT02667288|3470592|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621523|NCT02667288|3470592|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3621524|NCT02667288|3470592|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3621525|NCT02667288|3470592|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|133|133.0||||||
3621526|NCT02667288|3470592|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3621527|NCT02667288|3470592|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3621528|NCT02667288|3470592|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3621529|NCT02667288|3470592|B1|||Age||years|Mean|68.4|68.4|Standard Deviation|9.67|9.67|||
3621530|NCT02667288|3470592|B1||>=65 years|Age||Participants|Count of Participants|101|101.0||||||
3621531|NCT02667288|3470592|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
3621532|NCT02667288|3470592|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3621533|NCT02667275|3470597|B3|United States||Region of Enrollment||participants|Number|487|487.0||||||
3621534|NCT02667275|3470598|B2|United States||Region of Enrollment||participants|Number|243|243.0||||||
3621535|NCT02667275|3470599|B1|United States||Region of Enrollment||participants|Number|244|244.0||||||
3621536|NCT02667275|3470597|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621537|NCT02667275|3470598|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621538|NCT02667275|3470599|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621539|NCT02667275|3470597|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621540|NCT02667275|3470598|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621541|NCT02667275|3470599|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621542|NCT02667275|3470597|B3||White|Race (NIH/OMB)||Participants|Count of Participants|477|477.0||||||
3621543|NCT02667275|3470598|B2||White|Race (NIH/OMB)||Participants|Count of Participants|236|236.0||||||
3621544|NCT02667275|3470599|B1||White|Race (NIH/OMB)||Participants|Count of Participants|241|241.0||||||
3621545|NCT02667275|3470597|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3621546|NCT02667275|3470598|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3621547|NCT02667275|3470599|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3621548|NCT02667275|3470597|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621549|NCT02667275|3470598|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621550|NCT02667275|3470599|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621551|NCT02667275|3470597|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3621552|NCT02667275|3470598|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3621553|NCT02667275|3470599|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621554|NCT02667275|3470597|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621555|NCT02667275|3470598|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621556|NCT02667275|3470599|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621557|NCT02667275|3470597|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3621558|NCT02667275|3470598|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3621559|NCT02667275|3470599|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3621560|NCT02667275|3470597|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|451|451.0||||||
3621561|NCT02667275|3470598|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|222|222.0||||||
3621562|NCT02667275|3470599|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|229|229.0||||||
3621563|NCT02667275|3470597|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3621564|NCT02667275|3470598|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3621565|NCT02667275|3470599|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3621566|NCT02667275|3470597|B3||Male|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
3621567|NCT02667275|3470598|B2||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3621568|NCT02667275|3470599|B1||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3621569|NCT02667275|3470597|B3||Female|Sex: Female, Male||Participants|Count of Participants|284|284.0||||||
3621570|NCT02667275|3470598|B2||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3621571|NCT02667275|3470599|B1||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3621572|NCT02667275|3470597|B3|||Age||years|Mean|68.7|68.7|Standard Deviation|8.78|8.78|||
3621573|NCT02667275|3470598|B2|||Age||years|Mean|69.1|69.1|Standard Deviation|8.64|8.64|||
3621574|NCT02667275|3470599|B1|||Age||years|Mean|68.4|68.4|Standard Deviation|8.92|8.92|||
3621575|NCT02667275|3470597|B3||>=65 years|Age||Participants|Count of Participants|331|331.0||||||
3621576|NCT02667275|3470598|B2||>=65 years|Age||Participants|Count of Participants|169|169.0||||||
3621577|NCT02667275|3470599|B1||>=65 years|Age||Participants|Count of Participants|162|162.0||||||
3621578|NCT02667275|3470597|B3||Between 18 and 65 years|Age||Participants|Count of Participants|156|156.0||||||
3621579|NCT02667275|3470598|B2||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
3621580|NCT02667275|3470599|B1||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
3621581|NCT02667275|3470597|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3621582|NCT02667275|3470598|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3621583|NCT02667275|3470599|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3621584|NCT02667236|3470608|B3|United States||Region of Enrollment||participants|Number|450|450.0||||||
3621585|NCT02667236|3470609|B2|United States||Region of Enrollment||participants|Number|227|227.0||||||
3621586|NCT02667236|3470610|B1|United States||Region of Enrollment||participants|Number|223|223.0||||||
3621587|NCT02667236|3470608|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3621588|NCT02667236|3470609|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621589|NCT02667236|3470610|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621590|NCT02667236|3470608|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621591|NCT02667236|3470609|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621592|NCT02667236|3470610|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621593|NCT02667236|3470608|B3||White|Race (NIH/OMB)||Participants|Count of Participants|440|440.0||||||
3621594|NCT02667236|3470609|B2||White|Race (NIH/OMB)||Participants|Count of Participants|221|221.0||||||
3621595|NCT02667236|3470610|B1||White|Race (NIH/OMB)||Participants|Count of Participants|219|219.0||||||
3621596|NCT02667236|3470608|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3621597|NCT02667236|3470609|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621598|NCT02667236|3470610|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621599|NCT02667236|3470608|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621600|NCT02667236|3470609|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621601|NCT02667236|3470610|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621602|NCT02667236|3470608|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3621603|NCT02667236|3470609|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3621604|NCT02667236|3470610|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3621605|NCT02667236|3470608|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621606|NCT02667236|3470609|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621607|NCT02667236|3470610|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621608|NCT02667236|3470608|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3621609|NCT02667236|3470609|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3621610|NCT02667236|3470610|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3621611|NCT02667236|3470608|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|430|430.0||||||
3621612|NCT02667236|3470609|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|216|216.0||||||
3621613|NCT02667236|3470610|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|214|214.0||||||
3621614|NCT02667236|3470608|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3621615|NCT02667236|3470609|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3621616|NCT02667236|3470610|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3621617|NCT02667236|3470608|B3||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
3621618|NCT02667236|3470609|B2||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3621619|NCT02667236|3470610|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3621620|NCT02667236|3470608|B3||Female|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
3621621|NCT02667236|3470609|B2||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3621622|NCT02667236|3470610|B1||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3621623|NCT02667236|3470608|B3|||Age||years|Mean|68.7|68.7|Standard Deviation|8.57|8.57|||
3621624|NCT02667236|3470609|B2|||Age||years|Mean|69.1|69.1|Standard Deviation|8.71|8.71|||
3621625|NCT02667236|3470610|B1|||Age||years|Mean|68.3|68.3|Standard Deviation|8.42|8.42|||
3621626|NCT02667236|3470608|B3||>=65 years|Age||Participants|Count of Participants|323|323.0||||||
3621627|NCT02667236|3470609|B2||>=65 years|Age||Participants|Count of Participants|172|172.0||||||
3621628|NCT02667236|3470610|B1||>=65 years|Age||Participants|Count of Participants|151|151.0||||||
3621629|NCT02667236|3470608|B3||Between 18 and 65 years|Age||Participants|Count of Participants|127|127.0||||||
3621630|NCT02667236|3470609|B2||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
3621631|NCT02667236|3470610|B1||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
3621632|NCT02667236|3470608|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3621633|NCT02667236|3470609|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3621634|NCT02667236|3470610|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3621635|NCT02666560|3470619|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3621636|NCT02666560|3470619|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3621637|NCT02666560|3470619|B1|||Age||months|Mean|104.3|104.3|Standard Deviation|25.5|25.5|||
3621638|NCT02666560|3470619|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3621639|NCT02666560|3470619|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3621640|NCT02666560|3470619|B1||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
3621641|NCT02666352|3470636|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3621642|NCT02666352|3470637|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3621643|NCT02666352|3470638|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3621644|NCT02666352|3470639|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3621645|NCT02666352|3470636|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3621646|NCT02666352|3470637|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3621647|NCT02666352|3470638|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3621648|NCT02666352|3470639|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3621649|NCT02666352|3470636|B4|||Age||Years|Mean|57.1|57.1|Standard Deviation|7.5|7.5|||
3621650|NCT02666352|3470637|B3|||Age||Years|Mean|57.6|57.6|Standard Deviation|6.3|6.3|||
3621651|NCT02666352|3470638|B2|||Age||Years|Mean|55.4|55.4|Standard Deviation|8.2|8.2|||
3621652|NCT02666352|3470639|B1|||Age||Years|Mean|58.3|58.3|Standard Deviation|8.7|8.7|||
3621653|NCT02666222|3470745|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3621654|NCT02666222|3470745|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3621655|NCT02666222|3470745|B1|Black/Non-Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3621656|NCT02666222|3470745|B1|White/Caucasian||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
3621657|NCT02666222|3470745|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3621658|NCT02666222|3470745|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3621659|NCT02666222|3470745|B1|||Age||years|Mean|56.1|56.1|Standard Deviation|15.6|15.6|||
3621660|NCT02665455|3470753|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3621661|NCT02665455|3470753|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3621662|NCT02665455|3470753|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3621663|NCT02665455|3470753|B1||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
3621664|NCT02665455|3470753|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3621665|NCT02665286|3470757|B4|||Duration of Back Pain Prior to Study||Hours|Median|48|48.0|Inter-Quartile Range|||24.0|96.0|
3621666|NCT02665286|3470758|B3|||Duration of Back Pain Prior to Study||Hours|Median|48|48.0|Inter-Quartile Range|||24.0|120.0|
3621667|NCT02665286|3470759|B2|||Duration of Back Pain Prior to Study||Hours|Median|72|72.0|Inter-Quartile Range|||24.0|96.0|
3621668|NCT02665286|3470760|B1|||Duration of Back Pain Prior to Study||Hours|Median|48|48.0|Inter-Quartile Range|||24.0|108.0|
3621669|NCT02665286|3470757|B4|United States||Region of Enrollment||Participants|Count of Participants|240|240.0||||||
3621670|NCT02665286|3470758|B3|United States||Region of Enrollment||Participants|Count of Participants|81|81.0||||||
3621671|NCT02665286|3470759|B2|United States||Region of Enrollment||Participants|Count of Participants|80|80.0||||||
3621672|NCT02665286|3470760|B1|United States||Region of Enrollment||Participants|Count of Participants|79|79.0||||||
3621673|NCT02665286|3470757|B4|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3621674|NCT02665286|3470757|B4||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3621675|NCT02665286|3470758|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3621676|NCT02665286|3470759|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3621677|NCT02665286|3470760|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3621678|NCT02665286|3470757|B4||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3621679|NCT02665286|3470758|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3621680|NCT02665286|3470759|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3621681|NCT02665286|3470760|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3621682|NCT02665286|3470757|B4|||Age||years|Mean|39|39.0|Standard Deviation|12|12.0|||
3621683|NCT02665286|3470758|B3|||Age||years|Mean|38|38.0|Standard Deviation|12|12.0|||
3621684|NCT02665286|3470759|B2|||Age||years|Mean|40|40.0|Standard Deviation|12|12.0|||
3621685|NCT02665286|3470760|B1|||Age||years|Mean|39|39.0|Standard Deviation|12|12.0|||
3621686|NCT02665260|3470779|B5|Jamaican||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3621687|NCT02665260|3470780|B4|Jamaican||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3621688|NCT02665260|3470781|B3|Jamaican||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3621689|NCT02665260|3470782|B2|Jamaican||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3621690|NCT02665260|3470783|B1|Jamaican||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3621691|NCT02665260|3470779|B5|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3621692|NCT02665260|3470780|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3621693|NCT02665260|3470781|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3621694|NCT02665260|3470782|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3621695|NCT02665260|3470783|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3621696|NCT02665260|3470779|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3621697|NCT02665260|3470780|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3621698|NCT02665260|3470781|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3621699|NCT02665260|3470782|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3621700|NCT02665260|3470783|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3621701|NCT02665260|3470779|B5|African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3621702|NCT02665260|3470780|B4|African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3621703|NCT02665260|3470781|B3|African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3621704|NCT02665260|3470782|B2|African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3621705|NCT02665260|3470783|B1|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3621706|NCT02665260|3470779|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
3621707|NCT02665260|3470780|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3621708|NCT02665260|3470781|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3621709|NCT02665260|3470782|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3621710|NCT02665260|3470783|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3621711|NCT02665260|3470779|B5||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3621712|NCT02665260|3470780|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3621713|NCT02665260|3470781|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3621714|NCT02665260|3470782|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3621715|NCT02665260|3470783|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3621716|NCT02665260|3470779|B5||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3621717|NCT02665260|3470780|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3621718|NCT02665260|3470781|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3621719|NCT02665260|3470782|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3621720|NCT02665260|3470783|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3621721|NCT02665260|3470779|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3621722|NCT02665260|3470780|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3621723|NCT02665260|3470781|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3621724|NCT02665260|3470782|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3621725|NCT02665260|3470783|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3621727|NCT02665260|3470780|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3621728|NCT02665260|3470781|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3621729|NCT02665260|3470782|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3621730|NCT02665260|3470783|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3621731|NCT02665260|3470779|B5||<=18 years|Age||Participants|Count of Participants|94|94.0||||||
3621732|NCT02665260|3470780|B4||<=18 years|Age||Participants|Count of Participants|25|25.0||||||
3621733|NCT02665260|3470781|B3||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
3621734|NCT02665260|3470782|B2||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
3621735|NCT02665260|3470783|B1||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
3621736|NCT02665221|3470800|B3|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3621737|NCT02665221|3470801|B2|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3621738|NCT02665221|3470802|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3621739|NCT02665221|3470800|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621740|NCT02665221|3470801|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621741|NCT02665221|3470802|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621742|NCT02665221|3470800|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621743|NCT02665221|3470801|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621744|NCT02665221|3470802|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621745|NCT02665221|3470800|B3||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3621746|NCT02665221|3470801|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3621747|NCT02665221|3470802|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3621748|NCT02665221|3470800|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3621749|NCT02665221|3470801|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3621750|NCT02665221|3470802|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621751|NCT02665221|3470800|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621752|NCT02665221|3470801|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621753|NCT02665221|3470802|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621754|NCT02665221|3470800|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621755|NCT02665221|3470801|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621756|NCT02665221|3470802|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621757|NCT02665221|3470800|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621758|NCT02665221|3470801|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621759|NCT02665221|3470802|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621760|NCT02665221|3470800|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3621761|NCT02665221|3470801|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3621762|NCT02665221|3470802|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3621763|NCT02665221|3470800|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3621764|NCT02665221|3470801|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3621765|NCT02665221|3470802|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3621766|NCT02665221|3470800|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3621767|NCT02665221|3470801|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3621768|NCT02665221|3470802|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3621769|NCT02665221|3470800|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3621770|NCT02665221|3470801|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3621771|NCT02665221|3470802|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3621772|NCT02665221|3470800|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3621773|NCT02665221|3470801|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3621774|NCT02665221|3470802|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3621775|NCT02664987|3470815|B1||Male|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
3621776|NCT02664987|3470815|B1||Female|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
3621777|NCT02664987|3470815|B1|||Age||years|Mean|55.14|55.14|Standard Deviation|13.39|13.39|||
3621778|NCT02664610|3470824|B3|United States||Region of Enrollment||Participants|Count of Participants|94|94.0||||||
3621779|NCT02664610|3470825|B2|United States||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
3621780|NCT02664610|3470826|B1|United States||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
3621781|NCT02664610|3470824|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621782|NCT02664610|3470825|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621783|NCT02664610|3470826|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621784|NCT02664610|3470824|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621785|NCT02664610|3470825|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621786|NCT02664610|3470826|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621787|NCT02664610|3470824|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3621788|NCT02664610|3470825|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621789|NCT02664610|3470826|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621790|NCT02664610|3470824|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
3621791|NCT02664610|3470825|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3621792|NCT02664610|3470826|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3621793|NCT02664610|3470824|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621794|NCT02664610|3470825|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621795|NCT02664610|3470826|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621796|NCT02664610|3470824|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621797|NCT02664610|3470825|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621798|NCT02664610|3470826|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621799|NCT02664610|3470824|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621800|NCT02664610|3470825|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621801|NCT02664610|3470826|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621802|NCT02664610|3470824|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3621803|NCT02664610|3470825|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3621804|NCT02664610|3470826|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3621805|NCT02664610|3470824|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3621806|NCT02664610|3470825|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3621807|NCT02664610|3470826|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3621808|NCT02664610|3470824|B3|||Age||years|Mean|58|58.0|Standard Deviation|9.8|9.8|||
3621809|NCT02664610|3470825|B2|||Age||years|Mean|58|58.0|Standard Deviation|8.5|8.5|||
3621810|NCT02664610|3470826|B1|||Age||years|Mean|59|59.0|Standard Deviation|9.8|9.8|||
3621811|NCT02664532|3470835|B3|India||Region of Enrollment|All patients were from India (Jamshedpur)|participants|Number|150|150.0||||||
3621812|NCT02664532|3470836|B2|India||Region of Enrollment|All patients were from India (Jamshedpur)|participants|Number|75|75.0||||||
3621813|NCT02664532|3470837|B1|India||Region of Enrollment|All patients were from India (Jamshedpur)|participants|Number|75|75.0||||||
3621814|NCT02664532|3470835|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3621815|NCT02664532|3470836|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3621816|NCT02664532|3470837|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3621817|NCT02664532|3470835|B3||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3621818|NCT02664532|3470836|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3621819|NCT02664532|3470837|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3621820|NCT02664532|3470835|B3|||Age||years|Mean|47.6|47.6|Standard Deviation|13.7|13.7|||
3621821|NCT02664532|3470836|B2|||Age||years|Mean|48.2|48.2|Standard Deviation|14|14.0|||
3621822|NCT02664532|3470837|B1|||Age||years|Mean|44.8|44.8|Standard Deviation|13.1|13.1|||
3621823|NCT02664532|3470835|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3621824|NCT02664532|3470836|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3621825|NCT02664532|3470837|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3621826|NCT02664532|3470835|B3||Between 18 and 65 years|Age||Participants|Count of Participants|150|150.0||||||
3621827|NCT02664532|3470836|B2||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
3621828|NCT02664532|3470837|B1||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
3621829|NCT02664532|3470835|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3621830|NCT02664532|3470836|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3621831|NCT02664532|3470837|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3621832|NCT02664415|3470850|B3||III (IgM+, WB-)|Feibig stage at ART initiation|"Fiebig stage is a laboratory staging system for primary HIV infection (Fiebig et al).~Stage I: HIV present in blood samples, only RNA assay positive (RNA+); Stage II: RNA+ and HIV-1 p24 antigen positive (p24+), antibody EIA non-reactive (IgM-); Stage III: RNA+, HIV-1 antigen and HIV IgM-sensitive EIA reactive (IgM+), but Western blot without HIV-a-specific band (WB-) .~The higher stage refers to the later stage of infection."|Participants|Count of Participants|7|7.0||||||
3621833|NCT02664415|3470851|B2||III (IgM+, WB-)|Feibig stage at ART initiation|"Fiebig stage is a laboratory staging system for primary HIV infection (Fiebig et al).~Stage I: HIV present in blood samples, only RNA assay positive (RNA+); Stage II: RNA+ and HIV-1 p24 antigen positive (p24+), antibody EIA non-reactive (IgM-); Stage III: RNA+, HIV-1 antigen and HIV IgM-sensitive EIA reactive (IgM+), but Western blot without HIV-a-specific band (WB-) .~The higher stage refers to the later stage of infection."|Participants|Count of Participants|2|2.0||||||
3621834|NCT02664415|3470852|B1||III (IgM+, WB-)|Feibig stage at ART initiation|"Fiebig stage is a laboratory staging system for primary HIV infection (Fiebig et al).~Stage I: HIV present in blood samples, only RNA assay positive (RNA+); Stage II: RNA+ and HIV-1 p24 antigen positive (p24+), antibody EIA non-reactive (IgM-); Stage III: RNA+, HIV-1 antigen and HIV IgM-sensitive EIA reactive (IgM+), but Western blot without HIV-a-specific band (WB-) .~The higher stage refers to the later stage of infection."|Participants|Count of Participants|5|5.0||||||
3621874|NCT02664415|3470850|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3621835|NCT02664415|3470850|B3||II (p24+, IgM-)|Feibig stage at ART initiation|"Fiebig stage is a laboratory staging system for primary HIV infection (Fiebig et al).~Stage I: HIV present in blood samples, only RNA assay positive (RNA+); Stage II: RNA+ and HIV-1 p24 antigen positive (p24+), antibody EIA non-reactive (IgM-); Stage III: RNA+, HIV-1 antigen and HIV IgM-sensitive EIA reactive (IgM+), but Western blot without HIV-a-specific band (WB-) .~The higher stage refers to the later stage of infection."|Participants|Count of Participants|10|10.0||||||
3621836|NCT02664415|3470851|B2||II (p24+, IgM-)|Feibig stage at ART initiation|"Fiebig stage is a laboratory staging system for primary HIV infection (Fiebig et al).~Stage I: HIV present in blood samples, only RNA assay positive (RNA+); Stage II: RNA+ and HIV-1 p24 antigen positive (p24+), antibody EIA non-reactive (IgM-); Stage III: RNA+, HIV-1 antigen and HIV IgM-sensitive EIA reactive (IgM+), but Western blot without HIV-a-specific band (WB-) .~The higher stage refers to the later stage of infection."|Participants|Count of Participants|3|3.0||||||
3621837|NCT02664415|3470852|B1||II (p24+, IgM-)|Feibig stage at ART initiation|"Fiebig stage is a laboratory staging system for primary HIV infection (Fiebig et al).~Stage I: HIV present in blood samples, only RNA assay positive (RNA+); Stage II: RNA+ and HIV-1 p24 antigen positive (p24+), antibody EIA non-reactive (IgM-); Stage III: RNA+, HIV-1 antigen and HIV IgM-sensitive EIA reactive (IgM+), but Western blot without HIV-a-specific band (WB-) .~The higher stage refers to the later stage of infection."|Participants|Count of Participants|7|7.0||||||
3621838|NCT02664415|3470850|B3||I (RNA+, p24-)|Feibig stage at ART initiation|"Fiebig stage is a laboratory staging system for primary HIV infection (Fiebig et al).~Stage I: HIV present in blood samples, only RNA assay positive (RNA+); Stage II: RNA+ and HIV-1 p24 antigen positive (p24+), antibody EIA non-reactive (IgM-); Stage III: RNA+, HIV-1 antigen and HIV IgM-sensitive EIA reactive (IgM+), but Western blot without HIV-a-specific band (WB-) .~The higher stage refers to the later stage of infection."|Participants|Count of Participants|1|1.0||||||
3621839|NCT02664415|3470851|B2||I (RNA+, p24-)|Feibig stage at ART initiation|"Fiebig stage is a laboratory staging system for primary HIV infection (Fiebig et al).~Stage I: HIV present in blood samples, only RNA assay positive (RNA+); Stage II: RNA+ and HIV-1 p24 antigen positive (p24+), antibody EIA non-reactive (IgM-); Stage III: RNA+, HIV-1 antigen and HIV IgM-sensitive EIA reactive (IgM+), but Western blot without HIV-a-specific band (WB-) .~The higher stage refers to the later stage of infection."|Participants|Count of Participants|0|0.0||||||
3621840|NCT02664415|3470852|B1||I (RNA+, p24-)|Feibig stage at ART initiation|"Fiebig stage is a laboratory staging system for primary HIV infection (Fiebig et al).~Stage I: HIV present in blood samples, only RNA assay positive (RNA+); Stage II: RNA+ and HIV-1 p24 antigen positive (p24+), antibody EIA non-reactive (IgM-); Stage III: RNA+, HIV-1 antigen and HIV IgM-sensitive EIA reactive (IgM+), but Western blot without HIV-a-specific band (WB-) .~The higher stage refers to the later stage of infection."|Participants|Count of Participants|1|1.0||||||
3621841|NCT02664415|3470850|B3||CRF01_AE/B/C recombinant|HIV-subtype||Participants|Count of Participants|1|1.0||||||
3621842|NCT02664415|3470851|B2||CRF01_AE/B/C recombinant|HIV-subtype||Participants|Count of Participants|0|0.0||||||
3621843|NCT02664415|3470852|B1||CRF01_AE/B/C recombinant|HIV-subtype||Participants|Count of Participants|1|1.0||||||
3621844|NCT02664415|3470850|B3||CRF01_AE and B co-infection|HIV-subtype||Participants|Count of Participants|1|1.0||||||
3621845|NCT02664415|3470851|B2||CRF01_AE and B co-infection|HIV-subtype||Participants|Count of Participants|0|0.0||||||
3621846|NCT02664415|3470852|B1||CRF01_AE and B co-infection|HIV-subtype||Participants|Count of Participants|1|1.0||||||
3621847|NCT02664415|3470850|B3||B|HIV-subtype||Participants|Count of Participants|4|4.0||||||
3621848|NCT02664415|3470851|B2||B|HIV-subtype||Participants|Count of Participants|1|1.0||||||
3621849|NCT02664415|3470852|B1||B|HIV-subtype||Participants|Count of Participants|3|3.0||||||
3621850|NCT02664415|3470850|B3||CRF01_AE|HIV-subtype||Participants|Count of Participants|12|12.0||||||
3621851|NCT02664415|3470851|B2||CRF01_AE|HIV-subtype||Participants|Count of Participants|4|4.0||||||
3621852|NCT02664415|3470852|B1||CRF01_AE|HIV-subtype||Participants|Count of Participants|8|8.0||||||
3621853|NCT02664415|3470850|B3|Thailand||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3621854|NCT02664415|3470851|B2|Thailand||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3621855|NCT02664415|3470852|B1|Thailand||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3621856|NCT02664415|3470850|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621857|NCT02664415|3470851|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621858|NCT02664415|3470852|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621859|NCT02664415|3470850|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3621860|NCT02664415|3470851|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3621861|NCT02664415|3470852|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3621862|NCT02664415|3470850|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621863|NCT02664415|3470851|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621864|NCT02664415|3470852|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621865|NCT02664415|3470850|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3621866|NCT02664415|3470851|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3621867|NCT02664415|3470852|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3621868|NCT02664415|3470850|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3621869|NCT02664415|3470851|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3621870|NCT02664415|3470852|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3621871|NCT02664415|3470850|B3|||Age||years|Median|29|29.0|Full Range|||21.0|50.0|
3621872|NCT02664415|3470851|B2|||Age||years|Median|25|25.0|Full Range|||23.0|48.0|
3621873|NCT02664415|3470852|B1|||Age||years|Median|32|32.0|Full Range|||21.0|50.0|
3621875|NCT02664415|3470851|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3621876|NCT02664415|3470852|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3621877|NCT02664415|3470850|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3621878|NCT02664415|3470851|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3621879|NCT02664415|3470852|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3621880|NCT02664415|3470850|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3621881|NCT02664415|3470851|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3621882|NCT02664415|3470852|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3621883|NCT02664311|3470881|B3||Atrial fibrillation - persistent|Atrial fibrillation||Participants|Count of Participants|4|4.0||||||
3621884|NCT02664311|3470882|B2||Atrial fibrillation - persistent|Atrial fibrillation||Participants|Count of Participants|2|2.0||||||
3621885|NCT02664311|3470883|B1||Atrial fibrillation - persistent|Atrial fibrillation||Participants|Count of Participants|2|2.0||||||
3621886|NCT02664311|3470881|B3||Atrial fibrillation - paroxysmal|Atrial fibrillation||Participants|Count of Participants|5|5.0||||||
3621887|NCT02664311|3470882|B2||Atrial fibrillation - paroxysmal|Atrial fibrillation||Participants|Count of Participants|1|1.0||||||
3621888|NCT02664311|3470883|B1||Atrial fibrillation - paroxysmal|Atrial fibrillation||Participants|Count of Participants|4|4.0||||||
3621889|NCT02664311|3470881|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
3621890|NCT02664311|3470882|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3621891|NCT02664311|3470883|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3621892|NCT02664311|3470881|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621893|NCT02664311|3470882|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621894|NCT02664311|3470883|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621895|NCT02664311|3470881|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621896|NCT02664311|3470882|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621897|NCT02664311|3470883|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621898|NCT02664311|3470881|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3621899|NCT02664311|3470882|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3621900|NCT02664311|3470883|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3621901|NCT02664311|3470881|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3621902|NCT02664311|3470882|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621903|NCT02664311|3470883|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621904|NCT02664311|3470881|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621905|NCT02664311|3470882|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621906|NCT02664311|3470883|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621907|NCT02664311|3470881|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621908|NCT02664311|3470882|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621909|NCT02664311|3470883|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621910|NCT02664311|3470881|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621911|NCT02664311|3470882|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621912|NCT02664311|3470883|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621913|NCT02664311|3470881|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3621914|NCT02664311|3470882|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3621915|NCT02664311|3470883|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3621916|NCT02664311|3470881|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3621917|NCT02664311|3470882|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3621918|NCT02664311|3470883|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3621919|NCT02664311|3470881|B3|||Age||years|Mean|59|59.0|Standard Deviation|14|14.0|||
3621920|NCT02664311|3470882|B2|||Age||years|Mean|60|60.0|Standard Deviation|9|9.0|||
3621921|NCT02664311|3470883|B1|||Age||years|Mean|59|59.0|Standard Deviation|17|17.0|||
3621922|NCT02664311|3470881|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3621923|NCT02664311|3470882|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3621924|NCT02664311|3470883|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3621925|NCT02664311|3470881|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3621926|NCT02664311|3470882|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3621927|NCT02664311|3470883|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3621928|NCT02664311|3470881|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3621929|NCT02664311|3470882|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3621930|NCT02664311|3470883|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3621931|NCT02663687|3470903|B6||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3621932|NCT02663687|3470904|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3621933|NCT02663687|3470905|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3621934|NCT02663687|3470906|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3621935|NCT02663687|3470907|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3621936|NCT02663687|3470908|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3621937|NCT02663687|3470903|B6||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3621938|NCT02663687|3470904|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3621939|NCT02663687|3470905|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3621940|NCT02663687|3470906|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3621941|NCT02663687|3470907|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3621942|NCT02663687|3470908|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3621943|NCT02663687|3470903|B6|||Age|Age was calculated as the difference between date of birth and date of informed consent, truncated to years.|Years|Mean|37.4|37.4|Standard Deviation|8.17|8.17|||
3621944|NCT02663687|3470904|B5|||Age|Age was calculated as the difference between date of birth and date of informed consent, truncated to years.|Years|Mean|35.7|35.7|Standard Deviation|8.63|8.63|||
3621945|NCT02663687|3470905|B4|||Age|Age was calculated as the difference between date of birth and date of informed consent, truncated to years.|Years|Mean|38.0|38.0|Standard Deviation|10.49|10.49|||
3621946|NCT02663687|3470906|B3|||Age|Age was calculated as the difference between date of birth and date of informed consent, truncated to years.|Years|Mean|36.8|36.8|Standard Deviation|7.08|7.08|||
3621947|NCT02663687|3470907|B2|||Age|Age was calculated as the difference between date of birth and date of informed consent, truncated to years.|Years|Mean|40.7|40.7|Standard Deviation|7.25|7.25|||
3621948|NCT02663687|3470908|B1|||Age|Age was calculated as the difference between date of birth and date of informed consent, truncated to years.|Years|Mean|36.3|36.3|Standard Deviation|7.93|7.93|||
3621949|NCT02663453|3470964|B3|Thailand||Region of Enrollment||participants|Number|44|44.0||||||
3621950|NCT02663453|3470965|B2|Thailand||Region of Enrollment||participants|Number|22|22.0||||||
3621951|NCT02663453|3470966|B1|Thailand||Region of Enrollment||participants|Number|22|22.0||||||
3621952|NCT02663453|3470964|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3621953|NCT02663453|3470965|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3621954|NCT02663453|3470966|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3621955|NCT02663453|3470964|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3621956|NCT02663453|3470965|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3621957|NCT02663453|3470966|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3621958|NCT02663453|3470964|B3|||Age||weeks|Mean|28.0|28.0|Standard Deviation|1.8|1.8|||
3621959|NCT02663453|3470965|B2|||Age||weeks|Mean|28.4|28.4|Standard Deviation|1.2|1.2|||
3621960|NCT02663453|3470966|B1|||Age||weeks|Mean|27.6|27.6|Standard Deviation|2.2|2.2|||
3621961|NCT02663232|3470989|B1||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3621962|NCT02663232|3470989|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3621963|NCT02663232|3470989|B1|||Age||years|Median|68.0|68.0|Full Range|||56.0|77.0|
3621964|NCT02662764|3471010|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621965|NCT02662764|3471010|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621966|NCT02662764|3471010|B1||White|Race (NIH/OMB)||Participants|Count of Participants|280|280.0||||||
3621967|NCT02662764|3471010|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3621968|NCT02662764|3471010|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3621969|NCT02662764|3471010|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3621970|NCT02662764|3471010|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621971|NCT02662764|3471010|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621972|NCT02662764|3471010|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|302|302.0||||||
3621973|NCT02662764|3471010|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3621974|NCT02662764|3471010|B1||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3621975|NCT02662764|3471010|B1||Female|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
3621976|NCT02662764|3471010|B1|Age, Customized|> or equal to 65|Age, Customized||Participants|Count of Participants|122|122.0||||||
3621977|NCT02662764|3471010|B1|Age, Customized|<65|Age, Customized||Participants|Count of Participants|198|198.0||||||
3621978|NCT02662608|3471070|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3621979|NCT02662608|3471070|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3621980|NCT02662608|3471070|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3621981|NCT02662608|3471070|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3621982|NCT02662608|3471070|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3621983|NCT02662608|3471070|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3621984|NCT02662556|3471074|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3621985|NCT02662556|3471074|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3621986|NCT02662556|3471074|B1||>=65 years|Age|All subjects must have been at least 40 years of age at the time of screening|Participants|Count of Participants|24|24.0||||||
3621987|NCT02662556|3471074|B1||Between 18 and 65 years|Age|All subjects must have been at least 40 years of age at the time of screening|Participants|Count of Participants|116|116.0||||||
3622103|NCT02661594|3471105|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3621988|NCT02662556|3471074|B1||<=18 years|Age|All subjects must have been at least 40 years of age at the time of screening|Participants|Count of Participants|0|0.0||||||
3621989|NCT02662387|3471081|B3|United States||Region of Enrollment||participants|Number|55|55.0||||||
3621990|NCT02662387|3471082|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
3621991|NCT02662387|3471083|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3621992|NCT02662387|3471081|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3621993|NCT02662387|3471082|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3621994|NCT02662387|3471083|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3621995|NCT02662387|3471081|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621996|NCT02662387|3471082|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621997|NCT02662387|3471083|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3621998|NCT02662387|3471081|B3||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3621999|NCT02662387|3471082|B2||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3622000|NCT02662387|3471083|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3622001|NCT02662387|3471081|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622002|NCT02662387|3471082|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622003|NCT02662387|3471083|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622004|NCT02662387|3471081|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622005|NCT02662387|3471082|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622006|NCT02662387|3471083|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622007|NCT02662387|3471081|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622008|NCT02662387|3471082|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622009|NCT02662387|3471083|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622010|NCT02662387|3471081|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622011|NCT02662387|3471082|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622012|NCT02662387|3471083|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622013|NCT02662387|3471081|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3622014|NCT02662387|3471082|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3622015|NCT02662387|3471083|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3622016|NCT02662387|3471081|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3622017|NCT02662387|3471082|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3622018|NCT02662387|3471083|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3622019|NCT02662387|3471081|B3|||Age||months|Median|10.8|10.8|Full Range|||0.0|36.0|
3622020|NCT02662387|3471082|B2|||Age||months|Median|11.36|11.36|Full Range|||0.0|36.0|
3622021|NCT02662387|3471083|B1|||Age||months|Median|10.31|10.31|Full Range|||0.0|36.0|
3622022|NCT02662387|3471081|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3622023|NCT02662387|3471082|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3622024|NCT02662387|3471083|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3622025|NCT02662387|3471081|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3622026|NCT02662387|3471082|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3622027|NCT02662387|3471083|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3622028|NCT02662387|3471081|B3||<=18 years|Age||Participants|Count of Participants|55|55.0||||||
3622029|NCT02662387|3471082|B2||<=18 years|Age||Participants|Count of Participants|28|28.0||||||
3622030|NCT02662387|3471083|B1||<=18 years|Age||Participants|Count of Participants|27|27.0||||||
3622031|NCT02661828|3471092|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3622032|NCT02661828|3471094|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3622033|NCT02661828|3471092|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622034|NCT02661828|3471094|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622035|NCT02661828|3471092|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622036|NCT02661828|3471094|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622037|NCT02661828|3471092|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3622038|NCT02661828|3471094|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3622039|NCT02661828|3471092|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622040|NCT02661828|3471094|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622041|NCT02661828|3471092|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622042|NCT02661828|3471094|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622043|NCT02661828|3471092|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622044|NCT02661828|3471094|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622045|NCT02661828|3471092|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622046|NCT02661828|3471094|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622047|NCT02661828|3471092|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622048|NCT02661828|3471094|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622049|NCT02661828|3471092|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3622050|NCT02661828|3471094|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3622051|NCT02661828|3471092|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622052|NCT02661828|3471094|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622053|NCT02661828|3471092|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3622054|NCT02661828|3471094|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3622055|NCT02661828|3471092|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3622056|NCT02661828|3471094|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3622057|NCT02661828|3471092|B3|||Age||years|Mean|47|47.0|Full Range|||47.0|47.0|
3622058|NCT02661828|3471094|B1|||Age||years|Mean|47|47.0|Full Range|||47.0|47.0|
3622059|NCT02661828|3471092|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3622060|NCT02661828|3471094|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3622061|NCT02661828|3471092|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3622062|NCT02661828|3471094|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3622063|NCT02661828|3471092|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3622064|NCT02661828|3471094|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3622065|NCT02661594|3471102|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622066|NCT02661594|3471103|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622067|NCT02661594|3471104|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622068|NCT02661594|3471105|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622069|NCT02661594|3471106|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622070|NCT02661594|3471102|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622071|NCT02661594|3471103|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622072|NCT02661594|3471104|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622073|NCT02661594|3471105|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622074|NCT02661594|3471106|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622075|NCT02661594|3471102|B5||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3622076|NCT02661594|3471103|B4||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3622077|NCT02661594|3471104|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3622078|NCT02661594|3471105|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3622079|NCT02661594|3471106|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3622080|NCT02661594|3471102|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622081|NCT02661594|3471103|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622082|NCT02661594|3471104|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622083|NCT02661594|3471105|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622084|NCT02661594|3471106|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622085|NCT02661594|3471102|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622086|NCT02661594|3471103|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622087|NCT02661594|3471104|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622088|NCT02661594|3471105|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622089|NCT02661594|3471106|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622090|NCT02661594|3471102|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3622091|NCT02661594|3471103|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3622092|NCT02661594|3471104|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3622093|NCT02661594|3471105|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3622094|NCT02661594|3471106|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3622095|NCT02661594|3471102|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622096|NCT02661594|3471103|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622097|NCT02661594|3471104|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622098|NCT02661594|3471105|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622099|NCT02661594|3471106|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622100|NCT02661594|3471102|B5||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3622101|NCT02661594|3471103|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3622102|NCT02661594|3471104|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3622104|NCT02661594|3471106|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3622105|NCT02661594|3471102|B5||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3622106|NCT02661594|3471103|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3622107|NCT02661594|3471104|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3622108|NCT02661594|3471105|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3622109|NCT02661594|3471106|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3622110|NCT02661594|3471102|B5|||Age||Years|Mean|27.99|27.99|Standard Deviation|5.36|5.36|||
3622111|NCT02661594|3471103|B4|||Age||Years|Mean|27.44|27.44|Standard Deviation|4.93|4.93|||
3622112|NCT02661594|3471104|B3|||Age||Years|Mean|30.20|30.2|Standard Deviation|8.07|8.07|||
3622113|NCT02661594|3471105|B2|||Age||Years|Mean|26.82|26.82|Standard Deviation|4.24|4.24|||
3622114|NCT02661594|3471106|B1|||Age||Years|Mean|27.50|27.5|Standard Deviation|4.22|4.22|||
3622115|NCT02661126|3471119|B3|||Body Mass Index (BMI)|Healthy participants were matched to moderate RI participants based on BMI.|kg/m^2|Mean|30.22|30.22|Standard Deviation|3.088|3.088|||
3622116|NCT02661126|3471120|B2|||Body Mass Index (BMI)|Healthy participants were matched to moderate RI participants based on BMI.|kg/m^2|Mean|30.11|30.11|Standard Deviation|2.057|2.057|||
3622117|NCT02661126|3471121|B1|||Body Mass Index (BMI)|Healthy participants were matched to moderate RI participants based on BMI.|kg/m^2|Mean|30.32|30.32|Standard Deviation|4.023|4.023|||
3622118|NCT02661126|3471119|B3||Male|Sex: Female, Male|Healthy participants were matched to moderate RI participants based on gender.|Participants|Count of Participants|12|12.0||||||
3622119|NCT02661126|3471120|B2||Male|Sex: Female, Male|Healthy participants were matched to moderate RI participants based on gender.|Participants|Count of Participants|6|6.0||||||
3622120|NCT02661126|3471121|B1||Male|Sex: Female, Male|Healthy participants were matched to moderate RI participants based on gender.|Participants|Count of Participants|6|6.0||||||
3622121|NCT02661126|3471119|B3||Female|Sex: Female, Male|Healthy participants were matched to moderate RI participants based on gender.|Participants|Count of Participants|4|4.0||||||
3622122|NCT02661126|3471120|B2||Female|Sex: Female, Male|Healthy participants were matched to moderate RI participants based on gender.|Participants|Count of Participants|2|2.0||||||
3622123|NCT02661126|3471121|B1||Female|Sex: Female, Male|Healthy participants were matched to moderate RI participants based on gender.|Participants|Count of Participants|2|2.0||||||
3622124|NCT02661126|3471119|B3|||Age|Healthy participants were matched to moderate RI participants based on age.|Years|Mean|67.7|67.7|Standard Deviation|6.7|6.7|||
3622125|NCT02661126|3471120|B2|||Age|Healthy participants were matched to moderate RI participants based on age.|Years|Mean|65.8|65.8|Standard Deviation|2.6|2.6|||
3622126|NCT02661126|3471121|B1|||Age|Healthy participants were matched to moderate RI participants based on age.|Years|Mean|69.6|69.6|Standard Deviation|9.0|9.0|||
3622127|NCT02660242|3471210|B1|||VO2Max||mL/kg/min|Median|42|42.0|Inter-Quartile Range|||35.0|51.0|
3622128|NCT02660242|3471210|B1|||Body Mass Index (BMI)||kg/m^2|Median|24|24.0|Inter-Quartile Range|||23.0|27.0|
3622129|NCT02660242|3471210|B1|||HbA1c||%|Median|6.8|6.8|Inter-Quartile Range|||6.5|7.6|
3622130|NCT02660242|3471210|B1|||Type 1 Diabetes Duration, Continuous||years|Median|22|22.0|Inter-Quartile Range|||14.0|31.0|
3622131|NCT02660242|3471210|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622132|NCT02660242|3471210|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622133|NCT02660242|3471210|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3622134|NCT02660242|3471210|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622135|NCT02660242|3471210|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622136|NCT02660242|3471210|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3622137|NCT02660242|3471210|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622138|NCT02660242|3471210|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3622139|NCT02660242|3471210|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3622140|NCT02660242|3471210|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3622141|NCT02660242|3471210|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3622142|NCT02660242|3471210|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3622143|NCT02660242|3471210|B1|||Age||years|Median|30|30.0|Inter-Quartile Range|||25.0|43.0|
3622144|NCT02660229|3471264|B3|Korea, Republic of||Region of Enrollment||participants|Number|65|65.0||||||
3622145|NCT02660229|3471265|B2|Korea, Republic of||Region of Enrollment||participants|Number|32|32.0||||||
3622146|NCT02660229|3471266|B1|Korea, Republic of||Region of Enrollment||participants|Number|33|33.0||||||
3622147|NCT02660229|3471264|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3622148|NCT02660229|3471265|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3622149|NCT02660229|3471266|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3622150|NCT02660229|3471264|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3622151|NCT02660229|3471265|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3622152|NCT02660229|3471266|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3622153|NCT02660229|3471264|B3|60-69 years||Age, Customized||participants|Number|49|49.0||||||
3622154|NCT02660229|3471265|B2|60-69 years||Age, Customized||participants|Number|22|22.0||||||
3622155|NCT02660229|3471266|B1|60-69 years||Age, Customized||participants|Number|27|27.0||||||
3622156|NCT02660229|3471264|B3|50-59 years||Age, Customized||participants|Number|11|11.0||||||
3622157|NCT02660229|3471265|B2|50-59 years||Age, Customized||participants|Number|6|6.0||||||
3622158|NCT02660229|3471266|B1|50-59 years||Age, Customized||participants|Number|5|5.0||||||
3622159|NCT02660229|3471264|B3|40-49 years||Age, Customized||participants|Number|3|3.0||||||
3622160|NCT02660229|3471265|B2|40-49 years||Age, Customized||participants|Number|2|2.0||||||
3622161|NCT02660229|3471266|B1|40-49 years||Age, Customized||participants|Number|1|1.0||||||
3622162|NCT02660229|3471264|B3|<39 years||Age, Customized||participants|Number|2|2.0||||||
3622163|NCT02660229|3471265|B2|<39 years||Age, Customized||participants|Number|2|2.0||||||
3622164|NCT02660229|3471266|B1|<39 years||Age, Customized||participants|Number|0|0.0||||||
3622165|NCT02658461|3471279|B4||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3622166|NCT02658461|3471280|B3||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||The study observed resources required for provision of episodes of care delivered by HCPs. The focus of the observation was the HCP rather than the person being treated, so no demographic data were collected.
3622167|NCT02658461|3471281|B2||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||The study observed resources required for provision of episodes of care delivered by HCPs. The focus of the observation was the HCP rather than the person being treated, so no demographic data were collected.
3622168|NCT02658461|3471282|B1||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||The study observed resources required for provision of episodes of care delivered by HCPs. The focus of the observation was the HCP rather than the person being treated, so no demographic data were collected.
3622169|NCT02658461|3471279|B4||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3622170|NCT02658461|3471280|B3||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||The study observed resources required for provision of episodes of care delivered by HCPs. The focus of the observation was the HCP rather than the person being treated, so no demographic data were collected.
3622171|NCT02658461|3471281|B2||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||The study observed resources required for provision of episodes of care delivered by HCPs. The focus of the observation was the HCP rather than the person being treated, so no demographic data were collected.
3622172|NCT02658461|3471282|B1||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||The study observed resources required for provision of episodes of care delivered by HCPs. The focus of the observation was the HCP rather than the person being treated, so no demographic data were collected.
3622173|NCT02658461|3471279|B4|||Age||years|Mean|NA||Standard Deviation|NA||||The study observed resources required for provision of episodes of care delivered by HCPs. The focus of the observation was the HCP rather than the person being treated, so no demographic data were collected.
3622174|NCT02658461|3471280|B3|||Age||years|Mean|NA||Standard Deviation|NA||||The study observed resources required for provision of episodes of care delivered by HCPs. The focus of the observation was the HCP rather than the person being treated, so no demographic data were collected.
3622175|NCT02658461|3471281|B2|||Age||years|Mean|NA||Standard Deviation|NA||||The study observed resources required for provision of episodes of care delivered by HCPs. The focus of the observation was the HCP rather than the person being treated, so no demographic data were collected.
3622176|NCT02658461|3471282|B1|||Age||years|Mean|NA||Standard Deviation|NA||||The study observed resources required for provision of episodes of care delivered by health care professionals (HCPs). The focus of the observation was the HCP rather than the person being treated, so no demographic data were collected.
3622177|NCT02658240|3471310|B3|||Preoperative Pain Score with Cough|The Visual Analog Pain Score (VAS) with cough on the scale of 10 (0= No pain, 10= Worst pain) preoperatively|units on a scale|Median|8|8.0|Inter-Quartile Range|||6.75|10.0|
3622178|NCT02658240|3471311|B2|||Preoperative Pain Score with Cough|The Visual Analog Pain Score (VAS) with cough on the scale of 10 (0= No pain, 10= Worst pain) preoperatively|units on a scale|Median|8|8.0|Inter-Quartile Range|||7.0|10.0|
3622179|NCT02658240|3471312|B1|||Preoperative Pain Score with Cough|The Visual Analog Pain Score (VAS) with cough on the scale of 10 (0= No pain, 10= Worst pain) preoperatively|units on a scale|Median|4|4.0|Inter-Quartile Range|||3.0|5.0|
3622180|NCT02658240|3471310|B3|||Preoperative Pain Score at Rest|The Visual Analog Pain Score (VAS) on the scale of 10 (0= No pain, 10= Worst pain) at preoperatively|units on a scale|Median|4|4.0|Inter-Quartile Range|||2.0|6.0|
3622181|NCT02658240|3471311|B2|||Preoperative Pain Score at Rest|The Visual Analog Pain Score (VAS) on the scale of 10 (0= No pain, 10= Worst pain) at preoperatively|units on a scale|Median|4|4.0|Inter-Quartile Range|||3.0|6.0|
3622182|NCT02658240|3471312|B1|||Preoperative Pain Score at Rest|The Visual Analog Pain Score (VAS) on the scale of 10 (0= No pain, 10= Worst pain) at preoperatively|units on a scale|Median|3|3.0|Inter-Quartile Range|||0.0|4.0|
3622183|NCT02658240|3471310|B3|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3622184|NCT02658240|3471311|B2|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3622185|NCT02658240|3471312|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3622186|NCT02658240|3471310|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622187|NCT02658240|3471311|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622188|NCT02658240|3471312|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622189|NCT02658240|3471310|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3622190|NCT02658240|3471311|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3622191|NCT02658240|3471312|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3622192|NCT02658240|3471310|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3622193|NCT02658240|3471311|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3622194|NCT02658240|3471312|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3622195|NCT02658240|3471310|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3622196|NCT02658240|3471311|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3622197|NCT02658240|3471312|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3622198|NCT02658240|3471310|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3622199|NCT02658240|3471311|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3622200|NCT02658240|3471312|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3622201|NCT02658240|3471310|B3|||Age||years|Mean|57.6|57.6|Standard Deviation|12.4|12.4|||
3622202|NCT02658240|3471311|B2|||Age||years|Mean|59.0|59.0|Standard Deviation|11.2|11.2|||
3622203|NCT02658240|3471312|B1|||Age||years|Mean|56.2|56.2|Standard Deviation|13.6|13.6|||
3622204|NCT02658149|3471325|B3|||Preoperative Pain Score|Visual Analog Pain Score; 0=no pain, 10=maximum pain|units on a scale|Mean|2.9|2.9|Standard Deviation|2.6|2.6|||
3622205|NCT02658149|3471326|B2|||Preoperative Pain Score|Visual Analog Pain Score; 0=no pain, 10=maximum pain|units on a scale|Mean|2.5|2.5|Standard Deviation|2.6|2.6|||
3622206|NCT02658149|3471327|B1|||Preoperative Pain Score|Visual Analog Pain Score; 0=no pain, 10=maximum pain|units on a scale|Mean|3.4|3.4|Standard Deviation|2.5|2.5|||
3622207|NCT02658149|3471325|B3|United States||Region of Enrollment||Participants|Count of Participants|99|99.0||||||
3622208|NCT02658149|3471326|B2|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3622209|NCT02658149|3471327|B1|United States||Region of Enrollment||Participants|Count of Participants|49|49.0||||||
3622210|NCT02658149|3471325|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622211|NCT02658149|3471326|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622212|NCT02658149|3471327|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622213|NCT02658149|3471325|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622214|NCT02658149|3471326|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622215|NCT02658149|3471327|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622216|NCT02658149|3471325|B3||White|Race (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
3622217|NCT02658149|3471326|B2||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3622218|NCT02658149|3471327|B1||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3622219|NCT02658149|3471325|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3622220|NCT02658149|3471326|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3622221|NCT02658149|3471327|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3622222|NCT02658149|3471325|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622223|NCT02658149|3471326|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622224|NCT02658149|3471327|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622225|NCT02658149|3471325|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622226|NCT02658149|3471326|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622227|NCT02658149|3471327|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622228|NCT02658149|3471325|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622229|NCT02658149|3471326|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622230|NCT02658149|3471327|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622231|NCT02658149|3471325|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3622232|NCT02658149|3471326|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3622233|NCT02658149|3471327|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3622234|NCT02658149|3471325|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3622235|NCT02658149|3471326|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3622236|NCT02658149|3471327|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3622237|NCT02658149|3471325|B3|||Age||years|Mean|67|67.0|Standard Deviation|8|8.0|||
3622238|NCT02658149|3471326|B2|||Age||years|Mean|68|68.0|Standard Deviation|8|8.0|||
3622239|NCT02658149|3471327|B1|||Age||years|Mean|65|65.0|Standard Deviation|8|8.0|||
3622240|NCT02657629|3471342|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3622241|NCT02657629|3471343|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3622242|NCT02657629|3471344|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3622243|NCT02657629|3471342|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3622244|NCT02657629|3471343|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3622245|NCT02657629|3471344|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3622246|NCT02657629|3471342|B3|||Age||gestational age in weeks at birth|Mean|38.6|38.6|Standard Deviation|1.3|1.3|||
3622247|NCT02657629|3471343|B2|||Age||gestational age in weeks at birth|Mean|38.9|38.9|Standard Deviation|1.5|1.5|||
3622248|NCT02657629|3471344|B1|||Age||gestational age in weeks at birth|Mean|38.3|38.3|Standard Deviation|1|1.0|||
3622249|NCT02657629|3471342|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3622250|NCT02657629|3471343|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3622251|NCT02657629|3471344|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3622252|NCT02657629|3471342|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3622253|NCT02657629|3471343|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3622254|NCT02657629|3471344|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3622255|NCT02657629|3471342|B3||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
3622256|NCT02657629|3471343|B2||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
3622257|NCT02657629|3471344|B1||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
3622258|NCT02657538|3471351|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3622259|NCT02657538|3471351|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3622260|NCT02657538|3471351|B1|||Age||years|Mean|27.5|27.5|Full Range|||18.0|37.0|
3622261|NCT02657538|3471351|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3622262|NCT02657538|3471351|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3622263|NCT02657538|3471351|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3622264|NCT02657252|3471358|B3|Brazil||Region of Enrollment|The patients were from Botucatu (or nearby), São Paulo, Brazil|Participants|Count of Participants|115|115.0||||||
3622265|NCT02657252|3471359|B2|Brazil||Region of Enrollment|The patients were from Botucatu (or nearby), São Paulo, Brazil|Participants|Count of Participants|58|58.0||||||
3622266|NCT02657252|3471360|B1|Brazil||Region of Enrollment|The patients were from Botucatu (or nearby), São Paulo, Brazil|Participants|Count of Participants|57|57.0||||||
3622267|NCT02657252|3471358|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3622268|NCT02657252|3471359|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3622269|NCT02657252|3471360|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3622270|NCT02657252|3471358|B3||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3622271|NCT02657252|3471359|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3622272|NCT02657252|3471360|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3622273|NCT02657252|3471358|B3|||Age||years|Mean|42.2|42.2|Standard Deviation|10|10.0|||
3622274|NCT02657252|3471359|B2|||Age||years|Mean|43.6|43.6|Standard Deviation|10|10.0|||
3622275|NCT02657252|3471360|B1|||Age||years|Mean|40.7|40.7|Standard Deviation|10|10.0|||
3622276|NCT02657252|3471358|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3622277|NCT02657252|3471359|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3622278|NCT02657252|3471360|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3622279|NCT02657252|3471358|B3||Between 18 and 65 years|Age||Participants|Count of Participants|115|115.0||||||
3622280|NCT02657252|3471359|B2||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3622281|NCT02657252|3471360|B1||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
3622282|NCT02657252|3471358|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3622283|NCT02657252|3471359|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3622284|NCT02657252|3471360|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3622285|NCT02657031|3471371|B3|||Visual Analog Scale (VAS) Pain Score, mm|Scores range from 0 mm (no pain) to 100 mm (maximum pain)|mm|Mean|78|78.0|Standard Deviation|17|17.0|||
3622286|NCT02657031|3471372|B2|||Visual Analog Scale (VAS) Pain Score, mm|Scores range from 0 mm (no pain) to 100 mm (maximum pain)|mm|Mean|77.8|77.8|Standard Deviation|14.6|14.6|||
3622287|NCT02657031|3471373|B1|||Visual Analog Scale (VAS) Pain Score, mm|Scores range from 0 mm (no pain) to 100 mm (maximum pain)|mm|Mean|78.3|78.3|Standard Deviation|17.7|17.7|||
3622288|NCT02657031|3471371|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
3622289|NCT02657031|3471372|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
3622290|NCT02657031|3471373|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
3622291|NCT02657031|3471371|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3622292|NCT02657031|3471372|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3622293|NCT02657031|3471373|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3622294|NCT02657031|3471371|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3622295|NCT02657031|3471372|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3622296|NCT02657031|3471373|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3622297|NCT02657031|3471371|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3622298|NCT02657031|3471372|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3622299|NCT02657031|3471373|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3622300|NCT02657031|3471371|B3|||Age||years|Mean|34.9|34.9|Standard Deviation|10.3|10.3|||
3622301|NCT02657031|3471372|B2|||Age||years|Mean|32.3|32.3|Standard Deviation|10.3|10.3|||
3622302|NCT02657031|3471373|B1|||Age||years|Mean|37.4|37.4|Standard Deviation|10.4|10.4|||
3622303|NCT02657031|3471371|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3622304|NCT02657031|3471372|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3622305|NCT02657031|3471373|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3622306|NCT02657031|3471371|B3||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3622307|NCT02657031|3471372|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3622308|NCT02657031|3471373|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3622309|NCT02657031|3471371|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3622310|NCT02657031|3471372|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3622311|NCT02657031|3471373|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3622312|NCT02656745|3471388|B1|United States||Region of Enrollment||participants|Number|416|416.0||||||
3622313|NCT02656745|3471388|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3622314|NCT02656745|3471388|B1|Native American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3622315|NCT02656745|3471388|B1|Asian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3622316|NCT02656745|3471388|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3622317|NCT02656745|3471388|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
3622318|NCT02656745|3471388|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|315|315.0||||||
3622319|NCT02656745|3471388|B1||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3622320|NCT02656745|3471388|B1||Female|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
3622321|NCT02656745|3471388|B1|||Age||years|Mean|36|36.0|Standard Deviation|10.8|10.8|||
3622322|NCT02656485|3471395|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3622323|NCT02656485|3471396|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3622324|NCT02656485|3471397|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3622325|NCT02656485|3471398|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3622326|NCT02656485|3471399|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3622327|NCT02656485|3471395|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3622328|NCT02656485|3471396|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622329|NCT02656485|3471397|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622330|NCT02656485|3471398|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3622331|NCT02656485|3471399|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3622332|NCT02656485|3471395|B5||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3622333|NCT02656485|3471396|B4||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3622334|NCT02656485|3471397|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3622335|NCT02656485|3471398|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3622336|NCT02656485|3471399|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3622337|NCT02656485|3471395|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3622338|NCT02656485|3471396|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3622339|NCT02656485|3471397|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3622340|NCT02656485|3471398|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3622341|NCT02656485|3471399|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3622342|NCT02656485|3471395|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622343|NCT02656485|3471396|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622344|NCT02656485|3471397|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622345|NCT02656485|3471398|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622346|NCT02656485|3471399|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622347|NCT02656485|3471395|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3622348|NCT02656485|3471396|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3622349|NCT02656485|3471397|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622350|NCT02656485|3471398|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622351|NCT02656485|3471399|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3622352|NCT02656485|3471395|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3622353|NCT02656485|3471396|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622354|NCT02656485|3471397|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622355|NCT02656485|3471398|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3622356|NCT02656485|3471399|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622357|NCT02656485|3471395|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3622358|NCT02656485|3471396|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3622359|NCT02656485|3471397|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3622360|NCT02656485|3471398|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3622361|NCT02656485|3471399|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3622362|NCT02656485|3471395|B5||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3622363|NCT02656485|3471396|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3622364|NCT02656485|3471397|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3622365|NCT02656485|3471398|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3622366|NCT02656485|3471399|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3622367|NCT02656485|3471395|B5|||Age||years|Mean|29.1|29.1|Standard Deviation|8.4|8.4|||
3622368|NCT02656485|3471396|B4|||Age||years|Mean|31.7|31.7|Standard Deviation|10.1|10.1|||
3622369|NCT02656485|3471397|B3|||Age||years|Mean|29.2|29.2|Standard Deviation|4.8|4.8|||
3622370|NCT02656485|3471398|B2|||Age||years|Mean|26|26.0|Standard Deviation|8.2|8.2|||
3622371|NCT02656485|3471399|B1|||Age||years|Mean|29.4|29.4|Standard Deviation|10.0|10.0|||
3622372|NCT02656173|3471414|B3|||Mean number of micturitions per 24 hours|A micturition was defined as any voluntary micturition (excluding incontinence only episodes). The mean number of micturitions per 24 hours was calculated from data recorded by participants on a 3-day micturition diary before each visit.|micturitions|Mean|10.581|10.581|Standard Deviation|2.301|2.301|||
3622373|NCT02656173|3471415|B2|||Mean number of micturitions per 24 hours|A micturition was defined as any voluntary micturition (excluding incontinence only episodes). The mean number of micturitions per 24 hours was calculated from data recorded by participants on a 3-day micturition diary before each visit.|micturitions|Mean|10.401|10.401|Standard Deviation|2.236|2.236|||
3622374|NCT02656173|3471416|B1|||Mean number of micturitions per 24 hours|A micturition was defined as any voluntary micturition (excluding incontinence only episodes). The mean number of micturitions per 24 hours was calculated from data recorded by participants on a 3-day micturition diary before each visit.|micturitions|Mean|10.760|10.76|Standard Deviation|2.355|2.355|||
3622375|NCT02656173|3471414|B3|Korean||Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3622376|NCT02656173|3471415|B2|Korean||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3622377|NCT02656173|3471416|B1|Korean||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3622378|NCT02656173|3471414|B3|Japanese||Race/Ethnicity, Customized||Participants|Count of Participants|538|538.0||||||
3622379|NCT02656173|3471415|B2|Japanese||Race/Ethnicity, Customized||Participants|Count of Participants|269|269.0||||||
3622380|NCT02656173|3471416|B1|Japanese||Race/Ethnicity, Customized||Participants|Count of Participants|269|269.0||||||
3622381|NCT02656173|3471414|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622382|NCT02656173|3471415|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622383|NCT02656173|3471416|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622384|NCT02656173|3471414|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622385|NCT02656173|3471415|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622386|NCT02656173|3471416|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622387|NCT02656173|3471414|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622388|NCT02656173|3471415|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622389|NCT02656173|3471416|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622390|NCT02656173|3471414|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622391|NCT02656173|3471415|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622392|NCT02656173|3471416|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622393|NCT02656173|3471414|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622394|NCT02656173|3471415|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622395|NCT02656173|3471416|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622396|NCT02656173|3471414|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|568|568.0||||||
3622397|NCT02656173|3471415|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|283|283.0||||||
3622398|NCT02656173|3471416|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|285|285.0||||||
3622399|NCT02656173|3471414|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622400|NCT02656173|3471415|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622401|NCT02656173|3471416|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622402|NCT02656173|3471414|B3||Male|Sex: Female, Male||Participants|Count of Participants|568|568.0||||||
3622403|NCT02656173|3471415|B2||Male|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
3622404|NCT02656173|3471416|B1||Male|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
3622405|NCT02656173|3471414|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3622406|NCT02656173|3471415|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3622407|NCT02656173|3471416|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3622408|NCT02656173|3471414|B3|||Age||year|Mean|65.4|65.4|Standard Deviation|8.7|8.7|||
3622409|NCT02656173|3471415|B2|||Age||year|Mean|65.3|65.3|Standard Deviation|8.5|8.5|||
3622410|NCT02656173|3471416|B1|||Age||year|Mean|65.6|65.6|Standard Deviation|9.0|9.0|||
3622411|NCT02656160|3471453|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3622412|NCT02656160|3471453|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3622413|NCT02656160|3471453|B1|||Age||years|Median|28|28.0|Inter-Quartile Range|||25.3|33.3|
3622414|NCT02656069|3471462|B3|North America|United Staates|Region of Enrollment||Participants|Count of Participants|72|72.0||||||
3622415|NCT02656069|3471463|B2|North America|United Staates|Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3622416|NCT02656069|3471464|B1|North America|United Staates|Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3622417|NCT02656069|3471462|B3|North America|Canada|Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3622418|NCT02656069|3471463|B2|North America|Canada|Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3622419|NCT02656069|3471464|B1|North America|Canada|Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3622420|NCT02656069|3471462|B3|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3622421|NCT02656069|3471463|B2|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3622422|NCT02656069|3471464|B1|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3622423|NCT02656069|3471462|B3|Race/Ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3622424|NCT02656069|3471463|B2|Race/Ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3622425|NCT02656069|3471464|B1|Race/Ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3622426|NCT02656069|3471462|B3|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3622427|NCT02656069|3471463|B2|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3622428|NCT02656069|3471464|B1|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3622429|NCT02656069|3471462|B3|Race/Ethnicity|Non-Hispanic White|Race/Ethnicity, Customized||Participants|Count of Participants|67|67.0||||||
3622430|NCT02656069|3471463|B2|Race/Ethnicity|Non-Hispanic White|Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3622431|NCT02656069|3471464|B1|Race/Ethnicity|Non-Hispanic White|Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
3622432|NCT02656069|3471462|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3622433|NCT02656069|3471463|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3622434|NCT02656069|3471464|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3622435|NCT02656069|3471462|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3622436|NCT02656069|3471463|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3622437|NCT02656069|3471464|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3622438|NCT02656069|3471462|B3|||Age||years|Mean|43.6|43.6|Standard Deviation|15.25|15.25|||
3622439|NCT02656069|3471463|B2|||Age||years|Mean|45.5|45.5|Standard Deviation|14.87|14.87|||
3622440|NCT02656069|3471464|B1|||Age||years|Mean|42.1|42.1|Standard Deviation|15.55|15.55|||
3622441|NCT02656069|3471462|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3622442|NCT02656069|3471463|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3622443|NCT02656069|3471464|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3622444|NCT02656069|3471462|B3||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
3622445|NCT02656069|3471463|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3622446|NCT02656069|3471464|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3622447|NCT02656069|3471462|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3622448|NCT02656069|3471463|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3622449|NCT02656069|3471464|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3622450|NCT02655666|3471489|B1|China||Region of Enrollment||participants|Number|16|16.0||||||
3622451|NCT02655666|3471489|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3622452|NCT02655666|3471489|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3622453|NCT02655666|3471489|B1|||Age||years|Mean|11.3|11.3|Standard Deviation|2.85|2.85|||
3622454|NCT02654639|3471502|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3622455|NCT02654639|3471502|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622456|NCT02654639|3471502|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622457|NCT02654639|3471502|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3622458|NCT02654639|3471502|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3622459|NCT02654639|3471502|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622460|NCT02654639|3471502|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622461|NCT02654639|3471502|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622462|NCT02654639|3471502|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3622463|NCT02654639|3471502|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3622464|NCT02654639|3471502|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3622465|NCT02654639|3471502|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3622466|NCT02654639|3471502|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3622467|NCT02654145|3471506|B1|Race customized|Multiple-Black/African American and White Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3622468|NCT02654145|3471506|B1|Race customized|White- White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|124|124.0||||||
3622469|NCT02654145|3471506|B1|Race customized|White- Arabic/ North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3622470|NCT02654145|3471506|B1|Race customized|Black or African American heritage|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3622471|NCT02654145|3471506|B1|Race customized|Asian- South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3622472|NCT02654145|3471506|B1|Race customized|Asian- East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3622473|NCT02654145|3471506|B1|Race customized|Asian- Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3622474|NCT02654145|3471506|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3622475|NCT02654145|3471506|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3622476|NCT02654145|3471506|B1|||Age||Years|Mean|53.6|53.6|Standard Deviation|13.83|13.83|||
3622477|NCT02653872|3471513|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3622478|NCT02653872|3471513|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3622479|NCT02653872|3471513|B1|||Age||Years|Mean|33|33.0|Standard Deviation|12|12.0|||
3622480|NCT02653625|3471548|B1|Not Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3622481|NCT02653625|3471548|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3622482|NCT02653625|3471548|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3622483|NCT02653625|3471548|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3622484|NCT02653625|3471548|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3622485|NCT02653625|3471548|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3622486|NCT02653625|3471548|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3622487|NCT02653625|3471548|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3622488|NCT02653625|3471548|B1|||Age||years|Mean|43.3|43.3|Standard Deviation|12.93|12.93|||
3622489|NCT02653560|3471557|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3622490|NCT02653560|3471557|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3622491|NCT02653560|3471557|B1|||Age||years|Mean|54|54.0|Standard Deviation|12|12.0|||
3622492|NCT02653495|3471570|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3622493|NCT02653495|3471571|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3622494|NCT02653495|3471572|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3622495|NCT02653495|3471570|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3622496|NCT02653495|3471570|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3622497|NCT02653495|3471571|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3622498|NCT02653495|3471572|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3622499|NCT02653495|3471570|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3622500|NCT02653495|3471571|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3622501|NCT02653495|3471572|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3622502|NCT02653495|3471570|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3622503|NCT02653495|3471571|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3622504|NCT02653495|3471572|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3622505|NCT02653495|3471570|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3622506|NCT02653495|3471571|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3622507|NCT02653495|3471572|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3622508|NCT02653495|3471570|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3622509|NCT02653495|3471571|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3622510|NCT02653495|3471572|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3622511|NCT02653456|3471587|B1|||Chronic total occlusion||Participants|Count of Participants|64|64.0||||||
3622512|NCT02653456|3471587|B1|Mexico||Region of Enrollment||participants|Number|15|15.0||||||
3622513|NCT02653456|3471587|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
3622514|NCT02653456|3471587|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3622515|NCT02653456|3471587|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622516|NCT02653456|3471587|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622517|NCT02653456|3471587|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622518|NCT02653456|3471587|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622519|NCT02653456|3471587|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622520|NCT02653456|3471587|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622521|NCT02653456|3471587|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3622522|NCT02653456|3471587|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3622523|NCT02653456|3471587|B1|||Age||years|Mean|72|72.0|Full Range|||47.0|96.0|
3622524|NCT02652624|3471594|B3||RTV + ATV + FTC/TDF|Prior Antiretroviral (ARV) Regimen||Participants|Count of Participants|24|24.0||||||
3622525|NCT02652624|3471595|B2||RTV + ATV + FTC/TDF|Prior Antiretroviral (ARV) Regimen||Participants|Count of Participants|13|13.0||||||
3622526|NCT02652624|3471596|B1||RTV + ATV + FTC/TDF|Prior Antiretroviral (ARV) Regimen||Participants|Count of Participants|11|11.0||||||
3622527|NCT02652624|3471594|B3||E/C/F/TDF|Prior Antiretroviral (ARV) Regimen||Participants|Count of Participants|197|197.0||||||
3622528|NCT02652624|3471595|B2||E/C/F/TDF|Prior Antiretroviral (ARV) Regimen||Participants|Count of Participants|98|98.0||||||
3622529|NCT02652624|3471596|B1||E/C/F/TDF|Prior Antiretroviral (ARV) Regimen||Participants|Count of Participants|99|99.0||||||
3622530|NCT02652624|3471594|B3||E/C/F/TAF|Prior Antiretroviral (ARV) Regimen||Participants|Count of Participants|249|249.0||||||
3622531|NCT02652624|3471595|B2||E/C/F/TAF|Prior Antiretroviral (ARV) Regimen||Participants|Count of Participants|125|125.0||||||
3622532|NCT02652624|3471596|B1||E/C/F/TAF|Prior Antiretroviral (ARV) Regimen||Participants|Count of Participants|124|124.0||||||
3622533|NCT02652624|3471594|B3||≥ 500 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|391|391.0||||||
3622534|NCT02652624|3471595|B2||≥ 500 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|201|201.0||||||
3622535|NCT02652624|3471596|B1||≥ 500 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|190|190.0||||||
3622536|NCT02652624|3471594|B3||≥ 350 to < 500 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|58|58.0||||||
3622537|NCT02652624|3471595|B2||≥ 350 to < 500 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|25|25.0||||||
3622538|NCT02652624|3471596|B1||≥ 350 to < 500 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|33|33.0||||||
3622539|NCT02652624|3471594|B3||≥ 200 to < 350 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|19|19.0||||||
3622540|NCT02652624|3471595|B2||≥ 200 to < 350 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|9|9.0||||||
3622541|NCT02652624|3471596|B1||≥ 200 to < 350 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|10|10.0||||||
3622542|NCT02652624|3471594|B3||≥ 50 to < 200 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|2|2.0||||||
3622543|NCT02652624|3471595|B2||≥ 50 to < 200 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|1|1.0||||||
3622544|NCT02652624|3471596|B1||≥ 50 to < 200 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|1|1.0||||||
3622545|NCT02652624|3471594|B3|||CD4 Cell Count||cells/µL|Mean|725|725.0|Standard Deviation|268.3|268.3|||
3622546|NCT02652624|3471595|B2|||CD4 Cell Count||cells/µL|Mean|738|738.0|Standard Deviation|268.4|268.4|||
3622547|NCT02652624|3471596|B1|||CD4 Cell Count||cells/µL|Mean|712|712.0|Standard Deviation|268.1|268.1|||
3622548|NCT02652624|3471594|B3||≥ 50 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|3|3.0||||||
3622549|NCT02652624|3471595|B2||≥ 50 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|3|3.0||||||
3622550|NCT02652624|3471596|B1||≥ 50 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|0|0.0||||||
3622551|NCT02652624|3471594|B3||< 50 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|467|467.0||||||
3622552|NCT02652624|3471595|B2||< 50 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|233|233.0||||||
3622553|NCT02652624|3471596|B1||< 50 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|234|234.0||||||
3622554|NCT02652624|3471594|B3|Russia||Region of Enrollment||Participants|Count of Participants|112|112.0||||||
3622555|NCT02652624|3471595|B2|Russia||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
3622556|NCT02652624|3471596|B1|Russia||Region of Enrollment||Participants|Count of Participants|58|58.0||||||
3622557|NCT02652624|3471594|B3|Thailand||Region of Enrollment||Participants|Count of Participants|101|101.0||||||
3622558|NCT02652624|3471595|B2|Thailand||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
3622559|NCT02652624|3471596|B1|Thailand||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
3622560|NCT02652624|3471594|B3|Uganda||Region of Enrollment||Participants|Count of Participants|127|127.0||||||
3622561|NCT02652624|3471595|B2|Uganda||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
3622562|NCT02652624|3471596|B1|Uganda||Region of Enrollment||Participants|Count of Participants|65|65.0||||||
3622563|NCT02652624|3471594|B3|Dominican Republic||Region of Enrollment||Participants|Count of Participants|58|58.0||||||
3622564|NCT02652624|3471595|B2|Dominican Republic||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3622565|NCT02652624|3471596|B1|Dominican Republic||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3622566|NCT02652624|3471594|B3|United States||Region of Enrollment||Participants|Count of Participants|72|72.0||||||
3622567|NCT02652624|3471595|B2|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3622568|NCT02652624|3471596|B1|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3622569|NCT02652624|3471594|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|61|61.0||||||
3622570|NCT02652624|3471595|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3622571|NCT02652624|3471596|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3622572|NCT02652624|3471594|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|133|133.0||||||
3622573|NCT02652624|3471595|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|67|67.0||||||
3622574|NCT02652624|3471596|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|66|66.0||||||
3622575|NCT02652624|3471594|B3||Black|Race/Ethnicity, Customized||Participants|Count of Participants|174|174.0||||||
3622576|NCT02652624|3471595|B2||Black|Race/Ethnicity, Customized||Participants|Count of Participants|83|83.0||||||
3622577|NCT02652624|3471596|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|91|91.0||||||
3622578|NCT02652624|3471594|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|102|102.0||||||
3622579|NCT02652624|3471595|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|54|54.0||||||
3622580|NCT02652624|3471596|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
3622581|NCT02652624|3471594|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622582|NCT02652624|3471595|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622583|NCT02652624|3471596|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622584|NCT02652624|3471594|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|396|396.0||||||
3622585|NCT02652624|3471595|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|198|198.0||||||
3622586|NCT02652624|3471596|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|198|198.0||||||
3622587|NCT02652624|3471594|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3622588|NCT02652624|3471595|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3622589|NCT02652624|3471596|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3622590|NCT02652624|3471594|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3622591|NCT02652624|3471595|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3622592|NCT02652624|3471596|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3622593|NCT02652624|3471594|B3||Female|Sex: Female, Male||Participants|Count of Participants|470|470.0||||||
3622594|NCT02652624|3471595|B2||Female|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
3622595|NCT02652624|3471596|B1||Female|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
3622596|NCT02652624|3471594|B3|||Age||years|Mean|40|40.0|Standard Deviation|9.3|9.3|||
3622597|NCT02652624|3471595|B2|||Age||years|Mean|40|40.0|Standard Deviation|9.1|9.1|||
3622598|NCT02652624|3471596|B1|||Age||years|Mean|40|40.0|Standard Deviation|9.5|9.5|||
3622599|NCT02652390|3471607|B4|||Follow-up time from randomization/treatment||months|Mean|74|74.0|Standard Deviation|7.2|7.2|||
3622600|NCT02652390|3471608|B3|||Follow-up time from randomization/treatment||months|Mean|74|74.0|Standard Deviation|7.1|7.1|||
3622601|NCT02652390|3471609|B2|||Follow-up time from randomization/treatment||months|Mean|74|74.0|Standard Deviation|7.1|7.1|||
3622602|NCT02652390|3471610|B1|||Follow-up time from randomization/treatment||months|Mean|74|74.0|Standard Deviation|7.5|7.5|||
3622603|NCT02652390|3471607|B4|||Body mass index|BMI at follow-up|kg/m2|Mean|27.5|27.5|Standard Deviation|4.8|4.8|||
3622604|NCT02652390|3471608|B3|||Body mass index|BMI at follow-up|kg/m2|Mean|27.7|27.7|Standard Deviation|5.7|5.7|||
3622605|NCT02652390|3471609|B2|||Body mass index|BMI at follow-up|kg/m2|Mean|27.6|27.6|Standard Deviation|4.3|4.3|||
3622606|NCT02652390|3471610|B1|||Body mass index|BMI at follow-up|kg/m2|Mean|27.3|27.3|Standard Deviation|4.2|4.2|||
3622607|NCT02652390|3471607|B4|||Dominant hand treated||Participants|Count of Participants|87|87.0||||||
3622608|NCT02652390|3471608|B3|||Dominant hand treated||Participants|Count of Participants|28|28.0||||||
3622609|NCT02652390|3471609|B2|||Dominant hand treated||Participants|Count of Participants|29|29.0||||||
3622610|NCT02652390|3471610|B1|||Dominant hand treated||Participants|Count of Participants|30|30.0||||||
3622611|NCT02652390|3471607|B4|Sweden||Region of Enrollment||participants|Number|111|111.0||||||
3622612|NCT02652390|3471608|B3|Sweden||Region of Enrollment||participants|Number|37|37.0||||||
3622613|NCT02652390|3471609|B2|Sweden||Region of Enrollment||participants|Number|37|37.0||||||
3622614|NCT02652390|3471610|B1|Sweden||Region of Enrollment||participants|Number|37|37.0||||||
3622615|NCT02652390|3471607|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622616|NCT02652390|3471608|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622617|NCT02652390|3471609|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622618|NCT02652390|3471610|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622619|NCT02652390|3471607|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622620|NCT02652390|3471608|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622621|NCT02652390|3471609|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622622|NCT02652390|3471610|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622623|NCT02652390|3471607|B4||White|Race (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
3622624|NCT02652390|3471608|B3||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3622625|NCT02652390|3471609|B2||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3622626|NCT02652390|3471610|B1||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3622627|NCT02652390|3471607|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622628|NCT02652390|3471608|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622629|NCT02652390|3471609|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622630|NCT02652390|3471610|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622631|NCT02652390|3471607|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622632|NCT02652390|3471608|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622633|NCT02652390|3471609|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622634|NCT02652390|3471610|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622635|NCT02652390|3471607|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622636|NCT02652390|3471608|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622637|NCT02652390|3471609|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622638|NCT02652390|3471610|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622639|NCT02652390|3471607|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622640|NCT02652390|3471608|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622641|NCT02652390|3471609|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622642|NCT02652390|3471610|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622643|NCT02652390|3471607|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3622644|NCT02652390|3471608|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3622645|NCT02652390|3471609|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3622646|NCT02652390|3471610|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3622647|NCT02652390|3471607|B4||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3622648|NCT02652390|3471608|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3622649|NCT02652390|3471609|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3622650|NCT02652390|3471610|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3622651|NCT02652390|3471607|B4|||Age|Age at follow-up|years|Mean|53|53.0|Standard Deviation|12|12.0|||
3622652|NCT02652390|3471608|B3|||Age|Age at follow-up|years|Mean|55|55.0|Standard Deviation|12|12.0|||
3622653|NCT02652390|3471609|B2|||Age|Age at follow-up|years|Mean|50|50.0|Standard Deviation|11|11.0|||
3622654|NCT02652390|3471610|B1|||Age|Age at follow-up|years|Mean|53|53.0|Standard Deviation|12|12.0|||
3622655|NCT02652221|3471634|B1|||BMI||kg/m2|Mean|29.1|29.1|Standard Deviation|8.7|8.7|||
3622656|NCT02652221|3471634|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
3622657|NCT02652221|3471634|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3622658|NCT02652221|3471634|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3622659|NCT02652221|3471634|B1|||Age||years|Mean|14|14.0|Standard Deviation|3.9|3.9|||
3622660|NCT02652208|3471641|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
3622661|NCT02652208|3471642|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3622662|NCT02652208|3471643|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3622663|NCT02652208|3471641|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3622664|NCT02652208|3471642|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622665|NCT02652208|3471643|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3622666|NCT02652208|3471641|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622667|NCT02652208|3471642|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622668|NCT02652208|3471643|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622669|NCT02652208|3471641|B3||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3622670|NCT02652208|3471642|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3622671|NCT02652208|3471643|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3622672|NCT02652208|3471641|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622673|NCT02652208|3471642|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622674|NCT02652208|3471643|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622675|NCT02652208|3471641|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622676|NCT02652208|3471642|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622677|NCT02652208|3471643|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622678|NCT02652208|3471641|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622679|NCT02652208|3471642|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622680|NCT02652208|3471643|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622681|NCT02652208|3471641|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622682|NCT02652208|3471642|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622683|NCT02652208|3471643|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622684|NCT02652208|3471641|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622685|NCT02652208|3471642|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622686|NCT02652208|3471643|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622687|NCT02652208|3471641|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3622688|NCT02652208|3471642|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3622689|NCT02652208|3471643|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3622690|NCT02652208|3471641|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622691|NCT02652208|3471642|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622692|NCT02652208|3471643|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622693|NCT02652208|3471641|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3622694|NCT02652208|3471642|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3622695|NCT02652208|3471643|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3622696|NCT02652208|3471641|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3622697|NCT02652208|3471642|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3622698|NCT02652208|3471643|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3622699|NCT02652208|3471641|B3|||Age||years|Mean|70|70.0|Standard Deviation|11.1|11.1|||
3622700|NCT02652208|3471642|B2|||Age||years|Mean|73|73.0|Standard Deviation|11.6|11.6|||
3622701|NCT02652208|3471643|B1|||Age||years|Mean|67|67.0|Standard Deviation|10.2|10.2|||
3622702|NCT02652208|3471641|B3||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3622703|NCT02652208|3471642|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3622704|NCT02652208|3471643|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3622705|NCT02652208|3471641|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3622706|NCT02652208|3471642|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3622764|NCT02652156|3471655|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3622707|NCT02652208|3471643|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3622708|NCT02652208|3471641|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3622709|NCT02652208|3471642|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3622710|NCT02652208|3471643|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3622711|NCT02652156|3471654|B4|United States||Region of Enrollment||participants|Number|14|14.0||||||
3622712|NCT02652156|3471655|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3622713|NCT02652156|3471656|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3622714|NCT02652156|3471657|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3622715|NCT02652156|3471654|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622716|NCT02652156|3471655|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622717|NCT02652156|3471656|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622718|NCT02652156|3471657|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622719|NCT02652156|3471654|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3622720|NCT02652156|3471655|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622721|NCT02652156|3471656|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3622722|NCT02652156|3471657|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622723|NCT02652156|3471654|B4||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3622724|NCT02652156|3471655|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3622725|NCT02652156|3471656|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3622726|NCT02652156|3471657|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3622727|NCT02652156|3471654|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3622728|NCT02652156|3471655|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3622729|NCT02652156|3471656|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3622730|NCT02652156|3471657|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3622731|NCT02652156|3471654|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622732|NCT02652156|3471655|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622733|NCT02652156|3471656|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622734|NCT02652156|3471657|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622735|NCT02652156|3471654|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622736|NCT02652156|3471655|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622737|NCT02652156|3471656|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622738|NCT02652156|3471657|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622739|NCT02652156|3471654|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622740|NCT02652156|3471655|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622741|NCT02652156|3471656|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622742|NCT02652156|3471657|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622743|NCT02652156|3471654|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3622744|NCT02652156|3471655|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622745|NCT02652156|3471656|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3622746|NCT02652156|3471657|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622747|NCT02652156|3471654|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3622748|NCT02652156|3471655|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3622749|NCT02652156|3471656|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3622750|NCT02652156|3471657|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3622751|NCT02652156|3471654|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622752|NCT02652156|3471655|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622753|NCT02652156|3471656|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622754|NCT02652156|3471657|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622755|NCT02652156|3471654|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3622756|NCT02652156|3471655|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3622757|NCT02652156|3471656|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3622758|NCT02652156|3471657|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3622759|NCT02652156|3471654|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3622760|NCT02652156|3471655|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3622761|NCT02652156|3471656|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3622762|NCT02652156|3471657|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3622763|NCT02652156|3471654|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3622765|NCT02652156|3471656|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3622766|NCT02652156|3471657|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3622767|NCT02652156|3471654|B4||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3622768|NCT02652156|3471655|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3622769|NCT02652156|3471656|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3622770|NCT02652156|3471657|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3622771|NCT02652156|3471654|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3622772|NCT02652156|3471655|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3622773|NCT02652156|3471656|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3622774|NCT02652156|3471657|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3622775|NCT02651922|3471685|B1|Germany||Region of Enrollment||participants|Number|154|154.0||||||
3622776|NCT02651922|3471685|B1|missing data||Sex/Gender, Customized||participants|Number|1|1.0||||||
3622777|NCT02651922|3471685|B1|Male||Sex/Gender, Customized||participants|Number|38|38.0||||||
3622778|NCT02651922|3471685|B1|Female||Sex/Gender, Customized||participants|Number|115|115.0||||||
3622779|NCT02651922|3471685|B1|||Age||years|Mean|47.9|47.9|Standard Deviation|17.1|17.1|||
3622780|NCT02651922|3471685|B1|missing data||Age, Customized|2 missinig data|participants|Number|2|2.0||||||
3622781|NCT02651922|3471685|B1|>=65 years||Age, Customized|2 missinig data|participants|Number|23|23.0||||||
3622782|NCT02651922|3471685|B1|Between 18 and 65 years||Age, Customized|2 missinig data|participants|Number|128|128.0||||||
3622783|NCT02651922|3471685|B1|<=18 years||Age, Customized|2 missinig data|participants|Number|1|1.0||||||
3622784|NCT02651467|3471702|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3622785|NCT02651467|3471703|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3622786|NCT02651467|3471704|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3622787|NCT02651467|3471705|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3622788|NCT02651467|3471702|B4||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3622789|NCT02651467|3471703|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3622790|NCT02651467|3471704|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3622791|NCT02651467|3471705|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3622792|NCT02651467|3471702|B4|||Age||Years|Mean|44.4|44.4|Standard Deviation|12.21|12.21|||
3622793|NCT02651467|3471703|B3|||Age||Years|Mean|44.4|44.4|Standard Deviation|12.33|12.33|||
3622794|NCT02651467|3471704|B2|||Age||Years|Mean|44.9|44.9|Standard Deviation|11.99|11.99|||
3622795|NCT02651467|3471705|B1|||Age||Years|Mean|43.3|43.3|Standard Deviation|12.41|12.41|||
3622796|NCT02651194|3471726|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3622797|NCT02651194|3471726|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3622798|NCT02651194|3471726|B1|||Age||years|Mean|57.52|57.52|Standard Deviation|11.14|11.14|||
3622799|NCT02651155|3471732|B3|Participant is an ex-smoker||Smoking Classification||participants|Number|9|9.0||||||
3622800|NCT02651155|3471733|B2|Participant is an ex-smoker||Smoking Classification||participants|Number|6|6.0||||||
3622801|NCT02651155|3471734|B1|Participant is an ex-smoker||Smoking Classification||participants|Number|3|3.0||||||
3622802|NCT02651155|3471732|B3|Participant is a current smoker||Smoking Classification||participants|Number|20|20.0||||||
3622803|NCT02651155|3471733|B2|Participant is a current smoker||Smoking Classification||participants|Number|11|11.0||||||
3622804|NCT02651155|3471734|B1|Participant is a current smoker||Smoking Classification||participants|Number|9|9.0||||||
3622805|NCT02651155|3471732|B3|Participant has never smoked||Smoking Classification||participants|Number|175|175.0||||||
3622806|NCT02651155|3471733|B2|Participant has never smoked||Smoking Classification||participants|Number|88|88.0||||||
3622807|NCT02651155|3471734|B1|Participant has never smoked||Smoking Classification||participants|Number|87|87.0||||||
3622808|NCT02651155|3471732|B3|||Body Mass Index||kg/m^2|Mean|25.259|25.259|Standard Deviation|4.1415|4.1415|||
3622809|NCT02651155|3471733|B2|||Body Mass Index||kg/m^2|Mean|25.254|25.254|Standard Deviation|4.0513|4.0513|||
3622810|NCT02651155|3471734|B1|||Body Mass Index||kg/m^2|Mean|25.265|25.265|Standard Deviation|4.2558|4.2558|||
3622811|NCT02651155|3471732|B3|||Weight||kg|Mean|69.39|69.39|Standard Deviation|12.751|12.751|||
3622812|NCT02651155|3471733|B2|||Weight||kg|Mean|68.75|68.75|Standard Deviation|11.240|11.24|||
3622813|NCT02651155|3471734|B1|||Weight||kg|Mean|70.08|70.08|Standard Deviation|14.206|14.206|||
3622814|NCT02651155|3471732|B3|||Height||cm|Mean|165.6|165.6|Standard Deviation|7.49|7.49|||
3622815|NCT02651155|3471733|B2|||Height||cm|Mean|165.1|165.1|Standard Deviation|7.77|7.77|||
3622816|NCT02651155|3471734|B1|||Height||cm|Mean|166.2|166.2|Standard Deviation|7.16|7.16|||
3622817|NCT02651155|3471732|B3|Russia||Region of Enrollment||participants|Number|204|204.0||||||
3622818|NCT02651155|3471733|B2|Russia||Region of Enrollment||participants|Number|105|105.0||||||
3622819|NCT02651155|3471734|B1|Russia||Region of Enrollment||participants|Number|99|99.0||||||
3622820|NCT02651155|3471732|B3|Multiracial||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3622821|NCT02651155|3471733|B2|Multiracial||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3622822|NCT02651155|3471734|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3622823|NCT02651155|3471732|B3|White||Race/Ethnicity, Customized||participants|Number|201|201.0||||||
3622824|NCT02651155|3471733|B2|White||Race/Ethnicity, Customized||participants|Number|102|102.0||||||
3622825|NCT02651155|3471734|B1|White||Race/Ethnicity, Customized||participants|Number|99|99.0||||||
3622826|NCT02651155|3471732|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3622827|NCT02651155|3471733|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3622828|NCT02651155|3471734|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3622829|NCT02651155|3471732|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3622830|NCT02651155|3471733|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3622831|NCT02651155|3471734|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3622832|NCT02651155|3471732|B3||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3622833|NCT02651155|3471733|B2||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3622834|NCT02651155|3471734|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3622835|NCT02651155|3471732|B3|||Age||years|Mean|50.1|50.1|Full Range|||19.0|84.0|
3622836|NCT02651155|3471733|B2|||Age||years|Mean|51.1|51.1|Full Range|||19.0|79.0|
3622837|NCT02651155|3471734|B1|||Age||years|Mean|49.0|49.0|Full Range|||20.0|84.0|
3622838|NCT02651103|3471751|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3622839|NCT02651103|3471751|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3622840|NCT02651103|3471751|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3622841|NCT02651103|3471751|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3622842|NCT02651103|3471751|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3622843|NCT02651103|3471751|B1||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
3622844|NCT02650921|3471755|B1||4 (Very severe loss of fatty tissue)|Hand Grading Scale - Fellow Hand|Hand grading scale assessed by the Blinded evaluator|Participants|Count of Participants|28|28.0||||||
3622845|NCT02650921|3471755|B1||3 (Severe loss of fatty tissue)|Hand Grading Scale - Fellow Hand|Hand grading scale assessed by the Blinded evaluator|Participants|Count of Participants|39|39.0||||||
3622846|NCT02650921|3471755|B1||2 (Moderate loss of fatty tissue)|Hand Grading Scale - Fellow Hand|Hand grading scale assessed by the Blinded evaluator|Participants|Count of Participants|18|18.0||||||
3622847|NCT02650921|3471755|B1||1 (Mild loss of fatty tissue)|Hand Grading Scale - Fellow Hand|Hand grading scale assessed by the Blinded evaluator|Participants|Count of Participants|0|0.0||||||
3622848|NCT02650921|3471755|B1||0 (No loss of fatty tissue)|Hand Grading Scale - Fellow Hand|Hand grading scale assessed by the Blinded evaluator|Participants|Count of Participants|0|0.0||||||
3622849|NCT02650921|3471755|B1||4 (Very severe loss of fatty tissue)|Hand Grading Scale - Treated hand|Hand grading scale assessed by the Blinded evaluator|Participants|Count of Participants|27|27.0||||||
3622850|NCT02650921|3471755|B1||3 (Severe loss of fatty tissue)|Hand Grading Scale - Treated hand|Hand grading scale assessed by the Blinded evaluator|Participants|Count of Participants|31|31.0||||||
3622851|NCT02650921|3471755|B1||2 (Moderate loss of fatty tissue)|Hand Grading Scale - Treated hand|Hand grading scale assessed by the Blinded evaluator|Participants|Count of Participants|27|27.0||||||
3622852|NCT02650921|3471755|B1||1 (Mild loss of fatty tissue)|Hand Grading Scale - Treated hand|Hand grading scale assessed by the Blinded evaluator|Participants|Count of Participants|0|0.0||||||
3622853|NCT02650921|3471755|B1||0 (No loss of fatty tissue)|Hand Grading Scale - Treated hand|Hand grading scale assessed by the Blinded evaluator|Participants|Count of Participants|0|0.0||||||
3622854|NCT02650921|3471755|B1||FST VI (Never burns, tans very easily)|Fitzpatrick Skin Type||Participants|Count of Participants|2|2.0||||||
3622855|NCT02650921|3471755|B1||FST V (Very rarely burns, tans with ease)|Fitzpatrick Skin Type||Participants|Count of Participants|7|7.0||||||
3622856|NCT02650921|3471755|B1||FST IV (Rarely burns, tans with ease)|Fitzpatrick Skin Type||Participants|Count of Participants|12|12.0||||||
3622857|NCT02650921|3471755|B1||FST III (Sometimes mild burns, gradually tans)|Fitzpatrick Skin Type||Participants|Count of Participants|39|39.0||||||
3622858|NCT02650921|3471755|B1||FST II (Usually burns, tans with difficulty)|Fitzpatrick Skin Type||Participants|Count of Participants|21|21.0||||||
3622859|NCT02650921|3471755|B1||FST I (Always burns, never tans)|Fitzpatrick Skin Type||Participants|Count of Participants|4|4.0||||||
3622860|NCT02650921|3471755|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622861|NCT02650921|3471755|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3622862|NCT02650921|3471755|B1||White|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3622863|NCT02650921|3471755|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3622864|NCT02650921|3471755|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3622865|NCT02650921|3471755|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622866|NCT02650921|3471755|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622867|NCT02650921|3471755|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3622868|NCT02650921|3471755|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3622869|NCT02650921|3471755|B1|||Age||years|Mean|55.7|55.7|Standard Deviation|9.13|9.13|||
3622870|NCT02650440|3471803|B3|Brazil||Region of Enrollment||participants|Number|18|18.0||||||
3622871|NCT02650440|3471804|B2|Brazil||Region of Enrollment||participants|Number|8|8.0||||||
3622872|NCT02650440|3471805|B1|Brazil||Region of Enrollment||participants|Number|10|10.0||||||
3622873|NCT02650440|3471803|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3622874|NCT02650440|3471804|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3622875|NCT02650440|3471805|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3622876|NCT02650440|3471803|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3622877|NCT02650440|3471804|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3622878|NCT02650440|3471805|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3622879|NCT02650440|3471803|B3|||Age||years|Mean|50.6|50.6|Standard Deviation|14.3|14.3|||
3622880|NCT02650440|3471804|B2|||Age||years|Mean|59.3|59.3|Standard Deviation|13.8|13.8|||
3622881|NCT02650440|3471805|B1|||Age||years|Mean|50.6|50.6|Standard Deviation|14.4|14.4|||
3622882|NCT02650440|3471803|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3622883|NCT02650440|3471804|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3622884|NCT02650440|3471805|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3622885|NCT02650440|3471803|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3622886|NCT02650440|3471804|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3622887|NCT02650440|3471805|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3622888|NCT02650440|3471803|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3622889|NCT02650440|3471804|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3622890|NCT02650440|3471805|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3622891|NCT02650219|3471822|B3|France||Region of Enrollment||participants|Number|60|60.0||||||
3622892|NCT02650219|3471823|B2|France||Region of Enrollment||participants|Number|20|20.0||||||
3622893|NCT02650219|3471824|B1|France||Region of Enrollment||participants|Number|40|40.0||||||
3622894|NCT02650219|3471822|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3622895|NCT02650219|3471823|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3622896|NCT02650219|3471824|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3622897|NCT02650219|3471822|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3622898|NCT02650219|3471823|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3622899|NCT02650219|3471824|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3622900|NCT02650219|3471822|B3|||Age||YEARS|Mean|50.7|50.7|Standard Deviation|14.2|14.2|||
3622901|NCT02650219|3471823|B2|||Age||YEARS|Mean|47.3|47.3|Standard Deviation|15.4|15.4|||
3622902|NCT02650219|3471824|B1|||Age||YEARS|Mean|52.4|52.4|Standard Deviation|13.4|13.4|||
3622903|NCT02650219|3471822|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3622904|NCT02650219|3471823|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3622905|NCT02650219|3471824|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3622906|NCT02650219|3471822|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
3622907|NCT02650219|3471823|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3622908|NCT02650219|3471824|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3622909|NCT02650219|3471822|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3622910|NCT02650219|3471823|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3622911|NCT02650219|3471824|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3622912|NCT02650193|3471835|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622913|NCT02650193|3471836|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622914|NCT02650193|3471837|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622915|NCT02650193|3471838|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622916|NCT02650193|3471835|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622917|NCT02650193|3471836|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622918|NCT02650193|3471837|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622919|NCT02650193|3471838|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622920|NCT02650193|3471835|B4||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3622921|NCT02650193|3471836|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3622922|NCT02650193|3471837|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3622923|NCT02650193|3471838|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3622924|NCT02650193|3471835|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622925|NCT02650193|3471836|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622926|NCT02650193|3471837|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622927|NCT02650193|3471838|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622928|NCT02650193|3471835|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622929|NCT02650193|3471836|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622930|NCT02650193|3471837|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622931|NCT02650193|3471838|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622932|NCT02650193|3471835|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3622933|NCT02650193|3471836|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622934|NCT02650193|3471837|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622935|NCT02650193|3471838|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3622936|NCT02650193|3471835|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622937|NCT02650193|3471836|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622938|NCT02650193|3471837|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622939|NCT02650193|3471838|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622940|NCT02650193|3471835|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3622941|NCT02650193|3471836|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3622942|NCT02650193|3471837|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3622943|NCT02650193|3471838|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622944|NCT02650193|3471835|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3622945|NCT02650193|3471836|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3622946|NCT02650193|3471837|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3622947|NCT02650193|3471838|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3622948|NCT02650193|3471835|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622949|NCT02650193|3471836|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622950|NCT02650193|3471837|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622951|NCT02650193|3471838|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622952|NCT02650193|3471835|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3622953|NCT02650193|3471836|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3622954|NCT02650193|3471837|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3622955|NCT02650193|3471838|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3622956|NCT02650193|3471835|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3622957|NCT02650193|3471836|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3622958|NCT02650193|3471837|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3622959|NCT02650193|3471838|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3622960|NCT02650193|3471835|B4|||Age||years|Mean|59.3|59.3|Standard Deviation|10.93|10.93|||
3622961|NCT02650193|3471836|B3|||Age||years|Mean|55.1|55.1|Standard Deviation|8.95|8.95|||
3622962|NCT02650193|3471837|B2|||Age||years|Mean|60.8|60.8|Standard Deviation|13.60|13.6|||
3622963|NCT02650193|3471838|B1|||Age||years|Mean|66.8|66.8|Standard Deviation|8.89|8.89|||
3622964|NCT02650128|3471927|B1|France||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3622965|NCT02650128|3471927|B1|Australia||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3622966|NCT02650128|3471927|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3622967|NCT02650128|3471927|B1|Sweden||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3622968|NCT02650128|3471927|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3622969|NCT02650128|3471927|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3622970|NCT02650128|3471927|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622971|NCT02650128|3471927|B1||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3622972|NCT02650128|3471927|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3622973|NCT02650128|3471927|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622974|NCT02650128|3471927|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3622975|NCT02650128|3471927|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3622976|NCT02650128|3471927|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3622977|NCT02650128|3471927|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3622978|NCT02650128|3471927|B1||>=65 years|Age||Participants|Count of Participants|47|47.0||||||
3622979|NCT02650128|3471927|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3622980|NCT02650128|3471927|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3622981|NCT02649634|3471934|B3|||Self-efficacy Related to Eating Patterns (WEL) - global score|The Weight Efficacy Lifestyle Questionnaire (WEL) is a 20-item measure that yields 5 subscale scores which rate self-efficacy for controlling eating in different dimensions: negative emotions, availability, social pressure, physical discomfort, and positive activities. A global/total score (which ranges from 0 - 180) is obtained by summing the scores of each of the five subscales. Higher scores are indicative of greater self-efficacy (i.e., higher scores = better outcome).|units on a scale|Mean|119.82|119.82|Standard Deviation|32.63|32.63|||
3622982|NCT02649634|3471935|B2|||Self-efficacy Related to Eating Patterns (WEL) - global score|The Weight Efficacy Lifestyle Questionnaire (WEL) is a 20-item measure that yields 5 subscale scores which rate self-efficacy for controlling eating in different dimensions: negative emotions, availability, social pressure, physical discomfort, and positive activities. A global/total score (which ranges from 0 - 180) is obtained by summing the scores of each of the five subscales. Higher scores are indicative of greater self-efficacy (i.e., higher scores = better outcome).|units on a scale|Mean|117.87|117.87|Standard Deviation|33.79|33.79|||
3622983|NCT02649634|3471936|B1|||Self-efficacy Related to Eating Patterns (WEL) - global score|The Weight Efficacy Lifestyle Questionnaire (WEL) is a 20-item measure that yields 5 subscale scores which rate self-efficacy for controlling eating in different dimensions: negative emotions, availability, social pressure, physical discomfort, and positive activities. A global/total score (which ranges from 0 - 180) is obtained by summing the scores of each of the five subscales. Higher scores are indicative of greater self-efficacy (i.e., higher scores = better outcome).|units on a scale|Mean|121.68|121.68|Standard Deviation|31.63|31.63|||
3623052|NCT02648204|3472109|B3|||Fasting plasma glucose||mmol/L|Mean|9.7|9.7|Standard Deviation|2.65|2.65|||
3622984|NCT02649634|3471934|B3|||Self-efficacy for Engaging in Physical Activity (ESE)|The Exercise Self-Efficacy Scale (ESE), is a six-item measure that assessed self-efficacy for engaging in physical activity. Participants rated their confidence that they could exercise on a 5-point Likert scale for six barriers to exercise (e.g., bad weather, stress, availability of equipment). Scores range from 1 - 5. Higher scores are indicative of greater self-efficacy (i.e., higher scores = better outcome).|units on a scale|Mean|2.84|2.84|Standard Deviation|0.84|0.84|||
3622985|NCT02649634|3471935|B2|||Self-efficacy for Engaging in Physical Activity (ESE)|The Exercise Self-Efficacy Scale (ESE), is a six-item measure that assessed self-efficacy for engaging in physical activity. Participants rated their confidence that they could exercise on a 5-point Likert scale for six barriers to exercise (e.g., bad weather, stress, availability of equipment). Scores range from 1 - 5. Higher scores are indicative of greater self-efficacy (i.e., higher scores = better outcome).|units on a scale|Mean|2.83|2.83|Standard Deviation|0.88|0.88|||
3622986|NCT02649634|3471936|B1|||Self-efficacy for Engaging in Physical Activity (ESE)|The Exercise Self-Efficacy Scale (ESE), is a six-item measure that assessed self-efficacy for engaging in physical activity. Participants rated their confidence that they could exercise on a 5-point Likert scale for six barriers to exercise (e.g., bad weather, stress, availability of equipment). Scores range from 1 - 5. Higher scores are indicative of greater self-efficacy (i.e., higher scores = better outcome).|units on a scale|Mean|2.84|2.84|Standard Deviation|0.81|0.81|||
3622987|NCT02649634|3471934|B3|||Eating Disorder Symptomology (EDEQ) - global score|Measured by the Eating Disorder Examination Questionnaire (EDEQ). The EDEQ is a 36-item self-report rating scale, which assesses the presence and degree of specific psychopathology associated with eating disorders over the previous 28 days. Consists of a global score as well as four subscales: Eating Concern, Restraint, Shape Concern, and Weight Concern. The global score is obtained by summing the subscale scores and then dividing this sum by the number of subscales (i.e. four). Range is 0 - 6. Higher scores are indicative of greater eating disorder symptomatology (i.e., worse outcome).|units on a scale|Mean|2.30|2.3|Standard Deviation|0.99|0.99|||
3622988|NCT02649634|3471935|B2|||Eating Disorder Symptomology (EDEQ) - global score|Measured by the Eating Disorder Examination Questionnaire (EDEQ). The EDEQ is a 36-item self-report rating scale, which assesses the presence and degree of specific psychopathology associated with eating disorders over the previous 28 days. Consists of a global score as well as four subscales: Eating Concern, Restraint, Shape Concern, and Weight Concern. The global score is obtained by summing the subscale scores and then dividing this sum by the number of subscales (i.e. four). Range is 0 - 6. Higher scores are indicative of greater eating disorder symptomatology (i.e., worse outcome).|units on a scale|Mean|2.34|2.34|Standard Deviation|0.90|0.9|||
3622989|NCT02649634|3471936|B1|||Eating Disorder Symptomology (EDEQ) - global score|Measured by the Eating Disorder Examination Questionnaire (EDEQ). The EDEQ is a 36-item self-report rating scale, which assesses the presence and degree of specific psychopathology associated with eating disorders over the previous 28 days. Consists of a global score as well as four subscales: Eating Concern, Restraint, Shape Concern, and Weight Concern. The global score is obtained by summing the subscale scores and then dividing this sum by the number of subscales (i.e. four). Range is 0 - 6. Higher scores are indicative of greater eating disorder symptomatology (i.e., worse outcome).|units on a scale|Mean|2.27|2.27|Standard Deviation|1.08|1.08|||
3622990|NCT02649634|3471934|B3|Diastolic||Blood Pressure||mmHg|Mean|78|78.0|Standard Deviation|10.18|10.18|||
3622991|NCT02649634|3471935|B2|Diastolic||Blood Pressure||mmHg|Mean|78|78.0|Standard Deviation|10.66|10.66|||
3622992|NCT02649634|3471936|B1|Diastolic||Blood Pressure||mmHg|Mean|78|78.0|Standard Deviation|9.77|9.77|||
3622993|NCT02649634|3471934|B3|Systolic||Blood Pressure||mmHg|Mean|129|129.0|Standard Deviation|13.44|13.44|||
3622994|NCT02649634|3471935|B2|Systolic||Blood Pressure||mmHg|Mean|129|129.0|Standard Deviation|13.46|13.46|||
3622995|NCT02649634|3471936|B1|Systolic||Blood Pressure||mmHg|Mean|129|129.0|Standard Deviation|13.52|13.52|||
3622996|NCT02649634|3471934|B3|||Dietary Behaviour (DHQ) - overall score|The Fat-related Dietary Habits Questionnaire (DHQ) is a 22-item questionnaire that was used to collect information on dietary behaviours and high-fat eating patterns. The DHQ consists of an overall summary score and five subscale scores assessing different dimensions of fat-related dietary habits. The overall summary score is the mean of all non-missing subscales scores. Responses are scored on a 4-point scale (usually, often, sometimes, rarely/never). Range of overall summary score is 1 - 4. Higher scores correspond to higher fat intakes (i.e., higher scores = worse outcome).|units on a scale|Mean|2.84|2.84|Standard Deviation|0.46|0.46|||
3622997|NCT02649634|3471935|B2|||Dietary Behaviour (DHQ) - overall score|The Fat-related Dietary Habits Questionnaire (DHQ) is a 22-item questionnaire that was used to collect information on dietary behaviours and high-fat eating patterns. The DHQ consists of an overall summary score and five subscale scores assessing different dimensions of fat-related dietary habits. The overall summary score is the mean of all non-missing subscales scores. Responses are scored on a 4-point scale (usually, often, sometimes, rarely/never). Range of overall summary score is 1 - 4. Higher scores correspond to higher fat intakes (i.e., higher scores = worse outcome).|units on a scale|Mean|2.78|2.78|Standard Deviation|0.44|0.44|||
3622998|NCT02649634|3471936|B1|||Dietary Behaviour (DHQ) - overall score|The Fat-related Dietary Habits Questionnaire (DHQ) is a 22-item questionnaire that was used to collect information on dietary behaviours and high-fat eating patterns. The DHQ consists of an overall summary score and five subscale scores assessing different dimensions of fat-related dietary habits. The overall summary score is the mean of all non-missing subscales scores. Responses are scored on a 4-point scale (usually, often, sometimes, rarely/never). Range of overall summary score is 1 - 4. Higher scores correspond to higher fat intakes (i.e., higher scores = worse outcome).|units on a scale|Mean|2.90|2.9|Standard Deviation|0.47|0.47|||
3622999|NCT02649634|3471934|B3|||Physical Activity (PPAQ)|The Paffenbarger questionnaire (PPAQ) assesses amount of planned and lifestyle associated physical activity performed during a typical week. The PPAQ consists of three components: (1) stair climbing, (2) walking, and (3) sports and recreation. Participants report the frequency and duration of physical activity in the past week. Scoring yields energy expenditure from physical activity per week (kcal/kg/week). Higher scores translate into greater energy expenditure per week (i.e.,better outcome). Range is 0 - no theoretical maximum. Highest observed score in our study was 10902 kcal/kg/week.|kilocalories per week|Mean|1384.93|1384.93|Standard Deviation|1213.04|1213.04|||
3623172|NCT02648022|3472232|B3|Grade 9 to 11||Education||participants|Number|4|4.0||||||
3623000|NCT02649634|3471935|B2|||Physical Activity (PPAQ)|The Paffenbarger questionnaire (PPAQ) assesses amount of planned and lifestyle associated physical activity performed during a typical week. The PPAQ consists of three components: (1) stair climbing, (2) walking, and (3) sports and recreation. Participants report the frequency and duration of physical activity in the past week. Scoring yields energy expenditure from physical activity per week (kcal/kg/week). Higher scores translate into greater energy expenditure per week (i.e.,better outcome). Range is 0 - no theoretical maximum. Highest observed score in our study was 10902 kcal/kg/week.|kilocalories per week|Mean|1183.37|1183.37|Standard Deviation|1106.95|1106.95|||
3623001|NCT02649634|3471936|B1|||Physical Activity (PPAQ)|The Paffenbarger questionnaire (PPAQ) assesses amount of planned and lifestyle associated physical activity performed during a typical week. The PPAQ consists of three components: (1) stair climbing, (2) walking, and (3) sports and recreation. Participants report the frequency and duration of physical activity in the past week. Scoring yields energy expenditure from physical activity per week (kcal/kg/week). Higher scores translate into greater energy expenditure per week (i.e.,better outcome). Range is 0 - no theoretical maximum. Highest observed score in our study was 10902 kcal/kg/week.|kilocalories per week|Mean|1574.46|1574.46|Standard Deviation|1284.43|1284.43|||
3623002|NCT02649634|3471934|B3|||BMI||kg/m^2|Mean|33.58|33.58|Standard Deviation|6.26|6.26|||
3623003|NCT02649634|3471935|B2|||BMI||kg/m^2|Mean|33.37|33.37|Standard Deviation|6.58|6.58|||
3623004|NCT02649634|3471936|B1|||BMI||kg/m^2|Mean|33.78|33.78|Standard Deviation|5.98|5.98|||
3623005|NCT02649634|3471934|B3|||Weight||kilograms|Mean|92.78|92.78|Standard Deviation|20.57|20.57|||
3623006|NCT02649634|3471935|B2|||Weight||kilograms|Mean|90.34|90.34|Standard Deviation|19.46|19.46|||
3623007|NCT02649634|3471936|B1|||Weight||kilograms|Mean|95.11|95.11|Standard Deviation|21.45|21.45|||
3623008|NCT02649634|3471934|B3|Canada||Region of Enrollment||participants|Number|135|135.0||||||
3623009|NCT02649634|3471935|B2|Canada||Region of Enrollment||participants|Number|66|66.0||||||
3623010|NCT02649634|3471936|B1|Canada||Region of Enrollment||participants|Number|69|69.0||||||
3623011|NCT02649634|3471934|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3623012|NCT02649634|3471935|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3623013|NCT02649634|3471936|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3623014|NCT02649634|3471934|B3||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3623015|NCT02649634|3471935|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3623016|NCT02649634|3471936|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3623017|NCT02649634|3471934|B3|||Age||years|Mean|45.16|45.16|Standard Deviation|11.30|11.3|||
3623018|NCT02649634|3471935|B2|||Age||years|Mean|44.67|44.67|Standard Deviation|12.91|12.91|||
3623019|NCT02649634|3471936|B1|||Age||years|Mean|45.56|45.56|Standard Deviation|9.78|9.78|||
3623020|NCT02648646|3471993|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3623021|NCT02648646|3471993|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3623022|NCT02648646|3471993|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3623023|NCT02648646|3471993|B1|||Age||years|Median|71.3|71.3|Full Range|||65.4|79.9|
3623024|NCT02648646|3471993|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3623025|NCT02648646|3471993|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3623026|NCT02648646|3471993|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3623027|NCT02648438|3472041|B4|Male||Sex/Gender, Customized||Participants|Number|30|30.0||||||
3623028|NCT02648438|3472042|B3|Male||Sex/Gender, Customized||Participants|Number|6|6.0||||||
3623029|NCT02648438|3472043|B2|Male||Sex/Gender, Customized||Participants|Number|12|12.0||||||
3623030|NCT02648438|3472044|B1|Male||Sex/Gender, Customized||Participants|Number|12|12.0||||||
3623031|NCT02648438|3472041|B4|||Age||Years|Mean|32.9|32.9|Standard Deviation|5.56|5.56|||
3623032|NCT02648438|3472042|B3|||Age||Years|Mean|35.5|35.5|Standard Deviation|2.88|2.88|||
3623033|NCT02648438|3472043|B2|||Age||Years|Mean|31.3|31.3|Standard Deviation|4.58|4.58|||
3623034|NCT02648438|3472044|B1|||Age||Years|Mean|33.3|33.3|Standard Deviation|7.07|7.07|||
3623035|NCT02648217|3472086|B3|||Fasting plasma glucose (FPG)||mmol/L|Mean|10.3|10.3|Standard Deviation|13.6|13.6|||
3623036|NCT02648217|3472087|B2|||Fasting plasma glucose (FPG)||mmol/L|Mean|10.6|10.6|Standard Deviation|16.3|16.3|||
3623037|NCT02648217|3472088|B1|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.9|9.9|Standard Deviation|10.4|10.4|||
3623038|NCT02648217|3472086|B3|||Glycated haemoglobin (HbA1c)||Percentage of HbA1c|Mean|8.5|8.5|Standard Deviation|0.9|0.9|||
3623039|NCT02648217|3472087|B2|||Glycated haemoglobin (HbA1c)||Percentage of HbA1c|Mean|8.5|8.5|Standard Deviation|0.9|0.9|||
3623040|NCT02648217|3472088|B1|||Glycated haemoglobin (HbA1c)||Percentage of HbA1c|Mean|8.5|8.5|Standard Deviation|0.9|0.9|||
3623041|NCT02648217|3472086|B3||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3623042|NCT02648217|3472087|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3623043|NCT02648217|3472088|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3623044|NCT02648217|3472086|B3||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3623045|NCT02648217|3472087|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3623046|NCT02648217|3472088|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3623047|NCT02648217|3472086|B3|||Age||Years|Mean|55.1|55.1|Standard Deviation|9.5|9.5|||
3623048|NCT02648217|3472087|B2|||Age||Years|Mean|55.3|55.3|Standard Deviation|9.2|9.2|||
3623049|NCT02648217|3472088|B1|||Age||Years|Mean|54.9|54.9|Standard Deviation|9.8|9.8|||
3623050|NCT02648204|3472107|B5|||Fasting plasma glucose||mmol/L|Mean|9.7|9.7|Standard Deviation|2.52|2.52|||
3623051|NCT02648204|3472108|B4|||Fasting plasma glucose||mmol/L|Mean|9.6|9.6|Standard Deviation|2.29|2.29|||
3623053|NCT02648204|3472110|B2|||Fasting plasma glucose||mmol/L|Mean|9.8|9.8|Standard Deviation|2.58|2.58|||
3623054|NCT02648204|3472111|B1|||Fasting plasma glucose||mmol/L|Mean|9.8|9.8|Standard Deviation|2.54|2.54|||
3623055|NCT02648204|3472107|B5|||Body weight||kg|Mean|95.2|95.2|Standard Deviation|22.56|22.56|||
3623056|NCT02648204|3472108|B4|||Body weight||kg|Mean|93.4|93.4|Standard Deviation|21.79|21.79|||
3623057|NCT02648204|3472109|B3|||Body weight||kg|Mean|95.6|95.6|Standard Deviation|23.01|23.01|||
3623058|NCT02648204|3472110|B2|||Body weight||kg|Mean|95.5|95.5|Standard Deviation|20.90|20.9|||
3623059|NCT02648204|3472111|B1|||Body weight||kg|Mean|96.4|96.4|Standard Deviation|24.38|24.38|||
3623060|NCT02648204|3472107|B5|||Glycosylated haemoglobin (Hb1Ac)||percentage of HbA1c|Mean|8.2|8.2|Standard Deviation|0.92|0.92|||
3623061|NCT02648204|3472108|B4|||Glycosylated haemoglobin (Hb1Ac)||percentage of HbA1c|Mean|8.2|8.2|Standard Deviation|0.89|0.89|||
3623062|NCT02648204|3472109|B3|||Glycosylated haemoglobin (Hb1Ac)||percentage of HbA1c|Mean|8.2|8.2|Standard Deviation|0.91|0.91|||
3623063|NCT02648204|3472110|B2|||Glycosylated haemoglobin (Hb1Ac)||percentage of HbA1c|Mean|8.2|8.2|Standard Deviation|0.92|0.92|||
3623064|NCT02648204|3472111|B1|||Glycosylated haemoglobin (Hb1Ac)||percentage of HbA1c|Mean|8.3|8.3|Standard Deviation|0.96|0.96|||
3623065|NCT02648204|3472107|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3623066|NCT02648204|3472108|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3623067|NCT02648204|3472109|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3623068|NCT02648204|3472110|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3623069|NCT02648204|3472111|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3623070|NCT02648204|3472107|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623071|NCT02648204|3472108|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623072|NCT02648204|3472109|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623073|NCT02648204|3472110|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623074|NCT02648204|3472111|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623075|NCT02648204|3472107|B5||White|Race (NIH/OMB)||Participants|Count of Participants|928|928.0||||||
3623076|NCT02648204|3472108|B4||White|Race (NIH/OMB)||Participants|Count of Participants|220|220.0||||||
3623077|NCT02648204|3472109|B3||White|Race (NIH/OMB)||Participants|Count of Participants|232|232.0||||||
3623078|NCT02648204|3472110|B2||White|Race (NIH/OMB)||Participants|Count of Participants|243|243.0||||||
3623079|NCT02648204|3472111|B1||White|Race (NIH/OMB)||Participants|Count of Participants|233|233.0||||||
3623080|NCT02648204|3472107|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3623081|NCT02648204|3472108|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3623082|NCT02648204|3472109|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3623083|NCT02648204|3472110|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3623084|NCT02648204|3472111|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3623085|NCT02648204|3472107|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623086|NCT02648204|3472108|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623087|NCT02648204|3472109|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623088|NCT02648204|3472110|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623089|NCT02648204|3472111|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623090|NCT02648204|3472107|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|191|191.0||||||
3623091|NCT02648204|3472108|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3623092|NCT02648204|3472109|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3623093|NCT02648204|3472110|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3623094|NCT02648204|3472111|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3623095|NCT02648204|3472107|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623096|NCT02648204|3472108|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623097|NCT02648204|3472109|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623098|NCT02648204|3472110|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623099|NCT02648204|3472111|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623100|NCT02648204|3472107|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623101|NCT02648204|3472108|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623102|NCT02648204|3472109|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623103|NCT02648204|3472110|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623104|NCT02648204|3472111|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623105|NCT02648204|3472107|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1061|1061.0||||||
3623106|NCT02648204|3472108|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|256|256.0||||||
3623107|NCT02648204|3472109|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|268|268.0||||||
3623108|NCT02648204|3472110|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|265|265.0||||||
3623109|NCT02648204|3472111|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|272|272.0||||||
3623110|NCT02648204|3472107|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
3623111|NCT02648204|3472108|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3623112|NCT02648204|3472109|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3623113|NCT02648204|3472110|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3623114|NCT02648204|3472111|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3623115|NCT02648204|3472107|B5||Male|Sex: Female, Male||Participants|Count of Participants|537|537.0||||||
3623116|NCT02648204|3472108|B4||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3623117|NCT02648204|3472109|B3||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3623118|NCT02648204|3472110|B2||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3623119|NCT02648204|3472111|B1||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3623120|NCT02648204|3472107|B5||Female|Sex: Female, Male||Participants|Count of Participants|662|662.0||||||
3623121|NCT02648204|3472108|B4||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3623122|NCT02648204|3472109|B3||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3623123|NCT02648204|3472110|B2||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3623124|NCT02648204|3472111|B1||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3623125|NCT02648204|3472107|B5|||Age||years|Mean|56|56.0|Standard Deviation|10.6|10.6|||
3623126|NCT02648204|3472108|B4|||Age||years|Mean|56|56.0|Standard Deviation|10.6|10.6|||
3623127|NCT02648204|3472109|B3|||Age||years|Mean|55|55.0|Standard Deviation|10.4|10.4|||
3623128|NCT02648204|3472110|B2|||Age||years|Mean|55|55.0|Standard Deviation|10.6|10.6|||
3623129|NCT02648204|3472111|B1|||Age||years|Mean|56|56.0|Standard Deviation|10.9|10.9|||
3623130|NCT02648022|3472232|B3|||BMI||Kilograms/m2|Mean|28.8|28.8|Standard Deviation|5.5|5.5|||
3623131|NCT02648022|3472233|B2|||BMI||Kilograms/m2|Mean|28.6|28.6|Standard Deviation|5.3|5.3|||
3623132|NCT02648022|3472234|B1|||BMI||Kilograms/m2|Mean|29.0|29.0|Standard Deviation|5.8|5.8|||
3623133|NCT02648022|3472232|B3|Not Homeless||Homeless in last 5 years||participants|Number|33|33.0||||||
3623134|NCT02648022|3472233|B2|Not Homeless||Homeless in last 5 years||participants|Number|14|14.0||||||
3623135|NCT02648022|3472234|B1|Not Homeless||Homeless in last 5 years||participants|Number|19|19.0||||||
3623136|NCT02648022|3472232|B3|Missing||Homeless in last 5 years||participants|Number|8|8.0||||||
3623137|NCT02648022|3472233|B2|Missing||Homeless in last 5 years||participants|Number|5|5.0||||||
3623138|NCT02648022|3472234|B1|Missing||Homeless in last 5 years||participants|Number|3|3.0||||||
3623139|NCT02648022|3472232|B3|Homeless in the last 5 years||Homeless in last 5 years||participants|Number|38|38.0||||||
3623140|NCT02648022|3472233|B2|Homeless in the last 5 years||Homeless in last 5 years||participants|Number|20|20.0||||||
3623141|NCT02648022|3472234|B1|Homeless in the last 5 years||Homeless in last 5 years||participants|Number|18|18.0||||||
3623142|NCT02648022|3472232|B3|Missing||Employment||participants|Number|2|2.0||||||
3623143|NCT02648022|3472233|B2|Missing||Employment||participants|Number|1|1.0||||||
3623144|NCT02648022|3472234|B1|Missing||Employment||participants|Number|1|1.0||||||
3623145|NCT02648022|3472232|B3|Retired or Volunteer||Employment||participants|Number|11|11.0||||||
3623146|NCT02648022|3472233|B2|Retired or Volunteer||Employment||participants|Number|4|4.0||||||
3623147|NCT02648022|3472234|B1|Retired or Volunteer||Employment||participants|Number|7|7.0||||||
3623148|NCT02648022|3472232|B3|Disabled||Employment||participants|Number|29|29.0||||||
3623149|NCT02648022|3472233|B2|Disabled||Employment||participants|Number|14|14.0||||||
3623150|NCT02648022|3472234|B1|Disabled||Employment||participants|Number|15|15.0||||||
3623151|NCT02648022|3472232|B3|Unemployed||Employment||participants|Number|28|28.0||||||
3623152|NCT02648022|3472233|B2|Unemployed||Employment||participants|Number|15|15.0||||||
3623153|NCT02648022|3472234|B1|Unemployed||Employment||participants|Number|13|13.0||||||
3623154|NCT02648022|3472232|B3|Full and Part time||Employment||participants|Number|9|9.0||||||
3623155|NCT02648022|3472233|B2|Full and Part time||Employment||participants|Number|5|5.0||||||
3623156|NCT02648022|3472234|B1|Full and Part time||Employment||participants|Number|4|4.0||||||
3623157|NCT02648022|3472232|B3|Missing||Education||participants|Number|6|6.0||||||
3623158|NCT02648022|3472233|B2|Missing||Education||participants|Number|3|3.0||||||
3623159|NCT02648022|3472234|B1|Missing||Education||participants|Number|3|3.0||||||
3623160|NCT02648022|3472232|B3|Post Grad||Education||participants|Number|1|1.0||||||
3623161|NCT02648022|3472233|B2|Post Grad||Education||participants|Number|1|1.0||||||
3623162|NCT02648022|3472234|B1|Post Grad||Education||participants|Number|0|0.0||||||
3623163|NCT02648022|3472232|B3|College Grad||Education||participants|Number|6|6.0||||||
3623164|NCT02648022|3472233|B2|College Grad||Education||participants|Number|4|4.0||||||
3623165|NCT02648022|3472234|B1|College Grad||Education||participants|Number|2|2.0||||||
3623166|NCT02648022|3472232|B3|Some College||Education||participants|Number|43|43.0||||||
3623167|NCT02648022|3472233|B2|Some College||Education||participants|Number|22|22.0||||||
3623168|NCT02648022|3472234|B1|Some College||Education||participants|Number|21|21.0||||||
3623169|NCT02648022|3472232|B3|High school/GED||Education||participants|Number|18|18.0||||||
3623170|NCT02648022|3472233|B2|High school/GED||Education||participants|Number|6|6.0||||||
3623171|NCT02648022|3472234|B1|High school/GED||Education||participants|Number|12|12.0||||||
3623173|NCT02648022|3472233|B2|Grade 9 to 11||Education||participants|Number|2|2.0||||||
3623174|NCT02648022|3472234|B1|Grade 9 to 11||Education||participants|Number|2|2.0||||||
3623175|NCT02648022|3472232|B3|Grade 1 to 8||Education||participants|Number|1|1.0||||||
3623176|NCT02648022|3472233|B2|Grade 1 to 8||Education||participants|Number|1|1.0||||||
3623177|NCT02648022|3472234|B1|Grade 1 to 8||Education||participants|Number|0|0.0||||||
3623178|NCT02648022|3472232|B3|Missing||Marital Status||participants|Number|1|1.0||||||
3623179|NCT02648022|3472233|B2|Missing||Marital Status||participants|Number|1|1.0||||||
3623180|NCT02648022|3472234|B1|Missing||Marital Status||participants|Number|0|0.0||||||
3623181|NCT02648022|3472232|B3|Separated or Divorced||Marital Status||participants|Number|33|33.0||||||
3623182|NCT02648022|3472233|B2|Separated or Divorced||Marital Status||participants|Number|15|15.0||||||
3623183|NCT02648022|3472234|B1|Separated or Divorced||Marital Status||participants|Number|18|18.0||||||
3623184|NCT02648022|3472232|B3|Married or widowed||Marital Status||participants|Number|25|25.0||||||
3623185|NCT02648022|3472233|B2|Married or widowed||Marital Status||participants|Number|14|14.0||||||
3623186|NCT02648022|3472234|B1|Married or widowed||Marital Status||participants|Number|11|11.0||||||
3623187|NCT02648022|3472232|B3|Single||Marital Status||participants|Number|20|20.0||||||
3623188|NCT02648022|3472233|B2|Single||Marital Status||participants|Number|9|9.0||||||
3623189|NCT02648022|3472234|B1|Single||Marital Status||participants|Number|11|11.0||||||
3623190|NCT02648022|3472232|B3|United States||Region of Enrollment||participants|Number|79|79.0||||||
3623191|NCT02648022|3472233|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
3623192|NCT02648022|3472234|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3623193|NCT02648022|3472232|B3|White||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
3623194|NCT02648022|3472233|B2|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3623195|NCT02648022|3472234|B1|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3623196|NCT02648022|3472232|B3|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3623197|NCT02648022|3472233|B2|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3623198|NCT02648022|3472234|B1|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3623199|NCT02648022|3472232|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3623200|NCT02648022|3472233|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3623201|NCT02648022|3472234|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3623202|NCT02648022|3472232|B3|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3623203|NCT02648022|3472233|B2|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3623204|NCT02648022|3472234|B1|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3623205|NCT02648022|3472232|B3|African American or Black||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3623206|NCT02648022|3472233|B2|African American or Black||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3623207|NCT02648022|3472234|B1|African American or Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3623208|NCT02648022|3472232|B3|Male||Gender|Gender data was not collected from 4 participants.|participants|Number|75|75.0||||||
3623209|NCT02648022|3472233|B2|Male||Gender|Gender data was not collected from 4 participants.|participants|Number|38|38.0||||||
3623210|NCT02648022|3472234|B1|Male||Gender|Gender data was not collected from 4 participants.|participants|Number|37|37.0||||||
3623211|NCT02648022|3472232|B3|Female||Gender|Gender data was not collected from 4 participants.|participants|Number|0|0.0||||||
3623212|NCT02648022|3472233|B2|Female||Gender|Gender data was not collected from 4 participants.|participants|Number|0|0.0||||||
3623213|NCT02648022|3472234|B1|Female||Gender|Gender data was not collected from 4 participants.|participants|Number|0|0.0||||||
3623214|NCT02648022|3472232|B3|||Age||years|Mean|55.7|55.7|Standard Deviation|8.4|8.4|||
3623215|NCT02648022|3472233|B2|||Age||years|Mean|57.4|57.4|Standard Deviation|7.7|7.7|||
3623216|NCT02648022|3472234|B1|||Age||years|Mean|54.0|54.0|Standard Deviation|8.7|8.7|||
3623217|NCT02647944|3472245|B3|||Body Weight||kg|Mean|103|103.0|Inter-Quartile Range|||90.0|111.5|
3623218|NCT02647944|3472246|B2|||Body Weight||kg|Mean|99.1|99.1|Inter-Quartile Range|||90.1|111.2|
3623219|NCT02647944|3472247|B1|||Body Weight||kg|Mean|103.7|103.7|Inter-Quartile Range|||90.0|112.2|
3623220|NCT02647944|3472245|B3|||Body Mass Index (BMI)||kg/m^2|Mean|36.65|36.65|Inter-Quartile Range|||33.5|39.5|
3623221|NCT02647944|3472246|B2|||Body Mass Index (BMI)||kg/m^2|Mean|34.6|34.6|Inter-Quartile Range|||33.4|38.9|
3623222|NCT02647944|3472247|B1|||Body Mass Index (BMI)||kg/m^2|Mean|37.2|37.2|Inter-Quartile Range|||33.6|41.0|
3623223|NCT02647944|3472245|B3|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3623224|NCT02647944|3472246|B2|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3623225|NCT02647944|3472247|B1|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3623226|NCT02647944|3472245|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3623227|NCT02647944|3472246|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623228|NCT02647944|3472247|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3623229|NCT02647944|3472245|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3623230|NCT02647944|3472246|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3623231|NCT02647944|3472247|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623232|NCT02647944|3472245|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3623233|NCT02647944|3472246|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623234|NCT02647944|3472247|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3623235|NCT02647944|3472245|B3|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3623236|NCT02647944|3472246|B2|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3623237|NCT02647944|3472247|B1|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3623238|NCT02647944|3472245|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3623239|NCT02647944|3472246|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3623240|NCT02647944|3472247|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3623241|NCT02647944|3472245|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3623242|NCT02647944|3472246|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3623243|NCT02647944|3472247|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3623244|NCT02647944|3472245|B3|||Age||years|Mean|39.30|39.3|Standard Deviation|11.61|11.61|||
3623245|NCT02647944|3472246|B2|||Age||years|Mean|37.81|37.81|Standard Deviation|12.14|12.14|||
3623246|NCT02647944|3472247|B1|||Age||years|Mean|40.95|40.95|Standard Deviation|11.08|11.08|||
3623247|NCT02647905|3472272|B1|Hypoglycemia||History of||Participants|Count of Participants|1|1.0||||||
3623248|NCT02647905|3472272|B1|Ketoacidosis||History of||Participants|Count of Participants|0|0.0||||||
3623249|NCT02647905|3472272|B1||Other|Type of insulin therapy||Participants|Count of Participants|3|3.0||||||
3623250|NCT02647905|3472272|B1||continuous insulin infusion pump|Type of insulin therapy||Participants|Count of Participants|43|43.0||||||
3623251|NCT02647905|3472272|B1||Multiple daily injections|Type of insulin therapy||Participants|Count of Participants|24|24.0||||||
3623252|NCT02647905|3472272|B1||None|Type of insulin therapy||Participants|Count of Participants|20|20.0||||||
3623253|NCT02647905|3472272|B1|Type II||Diabetes Type||Participants|Count of Participants|29|29.0||||||
3623254|NCT02647905|3472272|B1|Type I||Diabetes Type||Participants|Count of Participants|61|61.0||||||
3623255|NCT02647905|3472272|B1|||Years since diabetes diagnosis||years|Mean|20.1|20.1|Standard Deviation|13.7|13.7|||
3623256|NCT02647905|3472272|B1||Obese (≥ 30)|Body mass Index||Participants|Count of Participants|41|41.0||||||
3623257|NCT02647905|3472272|B1||Overweight (≥25 and <30)|Body mass Index||Participants|Count of Participants|27|27.0||||||
3623258|NCT02647905|3472272|B1||Normal (<25 kg/m2)|Body mass Index||Participants|Count of Participants|22|22.0||||||
3623259|NCT02647905|3472272|B1||Left|Dominant Hand||Participants|Count of Participants|12|12.0||||||
3623260|NCT02647905|3472272|B1||Right|Dominant Hand||Participants|Count of Participants|78|78.0||||||
3623261|NCT02647905|3472272|B1|United States||Region of Enrollment||Participants|Count of Participants|90|90.0||||||
3623262|NCT02647905|3472272|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623263|NCT02647905|3472272|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623264|NCT02647905|3472272|B1||White|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3623265|NCT02647905|3472272|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3623266|NCT02647905|3472272|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3623267|NCT02647905|3472272|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3623268|NCT02647905|3472272|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3623269|NCT02647905|3472272|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3623270|NCT02647905|3472272|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3623271|NCT02647905|3472272|B1|||Age||years|Mean|45.1|45.1|Standard Deviation|16.2|16.2|||
3623272|NCT02647645|3472277|B3|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3623273|NCT02647645|3472278|B2|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3623274|NCT02647645|3472279|B1|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3623275|NCT02647645|3472277|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623276|NCT02647645|3472278|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623277|NCT02647645|3472279|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623278|NCT02647645|3472277|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623279|NCT02647645|3472278|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623280|NCT02647645|3472279|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623281|NCT02647645|3472277|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3623282|NCT02647645|3472278|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3623283|NCT02647645|3472279|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3623284|NCT02647645|3472277|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3623285|NCT02647645|3472278|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3623286|NCT02647645|3472279|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3623287|NCT02647645|3472277|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623288|NCT02647645|3472278|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623289|NCT02647645|3472279|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623290|NCT02647645|3472277|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623291|NCT02647645|3472278|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623292|NCT02647645|3472279|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623293|NCT02647645|3472277|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623294|NCT02647645|3472278|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623295|NCT02647645|3472279|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623296|NCT02647645|3472277|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3623297|NCT02647645|3472278|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3623298|NCT02647645|3472279|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3623299|NCT02647645|3472277|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3623300|NCT02647645|3472278|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3623301|NCT02647645|3472279|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3623302|NCT02647645|3472277|B3|||Age||years|Mean|47.52|47.52|Standard Deviation|8.68|8.68|||
3623303|NCT02647645|3472278|B2|||Age||years|Mean|48.70|48.7|Standard Deviation|7.04|7.04|||
3623304|NCT02647645|3472279|B1|||Age||years|Mean|46.45|46.45|Standard Deviation|10.16|10.16|||
3623305|NCT02647320|3472290|B6|||6. Triglycerides|Triglycerides are a type of fat found in the blood. The body uses them for energy. Some triglycerides are needed for good health. But high triglycerides might raise the risk of heart disease.|mg/dL|Mean|175.5|175.5|Standard Deviation|94.54|94.54|||
3623306|NCT02647320|3472291|B5|||6. Triglycerides|Triglycerides are a type of fat found in the blood. The body uses them for energy. Some triglycerides are needed for good health. But high triglycerides might raise the risk of heart disease.|mg/dL|Mean|184.2|184.2|Standard Deviation|91.02|91.02|||
3623307|NCT02647320|3472292|B4|||6. Triglycerides|Triglycerides are a type of fat found in the blood. The body uses them for energy. Some triglycerides are needed for good health. But high triglycerides might raise the risk of heart disease.|mg/dL|Mean|169.8|169.8|Standard Deviation|84.90|84.9|||
3623308|NCT02647320|3472293|B3|||6. Triglycerides|Triglycerides are a type of fat found in the blood. The body uses them for energy. Some triglycerides are needed for good health. But high triglycerides might raise the risk of heart disease.|mg/dL|Mean|179.6|179.6|Standard Deviation|83.39|83.39|||
3623309|NCT02647320|3472294|B2|||6. Triglycerides|Triglycerides are a type of fat found in the blood. The body uses them for energy. Some triglycerides are needed for good health. But high triglycerides might raise the risk of heart disease.|mg/dL|Mean|174.9|174.9|Standard Deviation|95.55|95.55|||
3623310|NCT02647320|3472295|B1|||6. Triglycerides|Triglycerides are a type of fat found in the blood. The body uses them for energy. Some triglycerides are needed for good health. But high triglycerides might raise the risk of heart disease.|mg/dL|Mean|165.3|165.3|Standard Deviation|114.5|114.5|||
3623311|NCT02647320|3472290|B6|||5. Non-High Density Lipoprotein-C|"Non-HDL-C is the measure of bad cholesterol in the blood, including triglycerides and LDL-C."|mg/dL|Mean|131.21|131.21|Standard Deviation|38.56|38.56|||
3623312|NCT02647320|3472291|B5|||5. Non-High Density Lipoprotein-C|"Non-HDL-C is the measure of bad cholesterol in the blood, including triglycerides and LDL-C."|mg/dL|Mean|136.1|136.1|Standard Deviation|40.69|40.69|||
3623313|NCT02647320|3472292|B4|||5. Non-High Density Lipoprotein-C|"Non-HDL-C is the measure of bad cholesterol in the blood, including triglycerides and LDL-C."|mg/dL|Mean|128.4|128.4|Standard Deviation|44.46|44.46|||
3623314|NCT02647320|3472293|B3|||5. Non-High Density Lipoprotein-C|"Non-HDL-C is the measure of bad cholesterol in the blood, including triglycerides and LDL-C."|mg/dL|Mean|131.6|131.6|Standard Deviation|35.93|35.93|||
3623315|NCT02647320|3472294|B2|||5. Non-High Density Lipoprotein-C|"Non-HDL-C is the measure of bad cholesterol in the blood, including triglycerides and LDL-C."|mg/dL|Mean|131.0|131.0|Standard Deviation|32.54|32.54|||
3623316|NCT02647320|3472295|B1|||5. Non-High Density Lipoprotein-C|"Non-HDL-C is the measure of bad cholesterol in the blood, including triglycerides and LDL-C."|mg/dL|Mean|127.6|127.6|Standard Deviation|38.13|38.13|||
3623317|NCT02647320|3472290|B6|||4. High Density Lipoprotein-C|"HDL-C is known as the good cholesterol."|mg/dL|Mean|46.87|46.87|Standard Deviation|12.19|12.19|||
3623318|NCT02647320|3472291|B5|||4. High Density Lipoprotein-C|"HDL-C is known as the good cholesterol."|mg/dL|Mean|46.7|46.7|Standard Deviation|10.93|10.93|||
3623319|NCT02647320|3472292|B4|||4. High Density Lipoprotein-C|"HDL-C is known as the good cholesterol."|mg/dL|Mean|44.3|44.3|Standard Deviation|12.17|12.17|||
3623320|NCT02647320|3472293|B3|||4. High Density Lipoprotein-C|"HDL-C is known as the good cholesterol."|mg/dL|Mean|46.4|46.4|Standard Deviation|11.77|11.77|||
3623321|NCT02647320|3472294|B2|||4. High Density Lipoprotein-C|"HDL-C is known as the good cholesterol."|mg/dL|Mean|49.3|49.3|Standard Deviation|13.20|13.2|||
3623322|NCT02647320|3472295|B1|||4. High Density Lipoprotein-C|"HDL-C is known as the good cholesterol."|mg/dL|Mean|49.5|49.5|Standard Deviation|12.80|12.8|||
3623323|NCT02647320|3472290|B6|||3. Low Density Lipoprotein-C|"LDL-C is known as the bad cholesterol."|mg/dL|Mean|97.0|97.0|Standard Deviation|34.51|34.51|||
3623324|NCT02647320|3472291|B5|||3. Low Density Lipoprotein-C|"LDL-C is known as the bad cholesterol."|mg/dL|Mean|99.8|99.8|Standard Deviation|37.14|37.14|||
3623325|NCT02647320|3472292|B4|||3. Low Density Lipoprotein-C|"LDL-C is known as the bad cholesterol."|mg/dL|Mean|95.1|95.1|Standard Deviation|37.93|37.93|||
3623326|NCT02647320|3472293|B3|||3. Low Density Lipoprotein-C|"LDL-C is known as the bad cholesterol."|mg/dL|Mean|96.6|96.6|Standard Deviation|32.84|32.84|||
3623327|NCT02647320|3472294|B2|||3. Low Density Lipoprotein-C|"LDL-C is known as the bad cholesterol."|mg/dL|Mean|96.9|96.9|Standard Deviation|30.53|30.53|||
3623328|NCT02647320|3472295|B1|||3. Low Density Lipoprotein-C|"LDL-C is known as the bad cholesterol."|mg/dL|Mean|96.6|96.6|Standard Deviation|33.58|33.58|||
3623361|NCT02647320|3472292|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623362|NCT02647320|3472293|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623329|NCT02647320|3472290|B6|||2. Total Cholesterol|"Total cholesterol is a measure of the total amount of cholesterol in the blood, including low-density lipoprotein cholesterol (LDL-C) - the bad cholesterol, high-density lipoprotein cholesterol (HDL-C) - the good cholesterol, and triglycerides. The equation to calculate total cholesterol is: LDL + HDL + (triglycerides/5) = total cholesterol."|mg/dL|Mean|178.1|178.1|Standard Deviation|41.70|41.7|||
3623330|NCT02647320|3472291|B5|||2. Total Cholesterol|"Total cholesterol is a measure of the total amount of cholesterol in the blood, including low-density lipoprotein cholesterol (LDL-C) - the bad cholesterol, high-density lipoprotein cholesterol (HDL-C) - the good cholesterol, and triglycerides. The equation to calculate total cholesterol is: LDL + HDL + (triglycerides/5) = total cholesterol."|mg/dL|Mean|182.8|182.8|Standard Deviation|43.11|43.11|||
3623331|NCT02647320|3472292|B4|||2. Total Cholesterol|"Total cholesterol is a measure of the total amount of cholesterol in the blood, including low-density lipoprotein cholesterol (LDL-C) - the bad cholesterol, high-density lipoprotein cholesterol (HDL-C) - the good cholesterol, and triglycerides. The equation to calculate total cholesterol is: LDL + HDL + (triglycerides/5) = total cholesterol."|mg/dL|Mean|172.6|172.6|Standard Deviation|55.25|55.25|||
3623332|NCT02647320|3472293|B3|||2. Total Cholesterol|"Total cholesterol is a measure of the total amount of cholesterol in the blood, including low-density lipoprotein cholesterol (LDL-C) - the bad cholesterol, high-density lipoprotein cholesterol (HDL-C) - the good cholesterol, and triglycerides. The equation to calculate total cholesterol is: LDL + HDL + (triglycerides/5) = total cholesterol."|mg/dL|Mean|178.0|178.0|Standard Deviation|37.38|37.38|||
3623333|NCT02647320|3472294|B2|||2. Total Cholesterol|"Total cholesterol is a measure of the total amount of cholesterol in the blood, including low-density lipoprotein cholesterol (LDL-C) - the bad cholesterol, high-density lipoprotein cholesterol (HDL-C) - the good cholesterol, and triglycerides. The equation to calculate total cholesterol is: LDL + HDL + (triglycerides/5) = total cholesterol."|mg/dL|Mean|180.3|180.3|Standard Deviation|32.21|32.21|||
3623334|NCT02647320|3472295|B1|||2. Total Cholesterol|"Total cholesterol is a measure of the total amount of cholesterol in the blood, including low-density lipoprotein cholesterol (LDL-C) - the bad cholesterol, high-density lipoprotein cholesterol (HDL-C) - the good cholesterol, and triglycerides. The equation to calculate total cholesterol is: LDL + HDL + (triglycerides/5) = total cholesterol."|mg/dL|Mean|177.1|177.1|Standard Deviation|36.72|36.72|||
3623335|NCT02647320|3472290|B6|||1. Glycated Hemoglobin|Glycated hemoglobin is a form of hemoglobin that is measured primarily to identify the three-month average glucose concentration in the blood. Target HbA1c for Type 2 diabetics was less than 7% at the time of this trial.|mmol/mol|Mean|7.93|7.93|Standard Deviation|0.852|0.852|||
3623336|NCT02647320|3472291|B5|||1. Glycated Hemoglobin|Glycated hemoglobin is a form of hemoglobin that is measured primarily to identify the three-month average glucose concentration in the blood. Target HbA1c for Type 2 diabetics was less than 7% at the time of this trial.|mmol/mol|Mean|7.92|7.92|Standard Deviation|0.699|0.699|||
3623337|NCT02647320|3472292|B4|||1. Glycated Hemoglobin|Glycated hemoglobin is a form of hemoglobin that is measured primarily to identify the three-month average glucose concentration in the blood. Target HbA1c for Type 2 diabetics was less than 7% at the time of this trial.|mmol/mol|Mean|7.78|7.78|Standard Deviation|0.790|0.79|||
3623338|NCT02647320|3472293|B3|||1. Glycated Hemoglobin|Glycated hemoglobin is a form of hemoglobin that is measured primarily to identify the three-month average glucose concentration in the blood. Target HbA1c for Type 2 diabetics was less than 7% at the time of this trial.|mmol/mol|Mean|7.99|7.99|Standard Deviation|0.900|0.9|||
3623339|NCT02647320|3472294|B2|||1. Glycated Hemoglobin|Glycated hemoglobin is a form of hemoglobin that is measured primarily to identify the three-month average glucose concentration in the blood. Target HbA1c for Type 2 diabetics was less than 7% at the time of this trial.|mmol/mol|Mean|8.09|8.09|Standard Deviation|0.910|0.91|||
3623340|NCT02647320|3472295|B1|||1. Glycated Hemoglobin|Glycated hemoglobin is a form of hemoglobin that is measured primarily to identify the three-month average glucose concentration in the blood. Target HbA1c for Type 2 diabetics was less than 7% at the time of this trial.|mmol/mol|Mean|7.94|7.94|Standard Deviation|0.939|0.939|||
3623341|NCT02647320|3472290|B6|United States||Region of Enrollment||Participants|Count of Participants|251|251.0||||||
3623342|NCT02647320|3472291|B5|United States||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
3623343|NCT02647320|3472292|B4|United States||Region of Enrollment||Participants|Count of Participants|56|56.0||||||
3623344|NCT02647320|3472293|B3|United States||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
3623345|NCT02647320|3472294|B2|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3623346|NCT02647320|3472295|B1|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3623347|NCT02647320|3472290|B6|Canada||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
3623348|NCT02647320|3472291|B5|Canada||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3623349|NCT02647320|3472292|B4|Canada||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3623350|NCT02647320|3472293|B3|Canada||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3623351|NCT02647320|3472294|B2|Canada||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3623352|NCT02647320|3472295|B1|Canada||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3623353|NCT02647320|3472290|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3623354|NCT02647320|3472291|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623355|NCT02647320|3472292|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3623356|NCT02647320|3472293|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623357|NCT02647320|3472294|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623358|NCT02647320|3472295|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3623359|NCT02647320|3472290|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623360|NCT02647320|3472291|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623363|NCT02647320|3472294|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623364|NCT02647320|3472295|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623365|NCT02647320|3472290|B6||White|Race (NIH/OMB)||Participants|Count of Participants|222|222.0||||||
3623366|NCT02647320|3472291|B5||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3623367|NCT02647320|3472292|B4||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3623368|NCT02647320|3472293|B3||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3623369|NCT02647320|3472294|B2||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3623370|NCT02647320|3472295|B1||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3623371|NCT02647320|3472290|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3623372|NCT02647320|3472291|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3623373|NCT02647320|3472292|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3623374|NCT02647320|3472293|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3623375|NCT02647320|3472294|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3623376|NCT02647320|3472295|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3623377|NCT02647320|3472290|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623378|NCT02647320|3472291|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623379|NCT02647320|3472292|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623380|NCT02647320|3472293|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623381|NCT02647320|3472294|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623382|NCT02647320|3472295|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623383|NCT02647320|3472290|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3623384|NCT02647320|3472291|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3623385|NCT02647320|3472292|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3623386|NCT02647320|3472293|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3623387|NCT02647320|3472294|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3623388|NCT02647320|3472295|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3623389|NCT02647320|3472290|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3623390|NCT02647320|3472291|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3623391|NCT02647320|3472292|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623392|NCT02647320|3472293|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3623393|NCT02647320|3472294|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623394|NCT02647320|3472295|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3623395|NCT02647320|3472290|B6||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3623396|NCT02647320|3472291|B5||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3623397|NCT02647320|3472292|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3623398|NCT02647320|3472293|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3623399|NCT02647320|3472294|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3623400|NCT02647320|3472295|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3623401|NCT02647320|3472290|B6||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3623402|NCT02647320|3472291|B5||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3623403|NCT02647320|3472292|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3623404|NCT02647320|3472293|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3623405|NCT02647320|3472294|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3623406|NCT02647320|3472295|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3623407|NCT02647320|3472290|B6|||Age||years|Mean|56.7|56.7|Standard Deviation|8.56|8.56|||
3623408|NCT02647320|3472291|B5|||Age||years|Mean|55.6|55.6|Standard Deviation|7.72|7.72|||
3623409|NCT02647320|3472292|B4|||Age||years|Mean|57.4|57.4|Standard Deviation|7.77|7.77|||
3623410|NCT02647320|3472293|B3|||Age||years|Mean|57.0|57.0|Standard Deviation|9.41|9.41|||
3623411|NCT02647320|3472294|B2|||Age||years|Mean|57.0|57.0|Standard Deviation|8.95|8.95|||
3623412|NCT02647320|3472295|B1|||Age||years|Mean|56.4|56.4|Standard Deviation|9.30|9.3|||
3623413|NCT02647281|3472381|B10|Race/Ethnicity, Customized|Caribbean British|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3623414|NCT02647281|3472382|B9|Race/Ethnicity, Customized|Caribbean British|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623415|NCT02647281|3472383|B8|Race/Ethnicity, Customized|Caribbean British|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3623416|NCT02647281|3472384|B7|Race/Ethnicity, Customized|Caribbean British|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623417|NCT02647281|3472385|B6|Race/Ethnicity, Customized|Caribbean British|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623418|NCT02647281|3472386|B5|Race/Ethnicity, Customized|Caribbean British|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623419|NCT02647281|3472387|B4|Race/Ethnicity, Customized|Caribbean British|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623420|NCT02647281|3472388|B3|Race/Ethnicity, Customized|Caribbean British|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623421|NCT02647281|3472389|B2|Race/Ethnicity, Customized|Caribbean British|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623422|NCT02647281|3472390|B1|Race/Ethnicity, Customized|Caribbean British|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623423|NCT02647281|3472381|B10|Race/Ethnicity, Customized|Caribbean|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3623424|NCT02647281|3472382|B9|Race/Ethnicity, Customized|Caribbean|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623425|NCT02647281|3472383|B8|Race/Ethnicity, Customized|Caribbean|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623426|NCT02647281|3472384|B7|Race/Ethnicity, Customized|Caribbean|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623427|NCT02647281|3472385|B6|Race/Ethnicity, Customized|Caribbean|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3623428|NCT02647281|3472386|B5|Race/Ethnicity, Customized|Caribbean|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623429|NCT02647281|3472387|B4|Race/Ethnicity, Customized|Caribbean|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623430|NCT02647281|3472388|B3|Race/Ethnicity, Customized|Caribbean|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623431|NCT02647281|3472389|B2|Race/Ethnicity, Customized|Caribbean|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623432|NCT02647281|3472390|B1|Race/Ethnicity, Customized|Caribbean|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623433|NCT02647281|3472381|B10|Race/Ethnicity, Customized|Asian-Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3623434|NCT02647281|3472382|B9|Race/Ethnicity, Customized|Asian-Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623435|NCT02647281|3472383|B8|Race/Ethnicity, Customized|Asian-Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3623436|NCT02647281|3472384|B7|Race/Ethnicity, Customized|Asian-Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3623437|NCT02647281|3472385|B6|Race/Ethnicity, Customized|Asian-Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623438|NCT02647281|3472386|B5|Race/Ethnicity, Customized|Asian-Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623439|NCT02647281|3472387|B4|Race/Ethnicity, Customized|Asian-Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623440|NCT02647281|3472388|B3|Race/Ethnicity, Customized|Asian-Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623441|NCT02647281|3472389|B2|Race/Ethnicity, Customized|Asian-Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623442|NCT02647281|3472390|B1|Race/Ethnicity, Customized|Asian-Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623443|NCT02647281|3472381|B10|Race/Ethnicity, Customized|White-White/Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|45|45.0||||||
3623444|NCT02647281|3472382|B9|Race/Ethnicity, Customized|White-White/Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3623445|NCT02647281|3472383|B8|Race/Ethnicity, Customized|White-White/Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3623446|NCT02647281|3472384|B7|Race/Ethnicity, Customized|White-White/Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3623447|NCT02647281|3472385|B6|Race/Ethnicity, Customized|White-White/Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3623448|NCT02647281|3472386|B5|Race/Ethnicity, Customized|White-White/Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3623449|NCT02647281|3472387|B4|Race/Ethnicity, Customized|White-White/Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3623450|NCT02647281|3472388|B3|Race/Ethnicity, Customized|White-White/Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3623451|NCT02647281|3472389|B2|Race/Ethnicity, Customized|White-White/Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3623452|NCT02647281|3472390|B1|Race/Ethnicity, Customized|White-White/Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3623453|NCT02647281|3472381|B10|Race/Ethnicity, Customized|African American/African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3623454|NCT02647281|3472382|B9|Race/Ethnicity, Customized|African American/African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623455|NCT02647281|3472383|B8|Race/Ethnicity, Customized|African American/African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623456|NCT02647281|3472384|B7|Race/Ethnicity, Customized|African American/African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623457|NCT02647281|3472385|B6|Race/Ethnicity, Customized|African American/African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623458|NCT02647281|3472386|B5|Race/Ethnicity, Customized|African American/African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623459|NCT02647281|3472387|B4|Race/Ethnicity, Customized|African American/African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623460|NCT02647281|3472388|B3|Race/Ethnicity, Customized|African American/African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3623514|NCT02646566|3472578|B2||White|Race (NIH/OMB)||Participants|Count of Participants|189|189.0||||||
3623461|NCT02647281|3472389|B2|Race/Ethnicity, Customized|African American/African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3623462|NCT02647281|3472390|B1|Race/Ethnicity, Customized|African American/African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623463|NCT02647281|3472381|B10|Race/Ethnicity, Customized|Asian-South East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3623464|NCT02647281|3472382|B9|Race/Ethnicity, Customized|Asian-South East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623465|NCT02647281|3472383|B8|Race/Ethnicity, Customized|Asian-South East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623466|NCT02647281|3472384|B7|Race/Ethnicity, Customized|Asian-South East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623467|NCT02647281|3472385|B6|Race/Ethnicity, Customized|Asian-South East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3623468|NCT02647281|3472386|B5|Race/Ethnicity, Customized|Asian-South East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623469|NCT02647281|3472387|B4|Race/Ethnicity, Customized|Asian-South East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623470|NCT02647281|3472388|B3|Race/Ethnicity, Customized|Asian-South East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3623471|NCT02647281|3472389|B2|Race/Ethnicity, Customized|Asian-South East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623472|NCT02647281|3472390|B1|Race/Ethnicity, Customized|Asian-South East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623473|NCT02647281|3472381|B10||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3623474|NCT02647281|3472382|B9||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3623475|NCT02647281|3472383|B8||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3623476|NCT02647281|3472384|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3623477|NCT02647281|3472385|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3623478|NCT02647281|3472386|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3623479|NCT02647281|3472387|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3623480|NCT02647281|3472388|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3623481|NCT02647281|3472389|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3623482|NCT02647281|3472390|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3623483|NCT02647281|3472381|B10||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3623484|NCT02647281|3472382|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3623485|NCT02647281|3472383|B8||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3623486|NCT02647281|3472384|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3623487|NCT02647281|3472385|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3623488|NCT02647281|3472386|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3623489|NCT02647281|3472387|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3623490|NCT02647281|3472388|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3623491|NCT02647281|3472389|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3623492|NCT02647281|3472390|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3623493|NCT02647281|3472381|B10|||Age|Data for Part 2 is presented.|Years|Mean|37.3|37.3|Standard Deviation|10.49|10.49|||
3623494|NCT02647281|3472382|B9|||Age|Data for Part 2 is presented.|Years|Mean|38.5|38.5|Standard Deviation|12.23|12.23|||
3623495|NCT02647281|3472383|B8|||Age|Data for Part 2 is presented.|Years|Mean|40.5|40.5|Standard Deviation|11.13|11.13|||
3623496|NCT02647281|3472384|B7|||Age|Data for Part 2 is presented.|Years|Mean|32.2|32.2|Standard Deviation|6.91|6.91|||
3623497|NCT02647281|3472385|B6|||Age|Data for Part 2 is presented.|Years|Mean|38.0|38.0|Standard Deviation|11.78|11.78|||
3623498|NCT02647281|3472381|B10|||Age|Data for Part 1 is presented.|Years|Mean|32.5|32.5|Standard Deviation|10.03|10.03|||
3623499|NCT02647281|3472386|B5|||Age|Data for Part 1 is presented.|Years|Mean|37.8|37.8|Standard Deviation|13.41|13.41|||
3623500|NCT02647281|3472387|B4|||Age|Data for Part 1 is presented.|Years|Mean|32.8|32.8|Standard Deviation|7.41|7.41|||
3623501|NCT02647281|3472388|B3|||Age|Data for Part 1 is presented.|Years|Mean|37.5|37.5|Standard Deviation|12.44|12.44|||
3623502|NCT02647281|3472389|B2|||Age|Data for Part 1 is presented.|Years|Mean|27.5|27.5|Standard Deviation|3.78|3.78|||
3623503|NCT02647281|3472390|B1|||Age|Data for Part 1 is presented.|Years|Mean|28.1|28.1|Standard Deviation|8.22|8.22|||
3623504|NCT02646566|3472576|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3623505|NCT02646566|3472577|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3623506|NCT02646566|3472578|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3623507|NCT02646566|3472579|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3623508|NCT02646566|3472576|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623509|NCT02646566|3472577|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623510|NCT02646566|3472578|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623511|NCT02646566|3472579|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623512|NCT02646566|3472576|B4||White|Race (NIH/OMB)||Participants|Count of Participants|578|578.0||||||
3623513|NCT02646566|3472577|B3||White|Race (NIH/OMB)||Participants|Count of Participants|193|193.0||||||
3623515|NCT02646566|3472579|B1||White|Race (NIH/OMB)||Participants|Count of Participants|196|196.0||||||
3623516|NCT02646566|3472576|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3623517|NCT02646566|3472577|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3623518|NCT02646566|3472578|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3623519|NCT02646566|3472579|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3623520|NCT02646566|3472576|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3623521|NCT02646566|3472577|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623522|NCT02646566|3472578|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623523|NCT02646566|3472579|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3623524|NCT02646566|3472576|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3623525|NCT02646566|3472577|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3623526|NCT02646566|3472578|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3623527|NCT02646566|3472579|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3623528|NCT02646566|3472576|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3623529|NCT02646566|3472577|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623530|NCT02646566|3472578|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623531|NCT02646566|3472579|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3623532|NCT02646566|3472576|B4||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3623533|NCT02646566|3472577|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3623534|NCT02646566|3472578|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3623535|NCT02646566|3472579|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3623536|NCT02646566|3472576|B4||Female|Sex: Female, Male||Participants|Count of Participants|633|633.0||||||
3623537|NCT02646566|3472577|B3||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
3623538|NCT02646566|3472578|B2||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
3623539|NCT02646566|3472579|B1||Female|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
3623540|NCT02646566|3472576|B4|||Age||Years|Mean|46.3|46.3|Standard Deviation|13.17|13.17|||
3623541|NCT02646566|3472577|B3|||Age||Years|Mean|46.0|46.0|Standard Deviation|13.38|13.38|||
3623542|NCT02646566|3472578|B2|||Age||Years|Mean|46.9|46.9|Standard Deviation|13.03|13.03|||
3623543|NCT02646566|3472579|B1|||Age||Years|Mean|45.8|45.8|Standard Deviation|13.12|13.12|||
3623544|NCT02646566|3472576|B4||>=65 years|Age||Participants|Count of Participants|64|64.0||||||
3623545|NCT02646566|3472577|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3623546|NCT02646566|3472578|B2||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3623547|NCT02646566|3472579|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3623548|NCT02646566|3472576|B4||Between 18 and 65 years|Age||Participants|Count of Participants|634|634.0||||||
3623549|NCT02646566|3472577|B3||Between 18 and 65 years|Age||Participants|Count of Participants|216|216.0||||||
3623550|NCT02646566|3472578|B2||Between 18 and 65 years|Age||Participants|Count of Participants|204|204.0||||||
3623551|NCT02646566|3472579|B1||Between 18 and 65 years|Age||Participants|Count of Participants|214|214.0||||||
3623552|NCT02646566|3472576|B4||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3623553|NCT02646566|3472577|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3623554|NCT02646566|3472578|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3623555|NCT02646566|3472579|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3623556|NCT02646449|3472619|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
3623557|NCT02646449|3472620|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3623558|NCT02646449|3472621|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3623559|NCT02646449|3472619|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3623560|NCT02646449|3472620|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3623561|NCT02646449|3472621|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3623562|NCT02646449|3472619|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3623563|NCT02646449|3472620|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3623564|NCT02646449|3472621|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3623565|NCT02646449|3472619|B3|||Age||years|Mean|22.9|22.9|Standard Deviation|2.8|2.8|||
3623566|NCT02646449|3472620|B2|||Age||years|Mean|24.4|24.4|Standard Deviation|3.7|3.7|||
3623567|NCT02646449|3472621|B1|||Age||years|Mean|21.8|21.8|Standard Deviation|1.5|1.5|||
3623568|NCT02646449|3472619|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3623569|NCT02646449|3472620|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3623570|NCT02646449|3472621|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3623571|NCT02646449|3472619|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3623572|NCT02646449|3472620|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3623573|NCT02646449|3472621|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3623574|NCT02646449|3472619|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3623575|NCT02646449|3472620|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3623576|NCT02646449|3472621|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3623577|NCT02646124|3472630|B3|||Duration of Back Pain Prior to Study||hours|Median|48|48.0|Inter-Quartile Range|||24.0|96.0|
3623578|NCT02646124|3472631|B2|||Duration of Back Pain Prior to Study||hours|Median|48|48.0|Inter-Quartile Range|||12.0|96.0|
3623579|NCT02646124|3472632|B1|||Duration of Back Pain Prior to Study||hours|Median|72|72.0|Inter-Quartile Range|||24.0|108.0|
3623580|NCT02646124|3472630|B3|United States||Region of Enrollment||Participants|Count of Participants|114|114.0||||||
3623581|NCT02646124|3472631|B2|United States||Region of Enrollment||Participants|Count of Participants|57|57.0||||||
3623582|NCT02646124|3472632|B1|United States||Region of Enrollment||Participants|Count of Participants|57|57.0||||||
3623583|NCT02646124|3472630|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3623584|NCT02646124|3472630|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3623585|NCT02646124|3472631|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3623586|NCT02646124|3472632|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3623587|NCT02646124|3472630|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3623588|NCT02646124|3472631|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3623589|NCT02646124|3472632|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3623590|NCT02646124|3472630|B3|||Age||Years|Mean|36|36.0|Standard Deviation|12|12.0|||
3623591|NCT02646124|3472631|B2|||Age||Years|Mean|38|38.0|Standard Deviation|12|12.0|||
3623592|NCT02646124|3472632|B1|||Age||Years|Mean|34|34.0|Standard Deviation|12|12.0|||
3623593|NCT02645760|3472647|B3|||BMI||kg/m^2|Mean|24.50|24.5|Standard Deviation|3.71|3.71|||
3623594|NCT02645760|3472648|B2|||BMI||kg/m^2|Mean|24.03|24.03|Standard Deviation|4.08|4.08|||
3623595|NCT02645760|3472649|B1|||BMI||kg/m^2|Mean|24.97|24.97|Standard Deviation|3.07|3.07|||
3623596|NCT02645760|3472647|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3623597|NCT02645760|3472648|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3623598|NCT02645760|3472649|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3623599|NCT02645760|3472647|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3623600|NCT02645760|3472648|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3623601|NCT02645760|3472649|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3623602|NCT02645760|3472647|B3|||Age||years|Mean|38.76|38.76|Standard Deviation|10.33|10.33|||
3623603|NCT02645760|3472648|B2|||Age||years|Mean|37.89|37.89|Standard Deviation|10.60|10.6|||
3623604|NCT02645760|3472649|B1|||Age||years|Mean|39.63|39.63|Standard Deviation|10.26|10.26|||
3623605|NCT02645253|3472662|B5||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3623606|NCT02645253|3472663|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3623607|NCT02645253|3472664|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3623608|NCT02645253|3472665|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3623609|NCT02645253|3472666|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3623610|NCT02645253|3472662|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3623611|NCT02645253|3472663|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3623612|NCT02645253|3472664|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3623613|NCT02645253|3472665|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3623614|NCT02645253|3472666|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3623615|NCT02645253|3472662|B5|||Age||Years|Mean|34.0|34.0|Standard Deviation|5.73|5.73|||
3623616|NCT02645253|3472663|B4|||Age||Years|Mean|35.7|35.7|Standard Deviation|5.54|5.54|||
3623617|NCT02645253|3472664|B3|||Age||Years|Mean|33.6|33.6|Standard Deviation|6.43|6.43|||
3623618|NCT02645253|3472665|B2|||Age||Years|Mean|34.1|34.1|Standard Deviation|6.41|6.41|||
3623619|NCT02645253|3472666|B1|||Age||Years|Mean|32.7|32.7|Standard Deviation|5.41|5.41|||
3623620|NCT02645123|3472788|B4|Greece||Region of Enrollment||participants|Number|75|75.0||||||
3623621|NCT02645123|3472789|B3|Greece||Region of Enrollment||participants|Number|25|25.0||||||
3623622|NCT02645123|3472790|B2|Greece||Region of Enrollment||participants|Number|25|25.0||||||
3623623|NCT02645123|3472791|B1|Greece||Region of Enrollment||participants|Number|25|25.0||||||
3623624|NCT02645123|3472788|B4||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3623625|NCT02645123|3472789|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3623626|NCT02645123|3472790|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3623627|NCT02645123|3472791|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3623628|NCT02645123|3472788|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3623629|NCT02645123|3472789|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3623630|NCT02645123|3472790|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3623631|NCT02645123|3472791|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3623632|NCT02645123|3472788|B4|||Age||years|Mean|47.5|47.5|Standard Deviation|14.58|14.58|||
3623633|NCT02645123|3472789|B3|||Age||years|Mean|45.48|45.48|Standard Deviation|14.58|14.58|||
3623634|NCT02645123|3472790|B2|||Age||years|Mean|50.08|50.08|Standard Deviation|12.61|12.61|||
3623635|NCT02645123|3472791|B1|||Age||years|Mean|46.96|46.96|Standard Deviation|16.07|16.07|||
3623636|NCT02645123|3472788|B4||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3623637|NCT02645123|3472789|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3623638|NCT02645123|3472790|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3623639|NCT02645123|3472791|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3623640|NCT02645123|3472788|B4||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
3623641|NCT02645123|3472789|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3623642|NCT02645123|3472790|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3623643|NCT02645123|3472791|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3623644|NCT02645123|3472788|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3623645|NCT02645123|3472789|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3623646|NCT02645123|3472790|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3623647|NCT02645123|3472791|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3623648|NCT02644356|3472810|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
3623649|NCT02644356|3472810|B1|American Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3623650|NCT02644356|3472810|B1|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3623651|NCT02644356|3472810|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3623652|NCT02644356|3472810|B1|Asian American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3623653|NCT02644356|3472810|B1|White non-hispanic||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3623654|NCT02644356|3472810|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3623655|NCT02644356|3472810|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3623656|NCT02644356|3472810|B1|||Age||years|Mean|43.8|43.8|Standard Deviation|12.3|12.3|||
3623657|NCT02644356|3472810|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3623658|NCT02644356|3472810|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3623659|NCT02644356|3472810|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3623660|NCT02644122|3472820|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3623661|NCT02644122|3472820|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3623662|NCT02644122|3472820|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3623663|NCT02644122|3472820|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3623664|NCT02644122|3472820|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3623665|NCT02644122|3472820|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3623666|NCT02644109|3472828|B3|||LDL-cholesterol||mg/dl|Mean|147.7|147.7|Standard Deviation|16.9|16.9|||
3623667|NCT02644109|3472829|B2|||LDL-cholesterol||mg/dl|Mean|146.3|146.3|Standard Deviation|15.6|15.6|||
3623668|NCT02644109|3472830|B1|||LDL-cholesterol||mg/dl|Mean|149.5|149.5|Standard Deviation|18.6|18.6|||
3623669|NCT02644109|3472828|B3|||Total Cholesterol||mg/dl|Mean|228.9|228.9|Standard Deviation|21|21.0|||
3623670|NCT02644109|3472829|B2|||Total Cholesterol||mg/dl|Mean|226.4|226.4|Standard Deviation|19.3|19.3|||
3623671|NCT02644109|3472830|B1|||Total Cholesterol||mg/dl|Mean|231.9|231.9|Standard Deviation|22.9|22.9|||
3623672|NCT02644109|3472828|B3|||Body mass index||kg/m^2|Mean|27.9|27.9|Standard Deviation|3.3|3.3|||
3623673|NCT02644109|3472829|B2|||Body mass index||kg/m^2|Mean|27.9|27.9|Standard Deviation|3.2|3.2|||
3623674|NCT02644109|3472830|B1|||Body mass index||kg/m^2|Mean|27.9|27.9|Standard Deviation|3.5|3.5|||
3623675|NCT02644109|3472828|B3|Chile||Region of Enrollment||participants|Number|52|52.0||||||
3623676|NCT02644109|3472829|B2|Chile||Region of Enrollment||participants|Number|28|28.0||||||
3623677|NCT02644109|3472830|B1|Chile||Region of Enrollment||participants|Number|24|24.0||||||
3623678|NCT02644109|3472828|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3623679|NCT02644109|3472829|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3623680|NCT02644109|3472830|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3623681|NCT02644109|3472828|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3623682|NCT02644109|3472829|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3623683|NCT02644109|3472830|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3623684|NCT02644109|3472828|B3|||Age||years|Mean|53.2|53.2|Standard Deviation|6.32|6.32|||
3623685|NCT02644109|3472829|B2|||Age||years|Mean|53.2|53.2|Standard Deviation|6.6|6.6|||
3623686|NCT02644109|3472830|B1|||Age||years|Mean|53.2|53.2|Standard Deviation|6.1|6.1|||
3623687|NCT02644096|3472837|B3|Denmark||Region of Enrollment||participants|Number|161|161.0||||||
3623688|NCT02644096|3472838|B2|Denmark||Region of Enrollment||participants|Number|68|68.0||||||
3623689|NCT02644096|3472839|B1|Denmark||Region of Enrollment||participants|Number|93|93.0||||||
3623690|NCT02644096|3472837|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3623691|NCT02644096|3472838|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3623692|NCT02644096|3472839|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3623693|NCT02644096|3472837|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3623694|NCT02644096|3472838|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3623695|NCT02644096|3472839|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3623696|NCT02644096|3472837|B3|||Age||years|Mean|74.9|74.9|Standard Deviation|8.3|8.3|||
3623697|NCT02644096|3472838|B2|||Age||years|Mean|75|75.0|Standard Deviation|8.6|8.6|||
3623698|NCT02644096|3472839|B1|||Age||years|Mean|74.8|74.8|Standard Deviation|8.1|8.1|||
3623699|NCT02644096|3472837|B3||>=65 years|Age|The baseline information was collected from hospital records.|Participants|Count of Participants|161|161.0||||||
3623700|NCT02644096|3472838|B2||>=65 years|Age|The baseline information was collected from hospital records.|Participants|Count of Participants|68|68.0||||||
3623701|NCT02644096|3472839|B1||>=65 years|Age|The baseline information was collected from hospital records.|Participants|Count of Participants|93|93.0||||||
3623702|NCT02644096|3472837|B3||Between 18 and 65 years|Age|The baseline information was collected from hospital records.|Participants|Count of Participants|0|0.0||||||
3623703|NCT02644096|3472838|B2||Between 18 and 65 years|Age|The baseline information was collected from hospital records.|Participants|Count of Participants|0|0.0||||||
3623704|NCT02644096|3472839|B1||Between 18 and 65 years|Age|The baseline information was collected from hospital records.|Participants|Count of Participants|0|0.0||||||
3623705|NCT02644096|3472837|B3||<=18 years|Age|The baseline information was collected from hospital records.|Participants|Count of Participants|0|0.0||||||
3623706|NCT02644096|3472838|B2||<=18 years|Age|The baseline information was collected from hospital records.|Participants|Count of Participants|0|0.0||||||
3623707|NCT02644096|3472839|B1||<=18 years|Age|The baseline information was collected from hospital records.|Participants|Count of Participants|0|0.0||||||
3623708|NCT02643862|3472846|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
3623709|NCT02643862|3472847|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3623710|NCT02643862|3472848|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
3623711|NCT02643862|3472846|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3623712|NCT02643862|3472847|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3623713|NCT02643862|3472848|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3623714|NCT02643862|3472846|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3623715|NCT02643862|3472847|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3623716|NCT02643862|3472848|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3623717|NCT02643862|3472846|B3|||Age||years|Median|8|8.0|Inter-Quartile Range|||5.0|11.0|
3623718|NCT02643862|3472847|B2|||Age||years|Median|7|7.0|Inter-Quartile Range|||5.0|9.0|
3623719|NCT02643862|3472848|B1|||Age||years|Median|8|8.0|Inter-Quartile Range|||5.0|11.0|
3623720|NCT02643862|3472846|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3623721|NCT02643862|3472847|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3623722|NCT02643862|3472848|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3623723|NCT02643862|3472846|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3623724|NCT02643862|3472847|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3623725|NCT02643862|3472848|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3623726|NCT02643862|3472846|B3||<=18 years|Age||Participants|Count of Participants|48|48.0||||||
3623727|NCT02643862|3472847|B2||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
3623728|NCT02643862|3472848|B1||<=18 years|Age||Participants|Count of Participants|36|36.0||||||
3623729|NCT02643615|3472857|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3623730|NCT02643615|3472858|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3623731|NCT02643615|3472859|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3623732|NCT02643615|3472857|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3623733|NCT02643615|3472858|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3623734|NCT02643615|3472859|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3623735|NCT02643615|3472857|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3623736|NCT02643615|3472858|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3623737|NCT02643615|3472859|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3623738|NCT02643615|3472857|B3|||Age||years|Mean|54.5|54.5|Standard Deviation|15.3|15.3|||
3623739|NCT02643615|3472858|B2|||Age||years|Mean|56.2|56.2|Standard Deviation|16.1|16.1|||
3623740|NCT02643615|3472859|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|14.8|14.8|||
3623741|NCT02643615|3472857|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3623742|NCT02643615|3472858|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3623743|NCT02643615|3472859|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3623744|NCT02643615|3472857|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3623745|NCT02643615|3472858|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3623746|NCT02643615|3472859|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3623747|NCT02643615|3472857|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3623748|NCT02643615|3472858|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3623749|NCT02643615|3472859|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3623750|NCT02643394|3472872|B3|United States||Region of Enrollment||participants|Number|110|110.0||||||
3623751|NCT02643394|3472873|B2|United States||Region of Enrollment||participants|Number|55|55.0||||||
3623752|NCT02643394|3472874|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
3623753|NCT02643394|3472872|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3623754|NCT02643394|3472873|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3623755|NCT02643394|3472874|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3623756|NCT02643394|3472872|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3623757|NCT02643394|3472873|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3623758|NCT02643394|3472874|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3623759|NCT02643394|3472872|B3|||Age||years|Mean|52.7|52.7|Standard Deviation|16.0|16.0|||
3623760|NCT02643394|3472873|B2|||Age||years|Mean|54.0|54.0|Standard Deviation|15.7|15.7|||
3623761|NCT02643394|3472874|B1|||Age||years|Mean|51.5|51.5|Standard Deviation|16.3|16.3|||
3623762|NCT02643394|3472872|B3||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3623763|NCT02643394|3472873|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3623764|NCT02643394|3472874|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3623765|NCT02643394|3472872|B3||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
3623766|NCT02643394|3472873|B2||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3623767|NCT02643394|3472874|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3623768|NCT02643394|3472872|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3623769|NCT02643394|3472873|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3623770|NCT02643394|3472874|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3623771|NCT02643251|3472883|B3|United States||Region of Enrollment||participants|Number|138|138.0||||||
3623772|NCT02643251|3472884|B2|United States||Region of Enrollment||participants|Number|69|69.0||||||
3623773|NCT02643251|3472885|B1|United States||Region of Enrollment||participants|Number|69|69.0||||||
3623774|NCT02643251|3472883|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623775|NCT02643251|3472884|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623776|NCT02643251|3472885|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623777|NCT02643251|3472883|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623778|NCT02643251|3472884|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623779|NCT02643251|3472885|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623780|NCT02643251|3472883|B3||White|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
3623781|NCT02643251|3472884|B2||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3623782|NCT02643251|3472885|B1||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3623783|NCT02643251|3472883|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3623784|NCT02643251|3472884|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3623785|NCT02643251|3472885|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3623786|NCT02643251|3472883|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623787|NCT02643251|3472884|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623788|NCT02643251|3472885|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623789|NCT02643251|3472883|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3623790|NCT02643251|3472884|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3623791|NCT02643251|3472885|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3623792|NCT02643251|3472883|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3623793|NCT02643251|3472884|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623794|NCT02643251|3472885|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3623795|NCT02643251|3472883|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623796|NCT02643251|3472884|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623797|NCT02643251|3472885|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623798|NCT02643251|3472883|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
3623799|NCT02643251|3472884|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3623800|NCT02643251|3472885|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3623801|NCT02643251|3472883|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3623802|NCT02643251|3472884|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3623803|NCT02643251|3472885|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3623804|NCT02643251|3472883|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3623805|NCT02643251|3472884|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3623806|NCT02643251|3472885|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3623807|NCT02643251|3472883|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3623808|NCT02643251|3472884|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3623809|NCT02643251|3472885|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3623810|NCT02643251|3472883|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|9.37|9.37|||
3623811|NCT02643251|3472884|B2|||Age||years|Mean|59.7|59.7|Standard Deviation|10.00|10.0|||
3623812|NCT02643251|3472885|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|8.76|8.76|||
3623813|NCT02643251|3472883|B3||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
3623814|NCT02643251|3472884|B2||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3623815|NCT02643251|3472885|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3623816|NCT02643251|3472883|B3||Between 18 and 65 years|Age||Participants|Count of Participants|98|98.0||||||
3623817|NCT02643251|3472884|B2||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3623818|NCT02643251|3472885|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3623819|NCT02643251|3472883|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3623820|NCT02643251|3472884|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3623821|NCT02643251|3472885|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3623822|NCT02643225|3472894|B3|||Umbilical Cord Cross-sectional area|the sonographic cross sectional area of umbilical cord, the umbilical arteries and umbilical vein will be measured in a free loop of the umbilical cord using the software of the ultrasound device at 27-28 weeks of gestation.|cm^2|Mean|2.42|2.42|Standard Deviation|.98|0.98|||
3623823|NCT02643225|3472895|B2|||Umbilical Cord Cross-sectional area|the sonographic cross sectional area of umbilical cord, the umbilical arteries and umbilical vein will be measured in a free loop of the umbilical cord using the software of the ultrasound device at 27-28 weeks of gestation.|cm^2|Mean|2.06|2.06|Standard Deviation|.77|0.77|||
3623824|NCT02643225|3472896|B1|||Umbilical Cord Cross-sectional area|the sonographic cross sectional area of umbilical cord, the umbilical arteries and umbilical vein will be measured in a free loop of the umbilical cord using the software of the ultrasound device at 27-28 weeks of gestation.|cm^2|Mean|2.77|2.77|Standard Deviation|1.19|1.19|||
3623825|NCT02643225|3472894|B3|Egypt||Region of Enrollment||participants|Number|80|80.0||||||
3623826|NCT02643225|3472895|B2|Egypt||Region of Enrollment||participants|Number|40|40.0||||||
3623827|NCT02643225|3472896|B1|Egypt||Region of Enrollment||participants|Number|40|40.0||||||
3623828|NCT02643225|3472894|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3623829|NCT02643225|3472895|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3623830|NCT02643225|3472896|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3623831|NCT02643225|3472894|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3623832|NCT02643225|3472895|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3623833|NCT02643225|3472896|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3623834|NCT02643225|3472894|B3|||Age||years|Mean|32|32.0|Standard Deviation|7|7.0|||
3623835|NCT02643225|3472895|B2|||Age||years|Mean|32|32.0|Standard Deviation|7|7.0|||
3623836|NCT02643225|3472896|B1|||Age||years|Mean|31|31.0|Standard Deviation|7|7.0|||
3623837|NCT02643225|3472894|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3623838|NCT02643225|3472895|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3623839|NCT02643225|3472896|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3623840|NCT02643225|3472894|B3||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
3623841|NCT02643225|3472895|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3623842|NCT02643225|3472896|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3623843|NCT02643225|3472894|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3623844|NCT02643225|3472895|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3623845|NCT02643225|3472896|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3623846|NCT02643199|3472909|B1|Egypt||Region of Enrollment||participants|Number|90|90.0||||||
3623847|NCT02643199|3472909|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3623848|NCT02643199|3472909|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3623849|NCT02643199|3472909|B1|||Age||years|Mean|25|25.0|Standard Deviation|5|5.0|||
3623850|NCT02643199|3472909|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3623851|NCT02643199|3472909|B1||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
3623852|NCT02643199|3472909|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3623853|NCT02643095|3472914|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3623854|NCT02643095|3472914|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3623855|NCT02643095|3472914|B1|Age 18 or older||Age, Customized||Participants|Count of Participants|22|22.0||||||
3623856|NCT02643004|3472918|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3623857|NCT02643004|3472918|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3623858|NCT02643004|3472918|B1|||Age||years|Mean|30.6|30.6|Standard Deviation|10.8|10.8|||
3623859|NCT02642835|3472959|B1|||time to follow up (months)||number of months|Mean|82|82.0|Full Range|||48.0|106.0|
3623860|NCT02642835|3472959|B1|||Parity||vaginal deliveries past 28 weeks|Median|2|2.0|Full Range|||1.0|4.0|
3623861|NCT02642835|3472959|B1|||BMI||wt kg/ht m squared|Mean|27.4|27.4|Full Range|||19.0|44.0|
3623862|NCT02642835|3472959|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3623863|NCT02642835|3472959|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3623864|NCT02642835|3472959|B1|||Age||years|Mean|66|66.0|Full Range|||47.0|83.0|
3623865|NCT02642679|3472972|B1|||Dermatome setting||inches|Mean|0.0122|0.0122|Full Range|||0.011|0.014|
3623866|NCT02642679|3472972|B1|||Donor site area||square centimeters|Mean|196.9|196.9|Full Range|||17.5|440.0|
3623867|NCT02642679|3472972|B1||Soft tissue defect|Reason for split-thickness skin graft||Participants|Count of Participants|3|3.0||||||
3623868|NCT02642679|3472972|B1||Burn|Reason for split-thickness skin graft||Participants|Count of Participants|16|16.0||||||
3623869|NCT02642679|3472972|B1|||Allergies to chitosan/shellfish||Participants|Count of Participants|0|0.0||||||
3623870|NCT02642679|3472972|B1|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3623871|NCT02642679|3472972|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623872|NCT02642679|3472972|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3623873|NCT02642679|3472972|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3623874|NCT02642679|3472972|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3623875|NCT02642679|3472972|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623876|NCT02642679|3472972|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623877|NCT02642679|3472972|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623878|NCT02642679|3472972|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623879|NCT02642679|3472972|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3623880|NCT02642679|3472972|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3623881|NCT02642679|3472972|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3623882|NCT02642679|3472972|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3623883|NCT02642679|3472972|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3623884|NCT02642679|3472972|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3623885|NCT02642679|3472972|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3623886|NCT02642575|3472978|B1|Egypt||Region of Enrollment||Count of Participants|Number|67|67.0||||||
3623887|NCT02642575|3472978|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3623888|NCT02642575|3472978|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3623889|NCT02642575|3472978|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3623890|NCT02642575|3472978|B1||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
3623891|NCT02642575|3472978|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3623892|NCT02642536|3472984|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623893|NCT02642536|3472985|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623894|NCT02642536|3472986|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623895|NCT02642536|3472984|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623896|NCT02642536|3472985|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623897|NCT02642536|3472986|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623898|NCT02642536|3472984|B3||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3623899|NCT02642536|3472985|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3623900|NCT02642536|3472986|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3623901|NCT02642536|3472984|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3623902|NCT02642536|3472985|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3623903|NCT02642536|3472986|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3623904|NCT02642536|3472984|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3623905|NCT02642536|3472985|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3623906|NCT02642536|3472986|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3623907|NCT02642536|3472984|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623908|NCT02642536|3472985|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623909|NCT02642536|3472986|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623910|NCT02642536|3472984|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623911|NCT02642536|3472985|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623912|NCT02642536|3472986|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623913|NCT02642536|3472984|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3623914|NCT02642536|3472985|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3623915|NCT02642536|3472986|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3623916|NCT02642536|3472984|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3623917|NCT02642536|3472985|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3623918|NCT02642536|3472986|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3623919|NCT02642536|3472984|B3|||Age||years|Mean|58.65|58.65|Standard Deviation|9.11|9.11|||
3623920|NCT02642536|3472985|B2|||Age||years|Mean|58.3|58.3|Standard Deviation|9.5|9.5|||
3623921|NCT02642536|3472986|B1|||Age||years|Mean|59.65|59.65|Standard Deviation|8.9|8.9|||
3623922|NCT02642432|3473013|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3623923|NCT02642432|3473013|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3623924|NCT02642432|3473013|B1|||Age||years|Mean|60.12|60.12|Standard Deviation|10.43|10.43|||
3623925|NCT02642159|3473019|B3||Nicotinic acid|Intent to Prescribe Treatment|Randomization was stratified by the Investigator’s selection of usual care therapy prior to randomization. LMTs were only ‘intended to prescribe’ in the Alirocumab arm but not actually administered.|Participants|Count of Participants|3|3.0||||||
3623926|NCT02642159|3473020|B2||Nicotinic acid|Intent to Prescribe Treatment|Randomization was stratified by the Investigator’s selection of usual care therapy prior to randomization. LMTs were only ‘intended to prescribe’ in the Alirocumab arm but not actually administered.|Participants|Count of Participants|1|1.0||||||
3623927|NCT02642159|3473021|B1||Nicotinic acid|Intent to Prescribe Treatment|Randomization was stratified by the Investigator’s selection of usual care therapy prior to randomization. LMTs were only ‘intended to prescribe’ in the Alirocumab arm but not actually administered.|Participants|Count of Participants|2|2.0||||||
3623928|NCT02642159|3473019|B3||Omega-3 fatty acids|Intent to Prescribe Treatment|Randomization was stratified by the Investigator’s selection of usual care therapy prior to randomization. LMTs were only ‘intended to prescribe’ in the Alirocumab arm but not actually administered.|Participants|Count of Participants|64|64.0||||||
3623929|NCT02642159|3473020|B2||Omega-3 fatty acids|Intent to Prescribe Treatment|Randomization was stratified by the Investigator’s selection of usual care therapy prior to randomization. LMTs were only ‘intended to prescribe’ in the Alirocumab arm but not actually administered.|Participants|Count of Participants|21|21.0||||||
3623930|NCT02642159|3473021|B1||Omega-3 fatty acids|Intent to Prescribe Treatment|Randomization was stratified by the Investigator’s selection of usual care therapy prior to randomization. LMTs were only ‘intended to prescribe’ in the Alirocumab arm but not actually administered.|Participants|Count of Participants|43|43.0||||||
3623931|NCT02642159|3473019|B3||Ezetimibe|Intent to Prescribe Treatment|Randomization was stratified by the Investigator’s selection of usual care therapy prior to randomization. LMTs were only ‘intended to prescribe’ in the Alirocumab arm but not actually administered.|Participants|Count of Participants|156|156.0||||||
3623932|NCT02642159|3473020|B2||Ezetimibe|Intent to Prescribe Treatment|Randomization was stratified by the Investigator’s selection of usual care therapy prior to randomization. LMTs were only ‘intended to prescribe’ in the Alirocumab arm but not actually administered.|Participants|Count of Participants|52|52.0||||||
3623933|NCT02642159|3473021|B1||Ezetimibe|Intent to Prescribe Treatment|Randomization was stratified by the Investigator’s selection of usual care therapy prior to randomization. LMTs were only ‘intended to prescribe’ in the Alirocumab arm but not actually administered.|Participants|Count of Participants|104|104.0||||||
3623934|NCT02642159|3473019|B3||No additional LMT|Intent to Prescribe Treatment|Randomization was stratified by the Investigator’s selection of usual care therapy prior to randomization. LMTs were only ‘intended to prescribe’ in the Alirocumab arm but not actually administered.|Participants|Count of Participants|118|118.0||||||
3623935|NCT02642159|3473020|B2||No additional LMT|Intent to Prescribe Treatment|Randomization was stratified by the Investigator’s selection of usual care therapy prior to randomization. LMTs were only ‘intended to prescribe’ in the Alirocumab arm but not actually administered.|Participants|Count of Participants|39|39.0||||||
3623936|NCT02642159|3473021|B1||No additional LMT|Intent to Prescribe Treatment|Randomization was stratified by the Investigator’s selection of usual care therapy prior to randomization. LMTs were only ‘intended to prescribe’ in the Alirocumab arm but not actually administered.|Participants|Count of Participants|79|79.0||||||
3623937|NCT02642159|3473019|B3||Fenofibrate|Intent to Prescribe Treatment|Randomization was stratified by the Investigator’s selection of usual care therapy prior to randomization. LMTs were only ‘intended to prescribe’ in the Alirocumab arm but not actually administered.|Participants|Count of Participants|72|72.0||||||
3623938|NCT02642159|3473020|B2||Fenofibrate|Intent to Prescribe Treatment|Randomization was stratified by the Investigator’s selection of usual care therapy prior to randomization. LMTs were only ‘intended to prescribe’ in the Alirocumab arm but not actually administered.|Participants|Count of Participants|24|24.0||||||
3623939|NCT02642159|3473021|B1||Fenofibrate|Intent to Prescribe Treatment|Randomization was stratified by the Investigator’s selection of usual care therapy prior to randomization. LMTs were only ‘intended to prescribe’ in the Alirocumab arm but not actually administered.|Participants|Count of Participants|48|48.0||||||
3623940|NCT02642159|3473019|B3|||Non-HDL-C|non-HDL-C = Total-C minus HDL-C|mmol/L|Mean|4.073|4.073|Standard Deviation|1.221|1.221|||
3623941|NCT02642159|3473020|B2|||Non-HDL-C|non-HDL-C = Total-C minus HDL-C|mmol/L|Mean|4.2|4.2|Standard Deviation|1.2|1.2|||
3623942|NCT02642159|3473021|B1|||Non-HDL-C|non-HDL-C = Total-C minus HDL-C|mmol/L|Mean|4.0|4.0|Standard Deviation|1.2|1.2|||
3623943|NCT02642159|3473019|B3|||Non-HDL-C|non-HDL-C = Total cholesterol (Total-C) minus high-density lipoprotein cholesterol (HDL-C)|mg/dL|Mean|157.2|157.2|Standard Deviation|47.1|47.1|||
3623944|NCT02642159|3473020|B2|||Non-HDL-C|non-HDL-C = Total cholesterol (Total-C) minus high-density lipoprotein cholesterol (HDL-C)|mg/dL|Mean|161.5|161.5|Standard Deviation|48.8|48.8|||
3623945|NCT02642159|3473021|B1|||Non-HDL-C|non-HDL-C = Total cholesterol (Total-C) minus high-density lipoprotein cholesterol (HDL-C)|mg/dL|Mean|155.1|155.1|Standard Deviation|46.2|46.2|||
3623946|NCT02642159|3473019|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3623947|NCT02642159|3473020|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3623948|NCT02642159|3473021|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3623949|NCT02642159|3473019|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623950|NCT02642159|3473020|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623951|NCT02642159|3473021|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623952|NCT02642159|3473019|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3623953|NCT02642159|3473020|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3623954|NCT02642159|3473021|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3623955|NCT02642159|3473019|B3|Asian/Oriental||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3623956|NCT02642159|3473020|B2|Asian/Oriental||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3623957|NCT02642159|3473021|B1|Asian/Oriental||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3623958|NCT02642159|3473019|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3623959|NCT02642159|3473020|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3623960|NCT02642159|3473021|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3623961|NCT02642159|3473019|B3|White/Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|370|370.0||||||
3623962|NCT02642159|3473020|B2|White/Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|123|123.0||||||
3623963|NCT02642159|3473021|B1|White/Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|247|247.0||||||
3623964|NCT02642159|3473019|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3623965|NCT02642159|3473020|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3623966|NCT02642159|3473021|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3623967|NCT02642159|3473019|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|363|363.0||||||
3623968|NCT02642159|3473020|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
3623969|NCT02642159|3473021|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|240|240.0||||||
3623970|NCT02642159|3473019|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3623971|NCT02642159|3473020|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3623972|NCT02642159|3473021|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3623973|NCT02642159|3473019|B3||Male|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
3623974|NCT02642159|3473020|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3623975|NCT02642159|3473021|B1||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3623976|NCT02642159|3473019|B3||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
3623977|NCT02642159|3473020|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3623978|NCT02642159|3473021|B1||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3623979|NCT02642159|3473019|B3|||Age||years|Mean|63.2|63.2|Standard Deviation|9.2|9.2|||
3623980|NCT02642159|3473020|B2|||Age||years|Mean|64.1|64.1|Standard Deviation|8.8|8.8|||
3623981|NCT02642159|3473021|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|9.3|9.3|||
3623982|NCT02641912|3473072|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3623983|NCT02641912|3473073|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3623984|NCT02641912|3473074|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3623985|NCT02641912|3473072|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3623986|NCT02641912|3473073|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3623987|NCT02641912|3473074|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3623988|NCT02641912|3473072|B3|||Age||Years|Mean|51.09|51.09|Standard Deviation|14.210|14.21|||
3623989|NCT02641912|3473073|B2|||Age||Years|Mean|51.57|51.57|Standard Deviation|14.111|14.111|||
3623990|NCT02641912|3473074|B1|||Age||Years|Mean|50.66|50.66|Standard Deviation|14.418|14.418|||
3623991|NCT02641561|3473143|B5|United States||Region of Enrollment||participants|Number|192|192.0||||||
3623992|NCT02641561|3473144|B4|United States||Region of Enrollment||participants|Number|48|48.0||||||
3623993|NCT02641561|3473145|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
3623994|NCT02641561|3473146|B2|United States||Region of Enrollment||participants|Number|48|48.0||||||
3623995|NCT02641561|3473147|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
3623996|NCT02641561|3473143|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3623997|NCT02641561|3473144|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3623998|NCT02641561|3473145|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3623999|NCT02641561|3473146|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3624000|NCT02641561|3473147|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3624001|NCT02641561|3473143|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3624002|NCT02641561|3473144|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624003|NCT02641561|3473145|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624004|NCT02641561|3473146|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624005|NCT02641561|3473147|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3624006|NCT02641561|3473143|B5||White|Race (NIH/OMB)||Participants|Count of Participants|147|147.0||||||
3624007|NCT02641561|3473144|B4||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3624008|NCT02641561|3473145|B3||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3624009|NCT02641561|3473146|B2||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3624010|NCT02641561|3473147|B1||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3624011|NCT02641561|3473143|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3624012|NCT02641561|3473144|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3624013|NCT02641561|3473145|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3624014|NCT02641561|3473146|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3624015|NCT02641561|3473147|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3624016|NCT02641561|3473143|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624017|NCT02641561|3473144|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624018|NCT02641561|3473145|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624019|NCT02641561|3473146|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624020|NCT02641561|3473147|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624021|NCT02641561|3473143|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3624022|NCT02641561|3473144|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3624023|NCT02641561|3473145|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3624024|NCT02641561|3473146|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3624025|NCT02641561|3473147|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3624026|NCT02641561|3473143|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624027|NCT02641561|3473144|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624028|NCT02641561|3473145|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624029|NCT02641561|3473146|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624030|NCT02641561|3473147|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624031|NCT02641561|3473143|B5||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3624032|NCT02641561|3473144|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3624033|NCT02641561|3473145|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3624034|NCT02641561|3473146|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3624035|NCT02641561|3473147|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3624036|NCT02641561|3473143|B5||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3624037|NCT02641561|3473144|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3624038|NCT02641561|3473145|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3624039|NCT02641561|3473146|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3624040|NCT02641561|3473147|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3624041|NCT02641561|3473143|B5|||Age||years|Mean|60|60.0|Full Range|||19.0|92.0|
3624042|NCT02641561|3473144|B4|||Age||years|Mean|63|63.0|Full Range|||26.0|85.0|
3624043|NCT02641561|3473145|B3|||Age||years|Mean|58|58.0|Full Range|||25.0|91.0|
3624044|NCT02641561|3473146|B2|||Age||years|Mean|62|62.0|Full Range|||19.0|92.0|
3624045|NCT02641561|3473147|B1|||Age||years|Mean|58|58.0|Full Range|||25.0|82.0|
3624046|NCT02641522|3473236|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3624047|NCT02641522|3473236|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624048|NCT02641522|3473236|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624049|NCT02641522|3473236|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3624050|NCT02641522|3473236|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624051|NCT02641522|3473236|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3624052|NCT02641522|3473236|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624053|NCT02641522|3473236|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624054|NCT02641522|3473236|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624055|NCT02641522|3473236|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3624056|NCT02641522|3473236|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624057|NCT02641522|3473236|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3624058|NCT02641522|3473236|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3624059|NCT02641522|3473236|B1|||Age||years|Mean|27.1|27.1|Standard Deviation|6.5|6.5|||
3624060|NCT02641522|3473236|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3624061|NCT02641522|3473236|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3624062|NCT02641522|3473236|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3624063|NCT02641379|3473240|B12||Male|Sex: Female, Male||Participants|Count of Participants|470|470.0||||||
3624064|NCT02641379|3473241|B11||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3624065|NCT02641379|3473242|B10||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3624066|NCT02641379|3473243|B9||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3624067|NCT02641379|3473244|B8||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3624068|NCT02641379|3473245|B7||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3624069|NCT02641379|3473246|B6||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3624070|NCT02641379|3473247|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3624071|NCT02641379|3473248|B4||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3624072|NCT02641379|3473249|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3624073|NCT02641379|3473250|B2||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3624074|NCT02641379|3473251|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3624075|NCT02641379|3473240|B12||Female|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
3624076|NCT02641379|3473241|B11||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3624077|NCT02641379|3473242|B10||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3624078|NCT02641379|3473243|B9||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3624079|NCT02641379|3473244|B8||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3624080|NCT02641379|3473245|B7||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3624081|NCT02641379|3473246|B6||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3624082|NCT02641379|3473247|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3624083|NCT02641379|3473248|B4||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3624084|NCT02641379|3473249|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3624085|NCT02641379|3473250|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3624086|NCT02641379|3473251|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3624087|NCT02641379|3473240|B12|||Age||years|Mean|43.5|43.5|Standard Deviation|10.78|10.78|||
3624088|NCT02641379|3473241|B11|||Age||years|Mean|43.6|43.6|Standard Deviation|15.4|15.4|||
3624089|NCT02641379|3473242|B10|||Age||years|Mean|41.1|41.1|Standard Deviation|10.2|10.2|||
3624090|NCT02641379|3473243|B9|||Age||years|Mean|37.8|37.8|Standard Deviation|11.1|11.1|||
3624091|NCT02641379|3473244|B8|||Age||years|Mean|46.6|46.6|Standard Deviation|8.7|8.7|||
3624092|NCT02641379|3473245|B7|||Age||years|Mean|47.3|47.3|Standard Deviation|9.8|9.8|||
3624093|NCT02641379|3473246|B6|||Age||years|Mean|44.6|44.6|Standard Deviation|9.1|9.1|||
3624094|NCT02641379|3473247|B5|||Age||years|Mean|46.5|46.5|Standard Deviation|9.5|9.5|||
3624095|NCT02641379|3473248|B4|||Age||years|Mean|40.5|40.5|Standard Deviation|11.7|11.7|||
3624096|NCT02641379|3473249|B3|||Age||years|Mean|46.6|46.6|Standard Deviation|9.0|9.0|||
3624097|NCT02641379|3473250|B2|||Age||years|Mean|44.2|44.2|Standard Deviation|10.2|10.2|||
3624098|NCT02641379|3473251|B1|||Age||years|Mean|45.0|45.0|Standard Deviation|10.7|10.7|||
3624099|NCT02641249|3473326|B1|||Caffeine use|Information was obtained from medical charts for caffeine use|Participants|Count of Participants|16|16.0||||||
3624100|NCT02641249|3473326|B1|||Oxygen use|Information regarding the fraction of inspired oxygen (FiO2) was obtained along with the mode of assisted ventilation (nasal cannula, CPAP, non-invasive ventilation etc.)|Participants|Count of Participants|15|15.0||||||
3624101|NCT02641249|3473326|B1|||Birth Weight|Birth weight in grams was obtained from medical records|grams|Mean|1213|1213.0|Standard Deviation|510|510.0|||
3624102|NCT02641249|3473326|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3624103|NCT02641249|3473326|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624104|NCT02641249|3473326|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624105|NCT02641249|3473326|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3624106|NCT02641249|3473326|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3624107|NCT02641249|3473326|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624108|NCT02641249|3473326|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3624109|NCT02641249|3473326|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624110|NCT02641249|3473326|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624111|NCT02641249|3473326|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3624112|NCT02641249|3473326|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3624113|NCT02641249|3473326|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3624114|NCT02641249|3473326|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3624115|NCT02641249|3473326|B1|||Age|gestational age in weeks|weeks|Mean|28.9|28.9|Standard Deviation|2.1|2.1|||
3624116|NCT02641249|3473326|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3624117|NCT02641249|3473326|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3624118|NCT02641249|3473326|B1||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
3624119|NCT02640612|3473335|B4||Unknown or Not Reported|Race (NIH/OMB)|Race of all patients included in the trial|Participants|Count of Participants|1|1.0||||||
3624120|NCT02640612|3473336|B3||Unknown or Not Reported|Race (NIH/OMB)|Race of all patients included in the trial|Participants|Count of Participants|0|0.0||||||
3624121|NCT02640612|3473337|B2||Unknown or Not Reported|Race (NIH/OMB)|Race of all patients included in the trial|Participants|Count of Participants|1|1.0||||||
3624122|NCT02640612|3473338|B1||Unknown or Not Reported|Race (NIH/OMB)|Race of all patients included in the trial|Participants|Count of Participants|0|0.0||||||
3624123|NCT02640612|3473335|B4||More than one race|Race (NIH/OMB)|Race of all patients included in the trial|Participants|Count of Participants|0|0.0||||||
3624124|NCT02640612|3473336|B3||More than one race|Race (NIH/OMB)|Race of all patients included in the trial|Participants|Count of Participants|0|0.0||||||
3624125|NCT02640612|3473337|B2||More than one race|Race (NIH/OMB)|Race of all patients included in the trial|Participants|Count of Participants|0|0.0||||||
3624126|NCT02640612|3473338|B1||More than one race|Race (NIH/OMB)|Race of all patients included in the trial|Participants|Count of Participants|0|0.0||||||
3624127|NCT02640612|3473335|B4||White|Race (NIH/OMB)|Race of all patients included in the trial|Participants|Count of Participants|415|415.0||||||
3624128|NCT02640612|3473336|B3||White|Race (NIH/OMB)|Race of all patients included in the trial|Participants|Count of Participants|100|100.0||||||
3624129|NCT02640612|3473337|B2||White|Race (NIH/OMB)|Race of all patients included in the trial|Participants|Count of Participants|100|100.0||||||
3624130|NCT02640612|3473338|B1||White|Race (NIH/OMB)|Race of all patients included in the trial|Participants|Count of Participants|215|215.0||||||
3624131|NCT02640612|3473335|B4||Black or African American|Race (NIH/OMB)|Race of all patients included in the trial|Participants|Count of Participants|5|5.0||||||
3624132|NCT02640612|3473336|B3||Black or African American|Race (NIH/OMB)|Race of all patients included in the trial|Participants|Count of Participants|2|2.0||||||
3624133|NCT02640612|3473337|B2||Black or African American|Race (NIH/OMB)|Race of all patients included in the trial|Participants|Count of Participants|0|0.0||||||
3624134|NCT02640612|3473338|B1||Black or African American|Race (NIH/OMB)|Race of all patients included in the trial|Participants|Count of Participants|3|3.0||||||
3624135|NCT02640612|3473335|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race of all patients included in the trial|Participants|Count of Participants|0|0.0||||||
3624136|NCT02640612|3473336|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race of all patients included in the trial|Participants|Count of Participants|0|0.0||||||
3624137|NCT02640612|3473337|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race of all patients included in the trial|Participants|Count of Participants|0|0.0||||||
3624138|NCT02640612|3473338|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race of all patients included in the trial|Participants|Count of Participants|0|0.0||||||
3624139|NCT02640612|3473335|B4||Asian|Race (NIH/OMB)|Race of all patients included in the trial|Participants|Count of Participants|9|9.0||||||
3624140|NCT02640612|3473336|B3||Asian|Race (NIH/OMB)|Race of all patients included in the trial|Participants|Count of Participants|0|0.0||||||
3624141|NCT02640612|3473337|B2||Asian|Race (NIH/OMB)|Race of all patients included in the trial|Participants|Count of Participants|2|2.0||||||
3624142|NCT02640612|3473338|B1||Asian|Race (NIH/OMB)|Race of all patients included in the trial|Participants|Count of Participants|7|7.0||||||
3624143|NCT02640612|3473335|B4||American Indian or Alaska Native|Race (NIH/OMB)|Race of all patients included in the trial|Participants|Count of Participants|0|0.0||||||
3624144|NCT02640612|3473336|B3||American Indian or Alaska Native|Race (NIH/OMB)|Race of all patients included in the trial|Participants|Count of Participants|0|0.0||||||
3624145|NCT02640612|3473337|B2||American Indian or Alaska Native|Race (NIH/OMB)|Race of all patients included in the trial|Participants|Count of Participants|0|0.0||||||
3624146|NCT02640612|3473338|B1||American Indian or Alaska Native|Race (NIH/OMB)|Race of all patients included in the trial|Participants|Count of Participants|0|0.0||||||
3624147|NCT02640612|3473335|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)|Ethnicity of all patients included in the trial|Participants|Count of Participants|4|4.0||||||
3624148|NCT02640612|3473336|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)|Ethnicity of all patients included in the trial|Participants|Count of Participants|0|0.0||||||
3624149|NCT02640612|3473337|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)|Ethnicity of all patients included in the trial|Participants|Count of Participants|1|1.0||||||
3624150|NCT02640612|3473338|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|Ethnicity of all patients included in the trial|Participants|Count of Participants|3|3.0||||||
3624151|NCT02640612|3473335|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity of all patients included in the trial|Participants|Count of Participants|385|385.0||||||
3624152|NCT02640612|3473336|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity of all patients included in the trial|Participants|Count of Participants|92|92.0||||||
3624153|NCT02640612|3473337|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity of all patients included in the trial|Participants|Count of Participants|94|94.0||||||
3624154|NCT02640612|3473338|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity of all patients included in the trial|Participants|Count of Participants|199|199.0||||||
3624155|NCT02640612|3473335|B4||Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity of all patients included in the trial|Participants|Count of Participants|41|41.0||||||
3624156|NCT02640612|3473336|B3||Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity of all patients included in the trial|Participants|Count of Participants|10|10.0||||||
3624157|NCT02640612|3473337|B2||Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity of all patients included in the trial|Participants|Count of Participants|8|8.0||||||
3624158|NCT02640612|3473338|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity of all patients included in the trial|Participants|Count of Participants|23|23.0||||||
3624159|NCT02640612|3473335|B4||Male|Sex: Female, Male|Gender distribution of all patients included in the trial.|Participants|Count of Participants|70|70.0||||||
3624160|NCT02640612|3473336|B3||Male|Sex: Female, Male|Gender distribution of all patients included in the trial.|Participants|Count of Participants|18|18.0||||||
3624161|NCT02640612|3473337|B2||Male|Sex: Female, Male|Gender distribution of all patients included in the trial.|Participants|Count of Participants|15|15.0||||||
3624162|NCT02640612|3473338|B1||Male|Sex: Female, Male|Gender distribution of all patients included in the trial.|Participants|Count of Participants|37|37.0||||||
3624163|NCT02640612|3473335|B4||Female|Sex: Female, Male|Gender distribution of all patients included in the trial.|Participants|Count of Participants|360|360.0||||||
3624164|NCT02640612|3473336|B3||Female|Sex: Female, Male|Gender distribution of all patients included in the trial.|Participants|Count of Participants|84|84.0||||||
3624165|NCT02640612|3473337|B2||Female|Sex: Female, Male|Gender distribution of all patients included in the trial.|Participants|Count of Participants|88|88.0||||||
3624166|NCT02640612|3473338|B1||Female|Sex: Female, Male|Gender distribution of all patients included in the trial.|Participants|Count of Participants|188|188.0||||||
3624167|NCT02640612|3473335|B4|||Age|Age of all patients included in the trial|Years|Mean|53.5|53.5|Standard Deviation|11.30|11.3|||
3624168|NCT02640612|3473336|B3|||Age|Age of all patients included in the trial|Years|Mean|54.6|54.6|Standard Deviation|9.90|9.9|||
3624169|NCT02640612|3473337|B2|||Age|Age of all patients included in the trial|Years|Mean|51.7|51.7|Standard Deviation|11.21|11.21|||
3624170|NCT02640612|3473338|B1|||Age|Age of all patients included in the trial|Years|Mean|53.8|53.8|Standard Deviation|11.87|11.87|||
3624171|NCT02640547|3473360|B1||Cirrhosis|Cirrhosis Status||Participants|Count of Participants|125|125.0||||||
3624172|NCT02640547|3473360|B1||Transition to cirrhosis|Cirrhosis Status||Participants|Count of Participants|58|58.0||||||
3624173|NCT02640547|3473360|B1||No cirrhosis|Cirrhosis Status||Participants|Count of Participants|211|211.0||||||
3624174|NCT02640547|3473360|B1||Genotype 4|HCV Genotype||Participants|Count of Participants|20|20.0||||||
3624175|NCT02640547|3473360|B1||Genotype 1b|HCV Genotype||Participants|Count of Participants|349|349.0||||||
3624176|NCT02640547|3473360|B1||Genotype 1a/1b|HCV Genotype||Participants|Count of Participants|1|1.0||||||
3624177|NCT02640547|3473360|B1||Genotype 1a|HCV Genotype||Participants|Count of Participants|24|24.0||||||
3624178|NCT02640547|3473360|B1|||Years Since Diagnosis of HCV Infection||years|Mean|6.6|6.6|Standard Deviation|5.94|5.94|||
3624179|NCT02640547|3473360|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|394|394.0||||||
3624180|NCT02640547|3473360|B1||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
3624181|NCT02640547|3473360|B1||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
3624182|NCT02640547|3473360|B1||66 to 84 years|Age, Customized||Participants|Count of Participants|78|78.0||||||
3624183|NCT02640547|3473360|B1||18 to 65 years|Age, Customized||Participants|Count of Participants|316|316.0||||||
3624184|NCT02640547|3473360|B1|||Age||years|Mean|54|54.0|Standard Deviation|14.3|14.3|||
3624185|NCT02640482|3473435|B3||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3624186|NCT02640482|3473436|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3624187|NCT02640482|3473437|B1||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3624188|NCT02640482|3473435|B3||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
3624189|NCT02640482|3473436|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3624190|NCT02640482|3473437|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3624191|NCT02640482|3473435|B3|||Age||years|Mean|57.04|57.04|Standard Deviation|12.53|12.53|||
3624192|NCT02640482|3473436|B2|||Age||years|Mean|57.60|57.6|Standard Deviation|12.04|12.04|||
3624193|NCT02640482|3473437|B1|||Age||years|Mean|56.77|56.77|Standard Deviation|12.79|12.79|||
3624194|NCT02640404|3473448|B3|Vietnam||Region of Enrollment||participants|Number|224|224.0||||||
3624195|NCT02640404|3473449|B2|Vietnam||Region of Enrollment||participants|Number|112|112.0||||||
3624196|NCT02640404|3473450|B1|Vietnam||Region of Enrollment||participants|Number|112|112.0||||||
3624197|NCT02640404|3473448|B3||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3624198|NCT02640404|3473449|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3624199|NCT02640404|3473450|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3624200|NCT02640404|3473448|B3||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3624201|NCT02640404|3473449|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3624202|NCT02640404|3473450|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3624203|NCT02640404|3473448|B3|18 to 55 years||Age, Customized||Participants|Count of Participants|36|36.0||||||
3624204|NCT02640404|3473449|B2|18 to 55 years||Age, Customized||Participants|Count of Participants|36|36.0||||||
3624205|NCT02640404|3473450|B1|18 to 55 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3624206|NCT02640404|3473448|B3|12 to 17 years||Age, Customized||Participants|Count of Participants|33|33.0||||||
3624207|NCT02640404|3473449|B2|12 to 17 years||Age, Customized||Participants|Count of Participants|33|33.0||||||
3624208|NCT02640404|3473450|B1|12 to 17 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3624209|NCT02640404|3473448|B3|2 to 11 years||Age, Customized||Participants|Count of Participants|43|43.0||||||
3624210|NCT02640404|3473449|B2|2 to 11 years||Age, Customized||Participants|Count of Participants|43|43.0||||||
3624211|NCT02640404|3473450|B1|2 to 11 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3624212|NCT02640404|3473448|B3|9 to 23 months||Age, Customized||Participants|Count of Participants|112|112.0||||||
3624213|NCT02640404|3473449|B2|9 to 23 months||Age, Customized||Participants|Count of Participants|0|0.0||||||
3624214|NCT02640404|3473450|B1|9 to 23 months||Age, Customized||Participants|Count of Participants|112|112.0||||||
3624215|NCT02640157|3473459|B4||Male|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
3624216|NCT02640157|3473460|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3624217|NCT02640157|3473461|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3624218|NCT02640157|3473462|B1||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3624219|NCT02640157|3473459|B4||Female|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
3624220|NCT02640157|3473460|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3624221|NCT02640157|3473461|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3624222|NCT02640157|3473462|B1||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3624223|NCT02640157|3473459|B4|||Age||years|Mean|46.61|46.61|Standard Deviation|11.32|11.32|||
3624224|NCT02640157|3473460|B3|||Age||years|Mean|45.43|45.43|Standard Deviation|12.19|12.19|||
3624225|NCT02640157|3473461|B2|||Age||years|Mean|47.06|47.06|Standard Deviation|11.31|11.31|||
3624226|NCT02640157|3473462|B1|||Age||years|Mean|47.18|47.18|Standard Deviation|10.68|10.68|||
3624227|NCT02640053|3473481|B3||1|ECOG Performance Status|Eastern Cooperative Oncology Group PS Scale: 0)Fully active, able to carry on all pre-disease performance without restriction; 1)Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2)Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours; 3)Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours; 4)Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair.|Participants|Count of Participants|6|6.0||||||
3624265|NCT02640053|3473483|B1|||Age||years|Median|53.0|53.0|Full Range|||33.0|70.0|
3624266|NCT02639637|3473504|B4|||Fasting glucose||mg/dL|Mean|88.0|88.0|Standard Deviation|15.3|15.3|||
3624267|NCT02639637|3473505|B3|||Fasting glucose||mg/dL|Mean|80.4|80.4|Standard Deviation|4.4|4.4|||
3624268|NCT02639637|3473506|B2|||Fasting glucose||mg/dL|Mean|105.7|105.7|Standard Deviation|12.7|12.7|||
3624228|NCT02640053|3473482|B2||1|ECOG Performance Status|Eastern Cooperative Oncology Group PS Scale: 0)Fully active, able to carry on all pre-disease performance without restriction; 1)Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2)Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours; 3)Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours; 4)Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair.|Participants|Count of Participants|3|3.0||||||
3624229|NCT02640053|3473483|B1||1|ECOG Performance Status|Eastern Cooperative Oncology Group PS Scale: 0)Fully active, able to carry on all pre-disease performance without restriction; 1)Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2)Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours; 3)Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours; 4)Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair.|Participants|Count of Participants|3|3.0||||||
3624230|NCT02640053|3473481|B3||0|ECOG Performance Status|Eastern Cooperative Oncology Group PS Scale: 0)Fully active, able to carry on all pre-disease performance without restriction; 1)Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2)Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours; 3)Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours; 4)Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair.|Participants|Count of Participants|36|36.0||||||
3624231|NCT02640053|3473482|B2||0|ECOG Performance Status|Eastern Cooperative Oncology Group PS Scale: 0)Fully active, able to carry on all pre-disease performance without restriction; 1)Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2)Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours; 3)Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours; 4)Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair.|Participants|Count of Participants|18|18.0||||||
3624232|NCT02640053|3473483|B1||0|ECOG Performance Status|Eastern Cooperative Oncology Group PS Scale: 0)Fully active, able to carry on all pre-disease performance without restriction; 1)Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2)Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours; 3)Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours; 4)Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair.|Participants|Count of Participants|18|18.0||||||
3624233|NCT02640053|3473481|B3|United States||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3624234|NCT02640053|3473482|B2|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3624235|NCT02640053|3473483|B1|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3624236|NCT02640053|3473481|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624237|NCT02640053|3473482|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624238|NCT02640053|3473483|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624239|NCT02640053|3473481|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624240|NCT02640053|3473482|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624241|NCT02640053|3473483|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624242|NCT02640053|3473481|B3||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3624243|NCT02640053|3473482|B2||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3624244|NCT02640053|3473483|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3624245|NCT02640053|3473481|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624246|NCT02640053|3473482|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624247|NCT02640053|3473483|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624248|NCT02640053|3473481|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624249|NCT02640053|3473482|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624250|NCT02640053|3473483|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624251|NCT02640053|3473481|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624252|NCT02640053|3473482|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624253|NCT02640053|3473483|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624254|NCT02640053|3473481|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624255|NCT02640053|3473482|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624256|NCT02640053|3473483|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624257|NCT02640053|3473481|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3624258|NCT02640053|3473482|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3624259|NCT02640053|3473483|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3624260|NCT02640053|3473481|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3624261|NCT02640053|3473482|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3624262|NCT02640053|3473483|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3624263|NCT02640053|3473481|B3|||Age||years|Median|53.0|53.0|Full Range|||27.0|80.0|
3624264|NCT02640053|3473482|B2|||Age||years|Median|55.0|55.0|Full Range|||27.0|80.0|
3624269|NCT02639637|3473507|B1|||Fasting glucose||mg/dL|Mean|78.3|78.3|Standard Deviation|12.7|12.7|||
3624270|NCT02639637|3473504|B4|||Hemoglobin A1c||percentage of hemoglobin|Mean|5.6|5.6|Standard Deviation|0.8|0.8|||
3624271|NCT02639637|3473505|B3|||Hemoglobin A1c||percentage of hemoglobin|Mean|5.0|5.0|Standard Deviation|0.2|0.2|||
3624272|NCT02639637|3473506|B2|||Hemoglobin A1c||percentage of hemoglobin|Mean|6.6|6.6|Standard Deviation|0.2|0.2|||
3624273|NCT02639637|3473507|B1|||Hemoglobin A1c||percentage of hemoglobin|Mean|5.2|5.2|Standard Deviation|0.6|0.6|||
3624274|NCT02639637|3473504|B4|||Body mass index||kg/m^2|Mean|28.4|28.4|Standard Deviation|6.3|6.3|||
3624275|NCT02639637|3473505|B3|||Body mass index||kg/m^2|Mean|25.7|25.7|Standard Deviation|2.0|2.0|||
3624276|NCT02639637|3473506|B2|||Body mass index||kg/m^2|Mean|33.6|33.6|Standard Deviation|8.7|8.7|||
3624277|NCT02639637|3473507|B1|||Body mass index||kg/m^2|Mean|25.9|25.9|Standard Deviation|2.7|2.7|||
3624278|NCT02639637|3473504|B4|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3624279|NCT02639637|3473505|B3|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3624280|NCT02639637|3473506|B2|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3624281|NCT02639637|3473507|B1|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3624282|NCT02639637|3473504|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624283|NCT02639637|3473505|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624284|NCT02639637|3473506|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624285|NCT02639637|3473507|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624286|NCT02639637|3473504|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624287|NCT02639637|3473505|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624288|NCT02639637|3473506|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624289|NCT02639637|3473507|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624290|NCT02639637|3473504|B4||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3624291|NCT02639637|3473505|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3624292|NCT02639637|3473506|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3624293|NCT02639637|3473507|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3624294|NCT02639637|3473504|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3624295|NCT02639637|3473505|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624296|NCT02639637|3473506|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3624297|NCT02639637|3473507|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3624298|NCT02639637|3473504|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624299|NCT02639637|3473505|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624300|NCT02639637|3473506|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624301|NCT02639637|3473507|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624302|NCT02639637|3473504|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3624303|NCT02639637|3473505|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624304|NCT02639637|3473506|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3624305|NCT02639637|3473507|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624306|NCT02639637|3473504|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624307|NCT02639637|3473505|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624308|NCT02639637|3473506|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624309|NCT02639637|3473507|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624310|NCT02639637|3473504|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3624311|NCT02639637|3473505|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3624312|NCT02639637|3473506|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3624313|NCT02639637|3473507|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3624314|NCT02639637|3473504|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3624315|NCT02639637|3473505|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3624316|NCT02639637|3473506|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3624317|NCT02639637|3473507|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3624318|NCT02639637|3473504|B4|||Age||years|Mean|36.2|36.2|Standard Deviation|9.7|9.7|||
3624319|NCT02639637|3473505|B3|||Age||years|Mean|31.4|31.4|Standard Deviation|9.0|9.0|||
3624320|NCT02639637|3473506|B2|||Age||years|Mean|43.6|43.6|Standard Deviation|6.0|6.0|||
3624321|NCT02639637|3473507|B1|||Age||years|Mean|33.2|33.2|Standard Deviation|10.0|10.0|||
3624322|NCT02639494|3473572|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3624323|NCT02639494|3473572|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624324|NCT02639494|3473572|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624325|NCT02639494|3473572|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3624438|NCT02639247|3473606|B3|Canada||Region of Enrollment||participants|Number|38|38.0||||||
3624326|NCT02639494|3473572|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624327|NCT02639494|3473572|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624328|NCT02639494|3473572|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624329|NCT02639494|3473572|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624330|NCT02639494|3473572|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624331|NCT02639494|3473572|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3624332|NCT02639494|3473572|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624333|NCT02639494|3473572|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3624334|NCT02639494|3473572|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3624335|NCT02639494|3473572|B1|||Age||years|Mean|78.0|78.0|Standard Deviation|9.04|9.04|||
3624336|NCT02639338|3473587|B3|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|151|151.0||||||
3624337|NCT02639338|3473588|B2|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|81|81.0||||||
3624338|NCT02639338|3473589|B1|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|70|70.0||||||
3624339|NCT02639338|3473587|B3|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|68|68.0||||||
3624340|NCT02639338|3473588|B2|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|28|28.0||||||
3624341|NCT02639338|3473589|B1|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|40|40.0||||||
3624342|NCT02639338|3473587|B3|||HCV RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.73|0.73|||
3624343|NCT02639338|3473588|B2|||HCV RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.63|0.63|||
3624344|NCT02639338|3473589|B1|||HCV RNA||log10 IU/mL|Mean|6.0|6.0|Standard Deviation|0.80|0.8|||
3624345|NCT02639338|3473587|B3|TT||IL28b Status||Participants|Count of Participants|25|25.0||||||
3624346|NCT02639338|3473588|B2|TT||IL28b Status||Participants|Count of Participants|13|13.0||||||
3624347|NCT02639338|3473589|B1|TT||IL28b Status||Participants|Count of Participants|12|12.0||||||
3624348|NCT02639338|3473587|B3|CT||IL28b Status||Participants|Count of Participants|101|101.0||||||
3624349|NCT02639338|3473588|B2|CT||IL28b Status||Participants|Count of Participants|44|44.0||||||
3624350|NCT02639338|3473589|B1|CT||IL28b Status||Participants|Count of Participants|57|57.0||||||
3624351|NCT02639338|3473587|B3|CC||IL28b Status||Participants|Count of Participants|93|93.0||||||
3624352|NCT02639338|3473588|B2|CC||IL28b Status||Participants|Count of Participants|52|52.0||||||
3624353|NCT02639338|3473589|B1|CC||IL28b Status||Participants|Count of Participants|41|41.0||||||
3624354|NCT02639338|3473587|B3|Germany||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3624355|NCT02639338|3473588|B2|Germany||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3624356|NCT02639338|3473589|B1|Germany||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3624357|NCT02639338|3473587|B3|France||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3624358|NCT02639338|3473588|B2|France||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3624359|NCT02639338|3473589|B1|France||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3624360|NCT02639338|3473587|B3|Australia||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3624361|NCT02639338|3473588|B2|Australia||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3624362|NCT02639338|3473589|B1|Australia||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3624363|NCT02639338|3473587|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3624364|NCT02639338|3473588|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3624365|NCT02639338|3473589|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3624366|NCT02639338|3473587|B3|United States||Region of Enrollment||Participants|Count of Participants|96|96.0||||||
3624367|NCT02639338|3473588|B2|United States||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
3624368|NCT02639338|3473589|B1|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3624369|NCT02639338|3473587|B3|Canada||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3624370|NCT02639338|3473588|B2|Canada||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3624371|NCT02639338|3473589|B1|Canada||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3624372|NCT02639338|3473587|B3|New Zealand||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3624373|NCT02639338|3473588|B2|New Zealand||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3624374|NCT02639338|3473589|B1|New Zealand||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3624375|NCT02639338|3473587|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|202|202.0||||||
3624376|NCT02639338|3473588|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|101|101.0||||||
3624377|NCT02639338|3473589|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|101|101.0||||||
3624378|NCT02639338|3473587|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3624379|NCT02639338|3473588|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3624380|NCT02639338|3473589|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3624381|NCT02639338|3473587|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3624382|NCT02639338|3473588|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3624439|NCT02639247|3473607|B2|Canada||Region of Enrollment||participants|Number|20|20.0||||||
3624383|NCT02639338|3473589|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3624384|NCT02639338|3473587|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3624385|NCT02639338|3473588|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3624386|NCT02639338|3473589|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3624387|NCT02639338|3473587|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3624388|NCT02639338|3473588|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3624389|NCT02639338|3473589|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3624390|NCT02639338|3473587|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3624391|NCT02639338|3473588|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3624392|NCT02639338|3473589|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3624393|NCT02639338|3473587|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3624394|NCT02639338|3473588|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3624395|NCT02639338|3473589|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3624396|NCT02639338|3473587|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|197|197.0||||||
3624397|NCT02639338|3473588|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|97|97.0||||||
3624398|NCT02639338|3473589|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|100|100.0||||||
3624399|NCT02639338|3473587|B3||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3624400|NCT02639338|3473588|B2||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3624401|NCT02639338|3473589|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3624402|NCT02639338|3473587|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3624403|NCT02639338|3473588|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3624404|NCT02639338|3473589|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3624405|NCT02639338|3473587|B3|||Age||years|Mean|55|55.0|Standard Deviation|8.4|8.4|||
3624406|NCT02639338|3473588|B2|||Age||years|Mean|55|55.0|Standard Deviation|8.4|8.4|||
3624407|NCT02639338|3473589|B1|||Age||years|Mean|54|54.0|Standard Deviation|8.5|8.5|||
3624408|NCT02639247|3473606|B3|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|249|249.0||||||
3624409|NCT02639247|3473607|B2|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|113|113.0||||||
3624410|NCT02639247|3473608|B1|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|136|136.0||||||
3624411|NCT02639247|3473606|B3|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|84|84.0||||||
3624412|NCT02639247|3473607|B2|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|38|38.0||||||
3624413|NCT02639247|3473608|B1|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|46|46.0||||||
3624414|NCT02639247|3473606|B3|||HCV RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.61|0.61|||
3624415|NCT02639247|3473607|B2|||HCV RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.66|0.66|||
3624416|NCT02639247|3473608|B1|||HCV RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.56|0.56|||
3624417|NCT02639247|3473606|B3|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene|Participants|Count of Participants|69|69.0||||||
3624418|NCT02639247|3473607|B2|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene|Participants|Count of Participants|27|27.0||||||
3624419|NCT02639247|3473608|B1|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene|Participants|Count of Participants|42|42.0||||||
3624420|NCT02639247|3473606|B3|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene|Participants|Count of Participants|202|202.0||||||
3624421|NCT02639247|3473607|B2|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene|Participants|Count of Participants|95|95.0||||||
3624422|NCT02639247|3473608|B1|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene|Participants|Count of Participants|107|107.0||||||
3624423|NCT02639247|3473606|B3|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene|Participants|Count of Participants|62|62.0||||||
3624424|NCT02639247|3473607|B2|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene|Participants|Count of Participants|29|29.0||||||
3624425|NCT02639247|3473608|B1|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene|Participants|Count of Participants|33|33.0||||||
3624426|NCT02639247|3473606|B3|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
3624427|NCT02639247|3473607|B2|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3624428|NCT02639247|3473608|B1|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
3624429|NCT02639247|3473606|B3|New Zealand||Region of Enrollment||participants|Number|3|3.0||||||
3624430|NCT02639247|3473607|B2|New Zealand||Region of Enrollment||participants|Number|2|2.0||||||
3624431|NCT02639247|3473608|B1|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
3624432|NCT02639247|3473606|B3|Germany||Region of Enrollment||participants|Number|24|24.0||||||
3624433|NCT02639247|3473607|B2|Germany||Region of Enrollment||participants|Number|10|10.0||||||
3624434|NCT02639247|3473608|B1|Germany||Region of Enrollment||participants|Number|14|14.0||||||
3624435|NCT02639247|3473606|B3|France||Region of Enrollment||participants|Number|45|45.0||||||
3624436|NCT02639247|3473607|B2|France||Region of Enrollment||participants|Number|19|19.0||||||
3624437|NCT02639247|3473608|B1|France||Region of Enrollment||participants|Number|26|26.0||||||
3624440|NCT02639247|3473608|B1|Canada||Region of Enrollment||participants|Number|18|18.0||||||
3624441|NCT02639247|3473606|B3|Australia||Region of Enrollment||participants|Number|23|23.0||||||
3624442|NCT02639247|3473607|B2|Australia||Region of Enrollment||participants|Number|10|10.0||||||
3624443|NCT02639247|3473608|B1|Australia||Region of Enrollment||participants|Number|13|13.0||||||
3624444|NCT02639247|3473606|B3|United States||Region of Enrollment||participants|Number|188|188.0||||||
3624445|NCT02639247|3473607|B2|United States||Region of Enrollment||participants|Number|87|87.0||||||
3624446|NCT02639247|3473608|B1|United States||Region of Enrollment||participants|Number|101|101.0||||||
3624447|NCT02639247|3473606|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|306|306.0||||||
3624448|NCT02639247|3473607|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|143|143.0||||||
3624449|NCT02639247|3473608|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|163|163.0||||||
3624450|NCT02639247|3473606|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3624451|NCT02639247|3473607|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3624452|NCT02639247|3473608|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3624453|NCT02639247|3473606|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3624454|NCT02639247|3473607|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3624455|NCT02639247|3473608|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3624456|NCT02639247|3473606|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3624457|NCT02639247|3473607|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3624458|NCT02639247|3473608|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3624459|NCT02639247|3473606|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3624460|NCT02639247|3473607|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3624461|NCT02639247|3473608|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3624462|NCT02639247|3473606|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3624463|NCT02639247|3473607|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3624464|NCT02639247|3473608|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3624465|NCT02639247|3473606|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3624466|NCT02639247|3473607|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3624467|NCT02639247|3473608|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3624468|NCT02639247|3473606|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|291|291.0||||||
3624469|NCT02639247|3473607|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|131|131.0||||||
3624470|NCT02639247|3473608|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|160|160.0||||||
3624471|NCT02639247|3473606|B3||Male|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
3624472|NCT02639247|3473607|B2||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3624473|NCT02639247|3473608|B1||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3624474|NCT02639247|3473606|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3624475|NCT02639247|3473607|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3624476|NCT02639247|3473608|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3624477|NCT02639247|3473606|B3|||Age||years|Mean|57|57.0|Standard Deviation|8.3|8.3|||
3624478|NCT02639247|3473607|B2|||Age||years|Mean|57|57.0|Standard Deviation|7.3|7.3|||
3624479|NCT02639247|3473608|B1|||Age||years|Mean|57|57.0|Standard Deviation|9.0|9.0|||
3624480|NCT02639052|3473625|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3624481|NCT02639052|3473625|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3624482|NCT02639052|3473625|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3624483|NCT02639052|3473625|B1|||Age||years|Mean|26.8|26.8|Standard Deviation|6.8|6.8|||
3624484|NCT02639052|3473625|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3624485|NCT02639052|3473625|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3624486|NCT02639052|3473625|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3624487|NCT02638493|3473639|B4|United States||Region of Enrollment||participants|Number|24|24.0||||||
3624488|NCT02638493|3473640|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3624489|NCT02638493|3473641|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3624490|NCT02638493|3473642|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3624491|NCT02638493|3473639|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3624492|NCT02638493|3473640|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3624493|NCT02638493|3473641|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3624494|NCT02638493|3473642|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3624495|NCT02638493|3473639|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3624496|NCT02638493|3473640|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3624497|NCT02638493|3473641|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3624498|NCT02638493|3473642|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3624499|NCT02638493|3473639|B4|||Age||years|Median|36.5|36.5|Full Range|||19.0|52.0|
3624500|NCT02638493|3473640|B3|||Age||years|Median|45.5|45.5|Full Range|||34.0|52.0|
3624501|NCT02638493|3473641|B2|||Age||years|Median|30.5|30.5|Full Range|||19.0|39.0|
3624502|NCT02638493|3473642|B1|||Age||years|Median|36.5|36.5|Full Range|||33.0|41.0|
3624503|NCT02638493|3473639|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3624504|NCT02638493|3473640|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3624505|NCT02638493|3473641|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3624506|NCT02638493|3473642|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3624507|NCT02638493|3473639|B4||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3624508|NCT02638493|3473640|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3624509|NCT02638493|3473641|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3624510|NCT02638493|3473642|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3624511|NCT02638493|3473639|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3624512|NCT02638493|3473640|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3624513|NCT02638493|3473641|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3624514|NCT02638493|3473642|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3624515|NCT02638259|3473673|B3|Estonia||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
3624516|NCT02638259|3473674|B2|Estonia||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3624517|NCT02638259|3473675|B1|Estonia||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3624518|NCT02638259|3473673|B3|Germany||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3624519|NCT02638259|3473674|B2|Germany||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3624520|NCT02638259|3473675|B1|Germany||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3624521|NCT02638259|3473673|B3|Serbia||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3624522|NCT02638259|3473674|B2|Serbia||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3624523|NCT02638259|3473675|B1|Serbia||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3624524|NCT02638259|3473673|B3|Lithuania||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3624525|NCT02638259|3473674|B2|Lithuania||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3624526|NCT02638259|3473675|B1|Lithuania||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3624527|NCT02638259|3473673|B3|Bulgaria||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3624528|NCT02638259|3473674|B2|Bulgaria||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3624529|NCT02638259|3473675|B1|Bulgaria||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3624530|NCT02638259|3473673|B3|Slovakia||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3624531|NCT02638259|3473674|B2|Slovakia||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3624532|NCT02638259|3473675|B1|Slovakia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3624533|NCT02638259|3473673|B3|Mexico||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3624534|NCT02638259|3473674|B2|Mexico||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3624535|NCT02638259|3473675|B1|Mexico||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3624536|NCT02638259|3473673|B3|Italy||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3624537|NCT02638259|3473674|B2|Italy||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3624538|NCT02638259|3473675|B1|Italy||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3624539|NCT02638259|3473673|B3|Poland||Region of Enrollment||Participants|Count of Participants|92|92.0||||||
3624540|NCT02638259|3473674|B2|Poland||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
3624541|NCT02638259|3473675|B1|Poland||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3624542|NCT02638259|3473673|B3|Latvia||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3624543|NCT02638259|3473674|B2|Latvia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3624544|NCT02638259|3473675|B1|Latvia||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3624545|NCT02638259|3473673|B3|Russia||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3624546|NCT02638259|3473674|B2|Russia||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3624547|NCT02638259|3473675|B1|Russia||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3624548|NCT02638259|3473673|B3|Spain||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3624549|NCT02638259|3473674|B2|Spain||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3624550|NCT02638259|3473675|B1|Spain||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3624551|NCT02638259|3473673|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3624552|NCT02638259|3473674|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3624553|NCT02638259|3473675|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3624554|NCT02638259|3473673|B3|Czechia||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3624555|NCT02638259|3473674|B2|Czechia||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3624556|NCT02638259|3473675|B1|Czechia||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3624557|NCT02638259|3473673|B3|United States||Region of Enrollment||Participants|Count of Participants|49|49.0||||||
3624558|NCT02638259|3473674|B2|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3624559|NCT02638259|3473675|B1|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3624560|NCT02638259|3473673|B3|Hungary||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3624561|NCT02638259|3473674|B2|Hungary||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3624562|NCT02638259|3473675|B1|Hungary||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3624563|NCT02638259|3473673|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624564|NCT02638259|3473674|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624565|NCT02638259|3473675|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624566|NCT02638259|3473673|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624567|NCT02638259|3473674|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624568|NCT02638259|3473675|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624569|NCT02638259|3473673|B3||White|Race (NIH/OMB)||Participants|Count of Participants|365|365.0||||||
3624570|NCT02638259|3473674|B2||White|Race (NIH/OMB)||Participants|Count of Participants|185|185.0||||||
3624571|NCT02638259|3473675|B1||White|Race (NIH/OMB)||Participants|Count of Participants|180|180.0||||||
3624572|NCT02638259|3473673|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3624573|NCT02638259|3473674|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3624574|NCT02638259|3473675|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3624575|NCT02638259|3473673|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624576|NCT02638259|3473674|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624577|NCT02638259|3473675|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624578|NCT02638259|3473673|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3624579|NCT02638259|3473674|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3624580|NCT02638259|3473675|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624581|NCT02638259|3473673|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3624582|NCT02638259|3473674|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3624583|NCT02638259|3473675|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3624584|NCT02638259|3473673|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3624585|NCT02638259|3473674|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3624586|NCT02638259|3473675|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3624587|NCT02638259|3473673|B3||Female|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
3624588|NCT02638259|3473674|B2||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3624589|NCT02638259|3473675|B1||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3624590|NCT02638259|3473673|B3|||Age||years|Mean|54.1|54.1|Standard Deviation|12.02|12.02|||
3624591|NCT02638259|3473674|B2|||Age||years|Mean|53.1|53.1|Standard Deviation|12.70|12.7|||
3624592|NCT02638259|3473675|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|11.22|11.22|||
3624593|NCT02638129|3473750|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624594|NCT02638129|3473751|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624595|NCT02638129|3473752|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624596|NCT02638129|3473750|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624597|NCT02638129|3473751|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624598|NCT02638129|3473752|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624599|NCT02638129|3473750|B3||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3624600|NCT02638129|3473751|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3624601|NCT02638129|3473752|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3624602|NCT02638129|3473750|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3624603|NCT02638129|3473751|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3624604|NCT02638129|3473752|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3624605|NCT02638129|3473750|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3624606|NCT02638129|3473751|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624607|NCT02638129|3473752|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3624608|NCT02638129|3473750|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3624609|NCT02638129|3473751|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624610|NCT02638129|3473752|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3624611|NCT02638129|3473750|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624612|NCT02638129|3473751|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624613|NCT02638129|3473752|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624614|NCT02638129|3473750|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624615|NCT02638129|3473751|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624616|NCT02638129|3473752|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624617|NCT02638129|3473750|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3624618|NCT02638129|3473751|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3624619|NCT02638129|3473752|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3624620|NCT02638129|3473750|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3624621|NCT02638129|3473751|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3624622|NCT02638129|3473752|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3624623|NCT02638129|3473750|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3624624|NCT02638129|3473751|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3624625|NCT02638129|3473752|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3624626|NCT02638129|3473750|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3624627|NCT02638129|3473751|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3624628|NCT02638129|3473752|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3624629|NCT02638129|3473750|B3|||Age||years|Mean|63.5|63.5|Standard Deviation|8.40|8.4|||
3624630|NCT02638129|3473751|B2|||Age||years|Mean|65.5|65.5|Standard Deviation|7.04|7.04|||
3624631|NCT02638129|3473752|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|9.29|9.29|||
3624632|NCT02638129|3473750|B3||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3624633|NCT02638129|3473751|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3624634|NCT02638129|3473752|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3624635|NCT02638129|3473750|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3624636|NCT02638129|3473751|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3624637|NCT02638129|3473752|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3624638|NCT02638129|3473750|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3624639|NCT02638129|3473751|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3624640|NCT02638129|3473752|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3624641|NCT02638051|3473765|B3|IPCI||Interventions||sessions|Median|NA||Full Range|||0.0|0.0|IPCI applied in Control Group only, total result is not applicable
3624642|NCT02638051|3473766|B2|IPCI||Interventions||sessions|Median|2|2.0|Full Range|||2.0|2.0|
3624643|NCT02638051|3473767|B1|IPCI||Interventions||sessions|Median|0|0.0|Full Range|||0.0|0.0|
3624644|NCT02638051|3473765|B3|TCM||Interventions||sessions|Median|NA||Full Range|||0.0|0.0|TCM applied in Study Group only, total result is not applicable
3624645|NCT02638051|3473766|B2|TCM||Interventions||sessions|Median|0|0.0|Full Range|||0.0|0.0|
3624646|NCT02638051|3473767|B1|TCM||Interventions||sessions|Median|28|28.0|Full Range|||28.0|28.0|
3624647|NCT02638051|3473765|B3|mEHT||Interventions||sessions|Median|NA||Full Range|||0.0|0.0|mEHT applied in Study Group only, total result is not applicable
3624648|NCT02638051|3473766|B2|mEHT||Interventions||sessions|Median|0|0.0|Full Range|||0.0|0.0|
3624649|NCT02638051|3473767|B1|mEHT||Interventions||sessions|Median|14|14.0|Full Range|||14.0|14.0|
3624650|NCT02638051|3473765|B3|||5-FU (Intraperitoneal Chemoinfusion) Dose Per Session||mg/sqm|Mean|NA||Standard Deviation|NA||||5FU applied in Control Group only, total result is not applicable
3624651|NCT02638051|3473766|B2|||5-FU (Intraperitoneal Chemoinfusion) Dose Per Session||mg/sqm|Mean|548.5|548.5|Standard Deviation|39.68|39.68|||
3624652|NCT02638051|3473767|B1|||5-FU (Intraperitoneal Chemoinfusion) Dose Per Session||mg/sqm|Mean|0|0.0|Standard Deviation|0|0.0|||
3624653|NCT02638051|3473765|B3|||CDDP (Intraperitoneal Chemoinfusion) Dose Per Session||mg|Mean|NA||Standard Deviation|NA||||CDDP applied in Control Group only, total result is not applicable
3624654|NCT02638051|3473766|B2|||CDDP (Intraperitoneal Chemoinfusion) Dose Per Session||mg|Mean|49.63|49.63|Standard Deviation|10.19|10.19|||
3624655|NCT02638051|3473767|B1|||CDDP (Intraperitoneal Chemoinfusion) Dose Per Session||mg|Mean|0|0.0|Standard Deviation|0|0.0|||
3624656|NCT02638051|3473765|B3|90||Karnofsky Performance Score|"KPS 90% - symptomatic patients with normal daily activity. KPS 80% - normal daily activity with effort. KPS 70% - limited daily activity (unable to work), complete self-care. KPS 60% - limited daily activity (unable to work), limited self-care (needs assistance), active >50% of daytime.~KPS <60% (Perforce inactive (sits or lies) ≥50% of daytime) excluded."|participants|Number|26|26.0||||||
3624657|NCT02638051|3473766|B2|90||Karnofsky Performance Score|"KPS 90% - symptomatic patients with normal daily activity. KPS 80% - normal daily activity with effort. KPS 70% - limited daily activity (unable to work), complete self-care. KPS 60% - limited daily activity (unable to work), limited self-care (needs assistance), active >50% of daytime.~KPS <60% (Perforce inactive (sits or lies) ≥50% of daytime) excluded."|participants|Number|14|14.0||||||
3624658|NCT02638051|3473767|B1|90||Karnofsky Performance Score|"KPS 90% - symptomatic patients with normal daily activity. KPS 80% - normal daily activity with effort. KPS 70% - limited daily activity (unable to work), complete self-care. KPS 60% - limited daily activity (unable to work), limited self-care (needs assistance), active >50% of daytime.~KPS <60% (Perforce inactive (sits or lies) ≥50% of daytime) excluded."|participants|Number|12|12.0||||||
3624659|NCT02638051|3473765|B3|80||Karnofsky Performance Score|"KPS 90% - symptomatic patients with normal daily activity. KPS 80% - normal daily activity with effort. KPS 70% - limited daily activity (unable to work), complete self-care. KPS 60% - limited daily activity (unable to work), limited self-care (needs assistance), active >50% of daytime.~KPS <60% (Perforce inactive (sits or lies) ≥50% of daytime) excluded."|participants|Number|90|90.0||||||
3624695|NCT02638051|3473765|B3|Ovarian Cancer||Primary Disease||participants|Number|27|27.0||||||
3624660|NCT02638051|3473766|B2|80||Karnofsky Performance Score|"KPS 90% - symptomatic patients with normal daily activity. KPS 80% - normal daily activity with effort. KPS 70% - limited daily activity (unable to work), complete self-care. KPS 60% - limited daily activity (unable to work), limited self-care (needs assistance), active >50% of daytime.~KPS <60% (Perforce inactive (sits or lies) ≥50% of daytime) excluded."|participants|Number|48|48.0||||||
3624661|NCT02638051|3473767|B1|80||Karnofsky Performance Score|"KPS 90% - symptomatic patients with normal daily activity. KPS 80% - normal daily activity with effort. KPS 70% - limited daily activity (unable to work), complete self-care. KPS 60% - limited daily activity (unable to work), limited self-care (needs assistance), active >50% of daytime.~KPS <60% (Perforce inactive (sits or lies) ≥50% of daytime) excluded."|participants|Number|42|42.0||||||
3624662|NCT02638051|3473765|B3|70||Karnofsky Performance Score|"KPS 90% - symptomatic patients with normal daily activity. KPS 80% - normal daily activity with effort. KPS 70% - limited daily activity (unable to work), complete self-care. KPS 60% - limited daily activity (unable to work), limited self-care (needs assistance), active >50% of daytime.~KPS <60% (Perforce inactive (sits or lies) ≥50% of daytime) excluded."|participants|Number|97|97.0||||||
3624663|NCT02638051|3473766|B2|70||Karnofsky Performance Score|"KPS 90% - symptomatic patients with normal daily activity. KPS 80% - normal daily activity with effort. KPS 70% - limited daily activity (unable to work), complete self-care. KPS 60% - limited daily activity (unable to work), limited self-care (needs assistance), active >50% of daytime.~KPS <60% (Perforce inactive (sits or lies) ≥50% of daytime) excluded."|participants|Number|47|47.0||||||
3624664|NCT02638051|3473767|B1|70||Karnofsky Performance Score|"KPS 90% - symptomatic patients with normal daily activity. KPS 80% - normal daily activity with effort. KPS 70% - limited daily activity (unable to work), complete self-care. KPS 60% - limited daily activity (unable to work), limited self-care (needs assistance), active >50% of daytime.~KPS <60% (Perforce inactive (sits or lies) ≥50% of daytime) excluded."|participants|Number|50|50.0||||||
3624665|NCT02638051|3473765|B3|60||Karnofsky Performance Score|"KPS 90% - symptomatic patients with normal daily activity. KPS 80% - normal daily activity with effort. KPS 70% - limited daily activity (unable to work), complete self-care. KPS 60% - limited daily activity (unable to work), limited self-care (needs assistance), active >50% of daytime.~KPS <60% (Perforce inactive (sits or lies) ≥50% of daytime) excluded."|participants|Number|47|47.0||||||
3624666|NCT02638051|3473766|B2|60||Karnofsky Performance Score|"KPS 90% - symptomatic patients with normal daily activity. KPS 80% - normal daily activity with effort. KPS 70% - limited daily activity (unable to work), complete self-care. KPS 60% - limited daily activity (unable to work), limited self-care (needs assistance), active >50% of daytime.~KPS <60% (Perforce inactive (sits or lies) ≥50% of daytime) excluded."|participants|Number|21|21.0||||||
3624667|NCT02638051|3473767|B1|60||Karnofsky Performance Score|"KPS 90% - symptomatic patients with normal daily activity. KPS 80% - normal daily activity with effort. KPS 70% - limited daily activity (unable to work), complete self-care. KPS 60% - limited daily activity (unable to work), limited self-care (needs assistance), active >50% of daytime.~KPS <60% (Perforce inactive (sits or lies) ≥50% of daytime) excluded."|participants|Number|26|26.0||||||
3624668|NCT02638051|3473765|B3|IV||Stage|Peritoneal carcinomatosis itself is considered III stage; evidence of distant metastases means IV stage.|participants|Number|118|118.0||||||
3624669|NCT02638051|3473766|B2|IV||Stage|Peritoneal carcinomatosis itself is considered III stage; evidence of distant metastases means IV stage.|participants|Number|54|54.0||||||
3624670|NCT02638051|3473767|B1|IV||Stage|Peritoneal carcinomatosis itself is considered III stage; evidence of distant metastases means IV stage.|participants|Number|64|64.0||||||
3624671|NCT02638051|3473765|B3|III||Stage|Peritoneal carcinomatosis itself is considered III stage; evidence of distant metastases means IV stage.|participants|Number|142|142.0||||||
3624672|NCT02638051|3473766|B2|III||Stage|Peritoneal carcinomatosis itself is considered III stage; evidence of distant metastases means IV stage.|participants|Number|76|76.0||||||
3624673|NCT02638051|3473767|B1|III||Stage|Peritoneal carcinomatosis itself is considered III stage; evidence of distant metastases means IV stage.|participants|Number|66|66.0||||||
3624674|NCT02638051|3473765|B3|II||Stage|Peritoneal carcinomatosis itself is considered III stage; evidence of distant metastases means IV stage.|participants|Number|0|0.0||||||
3624675|NCT02638051|3473766|B2|II||Stage|Peritoneal carcinomatosis itself is considered III stage; evidence of distant metastases means IV stage.|participants|Number|0|0.0||||||
3624676|NCT02638051|3473767|B1|II||Stage|Peritoneal carcinomatosis itself is considered III stage; evidence of distant metastases means IV stage.|participants|Number|0|0.0||||||
3624677|NCT02638051|3473765|B3|I||Stage|Peritoneal carcinomatosis itself is considered III stage; evidence of distant metastases means IV stage.|participants|Number|0|0.0||||||
3624678|NCT02638051|3473766|B2|I||Stage|Peritoneal carcinomatosis itself is considered III stage; evidence of distant metastases means IV stage.|participants|Number|0|0.0||||||
3624679|NCT02638051|3473767|B1|I||Stage|Peritoneal carcinomatosis itself is considered III stage; evidence of distant metastases means IV stage.|participants|Number|0|0.0||||||
3624680|NCT02638051|3473765|B3|Bones||Metastases||participants|Number|47|47.0||||||
3624681|NCT02638051|3473766|B2|Bones||Metastases||participants|Number|25|25.0||||||
3624682|NCT02638051|3473767|B1|Bones||Metastases||participants|Number|22|22.0||||||
3624683|NCT02638051|3473765|B3|Celiac lymph nodes||Metastases||participants|Number|103|103.0||||||
3624684|NCT02638051|3473766|B2|Celiac lymph nodes||Metastases||participants|Number|50|50.0||||||
3624685|NCT02638051|3473767|B1|Celiac lymph nodes||Metastases||participants|Number|53|53.0||||||
3624686|NCT02638051|3473765|B3|Liver||Metastases||participants|Number|67|67.0||||||
3624687|NCT02638051|3473766|B2|Liver||Metastases||participants|Number|35|35.0||||||
3624688|NCT02638051|3473767|B1|Liver||Metastases||participants|Number|32|32.0||||||
3624689|NCT02638051|3473765|B3|Lungs||Metastases||participants|Number|43|43.0||||||
3624690|NCT02638051|3473766|B2|Lungs||Metastases||participants|Number|20|20.0||||||
3624691|NCT02638051|3473767|B1|Lungs||Metastases||participants|Number|23|23.0||||||
3624692|NCT02638051|3473765|B3|Liver Cancer||Primary Disease||participants|Number|48|48.0||||||
3624693|NCT02638051|3473766|B2|Liver Cancer||Primary Disease||participants|Number|25|25.0||||||
3624694|NCT02638051|3473767|B1|Liver Cancer||Primary Disease||participants|Number|23|23.0||||||
3624696|NCT02638051|3473766|B2|Ovarian Cancer||Primary Disease||participants|Number|16|16.0||||||
3624697|NCT02638051|3473767|B1|Ovarian Cancer||Primary Disease||participants|Number|11|11.0||||||
3624698|NCT02638051|3473765|B3|Endometrial Cancer||Primary Disease||participants|Number|14|14.0||||||
3624699|NCT02638051|3473766|B2|Endometrial Cancer||Primary Disease||participants|Number|5|5.0||||||
3624700|NCT02638051|3473767|B1|Endometrial Cancer||Primary Disease||participants|Number|9|9.0||||||
3624701|NCT02638051|3473765|B3|Pancreatic Cancer||Primary Disease||participants|Number|21|21.0||||||
3624702|NCT02638051|3473766|B2|Pancreatic Cancer||Primary Disease||participants|Number|8|8.0||||||
3624703|NCT02638051|3473767|B1|Pancreatic Cancer||Primary Disease||participants|Number|13|13.0||||||
3624704|NCT02638051|3473765|B3|Rectal Cancer||Primary Disease||participants|Number|33|33.0||||||
3624705|NCT02638051|3473766|B2|Rectal Cancer||Primary Disease||participants|Number|15|15.0||||||
3624706|NCT02638051|3473767|B1|Rectal Cancer||Primary Disease||participants|Number|18|18.0||||||
3624707|NCT02638051|3473765|B3|Colon Cancer||Primary Disease||participants|Number|71|71.0||||||
3624708|NCT02638051|3473766|B2|Colon Cancer||Primary Disease||participants|Number|37|37.0||||||
3624709|NCT02638051|3473767|B1|Colon Cancer||Primary Disease||participants|Number|34|34.0||||||
3624710|NCT02638051|3473765|B3|Gastric Cancer||Primary Disease||participants|Number|46|46.0||||||
3624711|NCT02638051|3473766|B2|Gastric Cancer||Primary Disease||participants|Number|24|24.0||||||
3624712|NCT02638051|3473767|B1|Gastric Cancer||Primary Disease||participants|Number|22|22.0||||||
3624713|NCT02638051|3473765|B3|China||Region of Enrollment||participants|Number|260|260.0||||||
3624714|NCT02638051|3473766|B2|China||Region of Enrollment||participants|Number|130|130.0||||||
3624715|NCT02638051|3473767|B1|China||Region of Enrollment||participants|Number|130|130.0||||||
3624716|NCT02638051|3473765|B3||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3624717|NCT02638051|3473766|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3624718|NCT02638051|3473767|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3624719|NCT02638051|3473765|B3||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3624720|NCT02638051|3473766|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3624721|NCT02638051|3473767|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3624722|NCT02638051|3473765|B3|||Age||years|Mean|57.48|57.48|Standard Deviation|14.03|14.03|||
3624723|NCT02638051|3473766|B2|||Age||years|Mean|56.07|56.07|Standard Deviation|15.38|15.38|||
3624724|NCT02638051|3473767|B1|||Age||years|Mean|58.88|58.88|Standard Deviation|12.43|12.43|||
3624725|NCT02637999|3473778|B4|Russia||Region of Enrollment||participants|Number|24|24.0||||||
3624726|NCT02637999|3473779|B3|Russia||Region of Enrollment||participants|Number|8|8.0||||||
3624727|NCT02637999|3473780|B2|Russia||Region of Enrollment||participants|Number|8|8.0||||||
3624728|NCT02637999|3473781|B1|Russia||Region of Enrollment||participants|Number|8|8.0||||||
3624729|NCT02637999|3473778|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624730|NCT02637999|3473779|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624731|NCT02637999|3473780|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624732|NCT02637999|3473781|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624733|NCT02637999|3473778|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624734|NCT02637999|3473779|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624735|NCT02637999|3473780|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624736|NCT02637999|3473781|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624737|NCT02637999|3473778|B4||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3624738|NCT02637999|3473779|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3624739|NCT02637999|3473780|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3624740|NCT02637999|3473781|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3624741|NCT02637999|3473778|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624742|NCT02637999|3473779|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624743|NCT02637999|3473780|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624744|NCT02637999|3473781|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624745|NCT02637999|3473778|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624746|NCT02637999|3473779|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624747|NCT02637999|3473780|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624748|NCT02637999|3473781|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624749|NCT02637999|3473778|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624750|NCT02637999|3473779|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624751|NCT02637999|3473780|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624752|NCT02637999|3473781|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624753|NCT02637999|3473778|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624754|NCT02637999|3473779|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624755|NCT02637999|3473780|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624756|NCT02637999|3473781|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624757|NCT02637999|3473778|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3624758|NCT02637999|3473779|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3624759|NCT02637999|3473780|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3624760|NCT02637999|3473781|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3624761|NCT02637999|3473778|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3624762|NCT02637999|3473779|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3624763|NCT02637999|3473780|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3624764|NCT02637999|3473781|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3624765|NCT02637999|3473778|B4|||Age||years|Mean|37.8|37.8|Standard Deviation|9.19|9.19|||
3624766|NCT02637999|3473779|B3|||Age||years|Mean|42.1|42.1|Standard Deviation|10.23|10.23|||
3624767|NCT02637999|3473780|B2|||Age||years|Mean|33.0|33.0|Standard Deviation|4.87|4.87|||
3624768|NCT02637999|3473781|B1|||Age||years|Mean|38.3|38.3|Standard Deviation|10.05|10.05|||
3624769|NCT02637999|3473778|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3624770|NCT02637999|3473779|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3624771|NCT02637999|3473780|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3624772|NCT02637999|3473781|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3624773|NCT02637999|3473778|B4||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3624774|NCT02637999|3473779|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3624775|NCT02637999|3473780|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3624776|NCT02637999|3473781|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3624777|NCT02637999|3473778|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3624778|NCT02637999|3473779|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3624779|NCT02637999|3473780|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3624780|NCT02637999|3473781|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3624781|NCT02637804|3473815|B3|Japan||Region of Enrollment||participants|Number|106|106.0||||||
3624782|NCT02637804|3473816|B2|Japan||Region of Enrollment||participants|Number|51|51.0||||||
3624783|NCT02637804|3473817|B1|Japan||Region of Enrollment||participants|Number|55|55.0||||||
3624784|NCT02637804|3473815|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3624785|NCT02637804|3473816|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3624786|NCT02637804|3473817|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3624787|NCT02637804|3473815|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3624788|NCT02637804|3473816|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3624789|NCT02637804|3473817|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3624790|NCT02637804|3473815|B3|||Age||years|Mean|34|34.0|Standard Deviation|11|11.0|||
3624791|NCT02637804|3473816|B2|||Age||years|Mean|33|33.0|Standard Deviation|11|11.0|||
3624792|NCT02637804|3473817|B1|||Age||years|Mean|34|34.0|Standard Deviation|11|11.0|||
3624793|NCT02637323|3473924|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3624794|NCT02637323|3473925|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3624795|NCT02637323|3473926|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3624796|NCT02637323|3473924|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3624797|NCT02637323|3473925|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3624798|NCT02637323|3473926|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3624799|NCT02637323|3473924|B3|||Age||years|Mean|61|61.0|Standard Deviation|8.16|8.16|||
3624800|NCT02637323|3473925|B2|||Age||years|Mean|61.9|61.9|Standard Deviation|7.68|7.68|||
3624801|NCT02637323|3473926|B1|||Age||years|Mean|59.9|59.9|Standard Deviation|8.16|8.16|||
3624802|NCT02637063|3473935|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3624803|NCT02637063|3473936|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3624804|NCT02637063|3473937|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3624805|NCT02637063|3473938|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3624806|NCT02637063|3473935|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3624807|NCT02637063|3473936|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3624808|NCT02637063|3473937|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3624809|NCT02637063|3473938|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3624810|NCT02637063|3473935|B4||White|Race (NIH/OMB)||Participants|Count of Participants|141|141.0||||||
3624811|NCT02637063|3473936|B3||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3624812|NCT02637063|3473937|B2||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3624813|NCT02637063|3473938|B1||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3624814|NCT02637063|3473935|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3624815|NCT02637063|3473936|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3624816|NCT02637063|3473937|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3624817|NCT02637063|3473938|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3624818|NCT02637063|3473935|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624819|NCT02637063|3473936|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624820|NCT02637063|3473937|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624821|NCT02637063|3473938|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624822|NCT02637063|3473935|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3624823|NCT02637063|3473936|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3624824|NCT02637063|3473937|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3624825|NCT02637063|3473938|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3624826|NCT02637063|3473935|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3624827|NCT02637063|3473936|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3624828|NCT02637063|3473937|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3624829|NCT02637063|3473938|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624830|NCT02637063|3473935|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624831|NCT02637063|3473936|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624832|NCT02637063|3473937|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624833|NCT02637063|3473938|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624834|NCT02637063|3473935|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|184|184.0||||||
3624835|NCT02637063|3473936|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3624836|NCT02637063|3473937|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3624837|NCT02637063|3473938|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3624838|NCT02637063|3473935|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3624839|NCT02637063|3473936|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3624840|NCT02637063|3473937|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3624841|NCT02637063|3473938|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3624842|NCT02637063|3473935|B4||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3624843|NCT02637063|3473936|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3624844|NCT02637063|3473937|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3624845|NCT02637063|3473938|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3624846|NCT02637063|3473935|B4||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3624847|NCT02637063|3473936|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3624848|NCT02637063|3473937|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3624849|NCT02637063|3473938|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3624850|NCT02637063|3473935|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3624851|NCT02637063|3473936|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3624852|NCT02637063|3473937|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3624853|NCT02637063|3473938|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3624854|NCT02637063|3473935|B4||Between 18 and 65 years|Age||Participants|Count of Participants|203|203.0||||||
3624855|NCT02637063|3473936|B3||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
3624856|NCT02637063|3473937|B2||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
3624857|NCT02637063|3473938|B1||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
3624858|NCT02637063|3473935|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3624859|NCT02637063|3473936|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3624860|NCT02637063|3473937|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3624861|NCT02637063|3473938|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3624862|NCT02637037|3473966|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3624863|NCT02637037|3473967|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3624864|NCT02637037|3473968|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3624865|NCT02637037|3473966|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3624866|NCT02637037|3473967|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3624867|NCT02637037|3473968|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3624868|NCT02637037|3473966|B3|||Age||Years|Mean|36.5|36.5|Standard Deviation|10.04|10.04|||
3624869|NCT02637037|3473967|B2|||Age||Years|Mean|38.1|38.1|Standard Deviation|9.71|9.71|||
3624870|NCT02637037|3473968|B1|||Age||Years|Mean|35.4|35.4|Standard Deviation|10.38|10.38|||
3624871|NCT02636907|3474035|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3624872|NCT02636907|3474035|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3624873|NCT02636907|3474035|B1|||Age||Years|Mean|54.4|54.4|Standard Deviation|11.75|11.75|||
3624874|NCT02636595|3474044|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3624875|NCT02636595|3474044|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3624876|NCT02636595|3474044|B1|||Age||years|Mean|52.66|52.66|Standard Deviation|10.95|10.95|||
3624877|NCT02635984|3474050|B3||HCT Conditioning|Treatment Regimen||Participants|Count of Participants|68|68.0||||||
3624878|NCT02635984|3474051|B2||HCT Conditioning|Treatment Regimen||Participants|Count of Participants|34|34.0||||||
3624879|NCT02635984|3474052|B1||HCT Conditioning|Treatment Regimen||Participants|Count of Participants|34|34.0||||||
3624880|NCT02635984|3474050|B3||Chemotherapy Alone|Treatment Regimen||Participants|Count of Participants|33|33.0||||||
3624881|NCT02635984|3474051|B2||Chemotherapy Alone|Treatment Regimen||Participants|Count of Participants|17|17.0||||||
3624882|NCT02635984|3474052|B1||Chemotherapy Alone|Treatment Regimen||Participants|Count of Participants|16|16.0||||||
3624883|NCT02635984|3474050|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3624884|NCT02635984|3474051|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3624885|NCT02635984|3474052|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3624886|NCT02635984|3474050|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624887|NCT02635984|3474051|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624888|NCT02635984|3474052|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624889|NCT02635984|3474050|B3||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3624890|NCT02635984|3474051|B2||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3624891|NCT02635984|3474052|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3624892|NCT02635984|3474050|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3624893|NCT02635984|3474051|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3624894|NCT02635984|3474052|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3624895|NCT02635984|3474050|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624896|NCT02635984|3474051|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624897|NCT02635984|3474052|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624898|NCT02635984|3474050|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624899|NCT02635984|3474051|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624900|NCT02635984|3474052|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624901|NCT02635984|3474050|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624902|NCT02635984|3474051|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624903|NCT02635984|3474052|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624904|NCT02635984|3474050|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3624905|NCT02635984|3474051|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3624906|NCT02635984|3474052|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3624907|NCT02635984|3474050|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3624908|NCT02635984|3474051|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3624909|NCT02635984|3474052|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3624910|NCT02635984|3474050|B3|||Age||years|Median|55|55.0|Full Range|||22.0|74.0|
3624911|NCT02635984|3474051|B2|||Age||years|Median|54|54.0|Full Range|||22.0|72.0|
3624912|NCT02635984|3474052|B1|||Age||years|Median|56|56.0|Full Range|||22.0|74.0|
3624913|NCT02635880|3474073|B1|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3624914|NCT02635880|3474073|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3624915|NCT02635880|3474073|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3624916|NCT02635880|3474073|B1|||Age||years|Mean|46|46.0|Full Range|||25.0|65.0|
3624917|NCT02635880|3474073|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3624918|NCT02635880|3474073|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3624919|NCT02635880|3474073|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3624920|NCT02635828|3474078|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624921|NCT02635828|3474078|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624922|NCT02635828|3474078|B1||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3624923|NCT02635828|3474078|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3624924|NCT02635828|3474078|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624925|NCT02635828|3474078|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624926|NCT02635828|3474078|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624927|NCT02635828|3474078|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624928|NCT02635828|3474078|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3624929|NCT02635828|3474078|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624930|NCT02635828|3474078|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3624931|NCT02635828|3474078|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3624932|NCT02635828|3474078|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3624933|NCT02635828|3474078|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3624934|NCT02635828|3474078|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3624935|NCT02635646|3474083|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624936|NCT02635646|3474084|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624937|NCT02635646|3474085|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624938|NCT02635646|3474083|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624939|NCT02635646|3474084|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624940|NCT02635646|3474085|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3624941|NCT02635646|3474083|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|114|114.0||||||
3624942|NCT02635646|3474084|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3624943|NCT02635646|3474085|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3624944|NCT02635646|3474083|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3624945|NCT02635646|3474084|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3624946|NCT02635646|3474085|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3624947|NCT02635646|3474083|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3624948|NCT02635646|3474084|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3624949|NCT02635646|3474085|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3624950|NCT02635646|3474083|B3|||Age||years|Mean|44|44.0|Standard Deviation|12|12.0|||
3624951|NCT02635646|3474084|B2|||Age||years|Mean|46|46.0|Standard Deviation|12|12.0|||
3624952|NCT02635646|3474085|B1|||Age||years|Mean|44|44.0|Standard Deviation|13|13.0|||
3624953|NCT02635542|3474100|B3|||Body Mass Index||kg/m2|Mean|29.2|29.2|Standard Deviation|6.4|6.4|||
3624954|NCT02635542|3474101|B2|||Body Mass Index||kg/m2|Mean|28.2|28.2|Standard Deviation|5.9|5.9|||
3624955|NCT02635542|3474102|B1|||Body Mass Index||kg/m2|Mean|30.2|30.2|Standard Deviation|6.9|6.9|||
3624956|NCT02635542|3474100|B3|||Euroscore|The additive Euroscore (European System for Cardiac Operative Risk Evaluation) is a measure of predicted operative mortality for patients undergoing cardiac surgery. The score is comprised of patient-related factors, cardiac-related factors, and operation-related factors. Higher scores indicate greater risk for operative mortality (possible range 0-43).|units on a scale|Mean|5.42|5.42|Standard Deviation|3.07|3.07|||
3624957|NCT02635542|3474101|B2|||Euroscore|The additive Euroscore (European System for Cardiac Operative Risk Evaluation) is a measure of predicted operative mortality for patients undergoing cardiac surgery. The score is comprised of patient-related factors, cardiac-related factors, and operation-related factors. Higher scores indicate greater risk for operative mortality (possible range 0-43).|units on a scale|Mean|5.28|5.28|Standard Deviation|3.08|3.08|||
3624958|NCT02635542|3474102|B1|||Euroscore|The additive Euroscore (European System for Cardiac Operative Risk Evaluation) is a measure of predicted operative mortality for patients undergoing cardiac surgery. The score is comprised of patient-related factors, cardiac-related factors, and operation-related factors. Higher scores indicate greater risk for operative mortality (possible range 0-43).|units on a scale|Mean|5.56|5.56|Standard Deviation|3.08|3.08|||
3624959|NCT02635542|3474100|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
3624960|NCT02635542|3474101|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
3624961|NCT02635542|3474102|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3624962|NCT02635542|3474100|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3624963|NCT02635542|3474100|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3624964|NCT02635542|3474101|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3624965|NCT02635542|3474102|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3624966|NCT02635542|3474100|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3624967|NCT02635542|3474101|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3624968|NCT02635542|3474102|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3624969|NCT02635542|3474100|B3|||Age||years|Mean|65.1|65.1|Standard Deviation|14.5|14.5|||
3624970|NCT02635542|3474101|B2|||Age||years|Mean|64.1|64.1|Standard Deviation|14.6|14.6|||
3624971|NCT02635542|3474102|B1|||Age||years|Mean|66.0|66.0|Standard Deviation|14.5|14.5|||
3624972|NCT02635425|3474111|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3624973|NCT02635425|3474112|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3624974|NCT02635425|3474113|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3624975|NCT02635425|3474111|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3624976|NCT02635425|3474112|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3624977|NCT02635425|3474113|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3624978|NCT02635425|3474111|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3624979|NCT02635425|3474112|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3624980|NCT02635425|3474113|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3624981|NCT02635425|3474111|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3624982|NCT02635425|3474112|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3624983|NCT02635425|3474113|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3624984|NCT02635425|3474111|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3624985|NCT02635425|3474112|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3624986|NCT02635425|3474113|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3624987|NCT02635204|3474120|B3|United States||Region of Enrollment||Participants|Count of Participants|267|267.0||||||
3624988|NCT02635204|3474121|B2|United States||Region of Enrollment||Participants|Count of Participants|89|89.0||||||
3624989|NCT02635204|3474122|B1|United States||Region of Enrollment||Participants|Count of Participants|178|178.0||||||
3624990|NCT02635204|3474120|B3||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3624991|NCT02635204|3474121|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3624992|NCT02635204|3474122|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3624993|NCT02635204|3474120|B3||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3624994|NCT02635204|3474121|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3624995|NCT02635204|3474122|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3624996|NCT02635204|3474120|B3|||Age||years|Mean|49.8|49.8|Standard Deviation|14.40|14.4|||
3624997|NCT02635204|3474121|B2|||Age||years|Mean|50.6|50.6|Standard Deviation|15.93|15.93|||
3624998|NCT02635204|3474122|B1|||Age||years|Mean|49.5|49.5|Standard Deviation|13.59|13.59|||
3624999|NCT02635204|3474120|B3||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
3625000|NCT02635204|3474121|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3625001|NCT02635204|3474122|B1||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
3625002|NCT02635204|3474120|B3||Between 18 and 65 years|Age||Participants|Count of Participants|226|226.0||||||
3625003|NCT02635204|3474121|B2||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
3625004|NCT02635204|3474122|B1||Between 18 and 65 years|Age||Participants|Count of Participants|151|151.0||||||
3625005|NCT02635204|3474120|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3625006|NCT02635204|3474121|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3625007|NCT02635204|3474122|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3625008|NCT02634801|3474133|B4|Germany||Region of Enrollment||Participants|Count of Participants|162|162.0||||||
3625009|NCT02634801|3474134|B3|Germany||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
3625010|NCT02634801|3474135|B2|Germany||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
3625011|NCT02634801|3474136|B1|Germany||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
3625012|NCT02634801|3474133|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625013|NCT02634801|3474134|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625014|NCT02634801|3474135|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625015|NCT02634801|3474136|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625016|NCT02634801|3474133|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3625017|NCT02634801|3474134|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3625018|NCT02634801|3474135|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3625019|NCT02634801|3474136|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3625020|NCT02634801|3474133|B4||White|Race (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
3625021|NCT02634801|3474134|B3||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3625022|NCT02634801|3474135|B2||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3625023|NCT02634801|3474136|B1||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3625024|NCT02634801|3474133|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625025|NCT02634801|3474134|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625026|NCT02634801|3474135|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625027|NCT02634801|3474136|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625028|NCT02634801|3474133|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625029|NCT02634801|3474134|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625030|NCT02634801|3474135|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625031|NCT02634801|3474136|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625032|NCT02634801|3474133|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3625033|NCT02634801|3474134|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3625034|NCT02634801|3474135|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625035|NCT02634801|3474136|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3625036|NCT02634801|3474133|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625037|NCT02634801|3474134|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625038|NCT02634801|3474135|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625039|NCT02634801|3474136|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625040|NCT02634801|3474133|B4||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3625041|NCT02634801|3474134|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3625042|NCT02634801|3474135|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3625043|NCT02634801|3474136|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3625044|NCT02634801|3474133|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3625045|NCT02634801|3474134|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3625046|NCT02634801|3474135|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3625047|NCT02634801|3474136|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3625048|NCT02634801|3474133|B4|||Age||Years|Mean|42.1|42.1|Standard Deviation|13.77|13.77|||
3625049|NCT02634801|3474134|B3|||Age||Years|Mean|38.7|38.7|Standard Deviation|12.90|12.9|||
3625050|NCT02634801|3474135|B2|||Age||Years|Mean|43.1|43.1|Standard Deviation|14.16|14.16|||
3625051|NCT02634801|3474136|B1|||Age||Years|Mean|44.3|44.3|Standard Deviation|13.84|13.84|||
3625052|NCT02634788|3474234|B5||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3625053|NCT02634788|3474235|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3625054|NCT02634788|3474236|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3625055|NCT02634788|3474237|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3625056|NCT02634788|3474238|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3625057|NCT02634788|3474234|B5||Female|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
3625058|NCT02634788|3474235|B4||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3625059|NCT02634788|3474236|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3625060|NCT02634788|3474237|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3625061|NCT02634788|3474238|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3625062|NCT02634788|3474234|B5|||Age||years|Mean|45.7|45.7|Standard Deviation|13.17|13.17|||
3625063|NCT02634788|3474235|B4|||Age||years|Mean|48.4|48.4|Standard Deviation|11.75|11.75|||
3625064|NCT02634788|3474236|B3|||Age||years|Mean|45.6|45.6|Standard Deviation|11.78|11.78|||
3625065|NCT02634788|3474237|B2|||Age||years|Mean|43.7|43.7|Standard Deviation|14.17|14.17|||
3625066|NCT02634788|3474238|B1|||Age||years|Mean|45.3|45.3|Standard Deviation|14.55|14.55|||
3625067|NCT02634580|3474307|B5|||Lipoprotein(a) Concentration||nmol/L|Mean|61.7|61.7|Standard Deviation|79.5|79.5|||
3625068|NCT02634580|3474308|B4|||Lipoprotein(a) Concentration||nmol/L|Mean|66.2|66.2|Standard Deviation|91.0|91.0|||
3625069|NCT02634580|3474309|B3|||Lipoprotein(a) Concentration||nmol/L|Mean|61.3|61.3|Standard Deviation|72.6|72.6|||
3625070|NCT02634580|3474310|B2|||Lipoprotein(a) Concentration||nmol/L|Mean|66.0|66.0|Standard Deviation|83.2|83.2|||
3625071|NCT02634580|3474311|B1|||Lipoprotein(a) Concentration||nmol/L|Mean|48.0|48.0|Standard Deviation|72.3|72.3|||
3625072|NCT02634580|3474307|B5|||ApolipoproteinB/Apolipoprotein A1 Ratio||ratio|Mean|0.9|0.9|Standard Deviation|0.3|0.3|||
3625073|NCT02634580|3474308|B4|||ApolipoproteinB/Apolipoprotein A1 Ratio||ratio|Mean|0.9|0.9|Standard Deviation|0.2|0.2|||
3625074|NCT02634580|3474309|B3|||ApolipoproteinB/Apolipoprotein A1 Ratio||ratio|Mean|1.0|1.0|Standard Deviation|0.4|0.4|||
3625075|NCT02634580|3474310|B2|||ApolipoproteinB/Apolipoprotein A1 Ratio||ratio|Mean|0.8|0.8|Standard Deviation|0.2|0.2|||
3625076|NCT02634580|3474311|B1|||ApolipoproteinB/Apolipoprotein A1 Ratio||ratio|Mean|0.8|0.8|Standard Deviation|0.2|0.2|||
3625077|NCT02634580|3474307|B5|||Total cholesterol/HDL-C ratio||ratio|Mean|5.0|5.0|Standard Deviation|1.6|1.6|||
3625078|NCT02634580|3474308|B4|||Total cholesterol/HDL-C ratio||ratio|Mean|4.8|4.8|Standard Deviation|1.4|1.4|||
3625079|NCT02634580|3474309|B3|||Total cholesterol/HDL-C ratio||ratio|Mean|5.7|5.7|Standard Deviation|2.0|2.0|||
3625080|NCT02634580|3474310|B2|||Total cholesterol/HDL-C ratio||ratio|Mean|4.4|4.4|Standard Deviation|1.1|1.1|||
3625081|NCT02634580|3474311|B1|||Total cholesterol/HDL-C ratio||ratio|Mean|4.8|4.8|Standard Deviation|1.4|1.4|||
3625082|NCT02634580|3474307|B5|||Non-HDL-C Concentration||mg/dL|Mean|219.8|219.8|Standard Deviation|53.7|53.7|||
3625083|NCT02634580|3474308|B4|||Non-HDL-C Concentration||mg/dL|Mean|218.2|218.2|Standard Deviation|42.2|42.2|||
3625084|NCT02634580|3474309|B3|||Non-HDL-C Concentration||mg/dL|Mean|227.7|227.7|Standard Deviation|63.3|63.3|||
3625085|NCT02634580|3474310|B2|||Non-HDL-C Concentration||mg/dL|Mean|211.1|211.1|Standard Deviation|71.2|71.2|||
3625086|NCT02634580|3474311|B1|||Non-HDL-C Concentration||mg/dL|Mean|217.5|217.5|Standard Deviation|37.3|37.3|||
3625087|NCT02634580|3474307|B5|||Apolipoprotein B Concentration||mg/dL|Mean|135.1|135.1|Standard Deviation|27.9|27.9|||
3625088|NCT02634580|3474308|B4|||Apolipoprotein B Concentration||mg/dL|Mean|138.7|138.7|Standard Deviation|26.2|26.2|||
3625089|NCT02634580|3474309|B3|||Apolipoprotein B Concentration||mg/dL|Mean|140.4|140.4|Standard Deviation|31.7|31.7|||
3625090|NCT02634580|3474310|B2|||Apolipoprotein B Concentration||mg/dL|Mean|121.9|121.9|Standard Deviation|29.3|29.3|||
3625091|NCT02634580|3474311|B1|||Apolipoprotein B Concentration||mg/dL|Mean|132.1|132.1|Standard Deviation|19.4|19.4|||
3625092|NCT02634580|3474307|B5|||Triglycerides Concentration||mg/dL|Mean|153.8|153.8|Standard Deviation|73.7|73.7|||
3625093|NCT02634580|3474308|B4|||Triglycerides Concentration||mg/dL|Mean|151.0|151.0|Standard Deviation|61.3|61.3|||
3625094|NCT02634580|3474309|B3|||Triglycerides Concentration||mg/dL|Mean|148.0|148.0|Standard Deviation|59.8|59.8|||
3625095|NCT02634580|3474310|B2|||Triglycerides Concentration||mg/dL|Mean|142.3|142.3|Standard Deviation|80.1|80.1|||
3625096|NCT02634580|3474311|B1|||Triglycerides Concentration||mg/dL|Mean|183.1|183.1|Standard Deviation|111.1|111.1|||
3625097|NCT02634580|3474307|B5|||Very Low-density Lipoprotein Cholesterol (VLDL) Concentration||mg/dL|Mean|30.7|30.7|Standard Deviation|14.7|14.7|||
3625098|NCT02634580|3474308|B4|||Very Low-density Lipoprotein Cholesterol (VLDL) Concentration||mg/dL|Mean|30.2|30.2|Standard Deviation|12.3|12.3|||
3625099|NCT02634580|3474309|B3|||Very Low-density Lipoprotein Cholesterol (VLDL) Concentration||mg/dL|Mean|29.6|29.6|Standard Deviation|12.0|12.0|||
3625342|NCT02633956|3474488|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3625100|NCT02634580|3474310|B2|||Very Low-density Lipoprotein Cholesterol (VLDL) Concentration||mg/dL|Mean|28.4|28.4|Standard Deviation|16.1|16.1|||
3625101|NCT02634580|3474311|B1|||Very Low-density Lipoprotein Cholesterol (VLDL) Concentration||mg/dL|Mean|36.5|36.5|Standard Deviation|21.9|21.9|||
3625102|NCT02634580|3474307|B5|||High-density Lipoprotein Cholesterol (HDL-C) Concentration||mg/dL|Mean|60.8|60.8|Standard Deviation|18.6|18.6|||
3625103|NCT02634580|3474308|B4|||High-density Lipoprotein Cholesterol (HDL-C) Concentration||mg/dL|Mean|64.1|64.1|Standard Deviation|20.9|20.9|||
3625104|NCT02634580|3474309|B3|||High-density Lipoprotein Cholesterol (HDL-C) Concentration||mg/dL|Mean|54.3|54.3|Standard Deviation|18.2|18.2|||
3625105|NCT02634580|3474310|B2|||High-density Lipoprotein Cholesterol (HDL-C) Concentration||mg/dL|Mean|64.1|64.1|Standard Deviation|16.1|16.1|||
3625106|NCT02634580|3474311|B1|||High-density Lipoprotein Cholesterol (HDL-C) Concentration||mg/dL|Mean|62.5|62.5|Standard Deviation|15.6|15.6|||
3625107|NCT02634580|3474307|B5|||Total Cholesterol Concentration||mg/dL|Mean|280.5|280.5|Standard Deviation|57.3|57.3|||
3625108|NCT02634580|3474308|B4|||Total Cholesterol Concentration||mg/dL|Mean|282.3|282.3|Standard Deviation|49.6|49.6|||
3625109|NCT02634580|3474309|B3|||Total Cholesterol Concentration||mg/dL|Mean|282.0|282.0|Standard Deviation|63.9|63.9|||
3625110|NCT02634580|3474310|B2|||Total Cholesterol Concentration||mg/dL|Mean|275.2|275.2|Standard Deviation|79.7|79.7|||
3625111|NCT02634580|3474311|B1|||Total Cholesterol Concentration||mg/dL|Mean|280.0|280.0|Standard Deviation|34.4|34.4|||
3625112|NCT02634580|3474307|B5|||LDL-C Concentration||mg/dL|Mean|189.0|189.0|Standard Deviation|53.9|53.9|||
3625113|NCT02634580|3474308|B4|||LDL-C Concentration||mg/dL|Mean|188.0|188.0|Standard Deviation|41.6|41.6|||
3625114|NCT02634580|3474309|B3|||LDL-C Concentration||mg/dL|Mean|198.1|198.1|Standard Deviation|64.1|64.1|||
3625115|NCT02634580|3474310|B2|||LDL-C Concentration||mg/dL|Mean|182.7|182.7|Standard Deviation|72.2|72.2|||
3625116|NCT02634580|3474311|B1|||LDL-C Concentration||mg/dL|Mean|181.0|181.0|Standard Deviation|34.7|34.7|||
3625117|NCT02634580|3474307|B5||No|Stratification Factor: Baseline Statin Use||Participants|Count of Participants|47|47.0||||||
3625118|NCT02634580|3474308|B4||No|Stratification Factor: Baseline Statin Use||Participants|Count of Participants|16|16.0||||||
3625119|NCT02634580|3474309|B3||No|Stratification Factor: Baseline Statin Use||Participants|Count of Participants|16|16.0||||||
3625120|NCT02634580|3474310|B2||No|Stratification Factor: Baseline Statin Use||Participants|Count of Participants|8|8.0||||||
3625121|NCT02634580|3474311|B1||No|Stratification Factor: Baseline Statin Use||Participants|Count of Participants|7|7.0||||||
3625122|NCT02634580|3474307|B5||Yes|Stratification Factor: Baseline Statin Use||Participants|Count of Participants|14|14.0||||||
3625123|NCT02634580|3474308|B4||Yes|Stratification Factor: Baseline Statin Use||Participants|Count of Participants|5|5.0||||||
3625124|NCT02634580|3474309|B3||Yes|Stratification Factor: Baseline Statin Use||Participants|Count of Participants|3|3.0||||||
3625125|NCT02634580|3474310|B2||Yes|Stratification Factor: Baseline Statin Use||Participants|Count of Participants|3|3.0||||||
3625126|NCT02634580|3474311|B1||Yes|Stratification Factor: Baseline Statin Use||Participants|Count of Participants|3|3.0||||||
3625127|NCT02634580|3474307|B5||≥ 180 mg/dL [4.66 mmol/L]|Stratification Factor: Screening LDL-C Level||Participants|Count of Participants|31|31.0||||||
3625128|NCT02634580|3474308|B4||≥ 180 mg/dL [4.66 mmol/L]|Stratification Factor: Screening LDL-C Level||Participants|Count of Participants|11|11.0||||||
3625129|NCT02634580|3474309|B3||≥ 180 mg/dL [4.66 mmol/L]|Stratification Factor: Screening LDL-C Level||Participants|Count of Participants|10|10.0||||||
3625130|NCT02634580|3474310|B2||≥ 180 mg/dL [4.66 mmol/L]|Stratification Factor: Screening LDL-C Level||Participants|Count of Participants|5|5.0||||||
3625131|NCT02634580|3474311|B1||≥ 180 mg/dL [4.66 mmol/L]|Stratification Factor: Screening LDL-C Level||Participants|Count of Participants|5|5.0||||||
3625132|NCT02634580|3474307|B5||< 180 mg/dL [4.66 mmol/L]|Stratification Factor: Screening LDL-C Level||Participants|Count of Participants|30|30.0||||||
3625133|NCT02634580|3474308|B4||< 180 mg/dL [4.66 mmol/L]|Stratification Factor: Screening LDL-C Level||Participants|Count of Participants|10|10.0||||||
3625134|NCT02634580|3474309|B3||< 180 mg/dL [4.66 mmol/L]|Stratification Factor: Screening LDL-C Level||Participants|Count of Participants|9|9.0||||||
3625135|NCT02634580|3474310|B2||< 180 mg/dL [4.66 mmol/L]|Stratification Factor: Screening LDL-C Level||Participants|Count of Participants|6|6.0||||||
3625136|NCT02634580|3474311|B1||< 180 mg/dL [4.66 mmol/L]|Stratification Factor: Screening LDL-C Level||Participants|Count of Participants|5|5.0||||||
3625137|NCT02634580|3474307|B5||Four or more statins|Intolerance to Statins||Participants|Count of Participants|4|4.0||||||
3625138|NCT02634580|3474308|B4||Four or more statins|Intolerance to Statins||Participants|Count of Participants|3|3.0||||||
3625139|NCT02634580|3474309|B3||Four or more statins|Intolerance to Statins||Participants|Count of Participants|1|1.0||||||
3625140|NCT02634580|3474310|B2||Four or more statins|Intolerance to Statins||Participants|Count of Participants|0|0.0||||||
3625141|NCT02634580|3474311|B1||Four or more statins|Intolerance to Statins||Participants|Count of Participants|0|0.0||||||
3625142|NCT02634580|3474307|B5||Three statins|Intolerance to Statins||Participants|Count of Participants|10|10.0||||||
3625143|NCT02634580|3474308|B4||Three statins|Intolerance to Statins||Participants|Count of Participants|4|4.0||||||
3625144|NCT02634580|3474309|B3||Three statins|Intolerance to Statins||Participants|Count of Participants|3|3.0||||||
3625145|NCT02634580|3474310|B2||Three statins|Intolerance to Statins||Participants|Count of Participants|1|1.0||||||
3625146|NCT02634580|3474311|B1||Three statins|Intolerance to Statins||Participants|Count of Participants|2|2.0||||||
3625147|NCT02634580|3474307|B5||Two statins|Intolerance to Statins||Participants|Count of Participants|45|45.0||||||
3625148|NCT02634580|3474308|B4||Two statins|Intolerance to Statins||Participants|Count of Participants|14|14.0||||||
3625149|NCT02634580|3474309|B3||Two statins|Intolerance to Statins||Participants|Count of Participants|14|14.0||||||
3625343|NCT02633956|3474489|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3625150|NCT02634580|3474310|B2||Two statins|Intolerance to Statins||Participants|Count of Participants|10|10.0||||||
3625151|NCT02634580|3474311|B1||Two statins|Intolerance to Statins||Participants|Count of Participants|7|7.0||||||
3625152|NCT02634580|3474307|B5||One statin|Intolerance to Statins||Participants|Count of Participants|2|2.0||||||
3625153|NCT02634580|3474308|B4||One statin|Intolerance to Statins||Participants|Count of Participants|0|0.0||||||
3625154|NCT02634580|3474309|B3||One statin|Intolerance to Statins||Participants|Count of Participants|1|1.0||||||
3625155|NCT02634580|3474310|B2||One statin|Intolerance to Statins||Participants|Count of Participants|0|0.0||||||
3625156|NCT02634580|3474311|B1||One statin|Intolerance to Statins||Participants|Count of Participants|1|1.0||||||
3625157|NCT02634580|3474307|B5||Japanese|Race/Ethnicity, Customized||Participants|Count of Participants|61|61.0||||||
3625158|NCT02634580|3474308|B4||Japanese|Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3625159|NCT02634580|3474309|B3||Japanese|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3625160|NCT02634580|3474310|B2||Japanese|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3625161|NCT02634580|3474311|B1||Japanese|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3625162|NCT02634580|3474307|B5||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3625163|NCT02634580|3474308|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3625164|NCT02634580|3474309|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3625165|NCT02634580|3474310|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3625166|NCT02634580|3474311|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3625167|NCT02634580|3474307|B5||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3625168|NCT02634580|3474308|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3625169|NCT02634580|3474309|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3625170|NCT02634580|3474310|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3625171|NCT02634580|3474311|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3625172|NCT02634580|3474307|B5|||Age||years|Mean|64.4|64.4|Standard Deviation|10.6|10.6|||
3625173|NCT02634580|3474308|B4|||Age||years|Mean|66.4|66.4|Standard Deviation|9.3|9.3|||
3625174|NCT02634580|3474309|B3|||Age||years|Mean|65.1|65.1|Standard Deviation|10.5|10.5|||
3625175|NCT02634580|3474310|B2|||Age||years|Mean|58.7|58.7|Standard Deviation|12.5|12.5|||
3625176|NCT02634580|3474311|B1|||Age||years|Mean|65.2|65.2|Standard Deviation|10.8|10.8|||
3625177|NCT02634346|3474368|B4|Serbia||Region of Enrollment||participants|Number|41|41.0||||||
3625178|NCT02634346|3474369|B3|Serbia||Region of Enrollment||participants|Number|11|11.0||||||
3625179|NCT02634346|3474370|B2|Serbia||Region of Enrollment||participants|Number|19|19.0||||||
3625180|NCT02634346|3474371|B1|Serbia||Region of Enrollment||participants|Number|11|11.0||||||
3625181|NCT02634346|3474368|B4|Bulgaria||Region of Enrollment||participants|Number|127|127.0||||||
3625182|NCT02634346|3474369|B3|Bulgaria||Region of Enrollment||participants|Number|45|45.0||||||
3625183|NCT02634346|3474370|B2|Bulgaria||Region of Enrollment||participants|Number|38|38.0||||||
3625184|NCT02634346|3474371|B1|Bulgaria||Region of Enrollment||participants|Number|44|44.0||||||
3625185|NCT02634346|3474368|B4|Ukraine||Region of Enrollment||participants|Number|79|79.0||||||
3625186|NCT02634346|3474369|B3|Ukraine||Region of Enrollment||participants|Number|29|29.0||||||
3625187|NCT02634346|3474370|B2|Ukraine||Region of Enrollment||participants|Number|26|26.0||||||
3625188|NCT02634346|3474371|B1|Ukraine||Region of Enrollment||participants|Number|24|24.0||||||
3625189|NCT02634346|3474368|B4|United States||Region of Enrollment||participants|Number|154|154.0||||||
3625190|NCT02634346|3474369|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
3625191|NCT02634346|3474370|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
3625192|NCT02634346|3474371|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
3625193|NCT02634346|3474368|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3625194|NCT02634346|3474369|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3625195|NCT02634346|3474370|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3625196|NCT02634346|3474371|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3625197|NCT02634346|3474368|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625198|NCT02634346|3474369|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625199|NCT02634346|3474370|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625200|NCT02634346|3474371|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625201|NCT02634346|3474368|B4||White|Race (NIH/OMB)||Participants|Count of Participants|277|277.0||||||
3625202|NCT02634346|3474369|B3||White|Race (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3625203|NCT02634346|3474370|B2||White|Race (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3625204|NCT02634346|3474371|B1||White|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3625205|NCT02634346|3474368|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
3625206|NCT02634346|3474369|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3625207|NCT02634346|3474370|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3625208|NCT02634346|3474371|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3625209|NCT02634346|3474368|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3625210|NCT02634346|3474369|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625211|NCT02634346|3474370|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625212|NCT02634346|3474371|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3625213|NCT02634346|3474368|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3625214|NCT02634346|3474369|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3625215|NCT02634346|3474370|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625216|NCT02634346|3474371|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3625217|NCT02634346|3474368|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3625218|NCT02634346|3474369|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3625219|NCT02634346|3474370|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625220|NCT02634346|3474371|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625221|NCT02634346|3474368|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625222|NCT02634346|3474369|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625223|NCT02634346|3474370|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625224|NCT02634346|3474371|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625225|NCT02634346|3474368|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|388|388.0||||||
3625226|NCT02634346|3474369|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
3625227|NCT02634346|3474370|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
3625228|NCT02634346|3474371|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
3625229|NCT02634346|3474368|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3625230|NCT02634346|3474369|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3625231|NCT02634346|3474370|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3625232|NCT02634346|3474371|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3625233|NCT02634346|3474368|B4||Male|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
3625234|NCT02634346|3474369|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3625235|NCT02634346|3474370|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3625236|NCT02634346|3474371|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3625237|NCT02634346|3474368|B4||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3625238|NCT02634346|3474369|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3625239|NCT02634346|3474370|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3625240|NCT02634346|3474371|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3625241|NCT02634346|3474368|B4|||Age||years|Mean|41.1|41.1|Standard Deviation|11.35|11.35|||
3625242|NCT02634346|3474369|B3|||Age||years|Mean|41.1|41.1|Standard Deviation|10.59|10.59|||
3625243|NCT02634346|3474370|B2|||Age||years|Mean|41.5|41.5|Standard Deviation|10.89|10.89|||
3625244|NCT02634346|3474371|B1|||Age||years|Mean|40.8|40.8|Standard Deviation|12.55|12.55|||
3625245|NCT02634320|3474387|B1|United States||Region of Enrollment||Participants|Count of Participants|51|51.0||||||
3625246|NCT02634320|3474387|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3625247|NCT02634320|3474387|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625248|NCT02634320|3474387|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3625249|NCT02634320|3474387|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3625250|NCT02634320|3474387|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625251|NCT02634320|3474387|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3625252|NCT02634320|3474387|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625253|NCT02634320|3474387|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3625254|NCT02634320|3474387|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3625255|NCT02634320|3474387|B1|||Age||years|Mean|40|40.0|Standard Deviation|11.74|11.74|||
3625256|NCT02634320|3474387|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3625257|NCT02634320|3474387|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3625258|NCT02634320|3474387|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3625259|NCT02634073|3474396|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
3625260|NCT02634073|3474396|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3625261|NCT02634073|3474396|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3625262|NCT02634073|3474396|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3625263|NCT02634073|3474396|B1|||Age||Years|Mean|40.6|40.6|Standard Deviation|12.30|12.3|||
3625264|NCT02633956|3474485|B5||Greater than 125 mg/dL|Screening LDL|Fasting LDL concentration|Participants|Count of Participants|38|38.0||||||
3625265|NCT02633956|3474486|B4||Greater than 125 mg/dL|Screening LDL|Fasting LDL concentration|Participants|Count of Participants|10|10.0||||||
3625266|NCT02633956|3474487|B3||Greater than 125 mg/dL|Screening LDL|Fasting LDL concentration|Participants|Count of Participants|9|9.0||||||
3625267|NCT02633956|3474488|B2||Greater than 125 mg/dL|Screening LDL|Fasting LDL concentration|Participants|Count of Participants|10|10.0||||||
3625268|NCT02633956|3474489|B1||Greater than 125 mg/dL|Screening LDL|Fasting LDL concentration|Participants|Count of Participants|9|9.0||||||
3625269|NCT02633956|3474485|B5||Less than or equal 125 mg/dL|Screening LDL|Fasting LDL concentration|Participants|Count of Participants|46|46.0||||||
3625270|NCT02633956|3474486|B4||Less than or equal 125 mg/dL|Screening LDL|Fasting LDL concentration|Participants|Count of Participants|11|11.0||||||
3625271|NCT02633956|3474487|B3||Less than or equal 125 mg/dL|Screening LDL|Fasting LDL concentration|Participants|Count of Participants|13|13.0||||||
3625272|NCT02633956|3474488|B2||Less than or equal 125 mg/dL|Screening LDL|Fasting LDL concentration|Participants|Count of Participants|11|11.0||||||
3625273|NCT02633956|3474489|B1||Less than or equal 125 mg/dL|Screening LDL|Fasting LDL concentration|Participants|Count of Participants|11|11.0||||||
3625274|NCT02633956|3474485|B5||Stage 3 and 4|Fibrosis stage (NASH Clinical Research Network (CRN) categories)|"The NASH CRN Fibrosis Staging is based on the degree of liver fibrosis from Stage 0: no fibrosis to Stage 4: cirrhosis. The related histological classification of each stage is as follows: Fibrosis Stage: Stage 0: none; Stage 1a: zone 3 perisinusoidal, delicate; 1b: zone 3 perisinusoidal, dense; 1c: portal only; Stage 2: 1a or 1b + periportal fibrosis; Stage 3: bridging fibrosis; and Stage 4: cirrhosis.~The higher the fibrosis stage the worse the prognosis."|Participants|Count of Participants|43|43.0||||||
3625275|NCT02633956|3474486|B4||Stage 3 and 4|Fibrosis stage (NASH Clinical Research Network (CRN) categories)|"The NASH CRN Fibrosis Staging is based on the degree of liver fibrosis from Stage 0: no fibrosis to Stage 4: cirrhosis. The related histological classification of each stage is as follows: Fibrosis Stage: Stage 0: none; Stage 1a: zone 3 perisinusoidal, delicate; 1b: zone 3 perisinusoidal, dense; 1c: portal only; Stage 2: 1a or 1b + periportal fibrosis; Stage 3: bridging fibrosis; and Stage 4: cirrhosis.~The higher the fibrosis stage the worse the prognosis."|Participants|Count of Participants|11|11.0||||||
3625276|NCT02633956|3474487|B3||Stage 3 and 4|Fibrosis stage (NASH Clinical Research Network (CRN) categories)|"The NASH CRN Fibrosis Staging is based on the degree of liver fibrosis from Stage 0: no fibrosis to Stage 4: cirrhosis. The related histological classification of each stage is as follows: Fibrosis Stage: Stage 0: none; Stage 1a: zone 3 perisinusoidal, delicate; 1b: zone 3 perisinusoidal, dense; 1c: portal only; Stage 2: 1a or 1b + periportal fibrosis; Stage 3: bridging fibrosis; and Stage 4: cirrhosis.~The higher the fibrosis stage the worse the prognosis."|Participants|Count of Participants|11|11.0||||||
3625277|NCT02633956|3474488|B2||Stage 3 and 4|Fibrosis stage (NASH Clinical Research Network (CRN) categories)|"The NASH CRN Fibrosis Staging is based on the degree of liver fibrosis from Stage 0: no fibrosis to Stage 4: cirrhosis. The related histological classification of each stage is as follows: Fibrosis Stage: Stage 0: none; Stage 1a: zone 3 perisinusoidal, delicate; 1b: zone 3 perisinusoidal, dense; 1c: portal only; Stage 2: 1a or 1b + periportal fibrosis; Stage 3: bridging fibrosis; and Stage 4: cirrhosis.~The higher the fibrosis stage the worse the prognosis."|Participants|Count of Participants|11|11.0||||||
3625278|NCT02633956|3474489|B1||Stage 3 and 4|Fibrosis stage (NASH Clinical Research Network (CRN) categories)|"The NASH CRN Fibrosis Staging is based on the degree of liver fibrosis from Stage 0: no fibrosis to Stage 4: cirrhosis. The related histological classification of each stage is as follows: Fibrosis Stage: Stage 0: none; Stage 1a: zone 3 perisinusoidal, delicate; 1b: zone 3 perisinusoidal, dense; 1c: portal only; Stage 2: 1a or 1b + periportal fibrosis; Stage 3: bridging fibrosis; and Stage 4: cirrhosis.~The higher the fibrosis stage the worse the prognosis."|Participants|Count of Participants|10|10.0||||||
3625279|NCT02633956|3474485|B5||Stage 1 and 2|Fibrosis stage (NASH Clinical Research Network (CRN) categories)|"The NASH CRN Fibrosis Staging is based on the degree of liver fibrosis from Stage 0: no fibrosis to Stage 4: cirrhosis. The related histological classification of each stage is as follows: Fibrosis Stage: Stage 0: none; Stage 1a: zone 3 perisinusoidal, delicate; 1b: zone 3 perisinusoidal, dense; 1c: portal only; Stage 2: 1a or 1b + periportal fibrosis; Stage 3: bridging fibrosis; and Stage 4: cirrhosis.~The higher the fibrosis stage the worse the prognosis."|Participants|Count of Participants|41|41.0||||||
3625280|NCT02633956|3474486|B4||Stage 1 and 2|Fibrosis stage (NASH Clinical Research Network (CRN) categories)|"The NASH CRN Fibrosis Staging is based on the degree of liver fibrosis from Stage 0: no fibrosis to Stage 4: cirrhosis. The related histological classification of each stage is as follows: Fibrosis Stage: Stage 0: none; Stage 1a: zone 3 perisinusoidal, delicate; 1b: zone 3 perisinusoidal, dense; 1c: portal only; Stage 2: 1a or 1b + periportal fibrosis; Stage 3: bridging fibrosis; and Stage 4: cirrhosis.~The higher the fibrosis stage the worse the prognosis."|Participants|Count of Participants|10|10.0||||||
3625281|NCT02633956|3474487|B3||Stage 1 and 2|Fibrosis stage (NASH Clinical Research Network (CRN) categories)|"The NASH CRN Fibrosis Staging is based on the degree of liver fibrosis from Stage 0: no fibrosis to Stage 4: cirrhosis. The related histological classification of each stage is as follows: Fibrosis Stage: Stage 0: none; Stage 1a: zone 3 perisinusoidal, delicate; 1b: zone 3 perisinusoidal, dense; 1c: portal only; Stage 2: 1a or 1b + periportal fibrosis; Stage 3: bridging fibrosis; and Stage 4: cirrhosis.~The higher the fibrosis stage the worse the prognosis."|Participants|Count of Participants|11|11.0||||||
3625282|NCT02633956|3474488|B2||Stage 1 and 2|Fibrosis stage (NASH Clinical Research Network (CRN) categories)|"The NASH CRN Fibrosis Staging is based on the degree of liver fibrosis from Stage 0: no fibrosis to Stage 4: cirrhosis. The related histological classification of each stage is as follows: Fibrosis Stage: Stage 0: none; Stage 1a: zone 3 perisinusoidal, delicate; 1b: zone 3 perisinusoidal, dense; 1c: portal only; Stage 2: 1a or 1b + periportal fibrosis; Stage 3: bridging fibrosis; and Stage 4: cirrhosis.~The higher the fibrosis stage the worse the prognosis."|Participants|Count of Participants|10|10.0||||||
3625283|NCT02633956|3474489|B1||Stage 1 and 2|Fibrosis stage (NASH Clinical Research Network (CRN) categories)|"The NASH CRN Fibrosis Staging is based on the degree of liver fibrosis from Stage 0: no fibrosis to Stage 4: cirrhosis. The related histological classification of each stage is as follows: Fibrosis Stage: Stage 0: none; Stage 1a: zone 3 perisinusoidal, delicate; 1b: zone 3 perisinusoidal, dense; 1c: portal only; Stage 2: 1a or 1b + periportal fibrosis; Stage 3: bridging fibrosis; and Stage 4: cirrhosis.~The higher the fibrosis stage the worse the prognosis."|Participants|Count of Participants|10|10.0||||||
3625284|NCT02633956|3474485|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625285|NCT02633956|3474486|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625286|NCT02633956|3474487|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625287|NCT02633956|3474488|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625288|NCT02633956|3474489|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625289|NCT02633956|3474485|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625290|NCT02633956|3474486|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625291|NCT02633956|3474487|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625292|NCT02633956|3474488|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625293|NCT02633956|3474489|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625294|NCT02633956|3474485|B5||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3625295|NCT02633956|3474486|B4||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3625296|NCT02633956|3474487|B3||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3625297|NCT02633956|3474488|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3625298|NCT02633956|3474489|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3625299|NCT02633956|3474485|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3625300|NCT02633956|3474486|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3625301|NCT02633956|3474487|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625302|NCT02633956|3474488|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625303|NCT02633956|3474489|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625304|NCT02633956|3474485|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3625305|NCT02633956|3474486|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3625306|NCT02633956|3474487|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3625307|NCT02633956|3474488|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625308|NCT02633956|3474489|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625309|NCT02633956|3474485|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3625310|NCT02633956|3474486|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3625311|NCT02633956|3474487|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3625312|NCT02633956|3474488|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625313|NCT02633956|3474489|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3625314|NCT02633956|3474485|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3625315|NCT02633956|3474486|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625316|NCT02633956|3474487|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625317|NCT02633956|3474488|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3625318|NCT02633956|3474489|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625319|NCT02633956|3474485|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625320|NCT02633956|3474486|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625321|NCT02633956|3474487|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625322|NCT02633956|3474488|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625323|NCT02633956|3474489|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625324|NCT02633956|3474485|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3625325|NCT02633956|3474486|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3625326|NCT02633956|3474487|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3625327|NCT02633956|3474488|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3625328|NCT02633956|3474489|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3625329|NCT02633956|3474485|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3625330|NCT02633956|3474486|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3625331|NCT02633956|3474487|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3625332|NCT02633956|3474488|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3625333|NCT02633956|3474489|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3625334|NCT02633956|3474485|B5||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3625335|NCT02633956|3474486|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3625336|NCT02633956|3474487|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3625337|NCT02633956|3474488|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3625338|NCT02633956|3474489|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3625339|NCT02633956|3474485|B5||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3625340|NCT02633956|3474486|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3625341|NCT02633956|3474487|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3625344|NCT02633956|3474485|B5|||Age||years|Mean|58.1|58.1|Standard Deviation|11.07|11.07|||
3625345|NCT02633956|3474486|B4|||Age||years|Mean|59.8|59.8|Standard Deviation|9.88|9.88|||
3625346|NCT02633956|3474487|B3|||Age||years|Mean|62.2|62.2|Standard Deviation|11.06|11.06|||
3625347|NCT02633956|3474488|B2|||Age||years|Mean|57.1|57.1|Standard Deviation|11.62|11.62|||
3625348|NCT02633956|3474489|B1|||Age||years|Mean|52.9|52.9|Standard Deviation|10.13|10.13|||
3625349|NCT02633787|3474510|B1|United States||Region of Enrollment||Participants|Number|110|110.0||||||
3625350|NCT02633787|3474510|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3625351|NCT02633787|3474510|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3625352|NCT02633787|3474510|B1|||Age||Years|Mean|22.2|22.2|Standard Deviation|3.54|3.54|||
3625353|NCT02633787|3474510|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3625354|NCT02633787|3474510|B1||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
3625355|NCT02633787|3474510|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3625356|NCT02633371|3474516|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3625357|NCT02633371|3474516|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3625358|NCT02633371|3474516|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3625359|NCT02633371|3474516|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3625360|NCT02633371|3474516|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625361|NCT02633371|3474516|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625362|NCT02633371|3474516|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625363|NCT02633371|3474516|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625364|NCT02633371|3474516|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625365|NCT02633371|3474516|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3625366|NCT02633371|3474516|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3625367|NCT02633371|3474516|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3625368|NCT02633371|3474516|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3625369|NCT02633371|3474516|B1|||Age||years|Mean|18.5|18.5|Full Range|||13.0|24.0|
3625370|NCT02633215|3474520|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3625371|NCT02633215|3474521|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3625372|NCT02633215|3474522|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3625373|NCT02633215|3474520|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3625374|NCT02633215|3474521|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3625375|NCT02633215|3474522|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3625376|NCT02633215|3474520|B3|||Age||years|Mean|62.1|62.1|Standard Deviation|11.8|11.8|||
3625377|NCT02633215|3474521|B2|||Age||years|Mean|65.4|65.4|Standard Deviation|10.8|10.8|||
3625378|NCT02633215|3474522|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|12.1|12.1|||
3625379|NCT02632838|3474533|B3|||Hospital Admissions for Hypertension Related Illnesses|Data obtained from patients' electronic health records. Total number of hospital admissions for hypertension related illnesses were recorded.|hosptial Admissions|Number|4|4.0||||||
3625380|NCT02632838|3474534|B2|||Hospital Admissions for Hypertension Related Illnesses|Data obtained from patients' electronic health records. Total number of hospital admissions for hypertension related illnesses were recorded.|hosptial Admissions|Number|1|1.0||||||
3625381|NCT02632838|3474535|B1|||Hospital Admissions for Hypertension Related Illnesses|Data obtained from patients' electronic health records. Total number of hospital admissions for hypertension related illnesses were recorded.|hosptial Admissions|Number|3|3.0||||||
3625382|NCT02632838|3474533|B3|||Patient Self-efficacy|Medication Adherence Self-Efficacy Scale (MASES) were used to measure the patient self-efficacy in adhering to prescribed hypertension medications. MASES was developed to measure several aspects of self-efficacy, including adherence to prescribed medication for the management of hypertension. The MASES includes 26 items rated on a 3-point Likert scale (1= Not at all Sure, 2= Somewhat Sure, and 3= Very Sure). The range of this scale is from 26 to 78. A total mean score is calculated by averaging responses to all items. Higher scores indicate a great level of self-efficacy|units on a scale|Mean|64.80|64.8|Standard Deviation|10.92|10.92|||
3625383|NCT02632838|3474534|B2|||Patient Self-efficacy|Medication Adherence Self-Efficacy Scale (MASES) were used to measure the patient self-efficacy in adhering to prescribed hypertension medications. MASES was developed to measure several aspects of self-efficacy, including adherence to prescribed medication for the management of hypertension. The MASES includes 26 items rated on a 3-point Likert scale (1= Not at all Sure, 2= Somewhat Sure, and 3= Very Sure). The range of this scale is from 26 to 78. A total mean score is calculated by averaging responses to all items. Higher scores indicate a great level of self-efficacy|units on a scale|Mean|64.85|64.85|Standard Deviation|11.44|11.44|||
3625384|NCT02632838|3474535|B1|||Patient Self-efficacy|Medication Adherence Self-Efficacy Scale (MASES) were used to measure the patient self-efficacy in adhering to prescribed hypertension medications. MASES was developed to measure several aspects of self-efficacy, including adherence to prescribed medication for the management of hypertension. The MASES includes 26 items rated on a 3-point Likert scale (1= Not at all Sure, 2= Somewhat Sure, and 3= Very Sure). The range of this scale is from 26 to 78. A total mean score is calculated by averaging responses to all items. Higher scores indicate a great level of self-efficacy|units on a scale|Mean|64.75|64.75|Standard Deviation|10.85|10.85|||
3625397|NCT02632838|3474533|B3|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3625398|NCT02632838|3474534|B2|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3625385|NCT02632838|3474533|B3|Mental compent summary_Baseline||Health-Related Quality of Life|Health-Related Quality of Life were measured by 36-Item Short Form Health Survey (SF-36). SF-36 consisted of the sum scores of eight subscales(physical functioning, physical role limitations, mental health, emotional role limitations, social functioning, vitality, pain, general health perceptions), which are the weighted sums of the questions. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability.The eight subscales were summarized into two composite scores: physical and mental quality of life.|units on a scale|Mean|45.58|45.58|Standard Deviation|10.83|10.83|||
3625386|NCT02632838|3474534|B2|Mental compent summary_Baseline||Health-Related Quality of Life|Health-Related Quality of Life were measured by 36-Item Short Form Health Survey (SF-36). SF-36 consisted of the sum scores of eight subscales(physical functioning, physical role limitations, mental health, emotional role limitations, social functioning, vitality, pain, general health perceptions), which are the weighted sums of the questions. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability.The eight subscales were summarized into two composite scores: physical and mental quality of life.|units on a scale|Mean|48.73|48.73|Standard Deviation|10.26|10.26|||
3625387|NCT02632838|3474535|B1|Mental compent summary_Baseline||Health-Related Quality of Life|Health-Related Quality of Life were measured by 36-Item Short Form Health Survey (SF-36). SF-36 consisted of the sum scores of eight subscales(physical functioning, physical role limitations, mental health, emotional role limitations, social functioning, vitality, pain, general health perceptions), which are the weighted sums of the questions. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability.The eight subscales were summarized into two composite scores: physical and mental quality of life.|units on a scale|Mean|42.16|42.16|Standard Deviation|10.79|10.79|||
3625388|NCT02632838|3474533|B3|Physicalcomponent summary_Baseline||Health-Related Quality of Life|Health-Related Quality of Life were measured by 36-Item Short Form Health Survey (SF-36). SF-36 consisted of the sum scores of eight subscales(physical functioning, physical role limitations, mental health, emotional role limitations, social functioning, vitality, pain, general health perceptions), which are the weighted sums of the questions. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability.The eight subscales were summarized into two composite scores: physical and mental quality of life.|units on a scale|Mean|40.69|40.69|Standard Deviation|9.77|9.77|||
3625389|NCT02632838|3474534|B2|Physicalcomponent summary_Baseline||Health-Related Quality of Life|Health-Related Quality of Life were measured by 36-Item Short Form Health Survey (SF-36). SF-36 consisted of the sum scores of eight subscales(physical functioning, physical role limitations, mental health, emotional role limitations, social functioning, vitality, pain, general health perceptions), which are the weighted sums of the questions. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability.The eight subscales were summarized into two composite scores: physical and mental quality of life.|units on a scale|Mean|40.19|40.19|Standard Deviation|10.85|10.85|||
3625390|NCT02632838|3474535|B1|Physicalcomponent summary_Baseline||Health-Related Quality of Life|Health-Related Quality of Life were measured by 36-Item Short Form Health Survey (SF-36). SF-36 consisted of the sum scores of eight subscales(physical functioning, physical role limitations, mental health, emotional role limitations, social functioning, vitality, pain, general health perceptions), which are the weighted sums of the questions. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability.The eight subscales were summarized into two composite scores: physical and mental quality of life.|units on a scale|Mean|41.22|41.22|Standard Deviation|8.91|8.91|||
3625391|NCT02632838|3474533|B3|Diastolic BP_Baseline||Blood Pressure (BP)|At the baseline, all study participants' blood pressure were measured in an upright seated position with feet flat on the floor while being at rest for at least 5 minutes. Participants were measured twice or more, separated by two minutes in each arm. The Welch Allyn Spot Vital Signs LXi electronic blood pressure monitor was utilized for this group. An average of the BP readings recorded.|mm Hg|Mean|90.39|90.39|Standard Deviation|7.09|7.09|||
3625392|NCT02632838|3474534|B2|Diastolic BP_Baseline||Blood Pressure (BP)|At the baseline, all study participants' blood pressure were measured in an upright seated position with feet flat on the floor while being at rest for at least 5 minutes. Participants were measured twice or more, separated by two minutes in each arm. The Welch Allyn Spot Vital Signs LXi electronic blood pressure monitor was utilized for this group. An average of the BP readings recorded.|mm Hg|Mean|90.30|90.3|Standard Deviation|6.46|6.46|||
3625393|NCT02632838|3474535|B1|Diastolic BP_Baseline||Blood Pressure (BP)|At the baseline, all study participants' blood pressure were measured in an upright seated position with feet flat on the floor while being at rest for at least 5 minutes. Participants were measured twice or more, separated by two minutes in each arm. The Welch Allyn Spot Vital Signs LXi electronic blood pressure monitor was utilized for this group. An average of the BP readings recorded.|mm Hg|Mean|90.48|90.48|Standard Deviation|7.58|7.58|||
3625394|NCT02632838|3474533|B3|Systolic BP_Baseline||Blood Pressure (BP)|At the baseline, all study participants' blood pressure were measured in an upright seated position with feet flat on the floor while being at rest for at least 5 minutes. Participants were measured twice or more, separated by two minutes in each arm. The Welch Allyn Spot Vital Signs LXi electronic blood pressure monitor was utilized for this group. An average of the BP readings recorded.|mm Hg|Mean|145.72|145.72|Standard Deviation|4.32|4.32|||
3625395|NCT02632838|3474534|B2|Systolic BP_Baseline||Blood Pressure (BP)|At the baseline, all study participants' blood pressure were measured in an upright seated position with feet flat on the floor while being at rest for at least 5 minutes. Participants were measured twice or more, separated by two minutes in each arm. The Welch Allyn Spot Vital Signs LXi electronic blood pressure monitor was utilized for this group. An average of the BP readings recorded.|mm Hg|Mean|145.67|145.67|Standard Deviation|3.68|3.68|||
3625396|NCT02632838|3474535|B1|Systolic BP_Baseline||Blood Pressure (BP)|At the baseline, all study participants' blood pressure were measured in an upright seated position with feet flat on the floor while being at rest for at least 5 minutes. Participants were measured twice or more, separated by two minutes in each arm. The Welch Allyn Spot Vital Signs LXi electronic blood pressure monitor was utilized for this group. An average of the BP readings recorded.|mm Hg|Mean|145.77|145.77|Standard Deviation|5.10|5.1|||
3625399|NCT02632838|3474535|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3625400|NCT02632838|3474533|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625401|NCT02632838|3474534|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625402|NCT02632838|3474535|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625403|NCT02632838|3474533|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625404|NCT02632838|3474534|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625405|NCT02632838|3474535|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625406|NCT02632838|3474533|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3625407|NCT02632838|3474534|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3625408|NCT02632838|3474535|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625409|NCT02632838|3474533|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3625410|NCT02632838|3474534|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3625411|NCT02632838|3474535|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3625412|NCT02632838|3474533|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625413|NCT02632838|3474534|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625414|NCT02632838|3474535|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625415|NCT02632838|3474533|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625416|NCT02632838|3474534|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625417|NCT02632838|3474535|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625418|NCT02632838|3474533|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625419|NCT02632838|3474534|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625420|NCT02632838|3474535|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625421|NCT02632838|3474533|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625422|NCT02632838|3474534|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625423|NCT02632838|3474535|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625424|NCT02632838|3474533|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3625425|NCT02632838|3474534|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3625426|NCT02632838|3474535|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3625427|NCT02632838|3474533|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3625428|NCT02632838|3474534|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3625429|NCT02632838|3474535|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625430|NCT02632838|3474533|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3625431|NCT02632838|3474534|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3625432|NCT02632838|3474535|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3625433|NCT02632838|3474533|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3625434|NCT02632838|3474534|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3625435|NCT02632838|3474535|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3625436|NCT02632838|3474533|B3|||Age||years|Mean|52.4|52.4|Standard Deviation|7.4|7.4|||
3625437|NCT02632838|3474534|B2|||Age||years|Mean|55.5|55.5|Standard Deviation|5.2|5.2|||
3625438|NCT02632838|3474535|B1|||Age||years|Mean|48.9|48.9|Standard Deviation|8|8.0|||
3625439|NCT02632838|3474533|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3625440|NCT02632838|3474534|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3625441|NCT02632838|3474535|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3625442|NCT02632838|3474533|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3625443|NCT02632838|3474534|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3625444|NCT02632838|3474535|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3625445|NCT02632838|3474533|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3625446|NCT02632838|3474534|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3625447|NCT02632838|3474535|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3625448|NCT02632812|3474550|B3|Brazil||Region of Enrollment||participants|Number|24|24.0||||||
3625449|NCT02632812|3474551|B2|Brazil||Region of Enrollment||participants|Number|12|12.0||||||
3625450|NCT02632812|3474552|B1|Brazil||Region of Enrollment||participants|Number|12|12.0||||||
3625451|NCT02632812|3474550|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3625452|NCT02632812|3474551|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3625453|NCT02632812|3474552|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3625454|NCT02632812|3474550|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3625455|NCT02632812|3474551|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3625456|NCT02632812|3474552|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3625457|NCT02632812|3474550|B3|||Age||years|Median|24.5|24.5|Full Range|||18.0|49.0|
3625458|NCT02632812|3474551|B2|||Age||years|Median|28.5|28.5|Full Range|||19.0|49.0|
3625459|NCT02632812|3474552|B1|||Age||years|Median|23.5|23.5|Full Range|||18.0|49.0|
3625460|NCT02632812|3474550|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3625461|NCT02632812|3474551|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3625462|NCT02632812|3474552|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3625463|NCT02632812|3474550|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3625464|NCT02632812|3474551|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3625465|NCT02632812|3474552|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3625466|NCT02632812|3474550|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3625467|NCT02632812|3474551|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3625468|NCT02632812|3474552|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3625469|NCT02632110|3474571|B6||Type IV - Burns minimally, tans well|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well"|Participants|Count of Participants|6|6.0||||||
3625470|NCT02632110|3474572|B5||Type IV - Burns minimally, tans well|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well"|Participants|Count of Participants|0|0.0||||||
3625471|NCT02632110|3474573|B4||Type IV - Burns minimally, tans well|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well"|Participants|Count of Participants|2|2.0||||||
3625472|NCT02632110|3474574|B3||Type IV - Burns minimally, tans well|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well"|Participants|Count of Participants|2|2.0||||||
3625473|NCT02632110|3474575|B2||Type IV - Burns minimally, tans well|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well"|Participants|Count of Participants|2|2.0||||||
3625474|NCT02632110|3474576|B1||Type IV - Burns minimally, tans well|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well"|Participants|Count of Participants|0|0.0||||||
3625475|NCT02632110|3474571|B6||Type III - Burns moderately, tans gradually|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well"|Participants|Count of Participants|48|48.0||||||
3625476|NCT02632110|3474572|B5||Type III - Burns moderately, tans gradually|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well"|Participants|Count of Participants|9|9.0||||||
3625477|NCT02632110|3474573|B4||Type III - Burns moderately, tans gradually|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well"|Participants|Count of Participants|10|10.0||||||
3625478|NCT02632110|3474574|B3||Type III - Burns moderately, tans gradually|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well"|Participants|Count of Participants|6|6.0||||||
3625479|NCT02632110|3474575|B2||Type III - Burns moderately, tans gradually|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well"|Participants|Count of Participants|11|11.0||||||
3625480|NCT02632110|3474576|B1||Type III - Burns moderately, tans gradually|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well"|Participants|Count of Participants|12|12.0||||||
3625481|NCT02632110|3474571|B6||Type II - Burns easily, tans minimally|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well"|Participants|Count of Participants|76|76.0||||||
3625482|NCT02632110|3474572|B5||Type II - Burns easily, tans minimally|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well"|Participants|Count of Participants|21|21.0||||||
3625483|NCT02632110|3474573|B4||Type II - Burns easily, tans minimally|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well"|Participants|Count of Participants|14|14.0||||||
3625484|NCT02632110|3474574|B3||Type II - Burns easily, tans minimally|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well"|Participants|Count of Participants|19|19.0||||||
3625485|NCT02632110|3474575|B2||Type II - Burns easily, tans minimally|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well"|Participants|Count of Participants|12|12.0||||||
3625486|NCT02632110|3474576|B1||Type II - Burns easily, tans minimally|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well"|Participants|Count of Participants|10|10.0||||||
3625487|NCT02632110|3474571|B6||Type I - Burns easily, never tans|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well"|Participants|Count of Participants|7|7.0||||||
3625488|NCT02632110|3474572|B5||Type I - Burns easily, never tans|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well"|Participants|Count of Participants|0|0.0||||||
3625489|NCT02632110|3474573|B4||Type I - Burns easily, never tans|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well"|Participants|Count of Participants|0|0.0||||||
3625490|NCT02632110|3474574|B3||Type I - Burns easily, never tans|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well"|Participants|Count of Participants|2|2.0||||||
3625491|NCT02632110|3474575|B2||Type I - Burns easily, never tans|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well"|Participants|Count of Participants|2|2.0||||||
3625492|NCT02632110|3474576|B1||Type I - Burns easily, never tans|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well"|Participants|Count of Participants|3|3.0||||||
3625493|NCT02632110|3474571|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625494|NCT02632110|3474572|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625495|NCT02632110|3474573|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625496|NCT02632110|3474574|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625497|NCT02632110|3474575|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625498|NCT02632110|3474576|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625499|NCT02632110|3474571|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625500|NCT02632110|3474572|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625501|NCT02632110|3474573|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625502|NCT02632110|3474574|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625503|NCT02632110|3474575|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625504|NCT02632110|3474576|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625505|NCT02632110|3474571|B6||White|Race (NIH/OMB)||Participants|Count of Participants|137|137.0||||||
3625506|NCT02632110|3474572|B5||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3625507|NCT02632110|3474573|B4||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3625508|NCT02632110|3474574|B3||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3625509|NCT02632110|3474575|B2||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3625510|NCT02632110|3474576|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3625511|NCT02632110|3474571|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625512|NCT02632110|3474572|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625513|NCT02632110|3474573|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625514|NCT02632110|3474574|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625515|NCT02632110|3474575|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625516|NCT02632110|3474576|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625517|NCT02632110|3474571|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625518|NCT02632110|3474572|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625519|NCT02632110|3474573|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625520|NCT02632110|3474574|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625521|NCT02632110|3474575|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625522|NCT02632110|3474576|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625523|NCT02632110|3474571|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625524|NCT02632110|3474572|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625525|NCT02632110|3474573|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625526|NCT02632110|3474574|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625527|NCT02632110|3474575|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625528|NCT02632110|3474576|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625529|NCT02632110|3474571|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625530|NCT02632110|3474572|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625531|NCT02632110|3474573|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625532|NCT02632110|3474574|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625533|NCT02632110|3474575|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625534|NCT02632110|3474576|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625535|NCT02632110|3474571|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625536|NCT02632110|3474572|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625537|NCT02632110|3474573|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625538|NCT02632110|3474574|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625539|NCT02632110|3474575|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625540|NCT02632110|3474576|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625541|NCT02632110|3474571|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|136|136.0||||||
3625542|NCT02632110|3474572|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3625543|NCT02632110|3474573|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3625544|NCT02632110|3474574|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3625545|NCT02632110|3474575|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3625546|NCT02632110|3474576|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3625547|NCT02632110|3474571|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3625548|NCT02632110|3474572|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625549|NCT02632110|3474573|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625550|NCT02632110|3474574|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3625551|NCT02632110|3474575|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625552|NCT02632110|3474576|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625553|NCT02632110|3474571|B6||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3625554|NCT02632110|3474572|B5||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3625555|NCT02632110|3474573|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3625556|NCT02632110|3474574|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3625557|NCT02632110|3474575|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3625558|NCT02632110|3474576|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3625559|NCT02632110|3474571|B6||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3625560|NCT02632110|3474572|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3625561|NCT02632110|3474573|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3625562|NCT02632110|3474574|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3625563|NCT02632110|3474575|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3625564|NCT02632110|3474576|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3625565|NCT02632110|3474571|B6|||Age||years|Mean|65|65.0|Standard Deviation|9|9.0|||
3625566|NCT02632110|3474572|B5|||Age||years|Mean|64|64.0|Standard Deviation|10|10.0|||
3625567|NCT02632110|3474573|B4|||Age||years|Mean|66|66.0|Standard Deviation|9|9.0|||
3625568|NCT02632110|3474574|B3|||Age||years|Mean|67|67.0|Standard Deviation|8|8.0|||
3625569|NCT02632110|3474575|B2|||Age||years|Mean|64|64.0|Standard Deviation|8|8.0|||
3625570|NCT02632110|3474576|B1|||Age||years|Mean|66|66.0|Standard Deviation|10|10.0|||
3625571|NCT02631551|3475052|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3625572|NCT02631551|3475053|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625573|NCT02631551|3475054|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3625574|NCT02631551|3475055|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3625575|NCT02631551|3475056|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3625576|NCT02631551|3475052|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625577|NCT02631551|3475053|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625578|NCT02631551|3475054|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625579|NCT02631551|3475055|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625580|NCT02631551|3475056|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625581|NCT02631551|3475052|B5||White|Race (NIH/OMB)||Participants|Count of Participants|915|915.0||||||
3625582|NCT02631551|3475053|B4||White|Race (NIH/OMB)||Participants|Count of Participants|231|231.0||||||
3625583|NCT02631551|3475054|B3||White|Race (NIH/OMB)||Participants|Count of Participants|224|224.0||||||
3625584|NCT02631551|3475055|B2||White|Race (NIH/OMB)||Participants|Count of Participants|219|219.0||||||
3625585|NCT02631551|3475056|B1||White|Race (NIH/OMB)||Participants|Count of Participants|241|241.0||||||
3625586|NCT02631551|3475052|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|230|230.0||||||
3625587|NCT02631551|3475053|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3625588|NCT02631551|3475054|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3625589|NCT02631551|3475055|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3625590|NCT02631551|3475056|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3625591|NCT02631551|3475052|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3625592|NCT02631551|3475053|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3625593|NCT02631551|3475054|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625594|NCT02631551|3475055|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3625595|NCT02631551|3475056|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3625596|NCT02631551|3475052|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3625597|NCT02631551|3475053|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3625598|NCT02631551|3475054|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3625599|NCT02631551|3475055|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3625600|NCT02631551|3475056|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3625601|NCT02631551|3475052|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3625602|NCT02631551|3475053|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625603|NCT02631551|3475054|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3625604|NCT02631551|3475055|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3625605|NCT02631551|3475056|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625606|NCT02631551|3475052|B5||Male|Sex: Female, Male||Participants|Count of Participants|418|418.0||||||
3625607|NCT02631551|3475053|B4||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3625608|NCT02631551|3475054|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3625609|NCT02631551|3475055|B2||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3625610|NCT02631551|3475056|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3625611|NCT02631551|3475052|B5||Female|Sex: Female, Male||Participants|Count of Participants|762|762.0||||||
3625612|NCT02631551|3475053|B4||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3625613|NCT02631551|3475054|B3||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
3625614|NCT02631551|3475055|B2||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
3625615|NCT02631551|3475056|B1||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3625616|NCT02631551|3475052|B5|||Age||years|Mean|39.3|39.3|Standard Deviation|15.3|15.3|||
3625617|NCT02631551|3475053|B4|||Age||years|Mean|39.4|39.4|Standard Deviation|14.8|14.8|||
3625618|NCT02631551|3475054|B3|||Age||years|Mean|38.7|38.7|Standard Deviation|16.3|16.3|||
3625619|NCT02631551|3475055|B2|||Age||years|Mean|39.6|39.6|Standard Deviation|14.9|14.9|||
3625620|NCT02631551|3475056|B1|||Age||years|Mean|39.5|39.5|Standard Deviation|15.4|15.4|||
3625621|NCT02631057|3475069|B3||Male|Sex: Female, Male||Participants|Count of Participants|2618|2618.0||||||
3625622|NCT02631057|3475070|B2||Male|Sex: Female, Male||Participants|Count of Participants|2016|2016.0||||||
3625623|NCT02631057|3475071|B1||Male|Sex: Female, Male||Participants|Count of Participants|602|602.0||||||
3625624|NCT02631057|3475069|B3||Female|Sex: Female, Male||Participants|Count of Participants|1695|1695.0||||||
3625625|NCT02631057|3475070|B2||Female|Sex: Female, Male||Participants|Count of Participants|1398|1398.0||||||
3625626|NCT02631057|3475071|B1||Female|Sex: Female, Male||Participants|Count of Participants|297|297.0||||||
3625627|NCT02631057|3475069|B3|||Age||Years|Mean|74.9|74.9|Standard Deviation|10.9|10.9|||
3625628|NCT02631057|3475070|B2|||Age||Years|Mean|76.1|76.1|Standard Deviation|10.4|10.4|||
3625629|NCT02631057|3475071|B1|||Age||Years|Mean|70.2|70.2|Standard Deviation|11.6|11.6|||
3625630|NCT02630992|3475078|B1||Moderate or marked|Degree of Tympanic Membrane (TM) Bulging|If a child has unilateral AOM, the degree of bulging reflects the degree of bulging in the ear with AOM. If a child has bilateral AOM, the degree of bulging reflects the degree of bulging in the ear with the greater level of bulging,|Participants|Count of Participants|103|103.0||||||
3625631|NCT02630992|3475078|B1||Slight|Degree of Tympanic Membrane (TM) Bulging|If a child has unilateral AOM, the degree of bulging reflects the degree of bulging in the ear with AOM. If a child has bilateral AOM, the degree of bulging reflects the degree of bulging in the ear with the greater level of bulging,|Participants|Count of Participants|9|9.0||||||
3625632|NCT02630992|3475078|B1||Bilateral|Laterality of Acute Otitis Media (AOM)||Participants|Count of Participants|47|47.0||||||
3625633|NCT02630992|3475078|B1||Unilateral|Laterality of Acute Otitis Media (AOM)||Participants|Count of Participants|65|65.0||||||
3625634|NCT02630992|3475078|B1|||Mean AOM-SOS Score|"The AOM-SOS scale measures five discrete items: tugging of ears, crying, irritability, difficulty sleeping, and fever. Parents are asked to rate these symptoms in comparison with the child's usual state, as none, a little, or a lot, with corresponding scores of 0, 1, and 2. Thus, total scores range from 0 to 10, with higher scores indicating greater severity of symptoms."|AOM-SOS score|Mean|6.4|6.4|Standard Deviation|2.0|2.0|||
3625635|NCT02630992|3475078|B1||9-10|Acute Otitis Media Severity of Symptoms (AOM-SOS) Score|"The AOM-SOS scale measures five discrete items: tugging of ears, crying, irritability, difficulty sleeping, and fever. Parents are asked to rate these symptoms in comparison with the child's usual state, as none, a little, or a lot, with corresponding scores of 0, 1, and 2. Thus, total scores range from 0 to 10, with higher scores indicating greater severity of symptoms."|Participants|Count of Participants|22|22.0||||||
3625636|NCT02630992|3475078|B1||6-8|Acute Otitis Media Severity of Symptoms (AOM-SOS) Score|"The AOM-SOS scale measures five discrete items: tugging of ears, crying, irritability, difficulty sleeping, and fever. Parents are asked to rate these symptoms in comparison with the child's usual state, as none, a little, or a lot, with corresponding scores of 0, 1, and 2. Thus, total scores range from 0 to 10, with higher scores indicating greater severity of symptoms."|Participants|Count of Participants|50|50.0||||||
3625672|NCT02630706|3475095|B4|||Baseline FPG (China Substudy)||mg/dL|Mean|170.6|170.6|Standard Deviation|39.3|39.3|||
3625637|NCT02630992|3475078|B1||3-5|Acute Otitis Media Severity of Symptoms (AOM-SOS) Score|"The AOM-SOS scale measures five discrete items: tugging of ears, crying, irritability, difficulty sleeping, and fever. Parents are asked to rate these symptoms in comparison with the child's usual state, as none, a little, or a lot, with corresponding scores of 0, 1, and 2. Thus, total scores range from 0 to 10, with higher scores indicating greater severity of symptoms."|Participants|Count of Participants|40|40.0||||||
3625638|NCT02630992|3475078|B1||Yes|Exposure to Other Children|Exposed to other children is defined as exposure to at least 3 children for at least 10 hours per week.|Participants|Count of Participants|65|65.0||||||
3625639|NCT02630992|3475078|B1||No|Exposure to Other Children|Exposed to other children is defined as exposure to at least 3 children for at least 10 hours per week.|Participants|Count of Participants|47|47.0||||||
3625640|NCT02630992|3475078|B1||Public|Type of Health Insurance|Type of health insurance relates to the child's insurance.|Participants|Count of Participants|78|78.0||||||
3625641|NCT02630992|3475078|B1||Private|Type of Health Insurance|Type of health insurance relates to the child's insurance.|Participants|Count of Participants|34|34.0||||||
3625642|NCT02630992|3475078|B1||Unknown|Maternal Education||Participants|Count of Participants|1|1.0||||||
3625643|NCT02630992|3475078|B1||College graduate|Maternal Education||Participants|Count of Participants|24|24.0||||||
3625644|NCT02630992|3475078|B1||High school graduate or equivalent|Maternal Education||Participants|Count of Participants|80|80.0||||||
3625645|NCT02630992|3475078|B1||Below high school graduate|Maternal Education||Participants|Count of Participants|7|7.0||||||
3625646|NCT02630992|3475078|B1||Unknown or Not Reported|Race (NIH/OMB)|Race was reported by the children's parents.|Participants|Count of Participants|3|3.0||||||
3625647|NCT02630992|3475078|B1||More than one race|Race (NIH/OMB)|Race was reported by the children's parents.|Participants|Count of Participants|13|13.0||||||
3625648|NCT02630992|3475078|B1||White|Race (NIH/OMB)|Race was reported by the children's parents.|Participants|Count of Participants|17|17.0||||||
3625649|NCT02630992|3475078|B1||Black or African American|Race (NIH/OMB)|Race was reported by the children's parents.|Participants|Count of Participants|74|74.0||||||
3625650|NCT02630992|3475078|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race was reported by the children's parents.|Participants|Count of Participants|0|0.0||||||
3625651|NCT02630992|3475078|B1||Asian|Race (NIH/OMB)|Race was reported by the children's parents.|Participants|Count of Participants|5|5.0||||||
3625652|NCT02630992|3475078|B1||American Indian or Alaska Native|Race (NIH/OMB)|Race was reported by the children's parents.|Participants|Count of Participants|0|0.0||||||
3625653|NCT02630992|3475078|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|Ethnicity was reported by the children's parents.|Participants|Count of Participants|1|1.0||||||
3625654|NCT02630992|3475078|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity was reported by the children's parents.|Participants|Count of Participants|99|99.0||||||
3625655|NCT02630992|3475078|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity was reported by the children's parents.|Participants|Count of Participants|12|12.0||||||
3625656|NCT02630992|3475078|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3625657|NCT02630992|3475078|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3625658|NCT02630992|3475078|B1||12-23 months|Age, Customized||Participants|Count of Participants|53|53.0||||||
3625659|NCT02630992|3475078|B1||6-11 months|Age, Customized||Participants|Count of Participants|59|59.0||||||
3625660|NCT02630706|3475095|B4|Metformin + Another AHA||Anti-AHA status at Screening (Metformin Alone OR Metformin + Another AHA) (China Substudy)|Background AHA therapy at screening. Combination blood glucose lowering agents were counted twice, under each component of the combination.|Participants|Count of Participants|136|136.0||||||
3625661|NCT02630706|3475096|B3|Metformin + Another AHA||Anti-AHA status at Screening (Metformin Alone OR Metformin + Another AHA) (China Substudy)|Background AHA therapy at screening. Combination blood glucose lowering agents were counted twice, under each component of the combination.|Participants|Count of Participants|42|42.0||||||
3625662|NCT02630706|3475097|B2|Metformin + Another AHA||Anti-AHA status at Screening (Metformin Alone OR Metformin + Another AHA) (China Substudy)|Background AHA therapy at screening. Combination blood glucose lowering agents were counted twice, under each component of the combination.|Participants|Count of Participants|43|43.0||||||
3625663|NCT02630706|3475098|B1|Metformin + Another AHA||Anti-AHA status at Screening (Metformin Alone OR Metformin + Another AHA) (China Substudy)|Background AHA therapy at screening. Combination blood glucose lowering agents were counted twice, under each component of the combination.|Participants|Count of Participants|51|51.0||||||
3625664|NCT02630706|3475095|B4|Metformin Alone||Anti-AHA status at Screening (Metformin Alone OR Metformin + Another AHA) (China Substudy)|Background AHA therapy at screening. Combination blood glucose lowering agents were counted twice, under each component of the combination.|Participants|Count of Participants|270|270.0||||||
3625665|NCT02630706|3475096|B3|Metformin Alone||Anti-AHA status at Screening (Metformin Alone OR Metformin + Another AHA) (China Substudy)|Background AHA therapy at screening. Combination blood glucose lowering agents were counted twice, under each component of the combination.|Participants|Count of Participants|93|93.0||||||
3625666|NCT02630706|3475097|B2|Metformin Alone||Anti-AHA status at Screening (Metformin Alone OR Metformin + Another AHA) (China Substudy)|Background AHA therapy at screening. Combination blood glucose lowering agents were counted twice, under each component of the combination.|Participants|Count of Participants|92|92.0||||||
3625667|NCT02630706|3475098|B1|Metformin Alone||Anti-AHA status at Screening (Metformin Alone OR Metformin + Another AHA) (China Substudy)|Background AHA therapy at screening. Combination blood glucose lowering agents were counted twice, under each component of the combination.|Participants|Count of Participants|85|85.0||||||
3625668|NCT02630706|3475095|B4|||Baseline eGFR (China Substudy)||mL/min/1.73 m^2|Mean|101.1|101.1|Standard Deviation|19.9|19.9|||
3625669|NCT02630706|3475096|B3|||Baseline eGFR (China Substudy)||mL/min/1.73 m^2|Mean|100.8|100.8|Standard Deviation|21.1|21.1|||
3625670|NCT02630706|3475097|B2|||Baseline eGFR (China Substudy)||mL/min/1.73 m^2|Mean|102.7|102.7|Standard Deviation|19.8|19.8|||
3625671|NCT02630706|3475098|B1|||Baseline eGFR (China Substudy)||mL/min/1.73 m^2|Mean|99.8|99.8|Standard Deviation|19.0|19.0|||
3625673|NCT02630706|3475096|B3|||Baseline FPG (China Substudy)||mg/dL|Mean|165.5|165.5|Standard Deviation|37.9|37.9|||
3625674|NCT02630706|3475097|B2|||Baseline FPG (China Substudy)||mg/dL|Mean|170.5|170.5|Standard Deviation|43.0|43.0|||
3625675|NCT02630706|3475098|B1|||Baseline FPG (China Substudy)||mg/dL|Mean|175.7|175.7|Standard Deviation|36.2|36.2|||
3625676|NCT02630706|3475095|B4|||Baseline A1C (China Substudy)|A1C is the ratio of glycated hemoglobin to total hemoglobin x 100.|Percentage A1C|Mean|8.14|8.14|Standard Deviation|0.96|0.96|||
3625677|NCT02630706|3475096|B3|||Baseline A1C (China Substudy)|A1C is the ratio of glycated hemoglobin to total hemoglobin x 100.|Percentage A1C|Mean|8.09|8.09|Standard Deviation|0.98|0.98|||
3625678|NCT02630706|3475097|B2|||Baseline A1C (China Substudy)|A1C is the ratio of glycated hemoglobin to total hemoglobin x 100.|Percentage A1C|Mean|8.13|8.13|Standard Deviation|0.96|0.96|||
3625679|NCT02630706|3475098|B1|||Baseline A1C (China Substudy)|A1C is the ratio of glycated hemoglobin to total hemoglobin x 100.|Percentage A1C|Mean|8.22|8.22|Standard Deviation|0.94|0.94|||
3625680|NCT02630706|3475095|B4|||Body Weight (China Substudy)||Kilograms|Mean|70.7|70.7|Standard Deviation|11.2|11.2|||
3625681|NCT02630706|3475096|B3|||Body Weight (China Substudy)||Kilograms|Mean|70.6|70.6|Standard Deviation|12.2|12.2|||
3625682|NCT02630706|3475097|B2|||Body Weight (China Substudy)||Kilograms|Mean|70.2|70.2|Standard Deviation|10.2|10.2|||
3625683|NCT02630706|3475098|B1|||Body Weight (China Substudy)||Kilograms|Mean|71.4|71.4|Standard Deviation|11.1|11.1|||
3625684|NCT02630706|3475095|B4|||Age Continuous (China Substudy)||Years|Mean|56.3|56.3|Standard Deviation|9.0|9.0|||
3625685|NCT02630706|3475096|B3|||Age Continuous (China Substudy)||Years|Mean|56.8|56.8|Standard Deviation|8.6|8.6|||
3625686|NCT02630706|3475097|B2|||Age Continuous (China Substudy)||Years|Mean|56.2|56.2|Standard Deviation|9.4|9.4|||
3625687|NCT02630706|3475098|B1|||Age Continuous (China Substudy)||Years|Mean|56.0|56.0|Standard Deviation|9.0|9.0|||
3625688|NCT02630706|3475095|B4||Male|Gender (China Substudy)||Participants|Count of Participants|224|224.0||||||
3625689|NCT02630706|3475096|B3||Male|Gender (China Substudy)||Participants|Count of Participants|69|69.0||||||
3625690|NCT02630706|3475097|B2||Male|Gender (China Substudy)||Participants|Count of Participants|84|84.0||||||
3625691|NCT02630706|3475098|B1||Male|Gender (China Substudy)||Participants|Count of Participants|71|71.0||||||
3625692|NCT02630706|3475095|B4||Female|Gender (China Substudy)||Participants|Count of Participants|182|182.0||||||
3625693|NCT02630706|3475096|B3||Female|Gender (China Substudy)||Participants|Count of Participants|66|66.0||||||
3625694|NCT02630706|3475097|B2||Female|Gender (China Substudy)||Participants|Count of Participants|51|51.0||||||
3625695|NCT02630706|3475098|B1||Female|Gender (China Substudy)||Participants|Count of Participants|65|65.0||||||
3625696|NCT02630706|3475095|B4|Metformin + Another AHA||Anti-hyperglycemic Agent (AHA) Status at Screening (Metformin Alone OR Metformin + Another AHA)|Background AHA therapy at screening. Combination blood glucose lowering agents were counted twice, under each component of the combination.|Participants|Count of Participants|153|153.0||||||
3625697|NCT02630706|3475096|B3|Metformin + Another AHA||Anti-hyperglycemic Agent (AHA) Status at Screening (Metformin Alone OR Metformin + Another AHA)|Background AHA therapy at screening. Combination blood glucose lowering agents were counted twice, under each component of the combination.|Participants|Count of Participants|46|46.0||||||
3625698|NCT02630706|3475097|B2|Metformin + Another AHA||Anti-hyperglycemic Agent (AHA) Status at Screening (Metformin Alone OR Metformin + Another AHA)|Background AHA therapy at screening. Combination blood glucose lowering agents were counted twice, under each component of the combination.|Participants|Count of Participants|48|48.0||||||
3625699|NCT02630706|3475098|B1|Metformin + Another AHA||Anti-hyperglycemic Agent (AHA) Status at Screening (Metformin Alone OR Metformin + Another AHA)|Background AHA therapy at screening. Combination blood glucose lowering agents were counted twice, under each component of the combination.|Participants|Count of Participants|59|59.0||||||
3625700|NCT02630706|3475095|B4|Metformin alone||Anti-hyperglycemic Agent (AHA) Status at Screening (Metformin Alone OR Metformin + Another AHA)|Background AHA therapy at screening. Combination blood glucose lowering agents were counted twice, under each component of the combination.|Participants|Count of Participants|353|353.0||||||
3625701|NCT02630706|3475096|B3|Metformin alone||Anti-hyperglycemic Agent (AHA) Status at Screening (Metformin Alone OR Metformin + Another AHA)|Background AHA therapy at screening. Combination blood glucose lowering agents were counted twice, under each component of the combination.|Participants|Count of Participants|121|121.0||||||
3625702|NCT02630706|3475097|B2|Metformin alone||Anti-hyperglycemic Agent (AHA) Status at Screening (Metformin Alone OR Metformin + Another AHA)|Background AHA therapy at screening. Combination blood glucose lowering agents were counted twice, under each component of the combination.|Participants|Count of Participants|121|121.0||||||
3625703|NCT02630706|3475098|B1|Metformin alone||Anti-hyperglycemic Agent (AHA) Status at Screening (Metformin Alone OR Metformin + Another AHA)|Background AHA therapy at screening. Combination blood glucose lowering agents were counted twice, under each component of the combination.|Participants|Count of Participants|111|111.0||||||
3625704|NCT02630706|3475095|B4||Taiwan|Country||Participants|Count of Participants|18|18.0||||||
3625705|NCT02630706|3475096|B3||Taiwan|Country||Participants|Count of Participants|8|8.0||||||
3625706|NCT02630706|3475097|B2||Taiwan|Country||Participants|Count of Participants|6|6.0||||||
3625707|NCT02630706|3475098|B1||Taiwan|Country||Participants|Count of Participants|4|4.0||||||
3625708|NCT02630706|3475095|B4||Philippines|Country||Participants|Count of Participants|23|23.0||||||
3625709|NCT02630706|3475096|B3||Philippines|Country||Participants|Count of Participants|8|8.0||||||
3625710|NCT02630706|3475097|B2||Philippines|Country||Participants|Count of Participants|8|8.0||||||
3625711|NCT02630706|3475098|B1||Philippines|Country||Participants|Count of Participants|7|7.0||||||
3625712|NCT02630706|3475095|B4||Korea, Republic of|Country||Participants|Count of Participants|32|32.0||||||
3625713|NCT02630706|3475096|B3||Korea, Republic of|Country||Participants|Count of Participants|9|9.0||||||
3625714|NCT02630706|3475097|B2||Korea, Republic of|Country||Participants|Count of Participants|10|10.0||||||
3625715|NCT02630706|3475098|B1||Korea, Republic of|Country||Participants|Count of Participants|13|13.0||||||
3625716|NCT02630706|3475095|B4||Hong Kong|Country||Participants|Count of Participants|27|27.0||||||
3625717|NCT02630706|3475096|B3||Hong Kong|Country||Participants|Count of Participants|7|7.0||||||
3625718|NCT02630706|3475097|B2||Hong Kong|Country||Participants|Count of Participants|10|10.0||||||
3625719|NCT02630706|3475098|B1||Hong Kong|Country||Participants|Count of Participants|10|10.0||||||
3625720|NCT02630706|3475095|B4||China|Country||Participants|Count of Participants|406|406.0||||||
3625721|NCT02630706|3475096|B3||China|Country||Participants|Count of Participants|135|135.0||||||
3625722|NCT02630706|3475097|B2||China|Country||Participants|Count of Participants|135|135.0||||||
3625723|NCT02630706|3475098|B1||China|Country||Participants|Count of Participants|136|136.0||||||
3625724|NCT02630706|3475095|B4|||Baseline estimated glomerular filtration rate (eGFR)||mL/min/1.73 m^2|Mean|99.3|99.3|Standard Deviation|19.7|19.7|||
3625725|NCT02630706|3475096|B3|||Baseline estimated glomerular filtration rate (eGFR)||mL/min/1.73 m^2|Mean|99.9|99.9|Standard Deviation|20.2|20.2|||
3625726|NCT02630706|3475097|B2|||Baseline estimated glomerular filtration rate (eGFR)||mL/min/1.73 m^2|Mean|100.2|100.2|Standard Deviation|19.8|19.8|||
3625727|NCT02630706|3475098|B1|||Baseline estimated glomerular filtration rate (eGFR)||mL/min/1.73 m^2|Mean|97.9|97.9|Standard Deviation|19.2|19.2|||
3625728|NCT02630706|3475095|B4|||Baseline Fasting Plasma Glucose (FPG)||mg/dL|Mean|167.8|167.8|Standard Deviation|38.3|38.3|||
3625729|NCT02630706|3475096|B3|||Baseline Fasting Plasma Glucose (FPG)||mg/dL|Mean|165.8|165.8|Standard Deviation|37.6|37.6|||
3625730|NCT02630706|3475097|B2|||Baseline Fasting Plasma Glucose (FPG)||mg/dL|Mean|167.3|167.3|Standard Deviation|41.1|41.1|||
3625731|NCT02630706|3475098|B1|||Baseline Fasting Plasma Glucose (FPG)||mg/dL|Mean|170.1|170.1|Standard Deviation|36.0|36.0|||
3625732|NCT02630706|3475095|B4|||Baseline Hemoglobin A1C (A1C)|Percentage A1C is the ratio of glycated hemoglobin to total hemoglobin x 100.|Percentage A1C|Mean|8.12|8.12|Standard Deviation|0.92|0.92|||
3625733|NCT02630706|3475096|B3|||Baseline Hemoglobin A1C (A1C)|Percentage A1C is the ratio of glycated hemoglobin to total hemoglobin x 100.|Percentage A1C|Mean|8.13|8.13|Standard Deviation|0.96|0.96|||
3625734|NCT02630706|3475097|B2|||Baseline Hemoglobin A1C (A1C)|Percentage A1C is the ratio of glycated hemoglobin to total hemoglobin x 100.|Percentage A1C|Mean|8.09|8.09|Standard Deviation|0.91|0.91|||
3625735|NCT02630706|3475098|B1|||Baseline Hemoglobin A1C (A1C)|Percentage A1C is the ratio of glycated hemoglobin to total hemoglobin x 100.|Percentage A1C|Mean|8.14|8.14|Standard Deviation|0.89|0.89|||
3625736|NCT02630706|3475095|B4|||Body Weight||Kilograms|Mean|70.3|70.3|Standard Deviation|11.5|11.5|||
3625737|NCT02630706|3475096|B3|||Body Weight||Kilograms|Mean|70.1|70.1|Standard Deviation|12.4|12.4|||
3625738|NCT02630706|3475097|B2|||Body Weight||Kilograms|Mean|69.5|69.5|Standard Deviation|10.9|10.9|||
3625739|NCT02630706|3475098|B1|||Body Weight||Kilograms|Mean|71.4|71.4|Standard Deviation|11.1|11.1|||
3625740|NCT02630706|3475095|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625741|NCT02630706|3475096|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625742|NCT02630706|3475097|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625743|NCT02630706|3475098|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625744|NCT02630706|3475095|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625745|NCT02630706|3475096|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625746|NCT02630706|3475097|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625747|NCT02630706|3475098|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625748|NCT02630706|3475095|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625749|NCT02630706|3475096|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625750|NCT02630706|3475097|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625751|NCT02630706|3475098|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625752|NCT02630706|3475095|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625753|NCT02630706|3475096|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625754|NCT02630706|3475097|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625755|NCT02630706|3475098|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625756|NCT02630706|3475095|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625757|NCT02630706|3475096|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625758|NCT02630706|3475097|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625759|NCT02630706|3475098|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625760|NCT02630706|3475095|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|506|506.0||||||
3625761|NCT02630706|3475096|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
3625762|NCT02630706|3475097|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|169|169.0||||||
3625763|NCT02630706|3475098|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|170|170.0||||||
3625764|NCT02630706|3475095|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625765|NCT02630706|3475096|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625766|NCT02630706|3475097|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625767|NCT02630706|3475098|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625768|NCT02630706|3475095|B4||Male|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
3625769|NCT02630706|3475096|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3625770|NCT02630706|3475097|B2||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3625771|NCT02630706|3475098|B1||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3625772|NCT02630706|3475095|B4||Female|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
3625773|NCT02630706|3475096|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3625774|NCT02630706|3475097|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3625775|NCT02630706|3475098|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3625776|NCT02630706|3475095|B4|||Age||Years|Mean|56.5|56.5|Standard Deviation|9.1|9.1|||
3625777|NCT02630706|3475096|B3|||Age||Years|Mean|56.9|56.9|Standard Deviation|9.0|9.0|||
3625778|NCT02630706|3475097|B2|||Age||Years|Mean|56.3|56.3|Standard Deviation|9.3|9.3|||
3625779|NCT02630706|3475098|B1|||Age||Years|Mean|56.1|56.1|Standard Deviation|9.0|9.0|||
3625780|NCT02630563|3475207|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3625781|NCT02630563|3475207|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3625782|NCT02630563|3475207|B1|||Age||years|Mean|1.3|1.3|Standard Deviation|1.5|1.5|||
3625783|NCT02629861|3475216|B4|||Migraine Disability Assessment (MIDAS) Total Score|The MIDAS questionnaire is a 5-item instrument developed to assess headache-related disability based on lost days of activity in 3 domains (work, household work, and nonwork) over the previous 3 months. The total score, ie, the sum of the # lost days answered for the first 5 questions, is used for grading of disability, with scores of 0-5 = grade 1 (little or no disability), 6-10 =grade 2 (mild disability), 11-20 = grade 3 (moderate disability), and ≥21 interpreted as grade 4 (severe disability).|units on a scale|Mean|39.0|39.0|Standard Deviation|31.36|31.36|||
3625784|NCT02629861|3475217|B3|||Migraine Disability Assessment (MIDAS) Total Score|The MIDAS questionnaire is a 5-item instrument developed to assess headache-related disability based on lost days of activity in 3 domains (work, household work, and nonwork) over the previous 3 months. The total score, ie, the sum of the # lost days answered for the first 5 questions, is used for grading of disability, with scores of 0-5 = grade 1 (little or no disability), 6-10 =grade 2 (mild disability), 11-20 = grade 3 (moderate disability), and ≥21 interpreted as grade 4 (severe disability).|units on a scale|Mean|38.0|38.0|Standard Deviation|33.19|33.19|||
3625785|NCT02629861|3475218|B2|||Migraine Disability Assessment (MIDAS) Total Score|The MIDAS questionnaire is a 5-item instrument developed to assess headache-related disability based on lost days of activity in 3 domains (work, household work, and nonwork) over the previous 3 months. The total score, ie, the sum of the # lost days answered for the first 5 questions, is used for grading of disability, with scores of 0-5 = grade 1 (little or no disability), 6-10 =grade 2 (mild disability), 11-20 = grade 3 (moderate disability), and ≥21 interpreted as grade 4 (severe disability).|units on a scale|Mean|41.7|41.7|Standard Deviation|32.96|32.96|||
3625786|NCT02629861|3475219|B1|||Migraine Disability Assessment (MIDAS) Total Score|The MIDAS questionnaire is a 5-item instrument developed to assess headache-related disability based on lost days of activity in 3 domains (work, household work, and nonwork) over the previous 3 months. The total score, ie, the sum of the # lost days answered for the first 5 questions, is used for grading of disability, with scores of 0-5 = grade 1 (little or no disability), 6-10 =grade 2 (mild disability), 11-20 = grade 3 (moderate disability), and ≥21 interpreted as grade 4 (severe disability).|units on a scale|Mean|37.3|37.3|Standard Deviation|27.59|27.59|||
3625787|NCT02629861|3475216|B4|||Number of Days of Use of Any Acute Headache Medications|Eligible patients entered a 28-day run-in/baseline period during which headache information (including information about use of headache medications) was captured daily throughout study participation using the electronic headache diary device.|days|Mean|7.8|7.8|Standard Deviation|3.57|3.57|||
3625788|NCT02629861|3475217|B3|||Number of Days of Use of Any Acute Headache Medications|Eligible patients entered a 28-day run-in/baseline period during which headache information (including information about use of headache medications) was captured daily throughout study participation using the electronic headache diary device.|days|Mean|7.7|7.7|Standard Deviation|3.37|3.37|||
3625789|NCT02629861|3475218|B2|||Number of Days of Use of Any Acute Headache Medications|Eligible patients entered a 28-day run-in/baseline period during which headache information (including information about use of headache medications) was captured daily throughout study participation using the electronic headache diary device.|days|Mean|7.8|7.8|Standard Deviation|3.74|3.74|||
3625790|NCT02629861|3475219|B1|||Number of Days of Use of Any Acute Headache Medications|Eligible patients entered a 28-day run-in/baseline period during which headache information (including information about use of headache medications) was captured daily throughout study participation using the electronic headache diary device.|days|Mean|7.7|7.7|Standard Deviation|3.60|3.6|||
3625791|NCT02629861|3475216|B4|||Number of Headache Days of At Least Moderate Severity|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device. Headache severity was subjectively rated by the patient as mild, moderate or severe.|days|Mean|7.0|7.0|Standard Deviation|3.06|3.06|||
3625792|NCT02629861|3475217|B3|||Number of Headache Days of At Least Moderate Severity|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device. Headache severity was subjectively rated by the patient as mild, moderate or severe.|days|Mean|6.8|6.8|Standard Deviation|2.90|2.9|||
3625793|NCT02629861|3475218|B2|||Number of Headache Days of At Least Moderate Severity|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device. Headache severity was subjectively rated by the patient as mild, moderate or severe.|days|Mean|7.2|7.2|Standard Deviation|3.14|3.14|||
3625794|NCT02629861|3475219|B1|||Number of Headache Days of At Least Moderate Severity|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device. Headache severity was subjectively rated by the patient as mild, moderate or severe.|days|Mean|6.9|6.9|Standard Deviation|3.12|3.12|||
3626072|NCT02626910|3475419|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3625795|NCT02629861|3475216|B4|||Number of Migraine Days|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device. Migraine headaches are as defined in The International Classification of Headache Disorders 3rd edition (ICHD-3).|days|Mean|9.1|9.1|Standard Deviation|2.64|2.64|||
3625796|NCT02629861|3475217|B3|||Number of Migraine Days|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device. Migraine headaches are as defined in The International Classification of Headache Disorders 3rd edition (ICHD-3).|days|Mean|8.9|8.9|Standard Deviation|2.63|2.63|||
3625797|NCT02629861|3475218|B2|||Number of Migraine Days|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device. Migraine headaches are as defined in The International Classification of Headache Disorders 3rd edition (ICHD-3).|days|Mean|9.3|9.3|Standard Deviation|2.65|2.65|||
3625798|NCT02629861|3475219|B1|||Number of Migraine Days|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device. Migraine headaches are as defined in The International Classification of Headache Disorders 3rd edition (ICHD-3).|days|Mean|9.1|9.1|Standard Deviation|2.65|2.65|||
3625799|NCT02629861|3475216|B4|||Total Number of Headache Days of Any Duration And Any Severity During the 28 Day Baseline Period|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device.|days|Mean|11.1|11.1|Standard Deviation|2.45|2.45|||
3625800|NCT02629861|3475217|B3|||Total Number of Headache Days of Any Duration And Any Severity During the 28 Day Baseline Period|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device.|days|Mean|11.0|11.0|Standard Deviation|2.49|2.49|||
3625801|NCT02629861|3475218|B2|||Total Number of Headache Days of Any Duration And Any Severity During the 28 Day Baseline Period|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device.|days|Mean|11.1|11.1|Standard Deviation|2.42|2.42|||
3625802|NCT02629861|3475219|B1|||Total Number of Headache Days of Any Duration And Any Severity During the 28 Day Baseline Period|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device.|days|Mean|11.2|11.2|Standard Deviation|2.45|2.45|||
3625803|NCT02629861|3475216|B4|||Time Since Initial Migraine Diagnosis||years|Mean|20.2|20.2|Standard Deviation|12.28|12.28|||
3625804|NCT02629861|3475217|B3|||Time Since Initial Migraine Diagnosis||years|Mean|20.7|20.7|Standard Deviation|12.85|12.85|||
3625805|NCT02629861|3475218|B2|||Time Since Initial Migraine Diagnosis||years|Mean|20.0|20.0|Standard Deviation|12.14|12.14|||
3625806|NCT02629861|3475219|B1|||Time Since Initial Migraine Diagnosis||years|Mean|19.9|19.9|Standard Deviation|11.87|11.87|||
3625807|NCT02629861|3475216|B4|||Weight||kg|Mean|73.9|73.9|Standard Deviation|15.77|15.77|||
3625808|NCT02629861|3475217|B3|||Weight||kg|Mean|72.1|72.1|Standard Deviation|15.77|15.77|||
3625809|NCT02629861|3475218|B2|||Weight||kg|Mean|74.2|74.2|Standard Deviation|15.42|15.42|||
3625810|NCT02629861|3475219|B1|||Weight||kg|Mean|75.3|75.3|Standard Deviation|16.01|16.01|||
3625811|NCT02629861|3475216|B4||No|Preventive Medication Use During Baseline Period|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device. During randomization, patients were stratified based on sex, country, and baseline preventive migraine medication use (yes, no) to ensure balance for the covariates.|Participants|Count of Participants|693|693.0||||||
3625812|NCT02629861|3475217|B3||No|Preventive Medication Use During Baseline Period|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device. During randomization, patients were stratified based on sex, country, and baseline preventive migraine medication use (yes, no) to ensure balance for the covariates.|Participants|Count of Participants|228|228.0||||||
3625813|NCT02629861|3475218|B2||No|Preventive Medication Use During Baseline Period|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device. During randomization, patients were stratified based on sex, country, and baseline preventive migraine medication use (yes, no) to ensure balance for the covariates.|Participants|Count of Participants|233|233.0||||||
3625814|NCT02629861|3475219|B1||No|Preventive Medication Use During Baseline Period|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device. During randomization, patients were stratified based on sex, country, and baseline preventive migraine medication use (yes, no) to ensure balance for the covariates.|Participants|Count of Participants|232|232.0||||||
3625815|NCT02629861|3475216|B4||Yes|Preventive Medication Use During Baseline Period|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device. During randomization, patients were stratified based on sex, country, and baseline preventive migraine medication use (yes, no) to ensure balance for the covariates.|Participants|Count of Participants|182|182.0||||||
3625816|NCT02629861|3475217|B3||Yes|Preventive Medication Use During Baseline Period|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device. During randomization, patients were stratified based on sex, country, and baseline preventive migraine medication use (yes, no) to ensure balance for the covariates.|Participants|Count of Participants|62|62.0||||||
3625817|NCT02629861|3475218|B2||Yes|Preventive Medication Use During Baseline Period|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device. During randomization, patients were stratified based on sex, country, and baseline preventive migraine medication use (yes, no) to ensure balance for the covariates.|Participants|Count of Participants|58|58.0||||||
3625818|NCT02629861|3475219|B1||Yes|Preventive Medication Use During Baseline Period|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device. During randomization, patients were stratified based on sex, country, and baseline preventive migraine medication use (yes, no) to ensure balance for the covariates.|Participants|Count of Participants|62|62.0||||||
3625819|NCT02629861|3475216|B4||Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3625820|NCT02629861|3475217|B3||Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3625821|NCT02629861|3475218|B2||Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3625822|NCT02629861|3475219|B1||Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3625823|NCT02629861|3475216|B4||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|103|103.0||||||
3625824|NCT02629861|3475217|B3||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
3625825|NCT02629861|3475218|B2||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
3625826|NCT02629861|3475219|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3625827|NCT02629861|3475216|B4||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|770|770.0||||||
3625828|NCT02629861|3475217|B3||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|252|252.0||||||
3625829|NCT02629861|3475218|B2||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|251|251.0||||||
3625830|NCT02629861|3475219|B1||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|267|267.0||||||
3625831|NCT02629861|3475216|B4||Other|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3625832|NCT02629861|3475217|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3625833|NCT02629861|3475218|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3625834|NCT02629861|3475219|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3625835|NCT02629861|3475216|B4||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3625836|NCT02629861|3475217|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3625837|NCT02629861|3475218|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3625838|NCT02629861|3475219|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3625839|NCT02629861|3475216|B4||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3625840|NCT02629861|3475217|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3625841|NCT02629861|3475218|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3625842|NCT02629861|3475219|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3625843|NCT02629861|3475216|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|77|77.0||||||
3625844|NCT02629861|3475217|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3625845|NCT02629861|3475218|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3625846|NCT02629861|3475219|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3625847|NCT02629861|3475216|B4||Black|Race/Ethnicity, Customized||Participants|Count of Participants|86|86.0||||||
3625848|NCT02629861|3475217|B3||Black|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3625849|NCT02629861|3475218|B2||Black|Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3625850|NCT02629861|3475219|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3625851|NCT02629861|3475216|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|700|700.0||||||
3625852|NCT02629861|3475217|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|243|243.0||||||
3625853|NCT02629861|3475218|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|232|232.0||||||
3625854|NCT02629861|3475219|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|225|225.0||||||
3625855|NCT02629861|3475216|B4||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3625856|NCT02629861|3475217|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3625857|NCT02629861|3475218|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3625858|NCT02629861|3475219|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3625859|NCT02629861|3475216|B4||Female|Sex: Female, Male||Participants|Count of Participants|742|742.0||||||
3625860|NCT02629861|3475217|B3||Female|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
3625861|NCT02629861|3475218|B2||Female|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
3625862|NCT02629861|3475219|B1||Female|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
3625863|NCT02629861|3475216|B4||>65 years|Age, Customized||Participants|Count of Participants|18|18.0||||||
3625864|NCT02629861|3475217|B3||>65 years|Age, Customized||Participants|Count of Participants|7|7.0||||||
3625865|NCT02629861|3475218|B2||>65 years|Age, Customized||Participants|Count of Participants|3|3.0||||||
3625866|NCT02629861|3475219|B1||>65 years|Age, Customized||Participants|Count of Participants|8|8.0||||||
3625867|NCT02629861|3475216|B4||46-65 years|Age, Customized||Participants|Count of Participants|332|332.0||||||
3625868|NCT02629861|3475217|B3||46-65 years|Age, Customized||Participants|Count of Participants|120|120.0||||||
3625869|NCT02629861|3475218|B2||46-65 years|Age, Customized||Participants|Count of Participants|110|110.0||||||
3625870|NCT02629861|3475219|B1||46-65 years|Age, Customized||Participants|Count of Participants|102|102.0||||||
3625871|NCT02629861|3475216|B4||18-45 years|Age, Customized||Participants|Count of Participants|525|525.0||||||
3625872|NCT02629861|3475217|B3||18-45 years|Age, Customized||Participants|Count of Participants|163|163.0||||||
3625873|NCT02629861|3475218|B2||18-45 years|Age, Customized||Participants|Count of Participants|178|178.0||||||
3625874|NCT02629861|3475219|B1||18-45 years|Age, Customized||Participants|Count of Participants|184|184.0||||||
3625875|NCT02629861|3475216|B4|||Age||years|Mean|41.8|41.8|Standard Deviation|12.06|12.06|||
3625876|NCT02629861|3475217|B3|||Age||years|Mean|42.9|42.9|Standard Deviation|12.67|12.67|||
3625877|NCT02629861|3475218|B2|||Age||years|Mean|41.1|41.1|Standard Deviation|11.41|11.41|||
3625878|NCT02629861|3475219|B1|||Age||years|Mean|41.3|41.3|Standard Deviation|12.04|12.04|||
3625879|NCT02629354|3475268|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3625880|NCT02629354|3475269|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3625881|NCT02629354|3475270|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3625882|NCT02629354|3475268|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3625883|NCT02629354|3475269|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3625884|NCT02629354|3475270|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3625885|NCT02629354|3475268|B3|||Age||years|Mean|28.0|28.0|Standard Deviation|7.33|7.33|||
3625886|NCT02629354|3475269|B2|||Age||years|Mean|26.1|26.1|Standard Deviation|5.59|5.59|||
3625887|NCT02629354|3475270|B1|||Age||years|Mean|29.8|29.8|Standard Deviation|8.49|8.49|||
3625888|NCT02629094|3475293|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625889|NCT02629094|3475293|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625890|NCT02629094|3475293|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3625891|NCT02629094|3475293|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3625892|NCT02629094|3475293|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625893|NCT02629094|3475293|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3625894|NCT02629094|3475293|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625895|NCT02629094|3475293|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625896|NCT02629094|3475293|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3625897|NCT02629094|3475293|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625898|NCT02629094|3475293|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3625899|NCT02629094|3475293|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3625900|NCT02629094|3475293|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3625901|NCT02629094|3475293|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3625902|NCT02629094|3475293|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3625903|NCT02628938|3475298|B4|||Volatile sulfur compound|Scores using breath checker device (Tanita FitScan HC-212SF Breath Checker) were recorded (0=no odor, 1=slight odor, 2=moderate odor, 3=heavy odor, 4=strong odor, 5=intense odor).|units on a scale|Mean|3.85|3.85|Standard Deviation|0.99|0.99|||
3625904|NCT02628938|3475299|B3|||Volatile sulfur compound|Scores using breath checker device (Tanita FitScan HC-212SF Breath Checker) were recorded (0=no odor, 1=slight odor, 2=moderate odor, 3=heavy odor, 4=strong odor, 5=intense odor).|units on a scale|Mean|4.27|4.27|Standard Deviation|0.47|0.47|||
3625905|NCT02628938|3475300|B2|||Volatile sulfur compound|Scores using breath checker device (Tanita FitScan HC-212SF Breath Checker) were recorded (0=no odor, 1=slight odor, 2=moderate odor, 3=heavy odor, 4=strong odor, 5=intense odor).|units on a scale|Mean|3.15|3.15|Standard Deviation|1.21|1.21|||
3625906|NCT02628938|3475301|B1|||Volatile sulfur compound|Scores using breath checker device (Tanita FitScan HC-212SF Breath Checker) were recorded (0=no odor, 1=slight odor, 2=moderate odor, 3=heavy odor, 4=strong odor, 5=intense odor).|units on a scale|Mean|4.3|4.3|Standard Deviation|0.48|0.48|||
3625907|NCT02628938|3475298|B4|||Organoleptic scores|"Each patient was asked to close her mouth for 3 minutes while breathing only from the nose. Then she was asked to release air from the mouth slowly. The judge kept a distance of about 10 cm between her nose and the patient's mouth to determine the score based on the intensity of the odor.~The intensity ratings of 0 to 5 score was used where Score 0 stands for No odor present, score 1 stands barely noticeable odor, score 2 stands slight but clearly noticeable odor, score 3 stands moderate odor, score 4 stands strong offensive odor and a Score 5 stands extremely foul odor"|units on a scale|Mean|2.65|2.65|Standard Deviation|0.85|0.85|||
3625908|NCT02628938|3475299|B3|||Organoleptic scores|"Each patient was asked to close her mouth for 3 minutes while breathing only from the nose. Then she was asked to release air from the mouth slowly. The judge kept a distance of about 10 cm between her nose and the patient's mouth to determine the score based on the intensity of the odor.~The intensity ratings of 0 to 5 score was used where Score 0 stands for No odor present, score 1 stands barely noticeable odor, score 2 stands slight but clearly noticeable odor, score 3 stands moderate odor, score 4 stands strong offensive odor and a Score 5 stands extremely foul odor"|units on a scale|Mean|2.45|2.45|Standard Deviation|0.69|0.69|||
3625909|NCT02628938|3475300|B2|||Organoleptic scores|"Each patient was asked to close her mouth for 3 minutes while breathing only from the nose. Then she was asked to release air from the mouth slowly. The judge kept a distance of about 10 cm between her nose and the patient's mouth to determine the score based on the intensity of the odor.~The intensity ratings of 0 to 5 score was used where Score 0 stands for No odor present, score 1 stands barely noticeable odor, score 2 stands slight but clearly noticeable odor, score 3 stands moderate odor, score 4 stands strong offensive odor and a Score 5 stands extremely foul odor"|units on a scale|Mean|2.85|2.85|Standard Deviation|0.99|0.99|||
3626012|NCT02626910|3475419|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625910|NCT02628938|3475301|B1|||Organoleptic scores|"Each patient was asked to close her mouth for 3 minutes while breathing only from the nose. Then she was asked to release air from the mouth slowly. The judge kept a distance of about 10 cm between her nose and the patient's mouth to determine the score based on the intensity of the odor.~The intensity ratings of 0 to 5 score was used where Score 0 stands for No odor present, score 1 stands barely noticeable odor, score 2 stands slight but clearly noticeable odor, score 3 stands moderate odor, score 4 stands strong offensive odor and a Score 5 stands extremely foul odor"|units on a scale|Mean|2.6|2.6|Standard Deviation|0.84|0.84|||
3625911|NCT02628938|3475298|B4|||Self-assessment of mouth odor|"Participants were asked to score their own halitosis on a continuous 10-cm visual analogue scale that is marked as no odor on the 0-cm end, and as extremely foul odor on the 10-cm end"|units on a scale|Mean|3.83|3.83|Standard Deviation|2.11|2.11|||
3625912|NCT02628938|3475299|B3|||Self-assessment of mouth odor|"Participants were asked to score their own halitosis on a continuous 10-cm visual analogue scale that is marked as no odor on the 0-cm end, and as extremely foul odor on the 10-cm end"|units on a scale|Mean|3.91|3.91|Standard Deviation|1.3|1.3|||
3625913|NCT02628938|3475300|B2|||Self-assessment of mouth odor|"Participants were asked to score their own halitosis on a continuous 10-cm visual analogue scale that is marked as no odor on the 0-cm end, and as extremely foul odor on the 10-cm end"|units on a scale|Mean|3.85|3.85|Standard Deviation|1.57|1.57|||
3625914|NCT02628938|3475301|B1|||Self-assessment of mouth odor|"Participants were asked to score their own halitosis on a continuous 10-cm visual analogue scale that is marked as no odor on the 0-cm end, and as extremely foul odor on the 10-cm end"|units on a scale|Mean|3.70|3.7|Standard Deviation|3.33|3.33|||
3625915|NCT02628938|3475298|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3625916|NCT02628938|3475299|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3625917|NCT02628938|3475300|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3625918|NCT02628938|3475301|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3625919|NCT02628938|3475298|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3625920|NCT02628938|3475299|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3625921|NCT02628938|3475300|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3625922|NCT02628938|3475301|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3625923|NCT02628938|3475298|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3625924|NCT02628938|3475299|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3625925|NCT02628938|3475300|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3625926|NCT02628938|3475301|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3625927|NCT02628938|3475298|B4||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3625928|NCT02628938|3475299|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3625929|NCT02628938|3475300|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3625930|NCT02628938|3475301|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3625931|NCT02628938|3475298|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3625932|NCT02628938|3475299|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3625933|NCT02628938|3475300|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3625934|NCT02628938|3475301|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3625935|NCT02628418|3475317|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3625936|NCT02628418|3475318|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3625937|NCT02628418|3475319|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3625938|NCT02628418|3475317|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3625939|NCT02628418|3475318|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3625940|NCT02628418|3475319|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3625941|NCT02628418|3475317|B3|||Age||years|Mean|72.5|72.5|Standard Deviation|12.5|12.5|||
3625942|NCT02628418|3475318|B2|||Age||years|Mean|73|73.0|Standard Deviation|14|14.0|||
3625943|NCT02628418|3475319|B1|||Age||years|Mean|72|72.0|Standard Deviation|11|11.0|||
3625944|NCT02628236|3475341|B1|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3625945|NCT02628236|3475341|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625946|NCT02628236|3475341|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625947|NCT02628236|3475341|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3625948|NCT02628236|3475341|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625949|NCT02628236|3475341|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625950|NCT02628236|3475341|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625951|NCT02628236|3475341|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625952|NCT02628236|3475341|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625953|NCT02628236|3475341|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3625954|NCT02628236|3475341|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3625955|NCT02628236|3475341|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3625956|NCT02628236|3475341|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3625957|NCT02628236|3475341|B1|||Age||years|Mean|65.6|65.6|Standard Deviation|7.7|7.7|||
3626013|NCT02626910|3475420|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3625958|NCT02628106|3475378|B1|||R2* values|Deoxyhemoglobin, as an endogenous contrast agent, is paramagnetic; the change in deoxyhemoglobin level can cause inhomogeneity in the magnetic field in the local tissue. R2* is a measure of the tissue content of deoxyhemoglobin, which is inversely proportional to the oxygen content in tissue. Thus, a decrease in R2* implies decreased deoxyhemoglobin concentrations and increased oxygen content in tissue.|1/ms|Mean|23.32|23.32|Standard Deviation|6.48|6.48|||
3625959|NCT02628106|3475378|B1|China||Region of Enrollment|A random sample, west China hospital, in accord with a standard 21 people|participants|Number|21|21.0||||||
3625960|NCT02628106|3475378|B1||Male|Gender|men and women randomly, but try to match proportion|Participants|Count of Participants|9|9.0||||||
3625961|NCT02628106|3475378|B1||Female|Gender|men and women randomly, but try to match proportion|Participants|Count of Participants|12|12.0||||||
3625962|NCT02628106|3475378|B1|||Age|All applicable patients with CKD were eligible for this study. Other inclusion criteria were as follows: an age > 18 years and a diagnosis of type 2 diabetes based on the definition of the World Health Organization|years|Mean|59|59.0|Standard Deviation|13|13.0|||
3625963|NCT02627794|3475382|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3625964|NCT02627794|3475382|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3625965|NCT02627794|3475382|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3625966|NCT02627794|3475382|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3625967|NCT02627794|3475382|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3625968|NCT02627794|3475382|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3625969|NCT02627144|3475395|B1|Not available||Sex/Gender, Customized||participants|Number|3|3.0||||||
3625970|NCT02627144|3475395|B1|Female||Sex/Gender, Customized||participants|Number|114|114.0||||||
3625971|NCT02627144|3475395|B1|Male||Sex/Gender, Customized||participants|Number|242|242.0||||||
3625972|NCT02627144|3475395|B1|||Age||years|Mean|65.5|65.5|Standard Deviation|10.1|10.1|||
3625973|NCT02627118|3475403|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3625974|NCT02627118|3475403|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3625975|NCT02627118|3475403|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3625976|NCT02627118|3475403|B1|White Non-Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3625977|NCT02627118|3475403|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3625978|NCT02627118|3475403|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3625979|NCT02627118|3475403|B1|||Age||years|Mean|56.1|56.1|Standard Deviation|16.6|16.6|||
3625980|NCT02627001|3475408|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3625981|NCT02627001|3475409|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3625982|NCT02627001|3475410|B1||Male|Sex: Female, Male||Participants|Count of Participants|013|13.0||||||
3625983|NCT02627001|3475408|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3625984|NCT02627001|3475409|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3625985|NCT02627001|3475410|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3625986|NCT02627001|3475408|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3625987|NCT02627001|3475409|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3625988|NCT02627001|3475410|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3625989|NCT02627001|3475408|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3625990|NCT02627001|3475409|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3625991|NCT02627001|3475410|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3625992|NCT02627001|3475408|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3625993|NCT02627001|3475409|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3625994|NCT02627001|3475410|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3625995|NCT02626910|3475417|B5|||Number of people analyzed in each focus group||Participants|Count of Participants|49|49.0||||||
3625996|NCT02626910|3475418|B4|||Number of people analyzed in each focus group||Participants|Count of Participants|10|10.0||||||
3625997|NCT02626910|3475419|B3|||Number of people analyzed in each focus group||Participants|Count of Participants|6|6.0||||||
3625998|NCT02626910|3475420|B2|||Number of people analyzed in each focus group||Participants|Count of Participants|10|10.0||||||
3625999|NCT02626910|3475421|B1|||Number of people analyzed in each focus group||Participants|Count of Participants|23|23.0||||||
3626000|NCT02626910|3475417|B5|United States||Region of Enrollment||participants|Number|49|49.0||||||
3626001|NCT02626910|3475418|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
3626002|NCT02626910|3475419|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3626003|NCT02626910|3475420|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3626004|NCT02626910|3475421|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
3626005|NCT02626910|3475417|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626006|NCT02626910|3475418|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626007|NCT02626910|3475419|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626008|NCT02626910|3475420|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626009|NCT02626910|3475421|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626010|NCT02626910|3475417|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3626011|NCT02626910|3475418|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3626014|NCT02626910|3475421|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3626015|NCT02626910|3475417|B5||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3626016|NCT02626910|3475418|B4||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3626017|NCT02626910|3475419|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3626018|NCT02626910|3475420|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3626019|NCT02626910|3475421|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3626020|NCT02626910|3475417|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3626021|NCT02626910|3475418|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3626022|NCT02626910|3475419|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626023|NCT02626910|3475420|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3626024|NCT02626910|3475421|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3626025|NCT02626910|3475417|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626026|NCT02626910|3475418|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626027|NCT02626910|3475419|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626028|NCT02626910|3475420|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626029|NCT02626910|3475421|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626030|NCT02626910|3475417|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626031|NCT02626910|3475418|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626032|NCT02626910|3475419|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626033|NCT02626910|3475420|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626034|NCT02626910|3475421|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626035|NCT02626910|3475417|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3626036|NCT02626910|3475418|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626037|NCT02626910|3475419|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626038|NCT02626910|3475420|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3626039|NCT02626910|3475421|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3626040|NCT02626910|3475417|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626041|NCT02626910|3475418|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626042|NCT02626910|3475419|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626043|NCT02626910|3475420|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626044|NCT02626910|3475421|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626045|NCT02626910|3475417|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3626046|NCT02626910|3475418|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3626047|NCT02626910|3475419|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3626048|NCT02626910|3475420|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3626049|NCT02626910|3475421|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3626050|NCT02626910|3475417|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3626051|NCT02626910|3475418|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3626052|NCT02626910|3475419|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626053|NCT02626910|3475420|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3626054|NCT02626910|3475421|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3626055|NCT02626910|3475417|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3626056|NCT02626910|3475418|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3626057|NCT02626910|3475419|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3626058|NCT02626910|3475420|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3626059|NCT02626910|3475421|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3626060|NCT02626910|3475417|B5||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3626061|NCT02626910|3475418|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3626062|NCT02626910|3475419|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3626063|NCT02626910|3475420|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3626064|NCT02626910|3475421|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3626065|NCT02626910|3475417|B5|||Age||Years|Mean|59|59.0|Standard Deviation|5.9|5.9|||
3626066|NCT02626910|3475418|B4|||Age||Years|Mean|68|68.0|Standard Deviation|7.9|7.9|||
3626067|NCT02626910|3475419|B3|||Age||Years|Mean|56|56.0|Standard Deviation|2.7|2.7|||
3626068|NCT02626910|3475420|B2|||Age||Years|Mean|45|45.0|Standard Deviation|6.3|6.3|||
3626069|NCT02626910|3475421|B1|||Age||Years|Mean|43|43.0|Standard Deviation|8.2|8.2|||
3626070|NCT02626910|3475417|B5||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3626071|NCT02626910|3475418|B4||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3626073|NCT02626910|3475420|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3626074|NCT02626910|3475421|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3626075|NCT02626910|3475417|B5||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3626076|NCT02626910|3475418|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3626077|NCT02626910|3475419|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3626078|NCT02626910|3475420|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3626079|NCT02626910|3475421|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3626080|NCT02626910|3475417|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3626081|NCT02626910|3475418|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3626082|NCT02626910|3475419|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3626083|NCT02626910|3475420|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3626084|NCT02626910|3475421|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3626085|NCT02626819|3475434|B3|||Body Mass Index (BMI)||kg/m2|Mean|31.8|31.8|Standard Deviation|4.9|4.9|||
3626086|NCT02626819|3475435|B2|||Body Mass Index (BMI)||kg/m2|Mean|33.0|33.0|Standard Deviation|5.8|5.8|||
3626087|NCT02626819|3475436|B1|||Body Mass Index (BMI)||kg/m2|Mean|30.7|30.7|Standard Deviation|3.4|3.4|||
3626088|NCT02626819|3475434|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3626089|NCT02626819|3475435|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3626090|NCT02626819|3475436|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626091|NCT02626819|3475434|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3626092|NCT02626819|3475435|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3626093|NCT02626819|3475436|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3626094|NCT02626819|3475434|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3626095|NCT02626819|3475435|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3626096|NCT02626819|3475436|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3626097|NCT02626819|3475434|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3626098|NCT02626819|3475435|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3626099|NCT02626819|3475436|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3626100|NCT02626819|3475434|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626101|NCT02626819|3475435|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626102|NCT02626819|3475436|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626103|NCT02626819|3475434|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3626104|NCT02626819|3475435|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626105|NCT02626819|3475436|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3626106|NCT02626819|3475434|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3626107|NCT02626819|3475435|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626108|NCT02626819|3475436|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3626109|NCT02626819|3475434|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3626110|NCT02626819|3475435|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3626111|NCT02626819|3475436|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626112|NCT02626819|3475434|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3626113|NCT02626819|3475435|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3626114|NCT02626819|3475436|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3626115|NCT02626819|3475434|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3626116|NCT02626819|3475435|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3626117|NCT02626819|3475436|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3626118|NCT02626819|3475434|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3626119|NCT02626819|3475435|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3626120|NCT02626819|3475436|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3626121|NCT02626819|3475434|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3626122|NCT02626819|3475435|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3626123|NCT02626819|3475436|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3626124|NCT02626819|3475434|B3|||Age||years|Mean|54.74|54.74|Standard Deviation|10.53|10.53|||
3626125|NCT02626819|3475435|B2|||Age||years|Mean|56.14|56.14|Standard Deviation|10.73|10.73|||
3626126|NCT02626819|3475436|B1|||Age||years|Mean|53.29|53.29|Standard Deviation|10.37|10.37|||
3626127|NCT02626819|3475434|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3626128|NCT02626819|3475435|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3626129|NCT02626819|3475436|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3626130|NCT02626819|3475434|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3626131|NCT02626819|3475435|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3626132|NCT02626819|3475436|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3626133|NCT02626819|3475434|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3626134|NCT02626819|3475435|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3626135|NCT02626819|3475436|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3626136|NCT02626611|3475457|B4|United States||Region of Enrollment||participants|Number|60|60.0||||||
3626137|NCT02626611|3475458|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
3626138|NCT02626611|3475459|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
3626139|NCT02626611|3475460|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3626140|NCT02626611|3475457|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3626141|NCT02626611|3475458|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3626142|NCT02626611|3475459|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3626143|NCT02626611|3475460|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3626144|NCT02626611|3475457|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3626145|NCT02626611|3475458|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3626146|NCT02626611|3475459|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3626147|NCT02626611|3475460|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3626148|NCT02626611|3475457|B4||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3626149|NCT02626611|3475458|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3626150|NCT02626611|3475459|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3626151|NCT02626611|3475460|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3626152|NCT02626611|3475457|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3626153|NCT02626611|3475458|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3626154|NCT02626611|3475459|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3626155|NCT02626611|3475460|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3626156|NCT02626611|3475457|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626157|NCT02626611|3475458|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626158|NCT02626611|3475459|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626159|NCT02626611|3475460|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626160|NCT02626611|3475457|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3626161|NCT02626611|3475458|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3626162|NCT02626611|3475459|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3626163|NCT02626611|3475460|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3626164|NCT02626611|3475457|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626165|NCT02626611|3475458|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626166|NCT02626611|3475459|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626167|NCT02626611|3475460|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626168|NCT02626611|3475457|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3626169|NCT02626611|3475458|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3626170|NCT02626611|3475459|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3626171|NCT02626611|3475460|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3626172|NCT02626611|3475457|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3626173|NCT02626611|3475458|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3626174|NCT02626611|3475459|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3626175|NCT02626611|3475460|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3626176|NCT02626611|3475457|B4|||Age||years|Mean|9.3|9.3|Standard Deviation|5.1|5.1|||
3626177|NCT02626611|3475458|B3|||Age||years|Mean|8.9|8.9|Standard Deviation|3.2|3.2|||
3626178|NCT02626611|3475459|B2|||Age||years|Mean|8.1|8.1|Standard Deviation|5.9|5.9|||
3626179|NCT02626611|3475460|B1|||Age||years|Mean|10.8|10.8|Standard Deviation|4.9|4.9|||
3626180|NCT02626520|3475483|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3626181|NCT02626520|3475484|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3626182|NCT02626520|3475485|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3626183|NCT02626520|3475483|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3626184|NCT02626520|3475483|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3626185|NCT02626520|3475484|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3626186|NCT02626520|3475485|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3626187|NCT02626520|3475483|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3626188|NCT02626520|3475484|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3626189|NCT02626520|3475485|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3626190|NCT02626520|3475483|B3|||Age||years|Median|63|63.0|Full Range|||57.0|80.0|
3626191|NCT02626520|3475484|B2|||Age||years|Median|63|63.0|Full Range|||57.0|80.0|
3626192|NCT02626520|3475485|B1|||Age||years|Median|64|64.0|Full Range|||64.0|64.0|
3626193|NCT02626520|3475483|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3626194|NCT02626520|3475484|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3626195|NCT02626520|3475485|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3626196|NCT02626520|3475483|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3626197|NCT02626520|3475484|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3626198|NCT02626520|3475485|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3626199|NCT02626520|3475483|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3626200|NCT02626520|3475484|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3626201|NCT02626520|3475485|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3626202|NCT02625922|3475496|B3|||Childbearing status|Number of post-menopausal participants.|Participants|Count of Participants|3|3.0||||||
3626203|NCT02625922|3475497|B2|||Childbearing status|Number of post-menopausal participants.|Participants|Count of Participants|2|2.0||||||
3626204|NCT02625922|3475498|B1|||Childbearing status|Number of post-menopausal participants.|Participants|Count of Participants|1|1.0||||||
3626205|NCT02625922|3475496|B3|||Weight (kg)||kilogram (kg)|Mean|84.2|84.2|Standard Deviation|15.65|15.65|||
3626206|NCT02625922|3475497|B2|||Weight (kg)||kilogram (kg)|Mean|83.9|83.9|Standard Deviation|17.85|17.85|||
3626207|NCT02625922|3475498|B1|||Weight (kg)||kilogram (kg)|Mean|84.5|84.5|Standard Deviation|14.19|14.19|||
3626208|NCT02625922|3475496|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3626209|NCT02625922|3475497|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3626210|NCT02625922|3475498|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3626211|NCT02625922|3475496|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3626212|NCT02625922|3475497|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3626213|NCT02625922|3475498|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3626214|NCT02625922|3475496|B3|||Age||years|Mean|70.9|70.9|Standard Deviation|11.51|11.51|||
3626215|NCT02625922|3475497|B2|||Age||years|Mean|66.5|66.5|Standard Deviation|13.89|13.89|||
3626216|NCT02625922|3475498|B1|||Age||years|Mean|74.7|74.7|Standard Deviation|7.62|7.62|||
3626217|NCT02625844|3475512|B1||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Gender data were not collected for study participants.
3626218|NCT02625844|3475512|B1||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Gender data were not collected for study participants.
3626219|NCT02625844|3475512|B1|>/= 18 years||Age, Customized||participants|Number|110|110.0||||||
3626220|NCT02625623|3475516|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3626221|NCT02625623|3475517|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3626222|NCT02625623|3475518|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3626223|NCT02625623|3475516|B3||Not collected/Missing|Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3626224|NCT02625623|3475517|B2||Not collected/Missing|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3626225|NCT02625623|3475518|B1||Not collected/Missing|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3626226|NCT02625623|3475516|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3626227|NCT02625623|3475517|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3626228|NCT02625623|3475518|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3626229|NCT02625623|3475516|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3626230|NCT02625623|3475517|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3626231|NCT02625623|3475518|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3626232|NCT02625623|3475516|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|94|94.0||||||
3626233|NCT02625623|3475517|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
3626234|NCT02625623|3475518|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
3626235|NCT02625623|3475516|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3626236|NCT02625623|3475517|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3626237|NCT02625623|3475518|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3626238|NCT02625623|3475516|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|236|236.0||||||
3626239|NCT02625623|3475517|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|119|119.0||||||
3626240|NCT02625623|3475518|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|117|117.0||||||
3626241|NCT02625623|3475516|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3626242|NCT02625623|3475517|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3626243|NCT02625623|3475518|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3626244|NCT02625623|3475516|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|303|303.0||||||
3626245|NCT02625623|3475517|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|153|153.0||||||
3626246|NCT02625623|3475518|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|150|150.0||||||
3626247|NCT02625623|3475516|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3626248|NCT02625623|3475517|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3626249|NCT02625623|3475518|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3626250|NCT02625623|3475516|B3||Male|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
3626251|NCT02625623|3475517|B2||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3626252|NCT02625623|3475518|B1||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3626253|NCT02625623|3475516|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3626254|NCT02625623|3475517|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3626255|NCT02625623|3475518|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3626256|NCT02625623|3475516|B3|||Age||Years|Mean|59.5|59.5|Standard Deviation|12.31|12.31|||
3626257|NCT02625623|3475517|B2|||Age||Years|Mean|58.8|58.8|Standard Deviation|11.66|11.66|||
3626258|NCT02625623|3475518|B1|||Age||Years|Mean|60.1|60.1|Standard Deviation|12.93|12.93|||
3626259|NCT02625402|3475539|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3626260|NCT02625402|3475539|B3||Male|Sex: Female, Male|Gender data was collected through chart review of enrolled patients.|Participants|Count of Participants|28|28.0||||||
3626261|NCT02625402|3475540|B2||Male|Sex: Female, Male|Gender data was collected through chart review of enrolled patients.|Participants|Count of Participants|11|11.0||||||
3626262|NCT02625402|3475541|B1||Male|Sex: Female, Male|Gender data was collected through chart review of enrolled patients.|Participants|Count of Participants|17|17.0||||||
3626263|NCT02625402|3475539|B3||Female|Sex: Female, Male|Gender data was collected through chart review of enrolled patients.|Participants|Count of Participants|30|30.0||||||
3626264|NCT02625402|3475540|B2||Female|Sex: Female, Male|Gender data was collected through chart review of enrolled patients.|Participants|Count of Participants|14|14.0||||||
3626265|NCT02625402|3475541|B1||Female|Sex: Female, Male|Gender data was collected through chart review of enrolled patients.|Participants|Count of Participants|16|16.0||||||
3626266|NCT02625402|3475539|B3|||Age||years|Mean|63.7|63.7|Standard Deviation|8.6|8.6|||
3626267|NCT02625402|3475540|B2|||Age||years|Mean|62.8|62.8|Standard Deviation|8.5|8.5|||
3626268|NCT02625402|3475541|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|8.7|8.7|||
3626269|NCT02625298|3475552|B3|Serbia||Region of Enrollment||tooth|Number|27|27.0||||||
3626270|NCT02625298|3475553|B2|Serbia||Region of Enrollment||tooth|Number|13|13.0||||||
3626271|NCT02625298|3475554|B1|Serbia||Region of Enrollment||tooth|Number|14|14.0||||||
3626272|NCT02625298|3475552|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3626273|NCT02625298|3475553|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3626274|NCT02625298|3475554|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3626275|NCT02625298|3475552|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3626276|NCT02625298|3475553|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3626277|NCT02625298|3475554|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3626278|NCT02625298|3475552|B3||>=65 years|Age||tooth|Count of Units|0|0.0||||||
3626279|NCT02625298|3475553|B2||>=65 years|Age||tooth|Count of Units|0|0.0||||||
3626280|NCT02625298|3475554|B1||>=65 years|Age||tooth|Count of Units|0|0.0||||||
3626281|NCT02625298|3475552|B3||Between 18 and 65 years|Age||tooth|Count of Units|0|0.0||||||
3626282|NCT02625298|3475553|B2||Between 18 and 65 years|Age||tooth|Count of Units|0|0.0||||||
3626283|NCT02625298|3475554|B1||Between 18 and 65 years|Age||tooth|Count of Units|0|0.0||||||
3626284|NCT02625298|3475552|B3||<=18 years|Age||tooth|Count of Units|27|27.0||||||
3626285|NCT02625298|3475553|B2||<=18 years|Age||tooth|Count of Units|13|13.0||||||
3626286|NCT02625298|3475554|B1||<=18 years|Age||tooth|Count of Units|14|14.0||||||
3626287|NCT02625259|3475563|B6|United States||Region of Enrollment||participants|Number|54|54.0||||||
3626288|NCT02625259|3475564|B5|United States||Region of Enrollment||participants|Number|16|16.0||||||
3626289|NCT02625259|3475565|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
3626290|NCT02625259|3475566|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3626291|NCT02625259|3475567|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3626292|NCT02625259|3475568|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3626293|NCT02625259|3475563|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626294|NCT02625259|3475564|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626295|NCT02625259|3475565|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626296|NCT02625259|3475566|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626297|NCT02625259|3475567|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626298|NCT02625259|3475568|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626299|NCT02625259|3475563|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3626300|NCT02625259|3475564|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3626301|NCT02625259|3475565|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626302|NCT02625259|3475566|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626303|NCT02625259|3475567|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626304|NCT02625259|3475568|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626305|NCT02625259|3475563|B6||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3626306|NCT02625259|3475564|B5||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3626307|NCT02625259|3475565|B4||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3626308|NCT02625259|3475566|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3626309|NCT02625259|3475567|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3626310|NCT02625259|3475568|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3626311|NCT02625259|3475563|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3626312|NCT02625259|3475564|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3626313|NCT02625259|3475565|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3626314|NCT02625259|3475566|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3626315|NCT02625259|3475567|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3626316|NCT02625259|3475568|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3626317|NCT02625259|3475563|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626318|NCT02625259|3475564|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626319|NCT02625259|3475565|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626320|NCT02625259|3475566|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626321|NCT02625259|3475567|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626322|NCT02625259|3475568|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626323|NCT02625259|3475563|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3626324|NCT02625259|3475564|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626325|NCT02625259|3475565|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626326|NCT02625259|3475566|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3626327|NCT02625259|3475567|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626328|NCT02625259|3475568|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3626329|NCT02625259|3475563|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3626330|NCT02625259|3475564|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3626331|NCT02625259|3475565|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626332|NCT02625259|3475566|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626333|NCT02625259|3475567|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3626334|NCT02625259|3475568|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626335|NCT02625259|3475563|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626336|NCT02625259|3475564|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626337|NCT02625259|3475565|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626338|NCT02625259|3475566|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626339|NCT02625259|3475567|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626340|NCT02625259|3475568|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626341|NCT02625259|3475563|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3626342|NCT02625259|3475564|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3626343|NCT02625259|3475565|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3626344|NCT02625259|3475566|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3626345|NCT02625259|3475567|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3626346|NCT02625259|3475568|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3626347|NCT02625259|3475563|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3626348|NCT02625259|3475564|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3626349|NCT02625259|3475565|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3626350|NCT02625259|3475566|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3626351|NCT02625259|3475567|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3626352|NCT02625259|3475568|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3626353|NCT02625259|3475563|B6||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3626354|NCT02625259|3475564|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3626355|NCT02625259|3475565|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3626356|NCT02625259|3475566|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3626357|NCT02625259|3475567|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3626358|NCT02625259|3475568|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3626359|NCT02625259|3475563|B6||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3626360|NCT02625259|3475564|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3626361|NCT02625259|3475565|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3626362|NCT02625259|3475566|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3626363|NCT02625259|3475567|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3626364|NCT02625259|3475568|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3626365|NCT02625259|3475563|B6|18-45 years||Age, Customized||participants|Number|54|54.0||||||
3626366|NCT02625259|3475564|B5|18-45 years||Age, Customized||participants|Number|16|16.0||6.88|6.88|||
3626367|NCT02625259|3475565|B4|18-45 years||Age, Customized||participants|Number|10|10.0||6.13|6.13|||
3626368|NCT02625259|3475566|B3|18-45 years||Age, Customized||participants|Number|8|8.0||7.15|7.15|||
3626369|NCT02625259|3475567|B2|18-45 years||Age, Customized||participants|Number|9|9.0||7.79|7.79|||
3626370|NCT02625259|3475568|B1|18-45 years||Age, Customized||participants|Number|11|11.0||7.63|7.63|||
3626371|NCT02625233|3475607|B3|United States||Region of Enrollment||Participants|Number|105|105.0||||||
3626372|NCT02625233|3475608|B2|United States||Region of Enrollment||Participants|Number|56|56.0||||||
3626373|NCT02625233|3475609|B1|United States||Region of Enrollment||Participants|Number|49|49.0||||||
3626374|NCT02625233|3475607|B3|White||Race/Ethnicity, Customized||Participants|Number|95|95.0||||||
3626375|NCT02625233|3475608|B2|White||Race/Ethnicity, Customized||Participants|Number|52|52.0||||||
3626376|NCT02625233|3475609|B1|White||Race/Ethnicity, Customized||Participants|Number|43|43.0||||||
3626377|NCT02625233|3475607|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3626378|NCT02625233|3475608|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3626379|NCT02625233|3475609|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3626380|NCT02625233|3475607|B3|Asian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3626381|NCT02625233|3475608|B2|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3626382|NCT02625233|3475609|B1|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3626383|NCT02625233|3475607|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3626384|NCT02625233|3475608|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3626385|NCT02625233|3475609|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3626386|NCT02625233|3475607|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3626387|NCT02625233|3475608|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3626388|NCT02625233|3475609|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3626389|NCT02625233|3475607|B3|||Age||Years|Mean|31.4|31.4|Standard Deviation|7.15|7.15|||
3626390|NCT02625233|3475608|B2|||Age||Years|Mean|31.5|31.5|Standard Deviation|7.31|7.31|||
3626391|NCT02625233|3475609|B1|||Age||Years|Mean|31.2|31.2|Standard Deviation|7.03|7.03|||
3626392|NCT02625220|3475618|B1|United States||Region of Enrollment||participants|Number|170|170.0||||||
3626393|NCT02625220|3475618|B1|Other||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3626394|NCT02625220|3475618|B1|White||Race/Ethnicity, Customized||Participants|Number|131|131.0||||||
3626395|NCT02625220|3475618|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3626396|NCT02625220|3475618|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
3626397|NCT02625220|3475618|B1|Asian||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3626398|NCT02625220|3475618|B1|American Indian or Native Alaskian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3626399|NCT02625220|3475618|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3626400|NCT02625220|3475618|B1||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3626401|NCT02625220|3475618|B1|||Age||Years|Mean|28.8|28.8|Standard Deviation|5.71|5.71|||
3626402|NCT02625207|3475625|B5||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3626403|NCT02625207|3475626|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3626404|NCT02625207|3475627|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3626405|NCT02625207|3475628|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3626406|NCT02625207|3475629|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3626407|NCT02625207|3475625|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3626408|NCT02625207|3475626|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3626409|NCT02625207|3475627|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3626410|NCT02625207|3475628|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3626411|NCT02625207|3475629|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3626412|NCT02625207|3475625|B5|||Age||years|Mean|39.6|39.6|Standard Deviation|10.6|10.6|||
3626413|NCT02625207|3475626|B4|||Age||years|Mean|48.2|48.2|Standard Deviation|6|6.0|||
3626414|NCT02625207|3475627|B3|||Age||years|Mean|34.6|34.6|Standard Deviation|11.4|11.4|||
3626415|NCT02625207|3475628|B2|||Age||years|Mean|38.3|38.3|Standard Deviation|10.4|10.4|||
3626416|NCT02625207|3475629|B1|||Age||years|Mean|37.3|37.3|Standard Deviation|9.7|9.7|||
3626417|NCT02624791|3475718|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3626418|NCT02624791|3475718|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3626419|NCT02624791|3475718|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3626420|NCT02624791|3475718|B1|||Age||years|Mean|22.2|22.2|Standard Deviation|4.60|4.6|||
3626421|NCT02623361|3475728|B3|United States||Region of Enrollment||participants|Number|78|78.0||||||
3626422|NCT02623361|3475729|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
3626423|NCT02623361|3475730|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3626424|NCT02623361|3475728|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3626425|NCT02623361|3475728|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3626426|NCT02623361|3475729|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3626427|NCT02623361|3475730|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3626428|NCT02623361|3475728|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3626429|NCT02623361|3475729|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3626430|NCT02623361|3475730|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3626431|NCT02623361|3475728|B3|||Age||years|Mean|34|34.0|Standard Deviation|10|10.0|||
3626432|NCT02623361|3475729|B2|||Age||years|Mean|35|35.0|Standard Deviation|11|11.0|||
3626433|NCT02623361|3475730|B1|||Age||years|Mean|32|32.0|Standard Deviation|9|9.0|||
3626434|NCT02622568|3475741|B3|||Diameter of verrucae at presentation||mm|Mean|6.3|6.3|Standard Deviation|1.88|1.88|||
3626435|NCT02622568|3475742|B2|||Diameter of verrucae at presentation||mm|Mean|6.222|6.222|Standard Deviation|1.922|1.922|||
3626436|NCT02622568|3475743|B1|||Diameter of verrucae at presentation||mm|Mean|6.444|6.444|Standard Deviation|1.9437|1.9437|||
3626437|NCT02622568|3475741|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
3626438|NCT02622568|3475742|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3626439|NCT02622568|3475743|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3626440|NCT02622568|3475741|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3626441|NCT02622568|3475741|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3626442|NCT02622568|3475742|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3626443|NCT02622568|3475743|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3626444|NCT02622568|3475741|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3626445|NCT02622568|3475742|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3626446|NCT02622568|3475743|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3626447|NCT02622568|3475741|B3|||Age||years|Mean|9.6|9.6|Standard Deviation|2.79|2.79|||
3626448|NCT02622568|3475742|B2|||Age||years|Mean|10.1|10.1|Standard Deviation|2.47|2.47|||
3626449|NCT02622568|3475743|B1|||Age||years|Mean|9.1|9.1|Standard Deviation|3.14|3.14|||
3626450|NCT02622568|3475741|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3626451|NCT02622568|3475742|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3626452|NCT02622568|3475743|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3626453|NCT02622568|3475741|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3626454|NCT02622568|3475742|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3626455|NCT02622568|3475743|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3626456|NCT02622568|3475741|B3||<=18 years|Age||Participants|Count of Participants|28|28.0||||||
3626457|NCT02622568|3475742|B2||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
3626458|NCT02622568|3475743|B1||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
3626459|NCT02622321|3475750|B5||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3626460|NCT02622321|3475751|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3626461|NCT02622321|3475752|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3626462|NCT02622321|3475753|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3626463|NCT02622321|3475754|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3626464|NCT02622321|3475750|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3626465|NCT02622321|3475751|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3626466|NCT02622321|3475752|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3626467|NCT02622321|3475753|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3626468|NCT02622321|3475754|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3626469|NCT02622321|3475750|B5|||Age||years|Mean|31.1|31.1|Standard Deviation|15.8|15.8|||
3626470|NCT02622321|3475751|B4|||Age||years|Mean|30.3|30.3|Standard Deviation|10.8|10.8|||
3626471|NCT02622321|3475752|B3|||Age||years|Mean|25.6|25.6|Standard Deviation|16.8|16.8|||
3626472|NCT02622321|3475753|B2|||Age||years|Mean|37.2|37.2|Standard Deviation|13.7|13.7|||
3626473|NCT02622321|3475754|B1|||Age||years|Mean|35.8|35.8|Standard Deviation|13.9|13.9|||
3626474|NCT02622178|3475800|B4|United States||Region of Enrollment||participants|Number|136|136.0||||||
3626475|NCT02622178|3475801|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
3626476|NCT02622178|3475802|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
3626477|NCT02622178|3475803|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
3626478|NCT02622178|3475800|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626479|NCT02622178|3475801|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626480|NCT02622178|3475802|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626481|NCT02622178|3475803|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626482|NCT02622178|3475800|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3626483|NCT02622178|3475801|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3626484|NCT02622178|3475802|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3626485|NCT02622178|3475803|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626486|NCT02622178|3475800|B4||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3626487|NCT02622178|3475801|B3||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3626488|NCT02622178|3475802|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3626489|NCT02622178|3475803|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3626490|NCT02622178|3475800|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3626491|NCT02622178|3475801|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3626492|NCT02622178|3475802|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3626493|NCT02622178|3475803|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3626494|NCT02622178|3475800|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626495|NCT02622178|3475801|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626496|NCT02622178|3475802|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626497|NCT02622178|3475803|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626498|NCT02622178|3475800|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3626499|NCT02622178|3475801|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626500|NCT02622178|3475802|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3626501|NCT02622178|3475803|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3626502|NCT02622178|3475800|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626503|NCT02622178|3475801|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626504|NCT02622178|3475802|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626505|NCT02622178|3475803|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626506|NCT02622178|3475800|B4||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3626507|NCT02622178|3475801|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3626508|NCT02622178|3475802|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3626509|NCT02622178|3475803|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3626510|NCT02622178|3475800|B4||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3626511|NCT02622178|3475801|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3626512|NCT02622178|3475802|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3626513|NCT02622178|3475803|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3626514|NCT02622178|3475800|B4||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
3626515|NCT02622178|3475801|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3626516|NCT02622178|3475802|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3626517|NCT02622178|3475803|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3626518|NCT02622178|3475800|B4||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
3626519|NCT02622178|3475801|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3626520|NCT02622178|3475802|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3626521|NCT02622178|3475803|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3626522|NCT02622178|3475800|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3626523|NCT02622178|3475801|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3626524|NCT02622178|3475802|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3626525|NCT02622178|3475803|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3626526|NCT02621931|3475816|B4|||Headache Impact Test (HIT-6) Disability Score|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device. HIT-6 measures the adverse impact of headache on social functioning, role functioning, vitality, cognitive functioning, and psychological distress. It also assesses headache severity. Scores range from 36 to 78, where a higher score indicates a greater impact of headache on the daily life of the patient. Scores ≥60 indicate severe impact.|units on a scale|Mean|64.3|64.3|Standard Deviation|4.65|4.65|||
3626527|NCT02621931|3475817|B3|||Headache Impact Test (HIT-6) Disability Score|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device. HIT-6 measures the adverse impact of headache on social functioning, role functioning, vitality, cognitive functioning, and psychological distress. It also assesses headache severity. Scores range from 36 to 78, where a higher score indicates a greater impact of headache on the daily life of the patient. Scores ≥60 indicate severe impact.|units on a scale|Mean|64.6|64.6|Standard Deviation|4.42|4.42|||
3626528|NCT02621931|3475818|B2|||Headache Impact Test (HIT-6) Disability Score|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device. HIT-6 measures the adverse impact of headache on social functioning, role functioning, vitality, cognitive functioning, and psychological distress. It also assesses headache severity. Scores range from 36 to 78, where a higher score indicates a greater impact of headache on the daily life of the patient. Scores ≥60 indicate severe impact.|units on a scale|Mean|64.3|64.3|Standard Deviation|4.74|4.74|||
3626529|NCT02621931|3475819|B1|||Headache Impact Test (HIT-6) Disability Score|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device. HIT-6 measures the adverse impact of headache on social functioning, role functioning, vitality, cognitive functioning, and psychological distress. It also assesses headache severity. Scores range from 36 to 78, where a higher score indicates a greater impact of headache on the daily life of the patient. Scores ≥60 indicate severe impact.|units on a scale|Mean|64.1|64.1|Standard Deviation|4.80|4.8|||
3626530|NCT02621931|3475816|B4|||Number of Days of Use of Any Acute Headache Medications|Eligible patients entered a 28-day run-in/baseline period during which headache information (including information about use of headache medications) was captured daily throughout study participation using the electronic headache diary device.|days|Mean|13.1|13.1|Standard Deviation|6.96|6.96|||
3626531|NCT02621931|3475817|B3|||Number of Days of Use of Any Acute Headache Medications|Eligible patients entered a 28-day run-in/baseline period during which headache information (including information about use of headache medications) was captured daily throughout study participation using the electronic headache diary device.|days|Mean|13.1|13.1|Standard Deviation|7.20|7.2|||
3626532|NCT02621931|3475818|B2|||Number of Days of Use of Any Acute Headache Medications|Eligible patients entered a 28-day run-in/baseline period during which headache information (including information about use of headache medications) was captured daily throughout study participation using the electronic headache diary device.|days|Mean|13.1|13.1|Standard Deviation|6.79|6.79|||
3626533|NCT02621931|3475819|B1|||Number of Days of Use of Any Acute Headache Medications|Eligible patients entered a 28-day run-in/baseline period during which headache information (including information about use of headache medications) was captured daily throughout study participation using the electronic headache diary device.|days|Mean|13.0|13.0|Standard Deviation|6.92|6.92|||
3626534|NCT02621931|3475816|B4|||Number of Migraine Days|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device. Migraine headaches are as defined in The International Classification of Headache Disorders 3rd edition (ICHD-3).|days|Mean|16.2|16.2|Standard Deviation|5.97|5.97|||
3626535|NCT02621931|3475817|B3|||Number of Migraine Days|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device. Migraine headaches are as defined in The International Classification of Headache Disorders 3rd edition (ICHD-3).|days|Mean|16.0|16.0|Standard Deviation|5.19|5.19|||
3626536|NCT02621931|3475818|B2|||Number of Migraine Days|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device. Migraine headaches are as defined in The International Classification of Headache Disorders 3rd edition (ICHD-3).|days|Mean|16.2|16.2|Standard Deviation|4.88|4.88|||
3626537|NCT02621931|3475819|B1|||Number of Migraine Days|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device. Migraine headaches are as defined in The International Classification of Headache Disorders 3rd edition (ICHD-3).|days|Mean|16.4|16.4|Standard Deviation|5.15|5.15|||
3626538|NCT02621931|3475816|B4|||Number of Headache Days of At Least Moderate Severity|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device. Headache severity was subjectively rated by the patient as mild, moderate or severe.|days|Mean|13.1|13.1|Standard Deviation|5.70|5.7|||
3626539|NCT02621931|3475817|B3|||Number of Headache Days of At Least Moderate Severity|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device. Headache severity was subjectively rated by the patient as mild, moderate or severe.|days|Mean|12.8|12.8|Standard Deviation|5.80|5.8|||
3626540|NCT02621931|3475818|B2|||Number of Headache Days of At Least Moderate Severity|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device. Headache severity was subjectively rated by the patient as mild, moderate or severe.|days|Mean|13.2|13.2|Standard Deviation|5.47|5.47|||
3626541|NCT02621931|3475819|B1|||Number of Headache Days of At Least Moderate Severity|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device. Headache severity was subjectively rated by the patient as mild, moderate or severe.|days|Mean|13.3|13.3|Standard Deviation|5.82|5.82|||
3626542|NCT02621931|3475816|B4|||Total Number of Headache Days of Any Duration And Any Severity During the 28 Day Baseline Period|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device.|days|Mean|20.3|20.3|Standard Deviation|4.13|4.13|||
3626543|NCT02621931|3475817|B3|||Total Number of Headache Days of Any Duration And Any Severity During the 28 Day Baseline Period|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device.|days|Mean|20.3|20.3|Standard Deviation|4.26|4.26|||
3626544|NCT02621931|3475818|B2|||Total Number of Headache Days of Any Duration And Any Severity During the 28 Day Baseline Period|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device.|days|Mean|20.4|20.4|Standard Deviation|3.93|3.93|||
3626545|NCT02621931|3475819|B1|||Total Number of Headache Days of Any Duration And Any Severity During the 28 Day Baseline Period|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device.|days|Mean|20.3|20.3|Standard Deviation|4.19|4.19|||
3626546|NCT02621931|3475816|B4||No|Preventative Medication Use During Baseline Period|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device. During randomization, patients were stratified based on sex, country, and baseline preventive migraine medication use (yes, no) to ensure balance for the covariates.|Participants|Count of Participants|891|891.0||||||
3626547|NCT02621931|3475817|B3||No|Preventative Medication Use During Baseline Period|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device. During randomization, patients were stratified based on sex, country, and baseline preventive migraine medication use (yes, no) to ensure balance for the covariates.|Participants|Count of Participants|294|294.0||||||
3626548|NCT02621931|3475818|B2||No|Preventative Medication Use During Baseline Period|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device. During randomization, patients were stratified based on sex, country, and baseline preventive migraine medication use (yes, no) to ensure balance for the covariates.|Participants|Count of Participants|299|299.0||||||
3626549|NCT02621931|3475819|B1||No|Preventative Medication Use During Baseline Period|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device. During randomization, patients were stratified based on sex, country, and baseline preventive migraine medication use (yes, no) to ensure balance for the covariates.|Participants|Count of Participants|298|298.0||||||
3626550|NCT02621931|3475816|B4||Yes|Preventative Medication Use During Baseline Period|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device. During randomization, patients were stratified based on sex, country, and baseline preventive migraine medication use (yes, no) to ensure balance for the covariates.|Participants|Count of Participants|239|239.0||||||
3626551|NCT02621931|3475817|B3||Yes|Preventative Medication Use During Baseline Period|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device. During randomization, patients were stratified based on sex, country, and baseline preventive migraine medication use (yes, no) to ensure balance for the covariates.|Participants|Count of Participants|85|85.0||||||
3626552|NCT02621931|3475818|B2||Yes|Preventative Medication Use During Baseline Period|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device. During randomization, patients were stratified based on sex, country, and baseline preventive migraine medication use (yes, no) to ensure balance for the covariates.|Participants|Count of Participants|77|77.0||||||
3626553|NCT02621931|3475819|B1||Yes|Preventative Medication Use During Baseline Period|Eligible patients entered a 28-day run-in/baseline period during which headache information was captured daily throughout study participation using the electronic headache diary device. During randomization, patients were stratified based on sex, country, and baseline preventive migraine medication use (yes, no) to ensure balance for the covariates.|Participants|Count of Participants|77|77.0||||||
3626554|NCT02621931|3475816|B4|||Time Since Initial Migraine Diagnosis||years|Mean|19.9|19.9|Standard Deviation|12.55|12.55|||
3626555|NCT02621931|3475817|B3|||Time Since Initial Migraine Diagnosis||years|Mean|20.1|20.1|Standard Deviation|11.98|11.98|||
3626556|NCT02621931|3475818|B2|||Time Since Initial Migraine Diagnosis||years|Mean|19.7|19.7|Standard Deviation|12.84|12.84|||
3626557|NCT02621931|3475819|B1|||Time Since Initial Migraine Diagnosis||years|Mean|19.9|19.9|Standard Deviation|12.86|12.86|||
3626558|NCT02621931|3475816|B4|||Weight||kg|Mean|72.5|72.5|Standard Deviation|15.90|15.9|||
3626559|NCT02621931|3475817|B3|||Weight||kg|Mean|72.5|72.5|Standard Deviation|16.36|16.36|||
3626560|NCT02621931|3475818|B2|||Weight||kg|Mean|72.4|72.4|Standard Deviation|15.79|15.79|||
3626561|NCT02621931|3475819|B1|||Weight||kg|Mean|72.6|72.6|Standard Deviation|15.58|15.58|||
3626562|NCT02621931|3475816|B4||Not reported|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3626563|NCT02621931|3475817|B3||Not reported|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3626564|NCT02621931|3475818|B2||Not reported|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3626565|NCT02621931|3475819|B1||Not reported|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3626566|NCT02621931|3475816|B4||Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3626567|NCT02621931|3475817|B3||Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3626568|NCT02621931|3475818|B2||Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3626569|NCT02621931|3475819|B1||Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3626570|NCT02621931|3475816|B4||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|95|95.0||||||
3626571|NCT02621931|3475817|B3||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
3626572|NCT02621931|3475818|B2||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3626573|NCT02621931|3475819|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3626574|NCT02621931|3475816|B4||Not HIspanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|1033|1033.0||||||
3626575|NCT02621931|3475817|B3||Not HIspanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|338|338.0||||||
3626576|NCT02621931|3475818|B2||Not HIspanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|352|352.0||||||
3626577|NCT02621931|3475819|B1||Not HIspanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|343|343.0||||||
3626578|NCT02621931|3475816|B4||Other|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3626579|NCT02621931|3475817|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3626580|NCT02621931|3475818|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3626581|NCT02621931|3475819|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3626582|NCT02621931|3475816|B4||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3626583|NCT02621931|3475817|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3626584|NCT02621931|3475818|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3626585|NCT02621931|3475819|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3626586|NCT02621931|3475816|B4||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3626587|NCT02621931|3475817|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3626588|NCT02621931|3475818|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3626589|NCT02621931|3475819|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3626590|NCT02621931|3475816|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|121|121.0||||||
3626591|NCT02621931|3475817|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
3626592|NCT02621931|3475818|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3626593|NCT02621931|3475819|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3626594|NCT02621931|3475816|B4||Black|Race/Ethnicity, Customized||Participants|Count of Participants|99|99.0||||||
3626595|NCT02621931|3475817|B3||Black|Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
3626596|NCT02621931|3475818|B2||Black|Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3626597|NCT02621931|3475819|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3626598|NCT02621931|3475816|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|893|893.0||||||
3626599|NCT02621931|3475817|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|297|297.0||||||
3626600|NCT02621931|3475818|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|293|293.0||||||
3626601|NCT02621931|3475819|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|303|303.0||||||
3626602|NCT02621931|3475816|B4||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3626603|NCT02621931|3475817|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3626604|NCT02621931|3475818|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3626605|NCT02621931|3475819|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3626606|NCT02621931|3475816|B4||Female|Sex: Female, Male||Participants|Count of Participants|991|991.0||||||
3626607|NCT02621931|3475817|B3||Female|Sex: Female, Male||Participants|Count of Participants|330|330.0||||||
3626608|NCT02621931|3475818|B2||Female|Sex: Female, Male||Participants|Count of Participants|331|331.0||||||
3626609|NCT02621931|3475819|B1||Female|Sex: Female, Male||Participants|Count of Participants|330|330.0||||||
3626610|NCT02621931|3475816|B4||>65 years|Age, Customized||Participants|Count of Participants|20|20.0||||||
3626611|NCT02621931|3475817|B3||>65 years|Age, Customized||Participants|Count of Participants|8|8.0||||||
3626612|NCT02621931|3475818|B2||>65 years|Age, Customized||Participants|Count of Participants|9|9.0||||||
3626613|NCT02621931|3475819|B1||>65 years|Age, Customized||Participants|Count of Participants|3|3.0||||||
3626614|NCT02621931|3475816|B4||46-65 years|Age, Customized||Participants|Count of Participants|415|415.0||||||
3626615|NCT02621931|3475817|B3||46-65 years|Age, Customized||Participants|Count of Participants|123|123.0||||||
3626616|NCT02621931|3475818|B2||46-65 years|Age, Customized||Participants|Count of Participants|149|149.0||||||
3626617|NCT02621931|3475819|B1||46-65 years|Age, Customized||Participants|Count of Participants|143|143.0||||||
3626618|NCT02621931|3475816|B4||18-45 years|Age, Customized||Participants|Count of Participants|695|695.0||||||
3626619|NCT02621931|3475817|B3||18-45 years|Age, Customized||Participants|Count of Participants|248|248.0||||||
3626620|NCT02621931|3475818|B2||18-45 years|Age, Customized||Participants|Count of Participants|218|218.0||||||
3626621|NCT02621931|3475819|B1||18-45 years|Age, Customized||Participants|Count of Participants|229|229.0||||||
3626622|NCT02621931|3475816|B4|||Age||years|Mean|41.3|41.3|Standard Deviation|12.12|12.12|||
3626623|NCT02621931|3475817|B3|||Age||years|Mean|40.6|40.6|Standard Deviation|11.95|11.95|||
3626624|NCT02621931|3475818|B2|||Age||years|Mean|42.0|42.0|Standard Deviation|12.37|12.37|||
3626625|NCT02621931|3475819|B1|||Age||years|Mean|41.4|41.4|Standard Deviation|12.03|12.03|||
3626626|NCT02621619|3475870|B3||No - Did not vomit|Number of patients vomited before receiving study medication|Number of patients vomiting due to their condition, whether as a symptom on its own or due to their level of pain. Those experiencing nausea or vomiting at baseline would not be counted with those who experience nausea or vomiting as a side effect of study medication when comparing the effects and side effects of the study medication.|Participants|Count of Participants|124|124.0||||||
3626627|NCT02621619|3475871|B2||No - Did not vomit|Number of patients vomited before receiving study medication|Number of patients vomiting due to their condition, whether as a symptom on its own or due to their level of pain. Those experiencing nausea or vomiting at baseline would not be counted with those who experience nausea or vomiting as a side effect of study medication when comparing the effects and side effects of the study medication.|Participants|Count of Participants|61|61.0||||||
3626628|NCT02621619|3475872|B1||No - Did not vomit|Number of patients vomited before receiving study medication|Number of patients vomiting due to their condition, whether as a symptom on its own or due to their level of pain. Those experiencing nausea or vomiting at baseline would not be counted with those who experience nausea or vomiting as a side effect of study medication when comparing the effects and side effects of the study medication.|Participants|Count of Participants|63|63.0||||||
3626629|NCT02621619|3475870|B3||Yes - Vomited|Number of patients vomited before receiving study medication|Number of patients vomiting due to their condition, whether as a symptom on its own or due to their level of pain. Those experiencing nausea or vomiting at baseline would not be counted with those who experience nausea or vomiting as a side effect of study medication when comparing the effects and side effects of the study medication.|Participants|Count of Participants|35|35.0||||||
3626630|NCT02621619|3475871|B2||Yes - Vomited|Number of patients vomited before receiving study medication|Number of patients vomiting due to their condition, whether as a symptom on its own or due to their level of pain. Those experiencing nausea or vomiting at baseline would not be counted with those who experience nausea or vomiting as a side effect of study medication when comparing the effects and side effects of the study medication.|Participants|Count of Participants|18|18.0||||||
3626631|NCT02621619|3475872|B1||Yes - Vomited|Number of patients vomited before receiving study medication|Number of patients vomiting due to their condition, whether as a symptom on its own or due to their level of pain. Those experiencing nausea or vomiting at baseline would not be counted with those who experience nausea or vomiting as a side effect of study medication when comparing the effects and side effects of the study medication.|Participants|Count of Participants|17|17.0||||||
3626632|NCT02621619|3475870|B3||No - not nauseated|Number of patients nauseated before receiving study medication|Number of patients nauseated due to their condition, whether as a symptom on its own or due to their level of pain. Those experiencing nausea or vomiting at baseline would not be counted with those who experience nausea or vomiting as a side effect of study medication when comparing the effects and side effects of the study medication.|Participants|Count of Participants|87|87.0||||||
3626633|NCT02621619|3475871|B2||No - not nauseated|Number of patients nauseated before receiving study medication|Number of patients nauseated due to their condition, whether as a symptom on its own or due to their level of pain. Those experiencing nausea or vomiting at baseline would not be counted with those who experience nausea or vomiting as a side effect of study medication when comparing the effects and side effects of the study medication.|Participants|Count of Participants|41|41.0||||||
3626634|NCT02621619|3475872|B1||No - not nauseated|Number of patients nauseated before receiving study medication|Number of patients nauseated due to their condition, whether as a symptom on its own or due to their level of pain. Those experiencing nausea or vomiting at baseline would not be counted with those who experience nausea or vomiting as a side effect of study medication when comparing the effects and side effects of the study medication.|Participants|Count of Participants|46|46.0||||||
3626635|NCT02621619|3475870|B3||Yes - Nauseated|Number of patients nauseated before receiving study medication|Number of patients nauseated due to their condition, whether as a symptom on its own or due to their level of pain. Those experiencing nausea or vomiting at baseline would not be counted with those who experience nausea or vomiting as a side effect of study medication when comparing the effects and side effects of the study medication.|Participants|Count of Participants|72|72.0||||||
3626636|NCT02621619|3475871|B2||Yes - Nauseated|Number of patients nauseated before receiving study medication|Number of patients nauseated due to their condition, whether as a symptom on its own or due to their level of pain. Those experiencing nausea or vomiting at baseline would not be counted with those who experience nausea or vomiting as a side effect of study medication when comparing the effects and side effects of the study medication.|Participants|Count of Participants|38|38.0||||||
3626637|NCT02621619|3475872|B1||Yes - Nauseated|Number of patients nauseated before receiving study medication|Number of patients nauseated due to their condition, whether as a symptom on its own or due to their level of pain. Those experiencing nausea or vomiting at baseline would not be counted with those who experience nausea or vomiting as a side effect of study medication when comparing the effects and side effects of the study medication.|Participants|Count of Participants|34|34.0||||||
3626638|NCT02621619|3475870|B3|10||Baseline Pain intensity|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable).~This baseline measure indicates the number of participants reporting a given NRS score."|Participants|Count of Participants|35|35.0||||||
3626639|NCT02621619|3475871|B2|10||Baseline Pain intensity|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable).~This baseline measure indicates the number of participants reporting a given NRS score."|Participants|Count of Participants|18|18.0||||||
3626640|NCT02621619|3475872|B1|10||Baseline Pain intensity|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable).~This baseline measure indicates the number of participants reporting a given NRS score."|Participants|Count of Participants|17|17.0||||||
3626641|NCT02621619|3475870|B3|9||Baseline Pain intensity|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable).~This baseline measure indicates the number of participants reporting a given NRS score."|Participants|Count of Participants|22|22.0||||||
3626642|NCT02621619|3475871|B2|9||Baseline Pain intensity|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable).~This baseline measure indicates the number of participants reporting a given NRS score."|Participants|Count of Participants|8|8.0||||||
3626643|NCT02621619|3475872|B1|9||Baseline Pain intensity|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable).~This baseline measure indicates the number of participants reporting a given NRS score."|Participants|Count of Participants|14|14.0||||||
3626644|NCT02621619|3475870|B3|8||Baseline Pain intensity|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable).~This baseline measure indicates the number of participants reporting a given NRS score."|Participants|Count of Participants|38|38.0||||||
3626645|NCT02621619|3475871|B2|8||Baseline Pain intensity|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable).~This baseline measure indicates the number of participants reporting a given NRS score."|Participants|Count of Participants|24|24.0||||||
3626646|NCT02621619|3475872|B1|8||Baseline Pain intensity|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable).~This baseline measure indicates the number of participants reporting a given NRS score."|Participants|Count of Participants|14|14.0||||||
3626647|NCT02621619|3475870|B3|5-7||Baseline Pain intensity|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable).~This baseline measure indicates the number of participants reporting a given NRS score."|Participants|Count of Participants|23|23.0||||||
3626648|NCT02621619|3475871|B2|5-7||Baseline Pain intensity|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable).~This baseline measure indicates the number of participants reporting a given NRS score."|Participants|Count of Participants|10|10.0||||||
3626708|NCT02620683|3476017|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3626649|NCT02621619|3475872|B1|5-7||Baseline Pain intensity|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable).~This baseline measure indicates the number of participants reporting a given NRS score."|Participants|Count of Participants|13|13.0||||||
3626650|NCT02621619|3475870|B3|United States||Region of Enrollment||participants|Number|159|159.0||||||
3626651|NCT02621619|3475871|B2|United States||Region of Enrollment||participants|Number|79|79.0||||||
3626652|NCT02621619|3475872|B1|United States||Region of Enrollment||participants|Number|80|80.0||||||
3626653|NCT02621619|3475870|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3626654|NCT02621619|3475871|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3626655|NCT02621619|3475872|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3626656|NCT02621619|3475870|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3626657|NCT02621619|3475871|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3626658|NCT02621619|3475872|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3626659|NCT02621619|3475870|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3626660|NCT02621619|3475871|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3626661|NCT02621619|3475872|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3626662|NCT02621619|3475870|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|102|102.0||||||
3626663|NCT02621619|3475871|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
3626664|NCT02621619|3475872|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
3626665|NCT02621619|3475870|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3626666|NCT02621619|3475871|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3626667|NCT02621619|3475872|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3626668|NCT02621619|3475870|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3626669|NCT02621619|3475871|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3626670|NCT02621619|3475872|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3626671|NCT02621619|3475870|B3|||Age||years|Median|72|72.0|Inter-Quartile Range|||69.0|78.0|
3626672|NCT02621619|3475871|B2|||Age||years|Median|72|72.0|Inter-Quartile Range|||68.0|77.0|
3626673|NCT02621619|3475872|B1|||Age||years|Median|72|72.0|Inter-Quartile Range|||69.0|79.0|
3626674|NCT02621047|3475881|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3626675|NCT02621047|3475882|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3626676|NCT02621047|3475883|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3626677|NCT02621047|3475884|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3626678|NCT02621047|3475881|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3626679|NCT02621047|3475882|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3626680|NCT02621047|3475883|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3626681|NCT02621047|3475884|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3626682|NCT02621047|3475881|B4|||Age||years|Mean|53.1|53.1|Standard Deviation|7.35|7.35|||
3626683|NCT02621047|3475882|B3|||Age||years|Mean|52.2|52.2|Standard Deviation|7.98|7.98|||
3626684|NCT02621047|3475883|B2|||Age||years|Mean|53.1|53.1|Standard Deviation|5.62|5.62|||
3626685|NCT02621047|3475884|B1|||Age||years|Mean|54.6|54.6|Standard Deviation|8.52|8.52|||
3626686|NCT02621034|3475999|B4|Mandibular molars||Tooth type||participants|Number|94|94.0||||||
3626687|NCT02621034|3476000|B3|Mandibular molars||Tooth type||participants|Number|30|30.0||||||
3626688|NCT02621034|3476001|B2|Mandibular molars||Tooth type||participants|Number|39|39.0||||||
3626689|NCT02621034|3476002|B1|Mandibular molars||Tooth type||participants|Number|25|25.0||||||
3626690|NCT02621034|3475999|B4|Maxillary molars||Tooth type||participants|Number|56|56.0||||||
3626691|NCT02621034|3476000|B3|Maxillary molars||Tooth type||participants|Number|20|20.0||||||
3626692|NCT02621034|3476001|B2|Maxillary molars||Tooth type||participants|Number|11|11.0||||||
3626693|NCT02621034|3476002|B1|Maxillary molars||Tooth type||participants|Number|25|25.0||||||
3626694|NCT02621034|3475999|B4||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3626695|NCT02621034|3476000|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3626696|NCT02621034|3476001|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3626697|NCT02621034|3476002|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3626698|NCT02621034|3475999|B4||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3626699|NCT02621034|3476000|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3626700|NCT02621034|3476001|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3626701|NCT02621034|3476002|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3626702|NCT02621034|3475999|B4|||Age||years|Mean|31.7|31.7|Standard Deviation|12.3|12.3|||
3626703|NCT02621034|3476000|B3|||Age||years|Mean|30.2|30.2|Standard Deviation|10.1|10.1|||
3626704|NCT02621034|3476001|B2|||Age||years|Mean|33.2|33.2|Standard Deviation|13.7|13.7|||
3626705|NCT02621034|3476002|B1|||Age||years|Mean|31.7|31.7|Standard Deviation|13.4|13.4|||
3626706|NCT02620683|3476017|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
3626707|NCT02620683|3476017|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626760|NCT02619591|3476068|B1|Blunt Truama||Blunt Trauma||participants|Number|133|133.0||||||
3626709|NCT02620683|3476017|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626710|NCT02620683|3476017|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3626711|NCT02620683|3476017|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3626712|NCT02620683|3476017|B1|||Age||years|Median|21|21.0|Inter-Quartile Range|||20.0|22.0|
3626713|NCT02620683|3476017|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3626714|NCT02620683|3476017|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3626715|NCT02620683|3476017|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3626716|NCT02619812|3476026|B5|United States||Region of Enrollment||participants|Number|3|3.0||||||
3626717|NCT02619812|3476027|B4|United States||Region of Enrollment||participants|Number|2|2.0||||||
3626718|NCT02619812|3476028|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3626719|NCT02619812|3476026|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3626720|NCT02619812|3476027|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3626721|NCT02619812|3476028|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3626722|NCT02619812|3476026|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3626723|NCT02619812|3476027|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3626724|NCT02619812|3476028|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3626725|NCT02619812|3476026|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3626726|NCT02619812|3476027|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3626727|NCT02619812|3476028|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3626728|NCT02619812|3476026|B5||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3626729|NCT02619812|3476027|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3626730|NCT02619812|3476028|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3626731|NCT02619812|3476026|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3626732|NCT02619812|3476027|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3626733|NCT02619812|3476028|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3626734|NCT02619799|3476047|B3|||height in centimeters|Parturients with height range between 150-170 cms were included in the study|centimeters|Mean|157|157.0|Standard Deviation|4.5|4.5|||
3626735|NCT02619799|3476048|B2|||height in centimeters|Parturients with height range between 150-170 cms were included in the study|centimeters|Mean|158|158.0|Standard Deviation|6|6.0|||
3626736|NCT02619799|3476049|B1|||height in centimeters|Parturients with height range between 150-170 cms were included in the study|centimeters|Mean|156|156.0|Standard Deviation|3|3.0|||
3626737|NCT02619799|3476047|B3|||age in years||years|Mean|24.5|24.5|Standard Deviation|2.5|2.5|||
3626738|NCT02619799|3476048|B2|||age in years||years|Mean|26|26.0|Standard Deviation|3|3.0|||
3626739|NCT02619799|3476049|B1|||age in years||years|Mean|23|23.0|Standard Deviation|2|2.0|||
3626740|NCT02619799|3476047|B3|||weight in kilograms|parturients weighing between 50 -80 kilograms were included in the study|kilograms|Mean|70|70.0|Standard Deviation|5.5|5.5|||
3626741|NCT02619799|3476048|B2|||weight in kilograms|parturients weighing between 50 -80 kilograms were included in the study|kilograms|Mean|72|72.0|Standard Deviation|6|6.0|||
3626742|NCT02619799|3476049|B1|||weight in kilograms|parturients weighing between 50 -80 kilograms were included in the study|kilograms|Mean|68|68.0|Standard Deviation|5|5.0|||
3626743|NCT02619799|3476047|B3|female pregnant patients||Sex/Gender, Customized|female parturients who completed 37 weeks of gestational age and who are preeclamptic were included in the study|participants|Number|50|50.0||||||
3626744|NCT02619799|3476048|B2|female pregnant patients||Sex/Gender, Customized|female parturients who completed 37 weeks of gestational age and who are preeclamptic were included in the study|participants|Number|25|25.0||||||
3626745|NCT02619799|3476049|B1|female pregnant patients||Sex/Gender, Customized|female parturients who completed 37 weeks of gestational age and who are preeclamptic were included in the study|participants|Number|25|25.0||||||
3626746|NCT02619799|3476047|B3||>=65 years|Age|parturients aged between 18-28 years were included in the study|Participants|Count of Participants|0|0.0||||||
3626747|NCT02619799|3476048|B2||>=65 years|Age|parturients aged between 18-28 years were included in the study|Participants|Count of Participants|0|0.0||||||
3626748|NCT02619799|3476049|B1||>=65 years|Age|parturients aged between 18-28 years were included in the study|Participants|Count of Participants|0|0.0||||||
3626749|NCT02619799|3476047|B3||Between 18 and 65 years|Age|parturients aged between 18-28 years were included in the study|Participants|Count of Participants|50|50.0||||||
3626750|NCT02619799|3476048|B2||Between 18 and 65 years|Age|parturients aged between 18-28 years were included in the study|Participants|Count of Participants|25|25.0||||||
3626751|NCT02619799|3476049|B1||Between 18 and 65 years|Age|parturients aged between 18-28 years were included in the study|Participants|Count of Participants|25|25.0||||||
3626752|NCT02619799|3476047|B3||<=18 years|Age|parturients aged between 18-28 years were included in the study|Participants|Count of Participants|0|0.0||||||
3626753|NCT02619799|3476048|B2||<=18 years|Age|parturients aged between 18-28 years were included in the study|Participants|Count of Participants|0|0.0||||||
3626754|NCT02619799|3476049|B1||<=18 years|Age|parturients aged between 18-28 years were included in the study|Participants|Count of Participants|0|0.0||||||
3626755|NCT02619591|3476066|B3|Penetrating Trauma||Blunt Trauma||participants|Number|12|12.0||||||
3626756|NCT02619591|3476067|B2|Penetrating Trauma||Blunt Trauma||participants|Number|6|6.0||||||
3626757|NCT02619591|3476068|B1|Penetrating Trauma||Blunt Trauma||participants|Number|6|6.0||||||
3626758|NCT02619591|3476066|B3|Blunt Truama||Blunt Trauma||participants|Number|248|248.0||||||
3626759|NCT02619591|3476067|B2|Blunt Truama||Blunt Trauma||participants|Number|115|115.0||||||
3626761|NCT02619591|3476066|B3|United States||Region of Enrollment||participants|Number|260|260.0||||||
3626762|NCT02619591|3476067|B2|United States||Region of Enrollment||participants|Number|121|121.0||||||
3626763|NCT02619591|3476068|B1|United States||Region of Enrollment||participants|Number|139|139.0||||||
3626764|NCT02619591|3476066|B3||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
3626765|NCT02619591|3476067|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3626766|NCT02619591|3476068|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3626767|NCT02619591|3476066|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3626768|NCT02619591|3476067|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3626769|NCT02619591|3476068|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3626770|NCT02619591|3476066|B3|||Age||years|Mean|45|45.0|Standard Deviation|11|11.0|||
3626771|NCT02619591|3476067|B2|||Age||years|Mean|45|45.0|Standard Deviation|12|12.0|||
3626772|NCT02619591|3476068|B1|||Age||years|Mean|44|44.0|Standard Deviation|13|13.0|||
3626773|NCT02619409|3476075|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626774|NCT02619409|3476076|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626775|NCT02619409|3476077|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626776|NCT02619409|3476078|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626777|NCT02619409|3476079|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626778|NCT02619409|3476080|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626779|NCT02619409|3476075|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626780|NCT02619409|3476076|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626781|NCT02619409|3476077|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626782|NCT02619409|3476078|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626783|NCT02619409|3476079|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626784|NCT02619409|3476080|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626785|NCT02619409|3476075|B6||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3626786|NCT02619409|3476076|B5||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3626787|NCT02619409|3476077|B4||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3626788|NCT02619409|3476078|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3626789|NCT02619409|3476079|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3626790|NCT02619409|3476080|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3626791|NCT02619409|3476075|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3626792|NCT02619409|3476076|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626793|NCT02619409|3476077|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3626794|NCT02619409|3476078|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3626795|NCT02619409|3476079|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626796|NCT02619409|3476080|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3626797|NCT02619409|3476075|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626798|NCT02619409|3476076|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626799|NCT02619409|3476077|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626800|NCT02619409|3476078|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626801|NCT02619409|3476079|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626802|NCT02619409|3476080|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626803|NCT02619409|3476075|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3626804|NCT02619409|3476076|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626805|NCT02619409|3476077|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626806|NCT02619409|3476078|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626807|NCT02619409|3476079|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3626808|NCT02619409|3476080|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626809|NCT02619409|3476075|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626810|NCT02619409|3476076|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626811|NCT02619409|3476077|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626812|NCT02619409|3476078|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626813|NCT02619409|3476079|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626814|NCT02619409|3476080|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626815|NCT02619409|3476075|B6||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3626816|NCT02619409|3476076|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3626817|NCT02619409|3476077|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3626818|NCT02619409|3476078|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3626819|NCT02619409|3476079|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3626820|NCT02619409|3476080|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3626821|NCT02619409|3476075|B6||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3626822|NCT02619409|3476076|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3626823|NCT02619409|3476077|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3626824|NCT02619409|3476078|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3626825|NCT02619409|3476079|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3626826|NCT02619409|3476080|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3626827|NCT02619409|3476075|B6|||Age||years|Mean|64|64.0|Full Range|||28.0|85.0|
3626828|NCT02619409|3476076|B5|||Age||years|Mean|59|59.0|Full Range|||28.0|71.0|
3626829|NCT02619409|3476077|B4|||Age||years|Mean|67|67.0|Full Range|||53.0|85.0|
3626830|NCT02619409|3476078|B3|||Age||years|Mean|58|58.0|Full Range|||55.0|77.0|
3626831|NCT02619409|3476079|B2|||Age||years|Mean|63|63.0|Full Range|||50.0|73.0|
3626832|NCT02619409|3476080|B1|||Age||years|Mean|70|70.0|Full Range|||53.0|84.0|
3626833|NCT02618915|3476101|B3|||Factor IX (FIX) Activity|The documented history or measurement before the Day 0 visit following the appropriate washout was used for the baseline values of FIX activity.|IU/dL|Mean|1.27|1.27|Standard Deviation|0.566|0.566|||
3626834|NCT02618915|3476102|B2|||Factor IX (FIX) Activity|The documented history or measurement before the Day 0 visit following the appropriate washout was used for the baseline values of FIX activity.|IU/dL|Mean|0.87|0.87|Standard Deviation|0.709|0.709|||
3626835|NCT02618915|3476103|B1|||Factor IX (FIX) Activity|The documented history or measurement before the Day 0 visit following the appropriate washout was used for the baseline values of FIX activity.|IU/dL|Mean|1.67|1.67|Standard Deviation|0.577|0.577|||
3626836|NCT02618915|3476101|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626837|NCT02618915|3476102|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626838|NCT02618915|3476103|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626839|NCT02618915|3476101|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3626840|NCT02618915|3476102|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3626841|NCT02618915|3476103|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3626842|NCT02618915|3476101|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626843|NCT02618915|3476102|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626844|NCT02618915|3476103|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3626845|NCT02618915|3476101|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3626846|NCT02618915|3476102|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3626847|NCT02618915|3476103|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3626848|NCT02618915|3476101|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3626849|NCT02618915|3476102|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3626850|NCT02618915|3476103|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3626851|NCT02618915|3476101|B3|50-84 years||Age, Customized||participants|Number|3|3.0||||||
3626852|NCT02618915|3476102|B2|50-84 years||Age, Customized||participants|Number|0|0.0||||||
3626853|NCT02618915|3476103|B1|50-84 years||Age, Customized||participants|Number|3|3.0||||||
3626854|NCT02618915|3476101|B3|18-49 years||Age, Customized||participants|Number|3|3.0||||||
3626855|NCT02618915|3476102|B2|18-49 years||Age, Customized||participants|Number|3|3.0||||||
3626856|NCT02618915|3476103|B1|18-49 years||Age, Customized||participants|Number|0|0.0||||||
3626857|NCT02618772|3476128|B3|Per-Protocol (PP)||LET: Lidocaine, Epinephrine and Tetracaine Gel Use|"LET is a combination of lidocaine (4 percent), epinephrine (0.1 percent), and tetracaine (0.5 percent) available for use as a topical anesthetic. This baseline variable describes participants who had LET applied to their wounds prior to sutures.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|participants|Number|45|45.0||||||
3626858|NCT02618772|3476129|B2|Per-Protocol (PP)||LET: Lidocaine, Epinephrine and Tetracaine Gel Use|"LET is a combination of lidocaine (4 percent), epinephrine (0.1 percent), and tetracaine (0.5 percent) available for use as a topical anesthetic. This baseline variable describes participants who had LET applied to their wounds prior to sutures.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|participants|Number|24|24.0||||||
3626859|NCT02618772|3476130|B1|Per-Protocol (PP)||LET: Lidocaine, Epinephrine and Tetracaine Gel Use|"LET is a combination of lidocaine (4 percent), epinephrine (0.1 percent), and tetracaine (0.5 percent) available for use as a topical anesthetic. This baseline variable describes participants who had LET applied to their wounds prior to sutures.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|participants|Number|21|21.0||||||
3626920|NCT02618772|3476128|B3|Per-Protocol (PP): Male||Sex/Gender, Customized|"This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|participants|Number|48|48.0||||||
3626860|NCT02618772|3476128|B3|Intention to Treat (ITT)||LET: Lidocaine, Epinephrine and Tetracaine Gel Use|"LET is a combination of lidocaine (4 percent), epinephrine (0.1 percent), and tetracaine (0.5 percent) available for use as a topical anesthetic. This baseline variable describes participants who had LET applied to their wounds prior to sutures.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|participants|Number|50|50.0||||||
3626861|NCT02618772|3476129|B2|Intention to Treat (ITT)||LET: Lidocaine, Epinephrine and Tetracaine Gel Use|"LET is a combination of lidocaine (4 percent), epinephrine (0.1 percent), and tetracaine (0.5 percent) available for use as a topical anesthetic. This baseline variable describes participants who had LET applied to their wounds prior to sutures.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|participants|Number|26|26.0||||||
3626862|NCT02618772|3476130|B1|Intention to Treat (ITT)||LET: Lidocaine, Epinephrine and Tetracaine Gel Use|"LET is a combination of lidocaine (4 percent), epinephrine (0.1 percent), and tetracaine (0.5 percent) available for use as a topical anesthetic. This baseline variable describes participants who had LET applied to their wounds prior to sutures.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|participants|Number|24|24.0||||||
3626863|NCT02618772|3476128|B3|Per-Protocol (PP)||Nasal Congestion|"This baseline characteristic is a measure of the number of participants who experienced nasal congestion at the time of recruitment.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Participants|Number|13|13.0||||||
3626864|NCT02618772|3476129|B2|Per-Protocol (PP)||Nasal Congestion|"This baseline characteristic is a measure of the number of participants who experienced nasal congestion at the time of recruitment.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Participants|Number|9|9.0||||||
3626865|NCT02618772|3476130|B1|Per-Protocol (PP)||Nasal Congestion|"This baseline characteristic is a measure of the number of participants who experienced nasal congestion at the time of recruitment.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Participants|Number|4|4.0||||||
3626866|NCT02618772|3476128|B3|Intention to Treat (ITT)||Nasal Congestion|"This baseline characteristic is a measure of the number of participants who experienced nasal congestion at the time of recruitment.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Participants|Number|14|14.0||||||
3626867|NCT02618772|3476129|B2|Intention to Treat (ITT)||Nasal Congestion|"This baseline characteristic is a measure of the number of participants who experienced nasal congestion at the time of recruitment.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Participants|Number|9|9.0||||||
3626868|NCT02618772|3476130|B1|Intention to Treat (ITT)||Nasal Congestion|"This baseline characteristic is a measure of the number of participants who experienced nasal congestion at the time of recruitment.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Participants|Number|5|5.0||||||
3626869|NCT02618772|3476128|B3|Per-Protocol (PP): (n = 9, 8, 17)||Triage Vitals: Oxygen Saturation|"This baseline measure describes the oxygen saturation at triage measured in percent (%). Note: not all participants had their oxygen saturation measured at triage.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Percent (%)|Mean|99.06|99.06|Standard Deviation|1.519|1.519|||
3626870|NCT02618772|3476129|B2|Per-Protocol (PP): (n = 9, 8, 17)||Triage Vitals: Oxygen Saturation|"This baseline measure describes the oxygen saturation at triage measured in percent (%). Note: not all participants had their oxygen saturation measured at triage.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Percent (%)|Mean|99.13|99.13|Standard Deviation|1.458|1.458|||
3626871|NCT02618772|3476130|B1|Per-Protocol (PP): (n = 9, 8, 17)||Triage Vitals: Oxygen Saturation|"This baseline measure describes the oxygen saturation at triage measured in percent (%). Note: not all participants had their oxygen saturation measured at triage.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Percent (%)|Mean|99.00|99.0|Standard Deviation|1.658|1.658|||
3627117|NCT02617888|3476192|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3626872|NCT02618772|3476128|B3|Intention to Treat (ITT): (n = 9, 9, 18)||Triage Vitals: Oxygen Saturation|"This baseline measure describes the oxygen saturation at triage measured in percent (%). Note: not all participants had their oxygen saturation measured at triage.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Percent (%)|Mean|99.11|99.11|Standard Deviation|1.491|1.491|||
3626873|NCT02618772|3476129|B2|Intention to Treat (ITT): (n = 9, 9, 18)||Triage Vitals: Oxygen Saturation|"This baseline measure describes the oxygen saturation at triage measured in percent (%). Note: not all participants had their oxygen saturation measured at triage.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Percent (%)|Mean|99.22|99.22|Standard Deviation|1.394|1.394|||
3626874|NCT02618772|3476130|B1|Intention to Treat (ITT): (n = 9, 9, 18)||Triage Vitals: Oxygen Saturation|"This baseline measure describes the oxygen saturation at triage measured in percent (%). Note: not all participants had their oxygen saturation measured at triage.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Percent (%)|Mean|99.00|99.0|Standard Deviation|1.658|1.658|||
3626875|NCT02618772|3476128|B3|Per-Protocol (PP): (n = 10, 9, 19)||Triage Vitals: Blood Pressure (Diastolic)|"This baseline measure describes the blood pressure (diastolic) at triage measured in millimeters of mercury (mm Hg). Note: not all participants had their blood pressure (diastolic) measured at triage.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|mm Hg|Mean|69.42|69.42|Standard Deviation|11.007|11.007|||
3626876|NCT02618772|3476129|B2|Per-Protocol (PP): (n = 10, 9, 19)||Triage Vitals: Blood Pressure (Diastolic)|"This baseline measure describes the blood pressure (diastolic) at triage measured in millimeters of mercury (mm Hg). Note: not all participants had their blood pressure (diastolic) measured at triage.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|mm Hg|Mean|73.22|73.22|Standard Deviation|7.759|7.759|||
3626877|NCT02618772|3476130|B1|Per-Protocol (PP): (n = 10, 9, 19)||Triage Vitals: Blood Pressure (Diastolic)|"This baseline measure describes the blood pressure (diastolic) at triage measured in millimeters of mercury (mm Hg). Note: not all participants had their blood pressure (diastolic) measured at triage.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|mm Hg|Mean|66.00|66.0|Standard Deviation|12.702|12.702|||
3626878|NCT02618772|3476128|B3|Intention to Treat (ITT): (n = 10, 9, 19)||Triage Vitals: Blood Pressure (Diastolic)|"This baseline measure describes the blood pressure (diastolic) at triage measured in millimeters of mercury (mm Hg). Note: not all participants had their blood pressure (diastolic) measured at triage.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|mm Hg|Mean|69.42|69.42|Standard Deviation|11.007|11.007|||
3626879|NCT02618772|3476129|B2|Intention to Treat (ITT): (n = 10, 9, 19)||Triage Vitals: Blood Pressure (Diastolic)|"This baseline measure describes the blood pressure (diastolic) at triage measured in millimeters of mercury (mm Hg). Note: not all participants had their blood pressure (diastolic) measured at triage.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|mm Hg|Mean|73.22|73.22|Standard Deviation|7.759|7.759|||
3626880|NCT02618772|3476130|B1|Intention to Treat (ITT): (n = 10, 9, 19)||Triage Vitals: Blood Pressure (Diastolic)|"This baseline measure describes the blood pressure (diastolic) at triage measured in millimeters of mercury (mm Hg). Note: not all participants had their blood pressure (diastolic) measured at triage.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|mm Hg|Mean|66.00|66.0|Standard Deviation|12.702|12.702|||
3626881|NCT02618772|3476128|B3|Per-Protocol (PP): (n = 10, 9, 19)||Triage Vitals: Blood Pressure (Systolic)|"This baseline measure describes the blood pressure (systolic) at triage measured in millimeters of mercury (mm Hg). Note: not all participants had their blood pressure (systolic) measured at triage.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|mm Hg|Mean|113.11|113.11|Standard Deviation|13.300|13.3|||
3626882|NCT02618772|3476129|B2|Per-Protocol (PP): (n = 10, 9, 19)||Triage Vitals: Blood Pressure (Systolic)|"This baseline measure describes the blood pressure (systolic) at triage measured in millimeters of mercury (mm Hg). Note: not all participants had their blood pressure (systolic) measured at triage.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|mm Hg|Mean|115.56|115.56|Standard Deviation|15.915|15.915|||
3626883|NCT02618772|3476130|B1|Per-Protocol (PP): (n = 10, 9, 19)||Triage Vitals: Blood Pressure (Systolic)|"This baseline measure describes the blood pressure (systolic) at triage measured in millimeters of mercury (mm Hg). Note: not all participants had their blood pressure (systolic) measured at triage.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|mm Hg|Mean|110.9|110.9|Standard Deviation|10.826|10.826|||
3626884|NCT02618772|3476128|B3|Intention to Treat (ITT): (n = 10, 9, 19)||Triage Vitals: Blood Pressure (Systolic)|"This baseline measure describes the blood pressure (systolic) at triage measured in millimeters of mercury (mm Hg). Note: not all participants had their blood pressure (systolic) measured at triage.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|mm Hg|Mean|113.11|113.11|Standard Deviation|13.300|13.3|||
3626885|NCT02618772|3476129|B2|Intention to Treat (ITT): (n = 10, 9, 19)||Triage Vitals: Blood Pressure (Systolic)|"This baseline measure describes the blood pressure (systolic) at triage measured in millimeters of mercury (mm Hg). Note: not all participants had their blood pressure (systolic) measured at triage.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|mm Hg|Mean|115.56|115.56|Standard Deviation|15.915|15.915|||
3626886|NCT02618772|3476130|B1|Intention to Treat (ITT): (n = 10, 9, 19)||Triage Vitals: Blood Pressure (Systolic)|"This baseline measure describes the blood pressure (systolic) at triage measured in millimeters of mercury (mm Hg). Note: not all participants had their blood pressure (systolic) measured at triage.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|mm Hg|Mean|110.9|110.9|Standard Deviation|10.826|10.826|||
3626887|NCT02618772|3476128|B3|Per-Protocol (PP): (n = 13, 13, 26)||Triage Vitals: Heart Rate|"This baseline measure describes the heart rate of participants at triage. Heart rate is measured by the number of contractions of the heart per minute (bpm). Note: not all participants had their heart rate measured at triage.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Beats per Minute (bpm)|Mean|99.27|99.27|Standard Deviation|14.496|14.496|||
3626888|NCT02618772|3476129|B2|Per-Protocol (PP): (n = 13, 13, 26)||Triage Vitals: Heart Rate|"This baseline measure describes the heart rate of participants at triage. Heart rate is measured by the number of contractions of the heart per minute (bpm). Note: not all participants had their heart rate measured at triage.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Beats per Minute (bpm)|Mean|102.00|102.0|Standard Deviation|13.335|13.335|||
3626889|NCT02618772|3476130|B1|Per-Protocol (PP): (n = 13, 13, 26)||Triage Vitals: Heart Rate|"This baseline measure describes the heart rate of participants at triage. Heart rate is measured by the number of contractions of the heart per minute (bpm). Note: not all participants had their heart rate measured at triage.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Beats per Minute (bpm)|Mean|96.54|96.54|Standard Deviation|15.613|15.613|||
3626890|NCT02618772|3476128|B3|Intention to Treat (ITT): (n = 13, 14, 27)||Triage Vitals: Heart Rate|"This baseline measure describes the heart rate of participants at triage. Heart rate is measured by the number of contractions of the heart per minute (bpm). Note: not all participants had their heart rate measured at triage.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Beats per Minute (bpm)|Mean|99.74|99.74|Standard Deviation|14.42|14.42|||
3626891|NCT02618772|3476129|B2|Intention to Treat (ITT): (n = 13, 14, 27)||Triage Vitals: Heart Rate|"This baseline measure describes the heart rate of participants at triage. Heart rate is measured by the number of contractions of the heart per minute (bpm). Note: not all participants had their heart rate measured at triage.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Beats per Minute (bpm)|Mean|102.71|102.71|Standard Deviation|13.088|13.088|||
3626892|NCT02618772|3476130|B1|Intention to Treat (ITT): (n = 13, 14, 27)||Triage Vitals: Heart Rate|"This baseline measure describes the heart rate of participants at triage. Heart rate is measured by the number of contractions of the heart per minute (bpm). Note: not all participants had their heart rate measured at triage.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Beats per Minute (bpm)|Mean|96.54|96.54|Standard Deviation|15.613|15.613|||
3626921|NCT02618772|3476129|B2|Per-Protocol (PP): Male||Sex/Gender, Customized|"This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|participants|Number|22|22.0||||||
3626893|NCT02618772|3476128|B3|Per-Protocol (PP): (n = 35, 37, 72)||Weight (kg)|"This baseline measure describes weight of the participants in kilograms.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Kilograms (kg)|Mean|27.72|27.72|Standard Deviation|14.675|14.675|||
3626894|NCT02618772|3476129|B2|Per-Protocol (PP): (n = 35, 37, 72)||Weight (kg)|"This baseline measure describes weight of the participants in kilograms.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Kilograms (kg)|Mean|28.02|28.02|Standard Deviation|18.002|18.002|||
3626895|NCT02618772|3476130|B1|Per-Protocol (PP): (n = 35, 37, 72)||Weight (kg)|"This baseline measure describes weight of the participants in kilograms.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Kilograms (kg)|Mean|27.41|27.41|Standard Deviation|10.315|10.315|||
3626896|NCT02618772|3476128|B3|Intention to Treat (ITT): (n = 39, 40, 79)||Weight (kg)|"This baseline measure describes weight of the participants in kilograms.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Kilograms (kg)|Mean|27.65|27.65|Standard Deviation|14.208|14.208|||
3626897|NCT02618772|3476129|B2|Intention to Treat (ITT): (n = 39, 40, 79)||Weight (kg)|"This baseline measure describes weight of the participants in kilograms.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Kilograms (kg)|Mean|27.67|27.67|Standard Deviation|17.348|17.348|||
3626898|NCT02618772|3476130|B1|Intention to Treat (ITT): (n = 39, 40, 79)||Weight (kg)|"This baseline measure describes weight of the participants in kilograms.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Kilograms (kg)|Mean|27.63|27.63|Standard Deviation|10.271|10.271|||
3626899|NCT02618772|3476128|B3|Per-Protocol (PP)||Laceration Location: Below Neck|"This baseline measure describes the number of participants whose laceration was located above the neck i.e., either on the participant's neck or head.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Participants|Number|34|34.0||||||
3626900|NCT02618772|3476129|B2|Per-Protocol (PP)||Laceration Location: Below Neck|"This baseline measure describes the number of participants whose laceration was located above the neck i.e., either on the participant's neck or head.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Participants|Number|21|21.0||||||
3626901|NCT02618772|3476130|B1|Per-Protocol (PP)||Laceration Location: Below Neck|"This baseline measure describes the number of participants whose laceration was located above the neck i.e., either on the participant's neck or head.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Participants|Number|13|13.0||||||
3626902|NCT02618772|3476128|B3|Intention to Treat (ITT)||Laceration Location: Below Neck|"This baseline measure describes the number of participants whose laceration was located above the neck i.e., either on the participant's neck or head.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Participants|Number|36|36.0||||||
3626903|NCT02618772|3476129|B2|Intention to Treat (ITT)||Laceration Location: Below Neck|"This baseline measure describes the number of participants whose laceration was located above the neck i.e., either on the participant's neck or head.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Participants|Number|22|22.0||||||
3626904|NCT02618772|3476130|B1|Intention to Treat (ITT)||Laceration Location: Below Neck|"This baseline measure describes the number of participants whose laceration was located above the neck i.e., either on the participant's neck or head.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Participants|Number|14|14.0||||||
3626905|NCT02618772|3476128|B3|Per-Protocol (PP)||Laceration Location: Above Neck|"This baseline measure describes the number of participants whose laceration was located above the neck i.e., either on the participant's neck or head.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Participants|Number|38|38.0||||||
3627059|NCT02618759|3476164|B2|||Age||years|Mean|57.3|57.3|Standard Deviation|14.3|14.3|||
3626906|NCT02618772|3476129|B2|Per-Protocol (PP)||Laceration Location: Above Neck|"This baseline measure describes the number of participants whose laceration was located above the neck i.e., either on the participant's neck or head.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Participants|Number|16|16.0||||||
3626907|NCT02618772|3476130|B1|Per-Protocol (PP)||Laceration Location: Above Neck|"This baseline measure describes the number of participants whose laceration was located above the neck i.e., either on the participant's neck or head.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Participants|Number|22|22.0||||||
3626908|NCT02618772|3476128|B3|Intention to Treat (ITT)||Laceration Location: Above Neck|"This baseline measure describes the number of participants whose laceration was located above the neck i.e., either on the participant's neck or head.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Participants|Number|43|43.0||||||
3626909|NCT02618772|3476129|B2|Intention to Treat (ITT)||Laceration Location: Above Neck|"This baseline measure describes the number of participants whose laceration was located above the neck i.e., either on the participant's neck or head.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Participants|Number|18|18.0||||||
3626910|NCT02618772|3476130|B1|Intention to Treat (ITT)||Laceration Location: Above Neck|"This baseline measure describes the number of participants whose laceration was located above the neck i.e., either on the participant's neck or head.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Participants|Number|25|25.0||||||
3626911|NCT02618772|3476128|B3|Per-Protocol (PP): (n = 35, 36, 71)||Laceration Length (cm)|"This baseline measure describes the length of the participant's laceration (centimeters) at the time of recruitment.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Centimeters (cm)|Mean|2.727|2.727|Standard Deviation|2.7003|2.7003|||
3626912|NCT02618772|3476129|B2|Per-Protocol (PP): (n = 35, 36, 71)||Laceration Length (cm)|"This baseline measure describes the length of the participant's laceration (centimeters) at the time of recruitment.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Centimeters (cm)|Mean|3.056|3.056|Standard Deviation|3.0184|3.0184|||
3626913|NCT02618772|3476130|B1|Per-Protocol (PP): (n = 35, 36, 71)||Laceration Length (cm)|"This baseline measure describes the length of the participant's laceration (centimeters) at the time of recruitment.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Centimeters (cm)|Mean|2.389|2.389|Standard Deviation|2.3241|2.3241|||
3626914|NCT02618772|3476128|B3|Intention to Treat (ITT): (n = 39, 38, 77)||Laceration Length (cm)|"This baseline measure describes the length of the participant's laceration (centimeters) at the time of recruitment.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Centimeters (cm)|Mean|2.691|2.691|Standard Deviation|2.6116|2.6116|||
3626915|NCT02618772|3476129|B2|Intention to Treat (ITT): (n = 39, 38, 77)||Laceration Length (cm)|"This baseline measure describes the length of the participant's laceration (centimeters) at the time of recruitment.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Centimeters (cm)|Mean|2.995|2.995|Standard Deviation|2.9506|2.9506|||
3626916|NCT02618772|3476130|B1|Intention to Treat (ITT): (n = 39, 38, 77)||Laceration Length (cm)|"This baseline measure describes the length of the participant's laceration (centimeters) at the time of recruitment.~This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|Centimeters (cm)|Mean|2.395|2.395|Standard Deviation|2.2319|2.2319|||
3626917|NCT02618772|3476128|B3|Canada||Region of Enrollment|All participants were enrolled at the Montreal Children's Hospital in Montreal, Quebec (Canada). The address is as follows: 2300 Tupper, Montreal (QC), Canada, H3H 1P3.|Participants|Number|79|79.0||||||
3626918|NCT02618772|3476129|B2|Canada||Region of Enrollment|All participants were enrolled at the Montreal Children's Hospital in Montreal, Quebec (Canada). The address is as follows: 2300 Tupper, Montreal (QC), Canada, H3H 1P3.|Participants|Number|40|40.0||||||
3626919|NCT02618772|3476130|B1|Canada||Region of Enrollment|All participants were enrolled at the Montreal Children's Hospital in Montreal, Quebec (Canada). The address is as follows: 2300 Tupper, Montreal (QC), Canada, H3H 1P3.|Participants|Number|39|39.0||||||
3627060|NCT02618759|3476165|B1|||Age||years|Mean|53.6|53.6|Standard Deviation|15.2|15.2|||
3626922|NCT02618772|3476130|B1|Per-Protocol (PP): Male||Sex/Gender, Customized|"This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|participants|Number|26|26.0||||||
3626923|NCT02618772|3476128|B3|Per-Protocol (PP): Female||Sex/Gender, Customized|"This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|participants|Number|24|24.0||||||
3626924|NCT02618772|3476129|B2|Per-Protocol (PP): Female||Sex/Gender, Customized|"This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|participants|Number|15|15.0||||||
3626925|NCT02618772|3476130|B1|Per-Protocol (PP): Female||Sex/Gender, Customized|"This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|participants|Number|9|9.0||||||
3626926|NCT02618772|3476128|B3|Intention to Treat (ITT): Male||Sex/Gender, Customized|"This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|participants|Number|54|54.0||||||
3626927|NCT02618772|3476129|B2|Intention to Treat (ITT): Male||Sex/Gender, Customized|"This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|participants|Number|25|25.0||||||
3626928|NCT02618772|3476130|B1|Intention to Treat (ITT): Male||Sex/Gender, Customized|"This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|participants|Number|29|29.0||||||
3626929|NCT02618772|3476128|B3|Intention to Treat (ITT): Female||Sex/Gender, Customized|"This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|participants|Number|25|25.0||||||
3626930|NCT02618772|3476129|B2|Intention to Treat (ITT): Female||Sex/Gender, Customized|"This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|participants|Number|15|15.0||||||
3626931|NCT02618772|3476130|B1|Intention to Treat (ITT): Female||Sex/Gender, Customized|"This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|participants|Number|10|10.0||||||
3626932|NCT02618772|3476128|B3|Per-Protocol (PP): (n = 35, 37, 72)||Age, Customized|"This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|years|Mean|7.1076|7.1076|Standard Deviation|3.4077|3.4077|||
3626933|NCT02618772|3476129|B2|Per-Protocol (PP): (n = 35, 37, 72)||Age, Customized|"This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|years|Mean|6.8454|6.8454|Standard Deviation|3.6318|3.6318|||
3626934|NCT02618772|3476130|B1|Per-Protocol (PP): (n = 35, 37, 72)||Age, Customized|"This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|years|Mean|7.3848|7.3848|Standard Deviation|3.1826|3.1826|||
3626935|NCT02618772|3476128|B3|Intention to Treat (ITT): (n = 39, 40, 79)||Age, Customized|"This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|years|Mean|7.1067|7.1067|Standard Deviation|3.35997|3.35997|||
3626936|NCT02618772|3476129|B2|Intention to Treat (ITT): (n = 39, 40, 79)||Age, Customized|"This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|years|Mean|6.8642|6.8642|Standard Deviation|3.5191|3.5191|||
3626937|NCT02618772|3476130|B1|Intention to Treat (ITT): (n = 39, 40, 79)||Age, Customized|"This is for the Intention to Treat analysis and thus, includes all participants that received the study intervention i.e., intranasal saline or intranasal midazolam.~This is for the per-protocol analysis and thus, includes all participants who fulfill the protocol in the terms of eligibility, all interventions, and outcome assessment."|years|Mean|7.3554|7.3554|Standard Deviation|3.2152|3.2152|||
3627118|NCT02617888|3476193|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3626938|NCT02618759|3476163|B3|||Target Lesion Size (area)||centimeters squared|Mean|42.7|42.7|Standard Deviation|43.5|43.5|||
3626939|NCT02618759|3476164|B2|||Target Lesion Size (area)||centimeters squared|Mean|36.7|36.7|Standard Deviation|26.3|26.3|||
3626940|NCT02618759|3476165|B1|||Target Lesion Size (area)||centimeters squared|Mean|48.7|48.7|Standard Deviation|55.1|55.1|||
3626941|NCT02618759|3476163|B3|||Baseline Psoriasis Area Severity Index (PASI) Score|The PASI is a composite score based on the severity of three different clinical signs of psoriasis (Erythema, Induration, and Scaling, each rated 0 to 4 in severity) in four different areas of the body (Head/Neck, Upper Limbs, Trunk, and Lower Limbs) multiplied by the percent of that specific body area affected multiplied by a weighting factor. The scale is explained in detail in the study protocol Appendix D. The minimum score would be 0 and the Maximum Score would be 72. A higher value would represent a more severe case of psoriasis.|units on a scale|Mean|6.0|6.0|Standard Deviation|2.5|2.5|||
3626942|NCT02618759|3476164|B2|||Baseline Psoriasis Area Severity Index (PASI) Score|The PASI is a composite score based on the severity of three different clinical signs of psoriasis (Erythema, Induration, and Scaling, each rated 0 to 4 in severity) in four different areas of the body (Head/Neck, Upper Limbs, Trunk, and Lower Limbs) multiplied by the percent of that specific body area affected multiplied by a weighting factor. The scale is explained in detail in the study protocol Appendix D. The minimum score would be 0 and the Maximum Score would be 72. A higher value would represent a more severe case of psoriasis.|units on a scale|Mean|6.2|6.2|Standard Deviation|2.4|2.4|||
3626943|NCT02618759|3476165|B1|||Baseline Psoriasis Area Severity Index (PASI) Score|The PASI is a composite score based on the severity of three different clinical signs of psoriasis (Erythema, Induration, and Scaling, each rated 0 to 4 in severity) in four different areas of the body (Head/Neck, Upper Limbs, Trunk, and Lower Limbs) multiplied by the percent of that specific body area affected multiplied by a weighting factor. The scale is explained in detail in the study protocol Appendix D. The minimum score would be 0 and the Maximum Score would be 72. A higher value would represent a more severe case of psoriasis.|units on a scale|Mean|5.8|5.8|Standard Deviation|2.5|2.5|||
3626944|NCT02618759|3476163|B3||Very Severe|Baseline Plaque Elevation||Participants|Count of Participants|0|0.0||||||
3626945|NCT02618759|3476164|B2||Very Severe|Baseline Plaque Elevation||Participants|Count of Participants|0|0.0||||||
3626946|NCT02618759|3476165|B1||Very Severe|Baseline Plaque Elevation||Participants|Count of Participants|0|0.0||||||
3626947|NCT02618759|3476163|B3||Severe|Baseline Plaque Elevation||Participants|Count of Participants|8|8.0||||||
3626948|NCT02618759|3476164|B2||Severe|Baseline Plaque Elevation||Participants|Count of Participants|5|5.0||||||
3626949|NCT02618759|3476165|B1||Severe|Baseline Plaque Elevation||Participants|Count of Participants|3|3.0||||||
3626950|NCT02618759|3476163|B3||Moderate|Baseline Plaque Elevation||Participants|Count of Participants|86|86.0||||||
3626951|NCT02618759|3476164|B2||Moderate|Baseline Plaque Elevation||Participants|Count of Participants|43|43.0||||||
3626952|NCT02618759|3476165|B1||Moderate|Baseline Plaque Elevation||Participants|Count of Participants|43|43.0||||||
3626953|NCT02618759|3476163|B3||Mild|Baseline Plaque Elevation||Participants|Count of Participants|25|25.0||||||
3626954|NCT02618759|3476164|B2||Mild|Baseline Plaque Elevation||Participants|Count of Participants|11|11.0||||||
3626955|NCT02618759|3476165|B1||Mild|Baseline Plaque Elevation||Participants|Count of Participants|14|14.0||||||
3626956|NCT02618759|3476163|B3||Almost Clear|Baseline Plaque Elevation||Participants|Count of Participants|0|0.0||||||
3626957|NCT02618759|3476164|B2||Almost Clear|Baseline Plaque Elevation||Participants|Count of Participants|0|0.0||||||
3626958|NCT02618759|3476165|B1||Almost Clear|Baseline Plaque Elevation||Participants|Count of Participants|0|0.0||||||
3626959|NCT02618759|3476163|B3||Clear|Baseline Plaque Elevation||Participants|Count of Participants|0|0.0||||||
3626960|NCT02618759|3476164|B2||Clear|Baseline Plaque Elevation||Participants|Count of Participants|0|0.0||||||
3626961|NCT02618759|3476165|B1||Clear|Baseline Plaque Elevation||Participants|Count of Participants|0|0.0||||||
3626962|NCT02618759|3476163|B3||Very Severe|Baseline Erythema Score||Participants|Count of Participants|0|0.0||||||
3626963|NCT02618759|3476164|B2||Very Severe|Baseline Erythema Score||Participants|Count of Participants|0|0.0||||||
3626964|NCT02618759|3476165|B1||Very Severe|Baseline Erythema Score||Participants|Count of Participants|0|0.0||||||
3626965|NCT02618759|3476163|B3||Severe|Baseline Erythema Score||Participants|Count of Participants|9|9.0||||||
3626966|NCT02618759|3476164|B2||Severe|Baseline Erythema Score||Participants|Count of Participants|5|5.0||||||
3626967|NCT02618759|3476165|B1||Severe|Baseline Erythema Score||Participants|Count of Participants|4|4.0||||||
3626968|NCT02618759|3476163|B3||Moderate|Baseline Erythema Score||Participants|Count of Participants|77|77.0||||||
3626969|NCT02618759|3476164|B2||Moderate|Baseline Erythema Score||Participants|Count of Participants|37|37.0||||||
3626970|NCT02618759|3476165|B1||Moderate|Baseline Erythema Score||Participants|Count of Participants|40|40.0||||||
3626971|NCT02618759|3476163|B3||Mild|Baseline Erythema Score||Participants|Count of Participants|31|31.0||||||
3626972|NCT02618759|3476164|B2||Mild|Baseline Erythema Score||Participants|Count of Participants|16|16.0||||||
3626973|NCT02618759|3476165|B1||Mild|Baseline Erythema Score||Participants|Count of Participants|15|15.0||||||
3626974|NCT02618759|3476163|B3||Almost Clear|Baseline Erythema Score||Participants|Count of Participants|2|2.0||||||
3626975|NCT02618759|3476164|B2||Almost Clear|Baseline Erythema Score||Participants|Count of Participants|1|1.0||||||
3626976|NCT02618759|3476165|B1||Almost Clear|Baseline Erythema Score||Participants|Count of Participants|1|1.0||||||
3626977|NCT02618759|3476163|B3||Clear|Baseline Erythema Score||Participants|Count of Participants|0|0.0||||||
3626978|NCT02618759|3476164|B2||Clear|Baseline Erythema Score||Participants|Count of Participants|0|0.0||||||
3626979|NCT02618759|3476165|B1||Clear|Baseline Erythema Score||Participants|Count of Participants|0|0.0||||||
3626980|NCT02618759|3476163|B3||Very Severe|Baseline Scaling Score||Participants|Count of Participants|0|0.0||||||
3626981|NCT02618759|3476164|B2||Very Severe|Baseline Scaling Score||Participants|Count of Participants|0|0.0||||||
3626982|NCT02618759|3476165|B1||Very Severe|Baseline Scaling Score||Participants|Count of Participants|0|0.0||||||
3626983|NCT02618759|3476163|B3||Severe|Baseline Scaling Score||Participants|Count of Participants|10|10.0||||||
3626984|NCT02618759|3476164|B2||Severe|Baseline Scaling Score||Participants|Count of Participants|6|6.0||||||
3626985|NCT02618759|3476165|B1||Severe|Baseline Scaling Score||Participants|Count of Participants|4|4.0||||||
3626986|NCT02618759|3476163|B3||Moderate|Baseline Scaling Score||Participants|Count of Participants|75|75.0||||||
3626987|NCT02618759|3476164|B2||Moderate|Baseline Scaling Score||Participants|Count of Participants|35|35.0||||||
3626988|NCT02618759|3476165|B1||Moderate|Baseline Scaling Score||Participants|Count of Participants|40|40.0||||||
3626989|NCT02618759|3476163|B3||Mild|Baseline Scaling Score||Participants|Count of Participants|30|30.0||||||
3626990|NCT02618759|3476164|B2||Mild|Baseline Scaling Score||Participants|Count of Participants|15|15.0||||||
3626991|NCT02618759|3476165|B1||Mild|Baseline Scaling Score||Participants|Count of Participants|15|15.0||||||
3626992|NCT02618759|3476163|B3||Almost Clear|Baseline Scaling Score||Participants|Count of Participants|4|4.0||||||
3626993|NCT02618759|3476164|B2||Almost Clear|Baseline Scaling Score||Participants|Count of Participants|3|3.0||||||
3626994|NCT02618759|3476165|B1||Almost Clear|Baseline Scaling Score||Participants|Count of Participants|1|1.0||||||
3626995|NCT02618759|3476163|B3||Clear|Baseline Scaling Score||Participants|Count of Participants|0|0.0||||||
3626996|NCT02618759|3476164|B2||Clear|Baseline Scaling Score||Participants|Count of Participants|0|0.0||||||
3626997|NCT02618759|3476165|B1||Clear|Baseline Scaling Score||Participants|Count of Participants|0|0.0||||||
3626998|NCT02618759|3476163|B3|||Baseline Total Lesion Severity Score (TLSS)|TLSS is a lesion assessment to determine severity of a plaque psoriasis lesion based on a summation of scores Erythema, Scaling, and Plaque Elevation (each rated 0 to 5 in severity). This is detailed in Appendix B of the study protocol. The minimum value is 0, and the maximum value is 15. A higher value indicates a more severe plaque psoriasis lesion. To be considered for inclusion in the study, the Target Lesion must have a Plaque Elevation sub-scale score of at least 2.|units on a scale|Mean|8.4|8.4|Standard Deviation|1.5|1.5|||
3626999|NCT02618759|3476164|B2|||Baseline Total Lesion Severity Score (TLSS)|TLSS is a lesion assessment to determine severity of a plaque psoriasis lesion based on a summation of scores Erythema, Scaling, and Plaque Elevation (each rated 0 to 5 in severity). This is detailed in Appendix B of the study protocol. The minimum value is 0, and the maximum value is 15. A higher value indicates a more severe plaque psoriasis lesion. To be considered for inclusion in the study, the Target Lesion must have a Plaque Elevation sub-scale score of at least 2.|units on a scale|Mean|8.4|8.4|Standard Deviation|1.5|1.5|||
3627000|NCT02618759|3476165|B1|||Baseline Total Lesion Severity Score (TLSS)|TLSS is a lesion assessment to determine severity of a plaque psoriasis lesion based on a summation of scores Erythema, Scaling, and Plaque Elevation (each rated 0 to 5 in severity). This is detailed in Appendix B of the study protocol. The minimum value is 0, and the maximum value is 15. A higher value indicates a more severe plaque psoriasis lesion. To be considered for inclusion in the study, the Target Lesion must have a Plaque Elevation sub-scale score of at least 2.|units on a scale|Mean|8.4|8.4|Standard Deviation|1.4|1.4|||
3627001|NCT02618759|3476163|B3||Severe|Baseline Investigator's Global Assessment (IGA) Score|IGA is an overall assessment of the severity of a patient's case of plaque psoriasis, rated 0 to 5 as detailed in Appendix C of the protocol. A higher value represents a more severe case of plaque psoriasis.|Participants|Count of Participants|0|0.0||||||
3627002|NCT02618759|3476164|B2||Severe|Baseline Investigator's Global Assessment (IGA) Score|IGA is an overall assessment of the severity of a patient's case of plaque psoriasis, rated 0 to 5 as detailed in Appendix C of the protocol. A higher value represents a more severe case of plaque psoriasis.|Participants|Count of Participants|0|0.0||||||
3627003|NCT02618759|3476165|B1||Severe|Baseline Investigator's Global Assessment (IGA) Score|IGA is an overall assessment of the severity of a patient's case of plaque psoriasis, rated 0 to 5 as detailed in Appendix C of the protocol. A higher value represents a more severe case of plaque psoriasis.|Participants|Count of Participants|0|0.0||||||
3627004|NCT02618759|3476163|B3||Moderate|Baseline Investigator's Global Assessment (IGA) Score|IGA is an overall assessment of the severity of a patient's case of plaque psoriasis, rated 0 to 5 as detailed in Appendix C of the protocol. A higher value represents a more severe case of plaque psoriasis.|Participants|Count of Participants|93|93.0||||||
3627005|NCT02618759|3476164|B2||Moderate|Baseline Investigator's Global Assessment (IGA) Score|IGA is an overall assessment of the severity of a patient's case of plaque psoriasis, rated 0 to 5 as detailed in Appendix C of the protocol. A higher value represents a more severe case of plaque psoriasis.|Participants|Count of Participants|49|49.0||||||
3627006|NCT02618759|3476165|B1||Moderate|Baseline Investigator's Global Assessment (IGA) Score|IGA is an overall assessment of the severity of a patient's case of plaque psoriasis, rated 0 to 5 as detailed in Appendix C of the protocol. A higher value represents a more severe case of plaque psoriasis.|Participants|Count of Participants|44|44.0||||||
3627007|NCT02618759|3476163|B3||Mild|Baseline Investigator's Global Assessment (IGA) Score|IGA is an overall assessment of the severity of a patient's case of plaque psoriasis, rated 0 to 5 as detailed in Appendix C of the protocol. A higher value represents a more severe case of plaque psoriasis.|Participants|Count of Participants|26|26.0||||||
3627008|NCT02618759|3476164|B2||Mild|Baseline Investigator's Global Assessment (IGA) Score|IGA is an overall assessment of the severity of a patient's case of plaque psoriasis, rated 0 to 5 as detailed in Appendix C of the protocol. A higher value represents a more severe case of plaque psoriasis.|Participants|Count of Participants|10|10.0||||||
3627009|NCT02618759|3476165|B1||Mild|Baseline Investigator's Global Assessment (IGA) Score|IGA is an overall assessment of the severity of a patient's case of plaque psoriasis, rated 0 to 5 as detailed in Appendix C of the protocol. A higher value represents a more severe case of plaque psoriasis.|Participants|Count of Participants|16|16.0||||||
3627010|NCT02618759|3476163|B3||Minimal|Baseline Investigator's Global Assessment (IGA) Score|IGA is an overall assessment of the severity of a patient's case of plaque psoriasis, rated 0 to 5 as detailed in Appendix C of the protocol. A higher value represents a more severe case of plaque psoriasis.|Participants|Count of Participants|0|0.0||||||
3627061|NCT02618512|3476182|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3627011|NCT02618759|3476164|B2||Minimal|Baseline Investigator's Global Assessment (IGA) Score|IGA is an overall assessment of the severity of a patient's case of plaque psoriasis, rated 0 to 5 as detailed in Appendix C of the protocol. A higher value represents a more severe case of plaque psoriasis.|Participants|Count of Participants|0|0.0||||||
3627012|NCT02618759|3476165|B1||Minimal|Baseline Investigator's Global Assessment (IGA) Score|IGA is an overall assessment of the severity of a patient's case of plaque psoriasis, rated 0 to 5 as detailed in Appendix C of the protocol. A higher value represents a more severe case of plaque psoriasis.|Participants|Count of Participants|0|0.0||||||
3627013|NCT02618759|3476163|B3||Clear|Baseline Investigator's Global Assessment (IGA) Score|IGA is an overall assessment of the severity of a patient's case of plaque psoriasis, rated 0 to 5 as detailed in Appendix C of the protocol. A higher value represents a more severe case of plaque psoriasis.|Participants|Count of Participants|0|0.0||||||
3627014|NCT02618759|3476164|B2||Clear|Baseline Investigator's Global Assessment (IGA) Score|IGA is an overall assessment of the severity of a patient's case of plaque psoriasis, rated 0 to 5 as detailed in Appendix C of the protocol. A higher value represents a more severe case of plaque psoriasis.|Participants|Count of Participants|0|0.0||||||
3627015|NCT02618759|3476165|B1||Clear|Baseline Investigator's Global Assessment (IGA) Score|IGA is an overall assessment of the severity of a patient's case of plaque psoriasis, rated 0 to 5 as detailed in Appendix C of the protocol. A higher value represents a more severe case of plaque psoriasis.|Participants|Count of Participants|0|0.0||||||
3627016|NCT02618759|3476163|B3|||%BSA Affected with Psoriasis||percent of BSA|Mean|7.3|7.3|Standard Deviation|1.6|1.6|||
3627017|NCT02618759|3476164|B2|||%BSA Affected with Psoriasis||percent of BSA|Mean|7.5|7.5|Standard Deviation|1.7|1.7|||
3627018|NCT02618759|3476165|B1|||%BSA Affected with Psoriasis||percent of BSA|Mean|7.2|7.2|Standard Deviation|1.5|1.5|||
3627019|NCT02618759|3476163|B3|||Baseline Total BSA||meters squared|Mean|2.0|2.0|Standard Deviation|0.3|0.3|||
3627020|NCT02618759|3476164|B2|||Baseline Total BSA||meters squared|Mean|2.0|2.0|Standard Deviation|0.3|0.3|||
3627021|NCT02618759|3476165|B1|||Baseline Total BSA||meters squared|Mean|2.0|2.0|Standard Deviation|0.3|0.3|||
3627022|NCT02618759|3476163|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3627023|NCT02618759|3476164|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3627024|NCT02618759|3476165|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627025|NCT02618759|3476163|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627026|NCT02618759|3476164|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627027|NCT02618759|3476165|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627028|NCT02618759|3476163|B3||White|Race (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
3627029|NCT02618759|3476164|B2||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3627030|NCT02618759|3476165|B1||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3627031|NCT02618759|3476163|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3627032|NCT02618759|3476164|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3627033|NCT02618759|3476165|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3627034|NCT02618759|3476163|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627035|NCT02618759|3476164|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627036|NCT02618759|3476165|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627037|NCT02618759|3476163|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627038|NCT02618759|3476164|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627039|NCT02618759|3476165|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627040|NCT02618759|3476163|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627041|NCT02618759|3476164|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627042|NCT02618759|3476165|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627043|NCT02618759|3476163|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627044|NCT02618759|3476164|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627045|NCT02618759|3476165|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627046|NCT02618759|3476163|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3627047|NCT02618759|3476164|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3627048|NCT02618759|3476165|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3627049|NCT02618759|3476163|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3627050|NCT02618759|3476164|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3627051|NCT02618759|3476165|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3627052|NCT02618759|3476163|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3627053|NCT02618759|3476164|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3627054|NCT02618759|3476165|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3627055|NCT02618759|3476163|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3627056|NCT02618759|3476164|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3627057|NCT02618759|3476165|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3627058|NCT02618759|3476163|B3|||Age||years|Mean|55.4|55.4|Standard Deviation|14.8|14.8|||
3627062|NCT02618512|3476182|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627063|NCT02618512|3476182|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627064|NCT02618512|3476182|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3627065|NCT02618512|3476182|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627066|NCT02618512|3476182|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627067|NCT02618512|3476182|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627068|NCT02618512|3476182|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627069|NCT02618512|3476182|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627070|NCT02618512|3476182|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3627071|NCT02618512|3476182|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627072|NCT02618512|3476182|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3627073|NCT02618512|3476182|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3627074|NCT02618512|3476182|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3627075|NCT02618512|3476182|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3627076|NCT02618512|3476182|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3627077|NCT02617901|3476186|B1|United Kingdom||Region of Enrollment|Children presenting to Sheffield Children's Hospital Endocrine Clinic and who required a left hand and wrist radiograph for bone age estimation.|participants|Number|20|20.0||||||
3627078|NCT02617901|3476186|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3627079|NCT02617901|3476186|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3627080|NCT02617901|3476186|B1||>=65 years|Age|1 male and 1 female recruited from each of 5 age groups (<5, 5-7, 8-10, 11-13 and 14-16 years)|Participants|Count of Participants|0|0.0||||||
3627081|NCT02617901|3476186|B1||Between 18 and 65 years|Age|1 male and 1 female recruited from each of 5 age groups (<5, 5-7, 8-10, 11-13 and 14-16 years)|Participants|Count of Participants|0|0.0||||||
3627082|NCT02617901|3476186|B1||<=18 years|Age|1 male and 1 female recruited from each of 5 age groups (<5, 5-7, 8-10, 11-13 and 14-16 years)|Participants|Count of Participants|20|20.0||||||
3627083|NCT02617888|3476190|B4|||Heart rate (beats/min)||beats/min|Mean|55.7|55.7|Standard Deviation|6.6|6.6|||
3627084|NCT02617888|3476191|B3|||Heart rate (beats/min)||beats/min|Mean|64|64.0|Standard Deviation|9|9.0|||
3627085|NCT02617888|3476192|B2|||Heart rate (beats/min)||beats/min|Mean|56.2|56.2|Standard Deviation|7.4|7.4|||
3627086|NCT02617888|3476193|B1|||Heart rate (beats/min)||beats/min|Mean|55.2|55.2|Standard Deviation|5.6|5.6|||
3627087|NCT02617888|3476190|B4|||Current smokers||Participants|Count of Participants|27|27.0||||||
3627088|NCT02617888|3476191|B3|||Current smokers||Participants|Count of Participants|15|15.0||||||
3627089|NCT02617888|3476192|B2|||Current smokers||Participants|Count of Participants|7|7.0||||||
3627090|NCT02617888|3476193|B1|||Current smokers||Participants|Count of Participants|5|5.0||||||
3627091|NCT02617888|3476190|B4|||Chest circumference (cm)||cm|Mean|97.7|97.7|Standard Deviation|11.1|11.1|||
3627092|NCT02617888|3476191|B3|||Chest circumference (cm)||cm|Mean|97.7|97.7|Standard Deviation|11|11.0|||
3627093|NCT02617888|3476192|B2|||Chest circumference (cm)||cm|Mean|97.8|97.8|Standard Deviation|10.5|10.5|||
3627094|NCT02617888|3476193|B1|||Chest circumference (cm)||cm|Mean|97.6|97.6|Standard Deviation|11.7|11.7|||
3627095|NCT02617888|3476190|B4|||BMI (kg/m^2)||kg/m^2|Mean|27.9|27.9|Standard Deviation|5.5|5.5|||
3627096|NCT02617888|3476191|B3|||BMI (kg/m^2)||kg/m^2|Mean|27.3|27.3|Standard Deviation|5|5.0|||
3627097|NCT02617888|3476192|B2|||BMI (kg/m^2)||kg/m^2|Mean|28.1|28.1|Standard Deviation|4.5|4.5|||
3627098|NCT02617888|3476193|B1|||BMI (kg/m^2)||kg/m^2|Mean|27.6|27.6|Standard Deviation|6.3|6.3|||
3627099|NCT02617888|3476190|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3627100|NCT02617888|3476191|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3627101|NCT02617888|3476192|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627102|NCT02617888|3476193|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627103|NCT02617888|3476190|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|209|209.0||||||
3627104|NCT02617888|3476191|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
3627105|NCT02617888|3476192|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3627106|NCT02617888|3476193|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3627107|NCT02617888|3476190|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3627108|NCT02617888|3476191|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3627109|NCT02617888|3476192|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3627110|NCT02617888|3476193|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3627111|NCT02617888|3476190|B4||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3627112|NCT02617888|3476191|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3627113|NCT02617888|3476192|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3627114|NCT02617888|3476193|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3627115|NCT02617888|3476190|B4||Female|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
3627116|NCT02617888|3476191|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3627119|NCT02617888|3476190|B4|||Age||years|Mean|52|52.0|Standard Deviation|14|14.0|||
3627120|NCT02617888|3476191|B3|||Age||years|Mean|51|51.0|Standard Deviation|12|12.0|||
3627121|NCT02617888|3476192|B2|||Age||years|Mean|51|51.0|Standard Deviation|14|14.0|||
3627122|NCT02617888|3476193|B1|||Age||years|Mean|52|52.0|Standard Deviation|14|14.0|||
3627123|NCT02617784|3476202|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3627124|NCT02617784|3476203|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3627125|NCT02617784|3476204|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3627126|NCT02617784|3476202|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3627127|NCT02617784|3476203|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3627128|NCT02617784|3476204|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3627129|NCT02617784|3476202|B3|||Age||years|Mean|51.21|51.21|Standard Deviation|13.87|13.87|||
3627130|NCT02617784|3476203|B2|||Age||years|Mean|54.42|54.42|Standard Deviation|14.30|14.3|||
3627131|NCT02617784|3476204|B1|||Age||years|Mean|48.00|48.0|Standard Deviation|13.23|13.23|||
3627132|NCT02617667|3476252|B5||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3627133|NCT02617667|3476253|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3627134|NCT02617667|3476254|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3627135|NCT02617667|3476255|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3627136|NCT02617667|3476256|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3627137|NCT02617667|3476252|B5||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3627138|NCT02617667|3476253|B4||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3627139|NCT02617667|3476254|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3627140|NCT02617667|3476255|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3627141|NCT02617667|3476256|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3627142|NCT02617667|3476252|B5|||Age||years|Mean|62.4|62.4|Standard Deviation|11.36|11.36|||
3627143|NCT02617667|3476253|B4|||Age||years|Mean|62.8|62.8|Standard Deviation|11.20|11.2|||
3627144|NCT02617667|3476254|B3|||Age||years|Mean|61.3|61.3|Standard Deviation|10.45|10.45|||
3627145|NCT02617667|3476255|B2|||Age||years|Mean|61.1|61.1|Standard Deviation|12.29|12.29|||
3627146|NCT02617667|3476256|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|10.72|10.72|||
3627147|NCT02616523|3476271|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3627148|NCT02616523|3476272|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3627149|NCT02616523|3476273|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3627150|NCT02616523|3476274|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3627151|NCT02616523|3476271|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3627152|NCT02616523|3476272|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3627153|NCT02616523|3476273|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3627154|NCT02616523|3476274|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3627155|NCT02616523|3476271|B4|||Age||years|Mean|62|62.0|Standard Deviation|12|12.0|||
3627156|NCT02616523|3476272|B3|||Age||years|Mean|58|58.0|Standard Deviation|12|12.0|||
3627157|NCT02616523|3476273|B2|||Age||years|Mean|61|61.0|Standard Deviation|11|11.0|||
3627158|NCT02616523|3476274|B1|||Age||years|Mean|66|66.0|Standard Deviation|12|12.0|||
3627159|NCT02616250|3476290|B3||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3627160|NCT02616250|3476291|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3627161|NCT02616250|3476292|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3627162|NCT02616250|3476290|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3627163|NCT02616250|3476291|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3627164|NCT02616250|3476292|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3627165|NCT02616250|3476290|B3|||Age||years|Mean|50.0|50.0|Standard Deviation|14.2|14.2|||
3627166|NCT02616250|3476291|B2|||Age||years|Mean|48.0|48.0|Standard Deviation|13.6|13.6|||
3627167|NCT02616250|3476292|B1|||Age||years|Mean|51.0|51.0|Standard Deviation|14.8|14.8|||
3627168|NCT02615990|3476299|B3|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3627169|NCT02615990|3476300|B2|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3627170|NCT02615990|3476301|B1|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3627171|NCT02615990|3476299|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3627172|NCT02615990|3476299|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3627173|NCT02615990|3476300|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3627174|NCT02615990|3476301|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3627175|NCT02615990|3476299|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3627176|NCT02615990|3476300|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3627177|NCT02615990|3476301|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3627178|NCT02615990|3476299|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3627179|NCT02615990|3476300|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3627180|NCT02615990|3476301|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3627181|NCT02615990|3476299|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3627182|NCT02615990|3476300|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3627183|NCT02615990|3476301|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3627184|NCT02615990|3476299|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3627185|NCT02615990|3476300|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3627186|NCT02615990|3476301|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3627187|NCT02615743|3476346|B3|||Prior asthma-related hospitalizations in year before enrollment, mean (std)||hospitalizations|Mean|0.4|0.4|Standard Deviation|0.7|0.7|||
3627188|NCT02615743|3476347|B2|||Prior asthma-related hospitalizations in year before enrollment, mean (std)||hospitalizations|Mean|0.5|0.5|Standard Deviation|0.8|0.8|||
3627189|NCT02615743|3476348|B1|||Prior asthma-related hospitalizations in year before enrollment, mean (std)||hospitalizations|Mean|0.3|0.3|Standard Deviation|0.6|0.6|||
3627190|NCT02615743|3476346|B3|||Prior asthma-related emergency department visits in year before enrollment, mean (std)||visits|Mean|1.0|1.0|Standard Deviation|1.5|1.5|||
3627191|NCT02615743|3476347|B2|||Prior asthma-related emergency department visits in year before enrollment, mean (std)||visits|Mean|1.0|1.0|Standard Deviation|1.6|1.6|||
3627192|NCT02615743|3476348|B1|||Prior asthma-related emergency department visits in year before enrollment, mean (std)||visits|Mean|1.0|1.0|Standard Deviation|1.5|1.5|||
3627193|NCT02615743|3476346|B3|||Baseline adherence intent , mean (std)|Participants indicate, on a scale of 0-10, how much controller medication their child will take in the next month. 10 means they intend to take every single dose of medication (100%), 5 means half, and 0 means that they intend to not take any medication.|percentage of intended medication|Mean|85|85.0|Standard Deviation|21|21.0|||
3627194|NCT02615743|3476347|B2|||Baseline adherence intent , mean (std)|Participants indicate, on a scale of 0-10, how much controller medication their child will take in the next month. 10 means they intend to take every single dose of medication (100%), 5 means half, and 0 means that they intend to not take any medication.|percentage of intended medication|Mean|85|85.0|Standard Deviation|21|21.0|||
3627195|NCT02615743|3476348|B1|||Baseline adherence intent , mean (std)|Participants indicate, on a scale of 0-10, how much controller medication their child will take in the next month. 10 means they intend to take every single dose of medication (100%), 5 means half, and 0 means that they intend to not take any medication.|percentage of intended medication|Mean|80|80.0|Standard Deviation|23|23.0|||
3627196|NCT02615743|3476346|B3|||Baseline prior adherence (caregiver-reported), mean (std)|Participants indicate, on a scale of 0-10, how much controller medication their child took in the last month. 10 means they took every single dose of medication (100%), 5 means half, and 0 means that their child took no medication.|percentage of medication taken|Mean|64|64.0|Standard Deviation|24|24.0|||
3627197|NCT02615743|3476347|B2|||Baseline prior adherence (caregiver-reported), mean (std)|Participants indicate, on a scale of 0-10, how much controller medication their child took in the last month. 10 means they took every single dose of medication (100%), 5 means half, and 0 means that their child took no medication.|percentage of medication taken|Mean|62|62.0|Standard Deviation|25|25.0|||
3627198|NCT02615743|3476348|B1|||Baseline prior adherence (caregiver-reported), mean (std)|Participants indicate, on a scale of 0-10, how much controller medication their child took in the last month. 10 means they took every single dose of medication (100%), 5 means half, and 0 means that their child took no medication.|percentage of medication taken|Mean|65|65.0|Standard Deviation|23|23.0|||
3627199|NCT02615743|3476346|B3|||Baseline child Asthma Control Test|Asthma Control Test (ACT) provides a numerical score to determine if asthma symptoms are well controlled. The scores range from 5 (poor control of asthma) to 25 (complete control of asthma), with higher scores reflecting greater asthma control. An ACT score >19 indicates well controlled asthma.|units on a scale|Mean|17.3|17.3|Standard Deviation|4.4|4.4|||
3627200|NCT02615743|3476347|B2|||Baseline child Asthma Control Test|Asthma Control Test (ACT) provides a numerical score to determine if asthma symptoms are well controlled. The scores range from 5 (poor control of asthma) to 25 (complete control of asthma), with higher scores reflecting greater asthma control. An ACT score >19 indicates well controlled asthma.|units on a scale|Mean|17.2|17.2|Standard Deviation|4.7|4.7|||
3627201|NCT02615743|3476348|B1|||Baseline child Asthma Control Test|Asthma Control Test (ACT) provides a numerical score to determine if asthma symptoms are well controlled. The scores range from 5 (poor control of asthma) to 25 (complete control of asthma), with higher scores reflecting greater asthma control. An ACT score >19 indicates well controlled asthma.|units on a scale|Mean|17.8|17.8|Standard Deviation|4.3|4.3|||
3627202|NCT02615743|3476346|B3|||Baseline Caregiver Asthma Knowledge Questionnaire|The minimum score is a 0 and the maximum is 100. Higher values are better scores meaning better Asthma knowledge.|percentage score|Mean|93|93.0|Standard Deviation|8.5|8.5|||
3627203|NCT02615743|3476347|B2|||Baseline Caregiver Asthma Knowledge Questionnaire|The minimum score is a 0 and the maximum is 100. Higher values are better scores meaning better Asthma knowledge.|percentage score|Mean|92|92.0|Standard Deviation|8.4|8.4|||
3627204|NCT02615743|3476348|B1|||Baseline Caregiver Asthma Knowledge Questionnaire|The minimum score is a 0 and the maximum is 100. Higher values are better scores meaning better Asthma knowledge.|percentage score|Mean|93|93.0|Standard Deviation|8.7|8.7|||
3627205|NCT02615743|3476346|B3||public|Child Health Insurance||Participants|Count of Participants|36|36.0||||||
3627206|NCT02615743|3476347|B2||public|Child Health Insurance||Participants|Count of Participants|16|16.0||||||
3627207|NCT02615743|3476348|B1||public|Child Health Insurance||Participants|Count of Participants|20|20.0||||||
3627208|NCT02615743|3476346|B3||private|Child Health Insurance||Participants|Count of Participants|5|5.0||||||
3627209|NCT02615743|3476347|B2||private|Child Health Insurance||Participants|Count of Participants|4|4.0||||||
3627210|NCT02615743|3476348|B1||private|Child Health Insurance||Participants|Count of Participants|1|1.0||||||
3627211|NCT02615743|3476346|B3||>$30,000|Family Income Level||Participants|Count of Participants|14|14.0||||||
3627212|NCT02615743|3476347|B2||>$30,000|Family Income Level||Participants|Count of Participants|8|8.0||||||
3627213|NCT02615743|3476348|B1||>$30,000|Family Income Level||Participants|Count of Participants|6|6.0||||||
3627214|NCT02615743|3476346|B3||<$30,000|Family Income Level||Participants|Count of Participants|27|27.0||||||
3627215|NCT02615743|3476347|B2||<$30,000|Family Income Level||Participants|Count of Participants|12|12.0||||||
3627216|NCT02615743|3476348|B1||<$30,000|Family Income Level||Participants|Count of Participants|15|15.0||||||
3627217|NCT02615743|3476346|B3|Some College and above||Primary Caregiver Education||primary caregiver of participant|Number|20|20.0||||||
3627218|NCT02615743|3476347|B2|Some College and above||Primary Caregiver Education||primary caregiver of participant|Number|13|13.0||||||
3627219|NCT02615743|3476348|B1|Some College and above||Primary Caregiver Education||primary caregiver of participant|Number|7|7.0||||||
3627220|NCT02615743|3476346|B3|High School or less||Primary Caregiver Education||primary caregiver of participant|Number|21|21.0||||||
3627221|NCT02615743|3476347|B2|High School or less||Primary Caregiver Education||primary caregiver of participant|Number|7|7.0||||||
3627222|NCT02615743|3476348|B1|High School or less||Primary Caregiver Education||primary caregiver of participant|Number|14|14.0||||||
3627223|NCT02615743|3476346|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3627224|NCT02615743|3476347|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3627225|NCT02615743|3476348|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3627226|NCT02615743|3476346|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
3627227|NCT02615743|3476347|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3627228|NCT02615743|3476348|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3627229|NCT02615743|3476346|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3627230|NCT02615743|3476347|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3627231|NCT02615743|3476348|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3627232|NCT02615743|3476346|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3627233|NCT02615743|3476347|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3627234|NCT02615743|3476348|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3627235|NCT02615743|3476346|B3|||Age||years|Mean|5.9|5.9|Standard Deviation|2.1|2.1|||
3627236|NCT02615743|3476347|B2|||Age||years|Mean|5.8|5.8|Standard Deviation|2.1|2.1|||
3627237|NCT02615743|3476348|B1|||Age||years|Mean|6.1|6.1|Standard Deviation|2.1|2.1|||
3627238|NCT02615717|3476361|B3|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3627239|NCT02615717|3476362|B2|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3627240|NCT02615717|3476363|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3627241|NCT02615717|3476361|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627242|NCT02615717|3476362|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627243|NCT02615717|3476363|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627244|NCT02615717|3476361|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627245|NCT02615717|3476362|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627246|NCT02615717|3476363|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627247|NCT02615717|3476361|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3627248|NCT02615717|3476362|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3627249|NCT02615717|3476363|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3627250|NCT02615717|3476361|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627251|NCT02615717|3476362|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627252|NCT02615717|3476363|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627253|NCT02615717|3476361|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627254|NCT02615717|3476362|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627255|NCT02615717|3476363|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627256|NCT02615717|3476361|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3627257|NCT02615717|3476362|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3627258|NCT02615717|3476363|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627259|NCT02615717|3476361|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627260|NCT02615717|3476362|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627261|NCT02615717|3476363|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627262|NCT02615717|3476361|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3627263|NCT02615717|3476362|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3627264|NCT02615717|3476363|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3627265|NCT02615717|3476361|B3||Female|Gender||Participants|Count of Participants|6|6.0||||||
3627266|NCT02615717|3476362|B2||Female|Gender||Participants|Count of Participants|3|3.0||||||
3627267|NCT02615717|3476363|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
3627268|NCT02615717|3476361|B3|||Age||years|Mean|20.7|20.7|Standard Deviation|2.2|2.2|||
3627269|NCT02615717|3476362|B2|||Age||years|Mean|21.7|21.7|Standard Deviation|2.9|2.9|||
3627270|NCT02615717|3476363|B1|||Age||years|Mean|19.7|19.7|Standard Deviation|1.2|1.2|||
3627271|NCT02614924|3476376|B3|United Kingdom||Region of Enrollment||participants|Number|40|40.0||||||
3627272|NCT02614924|3476377|B2|United Kingdom||Region of Enrollment||participants|Number|20|20.0||||||
3627273|NCT02614924|3476378|B1|United Kingdom||Region of Enrollment||participants|Number|20|20.0||||||
3627274|NCT02614924|3476376|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3627275|NCT02614924|3476377|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3627276|NCT02614924|3476378|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3627277|NCT02614924|3476376|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3627278|NCT02614924|3476377|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3627279|NCT02614924|3476378|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3627280|NCT02614924|3476376|B3|||Age||years|Median|60.5|60.5|Full Range|||23.0|77.0|
3627281|NCT02614924|3476377|B2|||Age||years|Median|66.5|66.5|Full Range|||44.0|77.0|
3627282|NCT02614924|3476378|B1|||Age||years|Median|55.5|55.5|Full Range|||23.0|77.0|
3627283|NCT02614924|3476376|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3627284|NCT02614924|3476377|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3627285|NCT02614924|3476378|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3627286|NCT02614924|3476376|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3627287|NCT02614924|3476377|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3627288|NCT02614924|3476378|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3627289|NCT02614924|3476376|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3627290|NCT02614924|3476377|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3627291|NCT02614924|3476378|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3627292|NCT02614586|3476387|B1|Not Applicable||Female Reproductive Status|Reproductive status was not applicable for male participants.|participants|Number|6|6.0||||||
3627293|NCT02614586|3476387|B1|Have Childbearing Potential||Female Reproductive Status|Reproductive status was not applicable for male participants.|participants|Number|3|3.0||||||
3627294|NCT02614586|3476387|B1|Surgically Sterile||Female Reproductive Status|Reproductive status was not applicable for male participants.|participants|Number|1|1.0||||||
3627295|NCT02614586|3476387|B1|Postmenopausal||Female Reproductive Status|Reproductive status was not applicable for male participants.|participants|Number|1|1.0||||||
3627296|NCT02614586|3476387|B1|Did not Consume Caffeine||Caffeine Consumption||participants|Number|2|2.0||||||
3627297|NCT02614586|3476387|B1|Consumed Caffeine||Caffeine Consumption||participants|Number|9|9.0||||||
3627298|NCT02614586|3476387|B1|Current Smoker||Smoking Classification||participants|Number|5|5.0||||||
3627299|NCT02614586|3476387|B1|Never Smoked||Smoking Classification||participants|Number|6|6.0||||||
3627300|NCT02614586|3476387|B1|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|29.93|29.93|Standard Deviation|4.929|4.929|||
3627301|NCT02614586|3476387|B1|||Weight||kilogram (kg)|Mean|87.75|87.75|Standard Deviation|19.351|19.351|||
3627302|NCT02614586|3476387|B1|||Height||centimeter (cm)|Mean|170.7|170.7|Standard Deviation|12.39|12.39|||
3627303|NCT02614586|3476387|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3627304|NCT02614586|3476387|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3627305|NCT02614586|3476387|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3627306|NCT02614586|3476387|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3627307|NCT02614586|3476387|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3627308|NCT02614586|3476387|B1|||Age||years|Mean|46.5|46.5|Standard Deviation|4.63|4.63|||
3627309|NCT02614469|3476392|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
3627310|NCT02614469|3476393|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3627311|NCT02614469|3476394|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3627312|NCT02614469|3476392|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3627313|NCT02614469|3476393|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3627314|NCT02614469|3476394|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3627315|NCT02614469|3476392|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3627316|NCT02614469|3476393|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3627317|NCT02614469|3476394|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3627318|NCT02614469|3476392|B3|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3627319|NCT02614469|3476393|B2|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3627320|NCT02614469|3476394|B1|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3627321|NCT02614469|3476392|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3627322|NCT02614469|3476393|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3627323|NCT02614469|3476394|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3627324|NCT02614469|3476392|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3627325|NCT02614469|3476393|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3627326|NCT02614469|3476394|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3627327|NCT02614469|3476392|B3|||Age||years|Mean|38.06|38.06|Standard Deviation|12.44|12.44|||
3627328|NCT02614469|3476393|B2|||Age||years|Mean|34.67|34.67|Standard Deviation|5.92|5.92|||
3627329|NCT02614469|3476394|B1|||Age||years|Mean|41.44|41.44|Standard Deviation|16.37|16.37|||
3627330|NCT02614274|3476423|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3627331|NCT02614274|3476423|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3627332|NCT02614274|3476423|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3627333|NCT02614274|3476423|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3627334|NCT02614274|3476423|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3627335|NCT02614274|3476423|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3627336|NCT02614222|3476432|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
3627337|NCT02614222|3476433|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3627338|NCT02614222|3476434|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3627339|NCT02614222|3476432|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3627340|NCT02614222|3476433|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3627341|NCT02614222|3476434|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3627342|NCT02614222|3476432|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3627343|NCT02614222|3476433|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3627344|NCT02614222|3476434|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3627345|NCT02614222|3476432|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3627346|NCT02614222|3476433|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3627347|NCT02614222|3476434|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3627348|NCT02614222|3476432|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3627349|NCT02614222|3476433|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3627350|NCT02614222|3476434|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3627351|NCT02614222|3476432|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3627352|NCT02614222|3476433|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3627353|NCT02614222|3476434|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3627354|NCT02614183|3476455|B4|||Migraine Headache Days (MHD) per month|Migraine Headache Day (MHD): A calendar day on which a migraine headache or probable migraine headache occurred.|Days per Month|Mean|9.13|9.13|Standard Deviation|2.97|2.97|||
3627355|NCT02614183|3476456|B3|||Migraine Headache Days (MHD) per month|Migraine Headache Day (MHD): A calendar day on which a migraine headache or probable migraine headache occurred.|Days per Month|Mean|9.14|9.14|Standard Deviation|2.91|2.91|||
3627356|NCT02614183|3476457|B2|||Migraine Headache Days (MHD) per month|Migraine Headache Day (MHD): A calendar day on which a migraine headache or probable migraine headache occurred.|Days per Month|Mean|9.21|9.21|Standard Deviation|3.05|3.05|||
3627357|NCT02614183|3476458|B1|||Migraine Headache Days (MHD) per month|Migraine Headache Day (MHD): A calendar day on which a migraine headache or probable migraine headache occurred.|Days per Month|Mean|9.08|9.08|Standard Deviation|2.97|2.97|||
3627358|NCT02614183|3476455|B4|United States||Region of Enrollment||Participants|Count of Participants|753|753.0||||||
3627359|NCT02614183|3476456|B3|United States||Region of Enrollment||Participants|Count of Participants|187|187.0||||||
3627360|NCT02614183|3476457|B2|United States||Region of Enrollment||Participants|Count of Participants|188|188.0||||||
3627361|NCT02614183|3476458|B1|United States||Region of Enrollment||Participants|Count of Participants|378|378.0||||||
3627362|NCT02614183|3476455|B4|Puerto Rico||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3627363|NCT02614183|3476456|B3|Puerto Rico||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3627364|NCT02614183|3476457|B2|Puerto Rico||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3627365|NCT02614183|3476458|B1|Puerto Rico||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3627366|NCT02614183|3476455|B4|Canada||Region of Enrollment||Participants|Count of Participants|85|85.0||||||
3627367|NCT02614183|3476456|B3|Canada||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3627368|NCT02614183|3476457|B2|Canada||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3627369|NCT02614183|3476458|B1|Canada||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3627370|NCT02614183|3476455|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627371|NCT02614183|3476456|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627372|NCT02614183|3476457|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627373|NCT02614183|3476458|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627374|NCT02614183|3476455|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3627375|NCT02614183|3476456|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3627376|NCT02614183|3476457|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3627377|NCT02614183|3476458|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3627378|NCT02614183|3476455|B4||White|Race (NIH/OMB)||Participants|Count of Participants|690|690.0||||||
3627379|NCT02614183|3476456|B3||White|Race (NIH/OMB)||Participants|Count of Participants|165|165.0||||||
3627380|NCT02614183|3476457|B2||White|Race (NIH/OMB)||Participants|Count of Participants|169|169.0||||||
3627381|NCT02614183|3476458|B1||White|Race (NIH/OMB)||Participants|Count of Participants|356|356.0||||||
3627382|NCT02614183|3476455|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3627383|NCT02614183|3476456|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3627384|NCT02614183|3476457|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3627385|NCT02614183|3476458|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3627386|NCT02614183|3476455|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3627387|NCT02614183|3476456|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3627388|NCT02614183|3476457|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627389|NCT02614183|3476458|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3627390|NCT02614183|3476455|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3627391|NCT02614183|3476456|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3627392|NCT02614183|3476457|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3627393|NCT02614183|3476458|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3627394|NCT02614183|3476455|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3627395|NCT02614183|3476456|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3627396|NCT02614183|3476457|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627397|NCT02614183|3476458|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627398|NCT02614183|3476455|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3627399|NCT02614183|3476456|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3627400|NCT02614183|3476457|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3627401|NCT02614183|3476458|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3627402|NCT02614183|3476455|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|710|710.0||||||
3627403|NCT02614183|3476456|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|171|171.0||||||
3627404|NCT02614183|3476457|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|180|180.0||||||
3627405|NCT02614183|3476458|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|359|359.0||||||
3627406|NCT02614183|3476455|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
3627407|NCT02614183|3476456|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3627408|NCT02614183|3476457|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3627409|NCT02614183|3476458|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3627410|NCT02614183|3476455|B4||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3627411|NCT02614183|3476456|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3627412|NCT02614183|3476457|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3627413|NCT02614183|3476458|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3627414|NCT02614183|3476455|B4||Female|Sex: Female, Male||Participants|Count of Participants|718|718.0||||||
3627415|NCT02614183|3476456|B3||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
3627416|NCT02614183|3476457|B2||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
3627417|NCT02614183|3476458|B1||Female|Sex: Female, Male||Participants|Count of Participants|362|362.0||||||
3627418|NCT02614183|3476455|B4|||Age||years|Mean|40.67|40.67|Standard Deviation|11.57|11.57|||
3627419|NCT02614183|3476456|B3|||Age||years|Mean|39.07|39.07|Standard Deviation|11.52|11.52|||
3627420|NCT02614183|3476457|B2|||Age||years|Mean|40.93|40.93|Standard Deviation|11.87|11.87|||
3627421|NCT02614183|3476458|B1|||Age||years|Mean|41.33|41.33|Standard Deviation|11.40|11.4|||
3627422|NCT02614079|3476497|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3627423|NCT02614079|3476497|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3627424|NCT02614079|3476497|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3627425|NCT02614079|3476497|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3627426|NCT02614079|3476497|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3627427|NCT02613910|3476501|B1||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Gender of the one participant enrolled in this study is not provided in order to ensure protection of participant identity.
3627428|NCT02613910|3476501|B1||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Gender of the one participant enrolled in this study is not provided in order to ensure protection of participant identity.
3627429|NCT02613910|3476501|B1|||Age||Years|Mean|NA||Standard Deviation|NA||||Age of the one participant enrolled in this study is not provided in order to ensure protection of participant identity.
3627430|NCT02613871|3476550|B1||Genotype 2|HCV Genotype||Participants|Count of Participants|43|43.0||||||
3627431|NCT02613871|3476550|B1||Genotype 1b|HCV Genotype||Participants|Count of Participants|64|64.0||||||
3627432|NCT02613871|3476550|B1||Genotype 1a|HCV Genotype||Participants|Count of Participants|3|3.0||||||
3627433|NCT02613871|3476550|B1||Genotype 1|HCV Genotype||Participants|Count of Participants|1|1.0||||||
3627434|NCT02613871|3476550|B1|||Serum Lysyl oxidase-like 2 (LOXL-2)||pg/mL|Mean|98|98.0|Standard Deviation|64.4|64.4|||
3627435|NCT02613871|3476550|B1|||HBsAg||IU/mL|Mean|578.6|578.6|Standard Deviation|1113.56|1113.56|||
3627436|NCT02613871|3476550|B1|||Plasma HBV DNA||IU/mL|Mean|9423.1|9423.1|Standard Deviation|69641.90|69641.9|||
3627437|NCT02613871|3476550|B1|||Hepatitis B Virus (HBV) DNA||log10 IU/mL|Mean|2.1|2.1|Standard Deviation|0.92|0.92|||
3627438|NCT02613871|3476550|B1|||Fibroscan Score|"FibroScan® is a non-invasive device that assesses the hardness (or stiffness) of the liver using the technique of transient elastography. FibroScan® results range from 2.5 kPa to 75 kPa with higher scores indicating greater liver stiffness. Per protocol, cirrhosis status was determined as follows:~Presence of cirrhosis = FibroScan® result of > 12.5 kPa~Absence of cirrhosis = FibroScan® result of ≤ 12.5 kPa"|kPa|Mean|9.3|9.3|Standard Deviation|7.05|7.05|||
3627439|NCT02613871|3476550|B1||Presence|Cirrhosis status||Participants|Count of Participants|18|18.0||||||
3627440|NCT02613871|3476550|B1||Absence|Cirrhosis status||Participants|Count of Participants|93|93.0||||||
3627441|NCT02613871|3476550|B1||≥ 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|67|67.0||||||
3627442|NCT02613871|3476550|B1||< 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|44|44.0||||||
3627443|NCT02613871|3476550|B1|||HCV RNA||log10 IU/mL|Mean|5.9|5.9|Standard Deviation|0.73|0.73|||
3627444|NCT02613871|3476550|B1||CT|IL28b Status|CC and CT alleles are different forms of the IL28b gene.|Participants|Count of Participants|26|26.0||||||
3627445|NCT02613871|3476550|B1||CC|IL28b Status|CC and CT alleles are different forms of the IL28b gene.|Participants|Count of Participants|85|85.0||||||
3627446|NCT02613871|3476550|B1||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3627447|NCT02613871|3476550|B1||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|99|99.0||||||
3627448|NCT02613871|3476550|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|111|111.0||||||
3627449|NCT02613871|3476550|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3627450|NCT02613871|3476550|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3627451|NCT02613871|3476550|B1|||Age||years|Mean|55|55.0|Standard Deviation|9.3|9.3|||
3627452|NCT02613403|3476565|B5||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3627453|NCT02613403|3476566|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3627454|NCT02613403|3476567|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3627455|NCT02613403|3476568|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3627456|NCT02613403|3476569|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3627457|NCT02613403|3476565|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3627458|NCT02613403|3476566|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3627459|NCT02613403|3476567|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3627460|NCT02613403|3476568|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3627461|NCT02613403|3476569|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3627462|NCT02613403|3476565|B5|||Age||years|Mean|58.1|58.1|Standard Deviation|8.2|8.2|||
3627463|NCT02613403|3476566|B4|||Age||years|Mean|53.9|53.9|Standard Deviation|11.0|11.0|||
3627464|NCT02613403|3476567|B3|||Age||years|Mean|57.3|57.3|Standard Deviation|8.5|8.5|||
3627465|NCT02613403|3476568|B2|||Age||years|Mean|58.9|58.9|Standard Deviation|6.6|6.6|||
3627466|NCT02613403|3476569|B1|||Age||years|Mean|59.1|59.1|Standard Deviation|8.4|8.4|||
3627467|NCT02612610|3476615|B5||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3627468|NCT02612610|3476616|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3627469|NCT02612610|3476617|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3627470|NCT02612610|3476618|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3627471|NCT02612610|3476619|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3627472|NCT02612610|3476615|B5||Female|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
3627473|NCT02612610|3476616|B4||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3627474|NCT02612610|3476617|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3627475|NCT02612610|3476618|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3627476|NCT02612610|3476619|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3627477|NCT02612610|3476615|B5|||Age||years|Mean|60.2|60.2|Standard Deviation|9.94|9.94|||
3627478|NCT02612610|3476616|B4|||Age||years|Mean|59.3|59.3|Standard Deviation|9.19|9.19|||
3627479|NCT02612610|3476617|B3|||Age||years|Mean|61.8|61.8|Standard Deviation|9.13|9.13|||
3627480|NCT02612610|3476618|B2|||Age||years|Mean|59.9|59.9|Standard Deviation|10.46|10.46|||
3627481|NCT02612610|3476619|B1|||Age||years|Mean|60.0|60.0|Standard Deviation|10.9|10.9|||
3627482|NCT02612285|3476864|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3627483|NCT02612285|3476864|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3627484|NCT02612285|3476864|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3627485|NCT02612285|3476864|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3627486|NCT02612285|3476864|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3627487|NCT02612285|3476864|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3627488|NCT02612077|3476868|B1|France||Region of Enrollment||participants|Number|737|737.0||||||
3627489|NCT02612077|3476868|B1|Male||Gender|Gender was not recorded for two patients.|participants|Number|442|442.0||||||
3627490|NCT02612077|3476868|B1|Female||Gender|Gender was not recorded for two patients.|participants|Number|293|293.0||||||
3627491|NCT02612077|3476868|B1|||Age||years|Mean|64.5|64.5|Standard Deviation|10.9|10.9|||
3627492|NCT02612077|3476868|B1||>=65 years|Age||Participants|Count of Participants|390|390.0||||||
3627493|NCT02612077|3476868|B1||Between 18 and 65 years|Age||Participants|Count of Participants|347|347.0||||||
3627494|NCT02612077|3476868|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3627525|NCT02612064|3476878|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|230|230.0||||||
3627526|NCT02612064|3476879|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
3627527|NCT02612064|3476880|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
3627528|NCT02612064|3476878|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627495|NCT02612064|3476878|B3|||Tactile Sensitivity - Tactile Threshold at Baseline|Tactile threshold was assessed by examiner using a constant pressure probe (Yeaple probe) which allowed application of a known force to the dentin surface from 10 g to an upper threshold of 80g in increments of 10g. Tactile threshold is the maximum pressure applied at which participant do not report any pain or discomfort. Tactile threshold for each tooth was determined by asking participant whether sensation caused discomfort. The pressure setting at which participant gave two consecutive 'yes' responses was recorded as tactile threshold. Higher tactile threshold, less sensitive tooth.|gram (g)|Mean|12.39|12.39|Standard Deviation|3.053|3.053|||
3627496|NCT02612064|3476879|B2|||Tactile Sensitivity - Tactile Threshold at Baseline|Tactile threshold was assessed by examiner using a constant pressure probe (Yeaple probe) which allowed application of a known force to the dentin surface from 10 g to an upper threshold of 80g in increments of 10g. Tactile threshold is the maximum pressure applied at which participant do not report any pain or discomfort. Tactile threshold for each tooth was determined by asking participant whether sensation caused discomfort. The pressure setting at which participant gave two consecutive 'yes' responses was recorded as tactile threshold. Higher tactile threshold, less sensitive tooth.|gram (g)|Mean|12.52|12.52|Standard Deviation|3.202|3.202|||
3627497|NCT02612064|3476880|B1|||Tactile Sensitivity - Tactile Threshold at Baseline|Tactile threshold was assessed by examiner using a constant pressure probe (Yeaple probe) which allowed application of a known force to the dentin surface from 10 g to an upper threshold of 80g in increments of 10g. Tactile threshold is the maximum pressure applied at which participant do not report any pain or discomfort. Tactile threshold for each tooth was determined by asking participant whether sensation caused discomfort. The pressure setting at which participant gave two consecutive 'yes' responses was recorded as tactile threshold. Higher tactile threshold, less sensitive tooth.|gram (g)|Mean|12.26|12.26|Standard Deviation|2.905|2.905|||
3627498|NCT02612064|3476878|B3|||Schiff Sensitivity Score at Baseline|Assessed by examiner as participant's response to an evaporative (air) stimulus after stimulation of each individual tooth, scored using Schiff sensitivity scale range of 0-3; 0=Participant does not respond to air stimulation; 1=Participant responds to air stimulus but does not request discontinuation of stimulus; 2=Participant responds to air stimulus & requests discontinuation or moves from stimulus; 3=Participant responds to stimulus, considers stimulus to be painful, & requests discontinuation of stimulus. A reduction in Schiff Sensitivity score indicates improvement in sensitivity.|score on a scale|Mean|2.81|2.81|Standard Deviation|0.331|0.331|||
3627499|NCT02612064|3476879|B2|||Schiff Sensitivity Score at Baseline|Assessed by examiner as participant's response to an evaporative (air) stimulus after stimulation of each individual tooth, scored using Schiff sensitivity scale range of 0-3; 0=Participant does not respond to air stimulation; 1=Participant responds to air stimulus but does not request discontinuation of stimulus; 2=Participant responds to air stimulus & requests discontinuation or moves from stimulus; 3=Participant responds to stimulus, considers stimulus to be painful, & requests discontinuation of stimulus. A reduction in Schiff Sensitivity score indicates improvement in sensitivity.|score on a scale|Mean|2.80|2.8|Standard Deviation|0.330|0.33|||
3627500|NCT02612064|3476880|B1|||Schiff Sensitivity Score at Baseline|Assessed by examiner as participant's response to an evaporative (air) stimulus after stimulation of each individual tooth, scored using Schiff sensitivity scale range of 0-3; 0=Participant does not respond to air stimulation; 1=Participant responds to air stimulus but does not request discontinuation of stimulus; 2=Participant responds to air stimulus & requests discontinuation or moves from stimulus; 3=Participant responds to stimulus, considers stimulus to be painful, & requests discontinuation of stimulus. A reduction in Schiff Sensitivity score indicates improvement in sensitivity.|score on a scale|Mean|2.82|2.82|Standard Deviation|0.333|0.333|||
3627501|NCT02612064|3476878|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627502|NCT02612064|3476879|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627503|NCT02612064|3476880|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627504|NCT02612064|3476878|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3627505|NCT02612064|3476879|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3627506|NCT02612064|3476880|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627507|NCT02612064|3476878|B3||White|Race (NIH/OMB)||Participants|Count of Participants|224|224.0||||||
3627508|NCT02612064|3476879|B2||White|Race (NIH/OMB)||Participants|Count of Participants|112|112.0||||||
3627509|NCT02612064|3476880|B1||White|Race (NIH/OMB)||Participants|Count of Participants|112|112.0||||||
3627510|NCT02612064|3476878|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3627511|NCT02612064|3476879|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627512|NCT02612064|3476880|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3627513|NCT02612064|3476878|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627514|NCT02612064|3476879|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627515|NCT02612064|3476880|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627516|NCT02612064|3476878|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3627517|NCT02612064|3476879|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3627518|NCT02612064|3476880|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3627519|NCT02612064|3476878|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627520|NCT02612064|3476879|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627521|NCT02612064|3476880|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627522|NCT02612064|3476878|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627523|NCT02612064|3476879|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627524|NCT02612064|3476880|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627529|NCT02612064|3476879|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627530|NCT02612064|3476880|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627531|NCT02612064|3476878|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3627532|NCT02612064|3476879|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3627533|NCT02612064|3476880|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3627534|NCT02612064|3476878|B3||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3627535|NCT02612064|3476879|B2||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3627536|NCT02612064|3476880|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3627537|NCT02612064|3476878|B3|||Age||Years|Mean|40.3|40.3|Standard Deviation|8.89|8.89|||
3627538|NCT02612064|3476879|B2|||Age||Years|Mean|39.9|39.9|Standard Deviation|9.18|9.18|||
3627539|NCT02612064|3476880|B1|||Age||Years|Mean|40.7|40.7|Standard Deviation|8.62|8.62|||
3627540|NCT02611765|3476891|B3|Hispanics||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3627541|NCT02611765|3476892|B2|Hispanics||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3627542|NCT02611765|3476893|B1|Hispanics||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3627543|NCT02611765|3476891|B3|African Americans||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
3627544|NCT02611765|3476892|B2|African Americans||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3627545|NCT02611765|3476893|B1|African Americans||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3627546|NCT02611765|3476891|B3|Whites||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3627547|NCT02611765|3476892|B2|Whites||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3627548|NCT02611765|3476893|B1|Whites||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3627549|NCT02611765|3476891|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3627550|NCT02611765|3476892|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3627551|NCT02611765|3476893|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3627552|NCT02611765|3476891|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3627553|NCT02611765|3476892|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3627554|NCT02611765|3476893|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3627555|NCT02611765|3476891|B3|||Age||years|Mean|35|35.0|Standard Deviation|10|10.0|||
3627556|NCT02611765|3476892|B2|||Age||years|Mean|35|35.0|Standard Deviation|10|10.0|||
3627557|NCT02611765|3476893|B1|||Age||years|Mean|35|35.0|Standard Deviation|11|11.0|||
3627558|NCT02611154|3476900|B1|United States||Region of Enrollment|Salt Lake City, Utah, USA|participants|Number|5|5.0||||||
3627559|NCT02611154|3476900|B1|Male Participants||Sex/Gender, Customized||participants|Number|5|5.0||||||
3627560|NCT02611154|3476900|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3627561|NCT02611154|3476900|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3627562|NCT02611154|3476900|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3627563|NCT02610842|3476919|B1|Brazil||Region of Enrollment||participants|Number|22|22.0||||||
3627564|NCT02610842|3476919|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627565|NCT02610842|3476919|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3627566|NCT02610842|3476919|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3627567|NCT02610842|3476919|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627568|NCT02610842|3476919|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627569|NCT02610842|3476919|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627570|NCT02610842|3476919|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627571|NCT02610842|3476919|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3627572|NCT02610842|3476919|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3627573|NCT02610842|3476919|B1|||Age||years|Mean|48.09|48.09|Standard Deviation|11.67|11.67|||
3627574|NCT02610816|3476926|B3||Not Atopic|Atopy||Participants|Count of Participants|10|10.0||||||
3627575|NCT02610816|3476927|B2||Not Atopic|Atopy||Participants|Count of Participants|6|6.0||||||
3627576|NCT02610816|3476928|B1||Not Atopic|Atopy||Participants|Count of Participants|4|4.0||||||
3627577|NCT02610816|3476926|B3||Atopic|Atopy||Participants|Count of Participants|53|53.0||||||
3627578|NCT02610816|3476927|B2||Atopic|Atopy||Participants|Count of Participants|19|19.0||||||
3627579|NCT02610816|3476928|B1||Atopic|Atopy||Participants|Count of Participants|34|34.0||||||
3627580|NCT02610816|3476926|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3627581|NCT02610816|3476927|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3627582|NCT02610816|3476928|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3627583|NCT02610816|3476926|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3627584|NCT02610816|3476927|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3627585|NCT02610816|3476928|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3627586|NCT02610816|3476926|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|55|55.0||||||
3627587|NCT02610816|3476927|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3627588|NCT02610816|3476928|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3627589|NCT02610816|3476926|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3627590|NCT02610816|3476927|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3627591|NCT02610816|3476928|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3627592|NCT02610816|3476926|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3627593|NCT02610816|3476927|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3627594|NCT02610816|3476928|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3627595|NCT02610816|3476926|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3627596|NCT02610816|3476927|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3627597|NCT02610816|3476928|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3627598|NCT02610816|3476926|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3627599|NCT02610816|3476927|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3627600|NCT02610816|3476928|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3627601|NCT02610816|3476926|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3627602|NCT02610816|3476927|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3627603|NCT02610816|3476928|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3627604|NCT02610816|3476926|B3|||Age||Years|Mean|12.2|12.2|Standard Deviation|3.3|3.3|||
3627605|NCT02610816|3476927|B2|||Age||Years|Mean|12.1|12.1|Standard Deviation|3.7|3.7|||
3627606|NCT02610816|3476928|B1|||Age||Years|Mean|12.3|12.3|Standard Deviation|3.1|3.1|||
3627607|NCT02610634|3476952|B3|United Kingdom||Region of Enrollment||participants|Number|100|100.0||||||
3627608|NCT02610634|3476953|B2|United Kingdom||Region of Enrollment||participants|Number|40|40.0||||||
3627609|NCT02610634|3476954|B1|United Kingdom||Region of Enrollment||participants|Number|60|60.0||||||
3627610|NCT02610634|3476952|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3627611|NCT02610634|3476953|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3627612|NCT02610634|3476954|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3627613|NCT02610634|3476952|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3627614|NCT02610634|3476953|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3627615|NCT02610634|3476954|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3627616|NCT02610634|3476952|B3|||Age||years|Mean|67.4|67.4|Standard Deviation|9.0|9.0|||
3627617|NCT02610634|3476953|B2|||Age||years|Mean|66.9|66.9|Standard Deviation|10.9|10.9|||
3627618|NCT02610634|3476954|B1|||Age||years|Mean|67.8|67.8|Standard Deviation|7.6|7.6|||
3627619|NCT02609841|3476961|B3|Male||Sex/Gender, Customized||Participants|Number|135|135.0||||||
3627620|NCT02609841|3476962|B2|Male||Sex/Gender, Customized||Participants|Number|20|20.0||||||
3627621|NCT02609841|3476963|B1|Male||Sex/Gender, Customized||Participants|Number|115|115.0||||||
3627622|NCT02609841|3476961|B3|Female||Sex/Gender, Customized||Participants|Number|77|77.0||||||
3627623|NCT02609841|3476962|B2|Female||Sex/Gender, Customized||Participants|Number|13|13.0||||||
3627624|NCT02609841|3476963|B1|Female||Sex/Gender, Customized||Participants|Number|64|64.0||||||
3627625|NCT02609841|3476961|B3|||Age, Customized||Years|Mean|57.1|57.1|Standard Deviation|12.5|12.5|||
3627626|NCT02609841|3476962|B2|||Age, Customized||Years|Mean|58.5|58.5|Standard Deviation|12.4|12.4|||
3627627|NCT02609841|3476963|B1|||Age, Customized||Years|Mean|56.9|56.9|Standard Deviation|12.4|12.4|||
3627628|NCT02609672|3476969|B3|Canada||Region of Enrollment||participants|Number|24|24.0||||||
3627629|NCT02609672|3476970|B2|Canada||Region of Enrollment||participants|Number|12|12.0||||||
3627630|NCT02609672|3476971|B1|Canada||Region of Enrollment||participants|Number|12|12.0||||||
3627631|NCT02609672|3476969|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3627632|NCT02609672|3476970|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3627633|NCT02609672|3476971|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3627634|NCT02609672|3476969|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3627635|NCT02609672|3476970|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3627636|NCT02609672|3476971|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3627637|NCT02609672|3476969|B3|||Age||years|Mean|53.9|53.9|Standard Deviation|6.5|6.5|||
3627638|NCT02609672|3476970|B2|||Age||years|Mean|54.9|54.9|Standard Deviation|6.7|6.7|||
3627639|NCT02609672|3476971|B1|||Age||years|Mean|52.8|52.8|Standard Deviation|6.4|6.4|||
3627640|NCT02609672|3476969|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3627641|NCT02609672|3476970|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3627642|NCT02609672|3476971|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3627643|NCT02609672|3476969|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3627644|NCT02609672|3476970|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3627645|NCT02609672|3476971|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3627646|NCT02609672|3476969|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3627647|NCT02609672|3476970|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3627648|NCT02609672|3476971|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3627649|NCT02609659|3477006|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3627650|NCT02609659|3477006|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3627651|NCT02609659|3477006|B1|||Age||years|Mean|49.8|49.8|Standard Deviation|13.03|13.03|||
3627652|NCT02609633|3477014|B3|||Diabetes-Related Distress According to the PAID Child and Teen (C&T) Parent Questionnaire Score|"The PAID Questionnaire encompassed 26 items. Score for each question ranges from 1-2 = Not a Problem to 5-6 = Big Problem (Child version) or 1-2 = Not a Problem to 5-6 = Serious Problem (Teen or Parent versions). The derived total score (26 questions) ranges between 26 and 156, where higher score indicates worsened condition."|Score on a Scale|Mean|69.1|69.1|Standard Deviation|23.40|23.4|||
3627653|NCT02609633|3477015|B2|||Diabetes-Related Distress According to the PAID Child and Teen (C&T) Parent Questionnaire Score|"The PAID Questionnaire encompassed 26 items. Score for each question ranges from 1-2 = Not a Problem to 5-6 = Big Problem (Child version) or 1-2 = Not a Problem to 5-6 = Serious Problem (Teen or Parent versions). The derived total score (26 questions) ranges between 26 and 156, where higher score indicates worsened condition."|Score on a Scale|Mean|71.1|71.1|Standard Deviation|24.53|24.53|||
3627654|NCT02609633|3477016|B1|||Diabetes-Related Distress According to the PAID Child and Teen (C&T) Parent Questionnaire Score|"The PAID Questionnaire encompassed 26 items. Score for each question ranges from 1-2 = Not a Problem to 5-6 = Big Problem (Child version) or 1-2 = Not a Problem to 5-6 = Serious Problem (Teen or Parent versions). The derived total score (26 questions) ranges between 26 and 156, where higher score indicates worsened condition."|Score on a Scale|Mean|66.2|66.2|Standard Deviation|21.72|21.72|||
3627655|NCT02609633|3477014|B3|Ethnicity|Hispanic/latino:No|Race/Ethnicity, Customized||Participants|Count of Participants|72|72.0||||||
3627656|NCT02609633|3477015|B2|Ethnicity|Hispanic/latino:No|Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3627657|NCT02609633|3477016|B1|Ethnicity|Hispanic/latino:No|Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3627658|NCT02609633|3477014|B3|Ethnicity|Hispanic/latino:Yes|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3627659|NCT02609633|3477015|B2|Ethnicity|Hispanic/latino:Yes|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3627660|NCT02609633|3477016|B1|Ethnicity|Hispanic/latino:Yes|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3627661|NCT02609633|3477014|B3|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3627662|NCT02609633|3477015|B2|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3627663|NCT02609633|3477016|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3627664|NCT02609633|3477014|B3|Race|Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3627665|NCT02609633|3477015|B2|Race|Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3627666|NCT02609633|3477016|B1|Race|Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3627667|NCT02609633|3477014|B3|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3627668|NCT02609633|3477015|B2|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3627669|NCT02609633|3477016|B1|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3627670|NCT02609633|3477014|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|58|58.0||||||
3627671|NCT02609633|3477015|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3627672|NCT02609633|3477016|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3627673|NCT02609633|3477014|B3|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3627674|NCT02609633|3477015|B2|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3627675|NCT02609633|3477016|B1|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3627676|NCT02609633|3477014|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3627677|NCT02609633|3477015|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3627678|NCT02609633|3477016|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3627679|NCT02609633|3477014|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3627680|NCT02609633|3477015|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3627681|NCT02609633|3477016|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3627682|NCT02609633|3477014|B3|||Age||years|Mean|12.9|12.9|Standard Deviation|3.04|3.04|||
3627683|NCT02609633|3477015|B2|||Age||years|Mean|12.6|12.6|Standard Deviation|3.03|3.03|||
3627684|NCT02609633|3477016|B1|||Age||years|Mean|13.3|13.3|Standard Deviation|3.06|3.06|||
3627685|NCT02609399|3477042|B3||Unknown or Not Reported|Race (NIH/OMB) (Influenza Season 2016-2017)||Participants|Count of Participants|3|3.0||||||
3627686|NCT02609399|3477043|B2||Unknown or Not Reported|Race (NIH/OMB) (Influenza Season 2016-2017)||Participants|Count of Participants|3|3.0||||||
3627687|NCT02609399|3477044|B1||Unknown or Not Reported|Race (NIH/OMB) (Influenza Season 2016-2017)||Participants|Count of Participants|0|0.0||||||
3627688|NCT02609399|3477042|B3||More than one race|Race (NIH/OMB) (Influenza Season 2016-2017)||Participants|Count of Participants|0|0.0||||||
3627689|NCT02609399|3477043|B2||More than one race|Race (NIH/OMB) (Influenza Season 2016-2017)||Participants|Count of Participants|0|0.0||||||
3627690|NCT02609399|3477044|B1||More than one race|Race (NIH/OMB) (Influenza Season 2016-2017)||Participants|Count of Participants|0|0.0||||||
3627691|NCT02609399|3477042|B3||White|Race (NIH/OMB) (Influenza Season 2016-2017)||Participants|Count of Participants|40|40.0||||||
3627692|NCT02609399|3477043|B2||White|Race (NIH/OMB) (Influenza Season 2016-2017)||Participants|Count of Participants|24|24.0||||||
3627693|NCT02609399|3477044|B1||White|Race (NIH/OMB) (Influenza Season 2016-2017)||Participants|Count of Participants|16|16.0||||||
3627740|NCT02609399|3477043|B2||Male|Sex: Female, Male (Influenza Season 2016-2017)||Participants|Count of Participants|23|23.0||||||
3627694|NCT02609399|3477042|B3||Black or African American|Race (NIH/OMB) (Influenza Season 2016-2017)||Participants|Count of Participants|74|74.0||||||
3627695|NCT02609399|3477043|B2||Black or African American|Race (NIH/OMB) (Influenza Season 2016-2017)||Participants|Count of Participants|36|36.0||||||
3627696|NCT02609399|3477044|B1||Black or African American|Race (NIH/OMB) (Influenza Season 2016-2017)||Participants|Count of Participants|38|38.0||||||
3627697|NCT02609399|3477042|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB) (Influenza Season 2016-2017)||Participants|Count of Participants|0|0.0||||||
3627698|NCT02609399|3477043|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB) (Influenza Season 2016-2017)||Participants|Count of Participants|0|0.0||||||
3627699|NCT02609399|3477044|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB) (Influenza Season 2016-2017)||Participants|Count of Participants|0|0.0||||||
3627700|NCT02609399|3477042|B3||Asian|Race (NIH/OMB) (Influenza Season 2016-2017)||Participants|Count of Participants|2|2.0||||||
3627701|NCT02609399|3477043|B2||Asian|Race (NIH/OMB) (Influenza Season 2016-2017)||Participants|Count of Participants|0|0.0||||||
3627702|NCT02609399|3477044|B1||Asian|Race (NIH/OMB) (Influenza Season 2016-2017)||Participants|Count of Participants|2|2.0||||||
3627703|NCT02609399|3477042|B3||American Indian or Alaska Native|Race (NIH/OMB) (Influenza Season 2016-2017)||Participants|Count of Participants|2|2.0||||||
3627704|NCT02609399|3477043|B2||American Indian or Alaska Native|Race (NIH/OMB) (Influenza Season 2016-2017)||Participants|Count of Participants|1|1.0||||||
3627705|NCT02609399|3477044|B1||American Indian or Alaska Native|Race (NIH/OMB) (Influenza Season 2016-2017)||Participants|Count of Participants|1|1.0||||||
3627706|NCT02609399|3477042|B3||Unknown or Not Reported|Race (NIH/OMB) (Influenza Season 2015-2016)||Participants|Count of Participants|0|0.0||||||
3627707|NCT02609399|3477043|B2||Unknown or Not Reported|Race (NIH/OMB) (Influenza Season 2015-2016)||Participants|Count of Participants|0|0.0||||||
3627708|NCT02609399|3477044|B1||Unknown or Not Reported|Race (NIH/OMB) (Influenza Season 2015-2016)||Participants|Count of Participants|0|0.0||||||
3627709|NCT02609399|3477042|B3||More than one race|Race (NIH/OMB) (Influenza Season 2015-2016)||Participants|Count of Participants|0|0.0||||||
3627710|NCT02609399|3477043|B2||More than one race|Race (NIH/OMB) (Influenza Season 2015-2016)||Participants|Count of Participants|0|0.0||||||
3627711|NCT02609399|3477044|B1||More than one race|Race (NIH/OMB) (Influenza Season 2015-2016)||Participants|Count of Participants|0|0.0||||||
3627712|NCT02609399|3477042|B3||White|Race (NIH/OMB) (Influenza Season 2015-2016)||Participants|Count of Participants|10|10.0||||||
3627713|NCT02609399|3477043|B2||White|Race (NIH/OMB) (Influenza Season 2015-2016)||Participants|Count of Participants|5|5.0||||||
3627714|NCT02609399|3477044|B1||White|Race (NIH/OMB) (Influenza Season 2015-2016)||Participants|Count of Participants|5|5.0||||||
3627715|NCT02609399|3477042|B3||Black or African American|Race (NIH/OMB) (Influenza Season 2015-2016)||Participants|Count of Participants|46|46.0||||||
3627716|NCT02609399|3477043|B2||Black or African American|Race (NIH/OMB) (Influenza Season 2015-2016)||Participants|Count of Participants|24|24.0||||||
3627717|NCT02609399|3477044|B1||Black or African American|Race (NIH/OMB) (Influenza Season 2015-2016)||Participants|Count of Participants|22|22.0||||||
3627718|NCT02609399|3477042|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB) (Influenza Season 2015-2016)||Participants|Count of Participants|0|0.0||||||
3627719|NCT02609399|3477043|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB) (Influenza Season 2015-2016)||Participants|Count of Participants|0|0.0||||||
3627720|NCT02609399|3477044|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB) (Influenza Season 2015-2016)||Participants|Count of Participants|0|0.0||||||
3627721|NCT02609399|3477042|B3||Asian|Race (NIH/OMB) (Influenza Season 2015-2016)||Participants|Count of Participants|1|1.0||||||
3627722|NCT02609399|3477043|B2||Asian|Race (NIH/OMB) (Influenza Season 2015-2016)||Participants|Count of Participants|1|1.0||||||
3627723|NCT02609399|3477044|B1||Asian|Race (NIH/OMB) (Influenza Season 2015-2016)||Participants|Count of Participants|0|0.0||||||
3627724|NCT02609399|3477042|B3||American Indian or Alaska Native|Race (NIH/OMB) (Influenza Season 2015-2016)||Participants|Count of Participants|1|1.0||||||
3627725|NCT02609399|3477043|B2||American Indian or Alaska Native|Race (NIH/OMB) (Influenza Season 2015-2016)||Participants|Count of Participants|1|1.0||||||
3627726|NCT02609399|3477044|B1||American Indian or Alaska Native|Race (NIH/OMB) (Influenza Season 2015-2016)||Participants|Count of Participants|0|0.0||||||
3627727|NCT02609399|3477042|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB) (Influenza Season 2016-2017)||Participants|Count of Participants|92|92.0||||||
3627728|NCT02609399|3477043|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB) (Influenza Season 2016-2017)||Participants|Count of Participants|45|45.0||||||
3627729|NCT02609399|3477044|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB) (Influenza Season 2016-2017)||Participants|Count of Participants|47|47.0||||||
3627730|NCT02609399|3477042|B3||Hispanic or Latino|Ethnicity (NIH/OMB) (Influenza Season 2016-2017)||Participants|Count of Participants|29|29.0||||||
3627731|NCT02609399|3477043|B2||Hispanic or Latino|Ethnicity (NIH/OMB) (Influenza Season 2016-2017)||Participants|Count of Participants|19|19.0||||||
3627732|NCT02609399|3477044|B1||Hispanic or Latino|Ethnicity (NIH/OMB) (Influenza Season 2016-2017)||Participants|Count of Participants|10|10.0||||||
3627733|NCT02609399|3477042|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB) (Influenza Season 2015-2016)||Participants|Count of Participants|58|58.0||||||
3627734|NCT02609399|3477043|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB) (Influenza Season 2015-2016)||Participants|Count of Participants|31|31.0||||||
3627735|NCT02609399|3477044|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB) (Influenza Season 2015-2016)||Participants|Count of Participants|27|27.0||||||
3627736|NCT02609399|3477042|B3||Hispanic or Latino|Ethnicity (NIH/OMB) (Influenza Season 2015-2016)||Participants|Count of Participants|0|0.0||||||
3627737|NCT02609399|3477043|B2||Hispanic or Latino|Ethnicity (NIH/OMB) (Influenza Season 2015-2016)||Participants|Count of Participants|0|0.0||||||
3627738|NCT02609399|3477044|B1||Hispanic or Latino|Ethnicity (NIH/OMB) (Influenza Season 2015-2016)||Participants|Count of Participants|0|0.0||||||
3627739|NCT02609399|3477042|B3||Male|Sex: Female, Male (Influenza Season 2016-2017)||Participants|Count of Participants|43|43.0||||||
3627741|NCT02609399|3477044|B1||Male|Sex: Female, Male (Influenza Season 2016-2017)||Participants|Count of Participants|20|20.0||||||
3627742|NCT02609399|3477042|B3||Female|Sex: Female, Male (Influenza Season 2016-2017)||Participants|Count of Participants|78|78.0||||||
3627743|NCT02609399|3477043|B2||Female|Sex: Female, Male (Influenza Season 2016-2017)||Participants|Count of Participants|41|41.0||||||
3627744|NCT02609399|3477044|B1||Female|Sex: Female, Male (Influenza Season 2016-2017)||Participants|Count of Participants|37|37.0||||||
3627745|NCT02609399|3477042|B3||Male|Sex: Female, Male (Influenza Season 2015-2016)||Participants|Count of Participants|30|30.0||||||
3627746|NCT02609399|3477043|B2||Male|Sex: Female, Male (Influenza Season 2015-2016)||Participants|Count of Participants|14|14.0||||||
3627747|NCT02609399|3477044|B1||Male|Sex: Female, Male (Influenza Season 2015-2016)||Participants|Count of Participants|16|16.0||||||
3627748|NCT02609399|3477042|B3||Female|Sex: Female, Male (Influenza Season 2015-2016)||Participants|Count of Participants|28|28.0||||||
3627749|NCT02609399|3477043|B2||Female|Sex: Female, Male (Influenza Season 2015-2016)||Participants|Count of Participants|17|17.0||||||
3627750|NCT02609399|3477044|B1||Female|Sex: Female, Male (Influenza Season 2015-2016)||Participants|Count of Participants|11|11.0||||||
3627751|NCT02609399|3477042|B3|||Age, Continuous (Influenza Season 2016-2017)||years|Mean|48.0|48.0|Full Range|||20.0|80.0|
3627752|NCT02609399|3477043|B2|||Age, Continuous (Influenza Season 2016-2017)||years|Mean|49.3|49.3|Full Range|||20.0|80.0|
3627753|NCT02609399|3477044|B1|||Age, Continuous (Influenza Season 2016-2017)||years|Mean|46.6|46.6|Full Range|||20.0|78.0|
3627754|NCT02609399|3477042|B3|||Age, Continuous (Influenza Season 2015-2016)||years|Mean|46|46.0|Full Range|||19.0|72.0|
3627755|NCT02609399|3477043|B2|||Age, Continuous (Influenza Season 2015-2016)||years|Mean|43.7|43.7|Full Range|||19.0|72.0|
3627756|NCT02609399|3477044|B1|||Age, Continuous (Influenza Season 2015-2016)||years|Mean|48.7|48.7|Full Range|||20.0|68.0|
3627757|NCT02609399|3477042|B3|United States||Region of Enrollment||participants|Number|179|179.0||||||
3627758|NCT02609399|3477043|B2|United States||Region of Enrollment||participants|Number|95|95.0||||||
3627759|NCT02609399|3477044|B1|United States||Region of Enrollment||participants|Number|84|84.0||||||
3627760|NCT02609399|3477042|B3||Unknown or Not Reported|Race (NIH/OMB)|Baseline measures includes both influenza seasons 2015-2016 and 2016-2017. A total of 180 subjects were enrolled across both seasons. Baseline information is unavailable for 1 participant in the oseltamivir arm|Participants|Count of Participants|3|3.0||||||
3627761|NCT02609399|3477043|B2||Unknown or Not Reported|Race (NIH/OMB)|Baseline measures includes both influenza seasons 2015-2016 and 2016-2017. A total of 180 subjects were enrolled across both seasons. Baseline information is unavailable for 1 participant in the oseltamivir arm|Participants|Count of Participants|3|3.0||||||
3627762|NCT02609399|3477044|B1||Unknown or Not Reported|Race (NIH/OMB)|Baseline measures includes both influenza seasons 2015-2016 and 2016-2017. A total of 180 subjects were enrolled across both seasons. Baseline information is unavailable for 1 participant in the oseltamivir arm|Participants|Count of Participants|0|0.0||||||
3627763|NCT02609399|3477042|B3||More than one race|Race (NIH/OMB)|Baseline measures includes both influenza seasons 2015-2016 and 2016-2017. A total of 180 subjects were enrolled across both seasons. Baseline information is unavailable for 1 participant in the oseltamivir arm|Participants|Count of Participants|0|0.0||||||
3627764|NCT02609399|3477043|B2||More than one race|Race (NIH/OMB)|Baseline measures includes both influenza seasons 2015-2016 and 2016-2017. A total of 180 subjects were enrolled across both seasons. Baseline information is unavailable for 1 participant in the oseltamivir arm|Participants|Count of Participants|0|0.0||||||
3627765|NCT02609399|3477044|B1||More than one race|Race (NIH/OMB)|Baseline measures includes both influenza seasons 2015-2016 and 2016-2017. A total of 180 subjects were enrolled across both seasons. Baseline information is unavailable for 1 participant in the oseltamivir arm|Participants|Count of Participants|0|0.0||||||
3627766|NCT02609399|3477042|B3||White|Race (NIH/OMB)|Baseline measures includes both influenza seasons 2015-2016 and 2016-2017. A total of 180 subjects were enrolled across both seasons. Baseline information is unavailable for 1 participant in the oseltamivir arm|Participants|Count of Participants|50|50.0||||||
3627767|NCT02609399|3477043|B2||White|Race (NIH/OMB)|Baseline measures includes both influenza seasons 2015-2016 and 2016-2017. A total of 180 subjects were enrolled across both seasons. Baseline information is unavailable for 1 participant in the oseltamivir arm|Participants|Count of Participants|29|29.0||||||
3627768|NCT02609399|3477044|B1||White|Race (NIH/OMB)|Baseline measures includes both influenza seasons 2015-2016 and 2016-2017. A total of 180 subjects were enrolled across both seasons. Baseline information is unavailable for 1 participant in the oseltamivir arm|Participants|Count of Participants|21|21.0||||||
3627769|NCT02609399|3477042|B3||Black or African American|Race (NIH/OMB)|Baseline measures includes both influenza seasons 2015-2016 and 2016-2017. A total of 180 subjects were enrolled across both seasons. Baseline information is unavailable for 1 participant in the oseltamivir arm|Participants|Count of Participants|120|120.0||||||
3627770|NCT02609399|3477043|B2||Black or African American|Race (NIH/OMB)|Baseline measures includes both influenza seasons 2015-2016 and 2016-2017. A total of 180 subjects were enrolled across both seasons. Baseline information is unavailable for 1 participant in the oseltamivir arm|Participants|Count of Participants|60|60.0||||||
3627771|NCT02609399|3477044|B1||Black or African American|Race (NIH/OMB)|Baseline measures includes both influenza seasons 2015-2016 and 2016-2017. A total of 180 subjects were enrolled across both seasons. Baseline information is unavailable for 1 participant in the oseltamivir arm|Participants|Count of Participants|60|60.0||||||
3627772|NCT02609399|3477042|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Baseline measures includes both influenza seasons 2015-2016 and 2016-2017. A total of 180 subjects were enrolled across both seasons. Baseline information is unavailable for 1 participant in the oseltamivir arm|Participants|Count of Participants|0|0.0||||||
3627773|NCT02609399|3477043|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Baseline measures includes both influenza seasons 2015-2016 and 2016-2017. A total of 180 subjects were enrolled across both seasons. Baseline information is unavailable for 1 participant in the oseltamivir arm|Participants|Count of Participants|0|0.0||||||
3628265|NCT02607618|3477245|B1|Mexico||Region of Enrollment||participants|Number|2|2.0||||||
3627774|NCT02609399|3477044|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Baseline measures includes both influenza seasons 2015-2016 and 2016-2017. A total of 180 subjects were enrolled across both seasons. Baseline information is unavailable for 1 participant in the oseltamivir arm|Participants|Count of Participants|0|0.0||||||
3627775|NCT02609399|3477042|B3||Asian|Race (NIH/OMB)|Baseline measures includes both influenza seasons 2015-2016 and 2016-2017. A total of 180 subjects were enrolled across both seasons. Baseline information is unavailable for 1 participant in the oseltamivir arm|Participants|Count of Participants|3|3.0||||||
3627776|NCT02609399|3477043|B2||Asian|Race (NIH/OMB)|Baseline measures includes both influenza seasons 2015-2016 and 2016-2017. A total of 180 subjects were enrolled across both seasons. Baseline information is unavailable for 1 participant in the oseltamivir arm|Participants|Count of Participants|1|1.0||||||
3627777|NCT02609399|3477044|B1||Asian|Race (NIH/OMB)|Baseline measures includes both influenza seasons 2015-2016 and 2016-2017. A total of 180 subjects were enrolled across both seasons. Baseline information is unavailable for 1 participant in the oseltamivir arm|Participants|Count of Participants|2|2.0||||||
3627778|NCT02609399|3477042|B3||American Indian or Alaska Native|Race (NIH/OMB)|Baseline measures includes both influenza seasons 2015-2016 and 2016-2017. A total of 180 subjects were enrolled across both seasons. Baseline information is unavailable for 1 participant in the oseltamivir arm|Participants|Count of Participants|3|3.0||||||
3627779|NCT02609399|3477043|B2||American Indian or Alaska Native|Race (NIH/OMB)|Baseline measures includes both influenza seasons 2015-2016 and 2016-2017. A total of 180 subjects were enrolled across both seasons. Baseline information is unavailable for 1 participant in the oseltamivir arm|Participants|Count of Participants|2|2.0||||||
3627780|NCT02609399|3477044|B1||American Indian or Alaska Native|Race (NIH/OMB)|Baseline measures includes both influenza seasons 2015-2016 and 2016-2017. A total of 180 subjects were enrolled across both seasons. Baseline information is unavailable for 1 participant in the oseltamivir arm|Participants|Count of Participants|1|1.0||||||
3627781|NCT02609399|3477042|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)|Baseline measures includes both influenza seasons 2015-2016 and 2016-2017. A total of 180 subjects were enrolled across both seasons. Baseline information is unavailable for 1 participant in the oseltamivir arm|Participants|Count of Participants|0|0.0||||||
3627782|NCT02609399|3477043|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)|Baseline measures includes both influenza seasons 2015-2016 and 2016-2017. A total of 180 subjects were enrolled across both seasons. Baseline information is unavailable for 1 participant in the oseltamivir arm|Participants|Count of Participants|0|0.0||||||
3627783|NCT02609399|3477044|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|Baseline measures includes both influenza seasons 2015-2016 and 2016-2017. A total of 180 subjects were enrolled across both seasons. Baseline information is unavailable for 1 participant in the oseltamivir arm|Participants|Count of Participants|0|0.0||||||
3627784|NCT02609399|3477042|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Baseline measures includes both influenza seasons 2015-2016 and 2016-2017. A total of 180 subjects were enrolled across both seasons. Baseline information is unavailable for 1 participant in the oseltamivir arm|Participants|Count of Participants|150|150.0||||||
3627785|NCT02609399|3477043|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Baseline measures includes both influenza seasons 2015-2016 and 2016-2017. A total of 180 subjects were enrolled across both seasons. Baseline information is unavailable for 1 participant in the oseltamivir arm|Participants|Count of Participants|76|76.0||||||
3627786|NCT02609399|3477044|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Baseline measures includes both influenza seasons 2015-2016 and 2016-2017. A total of 180 subjects were enrolled across both seasons. Baseline information is unavailable for 1 participant in the oseltamivir arm|Participants|Count of Participants|74|74.0||||||
3627787|NCT02609399|3477042|B3||Hispanic or Latino|Ethnicity (NIH/OMB)|Baseline measures includes both influenza seasons 2015-2016 and 2016-2017. A total of 180 subjects were enrolled across both seasons. Baseline information is unavailable for 1 participant in the oseltamivir arm|Participants|Count of Participants|29|29.0||||||
3627788|NCT02609399|3477043|B2||Hispanic or Latino|Ethnicity (NIH/OMB)|Baseline measures includes both influenza seasons 2015-2016 and 2016-2017. A total of 180 subjects were enrolled across both seasons. Baseline information is unavailable for 1 participant in the oseltamivir arm|Participants|Count of Participants|19|19.0||||||
3627789|NCT02609399|3477044|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|Baseline measures includes both influenza seasons 2015-2016 and 2016-2017. A total of 180 subjects were enrolled across both seasons. Baseline information is unavailable for 1 participant in the oseltamivir arm|Participants|Count of Participants|10|10.0||||||
3627790|NCT02609399|3477042|B3||Male|Sex: Female, Male|Baseline measures includes both influenza seasons 2015-2016 and 2016-2017. A total of 180 subjects were enrolled across both seasons. Baseline information is unavailable for 1 participant in the oseltamivir arm|Participants|Count of Participants|73|73.0||||||
3627791|NCT02609399|3477043|B2||Male|Sex: Female, Male|Baseline measures includes both influenza seasons 2015-2016 and 2016-2017. A total of 180 subjects were enrolled across both seasons. Baseline information is unavailable for 1 participant in the oseltamivir arm|Participants|Count of Participants|37|37.0||||||
3627792|NCT02609399|3477044|B1||Male|Sex: Female, Male|Baseline measures includes both influenza seasons 2015-2016 and 2016-2017. A total of 180 subjects were enrolled across both seasons. Baseline information is unavailable for 1 participant in the oseltamivir arm|Participants|Count of Participants|36|36.0||||||
3627793|NCT02609399|3477042|B3||Female|Sex: Female, Male|Baseline measures includes both influenza seasons 2015-2016 and 2016-2017. A total of 180 subjects were enrolled across both seasons. Baseline information is unavailable for 1 participant in the oseltamivir arm|Participants|Count of Participants|106|106.0||||||
3627794|NCT02609399|3477043|B2||Female|Sex: Female, Male|Baseline measures includes both influenza seasons 2015-2016 and 2016-2017. A total of 180 subjects were enrolled across both seasons. Baseline information is unavailable for 1 participant in the oseltamivir arm|Participants|Count of Participants|58|58.0||||||
3627795|NCT02609399|3477044|B1||Female|Sex: Female, Male|Baseline measures includes both influenza seasons 2015-2016 and 2016-2017. A total of 180 subjects were enrolled across both seasons. Baseline information is unavailable for 1 participant in the oseltamivir arm|Participants|Count of Participants|48|48.0||||||
3627850|NCT02609100|3477098|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627796|NCT02609399|3477042|B3|||Age|Baseline measures includes both influenza seasons 2015-2016 and 2016-2017. A total of 180 subjects were enrolled across both seasons. Baseline information is unavailable for 1 participant in the oseltamivir arm|years|Mean|47.4|47.4|Full Range|||19.0|80.0|
3627797|NCT02609399|3477043|B2|||Age|Baseline measures includes both influenza seasons 2015-2016 and 2016-2017. A total of 180 subjects were enrolled across both seasons. Baseline information is unavailable for 1 participant in the oseltamivir arm|years|Mean|47.5|47.5|Full Range|||19.0|80.0|
3627798|NCT02609399|3477044|B1|||Age|Baseline measures includes both influenza seasons 2015-2016 and 2016-2017. A total of 180 subjects were enrolled across both seasons. Baseline information is unavailable for 1 participant in the oseltamivir arm|years|Mean|47.3|47.3|Full Range|||20.0|78.0|
3627799|NCT02609204|3477057|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
3627800|NCT02609204|3477057|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627801|NCT02609204|3477057|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3627802|NCT02609204|3477057|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3627803|NCT02609204|3477057|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3627804|NCT02609204|3477057|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627805|NCT02609204|3477057|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3627806|NCT02609204|3477057|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627807|NCT02609204|3477057|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3627808|NCT02609204|3477057|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3627809|NCT02609204|3477057|B1|||Age||years|Mean|53.3|53.3|Full Range|||20.0|81.0|
3627810|NCT02609178|3477062|B1|China||Region of Enrollment||participants|Number|12|12.0||||||
3627811|NCT02609178|3477062|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3627812|NCT02609178|3477062|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3627813|NCT02609178|3477062|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3627814|NCT02609178|3477062|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3627815|NCT02609178|3477062|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3627816|NCT02609113|3477082|B3|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3627817|NCT02609113|3477083|B2|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3627818|NCT02609113|3477084|B1|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3627819|NCT02609113|3477082|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3627820|NCT02609113|3477083|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3627821|NCT02609113|3477084|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3627822|NCT02609113|3477082|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3627823|NCT02609113|3477083|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3627824|NCT02609113|3477084|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3627825|NCT02609113|3477082|B3|||Age||years|Median|48.7|48.7|Standard Deviation|8.8|8.8|||
3627826|NCT02609113|3477083|B2|||Age||years|Median|52|52.0|Standard Deviation|6.12|6.12|||
3627827|NCT02609113|3477084|B1|||Age||years|Median|46|46.0|Standard Deviation|9.60|9.6|||
3627828|NCT02609100|3477097|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3627829|NCT02609100|3477098|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3627830|NCT02609100|3477099|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3627831|NCT02609100|3477097|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627832|NCT02609100|3477098|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627833|NCT02609100|3477099|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627834|NCT02609100|3477097|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627835|NCT02609100|3477098|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627836|NCT02609100|3477099|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627837|NCT02609100|3477097|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3627838|NCT02609100|3477098|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3627839|NCT02609100|3477099|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3627840|NCT02609100|3477097|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3627841|NCT02609100|3477098|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3627842|NCT02609100|3477099|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627843|NCT02609100|3477097|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627844|NCT02609100|3477098|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627845|NCT02609100|3477099|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627846|NCT02609100|3477097|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627847|NCT02609100|3477098|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627848|NCT02609100|3477099|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627849|NCT02609100|3477097|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628266|NCT02607618|3477243|B3|Croatia||Region of Enrollment||participants|Number|22|22.0||||||
3627851|NCT02609100|3477099|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3627852|NCT02609100|3477097|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3627853|NCT02609100|3477098|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3627854|NCT02609100|3477099|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3627855|NCT02609100|3477097|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3627856|NCT02609100|3477098|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3627857|NCT02609100|3477099|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3627858|NCT02609100|3477097|B3|||Age||years|Median|75.5|75.5|Full Range|||71.0|87.0|
3627859|NCT02609100|3477098|B2|||Age||years|Median|79.5|79.5|Full Range|||72.0|87.0|
3627860|NCT02609100|3477099|B1|||Age||years|Median|71.5|71.5|Full Range|||71.0|72.0|
3627861|NCT02609100|3477097|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3627862|NCT02609100|3477098|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3627863|NCT02609100|3477099|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3627864|NCT02609100|3477097|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3627865|NCT02609100|3477098|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3627866|NCT02609100|3477099|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3627867|NCT02609100|3477097|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3627868|NCT02609100|3477098|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3627869|NCT02609100|3477099|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3627870|NCT02608489|3477116|B3|||Grade of anterior chamber cells|"Grade ranges (0-4+), Evaluate cells using slit-lamp biomicroscopy. The slit beam should be 1mm x 1mm.~Grade 0 : < 1 cell in field, Grade 0.5+ : 1-5 cells in field, Grade 1+ : 6-15 cells in field, Grade 2+ : 16-25 cells in fields Grade 3+ : 26-50 cells in field, Grade 4+ : 50+ cells in fields"|grade|Mean|0|0.0|Standard Deviation|0|0.0|||
3627871|NCT02608489|3477117|B2|||Grade of anterior chamber cells|"Grade ranges (0-4+), Evaluate cells using slit-lamp biomicroscopy. The slit beam should be 1mm x 1mm.~Grade 0 : < 1 cell in field, Grade 0.5+ : 1-5 cells in field, Grade 1+ : 6-15 cells in field, Grade 2+ : 16-25 cells in fields Grade 3+ : 26-50 cells in field, Grade 4+ : 50+ cells in fields"|grade|Mean|0|0.0|Standard Deviation|0|0.0|||
3627872|NCT02608489|3477118|B1|||Grade of anterior chamber cells|"Grade ranges (0-4+), Evaluate cells using slit-lamp biomicroscopy. The slit beam should be 1mm x 1mm.~Grade 0 : < 1 cell in field, Grade 0.5+ : 1-5 cells in field, Grade 1+ : 6-15 cells in field, Grade 2+ : 16-25 cells in fields Grade 3+ : 26-50 cells in field, Grade 4+ : 50+ cells in fields"|grade|Mean|0|0.0|Standard Deviation|0|0.0|||
3627873|NCT02608489|3477116|B3|||Uncorrected visual acuity (LogMAR) ± SD||logMAR|Mean|0.78|0.78|Standard Deviation|0.47|0.47|||
3627874|NCT02608489|3477117|B2|||Uncorrected visual acuity (LogMAR) ± SD||logMAR|Mean|0.77|0.77|Standard Deviation|0.45|0.45|||
3627875|NCT02608489|3477118|B1|||Uncorrected visual acuity (LogMAR) ± SD||logMAR|Mean|0.80|0.8|Standard Deviation|0.52|0.52|||
3627876|NCT02608489|3477116|B3|||Total High Order Aberration (HOA) changes ± SD||microns|Mean|0.041|0.041|Standard Deviation|0.045|0.045|||
3627877|NCT02608489|3477117|B2|||Total High Order Aberration (HOA) changes ± SD||microns|Mean|0.041|0.041|Standard Deviation|0.048|0.048|||
3627878|NCT02608489|3477118|B1|||Total High Order Aberration (HOA) changes ± SD||microns|Mean|0.042|0.042|Standard Deviation|0.041|0.041|||
3627879|NCT02608489|3477116|B3|||Lissamine green staining score ± SD|"Instillation of 1% lissamine green in both eyes. After 1 or 2 full blinks, the intensity of staining of both medial and lateral bulbar conjunctiva was cored. According to the National Eye Institute (NEI) workshop grading system, the conjunctiva was divided into six sections. The minimum staining score was 0 and the maximum staining score was 18 points (up to 3 points for each section).~0 : best score (no conjunctival damage) 18 : worst score (severe conjunctival damages)"|score|Mean|1.79|1.79|Standard Deviation|1.38|1.38|||
3627880|NCT02608489|3477117|B2|||Lissamine green staining score ± SD|"Instillation of 1% lissamine green in both eyes. After 1 or 2 full blinks, the intensity of staining of both medial and lateral bulbar conjunctiva was cored. According to the National Eye Institute (NEI) workshop grading system, the conjunctiva was divided into six sections. The minimum staining score was 0 and the maximum staining score was 18 points (up to 3 points for each section).~0 : best score (no conjunctival damage) 18 : worst score (severe conjunctival damages)"|score|Mean|1.94|1.94|Standard Deviation|1.56|1.56|||
3627881|NCT02608489|3477118|B1|||Lissamine green staining score ± SD|"Instillation of 1% lissamine green in both eyes. After 1 or 2 full blinks, the intensity of staining of both medial and lateral bulbar conjunctiva was cored. According to the National Eye Institute (NEI) workshop grading system, the conjunctiva was divided into six sections. The minimum staining score was 0 and the maximum staining score was 18 points (up to 3 points for each section).~0 : best score (no conjunctival damage) 18 : worst score (severe conjunctival damages)"|score|Mean|1.55|1.55|Standard Deviation|1.19|1.19|||
3627882|NCT02608489|3477116|B3|||Fluorescein staining score ± SD|"Instillation of fluorescein in both eyes. After 1 or 2 full blinks, the intensity of staining of both cornea was scored. According to the National Eye Institute (NEI) workshop grading system, the cornea was divided into five sections. The minimum staining score was 0 and the maximum staining score was 15 points (up to 3 points for each section).~0 : best score (no corneal damage) 15 : worst score (severe corneal damages)"|score|Mean|1.69|1.69|Standard Deviation|1.75|1.75|||
3627883|NCT02608489|3477117|B2|||Fluorescein staining score ± SD|"Instillation of fluorescein in both eyes. After 1 or 2 full blinks, the intensity of staining of both cornea was scored. According to the National Eye Institute (NEI) workshop grading system, the cornea was divided into five sections. The minimum staining score was 0 and the maximum staining score was 15 points (up to 3 points for each section).~0 : best score (no corneal damage) 15 : worst score (severe corneal damages)"|score|Mean|1.77|1.77|Standard Deviation|1.73|1.73|||
3627935|NCT02607956|3477164|B1||≥ 50 to < 200 cells/μL|CD4 Cell Count Categories||Participants|Count of Participants|29|29.0||||||
3627936|NCT02607956|3477162|B3||< 50 cells/μL|CD4 Cell Count Categories||Participants|Count of Participants|28|28.0||||||
3627884|NCT02608489|3477118|B1|||Fluorescein staining score ± SD|"Instillation of fluorescein in both eyes. After 1 or 2 full blinks, the intensity of staining of both cornea was scored. According to the National Eye Institute (NEI) workshop grading system, the cornea was divided into five sections. The minimum staining score was 0 and the maximum staining score was 15 points (up to 3 points for each section).~0 : best score (no corneal damage) 15 : worst score (severe corneal damages)"|score|Mean|1.62|1.62|Standard Deviation|1.77|1.77|||
3627885|NCT02608489|3477116|B3|||Schirmer test ± SD||mm|Mean|3.58|3.58|Standard Deviation|3.31|3.31|||
3627886|NCT02608489|3477117|B2|||Schirmer test ± SD||mm|Mean|3.67|3.67|Standard Deviation|2.88|2.88|||
3627887|NCT02608489|3477118|B1|||Schirmer test ± SD||mm|Mean|3.52|3.52|Standard Deviation|4.13|4.13|||
3627888|NCT02608489|3477116|B3|||tear Break-Up Time ± SD||seconds|Mean|4.70|4.7|Standard Deviation|2.06|2.06|||
3627889|NCT02608489|3477117|B2|||tear Break-Up Time ± SD||seconds|Mean|4.54|4.54|Standard Deviation|1.85|1.85|||
3627890|NCT02608489|3477118|B1|||tear Break-Up Time ± SD||seconds|Mean|4.88|4.88|Standard Deviation|2.52|2.52|||
3627891|NCT02608489|3477116|B3|||Ocular Surface Disease Index ± SD|scale ranges (0-100). Higher values represent a worse outcome.|Scores on a scale|Mean|22.96|22.96|Standard Deviation|15.11|15.11|||
3627892|NCT02608489|3477117|B2|||Ocular Surface Disease Index ± SD|scale ranges (0-100). Higher values represent a worse outcome.|Scores on a scale|Mean|23.64|23.64|Standard Deviation|16.62|16.62|||
3627893|NCT02608489|3477118|B1|||Ocular Surface Disease Index ± SD|scale ranges (0-100). Higher values represent a worse outcome.|Scores on a scale|Mean|22.23|22.23|Standard Deviation|14.65|14.65|||
3627894|NCT02608489|3477116|B3|Mild||Obstructive Meibomian Gland Dysfunction (MGD)||participants|Number|27|27.0||||||
3627895|NCT02608489|3477117|B2|Mild||Obstructive Meibomian Gland Dysfunction (MGD)||participants|Number|14|14.0||||||
3627896|NCT02608489|3477118|B1|Mild||Obstructive Meibomian Gland Dysfunction (MGD)||participants|Number|13|13.0||||||
3627897|NCT02608489|3477116|B3|None||Obstructive Meibomian Gland Dysfunction (MGD)||participants|Number|36|36.0||||||
3627898|NCT02608489|3477117|B2|None||Obstructive Meibomian Gland Dysfunction (MGD)||participants|Number|19|19.0||||||
3627899|NCT02608489|3477118|B1|None||Obstructive Meibomian Gland Dysfunction (MGD)||participants|Number|17|17.0||||||
3627900|NCT02608489|3477116|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3627901|NCT02608489|3477117|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3627902|NCT02608489|3477118|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3627903|NCT02608489|3477116|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3627904|NCT02608489|3477117|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3627905|NCT02608489|3477118|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3627906|NCT02608489|3477116|B3|||Age||years|Mean|65.45|65.45|Standard Deviation|10.62|10.62|||
3627907|NCT02608489|3477117|B2|||Age||years|Mean|65.37|65.37|Standard Deviation|10.02|10.02|||
3627908|NCT02608489|3477118|B1|||Age||years|Mean|65.53|65.53|Standard Deviation|11.15|11.15|||
3627909|NCT02608177|3477139|B3|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3627910|NCT02608177|3477140|B2|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3627911|NCT02608177|3477141|B1|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3627912|NCT02608177|3477139|B3|Non-Hispanic white race/ethnicity||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3627913|NCT02608177|3477140|B2|Non-Hispanic white race/ethnicity||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3627914|NCT02608177|3477141|B1|Non-Hispanic white race/ethnicity||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3627915|NCT02608177|3477139|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3627916|NCT02608177|3477140|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3627917|NCT02608177|3477141|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3627918|NCT02608177|3477139|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3627919|NCT02608177|3477140|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3627920|NCT02608177|3477141|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3627921|NCT02608177|3477139|B3|||Age||years|Mean|68.3|68.3|Standard Deviation|7.2|7.2|||
3627922|NCT02608177|3477140|B2|||Age||years|Mean|70.4|70.4|Standard Deviation|NA||||no SD due to one participant enrolled
3627923|NCT02608177|3477141|B1|||Age||years|Mean|67.3|67.3|Standard Deviation|9.9|9.9|||
3627924|NCT02607956|3477162|B3||≥ 500 cells/μL|CD4 Cell Count Categories||Participants|Count of Participants|238|238.0||||||
3627925|NCT02607956|3477163|B2||≥ 500 cells/μL|CD4 Cell Count Categories||Participants|Count of Participants|120|120.0||||||
3627926|NCT02607956|3477164|B1||≥ 500 cells/μL|CD4 Cell Count Categories||Participants|Count of Participants|118|118.0||||||
3627927|NCT02607956|3477162|B3||≥ 350 to < 500 cells/μL|CD4 Cell Count Categories||Participants|Count of Participants|185|185.0||||||
3627928|NCT02607956|3477163|B2||≥ 350 to < 500 cells/μL|CD4 Cell Count Categories||Participants|Count of Participants|94|94.0||||||
3627929|NCT02607956|3477164|B1||≥ 350 to < 500 cells/μL|CD4 Cell Count Categories||Participants|Count of Participants|91|91.0||||||
3627930|NCT02607956|3477162|B3||≥ 200 to < 350 cells/μL|CD4 Cell Count Categories||Participants|Count of Participants|144|144.0||||||
3627931|NCT02607956|3477163|B2||≥ 200 to < 350 cells/μL|CD4 Cell Count Categories||Participants|Count of Participants|77|77.0||||||
3627932|NCT02607956|3477164|B1||≥ 200 to < 350 cells/μL|CD4 Cell Count Categories||Participants|Count of Participants|67|67.0||||||
3627933|NCT02607956|3477162|B3||≥ 50 to < 200 cells/μL|CD4 Cell Count Categories||Participants|Count of Participants|50|50.0||||||
3627934|NCT02607956|3477163|B2||≥ 50 to < 200 cells/μL|CD4 Cell Count Categories||Participants|Count of Participants|21|21.0||||||
3627937|NCT02607956|3477163|B2||< 50 cells/μL|CD4 Cell Count Categories||Participants|Count of Participants|13|13.0||||||
3627938|NCT02607956|3477164|B1||< 50 cells/μL|CD4 Cell Count Categories||Participants|Count of Participants|15|15.0||||||
3627939|NCT02607956|3477162|B3|||CD4 Cell Count||Cells/µL|Mean|456|456.0|Standard Deviation|243.4|243.4|||
3627940|NCT02607956|3477163|B2|||CD4 Cell Count||Cells/µL|Mean|454|454.0|Standard Deviation|231.5|231.5|||
3627941|NCT02607956|3477164|B1|||CD4 Cell Count||Cells/µL|Mean|457|457.0|Standard Deviation|255.3|255.3|||
3627942|NCT02607956|3477162|B3||> 400,000 copies/mL|HIV-1 RNA Categories||Participants|Count of Participants|25|25.0||||||
3627943|NCT02607956|3477163|B2||> 400,000 copies/mL|HIV-1 RNA Categories||Participants|Count of Participants|13|13.0||||||
3627944|NCT02607956|3477164|B1||> 400,000 copies/mL|HIV-1 RNA Categories||Participants|Count of Participants|12|12.0||||||
3627945|NCT02607956|3477162|B3||> 100,000 ≤ 400,000 copies/mL|HIV-1 RNA Categories||Participants|Count of Participants|95|95.0||||||
3627946|NCT02607956|3477163|B2||> 100,000 ≤ 400,000 copies/mL|HIV-1 RNA Categories||Participants|Count of Participants|41|41.0||||||
3627947|NCT02607956|3477164|B1||> 100,000 ≤ 400,000 copies/mL|HIV-1 RNA Categories||Participants|Count of Participants|54|54.0||||||
3627948|NCT02607956|3477162|B3||≤ 100,000 copies/mL|HIV-1 RNA Categories||Participants|Count of Participants|525|525.0||||||
3627949|NCT02607956|3477163|B2||≤ 100,000 copies/mL|HIV-1 RNA Categories||Participants|Count of Participants|271|271.0||||||
3627950|NCT02607956|3477164|B1||≤ 100,000 copies/mL|HIV-1 RNA Categories||Participants|Count of Participants|254|254.0||||||
3627951|NCT02607956|3477162|B3|||HIV-1 RNA||log10 copies/mL|Mean|4.41|4.41|Standard Deviation|0.700|0.7|||
3627952|NCT02607956|3477163|B2|||HIV-1 RNA||log10 copies/mL|Mean|4.42|4.42|Standard Deviation|0.669|0.669|||
3627953|NCT02607956|3477164|B1|||HIV-1 RNA||log10 copies/mL|Mean|4.39|4.39|Standard Deviation|0.730|0.73|||
3627954|NCT02607956|3477162|B3|Spain||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3627955|NCT02607956|3477163|B2|Spain||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3627956|NCT02607956|3477164|B1|Spain||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3627957|NCT02607956|3477162|B3|Germany||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
3627958|NCT02607956|3477163|B2|Germany||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3627959|NCT02607956|3477164|B1|Germany||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3627960|NCT02607956|3477162|B3|France||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3627961|NCT02607956|3477163|B2|France||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3627962|NCT02607956|3477164|B1|France||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3627963|NCT02607956|3477162|B3|Australia||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3627964|NCT02607956|3477163|B2|Australia||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3627965|NCT02607956|3477164|B1|Australia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3627966|NCT02607956|3477162|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3627967|NCT02607956|3477163|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3627968|NCT02607956|3477164|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3627969|NCT02607956|3477162|B3|Italy||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3627970|NCT02607956|3477163|B2|Italy||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3627971|NCT02607956|3477164|B1|Italy||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3627972|NCT02607956|3477162|B3|Dominican Republic||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3627973|NCT02607956|3477163|B2|Dominican Republic||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3627974|NCT02607956|3477164|B1|Dominican Republic||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3627975|NCT02607956|3477162|B3|United States||Region of Enrollment||Participants|Count of Participants|386|386.0||||||
3627976|NCT02607956|3477163|B2|United States||Region of Enrollment||Participants|Count of Participants|193|193.0||||||
3627977|NCT02607956|3477164|B1|United States||Region of Enrollment||Participants|Count of Participants|193|193.0||||||
3627978|NCT02607956|3477162|B3|Belgium||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3627979|NCT02607956|3477163|B2|Belgium||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3627980|NCT02607956|3477164|B1|Belgium||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3627981|NCT02607956|3477162|B3|Canada||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3627982|NCT02607956|3477163|B2|Canada||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3627983|NCT02607956|3477164|B1|Canada||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3627984|NCT02607956|3477162|B3||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|481|481.0||||||
3627985|NCT02607956|3477163|B2||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|244|244.0||||||
3627986|NCT02607956|3477164|B1||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|237|237.0||||||
3627987|NCT02607956|3477162|B3||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|164|164.0||||||
3627988|NCT02607956|3477163|B2||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|81|81.0||||||
3627989|NCT02607956|3477164|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|83|83.0||||||
3627990|NCT02607956|3477162|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
3627991|NCT02607956|3477163|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3627992|NCT02607956|3477164|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3627993|NCT02607956|3477162|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|378|378.0||||||
3627994|NCT02607956|3477163|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|195|195.0||||||
3627995|NCT02607956|3477164|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|183|183.0||||||
3627996|NCT02607956|3477162|B3||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3627997|NCT02607956|3477163|B2||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3627998|NCT02607956|3477164|B1||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3627999|NCT02607956|3477162|B3||Black|Race/Ethnicity, Customized||Participants|Count of Participants|197|197.0||||||
3628000|NCT02607956|3477163|B2||Black|Race/Ethnicity, Customized||Participants|Count of Participants|100|100.0||||||
3628001|NCT02607956|3477164|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|97|97.0||||||
3628002|NCT02607956|3477162|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3628003|NCT02607956|3477163|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3628004|NCT02607956|3477164|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3628005|NCT02607956|3477162|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3628006|NCT02607956|3477163|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3628007|NCT02607956|3477164|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3628008|NCT02607956|3477162|B3||Male|Sex: Female, Male||Participants|Count of Participants|568|568.0||||||
3628009|NCT02607956|3477163|B2||Male|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
3628010|NCT02607956|3477164|B1||Male|Sex: Female, Male||Participants|Count of Participants|280|280.0||||||
3628011|NCT02607956|3477162|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3628012|NCT02607956|3477163|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3628013|NCT02607956|3477164|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3628014|NCT02607956|3477162|B3|||Age||years|Mean|37|37.0|Standard Deviation|11.9|11.9|||
3628015|NCT02607956|3477163|B2|||Age||years|Mean|37|37.0|Standard Deviation|11.6|11.6|||
3628016|NCT02607956|3477164|B1|||Age||years|Mean|37|37.0|Standard Deviation|12.3|12.3|||
3628017|NCT02607930|3477177|B3||≥ 500 Cells/µL|CD4 Cell Count Categories||Participants|Count of Participants|256|256.0||||||
3628018|NCT02607930|3477178|B2||≥ 500 Cells/µL|CD4 Cell Count Categories||Participants|Count of Participants|134|134.0||||||
3628019|NCT02607930|3477179|B1||≥ 500 Cells/µL|CD4 Cell Count Categories||Participants|Count of Participants|122|122.0||||||
3628020|NCT02607930|3477177|B3||≥ 350 to < 500 Cells/µL|CD4 Cell Count Categories||Participants|Count of Participants|178|178.0||||||
3628021|NCT02607930|3477178|B2||≥ 350 to < 500 Cells/µL|CD4 Cell Count Categories||Participants|Count of Participants|91|91.0||||||
3628022|NCT02607930|3477179|B1||≥ 350 to < 500 Cells/µL|CD4 Cell Count Categories||Participants|Count of Participants|87|87.0||||||
3628023|NCT02607930|3477177|B3||≥ 200 to < 350 Cells/µL|CD4 Cell Count Categories||Participants|Count of Participants|127|127.0||||||
3628024|NCT02607930|3477178|B2||≥ 200 to < 350 Cells/µL|CD4 Cell Count Categories||Participants|Count of Participants|58|58.0||||||
3628025|NCT02607930|3477179|B1||≥ 200 to < 350 Cells/µL|CD4 Cell Count Categories||Participants|Count of Participants|69|69.0||||||
3628026|NCT02607930|3477177|B3||≥ 50 to < 200 Cells/µL|CD4 Cell Count Categories||Participants|Count of Participants|51|51.0||||||
3628027|NCT02607930|3477178|B2||≥ 50 to < 200 Cells/µL|CD4 Cell Count Categories||Participants|Count of Participants|22|22.0||||||
3628028|NCT02607930|3477179|B1||≥ 50 to < 200 Cells/µL|CD4 Cell Count Categories||Participants|Count of Participants|29|29.0||||||
3628029|NCT02607930|3477177|B3||< 50 Cells/µL|CD4 Cell Count Categories||Participants|Count of Participants|17|17.0||||||
3628030|NCT02607930|3477178|B2||< 50 Cells/µL|CD4 Cell Count Categories||Participants|Count of Participants|10|10.0||||||
3628031|NCT02607930|3477179|B1||< 50 Cells/µL|CD4 Cell Count Categories||Participants|Count of Participants|7|7.0||||||
3628032|NCT02607930|3477177|B3|||CD4 Cell Count||Cells/µL|Mean|464|464.0|Standard Deviation|226.3|226.3|||
3628033|NCT02607930|3477178|B2|||CD4 Cell Count||Cells/µL|Mean|476|476.0|Standard Deviation|231.4|231.4|||
3628034|NCT02607930|3477179|B1|||CD4 Cell Count||Cells/µL|Mean|453|453.0|Standard Deviation|220.8|220.8|||
3628035|NCT02607930|3477177|B3||> 400,000 copies/mL|HIV-1 RNA Categories||Participants|Count of Participants|20|20.0||||||
3628036|NCT02607930|3477178|B2||> 400,000 copies/mL|HIV-1 RNA Categories||Participants|Count of Participants|12|12.0||||||
3628037|NCT02607930|3477179|B1||> 400,000 copies/mL|HIV-1 RNA Categories||Participants|Count of Participants|8|8.0||||||
3628038|NCT02607930|3477177|B3||> 100,000 ≤ 400,000 copies/mL|HIV-1 RNA Categories||Participants|Count of Participants|83|83.0||||||
3628039|NCT02607930|3477178|B2||> 100,000 ≤ 400,000 copies/mL|HIV-1 RNA Categories||Participants|Count of Participants|38|38.0||||||
3628040|NCT02607930|3477179|B1||> 100,000 ≤ 400,000 copies/mL|HIV-1 RNA Categories||Participants|Count of Participants|45|45.0||||||
3628041|NCT02607930|3477177|B3||≤ 100,000 copies/mL|HIV-1 RNA Categories||Participants|Count of Participants|526|526.0||||||
3628042|NCT02607930|3477178|B2||≤ 100,000 copies/mL|HIV-1 RNA Categories||Participants|Count of Participants|265|265.0||||||
3628043|NCT02607930|3477179|B1||≤ 100,000 copies/mL|HIV-1 RNA Categories||Participants|Count of Participants|261|261.0||||||
3628044|NCT02607930|3477177|B3|||HIV-1 RNA||log10 copies/mL|Mean|4.42|4.42|Standard Deviation|0.665|0.665|||
3628045|NCT02607930|3477178|B2|||HIV-1 RNA||log10 copies/mL|Mean|4.42|4.42|Standard Deviation|0.685|0.685|||
3628046|NCT02607930|3477179|B1|||HIV-1 RNA||log10 copies/mL|Mean|4.41|4.41|Standard Deviation|0.647|0.647|||
3628047|NCT02607930|3477177|B3|Spain||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
3628048|NCT02607930|3477178|B2|Spain||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3628049|NCT02607930|3477179|B1|Spain||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3628050|NCT02607930|3477177|B3|Germany||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3628051|NCT02607930|3477178|B2|Germany||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3628052|NCT02607930|3477179|B1|Germany||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3628053|NCT02607930|3477177|B3|France||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3628054|NCT02607930|3477178|B2|France||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3628055|NCT02607930|3477179|B1|France||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3628056|NCT02607930|3477177|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3628057|NCT02607930|3477178|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3628058|NCT02607930|3477179|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3628059|NCT02607930|3477177|B3|Italy||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3628060|NCT02607930|3477178|B2|Italy||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3628061|NCT02607930|3477179|B1|Italy||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3628062|NCT02607930|3477177|B3|Dominican Republic||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3628063|NCT02607930|3477178|B2|Dominican Republic||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3628064|NCT02607930|3477179|B1|Dominican Republic||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3628065|NCT02607930|3477177|B3|United States||Region of Enrollment||Participants|Count of Participants|461|461.0||||||
3628066|NCT02607930|3477178|B2|United States||Region of Enrollment||Participants|Count of Participants|233|233.0||||||
3628067|NCT02607930|3477179|B1|United States||Region of Enrollment||Participants|Count of Participants|228|228.0||||||
3628068|NCT02607930|3477177|B3|Belgium||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3628069|NCT02607930|3477178|B2|Belgium||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3628070|NCT02607930|3477179|B1|Belgium||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3628071|NCT02607930|3477177|B3|Canada||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3628072|NCT02607930|3477178|B2|Canada||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3628073|NCT02607930|3477179|B1|Canada||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3628074|NCT02607930|3477177|B3||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3628075|NCT02607930|3477178|B2||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3628076|NCT02607930|3477179|B1||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3628077|NCT02607930|3477177|B3||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|489|489.0||||||
3628078|NCT02607930|3477178|B2||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|249|249.0||||||
3628079|NCT02607930|3477179|B1||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|240|240.0||||||
3628080|NCT02607930|3477177|B3||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|137|137.0||||||
3628081|NCT02607930|3477178|B2||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|65|65.0||||||
3628082|NCT02607930|3477179|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|72|72.0||||||
3628083|NCT02607930|3477177|B3||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3628084|NCT02607930|3477178|B2||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3628085|NCT02607930|3477179|B1||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3628086|NCT02607930|3477177|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3628087|NCT02607930|3477178|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3628088|NCT02607930|3477179|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3628089|NCT02607930|3477177|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|359|359.0||||||
3628090|NCT02607930|3477178|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|179|179.0||||||
3628091|NCT02607930|3477179|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|180|180.0||||||
3628092|NCT02607930|3477177|B3||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3628093|NCT02607930|3477178|B2||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3628094|NCT02607930|3477179|B1||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3628095|NCT02607930|3477177|B3||Black|Race/Ethnicity, Customized||Participants|Count of Participants|226|226.0||||||
3628096|NCT02607930|3477178|B2||Black|Race/Ethnicity, Customized||Participants|Count of Participants|112|112.0||||||
3628097|NCT02607930|3477179|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|114|114.0||||||
3628098|NCT02607930|3477177|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3628099|NCT02607930|3477178|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3628100|NCT02607930|3477179|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3628264|NCT02607618|3477244|B2|Mexico||Region of Enrollment||participants|Number|3|3.0||||||
3628101|NCT02607930|3477177|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3628102|NCT02607930|3477178|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3628103|NCT02607930|3477179|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3628104|NCT02607930|3477177|B3||Male|Sex: Female, Male||Participants|Count of Participants|567|567.0||||||
3628105|NCT02607930|3477178|B2||Male|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
3628106|NCT02607930|3477179|B1||Male|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
3628107|NCT02607930|3477177|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3628108|NCT02607930|3477178|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3628109|NCT02607930|3477179|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3628110|NCT02607930|3477177|B3|||Age||years|Mean|34|34.0|Standard Deviation|10.8|10.8|||
3628111|NCT02607930|3477178|B2|||Age||years|Mean|34|34.0|Standard Deviation|10.8|10.8|||
3628112|NCT02607930|3477179|B1|||Age||years|Mean|34|34.0|Standard Deviation|10.9|10.9|||
3628113|NCT02607800|3477200|B3|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|648|648.0||||||
3628114|NCT02607800|3477201|B2|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|302|302.0||||||
3628115|NCT02607800|3477202|B1|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|346|346.0||||||
3628116|NCT02607800|3477200|B3|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|293|293.0||||||
3628117|NCT02607800|3477201|B2|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|138|138.0||||||
3628118|NCT02607800|3477202|B1|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|155|155.0||||||
3628119|NCT02607800|3477200|B3|||HCV RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.71|0.71|||
3628120|NCT02607800|3477201|B2|||HCV RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.66|0.66|||
3628121|NCT02607800|3477202|B1|||HCV RNA||log10 IU/mL|Mean|6.1|6.1|Standard Deviation|0.75|0.75|||
3628122|NCT02607800|3477200|B3|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|141|141.0||||||
3628123|NCT02607800|3477201|B2|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|59|59.0||||||
3628124|NCT02607800|3477202|B1|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|82|82.0||||||
3628125|NCT02607800|3477200|B3|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|498|498.0||||||
3628126|NCT02607800|3477201|B2|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|245|245.0||||||
3628127|NCT02607800|3477202|B1|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|253|253.0||||||
3628128|NCT02607800|3477200|B3|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|302|302.0||||||
3628129|NCT02607800|3477201|B2|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|136|136.0||||||
3628130|NCT02607800|3477202|B1|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|166|166.0||||||
3628131|NCT02607800|3477200|B3|Germany||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3628132|NCT02607800|3477201|B2|Germany||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3628133|NCT02607800|3477202|B1|Germany||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3628134|NCT02607800|3477200|B3|France||Region of Enrollment||Participants|Count of Participants|187|187.0||||||
3628135|NCT02607800|3477201|B2|France||Region of Enrollment||Participants|Count of Participants|82|82.0||||||
3628136|NCT02607800|3477202|B1|France||Region of Enrollment||Participants|Count of Participants|105|105.0||||||
3628137|NCT02607800|3477200|B3|Australia||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3628138|NCT02607800|3477201|B2|Australia||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3628139|NCT02607800|3477202|B1|Australia||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3628140|NCT02607800|3477200|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
3628141|NCT02607800|3477201|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3628142|NCT02607800|3477202|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3628143|NCT02607800|3477200|B3|United States||Region of Enrollment||Participants|Count of Participants|552|552.0||||||
3628144|NCT02607800|3477201|B2|United States||Region of Enrollment||Participants|Count of Participants|269|269.0||||||
3628145|NCT02607800|3477202|B1|United States||Region of Enrollment||Participants|Count of Participants|283|283.0||||||
3628146|NCT02607800|3477200|B3|Canada||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3628147|NCT02607800|3477201|B2|Canada||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3628148|NCT02607800|3477202|B1|Canada||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3628149|NCT02607800|3477200|B3|New Zealand||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3628150|NCT02607800|3477201|B2|New Zealand||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3628151|NCT02607800|3477202|B1|New Zealand||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3628152|NCT02607800|3477200|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|857|857.0||||||
3628153|NCT02607800|3477201|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|388|388.0||||||
3628154|NCT02607800|3477202|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|469|469.0||||||
3628155|NCT02607800|3477200|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|84|84.0||||||
3628156|NCT02607800|3477201|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|52|52.0||||||
3628157|NCT02607800|3477202|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3628158|NCT02607800|3477200|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3628159|NCT02607800|3477201|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3628160|NCT02607800|3477202|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3628161|NCT02607800|3477200|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3628162|NCT02607800|3477201|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3628163|NCT02607800|3477202|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3628164|NCT02607800|3477200|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3628165|NCT02607800|3477201|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3628166|NCT02607800|3477202|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3628167|NCT02607800|3477200|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|73|73.0||||||
3628168|NCT02607800|3477201|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3628169|NCT02607800|3477202|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
3628170|NCT02607800|3477200|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|95|95.0||||||
3628171|NCT02607800|3477201|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
3628172|NCT02607800|3477202|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
3628173|NCT02607800|3477200|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|756|756.0||||||
3628174|NCT02607800|3477201|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|365|365.0||||||
3628175|NCT02607800|3477202|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|391|391.0||||||
3628176|NCT02607800|3477200|B3||Male|Sex: Female, Male||Participants|Count of Participants|492|492.0||||||
3628177|NCT02607800|3477201|B2||Male|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
3628178|NCT02607800|3477202|B1||Male|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
3628179|NCT02607800|3477200|B3||Female|Sex: Female, Male||Participants|Count of Participants|449|449.0||||||
3628180|NCT02607800|3477201|B2||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
3628181|NCT02607800|3477202|B1||Female|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
3628182|NCT02607800|3477200|B3|||Age||years|Mean|52|52.0|Standard Deviation|11.5|11.5|||
3628183|NCT02607800|3477201|B2|||Age||years|Mean|52|52.0|Standard Deviation|11.9|11.9|||
3628184|NCT02607800|3477202|B1|||Age||years|Mean|53|53.0|Standard Deviation|11.1|11.1|||
3628185|NCT02607735|3477219|B3||≥ 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|306|306.0||||||
3628186|NCT02607735|3477220|B2||≥ 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|116|116.0||||||
3628187|NCT02607735|3477221|B1||≥ 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|190|190.0||||||
3628188|NCT02607735|3477219|B3||< 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|109|109.0||||||
3628189|NCT02607735|3477220|B2||< 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|36|36.0||||||
3628190|NCT02607735|3477221|B1||< 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|73|73.0||||||
3628191|NCT02607735|3477219|B3|||HCV RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.66|0.66|||
3628192|NCT02607735|3477220|B2|||HCV RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.63|0.63|||
3628193|NCT02607735|3477221|B1|||HCV RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.68|0.68|||
3628194|NCT02607735|3477219|B3||TT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene|Participants|Count of Participants|83|83.0||||||
3628195|NCT02607735|3477220|B2||TT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene|Participants|Count of Participants|32|32.0||||||
3628196|NCT02607735|3477221|B1||TT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene|Participants|Count of Participants|51|51.0||||||
3628197|NCT02607735|3477219|B3||CT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene|Participants|Count of Participants|258|258.0||||||
3628198|NCT02607735|3477220|B2||CT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene|Participants|Count of Participants|93|93.0||||||
3628199|NCT02607735|3477221|B1||CT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene|Participants|Count of Participants|165|165.0||||||
3628200|NCT02607735|3477219|B3||CC|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene|Participants|Count of Participants|74|74.0||||||
3628201|NCT02607735|3477220|B2||CC|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene|Participants|Count of Participants|27|27.0||||||
3628202|NCT02607735|3477221|B1||CC|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene|Participants|Count of Participants|47|47.0||||||
3628203|NCT02607735|3477219|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3628204|NCT02607735|3477220|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3628205|NCT02607735|3477221|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3628206|NCT02607735|3477219|B3|New Zealand||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3628207|NCT02607735|3477220|B2|New Zealand||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3628208|NCT02607735|3477221|B1|New Zealand||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3628209|NCT02607735|3477219|B3|Germany||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3628210|NCT02607735|3477220|B2|Germany||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3628211|NCT02607735|3477221|B1|Germany||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3628212|NCT02607735|3477219|B3|France||Region of Enrollment||Participants|Count of Participants|72|72.0||||||
3628213|NCT02607735|3477220|B2|France||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3628214|NCT02607735|3477221|B1|France||Region of Enrollment||Participants|Count of Participants|56|56.0||||||
3628215|NCT02607735|3477219|B3|Canada||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3628216|NCT02607735|3477220|B2|Canada||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3628217|NCT02607735|3477221|B1|Canada||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3628218|NCT02607735|3477219|B3|Australia||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3628219|NCT02607735|3477220|B2|Australia||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3628220|NCT02607735|3477221|B1|Australia||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3628221|NCT02607735|3477219|B3|United States||Region of Enrollment||Participants|Count of Participants|236|236.0||||||
3628222|NCT02607735|3477220|B2|United States||Region of Enrollment||Participants|Count of Participants|101|101.0||||||
3628223|NCT02607735|3477221|B1|United States||Region of Enrollment||Participants|Count of Participants|135|135.0||||||
3628224|NCT02607735|3477219|B3||Not Disclosed|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3628225|NCT02607735|3477220|B2||Not Disclosed|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3628226|NCT02607735|3477221|B1||Not Disclosed|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3628227|NCT02607735|3477219|B3||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|389|389.0||||||
3628228|NCT02607735|3477220|B2||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|142|142.0||||||
3628229|NCT02607735|3477221|B1||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|247|247.0||||||
3628230|NCT02607735|3477219|B3||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3628231|NCT02607735|3477220|B2||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3628232|NCT02607735|3477221|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3628233|NCT02607735|3477219|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3628234|NCT02607735|3477220|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3628235|NCT02607735|3477221|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3628236|NCT02607735|3477219|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3628237|NCT02607735|3477220|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3628238|NCT02607735|3477221|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3628239|NCT02607735|3477219|B3||Not Disclosed|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3628240|NCT02607735|3477220|B2||Not Disclosed|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3628241|NCT02607735|3477221|B1||Not Disclosed|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3628242|NCT02607735|3477219|B3||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3628243|NCT02607735|3477220|B2||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3628244|NCT02607735|3477221|B1||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3628245|NCT02607735|3477219|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3628246|NCT02607735|3477220|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3628247|NCT02607735|3477221|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3628248|NCT02607735|3477219|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|60|60.0||||||
3628249|NCT02607735|3477220|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3628250|NCT02607735|3477221|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
3628251|NCT02607735|3477219|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|335|335.0||||||
3628252|NCT02607735|3477220|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|124|124.0||||||
3628253|NCT02607735|3477221|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|211|211.0||||||
3628254|NCT02607735|3477219|B3||Male|Sex: Female, Male||Participants|Count of Participants|321|321.0||||||
3628255|NCT02607735|3477220|B2||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3628256|NCT02607735|3477221|B1||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
3628257|NCT02607735|3477219|B3||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3628258|NCT02607735|3477220|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3628259|NCT02607735|3477221|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3628260|NCT02607735|3477219|B3|||Age||years|Mean|58|58.0|Standard Deviation|8.5|8.5|||
3628261|NCT02607735|3477220|B2|||Age||years|Mean|59|59.0|Standard Deviation|8.0|8.0|||
3628262|NCT02607735|3477221|B1|||Age||years|Mean|58|58.0|Standard Deviation|8.5|8.5|||
3628263|NCT02607618|3477243|B3|Mexico||Region of Enrollment||participants|Number|5|5.0||||||
3628267|NCT02607618|3477244|B2|Croatia||Region of Enrollment||participants|Number|12|12.0||||||
3628268|NCT02607618|3477245|B1|Croatia||Region of Enrollment||participants|Number|10|10.0||||||
3628269|NCT02607618|3477243|B3|Estonia||Region of Enrollment||participants|Number|84|84.0||||||
3628270|NCT02607618|3477244|B2|Estonia||Region of Enrollment||participants|Number|48|48.0||||||
3628271|NCT02607618|3477245|B1|Estonia||Region of Enrollment||participants|Number|36|36.0||||||
3628272|NCT02607618|3477243|B3|Portugal||Region of Enrollment||participants|Number|8|8.0||||||
3628273|NCT02607618|3477244|B2|Portugal||Region of Enrollment||participants|Number|5|5.0||||||
3628274|NCT02607618|3477245|B1|Portugal||Region of Enrollment||participants|Number|3|3.0||||||
3628275|NCT02607618|3477243|B3|Czechia||Region of Enrollment||participants|Number|7|7.0||||||
3628276|NCT02607618|3477244|B2|Czechia||Region of Enrollment||participants|Number|3|3.0||||||
3628277|NCT02607618|3477245|B1|Czechia||Region of Enrollment||participants|Number|4|4.0||||||
3628278|NCT02607618|3477243|B3|United States||Region of Enrollment||participants|Number|405|405.0||||||
3628279|NCT02607618|3477244|B2|United States||Region of Enrollment||participants|Number|205|205.0||||||
3628280|NCT02607618|3477245|B1|United States||Region of Enrollment||participants|Number|200|200.0||||||
3628281|NCT02607618|3477243|B3|Hungary||Region of Enrollment||participants|Number|9|9.0||||||
3628282|NCT02607618|3477244|B2|Hungary||Region of Enrollment||participants|Number|5|5.0||||||
3628283|NCT02607618|3477245|B1|Hungary||Region of Enrollment||participants|Number|4|4.0||||||
3628284|NCT02607618|3477243|B3|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
3628285|NCT02607618|3477244|B2|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
3628286|NCT02607618|3477245|B1|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
3628287|NCT02607618|3477243|B3|Turkey||Region of Enrollment||participants|Number|12|12.0||||||
3628288|NCT02607618|3477244|B2|Turkey||Region of Enrollment||participants|Number|7|7.0||||||
3628289|NCT02607618|3477245|B1|Turkey||Region of Enrollment||participants|Number|5|5.0||||||
3628290|NCT02607618|3477243|B3|Romania||Region of Enrollment||participants|Number|34|34.0||||||
3628291|NCT02607618|3477244|B2|Romania||Region of Enrollment||participants|Number|14|14.0||||||
3628292|NCT02607618|3477245|B1|Romania||Region of Enrollment||participants|Number|20|20.0||||||
3628293|NCT02607618|3477243|B3|Argentina||Region of Enrollment||participants|Number|12|12.0||||||
3628294|NCT02607618|3477244|B2|Argentina||Region of Enrollment||participants|Number|3|3.0||||||
3628295|NCT02607618|3477245|B1|Argentina||Region of Enrollment||participants|Number|9|9.0||||||
3628296|NCT02607618|3477243|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3628297|NCT02607618|3477244|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3628298|NCT02607618|3477245|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3628299|NCT02607618|3477243|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3628300|NCT02607618|3477244|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3628301|NCT02607618|3477245|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628302|NCT02607618|3477243|B3||White|Race (NIH/OMB)||Participants|Count of Participants|543|543.0||||||
3628303|NCT02607618|3477244|B2||White|Race (NIH/OMB)||Participants|Count of Participants|276|276.0||||||
3628304|NCT02607618|3477245|B1||White|Race (NIH/OMB)||Participants|Count of Participants|267|267.0||||||
3628305|NCT02607618|3477243|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3628306|NCT02607618|3477244|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3628307|NCT02607618|3477245|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3628308|NCT02607618|3477243|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3628309|NCT02607618|3477244|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3628310|NCT02607618|3477245|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3628311|NCT02607618|3477243|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3628312|NCT02607618|3477244|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3628313|NCT02607618|3477245|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3628314|NCT02607618|3477243|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3628315|NCT02607618|3477244|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3628316|NCT02607618|3477245|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3628317|NCT02607618|3477243|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3628318|NCT02607618|3477244|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3628319|NCT02607618|3477245|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3628320|NCT02607618|3477243|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|400|400.0||||||
3628321|NCT02607618|3477244|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|207|207.0||||||
3628322|NCT02607618|3477245|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|193|193.0||||||
3628323|NCT02607618|3477243|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|193|193.0||||||
3628324|NCT02607618|3477244|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3628325|NCT02607618|3477245|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3628326|NCT02607618|3477243|B3||Male|Sex: Female, Male||Participants|Count of Participants|389|389.0||||||
3628327|NCT02607618|3477244|B2||Male|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
3628328|NCT02607618|3477245|B1||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
3628329|NCT02607618|3477243|B3||Female|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
3628330|NCT02607618|3477244|B2||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3628331|NCT02607618|3477245|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3628332|NCT02607618|3477243|B3|||Age||years|Mean|50.4|50.4|Standard Deviation|15.3|15.3|||
3628333|NCT02607618|3477244|B2|||Age||years|Mean|50.8|50.8|Standard Deviation|15.0|15.0|||
3628334|NCT02607618|3477245|B1|||Age||years|Mean|50.0|50.0|Standard Deviation|15.7|15.7|||
3628335|NCT02607618|3477243|B3||>=65 years|Age||Participants|Count of Participants|110|110.0||||||
3628336|NCT02607618|3477244|B2||>=65 years|Age||Participants|Count of Participants|55|55.0||||||
3628337|NCT02607618|3477245|B1||>=65 years|Age||Participants|Count of Participants|55|55.0||||||
3628338|NCT02607618|3477243|B3||Between 18 and 65 years|Age||Participants|Count of Participants|490|490.0||||||
3628339|NCT02607618|3477244|B2||Between 18 and 65 years|Age||Participants|Count of Participants|250|250.0||||||
3628340|NCT02607618|3477245|B1||Between 18 and 65 years|Age||Participants|Count of Participants|240|240.0||||||
3628341|NCT02607618|3477243|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3628342|NCT02607618|3477244|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3628343|NCT02607618|3477245|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3628344|NCT02607254|3477254|B4|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3628345|NCT02607254|3477255|B3|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3628346|NCT02607254|3477256|B2|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3628347|NCT02607254|3477257|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3628348|NCT02607254|3477254|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628349|NCT02607254|3477255|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628350|NCT02607254|3477256|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628351|NCT02607254|3477257|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628352|NCT02607254|3477254|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628353|NCT02607254|3477255|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628354|NCT02607254|3477256|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628355|NCT02607254|3477257|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628356|NCT02607254|3477254|B4||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3628357|NCT02607254|3477255|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3628358|NCT02607254|3477256|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3628359|NCT02607254|3477257|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3628360|NCT02607254|3477254|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3628361|NCT02607254|3477255|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3628362|NCT02607254|3477256|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3628363|NCT02607254|3477257|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628364|NCT02607254|3477254|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628365|NCT02607254|3477255|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628366|NCT02607254|3477256|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628367|NCT02607254|3477257|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628368|NCT02607254|3477254|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628369|NCT02607254|3477255|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628370|NCT02607254|3477256|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628371|NCT02607254|3477257|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628372|NCT02607254|3477254|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628373|NCT02607254|3477255|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628374|NCT02607254|3477256|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628375|NCT02607254|3477257|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628376|NCT02607254|3477254|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3628377|NCT02607254|3477255|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3628378|NCT02607254|3477256|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3628379|NCT02607254|3477257|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3628380|NCT02607254|3477254|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3628381|NCT02607254|3477255|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3628382|NCT02607254|3477256|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3628383|NCT02607254|3477257|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3628384|NCT02607254|3477254|B4|||Age||years|Mean|53.4|53.4|Standard Deviation|8.2|8.2|||
3628385|NCT02607254|3477255|B3|||Age||years|Mean|57.2|57.2|Standard Deviation|7.1|7.1|||
3628386|NCT02607254|3477256|B2|||Age||years|Mean|47.3|47.3|Standard Deviation|3.9|3.9|||
3628387|NCT02607254|3477257|B1|||Age||years|Mean|50.6|50.6|Standard Deviation|6.4|6.4|||
3628388|NCT02607254|3477254|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3628389|NCT02607254|3477255|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3628390|NCT02607254|3477256|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3628391|NCT02607254|3477257|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3628392|NCT02607254|3477254|B4||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3628393|NCT02607254|3477255|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3628394|NCT02607254|3477256|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3628395|NCT02607254|3477257|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3628396|NCT02607254|3477254|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3628397|NCT02607254|3477255|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3628398|NCT02607254|3477256|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3628399|NCT02607254|3477257|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3628400|NCT02606903|3477276|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3628401|NCT02606903|3477277|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3628402|NCT02606903|3477278|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3628403|NCT02606903|3477276|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3628404|NCT02606903|3477277|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3628405|NCT02606903|3477278|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3628406|NCT02606903|3477276|B3|||Age||Years|Mean|39.7|39.7|Standard Deviation|13.45|13.45|||
3628407|NCT02606903|3477277|B2|||Age||Years|Mean|40.1|40.1|Standard Deviation|13.32|13.32|||
3628408|NCT02606903|3477278|B1|||Age||Years|Mean|39.3|39.3|Standard Deviation|13.77|13.77|||
3628409|NCT02606838|3477291|B1|United States||Region of Enrollment||participants|Number|119|119.0||||||
3628410|NCT02606838|3477291|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3628411|NCT02606838|3477291|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3628412|NCT02606838|3477291|B1||White|Race (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
3628413|NCT02606838|3477291|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3628414|NCT02606838|3477291|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628415|NCT02606838|3477291|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3628416|NCT02606838|3477291|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3628417|NCT02606838|3477291|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3628418|NCT02606838|3477291|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
3628419|NCT02606838|3477291|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3628420|NCT02606838|3477291|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3628421|NCT02606838|3477291|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3628422|NCT02606838|3477291|B1|||Age||years|Mean|55.1|55.1|Full Range|||23.0|84.0|
3628423|NCT02606734|3477299|B1|Germany||Region of Enrollment||participants|Number|24|24.0||||||
3628424|NCT02606734|3477299|B1|Australia||Region of Enrollment||participants|Number|20|20.0||||||
3628425|NCT02606734|3477299|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628426|NCT02606734|3477299|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628427|NCT02606734|3477299|B1||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3628428|NCT02606734|3477299|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628429|NCT02606734|3477299|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3628430|NCT02606734|3477299|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3628431|NCT02606734|3477299|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628432|NCT02606734|3477299|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3628433|NCT02606734|3477299|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3628434|NCT02606734|3477299|B1|||Age||years|Mean|69.3|69.3|Standard Deviation|10.6|10.6|||
3628435|NCT02606643|3477303|B3|||Bishop score at time of transcervical|A women with a low score of 1 would not expected go into labor for about 3 weeks. A woman with a higher score score of 10 could be expected to go into labor within a few days.|units on a scale|Mean|3.75|3.75|Full Range|||3.0|5.0|
3628436|NCT02606643|3477304|B2|||Bishop score at time of transcervical|A women with a low score of 1 would not expected go into labor for about 3 weeks. A woman with a higher score score of 10 could be expected to go into labor within a few days.|units on a scale|Mean|3.5|3.5|Full Range|||3.0|5.0|
3628437|NCT02606643|3477305|B1|||Bishop score at time of transcervical|A women with a low score of 1 would not expected go into labor for about 3 weeks. A woman with a higher score score of 10 could be expected to go into labor within a few days.|units on a scale|Mean|4|4.0|Full Range|||3.0|5.0|
3628438|NCT02606643|3477303|B3|||Body mass index at admission|Body mass index at admission (kg/m^2)|kg/m2|Mean|35.05|35.05|Full Range|||28.9|42.2|
3628439|NCT02606643|3477304|B2|||Body mass index at admission|Body mass index at admission (kg/m^2)|kg/m2|Mean|37.0|37.0|Full Range|||29.0|42.2|
3628440|NCT02606643|3477305|B1|||Body mass index at admission|Body mass index at admission (kg/m^2)|kg/m2|Mean|33.1|33.1|Full Range|||28.9|41.6|
3628441|NCT02606643|3477303|B3|||Gestational age at enrollment (wk||weeks|Mean|39.05|39.05|Full Range|||37.6|40.1|
3628442|NCT02606643|3477304|B2|||Gestational age at enrollment (wk||weeks|Mean|39.0|39.0|Full Range|||37.6|40.1|
3628443|NCT02606643|3477305|B1|||Gestational age at enrollment (wk||weeks|Mean|39.1|39.1|Full Range|||37.6|40.4|
3628444|NCT02606643|3477303|B3|United States||Region of Enrollment||participants|Number|144|144.0||||||
3628445|NCT02606643|3477304|B2|United States||Region of Enrollment||participants|Number|76|76.0||||||
3628446|NCT02606643|3477305|B1|United States||Region of Enrollment||participants|Number|68|68.0||||||
3628447|NCT02606643|3477303|B3|Unknown or Not Reported||Race/Ethnicity, Customized|11 participants failed screening and were not included in analysis|participants|Number|2|2.0||||||
3628448|NCT02606643|3477304|B2|Unknown or Not Reported||Race/Ethnicity, Customized|11 participants failed screening and were not included in analysis|participants|Number|1|1.0||||||
3628449|NCT02606643|3477305|B1|Unknown or Not Reported||Race/Ethnicity, Customized|11 participants failed screening and were not included in analysis|participants|Number|1|1.0||||||
3628450|NCT02606643|3477303|B3|More than one race||Race/Ethnicity, Customized|11 participants failed screening and were not included in analysis|participants|Number|0|0.0||||||
3628451|NCT02606643|3477304|B2|More than one race||Race/Ethnicity, Customized|11 participants failed screening and were not included in analysis|participants|Number|0|0.0||||||
3628452|NCT02606643|3477305|B1|More than one race||Race/Ethnicity, Customized|11 participants failed screening and were not included in analysis|participants|Number|0|0.0||||||
3628453|NCT02606643|3477303|B3|White||Race/Ethnicity, Customized|11 participants failed screening and were not included in analysis|participants|Number|37|37.0||||||
3628454|NCT02606643|3477304|B2|White||Race/Ethnicity, Customized|11 participants failed screening and were not included in analysis|participants|Number|17|17.0||||||
3628455|NCT02606643|3477305|B1|White||Race/Ethnicity, Customized|11 participants failed screening and were not included in analysis|participants|Number|20|20.0||||||
3628456|NCT02606643|3477303|B3|Black or African American||Race/Ethnicity, Customized|11 participants failed screening and were not included in analysis|participants|Number|94|94.0||||||
3628457|NCT02606643|3477304|B2|Black or African American||Race/Ethnicity, Customized|11 participants failed screening and were not included in analysis|participants|Number|53|53.0||||||
3628458|NCT02606643|3477305|B1|Black or African American||Race/Ethnicity, Customized|11 participants failed screening and were not included in analysis|participants|Number|41|41.0||||||
3628459|NCT02606643|3477303|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|11 participants failed screening and were not included in analysis|participants|Number|0|0.0||||||
3628460|NCT02606643|3477304|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|11 participants failed screening and were not included in analysis|participants|Number|0|0.0||||||
3628461|NCT02606643|3477305|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|11 participants failed screening and were not included in analysis|participants|Number|0|0.0||||||
3628462|NCT02606643|3477303|B3|Asian||Race/Ethnicity, Customized|11 participants failed screening and were not included in analysis|participants|Number|0|0.0||||||
3628463|NCT02606643|3477304|B2|Asian||Race/Ethnicity, Customized|11 participants failed screening and were not included in analysis|participants|Number|0|0.0||||||
3628464|NCT02606643|3477305|B1|Asian||Race/Ethnicity, Customized|11 participants failed screening and were not included in analysis|participants|Number|0|0.0||||||
3628465|NCT02606643|3477303|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|11 participants failed screening and were not included in analysis|participants|Number|0|0.0||||||
3628466|NCT02606643|3477304|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|11 participants failed screening and were not included in analysis|participants|Number|0|0.0||||||
3628467|NCT02606643|3477305|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|11 participants failed screening and were not included in analysis|participants|Number|0|0.0||||||
3628468|NCT02606643|3477303|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3628469|NCT02606643|3477304|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3628470|NCT02606643|3477305|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3628471|NCT02606643|3477303|B3||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3628472|NCT02606643|3477304|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3628473|NCT02606643|3477305|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3628474|NCT02606643|3477303|B3|||Age||years|Mean|026|26.0|Full Range|||22.0|30.0|
3628475|NCT02606643|3477304|B2|||Age||years|Mean|26|26.0|Full Range|||22.0|30.0|
3628476|NCT02606643|3477305|B1|||Age||years|Mean|26|26.0|Full Range|||23.0|30.0|
3628477|NCT02606500|3477316|B3|Slovenia||Region of Enrollment||Participants|Count of Participants|70|70.0||||||
3628478|NCT02606500|3477317|B2|Slovenia||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3628479|NCT02606500|3477318|B1|Slovenia||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3628480|NCT02606500|3477316|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628481|NCT02606500|3477317|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628482|NCT02606500|3477318|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628483|NCT02606500|3477316|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628484|NCT02606500|3477317|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628485|NCT02606500|3477318|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628486|NCT02606500|3477316|B3||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3628487|NCT02606500|3477317|B2||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3628488|NCT02606500|3477318|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3628489|NCT02606500|3477316|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628490|NCT02606500|3477317|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628491|NCT02606500|3477318|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628492|NCT02606500|3477316|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628493|NCT02606500|3477317|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628494|NCT02606500|3477318|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628495|NCT02606500|3477316|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628496|NCT02606500|3477317|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628497|NCT02606500|3477318|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628498|NCT02606500|3477316|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628499|NCT02606500|3477317|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628500|NCT02606500|3477318|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628501|NCT02606500|3477316|B3|Women||Sex/Gender, Customized|Only women were included in the study.|Participants|Count of Participants|70|70.0||||||
3628502|NCT02606500|3477317|B2|Women||Sex/Gender, Customized|Only women were included in the study.|Participants|Count of Participants|35|35.0||||||
3628503|NCT02606500|3477318|B1|Women||Sex/Gender, Customized|Only women were included in the study.|Participants|Count of Participants|35|35.0||||||
3628504|NCT02606500|3477316|B3|Age||Age, Customized||Years|Mean|30.9|30.9|Standard Deviation|3.7|3.7|||
3628505|NCT02606500|3477317|B2|Age||Age, Customized||Years|Mean|31.5|31.5|Standard Deviation|3.6|3.6|||
3628506|NCT02606500|3477318|B1|Age||Age, Customized||Years|Mean|30.3|30.3|Standard Deviation|3.9|3.9|||
3628507|NCT02606279|3477335|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3628508|NCT02606279|3477336|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3628509|NCT02606279|3477335|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3628510|NCT02606279|3477336|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3628511|NCT02606279|3477335|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628512|NCT02606279|3477336|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628513|NCT02606279|3477335|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628514|NCT02606279|3477336|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628515|NCT02606279|3477335|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628516|NCT02606279|3477336|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628517|NCT02606279|3477335|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628518|NCT02606279|3477336|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628519|NCT02606279|3477335|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628520|NCT02606279|3477336|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628521|NCT02606279|3477335|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628522|NCT02606279|3477336|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628523|NCT02606279|3477335|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3628524|NCT02606279|3477336|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3628525|NCT02606279|3477335|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628526|NCT02606279|3477336|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628527|NCT02606279|3477335|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628528|NCT02606279|3477336|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628529|NCT02606279|3477335|B3|Prefers not to identify||Sex/Gender, Customized||Participants|Count of Participants|1|1.0||||||
3628530|NCT02606279|3477336|B2|Prefers not to identify||Sex/Gender, Customized||Participants|Count of Participants|1|1.0||||||
3628531|NCT02606279|3477335|B3|Female||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3628532|NCT02606279|3477336|B2|Female||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3628533|NCT02606279|3477335|B3|Male||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3628534|NCT02606279|3477336|B2|Male||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3628535|NCT02606279|3477335|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3628536|NCT02606279|3477336|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3628537|NCT02606279|3477335|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3628538|NCT02606279|3477336|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3628539|NCT02606279|3477335|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3628540|NCT02606279|3477336|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3628541|NCT02605954|3477350|B3||≥ 500 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|211|211.0||||||
3628542|NCT02605954|3477351|B2||≥ 500 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|71|71.0||||||
3628543|NCT02605954|3477352|B1||≥ 500 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|140|140.0||||||
3628544|NCT02605954|3477350|B3||≥ 350 to < 500 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|43|43.0||||||
3628545|NCT02605954|3477351|B2||≥ 350 to < 500 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|13|13.0||||||
3628546|NCT02605954|3477352|B1||≥ 350 to < 500 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|30|30.0||||||
3628547|NCT02605954|3477350|B3||≥ 200 to < 350 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|18|18.0||||||
3628548|NCT02605954|3477351|B2||≥ 200 to < 350 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|7|7.0||||||
3628549|NCT02605954|3477352|B1||≥ 200 to < 350 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|11|11.0||||||
3628550|NCT02605954|3477350|B3||≥ 50 to < 200 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|2|2.0||||||
3628551|NCT02605954|3477351|B2||≥ 50 to < 200 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|0|0.0||||||
3628552|NCT02605954|3477352|B1||≥ 50 to < 200 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|2|2.0||||||
3628553|NCT02605954|3477350|B3|||CD4 Cell Count||cells/µL|Mean|718|718.0|Standard Deviation|291.8|291.8|||
3628554|NCT02605954|3477351|B2|||CD4 Cell Count||cells/µL|Mean|753|753.0|Standard Deviation|312.8|312.8|||
3628555|NCT02605954|3477352|B1|||CD4 Cell Count||cells/µL|Mean|701|701.0|Standard Deviation|280.1|280.1|||
3628556|NCT02605954|3477350|B3||50 ≥ copies/mL|HIV-1 RNA Categories||Participants|Count of Participants|6|6.0||||||
3628557|NCT02605954|3477351|B2||50 ≥ copies/mL|HIV-1 RNA Categories||Participants|Count of Participants|0|0.0||||||
3628558|NCT02605954|3477352|B1||50 ≥ copies/mL|HIV-1 RNA Categories||Participants|Count of Participants|6|6.0||||||
3628559|NCT02605954|3477350|B3||< 50 copies/mL|HIV-1 RNA Categories||Participants|Count of Participants|268|268.0||||||
3628560|NCT02605954|3477351|B2||< 50 copies/mL|HIV-1 RNA Categories||Participants|Count of Participants|91|91.0||||||
3628561|NCT02605954|3477352|B1||< 50 copies/mL|HIV-1 RNA Categories||Participants|Count of Participants|177|177.0||||||
3628562|NCT02605954|3477350|B3|Spain||Region of Enrollment||Participants|Count of Participants|86|86.0||||||
3628563|NCT02605954|3477351|B2|Spain||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3628564|NCT02605954|3477352|B1|Spain||Region of Enrollment||Participants|Count of Participants|56|56.0||||||
3628565|NCT02605954|3477350|B3|Germany||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3628566|NCT02605954|3477351|B2|Germany||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3628567|NCT02605954|3477352|B1|Germany||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3628568|NCT02605954|3477350|B3|France||Region of Enrollment||Participants|Count of Participants|63|63.0||||||
3628569|NCT02605954|3477351|B2|France||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3628570|NCT02605954|3477352|B1|France||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3628571|NCT02605954|3477350|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3628572|NCT02605954|3477351|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3628573|NCT02605954|3477352|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3628574|NCT02605954|3477350|B3|Italy||Region of Enrollment||Participants|Count of Participants|59|59.0||||||
3628575|NCT02605954|3477351|B2|Italy||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3628576|NCT02605954|3477352|B1|Italy||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
3628577|NCT02605954|3477350|B3|United States||Region of Enrollment||Participants|Count of Participants|55|55.0||||||
3628578|NCT02605954|3477351|B2|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3628579|NCT02605954|3477352|B1|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3628580|NCT02605954|3477350|B3||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3628581|NCT02605954|3477351|B2||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3628582|NCT02605954|3477352|B1||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3628583|NCT02605954|3477350|B3||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|228|228.0||||||
3628584|NCT02605954|3477351|B2||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|73|73.0||||||
3628585|NCT02605954|3477352|B1||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|155|155.0||||||
3628586|NCT02605954|3477350|B3||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
3628587|NCT02605954|3477351|B2||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3628588|NCT02605954|3477352|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3628589|NCT02605954|3477350|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3628590|NCT02605954|3477351|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3628591|NCT02605954|3477352|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3628592|NCT02605954|3477350|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|225|225.0||||||
3628593|NCT02605954|3477351|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|75|75.0||||||
3628594|NCT02605954|3477352|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|150|150.0||||||
3628595|NCT02605954|3477350|B3||Black|Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3628596|NCT02605954|3477351|B2||Black|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3628597|NCT02605954|3477352|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3628598|NCT02605954|3477350|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3628599|NCT02605954|3477351|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3628600|NCT02605954|3477352|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3628601|NCT02605954|3477350|B3||Male|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
3628602|NCT02605954|3477351|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3628603|NCT02605954|3477352|B1||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3628604|NCT02605954|3477350|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3628605|NCT02605954|3477351|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3628606|NCT02605954|3477352|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3628607|NCT02605954|3477350|B3|||Age||years|Mean|49|49.0|Standard Deviation|11.3|11.3|||
3628608|NCT02605954|3477351|B2|||Age||years|Mean|49|49.0|Standard Deviation|10.7|10.7|||
3628609|NCT02605954|3477352|B1|||Age||years|Mean|50|50.0|Standard Deviation|11.6|11.6|||
3628610|NCT02605928|3477370|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3628611|NCT02605928|3477370|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3628612|NCT02605928|3477370|B1|||Age||years|Mean|51|51.0|Full Range|||19.0|84.0|
3628613|NCT02605928|3477370|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3628614|NCT02605928|3477370|B1||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3628615|NCT02605928|3477370|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3628616|NCT02605863|3477374|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3628617|NCT02605863|3477376|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3628618|NCT02605863|3477374|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628619|NCT02605863|3477375|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628620|NCT02605863|3477376|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628621|NCT02605863|3477374|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628622|NCT02605863|3477375|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628623|NCT02605863|3477376|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628624|NCT02605863|3477374|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3628625|NCT02605863|3477375|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628626|NCT02605863|3477376|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3628627|NCT02605863|3477374|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628628|NCT02605863|3477375|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628629|NCT02605863|3477376|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628630|NCT02605863|3477374|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628631|NCT02605863|3477375|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628632|NCT02605863|3477376|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628633|NCT02605863|3477374|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628634|NCT02605863|3477375|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628635|NCT02605863|3477376|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628636|NCT02605863|3477374|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628637|NCT02605863|3477375|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628638|NCT02605863|3477376|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628639|NCT02605863|3477374|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628640|NCT02605863|3477375|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628641|NCT02605863|3477376|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628642|NCT02605863|3477374|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3628643|NCT02605863|3477375|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628644|NCT02605863|3477376|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3628645|NCT02605863|3477374|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628646|NCT02605863|3477375|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628647|NCT02605863|3477376|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628648|NCT02605863|3477374|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3628649|NCT02605863|3477375|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3628650|NCT02605863|3477376|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3628651|NCT02605863|3477374|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3628652|NCT02605863|3477375|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3628653|NCT02605863|3477376|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3628654|NCT02605863|3477374|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3628655|NCT02605863|3477375|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3628656|NCT02605863|3477376|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3628657|NCT02605863|3477374|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3628658|NCT02605863|3477375|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3628659|NCT02605863|3477376|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3628660|NCT02605863|3477374|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3628661|NCT02605863|3477375|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3628662|NCT02605863|3477376|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3628663|NCT02605395|3477383|B1|Egypt||Region of Enrollment||Participants|Count of Participants|70|70.0||||||
3628664|NCT02605395|3477383|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3628665|NCT02605395|3477383|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3628666|NCT02605395|3477383|B1|||Age||Years|Mean|30.76|30.76|Standard Deviation|9.05|9.05|||
3628667|NCT02605304|3477400|B3|||CD4+ T-cell count||cells/mm^3|Median|528|528.0|Inter-Quartile Range|||341.0|628.0|
3628668|NCT02605304|3477401|B2|||CD4+ T-cell count||cells/mm^3|Median|387|387.0|Inter-Quartile Range|||200.0|1150.0|
3628669|NCT02605304|3477402|B1|||CD4+ T-cell count||cells/mm^3|Median|564|564.0|Inter-Quartile Range|||435.0|614.0|
3628670|NCT02605304|3477400|B3||Quantifiable|HIV-1 RNA quantitation|HIV-1 RNA testing was performed at a central laboratory using Abbott RealTime HIV-1 assay (Abbott Laboratories, Lake Bluff, IL, USA). Unquantifiable was defined as below the lower limit of quantitation (LLOQ) of the assay (40 copies/mL).|Participants|Count of Participants|0|0.0||||||
3628671|NCT02605304|3477401|B2||Quantifiable|HIV-1 RNA quantitation|HIV-1 RNA testing was performed at a central laboratory using Abbott RealTime HIV-1 assay (Abbott Laboratories, Lake Bluff, IL, USA). Unquantifiable was defined as below the lower limit of quantitation (LLOQ) of the assay (40 copies/mL).|Participants|Count of Participants|0|0.0||||||
3628672|NCT02605304|3477402|B1||Quantifiable|HIV-1 RNA quantitation|HIV-1 RNA testing was performed at a central laboratory using Abbott RealTime HIV-1 assay (Abbott Laboratories, Lake Bluff, IL, USA). Unquantifiable was defined as below the lower limit of quantitation (LLOQ) of the assay (40 copies/mL).|Participants|Count of Participants|0|0.0||||||
3628673|NCT02605304|3477400|B3||Unquantifiable|HIV-1 RNA quantitation|HIV-1 RNA testing was performed at a central laboratory using Abbott RealTime HIV-1 assay (Abbott Laboratories, Lake Bluff, IL, USA). Unquantifiable was defined as below the lower limit of quantitation (LLOQ) of the assay (40 copies/mL).|Participants|Count of Participants|7|7.0||||||
3628674|NCT02605304|3477401|B2||Unquantifiable|HIV-1 RNA quantitation|HIV-1 RNA testing was performed at a central laboratory using Abbott RealTime HIV-1 assay (Abbott Laboratories, Lake Bluff, IL, USA). Unquantifiable was defined as below the lower limit of quantitation (LLOQ) of the assay (40 copies/mL).|Participants|Count of Participants|3|3.0||||||
3628675|NCT02605304|3477402|B1||Unquantifiable|HIV-1 RNA quantitation|HIV-1 RNA testing was performed at a central laboratory using Abbott RealTime HIV-1 assay (Abbott Laboratories, Lake Bluff, IL, USA). Unquantifiable was defined as below the lower limit of quantitation (LLOQ) of the assay (40 copies/mL).|Participants|Count of Participants|4|4.0||||||
3628676|NCT02605304|3477400|B3||Not on ART|HIV antiretroviral treatment (ART) status||Participants|Count of Participants|0|0.0||||||
3628677|NCT02605304|3477401|B2||Not on ART|HIV antiretroviral treatment (ART) status||Participants|Count of Participants|0|0.0||||||
3628678|NCT02605304|3477402|B1||Not on ART|HIV antiretroviral treatment (ART) status||Participants|Count of Participants|0|0.0||||||
3628679|NCT02605304|3477400|B3||On ART|HIV antiretroviral treatment (ART) status||Participants|Count of Participants|7|7.0||||||
3628680|NCT02605304|3477401|B2||On ART|HIV antiretroviral treatment (ART) status||Participants|Count of Participants|3|3.0||||||
3628681|NCT02605304|3477402|B1||On ART|HIV antiretroviral treatment (ART) status||Participants|Count of Participants|4|4.0||||||
3628682|NCT02605304|3477400|B3|||HCV RNA|HCV RNA testing was performed at a central laboratory using the COBAS® AmpliPrep/COBAS® TaqMan® HCV Quantitative Test, version 2.0 (Roche Diagnostics, Rotkreuz, Switzerland).|log10 IU/mL|Median|6.71|6.71|Inter-Quartile Range|||6.0|7.01|
3628683|NCT02605304|3477401|B2|||HCV RNA|HCV RNA testing was performed at a central laboratory using the COBAS® AmpliPrep/COBAS® TaqMan® HCV Quantitative Test, version 2.0 (Roche Diagnostics, Rotkreuz, Switzerland).|log10 IU/mL|Median|7.01|7.01|Inter-Quartile Range|||6.73|7.48|
3628684|NCT02605304|3477402|B1|||HCV RNA|HCV RNA testing was performed at a central laboratory using the COBAS® AmpliPrep/COBAS® TaqMan® HCV Quantitative Test, version 2.0 (Roche Diagnostics, Rotkreuz, Switzerland).|log10 IU/mL|Median|6.31|6.31|Inter-Quartile Range|||5.8|6.66|
3628685|NCT02605304|3477400|B3||1B|HCV genotype||Participants|Count of Participants|2|2.0||||||
3628686|NCT02605304|3477401|B2||1B|HCV genotype||Participants|Count of Participants|0|0.0||||||
3628687|NCT02605304|3477402|B1||1B|HCV genotype||Participants|Count of Participants|2|2.0||||||
3628688|NCT02605304|3477400|B3||1A|HCV genotype||Participants|Count of Participants|5|5.0||||||
3628689|NCT02605304|3477401|B2||1A|HCV genotype||Participants|Count of Participants|3|3.0||||||
3628690|NCT02605304|3477402|B1||1A|HCV genotype||Participants|Count of Participants|2|2.0||||||
3628691|NCT02605304|3477400|B3||Non-cirrhotic|Cirrhosis status|Cirrhotic was defined as: liver biopsy showing cirrhosis (Metavir score =4, Ishak score ≥5 or equivalent) at any time prior to study entry; or transient elastography (FibroScan®; Echosens, Paris, France) ≥12.5 kPa within 12 months of study entry; or HCV FibroSURE® (Laboratory Corporation of America, Raritan, NJ, USA) score of ≥0.72 with aspartate aminotransferase:platelet ratio index (APRI) ≥2 within 12 months of study entry.|Participants|Count of Participants|6|6.0||||||
3628692|NCT02605304|3477401|B2||Non-cirrhotic|Cirrhosis status|Cirrhotic was defined as: liver biopsy showing cirrhosis (Metavir score =4, Ishak score ≥5 or equivalent) at any time prior to study entry; or transient elastography (FibroScan®; Echosens, Paris, France) ≥12.5 kPa within 12 months of study entry; or HCV FibroSURE® (Laboratory Corporation of America, Raritan, NJ, USA) score of ≥0.72 with aspartate aminotransferase:platelet ratio index (APRI) ≥2 within 12 months of study entry.|Participants|Count of Participants|3|3.0||||||
3628736|NCT02605304|3477400|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3628737|NCT02605304|3477401|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3628738|NCT02605304|3477402|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3628693|NCT02605304|3477402|B1||Non-cirrhotic|Cirrhosis status|Cirrhotic was defined as: liver biopsy showing cirrhosis (Metavir score =4, Ishak score ≥5 or equivalent) at any time prior to study entry; or transient elastography (FibroScan®; Echosens, Paris, France) ≥12.5 kPa within 12 months of study entry; or HCV FibroSURE® (Laboratory Corporation of America, Raritan, NJ, USA) score of ≥0.72 with aspartate aminotransferase:platelet ratio index (APRI) ≥2 within 12 months of study entry.|Participants|Count of Participants|3|3.0||||||
3628694|NCT02605304|3477400|B3||Cirrhotic|Cirrhosis status|Cirrhotic was defined as: liver biopsy showing cirrhosis (Metavir score =4, Ishak score ≥5 or equivalent) at any time prior to study entry; or transient elastography (FibroScan®; Echosens, Paris, France) ≥12.5 kPa within 12 months of study entry; or HCV FibroSURE® (Laboratory Corporation of America, Raritan, NJ, USA) score of ≥0.72 with aspartate aminotransferase:platelet ratio index (APRI) ≥2 within 12 months of study entry.|Participants|Count of Participants|1|1.0||||||
3628695|NCT02605304|3477401|B2||Cirrhotic|Cirrhosis status|Cirrhotic was defined as: liver biopsy showing cirrhosis (Metavir score =4, Ishak score ≥5 or equivalent) at any time prior to study entry; or transient elastography (FibroScan®; Echosens, Paris, France) ≥12.5 kPa within 12 months of study entry; or HCV FibroSURE® (Laboratory Corporation of America, Raritan, NJ, USA) score of ≥0.72 with aspartate aminotransferase:platelet ratio index (APRI) ≥2 within 12 months of study entry.|Participants|Count of Participants|0|0.0||||||
3628696|NCT02605304|3477402|B1||Cirrhotic|Cirrhosis status|Cirrhotic was defined as: liver biopsy showing cirrhosis (Metavir score =4, Ishak score ≥5 or equivalent) at any time prior to study entry; or transient elastography (FibroScan®; Echosens, Paris, France) ≥12.5 kPa within 12 months of study entry; or HCV FibroSURE® (Laboratory Corporation of America, Raritan, NJ, USA) score of ≥0.72 with aspartate aminotransferase:platelet ratio index (APRI) ≥2 within 12 months of study entry.|Participants|Count of Participants|1|1.0||||||
3628697|NCT02605304|3477400|B3||SOF/RBV/PEG-IFN|Prior hepatitis C virus (HCV) treatment regimen||Participants|Count of Participants|4|4.0||||||
3628698|NCT02605304|3477401|B2||SOF/RBV/PEG-IFN|Prior hepatitis C virus (HCV) treatment regimen||Participants|Count of Participants|2|2.0||||||
3628699|NCT02605304|3477402|B1||SOF/RBV/PEG-IFN|Prior hepatitis C virus (HCV) treatment regimen||Participants|Count of Participants|2|2.0||||||
3628700|NCT02605304|3477400|B3||SOF/RBV|Prior hepatitis C virus (HCV) treatment regimen||Participants|Count of Participants|3|3.0||||||
3628701|NCT02605304|3477401|B2||SOF/RBV|Prior hepatitis C virus (HCV) treatment regimen||Participants|Count of Participants|1|1.0||||||
3628702|NCT02605304|3477402|B1||SOF/RBV|Prior hepatitis C virus (HCV) treatment regimen||Participants|Count of Participants|2|2.0||||||
3628703|NCT02605304|3477400|B3||Previously|Intravenous drug use history||Participants|Count of Participants|2|2.0||||||
3628704|NCT02605304|3477401|B2||Previously|Intravenous drug use history||Participants|Count of Participants|0|0.0||||||
3628705|NCT02605304|3477402|B1||Previously|Intravenous drug use history||Participants|Count of Participants|2|2.0||||||
3628706|NCT02605304|3477400|B3||Never|Intravenous drug use history||Participants|Count of Participants|5|5.0||||||
3628707|NCT02605304|3477401|B2||Never|Intravenous drug use history||Participants|Count of Participants|3|3.0||||||
3628708|NCT02605304|3477402|B1||Never|Intravenous drug use history||Participants|Count of Participants|2|2.0||||||
3628709|NCT02605304|3477400|B3|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3628710|NCT02605304|3477401|B2|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3628711|NCT02605304|3477402|B1|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3628712|NCT02605304|3477400|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628713|NCT02605304|3477401|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628714|NCT02605304|3477402|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628715|NCT02605304|3477400|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628716|NCT02605304|3477401|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628717|NCT02605304|3477402|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628718|NCT02605304|3477400|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3628719|NCT02605304|3477401|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3628720|NCT02605304|3477402|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3628721|NCT02605304|3477400|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3628722|NCT02605304|3477401|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3628723|NCT02605304|3477402|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3628724|NCT02605304|3477400|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628725|NCT02605304|3477401|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628726|NCT02605304|3477402|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628727|NCT02605304|3477400|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628728|NCT02605304|3477401|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628729|NCT02605304|3477402|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628730|NCT02605304|3477400|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628731|NCT02605304|3477401|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628732|NCT02605304|3477402|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628733|NCT02605304|3477400|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628734|NCT02605304|3477401|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628735|NCT02605304|3477402|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628739|NCT02605304|3477400|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3628740|NCT02605304|3477401|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3628741|NCT02605304|3477402|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3628742|NCT02605304|3477400|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3628743|NCT02605304|3477401|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3628744|NCT02605304|3477402|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3628745|NCT02605304|3477400|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3628746|NCT02605304|3477401|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3628747|NCT02605304|3477402|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3628748|NCT02605304|3477400|B3|||Age||years|Median|53|53.0|Inter-Quartile Range|||49.0|61.0|
3628749|NCT02605304|3477401|B2|||Age||years|Median|58|58.0|Inter-Quartile Range|||49.0|65.0|
3628750|NCT02605304|3477402|B1|||Age||years|Median|52|52.0|Inter-Quartile Range|||49.0|57.0|
3628751|NCT02605187|3477423|B5||Other|Language||Participants|Count of Participants|15|15.0||||||
3628752|NCT02605187|3477424|B4||Other|Language||Participants|Count of Participants|4|4.0||||||
3628753|NCT02605187|3477425|B3||Other|Language||Participants|Count of Participants|6|6.0||||||
3628754|NCT02605187|3477426|B2||Other|Language||Participants|Count of Participants|0|0.0||||||
3628755|NCT02605187|3477427|B1||Other|Language||Participants|Count of Participants|5|5.0||||||
3628756|NCT02605187|3477423|B5||English|Language||Participants|Count of Participants|123|123.0||||||
3628757|NCT02605187|3477424|B4||English|Language||Participants|Count of Participants|11|11.0||||||
3628758|NCT02605187|3477425|B3||English|Language||Participants|Count of Participants|66|66.0||||||
3628759|NCT02605187|3477426|B2||English|Language||Participants|Count of Participants|19|19.0||||||
3628760|NCT02605187|3477427|B1||English|Language||Participants|Count of Participants|27|27.0||||||
3628761|NCT02605187|3477423|B5|||Previous Cesarean Delivery||Participants|Count of Participants|91|91.0||||||
3628762|NCT02605187|3477424|B4|||Previous Cesarean Delivery||Participants|Count of Participants|10|10.0||||||
3628763|NCT02605187|3477425|B3|||Previous Cesarean Delivery||Participants|Count of Participants|45|45.0||||||
3628764|NCT02605187|3477426|B2|||Previous Cesarean Delivery||Participants|Count of Participants|15|15.0||||||
3628765|NCT02605187|3477427|B1|||Previous Cesarean Delivery||Participants|Count of Participants|21|21.0||||||
3628766|NCT02605187|3477423|B5|||Nulliparous||Participants|Count of Participants|29|29.0||||||
3628767|NCT02605187|3477424|B4|||Nulliparous||Participants|Count of Participants|3|3.0||||||
3628768|NCT02605187|3477425|B3|||Nulliparous||Participants|Count of Participants|16|16.0||||||
3628769|NCT02605187|3477426|B2|||Nulliparous||Participants|Count of Participants|6|6.0||||||
3628770|NCT02605187|3477427|B1|||Nulliparous||Participants|Count of Participants|4|4.0||||||
3628771|NCT02605187|3477423|B5||Graduate Degree|Education||Participants|Count of Participants|65|65.0||||||
3628772|NCT02605187|3477424|B4||Graduate Degree|Education||Participants|Count of Participants|5|5.0||||||
3628773|NCT02605187|3477425|B3||Graduate Degree|Education||Participants|Count of Participants|33|33.0||||||
3628774|NCT02605187|3477426|B2||Graduate Degree|Education||Participants|Count of Participants|14|14.0||||||
3628775|NCT02605187|3477427|B1||Graduate Degree|Education||Participants|Count of Participants|13|13.0||||||
3628776|NCT02605187|3477423|B5||BA or equivalent|Education||Participants|Count of Participants|47|47.0||||||
3628777|NCT02605187|3477424|B4||BA or equivalent|Education||Participants|Count of Participants|6|6.0||||||
3628778|NCT02605187|3477425|B3||BA or equivalent|Education||Participants|Count of Participants|28|28.0||||||
3628779|NCT02605187|3477426|B2||BA or equivalent|Education||Participants|Count of Participants|3|3.0||||||
3628780|NCT02605187|3477427|B1||BA or equivalent|Education||Participants|Count of Participants|10|10.0||||||
3628781|NCT02605187|3477423|B5||Some college|Education||Participants|Count of Participants|16|16.0||||||
3628782|NCT02605187|3477424|B4||Some college|Education||Participants|Count of Participants|2|2.0||||||
3628783|NCT02605187|3477425|B3||Some college|Education||Participants|Count of Participants|8|8.0||||||
3628784|NCT02605187|3477426|B2||Some college|Education||Participants|Count of Participants|1|1.0||||||
3628785|NCT02605187|3477427|B1||Some college|Education||Participants|Count of Participants|5|5.0||||||
3628786|NCT02605187|3477423|B5||High school|Education||Participants|Count of Participants|10|10.0||||||
3628787|NCT02605187|3477424|B4||High school|Education||Participants|Count of Participants|2|2.0||||||
3628788|NCT02605187|3477425|B3||High school|Education||Participants|Count of Participants|3|3.0||||||
3628789|NCT02605187|3477426|B2||High school|Education||Participants|Count of Participants|1|1.0||||||
3628790|NCT02605187|3477427|B1||High school|Education||Participants|Count of Participants|4|4.0||||||
3628791|NCT02605187|3477423|B5|||Gestational age (week)||week|Median|39.0|39.0|Inter-Quartile Range|||39.0|39.4|
3628792|NCT02605187|3477424|B4|||Gestational age (week)||week|Median|39.0|39.0|Inter-Quartile Range|||39.0|39.2|
3628793|NCT02605187|3477425|B3|||Gestational age (week)||week|Median|39.0|39.0|Inter-Quartile Range|||39.0|39.4|
3628794|NCT02605187|3477426|B2|||Gestational age (week)||week|Median|39.1|39.1|Inter-Quartile Range|||39.1|39.4|
3628795|NCT02605187|3477427|B1|||Gestational age (week)||week|Median|39.0|39.0|Inter-Quartile Range|||39.0|39.1|
3628796|NCT02605187|3477423|B5|||Body Mass Index (BMI)||kg/m^2|Median|28|28.0|Inter-Quartile Range|||26.0|33.0|
3628797|NCT02605187|3477424|B4|||Body Mass Index (BMI)||kg/m^2|Median|30|30.0|Inter-Quartile Range|||28.0|35.0|
3628798|NCT02605187|3477425|B3|||Body Mass Index (BMI)||kg/m^2|Median|29|29.0|Inter-Quartile Range|||26.0|33.0|
3628799|NCT02605187|3477426|B2|||Body Mass Index (BMI)||kg/m^2|Median|28|28.0|Inter-Quartile Range|||25.0|30.0|
3628800|NCT02605187|3477427|B1|||Body Mass Index (BMI)||kg/m^2|Median|28|28.0|Inter-Quartile Range|||27.0|31.0|
3628801|NCT02605187|3477423|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3628802|NCT02605187|3477424|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3628803|NCT02605187|3477425|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3628804|NCT02605187|3477426|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3628805|NCT02605187|3477427|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3628806|NCT02605187|3477423|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
3628807|NCT02605187|3477424|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3628808|NCT02605187|3477425|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3628809|NCT02605187|3477426|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3628810|NCT02605187|3477427|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3628811|NCT02605187|3477423|B5|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|83|83.0||||||
3628812|NCT02605187|3477424|B4|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3628813|NCT02605187|3477425|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3628814|NCT02605187|3477426|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3628815|NCT02605187|3477427|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3628816|NCT02605187|3477423|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3628817|NCT02605187|3477424|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3628818|NCT02605187|3477425|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3628819|NCT02605187|3477426|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3628820|NCT02605187|3477427|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3628821|NCT02605187|3477423|B5||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3628822|NCT02605187|3477424|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3628823|NCT02605187|3477425|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3628824|NCT02605187|3477426|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3628825|NCT02605187|3477427|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3628826|NCT02605187|3477423|B5|||Age||years|Median|35|35.0|Inter-Quartile Range|||31.0|38.0|
3628827|NCT02605187|3477424|B4|||Age||years|Median|33|33.0|Inter-Quartile Range|||30.0|36.0|
3628828|NCT02605187|3477425|B3|||Age||years|Median|34|34.0|Inter-Quartile Range|||32.0|36.0|
3628829|NCT02605187|3477426|B2|||Age||years|Median|37|37.0|Inter-Quartile Range|||34.0|39.0|
3628830|NCT02605187|3477427|B1|||Age||years|Median|35|35.0|Inter-Quartile Range|||32.0|39.0|
3628831|NCT02605174|3477484|B5|United States||Region of Enrollment||Participants|Count of Participants|2504|2504.0||||||
3628832|NCT02605174|3477485|B4|United States||Region of Enrollment||Participants|Count of Participants|626|626.0||||||
3628833|NCT02605174|3477486|B3|United States||Region of Enrollment||Participants|Count of Participants|626|626.0||||||
3628834|NCT02605174|3477487|B2|United States||Region of Enrollment||Participants|Count of Participants|627|627.0||||||
3628835|NCT02605174|3477488|B1|United States||Region of Enrollment||Participants|Count of Participants|625|625.0||||||
3628836|NCT02605174|3477484|B5|United Kingdom||Region of Enrollment||Participants|Count of Participants|191|191.0||||||
3628837|NCT02605174|3477485|B4|United Kingdom||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
3628838|NCT02605174|3477486|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
3628839|NCT02605174|3477487|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
3628840|NCT02605174|3477488|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
3628841|NCT02605174|3477484|B5|Germany||Region of Enrollment||Participants|Count of Participants|310|310.0||||||
3628842|NCT02605174|3477485|B4|Germany||Region of Enrollment||Participants|Count of Participants|77|77.0||||||
3628843|NCT02605174|3477486|B3|Germany||Region of Enrollment||Participants|Count of Participants|77|77.0||||||
3628844|NCT02605174|3477487|B2|Germany||Region of Enrollment||Participants|Count of Participants|79|79.0||||||
3628845|NCT02605174|3477488|B1|Germany||Region of Enrollment||Participants|Count of Participants|77|77.0||||||
3628846|NCT02605174|3477484|B5|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3628847|NCT02605174|3477485|B4|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3628848|NCT02605174|3477486|B3|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3628849|NCT02605174|3477487|B2|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3628850|NCT02605174|3477488|B1|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3628851|NCT02605174|3477484|B5|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3628852|NCT02605174|3477485|B4|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3628853|NCT02605174|3477486|B3|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3628854|NCT02605174|3477487|B2|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3628855|NCT02605174|3477488|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3628856|NCT02605174|3477484|B5|Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3628857|NCT02605174|3477485|B4|Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3628858|NCT02605174|3477486|B3|Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3628859|NCT02605174|3477487|B2|Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3628860|NCT02605174|3477488|B1|Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3628861|NCT02605174|3477484|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|2037|2037.0||||||
3628862|NCT02605174|3477485|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|518|518.0||||||
3628863|NCT02605174|3477486|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|511|511.0||||||
3628864|NCT02605174|3477487|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|493|493.0||||||
3628865|NCT02605174|3477488|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|515|515.0||||||
3628866|NCT02605174|3477484|B5|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|532|532.0||||||
3628867|NCT02605174|3477485|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|124|124.0||||||
3628868|NCT02605174|3477486|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|136|136.0||||||
3628869|NCT02605174|3477487|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|137|137.0||||||
3628870|NCT02605174|3477488|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|135|135.0||||||
3628871|NCT02605174|3477484|B5|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3628872|NCT02605174|3477485|B4|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3628873|NCT02605174|3477486|B3|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3628874|NCT02605174|3477487|B2|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3628875|NCT02605174|3477488|B1|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3628876|NCT02605174|3477484|B5|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3628877|NCT02605174|3477485|B4|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3628878|NCT02605174|3477486|B3|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3628879|NCT02605174|3477487|B2|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3628880|NCT02605174|3477488|B1|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3628881|NCT02605174|3477484|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3628882|NCT02605174|3477485|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3628883|NCT02605174|3477486|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3628884|NCT02605174|3477487|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3628885|NCT02605174|3477488|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3628886|NCT02605174|3477484|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|2071|2071.0||||||
3628887|NCT02605174|3477485|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|516|516.0||||||
3628888|NCT02605174|3477486|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|522|522.0||||||
3628889|NCT02605174|3477487|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|509|509.0||||||
3628890|NCT02605174|3477488|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|524|524.0||||||
3628891|NCT02605174|3477484|B5|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3628892|NCT02605174|3477485|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3628893|NCT02605174|3477486|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3628894|NCT02605174|3477487|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3628895|NCT02605174|3477488|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3628896|NCT02605174|3477484|B5|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|426|426.0||||||
3628897|NCT02605174|3477485|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|110|110.0||||||
3628898|NCT02605174|3477486|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|106|106.0||||||
3628899|NCT02605174|3477487|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|104|104.0||||||
3628900|NCT02605174|3477488|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|106|106.0||||||
3628901|NCT02605174|3477484|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3628902|NCT02605174|3477485|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3628903|NCT02605174|3477486|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3628904|NCT02605174|3477487|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3628905|NCT02605174|3477488|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3628906|NCT02605174|3477484|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3628907|NCT02605174|3477485|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3628908|NCT02605174|3477486|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3628909|NCT02605174|3477487|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3628967|NCT02604550|3477586|B2|United States||Region of Enrollment||participants|Number|59|59.0||||||
3628910|NCT02605174|3477488|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3628911|NCT02605174|3477484|B5||Male|Sex: Female, Male||Participants|Count of Participants|409|409.0||||||
3628912|NCT02605174|3477485|B4||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3628913|NCT02605174|3477486|B3||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3628914|NCT02605174|3477487|B2||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3628915|NCT02605174|3477488|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3628916|NCT02605174|3477484|B5||Female|Sex: Female, Male||Participants|Count of Participants|2174|2174.0||||||
3628917|NCT02605174|3477485|B4||Female|Sex: Female, Male||Participants|Count of Participants|545|545.0||||||
3628918|NCT02605174|3477486|B3||Female|Sex: Female, Male||Participants|Count of Participants|536|536.0||||||
3628919|NCT02605174|3477487|B2||Female|Sex: Female, Male||Participants|Count of Participants|539|539.0||||||
3628920|NCT02605174|3477488|B1||Female|Sex: Female, Male||Participants|Count of Participants|554|554.0||||||
3628921|NCT02605174|3477484|B5|||Age||years|Mean|42.7|42.7|Standard Deviation|12.79|12.79|||
3628922|NCT02605174|3477485|B4|||Age||years|Mean|42.6|42.6|Standard Deviation|12.90|12.9|||
3628923|NCT02605174|3477486|B3|||Age||years|Mean|41.8|41.8|Standard Deviation|12.40|12.4|||
3628924|NCT02605174|3477487|B2|||Age||years|Mean|43.4|43.4|Standard Deviation|12.59|12.59|||
3628925|NCT02605174|3477488|B1|||Age||years|Mean|42.8|42.8|Standard Deviation|13.20|13.2|||
3628926|NCT02604589|3477554|B4|||Admission Pain Score|Analog pain scale of 1-10, where 1= no pain and 10= worst pain ever|units on a scale|Median|8|8.0|Full Range|||6.0|10.0|
3628927|NCT02604589|3477555|B3|||Admission Pain Score|Analog pain scale of 1-10, where 1= no pain and 10= worst pain ever|units on a scale|Median|7|7.0|Full Range|||6.0|9.0|
3628928|NCT02604589|3477556|B2|||Admission Pain Score|Analog pain scale of 1-10, where 1= no pain and 10= worst pain ever|units on a scale|Median|8|8.0|Full Range|||7.0|10.0|
3628929|NCT02604589|3477557|B1|||Admission Pain Score|Analog pain scale of 1-10, where 1= no pain and 10= worst pain ever|units on a scale|Median|8|8.0|Full Range|||8.0|8.0|
3628930|NCT02604589|3477554|B4|||Admission Incentive Spirometry (IS) Volume|Maximal inspiratory lung volume measured by incentive spirometer (IS)|cc|Mean|998|998.0|Standard Deviation|696|696.0|||
3628931|NCT02604589|3477555|B3|||Admission Incentive Spirometry (IS) Volume|Maximal inspiratory lung volume measured by incentive spirometer (IS)|cc|Mean|1567|1567.0|Standard Deviation|818|818.0|||
3628932|NCT02604589|3477556|B2|||Admission Incentive Spirometry (IS) Volume|Maximal inspiratory lung volume measured by incentive spirometer (IS)|cc|Mean|783|783.0|Standard Deviation|630|630.0|||
3628933|NCT02604589|3477557|B1|||Admission Incentive Spirometry (IS) Volume|Maximal inspiratory lung volume measured by incentive spirometer (IS)|cc|Mean|978|978.0|Standard Deviation|563|563.0|||
3628934|NCT02604589|3477554|B4|||Number of Ribs Fractured||ribs|Mean|5.7|5.7|Standard Deviation|2.9|2.9|||
3628935|NCT02604589|3477555|B3|||Number of Ribs Fractured||ribs|Mean|5.0|5.0|Standard Deviation|1.4|1.4|||
3628936|NCT02604589|3477556|B2|||Number of Ribs Fractured||ribs|Mean|6.6|6.6|Standard Deviation|3.7|3.7|||
3628937|NCT02604589|3477557|B1|||Number of Ribs Fractured||ribs|Mean|4.7|4.7|Standard Deviation|2.5|2.5|||
3628938|NCT02604589|3477554|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
3628939|NCT02604589|3477555|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3628940|NCT02604589|3477556|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3628941|NCT02604589|3477557|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3628942|NCT02604589|3477554|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3628943|NCT02604589|3477555|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3628944|NCT02604589|3477556|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3628945|NCT02604589|3477557|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3628946|NCT02604589|3477554|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3628947|NCT02604589|3477555|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3628948|NCT02604589|3477556|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3628949|NCT02604589|3477557|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3628950|NCT02604589|3477554|B4|||Age||years|Mean|61.40|61.4|Standard Deviation|18.52|18.52|||
3628951|NCT02604589|3477555|B3|||Age||years|Mean|63.50|63.5|Standard Deviation|6.36|6.36|||
3628952|NCT02604589|3477556|B2|||Age||years|Mean|60.40|60.4|Standard Deviation|24.93|24.93|||
3628953|NCT02604589|3477557|B1|||Age||years|Mean|61.67|61.67|Standard Deviation|16.56|16.56|||
3628954|NCT02604589|3477554|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3628955|NCT02604589|3477555|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3628956|NCT02604589|3477556|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3628957|NCT02604589|3477557|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3628958|NCT02604589|3477554|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3628959|NCT02604589|3477555|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3628960|NCT02604589|3477556|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3628961|NCT02604589|3477557|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3628962|NCT02604589|3477554|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3628963|NCT02604589|3477555|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3628964|NCT02604589|3477556|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3628965|NCT02604589|3477557|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3628966|NCT02604550|3477585|B3|United States||Region of Enrollment||participants|Number|115|115.0||||||
3628968|NCT02604550|3477587|B1|United States||Region of Enrollment||participants|Number|56|56.0||||||
3628969|NCT02604550|3477585|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3628970|NCT02604550|3477586|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3628971|NCT02604550|3477587|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3628972|NCT02604550|3477585|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628973|NCT02604550|3477586|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628974|NCT02604550|3477587|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628975|NCT02604550|3477585|B3||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3628976|NCT02604550|3477586|B2||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3628977|NCT02604550|3477587|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3628978|NCT02604550|3477585|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3628979|NCT02604550|3477586|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3628980|NCT02604550|3477587|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3628981|NCT02604550|3477585|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628982|NCT02604550|3477586|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628983|NCT02604550|3477587|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628984|NCT02604550|3477585|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3628985|NCT02604550|3477586|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3628986|NCT02604550|3477587|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3628987|NCT02604550|3477585|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628988|NCT02604550|3477586|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628989|NCT02604550|3477587|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628990|NCT02604550|3477585|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3628991|NCT02604550|3477586|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3628992|NCT02604550|3477587|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3628993|NCT02604550|3477585|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3628994|NCT02604550|3477586|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3628995|NCT02604550|3477587|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3628996|NCT02604550|3477585|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628997|NCT02604550|3477586|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628998|NCT02604550|3477587|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3628999|NCT02604550|3477585|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3629000|NCT02604550|3477586|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3629001|NCT02604550|3477587|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3629002|NCT02604550|3477585|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3629003|NCT02604550|3477586|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3629004|NCT02604550|3477587|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3629005|NCT02604550|3477585|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3629006|NCT02604550|3477586|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3629007|NCT02604550|3477587|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3629008|NCT02604550|3477585|B3||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
3629009|NCT02604550|3477586|B2||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3629010|NCT02604550|3477587|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3629011|NCT02604550|3477585|B3||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
3629012|NCT02604550|3477586|B2||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
3629013|NCT02604550|3477587|B1||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
3629014|NCT02604407|3477612|B4||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3629015|NCT02604407|3477613|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3629016|NCT02604407|3477614|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3629017|NCT02604407|3477615|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3629018|NCT02604407|3477612|B4||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3629019|NCT02604407|3477613|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3629020|NCT02604407|3477614|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3629021|NCT02604407|3477615|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3629022|NCT02604407|3477612|B4|||Age||Years|Mean|33.3|33.3|Standard Deviation|10.40|10.4|||
3629023|NCT02604407|3477613|B3|||Age||Years|Mean|32.4|32.4|Standard Deviation|10.02|10.02|||
3629024|NCT02604407|3477614|B2|||Age||Years|Mean|33|33.0|Standard Deviation|10.40|10.4|||
3629025|NCT02604407|3477615|B1|||Age||Years|Mean|34.5|34.5|Standard Deviation|10.77|10.77|||
3629026|NCT02604342|3477628|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3629027|NCT02604342|3477629|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3629028|NCT02604342|3477630|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3629029|NCT02604342|3477628|B3|Unknown||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3629030|NCT02604342|3477629|B2|Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3629031|NCT02604342|3477630|B1|Unknown||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3629032|NCT02604342|3477628|B3|Asian||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3629033|NCT02604342|3477629|B2|Asian||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3629034|NCT02604342|3477630|B1|Asian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3629035|NCT02604342|3477628|B3|White||Race/Ethnicity, Customized||Participants|Number|89|89.0||||||
3629036|NCT02604342|3477629|B2|White||Race/Ethnicity, Customized||Participants|Number|28|28.0||||||
3629037|NCT02604342|3477630|B1|White||Race/Ethnicity, Customized||Participants|Number|61|61.0||||||
3629038|NCT02604342|3477628|B3|Missing||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3629039|NCT02604342|3477629|B2|Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3629040|NCT02604342|3477630|B1|Missing||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3629041|NCT02604342|3477628|B3|Unknown||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3629042|NCT02604342|3477629|B2|Unknown||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3629043|NCT02604342|3477630|B1|Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3629044|NCT02604342|3477628|B3|Not reported||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3629045|NCT02604342|3477629|B2|Not reported||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3629046|NCT02604342|3477630|B1|Not reported||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3629047|NCT02604342|3477628|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|90|90.0||||||
3629048|NCT02604342|3477629|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
3629049|NCT02604342|3477630|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|61|61.0||||||
3629050|NCT02604342|3477628|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3629051|NCT02604342|3477629|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3629052|NCT02604342|3477630|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3629053|NCT02604342|3477628|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3629054|NCT02604342|3477629|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3629055|NCT02604342|3477630|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3629056|NCT02604342|3477628|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3629057|NCT02604342|3477629|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3629058|NCT02604342|3477630|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3629059|NCT02604342|3477628|B3|||Age||years|Mean|55.9|55.9|Standard Deviation|12.1|12.1|||
3629060|NCT02604342|3477629|B2|||Age||years|Mean|58.8|58.8|Standard Deviation|10.4|10.4|||
3629061|NCT02604342|3477630|B1|||Age||years|Mean|54.5|54.5|Standard Deviation|12.6|12.6|||
3629062|NCT02604264|3477681|B3|United States||Region of Enrollment||Participants|Count of Participants|2470|2470.0||||||
3629063|NCT02604264|3477682|B2|United States||Region of Enrollment||Participants|Count of Participants|1225|1225.0||||||
3629064|NCT02604264|3477683|B1|United States||Region of Enrollment||Participants|Count of Participants|1245|1245.0||||||
3629065|NCT02604264|3477681|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|112|112.0||||||
3629066|NCT02604264|3477682|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3629067|NCT02604264|3477683|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3629068|NCT02604264|3477681|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629069|NCT02604264|3477682|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629070|NCT02604264|3477683|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629071|NCT02604264|3477681|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1240|1240.0||||||
3629072|NCT02604264|3477682|B2||White|Race (NIH/OMB)||Participants|Count of Participants|631|631.0||||||
3629073|NCT02604264|3477683|B1||White|Race (NIH/OMB)||Participants|Count of Participants|609|609.0||||||
3629074|NCT02604264|3477681|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1061|1061.0||||||
3629075|NCT02604264|3477682|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|495|495.0||||||
3629076|NCT02604264|3477683|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|566|566.0||||||
3629077|NCT02604264|3477681|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3629078|NCT02604264|3477682|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3629079|NCT02604264|3477683|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3629080|NCT02604264|3477681|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3629081|NCT02604264|3477682|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3629082|NCT02604264|3477683|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3629083|NCT02604264|3477681|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3629200|NCT02603666|3477792|B1||Male|Gender||Participants|Count of Participants|57|57.0||||||
3629084|NCT02604264|3477682|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3629085|NCT02604264|3477683|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3629086|NCT02604264|3477681|B3||Male|Sex: Female, Male||Participants|Count of Participants|1320|1320.0||||||
3629087|NCT02604264|3477682|B2||Male|Sex: Female, Male||Participants|Count of Participants|666|666.0||||||
3629088|NCT02604264|3477683|B1||Male|Sex: Female, Male||Participants|Count of Participants|654|654.0||||||
3629089|NCT02604264|3477681|B3||Female|Sex: Female, Male||Participants|Count of Participants|1150|1150.0||||||
3629090|NCT02604264|3477682|B2||Female|Sex: Female, Male||Participants|Count of Participants|559|559.0||||||
3629091|NCT02604264|3477683|B1||Female|Sex: Female, Male||Participants|Count of Participants|591|591.0||||||
3629092|NCT02604264|3477681|B3|||Age||years|Mean|61.1|61.1|Standard Deviation|15.1|15.1|||
3629093|NCT02604264|3477682|B2|||Age||years|Mean|60.6|60.6|Standard Deviation|15.1|15.1|||
3629094|NCT02604264|3477683|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|15.1|15.1|||
3629095|NCT02604173|3477690|B4|United States||Region of Enrollment||participants|Number|103|103.0||||||
3629096|NCT02604173|3477691|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
3629097|NCT02604173|3477692|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
3629098|NCT02604173|3477693|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
3629099|NCT02604173|3477690|B4||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3629100|NCT02604173|3477691|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3629101|NCT02604173|3477692|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3629102|NCT02604173|3477693|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3629103|NCT02604173|3477690|B4||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3629104|NCT02604173|3477691|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3629105|NCT02604173|3477692|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3629106|NCT02604173|3477693|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3629107|NCT02604173|3477690|B4|||Age||years|Mean|33|33.0|Standard Deviation|9|9.0|||
3629108|NCT02604173|3477691|B3|||Age||years|Mean|32|32.0|Standard Deviation|7|7.0|||
3629109|NCT02604173|3477692|B2|||Age||years|Mean|33|33.0|Standard Deviation|9|9.0|||
3629110|NCT02604173|3477693|B1|||Age||years|Mean|33|33.0|Standard Deviation|10|10.0|||
3629111|NCT02604017|3477709|B3||Male|Sex: Female, Male||Participants|Count of Participants|343|343.0||||||
3629112|NCT02604017|3477710|B2||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3629113|NCT02604017|3477711|B1||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
3629114|NCT02604017|3477709|B3||Female|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
3629115|NCT02604017|3477710|B2||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3629116|NCT02604017|3477711|B1||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
3629117|NCT02604017|3477709|B3|||Age||years|Mean|50.93|50.93|Standard Deviation|11.77|11.77|||
3629118|NCT02604017|3477710|B2|||Age||years|Mean|51.58|51.58|Standard Deviation|11.90|11.9|||
3629119|NCT02604017|3477711|B1|||Age||years|Mean|50.27|50.27|Standard Deviation|11.62|11.62|||
3629120|NCT02603952|3477737|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629121|NCT02603952|3477738|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629122|NCT02603952|3477739|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629123|NCT02603952|3477740|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629124|NCT02603952|3477741|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629125|NCT02603952|3477737|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629126|NCT02603952|3477738|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629127|NCT02603952|3477739|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629128|NCT02603952|3477740|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629129|NCT02603952|3477741|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629130|NCT02603952|3477737|B5||White|Race (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
3629131|NCT02603952|3477738|B4||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3629132|NCT02603952|3477739|B3||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3629133|NCT02603952|3477740|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3629134|NCT02603952|3477741|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3629135|NCT02603952|3477737|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3629136|NCT02603952|3477738|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3629137|NCT02603952|3477739|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3629138|NCT02603952|3477740|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3629139|NCT02603952|3477741|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3629140|NCT02603952|3477737|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629141|NCT02603952|3477738|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629142|NCT02603952|3477739|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629201|NCT02603666|3477792|B1||Female|Gender||Participants|Count of Participants|73|73.0||||||
3629143|NCT02603952|3477740|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629144|NCT02603952|3477741|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629145|NCT02603952|3477737|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3629146|NCT02603952|3477738|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629147|NCT02603952|3477739|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629148|NCT02603952|3477740|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629149|NCT02603952|3477741|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3629150|NCT02603952|3477737|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629151|NCT02603952|3477738|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629152|NCT02603952|3477739|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629153|NCT02603952|3477740|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629154|NCT02603952|3477741|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629155|NCT02603952|3477737|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629156|NCT02603952|3477738|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629157|NCT02603952|3477739|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629158|NCT02603952|3477740|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629159|NCT02603952|3477741|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629160|NCT02603952|3477737|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3629161|NCT02603952|3477738|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3629162|NCT02603952|3477739|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3629163|NCT02603952|3477740|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3629164|NCT02603952|3477741|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3629165|NCT02603952|3477737|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3629166|NCT02603952|3477738|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3629167|NCT02603952|3477739|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3629168|NCT02603952|3477740|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3629169|NCT02603952|3477741|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3629170|NCT02603952|3477737|B5||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3629171|NCT02603952|3477738|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3629172|NCT02603952|3477739|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3629173|NCT02603952|3477740|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3629174|NCT02603952|3477741|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3629175|NCT02603952|3477737|B5||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3629176|NCT02603952|3477738|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3629177|NCT02603952|3477739|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3629178|NCT02603952|3477740|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3629179|NCT02603952|3477741|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3629180|NCT02603952|3477737|B5|||Age||Years|Mean|42.2|42.2|Standard Deviation|12.66|12.66|||
3629181|NCT02603952|3477738|B4|||Age||Years|Mean|44.3|44.3|Standard Deviation|13.96|13.96|||
3629182|NCT02603952|3477739|B3|||Age||Years|Mean|41.7|41.7|Standard Deviation|12.90|12.9|||
3629183|NCT02603952|3477740|B2|||Age||Years|Mean|40.5|40.5|Standard Deviation|11.97|11.97|||
3629184|NCT02603952|3477741|B1|||Age||Years|Mean|42.3|42.3|Standard Deviation|11.97|11.97|||
3629185|NCT02603926|3477785|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3629186|NCT02603926|3477785|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629187|NCT02603926|3477785|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3629188|NCT02603926|3477785|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3629189|NCT02603926|3477785|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629190|NCT02603926|3477785|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629191|NCT02603926|3477785|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629192|NCT02603926|3477785|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629193|NCT02603926|3477785|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629194|NCT02603926|3477785|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3629195|NCT02603926|3477785|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3629196|NCT02603926|3477785|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3629197|NCT02603926|3477785|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3629198|NCT02603926|3477785|B1|||Age||years|Mean|68.3|68.3|Full Range|||57.0|79.0|
3629199|NCT02603666|3477792|B1|Sweden||Region of Enrollment|Stockholm Cystic Fibrosis Center, Sweden Prospective inclusion|participants|Number|130|130.0||||||
3629202|NCT02603666|3477792|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3629203|NCT02603666|3477792|B1||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
3629204|NCT02603666|3477792|B1||<=18 years|Age||Participants|Count of Participants|57|57.0||||||
3629205|NCT02603120|3477796|B3||≥ 500 cells/μL|CD4 Cell Count Category||Participants|Count of Participants|432|432.0||||||
3629206|NCT02603120|3477797|B2||≥ 500 cells/μL|CD4 Cell Count Category||Participants|Count of Participants|205|205.0||||||
3629207|NCT02603120|3477798|B1||≥ 500 cells/μL|CD4 Cell Count Category||Participants|Count of Participants|227|227.0||||||
3629208|NCT02603120|3477796|B3||≥ 350 to < 500 cells/μL|CD4 Cell Count Category||Participants|Count of Participants|75|75.0||||||
3629209|NCT02603120|3477797|B2||≥ 350 to < 500 cells/μL|CD4 Cell Count Category||Participants|Count of Participants|42|42.0||||||
3629210|NCT02603120|3477798|B1||≥ 350 to < 500 cells/μL|CD4 Cell Count Category||Participants|Count of Participants|33|33.0||||||
3629211|NCT02603120|3477796|B3||≥ 200 to < 350 cells/μL|CD4 Cell Count Category||Participants|Count of Participants|46|46.0||||||
3629212|NCT02603120|3477797|B2||≥ 200 to < 350 cells/μL|CD4 Cell Count Category||Participants|Count of Participants|30|30.0||||||
3629213|NCT02603120|3477798|B1||≥ 200 to < 350 cells/μL|CD4 Cell Count Category||Participants|Count of Participants|16|16.0||||||
3629214|NCT02603120|3477796|B3||≥ 50 to < 200 cells/μL|CD4 Cell Count Category||Participants|Count of Participants|10|10.0||||||
3629215|NCT02603120|3477797|B2||≥ 50 to < 200 cells/μL|CD4 Cell Count Category||Participants|Count of Participants|4|4.0||||||
3629216|NCT02603120|3477798|B1||≥ 50 to < 200 cells/μL|CD4 Cell Count Category||Participants|Count of Participants|6|6.0||||||
3629217|NCT02603120|3477796|B3|||CD4 Cell Count||cell/µL|Mean|723|723.0|Standard Deviation|298.1|298.1|||
3629218|NCT02603120|3477797|B2|||CD4 Cell Count||cell/µL|Mean|694|694.0|Standard Deviation|291.6|291.6|||
3629219|NCT02603120|3477798|B1|||CD4 Cell Count||cell/µL|Mean|752|752.0|Standard Deviation|302.2|302.2|||
3629220|NCT02603120|3477796|B3||≥ 50 copies/mL|HIV-1 RNA Categories||Participants|Count of Participants|13|13.0||||||
3629221|NCT02603120|3477797|B2||≥ 50 copies/mL|HIV-1 RNA Categories||Participants|Count of Participants|9|9.0||||||
3629222|NCT02603120|3477798|B1||≥ 50 copies/mL|HIV-1 RNA Categories||Participants|Count of Participants|4|4.0||||||
3629223|NCT02603120|3477796|B3||< 50 copies/mL|HIV-1 RNA Categories||Participants|Count of Participants|550|550.0||||||
3629224|NCT02603120|3477797|B2||< 50 copies/mL|HIV-1 RNA Categories||Participants|Count of Participants|272|272.0||||||
3629225|NCT02603120|3477798|B1||< 50 copies/mL|HIV-1 RNA Categories||Participants|Count of Participants|278|278.0||||||
3629226|NCT02603120|3477796|B3|Australia||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3629227|NCT02603120|3477797|B2|Australia||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3629228|NCT02603120|3477798|B1|Australia||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3629229|NCT02603120|3477796|B3|Spain||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
3629230|NCT02603120|3477797|B2|Spain||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3629231|NCT02603120|3477798|B1|Spain||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3629232|NCT02603120|3477796|B3|Germany||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3629233|NCT02603120|3477797|B2|Germany||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3629234|NCT02603120|3477798|B1|Germany||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3629235|NCT02603120|3477796|B3|France||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3629236|NCT02603120|3477797|B2|France||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3629237|NCT02603120|3477798|B1|France||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3629238|NCT02603120|3477796|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3629239|NCT02603120|3477797|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3629240|NCT02603120|3477798|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3629241|NCT02603120|3477796|B3|Italy||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3629242|NCT02603120|3477797|B2|Italy||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3629243|NCT02603120|3477798|B1|Italy||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3629244|NCT02603120|3477796|B3|United States||Region of Enrollment||Participants|Count of Participants|401|401.0||||||
3629245|NCT02603120|3477797|B2|United States||Region of Enrollment||Participants|Count of Participants|198|198.0||||||
3629246|NCT02603120|3477798|B1|United States||Region of Enrollment||Participants|Count of Participants|203|203.0||||||
3629247|NCT02603120|3477796|B3|Belgium||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3629248|NCT02603120|3477797|B2|Belgium||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3629249|NCT02603120|3477798|B1|Belgium||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3629250|NCT02603120|3477796|B3|Canada||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3629251|NCT02603120|3477797|B2|Canada||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3629252|NCT02603120|3477798|B1|Canada||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3629253|NCT02603120|3477796|B3||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3629254|NCT02603120|3477797|B2||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3629255|NCT02603120|3477798|B1||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3629256|NCT02603120|3477796|B3||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|463|463.0||||||
3629482|NCT02601469|3478088|B2||Clear|Baseline IGA||Participants|Count of Participants|0|0.0||||||
3629257|NCT02603120|3477797|B2||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|227|227.0||||||
3629258|NCT02603120|3477798|B1||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|236|236.0||||||
3629259|NCT02603120|3477796|B3||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|98|98.0||||||
3629260|NCT02603120|3477797|B2||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|52|52.0||||||
3629261|NCT02603120|3477798|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
3629262|NCT02603120|3477796|B3||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3629263|NCT02603120|3477797|B2||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3629264|NCT02603120|3477798|B1||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3629265|NCT02603120|3477796|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3629266|NCT02603120|3477797|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3629267|NCT02603120|3477798|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3629268|NCT02603120|3477796|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|408|408.0||||||
3629269|NCT02603120|3477797|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|202|202.0||||||
3629270|NCT02603120|3477798|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|206|206.0||||||
3629271|NCT02603120|3477796|B3||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3629272|NCT02603120|3477797|B2||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3629273|NCT02603120|3477798|B1||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3629274|NCT02603120|3477796|B3||Black|Race/Ethnicity, Customized||Participants|Count of Participants|121|121.0||||||
3629275|NCT02603120|3477797|B2||Black|Race/Ethnicity, Customized||Participants|Count of Participants|62|62.0||||||
3629276|NCT02603120|3477798|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|59|59.0||||||
3629277|NCT02603120|3477796|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3629278|NCT02603120|3477797|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3629279|NCT02603120|3477798|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3629280|NCT02603120|3477796|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3629281|NCT02603120|3477797|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3629282|NCT02603120|3477798|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3629283|NCT02603120|3477796|B3||Male|Sex: Female, Male||Participants|Count of Participants|499|499.0||||||
3629284|NCT02603120|3477797|B2||Male|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
3629285|NCT02603120|3477798|B1||Male|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
3629286|NCT02603120|3477796|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3629287|NCT02603120|3477797|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3629288|NCT02603120|3477798|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3629289|NCT02603120|3477796|B3|||Age||years|Mean|45|45.0|Standard Deviation|11.3|11.3|||
3629290|NCT02603120|3477797|B2|||Age||years|Mean|45|45.0|Standard Deviation|11.5|11.5|||
3629291|NCT02603120|3477798|B1|||Age||years|Mean|46|46.0|Standard Deviation|11.1|11.1|||
3629292|NCT02603107|3477817|B3||Boosted DRV + FTC/TDF|Prior ARV Regimen||Participants|Count of Participants|273|273.0||||||
3629293|NCT02603107|3477818|B2||Boosted DRV + FTC/TDF|Prior ARV Regimen||Participants|Count of Participants|133|133.0||||||
3629294|NCT02603107|3477819|B1||Boosted DRV + FTC/TDF|Prior ARV Regimen||Participants|Count of Participants|140|140.0||||||
3629295|NCT02603107|3477817|B3||Boosted ATV + FTC/TDF|Prior ARV Regimen||Participants|Count of Participants|215|215.0||||||
3629296|NCT02603107|3477818|B2||Boosted ATV + FTC/TDF|Prior ARV Regimen||Participants|Count of Participants|110|110.0||||||
3629297|NCT02603107|3477819|B1||Boosted ATV + FTC/TDF|Prior ARV Regimen||Participants|Count of Participants|105|105.0||||||
3629298|NCT02603107|3477817|B3||Boosted DRV + ABC/3TC|Prior ARV Regimen||Participants|Count of Participants|45|45.0||||||
3629299|NCT02603107|3477818|B2||Boosted DRV + ABC/3TC|Prior ARV Regimen||Participants|Count of Participants|21|21.0||||||
3629300|NCT02603107|3477819|B1||Boosted DRV + ABC/3TC|Prior ARV Regimen||Participants|Count of Participants|24|24.0||||||
3629301|NCT02603107|3477817|B3||Boosted ATV + ABC/3TC|Prior ARV Regimen||Participants|Count of Participants|44|44.0||||||
3629302|NCT02603107|3477818|B2||Boosted ATV + ABC/3TC|Prior ARV Regimen||Participants|Count of Participants|23|23.0||||||
3629303|NCT02603107|3477819|B1||Boosted ATV + ABC/3TC|Prior ARV Regimen||Participants|Count of Participants|21|21.0||||||
3629304|NCT02603107|3477817|B3||Acquired Immunodeficiency Syndrome (AIDS)|HIV Disease Status||Participants|Count of Participants|67|67.0||||||
3629305|NCT02603107|3477818|B2||Acquired Immunodeficiency Syndrome (AIDS)|HIV Disease Status||Participants|Count of Participants|33|33.0||||||
3629306|NCT02603107|3477819|B1||Acquired Immunodeficiency Syndrome (AIDS)|HIV Disease Status||Participants|Count of Participants|34|34.0||||||
3629307|NCT02603107|3477817|B3||Symptomatic HIV Infection|HIV Disease Status||Participants|Count of Participants|36|36.0||||||
3629308|NCT02603107|3477818|B2||Symptomatic HIV Infection|HIV Disease Status||Participants|Count of Participants|20|20.0||||||
3629309|NCT02603107|3477819|B1||Symptomatic HIV Infection|HIV Disease Status||Participants|Count of Participants|16|16.0||||||
3629310|NCT02603107|3477817|B3||Asymptomatic|HIV Disease Status||Participants|Count of Participants|474|474.0||||||
3629311|NCT02603107|3477818|B2||Asymptomatic|HIV Disease Status||Participants|Count of Participants|234|234.0||||||
3629312|NCT02603107|3477819|B1||Asymptomatic|HIV Disease Status||Participants|Count of Participants|240|240.0||||||
3629313|NCT02603107|3477817|B3||≥ 500 cells/μL|CD4 Cell Count Category||Participants|Count of Participants|387|387.0||||||
3629314|NCT02603107|3477818|B2||≥ 500 cells/μL|CD4 Cell Count Category||Participants|Count of Participants|189|189.0||||||
3629315|NCT02603107|3477819|B1||≥ 500 cells/μL|CD4 Cell Count Category||Participants|Count of Participants|198|198.0||||||
3629316|NCT02603107|3477817|B3||≥ 350 to < 500 cells/μL|CD4 Cell Count Category||Participants|Count of Participants|122|122.0||||||
3629317|NCT02603107|3477818|B2||≥ 350 to < 500 cells/μL|CD4 Cell Count Category||Participants|Count of Participants|60|60.0||||||
3629318|NCT02603107|3477819|B1||≥ 350 to < 500 cells/μL|CD4 Cell Count Category||Participants|Count of Participants|62|62.0||||||
3629319|NCT02603107|3477817|B3||≥ 200 to < 350 cells/μL|CD4 Cell Count Category||Participants|Count of Participants|56|56.0||||||
3629320|NCT02603107|3477818|B2||≥ 200 to < 350 cells/μL|CD4 Cell Count Category||Participants|Count of Participants|30|30.0||||||
3629321|NCT02603107|3477819|B1||≥ 200 to < 350 cells/μL|CD4 Cell Count Category||Participants|Count of Participants|26|26.0||||||
3629322|NCT02603107|3477817|B3||≥ 50 to < 200 cells/μL|CD4 Cell Count Category||Participants|Count of Participants|12|12.0||||||
3629323|NCT02603107|3477818|B2||≥ 50 to < 200 cells/μL|CD4 Cell Count Category||Participants|Count of Participants|8|8.0||||||
3629324|NCT02603107|3477819|B1||≥ 50 to < 200 cells/μL|CD4 Cell Count Category||Participants|Count of Participants|4|4.0||||||
3629325|NCT02603107|3477817|B3||< 50 cells/μL|CD4 Cell Count Category||Participants|Count of Participants|0|0.0||||||
3629326|NCT02603107|3477818|B2||< 50 cells/μL|CD4 Cell Count Category||Participants|Count of Participants|0|0.0||||||
3629327|NCT02603107|3477819|B1||< 50 cells/μL|CD4 Cell Count Category||Participants|Count of Participants|0|0.0||||||
3629328|NCT02603107|3477817|B3|||CD4 Cell Count||cells/μL|Mean|663|663.0|Standard Deviation|294.2|294.2|||
3629329|NCT02603107|3477818|B2|||CD4 Cell Count||cells/μL|Mean|657|657.0|Standard Deviation|285.0|285.0|||
3629330|NCT02603107|3477819|B1|||CD4 Cell Count||cells/μL|Mean|669|669.0|Standard Deviation|303.4|303.4|||
3629331|NCT02603107|3477817|B3||≥ 50 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|15|15.0||||||
3629332|NCT02603107|3477818|B2||≥ 50 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|10|10.0||||||
3629333|NCT02603107|3477819|B1||≥ 50 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|5|5.0||||||
3629334|NCT02603107|3477817|B3||< 50 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|562|562.0||||||
3629335|NCT02603107|3477818|B2||< 50 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|277|277.0||||||
3629336|NCT02603107|3477819|B1||< 50 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|285|285.0||||||
3629337|NCT02603107|3477817|B3|Dominican Republic||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3629338|NCT02603107|3477818|B2|Dominican Republic||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3629339|NCT02603107|3477819|B1|Dominican Republic||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3629340|NCT02603107|3477817|B3|United States||Region of Enrollment||Participants|Count of Participants|330|330.0||||||
3629341|NCT02603107|3477818|B2|United States||Region of Enrollment||Participants|Count of Participants|164|164.0||||||
3629342|NCT02603107|3477819|B1|United States||Region of Enrollment||Participants|Count of Participants|166|166.0||||||
3629343|NCT02603107|3477817|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
3629344|NCT02603107|3477818|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3629345|NCT02603107|3477819|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3629346|NCT02603107|3477817|B3|Spain||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3629347|NCT02603107|3477818|B2|Spain||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3629348|NCT02603107|3477819|B1|Spain||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3629349|NCT02603107|3477817|B3|Italy||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3629350|NCT02603107|3477818|B2|Italy||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3629351|NCT02603107|3477819|B1|Italy||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3629352|NCT02603107|3477817|B3|Germany||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
3629353|NCT02603107|3477818|B2|Germany||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3629354|NCT02603107|3477819|B1|Germany||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3629355|NCT02603107|3477817|B3|France||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3629356|NCT02603107|3477818|B2|France||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3629357|NCT02603107|3477819|B1|France||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3629358|NCT02603107|3477817|B3|Belgium||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3629359|NCT02603107|3477818|B2|Belgium||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3629360|NCT02603107|3477819|B1|Belgium||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3629361|NCT02603107|3477817|B3|Canada||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3629362|NCT02603107|3477818|B2|Canada||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3629363|NCT02603107|3477819|B1|Canada||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3629364|NCT02603107|3477817|B3|Australia||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3629365|NCT02603107|3477818|B2|Australia||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3629366|NCT02603107|3477819|B1|Australia||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3629483|NCT02601469|3478089|B1||Clear|Baseline IGA||Participants|Count of Participants|0|0.0||||||
3629367|NCT02603107|3477817|B3||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|470|470.0||||||
3629368|NCT02603107|3477818|B2||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|240|240.0||||||
3629369|NCT02603107|3477819|B1||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|230|230.0||||||
3629370|NCT02603107|3477817|B3||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|107|107.0||||||
3629371|NCT02603107|3477818|B2||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
3629372|NCT02603107|3477819|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|60|60.0||||||
3629373|NCT02603107|3477817|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3629374|NCT02603107|3477818|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3629375|NCT02603107|3477819|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3629376|NCT02603107|3477817|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|378|378.0||||||
3629377|NCT02603107|3477818|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|190|190.0||||||
3629378|NCT02603107|3477819|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|188|188.0||||||
3629379|NCT02603107|3477817|B3||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3629380|NCT02603107|3477818|B2||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3629381|NCT02603107|3477819|B1||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3629382|NCT02603107|3477817|B3||Black|Race/Ethnicity, Customized||Participants|Count of Participants|151|151.0||||||
3629383|NCT02603107|3477818|B2||Black|Race/Ethnicity, Customized||Participants|Count of Participants|72|72.0||||||
3629384|NCT02603107|3477819|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|79|79.0||||||
3629385|NCT02603107|3477817|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3629386|NCT02603107|3477818|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3629387|NCT02603107|3477819|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3629388|NCT02603107|3477817|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3629389|NCT02603107|3477818|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3629390|NCT02603107|3477819|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3629391|NCT02603107|3477817|B3||Male|Sex: Female, Male||Participants|Count of Participants|477|477.0||||||
3629392|NCT02603107|3477818|B2||Male|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
3629393|NCT02603107|3477819|B1||Male|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
3629394|NCT02603107|3477817|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3629395|NCT02603107|3477818|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3629396|NCT02603107|3477819|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3629397|NCT02603107|3477817|B3|||Age||years|Mean|46|46.0|Standard Deviation|10.5|10.5|||
3629398|NCT02603107|3477818|B2|||Age||years|Mean|46|46.0|Standard Deviation|10.5|10.5|||
3629399|NCT02603107|3477819|B1|||Age||years|Mean|47|47.0|Standard Deviation|10.5|10.5|||
3629400|NCT02602223|3477830|B1|Multiple (two) paired study sites||Number of participants with multiple study sites|Number of participants who received either single vs multiple bilateral sites|participants|Number|2|2.0||||||
3629401|NCT02602223|3477830|B1|Single paired study sites||Number of participants with multiple study sites|Number of participants who received either single vs multiple bilateral sites|participants|Number|7|7.0||||||
3629402|NCT02602223|3477830|B1|Mandible||Total Number of sites (maxilla vs Mandible)|Number of sites in maxilla that received either ACM or d-PTFE|Sites|Number|8|8.0||||||
3629403|NCT02602223|3477830|B1|Maxilla||Total Number of sites (maxilla vs Mandible)|Number of sites in maxilla that received either ACM or d-PTFE|Sites|Number|14|14.0||||||
3629404|NCT02602223|3477830|B1|Total||Total Number of sites (maxilla vs Mandible)|Number of sites in maxilla that received either ACM or d-PTFE|Sites|Number|22|22.0||||||
3629405|NCT02602223|3477830|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3629406|NCT02602223|3477830|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3629407|NCT02602223|3477830|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3629408|NCT02602223|3477830|B1|||Age||Years|Mean|54.88|54.88|Full Range|||34.0|71.0|
3629409|NCT02602223|3477830|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3629410|NCT02602223|3477830|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3629411|NCT02602223|3477830|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3629412|NCT02601976|3477846|B1|||Number of HCV Patients confirmed through Polymerase Chain Reaction|Patients sent for Polymerase Chain Reaction (PCR) Lab investigation and those were selected who had positive PCR.|participants|Number|64|64.0||||||
3629413|NCT02601976|3477846|B1|Pakistan||Region of Enrollment||Participants|Count of Participants|64|64.0||||||
3629414|NCT02601976|3477846|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629415|NCT02601976|3477846|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629416|NCT02601976|3477846|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629417|NCT02601976|3477846|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629418|NCT02601976|3477846|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629419|NCT02601976|3477846|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3629420|NCT02601976|3477846|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629421|NCT02601976|3477846|B1|Count|Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3629422|NCT02601976|3477846|B1|Count|Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3629423|NCT02601976|3477846|B1|Count||Age, Customized||participants|Mean|35.4|35.4|Standard Deviation|9.5|9.5|||
3629424|NCT02601573|3477854|B6||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3629425|NCT02601573|3477855|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3629426|NCT02601573|3477856|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3629427|NCT02601573|3477857|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3629428|NCT02601573|3477858|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3629429|NCT02601573|3477859|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3629430|NCT02601573|3477854|B6||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3629431|NCT02601573|3477855|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3629432|NCT02601573|3477856|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3629433|NCT02601573|3477857|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3629434|NCT02601573|3477858|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3629435|NCT02601573|3477859|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3629436|NCT02601573|3477854|B6|||Age||Years|Mean|53.4|53.4|Standard Deviation|8.7|8.7|||
3629437|NCT02601573|3477855|B5|||Age||Years|Mean|53.8|53.8|Standard Deviation|6.4|6.4|||
3629438|NCT02601573|3477856|B4|||Age||Years|Mean|56.1|56.1|Standard Deviation|8.4|8.4|||
3629439|NCT02601573|3477857|B3|||Age||Years|Mean|58.6|58.6|Standard Deviation|6.1|6.1|||
3629440|NCT02601573|3477858|B2|||Age||Years|Mean|48.1|48.1|Standard Deviation|9.3|9.3|||
3629441|NCT02601573|3477859|B1|||Age||Years|Mean|52.5|52.5|Standard Deviation|9.0|9.0|||
3629442|NCT02601560|3477890|B9||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3629443|NCT02601560|3477891|B8||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3629444|NCT02601560|3477892|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3629445|NCT02601560|3477893|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3629446|NCT02601560|3477894|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3629447|NCT02601560|3477895|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3629448|NCT02601560|3477896|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3629449|NCT02601560|3477897|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3629450|NCT02601560|3477898|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3629451|NCT02601560|3477890|B9||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3629452|NCT02601560|3477891|B8||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3629453|NCT02601560|3477892|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3629454|NCT02601560|3477893|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3629455|NCT02601560|3477894|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3629456|NCT02601560|3477895|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3629457|NCT02601560|3477896|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3629458|NCT02601560|3477897|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3629459|NCT02601560|3477898|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3629460|NCT02601560|3477890|B9|||Age||Years|Mean|64.0|64.0|Standard Deviation|6.9|6.9|||
3629461|NCT02601560|3477891|B8|||Age||Years|Mean|66.5|66.5|Standard Deviation|4.7|4.7|||
3629462|NCT02601560|3477892|B7|||Age||Years|Mean|71.3|71.3|Standard Deviation|3.4|3.4|||
3629463|NCT02601560|3477893|B6|||Age||Years|Mean|62.0|62.0|Standard Deviation|9.3|9.3|||
3629464|NCT02601560|3477894|B5|||Age||Years|Mean|65.8|65.8|Standard Deviation|8.2|8.2|||
3629465|NCT02601560|3477895|B4|||Age||Years|Mean|63.5|63.5|Standard Deviation|5.4|5.4|||
3629466|NCT02601560|3477896|B3|||Age||Years|Mean|60.0|60.0|Standard Deviation|6.4|6.4|||
3629467|NCT02601560|3477897|B2|||Age||Years|Mean|59.8|59.8|Standard Deviation|7.0|7.0|||
3629468|NCT02601560|3477898|B1|||Age||Years|Mean|62.8|62.8|Standard Deviation|6.5|6.5|||
3629469|NCT02601469|3478087|B3||Severe|Baseline IGA||Participants|Count of Participants|5|5.0||||||
3629470|NCT02601469|3478088|B2||Severe|Baseline IGA||Participants|Count of Participants|0|0.0||||||
3629471|NCT02601469|3478089|B1||Severe|Baseline IGA||Participants|Count of Participants|5|5.0||||||
3629472|NCT02601469|3478087|B3||Moderate|Baseline IGA||Participants|Count of Participants|21|21.0||||||
3629473|NCT02601469|3478088|B2||Moderate|Baseline IGA||Participants|Count of Participants|1|1.0||||||
3629474|NCT02601469|3478089|B1||Moderate|Baseline IGA||Participants|Count of Participants|20|20.0||||||
3629475|NCT02601469|3478087|B3||Mild|Baseline IGA||Participants|Count of Participants|0|0.0||||||
3629476|NCT02601469|3478088|B2||Mild|Baseline IGA||Participants|Count of Participants|0|0.0||||||
3629477|NCT02601469|3478089|B1||Mild|Baseline IGA||Participants|Count of Participants|0|0.0||||||
3629478|NCT02601469|3478087|B3||Minimal|Baseline IGA||Participants|Count of Participants|0|0.0||||||
3629479|NCT02601469|3478088|B2||Minimal|Baseline IGA||Participants|Count of Participants|0|0.0||||||
3629480|NCT02601469|3478089|B1||Minimal|Baseline IGA||Participants|Count of Participants|0|0.0||||||
3629481|NCT02601469|3478087|B3||Clear|Baseline IGA||Participants|Count of Participants|0|0.0||||||
3629484|NCT02601469|3478087|B3|||Baseline Total BSA||meters squared|Mean|2.10|2.1|Standard Deviation|0.30|0.3|||
3629485|NCT02601469|3478088|B2|||Baseline Total BSA||meters squared|Mean|1.83|1.83|Standard Deviation|||||
3629486|NCT02601469|3478089|B1|||Baseline Total BSA||meters squared|Mean|2.11|2.11|Standard Deviation|0.30|0.3|||
3629487|NCT02601469|3478087|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629488|NCT02601469|3478088|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629489|NCT02601469|3478089|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629490|NCT02601469|3478087|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629491|NCT02601469|3478088|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629492|NCT02601469|3478089|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629493|NCT02601469|3478087|B3||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3629494|NCT02601469|3478088|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3629495|NCT02601469|3478089|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3629496|NCT02601469|3478087|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3629497|NCT02601469|3478088|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629498|NCT02601469|3478089|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3629499|NCT02601469|3478087|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629500|NCT02601469|3478088|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629501|NCT02601469|3478089|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629502|NCT02601469|3478087|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629503|NCT02601469|3478088|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629504|NCT02601469|3478089|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629505|NCT02601469|3478087|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629506|NCT02601469|3478088|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629507|NCT02601469|3478089|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629508|NCT02601469|3478087|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629509|NCT02601469|3478088|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629510|NCT02601469|3478089|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629511|NCT02601469|3478087|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629512|NCT02601469|3478088|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629513|NCT02601469|3478089|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629514|NCT02601469|3478087|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3629515|NCT02601469|3478088|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3629516|NCT02601469|3478089|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3629517|NCT02601469|3478087|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3629518|NCT02601469|3478088|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3629519|NCT02601469|3478089|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3629520|NCT02601469|3478087|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3629521|NCT02601469|3478088|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3629522|NCT02601469|3478089|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3629523|NCT02601469|3478087|B3|||Age||years|Mean|55.19|55.19|Standard Deviation|14.85|14.85|||
3629524|NCT02601469|3478088|B2|||Age||years|Mean|17.00|17.0|Standard Deviation|||||
3629525|NCT02601469|3478089|B1|||Age||years|Mean|56.72|56.72|Standard Deviation|12.90|12.9|||
3629526|NCT02601300|3478096|B1|||Baseline Mayo Endoscopic Subscore|"The Mayo endoscopic subscore is one of the components of the Mayo score and ranges from 0 - 3 points and is defined as:~0 = Normal or inactive disease~= Mild Disease (erythema, decreased vascular pattern, mild friability)~= Moderate Disease (marked erythema, lack of vascular pattern, friability erosions)~= Severe Disease (spontaneous bleeding, ulceration)"|units on a scale|Mean|2.6|2.6|Standard Deviation|0.50|0.5|||
3629527|NCT02601300|3478096|B1|||Baseline Modified Mayo Score (MMS)|A modification to the total Mayo score (TMS) was implemented. The MMS was based on the stool frequency, rectal bleeding and endoscopy subscores of the total Mayo score, and excluded the Physician's Global subscore, since this was a global measure that is subjective in nature. The MMS ranges from 0 to 9 points, with higher scores indicating greater disease severity.|units on a scale|Mean|6.5|6.5|Standard Deviation|1.50|1.5|||
3629528|NCT02601300|3478096|B1|||Duration of Ulcerative Colitis||years|Mean|9.91|9.91|Standard Deviation|9.107|9.107|||
3629529|NCT02601300|3478096|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3629530|NCT02601300|3478096|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
3629531|NCT02601300|3478096|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3629532|NCT02601300|3478096|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3629533|NCT02601300|3478096|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3629534|NCT02601300|3478096|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3629535|NCT02601300|3478096|B1|||Age||years|Mean|42.0|42.0|Standard Deviation|11.91|11.91|||
3629536|NCT02600871|3478109|B3|Other||Culture results||Participants|Count of Participants|28|28.0||||||
3629537|NCT02600871|3478110|B2|Other||Culture results||Participants|Count of Participants|14|14.0||||||
3629538|NCT02600871|3478111|B1|Other||Culture results||Participants|Count of Participants|14|14.0||||||
3629539|NCT02600871|3478109|B3|No growth||Culture results||Participants|Count of Participants|6|6.0||||||
3629540|NCT02600871|3478110|B2|No growth||Culture results||Participants|Count of Participants|2|2.0||||||
3629541|NCT02600871|3478111|B1|No growth||Culture results||Participants|Count of Participants|4|4.0||||||
3629542|NCT02600871|3478109|B3|Streptococcus||Culture results||Participants|Count of Participants|11|11.0||||||
3629543|NCT02600871|3478110|B2|Streptococcus||Culture results||Participants|Count of Participants|6|6.0||||||
3629544|NCT02600871|3478111|B1|Streptococcus||Culture results||Participants|Count of Participants|5|5.0||||||
3629545|NCT02600871|3478109|B3|Coag neg Staph||Culture results||Participants|Count of Participants|18|18.0||||||
3629546|NCT02600871|3478110|B2|Coag neg Staph||Culture results||Participants|Count of Participants|11|11.0||||||
3629547|NCT02600871|3478111|B1|Coag neg Staph||Culture results||Participants|Count of Participants|7|7.0||||||
3629548|NCT02600871|3478109|B3|MSSA||Culture results||Participants|Count of Participants|16|16.0||||||
3629549|NCT02600871|3478110|B2|MSSA||Culture results||Participants|Count of Participants|10|10.0||||||
3629550|NCT02600871|3478111|B1|MSSA||Culture results||Participants|Count of Participants|6|6.0||||||
3629551|NCT02600871|3478109|B3|MRSA||Culture results||Participants|Count of Participants|34|34.0||||||
3629552|NCT02600871|3478110|B2|MRSA||Culture results||Participants|Count of Participants|17|17.0||||||
3629553|NCT02600871|3478111|B1|MRSA||Culture results||Participants|Count of Participants|17|17.0||||||
3629554|NCT02600871|3478109|B3|||Abscess size||cm^2|Median|15|15.0|Inter-Quartile Range|||7.3|28.5|
3629555|NCT02600871|3478110|B2|||Abscess size||cm^2|Median|12|12.0|Inter-Quartile Range|||5.0|33.0|
3629556|NCT02600871|3478111|B1|||Abscess size||cm^2|Median|18|18.0|Inter-Quartile Range|||8.0|27.0|
3629557|NCT02600871|3478109|B3|||Cellulitis||cm^2|Median|5|5.0|Inter-Quartile Range|||0.0|10.13|
3629558|NCT02600871|3478110|B2|||Cellulitis||cm^2|Median|5|5.0|Inter-Quartile Range|||0.0|9.0|
3629559|NCT02600871|3478111|B1|||Cellulitis||cm^2|Median|5|5.0|Inter-Quartile Range|||1.25|12.5|
3629560|NCT02600871|3478109|B3|Head and Neck||Abscess location||Participants|Count of Participants|11|11.0||||||
3629561|NCT02600871|3478110|B2|Head and Neck||Abscess location||Participants|Count of Participants|5|5.0||||||
3629562|NCT02600871|3478111|B1|Head and Neck||Abscess location||Participants|Count of Participants|6|6.0||||||
3629563|NCT02600871|3478109|B3|Axilla||Abscess location||Participants|Count of Participants|11|11.0||||||
3629564|NCT02600871|3478110|B2|Axilla||Abscess location||Participants|Count of Participants|6|6.0||||||
3629565|NCT02600871|3478111|B1|Axilla||Abscess location||Participants|Count of Participants|5|5.0||||||
3629566|NCT02600871|3478109|B3|Groin/Buttock||Abscess location||Participants|Count of Participants|24|24.0||||||
3629567|NCT02600871|3478110|B2|Groin/Buttock||Abscess location||Participants|Count of Participants|10|10.0||||||
3629568|NCT02600871|3478111|B1|Groin/Buttock||Abscess location||Participants|Count of Participants|14|14.0||||||
3629569|NCT02600871|3478109|B3|Extremity||Abscess location||Participants|Count of Participants|31|31.0||||||
3629570|NCT02600871|3478110|B2|Extremity||Abscess location||Participants|Count of Participants|14|14.0||||||
3629571|NCT02600871|3478111|B1|Extremity||Abscess location||Participants|Count of Participants|17|17.0||||||
3629572|NCT02600871|3478109|B3|Trunk||Abscess location||Participants|Count of Participants|27|27.0||||||
3629573|NCT02600871|3478110|B2|Trunk||Abscess location||Participants|Count of Participants|12|12.0||||||
3629574|NCT02600871|3478111|B1|Trunk||Abscess location||Participants|Count of Participants|15|15.0||||||
3629575|NCT02600871|3478109|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|56|56.0||||||
3629576|NCT02600871|3478110|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3629577|NCT02600871|3478111|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3629578|NCT02600871|3478109|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3629579|NCT02600871|3478110|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3629580|NCT02600871|3478111|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3629581|NCT02600871|3478109|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3629582|NCT02600871|3478110|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3629583|NCT02600871|3478111|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3629584|NCT02600871|3478109|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3629585|NCT02600871|3478110|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3629586|NCT02600871|3478111|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3629587|NCT02600871|3478109|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3629588|NCT02600871|3478110|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3629589|NCT02600871|3478111|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3629590|NCT02600871|3478109|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3629591|NCT02600871|3478110|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3629592|NCT02600871|3478111|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3629593|NCT02600871|3478109|B3|||Age||years|Mean|41.53|41.53|Standard Deviation|14.16|14.16|||
3629594|NCT02600871|3478110|B2|||Age||years|Mean|41.76|41.76|Standard Deviation|13.57|13.57|||
3629595|NCT02600871|3478111|B1|||Age||years|Mean|41.33|41.33|Standard Deviation|14.82|14.82|||
3629596|NCT02600845|3478122|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3629597|NCT02600845|3478122|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3629598|NCT02600845|3478122|B1|||Age||years|Mean|57.9|57.9|Standard Deviation|12.04|12.04|||
3629599|NCT02600819|3478137|B1||≥ 50 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|1|1.0||||||
3629600|NCT02600819|3478137|B1||< 50 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|54|54.0||||||
3629601|NCT02600819|3478137|B1|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3629602|NCT02600819|3478137|B1|France||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3629603|NCT02600819|3478137|B1|United States||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
3629604|NCT02600819|3478137|B1|Austria||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3629605|NCT02600819|3478137|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629606|NCT02600819|3478137|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629607|NCT02600819|3478137|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3629608|NCT02600819|3478137|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3629609|NCT02600819|3478137|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629610|NCT02600819|3478137|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629611|NCT02600819|3478137|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629612|NCT02600819|3478137|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629613|NCT02600819|3478137|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3629614|NCT02600819|3478137|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3629615|NCT02600819|3478137|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3629616|NCT02600819|3478137|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3629617|NCT02600819|3478137|B1|||Age||years|Mean|48|48.0|Standard Deviation|11.0|11.0|||
3629618|NCT02600767|3478147|B1|Brazil||Region of Enrollment||Participants|Count of Participants|79|79.0||||||
3629619|NCT02600767|3478147|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629620|NCT02600767|3478147|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629621|NCT02600767|3478147|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3629622|NCT02600767|3478147|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3629623|NCT02600767|3478147|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3629624|NCT02600767|3478147|B1|||Age||years|Median|30|30.0|Full Range|||5.0|79.0|
3629625|NCT02600715|3478151|B3|Opioid medication||Medication use in Last 24 Hours|Participant medication use in last 24 hours prior to intravesical onabotulinum toxin A injection|Participants|Count of Participants|3|3.0||||||
3629626|NCT02600715|3478152|B2|Opioid medication||Medication use in Last 24 Hours|Participant medication use in last 24 hours prior to intravesical onabotulinum toxin A injection|Participants|Count of Participants|1|1.0||||||
3629627|NCT02600715|3478153|B1|Opioid medication||Medication use in Last 24 Hours|Participant medication use in last 24 hours prior to intravesical onabotulinum toxin A injection|Participants|Count of Participants|2|2.0||||||
3629628|NCT02600715|3478151|B3|Neuromodulator medication||Medication use in Last 24 Hours|Participant medication use in last 24 hours prior to intravesical onabotulinum toxin A injection|Participants|Count of Participants|2|2.0||||||
3629629|NCT02600715|3478152|B2|Neuromodulator medication||Medication use in Last 24 Hours|Participant medication use in last 24 hours prior to intravesical onabotulinum toxin A injection|Participants|Count of Participants|1|1.0||||||
3629630|NCT02600715|3478153|B1|Neuromodulator medication||Medication use in Last 24 Hours|Participant medication use in last 24 hours prior to intravesical onabotulinum toxin A injection|Participants|Count of Participants|1|1.0||||||
3629631|NCT02600715|3478151|B3|Sedative medication||Medication use in Last 24 Hours|Participant medication use in last 24 hours prior to intravesical onabotulinum toxin A injection|Participants|Count of Participants|6|6.0||||||
3629632|NCT02600715|3478152|B2|Sedative medication||Medication use in Last 24 Hours|Participant medication use in last 24 hours prior to intravesical onabotulinum toxin A injection|Participants|Count of Participants|5|5.0||||||
3629633|NCT02600715|3478153|B1|Sedative medication||Medication use in Last 24 Hours|Participant medication use in last 24 hours prior to intravesical onabotulinum toxin A injection|Participants|Count of Participants|1|1.0||||||
3629634|NCT02600715|3478151|B3|Nonsteroidal anti-inflammatory drugs (NSAIDs)||Medication use in Last 24 Hours|Participant medication use in last 24 hours prior to intravesical onabotulinum toxin A injection|Participants|Count of Participants|11|11.0||||||
3629635|NCT02600715|3478152|B2|Nonsteroidal anti-inflammatory drugs (NSAIDs)||Medication use in Last 24 Hours|Participant medication use in last 24 hours prior to intravesical onabotulinum toxin A injection|Participants|Count of Participants|6|6.0||||||
3629636|NCT02600715|3478153|B1|Nonsteroidal anti-inflammatory drugs (NSAIDs)||Medication use in Last 24 Hours|Participant medication use in last 24 hours prior to intravesical onabotulinum toxin A injection|Participants|Count of Participants|5|5.0||||||
3629637|NCT02600715|3478151|B3|Selective serotonin reuptake inhibitors (SSRIs)||Medication use in Last 24 Hours|Participant medication use in last 24 hours prior to intravesical onabotulinum toxin A injection|Participants|Count of Participants|7|7.0||||||
3629638|NCT02600715|3478152|B2|Selective serotonin reuptake inhibitors (SSRIs)||Medication use in Last 24 Hours|Participant medication use in last 24 hours prior to intravesical onabotulinum toxin A injection|Participants|Count of Participants|0|0.0||||||
3629692|NCT02600715|3478152|B2|Oral estrogen||Estrogen use||Participants|Count of Participants|1|1.0||||||
3629639|NCT02600715|3478153|B1|Selective serotonin reuptake inhibitors (SSRIs)||Medication use in Last 24 Hours|Participant medication use in last 24 hours prior to intravesical onabotulinum toxin A injection|Participants|Count of Participants|7|7.0||||||
3629640|NCT02600715|3478151|B3|Back or spinal surgery||Surgical history||Participants|Count of Participants|5|5.0||||||
3629641|NCT02600715|3478152|B2|Back or spinal surgery||Surgical history||Participants|Count of Participants|2|2.0||||||
3629642|NCT02600715|3478153|B1|Back or spinal surgery||Surgical history||Participants|Count of Participants|3|3.0||||||
3629643|NCT02600715|3478151|B3|Laparotomy||Surgical history||Participants|Count of Participants|10|10.0||||||
3629644|NCT02600715|3478152|B2|Laparotomy||Surgical history||Participants|Count of Participants|5|5.0||||||
3629645|NCT02600715|3478153|B1|Laparotomy||Surgical history||Participants|Count of Participants|5|5.0||||||
3629646|NCT02600715|3478151|B3|Previous sling procedure||Surgical history||Participants|Count of Participants|6|6.0||||||
3629647|NCT02600715|3478152|B2|Previous sling procedure||Surgical history||Participants|Count of Participants|3|3.0||||||
3629648|NCT02600715|3478153|B1|Previous sling procedure||Surgical history||Participants|Count of Participants|3|3.0||||||
3629649|NCT02600715|3478151|B3|Prolapse surgery without mesh||Surgical history||Participants|Count of Participants|5|5.0||||||
3629650|NCT02600715|3478152|B2|Prolapse surgery without mesh||Surgical history||Participants|Count of Participants|3|3.0||||||
3629651|NCT02600715|3478153|B1|Prolapse surgery without mesh||Surgical history||Participants|Count of Participants|2|2.0||||||
3629652|NCT02600715|3478151|B3|Prolapse surgery with mesh||Surgical history||Participants|Count of Participants|1|1.0||||||
3629653|NCT02600715|3478152|B2|Prolapse surgery with mesh||Surgical history||Participants|Count of Participants|1|1.0||||||
3629654|NCT02600715|3478153|B1|Prolapse surgery with mesh||Surgical history||Participants|Count of Participants|0|0.0||||||
3629655|NCT02600715|3478151|B3|Bilateral salpingo-oophorectomy (BSO)||Surgical history||Participants|Count of Participants|13|13.0||||||
3629656|NCT02600715|3478152|B2|Bilateral salpingo-oophorectomy (BSO)||Surgical history||Participants|Count of Participants|7|7.0||||||
3629657|NCT02600715|3478153|B1|Bilateral salpingo-oophorectomy (BSO)||Surgical history||Participants|Count of Participants|6|6.0||||||
3629658|NCT02600715|3478151|B3|Hysterectomy||Surgical history||Participants|Count of Participants|20|20.0||||||
3629659|NCT02600715|3478152|B2|Hysterectomy||Surgical history||Participants|Count of Participants|10|10.0||||||
3629660|NCT02600715|3478153|B1|Hysterectomy||Surgical history||Participants|Count of Participants|10|10.0||||||
3629661|NCT02600715|3478151|B3|Diuretic medication||Medication use||Participants|Count of Participants|5|5.0||||||
3629662|NCT02600715|3478152|B2|Diuretic medication||Medication use||Participants|Count of Participants|4|4.0||||||
3629663|NCT02600715|3478153|B1|Diuretic medication||Medication use||Participants|Count of Participants|1|1.0||||||
3629664|NCT02600715|3478151|B3|Narcotic medication||Medication use||Participants|Count of Participants|2|2.0||||||
3629665|NCT02600715|3478152|B2|Narcotic medication||Medication use||Participants|Count of Participants|1|1.0||||||
3629666|NCT02600715|3478153|B1|Narcotic medication||Medication use||Participants|Count of Participants|1|1.0||||||
3629667|NCT02600715|3478151|B3|Steroid medication||Medication use||Participants|Count of Participants|1|1.0||||||
3629668|NCT02600715|3478152|B2|Steroid medication||Medication use||Participants|Count of Participants|0|0.0||||||
3629669|NCT02600715|3478153|B1|Steroid medication||Medication use||Participants|Count of Participants|1|1.0||||||
3629670|NCT02600715|3478151|B3|Rectocele||Gynecologic disorders/diagnoses||Participants|Count of Participants|1|1.0||||||
3629671|NCT02600715|3478152|B2|Rectocele||Gynecologic disorders/diagnoses||Participants|Count of Participants|1|1.0||||||
3629672|NCT02600715|3478153|B1|Rectocele||Gynecologic disorders/diagnoses||Participants|Count of Participants|0|0.0||||||
3629673|NCT02600715|3478151|B3|Uterine prolapse||Gynecologic disorders/diagnoses||Participants|Count of Participants|0|0.0||||||
3629674|NCT02600715|3478152|B2|Uterine prolapse||Gynecologic disorders/diagnoses||Participants|Count of Participants|0|0.0||||||
3629675|NCT02600715|3478153|B1|Uterine prolapse||Gynecologic disorders/diagnoses||Participants|Count of Participants|0|0.0||||||
3629676|NCT02600715|3478151|B3|Vaginal vault prolapse||Gynecologic disorders/diagnoses||Participants|Count of Participants|3|3.0||||||
3629677|NCT02600715|3478152|B2|Vaginal vault prolapse||Gynecologic disorders/diagnoses||Participants|Count of Participants|2|2.0||||||
3629678|NCT02600715|3478153|B1|Vaginal vault prolapse||Gynecologic disorders/diagnoses||Participants|Count of Participants|1|1.0||||||
3629679|NCT02600715|3478151|B3|Cystocele||Gynecologic disorders/diagnoses||Participants|Count of Participants|3|3.0||||||
3629680|NCT02600715|3478152|B2|Cystocele||Gynecologic disorders/diagnoses||Participants|Count of Participants|3|3.0||||||
3629681|NCT02600715|3478153|B1|Cystocele||Gynecologic disorders/diagnoses||Participants|Count of Participants|0|0.0||||||
3629682|NCT02600715|3478151|B3|Chronic cystitis||Gynecologic disorders/diagnoses||Participants|Count of Participants|5|5.0||||||
3629683|NCT02600715|3478152|B2|Chronic cystitis||Gynecologic disorders/diagnoses||Participants|Count of Participants|2|2.0||||||
3629684|NCT02600715|3478153|B1|Chronic cystitis||Gynecologic disorders/diagnoses||Participants|Count of Participants|3|3.0||||||
3629685|NCT02600715|3478151|B3|Constipation||Gynecologic disorders/diagnoses||Participants|Count of Participants|3|3.0||||||
3629686|NCT02600715|3478152|B2|Constipation||Gynecologic disorders/diagnoses||Participants|Count of Participants|2|2.0||||||
3629687|NCT02600715|3478153|B1|Constipation||Gynecologic disorders/diagnoses||Participants|Count of Participants|1|1.0||||||
3629688|NCT02600715|3478151|B3|Vulvovaginal atrophy||Gynecologic disorders/diagnoses||Participants|Count of Participants|14|14.0||||||
3629689|NCT02600715|3478152|B2|Vulvovaginal atrophy||Gynecologic disorders/diagnoses||Participants|Count of Participants|7|7.0||||||
3629690|NCT02600715|3478153|B1|Vulvovaginal atrophy||Gynecologic disorders/diagnoses||Participants|Count of Participants|7|7.0||||||
3629691|NCT02600715|3478151|B3|Oral estrogen||Estrogen use||Participants|Count of Participants|3|3.0||||||
3629693|NCT02600715|3478153|B1|Oral estrogen||Estrogen use||Participants|Count of Participants|2|2.0||||||
3629694|NCT02600715|3478151|B3|Vaginal estrogen||Estrogen use||Participants|Count of Participants|11|11.0||||||
3629695|NCT02600715|3478152|B2|Vaginal estrogen||Estrogen use||Participants|Count of Participants|7|7.0||||||
3629696|NCT02600715|3478153|B1|Vaginal estrogen||Estrogen use||Participants|Count of Participants|4|4.0||||||
3629697|NCT02600715|3478151|B3|||Menopausal||Participants|Count of Participants|25|25.0||||||
3629698|NCT02600715|3478152|B2|||Menopausal||Participants|Count of Participants|12|12.0||||||
3629699|NCT02600715|3478153|B1|||Menopausal||Participants|Count of Participants|13|13.0||||||
3629700|NCT02600715|3478151|B3|||Current smoker||Participants|Count of Participants|2|2.0||||||
3629701|NCT02600715|3478152|B2|||Current smoker||Participants|Count of Participants|1|1.0||||||
3629702|NCT02600715|3478153|B1|||Current smoker||Participants|Count of Participants|1|1.0||||||
3629703|NCT02600715|3478151|B3|||Vaginal parity|"Vaginal parity is the number of pregnancies that the patient had, that was carried to greater 20 weeks.~Zero indicates that the patient did not have any pregnancies beyond 20 weeks (nulliparous)."|pregnancies|Median|2|2.0|Inter-Quartile Range|||2.0|3.0|
3629704|NCT02600715|3478152|B2|||Vaginal parity|"Vaginal parity is the number of pregnancies that the patient had, that was carried to greater 20 weeks.~Zero indicates that the patient did not have any pregnancies beyond 20 weeks (nulliparous)."|pregnancies|Median|3|3.0|Inter-Quartile Range|||1.0|3.0|
3629705|NCT02600715|3478153|B1|||Vaginal parity|"Vaginal parity is the number of pregnancies that the patient had, that was carried to greater 20 weeks.~Zero indicates that the patient did not have any pregnancies beyond 20 weeks (nulliparous)."|pregnancies|Median|2|2.0|Inter-Quartile Range|||2.0|3.0|
3629706|NCT02600715|3478151|B3|||Body mass index||kg/m^2|Mean|34.82|34.82|Standard Deviation|9.02|9.02|||
3629707|NCT02600715|3478152|B2|||Body mass index||kg/m^2|Mean|34.19|34.19|Standard Deviation|6.33|6.33|||
3629708|NCT02600715|3478153|B1|||Body mass index||kg/m^2|Mean|35.45|35.45|Standard Deviation|11.34|11.34|||
3629709|NCT02600715|3478151|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629710|NCT02600715|3478152|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629711|NCT02600715|3478153|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629712|NCT02600715|3478151|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629713|NCT02600715|3478152|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629714|NCT02600715|3478153|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629715|NCT02600715|3478151|B3||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3629716|NCT02600715|3478152|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3629717|NCT02600715|3478153|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3629718|NCT02600715|3478151|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629719|NCT02600715|3478152|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629720|NCT02600715|3478153|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629721|NCT02600715|3478151|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629722|NCT02600715|3478152|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629723|NCT02600715|3478153|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629724|NCT02600715|3478151|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629725|NCT02600715|3478152|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629726|NCT02600715|3478153|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629727|NCT02600715|3478151|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629728|NCT02600715|3478152|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629729|NCT02600715|3478153|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629730|NCT02600715|3478151|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3629731|NCT02600715|3478152|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3629732|NCT02600715|3478153|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3629733|NCT02600715|3478151|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3629734|NCT02600715|3478152|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3629735|NCT02600715|3478153|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3629736|NCT02600715|3478151|B3|||Age||years|Mean|69.58|69.58|Standard Deviation|10.84|10.84|||
3629737|NCT02600715|3478152|B2|||Age||years|Mean|65.54|65.54|Standard Deviation|10.22|10.22|||
3629738|NCT02600715|3478153|B1|||Age||years|Mean|73.62|73.62|Standard Deviation|10.25|10.25|||
3629739|NCT02600611|3478183|B3|Peru||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3629740|NCT02600611|3478184|B2|Peru||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3629741|NCT02600611|3478185|B1|Peru||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3629742|NCT02600611|3478183|B3|Bulgaria||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3629743|NCT02600611|3478184|B2|Bulgaria||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3629744|NCT02600611|3478185|B1|Bulgaria||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3629745|NCT02600611|3478183|B3|Ukraine||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3629746|NCT02600611|3478184|B2|Ukraine||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3629805|NCT02600403|3478194|B4||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3629747|NCT02600611|3478185|B1|Ukraine||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3629748|NCT02600611|3478183|B3|United States||Region of Enrollment||Participants|Count of Participants|419|419.0||||||
3629749|NCT02600611|3478184|B2|United States||Region of Enrollment||Participants|Count of Participants|200|200.0||||||
3629750|NCT02600611|3478185|B1|United States||Region of Enrollment||Participants|Count of Participants|219|219.0||||||
3629751|NCT02600611|3478183|B3|Puerto Rico||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3629752|NCT02600611|3478184|B2|Puerto Rico||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3629753|NCT02600611|3478185|B1|Puerto Rico||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3629754|NCT02600611|3478183|B3|Latvia||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3629755|NCT02600611|3478184|B2|Latvia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3629756|NCT02600611|3478185|B1|Latvia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3629757|NCT02600611|3478183|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3629758|NCT02600611|3478184|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3629759|NCT02600611|3478185|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3629760|NCT02600611|3478183|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629761|NCT02600611|3478184|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629762|NCT02600611|3478185|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629763|NCT02600611|3478183|B3||White|Race (NIH/OMB)||Participants|Count of Participants|535|535.0||||||
3629764|NCT02600611|3478184|B2||White|Race (NIH/OMB)||Participants|Count of Participants|269|269.0||||||
3629765|NCT02600611|3478185|B1||White|Race (NIH/OMB)||Participants|Count of Participants|266|266.0||||||
3629766|NCT02600611|3478183|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3629767|NCT02600611|3478184|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3629768|NCT02600611|3478185|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3629769|NCT02600611|3478183|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629770|NCT02600611|3478184|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629771|NCT02600611|3478185|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629772|NCT02600611|3478183|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629773|NCT02600611|3478184|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629774|NCT02600611|3478185|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629775|NCT02600611|3478183|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629776|NCT02600611|3478184|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629777|NCT02600611|3478185|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629778|NCT02600611|3478183|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629779|NCT02600611|3478184|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629780|NCT02600611|3478185|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629781|NCT02600611|3478183|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|535|535.0||||||
3629782|NCT02600611|3478184|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|269|269.0||||||
3629783|NCT02600611|3478185|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|266|266.0||||||
3629784|NCT02600611|3478183|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3629785|NCT02600611|3478184|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3629786|NCT02600611|3478185|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3629787|NCT02600611|3478183|B3||Male|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
3629788|NCT02600611|3478184|B2||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3629789|NCT02600611|3478185|B1||Male|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
3629790|NCT02600611|3478183|B3||Female|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
3629791|NCT02600611|3478184|B2||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3629792|NCT02600611|3478185|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3629793|NCT02600611|3478183|B3|||Age||years|Mean|47.8|47.8|Standard Deviation|14.1|14.1|||
3629794|NCT02600611|3478184|B2|||Age||years|Mean|48.2|48.2|Standard Deviation|14.8|14.8|||
3629795|NCT02600611|3478185|B1|||Age||years|Mean|46.4|46.4|Standard Deviation|13.3|13.3|||
3629796|NCT02600611|3478183|B3||>=65 years|Age||Participants|Count of Participants|118|118.0||||||
3629797|NCT02600611|3478184|B2||>=65 years|Age||Participants|Count of Participants|60|60.0||||||
3629798|NCT02600611|3478185|B1||>=65 years|Age||Participants|Count of Participants|58|58.0||||||
3629799|NCT02600611|3478183|B3||Between 18 and 65 years|Age||Participants|Count of Participants|480|480.0||||||
3629800|NCT02600611|3478184|B2||Between 18 and 65 years|Age||Participants|Count of Participants|240|240.0||||||
3629801|NCT02600611|3478185|B1||Between 18 and 65 years|Age||Participants|Count of Participants|240|240.0||||||
3629802|NCT02600611|3478183|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3629803|NCT02600611|3478184|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3629804|NCT02600611|3478185|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3629806|NCT02600403|3478195|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3629807|NCT02600403|3478196|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3629808|NCT02600403|3478197|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3629809|NCT02600403|3478194|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3629810|NCT02600403|3478195|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3629811|NCT02600403|3478196|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3629812|NCT02600403|3478197|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3629813|NCT02600403|3478194|B4|||Age||years|Mean|64.5|64.5|Full Range|||27.0|84.0|
3629814|NCT02600403|3478195|B3|||Age||years|Mean|60|60.0|Full Range|||45.0|79.0|
3629815|NCT02600403|3478196|B2|||Age||years|Mean|65.5|65.5|Full Range|||55.0|75.0|
3629816|NCT02600403|3478197|B1|||Age||years|Mean|65.5|65.5|Full Range|||27.0|84.0|
3629817|NCT02600351|3478222|B5|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|62|62.0||||||
3629818|NCT02600351|3478223|B4|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|16|16.0||||||
3629819|NCT02600351|3478224|B3|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|18|18.0||||||
3629820|NCT02600351|3478225|B2|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|13|13.0||||||
3629821|NCT02600351|3478226|B1|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|15|15.0||||||
3629822|NCT02600351|3478222|B5|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|20|20.0||||||
3629823|NCT02600351|3478223|B4|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|8|8.0||||||
3629824|NCT02600351|3478224|B3|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|7|7.0||||||
3629825|NCT02600351|3478225|B2|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|4|4.0||||||
3629826|NCT02600351|3478226|B1|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|1|1.0||||||
3629827|NCT02600351|3478222|B5|||HCV RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.67|0.67|||
3629828|NCT02600351|3478223|B4|||HCV RNA||log10 IU/mL|Mean|6.0|6.0|Standard Deviation|0.89|0.89|||
3629829|NCT02600351|3478224|B3|||HCV RNA||log10 IU/mL|Mean|6.1|6.1|Standard Deviation|0.59|0.59|||
3629830|NCT02600351|3478225|B2|||HCV RNA||log10 IU/mL|Mean|6.4|6.4|Standard Deviation|0.48|0.48|||
3629831|NCT02600351|3478226|B1|||HCV RNA||log10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.45|0.45|||
3629832|NCT02600351|3478222|B5|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|22|22.0||||||
3629833|NCT02600351|3478223|B4|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|6|6.0||||||
3629834|NCT02600351|3478224|B3|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|9|9.0||||||
3629835|NCT02600351|3478225|B2|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|4|4.0||||||
3629836|NCT02600351|3478226|B1|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|3|3.0||||||
3629837|NCT02600351|3478222|B5|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|56|56.0||||||
3629838|NCT02600351|3478223|B4|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|17|17.0||||||
3629839|NCT02600351|3478224|B3|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|16|16.0||||||
3629840|NCT02600351|3478225|B2|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|11|11.0||||||
3629841|NCT02600351|3478226|B1|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|12|12.0||||||
3629842|NCT02600351|3478222|B5|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|4|4.0||||||
3629843|NCT02600351|3478223|B4|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|1|1.0||||||
3629844|NCT02600351|3478224|B3|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|0|0.0||||||
3629845|NCT02600351|3478225|B2|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|2|2.0||||||
3629846|NCT02600351|3478226|B1|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|1|1.0||||||
3629847|NCT02600351|3478222|B5|United States||Region of Enrollment||participants|Number|67|67.0||||||
3629848|NCT02600351|3478223|B4|United States||Region of Enrollment||participants|Number|16|16.0||||||
3629849|NCT02600351|3478224|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
3629850|NCT02600351|3478225|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3629851|NCT02600351|3478226|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3629852|NCT02600351|3478222|B5|Puerto Rico||Region of Enrollment||participants|Number|3|3.0||||||
3629853|NCT02600351|3478223|B4|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
3629854|NCT02600351|3478224|B3|Puerto Rico||Region of Enrollment||participants|Number|0|0.0||||||
3629855|NCT02600351|3478225|B2|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
3629856|NCT02600351|3478226|B1|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
3629857|NCT02600351|3478222|B5|Canada||Region of Enrollment||participants|Number|12|12.0||||||
3629858|NCT02600351|3478223|B4|Canada||Region of Enrollment||participants|Number|7|7.0||||||
3629859|NCT02600351|3478224|B3|Canada||Region of Enrollment||participants|Number|2|2.0||||||
3629860|NCT02600351|3478225|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
3629861|NCT02600351|3478226|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3629862|NCT02600351|3478222|B5||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|66|66.0||||||
3629863|NCT02600351|3478223|B4||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3629864|NCT02600351|3478224|B3||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3629865|NCT02600351|3478225|B2||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3629866|NCT02600351|3478226|B1||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3629867|NCT02600351|3478222|B5||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3629868|NCT02600351|3478223|B4||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3629869|NCT02600351|3478224|B3||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3629870|NCT02600351|3478225|B2||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3629871|NCT02600351|3478226|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3629872|NCT02600351|3478222|B5||White|Race/Ethnicity, Customized||Participants|Count of Participants|58|58.0||||||
3629873|NCT02600351|3478223|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3629874|NCT02600351|3478224|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3629875|NCT02600351|3478225|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3629876|NCT02600351|3478226|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3629877|NCT02600351|3478222|B5||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3629878|NCT02600351|3478223|B4||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3629879|NCT02600351|3478224|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3629880|NCT02600351|3478225|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3629881|NCT02600351|3478226|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3629882|NCT02600351|3478222|B5||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3629883|NCT02600351|3478223|B4||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3629884|NCT02600351|3478224|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3629885|NCT02600351|3478225|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3629886|NCT02600351|3478226|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3629887|NCT02600351|3478222|B5||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3629888|NCT02600351|3478223|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3629889|NCT02600351|3478224|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3629890|NCT02600351|3478225|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3629891|NCT02600351|3478226|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3629892|NCT02600351|3478222|B5||American Indian Or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3629893|NCT02600351|3478223|B4||American Indian Or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3629894|NCT02600351|3478224|B3||American Indian Or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3629895|NCT02600351|3478225|B2||American Indian Or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3629896|NCT02600351|3478226|B1||American Indian Or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3629897|NCT02600351|3478222|B5||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3629898|NCT02600351|3478223|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3629899|NCT02600351|3478224|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3629900|NCT02600351|3478225|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3629901|NCT02600351|3478226|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3629902|NCT02600351|3478222|B5||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3629903|NCT02600351|3478223|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3629904|NCT02600351|3478224|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3629905|NCT02600351|3478225|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3629906|NCT02600351|3478226|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3629907|NCT02600351|3478222|B5|||Age||years|Mean|59|59.0|Standard Deviation|6.1|6.1|||
3629908|NCT02600351|3478223|B4|||Age||years|Mean|60|60.0|Standard Deviation|4.5|4.5|||
3629909|NCT02600351|3478224|B3|||Age||years|Mean|58|58.0|Standard Deviation|7.8|7.8|||
3629910|NCT02600351|3478225|B2|||Age||years|Mean|57|57.0|Standard Deviation|5.5|5.5|||
3629911|NCT02600351|3478226|B1|||Age||years|Mean|58|58.0|Standard Deviation|5.7|5.7|||
3629912|NCT02599129|3478259|B3|Vertex (Top) profile of scalp||Severity of Alopecial Tool (SALT) Score|Scalp is divided into 4 areas namely, Vertex - 40% (0.4) of scalp surface area; right profile of scalp - 18% (0.18) of scalp surface area; left profile of scalp - 18% (0.18) of scalp surface area; Posterior aspect of scalp - 24% (0.24) of scalp surface area. Percentage of hair loss in any of these areas is percentage hair loss multiplied by percent surface area of the scalp in that area. SALT score is the sum of percentage of hair loss in all above mentioned areas.|percent hair loss|Mean|85.8|85.8|Standard Deviation|23.5|23.5|||
3630264|NCT02596945|3478455|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3629913|NCT02599129|3478260|B2|Vertex (Top) profile of scalp||Severity of Alopecial Tool (SALT) Score|Scalp is divided into 4 areas namely, Vertex - 40% (0.4) of scalp surface area; right profile of scalp - 18% (0.18) of scalp surface area; left profile of scalp - 18% (0.18) of scalp surface area; Posterior aspect of scalp - 24% (0.24) of scalp surface area. Percentage of hair loss in any of these areas is percentage hair loss multiplied by percent surface area of the scalp in that area. SALT score is the sum of percentage of hair loss in all above mentioned areas.|percent hair loss|Mean|98.75|98.75|Standard Deviation|2.5|2.5|||
3629914|NCT02599129|3478261|B1|Vertex (Top) profile of scalp||Severity of Alopecial Tool (SALT) Score|Scalp is divided into 4 areas namely, Vertex - 40% (0.4) of scalp surface area; right profile of scalp - 18% (0.18) of scalp surface area; left profile of scalp - 18% (0.18) of scalp surface area; Posterior aspect of scalp - 24% (0.24) of scalp surface area. Percentage of hair loss in any of these areas is percentage hair loss multiplied by percent surface area of the scalp in that area. SALT score is the sum of percentage of hair loss in all above mentioned areas.|percent hair loss|Mean|78.4|78.4|Standard Deviation|27.2|27.2|||
3629915|NCT02599129|3478259|B3|Posterior profile of scalp||Severity of Alopecial Tool (SALT) Score|Scalp is divided into 4 areas namely, Vertex - 40% (0.4) of scalp surface area; right profile of scalp - 18% (0.18) of scalp surface area; left profile of scalp - 18% (0.18) of scalp surface area; Posterior aspect of scalp - 24% (0.24) of scalp surface area. Percentage of hair loss in any of these areas is percentage hair loss multiplied by percent surface area of the scalp in that area. SALT score is the sum of percentage of hair loss in all above mentioned areas.|percent hair loss|Mean|86.4|86.4|Standard Deviation|19.0|19.0|||
3629916|NCT02599129|3478260|B2|Posterior profile of scalp||Severity of Alopecial Tool (SALT) Score|Scalp is divided into 4 areas namely, Vertex - 40% (0.4) of scalp surface area; right profile of scalp - 18% (0.18) of scalp surface area; left profile of scalp - 18% (0.18) of scalp surface area; Posterior aspect of scalp - 24% (0.24) of scalp surface area. Percentage of hair loss in any of these areas is percentage hair loss multiplied by percent surface area of the scalp in that area. SALT score is the sum of percentage of hair loss in all above mentioned areas.|percent hair loss|Mean|90.0|90.0|Standard Deviation|14.1|14.1|||
3629917|NCT02599129|3478261|B1|Posterior profile of scalp||Severity of Alopecial Tool (SALT) Score|Scalp is divided into 4 areas namely, Vertex - 40% (0.4) of scalp surface area; right profile of scalp - 18% (0.18) of scalp surface area; left profile of scalp - 18% (0.18) of scalp surface area; Posterior aspect of scalp - 24% (0.24) of scalp surface area. Percentage of hair loss in any of these areas is percentage hair loss multiplied by percent surface area of the scalp in that area. SALT score is the sum of percentage of hair loss in all above mentioned areas.|percent hair loss|Mean|84.3|84.3|Standard Deviation|22.1|22.1|||
3629918|NCT02599129|3478259|B3|Right profile of scalp||Severity of Alopecial Tool (SALT) Score|Scalp is divided into 4 areas namely, Vertex - 40% (0.4) of scalp surface area; right profile of scalp - 18% (0.18) of scalp surface area; left profile of scalp - 18% (0.18) of scalp surface area; Posterior aspect of scalp - 24% (0.24) of scalp surface area. Percentage of hair loss in any of these areas is percentage hair loss multiplied by percent surface area of the scalp in that area. SALT score is the sum of percentage of hair loss in all above mentioned areas.|percent hair loss|Mean|90.5|90.5|Standard Deviation|11.9|11.9|||
3629919|NCT02599129|3478260|B2|Right profile of scalp||Severity of Alopecial Tool (SALT) Score|Scalp is divided into 4 areas namely, Vertex - 40% (0.4) of scalp surface area; right profile of scalp - 18% (0.18) of scalp surface area; left profile of scalp - 18% (0.18) of scalp surface area; Posterior aspect of scalp - 24% (0.24) of scalp surface area. Percentage of hair loss in any of these areas is percentage hair loss multiplied by percent surface area of the scalp in that area. SALT score is the sum of percentage of hair loss in all above mentioned areas.|percent hair loss|Mean|95.0|95.0|Standard Deviation|10.0|10.0|||
3629920|NCT02599129|3478261|B1|Right profile of scalp||Severity of Alopecial Tool (SALT) Score|Scalp is divided into 4 areas namely, Vertex - 40% (0.4) of scalp surface area; right profile of scalp - 18% (0.18) of scalp surface area; left profile of scalp - 18% (0.18) of scalp surface area; Posterior aspect of scalp - 24% (0.24) of scalp surface area. Percentage of hair loss in any of these areas is percentage hair loss multiplied by percent surface area of the scalp in that area. SALT score is the sum of percentage of hair loss in all above mentioned areas.|percent hair loss|Mean|87.9|87.9|Standard Deviation|12.9|12.9|||
3629921|NCT02599129|3478259|B3|Left profile of scalp||Severity of Alopecial Tool (SALT) Score|Scalp is divided into 4 areas namely, Vertex - 40% (0.4) of scalp surface area; right profile of scalp - 18% (0.18) of scalp surface area; left profile of scalp - 18% (0.18) of scalp surface area; Posterior aspect of scalp - 24% (0.24) of scalp surface area. Percentage of hair loss in any of these areas is percentage hair loss multiplied by percent surface area of the scalp in that area. SALT score is the sum of percentage of hair loss in all above mentioned areas.|percent hair loss|Mean|87.7|87.7|Standard Deviation|15.1|15.1|||
3629922|NCT02599129|3478260|B2|Left profile of scalp||Severity of Alopecial Tool (SALT) Score|Scalp is divided into 4 areas namely, Vertex - 40% (0.4) of scalp surface area; right profile of scalp - 18% (0.18) of scalp surface area; left profile of scalp - 18% (0.18) of scalp surface area; Posterior aspect of scalp - 24% (0.24) of scalp surface area. Percentage of hair loss in any of these areas is percentage hair loss multiplied by percent surface area of the scalp in that area. SALT score is the sum of percentage of hair loss in all above mentioned areas.|percent hair loss|Mean|95.0|95.0|Standard Deviation|10.0|10.0|||
3629923|NCT02599129|3478261|B1|Left profile of scalp||Severity of Alopecial Tool (SALT) Score|Scalp is divided into 4 areas namely, Vertex - 40% (0.4) of scalp surface area; right profile of scalp - 18% (0.18) of scalp surface area; left profile of scalp - 18% (0.18) of scalp surface area; Posterior aspect of scalp - 24% (0.24) of scalp surface area. Percentage of hair loss in any of these areas is percentage hair loss multiplied by percent surface area of the scalp in that area. SALT score is the sum of percentage of hair loss in all above mentioned areas.|percent hair loss|Mean|83.6|83.6|Standard Deviation|16.5|16.5|||
3629924|NCT02599129|3478259|B3|SALT Score||Severity of Alopecial Tool (SALT) Score|Scalp is divided into 4 areas namely, Vertex - 40% (0.4) of scalp surface area; right profile of scalp - 18% (0.18) of scalp surface area; left profile of scalp - 18% (0.18) of scalp surface area; Posterior aspect of scalp - 24% (0.24) of scalp surface area. Percentage of hair loss in any of these areas is percentage hair loss multiplied by percent surface area of the scalp in that area. SALT score is the sum of percentage of hair loss in all above mentioned areas.|percent hair loss|Mean|87.1|87.1|Standard Deviation|8.6|8.6|||
3629976|NCT02598622|3478289|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629925|NCT02599129|3478260|B2|SALT Score||Severity of Alopecial Tool (SALT) Score|Scalp is divided into 4 areas namely, Vertex - 40% (0.4) of scalp surface area; right profile of scalp - 18% (0.18) of scalp surface area; left profile of scalp - 18% (0.18) of scalp surface area; Posterior aspect of scalp - 24% (0.24) of scalp surface area. Percentage of hair loss in any of these areas is percentage hair loss multiplied by percent surface area of the scalp in that area. SALT score is the sum of percentage of hair loss in all above mentioned areas.|percent hair loss|Mean|95.3|95.3|Standard Deviation|7.9|7.9|||
3629926|NCT02599129|3478261|B1|SALT Score||Severity of Alopecial Tool (SALT) Score|Scalp is divided into 4 areas namely, Vertex - 40% (0.4) of scalp surface area; right profile of scalp - 18% (0.18) of scalp surface area; left profile of scalp - 18% (0.18) of scalp surface area; Posterior aspect of scalp - 24% (0.24) of scalp surface area. Percentage of hair loss in any of these areas is percentage hair loss multiplied by percent surface area of the scalp in that area. SALT score is the sum of percentage of hair loss in all above mentioned areas.|percent hair loss|Mean|82.5|82.5|Standard Deviation|19.3|19.3|||
3629927|NCT02599129|3478259|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629928|NCT02599129|3478260|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629929|NCT02599129|3478261|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629930|NCT02599129|3478259|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629931|NCT02599129|3478260|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629932|NCT02599129|3478261|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629933|NCT02599129|3478259|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3629934|NCT02599129|3478260|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3629935|NCT02599129|3478261|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3629936|NCT02599129|3478259|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3629937|NCT02599129|3478260|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3629938|NCT02599129|3478261|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3629939|NCT02599129|3478259|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629940|NCT02599129|3478260|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629941|NCT02599129|3478261|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629942|NCT02599129|3478259|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629943|NCT02599129|3478260|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629944|NCT02599129|3478261|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629945|NCT02599129|3478259|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629946|NCT02599129|3478260|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629947|NCT02599129|3478261|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629948|NCT02599129|3478259|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3629949|NCT02599129|3478260|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3629950|NCT02599129|3478261|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3629951|NCT02599129|3478259|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3629952|NCT02599129|3478260|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3629953|NCT02599129|3478261|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3629954|NCT02599129|3478259|B3|||Age||years|Mean|39.3|39.3|Standard Deviation|16.3|16.3|||
3629955|NCT02599129|3478260|B2|||Age||years|Mean|52.2|52.2|Standard Deviation|11.3|11.3|||
3629956|NCT02599129|3478261|B1|||Age||years|Mean|31.9|31.9|Standard Deviation|14.3|14.3|||
3629957|NCT02598934|3478276|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3629958|NCT02598934|3478277|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3629959|NCT02598934|3478278|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3629960|NCT02598934|3478276|B3||Female|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
3629961|NCT02598934|3478277|B2||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3629962|NCT02598934|3478278|B1||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3629963|NCT02598934|3478276|B3|||Age||years|Mean|65.1|65.1|Standard Deviation|9.80|9.8|||
3629964|NCT02598934|3478277|B2|||Age||years|Mean|64.9|64.9|Standard Deviation|9.69|9.69|||
3629965|NCT02598934|3478278|B1|||Age||years|Mean|65.3|65.3|Standard Deviation|9.94|9.94|||
3629966|NCT02598622|3478289|B3|United States||Region of Enrollment||participants|Number|0|0.0||||||
3629967|NCT02598622|3478291|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3629968|NCT02598622|3478289|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629969|NCT02598622|3478291|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629970|NCT02598622|3478289|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629971|NCT02598622|3478291|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629972|NCT02598622|3478289|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3629973|NCT02598622|3478291|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3629974|NCT02598622|3478289|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629975|NCT02598622|3478291|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629977|NCT02598622|3478291|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629978|NCT02598622|3478289|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629979|NCT02598622|3478291|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629980|NCT02598622|3478289|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629981|NCT02598622|3478291|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629982|NCT02598622|3478289|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629983|NCT02598622|3478291|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3629984|NCT02598622|3478289|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3629985|NCT02598622|3478291|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3629986|NCT02598622|3478289|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3629987|NCT02598622|3478291|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3629988|NCT02598622|3478289|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3629989|NCT02598622|3478291|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3629990|NCT02598622|3478289|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3629991|NCT02598622|3478291|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3629992|NCT02598622|3478289|B3|||Age||years|Mean|8|8.0|Full Range|||5.0|14.0|
3629993|NCT02598622|3478291|B1|||Age||years|Mean|8|8.0|Full Range|||5.0|14.0|
3629994|NCT02598622|3478289|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3629995|NCT02598622|3478291|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3629996|NCT02598622|3478289|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3629997|NCT02598622|3478291|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3629998|NCT02598622|3478289|B3||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
3629999|NCT02598622|3478291|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
3630000|NCT02598583|3478298|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3630001|NCT02598583|3478299|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3630002|NCT02598583|3478300|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3630003|NCT02598583|3478298|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3630004|NCT02598583|3478299|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3630005|NCT02598583|3478300|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3630006|NCT02598583|3478298|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3630007|NCT02598583|3478299|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3630008|NCT02598583|3478300|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3630009|NCT02598583|3478298|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3630010|NCT02598583|3478299|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3630011|NCT02598583|3478300|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3630012|NCT02598583|3478298|B3|||Age||years|Mean|42.4|42.4|Standard Deviation|11.91|11.91|||
3630013|NCT02598583|3478299|B2|||Age||years|Mean|43.6|43.6|Standard Deviation|13.48|13.48|||
3630014|NCT02598583|3478300|B1|||Age||years|Mean|41.1|41.1|Standard Deviation|10.87|10.87|||
3630015|NCT02598193|3478319|B1|Asian/White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3630016|NCT02598193|3478319|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3630017|NCT02598193|3478319|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3630018|NCT02598193|3478319|B1|White||Race/Ethnicity, Customized||Participants|Number|84|84.0||||||
3630019|NCT02598193|3478319|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3630020|NCT02598193|3478319|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3630021|NCT02598193|3478319|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3630022|NCT02598193|3478319|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3630023|NCT02598193|3478319|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3630024|NCT02598193|3478319|B1|||Age||Years|Mean|68.2|68.2|Standard Deviation|6.82|6.82|||
3630025|NCT02598128|3478327|B1|||Baseline Body Mass Index||kg/m^2|Mean|17.47|17.47|Standard Deviation|2.026|2.026|||
3630026|NCT02598128|3478327|B1|||Baseline Height|Safety Population: Baseline Height|centimeters|Mean|152.32|152.32|Standard Deviation|19.640|19.64|||
3630027|NCT02598128|3478327|B1|||Baseline Weight||kilograms|Mean|41.81|41.81|Standard Deviation|13.332|13.332|||
3630028|NCT02598128|3478327|B1|United States||Region of Enrollment|11 United States clinical sites.|Participants|Count of Participants|33|33.0||||||
3630029|NCT02598128|3478327|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3630030|NCT02598128|3478327|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630031|NCT02598128|3478327|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3630032|NCT02598128|3478327|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3630033|NCT02598128|3478327|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630034|NCT02598128|3478327|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630035|NCT02598128|3478327|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630036|NCT02598128|3478327|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630037|NCT02598128|3478327|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3630038|NCT02598128|3478327|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3630039|NCT02598128|3478327|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3630040|NCT02598128|3478327|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3630041|NCT02598128|3478327|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3630042|NCT02598128|3478327|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3630043|NCT02598128|3478327|B1||<=18 years|Age||Participants|Count of Participants|27|27.0||||||
3630044|NCT02597907|3478342|B3|Korea, Republic of||Region of Enrollment||Participants|Count of Participants|88|88.0||||||
3630045|NCT02597907|3478343|B2|Korea, Republic of||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3630046|NCT02597907|3478344|B1|Korea, Republic of||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3630047|NCT02597907|3478342|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3630048|NCT02597907|3478342|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3630049|NCT02597907|3478343|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3630050|NCT02597907|3478344|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3630051|NCT02597907|3478342|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3630052|NCT02597907|3478343|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3630053|NCT02597907|3478344|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3630054|NCT02597907|3478342|B3|||Age||years|Mean|48.8|48.8|Standard Deviation|10.2|10.2|||
3630055|NCT02597907|3478343|B2|||Age||years|Mean|48.8|48.8|Standard Deviation|10.2|10.2|||
3630056|NCT02597907|3478344|B1|||Age||years|Mean|48.9|48.9|Standard Deviation|10.6|10.6|||
3630057|NCT02597907|3478342|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3630058|NCT02597907|3478343|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3630059|NCT02597907|3478344|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3630060|NCT02597907|3478342|B3||Between 18 and 65 years|Age||Participants|Count of Participants|88|88.0||||||
3630061|NCT02597907|3478343|B2||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3630062|NCT02597907|3478344|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3630063|NCT02597907|3478342|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3630064|NCT02597907|3478343|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3630065|NCT02597907|3478344|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3630066|NCT02597855|3478351|B3|Korea, Republic of||Region of Enrollment||participants|Number|29|29.0||||||
3630067|NCT02597855|3478352|B2|Korea, Republic of||Region of Enrollment||participants|Number|13|13.0||||||
3630068|NCT02597855|3478353|B1|Korea, Republic of||Region of Enrollment||participants|Number|16|16.0||||||
3630069|NCT02597855|3478351|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3630070|NCT02597855|3478352|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3630071|NCT02597855|3478353|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3630072|NCT02597855|3478351|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3630073|NCT02597855|3478352|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3630074|NCT02597855|3478353|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3630075|NCT02597855|3478351|B3|||Age||years|Mean|67.2|67.2|Standard Deviation|7.5|7.5|||
3630076|NCT02597855|3478352|B2|||Age||years|Mean|64.2|64.2|Standard Deviation|6.6|6.6|||
3630077|NCT02597855|3478353|B1|||Age||years|Mean|69.7|69.7|Standard Deviation|7.4|7.4|||
3630078|NCT02597582|3478362|B3|Level II, III, IV||Levels of neck dissection|"Level of cervical lymph node is based on the anatomical location~Briefly, the level of cervical lymph node is described as below~Level I: Submental and submandibular nodes~Level II: Upper jugular nodes - Between posterior belly of digastric muscles superiorly and hyoid bone inferiorly~Level III: Middle jugular nodes - between the hyoid bone and cricoid cartilage~Level IV: Lower jugular nodes - between the cricoid cartilage and the clavicle~Level V: Posterior cervical or spinal accessory nodes, posterior to the sternocleidomastoid muscle"|participants|Number|9|9.0||||||
3630079|NCT02597582|3478363|B2|Level II, III, IV||Levels of neck dissection|"Level of cervical lymph node is based on the anatomical location~Briefly, the level of cervical lymph node is described as below~Level I: Submental and submandibular nodes~Level II: Upper jugular nodes - Between posterior belly of digastric muscles superiorly and hyoid bone inferiorly~Level III: Middle jugular nodes - between the hyoid bone and cricoid cartilage~Level IV: Lower jugular nodes - between the cricoid cartilage and the clavicle~Level V: Posterior cervical or spinal accessory nodes, posterior to the sternocleidomastoid muscle"|participants|Number|3|3.0||||||
3630080|NCT02597582|3478364|B1|Level II, III, IV||Levels of neck dissection|"Level of cervical lymph node is based on the anatomical location~Briefly, the level of cervical lymph node is described as below~Level I: Submental and submandibular nodes~Level II: Upper jugular nodes - Between posterior belly of digastric muscles superiorly and hyoid bone inferiorly~Level III: Middle jugular nodes - between the hyoid bone and cricoid cartilage~Level IV: Lower jugular nodes - between the cricoid cartilage and the clavicle~Level V: Posterior cervical or spinal accessory nodes, posterior to the sternocleidomastoid muscle"|participants|Number|6|6.0||||||
3630144|NCT02597543|3478381|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630145|NCT02597543|3478382|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630146|NCT02597543|3478383|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630081|NCT02597582|3478362|B3|Level I, II, III, IV||Levels of neck dissection|"Level of cervical lymph node is based on the anatomical location~Briefly, the level of cervical lymph node is described as below~Level I: Submental and submandibular nodes~Level II: Upper jugular nodes - Between posterior belly of digastric muscles superiorly and hyoid bone inferiorly~Level III: Middle jugular nodes - between the hyoid bone and cricoid cartilage~Level IV: Lower jugular nodes - between the cricoid cartilage and the clavicle~Level V: Posterior cervical or spinal accessory nodes, posterior to the sternocleidomastoid muscle"|participants|Number|6|6.0||||||
3630082|NCT02597582|3478363|B2|Level I, II, III, IV||Levels of neck dissection|"Level of cervical lymph node is based on the anatomical location~Briefly, the level of cervical lymph node is described as below~Level I: Submental and submandibular nodes~Level II: Upper jugular nodes - Between posterior belly of digastric muscles superiorly and hyoid bone inferiorly~Level III: Middle jugular nodes - between the hyoid bone and cricoid cartilage~Level IV: Lower jugular nodes - between the cricoid cartilage and the clavicle~Level V: Posterior cervical or spinal accessory nodes, posterior to the sternocleidomastoid muscle"|participants|Number|3|3.0||||||
3630083|NCT02597582|3478364|B1|Level I, II, III, IV||Levels of neck dissection|"Level of cervical lymph node is based on the anatomical location~Briefly, the level of cervical lymph node is described as below~Level I: Submental and submandibular nodes~Level II: Upper jugular nodes - Between posterior belly of digastric muscles superiorly and hyoid bone inferiorly~Level III: Middle jugular nodes - between the hyoid bone and cricoid cartilage~Level IV: Lower jugular nodes - between the cricoid cartilage and the clavicle~Level V: Posterior cervical or spinal accessory nodes, posterior to the sternocleidomastoid muscle"|participants|Number|3|3.0||||||
3630084|NCT02597582|3478362|B3|Level I, II, III||Levels of neck dissection|"Level of cervical lymph node is based on the anatomical location~Briefly, the level of cervical lymph node is described as below~Level I: Submental and submandibular nodes~Level II: Upper jugular nodes - Between posterior belly of digastric muscles superiorly and hyoid bone inferiorly~Level III: Middle jugular nodes - between the hyoid bone and cricoid cartilage~Level IV: Lower jugular nodes - between the cricoid cartilage and the clavicle~Level V: Posterior cervical or spinal accessory nodes, posterior to the sternocleidomastoid muscle"|participants|Number|26|26.0||||||
3630085|NCT02597582|3478363|B2|Level I, II, III||Levels of neck dissection|"Level of cervical lymph node is based on the anatomical location~Briefly, the level of cervical lymph node is described as below~Level I: Submental and submandibular nodes~Level II: Upper jugular nodes - Between posterior belly of digastric muscles superiorly and hyoid bone inferiorly~Level III: Middle jugular nodes - between the hyoid bone and cricoid cartilage~Level IV: Lower jugular nodes - between the cricoid cartilage and the clavicle~Level V: Posterior cervical or spinal accessory nodes, posterior to the sternocleidomastoid muscle"|participants|Number|14|14.0||||||
3630086|NCT02597582|3478364|B1|Level I, II, III||Levels of neck dissection|"Level of cervical lymph node is based on the anatomical location~Briefly, the level of cervical lymph node is described as below~Level I: Submental and submandibular nodes~Level II: Upper jugular nodes - Between posterior belly of digastric muscles superiorly and hyoid bone inferiorly~Level III: Middle jugular nodes - between the hyoid bone and cricoid cartilage~Level IV: Lower jugular nodes - between the cricoid cartilage and the clavicle~Level V: Posterior cervical or spinal accessory nodes, posterior to the sternocleidomastoid muscle"|participants|Number|12|12.0||||||
3630087|NCT02597582|3478362|B3|N2||Clinical N stage|"Clinical N stage was in accordance with the guidelines of the American Joint Committee on Cancer (7th edition, 2009)~Briefly, the clinical N stage was described at below.~N0: No regional lymph node metastasis~N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension~N2: Metastasis of regional lymph node(s), none more than 6 cm in greatest dimension~Basically, a better survival is expected in N0 stage yet a worse survival is anticipated in N2 stage."|participants|Number|14|14.0||||||
3630088|NCT02597582|3478363|B2|N2||Clinical N stage|"Clinical N stage was in accordance with the guidelines of the American Joint Committee on Cancer (7th edition, 2009)~Briefly, the clinical N stage was described at below.~N0: No regional lymph node metastasis~N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension~N2: Metastasis of regional lymph node(s), none more than 6 cm in greatest dimension~Basically, a better survival is expected in N0 stage yet a worse survival is anticipated in N2 stage."|participants|Number|7|7.0||||||
3630089|NCT02597582|3478364|B1|N2||Clinical N stage|"Clinical N stage was in accordance with the guidelines of the American Joint Committee on Cancer (7th edition, 2009)~Briefly, the clinical N stage was described at below.~N0: No regional lymph node metastasis~N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension~N2: Metastasis of regional lymph node(s), none more than 6 cm in greatest dimension~Basically, a better survival is expected in N0 stage yet a worse survival is anticipated in N2 stage."|participants|Number|7|7.0||||||
3630090|NCT02597582|3478362|B3|N1||Clinical N stage|"Clinical N stage was in accordance with the guidelines of the American Joint Committee on Cancer (7th edition, 2009)~Briefly, the clinical N stage was described at below.~N0: No regional lymph node metastasis~N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension~N2: Metastasis of regional lymph node(s), none more than 6 cm in greatest dimension~Basically, a better survival is expected in N0 stage yet a worse survival is anticipated in N2 stage."|participants|Number|8|8.0||||||
3630091|NCT02597582|3478363|B2|N1||Clinical N stage|"Clinical N stage was in accordance with the guidelines of the American Joint Committee on Cancer (7th edition, 2009)~Briefly, the clinical N stage was described at below.~N0: No regional lymph node metastasis~N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension~N2: Metastasis of regional lymph node(s), none more than 6 cm in greatest dimension~Basically, a better survival is expected in N0 stage yet a worse survival is anticipated in N2 stage."|participants|Number|2|2.0||||||
3630092|NCT02597582|3478364|B1|N1||Clinical N stage|"Clinical N stage was in accordance with the guidelines of the American Joint Committee on Cancer (7th edition, 2009)~Briefly, the clinical N stage was described at below.~N0: No regional lymph node metastasis~N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension~N2: Metastasis of regional lymph node(s), none more than 6 cm in greatest dimension~Basically, a better survival is expected in N0 stage yet a worse survival is anticipated in N2 stage."|participants|Number|6|6.0||||||
3630147|NCT02597543|3478381|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630148|NCT02597543|3478382|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630149|NCT02597543|3478383|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630093|NCT02597582|3478362|B3|N0||Clinical N stage|"Clinical N stage was in accordance with the guidelines of the American Joint Committee on Cancer (7th edition, 2009)~Briefly, the clinical N stage was described at below.~N0: No regional lymph node metastasis~N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension~N2: Metastasis of regional lymph node(s), none more than 6 cm in greatest dimension~Basically, a better survival is expected in N0 stage yet a worse survival is anticipated in N2 stage."|participants|Number|19|19.0||||||
3630094|NCT02597582|3478363|B2|N0||Clinical N stage|"Clinical N stage was in accordance with the guidelines of the American Joint Committee on Cancer (7th edition, 2009)~Briefly, the clinical N stage was described at below.~N0: No regional lymph node metastasis~N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension~N2: Metastasis of regional lymph node(s), none more than 6 cm in greatest dimension~Basically, a better survival is expected in N0 stage yet a worse survival is anticipated in N2 stage."|participants|Number|11|11.0||||||
3630095|NCT02597582|3478364|B1|N0||Clinical N stage|"Clinical N stage was in accordance with the guidelines of the American Joint Committee on Cancer (7th edition, 2009)~Briefly, the clinical N stage was described at below.~N0: No regional lymph node metastasis~N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension~N2: Metastasis of regional lymph node(s), none more than 6 cm in greatest dimension~Basically, a better survival is expected in N0 stage yet a worse survival is anticipated in N2 stage."|participants|Number|8|8.0||||||
3630096|NCT02597582|3478362|B3|Others||Primary tumor site||participants|Number|6|6.0||||||
3630097|NCT02597582|3478363|B2|Others||Primary tumor site||participants|Number|3|3.0||||||
3630098|NCT02597582|3478364|B1|Others||Primary tumor site||participants|Number|3|3.0||||||
3630099|NCT02597582|3478362|B3|Thyroid gland||Primary tumor site||participants|Number|5|5.0||||||
3630100|NCT02597582|3478363|B2|Thyroid gland||Primary tumor site||participants|Number|2|2.0||||||
3630101|NCT02597582|3478364|B1|Thyroid gland||Primary tumor site||participants|Number|3|3.0||||||
3630102|NCT02597582|3478362|B3|Oropharynx||Primary tumor site||participants|Number|6|6.0||||||
3630103|NCT02597582|3478363|B2|Oropharynx||Primary tumor site||participants|Number|3|3.0||||||
3630104|NCT02597582|3478364|B1|Oropharynx||Primary tumor site||participants|Number|3|3.0||||||
3630105|NCT02597582|3478362|B3|Oral cavity||Primary tumor site||participants|Number|24|24.0||||||
3630106|NCT02597582|3478363|B2|Oral cavity||Primary tumor site||participants|Number|12|12.0||||||
3630107|NCT02597582|3478364|B1|Oral cavity||Primary tumor site||participants|Number|12|12.0||||||
3630108|NCT02597582|3478362|B3|Taiwan||Region of Enrollment||participants|Number|41|41.0||||||
3630109|NCT02597582|3478363|B2|Taiwan||Region of Enrollment||participants|Number|20|20.0||||||
3630110|NCT02597582|3478364|B1|Taiwan||Region of Enrollment||participants|Number|21|21.0||||||
3630111|NCT02597582|3478362|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3630112|NCT02597582|3478363|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3630113|NCT02597582|3478364|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3630114|NCT02597582|3478362|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3630115|NCT02597582|3478363|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3630116|NCT02597582|3478364|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3630117|NCT02597582|3478362|B3|||Age||years|Mean|52.4|52.4|Standard Deviation|8.7|8.7|||
3630118|NCT02597582|3478363|B2|||Age||years|Mean|51.1|51.1|Standard Deviation|8.1|8.1|||
3630119|NCT02597582|3478364|B1|||Age||years|Mean|53.6|53.6|Standard Deviation|9.3|9.3|||
3630120|NCT02597582|3478362|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3630121|NCT02597582|3478363|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3630122|NCT02597582|3478364|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3630123|NCT02597582|3478362|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3630124|NCT02597582|3478363|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3630125|NCT02597582|3478364|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3630126|NCT02597582|3478362|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3630127|NCT02597582|3478363|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3630128|NCT02597582|3478364|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3630129|NCT02597543|3478381|B3|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3630130|NCT02597543|3478382|B2|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3630131|NCT02597543|3478383|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3630132|NCT02597543|3478381|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3630133|NCT02597543|3478382|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3630134|NCT02597543|3478383|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3630135|NCT02597543|3478381|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630136|NCT02597543|3478382|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630137|NCT02597543|3478383|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630138|NCT02597543|3478381|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3630139|NCT02597543|3478382|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3630140|NCT02597543|3478383|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3630141|NCT02597543|3478381|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3630142|NCT02597543|3478382|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3630143|NCT02597543|3478383|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3630150|NCT02597543|3478381|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630151|NCT02597543|3478382|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630152|NCT02597543|3478383|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630153|NCT02597543|3478381|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3630154|NCT02597543|3478382|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3630155|NCT02597543|3478383|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3630156|NCT02597543|3478381|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3630157|NCT02597543|3478382|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3630158|NCT02597543|3478383|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3630159|NCT02597543|3478381|B3|||Age||years|Median|64|64.0|Inter-Quartile Range|||48.0|70.5|
3630160|NCT02597543|3478382|B2|||Age||years|Median|66|66.0|Inter-Quartile Range|||52.0|68.5|
3630161|NCT02597543|3478383|B1|||Age||years|Median|61.5|61.5|Inter-Quartile Range|||48.0|70.5|
3630162|NCT02597543|3478381|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3630163|NCT02597543|3478382|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3630164|NCT02597543|3478383|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3630165|NCT02597543|3478381|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3630166|NCT02597543|3478382|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3630167|NCT02597543|3478383|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3630168|NCT02597543|3478381|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3630169|NCT02597543|3478382|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3630170|NCT02597543|3478383|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3630171|NCT02597049|3478400|B4|||Baseline Mean Hemoglobin A1c (HbA1c) Treatment-Regimen Estimand||percentage of HbA1c|Mean|8.04|8.04|Standard Deviation|0.64|0.64|||
3630172|NCT02597049|3478401|B3|||Baseline Mean Hemoglobin A1c (HbA1c) Treatment-Regimen Estimand||percentage of HbA1c|Mean|8.05|8.05|Standard Deviation|0.66|0.66|||
3630173|NCT02597049|3478402|B2|||Baseline Mean Hemoglobin A1c (HbA1c) Treatment-Regimen Estimand||percentage of HbA1c|Mean|8.04|8.04|Standard Deviation|0.61|0.61|||
3630174|NCT02597049|3478403|B1|||Baseline Mean Hemoglobin A1c (HbA1c) Treatment-Regimen Estimand||percentage of HbA1c|Mean|8.04|8.04|Standard Deviation|0.66|0.66|||
3630175|NCT02597049|3478400|B4|Spain||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3630176|NCT02597049|3478401|B3|Spain||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3630177|NCT02597049|3478402|B2|Spain||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3630178|NCT02597049|3478403|B1|Spain||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3630179|NCT02597049|3478400|B4|Germany||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3630180|NCT02597049|3478401|B3|Germany||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3630181|NCT02597049|3478402|B2|Germany||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3630182|NCT02597049|3478403|B1|Germany||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3630183|NCT02597049|3478400|B4|Israel||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3630184|NCT02597049|3478401|B3|Israel||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3630185|NCT02597049|3478402|B2|Israel||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3630186|NCT02597049|3478403|B1|Israel||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3630187|NCT02597049|3478400|B4|Mexico||Region of Enrollment||Participants|Count of Participants|83|83.0||||||
3630188|NCT02597049|3478401|B3|Mexico||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3630189|NCT02597049|3478402|B2|Mexico||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3630190|NCT02597049|3478403|B1|Mexico||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3630191|NCT02597049|3478400|B4|Czechia||Region of Enrollment||Participants|Count of Participants|73|73.0||||||
3630192|NCT02597049|3478401|B3|Czechia||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3630193|NCT02597049|3478402|B2|Czechia||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3630194|NCT02597049|3478403|B1|Czechia||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3630195|NCT02597049|3478400|B4|United States||Region of Enrollment||Participants|Count of Participants|88|88.0||||||
3630196|NCT02597049|3478401|B3|United States||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3630197|NCT02597049|3478402|B2|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3630198|NCT02597049|3478403|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3630199|NCT02597049|3478400|B4|Hungary||Region of Enrollment||Participants|Count of Participants|57|57.0||||||
3630200|NCT02597049|3478401|B3|Hungary||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3630201|NCT02597049|3478402|B2|Hungary||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3630202|NCT02597049|3478403|B1|Hungary||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3630203|NCT02597049|3478400|B4|Austria||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3630204|NCT02597049|3478401|B3|Austria||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3630205|NCT02597049|3478402|B2|Austria||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3630206|NCT02597049|3478403|B1|Austria||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3630207|NCT02597049|3478400|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630208|NCT02597049|3478401|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630209|NCT02597049|3478402|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630210|NCT02597049|3478403|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630211|NCT02597049|3478400|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3630212|NCT02597049|3478401|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3630213|NCT02597049|3478402|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3630214|NCT02597049|3478403|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3630215|NCT02597049|3478400|B4||White|Race (NIH/OMB)||Participants|Count of Participants|378|378.0||||||
3630216|NCT02597049|3478401|B3||White|Race (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
3630217|NCT02597049|3478402|B2||White|Race (NIH/OMB)||Participants|Count of Participants|127|127.0||||||
3630218|NCT02597049|3478403|B1||White|Race (NIH/OMB)||Participants|Count of Participants|127|127.0||||||
3630219|NCT02597049|3478400|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3630220|NCT02597049|3478401|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3630221|NCT02597049|3478402|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3630222|NCT02597049|3478403|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3630223|NCT02597049|3478400|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630224|NCT02597049|3478401|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630225|NCT02597049|3478402|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630226|NCT02597049|3478403|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630227|NCT02597049|3478400|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3630228|NCT02597049|3478401|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630229|NCT02597049|3478402|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3630230|NCT02597049|3478403|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630231|NCT02597049|3478400|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3630232|NCT02597049|3478401|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3630233|NCT02597049|3478402|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3630234|NCT02597049|3478403|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3630235|NCT02597049|3478400|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3630236|NCT02597049|3478401|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3630237|NCT02597049|3478402|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630238|NCT02597049|3478403|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3630239|NCT02597049|3478400|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|281|281.0||||||
3630240|NCT02597049|3478401|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3630241|NCT02597049|3478402|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
3630242|NCT02597049|3478403|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
3630243|NCT02597049|3478400|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|139|139.0||||||
3630244|NCT02597049|3478401|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3630245|NCT02597049|3478402|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3630246|NCT02597049|3478403|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3630247|NCT02597049|3478400|B4||Male|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
3630248|NCT02597049|3478401|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3630249|NCT02597049|3478402|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3630250|NCT02597049|3478403|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3630251|NCT02597049|3478400|B4||Female|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
3630252|NCT02597049|3478401|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3630253|NCT02597049|3478402|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3630254|NCT02597049|3478403|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3630255|NCT02597049|3478400|B4|||Age||years|Mean|57.27|57.27|Standard Deviation|9.36|9.36|||
3630256|NCT02597049|3478401|B3|||Age||years|Mean|57.10|57.1|Standard Deviation|9.59|9.59|||
3630257|NCT02597049|3478402|B2|||Age||years|Mean|58.55|58.55|Standard Deviation|9.14|9.14|||
3630258|NCT02597049|3478403|B1|||Age||years|Mean|56.17|56.17|Standard Deviation|9.26|9.26|||
3630259|NCT02596958|3478443|B1|Missing||Sex/Gender, Customized||participants|Number|1|1.0||||||
3630260|NCT02596958|3478443|B1|Male||Sex/Gender, Customized||participants|Number|590|590.0||||||
3630261|NCT02596958|3478443|B1|Female||Sex/Gender, Customized||participants|Number|396|396.0||||||
3630262|NCT02596958|3478443|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|9.8|9.8|||
3630263|NCT02596945|3478455|B1||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3630265|NCT02596945|3478455|B1|||Age||years|Mean|59.6|59.6|Standard Deviation|15.1|15.1|||
3630266|NCT02596867|3478461|B1|||Tumor response by Ki 67||Participants|Count of Participants|2|2.0||||||
3630267|NCT02596867|3478461|B1|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3630268|NCT02596867|3478461|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630269|NCT02596867|3478461|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630270|NCT02596867|3478461|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3630271|NCT02596867|3478461|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630272|NCT02596867|3478461|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630273|NCT02596867|3478461|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630274|NCT02596867|3478461|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630275|NCT02596867|3478461|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3630276|NCT02596867|3478461|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3630277|NCT02596867|3478461|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3630278|NCT02596867|3478461|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3630279|NCT02596867|3478461|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3630280|NCT02596854|3478466|B1||3.0T Scans|Static Field Strength of MRI Scans||Participants|Count of Participants|59|59.0||||||
3630281|NCT02596854|3478466|B1||1.5T Scans|Static Field Strength of MRI Scans||Participants|Count of Participants|58|58.0||||||
3630282|NCT02596854|3478466|B1|United States||Region of Enrollment||Participants|Count of Participants|117|117.0||||||
3630283|NCT02596854|3478466|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3630284|NCT02596854|3478466|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3630285|NCT02596854|3478466|B1|||Age||years|Mean|53.1|53.1|Full Range|||19.0|89.0|
3630286|NCT02596854|3478466|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3630287|NCT02596854|3478466|B1||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
3630288|NCT02596854|3478466|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3630289|NCT02596750|3478470|B3|United States||Region of Enrollment||Participants|Number|21|21.0||||||
3630290|NCT02596750|3478471|B2|United States||Region of Enrollment||Participants|Number|21|21.0||||||
3630291|NCT02596750|3478472|B1|United States||Region of Enrollment||Participants|Number|21|21.0||||||
3630292|NCT02596750|3478470|B3||Male|Sex: Female, Male||Forearms|Count of Units|42|42.0||||||
3630293|NCT02596750|3478471|B2||Male|Sex: Female, Male||Forearms|Count of Units|21|21.0||||||
3630294|NCT02596750|3478472|B1||Male|Sex: Female, Male||Forearms|Count of Units|21|21.0||||||
3630295|NCT02596750|3478470|B3||Female|Sex: Female, Male||Forearms|Count of Units|0|0.0||||||
3630296|NCT02596750|3478471|B2||Female|Sex: Female, Male||Forearms|Count of Units|0|0.0||||||
3630297|NCT02596750|3478472|B1||Female|Sex: Female, Male||Forearms|Count of Units|0|0.0||||||
3630298|NCT02596750|3478470|B3|||Age||years|Mean|29|29.0|Full Range|||19.0|59.0|
3630299|NCT02596750|3478471|B2|||Age||years|Mean|29|29.0|Full Range|||19.0|59.0|
3630300|NCT02596750|3478472|B1|||Age||years|Mean|29|29.0|Full Range|||19.0|59.0|
3630301|NCT02596620|3478485|B3|Taiwan||Region of Enrollment||participants|Number|164|164.0||||||
3630302|NCT02596620|3478486|B2|Taiwan||Region of Enrollment||participants|Number|82|82.0||||||
3630303|NCT02596620|3478487|B1|Taiwan||Region of Enrollment||participants|Number|82|82.0||||||
3630304|NCT02596620|3478485|B3||Male|Gender||Participants|Count of Participants|76|76.0||||||
3630305|NCT02596620|3478486|B2||Male|Gender||Participants|Count of Participants|40|40.0||||||
3630306|NCT02596620|3478487|B1||Male|Gender||Participants|Count of Participants|36|36.0||||||
3630307|NCT02596620|3478485|B3||Female|Gender||Participants|Count of Participants|88|88.0||||||
3630308|NCT02596620|3478486|B2||Female|Gender||Participants|Count of Participants|42|42.0||||||
3630309|NCT02596620|3478487|B1||Female|Gender||Participants|Count of Participants|46|46.0||||||
3630310|NCT02596620|3478485|B3||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
3630311|NCT02596620|3478486|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3630312|NCT02596620|3478487|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3630313|NCT02596620|3478485|B3||Between 18 and 65 years|Age||Participants|Count of Participants|138|138.0||||||
3630314|NCT02596620|3478486|B2||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
3630315|NCT02596620|3478487|B1||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
3630316|NCT02596620|3478485|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3630317|NCT02596620|3478486|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3630318|NCT02596620|3478487|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3630319|NCT02596451|3478494|B4||Male|Sex: Female, Male||Participants|Count of Participants|409|409.0||||||
3630320|NCT02596451|3478495|B3||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3630321|NCT02596451|3478496|B2||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3630322|NCT02596451|3478497|B1||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3630323|NCT02596451|3478494|B4||Female|Sex: Female, Male||Participants|Count of Participants|734|734.0||||||
3630324|NCT02596451|3478495|B3||Female|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
3630325|NCT02596451|3478496|B2||Female|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
3630326|NCT02596451|3478497|B1||Female|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
3630327|NCT02596451|3478494|B4|||Age||years|Mean|56.4|56.4|Standard Deviation|10.51|10.51|||
3630328|NCT02596451|3478495|B3|||Age||years|Mean|56.7|56.7|Standard Deviation|10.52|10.52|||
3630329|NCT02596451|3478496|B2|||Age||years|Mean|56.5|56.5|Standard Deviation|10.68|10.68|||
3630330|NCT02596451|3478497|B1|||Age||years|Mean|56.2|56.2|Standard Deviation|10.36|10.36|||
3630331|NCT02596321|3478506|B3|Russia||Region of Enrollment||Participants|Count of Participants|88|88.0||||||
3630332|NCT02596321|3478507|B2|Russia||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3630333|NCT02596321|3478508|B1|Russia||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3630334|NCT02596321|3478506|B3|Belarus||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3630335|NCT02596321|3478507|B2|Belarus||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3630336|NCT02596321|3478508|B1|Belarus||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3630337|NCT02596321|3478506|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3630338|NCT02596321|3478507|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3630339|NCT02596321|3478508|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3630340|NCT02596321|3478506|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3630341|NCT02596321|3478507|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3630342|NCT02596321|3478508|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3630343|NCT02596321|3478506|B3|||Age||years|Mean|31.6|31.6|Standard Deviation|9.4|9.4|||
3630344|NCT02596321|3478507|B2|||Age||years|Mean|31.4|31.4|Standard Deviation|9.8|9.8|||
3630345|NCT02596321|3478508|B1|||Age||years|Mean|31.7|31.7|Standard Deviation|9.1|9.1|||
3630346|NCT02596321|3478506|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3630347|NCT02596321|3478507|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3630348|NCT02596321|3478508|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3630349|NCT02596321|3478506|B3||Between 18 and 65 years|Age||Participants|Count of Participants|108|108.0||||||
3630350|NCT02596321|3478507|B2||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
3630351|NCT02596321|3478508|B1||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
3630352|NCT02596321|3478506|B3||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3630353|NCT02596321|3478507|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3630354|NCT02596321|3478508|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3630355|NCT02596022|3478521|B3|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3630356|NCT02596022|3478522|B2|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3630357|NCT02596022|3478523|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3630358|NCT02596022|3478521|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630359|NCT02596022|3478522|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630360|NCT02596022|3478523|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630361|NCT02596022|3478521|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630362|NCT02596022|3478522|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630363|NCT02596022|3478523|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630364|NCT02596022|3478521|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3630365|NCT02596022|3478522|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3630366|NCT02596022|3478523|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3630367|NCT02596022|3478521|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3630368|NCT02596022|3478522|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3630369|NCT02596022|3478523|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3630370|NCT02596022|3478521|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630371|NCT02596022|3478522|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630372|NCT02596022|3478523|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630373|NCT02596022|3478521|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630374|NCT02596022|3478522|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630375|NCT02596022|3478523|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630376|NCT02596022|3478521|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630377|NCT02596022|3478522|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630378|NCT02596022|3478523|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630379|NCT02596022|3478521|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3630380|NCT02596022|3478522|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3630381|NCT02596022|3478523|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3630382|NCT02596022|3478521|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3630383|NCT02596022|3478522|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3630384|NCT02596022|3478523|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3630385|NCT02596022|3478521|B3|||Age||years|Mean|48.6|48.6|Standard Deviation|6.1|6.1|||
3630386|NCT02596022|3478522|B2|||Age||years|Mean|48.6|48.6|Standard Deviation|6.1|6.1|||
3630387|NCT02596022|3478523|B1|||Age||years|Mean|48.6|48.6|Standard Deviation|6.1|6.1|||
3630388|NCT02596009|3478530|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3630389|NCT02596009|3478530|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3630390|NCT02596009|3478530|B1|≥75 years||Age, Customized||Years|Number|24|24.0||||||
3630391|NCT02596009|3478530|B1|65 - 74 years||Age, Customized||Years|Number|46|46.0||||||
3630392|NCT02596009|3478530|B1|40 - 64 years||Age, Customized||Years|Number|27|27.0||||||
3630393|NCT02595567|3478544|B1|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3630394|NCT02595567|3478544|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3630395|NCT02595567|3478544|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3630396|NCT02595567|3478544|B1|||Age||Years|Mean|60|60.0|Standard Deviation|1|1.0|||
3630397|NCT02595567|3478544|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3630398|NCT02595567|3478544|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3630399|NCT02595567|3478544|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3630400|NCT02595502|3478548|B1|United States||Region of Enrollment||participants|Number|285|285.0||||||
3630401|NCT02595502|3478548|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3630402|NCT02595502|3478548|B1|White||Race/Ethnicity, Customized||participants|Number|238|238.0||||||
3630403|NCT02595502|3478548|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3630404|NCT02595502|3478548|B1|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3630405|NCT02595502|3478548|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3630406|NCT02595502|3478548|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3630407|NCT02595502|3478548|B1||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
3630408|NCT02595502|3478548|B1|||Age||years|Mean|28.1|28.1|Standard Deviation|6.13|6.13|||
3630409|NCT02595450|3478555|B1||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3630410|NCT02595450|3478555|B1||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3630411|NCT02595450|3478555|B1|||Age||years|Mean|66.0|66.0|Standard Deviation|10.7|10.7|||
3630412|NCT02595437|3478561|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3630413|NCT02595437|3478561|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630414|NCT02595437|3478561|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3630415|NCT02595437|3478561|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3630416|NCT02595437|3478561|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630417|NCT02595437|3478561|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3630418|NCT02595437|3478561|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630419|NCT02595437|3478561|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3630420|NCT02595437|3478561|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3630421|NCT02595437|3478561|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3630422|NCT02595437|3478561|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3630423|NCT02595437|3478561|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3630424|NCT02595437|3478561|B1|||Age||years|Mean|11.8|11.8|Standard Deviation|4.98|4.98|||
3630425|NCT02595073|3478579|B3|||Eczema Area and Severity Index (EASI) Score|The EASI is a composite score based on the severity of four different signs of atopic dermatitis (Erythema, Induration/Papulation/Edema, Lichenification, and Excoriation rated 0 to 3 in severity) in four different areas of the body (Head/Neck, Upper Limbs, Trunk, Lower Limbs) multiplied by the percent of that specific body area affected multiplied by a weighting factor. The minimum score would be 0 and the maximum score would be 72. To be eligible for participation in this study a patient must have an EASI of at least 15 at baseline. A higher EASI value represents a more severe case of eczema.|units on a scale|Mean|18.7|18.7|Standard Deviation|4.0|4.0|||
3630426|NCT02595073|3478580|B2|||Eczema Area and Severity Index (EASI) Score|The EASI is a composite score based on the severity of four different signs of atopic dermatitis (Erythema, Induration/Papulation/Edema, Lichenification, and Excoriation rated 0 to 3 in severity) in four different areas of the body (Head/Neck, Upper Limbs, Trunk, Lower Limbs) multiplied by the percent of that specific body area affected multiplied by a weighting factor. The minimum score would be 0 and the maximum score would be 72. To be eligible for participation in this study a patient must have an EASI of at least 15 at baseline. A higher EASI value represents a more severe case of eczema.|units on a scale|Mean|18.6|18.6|Standard Deviation|3.6|3.6|||
3630427|NCT02595073|3478581|B1|||Eczema Area and Severity Index (EASI) Score|The EASI is a composite score based on the severity of four different signs of atopic dermatitis (Erythema, Induration/Papulation/Edema, Lichenification, and Excoriation rated 0 to 3 in severity) in four different areas of the body (Head/Neck, Upper Limbs, Trunk, Lower Limbs) multiplied by the percent of that specific body area affected multiplied by a weighting factor. The minimum score would be 0 and the maximum score would be 72. To be eligible for participation in this study a patient must have an EASI of at least 15 at baseline. A higher EASI value represents a more severe case of eczema.|units on a scale|Mean|18.8|18.8|Standard Deviation|4.4|4.4|||
3630428|NCT02595073|3478579|B3||Severe Disease|Baseline Investigator Global Assessment (IGA) Score||Participants|Count of Participants|15|15.0||||||
3630429|NCT02595073|3478580|B2||Severe Disease|Baseline Investigator Global Assessment (IGA) Score||Participants|Count of Participants|7|7.0||||||
3630430|NCT02595073|3478581|B1||Severe Disease|Baseline Investigator Global Assessment (IGA) Score||Participants|Count of Participants|8|8.0||||||
3630431|NCT02595073|3478579|B3||Moderate Disease|Baseline Investigator Global Assessment (IGA) Score||Participants|Count of Participants|109|109.0||||||
3630432|NCT02595073|3478580|B2||Moderate Disease|Baseline Investigator Global Assessment (IGA) Score||Participants|Count of Participants|56|56.0||||||
3630433|NCT02595073|3478581|B1||Moderate Disease|Baseline Investigator Global Assessment (IGA) Score||Participants|Count of Participants|53|53.0||||||
3630434|NCT02595073|3478579|B3||Mild Disease|Baseline Investigator Global Assessment (IGA) Score||Participants|Count of Participants|0|0.0||||||
3630435|NCT02595073|3478580|B2||Mild Disease|Baseline Investigator Global Assessment (IGA) Score||Participants|Count of Participants|0|0.0||||||
3630436|NCT02595073|3478581|B1||Mild Disease|Baseline Investigator Global Assessment (IGA) Score||Participants|Count of Participants|0|0.0||||||
3630437|NCT02595073|3478579|B3||Almost Clear|Baseline Investigator Global Assessment (IGA) Score||Participants|Count of Participants|0|0.0||||||
3630438|NCT02595073|3478580|B2||Almost Clear|Baseline Investigator Global Assessment (IGA) Score||Participants|Count of Participants|0|0.0||||||
3630439|NCT02595073|3478581|B1||Almost Clear|Baseline Investigator Global Assessment (IGA) Score||Participants|Count of Participants|0|0.0||||||
3630440|NCT02595073|3478579|B3||Clear|Baseline Investigator Global Assessment (IGA) Score||Participants|Count of Participants|0|0.0||||||
3630441|NCT02595073|3478580|B2||Clear|Baseline Investigator Global Assessment (IGA) Score||Participants|Count of Participants|0|0.0||||||
3630442|NCT02595073|3478581|B1||Clear|Baseline Investigator Global Assessment (IGA) Score||Participants|Count of Participants|0|0.0||||||
3630443|NCT02595073|3478579|B3|||%BSA Affected with Atopic Dermatitis (AD)||percent|Mean|23.4|23.4|Standard Deviation|8.9|8.9|||
3630444|NCT02595073|3478580|B2|||%BSA Affected with Atopic Dermatitis (AD)||percent|Mean|23.3|23.3|Standard Deviation|10.1|10.1|||
3630445|NCT02595073|3478581|B1|||%BSA Affected with Atopic Dermatitis (AD)||percent|Mean|23.4|23.4|Standard Deviation|7.5|7.5|||
3630446|NCT02595073|3478579|B3|||Baseline Total Body Surface Area (BSA)||meters squared|Mean|1.9|1.9|Standard Deviation|0.3|0.3|||
3630447|NCT02595073|3478580|B2|||Baseline Total Body Surface Area (BSA)||meters squared|Mean|1.9|1.9|Standard Deviation|0.3|0.3|||
3630448|NCT02595073|3478581|B1|||Baseline Total Body Surface Area (BSA)||meters squared|Mean|1.8|1.8|Standard Deviation|0.2|0.2|||
3630449|NCT02595073|3478579|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3630450|NCT02595073|3478580|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3630451|NCT02595073|3478581|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630452|NCT02595073|3478579|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630453|NCT02595073|3478580|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630454|NCT02595073|3478581|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630455|NCT02595073|3478579|B3||White|Race (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3630456|NCT02595073|3478580|B2||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3630457|NCT02595073|3478581|B1||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3630458|NCT02595073|3478579|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3630459|NCT02595073|3478580|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3630460|NCT02595073|3478581|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3630461|NCT02595073|3478579|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630462|NCT02595073|3478580|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630463|NCT02595073|3478581|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630464|NCT02595073|3478579|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3630465|NCT02595073|3478580|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3630466|NCT02595073|3478581|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3630467|NCT02595073|3478579|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630468|NCT02595073|3478580|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630469|NCT02595073|3478581|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630470|NCT02595073|3478579|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630471|NCT02595073|3478580|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630472|NCT02595073|3478581|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630473|NCT02595073|3478579|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3630474|NCT02595073|3478580|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3630475|NCT02595073|3478581|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3630476|NCT02595073|3478579|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3630477|NCT02595073|3478580|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3630478|NCT02595073|3478581|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3630479|NCT02595073|3478579|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3630480|NCT02595073|3478580|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3630481|NCT02595073|3478581|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3630482|NCT02595073|3478579|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3630483|NCT02595073|3478580|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3630484|NCT02595073|3478581|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3630485|NCT02595073|3478579|B3|||Age||years|Mean|42.6|42.6|Standard Deviation|18.6|18.6|||
3630486|NCT02595073|3478580|B2|||Age||years|Mean|41.7|41.7|Standard Deviation|18.5|18.5|||
3630487|NCT02595073|3478581|B1|||Age||years|Mean|43.5|43.5|Standard Deviation|18.8|18.8|||
3630488|NCT02595008|3478590|B3|||Eczema Area and Severity Index (EASI) Score|The EASI is a composite score based on the severity of four different signs of atopic dermatitis (Erythema, Induration/Papulation/Edema, Lichenification, and Excoriation rated 0 to 3 in severity) in four different areas of the body (Head/Neck, Upper Limbs, Trunk, Lower Limbs) multiplied by the percent of that specific body area affected multiplied by a weighting factor. The minimum score would be 0 and the maximum score would be 72. To be eligible for participation in this study a patient must have an EASI of at least 15 at baseline. A higher EASI value represents a more severe case of eczema.|units on a scale|Mean|21.26|21.26|Standard Deviation|11.53|11.53|||
3630489|NCT02595008|3478591|B2|||Eczema Area and Severity Index (EASI) Score|The EASI is a composite score based on the severity of four different signs of atopic dermatitis (Erythema, Induration/Papulation/Edema, Lichenification, and Excoriation rated 0 to 3 in severity) in four different areas of the body (Head/Neck, Upper Limbs, Trunk, Lower Limbs) multiplied by the percent of that specific body area affected multiplied by a weighting factor. The minimum score would be 0 and the maximum score would be 72. To be eligible for participation in this study a patient must have an EASI of at least 15 at baseline. A higher EASI value represents a more severe case of eczema.|units on a scale|Mean|28.50|28.5|Standard Deviation|19.91|19.91|||
3630490|NCT02595008|3478592|B1|||Eczema Area and Severity Index (EASI) Score|The EASI is a composite score based on the severity of four different signs of atopic dermatitis (Erythema, Induration/Papulation/Edema, Lichenification, and Excoriation rated 0 to 3 in severity) in four different areas of the body (Head/Neck, Upper Limbs, Trunk, Lower Limbs) multiplied by the percent of that specific body area affected multiplied by a weighting factor. The minimum score would be 0 and the maximum score would be 72. To be eligible for participation in this study a patient must have an EASI of at least 15 at baseline. A higher EASI value represents a more severe case of eczema.|units on a scale|Mean|19.74|19.74|Standard Deviation|9.08|9.08|||
3630491|NCT02595008|3478590|B3||Severe Disease|Baseline IGA||Participants|Count of Participants|4|4.0||||||
3630492|NCT02595008|3478591|B2||Severe Disease|Baseline IGA||Participants|Count of Participants|2|2.0||||||
3630493|NCT02595008|3478592|B1||Severe Disease|Baseline IGA||Participants|Count of Participants|2|2.0||||||
3630494|NCT02595008|3478590|B3||Moderate Disease|Baseline IGA||Participants|Count of Participants|19|19.0||||||
3630495|NCT02595008|3478591|B2||Moderate Disease|Baseline IGA||Participants|Count of Participants|2|2.0||||||
3630496|NCT02595008|3478592|B1||Moderate Disease|Baseline IGA||Participants|Count of Participants|17|17.0||||||
3630497|NCT02595008|3478590|B3||Mild Disease|Baseline IGA||Participants|Count of Participants|0|0.0||||||
3630498|NCT02595008|3478591|B2||Mild Disease|Baseline IGA||Participants|Count of Participants|0|0.0||||||
3630499|NCT02595008|3478592|B1||Mild Disease|Baseline IGA||Participants|Count of Participants|0|0.0||||||
3630500|NCT02595008|3478590|B3||Almost Clear|Baseline IGA||Participants|Count of Participants|0|0.0||||||
3630501|NCT02595008|3478591|B2||Almost Clear|Baseline IGA||Participants|Count of Participants|0|0.0||||||
3630502|NCT02595008|3478592|B1||Almost Clear|Baseline IGA||Participants|Count of Participants|0|0.0||||||
3630503|NCT02595008|3478590|B3||Clear|Baseline IGA||Participants|Count of Participants|0|0.0||||||
3630504|NCT02595008|3478591|B2||Clear|Baseline IGA||Participants|Count of Participants|0|0.0||||||
3630505|NCT02595008|3478592|B1||Clear|Baseline IGA||Participants|Count of Participants|0|0.0||||||
3630506|NCT02595008|3478590|B3|||Baseline Total BSA||meters squared|Mean|1.98|1.98|Standard Deviation|0.30|0.3|||
3630507|NCT02595008|3478591|B2|||Baseline Total BSA||meters squared|Mean|1.78|1.78|Standard Deviation|0.31|0.31|||
3630508|NCT02595008|3478592|B1|||Baseline Total BSA||meters squared|Mean|2.03|2.03|Standard Deviation|0.29|0.29|||
3630509|NCT02595008|3478590|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630510|NCT02595008|3478591|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630511|NCT02595008|3478592|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630512|NCT02595008|3478590|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630513|NCT02595008|3478591|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630514|NCT02595008|3478592|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630515|NCT02595008|3478590|B3||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3630516|NCT02595008|3478591|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3630517|NCT02595008|3478592|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3630518|NCT02595008|3478590|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3630519|NCT02595008|3478591|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3630520|NCT02595008|3478592|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3630521|NCT02595008|3478590|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630522|NCT02595008|3478591|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630523|NCT02595008|3478592|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630524|NCT02595008|3478590|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630525|NCT02595008|3478591|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630526|NCT02595008|3478592|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630527|NCT02595008|3478590|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630586|NCT02594644|3478609|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3630528|NCT02595008|3478591|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630529|NCT02595008|3478592|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630530|NCT02595008|3478590|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630531|NCT02595008|3478591|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630532|NCT02595008|3478592|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630533|NCT02595008|3478590|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3630534|NCT02595008|3478591|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3630535|NCT02595008|3478592|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3630536|NCT02595008|3478590|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3630537|NCT02595008|3478591|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3630538|NCT02595008|3478592|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3630539|NCT02595008|3478590|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3630540|NCT02595008|3478591|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3630541|NCT02595008|3478592|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3630542|NCT02595008|3478590|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3630543|NCT02595008|3478591|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3630544|NCT02595008|3478592|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3630545|NCT02595008|3478590|B3|||Age||years|Mean|38.43|38.43|Standard Deviation|14.87|14.87|||
3630546|NCT02595008|3478591|B2|||Age||years|Mean|15.25|15.25|Standard Deviation|2.36|2.36|||
3630547|NCT02595008|3478592|B1|||Age||years|Mean|43.32|43.32|Standard Deviation|11.18|11.18|||
3630548|NCT02594826|3478599|B3|United States||Region of Enrollment||participants|Number|705|705.0||||||
3630549|NCT02594826|3478600|B2|United States||Region of Enrollment||participants|Number|358|358.0||||||
3630550|NCT02594826|3478601|B1|United States||Region of Enrollment||participants|Number|347|347.0||||||
3630551|NCT02594826|3478599|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630552|NCT02594826|3478600|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630553|NCT02594826|3478601|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630554|NCT02594826|3478599|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630555|NCT02594826|3478600|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630556|NCT02594826|3478601|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630557|NCT02594826|3478599|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630558|NCT02594826|3478600|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630559|NCT02594826|3478601|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630560|NCT02594826|3478599|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630561|NCT02594826|3478600|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630562|NCT02594826|3478601|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630563|NCT02594826|3478599|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630564|NCT02594826|3478600|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630565|NCT02594826|3478601|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630566|NCT02594826|3478599|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|705|705.0||||||
3630567|NCT02594826|3478600|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|358|358.0||||||
3630568|NCT02594826|3478601|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|347|347.0||||||
3630569|NCT02594826|3478599|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630570|NCT02594826|3478600|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630571|NCT02594826|3478601|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630572|NCT02594826|3478599|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3630573|NCT02594826|3478600|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3630574|NCT02594826|3478601|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3630575|NCT02594826|3478599|B3||Female|Sex: Female, Male||Participants|Count of Participants|705|705.0||||||
3630576|NCT02594826|3478600|B2||Female|Sex: Female, Male||Participants|Count of Participants|358|358.0||||||
3630577|NCT02594826|3478601|B1||Female|Sex: Female, Male||Participants|Count of Participants|347|347.0||||||
3630578|NCT02594826|3478599|B3|||Age||years|Mean|52.9|52.9|Standard Deviation|10.7|10.7|||
3630579|NCT02594826|3478600|B2|||Age||years|Mean|53.9|53.9|Standard Deviation|11.6|11.6|||
3630580|NCT02594826|3478601|B1|||Age||years|Mean|51.9|51.9|Standard Deviation|9.5|9.5|||
3630581|NCT02594644|3478608|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3630582|NCT02594644|3478608|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3630583|NCT02594644|3478609|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3630584|NCT02594644|3478610|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3630585|NCT02594644|3478608|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3630587|NCT02594644|3478610|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3630588|NCT02594644|3478608|B3|||Age||years|Mean|64.09|64.09|Standard Deviation|9.19101|9.19101|||
3630589|NCT02594644|3478609|B2|||Age||years|Mean|62.75|62.75|Standard Deviation|8.575158|8.575158|||
3630590|NCT02594644|3478610|B1|||Age||years|Mean|65.4375|65.4375|Standard Deviation|9.858795|9.858795|||
3630591|NCT02594644|3478608|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3630592|NCT02594644|3478609|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3630593|NCT02594644|3478610|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3630594|NCT02594644|3478608|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3630595|NCT02594644|3478609|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3630596|NCT02594644|3478610|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3630597|NCT02594644|3478608|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3630598|NCT02594644|3478609|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3630599|NCT02594644|3478610|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3630600|NCT02594163|3478627|B3||2: In bed less than 50% of the time|Eastern Cooperative Oncology Group (ECOG) Performance Status|Measure Description: 0=Normal activity; 1=Symptoms but ambulatory; 2=In bed <50% of the time; 3= In bed >50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|3|3.0||||||
3630601|NCT02594163|3478628|B2||2: In bed less than 50% of the time|Eastern Cooperative Oncology Group (ECOG) Performance Status|Measure Description: 0=Normal activity; 1=Symptoms but ambulatory; 2=In bed <50% of the time; 3= In bed >50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|3|3.0||||||
3630602|NCT02594163|3478629|B1||2: In bed less than 50% of the time|Eastern Cooperative Oncology Group (ECOG) Performance Status|Measure Description: 0=Normal activity; 1=Symptoms but ambulatory; 2=In bed <50% of the time; 3= In bed >50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|0|0.0||||||
3630603|NCT02594163|3478627|B3||1: Symptoms but ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status|Measure Description: 0=Normal activity; 1=Symptoms but ambulatory; 2=In bed <50% of the time; 3= In bed >50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|9|9.0||||||
3630604|NCT02594163|3478628|B2||1: Symptoms but ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status|Measure Description: 0=Normal activity; 1=Symptoms but ambulatory; 2=In bed <50% of the time; 3= In bed >50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|4|4.0||||||
3630605|NCT02594163|3478629|B1||1: Symptoms but ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status|Measure Description: 0=Normal activity; 1=Symptoms but ambulatory; 2=In bed <50% of the time; 3= In bed >50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|5|5.0||||||
3630606|NCT02594163|3478627|B3||0: Normal Activity|Eastern Cooperative Oncology Group (ECOG) Performance Status|Measure Description: 0=Normal activity; 1=Symptoms but ambulatory; 2=In bed <50% of the time; 3= In bed >50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|13|13.0||||||
3630607|NCT02594163|3478628|B2||0: Normal Activity|Eastern Cooperative Oncology Group (ECOG) Performance Status|Measure Description: 0=Normal activity; 1=Symptoms but ambulatory; 2=In bed <50% of the time; 3= In bed >50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|6|6.0||||||
3630608|NCT02594163|3478629|B1||0: Normal Activity|Eastern Cooperative Oncology Group (ECOG) Performance Status|Measure Description: 0=Normal activity; 1=Symptoms but ambulatory; 2=In bed <50% of the time; 3= In bed >50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|7|7.0||||||
3630609|NCT02594163|3478627|B3|France||Region of Enrollment||participants|Number|6|6.0||||||
3630610|NCT02594163|3478628|B2|France||Region of Enrollment||participants|Number|2|2.0||||||
3630611|NCT02594163|3478629|B1|France||Region of Enrollment||participants|Number|4|4.0||||||
3630612|NCT02594163|3478627|B3|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
3630613|NCT02594163|3478628|B2|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3630614|NCT02594163|3478629|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3630615|NCT02594163|3478627|B3|Italy||Region of Enrollment||participants|Number|7|7.0||||||
3630616|NCT02594163|3478628|B2|Italy||Region of Enrollment||participants|Number|4|4.0||||||
3630617|NCT02594163|3478629|B1|Italy||Region of Enrollment||participants|Number|3|3.0||||||
3630618|NCT02594163|3478627|B3|Poland||Region of Enrollment||participants|Number|1|1.0||||||
3630619|NCT02594163|3478628|B2|Poland||Region of Enrollment||participants|Number|0|0.0||||||
3630620|NCT02594163|3478629|B1|Poland||Region of Enrollment||participants|Number|1|1.0||||||
3630621|NCT02594163|3478627|B3|Czechia||Region of Enrollment||participants|Number|1|1.0||||||
3630622|NCT02594163|3478628|B2|Czechia||Region of Enrollment||participants|Number|0|0.0||||||
3630623|NCT02594163|3478629|B1|Czechia||Region of Enrollment||participants|Number|1|1.0||||||
3630624|NCT02594163|3478627|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3630625|NCT02594163|3478628|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3630626|NCT02594163|3478629|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3630627|NCT02594163|3478627|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3630628|NCT02594163|3478628|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3630629|NCT02594163|3478629|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3630630|NCT02594163|3478627|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630631|NCT02594163|3478628|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630632|NCT02594163|3478629|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630633|NCT02594163|3478627|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3630634|NCT02594163|3478628|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3630635|NCT02594163|3478629|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3630636|NCT02594163|3478627|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630637|NCT02594163|3478628|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630638|NCT02594163|3478629|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630639|NCT02594163|3478627|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630640|NCT02594163|3478628|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630641|NCT02594163|3478629|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630642|NCT02594163|3478627|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630643|NCT02594163|3478628|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630644|NCT02594163|3478629|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630645|NCT02594163|3478627|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630646|NCT02594163|3478628|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630647|NCT02594163|3478629|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630648|NCT02594163|3478627|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3630649|NCT02594163|3478628|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3630650|NCT02594163|3478629|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3630651|NCT02594163|3478627|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3630652|NCT02594163|3478628|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3630653|NCT02594163|3478629|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3630654|NCT02594163|3478627|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3630655|NCT02594163|3478628|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3630656|NCT02594163|3478629|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3630657|NCT02594163|3478627|B3||Male|Sex: Female, Male|According to programmed outputs, 7 patients in the R+B comparator arm were female (sex data were missing for 1 patient). Upon review of available data in a case report form, it was discovered the patient’s sex was reported to be female. Therefore 8 patients in the R+B arm are female, a noted discrepancy between the CSR.|Participants|Count of Participants|11|11.0||||||
3630658|NCT02594163|3478628|B2||Male|Sex: Female, Male|According to programmed outputs, 7 patients in the R+B comparator arm were female (sex data were missing for 1 patient). Upon review of available data in a case report form, it was discovered the patient’s sex was reported to be female. Therefore 8 patients in the R+B arm are female, a noted discrepancy between the CSR.|Participants|Count of Participants|7|7.0||||||
3630659|NCT02594163|3478629|B1||Male|Sex: Female, Male|According to programmed outputs, 7 patients in the R+B comparator arm were female (sex data were missing for 1 patient). Upon review of available data in a case report form, it was discovered the patient’s sex was reported to be female. Therefore 8 patients in the R+B arm are female, a noted discrepancy between the CSR.|Participants|Count of Participants|4|4.0||||||
3630660|NCT02594163|3478627|B3||Female|Sex: Female, Male|According to programmed outputs, 7 patients in the R+B comparator arm were female (sex data were missing for 1 patient). Upon review of available data in a case report form, it was discovered the patient’s sex was reported to be female. Therefore 8 patients in the R+B arm are female, a noted discrepancy between the CSR.|Participants|Count of Participants|14|14.0||||||
3630661|NCT02594163|3478628|B2||Female|Sex: Female, Male|According to programmed outputs, 7 patients in the R+B comparator arm were female (sex data were missing for 1 patient). Upon review of available data in a case report form, it was discovered the patient’s sex was reported to be female. Therefore 8 patients in the R+B arm are female, a noted discrepancy between the CSR.|Participants|Count of Participants|6|6.0||||||
3630662|NCT02594163|3478629|B1||Female|Sex: Female, Male|According to programmed outputs, 7 patients in the R+B comparator arm were female (sex data were missing for 1 patient). Upon review of available data in a case report form, it was discovered the patient’s sex was reported to be female. Therefore 8 patients in the R+B arm are female, a noted discrepancy between the CSR.|Participants|Count of Participants|8|8.0||||||
3630663|NCT02594163|3478627|B3|||Age||years|Median|68.0|68.0|Full Range|||40.0|85.0|
3630664|NCT02594163|3478628|B2|||Age||years|Median|68.0|68.0|Full Range|||40.0|79.0|
3630665|NCT02594163|3478629|B1|||Age||years|Median|64.5|64.5|Full Range|||47.0|85.0|
3630666|NCT02594163|3478627|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3630667|NCT02594163|3478628|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3630668|NCT02594163|3478629|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3630669|NCT02594163|3478627|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3630670|NCT02594163|3478628|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3630671|NCT02594163|3478629|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3630672|NCT02594163|3478627|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3630673|NCT02594163|3478628|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3630674|NCT02594163|3478629|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3630675|NCT02593903|3478646|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3630676|NCT02593903|3478646|B3|Male||Sex/Gender, Customized||Participants|Count of Participants|67|67.0||||||
3630677|NCT02593903|3478647|B2|Male||Sex/Gender, Customized||Participants|Count of Participants|32|32.0||||||
3630678|NCT02593903|3478648|B1|Male||Sex/Gender, Customized||Participants|Count of Participants|35|35.0||||||
3630679|NCT02593903|3478646|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3630680|NCT02593903|3478647|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3630681|NCT02593903|3478648|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3630682|NCT02593903|3478646|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3630683|NCT02593903|3478647|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3630684|NCT02593903|3478648|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3630685|NCT02593903|3478646|B3||<=18 years|Age||Participants|Count of Participants|67|67.0||||||
3630686|NCT02593903|3478647|B2||<=18 years|Age||Participants|Count of Participants|32|32.0||||||
3630687|NCT02593903|3478648|B1||<=18 years|Age||Participants|Count of Participants|35|35.0||||||
3630688|NCT02593773|3478655|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3630689|NCT02593773|3478655|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3630690|NCT02593773|3478655|B1||White|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
3630691|NCT02593773|3478655|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630692|NCT02593773|3478655|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630693|NCT02593773|3478655|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630694|NCT02593773|3478655|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3630695|NCT02593773|3478655|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630696|NCT02593773|3478655|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3630697|NCT02593773|3478655|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3630698|NCT02593773|3478655|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3630699|NCT02593773|3478655|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3630700|NCT02593773|3478655|B1|||Age||years|Mean|16.8|16.8|Standard Deviation|4.05|4.05|||
3630701|NCT02592655|3478665|B3|||Ankle Brachial Index (ABI)|For each participant the Ankle Brachial Index (ABI) was measured bilaterally, and the highest of the two were used to determine the mean and standard deviation for the specified group reported. An ABI less than 1.0 would be indicative of peripheral artery disease. An ABI greater than 1.4 would be indicative of an incompressible artery.|Ratio|Mean|1.16|1.16|Standard Deviation|0.09|0.09|||
3630702|NCT02592655|3478666|B2|||Ankle Brachial Index (ABI)|For each participant the Ankle Brachial Index (ABI) was measured bilaterally, and the highest of the two were used to determine the mean and standard deviation for the specified group reported. An ABI less than 1.0 would be indicative of peripheral artery disease. An ABI greater than 1.4 would be indicative of an incompressible artery.|Ratio|Mean|1.16|1.16|Standard Deviation|0.11|0.11|||
3630703|NCT02592655|3478667|B1|||Ankle Brachial Index (ABI)|For each participant the Ankle Brachial Index (ABI) was measured bilaterally, and the highest of the two were used to determine the mean and standard deviation for the specified group reported. An ABI less than 1.0 would be indicative of peripheral artery disease. An ABI greater than 1.4 would be indicative of an incompressible artery.|Ratio|Mean|1.15|1.15|Standard Deviation|0.08|0.08|||
3630704|NCT02592655|3478665|B3|||Limb Occlusion Pressure|A 10 cm (4 inch) wide pneumatic tourniquet cuff was used with the Automatic Tourniquet System (ATS) 1500 by Aspen Labs to obtain Limb Occlusion Pressures (LOP) on the upper half of each participants thigh. Pulsatile flow was not observable for one sustained minute with duplex ultrasound at the popliteal artery.|mmHg|Mean|302|302.0|Standard Deviation|43|43.0|||
3630705|NCT02592655|3478666|B2|||Limb Occlusion Pressure|A 10 cm (4 inch) wide pneumatic tourniquet cuff was used with the Automatic Tourniquet System (ATS) 1500 by Aspen Labs to obtain Limb Occlusion Pressures (LOP) on the upper half of each participants thigh. Pulsatile flow was not observable for one sustained minute with duplex ultrasound at the popliteal artery.|mmHg|Mean|319|319.0|Standard Deviation|44|44.0|||
3630706|NCT02592655|3478667|B1|||Limb Occlusion Pressure|A 10 cm (4 inch) wide pneumatic tourniquet cuff was used with the Automatic Tourniquet System (ATS) 1500 by Aspen Labs to obtain Limb Occlusion Pressures (LOP) on the upper half of each participants thigh. Pulsatile flow was not observable for one sustained minute with duplex ultrasound at the popliteal artery.|mmHg|Mean|280|280.0|Standard Deviation|30|30.0|||
3630707|NCT02592655|3478665|B3|||Systolic Blood Pressure (SBP)||mmHg|Mean|133|133.0|Standard Deviation|10.0|10.0|||
3630708|NCT02592655|3478666|B2|||Systolic Blood Pressure (SBP)||mmHg|Mean|136|136.0|Standard Deviation|10.4|10.4|||
3630709|NCT02592655|3478667|B1|||Systolic Blood Pressure (SBP)||mmHg|Mean|130|130.0|Standard Deviation|8.8|8.8|||
3630710|NCT02592655|3478665|B3|Lower thigh circumference percentile||Percentile of Mean Thigh Circumference|The mean thigh circumference for the specified set of participants has been compared to the 2010 ANTHROPOMETRIC SURVEY OF U.S. MARINE CORPS PERSONNEL: METHODS AND SUMMARY STATISTICS to determine the nth percentile rank reported. (see references)|Percentile|Number|90|90.0||||||
3630711|NCT02592655|3478666|B2|Lower thigh circumference percentile||Percentile of Mean Thigh Circumference|The mean thigh circumference for the specified set of participants has been compared to the 2010 ANTHROPOMETRIC SURVEY OF U.S. MARINE CORPS PERSONNEL: METHODS AND SUMMARY STATISTICS to determine the nth percentile rank reported. (see references)|Percentile|Number|95|95.0||||||
3630712|NCT02592655|3478667|B1|Lower thigh circumference percentile||Percentile of Mean Thigh Circumference|The mean thigh circumference for the specified set of participants has been compared to the 2010 ANTHROPOMETRIC SURVEY OF U.S. MARINE CORPS PERSONNEL: METHODS AND SUMMARY STATISTICS to determine the nth percentile rank reported. (see references)|Percentile|Number|75|75.0||||||
3630713|NCT02592655|3478665|B3|Upper thigh circumference percentile||Percentile of Mean Thigh Circumference|The mean thigh circumference for the specified set of participants has been compared to the 2010 ANTHROPOMETRIC SURVEY OF U.S. MARINE CORPS PERSONNEL: METHODS AND SUMMARY STATISTICS to determine the nth percentile rank reported. (see references)|Percentile|Number|90|90.0||||||
3630714|NCT02592655|3478666|B2|Upper thigh circumference percentile||Percentile of Mean Thigh Circumference|The mean thigh circumference for the specified set of participants has been compared to the 2010 ANTHROPOMETRIC SURVEY OF U.S. MARINE CORPS PERSONNEL: METHODS AND SUMMARY STATISTICS to determine the nth percentile rank reported. (see references)|Percentile|Number|95|95.0||||||
3630715|NCT02592655|3478667|B1|Upper thigh circumference percentile||Percentile of Mean Thigh Circumference|The mean thigh circumference for the specified set of participants has been compared to the 2010 ANTHROPOMETRIC SURVEY OF U.S. MARINE CORPS PERSONNEL: METHODS AND SUMMARY STATISTICS to determine the nth percentile rank reported. (see references)|Percentile|Number|65|65.0||||||
3630716|NCT02592655|3478665|B3|Lower Thigh||Thigh Circumference|"All thigh circumference measures taken from the participants right thigh while standing.~Upper thigh circumference: Measured just below the gluteal furrow.~10 cm Above Mid Thigh: Circumference measured 10 cm above the mid point between the gluteal furrow and supra-patellar border.~Middle thigh circumference: Circumference measured at the mid point between the gluteal furrow and the supra-patellar border.~Lower Thigh: Circumference measured just above the supra-patellar border."|cm|Mean|44.3|44.3|Standard Deviation|4.0|4.0|||
3630717|NCT02592655|3478666|B2|Lower Thigh||Thigh Circumference|"All thigh circumference measures taken from the participants right thigh while standing.~Upper thigh circumference: Measured just below the gluteal furrow.~10 cm Above Mid Thigh: Circumference measured 10 cm above the mid point between the gluteal furrow and supra-patellar border.~Middle thigh circumference: Circumference measured at the mid point between the gluteal furrow and the supra-patellar border.~Lower Thigh: Circumference measured just above the supra-patellar border."|cm|Mean|45.8|45.8|Standard Deviation|3.1|3.1|||
3630718|NCT02592655|3478667|B1|Lower Thigh||Thigh Circumference|"All thigh circumference measures taken from the participants right thigh while standing.~Upper thigh circumference: Measured just below the gluteal furrow.~10 cm Above Mid Thigh: Circumference measured 10 cm above the mid point between the gluteal furrow and supra-patellar border.~Middle thigh circumference: Circumference measured at the mid point between the gluteal furrow and the supra-patellar border.~Lower Thigh: Circumference measured just above the supra-patellar border."|cm|Mean|42.3|42.3|Standard Deviation|4.4|4.4|||
3630719|NCT02592655|3478665|B3|Middle Thigh||Thigh Circumference|"All thigh circumference measures taken from the participants right thigh while standing.~Upper thigh circumference: Measured just below the gluteal furrow.~10 cm Above Mid Thigh: Circumference measured 10 cm above the mid point between the gluteal furrow and supra-patellar border.~Middle thigh circumference: Circumference measured at the mid point between the gluteal furrow and the supra-patellar border.~Lower Thigh: Circumference measured just above the supra-patellar border."|cm|Mean|58.1|58.1|Standard Deviation|5.5|5.5|||
3630720|NCT02592655|3478666|B2|Middle Thigh||Thigh Circumference|"All thigh circumference measures taken from the participants right thigh while standing.~Upper thigh circumference: Measured just below the gluteal furrow.~10 cm Above Mid Thigh: Circumference measured 10 cm above the mid point between the gluteal furrow and supra-patellar border.~Middle thigh circumference: Circumference measured at the mid point between the gluteal furrow and the supra-patellar border.~Lower Thigh: Circumference measured just above the supra-patellar border."|cm|Mean|60.3|60.3|Standard Deviation|5.3|5.3|||
3630721|NCT02592655|3478667|B1|Middle Thigh||Thigh Circumference|"All thigh circumference measures taken from the participants right thigh while standing.~Upper thigh circumference: Measured just below the gluteal furrow.~10 cm Above Mid Thigh: Circumference measured 10 cm above the mid point between the gluteal furrow and supra-patellar border.~Middle thigh circumference: Circumference measured at the mid point between the gluteal furrow and the supra-patellar border.~Lower Thigh: Circumference measured just above the supra-patellar border."|cm|Mean|55|55.0|Standard Deviation|4.2|4.2|||
3630722|NCT02592655|3478665|B3|10 cm above Mid Thigh||Thigh Circumference|"All thigh circumference measures taken from the participants right thigh while standing.~Upper thigh circumference: Measured just below the gluteal furrow.~10 cm Above Mid Thigh: Circumference measured 10 cm above the mid point between the gluteal furrow and supra-patellar border.~Middle thigh circumference: Circumference measured at the mid point between the gluteal furrow and the supra-patellar border.~Lower Thigh: Circumference measured just above the supra-patellar border."|cm|Mean|65.4|65.4|Standard Deviation|6.3|6.3|||
3630723|NCT02592655|3478666|B2|10 cm above Mid Thigh||Thigh Circumference|"All thigh circumference measures taken from the participants right thigh while standing.~Upper thigh circumference: Measured just below the gluteal furrow.~10 cm Above Mid Thigh: Circumference measured 10 cm above the mid point between the gluteal furrow and supra-patellar border.~Middle thigh circumference: Circumference measured at the mid point between the gluteal furrow and the supra-patellar border.~Lower Thigh: Circumference measured just above the supra-patellar border."|cm|Mean|68.7|68.7|Standard Deviation|5.7|5.7|||
3630724|NCT02592655|3478667|B1|10 cm above Mid Thigh||Thigh Circumference|"All thigh circumference measures taken from the participants right thigh while standing.~Upper thigh circumference: Measured just below the gluteal furrow.~10 cm Above Mid Thigh: Circumference measured 10 cm above the mid point between the gluteal furrow and supra-patellar border.~Middle thigh circumference: Circumference measured at the mid point between the gluteal furrow and the supra-patellar border.~Lower Thigh: Circumference measured just above the supra-patellar border."|cm|Mean|61.0|61.0|Standard Deviation|4.0|4.0|||
3630725|NCT02592655|3478665|B3|Upper Thigh||Thigh Circumference|"All thigh circumference measures taken from the participants right thigh while standing.~Upper thigh circumference: Measured just below the gluteal furrow.~10 cm Above Mid Thigh: Circumference measured 10 cm above the mid point between the gluteal furrow and supra-patellar border.~Middle thigh circumference: Circumference measured at the mid point between the gluteal furrow and the supra-patellar border.~Lower Thigh: Circumference measured just above the supra-patellar border."|cm|Mean|68.0|68.0|Standard Deviation|6.3|6.3|||
3630726|NCT02592655|3478666|B2|Upper Thigh||Thigh Circumference|"All thigh circumference measures taken from the participants right thigh while standing.~Upper thigh circumference: Measured just below the gluteal furrow.~10 cm Above Mid Thigh: Circumference measured 10 cm above the mid point between the gluteal furrow and supra-patellar border.~Middle thigh circumference: Circumference measured at the mid point between the gluteal furrow and the supra-patellar border.~Lower Thigh: Circumference measured just above the supra-patellar border."|cm|Mean|71.2|71.2|Standard Deviation|5.9|5.9|||
3630776|NCT02592629|3478682|B4||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3630777|NCT02592629|3478683|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3630727|NCT02592655|3478667|B1|Upper Thigh||Thigh Circumference|"All thigh circumference measures taken from the participants right thigh while standing.~Upper thigh circumference: Measured just below the gluteal furrow.~10 cm Above Mid Thigh: Circumference measured 10 cm above the mid point between the gluteal furrow and supra-patellar border.~Middle thigh circumference: Circumference measured at the mid point between the gluteal furrow and the supra-patellar border.~Lower Thigh: Circumference measured just above the supra-patellar border."|cm|Mean|63.5|63.5|Standard Deviation|3.7|3.7|||
3630728|NCT02592655|3478665|B3|||Height||cm|Mean|176.5|176.5|Standard Deviation|9.8|9.8|||
3630729|NCT02592655|3478666|B2|||Height||cm|Mean|175.0|175.0|Standard Deviation|10.1|10.1|||
3630730|NCT02592655|3478667|B1|||Height||cm|Mean|178.6|178.6|Standard Deviation|9.7|9.7|||
3630731|NCT02592655|3478665|B3|||Weight||kg|Mean|101.25|101.25|Standard Deviation|21.22|21.22|||
3630732|NCT02592655|3478666|B2|||Weight||kg|Mean|111.3|111.3|Standard Deviation|21.5|21.5|||
3630733|NCT02592655|3478667|B1|||Weight||kg|Mean|87.5|87.5|Standard Deviation|11.0|11.0|||
3630734|NCT02592655|3478665|B3||BMI 30.0 and Above Obese|BMI Weight Status Category (CDC)||Participants|Count of Participants|10|10.0||||||
3630735|NCT02592655|3478666|B2||BMI 30.0 and Above Obese|BMI Weight Status Category (CDC)||Participants|Count of Participants|10|10.0||||||
3630736|NCT02592655|3478667|B1||BMI 30.0 and Above Obese|BMI Weight Status Category (CDC)||Participants|Count of Participants|0|0.0||||||
3630737|NCT02592655|3478665|B3||BMI 25.0 – 29.9 Overweight|BMI Weight Status Category (CDC)||Participants|Count of Participants|8|8.0||||||
3630738|NCT02592655|3478666|B2||BMI 25.0 – 29.9 Overweight|BMI Weight Status Category (CDC)||Participants|Count of Participants|1|1.0||||||
3630739|NCT02592655|3478667|B1||BMI 25.0 – 29.9 Overweight|BMI Weight Status Category (CDC)||Participants|Count of Participants|7|7.0||||||
3630740|NCT02592655|3478665|B3||BMI 18.5 – 24.9 Normal|BMI Weight Status Category (CDC)||Participants|Count of Participants|1|1.0||||||
3630741|NCT02592655|3478666|B2||BMI 18.5 – 24.9 Normal|BMI Weight Status Category (CDC)||Participants|Count of Participants|0|0.0||||||
3630742|NCT02592655|3478667|B1||BMI 18.5 – 24.9 Normal|BMI Weight Status Category (CDC)||Participants|Count of Participants|1|1.0||||||
3630743|NCT02592655|3478665|B3|||Body Mass Index (BMI)|Body Mass Index is the individual participants body weight in kilograms divided by the individual participants height in meters squared.|Kg/m^2|Mean|32.4|32.4|Standard Deviation|5.6|5.6|||
3630744|NCT02592655|3478666|B2|||Body Mass Index (BMI)|Body Mass Index is the individual participants body weight in kilograms divided by the individual participants height in meters squared.|Kg/m^2|Mean|36.1|36.1|Standard Deviation|4.3|4.3|||
3630745|NCT02592655|3478667|B1|||Body Mass Index (BMI)|Body Mass Index is the individual participants body weight in kilograms divided by the individual participants height in meters squared.|Kg/m^2|Mean|27.4|27.4|Standard Deviation|1.7|1.7|||
3630746|NCT02592655|3478665|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3630747|NCT02592655|3478666|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3630748|NCT02592655|3478667|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3630749|NCT02592655|3478665|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3630750|NCT02592655|3478666|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3630751|NCT02592655|3478667|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3630752|NCT02592655|3478665|B3|||Age||years|Mean|33.7|33.7|Standard Deviation|9.25|9.25|||
3630753|NCT02592655|3478666|B2|||Age||years|Mean|36.1|36.1|Standard Deviation|8.8|8.8|||
3630754|NCT02592655|3478667|B1|||Age||years|Mean|30.5|30.5|Standard Deviation|9.5|9.5|||
3630755|NCT02592629|3478682|B4|||baseline pain|"The pain will be measured with a scale from 0 (no pain) to 10 (worst possible pain)."|units on a scale|Mean|4.78|4.78|Standard Deviation|2.11|2.11|||
3630756|NCT02592629|3478683|B3|||baseline pain|"The pain will be measured with a scale from 0 (no pain) to 10 (worst possible pain)."|units on a scale|Mean|4.7|4.7|Standard Deviation|1.84|1.84|||
3630757|NCT02592629|3478684|B2|||baseline pain|"The pain will be measured with a scale from 0 (no pain) to 10 (worst possible pain)."|units on a scale|Mean|5.16|5.16|Standard Deviation|1.93|1.93|||
3630758|NCT02592629|3478685|B1|||baseline pain|"The pain will be measured with a scale from 0 (no pain) to 10 (worst possible pain)."|units on a scale|Mean|4.2|4.2|Standard Deviation|2.56|2.56|||
3630759|NCT02592629|3478682|B4|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3630760|NCT02592629|3478683|B3|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3630761|NCT02592629|3478684|B2|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3630762|NCT02592629|3478685|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3630763|NCT02592629|3478682|B4|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3630764|NCT02592629|3478682|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3630765|NCT02592629|3478683|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3630766|NCT02592629|3478684|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3630767|NCT02592629|3478685|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3630768|NCT02592629|3478682|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3630769|NCT02592629|3478683|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3630770|NCT02592629|3478684|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3630771|NCT02592629|3478685|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3630772|NCT02592629|3478682|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3630773|NCT02592629|3478683|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3630774|NCT02592629|3478684|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3630775|NCT02592629|3478685|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3630778|NCT02592629|3478684|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3630779|NCT02592629|3478685|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3630780|NCT02592629|3478682|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3630781|NCT02592629|3478683|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3630782|NCT02592629|3478684|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3630783|NCT02592629|3478685|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3630784|NCT02591537|3478695|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3630785|NCT02591537|3478696|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3630786|NCT02591537|3478697|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3630787|NCT02591537|3478695|B3||Unknown or Not Reported|Race (NIH/OMB)||wounds|Count of Units|0|0.0||||||
3630788|NCT02591537|3478696|B2||Unknown or Not Reported|Race (NIH/OMB)||wounds|Count of Units|0|0.0||||||
3630789|NCT02591537|3478697|B1||Unknown or Not Reported|Race (NIH/OMB)||wounds|Count of Units|0|0.0||||||
3630790|NCT02591537|3478695|B3||More than one race|Race (NIH/OMB)||wounds|Count of Units|0|0.0||||||
3630791|NCT02591537|3478696|B2||More than one race|Race (NIH/OMB)||wounds|Count of Units|0|0.0||||||
3630792|NCT02591537|3478697|B1||More than one race|Race (NIH/OMB)||wounds|Count of Units|0|0.0||||||
3630793|NCT02591537|3478695|B3||White|Race (NIH/OMB)||wounds|Count of Units|48|48.0||||||
3630794|NCT02591537|3478696|B2||White|Race (NIH/OMB)||wounds|Count of Units|24|24.0||||||
3630795|NCT02591537|3478697|B1||White|Race (NIH/OMB)||wounds|Count of Units|24|24.0||||||
3630796|NCT02591537|3478695|B3||Black or African American|Race (NIH/OMB)||wounds|Count of Units|16|16.0||||||
3630797|NCT02591537|3478696|B2||Black or African American|Race (NIH/OMB)||wounds|Count of Units|8|8.0||||||
3630798|NCT02591537|3478697|B1||Black or African American|Race (NIH/OMB)||wounds|Count of Units|8|8.0||||||
3630799|NCT02591537|3478695|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||wounds|Count of Units|0|0.0||||||
3630800|NCT02591537|3478696|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||wounds|Count of Units|0|0.0||||||
3630801|NCT02591537|3478697|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||wounds|Count of Units|0|0.0||||||
3630802|NCT02591537|3478695|B3||Asian|Race (NIH/OMB)||wounds|Count of Units|0|0.0||||||
3630803|NCT02591537|3478696|B2||Asian|Race (NIH/OMB)||wounds|Count of Units|0|0.0||||||
3630804|NCT02591537|3478697|B1||Asian|Race (NIH/OMB)||wounds|Count of Units|0|0.0||||||
3630805|NCT02591537|3478695|B3||American Indian or Alaska Native|Race (NIH/OMB)||wounds|Count of Units|0|0.0||||||
3630806|NCT02591537|3478696|B2||American Indian or Alaska Native|Race (NIH/OMB)||wounds|Count of Units|0|0.0||||||
3630807|NCT02591537|3478697|B1||American Indian or Alaska Native|Race (NIH/OMB)||wounds|Count of Units|0|0.0||||||
3630808|NCT02591537|3478695|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||wounds|Count of Units|0|0.0||||||
3630809|NCT02591537|3478696|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||wounds|Count of Units|0|0.0||||||
3630810|NCT02591537|3478697|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||wounds|Count of Units|0|0.0||||||
3630811|NCT02591537|3478695|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||wounds|Count of Units|32|32.0||||||
3630812|NCT02591537|3478696|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||wounds|Count of Units|16|16.0||||||
3630813|NCT02591537|3478697|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||wounds|Count of Units|16|16.0||||||
3630814|NCT02591537|3478695|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||wounds|Count of Units|32|32.0||||||
3630815|NCT02591537|3478696|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||wounds|Count of Units|16|16.0||||||
3630816|NCT02591537|3478697|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||wounds|Count of Units|16|16.0||||||
3630817|NCT02591537|3478695|B3||Male|Sex: Female, Male||wounds|Count of Units|0|0.0||||||
3630818|NCT02591537|3478696|B2||Male|Sex: Female, Male||wounds|Count of Units|0|0.0||||||
3630819|NCT02591537|3478697|B1||Male|Sex: Female, Male||wounds|Count of Units|0|0.0||||||
3630820|NCT02591537|3478695|B3||Female|Sex: Female, Male||wounds|Count of Units|64|64.0||||||
3630821|NCT02591537|3478696|B2||Female|Sex: Female, Male||wounds|Count of Units|32|32.0||||||
3630822|NCT02591537|3478697|B1||Female|Sex: Female, Male||wounds|Count of Units|32|32.0||||||
3630823|NCT02591537|3478695|B3|||Age||years|Mean|41.6|41.6|Standard Deviation|12|12.0|||
3630824|NCT02591537|3478696|B2|||Age||years|Mean|41.6|41.6|Standard Deviation|12|12.0|||
3630825|NCT02591537|3478697|B1|||Age||years|Mean|41.6|41.6|Standard Deviation|12|12.0|||
3630826|NCT02591511|3478718|B3|||Stroke knowledge questionnaire||participants|Mean|25.72|25.72|Standard Deviation|6.10|6.1|||
3630827|NCT02591511|3478719|B2|||Stroke knowledge questionnaire||participants|Mean|25.21|25.21|Standard Deviation|5.54|5.54|||
3630828|NCT02591511|3478720|B1|||Stroke knowledge questionnaire||participants|Mean|26.23|26.23|Standard Deviation|6.65|6.65|||
3630829|NCT02591511|3478718|B3|Taiwan||Region of Enrollment||participants|Number|63|63.0||||||
3630830|NCT02591511|3478719|B2|Taiwan||Region of Enrollment||participants|Number|33|33.0||||||
3630831|NCT02591511|3478720|B1|Taiwan||Region of Enrollment||participants|Number|30|30.0||||||
3630832|NCT02591511|3478718|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3630833|NCT02591511|3478719|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3630834|NCT02591511|3478720|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3630835|NCT02591511|3478718|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3630836|NCT02591511|3478719|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3630837|NCT02591511|3478720|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3630838|NCT02591511|3478718|B3|||Age||years|Mean|51.40|51.4|Standard Deviation|11.08|11.08|||
3630839|NCT02591511|3478719|B2|||Age||years|Mean|52.33|52.33|Standard Deviation|11.33|11.33|||
3630840|NCT02591511|3478720|B1|||Age||years|Mean|50.47|50.47|Standard Deviation|10.82|10.82|||
3630841|NCT02591511|3478718|B3||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3630842|NCT02591511|3478719|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3630843|NCT02591511|3478720|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3630844|NCT02591511|3478718|B3||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
3630845|NCT02591511|3478719|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3630846|NCT02591511|3478720|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3630847|NCT02591511|3478718|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3630848|NCT02591511|3478719|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3630849|NCT02591511|3478720|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3630850|NCT02591290|3478727|B1|Japan||Region of Enrollment||participants|Number|60|60.0||||||
3630851|NCT02591290|3478727|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3630852|NCT02591290|3478727|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3630853|NCT02591290|3478727|B1|||Age||years|Mean|38.6|38.6|Standard Deviation|9.8|9.8|||
3630854|NCT02591238|3478733|B5||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3630855|NCT02591238|3478734|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3630856|NCT02591238|3478735|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3630857|NCT02591238|3478736|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3630858|NCT02591238|3478737|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3630859|NCT02591238|3478733|B5||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3630860|NCT02591238|3478734|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3630861|NCT02591238|3478735|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3630862|NCT02591238|3478736|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3630863|NCT02591238|3478737|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3630864|NCT02591238|3478733|B5|||Age||years|Mean|33.37|33.37|Standard Deviation|3.1|3.1|||
3630865|NCT02591238|3478734|B4|||Age||years|Mean|31.7|31.7|Standard Deviation|2.8|2.8|||
3630866|NCT02591238|3478735|B3|||Age||years|Mean|31.7|31.7|Standard Deviation|3.4|3.4|||
3630867|NCT02591238|3478736|B2|||Age||years|Mean|34.6|34.6|Standard Deviation|3.8|3.8|||
3630868|NCT02591238|3478737|B1|||Age||years|Mean|35.5|35.5|Standard Deviation|3.4|3.4|||
3630869|NCT02591056|3478770|B1|||Body Mass Index (BMI)||kg/m^2|Mean|30.64|30.64|Standard Deviation|3.97|3.97|||
3630870|NCT02591056|3478770|B1|||Combined Circumference|Measurements in inches were taken for the subject's waist, hips and upper abdomen and added together to get a combined circumference measurement.|inches|Mean|112.34|112.34|Standard Deviation|13.67|13.67|||
3630871|NCT02591056|3478770|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3630872|NCT02591056|3478770|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630873|NCT02591056|3478770|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3630874|NCT02591056|3478770|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3630875|NCT02591056|3478770|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
3630876|NCT02591056|3478770|B1||Female|Gender||Participants|Count of Participants|22|22.0||||||
3630877|NCT02591056|3478770|B1|||Age||years|Mean|44.15|44.15|Standard Deviation|13.13|13.13|||
3630878|NCT02591056|3478770|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3630879|NCT02591056|3478770|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3630880|NCT02591056|3478770|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3630881|NCT02590939|3478774|B3|||Use of acute medication before enrollment||Participants|Count of Participants|31|31.0||||||
3630882|NCT02590939|3478775|B2|||Use of acute medication before enrollment||Participants|Count of Participants|14|14.0||||||
3630883|NCT02590939|3478776|B1|||Use of acute medication before enrollment||Participants|Count of Participants|17|17.0||||||
3630884|NCT02590939|3478774|B3|||Migraine duration (hours)||hours|Median|6|6.0|Inter-Quartile Range|||4.0|24.0|
3630885|NCT02590939|3478775|B2|||Migraine duration (hours)||hours|Median|6|6.0|Inter-Quartile Range|||4.63|20.75|
3630886|NCT02590939|3478776|B1|||Migraine duration (hours)||hours|Median|7|7.0|Inter-Quartile Range|||4.0|48.0|
3630887|NCT02590939|3478774|B3||Migraine without aura|Migraine type||Participants|Count of Participants|89|89.0||||||
3630888|NCT02590939|3478775|B2||Migraine without aura|Migraine type||Participants|Count of Participants|49|49.0||||||
3630889|NCT02590939|3478776|B1||Migraine without aura|Migraine type||Participants|Count of Participants|40|40.0||||||
3630890|NCT02590939|3478774|B3||Migraine with aura|Migraine type||Participants|Count of Participants|17|17.0||||||
3630891|NCT02590939|3478775|B2||Migraine with aura|Migraine type||Participants|Count of Participants|5|5.0||||||
3630892|NCT02590939|3478776|B1||Migraine with aura|Migraine type||Participants|Count of Participants|12|12.0||||||
3630893|NCT02590939|3478774|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3630894|NCT02590939|3478774|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3630895|NCT02590939|3478775|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3630896|NCT02590939|3478776|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3630897|NCT02590939|3478774|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3630898|NCT02590939|3478775|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3630899|NCT02590939|3478776|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3630900|NCT02590939|3478774|B3|||Age||years|Mean|39.90|39.9|Standard Deviation|13.14|13.14|||
3630901|NCT02590939|3478775|B2|||Age||years|Mean|40.09|40.09|Standard Deviation|12.65|12.65|||
3630902|NCT02590939|3478776|B1|||Age||years|Mean|39.71|39.71|Standard Deviation|13.62|13.62|||
3630903|NCT02590588|3478797|B1||Unknown or Not Reported|Race (NIH/OMB)|Unit of measure based on patient identification|Participants|Count of Participants|0|0.0||||||
3630904|NCT02590588|3478797|B1||More than one race|Race (NIH/OMB)|Unit of measure based on patient identification|Participants|Count of Participants|0|0.0||||||
3630905|NCT02590588|3478797|B1||White|Race (NIH/OMB)|Unit of measure based on patient identification|Participants|Count of Participants|1|1.0||||||
3630906|NCT02590588|3478797|B1||Black or African American|Race (NIH/OMB)|Unit of measure based on patient identification|Participants|Count of Participants|0|0.0||||||
3630907|NCT02590588|3478797|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Unit of measure based on patient identification|Participants|Count of Participants|0|0.0||||||
3630908|NCT02590588|3478797|B1||Asian|Race (NIH/OMB)|Unit of measure based on patient identification|Participants|Count of Participants|0|0.0||||||
3630909|NCT02590588|3478797|B1||American Indian or Alaska Native|Race (NIH/OMB)|Unit of measure based on patient identification|Participants|Count of Participants|0|0.0||||||
3630910|NCT02590588|3478797|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3630911|NCT02590588|3478797|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3630912|NCT02590588|3478797|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3630913|NCT02590588|3478797|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3630914|NCT02590588|3478797|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3630915|NCT02590562|3478805|B1||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3630916|NCT02590562|3478805|B1||Female|Sex: Female, Male||Participants|Count of Participants|652|652.0||||||
3630917|NCT02590562|3478805|B1|>60 years||Age, Customized|Age was available for 800 participants only; age was missing for 2 participants who were thus not included in the age results.|participants|Number|185|185.0||||||
3630918|NCT02590562|3478805|B1|>40 to <=60 years||Age, Customized|Age was available for 800 participants only; age was missing for 2 participants who were thus not included in the age results.|participants|Number|402|402.0||||||
3630919|NCT02590562|3478805|B1|greater than (>) 20 to <=40 years||Age, Customized|Age was available for 800 participants only; age was missing for 2 participants who were thus not included in the age results.|participants|Number|201|201.0||||||
3630920|NCT02590562|3478805|B1|less than or equal to (<=) 20 years||Age, Customized|Age was available for 800 participants only; age was missing for 2 participants who were thus not included in the age results.|participants|Number|12|12.0||||||
3630921|NCT02590562|3478805|B1|||Age|Age was available for 800 participants only; age was missing for 2 participants who were thus not included in the age results.|years|Mean|49.0|49.0|Standard Deviation|13.89|13.89|||
3630922|NCT02590003|3478862|B3|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3630923|NCT02590003|3478863|B2|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3630924|NCT02590003|3478864|B1|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3630925|NCT02590003|3478862|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3630926|NCT02590003|3478863|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3630927|NCT02590003|3478864|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3630928|NCT02590003|3478862|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630929|NCT02590003|3478863|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630930|NCT02590003|3478864|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630931|NCT02590003|3478862|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3630932|NCT02590003|3478863|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3630933|NCT02590003|3478864|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630934|NCT02590003|3478862|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630935|NCT02590003|3478863|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630936|NCT02590003|3478864|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630937|NCT02590003|3478862|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630938|NCT02590003|3478863|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630939|NCT02590003|3478864|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630940|NCT02590003|3478862|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630941|NCT02590003|3478863|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630942|NCT02590003|3478864|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630943|NCT02590003|3478862|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630944|NCT02590003|3478863|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630945|NCT02590003|3478864|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630946|NCT02590003|3478862|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3630947|NCT02590003|3478863|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630948|NCT02590003|3478864|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3630949|NCT02590003|3478862|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3630950|NCT02590003|3478863|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3630951|NCT02590003|3478864|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630952|NCT02590003|3478862|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3630953|NCT02590003|3478863|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3630954|NCT02590003|3478864|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630955|NCT02590003|3478862|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3630956|NCT02590003|3478863|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3630957|NCT02590003|3478864|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3630958|NCT02590003|3478862|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3630959|NCT02590003|3478863|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3630960|NCT02590003|3478864|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3630961|NCT02590003|3478862|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3630962|NCT02590003|3478863|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3630963|NCT02590003|3478864|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3630964|NCT02590003|3478862|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3630965|NCT02590003|3478863|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3630966|NCT02590003|3478864|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3630967|NCT02590003|3478862|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3630968|NCT02590003|3478863|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3630969|NCT02590003|3478864|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3630970|NCT02588976|3478885|B1|Switzerland||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3630971|NCT02588976|3478885|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3630972|NCT02588976|3478885|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3630973|NCT02588976|3478885|B1|||Age||years|Mean|67|67.0|Standard Deviation|15|15.0|||
3630974|NCT02588976|3478885|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3630975|NCT02588976|3478885|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3630976|NCT02588976|3478885|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3630977|NCT02588872|3478890|B3|||BMI||kg/m^2|Mean|28.2|28.2|Standard Deviation|5.1|5.1|||
3630978|NCT02588872|3478891|B2|||BMI||kg/m^2|Mean|27.4|27.4|Standard Deviation|3.9|3.9|||
3630979|NCT02588872|3478892|B1|||BMI||kg/m^2|Mean|29|29.0|Standard Deviation|6.4|6.4|||
3630980|NCT02588872|3478890|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3630981|NCT02588872|3478891|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3630982|NCT02588872|3478892|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3630983|NCT02588872|3478890|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3630984|NCT02588872|3478891|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3630985|NCT02588872|3478892|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3630986|NCT02588872|3478890|B3|||Age||years|Mean|56.3|56.3|Standard Deviation|10.4|10.4|||
3630987|NCT02588872|3478891|B2|||Age||years|Mean|55.9|55.9|Standard Deviation|10.4|10.4|||
3630988|NCT02588872|3478892|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|10.5|10.5|||
3630989|NCT02588599|3478907|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3630990|NCT02588599|3478907|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3630991|NCT02588599|3478907|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3630992|NCT02588599|3478907|B1||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3630993|NCT02588599|3478907|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3630994|NCT02587819|3478912|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630995|NCT02587819|3478912|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630996|NCT02587819|3478912|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3630997|NCT02587819|3478912|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630998|NCT02587819|3478912|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3630999|NCT02587819|3478912|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631000|NCT02587819|3478912|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631001|NCT02587819|3478912|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631002|NCT02587819|3478912|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3631003|NCT02587819|3478912|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631004|NCT02587819|3478912|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3631005|NCT02587819|3478912|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3631006|NCT02587819|3478912|B1|||Age||years|Mean|65.0|65.0|Standard Deviation|14.4|14.4|||
3631007|NCT02587234|3478919|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3631008|NCT02587234|3478920|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3631009|NCT02587234|3478921|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3631010|NCT02587234|3478919|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3631011|NCT02587234|3478920|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3631012|NCT02587234|3478921|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3631013|NCT02587234|3478919|B3|||Age||years|Mean|55.7|55.7|Standard Deviation|9.2|9.2|||
3631014|NCT02587234|3478920|B2|||Age||years|Mean|54.6|54.6|Standard Deviation|10.2|10.2|||
3631015|NCT02587234|3478921|B1|||Age||years|Mean|56.7|56.7|Standard Deviation|8.6|8.6|||
3631016|NCT02587117|3478932|B3|||Baseline NRS (numerical rating scale) burning sensation score|Each patient was provided standard self-response Numerical Rating Scale (NRS) of 0 (no oral discomfort) to 10 (worst imaginable oral discomfort) to respond the intensity of burning sensation or pain or discomfort during each visit. the mean of NRS burning sensation score was calculated and considered as baseline NRS burning sensation score.|Scores on a scale|Mean|3.64|3.64|Standard Deviation|1.87|1.87|||
3631017|NCT02587117|3478933|B2|||Baseline NRS (numerical rating scale) burning sensation score|Each patient was provided standard self-response Numerical Rating Scale (NRS) of 0 (no oral discomfort) to 10 (worst imaginable oral discomfort) to respond the intensity of burning sensation or pain or discomfort during each visit. the mean of NRS burning sensation score was calculated and considered as baseline NRS burning sensation score.|Scores on a scale|Mean|3.60|3.6|Standard Deviation|2.03|2.03|||
3631018|NCT02587117|3478934|B1|||Baseline NRS (numerical rating scale) burning sensation score|Each patient was provided standard self-response Numerical Rating Scale (NRS) of 0 (no oral discomfort) to 10 (worst imaginable oral discomfort) to respond the intensity of burning sensation or pain or discomfort during each visit. the mean of NRS burning sensation score was calculated and considered as baseline NRS burning sensation score.|Scores on a scale|Mean|3.69|3.69|Standard Deviation|1.75|1.75|||
3631019|NCT02587117|3478932|B3|||Piboonniyom REU (Reticular, Erythematous and Ulceration) severity score|Reticular:score 0=no white striations; score1= white striations. Erythematous:score 0=no lesion; score1= lesion <1 cm2; score2: lesion 1-3 cm2; score3= lesion >3 cm2. Ulceration:score 0=no lesion; score1= lesion <1 cm2; score2= lesion 1-3 cm2; score3= lesion >3 cm2. Total weighted score was sum total scores of each lesion & multiplication with weighted score 1.5 & 2.0 in total erythematous & total ulceration scores=ΣR+ΣE×1.5+ΣU×2.0. Total score was dependent on the number of lesions of each participant. Higher values of total score represent worse outcome & zero value represent no lesion.|Scores on a scale|Mean|8.28|8.28|Standard Deviation|6.86|6.86|||
3631020|NCT02587117|3478933|B2|||Piboonniyom REU (Reticular, Erythematous and Ulceration) severity score|Reticular:score 0=no white striations; score1= white striations. Erythematous:score 0=no lesion; score1= lesion <1 cm2; score2: lesion 1-3 cm2; score3= lesion >3 cm2. Ulceration:score 0=no lesion; score1= lesion <1 cm2; score2= lesion 1-3 cm2; score3= lesion >3 cm2. Total weighted score was sum total scores of each lesion & multiplication with weighted score 1.5 & 2.0 in total erythematous & total ulceration scores=ΣR+ΣE×1.5+ΣU×2.0. Total score was dependent on the number of lesions of each participant. Higher values of total score represent worse outcome & zero value represent no lesion.|Scores on a scale|Mean|8.34|8.34|Standard Deviation|7.83|7.83|||
3631021|NCT02587117|3478934|B1|||Piboonniyom REU (Reticular, Erythematous and Ulceration) severity score|Reticular:score 0=no white striations; score1= white striations. Erythematous:score 0=no lesion; score1= lesion <1 cm2; score2: lesion 1-3 cm2; score3= lesion >3 cm2. Ulceration:score 0=no lesion; score1= lesion <1 cm2; score2= lesion 1-3 cm2; score3= lesion >3 cm2. Total weighted score was sum total scores of each lesion & multiplication with weighted score 1.5 & 2.0 in total erythematous & total ulceration scores=ΣR+ΣE×1.5+ΣU×2.0. Total score was dependent on the number of lesions of each participant. Higher values of total score represent worse outcome & zero value represent no lesion.|Scores on a scale|Mean|8.23|8.23|Standard Deviation|5.85|5.85|||
3631022|NCT02587117|3478932|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3631023|NCT02587117|3478933|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3631024|NCT02587117|3478934|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3631025|NCT02587117|3478932|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3631026|NCT02587117|3478933|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3631027|NCT02587117|3478934|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3631028|NCT02587117|3478932|B3|||Age||years|Mean|45.11|45.11|Standard Deviation|13.24|13.24|||
3631029|NCT02587117|3478933|B2|||Age||years|Mean|48.07|48.07|Standard Deviation|12.27|12.27|||
3631030|NCT02587117|3478934|B1|||Age||years|Mean|41.69|41.69|Standard Deviation|13.97|13.97|||
3631031|NCT02586805|3478943|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631032|NCT02586805|3478944|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631033|NCT02586805|3478945|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631034|NCT02586805|3478946|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631035|NCT02586805|3478947|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631036|NCT02586805|3478943|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
3631037|NCT02586805|3478944|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3631038|NCT02586805|3478945|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3631039|NCT02586805|3478946|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3631040|NCT02586805|3478947|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3631041|NCT02586805|3478943|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3631042|NCT02586805|3478944|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3631043|NCT02586805|3478945|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3631044|NCT02586805|3478946|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631045|NCT02586805|3478947|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3631046|NCT02586805|3478943|B5||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3631047|NCT02586805|3478944|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3631048|NCT02586805|3478945|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3631049|NCT02586805|3478946|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3631050|NCT02586805|3478947|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3631051|NCT02586805|3478943|B5||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3631052|NCT02586805|3478944|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3631053|NCT02586805|3478945|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3631054|NCT02586805|3478946|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3631055|NCT02586805|3478947|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3631056|NCT02586805|3478943|B5|||Age||Years|Mean|40.7|40.7|Standard Deviation|14.69|14.69|||
3631057|NCT02586805|3478944|B4|||Age||Years|Mean|40.3|40.3|Standard Deviation|13.35|13.35|||
3631058|NCT02586805|3478945|B3|||Age||Years|Mean|39.5|39.5|Standard Deviation|12.85|12.85|||
3631059|NCT02586805|3478946|B2|||Age||Years|Mean|43.4|43.4|Standard Deviation|14.91|14.91|||
3631060|NCT02586805|3478947|B1|||Age||Years|Mean|40.1|40.1|Standard Deviation|16.75|16.75|||
3631061|NCT02586506|3478972|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3631062|NCT02586506|3478972|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631063|NCT02586506|3478972|B1||White|Race (NIH/OMB)||Participants|Count of Participants|184|184.0||||||
3631064|NCT02586506|3478972|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3631065|NCT02586506|3478972|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631066|NCT02586506|3478972|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3631067|NCT02586506|3478972|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3631068|NCT02586506|3478972|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3631069|NCT02586506|3478972|B1||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3631070|NCT02586506|3478972|B1|||Age||Years|Mean|47.3|47.3|Standard Deviation|15.23|15.23|||
3631071|NCT02586493|3478978|B1|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|249|249.0||||||
3631072|NCT02586493|3478978|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3631073|NCT02586493|3478978|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|28|28.0||||||
3631074|NCT02586493|3478978|B1||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3631075|NCT02586493|3478978|B1||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3631076|NCT02586493|3478978|B1|||Age||Years|Mean|64.8|64.8|Standard Deviation|8.56|8.56|||
3631077|NCT02586415|3478984|B3|||NIHSS, continuous|The NIHSS is a clinician-rated, 15-item scale designed to assess the severity of stroke-related neurological deficits: level of consciousness, eye movements, visual fields, facial symmetry, motor strength (arm and leg), coordination, sensation, language (aphasia and dysarthria), and neglect. Each item is rated on a 3-, 4-, or 5-point scale ranging from 0 (normal) to the maximum score (extremely severe symptoms). The total score of the 15 items ranges from 0 to 42, where lower scores indicate less impairment.|units on a scale|Median|16|16.0|Inter-Quartile Range|||11.0|21.0|
3631078|NCT02586415|3478985|B2|||NIHSS, continuous|The NIHSS is a clinician-rated, 15-item scale designed to assess the severity of stroke-related neurological deficits: level of consciousness, eye movements, visual fields, facial symmetry, motor strength (arm and leg), coordination, sensation, language (aphasia and dysarthria), and neglect. Each item is rated on a 3-, 4-, or 5-point scale ranging from 0 (normal) to the maximum score (extremely severe symptoms). The total score of the 15 items ranges from 0 to 42, where lower scores indicate less impairment.|units on a scale|Median|16|16.0|Inter-Quartile Range|||12.0|21.0|
3631079|NCT02586415|3478986|B1|||NIHSS, continuous|The NIHSS is a clinician-rated, 15-item scale designed to assess the severity of stroke-related neurological deficits: level of consciousness, eye movements, visual fields, facial symmetry, motor strength (arm and leg), coordination, sensation, language (aphasia and dysarthria), and neglect. Each item is rated on a 3-, 4-, or 5-point scale ranging from 0 (normal) to the maximum score (extremely severe symptoms). The total score of the 15 items ranges from 0 to 42, where lower scores indicate less impairment.|units on a scale|Median|16|16.0|Inter-Quartile Range|||10.0|20.0|
3631080|NCT02586415|3478984|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3631081|NCT02586415|3478985|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631082|NCT02586415|3478986|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631083|NCT02586415|3478984|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631084|NCT02586415|3478985|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631085|NCT02586415|3478986|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631086|NCT02586415|3478984|B3||White|Race (NIH/OMB)||Participants|Count of Participants|158|158.0||||||
3631087|NCT02586415|3478985|B2||White|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3631088|NCT02586415|3478986|B1||White|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3631089|NCT02586415|3478984|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3631090|NCT02586415|3478985|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3631091|NCT02586415|3478986|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3631092|NCT02586415|3478984|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631093|NCT02586415|3478985|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631094|NCT02586415|3478986|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631095|NCT02586415|3478984|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3631096|NCT02586415|3478985|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3631097|NCT02586415|3478986|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3631098|NCT02586415|3478984|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631099|NCT02586415|3478985|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631100|NCT02586415|3478986|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631101|NCT02586415|3478984|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631102|NCT02586415|3478985|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631103|NCT02586415|3478986|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631104|NCT02586415|3478984|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|157|157.0||||||
3631105|NCT02586415|3478985|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3631106|NCT02586415|3478986|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3631107|NCT02586415|3478984|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3631108|NCT02586415|3478985|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3631109|NCT02586415|3478986|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3631110|NCT02586415|3478984|B3||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3631111|NCT02586415|3478985|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3631112|NCT02586415|3478986|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3631113|NCT02586415|3478984|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3631114|NCT02586415|3478985|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3631115|NCT02586415|3478986|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3631116|NCT02586415|3478984|B3|||Age||years|Median|70.5|70.5|Inter-Quartile Range|||59.0|80.0|
3631117|NCT02586415|3478985|B2|||Age||years|Median|71|71.0|Inter-Quartile Range|||59.0|80.0|
3631118|NCT02586415|3478986|B1|||Age||years|Median|70|70.0|Inter-Quartile Range|||59.0|78.5|
3631119|NCT02585999|3478995|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
3631120|NCT02585999|3478995|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631121|NCT02585999|3478995|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3631122|NCT02585999|3478995|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3631123|NCT02585999|3478995|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3631124|NCT02585999|3478995|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631125|NCT02585999|3478995|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3631126|NCT02585999|3478995|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631127|NCT02585999|3478995|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631128|NCT02585999|3478995|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3631129|NCT02585999|3478995|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3631130|NCT02585999|3478995|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3631131|NCT02585999|3478995|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3631132|NCT02585999|3478995|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3631133|NCT02585999|3478995|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3631134|NCT02585999|3478995|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3631135|NCT02585934|3479000|B3|||BMI||kg/m^2|Mean|26.4|26.4|Full Range|||15.2|56.3|
3631136|NCT02585934|3479001|B2|||BMI||kg/m^2|Mean|26.5|26.5|Full Range|||15.2|45.3|
3631137|NCT02585934|3479002|B1|||BMI||kg/m^2|Mean|26.4|26.4|Full Range|||17.2|56.3|
3631138|NCT02585934|3479000|B3|Race|Missing|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3631139|NCT02585934|3479001|B2|Race|Missing|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3631140|NCT02585934|3479002|B1|Race|Missing|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3631141|NCT02585934|3479000|B3|Race|Not Applicable|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3631142|NCT02585934|3479001|B2|Race|Not Applicable|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3631143|NCT02585934|3479002|B1|Race|Not Applicable|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3631144|NCT02585934|3479000|B3|Race|Others|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3631145|NCT02585934|3479001|B2|Race|Others|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3631146|NCT02585934|3479002|B1|Race|Others|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3631147|NCT02585934|3479000|B3|Race|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3631148|NCT02585934|3479001|B2|Race|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3631149|NCT02585934|3479002|B1|Race|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3631150|NCT02585934|3479000|B3|Race|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3631151|NCT02585934|3479001|B2|Race|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3631152|NCT02585934|3479002|B1|Race|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3631153|NCT02585934|3479000|B3|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
3631154|NCT02585934|3479001|B2|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3631155|NCT02585934|3479002|B1|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3631156|NCT02585934|3479000|B3|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3631157|NCT02585934|3479001|B2|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3631158|NCT02585934|3479002|B1|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3631159|NCT02585934|3479000|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|1187|1187.0||||||
3631160|NCT02585934|3479001|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|592|592.0||||||
3631161|NCT02585934|3479002|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|595|595.0||||||
3631162|NCT02585934|3479000|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3631163|NCT02585934|3479001|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3631164|NCT02585934|3479002|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3631165|NCT02585934|3479000|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1037|1037.0||||||
3631166|NCT02585934|3479001|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|519|519.0||||||
3631167|NCT02585934|3479002|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|518|518.0||||||
3631168|NCT02585934|3479000|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|228|228.0||||||
3631169|NCT02585934|3479001|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
3631170|NCT02585934|3479002|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
3631171|NCT02585934|3479000|B3||Male|Sex: Female, Male||Participants|Count of Participants|496|496.0||||||
3631172|NCT02585934|3479001|B2||Male|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
3631173|NCT02585934|3479002|B1||Male|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
3631174|NCT02585934|3479000|B3||Female|Sex: Female, Male||Participants|Count of Participants|780|780.0||||||
3631175|NCT02585934|3479001|B2||Female|Sex: Female, Male||Participants|Count of Participants|394|394.0||||||
3631176|NCT02585934|3479002|B1||Female|Sex: Female, Male||Participants|Count of Participants|386|386.0||||||
3631177|NCT02585934|3479000|B3|>/=65 years||Age, Customized||Participants|Count of Participants|1081|1081.0||||||
3631178|NCT02585934|3479001|B2|>/=65 years||Age, Customized||Participants|Count of Participants|536|536.0||||||
3631179|NCT02585934|3479002|B1|>/=65 years||Age, Customized||Participants|Count of Participants|545|545.0||||||
3631180|NCT02585934|3479000|B3|< 65 years||Age, Customized||Participants|Count of Participants|195|195.0||||||
3631181|NCT02585934|3479001|B2|< 65 years||Age, Customized||Participants|Count of Participants|97|97.0||||||
3631182|NCT02585934|3479002|B1|< 65 years||Age, Customized||Participants|Count of Participants|98|98.0||||||
3631183|NCT02585934|3479000|B3|>/= 74 years||Age, Customized||Participants|Count of Participants|655|655.0||||||
3631184|NCT02585934|3479001|B2|>/= 74 years||Age, Customized||Participants|Count of Participants|321|321.0||||||
3631185|NCT02585934|3479002|B1|>/= 74 years||Age, Customized||Participants|Count of Participants|334|334.0||||||
3631186|NCT02585934|3479000|B3|< 74 years||Age, Customized||Participants|Count of Participants|621|621.0||||||
3631187|NCT02585934|3479001|B2|< 74 years||Age, Customized||Participants|Count of Participants|312|312.0||||||
3631188|NCT02585934|3479002|B1|< 74 years||Age, Customized||Participants|Count of Participants|309|309.0||||||
3631189|NCT02585934|3479000|B3|||Age||years|Mean|72.6|72.6|Full Range|||50.0|86.0|
3631190|NCT02585934|3479001|B2|||Age||years|Mean|72.5|72.5|Full Range|||50.0|86.0|
3631191|NCT02585934|3479002|B1|||Age||years|Mean|72.7|72.7|Full Range|||50.0|85.0|
3631192|NCT02585895|3479024|B3|||LDL-C Concentration||mg/dL|Mean|151.5|151.5|Standard Deviation|23.3|23.3|||
3631193|NCT02585895|3479025|B2|||LDL-C Concentration||mg/dL|Mean|152.4|152.4|Standard Deviation|21.2|21.2|||
3631194|NCT02585895|3479026|B1|||LDL-C Concentration||mg/dL|Mean|150.6|150.6|Standard Deviation|25.6|25.6|||
3631195|NCT02585895|3479024|B3|≥ 160 mg/dL||Stratification Factor: Screening LDL-C Level||participants|Number|17|17.0||||||
3631196|NCT02585895|3479025|B2|≥ 160 mg/dL||Stratification Factor: Screening LDL-C Level||participants|Number|8|8.0||||||
3631197|NCT02585895|3479026|B1|≥ 160 mg/dL||Stratification Factor: Screening LDL-C Level||participants|Number|9|9.0||||||
3631198|NCT02585895|3479024|B3|< 160 mg/dL||Stratification Factor: Screening LDL-C Level||participants|Number|22|22.0||||||
3631199|NCT02585895|3479025|B2|< 160 mg/dL||Stratification Factor: Screening LDL-C Level||participants|Number|11|11.0||||||
3631200|NCT02585895|3479026|B1|< 160 mg/dL||Stratification Factor: Screening LDL-C Level||participants|Number|11|11.0||||||
3631201|NCT02585895|3479024|B3|White||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
3631202|NCT02585895|3479025|B2|White||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3631203|NCT02585895|3479026|B1|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3631204|NCT02585895|3479024|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3631205|NCT02585895|3479025|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3631206|NCT02585895|3479026|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3631207|NCT02585895|3479024|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3631208|NCT02585895|3479025|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3631209|NCT02585895|3479026|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3631210|NCT02585895|3479024|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3631211|NCT02585895|3479025|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3631212|NCT02585895|3479026|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3631213|NCT02585895|3479024|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3631214|NCT02585895|3479025|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3631215|NCT02585895|3479026|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3631216|NCT02585895|3479024|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631217|NCT02585895|3479025|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631218|NCT02585895|3479026|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631219|NCT02585895|3479024|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3631220|NCT02585895|3479025|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3631221|NCT02585895|3479026|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3631222|NCT02585895|3479024|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3631223|NCT02585895|3479025|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3631224|NCT02585895|3479026|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631225|NCT02585895|3479024|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3631226|NCT02585895|3479025|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3631227|NCT02585895|3479026|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3631228|NCT02585895|3479024|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3631229|NCT02585895|3479025|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3631230|NCT02585895|3479026|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3631231|NCT02585895|3479024|B3|≥ 65 years||Age, Customized||participants|Number|18|18.0||||||
3631232|NCT02585895|3479025|B2|≥ 65 years||Age, Customized||participants|Number|12|12.0||||||
3631233|NCT02585895|3479026|B1|≥ 65 years||Age, Customized||participants|Number|6|6.0||||||
3631234|NCT02585895|3479024|B3|< 65 years||Age, Customized||participants|Number|21|21.0||||||
3631235|NCT02585895|3479025|B2|< 65 years||Age, Customized||participants|Number|7|7.0||||||
3631236|NCT02585895|3479026|B1|< 65 years||Age, Customized||participants|Number|14|14.0||||||
3631237|NCT02585895|3479024|B3|||Age||years|Mean|62.4|62.4|Standard Deviation|9.5|9.5|||
3631238|NCT02585895|3479025|B2|||Age||years|Mean|65.4|65.4|Standard Deviation|8.1|8.1|||
3631239|NCT02585895|3479026|B1|||Age||years|Mean|59.6|59.6|Standard Deviation|10.0|10.0|||
3631240|NCT02585778|3479042|B5|||Calculated LDL-C in mmol/L|Calculated LDL-C in mmol/L from Friedewald formula (LDL cholesterol = Total cholesterol - HDL cholesterol - [Triglyceride/2.2]).|mmol/L|Mean|2.900|2.9|Standard Deviation|1.031|1.031|||
3631241|NCT02585778|3479043|B4|||Calculated LDL-C in mmol/L|Calculated LDL-C in mmol/L from Friedewald formula (LDL cholesterol = Total cholesterol - HDL cholesterol - [Triglyceride/2.2]).|mmol/L|Mean|2.838|2.838|Standard Deviation|1.013|1.013|||
3631242|NCT02585778|3479044|B3|||Calculated LDL-C in mmol/L|Calculated LDL-C in mmol/L from Friedewald formula (LDL cholesterol = Total cholesterol - HDL cholesterol - [Triglyceride/2.2]).|mmol/L|Mean|2.871|2.871|Standard Deviation|0.944|0.944|||
3631243|NCT02585778|3479045|B2|||Calculated LDL-C in mmol/L|Calculated LDL-C in mmol/L from Friedewald formula (LDL cholesterol = Total cholesterol - HDL cholesterol - [Triglyceride/2.2]).|mmol/L|Mean|2.853|2.853|Standard Deviation|0.807|0.807|||
3631244|NCT02585778|3479046|B1|||Calculated LDL-C in mmol/L|Calculated LDL-C in mmol/L from Friedewald formula (LDL cholesterol = Total cholesterol - HDL cholesterol - [Triglyceride/2.2]).|mmol/L|Mean|3.273|3.273|Standard Deviation|1.506|1.506|||
3631245|NCT02585778|3479042|B5|||Calculated LDL-C in mg/dL|Calculated LDL-C in mg/dL from Friedewald formula (LDL cholesterol = Total cholesterol - high density lipoprotein [HDL] cholesterol - [Triglyceride/5]).|mg/dL|Mean|112.0|112.0|Standard Deviation|39.8|39.8|||
3631246|NCT02585778|3479043|B4|||Calculated LDL-C in mg/dL|Calculated LDL-C in mg/dL from Friedewald formula (LDL cholesterol = Total cholesterol - high density lipoprotein [HDL] cholesterol - [Triglyceride/5]).|mg/dL|Mean|109.6|109.6|Standard Deviation|39.1|39.1|||
3631247|NCT02585778|3479044|B3|||Calculated LDL-C in mg/dL|Calculated LDL-C in mg/dL from Friedewald formula (LDL cholesterol = Total cholesterol - high density lipoprotein [HDL] cholesterol - [Triglyceride/5]).|mg/dL|Mean|110.8|110.8|Standard Deviation|36.5|36.5|||
3631248|NCT02585778|3479045|B2|||Calculated LDL-C in mg/dL|Calculated LDL-C in mg/dL from Friedewald formula (LDL cholesterol = Total cholesterol - high density lipoprotein [HDL] cholesterol - [Triglyceride/5]).|mg/dL|Mean|110.2|110.2|Standard Deviation|31.2|31.2|||
3631249|NCT02585778|3479046|B1|||Calculated LDL-C in mg/dL|Calculated LDL-C in mg/dL from Friedewald formula (LDL cholesterol = Total cholesterol - high density lipoprotein [HDL] cholesterol - [Triglyceride/5]).|mg/dL|Mean|126.4|126.4|Standard Deviation|58.2|58.2|||
3631250|NCT02585778|3479042|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3631251|NCT02585778|3479043|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3631306|NCT02585778|3479043|B4|||Age||years|Mean|64.0|64.0|Standard Deviation|9.4|9.4|||
3631252|NCT02585778|3479044|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3631253|NCT02585778|3479045|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3631254|NCT02585778|3479046|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3631255|NCT02585778|3479042|B5|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3631256|NCT02585778|3479043|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3631257|NCT02585778|3479044|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3631258|NCT02585778|3479045|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3631259|NCT02585778|3479046|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3631260|NCT02585778|3479042|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3631261|NCT02585778|3479043|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3631262|NCT02585778|3479044|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3631263|NCT02585778|3479045|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3631264|NCT02585778|3479046|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3631265|NCT02585778|3479042|B5|Asian/Oriental||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3631266|NCT02585778|3479043|B4|Asian/Oriental||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3631267|NCT02585778|3479044|B3|Asian/Oriental||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3631268|NCT02585778|3479045|B2|Asian/Oriental||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3631269|NCT02585778|3479046|B1|Asian/Oriental||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3631270|NCT02585778|3479042|B5|Black||Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
3631271|NCT02585778|3479043|B4|Black||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3631272|NCT02585778|3479044|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3631273|NCT02585778|3479045|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3631274|NCT02585778|3479046|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3631275|NCT02585778|3479042|B5|White/Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|468|468.0||||||
3631276|NCT02585778|3479043|B4|White/Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|135|135.0||||||
3631277|NCT02585778|3479044|B3|White/Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|259|259.0||||||
3631278|NCT02585778|3479045|B2|White/Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3631279|NCT02585778|3479046|B1|White/Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
3631280|NCT02585778|3479042|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3631281|NCT02585778|3479043|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631282|NCT02585778|3479044|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631283|NCT02585778|3479045|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631284|NCT02585778|3479046|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631285|NCT02585778|3479042|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|493|493.0||||||
3631286|NCT02585778|3479043|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
3631287|NCT02585778|3479044|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|280|280.0||||||
3631288|NCT02585778|3479045|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3631289|NCT02585778|3479046|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3631290|NCT02585778|3479042|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3631291|NCT02585778|3479043|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3631292|NCT02585778|3479044|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3631293|NCT02585778|3479045|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631294|NCT02585778|3479046|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631295|NCT02585778|3479042|B5||Male|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
3631296|NCT02585778|3479043|B4||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3631297|NCT02585778|3479044|B3||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3631298|NCT02585778|3479045|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3631299|NCT02585778|3479046|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3631300|NCT02585778|3479042|B5||Female|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
3631301|NCT02585778|3479043|B4||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3631302|NCT02585778|3479044|B3||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3631303|NCT02585778|3479045|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3631304|NCT02585778|3479046|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3631305|NCT02585778|3479042|B5|||Age||years|Mean|62.8|62.8|Standard Deviation|9.6|9.6|||
3631307|NCT02585778|3479044|B3|||Age||years|Mean|63.9|63.9|Standard Deviation|8.9|8.9|||
3631308|NCT02585778|3479045|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|7.8|7.8|||
3631309|NCT02585778|3479046|B1|||Age||years|Mean|54.9|54.9|Standard Deviation|10.1|10.1|||
3631310|NCT02585245|3479161|B1|United States||Region of Enrollment||Participants|Count of Participants|594|594.0||||||
3631311|NCT02585245|3479161|B1||Male|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
3631312|NCT02585245|3479161|B1||Female|Sex: Female, Male||Participants|Count of Participants|318|318.0||||||
3631313|NCT02585245|3479161|B1|||Age||years|Mean|63|63.0|Standard Deviation|16|16.0|||
3631314|NCT02584998|3479166|B4|United States||Region of Enrollment||Participants|Count of Participants|782|782.0||||||
3631315|NCT02584998|3479167|B3|United States||Region of Enrollment||Participants|Count of Participants|261|261.0||||||
3631316|NCT02584998|3479168|B2|United States||Region of Enrollment||Participants|Count of Participants|261|261.0||||||
3631317|NCT02584998|3479169|B1|United States||Region of Enrollment||Participants|Count of Participants|260|260.0||||||
3631318|NCT02584998|3479166|B4|Race|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3631319|NCT02584998|3479167|B3|Race|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3631320|NCT02584998|3479168|B2|Race|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3631321|NCT02584998|3479169|B1|Race|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3631322|NCT02584998|3479166|B4|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3631323|NCT02584998|3479167|B3|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3631324|NCT02584998|3479168|B2|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3631325|NCT02584998|3479169|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3631326|NCT02584998|3479166|B4|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|270|270.0||||||
3631327|NCT02584998|3479167|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|88|88.0||||||
3631328|NCT02584998|3479168|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|97|97.0||||||
3631329|NCT02584998|3479169|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|85|85.0||||||
3631330|NCT02584998|3479166|B4|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|471|471.0||||||
3631331|NCT02584998|3479167|B3|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|160|160.0||||||
3631332|NCT02584998|3479168|B2|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|149|149.0||||||
3631333|NCT02584998|3479169|B1|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|162|162.0||||||
3631334|NCT02584998|3479166|B4||Male|Sex: Female, Male||Participants|Count of Participants|760|760.0||||||
3631335|NCT02584998|3479167|B3||Male|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
3631336|NCT02584998|3479168|B2||Male|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
3631337|NCT02584998|3479169|B1||Male|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
3631338|NCT02584998|3479166|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3631339|NCT02584998|3479167|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3631340|NCT02584998|3479168|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3631341|NCT02584998|3479169|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3631342|NCT02584998|3479166|B4|||Age||years|Mean|61|61.0|Standard Deviation|6.8|6.8|||
3631343|NCT02584998|3479167|B3|||Age||years|Mean|61|61.0|Standard Deviation|6.5|6.5|||
3631344|NCT02584998|3479168|B2|||Age||years|Mean|60|60.0|Standard Deviation|7.0|7.0|||
3631345|NCT02584998|3479169|B1|||Age||years|Mean|61|61.0|Standard Deviation|7.0|7.0|||
3631346|NCT02584959|3479182|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631347|NCT02584959|3479183|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631348|NCT02584959|3479184|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631349|NCT02584959|3479185|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631350|NCT02584959|3479182|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631351|NCT02584959|3479183|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631352|NCT02584959|3479184|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631353|NCT02584959|3479185|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631354|NCT02584959|3479182|B4||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3631355|NCT02584959|3479183|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3631356|NCT02584959|3479184|B2||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3631357|NCT02584959|3479185|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3631358|NCT02584959|3479182|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3631359|NCT02584959|3479183|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631360|NCT02584959|3479184|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631361|NCT02584959|3479185|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631362|NCT02584959|3479182|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631363|NCT02584959|3479183|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631364|NCT02584959|3479184|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631365|NCT02584959|3479185|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631366|NCT02584959|3479182|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631367|NCT02584959|3479183|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631368|NCT02584959|3479184|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631369|NCT02584959|3479185|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631370|NCT02584959|3479182|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631371|NCT02584959|3479183|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631372|NCT02584959|3479184|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631373|NCT02584959|3479185|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631374|NCT02584959|3479182|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3631375|NCT02584959|3479183|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3631376|NCT02584959|3479184|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3631377|NCT02584959|3479185|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3631378|NCT02584959|3479182|B4||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3631379|NCT02584959|3479183|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3631380|NCT02584959|3479184|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3631381|NCT02584959|3479185|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3631382|NCT02584959|3479182|B4|||Age||years|Mean|41.3|41.3|Standard Deviation|14.58|14.58|||
3631383|NCT02584959|3479183|B3|||Age||years|Mean|44.4|44.4|Standard Deviation|16.40|16.4|||
3631384|NCT02584959|3479184|B2|||Age||years|Mean|40.7|40.7|Standard Deviation|15.34|15.34|||
3631385|NCT02584959|3479185|B1|||Age||years|Mean|40.5|40.5|Standard Deviation|13.16|13.16|||
3631386|NCT02584959|3479182|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3631387|NCT02584959|3479183|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3631388|NCT02584959|3479184|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3631389|NCT02584959|3479185|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3631390|NCT02584959|3479182|B4||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
3631391|NCT02584959|3479183|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3631392|NCT02584959|3479184|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3631393|NCT02584959|3479185|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3631394|NCT02584959|3479182|B4||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3631395|NCT02584959|3479183|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3631396|NCT02584959|3479184|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3631397|NCT02584959|3479185|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3631398|NCT02584790|3479242|B1|||NPC patients||Participants|Count of Participants|40|40.0||||||
3631399|NCT02584790|3479242|B1|Hong Kong||Region of Enrollment||participants|Number|55|55.0||||||
3631400|NCT02584790|3479242|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3631401|NCT02584790|3479242|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3631402|NCT02584790|3479242|B1|>= 18 years old||Age, Customized||Participants|Count of Participants|55|55.0||||||
3631403|NCT02584790|3479242|B1|< 18 years old||Age, Customized||Participants|Count of Participants|0|0.0||||||
3631404|NCT02584686|3479248|B3|Egypt||Region of Enrollment||participants|Number|24|24.0||||||
3631405|NCT02584686|3479249|B2|Egypt||Region of Enrollment||participants|Number|12|12.0||||||
3631406|NCT02584686|3479250|B1|Egypt||Region of Enrollment||participants|Number|12|12.0||||||
3631407|NCT02584686|3479248|B3||Male|Gender||Participants|Count of Participants|24|24.0||||||
3631408|NCT02584686|3479249|B2||Male|Gender||Participants|Count of Participants|12|12.0||||||
3631409|NCT02584686|3479250|B1||Male|Gender||Participants|Count of Participants|12|12.0||||||
3631410|NCT02584686|3479248|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
3631411|NCT02584686|3479249|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
3631412|NCT02584686|3479250|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3631413|NCT02584686|3479248|B3|||Age||years|Mean|53.6|53.6|Full Range|||40.0|66.0|
3631414|NCT02584686|3479249|B2|||Age||years|Mean|55.1|55.1|Full Range|||51.0|62.0|
3631415|NCT02584686|3479250|B1|||Age||years|Mean|52.1|52.1|Full Range|||40.0|66.0|
3631416|NCT02584686|3479248|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3631417|NCT02584686|3479249|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3631418|NCT02584686|3479250|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3631419|NCT02584686|3479248|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3631420|NCT02584686|3479249|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3631421|NCT02584686|3479250|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3631422|NCT02584686|3479248|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3631423|NCT02584686|3479249|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3631424|NCT02584686|3479250|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3631425|NCT02584673|3479277|B3|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3631426|NCT02584673|3479278|B2|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3631427|NCT02584673|3479279|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3631428|NCT02584673|3479277|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3631429|NCT02584673|3479277|B3|||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3631430|NCT02584673|3479278|B2|||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3631431|NCT02584673|3479279|B1|||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3631432|NCT02584673|3479277|B3|||Age, Customized|At least 18 years of age|Participants|Count of Participants|0|0.0||||||
3631433|NCT02584660|3479292|B3|UNITED STATES||Region of Enrollment||Participants|Count of Participants|114|114.0||||||
3631434|NCT02584660|3479293|B2|UNITED STATES||Region of Enrollment||Participants|Count of Participants|63|63.0||||||
3631435|NCT02584660|3479294|B1|UNITED STATES||Region of Enrollment||Participants|Count of Participants|51|51.0||||||
3631436|NCT02584660|3479292|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|107|107.0||||||
3631437|NCT02584660|3479293|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|60|60.0||||||
3631438|NCT02584660|3479294|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
3631439|NCT02584660|3479292|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|77|77.0||||||
3631440|NCT02584660|3479293|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
3631441|NCT02584660|3479294|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3631442|NCT02584660|3479292|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3631443|NCT02584660|3479293|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3631444|NCT02584660|3479294|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3631445|NCT02584660|3479292|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3631446|NCT02584660|3479293|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3631447|NCT02584660|3479294|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3631448|NCT02584660|3479292|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3631449|NCT02584660|3479293|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3631450|NCT02584660|3479294|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3631451|NCT02584660|3479292|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3631452|NCT02584660|3479293|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3631453|NCT02584660|3479294|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3631454|NCT02584660|3479292|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3631455|NCT02584660|3479293|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631456|NCT02584660|3479294|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631457|NCT02584660|3479292|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631458|NCT02584660|3479293|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631459|NCT02584660|3479294|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631460|NCT02584660|3479292|B3||White|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3631461|NCT02584660|3479293|B2||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3631462|NCT02584660|3479294|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3631463|NCT02584660|3479292|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3631464|NCT02584660|3479293|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3631465|NCT02584660|3479294|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3631466|NCT02584660|3479292|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631467|NCT02584660|3479293|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631468|NCT02584660|3479294|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631469|NCT02584660|3479292|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631470|NCT02584660|3479293|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631471|NCT02584660|3479294|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631472|NCT02584660|3479292|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631473|NCT02584660|3479293|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631474|NCT02584660|3479294|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631475|NCT02584660|3479292|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3631476|NCT02584660|3479293|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631477|NCT02584660|3479294|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3631478|NCT02584660|3479292|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
3631479|NCT02584660|3479293|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3631480|NCT02584660|3479294|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3631481|NCT02584660|3479292|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3631482|NCT02584660|3479293|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3631483|NCT02584660|3479294|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3631484|NCT02584660|3479292|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3631485|NCT02584660|3479293|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3631486|NCT02584660|3479294|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3631487|NCT02584660|3479292|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3631488|NCT02584660|3479293|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3631489|NCT02584660|3479294|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3631490|NCT02584660|3479292|B3|||Age||years|Mean|48.3|48.3|Standard Deviation|15.53|15.53|||
3631491|NCT02584660|3479293|B2|||Age||years|Mean|47.6|47.6|Standard Deviation|17.22|17.22|||
3631492|NCT02584660|3479294|B1|||Age||years|Mean|49.1|49.1|Standard Deviation|13.27|13.27|||
3631493|NCT02584504|3479311|B4|||Calculated LDL-C in mmol/L||mmol/L|Mean|3.909|3.909|Standard Deviation|1.109|1.109|||
3631494|NCT02584504|3479312|B3|||Calculated LDL-C in mmol/L||mmol/L|Mean|3.870|3.87|Standard Deviation|0.844|0.844|||
3631495|NCT02584504|3479313|B2|||Calculated LDL-C in mmol/L||mmol/L|Mean|3.865|3.865|Standard Deviation|0.806|0.806|||
3631496|NCT02584504|3479314|B1|||Calculated LDL-C in mmol/L||mmol/L|Mean|3.993|3.993|Standard Deviation|1.541|1.541|||
3631497|NCT02584504|3479311|B4|||Calculated LDL-C in mg/dL|Calculated LDL-C in mg/dL from Friedewald formula (LDL cholesterol = Total cholesterol - high density lipoprotein [HDL] cholesterol - [Triglyceride/5]).|mg/dL|Mean|150.9|150.9|Standard Deviation|42.8|42.8|||
3631498|NCT02584504|3479312|B3|||Calculated LDL-C in mg/dL|Calculated LDL-C in mg/dL from Friedewald formula (LDL cholesterol = Total cholesterol - high density lipoprotein [HDL] cholesterol - [Triglyceride/5]).|mg/dL|Mean|149.4|149.4|Standard Deviation|32.6|32.6|||
3631499|NCT02584504|3479313|B2|||Calculated LDL-C in mg/dL|Calculated LDL-C in mg/dL from Friedewald formula (LDL cholesterol = Total cholesterol - high density lipoprotein [HDL] cholesterol - [Triglyceride/5]).|mg/dL|Mean|149.2|149.2|Standard Deviation|31.1|31.1|||
3631500|NCT02584504|3479314|B1|||Calculated LDL-C in mg/dL|Calculated LDL-C in mg/dL from Friedewald formula (LDL cholesterol = Total cholesterol - high density lipoprotein [HDL] cholesterol - [Triglyceride/5]).|mg/dL|Mean|154.2|154.2|Standard Deviation|59.5|59.5|||
3631501|NCT02584504|3479311|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|163|163.0||||||
3631502|NCT02584504|3479312|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|56|56.0||||||
3631503|NCT02584504|3479313|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|53|53.0||||||
3631504|NCT02584504|3479314|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|54|54.0||||||
3631505|NCT02584504|3479311|B4||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3631506|NCT02584504|3479312|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3631507|NCT02584504|3479313|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3631508|NCT02584504|3479314|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3631509|NCT02584504|3479311|B4||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3631510|NCT02584504|3479312|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3631511|NCT02584504|3479313|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3631512|NCT02584504|3479314|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3631513|NCT02584504|3479311|B4|||Age||years|Mean|63.6|63.6|Standard Deviation|10.1|10.1|||
3631514|NCT02584504|3479312|B3|||Age||years|Mean|64.6|64.6|Standard Deviation|10.0|10.0|||
3631515|NCT02584504|3479313|B2|||Age||years|Mean|63.6|63.6|Standard Deviation|10.4|10.4|||
3631516|NCT02584504|3479314|B1|||Age||years|Mean|62.6|62.6|Standard Deviation|9.8|9.8|||
3631517|NCT02583425|3479367|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631518|NCT02583425|3479367|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631519|NCT02583425|3479367|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3631520|NCT02583425|3479367|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631521|NCT02583425|3479367|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631522|NCT02583425|3479367|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631523|NCT02583425|3479367|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631524|NCT02583425|3479367|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3631525|NCT02583425|3479367|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3631526|NCT02583425|3479367|B1|||Age||years|Mean|38.6|38.6|Standard Deviation|11.94|11.94|||
3631527|NCT02583230|3479372|B1||Study provided device|Mobile device||Participants|Count of Participants|7|7.0||||||
3631528|NCT02583230|3479372|B1||Personal device|Mobile device||Participants|Count of Participants|4|4.0||||||
3631529|NCT02583230|3479372|B1||Student|Employment status||Participants|Count of Participants|1|1.0||||||
3631530|NCT02583230|3479372|B1||Retired|Employment status||Participants|Count of Participants|2|2.0||||||
3631531|NCT02583230|3479372|B1||Unemployed|Employment status||Participants|Count of Participants|1|1.0||||||
3631532|NCT02583230|3479372|B1||Employed|Employment status||Participants|Count of Participants|7|7.0||||||
3631533|NCT02583230|3479372|B1||Master’s degree|Education||Participants|Count of Participants|4|4.0||||||
3631534|NCT02583230|3479372|B1||4-year college (BA, BS)|Education||Participants|Count of Participants|5|5.0||||||
3631535|NCT02583230|3479372|B1||Completed high school|Education||Participants|Count of Participants|1|1.0||||||
3631536|NCT02583230|3479372|B1||Some high school|Education||Participants|Count of Participants|1|1.0||||||
3631537|NCT02583230|3479372|B1||Married/Domestic partner|Marital Status||Participants|Count of Participants|3|3.0||||||
3631538|NCT02583230|3479372|B1||Living with significant other|Marital Status||Participants|Count of Participants|1|1.0||||||
3631539|NCT02583230|3479372|B1||Single|Marital Status||Participants|Count of Participants|7|7.0||||||
3631540|NCT02583230|3479372|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631541|NCT02583230|3479372|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631542|NCT02583230|3479372|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3631543|NCT02583230|3479372|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3631544|NCT02583230|3479372|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631545|NCT02583230|3479372|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631546|NCT02583230|3479372|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631547|NCT02583230|3479372|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631548|NCT02583230|3479372|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3631549|NCT02583230|3479372|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631550|NCT02583230|3479372|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3631551|NCT02583230|3479372|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3631552|NCT02583230|3479372|B1|||Age||years|Mean|45.1|45.1|Standard Deviation|16.7|16.7|||
3631553|NCT02582983|3479378|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3631554|NCT02582983|3479378|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3631555|NCT02582983|3479378|B1|||Age||years|Mean|42.17|42.17|Standard Deviation|8.56|8.56|||
3631556|NCT02582970|3479383|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3631557|NCT02582970|3479383|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3631558|NCT02582970|3479383|B1|||Age||years|Mean|58.6|58.6|Standard Deviation|13.18|13.18|||
3631559|NCT02582684|3479393|B1||No|Post-exposure Prophylaxis or Pre-Exposure Prophylaxis History||Participants|Count of Participants|119|119.0||||||
3631560|NCT02582684|3479393|B1||Yes|Post-exposure Prophylaxis or Pre-Exposure Prophylaxis History||Participants|Count of Participants|1|1.0||||||
3631561|NCT02582684|3479393|B1||Negative|Hepatitis C Antibody Status||Participants|Count of Participants|116|116.0||||||
3631562|NCT02582684|3479393|B1||Positive|Hepatitis C Antibody Status||Participants|Count of Participants|4|4.0||||||
3631563|NCT02582684|3479393|B1||> 200,000 copies/mL|Baseline HIV-1 RNA Category|Baseline HIV-1 RNA is defined as the last nonmissing observation on or prior to first dose date after screening.|Participants|Count of Participants|14|14.0||||||
3631564|NCT02582684|3479393|B1||100,000 - 200,000 copies/mL|Baseline HIV-1 RNA Category|Baseline HIV-1 RNA is defined as the last nonmissing observation on or prior to first dose date after screening.|Participants|Count of Participants|23|23.0||||||
3631565|NCT02582684|3479393|B1||10,000 - 99,999 copies/mL|Baseline HIV-1 RNA Category|Baseline HIV-1 RNA is defined as the last nonmissing observation on or prior to first dose date after screening.|Participants|Count of Participants|48|48.0||||||
3631566|NCT02582684|3479393|B1||1,000 - 9,999 copies/mL|Baseline HIV-1 RNA Category|Baseline HIV-1 RNA is defined as the last nonmissing observation on or prior to first dose date after screening.|Participants|Count of Participants|34|34.0||||||
3631567|NCT02582684|3479393|B1||< 1,000 copies/mL|Baseline HIV-1 RNA Category|Baseline HIV-1 RNA is defined as the last nonmissing observation on or prior to first dose date after screening.|Participants|Count of Participants|1|1.0||||||
3631568|NCT02582684|3479393|B1|||Baseline HIV-1 RNA|Baseline HIV-1 RNA is defined as the last nonmissing observation on or prior to first dose date after screening.|log10 copies/mL|Median|4.61|4.61|Inter-Quartile Range|||3.94|5.05|
3631569|NCT02582684|3479393|B1|||Screening HIV-1 RNA||log10 copies/mL|Median|4.70|4.7|Inter-Quartile Range|||4.08|5.0|
3631570|NCT02582684|3479393|B1|||CD4/CD8 Ratio||ratio|Median|0.44|0.44|Inter-Quartile Range|||0.31|0.7|
3631571|NCT02582684|3479393|B1|||CD8 Count||cells/mm^3|Median|871|871.0|Inter-Quartile Range|||610.0|1167.0|
3631572|NCT02582684|3479393|B1||Missing|CD4 Count, Categorized||Participants|Count of Participants|2|2.0||||||
3631573|NCT02582684|3479393|B1||>=800 cells/mm^3|CD4 Count, Categorized||Participants|Count of Participants|11|11.0||||||
3631574|NCT02582684|3479393|B1||650-799 cells/mm^3|CD4 Count, Categorized||Participants|Count of Participants|15|15.0||||||
3631575|NCT02582684|3479393|B1||500-649 cells/mm^3|CD4 Count, Categorized||Participants|Count of Participants|19|19.0||||||
3631576|NCT02582684|3479393|B1||350-499 cells/mm^3|CD4 Count, Categorized||Participants|Count of Participants|30|30.0||||||
3631577|NCT02582684|3479393|B1||200-349 cells/mm^3|CD4 Count, Categorized||Participants|Count of Participants|27|27.0||||||
3631578|NCT02582684|3479393|B1||<200 cells/mm^3|CD4 Count, Categorized||Participants|Count of Participants|16|16.0||||||
3631579|NCT02582684|3479393|B1|||CD4 Count, Continuous||cells/mm^3|Median|387|387.0|Inter-Quartile Range|||288.0|596.0|
3631580|NCT02582684|3479393|B1||Previously|Intravenous Drug Use||Participants|Count of Participants|5|5.0||||||
3631581|NCT02582684|3479393|B1||Currently|Intravenous Drug Use||Participants|Count of Participants|2|2.0||||||
3631582|NCT02582684|3479393|B1||Never|Intravenous Drug Use||Participants|Count of Participants|113|113.0||||||
3631583|NCT02582684|3479393|B1|United States||Region of Enrollment||Participants|Count of Participants|117|117.0||||||
3631584|NCT02582684|3479393|B1|Puerto Rico||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3631585|NCT02582684|3479393|B1|Race/Ethnicity|Does not want to report|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3631586|NCT02582684|3479393|B1|Race/Ethnicity|More than one race|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3631587|NCT02582684|3479393|B1|Race/Ethnicity|Asian, Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3631588|NCT02582684|3479393|B1|Race/Ethnicity|Hispanic (Regardless of Race)|Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3631589|NCT02582684|3479393|B1|Race/Ethnicity|Black Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
3631590|NCT02582684|3479393|B1|Race/Ethnicity|White Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3631591|NCT02582684|3479393|B1||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3631592|NCT02582684|3479393|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3631593|NCT02582684|3479393|B1|Age Category|>= 60 years|Age, Customized||Participants|Count of Participants|4|4.0||||||
3631594|NCT02582684|3479393|B1|Age Category|50-59 years|Age, Customized||Participants|Count of Participants|12|12.0||||||
3631595|NCT02582684|3479393|B1|Age Category|40-49 years|Age, Customized||Participants|Count of Participants|17|17.0||||||
3631596|NCT02582684|3479393|B1|Age Category|30-39 years|Age, Customized||Participants|Count of Participants|29|29.0||||||
3631597|NCT02582684|3479393|B1|Age Category|18-29 years|Age, Customized||Participants|Count of Participants|58|58.0||||||
3631598|NCT02582684|3479393|B1|Age||Age||Years|Median|30|30.0|Inter-Quartile Range|||24.0|41.0|
3631599|NCT02582632|3479412|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3631600|NCT02582632|3479412|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3631601|NCT02582632|3479412|B1|||Age||years|Mean|51.3|51.3|Standard Deviation|13.42|13.42|||
3631602|NCT02582242|3479425|B3|||Body weight||kg|Mean|71.90|71.9|Standard Deviation|13.19|13.19|||
3631603|NCT02582242|3479426|B2|||Body weight||kg|Mean|72.24|72.24|Standard Deviation|13.01|13.01|||
3631604|NCT02582242|3479427|B1|||Body weight||kg|Mean|71.57|71.57|Standard Deviation|13.38|13.38|||
3631605|NCT02582242|3479425|B3|||Fasting plasma glucose (FPG)||mmol/L|Mean|8.70|8.7|Standard Deviation|2.54|2.54|||
3631606|NCT02582242|3479426|B2|||Fasting plasma glucose (FPG)||mmol/L|Mean|8.72|8.72|Standard Deviation|2.39|2.39|||
3631607|NCT02582242|3479427|B1|||Fasting plasma glucose (FPG)||mmol/L|Mean|8.68|8.68|Standard Deviation|2.68|2.68|||
3631608|NCT02582242|3479425|B3|||Glycosylated haemoglobin (HbA1c)||Percentage of HbA1c|Mean|8.71|8.71|Standard Deviation|0.69|0.69|||
3631609|NCT02582242|3479426|B2|||Glycosylated haemoglobin (HbA1c)||Percentage of HbA1c|Mean|8.68|8.68|Standard Deviation|0.69|0.69|||
3631610|NCT02582242|3479427|B1|||Glycosylated haemoglobin (HbA1c)||Percentage of HbA1c|Mean|8.74|8.74|Standard Deviation|0.69|0.69|||
3631611|NCT02582242|3479425|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631612|NCT02582242|3479426|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631613|NCT02582242|3479427|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631614|NCT02582242|3479425|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631615|NCT02582242|3479426|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631616|NCT02582242|3479427|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631617|NCT02582242|3479425|B3||White|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
3631618|NCT02582242|3479426|B2||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3631619|NCT02582242|3479427|B1||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3631620|NCT02582242|3479425|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631621|NCT02582242|3479426|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631622|NCT02582242|3479427|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631623|NCT02582242|3479425|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631624|NCT02582242|3479426|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631625|NCT02582242|3479427|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631626|NCT02582242|3479425|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|351|351.0||||||
3631627|NCT02582242|3479426|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|170|170.0||||||
3631628|NCT02582242|3479427|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|181|181.0||||||
3631629|NCT02582242|3479425|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631630|NCT02582242|3479426|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631631|NCT02582242|3479427|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631632|NCT02582242|3479425|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631633|NCT02582242|3479426|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631634|NCT02582242|3479427|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631635|NCT02582242|3479425|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|435|435.0||||||
3631636|NCT02582242|3479426|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|217|217.0||||||
3631637|NCT02582242|3479427|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|218|218.0||||||
3631638|NCT02582242|3479425|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3631639|NCT02582242|3479426|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631640|NCT02582242|3479427|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3631641|NCT02582242|3479425|B3||Male|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
3631642|NCT02582242|3479426|B2||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3631643|NCT02582242|3479427|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3631644|NCT02582242|3479425|B3||Female|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
3631645|NCT02582242|3479426|B2||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3631646|NCT02582242|3479427|B1||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3631647|NCT02582242|3479425|B3|||Age||years|Mean|56.8|56.8|Standard Deviation|9.5|9.5|||
3631648|NCT02582242|3479426|B2|||Age||years|Mean|56.6|56.6|Standard Deviation|9.3|9.3|||
3631649|NCT02582242|3479427|B1|||Age||years|Mean|57.0|57.0|Standard Deviation|9.8|9.8|||
3631650|NCT02581995|3479468|B1|||Body Temperature||celsius|Mean|36.37|36.37|Standard Deviation|0.38|0.38|||
3631651|NCT02581995|3479468|B1|||Heart Rate||beats per minute (beats/min)|Mean|75.1|75.1|Standard Deviation|10.1|10.1|||
3631652|NCT02581995|3479468|B1|||Diastolic Blood Pressure||millimeter of mercury (mmHg)|Mean|77.7|77.7|Standard Deviation|9.4|9.4|||
3631653|NCT02581995|3479468|B1|||Systolic Blood Pressure||millimeter of mercury (mmHg)|Mean|138.1|138.1|Standard Deviation|13.6|13.6|||
3631654|NCT02581995|3479468|B1|||Pre-injection Intraocular Pressure||millimeter of mercury (mmHg)|Mean|16.2|16.2|Standard Deviation|3.0|3.0|||
3631655|NCT02581995|3479468|B1|90 - Cannot grade||Number of Participants with Diabetic Retinopathy Severity Score (DRSS)|The following severities are possible. 10 = Diabetic retinopathy (DR) absent, 14 = DR questionable, 15 = DR questionable, 20 = Microaneurysms only, 35 = Mild Non-proliferative diabetic retinopathy (NPDR), 43 = Moderate NPDR, 47 = Moderately severe NPDR, 53 = Severe NPDR, 61 = Mild Proliferative diabetic retinopathy (PDR), 65 = Moderate PDR, 71 = High-risk PDR, 75 = High-risk PDR, 81 = Advanced PDR: fundus partially obscured, center of macula attached, 85 = Advanced PDR: posterior fundus obscured, or center of macula detached, 90 = cannot grade, even sufficiently for level 81 or 85.|Participants|Count of Participants|6|6.0||||||
3631656|NCT02581995|3479468|B1|71 - High-risk PDR||Number of Participants with Diabetic Retinopathy Severity Score (DRSS)|The following severities are possible. 10 = Diabetic retinopathy (DR) absent, 14 = DR questionable, 15 = DR questionable, 20 = Microaneurysms only, 35 = Mild Non-proliferative diabetic retinopathy (NPDR), 43 = Moderate NPDR, 47 = Moderately severe NPDR, 53 = Severe NPDR, 61 = Mild Proliferative diabetic retinopathy (PDR), 65 = Moderate PDR, 71 = High-risk PDR, 75 = High-risk PDR, 81 = Advanced PDR: fundus partially obscured, center of macula attached, 85 = Advanced PDR: posterior fundus obscured, or center of macula detached, 90 = cannot grade, even sufficiently for level 81 or 85.|Participants|Count of Participants|2|2.0||||||
3631657|NCT02581995|3479468|B1|65 - Moderate PDR||Number of Participants with Diabetic Retinopathy Severity Score (DRSS)|The following severities are possible. 10 = Diabetic retinopathy (DR) absent, 14 = DR questionable, 15 = DR questionable, 20 = Microaneurysms only, 35 = Mild Non-proliferative diabetic retinopathy (NPDR), 43 = Moderate NPDR, 47 = Moderately severe NPDR, 53 = Severe NPDR, 61 = Mild Proliferative diabetic retinopathy (PDR), 65 = Moderate PDR, 71 = High-risk PDR, 75 = High-risk PDR, 81 = Advanced PDR: fundus partially obscured, center of macula attached, 85 = Advanced PDR: posterior fundus obscured, or center of macula detached, 90 = cannot grade, even sufficiently for level 81 or 85.|Participants|Count of Participants|8|8.0||||||
3631658|NCT02581995|3479468|B1|61 - Mild PDR||Number of Participants with Diabetic Retinopathy Severity Score (DRSS)|The following severities are possible. 10 = Diabetic retinopathy (DR) absent, 14 = DR questionable, 15 = DR questionable, 20 = Microaneurysms only, 35 = Mild Non-proliferative diabetic retinopathy (NPDR), 43 = Moderate NPDR, 47 = Moderately severe NPDR, 53 = Severe NPDR, 61 = Mild Proliferative diabetic retinopathy (PDR), 65 = Moderate PDR, 71 = High-risk PDR, 75 = High-risk PDR, 81 = Advanced PDR: fundus partially obscured, center of macula attached, 85 = Advanced PDR: posterior fundus obscured, or center of macula detached, 90 = cannot grade, even sufficiently for level 81 or 85.|Participants|Count of Participants|8|8.0||||||
3631659|NCT02581995|3479468|B1|53 - Severe NPDR||Number of Participants with Diabetic Retinopathy Severity Score (DRSS)|The following severities are possible. 10 = Diabetic retinopathy (DR) absent, 14 = DR questionable, 15 = DR questionable, 20 = Microaneurysms only, 35 = Mild Non-proliferative diabetic retinopathy (NPDR), 43 = Moderate NPDR, 47 = Moderately severe NPDR, 53 = Severe NPDR, 61 = Mild Proliferative diabetic retinopathy (PDR), 65 = Moderate PDR, 71 = High-risk PDR, 75 = High-risk PDR, 81 = Advanced PDR: fundus partially obscured, center of macula attached, 85 = Advanced PDR: posterior fundus obscured, or center of macula detached, 90 = cannot grade, even sufficiently for level 81 or 85.|Participants|Count of Participants|48|48.0||||||
3631660|NCT02581995|3479468|B1|47 - Moderately severe NPDR||Number of Participants with Diabetic Retinopathy Severity Score (DRSS)|The following severities are possible. 10 = Diabetic retinopathy (DR) absent, 14 = DR questionable, 15 = DR questionable, 20 = Microaneurysms only, 35 = Mild Non-proliferative diabetic retinopathy (NPDR), 43 = Moderate NPDR, 47 = Moderately severe NPDR, 53 = Severe NPDR, 61 = Mild Proliferative diabetic retinopathy (PDR), 65 = Moderate PDR, 71 = High-risk PDR, 75 = High-risk PDR, 81 = Advanced PDR: fundus partially obscured, center of macula attached, 85 = Advanced PDR: posterior fundus obscured, or center of macula detached, 90 = cannot grade, even sufficiently for level 81 or 85.|Participants|Count of Participants|151|151.0||||||
3631661|NCT02581995|3479468|B1|43 - Moderate NPDR||Number of Participants with Diabetic Retinopathy Severity Score (DRSS)|The following severities are possible. 10 = Diabetic retinopathy (DR) absent, 14 = DR questionable, 15 = DR questionable, 20 = Microaneurysms only, 35 = Mild Non-proliferative diabetic retinopathy (NPDR), 43 = Moderate NPDR, 47 = Moderately severe NPDR, 53 = Severe NPDR, 61 = Mild Proliferative diabetic retinopathy (PDR), 65 = Moderate PDR, 71 = High-risk PDR, 75 = High-risk PDR, 81 = Advanced PDR: fundus partially obscured, center of macula attached, 85 = Advanced PDR: posterior fundus obscured, or center of macula detached, 90 = cannot grade, even sufficiently for level 81 or 85.|Participants|Count of Participants|184|184.0||||||
3631662|NCT02581995|3479468|B1|35 - Mild NPDR||Number of Participants with Diabetic Retinopathy Severity Score (DRSS)|The following severities are possible. 10 = Diabetic retinopathy (DR) absent, 14 = DR questionable, 15 = DR questionable, 20 = Microaneurysms only, 35 = Mild Non-proliferative diabetic retinopathy (NPDR), 43 = Moderate NPDR, 47 = Moderately severe NPDR, 53 = Severe NPDR, 61 = Mild Proliferative diabetic retinopathy (PDR), 65 = Moderate PDR, 71 = High-risk PDR, 75 = High-risk PDR, 81 = Advanced PDR: fundus partially obscured, center of macula attached, 85 = Advanced PDR: posterior fundus obscured, or center of macula detached, 90 = cannot grade, even sufficiently for level 81 or 85.|Participants|Count of Participants|144|144.0||||||
3631826|NCT02581345|3479547|B1||White|Race (NIH/OMB)||Participants|Count of Participants|281|281.0||||||
3631663|NCT02581995|3479468|B1|15 - DR questionable||Number of Participants with Diabetic Retinopathy Severity Score (DRSS)|The following severities are possible. 10 = Diabetic retinopathy (DR) absent, 14 = DR questionable, 15 = DR questionable, 20 = Microaneurysms only, 35 = Mild Non-proliferative diabetic retinopathy (NPDR), 43 = Moderate NPDR, 47 = Moderately severe NPDR, 53 = Severe NPDR, 61 = Mild Proliferative diabetic retinopathy (PDR), 65 = Moderate PDR, 71 = High-risk PDR, 75 = High-risk PDR, 81 = Advanced PDR: fundus partially obscured, center of macula attached, 85 = Advanced PDR: posterior fundus obscured, or center of macula detached, 90 = cannot grade, even sufficiently for level 81 or 85.|Participants|Count of Participants|2|2.0||||||
3631664|NCT02581995|3479468|B1|10 - DR absent||Number of Participants with Diabetic Retinopathy Severity Score (DRSS)|The following severities are possible. 10 = Diabetic retinopathy (DR) absent, 14 = DR questionable, 15 = DR questionable, 20 = Microaneurysms only, 35 = Mild Non-proliferative diabetic retinopathy (NPDR), 43 = Moderate NPDR, 47 = Moderately severe NPDR, 53 = Severe NPDR, 61 = Mild Proliferative diabetic retinopathy (PDR), 65 = Moderate PDR, 71 = High-risk PDR, 75 = High-risk PDR, 81 = Advanced PDR: fundus partially obscured, center of macula attached, 85 = Advanced PDR: posterior fundus obscured, or center of macula detached, 90 = cannot grade, even sufficiently for level 81 or 85.|Participants|Count of Participants|0|0.0||||||
3631665|NCT02581995|3479468|B1|||NEI VFQ-25 distant activities subscale|The NEI VFQ-25 distant activities subscale was scored from 0-100 with a score of 0 being the worst outcome and 100 being the best outcome. Distant activities are defined as activities requiring distance vision, such as recognizing faces or reading street signs.|score on a scale|Mean|71.964|71.964|Standard Deviation|23.973|23.973|||
3631666|NCT02581995|3479468|B1|||NEI VFQ-25 near activities subscale|The NEI VFQ-25 near activities subscale was scored from 0-100 with a score of 0 being the worst outcome and 100 being the best outcome. Near activities are defined activities requiring near vision such as reading ordinary print in newspapers, performing work or hobbies requiring near vision, or finding something on a crowded shelf.|score on a scale|Mean|62.967|62.967|Standard Deviation|23.479|23.479|||
3631667|NCT02581995|3479468|B1|||NEI VFQ-25 total score|The NEI VFQ-25 consists of a base set of 25 vision-targeted questions representing 11 vision-related constructs, plus an additional single-item general health rating question. All items are scored so that a high score represents better functioning. Each item is then converted to a 0 to 100 scale so that the lowest and highest possible scores are set at 0 and 100 points, respectively. In this format scores represent the achieved percentage of the total possible score, example: a score of 50 represents 50% of the highest possible score.|score on a scale|Mean|70.224|70.224|Standard Deviation|19.221|19.221|||
3631668|NCT02581995|3479468|B1|||Best Corrected Visual Acuity (BCVA)|The BCVA was recorded at the study eye only. Participants received active treatment (intravitreal aflibercept) for the study eye and received close medical supervision. Visual function was assessed using the ETDRS protocol (Early Treatment Diabetic Retinopathy Study Research Group 1985) starting at 4 meters. The values might range from 0 to 100. A higher score represents better functioning.|score on a scale|Mean|61.5|61.5|Standard Deviation|11.0|11.0|||
3631669|NCT02581995|3479468|B1|||Central Retinal Thickness (CRT)|The CRT was recorded at the study eye only. Participants received active treatment (intravitreal aflibercept) for the study eye and received close medical supervision.|microns|Mean|465.08|465.08|Standard Deviation|136.75|136.75|||
3631670|NCT02581995|3479468|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3631671|NCT02581995|3479468|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631672|NCT02581995|3479468|B1||White|Race (NIH/OMB)||Participants|Count of Participants|519|519.0||||||
3631673|NCT02581995|3479468|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3631674|NCT02581995|3479468|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631675|NCT02581995|3479468|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3631676|NCT02581995|3479468|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631677|NCT02581995|3479468|B1||Male|Sex: Female, Male||Participants|Count of Participants|336|336.0||||||
3631678|NCT02581995|3479468|B1||Female|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
3631679|NCT02581995|3479468|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|9.3|9.3|||
3631680|NCT02581488|3479482|B3|||Ulcer Duration||days|Mean|112.4|112.4|Standard Deviation|76.3|76.3|||
3631681|NCT02581488|3479483|B2|||Ulcer Duration||days|Mean|118.1|118.1|Standard Deviation|77.7|77.7|||
3631682|NCT02581488|3479484|B1|||Ulcer Duration||days|Mean|106.8|106.8|Standard Deviation|75.2|75.2|||
3631683|NCT02581488|3479482|B3|Lateral Heel||Target Ulcer Location||Participants|Count of Participants|1|1.0||||||
3631684|NCT02581488|3479483|B2|Lateral Heel||Target Ulcer Location||Participants|Count of Participants|0|0.0||||||
3631685|NCT02581488|3479484|B1|Lateral Heel||Target Ulcer Location||Participants|Count of Participants|1|1.0||||||
3631686|NCT02581488|3479482|B3|Medial Forefoot||Target Ulcer Location||Participants|Count of Participants|3|3.0||||||
3631687|NCT02581488|3479483|B2|Medial Forefoot||Target Ulcer Location||Participants|Count of Participants|1|1.0||||||
3631688|NCT02581488|3479484|B1|Medial Forefoot||Target Ulcer Location||Participants|Count of Participants|2|2.0||||||
3631689|NCT02581488|3479482|B3|Heel||Target Ulcer Location||Participants|Count of Participants|7|7.0||||||
3631690|NCT02581488|3479483|B2|Heel||Target Ulcer Location||Participants|Count of Participants|4|4.0||||||
3631691|NCT02581488|3479484|B1|Heel||Target Ulcer Location||Participants|Count of Participants|3|3.0||||||
3631692|NCT02581488|3479482|B3|Hallux||Target Ulcer Location||Participants|Count of Participants|16|16.0||||||
3631693|NCT02581488|3479483|B2|Hallux||Target Ulcer Location||Participants|Count of Participants|4|4.0||||||
3631694|NCT02581488|3479484|B1|Hallux||Target Ulcer Location||Participants|Count of Participants|12|12.0||||||
3631695|NCT02581488|3479482|B3|Forefoot||Target Ulcer Location||Participants|Count of Participants|75|75.0||||||
3631696|NCT02581488|3479483|B2|Forefoot||Target Ulcer Location||Participants|Count of Participants|42|42.0||||||
3631697|NCT02581488|3479484|B1|Forefoot||Target Ulcer Location||Participants|Count of Participants|33|33.0||||||
3631698|NCT02581488|3479482|B3|N/A, ABI not > 1.2||Foot Perfusion||Participants|Count of Participants|93|93.0||||||
3631699|NCT02581488|3479483|B2|N/A, ABI not > 1.2||Foot Perfusion||Participants|Count of Participants|45|45.0||||||
3631700|NCT02581488|3479484|B1|N/A, ABI not > 1.2||Foot Perfusion||Participants|Count of Participants|48|48.0||||||
3631701|NCT02581488|3479482|B3|No||Foot Perfusion||Participants|Count of Participants|9|9.0||||||
3631702|NCT02581488|3479483|B2|No||Foot Perfusion||Participants|Count of Participants|6|6.0||||||
3631703|NCT02581488|3479484|B1|No||Foot Perfusion||Participants|Count of Participants|3|3.0||||||
3631704|NCT02581488|3479482|B3|Yes||Foot Perfusion||Participants|Count of Participants|0|0.0||||||
3631705|NCT02581488|3479483|B2|Yes||Foot Perfusion||Participants|Count of Participants|0|0.0||||||
3631706|NCT02581488|3479484|B1|Yes||Foot Perfusion||Participants|Count of Participants|0|0.0||||||
3631707|NCT02581488|3479482|B3|||Target Ulcer Area||cm^2|Mean|1.6|1.6|Standard Deviation|1.9|1.9|||
3631708|NCT02581488|3479483|B2|||Target Ulcer Area||cm^2|Mean|1.7|1.7|Standard Deviation|2.0|2.0|||
3631709|NCT02581488|3479484|B1|||Target Ulcer Area||cm^2|Mean|1.6|1.6|Standard Deviation|1.8|1.8|||
3631710|NCT02581488|3479482|B3|||Ankle Brachial Index|"The Ankle-Brachial Index (ABI) is the ratio of the blood pressure at the ankle to the blood pressure in the upper arm (brachial). Lower values represent a worse outcome, indicating peripheral artery disease (PAD).~ABI = Ankle Systolic Pressure (mmHg) / Arm Systolic Pressure (mmHg)~Range of Scores based on American Diabetes Association Guidelines:~ABI Value, PAD Severity; >1.30, Poorly Compressible; 0.91 - 1.30, Normal; 0.70 - 0.90, Mild; 0.40 - 0.69, Moderate; <0.40, Severe"|ABI ratio (mmHg/mmHg)|Mean|1|1.0|Standard Deviation|1|1.0|||
3631711|NCT02581488|3479483|B2|||Ankle Brachial Index|"The Ankle-Brachial Index (ABI) is the ratio of the blood pressure at the ankle to the blood pressure in the upper arm (brachial). Lower values represent a worse outcome, indicating peripheral artery disease (PAD).~ABI = Ankle Systolic Pressure (mmHg) / Arm Systolic Pressure (mmHg)~Range of Scores based on American Diabetes Association Guidelines:~ABI Value, PAD Severity; >1.30, Poorly Compressible; 0.91 - 1.30, Normal; 0.70 - 0.90, Mild; 0.40 - 0.69, Moderate; <0.40, Severe"|ABI ratio (mmHg/mmHg)|Mean|1|1.0|Standard Deviation|0.2|0.2|||
3631712|NCT02581488|3479484|B1|||Ankle Brachial Index|"The Ankle-Brachial Index (ABI) is the ratio of the blood pressure at the ankle to the blood pressure in the upper arm (brachial). Lower values represent a worse outcome, indicating peripheral artery disease (PAD).~ABI = Ankle Systolic Pressure (mmHg) / Arm Systolic Pressure (mmHg)~Range of Scores based on American Diabetes Association Guidelines:~ABI Value, PAD Severity; >1.30, Poorly Compressible; 0.91 - 1.30, Normal; 0.70 - 0.90, Mild; 0.40 - 0.69, Moderate; <0.40, Severe"|ABI ratio (mmHg/mmHg)|Mean|1|1.0|Standard Deviation|0.1|0.1|||
3631713|NCT02581488|3479482|B3|||Weight||lbs|Mean|232.1|232.1|Standard Deviation|53.0|53.0|||
3631714|NCT02581488|3479483|B2|||Weight||lbs|Mean|226.6|226.6|Standard Deviation|49.1|49.1|||
3631715|NCT02581488|3479484|B1|||Weight||lbs|Mean|237.6|237.6|Standard Deviation|56.7|56.7|||
3631716|NCT02581488|3479482|B3|||Height||inches|Mean|69.2|69.2|Standard Deviation|3.5|3.5|||
3631717|NCT02581488|3479483|B2|||Height||inches|Mean|68.8|68.8|Standard Deviation|3.8|3.8|||
3631718|NCT02581488|3479484|B1|||Height||inches|Mean|69.6|69.6|Standard Deviation|3.2|3.2|||
3631719|NCT02581488|3479482|B3|||Body Mass Index (BMI)||kg/m^2|Mean|34|34.0|Standard Deviation|7.0|7.0|||
3631720|NCT02581488|3479483|B2|||Body Mass Index (BMI)||kg/m^2|Mean|33.6|33.6|Standard Deviation|6.3|6.3|||
3631721|NCT02581488|3479484|B1|||Body Mass Index (BMI)||kg/m^2|Mean|34.3|34.3|Standard Deviation|7.7|7.7|||
3631722|NCT02581488|3479482|B3|United States||Region of Enrollment||Participants|Count of Participants|82|82.0||||||
3631723|NCT02581488|3479483|B2|United States||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3631724|NCT02581488|3479484|B1|United States||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3631725|NCT02581488|3479482|B3|Canada||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3631726|NCT02581488|3479483|B2|Canada||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3631727|NCT02581488|3479484|B1|Canada||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3631728|NCT02581488|3479482|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631729|NCT02581488|3479483|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631730|NCT02581488|3479484|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631731|NCT02581488|3479482|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631732|NCT02581488|3479483|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631733|NCT02581488|3479484|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631734|NCT02581488|3479482|B3||White|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3631735|NCT02581488|3479483|B2||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3631736|NCT02581488|3479484|B1||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3631737|NCT02581488|3479482|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3631738|NCT02581488|3479483|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3631739|NCT02581488|3479484|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3631740|NCT02581488|3479482|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631741|NCT02581488|3479483|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631742|NCT02581488|3479484|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631743|NCT02581488|3479482|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631744|NCT02581488|3479483|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631745|NCT02581488|3479484|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631746|NCT02581488|3479482|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631747|NCT02581488|3479483|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631748|NCT02581488|3479484|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631749|NCT02581488|3479482|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631750|NCT02581488|3479483|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631751|NCT02581488|3479484|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631752|NCT02581488|3479482|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3631753|NCT02581488|3479483|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3631754|NCT02581488|3479484|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3631755|NCT02581488|3479482|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3631756|NCT02581488|3479483|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3631757|NCT02581488|3479484|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3631758|NCT02581488|3479482|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3631759|NCT02581488|3479483|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3631760|NCT02581488|3479484|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3631761|NCT02581488|3479482|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3631762|NCT02581488|3479483|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3631763|NCT02581488|3479484|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3631764|NCT02581488|3479482|B3|||Age||years|Mean|57|57.0|Standard Deviation|12|12.0|||
3631765|NCT02581488|3479483|B2|||Age||years|Mean|57.6|57.6|Standard Deviation|10.8|10.8|||
3631766|NCT02581488|3479484|B1|||Age||years|Mean|56.4|56.4|Standard Deviation|13.1|13.1|||
3631767|NCT02581488|3479482|B3||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
3631768|NCT02581488|3479483|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3631769|NCT02581488|3479484|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3631770|NCT02581488|3479482|B3||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
3631771|NCT02581488|3479483|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3631772|NCT02581488|3479484|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3631773|NCT02581488|3479482|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3631774|NCT02581488|3479483|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3631775|NCT02581488|3479484|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3631776|NCT02581475|3479499|B3||Male|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
3631777|NCT02581475|3479500|B2||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3631778|NCT02581475|3479501|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3631779|NCT02581475|3479499|B3||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3631780|NCT02581475|3479500|B2||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3631781|NCT02581475|3479501|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3631782|NCT02581475|3479499|B3|||Age||years|Mean|54.9|54.9|Standard Deviation|10.7|10.7|||
3631783|NCT02581475|3479500|B2|||Age||years|Mean|55.0|55.0|Standard Deviation|11.0|11.0|||
3631784|NCT02581475|3479501|B1|||Age||years|Mean|54.9|54.9|Standard Deviation|10.3|10.3|||
3631785|NCT02581410|3479514|B3|White - Caucasian / European Heritage|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|430|430.0||||||
3631786|NCT02581410|3479515|B2|White - Caucasian / European Heritage|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|215|215.0||||||
3631787|NCT02581410|3479516|B1|White - Caucasian / European Heritage|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|215|215.0||||||
3631788|NCT02581410|3479514|B3||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
3631789|NCT02581410|3479515|B2||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3631790|NCT02581410|3479516|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3631791|NCT02581410|3479514|B3||Female|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
3631792|NCT02581410|3479515|B2||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3631793|NCT02581410|3479516|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3631794|NCT02581410|3479514|B3|||Age||Years|Mean|70.9|70.9|Standard Deviation|4.6|4.6|||
3631795|NCT02581410|3479515|B2|||Age||Years|Mean|70.8|70.8|Standard Deviation|4.6|4.6|||
3631796|NCT02581410|3479516|B1|||Age||Years|Mean|71.1|71.1|Standard Deviation|4.5|4.5|||
3631797|NCT02581345|3479545|B3||Mild|Number of Participants with the Indicated Static Physician’s Global Assessment (sPGA) Score|The sPGA is a 6-point scale ranging from 0 (clear) to 5 (very severe) used to measure the severity of disease (induration, scaling, and erythema).|Participants|Count of Participants|0|0.0||||||
3631798|NCT02581345|3479546|B2||Mild|Number of Participants with the Indicated Static Physician’s Global Assessment (sPGA) Score|The sPGA is a 6-point scale ranging from 0 (clear) to 5 (very severe) used to measure the severity of disease (induration, scaling, and erythema).|Participants|Count of Participants|0|0.0||||||
3631799|NCT02581345|3479547|B1||Mild|Number of Participants with the Indicated Static Physician’s Global Assessment (sPGA) Score|The sPGA is a 6-point scale ranging from 0 (clear) to 5 (very severe) used to measure the severity of disease (induration, scaling, and erythema).|Participants|Count of Participants|0|0.0||||||
3631883|NCT02581111|3479654|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3631800|NCT02581345|3479545|B3||Almost Clear|Number of Participants with the Indicated Static Physician’s Global Assessment (sPGA) Score|The sPGA is a 6-point scale ranging from 0 (clear) to 5 (very severe) used to measure the severity of disease (induration, scaling, and erythema).|Participants|Count of Participants|0|0.0||||||
3631801|NCT02581345|3479546|B2||Almost Clear|Number of Participants with the Indicated Static Physician’s Global Assessment (sPGA) Score|The sPGA is a 6-point scale ranging from 0 (clear) to 5 (very severe) used to measure the severity of disease (induration, scaling, and erythema).|Participants|Count of Participants|0|0.0||||||
3631802|NCT02581345|3479547|B1||Almost Clear|Number of Participants with the Indicated Static Physician’s Global Assessment (sPGA) Score|The sPGA is a 6-point scale ranging from 0 (clear) to 5 (very severe) used to measure the severity of disease (induration, scaling, and erythema).|Participants|Count of Participants|0|0.0||||||
3631803|NCT02581345|3479545|B3||Clear|Number of Participants with the Indicated Static Physician’s Global Assessment (sPGA) Score|The sPGA is a 6-point scale ranging from 0 (clear) to 5 (very severe) used to measure the severity of disease (induration, scaling, and erythema).|Participants|Count of Participants|0|0.0||||||
3631804|NCT02581345|3479546|B2||Clear|Number of Participants with the Indicated Static Physician’s Global Assessment (sPGA) Score|The sPGA is a 6-point scale ranging from 0 (clear) to 5 (very severe) used to measure the severity of disease (induration, scaling, and erythema).|Participants|Count of Participants|0|0.0||||||
3631805|NCT02581345|3479547|B1||Clear|Number of Participants with the Indicated Static Physician’s Global Assessment (sPGA) Score|The sPGA is a 6-point scale ranging from 0 (clear) to 5 (very severe) used to measure the severity of disease (induration, scaling, and erythema).|Participants|Count of Participants|0|0.0||||||
3631806|NCT02581345|3479545|B3||Very Severe|Number of Participants with the Indicated Static Physician’s Global Assessment (sPGA) Score|The sPGA is a 6-point scale ranging from 0 (clear) to 5 (very severe) used to measure the severity of disease (induration, scaling, and erythema).|Participants|Count of Participants|24|24.0||||||
3631807|NCT02581345|3479546|B2||Very Severe|Number of Participants with the Indicated Static Physician’s Global Assessment (sPGA) Score|The sPGA is a 6-point scale ranging from 0 (clear) to 5 (very severe) used to measure the severity of disease (induration, scaling, and erythema).|Participants|Count of Participants|12|12.0||||||
3631808|NCT02581345|3479547|B1||Very Severe|Number of Participants with the Indicated Static Physician’s Global Assessment (sPGA) Score|The sPGA is a 6-point scale ranging from 0 (clear) to 5 (very severe) used to measure the severity of disease (induration, scaling, and erythema).|Participants|Count of Participants|12|12.0||||||
3631809|NCT02581345|3479545|B3||Severe|Number of Participants with the Indicated Static Physician’s Global Assessment (sPGA) Score|The sPGA is a 6-point scale ranging from 0 (clear) to 5 (very severe) used to measure the severity of disease (induration, scaling, and erythema).|Participants|Count of Participants|194|194.0||||||
3631810|NCT02581345|3479546|B2||Severe|Number of Participants with the Indicated Static Physician’s Global Assessment (sPGA) Score|The sPGA is a 6-point scale ranging from 0 (clear) to 5 (very severe) used to measure the severity of disease (induration, scaling, and erythema).|Participants|Count of Participants|91|91.0||||||
3631811|NCT02581345|3479547|B1||Severe|Number of Participants with the Indicated Static Physician’s Global Assessment (sPGA) Score|The sPGA is a 6-point scale ranging from 0 (clear) to 5 (very severe) used to measure the severity of disease (induration, scaling, and erythema).|Participants|Count of Participants|103|103.0||||||
3631812|NCT02581345|3479545|B3||Moderate|Number of Participants with the Indicated Static Physician’s Global Assessment (sPGA) Score|The sPGA is a 6-point scale ranging from 0 (clear) to 5 (very severe) used to measure the severity of disease (induration, scaling, and erythema).|Participants|Count of Participants|352|352.0||||||
3631813|NCT02581345|3479546|B2||Moderate|Number of Participants with the Indicated Static Physician’s Global Assessment (sPGA) Score|The sPGA is a 6-point scale ranging from 0 (clear) to 5 (very severe) used to measure the severity of disease (induration, scaling, and erythema).|Participants|Count of Participants|182|182.0||||||
3631814|NCT02581345|3479547|B1||Moderate|Number of Participants with the Indicated Static Physician’s Global Assessment (sPGA) Score|The sPGA is a 6-point scale ranging from 0 (clear) to 5 (very severe) used to measure the severity of disease (induration, scaling, and erythema).|Participants|Count of Participants|170|170.0||||||
3631815|NCT02581345|3479545|B3|||Psoriasis Area and Severity Index (PASI) Score|The PASI measures the average redness (erythema), thickness (induration), and scaliness [each graded on a scale of 0 (no disease) to 4 (very severe)] of psoriasis lesions, weighted by the area of involvement. The total PASI score ranges from 0 to 72. The higher the total score, the more severe the disease.|units on a scale|Mean|20.70|20.7|Standard Deviation|8.74|8.74|||
3631816|NCT02581345|3479546|B2|||Psoriasis Area and Severity Index (PASI) Score|The PASI measures the average redness (erythema), thickness (induration), and scaliness [each graded on a scale of 0 (no disease) to 4 (very severe)] of psoriasis lesions, weighted by the area of involvement. The total PASI score ranges from 0 to 72. The higher the total score, the more severe the disease.|units on a scale|Mean|20.16|20.16|Standard Deviation|8.16|8.16|||
3631817|NCT02581345|3479547|B1|||Psoriasis Area and Severity Index (PASI) Score|The PASI measures the average redness (erythema), thickness (induration), and scaliness [each graded on a scale of 0 (no disease) to 4 (very severe)] of psoriasis lesions, weighted by the area of involvement. The total PASI score ranges from 0 to 72. The higher the total score, the more severe the disease.|units on a scale|Mean|21.24|21.24|Standard Deviation|9.27|9.27|||
3631818|NCT02581345|3479545|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631819|NCT02581345|3479546|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631820|NCT02581345|3479547|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631821|NCT02581345|3479545|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631822|NCT02581345|3479546|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631823|NCT02581345|3479547|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631824|NCT02581345|3479545|B3||White|Race (NIH/OMB)||Participants|Count of Participants|563|563.0||||||
3631825|NCT02581345|3479546|B2||White|Race (NIH/OMB)||Participants|Count of Participants|282|282.0||||||
3631827|NCT02581345|3479545|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3631828|NCT02581345|3479546|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631829|NCT02581345|3479547|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3631830|NCT02581345|3479545|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631831|NCT02581345|3479546|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631832|NCT02581345|3479547|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631833|NCT02581345|3479545|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3631834|NCT02581345|3479546|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631835|NCT02581345|3479547|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3631836|NCT02581345|3479545|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631837|NCT02581345|3479546|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631838|NCT02581345|3479547|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631839|NCT02581345|3479545|B3||Male|Sex: Female, Male||Participants|Count of Participants|377|377.0||||||
3631840|NCT02581345|3479546|B2||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
3631841|NCT02581345|3479547|B1||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
3631842|NCT02581345|3479545|B3||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
3631843|NCT02581345|3479546|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3631844|NCT02581345|3479547|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3631845|NCT02581345|3479545|B3|||Age||years|Mean|45.0|45.0|Standard Deviation|12.6|12.6|||
3631846|NCT02581345|3479546|B2|||Age||years|Mean|45.5|45.5|Standard Deviation|12.9|12.9|||
3631847|NCT02581345|3479547|B1|||Age||years|Mean|44.6|44.6|Standard Deviation|12.4|12.4|||
3631848|NCT02581111|3479652|B3|United States||Region of Enrollment||participants|Number|199|199.0||||||
3631849|NCT02581111|3479653|B2|United States||Region of Enrollment||participants|Number|101|101.0||||||
3631850|NCT02581111|3479654|B1|United States||Region of Enrollment||participants|Number|98|98.0||||||
3631851|NCT02581111|3479652|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3631852|NCT02581111|3479653|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3631853|NCT02581111|3479654|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3631854|NCT02581111|3479652|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631855|NCT02581111|3479653|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631856|NCT02581111|3479654|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631857|NCT02581111|3479652|B3||White|Race (NIH/OMB)||Participants|Count of Participants|153|153.0||||||
3631858|NCT02581111|3479653|B2||White|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
3631859|NCT02581111|3479654|B1||White|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3631860|NCT02581111|3479652|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3631861|NCT02581111|3479653|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3631862|NCT02581111|3479654|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3631863|NCT02581111|3479652|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631864|NCT02581111|3479653|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631865|NCT02581111|3479654|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631866|NCT02581111|3479652|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631867|NCT02581111|3479653|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631868|NCT02581111|3479654|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631869|NCT02581111|3479652|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631870|NCT02581111|3479653|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631871|NCT02581111|3479654|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631872|NCT02581111|3479652|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3631873|NCT02581111|3479653|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3631874|NCT02581111|3479654|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3631875|NCT02581111|3479652|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|170|170.0||||||
3631876|NCT02581111|3479653|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3631877|NCT02581111|3479654|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3631878|NCT02581111|3479652|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3631879|NCT02581111|3479653|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3631880|NCT02581111|3479654|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3631881|NCT02581111|3479652|B3||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3631882|NCT02581111|3479653|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3631884|NCT02581111|3479652|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3631885|NCT02581111|3479653|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3631886|NCT02581111|3479654|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3631887|NCT02581111|3479652|B3|||Age||years|Mean|37|37.0|Standard Deviation|13|13.0|||
3631888|NCT02581111|3479653|B2|||Age||years|Mean|36.8|36.8|Standard Deviation|13|13.0|||
3631889|NCT02581111|3479654|B1|||Age||years|Mean|37.4|37.4|Standard Deviation|13|13.0|||
3631890|NCT02580799|3479665|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3631891|NCT02580799|3479665|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3631892|NCT02580799|3479665|B1|≥ 18 and < 75 years||Age, Customized||participants|Number|30|30.0||||||
3631893|NCT02580591|3479687|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631894|NCT02580591|3479688|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631895|NCT02580591|3479689|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631896|NCT02580591|3479690|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631897|NCT02580591|3479691|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631898|NCT02580591|3479687|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3631899|NCT02580591|3479688|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631900|NCT02580591|3479689|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631901|NCT02580591|3479690|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3631902|NCT02580591|3479691|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631903|NCT02580591|3479687|B5||White|Race (NIH/OMB)||Participants|Count of Participants|926|926.0||||||
3631904|NCT02580591|3479688|B4||White|Race (NIH/OMB)||Participants|Count of Participants|231|231.0||||||
3631905|NCT02580591|3479689|B3||White|Race (NIH/OMB)||Participants|Count of Participants|234|234.0||||||
3631906|NCT02580591|3479690|B2||White|Race (NIH/OMB)||Participants|Count of Participants|234|234.0||||||
3631907|NCT02580591|3479691|B1||White|Race (NIH/OMB)||Participants|Count of Participants|227|227.0||||||
3631908|NCT02580591|3479687|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3631909|NCT02580591|3479688|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3631910|NCT02580591|3479689|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3631911|NCT02580591|3479690|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3631912|NCT02580591|3479691|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3631913|NCT02580591|3479687|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631914|NCT02580591|3479688|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631915|NCT02580591|3479689|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631916|NCT02580591|3479690|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631917|NCT02580591|3479691|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631918|NCT02580591|3479687|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3631919|NCT02580591|3479688|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3631920|NCT02580591|3479689|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3631921|NCT02580591|3479690|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3631922|NCT02580591|3479691|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3631923|NCT02580591|3479687|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3631924|NCT02580591|3479688|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3631925|NCT02580591|3479689|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3631926|NCT02580591|3479690|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631927|NCT02580591|3479691|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3631928|NCT02580591|3479687|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631929|NCT02580591|3479688|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631930|NCT02580591|3479689|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631931|NCT02580591|3479690|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631932|NCT02580591|3479691|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3631933|NCT02580591|3479687|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3631934|NCT02580591|3479688|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3631935|NCT02580591|3479689|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3631936|NCT02580591|3479690|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3631937|NCT02580591|3479691|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3631938|NCT02580591|3479687|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|892|892.0||||||
3631939|NCT02580591|3479688|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|224|224.0||||||
3631940|NCT02580591|3479689|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|233|233.0||||||
3631941|NCT02580591|3479690|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|220|220.0||||||
3631942|NCT02580591|3479691|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|215|215.0||||||
3631943|NCT02580591|3479687|B5||Male|Sex: Female, Male||Participants|Count of Participants|478|478.0||||||
3631944|NCT02580591|3479688|B4||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3631945|NCT02580591|3479689|B3||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3631946|NCT02580591|3479690|B2||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3631947|NCT02580591|3479691|B1||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3631948|NCT02580591|3479687|B5||Female|Sex: Female, Male||Participants|Count of Participants|499|499.0||||||
3631949|NCT02580591|3479688|B4||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3631950|NCT02580591|3479689|B3||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3631951|NCT02580591|3479690|B2||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3631952|NCT02580591|3479691|B1||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3631953|NCT02580591|3479687|B5|||Age||Years|Mean|43.1|43.1|Standard Deviation|13.6|13.6|||
3631954|NCT02580591|3479688|B4|||Age||Years|Mean|44.4|44.4|Standard Deviation|13.6|13.6|||
3631955|NCT02580591|3479689|B3|||Age||Years|Mean|42.3|42.3|Standard Deviation|13.2|13.2|||
3631956|NCT02580591|3479690|B2|||Age||Years|Mean|43.4|43.4|Standard Deviation|14.3|14.3|||
3631957|NCT02580591|3479691|B1|||Age||Years|Mean|42.3|42.3|Standard Deviation|13.2|13.2|||
3631958|NCT02580357|3479724|B4|||Remaining wound area (RWA—mm2 )||square millimeters|Mean|59.6|59.6|Standard Deviation|22.28|22.28|||
3631959|NCT02580357|3479725|B3|||Remaining wound area (RWA—mm2 )||square millimeters|Mean|65.74|65.74|Standard Deviation|25.08|25.08|||
3631960|NCT02580357|3479726|B2|||Remaining wound area (RWA—mm2 )||square millimeters|Mean|50.15|50.15|Standard Deviation|18.49|18.49|||
3631961|NCT02580357|3479727|B1|||Remaining wound area (RWA—mm2 )||square millimeters|Mean|62.91|62.91|Standard Deviation|23.27|23.27|||
3631962|NCT02580357|3479724|B4|Brazil||Region of Enrollment||participants|Number|51|51.0||||||
3631963|NCT02580357|3479725|B3|Brazil||Region of Enrollment||participants|Number|18|18.0||||||
3631964|NCT02580357|3479726|B2|Brazil||Region of Enrollment||participants|Number|18|18.0||||||
3631965|NCT02580357|3479727|B1|Brazil||Region of Enrollment||participants|Number|15|15.0||||||
3631966|NCT02580357|3479724|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3631967|NCT02580357|3479725|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3631968|NCT02580357|3479726|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3631969|NCT02580357|3479727|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3631970|NCT02580357|3479724|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3631971|NCT02580357|3479725|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3631972|NCT02580357|3479726|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3631973|NCT02580357|3479727|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3631974|NCT02580357|3479724|B4|||Age||years|Mean|43.4|43.4|Standard Deviation|8.9|8.9|||
3631975|NCT02580357|3479725|B3|||Age||years|Mean|47|47.0|Standard Deviation|9.3|9.3|||
3631976|NCT02580357|3479726|B2|||Age||years|Mean|43.2|43.2|Standard Deviation|9.8|9.8|||
3631977|NCT02580357|3479727|B1|||Age||years|Mean|40.01|40.01|Standard Deviation|7.6|7.6|||
3631978|NCT02580357|3479724|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3631979|NCT02580357|3479725|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3631980|NCT02580357|3479726|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3631981|NCT02580357|3479727|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3631982|NCT02580357|3479724|B4||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3631983|NCT02580357|3479725|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3631984|NCT02580357|3479726|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3631985|NCT02580357|3479727|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3631986|NCT02580357|3479724|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3631987|NCT02580357|3479725|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3631988|NCT02580357|3479726|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3631989|NCT02580357|3479727|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3631990|NCT02580318|3479740|B1|United States||Region of Enrollment||participants|Number|54|54.0||||||
3631991|NCT02580318|3479740|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3631992|NCT02580318|3479740|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3631993|NCT02580318|3479740|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3631994|NCT02580318|3479740|B1||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3631995|NCT02580318|3479740|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3631996|NCT02580240|3479744|B3|China||Region of Enrollment||participants|Number|118|118.0||||||
3631997|NCT02580240|3479745|B2|China||Region of Enrollment||participants|Number|58|58.0||||||
3631998|NCT02580240|3479746|B1|China||Region of Enrollment||participants|Number|60|60.0||||||
3631999|NCT02580240|3479744|B3||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3632000|NCT02580240|3479745|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3632001|NCT02580240|3479746|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3632002|NCT02580240|3479744|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3632003|NCT02580240|3479745|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3632004|NCT02580240|3479746|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3632005|NCT02580240|3479744|B3|||Age||years|Mean|66.77|66.77|Standard Deviation|14.9|14.9|||
3632006|NCT02580240|3479745|B2|||Age||years|Mean|68.8|68.8|Standard Deviation|12.6|12.6|||
3632007|NCT02580240|3479746|B1|||Age||years|Mean|64.8|64.8|Standard Deviation|16.7|16.7|||
3632008|NCT02580188|3479755|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3632009|NCT02580188|3479756|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3632010|NCT02580188|3479757|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3632011|NCT02580188|3479755|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3632012|NCT02580188|3479756|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3632013|NCT02580188|3479757|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3632014|NCT02580188|3479755|B3||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3632015|NCT02580188|3479756|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3632016|NCT02580188|3479757|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3632017|NCT02580188|3479755|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3632018|NCT02580188|3479756|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3632019|NCT02580188|3479757|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3632020|NCT02580188|3479755|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3632021|NCT02580188|3479756|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3632022|NCT02580188|3479757|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3632023|NCT02579772|3479764|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3632024|NCT02579772|3479764|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3632025|NCT02579772|3479764|B1|||Age||years|Mean|67|67.0|Standard Deviation|9|9.0|||
3632026|NCT02579603|3479783|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3632027|NCT02579603|3479784|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3632028|NCT02579603|3479785|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3632029|NCT02579603|3479783|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3632030|NCT02579603|3479784|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3632031|NCT02579603|3479785|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3632032|NCT02579603|3479783|B3|||Age||Years|Mean|68.9|68.9|Standard Deviation|6.6|6.6|||
3632033|NCT02579603|3479784|B2|||Age||Years|Mean|68.9|68.9|Standard Deviation|6.6|6.6|||
3632034|NCT02579603|3479785|B1|||Age||Years|Mean|68.9|68.9|Standard Deviation|6.8|6.8|||
3632035|NCT02579135|3479795|B3|United States||Region of Enrollment||Participants|Count of Participants|222|222.0||||||
3632036|NCT02579135|3479796|B2|United States||Region of Enrollment||Participants|Count of Participants|115|115.0||||||
3632037|NCT02579135|3479797|B1|United States||Region of Enrollment||Participants|Count of Participants|107|107.0||||||
3632038|NCT02579135|3479795|B3|Other/Mixed Race-Ethnicity||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3632039|NCT02579135|3479796|B2|Other/Mixed Race-Ethnicity||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3632040|NCT02579135|3479797|B1|Other/Mixed Race-Ethnicity||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3632041|NCT02579135|3479795|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|65|65.0||||||
3632042|NCT02579135|3479796|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3632043|NCT02579135|3479797|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3632044|NCT02579135|3479795|B3|Black/Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|54|54.0||||||
3632045|NCT02579135|3479796|B2|Black/Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3632046|NCT02579135|3479797|B1|Black/Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3632047|NCT02579135|3479795|B3|White/Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|83|83.0||||||
3632048|NCT02579135|3479796|B2|White/Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|45|45.0||||||
3632049|NCT02579135|3479797|B1|White/Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
3632050|NCT02579135|3479795|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3632051|NCT02579135|3479796|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3632052|NCT02579135|3479797|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3632053|NCT02579135|3479795|B3||Female|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
3632054|NCT02579135|3479796|B2||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3632055|NCT02579135|3479797|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3632056|NCT02579135|3479795|B3|||Age||years|Mean|15.24|15.24|Standard Deviation|.48|0.48|||
3632057|NCT02579135|3479796|B2|||Age||years|Mean|15.22|15.22|Standard Deviation|.47|0.47|||
3632058|NCT02579135|3479797|B1|||Age||years|Mean|15.26|15.26|Standard Deviation|.48|0.48|||
3632059|NCT02579057|3479807|B3|||Furosemide daily dose||mg|Mean|246|246.0|Standard Deviation|167|167.0|||
3632060|NCT02579057|3479808|B2|||Furosemide daily dose||mg|Mean|261|261.0|Standard Deviation|164|164.0|||
3632061|NCT02579057|3479809|B1|||Furosemide daily dose||mg|Mean|228|228.0|Standard Deviation|174|174.0|||
3632062|NCT02579057|3479807|B3|||Ejection fraction||% left ventricular function|Median|25|25.0|Inter-Quartile Range|||15.0|55.0|
3632063|NCT02579057|3479808|B2|||Ejection fraction||% left ventricular function|Median|25|25.0|Inter-Quartile Range|||15.0|55.0|
3632064|NCT02579057|3479809|B1|||Ejection fraction||% left ventricular function|Median|20|20.0|Inter-Quartile Range|||20.0|55.0|
3632065|NCT02579057|3479807|B3|||Body mass index||kg/m2|Mean|38.7|38.7|Standard Deviation|11.2|11.2|||
3632066|NCT02579057|3479808|B2|||Body mass index||kg/m2|Mean|37.8|37.8|Standard Deviation|11.3|11.3|||
3632067|NCT02579057|3479809|B1|||Body mass index||kg/m2|Mean|39.7|39.7|Standard Deviation|11.2|11.2|||
3632068|NCT02579057|3479807|B3|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3632069|NCT02579057|3479808|B2|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3632070|NCT02579057|3479809|B1|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3632071|NCT02579057|3479807|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632072|NCT02579057|3479808|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632073|NCT02579057|3479809|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632074|NCT02579057|3479807|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632075|NCT02579057|3479808|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632076|NCT02579057|3479809|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632077|NCT02579057|3479807|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3632078|NCT02579057|3479808|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3632079|NCT02579057|3479809|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3632080|NCT02579057|3479807|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3632081|NCT02579057|3479808|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3632082|NCT02579057|3479809|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3632083|NCT02579057|3479807|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632084|NCT02579057|3479808|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632085|NCT02579057|3479809|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632086|NCT02579057|3479807|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3632087|NCT02579057|3479808|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3632088|NCT02579057|3479809|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632089|NCT02579057|3479807|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632090|NCT02579057|3479808|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632091|NCT02579057|3479809|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632092|NCT02579057|3479807|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3632093|NCT02579057|3479808|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3632094|NCT02579057|3479809|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3632095|NCT02579057|3479807|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3632096|NCT02579057|3479808|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3632097|NCT02579057|3479809|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3632098|NCT02579057|3479807|B3|||Age||years|Mean|57|57.0|Standard Deviation|13|13.0|||
3632099|NCT02579057|3479808|B2|||Age||years|Mean|59|59.0|Standard Deviation|13|13.0|||
3632100|NCT02579057|3479809|B1|||Age||years|Mean|54|54.0|Standard Deviation|13|13.0|||
3632101|NCT02578992|3479822|B3|||Body weight||kilogram|Mean|66|66.0|Standard Deviation|14|14.0|||
3632102|NCT02578992|3479823|B2|||Body weight||kilogram|Mean|66|66.0|Standard Deviation|12|12.0|||
3632103|NCT02578992|3479824|B1|||Body weight||kilogram|Mean|66.08|66.08|Standard Deviation|15.8|15.8|||
3632104|NCT02578992|3479822|B3|Neck Length||Height, Thyromental distance, Sternomental distance, Neck length||cm|Mean|17.0|17.0|Standard Deviation|1.7|1.7|||
3632105|NCT02578992|3479823|B2|Neck Length||Height, Thyromental distance, Sternomental distance, Neck length||cm|Mean|17.3|17.3|Standard Deviation|1.7|1.7|||
3632106|NCT02578992|3479824|B1|Neck Length||Height, Thyromental distance, Sternomental distance, Neck length||cm|Mean|16.7|16.7|Standard Deviation|1.8|1.8|||
3632107|NCT02578992|3479822|B3|Sternomental distance||Height, Thyromental distance, Sternomental distance, Neck length||cm|Mean|15.5|15.5|Standard Deviation|1.8|1.8|||
3632108|NCT02578992|3479823|B2|Sternomental distance||Height, Thyromental distance, Sternomental distance, Neck length||cm|Mean|15.7|15.7|Standard Deviation|1.8|1.8|||
3632109|NCT02578992|3479824|B1|Sternomental distance||Height, Thyromental distance, Sternomental distance, Neck length||cm|Mean|15.2|15.2|Standard Deviation|1.9|1.9|||
3632110|NCT02578992|3479822|B3|Thyromental distance||Height, Thyromental distance, Sternomental distance, Neck length||cm|Mean|7.8|7.8|Standard Deviation|1.0|1.0|||
3632111|NCT02578992|3479823|B2|Thyromental distance||Height, Thyromental distance, Sternomental distance, Neck length||cm|Mean|8.0|8.0|Standard Deviation|0.9|0.9|||
3632112|NCT02578992|3479824|B1|Thyromental distance||Height, Thyromental distance, Sternomental distance, Neck length||cm|Mean|7.7|7.7|Standard Deviation|1.1|1.1|||
3632113|NCT02578992|3479822|B3|Height||Height, Thyromental distance, Sternomental distance, Neck length||cm|Mean|162|162.0|Standard Deviation|9|9.0|||
3632194|NCT02578862|3479837|B3|United States||Region of Enrollment||participants|Number|72|72.0||||||
3632114|NCT02578992|3479823|B2|Height||Height, Thyromental distance, Sternomental distance, Neck length||cm|Mean|161.9|161.9|Standard Deviation|9.1|9.1|||
3632115|NCT02578992|3479824|B1|Height||Height, Thyromental distance, Sternomental distance, Neck length||cm|Mean|162.3|162.3|Standard Deviation|8.8|8.8|||
3632116|NCT02578992|3479822|B3|Taiwan||Region of Enrollment||participants|Number|124|124.0||||||
3632117|NCT02578992|3479823|B2|Taiwan||Region of Enrollment||participants|Number|62|62.0||||||
3632118|NCT02578992|3479824|B1|Taiwan||Region of Enrollment||participants|Number|62|62.0||||||
3632119|NCT02578992|3479822|B3|Asian||Race/Ethnicity, Customized||participants|Number|124|124.0||||||
3632120|NCT02578992|3479823|B2|Asian||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
3632121|NCT02578992|3479824|B1|Asian||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
3632122|NCT02578992|3479822|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3632123|NCT02578992|3479823|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3632124|NCT02578992|3479824|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3632125|NCT02578992|3479822|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3632126|NCT02578992|3479823|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3632127|NCT02578992|3479824|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3632128|NCT02578992|3479822|B3|||Age||years|Mean|50.8|50.8|Standard Deviation|14.9|14.9|||
3632129|NCT02578992|3479823|B2|||Age||years|Mean|50.0|50.0|Standard Deviation|15.0|15.0|||
3632130|NCT02578992|3479824|B1|||Age||years|Mean|51.6|51.6|Standard Deviation|14.8|14.8|||
3632131|NCT02578862|3479837|B3|Liver Disease||Co-morbidities||participants|Number|2|2.0||||||
3632132|NCT02578862|3479838|B2|Liver Disease||Co-morbidities||participants|Number|0|0.0||||||
3632133|NCT02578862|3479839|B1|Liver Disease||Co-morbidities||participants|Number|2|2.0||||||
3632134|NCT02578862|3479837|B3|Peripheral Vascular Disease||Co-morbidities||participants|Number|4|4.0||||||
3632135|NCT02578862|3479838|B2|Peripheral Vascular Disease||Co-morbidities||participants|Number|1|1.0||||||
3632136|NCT02578862|3479839|B1|Peripheral Vascular Disease||Co-morbidities||participants|Number|3|3.0||||||
3632137|NCT02578862|3479837|B3|Chronic Obstructive Pulmonary Disease (COPD)||Co-morbidities||participants|Number|7|7.0||||||
3632138|NCT02578862|3479838|B2|Chronic Obstructive Pulmonary Disease (COPD)||Co-morbidities||participants|Number|4|4.0||||||
3632139|NCT02578862|3479839|B1|Chronic Obstructive Pulmonary Disease (COPD)||Co-morbidities||participants|Number|3|3.0||||||
3632140|NCT02578862|3479837|B3|Tobacco Use||Co-morbidities||participants|Number|21|21.0||||||
3632141|NCT02578862|3479838|B2|Tobacco Use||Co-morbidities||participants|Number|13|13.0||||||
3632142|NCT02578862|3479839|B1|Tobacco Use||Co-morbidities||participants|Number|8|8.0||||||
3632143|NCT02578862|3479837|B3|Congestive Heart Failure||Co-morbidities||participants|Number|1|1.0||||||
3632144|NCT02578862|3479838|B2|Congestive Heart Failure||Co-morbidities||participants|Number|0|0.0||||||
3632145|NCT02578862|3479839|B1|Congestive Heart Failure||Co-morbidities||participants|Number|1|1.0||||||
3632146|NCT02578862|3479837|B3|Non-sinus Dysrhythmias||Co-morbidities||participants|Number|1|1.0||||||
3632147|NCT02578862|3479838|B2|Non-sinus Dysrhythmias||Co-morbidities||participants|Number|1|1.0||||||
3632148|NCT02578862|3479839|B1|Non-sinus Dysrhythmias||Co-morbidities||participants|Number|0|0.0||||||
3632149|NCT02578862|3479837|B3|Renal Disease||Co-morbidities||participants|Number|2|2.0||||||
3632150|NCT02578862|3479838|B2|Renal Disease||Co-morbidities||participants|Number|2|2.0||||||
3632151|NCT02578862|3479839|B1|Renal Disease||Co-morbidities||participants|Number|0|0.0||||||
3632152|NCT02578862|3479837|B3|Coronary Artery Disease||Co-morbidities||participants|Number|2|2.0||||||
3632153|NCT02578862|3479838|B2|Coronary Artery Disease||Co-morbidities||participants|Number|1|1.0||||||
3632154|NCT02578862|3479839|B1|Coronary Artery Disease||Co-morbidities||participants|Number|1|1.0||||||
3632155|NCT02578862|3479837|B3|Reactive Airway Disease||Co-morbidities||participants|Number|32|32.0||||||
3632156|NCT02578862|3479838|B2|Reactive Airway Disease||Co-morbidities||participants|Number|16|16.0||||||
3632157|NCT02578862|3479839|B1|Reactive Airway Disease||Co-morbidities||participants|Number|16|16.0||||||
3632158|NCT02578862|3479837|B3|Diabetes Mellitus||Co-morbidities||participants|Number|5|5.0||||||
3632159|NCT02578862|3479838|B2|Diabetes Mellitus||Co-morbidities||participants|Number|3|3.0||||||
3632160|NCT02578862|3479839|B1|Diabetes Mellitus||Co-morbidities||participants|Number|2|2.0||||||
3632161|NCT02578862|3479837|B3|Systemic Hypertension||Co-morbidities||participants|Number|29|29.0||||||
3632162|NCT02578862|3479838|B2|Systemic Hypertension||Co-morbidities||participants|Number|13|13.0||||||
3632163|NCT02578862|3479839|B1|Systemic Hypertension||Co-morbidities||participants|Number|16|16.0||||||
3632164|NCT02578862|3479837|B3|SNOT-22 Score (Baseline)||Patient Assessments|"Lund Mackay Score- measures sinus opacification, Min 0 Max 24. Higher score indicates more opacification.~SNOT-22 Score (Sinonasal Outcome Test-22)- measures sinus symptoms. Min 0 Max 110. Higher score indicates worse symptoms."|units on a scale|Median|47|47.0|Inter-Quartile Range|||34.0|58.0|
3632165|NCT02578862|3479838|B2|SNOT-22 Score (Baseline)||Patient Assessments|"Lund Mackay Score- measures sinus opacification, Min 0 Max 24. Higher score indicates more opacification.~SNOT-22 Score (Sinonasal Outcome Test-22)- measures sinus symptoms. Min 0 Max 110. Higher score indicates worse symptoms."|units on a scale|Median|45.5|45.5|Inter-Quartile Range|||27.0|58.0|
3632166|NCT02578862|3479839|B1|SNOT-22 Score (Baseline)||Patient Assessments|"Lund Mackay Score- measures sinus opacification, Min 0 Max 24. Higher score indicates more opacification.~SNOT-22 Score (Sinonasal Outcome Test-22)- measures sinus symptoms. Min 0 Max 110. Higher score indicates worse symptoms."|units on a scale|Median|48|48.0|Inter-Quartile Range|||37.0|59.0|
3632195|NCT02578862|3479838|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
3632196|NCT02578862|3479839|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
3632167|NCT02578862|3479837|B3|Lund-Mackay Score||Patient Assessments|"Lund Mackay Score- measures sinus opacification, Min 0 Max 24. Higher score indicates more opacification.~SNOT-22 Score (Sinonasal Outcome Test-22)- measures sinus symptoms. Min 0 Max 110. Higher score indicates worse symptoms."|units on a scale|Median|14|14.0|Inter-Quartile Range|||13.0|18.0|
3632168|NCT02578862|3479838|B2|Lund-Mackay Score||Patient Assessments|"Lund Mackay Score- measures sinus opacification, Min 0 Max 24. Higher score indicates more opacification.~SNOT-22 Score (Sinonasal Outcome Test-22)- measures sinus symptoms. Min 0 Max 110. Higher score indicates worse symptoms."|units on a scale|Median|15|15.0|Inter-Quartile Range|||13.0|20.0|
3632169|NCT02578862|3479839|B1|Lund-Mackay Score||Patient Assessments|"Lund Mackay Score- measures sinus opacification, Min 0 Max 24. Higher score indicates more opacification.~SNOT-22 Score (Sinonasal Outcome Test-22)- measures sinus symptoms. Min 0 Max 110. Higher score indicates worse symptoms."|units on a scale|Median|14|14.0|Inter-Quartile Range|||13.0|16.0|
3632170|NCT02578862|3479837|B3|Aspirin Exacerbated Respiratory Disease (AERD)||Disease Factors||participants|Number|6|6.0||||||
3632171|NCT02578862|3479838|B2|Aspirin Exacerbated Respiratory Disease (AERD)||Disease Factors||participants|Number|3|3.0||||||
3632172|NCT02578862|3479839|B1|Aspirin Exacerbated Respiratory Disease (AERD)||Disease Factors||participants|Number|3|3.0||||||
3632173|NCT02578862|3479837|B3|Allergic Fungal Rhinosinusitis (AFRS)||Disease Factors||participants|Number|8|8.0||||||
3632174|NCT02578862|3479838|B2|Allergic Fungal Rhinosinusitis (AFRS)||Disease Factors||participants|Number|3|3.0||||||
3632175|NCT02578862|3479839|B1|Allergic Fungal Rhinosinusitis (AFRS)||Disease Factors||participants|Number|5|5.0||||||
3632176|NCT02578862|3479837|B3|Tissue Eosinophilia||Disease Factors||participants|Number|58|58.0||||||
3632177|NCT02578862|3479838|B2|Tissue Eosinophilia||Disease Factors||participants|Number|30|30.0||||||
3632178|NCT02578862|3479839|B1|Tissue Eosinophilia||Disease Factors||participants|Number|28|28.0||||||
3632179|NCT02578862|3479837|B3|Polyposis||Disease Factors||participants|Number|64|64.0||||||
3632180|NCT02578862|3479838|B2|Polyposis||Disease Factors||participants|Number|33|33.0||||||
3632181|NCT02578862|3479839|B1|Polyposis||Disease Factors||participants|Number|31|31.0||||||
3632182|NCT02578862|3479837|B3||III|American Society of Anesthesiologists (ASA) Physical Status|ASA I A normal healthy patient ASA II A patient with mild systemic disease ASA III A patient with severe systemic disease ASA IV A patient with severe systemic disease that is a constant threat to life ASA V A moribund patient who is not expected to survive without the operation ASA VI A declared brain-dead patient whose organs are being removed for donor purposes|Participants|Count of Participants|14|14.0||||||
3632183|NCT02578862|3479838|B2||III|American Society of Anesthesiologists (ASA) Physical Status|ASA I A normal healthy patient ASA II A patient with mild systemic disease ASA III A patient with severe systemic disease ASA IV A patient with severe systemic disease that is a constant threat to life ASA V A moribund patient who is not expected to survive without the operation ASA VI A declared brain-dead patient whose organs are being removed for donor purposes|Participants|Count of Participants|7|7.0||||||
3632184|NCT02578862|3479839|B1||III|American Society of Anesthesiologists (ASA) Physical Status|ASA I A normal healthy patient ASA II A patient with mild systemic disease ASA III A patient with severe systemic disease ASA IV A patient with severe systemic disease that is a constant threat to life ASA V A moribund patient who is not expected to survive without the operation ASA VI A declared brain-dead patient whose organs are being removed for donor purposes|Participants|Count of Participants|7|7.0||||||
3632185|NCT02578862|3479837|B3||II|American Society of Anesthesiologists (ASA) Physical Status|ASA I A normal healthy patient ASA II A patient with mild systemic disease ASA III A patient with severe systemic disease ASA IV A patient with severe systemic disease that is a constant threat to life ASA V A moribund patient who is not expected to survive without the operation ASA VI A declared brain-dead patient whose organs are being removed for donor purposes|Participants|Count of Participants|53|53.0||||||
3632186|NCT02578862|3479838|B2||II|American Society of Anesthesiologists (ASA) Physical Status|ASA I A normal healthy patient ASA II A patient with mild systemic disease ASA III A patient with severe systemic disease ASA IV A patient with severe systemic disease that is a constant threat to life ASA V A moribund patient who is not expected to survive without the operation ASA VI A declared brain-dead patient whose organs are being removed for donor purposes|Participants|Count of Participants|25|25.0||||||
3632187|NCT02578862|3479839|B1||II|American Society of Anesthesiologists (ASA) Physical Status|ASA I A normal healthy patient ASA II A patient with mild systemic disease ASA III A patient with severe systemic disease ASA IV A patient with severe systemic disease that is a constant threat to life ASA V A moribund patient who is not expected to survive without the operation ASA VI A declared brain-dead patient whose organs are being removed for donor purposes|Participants|Count of Participants|28|28.0||||||
3632188|NCT02578862|3479837|B3||I|American Society of Anesthesiologists (ASA) Physical Status|ASA I A normal healthy patient ASA II A patient with mild systemic disease ASA III A patient with severe systemic disease ASA IV A patient with severe systemic disease that is a constant threat to life ASA V A moribund patient who is not expected to survive without the operation ASA VI A declared brain-dead patient whose organs are being removed for donor purposes|Participants|Count of Participants|5|5.0||||||
3632189|NCT02578862|3479838|B2||I|American Society of Anesthesiologists (ASA) Physical Status|ASA I A normal healthy patient ASA II A patient with mild systemic disease ASA III A patient with severe systemic disease ASA IV A patient with severe systemic disease that is a constant threat to life ASA V A moribund patient who is not expected to survive without the operation ASA VI A declared brain-dead patient whose organs are being removed for donor purposes|Participants|Count of Participants|3|3.0||||||
3632190|NCT02578862|3479839|B1||I|American Society of Anesthesiologists (ASA) Physical Status|ASA I A normal healthy patient ASA II A patient with mild systemic disease ASA III A patient with severe systemic disease ASA IV A patient with severe systemic disease that is a constant threat to life ASA V A moribund patient who is not expected to survive without the operation ASA VI A declared brain-dead patient whose organs are being removed for donor purposes|Participants|Count of Participants|2|2.0||||||
3632191|NCT02578862|3479837|B3|||Body Mass Index (BMI)||kg/m^2|Mean|29.1|29.1|Inter-Quartile Range|||25.9|34.6|
3632192|NCT02578862|3479838|B2|||Body Mass Index (BMI)||kg/m^2|Mean|28|28.0|Inter-Quartile Range|||19.0|53.0|
3632193|NCT02578862|3479839|B1|||Body Mass Index (BMI)||kg/m^2|Mean|31|31.0|Inter-Quartile Range|||21.0|56.0|
3632197|NCT02578862|3479837|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3632198|NCT02578862|3479837|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3632199|NCT02578862|3479838|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3632200|NCT02578862|3479839|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3632201|NCT02578862|3479837|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3632202|NCT02578862|3479838|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3632203|NCT02578862|3479839|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3632204|NCT02578862|3479837|B3|||Age||years|Mean|51.5|51.5|Inter-Quartile Range|||35.3|62.0|
3632205|NCT02578862|3479838|B2|||Age||years|Mean|55|55.0|Inter-Quartile Range|||25.0|81.0|
3632206|NCT02578862|3479839|B1|||Age||years|Mean|45|45.0|Inter-Quartile Range|||20.0|77.0|
3632207|NCT02578706|3479856|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3632208|NCT02578706|3479857|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3632209|NCT02578706|3479858|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3632210|NCT02578706|3479859|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3632211|NCT02578706|3479856|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3632212|NCT02578706|3479857|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3632213|NCT02578706|3479858|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3632214|NCT02578706|3479859|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3632215|NCT02578706|3479856|B4|||Age||years|Mean|46.4|46.4|Standard Deviation|10.6|10.6|||
3632216|NCT02578706|3479857|B3|||Age||years|Mean|50.75|50.75|Standard Deviation|11.7|11.7|||
3632217|NCT02578706|3479858|B2|||Age||years|Mean|44.2|44.2|Standard Deviation|8.3|8.3|||
3632218|NCT02578706|3479859|B1|||Age||years|Mean|45|45.0|Standard Deviation|11.9|11.9|||
3632219|NCT02578680|3479938|B3|Former/Current Smoker||Smoking Status|Participants were classified according to their smoking status: Never Smoker or Former/Current Smoker.|Participants|Count of Participants|543|543.0||||||
3632220|NCT02578680|3479939|B2|Former/Current Smoker||Smoking Status|Participants were classified according to their smoking status: Never Smoker or Former/Current Smoker.|Participants|Count of Participants|181|181.0||||||
3632221|NCT02578680|3479940|B1|Former/Current Smoker||Smoking Status|Participants were classified according to their smoking status: Never Smoker or Former/Current Smoker.|Participants|Count of Participants|362|362.0||||||
3632222|NCT02578680|3479938|B3|Never Smoker||Smoking Status|Participants were classified according to their smoking status: Never Smoker or Former/Current Smoker.|Participants|Count of Participants|73|73.0||||||
3632223|NCT02578680|3479939|B2|Never Smoker||Smoking Status|Participants were classified according to their smoking status: Never Smoker or Former/Current Smoker.|Participants|Count of Participants|25|25.0||||||
3632224|NCT02578680|3479940|B1|Never Smoker||Smoking Status|Participants were classified according to their smoking status: Never Smoker or Former/Current Smoker.|Participants|Count of Participants|48|48.0||||||
3632225|NCT02578680|3479938|B3|Carboplatin||Platinum Chemotherapy|Participants were classified according to the type of platinum chemotherapy the Investigator chose for them to receive: Cisplatin or Carboplatin.|Participants|Count of Participants|445|445.0||||||
3632226|NCT02578680|3479939|B2|Carboplatin||Platinum Chemotherapy|Participants were classified according to the type of platinum chemotherapy the Investigator chose for them to receive: Cisplatin or Carboplatin.|Participants|Count of Participants|148|148.0||||||
3632227|NCT02578680|3479940|B1|Carboplatin||Platinum Chemotherapy|Participants were classified according to the type of platinum chemotherapy the Investigator chose for them to receive: Cisplatin or Carboplatin.|Participants|Count of Participants|297|297.0||||||
3632228|NCT02578680|3479938|B3|Cisplatin||Platinum Chemotherapy|Participants were classified according to the type of platinum chemotherapy the Investigator chose for them to receive: Cisplatin or Carboplatin.|Participants|Count of Participants|171|171.0||||||
3632229|NCT02578680|3479939|B2|Cisplatin||Platinum Chemotherapy|Participants were classified according to the type of platinum chemotherapy the Investigator chose for them to receive: Cisplatin or Carboplatin.|Participants|Count of Participants|58|58.0||||||
3632230|NCT02578680|3479940|B1|Cisplatin||Platinum Chemotherapy|Participants were classified according to the type of platinum chemotherapy the Investigator chose for them to receive: Cisplatin or Carboplatin.|Participants|Count of Participants|113|113.0||||||
3632231|NCT02578680|3479938|B3|Not Evaluable||Programmed Cell Death-Ligand 1 (PD-L1) Tumor Status|Participants were assessed for their PD-L1 tumor expression level by immunohistochemistry assay using tumor tissue from an archival or newly obtained biopsy. Participants with a TPS ≥1% were classified as PD-L1 positive and participants with a TPS <1% were classified as PD-L1 negative.|Participants|Count of Participants|38|38.0||||||
3632232|NCT02578680|3479939|B2|Not Evaluable||Programmed Cell Death-Ligand 1 (PD-L1) Tumor Status|Participants were assessed for their PD-L1 tumor expression level by immunohistochemistry assay using tumor tissue from an archival or newly obtained biopsy. Participants with a TPS ≥1% were classified as PD-L1 positive and participants with a TPS <1% were classified as PD-L1 negative.|Participants|Count of Participants|15|15.0||||||
3632233|NCT02578680|3479940|B1|Not Evaluable||Programmed Cell Death-Ligand 1 (PD-L1) Tumor Status|Participants were assessed for their PD-L1 tumor expression level by immunohistochemistry assay using tumor tissue from an archival or newly obtained biopsy. Participants with a TPS ≥1% were classified as PD-L1 positive and participants with a TPS <1% were classified as PD-L1 negative.|Participants|Count of Participants|23|23.0||||||
3632234|NCT02578680|3479938|B3|TPS ≥1%||Programmed Cell Death-Ligand 1 (PD-L1) Tumor Status|Participants were assessed for their PD-L1 tumor expression level by immunohistochemistry assay using tumor tissue from an archival or newly obtained biopsy. Participants with a TPS ≥1% were classified as PD-L1 positive and participants with a TPS <1% were classified as PD-L1 negative.|Participants|Count of Participants|388|388.0||||||
3632281|NCT02578199|3479985|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3632235|NCT02578680|3479939|B2|TPS ≥1%||Programmed Cell Death-Ligand 1 (PD-L1) Tumor Status|Participants were assessed for their PD-L1 tumor expression level by immunohistochemistry assay using tumor tissue from an archival or newly obtained biopsy. Participants with a TPS ≥1% were classified as PD-L1 positive and participants with a TPS <1% were classified as PD-L1 negative.|Participants|Count of Participants|128|128.0||||||
3632236|NCT02578680|3479940|B1|TPS ≥1%||Programmed Cell Death-Ligand 1 (PD-L1) Tumor Status|Participants were assessed for their PD-L1 tumor expression level by immunohistochemistry assay using tumor tissue from an archival or newly obtained biopsy. Participants with a TPS ≥1% were classified as PD-L1 positive and participants with a TPS <1% were classified as PD-L1 negative.|Participants|Count of Participants|260|260.0||||||
3632237|NCT02578680|3479938|B3|TPS <1%||Programmed Cell Death-Ligand 1 (PD-L1) Tumor Status|Participants were assessed for their PD-L1 tumor expression level by immunohistochemistry assay using tumor tissue from an archival or newly obtained biopsy. Participants with a TPS ≥1% were classified as PD-L1 positive and participants with a TPS <1% were classified as PD-L1 negative.|Participants|Count of Participants|190|190.0||||||
3632238|NCT02578680|3479939|B2|TPS <1%||Programmed Cell Death-Ligand 1 (PD-L1) Tumor Status|Participants were assessed for their PD-L1 tumor expression level by immunohistochemistry assay using tumor tissue from an archival or newly obtained biopsy. Participants with a TPS ≥1% were classified as PD-L1 positive and participants with a TPS <1% were classified as PD-L1 negative.|Participants|Count of Participants|63|63.0||||||
3632239|NCT02578680|3479940|B1|TPS <1%||Programmed Cell Death-Ligand 1 (PD-L1) Tumor Status|Participants were assessed for their PD-L1 tumor expression level by immunohistochemistry assay using tumor tissue from an archival or newly obtained biopsy. Participants with a TPS ≥1% were classified as PD-L1 positive and participants with a TPS <1% were classified as PD-L1 negative.|Participants|Count of Participants|127|127.0||||||
3632240|NCT02578680|3479938|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3632241|NCT02578680|3479939|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3632242|NCT02578680|3479940|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3632243|NCT02578680|3479938|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632244|NCT02578680|3479939|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632245|NCT02578680|3479940|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632246|NCT02578680|3479938|B3||White|Race (NIH/OMB)||Participants|Count of Participants|581|581.0||||||
3632247|NCT02578680|3479939|B2||White|Race (NIH/OMB)||Participants|Count of Participants|194|194.0||||||
3632248|NCT02578680|3479940|B1||White|Race (NIH/OMB)||Participants|Count of Participants|387|387.0||||||
3632249|NCT02578680|3479938|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3632250|NCT02578680|3479939|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3632251|NCT02578680|3479940|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3632252|NCT02578680|3479938|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632253|NCT02578680|3479939|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632254|NCT02578680|3479940|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632255|NCT02578680|3479938|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3632256|NCT02578680|3479939|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3632257|NCT02578680|3479940|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3632258|NCT02578680|3479938|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632259|NCT02578680|3479939|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632260|NCT02578680|3479940|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632261|NCT02578680|3479938|B3||Male|Sex: Female, Male||Participants|Count of Participants|363|363.0||||||
3632262|NCT02578680|3479939|B2||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3632263|NCT02578680|3479940|B1||Male|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
3632264|NCT02578680|3479938|B3||Female|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
3632265|NCT02578680|3479939|B2||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3632266|NCT02578680|3479940|B1||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3632267|NCT02578680|3479938|B3|||Age||Years|Mean|63.1|63.1|Standard Deviation|9.3|9.3|||
3632268|NCT02578680|3479939|B2|||Age||Years|Mean|62.8|62.8|Standard Deviation|9.1|9.1|||
3632269|NCT02578680|3479940|B1|||Age||Years|Mean|63.2|63.2|Standard Deviation|9.4|9.4|||
3632270|NCT02578316|3479957|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3632271|NCT02578316|3479957|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3632272|NCT02578316|3479957|B1|||Age||Years|Mean|48.8|48.8|Standard Deviation|12.62|12.62|||
3632273|NCT02578238|3479981|B1|Korean||Race/Ethnicity, Customized||Participants|Count of Participants|143|143.0||||||
3632274|NCT02578238|3479981|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3632275|NCT02578238|3479981|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3632276|NCT02578238|3479981|B1|||Age||years|Mean|14.14|14.14|Standard Deviation|2.43|2.43|||
3632277|NCT02578199|3479985|B1|||Baseline Weight||pounds|Mean|212.2|212.2|Standard Deviation|34.0|34.0|||
3632278|NCT02578199|3479985|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3632279|NCT02578199|3479985|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3632280|NCT02578199|3479985|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3632796|NCT02575833|3480355|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3632282|NCT02578199|3479985|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632283|NCT02578199|3479985|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632284|NCT02578199|3479985|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632285|NCT02578199|3479985|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3632286|NCT02578199|3479985|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3632287|NCT02578199|3479985|B1|||Age||years|Mean|48.4|48.4|Standard Deviation|10.6|10.6|||
3632288|NCT02578186|3479990|B1|||Body Mass Index (BMI)||kg/m2|Mean|25.9|25.9|Standard Deviation|4.81|4.81|||
3632289|NCT02578186|3479990|B1|||Height||inches|Mean|66.4|66.4|Standard Deviation|3.00|3.0|||
3632290|NCT02578186|3479990|B1|||Weight||lb|Mean|163.3|163.3|Standard Deviation|34.29|34.29|||
3632291|NCT02578186|3479990|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632292|NCT02578186|3479990|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3632293|NCT02578186|3479990|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3632294|NCT02578186|3479990|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3632295|NCT02578186|3479990|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3632296|NCT02578186|3479990|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3632297|NCT02578186|3479990|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632298|NCT02578186|3479990|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632299|NCT02578186|3479990|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3632300|NCT02578186|3479990|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3632301|NCT02578186|3479990|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3632302|NCT02578186|3479990|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3632303|NCT02578186|3479990|B1|||Age||years|Mean|36.2|36.2|Standard Deviation|9.64|9.64|||
3632304|NCT02577718|3479997|B1|||Median Standard Deviation of Systolic Blood Pressure||mm Hg|Median|7.86|7.86|Full Range|||1.15|41.48|
3632305|NCT02577718|3479997|B1|Biphenotypic acute leukemia||Type of Cancer||Participants|Count of Participants|1|1.0||||||
3632306|NCT02577718|3479997|B1|B cell Acute Lymphatic Leukemia||Type of Cancer||Participants|Count of Participants|1|1.0||||||
3632307|NCT02577718|3479997|B1|Myelodysplastic Syndrome||Type of Cancer||Participants|Count of Participants|3|3.0||||||
3632308|NCT02577718|3479997|B1|Acute Myelogenous Leukemia||Type of Cancer||Participants|Count of Participants|2|2.0||||||
3632309|NCT02577718|3479997|B1|Chronic Monocytic Leukemia||Type of Cancer||Participants|Count of Participants|3|3.0||||||
3632310|NCT02577718|3479997|B1|Chronic Lymphatic Leukemia||Type of Cancer||Participants|Count of Participants|1|1.0||||||
3632311|NCT02577718|3479997|B1|Myelofibrosis||Type of Cancer||Participants|Count of Participants|1|1.0||||||
3632312|NCT02577718|3479997|B1|Aplastic Anemia||Type of Cancer||Participants|Count of Participants|1|1.0||||||
3632313|NCT02577718|3479997|B1|Lymphoma||Type of Cancer||Participants|Count of Participants|1|1.0||||||
3632314|NCT02577718|3479997|B1|Acute Monocytic Leukemia||Type of Cancer||Participants|Count of Participants|34|34.0||||||
3632315|NCT02577718|3479997|B1|Acute Lymphatic Leukemia||Type of Cancer||Participants|Count of Participants|12|12.0||||||
3632316|NCT02577718|3479997|B1|||Number of patients with Hypertension|Number|Participants|Count of Participants|36|36.0||||||
3632317|NCT02577718|3479997|B1|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3632318|NCT02577718|3479997|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3632319|NCT02577718|3479997|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632320|NCT02577718|3479997|B1||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3632321|NCT02577718|3479997|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3632322|NCT02577718|3479997|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632323|NCT02577718|3479997|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3632324|NCT02577718|3479997|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632325|NCT02577718|3479997|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3632326|NCT02577718|3479997|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3632327|NCT02577718|3479997|B1|||Age||years|Median|67|67.0|Full Range|||26.0|85.0|
3632328|NCT02577601|3480003|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
3632329|NCT02577601|3480003|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632330|NCT02577601|3480003|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3632331|NCT02577601|3480003|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3632332|NCT02577601|3480003|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3632333|NCT02577601|3480003|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3632334|NCT02577601|3480003|B1|||Age||years|Mean|28.4|28.4|Standard Deviation|3.9|3.9|||
3632335|NCT02577601|3480003|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3632336|NCT02577601|3480003|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3632337|NCT02577601|3480003|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3632338|NCT02577510|3480010|B1|||BMI||kg/m^2|Mean|26.7|26.7|Standard Deviation|3.5|3.5|||
3632339|NCT02577510|3480010|B1|Canada||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3632340|NCT02577510|3480010|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3632341|NCT02577510|3480010|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3632342|NCT02577510|3480010|B1|||Age||years|Mean|40.3|40.3|Standard Deviation|10.1|10.1|||
3632343|NCT02577445|3480023|B3|Spain||Region of Enrollment||participants|Number|3|3.0||||||
3632344|NCT02577445|3480024|B2|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3632345|NCT02577445|3480025|B1|Spain||Region of Enrollment||participants|Number|2|2.0||||||
3632346|NCT02577445|3480023|B3|Germany||Region of Enrollment||participants|Number|28|28.0||||||
3632347|NCT02577445|3480024|B2|Germany||Region of Enrollment||participants|Number|16|16.0||||||
3632348|NCT02577445|3480025|B1|Germany||Region of Enrollment||participants|Number|12|12.0||||||
3632349|NCT02577445|3480023|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3632350|NCT02577445|3480024|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3632351|NCT02577445|3480025|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3632352|NCT02577445|3480023|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3632353|NCT02577445|3480024|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3632354|NCT02577445|3480025|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3632355|NCT02577445|3480023|B3|||Age||years|Mean|70.5|70.5|Standard Deviation|9.7|9.7|||
3632356|NCT02577445|3480024|B2|||Age||years|Mean|69.2|69.2|Standard Deviation|11.5|11.5|||
3632357|NCT02577445|3480025|B1|||Age||years|Mean|72.0|72.0|Standard Deviation|6.8|6.8|||
3632358|NCT02577315|3480037|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3632359|NCT02577315|3480038|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3632360|NCT02577315|3480039|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3632361|NCT02577315|3480037|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3632362|NCT02577315|3480038|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3632363|NCT02577315|3480039|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3632364|NCT02577315|3480037|B3|||Age||Years|Mean|27.6|27.6|Standard Deviation|6.7|6.7|||
3632365|NCT02577315|3480038|B2|||Age||Years|Mean|30.4|30.4|Standard Deviation|7.8|7.8|||
3632366|NCT02577315|3480039|B1|||Age||Years|Mean|24.7|24.7|Standard Deviation|3.6|3.6|||
3632367|NCT02577107|3480056|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3632368|NCT02577107|3480057|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3632369|NCT02577107|3480058|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3632370|NCT02577107|3480056|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3632371|NCT02577107|3480057|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3632372|NCT02577107|3480058|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3632373|NCT02577107|3480056|B3|||Age||years|Mean|67.3|67.3|Standard Deviation|7.09|7.09|||
3632374|NCT02577107|3480057|B2|||Age||years|Mean|69.3|69.3|Standard Deviation|8.41|8.41|||
3632375|NCT02577107|3480058|B1|||Age||years|Mean|65.3|65.3|Standard Deviation|5.50|5.5|||
3632376|NCT02577016|3480071|B3||No|Prior use of other antihyperglycemic agents (AHAs)|Other AHAs refers to the use of AHAs other than sodium-glucose cotransporter 2 (SGLT2) inhibitors within 8 weeks of study start.|Participants|Count of Participants|92|92.0||||||
3632377|NCT02577016|3480072|B2||No|Prior use of other antihyperglycemic agents (AHAs)|Other AHAs refers to the use of AHAs other than sodium-glucose cotransporter 2 (SGLT2) inhibitors within 8 weeks of study start.|Participants|Count of Participants|46|46.0||||||
3632378|NCT02577016|3480073|B1||No|Prior use of other antihyperglycemic agents (AHAs)|Other AHAs refers to the use of AHAs other than sodium-glucose cotransporter 2 (SGLT2) inhibitors within 8 weeks of study start.|Participants|Count of Participants|46|46.0||||||
3632379|NCT02577016|3480071|B3||Yes|Prior use of other antihyperglycemic agents (AHAs)|Other AHAs refers to the use of AHAs other than sodium-glucose cotransporter 2 (SGLT2) inhibitors within 8 weeks of study start.|Participants|Count of Participants|49|49.0||||||
3632380|NCT02577016|3480072|B2||Yes|Prior use of other antihyperglycemic agents (AHAs)|Other AHAs refers to the use of AHAs other than sodium-glucose cotransporter 2 (SGLT2) inhibitors within 8 weeks of study start.|Participants|Count of Participants|25|25.0||||||
3632381|NCT02577016|3480073|B1||Yes|Prior use of other antihyperglycemic agents (AHAs)|Other AHAs refers to the use of AHAs other than sodium-glucose cotransporter 2 (SGLT2) inhibitors within 8 weeks of study start.|Participants|Count of Participants|24|24.0||||||
3632382|NCT02577016|3480071|B3|||Fasting plasma glucose (FPG)||md/dL|Mean|150.0|150.0|Standard Deviation|26.1|26.1|||
3632383|NCT02577016|3480072|B2|||Fasting plasma glucose (FPG)||md/dL|Mean|151.2|151.2|Standard Deviation|27.0|27.0|||
3632384|NCT02577016|3480073|B1|||Fasting plasma glucose (FPG)||md/dL|Mean|148.8|148.8|Standard Deviation|25.4|25.4|||
3632385|NCT02577016|3480071|B3|||Glucose total AUC0-2hr after meal||mg･hr/dL|Mean|418.5|418.5|Standard Deviation|70.9|70.9|||
3632386|NCT02577016|3480072|B2|||Glucose total AUC0-2hr after meal||mg･hr/dL|Mean|422.5|422.5|Standard Deviation|68.2|68.2|||
3632387|NCT02577016|3480073|B1|||Glucose total AUC0-2hr after meal||mg･hr/dL|Mean|414.4|414.4|Standard Deviation|73.8|73.8|||
3632388|NCT02577016|3480071|B3|||2-hour postmeal glucose (2-hr PMG)||mg/dL|Mean|213.6|213.6|Standard Deviation|48.3|48.3|||
3632389|NCT02577016|3480072|B2|||2-hour postmeal glucose (2-hr PMG)||mg/dL|Mean|215.3|215.3|Standard Deviation|47.0|47.0|||
3632390|NCT02577016|3480073|B1|||2-hour postmeal glucose (2-hr PMG)||mg/dL|Mean|211.9|211.9|Standard Deviation|49.8|49.8|||
3632391|NCT02577016|3480071|B3|||Hemoglobin A1c (HbA1c)||Percent|Mean|8.04|8.04|Standard Deviation|0.80|0.8|||
3632392|NCT02577016|3480072|B2|||Hemoglobin A1c (HbA1c)||Percent|Mean|8.08|8.08|Standard Deviation|0.79|0.79|||
3632393|NCT02577016|3480073|B1|||Hemoglobin A1c (HbA1c)||Percent|Mean|8.01|8.01|Standard Deviation|0.81|0.81|||
3632394|NCT02577016|3480071|B3||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3632395|NCT02577016|3480072|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3632396|NCT02577016|3480073|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3632397|NCT02577016|3480071|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3632398|NCT02577016|3480072|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3632399|NCT02577016|3480073|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3632400|NCT02577016|3480071|B3|||Age||Years|Mean|55.5|55.5|Standard Deviation|10.7|10.7|||
3632401|NCT02577016|3480072|B2|||Age||Years|Mean|54.0|54.0|Standard Deviation|9.5|9.5|||
3632402|NCT02577016|3480073|B1|||Age||Years|Mean|57.0|57.0|Standard Deviation|11.6|11.6|||
3632403|NCT02577003|3480090|B3||No|Prior use of other antihyperglycemic agents (AHAs)|Other AHAs refers to the use of AHAs other than sitagliptin within 8 weeks of study start.|Participants|Count of Participants|82|82.0||||||
3632404|NCT02577003|3480091|B2||No|Prior use of other antihyperglycemic agents (AHAs)|Other AHAs refers to the use of AHAs other than sitagliptin within 8 weeks of study start.|Participants|Count of Participants|40|40.0||||||
3632405|NCT02577003|3480092|B1||No|Prior use of other antihyperglycemic agents (AHAs)|Other AHAs refers to the use of AHAs other than sitagliptin within 8 weeks of study start.|Participants|Count of Participants|42|42.0||||||
3632406|NCT02577003|3480090|B3||Yes|Prior use of other antihyperglycemic agents (AHAs)|Other AHAs refers to the use of AHAs other than sitagliptin within 8 weeks of study start.|Participants|Count of Participants|61|61.0||||||
3632407|NCT02577003|3480091|B2||Yes|Prior use of other antihyperglycemic agents (AHAs)|Other AHAs refers to the use of AHAs other than sitagliptin within 8 weeks of study start.|Participants|Count of Participants|30|30.0||||||
3632408|NCT02577003|3480092|B1||Yes|Prior use of other antihyperglycemic agents (AHAs)|Other AHAs refers to the use of AHAs other than sitagliptin within 8 weeks of study start.|Participants|Count of Participants|31|31.0||||||
3632409|NCT02577003|3480090|B3|||Body Weight||kg|Mean|69.9|69.9|Standard Deviation|11.4|11.4|||
3632410|NCT02577003|3480091|B2|||Body Weight||kg|Mean|70.1|70.1|Standard Deviation|11.1|11.1|||
3632411|NCT02577003|3480092|B1|||Body Weight||kg|Mean|69.8|69.8|Standard Deviation|11.7|11.7|||
3632412|NCT02577003|3480090|B3|||Glucose Total Area Under the Plasma Concentration Curve from Hour 0 to Hour 2 (AUC0-2hr) after Meal||mg･hr/dL|Mean|436.2|436.2|Standard Deviation|77.5|77.5|||
3632413|NCT02577003|3480091|B2|||Glucose Total Area Under the Plasma Concentration Curve from Hour 0 to Hour 2 (AUC0-2hr) after Meal||mg･hr/dL|Mean|443.4|443.4|Standard Deviation|67.0|67.0|||
3632414|NCT02577003|3480092|B1|||Glucose Total Area Under the Plasma Concentration Curve from Hour 0 to Hour 2 (AUC0-2hr) after Meal||mg･hr/dL|Mean|429.4|429.4|Standard Deviation|86.3|86.3|||
3632415|NCT02577003|3480090|B3|||2-hour Post-Meal Glucose (2-hr PMG)||mg/dL|Mean|228.3|228.3|Standard Deviation|54.7|54.7|||
3632416|NCT02577003|3480091|B2|||2-hour Post-Meal Glucose (2-hr PMG)||mg/dL|Mean|231.5|231.5|Standard Deviation|48.9|48.9|||
3632417|NCT02577003|3480092|B1|||2-hour Post-Meal Glucose (2-hr PMG)||mg/dL|Mean|225.3|225.3|Standard Deviation|59.9|59.9|||
3632418|NCT02577003|3480090|B3|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|160.5|160.5|Standard Deviation|30.0|30.0|||
3632419|NCT02577003|3480091|B2|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|163.0|163.0|Standard Deviation|26.2|26.2|||
3632420|NCT02577003|3480092|B1|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|158.0|158.0|Standard Deviation|33.2|33.2|||
3632421|NCT02577003|3480090|B3|||Estimated Glomerular Filtration Rate (eGFR)||mL/min/1.73m^2|Mean|82.7|82.7|Standard Deviation|15.1|15.1|||
3632422|NCT02577003|3480091|B2|||Estimated Glomerular Filtration Rate (eGFR)||mL/min/1.73m^2|Mean|83.4|83.4|Standard Deviation|16.7|16.7|||
3632423|NCT02577003|3480092|B1|||Estimated Glomerular Filtration Rate (eGFR)||mL/min/1.73m^2|Mean|82.0|82.0|Standard Deviation|13.5|13.5|||
3632424|NCT02577003|3480090|B3|||HbA1c||Percent|Mean|8.02|8.02|Standard Deviation|0.73|0.73|||
3632425|NCT02577003|3480091|B2|||HbA1c||Percent|Mean|7.99|7.99|Standard Deviation|0.62|0.62|||
3632426|NCT02577003|3480092|B1|||HbA1c||Percent|Mean|8.05|8.05|Standard Deviation|0.83|0.83|||
3632427|NCT02577003|3480090|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3632428|NCT02577003|3480091|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3632429|NCT02577003|3480092|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3632430|NCT02577003|3480090|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3632431|NCT02577003|3480091|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3632432|NCT02577003|3480092|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3632433|NCT02577003|3480090|B3|||Age||Years|Mean|60.5|60.5|Standard Deviation|9.7|9.7|||
3632434|NCT02577003|3480091|B2|||Age||Years|Mean|60.0|60.0|Standard Deviation|10.4|10.4|||
3632435|NCT02577003|3480092|B1|||Age||Years|Mean|61.0|61.0|Standard Deviation|9.1|9.1|||
3632436|NCT02576938|3480111|B4|||Median EASI Total Score|The Eczema Area and Severity Index (EASI) assesses extent of disease based on dividing the skin into 4 regions (head/neck, trunk, upper limbs, and lower limbs) and measures the following clinical signs: (1) erythema, (2) edema/papulation, (3) excoriation, and (4) lichenification each on a scale of 0 to 3.The EASI confers a maximum score of 72 with 0 = clear; 0.1 -1 = almost clear; 1.1 -7 = mild; 7.1 - 21 = moderate; 21.1 - 50 = severe; 50.1 - 72 = very severe.|units on a scale|Median|21.2|21.2|Full Range|||12.0|72.0|
3632483|NCT02576938|3480114|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3632484|NCT02576938|3480111|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3632485|NCT02576938|3480112|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3632437|NCT02576938|3480112|B3|||Median EASI Total Score|The Eczema Area and Severity Index (EASI) assesses extent of disease based on dividing the skin into 4 regions (head/neck, trunk, upper limbs, and lower limbs) and measures the following clinical signs: (1) erythema, (2) edema/papulation, (3) excoriation, and (4) lichenification each on a scale of 0 to 3.The EASI confers a maximum score of 72 with 0 = clear; 0.1 -1 = almost clear; 1.1 -7 = mild; 7.1 - 21 = moderate; 21.1 - 50 = severe; 50.1 - 72 = very severe.|units on a scale|Median|19.5|19.5|Full Range|||12.2|71.4|
3632438|NCT02576938|3480113|B2|||Median EASI Total Score|The Eczema Area and Severity Index (EASI) assesses extent of disease based on dividing the skin into 4 regions (head/neck, trunk, upper limbs, and lower limbs) and measures the following clinical signs: (1) erythema, (2) edema/papulation, (3) excoriation, and (4) lichenification each on a scale of 0 to 3.The EASI confers a maximum score of 72 with 0 = clear; 0.1 -1 = almost clear; 1.1 -7 = mild; 7.1 - 21 = moderate; 21.1 - 50 = severe; 50.1 - 72 = very severe.|units on a scale|Median|22.1|22.1|Full Range|||12.2|72.0|
3632439|NCT02576938|3480114|B1|||Median EASI Total Score|The Eczema Area and Severity Index (EASI) assesses extent of disease based on dividing the skin into 4 regions (head/neck, trunk, upper limbs, and lower limbs) and measures the following clinical signs: (1) erythema, (2) edema/papulation, (3) excoriation, and (4) lichenification each on a scale of 0 to 3.The EASI confers a maximum score of 72 with 0 = clear; 0.1 -1 = almost clear; 1.1 -7 = mild; 7.1 - 21 = moderate; 21.1 - 50 = severe; 50.1 - 72 = very severe.|units on a scale|Median|22.1|22.1|Full Range|||12.0|70.3|
3632440|NCT02576938|3480111|B4|Japan||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3632441|NCT02576938|3480112|B3|Japan||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3632442|NCT02576938|3480113|B2|Japan||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3632443|NCT02576938|3480114|B1|Japan||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3632444|NCT02576938|3480111|B4|United States||Region of Enrollment||Participants|Count of Participants|105|105.0||||||
3632445|NCT02576938|3480112|B3|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3632446|NCT02576938|3480113|B2|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3632447|NCT02576938|3480114|B1|United States||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3632448|NCT02576938|3480111|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632449|NCT02576938|3480112|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632450|NCT02576938|3480113|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632451|NCT02576938|3480114|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632452|NCT02576938|3480111|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3632453|NCT02576938|3480112|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632454|NCT02576938|3480113|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632455|NCT02576938|3480114|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3632456|NCT02576938|3480111|B4||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3632457|NCT02576938|3480112|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3632458|NCT02576938|3480113|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3632459|NCT02576938|3480114|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3632460|NCT02576938|3480111|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3632461|NCT02576938|3480112|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3632462|NCT02576938|3480113|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3632463|NCT02576938|3480114|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3632464|NCT02576938|3480111|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3632465|NCT02576938|3480112|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3632466|NCT02576938|3480113|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632467|NCT02576938|3480114|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3632468|NCT02576938|3480111|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3632469|NCT02576938|3480112|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3632470|NCT02576938|3480113|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3632471|NCT02576938|3480114|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3632472|NCT02576938|3480111|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632473|NCT02576938|3480112|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632474|NCT02576938|3480113|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632475|NCT02576938|3480114|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632476|NCT02576938|3480111|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632477|NCT02576938|3480112|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632478|NCT02576938|3480113|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632479|NCT02576938|3480114|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632480|NCT02576938|3480111|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
3632481|NCT02576938|3480112|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3632482|NCT02576938|3480113|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3632486|NCT02576938|3480113|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3632487|NCT02576938|3480114|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3632488|NCT02576938|3480111|B4||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3632489|NCT02576938|3480112|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3632490|NCT02576938|3480113|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3632491|NCT02576938|3480114|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3632492|NCT02576938|3480111|B4||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3632493|NCT02576938|3480112|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3632494|NCT02576938|3480113|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3632495|NCT02576938|3480114|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3632496|NCT02576938|3480111|B4|||Age||years|Mean|37.8|37.8|Standard Deviation|14.03|14.03|||
3632497|NCT02576938|3480112|B3|||Age||years|Mean|36.4|36.4|Standard Deviation|14.47|14.47|||
3632498|NCT02576938|3480113|B2|||Age||years|Mean|40.0|40.0|Standard Deviation|14.38|14.38|||
3632499|NCT02576938|3480114|B1|||Age||years|Mean|37.3|37.3|Standard Deviation|13.49|13.49|||
3632500|NCT02576678|3480144|B4||Obesity|Baseline Body Mass Index (BMI) category||Participants|Count of Participants|15|15.0||||||
3632501|NCT02576678|3480145|B3||Obesity|Baseline Body Mass Index (BMI) category||Participants|Count of Participants|5|5.0||||||
3632502|NCT02576678|3480146|B2||Obesity|Baseline Body Mass Index (BMI) category||Participants|Count of Participants|6|6.0||||||
3632503|NCT02576678|3480147|B1||Obesity|Baseline Body Mass Index (BMI) category||Participants|Count of Participants|4|4.0||||||
3632504|NCT02576678|3480144|B4||Overweight|Baseline Body Mass Index (BMI) category||Participants|Count of Participants|4|4.0||||||
3632505|NCT02576678|3480145|B3||Overweight|Baseline Body Mass Index (BMI) category||Participants|Count of Participants|1|1.0||||||
3632506|NCT02576678|3480146|B2||Overweight|Baseline Body Mass Index (BMI) category||Participants|Count of Participants|1|1.0||||||
3632507|NCT02576678|3480147|B1||Overweight|Baseline Body Mass Index (BMI) category||Participants|Count of Participants|2|2.0||||||
3632508|NCT02576678|3480144|B4||Healthy Weight|Baseline Body Mass Index (BMI) category||Participants|Count of Participants|23|23.0||||||
3632509|NCT02576678|3480145|B3||Healthy Weight|Baseline Body Mass Index (BMI) category||Participants|Count of Participants|15|15.0||||||
3632510|NCT02576678|3480146|B2||Healthy Weight|Baseline Body Mass Index (BMI) category||Participants|Count of Participants|1|1.0||||||
3632511|NCT02576678|3480147|B1||Healthy Weight|Baseline Body Mass Index (BMI) category||Participants|Count of Participants|7|7.0||||||
3632512|NCT02576678|3480144|B4|||Psoriasis Area Severity Index (PASI)|The PASI is a measure of psoriatic disease severity taking into account qualitative lesion characteristics (erythema, thickness, and scaling) and degree of skin surface area involvement on defined anatomical regions. PASI scores range from 0 to 72, with higher scores reflecting greater disease severity. Erythema, thickness, and scaling are scored on a scale of 0 (none) to 4 (very severe) on 4 anatomic regions of the body: head, trunk, upper limbs, and lower limbs. Degree of involvement on each of the 4 anatomic regions is scored on a scale of 0 (no involvement) to 6 (90% to 100% involvement).|Units on a scale|Mean|17.84|17.84|Standard Deviation|7.854|7.854|||
3632513|NCT02576678|3480145|B3|||Psoriasis Area Severity Index (PASI)|The PASI is a measure of psoriatic disease severity taking into account qualitative lesion characteristics (erythema, thickness, and scaling) and degree of skin surface area involvement on defined anatomical regions. PASI scores range from 0 to 72, with higher scores reflecting greater disease severity. Erythema, thickness, and scaling are scored on a scale of 0 (none) to 4 (very severe) on 4 anatomic regions of the body: head, trunk, upper limbs, and lower limbs. Degree of involvement on each of the 4 anatomic regions is scored on a scale of 0 (no involvement) to 6 (90% to 100% involvement).|Units on a scale|Mean|18.09|18.09|Standard Deviation|6.144|6.144|||
3632514|NCT02576678|3480146|B2|||Psoriasis Area Severity Index (PASI)|The PASI is a measure of psoriatic disease severity taking into account qualitative lesion characteristics (erythema, thickness, and scaling) and degree of skin surface area involvement on defined anatomical regions. PASI scores range from 0 to 72, with higher scores reflecting greater disease severity. Erythema, thickness, and scaling are scored on a scale of 0 (none) to 4 (very severe) on 4 anatomic regions of the body: head, trunk, upper limbs, and lower limbs. Degree of involvement on each of the 4 anatomic regions is scored on a scale of 0 (no involvement) to 6 (90% to 100% involvement).|Units on a scale|Mean|15.65|15.65|Standard Deviation|3.430|3.43|||
3632515|NCT02576678|3480147|B1|||Psoriasis Area Severity Index (PASI)|The PASI is a measure of psoriatic disease severity taking into account qualitative lesion characteristics (erythema, thickness, and scaling) and degree of skin surface area involvement on defined anatomical regions. PASI scores range from 0 to 72, with higher scores reflecting greater disease severity. Erythema, thickness, and scaling are scored on a scale of 0 (none) to 4 (very severe) on 4 anatomic regions of the body: head, trunk, upper limbs, and lower limbs. Degree of involvement on each of the 4 anatomic regions is scored on a scale of 0 (no involvement) to 6 (90% to 100% involvement).|Units on a scale|Mean|18.78|18.78|Standard Deviation|11.693|11.693|||
3632516|NCT02576678|3480144|B4|||Duration of Plaque Psoriasis||Years|Mean|4.99|4.99|Standard Deviation|3.611|3.611|||
3632517|NCT02576678|3480145|B3|||Duration of Plaque Psoriasis||Years|Mean|2.75|2.75|Standard Deviation|2.057|2.057|||
3632518|NCT02576678|3480146|B2|||Duration of Plaque Psoriasis||Years|Mean|6.96|6.96|Standard Deviation|4.057|4.057|||
3632519|NCT02576678|3480147|B1|||Duration of Plaque Psoriasis||Years|Mean|7.41|7.41|Standard Deviation|3.190|3.19|||
3632520|NCT02576678|3480144|B4||≥ 70 kg|Baseline Weight Category (kg)||Participants|Count of Participants|8|8.0||||||
3632521|NCT02576678|3480145|B3||≥ 70 kg|Baseline Weight Category (kg)||Participants|Count of Participants|0|0.0||||||
3632522|NCT02576678|3480146|B2||≥ 70 kg|Baseline Weight Category (kg)||Participants|Count of Participants|8|8.0||||||
3632523|NCT02576678|3480147|B1||≥ 70 kg|Baseline Weight Category (kg)||Participants|Count of Participants|0|0.0||||||
3632692|NCT02576587|3480247|B3|||Age||years|Mean|61|61.0|Standard Deviation|12|12.0|||
3632524|NCT02576678|3480144|B4||≥ 50 - < 70 kg|Baseline Weight Category (kg)||Participants|Count of Participants|14|14.0||||||
3632525|NCT02576678|3480145|B3||≥ 50 - < 70 kg|Baseline Weight Category (kg)||Participants|Count of Participants|4|4.0||||||
3632526|NCT02576678|3480146|B2||≥ 50 - < 70 kg|Baseline Weight Category (kg)||Participants|Count of Participants|0|0.0||||||
3632527|NCT02576678|3480147|B1||≥ 50 - < 70 kg|Baseline Weight Category (kg)||Participants|Count of Participants|10|10.0||||||
3632528|NCT02576678|3480144|B4||≥ 35 - < 50 kg|Baseline Weight Category (kg)||Participants|Count of Participants|7|7.0||||||
3632529|NCT02576678|3480145|B3||≥ 35 - < 50 kg|Baseline Weight Category (kg)||Participants|Count of Participants|4|4.0||||||
3632530|NCT02576678|3480146|B2||≥ 35 - < 50 kg|Baseline Weight Category (kg)||Participants|Count of Participants|0|0.0||||||
3632531|NCT02576678|3480147|B1||≥ 35 - < 50 kg|Baseline Weight Category (kg)||Participants|Count of Participants|3|3.0||||||
3632532|NCT02576678|3480144|B4||≥ 15 - < 35 kg|Baseline Weight Category (kg)||Participants|Count of Participants|13|13.0||||||
3632533|NCT02576678|3480145|B3||≥ 15 - < 35 kg|Baseline Weight Category (kg)||Participants|Count of Participants|13|13.0||||||
3632534|NCT02576678|3480146|B2||≥ 15 - < 35 kg|Baseline Weight Category (kg)||Participants|Count of Participants|0|0.0||||||
3632535|NCT02576678|3480147|B1||≥ 15 - < 35 kg|Baseline Weight Category (kg)||Participants|Count of Participants|0|0.0||||||
3632536|NCT02576678|3480144|B4||< 15 kg|Baseline Weight Category (kg)||Participants|Count of Participants|0|0.0||||||
3632537|NCT02576678|3480145|B3||< 15 kg|Baseline Weight Category (kg)||Participants|Count of Participants|0|0.0||||||
3632538|NCT02576678|3480146|B2||< 15 kg|Baseline Weight Category (kg)||Participants|Count of Participants|0|0.0||||||
3632539|NCT02576678|3480147|B1||< 15 kg|Baseline Weight Category (kg)||Participants|Count of Participants|0|0.0||||||
3632540|NCT02576678|3480144|B4||Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3632541|NCT02576678|3480145|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3632542|NCT02576678|3480146|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3632543|NCT02576678|3480147|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3632544|NCT02576678|3480144|B4||White or Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3632545|NCT02576678|3480145|B3||White or Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3632546|NCT02576678|3480146|B2||White or Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3632547|NCT02576678|3480147|B1||White or Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3632548|NCT02576678|3480144|B4||Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3632549|NCT02576678|3480145|B3||Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3632550|NCT02576678|3480146|B2||Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3632551|NCT02576678|3480147|B1||Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3632552|NCT02576678|3480144|B4||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3632553|NCT02576678|3480145|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3632554|NCT02576678|3480146|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3632555|NCT02576678|3480147|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3632556|NCT02576678|3480144|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3632557|NCT02576678|3480145|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3632558|NCT02576678|3480146|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3632559|NCT02576678|3480147|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3632560|NCT02576678|3480144|B4||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3632561|NCT02576678|3480145|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3632562|NCT02576678|3480146|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3632563|NCT02576678|3480147|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3632564|NCT02576678|3480144|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3632565|NCT02576678|3480145|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3632566|NCT02576678|3480146|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3632567|NCT02576678|3480147|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3632568|NCT02576678|3480144|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3632569|NCT02576678|3480145|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3632570|NCT02576678|3480146|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3632571|NCT02576678|3480147|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3632572|NCT02576678|3480144|B4||12 to 17 years|Age, Customized||Participants|Count of Participants|21|21.0||||||
3632573|NCT02576678|3480145|B3||12 to 17 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3632574|NCT02576678|3480146|B2||12 to 17 years|Age, Customized||Participants|Count of Participants|8|8.0||||||
3632575|NCT02576678|3480147|B1||12 to 17 years|Age, Customized||Participants|Count of Participants|13|13.0||||||
3632576|NCT02576678|3480144|B4||6 to 11 years|Age, Customized||Participants|Count of Participants|21|21.0||||||
3632577|NCT02576678|3480145|B3||6 to 11 years|Age, Customized||Participants|Count of Participants|21|21.0||||||
3632578|NCT02576678|3480146|B2||6 to 11 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3632579|NCT02576678|3480147|B1||6 to 11 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3632580|NCT02576678|3480144|B4|||Age||Years|Mean|11.8|11.8|Standard Deviation|2.95|2.95|||
3632581|NCT02576678|3480145|B3|||Age||Years|Mean|9.3|9.3|Standard Deviation|1.35|1.35|||
3632582|NCT02576678|3480146|B2|||Age||Years|Mean|14.8|14.8|Standard Deviation|2.05|2.05|||
3632583|NCT02576678|3480147|B1|||Age||Years|Mean|13.8|13.8|Standard Deviation|1.77|1.77|||
3632584|NCT02576639|3480181|B6||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3632585|NCT02576639|3480182|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3632586|NCT02576639|3480183|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3632587|NCT02576639|3480184|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3632588|NCT02576639|3480185|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3632589|NCT02576639|3480186|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3632590|NCT02576639|3480181|B6||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3632591|NCT02576639|3480182|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3632592|NCT02576639|3480183|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3632593|NCT02576639|3480184|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3632594|NCT02576639|3480185|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3632595|NCT02576639|3480186|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3632596|NCT02576639|3480181|B6|||Age||Years|Mean|66.3|66.3|Standard Deviation|4.9|4.9|||
3632597|NCT02576639|3480182|B5|||Age||Years|Mean|66.5|66.5|Standard Deviation|5.2|5.2|||
3632598|NCT02576639|3480183|B4|||Age||Years|Mean|66.1|66.1|Standard Deviation|4.6|4.6|||
3632599|NCT02576639|3480184|B3|||Age||Years|Mean|66.8|66.8|Standard Deviation|5.1|5.1|||
3632600|NCT02576639|3480185|B2|||Age||Years|Mean|65.4|65.4|Standard Deviation|4.6|4.6|||
3632601|NCT02576639|3480186|B1|||Age||Years|Mean|66.6|66.6|Standard Deviation|5.3|5.3|||
3632602|NCT02576587|3480247|B3|||Any use of antihypertension medications|Medications included Ace Inhibitors, Antihypertensive, Alpha-2 Blocker, Beta-Blocker, Calcium blocker, Diuretic and Nitrates.|Participants|Count of Participants|190|190.0||||||
3632603|NCT02576587|3480248|B2|||Any use of antihypertension medications|Medications included Ace Inhibitors, Antihypertensive, Alpha-2 Blocker, Beta-Blocker, Calcium blocker, Diuretic and Nitrates.|Participants|Count of Participants|69|69.0||||||
3632604|NCT02576587|3480249|B1|||Any use of antihypertension medications|Medications included Ace Inhibitors, Antihypertensive, Alpha-2 Blocker, Beta-Blocker, Calcium blocker, Diuretic and Nitrates.|Participants|Count of Participants|121|121.0||||||
3632605|NCT02576587|3480247|B3|||Use of beta blocker||Participants|Count of Participants|120|120.0||||||
3632606|NCT02576587|3480248|B2|||Use of beta blocker||Participants|Count of Participants|35|35.0||||||
3632607|NCT02576587|3480249|B1|||Use of beta blocker||Participants|Count of Participants|85|85.0||||||
3632608|NCT02576587|3480247|B3|||Use of Calcium blocker||Participants|Count of Participants|28|28.0||||||
3632609|NCT02576587|3480248|B2|||Use of Calcium blocker||Participants|Count of Participants|8|8.0||||||
3632610|NCT02576587|3480249|B1|||Use of Calcium blocker||Participants|Count of Participants|20|20.0||||||
3632611|NCT02576587|3480247|B3|||Diabetes||Participants|Count of Participants|42|42.0||||||
3632612|NCT02576587|3480248|B2|||Diabetes||Participants|Count of Participants|23|23.0||||||
3632613|NCT02576587|3480249|B1|||Diabetes||Participants|Count of Participants|19|19.0||||||
3632614|NCT02576587|3480247|B3|||Depression||Participants|Count of Participants|57|57.0||||||
3632615|NCT02576587|3480248|B2|||Depression||Participants|Count of Participants|35|35.0||||||
3632616|NCT02576587|3480249|B1|||Depression||Participants|Count of Participants|22|22.0||||||
3632617|NCT02576587|3480247|B3|||History of heart attack||Participants|Count of Participants|25|25.0||||||
3632618|NCT02576587|3480248|B2|||History of heart attack||Participants|Count of Participants|16|16.0||||||
3632619|NCT02576587|3480249|B1|||History of heart attack||Participants|Count of Participants|9|9.0||||||
3632620|NCT02576587|3480247|B3|||High Blood cholesterol||Participants|Count of Participants|177|177.0||||||
3632621|NCT02576587|3480248|B2|||High Blood cholesterol||Participants|Count of Participants|91|91.0||||||
3632622|NCT02576587|3480249|B1|||High Blood cholesterol||Participants|Count of Participants|86|86.0||||||
3632623|NCT02576587|3480247|B3|||High Blood Pressure or Hypertension||Participants|Count of Participants|166|166.0||||||
3632624|NCT02576587|3480248|B2|||High Blood Pressure or Hypertension||Participants|Count of Participants|79|79.0||||||
3632625|NCT02576587|3480249|B1|||High Blood Pressure or Hypertension||Participants|Count of Participants|87|87.0||||||
3632626|NCT02576587|3480247|B3|||Left Atrial Systolic Strain by apical two-chamber (A2C) view|Left atrial systolic strain, a measure of left atrial remodeling which is inversely related to fibrosis in PAF, is measured by 2-dimensional echocardiography. Apical four-chamber and two-chamber views are the most commonly used approaches to measure the strain rate (%) of left atrial.|percent of left atrial volume|Median|35|35.0|Inter-Quartile Range|||29.0|42.0|
3632627|NCT02576587|3480248|B2|||Left Atrial Systolic Strain by apical two-chamber (A2C) view|Left atrial systolic strain, a measure of left atrial remodeling which is inversely related to fibrosis in PAF, is measured by 2-dimensional echocardiography. Apical four-chamber and two-chamber views are the most commonly used approaches to measure the strain rate (%) of left atrial.|percent of left atrial volume|Median|35|35.0|Inter-Quartile Range|||29.0|43.0|
3632628|NCT02576587|3480249|B1|||Left Atrial Systolic Strain by apical two-chamber (A2C) view|Left atrial systolic strain, a measure of left atrial remodeling which is inversely related to fibrosis in PAF, is measured by 2-dimensional echocardiography. Apical four-chamber and two-chamber views are the most commonly used approaches to measure the strain rate (%) of left atrial.|percent of left atrial volume|Median|34|34.0|Inter-Quartile Range|||29.0|41.0|
3632629|NCT02576587|3480247|B3|||Left Atrial Systolic Strain by apical four-chamber (A4C) view|Left atrial systolic strain, a measure of left atrial remodeling which is inversely related to fibrosis in PAF, is measured by 2-dimensional echocardiography. Apical four-chamber and two-chamber views are the most commonly used approaches to measure the strain rate (%) of left atrial.|percent of left atrial volume|Median|33|33.0|Inter-Quartile Range|||27.0|41.0|
3632630|NCT02576587|3480248|B2|||Left Atrial Systolic Strain by apical four-chamber (A4C) view|Left atrial systolic strain, a measure of left atrial remodeling which is inversely related to fibrosis in PAF, is measured by 2-dimensional echocardiography. Apical four-chamber and two-chamber views are the most commonly used approaches to measure the strain rate (%) of left atrial.|percent of left atrial volume|Median|33|33.0|Inter-Quartile Range|||27.0|41.0|
3632631|NCT02576587|3480249|B1|||Left Atrial Systolic Strain by apical four-chamber (A4C) view|Left atrial systolic strain, a measure of left atrial remodeling which is inversely related to fibrosis in PAF, is measured by 2-dimensional echocardiography. Apical four-chamber and two-chamber views are the most commonly used approaches to measure the strain rate (%) of left atrial.|percent of left atrial volume|Median|34|34.0|Inter-Quartile Range|||25.0|40.0|
3632632|NCT02576587|3480247|B3|||Left Atrial Volume Index|"Increased left atrial volume and strain are known risk factors of AF and PAF. Left atrial volume index (LAVI) is left atrial size indexed to Body surface area (BSA). The reference range of LAVI is 16-28 mL/m^2.~Mildly abnormal: 29-33 mL/m^2; Moderately abnormal: 34-39 mL/m^2; Severely abnormal: greater than or equal to 40 mL/m^2."|mL/m^2|Median|29|29.0|Inter-Quartile Range|||23.0|35.0|
3632633|NCT02576587|3480248|B2|||Left Atrial Volume Index|"Increased left atrial volume and strain are known risk factors of AF and PAF. Left atrial volume index (LAVI) is left atrial size indexed to Body surface area (BSA). The reference range of LAVI is 16-28 mL/m^2.~Mildly abnormal: 29-33 mL/m^2; Moderately abnormal: 34-39 mL/m^2; Severely abnormal: greater than or equal to 40 mL/m^2."|mL/m^2|Median|28|28.0|Inter-Quartile Range|||22.0|33.0|
3632634|NCT02576587|3480249|B1|||Left Atrial Volume Index|"Increased left atrial volume and strain are known risk factors of AF and PAF. Left atrial volume index (LAVI) is left atrial size indexed to Body surface area (BSA). The reference range of LAVI is 16-28 mL/m^2.~Mildly abnormal: 29-33 mL/m^2; Moderately abnormal: 34-39 mL/m^2; Severely abnormal: greater than or equal to 40 mL/m^2."|mL/m^2|Median|30|30.0|Inter-Quartile Range|||23.0|37.0|
3632635|NCT02576587|3480247|B3|||Left Atrial Volume|Increased left atrial volume and strain are known risk factors of AF and PAF.|mL|Median|60|60.0|Inter-Quartile Range|||46.0|75.0|
3632636|NCT02576587|3480248|B2|||Left Atrial Volume|Increased left atrial volume and strain are known risk factors of AF and PAF.|mL|Median|51|51.0|Inter-Quartile Range|||45.0|71.0|
3632637|NCT02576587|3480249|B1|||Left Atrial Volume|Increased left atrial volume and strain are known risk factors of AF and PAF.|mL|Median|63|63.0|Inter-Quartile Range|||48.0|77.0|
3632638|NCT02576587|3480247|B3|||Percent sleep time with oxygen saturation<90%||percent of sleep time|Median|0.4|0.4|Inter-Quartile Range|||0.0|3.0|
3632639|NCT02576587|3480248|B2|||Percent sleep time with oxygen saturation<90%||percent of sleep time|Median|0.4|0.4|Inter-Quartile Range|||0.0|2.0|
3632640|NCT02576587|3480249|B1|||Percent sleep time with oxygen saturation<90%||percent of sleep time|Median|0.4|0.4|Inter-Quartile Range|||0.0|3.0|
3632641|NCT02576587|3480247|B3|||Central Apnea Index|"Central apnea index (CAI) equals number of central apneas divided by sleep duration in hours. Greater central apnea index indicates higher severity of sleep apnea. It has a lower limit zero, but no upper limit. The CAI values for adults are categorized as:~Normal: CAI<5; Mild sleep apnea: CAI greater than or equal to 5 and <15; Moderate sleep apnea: CAI greater than or equal to 15 and <30; Severe sleep apnea: any CAI value greater than or equal to 30."|Central apneas per hour|Median|0|0.0|Inter-Quartile Range|||0.0|0.4|
3632642|NCT02576587|3480248|B2|||Central Apnea Index|"Central apnea index (CAI) equals number of central apneas divided by sleep duration in hours. Greater central apnea index indicates higher severity of sleep apnea. It has a lower limit zero, but no upper limit. The CAI values for adults are categorized as:~Normal: CAI<5; Mild sleep apnea: CAI greater than or equal to 5 and <15; Moderate sleep apnea: CAI greater than or equal to 15 and <30; Severe sleep apnea: any CAI value greater than or equal to 30."|Central apneas per hour|Median|0|0.0|Inter-Quartile Range|||0.0|0.4|
3632643|NCT02576587|3480249|B1|||Central Apnea Index|"Central apnea index (CAI) equals number of central apneas divided by sleep duration in hours. Greater central apnea index indicates higher severity of sleep apnea. It has a lower limit zero, but no upper limit. The CAI values for adults are categorized as:~Normal: CAI<5; Mild sleep apnea: CAI greater than or equal to 5 and <15; Moderate sleep apnea: CAI greater than or equal to 15 and <30; Severe sleep apnea: any CAI value greater than or equal to 30."|Central apneas per hour|Median|0|0.0|Inter-Quartile Range|||0.0|0.4|
3632644|NCT02576587|3480247|B3|||Arousal Index|Arousal index (AI) equals number of arousals divided by sleep duration in hours. Arousals are interruptions of sleep lasting 3 to 15 seconds, spontaneously or as a result of sleep disordered breathing or other sleep disorders. It has a lower limit zero, but no upper limit. The range of AI for adults varies by age, e.g. 10-12/hour are normal at age 20, 20-22/hour are normal at age 50-60.|Arousals per hour|Median|19|19.0|Inter-Quartile Range|||13.0|27.0|
3632645|NCT02576587|3480248|B2|||Arousal Index|Arousal index (AI) equals number of arousals divided by sleep duration in hours. Arousals are interruptions of sleep lasting 3 to 15 seconds, spontaneously or as a result of sleep disordered breathing or other sleep disorders. It has a lower limit zero, but no upper limit. The range of AI for adults varies by age, e.g. 10-12/hour are normal at age 20, 20-22/hour are normal at age 50-60.|Arousals per hour|Median|19|19.0|Inter-Quartile Range|||13.0|28.0|
3632646|NCT02576587|3480249|B1|||Arousal Index|Arousal index (AI) equals number of arousals divided by sleep duration in hours. Arousals are interruptions of sleep lasting 3 to 15 seconds, spontaneously or as a result of sleep disordered breathing or other sleep disorders. It has a lower limit zero, but no upper limit. The range of AI for adults varies by age, e.g. 10-12/hour are normal at age 20, 20-22/hour are normal at age 50-60.|Arousals per hour|Median|18|18.0|Inter-Quartile Range|||13.0|26.0|
3632693|NCT02576587|3480248|B2|||Age||years|Mean|62|62.0|Standard Deviation|12|12.0|||
3632694|NCT02576587|3480249|B1|||Age||years|Mean|61|61.0|Standard Deviation|12|12.0|||
3632695|NCT02576535|3480268|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3632696|NCT02576535|3480268|B1|White, not of Hispanic-American Origin||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3632647|NCT02576587|3480247|B3|||Apnea Hypopnea Index (AHI)|"AHI equals number of apnea and hypopnea breathing pauses divided by sleep duration in hours. It has a lower limit zero, but no upper limit. Greater AHI indicates higher severity of sleep apnea. The AHI values for adults are categorized as:~Normal: AHI<5; Mild sleep apnea: AHI greater than or equal to 5 and <15; Moderate sleep apnea: AHI greater than or equal to 15 and <30; Severe sleep apnea: any AHI value greater than or equal to 30.~In this study, cases having AHI greater than or equal to 15 qualifies for follow-up."|apneas plus hypopneas per hour|Median|12|12.0|Inter-Quartile Range|||4.0|24.0|
3632648|NCT02576587|3480248|B2|||Apnea Hypopnea Index (AHI)|"AHI equals number of apnea and hypopnea breathing pauses divided by sleep duration in hours. It has a lower limit zero, but no upper limit. Greater AHI indicates higher severity of sleep apnea. The AHI values for adults are categorized as:~Normal: AHI<5; Mild sleep apnea: AHI greater than or equal to 5 and <15; Moderate sleep apnea: AHI greater than or equal to 15 and <30; Severe sleep apnea: any AHI value greater than or equal to 30.~In this study, cases having AHI greater than or equal to 15 qualifies for follow-up."|apneas plus hypopneas per hour|Median|13|13.0|Inter-Quartile Range|||4.0|24.0|
3632649|NCT02576587|3480249|B1|||Apnea Hypopnea Index (AHI)|"AHI equals number of apnea and hypopnea breathing pauses divided by sleep duration in hours. It has a lower limit zero, but no upper limit. Greater AHI indicates higher severity of sleep apnea. The AHI values for adults are categorized as:~Normal: AHI<5; Mild sleep apnea: AHI greater than or equal to 5 and <15; Moderate sleep apnea: AHI greater than or equal to 15 and <30; Severe sleep apnea: any AHI value greater than or equal to 30.~In this study, cases having AHI greater than or equal to 15 qualifies for follow-up."|apneas plus hypopneas per hour|Median|11|11.0|Inter-Quartile Range|||4.0|24.0|
3632650|NCT02576587|3480247|B3|||Body Mass Index||kg/m^2|Mean|31|31.0|Standard Deviation|7|7.0|||
3632651|NCT02576587|3480248|B2|||Body Mass Index||kg/m^2|Mean|32|32.0|Standard Deviation|7|7.0|||
3632652|NCT02576587|3480249|B1|||Body Mass Index||kg/m^2|Mean|31|31.0|Standard Deviation|7|7.0|||
3632653|NCT02576587|3480247|B3|United States||Region of Enrollment||participants|Number|300|300.0||||||
3632654|NCT02576587|3480248|B2|United States||Region of Enrollment||participants|Number|150|150.0||||||
3632655|NCT02576587|3480249|B1|United States||Region of Enrollment||participants|Number|150|150.0||||||
3632656|NCT02576587|3480247|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632657|NCT02576587|3480248|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632658|NCT02576587|3480249|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632659|NCT02576587|3480247|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3632660|NCT02576587|3480248|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3632661|NCT02576587|3480249|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3632662|NCT02576587|3480247|B3||White|Race (NIH/OMB)||Participants|Count of Participants|250|250.0||||||
3632663|NCT02576587|3480248|B2||White|Race (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
3632664|NCT02576587|3480249|B1||White|Race (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
3632665|NCT02576587|3480247|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3632666|NCT02576587|3480248|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3632667|NCT02576587|3480249|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3632668|NCT02576587|3480247|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632669|NCT02576587|3480248|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632670|NCT02576587|3480249|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632671|NCT02576587|3480247|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3632672|NCT02576587|3480248|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3632673|NCT02576587|3480249|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3632674|NCT02576587|3480247|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632675|NCT02576587|3480248|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632676|NCT02576587|3480249|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632677|NCT02576587|3480247|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632678|NCT02576587|3480248|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632679|NCT02576587|3480249|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632680|NCT02576587|3480247|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|298|298.0||||||
3632681|NCT02576587|3480248|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|149|149.0||||||
3632682|NCT02576587|3480249|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|149|149.0||||||
3632683|NCT02576587|3480247|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3632684|NCT02576587|3480248|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3632685|NCT02576587|3480249|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3632686|NCT02576587|3480247|B3||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
3632687|NCT02576587|3480248|B2||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3632688|NCT02576587|3480249|B1||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3632689|NCT02576587|3480247|B3||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3632690|NCT02576587|3480248|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3632691|NCT02576587|3480249|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3632697|NCT02576535|3480268|B1|Hispanic-American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3632698|NCT02576535|3480268|B1|Black, not of Hispanic-American Origin||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3632699|NCT02576535|3480268|B1|Asian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3632700|NCT02576535|3480268|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3632701|NCT02576535|3480268|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3632702|NCT02576535|3480268|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3632703|NCT02576535|3480268|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3632704|NCT02576535|3480268|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3632705|NCT02576249|3480277|B3|No||Knee Effusion|Knee effusion, colloquially known as water on the knee, occurs when excess fluid accumulates in or around the knee joint.|Participants|Count of Participants|20|20.0||||||
3632706|NCT02576249|3480278|B2|No||Knee Effusion|Knee effusion, colloquially known as water on the knee, occurs when excess fluid accumulates in or around the knee joint.|Participants|Count of Participants|10|10.0||||||
3632707|NCT02576249|3480279|B1|No||Knee Effusion|Knee effusion, colloquially known as water on the knee, occurs when excess fluid accumulates in or around the knee joint.|Participants|Count of Participants|10|10.0||||||
3632708|NCT02576249|3480277|B3|Yes||Knee Effusion|Knee effusion, colloquially known as water on the knee, occurs when excess fluid accumulates in or around the knee joint.|Participants|Count of Participants|9|9.0||||||
3632709|NCT02576249|3480278|B2|Yes||Knee Effusion|Knee effusion, colloquially known as water on the knee, occurs when excess fluid accumulates in or around the knee joint.|Participants|Count of Participants|4|4.0||||||
3632710|NCT02576249|3480279|B1|Yes||Knee Effusion|Knee effusion, colloquially known as water on the knee, occurs when excess fluid accumulates in or around the knee joint.|Participants|Count of Participants|5|5.0||||||
3632711|NCT02576249|3480277|B3|||Body Mass Index (BMI)||kg/m^2|Mean|30.4|30.4|Standard Deviation|7.01|7.01|||
3632712|NCT02576249|3480278|B2|||Body Mass Index (BMI)||kg/m^2|Mean|30.9|30.9|Standard Deviation|6.46|6.46|||
3632713|NCT02576249|3480279|B1|||Body Mass Index (BMI)||kg/m^2|Mean|29.9|29.9|Standard Deviation|7.68|7.68|||
3632714|NCT02576249|3480277|B3|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3632715|NCT02576249|3480278|B2|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3632716|NCT02576249|3480279|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3632717|NCT02576249|3480277|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3632718|NCT02576249|3480278|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3632719|NCT02576249|3480279|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3632720|NCT02576249|3480277|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3632721|NCT02576249|3480278|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3632722|NCT02576249|3480279|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3632723|NCT02576249|3480277|B3|||Age||years|Mean|57|57.0|Standard Deviation|9.58|9.58|||
3632724|NCT02576249|3480278|B2|||Age||years|Mean|57|57.0|Standard Deviation|11.8|11.8|||
3632725|NCT02576249|3480279|B1|||Age||years|Mean|57|57.0|Standard Deviation|7.43|7.43|||
3632726|NCT02576145|3480290|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3632727|NCT02576145|3480291|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3632728|NCT02576145|3480292|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3632729|NCT02576145|3480290|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3632730|NCT02576145|3480291|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3632731|NCT02576145|3480292|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3632732|NCT02576145|3480290|B3|||Age||years|Mean|12.2|12.2|Standard Deviation|4.87|4.87|||
3632733|NCT02576145|3480291|B2|||Age||years|Mean|12.6|12.6|Standard Deviation|4.16|4.16|||
3632734|NCT02576145|3480292|B1|||Age||years|Mean|11.8|11.8|Standard Deviation|5.78|5.78|||
3632735|NCT02576041|3480329|B1|Italy||Region of Enrollment||participants|Number|18|18.0||||||
3632736|NCT02576041|3480329|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632737|NCT02576041|3480329|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632738|NCT02576041|3480329|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3632739|NCT02576041|3480329|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632740|NCT02576041|3480329|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632741|NCT02576041|3480329|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632742|NCT02576041|3480329|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632743|NCT02576041|3480329|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632744|NCT02576041|3480329|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632745|NCT02576041|3480329|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3632746|NCT02576041|3480329|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3632747|NCT02576041|3480329|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3632748|NCT02576041|3480329|B1|||Age||years|Mean|38.4|38.4|Standard Deviation|7.3|7.3|||
3632749|NCT02575911|3480335|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3632750|NCT02575911|3480335|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3632751|NCT02575911|3480335|B1|||Age||years|Mean|34.5|34.5|Standard Deviation|11.0|11.0|||
3632752|NCT02575833|3480353|B3||≥ 7 minutes|Stratification Factor: Total Exercise Time||Participants|Count of Participants|53|53.0||||||
3632753|NCT02575833|3480354|B2||≥ 7 minutes|Stratification Factor: Total Exercise Time||Participants|Count of Participants|27|27.0||||||
3632754|NCT02575833|3480355|B1||≥ 7 minutes|Stratification Factor: Total Exercise Time||Participants|Count of Participants|26|26.0||||||
3632755|NCT02575833|3480353|B3||< 7 minutes|Stratification Factor: Total Exercise Time||Participants|Count of Participants|36|36.0||||||
3632756|NCT02575833|3480354|B2||< 7 minutes|Stratification Factor: Total Exercise Time||Participants|Count of Participants|18|18.0||||||
3632757|NCT02575833|3480355|B1||< 7 minutes|Stratification Factor: Total Exercise Time||Participants|Count of Participants|18|18.0||||||
3632758|NCT02575833|3480353|B3|||Baseline Total Exercise Time|"Total exercise time (TET) was assessed using an exercise treadmill test according to the standard Bruce protocol.~The Bruce protocol is a standardized multistage treadmill test for assessing cardiovascular health, where the participant walks on an uphill treadmill in a graded exercise test with electrodes on the chest to monitor cardiac function. Every 3 minutes, the speed and incline of the treadmill are increased. There are 7 such stages for a total possible exercise time of 21 minutes."|seconds|Mean|482.7|482.7|Standard Deviation|148.9|148.9|||
3632759|NCT02575833|3480354|B2|||Baseline Total Exercise Time|"Total exercise time (TET) was assessed using an exercise treadmill test according to the standard Bruce protocol.~The Bruce protocol is a standardized multistage treadmill test for assessing cardiovascular health, where the participant walks on an uphill treadmill in a graded exercise test with electrodes on the chest to monitor cardiac function. Every 3 minutes, the speed and incline of the treadmill are increased. There are 7 such stages for a total possible exercise time of 21 minutes."|seconds|Mean|490.7|490.7|Standard Deviation|149.7|149.7|||
3632760|NCT02575833|3480355|B1|||Baseline Total Exercise Time|"Total exercise time (TET) was assessed using an exercise treadmill test according to the standard Bruce protocol.~The Bruce protocol is a standardized multistage treadmill test for assessing cardiovascular health, where the participant walks on an uphill treadmill in a graded exercise test with electrodes on the chest to monitor cardiac function. Every 3 minutes, the speed and incline of the treadmill are increased. There are 7 such stages for a total possible exercise time of 21 minutes."|seconds|Mean|474.8|474.8|Standard Deviation|149.5|149.5|||
3632761|NCT02575833|3480353|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3632762|NCT02575833|3480354|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3632763|NCT02575833|3480355|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3632764|NCT02575833|3480353|B3||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3632765|NCT02575833|3480354|B2||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3632766|NCT02575833|3480355|B1||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3632767|NCT02575833|3480353|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|80|80.0||||||
3632768|NCT02575833|3480354|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
3632769|NCT02575833|3480355|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
3632770|NCT02575833|3480353|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3632771|NCT02575833|3480354|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3632772|NCT02575833|3480355|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3632773|NCT02575833|3480353|B3||Black (or African American)|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3632774|NCT02575833|3480354|B2||Black (or African American)|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3632775|NCT02575833|3480355|B1||Black (or African American)|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3632776|NCT02575833|3480353|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3632777|NCT02575833|3480354|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3632778|NCT02575833|3480355|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3632779|NCT02575833|3480353|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3632780|NCT02575833|3480354|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3632781|NCT02575833|3480355|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3632782|NCT02575833|3480353|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632783|NCT02575833|3480354|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632784|NCT02575833|3480355|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632785|NCT02575833|3480353|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
3632786|NCT02575833|3480354|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3632787|NCT02575833|3480355|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3632788|NCT02575833|3480353|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3632789|NCT02575833|3480354|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3632790|NCT02575833|3480355|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3632791|NCT02575833|3480353|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3632792|NCT02575833|3480354|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3632793|NCT02575833|3480355|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3632794|NCT02575833|3480353|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3632795|NCT02575833|3480354|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3632797|NCT02575833|3480353|B3||65 - 85 years|Age, Customized||Participants|Count of Participants|45|45.0||||||
3632798|NCT02575833|3480354|B2||65 - 85 years|Age, Customized||Participants|Count of Participants|22|22.0||||||
3632799|NCT02575833|3480355|B1||65 - 85 years|Age, Customized||Participants|Count of Participants|23|23.0||||||
3632800|NCT02575833|3480353|B3||18 - < 65 years|Age, Customized||Participants|Count of Participants|44|44.0||||||
3632801|NCT02575833|3480354|B2||18 - < 65 years|Age, Customized||Participants|Count of Participants|23|23.0||||||
3632802|NCT02575833|3480355|B1||18 - < 65 years|Age, Customized||Participants|Count of Participants|21|21.0||||||
3632803|NCT02575833|3480353|B3|||Age||years|Mean|62.6|62.6|Standard Deviation|9.9|9.9|||
3632804|NCT02575833|3480354|B2|||Age||years|Mean|61.8|61.8|Standard Deviation|10.1|10.1|||
3632805|NCT02575833|3480355|B1|||Age||years|Mean|63.5|63.5|Standard Deviation|9.6|9.6|||
3632806|NCT02574858|3480366|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3632807|NCT02574858|3480366|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632808|NCT02574858|3480366|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632809|NCT02574858|3480366|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3632810|NCT02574858|3480366|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3632811|NCT02574858|3480366|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632812|NCT02574858|3480366|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3632813|NCT02574858|3480366|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632814|NCT02574858|3480366|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632815|NCT02574858|3480366|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3632816|NCT02574858|3480366|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632817|NCT02574858|3480366|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3632818|NCT02574858|3480366|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3632819|NCT02574858|3480366|B1|Ages of Participants|60-69 years|Age, Customized||Participants|Count of Participants|6|6.0||||||
3632820|NCT02574858|3480366|B1|Ages of Participants|50-59 years|Age, Customized||Participants|Count of Participants|8|8.0||||||
3632821|NCT02574858|3480366|B1|Ages of Participants|40-49 years|Age, Customized||Participants|Count of Participants|5|5.0||||||
3632822|NCT02574858|3480366|B1|Ages of Participants|30-39 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
3632823|NCT02574858|3480366|B1|Ages of Participants|22-29 years|Age, Customized||Participants|Count of Participants|4|4.0||||||
3632824|NCT02574845|3480371|B7||Male|Gender||Participants|Count of Participants|18|18.0||||||
3632825|NCT02574845|3480372|B6||Male|Gender||Participants|Count of Participants|3|3.0||||||
3632826|NCT02574845|3480373|B5||Male|Gender||Participants|Count of Participants|3|3.0||||||
3632827|NCT02574845|3480374|B4||Male|Gender||Participants|Count of Participants|3|3.0||||||
3632828|NCT02574845|3480375|B3||Male|Gender||Participants|Count of Participants|3|3.0||||||
3632829|NCT02574845|3480376|B2||Male|Gender||Participants|Count of Participants|3|3.0||||||
3632830|NCT02574845|3480377|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
3632831|NCT02574845|3480371|B7||Female|Gender||Participants|Count of Participants|0|0.0||||||
3632832|NCT02574845|3480372|B6||Female|Gender||Participants|Count of Participants|0|0.0||||||
3632833|NCT02574845|3480373|B5||Female|Gender||Participants|Count of Participants|0|0.0||||||
3632834|NCT02574845|3480374|B4||Female|Gender||Participants|Count of Participants|0|0.0||||||
3632835|NCT02574845|3480375|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
3632836|NCT02574845|3480376|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
3632837|NCT02574845|3480377|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3632838|NCT02574845|3480371|B7|||Age||years|Mean|31.9|31.9|Standard Deviation|10.0|10.0|||
3632839|NCT02574845|3480372|B6|||Age||years|Mean|37.3|37.3|Standard Deviation|12.9|12.9|||
3632840|NCT02574845|3480373|B5|||Age||years|Mean|22.0|22.0|Standard Deviation|2.6|2.6|||
3632841|NCT02574845|3480374|B4|||Age||years|Mean|32.0|32.0|Standard Deviation|14.1|14.1|||
3632842|NCT02574845|3480375|B3|||Age||years|Mean|39.3|39.3|Standard Deviation|10.3|10.3|||
3632843|NCT02574845|3480376|B2|||Age||years|Mean|33.0|33.0|Standard Deviation|8.7|8.7|||
3632844|NCT02574845|3480377|B1|||Age||years|Mean|28.0|28.0|Standard Deviation|2.6|2.6|||
3632845|NCT02574832|3480408|B1|||Number of times pregnant||Number of pregnancies|Mean|4|4.0|Full Range|||3.0|5.0|
3632846|NCT02574832|3480408|B1|||Estimated Gestational Age||weeks|Mean|13.3|13.3|Full Range|||12.6|14.0|
3632847|NCT02574832|3480408|B1|||Baseline diastolic blood pressure||millimeters of mercury|Mean|60|60.0|Full Range|||57.0|63.0|
3632848|NCT02574832|3480408|B1|||Baseline systolic blood pressure||millimeters of mercury|Mean|111.5|111.5|Full Range|||107.0|116.0|
3632849|NCT02574832|3480408|B1|||Baseline heart rate||Beats per minute|Mean|73|73.0|Full Range|||65.0|82.0|
3632850|NCT02574832|3480408|B1|History of previous loss||Indication for cerclage||Participants|Count of Participants|1|1.0||||||
3632851|NCT02574832|3480408|B1|Cervical Incompetence||Indication for cerclage||Participants|Count of Participants|1|1.0||||||
3632852|NCT02574832|3480408|B1|||Number of live births||Number of live births|Mean|1|1.0|Full Range|||1.0|1.0|
3632853|NCT02574832|3480408|B1|||Weight||Kilograms|Mean|54.1|54.1|Full Range|||48.1|60.1|
3632854|NCT02574832|3480408|B1|||Height||centimeters|Mean|163.5|163.5|Full Range|||162.0|165.0|
3632855|NCT02574832|3480408|B1|United States||Region of Enrollment||count of participants|Number|2|2.0||||||
3632856|NCT02574832|3480408|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632857|NCT02574832|3480408|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632858|NCT02574832|3480408|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3632859|NCT02574832|3480408|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632860|NCT02574832|3480408|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632861|NCT02574832|3480408|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632862|NCT02574832|3480408|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632863|NCT02574832|3480408|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3632864|NCT02574832|3480408|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3632865|NCT02574832|3480408|B1|||Age||Years|Mean|34|34.0|Full Range|||30.0|38.0|
3632866|NCT02574832|3480408|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3632867|NCT02574832|3480408|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3632868|NCT02574832|3480408|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3632869|NCT02574260|3480412|B1|Stage IVM1c||Tumor, Node, Metastasis (TNM) Disease Stage|Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥ 4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs; normal LDH level; M1c: Spread to all other visceral organs, normal LDH level or any distant disease with elevated LDH level.|participants|Number|1|1.0||||||
3632870|NCT02574260|3480412|B1|Stage IVM1b||Tumor, Node, Metastasis (TNM) Disease Stage|Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥ 4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs; normal LDH level; M1c: Spread to all other visceral organs, normal LDH level or any distant disease with elevated LDH level.|participants|Number|0|0.0||||||
3632871|NCT02574260|3480412|B1|Stage IVM1a||Tumor, Node, Metastasis (TNM) Disease Stage|Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥ 4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs; normal LDH level; M1c: Spread to all other visceral organs, normal LDH level or any distant disease with elevated LDH level.|participants|Number|1|1.0||||||
3632872|NCT02574260|3480412|B1|Stage IIIC||Tumor, Node, Metastasis (TNM) Disease Stage|Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥ 4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs; normal LDH level; M1c: Spread to all other visceral organs, normal LDH level or any distant disease with elevated LDH level.|participants|Number|1|1.0||||||
3632873|NCT02574260|3480412|B1|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|1|1.0||||||
3632874|NCT02574260|3480412|B1|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|2|2.0||||||
3632875|NCT02574260|3480412|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3632876|NCT02574260|3480412|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3632877|NCT02574260|3480412|B1|||Age||years|Median|62|62.0|Full Range|||58.0|79.0|
3632878|NCT02574260|3480412|B1||>=65 years|Age|Baseline measure data are from the beginning of the 002/03 study.|Participants|Count of Participants|1|1.0||||||
3632879|NCT02574260|3480412|B1||Between 18 and 65 years|Age|Baseline measure data are from the beginning of the 002/03 study.|Participants|Count of Participants|2|2.0||||||
3632880|NCT02574260|3480412|B1||<=18 years|Age|Baseline measure data are from the beginning of the 002/03 study.|Participants|Count of Participants|0|0.0||||||
3632881|NCT02574247|3480418|B4|IEEE at -3 dB SNR||Performance on Untrained Speech Perception Tasks|Results obtained on Coordinate Response Measure (CRM) task and Institute of Electrical and Electronics Engineers (IEEE) sentences. CRM and IEEE tasks presented at two decibel signal-to-noise ratios (dB SNR). Results are displayed in percentage correct.|Percentage correct|Median|56|56.0|Full Range|||12.0|80.0|
3632882|NCT02574247|3480419|B3|IEEE at -3 dB SNR||Performance on Untrained Speech Perception Tasks|Results obtained on Coordinate Response Measure (CRM) task and Institute of Electrical and Electronics Engineers (IEEE) sentences. CRM and IEEE tasks presented at two decibel signal-to-noise ratios (dB SNR). Results are displayed in percentage correct.|Percentage correct|Median|47|47.0|Full Range|||16.0|57.0|
3632883|NCT02574247|3480420|B2|IEEE at -3 dB SNR||Performance on Untrained Speech Perception Tasks|Results obtained on Coordinate Response Measure (CRM) task and Institute of Electrical and Electronics Engineers (IEEE) sentences. CRM and IEEE tasks presented at two decibel signal-to-noise ratios (dB SNR). Results are displayed in percentage correct.|Percentage correct|Median|56|56.0|Full Range|||12.0|80.0|
3632909|NCT02574247|3480418|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3632884|NCT02574247|3480421|B1|IEEE at -3 dB SNR||Performance on Untrained Speech Perception Tasks|Results obtained on Coordinate Response Measure (CRM) task and Institute of Electrical and Electronics Engineers (IEEE) sentences. CRM and IEEE tasks presented at two decibel signal-to-noise ratios (dB SNR). Results are displayed in percentage correct.|Percentage correct|Median|62|62.0|Full Range|||14.0|78.0|
3632885|NCT02574247|3480418|B4|IEEE at -6 dB SNR||Performance on Untrained Speech Perception Tasks|Results obtained on Coordinate Response Measure (CRM) task and Institute of Electrical and Electronics Engineers (IEEE) sentences. CRM and IEEE tasks presented at two decibel signal-to-noise ratios (dB SNR). Results are displayed in percentage correct.|Percentage correct|Median|17|17.0|Full Range|||3.0|45.0|
3632886|NCT02574247|3480419|B3|IEEE at -6 dB SNR||Performance on Untrained Speech Perception Tasks|Results obtained on Coordinate Response Measure (CRM) task and Institute of Electrical and Electronics Engineers (IEEE) sentences. CRM and IEEE tasks presented at two decibel signal-to-noise ratios (dB SNR). Results are displayed in percentage correct.|Percentage correct|Median|17|17.0|Full Range|||12.0|25.0|
3632887|NCT02574247|3480420|B2|IEEE at -6 dB SNR||Performance on Untrained Speech Perception Tasks|Results obtained on Coordinate Response Measure (CRM) task and Institute of Electrical and Electronics Engineers (IEEE) sentences. CRM and IEEE tasks presented at two decibel signal-to-noise ratios (dB SNR). Results are displayed in percentage correct.|Percentage correct|Median|21|21.0|Full Range|||4.0|45.0|
3632888|NCT02574247|3480421|B1|IEEE at -6 dB SNR||Performance on Untrained Speech Perception Tasks|Results obtained on Coordinate Response Measure (CRM) task and Institute of Electrical and Electronics Engineers (IEEE) sentences. CRM and IEEE tasks presented at two decibel signal-to-noise ratios (dB SNR). Results are displayed in percentage correct.|Percentage correct|Median|14|14.0|Full Range|||3.0|36.0|
3632889|NCT02574247|3480418|B4|CRM at -6 dB SNR||Performance on Untrained Speech Perception Tasks|Results obtained on Coordinate Response Measure (CRM) task and Institute of Electrical and Electronics Engineers (IEEE) sentences. CRM and IEEE tasks presented at two decibel signal-to-noise ratios (dB SNR). Results are displayed in percentage correct.|Percentage correct|Median|62|62.0|Full Range|||36.0|74.0|
3632890|NCT02574247|3480419|B3|CRM at -6 dB SNR||Performance on Untrained Speech Perception Tasks|Results obtained on Coordinate Response Measure (CRM) task and Institute of Electrical and Electronics Engineers (IEEE) sentences. CRM and IEEE tasks presented at two decibel signal-to-noise ratios (dB SNR). Results are displayed in percentage correct.|Percentage correct|Median|62|62.0|Full Range|||44.0|66.0|
3632891|NCT02574247|3480420|B2|CRM at -6 dB SNR||Performance on Untrained Speech Perception Tasks|Results obtained on Coordinate Response Measure (CRM) task and Institute of Electrical and Electronics Engineers (IEEE) sentences. CRM and IEEE tasks presented at two decibel signal-to-noise ratios (dB SNR). Results are displayed in percentage correct.|Percentage correct|Median|58|58.0|Full Range|||52.0|74.0|
3632892|NCT02574247|3480421|B1|CRM at -6 dB SNR||Performance on Untrained Speech Perception Tasks|Results obtained on Coordinate Response Measure (CRM) task and Institute of Electrical and Electronics Engineers (IEEE) sentences. CRM and IEEE tasks presented at two decibel signal-to-noise ratios (dB SNR). Results are displayed in percentage correct.|Percentage correct|Median|62|62.0|Full Range|||36.0|74.0|
3632893|NCT02574247|3480418|B4|CRM at -9 dB SNR||Performance on Untrained Speech Perception Tasks|Results obtained on Coordinate Response Measure (CRM) task and Institute of Electrical and Electronics Engineers (IEEE) sentences. CRM and IEEE tasks presented at two decibel signal-to-noise ratios (dB SNR). Results are displayed in percentage correct.|Percentage correct|Median|28|28.0|Full Range|||8.0|56.0|
3632894|NCT02574247|3480419|B3|CRM at -9 dB SNR||Performance on Untrained Speech Perception Tasks|Results obtained on Coordinate Response Measure (CRM) task and Institute of Electrical and Electronics Engineers (IEEE) sentences. CRM and IEEE tasks presented at two decibel signal-to-noise ratios (dB SNR). Results are displayed in percentage correct.|Percentage correct|Median|28|28.0|Full Range|||8.0|38.0|
3632895|NCT02574247|3480420|B2|CRM at -9 dB SNR||Performance on Untrained Speech Perception Tasks|Results obtained on Coordinate Response Measure (CRM) task and Institute of Electrical and Electronics Engineers (IEEE) sentences. CRM and IEEE tasks presented at two decibel signal-to-noise ratios (dB SNR). Results are displayed in percentage correct.|Percentage correct|Median|26|26.0|Full Range|||20.0|56.0|
3632896|NCT02574247|3480421|B1|CRM at -9 dB SNR||Performance on Untrained Speech Perception Tasks|Results obtained on Coordinate Response Measure (CRM) task and Institute of Electrical and Electronics Engineers (IEEE) sentences. CRM and IEEE tasks presented at two decibel signal-to-noise ratios (dB SNR). Results are displayed in percentage correct.|Percentage correct|Median|28|28.0|Full Range|||18.0|42.0|
3632897|NCT02574247|3480418|B4|||Medial Olivocochlear Reflex Inhibition|Difference in transient-evoked otoacoustic emission magnitude (in decibels) obtained with versus without presence of contralateral noise.|decibels|Median|1.4|1.4|Full Range|||-0.01|5.1|
3632898|NCT02574247|3480419|B3|||Medial Olivocochlear Reflex Inhibition|Difference in transient-evoked otoacoustic emission magnitude (in decibels) obtained with versus without presence of contralateral noise.|decibels|Median|1.9|1.9|Full Range|||1.1|4.0|
3632899|NCT02574247|3480420|B2|||Medial Olivocochlear Reflex Inhibition|Difference in transient-evoked otoacoustic emission magnitude (in decibels) obtained with versus without presence of contralateral noise.|decibels|Median|0.6|0.6|Full Range|||-0.01|4.0|
3632900|NCT02574247|3480421|B1|||Medial Olivocochlear Reflex Inhibition|Difference in transient-evoked otoacoustic emission magnitude (in decibels) obtained with versus without presence of contralateral noise.|decibels|Median|1.4|1.4|Full Range|||0.8|5.1|
3632901|NCT02574247|3480418|B4|United States||Region of Enrollment||participants|Number|28|28.0||||||
3632902|NCT02574247|3480419|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3632903|NCT02574247|3480420|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3632904|NCT02574247|3480421|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3632905|NCT02574247|3480418|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3632906|NCT02574247|3480419|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632907|NCT02574247|3480420|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632908|NCT02574247|3480421|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3632910|NCT02574247|3480419|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3632911|NCT02574247|3480420|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632912|NCT02574247|3480421|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632913|NCT02574247|3480418|B4||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3632914|NCT02574247|3480419|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3632915|NCT02574247|3480420|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3632916|NCT02574247|3480421|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3632917|NCT02574247|3480418|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3632918|NCT02574247|3480419|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632919|NCT02574247|3480420|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3632920|NCT02574247|3480421|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3632921|NCT02574247|3480418|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632922|NCT02574247|3480419|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632923|NCT02574247|3480420|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632924|NCT02574247|3480421|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632925|NCT02574247|3480418|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3632926|NCT02574247|3480419|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632927|NCT02574247|3480420|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3632928|NCT02574247|3480421|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632929|NCT02574247|3480418|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632930|NCT02574247|3480419|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632931|NCT02574247|3480420|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632932|NCT02574247|3480421|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632933|NCT02574247|3480418|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632934|NCT02574247|3480419|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632935|NCT02574247|3480420|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632936|NCT02574247|3480421|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3632937|NCT02574247|3480418|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3632938|NCT02574247|3480419|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3632939|NCT02574247|3480420|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3632940|NCT02574247|3480421|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3632941|NCT02574247|3480418|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3632942|NCT02574247|3480419|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3632943|NCT02574247|3480420|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3632944|NCT02574247|3480421|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3632945|NCT02574247|3480418|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3632946|NCT02574247|3480419|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3632947|NCT02574247|3480420|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3632948|NCT02574247|3480421|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3632949|NCT02574247|3480418|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3632950|NCT02574247|3480419|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3632951|NCT02574247|3480420|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3632952|NCT02574247|3480421|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3632953|NCT02574247|3480418|B4|||Age||years|Mean|61.6|61.6|Standard Deviation|9.4|9.4|||
3632954|NCT02574247|3480419|B3|||Age||years|Mean|59.2|59.2|Standard Deviation|15.4|15.4|||
3632955|NCT02574247|3480420|B2|||Age||years|Mean|63.0|63.0|Standard Deviation|5.2|5.2|||
3632956|NCT02574247|3480421|B1|||Age||years|Mean|59.8|59.8|Standard Deviation|5.9|5.9|||
3632957|NCT02573948|3480435|B1|||HCV positive||Participants|Count of Participants|398|398.0||||||
3632958|NCT02573948|3480435|B1|||Currently under Methadone Maintenance Therapy||Participants|Count of Participants|36|36.0||||||
3632959|NCT02573948|3480435|B1|||HIV positive||Participants|Count of Participants|152|152.0||||||
3632960|NCT02573948|3480435|B1|||Injection with syringe already used by someone else (last 3 months)||Participants|Count of Participants|33|33.0||||||
3632961|NCT02573948|3480435|B1|||Injecting drug: heroin alone||Participants|Count of Participants|602|602.0||||||
3632962|NCT02573948|3480435|B1|||Number of drug injection (typical day)||injection per day|Mean|2.7|2.7|Standard Deviation|1|1.0|||
3632963|NCT02573948|3480435|B1|||Duration of Injection use||years|Median|8|8.0|Inter-Quartile Range|||4.0|13.0|
3632964|NCT02573948|3480435|B1|||Medical Insurance||Participants|Count of Participants|105|105.0||||||
3632965|NCT02573948|3480435|B1|Vietnam||Region of Enrollment||participants|Number|603|603.0||||||
3632966|NCT02573948|3480435|B1||Male|Sex: Female, Male||Participants|Count of Participants|542|542.0||||||
3632967|NCT02573948|3480435|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3632968|NCT02573948|3480435|B1|||Age||years|Mean|36.5|36.5|Standard Deviation|8.4|8.4|||
3632969|NCT02573870|3480443|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|52|52.0||||||
3632970|NCT02573870|3480444|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|36|36.0||||||
3632971|NCT02573870|3480445|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
3632972|NCT02573870|3480443|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3632973|NCT02573870|3480444|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3632974|NCT02573870|3480445|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3632975|NCT02573870|3480443|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3632976|NCT02573870|3480444|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3632977|NCT02573870|3480445|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3632978|NCT02573870|3480443|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3632979|NCT02573870|3480444|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3632980|NCT02573870|3480445|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3632981|NCT02573870|3480443|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3632982|NCT02573870|3480444|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3632983|NCT02573870|3480445|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3632984|NCT02573870|3480443|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3632985|NCT02573870|3480444|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3632986|NCT02573870|3480445|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3632987|NCT02573870|3480443|B3|||Age||Years|Mean|62.5|62.5|Standard Deviation|8.17|8.17|||
3632988|NCT02573870|3480444|B2|||Age||Years|Mean|63.0|63.0|Standard Deviation|7.88|7.88|||
3632989|NCT02573870|3480445|B1|||Age||Years|Mean|61.4|61.4|Standard Deviation|8.86|8.86|||
3632990|NCT02573467|3480452|B5||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3632991|NCT02573467|3480453|B4||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3632992|NCT02573467|3480454|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3632993|NCT02573467|3480455|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3632994|NCT02573467|3480456|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3632995|NCT02573467|3480452|B5||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3632996|NCT02573467|3480453|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3632997|NCT02573467|3480454|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3632998|NCT02573467|3480455|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3632999|NCT02573467|3480456|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3633000|NCT02573467|3480452|B5|||Age||Years|Mean|69.1|69.1|Standard Deviation|8.24|8.24|||
3633001|NCT02573467|3480453|B4|||Age||Years|Mean|69.9|69.9|Standard Deviation|7.95|7.95|||
3633002|NCT02573467|3480454|B3|||Age||Years|Mean|70.0|70.0|Standard Deviation|7.69|7.69|||
3633003|NCT02573467|3480455|B2|||Age||Years|Mean|67.3|67.3|Standard Deviation|9.04|9.04|||
3633004|NCT02573467|3480456|B1|||Age||Years|Mean|69.2|69.2|Standard Deviation|8.19|8.19|||
3633005|NCT02573402|3480498|B3|||American Spinal Injury Association (ASIA) Impairment Scale (AIS) grade D|"See ASIA Grade A baseline measure description for further description of ASIA grading.~D = Motor incomplete. Motor function is preserved below the neurological level of injury, and at least half (half or more) of key muscle functions below the neurological level of injury have a muscle grade >3."|Participants|Count of Participants|1|1.0||||||
3633006|NCT02573402|3480499|B2|||American Spinal Injury Association (ASIA) Impairment Scale (AIS) grade D|"See ASIA Grade A baseline measure description for further description of ASIA grading.~D = Motor incomplete. Motor function is preserved below the neurological level of injury, and at least half (half or more) of key muscle functions below the neurological level of injury have a muscle grade >3."|Participants|Count of Participants|1|1.0||||||
3633007|NCT02573402|3480500|B1|||American Spinal Injury Association (ASIA) Impairment Scale (AIS) grade D|"See ASIA Grade A baseline measure description for further description of ASIA grading.~D = Motor incomplete. Motor function is preserved below the neurological level of injury, and at least half (half or more) of key muscle functions below the neurological level of injury have a muscle grade >3."|Participants|Count of Participants|0|0.0||||||
3633008|NCT02573402|3480498|B3|||American Spinal Injury Association (ASIA) Impairment Scale (AIS) grade C|"See ASIA Grade A baseline measure description for further description of ASIA grading.~Grade C = Motor incomplete. Motor function is preserved below the neurological level of injury, and more than half of key muscle functions below the single neurological level of injury have a muscle grade less than 3 (Grades 0–2)."|Participants|Count of Participants|4|4.0||||||
3633009|NCT02573402|3480499|B2|||American Spinal Injury Association (ASIA) Impairment Scale (AIS) grade C|"See ASIA Grade A baseline measure description for further description of ASIA grading.~Grade C = Motor incomplete. Motor function is preserved below the neurological level of injury, and more than half of key muscle functions below the single neurological level of injury have a muscle grade less than 3 (Grades 0–2)."|Participants|Count of Participants|2|2.0||||||
3633067|NCT02572752|3480672|B2|||Age||Years|Mean|36.6|36.6|Standard Deviation|9.5|9.5|||
3633068|NCT02572752|3480673|B1|||Age||Years|Mean|34.0|34.0|Standard Deviation|10.3|10.3|||
3633069|NCT02572609|3480688|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3633010|NCT02573402|3480500|B1|||American Spinal Injury Association (ASIA) Impairment Scale (AIS) grade C|"See ASIA Grade A baseline measure description for further description of ASIA grading.~Grade C = Motor incomplete. Motor function is preserved below the neurological level of injury, and more than half of key muscle functions below the single neurological level of injury have a muscle grade less than 3 (Grades 0–2)."|Participants|Count of Participants|2|2.0||||||
3633011|NCT02573402|3480498|B3|||American Spinal Injury Association (ASIA) Impairment Scale (AIS) grade B|"See ASIA Grade A baseline measure description for further description of ASIA grading.~Grade B = Sensory incomplete. Sensory but not motor function is preserved below the neurological level and includes the sacral segments S4-S5, AND no motor function is preserved more than three levels below the motor level on either side of the body."|Participants|Count of Participants|3|3.0||||||
3633012|NCT02573402|3480499|B2|||American Spinal Injury Association (ASIA) Impairment Scale (AIS) grade B|"See ASIA Grade A baseline measure description for further description of ASIA grading.~Grade B = Sensory incomplete. Sensory but not motor function is preserved below the neurological level and includes the sacral segments S4-S5, AND no motor function is preserved more than three levels below the motor level on either side of the body."|Participants|Count of Participants|1|1.0||||||
3633013|NCT02573402|3480500|B1|||American Spinal Injury Association (ASIA) Impairment Scale (AIS) grade B|"See ASIA Grade A baseline measure description for further description of ASIA grading.~Grade B = Sensory incomplete. Sensory but not motor function is preserved below the neurological level and includes the sacral segments S4-S5, AND no motor function is preserved more than three levels below the motor level on either side of the body."|Participants|Count of Participants|2|2.0||||||
3633014|NCT02573402|3480498|B3|||Number of Participants with American Spinal Injury Association (ASIA) Impairment Scale (AIS) grade A|"Injuries are classified in as being neurologically “complete” or “incomplete” based “Sacral Sparing,” which refers to the presence of sensory or motor function in the most caudal sacral segments as determined by the examination (i.e. preservation of light touch or pin prick sensation at the S4-5 dermatome, DAP or voluntary anal sphincter contraction). A complete injury is defined as the absence of sacral sparing, whereas an incomplete injury is defined as the presence of sacral.~Grade A = Complete. No sensory or motor function is preserved in the sacral segments S4-S5."|Participants|Count of Participants|11|11.0||||||
3633015|NCT02573402|3480499|B2|||Number of Participants with American Spinal Injury Association (ASIA) Impairment Scale (AIS) grade A|"Injuries are classified in as being neurologically “complete” or “incomplete” based “Sacral Sparing,” which refers to the presence of sensory or motor function in the most caudal sacral segments as determined by the examination (i.e. preservation of light touch or pin prick sensation at the S4-5 dermatome, DAP or voluntary anal sphincter contraction). A complete injury is defined as the absence of sacral sparing, whereas an incomplete injury is defined as the presence of sacral.~Grade A = Complete. No sensory or motor function is preserved in the sacral segments S4-S5."|Participants|Count of Participants|3|3.0||||||
3633016|NCT02573402|3480500|B1|||Number of Participants with American Spinal Injury Association (ASIA) Impairment Scale (AIS) grade A|"Injuries are classified in as being neurologically “complete” or “incomplete” based “Sacral Sparing,” which refers to the presence of sensory or motor function in the most caudal sacral segments as determined by the examination (i.e. preservation of light touch or pin prick sensation at the S4-5 dermatome, DAP or voluntary anal sphincter contraction). A complete injury is defined as the absence of sacral sparing, whereas an incomplete injury is defined as the presence of sacral.~Grade A = Complete. No sensory or motor function is preserved in the sacral segments S4-S5."|Participants|Count of Participants|8|8.0||||||
3633017|NCT02573402|3480498|B3|||Number of Participants with Tetraplegia||Participants|Count of Participants|10|10.0||||||
3633018|NCT02573402|3480499|B2|||Number of Participants with Tetraplegia||Participants|Count of Participants|4|4.0||||||
3633019|NCT02573402|3480500|B1|||Number of Participants with Tetraplegia||Participants|Count of Participants|6|6.0||||||
3633020|NCT02573402|3480498|B3|||Admission Functional Independence Measure (FIM) cognition subscale|The FIM cognitive subscale consists of 5 items: Comprehension, Expression, Social interaction, Problem solving, and Memory. Each individual item is scored from 1 to 7. The range of total scores is 5 to 35, with a higher score indicating more independence in performing the task associated with each item.|units on a scale|Mean|28.3|28.3|Standard Deviation|5.4|5.4|||
3633021|NCT02573402|3480499|B2|||Admission Functional Independence Measure (FIM) cognition subscale|The FIM cognitive subscale consists of 5 items: Comprehension, Expression, Social interaction, Problem solving, and Memory. Each individual item is scored from 1 to 7. The range of total scores is 5 to 35, with a higher score indicating more independence in performing the task associated with each item.|units on a scale|Mean|29.1|29.1|Standard Deviation|5|5.0|||
3633022|NCT02573402|3480500|B1|||Admission Functional Independence Measure (FIM) cognition subscale|The FIM cognitive subscale consists of 5 items: Comprehension, Expression, Social interaction, Problem solving, and Memory. Each individual item is scored from 1 to 7. The range of total scores is 5 to 35, with a higher score indicating more independence in performing the task associated with each item.|units on a scale|Mean|27.8|27.8|Standard Deviation|5.6|5.6|||
3633023|NCT02573402|3480498|B3|||Admission Functional Independence Measure (FIM) bladder item|The FIM bladder item (which is part of the FIM motor subscale) is scored from 1 to 7, with a range of possible scores from 1 to 7. A higher score indicates more independence in bladder management.|units on a scale|Mean|1|1.0|Standard Deviation|0|0.0|||
3633024|NCT02573402|3480499|B2|||Admission Functional Independence Measure (FIM) bladder item|The FIM bladder item (which is part of the FIM motor subscale) is scored from 1 to 7, with a range of possible scores from 1 to 7. A higher score indicates more independence in bladder management.|units on a scale|Mean|1|1.0|Standard Deviation|0|0.0|||
3633025|NCT02573402|3480500|B1|||Admission Functional Independence Measure (FIM) bladder item|The FIM bladder item (which is part of the FIM motor subscale) is scored from 1 to 7, with a range of possible scores from 1 to 7. A higher score indicates more independence in bladder management.|units on a scale|Mean|1|1.0|Standard Deviation|0|0.0|||
3633070|NCT02572609|3480689|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3633071|NCT02572609|3480690|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3633072|NCT02572609|3480688|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3633073|NCT02572609|3480689|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3633026|NCT02573402|3480498|B3|||Admission Functional Independence Measure (FIM) motor subscale|The FIM motor subscale consists of 13 items: Eating, Grooming, Bathing, Dressing (upper body), Dressing (lower body), Toileting, Bladder management, Bowel management, Transfers (bed/chair/wheelchair), Transfers (toilet), Transfers (bath/shower), Walk/wheelchair, and Stairs. Each individual item is scored from 1 to 7. The range of total scores is 13 to 91, with a higher score indicating more independence in performing the task associated with each item.|units on a scale|Mean|16.6|16.6|Standard Deviation|5.3|5.3|||
3633027|NCT02573402|3480499|B2|||Admission Functional Independence Measure (FIM) motor subscale|The FIM motor subscale consists of 13 items: Eating, Grooming, Bathing, Dressing (upper body), Dressing (lower body), Toileting, Bladder management, Bowel management, Transfers (bed/chair/wheelchair), Transfers (toilet), Transfers (bath/shower), Walk/wheelchair, and Stairs. Each individual item is scored from 1 to 7. The range of total scores is 13 to 91, with a higher score indicating more independence in performing the task associated with each item.|units on a scale|Mean|16.4|16.4|Standard Deviation|5.6|5.6|||
3633028|NCT02573402|3480500|B1|||Admission Functional Independence Measure (FIM) motor subscale|The FIM motor subscale consists of 13 items: Eating, Grooming, Bathing, Dressing (upper body), Dressing (lower body), Toileting, Bladder management, Bowel management, Transfers (bed/chair/wheelchair), Transfers (toilet), Transfers (bath/shower), Walk/wheelchair, and Stairs. Each individual item is scored from 1 to 7. The range of total scores is 13 to 91, with a higher score indicating more independence in performing the task associated with each item.|units on a scale|Mean|16.7|16.7|Standard Deviation|5.1|5.1|||
3633029|NCT02573402|3480498|B3|||Number of Days from Injury||days|Mean|20.5|20.5|Standard Deviation|8.3|8.3|||
3633030|NCT02573402|3480499|B2|||Number of Days from Injury||days|Mean|19.9|19.9|Standard Deviation|6.2|6.2|||
3633031|NCT02573402|3480500|B1|||Number of Days from Injury||days|Mean|20.8|20.8|Standard Deviation|9.3|9.3|||
3633032|NCT02573402|3480498|B3|||Neurologic Level Number|The neurologic level number indicates the degree of neurologic functioning, with higher numbers indicating a higher degree of neurologic functioning. This is a continuous scale with 30 levels beginning at C1 (closest to the head) and moving caudal along the body to S5--C1 corresponds to level 1 and S5 corresponds to level 30.|units on a scale|Mean|7.8|7.8|Standard Deviation|5.9|5.9|||
3633033|NCT02573402|3480499|B2|||Neurologic Level Number|The neurologic level number indicates the degree of neurologic functioning, with higher numbers indicating a higher degree of neurologic functioning. This is a continuous scale with 30 levels beginning at C1 (closest to the head) and moving caudal along the body to S5--C1 corresponds to level 1 and S5 corresponds to level 30.|units on a scale|Mean|8.1|8.1|Standard Deviation|5.3|5.3|||
3633034|NCT02573402|3480500|B1|||Neurologic Level Number|The neurologic level number indicates the degree of neurologic functioning, with higher numbers indicating a higher degree of neurologic functioning. This is a continuous scale with 30 levels beginning at C1 (closest to the head) and moving caudal along the body to S5--C1 corresponds to level 1 and S5 corresponds to level 30.|units on a scale|Mean|7.7|7.7|Standard Deviation|6.2|6.2|||
3633035|NCT02573402|3480498|B3|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3633036|NCT02573402|3480499|B2|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3633037|NCT02573402|3480500|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3633038|NCT02573402|3480498|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3633039|NCT02573402|3480498|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3633040|NCT02573402|3480499|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3633041|NCT02573402|3480500|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3633042|NCT02573402|3480498|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3633043|NCT02573402|3480499|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3633044|NCT02573402|3480500|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3633045|NCT02573402|3480498|B3|||Age||years|Mean|40.7|40.7|Standard Deviation|13.3|13.3|||
3633046|NCT02573402|3480499|B2|||Age||years|Mean|48.3|48.3|Standard Deviation|12.9|12.9|||
3633047|NCT02573402|3480500|B1|||Age||years|Mean|36.3|36.3|Standard Deviation|13.5|13.5|||
3633048|NCT02573155|3480521|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3633049|NCT02573155|3480522|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3633050|NCT02573155|3480523|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3633051|NCT02573155|3480521|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3633052|NCT02573155|3480522|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3633053|NCT02573155|3480523|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3633054|NCT02573155|3480521|B3|||Age||Years|Mean|NA||Standard Deviation|NA||||Combined baseline demographic data were not calculated for Parts 1 and 2 of the study, which included separate patient populations (NA)
3633055|NCT02573155|3480522|B2|||Age||Years|Mean|65.6|65.6|Standard Deviation|6.4|6.4|||
3633056|NCT02573155|3480523|B1|||Age||Years|Mean|39.0|39.0|Standard Deviation|11.8|11.8|||
3633057|NCT02572752|3480670|B4||Male|Gender||Participants|Count of Participants|70|70.0||||||
3633058|NCT02572752|3480671|B3||Male|Gender||Participants|Count of Participants|24|24.0||||||
3633059|NCT02572752|3480672|B2||Male|Gender||Participants|Count of Participants|23|23.0||||||
3633060|NCT02572752|3480673|B1||Male|Gender||Participants|Count of Participants|23|23.0||||||
3633061|NCT02572752|3480670|B4||Female|Gender||Participants|Count of Participants|0|0.0||||||
3633062|NCT02572752|3480671|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
3633063|NCT02572752|3480672|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
3633064|NCT02572752|3480673|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3633065|NCT02572752|3480670|B4|||Age||Years|Mean|34.0|34.0|Standard Deviation|9.2|9.2|||
3633066|NCT02572752|3480671|B3|||Age||Years|Mean|31.6|31.6|Standard Deviation|7.2|7.2|||
3633074|NCT02572609|3480690|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3633075|NCT02572609|3480688|B3|||Age||Years|Mean|30.30|30.3|Standard Deviation|6.60|6.6|||
3633076|NCT02572609|3480689|B2|||Age||Years|Mean|31.22|31.22|Standard Deviation|7.30|7.3|||
3633077|NCT02572609|3480690|B1|||Age||Years|Mean|29.39|29.39|Standard Deviation|5.80|5.8|||
3633078|NCT02572427|3480699|B3|United States||Region of Enrollment||participants|Number|82|82.0||||||
3633079|NCT02572427|3480700|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
3633080|NCT02572427|3480701|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
3633081|NCT02572427|3480699|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633082|NCT02572427|3480700|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633083|NCT02572427|3480701|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633084|NCT02572427|3480699|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633085|NCT02572427|3480700|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633086|NCT02572427|3480701|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633087|NCT02572427|3480699|B3||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3633088|NCT02572427|3480700|B2||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3633089|NCT02572427|3480701|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3633090|NCT02572427|3480699|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3633091|NCT02572427|3480700|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3633092|NCT02572427|3480701|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3633093|NCT02572427|3480699|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633094|NCT02572427|3480700|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633095|NCT02572427|3480701|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633096|NCT02572427|3480699|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3633097|NCT02572427|3480700|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3633098|NCT02572427|3480701|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3633099|NCT02572427|3480699|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633100|NCT02572427|3480700|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633101|NCT02572427|3480701|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633102|NCT02572427|3480699|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633103|NCT02572427|3480700|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633104|NCT02572427|3480701|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633105|NCT02572427|3480699|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3633106|NCT02572427|3480700|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3633107|NCT02572427|3480701|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3633108|NCT02572427|3480699|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3633109|NCT02572427|3480700|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3633110|NCT02572427|3480701|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633111|NCT02572427|3480699|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3633112|NCT02572427|3480700|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3633113|NCT02572427|3480701|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3633114|NCT02572427|3480699|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3633115|NCT02572427|3480700|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3633116|NCT02572427|3480701|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3633117|NCT02572427|3480699|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3633118|NCT02572427|3480700|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3633119|NCT02572427|3480701|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3633120|NCT02572427|3480699|B3||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
3633121|NCT02572427|3480700|B2||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3633122|NCT02572427|3480701|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3633123|NCT02572427|3480699|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3633124|NCT02572427|3480700|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3633125|NCT02572427|3480701|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3633126|NCT02572076|3480710|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633127|NCT02572076|3480710|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633128|NCT02572076|3480710|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3633129|NCT02572076|3480710|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633130|NCT02572076|3480710|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633131|NCT02572076|3480710|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633132|NCT02572076|3480710|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633133|NCT02572076|3480710|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3633134|NCT02572076|3480710|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3633135|NCT02572076|3480710|B1|||Age||YEARS|Mean|46.5|46.5|Standard Deviation|13.4|13.4|||
3633136|NCT02571634|3480714|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3633137|NCT02571634|3480714|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633138|NCT02571634|3480714|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3633139|NCT02571634|3480714|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3633140|NCT02571634|3480714|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633141|NCT02571634|3480714|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633142|NCT02571634|3480714|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633143|NCT02571634|3480714|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3633144|NCT02571634|3480714|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3633145|NCT02571634|3480714|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3633146|NCT02571634|3480714|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3633147|NCT02571634|3480714|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3633148|NCT02571439|3480722|B3||No|Previous abdominal surgery||Participants|Count of Participants|8|8.0||||||
3633149|NCT02571439|3480723|B2||No|Previous abdominal surgery||Participants|Count of Participants|5|5.0||||||
3633150|NCT02571439|3480724|B1||No|Previous abdominal surgery||Participants|Count of Participants|3|3.0||||||
3633151|NCT02571439|3480722|B3||Yes|Previous abdominal surgery||Participants|Count of Participants|33|33.0||||||
3633152|NCT02571439|3480723|B2||Yes|Previous abdominal surgery||Participants|Count of Participants|16|16.0||||||
3633153|NCT02571439|3480724|B1||Yes|Previous abdominal surgery||Participants|Count of Participants|17|17.0||||||
3633154|NCT02571439|3480722|B3|||BMI|Kg/m2|Kg/m^2|Mean|31.0|31.0|Standard Deviation|6.0|6.0|||
3633155|NCT02571439|3480723|B2|||BMI|Kg/m2|Kg/m^2|Mean|30.7|30.7|Standard Deviation|6.5|6.5|||
3633156|NCT02571439|3480724|B1|||BMI|Kg/m2|Kg/m^2|Mean|31.2|31.2|Standard Deviation|5.6|5.6|||
3633157|NCT02571439|3480722|B3|United States||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3633158|NCT02571439|3480723|B2|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3633159|NCT02571439|3480724|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3633160|NCT02571439|3480722|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3633161|NCT02571439|3480723|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3633162|NCT02571439|3480724|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3633163|NCT02571439|3480722|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3633164|NCT02571439|3480723|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3633165|NCT02571439|3480724|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3633166|NCT02571439|3480722|B3|||Age||years|Mean|30.7|30.7|Standard Deviation|4.9|4.9|||
3633167|NCT02571439|3480723|B2|||Age||years|Mean|32.2|32.2|Standard Deviation|5.4|5.4|||
3633168|NCT02571439|3480724|B1|||Age||years|Mean|29.1|29.1|Standard Deviation|4.0|4.0|||
3633169|NCT02571244|3480749|B3|Race|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633170|NCT02571244|3480750|B2|Race|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633171|NCT02571244|3480751|B1|Race|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633172|NCT02571244|3480749|B3|Race|More than one race|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3633173|NCT02571244|3480750|B2|Race|More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3633174|NCT02571244|3480751|B1|Race|More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3633175|NCT02571244|3480749|B3|Race|White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3633176|NCT02571244|3480750|B2|Race|White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3633177|NCT02571244|3480751|B1|Race|White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3633178|NCT02571244|3480749|B3|Race|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3633179|NCT02571244|3480750|B2|Race|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3633180|NCT02571244|3480751|B1|Race|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3633181|NCT02571244|3480749|B3|Race|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633182|NCT02571244|3480750|B2|Race|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633183|NCT02571244|3480751|B1|Race|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633184|NCT02571244|3480749|B3|Race|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633185|NCT02571244|3480750|B2|Race|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633186|NCT02571244|3480751|B1|Race|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633187|NCT02571244|3480749|B3|Race|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633188|NCT02571244|3480750|B2|Race|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633189|NCT02571244|3480751|B1|Race|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633190|NCT02571244|3480749|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3633191|NCT02571244|3480750|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3633192|NCT02571244|3480751|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3633193|NCT02571244|3480749|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3633194|NCT02571244|3480750|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3633195|NCT02571244|3480751|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3633196|NCT02571244|3480749|B3|||Age||years|Mean|47.7|47.7|Standard Deviation|11.5|11.5|||
3633197|NCT02571244|3480750|B2|||Age||years|Mean|48.2|48.2|Standard Deviation|8.9|8.9|||
3633198|NCT02571244|3480751|B1|||Age||years|Mean|47.5|47.5|Standard Deviation|12.7|12.7|||
3633199|NCT02571153|3480766|B4||Male|Gender||Participants|Count of Participants|17|17.0||||||
3633200|NCT02571153|3480767|B3||Male|Gender||Participants|Count of Participants|6|6.0||||||
3633201|NCT02571153|3480768|B2||Male|Gender||Participants|Count of Participants|3|3.0||||||
3633202|NCT02571153|3480769|B1||Male|Gender||Participants|Count of Participants|8|8.0||||||
3633203|NCT02571153|3480766|B4||Female|Gender||Participants|Count of Participants|102|102.0||||||
3633204|NCT02571153|3480767|B3||Female|Gender||Participants|Count of Participants|37|37.0||||||
3633205|NCT02571153|3480768|B2||Female|Gender||Participants|Count of Participants|34|34.0||||||
3633206|NCT02571153|3480769|B1||Female|Gender||Participants|Count of Participants|31|31.0||||||
3633207|NCT02571153|3480766|B4|||Age||years|Median|44.3|44.3|Standard Deviation|12.1|12.1|||
3633208|NCT02571153|3480767|B3|||Age||years|Median|44.1|44.1|Standard Deviation|11.4|11.4|||
3633209|NCT02571153|3480768|B2|||Age||years|Median|47.2|47.2|Standard Deviation|13.3|13.3|||
3633210|NCT02571153|3480769|B1|||Age||years|Median|41.8|41.8|Standard Deviation|11.3|11.3|||
3633211|NCT02571153|3480766|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3633212|NCT02571153|3480767|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3633213|NCT02571153|3480768|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3633214|NCT02571153|3480769|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3633215|NCT02571153|3480766|B4||Between 18 and 65 years|Age||Participants|Count of Participants|119|119.0||||||
3633216|NCT02571153|3480767|B3||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
3633217|NCT02571153|3480768|B2||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3633218|NCT02571153|3480769|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3633219|NCT02571153|3480766|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3633220|NCT02571153|3480767|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3633221|NCT02571153|3480768|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3633222|NCT02571153|3480769|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3633223|NCT02571049|3480797|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3633224|NCT02571049|3480797|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3633225|NCT02571049|3480797|B1|||Age||years|Mean|39.80|39.8|Standard Deviation|10.40|10.4|||
3633226|NCT02570750|3480804|B3||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3633227|NCT02570750|3480805|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3633228|NCT02570750|3480806|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3633229|NCT02570750|3480804|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3633230|NCT02570750|3480805|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3633231|NCT02570750|3480806|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3633232|NCT02570750|3480804|B3|||Age||years|Mean|51.0|51.0|Standard Deviation|14.0|14.0|||
3633233|NCT02570750|3480805|B2|||Age||years|Mean|49.1|49.1|Standard Deviation|14.5|14.5|||
3633234|NCT02570750|3480806|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|13.5|13.5|||
3633235|NCT02570425|3480823|B3|Australia||Region of Enrollment||participants|Number|516|516.0||||||
3633236|NCT02570425|3480824|B2|Australia||Region of Enrollment||participants|Number|274|274.0||||||
3633237|NCT02570425|3480825|B1|Australia||Region of Enrollment||participants|Number|242|242.0||||||
3633238|NCT02570425|3480823|B3||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3633239|NCT02570425|3480824|B2||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3633240|NCT02570425|3480825|B1||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3633241|NCT02570425|3480823|B3||Female|Sex: Female, Male||Participants|Count of Participants|315|315.0||||||
3633242|NCT02570425|3480824|B2||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3633243|NCT02570425|3480825|B1||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3633244|NCT02570425|3480823|B3|||Age||years|Mean|22.6|22.6|Standard Deviation|4.6|4.6|||
3633245|NCT02570425|3480824|B2|||Age||years|Mean|22.3|22.3|Standard Deviation|4.7|4.7|||
3633246|NCT02570425|3480825|B1|||Age||years|Mean|22.9|22.9|Standard Deviation|4.5|4.5|||
3633247|NCT02570425|3480823|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3633248|NCT02570425|3480824|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3633249|NCT02570425|3480825|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3633250|NCT02570425|3480823|B3||Between 18 and 65 years|Age||Participants|Count of Participants|516|516.0||||||
3633251|NCT02570425|3480824|B2||Between 18 and 65 years|Age||Participants|Count of Participants|274|274.0||||||
3633252|NCT02570425|3480825|B1||Between 18 and 65 years|Age||Participants|Count of Participants|242|242.0||||||
3633253|NCT02570425|3480823|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3633254|NCT02570425|3480824|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3633255|NCT02570425|3480825|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3633256|NCT02570295|3480873|B3|male||Sex/Gender, Customized||participants|Number|722|722.0||||||
3633257|NCT02570295|3480874|B2|male||Sex/Gender, Customized||participants|Number|347|347.0||||||
3633258|NCT02570295|3480875|B1|male||Sex/Gender, Customized||participants|Number|375|375.0||||||
3633259|NCT02570295|3480873|B3|18-25 years||Age, Customized||participants|Number|722|722.0||||||
3633260|NCT02570295|3480874|B2|18-25 years||Age, Customized||participants|Number|347|347.0||||||
3633261|NCT02570295|3480875|B1|18-25 years||Age, Customized||participants|Number|375|375.0||||||
3633262|NCT02570165|3480898|B8|Multiple Geographic Ancestries||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
3633263|NCT02570165|3480899|B7|Multiple Geographic Ancestries||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3633264|NCT02570165|3480900|B6|Multiple Geographic Ancestries||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3633265|NCT02570165|3480901|B5|Multiple Geographic Ancestries||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3633266|NCT02570165|3480902|B4|Multiple Geographic Ancestries||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3633267|NCT02570165|3480903|B3|Multiple Geographic Ancestries||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3633268|NCT02570165|3480904|B2|Multiple Geographic Ancestries||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3633269|NCT02570165|3480905|B1|Multiple Geographic Ancestries||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3633270|NCT02570165|3480898|B8|White||Race/Ethnicity, Customized||Participants|Number|265|265.0||||||
3633271|NCT02570165|3480899|B7|White||Race/Ethnicity, Customized||Participants|Number|39|39.0||||||
3633272|NCT02570165|3480900|B6|White||Race/Ethnicity, Customized||Participants|Number|38|38.0||||||
3633273|NCT02570165|3480901|B5|White||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
3633274|NCT02570165|3480902|B4|White||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
3633275|NCT02570165|3480903|B3|White||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
3633276|NCT02570165|3480904|B2|White||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
3633277|NCT02570165|3480905|B1|White||Race/Ethnicity, Customized||Participants|Number|38|38.0||||||
3633278|NCT02570165|3480898|B8|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
3633279|NCT02570165|3480899|B7|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3633280|NCT02570165|3480900|B6|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3633281|NCT02570165|3480901|B5|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3633282|NCT02570165|3480902|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3633283|NCT02570165|3480903|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3633284|NCT02570165|3480904|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3633285|NCT02570165|3480905|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3633286|NCT02570165|3480898|B8||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3633287|NCT02570165|3480899|B7||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3633288|NCT02570165|3480900|B6||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3633289|NCT02570165|3480901|B5||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3633290|NCT02570165|3480902|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3633291|NCT02570165|3480903|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3633292|NCT02570165|3480904|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3633293|NCT02570165|3480905|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3633294|NCT02570165|3480898|B8||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3633295|NCT02570165|3480899|B7||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3633296|NCT02570165|3480900|B6||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3633297|NCT02570165|3480901|B5||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3633298|NCT02570165|3480902|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3633299|NCT02570165|3480903|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3633300|NCT02570165|3480904|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3633301|NCT02570165|3480905|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3633302|NCT02570165|3480898|B8|||Age||Years|Mean|62.6|62.6|Standard Deviation|7.78|7.78|||
3633303|NCT02570165|3480899|B7|||Age||Years|Mean|62.8|62.8|Standard Deviation|8.46|8.46|||
3633304|NCT02570165|3480900|B6|||Age||Years|Mean|63.7|63.7|Standard Deviation|7.06|7.06|||
3633305|NCT02570165|3480901|B5|||Age||Years|Mean|61.9|61.9|Standard Deviation|8.70|8.7|||
3633306|NCT02570165|3480902|B4|||Age||Years|Mean|63.6|63.6|Standard Deviation|8.11|8.11|||
3633307|NCT02570165|3480903|B3|||Age||Years|Mean|63.0|63.0|Standard Deviation|7.21|7.21|||
3633308|NCT02570165|3480904|B2|||Age||Years|Mean|61.9|61.9|Standard Deviation|8.16|8.16|||
3633309|NCT02570165|3480905|B1|||Age||Years|Mean|61.1|61.1|Standard Deviation|6.60|6.6|||
3633310|NCT02570139|3480934|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
3633311|NCT02570139|3480935|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
3633312|NCT02570139|3480936|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3633313|NCT02570139|3480934|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633314|NCT02570139|3480935|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633315|NCT02570139|3480936|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633316|NCT02570139|3480934|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633317|NCT02570139|3480935|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633318|NCT02570139|3480936|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633319|NCT02570139|3480934|B3||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3633320|NCT02570139|3480935|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3633321|NCT02570139|3480936|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3633322|NCT02570139|3480934|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3633323|NCT02570139|3480935|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3633324|NCT02570139|3480936|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3633325|NCT02570139|3480934|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633326|NCT02570139|3480935|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633327|NCT02570139|3480936|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633328|NCT02570139|3480934|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3633329|NCT02570139|3480935|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3633330|NCT02570139|3480936|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3633331|NCT02570139|3480934|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3633332|NCT02570139|3480935|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633333|NCT02570139|3480936|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3633334|NCT02570139|3480934|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633335|NCT02570139|3480935|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633336|NCT02570139|3480936|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633337|NCT02570139|3480934|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3633338|NCT02570139|3480935|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3633339|NCT02570139|3480936|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3633340|NCT02570139|3480934|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3633341|NCT02570139|3480935|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633342|NCT02570139|3480936|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3633343|NCT02570139|3480934|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3633344|NCT02570139|3480935|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3633345|NCT02570139|3480936|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3633346|NCT02570139|3480934|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3633347|NCT02570139|3480935|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3633348|NCT02570139|3480936|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3633349|NCT02570139|3480934|B3|Weeks||Age, Customized|Weeks of pediatrics|Weeks|Mean|15.8|15.8|Standard Deviation|7.36|7.36|||
3633350|NCT02570139|3480935|B2|Weeks||Age, Customized|Weeks of pediatrics|Weeks|Mean|20.3|20.3|Standard Deviation|4.51|4.51|||
3633351|NCT02570139|3480936|B1|Weeks||Age, Customized|Weeks of pediatrics|Weeks|Mean|11.3|11.3|Standard Deviation|7.37|7.37|||
3633352|NCT02570139|3480934|B3|Years||Age, Customized|adults are measured in years|years or weeks|Mean|64.8|64.8|Standard Deviation|19.54|19.54|||
3633353|NCT02570139|3480935|B2|Years||Age, Customized|adults are measured in years|years or weeks|Mean|62.1|62.1|Standard Deviation|19.97|19.97|||
3633354|NCT02570139|3480936|B1|Years||Age, Customized|adults are measured in years|years or weeks|Mean|67.1|67.1|Standard Deviation|19.33|19.33|||
3633355|NCT02570126|3480949|B3|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|760|760.0||||||
3633356|NCT02570126|3480950|B2|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|381|381.0||||||
3633357|NCT02570126|3480951|B1|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|379|379.0||||||
3633358|NCT02570126|3480949|B3|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3633359|NCT02570126|3480950|B2|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3633360|NCT02570126|3480951|B1|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3633361|NCT02570126|3480949|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|188|188.0||||||
3633362|NCT02570126|3480950|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|94|94.0||||||
3633363|NCT02570126|3480951|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|94|94.0||||||
3633364|NCT02570126|3480949|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|268|268.0||||||
3633365|NCT02570126|3480950|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|135|135.0||||||
3633592|NCT02567708|3481177|B1|||Age||Years|Mean|44.5|44.5|Standard Deviation|13.86|13.86|||
3633366|NCT02570126|3480951|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|133|133.0||||||
3633367|NCT02570126|3480949|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3633368|NCT02570126|3480950|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3633369|NCT02570126|3480951|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3633370|NCT02570126|3480949|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3633371|NCT02570126|3480950|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3633372|NCT02570126|3480951|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3633373|NCT02570126|3480949|B3|African Heritage / African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3633374|NCT02570126|3480950|B2|African Heritage / African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3633375|NCT02570126|3480951|B1|African Heritage / African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3633376|NCT02570126|3480949|B3||Male|Sex: Female, Male||Participants|Count of Participants|601|601.0||||||
3633377|NCT02570126|3480950|B2||Male|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
3633378|NCT02570126|3480951|B1||Male|Sex: Female, Male||Participants|Count of Participants|297|297.0||||||
3633379|NCT02570126|3480949|B3||Female|Sex: Female, Male||Participants|Count of Participants|630|630.0||||||
3633380|NCT02570126|3480950|B2||Female|Sex: Female, Male||Participants|Count of Participants|312|312.0||||||
3633381|NCT02570126|3480951|B1||Female|Sex: Female, Male||Participants|Count of Participants|318|318.0||||||
3633382|NCT02570126|3480949|B3|||Age||Months|Mean|16.8|16.8|Standard Deviation|3.3|3.3|||
3633383|NCT02570126|3480950|B2|||Age||Months|Mean|16.9|16.9|Standard Deviation|3.4|3.4|||
3633384|NCT02570126|3480951|B1|||Age||Months|Mean|16.7|16.7|Standard Deviation|3.3|3.3|||
3633385|NCT02570022|3480976|B3|United States||Region of Enrollment||participants|Number|57|57.0||||||
3633386|NCT02570022|3480977|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
3633387|NCT02570022|3480978|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
3633388|NCT02570022|3480976|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3633389|NCT02570022|3480977|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3633390|NCT02570022|3480978|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3633391|NCT02570022|3480976|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3633392|NCT02570022|3480977|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3633393|NCT02570022|3480978|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3633394|NCT02570022|3480976|B3|||Age||years|Mean|67.8|67.8|Full Range|||49.0|86.0|
3633395|NCT02570022|3480977|B2|||Age||years|Mean|67.1|67.1|Full Range|||49.0|86.0|
3633396|NCT02570022|3480978|B1|||Age||years|Mean|69.4|69.4|Full Range|||50.0|75.0|
3633397|NCT02570022|3480976|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3633398|NCT02570022|3480977|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3633399|NCT02570022|3480978|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3633400|NCT02570022|3480976|B3||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3633401|NCT02570022|3480977|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3633402|NCT02570022|3480978|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3633403|NCT02570022|3480976|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3633404|NCT02570022|3480977|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3633405|NCT02570022|3480978|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3633406|NCT02569996|3480987|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3633407|NCT02569996|3480987|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3633408|NCT02569996|3480987|B1|||Age||years|Median|53|53.0|Full Range|||26.0|81.0|
3633409|NCT02569996|3480987|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3633410|NCT02569996|3480987|B1||Between 18 and 65 years|Age||Participants|Count of Participants|102|102.0||||||
3633411|NCT02569996|3480987|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3633412|NCT02569957|3480997|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3633413|NCT02569957|3480998|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3633414|NCT02569957|3480997|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633415|NCT02569957|3480998|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633416|NCT02569957|3480999|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633417|NCT02569957|3480997|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633418|NCT02569957|3480998|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633419|NCT02569957|3480999|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633420|NCT02569957|3480997|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3633421|NCT02569957|3480998|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3633422|NCT02569957|3480999|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633423|NCT02569957|3480997|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633424|NCT02569957|3480998|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633425|NCT02569957|3480999|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633426|NCT02569957|3480997|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633427|NCT02569957|3480998|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633428|NCT02569957|3480999|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633429|NCT02569957|3480997|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633430|NCT02569957|3480998|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633431|NCT02569957|3480999|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633432|NCT02569957|3480997|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633433|NCT02569957|3480998|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633434|NCT02569957|3480999|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633435|NCT02569957|3480997|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633436|NCT02569957|3480998|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633437|NCT02569957|3480999|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633438|NCT02569957|3480997|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3633439|NCT02569957|3480998|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3633440|NCT02569957|3480999|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633441|NCT02569957|3480997|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633442|NCT02569957|3480998|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633443|NCT02569957|3480999|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633444|NCT02569957|3480997|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3633445|NCT02569957|3480998|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3633446|NCT02569957|3480999|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3633447|NCT02569957|3480997|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3633448|NCT02569957|3480998|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3633449|NCT02569957|3480999|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3633450|NCT02569957|3480997|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3633451|NCT02569957|3480998|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3633452|NCT02569957|3480999|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3633453|NCT02569957|3480997|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3633454|NCT02569957|3480998|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3633455|NCT02569957|3480999|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3633456|NCT02569957|3480997|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3633457|NCT02569957|3480998|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3633458|NCT02569957|3480999|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3633459|NCT02569853|3481030|B3|United States||Region of Enrollment||participants|Number|268|268.0||||||
3633460|NCT02569853|3481031|B2|United States||Region of Enrollment||participants|Number|137|137.0||||||
3633461|NCT02569853|3481032|B1|United States||Region of Enrollment||participants|Number|131|131.0||||||
3633462|NCT02569853|3481030|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3633463|NCT02569853|3481031|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3633464|NCT02569853|3481032|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3633465|NCT02569853|3481030|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633466|NCT02569853|3481031|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633467|NCT02569853|3481032|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633468|NCT02569853|3481030|B3||White|Race (NIH/OMB)||Participants|Count of Participants|203|203.0||||||
3633469|NCT02569853|3481031|B2||White|Race (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
3633470|NCT02569853|3481032|B1||White|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3633471|NCT02569853|3481030|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3633472|NCT02569853|3481031|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3633473|NCT02569853|3481032|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3633474|NCT02569853|3481030|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3633475|NCT02569853|3481031|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3633476|NCT02569853|3481032|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633477|NCT02569853|3481030|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3633478|NCT02569853|3481031|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3633479|NCT02569853|3481032|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3633480|NCT02569853|3481030|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633481|NCT02569853|3481031|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633482|NCT02569853|3481032|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633483|NCT02569853|3481030|B3||Male|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
3633484|NCT02569853|3481031|B2||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3633485|NCT02569853|3481032|B1||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3633486|NCT02569853|3481030|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3633487|NCT02569853|3481031|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3633488|NCT02569853|3481032|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3633489|NCT02569853|3481030|B3|||Age||years|Mean|41.0|41.0|Standard Deviation|12.38|12.38|||
3633490|NCT02569853|3481031|B2|||Age||years|Mean|40.2|40.2|Standard Deviation|12.28|12.28|||
3633491|NCT02569853|3481032|B1|||Age||years|Mean|41.9|41.9|Standard Deviation|12.47|12.47|||
3633492|NCT02569658|3481041|B3|||reverse total shoulder arthroplasty||Participants|Count of Participants|59|59.0||||||
3633493|NCT02569658|3481042|B2|||reverse total shoulder arthroplasty||Participants|Count of Participants|30|30.0||||||
3633494|NCT02569658|3481043|B1|||reverse total shoulder arthroplasty||Participants|Count of Participants|29|29.0||||||
3633495|NCT02569658|3481041|B3|||operative time||minutes|Mean|101.9|101.9|Standard Deviation|21.5|21.5|||
3633496|NCT02569658|3481042|B2|||operative time||minutes|Mean|102.7|102.7|Standard Deviation|21.6|21.6|||
3633497|NCT02569658|3481043|B1|||operative time||minutes|Mean|101.1|101.1|Standard Deviation|21.4|21.4|||
3633498|NCT02569658|3481041|B3|||weight||kg|Mean|86.4|86.4|Standard Deviation|19.3|19.3|||
3633499|NCT02569658|3481042|B2|||weight||kg|Mean|88.4|88.4|Standard Deviation|19.1|19.1|||
3633500|NCT02569658|3481043|B1|||weight||kg|Mean|84.2|84.2|Standard Deviation|19.6|19.6|||
3633501|NCT02569658|3481041|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3633502|NCT02569658|3481041|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3633503|NCT02569658|3481042|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3633504|NCT02569658|3481043|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3633505|NCT02569658|3481041|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3633506|NCT02569658|3481042|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3633507|NCT02569658|3481043|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3633508|NCT02569658|3481041|B3|||Age||years|Mean|66.4|66.4|Standard Deviation|10|10.0|||
3633509|NCT02569658|3481042|B2|||Age||years|Mean|65.2|65.2|Standard Deviation|9.2|9.2|||
3633510|NCT02569658|3481043|B1|||Age||years|Mean|67.7|67.7|Standard Deviation|10.9|10.9|||
3633511|NCT02569437|3481060|B3|||Number of Participants with Prior Endoscopic Sinus Surgery (ESS)||Participants|Count of Participants|26|26.0||||||
3633512|NCT02569437|3481061|B2|||Number of Participants with Prior Endoscopic Sinus Surgery (ESS)||Participants|Count of Participants|13|13.0||||||
3633513|NCT02569437|3481062|B1|||Number of Participants with Prior Endoscopic Sinus Surgery (ESS)||Participants|Count of Participants|13|13.0||||||
3633514|NCT02569437|3481060|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3633515|NCT02569437|3481061|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3633516|NCT02569437|3481062|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3633517|NCT02569437|3481060|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3633518|NCT02569437|3481061|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3633519|NCT02569437|3481062|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3633520|NCT02569437|3481060|B3|||Age||years|Mean|47.7|47.7|Standard Deviation|13.4|13.4|||
3633521|NCT02569437|3481061|B2|||Age||years|Mean|44.1|44.1|Standard Deviation|12.2|12.2|||
3633522|NCT02569437|3481062|B1|||Age||years|Mean|51.5|51.5|Standard Deviation|13.8|13.8|||
3633523|NCT02569112|3481077|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3633524|NCT02569112|3481077|B1|Male||Sex/Gender, Customized||participants|Number|1|1.0||||||
3633525|NCT02569112|3481077|B1|Female||Sex/Gender, Customized||participants|Number|9|9.0||||||
3633526|NCT02569112|3481077|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3633527|NCT02569112|3481077|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3633528|NCT02569112|3481077|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3633529|NCT02569086|3481083|B1|||estimated creatinine clearance (eCLCr)||mL/minute|Median|106|106.0|Inter-Quartile Range|||46.0|152.0|
3633530|NCT02569086|3481083|B1|||Body weight||kg|Median|76|76.0|Inter-Quartile Range|||64.0|82.0|
3633531|NCT02569086|3481083|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3633532|NCT02569086|3481083|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3633533|NCT02569086|3481083|B1|||Age||years|Median|57|57.0|Inter-Quartile Range|||33.0|76.0|
3633534|NCT02568852|3481088|B3|||BMI|BMI:Body Mass Index|kg/m^2|Median|28.15|28.15|Standard Deviation|3.72|3.72|||
3633535|NCT02568852|3481089|B2|||BMI|BMI:Body Mass Index|kg/m^2|Median|28.2|28.2|Standard Deviation|3.5|3.5|||
3633536|NCT02568852|3481090|B1|||BMI|BMI:Body Mass Index|kg/m^2|Median|28.1|28.1|Standard Deviation|4.0|4.0|||
3633537|NCT02568852|3481088|B3|||ASA(American Society of Anesthesiologists ) scores|ASA scores:ASA 1(better) and ASA VI(worse) ASA I:A normal healthy patient ASA II:A patient with mild systemic disease ASA III:A patient with severe systemic disease ASA IV:A patient with severe systemic disease that is a constant threat to life ASA V:A moribund patient who is not expected to survive without the operation ASA VI:A declared brain-dead patient whose organs are being removed for donor purposes|Scores on a scale(min:1 and max:6)|Median|2|2.0|Full Range|||1.0|3.0|
3633709|NCT02566759|3481300|B10|Current drinker||Alcohol history||participants|Number|3|3.0||||||
3633538|NCT02568852|3481089|B2|||ASA(American Society of Anesthesiologists ) scores|ASA scores:ASA 1(better) and ASA VI(worse) ASA I:A normal healthy patient ASA II:A patient with mild systemic disease ASA III:A patient with severe systemic disease ASA IV:A patient with severe systemic disease that is a constant threat to life ASA V:A moribund patient who is not expected to survive without the operation ASA VI:A declared brain-dead patient whose organs are being removed for donor purposes|Scores on a scale(min:1 and max:6)|Median|2|2.0|Full Range|||1.0|3.0|
3633539|NCT02568852|3481090|B1|||ASA(American Society of Anesthesiologists ) scores|ASA scores:ASA 1(better) and ASA VI(worse) ASA I:A normal healthy patient ASA II:A patient with mild systemic disease ASA III:A patient with severe systemic disease ASA IV:A patient with severe systemic disease that is a constant threat to life ASA V:A moribund patient who is not expected to survive without the operation ASA VI:A declared brain-dead patient whose organs are being removed for donor purposes|Scores on a scale(min:1 and max:6)|Median|1|1.0|Full Range|||1.0|3.0|
3633540|NCT02568852|3481088|B3|Turkey||Region of Enrollment||participants|Number|50|50.0||||||
3633541|NCT02568852|3481089|B2|Turkey||Region of Enrollment||participants|Number|25|25.0||||||
3633542|NCT02568852|3481090|B1|Turkey||Region of Enrollment||participants|Number|25|25.0||||||
3633543|NCT02568852|3481088|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3633544|NCT02568852|3481089|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3633545|NCT02568852|3481090|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3633546|NCT02568852|3481088|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3633547|NCT02568852|3481089|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3633548|NCT02568852|3481090|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3633549|NCT02568852|3481088|B3|||Age||years|Median|48|48.0|Full Range|||19.0|79.0|
3633550|NCT02568852|3481089|B2|||Age||years|Median|52|52.0|Full Range|||27.0|79.0|
3633551|NCT02568852|3481090|B1|||Age||years|Median|46|46.0|Full Range|||19.0|69.0|
3633552|NCT02568384|3481127|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
3633553|NCT02568384|3481127|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633554|NCT02568384|3481127|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633555|NCT02568384|3481127|B1||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3633556|NCT02568384|3481127|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3633557|NCT02568384|3481127|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3633558|NCT02568384|3481127|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3633559|NCT02568384|3481127|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633560|NCT02568384|3481127|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633561|NCT02568384|3481127|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3633562|NCT02568384|3481127|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3633563|NCT02568384|3481127|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3633564|NCT02568384|3481127|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3633565|NCT02568384|3481127|B1|||Age||years|Mean|45.9|45.9|Full Range|||19.0|75.0|
3633566|NCT02568345|3481137|B1|||body mass index: kg.m^2||kg/m^2|Median|49.3|49.3|Inter-Quartile Range|||44.3|52.0|
3633567|NCT02568345|3481137|B1|Brazil||Region of Enrollment||participants|Number|31|31.0||||||
3633568|NCT02568345|3481137|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3633569|NCT02568345|3481137|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3633570|NCT02568345|3481137|B1|||Age||years|Median|42|42.0|Inter-Quartile Range|||35.0|45.0|
3633571|NCT02568345|3481137|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3633572|NCT02568345|3481137|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3633573|NCT02568345|3481137|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3633574|NCT02568254|3481141|B1|North America||Region of Enrollment||Participants|Number|74|74.0||||||
3633575|NCT02568254|3481141|B1|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3633576|NCT02568254|3481141|B1|White||Race/Ethnicity, Customized||Participants|Number|45|45.0||||||
3633577|NCT02568254|3481141|B1|Asian||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
3633578|NCT02568254|3481141|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3633579|NCT02568254|3481141|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3633580|NCT02568254|3481141|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3633581|NCT02568254|3481141|B1|||Age||Years|Mean|24.3|24.3|Standard Deviation|5.71|5.71|||
3633582|NCT02567968|3481154|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3633583|NCT02567968|3481154|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3633584|NCT02567968|3481154|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3633585|NCT02567968|3481154|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3633586|NCT02567968|3481154|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3633587|NCT02567968|3481154|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3633588|NCT02567968|3481154|B1|||Age||years|Mean|31|31.0|Standard Deviation|4.3|4.3|||
3633589|NCT02567708|3481177|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
3633590|NCT02567708|3481177|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3633591|NCT02567708|3481177|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3633593|NCT02567552|3481217|B3|||Endometrial Thickness|Endometrial Thickness in day 0|mm|Mean|9.23|9.23|Standard Deviation|1.80|1.8|||
3633594|NCT02567552|3481218|B2|||Endometrial Thickness|Endometrial Thickness in day 0|mm|Mean|9.58|9.58|Standard Deviation|1.61|1.61|||
3633595|NCT02567552|3481219|B1|||Endometrial Thickness|Endometrial Thickness in day 0|mm|Mean|8.88|8.88|Standard Deviation|1.98|1.98|||
3633596|NCT02567552|3481217|B3|||Blood LH level|Blood LH level in day -2|pg/ml|Mean|1.25|1.25|Standard Deviation|0.70|0.7|||
3633597|NCT02567552|3481218|B2|||Blood LH level|Blood LH level in day -2|pg/ml|Mean|1.24|1.24|Standard Deviation|0.91|0.91|||
3633598|NCT02567552|3481219|B1|||Blood LH level|Blood LH level in day -2|pg/ml|Mean|1.25|1.25|Standard Deviation|0.45|0.45|||
3633599|NCT02567552|3481217|B3|||Blood Estradiol Level|Blood Estradiol Level in day -2|pg/ml|Mean|2262.52|2262.52|Standard Deviation|1078.94|1078.94|||
3633600|NCT02567552|3481218|B2|||Blood Estradiol Level|Blood Estradiol Level in day -2|pg/ml|Mean|2464.33|2464.33|Standard Deviation|1144.19|1144.19|||
3633601|NCT02567552|3481219|B1|||Blood Estradiol Level|Blood Estradiol Level in day -2|pg/ml|Mean|2020.35|2020.35|Standard Deviation|998.36|998.36|||
3633602|NCT02567552|3481217|B3|||Blood Progesterone Level|Blood progesterone level in Day -2|ng/ml|Mean|1.37|1.37|Standard Deviation|0.79|0.79|||
3633603|NCT02567552|3481218|B2|||Blood Progesterone Level|Blood progesterone level in Day -2|ng/ml|Mean|1.44|1.44|Standard Deviation|0.77|0.77|||
3633604|NCT02567552|3481219|B1|||Blood Progesterone Level|Blood progesterone level in Day -2|ng/ml|Mean|1.31|1.31|Standard Deviation|0.85|0.85|||
3633605|NCT02567552|3481217|B3|||Weight||Kg|Mean|61.00|61.0|Standard Deviation|9.12|9.12|||
3633606|NCT02567552|3481218|B2|||Weight||Kg|Mean|61.00|61.0|Standard Deviation|8.55|8.55|||
3633607|NCT02567552|3481219|B1|||Weight||Kg|Mean|61.00|61.0|Standard Deviation|10.05|10.05|||
3633608|NCT02567552|3481217|B3|||Height||cm|Mean|164.42|164.42|Standard Deviation|4.90|4.9|||
3633609|NCT02567552|3481218|B2|||Height||cm|Mean|162.08|162.08|Standard Deviation|3.50|3.5|||
3633610|NCT02567552|3481219|B1|||Height||cm|Mean|166.75|166.75|Standard Deviation|5.10|5.1|||
3633611|NCT02567552|3481217|B3|||Body Mass Index||kg/m^2|Mean|22.44|22.44|Standard Deviation|2.86|2.86|||
3633612|NCT02567552|3481218|B2|||Body Mass Index||kg/m^2|Mean|23.12|23.12|Standard Deviation|2.79|2.79|||
3633613|NCT02567552|3481219|B1|||Body Mass Index||kg/m^2|Mean|21.76|21.76|Standard Deviation|2.88|2.88|||
3633614|NCT02567552|3481217|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3633615|NCT02567552|3481218|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3633616|NCT02567552|3481219|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3633617|NCT02567552|3481217|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3633618|NCT02567552|3481218|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3633619|NCT02567552|3481219|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3633620|NCT02567552|3481217|B3|||Age||years|Mean|26.25|26.25|Standard Deviation|4.09|4.09|||
3633621|NCT02567552|3481218|B2|||Age||years|Mean|25.58|25.58|Standard Deviation|2.39|2.39|||
3633622|NCT02567552|3481219|B1|||Age||years|Mean|26.92|26.92|Standard Deviation|5.32|5.32|||
3633623|NCT02567188|3481250|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3633624|NCT02567188|3481250|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3633625|NCT02567188|3481250|B1|||Age||years|Mean|66.2|66.2|Standard Deviation|16.5|16.5|||
3633626|NCT02566785|3481279|B3|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3633627|NCT02566785|3481280|B2|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3633628|NCT02566785|3481281|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3633629|NCT02566785|3481279|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633630|NCT02566785|3481280|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633631|NCT02566785|3481281|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633632|NCT02566785|3481279|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633633|NCT02566785|3481280|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633634|NCT02566785|3481281|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633635|NCT02566785|3481279|B3||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3633636|NCT02566785|3481280|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3633637|NCT02566785|3481281|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3633638|NCT02566785|3481279|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633639|NCT02566785|3481280|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633640|NCT02566785|3481281|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633641|NCT02566785|3481279|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633642|NCT02566785|3481280|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633643|NCT02566785|3481281|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633644|NCT02566785|3481279|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633645|NCT02566785|3481280|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633646|NCT02566785|3481281|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633647|NCT02566785|3481279|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633648|NCT02566785|3481280|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633649|NCT02566785|3481281|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633650|NCT02566785|3481279|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3633651|NCT02566785|3481280|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3633652|NCT02566785|3481281|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3633653|NCT02566785|3481279|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3633654|NCT02566785|3481280|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3633655|NCT02566785|3481281|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3633656|NCT02566785|3481279|B3||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
3633657|NCT02566785|3481280|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3633658|NCT02566785|3481281|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3633659|NCT02566785|3481279|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3633660|NCT02566785|3481280|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3633661|NCT02566785|3481281|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3633662|NCT02566785|3481279|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3633663|NCT02566785|3481280|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3633664|NCT02566785|3481281|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3633665|NCT02566759|3481292|B18|No caffeine consumption||Caffeine Consumption||participants|Number|32|32.0||||||
3633666|NCT02566759|3481293|B17|No caffeine consumption||Caffeine Consumption||participants|Number|4|4.0||||||
3633667|NCT02566759|3481294|B16|No caffeine consumption||Caffeine Consumption||participants|Number|4|4.0||||||
3633668|NCT02566759|3481295|B15|No caffeine consumption||Caffeine Consumption||participants|Number|0|0.0||||||
3633669|NCT02566759|3481296|B14|No caffeine consumption||Caffeine Consumption||participants|Number|2|2.0||||||
3633670|NCT02566759|3481297|B13|No caffeine consumption||Caffeine Consumption||participants|Number|0|0.0||||||
3633671|NCT02566759|3481298|B12|No caffeine consumption||Caffeine Consumption||participants|Number|2|2.0||||||
3633672|NCT02566759|3481299|B11|No caffeine consumption||Caffeine Consumption||participants|Number|2|2.0||||||
3633673|NCT02566759|3481300|B10|No caffeine consumption||Caffeine Consumption||participants|Number|2|2.0||||||
3633674|NCT02566759|3481301|B9|No caffeine consumption||Caffeine Consumption||participants|Number|3|3.0||||||
3633675|NCT02566759|3481302|B8|No caffeine consumption||Caffeine Consumption||participants|Number|5|5.0||||||
3633676|NCT02566759|3481303|B7|No caffeine consumption||Caffeine Consumption||participants|Number|0|0.0||||||
3633677|NCT02566759|3481304|B6|No caffeine consumption||Caffeine Consumption||participants|Number|2|2.0||||||
3633678|NCT02566759|3481305|B5|No caffeine consumption||Caffeine Consumption||participants|Number|1|1.0||||||
3633679|NCT02566759|3481306|B4|No caffeine consumption||Caffeine Consumption||participants|Number|1|1.0||||||
3633680|NCT02566759|3481307|B3|No caffeine consumption||Caffeine Consumption||participants|Number|2|2.0||||||
3633681|NCT02566759|3481308|B2|No caffeine consumption||Caffeine Consumption||participants|Number|0|0.0||||||
3633682|NCT02566759|3481309|B1|No caffeine consumption||Caffeine Consumption||participants|Number|2|2.0||||||
3633683|NCT02566759|3481292|B18|Caffeine consumption||Caffeine Consumption||participants|Number|78|78.0||||||
3633684|NCT02566759|3481293|B17|Caffeine consumption||Caffeine Consumption||participants|Number|4|4.0||||||
3633685|NCT02566759|3481294|B16|Caffeine consumption||Caffeine Consumption||participants|Number|4|4.0||||||
3633686|NCT02566759|3481295|B15|Caffeine consumption||Caffeine Consumption||participants|Number|8|8.0||||||
3633687|NCT02566759|3481296|B14|Caffeine consumption||Caffeine Consumption||participants|Number|3|3.0||||||
3633688|NCT02566759|3481297|B13|Caffeine consumption||Caffeine Consumption||participants|Number|1|1.0||||||
3633689|NCT02566759|3481298|B12|Caffeine consumption||Caffeine Consumption||participants|Number|4|4.0||||||
3633690|NCT02566759|3481299|B11|Caffeine consumption||Caffeine Consumption||participants|Number|4|4.0||||||
3633691|NCT02566759|3481300|B10|Caffeine consumption||Caffeine Consumption||participants|Number|4|4.0||||||
3633692|NCT02566759|3481301|B9|Caffeine consumption||Caffeine Consumption||participants|Number|3|3.0||||||
3633693|NCT02566759|3481302|B8|Caffeine consumption||Caffeine Consumption||participants|Number|3|3.0||||||
3633694|NCT02566759|3481303|B7|Caffeine consumption||Caffeine Consumption||participants|Number|6|6.0||||||
3633695|NCT02566759|3481304|B6|Caffeine consumption||Caffeine Consumption||participants|Number|4|4.0||||||
3633696|NCT02566759|3481305|B5|Caffeine consumption||Caffeine Consumption||participants|Number|5|5.0||||||
3633697|NCT02566759|3481306|B4|Caffeine consumption||Caffeine Consumption||participants|Number|5|5.0||||||
3633698|NCT02566759|3481307|B3|Caffeine consumption||Caffeine Consumption||participants|Number|4|4.0||||||
3633699|NCT02566759|3481308|B2|Caffeine consumption||Caffeine Consumption||participants|Number|6|6.0||||||
3633700|NCT02566759|3481309|B1|Caffeine consumption||Caffeine Consumption||participants|Number|10|10.0||||||
3633701|NCT02566759|3481292|B18|Current drinker||Alcohol history||participants|Number|77|77.0||||||
3633702|NCT02566759|3481293|B17|Current drinker||Alcohol history||participants|Number|7|7.0||||||
3633703|NCT02566759|3481294|B16|Current drinker||Alcohol history||participants|Number|7|7.0||||||
3633704|NCT02566759|3481295|B15|Current drinker||Alcohol history||participants|Number|6|6.0||||||
3633705|NCT02566759|3481296|B14|Current drinker||Alcohol history||participants|Number|2|2.0||||||
3633706|NCT02566759|3481297|B13|Current drinker||Alcohol history||participants|Number|0|0.0||||||
3633707|NCT02566759|3481298|B12|Current drinker||Alcohol history||participants|Number|6|6.0||||||
3633708|NCT02566759|3481299|B11|Current drinker||Alcohol history||participants|Number|6|6.0||||||
3633710|NCT02566759|3481301|B9|Current drinker||Alcohol history||participants|Number|2|2.0||||||
3633711|NCT02566759|3481302|B8|Current drinker||Alcohol history||participants|Number|5|5.0||||||
3633712|NCT02566759|3481303|B7|Current drinker||Alcohol history||participants|Number|2|2.0||||||
3633713|NCT02566759|3481304|B6|Current drinker||Alcohol history||participants|Number|5|5.0||||||
3633714|NCT02566759|3481305|B5|Current drinker||Alcohol history||participants|Number|5|5.0||||||
3633715|NCT02566759|3481306|B4|Current drinker||Alcohol history||participants|Number|4|4.0||||||
3633716|NCT02566759|3481307|B3|Current drinker||Alcohol history||participants|Number|3|3.0||||||
3633717|NCT02566759|3481308|B2|Current drinker||Alcohol history||participants|Number|5|5.0||||||
3633718|NCT02566759|3481309|B1|Current drinker||Alcohol history||participants|Number|9|9.0||||||
3633719|NCT02566759|3481292|B18|Never drunk||Alcohol history||participants|Number|33|33.0||||||
3633720|NCT02566759|3481293|B17|Never drunk||Alcohol history||participants|Number|1|1.0||||||
3633721|NCT02566759|3481294|B16|Never drunk||Alcohol history||participants|Number|1|1.0||||||
3633722|NCT02566759|3481295|B15|Never drunk||Alcohol history||participants|Number|2|2.0||||||
3633723|NCT02566759|3481296|B14|Never drunk||Alcohol history||participants|Number|3|3.0||||||
3633724|NCT02566759|3481297|B13|Never drunk||Alcohol history||participants|Number|1|1.0||||||
3633725|NCT02566759|3481298|B12|Never drunk||Alcohol history||participants|Number|0|0.0||||||
3633726|NCT02566759|3481299|B11|Never drunk||Alcohol history||participants|Number|0|0.0||||||
3633727|NCT02566759|3481300|B10|Never drunk||Alcohol history||participants|Number|3|3.0||||||
3633728|NCT02566759|3481301|B9|Never drunk||Alcohol history||participants|Number|4|4.0||||||
3633729|NCT02566759|3481302|B8|Never drunk||Alcohol history||participants|Number|3|3.0||||||
3633730|NCT02566759|3481303|B7|Never drunk||Alcohol history||participants|Number|4|4.0||||||
3633731|NCT02566759|3481304|B6|Never drunk||Alcohol history||participants|Number|1|1.0||||||
3633732|NCT02566759|3481305|B5|Never drunk||Alcohol history||participants|Number|1|1.0||||||
3633733|NCT02566759|3481306|B4|Never drunk||Alcohol history||participants|Number|2|2.0||||||
3633734|NCT02566759|3481307|B3|Never drunk||Alcohol history||participants|Number|3|3.0||||||
3633735|NCT02566759|3481308|B2|Never drunk||Alcohol history||participants|Number|1|1.0||||||
3633736|NCT02566759|3481309|B1|Never drunk||Alcohol history||participants|Number|3|3.0||||||
3633737|NCT02566759|3481292|B18|Ex-smoker||Smoking History||participants|Number|28|28.0||||||
3633738|NCT02566759|3481293|B17|Ex-smoker||Smoking History||participants|Number|2|2.0||||||
3633739|NCT02566759|3481294|B16|Ex-smoker||Smoking History||participants|Number|3|3.0||||||
3633740|NCT02566759|3481295|B15|Ex-smoker||Smoking History||participants|Number|0|0.0||||||
3633741|NCT02566759|3481296|B14|Ex-smoker||Smoking History||participants|Number|1|1.0||||||
3633742|NCT02566759|3481297|B13|Ex-smoker||Smoking History||participants|Number|0|0.0||||||
3633743|NCT02566759|3481298|B12|Ex-smoker||Smoking History||participants|Number|1|1.0||||||
3633744|NCT02566759|3481299|B11|Ex-smoker||Smoking History||participants|Number|2|2.0||||||
3633745|NCT02566759|3481300|B10|Ex-smoker||Smoking History||participants|Number|1|1.0||||||
3633746|NCT02566759|3481301|B9|Ex-smoker||Smoking History||participants|Number|1|1.0||||||
3633747|NCT02566759|3481302|B8|Ex-smoker||Smoking History||participants|Number|3|3.0||||||
3633748|NCT02566759|3481303|B7|Ex-smoker||Smoking History||participants|Number|0|0.0||||||
3633749|NCT02566759|3481304|B6|Ex-smoker||Smoking History||participants|Number|3|3.0||||||
3633750|NCT02566759|3481305|B5|Ex-smoker||Smoking History||participants|Number|3|3.0||||||
3633751|NCT02566759|3481306|B4|Ex-smoker||Smoking History||participants|Number|1|1.0||||||
3633752|NCT02566759|3481307|B3|Ex-smoker||Smoking History||participants|Number|1|1.0||||||
3633753|NCT02566759|3481308|B2|Ex-smoker||Smoking History||participants|Number|2|2.0||||||
3633754|NCT02566759|3481309|B1|Ex-smoker||Smoking History||participants|Number|4|4.0||||||
3633755|NCT02566759|3481292|B18|Never smoked||Smoking History||participants|Number|82|82.0||||||
3633756|NCT02566759|3481293|B17|Never smoked||Smoking History||participants|Number|6|6.0||||||
3633757|NCT02566759|3481294|B16|Never smoked||Smoking History||participants|Number|5|5.0||||||
3633758|NCT02566759|3481295|B15|Never smoked||Smoking History||participants|Number|8|8.0||||||
3633759|NCT02566759|3481296|B14|Never smoked||Smoking History||participants|Number|4|4.0||||||
3633760|NCT02566759|3481297|B13|Never smoked||Smoking History||participants|Number|1|1.0||||||
3633761|NCT02566759|3481298|B12|Never smoked||Smoking History||participants|Number|5|5.0||||||
3633762|NCT02566759|3481299|B11|Never smoked||Smoking History||participants|Number|4|4.0||||||
3633763|NCT02566759|3481300|B10|Never smoked||Smoking History||participants|Number|5|5.0||||||
3633764|NCT02566759|3481301|B9|Never smoked||Smoking History||participants|Number|5|5.0||||||
3633765|NCT02566759|3481302|B8|Never smoked||Smoking History||participants|Number|5|5.0||||||
3633766|NCT02566759|3481303|B7|Never smoked||Smoking History||participants|Number|6|6.0||||||
3633767|NCT02566759|3481304|B6|Never smoked||Smoking History||participants|Number|3|3.0||||||
3633768|NCT02566759|3481305|B5|Never smoked||Smoking History||participants|Number|3|3.0||||||
3633769|NCT02566759|3481306|B4|Never smoked||Smoking History||participants|Number|5|5.0||||||
3633770|NCT02566759|3481307|B3|Never smoked||Smoking History||participants|Number|5|5.0||||||
3633771|NCT02566759|3481308|B2|Never smoked||Smoking History||participants|Number|4|4.0||||||
3633772|NCT02566759|3481309|B1|Never smoked||Smoking History||participants|Number|8|8.0||||||
3633773|NCT02566759|3481292|B18|United Kingdom||Region of Enrollment||participants|Number|110|110.0||||||
3633774|NCT02566759|3481293|B17|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3633775|NCT02566759|3481294|B16|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3633776|NCT02566759|3481295|B15|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3633777|NCT02566759|3481296|B14|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
3633778|NCT02566759|3481297|B13|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3633779|NCT02566759|3481298|B12|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3633780|NCT02566759|3481299|B11|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3633781|NCT02566759|3481300|B10|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3633782|NCT02566759|3481301|B9|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3633783|NCT02566759|3481302|B8|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3633784|NCT02566759|3481303|B7|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3633785|NCT02566759|3481304|B6|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3633786|NCT02566759|3481305|B5|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3633787|NCT02566759|3481306|B4|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3633788|NCT02566759|3481307|B3|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3633789|NCT02566759|3481308|B2|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3633790|NCT02566759|3481309|B1|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
3633791|NCT02566759|3481292|B18||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633792|NCT02566759|3481293|B17||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633793|NCT02566759|3481294|B16||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633794|NCT02566759|3481295|B15||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633795|NCT02566759|3481296|B14||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633796|NCT02566759|3481297|B13||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633797|NCT02566759|3481298|B12||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633798|NCT02566759|3481299|B11||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633799|NCT02566759|3481300|B10||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633800|NCT02566759|3481301|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633801|NCT02566759|3481302|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633802|NCT02566759|3481303|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633803|NCT02566759|3481304|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633804|NCT02566759|3481305|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633805|NCT02566759|3481306|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633806|NCT02566759|3481307|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633807|NCT02566759|3481308|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633808|NCT02566759|3481309|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633809|NCT02566759|3481292|B18||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3633810|NCT02566759|3481293|B17||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633811|NCT02566759|3481294|B16||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633812|NCT02566759|3481295|B15||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3633813|NCT02566759|3481296|B14||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633814|NCT02566759|3481297|B13||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633815|NCT02566759|3481298|B12||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633816|NCT02566759|3481299|B11||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633817|NCT02566759|3481300|B10||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633818|NCT02566759|3481301|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633819|NCT02566759|3481302|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633820|NCT02566759|3481303|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633821|NCT02566759|3481304|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633822|NCT02566759|3481305|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633823|NCT02566759|3481306|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633824|NCT02566759|3481307|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633825|NCT02566759|3481308|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633826|NCT02566759|3481309|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633827|NCT02566759|3481292|B18||White|Race (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
3633828|NCT02566759|3481293|B17||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3633829|NCT02566759|3481294|B16||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3633830|NCT02566759|3481295|B15||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3633831|NCT02566759|3481296|B14||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3633832|NCT02566759|3481297|B13||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3633833|NCT02566759|3481298|B12||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3633834|NCT02566759|3481299|B11||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3633835|NCT02566759|3481300|B10||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3633836|NCT02566759|3481301|B9||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3633837|NCT02566759|3481302|B8||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3633838|NCT02566759|3481303|B7||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3633839|NCT02566759|3481304|B6||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3633840|NCT02566759|3481305|B5||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3633841|NCT02566759|3481306|B4||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3633842|NCT02566759|3481307|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3633843|NCT02566759|3481308|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3633844|NCT02566759|3481309|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3633845|NCT02566759|3481292|B18||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3633846|NCT02566759|3481293|B17||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633847|NCT02566759|3481294|B16||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633848|NCT02566759|3481295|B15||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3633849|NCT02566759|3481296|B14||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633850|NCT02566759|3481297|B13||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633851|NCT02566759|3481298|B12||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633852|NCT02566759|3481299|B11||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633853|NCT02566759|3481300|B10||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3633854|NCT02566759|3481301|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3633855|NCT02566759|3481302|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3633856|NCT02566759|3481303|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633857|NCT02566759|3481304|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633858|NCT02566759|3481305|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633859|NCT02566759|3481306|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3633860|NCT02566759|3481307|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633861|NCT02566759|3481308|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3633862|NCT02566759|3481309|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633863|NCT02566759|3481292|B18||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633864|NCT02566759|3481293|B17||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633865|NCT02566759|3481294|B16||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633866|NCT02566759|3481295|B15||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633867|NCT02566759|3481296|B14||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633868|NCT02566759|3481297|B13||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633869|NCT02566759|3481298|B12||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633870|NCT02566759|3481299|B11||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633871|NCT02566759|3481300|B10||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633872|NCT02566759|3481301|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633873|NCT02566759|3481302|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633874|NCT02566759|3481303|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633875|NCT02566759|3481304|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633876|NCT02566759|3481305|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633877|NCT02566759|3481306|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633878|NCT02566759|3481307|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633879|NCT02566759|3481308|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633880|NCT02566759|3481309|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633881|NCT02566759|3481292|B18||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3633882|NCT02566759|3481293|B17||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633883|NCT02566759|3481294|B16||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3633884|NCT02566759|3481295|B15||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633885|NCT02566759|3481296|B14||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3633886|NCT02566759|3481297|B13||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633887|NCT02566759|3481298|B12||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633888|NCT02566759|3481299|B11||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3633889|NCT02566759|3481300|B10||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633890|NCT02566759|3481301|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633891|NCT02566759|3481302|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3633892|NCT02566759|3481303|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3633893|NCT02566759|3481304|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633894|NCT02566759|3481305|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3633895|NCT02566759|3481306|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633896|NCT02566759|3481307|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3633897|NCT02566759|3481308|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633898|NCT02566759|3481309|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3633899|NCT02566759|3481292|B18||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633900|NCT02566759|3481293|B17||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633901|NCT02566759|3481294|B16||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633902|NCT02566759|3481295|B15||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633903|NCT02566759|3481296|B14||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633904|NCT02566759|3481297|B13||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633905|NCT02566759|3481298|B12||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633906|NCT02566759|3481299|B11||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633907|NCT02566759|3481300|B10||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633908|NCT02566759|3481301|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633909|NCT02566759|3481302|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633910|NCT02566759|3481303|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633911|NCT02566759|3481304|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633912|NCT02566759|3481305|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633913|NCT02566759|3481306|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633914|NCT02566759|3481307|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633915|NCT02566759|3481308|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633916|NCT02566759|3481309|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3633917|NCT02566759|3481292|B18|Male||Sex/Gender, Customized||participants|Number|110|110.0||||||
3633918|NCT02566759|3481293|B17|Male||Sex/Gender, Customized||participants|Number|8|8.0||||||
3633919|NCT02566759|3481294|B16|Male||Sex/Gender, Customized||participants|Number|8|8.0||||||
3633920|NCT02566759|3481295|B15|Male||Sex/Gender, Customized||participants|Number|8|8.0||||||
3633921|NCT02566759|3481296|B14|Male||Sex/Gender, Customized||participants|Number|5|5.0||||||
3633922|NCT02566759|3481297|B13|Male||Sex/Gender, Customized||participants|Number|1|1.0||||||
3633923|NCT02566759|3481298|B12|Male||Sex/Gender, Customized||participants|Number|6|6.0||||||
3633924|NCT02566759|3481299|B11|Male||Sex/Gender, Customized||participants|Number|6|6.0||||||
3633925|NCT02566759|3481300|B10|Male||Sex/Gender, Customized||participants|Number|6|6.0||||||
3633926|NCT02566759|3481301|B9|Male||Sex/Gender, Customized||participants|Number|6|6.0||||||
3633927|NCT02566759|3481302|B8|Male||Sex/Gender, Customized||participants|Number|8|8.0||||||
3633928|NCT02566759|3481303|B7|Male||Sex/Gender, Customized||participants|Number|6|6.0||||||
3633929|NCT02566759|3481304|B6|Male||Sex/Gender, Customized||participants|Number|6|6.0||||||
3633930|NCT02566759|3481305|B5|Male||Sex/Gender, Customized||participants|Number|6|6.0||||||
3633931|NCT02566759|3481306|B4|Male||Sex/Gender, Customized||participants|Number|6|6.0||||||
3633932|NCT02566759|3481307|B3|Male||Sex/Gender, Customized||participants|Number|6|6.0||||||
3633933|NCT02566759|3481308|B2|Male||Sex/Gender, Customized||participants|Number|6|6.0||||||
3633934|NCT02566759|3481309|B1|Male||Sex/Gender, Customized||participants|Number|12|12.0||||||
3633935|NCT02566759|3481292|B18|18 to 55 years||Age, Customized||participants|Number|110|110.0||||||
3633936|NCT02566759|3481293|B17|18 to 55 years||Age, Customized||participants|Number|8|8.0||||||
3633937|NCT02566759|3481294|B16|18 to 55 years||Age, Customized||participants|Number|8|8.0||||||
3633938|NCT02566759|3481295|B15|18 to 55 years||Age, Customized||participants|Number|8|8.0||||||
3633939|NCT02566759|3481296|B14|18 to 55 years||Age, Customized||participants|Number|5|5.0||||||
3633940|NCT02566759|3481297|B13|18 to 55 years||Age, Customized||participants|Number|1|1.0||||||
3633941|NCT02566759|3481298|B12|18 to 55 years||Age, Customized||participants|Number|6|6.0||||||
3633942|NCT02566759|3481299|B11|18 to 55 years||Age, Customized||participants|Number|6|6.0||||||
3633943|NCT02566759|3481300|B10|18 to 55 years||Age, Customized||participants|Number|6|6.0||||||
3633944|NCT02566759|3481301|B9|18 to 55 years||Age, Customized||participants|Number|6|6.0||||||
3633945|NCT02566759|3481302|B8|18 to 55 years||Age, Customized||participants|Number|8|8.0||||||
3633946|NCT02566759|3481303|B7|18 to 55 years||Age, Customized||participants|Number|6|6.0||||||
3633947|NCT02566759|3481304|B6|18 to 55 years||Age, Customized||participants|Number|6|6.0||||||
3633948|NCT02566759|3481305|B5|18 to 55 years||Age, Customized||participants|Number|6|6.0||||||
3633949|NCT02566759|3481306|B4|18 to 55 years||Age, Customized||participants|Number|6|6.0||||||
3633950|NCT02566759|3481307|B3|18 to 55 years||Age, Customized||participants|Number|6|6.0||||||
3633951|NCT02566759|3481308|B2|18 to 55 years||Age, Customized||participants|Number|6|6.0||||||
3633952|NCT02566759|3481309|B1|18 to 55 years||Age, Customized||participants|Number|12|12.0||||||
3633953|NCT02566135|3481476|B3|||BMI (body mass index)||Kg/m2|Mean|21.36|21.36|Standard Deviation|2.57|2.57|||
3633954|NCT02566135|3481477|B2|||BMI (body mass index)||Kg/m2|Mean|21.43|21.43|Standard Deviation|2.19|2.19|||
3633955|NCT02566135|3481478|B1|||BMI (body mass index)||Kg/m2|Mean|21.30|21.3|Standard Deviation|2.96|2.96|||
3633956|NCT02566135|3481476|B3|ASAPS II||ASAPS ( American society of Anaesthesiologist's physical ststus|"ASA I:~A normal healthy patient Healthy, non-smoking, no or minimal alcohol use~ASA II:~A patient with mild systemic disease Mild diseases only without substantive functional limitations.~ASA III:~A patient with severe systemic disease Substantive functional limitations; One or more moderate to severe diseases.~ASA IV:~A patient with severe systemic disease that is a constant threat to life~ASA V:~A moribund patient who is not expected to survive without the operation~ASA VI:~A declared brain-dead patient whose organs are being removed for donor purposes"|participants|Number|14|14.0||||||
3633957|NCT02566135|3481477|B2|ASAPS II||ASAPS ( American society of Anaesthesiologist's physical ststus|"ASA I:~A normal healthy patient Healthy, non-smoking, no or minimal alcohol use~ASA II:~A patient with mild systemic disease Mild diseases only without substantive functional limitations.~ASA III:~A patient with severe systemic disease Substantive functional limitations; One or more moderate to severe diseases.~ASA IV:~A patient with severe systemic disease that is a constant threat to life~ASA V:~A moribund patient who is not expected to survive without the operation~ASA VI:~A declared brain-dead patient whose organs are being removed for donor purposes"|participants|Number|6|6.0||||||
3633958|NCT02566135|3481478|B1|ASAPS II||ASAPS ( American society of Anaesthesiologist's physical ststus|"ASA I:~A normal healthy patient Healthy, non-smoking, no or minimal alcohol use~ASA II:~A patient with mild systemic disease Mild diseases only without substantive functional limitations.~ASA III:~A patient with severe systemic disease Substantive functional limitations; One or more moderate to severe diseases.~ASA IV:~A patient with severe systemic disease that is a constant threat to life~ASA V:~A moribund patient who is not expected to survive without the operation~ASA VI:~A declared brain-dead patient whose organs are being removed for donor purposes"|participants|Number|8|8.0||||||
3633959|NCT02566135|3481476|B3|ASAPS I||ASAPS ( American society of Anaesthesiologist's physical ststus|"ASA I:~A normal healthy patient Healthy, non-smoking, no or minimal alcohol use~ASA II:~A patient with mild systemic disease Mild diseases only without substantive functional limitations.~ASA III:~A patient with severe systemic disease Substantive functional limitations; One or more moderate to severe diseases.~ASA IV:~A patient with severe systemic disease that is a constant threat to life~ASA V:~A moribund patient who is not expected to survive without the operation~ASA VI:~A declared brain-dead patient whose organs are being removed for donor purposes"|participants|Number|44|44.0||||||
3633960|NCT02566135|3481477|B2|ASAPS I||ASAPS ( American society of Anaesthesiologist's physical ststus|"ASA I:~A normal healthy patient Healthy, non-smoking, no or minimal alcohol use~ASA II:~A patient with mild systemic disease Mild diseases only without substantive functional limitations.~ASA III:~A patient with severe systemic disease Substantive functional limitations; One or more moderate to severe diseases.~ASA IV:~A patient with severe systemic disease that is a constant threat to life~ASA V:~A moribund patient who is not expected to survive without the operation~ASA VI:~A declared brain-dead patient whose organs are being removed for donor purposes"|participants|Number|23|23.0||||||
3633961|NCT02566135|3481478|B1|ASAPS I||ASAPS ( American society of Anaesthesiologist's physical ststus|"ASA I:~A normal healthy patient Healthy, non-smoking, no or minimal alcohol use~ASA II:~A patient with mild systemic disease Mild diseases only without substantive functional limitations.~ASA III:~A patient with severe systemic disease Substantive functional limitations; One or more moderate to severe diseases.~ASA IV:~A patient with severe systemic disease that is a constant threat to life~ASA V:~A moribund patient who is not expected to survive without the operation~ASA VI:~A declared brain-dead patient whose organs are being removed for donor purposes"|participants|Number|21|21.0||||||
3633962|NCT02566135|3481476|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3633963|NCT02566135|3481477|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3633964|NCT02566135|3481478|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3633965|NCT02566135|3481476|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3633966|NCT02566135|3481477|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3633967|NCT02566135|3481478|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3633968|NCT02566135|3481476|B3|||Age||Years|Mean|35.58|35.58|Standard Deviation|10.68|10.68|||
3633969|NCT02566135|3481477|B2|||Age||Years|Mean|36.13|36.13|Standard Deviation|11.24|11.24|||
3633970|NCT02566135|3481478|B1|||Age||Years|Mean|35.03|35.03|Standard Deviation|10.13|10.13|||
3633971|NCT02566135|3481476|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3633972|NCT02566135|3481477|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3633973|NCT02566135|3481478|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3633974|NCT02566135|3481476|B3||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3633975|NCT02566135|3481477|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3633976|NCT02566135|3481478|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3633977|NCT02566135|3481476|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3633978|NCT02566135|3481477|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3633979|NCT02566135|3481478|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3633980|NCT02566005|3481499|B3|General Anesthesia||Anesthesia||Participants|Count of Participants|3|3.0||||||
3633981|NCT02566005|3481500|B2|General Anesthesia||Anesthesia||Participants|Count of Participants|3|3.0||||||
3633982|NCT02566005|3481501|B1|General Anesthesia||Anesthesia||Participants|Count of Participants|0|0.0||||||
3633983|NCT02566005|3481499|B3|Neuraxial anesthesia||Anesthesia||Participants|Count of Participants|187|187.0||||||
3633984|NCT02566005|3481500|B2|Neuraxial anesthesia||Anesthesia||Participants|Count of Participants|91|91.0||||||
3633985|NCT02566005|3481501|B1|Neuraxial anesthesia||Anesthesia||Participants|Count of Participants|96|96.0||||||
3633986|NCT02566005|3481499|B3|None||Anesthesia||Participants|Count of Participants|10|10.0||||||
3633987|NCT02566005|3481500|B2|None||Anesthesia||Participants|Count of Participants|6|6.0||||||
3633988|NCT02566005|3481501|B1|None||Anesthesia||Participants|Count of Participants|4|4.0||||||
3633989|NCT02566005|3481499|B3|Service||Insurance||Participants|Count of Participants|88|88.0||||||
3633990|NCT02566005|3481500|B2|Service||Insurance||Participants|Count of Participants|47|47.0||||||
3633991|NCT02566005|3481501|B1|Service||Insurance||Participants|Count of Participants|41|41.0||||||
3633992|NCT02566005|3481499|B3|Private||Insurance||Participants|Count of Participants|112|112.0||||||
3633993|NCT02566005|3481500|B2|Private||Insurance||Participants|Count of Participants|53|53.0||||||
3633994|NCT02566005|3481501|B1|Private||Insurance||Participants|Count of Participants|59|59.0||||||
3633995|NCT02566005|3481499|B3|Others||Indications for cesarean delivery||Participants|Count of Participants|1|1.0||||||
3633996|NCT02566005|3481500|B2|Others||Indications for cesarean delivery||Participants|Count of Participants|0|0.0||||||
3633997|NCT02566005|3481501|B1|Others||Indications for cesarean delivery||Participants|Count of Participants|1|1.0||||||
3633998|NCT02566005|3481499|B3|Failed induction of labor||Indications for cesarean delivery||Participants|Count of Participants|4|4.0||||||
3633999|NCT02566005|3481500|B2|Failed induction of labor||Indications for cesarean delivery||Participants|Count of Participants|1|1.0||||||
3634000|NCT02566005|3481501|B1|Failed induction of labor||Indications for cesarean delivery||Participants|Count of Participants|3|3.0||||||
3634001|NCT02566005|3481499|B3|Arrest of descent||Indications for cesarean delivery||Participants|Count of Participants|9|9.0||||||
3634002|NCT02566005|3481500|B2|Arrest of descent||Indications for cesarean delivery||Participants|Count of Participants|4|4.0||||||
3634003|NCT02566005|3481501|B1|Arrest of descent||Indications for cesarean delivery||Participants|Count of Participants|5|5.0||||||
3634004|NCT02566005|3481499|B3|Arrest of dilation||Indications for cesarean delivery||Participants|Count of Participants|15|15.0||||||
3634005|NCT02566005|3481500|B2|Arrest of dilation||Indications for cesarean delivery||Participants|Count of Participants|6|6.0||||||
3634006|NCT02566005|3481501|B1|Arrest of dilation||Indications for cesarean delivery||Participants|Count of Participants|9|9.0||||||
3634007|NCT02566005|3481499|B3|Non-reassuring Fetal tracing||Indications for cesarean delivery||Participants|Count of Participants|39|39.0||||||
3634008|NCT02566005|3481500|B2|Non-reassuring Fetal tracing||Indications for cesarean delivery||Participants|Count of Participants|19|19.0||||||
3634009|NCT02566005|3481501|B1|Non-reassuring Fetal tracing||Indications for cesarean delivery||Participants|Count of Participants|20|20.0||||||
3634010|NCT02566005|3481499|B3|Cesarean Delivery||Mode of delivery||Participants|Count of Participants|68|68.0||||||
3634011|NCT02566005|3481500|B2|Cesarean Delivery||Mode of delivery||Participants|Count of Participants|30|30.0||||||
3634012|NCT02566005|3481501|B1|Cesarean Delivery||Mode of delivery||Participants|Count of Participants|38|38.0||||||
3634013|NCT02566005|3481499|B3|Vacuum Vaginal Delivery||Mode of delivery||Participants|Count of Participants|22|22.0||||||
3634014|NCT02566005|3481500|B2|Vacuum Vaginal Delivery||Mode of delivery||Participants|Count of Participants|10|10.0||||||
3634015|NCT02566005|3481501|B1|Vacuum Vaginal Delivery||Mode of delivery||Participants|Count of Participants|12|12.0||||||
3634016|NCT02566005|3481499|B3|Forceps Vaginal Delivery||Mode of delivery||Participants|Count of Participants|3|3.0||||||
3634017|NCT02566005|3481500|B2|Forceps Vaginal Delivery||Mode of delivery||Participants|Count of Participants|1|1.0||||||
3634018|NCT02566005|3481501|B1|Forceps Vaginal Delivery||Mode of delivery||Participants|Count of Participants|2|2.0||||||
3634019|NCT02566005|3481499|B3|Spontaneous Vaginal Delivery||Mode of delivery||Participants|Count of Participants|107|107.0||||||
3634020|NCT02566005|3481500|B2|Spontaneous Vaginal Delivery||Mode of delivery||Participants|Count of Participants|59|59.0||||||
3634021|NCT02566005|3481501|B1|Spontaneous Vaginal Delivery||Mode of delivery||Participants|Count of Participants|48|48.0||||||
3634022|NCT02566005|3481499|B3|||Bishop score at misoprostol placement|"5 item score, each item scored from 0 to 2-3, with total score from 0 to 13. A woman with a low score of 1 would not be expected to go into labor for about 3 weeks. A woman with a higher score of 10 could be expected to go into labor within a few days.~Also, If the Bishop score is 8 or greater the chances of having a vaginal delivery are good and the cervix is said to be favorable or ripe for induction. If the Bishop score is 6 or less the chances of having a vaginal delivery are low and the cervix is said to be unfavorable or unripe for induction."|units on a scale|Mean|2.9|2.9|Standard Deviation|1.8|1.8|||
3634023|NCT02566005|3481500|B2|||Bishop score at misoprostol placement|"5 item score, each item scored from 0 to 2-3, with total score from 0 to 13. A woman with a low score of 1 would not be expected to go into labor for about 3 weeks. A woman with a higher score of 10 could be expected to go into labor within a few days.~Also, If the Bishop score is 8 or greater the chances of having a vaginal delivery are good and the cervix is said to be favorable or ripe for induction. If the Bishop score is 6 or less the chances of having a vaginal delivery are low and the cervix is said to be unfavorable or unripe for induction."|units on a scale|Mean|3.17|3.17|Standard Deviation|1.94|1.94|||
3634024|NCT02566005|3481501|B1|||Bishop score at misoprostol placement|"5 item score, each item scored from 0 to 2-3, with total score from 0 to 13. A woman with a low score of 1 would not be expected to go into labor for about 3 weeks. A woman with a higher score of 10 could be expected to go into labor within a few days.~Also, If the Bishop score is 8 or greater the chances of having a vaginal delivery are good and the cervix is said to be favorable or ripe for induction. If the Bishop score is 6 or less the chances of having a vaginal delivery are low and the cervix is said to be unfavorable or unripe for induction."|units on a scale|Mean|2.71|2.71|Standard Deviation|1.78|1.78|||
3634025|NCT02566005|3481499|B3|Others||Indication for induction||Participants|Count of Participants|40|40.0||||||
3634026|NCT02566005|3481500|B2|Others||Indication for induction||Participants|Count of Participants|22|22.0||||||
3634027|NCT02566005|3481501|B1|Others||Indication for induction||Participants|Count of Participants|18|18.0||||||
3634028|NCT02566005|3481499|B3|Advanced maternal age||Indication for induction||Participants|Count of Participants|5|5.0||||||
3634029|NCT02566005|3481500|B2|Advanced maternal age||Indication for induction||Participants|Count of Participants|4|4.0||||||
3634030|NCT02566005|3481501|B1|Advanced maternal age||Indication for induction||Participants|Count of Participants|1|1.0||||||
3634031|NCT02566005|3481499|B3|Gestational diabetes/Diabetes||Indication for induction||Participants|Count of Participants|22|22.0||||||
3634032|NCT02566005|3481500|B2|Gestational diabetes/Diabetes||Indication for induction||Participants|Count of Participants|11|11.0||||||
3634033|NCT02566005|3481501|B1|Gestational diabetes/Diabetes||Indication for induction||Participants|Count of Participants|11|11.0||||||
3634034|NCT02566005|3481499|B3|Hypertensive disorder||Indication for induction||Participants|Count of Participants|48|48.0||||||
3634035|NCT02566005|3481500|B2|Hypertensive disorder||Indication for induction||Participants|Count of Participants|20|20.0||||||
3634036|NCT02566005|3481501|B1|Hypertensive disorder||Indication for induction||Participants|Count of Participants|28|28.0||||||
3634037|NCT02566005|3481499|B3|Post-EDC||Indication for induction||Participants|Count of Participants|42|42.0||||||
3634038|NCT02566005|3481500|B2|Post-EDC||Indication for induction||Participants|Count of Participants|21|21.0||||||
3634039|NCT02566005|3481501|B1|Post-EDC||Indication for induction||Participants|Count of Participants|21|21.0||||||
3634040|NCT02566005|3481499|B3|Oligohydramnios/Polyhydramnios||Indication for induction||Participants|Count of Participants|43|43.0||||||
3634041|NCT02566005|3481500|B2|Oligohydramnios/Polyhydramnios||Indication for induction||Participants|Count of Participants|22|22.0||||||
3634042|NCT02566005|3481501|B1|Oligohydramnios/Polyhydramnios||Indication for induction||Participants|Count of Participants|21|21.0||||||
3634043|NCT02566005|3481499|B3|||Gestational age at delivery||weeks|Mean|39.4|39.4|Standard Deviation|1.4|1.4|||
3634044|NCT02566005|3481500|B2|||Gestational age at delivery||weeks|Mean|39.6|39.6|Standard Deviation|1.3|1.3|||
3634045|NCT02566005|3481501|B1|||Gestational age at delivery||weeks|Mean|39.4|39.4|Standard Deviation|1.4|1.4|||
3634046|NCT02566005|3481499|B3|Multiparous||Parity||Participants|Count of Participants|56|56.0||||||
3634047|NCT02566005|3481500|B2|Multiparous||Parity||Participants|Count of Participants|30|30.0||||||
3634048|NCT02566005|3481501|B1|Multiparous||Parity||Participants|Count of Participants|26|26.0||||||
3634049|NCT02566005|3481499|B3|Nulliparous||Parity||Participants|Count of Participants|144|144.0||||||
3634050|NCT02566005|3481500|B2|Nulliparous||Parity||Participants|Count of Participants|70|70.0||||||
3634051|NCT02566005|3481501|B1|Nulliparous||Parity||Participants|Count of Participants|74|74.0||||||
3634052|NCT02566005|3481499|B3|||BMI||kg/m^2|Mean|31.56|31.56|Standard Deviation|6.3|6.3|||
3634053|NCT02566005|3481500|B2|||BMI||kg/m^2|Mean|31.22|31.22|Standard Deviation|5.7|5.7|||
3634054|NCT02566005|3481501|B1|||BMI||kg/m^2|Mean|31.8|31.8|Standard Deviation|6.8|6.8|||
3634055|NCT02566005|3481499|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3634056|NCT02566005|3481500|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3634057|NCT02566005|3481501|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3634058|NCT02566005|3481499|B3||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
3634059|NCT02566005|3481500|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3634060|NCT02566005|3481501|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3634061|NCT02566005|3481499|B3|||Age||years|Mean|31.6|31.6|Standard Deviation|6.1|6.1|||
3634062|NCT02566005|3481500|B2|||Age||years|Mean|31.8|31.8|Standard Deviation|6.3|6.3|||
3634063|NCT02566005|3481501|B1|||Age||years|Mean|31.5|31.5|Standard Deviation|5.9|5.9|||
3634064|NCT02565628|3481530|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3634065|NCT02565628|3481531|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3634066|NCT02565628|3481532|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3634067|NCT02565628|3481530|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3634068|NCT02565628|3481531|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3634069|NCT02565628|3481532|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3634070|NCT02565628|3481530|B3|||Age||years|Mean|66.6|66.6|Standard Deviation|6.6|6.6|||
3634071|NCT02565628|3481531|B2|||Age||years|Mean|67.9|67.9|Standard Deviation|5.9|5.9|||
3634072|NCT02565628|3481532|B1|||Age||years|Mean|65.5|65.5|Standard Deviation|7.4|7.4|||
3634073|NCT02565485|3481561|B3|United States||Region of Enrollment||Participants|Count of Participants|276|276.0||||||
3634074|NCT02565485|3481562|B2|United States||Region of Enrollment||Participants|Count of Participants|137|137.0||||||
3634075|NCT02565485|3481563|B1|United States||Region of Enrollment||Participants|Count of Participants|139|139.0||||||
3634076|NCT02565485|3481561|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3634077|NCT02565485|3481562|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3634078|NCT02565485|3481563|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3634079|NCT02565485|3481561|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634080|NCT02565485|3481562|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634081|NCT02565485|3481563|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634082|NCT02565485|3481561|B3||White|Race (NIH/OMB)||Participants|Count of Participants|127|127.0||||||
3634083|NCT02565485|3481562|B2||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3634084|NCT02565485|3481563|B1||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3634085|NCT02565485|3481561|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
3634086|NCT02565485|3481562|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3634087|NCT02565485|3481563|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3634088|NCT02565485|3481561|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634089|NCT02565485|3481562|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634090|NCT02565485|3481563|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634091|NCT02565485|3481561|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3634092|NCT02565485|3481562|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3634093|NCT02565485|3481563|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3634094|NCT02565485|3481561|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634095|NCT02565485|3481562|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634096|NCT02565485|3481563|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634097|NCT02565485|3481561|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3634098|NCT02565485|3481562|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3634099|NCT02565485|3481563|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3634100|NCT02565485|3481561|B3||Female|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
3634101|NCT02565485|3481562|B2||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3634102|NCT02565485|3481563|B1||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3634103|NCT02565485|3481561|B3|||Age||years|Mean|26.4|26.4|Standard Deviation|5.2|5.2|||
3634104|NCT02565485|3481562|B2|||Age||years|Mean|26.9|26.9|Standard Deviation|5.3|5.3|||
3634105|NCT02565485|3481563|B1|||Age||years|Mean|26.0|26.0|Standard Deviation|5.1|5.1|||
3634106|NCT02565485|3481561|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3634107|NCT02565485|3481562|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3634108|NCT02565485|3481563|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3634109|NCT02565485|3481561|B3||Between 18 and 65 years|Age||Participants|Count of Participants|276|276.0||||||
3634110|NCT02565485|3481562|B2||Between 18 and 65 years|Age||Participants|Count of Participants|137|137.0||||||
3634111|NCT02565485|3481563|B1||Between 18 and 65 years|Age||Participants|Count of Participants|139|139.0||||||
3634112|NCT02565485|3481561|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3634113|NCT02565485|3481562|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3634114|NCT02565485|3481563|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3634115|NCT02565381|3481576|B4|||Quitting importance|1-10 visual scale of importance of quitting, with higher scores indicating greater importance of quitting smoking.|units on a scale|Mean|8.8|8.8|Standard Deviation|1.7|1.7|||
3634116|NCT02565381|3481577|B3|||Quitting importance|1-10 visual scale of importance of quitting, with higher scores indicating greater importance of quitting smoking.|units on a scale|Mean|8.9|8.9|Standard Deviation|1.6|1.6|||
3634117|NCT02565381|3481578|B2|||Quitting importance|1-10 visual scale of importance of quitting, with higher scores indicating greater importance of quitting smoking.|units on a scale|Mean|8.5|8.5|Standard Deviation|2.1|2.1|||
3634118|NCT02565381|3481579|B1|||Quitting importance|1-10 visual scale of importance of quitting, with higher scores indicating greater importance of quitting smoking.|units on a scale|Mean|8.8|8.8|Standard Deviation|1.5|1.5|||
3634119|NCT02565381|3481576|B4|||Quitting confidence|1-10 visual scale of confidence to quit, with higher scores indicating greater confidence to quit smoking.|units on a scale|Mean|6.4|6.4|Standard Deviation|2.4|2.4|||
3634120|NCT02565381|3481577|B3|||Quitting confidence|1-10 visual scale of confidence to quit, with higher scores indicating greater confidence to quit smoking.|units on a scale|Mean|5.9|5.9|Standard Deviation|2.4|2.4|||
3634121|NCT02565381|3481578|B2|||Quitting confidence|1-10 visual scale of confidence to quit, with higher scores indicating greater confidence to quit smoking.|units on a scale|Mean|6.4|6.4|Standard Deviation|2.5|2.5|||
3634122|NCT02565381|3481579|B1|||Quitting confidence|1-10 visual scale of confidence to quit, with higher scores indicating greater confidence to quit smoking.|units on a scale|Mean|6.8|6.8|Standard Deviation|2.2|2.2|||
3634123|NCT02565381|3481576|B4|||Fagerstrom Test for Nicotine Dependence|Score range is 0-10, with higher scores indicating greater nicotine dependence.|units on a scale|Mean|5.0|5.0|Standard Deviation|1.9|1.9|||
3634124|NCT02565381|3481577|B3|||Fagerstrom Test for Nicotine Dependence|Score range is 0-10, with higher scores indicating greater nicotine dependence.|units on a scale|Mean|4.9|4.9|Standard Deviation|2.0|2.0|||
3634125|NCT02565381|3481578|B2|||Fagerstrom Test for Nicotine Dependence|Score range is 0-10, with higher scores indicating greater nicotine dependence.|units on a scale|Mean|5.1|5.1|Standard Deviation|1.9|1.9|||
3634126|NCT02565381|3481579|B1|||Fagerstrom Test for Nicotine Dependence|Score range is 0-10, with higher scores indicating greater nicotine dependence.|units on a scale|Mean|5.1|5.1|Standard Deviation|1.8|1.8|||
3634127|NCT02565381|3481576|B4|United States||Region of Enrollment||Participants|Count of Participants|75|75.0||||||
3634128|NCT02565381|3481577|B3|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3634129|NCT02565381|3481578|B2|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3634130|NCT02565381|3481579|B1|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3634131|NCT02565381|3481576|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3634132|NCT02565381|3481577|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3634133|NCT02565381|3481578|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3634134|NCT02565381|3481579|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3634135|NCT02565381|3481576|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634136|NCT02565381|3481577|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634137|NCT02565381|3481578|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634138|NCT02565381|3481579|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634139|NCT02565381|3481576|B4||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3634140|NCT02565381|3481577|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3634141|NCT02565381|3481578|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3634142|NCT02565381|3481579|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3634143|NCT02565381|3481576|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3634144|NCT02565381|3481577|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3634145|NCT02565381|3481578|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3634146|NCT02565381|3481579|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3634147|NCT02565381|3481576|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634148|NCT02565381|3481577|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634149|NCT02565381|3481578|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634150|NCT02565381|3481579|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634151|NCT02565381|3481576|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634152|NCT02565381|3481577|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634153|NCT02565381|3481578|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634154|NCT02565381|3481579|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634155|NCT02565381|3481576|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3634156|NCT02565381|3481577|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3634157|NCT02565381|3481578|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634158|NCT02565381|3481579|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634159|NCT02565381|3481576|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634160|NCT02565381|3481577|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634161|NCT02565381|3481578|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634162|NCT02565381|3481579|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634163|NCT02565381|3481576|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3634164|NCT02565381|3481577|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3634165|NCT02565381|3481578|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3634166|NCT02565381|3481579|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3634167|NCT02565381|3481576|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3634168|NCT02565381|3481577|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3634169|NCT02565381|3481578|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3634170|NCT02565381|3481579|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3634171|NCT02565381|3481576|B4||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3634172|NCT02565381|3481577|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3634173|NCT02565381|3481578|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3634174|NCT02565381|3481579|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3634175|NCT02565381|3481576|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3634176|NCT02565381|3481577|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3634177|NCT02565381|3481578|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3634178|NCT02565381|3481579|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3634179|NCT02565381|3481576|B4|||Age||years|Mean|46.4|46.4|Standard Deviation|9.1|9.1|||
3634180|NCT02565381|3481577|B3|||Age||years|Mean|46.1|46.1|Standard Deviation|9.2|9.2|||
3634181|NCT02565381|3481578|B2|||Age||years|Mean|48.1|48.1|Standard Deviation|8.5|8.5|||
3634182|NCT02565381|3481579|B1|||Age||years|Mean|45.1|45.1|Standard Deviation|9.6|9.6|||
3634183|NCT02565147|3481619|B3|France||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3634184|NCT02565147|3481620|B2|France||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3634185|NCT02565147|3481621|B1|France||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3634186|NCT02565147|3481619|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
3634187|NCT02565147|3481620|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3634188|NCT02565147|3481621|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3634189|NCT02565147|3481619|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3634190|NCT02565147|3481619|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3634191|NCT02565147|3481620|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3634192|NCT02565147|3481621|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3634193|NCT02565147|3481619|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3634194|NCT02565147|3481620|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3634195|NCT02565147|3481621|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3634196|NCT02565147|3481619|B3|||Age||Years|Mean|62.4|62.4|Standard Deviation|12.3|12.3|||
3634197|NCT02565147|3481620|B2|||Age||Years|Mean|61.2|61.2|Standard Deviation|13.2|13.2|||
3634198|NCT02565147|3481621|B1|||Age||Years|Mean|63.6|63.6|Standard Deviation|11.4|11.4|||
3634199|NCT02565108|3481644|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3634200|NCT02565108|3481645|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3634201|NCT02565108|3481646|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3634202|NCT02565108|3481644|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3634203|NCT02565108|3481645|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3634204|NCT02565108|3481646|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3634205|NCT02565108|3481644|B3|||Age||years|Mean|36.79|36.79|Standard Deviation|8.68|8.68|||
3634206|NCT02565108|3481645|B2|||Age||years|Mean|37.57|37.57|Standard Deviation|10.67|10.67|||
3634207|NCT02565108|3481646|B1|||Age||years|Mean|36.60|36.6|Standard Deviation|8.51|8.51|||
3634208|NCT02564952|3481663|B1|||Any History Of Current Seizures||Participants|Count of Participants|18|18.0||||||
3634209|NCT02564952|3481663|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634210|NCT02564952|3481663|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634211|NCT02564952|3481663|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3634212|NCT02564952|3481663|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634213|NCT02564952|3481663|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634214|NCT02564952|3481663|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634215|NCT02564952|3481663|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634216|NCT02564952|3481663|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3634217|NCT02564952|3481663|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3634218|NCT02564952|3481663|B1|||Age||years|Mean|36.35|36.35|Standard Deviation|9.05|9.05|||
3634219|NCT02564718|3481667|B3|||Activated Partial Thromboplastin Time (aPTT)||Seconds (sec)|Mean|NA||Standard Deviation|NA||||Mean and Standard Deviation of aPTT values for the overall participants was not calculated.
3634220|NCT02564718|3481668|B2|||Activated Partial Thromboplastin Time (aPTT)||Seconds (sec)|Mean|34.9|34.9|Standard Deviation|2.62|2.62|||
3634221|NCT02564718|3481669|B1|||Activated Partial Thromboplastin Time (aPTT)||Seconds (sec)|Mean|34.0|34.0|Standard Deviation|4.05|4.05|||
3634222|NCT02564718|3481667|B3|||Prothrombin Time||Seconds (sec)|Mean|NA||Standard Deviation|NA||||Mean and Standard Deviation of Prothrombin Time values for the overall participants was not calculated.
3634223|NCT02564718|3481668|B2|||Prothrombin Time||Seconds (sec)|Mean|13.9|13.9|Standard Deviation|1.31|1.31|||
3634224|NCT02564718|3481669|B1|||Prothrombin Time||Seconds (sec)|Mean|13.3|13.3|Standard Deviation|0.378|0.378|||
3634225|NCT02564718|3481667|B3|||Weight||Kilogram (kg)|Mean|4.02|4.02|Standard Deviation|1.60|1.6|||
3634226|NCT02564718|3481668|B2|||Weight||Kilogram (kg)|Mean|3.70|3.7|Standard Deviation|0.85|0.85|||
3634227|NCT02564718|3481669|B1|||Weight||Kilogram (kg)|Mean|4.33|4.33|Standard Deviation|2.19|2.19|||
3634228|NCT02564718|3481667|B3|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3634229|NCT02564718|3481668|B2|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634230|NCT02564718|3481669|B1|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3634231|NCT02564718|3481667|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3634232|NCT02564718|3481668|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3634233|NCT02564718|3481669|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3634234|NCT02564718|3481667|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3634235|NCT02564718|3481668|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634236|NCT02564718|3481669|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3634237|NCT02564718|3481667|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3634238|NCT02564718|3481668|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3634239|NCT02564718|3481669|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3634240|NCT02564718|3481667|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3634241|NCT02564718|3481668|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3634242|NCT02564718|3481669|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3634243|NCT02564718|3481667|B3|||Age||Months|Mean|1.47|1.47|Standard Deviation|1.59|1.59|||
3634244|NCT02564718|3481668|B2|||Age||Months|Mean|1.12|1.12|Standard Deviation|0.60|0.6|||
3634245|NCT02564718|3481669|B1|||Age||Months|Mean|1.81|1.81|Standard Deviation|2.24|2.24|||
3634246|NCT02564211|3481698|B1|||HbA1c||Percentage|Mean|8.01|8.01|Standard Deviation|0.69|0.69|||
3634247|NCT02564211|3481698|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634248|NCT02564211|3481698|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634249|NCT02564211|3481698|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634250|NCT02564211|3481698|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634251|NCT02564211|3481698|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634252|NCT02564211|3481698|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3634253|NCT02564211|3481698|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634254|NCT02564211|3481698|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3634255|NCT02564211|3481698|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3634256|NCT02564211|3481698|B1|||Age||years|Mean|58.9|58.9|Standard Deviation|10.5|10.5|||
3634257|NCT02564055|3481704|B7|Race/Ethnicity, Customized|Black/African American and White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3634258|NCT02564055|3481705|B6|Race/Ethnicity, Customized|Black/African American and White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3634259|NCT02564055|3481706|B5|Race/Ethnicity, Customized|Black/African American and White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3634260|NCT02564055|3481707|B4|Race/Ethnicity, Customized|Black/African American and White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634261|NCT02564055|3481708|B3|Race/Ethnicity, Customized|Black/African American and White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634262|NCT02564055|3481709|B2|Race/Ethnicity, Customized|Black/African American and White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634263|NCT02564055|3481710|B1|Race/Ethnicity, Customized|Black/African American and White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3634264|NCT02564055|3481704|B7|Race/Ethnicity, Customized|Asian/S.E. Asian/Japanese and White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3634265|NCT02564055|3481705|B6|Race/Ethnicity, Customized|Asian/S.E. Asian/Japanese and White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3634266|NCT02564055|3481706|B5|Race/Ethnicity, Customized|Asian/S.E. Asian/Japanese and White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634267|NCT02564055|3481707|B4|Race/Ethnicity, Customized|Asian/S.E. Asian/Japanese and White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634268|NCT02564055|3481708|B3|Race/Ethnicity, Customized|Asian/S.E. Asian/Japanese and White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634269|NCT02564055|3481709|B2|Race/Ethnicity, Customized|Asian/S.E. Asian/Japanese and White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634270|NCT02564055|3481710|B1|Race/Ethnicity, Customized|Asian/S.E. Asian/Japanese and White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634271|NCT02564055|3481704|B7|Race/Ethnicity, Customized|Asian/S.E. Asian/Japanese and Black and White|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3634272|NCT02564055|3481705|B6|Race/Ethnicity, Customized|Asian/S.E. Asian/Japanese and Black and White|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634273|NCT02564055|3481706|B5|Race/Ethnicity, Customized|Asian/S.E. Asian/Japanese and Black and White|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634274|NCT02564055|3481707|B4|Race/Ethnicity, Customized|Asian/S.E. Asian/Japanese and Black and White|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634275|NCT02564055|3481708|B3|Race/Ethnicity, Customized|Asian/S.E. Asian/Japanese and Black and White|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3634276|NCT02564055|3481709|B2|Race/Ethnicity, Customized|Asian/S.E. Asian/Japanese and Black and White|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634277|NCT02564055|3481710|B1|Race/Ethnicity, Customized|Asian/S.E. Asian/Japanese and Black and White|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634278|NCT02564055|3481704|B7|Race/Ethnicity, Customized|Asian/S.E. Asian/Japanese and African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3634279|NCT02564055|3481705|B6|Race/Ethnicity, Customized|Asian/S.E. Asian/Japanese and African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634280|NCT02564055|3481706|B5|Race/Ethnicity, Customized|Asian/S.E. Asian/Japanese and African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634281|NCT02564055|3481707|B4|Race/Ethnicity, Customized|Asian/S.E. Asian/Japanese and African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634282|NCT02564055|3481708|B3|Race/Ethnicity, Customized|Asian/S.E. Asian/Japanese and African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3634283|NCT02564055|3481709|B2|Race/Ethnicity, Customized|Asian/S.E. Asian/Japanese and African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634284|NCT02564055|3481710|B1|Race/Ethnicity, Customized|Asian/S.E. Asian/Japanese and African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3634285|NCT02564055|3481704|B7|Race/Ethnicity, Customized|American Indian/Alaska Native and African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3634286|NCT02564055|3481705|B6|Race/Ethnicity, Customized|American Indian/Alaska Native and African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634287|NCT02564055|3481706|B5|Race/Ethnicity, Customized|American Indian/Alaska Native and African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634288|NCT02564055|3481707|B4|Race/Ethnicity, Customized|American Indian/Alaska Native and African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3634289|NCT02564055|3481708|B3|Race/Ethnicity, Customized|American Indian/Alaska Native and African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634290|NCT02564055|3481709|B2|Race/Ethnicity, Customized|American Indian/Alaska Native and African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634291|NCT02564055|3481710|B1|Race/Ethnicity, Customized|American Indian/Alaska Native and African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634292|NCT02564055|3481704|B7|Race/Ethnicity, Customized|Asian/S.E. Asian Descent/Japanese|Race/Ethnicity, Customized||Participants|Count of Participants|80|80.0||||||
3634293|NCT02564055|3481705|B6|Race/Ethnicity, Customized|Asian/S.E. Asian Descent/Japanese|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3634294|NCT02564055|3481706|B5|Race/Ethnicity, Customized|Asian/S.E. Asian Descent/Japanese|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3634295|NCT02564055|3481707|B4|Race/Ethnicity, Customized|Asian/S.E. Asian Descent/Japanese|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3634296|NCT02564055|3481708|B3|Race/Ethnicity, Customized|Asian/S.E. Asian Descent/Japanese|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3634297|NCT02564055|3481709|B2|Race/Ethnicity, Customized|Asian/S.E. Asian Descent/Japanese|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3634298|NCT02564055|3481710|B1|Race/Ethnicity, Customized|Asian/S.E. Asian Descent/Japanese|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3634299|NCT02564055|3481704|B7|Race/Ethnicity, Customized|American Indian/Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3634300|NCT02564055|3481705|B6|Race/Ethnicity, Customized|American Indian/Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634301|NCT02564055|3481706|B5|Race/Ethnicity, Customized|American Indian/Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634302|NCT02564055|3481707|B4|Race/Ethnicity, Customized|American Indian/Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3634303|NCT02564055|3481708|B3|Race/Ethnicity, Customized|American Indian/Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634304|NCT02564055|3481709|B2|Race/Ethnicity, Customized|American Indian/Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634305|NCT02564055|3481710|B1|Race/Ethnicity, Customized|American Indian/Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634306|NCT02564055|3481704|B7|Race/Ethnicity, Customized|Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|58|58.0||||||
3634307|NCT02564055|3481705|B6|Race/Ethnicity, Customized|Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3634308|NCT02564055|3481706|B5|Race/Ethnicity, Customized|Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3634309|NCT02564055|3481707|B4|Race/Ethnicity, Customized|Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3634310|NCT02564055|3481708|B3|Race/Ethnicity, Customized|Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3634311|NCT02564055|3481709|B2|Race/Ethnicity, Customized|Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3634312|NCT02564055|3481710|B1|Race/Ethnicity, Customized|Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3634313|NCT02564055|3481704|B7|Race/Ethnicity, Customized|White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|100|100.0||||||
3634314|NCT02564055|3481705|B6|Race/Ethnicity, Customized|White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3634315|NCT02564055|3481706|B5|Race/Ethnicity, Customized|White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3634316|NCT02564055|3481707|B4|Race/Ethnicity, Customized|White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3634317|NCT02564055|3481708|B3|Race/Ethnicity, Customized|White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3634318|NCT02564055|3481709|B2|Race/Ethnicity, Customized|White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3634319|NCT02564055|3481710|B1|Race/Ethnicity, Customized|White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3634320|NCT02564055|3481704|B7||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3634321|NCT02564055|3481705|B6||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3634322|NCT02564055|3481706|B5||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3634323|NCT02564055|3481707|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3634324|NCT02564055|3481708|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3634325|NCT02564055|3481709|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3634326|NCT02564055|3481710|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3634327|NCT02564055|3481704|B7||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3634328|NCT02564055|3481705|B6||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3634329|NCT02564055|3481706|B5||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3634330|NCT02564055|3481707|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3634331|NCT02564055|3481708|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3634332|NCT02564055|3481709|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3634333|NCT02564055|3481710|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3634334|NCT02564055|3481704|B7|||Age||Years|Mean|29.3|29.3|Standard Deviation|14.83|14.83|||
3634335|NCT02564055|3481705|B6|||Age||Years|Mean|29.4|29.4|Standard Deviation|15.15|15.15|||
3634336|NCT02564055|3481706|B5|||Age||Years|Mean|27.9|27.9|Standard Deviation|14.72|14.72|||
3634337|NCT02564055|3481707|B4|||Age||Years|Mean|29.3|29.3|Standard Deviation|14.02|14.02|||
3634338|NCT02564055|3481708|B3|||Age||Years|Mean|29.0|29.0|Standard Deviation|15.91|15.91|||
3634339|NCT02564055|3481709|B2|||Age||Years|Mean|31.6|31.6|Standard Deviation|15.72|15.72|||
3634340|NCT02564055|3481710|B1|||Age||Years|Mean|28.5|28.5|Standard Deviation|13.90|13.9|||
3634341|NCT02564042|3481963|B7|Race, Customized|Black/Afr Amer & White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3634342|NCT02564042|3481964|B6|Race, Customized|Black/Afr Amer & White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634343|NCT02564042|3481965|B5|Race, Customized|Black/Afr Amer & White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634344|NCT02564042|3481966|B4|Race, Customized|Black/Afr Amer & White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634345|NCT02564042|3481967|B3|Race, Customized|Black/Afr Amer & White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634346|NCT02564042|3481968|B2|Race, Customized|Black/Afr Amer & White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634347|NCT02564042|3481969|B1|Race, Customized|Black/Afr Amer & White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3634348|NCT02564042|3481963|B7|Race, Customized|Amer Ind/Ala Nat & Black/Afr Amer &White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3634349|NCT02564042|3481964|B6|Race, Customized|Amer Ind/Ala Nat & Black/Afr Amer &White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634350|NCT02564042|3481965|B5|Race, Customized|Amer Ind/Ala Nat & Black/Afr Amer &White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634351|NCT02564042|3481966|B4|Race, Customized|Amer Ind/Ala Nat & Black/Afr Amer &White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634352|NCT02564042|3481967|B3|Race, Customized|Amer Ind/Ala Nat & Black/Afr Amer &White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3634353|NCT02564042|3481968|B2|Race, Customized|Amer Ind/Ala Nat & Black/Afr Amer &White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634354|NCT02564042|3481969|B1|Race, Customized|Amer Ind/Ala Nat & Black/Afr Amer &White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634355|NCT02564042|3481963|B7|Race, Customized|White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|166|166.0||||||
3634356|NCT02564042|3481964|B6|Race, Customized|White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3634357|NCT02564042|3481965|B5|Race, Customized|White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3634358|NCT02564042|3481966|B4|Race, Customized|White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3634359|NCT02564042|3481967|B3|Race, Customized|White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3634360|NCT02564042|3481968|B2|Race, Customized|White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3634361|NCT02564042|3481969|B1|Race, Customized|White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3634362|NCT02564042|3481963|B7|Race, Customized|Black/African American (Afr Amer)|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3634363|NCT02564042|3481964|B6|Race, Customized|Black/African American (Afr Amer)|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634364|NCT02564042|3481965|B5|Race, Customized|Black/African American (Afr Amer)|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3634365|NCT02564042|3481966|B4|Race, Customized|Black/African American (Afr Amer)|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3634366|NCT02564042|3481967|B3|Race, Customized|Black/African American (Afr Amer)|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3634367|NCT02564042|3481968|B2|Race, Customized|Black/African American (Afr Amer)|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3634368|NCT02564042|3481969|B1|Race, Customized|Black/African American (Afr Amer)|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3634369|NCT02564042|3481963|B7|Race, Customized|Asian/South East Asian Descent/Japanese Descent|Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
3634370|NCT02564042|3481964|B6|Race, Customized|Asian/South East Asian Descent/Japanese Descent|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3634371|NCT02564042|3481965|B5|Race, Customized|Asian/South East Asian Descent/Japanese Descent|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3634372|NCT02564042|3481966|B4|Race, Customized|Asian/South East Asian Descent/Japanese Descent|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3634373|NCT02564042|3481967|B3|Race, Customized|Asian/South East Asian Descent/Japanese Descent|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3634374|NCT02564042|3481968|B2|Race, Customized|Asian/South East Asian Descent/Japanese Descent|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3634375|NCT02564042|3481969|B1|Race, Customized|Asian/South East Asian Descent/Japanese Descent|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3634376|NCT02564042|3481963|B7|Race, Customized|American Indian (Amer Ind)/Alaska Native (Ala Nat)|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3634377|NCT02564042|3481964|B6|Race, Customized|American Indian (Amer Ind)/Alaska Native (Ala Nat)|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634378|NCT02564042|3481965|B5|Race, Customized|American Indian (Amer Ind)/Alaska Native (Ala Nat)|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634379|NCT02564042|3481966|B4|Race, Customized|American Indian (Amer Ind)/Alaska Native (Ala Nat)|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3634380|NCT02564042|3481967|B3|Race, Customized|American Indian (Amer Ind)/Alaska Native (Ala Nat)|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634381|NCT02564042|3481968|B2|Race, Customized|American Indian (Amer Ind)/Alaska Native (Ala Nat)|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634382|NCT02564042|3481969|B1|Race, Customized|American Indian (Amer Ind)/Alaska Native (Ala Nat)|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634383|NCT02564042|3481963|B7||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3634384|NCT02564042|3481964|B6||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3634385|NCT02564042|3481965|B5||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3634386|NCT02564042|3481966|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3634387|NCT02564042|3481967|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3634388|NCT02564042|3481968|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3634389|NCT02564042|3481969|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3634390|NCT02564042|3481963|B7||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3634391|NCT02564042|3481964|B6||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3634392|NCT02564042|3481965|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3634393|NCT02564042|3481966|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3634394|NCT02564042|3481967|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3634395|NCT02564042|3481968|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3634396|NCT02564042|3481969|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3634397|NCT02564042|3481963|B7|||Age||Years|Mean|47.6|47.6|Standard Deviation|10.99|10.99|||
3634398|NCT02564042|3481964|B6|||Age||Years|Mean|46.4|46.4|Standard Deviation|10.16|10.16|||
3634399|NCT02564042|3481965|B5|||Age||Years|Mean|46.7|46.7|Standard Deviation|12.62|12.62|||
3634400|NCT02564042|3481966|B4|||Age||Years|Mean|48.7|48.7|Standard Deviation|9.72|9.72|||
3634401|NCT02564042|3481967|B3|||Age||Years|Mean|49.6|49.6|Standard Deviation|10.93|10.93|||
3634402|NCT02564042|3481968|B2|||Age||Years|Mean|48.5|48.5|Standard Deviation|10.56|10.56|||
3634403|NCT02564042|3481969|B1|||Age||Years|Mean|45.9|45.9|Standard Deviation|11.93|11.93|||
3634404|NCT02564029|3482186|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634405|NCT02564029|3482186|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634406|NCT02564029|3482186|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3634407|NCT02564029|3482186|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634408|NCT02564029|3482186|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634409|NCT02564029|3482186|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634410|NCT02564029|3482186|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634411|NCT02564029|3482186|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3634412|NCT02564029|3482186|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3634413|NCT02564029|3482186|B1|||Age||years|Mean|27|27.0|Standard Deviation|7.3|7.3|||
3634414|NCT02564016|3482227|B3|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3634415|NCT02564016|3482228|B2|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3634416|NCT02564016|3482229|B1|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3634417|NCT02564016|3482227|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3634418|NCT02564016|3482228|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3634419|NCT02564016|3482229|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3634420|NCT02564016|3482227|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3634421|NCT02564016|3482228|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3634422|NCT02564016|3482229|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3634423|NCT02564016|3482227|B3|||Age||years|Mean|32|32.0|Full Range|||21.0|42.0|
3634424|NCT02564016|3482228|B2|||Age||years|Mean|32|32.0|Full Range|||22.0|41.0|
3634425|NCT02564016|3482229|B1|||Age||years|Mean|32|32.0|Full Range|||21.0|42.0|
3634426|NCT02564016|3482227|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3634427|NCT02564016|3482228|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3634428|NCT02564016|3482229|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3634429|NCT02564016|3482227|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3634430|NCT02564016|3482228|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3634431|NCT02564016|3482229|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3634432|NCT02564016|3482227|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3634433|NCT02564016|3482228|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3634434|NCT02564016|3482229|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3634435|NCT02563899|3482240|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634436|NCT02563899|3482241|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634437|NCT02563899|3482242|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634438|NCT02563899|3482243|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634439|NCT02563899|3482244|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634440|NCT02563899|3482240|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3634441|NCT02563899|3482241|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3634442|NCT02563899|3482242|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3634443|NCT02563899|3482243|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3634444|NCT02563899|3482244|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3634445|NCT02563899|3482240|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3634446|NCT02563899|3482241|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634447|NCT02563899|3482242|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634448|NCT02563899|3482243|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3634449|NCT02563899|3482244|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634450|NCT02563899|3482240|B5||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3634451|NCT02563899|3482241|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3634452|NCT02563899|3482242|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3634453|NCT02563899|3482243|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3634454|NCT02563899|3482244|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3634455|NCT02563899|3482240|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3634456|NCT02563899|3482241|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3634457|NCT02563899|3482242|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3634458|NCT02563899|3482243|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3634459|NCT02563899|3482244|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3634460|NCT02563899|3482240|B5|19 to 64 Years||Age, Customized||Participants|Count of Participants|39|39.0||||||
3634461|NCT02563899|3482241|B4|19 to 64 Years||Age, Customized||Participants|Count of Participants|6|6.0||||||
3634462|NCT02563899|3482242|B3|19 to 64 Years||Age, Customized||Participants|Count of Participants|10|10.0||||||
3634463|NCT02563899|3482243|B2|19 to 64 Years||Age, Customized||Participants|Count of Participants|5|5.0||||||
3634464|NCT02563899|3482244|B1|19 to 64 Years||Age, Customized||Participants|Count of Participants|18|18.0||||||
3634465|NCT02563834|3482288|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3634466|NCT02563834|3482289|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3634467|NCT02563834|3482290|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3634468|NCT02563834|3482288|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3634469|NCT02563834|3482289|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3634470|NCT02563834|3482290|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3634471|NCT02563834|3482288|B3|||Age||years|Mean|36.9|36.9|Standard Deviation|9.4|9.4|||
3634472|NCT02563834|3482289|B2|||Age||years|Mean|40.4|40.4|Standard Deviation|9.2|9.2|||
3634473|NCT02563834|3482290|B1|||Age||years|Mean|34.1|34.1|Standard Deviation|9.0|9.0|||
3634474|NCT02563834|3482288|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3634475|NCT02563834|3482289|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3634476|NCT02563834|3482290|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3634477|NCT02563834|3482288|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3634478|NCT02563834|3482289|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3634479|NCT02563834|3482290|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3634480|NCT02563834|3482288|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3634481|NCT02563834|3482289|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3634482|NCT02563834|3482290|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3634483|NCT02563106|3482307|B3|North America||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3634484|NCT02563106|3482308|B2|North America||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3634485|NCT02563106|3482309|B1|North America||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3634486|NCT02563106|3482307|B3|Europe||Region of Enrollment||Participants|Count of Participants|404|404.0||||||
3634487|NCT02563106|3482308|B2|Europe||Region of Enrollment||Participants|Count of Participants|201|201.0||||||
3634488|NCT02563106|3482309|B1|Europe||Region of Enrollment||Participants|Count of Participants|203|203.0||||||
3634489|NCT02563106|3482307|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634490|NCT02563106|3482308|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634491|NCT02563106|3482309|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634492|NCT02563106|3482307|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634493|NCT02563106|3482308|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634494|NCT02563106|3482309|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634495|NCT02563106|3482307|B3||White|Race (NIH/OMB)||Participants|Count of Participants|411|411.0||||||
3634496|NCT02563106|3482308|B2||White|Race (NIH/OMB)||Participants|Count of Participants|205|205.0||||||
3634497|NCT02563106|3482309|B1||White|Race (NIH/OMB)||Participants|Count of Participants|206|206.0||||||
3634498|NCT02563106|3482307|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3634499|NCT02563106|3482308|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3634500|NCT02563106|3482309|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634501|NCT02563106|3482307|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634502|NCT02563106|3482308|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634503|NCT02563106|3482309|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634504|NCT02563106|3482307|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634505|NCT02563106|3482308|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634506|NCT02563106|3482309|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634507|NCT02563106|3482307|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634508|NCT02563106|3482308|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634509|NCT02563106|3482309|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634510|NCT02563106|3482307|B3||Male|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
3634511|NCT02563106|3482308|B2||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3634512|NCT02563106|3482309|B1||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3634513|NCT02563106|3482307|B3||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3634514|NCT02563106|3482308|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3634515|NCT02563106|3482309|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3634516|NCT02563106|3482307|B3|||Age||years|Mean|69.2|69.2|Standard Deviation|9.37|9.37|||
3634517|NCT02563106|3482308|B2|||Age||years|Mean|69.7|69.7|Standard Deviation|9.37|9.37|||
3634518|NCT02563106|3482309|B1|||Age||years|Mean|68.8|68.8|Standard Deviation|9.37|9.37|||
3634519|NCT02563093|3482316|B5|United States||Region of Enrollment||Participants|Number|208|208.0||||||
3634520|NCT02563093|3482317|B4|United States||Region of Enrollment||Participants|Number|51|51.0||||||
3634521|NCT02563093|3482318|B3|United States||Region of Enrollment||Participants|Number|53|53.0||||||
3634522|NCT02563093|3482319|B2|United States||Region of Enrollment||Participants|Number|52|52.0||||||
3634523|NCT02563093|3482320|B1|United States||Region of Enrollment||Participants|Number|52|52.0||||||
3634524|NCT02563093|3482316|B5||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3634525|NCT02563093|3482317|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3634526|NCT02563093|3482318|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3634527|NCT02563093|3482319|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3634528|NCT02563093|3482320|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3634529|NCT02563093|3482316|B5||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3634530|NCT02563093|3482317|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3634531|NCT02563093|3482318|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3634532|NCT02563093|3482319|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3634533|NCT02563093|3482320|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3634534|NCT02563093|3482316|B5|||Age||Years|Mean|59.2|59.2|Standard Deviation|17.9|17.9|||
3634535|NCT02563093|3482317|B4|||Age||Years|Mean|74.2|74.2|Standard Deviation|6.2|6.2|||
3634536|NCT02563093|3482318|B3|||Age||Years|Mean|72.8|72.8|Standard Deviation|5.2|5.2|||
3634537|NCT02563093|3482319|B2|||Age||Years|Mean|43.4|43.4|Standard Deviation|14.7|14.7|||
3634538|NCT02563093|3482320|B1|||Age||Years|Mean|46.4|46.4|Standard Deviation|13.5|13.5|||
3634539|NCT02563093|3482316|B5||>=65 years|Age||Participants|Count of Participants|104|104.0||||||
3634540|NCT02563093|3482317|B4||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
3634541|NCT02563093|3482318|B3||>=65 years|Age||Participants|Count of Participants|53|53.0||||||
3634542|NCT02563093|3482319|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3634543|NCT02563093|3482320|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3634544|NCT02563093|3482316|B5||Between 18 and 65 years|Age||Participants|Count of Participants|104|104.0||||||
3634545|NCT02563093|3482317|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3634546|NCT02563093|3482318|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3634547|NCT02563093|3482319|B2||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3634548|NCT02563093|3482320|B1||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3634549|NCT02563093|3482316|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3634550|NCT02563093|3482317|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3634551|NCT02563093|3482318|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3634552|NCT02563093|3482319|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3634553|NCT02563093|3482320|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3634554|NCT02562989|3482349|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3634555|NCT02562989|3482350|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3634556|NCT02562989|3482351|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3634557|NCT02562989|3482352|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3634558|NCT02562989|3482349|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3634559|NCT02562989|3482350|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3634560|NCT02562989|3482351|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3634561|NCT02562989|3482352|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3634562|NCT02562989|3482349|B4|||Age||Years|Mean|60.1|60.1|Standard Deviation|19.9|19.9|||
3634563|NCT02562989|3482350|B3|||Age||Years|Mean|73.2|73.2|Standard Deviation|4.4|4.4|||
3634564|NCT02562989|3482351|B2|||Age||Years|Mean|65.3|65.3|Standard Deviation|5.4|5.4|||
3634565|NCT02562989|3482352|B1|||Age||Years|Mean|27.0|27.0|Standard Deviation|7.9|7.9|||
3634566|NCT02562521|3482377|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3634567|NCT02562521|3482378|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3634568|NCT02562521|3482379|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3634569|NCT02562521|3482377|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3634570|NCT02562521|3482378|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634571|NCT02562521|3482379|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3634572|NCT02562521|3482377|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3634573|NCT02562521|3482378|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3634574|NCT02562521|3482379|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3634575|NCT02562521|3482377|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3634576|NCT02562521|3482378|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3634577|NCT02562521|3482379|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3634578|NCT02562521|3482377|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634579|NCT02562521|3482378|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634580|NCT02562521|3482379|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634581|NCT02562521|3482377|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634582|NCT02562521|3482378|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634583|NCT02562521|3482379|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634584|NCT02562521|3482377|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634585|NCT02562521|3482378|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634586|NCT02562521|3482379|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634587|NCT02562521|3482377|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3634588|NCT02562521|3482378|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634589|NCT02562521|3482379|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3634590|NCT02562521|3482377|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3634591|NCT02562521|3482378|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3634592|NCT02562521|3482379|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3634593|NCT02562521|3482377|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3634594|NCT02562521|3482378|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634595|NCT02562521|3482379|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3634596|NCT02562521|3482377|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3634597|NCT02562521|3482378|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3634598|NCT02562521|3482379|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3634599|NCT02562521|3482377|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3634600|NCT02562521|3482378|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3634601|NCT02562521|3482379|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3634602|NCT02562521|3482377|B3|||Age||years|Mean|44.0|44.0|Standard Deviation|12.6|12.6|||
3634603|NCT02562521|3482378|B2|||Age||years|Mean|43.2|43.2|Standard Deviation|11.6|11.6|||
3634604|NCT02562521|3482379|B1|||Age||years|Mean|44.2|44.2|Standard Deviation|13.3|13.3|||
3634605|NCT02561806|3482394|B3|||Psoriasis Area & Severity Index (PASI)|"PASI combines the extent of body surface involvement in 4 anatomical regions (head, trunk, arms, & legs). For each region the % area of skin involved was estimated from 0(0%) to 6(90%-100%) & severity was estimated by clinical signs of erythema, induration & scaling with scores range from 0 to 4 (no to severe involvement). Each area is scored & scores were combined for final PASI (sum of severity parameters for each region * area score * weighing factor [head(0.1), upper limbs(0.2), trunk(0.3), lower limbs(0.4)]. Overall scores range from 0 (no Ps) to 72 (most severe disease)."|units on a scale|Mean|19.9|19.9|Standard Deviation|8.62|8.62|||
3634606|NCT02561806|3482395|B2|||Psoriasis Area & Severity Index (PASI)|"PASI combines the extent of body surface involvement in 4 anatomical regions (head, trunk, arms, & legs). For each region the % area of skin involved was estimated from 0(0%) to 6(90%-100%) & severity was estimated by clinical signs of erythema, induration & scaling with scores range from 0 to 4 (no to severe involvement). Each area is scored & scores were combined for final PASI (sum of severity parameters for each region * area score * weighing factor [head(0.1), upper limbs(0.2), trunk(0.3), lower limbs(0.4)]. Overall scores range from 0 (no Ps) to 72 (most severe disease)."|units on a scale|Mean|19.9|19.9|Standard Deviation|8.15|8.15|||
3634660|NCT02561806|3482395|B2|Switzerland||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3634661|NCT02561806|3482396|B1|Switzerland||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3634662|NCT02561806|3482394|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3634607|NCT02561806|3482396|B1|||Psoriasis Area & Severity Index (PASI)|"PASI combines the extent of body surface involvement in 4 anatomical regions (head, trunk, arms, & legs). For each region the % area of skin involved was estimated from 0(0%) to 6(90%-100%) & severity was estimated by clinical signs of erythema, induration & scaling with scores range from 0 to 4 (no to severe involvement). Each area is scored & scores were combined for final PASI (sum of severity parameters for each region * area score * weighing factor [head(0.1), upper limbs(0.2), trunk(0.3), lower limbs(0.4)]. Overall scores range from 0 (no Ps) to 72 (most severe disease)."|units on a scale|Mean|19.8|19.8|Standard Deviation|9.02|9.02|||
3634608|NCT02561806|3482394|B3||>=40 years (Type 2 psoriasis)|Age group at psoriasis onset||Participants|Count of Participants|55|55.0||||||
3634609|NCT02561806|3482395|B2||>=40 years (Type 2 psoriasis)|Age group at psoriasis onset||Participants|Count of Participants|23|23.0||||||
3634610|NCT02561806|3482396|B1||>=40 years (Type 2 psoriasis)|Age group at psoriasis onset||Participants|Count of Participants|32|32.0||||||
3634611|NCT02561806|3482394|B3||<40 years (Type 1 psoriasis)|Age group at psoriasis onset||Participants|Count of Participants|247|247.0||||||
3634612|NCT02561806|3482395|B2||<40 years (Type 1 psoriasis)|Age group at psoriasis onset||Participants|Count of Participants|113|113.0||||||
3634613|NCT02561806|3482396|B1||<40 years (Type 1 psoriasis)|Age group at psoriasis onset||Participants|Count of Participants|134|134.0||||||
3634614|NCT02561806|3482394|B3|||Duration of psoriasis||years|Mean|18.1|18.1|Standard Deviation|11.60|11.6|||
3634615|NCT02561806|3482395|B2|||Duration of psoriasis||years|Mean|18.0|18.0|Standard Deviation|11.14|11.14|||
3634616|NCT02561806|3482396|B1|||Duration of psoriasis||years|Mean|18.2|18.2|Standard Deviation|12.0|12.0|||
3634617|NCT02561806|3482394|B3|||BMI||kg/m^2|Mean|29.3|29.3|Standard Deviation|6.38|6.38|||
3634618|NCT02561806|3482395|B2|||BMI||kg/m^2|Mean|28.8|28.8|Standard Deviation|5.55|5.55|||
3634619|NCT02561806|3482396|B1|||BMI||kg/m^2|Mean|29.7|29.7|Standard Deviation|6.97|6.97|||
3634620|NCT02561806|3482394|B3|> 100 kg||Weight Categorical||Participants|Count of Participants|76|76.0||||||
3634621|NCT02561806|3482395|B2|> 100 kg||Weight Categorical||Participants|Count of Participants|31|31.0||||||
3634622|NCT02561806|3482396|B1|> 100 kg||Weight Categorical||Participants|Count of Participants|45|45.0||||||
3634623|NCT02561806|3482394|B3|<= 100 kg||Weight Categorical||Participants|Count of Participants|225|225.0||||||
3634624|NCT02561806|3482395|B2|<= 100 kg||Weight Categorical||Participants|Count of Participants|104|104.0||||||
3634625|NCT02561806|3482396|B1|<= 100 kg||Weight Categorical||Participants|Count of Participants|121|121.0||||||
3634626|NCT02561806|3482394|B3|||Weight||Kilogram|Mean|87.8|87.8|Standard Deviation|22.90|22.9|||
3634627|NCT02561806|3482395|B2|||Weight||Kilogram|Mean|85.8|85.8|Standard Deviation|20.30|20.3|||
3634628|NCT02561806|3482396|B1|||Weight||Kilogram|Mean|89.4|89.4|Standard Deviation|24.5|24.5|||
3634629|NCT02561806|3482394|B3|Germany||Region of Enrollment||Participants|Count of Participants|66|66.0||||||
3634630|NCT02561806|3482395|B2|Germany||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3634631|NCT02561806|3482396|B1|Germany||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3634632|NCT02561806|3482394|B3|France||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
3634633|NCT02561806|3482395|B2|France||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3634634|NCT02561806|3482396|B1|France||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3634635|NCT02561806|3482394|B3|Italy||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3634636|NCT02561806|3482395|B2|Italy||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3634637|NCT02561806|3482396|B1|Italy||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3634638|NCT02561806|3482394|B3|Poland||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
3634639|NCT02561806|3482395|B2|Poland||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3634640|NCT02561806|3482396|B1|Poland||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3634641|NCT02561806|3482394|B3|Belgium||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3634642|NCT02561806|3482395|B2|Belgium||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3634643|NCT02561806|3482396|B1|Belgium||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3634644|NCT02561806|3482394|B3|Sweden||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3634645|NCT02561806|3482395|B2|Sweden||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3634646|NCT02561806|3482396|B1|Sweden||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3634647|NCT02561806|3482394|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3634648|NCT02561806|3482395|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3634649|NCT02561806|3482396|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3634650|NCT02561806|3482394|B3|Austria||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3634651|NCT02561806|3482395|B2|Austria||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3634652|NCT02561806|3482396|B1|Austria||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3634653|NCT02561806|3482394|B3|Canada||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
3634654|NCT02561806|3482395|B2|Canada||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3634655|NCT02561806|3482396|B1|Canada||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3634656|NCT02561806|3482394|B3|Spain||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3634657|NCT02561806|3482395|B2|Spain||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3634658|NCT02561806|3482396|B1|Spain||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3634659|NCT02561806|3482394|B3|Switzerland||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3634663|NCT02561806|3482395|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3634664|NCT02561806|3482396|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3634665|NCT02561806|3482394|B3|Hungary||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3634666|NCT02561806|3482395|B2|Hungary||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3634667|NCT02561806|3482396|B1|Hungary||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3634668|NCT02561806|3482394|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3634669|NCT02561806|3482395|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3634670|NCT02561806|3482396|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3634671|NCT02561806|3482394|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3634672|NCT02561806|3482395|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3634673|NCT02561806|3482396|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3634674|NCT02561806|3482394|B3||White|Race (NIH/OMB)||Participants|Count of Participants|282|282.0||||||
3634675|NCT02561806|3482395|B2||White|Race (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
3634676|NCT02561806|3482396|B1||White|Race (NIH/OMB)||Participants|Count of Participants|157|157.0||||||
3634677|NCT02561806|3482394|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3634678|NCT02561806|3482395|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3634679|NCT02561806|3482396|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3634680|NCT02561806|3482394|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634681|NCT02561806|3482395|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634682|NCT02561806|3482396|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634683|NCT02561806|3482394|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3634684|NCT02561806|3482395|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3634685|NCT02561806|3482396|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3634686|NCT02561806|3482394|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634687|NCT02561806|3482395|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634688|NCT02561806|3482396|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634689|NCT02561806|3482394|B3||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3634690|NCT02561806|3482395|B2||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3634691|NCT02561806|3482396|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3634692|NCT02561806|3482394|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3634693|NCT02561806|3482395|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3634694|NCT02561806|3482396|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3634695|NCT02561806|3482394|B3|||Age||Years|Mean|43.4|43.4|Standard Deviation|12.99|12.99|||
3634696|NCT02561806|3482395|B2|||Age||Years|Mean|42.7|42.7|Standard Deviation|12.67|12.67|||
3634697|NCT02561806|3482396|B1|||Age||Years|Mean|44|44.0|Standard Deviation|13.25|13.25|||
3634698|NCT02561702|3482453|B1|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3634699|NCT02561702|3482453|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3634700|NCT02561702|3482453|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3634701|NCT02561702|3482453|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3634702|NCT02561702|3482453|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3634703|NCT02561702|3482453|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3634704|NCT02561572|3482462|B3|Male||Sex/Gender, Customized||participants|Number|56|56.0||||||
3634705|NCT02561572|3482463|B2|Male||Sex/Gender, Customized||participants|Number|30|30.0||||||
3634706|NCT02561572|3482464|B1|Male||Sex/Gender, Customized||participants|Number|26|26.0||||||
3634707|NCT02561572|3482462|B3|Female||Sex/Gender, Customized||participants|Number|68|68.0||||||
3634708|NCT02561572|3482463|B2|Female||Sex/Gender, Customized||participants|Number|32|32.0||||||
3634709|NCT02561572|3482464|B1|Female||Sex/Gender, Customized||participants|Number|36|36.0||||||
3634710|NCT02561572|3482462|B3|||Age||years|Mean|54.7|54.7|Standard Deviation|15.7|15.7|||
3634711|NCT02561572|3482463|B2|||Age||years|Mean|54|54.0|Standard Deviation|17.5|17.5|||
3634712|NCT02561572|3482464|B1|||Age||years|Mean|55|55.0|Standard Deviation|13.6|13.6|||
3634713|NCT02561195|3482481|B7|Ethnicity: Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|139|139.0||||||
3634714|NCT02561195|3482482|B6|Ethnicity: Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3634715|NCT02561195|3482483|B5|Ethnicity: Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3634716|NCT02561195|3482484|B4|Ethnicity: Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3634717|NCT02561195|3482485|B3|Ethnicity: Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3634718|NCT02561195|3482486|B2|Ethnicity: Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
3634719|NCT02561195|3482487|B1|Ethnicity: Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|55|55.0||||||
3634720|NCT02561195|3482481|B7|Ethnicity: Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|715|715.0||||||
3634721|NCT02561195|3482482|B6|Ethnicity: Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|57|57.0||||||
3634722|NCT02561195|3482483|B5|Ethnicity: Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|172|172.0||||||
3634723|NCT02561195|3482484|B4|Ethnicity: Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|168|168.0||||||
3634724|NCT02561195|3482485|B3|Ethnicity: Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
3634725|NCT02561195|3482486|B2|Ethnicity: Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|143|143.0||||||
3634726|NCT02561195|3482487|B1|Ethnicity: Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|127|127.0||||||
3634727|NCT02561195|3482481|B7|Race: Other||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3634728|NCT02561195|3482482|B6|Race: Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3634729|NCT02561195|3482483|B5|Race: Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3634730|NCT02561195|3482484|B4|Race: Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3634731|NCT02561195|3482485|B3|Race: Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634732|NCT02561195|3482486|B2|Race: Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634733|NCT02561195|3482487|B1|Race: Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3634734|NCT02561195|3482481|B7|Race: Asian||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3634735|NCT02561195|3482482|B6|Race: Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3634736|NCT02561195|3482483|B5|Race: Asian||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3634737|NCT02561195|3482484|B4|Race: Asian||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3634738|NCT02561195|3482485|B3|Race: Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634739|NCT02561195|3482486|B2|Race: Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634740|NCT02561195|3482487|B1|Race: Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3634741|NCT02561195|3482481|B7|Race: Black||Race/Ethnicity, Customized||Participants|Count of Participants|56|56.0||||||
3634742|NCT02561195|3482482|B6|Race: Black||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3634743|NCT02561195|3482483|B5|Race: Black||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3634744|NCT02561195|3482484|B4|Race: Black||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3634745|NCT02561195|3482485|B3|Race: Black||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3634746|NCT02561195|3482486|B2|Race: Black||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3634747|NCT02561195|3482487|B1|Race: Black||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3634748|NCT02561195|3482481|B7|Race: White||Race/Ethnicity, Customized||Participants|Count of Participants|763|763.0||||||
3634749|NCT02561195|3482482|B6|Race: White||Race/Ethnicity, Customized||Participants|Count of Participants|56|56.0||||||
3634750|NCT02561195|3482483|B5|Race: White||Race/Ethnicity, Customized||Participants|Count of Participants|157|157.0||||||
3634751|NCT02561195|3482484|B4|Race: White||Race/Ethnicity, Customized||Participants|Count of Participants|151|151.0||||||
3634752|NCT02561195|3482485|B3|Race: White||Race/Ethnicity, Customized||Participants|Count of Participants|59|59.0||||||
3634753|NCT02561195|3482486|B2|Race: White||Race/Ethnicity, Customized||Participants|Count of Participants|168|168.0||||||
3634754|NCT02561195|3482487|B1|Race: White||Race/Ethnicity, Customized||Participants|Count of Participants|172|172.0||||||
3634755|NCT02561195|3482481|B7||Male|Sex: Female, Male||Participants|Count of Participants|393|393.0||||||
3634756|NCT02561195|3482482|B6||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3634757|NCT02561195|3482483|B5||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3634758|NCT02561195|3482484|B4||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3634759|NCT02561195|3482485|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3634760|NCT02561195|3482486|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3634761|NCT02561195|3482487|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3634762|NCT02561195|3482481|B7||Female|Sex: Female, Male||Participants|Count of Participants|461|461.0||||||
3634763|NCT02561195|3482482|B6||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3634764|NCT02561195|3482483|B5||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3634765|NCT02561195|3482484|B4||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3634766|NCT02561195|3482485|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3634767|NCT02561195|3482486|B2||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3634768|NCT02561195|3482487|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3634769|NCT02561195|3482481|B7||>=65 years|Age||Participants|Count of Participants|854|854.0||||||
3634770|NCT02561195|3482482|B6||>=65 years|Age||Participants|Count of Participants|61|61.0||||||
3634771|NCT02561195|3482483|B5||>=65 years|Age||Participants|Count of Participants|183|183.0||||||
3634772|NCT02561195|3482484|B4||>=65 years|Age||Participants|Count of Participants|183|183.0||||||
3634773|NCT02561195|3482485|B3||>=65 years|Age||Participants|Count of Participants|61|61.0||||||
3634774|NCT02561195|3482486|B2||>=65 years|Age||Participants|Count of Participants|184|184.0||||||
3634775|NCT02561195|3482487|B1||>=65 years|Age||Participants|Count of Participants|182|182.0||||||
3634776|NCT02561195|3482481|B7||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3634777|NCT02561195|3482482|B6||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3634778|NCT02561195|3482483|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3634779|NCT02561195|3482484|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3634780|NCT02561195|3482485|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3634781|NCT02561195|3482486|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3634782|NCT02561195|3482487|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3634783|NCT02561195|3482481|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3634784|NCT02561195|3482482|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3634785|NCT02561195|3482483|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3634786|NCT02561195|3482484|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3634787|NCT02561195|3482485|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3634788|NCT02561195|3482486|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3634789|NCT02561195|3482487|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3634790|NCT02560753|3482640|B5||ApoE4 negative|ApoE4 genotype||Participants|Count of Participants|21|21.0||||||
3634791|NCT02560753|3482641|B4||ApoE4 negative|ApoE4 genotype||Participants|Count of Participants|5|5.0||||||
3634792|NCT02560753|3482642|B3||ApoE4 negative|ApoE4 genotype||Participants|Count of Participants|5|5.0||||||
3634793|NCT02560753|3482643|B2||ApoE4 negative|ApoE4 genotype||Participants|Count of Participants|7|7.0||||||
3634794|NCT02560753|3482644|B1||ApoE4 negative|ApoE4 genotype||Participants|Count of Participants|4|4.0||||||
3634795|NCT02560753|3482640|B5||ApoE4 positive|ApoE4 genotype||Participants|Count of Participants|13|13.0||||||
3634796|NCT02560753|3482641|B4||ApoE4 positive|ApoE4 genotype||Participants|Count of Participants|3|3.0||||||
3634797|NCT02560753|3482642|B3||ApoE4 positive|ApoE4 genotype||Participants|Count of Participants|4|4.0||||||
3634798|NCT02560753|3482643|B2||ApoE4 positive|ApoE4 genotype||Participants|Count of Participants|2|2.0||||||
3634799|NCT02560753|3482644|B1||ApoE4 positive|ApoE4 genotype||Participants|Count of Participants|4|4.0||||||
3634800|NCT02560753|3482640|B5||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3634801|NCT02560753|3482641|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3634802|NCT02560753|3482642|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3634803|NCT02560753|3482643|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3634804|NCT02560753|3482644|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3634805|NCT02560753|3482640|B5||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3634806|NCT02560753|3482641|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3634807|NCT02560753|3482642|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3634808|NCT02560753|3482643|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3634809|NCT02560753|3482644|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3634810|NCT02560753|3482640|B5||>84 years|Age, Customized||Participants|Count of Participants|6|6.0||||||
3634811|NCT02560753|3482641|B4||>84 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3634812|NCT02560753|3482642|B3||>84 years|Age, Customized||Participants|Count of Participants|4|4.0||||||
3634813|NCT02560753|3482643|B2||>84 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3634814|NCT02560753|3482644|B1||>84 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
3634815|NCT02560753|3482640|B5||75-84 years|Age, Customized||Participants|Count of Participants|12|12.0||||||
3634816|NCT02560753|3482641|B4||75-84 years|Age, Customized||Participants|Count of Participants|5|5.0||||||
3634817|NCT02560753|3482642|B3||75-84 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
3634818|NCT02560753|3482643|B2||75-84 years|Age, Customized||Participants|Count of Participants|3|3.0||||||
3634819|NCT02560753|3482644|B1||75-84 years|Age, Customized||Participants|Count of Participants|3|3.0||||||
3634820|NCT02560753|3482640|B5||65-74 years|Age, Customized||Participants|Count of Participants|10|10.0||||||
3634821|NCT02560753|3482641|B4||65-74 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
3634822|NCT02560753|3482642|B3||65-74 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
3634823|NCT02560753|3482643|B2||65-74 years|Age, Customized||Participants|Count of Participants|4|4.0||||||
3634824|NCT02560753|3482644|B1||65-74 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
3634825|NCT02560753|3482640|B5||<=65 years|Age, Customized||Participants|Count of Participants|8|8.0||||||
3634826|NCT02560753|3482641|B4||<=65 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
3634827|NCT02560753|3482642|B3||<=65 years|Age, Customized||Participants|Count of Participants|3|3.0||||||
3634828|NCT02560753|3482643|B2||<=65 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
3634829|NCT02560753|3482644|B1||<=65 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
3634830|NCT02560584|3482673|B1|||Patients with Previous Treatment with BCG Immunotherapy||Participants|Count of Participants|251|251.0||||||
3634831|NCT02560584|3482673|B1|||Patients Treated with intravesical chemotherapy||Participants|Count of Participants|114|114.0||||||
3634832|NCT02560584|3482673|B1|||History of High Grade (Grade 2 or 3) Ta or T1|Under the American Joint Committee on Cancer (AJCC) staging system, also known as the Tumor-Node-Metastases (TNM), pathological stages of NMIBC includes the following: (1) papillary tumors confined to the epithelial mucosa (stage Ta), (2) tumors invading the subepithelial tissue (i.e., lamina propria; T1), and (3) carcinoma in situ. The 1973 World Health Organization (WHO) classification was the widely accepted format for grading bladder neoplasia. The 1973 version designated tumors as either papilloma, grade 1, 2, or 3, whereas the 2004 revision designated tumors as 'low' or 'high' grade.|Participants|Count of Participants|222|222.0||||||
3634833|NCT02560584|3482673|B1|||History of CIS||Participants|Count of Participants|127|127.0||||||
3634834|NCT02560584|3482673|B1|||Number of Previous Recurrences||number of previous recurrences|Mean|1.7|1.7|Standard Deviation|2.0|2.0|||
3634835|NCT02560584|3482673|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3634836|NCT02560584|3482673|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634837|NCT02560584|3482673|B1||White|Race (NIH/OMB)||Participants|Count of Participants|272|272.0||||||
3634838|NCT02560584|3482673|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3634839|NCT02560584|3482673|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634840|NCT02560584|3482673|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3634841|NCT02560584|3482673|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634842|NCT02560584|3482673|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3634843|NCT02560584|3482673|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|296|296.0||||||
3634844|NCT02560584|3482673|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3634845|NCT02560584|3482673|B1||Male|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
3634846|NCT02560584|3482673|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3634847|NCT02560584|3482673|B1|||Age||years|Mean|69.0|69.0|Standard Deviation|10.4|10.4|||
3634848|NCT02560051|3482680|B4||5|ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status scale measures level of functioning. The scale ranges from 0 to 5, with 0 indicating the highest level of functioning and 5 the lowest.|Participants|Count of Participants|0|0.0||||||
3634849|NCT02560051|3482681|B3||5|ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status scale measures level of functioning. The scale ranges from 0 to 5, with 0 indicating the highest level of functioning and 5 the lowest.|Participants|Count of Participants|0|0.0||||||
3634850|NCT02560051|3482682|B2||5|ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status scale measures level of functioning. The scale ranges from 0 to 5, with 0 indicating the highest level of functioning and 5 the lowest.|Participants|Count of Participants|0|0.0||||||
3634851|NCT02560051|3482683|B1||5|ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status scale measures level of functioning. The scale ranges from 0 to 5, with 0 indicating the highest level of functioning and 5 the lowest.|Participants|Count of Participants|0|0.0||||||
3634852|NCT02560051|3482680|B4||4|ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status scale measures level of functioning. The scale ranges from 0 to 5, with 0 indicating the highest level of functioning and 5 the lowest.|Participants|Count of Participants|0|0.0||||||
3634853|NCT02560051|3482681|B3||4|ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status scale measures level of functioning. The scale ranges from 0 to 5, with 0 indicating the highest level of functioning and 5 the lowest.|Participants|Count of Participants|0|0.0||||||
3634854|NCT02560051|3482682|B2||4|ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status scale measures level of functioning. The scale ranges from 0 to 5, with 0 indicating the highest level of functioning and 5 the lowest.|Participants|Count of Participants|0|0.0||||||
3634855|NCT02560051|3482683|B1||4|ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status scale measures level of functioning. The scale ranges from 0 to 5, with 0 indicating the highest level of functioning and 5 the lowest.|Participants|Count of Participants|0|0.0||||||
3634856|NCT02560051|3482680|B4||3|ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status scale measures level of functioning. The scale ranges from 0 to 5, with 0 indicating the highest level of functioning and 5 the lowest.|Participants|Count of Participants|0|0.0||||||
3634857|NCT02560051|3482681|B3||3|ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status scale measures level of functioning. The scale ranges from 0 to 5, with 0 indicating the highest level of functioning and 5 the lowest.|Participants|Count of Participants|0|0.0||||||
3634858|NCT02560051|3482682|B2||3|ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status scale measures level of functioning. The scale ranges from 0 to 5, with 0 indicating the highest level of functioning and 5 the lowest.|Participants|Count of Participants|0|0.0||||||
3634859|NCT02560051|3482683|B1||3|ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status scale measures level of functioning. The scale ranges from 0 to 5, with 0 indicating the highest level of functioning and 5 the lowest.|Participants|Count of Participants|0|0.0||||||
3634860|NCT02560051|3482680|B4||2|ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status scale measures level of functioning. The scale ranges from 0 to 5, with 0 indicating the highest level of functioning and 5 the lowest.|Participants|Count of Participants|0|0.0||||||
3634861|NCT02560051|3482681|B3||2|ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status scale measures level of functioning. The scale ranges from 0 to 5, with 0 indicating the highest level of functioning and 5 the lowest.|Participants|Count of Participants|0|0.0||||||
3634862|NCT02560051|3482682|B2||2|ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status scale measures level of functioning. The scale ranges from 0 to 5, with 0 indicating the highest level of functioning and 5 the lowest.|Participants|Count of Participants|0|0.0||||||
3634863|NCT02560051|3482683|B1||2|ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status scale measures level of functioning. The scale ranges from 0 to 5, with 0 indicating the highest level of functioning and 5 the lowest.|Participants|Count of Participants|0|0.0||||||
3634864|NCT02560051|3482680|B4||1|ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status scale measures level of functioning. The scale ranges from 0 to 5, with 0 indicating the highest level of functioning and 5 the lowest.|Participants|Count of Participants|6|6.0||||||
3634865|NCT02560051|3482681|B3||1|ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status scale measures level of functioning. The scale ranges from 0 to 5, with 0 indicating the highest level of functioning and 5 the lowest.|Participants|Count of Participants|3|3.0||||||
3634866|NCT02560051|3482682|B2||1|ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status scale measures level of functioning. The scale ranges from 0 to 5, with 0 indicating the highest level of functioning and 5 the lowest.|Participants|Count of Participants|3|3.0||||||
3634867|NCT02560051|3482683|B1||1|ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status scale measures level of functioning. The scale ranges from 0 to 5, with 0 indicating the highest level of functioning and 5 the lowest.|Participants|Count of Participants|0|0.0||||||
3634868|NCT02560051|3482680|B4||0|ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status scale measures level of functioning. The scale ranges from 0 to 5, with 0 indicating the highest level of functioning and 5 the lowest.|Participants|Count of Participants|13|13.0||||||
3634869|NCT02560051|3482681|B3||0|ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status scale measures level of functioning. The scale ranges from 0 to 5, with 0 indicating the highest level of functioning and 5 the lowest.|Participants|Count of Participants|2|2.0||||||
3634870|NCT02560051|3482682|B2||0|ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status scale measures level of functioning. The scale ranges from 0 to 5, with 0 indicating the highest level of functioning and 5 the lowest.|Participants|Count of Participants|5|5.0||||||
3634871|NCT02560051|3482683|B1||0|ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status scale measures level of functioning. The scale ranges from 0 to 5, with 0 indicating the highest level of functioning and 5 the lowest.|Participants|Count of Participants|6|6.0||||||
3634872|NCT02560051|3482680|B4|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3634873|NCT02560051|3482681|B3|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3634874|NCT02560051|3482682|B2|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3634875|NCT02560051|3482683|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3634876|NCT02560051|3482680|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3634877|NCT02560051|3482681|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3634878|NCT02560051|3482682|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634879|NCT02560051|3482683|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634880|NCT02560051|3482680|B4|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3634881|NCT02560051|3482681|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634882|NCT02560051|3482682|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3634883|NCT02560051|3482683|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634884|NCT02560051|3482680|B4|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3634885|NCT02560051|3482681|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3634886|NCT02560051|3482682|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3634887|NCT02560051|3482683|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3634888|NCT02560051|3482680|B4|African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3634889|NCT02560051|3482681|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3634890|NCT02560051|3482682|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3634891|NCT02560051|3482683|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3634892|NCT02560051|3482680|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3634893|NCT02560051|3482681|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3634894|NCT02560051|3482682|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3634895|NCT02560051|3482683|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3634896|NCT02560051|3482680|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3634897|NCT02560051|3482681|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3634898|NCT02560051|3482682|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3634899|NCT02560051|3482683|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3634900|NCT02560051|3482680|B4|||Age||years|Median|68|68.0|Full Range|||54.0|84.0|
3634901|NCT02560051|3482681|B3|||Age||years|Median|60|60.0|Full Range|||55.0|84.0|
3634902|NCT02560051|3482682|B2|||Age||years|Median|71|71.0|Full Range|||65.0|80.0|
3634903|NCT02560051|3482683|B1|||Age||years|Median|66.5|66.5|Full Range|||54.0|73.0|
3634904|NCT02560038|3482741|B1|ECOG score of 5||ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status scale measures level of functioning. The scale ranges from 0 to 5, with 0 indicating the highest level of functioning and 5 the lowest.|Participants|Count of Participants|0|0.0||||||
3634905|NCT02560038|3482741|B1|ECOG score of 4||ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status scale measures level of functioning. The scale ranges from 0 to 5, with 0 indicating the highest level of functioning and 5 the lowest.|Participants|Count of Participants|0|0.0||||||
3634906|NCT02560038|3482741|B1|ECOG score of 3||ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status scale measures level of functioning. The scale ranges from 0 to 5, with 0 indicating the highest level of functioning and 5 the lowest.|Participants|Count of Participants|0|0.0||||||
3634907|NCT02560038|3482741|B1|ECOG score of 2||ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status scale measures level of functioning. The scale ranges from 0 to 5, with 0 indicating the highest level of functioning and 5 the lowest.|Participants|Count of Participants|0|0.0||||||
3634960|NCT02559622|3482760|B2|||Age||years|Mean|46.0|46.0|Standard Deviation|14.4|14.4|||
3634961|NCT02559622|3482761|B1|||Age||years|Mean|44.2|44.2|Standard Deviation|12.9|12.9|||
3634908|NCT02560038|3482741|B1|ECOG score of 1||ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status scale measures level of functioning. The scale ranges from 0 to 5, with 0 indicating the highest level of functioning and 5 the lowest.|Participants|Count of Participants|1|1.0||||||
3634909|NCT02560038|3482741|B1|ECOG score of 0||ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status scale measures level of functioning. The scale ranges from 0 to 5, with 0 indicating the highest level of functioning and 5 the lowest.|Participants|Count of Participants|2|2.0||||||
3634910|NCT02560038|3482741|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3634911|NCT02560038|3482741|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3634912|NCT02560038|3482741|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3634913|NCT02560038|3482741|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3634914|NCT02560038|3482741|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3634915|NCT02560038|3482741|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3634916|NCT02560038|3482741|B1|||Age||years|Median|65|65.0|Full Range|||54.0|76.0|
3634917|NCT02560025|3482747|B1|||Median White Blood Cell (WBC) Count||Thousand WBC/ microliter blood|Median|3.2|3.2|Full Range|||0.4|59.7|
3634918|NCT02560025|3482747|B1||Intermediate|Cytogenetic Risk|Higher risk represents an increased chance that the participant will experience undesirable disease outcomes.|Participants|Count of Participants|26|26.0||||||
3634919|NCT02560025|3482747|B1||High|Cytogenetic Risk|Higher risk represents an increased chance that the participant will experience undesirable disease outcomes.|Participants|Count of Participants|13|13.0||||||
3634920|NCT02560025|3482747|B1|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3634921|NCT02560025|3482747|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3634922|NCT02560025|3482747|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634923|NCT02560025|3482747|B1||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3634924|NCT02560025|3482747|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634925|NCT02560025|3482747|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634926|NCT02560025|3482747|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634927|NCT02560025|3482747|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3634928|NCT02560025|3482747|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3634929|NCT02560025|3482747|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3634930|NCT02560025|3482747|B1|||Age||years|Median|67|67.0|Full Range|||33.0|83.0|
3634931|NCT02560012|3482753|B1||5-Dead|Eastern Cooperative Oncology Group Performance Status (ECOG)||Participants|Count of Participants|0|0.0||||||
3634932|NCT02560012|3482753|B1||4-Completely disabled, no selfcare, bed/chair 100%|Eastern Cooperative Oncology Group Performance Status (ECOG)||Participants|Count of Participants|0|0.0||||||
3634933|NCT02560012|3482753|B1||3-Limited selfcare, confined to bed/chair > 50%|Eastern Cooperative Oncology Group Performance Status (ECOG)||Participants|Count of Participants|0|0.0||||||
3634934|NCT02560012|3482753|B1||2-Ambulatory, selfcare, unable to work|Eastern Cooperative Oncology Group Performance Status (ECOG)||Participants|Count of Participants|0|0.0||||||
3634935|NCT02560012|3482753|B1||1-No strenuous activity, ambulatory, light work|Eastern Cooperative Oncology Group Performance Status (ECOG)||Participants|Count of Participants|0|0.0||||||
3634936|NCT02560012|3482753|B1||0-Fully active, pre-disease performance|Eastern Cooperative Oncology Group Performance Status (ECOG)||Participants|Count of Participants|3|3.0||||||
3634937|NCT02560012|3482753|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3634938|NCT02560012|3482753|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3634939|NCT02560012|3482753|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3634940|NCT02560012|3482753|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3634941|NCT02560012|3482753|B1|||Age||years|Median|65|65.0|Full Range|||46.0|70.0|
3634942|NCT02559622|3482757|B5|Germany||Region of Enrollment||participants|Number|151|151.0||||||
3634943|NCT02559622|3482758|B4|Germany||Region of Enrollment||participants|Number|23|23.0||||||
3634944|NCT02559622|3482759|B3|Germany||Region of Enrollment||participants|Number|26|26.0||||||
3634945|NCT02559622|3482760|B2|Germany||Region of Enrollment||participants|Number|54|54.0||||||
3634946|NCT02559622|3482761|B1|Germany||Region of Enrollment||participants|Number|48|48.0||||||
3634947|NCT02559622|3482757|B5||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3634948|NCT02559622|3482758|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3634949|NCT02559622|3482759|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3634950|NCT02559622|3482760|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3634951|NCT02559622|3482761|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3634952|NCT02559622|3482757|B5||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3634953|NCT02559622|3482758|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3634954|NCT02559622|3482759|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3634955|NCT02559622|3482760|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3634956|NCT02559622|3482761|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3634957|NCT02559622|3482757|B5|||Age||years|Mean|45.2|45.2|Standard Deviation|13.2|13.2|||
3634958|NCT02559622|3482758|B4|||Age||years|Mean|46.8|46.8|Standard Deviation|13.1|13.1|||
3634959|NCT02559622|3482759|B3|||Age||years|Mean|43.7|43.7|Standard Deviation|11.4|11.4|||
3634962|NCT02559622|3482757|B5||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3634963|NCT02559622|3482758|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3634964|NCT02559622|3482759|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3634965|NCT02559622|3482760|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3634966|NCT02559622|3482761|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3634967|NCT02559622|3482757|B5||Between 18 and 65 years|Age||Participants|Count of Participants|140|140.0||||||
3634968|NCT02559622|3482758|B4||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3634969|NCT02559622|3482759|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3634970|NCT02559622|3482760|B2||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
3634971|NCT02559622|3482761|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
3634972|NCT02559622|3482757|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3634973|NCT02559622|3482758|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3634974|NCT02559622|3482759|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3634975|NCT02559622|3482760|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3634976|NCT02559622|3482761|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3634977|NCT02559414|3482843|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3634978|NCT02559414|3482844|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3634979|NCT02559414|3482845|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3634980|NCT02559414|3482846|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3634981|NCT02559414|3482843|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3634982|NCT02559414|3482844|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3634983|NCT02559414|3482845|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3634984|NCT02559414|3482846|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3634985|NCT02559414|3482843|B4||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3634986|NCT02559414|3482844|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3634987|NCT02559414|3482845|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3634988|NCT02559414|3482846|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3634989|NCT02559414|3482843|B4||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3634990|NCT02559414|3482844|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3634991|NCT02559414|3482845|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3634992|NCT02559414|3482846|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3634993|NCT02559414|3482843|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3634994|NCT02559414|3482844|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3634995|NCT02559414|3482845|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3634996|NCT02559414|3482846|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3634997|NCT02558894|3482886|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3634998|NCT02558894|3482887|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3634999|NCT02558894|3482888|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635000|NCT02558894|3482886|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635001|NCT02558894|3482887|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635002|NCT02558894|3482888|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635003|NCT02558894|3482886|B3||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3635004|NCT02558894|3482887|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3635005|NCT02558894|3482888|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3635006|NCT02558894|3482886|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635007|NCT02558894|3482887|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635008|NCT02558894|3482888|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635009|NCT02558894|3482886|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635010|NCT02558894|3482887|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635011|NCT02558894|3482888|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635012|NCT02558894|3482886|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3635013|NCT02558894|3482887|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3635014|NCT02558894|3482888|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3635015|NCT02558894|3482886|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635016|NCT02558894|3482887|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635017|NCT02558894|3482888|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635018|NCT02558894|3482886|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635019|NCT02558894|3482887|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635020|NCT02558894|3482888|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635021|NCT02558894|3482886|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3635022|NCT02558894|3482887|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3635023|NCT02558894|3482888|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3635024|NCT02558894|3482886|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3635025|NCT02558894|3482887|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635026|NCT02558894|3482888|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3635027|NCT02558894|3482886|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3635028|NCT02558894|3482887|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3635029|NCT02558894|3482888|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3635030|NCT02558894|3482886|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3635031|NCT02558894|3482887|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3635032|NCT02558894|3482888|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3635033|NCT02558894|3482886|B3|||Age||Years|Mean|61.5|61.5|Standard Deviation|9.49|9.49|||
3635034|NCT02558894|3482887|B2|||Age||Years|Mean|61.6|61.6|Standard Deviation|9.54|9.54|||
3635035|NCT02558894|3482888|B1|||Age||Years|Mean|61.3|61.3|Standard Deviation|9.60|9.6|||
3635036|NCT02558829|3482913|B5|||Body Mass Index (kg/m^2)||kg/m^2|Mean|28.0|28.0|Standard Deviation|4.8|4.8|||
3635037|NCT02558829|3482914|B4|||Body Mass Index (kg/m^2)||kg/m^2|Mean|26.1|26.1|Standard Deviation|3.2|3.2|||
3635038|NCT02558829|3482915|B3|||Body Mass Index (kg/m^2)||kg/m^2|Mean|27.9|27.9|Standard Deviation|5.7|5.7|||
3635039|NCT02558829|3482916|B2|||Body Mass Index (kg/m^2)||kg/m^2|Mean|29.8|29.8|Standard Deviation|4.5|4.5|||
3635040|NCT02558829|3482917|B1|||Body Mass Index (kg/m^2)||kg/m^2|Mean|27.6|27.6|Standard Deviation|4.6|4.6|||
3635041|NCT02558829|3482913|B5|Spain||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3635042|NCT02558829|3482914|B4|Spain||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3635043|NCT02558829|3482915|B3|Spain||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3635044|NCT02558829|3482916|B2|Spain||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3635045|NCT02558829|3482917|B1|Spain||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3635046|NCT02558829|3482913|B5|Germany||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3635047|NCT02558829|3482914|B4|Germany||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3635048|NCT02558829|3482915|B3|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3635049|NCT02558829|3482916|B2|Germany||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3635050|NCT02558829|3482917|B1|Germany||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3635051|NCT02558829|3482913|B5|Serbia||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3635052|NCT02558829|3482914|B4|Serbia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3635053|NCT02558829|3482915|B3|Serbia||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3635054|NCT02558829|3482916|B2|Serbia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3635055|NCT02558829|3482917|B1|Serbia||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3635056|NCT02558829|3482913|B5|France||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3635057|NCT02558829|3482914|B4|France||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3635058|NCT02558829|3482915|B3|France||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3635059|NCT02558829|3482916|B2|France||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3635060|NCT02558829|3482917|B1|France||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3635061|NCT02558829|3482913|B5|Italy||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3635062|NCT02558829|3482914|B4|Italy||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3635063|NCT02558829|3482915|B3|Italy||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3635064|NCT02558829|3482916|B2|Italy||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3635065|NCT02558829|3482917|B1|Italy||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3635066|NCT02558829|3482913|B5|United Kingdom||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3635067|NCT02558829|3482914|B4|United Kingdom||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3635068|NCT02558829|3482915|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3635069|NCT02558829|3482916|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3635070|NCT02558829|3482917|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3635071|NCT02558829|3482913|B5|Poland||Region of Enrollment||Participants|Count of Participants|49|49.0||||||
3635072|NCT02558829|3482914|B4|Poland||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3635073|NCT02558829|3482915|B3|Poland||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3635074|NCT02558829|3482916|B2|Poland||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3635075|NCT02558829|3482917|B1|Poland||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3635076|NCT02558829|3482913|B5|United States||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3635077|NCT02558829|3482914|B4|United States||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3635078|NCT02558829|3482915|B3|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3635079|NCT02558829|3482916|B2|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3635080|NCT02558829|3482917|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3635081|NCT02558829|3482913|B5|Austria||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3635082|NCT02558829|3482914|B4|Austria||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3635083|NCT02558829|3482915|B3|Austria||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3635084|NCT02558829|3482916|B2|Austria||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3635085|NCT02558829|3482917|B1|Austria||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3635086|NCT02558829|3482913|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3635087|NCT02558829|3482914|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635088|NCT02558829|3482915|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3635089|NCT02558829|3482916|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3635090|NCT02558829|3482917|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3635091|NCT02558829|3482913|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635092|NCT02558829|3482914|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635093|NCT02558829|3482915|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635094|NCT02558829|3482916|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635095|NCT02558829|3482917|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635096|NCT02558829|3482913|B5||White|Race (NIH/OMB)||Participants|Count of Participants|135|135.0||||||
3635097|NCT02558829|3482914|B4||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3635098|NCT02558829|3482915|B3||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3635099|NCT02558829|3482916|B2||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3635100|NCT02558829|3482917|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3635101|NCT02558829|3482913|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3635102|NCT02558829|3482914|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635103|NCT02558829|3482915|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3635104|NCT02558829|3482916|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3635105|NCT02558829|3482917|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635106|NCT02558829|3482913|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3635107|NCT02558829|3482914|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635108|NCT02558829|3482915|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3635109|NCT02558829|3482916|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635110|NCT02558829|3482917|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635111|NCT02558829|3482913|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3635112|NCT02558829|3482914|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635113|NCT02558829|3482915|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3635114|NCT02558829|3482916|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3635115|NCT02558829|3482917|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3635116|NCT02558829|3482913|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635117|NCT02558829|3482914|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635118|NCT02558829|3482915|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635119|NCT02558829|3482916|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635120|NCT02558829|3482917|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635121|NCT02558829|3482913|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3635122|NCT02558829|3482914|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635123|NCT02558829|3482915|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3635124|NCT02558829|3482916|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3635125|NCT02558829|3482917|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3635126|NCT02558829|3482913|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
3635127|NCT02558829|3482914|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3635128|NCT02558829|3482915|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3635129|NCT02558829|3482916|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3635130|NCT02558829|3482917|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3635131|NCT02558829|3482913|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3635132|NCT02558829|3482914|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635133|NCT02558829|3482915|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3635134|NCT02558829|3482916|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3635135|NCT02558829|3482917|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3635136|NCT02558829|3482913|B5||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3635137|NCT02558829|3482914|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3635138|NCT02558829|3482915|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3635139|NCT02558829|3482916|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3635140|NCT02558829|3482917|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3635141|NCT02558829|3482913|B5||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3635142|NCT02558829|3482914|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3635143|NCT02558829|3482915|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3635144|NCT02558829|3482916|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3635145|NCT02558829|3482917|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3635146|NCT02558829|3482913|B5|||Age||years|Mean|40.7|40.7|Standard Deviation|13.1|13.1|||
3635147|NCT02558829|3482914|B4|||Age||years|Mean|40.0|40.0|Standard Deviation|12.4|12.4|||
3635148|NCT02558829|3482915|B3|||Age||years|Mean|34.9|34.9|Standard Deviation|10.5|10.5|||
3635149|NCT02558829|3482916|B2|||Age||years|Mean|45.8|45.8|Standard Deviation|11.8|11.8|||
3635150|NCT02558829|3482917|B1|||Age||years|Mean|42.3|42.3|Standard Deviation|15.0|15.0|||
3635151|NCT02558790|3482950|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3635152|NCT02558790|3482950|B1|More than one race||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3635153|NCT02558790|3482950|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3635154|NCT02558790|3482950|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3635155|NCT02558790|3482950|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3635156|NCT02558790|3482950|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3635157|NCT02558790|3482950|B1|||Age||years|Mean|36.4|36.4|Standard Deviation|14.04|14.04|||
3635158|NCT02558790|3482950|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3635159|NCT02558790|3482950|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3635160|NCT02558790|3482950|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3635161|NCT02558374|3482954|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3635162|NCT02558374|3482955|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635163|NCT02558374|3482956|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3635164|NCT02558374|3482954|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3635165|NCT02558374|3482955|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3635166|NCT02558374|3482956|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635167|NCT02558374|3482954|B3||White|Race (NIH/OMB)||Participants|Count of Participants|533|533.0||||||
3635168|NCT02558374|3482955|B2||White|Race (NIH/OMB)||Participants|Count of Participants|274|274.0||||||
3635169|NCT02558374|3482956|B1||White|Race (NIH/OMB)||Participants|Count of Participants|259|259.0||||||
3635170|NCT02558374|3482954|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|159|159.0||||||
3635171|NCT02558374|3482955|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3635172|NCT02558374|3482956|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3635173|NCT02558374|3482954|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3635174|NCT02558374|3482955|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3635175|NCT02558374|3482956|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635176|NCT02558374|3482954|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3635177|NCT02558374|3482955|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3635178|NCT02558374|3482956|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3635179|NCT02558374|3482954|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635180|NCT02558374|3482955|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635181|NCT02558374|3482956|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635182|NCT02558374|3482954|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635183|NCT02558374|3482955|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635184|NCT02558374|3482956|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635185|NCT02558374|3482954|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|532|532.0||||||
3635186|NCT02558374|3482955|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|270|270.0||||||
3635187|NCT02558374|3482956|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|262|262.0||||||
3635188|NCT02558374|3482954|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|176|176.0||||||
3635189|NCT02558374|3482955|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3635190|NCT02558374|3482956|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
3635191|NCT02558374|3482954|B3||Male|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
3635192|NCT02558374|3482955|B2||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3635193|NCT02558374|3482956|B1||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3635194|NCT02558374|3482954|B3||Female|Sex: Female, Male||Participants|Count of Participants|445|445.0||||||
3635195|NCT02558374|3482955|B2||Female|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
3635196|NCT02558374|3482956|B1||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
3635197|NCT02558374|3482954|B3|||Age||years|Mean|64.3|64.3|Standard Deviation|11.25|11.25|||
3635198|NCT02558374|3482955|B2|||Age||years|Mean|64.5|64.5|Standard Deviation|10.97|10.97|||
3635199|NCT02558374|3482956|B1|||Age||years|Mean|64.1|64.1|Standard Deviation|11.55|11.55|||
3635200|NCT02557698|3482965|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3635201|NCT02557698|3482966|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3635202|NCT02557698|3482967|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3635203|NCT02557698|3482965|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3635204|NCT02557698|3482966|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3635205|NCT02557698|3482967|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3635206|NCT02557698|3482965|B3|||Age||years|Median|32.5|32.5|Inter-Quartile Range|||8.3|69.0|
3635207|NCT02557698|3482966|B2|||Age||years|Median|29.5|29.5|Inter-Quartile Range|||6.0|68.3|
3635208|NCT02557698|3482967|B1|||Age||years|Median|34.0|34.0|Inter-Quartile Range|||13.3|70.0|
3635209|NCT02557646|3483032|B1||Male|Sex: Female, Male||Participants|Count of Participants|311|311.0||||||
3635210|NCT02557646|3483032|B1||Female|Sex: Female, Male||Participants|Count of Participants|382|382.0||||||
3635211|NCT02557646|3483032|B1|||Age|Out of total 693 participants in ITT population, data for only 692 participants was available for this baseline measure.|years|Mean|50.35|50.35|Standard Deviation|10.76|10.76|||
3635212|NCT02557555|3483050|B1|||Patients completing survey||Participants|Count of Participants|100|100.0||||||
3635213|NCT02557555|3483050|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
3635214|NCT02557555|3483050|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3635215|NCT02557555|3483050|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3635216|NCT02557555|3483050|B1|18-45 years||Age, Customized|Patients age 18-45 admitted to labor and delivery|Participants|Count of Participants|100|100.0||||||
3635217|NCT02557399|3483055|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635218|NCT02557399|3483056|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635219|NCT02557399|3483057|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635220|NCT02557399|3483055|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635221|NCT02557399|3483056|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635222|NCT02557399|3483057|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635223|NCT02557399|3483055|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635224|NCT02557399|3483056|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635225|NCT02557399|3483057|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635226|NCT02557399|3483055|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635227|NCT02557399|3483056|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635228|NCT02557399|3483057|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635229|NCT02557399|3483055|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635230|NCT02557399|3483056|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635231|NCT02557399|3483057|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635232|NCT02557399|3483055|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|349|349.0||||||
3635233|NCT02557399|3483056|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|177|177.0||||||
3635234|NCT02557399|3483057|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|172|172.0||||||
3635235|NCT02557399|3483055|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635236|NCT02557399|3483056|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635237|NCT02557399|3483057|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635238|NCT02557399|3483055|B3||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3635239|NCT02557399|3483056|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3635240|NCT02557399|3483057|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3635241|NCT02557399|3483055|B3||Female|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
3635242|NCT02557399|3483056|B2||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3635243|NCT02557399|3483057|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3635244|NCT02557399|3483055|B3|||Age||Years|Mean|20.0|20.0|Standard Deviation|5.42|5.42|||
3635245|NCT02557399|3483056|B2|||Age||Years|Mean|19.8|19.8|Standard Deviation|4.90|4.9|||
3635246|NCT02557399|3483057|B1|||Age||Years|Mean|20.3|20.3|Standard Deviation|5.91|5.91|||
3635247|NCT02557035|3483090|B3||Occasional|Tobacco consumption||Participants|Count of Participants|5|5.0||||||
3635248|NCT02557035|3483091|B2||Occasional|Tobacco consumption||Participants|Count of Participants|2|2.0||||||
3635249|NCT02557035|3483092|B1||Occasional|Tobacco consumption||Participants|Count of Participants|3|3.0||||||
3635250|NCT02557035|3483090|B3||Regular|Tobacco consumption||Participants|Count of Participants|126|126.0||||||
3635251|NCT02557035|3483091|B2||Regular|Tobacco consumption||Participants|Count of Participants|66|66.0||||||
3635252|NCT02557035|3483092|B1||Regular|Tobacco consumption||Participants|Count of Participants|60|60.0||||||
3635253|NCT02557035|3483090|B3||Ex-smoker|Tobacco consumption||Participants|Count of Participants|151|151.0||||||
3635254|NCT02557035|3483091|B2||Ex-smoker|Tobacco consumption||Participants|Count of Participants|70|70.0||||||
3635255|NCT02557035|3483092|B1||Ex-smoker|Tobacco consumption||Participants|Count of Participants|81|81.0||||||
3635256|NCT02557035|3483090|B3||non-smoker|Tobacco consumption||Participants|Count of Participants|158|158.0||||||
3635257|NCT02557035|3483091|B2||non-smoker|Tobacco consumption||Participants|Count of Participants|77|77.0||||||
3635258|NCT02557035|3483092|B1||non-smoker|Tobacco consumption||Participants|Count of Participants|81|81.0||||||
3635259|NCT02557035|3483090|B3||Regular|Alcohol consumption||Participants|Count of Participants|10|10.0||||||
3635260|NCT02557035|3483091|B2||Regular|Alcohol consumption||Participants|Count of Participants|3|3.0||||||
3635261|NCT02557035|3483092|B1||Regular|Alcohol consumption||Participants|Count of Participants|7|7.0||||||
3635262|NCT02557035|3483090|B3||Occasional|Alcohol consumption||Participants|Count of Participants|125|125.0||||||
3635263|NCT02557035|3483091|B2||Occasional|Alcohol consumption||Participants|Count of Participants|67|67.0||||||
3635264|NCT02557035|3483092|B1||Occasional|Alcohol consumption||Participants|Count of Participants|58|58.0||||||
3635265|NCT02557035|3483090|B3||None|Alcohol consumption||Participants|Count of Participants|305|305.0||||||
3635266|NCT02557035|3483091|B2||None|Alcohol consumption||Participants|Count of Participants|145|145.0||||||
3635267|NCT02557035|3483092|B1||None|Alcohol consumption||Participants|Count of Participants|160|160.0||||||
3635268|NCT02557035|3483090|B3||Grade 2|ECOG Performance Status|The ECOG Scale is a standard criteria for measuring how the cancer disease impacts a patient's daily living abilities (known to physicians and researchers as a patient's performance status). It describes a patient's level of functioning in terms of their ability to care for themself, daily activity, and physical ability (walking, working, etc.). There 6 grades, where the performance gets worsening from 0 (patient is fully active, able to carry on all pre-disease performance without restriction) to 5 (patient is dead).|Participants|Count of Participants|14|14.0||||||
3635269|NCT02557035|3483091|B2||Grade 2|ECOG Performance Status|The ECOG Scale is a standard criteria for measuring how the cancer disease impacts a patient's daily living abilities (known to physicians and researchers as a patient's performance status). It describes a patient's level of functioning in terms of their ability to care for themself, daily activity, and physical ability (walking, working, etc.). There 6 grades, where the performance gets worsening from 0 (patient is fully active, able to carry on all pre-disease performance without restriction) to 5 (patient is dead).|Participants|Count of Participants|6|6.0||||||
3635270|NCT02557035|3483092|B1||Grade 2|ECOG Performance Status|The ECOG Scale is a standard criteria for measuring how the cancer disease impacts a patient's daily living abilities (known to physicians and researchers as a patient's performance status). It describes a patient's level of functioning in terms of their ability to care for themself, daily activity, and physical ability (walking, working, etc.). There 6 grades, where the performance gets worsening from 0 (patient is fully active, able to carry on all pre-disease performance without restriction) to 5 (patient is dead).|Participants|Count of Participants|8|8.0||||||
3635271|NCT02557035|3483090|B3||Grade 1|ECOG Performance Status|The ECOG Scale is a standard criteria for measuring how the cancer disease impacts a patient's daily living abilities (known to physicians and researchers as a patient's performance status). It describes a patient's level of functioning in terms of their ability to care for themself, daily activity, and physical ability (walking, working, etc.). There 6 grades, where the performance gets worsening from 0 (patient is fully active, able to carry on all pre-disease performance without restriction) to 5 (patient is dead).|Participants|Count of Participants|220|220.0||||||
3635272|NCT02557035|3483091|B2||Grade 1|ECOG Performance Status|The ECOG Scale is a standard criteria for measuring how the cancer disease impacts a patient's daily living abilities (known to physicians and researchers as a patient's performance status). It describes a patient's level of functioning in terms of their ability to care for themself, daily activity, and physical ability (walking, working, etc.). There 6 grades, where the performance gets worsening from 0 (patient is fully active, able to carry on all pre-disease performance without restriction) to 5 (patient is dead).|Participants|Count of Participants|100|100.0||||||
3635273|NCT02557035|3483092|B1||Grade 1|ECOG Performance Status|The ECOG Scale is a standard criteria for measuring how the cancer disease impacts a patient's daily living abilities (known to physicians and researchers as a patient's performance status). It describes a patient's level of functioning in terms of their ability to care for themself, daily activity, and physical ability (walking, working, etc.). There 6 grades, where the performance gets worsening from 0 (patient is fully active, able to carry on all pre-disease performance without restriction) to 5 (patient is dead).|Participants|Count of Participants|120|120.0||||||
3635274|NCT02557035|3483090|B3||Grade 0|ECOG Performance Status|The ECOG Scale is a standard criteria for measuring how the cancer disease impacts a patient's daily living abilities (known to physicians and researchers as a patient's performance status). It describes a patient's level of functioning in terms of their ability to care for themself, daily activity, and physical ability (walking, working, etc.). There 6 grades, where the performance gets worsening from 0 (patient is fully active, able to carry on all pre-disease performance without restriction) to 5 (patient is dead).|Participants|Count of Participants|206|206.0||||||
3635275|NCT02557035|3483091|B2||Grade 0|ECOG Performance Status|The ECOG Scale is a standard criteria for measuring how the cancer disease impacts a patient's daily living abilities (known to physicians and researchers as a patient's performance status). It describes a patient's level of functioning in terms of their ability to care for themself, daily activity, and physical ability (walking, working, etc.). There 6 grades, where the performance gets worsening from 0 (patient is fully active, able to carry on all pre-disease performance without restriction) to 5 (patient is dead).|Participants|Count of Participants|109|109.0||||||
3635359|NCT02556632|3483115|B4||No|Currently on Hormone Therapy||Participants|Count of Participants|148|148.0||||||
3635360|NCT02556632|3483116|B3||No|Currently on Hormone Therapy||Participants|Count of Participants|48|48.0||||||
3635276|NCT02557035|3483092|B1||Grade 0|ECOG Performance Status|The ECOG Scale is a standard criteria for measuring how the cancer disease impacts a patient's daily living abilities (known to physicians and researchers as a patient's performance status). It describes a patient's level of functioning in terms of their ability to care for themself, daily activity, and physical ability (walking, working, etc.). There 6 grades, where the performance gets worsening from 0 (patient is fully active, able to carry on all pre-disease performance without restriction) to 5 (patient is dead).|Participants|Count of Participants|97|97.0||||||
3635277|NCT02557035|3483090|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635278|NCT02557035|3483091|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635279|NCT02557035|3483092|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635280|NCT02557035|3483090|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635281|NCT02557035|3483091|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635282|NCT02557035|3483092|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635283|NCT02557035|3483090|B3||White|Race (NIH/OMB)||Participants|Count of Participants|440|440.0||||||
3635284|NCT02557035|3483091|B2||White|Race (NIH/OMB)||Participants|Count of Participants|215|215.0||||||
3635285|NCT02557035|3483092|B1||White|Race (NIH/OMB)||Participants|Count of Participants|225|225.0||||||
3635286|NCT02557035|3483090|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635287|NCT02557035|3483091|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635288|NCT02557035|3483092|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635289|NCT02557035|3483090|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635290|NCT02557035|3483091|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635291|NCT02557035|3483092|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635292|NCT02557035|3483090|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635293|NCT02557035|3483091|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635294|NCT02557035|3483092|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635295|NCT02557035|3483090|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635296|NCT02557035|3483091|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635297|NCT02557035|3483092|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635298|NCT02557035|3483090|B3||Male|Sex: Female, Male||Participants|Count of Participants|295|295.0||||||
3635299|NCT02557035|3483091|B2||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3635300|NCT02557035|3483092|B1||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3635301|NCT02557035|3483090|B3||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3635302|NCT02557035|3483091|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3635303|NCT02557035|3483092|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3635304|NCT02557035|3483090|B3|||Age||years|Mean|59.4|59.4|Standard Deviation|8.6|8.6|||
3635305|NCT02557035|3483091|B2|||Age||years|Mean|58.9|58.9|Standard Deviation|8.5|8.5|||
3635306|NCT02557035|3483092|B1|||Age||years|Mean|59.9|59.9|Standard Deviation|8.7|8.7|||
3635307|NCT02556632|3483115|B4|||Breast Field Separation|Breast field separation (BFS) evaluates the association of breast size with radiation-induced skin toxicity. BFS can be obtained from the radiation treatment plan for both 3D conformal breast radiation and IMRT. BFS is defined as the distance between the medial and lateral tangential fields. The tangential fields are created during simulation to achieve uniform dose distribution to the breast volume. The tangential fields align with the medial and lateral contours of the breast. BFS is similar to the width measurement of the breast and is calculated as part of the radiation treatment plan.|centimeters|Mean|23.1|23.1|Standard Deviation|4.6|4.6|||
3635308|NCT02556632|3483116|B3|||Breast Field Separation|Breast field separation (BFS) evaluates the association of breast size with radiation-induced skin toxicity. BFS can be obtained from the radiation treatment plan for both 3D conformal breast radiation and IMRT. BFS is defined as the distance between the medial and lateral tangential fields. The tangential fields are created during simulation to achieve uniform dose distribution to the breast volume. The tangential fields align with the medial and lateral contours of the breast. BFS is similar to the width measurement of the breast and is calculated as part of the radiation treatment plan.|centimeters|Mean|22.8|22.8|Standard Deviation|5.5|5.5|||
3635309|NCT02556632|3483117|B2|||Breast Field Separation|Breast field separation (BFS) evaluates the association of breast size with radiation-induced skin toxicity. BFS can be obtained from the radiation treatment plan for both 3D conformal breast radiation and IMRT. BFS is defined as the distance between the medial and lateral tangential fields. The tangential fields are created during simulation to achieve uniform dose distribution to the breast volume. The tangential fields align with the medial and lateral contours of the breast. BFS is similar to the width measurement of the breast and is calculated as part of the radiation treatment plan.|centimeters|Mean|23.8|23.8|Standard Deviation|4.2|4.2|||
3635310|NCT02556632|3483118|B1|||Breast Field Separation|Breast field separation (BFS) evaluates the association of breast size with radiation-induced skin toxicity. BFS can be obtained from the radiation treatment plan for both 3D conformal breast radiation and IMRT. BFS is defined as the distance between the medial and lateral tangential fields. The tangential fields are created during simulation to achieve uniform dose distribution to the breast volume. The tangential fields align with the medial and lateral contours of the breast. BFS is similar to the width measurement of the breast and is calculated as part of the radiation treatment plan.|centimeters|Mean|22.6|22.6|Standard Deviation|4.0|4.0|||
3635361|NCT02556632|3483117|B2||No|Currently on Hormone Therapy||Participants|Count of Participants|48|48.0||||||
3635362|NCT02556632|3483118|B1||No|Currently on Hormone Therapy||Participants|Count of Participants|52|52.0||||||
3635311|NCT02556632|3483115|B4|||Total Radiation Dose Prescribed|The international system (SI) unit of radiation dose expressed in terms of absorbed energy per unit mass of tissue. The gray is the unit of absorbed dose and has replaced the rad. 1 gray = 1 Joule/kilogram and also equals 100 rad.|Gray units|Mean|59.0|59.0|Standard Deviation|5.1|5.1|||
3635312|NCT02556632|3483116|B3|||Total Radiation Dose Prescribed|The international system (SI) unit of radiation dose expressed in terms of absorbed energy per unit mass of tissue. The gray is the unit of absorbed dose and has replaced the rad. 1 gray = 1 Joule/kilogram and also equals 100 rad.|Gray units|Mean|59.1|59.1|Standard Deviation|5.2|5.2|||
3635313|NCT02556632|3483117|B2|||Total Radiation Dose Prescribed|The international system (SI) unit of radiation dose expressed in terms of absorbed energy per unit mass of tissue. The gray is the unit of absorbed dose and has replaced the rad. 1 gray = 1 Joule/kilogram and also equals 100 rad.|Gray units|Mean|59.5|59.5|Standard Deviation|4.5|4.5|||
3635314|NCT02556632|3483118|B1|||Total Radiation Dose Prescribed|The international system (SI) unit of radiation dose expressed in terms of absorbed energy per unit mass of tissue. The gray is the unit of absorbed dose and has replaced the rad. 1 gray = 1 Joule/kilogram and also equals 100 rad.|Gray units|Mean|58.4|58.4|Standard Deviation|5.6|5.6|||
3635315|NCT02556632|3483115|B4||Unknown or Not Reported|Radiation Boost Planned||Participants|Count of Participants|2|2.0||||||
3635316|NCT02556632|3483116|B3||Unknown or Not Reported|Radiation Boost Planned||Participants|Count of Participants|1|1.0||||||
3635317|NCT02556632|3483117|B2||Unknown or Not Reported|Radiation Boost Planned||Participants|Count of Participants|1|1.0||||||
3635318|NCT02556632|3483118|B1||Unknown or Not Reported|Radiation Boost Planned||Participants|Count of Participants|0|0.0||||||
3635319|NCT02556632|3483115|B4||Yes|Radiation Boost Planned||Participants|Count of Participants|180|180.0||||||
3635320|NCT02556632|3483116|B3||Yes|Radiation Boost Planned||Participants|Count of Participants|59|59.0||||||
3635321|NCT02556632|3483117|B2||Yes|Radiation Boost Planned||Participants|Count of Participants|61|61.0||||||
3635322|NCT02556632|3483118|B1||Yes|Radiation Boost Planned||Participants|Count of Participants|60|60.0||||||
3635323|NCT02556632|3483115|B4||No|Radiation Boost Planned||Participants|Count of Participants|9|9.0||||||
3635324|NCT02556632|3483116|B3||No|Radiation Boost Planned||Participants|Count of Participants|2|2.0||||||
3635325|NCT02556632|3483117|B2||No|Radiation Boost Planned||Participants|Count of Participants|3|3.0||||||
3635326|NCT02556632|3483118|B1||No|Radiation Boost Planned||Participants|Count of Participants|4|4.0||||||
3635327|NCT02556632|3483115|B4||Unknown or Not Reported|Type of Radiation||Participants|Count of Participants|2|2.0||||||
3635328|NCT02556632|3483116|B3||Unknown or Not Reported|Type of Radiation||Participants|Count of Participants|1|1.0||||||
3635329|NCT02556632|3483117|B2||Unknown or Not Reported|Type of Radiation||Participants|Count of Participants|1|1.0||||||
3635330|NCT02556632|3483118|B1||Unknown or Not Reported|Type of Radiation||Participants|Count of Participants|0|0.0||||||
3635331|NCT02556632|3483115|B4||3D Conformal Whole Breast|Type of Radiation||Participants|Count of Participants|184|184.0||||||
3635332|NCT02556632|3483116|B3||3D Conformal Whole Breast|Type of Radiation||Participants|Count of Participants|59|59.0||||||
3635333|NCT02556632|3483117|B2||3D Conformal Whole Breast|Type of Radiation||Participants|Count of Participants|62|62.0||||||
3635334|NCT02556632|3483118|B1||3D Conformal Whole Breast|Type of Radiation||Participants|Count of Participants|63|63.0||||||
3635335|NCT02556632|3483115|B4||IMRT|Type of Radiation||Participants|Count of Participants|5|5.0||||||
3635336|NCT02556632|3483116|B3||IMRT|Type of Radiation||Participants|Count of Participants|2|2.0||||||
3635337|NCT02556632|3483117|B2||IMRT|Type of Radiation||Participants|Count of Participants|2|2.0||||||
3635338|NCT02556632|3483118|B1||IMRT|Type of Radiation||Participants|Count of Participants|1|1.0||||||
3635339|NCT02556632|3483115|B4||Unknown or Not Reported|Currently on Herceptin Treatment||Participants|Count of Participants|2|2.0||||||
3635340|NCT02556632|3483116|B3||Unknown or Not Reported|Currently on Herceptin Treatment||Participants|Count of Participants|1|1.0||||||
3635341|NCT02556632|3483117|B2||Unknown or Not Reported|Currently on Herceptin Treatment||Participants|Count of Participants|1|1.0||||||
3635342|NCT02556632|3483118|B1||Unknown or Not Reported|Currently on Herceptin Treatment||Participants|Count of Participants|0|0.0||||||
3635343|NCT02556632|3483115|B4||Yes|Currently on Herceptin Treatment||Participants|Count of Participants|19|19.0||||||
3635344|NCT02556632|3483116|B3||Yes|Currently on Herceptin Treatment||Participants|Count of Participants|3|3.0||||||
3635345|NCT02556632|3483117|B2||Yes|Currently on Herceptin Treatment||Participants|Count of Participants|8|8.0||||||
3635346|NCT02556632|3483118|B1||Yes|Currently on Herceptin Treatment||Participants|Count of Participants|8|8.0||||||
3635347|NCT02556632|3483115|B4||No|Currently on Herceptin Treatment||Participants|Count of Participants|170|170.0||||||
3635348|NCT02556632|3483116|B3||No|Currently on Herceptin Treatment||Participants|Count of Participants|58|58.0||||||
3635349|NCT02556632|3483117|B2||No|Currently on Herceptin Treatment||Participants|Count of Participants|56|56.0||||||
3635350|NCT02556632|3483118|B1||No|Currently on Herceptin Treatment||Participants|Count of Participants|56|56.0||||||
3635351|NCT02556632|3483115|B4||Unknown or Not Reported|Currently on Hormone Therapy||Participants|Count of Participants|2|2.0||||||
3635352|NCT02556632|3483116|B3||Unknown or Not Reported|Currently on Hormone Therapy||Participants|Count of Participants|1|1.0||||||
3635353|NCT02556632|3483117|B2||Unknown or Not Reported|Currently on Hormone Therapy||Participants|Count of Participants|1|1.0||||||
3635354|NCT02556632|3483118|B1||Unknown or Not Reported|Currently on Hormone Therapy||Participants|Count of Participants|0|0.0||||||
3635355|NCT02556632|3483115|B4||Yes|Currently on Hormone Therapy||Participants|Count of Participants|41|41.0||||||
3635356|NCT02556632|3483116|B3||Yes|Currently on Hormone Therapy||Participants|Count of Participants|13|13.0||||||
3635357|NCT02556632|3483117|B2||Yes|Currently on Hormone Therapy||Participants|Count of Participants|16|16.0||||||
3635358|NCT02556632|3483118|B1||Yes|Currently on Hormone Therapy||Participants|Count of Participants|12|12.0||||||
3635363|NCT02556632|3483115|B4||Unknown or Not Reported|Prior Chemotherapy||Participants|Count of Participants|2|2.0||||||
3635364|NCT02556632|3483116|B3||Unknown or Not Reported|Prior Chemotherapy||Participants|Count of Participants|1|1.0||||||
3635365|NCT02556632|3483117|B2||Unknown or Not Reported|Prior Chemotherapy||Participants|Count of Participants|1|1.0||||||
3635366|NCT02556632|3483118|B1||Unknown or Not Reported|Prior Chemotherapy||Participants|Count of Participants|0|0.0||||||
3635367|NCT02556632|3483115|B4||Yes|Prior Chemotherapy||Participants|Count of Participants|90|90.0||||||
3635368|NCT02556632|3483116|B3||Yes|Prior Chemotherapy||Participants|Count of Participants|27|27.0||||||
3635369|NCT02556632|3483117|B2||Yes|Prior Chemotherapy||Participants|Count of Participants|29|29.0||||||
3635370|NCT02556632|3483118|B1||Yes|Prior Chemotherapy||Participants|Count of Participants|34|34.0||||||
3635371|NCT02556632|3483115|B4||No|Prior Chemotherapy||Participants|Count of Participants|99|99.0||||||
3635372|NCT02556632|3483116|B3||No|Prior Chemotherapy||Participants|Count of Participants|34|34.0||||||
3635373|NCT02556632|3483117|B2||No|Prior Chemotherapy||Participants|Count of Participants|35|35.0||||||
3635374|NCT02556632|3483118|B1||No|Prior Chemotherapy||Participants|Count of Participants|30|30.0||||||
3635375|NCT02556632|3483115|B4||Unknown or Not Reported|Location of Breast Cancer||Participants|Count of Participants|2|2.0||||||
3635376|NCT02556632|3483116|B3||Unknown or Not Reported|Location of Breast Cancer||Participants|Count of Participants|1|1.0||||||
3635377|NCT02556632|3483117|B2||Unknown or Not Reported|Location of Breast Cancer||Participants|Count of Participants|1|1.0||||||
3635378|NCT02556632|3483118|B1||Unknown or Not Reported|Location of Breast Cancer||Participants|Count of Participants|0|0.0||||||
3635379|NCT02556632|3483115|B4||Right|Location of Breast Cancer||Participants|Count of Participants|103|103.0||||||
3635380|NCT02556632|3483116|B3||Right|Location of Breast Cancer||Participants|Count of Participants|31|31.0||||||
3635381|NCT02556632|3483117|B2||Right|Location of Breast Cancer||Participants|Count of Participants|37|37.0||||||
3635382|NCT02556632|3483118|B1||Right|Location of Breast Cancer||Participants|Count of Participants|35|35.0||||||
3635383|NCT02556632|3483115|B4||Left|Location of Breast Cancer||Participants|Count of Participants|86|86.0||||||
3635384|NCT02556632|3483116|B3||Left|Location of Breast Cancer||Participants|Count of Participants|30|30.0||||||
3635385|NCT02556632|3483117|B2||Left|Location of Breast Cancer||Participants|Count of Participants|27|27.0||||||
3635386|NCT02556632|3483118|B1||Left|Location of Breast Cancer||Participants|Count of Participants|29|29.0||||||
3635387|NCT02556632|3483115|B4||Unknown or Not Reported|Stage of Disease|"Ductal carcinoma in situ (DCIS) is considered the earliest form of cancer and consists of abnormal cells in the milk duct.~Stage I.This stage is a small cancer that has not grown deeply into nearby tissues and has not spread to lymph nodes.~Stage II and III.These stages indicate larger cancers that have grown more deeply into nearby tissue and may have also spread to lymph nodes.~Stage IV.This stage means that the cancer has spread to other organs or parts of the body.~Unknown or Not Reported Stage. There is not enough information to determine stage."|Participants|Count of Participants|2|2.0||||||
3635388|NCT02556632|3483116|B3||Unknown or Not Reported|Stage of Disease|"Ductal carcinoma in situ (DCIS) is considered the earliest form of cancer and consists of abnormal cells in the milk duct.~Stage I.This stage is a small cancer that has not grown deeply into nearby tissues and has not spread to lymph nodes.~Stage II and III.These stages indicate larger cancers that have grown more deeply into nearby tissue and may have also spread to lymph nodes.~Stage IV.This stage means that the cancer has spread to other organs or parts of the body.~Unknown or Not Reported Stage. There is not enough information to determine stage."|Participants|Count of Participants|1|1.0||||||
3635389|NCT02556632|3483117|B2||Unknown or Not Reported|Stage of Disease|"Ductal carcinoma in situ (DCIS) is considered the earliest form of cancer and consists of abnormal cells in the milk duct.~Stage I.This stage is a small cancer that has not grown deeply into nearby tissues and has not spread to lymph nodes.~Stage II and III.These stages indicate larger cancers that have grown more deeply into nearby tissue and may have also spread to lymph nodes.~Stage IV.This stage means that the cancer has spread to other organs or parts of the body.~Unknown or Not Reported Stage. There is not enough information to determine stage."|Participants|Count of Participants|1|1.0||||||
3635390|NCT02556632|3483118|B1||Unknown or Not Reported|Stage of Disease|"Ductal carcinoma in situ (DCIS) is considered the earliest form of cancer and consists of abnormal cells in the milk duct.~Stage I.This stage is a small cancer that has not grown deeply into nearby tissues and has not spread to lymph nodes.~Stage II and III.These stages indicate larger cancers that have grown more deeply into nearby tissue and may have also spread to lymph nodes.~Stage IV.This stage means that the cancer has spread to other organs or parts of the body.~Unknown or Not Reported Stage. There is not enough information to determine stage."|Participants|Count of Participants|0|0.0||||||
3635391|NCT02556632|3483115|B4||Stage IV|Stage of Disease|"Ductal carcinoma in situ (DCIS) is considered the earliest form of cancer and consists of abnormal cells in the milk duct.~Stage I.This stage is a small cancer that has not grown deeply into nearby tissues and has not spread to lymph nodes.~Stage II and III.These stages indicate larger cancers that have grown more deeply into nearby tissue and may have also spread to lymph nodes.~Stage IV.This stage means that the cancer has spread to other organs or parts of the body.~Unknown or Not Reported Stage. There is not enough information to determine stage."|Participants|Count of Participants|2|2.0||||||
3635392|NCT02556632|3483116|B3||Stage IV|Stage of Disease|"Ductal carcinoma in situ (DCIS) is considered the earliest form of cancer and consists of abnormal cells in the milk duct.~Stage I.This stage is a small cancer that has not grown deeply into nearby tissues and has not spread to lymph nodes.~Stage II and III.These stages indicate larger cancers that have grown more deeply into nearby tissue and may have also spread to lymph nodes.~Stage IV.This stage means that the cancer has spread to other organs or parts of the body.~Unknown or Not Reported Stage. There is not enough information to determine stage."|Participants|Count of Participants|0|0.0||||||
3635435|NCT02556632|3483115|B4||Married|Marital Status||Participants|Count of Participants|119|119.0||||||
3635436|NCT02556632|3483116|B3||Married|Marital Status||Participants|Count of Participants|37|37.0||||||
3635437|NCT02556632|3483117|B2||Married|Marital Status||Participants|Count of Participants|37|37.0||||||
3635438|NCT02556632|3483118|B1||Married|Marital Status||Participants|Count of Participants|45|45.0||||||
3635393|NCT02556632|3483117|B2||Stage IV|Stage of Disease|"Ductal carcinoma in situ (DCIS) is considered the earliest form of cancer and consists of abnormal cells in the milk duct.~Stage I.This stage is a small cancer that has not grown deeply into nearby tissues and has not spread to lymph nodes.~Stage II and III.These stages indicate larger cancers that have grown more deeply into nearby tissue and may have also spread to lymph nodes.~Stage IV.This stage means that the cancer has spread to other organs or parts of the body.~Unknown or Not Reported Stage. There is not enough information to determine stage."|Participants|Count of Participants|0|0.0||||||
3635394|NCT02556632|3483118|B1||Stage IV|Stage of Disease|"Ductal carcinoma in situ (DCIS) is considered the earliest form of cancer and consists of abnormal cells in the milk duct.~Stage I.This stage is a small cancer that has not grown deeply into nearby tissues and has not spread to lymph nodes.~Stage II and III.These stages indicate larger cancers that have grown more deeply into nearby tissue and may have also spread to lymph nodes.~Stage IV.This stage means that the cancer has spread to other organs or parts of the body.~Unknown or Not Reported Stage. There is not enough information to determine stage."|Participants|Count of Participants|2|2.0||||||
3635395|NCT02556632|3483115|B4||Stage III|Stage of Disease|"Ductal carcinoma in situ (DCIS) is considered the earliest form of cancer and consists of abnormal cells in the milk duct.~Stage I.This stage is a small cancer that has not grown deeply into nearby tissues and has not spread to lymph nodes.~Stage II and III.These stages indicate larger cancers that have grown more deeply into nearby tissue and may have also spread to lymph nodes.~Stage IV.This stage means that the cancer has spread to other organs or parts of the body.~Unknown or Not Reported Stage. There is not enough information to determine stage."|Participants|Count of Participants|20|20.0||||||
3635396|NCT02556632|3483116|B3||Stage III|Stage of Disease|"Ductal carcinoma in situ (DCIS) is considered the earliest form of cancer and consists of abnormal cells in the milk duct.~Stage I.This stage is a small cancer that has not grown deeply into nearby tissues and has not spread to lymph nodes.~Stage II and III.These stages indicate larger cancers that have grown more deeply into nearby tissue and may have also spread to lymph nodes.~Stage IV.This stage means that the cancer has spread to other organs or parts of the body.~Unknown or Not Reported Stage. There is not enough information to determine stage."|Participants|Count of Participants|8|8.0||||||
3635397|NCT02556632|3483117|B2||Stage III|Stage of Disease|"Ductal carcinoma in situ (DCIS) is considered the earliest form of cancer and consists of abnormal cells in the milk duct.~Stage I.This stage is a small cancer that has not grown deeply into nearby tissues and has not spread to lymph nodes.~Stage II and III.These stages indicate larger cancers that have grown more deeply into nearby tissue and may have also spread to lymph nodes.~Stage IV.This stage means that the cancer has spread to other organs or parts of the body.~Unknown or Not Reported Stage. There is not enough information to determine stage."|Participants|Count of Participants|5|5.0||||||
3635398|NCT02556632|3483118|B1||Stage III|Stage of Disease|"Ductal carcinoma in situ (DCIS) is considered the earliest form of cancer and consists of abnormal cells in the milk duct.~Stage I.This stage is a small cancer that has not grown deeply into nearby tissues and has not spread to lymph nodes.~Stage II and III.These stages indicate larger cancers that have grown more deeply into nearby tissue and may have also spread to lymph nodes.~Stage IV.This stage means that the cancer has spread to other organs or parts of the body.~Unknown or Not Reported Stage. There is not enough information to determine stage."|Participants|Count of Participants|7|7.0||||||
3635399|NCT02556632|3483115|B4||Stage II|Stage of Disease|"Ductal carcinoma in situ (DCIS) is considered the earliest form of cancer and consists of abnormal cells in the milk duct.~Stage I.This stage is a small cancer that has not grown deeply into nearby tissues and has not spread to lymph nodes.~Stage II and III.These stages indicate larger cancers that have grown more deeply into nearby tissue and may have also spread to lymph nodes.~Stage IV.This stage means that the cancer has spread to other organs or parts of the body.~Unknown or Not Reported Stage. There is not enough information to determine stage."|Participants|Count of Participants|54|54.0||||||
3635400|NCT02556632|3483116|B3||Stage II|Stage of Disease|"Ductal carcinoma in situ (DCIS) is considered the earliest form of cancer and consists of abnormal cells in the milk duct.~Stage I.This stage is a small cancer that has not grown deeply into nearby tissues and has not spread to lymph nodes.~Stage II and III.These stages indicate larger cancers that have grown more deeply into nearby tissue and may have also spread to lymph nodes.~Stage IV.This stage means that the cancer has spread to other organs or parts of the body.~Unknown or Not Reported Stage. There is not enough information to determine stage."|Participants|Count of Participants|20|20.0||||||
3635401|NCT02556632|3483117|B2||Stage II|Stage of Disease|"Ductal carcinoma in situ (DCIS) is considered the earliest form of cancer and consists of abnormal cells in the milk duct.~Stage I.This stage is a small cancer that has not grown deeply into nearby tissues and has not spread to lymph nodes.~Stage II and III.These stages indicate larger cancers that have grown more deeply into nearby tissue and may have also spread to lymph nodes.~Stage IV.This stage means that the cancer has spread to other organs or parts of the body.~Unknown or Not Reported Stage. There is not enough information to determine stage."|Participants|Count of Participants|18|18.0||||||
3635402|NCT02556632|3483118|B1||Stage II|Stage of Disease|"Ductal carcinoma in situ (DCIS) is considered the earliest form of cancer and consists of abnormal cells in the milk duct.~Stage I.This stage is a small cancer that has not grown deeply into nearby tissues and has not spread to lymph nodes.~Stage II and III.These stages indicate larger cancers that have grown more deeply into nearby tissue and may have also spread to lymph nodes.~Stage IV.This stage means that the cancer has spread to other organs or parts of the body.~Unknown or Not Reported Stage. There is not enough information to determine stage."|Participants|Count of Participants|16|16.0||||||
3635403|NCT02556632|3483115|B4||Stage I|Stage of Disease|"Ductal carcinoma in situ (DCIS) is considered the earliest form of cancer and consists of abnormal cells in the milk duct.~Stage I.This stage is a small cancer that has not grown deeply into nearby tissues and has not spread to lymph nodes.~Stage II and III.These stages indicate larger cancers that have grown more deeply into nearby tissue and may have also spread to lymph nodes.~Stage IV.This stage means that the cancer has spread to other organs or parts of the body.~Unknown or Not Reported Stage. There is not enough information to determine stage."|Participants|Count of Participants|85|85.0||||||
3635439|NCT02556632|3483115|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3635440|NCT02556632|3483116|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635441|NCT02556632|3483117|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635404|NCT02556632|3483116|B3||Stage I|Stage of Disease|"Ductal carcinoma in situ (DCIS) is considered the earliest form of cancer and consists of abnormal cells in the milk duct.~Stage I.This stage is a small cancer that has not grown deeply into nearby tissues and has not spread to lymph nodes.~Stage II and III.These stages indicate larger cancers that have grown more deeply into nearby tissue and may have also spread to lymph nodes.~Stage IV.This stage means that the cancer has spread to other organs or parts of the body.~Unknown or Not Reported Stage. There is not enough information to determine stage."|Participants|Count of Participants|22|22.0||||||
3635405|NCT02556632|3483117|B2||Stage I|Stage of Disease|"Ductal carcinoma in situ (DCIS) is considered the earliest form of cancer and consists of abnormal cells in the milk duct.~Stage I.This stage is a small cancer that has not grown deeply into nearby tissues and has not spread to lymph nodes.~Stage II and III.These stages indicate larger cancers that have grown more deeply into nearby tissue and may have also spread to lymph nodes.~Stage IV.This stage means that the cancer has spread to other organs or parts of the body.~Unknown or Not Reported Stage. There is not enough information to determine stage."|Participants|Count of Participants|29|29.0||||||
3635406|NCT02556632|3483118|B1||Stage I|Stage of Disease|"Ductal carcinoma in situ (DCIS) is considered the earliest form of cancer and consists of abnormal cells in the milk duct.~Stage I.This stage is a small cancer that has not grown deeply into nearby tissues and has not spread to lymph nodes.~Stage II and III.These stages indicate larger cancers that have grown more deeply into nearby tissue and may have also spread to lymph nodes.~Stage IV.This stage means that the cancer has spread to other organs or parts of the body.~Unknown or Not Reported Stage. There is not enough information to determine stage."|Participants|Count of Participants|34|34.0||||||
3635407|NCT02556632|3483115|B4||DCIS|Stage of Disease|"Ductal carcinoma in situ (DCIS) is considered the earliest form of cancer and consists of abnormal cells in the milk duct.~Stage I.This stage is a small cancer that has not grown deeply into nearby tissues and has not spread to lymph nodes.~Stage II and III.These stages indicate larger cancers that have grown more deeply into nearby tissue and may have also spread to lymph nodes.~Stage IV.This stage means that the cancer has spread to other organs or parts of the body.~Unknown or Not Reported Stage. There is not enough information to determine stage."|Participants|Count of Participants|28|28.0||||||
3635408|NCT02556632|3483116|B3||DCIS|Stage of Disease|"Ductal carcinoma in situ (DCIS) is considered the earliest form of cancer and consists of abnormal cells in the milk duct.~Stage I.This stage is a small cancer that has not grown deeply into nearby tissues and has not spread to lymph nodes.~Stage II and III.These stages indicate larger cancers that have grown more deeply into nearby tissue and may have also spread to lymph nodes.~Stage IV.This stage means that the cancer has spread to other organs or parts of the body.~Unknown or Not Reported Stage. There is not enough information to determine stage."|Participants|Count of Participants|11|11.0||||||
3635409|NCT02556632|3483117|B2||DCIS|Stage of Disease|"Ductal carcinoma in situ (DCIS) is considered the earliest form of cancer and consists of abnormal cells in the milk duct.~Stage I.This stage is a small cancer that has not grown deeply into nearby tissues and has not spread to lymph nodes.~Stage II and III.These stages indicate larger cancers that have grown more deeply into nearby tissue and may have also spread to lymph nodes.~Stage IV.This stage means that the cancer has spread to other organs or parts of the body.~Unknown or Not Reported Stage. There is not enough information to determine stage."|Participants|Count of Participants|12|12.0||||||
3635410|NCT02556632|3483118|B1||DCIS|Stage of Disease|"Ductal carcinoma in situ (DCIS) is considered the earliest form of cancer and consists of abnormal cells in the milk duct.~Stage I.This stage is a small cancer that has not grown deeply into nearby tissues and has not spread to lymph nodes.~Stage II and III.These stages indicate larger cancers that have grown more deeply into nearby tissue and may have also spread to lymph nodes.~Stage IV.This stage means that the cancer has spread to other organs or parts of the body.~Unknown or Not Reported Stage. There is not enough information to determine stage."|Participants|Count of Participants|5|5.0||||||
3635411|NCT02556632|3483115|B4||Unknown or Not Reported|Marital Status||Participants|Count of Participants|2|2.0||||||
3635412|NCT02556632|3483116|B3||Unknown or Not Reported|Marital Status||Participants|Count of Participants|1|1.0||||||
3635413|NCT02556632|3483117|B2||Unknown or Not Reported|Marital Status||Participants|Count of Participants|1|1.0||||||
3635414|NCT02556632|3483118|B1||Unknown or Not Reported|Marital Status||Participants|Count of Participants|0|0.0||||||
3635415|NCT02556632|3483115|B4||Widowed|Marital Status||Participants|Count of Participants|19|19.0||||||
3635416|NCT02556632|3483116|B3||Widowed|Marital Status||Participants|Count of Participants|4|4.0||||||
3635417|NCT02556632|3483117|B2||Widowed|Marital Status||Participants|Count of Participants|10|10.0||||||
3635418|NCT02556632|3483118|B1||Widowed|Marital Status||Participants|Count of Participants|5|5.0||||||
3635419|NCT02556632|3483115|B4||Single|Marital Status||Participants|Count of Participants|18|18.0||||||
3635420|NCT02556632|3483116|B3||Single|Marital Status||Participants|Count of Participants|2|2.0||||||
3635421|NCT02556632|3483117|B2||Single|Marital Status||Participants|Count of Participants|8|8.0||||||
3635422|NCT02556632|3483118|B1||Single|Marital Status||Participants|Count of Participants|8|8.0||||||
3635423|NCT02556632|3483115|B4||Separated|Marital Status||Participants|Count of Participants|2|2.0||||||
3635424|NCT02556632|3483116|B3||Separated|Marital Status||Participants|Count of Participants|1|1.0||||||
3635425|NCT02556632|3483117|B2||Separated|Marital Status||Participants|Count of Participants|0|0.0||||||
3635426|NCT02556632|3483118|B1||Separated|Marital Status||Participants|Count of Participants|1|1.0||||||
3635427|NCT02556632|3483115|B4||Divorced|Marital Status||Participants|Count of Participants|30|30.0||||||
3635428|NCT02556632|3483116|B3||Divorced|Marital Status||Participants|Count of Participants|16|16.0||||||
3635429|NCT02556632|3483117|B2||Divorced|Marital Status||Participants|Count of Participants|9|9.0||||||
3635430|NCT02556632|3483118|B1||Divorced|Marital Status||Participants|Count of Participants|5|5.0||||||
3635431|NCT02556632|3483115|B4||Domestic Partner|Marital Status||Participants|Count of Participants|1|1.0||||||
3635432|NCT02556632|3483116|B3||Domestic Partner|Marital Status||Participants|Count of Participants|1|1.0||||||
3635433|NCT02556632|3483117|B2||Domestic Partner|Marital Status||Participants|Count of Participants|0|0.0||||||
3635434|NCT02556632|3483118|B1||Domestic Partner|Marital Status||Participants|Count of Participants|0|0.0||||||
3635442|NCT02556632|3483118|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3635443|NCT02556632|3483115|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635444|NCT02556632|3483116|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635445|NCT02556632|3483117|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635446|NCT02556632|3483118|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635447|NCT02556632|3483115|B4||White|Race (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
3635448|NCT02556632|3483116|B3||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3635449|NCT02556632|3483117|B2||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3635450|NCT02556632|3483118|B1||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3635451|NCT02556632|3483115|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3635452|NCT02556632|3483116|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3635453|NCT02556632|3483117|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3635454|NCT02556632|3483118|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3635455|NCT02556632|3483115|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635456|NCT02556632|3483116|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635457|NCT02556632|3483117|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635458|NCT02556632|3483118|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635459|NCT02556632|3483115|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3635460|NCT02556632|3483116|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3635461|NCT02556632|3483117|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3635462|NCT02556632|3483118|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635463|NCT02556632|3483115|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635464|NCT02556632|3483116|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635465|NCT02556632|3483117|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635466|NCT02556632|3483118|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635467|NCT02556632|3483115|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3635468|NCT02556632|3483116|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635469|NCT02556632|3483117|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3635470|NCT02556632|3483118|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635471|NCT02556632|3483115|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|186|186.0||||||
3635472|NCT02556632|3483116|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3635473|NCT02556632|3483117|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3635474|NCT02556632|3483118|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3635475|NCT02556632|3483115|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3635476|NCT02556632|3483116|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3635477|NCT02556632|3483117|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635478|NCT02556632|3483118|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3635479|NCT02556632|3483115|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3635480|NCT02556632|3483116|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3635481|NCT02556632|3483117|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3635482|NCT02556632|3483118|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3635483|NCT02556632|3483115|B4||Female|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
3635484|NCT02556632|3483116|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3635485|NCT02556632|3483117|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3635486|NCT02556632|3483118|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3635487|NCT02556632|3483115|B4|||Age||years|Mean|59.8|59.8|Standard Deviation|10.3|10.3|||
3635488|NCT02556632|3483116|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|9.3|9.3|||
3635489|NCT02556632|3483117|B2|||Age||years|Mean|60.7|60.7|Standard Deviation|10.5|10.5|||
3635490|NCT02556632|3483118|B1|||Age||years|Mean|59.0|59.0|Standard Deviation|11.2|11.2|||
3635491|NCT02556333|3483134|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635492|NCT02556333|3483134|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635493|NCT02556333|3483134|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635494|NCT02556333|3483134|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3635495|NCT02556333|3483134|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635496|NCT02556333|3483134|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635497|NCT02556333|3483134|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635498|NCT02556333|3483134|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635499|NCT02556333|3483134|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3635500|NCT02556333|3483134|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635501|NCT02556333|3483134|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3635502|NCT02556333|3483134|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3635503|NCT02556333|3483134|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3635504|NCT02556333|3483134|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3635505|NCT02556333|3483134|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3635506|NCT02556307|3483138|B1||Male|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
3635507|NCT02556307|3483138|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3635508|NCT02556307|3483138|B1|||Age||years|Mean|37.7|37.7|Standard Deviation|10.1|10.1|||
3635509|NCT02556138|3483148|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3635510|NCT02556138|3483148|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3635511|NCT02556138|3483148|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3635512|NCT02556138|3483148|B1|||Age||years|Mean|56|56.0|Standard Deviation|4.6|4.6|||
3635513|NCT02555722|3483154|B3||Male|Gender||Participants|Count of Participants|27|27.0||||||
3635514|NCT02555722|3483155|B2||Male|Gender||Participants|Count of Participants|12|12.0||||||
3635515|NCT02555722|3483156|B1||Male|Gender||Participants|Count of Participants|15|15.0||||||
3635516|NCT02555722|3483154|B3||Female|Gender||Participants|Count of Participants|55|55.0||||||
3635517|NCT02555722|3483155|B2||Female|Gender||Participants|Count of Participants|17|17.0||||||
3635518|NCT02555722|3483156|B1||Female|Gender||Participants|Count of Participants|38|38.0||||||
3635519|NCT02555722|3483154|B3|||Age||years|Mean|33.5|33.5|Standard Deviation|8.75|8.75|||
3635520|NCT02555722|3483155|B2|||Age||years|Mean|33.3|33.3|Standard Deviation|9.05|9.05|||
3635521|NCT02555722|3483156|B1|||Age||years|Mean|33.6|33.6|Standard Deviation|8.67|8.67|||
3635522|NCT02555631|3483315|B1|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3635523|NCT02555631|3483315|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3635524|NCT02555631|3483315|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3635525|NCT02555631|3483315|B1|||Age||years|Mean|49.9|49.9|Standard Deviation|11.5|11.5|||
3635526|NCT02555631|3483315|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3635527|NCT02555631|3483315|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3635528|NCT02555631|3483315|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3635529|NCT02555618|3483322|B3|Titer ≥40||HI Antibody Titer (Egg-derived)-B Strain|HI Antibody Titer data is only available for N=199, 200 respectively.|participants|Number|208|208.0||||||
3635530|NCT02555618|3483323|B2|Titer ≥40||HI Antibody Titer (Egg-derived)-B Strain|HI Antibody Titer data is only available for N=199, 200 respectively.|participants|Number|102|102.0||||||
3635531|NCT02555618|3483324|B1|Titer ≥40||HI Antibody Titer (Egg-derived)-B Strain|HI Antibody Titer data is only available for N=199, 200 respectively.|participants|Number|106|106.0||||||
3635532|NCT02555618|3483322|B3|Titer <40||HI Antibody Titer (Egg-derived)-B Strain|HI Antibody Titer data is only available for N=199, 200 respectively.|participants|Number|191|191.0||||||
3635533|NCT02555618|3483323|B2|Titer <40||HI Antibody Titer (Egg-derived)-B Strain|HI Antibody Titer data is only available for N=199, 200 respectively.|participants|Number|98|98.0||||||
3635534|NCT02555618|3483324|B1|Titer <40||HI Antibody Titer (Egg-derived)-B Strain|HI Antibody Titer data is only available for N=199, 200 respectively.|participants|Number|93|93.0||||||
3635535|NCT02555618|3483322|B3|Titer ≥40||HI Antibody Titer (Egg-derived)-A/H3N2 Strain|HI Antibody Titer data is only available for N=199, 200 respectively.|participants|Number|188|188.0||||||
3635536|NCT02555618|3483323|B2|Titer ≥40||HI Antibody Titer (Egg-derived)-A/H3N2 Strain|HI Antibody Titer data is only available for N=199, 200 respectively.|participants|Number|95|95.0||||||
3635537|NCT02555618|3483324|B1|Titer ≥40||HI Antibody Titer (Egg-derived)-A/H3N2 Strain|HI Antibody Titer data is only available for N=199, 200 respectively.|participants|Number|93|93.0||||||
3635538|NCT02555618|3483322|B3|Titer <40||HI Antibody Titer (Egg-derived)-A/H3N2 Strain|HI Antibody Titer data is only available for N=199, 200 respectively.|participants|Number|211|211.0||||||
3635539|NCT02555618|3483323|B2|Titer <40||HI Antibody Titer (Egg-derived)-A/H3N2 Strain|HI Antibody Titer data is only available for N=199, 200 respectively.|participants|Number|105|105.0||||||
3635540|NCT02555618|3483324|B1|Titer <40||HI Antibody Titer (Egg-derived)-A/H3N2 Strain|HI Antibody Titer data is only available for N=199, 200 respectively.|participants|Number|106|106.0||||||
3635541|NCT02555618|3483322|B3|Titer ≥40||Hemagglutination Inhibition (HI) Antibody Titer (Egg-derived)-A/H1N1 Strain|HI Antibody Titer data is only available for N=199, 200 respectively.|participants|Number|260|260.0||||||
3635542|NCT02555618|3483323|B2|Titer ≥40||Hemagglutination Inhibition (HI) Antibody Titer (Egg-derived)-A/H1N1 Strain|HI Antibody Titer data is only available for N=199, 200 respectively.|participants|Number|135|135.0||||||
3635543|NCT02555618|3483324|B1|Titer ≥40||Hemagglutination Inhibition (HI) Antibody Titer (Egg-derived)-A/H1N1 Strain|HI Antibody Titer data is only available for N=199, 200 respectively.|participants|Number|125|125.0||||||
3635544|NCT02555618|3483322|B3|Titer <40||Hemagglutination Inhibition (HI) Antibody Titer (Egg-derived)-A/H1N1 Strain|HI Antibody Titer data is only available for N=199, 200 respectively.|participants|Number|139|139.0||||||
3635545|NCT02555618|3483323|B2|Titer <40||Hemagglutination Inhibition (HI) Antibody Titer (Egg-derived)-A/H1N1 Strain|HI Antibody Titer data is only available for N=199, 200 respectively.|participants|Number|65|65.0||||||
3635546|NCT02555618|3483324|B1|Titer <40||Hemagglutination Inhibition (HI) Antibody Titer (Egg-derived)-A/H1N1 Strain|HI Antibody Titer data is only available for N=199, 200 respectively.|participants|Number|74|74.0||||||
3635547|NCT02555618|3483322|B3|No||Influenza Infection within 1 Year||participants|Number|375|375.0||||||
3635548|NCT02555618|3483323|B2|No||Influenza Infection within 1 Year||participants|Number|189|189.0||||||
3635549|NCT02555618|3483324|B1|No||Influenza Infection within 1 Year||participants|Number|186|186.0||||||
3635550|NCT02555618|3483322|B3|Yes||Influenza Infection within 1 Year||participants|Number|25|25.0||||||
3635551|NCT02555618|3483323|B2|Yes||Influenza Infection within 1 Year||participants|Number|11|11.0||||||
3635552|NCT02555618|3483324|B1|Yes||Influenza Infection within 1 Year||participants|Number|14|14.0||||||
3635553|NCT02555618|3483322|B3|||Body Mass Index (BMI)||kg/m^2|Mean|20.98|20.98|Standard Deviation|1.835|1.835|||
3635554|NCT02555618|3483323|B2|||Body Mass Index (BMI)||kg/m^2|Mean|20.86|20.86|Standard Deviation|1.752|1.752|||
3635555|NCT02555618|3483324|B1|||Body Mass Index (BMI)||kg/m^2|Mean|21.10|21.1|Standard Deviation|1.912|1.912|||
3635556|NCT02555618|3483322|B3|||Weight||kg|Mean|58.18|58.18|Standard Deviation|8.445|8.445|||
3635557|NCT02555618|3483323|B2|||Weight||kg|Mean|57.69|57.69|Standard Deviation|7.937|7.937|||
3635558|NCT02555618|3483324|B1|||Weight||kg|Mean|58.67|58.67|Standard Deviation|8.918|8.918|||
3635559|NCT02555618|3483322|B3|||Height||cm|Mean|166.2|166.2|Standard Deviation|8.35|8.35|||
3635560|NCT02555618|3483323|B2|||Height||cm|Mean|166.0|166.0|Standard Deviation|8.32|8.32|||
3635561|NCT02555618|3483324|B1|||Height||cm|Mean|166.3|166.3|Standard Deviation|8.41|8.41|||
3635562|NCT02555618|3483322|B3|Japan||Region of Enrollment||participants|Number|400|400.0||||||
3635563|NCT02555618|3483323|B2|Japan||Region of Enrollment||participants|Number|200|200.0||||||
3635564|NCT02555618|3483324|B1|Japan||Region of Enrollment||participants|Number|200|200.0||||||
3635565|NCT02555618|3483322|B3||Male|Gender||Participants|Count of Participants|211|211.0||||||
3635566|NCT02555618|3483323|B2||Male|Gender||Participants|Count of Participants|105|105.0||||||
3635567|NCT02555618|3483324|B1||Male|Gender||Participants|Count of Participants|106|106.0||||||
3635568|NCT02555618|3483322|B3||Female|Gender||Participants|Count of Participants|189|189.0||||||
3635569|NCT02555618|3483323|B2||Female|Gender||Participants|Count of Participants|95|95.0||||||
3635570|NCT02555618|3483324|B1||Female|Gender||Participants|Count of Participants|94|94.0||||||
3635571|NCT02555618|3483322|B3|40 to 49 years||Age, Customized||participants|Number|107|107.0||||||
3635572|NCT02555618|3483323|B2|40 to 49 years||Age, Customized||participants|Number|55|55.0||||||
3635573|NCT02555618|3483324|B1|40 to 49 years||Age, Customized||participants|Number|52|52.0||||||
3635574|NCT02555618|3483322|B3|30 to 39 years||Age, Customized||participants|Number|93|93.0||||||
3635575|NCT02555618|3483323|B2|30 to 39 years||Age, Customized||participants|Number|47|47.0||||||
3635576|NCT02555618|3483324|B1|30 to 39 years||Age, Customized||participants|Number|46|46.0||||||
3635577|NCT02555618|3483322|B3|20 to 29 years||Age, Customized||participants|Number|200|200.0||||||
3635578|NCT02555618|3483323|B2|20 to 29 years||Age, Customized||participants|Number|98|98.0||||||
3635579|NCT02555618|3483324|B1|20 to 29 years||Age, Customized||participants|Number|102|102.0||||||
3635580|NCT02555618|3483322|B3|||Age||years|Mean|31.4|31.4|Standard Deviation|9.52|9.52|||
3635581|NCT02555618|3483323|B2|||Age||years|Mean|31.5|31.5|Standard Deviation|9.46|9.46|||
3635582|NCT02555618|3483324|B1|||Age||years|Mean|31.2|31.2|Standard Deviation|9.61|9.61|||
3635583|NCT02555228|3483367|B3|||Mean premedication time (min:sec)||seconds|Mean|2577|2577.0|Standard Deviation|676|676.0|||
3635584|NCT02555228|3483368|B2|||Mean premedication time (min:sec)||seconds|Mean|2468|2468.0|Standard Deviation|596|596.0|||
3635585|NCT02555228|3483369|B1|||Mean premedication time (min:sec)||seconds|Mean|2686|2686.0|Standard Deviation|756|756.0|||
3635586|NCT02555228|3483367|B3|Singapore||Region of Enrollment||participants|Number|54|54.0||||||
3635587|NCT02555228|3483368|B2|Singapore||Region of Enrollment||participants|Number|27|27.0||||||
3635588|NCT02555228|3483369|B1|Singapore||Region of Enrollment||participants|Number|27|27.0||||||
3635589|NCT02555228|3483367|B3|Female patients||Sex/Gender, Customized||participants|Number|30|30.0||||||
3635590|NCT02555228|3483368|B2|Female patients||Sex/Gender, Customized||participants|Number|18|18.0||||||
3635591|NCT02555228|3483369|B1|Female patients||Sex/Gender, Customized||participants|Number|12|12.0||||||
3635592|NCT02555228|3483367|B3|Male patients||Sex/Gender, Customized||participants|Number|24|24.0||||||
3635593|NCT02555228|3483368|B2|Male patients||Sex/Gender, Customized||participants|Number|9|9.0||||||
3635594|NCT02555228|3483369|B1|Male patients||Sex/Gender, Customized||participants|Number|15|15.0||||||
3635595|NCT02555228|3483367|B3|Age||Age, Customized||years|Mean|55.3|55.3|Standard Deviation|14|14.0|||
3635596|NCT02555228|3483368|B2|Age||Age, Customized||years|Mean|52.9|52.9|Standard Deviation|15.5|15.5|||
3635597|NCT02555228|3483369|B1|Age||Age, Customized||years|Mean|57.7|57.7|Standard Deviation|12.5|12.5|||
3635598|NCT02554981|3483382|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3635599|NCT02554981|3483382|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3635600|NCT02554981|3483382|B1|||Age||years|Mean|46.3|46.3|Standard Deviation|8.3|8.3|||
3635601|NCT02554877|3483406|B5||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3635602|NCT02554877|3483407|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3635603|NCT02554877|3483408|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3635604|NCT02554877|3483409|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3635605|NCT02554877|3483410|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3635606|NCT02554877|3483406|B5||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3635607|NCT02554877|3483407|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3635608|NCT02554877|3483408|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3635609|NCT02554877|3483409|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3635610|NCT02554877|3483410|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3635611|NCT02554877|3483406|B5|||Age||years|Mean|57.3|57.3|Standard Deviation|7|7.0|||
3635612|NCT02554877|3483407|B4|||Age||years|Mean|57.4|57.4|Standard Deviation|7.9|7.9|||
3635613|NCT02554877|3483408|B3|||Age||years|Mean|57.1|57.1|Standard Deviation|7.1|7.1|||
3635614|NCT02554877|3483409|B2|||Age||years|Mean|58.1|58.1|Standard Deviation|6.9|6.9|||
3635615|NCT02554877|3483410|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|6.3|6.3|||
3635616|NCT02554435|3483475|B3|||Steps||steps per day|Mean|4204.8|4204.8|Standard Deviation|2199.8|2199.8|||
3635617|NCT02554435|3483476|B2|||Steps||steps per day|Mean|3849.4|3849.4|Standard Deviation|2107.8|2107.8|||
3635618|NCT02554435|3483477|B1|||Steps||steps per day|Mean|4560.18|4560.18|Standard Deviation|2285.6|2285.6|||
3635619|NCT02554435|3483475|B3|||Physical Activity|Physical activity was defined as the minutes of moderate to vigorous physical activity as measured by the Sensewear Armband.|minutes per day|Mean|31.3|31.3|Standard Deviation|29.4|29.4|||
3635620|NCT02554435|3483476|B2|||Physical Activity|Physical activity was defined as the minutes of moderate to vigorous physical activity as measured by the Sensewear Armband.|minutes per day|Mean|22.5|22.5|Standard Deviation|21.5|21.5|||
3635621|NCT02554435|3483477|B1|||Physical Activity|Physical activity was defined as the minutes of moderate to vigorous physical activity as measured by the Sensewear Armband.|minutes per day|Mean|40.0|40.0|Standard Deviation|33.9|33.9|||
3635622|NCT02554435|3483475|B3|Non-Hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3635623|NCT02554435|3483476|B2|Non-Hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3635624|NCT02554435|3483477|B1|Non-Hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3635625|NCT02554435|3483475|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3635626|NCT02554435|3483476|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3635627|NCT02554435|3483477|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3635628|NCT02554435|3483475|B3|Black/African-American||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3635629|NCT02554435|3483476|B2|Black/African-American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3635630|NCT02554435|3483477|B1|Black/African-American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3635631|NCT02554435|3483475|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3635632|NCT02554435|3483476|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3635633|NCT02554435|3483477|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3635634|NCT02554435|3483475|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3635635|NCT02554435|3483476|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3635636|NCT02554435|3483477|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3635637|NCT02554435|3483475|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3635638|NCT02554435|3483476|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3635639|NCT02554435|3483477|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3635640|NCT02554435|3483475|B3|||Age||years|Mean|63.7|63.7|Standard Deviation|5.3|5.3|||
3635641|NCT02554435|3483476|B2|||Age||years|Mean|64.0|64.0|Standard Deviation|5.1|5.1|||
3635642|NCT02554435|3483477|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|5.7|5.7|||
3635643|NCT02554279|3483510|B3|United States||Region of Enrollment||Participants|Count of Participants|619|619.0||||||
3635644|NCT02554279|3483511|B2|United States||Region of Enrollment||Participants|Count of Participants|309|309.0||||||
3635645|NCT02554279|3483512|B1|United States||Region of Enrollment||Participants|Count of Participants|310|310.0||||||
3635646|NCT02554279|3483510|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3635647|NCT02554279|3483511|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3635648|NCT02554279|3483512|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3635649|NCT02554279|3483510|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3635650|NCT02554279|3483511|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3635651|NCT02554279|3483512|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3635652|NCT02554279|3483510|B3||White|Race (NIH/OMB)||Participants|Count of Participants|514|514.0||||||
3635653|NCT02554279|3483511|B2||White|Race (NIH/OMB)||Participants|Count of Participants|244|244.0||||||
3635654|NCT02554279|3483512|B1||White|Race (NIH/OMB)||Participants|Count of Participants|270|270.0||||||
3635655|NCT02554279|3483510|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3635656|NCT02554279|3483511|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3635657|NCT02554279|3483512|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3635658|NCT02554279|3483510|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635659|NCT02554279|3483511|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635660|NCT02554279|3483512|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635661|NCT02554279|3483510|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3635662|NCT02554279|3483511|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3635663|NCT02554279|3483512|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3635664|NCT02554279|3483510|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3635665|NCT02554279|3483511|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3635666|NCT02554279|3483512|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3635667|NCT02554279|3483510|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3635668|NCT02554279|3483511|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3635669|NCT02554279|3483512|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3635670|NCT02554279|3483510|B3||Female|Sex: Female, Male||Participants|Count of Participants|619|619.0||||||
3635671|NCT02554279|3483511|B2||Female|Sex: Female, Male||Participants|Count of Participants|309|309.0||||||
3635672|NCT02554279|3483512|B1||Female|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
3635673|NCT02554279|3483510|B3|||Age||years|Mean|30.2|30.2|Standard Deviation|3.05|3.05|||
3635674|NCT02554279|3483511|B2|||Age||years|Mean|30.4|30.4|Standard Deviation|3.02|3.02|||
3635675|NCT02554279|3483512|B1|||Age||years|Mean|30.0|30.0|Standard Deviation|3.08|3.08|||
3635676|NCT02553798|3483545|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635677|NCT02553798|3483545|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3635678|NCT02553798|3483545|B1||White|Race (NIH/OMB)||Participants|Count of Participants|470|470.0||||||
3635679|NCT02553798|3483545|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3635680|NCT02553798|3483545|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3635681|NCT02553798|3483545|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3635682|NCT02553798|3483545|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3635683|NCT02553798|3483545|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635684|NCT02553798|3483545|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|467|467.0||||||
3635685|NCT02553798|3483545|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
3635686|NCT02553798|3483545|B1||Male|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
3635687|NCT02553798|3483545|B1||Female|Sex: Female, Male||Participants|Count of Participants|309|309.0||||||
3635688|NCT02553798|3483545|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3635689|NCT02553798|3483545|B1||Between 18 and 65 years|Age||Participants|Count of Participants|499|499.0||||||
3635690|NCT02553798|3483545|B1||<=18 years|Age||Participants|Count of Participants|60|60.0||||||
3635691|NCT02553772|3483552|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3635692|NCT02553772|3483553|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3635693|NCT02553772|3483554|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3635694|NCT02553772|3483552|B3||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
3635695|NCT02553772|3483553|B2||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3635696|NCT02553772|3483554|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3635697|NCT02553772|3483552|B3|> 40 years||Age, Customized||participants|Number|183|183.0||||||
3635698|NCT02553772|3483553|B2|> 40 years||Age, Customized||participants|Number|90|90.0||||||
3635699|NCT02553772|3483554|B1|> 40 years||Age, Customized||participants|Number|93|93.0||||||
3635700|NCT02553772|3483552|B3|30 to 40 years||Age, Customized||participants|Number|29|29.0||||||
3635701|NCT02553772|3483553|B2|30 to 40 years||Age, Customized||participants|Number|18|18.0||||||
3635702|NCT02553772|3483554|B1|30 to 40 years||Age, Customized||participants|Number|11|11.0||||||
3635703|NCT02553772|3483552|B3|< 30 years||Age, Customized||participants|Number|30|30.0||||||
3635704|NCT02553772|3483553|B2|< 30 years||Age, Customized||participants|Number|14|14.0||||||
3635705|NCT02553772|3483554|B1|< 30 years||Age, Customized||participants|Number|16|16.0||||||
3635706|NCT02553772|3483552|B3|||Age||years|Mean|53.5|53.5|Standard Deviation|17.0|17.0|||
3635707|NCT02553772|3483553|B2|||Age||years|Mean|52.8|52.8|Standard Deviation|16.7|16.7|||
3635708|NCT02553772|3483554|B1|||Age||years|Mean|54.3|54.3|Standard Deviation|17.3|17.3|||
3635709|NCT02553629|3483569|B3||Male|Gender||Participants|Count of Participants|20|20.0||||||
3635710|NCT02553629|3483570|B2||Male|Gender||Participants|Count of Participants|11|11.0||||||
3635711|NCT02553629|3483571|B1||Male|Gender||Participants|Count of Participants|9|9.0||||||
3635712|NCT02553629|3483569|B3||Female|Gender||Participants|Count of Participants|80|80.0||||||
3635713|NCT02553629|3483570|B2||Female|Gender||Participants|Count of Participants|39|39.0||||||
3635714|NCT02553629|3483571|B1||Female|Gender||Participants|Count of Participants|41|41.0||||||
3635715|NCT02553629|3483569|B3|||Age||years|Mean|47.1|47.1|Standard Deviation|10.9|10.9|||
3635716|NCT02553629|3483570|B2|||Age||years|Mean|47.2|47.2|Standard Deviation|11.1|11.1|||
3635717|NCT02553629|3483571|B1|||Age||years|Mean|46.9|46.9|Standard Deviation|10.6|10.6|||
3635718|NCT02553538|3483586|B3|||Clinic Visits in Prior 3-Year||visits|Mean|6.85|6.85|Standard Deviation|6.75|6.75|||
3635719|NCT02553538|3483587|B2|||Clinic Visits in Prior 3-Year||visits|Mean|6.8|6.8|Standard Deviation|6.5|6.5|||
3635720|NCT02553538|3483588|B1|||Clinic Visits in Prior 3-Year||visits|Mean|6.9|6.9|Standard Deviation|7.0|7.0|||
3635721|NCT02553538|3483586|B3|Practice-connected||Patient-Physician Connectedness Status||participants|Number|268|268.0||||||
3635722|NCT02553538|3483587|B2|Practice-connected||Patient-Physician Connectedness Status||participants|Number|146|146.0||||||
3635723|NCT02553538|3483588|B1|Practice-connected||Patient-Physician Connectedness Status||participants|Number|122|122.0||||||
3635724|NCT02553538|3483586|B3|Physician-connected||Patient-Physician Connectedness Status||participants|Number|1344|1344.0||||||
3635725|NCT02553538|3483587|B2|Physician-connected||Patient-Physician Connectedness Status||participants|Number|674|674.0||||||
3635726|NCT02553538|3483588|B1|Physician-connected||Patient-Physician Connectedness Status||participants|Number|670|670.0||||||
3635727|NCT02553538|3483586|B3|Self-Pay||Insurance||participants|Number|82|82.0||||||
3635728|NCT02553538|3483587|B2|Self-Pay||Insurance||participants|Number|41|41.0||||||
3635729|NCT02553538|3483588|B1|Self-Pay||Insurance||participants|Number|41|41.0||||||
3635730|NCT02553538|3483586|B3|Medicare||Insurance||participants|Number|316|316.0||||||
3635731|NCT02553538|3483587|B2|Medicare||Insurance||participants|Number|169|169.0||||||
3635732|NCT02553538|3483588|B1|Medicare||Insurance||participants|Number|147|147.0||||||
3635733|NCT02553538|3483586|B3|Medicaid||Insurance||participants|Number|374|374.0||||||
3635734|NCT02553538|3483587|B2|Medicaid||Insurance||participants|Number|200|200.0||||||
3635735|NCT02553538|3483588|B1|Medicaid||Insurance||participants|Number|174|174.0||||||
3635736|NCT02553538|3483586|B3|Commercial||Insurance||participants|Number|840|840.0||||||
3635737|NCT02553538|3483587|B2|Commercial||Insurance||participants|Number|410|410.0||||||
3635738|NCT02553538|3483588|B1|Commercial||Insurance||participants|Number|430|430.0||||||
3635739|NCT02553538|3483586|B3|Not English||Language||participants|Number|439|439.0||||||
3635740|NCT02553538|3483587|B2|Not English||Language||participants|Number|212|212.0||||||
3635741|NCT02553538|3483588|B1|Not English||Language||participants|Number|227|227.0||||||
3635742|NCT02553538|3483586|B3|English||Language||participants|Number|1173|1173.0||||||
3635743|NCT02553538|3483587|B2|English||Language||participants|Number|608|608.0||||||
3635744|NCT02553538|3483588|B1|English||Language||participants|Number|565|565.0||||||
3635745|NCT02553538|3483586|B3|White||Race||participants|Number|1031|1031.0||||||
3635746|NCT02553538|3483587|B2|White||Race||participants|Number|542|542.0||||||
3635747|NCT02553538|3483588|B1|White||Race||participants|Number|489|489.0||||||
3635748|NCT02553538|3483586|B3|Other/Unknown||Race||participants|Number|86|86.0||||||
3635749|NCT02553538|3483587|B2|Other/Unknown||Race||participants|Number|42|42.0||||||
3635750|NCT02553538|3483588|B1|Other/Unknown||Race||participants|Number|44|44.0||||||
3635751|NCT02553538|3483586|B3|Hispanic||Race||participants|Number|175|175.0||||||
3635752|NCT02553538|3483587|B2|Hispanic||Race||participants|Number|71|71.0||||||
3635753|NCT02553538|3483588|B1|Hispanic||Race||participants|Number|104|104.0||||||
3635754|NCT02553538|3483586|B3|Black||Race||participants|Number|177|177.0||||||
3635755|NCT02553538|3483587|B2|Black||Race||participants|Number|83|83.0||||||
3635756|NCT02553538|3483588|B1|Black||Race||participants|Number|94|94.0||||||
3635757|NCT02553538|3483586|B3|Asian||Race||participants|Number|143|143.0||||||
3635758|NCT02553538|3483587|B2|Asian||Race||participants|Number|82|82.0||||||
3635759|NCT02553538|3483588|B1|Asian||Race||participants|Number|61|61.0||||||
3635760|NCT02553538|3483586|B3||Male|Sex: Female, Male||Participants|Count of Participants|637|637.0||||||
3635761|NCT02553538|3483587|B2||Male|Sex: Female, Male||Participants|Count of Participants|324|324.0||||||
3635762|NCT02553538|3483588|B1||Male|Sex: Female, Male||Participants|Count of Participants|313|313.0||||||
3635763|NCT02553538|3483586|B3||Female|Sex: Female, Male||Participants|Count of Participants|975|975.0||||||
3635764|NCT02553538|3483587|B2||Female|Sex: Female, Male||Participants|Count of Participants|496|496.0||||||
3635765|NCT02553538|3483588|B1||Female|Sex: Female, Male||Participants|Count of Participants|479|479.0||||||
3635766|NCT02553538|3483586|B3|||Age||years|Mean|57.0|57.0|Standard Deviation|9.35|9.35|||
3635767|NCT02553538|3483587|B2|||Age||years|Mean|57.1|57.1|Standard Deviation|9.4|9.4|||
3635768|NCT02553538|3483588|B1|||Age||years|Mean|56.9|56.9|Standard Deviation|9.3|9.3|||
3635769|NCT02553512|3483601|B1|Other||Anti-Hypertensives (Class)||Participants|Count of Participants|29|29.0||||||
3635770|NCT02553512|3483601|B1|Fixed-dose combination||Anti-Hypertensives (Class)||Participants|Count of Participants|3|3.0||||||
3635771|NCT02553512|3483601|B1|Diuiretic||Anti-Hypertensives (Class)||Participants|Count of Participants|72|72.0||||||
3635772|NCT02553512|3483601|B1|Calcium channnel antagonist||Anti-Hypertensives (Class)||Participants|Count of Participants|93|93.0||||||
3635773|NCT02553512|3483601|B1|Beta-blocker||Anti-Hypertensives (Class)||Participants|Count of Participants|43|43.0||||||
3635774|NCT02553512|3483601|B1|Angiotensin receptor blocker||Anti-Hypertensives (Class)||Participants|Count of Participants|57|57.0||||||
3635775|NCT02553512|3483601|B1|ACE inhibitor||Anti-Hypertensives (Class)||Participants|Count of Participants|82|82.0||||||
3635776|NCT02553512|3483601|B1|3-5||Anti-Hypertensives (Number)||Participants|Count of Participants|58|58.0||||||
3635777|NCT02553512|3483601|B1|2||Anti-Hypertensives (Number)||Participants|Count of Participants|93|93.0||||||
3635778|NCT02553512|3483601|B1|1||Anti-Hypertensives (Number)||Participants|Count of Participants|0|0.0||||||
3635779|NCT02553512|3483601|B1|Branded||Anti-Hypertensives (Type)||Participants|Count of Participants|0|0.0||||||
3635780|NCT02553512|3483601|B1|Generic and Branded||Anti-Hypertensives (Type)||Participants|Count of Participants|15|15.0||||||
3635781|NCT02553512|3483601|B1|Generic||Anti-Hypertensives (Type)||Participants|Count of Participants|136|136.0||||||
3635782|NCT02553512|3483601|B1|||Diabetes||Participants|Count of Participants|45|45.0||||||
3635783|NCT02553512|3483601|B1|Diastolic||Blood Pressure||mm Hg|Mean|88|88.0|Full Range|||47.0|110.0|
3635784|NCT02553512|3483601|B1|Systolic||Blood Pressure||mm Hg|Mean|154|154.0|Full Range|||125.0|207.0|
3635785|NCT02553512|3483601|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|151|151.0||||||
3635786|NCT02553512|3483601|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635787|NCT02553512|3483601|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635788|NCT02553512|3483601|B1||White|Race (NIH/OMB)||Participants|Count of Participants|151|151.0||||||
3635789|NCT02553512|3483601|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635790|NCT02553512|3483601|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635791|NCT02553512|3483601|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635792|NCT02553512|3483601|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635793|NCT02553512|3483601|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635794|NCT02553512|3483601|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|151|151.0||||||
3635795|NCT02553512|3483601|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635796|NCT02553512|3483601|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3635797|NCT02553512|3483601|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3635798|NCT02553512|3483601|B1|||Age||Years|Mean|68|68.0|Standard Deviation|9|9.0|||
3635799|NCT02553421|3483609|B3|Other||IV Site||participants|Number|4|4.0||||||
3635800|NCT02553421|3483610|B2|Other||IV Site||participants|Number|0|0.0||||||
3635801|NCT02553421|3483611|B1|Other||IV Site||participants|Number|4|4.0||||||
3635802|NCT02553421|3483609|B3|Leg/Foot||IV Site||participants|Number|12|12.0||||||
3635803|NCT02553421|3483610|B2|Leg/Foot||IV Site||participants|Number|0|0.0||||||
3635804|NCT02553421|3483611|B1|Leg/Foot||IV Site||participants|Number|12|12.0||||||
3635805|NCT02553421|3483609|B3|Forearm||IV Site||participants|Number|113|113.0||||||
3635806|NCT02553421|3483610|B2|Forearm||IV Site||participants|Number|32|32.0||||||
3635807|NCT02553421|3483611|B1|Forearm||IV Site||participants|Number|81|81.0||||||
3635808|NCT02553421|3483609|B3|Hand||IV Site||participants|Number|114|114.0||||||
3635809|NCT02553421|3483610|B2|Hand||IV Site||participants|Number|26|26.0||||||
3635810|NCT02553421|3483611|B1|Hand||IV Site||participants|Number|88|88.0||||||
3635811|NCT02553421|3483609|B3||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3635812|NCT02553421|3483610|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3635813|NCT02553421|3483611|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3635814|NCT02553421|3483609|B3||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3635815|NCT02553421|3483610|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3635816|NCT02553421|3483611|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3635817|NCT02553421|3483609|B3|||Age||years|Mean|7.51|7.51|Full Range|||0.04|17.0|
3635818|NCT02553421|3483610|B2|||Age||years|Mean|7.19|7.19|Full Range|||0.04|17.0|
3635819|NCT02553421|3483611|B1|||Age||years|Mean|7.61|7.61|Full Range|||0.06|17.0|
3635820|NCT02552810|3483620|B3|Spain||Region of Enrollment||participants|Number|30|30.0||||||
3635821|NCT02552810|3483621|B2|Spain||Region of Enrollment||participants|Number|15|15.0||||||
3635822|NCT02552810|3483622|B1|Spain||Region of Enrollment||participants|Number|15|15.0||||||
3635823|NCT02552810|3483620|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3635824|NCT02552810|3483621|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3635825|NCT02552810|3483622|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3635826|NCT02552810|3483620|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3635827|NCT02552810|3483621|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3635828|NCT02552810|3483622|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3635829|NCT02552810|3483620|B3|||Age||years|Mean|58.4|58.4|Full Range|||31.0|79.0|
3635830|NCT02552810|3483621|B2|||Age||years|Mean|60.1|60.1|Full Range|||37.0|79.0|
3635831|NCT02552810|3483622|B1|||Age||years|Mean|56.3|56.3|Full Range|||31.0|77.0|
3635832|NCT02552368|3483639|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3635833|NCT02552368|3483639|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3635834|NCT02552368|3483639|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3635835|NCT02552368|3483639|B1|||Age||years|Mean|58.6|58.6|Standard Deviation|10.3|10.3|||
3635836|NCT02552368|3483639|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3635837|NCT02552368|3483639|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3635838|NCT02552368|3483639|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3635839|NCT02552303|3483644|B5|United States||Region of Enrollment||participants|Number|39|39.0||||||
3635840|NCT02552303|3483645|B4|United States||Region of Enrollment||participants|Number|11|11.0||||||
3635841|NCT02552303|3483646|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3635842|NCT02552303|3483647|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3635843|NCT02552303|3483648|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3635844|NCT02552303|3483644|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3635845|NCT02552303|3483645|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3635846|NCT02552303|3483646|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3635847|NCT02552303|3483647|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3635848|NCT02552303|3483648|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3635849|NCT02552303|3483644|B5||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3635850|NCT02552303|3483645|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3635851|NCT02552303|3483646|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3635852|NCT02552303|3483647|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3635853|NCT02552303|3483648|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3635854|NCT02552303|3483644|B5|||Age||years|Mean|48.2|48.2|Standard Deviation|9.5|9.5|||
3635855|NCT02552303|3483645|B4|||Age||years|Mean|51.9|51.9|Standard Deviation|7.1|7.1|||
3635856|NCT02552303|3483646|B3|||Age||years|Mean|48.4|48.4|Standard Deviation|12.4|12.4|||
3635857|NCT02552303|3483647|B2|||Age||years|Mean|45.0|45.0|Standard Deviation|9.8|9.8|||
3635858|NCT02552303|3483648|B1|||Age||years|Mean|46.2|46.2|Standard Deviation|9.0|9.0|||
3635859|NCT02551887|3483665|B4|United States||Region of Enrollment||Participants|Number|647|647.0||||||
3635860|NCT02551887|3483666|B3|United States||Region of Enrollment||Participants|Number|222|222.0||||||
3635861|NCT02551887|3483667|B2|United States||Region of Enrollment||Participants|Number|124|124.0||||||
3635862|NCT02551887|3483668|B1|United States||Region of Enrollment||Participants|Number|301|301.0||||||
3635863|NCT02551887|3483665|B4||Male|Sex: Female, Male||Participants|Count of Participants|356|356.0||||||
3635864|NCT02551887|3483666|B3||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3635865|NCT02551887|3483667|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3635866|NCT02551887|3483668|B1||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3635867|NCT02551887|3483665|B4||Female|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
3635868|NCT02551887|3483666|B3||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3635869|NCT02551887|3483667|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3635870|NCT02551887|3483668|B1||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3635871|NCT02551887|3483665|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3635872|NCT02551887|3483666|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3635873|NCT02551887|3483667|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3635874|NCT02551887|3483668|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3635875|NCT02551887|3483665|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3635876|NCT02551887|3483666|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3635877|NCT02551887|3483667|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3635878|NCT02551887|3483668|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3635879|NCT02551887|3483665|B4||<=18 years|Age||Participants|Count of Participants|647|647.0||||||
3635880|NCT02551887|3483666|B3||<=18 years|Age||Participants|Count of Participants|222|222.0||||||
3635881|NCT02551887|3483667|B2||<=18 years|Age||Participants|Count of Participants|124|124.0||||||
3635882|NCT02551887|3483668|B1||<=18 years|Age||Participants|Count of Participants|301|301.0||||||
3635883|NCT02551874|3483681|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|517|517.0||||||
3635884|NCT02551874|3483682|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|254|254.0||||||
3635885|NCT02551874|3483683|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|263|263.0||||||
3635886|NCT02551874|3483681|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3635887|NCT02551874|3483682|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3635888|NCT02551874|3483683|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3635889|NCT02551874|3483681|B3|Native Hawaiian Or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3635890|NCT02551874|3483682|B2|Native Hawaiian Or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3635891|NCT02551874|3483683|B1|Native Hawaiian Or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3635892|NCT02551874|3483681|B3|Black Or African American||Race/Ethnicity, Customized||Participants|Count of Participants|63|63.0||||||
3635893|NCT02551874|3483682|B2|Black Or African American||Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
3635894|NCT02551874|3483683|B1|Black Or African American||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3635895|NCT02551874|3483681|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3635896|NCT02551874|3483682|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3635897|NCT02551874|3483683|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3635898|NCT02551874|3483681|B3|American Indian Or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3635899|NCT02551874|3483682|B2|American Indian Or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3635900|NCT02551874|3483683|B1|American Indian Or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3635901|NCT02551874|3483681|B3||Male|Sex: Female, Male||Participants|Count of Participants|347|347.0||||||
3635902|NCT02551874|3483682|B2||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3635903|NCT02551874|3483683|B1||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
3635904|NCT02551874|3483681|B3||Female|Sex: Female, Male||Participants|Count of Participants|296|296.0||||||
3635905|NCT02551874|3483682|B2||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3635906|NCT02551874|3483683|B1||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3635907|NCT02551874|3483681|B3|||Age||Years|Mean|55.5|55.5|Standard Deviation|9.57|9.57|||
3635908|NCT02551874|3483682|B2|||Age||Years|Mean|55.3|55.3|Standard Deviation|9.63|9.63|||
3635909|NCT02551874|3483683|B1|||Age||Years|Mean|55.7|55.7|Standard Deviation|9.52|9.52|||
3635910|NCT02551822|3483700|B3|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3635911|NCT02551822|3483701|B2|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3635912|NCT02551822|3483702|B1|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3635913|NCT02551822|3483700|B3||American Indian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3635914|NCT02551822|3483701|B2||American Indian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3635915|NCT02551822|3483702|B1||American Indian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3635916|NCT02551822|3483700|B3||Black|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3635917|NCT02551822|3483701|B2||Black|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3635918|NCT02551822|3483702|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3635919|NCT02551822|3483700|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3635920|NCT02551822|3483701|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3635921|NCT02551822|3483702|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3635922|NCT02551822|3483700|B3||Hispanic Latina|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3635923|NCT02551822|3483701|B2||Hispanic Latina|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3635924|NCT02551822|3483702|B1||Hispanic Latina|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3635925|NCT02551822|3483700|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3635926|NCT02551822|3483701|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3635927|NCT02551822|3483702|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3635928|NCT02551822|3483700|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3635929|NCT02551822|3483701|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3635930|NCT02551822|3483702|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3635931|NCT02551822|3483700|B3|||Age||years|Mean|66.5|66.5|Standard Deviation|12.0|12.0|||
3635932|NCT02551822|3483701|B2|||Age||years|Mean|63.4|63.4|Standard Deviation|13.1|13.1|||
3635933|NCT02551822|3483702|B1|||Age||years|Mean|69.8|69.8|Standard Deviation|10.4|10.4|||
3635934|NCT02551731|3483713|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635935|NCT02551731|3483713|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3635936|NCT02551731|3483713|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3635937|NCT02551731|3483713|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635938|NCT02551731|3483713|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635939|NCT02551731|3483713|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3635940|NCT02551731|3483713|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635941|NCT02551731|3483713|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3635942|NCT02551731|3483713|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3635943|NCT02551731|3483713|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3635944|NCT02551731|3483713|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3635945|NCT02551731|3483713|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3635946|NCT02551731|3483713|B1|||Age||Months|Mean|23.0|23.0|Standard Deviation|7.11|7.11|||
3635947|NCT02551653|3483730|B3|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3635948|NCT02551653|3483731|B2|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3635949|NCT02551653|3483732|B1|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3635950|NCT02551653|3483730|B3|White Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3635951|NCT02551653|3483731|B2|White Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3635952|NCT02551653|3483732|B1|White Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3635953|NCT02551653|3483730|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3635954|NCT02551653|3483731|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3635955|NCT02551653|3483732|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3635956|NCT02551653|3483730|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3635957|NCT02551653|3483731|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3635958|NCT02551653|3483732|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3635959|NCT02551653|3483730|B3|||Age||Years|Mean|63.6|63.6|Standard Deviation|6.08|6.08|||
3635960|NCT02551653|3483731|B2|||Age||Years|Mean|64.0|64.0|Standard Deviation|7.00|7.0|||
3635961|NCT02551653|3483732|B1|||Age||Years|Mean|63.2|63.2|Standard Deviation|5.81|5.81|||
3635962|NCT02551224|3483741|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3635963|NCT02551224|3483741|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3635964|NCT02551224|3483741|B1|||Age||years|Mean|65.2|65.2|Standard Deviation|9.07|9.07|||
3635965|NCT02550873|3483750|B3|Pulmonary Hypertension||Comorbid Conditions||Participants|Count of Participants|4|4.0||||||
3635966|NCT02550873|3483751|B2|Pulmonary Hypertension||Comorbid Conditions||Participants|Count of Participants|3|3.0||||||
3635967|NCT02550873|3483752|B1|Pulmonary Hypertension||Comorbid Conditions||Participants|Count of Participants|1|1.0||||||
3635968|NCT02550873|3483750|B3|Emphysema||Comorbid Conditions||Participants|Count of Participants|2|2.0||||||
3635969|NCT02550873|3483751|B2|Emphysema||Comorbid Conditions||Participants|Count of Participants|0|0.0||||||
3635970|NCT02550873|3483752|B1|Emphysema||Comorbid Conditions||Participants|Count of Participants|2|2.0||||||
3635971|NCT02550873|3483750|B3|Coronary Artery Disorders||Comorbid Conditions||Participants|Count of Participants|19|19.0||||||
3635972|NCT02550873|3483751|B2|Coronary Artery Disorders||Comorbid Conditions||Participants|Count of Participants|4|4.0||||||
3635973|NCT02550873|3483752|B1|Coronary Artery Disorders||Comorbid Conditions||Participants|Count of Participants|15|15.0||||||
3635974|NCT02550873|3483750|B3|Cardiac Disorders||Comorbid Conditions||Participants|Count of Participants|36|36.0||||||
3635975|NCT02550873|3483751|B2|Cardiac Disorders||Comorbid Conditions||Participants|Count of Participants|7|7.0||||||
3635976|NCT02550873|3483752|B1|Cardiac Disorders||Comorbid Conditions||Participants|Count of Participants|29|29.0||||||
3635977|NCT02550873|3483750|B3|Hypertension||Comorbid Conditions||Participants|Count of Participants|52|52.0||||||
3635978|NCT02550873|3483751|B2|Hypertension||Comorbid Conditions||Participants|Count of Participants|14|14.0||||||
3635979|NCT02550873|3483752|B1|Hypertension||Comorbid Conditions||Participants|Count of Participants|38|38.0||||||
3635980|NCT02550873|3483750|B3|GERD||Comorbid Conditions||Participants|Count of Participants|63|63.0||||||
3635981|NCT02550873|3483751|B2|GERD||Comorbid Conditions||Participants|Count of Participants|16|16.0||||||
3635982|NCT02550873|3483752|B1|GERD||Comorbid Conditions||Participants|Count of Participants|47|47.0||||||
3635983|NCT02550873|3483750|B3|IPF therapy naiive||IPF Therapy Status at Baseline||Participants|Count of Participants|15|15.0||||||
3635984|NCT02550873|3483751|B2|IPF therapy naiive||IPF Therapy Status at Baseline||Participants|Count of Participants|7|7.0||||||
3635985|NCT02550873|3483752|B1|IPF therapy naiive||IPF Therapy Status at Baseline||Participants|Count of Participants|8|8.0||||||
3635986|NCT02550873|3483750|B3|No concurrent IPF therapy||IPF Therapy Status at Baseline||Participants|Count of Participants|25|25.0||||||
3635987|NCT02550873|3483751|B2|No concurrent IPF therapy||IPF Therapy Status at Baseline||Participants|Count of Participants|9|9.0||||||
3635988|NCT02550873|3483752|B1|No concurrent IPF therapy||IPF Therapy Status at Baseline||Participants|Count of Participants|16|16.0||||||
3635989|NCT02550873|3483750|B3|Concurrent nintedanib||IPF Therapy Status at Baseline||Participants|Count of Participants|30|30.0||||||
3635990|NCT02550873|3483751|B2|Concurrent nintedanib||IPF Therapy Status at Baseline||Participants|Count of Participants|8|8.0||||||
3635991|NCT02550873|3483752|B1|Concurrent nintedanib||IPF Therapy Status at Baseline||Participants|Count of Participants|22|22.0||||||
3635992|NCT02550873|3483750|B3|Concurrent pirfenidone||IPF Therapy Status at Baseline||Participants|Count of Participants|61|61.0||||||
3635993|NCT02550873|3483751|B2|Concurrent pirfenidone||IPF Therapy Status at Baseline||Participants|Count of Participants|22|22.0||||||
3635994|NCT02550873|3483752|B1|Concurrent pirfenidone||IPF Therapy Status at Baseline||Participants|Count of Participants|39|39.0||||||
3635995|NCT02550873|3483750|B3|Concurrent IPF Therapy||IPF Therapy Status at Baseline||Participants|Count of Participants|91|91.0||||||
3635996|NCT02550873|3483751|B2|Concurrent IPF Therapy||IPF Therapy Status at Baseline||Participants|Count of Participants|30|30.0||||||
3635997|NCT02550873|3483752|B1|Concurrent IPF Therapy||IPF Therapy Status at Baseline||Participants|Count of Participants|61|61.0||||||
3635998|NCT02550873|3483750|B3|||SpO2 at rest||%|Mean|95.6|95.6|Standard Deviation|2.0|2.0|||
3635999|NCT02550873|3483751|B2|||SpO2 at rest||%|Mean|95.5|95.5|Standard Deviation|1.8|1.8|||
3636000|NCT02550873|3483752|B1|||SpO2 at rest||%|Mean|95.6|95.6|Standard Deviation|2.1|2.1|||
3636001|NCT02550873|3483750|B3|||6MWD||meters|Median|442.5|442.5|Standard Deviation|101.7|101.7|||
3636002|NCT02550873|3483751|B2|||6MWD||meters|Median|457.7|457.7|Standard Deviation|117.7|117.7|||
3636003|NCT02550873|3483752|B1|||6MWD||meters|Median|434.8|434.8|Standard Deviation|92.5|92.5|||
3636004|NCT02550873|3483750|B3|||Hemoglobin-corrected DLCO||% of predicted values|Mean|41.2|41.2|Standard Deviation|9.7|9.7|||
3636005|NCT02550873|3483751|B2|||Hemoglobin-corrected DLCO||% of predicted values|Mean|43.2|43.2|Standard Deviation|10.5|10.5|||
3636006|NCT02550873|3483752|B1|||Hemoglobin-corrected DLCO||% of predicted values|Mean|40.1|40.1|Standard Deviation|9.1|9.1|||
3636007|NCT02550873|3483750|B3|||FEV1/FVC||%|Mean|81.3|81.3|Standard Deviation|4.9|4.9|||
3636008|NCT02550873|3483751|B2|||FEV1/FVC||%|Mean|81.6|81.6|Standard Deviation|4.7|4.7|||
3636009|NCT02550873|3483752|B1|||FEV1/FVC||%|Mean|81.2|81.2|Standard Deviation|5.1|5.1|||
3636010|NCT02550873|3483750|B3|||FVC [% predicted]||%|Mean|67.6|67.6|Standard Deviation|11.0|11.0|||
3636011|NCT02550873|3483751|B2|||FVC [% predicted]||%|Mean|67.4|67.4|Standard Deviation|11.4|11.4|||
3636012|NCT02550873|3483752|B1|||FVC [% predicted]||%|Mean|67.7|67.7|Standard Deviation|10.9|10.9|||
3636013|NCT02550873|3483750|B3|||FVC||mL|Mean|2743|2743.0|Standard Deviation|635|635.0|||
3636014|NCT02550873|3483751|B2|||FVC||mL|Mean|2763|2763.0|Standard Deviation|654|654.0|||
3636015|NCT02550873|3483752|B1|||FVC||mL|Mean|2733|2733.0|Standard Deviation|630|630.0|||
3636016|NCT02550873|3483750|B3|||Years since IPF diagnosis, mean (SD)||years|Mean|3.79|3.79|Standard Deviation|2.32|2.32|||
3636017|NCT02550873|3483751|B2|||Years since IPF diagnosis, mean (SD)||years|Mean|3.90|3.9|Standard Deviation|2.62|2.62|||
3636018|NCT02550873|3483752|B1|||Years since IPF diagnosis, mean (SD)||years|Mean|3.74|3.74|Standard Deviation|2.16|2.16|||
3636019|NCT02550873|3483750|B3|||Weight||kg|Mean|86.5|86.5|Standard Deviation|14.5|14.5|||
3636020|NCT02550873|3483751|B2|||Weight||kg|Mean|87.5|87.5|Standard Deviation|13.4|13.4|||
3636021|NCT02550873|3483752|B1|||Weight||kg|Mean|86.1|86.1|Standard Deviation|15.2|15.2|||
3636022|NCT02550873|3483750|B3|Ethnicity/Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3636023|NCT02550873|3483751|B2|Ethnicity/Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3636024|NCT02550873|3483752|B1|Ethnicity/Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3636025|NCT02550873|3483750|B3|Ethnicity/Race|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3636026|NCT02550873|3483751|B2|Ethnicity/Race|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3636027|NCT02550873|3483752|B1|Ethnicity/Race|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3636028|NCT02550873|3483750|B3|Ethnicity/Race|Black/African|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3636029|NCT02550873|3483751|B2|Ethnicity/Race|Black/African|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3636030|NCT02550873|3483752|B1|Ethnicity/Race|Black/African|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3636031|NCT02550873|3483750|B3|Ethnicity/Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|113|113.0||||||
3636032|NCT02550873|3483751|B2|Ethnicity/Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
3636033|NCT02550873|3483752|B1|Ethnicity/Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|74|74.0||||||
3636034|NCT02550873|3483750|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3636035|NCT02550873|3483751|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3636036|NCT02550873|3483752|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3636037|NCT02550873|3483750|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3636038|NCT02550873|3483751|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3636039|NCT02550873|3483752|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3636040|NCT02550873|3483750|B3||>=65 years|Age||Participants|Count of Participants|78|78.0||||||
3636041|NCT02550873|3483751|B2||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3636042|NCT02550873|3483752|B1||>=65 years|Age||Participants|Count of Participants|53|53.0||||||
3636043|NCT02550873|3483750|B3||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3636044|NCT02550873|3483751|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3636045|NCT02550873|3483752|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3636046|NCT02550873|3483750|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636047|NCT02550873|3483751|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636048|NCT02550873|3483752|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636049|NCT02550288|3483832|B6||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3636050|NCT02550288|3483833|B5||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3636051|NCT02550288|3483834|B4||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3636052|NCT02550288|3483835|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3636053|NCT02550288|3483836|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3636054|NCT02550288|3483837|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3636055|NCT02550288|3483832|B6||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3636056|NCT02550288|3483833|B5||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3636057|NCT02550288|3483834|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3636058|NCT02550288|3483835|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3636059|NCT02550288|3483836|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3636060|NCT02550288|3483837|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3636061|NCT02550288|3483832|B6|||Age||years|Mean|58.3|58.3|Standard Deviation|10.0|10.0|||
3636062|NCT02550288|3483833|B5|||Age||years|Mean|57.9|57.9|Standard Deviation|11.0|11.0|||
3636063|NCT02550288|3483834|B4|||Age||years|Mean|58.7|58.7|Standard Deviation|10.4|10.4|||
3636064|NCT02550288|3483835|B3|||Age||years|Mean|58.3|58.3|Standard Deviation|10.3|10.3|||
3636065|NCT02550288|3483836|B2|||Age||years|Mean|58.9|58.9|Standard Deviation|8.6|8.6|||
3636066|NCT02550288|3483837|B1|||Age||years|Mean|57.1|57.1|Standard Deviation|9.8|9.8|||
3636067|NCT02550197|3483938|B3|Korea, Republic of||Region of Enrollment||Participants|Number|300|300.0||||||
3636068|NCT02550197|3483939|B2|Korea, Republic of||Region of Enrollment||Participants|Number|100|100.0||||||
3636069|NCT02550197|3483940|B1|Korea, Republic of||Region of Enrollment||Participants|Number|200|200.0||||||
3636070|NCT02550197|3483938|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3636071|NCT02550197|3483939|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3636072|NCT02550197|3483940|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3636073|NCT02550197|3483938|B3||Female|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
3636074|NCT02550197|3483939|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3636075|NCT02550197|3483940|B1||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3636076|NCT02550197|3483938|B3|Age Continuous||Age||Years|Mean|35.8|35.8|Standard Deviation|9.2|9.2|||
3636077|NCT02550197|3483939|B2|Age Continuous||Age||Years|Mean|35.6|35.6|Standard Deviation|9.5|9.5|||
3636078|NCT02550197|3483940|B1|Age Continuous||Age||Years|Mean|35.9|35.9|Standard Deviation|9.1|9.1|||
3636079|NCT02550197|3483938|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3636080|NCT02550197|3483939|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3636081|NCT02550197|3483940|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3636082|NCT02550197|3483938|B3||Between 18 and 65 years|Age||Participants|Count of Participants|300|300.0||||||
3636083|NCT02550197|3483939|B2||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
3636084|NCT02550197|3483940|B1||Between 18 and 65 years|Age||Participants|Count of Participants|200|200.0||||||
3636085|NCT02550197|3483938|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636086|NCT02550197|3483939|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636087|NCT02550197|3483940|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636088|NCT02550132|3483959|B1|Canada||Region of Enrollment||participants|Number|25|25.0||||||
3636089|NCT02550132|3483959|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3636090|NCT02550132|3483959|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3636091|NCT02550132|3483959|B1|||Age||years|Mean|24.76|24.76|Standard Deviation|3.8|3.8|||
3636092|NCT02549755|3483990|B1|||Number of participants||Participants|Count of Participants|1|1.0||||||
3636093|NCT02549755|3483990|B1|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3636094|NCT02549755|3483990|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3636095|NCT02549755|3483990|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3636096|NCT02549755|3483990|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3636097|NCT02549755|3483990|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3636098|NCT02549755|3483990|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636099|NCT02549573|3483994|B3|Race|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3636100|NCT02549573|3483995|B2|Race|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3636101|NCT02549573|3483996|B1|Race|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3636102|NCT02549573|3483994|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3636103|NCT02549573|3483995|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3636104|NCT02549573|3483996|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3636105|NCT02549573|3483994|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636106|NCT02549573|3483995|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636107|NCT02549573|3483996|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636108|NCT02549573|3483994|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3636109|NCT02549573|3483995|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3636110|NCT02549573|3483996|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3636111|NCT02549573|3483994|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3636112|NCT02549573|3483995|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3636113|NCT02549573|3483996|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636114|NCT02549573|3483994|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3636115|NCT02549573|3483995|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3636116|NCT02549573|3483996|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3636117|NCT02549573|3483994|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3636118|NCT02549573|3483995|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3636119|NCT02549573|3483996|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3636120|NCT02549573|3483994|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3636121|NCT02549573|3483995|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3636122|NCT02549573|3483996|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3636123|NCT02549573|3483994|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3636124|NCT02549573|3483995|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3636125|NCT02549573|3483996|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3636126|NCT02549573|3483994|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636127|NCT02549573|3483995|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636128|NCT02549573|3483996|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636129|NCT02549352|3484039|B3|United States||Region of Enrollment||Participants|Count of Participants|205|205.0||||||
3636130|NCT02549352|3484040|B2|United States||Region of Enrollment||Participants|Count of Participants|64|64.0||||||
3636131|NCT02549352|3484041|B1|United States||Region of Enrollment||Participants|Count of Participants|141|141.0||||||
3636132|NCT02549352|3484039|B3|Italy||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3636133|NCT02549352|3484040|B2|Italy||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3636134|NCT02549352|3484041|B1|Italy||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3636135|NCT02549352|3484039|B3|Germany||Region of Enrollment||Participants|Count of Participants|70|70.0||||||
3636136|NCT02549352|3484040|B2|Germany||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3636137|NCT02549352|3484041|B1|Germany||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3636138|NCT02549352|3484039|B3||Male|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
3636139|NCT02549352|3484040|B2||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3636140|NCT02549352|3484041|B1||Male|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
3636141|NCT02549352|3484039|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3636142|NCT02549352|3484040|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3636143|NCT02549352|3484041|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3636144|NCT02549352|3484039|B3|Age group|>=85 years|Age, Customized||Participants|Count of Participants|19|19.0||||||
3636145|NCT02549352|3484040|B2|Age group|>=85 years|Age, Customized||Participants|Count of Participants|9|9.0||||||
3636146|NCT02549352|3484041|B1|Age group|>=85 years|Age, Customized||Participants|Count of Participants|10|10.0||||||
3636147|NCT02549352|3484039|B3|Age group|65-84 years|Age, Customized||Participants|Count of Participants|214|214.0||||||
3636148|NCT02549352|3484040|B2|Age group|65-84 years|Age, Customized||Participants|Count of Participants|75|75.0||||||
3636149|NCT02549352|3484041|B1|Age group|65-84 years|Age, Customized||Participants|Count of Participants|139|139.0||||||
3636150|NCT02549352|3484039|B3|Age group|18-64 years|Age, Customized||Participants|Count of Participants|77|77.0||||||
3636151|NCT02549352|3484040|B2|Age group|18-64 years|Age, Customized||Participants|Count of Participants|17|17.0||||||
3636152|NCT02549352|3484041|B1|Age group|18-64 years|Age, Customized||Participants|Count of Participants|60|60.0||||||
3636153|NCT02549352|3484039|B3|||Age||years|Mean|70.1|70.1|Standard Deviation|9.1|9.1|||
3636154|NCT02549352|3484040|B2|||Age||years|Mean|71.0|71.0|Standard Deviation|9.3|9.3|||
3636155|NCT02549352|3484041|B1|||Age||years|Mean|69.7|69.7|Standard Deviation|9.0|9.0|||
3636156|NCT02549339|3484056|B3|Italy||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3636157|NCT02549339|3484057|B2|Italy||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3636158|NCT02549339|3484058|B1|Italy||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3636159|NCT02549339|3484056|B3|Spain||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3636160|NCT02549339|3484057|B2|Spain||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3636161|NCT02549339|3484058|B1|Spain||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3636162|NCT02549339|3484056|B3|Germany||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3636163|NCT02549339|3484057|B2|Germany||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3636164|NCT02549339|3484058|B1|Germany||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3636165|NCT02549339|3484056|B3|Canada||Region of Enrollment||Participants|Count of Participants|73|73.0||||||
3636166|NCT02549339|3484057|B2|Canada||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3636167|NCT02549339|3484058|B1|Canada||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
3636168|NCT02549339|3484056|B3|United States||Region of Enrollment||Participants|Count of Participants|158|158.0||||||
3636169|NCT02549339|3484057|B2|United States||Region of Enrollment||Participants|Count of Participants|55|55.0||||||
3636170|NCT02549339|3484058|B1|United States||Region of Enrollment||Participants|Count of Participants|103|103.0||||||
3636171|NCT02549339|3484056|B3||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
3636172|NCT02549339|3484057|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3636173|NCT02549339|3484058|B1||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3636174|NCT02549339|3484056|B3||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3636175|NCT02549339|3484057|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3636176|NCT02549339|3484058|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3636177|NCT02549339|3484056|B3|Age group|>=85 years|Age, Customized||Participants|Count of Participants|9|9.0||||||
3636178|NCT02549339|3484057|B2|Age group|>=85 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
3636179|NCT02549339|3484058|B1|Age group|>=85 years|Age, Customized||Participants|Count of Participants|8|8.0||||||
3636180|NCT02549339|3484056|B3|Age group|65-84 years|Age, Customized||Participants|Count of Participants|196|196.0||||||
3636181|NCT02549339|3484057|B2|Age group|65-84 years|Age, Customized||Participants|Count of Participants|65|65.0||||||
3636182|NCT02549339|3484058|B1|Age group|65-84 years|Age, Customized||Participants|Count of Participants|131|131.0||||||
3636183|NCT02549339|3484056|B3|Age group|18-64 years|Age, Customized||Participants|Count of Participants|101|101.0||||||
3636184|NCT02549339|3484057|B2|Age group|18-64 years|Age, Customized||Participants|Count of Participants|38|38.0||||||
3636185|NCT02549339|3484058|B1|Age group|18-64 years|Age, Customized||Participants|Count of Participants|63|63.0||||||
3636186|NCT02549339|3484056|B3|||Age||years|Mean|68.2|68.2|Standard Deviation|9.3|9.3|||
3636187|NCT02549339|3484057|B2|||Age||years|Mean|66.3|66.3|Standard Deviation|9.1|9.1|||
3636188|NCT02549339|3484058|B1|||Age||years|Mean|69.1|69.1|Standard Deviation|9.2|9.2|||
3636189|NCT02549027|3484073|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3636190|NCT02549027|3484073|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3636191|NCT02549027|3484073|B1|||Age||years|Mean|29.2|29.2|Standard Deviation|4.60|4.6|19.0|38.0|
3636192|NCT02549014|3484113|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3636193|NCT02549014|3484114|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3636194|NCT02549014|3484115|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3636195|NCT02549014|3484113|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3636196|NCT02549014|3484114|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3636197|NCT02549014|3484115|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3636198|NCT02549014|3484113|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3636199|NCT02549014|3484114|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3636200|NCT02549014|3484115|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3636201|NCT02549014|3484113|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3636202|NCT02549014|3484114|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3636203|NCT02549014|3484115|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3636204|NCT02549014|3484113|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636205|NCT02549014|3484114|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636206|NCT02549014|3484115|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636207|NCT02548845|3484206|B1|||Body Mass Index||kg/m2|Mean|25.075|25.075|Standard Deviation|4.3126|4.3126|||
3636208|NCT02548845|3484206|B1|||Height||meters|Mean|1.656|1.656|Standard Deviation|0.1031|0.1031|||
3636209|NCT02548845|3484206|B1|||Weight||kg|Mean|68.4|68.4|Standard Deviation|13.00|13.0|||
3636210|NCT02548845|3484206|B1|Spain||Region of Enrollment||Participants|Count of Participants|70|70.0||||||
3636211|NCT02548845|3484206|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3636212|NCT02548845|3484206|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3636213|NCT02548845|3484206|B1|||Age||years|Mean|64.1|64.1|Standard Deviation|13.42|13.42|||
3636214|NCT02548455|3484218|B1|United States||Region of Enrollment||Participants|Count of Participants|499|499.0||||||
3636215|NCT02548455|3484218|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3636216|NCT02548455|3484218|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636217|NCT02548455|3484218|B1||White|Race (NIH/OMB)||Participants|Count of Participants|450|450.0||||||
3636218|NCT02548455|3484218|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3636219|NCT02548455|3484218|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636220|NCT02548455|3484218|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3636221|NCT02548455|3484218|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3636222|NCT02548455|3484218|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3636223|NCT02548455|3484218|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|491|491.0||||||
3636224|NCT02548455|3484218|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3636225|NCT02548455|3484218|B1||Male|Sex: Female, Male||Participants|Count of Participants|305|305.0||||||
3636226|NCT02548455|3484218|B1||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
3636227|NCT02548455|3484218|B1|||Age||years|Mean|72.3|72.3|Standard Deviation|10.4|10.4|||
3636228|NCT02548156|3484222|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
3636229|NCT02548156|3484222|B1||Female|Gender||Participants|Count of Participants|23|23.0||||||
3636230|NCT02548156|3484222|B1|||Age||Years|Mean|34.8|34.8|Standard Deviation|9.12|9.12|||
3636231|NCT02548078|3484244|B3|AFRICAN HERITAGE/AFRICAN AMERICAN||Race/Ethnicity, Customized||Participants|Count of Participants|600|600.0||||||
3636232|NCT02548078|3484245|B2|AFRICAN HERITAGE/AFRICAN AMERICAN||Race/Ethnicity, Customized||Participants|Count of Participants|300|300.0||||||
3636233|NCT02548078|3484246|B1|AFRICAN HERITAGE/AFRICAN AMERICAN||Race/Ethnicity, Customized||Participants|Count of Participants|300|300.0||||||
3636234|NCT02548078|3484244|B3||Male|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
3636235|NCT02548078|3484245|B2||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3636236|NCT02548078|3484246|B1||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3636237|NCT02548078|3484244|B3||Female|Sex: Female, Male||Participants|Count of Participants|299|299.0||||||
3636238|NCT02548078|3484245|B2||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3636239|NCT02548078|3484246|B1||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3636240|NCT02548078|3484244|B3|||Age||Years|Mean|8.90|8.9|Standard Deviation|4.99|4.99|||
3636241|NCT02548078|3484245|B2|||Age||Years|Mean|8.8|8.8|Standard Deviation|5.03|5.03|||
3636242|NCT02548078|3484246|B1|||Age||Years|Mean|9.0|9.0|Standard Deviation|4.95|4.95|||
3636243|NCT02547974|3484435|B5|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|120|120.0||||||
3636244|NCT02547974|3484436|B4|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
3636245|NCT02547974|3484437|B3|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3636246|NCT02547974|3484438|B2|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3636247|NCT02547974|3484439|B1|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3636248|NCT02547974|3484435|B5||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3636249|NCT02547974|3484436|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3636250|NCT02547974|3484437|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3636251|NCT02547974|3484438|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3636252|NCT02547974|3484439|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3636253|NCT02547974|3484435|B5||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3636254|NCT02547974|3484436|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3636255|NCT02547974|3484437|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3636256|NCT02547974|3484438|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3636257|NCT02547974|3484439|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3636258|NCT02547974|3484435|B5|||Age||Years|Mean|50.8|50.8|Standard Deviation|14.83|14.83|||
3636259|NCT02547974|3484436|B4|||Age||Years|Mean|47.2|47.2|Standard Deviation|16.72|16.72|||
3636260|NCT02547974|3484437|B3|||Age||Years|Mean|58.5|58.5|Standard Deviation|5.82|5.82|||
3636261|NCT02547974|3484438|B2|||Age||Years|Mean|58.9|58.9|Standard Deviation|6.49|6.49|||
3636262|NCT02547974|3484439|B1|||Age||Years|Mean|29.1|29.1|Standard Deviation|5.91|5.91|||
3636263|NCT02547714|3484526|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3636264|NCT02547714|3484526|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3636265|NCT02547714|3484526|B1|||Age||Years|Mean|51.5|51.5|Standard Deviation|12.08|12.08|||
3636266|NCT02547623|3484536|B3||No|Use of Femto prior to the Surgery||Participants|Count of Participants|148|148.0||||||
3636267|NCT02547623|3484537|B2||No|Use of Femto prior to the Surgery||Participants|Count of Participants|47|47.0||||||
3636268|NCT02547623|3484538|B1||No|Use of Femto prior to the Surgery||Participants|Count of Participants|101|101.0||||||
3636269|NCT02547623|3484536|B3||Yes|Use of Femto prior to the Surgery||Participants|Count of Participants|33|33.0||||||
3636270|NCT02547623|3484537|B2||Yes|Use of Femto prior to the Surgery||Participants|Count of Participants|8|8.0||||||
3636271|NCT02547623|3484538|B1||Yes|Use of Femto prior to the Surgery||Participants|Count of Participants|25|25.0||||||
3636272|NCT02547623|3484536|B3||No|Use of Viscoelastic during the Surgery||Participants|Count of Participants|0|0.0||||||
3636273|NCT02547623|3484537|B2||No|Use of Viscoelastic during the Surgery||Participants|Count of Participants|0|0.0||||||
3636274|NCT02547623|3484538|B1||No|Use of Viscoelastic during the Surgery||Participants|Count of Participants|0|0.0||||||
3636275|NCT02547623|3484536|B3||Yes|Use of Viscoelastic during the Surgery||Participants|Count of Participants|181|181.0||||||
3636276|NCT02547623|3484537|B2||Yes|Use of Viscoelastic during the Surgery||Participants|Count of Participants|55|55.0||||||
3636277|NCT02547623|3484538|B1||Yes|Use of Viscoelastic during the Surgery||Participants|Count of Participants|126|126.0||||||
3636278|NCT02547623|3484536|B3|Fellow eye||Intraocular Pressure||mmHg|Mean|14.8|14.8|Standard Deviation|2.85|2.85|||
3636279|NCT02547623|3484537|B2|Fellow eye||Intraocular Pressure||mmHg|Mean|14.5|14.5|Standard Deviation|2.79|2.79|||
3636280|NCT02547623|3484538|B1|Fellow eye||Intraocular Pressure||mmHg|Mean|14.9|14.9|Standard Deviation|2.88|2.88|||
3636281|NCT02547623|3484536|B3|Study eye||Intraocular Pressure||mmHg|Mean|14.9|14.9|Standard Deviation|2.88|2.88|||
3636282|NCT02547623|3484537|B2|Study eye||Intraocular Pressure||mmHg|Mean|14.4|14.4|Standard Deviation|2.71|2.71|||
3636283|NCT02547623|3484538|B1|Study eye||Intraocular Pressure||mmHg|Mean|15.1|15.1|Standard Deviation|2.94|2.94|||
3636284|NCT02547623|3484536|B3|||Corneal Endothelial Cell Density - Specular Microscopy||cells/mm^2|Mean|2463.15|2463.15|Standard Deviation|359.902|359.902|||
3636285|NCT02547623|3484537|B2|||Corneal Endothelial Cell Density - Specular Microscopy||cells/mm^2|Mean|2398.33|2398.33|Standard Deviation|384.092|384.092|||
3636286|NCT02547623|3484538|B1|||Corneal Endothelial Cell Density - Specular Microscopy||cells/mm^2|Mean|2491.91|2491.91|Standard Deviation|346.365|346.365|||
3636287|NCT02547623|3484536|B3|fellow eye number||Best Corrected Visual Acuity|Visual Acuity assessed by the Snellen chart, was expressed as the logarithm of the minimum angle of resolution (logMAR), and could range from 0 (representing 20/20 vision) to 1|LogMar|Mean|.141|0.141|Standard Deviation|.1660|0.166|||
3636288|NCT02547623|3484537|B2|fellow eye number||Best Corrected Visual Acuity|Visual Acuity assessed by the Snellen chart, was expressed as the logarithm of the minimum angle of resolution (logMAR), and could range from 0 (representing 20/20 vision) to 1|LogMar|Mean|.176|0.176|Standard Deviation|.2123|0.2123|||
3636289|NCT02547623|3484538|B1|fellow eye number||Best Corrected Visual Acuity|Visual Acuity assessed by the Snellen chart, was expressed as the logarithm of the minimum angle of resolution (logMAR), and could range from 0 (representing 20/20 vision) to 1|LogMar|Mean|.126|0.126|Standard Deviation|.1394|0.1394|||
3636290|NCT02547623|3484536|B3|study eye number||Best Corrected Visual Acuity|Visual Acuity assessed by the Snellen chart, was expressed as the logarithm of the minimum angle of resolution (logMAR), and could range from 0 (representing 20/20 vision) to 1|LogMar|Mean|.311|0.311|Standard Deviation|.2141|0.2141|||
3636291|NCT02547623|3484537|B2|study eye number||Best Corrected Visual Acuity|Visual Acuity assessed by the Snellen chart, was expressed as the logarithm of the minimum angle of resolution (logMAR), and could range from 0 (representing 20/20 vision) to 1|LogMar|Mean|.355|0.355|Standard Deviation|.2557|0.2557|||
3636292|NCT02547623|3484538|B1|study eye number||Best Corrected Visual Acuity|Visual Acuity assessed by the Snellen chart, was expressed as the logarithm of the minimum angle of resolution (logMAR), and could range from 0 (representing 20/20 vision) to 1|LogMar|Mean|.292|0.292|Standard Deviation|.1913|0.1913|||
3636293|NCT02547623|3484536|B3|OS (Left eye)||Study Eye||study eye|Number|87|87.0||||||
3636294|NCT02547623|3484537|B2|OS (Left eye)||Study Eye||study eye|Number|28|28.0||||||
3636295|NCT02547623|3484538|B1|OS (Left eye)||Study Eye||study eye|Number|59|59.0||||||
3636296|NCT02547623|3484536|B3|OD (Right eye)||Study Eye||study eye|Number|94|94.0||||||
3636297|NCT02547623|3484537|B2|OD (Right eye)||Study Eye||study eye|Number|27|27.0||||||
3636298|NCT02547623|3484538|B1|OD (Right eye)||Study Eye||study eye|Number|67|67.0||||||
3636299|NCT02547623|3484536|B3|United States||Region of Enrollment||Participants|Count of Participants|181|181.0||||||
3636300|NCT02547623|3484537|B2|United States||Region of Enrollment||Participants|Count of Participants|55|55.0||||||
3636301|NCT02547623|3484538|B1|United States||Region of Enrollment||Participants|Count of Participants|126|126.0||||||
3636302|NCT02547623|3484536|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3636303|NCT02547623|3484537|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636304|NCT02547623|3484538|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3636305|NCT02547623|3484536|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636306|NCT02547623|3484537|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636307|NCT02547623|3484538|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636308|NCT02547623|3484536|B3||White|Race (NIH/OMB)||Participants|Count of Participants|163|163.0||||||
3636309|NCT02547623|3484537|B2||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3636310|NCT02547623|3484538|B1||White|Race (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
3636311|NCT02547623|3484536|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3636312|NCT02547623|3484537|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3636313|NCT02547623|3484538|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3636314|NCT02547623|3484536|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636315|NCT02547623|3484537|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636316|NCT02547623|3484538|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636317|NCT02547623|3484536|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3636318|NCT02547623|3484537|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3636319|NCT02547623|3484538|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3636320|NCT02547623|3484536|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636321|NCT02547623|3484537|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636322|NCT02547623|3484538|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636323|NCT02547623|3484536|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636324|NCT02547623|3484537|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636325|NCT02547623|3484538|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636326|NCT02547623|3484536|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|171|171.0||||||
3636327|NCT02547623|3484537|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3636328|NCT02547623|3484538|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|117|117.0||||||
3636329|NCT02547623|3484536|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3636330|NCT02547623|3484537|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3636331|NCT02547623|3484538|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3636332|NCT02547623|3484536|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3636333|NCT02547623|3484537|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3636334|NCT02547623|3484538|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3636335|NCT02547623|3484536|B3||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3636336|NCT02547623|3484537|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3636337|NCT02547623|3484538|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3636338|NCT02547623|3484536|B3||>=65 years|Age||Participants|Count of Participants|130|130.0||||||
3636339|NCT02547623|3484537|B2||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
3636340|NCT02547623|3484538|B1||>=65 years|Age||Participants|Count of Participants|92|92.0||||||
3636341|NCT02547623|3484536|B3||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3636342|NCT02547623|3484537|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3636343|NCT02547623|3484538|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3636344|NCT02547623|3484536|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636345|NCT02547623|3484537|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636346|NCT02547623|3484538|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636347|NCT02547454|3484569|B1||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
3636348|NCT02547454|3484569|B1||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
3636349|NCT02547454|3484569|B1|||Age||years|Mean|73|73.0|Standard Deviation|11.5|11.5|||
3636350|NCT02547363|3484597|B3|United States||Region of Enrollment||Participants|Count of Participants|160|160.0||||||
3636351|NCT02547363|3484598|B2|United States||Region of Enrollment||Participants|Count of Participants|51|51.0||||||
3636352|NCT02547363|3484599|B1|United States||Region of Enrollment||Participants|Count of Participants|109|109.0||||||
3636353|NCT02547363|3484597|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3636354|NCT02547363|3484598|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3636355|NCT02547363|3484599|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3636356|NCT02547363|3484597|B3|France||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3636357|NCT02547363|3484598|B2|France||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3636358|NCT02547363|3484599|B1|France||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3636359|NCT02547363|3484597|B3|Canada||Region of Enrollment||Participants|Count of Participants|106|106.0||||||
3636360|NCT02547363|3484598|B2|Canada||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3636361|NCT02547363|3484599|B1|Canada||Region of Enrollment||Participants|Count of Participants|69|69.0||||||
3636362|NCT02547363|3484597|B3||Male|Sex: Female, Male||Participants|Count of Participants|312|312.0||||||
3636363|NCT02547363|3484598|B2||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3636364|NCT02547363|3484599|B1||Male|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
3636365|NCT02547363|3484597|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3636366|NCT02547363|3484598|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3636367|NCT02547363|3484599|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3636368|NCT02547363|3484597|B3|Age group|>=85 years|Age, Customized||Participants|Count of Participants|15|15.0||||||
3636369|NCT02547363|3484598|B2|Age group|>=85 years|Age, Customized||Participants|Count of Participants|6|6.0||||||
3636370|NCT02547363|3484599|B1|Age group|>=85 years|Age, Customized||Participants|Count of Participants|9|9.0||||||
3636371|NCT02547363|3484597|B3|Age group|65-84 years|Age, Customized||Participants|Count of Participants|225|225.0||||||
3636372|NCT02547363|3484598|B2|Age group|65-84 years|Age, Customized||Participants|Count of Participants|70|70.0||||||
3636373|NCT02547363|3484599|B1|Age group|65-84 years|Age, Customized||Participants|Count of Participants|155|155.0||||||
3636374|NCT02547363|3484597|B3|Age group|18-64 years|Age, Customized||Participants|Count of Participants|73|73.0||||||
3636375|NCT02547363|3484598|B2|Age group|18-64 years|Age, Customized||Participants|Count of Participants|28|28.0||||||
3636376|NCT02547363|3484599|B1|Age group|18-64 years|Age, Customized||Participants|Count of Participants|45|45.0||||||
3636377|NCT02547363|3484597|B3|||Age||years|Mean|70.5|70.5|Standard Deviation|9.2|9.2|||
3636378|NCT02547363|3484598|B2|||Age||years|Mean|69.9|69.9|Standard Deviation|9.3|9.3|||
3636379|NCT02547363|3484599|B1|||Age||years|Mean|70.9|70.9|Standard Deviation|9.1|9.1|||
3636380|NCT02547233|3484614|B3|Spain||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3636381|NCT02547233|3484615|B2|Spain||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3636382|NCT02547233|3484616|B1|Spain||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3636383|NCT02547233|3484614|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3636384|NCT02547233|3484615|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3636385|NCT02547233|3484616|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3636386|NCT02547233|3484614|B3|France||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3636387|NCT02547233|3484615|B2|France||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3636388|NCT02547233|3484616|B1|France||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3636389|NCT02547233|3484614|B3|United States||Region of Enrollment||Participants|Count of Participants|244|244.0||||||
3636390|NCT02547233|3484615|B2|United States||Region of Enrollment||Participants|Count of Participants|79|79.0||||||
3636391|NCT02547233|3484616|B1|United States||Region of Enrollment||Participants|Count of Participants|165|165.0||||||
3636392|NCT02547233|3484614|B3||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
3636393|NCT02547233|3484615|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3636394|NCT02547233|3484616|B1||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3636395|NCT02547233|3484614|B3||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3636396|NCT02547233|3484615|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3636397|NCT02547233|3484616|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3636398|NCT02547233|3484614|B3|Age group|>=85 years|Age, Customized||Participants|Count of Participants|5|5.0||||||
3636399|NCT02547233|3484615|B2|Age group|>=85 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
3636400|NCT02547233|3484616|B1|Age group|>=85 years|Age, Customized||Participants|Count of Participants|3|3.0||||||
3636401|NCT02547233|3484614|B3|Age group|65-84 years|Age, Customized||Participants|Count of Participants|193|193.0||||||
3636402|NCT02547233|3484615|B2|Age group|65-84 years|Age, Customized||Participants|Count of Participants|64|64.0||||||
3636403|NCT02547233|3484616|B1|Age group|65-84 years|Age, Customized||Participants|Count of Participants|129|129.0||||||
3636404|NCT02547233|3484614|B3|Age group|18-64 years|Age, Customized||Participants|Count of Participants|107|107.0||||||
3636405|NCT02547233|3484615|B2|Age group|18-64 years|Age, Customized||Participants|Count of Participants|34|34.0||||||
3636406|NCT02547233|3484616|B1|Age group|18-64 years|Age, Customized||Participants|Count of Participants|73|73.0||||||
3636407|NCT02547233|3484614|B3|||Age||years|Mean|67.9|67.9|Standard Deviation|9.2|9.2|||
3636408|NCT02547233|3484615|B2|||Age||years|Mean|67.4|67.4|Standard Deviation|9.9|9.9|||
3636409|NCT02547233|3484616|B1|||Age||years|Mean|68.2|68.2|Standard Deviation|8.9|8.9|||
3636410|NCT02547064|3484631|B3|Korea, Republic of||Region of Enrollment||participants|Number|157|157.0||||||
3636411|NCT02547064|3484632|B2|Korea, Republic of||Region of Enrollment||participants|Number|79|79.0||||||
3636412|NCT02547064|3484633|B1|Korea, Republic of||Region of Enrollment||participants|Number|78|78.0||||||
3636413|NCT02547064|3484631|B3|Male||Sex/Gender, Customized||participants|Number|87|87.0||||||
3636414|NCT02547064|3484632|B2|Male||Sex/Gender, Customized||participants|Number|46|46.0||||||
3636415|NCT02547064|3484633|B1|Male||Sex/Gender, Customized||participants|Number|41|41.0||||||
3636416|NCT02547064|3484631|B3|Female||Sex/Gender, Customized||participants|Number|70|70.0||||||
3636417|NCT02547064|3484632|B2|Female||Sex/Gender, Customized||participants|Number|33|33.0||||||
3636418|NCT02547064|3484633|B1|Female||Sex/Gender, Customized||participants|Number|37|37.0||||||
3636419|NCT02547064|3484631|B3|||Age||years|Mean|58|58.0|Standard Deviation|14|14.0|||
3636420|NCT02547064|3484632|B2|||Age||years|Mean|57|57.0|Standard Deviation|16|16.0|||
3636421|NCT02547064|3484633|B1|||Age||years|Mean|58|58.0|Standard Deviation|13|13.0|||
3636422|NCT02547064|3484631|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3636423|NCT02547064|3484632|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3636424|NCT02547064|3484633|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3636425|NCT02547064|3484631|B3||Between 18 and 65 years|Age||Participants|Count of Participants|157|157.0||||||
3636426|NCT02547064|3484632|B2||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
3636427|NCT02547064|3484633|B1||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
3636428|NCT02547064|3484631|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636429|NCT02547064|3484632|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636430|NCT02547064|3484633|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636431|NCT02546986|3484660|B3|Non-Squamous Cell Carcinoma||Number of Participants Randomized by Strata||Participants|Count of Participants|82|82.0||||||
3636432|NCT02546986|3484661|B2|Non-Squamous Cell Carcinoma||Number of Participants Randomized by Strata||Participants|Count of Participants|40|40.0||||||
3636433|NCT02546986|3484662|B1|Non-Squamous Cell Carcinoma||Number of Participants Randomized by Strata||Participants|Count of Participants|42|42.0||||||
3636434|NCT02546986|3484660|B3|Squamous Cell Carcinoma||Number of Participants Randomized by Strata||Participants|Count of Participants|18|18.0||||||
3636435|NCT02546986|3484661|B2|Squamous Cell Carcinoma||Number of Participants Randomized by Strata||Participants|Count of Participants|9|9.0||||||
3636436|NCT02546986|3484662|B1|Squamous Cell Carcinoma||Number of Participants Randomized by Strata||Participants|Count of Participants|9|9.0||||||
3636437|NCT02546986|3484660|B3|||Number of Metastatic Sites||Metastatic sites|Mean|3.0|3.0|Standard Deviation|1.29|1.29|||
3636438|NCT02546986|3484661|B2|||Number of Metastatic Sites||Metastatic sites|Mean|2.8|2.8|Standard Deviation|1.25|1.25|||
3636439|NCT02546986|3484662|B1|||Number of Metastatic Sites||Metastatic sites|Mean|3.1|3.1|Standard Deviation|1.33|1.33|||
3636440|NCT02546986|3484660|B3||Other|Histology|"The different types of lung cancer are described histologically by the types of cells the pathologist sees under the microscope. There are three major types of non-small cell lung cancer:~Adenocarcinoma Squamous cell lung cancer (also called epidermoid carcinoma) Large cell lung cancer (Other)"|Participants|Count of Participants|8|8.0||||||
3636441|NCT02546986|3484661|B2||Other|Histology|"The different types of lung cancer are described histologically by the types of cells the pathologist sees under the microscope. There are three major types of non-small cell lung cancer:~Adenocarcinoma Squamous cell lung cancer (also called epidermoid carcinoma) Large cell lung cancer (Other)"|Participants|Count of Participants|5|5.0||||||
3636442|NCT02546986|3484662|B1||Other|Histology|"The different types of lung cancer are described histologically by the types of cells the pathologist sees under the microscope. There are three major types of non-small cell lung cancer:~Adenocarcinoma Squamous cell lung cancer (also called epidermoid carcinoma) Large cell lung cancer (Other)"|Participants|Count of Participants|3|3.0||||||
3636443|NCT02546986|3484660|B3||Adenocarcinoma|Histology|"The different types of lung cancer are described histologically by the types of cells the pathologist sees under the microscope. There are three major types of non-small cell lung cancer:~Adenocarcinoma Squamous cell lung cancer (also called epidermoid carcinoma) Large cell lung cancer (Other)"|Participants|Count of Participants|74|74.0||||||
3636444|NCT02546986|3484661|B2||Adenocarcinoma|Histology|"The different types of lung cancer are described histologically by the types of cells the pathologist sees under the microscope. There are three major types of non-small cell lung cancer:~Adenocarcinoma Squamous cell lung cancer (also called epidermoid carcinoma) Large cell lung cancer (Other)"|Participants|Count of Participants|36|36.0||||||
3636445|NCT02546986|3484662|B1||Adenocarcinoma|Histology|"The different types of lung cancer are described histologically by the types of cells the pathologist sees under the microscope. There are three major types of non-small cell lung cancer:~Adenocarcinoma Squamous cell lung cancer (also called epidermoid carcinoma) Large cell lung cancer (Other)"|Participants|Count of Participants|38|38.0||||||
3636446|NCT02546986|3484660|B3||Squamous cell carcinoma|Histology|"The different types of lung cancer are described histologically by the types of cells the pathologist sees under the microscope. There are three major types of non-small cell lung cancer:~Adenocarcinoma Squamous cell lung cancer (also called epidermoid carcinoma) Large cell lung cancer (Other)"|Participants|Count of Participants|18|18.0||||||
3636447|NCT02546986|3484661|B2||Squamous cell carcinoma|Histology|"The different types of lung cancer are described histologically by the types of cells the pathologist sees under the microscope. There are three major types of non-small cell lung cancer:~Adenocarcinoma Squamous cell lung cancer (also called epidermoid carcinoma) Large cell lung cancer (Other)"|Participants|Count of Participants|8|8.0||||||
3636448|NCT02546986|3484662|B1||Squamous cell carcinoma|Histology|"The different types of lung cancer are described histologically by the types of cells the pathologist sees under the microscope. There are three major types of non-small cell lung cancer:~Adenocarcinoma Squamous cell lung cancer (also called epidermoid carcinoma) Large cell lung cancer (Other)"|Participants|Count of Participants|10|10.0||||||
3636449|NCT02546986|3484660|B3||Stage IV|Stage at Primary Diagnosis|Disease Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|Participants|Count of Participants|70|70.0||||||
3636450|NCT02546986|3484661|B2||Stage IV|Stage at Primary Diagnosis|Disease Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|Participants|Count of Participants|32|32.0||||||
3636451|NCT02546986|3484662|B1||Stage IV|Stage at Primary Diagnosis|Disease Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|Participants|Count of Participants|38|38.0||||||
3636527|NCT02546609|3484687|B3|||Body mass Index (BMI)||kg/m^2|Mean|33.52|33.52|Standard Deviation|4.167|4.167|||
3636528|NCT02546609|3484688|B2|||Body mass Index (BMI)||kg/m^2|Mean|32.60|32.6|Standard Deviation|3.486|3.486|||
3636452|NCT02546986|3484660|B3||Stage IIIB|Stage at Primary Diagnosis|Disease Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|Participants|Count of Participants|15|15.0||||||
3636453|NCT02546986|3484661|B2||Stage IIIB|Stage at Primary Diagnosis|Disease Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|Participants|Count of Participants|7|7.0||||||
3636454|NCT02546986|3484662|B1||Stage IIIB|Stage at Primary Diagnosis|Disease Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|Participants|Count of Participants|8|8.0||||||
3636455|NCT02546986|3484660|B3||Stage IIIA|Stage at Primary Diagnosis|Disease Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|Participants|Count of Participants|6|6.0||||||
3636456|NCT02546986|3484661|B2||Stage IIIA|Stage at Primary Diagnosis|Disease Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|Participants|Count of Participants|4|4.0||||||
3636457|NCT02546986|3484662|B1||Stage IIIA|Stage at Primary Diagnosis|Disease Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|Participants|Count of Participants|2|2.0||||||
3636458|NCT02546986|3484660|B3||Stage II|Stage at Primary Diagnosis|Disease Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|Participants|Count of Participants|4|4.0||||||
3636459|NCT02546986|3484661|B2||Stage II|Stage at Primary Diagnosis|Disease Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|Participants|Count of Participants|4|4.0||||||
3636460|NCT02546986|3484662|B1||Stage II|Stage at Primary Diagnosis|Disease Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|Participants|Count of Participants|0|0.0||||||
3636461|NCT02546986|3484660|B3||Stage I|Stage at Primary Diagnosis|Disease Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|Participants|Count of Participants|5|5.0||||||
3636462|NCT02546986|3484661|B2||Stage I|Stage at Primary Diagnosis|Disease Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|Participants|Count of Participants|2|2.0||||||
3636529|NCT02546609|3484689|B1|||Body mass Index (BMI)||kg/m^2|Mean|33.5|33.5|Standard Deviation|4.534|4.534|||
3636530|NCT02546609|3484686|B4|||Height||cm|Mean|168.8|168.8|Standard Deviation|10.34|10.34|||
3636531|NCT02546609|3484687|B3|||Height||cm|Mean|167|167.0|Standard Deviation|10.75|10.75|||
3636532|NCT02546609|3484688|B2|||Height||cm|Mean|169.6|169.6|Standard Deviation|10.58|10.58|||
3636463|NCT02546986|3484662|B1||Stage I|Stage at Primary Diagnosis|Disease Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|Participants|Count of Participants|3|3.0||||||
3636464|NCT02546986|3484660|B3||3 = limited self-care|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant, and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|0|0.0||||||
3636465|NCT02546986|3484661|B2||3 = limited self-care|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant, and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|0|0.0||||||
3636466|NCT02546986|3484662|B1||3 = limited self-care|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant, and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|0|0.0||||||
3636467|NCT02546986|3484660|B3||2 = ambulatory but unable to work|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant, and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|0|0.0||||||
3636468|NCT02546986|3484661|B2||2 = ambulatory but unable to work|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant, and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|0|0.0||||||
3636469|NCT02546986|3484662|B1||2 = ambulatory but unable to work|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant, and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|0|0.0||||||
3636470|NCT02546986|3484660|B3||1 = Restrictive but ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant, and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|68|68.0||||||
3636471|NCT02546986|3484661|B2||1 = Restrictive but ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant, and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|32|32.0||||||
3636472|NCT02546986|3484662|B1||1 = Restrictive but ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant, and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|36|36.0||||||
3636473|NCT02546986|3484660|B3||0 = Fully Active|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant, and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|32|32.0||||||
3636474|NCT02546986|3484661|B2||0 = Fully Active|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant, and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|17|17.0||||||
3636475|NCT02546986|3484662|B1||0 = Fully Active|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant, and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|15|15.0||||||
3636476|NCT02546986|3484660|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3636477|NCT02546986|3484661|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3636478|NCT02546986|3484662|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3636479|NCT02546986|3484660|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636480|NCT02546986|3484661|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636481|NCT02546986|3484662|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636482|NCT02546986|3484660|B3||White|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3636483|NCT02546986|3484661|B2||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3636484|NCT02546986|3484662|B1||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3636485|NCT02546986|3484660|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3636486|NCT02546986|3484661|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3636487|NCT02546986|3484662|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3636488|NCT02546986|3484660|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636489|NCT02546986|3484661|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636490|NCT02546986|3484662|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636491|NCT02546986|3484660|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3636492|NCT02546986|3484661|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3636493|NCT02546986|3484662|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636494|NCT02546986|3484660|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636495|NCT02546986|3484661|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636496|NCT02546986|3484662|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636497|NCT02546986|3484660|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3636498|NCT02546986|3484661|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3636499|NCT02546986|3484662|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3636500|NCT02546986|3484660|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3636501|NCT02546986|3484661|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3636502|NCT02546986|3484662|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3636503|NCT02546986|3484660|B3|||Age||Years|Mean|63.9|63.9|Standard Deviation|9.96|9.96|||
3636504|NCT02546986|3484661|B2|||Age||Years|Mean|64.9|64.9|Standard Deviation|9.89|9.89|||
3636505|NCT02546986|3484662|B1|||Age||Years|Mean|62.8|62.8|Standard Deviation|10.03|10.03|||
3636506|NCT02546609|3484686|B4||Surgically Sterile|Childbearing Potential||Participants|Count of Participants|30|30.0||||||
3636507|NCT02546609|3484687|B3||Surgically Sterile|Childbearing Potential||Participants|Count of Participants|11|11.0||||||
3636508|NCT02546609|3484688|B2||Surgically Sterile|Childbearing Potential||Participants|Count of Participants|11|11.0||||||
3636509|NCT02546609|3484689|B1||Surgically Sterile|Childbearing Potential||Participants|Count of Participants|8|8.0||||||
3636510|NCT02546609|3484686|B4||Postmenopausal|Childbearing Potential||Participants|Count of Participants|8|8.0||||||
3636511|NCT02546609|3484687|B3||Postmenopausal|Childbearing Potential||Participants|Count of Participants|3|3.0||||||
3636512|NCT02546609|3484688|B2||Postmenopausal|Childbearing Potential||Participants|Count of Participants|4|4.0||||||
3636513|NCT02546609|3484689|B1||Postmenopausal|Childbearing Potential||Participants|Count of Participants|1|1.0||||||
3636514|NCT02546609|3484686|B4||Child-bearing potential with adequate birth contro|Childbearing Potential||Participants|Count of Participants|12|12.0||||||
3636515|NCT02546609|3484687|B3||Child-bearing potential with adequate birth contro|Childbearing Potential||Participants|Count of Participants|3|3.0||||||
3636516|NCT02546609|3484688|B2||Child-bearing potential with adequate birth contro|Childbearing Potential||Participants|Count of Participants|6|6.0||||||
3636517|NCT02546609|3484689|B1||Child-bearing potential with adequate birth contro|Childbearing Potential||Participants|Count of Participants|3|3.0||||||
3636518|NCT02546609|3484686|B4|||HbA1c||percentage of glycosylated hemoglobin|Mean|5.71|5.71|Standard Deviation|0.609|0.609|||
3636519|NCT02546609|3484687|B3|||HbA1c||percentage of glycosylated hemoglobin|Mean|5.86|5.86|Standard Deviation|0.738|0.738|||
3636520|NCT02546609|3484688|B2|||HbA1c||percentage of glycosylated hemoglobin|Mean|5.65|5.65|Standard Deviation|0.528|0.528|||
3636521|NCT02546609|3484689|B1|||HbA1c||percentage of glycosylated hemoglobin|Mean|5.59|5.59|Standard Deviation|0.495|0.495|||
3636522|NCT02546609|3484686|B4|||Fasting Plasma Glucose||mg/dL|Mean|109.3|109.3|Standard Deviation|20.86|20.86|||
3636523|NCT02546609|3484687|B3|||Fasting Plasma Glucose||mg/dL|Mean|115.4|115.4|Standard Deviation|27.61|27.61|||
3636524|NCT02546609|3484688|B2|||Fasting Plasma Glucose||mg/dL|Mean|104.3|104.3|Standard Deviation|14.28|14.28|||
3636525|NCT02546609|3484689|B1|||Fasting Plasma Glucose||mg/dL|Mean|108.2|108.2|Standard Deviation|16.53|16.53|||
3636526|NCT02546609|3484686|B4|||Body mass Index (BMI)||kg/m^2|Mean|33.17|33.17|Standard Deviation|4.008|4.008|||
3636533|NCT02546609|3484689|B1|||Height||cm|Mean|170.1|170.1|Standard Deviation|9.48|9.48|||
3636534|NCT02546609|3484686|B4|||Weight||kg|Mean|94.96|94.96|Standard Deviation|16.192|16.192|||
3636535|NCT02546609|3484687|B3|||Weight||kg|Mean|94.11|94.11|Standard Deviation|17.225|17.225|||
3636536|NCT02546609|3484688|B2|||Weight||kg|Mean|94.44|94.44|Standard Deviation|16.332|16.332|||
3636537|NCT02546609|3484689|B1|||Weight||kg|Mean|96.83|96.83|Standard Deviation|15.061|15.061|||
3636538|NCT02546609|3484686|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3636539|NCT02546609|3484687|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3636540|NCT02546609|3484688|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3636541|NCT02546609|3484689|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636542|NCT02546609|3484686|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3636543|NCT02546609|3484687|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636544|NCT02546609|3484688|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3636545|NCT02546609|3484689|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3636546|NCT02546609|3484686|B4||White|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
3636547|NCT02546609|3484687|B3||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3636548|NCT02546609|3484688|B2||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3636549|NCT02546609|3484689|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3636550|NCT02546609|3484686|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3636551|NCT02546609|3484687|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636552|NCT02546609|3484688|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3636553|NCT02546609|3484689|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3636554|NCT02546609|3484686|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636555|NCT02546609|3484687|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636556|NCT02546609|3484688|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636557|NCT02546609|3484689|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636558|NCT02546609|3484686|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636559|NCT02546609|3484687|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636560|NCT02546609|3484688|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636561|NCT02546609|3484689|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636562|NCT02546609|3484686|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3636563|NCT02546609|3484687|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3636564|NCT02546609|3484688|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636565|NCT02546609|3484689|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636566|NCT02546609|3484686|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636567|NCT02546609|3484687|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636568|NCT02546609|3484688|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636569|NCT02546609|3484689|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636570|NCT02546609|3484686|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3636571|NCT02546609|3484687|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3636572|NCT02546609|3484688|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3636573|NCT02546609|3484689|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3636574|NCT02546609|3484686|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3636575|NCT02546609|3484687|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3636576|NCT02546609|3484688|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3636577|NCT02546609|3484689|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3636578|NCT02546609|3484686|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3636579|NCT02546609|3484687|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3636580|NCT02546609|3484688|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3636581|NCT02546609|3484689|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3636582|NCT02546609|3484686|B4||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3636583|NCT02546609|3484687|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3636584|NCT02546609|3484688|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3636585|NCT02546609|3484689|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3636586|NCT02546609|3484686|B4|||Age||years|Mean|45.7|45.7|Standard Deviation|11.64|11.64|||
3636587|NCT02546609|3484687|B3|||Age||years|Mean|45.9|45.9|Standard Deviation|12.71|12.71|||
3636588|NCT02546609|3484688|B2|||Age||years|Mean|45.1|45.1|Standard Deviation|11.72|11.72|||
3636589|NCT02546609|3484689|B1|||Age||years|Mean|46.3|46.3|Standard Deviation|10.42|10.42|||
3636590|NCT02546609|3484686|B4||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3636591|NCT02546609|3484687|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3636592|NCT02546609|3484688|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3636593|NCT02546609|3484689|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3636594|NCT02546609|3484686|B4||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
3636595|NCT02546609|3484687|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3636596|NCT02546609|3484688|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3636597|NCT02546609|3484689|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3636598|NCT02546609|3484686|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636599|NCT02546609|3484687|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636600|NCT02546609|3484688|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636601|NCT02546609|3484689|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636602|NCT02546375|3484732|B1||Male|Sex/Gender, Customized||Participants|Count of Participants|47|47.0||||||
3636603|NCT02546375|3484732|B1||Female|Sex/Gender, Customized||Participants|Count of Participants|40|40.0||||||
3636604|NCT02546375|3484732|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|14.3|14.3|24.8|90.1|
3636605|NCT02545868|3484754|B4|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|94|94.0||||||
3636606|NCT02545868|3484755|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3636607|NCT02545868|3484756|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3636608|NCT02545868|3484757|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3636609|NCT02545868|3484754|B4|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3636610|NCT02545868|3484755|B3|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3636611|NCT02545868|3484756|B2|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3636612|NCT02545868|3484757|B1|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3636613|NCT02545868|3484754|B4|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3636614|NCT02545868|3484755|B3|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3636615|NCT02545868|3484756|B2|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3636616|NCT02545868|3484757|B1|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3636617|NCT02545868|3484754|B4|Ethnicity|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3636618|NCT02545868|3484755|B3|Ethnicity|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3636619|NCT02545868|3484756|B2|Ethnicity|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3636620|NCT02545868|3484757|B1|Ethnicity|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3636621|NCT02545868|3484754|B4|Ethnicity|Not reported|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3636622|NCT02545868|3484755|B3|Ethnicity|Not reported|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3636623|NCT02545868|3484756|B2|Ethnicity|Not reported|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3636624|NCT02545868|3484757|B1|Ethnicity|Not reported|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3636625|NCT02545868|3484754|B4|Ethnicity|Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|91|91.0||||||
3636626|NCT02545868|3484755|B3|Ethnicity|Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3636627|NCT02545868|3484756|B2|Ethnicity|Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3636628|NCT02545868|3484757|B1|Ethnicity|Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3636629|NCT02545868|3484754|B4|Ethnicity|Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3636630|NCT02545868|3484755|B3|Ethnicity|Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3636631|NCT02545868|3484756|B2|Ethnicity|Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3636632|NCT02545868|3484757|B1|Ethnicity|Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3636633|NCT02545868|3484754|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3636634|NCT02545868|3484755|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3636635|NCT02545868|3484756|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3636636|NCT02545868|3484757|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3636637|NCT02545868|3484754|B4||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3636638|NCT02545868|3484755|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3636639|NCT02545868|3484756|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3636640|NCT02545868|3484757|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3636641|NCT02545868|3484754|B4|||Age||years|Mean|40.3|40.3|Standard Deviation|8.6|8.6|||
3636642|NCT02545868|3484755|B3|||Age||years|Mean|41.4|41.4|Standard Deviation|7.9|7.9|||
3636643|NCT02545868|3484756|B2|||Age||years|Mean|39.3|39.3|Standard Deviation|9.7|9.7|||
3636644|NCT02545868|3484757|B1|||Age||years|Mean|40.1|40.1|Standard Deviation|8.0|8.0|||
3636645|NCT02545543|3484830|B3|United States||Region of Enrollment||participants|Number|2278|2278.0||||||
3636646|NCT02545543|3484831|B2|United States||Region of Enrollment||participants|Number|569|569.0||||||
3636647|NCT02545543|3484832|B1|United States||Region of Enrollment||participants|Number|1709|1709.0||||||
3636648|NCT02545543|3484830|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
3636649|NCT02545543|3484831|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3636650|NCT02545543|3484832|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3636651|NCT02545543|3484830|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636652|NCT02545543|3484831|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636653|NCT02545543|3484832|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636654|NCT02545543|3484830|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1669|1669.0||||||
3636655|NCT02545543|3484831|B2||White|Race (NIH/OMB)||Participants|Count of Participants|430|430.0||||||
3636656|NCT02545543|3484832|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1239|1239.0||||||
3636657|NCT02545543|3484830|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|472|472.0||||||
3636658|NCT02545543|3484831|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
3636659|NCT02545543|3484832|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|359|359.0||||||
3636660|NCT02545543|3484830|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3636661|NCT02545543|3484831|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3636662|NCT02545543|3484832|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3636663|NCT02545543|3484830|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3636664|NCT02545543|3484831|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3636665|NCT02545543|3484832|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3636666|NCT02545543|3484830|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3636667|NCT02545543|3484831|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3636668|NCT02545543|3484832|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3636669|NCT02545543|3484830|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3636670|NCT02545543|3484831|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3636671|NCT02545543|3484832|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3636672|NCT02545543|3484830|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1731|1731.0||||||
3636673|NCT02545543|3484831|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|438|438.0||||||
3636674|NCT02545543|3484832|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1293|1293.0||||||
3636675|NCT02545543|3484830|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|542|542.0||||||
3636676|NCT02545543|3484831|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
3636677|NCT02545543|3484832|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|412|412.0||||||
3636678|NCT02545543|3484830|B3||Male|Sex: Female, Male||Participants|Count of Participants|1186|1186.0||||||
3636679|NCT02545543|3484831|B2||Male|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
3636680|NCT02545543|3484832|B1||Male|Sex: Female, Male||Participants|Count of Participants|884|884.0||||||
3636681|NCT02545543|3484830|B3||Female|Sex: Female, Male||Participants|Count of Participants|1092|1092.0||||||
3636682|NCT02545543|3484831|B2||Female|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
3636683|NCT02545543|3484832|B1||Female|Sex: Female, Male||Participants|Count of Participants|825|825.0||||||
3636684|NCT02545543|3484830|B3|9 through 17 years||Age, Customized||Participants|Count of Participants|1112|1112.0||||||
3636685|NCT02545543|3484831|B2|9 through 17 years||Age, Customized||Participants|Count of Participants|278|278.0||||||
3636686|NCT02545543|3484832|B1|9 through 17 years||Age, Customized||Participants|Count of Participants|834|834.0||||||
3636687|NCT02545543|3484830|B3|5 through 8 years||Age, Customized||Participants|Count of Participants|1166|1166.0||||||
3636688|NCT02545543|3484831|B2|5 through 8 years||Age, Customized||Participants|Count of Participants|291|291.0||||||
3636689|NCT02545543|3484832|B1|5 through 8 years||Age, Customized||Participants|Count of Participants|875|875.0||||||
3636690|NCT02545543|3484830|B3|||Age||years|Mean|9.5|9.5|Standard Deviation|3.48|3.48|||
3636691|NCT02545543|3484831|B2|||Age||years|Mean|9.5|9.5|Standard Deviation|3.46|3.46|||
3636692|NCT02545543|3484832|B1|||Age||years|Mean|9.5|9.5|Standard Deviation|3.49|3.49|||
3636693|NCT02545322|3484857|B1|Austria||Region of Enrollment||participants|Number|18|18.0||||||
3636694|NCT02545322|3484857|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3636695|NCT02545322|3484857|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3636696|NCT02545322|3484857|B1|||Age||years|Mean|60.3|60.3|Standard Deviation|9.1|9.1|||
3636697|NCT02545322|3484857|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3636698|NCT02545322|3484857|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3636699|NCT02545322|3484857|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636700|NCT02545101|3484862|B1|||Body Mass Index||Kg/m^2|Mean|25.781|25.781|Standard Deviation|5.2890|5.289|||
3636701|NCT02545101|3484862|B1|||Height||meters|Mean|1.632|1.632|Standard Deviation|0.0831|0.0831|||
3636702|NCT02545101|3484862|B1|||Weight||kg|Mean|68.8|68.8|Standard Deviation|15.03|15.03|||
3636703|NCT02545101|3484862|B1|Spain||Region of Enrollment||participants|Number|56|56.0||||||
3636704|NCT02545101|3484862|B1|Germany||Region of Enrollment||participants|Number|44|44.0||||||
3636705|NCT02545101|3484862|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3636706|NCT02545101|3484862|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3636707|NCT02545101|3484862|B1|||Age||years|Mean|73.9|73.9|Standard Deviation|14.41|14.41|||
3636708|NCT02544984|3484879|B3|||Number of Patients with Tracheostomy||Participants|Count of Participants|10|10.0||||||
3636709|NCT02544984|3484880|B2|||Number of Patients with Tracheostomy||Participants|Count of Participants|5|5.0||||||
3636710|NCT02544984|3484881|B1|||Number of Patients with Tracheostomy||Participants|Count of Participants|5|5.0||||||
3636711|NCT02544984|3484879|B3|||Number of Participants who Received Synagis Injection||Participants|Count of Participants|30|30.0||||||
3636712|NCT02544984|3484880|B2|||Number of Participants who Received Synagis Injection||Participants|Count of Participants|16|16.0||||||
3636713|NCT02544984|3484881|B1|||Number of Participants who Received Synagis Injection||Participants|Count of Participants|14|14.0||||||
3636714|NCT02544984|3484879|B3||32-36 weeks|Gestational Age||Participants|Count of Participants|8|8.0||||||
3636715|NCT02544984|3484880|B2||32-36 weeks|Gestational Age||Participants|Count of Participants|6|6.0||||||
3636716|NCT02544984|3484881|B1||32-36 weeks|Gestational Age||Participants|Count of Participants|2|2.0||||||
3636717|NCT02544984|3484879|B3||28-31 weeks|Gestational Age||Participants|Count of Participants|10|10.0||||||
3636718|NCT02544984|3484880|B2||28-31 weeks|Gestational Age||Participants|Count of Participants|4|4.0||||||
3636719|NCT02544984|3484881|B1||28-31 weeks|Gestational Age||Participants|Count of Participants|6|6.0||||||
3636720|NCT02544984|3484879|B3||<28 weeks|Gestational Age||Participants|Count of Participants|42|42.0||||||
3636721|NCT02544984|3484880|B2||<28 weeks|Gestational Age||Participants|Count of Participants|20|20.0||||||
3636722|NCT02544984|3484881|B1||<28 weeks|Gestational Age||Participants|Count of Participants|22|22.0||||||
3636723|NCT02544984|3484879|B3|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3636724|NCT02544984|3484880|B2|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3636725|NCT02544984|3484881|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3636726|NCT02544984|3484879|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3636727|NCT02544984|3484880|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3636728|NCT02544984|3484881|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3636729|NCT02544984|3484879|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636730|NCT02544984|3484880|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636731|NCT02544984|3484881|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636732|NCT02544984|3484879|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3636733|NCT02544984|3484880|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3636734|NCT02544984|3484881|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3636735|NCT02544984|3484879|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3636736|NCT02544984|3484880|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3636737|NCT02544984|3484881|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3636738|NCT02544984|3484879|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636739|NCT02544984|3484880|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636740|NCT02544984|3484881|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636741|NCT02544984|3484879|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3636742|NCT02544984|3484880|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3636743|NCT02544984|3484881|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3636744|NCT02544984|3484879|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636745|NCT02544984|3484880|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636746|NCT02544984|3484881|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636747|NCT02544984|3484879|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636748|NCT02544984|3484880|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636749|NCT02544984|3484881|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636750|NCT02544984|3484879|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3636751|NCT02544984|3484880|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3636752|NCT02544984|3484881|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3636753|NCT02544984|3484879|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3636754|NCT02544984|3484880|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3636755|NCT02544984|3484881|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3636756|NCT02544984|3484879|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3636757|NCT02544984|3484880|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3636758|NCT02544984|3484881|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3636759|NCT02544984|3484879|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3636760|NCT02544984|3484880|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3636761|NCT02544984|3484881|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3636762|NCT02544984|3484879|B3|Age|24 months-72 months|Age, Customized||Participants|Count of Participants|22|22.0||||||
3636763|NCT02544984|3484880|B2|Age|24 months-72 months|Age, Customized||Participants|Count of Participants|11|11.0||||||
3636764|NCT02544984|3484881|B1|Age|24 months-72 months|Age, Customized||Participants|Count of Participants|11|11.0||||||
3636765|NCT02544984|3484879|B3|Age|6 -24 months|Age, Customized||Participants|Count of Participants|38|38.0||||||
3636766|NCT02544984|3484880|B2|Age|6 -24 months|Age, Customized||Participants|Count of Participants|19|19.0||||||
3636767|NCT02544984|3484881|B1|Age|6 -24 months|Age, Customized||Participants|Count of Participants|19|19.0||||||
3636768|NCT02544074|3484892|B22||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3636769|NCT02544074|3484893|B21||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3636770|NCT02544074|3484894|B20||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3636771|NCT02544074|3484895|B19||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3636772|NCT02544074|3484896|B18||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3636773|NCT02544074|3484897|B17||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3636774|NCT02544074|3484898|B16||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3636775|NCT02544074|3484899|B15||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3636776|NCT02544074|3484900|B14||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3636777|NCT02544074|3484901|B13||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3636778|NCT02544074|3484902|B12||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3636779|NCT02544074|3484903|B11||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3636780|NCT02544074|3484904|B10||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3636781|NCT02544074|3484905|B9||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3636782|NCT02544074|3484906|B8||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3636783|NCT02544074|3484907|B7||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3636784|NCT02544074|3484908|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3636785|NCT02544074|3484909|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3636786|NCT02544074|3484910|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3636787|NCT02544074|3484911|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3636788|NCT02544074|3484912|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3636789|NCT02544074|3484913|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3636790|NCT02544074|3484892|B22||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3636791|NCT02544074|3484893|B21||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3636792|NCT02544074|3484894|B20||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3636793|NCT02544074|3484895|B19||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3636794|NCT02544074|3484896|B18||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3636795|NCT02544074|3484897|B17||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3636796|NCT02544074|3484898|B16||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3636797|NCT02544074|3484899|B15||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3636798|NCT02544074|3484900|B14||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3636799|NCT02544074|3484901|B13||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3636800|NCT02544074|3484902|B12||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3636801|NCT02544074|3484903|B11||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3636802|NCT02544074|3484904|B10||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3636803|NCT02544074|3484905|B9||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3636804|NCT02544074|3484906|B8||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3636805|NCT02544074|3484907|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3636806|NCT02544074|3484908|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3636807|NCT02544074|3484909|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3636808|NCT02544074|3484910|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3636809|NCT02544074|3484911|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3636810|NCT02544074|3484912|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3636811|NCT02544074|3484913|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3636812|NCT02544074|3484892|B22||>=65 years|Age||Participants|Count of Participants|63|63.0||||||
3636813|NCT02544074|3484893|B21||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3636814|NCT02544074|3484894|B20||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3636815|NCT02544074|3484895|B19||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3636816|NCT02544074|3484896|B18||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3636817|NCT02544074|3484897|B17||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3636818|NCT02544074|3484898|B16||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3636819|NCT02544074|3484899|B15||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3636820|NCT02544074|3484900|B14||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3636821|NCT02544074|3484901|B13||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3636822|NCT02544074|3484902|B12||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3636823|NCT02544074|3484903|B11||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3636824|NCT02544074|3484904|B10||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3636825|NCT02544074|3484905|B9||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3636826|NCT02544074|3484906|B8||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3636827|NCT02544074|3484907|B7||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3636828|NCT02544074|3484908|B6||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3636829|NCT02544074|3484909|B5||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3636830|NCT02544074|3484910|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3636831|NCT02544074|3484911|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3636832|NCT02544074|3484912|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3636833|NCT02544074|3484913|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3636834|NCT02544074|3484892|B22||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3636835|NCT02544074|3484893|B21||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3636836|NCT02544074|3484894|B20||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3636837|NCT02544074|3484895|B19||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3636838|NCT02544074|3484896|B18||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3636839|NCT02544074|3484897|B17||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3636840|NCT02544074|3484898|B16||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3636841|NCT02544074|3484899|B15||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3636842|NCT02544074|3484900|B14||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3636843|NCT02544074|3484901|B13||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3636844|NCT02544074|3484902|B12||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3636845|NCT02544074|3484903|B11||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3636846|NCT02544074|3484904|B10||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3636847|NCT02544074|3484905|B9||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3636848|NCT02544074|3484906|B8||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3636849|NCT02544074|3484907|B7||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3636850|NCT02544074|3484908|B6||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3636851|NCT02544074|3484909|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3636852|NCT02544074|3484910|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3636853|NCT02544074|3484911|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3636854|NCT02544074|3484912|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3636855|NCT02544074|3484913|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3636856|NCT02544074|3484892|B22||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636857|NCT02544074|3484893|B21||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636858|NCT02544074|3484894|B20||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636859|NCT02544074|3484895|B19||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636860|NCT02544074|3484896|B18||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636861|NCT02544074|3484897|B17||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636862|NCT02544074|3484898|B16||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636863|NCT02544074|3484899|B15||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636864|NCT02544074|3484900|B14||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636865|NCT02544074|3484901|B13||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636866|NCT02544074|3484902|B12||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636867|NCT02544074|3484903|B11||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636868|NCT02544074|3484904|B10||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636869|NCT02544074|3484905|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636870|NCT02544074|3484906|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636871|NCT02544074|3484907|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636872|NCT02544074|3484908|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636873|NCT02544074|3484909|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636874|NCT02544074|3484910|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636875|NCT02544074|3484911|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636876|NCT02544074|3484912|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636877|NCT02544074|3484913|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3636878|NCT02543918|3484967|B3|United States||Region of Enrollment||participants|Number|84|84.0||||||
3636879|NCT02543918|3484968|B2|United States||Region of Enrollment||participants|Number|43|43.0||||||
3636880|NCT02543918|3484969|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
3636881|NCT02543918|3484967|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636882|NCT02543918|3484968|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636883|NCT02543918|3484969|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636884|NCT02543918|3484967|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3636885|NCT02543918|3484968|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3636886|NCT02543918|3484969|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3636887|NCT02543918|3484967|B3||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3636888|NCT02543918|3484968|B2||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3636889|NCT02543918|3484969|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3636890|NCT02543918|3484967|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3636891|NCT02543918|3484968|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3636892|NCT02543918|3484969|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3636893|NCT02543918|3484967|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636894|NCT02543918|3484968|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636895|NCT02543918|3484969|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636896|NCT02543918|3484967|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636897|NCT02543918|3484968|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636898|NCT02543918|3484969|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636899|NCT02543918|3484967|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636900|NCT02543918|3484968|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636901|NCT02543918|3484969|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636902|NCT02543918|3484967|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636903|NCT02543918|3484968|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636904|NCT02543918|3484969|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636905|NCT02543918|3484967|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3636906|NCT02543918|3484968|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3636907|NCT02543918|3484969|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3636908|NCT02543918|3484967|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3636909|NCT02543918|3484968|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3636910|NCT02543918|3484969|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3636911|NCT02543918|3484967|B3||Male|Gender||Participants|Count of Participants|46|46.0||||||
3636912|NCT02543918|3484968|B2||Male|Gender||Participants|Count of Participants|24|24.0||||||
3636913|NCT02543918|3484969|B1||Male|Gender||Participants|Count of Participants|22|22.0||||||
3636914|NCT02543918|3484967|B3||Female|Gender||Participants|Count of Participants|38|38.0||||||
3636915|NCT02543918|3484968|B2||Female|Gender||Participants|Count of Participants|19|19.0||||||
3636916|NCT02543918|3484969|B1||Female|Gender||Participants|Count of Participants|19|19.0||||||
3636917|NCT02543918|3484967|B3|||Age||years|Mean|41.4|41.4|Standard Deviation|11.5|11.5|||
3636918|NCT02543918|3484968|B2|||Age||years|Mean|39.5|39.5|Standard Deviation|10.5|10.5|||
3636919|NCT02543918|3484969|B1|||Age||years|Mean|43.5|43.5|Standard Deviation|12.2|12.2|||
3636920|NCT02543892|3484976|B9||Other|Ethnic Group||Participants|Count of Participants|13|13.0||||||
3636921|NCT02543892|3484977|B8||Other|Ethnic Group||Participants|Count of Participants|3|3.0||||||
3636922|NCT02543892|3484978|B7||Other|Ethnic Group||Participants|Count of Participants|1|1.0||||||
3636923|NCT02543892|3484979|B6||Other|Ethnic Group||Participants|Count of Participants|0|0.0||||||
3636924|NCT02543892|3484980|B5||Other|Ethnic Group||Participants|Count of Participants|2|2.0||||||
3636925|NCT02543892|3484981|B4||Other|Ethnic Group||Participants|Count of Participants|3|3.0||||||
3636926|NCT02543892|3484982|B3||Other|Ethnic Group||Participants|Count of Participants|2|2.0||||||
3636927|NCT02543892|3484983|B2||Other|Ethnic Group||Participants|Count of Participants|2|2.0||||||
3636928|NCT02543892|3484984|B1||Other|Ethnic Group||Participants|Count of Participants|0|0.0||||||
3636929|NCT02543892|3484976|B9||Luo|Ethnic Group||Participants|Count of Participants|1|1.0||||||
3636930|NCT02543892|3484977|B8||Luo|Ethnic Group||Participants|Count of Participants|0|0.0||||||
3636931|NCT02543892|3484978|B7||Luo|Ethnic Group||Participants|Count of Participants|0|0.0||||||
3636932|NCT02543892|3484979|B6||Luo|Ethnic Group||Participants|Count of Participants|0|0.0||||||
3636933|NCT02543892|3484980|B5||Luo|Ethnic Group||Participants|Count of Participants|1|1.0||||||
3636934|NCT02543892|3484981|B4||Luo|Ethnic Group||Participants|Count of Participants|0|0.0||||||
3636935|NCT02543892|3484982|B3||Luo|Ethnic Group||Participants|Count of Participants|0|0.0||||||
3636936|NCT02543892|3484983|B2||Luo|Ethnic Group||Participants|Count of Participants|0|0.0||||||
3636937|NCT02543892|3484984|B1||Luo|Ethnic Group||Participants|Count of Participants|0|0.0||||||
3636938|NCT02543892|3484976|B9||Giriama|Ethnic Group||Participants|Count of Participants|37|37.0||||||
3636939|NCT02543892|3484977|B8||Giriama|Ethnic Group||Participants|Count of Participants|5|5.0||||||
3636940|NCT02543892|3484978|B7||Giriama|Ethnic Group||Participants|Count of Participants|9|9.0||||||
3636941|NCT02543892|3484979|B6||Giriama|Ethnic Group||Participants|Count of Participants|5|5.0||||||
3636942|NCT02543892|3484980|B5||Giriama|Ethnic Group||Participants|Count of Participants|9|9.0||||||
3636943|NCT02543892|3484981|B4||Giriama|Ethnic Group||Participants|Count of Participants|2|2.0||||||
3636944|NCT02543892|3484982|B3||Giriama|Ethnic Group||Participants|Count of Participants|4|4.0||||||
3636945|NCT02543892|3484983|B2||Giriama|Ethnic Group||Participants|Count of Participants|2|2.0||||||
3636946|NCT02543892|3484984|B1||Giriama|Ethnic Group||Participants|Count of Participants|1|1.0||||||
3636947|NCT02543892|3484976|B9||Chonyi|Ethnic Group||Participants|Count of Participants|197|197.0||||||
3636948|NCT02543892|3484977|B8||Chonyi|Ethnic Group||Participants|Count of Participants|42|42.0||||||
3636949|NCT02543892|3484978|B7||Chonyi|Ethnic Group||Participants|Count of Participants|40|40.0||||||
3636950|NCT02543892|3484979|B6||Chonyi|Ethnic Group||Participants|Count of Participants|45|45.0||||||
3636951|NCT02543892|3484980|B5||Chonyi|Ethnic Group||Participants|Count of Participants|38|38.0||||||
3636952|NCT02543892|3484981|B4||Chonyi|Ethnic Group||Participants|Count of Participants|7|7.0||||||
3636953|NCT02543892|3484982|B3||Chonyi|Ethnic Group||Participants|Count of Participants|6|6.0||||||
3636954|NCT02543892|3484983|B2||Chonyi|Ethnic Group||Participants|Count of Participants|8|8.0||||||
3636955|NCT02543892|3484984|B1||Chonyi|Ethnic Group||Participants|Count of Participants|11|11.0||||||
3636956|NCT02543892|3484976|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636957|NCT02543892|3484977|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636958|NCT02543892|3484978|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636959|NCT02543892|3484979|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636960|NCT02543892|3484980|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636961|NCT02543892|3484981|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636962|NCT02543892|3484982|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636963|NCT02543892|3484983|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636964|NCT02543892|3484984|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636965|NCT02543892|3484976|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636966|NCT02543892|3484977|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636967|NCT02543892|3484978|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636968|NCT02543892|3484979|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636969|NCT02543892|3484980|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636970|NCT02543892|3484981|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636971|NCT02543892|3484982|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636972|NCT02543892|3484983|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636973|NCT02543892|3484984|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636974|NCT02543892|3484976|B9||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636975|NCT02543892|3484977|B8||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636976|NCT02543892|3484978|B7||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636977|NCT02543892|3484979|B6||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636978|NCT02543892|3484980|B5||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636979|NCT02543892|3484981|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636980|NCT02543892|3484982|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636981|NCT02543892|3484983|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636982|NCT02543892|3484984|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636983|NCT02543892|3484976|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|248|248.0||||||
3636984|NCT02543892|3484977|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3636985|NCT02543892|3484978|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3636986|NCT02543892|3484979|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3636987|NCT02543892|3484980|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3636988|NCT02543892|3484981|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3636989|NCT02543892|3484982|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3636990|NCT02543892|3484983|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3636991|NCT02543892|3484984|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3636992|NCT02543892|3484976|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636993|NCT02543892|3484977|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636994|NCT02543892|3484978|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636995|NCT02543892|3484979|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636996|NCT02543892|3484980|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636997|NCT02543892|3484981|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636998|NCT02543892|3484982|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3636999|NCT02543892|3484983|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637000|NCT02543892|3484984|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637001|NCT02543892|3484976|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637002|NCT02543892|3484977|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637003|NCT02543892|3484978|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637004|NCT02543892|3484979|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637005|NCT02543892|3484980|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637006|NCT02543892|3484981|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637007|NCT02543892|3484982|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637008|NCT02543892|3484983|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637009|NCT02543892|3484984|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637010|NCT02543892|3484976|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637011|NCT02543892|3484977|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637012|NCT02543892|3484978|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637013|NCT02543892|3484979|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637014|NCT02543892|3484980|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637015|NCT02543892|3484981|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637016|NCT02543892|3484982|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637017|NCT02543892|3484983|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637018|NCT02543892|3484984|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637019|NCT02543892|3484976|B9||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3637020|NCT02543892|3484977|B8||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3637021|NCT02543892|3484978|B7||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3637022|NCT02543892|3484979|B6||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3637023|NCT02543892|3484980|B5||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3637024|NCT02543892|3484981|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3637025|NCT02543892|3484982|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3637026|NCT02543892|3484983|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3637027|NCT02543892|3484984|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3637028|NCT02543892|3484976|B9||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3637029|NCT02543892|3484977|B8||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3637030|NCT02543892|3484978|B7||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3637031|NCT02543892|3484979|B6||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3637032|NCT02543892|3484980|B5||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3637033|NCT02543892|3484981|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3637034|NCT02543892|3484982|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3637035|NCT02543892|3484983|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3637036|NCT02543892|3484984|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3637037|NCT02543892|3484976|B9|||Age||years|Mean|6.6|6.6|Standard Deviation|11.1|11.1|||
3637038|NCT02543892|3484977|B8|||Age||years|Mean|1.4|1.4|Standard Deviation|0.21|0.21|||
3637039|NCT02543892|3484978|B7|||Age||years|Mean|1.3|1.3|Standard Deviation|0.21|0.21|||
3637040|NCT02543892|3484979|B6|||Age||years|Mean|1.4|1.4|Standard Deviation|0.19|0.19|||
3637041|NCT02543892|3484980|B5|||Age||years|Mean|1.4|1.4|Standard Deviation|0.25|0.25|||
3637042|NCT02543892|3484981|B4|||Age||years|Mean|27.6|27.6|Standard Deviation|6.78|6.78|||
3637043|NCT02543892|3484982|B3|||Age||years|Mean|29.5|29.5|Standard Deviation|6.74|6.74|||
3637044|NCT02543892|3484983|B2|||Age||years|Mean|30.8|30.8|Standard Deviation|5.51|5.51|||
3637045|NCT02543892|3484984|B1|||Age||years|Mean|25.7|25.7|Standard Deviation|7.04|7.04|||
3637046|NCT02543554|3485037|B3|United States||Region of Enrollment||participants|Number|1705|1705.0||||||
3637047|NCT02543554|3485038|B2|United States||Region of Enrollment||participants|Number|513|513.0||||||
3637048|NCT02543554|3485039|B1|United States||Region of Enrollment||participants|Number|1192|1192.0||||||
3637049|NCT02543554|3485037|B3||Male|Sex: Female, Male||Participants|Count of Participants|931|931.0||||||
3637050|NCT02543554|3485038|B2||Male|Sex: Female, Male||Participants|Count of Participants|303|303.0||||||
3637051|NCT02543554|3485039|B1||Male|Sex: Female, Male||Participants|Count of Participants|628|628.0||||||
3637052|NCT02543554|3485037|B3||Female|Sex: Female, Male||Participants|Count of Participants|774|774.0||||||
3637053|NCT02543554|3485038|B2||Female|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
3637054|NCT02543554|3485039|B1||Female|Sex: Female, Male||Participants|Count of Participants|564|564.0||||||
3637055|NCT02543554|3485037|B3|||Age||years|Mean|58.8|58.8|Standard Deviation|16.9|16.9|||
3637056|NCT02543554|3485038|B2|||Age||years|Mean|58.0|58.0|Standard Deviation|24.0|24.0|||
3637057|NCT02543554|3485039|B1|||Age||years|Mean|60.4|60.4|Standard Deviation|21.1|21.1|||
3637058|NCT02543554|3485037|B3||>=65 years|Age||Participants|Count of Participants|594|594.0||||||
3637059|NCT02543554|3485038|B2||>=65 years|Age||Participants|Count of Participants|156|156.0||||||
3637060|NCT02543554|3485039|B1||>=65 years|Age||Participants|Count of Participants|438|438.0||||||
3637061|NCT02543554|3485037|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1111|1111.0||||||
3637062|NCT02543554|3485038|B2||Between 18 and 65 years|Age||Participants|Count of Participants|357|357.0||||||
3637063|NCT02543554|3485039|B1||Between 18 and 65 years|Age||Participants|Count of Participants|754|754.0||||||
3637064|NCT02543554|3485037|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3637065|NCT02543554|3485038|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3637066|NCT02543554|3485039|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3637067|NCT02543528|3485048|B1|Asian Indian||Race/Ethnicity, Customized||Participants|Number|171|171.0||||||
3637068|NCT02543528|3485048|B1||Male|Sex/Gender, Customized||Participants|Count of Participants|61|61.0||||||
3637069|NCT02543528|3485048|B1||Female|Sex/Gender, Customized||Participants|Count of Participants|110|110.0||||||
3637070|NCT02543528|3485048|B1|||Age||Years|Mean|20.2|20.2|Standard Deviation|2.79|2.79|||
3637071|NCT02543437|3485071|B1|Japan||Region of Enrollment||participants|Number|117|117.0||||||
3637072|NCT02543437|3485071|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3637073|NCT02543437|3485071|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3637074|NCT02543437|3485071|B1|||Age||years|Mean|63.3|63.3|Standard Deviation|9.1|9.1|||
3637075|NCT02543398|3485076|B3|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3637076|NCT02543398|3485077|B2|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3637077|NCT02543398|3485078|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3637078|NCT02543398|3485076|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3637079|NCT02543398|3485077|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3637080|NCT02543398|3485078|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3637081|NCT02543398|3485076|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3637082|NCT02543398|3485077|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3637083|NCT02543398|3485078|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3637084|NCT02543398|3485076|B3|||Age||Years|Mean|53.6|53.6|Standard Deviation|11.6|11.6|||
3637085|NCT02543398|3485077|B2|||Age||Years|Mean|53.3|53.3|Standard Deviation|10.7|10.7|||
3637086|NCT02543398|3485078|B1|||Age||Years|Mean|54.1|54.1|Standard Deviation|11.5|11.5|||
3637087|NCT02542943|3485085|B4||Male|Gender||Participants|Count of Participants|80|80.0||||||
3637088|NCT02542943|3485086|B3||Male|Gender||Participants|Count of Participants|25|25.0||||||
3637089|NCT02542943|3485087|B2||Male|Gender||Participants|Count of Participants|27|27.0||||||
3637090|NCT02542943|3485088|B1||Male|Gender||Participants|Count of Participants|28|28.0||||||
3637091|NCT02542943|3485085|B4||Female|Gender||Participants|Count of Participants|160|160.0||||||
3637092|NCT02542943|3485086|B3||Female|Gender||Participants|Count of Participants|56|56.0||||||
3637093|NCT02542943|3485087|B2||Female|Gender||Participants|Count of Participants|53|53.0||||||
3637094|NCT02542943|3485088|B1||Female|Gender||Participants|Count of Participants|51|51.0||||||
3637095|NCT02542943|3485085|B4|||Age||Years|Mean|35.4|35.4|Standard Deviation|9.67|9.67|||
3637096|NCT02542943|3485086|B3|||Age||Years|Mean|36.5|36.5|Standard Deviation|10.07|10.07|||
3637097|NCT02542943|3485087|B2|||Age||Years|Mean|35.0|35.0|Standard Deviation|8.41|8.41|||
3637098|NCT02542943|3485088|B1|||Age||Years|Mean|34.8|34.8|Standard Deviation|10.45|10.45|||
3637099|NCT02542761|3485115|B1|||Body Mass Index (BMI)||kg/m^2|Mean|29|29.0|Standard Deviation|7|7.0|||
3637100|NCT02542761|3485115|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3637101|NCT02542761|3485115|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3637102|NCT02542761|3485115|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3637103|NCT02542761|3485115|B1|||Age||years|Mean|49|49.0|Standard Deviation|9|9.0|||
3637104|NCT02542761|3485115|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3637105|NCT02542761|3485115|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3637106|NCT02542761|3485115|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3637107|NCT02542631|3485132|B3|||A1C|Baseline A1C|A1C %|Mean|8.7|8.7|Standard Deviation|1.0|1.0|||
3637108|NCT02542631|3485133|B2|||A1C|Baseline A1C|A1C %|Mean|8.7|8.7|Standard Deviation|1.0|1.0|||
3637109|NCT02542631|3485134|B1|||A1C|Baseline A1C|A1C %|Mean|8.6|8.6|Standard Deviation|0.9|0.9|||
3637110|NCT02542631|3485132|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637111|NCT02542631|3485133|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637112|NCT02542631|3485134|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637113|NCT02542631|3485132|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637114|NCT02542631|3485133|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637115|NCT02542631|3485134|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637116|NCT02542631|3485132|B3||White|Race (NIH/OMB)||Participants|Count of Participants|246|246.0||||||
3637117|NCT02542631|3485133|B2||White|Race (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
3637118|NCT02542631|3485134|B1||White|Race (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
3637119|NCT02542631|3485132|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3637120|NCT02542631|3485133|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3637121|NCT02542631|3485134|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3637122|NCT02542631|3485132|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3637123|NCT02542631|3485133|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3637124|NCT02542631|3485134|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3637125|NCT02542631|3485132|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3637126|NCT02542631|3485133|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637127|NCT02542631|3485134|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3637128|NCT02542631|3485132|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3637129|NCT02542631|3485133|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3637130|NCT02542631|3485134|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637131|NCT02542631|3485132|B3||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3637132|NCT02542631|3485133|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3637133|NCT02542631|3485134|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3637134|NCT02542631|3485132|B3||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3637135|NCT02542631|3485133|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3637136|NCT02542631|3485134|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3637137|NCT02542631|3485132|B3|||Age||years|Mean|59.2|59.2|Standard Deviation|8.9|8.9|||
3637138|NCT02542631|3485133|B2|||Age||years|Mean|60.4|60.4|Standard Deviation|7.9|7.9|||
3637139|NCT02542631|3485134|B1|||Age||years|Mean|58.1|58.1|Standard Deviation|9.7|9.7|||
3637140|NCT02542462|3485157|B5|||Birthweight||kilograms|Mean|3|3.0|Full Range|||1.8|4.1|
3637141|NCT02542462|3485158|B4|||Birthweight||kilograms|Mean|3|3.0|Full Range|||2.3|3.7|
3637142|NCT02542462|3485159|B3|||Birthweight||kilograms|Mean|3|3.0|Full Range|||1.8|4.1|
3637143|NCT02542462|3485160|B2|||Birthweight||kilograms|Mean|3|3.0|Full Range|||1.9|3.7|
3637144|NCT02542462|3485161|B1|||Birthweight||kilograms|Mean|3|3.0|Full Range|||1.8|3.7|
3637145|NCT02542462|3485157|B5|||Gestational age at birth (weeks)||weeks|Mean|38.8|38.8|Full Range|||37.0|42.0|
3637146|NCT02542462|3485158|B4|||Gestational age at birth (weeks)||weeks|Mean|38.8|38.8|Full Range|||37.0|41.0|
3637147|NCT02542462|3485159|B3|||Gestational age at birth (weeks)||weeks|Mean|38.9|38.9|Full Range|||37.0|42.0|
3637148|NCT02542462|3485160|B2|||Gestational age at birth (weeks)||weeks|Mean|38.8|38.8|Full Range|||37.0|41.0|
3637149|NCT02542462|3485161|B1|||Gestational age at birth (weeks)||weeks|Mean|38.6|38.6|Full Range|||37.0|41.0|
3637150|NCT02542462|3485157|B5|United States||Region of Enrollment||Participants|Count of Participants|101|101.0||||||
3637151|NCT02542462|3485158|B4|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3637152|NCT02542462|3485159|B3|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3637153|NCT02542462|3485160|B2|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3637154|NCT02542462|3485161|B1|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3637155|NCT02542462|3485157|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637156|NCT02542462|3485158|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637157|NCT02542462|3485159|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637158|NCT02542462|3485160|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637159|NCT02542462|3485161|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637160|NCT02542462|3485157|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3637161|NCT02542462|3485158|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637162|NCT02542462|3485159|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3637163|NCT02542462|3485160|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3637164|NCT02542462|3485161|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3637165|NCT02542462|3485157|B5||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3637166|NCT02542462|3485158|B4||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3637167|NCT02542462|3485159|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3637168|NCT02542462|3485160|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637169|NCT02542462|3485161|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3637170|NCT02542462|3485157|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3637171|NCT02542462|3485158|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3637172|NCT02542462|3485159|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3637173|NCT02542462|3485160|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3637174|NCT02542462|3485161|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3637175|NCT02542462|3485157|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637176|NCT02542462|3485158|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637177|NCT02542462|3485159|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637178|NCT02542462|3485160|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637179|NCT02542462|3485161|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637180|NCT02542462|3485157|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637181|NCT02542462|3485158|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637182|NCT02542462|3485159|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637183|NCT02542462|3485160|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637184|NCT02542462|3485161|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637185|NCT02542462|3485157|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637186|NCT02542462|3485158|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637187|NCT02542462|3485159|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637188|NCT02542462|3485160|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637189|NCT02542462|3485161|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637190|NCT02542462|3485157|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637191|NCT02542462|3485158|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637192|NCT02542462|3485159|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637193|NCT02542462|3485160|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637194|NCT02542462|3485161|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637195|NCT02542462|3485157|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3637196|NCT02542462|3485158|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3637197|NCT02542462|3485159|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3637198|NCT02542462|3485160|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3637199|NCT02542462|3485161|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3637200|NCT02542462|3485157|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3637201|NCT02542462|3485158|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637202|NCT02542462|3485159|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3637203|NCT02542462|3485160|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637204|NCT02542462|3485161|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3637205|NCT02542462|3485157|B5||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3637206|NCT02542462|3485158|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3637207|NCT02542462|3485159|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3637208|NCT02542462|3485160|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3637209|NCT02542462|3485161|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3637210|NCT02542462|3485157|B5||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3637211|NCT02542462|3485158|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3637212|NCT02542462|3485159|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3637213|NCT02542462|3485160|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3637214|NCT02542462|3485161|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3637215|NCT02542462|3485157|B5|||Age||weeks|Mean|8.2|8.2|Full Range|||6.0|10.7|
3637216|NCT02542462|3485158|B4|||Age||weeks|Mean|8.4|8.4|Full Range|||6.1|10.4|
3637217|NCT02542462|3485159|B3|||Age||weeks|Mean|8.2|8.2|Full Range|||6.1|10.1|
3637218|NCT02542462|3485160|B2|||Age||weeks|Mean|8|8.0|Full Range|||6.0|10.7|
3637219|NCT02542462|3485161|B1|||Age||weeks|Mean|8.5|8.5|Full Range|||6.0|10.6|
3637220|NCT02542280|3485176|B3|||BMI||kg/m^2|Mean|28.9|28.9|Standard Deviation|3.6|3.6|||
3637221|NCT02542280|3485177|B2|||BMI||kg/m^2|Mean|29.35|29.35|Standard Deviation|3.02|3.02|||
3637222|NCT02542280|3485178|B1|||BMI||kg/m^2|Mean|28.5|28.5|Standard Deviation|4|4.0|||
3637223|NCT02542280|3485176|B3|Egypt||Region of Enrollment||participants|Number|329|329.0||||||
3637224|NCT02542280|3485177|B2|Egypt||Region of Enrollment||participants|Number|167|167.0||||||
3637225|NCT02542280|3485178|B1|Egypt||Region of Enrollment||participants|Number|162|162.0||||||
3637226|NCT02542280|3485176|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3637227|NCT02542280|3485177|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3637228|NCT02542280|3485178|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3637229|NCT02542280|3485176|B3||Female|Sex: Female, Male||Participants|Count of Participants|329|329.0||||||
3637230|NCT02542280|3485177|B2||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3637231|NCT02542280|3485178|B1||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3637232|NCT02542280|3485176|B3|||Age||years|Mean|29.1|29.1|Standard Deviation|4.1|4.1|||
3637233|NCT02542280|3485177|B2|||Age||years|Mean|29.52|29.52|Standard Deviation|4.09|4.09|||
3637234|NCT02542280|3485178|B1|||Age||years|Mean|28.57|28.57|Standard Deviation|3.99|3.99|||
3637235|NCT02542072|3485187|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3637236|NCT02542072|3485188|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3637237|NCT02542072|3485189|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3637238|NCT02542072|3485187|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3637239|NCT02542072|3485188|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3637240|NCT02542072|3485189|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3637241|NCT02542072|3485187|B3|||Age||years|Mean|31.4|31.4|Standard Deviation|8.7|8.7|||
3637242|NCT02542072|3485188|B2|||Age||years|Mean|30.8|30.8|Standard Deviation|8.0|8.0|||
3637243|NCT02542072|3485189|B1|||Age||years|Mean|32.1|32.1|Standard Deviation|9.3|9.3|||
3637244|NCT02541864|3485290|B3|Taiwan||Region of Enrollment||Participants|Count of Participants|330|330.0||||||
3637245|NCT02541864|3485291|B2|Taiwan||Region of Enrollment||Participants|Count of Participants|166|166.0||||||
3637246|NCT02541864|3485292|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|164|164.0||||||
3637247|NCT02541864|3485290|B3||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
3637248|NCT02541864|3485291|B2||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3637249|NCT02541864|3485292|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3637250|NCT02541864|3485290|B3||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3637251|NCT02541864|3485291|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3637252|NCT02541864|3485292|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3637253|NCT02541864|3485290|B3|||Age||years|Mean|53.97|53.97|Standard Deviation|11.86|11.86|||
3637254|NCT02541864|3485291|B2|||Age||years|Mean|54.48|54.48|Standard Deviation|11.45|11.45|||
3637255|NCT02541864|3485292|B1|||Age||years|Mean|53.46|53.46|Standard Deviation|12.28|12.28|||
3637256|NCT02541864|3485290|B3||>=65 years|Age||Participants|Count of Participants|60|60.0||||||
3637257|NCT02541864|3485291|B2||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
3637258|NCT02541864|3485292|B1||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
3637259|NCT02541864|3485290|B3||Between 18 and 65 years|Age||Participants|Count of Participants|270|270.0||||||
3637260|NCT02541864|3485291|B2||Between 18 and 65 years|Age||Participants|Count of Participants|136|136.0||||||
3637261|NCT02541864|3485292|B1||Between 18 and 65 years|Age||Participants|Count of Participants|134|134.0||||||
3637262|NCT02541864|3485290|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3637263|NCT02541864|3485291|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3637264|NCT02541864|3485292|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3637265|NCT02541422|3485299|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
3637266|NCT02541422|3485299|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3637267|NCT02541422|3485299|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3637268|NCT02541422|3485299|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3637269|NCT02541422|3485299|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3637270|NCT02541422|3485299|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3637271|NCT02540850|3485306|B4|China||Region of Enrollment||participants|Number|1031|1031.0||||||
3637272|NCT02540850|3485307|B3|China||Region of Enrollment||participants|Number|410|410.0||||||
3637273|NCT02540850|3485308|B2|China||Region of Enrollment||participants|Number|330|330.0||||||
3637274|NCT02540850|3485309|B1|China||Region of Enrollment||participants|Number|291|291.0||||||
3637275|NCT02540850|3485306|B4||Male|Sex: Female, Male||Participants|Count of Participants|545|545.0||||||
3637276|NCT02540850|3485307|B3||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
3637277|NCT02540850|3485308|B2||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
3637278|NCT02540850|3485309|B1||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3637279|NCT02540850|3485306|B4||Female|Sex: Female, Male||Participants|Count of Participants|486|486.0||||||
3637280|NCT02540850|3485307|B3||Female|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
3637281|NCT02540850|3485308|B2||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3637282|NCT02540850|3485309|B1||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3637283|NCT02540850|3485306|B4|||Age||years|Mean|53.5|53.5|Full Range|||17.0|88.0|
3637284|NCT02540850|3485307|B3|||Age||years|Mean|48.4|48.4|Full Range|||17.0|82.0|
3637285|NCT02540850|3485308|B2|||Age||years|Mean|54.7|54.7|Full Range|||24.0|85.0|
3637286|NCT02540850|3485309|B1|||Age||years|Mean|59.5|59.5|Full Range|||25.0|88.0|
3637287|NCT02540850|3485306|B4||>=65 years|Age||Participants|Count of Participants|187|187.0||||||
3637288|NCT02540850|3485307|B3||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3637289|NCT02540850|3485308|B2||>=65 years|Age||Participants|Count of Participants|65|65.0||||||
3637290|NCT02540850|3485309|B1||>=65 years|Age||Participants|Count of Participants|103|103.0||||||
3637291|NCT02540850|3485306|B4||Between 18 and 65 years|Age||Participants|Count of Participants|843|843.0||||||
3637292|NCT02540850|3485307|B3||Between 18 and 65 years|Age||Participants|Count of Participants|390|390.0||||||
3637293|NCT02540850|3485308|B2||Between 18 and 65 years|Age||Participants|Count of Participants|265|265.0||||||
3637294|NCT02540850|3485309|B1||Between 18 and 65 years|Age||Participants|Count of Participants|188|188.0||||||
3637295|NCT02540850|3485306|B4||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3637296|NCT02540850|3485307|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3637297|NCT02540850|3485308|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3637298|NCT02540850|3485309|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3637299|NCT02540772|3485337|B3|Spain||Region of Enrollment||participants|Number|20|20.0||||||
3637300|NCT02540772|3485338|B2|Spain||Region of Enrollment||participants|Number|10|10.0||||||
3637301|NCT02540772|3485339|B1|Spain||Region of Enrollment||participants|Number|10|10.0||||||
3637302|NCT02540772|3485337|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637303|NCT02540772|3485338|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637304|NCT02540772|3485339|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637305|NCT02540772|3485337|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637306|NCT02540772|3485338|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637307|NCT02540772|3485339|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637308|NCT02540772|3485337|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3637309|NCT02540772|3485338|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3637310|NCT02540772|3485339|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3637311|NCT02540772|3485337|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3637312|NCT02540772|3485338|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3637313|NCT02540772|3485339|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3637314|NCT02540772|3485337|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3637315|NCT02540772|3485338|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3637316|NCT02540772|3485339|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3637317|NCT02540772|3485337|B3|||Age||years|Mean|66.0|66.0|Standard Deviation|12.4|12.4|||
3637318|NCT02540772|3485338|B2|||Age||years|Mean|68.1|68.1|Standard Deviation|11.2|11.2|||
3637319|NCT02540772|3485339|B1|||Age||years|Mean|63.9|63.9|Standard Deviation|14.3|14.3|||
3637320|NCT02540772|3485337|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3637321|NCT02540772|3485338|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3637322|NCT02540772|3485339|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3637323|NCT02540772|3485337|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3637324|NCT02540772|3485338|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3637325|NCT02540772|3485339|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3637326|NCT02540772|3485337|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3637327|NCT02540772|3485338|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3637328|NCT02540772|3485339|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3637329|NCT02540538|3485352|B4|||Anti-HBs Titers < 2 IU/ml|Number of participants with Anti-HBs titers lower than 2 IU/ml|Participants|Count of Participants|32|32.0||||||
3637330|NCT02540538|3485353|B3|||Anti-HBs Titers < 2 IU/ml|Number of participants with Anti-HBs titers lower than 2 IU/ml|Participants|Count of Participants|8|8.0||||||
3637331|NCT02540538|3485354|B2|||Anti-HBs Titers < 2 IU/ml|Number of participants with Anti-HBs titers lower than 2 IU/ml|Participants|Count of Participants|12|12.0||||||
3637332|NCT02540538|3485355|B1|||Anti-HBs Titers < 2 IU/ml|Number of participants with Anti-HBs titers lower than 2 IU/ml|Participants|Count of Participants|12|12.0||||||
3637333|NCT02540538|3485352|B4|||BMI||kg/m^2|Mean|25|25.0|Inter-Quartile Range|||22.0|29.0|
3637334|NCT02540538|3485353|B3|||BMI||kg/m^2|Mean|29|29.0|Inter-Quartile Range|||24.0|31.0|
3637335|NCT02540538|3485354|B2|||BMI||kg/m^2|Mean|23|23.0|Inter-Quartile Range|||22.0|27.0|
3637336|NCT02540538|3485355|B1|||BMI||kg/m^2|Mean|25|25.0|Inter-Quartile Range|||20.0|25.0|
3637337|NCT02540538|3485352|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3637338|NCT02540538|3485353|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3637339|NCT02540538|3485354|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3637340|NCT02540538|3485355|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3637341|NCT02540538|3485352|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3637342|NCT02540538|3485353|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3637343|NCT02540538|3485354|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3637344|NCT02540538|3485355|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3637345|NCT02540538|3485352|B4|||Age||Years (IQR)|Mean|34|34.0|Inter-Quartile Range|||23.0|47.0|
3637346|NCT02540538|3485353|B3|||Age||Years (IQR)|Mean|48|48.0|Inter-Quartile Range|||42.0|58.0|
3637347|NCT02540538|3485354|B2|||Age||Years (IQR)|Mean|29|29.0|Inter-Quartile Range|||22.0|32.0|
3637348|NCT02540538|3485355|B1|||Age||Years (IQR)|Mean|29|29.0|Inter-Quartile Range|||22.0|35.0|
3637349|NCT02540447|3485371|B3|Egypt||Region of Enrollment||participants|Number|80|80.0||||||
3637350|NCT02540447|3485372|B2|Egypt||Region of Enrollment||participants|Number|40|40.0||||||
3637351|NCT02540447|3485373|B1|Egypt||Region of Enrollment||participants|Number|40|40.0||||||
3637352|NCT02540447|3485371|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3637353|NCT02540447|3485372|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3637354|NCT02540447|3485373|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3637355|NCT02540447|3485371|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3637356|NCT02540447|3485372|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3637357|NCT02540447|3485373|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3637358|NCT02540447|3485371|B3|||Age||years|Mean|51.15|51.15|Standard Deviation|6.94|6.94|||
3637359|NCT02540447|3485372|B2|||Age||years|Mean|50.9|50.9|Standard Deviation|7.62|7.62|||
3637360|NCT02540447|3485373|B1|||Age||years|Mean|51.5|51.5|Standard Deviation|6.19|6.19|||
3637361|NCT02540434|3485388|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3637362|NCT02540434|3485389|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3637363|NCT02540434|3485388|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3637364|NCT02540434|3485389|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3637365|NCT02540434|3485390|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3637366|NCT02540434|3485388|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3637367|NCT02540434|3485389|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3637368|NCT02540434|3485390|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3637369|NCT02540434|3485388|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3637370|NCT02540434|3485389|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3637371|NCT02540434|3485390|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3637372|NCT02540434|3485388|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3637373|NCT02540434|3485389|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3637374|NCT02540434|3485390|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3637375|NCT02540434|3485388|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3637376|NCT02540434|3485389|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3637377|NCT02540434|3485390|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3637378|NCT02540434|3485388|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3637379|NCT02540434|3485389|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3637380|NCT02540434|3485390|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3637381|NCT02540434|3485388|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3637382|NCT02540434|3485389|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3637383|NCT02540434|3485390|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3637384|NCT02540356|3485399|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3637385|NCT02540356|3485401|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3637386|NCT02540356|3485399|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3637387|NCT02540356|3485401|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3637388|NCT02540356|3485399|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3637389|NCT02540356|3485401|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3637390|NCT02540356|3485399|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3637391|NCT02540356|3485401|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3637392|NCT02540356|3485399|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3637393|NCT02540356|3485401|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3637394|NCT02540265|3485433|B4|||Baseline Pain Intensity (0-10 NPRS)|Pain intensity was recorded using a Numeric Pain Rating Scale (NPRS; Range 0-10) where 0 equates to no pain (better), and 10 equates to the worst pain imaginable (worse).|units on a scale|Mean|7.6|7.6|Standard Deviation|2.02|2.02|||
3637395|NCT02540265|3485434|B3|||Baseline Pain Intensity (0-10 NPRS)|Pain intensity was recorded using a Numeric Pain Rating Scale (NPRS; Range 0-10) where 0 equates to no pain (better), and 10 equates to the worst pain imaginable (worse).|units on a scale|Mean|7.7|7.7|Standard Deviation|2.24|2.24|||
3637396|NCT02540265|3485435|B2|||Baseline Pain Intensity (0-10 NPRS)|Pain intensity was recorded using a Numeric Pain Rating Scale (NPRS; Range 0-10) where 0 equates to no pain (better), and 10 equates to the worst pain imaginable (worse).|units on a scale|Mean|7.4|7.4|Standard Deviation|1.90|1.9|||
3637397|NCT02540265|3485436|B1|||Baseline Pain Intensity (0-10 NPRS)|Pain intensity was recorded using a Numeric Pain Rating Scale (NPRS; Range 0-10) where 0 equates to no pain (better), and 10 equates to the worst pain imaginable (worse).|units on a scale|Mean|7.7|7.7|Standard Deviation|2.00|2.0|||
3637398|NCT02540265|3485433|B4|United States||Region of Enrollment||participants|Number|59|59.0||||||
3637399|NCT02540265|3485434|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
3637400|NCT02540265|3485435|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3637401|NCT02540265|3485436|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3637402|NCT02540265|3485433|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637403|NCT02540265|3485434|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637404|NCT02540265|3485435|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637405|NCT02540265|3485436|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637406|NCT02540265|3485433|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3637407|NCT02540265|3485434|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637408|NCT02540265|3485435|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3637409|NCT02540265|3485436|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637410|NCT02540265|3485433|B4||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3637411|NCT02540265|3485434|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3637412|NCT02540265|3485435|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3637413|NCT02540265|3485436|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3637414|NCT02540265|3485433|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3637415|NCT02540265|3485434|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3637416|NCT02540265|3485435|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3637417|NCT02540265|3485436|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3637418|NCT02540265|3485433|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637419|NCT02540265|3485434|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637420|NCT02540265|3485435|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637421|NCT02540265|3485436|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637422|NCT02540265|3485433|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637423|NCT02540265|3485434|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637424|NCT02540265|3485435|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637425|NCT02540265|3485436|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637426|NCT02540265|3485433|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637427|NCT02540265|3485434|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637428|NCT02540265|3485435|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637429|NCT02540265|3485436|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637430|NCT02540265|3485433|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637431|NCT02540265|3485434|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637432|NCT02540265|3485435|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637433|NCT02540265|3485436|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637434|NCT02540265|3485433|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3637435|NCT02540265|3485434|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3637436|NCT02540265|3485435|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3637437|NCT02540265|3485436|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3637438|NCT02540265|3485433|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3637439|NCT02540265|3485434|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637440|NCT02540265|3485435|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637441|NCT02540265|3485436|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3637442|NCT02540265|3485433|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3637443|NCT02540265|3485434|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3637444|NCT02540265|3485435|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3637445|NCT02540265|3485436|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3637446|NCT02540265|3485433|B4||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3637447|NCT02540265|3485434|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3637448|NCT02540265|3485435|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3637449|NCT02540265|3485436|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3637450|NCT02540265|3485433|B4|||Age||years|Mean|47.2|47.2|Standard Deviation|14.06|14.06|||
3637451|NCT02540265|3485434|B3|||Age||years|Mean|49.2|49.2|Standard Deviation|12.81|12.81|||
3637452|NCT02540265|3485435|B2|||Age||years|Mean|44.9|44.9|Standard Deviation|16.67|16.67|||
3637453|NCT02540265|3485436|B1|||Age||years|Mean|47.6|47.6|Standard Deviation|12.66|12.66|||
3637454|NCT02540265|3485433|B4||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3637455|NCT02540265|3485434|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3637456|NCT02540265|3485435|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3637457|NCT02540265|3485436|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3637458|NCT02540265|3485433|B4||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3637459|NCT02540265|3485434|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3637460|NCT02540265|3485435|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3637461|NCT02540265|3485436|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3637462|NCT02540265|3485433|B4||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3637463|NCT02540265|3485434|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3637464|NCT02540265|3485435|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3637465|NCT02540265|3485436|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3637466|NCT02540213|3485458|B1||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3637467|NCT02540213|3485458|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3637468|NCT02540213|3485458|B1|||Age||years|Mean|66.8|66.8|Full Range|||24.0|93.0|
3637469|NCT02539992|3485479|B4|Germany||Region of Enrollment||participants|Number|8|8.0||||||
3637470|NCT02539992|3485480|B3|Germany||Region of Enrollment||participants|Number|2|2.0||||||
3637471|NCT02539992|3485481|B2|Germany||Region of Enrollment||participants|Number|3|3.0||||||
3637472|NCT02539992|3485482|B1|Germany||Region of Enrollment||participants|Number|3|3.0||||||
3637473|NCT02539992|3485479|B4|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3637474|NCT02539992|3485480|B3|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3637475|NCT02539992|3485481|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3637476|NCT02539992|3485482|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3637477|NCT02539992|3485479|B4|Italy||Region of Enrollment||participants|Number|30|30.0||||||
3637478|NCT02539992|3485480|B3|Italy||Region of Enrollment||participants|Number|12|12.0||||||
3637479|NCT02539992|3485481|B2|Italy||Region of Enrollment||participants|Number|7|7.0||||||
3637480|NCT02539992|3485482|B1|Italy||Region of Enrollment||participants|Number|11|11.0||||||
3637481|NCT02539992|3485479|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3637482|NCT02539992|3485480|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3637483|NCT02539992|3485481|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3637484|NCT02539992|3485482|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3637485|NCT02539992|3485479|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3637486|NCT02539992|3485480|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3637487|NCT02539992|3485481|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3637488|NCT02539992|3485482|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3637489|NCT02539992|3485479|B4|||Age||years|Mean|69|69.0|Standard Deviation|6.4|6.4|||
3637490|NCT02539992|3485480|B3|||Age||years|Mean|70|70.0|Standard Deviation|4.8|4.8|||
3637491|NCT02539992|3485481|B2|||Age||years|Mean|67|67.0|Standard Deviation|9.3|9.3|||
3637492|NCT02539992|3485482|B1|||Age||years|Mean|69|69.0|Standard Deviation|5.8|5.8|||
3637493|NCT02539797|3485510|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
3637494|NCT02539797|3485510|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3637495|NCT02539797|3485510|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3637496|NCT02539797|3485510|B1|||Age||years|Mean|42.7|42.7|Standard Deviation|8.57|8.57|||
3637497|NCT02539654|3485523|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3637498|NCT02539654|3485523|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3637499|NCT02539654|3485523|B1|||Age||years|Mean|3.4|3.4|Standard Deviation|2.78|2.78|||
3637500|NCT02539134|3485533|B7|Not applicable (Male participant)||Female Reproductive Status||participants|Number|30|30.0||||||
3637501|NCT02539134|3485534|B6|Not applicable (Male participant)||Female Reproductive Status||participants|Number|6|6.0||||||
3637502|NCT02539134|3485535|B5|Not applicable (Male participant)||Female Reproductive Status||participants|Number|4|4.0||||||
3637503|NCT02539134|3485536|B4|Not applicable (Male participant)||Female Reproductive Status||participants|Number|5|5.0||||||
3637504|NCT02539134|3485537|B3|Not applicable (Male participant)||Female Reproductive Status||participants|Number|3|3.0||||||
3637505|NCT02539134|3485538|B2|Not applicable (Male participant)||Female Reproductive Status||participants|Number|5|5.0||||||
3637506|NCT02539134|3485539|B1|Not applicable (Male participant)||Female Reproductive Status||participants|Number|7|7.0||||||
3637507|NCT02539134|3485533|B7|Female of childbearing potential||Female Reproductive Status||participants|Number|8|8.0||||||
3637508|NCT02539134|3485534|B6|Female of childbearing potential||Female Reproductive Status||participants|Number|0|0.0||||||
3637509|NCT02539134|3485535|B5|Female of childbearing potential||Female Reproductive Status||participants|Number|1|1.0||||||
3637510|NCT02539134|3485536|B4|Female of childbearing potential||Female Reproductive Status||participants|Number|1|1.0||||||
3637511|NCT02539134|3485537|B3|Female of childbearing potential||Female Reproductive Status||participants|Number|3|3.0||||||
3637512|NCT02539134|3485538|B2|Female of childbearing potential||Female Reproductive Status||participants|Number|1|1.0||||||
3637513|NCT02539134|3485539|B1|Female of childbearing potential||Female Reproductive Status||participants|Number|2|2.0||||||
3637514|NCT02539134|3485533|B7|Postmenopausal||Female Reproductive Status||participants|Number|2|2.0||||||
3637515|NCT02539134|3485534|B6|Postmenopausal||Female Reproductive Status||participants|Number|0|0.0||||||
3637516|NCT02539134|3485535|B5|Postmenopausal||Female Reproductive Status||participants|Number|1|1.0||||||
3637517|NCT02539134|3485536|B4|Postmenopausal||Female Reproductive Status||participants|Number|0|0.0||||||
3637518|NCT02539134|3485537|B3|Postmenopausal||Female Reproductive Status||participants|Number|0|0.0||||||
3637519|NCT02539134|3485538|B2|Postmenopausal||Female Reproductive Status||participants|Number|0|0.0||||||
3637520|NCT02539134|3485539|B1|Postmenopausal||Female Reproductive Status||participants|Number|1|1.0||||||
3637521|NCT02539134|3485533|B7|No Xanthine/Caffeine consumption||Xanthine/Caffeine Consumption||participants|Number|19|19.0||||||
3637522|NCT02539134|3485534|B6|No Xanthine/Caffeine consumption||Xanthine/Caffeine Consumption||participants|Number|2|2.0||||||
3637523|NCT02539134|3485535|B5|No Xanthine/Caffeine consumption||Xanthine/Caffeine Consumption||participants|Number|3|3.0||||||
3637524|NCT02539134|3485536|B4|No Xanthine/Caffeine consumption||Xanthine/Caffeine Consumption||participants|Number|4|4.0||||||
3637525|NCT02539134|3485537|B3|No Xanthine/Caffeine consumption||Xanthine/Caffeine Consumption||participants|Number|2|2.0||||||
3637526|NCT02539134|3485538|B2|No Xanthine/Caffeine consumption||Xanthine/Caffeine Consumption||participants|Number|4|4.0||||||
3637527|NCT02539134|3485539|B1|No Xanthine/Caffeine consumption||Xanthine/Caffeine Consumption||participants|Number|4|4.0||||||
3637528|NCT02539134|3485533|B7|Xanthine/Caffeine consumption||Xanthine/Caffeine Consumption||participants|Number|21|21.0||||||
3637529|NCT02539134|3485534|B6|Xanthine/Caffeine consumption||Xanthine/Caffeine Consumption||participants|Number|4|4.0||||||
3637530|NCT02539134|3485535|B5|Xanthine/Caffeine consumption||Xanthine/Caffeine Consumption||participants|Number|3|3.0||||||
3637531|NCT02539134|3485536|B4|Xanthine/Caffeine consumption||Xanthine/Caffeine Consumption||participants|Number|2|2.0||||||
3637532|NCT02539134|3485537|B3|Xanthine/Caffeine consumption||Xanthine/Caffeine Consumption||participants|Number|4|4.0||||||
3637593|NCT02539134|3485535|B5|White||Race||participants|Number|5|5.0||||||
3637533|NCT02539134|3485538|B2|Xanthine/Caffeine consumption||Xanthine/Caffeine Consumption||participants|Number|2|2.0||||||
3637534|NCT02539134|3485539|B1|Xanthine/Caffeine consumption||Xanthine/Caffeine Consumption||participants|Number|6|6.0||||||
3637535|NCT02539134|3485533|B7|Ex-drinker||Alcohol Classification||participants|Number|9|9.0||||||
3637536|NCT02539134|3485534|B6|Ex-drinker||Alcohol Classification||participants|Number|1|1.0||||||
3637537|NCT02539134|3485535|B5|Ex-drinker||Alcohol Classification||participants|Number|2|2.0||||||
3637538|NCT02539134|3485536|B4|Ex-drinker||Alcohol Classification||participants|Number|1|1.0||||||
3637539|NCT02539134|3485537|B3|Ex-drinker||Alcohol Classification||participants|Number|1|1.0||||||
3637540|NCT02539134|3485538|B2|Ex-drinker||Alcohol Classification||participants|Number|1|1.0||||||
3637541|NCT02539134|3485539|B1|Ex-drinker||Alcohol Classification||participants|Number|3|3.0||||||
3637542|NCT02539134|3485533|B7|Current drinker||Alcohol Classification||participants|Number|6|6.0||||||
3637543|NCT02539134|3485534|B6|Current drinker||Alcohol Classification||participants|Number|2|2.0||||||
3637544|NCT02539134|3485535|B5|Current drinker||Alcohol Classification||participants|Number|1|1.0||||||
3637545|NCT02539134|3485536|B4|Current drinker||Alcohol Classification||participants|Number|1|1.0||||||
3637546|NCT02539134|3485537|B3|Current drinker||Alcohol Classification||participants|Number|1|1.0||||||
3637547|NCT02539134|3485538|B2|Current drinker||Alcohol Classification||participants|Number|1|1.0||||||
3637548|NCT02539134|3485539|B1|Current drinker||Alcohol Classification||participants|Number|0|0.0||||||
3637549|NCT02539134|3485533|B7|Never drunk||Alcohol Classification||participants|Number|25|25.0||||||
3637550|NCT02539134|3485534|B6|Never drunk||Alcohol Classification||participants|Number|3|3.0||||||
3637551|NCT02539134|3485535|B5|Never drunk||Alcohol Classification||participants|Number|3|3.0||||||
3637552|NCT02539134|3485536|B4|Never drunk||Alcohol Classification||participants|Number|4|4.0||||||
3637553|NCT02539134|3485537|B3|Never drunk||Alcohol Classification||participants|Number|4|4.0||||||
3637554|NCT02539134|3485538|B2|Never drunk||Alcohol Classification||participants|Number|4|4.0||||||
3637555|NCT02539134|3485539|B1|Never drunk||Alcohol Classification||participants|Number|7|7.0||||||
3637556|NCT02539134|3485533|B7|Ex-smoker||Smoking Classification||participants|Number|8|8.0||||||
3637557|NCT02539134|3485534|B6|Ex-smoker||Smoking Classification||participants|Number|2|2.0||||||
3637558|NCT02539134|3485535|B5|Ex-smoker||Smoking Classification||participants|Number|2|2.0||||||
3637559|NCT02539134|3485536|B4|Ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3637560|NCT02539134|3485537|B3|Ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3637561|NCT02539134|3485538|B2|Ex-smoker||Smoking Classification||participants|Number|1|1.0||||||
3637562|NCT02539134|3485539|B1|Ex-smoker||Smoking Classification||participants|Number|3|3.0||||||
3637563|NCT02539134|3485533|B7|Never smoked||Smoking Classification||participants|Number|32|32.0||||||
3637564|NCT02539134|3485534|B6|Never smoked||Smoking Classification||participants|Number|4|4.0||||||
3637565|NCT02539134|3485535|B5|Never smoked||Smoking Classification||participants|Number|4|4.0||||||
3637566|NCT02539134|3485536|B4|Never smoked||Smoking Classification||participants|Number|6|6.0||||||
3637567|NCT02539134|3485537|B3|Never smoked||Smoking Classification||participants|Number|6|6.0||||||
3637568|NCT02539134|3485538|B2|Never smoked||Smoking Classification||participants|Number|5|5.0||||||
3637569|NCT02539134|3485539|B1|Never smoked||Smoking Classification||participants|Number|7|7.0||||||
3637570|NCT02539134|3485533|B7|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|25.56|25.56|Standard Deviation|2.666|2.666|||
3637571|NCT02539134|3485534|B6|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|25.31|25.31|Standard Deviation|1.491|1.491|||
3637572|NCT02539134|3485535|B5|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|26.67|26.67|Standard Deviation|2.971|2.971|||
3637573|NCT02539134|3485536|B4|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|24.16|24.16|Standard Deviation|2.629|2.629|||
3637574|NCT02539134|3485537|B3|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|24.66|24.66|Standard Deviation|3.476|3.476|||
3637575|NCT02539134|3485538|B2|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|25.76|25.76|Standard Deviation|2.386|2.386|||
3637576|NCT02539134|3485539|B1|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|26.30|26.3|Standard Deviation|2.756|2.756|||
3637577|NCT02539134|3485533|B7|||Weight||kilogram (kg)|Mean|75.85|75.85|Standard Deviation|10.647|10.647|||
3637578|NCT02539134|3485534|B6|||Weight||kilogram (kg)|Mean|78.25|78.25|Standard Deviation|7.936|7.936|||
3637579|NCT02539134|3485535|B5|||Weight||kilogram (kg)|Mean|75.28|75.28|Standard Deviation|12.367|12.367|||
3637580|NCT02539134|3485536|B4|||Weight||kilogram (kg)|Mean|73.55|73.55|Standard Deviation|6.227|6.227|||
3637581|NCT02539134|3485537|B3|||Weight||kilogram (kg)|Mean|67.68|67.68|Standard Deviation|10.860|10.86|||
3637582|NCT02539134|3485538|B2|||Weight||kilogram (kg)|Mean|79.37|79.37|Standard Deviation|8.596|8.596|||
3637583|NCT02539134|3485539|B1|||Weight||kilogram (kg)|Mean|78.90|78.9|Standard Deviation|13.136|13.136|||
3637584|NCT02539134|3485533|B7|||Height||centimeter (cm)|Mean|172.0|172.0|Standard Deviation|8.19|8.19|||
3637585|NCT02539134|3485534|B6|||Height||centimeter (cm)|Mean|175.7|175.7|Standard Deviation|5.43|5.43|||
3637586|NCT02539134|3485535|B5|||Height||centimeter (cm)|Mean|167.5|167.5|Standard Deviation|7.29|7.29|||
3637587|NCT02539134|3485536|B4|||Height||centimeter (cm)|Mean|174.8|174.8|Standard Deviation|8.57|8.57|||
3637588|NCT02539134|3485537|B3|||Height||centimeter (cm)|Mean|165.5|165.5|Standard Deviation|6.16|6.16|||
3637589|NCT02539134|3485538|B2|||Height||centimeter (cm)|Mean|175.5|175.5|Standard Deviation|5.65|5.65|||
3637590|NCT02539134|3485539|B1|||Height||centimeter (cm)|Mean|172.7|172.7|Standard Deviation|10.02|10.02|||
3637591|NCT02539134|3485533|B7|White||Race||participants|Number|31|31.0||||||
3637592|NCT02539134|3485534|B6|White||Race||participants|Number|5|5.0||||||
3637594|NCT02539134|3485536|B4|White||Race||participants|Number|5|5.0||||||
3637595|NCT02539134|3485537|B3|White||Race||participants|Number|4|4.0||||||
3637596|NCT02539134|3485538|B2|White||Race||participants|Number|5|5.0||||||
3637597|NCT02539134|3485539|B1|White||Race||participants|Number|7|7.0||||||
3637598|NCT02539134|3485533|B7|Black or African American||Race||participants|Number|9|9.0||||||
3637599|NCT02539134|3485534|B6|Black or African American||Race||participants|Number|1|1.0||||||
3637600|NCT02539134|3485535|B5|Black or African American||Race||participants|Number|1|1.0||||||
3637601|NCT02539134|3485536|B4|Black or African American||Race||participants|Number|1|1.0||||||
3637602|NCT02539134|3485537|B3|Black or African American||Race||participants|Number|2|2.0||||||
3637603|NCT02539134|3485538|B2|Black or African American||Race||participants|Number|1|1.0||||||
3637604|NCT02539134|3485539|B1|Black or African American||Race||participants|Number|3|3.0||||||
3637605|NCT02539134|3485533|B7|Not Hispanic or Latino||Ethnicity||participants|Number|21|21.0||||||
3637606|NCT02539134|3485534|B6|Not Hispanic or Latino||Ethnicity||participants|Number|5|5.0||||||
3637607|NCT02539134|3485535|B5|Not Hispanic or Latino||Ethnicity||participants|Number|1|1.0||||||
3637608|NCT02539134|3485536|B4|Not Hispanic or Latino||Ethnicity||participants|Number|2|2.0||||||
3637609|NCT02539134|3485537|B3|Not Hispanic or Latino||Ethnicity||participants|Number|2|2.0||||||
3637610|NCT02539134|3485538|B2|Not Hispanic or Latino||Ethnicity||participants|Number|6|6.0||||||
3637611|NCT02539134|3485539|B1|Not Hispanic or Latino||Ethnicity||participants|Number|5|5.0||||||
3637612|NCT02539134|3485533|B7|Hispanic or Latino||Ethnicity||participants|Number|19|19.0||||||
3637613|NCT02539134|3485534|B6|Hispanic or Latino||Ethnicity||participants|Number|1|1.0||||||
3637614|NCT02539134|3485535|B5|Hispanic or Latino||Ethnicity||participants|Number|5|5.0||||||
3637615|NCT02539134|3485536|B4|Hispanic or Latino||Ethnicity||participants|Number|4|4.0||||||
3637616|NCT02539134|3485537|B3|Hispanic or Latino||Ethnicity||participants|Number|4|4.0||||||
3637617|NCT02539134|3485538|B2|Hispanic or Latino||Ethnicity||participants|Number|0|0.0||||||
3637618|NCT02539134|3485539|B1|Hispanic or Latino||Ethnicity||participants|Number|5|5.0||||||
3637619|NCT02539134|3485533|B7|United States||Region of Enrollment||participants|Number|40|40.0||||||
3637620|NCT02539134|3485534|B6|United States||Region of Enrollment||participants|Number|6|6.0||||||
3637621|NCT02539134|3485535|B5|United States||Region of Enrollment||participants|Number|6|6.0||||||
3637622|NCT02539134|3485536|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
3637623|NCT02539134|3485537|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3637624|NCT02539134|3485538|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3637625|NCT02539134|3485539|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3637626|NCT02539134|3485533|B7||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3637627|NCT02539134|3485534|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3637628|NCT02539134|3485535|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3637629|NCT02539134|3485536|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3637630|NCT02539134|3485537|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3637631|NCT02539134|3485538|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3637632|NCT02539134|3485539|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3637633|NCT02539134|3485533|B7||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3637634|NCT02539134|3485534|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3637635|NCT02539134|3485535|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3637636|NCT02539134|3485536|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3637637|NCT02539134|3485537|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3637638|NCT02539134|3485538|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3637639|NCT02539134|3485539|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3637640|NCT02539134|3485533|B7|||Age||years|Mean|34.5|34.5|Standard Deviation|9.60|9.6|||
3637641|NCT02539134|3485534|B6|||Age||years|Mean|40.3|40.3|Standard Deviation|11.55|11.55|||
3637642|NCT02539134|3485535|B5|||Age||years|Mean|37.7|37.7|Standard Deviation|13.08|13.08|||
3637643|NCT02539134|3485536|B4|||Age||years|Mean|26.7|26.7|Standard Deviation|4.50|4.5|||
3637644|NCT02539134|3485537|B3|||Age||years|Mean|33.7|33.7|Standard Deviation|10.71|10.71|||
3637645|NCT02539134|3485538|B2|||Age||years|Mean|33.8|33.8|Standard Deviation|4.62|4.62|||
3637646|NCT02539134|3485539|B1|||Age||years|Mean|34.8|34.8|Standard Deviation|8.51|8.51|||
3637647|NCT02539108|3485596|B3|United States||Region of Enrollment||Participants|Number|60|60.0||||||
3637648|NCT02539108|3485597|B2|United States||Region of Enrollment||Participants|Number|30|30.0||||||
3637649|NCT02539108|3485598|B1|United States||Region of Enrollment||Participants|Number|30|30.0||||||
3637650|NCT02539108|3485596|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3637651|NCT02539108|3485597|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3637652|NCT02539108|3485598|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3637653|NCT02539108|3485596|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3637654|NCT02539108|3485597|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3637655|NCT02539108|3485598|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3637656|NCT02539108|3485596|B3|||Age||Months|Mean|46.9|46.9|Standard Deviation|30.50|30.5|||
3637657|NCT02539108|3485597|B2|||Age||Months|Mean|72.0|72.0|Standard Deviation|22.9|22.9|||
3637658|NCT02539108|3485598|B1|||Age||Months|Mean|21.9|21.9|Standard Deviation|8.59|8.59|||
3637659|NCT02539108|3485596|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3637660|NCT02539108|3485597|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3637661|NCT02539108|3485598|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3637662|NCT02539108|3485596|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3637663|NCT02539108|3485597|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3637664|NCT02539108|3485598|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3637665|NCT02539108|3485596|B3||<=18 years|Age||Participants|Count of Participants|60|60.0||||||
3637666|NCT02539108|3485597|B2||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
3637667|NCT02539108|3485598|B1||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
3637668|NCT02538965|3485613|B1|||Number of Prior Systemic Anti-Cancer Regimens||regimens|Median|5|5.0|Full Range|||2.0|7.0|
3637669|NCT02538965|3485613|B1|Other||Number of Participants With at Least One Cytogenetic Abnormality|A standard cytogenetic metaphase preparation from the fresh bone marrow aspirate was prepared for the cytogenetic testing/chromosome analysis including karyotype. Results from cytogenetics, FISH studies, flow cytometry studies, and molecular studies performed locally at initial diagnosis and/or relapse was reported for t(16;16), t(8;21), MLL (11q23), t(15;17), monosomy 7, del(5q), or any other recurring abnormalities and presence or absence of mutations. More than one category can apply to a participant.|Participants|Count of Participants|9|9.0||||||
3637670|NCT02538965|3485613|B1|inv (3)||Number of Participants With at Least One Cytogenetic Abnormality|A standard cytogenetic metaphase preparation from the fresh bone marrow aspirate was prepared for the cytogenetic testing/chromosome analysis including karyotype. Results from cytogenetics, FISH studies, flow cytometry studies, and molecular studies performed locally at initial diagnosis and/or relapse was reported for t(16;16), t(8;21), MLL (11q23), t(15;17), monosomy 7, del(5q), or any other recurring abnormalities and presence or absence of mutations. More than one category can apply to a participant.|Participants|Count of Participants|1|1.0||||||
3637671|NCT02538965|3485613|B1|11q 23 abnormalities||Number of Participants With at Least One Cytogenetic Abnormality|A standard cytogenetic metaphase preparation from the fresh bone marrow aspirate was prepared for the cytogenetic testing/chromosome analysis including karyotype. Results from cytogenetics, FISH studies, flow cytometry studies, and molecular studies performed locally at initial diagnosis and/or relapse was reported for t(16;16), t(8;21), MLL (11q23), t(15;17), monosomy 7, del(5q), or any other recurring abnormalities and presence or absence of mutations. More than one category can apply to a participant.|Participants|Count of Participants|3|3.0||||||
3637672|NCT02538965|3485613|B1|7q-||Number of Participants With at Least One Cytogenetic Abnormality|A standard cytogenetic metaphase preparation from the fresh bone marrow aspirate was prepared for the cytogenetic testing/chromosome analysis including karyotype. Results from cytogenetics, FISH studies, flow cytometry studies, and molecular studies performed locally at initial diagnosis and/or relapse was reported for t(16;16), t(8;21), MLL (11q23), t(15;17), monosomy 7, del(5q), or any other recurring abnormalities and presence or absence of mutations. More than one category can apply to a participant.|Participants|Count of Participants|2|2.0||||||
3637673|NCT02538965|3485613|B1|-7||Number of Participants With at Least One Cytogenetic Abnormality|A standard cytogenetic metaphase preparation from the fresh bone marrow aspirate was prepared for the cytogenetic testing/chromosome analysis including karyotype. Results from cytogenetics, FISH studies, flow cytometry studies, and molecular studies performed locally at initial diagnosis and/or relapse was reported for t(16;16), t(8;21), MLL (11q23), t(15;17), monosomy 7, del(5q), or any other recurring abnormalities and presence or absence of mutations. More than one category can apply to a participant.|Participants|Count of Participants|1|1.0||||||
3637674|NCT02538965|3485613|B1|complex (>/= 3 abnormalities)||Number of Participants With at Least One Cytogenetic Abnormality|A standard cytogenetic metaphase preparation from the fresh bone marrow aspirate was prepared for the cytogenetic testing/chromosome analysis including karyotype. Results from cytogenetics, FISH studies, flow cytometry studies, and molecular studies performed locally at initial diagnosis and/or relapse was reported for t(16;16), t(8;21), MLL (11q23), t(15;17), monosomy 7, del(5q), or any other recurring abnormalities and presence or absence of mutations. More than one category can apply to a participant.|Participants|Count of Participants|5|5.0||||||
3637675|NCT02538965|3485613|B1|+8||Number of Participants With at Least One Cytogenetic Abnormality|A standard cytogenetic metaphase preparation from the fresh bone marrow aspirate was prepared for the cytogenetic testing/chromosome analysis including karyotype. Results from cytogenetics, FISH studies, flow cytometry studies, and molecular studies performed locally at initial diagnosis and/or relapse was reported for t(16;16), t(8;21), MLL (11q23), t(15;17), monosomy 7, del(5q), or any other recurring abnormalities and presence or absence of mutations. More than one category can apply to a participant.|Participants|Count of Participants|1|1.0||||||
3637676|NCT02538965|3485613|B1|t(8;21)||Number of Participants With at Least One Cytogenetic Abnormality|A standard cytogenetic metaphase preparation from the fresh bone marrow aspirate was prepared for the cytogenetic testing/chromosome analysis including karyotype. Results from cytogenetics, FISH studies, flow cytometry studies, and molecular studies performed locally at initial diagnosis and/or relapse was reported for t(16;16), t(8;21), MLL (11q23), t(15;17), monosomy 7, del(5q), or any other recurring abnormalities and presence or absence of mutations. More than one category can apply to a participant.|Participants|Count of Participants|1|1.0||||||
3637677|NCT02538965|3485613|B1|||Bone Marrow (BM) Myeloblasts Count|Laboratory results obtained at baseline/screening include the peripheral white blood cells and blast counts, bone marrow blast percentage, cytogenetics and molecular alterations.|Percent of Myeloblasts|Median|57.5|57.5|Full Range|||7.0|92.0|
3637678|NCT02538965|3485613|B1|||White Blood Cell Count|Laboratory results obtained at baseline/screening include the peripheral white blood cells and blast counts, bone marrow blast percentage, cytogenetics and molecular alterations.|10^9/L|Median|3.700|3.7|Full Range|||0.13|158.9|
3637679|NCT02538965|3485613|B1|||Peripheral Blood Smear Blasts|Laboratory results obtained at baseline/screening include the peripheral white blood cells and blast counts, bone marrow blast percentage, cytogenetics and molecular alterations.|Percent of Blasts|Median|8.7|8.7|Full Range|||0.0|91.0|
3637680|NCT02538965|3485613|B1|≥ 17 years||Age Categories||Participants|Count of Participants|3|3.0||||||
3637681|NCT02538965|3485613|B1|13-16 years||Age Categories||Participants|Count of Participants|4|4.0||||||
3637682|NCT02538965|3485613|B1|7-12 years||Age Categories||Participants|Count of Participants|6|6.0||||||
3637683|NCT02538965|3485613|B1|3-6 years||Age Categories||Participants|Count of Participants|4|4.0||||||
3637684|NCT02538965|3485613|B1|≤ 2 years||Age Categories||Participants|Count of Participants|0|0.0||||||
3637685|NCT02538965|3485613|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3637686|NCT02538965|3485613|B1||Not Collected or Reported|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3637687|NCT02538965|3485613|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3637688|NCT02538965|3485613|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3637689|NCT02538965|3485613|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3637690|NCT02538965|3485613|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3637691|NCT02538965|3485613|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3637692|NCT02538965|3485613|B1|||Age||years|Mean|11.5|11.5|Standard Deviation|4.56|4.56|||
3637693|NCT02538679|3485632|B4||ASA III or higher|American Society of Anesthesiologist Classification|"American Society of Anesthesiologist Classification grading performed by anesthesiologist prior to surgery~Grading per standard ASA guidelines:~ASA class I - normal healthy adult ASA class II - patients with mild systemic disease ASA class III - patients with severe systemic disease ASA class IV - patients with severe systemic disease that is a constant threat to life ASA class V - a moribund patient that is not expected to survive"|Participants|Count of Participants|33|33.0||||||
3637694|NCT02538679|3485633|B3||ASA III or higher|American Society of Anesthesiologist Classification|"American Society of Anesthesiologist Classification grading performed by anesthesiologist prior to surgery~Grading per standard ASA guidelines:~ASA class I - normal healthy adult ASA class II - patients with mild systemic disease ASA class III - patients with severe systemic disease ASA class IV - patients with severe systemic disease that is a constant threat to life ASA class V - a moribund patient that is not expected to survive"|Participants|Count of Participants|7|7.0||||||
3637695|NCT02538679|3485634|B2||ASA III or higher|American Society of Anesthesiologist Classification|"American Society of Anesthesiologist Classification grading performed by anesthesiologist prior to surgery~Grading per standard ASA guidelines:~ASA class I - normal healthy adult ASA class II - patients with mild systemic disease ASA class III - patients with severe systemic disease ASA class IV - patients with severe systemic disease that is a constant threat to life ASA class V - a moribund patient that is not expected to survive"|Participants|Count of Participants|17|17.0||||||
3637696|NCT02538679|3485635|B1||ASA III or higher|American Society of Anesthesiologist Classification|"American Society of Anesthesiologist Classification grading performed by anesthesiologist prior to surgery~Grading per standard ASA guidelines:~ASA class I - normal healthy adult ASA class II - patients with mild systemic disease ASA class III - patients with severe systemic disease ASA class IV - patients with severe systemic disease that is a constant threat to life ASA class V - a moribund patient that is not expected to survive"|Participants|Count of Participants|9|9.0||||||
3637697|NCT02538679|3485632|B4||ASA I/II|American Society of Anesthesiologist Classification|"American Society of Anesthesiologist Classification grading performed by anesthesiologist prior to surgery~Grading per standard ASA guidelines:~ASA class I - normal healthy adult ASA class II - patients with mild systemic disease ASA class III - patients with severe systemic disease ASA class IV - patients with severe systemic disease that is a constant threat to life ASA class V - a moribund patient that is not expected to survive"|Participants|Count of Participants|74|74.0||||||
3637698|NCT02538679|3485633|B3||ASA I/II|American Society of Anesthesiologist Classification|"American Society of Anesthesiologist Classification grading performed by anesthesiologist prior to surgery~Grading per standard ASA guidelines:~ASA class I - normal healthy adult ASA class II - patients with mild systemic disease ASA class III - patients with severe systemic disease ASA class IV - patients with severe systemic disease that is a constant threat to life ASA class V - a moribund patient that is not expected to survive"|Participants|Count of Participants|34|34.0||||||
3637699|NCT02538679|3485634|B2||ASA I/II|American Society of Anesthesiologist Classification|"American Society of Anesthesiologist Classification grading performed by anesthesiologist prior to surgery~Grading per standard ASA guidelines:~ASA class I - normal healthy adult ASA class II - patients with mild systemic disease ASA class III - patients with severe systemic disease ASA class IV - patients with severe systemic disease that is a constant threat to life ASA class V - a moribund patient that is not expected to survive"|Participants|Count of Participants|28|28.0||||||
3637700|NCT02538679|3485635|B1||ASA I/II|American Society of Anesthesiologist Classification|"American Society of Anesthesiologist Classification grading performed by anesthesiologist prior to surgery~Grading per standard ASA guidelines:~ASA class I - normal healthy adult ASA class II - patients with mild systemic disease ASA class III - patients with severe systemic disease ASA class IV - patients with severe systemic disease that is a constant threat to life ASA class V - a moribund patient that is not expected to survive"|Participants|Count of Participants|12|12.0||||||
3637701|NCT02538679|3485632|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637702|NCT02538679|3485633|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637703|NCT02538679|3485634|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637704|NCT02538679|3485635|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637705|NCT02538679|3485632|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637706|NCT02538679|3485633|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637707|NCT02538679|3485634|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637708|NCT02538679|3485635|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637709|NCT02538679|3485632|B4||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3637710|NCT02538679|3485633|B3||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3637711|NCT02538679|3485634|B2||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3637712|NCT02538679|3485635|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3637713|NCT02538679|3485632|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3637714|NCT02538679|3485633|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3637715|NCT02538679|3485634|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3637716|NCT02538679|3485635|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3637717|NCT02538679|3485632|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3637718|NCT02538679|3485633|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3637719|NCT02538679|3485634|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3637720|NCT02538679|3485635|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3637721|NCT02538679|3485632|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3637722|NCT02538679|3485633|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3637723|NCT02538679|3485634|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3637724|NCT02538679|3485635|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3637725|NCT02538679|3485632|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637726|NCT02538679|3485633|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637727|NCT02538679|3485634|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637728|NCT02538679|3485635|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637729|NCT02538679|3485632|B4||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3637730|NCT02538679|3485633|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3637731|NCT02538679|3485634|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3637732|NCT02538679|3485635|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3637733|NCT02538679|3485632|B4||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3637734|NCT02538679|3485633|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3637735|NCT02538679|3485634|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3637736|NCT02538679|3485635|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3637737|NCT02538679|3485632|B4|||Age||years|Mean|50.2|50.2|Standard Deviation|18|18.0|||
3637738|NCT02538679|3485633|B3|||Age||years|Mean|48.4|48.4|Standard Deviation|18.8|18.8|||
3637739|NCT02538679|3485634|B2|||Age||years|Mean|54|54.0|Standard Deviation|16.6|16.6|||
3637740|NCT02538679|3485635|B1|||Age||years|Mean|46.7|46.7|Standard Deviation|18.5|18.5|||
3637741|NCT02538107|3485645|B1||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3637742|NCT02538107|3485645|B1||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3637743|NCT02538107|3485645|B1|||Age||years|Mean|51.1|51.1|Standard Deviation|14.07|14.07|||
3637744|NCT02538042|3485665|B3|||Fagerstrom Test for Nicotine Dependence (FTND) score|The survey used is the Fagerstrom Test for Nicotine Dependence which provides an assessment of the individual's nicotine dependence. The scale has a range of 0 to 10 where higher numbers are associated with higher levels of dependence.|units on a scale|Mean|4.97|4.97|Standard Deviation|2.22|2.22|||
3637745|NCT02538042|3485666|B2|||Fagerstrom Test for Nicotine Dependence (FTND) score|The survey used is the Fagerstrom Test for Nicotine Dependence which provides an assessment of the individual's nicotine dependence. The scale has a range of 0 to 10 where higher numbers are associated with higher levels of dependence.|units on a scale|Mean|5.47|5.47|Standard Deviation|2.12|2.12|||
3637746|NCT02538042|3485667|B1|||Fagerstrom Test for Nicotine Dependence (FTND) score|The survey used is the Fagerstrom Test for Nicotine Dependence which provides an assessment of the individual's nicotine dependence. The scale has a range of 0 to 10 where higher numbers are associated with higher levels of dependence.|units on a scale|Mean|4.47|4.47|Standard Deviation|2.27|2.27|||
3637747|NCT02538042|3485665|B3|||Cigarettes per day||cigarettes per day|Mean|19.41|19.41|Standard Deviation|9.35|9.35|||
3637748|NCT02538042|3485666|B2|||Cigarettes per day||cigarettes per day|Mean|21.88|21.88|Standard Deviation|10.21|10.21|||
3637749|NCT02538042|3485667|B1|||Cigarettes per day||cigarettes per day|Mean|16.94|16.94|Standard Deviation|7.94|7.94|||
3637750|NCT02538042|3485665|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3637751|NCT02538042|3485666|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3637752|NCT02538042|3485667|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637753|NCT02538042|3485665|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3637754|NCT02538042|3485666|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3637755|NCT02538042|3485667|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3637756|NCT02538042|3485665|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3637757|NCT02538042|3485666|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3637758|NCT02538042|3485667|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3637759|NCT02538042|3485665|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3637760|NCT02538042|3485666|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3637761|NCT02538042|3485667|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3637762|NCT02538042|3485665|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637763|NCT02538042|3485666|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637764|NCT02538042|3485667|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637765|NCT02538042|3485665|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3637766|NCT02538042|3485666|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637767|NCT02538042|3485667|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3637768|NCT02538042|3485665|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637769|NCT02538042|3485666|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637770|NCT02538042|3485667|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637771|NCT02538042|3485665|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3637772|NCT02538042|3485666|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3637773|NCT02538042|3485667|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637774|NCT02538042|3485665|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3637775|NCT02538042|3485666|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3637776|NCT02538042|3485667|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3637777|NCT02538042|3485665|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3637778|NCT02538042|3485666|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3637779|NCT02538042|3485667|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3637780|NCT02538042|3485665|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3637781|NCT02538042|3485666|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3637782|NCT02538042|3485667|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3637783|NCT02538042|3485665|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3637784|NCT02538042|3485666|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3637785|NCT02538042|3485667|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3637786|NCT02538042|3485665|B3|||Age||years|Mean|46.2|46.2|Standard Deviation|11.0|11.0|||
3637787|NCT02538042|3485666|B2|||Age||years|Mean|48.4|48.4|Standard Deviation|9.1|9.1|||
3637788|NCT02538042|3485667|B1|||Age||years|Mean|44.0|44.0|Standard Deviation|12.5|12.5|||
3637789|NCT02537730|3485684|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3637790|NCT02537730|3485684|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3637791|NCT02537730|3485684|B1|||Age||years|Mean|37|37.0|Standard Deviation|12|12.0|||
3637792|NCT02537522|3485697|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
3637793|NCT02537522|3485697|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3637794|NCT02537522|3485697|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3637795|NCT02537522|3485697|B1|||Age||years|Mean|28.7|28.7|Standard Deviation|6.24|6.24|||
3637796|NCT02537431|3485708|B1|||Mineralizing Surface/OsteoidSurface (MS/OS)||percentage of mineralizing surface|Mean|6.47|6.47|Standard Deviation|5.120|5.12|||
3637797|NCT02537431|3485708|B1|||Bone-Specific Alkaline Phosphatase (BALP)||μg/L|Mean|20.43|20.43|Standard Deviation|9.288|9.288|||
3637798|NCT02537431|3485708|B1|||Carboxy-Terminal Cross-Linked Telopeptide of Type I Collagen (CTx-I)||pg/mL|Mean|646.93|646.93|Standard Deviation|401.641|401.641|||
3637799|NCT02537431|3485708|B1|||Procollagen Type 1 N-Propeptide (P1NP)||ng/mL|Mean|77.00|77.0|Standard Deviation|33.273|33.273|||
3637800|NCT02537431|3485708|B1|||Tubular Reabsorption of Phosphate (TRP)||fraction of phosphorus reabsorbed|Mean|0.84|0.84|Standard Deviation|0.048|0.048|||
3637801|NCT02537431|3485708|B1|||Ratio of Renal Tubular Maximum Reabsorption Rate of Phosphate to Glomerular Filtration Rate(TmP/GFR)||mg/dL|Mean|1.87|1.87|Standard Deviation|0.307|0.307|||
3637802|NCT02537431|3485708|B1|||24-Hour Urinary Phosphorus||g/24hr|Mean|0.82|0.82|Standard Deviation|0.237|0.237|||
3637803|NCT02537431|3485708|B1|||1,25(OH) 2D||pg/mL|Mean|37.25|37.25|Standard Deviation|11.686|11.686|||
3637804|NCT02537431|3485708|B1|||Bone Formation Rate/Bone Volume (BFR/BV)|BFR/BV is equivalent to bone turnover rate.|percent/year|Mean|38.33|38.33|Standard Deviation|37.173|37.173|||
3637805|NCT02537431|3485708|B1|||Bone Formation Rate/Osteoblast Surface (BFR/OS)|Bone formation rate to osteoid surface ratio, related to the adjusted apposition rate (Aj.AR; amount of new bone created [bone formation rate over the entire osteoid surface]).|µm^3/µm^2/year|Mean|2309.00|2309.0|Standard Deviation|2941.970|2941.97|||
3637806|NCT02537431|3485708|B1|||Bone Formation Rate/Bone Surface (BFR/BS)|Amount of new bone formed in unit time per unit of bone surface; calculated by multiplying MS/BS by the MAR (see previous measure descriptions for MS/BS and MAR definitions).|µm^3/µm^2/year|Mean|26.68|26.68|Standard Deviation|19.480|19.48|||
3637807|NCT02537431|3485708|B1|||Mineralizing Surface/Bone Surface (MS/BS)|Percent of bone surface that displays a tetracycline label reflecting active mineralization; calculated as the double-labeled surface plus one half of the single-labeled surface and is expressed as a function of total bone surface ([dLS + sLS/2]/BS). It is a measure of the proportion of bone surface upon which new mineralized bone was being deposited during the period of tetracycline labeling.|percentage of mineralizing surface|Mean|5.99|5.99|Standard Deviation|4.763|4.763|||
3637808|NCT02537431|3485708|B1|||Mineral Apposition Rate (MAR)|Linear rate of new bone deposition; mean distance between the double labels, divided by the time interval between them.|µm/day|Mean|0.58|0.58|Standard Deviation|0.448|0.448|||
3637864|NCT02536313|3485770|B2|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|20|20.0||||||
3637865|NCT02536313|3485771|B1|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|20|20.0||||||
3637809|NCT02537431|3485708|B1|||Mineralization Lag Time (MLt)|Average time interval between osteoid formation and its subsequent mineralization; calculated by dividing the osteoid thickness by the adjusted apposition rate (O.Th/Aj.AR). Aj.AR; amount of new bone created (bone formation rate over the entire osteoid surface). The imputed result was used for some of the baseline data for MLt.|days|Mean|1539.81|1539.81|Standard Deviation|1587.086|1587.086|||
3637810|NCT02537431|3485708|B1|||Osteoid Surface/Bone Surface (OS/BS)|Percent of bone surface covered in osteoid.|percentage of osteoid surface|Mean|91.73|91.73|Standard Deviation|3.438|3.438|||
3637811|NCT02537431|3485708|B1|||Osteoid Thickness (O.Th)|Mean thickness, given in micrometers, for osteoid seams.|µm|Mean|17.21|17.21|Standard Deviation|4.105|4.105|||
3637812|NCT02537431|3485708|B1|||Serum Phosphorus||mg/dL|Mean|2.24|2.24|Standard Deviation|0.396|0.396|||
3637813|NCT02537431|3485708|B1|||Osteoid Volume/Bone Volume (OV/BV)|Percent of a given volume of bone tissue that consists of unmineralized bone (osteoid).|percentage of osteoid volume|Mean|26.12|26.12|Standard Deviation|12.357|12.357|||
3637814|NCT02537431|3485708|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637815|NCT02537431|3485708|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637816|NCT02537431|3485708|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3637817|NCT02537431|3485708|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3637818|NCT02537431|3485708|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637819|NCT02537431|3485708|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3637820|NCT02537431|3485708|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637821|NCT02537431|3485708|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637822|NCT02537431|3485708|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3637823|NCT02537431|3485708|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3637824|NCT02537431|3485708|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3637825|NCT02537431|3485708|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3637826|NCT02537431|3485708|B1|||Age||years|Mean|40.13|40.13|Standard Deviation|8.725|8.725|||
3637827|NCT02536781|3485737|B3|||wound area||mm^2|Mean|29.08|29.08|Standard Deviation|35.01|35.01|||
3637828|NCT02536781|3485738|B2|||wound area||mm^2|Mean|26.5|26.5|Standard Deviation|32.2|32.2|||
3637829|NCT02536781|3485739|B1|||wound area||mm^2|Mean|33.3|33.3|Standard Deviation|37.8|37.8|||
3637830|NCT02536781|3485737|B3|||VAS scores range from 0 (no pain) to 10 (severe pain)||scores on a scale|Mean|3.6|3.6|Standard Deviation|1.7|1.7|||
3637831|NCT02536781|3485738|B2|||VAS scores range from 0 (no pain) to 10 (severe pain)||scores on a scale|Mean|3.6|3.6|Standard Deviation|1.7|1.7|||
3637832|NCT02536781|3485739|B1|||VAS scores range from 0 (no pain) to 10 (severe pain)||scores on a scale|Mean|3.6|3.6|Standard Deviation|1.8|1.8|||
3637833|NCT02536781|3485737|B3|Thailand||Region of Enrollment||participants|Number|70|70.0||||||
3637834|NCT02536781|3485738|B2|Thailand||Region of Enrollment||participants|Number|34|34.0||||||
3637835|NCT02536781|3485739|B1|Thailand||Region of Enrollment||participants|Number|36|36.0||||||
3637836|NCT02536781|3485737|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3637837|NCT02536781|3485738|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3637838|NCT02536781|3485739|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3637839|NCT02536781|3485737|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3637840|NCT02536781|3485738|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3637841|NCT02536781|3485739|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3637842|NCT02536781|3485737|B3|||Age||years|Mean|22.3|22.3|Standard Deviation|1.6|1.6|||
3637843|NCT02536781|3485738|B2|||Age||years|Mean|22.4|22.4|Standard Deviation|1.6|1.6|||
3637844|NCT02536781|3485739|B1|||Age||years|Mean|22.1|22.1|Standard Deviation|1.5|1.5|||
3637845|NCT02536781|3485737|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3637846|NCT02536781|3485738|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3637847|NCT02536781|3485739|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3637848|NCT02536781|3485737|B3||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
3637849|NCT02536781|3485738|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3637850|NCT02536781|3485739|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3637851|NCT02536781|3485737|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3637852|NCT02536781|3485738|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3637853|NCT02536781|3485739|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3637854|NCT02536664|3485748|B3||Male|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
3637855|NCT02536664|3485749|B2||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3637856|NCT02536664|3485750|B1||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3637857|NCT02536664|3485748|B3||Female|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
3637858|NCT02536664|3485749|B2||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3637859|NCT02536664|3485750|B1||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3637860|NCT02536664|3485748|B3|||Age||years|Mean|63.1|63.1|Standard Deviation|11.4|11.4|||
3637861|NCT02536664|3485749|B2|||Age||years|Mean|64.0|64.0|Standard Deviation|11.0|11.0|||
3637862|NCT02536664|3485750|B1|||Age||years|Mean|62.7|62.7|Standard Deviation|11.6|11.6|||
3637863|NCT02536313|3485769|B3|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|40|40.0||||||
3637866|NCT02536313|3485769|B3|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|9|9.0||||||
3637867|NCT02536313|3485770|B2|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|5|5.0||||||
3637868|NCT02536313|3485771|B1|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|4|4.0||||||
3637869|NCT02536313|3485769|B3|||HCV RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.44|0.44|||
3637870|NCT02536313|3485770|B2|||HCV RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.46|0.46|||
3637871|NCT02536313|3485771|B1|||HCV RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.42|0.42|||
3637872|NCT02536313|3485769|B3|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|19|19.0||||||
3637873|NCT02536313|3485770|B2|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|7|7.0||||||
3637874|NCT02536313|3485771|B1|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|12|12.0||||||
3637875|NCT02536313|3485769|B3|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|23|23.0||||||
3637876|NCT02536313|3485770|B2|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|13|13.0||||||
3637877|NCT02536313|3485771|B1|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|10|10.0||||||
3637878|NCT02536313|3485769|B3|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|7|7.0||||||
3637879|NCT02536313|3485770|B2|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|5|5.0||||||
3637880|NCT02536313|3485771|B1|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|2|2.0||||||
3637881|NCT02536313|3485769|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3637882|NCT02536313|3485770|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3637883|NCT02536313|3485771|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3637884|NCT02536313|3485769|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3637885|NCT02536313|3485770|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3637886|NCT02536313|3485771|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3637887|NCT02536313|3485769|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
3637888|NCT02536313|3485770|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3637889|NCT02536313|3485771|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3637890|NCT02536313|3485769|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3637891|NCT02536313|3485770|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3637892|NCT02536313|3485771|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3637893|NCT02536313|3485769|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3637894|NCT02536313|3485770|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3637895|NCT02536313|3485771|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3637896|NCT02536313|3485769|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3637897|NCT02536313|3485770|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3637898|NCT02536313|3485771|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3637899|NCT02536313|3485769|B3|||Age||years|Mean|54|54.0|Standard Deviation|12.2|12.2|||
3637900|NCT02536313|3485770|B2|||Age||years|Mean|54|54.0|Standard Deviation|14.1|14.1|||
3637901|NCT02536313|3485771|B1|||Age||years|Mean|54|54.0|Standard Deviation|10.1|10.1|||
3637902|NCT02535741|3485788|B1|||Range of Motion (ROM)||degree|Mean|107.21|107.21|Standard Deviation|12.5|12.5|||
3637903|NCT02535741|3485788|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3637904|NCT02535741|3485788|B1||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3637905|NCT02535741|3485788|B1|||Age||years|Mean|66|66.0|Standard Deviation|8.3|8.3|||
3637906|NCT02535416|3485796|B10||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3637907|NCT02535416|3485797|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637908|NCT02535416|3485798|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637909|NCT02535416|3485799|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3637910|NCT02535416|3485800|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637911|NCT02535416|3485801|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637912|NCT02535416|3485802|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3637913|NCT02535416|3485803|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637914|NCT02535416|3485804|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637915|NCT02535416|3485805|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3637916|NCT02535416|3485796|B10||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3637917|NCT02535416|3485797|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3637918|NCT02535416|3485798|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637919|NCT02535416|3485799|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637920|NCT02535416|3485800|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637921|NCT02535416|3485801|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637922|NCT02535416|3485802|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637923|NCT02535416|3485803|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637924|NCT02535416|3485804|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3637925|NCT02535416|3485805|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637926|NCT02535416|3485796|B10||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3637927|NCT02535416|3485797|B9||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3637928|NCT02535416|3485798|B8||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3637929|NCT02535416|3485799|B7||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3637930|NCT02535416|3485800|B6||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3637931|NCT02535416|3485801|B5||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3637932|NCT02535416|3485802|B4||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3637933|NCT02535416|3485803|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3637934|NCT02535416|3485804|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3637935|NCT02535416|3485805|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3637936|NCT02535416|3485796|B10||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637937|NCT02535416|3485797|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637938|NCT02535416|3485798|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637939|NCT02535416|3485799|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637940|NCT02535416|3485800|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637941|NCT02535416|3485801|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637942|NCT02535416|3485802|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637943|NCT02535416|3485803|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637944|NCT02535416|3485804|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637945|NCT02535416|3485805|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637946|NCT02535416|3485796|B10||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637947|NCT02535416|3485797|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637948|NCT02535416|3485798|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637949|NCT02535416|3485799|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637950|NCT02535416|3485800|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637951|NCT02535416|3485801|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637952|NCT02535416|3485802|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637953|NCT02535416|3485803|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637954|NCT02535416|3485804|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637955|NCT02535416|3485805|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637956|NCT02535416|3485796|B10||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3637957|NCT02535416|3485797|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3637958|NCT02535416|3485798|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3637959|NCT02535416|3485799|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3637960|NCT02535416|3485800|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3637961|NCT02535416|3485801|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637962|NCT02535416|3485802|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637963|NCT02535416|3485803|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637964|NCT02535416|3485804|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637965|NCT02535416|3485805|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637966|NCT02535416|3485796|B10||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637967|NCT02535416|3485797|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637968|NCT02535416|3485798|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637969|NCT02535416|3485799|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637970|NCT02535416|3485800|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637971|NCT02535416|3485801|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637972|NCT02535416|3485802|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637973|NCT02535416|3485803|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637974|NCT02535416|3485804|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637975|NCT02535416|3485805|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3637976|NCT02535416|3485796|B10||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3637977|NCT02535416|3485797|B9||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3637978|NCT02535416|3485798|B8||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3637979|NCT02535416|3485799|B7||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3637980|NCT02535416|3485800|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3637981|NCT02535416|3485801|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3637982|NCT02535416|3485802|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3637983|NCT02535416|3485803|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3637984|NCT02535416|3485804|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3637985|NCT02535416|3485805|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3637986|NCT02535416|3485796|B10||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3637987|NCT02535416|3485797|B9||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3637988|NCT02535416|3485798|B8||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3637989|NCT02535416|3485799|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3637990|NCT02535416|3485800|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3637991|NCT02535416|3485801|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3637992|NCT02535416|3485802|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3637993|NCT02535416|3485803|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3637994|NCT02535416|3485804|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3637995|NCT02535416|3485805|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3637996|NCT02535416|3485796|B10|||Age||Years|Mean|28.75|28.75|Standard Deviation|8.74|8.74|||
3637997|NCT02535416|3485797|B9|||Age||Years|Mean|31.87|31.87|Standard Deviation|8.86|8.86|||
3637998|NCT02535416|3485798|B8|||Age||Years|Mean|31.19|31.19|Standard Deviation|11.06|11.06|||
3637999|NCT02535416|3485799|B7|||Age||Years|Mean|28.03|28.03|Standard Deviation|7.79|7.79|||
3638000|NCT02535416|3485800|B6|||Age||Years|Mean|28.73|28.73|Standard Deviation|11.15|11.15|||
3638001|NCT02535416|3485801|B5|||Age||Years|Mean|30.05|30.05|Standard Deviation|9.78|9.78|||
3638002|NCT02535416|3485802|B4|||Age||Years|Mean|27.36|27.36|Standard Deviation|4.91|4.91|||
3638003|NCT02535416|3485803|B3|||Age||Years|Mean|29.02|29.02|Standard Deviation|13.89|13.89|||
3638004|NCT02535416|3485804|B2|||Age||Years|Mean|25.96|25.96|Standard Deviation|7.83|7.83|||
3638005|NCT02535416|3485805|B1|||Age||Years|Mean|23.10|23.1|Standard Deviation|1.49|1.49|||
3638006|NCT02535364|3485865|B1||Philadelphia chromosome positive|Philadelphia Chromosome Status|The Philadelphia (Ph) chromosome is an abnormally short chromosome 22 that results from translocation between the BCR gene on chromosome 22 with the ABL gene on chromosome 9. The resulting BCR-ABL gene encodes a fusion protein with uncontrolled tyrosine kinase activity and has been linked to chronic myeloid leukemia and one form of ALL.|Participants|Count of Participants|4|4.0||||||
3638007|NCT02535364|3485865|B1||Philadelphia chromosome negative|Philadelphia Chromosome Status|The Philadelphia (Ph) chromosome is an abnormally short chromosome 22 that results from translocation between the BCR gene on chromosome 22 with the ABL gene on chromosome 9. The resulting BCR-ABL gene encodes a fusion protein with uncontrolled tyrosine kinase activity and has been linked to chronic myeloid leukemia and one form of ALL.|Participants|Count of Participants|34|34.0||||||
3638008|NCT02535364|3485865|B1||3|Eastern Cooperative Oncology Group (ECOG) Score|"0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg, light house work, office work; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair~From Oken MM, et al. Am J Clin Oncol 1982;5(6):649-655."|Participants|Count of Participants|1|1.0||||||
3638009|NCT02535364|3485865|B1||2|Eastern Cooperative Oncology Group (ECOG) Score|"0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg, light house work, office work; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair~From Oken MM, et al. Am J Clin Oncol 1982;5(6):649-655."|Participants|Count of Participants|5|5.0||||||
3638010|NCT02535364|3485865|B1||1|Eastern Cooperative Oncology Group (ECOG) Score|"0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg, light house work, office work; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair~From Oken MM, et al. Am J Clin Oncol 1982;5(6):649-655."|Participants|Count of Participants|29|29.0||||||
3638011|NCT02535364|3485865|B1||0|Eastern Cooperative Oncology Group (ECOG) Score|"0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg, light house work, office work; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair~From Oken MM, et al. Am J Clin Oncol 1982;5(6):649-655."|Participants|Count of Participants|3|3.0||||||
3638012|NCT02535364|3485865|B1||Did not receive prior stem cell transplant|Prior Stem Cell Transplant||Participants|Count of Participants|24|24.0||||||
3638013|NCT02535364|3485865|B1||Received prior stem cell transplant|Prior Stem Cell Transplant||Participants|Count of Participants|14|14.0||||||
3638014|NCT02535364|3485865|B1||Missing|Response to Most Recent Prior Regimen||Participants|Count of Participants|1|1.0||||||
3638015|NCT02535364|3485865|B1||Not applicable|Response to Most Recent Prior Regimen||Participants|Count of Participants|2|2.0||||||
3638016|NCT02535364|3485865|B1||No response|Response to Most Recent Prior Regimen||Participants|Count of Participants|27|27.0||||||
3638017|NCT02535364|3485865|B1||Remission|Response to Most Recent Prior Regimen||Participants|Count of Participants|8|8.0||||||
3638018|NCT02535364|3485865|B1||Other|Most Recent Prior Regimen||Participants|Count of Participants|6|6.0||||||
3638019|NCT02535364|3485865|B1||Tyrosine kinase inhibitor alone|Most Recent Prior Regimen||Participants|Count of Participants|1|1.0||||||
3638020|NCT02535364|3485865|B1||Tyrosine kinase inhibitor + chemotherapy|Most Recent Prior Regimen||Participants|Count of Participants|2|2.0||||||
3638021|NCT02535364|3485865|B1||Multi-agent chemotherapy|Most Recent Prior Regimen||Participants|Count of Participants|15|15.0||||||
3638022|NCT02535364|3485865|B1||Marqibo|Most Recent Prior Regimen||Participants|Count of Participants|2|2.0||||||
3638023|NCT02535364|3485865|B1||Investigational agent|Most Recent Prior Regimen||Participants|Count of Participants|1|1.0||||||
3638024|NCT02535364|3485865|B1||Blinatumomab monotherapy|Most Recent Prior Regimen||Participants|Count of Participants|11|11.0||||||
3638025|NCT02535364|3485865|B1|||Number of Prior Lines of Therapy||lines of therapy|Median|2|2.0|Full Range|||1.0|7.0|
3638026|NCT02535364|3485865|B1|||Time Since Diagnosis||years|Median|1.8|1.8|Full Range|||1.0|22.0|
3638027|NCT02535364|3485865|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638028|NCT02535364|3485865|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638029|NCT02535364|3485865|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3638030|NCT02535364|3485865|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638031|NCT02535364|3485865|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3638032|NCT02535364|3485865|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3638033|NCT02535364|3485865|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638034|NCT02535364|3485865|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638035|NCT02535364|3485865|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3638036|NCT02535364|3485865|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3638037|NCT02535364|3485865|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3638038|NCT02535364|3485865|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3638039|NCT02535364|3485865|B1||65 or older|Age, Customized||Participants|Count of Participants|4|4.0||||||
3638040|NCT02535364|3485865|B1||40 to 64|Age, Customized||Participants|Count of Participants|15|15.0||||||
3638041|NCT02535364|3485865|B1||39 or younger|Age, Customized||Participants|Count of Participants|19|19.0||||||
3638042|NCT02535364|3485865|B1|||Age||years|Median|39|39.0|Full Range|||19.0|69.0|
3638043|NCT02535065|3485890|B1||Never|Smoking Status||Participants|Count of Participants|6|6.0||||||
3638044|NCT02535065|3485890|B1||Past|Smoking Status||Participants|Count of Participants|40|40.0||||||
3638045|NCT02535065|3485890|B1||Current|Smoking Status||Participants|Count of Participants|16|16.0||||||
3638046|NCT02535065|3485890|B1||No|Diabetes||Participants|Count of Participants|47|47.0||||||
3638047|NCT02535065|3485890|B1||Yes|Diabetes||Participants|Count of Participants|15|15.0||||||
3638048|NCT02535065|3485890|B1|United States||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
3638049|NCT02535065|3485890|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638050|NCT02535065|3485890|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638051|NCT02535065|3485890|B1||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3638052|NCT02535065|3485890|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3638053|NCT02535065|3485890|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638054|NCT02535065|3485890|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638055|NCT02535065|3485890|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638056|NCT02535065|3485890|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3638057|NCT02535065|3485890|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3638058|NCT02535065|3485890|B1|||Age||years|Mean|70.5|70.5|Standard Deviation|8.9|8.9|||
3638059|NCT02535026|3485895|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3638060|NCT02535026|3485895|B1||Female|Sex: Female, Male||Participants|Count of Participants|580|580.0||||||
3638061|NCT02535026|3485895|B1|||Age||years|Median|58|58.0|Full Range|||27.0|90.0|
3638062|NCT02534935|3485947|B4|Ethnicity: Non-Hispanic||Race/Ethnicity, Customized||participants|Number|394|394.0||||||
3638063|NCT02534935|3485948|B3|Ethnicity: Non-Hispanic||Race/Ethnicity, Customized||participants|Number|132|132.0||||||
3638064|NCT02534935|3485949|B2|Ethnicity: Non-Hispanic||Race/Ethnicity, Customized||participants|Number|218|218.0||||||
3638065|NCT02534935|3485950|B1|Ethnicity: Non-Hispanic||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
3638066|NCT02534935|3485947|B4|Ethnicity: Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3638067|NCT02534935|3485948|B3|Ethnicity: Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3638068|NCT02534935|3485949|B2|Ethnicity: Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3638336|NCT02533401|3486284|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3638069|NCT02534935|3485950|B1|Ethnicity: Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3638070|NCT02534935|3485947|B4|Race: Other||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3638071|NCT02534935|3485948|B3|Race: Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3638072|NCT02534935|3485949|B2|Race: Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3638073|NCT02534935|3485950|B1|Race: Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3638074|NCT02534935|3485947|B4|Race: Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3638075|NCT02534935|3485948|B3|Race: Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3638076|NCT02534935|3485949|B2|Race: Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3638077|NCT02534935|3485950|B1|Race: Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3638078|NCT02534935|3485947|B4|Race: White||Race/Ethnicity, Customized||participants|Number|374|374.0||||||
3638079|NCT02534935|3485948|B3|Race: White||Race/Ethnicity, Customized||participants|Number|127|127.0||||||
3638080|NCT02534935|3485949|B2|Race: White||Race/Ethnicity, Customized||participants|Number|210|210.0||||||
3638081|NCT02534935|3485950|B1|Race: White||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
3638082|NCT02534935|3485947|B4||Male|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
3638083|NCT02534935|3485948|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3638084|NCT02534935|3485949|B2||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3638085|NCT02534935|3485950|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3638086|NCT02534935|3485947|B4||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
3638087|NCT02534935|3485948|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3638088|NCT02534935|3485949|B2||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3638089|NCT02534935|3485950|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3638090|NCT02534935|3485947|B4|||Age||months|Mean|17.3|17.3|Standard Deviation|3.61|3.61|||
3638091|NCT02534935|3485948|B3|||Age||months|Mean|17.3|17.3|Standard Deviation|3.58|3.58|||
3638092|NCT02534935|3485949|B2|||Age||months|Mean|17.4|17.4|Standard Deviation|3.54|3.54|||
3638093|NCT02534935|3485950|B1|||Age||months|Mean|16.9|16.9|Standard Deviation|4.08|4.08|||
3638094|NCT02534883|3486110|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3638095|NCT02534883|3486111|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3638096|NCT02534883|3486112|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3638097|NCT02534883|3486110|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3638098|NCT02534883|3486111|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3638099|NCT02534883|3486112|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3638100|NCT02534883|3486110|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3638101|NCT02534883|3486111|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3638102|NCT02534883|3486112|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3638103|NCT02534883|3486110|B3|||Age||years|Mean|61.2|61.2|Standard Deviation|5.5|5.5|||
3638104|NCT02534883|3486111|B2|||Age||years|Mean|58.7|58.7|Standard Deviation|6.1|6.1|||
3638105|NCT02534883|3486112|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|5.2|5.2|||
3638106|NCT02534883|3486110|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3638107|NCT02534883|3486111|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3638108|NCT02534883|3486112|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3638109|NCT02534883|3486110|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3638110|NCT02534883|3486111|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3638111|NCT02534883|3486112|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3638112|NCT02534883|3486110|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3638113|NCT02534883|3486111|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3638114|NCT02534883|3486112|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3638115|NCT02534493|3486129|B1||Severe|Severity|Severity determined using a shortened nerve conduction study protocol and using AANEM criteria.|Participants|Count of Participants|4|4.0||||||
3638116|NCT02534493|3486129|B1||Moderate|Severity|Severity determined using a shortened nerve conduction study protocol and using AANEM criteria.|Participants|Count of Participants|4|4.0||||||
3638117|NCT02534493|3486129|B1||Mild|Severity|Severity determined using a shortened nerve conduction study protocol and using AANEM criteria.|Participants|Count of Participants|3|3.0||||||
3638118|NCT02534493|3486129|B1||Bilateral CTS|Bilaterality|Participants presented with either unilateral CTS (only one wrist affected) or bilateral CTS (both wrists affected).|Participants|Count of Participants|4|4.0||||||
3638119|NCT02534493|3486129|B1||Unilateral CTS|Bilaterality|Participants presented with either unilateral CTS (only one wrist affected) or bilateral CTS (both wrists affected).|Participants|Count of Participants|7|7.0||||||
3638120|NCT02534493|3486129|B1||Unknown or Not Reported|Race (NIH/OMB)|The categories for race and ethnicity were combined, such that the Hispanic choice was lumped with Asian, Caucasian, Black, and Other. The single participant that identified as Hispanic was lumped in with Caucasian in the Race section.|Participants|Count of Participants|0|0.0||||||
3638121|NCT02534493|3486129|B1||More than one race|Race (NIH/OMB)|The categories for race and ethnicity were combined, such that the Hispanic choice was lumped with Asian, Caucasian, Black, and Other. The single participant that identified as Hispanic was lumped in with Caucasian in the Race section.|Participants|Count of Participants|0|0.0||||||
3638159|NCT02534350|3486140|B1|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3638122|NCT02534493|3486129|B1||White|Race (NIH/OMB)|The categories for race and ethnicity were combined, such that the Hispanic choice was lumped with Asian, Caucasian, Black, and Other. The single participant that identified as Hispanic was lumped in with Caucasian in the Race section.|Participants|Count of Participants|8|8.0||||||
3638123|NCT02534493|3486129|B1||Black or African American|Race (NIH/OMB)|The categories for race and ethnicity were combined, such that the Hispanic choice was lumped with Asian, Caucasian, Black, and Other. The single participant that identified as Hispanic was lumped in with Caucasian in the Race section.|Participants|Count of Participants|2|2.0||||||
3638124|NCT02534493|3486129|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|The categories for race and ethnicity were combined, such that the Hispanic choice was lumped with Asian, Caucasian, Black, and Other. The single participant that identified as Hispanic was lumped in with Caucasian in the Race section.|Participants|Count of Participants|0|0.0||||||
3638125|NCT02534493|3486129|B1||Asian|Race (NIH/OMB)|The categories for race and ethnicity were combined, such that the Hispanic choice was lumped with Asian, Caucasian, Black, and Other. The single participant that identified as Hispanic was lumped in with Caucasian in the Race section.|Participants|Count of Participants|1|1.0||||||
3638126|NCT02534493|3486129|B1||American Indian or Alaska Native|Race (NIH/OMB)|The categories for race and ethnicity were combined, such that the Hispanic choice was lumped with Asian, Caucasian, Black, and Other. The single participant that identified as Hispanic was lumped in with Caucasian in the Race section.|Participants|Count of Participants|0|0.0||||||
3638127|NCT02534493|3486129|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|The categories for race and ethnicity were combined, such that the Hispanic choice was lumped with Asian, Caucasian, Black, and Other. The single participant that identified as Hispanic was lumped in with Caucasian in the Race section.|Participants|Count of Participants|0|0.0||||||
3638128|NCT02534493|3486129|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|The categories for race and ethnicity were combined, such that the Hispanic choice was lumped with Asian, Caucasian, Black, and Other. The single participant that identified as Hispanic was lumped in with Caucasian in the Race section.|Participants|Count of Participants|10|10.0||||||
3638129|NCT02534493|3486129|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|The categories for race and ethnicity were combined, such that the Hispanic choice was lumped with Asian, Caucasian, Black, and Other. The single participant that identified as Hispanic was lumped in with Caucasian in the Race section.|Participants|Count of Participants|1|1.0||||||
3638130|NCT02534493|3486129|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3638131|NCT02534493|3486129|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3638132|NCT02534493|3486129|B1|||Age||years|Mean|51.4|51.4|Standard Deviation|11.1|11.1|||
3638133|NCT02534493|3486129|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3638134|NCT02534493|3486129|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3638135|NCT02534493|3486129|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3638136|NCT02534350|3486138|B3|||The Forced Expiratory Volume in One Second (FEV1) % Predicted||percent FEV1|Mean|63.10|63.1|Standard Deviation|22.834|22.834|||
3638137|NCT02534350|3486139|B2|||The Forced Expiratory Volume in One Second (FEV1) % Predicted||percent FEV1|Mean|61.95|61.95|Standard Deviation|18.625|18.625|||
3638138|NCT02534350|3486140|B1|||The Forced Expiratory Volume in One Second (FEV1) % Predicted||percent FEV1|Mean|63.64|63.64|Standard Deviation|24.787|24.787|||
3638139|NCT02534350|3486138|B3|||inFLUenza Patient-Reported Outcome (FLU-PRO) Score|Flu-PRO Score was calculated as the mean of 38 individual scores. Individual scores ranged from 0 (no symptoms) to 4 (worst symptoms) for the 5-point severity scale and 0 (never) to 4 or more times (always) for the 5-point frequency scale.|units on a scale|Mean|2.07|2.07|Standard Deviation|0.628|0.628|||
3638140|NCT02534350|3486139|B2|||inFLUenza Patient-Reported Outcome (FLU-PRO) Score|Flu-PRO Score was calculated as the mean of 38 individual scores. Individual scores ranged from 0 (no symptoms) to 4 (worst symptoms) for the 5-point severity scale and 0 (never) to 4 or more times (always) for the 5-point frequency scale.|units on a scale|Mean|2.11|2.11|Standard Deviation|0.684|0.684|||
3638141|NCT02534350|3486140|B1|||inFLUenza Patient-Reported Outcome (FLU-PRO) Score|Flu-PRO Score was calculated as the mean of 38 individual scores. Individual scores ranged from 0 (no symptoms) to 4 (worst symptoms) for the 5-point severity scale and 0 (never) to 4 or more times (always) for the 5-point frequency scale.|units on a scale|Mean|2.05|2.05|Standard Deviation|0.607|0.607|||
3638142|NCT02534350|3486138|B3|||Nasal Viral Load||log10 copies/mL|Mean|6.13|6.13|Standard Deviation|2.098|2.098|||
3638143|NCT02534350|3486139|B2|||Nasal Viral Load||log10 copies/mL|Mean|6.59|6.59|Standard Deviation|2.092|2.092|||
3638144|NCT02534350|3486140|B1|||Nasal Viral Load||log10 copies/mL|Mean|5.88|5.88|Standard Deviation|2.088|2.088|||
3638145|NCT02534350|3486138|B3|Germany||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3638146|NCT02534350|3486139|B2|Germany||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3638147|NCT02534350|3486140|B1|Germany||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3638148|NCT02534350|3486138|B3|France||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3638149|NCT02534350|3486139|B2|France||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3638150|NCT02534350|3486140|B1|France||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3638151|NCT02534350|3486138|B3|Australia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3638152|NCT02534350|3486139|B2|Australia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3638153|NCT02534350|3486140|B1|Australia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3638154|NCT02534350|3486138|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3638155|NCT02534350|3486139|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3638156|NCT02534350|3486140|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3638157|NCT02534350|3486138|B3|United States||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3638158|NCT02534350|3486139|B2|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3638160|NCT02534350|3486138|B3|Belgium||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3638161|NCT02534350|3486139|B2|Belgium||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3638162|NCT02534350|3486140|B1|Belgium||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3638163|NCT02534350|3486138|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3638164|NCT02534350|3486139|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3638165|NCT02534350|3486140|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3638166|NCT02534350|3486138|B3|Canada||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3638167|NCT02534350|3486139|B2|Canada||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3638168|NCT02534350|3486140|B1|Canada||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3638169|NCT02534350|3486138|B3||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3638170|NCT02534350|3486139|B2||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3638171|NCT02534350|3486140|B1||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3638172|NCT02534350|3486138|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3638173|NCT02534350|3486139|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3638174|NCT02534350|3486140|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3638175|NCT02534350|3486138|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|52|52.0||||||
3638176|NCT02534350|3486139|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3638177|NCT02534350|3486140|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3638178|NCT02534350|3486138|B3||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3638179|NCT02534350|3486139|B2||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3638180|NCT02534350|3486140|B1||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3638181|NCT02534350|3486138|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3638182|NCT02534350|3486139|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3638183|NCT02534350|3486140|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3638184|NCT02534350|3486138|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3638185|NCT02534350|3486139|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3638186|NCT02534350|3486140|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3638187|NCT02534350|3486138|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3638188|NCT02534350|3486139|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638189|NCT02534350|3486140|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3638190|NCT02534350|3486138|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3638191|NCT02534350|3486139|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3638192|NCT02534350|3486140|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3638193|NCT02534350|3486138|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3638194|NCT02534350|3486139|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3638195|NCT02534350|3486140|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3638196|NCT02534350|3486138|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3638197|NCT02534350|3486139|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3638198|NCT02534350|3486140|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3638199|NCT02534350|3486138|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3638200|NCT02534350|3486139|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3638201|NCT02534350|3486140|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3638202|NCT02534350|3486138|B3|||Age||years|Mean|56.0|56.0|Standard Deviation|13.02|13.02|||
3638203|NCT02534350|3486139|B2|||Age||years|Mean|55.1|55.1|Standard Deviation|14.23|14.23|||
3638204|NCT02534350|3486140|B1|||Age||years|Mean|56.4|56.4|Standard Deviation|12.54|12.54|||
3638205|NCT02534324|3486153|B3|Thailand||Region of Enrollment||participants|Number|146|146.0||||||
3638206|NCT02534324|3486154|B2|Thailand||Region of Enrollment||participants|Number|48|48.0||||||
3638207|NCT02534324|3486155|B1|Thailand||Region of Enrollment||participants|Number|98|98.0||||||
3638208|NCT02534324|3486153|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3638209|NCT02534324|3486154|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3638210|NCT02534324|3486155|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3638211|NCT02534324|3486153|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3638212|NCT02534324|3486154|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3638213|NCT02534324|3486155|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3638214|NCT02534324|3486153|B3|||Age||years|Mean|64.5|64.5|Standard Deviation|15.0|15.0|||
3638215|NCT02534324|3486154|B2|||Age||years|Mean|64.2|64.2|Standard Deviation|15.0|15.0|||
3638216|NCT02534324|3486155|B1|||Age||years|Mean|65.5|65.5|Standard Deviation|15.1|15.1|||
3638217|NCT02534129|3486166|B1|Participants|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3638218|NCT02534129|3486166|B1|Participants|Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3638219|NCT02534129|3486166|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3638220|NCT02534129|3486166|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3638221|NCT02534129|3486166|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3638222|NCT02533999|3486173|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
3638223|NCT02533999|3486174|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3638224|NCT02533999|3486175|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
3638225|NCT02533999|3486173|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3638226|NCT02533999|3486174|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3638227|NCT02533999|3486175|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3638228|NCT02533999|3486173|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3638229|NCT02533999|3486174|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3638230|NCT02533999|3486175|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3638231|NCT02533999|3486173|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3638232|NCT02533999|3486174|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3638233|NCT02533999|3486175|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3638234|NCT02533999|3486173|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3638235|NCT02533999|3486174|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3638236|NCT02533999|3486175|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3638237|NCT02533999|3486173|B3||<=18 years|Age||Participants|Count of Participants|62|62.0||||||
3638238|NCT02533999|3486174|B2||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
3638239|NCT02533999|3486175|B1||<=18 years|Age||Participants|Count of Participants|32|32.0||||||
3638240|NCT02533726|3486194|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3638241|NCT02533726|3486195|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3638242|NCT02533726|3486196|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3638243|NCT02533726|3486194|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|996|996.0||||||
3638244|NCT02533726|3486195|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|458|458.0||||||
3638245|NCT02533726|3486196|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|538|538.0||||||
3638246|NCT02533726|3486194|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|195|195.0||||||
3638247|NCT02533726|3486195|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3638248|NCT02533726|3486196|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
3638249|NCT02533726|3486194|B3||Male|Sex: Female, Male||Participants|Count of Participants|675|675.0||||||
3638250|NCT02533726|3486195|B2||Male|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
3638251|NCT02533726|3486196|B1||Male|Sex: Female, Male||Participants|Count of Participants|373|373.0||||||
3638252|NCT02533726|3486194|B3||Female|Sex: Female, Male||Participants|Count of Participants|551|551.0||||||
3638253|NCT02533726|3486195|B2||Female|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
3638254|NCT02533726|3486196|B1||Female|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
3638255|NCT02533726|3486194|B3|||Age||years|Mean|60|60.0|Standard Deviation|17|17.0|||
3638256|NCT02533726|3486195|B2|||Age||years|Mean|60|60.0|Standard Deviation|18|18.0|||
3638257|NCT02533726|3486196|B1|||Age||years|Mean|60|60.0|Standard Deviation|17|17.0|||
3638258|NCT02533570|3486205|B4|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3638259|NCT02533570|3486206|B3|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3638260|NCT02533570|3486207|B2|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3638261|NCT02533570|3486208|B1|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3638262|NCT02533570|3486205|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638263|NCT02533570|3486206|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638264|NCT02533570|3486207|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638265|NCT02533570|3486208|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638266|NCT02533570|3486205|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638267|NCT02533570|3486206|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638268|NCT02533570|3486207|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638269|NCT02533570|3486208|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638270|NCT02533570|3486205|B4||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3638271|NCT02533570|3486206|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3638272|NCT02533570|3486207|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3638273|NCT02533570|3486208|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3638274|NCT02533570|3486205|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3638275|NCT02533570|3486206|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3638276|NCT02533570|3486207|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3638277|NCT02533570|3486208|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3638278|NCT02533570|3486205|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638279|NCT02533570|3486206|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638280|NCT02533570|3486207|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638281|NCT02533570|3486208|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638282|NCT02533570|3486205|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638283|NCT02533570|3486206|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638284|NCT02533570|3486207|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638285|NCT02533570|3486208|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638286|NCT02533570|3486205|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3638287|NCT02533570|3486206|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638288|NCT02533570|3486207|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3638289|NCT02533570|3486208|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638290|NCT02533570|3486205|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638291|NCT02533570|3486206|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638292|NCT02533570|3486207|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638293|NCT02533570|3486208|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638294|NCT02533570|3486205|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3638295|NCT02533570|3486206|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3638296|NCT02533570|3486207|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3638297|NCT02533570|3486208|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3638298|NCT02533570|3486205|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3638299|NCT02533570|3486206|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3638300|NCT02533570|3486207|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638301|NCT02533570|3486208|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3638302|NCT02533570|3486205|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3638303|NCT02533570|3486206|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3638304|NCT02533570|3486207|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3638305|NCT02533570|3486208|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3638306|NCT02533570|3486205|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3638307|NCT02533570|3486206|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3638308|NCT02533570|3486207|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3638309|NCT02533570|3486208|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3638310|NCT02533570|3486205|B4|||Age||years|Mean|47.4|47.4|Standard Deviation|11.78|11.78|||
3638311|NCT02533570|3486206|B3|||Age||years|Mean|45.0|45.0|Standard Deviation|11.20|11.2|||
3638312|NCT02533570|3486207|B2|||Age||years|Mean|50.8|50.8|Standard Deviation|14.06|14.06|||
3638313|NCT02533570|3486208|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|8.66|8.66|||
3638314|NCT02533531|3486221|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3638315|NCT02533531|3486221|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3638316|NCT02533531|3486221|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3638317|NCT02533505|3486226|B1|White||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
3638318|NCT02533505|3486226|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3638319|NCT02533505|3486226|B1|Black Or African American||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
3638320|NCT02533505|3486226|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3638321|NCT02533505|3486226|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3638322|NCT02533505|3486226|B1|>=65||Age, Customized||Participants|Number|21|21.0||||||
3638323|NCT02533505|3486226|B1|>=50 - <65||Age, Customized||Participants|Number|27|27.0||||||
3638324|NCT02533505|3486226|B1|<50||Age, Customized||Participants|Number|3|3.0||||||
3638325|NCT02533505|3486226|B1|||Age||Years|Mean|62.9|62.9|Standard Deviation|8.32|8.32|45.0|79.0|
3638326|NCT02533466|3486257|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3638327|NCT02533466|3486258|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3638328|NCT02533466|3486259|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3638329|NCT02533466|3486257|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3638330|NCT02533466|3486258|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3638331|NCT02533466|3486259|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3638332|NCT02533466|3486257|B3|||Age||Years|Mean|37.1|37.1|Standard Deviation|11.51|11.51|||
3638333|NCT02533466|3486258|B2|||Age||Years|Mean|38.1|38.1|Standard Deviation|12.21|12.21|||
3638334|NCT02533466|3486259|B1|||Age||Years|Mean|36.1|36.1|Standard Deviation|11.17|11.17|||
3638335|NCT02533401|3486284|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3638337|NCT02533401|3486284|B1|||Age||years|Mean|60.3|60.3|Standard Deviation|8.8|8.8|||
3638338|NCT02533258|3486292|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3638339|NCT02533258|3486292|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3638340|NCT02533258|3486292|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3638341|NCT02533258|3486292|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3638342|NCT02533258|3486292|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3638343|NCT02533167|3486304|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
3638344|NCT02533167|3486304|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3638345|NCT02533167|3486304|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3638346|NCT02533167|3486304|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3638347|NCT02533167|3486304|B1||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
3638348|NCT02533167|3486304|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3638349|NCT02532998|3486313|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3638350|NCT02532998|3486313|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3638351|NCT02532998|3486313|B1|||Age||years|Mean|36|36.0|Standard Deviation|8|8.0|||
3638352|NCT02532855|3486395|B3|||Insulin AUC0-120 minutes to Glucagon AUC0-120 minutes Ratio|The insulin to glucagon AUC ratio endpoint was analyzed for participants who underwent the 3-point MMTT. Blood samples were drawn immediately prior to (T-0) and 60 (T-60) and 120 minutes (T-120) after a standard meal. The AUC curve was generated with the 3 time points|Ratio|Mean|3.8|3.8|Standard Deviation|3.4|3.4|||
3638353|NCT02532855|3486396|B2|||Insulin AUC0-120 minutes to Glucagon AUC0-120 minutes Ratio|The insulin to glucagon AUC ratio endpoint was analyzed for participants who underwent the 3-point MMTT. Blood samples were drawn immediately prior to (T-0) and 60 (T-60) and 120 minutes (T-120) after a standard meal. The AUC curve was generated with the 3 time points|Ratio|Mean|3.5|3.5|Standard Deviation|3.0|3.0|||
3638354|NCT02532855|3486397|B1|||Insulin AUC0-120 minutes to Glucagon AUC0-120 minutes Ratio|The insulin to glucagon AUC ratio endpoint was analyzed for participants who underwent the 3-point MMTT. Blood samples were drawn immediately prior to (T-0) and 60 (T-60) and 120 minutes (T-120) after a standard meal. The AUC curve was generated with the 3 time points|Ratio|Mean|4.0|4.0|Standard Deviation|3.7|3.7|||
3638355|NCT02532855|3486395|B3|||Insulin AUC0-120 minutes|The insulin area under the curve AUC endpoints were analyzed for participants who underwent the 3-point MMTT. Blood samples were drawn immediately prior to (T-0) and 60 (T-60) and 120 minutes (T-120) after a standard meal. The AUC curve was generated with the 3 time points.|mIU.hr/L|Mean|147.5|147.5|Standard Deviation|108.7|108.7|||
3638356|NCT02532855|3486396|B2|||Insulin AUC0-120 minutes|The insulin area under the curve AUC endpoints were analyzed for participants who underwent the 3-point MMTT. Blood samples were drawn immediately prior to (T-0) and 60 (T-60) and 120 minutes (T-120) after a standard meal. The AUC curve was generated with the 3 time points.|mIU.hr/L|Mean|139.9|139.9|Standard Deviation|93.5|93.5|||
3638357|NCT02532855|3486397|B1|||Insulin AUC0-120 minutes|The insulin area under the curve AUC endpoints were analyzed for participants who underwent the 3-point MMTT. Blood samples were drawn immediately prior to (T-0) and 60 (T-60) and 120 minutes (T-120) after a standard meal. The AUC curve was generated with the 3 time points.|mIU.hr/L|Mean|155.0|155.0|Standard Deviation|121.8|121.8|||
3638358|NCT02532855|3486395|B3|||Glucagon Area Under the Curve (AUC0-120 minutes)|The glucagon area under the curve AUC endpoints were analyzed for participants who underwent the 3-point MMTT. Blood samples were drawn immediately prior to (T-0) and 60 (T-60) and 120 minutes (T-120) after a standard meal. The AUC curve was generated with the 3 time points.|pmol.hr/L|Mean|50.7|50.7|Standard Deviation|44.8|44.8|||
3638359|NCT02532855|3486396|B2|||Glucagon Area Under the Curve (AUC0-120 minutes)|The glucagon area under the curve AUC endpoints were analyzed for participants who underwent the 3-point MMTT. Blood samples were drawn immediately prior to (T-0) and 60 (T-60) and 120 minutes (T-120) after a standard meal. The AUC curve was generated with the 3 time points.|pmol.hr/L|Mean|51.8|51.8|Standard Deviation|45.1|45.1|||
3638360|NCT02532855|3486397|B1|||Glucagon Area Under the Curve (AUC0-120 minutes)|The glucagon area under the curve AUC endpoints were analyzed for participants who underwent the 3-point MMTT. Blood samples were drawn immediately prior to (T-0) and 60 (T-60) and 120 minutes (T-120) after a standard meal. The AUC curve was generated with the 3 time points.|pmol.hr/L|Mean|49.6|49.6|Standard Deviation|44.7|44.7|||
3638361|NCT02532855|3486395|B3|||2-hr Postprandial Glucose|The 2-hour postprandial glucose was analyzed for participants who underwent the 2-point or 3-point MMTT. Blood samples were drawn immediately prior to (T-0) and 60 (T-60) and 120 minutes (T-120) after a standard meal.|mg/dL|Mean|258.8|258.8|Standard Deviation|65.7|65.7|||
3638362|NCT02532855|3486396|B2|||2-hr Postprandial Glucose|The 2-hour postprandial glucose was analyzed for participants who underwent the 2-point or 3-point MMTT. Blood samples were drawn immediately prior to (T-0) and 60 (T-60) and 120 minutes (T-120) after a standard meal.|mg/dL|Mean|259.9|259.9|Standard Deviation|64.4|64.4|||
3638363|NCT02532855|3486397|B1|||2-hr Postprandial Glucose|The 2-hour postprandial glucose was analyzed for participants who underwent the 2-point or 3-point MMTT. Blood samples were drawn immediately prior to (T-0) and 60 (T-60) and 120 minutes (T-120) after a standard meal.|mg/dL|Mean|257.7|257.7|Standard Deviation|67.1|67.1|||
3638364|NCT02532855|3486395|B3|||Incremental 2-hour Postprandial Glucose Excursion (PPGE)|The PPGE is the increment (mean increase) in glucose from T-0 (T=0 minutes) to T-120 (T=120 minutes) after eating the standard meal. The PPGE was analyzed for participants who underwent the 2-point or 3-point Mixed Meal Tolerance Test (MMTT). Blood samples were drawn immediately prior to (T-0) and 60 (T-60) and 120 minutes (T-120) after a standard meal.|mg/dL|Mean|95.9|95.9|Standard Deviation|51.4|51.4|||
3638365|NCT02532855|3486396|B2|||Incremental 2-hour Postprandial Glucose Excursion (PPGE)|The PPGE is the increment (mean increase) in glucose from T-0 (T=0 minutes) to T-120 (T=120 minutes) after eating the standard meal. The PPGE was analyzed for participants who underwent the 2-point or 3-point Mixed Meal Tolerance Test (MMTT). Blood samples were drawn immediately prior to (T-0) and 60 (T-60) and 120 minutes (T-120) after a standard meal.|mg/dL|Mean|95.7|95.7|Standard Deviation|47.1|47.1|||
3638366|NCT02532855|3486397|B1|||Incremental 2-hour Postprandial Glucose Excursion (PPGE)|The PPGE is the increment (mean increase) in glucose from T-0 (T=0 minutes) to T-120 (T=120 minutes) after eating the standard meal. The PPGE was analyzed for participants who underwent the 2-point or 3-point Mixed Meal Tolerance Test (MMTT). Blood samples were drawn immediately prior to (T-0) and 60 (T-60) and 120 minutes (T-120) after a standard meal.|mg/dL|Mean|96.2|96.2|Standard Deviation|55.3|55.3|||
3638367|NCT02532855|3486395|B3||Metformin and Sulfonylurea|Background Antihyperglycemic Agent (AHA)||Participants|Count of Participants|176|176.0||||||
3638368|NCT02532855|3486396|B2||Metformin and Sulfonylurea|Background Antihyperglycemic Agent (AHA)||Participants|Count of Participants|81|81.0||||||
3638369|NCT02532855|3486397|B1||Metformin and Sulfonylurea|Background Antihyperglycemic Agent (AHA)||Participants|Count of Participants|95|95.0||||||
3638370|NCT02532855|3486395|B3||Metformin Alone|Background Antihyperglycemic Agent (AHA)||Participants|Count of Participants|437|437.0||||||
3638371|NCT02532855|3486396|B2||Metformin Alone|Background Antihyperglycemic Agent (AHA)||Participants|Count of Participants|225|225.0||||||
3638372|NCT02532855|3486397|B1||Metformin Alone|Background Antihyperglycemic Agent (AHA)||Participants|Count of Participants|212|212.0||||||
3638373|NCT02532855|3486395|B3|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|163.8|163.8|Standard Deviation|40.5|40.5|||
3638374|NCT02532855|3486396|B2|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|165.2|165.2|Standard Deviation|40.6|40.6|||
3638375|NCT02532855|3486397|B1|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|162.3|162.3|Standard Deviation|40.4|40.4|||
3638376|NCT02532855|3486395|B3|||Hemoglobin A1C||Percent A1C|Mean|7.7|7.7|Standard Deviation|0.7|0.7|||
3638377|NCT02532855|3486396|B2|||Hemoglobin A1C||Percent A1C|Mean|7.8|7.8|Standard Deviation|0.7|0.7|||
3638378|NCT02532855|3486397|B1|||Hemoglobin A1C||Percent A1C|Mean|7.7|7.7|Standard Deviation|0.7|0.7|||
3638379|NCT02532855|3486395|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638380|NCT02532855|3486396|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638381|NCT02532855|3486397|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638382|NCT02532855|3486395|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3638383|NCT02532855|3486396|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3638384|NCT02532855|3486397|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3638385|NCT02532855|3486395|B3||White|Race (NIH/OMB)||Participants|Count of Participants|474|474.0||||||
3638386|NCT02532855|3486396|B2||White|Race (NIH/OMB)||Participants|Count of Participants|234|234.0||||||
3638387|NCT02532855|3486397|B1||White|Race (NIH/OMB)||Participants|Count of Participants|240|240.0||||||
3638388|NCT02532855|3486395|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3638389|NCT02532855|3486396|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3638390|NCT02532855|3486397|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3638391|NCT02532855|3486395|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3638392|NCT02532855|3486396|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3638393|NCT02532855|3486397|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638394|NCT02532855|3486395|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3638395|NCT02532855|3486396|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3638396|NCT02532855|3486397|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3638397|NCT02532855|3486395|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3638398|NCT02532855|3486396|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3638399|NCT02532855|3486397|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3638400|NCT02532855|3486395|B3||Male|Sex: Female, Male||Participants|Count of Participants|355|355.0||||||
3638401|NCT02532855|3486396|B2||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
3638402|NCT02532855|3486397|B1||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3638403|NCT02532855|3486395|B3||Female|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
3638404|NCT02532855|3486396|B2||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3638405|NCT02532855|3486397|B1||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3638406|NCT02532855|3486395|B3|||Age||Years|Mean|67.1|67.1|Standard Deviation|8.5|8.5|||
3638407|NCT02532855|3486396|B2|||Age||Years|Mean|66.6|66.6|Standard Deviation|8.6|8.6|||
3638408|NCT02532855|3486397|B1|||Age||Years|Mean|67.7|67.7|Standard Deviation|8.5|8.5|||
3638409|NCT02532374|3486422|B1|> 19 cig/day||Daily CC consumption at Screening||Participants|Count of Participants|6|6.0||||||
3638410|NCT02532374|3486422|B1|10 to 19 cig/day||Daily CC consumption at Screening||Participants|Count of Participants|9|9.0||||||
3638411|NCT02532374|3486422|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3638412|NCT02532374|3486422|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3638413|NCT02532374|3486422|B1|||Age||years|Mean|39.8|39.8|Standard Deviation|13.83|13.83|||
3638414|NCT02532179|3486446|B1|||Mouse-Specific Serum Immunoglobulin G4 (IgG4) Levels|Serum Immunoglobulin G4 (IgG4) is a certain subtype of antibody produced by the immune system. If a participant has bacterial or viral infections, the immune system will respond to that particular infection by producing antibodies called IgG4. We collect mouse-specific serum IgG4 at baseline and compare with post-baseline IgG4 in order to determine immune modulation over time. The higher the IgG4 present in the serum sample, the more likely there is to be a presence of a clinical allergy to the mouse allergen.|kU/L|Geometric Least Squares Mean|0.08|0.08|Standard Deviation|0.35|0.35|||
3638415|NCT02532179|3486446|B1|||Mouse-Specific Serum Immunoglobulin G (IgG) Levels|Serum Immunoglobulin G (IgG) is an antibody produced by the immune system. If a participant has bacterial or viral infections, the immune system will respond to that particular infection by producing antibodies called IgG. We collect mouse-specific serum IgG at baseline and compare with post-baseline IgG in order to determine immune modulation over time. The higher the IgG present in the serum sample, the more likely there is to be a presence of a clinical allergy to the mouse allergen.|kU/L|Geometric Least Squares Mean|1.23|1.23|Standard Deviation|0.20|0.2|||
3638416|NCT02532179|3486446|B1|||Mouse-Specific Serum Immunoglobulin E (IgE) Levels|Serum Immunoglobulin E (IgE) is an antibody produced by the immune system. If a participant has an allergy, the immune system will respond to that particular allergen by producing antibodies called IgE. These antibodies travel to cells that release chemicals, which cause allergic reactions. We collect mouse-specific serum IgE at baseline and compare with post-baseline IgE in order to determine immune modulation over time. The higher the IgE present in the serum sample, the more likely there is to be a presence of a clinical allergy to the mouse allergen.|kU/L|Geometric Least Squares Mean|2.34|2.34|Standard Deviation|0.45|0.45|||
3638417|NCT02532179|3486446|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3638418|NCT02532179|3486446|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638419|NCT02532179|3486446|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3638420|NCT02532179|3486446|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3638421|NCT02532179|3486446|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3638422|NCT02532179|3486446|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638423|NCT02532179|3486446|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638424|NCT02532179|3486446|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638425|NCT02532179|3486446|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638426|NCT02532179|3486446|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3638427|NCT02532179|3486446|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3638428|NCT02532179|3486446|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3638429|NCT02532179|3486446|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3638430|NCT02532179|3486446|B1|||Age||years|Mean|27.3|27.3|Standard Deviation|7.54|7.54|||
3638431|NCT02532179|3486446|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3638432|NCT02532179|3486446|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3638433|NCT02532179|3486446|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3638434|NCT02532010|3486455|B3|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3638435|NCT02532010|3486456|B2|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3638436|NCT02532010|3486457|B1|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3638437|NCT02532010|3486455|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3638438|NCT02532010|3486456|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3638439|NCT02532010|3486457|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638440|NCT02532010|3486455|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638441|NCT02532010|3486456|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638442|NCT02532010|3486457|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638443|NCT02532010|3486455|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3638444|NCT02532010|3486456|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3638445|NCT02532010|3486457|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3638446|NCT02532010|3486455|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3638447|NCT02532010|3486456|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638448|NCT02532010|3486457|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3638449|NCT02532010|3486455|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638450|NCT02532010|3486456|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638451|NCT02532010|3486457|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638452|NCT02532010|3486455|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638453|NCT02532010|3486456|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638454|NCT02532010|3486457|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638455|NCT02532010|3486455|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638456|NCT02532010|3486456|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638457|NCT02532010|3486457|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638458|NCT02532010|3486455|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3638459|NCT02532010|3486456|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3638460|NCT02532010|3486457|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3638461|NCT02532010|3486455|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3638462|NCT02532010|3486456|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3638463|NCT02532010|3486457|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3638464|NCT02532010|3486455|B3|||Age||years|Median|75|75.0|Full Range|||68.0|84.0|
3638465|NCT02532010|3486456|B2|||Age||years|Median|73|73.0|Full Range|||68.0|75.0|
3638466|NCT02532010|3486457|B1|||Age||years|Median|76|76.0|Full Range|||70.0|84.0|
3638467|NCT02532010|3486455|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3638468|NCT02532010|3486456|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3638469|NCT02532010|3486457|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3638470|NCT02532010|3486455|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3638471|NCT02532010|3486456|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3638472|NCT02532010|3486457|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3638473|NCT02532010|3486455|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3638474|NCT02532010|3486456|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3638475|NCT02532010|3486457|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3638476|NCT02531867|3486476|B1|Japan||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3638477|NCT02531867|3486476|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638478|NCT02531867|3486476|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3638479|NCT02531867|3486476|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638480|NCT02531867|3486476|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638481|NCT02531867|3486476|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638482|NCT02531867|3486476|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3638483|NCT02531867|3486476|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638484|NCT02531867|3486476|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3638485|NCT02531867|3486476|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638486|NCT02531867|3486476|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638487|NCT02531867|3486476|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3638488|NCT02531867|3486476|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3638489|NCT02531867|3486476|B1|||Age||years|Median|1.39|1.39|Full Range|||0.13|35.04|
3638490|NCT02531867|3486476|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3638491|NCT02531867|3486476|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3638492|NCT02531867|3486476|B1||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
3638493|NCT02531802|3486480|B22|||Weight||kilograms|Mean|14.2|14.2|Standard Deviation|14.3|14.3|||
3638494|NCT02531802|3486481|B21|||Weight||kilograms|Mean|7.76|7.76|Standard Deviation|0.598|0.598|||
3638495|NCT02531802|3486482|B20|||Weight||kilograms|Mean|7.41|7.41|Standard Deviation|0.876|0.876|||
3638496|NCT02531802|3486483|B19|||Weight||kilograms|Mean|7.85|7.85|Standard Deviation|1.226|1.226|||
3638497|NCT02531802|3486484|B18|||Weight||kilograms|Mean|7.37|7.37|Standard Deviation|0.728|0.728|||
3638498|NCT02531802|3486485|B17|||Weight||kilograms|Mean|7.84|7.84|Standard Deviation|1.006|1.006|||
3638499|NCT02531802|3486486|B16|||Weight||kilograms|Mean|7.66|7.66|Standard Deviation|0.958|0.958|||
3638500|NCT02531802|3486487|B15|||Weight||kilograms|Mean|9.24|9.24|Standard Deviation|0.998|0.998|||
3638501|NCT02531802|3486488|B14|||Weight||kilograms|Mean|9.5|9.5|Standard Deviation|1.271|1.271|||
3638502|NCT02531802|3486489|B13|||Weight||kilograms|Mean|9.64|9.64|Standard Deviation|0.946|0.946|||
3638503|NCT02531802|3486490|B12|||Weight||kilograms|Mean|9.23|9.23|Standard Deviation|0.959|0.959|||
3638504|NCT02531802|3486491|B11|||Weight||kilograms|Mean|9.47|9.47|Standard Deviation|1.226|1.226|||
3638505|NCT02531802|3486492|B10|||Weight||kilograms|Mean|12.61|12.61|Standard Deviation|1.936|1.936|||
3638506|NCT02531802|3486493|B9|||Weight||kilograms|Mean|13.35|13.35|Standard Deviation|1.957|1.957|||
3638507|NCT02531802|3486494|B8|||Weight||kilograms|Mean|12.1|12.1|Standard Deviation|1.465|1.465|||
3638508|NCT02531802|3486495|B7|||Weight||kilograms|Mean|12.43|12.43|Standard Deviation|0.513|0.513|||
3638509|NCT02531802|3486496|B6|||Weight||kilograms|Mean|13.61|13.61|Standard Deviation|1.914|1.914|||
3638510|NCT02531802|3486497|B5|||Weight||kilograms|Mean|13.59|13.59|Standard Deviation|1.488|1.488|||
3638511|NCT02531802|3486498|B4|||Weight||kilograms|Mean|13.71|13.71|Standard Deviation|2.043|2.043|||
3638512|NCT02531802|3486499|B3|||Weight||kilograms|Mean|55.25|55.25|Standard Deviation|11.441|11.441|||
3638513|NCT02531802|3486500|B2|||Weight||kilograms|Mean|56.86|56.86|Standard Deviation|11.776|11.776|||
3638514|NCT02531802|3486501|B1|||Weight||kilograms|Mean|56.65|56.65|Standard Deviation|9.867|9.867|||
3638515|NCT02531802|3486480|B22|||Height||centimeters|Mean|85.6|85.6|Standard Deviation|25.6|25.6|||
3638516|NCT02531802|3486481|B21|||Height||centimeters|Mean|67.57|67.57|Standard Deviation|2.58|2.58|||
3638517|NCT02531802|3486482|B20|||Height||centimeters|Mean|66.73|66.73|Standard Deviation|3.14|3.14|||
3638518|NCT02531802|3486483|B19|||Height||centimeters|Mean|68.83|68.83|Standard Deviation|3.04|3.04|||
3638519|NCT02531802|3486484|B18|||Height||centimeters|Mean|67.77|67.77|Standard Deviation|3.45|3.45|||
3638520|NCT02531802|3486485|B17|||Height||centimeters|Mean|68.83|68.83|Standard Deviation|3.04|3.04|||
3638521|NCT02531802|3486486|B16|||Height||centimeters|Mean|67.64|67.64|Standard Deviation|3.44|3.44|||
3638522|NCT02531802|3486487|B15|||Height||centimeters|Mean|76.6|76.6|Standard Deviation|2.59|2.59|||
3638523|NCT02531802|3486488|B14|||Height||centimeters|Mean|79.2|79.2|Standard Deviation|4.69|4.69|||
3638524|NCT02531802|3486489|B13|||Height||centimeters|Mean|79.33|79.33|Standard Deviation|4.27|4.27|||
3638525|NCT02531802|3486490|B12|||Height||centimeters|Mean|76.27|76.27|Standard Deviation|2.99|2.99|||
3638526|NCT02531802|3486491|B11|||Height||centimeters|Mean|77.83|77.83|Standard Deviation|4.60|4.6|||
3638527|NCT02531802|3486492|B10|||Height||centimeters|Mean|92.2|92.2|Standard Deviation|6.59|6.59|||
3638528|NCT02531802|3486493|B9|||Height||centimeters|Mean|94.13|94.13|Standard Deviation|7.27|7.27|||
3638529|NCT02531802|3486494|B8|||Height||centimeters|Mean|90.33|90.33|Standard Deviation|6.11|6.11|||
3638530|NCT02531802|3486495|B7|||Height||centimeters|Mean|96.67|96.67|Standard Deviation|2.52|2.52|||
3638531|NCT02531802|3486496|B6|||Height||centimeters|Mean|93.73|93.73|Standard Deviation|7.08|7.08|||
3638532|NCT02531802|3486497|B5|||Height||centimeters|Mean|97.73|97.73|Standard Deviation|5.33|5.33|||
3638533|NCT02531802|3486498|B4|||Height||centimeters|Mean|97.02|97.02|Standard Deviation|6.84|6.84|||
3638534|NCT02531802|3486499|B3|||Height||centimeters|Mean|154.26|154.26|Standard Deviation|10.16|10.16|||
3638535|NCT02531802|3486500|B2|||Height||centimeters|Mean|155.29|155.29|Standard Deviation|9.38|9.38|||
3638536|NCT02531802|3486501|B1|||Height||centimeters|Mean|154.69|154.69|Standard Deviation|8.01|8.01|||
3638537|NCT02531802|3486480|B22||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638538|NCT02531802|3486481|B21||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638539|NCT02531802|3486482|B20||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638540|NCT02531802|3486483|B19||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638541|NCT02531802|3486484|B18||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638542|NCT02531802|3486485|B17||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638543|NCT02531802|3486486|B16||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638544|NCT02531802|3486487|B15||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638545|NCT02531802|3486488|B14||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638546|NCT02531802|3486489|B13||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638547|NCT02531802|3486490|B12||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638548|NCT02531802|3486491|B11||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638549|NCT02531802|3486492|B10||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638550|NCT02531802|3486493|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638551|NCT02531802|3486494|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638552|NCT02531802|3486495|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638553|NCT02531802|3486496|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638554|NCT02531802|3486497|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638555|NCT02531802|3486498|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638556|NCT02531802|3486499|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638557|NCT02531802|3486500|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638558|NCT02531802|3486501|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638559|NCT02531802|3486480|B22||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638560|NCT02531802|3486481|B21||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638561|NCT02531802|3486482|B20||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638562|NCT02531802|3486483|B19||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638563|NCT02531802|3486484|B18||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638564|NCT02531802|3486485|B17||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638565|NCT02531802|3486486|B16||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638566|NCT02531802|3486487|B15||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638567|NCT02531802|3486488|B14||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638568|NCT02531802|3486489|B13||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638569|NCT02531802|3486490|B12||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638570|NCT02531802|3486491|B11||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638571|NCT02531802|3486492|B10||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638572|NCT02531802|3486493|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638573|NCT02531802|3486494|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638574|NCT02531802|3486495|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638575|NCT02531802|3486496|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638576|NCT02531802|3486497|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638577|NCT02531802|3486498|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638578|NCT02531802|3486499|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638579|NCT02531802|3486500|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638580|NCT02531802|3486501|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638581|NCT02531802|3486480|B22||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638582|NCT02531802|3486481|B21||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638583|NCT02531802|3486482|B20||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638584|NCT02531802|3486483|B19||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638585|NCT02531802|3486484|B18||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638586|NCT02531802|3486485|B17||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638587|NCT02531802|3486486|B16||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638588|NCT02531802|3486487|B15||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638589|NCT02531802|3486488|B14||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638590|NCT02531802|3486489|B13||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638591|NCT02531802|3486490|B12||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638592|NCT02531802|3486491|B11||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638593|NCT02531802|3486492|B10||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638594|NCT02531802|3486493|B9||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638595|NCT02531802|3486494|B8||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638596|NCT02531802|3486495|B7||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638597|NCT02531802|3486496|B6||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638598|NCT02531802|3486497|B5||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638599|NCT02531802|3486498|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638600|NCT02531802|3486499|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638601|NCT02531802|3486500|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638602|NCT02531802|3486501|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638603|NCT02531802|3486480|B22||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638604|NCT02531802|3486481|B21||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638605|NCT02531802|3486482|B20||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638606|NCT02531802|3486483|B19||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638607|NCT02531802|3486484|B18||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638608|NCT02531802|3486485|B17||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638609|NCT02531802|3486486|B16||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638610|NCT02531802|3486487|B15||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638611|NCT02531802|3486488|B14||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638612|NCT02531802|3486489|B13||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638613|NCT02531802|3486490|B12||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638614|NCT02531802|3486491|B11||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638615|NCT02531802|3486492|B10||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638616|NCT02531802|3486493|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638617|NCT02531802|3486494|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638618|NCT02531802|3486495|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638619|NCT02531802|3486496|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638620|NCT02531802|3486497|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638621|NCT02531802|3486498|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638622|NCT02531802|3486499|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638623|NCT02531802|3486500|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638624|NCT02531802|3486501|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638625|NCT02531802|3486480|B22||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638626|NCT02531802|3486481|B21||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638627|NCT02531802|3486482|B20||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638628|NCT02531802|3486483|B19||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638629|NCT02531802|3486484|B18||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638630|NCT02531802|3486485|B17||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638631|NCT02531802|3486486|B16||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638632|NCT02531802|3486487|B15||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638633|NCT02531802|3486488|B14||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638634|NCT02531802|3486489|B13||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638635|NCT02531802|3486490|B12||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638636|NCT02531802|3486491|B11||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638637|NCT02531802|3486492|B10||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638638|NCT02531802|3486493|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638639|NCT02531802|3486494|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638640|NCT02531802|3486495|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638641|NCT02531802|3486496|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638642|NCT02531802|3486497|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638643|NCT02531802|3486498|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638644|NCT02531802|3486499|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638645|NCT02531802|3486500|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638646|NCT02531802|3486501|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638647|NCT02531802|3486480|B22||Asian|Race (NIH/OMB)||Participants|Count of Participants|475|475.0||||||
3638648|NCT02531802|3486481|B21||Asian|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3638649|NCT02531802|3486482|B20||Asian|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3638650|NCT02531802|3486483|B19||Asian|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3638651|NCT02531802|3486484|B18||Asian|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3638652|NCT02531802|3486485|B17||Asian|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3638653|NCT02531802|3486486|B16||Asian|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3638654|NCT02531802|3486487|B15||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3638655|NCT02531802|3486488|B14||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3638656|NCT02531802|3486489|B13||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3638657|NCT02531802|3486490|B12||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3638658|NCT02531802|3486491|B11||Asian|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3638659|NCT02531802|3486492|B10||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3638660|NCT02531802|3486493|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3638661|NCT02531802|3486494|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3638662|NCT02531802|3486495|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3638663|NCT02531802|3486496|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3638664|NCT02531802|3486497|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3638665|NCT02531802|3486498|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3638666|NCT02531802|3486499|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3638667|NCT02531802|3486500|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3638668|NCT02531802|3486501|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3638669|NCT02531802|3486480|B22||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638670|NCT02531802|3486481|B21||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638671|NCT02531802|3486482|B20||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638672|NCT02531802|3486483|B19||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638673|NCT02531802|3486484|B18||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638674|NCT02531802|3486485|B17||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638675|NCT02531802|3486486|B16||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638676|NCT02531802|3486487|B15||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638677|NCT02531802|3486488|B14||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638678|NCT02531802|3486489|B13||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638679|NCT02531802|3486490|B12||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638680|NCT02531802|3486491|B11||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638681|NCT02531802|3486492|B10||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638682|NCT02531802|3486493|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638683|NCT02531802|3486494|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638684|NCT02531802|3486495|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638685|NCT02531802|3486496|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638686|NCT02531802|3486497|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638687|NCT02531802|3486498|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638688|NCT02531802|3486499|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638689|NCT02531802|3486500|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638690|NCT02531802|3486501|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638691|NCT02531802|3486480|B22||Male|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
3638692|NCT02531802|3486481|B21||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3638693|NCT02531802|3486482|B20||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3638694|NCT02531802|3486483|B19||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3638695|NCT02531802|3486484|B18||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3638696|NCT02531802|3486485|B17||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3638697|NCT02531802|3486486|B16||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3638698|NCT02531802|3486487|B15||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3638699|NCT02531802|3486488|B14||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3638700|NCT02531802|3486489|B13||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3638701|NCT02531802|3486490|B12||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3638702|NCT02531802|3486491|B11||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3638703|NCT02531802|3486492|B10||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3638704|NCT02531802|3486493|B9||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3638705|NCT02531802|3486494|B8||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3638706|NCT02531802|3486495|B7||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3638707|NCT02531802|3486496|B6||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3638708|NCT02531802|3486497|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3638709|NCT02531802|3486498|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3638710|NCT02531802|3486499|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3638711|NCT02531802|3486500|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3638712|NCT02531802|3486501|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3638713|NCT02531802|3486480|B22||Female|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
3638714|NCT02531802|3486481|B21||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3638715|NCT02531802|3486482|B20||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3638716|NCT02531802|3486483|B19||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3638717|NCT02531802|3486484|B18||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3638718|NCT02531802|3486485|B17||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3638719|NCT02531802|3486486|B16||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3638720|NCT02531802|3486487|B15||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3638721|NCT02531802|3486488|B14||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3638722|NCT02531802|3486489|B13||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3638723|NCT02531802|3486490|B12||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3638724|NCT02531802|3486491|B11||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3638725|NCT02531802|3486492|B10||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3638726|NCT02531802|3486493|B9||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3638727|NCT02531802|3486494|B8||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3638728|NCT02531802|3486495|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3638729|NCT02531802|3486496|B6||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3638730|NCT02531802|3486497|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3638731|NCT02531802|3486498|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3638732|NCT02531802|3486499|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3638733|NCT02531802|3486500|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3638734|NCT02531802|3486501|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3638735|NCT02531802|3486480|B22|||Age||years|Mean|4.4|4.4|Standard Deviation|8.7|8.7|||
3638736|NCT02531802|3486481|B21|||Age||years|Mean|0.6|0.6|Standard Deviation|0.10|0.1|||
3638737|NCT02531802|3486482|B20|||Age||years|Mean|0.7|0.7|Standard Deviation|0.15|0.15|||
3638738|NCT02531802|3486483|B19|||Age||years|Mean|0.7|0.7|Standard Deviation|0.11|0.11|||
3638739|NCT02531802|3486484|B18|||Age||years|Mean|0.7|0.7|Standard Deviation|0.14|0.14|||
3638740|NCT02531802|3486485|B17|||Age||years|Mean|0.7|0.7|Standard Deviation|0.15|0.15|||
3638741|NCT02531802|3486486|B16|||Age||years|Mean|0.7|0.7|Standard Deviation|0.13|0.13|||
3638742|NCT02531802|3486487|B15|||Age||years|Mean|1.4|1.4|Standard Deviation|0.27|0.27|||
3638743|NCT02531802|3486488|B14|||Age||years|Mean|1.6|1.6|Standard Deviation|0.28|0.28|||
3638744|NCT02531802|3486489|B13|||Age||years|Mean|1.5|1.5|Standard Deviation|0.30|0.3|||
3638745|NCT02531802|3486490|B12|||Age||years|Mean|1.3|1.3|Standard Deviation|0.21|0.21|||
3638746|NCT02531802|3486491|B11|||Age||years|Mean|1.4|1.4|Standard Deviation|0.27|0.27|||
3638747|NCT02531802|3486492|B10|||Age||years|Mean|3.4|3.4|Standard Deviation|0.73|0.73|||
3638748|NCT02531802|3486493|B9|||Age||years|Mean|3.6|3.6|Standard Deviation|0.91|0.91|||
3638749|NCT02531802|3486494|B8|||Age||years|Mean|3.4|3.4|Standard Deviation|0.86|0.86|||
3638750|NCT02531802|3486495|B7|||Age||years|Mean|4.2|4.2|Standard Deviation|0.59|0.59|||
3638751|NCT02531802|3486496|B6|||Age||years|Mean|3.4|3.4|Standard Deviation|0.68|0.68|||
3638752|NCT02531802|3486497|B5|||Age||years|Mean|4.1|4.1|Standard Deviation|0.62|0.62|||
3638753|NCT02531802|3486498|B4|||Age||years|Mean|3.7|3.7|Standard Deviation|0.77|0.77|||
3638754|NCT02531802|3486499|B3|||Age||years|Mean|29.4|29.4|Standard Deviation|6.96|6.96|||
3638755|NCT02531802|3486500|B2|||Age||years|Mean|30.1|30.1|Standard Deviation|6.96|6.96|||
3638756|NCT02531802|3486501|B1|||Age||years|Mean|31.5|31.5|Standard Deviation|5.58|5.58|||
3638757|NCT02531698|3486951|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3638758|NCT02531698|3486952|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3638759|NCT02531698|3486953|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3638760|NCT02531698|3486951|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638761|NCT02531698|3486952|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638762|NCT02531698|3486953|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638763|NCT02531698|3486951|B3||White|Race (NIH/OMB)||Participants|Count of Participants|395|395.0||||||
3638764|NCT02531698|3486952|B2||White|Race (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
3638765|NCT02531698|3486953|B1||White|Race (NIH/OMB)||Participants|Count of Participants|291|291.0||||||
3638766|NCT02531698|3486951|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638767|NCT02531698|3486952|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638768|NCT02531698|3486953|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638769|NCT02531698|3486951|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638770|NCT02531698|3486952|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638771|NCT02531698|3486953|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638772|NCT02531698|3486951|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638773|NCT02531698|3486952|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638774|NCT02531698|3486953|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638775|NCT02531698|3486951|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638776|NCT02531698|3486952|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638777|NCT02531698|3486953|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638778|NCT02531698|3486951|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638779|NCT02531698|3486952|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638780|NCT02531698|3486953|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638781|NCT02531698|3486951|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|400|400.0||||||
3638782|NCT02531698|3486952|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
3638783|NCT02531698|3486953|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|294|294.0||||||
3638784|NCT02531698|3486951|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638785|NCT02531698|3486952|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638786|NCT02531698|3486953|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638787|NCT02531698|3486951|B3||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
3638788|NCT02531698|3486952|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3638789|NCT02531698|3486953|B1||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3638790|NCT02531698|3486951|B3||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
3638791|NCT02531698|3486952|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3638792|NCT02531698|3486953|B1||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3638793|NCT02531698|3486951|B3|||Age||years|Mean|4.3|4.3|Standard Deviation|2.21|2.21|||
3638794|NCT02531698|3486952|B2|||Age||years|Mean|4.2|4.2|Standard Deviation|2.15|2.15|||
3638795|NCT02531698|3486953|B1|||Age||years|Mean|4.3|4.3|Standard Deviation|2.24|2.24|||
3638796|NCT02531646|3487198|B4|unknown||Sex/Gender, Customized||participants|Number|66|66.0||||||
3638797|NCT02531646|3487199|B3|unknown||Sex/Gender, Customized||participants|Number|11|11.0||||||
3638798|NCT02531646|3487200|B2|unknown||Sex/Gender, Customized||participants|Number|18|18.0||||||
3638799|NCT02531646|3487201|B1|unknown||Sex/Gender, Customized||participants|Number|37|37.0||||||
3638800|NCT02531646|3487198|B4|> 18 years||Age, Customized||years|Number|66|66.0||||||
3638801|NCT02531646|3487199|B3|> 18 years||Age, Customized||years|Number|11|11.0||||||
3638802|NCT02531646|3487200|B2|> 18 years||Age, Customized||years|Number|18|18.0||||||
3638803|NCT02531646|3487201|B1|> 18 years||Age, Customized||years|Number|37|37.0||||||
3638804|NCT02531438|3487217|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3638805|NCT02531438|3487218|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3638806|NCT02531438|3487219|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3638807|NCT02531438|3487217|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638808|NCT02531438|3487218|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638809|NCT02531438|3487219|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638810|NCT02531438|3487217|B3||White|Race (NIH/OMB)||Participants|Count of Participants|711|711.0||||||
3638811|NCT02531438|3487218|B2||White|Race (NIH/OMB)||Participants|Count of Participants|355|355.0||||||
3638812|NCT02531438|3487219|B1||White|Race (NIH/OMB)||Participants|Count of Participants|356|356.0||||||
3638813|NCT02531438|3487217|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3638814|NCT02531438|3487218|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3638815|NCT02531438|3487219|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3638816|NCT02531438|3487217|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638817|NCT02531438|3487218|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638818|NCT02531438|3487219|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638819|NCT02531438|3487217|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3638820|NCT02531438|3487218|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3638821|NCT02531438|3487219|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3638822|NCT02531438|3487217|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3638823|NCT02531438|3487218|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3638824|NCT02531438|3487219|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638825|NCT02531438|3487217|B3||Male|Sex: Female, Male||Participants|Count of Participants|427|427.0||||||
3638826|NCT02531438|3487218|B2||Male|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
3638827|NCT02531438|3487219|B1||Male|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
3638828|NCT02531438|3487217|B3||Female|Sex: Female, Male||Participants|Count of Participants|347|347.0||||||
3638829|NCT02531438|3487218|B2||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3638830|NCT02531438|3487219|B1||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
3638831|NCT02531438|3487217|B3|>75 years old||Age, Customized||Participants|Count of Participants|158|158.0||||||
3638832|NCT02531438|3487218|B2|>75 years old||Age, Customized||Participants|Count of Participants|83|83.0||||||
3638833|NCT02531438|3487219|B1|>75 years old||Age, Customized||Participants|Count of Participants|75|75.0||||||
3638834|NCT02531438|3487217|B3|>65 years old||Age, Customized||Participants|Count of Participants|324|324.0||||||
3638835|NCT02531438|3487218|B2|>65 years old||Age, Customized||Participants|Count of Participants|172|172.0||||||
3638836|NCT02531438|3487219|B1|>65 years old||Age, Customized||Participants|Count of Participants|152|152.0||||||
3638837|NCT02531438|3487217|B3|>45 to 65 years old||Age, Customized||Participants|Count of Participants|327|327.0||||||
3638838|NCT02531438|3487218|B2|>45 to 65 years old||Age, Customized||Participants|Count of Participants|155|155.0||||||
3638839|NCT02531438|3487219|B1|>45 to 65 years old||Age, Customized||Participants|Count of Participants|172|172.0||||||
3638840|NCT02531438|3487217|B3|18 to 45 years old||Age, Customized||Participants|Count of Participants|123|123.0||||||
3638841|NCT02531438|3487218|B2|18 to 45 years old||Age, Customized||Participants|Count of Participants|61|61.0||||||
3638842|NCT02531438|3487219|B1|18 to 45 years old||Age, Customized||Participants|Count of Participants|62|62.0||||||
3638843|NCT02531373|3487230|B10||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638844|NCT02531373|3487231|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638845|NCT02531373|3487232|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638846|NCT02531373|3487233|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638847|NCT02531373|3487234|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638848|NCT02531373|3487235|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638849|NCT02531373|3487236|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638850|NCT02531373|3487237|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638851|NCT02531373|3487238|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638852|NCT02531373|3487239|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638853|NCT02531373|3487230|B10||More than one race|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3638854|NCT02531373|3487231|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3638855|NCT02531373|3487232|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3638856|NCT02531373|3487233|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3638857|NCT02531373|3487234|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3638858|NCT02531373|3487235|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3638859|NCT02531373|3487236|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638860|NCT02531373|3487237|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638861|NCT02531373|3487238|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638862|NCT02531373|3487239|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3638863|NCT02531373|3487230|B10||White|Race (NIH/OMB)||Participants|Count of Participants|264|264.0||||||
3638864|NCT02531373|3487231|B9||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3638865|NCT02531373|3487232|B8||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3638866|NCT02531373|3487233|B7||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3638867|NCT02531373|3487234|B6||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3638868|NCT02531373|3487235|B5||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3638869|NCT02531373|3487236|B4||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3638870|NCT02531373|3487237|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3638871|NCT02531373|3487238|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3638872|NCT02531373|3487239|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3638873|NCT02531373|3487230|B10||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3638874|NCT02531373|3487231|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3638875|NCT02531373|3487232|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3638876|NCT02531373|3487233|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3638877|NCT02531373|3487234|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3638878|NCT02531373|3487235|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3638879|NCT02531373|3487236|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3638880|NCT02531373|3487237|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3638881|NCT02531373|3487238|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3638882|NCT02531373|3487239|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3638883|NCT02531373|3487230|B10||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3638884|NCT02531373|3487231|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638885|NCT02531373|3487232|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638886|NCT02531373|3487233|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638887|NCT02531373|3487234|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3638888|NCT02531373|3487235|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638889|NCT02531373|3487236|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638890|NCT02531373|3487237|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638891|NCT02531373|3487238|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638892|NCT02531373|3487239|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638893|NCT02531373|3487230|B10||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3638894|NCT02531373|3487231|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638895|NCT02531373|3487232|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638896|NCT02531373|3487233|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3638897|NCT02531373|3487234|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638898|NCT02531373|3487235|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638899|NCT02531373|3487236|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3638900|NCT02531373|3487237|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638901|NCT02531373|3487238|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638902|NCT02531373|3487239|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638903|NCT02531373|3487230|B10||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638904|NCT02531373|3487231|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638905|NCT02531373|3487232|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638906|NCT02531373|3487233|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638907|NCT02531373|3487234|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638908|NCT02531373|3487235|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638909|NCT02531373|3487236|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638910|NCT02531373|3487237|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638911|NCT02531373|3487238|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638912|NCT02531373|3487239|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3638913|NCT02531373|3487230|B10||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3638914|NCT02531373|3487231|B9||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3638915|NCT02531373|3487232|B8||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3638916|NCT02531373|3487233|B7||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3638917|NCT02531373|3487234|B6||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3638918|NCT02531373|3487235|B5||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3638919|NCT02531373|3487236|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3638920|NCT02531373|3487237|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3638921|NCT02531373|3487238|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3638922|NCT02531373|3487239|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3638923|NCT02531373|3487230|B10||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3638924|NCT02531373|3487231|B9||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3638925|NCT02531373|3487232|B8||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3638926|NCT02531373|3487233|B7||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3638927|NCT02531373|3487234|B6||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3638928|NCT02531373|3487235|B5||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3638929|NCT02531373|3487236|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3638930|NCT02531373|3487237|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3638931|NCT02531373|3487238|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3638932|NCT02531373|3487239|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3638933|NCT02531373|3487230|B10||40 to 49 years|Age, Customized||Participants|Count of Participants|25|25.0||||||
3638934|NCT02531373|3487231|B9||40 to 49 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3638935|NCT02531373|3487232|B8||40 to 49 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3638936|NCT02531373|3487233|B7||40 to 49 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3638937|NCT02531373|3487234|B6||40 to 49 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3638938|NCT02531373|3487235|B5||40 to 49 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3638939|NCT02531373|3487236|B4||40 to 49 years|Age, Customized||Participants|Count of Participants|7|7.0||||||
3638940|NCT02531373|3487237|B3||40 to 49 years|Age, Customized||Participants|Count of Participants|7|7.0||||||
3638941|NCT02531373|3487238|B2||40 to 49 years|Age, Customized||Participants|Count of Participants|7|7.0||||||
3638942|NCT02531373|3487239|B1||40 to 49 years|Age, Customized||Participants|Count of Participants|4|4.0||||||
3638943|NCT02531373|3487230|B10||30 to 39 years|Age, Customized||Participants|Count of Participants|35|35.0||||||
3638944|NCT02531373|3487231|B9||30 to 39 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3638945|NCT02531373|3487232|B8||30 to 39 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3638946|NCT02531373|3487233|B7||30 to 39 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3638947|NCT02531373|3487234|B6||30 to 39 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3638948|NCT02531373|3487235|B5||30 to 39 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3638949|NCT02531373|3487236|B4||30 to 39 years|Age, Customized||Participants|Count of Participants|6|6.0||||||
3638950|NCT02531373|3487237|B3||30 to 39 years|Age, Customized||Participants|Count of Participants|10|10.0||||||
3638951|NCT02531373|3487238|B2||30 to 39 years|Age, Customized||Participants|Count of Participants|9|9.0||||||
3638952|NCT02531373|3487239|B1||30 to 39 years|Age, Customized||Participants|Count of Participants|10|10.0||||||
3638953|NCT02531373|3487230|B10||18 to 29 years|Age, Customized||Participants|Count of Participants|20|20.0||||||
3638954|NCT02531373|3487231|B9||18 to 29 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3638955|NCT02531373|3487232|B8||18 to 29 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3638956|NCT02531373|3487233|B7||18 to 29 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3638957|NCT02531373|3487234|B6||18 to 29 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3638958|NCT02531373|3487235|B5||18 to 29 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3638959|NCT02531373|3487236|B4||18 to 29 years|Age, Customized||Participants|Count of Participants|7|7.0||||||
3638960|NCT02531373|3487237|B3||18 to 29 years|Age, Customized||Participants|Count of Participants|3|3.0||||||
3638961|NCT02531373|3487238|B2||18 to 29 years|Age, Customized||Participants|Count of Participants|4|4.0||||||
3638962|NCT02531373|3487239|B1||18 to 29 years|Age, Customized||Participants|Count of Participants|6|6.0||||||
3638963|NCT02531373|3487230|B10||12 weeks|Age, Customized||Participants|Count of Participants|7|7.0||||||
3638964|NCT02531373|3487231|B9||12 weeks|Age, Customized||Participants|Count of Participants|1|1.0||||||
3638965|NCT02531373|3487232|B8||12 weeks|Age, Customized||Participants|Count of Participants|2|2.0||||||
3638966|NCT02531373|3487233|B7||12 weeks|Age, Customized||Participants|Count of Participants|1|1.0||||||
3638967|NCT02531373|3487234|B6||12 weeks|Age, Customized||Participants|Count of Participants|1|1.0||||||
3638968|NCT02531373|3487235|B5||12 weeks|Age, Customized||Participants|Count of Participants|2|2.0||||||
3638969|NCT02531373|3487236|B4||12 weeks|Age, Customized||Participants|Count of Participants|0|0.0||||||
3638970|NCT02531373|3487237|B3||12 weeks|Age, Customized||Participants|Count of Participants|0|0.0||||||
3638971|NCT02531373|3487238|B2||12 weeks|Age, Customized||Participants|Count of Participants|0|0.0||||||
3638972|NCT02531373|3487239|B1||12 weeks|Age, Customized||Participants|Count of Participants|0|0.0||||||
3638973|NCT02531373|3487230|B10||11 weeks|Age, Customized||Participants|Count of Participants|16|16.0||||||
3638974|NCT02531373|3487231|B9||11 weeks|Age, Customized||Participants|Count of Participants|4|4.0||||||
3638975|NCT02531373|3487232|B8||11 weeks|Age, Customized||Participants|Count of Participants|0|0.0||||||
3638976|NCT02531373|3487233|B7||11 weeks|Age, Customized||Participants|Count of Participants|6|6.0||||||
3638977|NCT02531373|3487234|B6||11 weeks|Age, Customized||Participants|Count of Participants|3|3.0||||||
3638978|NCT02531373|3487235|B5||11 weeks|Age, Customized||Participants|Count of Participants|3|3.0||||||
3638979|NCT02531373|3487236|B4||11 weeks|Age, Customized||Participants|Count of Participants|0|0.0||||||
3638980|NCT02531373|3487237|B3||11 weeks|Age, Customized||Participants|Count of Participants|0|0.0||||||
3638981|NCT02531373|3487238|B2||11 weeks|Age, Customized||Participants|Count of Participants|0|0.0||||||
3638982|NCT02531373|3487239|B1||11 weeks|Age, Customized||Participants|Count of Participants|0|0.0||||||
3638983|NCT02531373|3487230|B10||10 weeks|Age, Customized||Participants|Count of Participants|20|20.0||||||
3638984|NCT02531373|3487231|B9||10 weeks|Age, Customized||Participants|Count of Participants|2|2.0||||||
3638985|NCT02531373|3487232|B8||10 weeks|Age, Customized||Participants|Count of Participants|4|4.0||||||
3638986|NCT02531373|3487233|B7||10 weeks|Age, Customized||Participants|Count of Participants|4|4.0||||||
3638987|NCT02531373|3487234|B6||10 weeks|Age, Customized||Participants|Count of Participants|6|6.0||||||
3638988|NCT02531373|3487235|B5||10 weeks|Age, Customized||Participants|Count of Participants|4|4.0||||||
3638989|NCT02531373|3487236|B4||10 weeks|Age, Customized||Participants|Count of Participants|0|0.0||||||
3638990|NCT02531373|3487237|B3||10 weeks|Age, Customized||Participants|Count of Participants|0|0.0||||||
3638991|NCT02531373|3487238|B2||10 weeks|Age, Customized||Participants|Count of Participants|0|0.0||||||
3638992|NCT02531373|3487239|B1||10 weeks|Age, Customized||Participants|Count of Participants|0|0.0||||||
3638993|NCT02531373|3487230|B10||9 weeks|Age, Customized||Participants|Count of Participants|94|94.0||||||
3638994|NCT02531373|3487231|B9||9 weeks|Age, Customized||Participants|Count of Participants|16|16.0||||||
3638995|NCT02531373|3487232|B8||9 weeks|Age, Customized||Participants|Count of Participants|20|20.0||||||
3638996|NCT02531373|3487233|B7||9 weeks|Age, Customized||Participants|Count of Participants|22|22.0||||||
3638997|NCT02531373|3487234|B6||9 weeks|Age, Customized||Participants|Count of Participants|22|22.0||||||
3638998|NCT02531373|3487235|B5||9 weeks|Age, Customized||Participants|Count of Participants|14|14.0||||||
3638999|NCT02531373|3487236|B4||9 weeks|Age, Customized||Participants|Count of Participants|0|0.0||||||
3639000|NCT02531373|3487237|B3||9 weeks|Age, Customized||Participants|Count of Participants|0|0.0||||||
3639001|NCT02531373|3487238|B2||9 weeks|Age, Customized||Participants|Count of Participants|0|0.0||||||
3639002|NCT02531373|3487239|B1||9 weeks|Age, Customized||Participants|Count of Participants|0|0.0||||||
3639003|NCT02531373|3487230|B10||8 weeks|Age, Customized||Participants|Count of Participants|95|95.0||||||
3639004|NCT02531373|3487231|B9||8 weeks|Age, Customized||Participants|Count of Participants|26|26.0||||||
3639005|NCT02531373|3487232|B8||8 weeks|Age, Customized||Participants|Count of Participants|19|19.0||||||
3639006|NCT02531373|3487233|B7||8 weeks|Age, Customized||Participants|Count of Participants|16|16.0||||||
3639007|NCT02531373|3487234|B6||8 weeks|Age, Customized||Participants|Count of Participants|15|15.0||||||
3639008|NCT02531373|3487235|B5||8 weeks|Age, Customized||Participants|Count of Participants|19|19.0||||||
3639009|NCT02531373|3487236|B4||8 weeks|Age, Customized||Participants|Count of Participants|0|0.0||||||
3639010|NCT02531373|3487237|B3||8 weeks|Age, Customized||Participants|Count of Participants|0|0.0||||||
3639011|NCT02531373|3487238|B2||8 weeks|Age, Customized||Participants|Count of Participants|0|0.0||||||
3639012|NCT02531373|3487239|B1||8 weeks|Age, Customized||Participants|Count of Participants|0|0.0||||||
3639013|NCT02531373|3487230|B10||7 weeks|Age, Customized||Participants|Count of Participants|15|15.0||||||
3639014|NCT02531373|3487231|B9||7 weeks|Age, Customized||Participants|Count of Participants|2|2.0||||||
3639015|NCT02531373|3487232|B8||7 weeks|Age, Customized||Participants|Count of Participants|4|4.0||||||
3639016|NCT02531373|3487233|B7||7 weeks|Age, Customized||Participants|Count of Participants|3|3.0||||||
3639017|NCT02531373|3487234|B6||7 weeks|Age, Customized||Participants|Count of Participants|2|2.0||||||
3639018|NCT02531373|3487235|B5||7 weeks|Age, Customized||Participants|Count of Participants|4|4.0||||||
3639019|NCT02531373|3487236|B4||7 weeks|Age, Customized||Participants|Count of Participants|0|0.0||||||
3639020|NCT02531373|3487237|B3||7 weeks|Age, Customized||Participants|Count of Participants|0|0.0||||||
3639021|NCT02531373|3487238|B2||7 weeks|Age, Customized||Participants|Count of Participants|0|0.0||||||
3639022|NCT02531373|3487239|B1||7 weeks|Age, Customized||Participants|Count of Participants|0|0.0||||||
3639023|NCT02531373|3487230|B10||6 weeks|Age, Customized||Participants|Count of Participants|9|9.0||||||
3639024|NCT02531373|3487231|B9||6 weeks|Age, Customized||Participants|Count of Participants|1|1.0||||||
3639025|NCT02531373|3487232|B8||6 weeks|Age, Customized||Participants|Count of Participants|3|3.0||||||
3639026|NCT02531373|3487233|B7||6 weeks|Age, Customized||Participants|Count of Participants|0|0.0||||||
3639027|NCT02531373|3487234|B6||6 weeks|Age, Customized||Participants|Count of Participants|1|1.0||||||
3639028|NCT02531373|3487235|B5||6 weeks|Age, Customized||Participants|Count of Participants|4|4.0||||||
3639029|NCT02531373|3487236|B4||6 weeks|Age, Customized||Participants|Count of Participants|0|0.0||||||
3639030|NCT02531373|3487237|B3||6 weeks|Age, Customized||Participants|Count of Participants|0|0.0||||||
3639031|NCT02531373|3487238|B2||6 weeks|Age, Customized||Participants|Count of Participants|0|0.0||||||
3639032|NCT02531373|3487239|B1||6 weeks|Age, Customized||Participants|Count of Participants|0|0.0||||||
3639033|NCT02531308|3487304|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
3639034|NCT02531308|3487304|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
3639035|NCT02531308|3487304|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3639036|NCT02531308|3487304|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3639037|NCT02531308|3487304|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3639038|NCT02530671|3487308|B3|Power Toothbrush||Previous used toothbrush (MT/PT)||participants|Number|43|43.0||||||
3639039|NCT02530671|3487309|B2|Power Toothbrush||Previous used toothbrush (MT/PT)||participants|Number|28|28.0||||||
3639040|NCT02530671|3487310|B1|Power Toothbrush||Previous used toothbrush (MT/PT)||participants|Number|15|15.0||||||
3639041|NCT02530671|3487308|B3|Manual Toothbrush||Previous used toothbrush (MT/PT)||participants|Number|67|67.0||||||
3639042|NCT02530671|3487309|B2|Manual Toothbrush||Previous used toothbrush (MT/PT)||participants|Number|27|27.0||||||
3639043|NCT02530671|3487310|B1|Manual Toothbrush||Previous used toothbrush (MT/PT)||participants|Number|40|40.0||||||
3639044|NCT02530671|3487308|B3|No||Smoker (Yes/Now)||participants|Number|96|96.0||||||
3639045|NCT02530671|3487309|B2|No||Smoker (Yes/Now)||participants|Number|48|48.0||||||
3639046|NCT02530671|3487310|B1|No||Smoker (Yes/Now)||participants|Number|48|48.0||||||
3639047|NCT02530671|3487308|B3|Yes||Smoker (Yes/Now)||participants|Number|14|14.0||||||
3639048|NCT02530671|3487309|B2|Yes||Smoker (Yes/Now)||participants|Number|7|7.0||||||
3639049|NCT02530671|3487310|B1|Yes||Smoker (Yes/Now)||participants|Number|7|7.0||||||
3639050|NCT02530671|3487308|B3|Germany||Region of Enrollment||participants|Number|110|110.0||||||
3639051|NCT02530671|3487309|B2|Germany||Region of Enrollment||participants|Number|55|55.0||||||
3639052|NCT02530671|3487310|B1|Germany||Region of Enrollment||participants|Number|55|55.0||||||
3639053|NCT02530671|3487308|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3639054|NCT02530671|3487309|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3639055|NCT02530671|3487310|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3639056|NCT02530671|3487308|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3639057|NCT02530671|3487309|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3639058|NCT02530671|3487310|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3639059|NCT02530671|3487308|B3|||Age||years|Mean|31|31.0|Standard Deviation|11.2|11.2|||
3639060|NCT02530671|3487309|B2|||Age||years|Mean|32|32.0|Standard Deviation|12.5|12.5|||
3639061|NCT02530671|3487310|B1|||Age||years|Mean|30|30.0|Standard Deviation|9.7|9.7|||
3639062|NCT02530450|3487327|B3|||Pubertal||Participants|Count of Participants|17|17.0||||||
3639063|NCT02530450|3487328|B2|||Pubertal||Participants|Count of Participants|8|8.0||||||
3639064|NCT02530450|3487329|B1|||Pubertal||Participants|Count of Participants|9|9.0||||||
3639065|NCT02530450|3487327|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639066|NCT02530450|3487328|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639067|NCT02530450|3487329|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639068|NCT02530450|3487327|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3639069|NCT02530450|3487328|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3639070|NCT02530450|3487329|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3639071|NCT02530450|3487327|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3639072|NCT02530450|3487328|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3639073|NCT02530450|3487329|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3639074|NCT02530450|3487327|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3639075|NCT02530450|3487328|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3639076|NCT02530450|3487329|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3639077|NCT02530450|3487327|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3639078|NCT02530450|3487328|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3639079|NCT02530450|3487329|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3639080|NCT02530450|3487327|B3|||Age||years|Mean|12.74|12.74|Standard Deviation|3.12|3.12|||
3639081|NCT02530450|3487328|B2|||Age||years|Mean|13|13.0|Standard Deviation|3.05|3.05|||
3639082|NCT02530450|3487329|B1|||Age||years|Mean|12|12.0|Standard Deviation|3.16|3.16|||
3639083|NCT02530294|3487336|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639084|NCT02530294|3487337|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639085|NCT02530294|3487338|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639086|NCT02530294|3487336|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3639087|NCT02530294|3487337|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3639088|NCT02530294|3487338|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3639089|NCT02530294|3487336|B3||White|Race (NIH/OMB)||Participants|Count of Participants|294|294.0||||||
3639090|NCT02530294|3487337|B2||White|Race (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
3639091|NCT02530294|3487338|B1||White|Race (NIH/OMB)||Participants|Count of Participants|192|192.0||||||
3639092|NCT02530294|3487336|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3639093|NCT02530294|3487337|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3639094|NCT02530294|3487338|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3639095|NCT02530294|3487336|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639096|NCT02530294|3487337|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639097|NCT02530294|3487338|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639098|NCT02530294|3487336|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3639099|NCT02530294|3487337|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639100|NCT02530294|3487338|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3639101|NCT02530294|3487336|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3639102|NCT02530294|3487337|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639103|NCT02530294|3487338|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3639104|NCT02530294|3487336|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639105|NCT02530294|3487337|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639106|NCT02530294|3487338|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639107|NCT02530294|3487336|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|310|310.0||||||
3639108|NCT02530294|3487337|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
3639109|NCT02530294|3487338|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|206|206.0||||||
3639110|NCT02530294|3487336|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3639111|NCT02530294|3487337|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3639112|NCT02530294|3487338|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3639113|NCT02530294|3487336|B3||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3639114|NCT02530294|3487337|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3639115|NCT02530294|3487338|B1||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3639116|NCT02530294|3487336|B3||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
3639117|NCT02530294|3487337|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3639118|NCT02530294|3487338|B1||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3639119|NCT02530294|3487336|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3639120|NCT02530294|3487337|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3639121|NCT02530294|3487338|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3639122|NCT02530294|3487336|B3||Between 18 and 65 years|Age||Participants|Count of Participants|314|314.0||||||
3639123|NCT02530294|3487337|B2||Between 18 and 65 years|Age||Participants|Count of Participants|104|104.0||||||
3639124|NCT02530294|3487338|B1||Between 18 and 65 years|Age||Participants|Count of Participants|210|210.0||||||
3639125|NCT02530294|3487336|B3||<=18 years|Age||Participants|Count of Participants|39|39.0||||||
3639126|NCT02530294|3487337|B2||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
3639127|NCT02530294|3487338|B1||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
3639128|NCT02530281|3487353|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639129|NCT02530281|3487354|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639130|NCT02530281|3487355|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639131|NCT02530281|3487353|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3639132|NCT02530281|3487354|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3639133|NCT02530281|3487355|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3639134|NCT02530281|3487353|B3||White|Race (NIH/OMB)||Participants|Count of Participants|276|276.0||||||
3639135|NCT02530281|3487354|B2||White|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3639136|NCT02530281|3487355|B1||White|Race (NIH/OMB)||Participants|Count of Participants|182|182.0||||||
3639137|NCT02530281|3487353|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3639138|NCT02530281|3487354|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3639139|NCT02530281|3487355|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3639140|NCT02530281|3487353|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3639141|NCT02530281|3487354|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3639142|NCT02530281|3487355|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639143|NCT02530281|3487353|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3639144|NCT02530281|3487354|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639145|NCT02530281|3487355|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3639146|NCT02530281|3487353|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3639147|NCT02530281|3487354|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639148|NCT02530281|3487355|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3639149|NCT02530281|3487353|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639150|NCT02530281|3487354|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639151|NCT02530281|3487355|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639152|NCT02530281|3487353|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|275|275.0||||||
3639153|NCT02530281|3487354|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
3639154|NCT02530281|3487355|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|183|183.0||||||
3639155|NCT02530281|3487353|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3639156|NCT02530281|3487354|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3639157|NCT02530281|3487355|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3639158|NCT02530281|3487353|B3||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3639159|NCT02530281|3487354|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3639160|NCT02530281|3487355|B1||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3639161|NCT02530281|3487353|B3||Female|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
3639162|NCT02530281|3487354|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3639163|NCT02530281|3487355|B1||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3639164|NCT02530281|3487353|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3639165|NCT02530281|3487354|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3639166|NCT02530281|3487355|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3639167|NCT02530281|3487353|B3||Between 18 and 65 years|Age||Participants|Count of Participants|305|305.0||||||
3639168|NCT02530281|3487354|B2||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
3639169|NCT02530281|3487355|B1||Between 18 and 65 years|Age||Participants|Count of Participants|204|204.0||||||
3639170|NCT02530281|3487353|B3||<=18 years|Age||Participants|Count of Participants|34|34.0||||||
3639171|NCT02530281|3487354|B2||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
3639172|NCT02530281|3487355|B1||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
3639173|NCT02530125|3487372|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3639174|NCT02530125|3487372|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639175|NCT02530125|3487372|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639176|NCT02530125|3487372|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3639177|NCT02530125|3487372|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639178|NCT02530125|3487372|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639179|NCT02530125|3487372|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639180|NCT02530125|3487372|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639181|NCT02530125|3487372|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639182|NCT02530125|3487372|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3639183|NCT02530125|3487372|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639184|NCT02530125|3487372|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3639185|NCT02530125|3487372|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3639186|NCT02530125|3487372|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3639187|NCT02530125|3487372|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3639188|NCT02530125|3487372|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3639189|NCT02529995|3487384|B3|Asian/Chinese||Race/Ethnicity, Customized||Participants|Number|31|31.0||||||
3639190|NCT02529995|3487385|B2|Asian/Chinese||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
3639191|NCT02529995|3487386|B1|Asian/Chinese||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
3639192|NCT02529995|3487384|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3639193|NCT02529995|3487385|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3639194|NCT02529995|3487386|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3639195|NCT02529995|3487384|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3639196|NCT02529995|3487385|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3639197|NCT02529995|3487386|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3639198|NCT02529995|3487384|B3|>=75 Years||Age, Customized||Participants|Number|1|1.0||||||
3639199|NCT02529995|3487385|B2|>=75 Years||Age, Customized||Participants|Number|1|1.0||||||
3639200|NCT02529995|3487386|B1|>=75 Years||Age, Customized||Participants|Number|0|0.0||||||
3639201|NCT02529995|3487384|B3|>=65-<75 Years||Age, Customized||Participants|Number|9|9.0||||||
3639202|NCT02529995|3487385|B2|>=65-<75 Years||Age, Customized||Participants|Number|6|6.0||||||
3639203|NCT02529995|3487386|B1|>=65-<75 Years||Age, Customized||Participants|Number|3|3.0||||||
3639204|NCT02529995|3487384|B3|>=50-<65 Years||Age, Customized||Participants|Number|15|15.0||||||
3639205|NCT02529995|3487385|B2|>=50-<65 Years||Age, Customized||Participants|Number|7|7.0||||||
3639206|NCT02529995|3487386|B1|>=50-<65 Years||Age, Customized||Participants|Number|8|8.0||||||
3639207|NCT02529995|3487384|B3|<50 Years||Age, Customized||Participants|Number|6|6.0||||||
3639208|NCT02529995|3487385|B2|<50 Years||Age, Customized||Participants|Number|2|2.0||||||
3639209|NCT02529995|3487386|B1|<50 Years||Age, Customized||Participants|Number|4|4.0||||||
3639210|NCT02529995|3487384|B3|||Age||Years|Mean|57.2|57.2|Standard Deviation|11.10|11.1|||
3639211|NCT02529995|3487385|B2|||Age||Years|Mean|60.1|60.1|Standard Deviation|10.92|10.92|||
3639212|NCT02529995|3487386|B1|||Age||Years|Mean|54.1|54.1|Standard Deviation|10.78|10.78|||
3639213|NCT02529488|3487421|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3639214|NCT02529488|3487421|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3639215|NCT02529488|3487421|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3639216|NCT02529488|3487421|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3639217|NCT02529488|3487421|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3639218|NCT02529488|3487421|B1|||Age||years|Mean|68.9|68.9|Standard Deviation|9.28|9.28|||
3639219|NCT02528786|3487429|B1|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3639220|NCT02528786|3487429|B1|Bulgaria||Region of Enrollment||participants|Number|4|4.0||||||
3639221|NCT02528786|3487429|B1|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
3639222|NCT02528786|3487429|B1|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3639223|NCT02528786|3487429|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3639224|NCT02528786|3487429|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3639225|NCT02528786|3487429|B1|Adults (65-84 years)||Age, Customized||participants|Number|3|3.0||||||
3639226|NCT02528786|3487429|B1|Adults (18-64 years)||Age, Customized||participants|Number|5|5.0||||||
3639227|NCT02528721|3487433|B3||Male|Gender||Participants|Count of Participants|108|108.0||||||
3639228|NCT02528721|3487434|B2||Male|Gender||Participants|Count of Participants|28|28.0||||||
3639229|NCT02528721|3487435|B1||Male|Gender||Participants|Count of Participants|80|80.0||||||
3639230|NCT02528721|3487433|B3||Female|Gender||Participants|Count of Participants|164|164.0||||||
3639231|NCT02528721|3487434|B2||Female|Gender||Participants|Count of Participants|48|48.0||||||
3639232|NCT02528721|3487435|B1||Female|Gender||Participants|Count of Participants|116|116.0||||||
3639233|NCT02528721|3487433|B3|||Age||years|Mean|48.64|48.64|Standard Deviation|15.11|15.11|||
3639234|NCT02528721|3487434|B2|||Age||years|Mean|49.0|49.0|Standard Deviation|15.53|15.53|||
3639235|NCT02528721|3487435|B1|||Age||years|Mean|48.5|48.5|Standard Deviation|14.94|14.94|||
3639236|NCT02528643|3487446|B3||Unknown|Ethnicty||Participants|Count of Participants|0|0.0||||||
3639237|NCT02528643|3487447|B2||Unknown|Ethnicty||Participants|Count of Participants|0|0.0||||||
3639238|NCT02528643|3487448|B1||Unknown|Ethnicty||Participants|Count of Participants|0|0.0||||||
3639239|NCT02528643|3487446|B3||Hispanic or Latino|Ethnicty||Participants|Count of Participants|3|3.0||||||
3639240|NCT02528643|3487447|B2||Hispanic or Latino|Ethnicty||Participants|Count of Participants|3|3.0||||||
3639241|NCT02528643|3487448|B1||Hispanic or Latino|Ethnicty||Participants|Count of Participants|0|0.0||||||
3639242|NCT02528643|3487446|B3||Not Hispanic or Latino|Ethnicty||Participants|Count of Participants|162|162.0||||||
3639243|NCT02528643|3487447|B2||Not Hispanic or Latino|Ethnicty||Participants|Count of Participants|107|107.0||||||
3639244|NCT02528643|3487448|B1||Not Hispanic or Latino|Ethnicty||Participants|Count of Participants|55|55.0||||||
3639245|NCT02528643|3487446|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3639246|NCT02528643|3487447|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3639247|NCT02528643|3487448|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3639248|NCT02528643|3487446|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3639249|NCT02528643|3487447|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3639250|NCT02528643|3487448|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3639251|NCT02528643|3487446|B3||American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3639252|NCT02528643|3487447|B2||American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3639253|NCT02528643|3487448|B1||American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3639254|NCT02528643|3487446|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|77|77.0||||||
3639255|NCT02528643|3487447|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|52|52.0||||||
3639256|NCT02528643|3487448|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3639257|NCT02528643|3487446|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3639258|NCT02528643|3487447|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3639259|NCT02528643|3487448|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3639260|NCT02528643|3487446|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|78|78.0||||||
3639261|NCT02528643|3487447|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|52|52.0||||||
3639262|NCT02528643|3487448|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3639263|NCT02528643|3487446|B3||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3639264|NCT02528643|3487447|B2||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3639265|NCT02528643|3487448|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3639266|NCT02528643|3487446|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3639267|NCT02528643|3487447|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3639268|NCT02528643|3487448|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3639269|NCT02528643|3487446|B3|||Age||Years|Mean|63.3|63.3|Standard Deviation|11.5|11.5|||
3639270|NCT02528643|3487447|B2|||Age||Years|Mean|63.7|63.7|Standard Deviation|10.9|10.9|||
3639271|NCT02528643|3487448|B1|||Age||Years|Mean|62.6|62.6|Standard Deviation|12.5|12.5|||
3639272|NCT02528500|3487462|B1|||Body Mass Index (BMI)||kg/m^2|Mean|28.2|28.2|Standard Deviation|5.07|5.07|||
3639273|NCT02528500|3487462|B1|||Weight||Kilograms (kg)|Mean|86.4|86.4|Standard Deviation|20.6|20.6|||
3639274|NCT02528500|3487462|B1|||Height||Centimeters (cm)|Mean|174.1|174.1|Standard Deviation|9.72|9.72|||
3639275|NCT02528500|3487462|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639276|NCT02528500|3487462|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639277|NCT02528500|3487462|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3639278|NCT02528500|3487462|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639279|NCT02528500|3487462|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639280|NCT02528500|3487462|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639281|NCT02528500|3487462|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639282|NCT02528500|3487462|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3639283|NCT02528500|3487462|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3639284|NCT02528500|3487462|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639285|NCT02528500|3487462|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3639286|NCT02528500|3487462|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3639287|NCT02528500|3487462|B1|||Age||Years|Mean|70.2|70.2|Standard Deviation|7.13|7.13|||
3639288|NCT02528331|3487466|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3639289|NCT02528331|3487466|B1||Male|Gender||Participants|Count of Participants|1|1.0||||||
3639290|NCT02528331|3487466|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
3639291|NCT02528331|3487466|B1|||Age||years|Mean|51.5|51.5|Full Range|||48.0|55.0|
3639292|NCT02528331|3487466|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3639293|NCT02528331|3487466|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3639294|NCT02528331|3487466|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3639295|NCT02528305|3487473|B1|Non-alcoholic Steatohepatitis (NASH)||diagnosis||participants|Number|5|5.0||||||
3639296|NCT02528305|3487473|B1|Non-alcoholic Fatty Liver Disease (NAFLD)||diagnosis||participants|Number|7|7.0||||||
3639297|NCT02528305|3487473|B1|||body mass index (BMI)||kg/m^2|Mean|29.6|29.6|Standard Deviation|3.8|3.8|||
3639298|NCT02528305|3487473|B1|||height||metres|Mean|1.71|1.71|Standard Deviation|0.09|0.09|||
3639299|NCT02528305|3487473|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3639300|NCT02528305|3487473|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3639301|NCT02528305|3487473|B1|||Age||years|Mean|45|45.0|Standard Deviation|8|8.0|||
3639302|NCT02528305|3487473|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3639303|NCT02528305|3487473|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3639304|NCT02528305|3487473|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3639305|NCT02528214|3487515|B3|||Daily OCS Dose at Visit 1 (i.e. preoptimization)||mg/day|Mean|11.81|11.81|Standard Deviation|6.20|6.2|||
3639306|NCT02528214|3487516|B2|||Daily OCS Dose at Visit 1 (i.e. preoptimization)||mg/day|Mean|11.79|11.79|Standard Deviation|6.4|6.4|||
3639307|NCT02528214|3487517|B1|||Daily OCS Dose at Visit 1 (i.e. preoptimization)||mg/day|Mean|11.83|11.83|Standard Deviation|6.02|6.02|||
3639308|NCT02528214|3487515|B3|||Baseline Optimized Daily OCS Dose|During screening period and before randomization, OCS dose was adjusted in each participant to achieve the lowest OCS dose, also known as optimized dose, required for management of participant’s asthma.Participants using OCS medications other than prednisone/prednisolone were switched to either of these corticosteroids at a dose clinically comparable to their current stable OCS dose. To optimize the OCS dose, investigators were instructed to adjust the OCS dose weekly according to a pre-specified titration schedule, based on changes in participant’s asthma control, and their clinical judgment.|mg/day|Mean|11.26|11.26|Standard Deviation|6.12|6.12|||
3639309|NCT02528214|3487516|B2|||Baseline Optimized Daily OCS Dose|During screening period and before randomization, OCS dose was adjusted in each participant to achieve the lowest OCS dose, also known as optimized dose, required for management of participant’s asthma.Participants using OCS medications other than prednisone/prednisolone were switched to either of these corticosteroids at a dose clinically comparable to their current stable OCS dose. To optimize the OCS dose, investigators were instructed to adjust the OCS dose weekly according to a pre-specified titration schedule, based on changes in participant’s asthma control, and their clinical judgment.|mg/day|Mean|10.75|10.75|Standard Deviation|5.9|5.9|||
3639310|NCT02528214|3487517|B1|||Baseline Optimized Daily OCS Dose|During screening period and before randomization, OCS dose was adjusted in each participant to achieve the lowest OCS dose, also known as optimized dose, required for management of participant’s asthma.Participants using OCS medications other than prednisone/prednisolone were switched to either of these corticosteroids at a dose clinically comparable to their current stable OCS dose. To optimize the OCS dose, investigators were instructed to adjust the OCS dose weekly according to a pre-specified titration schedule, based on changes in participant’s asthma control, and their clinical judgment.|mg/day|Mean|11.75|11.75|Standard Deviation|6.31|6.31|||
3639311|NCT02528214|3487515|B3||>=0.3 Giga/L|Baseline Blood Eosinophil Count||Participants|Count of Participants|89|89.0||||||
3639312|NCT02528214|3487516|B2||>=0.3 Giga/L|Baseline Blood Eosinophil Count||Participants|Count of Participants|48|48.0||||||
3639313|NCT02528214|3487517|B1||>=0.3 Giga/L|Baseline Blood Eosinophil Count||Participants|Count of Participants|41|41.0||||||
3639314|NCT02528214|3487515|B3||>=0.15 - <0.3 Giga/L|Baseline Blood Eosinophil Count||Participants|Count of Participants|61|61.0||||||
3639315|NCT02528214|3487516|B2||>=0.15 - <0.3 Giga/L|Baseline Blood Eosinophil Count||Participants|Count of Participants|33|33.0||||||
3639316|NCT02528214|3487517|B1||>=0.15 - <0.3 Giga/L|Baseline Blood Eosinophil Count||Participants|Count of Participants|28|28.0||||||
3639317|NCT02528214|3487515|B3||<0.15 Giga/L|Baseline Blood Eosinophil Count||Participants|Count of Participants|60|60.0||||||
3639318|NCT02528214|3487516|B2||<0.15 Giga/L|Baseline Blood Eosinophil Count||Participants|Count of Participants|22|22.0||||||
3639319|NCT02528214|3487517|B1||<0.15 Giga/L|Baseline Blood Eosinophil Count||Participants|Count of Participants|38|38.0||||||
3639320|NCT02528214|3487515|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3639321|NCT02528214|3487516|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3639322|NCT02528214|3487517|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3639323|NCT02528214|3487515|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3639324|NCT02528214|3487516|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3639325|NCT02528214|3487517|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3639326|NCT02528214|3487515|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3639327|NCT02528214|3487516|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3639328|NCT02528214|3487517|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3639329|NCT02528214|3487515|B3|Asian/Oriental||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3639330|NCT02528214|3487516|B2|Asian/Oriental||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3639331|NCT02528214|3487517|B1|Asian/Oriental||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3639332|NCT02528214|3487515|B3|Black/of African descent||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3639333|NCT02528214|3487516|B2|Black/of African descent||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3639334|NCT02528214|3487517|B1|Black/of African descent||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3639335|NCT02528214|3487515|B3|Caucasian/White||Race/Ethnicity, Customized||Participants|Count of Participants|197|197.0||||||
3639336|NCT02528214|3487516|B2|Caucasian/White||Race/Ethnicity, Customized||Participants|Count of Participants|97|97.0||||||
3639337|NCT02528214|3487517|B1|Caucasian/White||Race/Ethnicity, Customized||Participants|Count of Participants|100|100.0||||||
3639338|NCT02528214|3487515|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639339|NCT02528214|3487516|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639340|NCT02528214|3487517|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639341|NCT02528214|3487515|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|165|165.0||||||
3639342|NCT02528214|3487516|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3639343|NCT02528214|3487517|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3639344|NCT02528214|3487515|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3639345|NCT02528214|3487516|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3639346|NCT02528214|3487517|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3639347|NCT02528214|3487515|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3639348|NCT02528214|3487516|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3639349|NCT02528214|3487517|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3639350|NCT02528214|3487515|B3||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3639351|NCT02528214|3487516|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3639352|NCT02528214|3487517|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3639353|NCT02528214|3487515|B3|>=65 years||Age, Customized||Participants|Count of Participants|28|28.0||||||
3639354|NCT02528214|3487516|B2|>=65 years||Age, Customized||Participants|Count of Participants|11|11.0||||||
3639355|NCT02528214|3487517|B1|>=65 years||Age, Customized||Participants|Count of Participants|17|17.0||||||
3639356|NCT02528214|3487515|B3|Between 18 and 64 years||Age, Customized||Participants|Count of Participants|179|179.0||||||
3639357|NCT02528214|3487516|B2|Between 18 and 64 years||Age, Customized||Participants|Count of Participants|91|91.0||||||
3639358|NCT02528214|3487517|B1|Between 18 and 64 years||Age, Customized||Participants|Count of Participants|88|88.0||||||
3639359|NCT02528214|3487515|B3|<18 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
3639360|NCT02528214|3487516|B2|<18 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3639361|NCT02528214|3487517|B1|<18 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
3639362|NCT02528214|3487515|B3|||Age||years|Mean|51.3|51.3|Standard Deviation|12.6|12.6|||
3639363|NCT02528214|3487516|B2|||Age||years|Mean|51.9|51.9|Standard Deviation|12.5|12.5|||
3639364|NCT02528214|3487517|B1|||Age||years|Mean|50.7|50.7|Standard Deviation|12.8|12.8|||
3639365|NCT02528097|3487548|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3639366|NCT02528097|3487549|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3639367|NCT02528097|3487550|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3639368|NCT02528097|3487548|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3639369|NCT02528097|3487549|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3639370|NCT02528097|3487550|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3639371|NCT02528097|3487548|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3639372|NCT02528097|3487549|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3639373|NCT02528097|3487550|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3639374|NCT02528097|3487548|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3639375|NCT02528097|3487549|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3639376|NCT02528097|3487550|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3639377|NCT02528097|3487548|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3639378|NCT02528097|3487549|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3639379|NCT02528097|3487550|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3639380|NCT02527694|3487559|B3|South Korea||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3639381|NCT02527694|3487560|B2|South Korea||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3639382|NCT02527694|3487561|B1|South Korea||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3639383|NCT02527694|3487559|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3639384|NCT02527694|3487560|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3639385|NCT02527694|3487561|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3639386|NCT02527694|3487559|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3639387|NCT02527694|3487560|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3639388|NCT02527694|3487561|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3639389|NCT02527694|3487559|B3|||Age||years|Median|66|66.0|Inter-Quartile Range|||58.0|74.0|
3639390|NCT02527694|3487560|B2|||Age||years|Median|66|66.0|Inter-Quartile Range|||60.0|74.0|
3639391|NCT02527694|3487561|B1|||Age||years|Median|66|66.0|Inter-Quartile Range|||58.0|73.0|
3639392|NCT02527694|3487559|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3639393|NCT02527694|3487560|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3639394|NCT02527694|3487561|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3639395|NCT02527694|3487559|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3639396|NCT02527694|3487560|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3639397|NCT02527694|3487561|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3639398|NCT02527694|3487559|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3639399|NCT02527694|3487560|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3639400|NCT02527694|3487561|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3639401|NCT02527161|3487570|B1|Australia||Region of Enrollment||participants|Number|96|96.0||||||
3639402|NCT02527161|3487570|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3639403|NCT02527161|3487570|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3639404|NCT02527161|3487570|B1|||Age||years|Mean|68.04|68.04|Standard Deviation|8.30|8.3|||
3639405|NCT02527148|3487587|B3|New Zealand||Region of Enrollment||participants|Number|99|99.0||||||
3639406|NCT02527148|3487588|B2|New Zealand||Region of Enrollment||participants|Number|50|50.0||||||
3639407|NCT02527148|3487589|B1|New Zealand||Region of Enrollment||participants|Number|49|49.0||||||
3639408|NCT02527148|3487587|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3639409|NCT02527148|3487588|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3639410|NCT02527148|3487589|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3639411|NCT02527148|3487587|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3639412|NCT02527148|3487588|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3639413|NCT02527148|3487589|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3639414|NCT02527148|3487587|B3|||Age||years|Mean|70.8|70.8|Standard Deviation|7.0|7.0|||
3639415|NCT02527148|3487588|B2|||Age||years|Mean|69.6|69.6|Standard Deviation|7.5|7.5|||
3639416|NCT02527148|3487589|B1|||Age||years|Mean|71.9|71.9|Standard Deviation|6.5|6.5|||
3639417|NCT02526680|3487608|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3639418|NCT02526680|3487608|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3639419|NCT02526680|3487608|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3639420|NCT02526680|3487608|B1|||Age||years|Mean|59.3|59.3|Full Range|||22.0|92.0|
3639421|NCT02526550|3487615|B1|Thailand||Region of Enrollment||participants|Number|50|50.0||||||
3639422|NCT02526550|3487615|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3639423|NCT02526550|3487615|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3639424|NCT02526550|3487615|B1|||Age||months|Mean|20.5|20.5|Standard Deviation|0.8|0.8|||
3639425|NCT02526524|3487621|B7|||Prior Metformin Use||Participants|Count of Participants|277|277.0||||||
3639426|NCT02526524|3487622|B6|||Prior Metformin Use||Participants|Count of Participants|47|47.0||||||
3639427|NCT02526524|3487623|B5|||Prior Metformin Use||Participants|Count of Participants|54|54.0||||||
3639428|NCT02526524|3487624|B4|||Prior Metformin Use||Participants|Count of Participants|49|49.0||||||
3639429|NCT02526524|3487625|B3|||Prior Metformin Use||Participants|Count of Participants|40|40.0||||||
3639430|NCT02526524|3487626|B2|||Prior Metformin Use||Participants|Count of Participants|47|47.0||||||
3639431|NCT02526524|3487627|B1|||Prior Metformin Use||Participants|Count of Participants|40|40.0||||||
3639432|NCT02526524|3487621|B7||≥90 mL/min/1.73m²|Estimated Glomerular Filtration Rate Subgroup||Participants|Count of Participants|320|320.0||||||
3639433|NCT02526524|3487622|B6||≥90 mL/min/1.73m²|Estimated Glomerular Filtration Rate Subgroup||Participants|Count of Participants|51|51.0||||||
3639434|NCT02526524|3487623|B5||≥90 mL/min/1.73m²|Estimated Glomerular Filtration Rate Subgroup||Participants|Count of Participants|54|54.0||||||
3639435|NCT02526524|3487624|B4||≥90 mL/min/1.73m²|Estimated Glomerular Filtration Rate Subgroup||Participants|Count of Participants|54|54.0||||||
3639436|NCT02526524|3487625|B3||≥90 mL/min/1.73m²|Estimated Glomerular Filtration Rate Subgroup||Participants|Count of Participants|60|60.0||||||
3639437|NCT02526524|3487626|B2||≥90 mL/min/1.73m²|Estimated Glomerular Filtration Rate Subgroup||Participants|Count of Participants|49|49.0||||||
3639438|NCT02526524|3487627|B1||≥90 mL/min/1.73m²|Estimated Glomerular Filtration Rate Subgroup||Participants|Count of Participants|52|52.0||||||
3639439|NCT02526524|3487621|B7||<90 mL/min/1.73m²|Estimated Glomerular Filtration Rate Subgroup||Participants|Count of Participants|251|251.0||||||
3639440|NCT02526524|3487622|B6||<90 mL/min/1.73m²|Estimated Glomerular Filtration Rate Subgroup||Participants|Count of Participants|43|43.0||||||
3639441|NCT02526524|3487623|B5||<90 mL/min/1.73m²|Estimated Glomerular Filtration Rate Subgroup||Participants|Count of Participants|42|42.0||||||
3639442|NCT02526524|3487624|B4||<90 mL/min/1.73m²|Estimated Glomerular Filtration Rate Subgroup||Participants|Count of Participants|42|42.0||||||
3639693|NCT02525536|3487655|B2|Neoplasm, stomach||Primary Tumor Type||participants|Number|0|0.0||||||
3639443|NCT02526524|3487625|B3||<90 mL/min/1.73m²|Estimated Glomerular Filtration Rate Subgroup||Participants|Count of Participants|36|36.0||||||
3639444|NCT02526524|3487626|B2||<90 mL/min/1.73m²|Estimated Glomerular Filtration Rate Subgroup||Participants|Count of Participants|46|46.0||||||
3639445|NCT02526524|3487627|B1||<90 mL/min/1.73m²|Estimated Glomerular Filtration Rate Subgroup||Participants|Count of Participants|42|42.0||||||
3639446|NCT02526524|3487621|B7|||Estimated Glomerular Filtration Rate||mL/min/1.73m²|Mean|95.6|95.6|Standard Deviation|23.22|23.22|||
3639447|NCT02526524|3487622|B6|||Estimated Glomerular Filtration Rate||mL/min/1.73m²|Mean|96.2|96.2|Standard Deviation|22.42|22.42|||
3639448|NCT02526524|3487623|B5|||Estimated Glomerular Filtration Rate||mL/min/1.73m²|Mean|96.4|96.4|Standard Deviation|27.42|27.42|||
3639449|NCT02526524|3487624|B4|||Estimated Glomerular Filtration Rate||mL/min/1.73m²|Mean|95.9|95.9|Standard Deviation|22.77|22.77|||
3639450|NCT02526524|3487625|B3|||Estimated Glomerular Filtration Rate||mL/min/1.73m²|Mean|96.2|96.2|Standard Deviation|24.48|24.48|||
3639451|NCT02526524|3487626|B2|||Estimated Glomerular Filtration Rate||mL/min/1.73m²|Mean|94.5|94.5|Standard Deviation|22.83|22.83|||
3639452|NCT02526524|3487627|B1|||Estimated Glomerular Filtration Rate||mL/min/1.73m²|Mean|94.4|94.4|Standard Deviation|19.05|19.05|||
3639453|NCT02526524|3487621|B7|||Diabetes Duration||years|Mean|7.9|7.9|Standard Deviation|6.67|6.67|||
3639454|NCT02526524|3487622|B6|||Diabetes Duration||years|Mean|8.6|8.6|Standard Deviation|7.13|7.13|||
3639455|NCT02526524|3487623|B5|||Diabetes Duration||years|Mean|8.3|8.3|Standard Deviation|6.99|6.99|||
3639456|NCT02526524|3487624|B4|||Diabetes Duration||years|Mean|7.6|7.6|Standard Deviation|5.99|5.99|||
3639457|NCT02526524|3487625|B3|||Diabetes Duration||years|Mean|7.3|7.3|Standard Deviation|6.25|6.25|||
3639458|NCT02526524|3487626|B2|||Diabetes Duration||years|Mean|8.8|8.8|Standard Deviation|8.01|8.01|||
3639459|NCT02526524|3487627|B1|||Diabetes Duration||years|Mean|6.6|6.6|Standard Deviation|5.20|5.2|||
3639460|NCT02526524|3487621|B7|||Fasting Plasma Glucose||mg/dL|Mean|205|205.0|Standard Deviation|54.0|54.0|||
3639461|NCT02526524|3487622|B6|||Fasting Plasma Glucose||mg/dL|Mean|200|200.0|Standard Deviation|50.3|50.3|||
3639462|NCT02526524|3487623|B5|||Fasting Plasma Glucose||mg/dL|Mean|204|204.0|Standard Deviation|57.3|57.3|||
3639463|NCT02526524|3487624|B4|||Fasting Plasma Glucose||mg/dL|Mean|212|212.0|Standard Deviation|53.5|53.5|||
3639464|NCT02526524|3487625|B3|||Fasting Plasma Glucose||mg/dL|Mean|205|205.0|Standard Deviation|59.0|59.0|||
3639465|NCT02526524|3487626|B2|||Fasting Plasma Glucose||mg/dL|Mean|202|202.0|Standard Deviation|45.3|45.3|||
3639466|NCT02526524|3487627|B1|||Fasting Plasma Glucose||mg/dL|Mean|204|204.0|Standard Deviation|58.1|58.1|||
3639467|NCT02526524|3487621|B7||≥8.5%|HbA1c stratum||Participants|Count of Participants|299|299.0||||||
3639468|NCT02526524|3487622|B6||≥8.5%|HbA1c stratum||Participants|Count of Participants|49|49.0||||||
3639469|NCT02526524|3487623|B5||≥8.5%|HbA1c stratum||Participants|Count of Participants|51|51.0||||||
3639470|NCT02526524|3487624|B4||≥8.5%|HbA1c stratum||Participants|Count of Participants|50|50.0||||||
3639471|NCT02526524|3487625|B3||≥8.5%|HbA1c stratum||Participants|Count of Participants|50|50.0||||||
3639472|NCT02526524|3487626|B2||≥8.5%|HbA1c stratum||Participants|Count of Participants|50|50.0||||||
3639473|NCT02526524|3487627|B1||≥8.5%|HbA1c stratum||Participants|Count of Participants|49|49.0||||||
3639474|NCT02526524|3487621|B7||<8.5%|HbA1c stratum||Participants|Count of Participants|272|272.0||||||
3639475|NCT02526524|3487622|B6||<8.5%|HbA1c stratum||Participants|Count of Participants|45|45.0||||||
3639476|NCT02526524|3487623|B5||<8.5%|HbA1c stratum||Participants|Count of Participants|45|45.0||||||
3639477|NCT02526524|3487624|B4||<8.5%|HbA1c stratum||Participants|Count of Participants|46|46.0||||||
3639478|NCT02526524|3487625|B3||<8.5%|HbA1c stratum||Participants|Count of Participants|46|46.0||||||
3639479|NCT02526524|3487626|B2||<8.5%|HbA1c stratum||Participants|Count of Participants|45|45.0||||||
3639480|NCT02526524|3487627|B1||<8.5%|HbA1c stratum||Participants|Count of Participants|45|45.0||||||
3639481|NCT02526524|3487621|B7|||HbA1c||%|Mean|8.6|8.6|Standard Deviation|0.88|0.88|||
3639482|NCT02526524|3487622|B6|||HbA1c||%|Mean|8.6|8.6|Standard Deviation|0.92|0.92|||
3639483|NCT02526524|3487623|B5|||HbA1c||%|Mean|8.6|8.6|Standard Deviation|0.87|0.87|||
3639484|NCT02526524|3487624|B4|||HbA1c||%|Mean|8.6|8.6|Standard Deviation|0.94|0.94|||
3639485|NCT02526524|3487625|B3|||HbA1c||%|Mean|8.7|8.7|Standard Deviation|0.90|0.9|||
3639486|NCT02526524|3487626|B2|||HbA1c||%|Mean|8.7|8.7|Standard Deviation|0.82|0.82|||
3639487|NCT02526524|3487627|B1|||HbA1c||%|Mean|8.6|8.6|Standard Deviation|0.85|0.85|||
3639488|NCT02526524|3487621|B7|||Body Mass Index||kg/m²|Mean|32|32.0|Standard Deviation|5.5|5.5|||
3639489|NCT02526524|3487622|B6|||Body Mass Index||kg/m²|Mean|32|32.0|Standard Deviation|5.4|5.4|||
3639490|NCT02526524|3487623|B5|||Body Mass Index||kg/m²|Mean|31|31.0|Standard Deviation|5.1|5.1|||
3639491|NCT02526524|3487624|B4|||Body Mass Index||kg/m²|Mean|33|33.0|Standard Deviation|5.8|5.8|||
3639492|NCT02526524|3487625|B3|||Body Mass Index||kg/m²|Mean|32|32.0|Standard Deviation|5.9|5.9|||
3639493|NCT02526524|3487626|B2|||Body Mass Index||kg/m²|Mean|32|32.0|Standard Deviation|5.5|5.5|||
3639494|NCT02526524|3487627|B1|||Body Mass Index||kg/m²|Mean|33|33.0|Standard Deviation|5.1|5.1|||
3639495|NCT02526524|3487621|B7|||Body Weight||kg|Mean|91|91.0|Standard Deviation|20.2|20.2|||
3639496|NCT02526524|3487622|B6|||Body Weight||kg|Mean|89|89.0|Standard Deviation|21.3|21.3|||
3639497|NCT02526524|3487623|B5|||Body Weight||kg|Mean|86|86.0|Standard Deviation|17.1|17.1|||
3639498|NCT02526524|3487624|B4|||Body Weight||kg|Mean|95|95.0|Standard Deviation|22.2|22.2|||
3639499|NCT02526524|3487625|B3|||Body Weight||kg|Mean|93|93.0|Standard Deviation|20.9|20.9|||
3639500|NCT02526524|3487626|B2|||Body Weight||kg|Mean|89|89.0|Standard Deviation|18.5|18.5|||
3639501|NCT02526524|3487627|B1|||Body Weight||kg|Mean|94|94.0|Standard Deviation|19.9|19.9|||
3639502|NCT02526524|3487621|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3639503|NCT02526524|3487622|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639504|NCT02526524|3487623|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3639505|NCT02526524|3487624|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639506|NCT02526524|3487625|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639507|NCT02526524|3487626|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639508|NCT02526524|3487627|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639509|NCT02526524|3487621|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3639510|NCT02526524|3487622|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3639511|NCT02526524|3487623|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639512|NCT02526524|3487624|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639513|NCT02526524|3487625|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639514|NCT02526524|3487626|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639515|NCT02526524|3487627|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3639516|NCT02526524|3487621|B7||White|Race (NIH/OMB)||Participants|Count of Participants|454|454.0||||||
3639517|NCT02526524|3487622|B6||White|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3639518|NCT02526524|3487623|B5||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3639519|NCT02526524|3487624|B4||White|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3639520|NCT02526524|3487625|B3||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3639521|NCT02526524|3487626|B2||White|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3639522|NCT02526524|3487627|B1||White|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3639523|NCT02526524|3487621|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3639524|NCT02526524|3487622|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3639525|NCT02526524|3487623|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3639526|NCT02526524|3487624|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3639527|NCT02526524|3487625|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3639528|NCT02526524|3487626|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3639529|NCT02526524|3487627|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3639530|NCT02526524|3487621|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3639531|NCT02526524|3487622|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639532|NCT02526524|3487623|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3639533|NCT02526524|3487624|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3639534|NCT02526524|3487625|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639535|NCT02526524|3487626|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639536|NCT02526524|3487627|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639537|NCT02526524|3487621|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3639538|NCT02526524|3487622|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3639539|NCT02526524|3487623|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3639540|NCT02526524|3487624|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3639541|NCT02526524|3487625|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3639542|NCT02526524|3487626|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3639543|NCT02526524|3487627|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3639544|NCT02526524|3487621|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3639545|NCT02526524|3487622|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3639546|NCT02526524|3487623|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639547|NCT02526524|3487624|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639548|NCT02526524|3487625|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639549|NCT02526524|3487626|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639550|NCT02526524|3487627|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3639551|NCT02526524|3487621|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639552|NCT02526524|3487622|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639553|NCT02526524|3487623|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639554|NCT02526524|3487624|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639555|NCT02526524|3487625|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639556|NCT02526524|3487626|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639694|NCT02525536|3487656|B1|Neoplasm, stomach||Primary Tumor Type||participants|Number|3|3.0||||||
3639557|NCT02526524|3487627|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639558|NCT02526524|3487621|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|326|326.0||||||
3639559|NCT02526524|3487622|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3639560|NCT02526524|3487623|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3639561|NCT02526524|3487624|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3639562|NCT02526524|3487625|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3639563|NCT02526524|3487626|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3639564|NCT02526524|3487627|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3639565|NCT02526524|3487621|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|245|245.0||||||
3639566|NCT02526524|3487622|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3639567|NCT02526524|3487623|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3639568|NCT02526524|3487624|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3639569|NCT02526524|3487625|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3639570|NCT02526524|3487626|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3639571|NCT02526524|3487627|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3639572|NCT02526524|3487621|B7||Male|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
3639573|NCT02526524|3487622|B6||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3639574|NCT02526524|3487623|B5||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3639575|NCT02526524|3487624|B4||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3639576|NCT02526524|3487625|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3639577|NCT02526524|3487626|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3639578|NCT02526524|3487627|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3639579|NCT02526524|3487621|B7||Female|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
3639580|NCT02526524|3487622|B6||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3639581|NCT02526524|3487623|B5||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3639582|NCT02526524|3487624|B4||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3639583|NCT02526524|3487625|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3639584|NCT02526524|3487626|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3639585|NCT02526524|3487627|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3639586|NCT02526524|3487621|B7|||Age||years|Mean|56|56.0|Standard Deviation|10.5|10.5|||
3639587|NCT02526524|3487622|B6|||Age||years|Mean|57|57.0|Standard Deviation|11.1|11.1|||
3639588|NCT02526524|3487623|B5|||Age||years|Mean|57|57.0|Standard Deviation|11.0|11.0|||
3639589|NCT02526524|3487624|B4|||Age||years|Mean|55|55.0|Standard Deviation|8.9|8.9|||
3639590|NCT02526524|3487625|B3|||Age||years|Mean|55|55.0|Standard Deviation|11.1|11.1|||
3639591|NCT02526524|3487626|B2|||Age||years|Mean|55|55.0|Standard Deviation|10.5|10.5|||
3639592|NCT02526524|3487627|B1|||Age||years|Mean|56|56.0|Standard Deviation|10.2|10.2|||
3639593|NCT02526290|3487646|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3639594|NCT02526290|3487646|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3639595|NCT02526290|3487646|B1|≥70 years||Age, Customized||participants|Number|17|17.0||||||
3639596|NCT02526290|3487646|B1|60 to <70 years||Age, Customized||participants|Number|40|40.0||||||
3639597|NCT02526290|3487646|B1|50 to <60 years||Age, Customized||participants|Number|25|25.0||||||
3639598|NCT02526290|3487646|B1|< 50 years||Age, Customized||participants|Number|15|15.0||||||
3639599|NCT02525536|3487653|B4|||Region of Enrollment|Enrollment in Japan is reported in this measure.|participants|Number|18|18.0||||||
3639600|NCT02525536|3487654|B3|||Region of Enrollment|Enrollment in Japan is reported in this measure.|participants|Number|6|6.0||||||
3639601|NCT02525536|3487655|B2|||Region of Enrollment|Enrollment in Japan is reported in this measure.|participants|Number|6|6.0||||||
3639602|NCT02525536|3487656|B1|||Region of Enrollment|Enrollment in Japan is reported in this measure.|participants|Number|6|6.0||||||
3639603|NCT02525536|3487653|B4|Without Non-Target Lesions||Presence of Non-Target Lesions||participants|Number|0|0.0||||||
3639604|NCT02525536|3487654|B3|Without Non-Target Lesions||Presence of Non-Target Lesions||participants|Number|0|0.0||||||
3639605|NCT02525536|3487655|B2|Without Non-Target Lesions||Presence of Non-Target Lesions||participants|Number|0|0.0||||||
3639606|NCT02525536|3487656|B1|Without Non-Target Lesions||Presence of Non-Target Lesions||participants|Number|0|0.0||||||
3639607|NCT02525536|3487653|B4|With Non-Target Lesions||Presence of Non-Target Lesions||participants|Number|18|18.0||||||
3639608|NCT02525536|3487654|B3|With Non-Target Lesions||Presence of Non-Target Lesions||participants|Number|6|6.0||||||
3639609|NCT02525536|3487655|B2|With Non-Target Lesions||Presence of Non-Target Lesions||participants|Number|6|6.0||||||
3639610|NCT02525536|3487656|B1|With Non-Target Lesions||Presence of Non-Target Lesions||participants|Number|6|6.0||||||
3639611|NCT02525536|3487653|B4|||Sum of the Longest Diameter of Target Lesions||millimeters|Mean|129.5|129.5|Standard Deviation|91.04|91.04|||
3639612|NCT02525536|3487654|B3|||Sum of the Longest Diameter of Target Lesions||millimeters|Mean|96.8|96.8|Standard Deviation|63.07|63.07|||
3639613|NCT02525536|3487655|B2|||Sum of the Longest Diameter of Target Lesions||millimeters|Mean|179.3|179.3|Standard Deviation|99.23|99.23|||
3639614|NCT02525536|3487656|B1|||Sum of the Longest Diameter of Target Lesions||millimeters|Mean|112.3|112.3|Standard Deviation|98.70|98.7|||
3639615|NCT02525536|3487653|B4|>=5 Target Lesion||Number of Target Lesions||participants|Number|8|8.0||||||
3639616|NCT02525536|3487654|B3|>=5 Target Lesion||Number of Target Lesions||participants|Number|1|1.0||||||
3639617|NCT02525536|3487655|B2|>=5 Target Lesion||Number of Target Lesions||participants|Number|5|5.0||||||
3639618|NCT02525536|3487656|B1|>=5 Target Lesion||Number of Target Lesions||participants|Number|2|2.0||||||
3639619|NCT02525536|3487653|B4|4 Target Lesion||Number of Target Lesions||participants|Number|2|2.0||||||
3639620|NCT02525536|3487654|B3|4 Target Lesion||Number of Target Lesions||participants|Number|2|2.0||||||
3639621|NCT02525536|3487655|B2|4 Target Lesion||Number of Target Lesions||participants|Number|0|0.0||||||
3639622|NCT02525536|3487656|B1|4 Target Lesion||Number of Target Lesions||participants|Number|0|0.0||||||
3639623|NCT02525536|3487653|B4|3 Target Lesion||Number of Target Lesions||participants|Number|2|2.0||||||
3639624|NCT02525536|3487654|B3|3 Target Lesion||Number of Target Lesions||participants|Number|0|0.0||||||
3639625|NCT02525536|3487655|B2|3 Target Lesion||Number of Target Lesions||participants|Number|0|0.0||||||
3639626|NCT02525536|3487656|B1|3 Target Lesion||Number of Target Lesions||participants|Number|2|2.0||||||
3639627|NCT02525536|3487653|B4|2 Target Lesion||Number of Target Lesions||participants|Number|4|4.0||||||
3639628|NCT02525536|3487654|B3|2 Target Lesion||Number of Target Lesions||participants|Number|2|2.0||||||
3639629|NCT02525536|3487655|B2|2 Target Lesion||Number of Target Lesions||participants|Number|0|0.0||||||
3639630|NCT02525536|3487656|B1|2 Target Lesion||Number of Target Lesions||participants|Number|2|2.0||||||
3639631|NCT02525536|3487653|B4|1 Target Lesion||Number of Target Lesions||participants|Number|2|2.0||||||
3639632|NCT02525536|3487654|B3|1 Target Lesion||Number of Target Lesions||participants|Number|1|1.0||||||
3639633|NCT02525536|3487655|B2|1 Target Lesion||Number of Target Lesions||participants|Number|1|1.0||||||
3639634|NCT02525536|3487656|B1|1 Target Lesion||Number of Target Lesions||participants|Number|0|0.0||||||
3639635|NCT02525536|3487653|B4|Magnetic Resonance Imaging (MRI)||Method of Tumor Assessment||participants|Number|0|0.0||||||
3639636|NCT02525536|3487654|B3|Magnetic Resonance Imaging (MRI)||Method of Tumor Assessment||participants|Number|0|0.0||||||
3639637|NCT02525536|3487655|B2|Magnetic Resonance Imaging (MRI)||Method of Tumor Assessment||participants|Number|0|0.0||||||
3639638|NCT02525536|3487656|B1|Magnetic Resonance Imaging (MRI)||Method of Tumor Assessment||participants|Number|0|0.0||||||
3639639|NCT02525536|3487653|B4|Computed Tomography (CT)||Method of Tumor Assessment||participants|Number|18|18.0||||||
3639640|NCT02525536|3487654|B3|Computed Tomography (CT)||Method of Tumor Assessment||participants|Number|6|6.0||||||
3639641|NCT02525536|3487655|B2|Computed Tomography (CT)||Method of Tumor Assessment||participants|Number|6|6.0||||||
3639642|NCT02525536|3487656|B1|Computed Tomography (CT)||Method of Tumor Assessment||participants|Number|6|6.0||||||
3639643|NCT02525536|3487653|B4|ECOG performance status 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance status was defined as: 0 = fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (example, light house work, office work); 2 = Ambulatory and capable of all self-care but unable to carry out work activities. Up and about >50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair >50% of waking hours; 4 = completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; or 5 = Dead.|participants|Number|1|1.0||||||
3639644|NCT02525536|3487654|B3|ECOG performance status 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance status was defined as: 0 = fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (example, light house work, office work); 2 = Ambulatory and capable of all self-care but unable to carry out work activities. Up and about >50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair >50% of waking hours; 4 = completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; or 5 = Dead.|participants|Number|1|1.0||||||
3639645|NCT02525536|3487655|B2|ECOG performance status 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance status was defined as: 0 = fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (example, light house work, office work); 2 = Ambulatory and capable of all self-care but unable to carry out work activities. Up and about >50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair >50% of waking hours; 4 = completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; or 5 = Dead.|participants|Number|0|0.0||||||
3639646|NCT02525536|3487656|B1|ECOG performance status 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance status was defined as: 0 = fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (example, light house work, office work); 2 = Ambulatory and capable of all self-care but unable to carry out work activities. Up and about >50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair >50% of waking hours; 4 = completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; or 5 = Dead.|participants|Number|0|0.0||||||
3639647|NCT02525536|3487653|B4|ECOG performance status 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance status was defined as: 0 = fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (example, light house work, office work); 2 = Ambulatory and capable of all self-care but unable to carry out work activities. Up and about >50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair >50% of waking hours; 4 = completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; or 5 = Dead.|participants|Number|17|17.0||||||
3639695|NCT02525536|3487653|B4|Without medical and surgical history||Medical and surgical history||participants|Number|3|3.0||||||
3639648|NCT02525536|3487654|B3|ECOG performance status 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance status was defined as: 0 = fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (example, light house work, office work); 2 = Ambulatory and capable of all self-care but unable to carry out work activities. Up and about >50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair >50% of waking hours; 4 = completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; or 5 = Dead.|participants|Number|5|5.0||||||
3639649|NCT02525536|3487655|B2|ECOG performance status 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance status was defined as: 0 = fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (example, light house work, office work); 2 = Ambulatory and capable of all self-care but unable to carry out work activities. Up and about >50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair >50% of waking hours; 4 = completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; or 5 = Dead.|participants|Number|6|6.0||||||
3639650|NCT02525536|3487656|B1|ECOG performance status 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance status was defined as: 0 = fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (example, light house work, office work); 2 = Ambulatory and capable of all self-care but unable to carry out work activities. Up and about >50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair >50% of waking hours; 4 = completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; or 5 = Dead.|participants|Number|6|6.0||||||
3639651|NCT02525536|3487653|B4|Without prior other cancer medication||Prior Other Cancer Medication||participants|Number|0|0.0||||||
3639652|NCT02525536|3487654|B3|Without prior other cancer medication||Prior Other Cancer Medication||participants|Number|0|0.0||||||
3639653|NCT02525536|3487655|B2|Without prior other cancer medication||Prior Other Cancer Medication||participants|Number|0|0.0||||||
3639654|NCT02525536|3487656|B1|Without prior other cancer medication||Prior Other Cancer Medication||participants|Number|0|0.0||||||
3639655|NCT02525536|3487653|B4|With prior other cancer medication||Prior Other Cancer Medication||participants|Number|18|18.0||||||
3639656|NCT02525536|3487654|B3|With prior other cancer medication||Prior Other Cancer Medication||participants|Number|6|6.0||||||
3639657|NCT02525536|3487655|B2|With prior other cancer medication||Prior Other Cancer Medication||participants|Number|6|6.0||||||
3639658|NCT02525536|3487656|B1|With prior other cancer medication||Prior Other Cancer Medication||participants|Number|6|6.0||||||
3639659|NCT02525536|3487653|B4|Without prior radiotherapy||Prior Radiotherapy||participants|Number|16|16.0||||||
3639660|NCT02525536|3487654|B3|Without prior radiotherapy||Prior Radiotherapy||participants|Number|6|6.0||||||
3639661|NCT02525536|3487655|B2|Without prior radiotherapy||Prior Radiotherapy||participants|Number|4|4.0||||||
3639662|NCT02525536|3487656|B1|Without prior radiotherapy||Prior Radiotherapy||participants|Number|6|6.0||||||
3639663|NCT02525536|3487653|B4|With prior radiotherapy||Prior Radiotherapy||participants|Number|2|2.0||||||
3639664|NCT02525536|3487654|B3|With prior radiotherapy||Prior Radiotherapy||participants|Number|0|0.0||||||
3639665|NCT02525536|3487655|B2|With prior radiotherapy||Prior Radiotherapy||participants|Number|2|2.0||||||
3639666|NCT02525536|3487656|B1|With prior radiotherapy||Prior Radiotherapy||participants|Number|0|0.0||||||
3639667|NCT02525536|3487653|B4|Neoplasm, uterine||Primary Tumor Type||participants|Number|1|1.0||||||
3639668|NCT02525536|3487654|B3|Neoplasm, uterine||Primary Tumor Type||participants|Number|0|0.0||||||
3639669|NCT02525536|3487655|B2|Neoplasm, uterine||Primary Tumor Type||participants|Number|1|1.0||||||
3639670|NCT02525536|3487656|B1|Neoplasm, uterine||Primary Tumor Type||participants|Number|0|0.0||||||
3639671|NCT02525536|3487653|B4|Neoplasm, breast||Primary Tumor Type||participants|Number|1|1.0||||||
3639672|NCT02525536|3487654|B3|Neoplasm, breast||Primary Tumor Type||participants|Number|0|0.0||||||
3639673|NCT02525536|3487655|B2|Neoplasm, breast||Primary Tumor Type||participants|Number|1|1.0||||||
3639674|NCT02525536|3487656|B1|Neoplasm, breast||Primary Tumor Type||participants|Number|0|0.0||||||
3639675|NCT02525536|3487653|B4|Neoplasm, bladder||Primary Tumor Type||participants|Number|1|1.0||||||
3639676|NCT02525536|3487654|B3|Neoplasm, bladder||Primary Tumor Type||participants|Number|1|1.0||||||
3639677|NCT02525536|3487655|B2|Neoplasm, bladder||Primary Tumor Type||participants|Number|0|0.0||||||
3639678|NCT02525536|3487656|B1|Neoplasm, bladder||Primary Tumor Type||participants|Number|0|0.0||||||
3639679|NCT02525536|3487653|B4|Neoplasm, colon||Primary Tumor Type||participants|Number|2|2.0||||||
3639680|NCT02525536|3487654|B3|Neoplasm, colon||Primary Tumor Type||participants|Number|0|0.0||||||
3639681|NCT02525536|3487655|B2|Neoplasm, colon||Primary Tumor Type||participants|Number|1|1.0||||||
3639682|NCT02525536|3487656|B1|Neoplasm, colon||Primary Tumor Type||participants|Number|1|1.0||||||
3639683|NCT02525536|3487653|B4|Neoplasm, pancreatic||Primary Tumor Type||participants|Number|3|3.0||||||
3639684|NCT02525536|3487654|B3|Neoplasm, pancreatic||Primary Tumor Type||participants|Number|1|1.0||||||
3639685|NCT02525536|3487655|B2|Neoplasm, pancreatic||Primary Tumor Type||participants|Number|1|1.0||||||
3639686|NCT02525536|3487656|B1|Neoplasm, pancreatic||Primary Tumor Type||participants|Number|1|1.0||||||
3639687|NCT02525536|3487653|B4|Neoplasm, rectal||Primary Tumor Type||participants|Number|4|4.0||||||
3639688|NCT02525536|3487654|B3|Neoplasm, rectal||Primary Tumor Type||participants|Number|1|1.0||||||
3639689|NCT02525536|3487655|B2|Neoplasm, rectal||Primary Tumor Type||participants|Number|2|2.0||||||
3639690|NCT02525536|3487656|B1|Neoplasm, rectal||Primary Tumor Type||participants|Number|1|1.0||||||
3639691|NCT02525536|3487653|B4|Neoplasm, stomach||Primary Tumor Type||participants|Number|6|6.0||||||
3639692|NCT02525536|3487654|B3|Neoplasm, stomach||Primary Tumor Type||participants|Number|3|3.0||||||
3639696|NCT02525536|3487654|B3|Without medical and surgical history||Medical and surgical history||participants|Number|1|1.0||||||
3639697|NCT02525536|3487655|B2|Without medical and surgical history||Medical and surgical history||participants|Number|2|2.0||||||
3639698|NCT02525536|3487656|B1|Without medical and surgical history||Medical and surgical history||participants|Number|0|0.0||||||
3639699|NCT02525536|3487653|B4|With medical and surgical history||Medical and surgical history||participants|Number|15|15.0||||||
3639700|NCT02525536|3487654|B3|With medical and surgical history||Medical and surgical history||participants|Number|5|5.0||||||
3639701|NCT02525536|3487655|B2|With medical and surgical history||Medical and surgical history||participants|Number|4|4.0||||||
3639702|NCT02525536|3487656|B1|With medical and surgical history||Medical and surgical history||participants|Number|6|6.0||||||
3639703|NCT02525536|3487653|B4|||Weight||kilogram|Mean|55.74|55.74|Standard Deviation|10.257|10.257|||
3639704|NCT02525536|3487654|B3|||Weight||kilogram|Mean|50.40|50.4|Standard Deviation|3.683|3.683|||
3639705|NCT02525536|3487655|B2|||Weight||kilogram|Mean|64.03|64.03|Standard Deviation|10.623|10.623|||
3639706|NCT02525536|3487656|B1|||Weight||kilogram|Mean|52.80|52.8|Standard Deviation|10.208|10.208|||
3639707|NCT02525536|3487653|B4|||Height||centimeter|Mean|161.28|161.28|Standard Deviation|7.938|7.938|||
3639708|NCT02525536|3487654|B3|||Height||centimeter|Mean|160.48|160.48|Standard Deviation|3.136|3.136|||
3639709|NCT02525536|3487655|B2|||Height||centimeter|Mean|161.08|161.08|Standard Deviation|12.788|12.788|||
3639710|NCT02525536|3487656|B1|||Height||centimeter|Mean|162.28|162.28|Standard Deviation|6.233|6.233|||
3639711|NCT02525536|3487653|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3639712|NCT02525536|3487654|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3639713|NCT02525536|3487655|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3639714|NCT02525536|3487656|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3639715|NCT02525536|3487653|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3639716|NCT02525536|3487654|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3639717|NCT02525536|3487655|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3639718|NCT02525536|3487656|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3639719|NCT02525536|3487653|B4|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|6|6.0||||||
3639720|NCT02525536|3487654|B3|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|3|3.0||||||
3639721|NCT02525536|3487655|B2|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|1|1.0||||||
3639722|NCT02525536|3487656|B1|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|2|2.0||||||
3639723|NCT02525536|3487653|B4|Less than (<) 65 years||Age, Customized||participants|Number|12|12.0||||||
3639724|NCT02525536|3487654|B3|Less than (<) 65 years||Age, Customized||participants|Number|3|3.0||||||
3639725|NCT02525536|3487655|B2|Less than (<) 65 years||Age, Customized||participants|Number|5|5.0||||||
3639726|NCT02525536|3487656|B1|Less than (<) 65 years||Age, Customized||participants|Number|4|4.0||||||
3639727|NCT02525536|3487653|B4|||Age||years|Mean|57.9|57.9|Standard Deviation|8.22|8.22|||
3639728|NCT02525536|3487654|B3|||Age||years|Mean|60.7|60.7|Standard Deviation|6.71|6.71|||
3639729|NCT02525536|3487655|B2|||Age||years|Mean|55.3|55.3|Standard Deviation|7.71|7.71|||
3639730|NCT02525536|3487656|B1|||Age||years|Mean|57.7|57.7|Standard Deviation|10.41|10.41|||
3639731|NCT02525094|3487729|B3||Missing|Atopic Dermatitis Status||Participants|Count of Participants|2|2.0||||||
3639732|NCT02525094|3487730|B2||Missing|Atopic Dermatitis Status||Participants|Count of Participants|2|2.0||||||
3639733|NCT02525094|3487731|B1||Missing|Atopic Dermatitis Status||Participants|Count of Participants|0|0.0||||||
3639734|NCT02525094|3487729|B3||IgE < 150 kU/L and Negative Serum Specific IgEb|Atopic Dermatitis Status||Participants|Count of Participants|4|4.0||||||
3639735|NCT02525094|3487730|B2||IgE < 150 kU/L and Negative Serum Specific IgEb|Atopic Dermatitis Status||Participants|Count of Participants|3|3.0||||||
3639736|NCT02525094|3487731|B1||IgE < 150 kU/L and Negative Serum Specific IgEb|Atopic Dermatitis Status||Participants|Count of Participants|1|1.0||||||
3639737|NCT02525094|3487729|B3||IgE < 150 kU/L and Positive Serum Specific IgE|Atopic Dermatitis Status||Participants|Count of Participants|6|6.0||||||
3639738|NCT02525094|3487730|B2||IgE < 150 kU/L and Positive Serum Specific IgE|Atopic Dermatitis Status||Participants|Count of Participants|3|3.0||||||
3639739|NCT02525094|3487731|B1||IgE < 150 kU/L and Positive Serum Specific IgE|Atopic Dermatitis Status||Participants|Count of Participants|3|3.0||||||
3639740|NCT02525094|3487729|B3||IgE >= 150 kU/L and Negative Serum Specific IgE|Atopic Dermatitis Status||Participants|Count of Participants|2|2.0||||||
3639741|NCT02525094|3487730|B2||IgE >= 150 kU/L and Negative Serum Specific IgE|Atopic Dermatitis Status||Participants|Count of Participants|0|0.0||||||
3639742|NCT02525094|3487731|B1||IgE >= 150 kU/L and Negative Serum Specific IgE|Atopic Dermatitis Status||Participants|Count of Participants|2|2.0||||||
3639743|NCT02525094|3487729|B3||IgE >= 150 kU/L and Positive Serum Specific IgEa|Atopic Dermatitis Status||Participants|Count of Participants|97|97.0||||||
3639744|NCT02525094|3487730|B2||IgE >= 150 kU/L and Positive Serum Specific IgEa|Atopic Dermatitis Status||Participants|Count of Participants|47|47.0||||||
3639745|NCT02525094|3487731|B1||IgE >= 150 kU/L and Positive Serum Specific IgEa|Atopic Dermatitis Status||Participants|Count of Participants|50|50.0||||||
3639746|NCT02525094|3487729|B3||Category 4|Investigator's Global Assessment|The investigator’s global assessment (IGA) allows investigators to assess overall disease severity at one given time point and consists of a 5-point severity scale from clear to severe disease (0 = clear, 1 = almost clear, 2 = mild disease, 3 = moderate disease, and 4 = severe disease).|Participants|Count of Participants|20|20.0||||||
3639769|NCT02525094|3487731|B1||36-75 years|Age, Customized||Participants|Count of Participants|28|28.0||||||
3639770|NCT02525094|3487729|B3||18-35 years|Age, Customized||Participants|Count of Participants|55|55.0||||||
3639747|NCT02525094|3487730|B2||Category 4|Investigator's Global Assessment|The investigator’s global assessment (IGA) allows investigators to assess overall disease severity at one given time point and consists of a 5-point severity scale from clear to severe disease (0 = clear, 1 = almost clear, 2 = mild disease, 3 = moderate disease, and 4 = severe disease).|Participants|Count of Participants|10|10.0||||||
3639748|NCT02525094|3487731|B1||Category 4|Investigator's Global Assessment|The investigator’s global assessment (IGA) allows investigators to assess overall disease severity at one given time point and consists of a 5-point severity scale from clear to severe disease (0 = clear, 1 = almost clear, 2 = mild disease, 3 = moderate disease, and 4 = severe disease).|Participants|Count of Participants|10|10.0||||||
3639749|NCT02525094|3487729|B3||Category 3|Investigator's Global Assessment|The investigator’s global assessment (IGA) allows investigators to assess overall disease severity at one given time point and consists of a 5-point severity scale from clear to severe disease (0 = clear, 1 = almost clear, 2 = mild disease, 3 = moderate disease, and 4 = severe disease).|Participants|Count of Participants|90|90.0||||||
3639750|NCT02525094|3487730|B2||Category 3|Investigator's Global Assessment|The investigator’s global assessment (IGA) allows investigators to assess overall disease severity at one given time point and consists of a 5-point severity scale from clear to severe disease (0 = clear, 1 = almost clear, 2 = mild disease, 3 = moderate disease, and 4 = severe disease).|Participants|Count of Participants|44|44.0||||||
3639751|NCT02525094|3487731|B1||Category 3|Investigator's Global Assessment|The investigator’s global assessment (IGA) allows investigators to assess overall disease severity at one given time point and consists of a 5-point severity scale from clear to severe disease (0 = clear, 1 = almost clear, 2 = mild disease, 3 = moderate disease, and 4 = severe disease).|Participants|Count of Participants|46|46.0||||||
3639752|NCT02525094|3487729|B3||Category 2|Investigator's Global Assessment|The investigator’s global assessment (IGA) allows investigators to assess overall disease severity at one given time point and consists of a 5-point severity scale from clear to severe disease (0 = clear, 1 = almost clear, 2 = mild disease, 3 = moderate disease, and 4 = severe disease).|Participants|Count of Participants|1|1.0||||||
3639753|NCT02525094|3487730|B2||Category 2|Investigator's Global Assessment|The investigator’s global assessment (IGA) allows investigators to assess overall disease severity at one given time point and consists of a 5-point severity scale from clear to severe disease (0 = clear, 1 = almost clear, 2 = mild disease, 3 = moderate disease, and 4 = severe disease).|Participants|Count of Participants|1|1.0||||||
3639754|NCT02525094|3487731|B1||Category 2|Investigator's Global Assessment|The investigator’s global assessment (IGA) allows investigators to assess overall disease severity at one given time point and consists of a 5-point severity scale from clear to severe disease (0 = clear, 1 = almost clear, 2 = mild disease, 3 = moderate disease, and 4 = severe disease).|Participants|Count of Participants|0|0.0||||||
3639755|NCT02525094|3487729|B3||> 25 points|Eczema Area and Severity Index Score|The eczema area and severity index (EASI) evaluates 4 natural anatomical regions for severity (0 [none] to 3 [severe]) and extent of key disease signs and focuses on the key acute and chronic signs of inflammation (erythema, induration/papulation, excoriation, and lichenification). The total score is the sum of the four body-region scores, maximum=72, minimum=0. The higher values indicating more severe disease.|Participants|Count of Participants|42|42.0||||||
3639756|NCT02525094|3487730|B2||> 25 points|Eczema Area and Severity Index Score|The eczema area and severity index (EASI) evaluates 4 natural anatomical regions for severity (0 [none] to 3 [severe]) and extent of key disease signs and focuses on the key acute and chronic signs of inflammation (erythema, induration/papulation, excoriation, and lichenification). The total score is the sum of the four body-region scores, maximum=72, minimum=0. The higher values indicating more severe disease.|Participants|Count of Participants|22|22.0||||||
3639757|NCT02525094|3487731|B1||> 25 points|Eczema Area and Severity Index Score|The eczema area and severity index (EASI) evaluates 4 natural anatomical regions for severity (0 [none] to 3 [severe]) and extent of key disease signs and focuses on the key acute and chronic signs of inflammation (erythema, induration/papulation, excoriation, and lichenification). The total score is the sum of the four body-region scores, maximum=72, minimum=0. The higher values indicating more severe disease.|Participants|Count of Participants|20|20.0||||||
3639758|NCT02525094|3487729|B3||<= 25 points|Eczema Area and Severity Index Score|The eczema area and severity index (EASI) evaluates 4 natural anatomical regions for severity (0 [none] to 3 [severe]) and extent of key disease signs and focuses on the key acute and chronic signs of inflammation (erythema, induration/papulation, excoriation, and lichenification). The total score is the sum of the four body-region scores, maximum=72, minimum=0. The higher values indicating more severe disease.|Participants|Count of Participants|69|69.0||||||
3639759|NCT02525094|3487730|B2||<= 25 points|Eczema Area and Severity Index Score|The eczema area and severity index (EASI) evaluates 4 natural anatomical regions for severity (0 [none] to 3 [severe]) and extent of key disease signs and focuses on the key acute and chronic signs of inflammation (erythema, induration/papulation, excoriation, and lichenification). The total score is the sum of the four body-region scores, maximum=72, minimum=0. The higher values indicating more severe disease.|Participants|Count of Participants|33|33.0||||||
3639760|NCT02525094|3487731|B1||<= 25 points|Eczema Area and Severity Index Score|The eczema area and severity index (EASI) evaluates 4 natural anatomical regions for severity (0 [none] to 3 [severe]) and extent of key disease signs and focuses on the key acute and chronic signs of inflammation (erythema, induration/papulation, excoriation, and lichenification). The total score is the sum of the four body-region scores, maximum=72, minimum=0. The higher values indicating more severe disease.|Participants|Count of Participants|36|36.0||||||
3639761|NCT02525094|3487729|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3639762|NCT02525094|3487730|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3639763|NCT02525094|3487731|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3639764|NCT02525094|3487729|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3639765|NCT02525094|3487730|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3639766|NCT02525094|3487731|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3639767|NCT02525094|3487729|B3||36-75 years|Age, Customized||Participants|Count of Participants|56|56.0||||||
3639768|NCT02525094|3487730|B2||36-75 years|Age, Customized||Participants|Count of Participants|28|28.0||||||
3639771|NCT02525094|3487730|B2||18-35 years|Age, Customized||Participants|Count of Participants|27|27.0||||||
3639772|NCT02525094|3487731|B1||18-35 years|Age, Customized||Participants|Count of Participants|28|28.0||||||
3639773|NCT02525094|3487729|B3|||Age||Years|Mean|38.7|38.7|Standard Deviation|15.0|15.0|||
3639774|NCT02525094|3487730|B2|||Age||Years|Mean|38.5|38.5|Standard Deviation|14.9|14.9|||
3639775|NCT02525094|3487731|B1|||Age||Years|Mean|38.8|38.8|Standard Deviation|15.3|15.3|||
3639776|NCT02524977|3487759|B3|||Proportion Receiving Oral Anticoagulant Therapy||participants|Number|746|746.0||||||
3639777|NCT02524977|3487760|B2|||Proportion Receiving Oral Anticoagulant Therapy||participants|Number|400|400.0||||||
3639778|NCT02524977|3487761|B1|||Proportion Receiving Oral Anticoagulant Therapy||participants|Number|346|346.0||||||
3639779|NCT02524977|3487759|B3|||HAS-BLED|Scoring Details for HAS-BLED. Used to quantify risk of major bleeding in AF patients receiving treatment with warfarin. HAS-BLED is an acronym. Each letter stands for a risk factor, assigning 1 point for each: poorly controlled Hypertension, Abnormal renal or liver function (one point each), Stroke history, Bleeding history, Labile INR (time in therapeutic range < 60%), Elderly (age ≥ 65), Drugs or alcohol (1 point each – alcohol abuse, or concomitant use of antiplatelet or non-steroidal anti-inflammatory drugs). Risk of major bleeding ranges from 0 (score of 0) to 15.5% (score of 6) per year.|units on a scale|Mean|2.12|2.12|Standard Deviation|1.19|1.19|||
3639780|NCT02524977|3487760|B2|||HAS-BLED|Scoring Details for HAS-BLED. Used to quantify risk of major bleeding in AF patients receiving treatment with warfarin. HAS-BLED is an acronym. Each letter stands for a risk factor, assigning 1 point for each: poorly controlled Hypertension, Abnormal renal or liver function (one point each), Stroke history, Bleeding history, Labile INR (time in therapeutic range < 60%), Elderly (age ≥ 65), Drugs or alcohol (1 point each – alcohol abuse, or concomitant use of antiplatelet or non-steroidal anti-inflammatory drugs). Risk of major bleeding ranges from 0 (score of 0) to 15.5% (score of 6) per year.|units on a scale|Mean|2.07|2.07|Standard Deviation|1.15|1.15|||
3639781|NCT02524977|3487761|B1|||HAS-BLED|Scoring Details for HAS-BLED. Used to quantify risk of major bleeding in AF patients receiving treatment with warfarin. HAS-BLED is an acronym. Each letter stands for a risk factor, assigning 1 point for each: poorly controlled Hypertension, Abnormal renal or liver function (one point each), Stroke history, Bleeding history, Labile INR (time in therapeutic range < 60%), Elderly (age ≥ 65), Drugs or alcohol (1 point each – alcohol abuse, or concomitant use of antiplatelet or non-steroidal anti-inflammatory drugs). Risk of major bleeding ranges from 0 (score of 0) to 15.5% (score of 6) per year.|units on a scale|Mean|2.18|2.18|Standard Deviation|1.20|1.2|||
3639782|NCT02524977|3487759|B3|||CHADSVASc|Scoring Details for CHA2DS2VASc Used to quantify ischemic stroke risk in AF patients.(1) CHA2DS2VASc is an acronym. Each letter stands for a risk factor, assigning 1 point for each of the following: Congestive heart failure, Hypertension, Age 65 - 74, Diabetes, Vascular disease (prior myocardial infarction, peripheral arterial disease, or aortic plaque), and female Sex category. Two points are assigned for a history of Stroke or transient ischemic attack, and Age ≥ 75 years. Score range is 0 - 9. Stroke risk ranges from 0 (for score of zero) to 15.2%/year (for score of 9).|units on a scale|Mean|3.67|3.67|Standard Deviation|1.91|1.91|||
3639783|NCT02524977|3487760|B2|||CHADSVASc|Scoring Details for CHA2DS2VASc Used to quantify ischemic stroke risk in AF patients.(1) CHA2DS2VASc is an acronym. Each letter stands for a risk factor, assigning 1 point for each of the following: Congestive heart failure, Hypertension, Age 65 - 74, Diabetes, Vascular disease (prior myocardial infarction, peripheral arterial disease, or aortic plaque), and female Sex category. Two points are assigned for a history of Stroke or transient ischemic attack, and Age ≥ 75 years. Score range is 0 - 9. Stroke risk ranges from 0 (for score of zero) to 15.2%/year (for score of 9).|units on a scale|Mean|3.60|3.6|Standard Deviation|1.86|1.86|||
3639784|NCT02524977|3487761|B1|||CHADSVASc|Scoring Details for CHA2DS2VASc Used to quantify ischemic stroke risk in AF patients.(1) CHA2DS2VASc is an acronym. Each letter stands for a risk factor, assigning 1 point for each of the following: Congestive heart failure, Hypertension, Age 65 - 74, Diabetes, Vascular disease (prior myocardial infarction, peripheral arterial disease, or aortic plaque), and female Sex category. Two points are assigned for a history of Stroke or transient ischemic attack, and Age ≥ 75 years. Score range is 0 - 9. Stroke risk ranges from 0 (for score of zero) to 15.2%/year (for score of 9).|units on a scale|Mean|3.74|3.74|Standard Deviation|1.93|1.93|||
3639785|NCT02524977|3487759|B3||Male|Sex: Female, Male||Participants|Count of Participants|809|809.0||||||
3639786|NCT02524977|3487760|B2||Male|Sex: Female, Male||Participants|Count of Participants|449|449.0||||||
3639787|NCT02524977|3487761|B1||Male|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
3639788|NCT02524977|3487759|B3||Female|Sex: Female, Male||Participants|Count of Participants|684|684.0||||||
3639789|NCT02524977|3487760|B2||Female|Sex: Female, Male||Participants|Count of Participants|352|352.0||||||
3639790|NCT02524977|3487761|B1||Female|Sex: Female, Male||Participants|Count of Participants|332|332.0||||||
3639791|NCT02524977|3487759|B3|Mean Age||Age||years|Mean|70|70.0|Standard Deviation|13.0|13.0|||
3639792|NCT02524977|3487760|B2|Mean Age||Age||years|Mean|70.2|70.2|Standard Deviation|13.3|13.3|||
3639793|NCT02524977|3487761|B1|Mean Age||Age||years|Mean|69.8|69.8|Standard Deviation|13.5|13.5|||
3639794|NCT02524665|3487770|B1|White||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
3639795|NCT02524665|3487770|B1|Black||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3639796|NCT02524665|3487770|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3639797|NCT02524665|3487770|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3639798|NCT02524665|3487770|B1|||Age||Years|Mean|22.5|22.5|Standard Deviation|4.6|4.6|||
3639799|NCT02524561|3487785|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3639800|NCT02524561|3487786|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3639801|NCT02524561|3487787|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3639802|NCT02524561|3487788|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3639803|NCT02524561|3487785|B4||Female|Sex: Female, Male||Participants|Count of Participants|488|488.0||||||
3639804|NCT02524561|3487786|B3||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
3639805|NCT02524561|3487787|B2||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3639806|NCT02524561|3487788|B1||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3639807|NCT02524561|3487785|B4|||Age||years|Mean|52.7|52.7|Standard Deviation|2.5|2.5|||
3639808|NCT02524561|3487786|B3|||Age||years|Mean|52.6|52.6|Standard Deviation|2.4|2.4|||
3639809|NCT02524561|3487787|B2|||Age||years|Mean|52.8|52.8|Standard Deviation|2.5|2.5|||
3639810|NCT02524561|3487788|B1|||Age||years|Mean|52.7|52.7|Standard Deviation|2.7|2.7|||
3639811|NCT02524418|3487807|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
3639812|NCT02524418|3487807|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3639813|NCT02524418|3487807|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3639814|NCT02524418|3487807|B1|||Age||years|Mean|66|66.0|Full Range|||22.0|96.0|
3639815|NCT02524288|3487821|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3639816|NCT02524288|3487821|B1||Female|Sex: Female, Male||Participants|Count of Participants|1941|1941.0||||||
3639817|NCT02524288|3487821|B1|||Age||Years|Mean|27.6|27.6|Standard Deviation|6.2|6.2|||
3639818|NCT02524158|3487829|B3|United States||Region of Enrollment||Participants|Count of Participants|150|150.0||||||
3639819|NCT02524158|3487830|B2|United States||Region of Enrollment||Participants|Count of Participants|75|75.0||||||
3639820|NCT02524158|3487831|B1|United States||Region of Enrollment||Participants|Count of Participants|75|75.0||||||
3639821|NCT02524158|3487829|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639822|NCT02524158|3487830|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639823|NCT02524158|3487831|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639824|NCT02524158|3487829|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3639825|NCT02524158|3487830|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3639826|NCT02524158|3487831|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3639827|NCT02524158|3487829|B3||White|Race (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
3639828|NCT02524158|3487830|B2||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3639829|NCT02524158|3487831|B1||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3639830|NCT02524158|3487829|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3639831|NCT02524158|3487830|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3639832|NCT02524158|3487831|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3639833|NCT02524158|3487829|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639834|NCT02524158|3487830|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639835|NCT02524158|3487831|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639836|NCT02524158|3487829|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3639837|NCT02524158|3487830|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3639838|NCT02524158|3487831|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3639839|NCT02524158|3487829|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3639840|NCT02524158|3487830|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3639841|NCT02524158|3487831|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3639842|NCT02524158|3487829|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639843|NCT02524158|3487830|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639844|NCT02524158|3487831|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639845|NCT02524158|3487829|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
3639846|NCT02524158|3487830|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3639847|NCT02524158|3487831|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3639848|NCT02524158|3487829|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3639849|NCT02524158|3487830|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3639850|NCT02524158|3487831|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3639851|NCT02524158|3487829|B3||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3639852|NCT02524158|3487830|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3639853|NCT02524158|3487831|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3639854|NCT02524158|3487829|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3639855|NCT02524158|3487830|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3639856|NCT02524158|3487831|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3639857|NCT02524158|3487829|B3|||Age||years|Mean|53.4|53.4|Standard Deviation|13.3|13.3|||
3639858|NCT02524158|3487830|B2|||Age||years|Mean|53.6|53.6|Standard Deviation|13.9|13.9|||
3639859|NCT02524158|3487831|B1|||Age||years|Mean|53.3|53.3|Standard Deviation|12.7|12.7|||
3639860|NCT02524054|3487871|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
3639861|NCT02524054|3487872|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3639862|NCT02524054|3487873|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3639863|NCT02524054|3487871|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639864|NCT02524054|3487872|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639865|NCT02524054|3487873|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639866|NCT02524054|3487871|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639867|NCT02524054|3487872|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639868|NCT02524054|3487873|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639869|NCT02524054|3487871|B3||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3639870|NCT02524054|3487872|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3639871|NCT02524054|3487873|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3639872|NCT02524054|3487871|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3639873|NCT02524054|3487872|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3639874|NCT02524054|3487873|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3639875|NCT02524054|3487871|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639876|NCT02524054|3487872|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639877|NCT02524054|3487873|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639878|NCT02524054|3487871|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639879|NCT02524054|3487872|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639880|NCT02524054|3487873|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639881|NCT02524054|3487871|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639882|NCT02524054|3487872|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639883|NCT02524054|3487873|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639884|NCT02524054|3487871|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639885|NCT02524054|3487872|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639886|NCT02524054|3487873|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639887|NCT02524054|3487871|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3639888|NCT02524054|3487872|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3639889|NCT02524054|3487873|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3639890|NCT02524054|3487871|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3639891|NCT02524054|3487872|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3639892|NCT02524054|3487873|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639893|NCT02524054|3487871|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3639894|NCT02524054|3487872|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3639895|NCT02524054|3487873|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3639896|NCT02524054|3487871|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3639897|NCT02524054|3487872|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3639898|NCT02524054|3487873|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3639899|NCT02524054|3487871|B3|||Age||years|Mean|67.92|67.92|Standard Deviation|11.34|11.34|||
3639900|NCT02524054|3487872|B2|||Age||years|Mean|67.41|67.41|Standard Deviation|11.41|11.41|||
3639901|NCT02524054|3487873|B1|||Age||years|Mean|69.14|69.14|Standard Deviation|11.09|11.09|||
3639902|NCT02524054|3487871|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3639903|NCT02524054|3487872|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3639904|NCT02524054|3487873|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3639905|NCT02524054|3487871|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3639906|NCT02524054|3487872|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3639907|NCT02524054|3487873|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3639908|NCT02524054|3487871|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3639909|NCT02524054|3487872|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3639910|NCT02524054|3487873|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3639911|NCT02523586|3487886|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3639912|NCT02523586|3487886|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3639913|NCT02523586|3487886|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639914|NCT02523586|3487886|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3639915|NCT02523586|3487886|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3639916|NCT02523586|3487886|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3639917|NCT02523586|3487886|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3639918|NCT02523586|3487886|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3639919|NCT02523586|3487886|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3639920|NCT02523586|3487886|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3639921|NCT02523586|3487886|B1|||Age||years|Mean|34.6|34.6|Standard Deviation|5.2|5.2|||
3639922|NCT02522624|3487897|B3|||Objective Numeracy (Lipkus)|Four items from a validated objective numeracy scale assessed numeracy skills. Each of the open-ended responses to the four items were scored correct or incorrect. The number of correct items were summed to obtain a summary score. Values for Range are the actual score range obtained from the study's participants.The mean of the summary score was obtained to provide average scores for the DA and Control groups.|units on a scale|Mean|2.4|2.4|Full Range|||0.0|4.0|
3639923|NCT02522624|3487898|B2|||Objective Numeracy (Lipkus)|Four items from a validated objective numeracy scale assessed numeracy skills. Each of the open-ended responses to the four items were scored correct or incorrect. The number of correct items were summed to obtain a summary score. Values for Range are the actual score range obtained from the study's participants.The mean of the summary score was obtained to provide average scores for the DA and Control groups.|units on a scale|Mean|2.3|2.3|Full Range|||0.0|4.0|
3639924|NCT02522624|3487899|B1|||Objective Numeracy (Lipkus)|Four items from a validated objective numeracy scale assessed numeracy skills. Each of the open-ended responses to the four items were scored correct or incorrect. The number of correct items were summed to obtain a summary score. Values for Range are the actual score range obtained from the study's participants.The mean of the summary score was obtained to provide average scores for the DA and Control groups.|units on a scale|Mean|2.6|2.6|Full Range|||0.0|4.0|
3639925|NCT02522624|3487897|B3|||Subjective Numeracy (SNS)|"Three items from the Subjective Numeracy Scale (SNS) assessed numeracy skills. The SNS is a self-report measure scored from 1-6, with larger values indicating greater perceived ability with mathematical tasks. Scores from each of the three items were summed and averaged to obtain a composite score. Values for Range are the actual score range obtained from the study's participants.~One participant in the healthcare.gov condition did not complete the SNS or SILS (n=162)"|units on a scale|Mean|3.8|3.8|Full Range|||1.0|6.0|
3639926|NCT02522624|3487898|B2|||Subjective Numeracy (SNS)|"Three items from the Subjective Numeracy Scale (SNS) assessed numeracy skills. The SNS is a self-report measure scored from 1-6, with larger values indicating greater perceived ability with mathematical tasks. Scores from each of the three items were summed and averaged to obtain a composite score. Values for Range are the actual score range obtained from the study's participants.~One participant in the healthcare.gov condition did not complete the SNS or SILS (n=162)"|units on a scale|Mean|3.6|3.6|Full Range|||1.0|6.0|
3639927|NCT02522624|3487899|B1|||Subjective Numeracy (SNS)|"Three items from the Subjective Numeracy Scale (SNS) assessed numeracy skills. The SNS is a self-report measure scored from 1-6, with larger values indicating greater perceived ability with mathematical tasks. Scores from each of the three items were summed and averaged to obtain a composite score. Values for Range are the actual score range obtained from the study's participants.~One participant in the healthcare.gov condition did not complete the SNS or SILS (n=162)"|units on a scale|Mean|3.9|3.9|Full Range|||1.0|6.0|
3639928|NCT02522624|3487897|B3|Limited||Health Literacy (SILS)|"The Single Item Literacy Screener (SILS) assessed broader health literacy. The SILS is a single item question intended to identify adults in need of help with printed health material scored on a scale from 1-5 (1 indicating never needing help with printed health material; 5 indicating always needing help with printed health material). Participants with scores greater than 2 were categorized into the limited health literacy category; remaining participants were categorized into adequate category.~One participant in the healthcare.gov condition did not complete the SNS or SILS (n=162)"|participants|Number|59|59.0||||||
3639929|NCT02522624|3487898|B2|Limited||Health Literacy (SILS)|"The Single Item Literacy Screener (SILS) assessed broader health literacy. The SILS is a single item question intended to identify adults in need of help with printed health material scored on a scale from 1-5 (1 indicating never needing help with printed health material; 5 indicating always needing help with printed health material). Participants with scores greater than 2 were categorized into the limited health literacy category; remaining participants were categorized into adequate category.~One participant in the healthcare.gov condition did not complete the SNS or SILS (n=162)"|participants|Number|34|34.0||||||
3639930|NCT02522624|3487899|B1|Limited||Health Literacy (SILS)|"The Single Item Literacy Screener (SILS) assessed broader health literacy. The SILS is a single item question intended to identify adults in need of help with printed health material scored on a scale from 1-5 (1 indicating never needing help with printed health material; 5 indicating always needing help with printed health material). Participants with scores greater than 2 were categorized into the limited health literacy category; remaining participants were categorized into adequate category.~One participant in the healthcare.gov condition did not complete the SNS or SILS (n=162)"|participants|Number|25|25.0||||||
3639931|NCT02522624|3487897|B3|Adequate||Health Literacy (SILS)|"The Single Item Literacy Screener (SILS) assessed broader health literacy. The SILS is a single item question intended to identify adults in need of help with printed health material scored on a scale from 1-5 (1 indicating never needing help with printed health material; 5 indicating always needing help with printed health material). Participants with scores greater than 2 were categorized into the limited health literacy category; remaining participants were categorized into adequate category.~One participant in the healthcare.gov condition did not complete the SNS or SILS (n=162)"|participants|Number|267|267.0||||||
3639932|NCT02522624|3487898|B2|Adequate||Health Literacy (SILS)|"The Single Item Literacy Screener (SILS) assessed broader health literacy. The SILS is a single item question intended to identify adults in need of help with printed health material scored on a scale from 1-5 (1 indicating never needing help with printed health material; 5 indicating always needing help with printed health material). Participants with scores greater than 2 were categorized into the limited health literacy category; remaining participants were categorized into adequate category.~One participant in the healthcare.gov condition did not complete the SNS or SILS (n=162)"|participants|Number|128|128.0||||||
3639933|NCT02522624|3487899|B1|Adequate||Health Literacy (SILS)|"The Single Item Literacy Screener (SILS) assessed broader health literacy. The SILS is a single item question intended to identify adults in need of help with printed health material scored on a scale from 1-5 (1 indicating never needing help with printed health material; 5 indicating always needing help with printed health material). Participants with scores greater than 2 were categorized into the limited health literacy category; remaining participants were categorized into adequate category.~One participant in the healthcare.gov condition did not complete the SNS or SILS (n=162)"|participants|Number|139|139.0||||||
3639934|NCT02522624|3487897|B3|Insured||Insurance Status (Uninsured)||participants|Number|149|149.0||||||
3639935|NCT02522624|3487898|B2|Insured||Insurance Status (Uninsured)||participants|Number|70|70.0||||||
3639936|NCT02522624|3487899|B1|Insured||Insurance Status (Uninsured)||participants|Number|79|79.0||||||
3639937|NCT02522624|3487897|B3|Uninsured||Insurance Status (Uninsured)||participants|Number|178|178.0||||||
3639938|NCT02522624|3487898|B2|Uninsured||Insurance Status (Uninsured)||participants|Number|93|93.0||||||
3639939|NCT02522624|3487899|B1|Uninsured||Insurance Status (Uninsured)||participants|Number|85|85.0||||||
3639940|NCT02522624|3487897|B3|||Chronic Conditions - Participant + Dependents (n=107)||Number chronic conditions|Mean|NA||Standard Deviation|NA||||Only participants in the DA group were asked about their dependents' chronic conditions to allow the DA tool to personalize good fit plans.
3639941|NCT02522624|3487898|B2|||Chronic Conditions - Participant + Dependents (n=107)||Number chronic conditions|Mean|NA||Standard Deviation|NA||||Participants in Control condition were not asked about their dependents' chronic conditions.
3639942|NCT02522624|3487899|B1|||Chronic Conditions - Participant + Dependents (n=107)||Number chronic conditions|Mean|2.69|2.69|Standard Deviation|2.35|2.35|||
3639943|NCT02522624|3487897|B3|||Chronic Conditions - Participant (n=207)||Number chronic conditions|Mean|2.22|2.22|Standard Deviation|1.43|1.43|||
3639944|NCT02522624|3487898|B2|||Chronic Conditions - Participant (n=207)||Number chronic conditions|Mean|2.17|2.17|Standard Deviation|1.35|1.35|||
3639945|NCT02522624|3487899|B1|||Chronic Conditions - Participant (n=207)||Number chronic conditions|Mean|2.27|2.27|Standard Deviation|1.53|1.53|||
3639946|NCT02522624|3487897|B3|No||Smoking status - Dependent (n=124)|n=124|participants|Number|105|105.0||||||
3639947|NCT02522624|3487898|B2|No||Smoking status - Dependent (n=124)|n=124|participants|Number|48|48.0||||||
3639948|NCT02522624|3487899|B1|No||Smoking status - Dependent (n=124)|n=124|participants|Number|57|57.0||||||
3639949|NCT02522624|3487897|B3|Yes||Smoking status - Dependent (n=124)|n=124|participants|Number|19|19.0||||||
3639950|NCT02522624|3487898|B2|Yes||Smoking status - Dependent (n=124)|n=124|participants|Number|9|9.0||||||
3639951|NCT02522624|3487899|B1|Yes||Smoking status - Dependent (n=124)|n=124|participants|Number|10|10.0||||||
3639952|NCT02522624|3487897|B3|No||Smoking status - Participant||participants|Number|225|225.0||||||
3639953|NCT02522624|3487898|B2|No||Smoking status - Participant||participants|Number|116|116.0||||||
3639954|NCT02522624|3487899|B1|No||Smoking status - Participant||participants|Number|109|109.0||||||
3639955|NCT02522624|3487897|B3|Yes||Smoking status - Participant||participants|Number|102|102.0||||||
3639956|NCT02522624|3487898|B2|Yes||Smoking status - Participant||participants|Number|47|47.0||||||
3639957|NCT02522624|3487899|B1|Yes||Smoking status - Participant||participants|Number|55|55.0||||||
3639958|NCT02522624|3487897|B3|3+||Total number covering||participants|Number|71|71.0||||||
3639959|NCT02522624|3487898|B2|3+||Total number covering||participants|Number|36|36.0||||||
3639960|NCT02522624|3487899|B1|3+||Total number covering||participants|Number|35|35.0||||||
3639961|NCT02522624|3487897|B3|2||Total number covering||participants|Number|53|53.0||||||
3639962|NCT02522624|3487898|B2|2||Total number covering||participants|Number|21|21.0||||||
3639963|NCT02522624|3487899|B1|2||Total number covering||participants|Number|32|32.0||||||
3639964|NCT02522624|3487897|B3|1||Total number covering||participants|Number|203|203.0||||||
3639965|NCT02522624|3487898|B2|1||Total number covering||participants|Number|106|106.0||||||
3639966|NCT02522624|3487899|B1|1||Total number covering||participants|Number|97|97.0||||||
3639967|NCT02522624|3487897|B3|Urban||Urbanicity||participants|Number|111|111.0||||||
3639968|NCT02522624|3487898|B2|Urban||Urbanicity||participants|Number|53|53.0||||||
3639969|NCT02522624|3487899|B1|Urban||Urbanicity||participants|Number|58|58.0||||||
3639970|NCT02522624|3487897|B3|Suburban||Urbanicity||participants|Number|196|196.0||||||
3639971|NCT02522624|3487898|B2|Suburban||Urbanicity||participants|Number|99|99.0||||||
3639972|NCT02522624|3487899|B1|Suburban||Urbanicity||participants|Number|97|97.0||||||
3639973|NCT02522624|3487897|B3|Rural||Urbanicity||participants|Number|20|20.0||||||
3639974|NCT02522624|3487898|B2|Rural||Urbanicity||participants|Number|11|11.0||||||
3639975|NCT02522624|3487899|B1|Rural||Urbanicity||participants|Number|9|9.0||||||
3639976|NCT02522624|3487897|B3|400+||% Federal Poverty Line|Four participants in the healthcare.gov condition did not report FPL (n=159)|participants|Number|21|21.0||||||
3639977|NCT02522624|3487898|B2|400+||% Federal Poverty Line|Four participants in the healthcare.gov condition did not report FPL (n=159)|participants|Number|8|8.0||||||
3639978|NCT02522624|3487899|B1|400+||% Federal Poverty Line|Four participants in the healthcare.gov condition did not report FPL (n=159)|participants|Number|13|13.0||||||
3639979|NCT02522624|3487897|B3|250-399||% Federal Poverty Line|Four participants in the healthcare.gov condition did not report FPL (n=159)|participants|Number|25|25.0||||||
3639980|NCT02522624|3487898|B2|250-399||% Federal Poverty Line|Four participants in the healthcare.gov condition did not report FPL (n=159)|participants|Number|10|10.0||||||
3639981|NCT02522624|3487899|B1|250-399||% Federal Poverty Line|Four participants in the healthcare.gov condition did not report FPL (n=159)|participants|Number|15|15.0||||||
3639982|NCT02522624|3487897|B3|100-249||% Federal Poverty Line|Four participants in the healthcare.gov condition did not report FPL (n=159)|participants|Number|111|111.0||||||
3639983|NCT02522624|3487898|B2|100-249||% Federal Poverty Line|Four participants in the healthcare.gov condition did not report FPL (n=159)|participants|Number|47|47.0||||||
3639984|NCT02522624|3487899|B1|100-249||% Federal Poverty Line|Four participants in the healthcare.gov condition did not report FPL (n=159)|participants|Number|64|64.0||||||
3639985|NCT02522624|3487897|B3|< 100||% Federal Poverty Line|Four participants in the healthcare.gov condition did not report FPL (n=159)|participants|Number|166|166.0||||||
3639986|NCT02522624|3487898|B2|< 100||% Federal Poverty Line|Four participants in the healthcare.gov condition did not report FPL (n=159)|participants|Number|94|94.0||||||
3639987|NCT02522624|3487899|B1|< 100||% Federal Poverty Line|Four participants in the healthcare.gov condition did not report FPL (n=159)|participants|Number|72|72.0||||||
3639988|NCT02522624|3487897|B3|College +||Education||participants|Number|90|90.0||||||
3639989|NCT02522624|3487898|B2|College +||Education||participants|Number|49|49.0||||||
3639990|NCT02522624|3487899|B1|College +||Education||participants|Number|41|41.0||||||
3639991|NCT02522624|3487897|B3|HS or GED||Education||participants|Number|210|210.0||||||
3639992|NCT02522624|3487898|B2|HS or GED||Education||participants|Number|99|99.0||||||
3639993|NCT02522624|3487899|B1|HS or GED||Education||participants|Number|111|111.0||||||
3639994|NCT02522624|3487897|B3|Less than HS||Education||participants|Number|27|27.0||||||
3639995|NCT02522624|3487898|B2|Less than HS||Education||participants|Number|15|15.0||||||
3639996|NCT02522624|3487899|B1|Less than HS||Education||participants|Number|12|12.0||||||
3639997|NCT02522624|3487897|B3|Other (Including Mixed)||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
3639998|NCT02522624|3487898|B2|Other (Including Mixed)||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3639999|NCT02522624|3487899|B1|Other (Including Mixed)||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3640000|NCT02522624|3487897|B3|Caucasian only||Race/Ethnicity, Customized||participants|Number|87|87.0||||||
3640001|NCT02522624|3487898|B2|Caucasian only||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
3640002|NCT02522624|3487899|B1|Caucasian only||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
3640003|NCT02522624|3487897|B3|African American only||Race/Ethnicity, Customized||participants|Number|203|203.0||||||
3640004|NCT02522624|3487898|B2|African American only||Race/Ethnicity, Customized||participants|Number|107|107.0||||||
3640005|NCT02522624|3487899|B1|African American only||Race/Ethnicity, Customized||participants|Number|96|96.0||||||
3640006|NCT02522624|3487897|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3640007|NCT02522624|3487898|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3640008|NCT02522624|3487899|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3640009|NCT02522624|3487897|B3|Not Hispanic||Race/Ethnicity, Customized||participants|Number|315|315.0||||||
3640010|NCT02522624|3487898|B2|Not Hispanic||Race/Ethnicity, Customized||participants|Number|159|159.0||||||
3640011|NCT02522624|3487899|B1|Not Hispanic||Race/Ethnicity, Customized||participants|Number|156|156.0||||||
3640012|NCT02522624|3487897|B3||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3640013|NCT02522624|3487898|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3640014|NCT02522624|3487899|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3640015|NCT02522624|3487897|B3||Female|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
3640016|NCT02522624|3487898|B2||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3640017|NCT02522624|3487899|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3640018|NCT02522624|3487897|B3|||Age||years|Mean|42.3|42.3|Standard Deviation|12.9|12.9|||
3640019|NCT02522624|3487898|B2|||Age||years|Mean|41.4|41.4|Standard Deviation|12.5|12.5|||
3640020|NCT02522624|3487899|B1|||Age||years|Mean|43.1|43.1|Standard Deviation|13.2|13.2|||
3640021|NCT02522403|3487916|B3|Radial Deviation||Wrist Mobility|The degrees of wrist mobility in flexion, extension, pronation, supination, and radial and ulnar deviation were measured in all patients.|degrees|Mean|5.9|5.9|Standard Deviation|5.0|5.0|||
3640022|NCT02522403|3487917|B2|Radial Deviation||Wrist Mobility|The degrees of wrist mobility in flexion, extension, pronation, supination, and radial and ulnar deviation were measured in all patients.|degrees|Mean|4.6|4.6|Standard Deviation|4.1|4.1|||
3640023|NCT02522403|3487918|B1|Radial Deviation||Wrist Mobility|The degrees of wrist mobility in flexion, extension, pronation, supination, and radial and ulnar deviation were measured in all patients.|degrees|Mean|7.1|7.1|Standard Deviation|5.5|5.5|||
3640024|NCT02522403|3487916|B3|Ulnar Deviation||Wrist Mobility|The degrees of wrist mobility in flexion, extension, pronation, supination, and radial and ulnar deviation were measured in all patients.|degrees|Mean|17.9|17.9|Standard Deviation|7.4|7.4|||
3640025|NCT02522403|3487917|B2|Ulnar Deviation||Wrist Mobility|The degrees of wrist mobility in flexion, extension, pronation, supination, and radial and ulnar deviation were measured in all patients.|degrees|Mean|20.0|20.0|Standard Deviation|7.6|7.6|||
3640026|NCT02522403|3487918|B1|Ulnar Deviation||Wrist Mobility|The degrees of wrist mobility in flexion, extension, pronation, supination, and radial and ulnar deviation were measured in all patients.|degrees|Mean|15.7|15.7|Standard Deviation|6.8|6.8|||
3640027|NCT02522403|3487916|B3|Supination||Wrist Mobility|The degrees of wrist mobility in flexion, extension, pronation, supination, and radial and ulnar deviation were measured in all patients.|degrees|Mean|41.5|41.5|Standard Deviation|20.9|20.9|||
3640028|NCT02522403|3487917|B2|Supination||Wrist Mobility|The degrees of wrist mobility in flexion, extension, pronation, supination, and radial and ulnar deviation were measured in all patients.|degrees|Mean|42.6|42.6|Standard Deviation|21.3|21.3|||
3640029|NCT02522403|3487918|B1|Supination||Wrist Mobility|The degrees of wrist mobility in flexion, extension, pronation, supination, and radial and ulnar deviation were measured in all patients.|degrees|Mean|40.3|40.3|Standard Deviation|21.2|21.2|||
3640030|NCT02522403|3487916|B3|Pronation||Wrist Mobility|The degrees of wrist mobility in flexion, extension, pronation, supination, and radial and ulnar deviation were measured in all patients.|degrees|Mean|49.5|49.5|Standard Deviation|24.4|24.4|||
3640031|NCT02522403|3487917|B2|Pronation||Wrist Mobility|The degrees of wrist mobility in flexion, extension, pronation, supination, and radial and ulnar deviation were measured in all patients.|degrees|Mean|54.8|54.8|Standard Deviation|25.2|25.2|||
3640032|NCT02522403|3487918|B1|Pronation||Wrist Mobility|The degrees of wrist mobility in flexion, extension, pronation, supination, and radial and ulnar deviation were measured in all patients.|degrees|Mean|44.2|44.2|Standard Deviation|23.2|23.2|||
3640033|NCT02522403|3487916|B3|Extension||Wrist Mobility|The degrees of wrist mobility in flexion, extension, pronation, supination, and radial and ulnar deviation were measured in all patients.|degrees|Mean|18.5|18.5|Standard Deviation|14.9|14.9|||
3640079|NCT02522286|3487932|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
3640034|NCT02522403|3487917|B2|Extension||Wrist Mobility|The degrees of wrist mobility in flexion, extension, pronation, supination, and radial and ulnar deviation were measured in all patients.|degrees|Mean|22.0|22.0|Standard Deviation|14.4|14.4|||
3640035|NCT02522403|3487918|B1|Extension||Wrist Mobility|The degrees of wrist mobility in flexion, extension, pronation, supination, and radial and ulnar deviation were measured in all patients.|degrees|Mean|14.9|14.9|Standard Deviation|15.1|15.1|||
3640036|NCT02522403|3487916|B3|Flexion||Wrist Mobility|The degrees of wrist mobility in flexion, extension, pronation, supination, and radial and ulnar deviation were measured in all patients.|degrees|Mean|33.8|33.8|Standard Deviation|14.9|14.9|||
3640037|NCT02522403|3487917|B2|Flexion||Wrist Mobility|The degrees of wrist mobility in flexion, extension, pronation, supination, and radial and ulnar deviation were measured in all patients.|degrees|Mean|34.2|34.2|Standard Deviation|10.5|10.5|||
3640038|NCT02522403|3487918|B1|Flexion||Wrist Mobility|The degrees of wrist mobility in flexion, extension, pronation, supination, and radial and ulnar deviation were measured in all patients.|degrees|Mean|33.3|33.3|Standard Deviation|18.6|18.6|||
3640039|NCT02522403|3487916|B3|||Visual Analog Scale (VAS)|The VAS has a score of 0 to 10. The lowest score (0) represents the absence of pain, while the highest score (10) corresponds to the maximum pain possible.|units on a scale|Mean|5.5|5.5|Standard Deviation|2.0|2.0|||
3640040|NCT02522403|3487917|B2|||Visual Analog Scale (VAS)|The VAS has a score of 0 to 10. The lowest score (0) represents the absence of pain, while the highest score (10) corresponds to the maximum pain possible.|units on a scale|Mean|5.9|5.9|Standard Deviation|1.7|1.7|||
3640041|NCT02522403|3487918|B1|||Visual Analog Scale (VAS)|The VAS has a score of 0 to 10. The lowest score (0) represents the absence of pain, while the highest score (10) corresponds to the maximum pain possible.|units on a scale|Mean|5.0|5.0|Standard Deviation|2.2|2.2|||
3640042|NCT02522403|3487916|B3|||Patiet-Rated Wrist Evaluation (PRWE)|The PRWE assesses pain and the inability to perform daily acitivities. Is a 15-item questionnaire designed to measure wrist pain and disability in activities of daily living. It yields a score of 0 to 100, with lower scores indicanting better performance.|units on a scale|Mean|70.1|70.1|Standard Deviation|12.7|12.7|||
3640043|NCT02522403|3487917|B2|||Patiet-Rated Wrist Evaluation (PRWE)|The PRWE assesses pain and the inability to perform daily acitivities. Is a 15-item questionnaire designed to measure wrist pain and disability in activities of daily living. It yields a score of 0 to 100, with lower scores indicanting better performance.|units on a scale|Mean|69.1|69.1|Standard Deviation|12.2|12.2|||
3640044|NCT02522403|3487918|B1|||Patiet-Rated Wrist Evaluation (PRWE)|The PRWE assesses pain and the inability to perform daily acitivities. Is a 15-item questionnaire designed to measure wrist pain and disability in activities of daily living. It yields a score of 0 to 100, with lower scores indicanting better performance.|units on a scale|Mean|70.9|70.9|Standard Deviation|13.6|13.6|||
3640045|NCT02522403|3487916|B3|Mexico||Region of Enrollment||participants|Number|26|26.0||||||
3640046|NCT02522403|3487917|B2|Mexico||Region of Enrollment||participants|Number|13|13.0||||||
3640047|NCT02522403|3487918|B1|Mexico||Region of Enrollment||participants|Number|13|13.0||||||
3640048|NCT02522403|3487916|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3640049|NCT02522403|3487917|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3640050|NCT02522403|3487918|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3640051|NCT02522403|3487916|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3640052|NCT02522403|3487917|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3640053|NCT02522403|3487918|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3640054|NCT02522403|3487916|B3|||Age||years|Mean|54.8|54.8|Standard Deviation|13.07|13.07|||
3640055|NCT02522403|3487917|B2|||Age||years|Mean|53.2|53.2|Standard Deviation|9.7|9.7|||
3640056|NCT02522403|3487918|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|14.7|14.7|||
3640057|NCT02522403|3487916|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3640058|NCT02522403|3487917|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3640059|NCT02522403|3487918|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3640060|NCT02522403|3487916|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3640061|NCT02522403|3487917|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3640062|NCT02522403|3487918|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3640063|NCT02522403|3487916|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3640064|NCT02522403|3487917|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3640065|NCT02522403|3487918|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3640066|NCT02522286|3487929|B5|Other||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
3640067|NCT02522286|3487930|B4|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3640068|NCT02522286|3487931|B3|Other||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3640069|NCT02522286|3487932|B2|Other||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3640070|NCT02522286|3487933|B1|Other||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3640071|NCT02522286|3487929|B5|Asian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
3640072|NCT02522286|3487930|B4|Asian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3640073|NCT02522286|3487931|B3|Asian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3640074|NCT02522286|3487932|B2|Asian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3640075|NCT02522286|3487933|B1|Asian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3640076|NCT02522286|3487929|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|190|190.0||||||
3640077|NCT02522286|3487930|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
3640078|NCT02522286|3487931|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
3640080|NCT02522286|3487933|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
3640081|NCT02522286|3487929|B5||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3640082|NCT02522286|3487930|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3640083|NCT02522286|3487931|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3640084|NCT02522286|3487932|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3640085|NCT02522286|3487933|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3640086|NCT02522286|3487929|B5||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3640087|NCT02522286|3487930|B4||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3640088|NCT02522286|3487931|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3640089|NCT02522286|3487932|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3640090|NCT02522286|3487933|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3640091|NCT02522286|3487929|B5|||Age||years|Mean|54.0|54.0|Standard Deviation|16.2|16.2|||
3640092|NCT02522286|3487930|B4|||Age||years|Mean|61.4|61.4|Standard Deviation|15.3|15.3|||
3640093|NCT02522286|3487931|B3|||Age||years|Mean|49.0|49.0|Standard Deviation|15.0|15.0|||
3640094|NCT02522286|3487932|B2|||Age||years|Mean|50.7|50.7|Standard Deviation|15.6|15.6|||
3640095|NCT02522286|3487933|B1|||Age||years|Mean|54.7|54.7|Standard Deviation|16.2|16.2|||
3640096|NCT02521948|3487962|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640097|NCT02521948|3487962|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640098|NCT02521948|3487962|B1||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3640099|NCT02521948|3487962|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640100|NCT02521948|3487962|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640101|NCT02521948|3487962|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640102|NCT02521948|3487962|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640103|NCT02521948|3487962|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3640104|NCT02521948|3487962|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3640105|NCT02521948|3487962|B1|||Age||years|Mean|79.5|79.5|Standard Deviation|8.3|8.3|||
3640106|NCT02520726|3487971|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3640107|NCT02520726|3487972|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3640108|NCT02520726|3487973|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3640109|NCT02520726|3487971|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640110|NCT02520726|3487972|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640111|NCT02520726|3487973|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640112|NCT02520726|3487971|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640113|NCT02520726|3487972|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640114|NCT02520726|3487973|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640115|NCT02520726|3487971|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3640116|NCT02520726|3487972|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3640117|NCT02520726|3487973|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3640118|NCT02520726|3487971|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640119|NCT02520726|3487972|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640120|NCT02520726|3487973|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640121|NCT02520726|3487971|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640122|NCT02520726|3487972|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640123|NCT02520726|3487973|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640124|NCT02520726|3487971|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640125|NCT02520726|3487972|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640126|NCT02520726|3487973|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640127|NCT02520726|3487971|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640128|NCT02520726|3487972|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640129|NCT02520726|3487973|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640130|NCT02520726|3487971|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3640131|NCT02520726|3487972|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3640132|NCT02520726|3487973|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3640133|NCT02520726|3487971|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3640134|NCT02520726|3487972|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3640135|NCT02520726|3487973|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3640136|NCT02520726|3487971|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3640137|NCT02520726|3487972|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3640138|NCT02520726|3487973|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3640139|NCT02520726|3487971|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3640140|NCT02520726|3487972|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3640141|NCT02520726|3487973|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3640142|NCT02520726|3487971|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3640143|NCT02520726|3487972|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3640144|NCT02520726|3487973|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3640145|NCT02520518|3487982|B5|United States||Region of Enrollment||participants|Number|9|9.0||||||
3640146|NCT02520518|3487983|B4|United States||Region of Enrollment||participants|Number|2|2.0||||||
3640147|NCT02520518|3487984|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3640148|NCT02520518|3487985|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3640149|NCT02520518|3487986|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3640150|NCT02520518|3487982|B5|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3640151|NCT02520518|3487982|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3640152|NCT02520518|3487983|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3640153|NCT02520518|3487984|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3640154|NCT02520518|3487985|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3640155|NCT02520518|3487986|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3640156|NCT02520518|3487982|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3640157|NCT02520518|3487983|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3640158|NCT02520518|3487984|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3640159|NCT02520518|3487985|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3640160|NCT02520518|3487986|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3640161|NCT02520518|3487982|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3640162|NCT02520518|3487983|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3640163|NCT02520518|3487984|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3640164|NCT02520518|3487985|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3640165|NCT02520518|3487986|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3640166|NCT02520518|3487982|B5||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3640167|NCT02520518|3487983|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3640168|NCT02520518|3487984|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3640169|NCT02520518|3487985|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3640170|NCT02520518|3487986|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3640171|NCT02520518|3487982|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3640172|NCT02520518|3487983|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3640173|NCT02520518|3487984|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3640174|NCT02520518|3487985|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3640175|NCT02520518|3487986|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3640176|NCT02520414|3488047|B1|||Body Mass Index||kg/m^2|Mean|29.6|29.6|Standard Deviation|7.2|7.2|||
3640177|NCT02520414|3488047|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3640178|NCT02520414|3488047|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640179|NCT02520414|3488047|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3640180|NCT02520414|3488047|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3640181|NCT02520414|3488047|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3640182|NCT02520414|3488047|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3640183|NCT02520414|3488047|B1|||Age||years|Mean|50.4|50.4|Standard Deviation|5.7|5.7|||
3640184|NCT02520414|3488047|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3640185|NCT02520414|3488047|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3640186|NCT02520414|3488047|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3640187|NCT02520388|3488051|B3||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3640188|NCT02520388|3488052|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3640189|NCT02520388|3488053|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3640190|NCT02520388|3488051|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3640191|NCT02520388|3488052|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3640192|NCT02520388|3488053|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3640193|NCT02520388|3488051|B3|||Age||Years|Mean|9.3|9.3|Standard Deviation|1.79|1.79|||
3640194|NCT02520388|3488052|B2|||Age||Years|Mean|9.0|9.0|Standard Deviation|1.73|1.73|||
3640195|NCT02520388|3488053|B1|||Age||Years|Mean|9.6|9.6|Standard Deviation|1.79|1.79|||
3640196|NCT02520089|3488062|B3|Mexico||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3640197|NCT02520089|3488063|B2|Mexico||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3640198|NCT02520089|3488064|B1|Mexico||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3640199|NCT02520089|3488062|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3640200|NCT02520089|3488063|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3640201|NCT02520089|3488064|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3640202|NCT02520089|3488062|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3640203|NCT02520089|3488063|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3640204|NCT02520089|3488064|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3640205|NCT02520089|3488062|B3|||Age||years|Mean|38.1|38.1|Standard Deviation|12.9|12.9|||
3640206|NCT02520089|3488063|B2|||Age||years|Mean|37.1|37.1|Standard Deviation|10.2|10.2|||
3640207|NCT02520089|3488064|B1|||Age||years|Mean|38.8|38.8|Standard Deviation|15.3|15.3|||
3640208|NCT02520089|3488062|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3640209|NCT02520089|3488063|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3640210|NCT02520089|3488064|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3640211|NCT02520089|3488062|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3640212|NCT02520089|3488063|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3640213|NCT02520089|3488064|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3640214|NCT02520089|3488062|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3640215|NCT02520089|3488063|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3640216|NCT02520089|3488064|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3640217|NCT02519855|3488073|B3||Male|Sex: Female, Male||Participants|Count of Participants|354|354.0||||||
3640218|NCT02519855|3488074|B2||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3640219|NCT02519855|3488075|B1||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3640220|NCT02519855|3488073|B3||Female|Sex: Female, Male||Participants|Count of Participants|528|528.0||||||
3640221|NCT02519855|3488074|B2||Female|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
3640222|NCT02519855|3488075|B1||Female|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
3640223|NCT02519855|3488073|B3|||Age||Years|Mean|61.0|61.0|Standard Deviation|7.5|7.5|||
3640224|NCT02519855|3488074|B2|||Age||Years|Mean|61.3|61.3|Standard Deviation|7.7|7.7|||
3640225|NCT02519855|3488075|B1|||Age||Years|Mean|60.8|60.8|Standard Deviation|7.2|7.2|||
3640226|NCT02519842|3488092|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640227|NCT02519842|3488093|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640228|NCT02519842|3488094|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640229|NCT02519842|3488092|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3640230|NCT02519842|3488093|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3640231|NCT02519842|3488094|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3640232|NCT02519842|3488092|B3||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3640233|NCT02519842|3488093|B2||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3640234|NCT02519842|3488094|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3640235|NCT02519842|3488092|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640236|NCT02519842|3488093|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640237|NCT02519842|3488094|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640238|NCT02519842|3488092|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640239|NCT02519842|3488093|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640240|NCT02519842|3488094|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640241|NCT02519842|3488092|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3640242|NCT02519842|3488093|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3640243|NCT02519842|3488094|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3640244|NCT02519842|3488092|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3640245|NCT02519842|3488093|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640246|NCT02519842|3488094|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3640247|NCT02519842|3488092|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3640248|NCT02519842|3488093|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3640249|NCT02519842|3488094|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3640250|NCT02519842|3488092|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3640251|NCT02519842|3488093|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3640252|NCT02519842|3488094|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3640253|NCT02519842|3488092|B3|||Age||Years|Mean|10.9|10.9|Standard Deviation|4.3|4.3|||
3640254|NCT02519842|3488093|B2|||Age||Years|Mean|10.9|10.9|Standard Deviation|4.4|4.4|||
3640255|NCT02519842|3488094|B1|||Age||Years|Mean|10.8|10.8|Standard Deviation|4.2|4.2|||
3640256|NCT02519712|3488115|B1|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3640257|NCT02519712|3488115|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640258|NCT02519712|3488115|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640259|NCT02519712|3488115|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3640260|NCT02519712|3488115|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640261|NCT02519712|3488115|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640262|NCT02519712|3488115|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640263|NCT02519712|3488115|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640264|NCT02519712|3488115|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640265|NCT02519712|3488115|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3640266|NCT02519712|3488115|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640267|NCT02519712|3488115|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3640268|NCT02519712|3488115|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3640269|NCT02519712|3488115|B1|||Age||years|Median|61|61.0|Full Range|||46.0|73.0|
3640270|NCT02519595|3488119|B4|Laceration Repair||Procedure Type||participants|Number|11|11.0||||||
3640271|NCT02519595|3488120|B3|Laceration Repair||Procedure Type||participants|Number|3|3.0||||||
3640272|NCT02519595|3488121|B2|Laceration Repair||Procedure Type||participants|Number|3|3.0||||||
3640273|NCT02519595|3488122|B1|Laceration Repair||Procedure Type||participants|Number|5|5.0||||||
3640274|NCT02519595|3488119|B4|Incision and Drainage||Procedure Type||participants|Number|25|25.0||||||
3640275|NCT02519595|3488120|B3|Incision and Drainage||Procedure Type||participants|Number|2|2.0||||||
3640276|NCT02519595|3488121|B2|Incision and Drainage||Procedure Type||participants|Number|11|11.0||||||
3640277|NCT02519595|3488122|B1|Incision and Drainage||Procedure Type||participants|Number|12|12.0||||||
3640278|NCT02519595|3488119|B4|Fracture/Dislocation Reduction||Procedure Type||participants|Number|89|89.0||||||
3640279|NCT02519595|3488120|B3|Fracture/Dislocation Reduction||Procedure Type||participants|Number|35|35.0||||||
3640280|NCT02519595|3488121|B2|Fracture/Dislocation Reduction||Procedure Type||participants|Number|21|21.0||||||
3640281|NCT02519595|3488122|B1|Fracture/Dislocation Reduction||Procedure Type||participants|Number|33|33.0||||||
3640282|NCT02519595|3488119|B4|ASA class 3, Severe systemic disease||AMerican Society of Anesthesiologists (ASA) Category|"The purpose of the ASA is to evaluate the degree of a patient's sickness or physical state before selecting the sedative or before performing the procedure. There are 6 categories~Healthy person.~Mild systemic disease.~Severe systemic disease.~Severe systemic disease that is a constant threat to life.~A moribund person who is not expected to survive without the operation.~A declared brain-dead person whose organs are being removed for donor purposes."|participants|Number|1|1.0||||||
3640283|NCT02519595|3488120|B3|ASA class 3, Severe systemic disease||AMerican Society of Anesthesiologists (ASA) Category|"The purpose of the ASA is to evaluate the degree of a patient's sickness or physical state before selecting the sedative or before performing the procedure. There are 6 categories~Healthy person.~Mild systemic disease.~Severe systemic disease.~Severe systemic disease that is a constant threat to life.~A moribund person who is not expected to survive without the operation.~A declared brain-dead person whose organs are being removed for donor purposes."|participants|Number|0|0.0||||||
3640284|NCT02519595|3488121|B2|ASA class 3, Severe systemic disease||AMerican Society of Anesthesiologists (ASA) Category|"The purpose of the ASA is to evaluate the degree of a patient's sickness or physical state before selecting the sedative or before performing the procedure. There are 6 categories~Healthy person.~Mild systemic disease.~Severe systemic disease.~Severe systemic disease that is a constant threat to life.~A moribund person who is not expected to survive without the operation.~A declared brain-dead person whose organs are being removed for donor purposes."|participants|Number|1|1.0||||||
3640285|NCT02519595|3488122|B1|ASA class 3, Severe systemic disease||AMerican Society of Anesthesiologists (ASA) Category|"The purpose of the ASA is to evaluate the degree of a patient's sickness or physical state before selecting the sedative or before performing the procedure. There are 6 categories~Healthy person.~Mild systemic disease.~Severe systemic disease.~Severe systemic disease that is a constant threat to life.~A moribund person who is not expected to survive without the operation.~A declared brain-dead person whose organs are being removed for donor purposes."|participants|Number|0|0.0||||||
3640286|NCT02519595|3488119|B4|ASA class 2, Mild systemic disease||AMerican Society of Anesthesiologists (ASA) Category|"The purpose of the ASA is to evaluate the degree of a patient's sickness or physical state before selecting the sedative or before performing the procedure. There are 6 categories~Healthy person.~Mild systemic disease.~Severe systemic disease.~Severe systemic disease that is a constant threat to life.~A moribund person who is not expected to survive without the operation.~A declared brain-dead person whose organs are being removed for donor purposes."|participants|Number|5|5.0||||||
3640287|NCT02519595|3488120|B3|ASA class 2, Mild systemic disease||AMerican Society of Anesthesiologists (ASA) Category|"The purpose of the ASA is to evaluate the degree of a patient's sickness or physical state before selecting the sedative or before performing the procedure. There are 6 categories~Healthy person.~Mild systemic disease.~Severe systemic disease.~Severe systemic disease that is a constant threat to life.~A moribund person who is not expected to survive without the operation.~A declared brain-dead person whose organs are being removed for donor purposes."|participants|Number|3|3.0||||||
3640288|NCT02519595|3488121|B2|ASA class 2, Mild systemic disease||AMerican Society of Anesthesiologists (ASA) Category|"The purpose of the ASA is to evaluate the degree of a patient's sickness or physical state before selecting the sedative or before performing the procedure. There are 6 categories~Healthy person.~Mild systemic disease.~Severe systemic disease.~Severe systemic disease that is a constant threat to life.~A moribund person who is not expected to survive without the operation.~A declared brain-dead person whose organs are being removed for donor purposes."|participants|Number|2|2.0||||||
3640289|NCT02519595|3488122|B1|ASA class 2, Mild systemic disease||AMerican Society of Anesthesiologists (ASA) Category|"The purpose of the ASA is to evaluate the degree of a patient's sickness or physical state before selecting the sedative or before performing the procedure. There are 6 categories~Healthy person.~Mild systemic disease.~Severe systemic disease.~Severe systemic disease that is a constant threat to life.~A moribund person who is not expected to survive without the operation.~A declared brain-dead person whose organs are being removed for donor purposes."|participants|Number|0|0.0||||||
3640290|NCT02519595|3488119|B4|ASA Class 1, A normal healthy patient||AMerican Society of Anesthesiologists (ASA) Category|"The purpose of the ASA is to evaluate the degree of a patient's sickness or physical state before selecting the sedative or before performing the procedure. There are 6 categories~Healthy person.~Mild systemic disease.~Severe systemic disease.~Severe systemic disease that is a constant threat to life.~A moribund person who is not expected to survive without the operation.~A declared brain-dead person whose organs are being removed for donor purposes."|participants|Number|119|119.0||||||
3640291|NCT02519595|3488120|B3|ASA Class 1, A normal healthy patient||AMerican Society of Anesthesiologists (ASA) Category|"The purpose of the ASA is to evaluate the degree of a patient's sickness or physical state before selecting the sedative or before performing the procedure. There are 6 categories~Healthy person.~Mild systemic disease.~Severe systemic disease.~Severe systemic disease that is a constant threat to life.~A moribund person who is not expected to survive without the operation.~A declared brain-dead person whose organs are being removed for donor purposes."|participants|Number|37|37.0||||||
3640292|NCT02519595|3488121|B2|ASA Class 1, A normal healthy patient||AMerican Society of Anesthesiologists (ASA) Category|"The purpose of the ASA is to evaluate the degree of a patient's sickness or physical state before selecting the sedative or before performing the procedure. There are 6 categories~Healthy person.~Mild systemic disease.~Severe systemic disease.~Severe systemic disease that is a constant threat to life.~A moribund person who is not expected to survive without the operation.~A declared brain-dead person whose organs are being removed for donor purposes."|participants|Number|32|32.0||||||
3640293|NCT02519595|3488122|B1|ASA Class 1, A normal healthy patient||AMerican Society of Anesthesiologists (ASA) Category|"The purpose of the ASA is to evaluate the degree of a patient's sickness or physical state before selecting the sedative or before performing the procedure. There are 6 categories~Healthy person.~Mild systemic disease.~Severe systemic disease.~Severe systemic disease that is a constant threat to life.~A moribund person who is not expected to survive without the operation.~A declared brain-dead person whose organs are being removed for donor purposes."|participants|Number|50|50.0||||||
3640294|NCT02519595|3488119|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3640295|NCT02519595|3488120|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3640296|NCT02519595|3488121|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3640297|NCT02519595|3488122|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3640298|NCT02519595|3488119|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3640299|NCT02519595|3488120|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3640300|NCT02519595|3488121|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640301|NCT02519595|3488122|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3640302|NCT02519595|3488119|B4||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3640303|NCT02519595|3488120|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3640304|NCT02519595|3488121|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3640305|NCT02519595|3488122|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3640306|NCT02519595|3488119|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3640307|NCT02519595|3488120|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3640308|NCT02519595|3488121|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3640309|NCT02519595|3488122|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3640310|NCT02519595|3488119|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640311|NCT02519595|3488120|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640312|NCT02519595|3488121|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640313|NCT02519595|3488122|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640314|NCT02519595|3488119|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3640315|NCT02519595|3488120|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3640316|NCT02519595|3488121|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640317|NCT02519595|3488122|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3640318|NCT02519595|3488119|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3640319|NCT02519595|3488120|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640320|NCT02519595|3488121|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640321|NCT02519595|3488122|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3640322|NCT02519595|3488119|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3640323|NCT02519595|3488120|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3640324|NCT02519595|3488121|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3640325|NCT02519595|3488122|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3640326|NCT02519595|3488119|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
3640327|NCT02519595|3488120|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3640328|NCT02519595|3488121|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3640329|NCT02519595|3488122|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3640330|NCT02519595|3488119|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3640331|NCT02519595|3488120|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3640332|NCT02519595|3488121|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3640333|NCT02519595|3488122|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3640334|NCT02519595|3488119|B4||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3640335|NCT02519595|3488120|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3640336|NCT02519595|3488121|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3640337|NCT02519595|3488122|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3640338|NCT02519595|3488119|B4||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3640339|NCT02519595|3488120|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3640340|NCT02519595|3488121|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3640341|NCT02519595|3488122|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3640342|NCT02519595|3488119|B4|13-18 years||Age, Customized||participants|Number|16|16.0||||||
3640343|NCT02519595|3488120|B3|13-18 years||Age, Customized||participants|Number|6|6.0||||||
3640344|NCT02519595|3488121|B2|13-18 years||Age, Customized||participants|Number|4|4.0||||||
3640345|NCT02519595|3488122|B1|13-18 years||Age, Customized||participants|Number|6|6.0||||||
3640346|NCT02519595|3488119|B4|7-12 years||Age, Customized||participants|Number|53|53.0||||||
3640347|NCT02519595|3488120|B3|7-12 years||Age, Customized||participants|Number|18|18.0||||||
3640348|NCT02519595|3488121|B2|7-12 years||Age, Customized||participants|Number|13|13.0||||||
3640349|NCT02519595|3488122|B1|7-12 years||Age, Customized||participants|Number|22|22.0||||||
3640350|NCT02519595|3488119|B4|3-6 years||Age, Customized||participants|Number|56|56.0||||||
3640351|NCT02519595|3488120|B3|3-6 years||Age, Customized||participants|Number|16|16.0||||||
3640352|NCT02519595|3488121|B2|3-6 years||Age, Customized||participants|Number|18|18.0||||||
3640353|NCT02519595|3488122|B1|3-6 years||Age, Customized||participants|Number|22|22.0||||||
3640354|NCT02519387|3488147|B1|Malaysia||Region of Enrollment||participants|Number|78|78.0||||||
3640355|NCT02519387|3488147|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3640356|NCT02519387|3488147|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3640357|NCT02519387|3488147|B1|||Age||years|Mean|61.9|61.9|Standard Deviation|9.7|9.7|||
3640358|NCT02519023|3488155|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
3640359|NCT02519023|3488156|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
3640360|NCT02519023|3488157|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
3640361|NCT02519023|3488155|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3640362|NCT02519023|3488155|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3640363|NCT02519023|3488156|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3640364|NCT02519023|3488157|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3640365|NCT02519023|3488155|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3640366|NCT02519023|3488156|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3640367|NCT02519023|3488157|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3640368|NCT02519023|3488155|B3|||Age||years|Median|59|59.0|Full Range|||32.0|88.0|
3640369|NCT02519023|3488156|B2|||Age||years|Median|62|62.0|Full Range|||32.0|88.0|
3640370|NCT02519023|3488157|B1|||Age||years|Median|58|58.0|Full Range|||32.0|77.0|
3640371|NCT02518919|3488190|B4|Pre sedation pain medication no||Pre - sedation pain medication||Participants|Count of Participants|21|21.0||||||
3640372|NCT02518919|3488191|B3|Pre sedation pain medication no||Pre - sedation pain medication||Participants|Count of Participants|5|5.0||||||
3640373|NCT02518919|3488192|B2|Pre sedation pain medication no||Pre - sedation pain medication||Participants|Count of Participants|10|10.0||||||
3640374|NCT02518919|3488193|B1|Pre sedation pain medication no||Pre - sedation pain medication||Participants|Count of Participants|6|6.0||||||
3640375|NCT02518919|3488190|B4|Pre sedation pain medication yes||Pre - sedation pain medication||Participants|Count of Participants|38|38.0||||||
3640376|NCT02518919|3488191|B3|Pre sedation pain medication yes||Pre - sedation pain medication||Participants|Count of Participants|14|14.0||||||
3640377|NCT02518919|3488192|B2|Pre sedation pain medication yes||Pre - sedation pain medication||Participants|Count of Participants|10|10.0||||||
3640378|NCT02518919|3488193|B1|Pre sedation pain medication yes||Pre - sedation pain medication||Participants|Count of Participants|14|14.0||||||
3640379|NCT02518919|3488190|B4|laceration repair||Procedure Type||Participants|Count of Participants|14|14.0||||||
3640380|NCT02518919|3488191|B3|laceration repair||Procedure Type||Participants|Count of Participants|4|4.0||||||
3640381|NCT02518919|3488192|B2|laceration repair||Procedure Type||Participants|Count of Participants|3|3.0||||||
3640382|NCT02518919|3488193|B1|laceration repair||Procedure Type||Participants|Count of Participants|7|7.0||||||
3640383|NCT02518919|3488190|B4|Incision and drainage||Procedure Type||Participants|Count of Participants|4|4.0||||||
3640384|NCT02518919|3488191|B3|Incision and drainage||Procedure Type||Participants|Count of Participants|2|2.0||||||
3640385|NCT02518919|3488192|B2|Incision and drainage||Procedure Type||Participants|Count of Participants|1|1.0||||||
3640386|NCT02518919|3488193|B1|Incision and drainage||Procedure Type||Participants|Count of Participants|1|1.0||||||
3640387|NCT02518919|3488190|B4|fracture/dislocation reduction||Procedure Type||Participants|Count of Participants|41|41.0||||||
3640388|NCT02518919|3488191|B3|fracture/dislocation reduction||Procedure Type||Participants|Count of Participants|13|13.0||||||
3640528|NCT02517580|3488239|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3640389|NCT02518919|3488192|B2|fracture/dislocation reduction||Procedure Type||Participants|Count of Participants|16|16.0||||||
3640390|NCT02518919|3488193|B1|fracture/dislocation reduction||Procedure Type||Participants|Count of Participants|12|12.0||||||
3640391|NCT02518919|3488190|B4|American Society of Anesethesiologist, ASA II||American Society of Anesthesiologists(ASA) Classification|"American Society of Anesthesiologists physical status classification is a system to assess fitness prior to surgery/procedure.~ASA I A normal healthy patient ASA II A patient with mild systemic disease ASA III A patient with severe systemic disease ASA IV A patient with severe systemic disease that is a constant threat to life ASA V A moribund patient who is not expected to survive without the operation The addition of “E” denotes Emergency surgery Higher the ASA class higher the risk from sedation and procedure"|Participants|Count of Participants|12|12.0||||||
3640392|NCT02518919|3488191|B3|American Society of Anesethesiologist, ASA II||American Society of Anesthesiologists(ASA) Classification|"American Society of Anesthesiologists physical status classification is a system to assess fitness prior to surgery/procedure.~ASA I A normal healthy patient ASA II A patient with mild systemic disease ASA III A patient with severe systemic disease ASA IV A patient with severe systemic disease that is a constant threat to life ASA V A moribund patient who is not expected to survive without the operation The addition of “E” denotes Emergency surgery Higher the ASA class higher the risk from sedation and procedure"|Participants|Count of Participants|3|3.0||||||
3640393|NCT02518919|3488192|B2|American Society of Anesethesiologist, ASA II||American Society of Anesthesiologists(ASA) Classification|"American Society of Anesthesiologists physical status classification is a system to assess fitness prior to surgery/procedure.~ASA I A normal healthy patient ASA II A patient with mild systemic disease ASA III A patient with severe systemic disease ASA IV A patient with severe systemic disease that is a constant threat to life ASA V A moribund patient who is not expected to survive without the operation The addition of “E” denotes Emergency surgery Higher the ASA class higher the risk from sedation and procedure"|Participants|Count of Participants|5|5.0||||||
3640394|NCT02518919|3488193|B1|American Society of Anesethesiologist, ASA II||American Society of Anesthesiologists(ASA) Classification|"American Society of Anesthesiologists physical status classification is a system to assess fitness prior to surgery/procedure.~ASA I A normal healthy patient ASA II A patient with mild systemic disease ASA III A patient with severe systemic disease ASA IV A patient with severe systemic disease that is a constant threat to life ASA V A moribund patient who is not expected to survive without the operation The addition of “E” denotes Emergency surgery Higher the ASA class higher the risk from sedation and procedure"|Participants|Count of Participants|4|4.0||||||
3640395|NCT02518919|3488190|B4|American Society of Anesthesiologist, ASA I||American Society of Anesthesiologists(ASA) Classification|"American Society of Anesthesiologists physical status classification is a system to assess fitness prior to surgery/procedure.~ASA I A normal healthy patient ASA II A patient with mild systemic disease ASA III A patient with severe systemic disease ASA IV A patient with severe systemic disease that is a constant threat to life ASA V A moribund patient who is not expected to survive without the operation The addition of “E” denotes Emergency surgery Higher the ASA class higher the risk from sedation and procedure"|Participants|Count of Participants|47|47.0||||||
3640396|NCT02518919|3488191|B3|American Society of Anesthesiologist, ASA I||American Society of Anesthesiologists(ASA) Classification|"American Society of Anesthesiologists physical status classification is a system to assess fitness prior to surgery/procedure.~ASA I A normal healthy patient ASA II A patient with mild systemic disease ASA III A patient with severe systemic disease ASA IV A patient with severe systemic disease that is a constant threat to life ASA V A moribund patient who is not expected to survive without the operation The addition of “E” denotes Emergency surgery Higher the ASA class higher the risk from sedation and procedure"|Participants|Count of Participants|16|16.0||||||
3640397|NCT02518919|3488192|B2|American Society of Anesthesiologist, ASA I||American Society of Anesthesiologists(ASA) Classification|"American Society of Anesthesiologists physical status classification is a system to assess fitness prior to surgery/procedure.~ASA I A normal healthy patient ASA II A patient with mild systemic disease ASA III A patient with severe systemic disease ASA IV A patient with severe systemic disease that is a constant threat to life ASA V A moribund patient who is not expected to survive without the operation The addition of “E” denotes Emergency surgery Higher the ASA class higher the risk from sedation and procedure"|Participants|Count of Participants|15|15.0||||||
3640398|NCT02518919|3488193|B1|American Society of Anesthesiologist, ASA I||American Society of Anesthesiologists(ASA) Classification|"American Society of Anesthesiologists physical status classification is a system to assess fitness prior to surgery/procedure.~ASA I A normal healthy patient ASA II A patient with mild systemic disease ASA III A patient with severe systemic disease ASA IV A patient with severe systemic disease that is a constant threat to life ASA V A moribund patient who is not expected to survive without the operation The addition of “E” denotes Emergency surgery Higher the ASA class higher the risk from sedation and procedure"|Participants|Count of Participants|16|16.0||||||
3640399|NCT02518919|3488190|B4|Others||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3640400|NCT02518919|3488191|B3|Others||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3640401|NCT02518919|3488192|B2|Others||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3640402|NCT02518919|3488193|B1|Others||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3640403|NCT02518919|3488190|B4|Mixed||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3640404|NCT02518919|3488191|B3|Mixed||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3640405|NCT02518919|3488192|B2|Mixed||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3640406|NCT02518919|3488193|B1|Mixed||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3640407|NCT02518919|3488190|B4|African American||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3640408|NCT02518919|3488191|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3640409|NCT02518919|3488192|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3640410|NCT02518919|3488193|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3640411|NCT02518919|3488190|B4|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3640412|NCT02518919|3488191|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3640413|NCT02518919|3488192|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3640414|NCT02518919|3488193|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3640415|NCT02518919|3488190|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3640416|NCT02518919|3488191|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3640417|NCT02518919|3488192|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3640418|NCT02518919|3488193|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3640419|NCT02518919|3488190|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640420|NCT02518919|3488191|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640421|NCT02518919|3488192|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640422|NCT02518919|3488193|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640423|NCT02518919|3488190|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3640424|NCT02518919|3488191|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3640425|NCT02518919|3488192|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3640426|NCT02518919|3488193|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3640427|NCT02518919|3488190|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3640428|NCT02518919|3488191|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3640429|NCT02518919|3488192|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640430|NCT02518919|3488193|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3640431|NCT02518919|3488190|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3640432|NCT02518919|3488191|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3640433|NCT02518919|3488192|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3640434|NCT02518919|3488193|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3640435|NCT02518919|3488190|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3640436|NCT02518919|3488191|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3640437|NCT02518919|3488192|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3640438|NCT02518919|3488193|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3640439|NCT02518919|3488190|B4|||Age||years|Median|8|8.0|Inter-Quartile Range|||5.0|11.0|
3640440|NCT02518919|3488191|B3|||Age||years|Median|9|9.0|Inter-Quartile Range|||6.0|11.0|
3640441|NCT02518919|3488192|B2|||Age||years|Median|8.5|8.5|Inter-Quartile Range|||6.5|11.0|
3640442|NCT02518919|3488193|B1|||Age||years|Median|5|5.0|Inter-Quartile Range|||4.5|9.5|
3640443|NCT02518139|3488215|B4|Former Smoker||Smoking Status||Participants|Count of Participants|566|566.0||||||
3640444|NCT02518139|3488216|B3|Former Smoker||Smoking Status||Participants|Count of Participants|189|189.0||||||
3640445|NCT02518139|3488217|B2|Former Smoker||Smoking Status||Participants|Count of Participants|184|184.0||||||
3640446|NCT02518139|3488218|B1|Former Smoker||Smoking Status||Participants|Count of Participants|193|193.0||||||
3640447|NCT02518139|3488215|B4|Current Smoker||Smoking Status||Participants|Count of Participants|489|489.0||||||
3640448|NCT02518139|3488216|B3|Current Smoker||Smoking Status||Participants|Count of Participants|167|167.0||||||
3640449|NCT02518139|3488217|B2|Current Smoker||Smoking Status||Participants|Count of Participants|151|151.0||||||
3640450|NCT02518139|3488218|B1|Current Smoker||Smoking Status||Participants|Count of Participants|171|171.0||||||
3640451|NCT02518139|3488215|B4|United States||Region of Enrollment||participants|Number|1055|1055.0||||||
3640452|NCT02518139|3488216|B3|United States||Region of Enrollment||participants|Number|356|356.0||||||
3640453|NCT02518139|3488217|B2|United States||Region of Enrollment||participants|Number|335|335.0||||||
3640454|NCT02518139|3488218|B1|United States||Region of Enrollment||participants|Number|364|364.0||||||
3640455|NCT02518139|3488215|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3640456|NCT02518139|3488216|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640457|NCT02518139|3488217|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3640458|NCT02518139|3488218|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3640459|NCT02518139|3488215|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3640460|NCT02518139|3488216|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640461|NCT02518139|3488217|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3640462|NCT02518139|3488218|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3640463|NCT02518139|3488215|B4||White|Race (NIH/OMB)||Participants|Count of Participants|977|977.0||||||
3640464|NCT02518139|3488216|B3||White|Race (NIH/OMB)||Participants|Count of Participants|331|331.0||||||
3640465|NCT02518139|3488217|B2||White|Race (NIH/OMB)||Participants|Count of Participants|309|309.0||||||
3640466|NCT02518139|3488218|B1||White|Race (NIH/OMB)||Participants|Count of Participants|337|337.0||||||
3640467|NCT02518139|3488215|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3640468|NCT02518139|3488216|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3640469|NCT02518139|3488217|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3640470|NCT02518139|3488218|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3640471|NCT02518139|3488215|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640472|NCT02518139|3488216|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640473|NCT02518139|3488217|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640474|NCT02518139|3488218|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640475|NCT02518139|3488215|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3640476|NCT02518139|3488216|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3640477|NCT02518139|3488217|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3640478|NCT02518139|3488218|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3640479|NCT02518139|3488215|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640480|NCT02518139|3488216|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640481|NCT02518139|3488217|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640482|NCT02518139|3488218|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640483|NCT02518139|3488215|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3640484|NCT02518139|3488216|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3640485|NCT02518139|3488217|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3640486|NCT02518139|3488218|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3640487|NCT02518139|3488215|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1035|1035.0||||||
3640488|NCT02518139|3488216|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|352|352.0||||||
3640489|NCT02518139|3488217|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|326|326.0||||||
3640490|NCT02518139|3488218|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|357|357.0||||||
3640491|NCT02518139|3488215|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3640492|NCT02518139|3488216|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3640493|NCT02518139|3488217|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3640494|NCT02518139|3488218|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3640495|NCT02518139|3488215|B4||Male|Sex: Female, Male||Participants|Count of Participants|616|616.0||||||
3640496|NCT02518139|3488216|B3||Male|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
3640497|NCT02518139|3488217|B2||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
3640498|NCT02518139|3488218|B1||Male|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
3640499|NCT02518139|3488215|B4||Female|Sex: Female, Male||Participants|Count of Participants|439|439.0||||||
3640500|NCT02518139|3488216|B3||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3640501|NCT02518139|3488217|B2||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3640502|NCT02518139|3488218|B1||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3640503|NCT02518139|3488215|B4|||Age||years|Mean|64.4|64.4|Standard Deviation|8.97|8.97|||
3640504|NCT02518139|3488216|B3|||Age||years|Mean|64.9|64.9|Standard Deviation|8.91|8.91|||
3640505|NCT02518139|3488217|B2|||Age||years|Mean|64.4|64.4|Standard Deviation|8.61|8.61|||
3640506|NCT02518139|3488218|B1|||Age||years|Mean|64.1|64.1|Standard Deviation|9.36|9.36|||
3640507|NCT02518139|3488215|B4||>=65 years|Age||Participants|Count of Participants|542|542.0||||||
3640508|NCT02518139|3488216|B3||>=65 years|Age||Participants|Count of Participants|193|193.0||||||
3640509|NCT02518139|3488217|B2||>=65 years|Age||Participants|Count of Participants|168|168.0||||||
3640510|NCT02518139|3488218|B1||>=65 years|Age||Participants|Count of Participants|181|181.0||||||
3640511|NCT02518139|3488215|B4||Between 18 and 65 years|Age||Participants|Count of Participants|513|513.0||||||
3640512|NCT02518139|3488216|B3||Between 18 and 65 years|Age||Participants|Count of Participants|163|163.0||||||
3640513|NCT02518139|3488217|B2||Between 18 and 65 years|Age||Participants|Count of Participants|167|167.0||||||
3640514|NCT02518139|3488218|B1||Between 18 and 65 years|Age||Participants|Count of Participants|183|183.0||||||
3640515|NCT02518139|3488215|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3640516|NCT02518139|3488216|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3640517|NCT02518139|3488217|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3640518|NCT02518139|3488218|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3640519|NCT02518048|3488228|B1|France||Region of Enrollment||participants|Number|35|35.0||||||
3640520|NCT02518048|3488228|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3640521|NCT02518048|3488228|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3640522|NCT02518048|3488228|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3640523|NCT02518048|3488228|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3640524|NCT02518048|3488228|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3640525|NCT02517580|3488239|B1|||Transplantation duration||years|Mean|15.9|15.9|Standard Deviation|6|6.0|||
3640526|NCT02517580|3488239|B1|Lebanon||Region of Enrollment||participants|Number|60|60.0||||||
3640527|NCT02517580|3488239|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3640529|NCT02517580|3488239|B1|||Age||years|Mean|49.7|49.7|Standard Deviation|10.4|10.4|||
3640530|NCT02517567|3488243|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3640531|NCT02517567|3488243|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3640532|NCT02517567|3488243|B1|||Age||years|Mean|23.7|23.7|Standard Deviation|5.36|5.36|||
3640533|NCT02517541|3488255|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3640534|NCT02517541|3488255|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3640535|NCT02517541|3488255|B1|||Age||years|Mean|65.6|65.6|Standard Deviation|9.8|9.8|||
3640536|NCT02517528|3488261|B1|Taiwan||Region of Enrollment||participants|Number|20|20.0||||||
3640537|NCT02517528|3488261|B1|South Korea||Region of Enrollment||participants|Number|21|21.0||||||
3640538|NCT02517528|3488261|B1|China||Region of Enrollment||participants|Number|63|63.0||||||
3640539|NCT02517528|3488261|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3640540|NCT02517528|3488261|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3640541|NCT02517528|3488261|B1|||Age||years|Mean|56.43|56.43|Standard Deviation|8.11|8.11|||
3640542|NCT02517515|3488269|B3||Male|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
3640543|NCT02517515|3488270|B2||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3640544|NCT02517515|3488271|B1||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3640545|NCT02517515|3488269|B3||Female|Sex: Female, Male||Participants|Count of Participants|352|352.0||||||
3640546|NCT02517515|3488270|B2||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
3640547|NCT02517515|3488271|B1||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
3640548|NCT02517515|3488269|B3|||Age||years|Mean|46.2|46.2|Standard Deviation|13.95|13.95|||
3640549|NCT02517515|3488270|B2|||Age||years|Mean|45.6|45.6|Standard Deviation|14.05|14.05|||
3640550|NCT02517515|3488271|B1|||Age||years|Mean|46.8|46.8|Standard Deviation|13.84|13.84|||
3640551|NCT02517463|3488287|B3|Hong Kong||Region of Enrollment||participants|Number|693|693.0||||||
3640552|NCT02517463|3488288|B2|Hong Kong||Region of Enrollment||participants|Number|329|329.0||||||
3640553|NCT02517463|3488289|B1|Hong Kong||Region of Enrollment||participants|Number|364|364.0||||||
3640554|NCT02517463|3488287|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640555|NCT02517463|3488288|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640556|NCT02517463|3488289|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640557|NCT02517463|3488287|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640558|NCT02517463|3488288|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640559|NCT02517463|3488289|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640560|NCT02517463|3488287|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3640561|NCT02517463|3488288|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3640562|NCT02517463|3488289|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3640563|NCT02517463|3488287|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640564|NCT02517463|3488288|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640565|NCT02517463|3488289|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640566|NCT02517463|3488287|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640567|NCT02517463|3488288|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640568|NCT02517463|3488289|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640569|NCT02517463|3488287|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|677|677.0||||||
3640570|NCT02517463|3488288|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|322|322.0||||||
3640571|NCT02517463|3488289|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|355|355.0||||||
3640572|NCT02517463|3488287|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640573|NCT02517463|3488288|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640574|NCT02517463|3488289|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640575|NCT02517463|3488287|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3640576|NCT02517463|3488288|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3640577|NCT02517463|3488289|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3640578|NCT02517463|3488287|B3||Female|Sex: Female, Male||Participants|Count of Participants|693|693.0||||||
3640579|NCT02517463|3488288|B2||Female|Sex: Female, Male||Participants|Count of Participants|329|329.0||||||
3640580|NCT02517463|3488289|B1||Female|Sex: Female, Male||Participants|Count of Participants|364|364.0||||||
3640581|NCT02517463|3488287|B3|||Age||years|Median|32|32.0|Inter-Quartile Range|||28.0|38.0|
3640582|NCT02517463|3488288|B2|||Age||years|Median|34|34.0|Inter-Quartile Range|||28.0|39.0|
3640583|NCT02517463|3488289|B1|||Age||years|Median|31|31.0|Inter-Quartile Range|||28.0|37.0|
3640584|NCT02517463|3488287|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3640585|NCT02517463|3488288|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3640586|NCT02517463|3488289|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3640587|NCT02517463|3488287|B3||Between 18 and 65 years|Age||Participants|Count of Participants|693|693.0||||||
3640588|NCT02517463|3488288|B2||Between 18 and 65 years|Age||Participants|Count of Participants|329|329.0||||||
3640589|NCT02517463|3488289|B1||Between 18 and 65 years|Age||Participants|Count of Participants|364|364.0||||||
3640590|NCT02517463|3488287|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3640591|NCT02517463|3488288|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3640592|NCT02517463|3488289|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3640593|NCT02517047|3488300|B1|||Asthma control test|Asthma control test is a survey used to evaluate asthma control in patients. It includes 5 multiple questions that ask about how much of the time patient was having asthma symptoms. The higher the score the better asthma control. Lower scores especially less than 19 represent poor asthma control. each question has 5 answers. The total score is the sum of all the scores from 5 questions. the maximum score on the test is 25 which is excellent asthma control and the lowest is 0 which defines extremely poor asthma control.|units on a scale|Mean|20.6|20.6|Standard Deviation|3.5|3.5|||
3640594|NCT02517047|3488300|B1|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3640595|NCT02517047|3488300|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640596|NCT02517047|3488300|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3640597|NCT02517047|3488300|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3640598|NCT02517047|3488300|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3640599|NCT02517047|3488300|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640600|NCT02517047|3488300|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640601|NCT02517047|3488300|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640602|NCT02517047|3488300|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640603|NCT02517047|3488300|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3640604|NCT02517047|3488300|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3640605|NCT02517047|3488300|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3640606|NCT02517047|3488300|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3640607|NCT02517047|3488300|B1|||Age||years|Mean|9.1|9.1|Full Range|||6.0|14.0|
3640608|NCT02517047|3488300|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3640609|NCT02517047|3488300|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3640610|NCT02517047|3488300|B1||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
3640611|NCT02517021|3488307|B3||Regular|Tobacco consumption||Participants|Count of Participants|113|113.0||||||
3640612|NCT02517021|3488308|B2||Regular|Tobacco consumption||Participants|Count of Participants|55|55.0||||||
3640613|NCT02517021|3488309|B1||Regular|Tobacco consumption||Participants|Count of Participants|58|58.0||||||
3640614|NCT02517021|3488307|B3||Occasional|Tobacco consumption||Participants|Count of Participants|0|0.0||||||
3640615|NCT02517021|3488308|B2||Occasional|Tobacco consumption||Participants|Count of Participants|0|0.0||||||
3640616|NCT02517021|3488309|B1||Occasional|Tobacco consumption||Participants|Count of Participants|0|0.0||||||
3640617|NCT02517021|3488307|B3||Ex-smoker|Tobacco consumption||Participants|Count of Participants|131|131.0||||||
3640618|NCT02517021|3488308|B2||Ex-smoker|Tobacco consumption||Participants|Count of Participants|69|69.0||||||
3640619|NCT02517021|3488309|B1||Ex-smoker|Tobacco consumption||Participants|Count of Participants|62|62.0||||||
3640620|NCT02517021|3488307|B3||Non-smoker|Tobacco consumption||Participants|Count of Participants|160|160.0||||||
3640621|NCT02517021|3488308|B2||Non-smoker|Tobacco consumption||Participants|Count of Participants|77|77.0||||||
3640622|NCT02517021|3488309|B1||Non-smoker|Tobacco consumption||Participants|Count of Participants|83|83.0||||||
3640623|NCT02517021|3488307|B3||Regular|Alcohol consumption||Participants|Count of Participants|9|9.0||||||
3640624|NCT02517021|3488308|B2||Regular|Alcohol consumption||Participants|Count of Participants|8|8.0||||||
3640625|NCT02517021|3488309|B1||Regular|Alcohol consumption||Participants|Count of Participants|1|1.0||||||
3640626|NCT02517021|3488307|B3||Occasional|Alcohol consumption||Participants|Count of Participants|151|151.0||||||
3640627|NCT02517021|3488308|B2||Occasional|Alcohol consumption||Participants|Count of Participants|75|75.0||||||
3640628|NCT02517021|3488309|B1||Occasional|Alcohol consumption||Participants|Count of Participants|76|76.0||||||
3640629|NCT02517021|3488307|B3||None|Alcohol consumption||Participants|Count of Participants|244|244.0||||||
3640630|NCT02517021|3488308|B2||None|Alcohol consumption||Participants|Count of Participants|118|118.0||||||
3640631|NCT02517021|3488309|B1||None|Alcohol consumption||Participants|Count of Participants|126|126.0||||||
3640632|NCT02517021|3488307|B3||Grade 2|ECOG performance status|The ECOG Scale is a standard criteria for measuring how the cancer disease impacts a patient’s daily living abilities (known to physicians and researchers as a patient’s performance status). It describes a patient’s level of functioning in terms of their ability to care for themself, daily activity, and physical ability (walking, working, etc.). There 6 grades, where the performance gets worsening from 0 (patient is fully active, able to carry on all pre-disease performance without restriction) to 5 (patient is dead).|Participants|Count of Participants|10|10.0||||||
3640633|NCT02517021|3488308|B2||Grade 2|ECOG performance status|The ECOG Scale is a standard criteria for measuring how the cancer disease impacts a patient’s daily living abilities (known to physicians and researchers as a patient’s performance status). It describes a patient’s level of functioning in terms of their ability to care for themself, daily activity, and physical ability (walking, working, etc.). There 6 grades, where the performance gets worsening from 0 (patient is fully active, able to carry on all pre-disease performance without restriction) to 5 (patient is dead).|Participants|Count of Participants|5|5.0||||||
3640664|NCT02517021|3488309|B1||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3640665|NCT02517021|3488307|B3||Female|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
3640634|NCT02517021|3488309|B1||Grade 2|ECOG performance status|The ECOG Scale is a standard criteria for measuring how the cancer disease impacts a patient’s daily living abilities (known to physicians and researchers as a patient’s performance status). It describes a patient’s level of functioning in terms of their ability to care for themself, daily activity, and physical ability (walking, working, etc.). There 6 grades, where the performance gets worsening from 0 (patient is fully active, able to carry on all pre-disease performance without restriction) to 5 (patient is dead).|Participants|Count of Participants|5|5.0||||||
3640635|NCT02517021|3488307|B3||Grade 1|ECOG performance status|The ECOG Scale is a standard criteria for measuring how the cancer disease impacts a patient’s daily living abilities (known to physicians and researchers as a patient’s performance status). It describes a patient’s level of functioning in terms of their ability to care for themself, daily activity, and physical ability (walking, working, etc.). There 6 grades, where the performance gets worsening from 0 (patient is fully active, able to carry on all pre-disease performance without restriction) to 5 (patient is dead).|Participants|Count of Participants|230|230.0||||||
3640636|NCT02517021|3488308|B2||Grade 1|ECOG performance status|The ECOG Scale is a standard criteria for measuring how the cancer disease impacts a patient’s daily living abilities (known to physicians and researchers as a patient’s performance status). It describes a patient’s level of functioning in terms of their ability to care for themself, daily activity, and physical ability (walking, working, etc.). There 6 grades, where the performance gets worsening from 0 (patient is fully active, able to carry on all pre-disease performance without restriction) to 5 (patient is dead).|Participants|Count of Participants|113|113.0||||||
3640637|NCT02517021|3488309|B1||Grade 1|ECOG performance status|The ECOG Scale is a standard criteria for measuring how the cancer disease impacts a patient’s daily living abilities (known to physicians and researchers as a patient’s performance status). It describes a patient’s level of functioning in terms of their ability to care for themself, daily activity, and physical ability (walking, working, etc.). There 6 grades, where the performance gets worsening from 0 (patient is fully active, able to carry on all pre-disease performance without restriction) to 5 (patient is dead).|Participants|Count of Participants|117|117.0||||||
3640638|NCT02517021|3488307|B3||Grade 0|ECOG performance status|The ECOG Scale is a standard criteria for measuring how the cancer disease impacts a patient’s daily living abilities (known to physicians and researchers as a patient’s performance status). It describes a patient’s level of functioning in terms of their ability to care for themself, daily activity, and physical ability (walking, working, etc.). There 6 grades, where the performance gets worsening from 0 (patient is fully active, able to carry on all pre-disease performance without restriction) to 5 (patient is dead).|Participants|Count of Participants|164|164.0||||||
3640639|NCT02517021|3488308|B2||Grade 0|ECOG performance status|The ECOG Scale is a standard criteria for measuring how the cancer disease impacts a patient’s daily living abilities (known to physicians and researchers as a patient’s performance status). It describes a patient’s level of functioning in terms of their ability to care for themself, daily activity, and physical ability (walking, working, etc.). There 6 grades, where the performance gets worsening from 0 (patient is fully active, able to carry on all pre-disease performance without restriction) to 5 (patient is dead).|Participants|Count of Participants|83|83.0||||||
3640640|NCT02517021|3488309|B1||Grade 0|ECOG performance status|The ECOG Scale is a standard criteria for measuring how the cancer disease impacts a patient’s daily living abilities (known to physicians and researchers as a patient’s performance status). It describes a patient’s level of functioning in terms of their ability to care for themself, daily activity, and physical ability (walking, working, etc.). There 6 grades, where the performance gets worsening from 0 (patient is fully active, able to carry on all pre-disease performance without restriction) to 5 (patient is dead).|Participants|Count of Participants|81|81.0||||||
3640641|NCT02517021|3488307|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640642|NCT02517021|3488308|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640643|NCT02517021|3488309|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640644|NCT02517021|3488307|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640645|NCT02517021|3488308|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640646|NCT02517021|3488309|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640647|NCT02517021|3488307|B3||White|Race (NIH/OMB)||Participants|Count of Participants|401|401.0||||||
3640648|NCT02517021|3488308|B2||White|Race (NIH/OMB)||Participants|Count of Participants|200|200.0||||||
3640649|NCT02517021|3488309|B1||White|Race (NIH/OMB)||Participants|Count of Participants|201|201.0||||||
3640650|NCT02517021|3488307|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3640651|NCT02517021|3488308|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640652|NCT02517021|3488309|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3640653|NCT02517021|3488307|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640654|NCT02517021|3488308|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640655|NCT02517021|3488309|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640656|NCT02517021|3488307|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3640657|NCT02517021|3488308|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3640658|NCT02517021|3488309|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640659|NCT02517021|3488307|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640660|NCT02517021|3488308|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640661|NCT02517021|3488309|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640662|NCT02517021|3488307|B3||Male|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
3640663|NCT02517021|3488308|B2||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3640666|NCT02517021|3488308|B2||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3640667|NCT02517021|3488309|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3640668|NCT02517021|3488307|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|10.2|10.2|||
3640669|NCT02517021|3488308|B2|||Age||years|Mean|58.9|58.9|Standard Deviation|10.6|10.6|||
3640670|NCT02517021|3488309|B1|||Age||years|Mean|60.0|60.0|Standard Deviation|9.7|9.7|||
3640671|NCT02516410|3488334|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3640672|NCT02516410|3488335|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3640673|NCT02516410|3488336|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3640674|NCT02516410|3488334|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3640675|NCT02516410|3488335|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3640676|NCT02516410|3488336|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3640677|NCT02516410|3488334|B3|||Age||years|Mean|26.1|26.1|Standard Deviation|9.2|9.2|||
3640678|NCT02516410|3488335|B2|||Age||years|Mean|26.2|26.2|Standard Deviation|9.6|9.6|||
3640679|NCT02516410|3488336|B1|||Age||years|Mean|26|26.0|Standard Deviation|8.8|8.8|||
3640680|NCT02516306|3488364|B3|United States||Region of Enrollment||participants|Number|75|75.0||||||
3640681|NCT02516306|3488365|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3640682|NCT02516306|3488366|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3640683|NCT02516306|3488364|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3640684|NCT02516306|3488365|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3640685|NCT02516306|3488366|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3640686|NCT02516306|3488364|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3640687|NCT02516306|3488365|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3640688|NCT02516306|3488366|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3640689|NCT02516306|3488364|B3|||Age||years|Mean|50.5|50.5|Standard Deviation|3.1|3.1|||
3640690|NCT02516306|3488365|B2|||Age||years|Mean|51.4|51.4|Standard Deviation|3.0|3.0|||
3640691|NCT02516306|3488366|B1|||Age||years|Mean|50.1|50.1|Standard Deviation|3.2|3.2|||
3640692|NCT02516202|3488373|B4||Missing|Self-reported health||Participants|Count of Participants|1|1.0||||||
3640693|NCT02516202|3488374|B3||Missing|Self-reported health||Participants|Count of Participants|0|0.0||||||
3640694|NCT02516202|3488375|B2||Missing|Self-reported health||Participants|Count of Participants|0|0.0||||||
3640695|NCT02516202|3488376|B1||Missing|Self-reported health||Participants|Count of Participants|1|1.0||||||
3640696|NCT02516202|3488373|B4||Fair / poor|Self-reported health||Participants|Count of Participants|7|7.0||||||
3640697|NCT02516202|3488374|B3||Fair / poor|Self-reported health||Participants|Count of Participants|3|3.0||||||
3640698|NCT02516202|3488375|B2||Fair / poor|Self-reported health||Participants|Count of Participants|3|3.0||||||
3640699|NCT02516202|3488376|B1||Fair / poor|Self-reported health||Participants|Count of Participants|1|1.0||||||
3640700|NCT02516202|3488373|B4||Good|Self-reported health||Participants|Count of Participants|78|78.0||||||
3640701|NCT02516202|3488374|B3||Good|Self-reported health||Participants|Count of Participants|30|30.0||||||
3640702|NCT02516202|3488375|B2||Good|Self-reported health||Participants|Count of Participants|15|15.0||||||
3640703|NCT02516202|3488376|B1||Good|Self-reported health||Participants|Count of Participants|33|33.0||||||
3640704|NCT02516202|3488373|B4||Very good|Self-reported health||Participants|Count of Participants|143|143.0||||||
3640705|NCT02516202|3488374|B3||Very good|Self-reported health||Participants|Count of Participants|47|47.0||||||
3640706|NCT02516202|3488375|B2||Very good|Self-reported health||Participants|Count of Participants|55|55.0||||||
3640707|NCT02516202|3488376|B1||Very good|Self-reported health||Participants|Count of Participants|41|41.0||||||
3640708|NCT02516202|3488373|B4||Excellent|Self-reported health||Participants|Count of Participants|73|73.0||||||
3640709|NCT02516202|3488374|B3||Excellent|Self-reported health||Participants|Count of Participants|20|20.0||||||
3640710|NCT02516202|3488375|B2||Excellent|Self-reported health||Participants|Count of Participants|27|27.0||||||
3640711|NCT02516202|3488376|B1||Excellent|Self-reported health||Participants|Count of Participants|26|26.0||||||
3640712|NCT02516202|3488373|B4||Missing|Most bothersome symptom||Participants|Count of Participants|4|4.0||||||
3640713|NCT02516202|3488374|B3||Missing|Most bothersome symptom||Participants|Count of Participants|1|1.0||||||
3640714|NCT02516202|3488375|B2||Missing|Most bothersome symptom||Participants|Count of Participants|0|0.0||||||
3640715|NCT02516202|3488376|B1||Missing|Most bothersome symptom||Participants|Count of Participants|3|3.0||||||
3640716|NCT02516202|3488373|B4||Pain with vaginal penetration|Most bothersome symptom||Participants|Count of Participants|182|182.0||||||
3640717|NCT02516202|3488374|B3||Pain with vaginal penetration|Most bothersome symptom||Participants|Count of Participants|60|60.0||||||
3640718|NCT02516202|3488375|B2||Pain with vaginal penetration|Most bothersome symptom||Participants|Count of Participants|68|68.0||||||
3640719|NCT02516202|3488376|B1||Pain with vaginal penetration|Most bothersome symptom||Participants|Count of Participants|54|54.0||||||
3640720|NCT02516202|3488373|B4||Vulvar and/or vaginal irritation|Most bothersome symptom||Participants|Count of Participants|19|19.0||||||
3640721|NCT02516202|3488374|B3||Vulvar and/or vaginal irritation|Most bothersome symptom||Participants|Count of Participants|8|8.0||||||
3640722|NCT02516202|3488375|B2||Vulvar and/or vaginal irritation|Most bothersome symptom||Participants|Count of Participants|4|4.0||||||
3640723|NCT02516202|3488376|B1||Vulvar and/or vaginal irritation|Most bothersome symptom||Participants|Count of Participants|7|7.0||||||
3640724|NCT02516202|3488373|B4||Vaginal dryness|Most bothersome symptom||Participants|Count of Participants|63|63.0||||||
3640725|NCT02516202|3488374|B3||Vaginal dryness|Most bothersome symptom||Participants|Count of Participants|23|23.0||||||
3640726|NCT02516202|3488375|B2||Vaginal dryness|Most bothersome symptom||Participants|Count of Participants|17|17.0||||||
3640727|NCT02516202|3488376|B1||Vaginal dryness|Most bothersome symptom||Participants|Count of Participants|23|23.0||||||
3640728|NCT02516202|3488373|B4||Vulvar and/or vaginal pain|Most bothersome symptom||Participants|Count of Participants|14|14.0||||||
3640729|NCT02516202|3488374|B3||Vulvar and/or vaginal pain|Most bothersome symptom||Participants|Count of Participants|2|2.0||||||
3640730|NCT02516202|3488375|B2||Vulvar and/or vaginal pain|Most bothersome symptom||Participants|Count of Participants|7|7.0||||||
3640731|NCT02516202|3488376|B1||Vulvar and/or vaginal pain|Most bothersome symptom||Participants|Count of Participants|5|5.0||||||
3640732|NCT02516202|3488373|B4||Vulvar and/or vaginal itching|Most bothersome symptom||Participants|Count of Participants|20|20.0||||||
3640733|NCT02516202|3488374|B3||Vulvar and/or vaginal itching|Most bothersome symptom||Participants|Count of Participants|6|6.0||||||
3640734|NCT02516202|3488375|B2||Vulvar and/or vaginal itching|Most bothersome symptom||Participants|Count of Participants|4|4.0||||||
3640735|NCT02516202|3488376|B1||Vulvar and/or vaginal itching|Most bothersome symptom||Participants|Count of Participants|10|10.0||||||
3640736|NCT02516202|3488373|B4||Missing|Vaginal maturation index||Participants|Count of Participants|33|33.0||||||
3640737|NCT02516202|3488374|B3||Missing|Vaginal maturation index||Participants|Count of Participants|12|12.0||||||
3640738|NCT02516202|3488375|B2||Missing|Vaginal maturation index||Participants|Count of Participants|11|11.0||||||
3640739|NCT02516202|3488376|B1||Missing|Vaginal maturation index||Participants|Count of Participants|10|10.0||||||
3640740|NCT02516202|3488373|B4||> 5% superficial cells|Vaginal maturation index||Participants|Count of Participants|24|24.0||||||
3640741|NCT02516202|3488374|B3||> 5% superficial cells|Vaginal maturation index||Participants|Count of Participants|7|7.0||||||
3640742|NCT02516202|3488375|B2||> 5% superficial cells|Vaginal maturation index||Participants|Count of Participants|11|11.0||||||
3640743|NCT02516202|3488376|B1||> 5% superficial cells|Vaginal maturation index||Participants|Count of Participants|6|6.0||||||
3640744|NCT02516202|3488373|B4||≤ 5% superficial cells|Vaginal maturation index||Participants|Count of Participants|245|245.0||||||
3640745|NCT02516202|3488374|B3||≤ 5% superficial cells|Vaginal maturation index||Participants|Count of Participants|81|81.0||||||
3640746|NCT02516202|3488375|B2||≤ 5% superficial cells|Vaginal maturation index||Participants|Count of Participants|78|78.0||||||
3640747|NCT02516202|3488376|B1||≤ 5% superficial cells|Vaginal maturation index||Participants|Count of Participants|86|86.0||||||
3640748|NCT02516202|3488373|B4||Missing|Vaginal pH||Participants|Count of Participants|5|5.0||||||
3640749|NCT02516202|3488374|B3||Missing|Vaginal pH||Participants|Count of Participants|1|1.0||||||
3640750|NCT02516202|3488375|B2||Missing|Vaginal pH||Participants|Count of Participants|1|1.0||||||
3640751|NCT02516202|3488376|B1||Missing|Vaginal pH||Participants|Count of Participants|3|3.0||||||
3640752|NCT02516202|3488373|B4||> 5|Vaginal pH||Participants|Count of Participants|258|258.0||||||
3640753|NCT02516202|3488374|B3||> 5|Vaginal pH||Participants|Count of Participants|90|90.0||||||
3640754|NCT02516202|3488375|B2||> 5|Vaginal pH||Participants|Count of Participants|87|87.0||||||
3640755|NCT02516202|3488376|B1||> 5|Vaginal pH||Participants|Count of Participants|81|81.0||||||
3640756|NCT02516202|3488373|B4||≤ 5|Vaginal pH||Participants|Count of Participants|39|39.0||||||
3640757|NCT02516202|3488374|B3||≤ 5|Vaginal pH||Participants|Count of Participants|9|9.0||||||
3640758|NCT02516202|3488375|B2||≤ 5|Vaginal pH||Participants|Count of Participants|12|12.0||||||
3640759|NCT02516202|3488376|B1||≤ 5|Vaginal pH||Participants|Count of Participants|18|18.0||||||
3640760|NCT02516202|3488373|B4|||Female Sexual Function Index total|The Female Sexual Function Index (FSFI) assesses sexual functioning in women. It consists of 19 questions grouped into 6 domains: desire (2 questions), arousal (4), lubrication (4), orgasm (3), satisfaction (3), and pain (3). Each domain score ranges from a low value between 0 and 1.2 (varies by domain) and a high value of 6. The domain scores are summed to calculate the total FSFI score (range 2-36), with high scores indicating better sexual function.|units on a scale|Mean|15.5|15.5|Standard Deviation|6.4|6.4|||
3640761|NCT02516202|3488374|B3|||Female Sexual Function Index total|The Female Sexual Function Index (FSFI) assesses sexual functioning in women. It consists of 19 questions grouped into 6 domains: desire (2 questions), arousal (4), lubrication (4), orgasm (3), satisfaction (3), and pain (3). Each domain score ranges from a low value between 0 and 1.2 (varies by domain) and a high value of 6. The domain scores are summed to calculate the total FSFI score (range 2-36), with high scores indicating better sexual function.|units on a scale|Mean|16.1|16.1|Standard Deviation|6.6|6.6|||
3640762|NCT02516202|3488375|B2|||Female Sexual Function Index total|The Female Sexual Function Index (FSFI) assesses sexual functioning in women. It consists of 19 questions grouped into 6 domains: desire (2 questions), arousal (4), lubrication (4), orgasm (3), satisfaction (3), and pain (3). Each domain score ranges from a low value between 0 and 1.2 (varies by domain) and a high value of 6. The domain scores are summed to calculate the total FSFI score (range 2-36), with high scores indicating better sexual function.|units on a scale|Mean|15.2|15.2|Standard Deviation|6.5|6.5|||
3640763|NCT02516202|3488376|B1|||Female Sexual Function Index total|The Female Sexual Function Index (FSFI) assesses sexual functioning in women. It consists of 19 questions grouped into 6 domains: desire (2 questions), arousal (4), lubrication (4), orgasm (3), satisfaction (3), and pain (3). Each domain score ranges from a low value between 0 and 1.2 (varies by domain) and a high value of 6. The domain scores are summed to calculate the total FSFI score (range 2-36), with high scores indicating better sexual function.|units on a scale|Mean|15.2|15.2|Standard Deviation|539|539.0|||
3640764|NCT02516202|3488373|B4||Missing|Female Sexual Distress Scale-Revised, item 1, distressed about sex life||Participants|Count of Participants|2|2.0||||||
3640765|NCT02516202|3488374|B3||Missing|Female Sexual Distress Scale-Revised, item 1, distressed about sex life||Participants|Count of Participants|0|0.0||||||
3640766|NCT02516202|3488375|B2||Missing|Female Sexual Distress Scale-Revised, item 1, distressed about sex life||Participants|Count of Participants|1|1.0||||||
3640767|NCT02516202|3488376|B1||Missing|Female Sexual Distress Scale-Revised, item 1, distressed about sex life||Participants|Count of Participants|1|1.0||||||
3640768|NCT02516202|3488373|B4||Frequently / always|Female Sexual Distress Scale-Revised, item 1, distressed about sex life||Participants|Count of Participants|156|156.0||||||
3640769|NCT02516202|3488374|B3||Frequently / always|Female Sexual Distress Scale-Revised, item 1, distressed about sex life||Participants|Count of Participants|49|49.0||||||
3640770|NCT02516202|3488375|B2||Frequently / always|Female Sexual Distress Scale-Revised, item 1, distressed about sex life||Participants|Count of Participants|54|54.0||||||
3640771|NCT02516202|3488376|B1||Frequently / always|Female Sexual Distress Scale-Revised, item 1, distressed about sex life||Participants|Count of Participants|53|53.0||||||
3640772|NCT02516202|3488373|B4||Occasionally|Female Sexual Distress Scale-Revised, item 1, distressed about sex life||Participants|Count of Participants|99|99.0||||||
3640773|NCT02516202|3488374|B3||Occasionally|Female Sexual Distress Scale-Revised, item 1, distressed about sex life||Participants|Count of Participants|33|33.0||||||
3640774|NCT02516202|3488375|B2||Occasionally|Female Sexual Distress Scale-Revised, item 1, distressed about sex life||Participants|Count of Participants|33|33.0||||||
3640775|NCT02516202|3488376|B1||Occasionally|Female Sexual Distress Scale-Revised, item 1, distressed about sex life||Participants|Count of Participants|33|33.0||||||
3640776|NCT02516202|3488373|B4||Never / rarely|Female Sexual Distress Scale-Revised, item 1, distressed about sex life||Participants|Count of Participants|45|45.0||||||
3640777|NCT02516202|3488374|B3||Never / rarely|Female Sexual Distress Scale-Revised, item 1, distressed about sex life||Participants|Count of Participants|18|18.0||||||
3640778|NCT02516202|3488375|B2||Never / rarely|Female Sexual Distress Scale-Revised, item 1, distressed about sex life||Participants|Count of Participants|12|12.0||||||
3640779|NCT02516202|3488376|B1||Never / rarely|Female Sexual Distress Scale-Revised, item 1, distressed about sex life||Participants|Count of Participants|15|15.0||||||
3640780|NCT02516202|3488373|B4||Missing|Sexually active||Participants|Count of Participants|1|1.0||||||
3640781|NCT02516202|3488374|B3||Missing|Sexually active||Participants|Count of Participants|0|0.0||||||
3640782|NCT02516202|3488375|B2||Missing|Sexually active||Participants|Count of Participants|0|0.0||||||
3640783|NCT02516202|3488376|B1||Missing|Sexually active||Participants|Count of Participants|1|1.0||||||
3640784|NCT02516202|3488373|B4||No|Sexually active||Participants|Count of Participants|56|56.0||||||
3640785|NCT02516202|3488374|B3||No|Sexually active||Participants|Count of Participants|16|16.0||||||
3640786|NCT02516202|3488375|B2||No|Sexually active||Participants|Count of Participants|20|20.0||||||
3640787|NCT02516202|3488376|B1||No|Sexually active||Participants|Count of Participants|20|20.0||||||
3640788|NCT02516202|3488373|B4||Yes|Sexually active||Participants|Count of Participants|245|245.0||||||
3640789|NCT02516202|3488374|B3||Yes|Sexually active||Participants|Count of Participants|84|84.0||||||
3640790|NCT02516202|3488375|B2||Yes|Sexually active||Participants|Count of Participants|80|80.0||||||
3640791|NCT02516202|3488376|B1||Yes|Sexually active||Participants|Count of Participants|81|81.0||||||
3640792|NCT02516202|3488373|B4||Missing|Generalized Anxiety Disorder Questionnaire 7|Generalized Anxiety Disorder 7 (GAD-7) assesses generalized anxiety symptoms. It contains 7 questions, each scored from 0 to 3, that are summed to create a total score ranging from 0 to 21. The scores are categorized as follows: minimal GAD (0 to 4), mild GAD (5 to 9), moderate GAD (10 to 14), severe GAD (15 to 21).|Participants|Count of Participants|1|1.0||||||
3640793|NCT02516202|3488374|B3||Missing|Generalized Anxiety Disorder Questionnaire 7|Generalized Anxiety Disorder 7 (GAD-7) assesses generalized anxiety symptoms. It contains 7 questions, each scored from 0 to 3, that are summed to create a total score ranging from 0 to 21. The scores are categorized as follows: minimal GAD (0 to 4), mild GAD (5 to 9), moderate GAD (10 to 14), severe GAD (15 to 21).|Participants|Count of Participants|0|0.0||||||
3640794|NCT02516202|3488375|B2||Missing|Generalized Anxiety Disorder Questionnaire 7|Generalized Anxiety Disorder 7 (GAD-7) assesses generalized anxiety symptoms. It contains 7 questions, each scored from 0 to 3, that are summed to create a total score ranging from 0 to 21. The scores are categorized as follows: minimal GAD (0 to 4), mild GAD (5 to 9), moderate GAD (10 to 14), severe GAD (15 to 21).|Participants|Count of Participants|0|0.0||||||
3640795|NCT02516202|3488376|B1||Missing|Generalized Anxiety Disorder Questionnaire 7|Generalized Anxiety Disorder 7 (GAD-7) assesses generalized anxiety symptoms. It contains 7 questions, each scored from 0 to 3, that are summed to create a total score ranging from 0 to 21. The scores are categorized as follows: minimal GAD (0 to 4), mild GAD (5 to 9), moderate GAD (10 to 14), severe GAD (15 to 21).|Participants|Count of Participants|1|1.0||||||
3640796|NCT02516202|3488373|B4||Moderate - severe (≥10)|Generalized Anxiety Disorder Questionnaire 7|Generalized Anxiety Disorder 7 (GAD-7) assesses generalized anxiety symptoms. It contains 7 questions, each scored from 0 to 3, that are summed to create a total score ranging from 0 to 21. The scores are categorized as follows: minimal GAD (0 to 4), mild GAD (5 to 9), moderate GAD (10 to 14), severe GAD (15 to 21).|Participants|Count of Participants|28|28.0||||||
3640797|NCT02516202|3488374|B3||Moderate - severe (≥10)|Generalized Anxiety Disorder Questionnaire 7|Generalized Anxiety Disorder 7 (GAD-7) assesses generalized anxiety symptoms. It contains 7 questions, each scored from 0 to 3, that are summed to create a total score ranging from 0 to 21. The scores are categorized as follows: minimal GAD (0 to 4), mild GAD (5 to 9), moderate GAD (10 to 14), severe GAD (15 to 21).|Participants|Count of Participants|12|12.0||||||
3640798|NCT02516202|3488375|B2||Moderate - severe (≥10)|Generalized Anxiety Disorder Questionnaire 7|Generalized Anxiety Disorder 7 (GAD-7) assesses generalized anxiety symptoms. It contains 7 questions, each scored from 0 to 3, that are summed to create a total score ranging from 0 to 21. The scores are categorized as follows: minimal GAD (0 to 4), mild GAD (5 to 9), moderate GAD (10 to 14), severe GAD (15 to 21).|Participants|Count of Participants|4|4.0||||||
3640799|NCT02516202|3488376|B1||Moderate - severe (≥10)|Generalized Anxiety Disorder Questionnaire 7|Generalized Anxiety Disorder 7 (GAD-7) assesses generalized anxiety symptoms. It contains 7 questions, each scored from 0 to 3, that are summed to create a total score ranging from 0 to 21. The scores are categorized as follows: minimal GAD (0 to 4), mild GAD (5 to 9), moderate GAD (10 to 14), severe GAD (15 to 21).|Participants|Count of Participants|12|12.0||||||
3640800|NCT02516202|3488373|B4||Mild (5-9)|Generalized Anxiety Disorder Questionnaire 7|Generalized Anxiety Disorder 7 (GAD-7) assesses generalized anxiety symptoms. It contains 7 questions, each scored from 0 to 3, that are summed to create a total score ranging from 0 to 21. The scores are categorized as follows: minimal GAD (0 to 4), mild GAD (5 to 9), moderate GAD (10 to 14), severe GAD (15 to 21).|Participants|Count of Participants|70|70.0||||||
3640801|NCT02516202|3488374|B3||Mild (5-9)|Generalized Anxiety Disorder Questionnaire 7|Generalized Anxiety Disorder 7 (GAD-7) assesses generalized anxiety symptoms. It contains 7 questions, each scored from 0 to 3, that are summed to create a total score ranging from 0 to 21. The scores are categorized as follows: minimal GAD (0 to 4), mild GAD (5 to 9), moderate GAD (10 to 14), severe GAD (15 to 21).|Participants|Count of Participants|24|24.0||||||
3640802|NCT02516202|3488375|B2||Mild (5-9)|Generalized Anxiety Disorder Questionnaire 7|Generalized Anxiety Disorder 7 (GAD-7) assesses generalized anxiety symptoms. It contains 7 questions, each scored from 0 to 3, that are summed to create a total score ranging from 0 to 21. The scores are categorized as follows: minimal GAD (0 to 4), mild GAD (5 to 9), moderate GAD (10 to 14), severe GAD (15 to 21).|Participants|Count of Participants|21|21.0||||||
3640803|NCT02516202|3488376|B1||Mild (5-9)|Generalized Anxiety Disorder Questionnaire 7|Generalized Anxiety Disorder 7 (GAD-7) assesses generalized anxiety symptoms. It contains 7 questions, each scored from 0 to 3, that are summed to create a total score ranging from 0 to 21. The scores are categorized as follows: minimal GAD (0 to 4), mild GAD (5 to 9), moderate GAD (10 to 14), severe GAD (15 to 21).|Participants|Count of Participants|25|25.0||||||
3640804|NCT02516202|3488373|B4||None (0-4)|Generalized Anxiety Disorder Questionnaire 7|Generalized Anxiety Disorder 7 (GAD-7) assesses generalized anxiety symptoms. It contains 7 questions, each scored from 0 to 3, that are summed to create a total score ranging from 0 to 21. The scores are categorized as follows: minimal GAD (0 to 4), mild GAD (5 to 9), moderate GAD (10 to 14), severe GAD (15 to 21).|Participants|Count of Participants|203|203.0||||||
3640805|NCT02516202|3488374|B3||None (0-4)|Generalized Anxiety Disorder Questionnaire 7|Generalized Anxiety Disorder 7 (GAD-7) assesses generalized anxiety symptoms. It contains 7 questions, each scored from 0 to 3, that are summed to create a total score ranging from 0 to 21. The scores are categorized as follows: minimal GAD (0 to 4), mild GAD (5 to 9), moderate GAD (10 to 14), severe GAD (15 to 21).|Participants|Count of Participants|64|64.0||||||
3640806|NCT02516202|3488375|B2||None (0-4)|Generalized Anxiety Disorder Questionnaire 7|Generalized Anxiety Disorder 7 (GAD-7) assesses generalized anxiety symptoms. It contains 7 questions, each scored from 0 to 3, that are summed to create a total score ranging from 0 to 21. The scores are categorized as follows: minimal GAD (0 to 4), mild GAD (5 to 9), moderate GAD (10 to 14), severe GAD (15 to 21).|Participants|Count of Participants|75|75.0||||||
3640807|NCT02516202|3488376|B1||None (0-4)|Generalized Anxiety Disorder Questionnaire 7|Generalized Anxiety Disorder 7 (GAD-7) assesses generalized anxiety symptoms. It contains 7 questions, each scored from 0 to 3, that are summed to create a total score ranging from 0 to 21. The scores are categorized as follows: minimal GAD (0 to 4), mild GAD (5 to 9), moderate GAD (10 to 14), severe GAD (15 to 21).|Participants|Count of Participants|64|64.0||||||
3640808|NCT02516202|3488373|B4||Missing|Patient Health Questionnaire 8 depression|The Patient Health Questionnaire (PHQ-8) assesses severity of depression. There are 8 questions, each scored from 0 to 3, that are summed to create a total score ranging from 0 to 24. The scores are categorized as follows: minimal depression (0 to 4), mild depression (5 to 9), moderate depression (10 to 14), moderately severe depression (15 to 19), severe depression (20 to 24).|Participants|Count of Participants|1|1.0||||||
3640809|NCT02516202|3488374|B3||Missing|Patient Health Questionnaire 8 depression|The Patient Health Questionnaire (PHQ-8) assesses severity of depression. There are 8 questions, each scored from 0 to 3, that are summed to create a total score ranging from 0 to 24. The scores are categorized as follows: minimal depression (0 to 4), mild depression (5 to 9), moderate depression (10 to 14), moderately severe depression (15 to 19), severe depression (20 to 24).|Participants|Count of Participants|0|0.0||||||
3640810|NCT02516202|3488375|B2||Missing|Patient Health Questionnaire 8 depression|The Patient Health Questionnaire (PHQ-8) assesses severity of depression. There are 8 questions, each scored from 0 to 3, that are summed to create a total score ranging from 0 to 24. The scores are categorized as follows: minimal depression (0 to 4), mild depression (5 to 9), moderate depression (10 to 14), moderately severe depression (15 to 19), severe depression (20 to 24).|Participants|Count of Participants|0|0.0||||||
3640811|NCT02516202|3488376|B1||Missing|Patient Health Questionnaire 8 depression|The Patient Health Questionnaire (PHQ-8) assesses severity of depression. There are 8 questions, each scored from 0 to 3, that are summed to create a total score ranging from 0 to 24. The scores are categorized as follows: minimal depression (0 to 4), mild depression (5 to 9), moderate depression (10 to 14), moderately severe depression (15 to 19), severe depression (20 to 24).|Participants|Count of Participants|1|1.0||||||
3640812|NCT02516202|3488373|B4||Moderate - severe (≥10)|Patient Health Questionnaire 8 depression|The Patient Health Questionnaire (PHQ-8) assesses severity of depression. There are 8 questions, each scored from 0 to 3, that are summed to create a total score ranging from 0 to 24. The scores are categorized as follows: minimal depression (0 to 4), mild depression (5 to 9), moderate depression (10 to 14), moderately severe depression (15 to 19), severe depression (20 to 24).|Participants|Count of Participants|18|18.0||||||
3640813|NCT02516202|3488374|B3||Moderate - severe (≥10)|Patient Health Questionnaire 8 depression|The Patient Health Questionnaire (PHQ-8) assesses severity of depression. There are 8 questions, each scored from 0 to 3, that are summed to create a total score ranging from 0 to 24. The scores are categorized as follows: minimal depression (0 to 4), mild depression (5 to 9), moderate depression (10 to 14), moderately severe depression (15 to 19), severe depression (20 to 24).|Participants|Count of Participants|8|8.0||||||
3640814|NCT02516202|3488375|B2||Moderate - severe (≥10)|Patient Health Questionnaire 8 depression|The Patient Health Questionnaire (PHQ-8) assesses severity of depression. There are 8 questions, each scored from 0 to 3, that are summed to create a total score ranging from 0 to 24. The scores are categorized as follows: minimal depression (0 to 4), mild depression (5 to 9), moderate depression (10 to 14), moderately severe depression (15 to 19), severe depression (20 to 24).|Participants|Count of Participants|3|3.0||||||
3640832|NCT02516202|3488373|B4||≥ 7 drinks / week|Alcohol Use||Participants|Count of Participants|63|63.0||||||
3640833|NCT02516202|3488374|B3||≥ 7 drinks / week|Alcohol Use||Participants|Count of Participants|19|19.0||||||
3640834|NCT02516202|3488375|B2||≥ 7 drinks / week|Alcohol Use||Participants|Count of Participants|23|23.0||||||
3640815|NCT02516202|3488376|B1||Moderate - severe (≥10)|Patient Health Questionnaire 8 depression|The Patient Health Questionnaire (PHQ-8) assesses severity of depression. There are 8 questions, each scored from 0 to 3, that are summed to create a total score ranging from 0 to 24. The scores are categorized as follows: minimal depression (0 to 4), mild depression (5 to 9), moderate depression (10 to 14), moderately severe depression (15 to 19), severe depression (20 to 24).|Participants|Count of Participants|7|7.0||||||
3640816|NCT02516202|3488373|B4||Mild (5-9)|Patient Health Questionnaire 8 depression|The Patient Health Questionnaire (PHQ-8) assesses severity of depression. There are 8 questions, each scored from 0 to 3, that are summed to create a total score ranging from 0 to 24. The scores are categorized as follows: minimal depression (0 to 4), mild depression (5 to 9), moderate depression (10 to 14), moderately severe depression (15 to 19), severe depression (20 to 24).|Participants|Count of Participants|70|70.0||||||
3640817|NCT02516202|3488374|B3||Mild (5-9)|Patient Health Questionnaire 8 depression|The Patient Health Questionnaire (PHQ-8) assesses severity of depression. There are 8 questions, each scored from 0 to 3, that are summed to create a total score ranging from 0 to 24. The scores are categorized as follows: minimal depression (0 to 4), mild depression (5 to 9), moderate depression (10 to 14), moderately severe depression (15 to 19), severe depression (20 to 24).|Participants|Count of Participants|23|23.0||||||
3640818|NCT02516202|3488375|B2||Mild (5-9)|Patient Health Questionnaire 8 depression|The Patient Health Questionnaire (PHQ-8) assesses severity of depression. There are 8 questions, each scored from 0 to 3, that are summed to create a total score ranging from 0 to 24. The scores are categorized as follows: minimal depression (0 to 4), mild depression (5 to 9), moderate depression (10 to 14), moderately severe depression (15 to 19), severe depression (20 to 24).|Participants|Count of Participants|22|22.0||||||
3640819|NCT02516202|3488376|B1||Mild (5-9)|Patient Health Questionnaire 8 depression|The Patient Health Questionnaire (PHQ-8) assesses severity of depression. There are 8 questions, each scored from 0 to 3, that are summed to create a total score ranging from 0 to 24. The scores are categorized as follows: minimal depression (0 to 4), mild depression (5 to 9), moderate depression (10 to 14), moderately severe depression (15 to 19), severe depression (20 to 24).|Participants|Count of Participants|25|25.0||||||
3640820|NCT02516202|3488373|B4||None (0-4)|Patient Health Questionnaire 8 depression|The Patient Health Questionnaire (PHQ-8) assesses severity of depression. There are 8 questions, each scored from 0 to 3, that are summed to create a total score ranging from 0 to 24. The scores are categorized as follows: minimal depression (0 to 4), mild depression (5 to 9), moderate depression (10 to 14), moderately severe depression (15 to 19), severe depression (20 to 24).|Participants|Count of Participants|213|213.0||||||
3640821|NCT02516202|3488374|B3||None (0-4)|Patient Health Questionnaire 8 depression|The Patient Health Questionnaire (PHQ-8) assesses severity of depression. There are 8 questions, each scored from 0 to 3, that are summed to create a total score ranging from 0 to 24. The scores are categorized as follows: minimal depression (0 to 4), mild depression (5 to 9), moderate depression (10 to 14), moderately severe depression (15 to 19), severe depression (20 to 24).|Participants|Count of Participants|69|69.0||||||
3640822|NCT02516202|3488375|B2||None (0-4)|Patient Health Questionnaire 8 depression|The Patient Health Questionnaire (PHQ-8) assesses severity of depression. There are 8 questions, each scored from 0 to 3, that are summed to create a total score ranging from 0 to 24. The scores are categorized as follows: minimal depression (0 to 4), mild depression (5 to 9), moderate depression (10 to 14), moderately severe depression (15 to 19), severe depression (20 to 24).|Participants|Count of Participants|75|75.0||||||
3640823|NCT02516202|3488376|B1||None (0-4)|Patient Health Questionnaire 8 depression|The Patient Health Questionnaire (PHQ-8) assesses severity of depression. There are 8 questions, each scored from 0 to 3, that are summed to create a total score ranging from 0 to 24. The scores are categorized as follows: minimal depression (0 to 4), mild depression (5 to 9), moderate depression (10 to 14), moderately severe depression (15 to 19), severe depression (20 to 24).|Participants|Count of Participants|69|69.0||||||
3640824|NCT02516202|3488373|B4|||Menopause Quality of Life Questionnaire total|The Menopause Quality of Life Questionnaire (MENQOL) is a series of 29 questions to assess quality of life in four domains: physical (16 questions), psychosocial (7), sexual (3), and vasomotor (3). Each domain includes occurrence and severity of symptoms; the item scores are averaged for a domain score ranging from 0 (no symptom) to 8 (maximum severity). The four domain scores are then averaged to calculate the total MENQOL score, ranging from 0 (high quality of life) to 8 (low quality of life).|units on a scale|Mean|3.3|3.3|Standard Deviation|1.1|1.1|||
3640825|NCT02516202|3488374|B3|||Menopause Quality of Life Questionnaire total|The Menopause Quality of Life Questionnaire (MENQOL) is a series of 29 questions to assess quality of life in four domains: physical (16 questions), psychosocial (7), sexual (3), and vasomotor (3). Each domain includes occurrence and severity of symptoms; the item scores are averaged for a domain score ranging from 0 (no symptom) to 8 (maximum severity). The four domain scores are then averaged to calculate the total MENQOL score, ranging from 0 (high quality of life) to 8 (low quality of life).|units on a scale|Mean|3.3|3.3|Standard Deviation|1.0|1.0|||
3640826|NCT02516202|3488375|B2|||Menopause Quality of Life Questionnaire total|The Menopause Quality of Life Questionnaire (MENQOL) is a series of 29 questions to assess quality of life in four domains: physical (16 questions), psychosocial (7), sexual (3), and vasomotor (3). Each domain includes occurrence and severity of symptoms; the item scores are averaged for a domain score ranging from 0 (no symptom) to 8 (maximum severity). The four domain scores are then averaged to calculate the total MENQOL score, ranging from 0 (high quality of life) to 8 (low quality of life).|units on a scale|Mean|3.2|3.2|Standard Deviation|1.1|1.1|||
3640827|NCT02516202|3488376|B1|||Menopause Quality of Life Questionnaire total|The Menopause Quality of Life Questionnaire (MENQOL) is a series of 29 questions to assess quality of life in four domains: physical (16 questions), psychosocial (7), sexual (3), and vasomotor (3). Each domain includes occurrence and severity of symptoms; the item scores are averaged for a domain score ranging from 0 (no symptom) to 8 (maximum severity). The four domain scores are then averaged to calculate the total MENQOL score, ranging from 0 (high quality of life) to 8 (low quality of life).|units on a scale|Mean|3.3|3.3|Standard Deviation|1.2|1.2|||
3640828|NCT02516202|3488373|B4||Missing|Alcohol Use||Participants|Count of Participants|1|1.0||||||
3640829|NCT02516202|3488374|B3||Missing|Alcohol Use||Participants|Count of Participants|0|0.0||||||
3640830|NCT02516202|3488375|B2||Missing|Alcohol Use||Participants|Count of Participants|0|0.0||||||
3640831|NCT02516202|3488376|B1||Missing|Alcohol Use||Participants|Count of Participants|1|1.0||||||
3640835|NCT02516202|3488376|B1||≥ 7 drinks / week|Alcohol Use||Participants|Count of Participants|21|21.0||||||
3640836|NCT02516202|3488373|B4||1-6 drinks / week|Alcohol Use||Participants|Count of Participants|149|149.0||||||
3640837|NCT02516202|3488374|B3||1-6 drinks / week|Alcohol Use||Participants|Count of Participants|53|53.0||||||
3640838|NCT02516202|3488375|B2||1-6 drinks / week|Alcohol Use||Participants|Count of Participants|46|46.0||||||
3640839|NCT02516202|3488376|B1||1-6 drinks / week|Alcohol Use||Participants|Count of Participants|50|50.0||||||
3640840|NCT02516202|3488373|B4||0 drinks / week|Alcohol Use||Participants|Count of Participants|89|89.0||||||
3640841|NCT02516202|3488374|B3||0 drinks / week|Alcohol Use||Participants|Count of Participants|28|28.0||||||
3640842|NCT02516202|3488375|B2||0 drinks / week|Alcohol Use||Participants|Count of Participants|31|31.0||||||
3640843|NCT02516202|3488376|B1||0 drinks / week|Alcohol Use||Participants|Count of Participants|30|30.0||||||
3640844|NCT02516202|3488373|B4||Missing|Smoking||Participants|Count of Participants|1|1.0||||||
3640845|NCT02516202|3488374|B3||Missing|Smoking||Participants|Count of Participants|0|0.0||||||
3640846|NCT02516202|3488375|B2||Missing|Smoking||Participants|Count of Participants|0|0.0||||||
3640847|NCT02516202|3488376|B1||Missing|Smoking||Participants|Count of Participants|1|1.0||||||
3640848|NCT02516202|3488373|B4||Current|Smoking||Participants|Count of Participants|6|6.0||||||
3640849|NCT02516202|3488374|B3||Current|Smoking||Participants|Count of Participants|2|2.0||||||
3640850|NCT02516202|3488375|B2||Current|Smoking||Participants|Count of Participants|0|0.0||||||
3640851|NCT02516202|3488376|B1||Current|Smoking||Participants|Count of Participants|4|4.0||||||
3640852|NCT02516202|3488373|B4||Past|Smoking||Participants|Count of Participants|96|96.0||||||
3640853|NCT02516202|3488374|B3||Past|Smoking||Participants|Count of Participants|32|32.0||||||
3640854|NCT02516202|3488375|B2||Past|Smoking||Participants|Count of Participants|33|33.0||||||
3640855|NCT02516202|3488376|B1||Past|Smoking||Participants|Count of Participants|31|31.0||||||
3640856|NCT02516202|3488373|B4||Never|Smoking||Participants|Count of Participants|199|199.0||||||
3640857|NCT02516202|3488374|B3||Never|Smoking||Participants|Count of Participants|66|66.0||||||
3640858|NCT02516202|3488375|B2||Never|Smoking||Participants|Count of Participants|67|67.0||||||
3640859|NCT02516202|3488376|B1||Never|Smoking||Participants|Count of Participants|66|66.0||||||
3640860|NCT02516202|3488373|B4||Missing|Marital status||Participants|Count of Participants|1|1.0||||||
3640861|NCT02516202|3488374|B3||Missing|Marital status||Participants|Count of Participants|0|0.0||||||
3640862|NCT02516202|3488375|B2||Missing|Marital status||Participants|Count of Participants|0|0.0||||||
3640863|NCT02516202|3488376|B1||Missing|Marital status||Participants|Count of Participants|1|1.0||||||
3640864|NCT02516202|3488373|B4||Married or like relationship|Marital status||Participants|Count of Participants|257|257.0||||||
3640865|NCT02516202|3488374|B3||Married or like relationship|Marital status||Participants|Count of Participants|84|84.0||||||
3640866|NCT02516202|3488375|B2||Married or like relationship|Marital status||Participants|Count of Participants|90|90.0||||||
3640867|NCT02516202|3488376|B1||Married or like relationship|Marital status||Participants|Count of Participants|83|83.0||||||
3640868|NCT02516202|3488373|B4||Divorced or widowed|Marital status||Participants|Count of Participants|30|30.0||||||
3640869|NCT02516202|3488374|B3||Divorced or widowed|Marital status||Participants|Count of Participants|12|12.0||||||
3640870|NCT02516202|3488375|B2||Divorced or widowed|Marital status||Participants|Count of Participants|8|8.0||||||
3640871|NCT02516202|3488376|B1||Divorced or widowed|Marital status||Participants|Count of Participants|10|10.0||||||
3640872|NCT02516202|3488373|B4||Never married|Marital status||Participants|Count of Participants|14|14.0||||||
3640873|NCT02516202|3488374|B3||Never married|Marital status||Participants|Count of Participants|4|4.0||||||
3640874|NCT02516202|3488375|B2||Never married|Marital status||Participants|Count of Participants|2|2.0||||||
3640875|NCT02516202|3488376|B1||Never married|Marital status||Participants|Count of Participants|8|8.0||||||
3640876|NCT02516202|3488373|B4||Missing|Education||Participants|Count of Participants|2|2.0||||||
3640877|NCT02516202|3488374|B3||Missing|Education||Participants|Count of Participants|0|0.0||||||
3640878|NCT02516202|3488375|B2||Missing|Education||Participants|Count of Participants|0|0.0||||||
3640879|NCT02516202|3488376|B1||Missing|Education||Participants|Count of Participants|2|2.0||||||
3640880|NCT02516202|3488373|B4||College graduate|Education||Participants|Count of Participants|200|200.0||||||
3640881|NCT02516202|3488374|B3||College graduate|Education||Participants|Count of Participants|63|63.0||||||
3640882|NCT02516202|3488375|B2||College graduate|Education||Participants|Count of Participants|70|70.0||||||
3640883|NCT02516202|3488376|B1||College graduate|Education||Participants|Count of Participants|67|67.0||||||
3640884|NCT02516202|3488373|B4||School after high school|Education||Participants|Count of Participants|89|89.0||||||
3640885|NCT02516202|3488374|B3||School after high school|Education||Participants|Count of Participants|31|31.0||||||
3640886|NCT02516202|3488375|B2||School after high school|Education||Participants|Count of Participants|27|27.0||||||
3640887|NCT02516202|3488376|B1||School after high school|Education||Participants|Count of Participants|31|31.0||||||
3640888|NCT02516202|3488373|B4||High school diploma / GED or less|Education||Participants|Count of Participants|11|11.0||||||
3640889|NCT02516202|3488374|B3||High school diploma / GED or less|Education||Participants|Count of Participants|6|6.0||||||
3640890|NCT02516202|3488375|B2||High school diploma / GED or less|Education||Participants|Count of Participants|3|3.0||||||
3640891|NCT02516202|3488376|B1||High school diploma / GED or less|Education||Participants|Count of Participants|2|2.0||||||
3640892|NCT02516202|3488373|B4|||Body Mass Index (BMI)||kg/m^2|Mean|26|26.0|Standard Deviation|5|5.0|||
3640893|NCT02516202|3488374|B3|||Body Mass Index (BMI)||kg/m^2|Mean|26|26.0|Standard Deviation|6|6.0|||
3640894|NCT02516202|3488375|B2|||Body Mass Index (BMI)||kg/m^2|Mean|26|26.0|Standard Deviation|4|4.0|||
3640895|NCT02516202|3488376|B1|||Body Mass Index (BMI)||kg/m^2|Mean|27|27.0|Standard Deviation|5|5.0|||
3640896|NCT02516202|3488373|B4|Race|Other / unknown|Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3640897|NCT02516202|3488374|B3|Race|Other / unknown|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3640898|NCT02516202|3488375|B2|Race|Other / unknown|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3640899|NCT02516202|3488376|B1|Race|Other / unknown|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3640900|NCT02516202|3488373|B4|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3640901|NCT02516202|3488374|B3|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3640902|NCT02516202|3488375|B2|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3640903|NCT02516202|3488376|B1|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3640904|NCT02516202|3488373|B4|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|267|267.0||||||
3640905|NCT02516202|3488374|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|90|90.0||||||
3640906|NCT02516202|3488375|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|90|90.0||||||
3640907|NCT02516202|3488376|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|87|87.0||||||
3640908|NCT02516202|3488373|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3640909|NCT02516202|3488374|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3640910|NCT02516202|3488375|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3640911|NCT02516202|3488376|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3640912|NCT02516202|3488373|B4||Female|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
3640913|NCT02516202|3488374|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3640914|NCT02516202|3488375|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3640915|NCT02516202|3488376|B1||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3640916|NCT02516202|3488373|B4|||Age||years|Mean|61|61.0|Standard Deviation|4|4.0|||
3640917|NCT02516202|3488374|B3|||Age||years|Mean|61|61.0|Standard Deviation|4|4.0|||
3640918|NCT02516202|3488375|B2|||Age||years|Mean|61|61.0|Standard Deviation|4|4.0|||
3640919|NCT02516202|3488376|B1|||Age||years|Mean|61|61.0|Standard Deviation|4|4.0|||
3640920|NCT02516163|3488404|B1|Australia||Region of Enrollment||participants|Number|24|24.0||||||
3640921|NCT02516163|3488404|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3640922|NCT02516163|3488404|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3640923|NCT02516163|3488404|B1|||Age||years|Mean|66.2|66.2|Standard Deviation|7.7|7.7|||
3640924|NCT02516150|3488408|B1|||Diabetes Duration||years|Mean|28.4|28.4|Standard Deviation|17.1|17.1|||
3640925|NCT02516150|3488408|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3640926|NCT02516150|3488408|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3640927|NCT02516150|3488408|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3640928|NCT02516150|3488408|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3640929|NCT02516150|3488408|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640930|NCT02516150|3488408|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640931|NCT02516150|3488408|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640932|NCT02516150|3488408|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3640933|NCT02516150|3488408|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3640934|NCT02516150|3488408|B1|||Age||years|Mean|39.3|39.3|Standard Deviation|17.4|17.4|||
3640935|NCT02516098|3488416|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3640936|NCT02516098|3488417|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3640937|NCT02516098|3488418|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3640938|NCT02516098|3488416|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3640939|NCT02516098|3488417|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3640940|NCT02516098|3488418|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3640941|NCT02516098|3488416|B3|||Age||years|Mean|25.6|25.6|Standard Deviation|5.83|5.83|||
3640942|NCT02516098|3488417|B2|||Age||years|Mean|24.5|24.5|Standard Deviation|3.90|3.9|||
3640943|NCT02516098|3488418|B1|||Age||years|Mean|26.7|26.7|Standard Deviation|7.17|7.17|||
3640944|NCT02515994|3488431|B3|United States||Region of Enrollment||participants|Number|221|221.0||||||
3640945|NCT02515994|3488432|B2|United States||Region of Enrollment||participants|Number|112|112.0||||||
3640946|NCT02515994|3488433|B1|United States||Region of Enrollment||participants|Number|109|109.0||||||
3640947|NCT02515994|3488431|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3640948|NCT02515994|3488432|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3640949|NCT02515994|3488433|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3640950|NCT02515994|3488431|B3||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3640951|NCT02515994|3488432|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3640952|NCT02515994|3488433|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3640953|NCT02515994|3488431|B3|||Age||years|Mean|30.7|30.7|Standard Deviation|7.24|7.24|||
3640954|NCT02515994|3488432|B2|||Age||years|Mean|30.9|30.9|Standard Deviation|7.33|7.33|||
3640955|NCT02515994|3488433|B1|||Age||years|Mean|30.4|30.4|Standard Deviation|7.26|7.26|||
3640956|NCT02515942|3488446|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3640957|NCT02515942|3488447|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3640958|NCT02515942|3488448|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640959|NCT02515942|3488449|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640960|NCT02515942|3488446|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3640961|NCT02515942|3488447|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640962|NCT02515942|3488448|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640963|NCT02515942|3488449|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3640964|NCT02515942|3488446|B4||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3640965|NCT02515942|3488447|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640966|NCT02515942|3488448|B2||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3640967|NCT02515942|3488449|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3640968|NCT02515942|3488446|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640969|NCT02515942|3488447|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640970|NCT02515942|3488448|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640971|NCT02515942|3488449|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640972|NCT02515942|3488446|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640973|NCT02515942|3488447|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640974|NCT02515942|3488448|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640975|NCT02515942|3488449|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640976|NCT02515942|3488446|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640977|NCT02515942|3488447|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640978|NCT02515942|3488448|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640979|NCT02515942|3488449|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640980|NCT02515942|3488446|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3640981|NCT02515942|3488447|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3640982|NCT02515942|3488448|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640983|NCT02515942|3488449|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640984|NCT02515942|3488446|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3640985|NCT02515942|3488447|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3640986|NCT02515942|3488448|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3640987|NCT02515942|3488449|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3640988|NCT02515942|3488446|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3640989|NCT02515942|3488447|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3640990|NCT02515942|3488448|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3640991|NCT02515942|3488449|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3640992|NCT02515942|3488446|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3640993|NCT02515942|3488447|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3640994|NCT02515942|3488448|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3640995|NCT02515942|3488449|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3640996|NCT02515942|3488446|B4||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3640997|NCT02515942|3488447|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3640998|NCT02515942|3488448|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3640999|NCT02515942|3488449|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3641000|NCT02515942|3488446|B4||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3641001|NCT02515942|3488447|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3641002|NCT02515942|3488448|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3641003|NCT02515942|3488449|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3641004|NCT02515942|3488446|B4|||Age||years|Mean|78.4|78.4|Standard Deviation|8.52|8.52|||
3641005|NCT02515942|3488447|B3|||Age||years|Mean|78.7|78.7|Standard Deviation|9.80|9.8|||
3641006|NCT02515942|3488448|B2|||Age||years|Mean|78.8|78.8|Standard Deviation|7.11|7.11|||
3641007|NCT02515942|3488449|B1|||Age||years|Mean|77.7|77.7|Standard Deviation|8.61|8.61|||
3641008|NCT02515851|3488492|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3641009|NCT02515851|3488493|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3641010|NCT02515851|3488494|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3641011|NCT02515851|3488492|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3641012|NCT02515851|3488493|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3641013|NCT02515851|3488494|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3641014|NCT02515851|3488492|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3641015|NCT02515851|3488493|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3641016|NCT02515851|3488494|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3641017|NCT02515851|3488492|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3641018|NCT02515851|3488493|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3641019|NCT02515851|3488494|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3641020|NCT02515851|3488492|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3641021|NCT02515851|3488493|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3641022|NCT02515851|3488494|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3641023|NCT02515331|3488507|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3641024|NCT02515331|3488508|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641025|NCT02515331|3488509|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3641026|NCT02515331|3488510|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3641027|NCT02515331|3488507|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641028|NCT02515331|3488508|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641029|NCT02515331|3488509|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641030|NCT02515331|3488510|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641031|NCT02515331|3488507|B4||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3641032|NCT02515331|3488508|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3641033|NCT02515331|3488509|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3641034|NCT02515331|3488510|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3641035|NCT02515331|3488507|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3641036|NCT02515331|3488508|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3641037|NCT02515331|3488509|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3641038|NCT02515331|3488510|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3641039|NCT02515331|3488507|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641040|NCT02515331|3488508|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641041|NCT02515331|3488509|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641042|NCT02515331|3488510|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641043|NCT02515331|3488507|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3641044|NCT02515331|3488508|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641045|NCT02515331|3488509|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641046|NCT02515331|3488510|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3641047|NCT02515331|3488507|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641048|NCT02515331|3488508|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641049|NCT02515331|3488509|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641050|NCT02515331|3488510|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641051|NCT02515331|3488507|B4||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3641052|NCT02515331|3488508|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3641053|NCT02515331|3488509|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3641054|NCT02515331|3488510|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3641055|NCT02515331|3488507|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3641056|NCT02515331|3488508|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3641057|NCT02515331|3488509|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3641058|NCT02515331|3488510|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3641059|NCT02515331|3488507|B4|||Age||Years|Mean|63.8|63.8|Standard Deviation|8.38|8.38|||
3641060|NCT02515331|3488508|B3|||Age||Years|Mean|64.4|64.4|Standard Deviation|9.56|9.56|||
3641061|NCT02515331|3488509|B2|||Age||Years|Mean|61.8|61.8|Standard Deviation|5.16|5.16|||
3641062|NCT02515331|3488510|B1|||Age||Years|Mean|64.2|64.2|Standard Deviation|8.42|8.42|||
3641063|NCT02515279|3488533|B1|Missing||Sex/Gender, Customized||participants|Number|2|2.0||||||
3641064|NCT02515279|3488533|B1|Male||Sex/Gender, Customized||participants|Number|310|310.0||||||
3641065|NCT02515279|3488533|B1|Female||Sex/Gender, Customized||participants|Number|151|151.0||||||
3641066|NCT02515279|3488533|B1|||Age||years|Mean|41.0|41.0|Standard Deviation|13.3|13.3|||
3641067|NCT02515058|3488539|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641068|NCT02515058|3488540|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641069|NCT02515058|3488541|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641070|NCT02515058|3488539|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641071|NCT02515058|3488540|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641072|NCT02515058|3488541|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641073|NCT02515058|3488539|B3||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3641074|NCT02515058|3488540|B2||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3641075|NCT02515058|3488541|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3641076|NCT02515058|3488539|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3641077|NCT02515058|3488540|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3641078|NCT02515058|3488541|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3641079|NCT02515058|3488539|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641080|NCT02515058|3488540|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641081|NCT02515058|3488541|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641082|NCT02515058|3488539|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641083|NCT02515058|3488540|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641084|NCT02515058|3488541|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641085|NCT02515058|3488539|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641086|NCT02515058|3488540|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641087|NCT02515058|3488541|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641088|NCT02515058|3488539|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3641089|NCT02515058|3488540|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3641090|NCT02515058|3488541|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3641091|NCT02515058|3488539|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3641092|NCT02515058|3488540|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3641093|NCT02515058|3488541|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3641094|NCT02515058|3488539|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3641095|NCT02515058|3488540|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3641096|NCT02515058|3488541|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3641097|NCT02515058|3488539|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3641098|NCT02515058|3488540|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3641099|NCT02515058|3488541|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3641100|NCT02515058|3488539|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3641101|NCT02515058|3488540|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3641102|NCT02515058|3488541|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3641103|NCT02515045|3488550|B3|United States||Region of Enrollment||participants|Number|59|59.0||||||
3641104|NCT02515045|3488551|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3641105|NCT02515045|3488552|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3641106|NCT02515045|3488550|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641107|NCT02515045|3488551|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641108|NCT02515045|3488552|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641109|NCT02515045|3488550|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3641110|NCT02515045|3488551|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3641111|NCT02515045|3488552|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3641112|NCT02515045|3488550|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641113|NCT02515045|3488551|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641114|NCT02515045|3488552|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641115|NCT02515045|3488550|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3641116|NCT02515045|3488551|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3641117|NCT02515045|3488552|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3641118|NCT02515045|3488550|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3641119|NCT02515045|3488551|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3641120|NCT02515045|3488552|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3641121|NCT02515045|3488550|B3|||Age||Years|Mean|68.5|68.5|Standard Deviation|7.1|7.1|||
3641122|NCT02515045|3488551|B2|||Age||Years|Mean|69.3|69.3|Standard Deviation|6.8|6.8|||
3641123|NCT02515045|3488552|B1|||Age||Years|Mean|67.9|67.9|Standard Deviation|7.5|7.5|||
3641124|NCT02514889|3488568|B3|||Systolic blood pressure||mm (mercury-equivalent)|Mean|122.43|122.43|Standard Deviation|0.93|0.93|||
3641125|NCT02514889|3488569|B2|||Systolic blood pressure||mm (mercury-equivalent)|Mean|122.67|122.67|Standard Deviation|1.40|1.4|||
3641126|NCT02514889|3488570|B1|||Systolic blood pressure||mm (mercury-equivalent)|Mean|122.19|122.19|Standard Deviation|1.24|1.24|||
3641148|NCT02514889|3488568|B3|Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3641127|NCT02514889|3488568|B3|||Waist circumference (cm)|The waist circumference measure was variably taken against the skin and taken over clothing, depending on patient preference. On average, collecting waist circumference over clothing appeared to add 3.47cm to measurements. The measure reported here does not correct for this error but measures that did subtract 3.47 cm from all waist circumference measurements taken over light clothing did not yield different findings compared to the findings based on uncorrected waist circumference measures.|cm|Mean|102.03|102.03|Standard Deviation|0.58|0.58|||
3641128|NCT02514889|3488569|B2|||Waist circumference (cm)|The waist circumference measure was variably taken against the skin and taken over clothing, depending on patient preference. On average, collecting waist circumference over clothing appeared to add 3.47cm to measurements. The measure reported here does not correct for this error but measures that did subtract 3.47 cm from all waist circumference measurements taken over light clothing did not yield different findings compared to the findings based on uncorrected waist circumference measures.|cm|Mean|103.47|103.47|Standard Deviation|0.85|0.85|||
3641129|NCT02514889|3488570|B1|||Waist circumference (cm)|The waist circumference measure was variably taken against the skin and taken over clothing, depending on patient preference. On average, collecting waist circumference over clothing appeared to add 3.47cm to measurements. The measure reported here does not correct for this error but measures that did subtract 3.47 cm from all waist circumference measurements taken over light clothing did not yield different findings compared to the findings based on uncorrected waist circumference measures.|cm|Mean|100.60|100.6|Standard Deviation|0.78|0.78|||
3641130|NCT02514889|3488568|B3|||Body Mass Index (kg/m^2)||kg/m^2|Mean|33.32|33.32|Standard Deviation|0.23|0.23|||
3641131|NCT02514889|3488569|B2|||Body Mass Index (kg/m^2)||kg/m^2|Mean|33.66|33.66|Standard Deviation|0.32|0.32|||
3641132|NCT02514889|3488570|B1|||Body Mass Index (kg/m^2)||kg/m^2|Mean|32.98|32.98|Standard Deviation|0.32|0.32|||
3641133|NCT02514889|3488568|B3|||Body weight (kg)||kg|Mean|82.23|82.23|Standard Deviation|0.72|0.72|||
3641134|NCT02514889|3488569|B2|||Body weight (kg)||kg|Mean|83.29|83.29|Standard Deviation|0.72|0.72|||
3641135|NCT02514889|3488570|B1|||Body weight (kg)||kg|Mean|81.17|81.17|Standard Deviation|0.95|0.95|||
3641136|NCT02514889|3488568|B3|||Feeling full after last meal yesterday|"Response to the question Take a moment to remember the last meal you ate yesterday. Thinking about the last meal you ate, how full did you feel after you ate that meal? Response was recorded on a 100mm visual analogue scale, with Extremely full anchoring the low end of the scale (0) and Not at all full anchoring the high end of the scale (100). For analysis purposes this measure was reverse-scored, so that greater values represent greater fullness ratings."|units on a scale|Mean|67.97|67.97|Standard Deviation|28.93|28.93|||
3641137|NCT02514889|3488569|B2|||Feeling full after last meal yesterday|"Response to the question Take a moment to remember the last meal you ate yesterday. Thinking about the last meal you ate, how full did you feel after you ate that meal? Response was recorded on a 100mm visual analogue scale, with Extremely full anchoring the low end of the scale (0) and Not at all full anchoring the high end of the scale (100). For analysis purposes this measure was reverse-scored, so that greater values represent greater fullness ratings."|units on a scale|Mean|69.92|69.92|Standard Deviation|28.50|28.5|||
3641138|NCT02514889|3488570|B1|||Feeling full after last meal yesterday|"Response to the question Take a moment to remember the last meal you ate yesterday. Thinking about the last meal you ate, how full did you feel after you ate that meal? Response was recorded on a 100mm visual analogue scale, with Extremely full anchoring the low end of the scale (0) and Not at all full anchoring the high end of the scale (100). For analysis purposes this measure was reverse-scored, so that greater values represent greater fullness ratings."|units on a scale|Mean|66.05|66.05|Standard Deviation|29.34|29.34|||
3641139|NCT02514889|3488568|B3|||Meal satisfaction yesterday|"Response to question Take a moment to think about the last meal you ate yesterday. Thinking about the last meal you ate, how satisfied were you after you ate that meal?, marked on a 100 mm visual analogue scale, with 0=Very satisfied 100=Very unsatisfied anchoring the high end of the scale, and reverse-coded for analysis, so that higher values (up to 100) represent greater meal satisfaction than lower values (as low as 0)."|Units on a scale|Mean|67.92|67.92|Standard Deviation|2.03|2.03|||
3641140|NCT02514889|3488569|B2|||Meal satisfaction yesterday|"Response to question Take a moment to think about the last meal you ate yesterday. Thinking about the last meal you ate, how satisfied were you after you ate that meal?, marked on a 100 mm visual analogue scale, with 0=Very satisfied 100=Very unsatisfied anchoring the high end of the scale, and reverse-coded for analysis, so that higher values (up to 100) represent greater meal satisfaction than lower values (as low as 0)."|Units on a scale|Mean|69.15|69.15|Standard Deviation|2.88|2.88|||
3641141|NCT02514889|3488570|B1|||Meal satisfaction yesterday|"Response to question Take a moment to think about the last meal you ate yesterday. Thinking about the last meal you ate, how satisfied were you after you ate that meal?, marked on a 100 mm visual analogue scale, with 0=Very satisfied 100=Very unsatisfied anchoring the high end of the scale, and reverse-coded for analysis, so that higher values (up to 100) represent greater meal satisfaction than lower values (as low as 0)."|Units on a scale|Mean|66.69|66.69|Standard Deviation|2.88|2.88|||
3641142|NCT02514889|3488568|B3|||Hunger level yesterday|"Primary patient-centered outcome measure was response to question: Thinking about yesterday, how hungry did you feel during the day? Response was a mark on a 100mm scale, 0=Not at all hungry and 100=Extremely hungry."|Units on a scale|Mean|49.05|49.05|Standard Deviation|27.43|27.43|||
3641143|NCT02514889|3488569|B2|||Hunger level yesterday|"Primary patient-centered outcome measure was response to question: Thinking about yesterday, how hungry did you feel during the day? Response was a mark on a 100mm scale, 0=Not at all hungry and 100=Extremely hungry."|Units on a scale|Mean|51.01|51.01|Standard Deviation|27.36|27.36|||
3641144|NCT02514889|3488570|B1|||Hunger level yesterday|"Primary patient-centered outcome measure was response to question: Thinking about yesterday, how hungry did you feel during the day? Response was a mark on a 100mm scale, 0=Not at all hungry and 100=Extremely hungry."|Units on a scale|Mean|47.11|47.11|Standard Deviation|27.46|27.46|||
3641145|NCT02514889|3488568|B3|United States||Region of Enrollment||Count of participants|Number|261|261.0||||||
3641146|NCT02514889|3488569|B2|United States||Region of Enrollment||Count of participants|Number|130|130.0||||||
3641147|NCT02514889|3488570|B1|United States||Region of Enrollment||Count of participants|Number|131|131.0||||||
3641149|NCT02514889|3488569|B2|Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3641150|NCT02514889|3488570|B1|Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3641151|NCT02514889|3488568|B3|Ethnicity|Native American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3641152|NCT02514889|3488569|B2|Ethnicity|Native American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3641153|NCT02514889|3488570|B1|Ethnicity|Native American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3641154|NCT02514889|3488568|B3|Ethnicity|Hispanic/Latino|Race/Ethnicity, Customized||Participants|Count of Participants|225|225.0||||||
3641155|NCT02514889|3488569|B2|Ethnicity|Hispanic/Latino|Race/Ethnicity, Customized||Participants|Count of Participants|113|113.0||||||
3641156|NCT02514889|3488570|B1|Ethnicity|Hispanic/Latino|Race/Ethnicity, Customized||Participants|Count of Participants|112|112.0||||||
3641157|NCT02514889|3488568|B3|Ethnicity|Non-Hispanic White|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3641158|NCT02514889|3488569|B2|Ethnicity|Non-Hispanic White|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3641159|NCT02514889|3488570|B1|Ethnicity|Non-Hispanic White|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3641160|NCT02514889|3488568|B3|Ethnicity|Asian American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3641161|NCT02514889|3488569|B2|Ethnicity|Asian American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3641162|NCT02514889|3488570|B1|Ethnicity|Asian American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3641163|NCT02514889|3488568|B3|Ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3641164|NCT02514889|3488569|B2|Ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3641165|NCT02514889|3488570|B1|Ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3641166|NCT02514889|3488568|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3641167|NCT02514889|3488569|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3641168|NCT02514889|3488570|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3641169|NCT02514889|3488568|B3||Female|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
3641170|NCT02514889|3488569|B2||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3641171|NCT02514889|3488570|B1||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3641172|NCT02514889|3488568|B3|||Age||years|Mean|41.8|41.8|Standard Deviation|11.5|11.5|||
3641173|NCT02514889|3488569|B2|||Age||years|Mean|41.8|41.8|Standard Deviation|11.5|11.5|||
3641174|NCT02514889|3488570|B1|||Age||years|Mean|41.7|41.7|Standard Deviation|11.5|11.5|||
3641175|NCT02514772|3488589|B3|Positive||Anti-drug antibodies (ADA) at screening||participants|Number|2|2.0||||||
3641176|NCT02514772|3488590|B2|Positive||Anti-drug antibodies (ADA) at screening||participants|Number|1|1.0||||||
3641177|NCT02514772|3488591|B1|Positive||Anti-drug antibodies (ADA) at screening||participants|Number|1|1.0||||||
3641178|NCT02514772|3488589|B3|Negative||Anti-drug antibodies (ADA) at screening||participants|Number|105|105.0||||||
3641179|NCT02514772|3488590|B2|Negative||Anti-drug antibodies (ADA) at screening||participants|Number|53|53.0||||||
3641180|NCT02514772|3488591|B1|Negative||Anti-drug antibodies (ADA) at screening||participants|Number|52|52.0||||||
3641181|NCT02514772|3488589|B3|Yes||Experienced infusion-related reactions during rituximab treatments prior to randomization||participants|Number|5|5.0||||||
3641182|NCT02514772|3488590|B2|Yes||Experienced infusion-related reactions during rituximab treatments prior to randomization||participants|Number|3|3.0||||||
3641183|NCT02514772|3488591|B1|Yes||Experienced infusion-related reactions during rituximab treatments prior to randomization||participants|Number|2|2.0||||||
3641184|NCT02514772|3488589|B3|No||Experienced infusion-related reactions during rituximab treatments prior to randomization||participants|Number|102|102.0||||||
3641185|NCT02514772|3488590|B2|No||Experienced infusion-related reactions during rituximab treatments prior to randomization||participants|Number|51|51.0||||||
3641186|NCT02514772|3488591|B1|No||Experienced infusion-related reactions during rituximab treatments prior to randomization||participants|Number|51|51.0||||||
3641187|NCT02514772|3488589|B3|>1||Number of previous treatment courses with rituximab||treatment course|Number|81|81.0||||||
3641188|NCT02514772|3488590|B2|>1||Number of previous treatment courses with rituximab||treatment course|Number|41|41.0||||||
3641189|NCT02514772|3488591|B1|>1||Number of previous treatment courses with rituximab||treatment course|Number|40|40.0||||||
3641190|NCT02514772|3488589|B3|1||Number of previous treatment courses with rituximab||treatment course|Number|26|26.0||||||
3641191|NCT02514772|3488590|B2|1||Number of previous treatment courses with rituximab||treatment course|Number|13|13.0||||||
3641192|NCT02514772|3488591|B1|1||Number of previous treatment courses with rituximab||treatment course|Number|13|13.0||||||
3641193|NCT02514772|3488589|B3|||Number of previous treatments courses with rituximab||treatment course|Mean|4.6|4.6|Standard Deviation|3.56|3.56|||
3641194|NCT02514772|3488590|B2|||Number of previous treatments courses with rituximab||treatment course|Mean|5.0|5.0|Standard Deviation|3.75|3.75|||
3641195|NCT02514772|3488591|B1|||Number of previous treatments courses with rituximab||treatment course|Mean|4.1|4.1|Standard Deviation|3.32|3.32|||
3641196|NCT02514772|3488589|B3|||Prednisone equivalent steroid dose at baseline||mg/day|Mean|4.99|4.99|Standard Deviation|2.13|2.13|||
3641197|NCT02514772|3488590|B2|||Prednisone equivalent steroid dose at baseline||mg/day|Mean|4.64|4.64|Standard Deviation|2.36|2.36|||
3641198|NCT02514772|3488591|B1|||Prednisone equivalent steroid dose at baseline||mg/day|Mean|5.39|5.39|Standard Deviation|1.80|1.8|||
3641199|NCT02514772|3488589|B3|||Dose of methotrexate at baseline||mg/week|Mean|15.00|15.0|Standard Deviation|5.684|5.684|||
3641200|NCT02514772|3488590|B2|||Dose of methotrexate at baseline||mg/week|Mean|15.46|15.46|Standard Deviation|5.141|5.141|||
3641201|NCT02514772|3488591|B1|||Dose of methotrexate at baseline||mg/week|Mean|14.53|14.53|Standard Deviation|6.203|6.203|||
3641202|NCT02514772|3488589|B3|||C-reactive protein (CRP) at baseline||mg/L|Mean|10.66|10.66|Standard Deviation|23.84|23.84|||
3641203|NCT02514772|3488590|B2|||C-reactive protein (CRP) at baseline||mg/L|Mean|11.64|11.64|Standard Deviation|23.63|23.63|||
3641204|NCT02514772|3488591|B1|||C-reactive protein (CRP) at baseline||mg/L|Mean|9.67|9.67|Standard Deviation|24.25|24.25|||
3641205|NCT02514772|3488589|B3|||Duration since initial diagnosis of rheumatoid arthritis||years|Mean|13.74|13.74|Standard Deviation|8.92|8.92|||
3641206|NCT02514772|3488590|B2|||Duration since initial diagnosis of rheumatoid arthritis||years|Mean|14.01|14.01|Standard Deviation|8.51|8.51|||
3641207|NCT02514772|3488591|B1|||Duration since initial diagnosis of rheumatoid arthritis||years|Mean|13.46|13.46|Standard Deviation|9.39|9.39|||
3641208|NCT02514772|3488589|B3|||Weight at screening||kg|Mean|80.88|80.88|Standard Deviation|20.26|20.26|||
3641209|NCT02514772|3488590|B2|||Weight at screening||kg|Mean|81.62|81.62|Standard Deviation|20.46|20.46|||
3641210|NCT02514772|3488591|B1|||Weight at screening||kg|Mean|80.12|80.12|Standard Deviation|20.22|20.22|||
3641211|NCT02514772|3488589|B3|Europe||Region of Enrollment||Participants|Count of Participants|72|72.0||||||
3641212|NCT02514772|3488590|B2|Europe||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3641213|NCT02514772|3488591|B1|Europe||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3641214|NCT02514772|3488589|B3|United States||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3641215|NCT02514772|3488590|B2|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3641216|NCT02514772|3488591|B1|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3641217|NCT02514772|3488589|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641218|NCT02514772|3488590|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641219|NCT02514772|3488591|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641220|NCT02514772|3488589|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641221|NCT02514772|3488590|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641222|NCT02514772|3488591|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641223|NCT02514772|3488589|B3||White|Race (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
3641224|NCT02514772|3488590|B2||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3641225|NCT02514772|3488591|B1||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3641226|NCT02514772|3488589|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3641227|NCT02514772|3488590|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3641228|NCT02514772|3488591|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641229|NCT02514772|3488589|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641230|NCT02514772|3488590|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641231|NCT02514772|3488591|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641232|NCT02514772|3488589|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3641233|NCT02514772|3488590|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641234|NCT02514772|3488591|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3641235|NCT02514772|3488589|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3641236|NCT02514772|3488590|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641237|NCT02514772|3488591|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3641238|NCT02514772|3488589|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3641239|NCT02514772|3488590|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3641240|NCT02514772|3488591|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3641241|NCT02514772|3488589|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3641242|NCT02514772|3488590|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3641243|NCT02514772|3488591|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3641244|NCT02514772|3488589|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3641245|NCT02514772|3488590|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3641246|NCT02514772|3488591|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3641247|NCT02514772|3488589|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3641248|NCT02514772|3488590|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3641249|NCT02514772|3488591|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3641250|NCT02514772|3488589|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3641251|NCT02514772|3488590|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3641252|NCT02514772|3488591|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3641253|NCT02514772|3488589|B3|||Age||years|Mean|57|57.0|Standard Deviation|11.04|11.04|||
3641254|NCT02514772|3488590|B2|||Age||years|Mean|57.1|57.1|Standard Deviation|12.14|12.14|||
3641255|NCT02514772|3488591|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|9.91|9.91|||
3641256|NCT02514772|3488589|B3||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3641257|NCT02514772|3488590|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3641258|NCT02514772|3488591|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3641259|NCT02514772|3488589|B3||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
3641260|NCT02514772|3488590|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3641261|NCT02514772|3488591|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3641262|NCT02514772|3488589|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3641263|NCT02514772|3488590|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3641264|NCT02514772|3488591|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3641265|NCT02514551|3488604|B3|Spain||Region of Enrollment||Participants|Count of Participants|56|56.0||||||
3641266|NCT02514551|3488605|B2|Spain||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3641267|NCT02514551|3488606|B1|Spain||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3641268|NCT02514551|3488604|B3|Germany||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3641269|NCT02514551|3488605|B2|Germany||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3641270|NCT02514551|3488606|B1|Germany||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3641271|NCT02514551|3488604|B3|Italy||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3641272|NCT02514551|3488605|B2|Italy||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3641273|NCT02514551|3488606|B1|Italy||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3641274|NCT02514551|3488604|B3|Ukraine||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3641275|NCT02514551|3488605|B2|Ukraine||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3641276|NCT02514551|3488606|B1|Ukraine||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3641277|NCT02514551|3488604|B3|Czechia||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3641278|NCT02514551|3488605|B2|Czechia||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3641279|NCT02514551|3488606|B1|Czechia||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3641280|NCT02514551|3488604|B3|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3641281|NCT02514551|3488605|B2|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3641282|NCT02514551|3488606|B1|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3641283|NCT02514551|3488604|B3|Belgium||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3641284|NCT02514551|3488605|B2|Belgium||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3641285|NCT02514551|3488606|B1|Belgium||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3641286|NCT02514551|3488604|B3|Turkey||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3641287|NCT02514551|3488605|B2|Turkey||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3641288|NCT02514551|3488606|B1|Turkey||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3641289|NCT02514551|3488604|B3|Sweden||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3641290|NCT02514551|3488605|B2|Sweden||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3641291|NCT02514551|3488606|B1|Sweden||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3641292|NCT02514551|3488604|B3|Canada||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3641293|NCT02514551|3488605|B2|Canada||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3641294|NCT02514551|3488606|B1|Canada||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3641295|NCT02514551|3488604|B3|Greece||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3641296|NCT02514551|3488605|B2|Greece||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3641297|NCT02514551|3488606|B1|Greece||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3641298|NCT02514551|3488604|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3641299|NCT02514551|3488605|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641300|NCT02514551|3488606|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3641301|NCT02514551|3488604|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641302|NCT02514551|3488605|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641303|NCT02514551|3488606|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641304|NCT02514551|3488604|B3||White|Race (NIH/OMB)||Participants|Count of Participants|236|236.0||||||
3641305|NCT02514551|3488605|B2||White|Race (NIH/OMB)||Participants|Count of Participants|117|117.0||||||
3641306|NCT02514551|3488606|B1||White|Race (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
3641307|NCT02514551|3488604|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3641308|NCT02514551|3488605|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3641309|NCT02514551|3488606|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3641310|NCT02514551|3488604|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641311|NCT02514551|3488605|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641312|NCT02514551|3488606|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641313|NCT02514551|3488604|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3641314|NCT02514551|3488605|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3641315|NCT02514551|3488606|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641316|NCT02514551|3488604|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3641317|NCT02514551|3488605|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641318|NCT02514551|3488606|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3641319|NCT02514551|3488604|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3641320|NCT02514551|3488605|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3641321|NCT02514551|3488606|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3641322|NCT02514551|3488604|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|218|218.0||||||
3641323|NCT02514551|3488605|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
3641324|NCT02514551|3488606|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
3641325|NCT02514551|3488604|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3641326|NCT02514551|3488605|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3641327|NCT02514551|3488606|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3641328|NCT02514551|3488604|B3||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3641329|NCT02514551|3488605|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3641330|NCT02514551|3488606|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3641331|NCT02514551|3488604|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3641332|NCT02514551|3488605|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3641333|NCT02514551|3488606|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3641334|NCT02514551|3488604|B3|||Age||years|Mean|58.3|58.3|Standard Deviation|11.8|11.8|||
3641335|NCT02514551|3488605|B2|||Age||years|Mean|57.9|57.9|Standard Deviation|12.3|12.3|||
3641336|NCT02514551|3488606|B1|||Age||years|Mean|58.6|58.6|Standard Deviation|11.4|11.4|||
3641337|NCT02514473|3488622|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3641338|NCT02514473|3488623|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3641339|NCT02514473|3488624|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3641340|NCT02514473|3488622|B3||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3641341|NCT02514473|3488623|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3641342|NCT02514473|3488624|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3641343|NCT02514473|3488622|B3|||Age||years|Mean|8.8|8.8|Standard Deviation|1.59|1.59|||
3641344|NCT02514473|3488623|B2|||Age||years|Mean|8.7|8.7|Standard Deviation|1.6|1.6|||
3641345|NCT02514473|3488624|B1|||Age||years|Mean|8.9|8.9|Standard Deviation|1.59|1.59|||
3641346|NCT02514122|3488666|B3|Rwanda||Region of Enrollment||Participants|Count of Participants|59|59.0||||||
3641347|NCT02514122|3488667|B2|Rwanda||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3641348|NCT02514122|3488668|B1|Rwanda||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3641349|NCT02514122|3488666|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3641350|NCT02514122|3488666|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3641351|NCT02514122|3488667|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3641352|NCT02514122|3488668|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3641353|NCT02514122|3488666|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3641354|NCT02514122|3488667|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3641355|NCT02514122|3488668|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3641356|NCT02514122|3488666|B3|||Age||years|Mean|38.7|38.7|Standard Deviation|12.1|12.1|||
3641357|NCT02514122|3488667|B2|||Age||years|Mean|35.3|35.3|Standard Deviation|10.8|10.8|||
3641358|NCT02514122|3488668|B1|||Age||years|Mean|42.2|42.2|Standard Deviation|12.6|12.6|||
3641359|NCT02514044|3488677|B1|||Non-fluent aphasia assessed by clinicians||Participants|Count of Participants|10|10.0||||||
3641360|NCT02514044|3488677|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3641361|NCT02514044|3488677|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641362|NCT02514044|3488677|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641363|NCT02514044|3488677|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3641364|NCT02514044|3488677|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3641365|NCT02514044|3488677|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641366|NCT02514044|3488677|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641367|NCT02514044|3488677|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641368|NCT02514044|3488677|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641369|NCT02514044|3488677|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3641370|NCT02514044|3488677|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641371|NCT02514044|3488677|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3641372|NCT02514044|3488677|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3641373|NCT02514044|3488677|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3641374|NCT02514044|3488677|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3641375|NCT02514044|3488677|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3641376|NCT02513771|3488691|B3|||Baseline sCD14|sCD14 is the primary endpoint of the study. Baseline sCD14 is the average of pre-entry and entry values|log10 pg/mL|Median|6.39|6.39|Inter-Quartile Range|||6.32|6.46|
3641377|NCT02513771|3488692|B2|||Baseline sCD14|sCD14 is the primary endpoint of the study. Baseline sCD14 is the average of pre-entry and entry values|log10 pg/mL|Median|6.38|6.38|Inter-Quartile Range|||6.33|6.48|
3641378|NCT02513771|3488693|B1|||Baseline sCD14|sCD14 is the primary endpoint of the study. Baseline sCD14 is the average of pre-entry and entry values|log10 pg/mL|Median|6.39|6.39|Inter-Quartile Range|||6.31|6.44|
3641379|NCT02513771|3488691|B3|||CD4 count|CD4 count at entry|cells/mm^3|Median|586|586.0|Inter-Quartile Range|||317.0|796.0|
3641380|NCT02513771|3488692|B2|||CD4 count|CD4 count at entry|cells/mm^3|Median|551|551.0|Inter-Quartile Range|||313.0|801.0|
3641381|NCT02513771|3488693|B1|||CD4 count|CD4 count at entry|cells/mm^3|Median|609|609.0|Inter-Quartile Range|||323.0|796.0|
3641382|NCT02513771|3488691|B3|Previously||IV drug use||Participants|Count of Participants|4|4.0||||||
3641383|NCT02513771|3488692|B2|Previously||IV drug use||Participants|Count of Participants|3|3.0||||||
3641384|NCT02513771|3488693|B1|Previously||IV drug use||Participants|Count of Participants|1|1.0||||||
3641385|NCT02513771|3488691|B3|Never||IV drug use||Participants|Count of Participants|86|86.0||||||
3641386|NCT02513771|3488692|B2|Never||IV drug use||Participants|Count of Participants|42|42.0||||||
3641387|NCT02513771|3488693|B1|Never||IV drug use||Participants|Count of Participants|44|44.0||||||
3641388|NCT02513771|3488691|B3|United States||Region of Enrollment||Participants|Count of Participants|90|90.0||||||
3641389|NCT02513771|3488692|B2|United States||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3641390|NCT02513771|3488693|B1|United States||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3641391|NCT02513771|3488691|B3|more than one race||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3641392|NCT02513771|3488692|B2|more than one race||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3641393|NCT02513771|3488693|B1|more than one race||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3641394|NCT02513771|3488691|B3|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3641395|NCT02513771|3488692|B2|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3641396|NCT02513771|3488693|B1|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3641397|NCT02513771|3488691|B3|Non-Hispanic Black||Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3641398|NCT02513771|3488692|B2|Non-Hispanic Black||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3641399|NCT02513771|3488693|B1|Non-Hispanic Black||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3641400|NCT02513771|3488691|B3|Non-Hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
3641401|NCT02513771|3488692|B2|Non-Hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3641402|NCT02513771|3488693|B1|Non-Hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3641403|NCT02513771|3488691|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3641404|NCT02513771|3488692|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3641405|NCT02513771|3488693|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3641406|NCT02513771|3488691|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3641407|NCT02513771|3488692|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3641408|NCT02513771|3488693|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3641409|NCT02513771|3488691|B3|>=60 years||Age, Customized||Participants|Count of Participants|14|14.0||||||
3641410|NCT02513771|3488692|B2|>=60 years||Age, Customized||Participants|Count of Participants|7|7.0||||||
3641411|NCT02513771|3488693|B1|>=60 years||Age, Customized||Participants|Count of Participants|7|7.0||||||
3641412|NCT02513771|3488691|B3|40-59 years||Age, Customized||Participants|Count of Participants|59|59.0||||||
3641413|NCT02513771|3488692|B2|40-59 years||Age, Customized||Participants|Count of Participants|32|32.0||||||
3641414|NCT02513771|3488693|B1|40-59 years||Age, Customized||Participants|Count of Participants|27|27.0||||||
3641415|NCT02513771|3488691|B3|18-39 years||Age, Customized||Participants|Count of Participants|17|17.0||||||
3641416|NCT02513771|3488692|B2|18-39 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
3641417|NCT02513771|3488693|B1|18-39 years||Age, Customized||Participants|Count of Participants|11|11.0||||||
3641418|NCT02513771|3488691|B3|||Age||years|Median|51|51.0|Inter-Quartile Range|||44.0|56.0|
3641419|NCT02513771|3488692|B2|||Age||years|Median|50|50.0|Inter-Quartile Range|||45.0|55.0|
3641420|NCT02513771|3488693|B1|||Age||years|Median|52|52.0|Inter-Quartile Range|||40.0|56.0|
3641421|NCT02513550|3488730|B7|Germany||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3641422|NCT02513550|3488731|B6|Germany||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3641423|NCT02513550|3488732|B5|Germany||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3641424|NCT02513550|3488733|B4|Germany||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3641425|NCT02513550|3488734|B3|Germany||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3641426|NCT02513550|3488735|B2|Germany||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3641427|NCT02513550|3488736|B1|Germany||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3641428|NCT02513550|3488730|B7|Australia||Region of Enrollment||Participants|Count of Participants|56|56.0||||||
3641429|NCT02513550|3488731|B6|Australia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3641430|NCT02513550|3488732|B5|Australia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3641431|NCT02513550|3488733|B4|Australia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3641432|NCT02513550|3488734|B3|Australia||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3641433|NCT02513550|3488735|B2|Australia||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3641434|NCT02513550|3488736|B1|Australia||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3641435|NCT02513550|3488730|B7|Mexico||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3641436|NCT02513550|3488731|B6|Mexico||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3641437|NCT02513550|3488732|B5|Mexico||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3641438|NCT02513550|3488733|B4|Mexico||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3641439|NCT02513550|3488734|B3|Mexico||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3641440|NCT02513550|3488735|B2|Mexico||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3641441|NCT02513550|3488736|B1|Mexico||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3641442|NCT02513550|3488730|B7|Poland||Region of Enrollment||Participants|Count of Participants|169|169.0||||||
3641443|NCT02513550|3488731|B6|Poland||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3641444|NCT02513550|3488732|B5|Poland||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3641445|NCT02513550|3488733|B4|Poland||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3641446|NCT02513550|3488734|B3|Poland||Region of Enrollment||Participants|Count of Participants|83|83.0||||||
3641447|NCT02513550|3488735|B2|Poland||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
3641448|NCT02513550|3488736|B1|Poland||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
3641449|NCT02513550|3488730|B7|Taiwan||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3641450|NCT02513550|3488731|B6|Taiwan||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3641451|NCT02513550|3488732|B5|Taiwan||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3641452|NCT02513550|3488733|B4|Taiwan||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3641453|NCT02513550|3488734|B3|Taiwan||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3641454|NCT02513550|3488735|B2|Taiwan||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3641455|NCT02513550|3488736|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3641456|NCT02513550|3488730|B7|South Korea||Region of Enrollment||Participants|Count of Participants|75|75.0||||||
3641457|NCT02513550|3488731|B6|South Korea||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3641458|NCT02513550|3488732|B5|South Korea||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3641459|NCT02513550|3488733|B4|South Korea||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3641460|NCT02513550|3488734|B3|South Korea||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3641461|NCT02513550|3488735|B2|South Korea||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3641462|NCT02513550|3488736|B1|South Korea||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3641463|NCT02513550|3488730|B7|Canada||Region of Enrollment||Participants|Count of Participants|197|197.0||||||
3641464|NCT02513550|3488731|B6|Canada||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3641465|NCT02513550|3488732|B5|Canada||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3641466|NCT02513550|3488733|B4|Canada||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3641467|NCT02513550|3488734|B3|Canada||Region of Enrollment||Participants|Count of Participants|99|99.0||||||
3641468|NCT02513550|3488735|B2|Canada||Region of Enrollment||Participants|Count of Participants|49|49.0||||||
3641469|NCT02513550|3488736|B1|Canada||Region of Enrollment||Participants|Count of Participants|49|49.0||||||
3641470|NCT02513550|3488730|B7|Japan||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3641471|NCT02513550|3488731|B6|Japan||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3641472|NCT02513550|3488732|B5|Japan||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3641473|NCT02513550|3488733|B4|Japan||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3641474|NCT02513550|3488734|B3|Japan||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3641475|NCT02513550|3488735|B2|Japan||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3641476|NCT02513550|3488736|B1|Japan||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3641477|NCT02513550|3488730|B7|Czechia||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3641478|NCT02513550|3488731|B6|Czechia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3641479|NCT02513550|3488732|B5|Czechia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3641480|NCT02513550|3488733|B4|Czechia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3641481|NCT02513550|3488734|B3|Czechia||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3641482|NCT02513550|3488735|B2|Czechia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3641483|NCT02513550|3488736|B1|Czechia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3641484|NCT02513550|3488730|B7|United States||Region of Enrollment||Participants|Count of Participants|475|475.0||||||
3641485|NCT02513550|3488731|B6|United States||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3641486|NCT02513550|3488732|B5|United States||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3641487|NCT02513550|3488733|B4|United States||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3641488|NCT02513550|3488734|B3|United States||Region of Enrollment||Participants|Count of Participants|238|238.0||||||
3641489|NCT02513550|3488735|B2|United States||Region of Enrollment||Participants|Count of Participants|118|118.0||||||
3641490|NCT02513550|3488736|B1|United States||Region of Enrollment||Participants|Count of Participants|119|119.0||||||
3641491|NCT02513550|3488730|B7|Hungary||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3641492|NCT02513550|3488731|B6|Hungary||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3641493|NCT02513550|3488732|B5|Hungary||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3641494|NCT02513550|3488733|B4|Hungary||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3641495|NCT02513550|3488734|B3|Hungary||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3641496|NCT02513550|3488735|B2|Hungary||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3641497|NCT02513550|3488736|B1|Hungary||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3641498|NCT02513550|3488730|B7|Romania||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3641499|NCT02513550|3488731|B6|Romania||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3641500|NCT02513550|3488732|B5|Romania||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3641501|NCT02513550|3488733|B4|Romania||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3641502|NCT02513550|3488734|B3|Romania||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3641503|NCT02513550|3488735|B2|Romania||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3641504|NCT02513550|3488736|B1|Romania||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3641505|NCT02513550|3488730|B7|Argentina||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3641506|NCT02513550|3488731|B6|Argentina||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3641507|NCT02513550|3488732|B5|Argentina||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3641508|NCT02513550|3488733|B4|Argentina||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3641509|NCT02513550|3488734|B3|Argentina||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3641510|NCT02513550|3488735|B2|Argentina||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3641511|NCT02513550|3488736|B1|Argentina||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3641512|NCT02513550|3488730|B7|Puerto Rico||Region of Enrollment||Participants|Count of Participants|59|59.0||||||
3641513|NCT02513550|3488731|B6|Puerto Rico||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3641514|NCT02513550|3488732|B5|Puerto Rico||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3641515|NCT02513550|3488733|B4|Puerto Rico||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3641516|NCT02513550|3488734|B3|Puerto Rico||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3641517|NCT02513550|3488735|B2|Puerto Rico||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3641518|NCT02513550|3488736|B1|Puerto Rico||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3641519|NCT02513550|3488730|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641520|NCT02513550|3488731|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641521|NCT02513550|3488732|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641522|NCT02513550|3488733|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641523|NCT02513550|3488734|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641524|NCT02513550|3488735|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641525|NCT02513550|3488736|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641526|NCT02513550|3488730|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3641527|NCT02513550|3488731|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641528|NCT02513550|3488732|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641529|NCT02513550|3488733|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641530|NCT02513550|3488734|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3641531|NCT02513550|3488735|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3641532|NCT02513550|3488736|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3641533|NCT02513550|3488730|B7||White|Race (NIH/OMB)||Participants|Count of Participants|990|990.0||||||
3641534|NCT02513550|3488731|B6||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641535|NCT02513550|3488732|B5||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641536|NCT02513550|3488733|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641537|NCT02513550|3488734|B3||White|Race (NIH/OMB)||Participants|Count of Participants|486|486.0||||||
3641538|NCT02513550|3488735|B2||White|Race (NIH/OMB)||Participants|Count of Participants|253|253.0||||||
3641539|NCT02513550|3488736|B1||White|Race (NIH/OMB)||Participants|Count of Participants|251|251.0||||||
3641540|NCT02513550|3488730|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3641541|NCT02513550|3488731|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641542|NCT02513550|3488732|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641543|NCT02513550|3488733|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641544|NCT02513550|3488734|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3641545|NCT02513550|3488735|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3641546|NCT02513550|3488736|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3641547|NCT02513550|3488730|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3641548|NCT02513550|3488731|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641549|NCT02513550|3488732|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641550|NCT02513550|3488733|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641551|NCT02513550|3488734|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3641552|NCT02513550|3488735|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641553|NCT02513550|3488736|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641554|NCT02513550|3488730|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|157|157.0||||||
3641555|NCT02513550|3488731|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3641556|NCT02513550|3488732|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3641557|NCT02513550|3488733|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3641558|NCT02513550|3488734|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3641559|NCT02513550|3488735|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3641560|NCT02513550|3488736|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3641561|NCT02513550|3488730|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3641562|NCT02513550|3488731|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641563|NCT02513550|3488732|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641564|NCT02513550|3488733|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641565|NCT02513550|3488734|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3641566|NCT02513550|3488735|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3641567|NCT02513550|3488736|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3641568|NCT02513550|3488730|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3641569|NCT02513550|3488731|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641570|NCT02513550|3488732|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641571|NCT02513550|3488733|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641572|NCT02513550|3488734|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3641573|NCT02513550|3488735|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3641574|NCT02513550|3488736|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3641575|NCT02513550|3488730|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1006|1006.0||||||
3641576|NCT02513550|3488731|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3641577|NCT02513550|3488732|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3641578|NCT02513550|3488733|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3641579|NCT02513550|3488734|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|489|489.0||||||
3641580|NCT02513550|3488735|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|244|244.0||||||
3641581|NCT02513550|3488736|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|243|243.0||||||
3641582|NCT02513550|3488730|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|225|225.0||||||
3641583|NCT02513550|3488731|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641584|NCT02513550|3488732|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641585|NCT02513550|3488733|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641586|NCT02513550|3488734|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
3641587|NCT02513550|3488735|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3641588|NCT02513550|3488736|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3641589|NCT02513550|3488730|B7||Male|Sex: Female, Male||Participants|Count of Participants|834|834.0||||||
3641590|NCT02513550|3488731|B6||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3641591|NCT02513550|3488732|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3641592|NCT02513550|3488733|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3641593|NCT02513550|3488734|B3||Male|Sex: Female, Male||Participants|Count of Participants|412|412.0||||||
3641594|NCT02513550|3488735|B2||Male|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
3641595|NCT02513550|3488736|B1||Male|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
3641596|NCT02513550|3488730|B7||Female|Sex: Female, Male||Participants|Count of Participants|423|423.0||||||
3641597|NCT02513550|3488731|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3641598|NCT02513550|3488732|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3641599|NCT02513550|3488733|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3641600|NCT02513550|3488734|B3||Female|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
3641601|NCT02513550|3488735|B2||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3641602|NCT02513550|3488736|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3641603|NCT02513550|3488730|B7|||Age||years|Mean|47.8|47.8|Standard Deviation|13.45|13.45|||
3641604|NCT02513550|3488731|B6|||Age||years|Mean|46.1|46.1|Standard Deviation|13.05|13.05|||
3641605|NCT02513550|3488732|B5|||Age||years|Mean|46.0|46.0|Standard Deviation|13.17|13.17|||
3641606|NCT02513550|3488733|B4|||Age||years|Mean|40.0|40.0|Standard Deviation|9.62|9.62|||
3641607|NCT02513550|3488734|B3|||Age||years|Mean|49.0|49.0|Standard Deviation|13.61|13.61|||
3641608|NCT02513550|3488735|B2|||Age||years|Mean|45.9|45.9|Standard Deviation|12.85|12.85|||
3641609|NCT02513550|3488736|B1|||Age||years|Mean|47.4|47.4|Standard Deviation|13.50|13.5|||
3641610|NCT02513160|3488813|B5|Non-corticosteroid||Current Asthma Therapy||Participants|Count of Participants|163|163.0||||||
3641611|NCT02513160|3488814|B4|Non-corticosteroid||Current Asthma Therapy||Participants|Count of Participants|40|40.0||||||
3641612|NCT02513160|3488815|B3|Non-corticosteroid||Current Asthma Therapy||Participants|Count of Participants|40|40.0||||||
3641613|NCT02513160|3488816|B2|Non-corticosteroid||Current Asthma Therapy||Participants|Count of Participants|42|42.0||||||
3641614|NCT02513160|3488817|B1|Non-corticosteroid||Current Asthma Therapy||Participants|Count of Participants|41|41.0||||||
3641615|NCT02513160|3488813|B5|Inhaled corticosteroid||Current Asthma Therapy||Participants|Count of Participants|262|262.0||||||
3641616|NCT02513160|3488814|B4|Inhaled corticosteroid||Current Asthma Therapy||Participants|Count of Participants|65|65.0||||||
3641617|NCT02513160|3488815|B3|Inhaled corticosteroid||Current Asthma Therapy||Participants|Count of Participants|65|65.0||||||
3641618|NCT02513160|3488816|B2|Inhaled corticosteroid||Current Asthma Therapy||Participants|Count of Participants|66|66.0||||||
3641619|NCT02513160|3488817|B1|Inhaled corticosteroid||Current Asthma Therapy||Participants|Count of Participants|66|66.0||||||
3641620|NCT02513160|3488813|B5|>=15 years||Duration of Asthma||Participants|Count of Participants|329|329.0||||||
3641621|NCT02513160|3488814|B4|>=15 years||Duration of Asthma||Participants|Count of Participants|80|80.0||||||
3641622|NCT02513160|3488815|B3|>=15 years||Duration of Asthma||Participants|Count of Participants|84|84.0||||||
3641623|NCT02513160|3488816|B2|>=15 years||Duration of Asthma||Participants|Count of Participants|81|81.0||||||
3641624|NCT02513160|3488817|B1|>=15 years||Duration of Asthma||Participants|Count of Participants|84|84.0||||||
3641625|NCT02513160|3488813|B5|10 years to <15 years||Duration of Asthma||Participants|Count of Participants|39|39.0||||||
3641626|NCT02513160|3488814|B4|10 years to <15 years||Duration of Asthma||Participants|Count of Participants|12|12.0||||||
3641627|NCT02513160|3488815|B3|10 years to <15 years||Duration of Asthma||Participants|Count of Participants|8|8.0||||||
3641628|NCT02513160|3488816|B2|10 years to <15 years||Duration of Asthma||Participants|Count of Participants|7|7.0||||||
3641629|NCT02513160|3488817|B1|10 years to <15 years||Duration of Asthma||Participants|Count of Participants|12|12.0||||||
3641630|NCT02513160|3488813|B5|5 years to <10 years||Duration of Asthma||Participants|Count of Participants|32|32.0||||||
3641631|NCT02513160|3488814|B4|5 years to <10 years||Duration of Asthma||Participants|Count of Participants|8|8.0||||||
3641632|NCT02513160|3488815|B3|5 years to <10 years||Duration of Asthma||Participants|Count of Participants|7|7.0||||||
3641633|NCT02513160|3488816|B2|5 years to <10 years||Duration of Asthma||Participants|Count of Participants|11|11.0||||||
3641634|NCT02513160|3488817|B1|5 years to <10 years||Duration of Asthma||Participants|Count of Participants|6|6.0||||||
3641635|NCT02513160|3488813|B5|1 year to <5 years||Duration of Asthma||Participants|Count of Participants|24|24.0||||||
3641636|NCT02513160|3488814|B4|1 year to <5 years||Duration of Asthma||Participants|Count of Participants|5|5.0||||||
3641637|NCT02513160|3488815|B3|1 year to <5 years||Duration of Asthma||Participants|Count of Participants|6|6.0||||||
3641638|NCT02513160|3488816|B2|1 year to <5 years||Duration of Asthma||Participants|Count of Participants|8|8.0||||||
3641639|NCT02513160|3488817|B1|1 year to <5 years||Duration of Asthma||Participants|Count of Participants|5|5.0||||||
3641640|NCT02513160|3488813|B5|6 months to <1 year||Duration of Asthma||Participants|Count of Participants|1|1.0||||||
3641641|NCT02513160|3488814|B4|6 months to <1 year||Duration of Asthma||Participants|Count of Participants|0|0.0||||||
3641642|NCT02513160|3488815|B3|6 months to <1 year||Duration of Asthma||Participants|Count of Participants|0|0.0||||||
3641643|NCT02513160|3488816|B2|6 months to <1 year||Duration of Asthma||Participants|Count of Participants|1|1.0||||||
3641644|NCT02513160|3488817|B1|6 months to <1 year||Duration of Asthma||Participants|Count of Participants|0|0.0||||||
3641645|NCT02513160|3488813|B5|3 months to <6 months||Duration of Asthma||Participants|Count of Participants|0|0.0||||||
3641646|NCT02513160|3488814|B4|3 months to <6 months||Duration of Asthma||Participants|Count of Participants|0|0.0||||||
3641647|NCT02513160|3488815|B3|3 months to <6 months||Duration of Asthma||Participants|Count of Participants|0|0.0||||||
3641648|NCT02513160|3488816|B2|3 months to <6 months||Duration of Asthma||Participants|Count of Participants|0|0.0||||||
3641649|NCT02513160|3488817|B1|3 months to <6 months||Duration of Asthma||Participants|Count of Participants|0|0.0||||||
3641650|NCT02513160|3488813|B5|<3 months||Duration of Asthma||Participants|Count of Participants|0|0.0||||||
3641651|NCT02513160|3488814|B4|<3 months||Duration of Asthma||Participants|Count of Participants|0|0.0||||||
3641652|NCT02513160|3488815|B3|<3 months||Duration of Asthma||Participants|Count of Participants|0|0.0||||||
3641653|NCT02513160|3488816|B2|<3 months||Duration of Asthma||Participants|Count of Participants|0|0.0||||||
3641654|NCT02513160|3488817|B1|<3 months||Duration of Asthma||Participants|Count of Participants|0|0.0||||||
3641655|NCT02513160|3488813|B5|||Body Mass Index||kg/m^2|Mean|30.625|30.625|Standard Deviation|8.2624|8.2624|||
3641656|NCT02513160|3488814|B4|||Body Mass Index||kg/m^2|Mean|30.944|30.944|Standard Deviation|8.1645|8.1645|||
3641657|NCT02513160|3488815|B3|||Body Mass Index||kg/m^2|Mean|30.327|30.327|Standard Deviation|8.3470|8.347|||
3641658|NCT02513160|3488816|B2|||Body Mass Index||kg/m^2|Mean|31.315|31.315|Standard Deviation|8.1551|8.1551|||
3641659|NCT02513160|3488817|B1|||Body Mass Index||kg/m^2|Mean|29.909|29.909|Standard Deviation|8.4253|8.4253|||
3641660|NCT02513160|3488813|B5|||Height||cm|Mean|168.40|168.4|Standard Deviation|9.308|9.308|||
3641661|NCT02513160|3488814|B4|||Height||cm|Mean|169.14|169.14|Standard Deviation|8.770|8.77|||
3641662|NCT02513160|3488815|B3|||Height||cm|Mean|167.82|167.82|Standard Deviation|8.753|8.753|||
3641663|NCT02513160|3488816|B2|||Height||cm|Mean|169.30|169.3|Standard Deviation|9.457|9.457|||
3641664|NCT02513160|3488817|B1|||Height||cm|Mean|167.34|167.34|Standard Deviation|10.138|10.138|||
3641665|NCT02513160|3488813|B5|||Weight||kg|Mean|87.07|87.07|Standard Deviation|24.987|24.987|||
3641666|NCT02513160|3488814|B4|||Weight||kg|Mean|88.56|88.56|Standard Deviation|23.820|23.82|||
3641667|NCT02513160|3488815|B3|||Weight||kg|Mean|85.71|85.71|Standard Deviation|25.590|25.59|||
3641668|NCT02513160|3488816|B2|||Weight||kg|Mean|89.93|89.93|Standard Deviation|24.719|24.719|||
3641669|NCT02513160|3488817|B1|||Weight||kg|Mean|84.06|84.06|Standard Deviation|25.337|25.337|||
3641670|NCT02513160|3488813|B5|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|65|65.0||||||
3641671|NCT02513160|3488814|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3641672|NCT02513160|3488815|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3641673|NCT02513160|3488816|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3641674|NCT02513160|3488817|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3641675|NCT02513160|3488813|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|360|360.0||||||
3641676|NCT02513160|3488814|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|88|88.0||||||
3641677|NCT02513160|3488815|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|93|93.0||||||
3641678|NCT02513160|3488816|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|90|90.0||||||
3641679|NCT02513160|3488817|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|89|89.0||||||
3641680|NCT02513160|3488813|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3641681|NCT02513160|3488814|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3641682|NCT02513160|3488815|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3641683|NCT02513160|3488816|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3641684|NCT02513160|3488817|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3641685|NCT02513160|3488813|B5|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3641686|NCT02513160|3488814|B4|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3641687|NCT02513160|3488815|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3641688|NCT02513160|3488816|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3641689|NCT02513160|3488817|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3641690|NCT02513160|3488813|B5|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3641691|NCT02513160|3488814|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3641692|NCT02513160|3488815|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3641693|NCT02513160|3488816|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3641694|NCT02513160|3488817|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3641695|NCT02513160|3488813|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3641696|NCT02513160|3488814|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3641697|NCT02513160|3488815|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3641698|NCT02513160|3488816|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3641699|NCT02513160|3488817|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3641700|NCT02513160|3488813|B5|Black||Race/Ethnicity, Customized||Participants|Count of Participants|63|63.0||||||
3641701|NCT02513160|3488814|B4|Black||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3641702|NCT02513160|3488815|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3641703|NCT02513160|3488816|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3641704|NCT02513160|3488817|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3641705|NCT02513160|3488813|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|346|346.0||||||
3641706|NCT02513160|3488814|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|84|84.0||||||
3641707|NCT02513160|3488815|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|83|83.0||||||
3641708|NCT02513160|3488816|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|92|92.0||||||
3641709|NCT02513160|3488817|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|87|87.0||||||
3641710|NCT02513160|3488813|B5||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3641711|NCT02513160|3488814|B4||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3641712|NCT02513160|3488815|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3641713|NCT02513160|3488816|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3641714|NCT02513160|3488817|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3641715|NCT02513160|3488813|B5||Female|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
3641716|NCT02513160|3488814|B4||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3641717|NCT02513160|3488815|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3641718|NCT02513160|3488816|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3641719|NCT02513160|3488817|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3641720|NCT02513160|3488813|B5|>=65 years||Age, Customized||Participants|Count of Participants|26|26.0||||||
3641721|NCT02513160|3488814|B4|>=65 years||Age, Customized||Participants|Count of Participants|13|13.0||||||
3641722|NCT02513160|3488815|B3|>=65 years||Age, Customized||Participants|Count of Participants|7|7.0||||||
3641723|NCT02513160|3488816|B2|>=65 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
3641724|NCT02513160|3488817|B1|>=65 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3641725|NCT02513160|3488813|B5|18-64 years||Age, Customized||Participants|Count of Participants|378|378.0||||||
3641726|NCT02513160|3488814|B4|18-64 years||Age, Customized||Participants|Count of Participants|85|85.0||||||
3641727|NCT02513160|3488815|B3|18-64 years||Age, Customized||Participants|Count of Participants|94|94.0||||||
3641728|NCT02513160|3488816|B2|18-64 years||Age, Customized||Participants|Count of Participants|101|101.0||||||
3641729|NCT02513160|3488817|B1|18-64 years||Age, Customized||Participants|Count of Participants|98|98.0||||||
3641730|NCT02513160|3488813|B5|12-17 years||Age, Customized||Participants|Count of Participants|21|21.0||||||
3641731|NCT02513160|3488814|B4|12-17 years||Age, Customized||Participants|Count of Participants|7|7.0||||||
3641732|NCT02513160|3488815|B3|12-17 years||Age, Customized||Participants|Count of Participants|4|4.0||||||
3641733|NCT02513160|3488816|B2|12-17 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
3641734|NCT02513160|3488817|B1|12-17 years||Age, Customized||Participants|Count of Participants|8|8.0||||||
3641735|NCT02513160|3488813|B5|||Age||years|Mean|41.7|41.7|Standard Deviation|14.52|14.52|||
3641736|NCT02513160|3488814|B4|||Age||years|Mean|43.1|43.1|Standard Deviation|16.04|16.04|||
3641737|NCT02513160|3488815|B3|||Age||years|Mean|42.6|42.6|Standard Deviation|14.19|14.19|||
3641738|NCT02513160|3488816|B2|||Age||years|Mean|41.8|41.8|Standard Deviation|14.29|14.29|||
3641739|NCT02513160|3488817|B1|||Age||years|Mean|39.2|39.2|Standard Deviation|13.33|13.33|||
3641740|NCT02513095|3488855|B3|Syrian Arab Republic||Region of Enrollment||participants|Number|2|2.0||||||
3641741|NCT02513095|3488856|B2|Syrian Arab Republic||Region of Enrollment||participants|Number|0|0.0||||||
3641742|NCT02513095|3488857|B1|Syrian Arab Republic||Region of Enrollment||participants|Number|2|2.0||||||
3641743|NCT02513095|3488855|B3|Palestinian Territory, occupied||Region of Enrollment||participants|Number|1|1.0||||||
3641744|NCT02513095|3488856|B2|Palestinian Territory, occupied||Region of Enrollment||participants|Number|1|1.0||||||
3641745|NCT02513095|3488857|B1|Palestinian Territory, occupied||Region of Enrollment||participants|Number|0|0.0||||||
3641746|NCT02513095|3488855|B3|Nigeria||Region of Enrollment||participants|Number|1|1.0||||||
3641747|NCT02513095|3488856|B2|Nigeria||Region of Enrollment||participants|Number|1|1.0||||||
3641748|NCT02513095|3488857|B1|Nigeria||Region of Enrollment||participants|Number|0|0.0||||||
3641749|NCT02513095|3488855|B3|Morocco||Region of Enrollment||participants|Number|2|2.0||||||
3641750|NCT02513095|3488856|B2|Morocco||Region of Enrollment||participants|Number|0|0.0||||||
3641751|NCT02513095|3488857|B1|Morocco||Region of Enrollment||participants|Number|2|2.0||||||
3641752|NCT02513095|3488855|B3|Mauritius||Region of Enrollment||participants|Number|1|1.0||||||
3641753|NCT02513095|3488856|B2|Mauritius||Region of Enrollment||participants|Number|0|0.0||||||
3641754|NCT02513095|3488857|B1|Mauritius||Region of Enrollment||participants|Number|1|1.0||||||
3641755|NCT02513095|3488855|B3|Bangladesh||Region of Enrollment||participants|Number|1|1.0||||||
3641756|NCT02513095|3488856|B2|Bangladesh||Region of Enrollment||participants|Number|1|1.0||||||
3641757|NCT02513095|3488857|B1|Bangladesh||Region of Enrollment||participants|Number|0|0.0||||||
3641758|NCT02513095|3488855|B3|Algeria||Region of Enrollment||participants|Number|2|2.0||||||
3641759|NCT02513095|3488856|B2|Algeria||Region of Enrollment||participants|Number|1|1.0||||||
3641760|NCT02513095|3488857|B1|Algeria||Region of Enrollment||participants|Number|1|1.0||||||
3641761|NCT02513095|3488855|B3|Egypt||Region of Enrollment||participants|Number|9|9.0||||||
3641762|NCT02513095|3488856|B2|Egypt||Region of Enrollment||participants|Number|5|5.0||||||
3641763|NCT02513095|3488857|B1|Egypt||Region of Enrollment||participants|Number|4|4.0||||||
3641764|NCT02513095|3488855|B3|Indonesia||Region of Enrollment||participants|Number|3|3.0||||||
3641765|NCT02513095|3488856|B2|Indonesia||Region of Enrollment||participants|Number|1|1.0||||||
3641766|NCT02513095|3488857|B1|Indonesia||Region of Enrollment||participants|Number|2|2.0||||||
3641767|NCT02513095|3488855|B3|India||Region of Enrollment||participants|Number|5|5.0||||||
3641768|NCT02513095|3488856|B2|India||Region of Enrollment||participants|Number|3|3.0||||||
3641769|NCT02513095|3488857|B1|India||Region of Enrollment||participants|Number|2|2.0||||||
3641770|NCT02513095|3488855|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641771|NCT02513095|3488856|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641772|NCT02513095|3488857|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641773|NCT02513095|3488855|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3641774|NCT02513095|3488856|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3641775|NCT02513095|3488857|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3641776|NCT02513095|3488855|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3641777|NCT02513095|3488856|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3641778|NCT02513095|3488857|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3641779|NCT02513095|3488855|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3641780|NCT02513095|3488856|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3641781|NCT02513095|3488857|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3641782|NCT02513095|3488855|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641783|NCT02513095|3488856|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641784|NCT02513095|3488857|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641785|NCT02513095|3488855|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3641786|NCT02513095|3488856|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3641787|NCT02513095|3488857|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3641788|NCT02513095|3488855|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641789|NCT02513095|3488856|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641790|NCT02513095|3488857|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641791|NCT02513095|3488855|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3641792|NCT02513095|3488856|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3641793|NCT02513095|3488857|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3641794|NCT02513095|3488855|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3641795|NCT02513095|3488856|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3641796|NCT02513095|3488857|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3641797|NCT02513095|3488855|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3641798|NCT02513095|3488856|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3641799|NCT02513095|3488857|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3641800|NCT02513095|3488855|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3641801|NCT02513095|3488856|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3641802|NCT02513095|3488857|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3641803|NCT02513095|3488855|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3641804|NCT02513095|3488856|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3641805|NCT02513095|3488857|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3641806|NCT02512900|3488864|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3641807|NCT02512900|3488865|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3641808|NCT02512900|3488866|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3641809|NCT02512900|3488864|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3641810|NCT02512900|3488865|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3641811|NCT02512900|3488866|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3641812|NCT02512900|3488864|B3|||Age||Years|Mean|14.7|14.7|Standard Deviation|1.4|1.4|||
3641813|NCT02512900|3488865|B2|||Age||Years|Mean|15.9|15.9|Standard Deviation|0.7|0.7|||
3641814|NCT02512900|3488866|B1|||Age||Years|Mean|13.5|13.5|Standard Deviation|0.8|0.8|||
3641815|NCT02512874|3488898|B1|||Pulmonary Function - % Predicted|The % predicted represents the percent of the lung size that can be exhaled in one second.|percent|Median|49|49.0|Inter-Quartile Range|||39.0|66.0|
3641816|NCT02512874|3488898|B1|||Pulmonary Function - Forced expiratory volume|The forced expiratory volume in one second (FEV1) measurement shows the amount of air in liters a person can forcefully exhale in one second.|liters|Median|1.3|1.3|Inter-Quartile Range|||1.0|2.0|
3641817|NCT02512874|3488898|B1||Other|Primary Pulmonary Diagnosis||Participants|Count of Participants|5|5.0||||||
3641818|NCT02512874|3488898|B1||Interstitial Lung Disease|Primary Pulmonary Diagnosis||Participants|Count of Participants|10|10.0||||||
3641819|NCT02512874|3488898|B1||Post Lung Transplant|Primary Pulmonary Diagnosis||Participants|Count of Participants|13|13.0||||||
3641820|NCT02512874|3488898|B1||Obstructive|Primary Pulmonary Diagnosis||Participants|Count of Participants|35|35.0||||||
3641821|NCT02512874|3488898|B1|United States||Region of Enrollment||participants|Number|63|63.0||||||
3641822|NCT02512874|3488898|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3641823|NCT02512874|3488898|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641824|NCT02512874|3488898|B1||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3641825|NCT02512874|3488898|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641826|NCT02512874|3488898|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641827|NCT02512874|3488898|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641828|NCT02512874|3488898|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641829|NCT02512874|3488898|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3641830|NCT02512874|3488898|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3641831|NCT02512874|3488898|B1|||Age||years|Median|65|65.0|Inter-Quartile Range|||59.0|73.0|
3641968|NCT02512575|3488958|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3641832|NCT02512861|3488902|B3||Other|Comorbidities|"Any additional medical conditions that the patient had in addition to the cardiac defect were collected and categorized into the following:~Respiratory~Gastrointestinal~Genetic~Neurodevelopmental/Developmental Delay~Other"|Participants|Count of Participants|3|3.0||||||
3641833|NCT02512861|3488903|B2||Other|Comorbidities|"Any additional medical conditions that the patient had in addition to the cardiac defect were collected and categorized into the following:~Respiratory~Gastrointestinal~Genetic~Neurodevelopmental/Developmental Delay~Other"|Participants|Count of Participants|2|2.0||||||
3641834|NCT02512861|3488904|B1||Other|Comorbidities|"Any additional medical conditions that the patient had in addition to the cardiac defect were collected and categorized into the following:~Respiratory~Gastrointestinal~Genetic~Neurodevelopmental/Developmental Delay~Other"|Participants|Count of Participants|1|1.0||||||
3641835|NCT02512861|3488902|B3||None|Comorbidities|"Any additional medical conditions that the patient had in addition to the cardiac defect were collected and categorized into the following:~Respiratory~Gastrointestinal~Genetic~Neurodevelopmental/Developmental Delay~Other"|Participants|Count of Participants|49|49.0||||||
3641836|NCT02512861|3488903|B2||None|Comorbidities|"Any additional medical conditions that the patient had in addition to the cardiac defect were collected and categorized into the following:~Respiratory~Gastrointestinal~Genetic~Neurodevelopmental/Developmental Delay~Other"|Participants|Count of Participants|25|25.0||||||
3641837|NCT02512861|3488904|B1||None|Comorbidities|"Any additional medical conditions that the patient had in addition to the cardiac defect were collected and categorized into the following:~Respiratory~Gastrointestinal~Genetic~Neurodevelopmental/Developmental Delay~Other"|Participants|Count of Participants|24|24.0||||||
3641838|NCT02512861|3488902|B3||Neurodevelopmental/Developmental Delay|Comorbidities|"Any additional medical conditions that the patient had in addition to the cardiac defect were collected and categorized into the following:~Respiratory~Gastrointestinal~Genetic~Neurodevelopmental/Developmental Delay~Other"|Participants|Count of Participants|3|3.0||||||
3641839|NCT02512861|3488903|B2||Neurodevelopmental/Developmental Delay|Comorbidities|"Any additional medical conditions that the patient had in addition to the cardiac defect were collected and categorized into the following:~Respiratory~Gastrointestinal~Genetic~Neurodevelopmental/Developmental Delay~Other"|Participants|Count of Participants|2|2.0||||||
3641840|NCT02512861|3488904|B1||Neurodevelopmental/Developmental Delay|Comorbidities|"Any additional medical conditions that the patient had in addition to the cardiac defect were collected and categorized into the following:~Respiratory~Gastrointestinal~Genetic~Neurodevelopmental/Developmental Delay~Other"|Participants|Count of Participants|1|1.0||||||
3641841|NCT02512861|3488902|B3||Genetic|Comorbidities|"Any additional medical conditions that the patient had in addition to the cardiac defect were collected and categorized into the following:~Respiratory~Gastrointestinal~Genetic~Neurodevelopmental/Developmental Delay~Other"|Participants|Count of Participants|18|18.0||||||
3641842|NCT02512861|3488903|B2||Genetic|Comorbidities|"Any additional medical conditions that the patient had in addition to the cardiac defect were collected and categorized into the following:~Respiratory~Gastrointestinal~Genetic~Neurodevelopmental/Developmental Delay~Other"|Participants|Count of Participants|7|7.0||||||
3641843|NCT02512861|3488904|B1||Genetic|Comorbidities|"Any additional medical conditions that the patient had in addition to the cardiac defect were collected and categorized into the following:~Respiratory~Gastrointestinal~Genetic~Neurodevelopmental/Developmental Delay~Other"|Participants|Count of Participants|11|11.0||||||
3641844|NCT02512861|3488902|B3||Gastrointestinal|Comorbidities|"Any additional medical conditions that the patient had in addition to the cardiac defect were collected and categorized into the following:~Respiratory~Gastrointestinal~Genetic~Neurodevelopmental/Developmental Delay~Other"|Participants|Count of Participants|2|2.0||||||
3641845|NCT02512861|3488903|B2||Gastrointestinal|Comorbidities|"Any additional medical conditions that the patient had in addition to the cardiac defect were collected and categorized into the following:~Respiratory~Gastrointestinal~Genetic~Neurodevelopmental/Developmental Delay~Other"|Participants|Count of Participants|1|1.0||||||
3641846|NCT02512861|3488904|B1||Gastrointestinal|Comorbidities|"Any additional medical conditions that the patient had in addition to the cardiac defect were collected and categorized into the following:~Respiratory~Gastrointestinal~Genetic~Neurodevelopmental/Developmental Delay~Other"|Participants|Count of Participants|1|1.0||||||
3641847|NCT02512861|3488902|B3||Respiratory|Comorbidities|"Any additional medical conditions that the patient had in addition to the cardiac defect were collected and categorized into the following:~Respiratory~Gastrointestinal~Genetic~Neurodevelopmental/Developmental Delay~Other"|Participants|Count of Participants|3|3.0||||||
3641848|NCT02512861|3488903|B2||Respiratory|Comorbidities|"Any additional medical conditions that the patient had in addition to the cardiac defect were collected and categorized into the following:~Respiratory~Gastrointestinal~Genetic~Neurodevelopmental/Developmental Delay~Other"|Participants|Count of Participants|3|3.0||||||
3641849|NCT02512861|3488904|B1||Respiratory|Comorbidities|"Any additional medical conditions that the patient had in addition to the cardiac defect were collected and categorized into the following:~Respiratory~Gastrointestinal~Genetic~Neurodevelopmental/Developmental Delay~Other"|Participants|Count of Participants|0|0.0||||||
3641850|NCT02512861|3488902|B3|United States||Region of Enrollment||participants|Number|78|78.0||||||
3641851|NCT02512861|3488903|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
3641852|NCT02512861|3488904|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
3641853|NCT02512861|3488902|B3|Declined||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3641854|NCT02512861|3488903|B2|Declined||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3641855|NCT02512861|3488904|B1|Declined||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3641856|NCT02512861|3488902|B3|Bi-racial||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3641857|NCT02512861|3488903|B2|Bi-racial||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3641858|NCT02512861|3488904|B1|Bi-racial||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3641859|NCT02512861|3488902|B3|American Indian/Alaskan||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3641860|NCT02512861|3488903|B2|American Indian/Alaskan||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3641861|NCT02512861|3488904|B1|American Indian/Alaskan||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3641862|NCT02512861|3488902|B3|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3641863|NCT02512861|3488903|B2|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3641864|NCT02512861|3488904|B1|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3641865|NCT02512861|3488902|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3641866|NCT02512861|3488903|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3641867|NCT02512861|3488904|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3641868|NCT02512861|3488902|B3|White/Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|56|56.0||||||
3641869|NCT02512861|3488903|B2|White/Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3641870|NCT02512861|3488904|B1|White/Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3641871|NCT02512861|3488902|B3|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3641872|NCT02512861|3488903|B2|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3641873|NCT02512861|3488904|B1|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3641874|NCT02512861|3488902|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3641875|NCT02512861|3488903|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3641876|NCT02512861|3488904|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3641877|NCT02512861|3488902|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3641878|NCT02512861|3488903|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3641879|NCT02512861|3488904|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3641880|NCT02512861|3488902|B3|||Age||years|Median|0.84|0.84|Inter-Quartile Range|||0.0|3.0|
3641881|NCT02512861|3488903|B2|||Age||years|Median|0.8|0.8|Inter-Quartile Range|||0.4|3.7|
3641882|NCT02512861|3488904|B1|||Age||years|Median|1|1.0|Inter-Quartile Range|||0.4|3.3|
3641883|NCT02512809|3488923|B4|ASA 2||American Society of Anesthesiologists (ASA) Physical Status classification|"ASA 1: Normal healthy patient~ASA 2: Patients with mild systemic disease~ASA 3: Patients with severe systemic disease~ASA 4: Patients with severe systemic disease that is a constant threat to life~ASA 5: Moribund patients who are not expected to survive without the operation~ASA 6: A declared brain-dead patient whose organs are being removed for donor purposes"|Participants|Count of Participants|17|17.0||||||
3641884|NCT02512809|3488924|B3|ASA 2||American Society of Anesthesiologists (ASA) Physical Status classification|"ASA 1: Normal healthy patient~ASA 2: Patients with mild systemic disease~ASA 3: Patients with severe systemic disease~ASA 4: Patients with severe systemic disease that is a constant threat to life~ASA 5: Moribund patients who are not expected to survive without the operation~ASA 6: A declared brain-dead patient whose organs are being removed for donor purposes"|Participants|Count of Participants|17|17.0||||||
3641885|NCT02512809|3488923|B4|ASA 1||American Society of Anesthesiologists (ASA) Physical Status classification|"ASA 1: Normal healthy patient~ASA 2: Patients with mild systemic disease~ASA 3: Patients with severe systemic disease~ASA 4: Patients with severe systemic disease that is a constant threat to life~ASA 5: Moribund patients who are not expected to survive without the operation~ASA 6: A declared brain-dead patient whose organs are being removed for donor purposes"|Participants|Count of Participants|8|8.0||||||
3641886|NCT02512809|3488924|B3|ASA 1||American Society of Anesthesiologists (ASA) Physical Status classification|"ASA 1: Normal healthy patient~ASA 2: Patients with mild systemic disease~ASA 3: Patients with severe systemic disease~ASA 4: Patients with severe systemic disease that is a constant threat to life~ASA 5: Moribund patients who are not expected to survive without the operation~ASA 6: A declared brain-dead patient whose organs are being removed for donor purposes"|Participants|Count of Participants|8|8.0||||||
3641887|NCT02512809|3488923|B4|No||Previous Anesthesia||Participants|Count of Participants|13|13.0||||||
3641888|NCT02512809|3488924|B3|No||Previous Anesthesia||Participants|Count of Participants|13|13.0||||||
3641889|NCT02512809|3488923|B4|Yes||Previous Anesthesia||Participants|Count of Participants|12|12.0||||||
3641890|NCT02512809|3488924|B3|Yes||Previous Anesthesia||Participants|Count of Participants|12|12.0||||||
3641891|NCT02512809|3488923|B4|||Anesthetic Time||minutes|Mean|54.7|54.7|Standard Deviation|24.7|24.7|||
3641892|NCT02512809|3488924|B3|||Anesthetic Time||minutes|Mean|54.7|54.7|Standard Deviation|24.7|24.7|||
3641893|NCT02512809|3488923|B4|||Weight||kilograms|Mean|17.4|17.4|Standard Deviation|8.3|8.3|||
3641894|NCT02512809|3488924|B3|||Weight||kilograms|Mean|17.4|17.4|Standard Deviation|8.3|8.3|||
3641895|NCT02512809|3488923|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641896|NCT02512809|3488924|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641897|NCT02512809|3488923|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641898|NCT02512809|3488924|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641899|NCT02512809|3488923|B4||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3641900|NCT02512809|3488924|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3641901|NCT02512809|3488923|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3641902|NCT02512809|3488924|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3641903|NCT02512809|3488923|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641904|NCT02512809|3488924|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641905|NCT02512809|3488923|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3641906|NCT02512809|3488924|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3641907|NCT02512809|3488923|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641908|NCT02512809|3488924|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3641909|NCT02512809|3488923|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3641910|NCT02512809|3488924|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3641911|NCT02512809|3488923|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3641912|NCT02512809|3488924|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3641913|NCT02512809|3488923|B4|||Age||years|Mean|3.73|3.73|Standard Deviation|2.49|2.49|||
3641914|NCT02512809|3488924|B3|||Age||years|Mean|3.73|3.73|Standard Deviation|2.49|2.49|||
3641915|NCT02512809|3488923|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3641916|NCT02512809|3488924|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3641917|NCT02512809|3488925|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3641918|NCT02512809|3488926|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3641919|NCT02512809|3488923|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3641920|NCT02512809|3488924|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3641921|NCT02512809|3488925|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3641922|NCT02512809|3488926|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3641923|NCT02512809|3488923|B4||<=18 years|Age||Participants|Count of Participants|25|25.0||||||
3641924|NCT02512809|3488924|B3||<=18 years|Age||Participants|Count of Participants|25|25.0||||||
3641925|NCT02512809|3488925|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3641926|NCT02512809|3488926|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3641927|NCT02512783|3488930|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3641928|NCT02512783|3488931|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3641929|NCT02512783|3488932|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3641930|NCT02512783|3488930|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3641931|NCT02512783|3488931|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3641932|NCT02512783|3488932|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3641933|NCT02512783|3488930|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3641934|NCT02512783|3488931|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3641935|NCT02512783|3488932|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3641936|NCT02512783|3488930|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3641937|NCT02512783|3488931|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3641938|NCT02512783|3488932|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3641939|NCT02512783|3488930|B3||<=18 years|Age||Participants|Count of Participants|171|171.0||||||
3641940|NCT02512783|3488931|B2||<=18 years|Age||Participants|Count of Participants|75|75.0||||||
3641941|NCT02512783|3488932|B1||<=18 years|Age||Participants|Count of Participants|96|96.0||||||
3641942|NCT02512679|3488941|B1|United States||Region of Enrollment|Enrollment of participants was conducted in California.|participants|Number|20|20.0||||||
3641943|NCT02512679|3488941|B1||Male|Gender||Participants|Count of Participants|7|7.0||||||
3641944|NCT02512679|3488941|B1||Female|Gender||Participants|Count of Participants|13|13.0||||||
3641945|NCT02512679|3488941|B1|||Age|Deviation from study protocol - enrollment of 26-year-old subject with pediatric disease. Subject's data included in outcome measurements/analysis.|years|Median|2.3|2.3|Full Range|||0.4|26.0|
3641946|NCT02512679|3488941|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3641947|NCT02512679|3488941|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3641948|NCT02512679|3488941|B1||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
3641949|NCT02512575|3488950|B11||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3641950|NCT02512575|3488951|B10||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3641951|NCT02512575|3488952|B9||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3641952|NCT02512575|3488953|B8||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3641953|NCT02512575|3488954|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3641954|NCT02512575|3488955|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3641955|NCT02512575|3488956|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3641956|NCT02512575|3488957|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3641957|NCT02512575|3488958|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3641958|NCT02512575|3488959|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3641959|NCT02512575|3488960|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3641960|NCT02512575|3488950|B11||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3641961|NCT02512575|3488951|B10||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3641962|NCT02512575|3488952|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3641963|NCT02512575|3488953|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3641964|NCT02512575|3488954|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3641965|NCT02512575|3488955|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3641966|NCT02512575|3488956|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3641967|NCT02512575|3488957|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3641969|NCT02512575|3488959|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3641970|NCT02512575|3488960|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3641971|NCT02512575|3488950|B11|Pooled Placebo||Age||Years|Mean|37|37.0|Standard Deviation|11|11.0|||
3641972|NCT02512575|3488951|B10|Pooled Placebo||Age||Years|Mean|37|37.0|Standard Deviation|11|11.0|||
3641973|NCT02512575|3488952|B9|Pooled Placebo||Age||Years|Mean|0|0.0|Standard Deviation|0|0.0|||
3641974|NCT02512575|3488953|B8|Pooled Placebo||Age||Years|Mean|0|0.0|Standard Deviation|0|0.0|||
3641975|NCT02512575|3488954|B7|Pooled Placebo||Age||Years|Mean|0|0.0|Standard Deviation|0|0.0|||
3641976|NCT02512575|3488955|B6|Pooled Placebo||Age||Years|Mean|0|0.0|Standard Deviation|0|0.0|||
3641977|NCT02512575|3488956|B5|Pooled Placebo||Age||Years|Mean|0|0.0|Standard Deviation|0|0.0|||
3641978|NCT02512575|3488957|B4|Pooled Placebo||Age||Years|Mean|0|0.0|Standard Deviation|0|0.0|||
3641979|NCT02512575|3488958|B3|Pooled Placebo||Age||Years|Mean|0|0.0|Standard Deviation|0|0.0|||
3641980|NCT02512575|3488959|B2|Pooled Placebo||Age||Years|Mean|0|0.0|Standard Deviation|0|0.0|||
3641981|NCT02512575|3488960|B1|Pooled Placebo||Age||Years|Mean|0|0.0|Standard Deviation|0|0.0|||
3641982|NCT02512575|3488950|B11|Cohort 9 Prenisolone||Age||Years|Mean|36|36.0|Standard Deviation|9|9.0|||
3641983|NCT02512575|3488951|B10|Cohort 9 Prenisolone||Age||Years|Mean|0|0.0|Standard Deviation|0|0.0|||
3641984|NCT02512575|3488952|B9|Cohort 9 Prenisolone||Age||Years|Mean|36|36.0|Standard Deviation|9|9.0|||
3641985|NCT02512575|3488953|B8|Cohort 9 Prenisolone||Age||Years|Mean|0|0.0|Standard Deviation|0|0.0|||
3641986|NCT02512575|3488954|B7|Cohort 9 Prenisolone||Age||Years|Mean|0|0.0|Standard Deviation|0|0.0|||
3641987|NCT02512575|3488955|B6|Cohort 9 Prenisolone||Age||Years|Mean|0|0.0|Standard Deviation|0|0.0|||
3641988|NCT02512575|3488956|B5|Cohort 9 Prenisolone||Age||Years|Mean|0|0.0|Standard Deviation|0|0.0|||
3641989|NCT02512575|3488957|B4|Cohort 9 Prenisolone||Age||Years|Mean|0|0.0|Standard Deviation|0|0.0|||
3641990|NCT02512575|3488958|B3|Cohort 9 Prenisolone||Age||Years|Mean|0|0.0|Standard Deviation|0|0.0|||
3641991|NCT02512575|3488959|B2|Cohort 9 Prenisolone||Age||Years|Mean|0|0.0|Standard Deviation|0|0.0|||
3641992|NCT02512575|3488960|B1|Cohort 9 Prenisolone||Age||Years|Mean|0|0.0|Standard Deviation|0|0.0|||
3641993|NCT02512575|3488950|B11|Cohort 1-8 AZD9567||Age||Years|Mean|37|37.0|Standard Deviation|10|10.0|||
3641994|NCT02512575|3488951|B10|Cohort 1-8 AZD9567||Age||Years|Mean|0|0.0|Standard Deviation|0|0.0|||
3641995|NCT02512575|3488952|B9|Cohort 1-8 AZD9567||Age||Years|Mean|0|0.0|Standard Deviation|0|0.0|||
3641996|NCT02512575|3488953|B8|Cohort 1-8 AZD9567||Age||Years|Mean|32|32.0|Standard Deviation|8|8.0|||
3641997|NCT02512575|3488954|B7|Cohort 1-8 AZD9567||Age||Years|Mean|41|41.0|Standard Deviation|8|8.0|||
3641998|NCT02512575|3488955|B6|Cohort 1-8 AZD9567||Age||Years|Mean|34|34.0|Standard Deviation|9|9.0|||
3641999|NCT02512575|3488956|B5|Cohort 1-8 AZD9567||Age||Years|Mean|38|38.0|Standard Deviation|12|12.0|||
3642000|NCT02512575|3488957|B4|Cohort 1-8 AZD9567||Age||Years|Mean|35|35.0|Standard Deviation|9|9.0|||
3642001|NCT02512575|3488958|B3|Cohort 1-8 AZD9567||Age||Years|Mean|35|35.0|Standard Deviation|8|8.0|||
3642002|NCT02512575|3488959|B2|Cohort 1-8 AZD9567||Age||Years|Mean|35|35.0|Standard Deviation|14|14.0|||
3642003|NCT02512575|3488960|B1|Cohort 1-8 AZD9567||Age||Years|Mean|44|44.0|Standard Deviation|10|10.0|||
3642004|NCT02512510|3489061|B4|Former Smoker||Smoking Status||Participants|Count of Participants|324|324.0||||||
3642005|NCT02512510|3489062|B3|Former Smoker||Smoking Status||Participants|Count of Participants|113|113.0||||||
3642006|NCT02512510|3489063|B2|Former Smoker||Smoking Status||Participants|Count of Participants|103|103.0||||||
3642007|NCT02512510|3489064|B1|Former Smoker||Smoking Status||Participants|Count of Participants|108|108.0||||||
3642008|NCT02512510|3489061|B4|Current Smoker||Smoking Status||Participants|Count of Participants|286|286.0||||||
3642009|NCT02512510|3489062|B3|Current Smoker||Smoking Status||Participants|Count of Participants|95|95.0||||||
3642010|NCT02512510|3489063|B2|Current Smoker||Smoking Status||Participants|Count of Participants|94|94.0||||||
3642011|NCT02512510|3489064|B1|Current Smoker||Smoking Status||Participants|Count of Participants|97|97.0||||||
3642012|NCT02512510|3489061|B4|United States||Region of Enrollment||participants|Number|610|610.0||||||
3642013|NCT02512510|3489062|B3|United States||Region of Enrollment||participants|Number|208|208.0||||||
3642014|NCT02512510|3489063|B2|United States||Region of Enrollment||participants|Number|197|197.0||||||
3642015|NCT02512510|3489064|B1|United States||Region of Enrollment||participants|Number|205|205.0||||||
3642016|NCT02512510|3489061|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642017|NCT02512510|3489062|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642018|NCT02512510|3489063|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642019|NCT02512510|3489064|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642020|NCT02512510|3489061|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3642021|NCT02512510|3489062|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642022|NCT02512510|3489063|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3642023|NCT02512510|3489064|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3642024|NCT02512510|3489061|B4||White|Race (NIH/OMB)||Participants|Count of Participants|545|545.0||||||
3642025|NCT02512510|3489062|B3||White|Race (NIH/OMB)||Participants|Count of Participants|188|188.0||||||
3642026|NCT02512510|3489063|B2||White|Race (NIH/OMB)||Participants|Count of Participants|171|171.0||||||
3642027|NCT02512510|3489064|B1||White|Race (NIH/OMB)||Participants|Count of Participants|186|186.0||||||
3642028|NCT02512510|3489061|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3642087|NCT02512393|3489090|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3642029|NCT02512510|3489062|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3642030|NCT02512510|3489063|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3642031|NCT02512510|3489064|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3642032|NCT02512510|3489061|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642033|NCT02512510|3489062|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642034|NCT02512510|3489063|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642035|NCT02512510|3489064|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642036|NCT02512510|3489061|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3642037|NCT02512510|3489062|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642038|NCT02512510|3489063|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3642039|NCT02512510|3489064|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3642040|NCT02512510|3489061|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3642041|NCT02512510|3489062|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642042|NCT02512510|3489063|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3642043|NCT02512510|3489064|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642044|NCT02512510|3489061|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3642045|NCT02512510|3489062|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3642046|NCT02512510|3489063|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3642047|NCT02512510|3489064|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642048|NCT02512510|3489061|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|568|568.0||||||
3642049|NCT02512510|3489062|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|194|194.0||||||
3642050|NCT02512510|3489063|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|186|186.0||||||
3642051|NCT02512510|3489064|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|188|188.0||||||
3642052|NCT02512510|3489061|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3642053|NCT02512510|3489062|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3642054|NCT02512510|3489063|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3642055|NCT02512510|3489064|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3642056|NCT02512510|3489061|B4||Male|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
3642057|NCT02512510|3489062|B3||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3642058|NCT02512510|3489063|B2||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3642059|NCT02512510|3489064|B1||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3642060|NCT02512510|3489061|B4||Female|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
3642061|NCT02512510|3489062|B3||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3642062|NCT02512510|3489063|B2||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3642063|NCT02512510|3489064|B1||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3642064|NCT02512510|3489061|B4|||Age||years|Mean|63.4|63.4|Standard Deviation|8.95|8.95|||
3642065|NCT02512510|3489062|B3|||Age||years|Mean|63.5|63.5|Standard Deviation|8.91|8.91|||
3642066|NCT02512510|3489063|B2|||Age||years|Mean|63.6|63.6|Standard Deviation|9.19|9.19|||
3642067|NCT02512510|3489064|B1|||Age||years|Mean|63.1|63.1|Standard Deviation|8.81|8.81|||
3642068|NCT02512510|3489061|B4||>=65 years|Age||Participants|Count of Participants|268|268.0||||||
3642069|NCT02512510|3489062|B3||>=65 years|Age||Participants|Count of Participants|93|93.0||||||
3642070|NCT02512510|3489063|B2||>=65 years|Age||Participants|Count of Participants|91|91.0||||||
3642071|NCT02512510|3489064|B1||>=65 years|Age||Participants|Count of Participants|84|84.0||||||
3642072|NCT02512510|3489061|B4||Between 18 and 65 years|Age||Participants|Count of Participants|342|342.0||||||
3642073|NCT02512510|3489062|B3||Between 18 and 65 years|Age||Participants|Count of Participants|115|115.0||||||
3642074|NCT02512510|3489063|B2||Between 18 and 65 years|Age||Participants|Count of Participants|106|106.0||||||
3642075|NCT02512510|3489064|B1||Between 18 and 65 years|Age||Participants|Count of Participants|121|121.0||||||
3642076|NCT02512510|3489061|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642077|NCT02512510|3489062|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642078|NCT02512510|3489063|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642079|NCT02512510|3489064|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642080|NCT02512393|3489089|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3642081|NCT02512393|3489090|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3642082|NCT02512393|3489091|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3642083|NCT02512393|3489089|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3642084|NCT02512393|3489090|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3642085|NCT02512393|3489091|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3642086|NCT02512393|3489089|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3642088|NCT02512393|3489091|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3642089|NCT02512393|3489089|B3|||Age||years|Mean|59.95|59.95|Standard Deviation|9.2|9.2|||
3642090|NCT02512393|3489090|B2|||Age||years|Mean|59.30|59.3|Standard Deviation|8.60|8.6|||
3642091|NCT02512393|3489091|B1|||Age||years|Mean|60.60|60.6|Standard Deviation|9.80|9.8|||
3642092|NCT02512302|3489172|B1|United Kingdom||Region of Enrollment||participants|Number|30|30.0||||||
3642093|NCT02512302|3489172|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642094|NCT02512302|3489172|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642095|NCT02512302|3489172|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3642096|NCT02512302|3489172|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642097|NCT02512302|3489172|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642098|NCT02512302|3489172|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3642099|NCT02512302|3489172|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642100|NCT02512302|3489172|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642101|NCT02512302|3489172|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3642102|NCT02512302|3489172|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642103|NCT02512302|3489172|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3642104|NCT02512302|3489172|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3642105|NCT02512302|3489172|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3642106|NCT02512302|3489172|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3642107|NCT02512302|3489172|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642108|NCT02512224|3489253|B3|Japan||Region of Enrollment||participants|Number|5824|5824.0||||||
3642109|NCT02512224|3489254|B2|Japan||Region of Enrollment||participants|Number|2912|2912.0||||||
3642110|NCT02512224|3489255|B1|Japan||Region of Enrollment||participants|Number|2912|2912.0||||||
3642111|NCT02512224|3489253|B3||Male|Sex: Female, Male||Participants|Count of Participants|2927|2927.0||||||
3642112|NCT02512224|3489254|B2||Male|Sex: Female, Male||Participants|Count of Participants|1475|1475.0||||||
3642113|NCT02512224|3489255|B1||Male|Sex: Female, Male||Participants|Count of Participants|1452|1452.0||||||
3642114|NCT02512224|3489253|B3||Female|Sex: Female, Male||Participants|Count of Participants|2897|2897.0||||||
3642115|NCT02512224|3489254|B2||Female|Sex: Female, Male||Participants|Count of Participants|1437|1437.0||||||
3642116|NCT02512224|3489255|B1||Female|Sex: Female, Male||Participants|Count of Participants|1460|1460.0||||||
3642117|NCT02512224|3489253|B3|||Age||years|Mean|78.62|78.62|Standard Deviation|13.824|13.824|||
3642118|NCT02512224|3489254|B2|||Age||years|Mean|78.81|78.81|Standard Deviation|13.558|13.558|||
3642119|NCT02512224|3489255|B1|||Age||years|Mean|78.43|78.43|Standard Deviation|14.086|14.086|||
3642120|NCT02512224|3489253|B3||>=65 years|Age||Participants|Count of Participants|5080|5080.0||||||
3642121|NCT02512224|3489254|B2||>=65 years|Age||Participants|Count of Participants|2558|2558.0||||||
3642122|NCT02512224|3489255|B1||>=65 years|Age||Participants|Count of Participants|2522|2522.0||||||
3642123|NCT02512224|3489253|B3||Between 18 and 65 years|Age||Participants|Count of Participants|744|744.0||||||
3642124|NCT02512224|3489254|B2||Between 18 and 65 years|Age||Participants|Count of Participants|354|354.0||||||
3642125|NCT02512224|3489255|B1||Between 18 and 65 years|Age||Participants|Count of Participants|390|390.0||||||
3642126|NCT02512224|3489253|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642127|NCT02512224|3489254|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642128|NCT02512224|3489255|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642129|NCT02512094|3489272|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3642130|NCT02512094|3489272|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3642131|NCT02512094|3489272|B1|||Age||years|Mean|77.3|77.3|Standard Deviation|8.1|8.1|||
3642132|NCT02511782|3489276|B4||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3642133|NCT02511782|3489277|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3642134|NCT02511782|3489278|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3642135|NCT02511782|3489279|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3642136|NCT02511782|3489276|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3642137|NCT02511782|3489277|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3642138|NCT02511782|3489278|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3642139|NCT02511782|3489279|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3642140|NCT02511782|3489276|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3642141|NCT02511782|3489277|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3642142|NCT02511782|3489278|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3642143|NCT02511782|3489279|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3642144|NCT02511782|3489276|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3642145|NCT02511782|3489277|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3642146|NCT02511782|3489278|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3642147|NCT02511782|3489279|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3642148|NCT02511782|3489276|B4||<=18 years|Age||Participants|Count of Participants|63|63.0||||||
3642149|NCT02511782|3489277|B3||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
3642150|NCT02511782|3489278|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3642151|NCT02511782|3489279|B1||<=18 years|Age||Participants|Count of Participants|51|51.0||||||
3642152|NCT02511587|3489291|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3642153|NCT02511587|3489292|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3642154|NCT02511587|3489293|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3642155|NCT02511587|3489291|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3642156|NCT02511587|3489292|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3642157|NCT02511587|3489293|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3642158|NCT02511587|3489291|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3642159|NCT02511587|3489292|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3642160|NCT02511587|3489293|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3642161|NCT02511587|3489291|B3||Between 18 and 65 years|Age||Participants|Count of Participants|116|116.0||||||
3642162|NCT02511587|3489292|B2||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3642163|NCT02511587|3489293|B1||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3642164|NCT02511587|3489291|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642165|NCT02511587|3489292|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642166|NCT02511587|3489293|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642167|NCT02511431|3489304|B7|White||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3642168|NCT02511431|3489305|B6|White||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3642169|NCT02511431|3489306|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3642170|NCT02511431|3489307|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3642171|NCT02511431|3489308|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3642172|NCT02511431|3489309|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3642173|NCT02511431|3489310|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3642174|NCT02511431|3489304|B7|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3642175|NCT02511431|3489305|B6|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3642176|NCT02511431|3489306|B5|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3642177|NCT02511431|3489307|B4|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3642178|NCT02511431|3489308|B3|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3642179|NCT02511431|3489309|B2|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3642180|NCT02511431|3489310|B1|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3642181|NCT02511431|3489304|B7|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3642182|NCT02511431|3489305|B6|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3642183|NCT02511431|3489306|B5|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3642184|NCT02511431|3489307|B4|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3642185|NCT02511431|3489308|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3642186|NCT02511431|3489309|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3642187|NCT02511431|3489310|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3642188|NCT02511431|3489304|B7|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3642189|NCT02511431|3489305|B6|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3642190|NCT02511431|3489306|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3642191|NCT02511431|3489307|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3642192|NCT02511431|3489308|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3642193|NCT02511431|3489309|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3642194|NCT02511431|3489310|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3642195|NCT02511431|3489304|B7||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3642196|NCT02511431|3489305|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3642197|NCT02511431|3489306|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3642198|NCT02511431|3489307|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3642199|NCT02511431|3489308|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3642200|NCT02511431|3489309|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3642201|NCT02511431|3489310|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3642202|NCT02511431|3489304|B7||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3642203|NCT02511431|3489305|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3642204|NCT02511431|3489306|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3642205|NCT02511431|3489307|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3642206|NCT02511431|3489308|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3642207|NCT02511431|3489309|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3642208|NCT02511431|3489310|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3642209|NCT02511431|3489304|B7|||Age||years|Median|45|45.0|Full Range|||22.0|66.0|
3642210|NCT02511431|3489305|B6|||Age||years|Median|45|45.0|Full Range|||33.0|47.0|
3642211|NCT02511431|3489306|B5|||Age||years|Median|52|52.0|Full Range|||47.0|54.0|
3642212|NCT02511431|3489307|B4|||Age||years|Median|39|39.0|Full Range|||30.0|53.0|
3642213|NCT02511431|3489308|B3|||Age||years|Median|40.5|40.5|Full Range|||31.0|45.0|
3642214|NCT02511431|3489309|B2|||Age||years|Median|43.5|43.5|Full Range|||22.0|53.0|
3642215|NCT02511431|3489310|B1|||Age||years|Median|48|48.0|Full Range|||34.0|66.0|
3642216|NCT02511379|3489336|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3642217|NCT02511379|3489336|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3642218|NCT02511379|3489336|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3642219|NCT02511379|3489336|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3642220|NCT02511379|3489336|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642221|NCT02510820|3489340|B1|United Kingdom||Region of Enrollment||participants|Number|51|51.0||||||
3642222|NCT02510820|3489340|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3642223|NCT02510820|3489340|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3642224|NCT02510820|3489340|B1|||Age||years|Mean|33.3|33.3|Standard Deviation|10.9|10.9|||
3642225|NCT02510014|3489379|B3||Current|Alcohol use||Participants|Count of Participants|337|337.0||||||
3642226|NCT02510014|3489380|B2||Current|Alcohol use||Participants|Count of Participants|144|144.0||||||
3642227|NCT02510014|3489381|B1||Current|Alcohol use||Participants|Count of Participants|193|193.0||||||
3642228|NCT02510014|3489379|B3||Former|Alcohol use||Participants|Count of Participants|162|162.0||||||
3642229|NCT02510014|3489380|B2||Former|Alcohol use||Participants|Count of Participants|65|65.0||||||
3642230|NCT02510014|3489381|B1||Former|Alcohol use||Participants|Count of Participants|97|97.0||||||
3642231|NCT02510014|3489379|B3||Never|Alcohol use||Participants|Count of Participants|170|170.0||||||
3642232|NCT02510014|3489380|B2||Never|Alcohol use||Participants|Count of Participants|48|48.0||||||
3642233|NCT02510014|3489381|B1||Never|Alcohol use||Participants|Count of Participants|122|122.0||||||
3642234|NCT02510014|3489379|B3||Missing data|Caffeine use||Participants|Count of Participants|1|1.0||||||
3642235|NCT02510014|3489380|B2||Missing data|Caffeine use||Participants|Count of Participants|0|0.0||||||
3642236|NCT02510014|3489381|B1||Missing data|Caffeine use||Participants|Count of Participants|1|1.0||||||
3642237|NCT02510014|3489379|B3||Current|Caffeine use||Participants|Count of Participants|594|594.0||||||
3642238|NCT02510014|3489380|B2||Current|Caffeine use||Participants|Count of Participants|229|229.0||||||
3642239|NCT02510014|3489381|B1||Current|Caffeine use||Participants|Count of Participants|365|365.0||||||
3642240|NCT02510014|3489379|B3||Former|Caffeine use||Participants|Count of Participants|20|20.0||||||
3642241|NCT02510014|3489380|B2||Former|Caffeine use||Participants|Count of Participants|7|7.0||||||
3642242|NCT02510014|3489381|B1||Former|Caffeine use||Participants|Count of Participants|13|13.0||||||
3642243|NCT02510014|3489379|B3||Never|Caffeine use||Participants|Count of Participants|54|54.0||||||
3642244|NCT02510014|3489380|B2||Never|Caffeine use||Participants|Count of Participants|21|21.0||||||
3642245|NCT02510014|3489381|B1||Never|Caffeine use||Participants|Count of Participants|33|33.0||||||
3642246|NCT02510014|3489379|B3||Current|Tobacco use||Participants|Count of Participants|576|576.0||||||
3642247|NCT02510014|3489380|B2||Current|Tobacco use||Participants|Count of Participants|222|222.0||||||
3642248|NCT02510014|3489381|B1||Current|Tobacco use||Participants|Count of Participants|354|354.0||||||
3642249|NCT02510014|3489379|B3||Former|Tobacco use||Participants|Count of Participants|30|30.0||||||
3642250|NCT02510014|3489380|B2||Former|Tobacco use||Participants|Count of Participants|12|12.0||||||
3642251|NCT02510014|3489381|B1||Former|Tobacco use||Participants|Count of Participants|18|18.0||||||
3642252|NCT02510014|3489379|B3||Never|Tobacco use||Participants|Count of Participants|63|63.0||||||
3642253|NCT02510014|3489380|B2||Never|Tobacco use||Participants|Count of Participants|23|23.0||||||
3642254|NCT02510014|3489381|B1||Never|Tobacco use||Participants|Count of Participants|40|40.0||||||
3642255|NCT02510014|3489379|B3|||Body Mass Index||kg/m^2|Mean|25.67|25.67|Standard Deviation|4.613|4.613|||
3642256|NCT02510014|3489380|B2|||Body Mass Index||kg/m^2|Mean|26.14|26.14|Standard Deviation|5.067|5.067|||
3642257|NCT02510014|3489381|B1|||Body Mass Index||kg/m^2|Mean|25.38|25.38|Standard Deviation|4.286|4.286|||
3642258|NCT02510014|3489379|B3|||Waist-to-Hip Ratio|Waist-to-hip ratio is the ratio of the waist circumference to hip circumference (calculated by dividing the waist circumference by the hip circumference). It is a measurement of abdominal fat distribution.|ratio|Mean|0.90|0.9|Standard Deviation|0.085|0.085|||
3642259|NCT02510014|3489380|B2|||Waist-to-Hip Ratio|Waist-to-hip ratio is the ratio of the waist circumference to hip circumference (calculated by dividing the waist circumference by the hip circumference). It is a measurement of abdominal fat distribution.|ratio|Mean|0.90|0.9|Standard Deviation|0.083|0.083|||
3642260|NCT02510014|3489381|B1|||Waist-to-Hip Ratio|Waist-to-hip ratio is the ratio of the waist circumference to hip circumference (calculated by dividing the waist circumference by the hip circumference). It is a measurement of abdominal fat distribution.|ratio|Mean|0.91|0.91|Standard Deviation|0.086|0.086|||
3642261|NCT02510014|3489379|B3|||Weight||kg|Mean|76.62|76.62|Standard Deviation|16.117|16.117|||
3642262|NCT02510014|3489380|B2|||Weight||kg|Mean|78.43|78.43|Standard Deviation|18.097|18.097|||
3642263|NCT02510014|3489381|B1|||Weight||kg|Mean|75.49|75.49|Standard Deviation|14.658|14.658|||
3642264|NCT02510014|3489379|B3||Other|Race||Participants|Count of Participants|4|4.0||||||
3642265|NCT02510014|3489380|B2||Other|Race||Participants|Count of Participants|0|0.0||||||
3642266|NCT02510014|3489381|B1||Other|Race||Participants|Count of Participants|4|4.0||||||
3642267|NCT02510014|3489379|B3||Multiple|Race||Participants|Count of Participants|4|4.0||||||
3642268|NCT02510014|3489380|B2||Multiple|Race||Participants|Count of Participants|2|2.0||||||
3642269|NCT02510014|3489381|B1||Multiple|Race||Participants|Count of Participants|2|2.0||||||
3642270|NCT02510014|3489379|B3||Asian|Race||Participants|Count of Participants|2|2.0||||||
3642271|NCT02510014|3489380|B2||Asian|Race||Participants|Count of Participants|0|0.0||||||
3642272|NCT02510014|3489381|B1||Asian|Race||Participants|Count of Participants|2|2.0||||||
3642273|NCT02510014|3489379|B3||American Indian or Alaska Native|Race||Participants|Count of Participants|4|4.0||||||
3642274|NCT02510014|3489380|B2||American Indian or Alaska Native|Race||Participants|Count of Participants|2|2.0||||||
3642275|NCT02510014|3489381|B1||American Indian or Alaska Native|Race||Participants|Count of Participants|2|2.0||||||
3642276|NCT02510014|3489379|B3||Native Hawaiian or Other Pacific Islander|Race||Participants|Count of Participants|1|1.0||||||
3642277|NCT02510014|3489380|B2||Native Hawaiian or Other Pacific Islander|Race||Participants|Count of Participants|1|1.0||||||
3642278|NCT02510014|3489381|B1||Native Hawaiian or Other Pacific Islander|Race||Participants|Count of Participants|0|0.0||||||
3642279|NCT02510014|3489379|B3||Black or African American|Race||Participants|Count of Participants|192|192.0||||||
3642280|NCT02510014|3489380|B2||Black or African American|Race||Participants|Count of Participants|85|85.0||||||
3642281|NCT02510014|3489381|B1||Black or African American|Race||Participants|Count of Participants|107|107.0||||||
3642282|NCT02510014|3489379|B3||White|Race||Participants|Count of Participants|462|462.0||||||
3642283|NCT02510014|3489380|B2||White|Race||Participants|Count of Participants|167|167.0||||||
3642284|NCT02510014|3489381|B1||White|Race||Participants|Count of Participants|295|295.0||||||
3642285|NCT02510014|3489379|B3||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|610|610.0||||||
3642286|NCT02510014|3489380|B2||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|241|241.0||||||
3642287|NCT02510014|3489381|B1||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|369|369.0||||||
3642288|NCT02510014|3489379|B3||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|59|59.0||||||
3642289|NCT02510014|3489380|B2||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3642290|NCT02510014|3489381|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
3642291|NCT02510014|3489379|B3||Male|Sex: Female, Male||Participants|Count of Participants|432|432.0||||||
3642292|NCT02510014|3489380|B2||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3642293|NCT02510014|3489381|B1||Male|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
3642294|NCT02510014|3489379|B3||Female|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
3642295|NCT02510014|3489380|B2||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3642296|NCT02510014|3489381|B1||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3642297|NCT02510014|3489379|B3||>=65 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
3642298|NCT02510014|3489380|B2||>=65 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3642299|NCT02510014|3489381|B1||>=65 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
3642300|NCT02510014|3489379|B3||>= 60 to < 65 years|Age, Customized||Participants|Count of Participants|39|39.0||||||
3642301|NCT02510014|3489380|B2||>= 60 to < 65 years|Age, Customized||Participants|Count of Participants|14|14.0||||||
3642302|NCT02510014|3489381|B1||>= 60 to < 65 years|Age, Customized||Participants|Count of Participants|25|25.0||||||
3642303|NCT02510014|3489379|B3||>=45 to <60 years|Age, Customized||Participants|Count of Participants|196|196.0||||||
3642304|NCT02510014|3489380|B2||>=45 to <60 years|Age, Customized||Participants|Count of Participants|89|89.0||||||
3642305|NCT02510014|3489381|B1||>=45 to <60 years|Age, Customized||Participants|Count of Participants|107|107.0||||||
3642306|NCT02510014|3489379|B3||>=30 to <45 years|Age, Customized||Participants|Count of Participants|271|271.0||||||
3642307|NCT02510014|3489380|B2||>=30 to <45 years|Age, Customized||Participants|Count of Participants|114|114.0||||||
3642308|NCT02510014|3489381|B1||>=30 to <45 years|Age, Customized||Participants|Count of Participants|157|157.0||||||
3642309|NCT02510014|3489379|B3||>=18 to <30 years|Age, Customized||Participants|Count of Participants|162|162.0||||||
3642310|NCT02510014|3489380|B2||>=18 to <30 years|Age, Customized||Participants|Count of Participants|40|40.0||||||
3642311|NCT02510014|3489381|B1||>=18 to <30 years|Age, Customized||Participants|Count of Participants|122|122.0||||||
3642312|NCT02510014|3489379|B3|||Age||years|Mean|39.6|39.6|Standard Deviation|11.81|11.81|||
3642313|NCT02510014|3489380|B2|||Age||years|Mean|41.6|41.6|Standard Deviation|11.07|11.07|||
3642314|NCT02510014|3489381|B1|||Age||years|Mean|38.4|38.4|Standard Deviation|12.10|12.1|||
3642315|NCT02509117|3489402|B11||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3642316|NCT02509117|3489403|B10||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3642317|NCT02509117|3489404|B9||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3642318|NCT02509117|3489405|B8||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3642319|NCT02509117|3489406|B7||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3642320|NCT02509117|3489407|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3642321|NCT02509117|3489408|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3642322|NCT02509117|3489409|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3642323|NCT02509117|3489410|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3642324|NCT02509117|3489411|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3642325|NCT02509117|3489412|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3642326|NCT02509117|3489402|B11||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3642327|NCT02509117|3489403|B10||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3642328|NCT02509117|3489404|B9||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3642329|NCT02509117|3489405|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3642330|NCT02509117|3489406|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3642331|NCT02509117|3489407|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3642332|NCT02509117|3489408|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3642333|NCT02509117|3489409|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3642334|NCT02509117|3489410|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3642335|NCT02509117|3489411|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3642336|NCT02509117|3489412|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3642337|NCT02509117|3489402|B11||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3642338|NCT02509117|3489403|B10||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3642339|NCT02509117|3489404|B9||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3642340|NCT02509117|3489405|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3642341|NCT02509117|3489406|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3642342|NCT02509117|3489407|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3642343|NCT02509117|3489408|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3642344|NCT02509117|3489409|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3642345|NCT02509117|3489410|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3642346|NCT02509117|3489411|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3642347|NCT02509117|3489412|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3642348|NCT02509117|3489402|B11||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
3642349|NCT02509117|3489403|B10||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3642350|NCT02509117|3489404|B9||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3642351|NCT02509117|3489405|B8||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3642352|NCT02509117|3489406|B7||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3642353|NCT02509117|3489407|B6||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3642354|NCT02509117|3489408|B5||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3642355|NCT02509117|3489409|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3642356|NCT02509117|3489410|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3642357|NCT02509117|3489411|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3642358|NCT02509117|3489412|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3642359|NCT02509117|3489402|B11||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642360|NCT02509117|3489403|B10||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642361|NCT02509117|3489404|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642362|NCT02509117|3489405|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642363|NCT02509117|3489406|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642364|NCT02509117|3489407|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642365|NCT02509117|3489408|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642366|NCT02509117|3489409|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642367|NCT02509117|3489410|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642368|NCT02509117|3489411|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642369|NCT02509117|3489412|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642370|NCT02509065|3489630|B1|||Hemoglobin A1c||percent|Mean|7.3|7.3|Standard Deviation|0.9|0.9|||
3642371|NCT02509065|3489630|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3642372|NCT02509065|3489630|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642373|NCT02509065|3489630|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3642374|NCT02509065|3489630|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642375|NCT02509065|3489630|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642376|NCT02509065|3489630|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642377|NCT02509065|3489630|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642378|NCT02509065|3489630|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3642379|NCT02509065|3489630|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3642380|NCT02509065|3489630|B1|||Age||years|Mean|38.6|38.6|Standard Deviation|15.5|15.5|||
3642381|NCT02508701|3489737|B5|United States||Region of Enrollment||participants|Number|24|24.0||||||
3642382|NCT02508701|3489738|B4|United States||Region of Enrollment||participants|Number|4|4.0||||||
3642383|NCT02508701|3489739|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3642384|NCT02508701|3489740|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3642385|NCT02508701|3489741|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3642386|NCT02508701|3489737|B5||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3642387|NCT02508701|3489738|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3642388|NCT02508701|3489739|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3642389|NCT02508701|3489740|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3642390|NCT02508701|3489741|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3642391|NCT02508701|3489737|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3642392|NCT02508701|3489738|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3642393|NCT02508701|3489739|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3642394|NCT02508701|3489740|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3642395|NCT02508701|3489741|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3642396|NCT02508701|3489737|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3642397|NCT02508701|3489738|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3642398|NCT02508701|3489739|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3642399|NCT02508701|3489740|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3642400|NCT02508701|3489741|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3642401|NCT02508701|3489737|B5||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3642402|NCT02508701|3489738|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3642403|NCT02508701|3489739|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3642404|NCT02508701|3489740|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3642405|NCT02508701|3489741|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3642406|NCT02508701|3489737|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642407|NCT02508701|3489738|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642408|NCT02508701|3489739|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642409|NCT02508701|3489740|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642410|NCT02508701|3489741|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642411|NCT02508207|3489766|B3|||Small-bowel Area Under the Curve (AUC) Over 1-minute Mean pH Increments|Small-bowel AUC through 30 minutes of 1 minute mean pH profile through gastric emptying at Baseline was reported.|pH minutes|Mean|5.8|5.8|Standard Deviation|0.6|0.6|||
3642412|NCT02508207|3489767|B2|||Small-bowel Area Under the Curve (AUC) Over 1-minute Mean pH Increments|Small-bowel AUC through 30 minutes of 1 minute mean pH profile through gastric emptying at Baseline was reported.|pH minutes|Mean|5.7|5.7|Standard Deviation|0.6|0.6|||
3642413|NCT02508207|3489768|B1|||Small-bowel Area Under the Curve (AUC) Over 1-minute Mean pH Increments|Small-bowel AUC through 30 minutes of 1 minute mean pH profile through gastric emptying at Baseline was reported.|pH minutes|Mean|5.8|5.8|Standard Deviation|0.4|0.4|||
3642414|NCT02508207|3489766|B3|||Mucociliary Clearance (MCC): Percentage of Whole-lung Clearance|MCC was assessed using an imaging technique that enables the tracking of mucus within the airways. MCC was expressed as the percentage of whole-lung clearance through 60 minutes at Baseline.|percentage of whole-lung clearance|Mean|16.9|16.9|Standard Deviation|11.8|11.8|||
3642415|NCT02508207|3489767|B2|||Mucociliary Clearance (MCC): Percentage of Whole-lung Clearance|MCC was assessed using an imaging technique that enables the tracking of mucus within the airways. MCC was expressed as the percentage of whole-lung clearance through 60 minutes at Baseline.|percentage of whole-lung clearance|Mean|17.6|17.6|Standard Deviation|11.2|11.2|||
3642416|NCT02508207|3489768|B1|||Mucociliary Clearance (MCC): Percentage of Whole-lung Clearance|MCC was assessed using an imaging technique that enables the tracking of mucus within the airways. MCC was expressed as the percentage of whole-lung clearance through 60 minutes at Baseline.|percentage of whole-lung clearance|Mean|13.8|13.8|Standard Deviation|14.4|14.4|||
3642417|NCT02508207|3489766|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642418|NCT02508207|3489767|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642419|NCT02508207|3489768|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642420|NCT02508207|3489766|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642421|NCT02508207|3489767|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642422|NCT02508207|3489768|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642423|NCT02508207|3489766|B3||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3642424|NCT02508207|3489767|B2||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3642425|NCT02508207|3489768|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3642426|NCT02508207|3489766|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642427|NCT02508207|3489767|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642428|NCT02508207|3489768|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642429|NCT02508207|3489766|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642430|NCT02508207|3489767|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642431|NCT02508207|3489768|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642432|NCT02508207|3489766|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642433|NCT02508207|3489767|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642434|NCT02508207|3489768|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642435|NCT02508207|3489766|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642436|NCT02508207|3489767|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642437|NCT02508207|3489768|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642438|NCT02508207|3489766|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642439|NCT02508207|3489767|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642440|NCT02508207|3489768|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642441|NCT02508207|3489766|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3642442|NCT02508207|3489767|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3642443|NCT02508207|3489768|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3642444|NCT02508207|3489766|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642445|NCT02508207|3489767|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642446|NCT02508207|3489768|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642447|NCT02508207|3489766|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3642448|NCT02508207|3489767|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3642449|NCT02508207|3489768|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3642450|NCT02508207|3489766|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3642451|NCT02508207|3489767|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3642452|NCT02508207|3489768|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3642453|NCT02508207|3489766|B3|||Age||years|Mean|33.4|33.4|Standard Deviation|9.5|9.5|||
3642454|NCT02508207|3489767|B2|||Age||years|Mean|32.1|32.1|Standard Deviation|8.6|8.6|||
3642455|NCT02508207|3489768|B1|||Age||years|Mean|38|38.0|Standard Deviation|11.8|11.8|||
3642456|NCT02508194|3489783|B3||Male|Sex: Female, Male||Participants|Count of Participants|783|783.0||||||
3642457|NCT02508194|3489784|B2||Male|Sex: Female, Male||Participants|Count of Participants|421|421.0||||||
3642458|NCT02508194|3489785|B1||Male|Sex: Female, Male||Participants|Count of Participants|362|362.0||||||
3642459|NCT02508194|3489783|B3||Female|Sex: Female, Male||Participants|Count of Participants|1117|1117.0||||||
3642460|NCT02508194|3489784|B2||Female|Sex: Female, Male||Participants|Count of Participants|530|530.0||||||
3642461|NCT02508194|3489785|B1||Female|Sex: Female, Male||Participants|Count of Participants|587|587.0||||||
3642462|NCT02508194|3489783|B3|||Age||Years|Mean|68.1|68.1|Standard Deviation|6.2|6.2|||
3642463|NCT02508194|3489784|B2|||Age||Years|Mean|68.1|68.1|Standard Deviation|6.3|6.3|||
3642464|NCT02508194|3489785|B1|||Age||Years|Mean|68.1|68.1|Standard Deviation|6.2|6.2|||
3642465|NCT02508116|3489824|B3|Other anti-anginal||Pharmacotherapy prior to admission||Participants|Count of Participants|161|161.0||||||
3642466|NCT02508116|3489825|B2|Other anti-anginal||Pharmacotherapy prior to admission||Participants|Count of Participants|78|78.0||||||
3642467|NCT02508116|3489826|B1|Other anti-anginal||Pharmacotherapy prior to admission||Participants|Count of Participants|83|83.0||||||
3642468|NCT02508116|3489824|B3|Statin||Pharmacotherapy prior to admission||Participants|Count of Participants|225|225.0||||||
3642469|NCT02508116|3489825|B2|Statin||Pharmacotherapy prior to admission||Participants|Count of Participants|113|113.0||||||
3642470|NCT02508116|3489826|B1|Statin||Pharmacotherapy prior to admission||Participants|Count of Participants|112|112.0||||||
3642471|NCT02508116|3489824|B3|Calcium channel blocker||Pharmacotherapy prior to admission||Participants|Count of Participants|112|112.0||||||
3642472|NCT02508116|3489825|B2|Calcium channel blocker||Pharmacotherapy prior to admission||Participants|Count of Participants|62|62.0||||||
3642473|NCT02508116|3489826|B1|Calcium channel blocker||Pharmacotherapy prior to admission||Participants|Count of Participants|50|50.0||||||
3642474|NCT02508116|3489824|B3|Beta-blocker||Pharmacotherapy prior to admission||Participants|Count of Participants|246|246.0||||||
3642475|NCT02508116|3489825|B2|Beta-blocker||Pharmacotherapy prior to admission||Participants|Count of Participants|125|125.0||||||
3642476|NCT02508116|3489826|B1|Beta-blocker||Pharmacotherapy prior to admission||Participants|Count of Participants|121|121.0||||||
3642477|NCT02508116|3489824|B3|ACE inhibitor or ARB||Pharmacotherapy prior to admission||Participants|Count of Participants|224|224.0||||||
3642478|NCT02508116|3489825|B2|ACE inhibitor or ARB||Pharmacotherapy prior to admission||Participants|Count of Participants|109|109.0||||||
3642479|NCT02508116|3489826|B1|ACE inhibitor or ARB||Pharmacotherapy prior to admission||Participants|Count of Participants|115|115.0||||||
3642480|NCT02508116|3489824|B3|Aspirin||Pharmacotherapy prior to admission||Participants|Count of Participants|322|322.0||||||
3642481|NCT02508116|3489825|B2|Aspirin||Pharmacotherapy prior to admission||Participants|Count of Participants|157|157.0||||||
3642482|NCT02508116|3489826|B1|Aspirin||Pharmacotherapy prior to admission||Participants|Count of Participants|165|165.0||||||
3642483|NCT02508116|3489824|B3||None|P2Y12 inhibitor use prior to admission||Participants|Count of Participants|310|310.0||||||
3642484|NCT02508116|3489825|B2||None|P2Y12 inhibitor use prior to admission||Participants|Count of Participants|155|155.0||||||
3642485|NCT02508116|3489826|B1||None|P2Y12 inhibitor use prior to admission||Participants|Count of Participants|155|155.0||||||
3642486|NCT02508116|3489824|B3||Ticagrelor|P2Y12 inhibitor use prior to admission||Participants|Count of Participants|8|8.0||||||
3642487|NCT02508116|3489825|B2||Ticagrelor|P2Y12 inhibitor use prior to admission||Participants|Count of Participants|6|6.0||||||
3642488|NCT02508116|3489826|B1||Ticagrelor|P2Y12 inhibitor use prior to admission||Participants|Count of Participants|2|2.0||||||
3642489|NCT02508116|3489824|B3||Prasugrel|P2Y12 inhibitor use prior to admission||Participants|Count of Participants|21|21.0||||||
3642490|NCT02508116|3489825|B2||Prasugrel|P2Y12 inhibitor use prior to admission||Participants|Count of Participants|9|9.0||||||
3642491|NCT02508116|3489826|B1||Prasugrel|P2Y12 inhibitor use prior to admission||Participants|Count of Participants|12|12.0||||||
3642492|NCT02508116|3489824|B3||Clopidogrel|P2Y12 inhibitor use prior to admission||Participants|Count of Participants|165|165.0||||||
3642493|NCT02508116|3489825|B2||Clopidogrel|P2Y12 inhibitor use prior to admission||Participants|Count of Participants|85|85.0||||||
3642494|NCT02508116|3489826|B1||Clopidogrel|P2Y12 inhibitor use prior to admission||Participants|Count of Participants|80|80.0||||||
3642495|NCT02508116|3489824|B3|Previous Stroke||Medical history||Participants|Count of Participants|22|22.0||||||
3642496|NCT02508116|3489825|B2|Previous Stroke||Medical history||Participants|Count of Participants|15|15.0||||||
3642497|NCT02508116|3489826|B1|Previous Stroke||Medical history||Participants|Count of Participants|7|7.0||||||
3642498|NCT02508116|3489824|B3|Previous CABG||Medical history||Participants|Count of Participants|68|68.0||||||
3642499|NCT02508116|3489825|B2|Previous CABG||Medical history||Participants|Count of Participants|36|36.0||||||
3642500|NCT02508116|3489826|B1|Previous CABG||Medical history||Participants|Count of Participants|32|32.0||||||
3642501|NCT02508116|3489824|B3|Previous PCI||Medical history||Participants|Count of Participants|166|166.0||||||
3642502|NCT02508116|3489825|B2|Previous PCI||Medical history||Participants|Count of Participants|83|83.0||||||
3642503|NCT02508116|3489826|B1|Previous PCI||Medical history||Participants|Count of Participants|83|83.0||||||
3642504|NCT02508116|3489824|B3|Previous MI||Medical history||Participants|Count of Participants|130|130.0||||||
3642505|NCT02508116|3489825|B2|Previous MI||Medical history||Participants|Count of Participants|67|67.0||||||
3642506|NCT02508116|3489826|B1|Previous MI||Medical history||Participants|Count of Participants|63|63.0||||||
3642507|NCT02508116|3489824|B3|Diabetes Mellitus||Medical history||Participants|Count of Participants|168|168.0||||||
3642508|NCT02508116|3489825|B2|Diabetes Mellitus||Medical history||Participants|Count of Participants|79|79.0||||||
3642509|NCT02508116|3489826|B1|Diabetes Mellitus||Medical history||Participants|Count of Participants|89|89.0||||||
3642510|NCT02508116|3489824|B3|Hypercholesterolemia||Medical history||Participants|Count of Participants|225|225.0||||||
3642511|NCT02508116|3489825|B2|Hypercholesterolemia||Medical history||Participants|Count of Participants|113|113.0||||||
3642512|NCT02508116|3489826|B1|Hypercholesterolemia||Medical history||Participants|Count of Participants|112|112.0||||||
3642513|NCT02508116|3489824|B3|Hypertension||Medical history||Participants|Count of Participants|389|389.0||||||
3642514|NCT02508116|3489825|B2|Hypertension||Medical history||Participants|Count of Participants|199|199.0||||||
3642515|NCT02508116|3489826|B1|Hypertension||Medical history||Participants|Count of Participants|190|190.0||||||
3642516|NCT02508116|3489824|B3||unknown|Tobacco use||Participants|Count of Participants|3|3.0||||||
3642517|NCT02508116|3489825|B2||unknown|Tobacco use||Participants|Count of Participants|1|1.0||||||
3642518|NCT02508116|3489826|B1||unknown|Tobacco use||Participants|Count of Participants|2|2.0||||||
3642519|NCT02508116|3489824|B3||Current|Tobacco use||Participants|Count of Participants|65|65.0||||||
3642520|NCT02508116|3489825|B2||Current|Tobacco use||Participants|Count of Participants|37|37.0||||||
3642521|NCT02508116|3489826|B1||Current|Tobacco use||Participants|Count of Participants|28|28.0||||||
3642522|NCT02508116|3489824|B3||Former|Tobacco use||Participants|Count of Participants|199|199.0||||||
3642523|NCT02508116|3489825|B2||Former|Tobacco use||Participants|Count of Participants|94|94.0||||||
3642524|NCT02508116|3489826|B1||Former|Tobacco use||Participants|Count of Participants|105|105.0||||||
3642525|NCT02508116|3489824|B3||Never|Tobacco use||Participants|Count of Participants|237|237.0||||||
3642526|NCT02508116|3489825|B2||Never|Tobacco use||Participants|Count of Participants|123|123.0||||||
3642527|NCT02508116|3489826|B1||Never|Tobacco use||Participants|Count of Participants|114|114.0||||||
3642528|NCT02508116|3489824|B3||Other/unknown|Work Status||Participants|Count of Participants|41|41.0||||||
3642529|NCT02508116|3489825|B2||Other/unknown|Work Status||Participants|Count of Participants|21|21.0||||||
3642530|NCT02508116|3489826|B1||Other/unknown|Work Status||Participants|Count of Participants|20|20.0||||||
3642531|NCT02508116|3489824|B3||Not provided|Work Status||Participants|Count of Participants|89|89.0||||||
3642532|NCT02508116|3489825|B2||Not provided|Work Status||Participants|Count of Participants|44|44.0||||||
3642533|NCT02508116|3489826|B1||Not provided|Work Status||Participants|Count of Participants|45|45.0||||||
3642534|NCT02508116|3489824|B3||Disabled|Work Status||Participants|Count of Participants|25|25.0||||||
3642535|NCT02508116|3489825|B2||Disabled|Work Status||Participants|Count of Participants|13|13.0||||||
3642536|NCT02508116|3489826|B1||Disabled|Work Status||Participants|Count of Participants|12|12.0||||||
3642537|NCT02508116|3489824|B3||Retired|Work Status||Participants|Count of Participants|169|169.0||||||
3642538|NCT02508116|3489825|B2||Retired|Work Status||Participants|Count of Participants|85|85.0||||||
3642539|NCT02508116|3489826|B1||Retired|Work Status||Participants|Count of Participants|84|84.0||||||
3642540|NCT02508116|3489824|B3||Full time|Work Status||Participants|Count of Participants|180|180.0||||||
3642541|NCT02508116|3489825|B2||Full time|Work Status||Participants|Count of Participants|92|92.0||||||
3642542|NCT02508116|3489826|B1||Full time|Work Status||Participants|Count of Participants|88|88.0||||||
3642543|NCT02508116|3489824|B3||Other|Insurance Status||Participants|Count of Participants|294|294.0||||||
3642544|NCT02508116|3489825|B2||Other|Insurance Status||Participants|Count of Participants|145|145.0||||||
3642545|NCT02508116|3489826|B1||Other|Insurance Status||Participants|Count of Participants|149|149.0||||||
3642546|NCT02508116|3489824|B3||Public|Insurance Status||Participants|Count of Participants|210|210.0||||||
3642547|NCT02508116|3489825|B2||Public|Insurance Status||Participants|Count of Participants|110|110.0||||||
3642548|NCT02508116|3489826|B1||Public|Insurance Status||Participants|Count of Participants|100|100.0||||||
3642549|NCT02508116|3489824|B3|||Acute coronary syndrome||Participants|Count of Participants|253|253.0||||||
3642550|NCT02508116|3489825|B2|||Acute coronary syndrome||Participants|Count of Participants|129|129.0||||||
3642551|NCT02508116|3489826|B1|||Acute coronary syndrome||Participants|Count of Participants|124|124.0||||||
3642552|NCT02508116|3489824|B3||Penn Presbyterian Hospital|Hospital Site||Participants|Count of Participants|228|228.0||||||
3642553|NCT02508116|3489825|B2||Penn Presbyterian Hospital|Hospital Site||Participants|Count of Participants|114|114.0||||||
3642554|NCT02508116|3489826|B1||Penn Presbyterian Hospital|Hospital Site||Participants|Count of Participants|114|114.0||||||
3642555|NCT02508116|3489824|B3||Hospital of the University of Pennsylvania|Hospital Site||Participants|Count of Participants|276|276.0||||||
3642556|NCT02508116|3489825|B2||Hospital of the University of Pennsylvania|Hospital Site||Participants|Count of Participants|141|141.0||||||
3642557|NCT02508116|3489826|B1||Hospital of the University of Pennsylvania|Hospital Site||Participants|Count of Participants|135|135.0||||||
3642558|NCT02508116|3489824|B3|United States||Region of Enrollment||participants|Number|504|504.0||||||
3642559|NCT02508116|3489825|B2|United States||Region of Enrollment||participants|Number|255|255.0||||||
3642560|NCT02508116|3489826|B1|United States||Region of Enrollment||participants|Number|249|249.0||||||
3642561|NCT02508116|3489824|B3|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3642562|NCT02508116|3489825|B2|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3642563|NCT02508116|3489826|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3642564|NCT02508116|3489824|B3|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3642565|NCT02508116|3489825|B2|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3642566|NCT02508116|3489826|B1|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3642567|NCT02508116|3489824|B3|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|99|99.0||||||
3642568|NCT02508116|3489825|B2|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
3642569|NCT02508116|3489826|B1|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
3642570|NCT02508116|3489824|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|391|391.0||||||
3642571|NCT02508116|3489825|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|197|197.0||||||
3642572|NCT02508116|3489826|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|194|194.0||||||
3642573|NCT02508116|3489824|B3||Male|Sex: Female, Male||Participants|Count of Participants|370|370.0||||||
3642574|NCT02508116|3489825|B2||Male|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
3642575|NCT02508116|3489826|B1||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
3642576|NCT02508116|3489824|B3||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3642577|NCT02508116|3489825|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3642578|NCT02508116|3489826|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3642579|NCT02508116|3489824|B3|||Age||years|Mean|62.9|62.9|Standard Deviation|10.0|10.0|||
3642580|NCT02508116|3489825|B2|||Age||years|Mean|62.9|62.9|Standard Deviation|10.2|10.2|||
3642581|NCT02508116|3489826|B1|||Age||years|Mean|63|63.0|Standard Deviation|9.7|9.7|||
3642582|NCT02508103|3489839|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3642583|NCT02508103|3489840|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3642584|NCT02508103|3489841|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3642585|NCT02508103|3489839|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642586|NCT02508103|3489840|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642587|NCT02508103|3489841|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642588|NCT02508103|3489839|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642589|NCT02508103|3489840|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642590|NCT02508103|3489841|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642591|NCT02508103|3489839|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3642592|NCT02508103|3489840|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3642593|NCT02508103|3489841|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3642594|NCT02508103|3489839|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3642595|NCT02508103|3489840|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3642596|NCT02508103|3489841|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642597|NCT02508103|3489839|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642598|NCT02508103|3489840|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642599|NCT02508103|3489841|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642600|NCT02508103|3489839|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642601|NCT02508103|3489840|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642602|NCT02508103|3489841|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642603|NCT02508103|3489839|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3642604|NCT02508103|3489840|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3642605|NCT02508103|3489841|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642606|NCT02508103|3489839|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642607|NCT02508103|3489840|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642608|NCT02508103|3489841|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642609|NCT02508103|3489839|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3642610|NCT02508103|3489840|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3642611|NCT02508103|3489841|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3642612|NCT02508103|3489839|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3642613|NCT02508103|3489840|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3642614|NCT02508103|3489841|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642615|NCT02508103|3489839|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3642616|NCT02508103|3489840|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3642617|NCT02508103|3489841|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3642618|NCT02508103|3489839|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3642619|NCT02508103|3489840|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3642620|NCT02508103|3489841|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3642621|NCT02508103|3489839|B3|||Age||years|Mean|36.6|36.6|Full Range|||28.0|45.0|
3642622|NCT02508103|3489840|B2|||Age||years|Mean|36.8|36.8|Full Range|||31.0|41.0|
3642623|NCT02508103|3489841|B1|||Age||years|Mean|36.4|36.4|Full Range|||28.0|45.0|
3642624|NCT02508103|3489839|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3642625|NCT02508103|3489840|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3642626|NCT02508103|3489841|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3642627|NCT02508103|3489839|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3642628|NCT02508103|3489840|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3642629|NCT02508103|3489841|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3642630|NCT02508103|3489839|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642631|NCT02508103|3489840|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642632|NCT02508103|3489841|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642633|NCT02508077|3489850|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3642634|NCT02508077|3489850|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642635|NCT02508077|3489850|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642636|NCT02508077|3489850|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3642637|NCT02508077|3489850|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642638|NCT02508077|3489850|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642639|NCT02508077|3489850|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642640|NCT02508077|3489850|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642641|NCT02508077|3489850|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642642|NCT02508077|3489850|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3642643|NCT02508077|3489850|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642644|NCT02508077|3489850|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3642645|NCT02508077|3489850|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3642646|NCT02508077|3489850|B1|||Age||years|Median|57|57.0|Full Range|||57.0|57.0|
3642647|NCT02507752|3489854|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3642648|NCT02507752|3489854|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3642649|NCT02507752|3489854|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|12.3|12.3|||
3642650|NCT02507388|3489872|B3|Positive||Pre-dose Anti-Drug Antibody (ADA) Status|A positive ADA titer prior to the first injection is not unexpected, as pre-existing antibodies to biotherapeutic drugs have been detected in drug-naïve subjects for a variety of antibody fragments.|Participants|Count of Participants|32|32.0||||||
3642651|NCT02507388|3489873|B2|Positive||Pre-dose Anti-Drug Antibody (ADA) Status|A positive ADA titer prior to the first injection is not unexpected, as pre-existing antibodies to biotherapeutic drugs have been detected in drug-naïve subjects for a variety of antibody fragments.|Participants|Count of Participants|18|18.0||||||
3642652|NCT02507388|3489874|B1|Positive||Pre-dose Anti-Drug Antibody (ADA) Status|A positive ADA titer prior to the first injection is not unexpected, as pre-existing antibodies to biotherapeutic drugs have been detected in drug-naïve subjects for a variety of antibody fragments.|Participants|Count of Participants|14|14.0||||||
3642653|NCT02507388|3489872|B3|Negative||Pre-dose Anti-Drug Antibody (ADA) Status|A positive ADA titer prior to the first injection is not unexpected, as pre-existing antibodies to biotherapeutic drugs have been detected in drug-naïve subjects for a variety of antibody fragments.|Participants|Count of Participants|18|18.0||||||
3642654|NCT02507388|3489873|B2|Negative||Pre-dose Anti-Drug Antibody (ADA) Status|A positive ADA titer prior to the first injection is not unexpected, as pre-existing antibodies to biotherapeutic drugs have been detected in drug-naïve subjects for a variety of antibody fragments.|Participants|Count of Participants|7|7.0||||||
3642655|NCT02507388|3489874|B1|Negative||Pre-dose Anti-Drug Antibody (ADA) Status|A positive ADA titer prior to the first injection is not unexpected, as pre-existing antibodies to biotherapeutic drugs have been detected in drug-naïve subjects for a variety of antibody fragments.|Participants|Count of Participants|11|11.0||||||
3642656|NCT02507388|3489872|B3|||Primary Diagnosis of Neovascular Age-Related Macular Degeneration|As required by the protocol for inclusion in the study|Participants|Count of Participants|50|50.0||||||
3642657|NCT02507388|3489873|B2|||Primary Diagnosis of Neovascular Age-Related Macular Degeneration|As required by the protocol for inclusion in the study|Participants|Count of Participants|25|25.0||||||
3642658|NCT02507388|3489874|B1|||Primary Diagnosis of Neovascular Age-Related Macular Degeneration|As required by the protocol for inclusion in the study|Participants|Count of Participants|25|25.0||||||
3642659|NCT02507388|3489872|B3|Non-Japanese||Ancestry||Participants|Count of Participants|24|24.0||||||
3642660|NCT02507388|3489873|B2|Non-Japanese||Ancestry||Participants|Count of Participants|12|12.0||||||
3642661|NCT02507388|3489874|B1|Non-Japanese||Ancestry||Participants|Count of Participants|12|12.0||||||
3642662|NCT02507388|3489872|B3|Japanese||Ancestry||Participants|Count of Participants|26|26.0||||||
3642663|NCT02507388|3489873|B2|Japanese||Ancestry||Participants|Count of Participants|13|13.0||||||
3642664|NCT02507388|3489874|B1|Japanese||Ancestry||Participants|Count of Participants|13|13.0||||||
3642665|NCT02507388|3489872|B3|Japan||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3642666|NCT02507388|3489873|B2|Japan||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3642667|NCT02507388|3489874|B1|Japan||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3642668|NCT02507388|3489872|B3|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3642669|NCT02507388|3489873|B2|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3642670|NCT02507388|3489874|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3642671|NCT02507388|3489872|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642672|NCT02507388|3489873|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642673|NCT02507388|3489874|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642674|NCT02507388|3489872|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642675|NCT02507388|3489873|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642676|NCT02507388|3489874|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642677|NCT02507388|3489872|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3642678|NCT02507388|3489873|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3642679|NCT02507388|3489874|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3642680|NCT02507388|3489872|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642681|NCT02507388|3489873|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642682|NCT02507388|3489874|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642683|NCT02507388|3489872|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642684|NCT02507388|3489873|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642685|NCT02507388|3489874|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642686|NCT02507388|3489872|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3642687|NCT02507388|3489873|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3642688|NCT02507388|3489874|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3642689|NCT02507388|3489872|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642690|NCT02507388|3489873|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642691|NCT02507388|3489874|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642692|NCT02507388|3489872|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642693|NCT02507388|3489873|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642694|NCT02507388|3489874|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642695|NCT02507388|3489872|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3642696|NCT02507388|3489873|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3642697|NCT02507388|3489874|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3642698|NCT02507388|3489872|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3642699|NCT02507388|3489873|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3642700|NCT02507388|3489874|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3642701|NCT02507388|3489872|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3642702|NCT02507388|3489873|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3642703|NCT02507388|3489874|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3642704|NCT02507388|3489872|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3642705|NCT02507388|3489873|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3642706|NCT02507388|3489874|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3642707|NCT02507388|3489872|B3|||Age||years|Mean|72.4|72.4|Standard Deviation|7.87|7.87|||
3642708|NCT02507388|3489873|B2|||Age||years|Mean|73.6|73.6|Standard Deviation|7.09|7.09|||
3642709|NCT02507388|3489874|B1|||Age||years|Mean|71.1|71.1|Standard Deviation|8.53|8.53|||
3642710|NCT02507375|3489896|B3|Spain||Region of Enrollment||participants|Number|12|12.0||||||
3642711|NCT02507375|3489897|B2|Spain||Region of Enrollment||participants|Number|8|8.0||||||
3642712|NCT02507375|3489898|B1|Spain||Region of Enrollment||participants|Number|4|4.0||||||
3642713|NCT02507375|3489896|B3|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
3642714|NCT02507375|3489897|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3642715|NCT02507375|3489898|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3642716|NCT02507375|3489896|B3|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
3642717|NCT02507375|3489897|B2|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
3642718|NCT02507375|3489898|B1|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
3642719|NCT02507375|3489896|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3642720|NCT02507375|3489897|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3642721|NCT02507375|3489898|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3642722|NCT02507375|3489896|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3642723|NCT02507375|3489897|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3642724|NCT02507375|3489898|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3642725|NCT02507375|3489896|B3|||Age||years|Mean|60.2|60.2|Standard Deviation|10.06|10.06|||
3642726|NCT02507375|3489897|B2|||Age||years|Mean|56.0|56.0|Standard Deviation|10.28|10.28|||
3642727|NCT02507375|3489898|B1|||Age||years|Mean|66.5|66.5|Standard Deviation|5.89|5.89|||
3642728|NCT02507219|3489916|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3642729|NCT02507219|3489916|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642730|NCT02507219|3489916|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642731|NCT02507219|3489916|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3642732|NCT02507219|3489916|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642733|NCT02507219|3489916|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642734|NCT02507219|3489916|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642735|NCT02507219|3489916|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642736|NCT02507219|3489916|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642737|NCT02507219|3489916|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3642738|NCT02507219|3489916|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3642739|NCT02507219|3489916|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3642740|NCT02507219|3489916|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3642741|NCT02507219|3489916|B1|||Age||Years|Mean|31.75|31.75|Standard Deviation|6.72|6.72|||
3642742|NCT02507219|3489916|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3642743|NCT02507219|3489916|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3642744|NCT02507219|3489916|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642745|NCT02506985|3489929|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3642746|NCT02506985|3489930|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3642747|NCT02506985|3489931|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3642748|NCT02506985|3489929|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3642749|NCT02506985|3489930|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3642750|NCT02506985|3489931|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3642751|NCT02506985|3489929|B3|||Age||years|Mean|52.8|52.8|Standard Deviation|15.1|15.1|||
3642752|NCT02506985|3489930|B2|||Age||years|Mean|50.3|50.3|Standard Deviation|12.5|12.5|||
3642753|NCT02506985|3489931|B1|||Age||years|Mean|54.5|54.5|Standard Deviation|17.5|17.5|||
3642754|NCT02506881|3489946|B5||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3642755|NCT02506881|3489947|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3642756|NCT02506881|3489948|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3642757|NCT02506881|3489949|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3642758|NCT02506881|3489950|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3642759|NCT02506881|3489946|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3642760|NCT02506881|3489947|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3642761|NCT02506881|3489948|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3642762|NCT02506881|3489949|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3642763|NCT02506881|3489950|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3642764|NCT02506881|3489946|B5|||Age||years|Median|24|24.0|Inter-Quartile Range|||21.0|28.0|
3642765|NCT02506881|3489947|B4|||Age||years|Median|24.5|24.5|Inter-Quartile Range|||21.0|28.0|
3642766|NCT02506881|3489948|B3|||Age||years|Median|24|24.0|Inter-Quartile Range|||22.0|27.0|
3642767|NCT02506881|3489949|B2|||Age||years|Median|22|22.0|Inter-Quartile Range|||21.0|26.0|
3642768|NCT02506881|3489950|B1|||Age||years|Median|23|23.0|Inter-Quartile Range|||21.0|32.0|
3642769|NCT02506881|3489946|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3642770|NCT02506881|3489947|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3642771|NCT02506881|3489948|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3642772|NCT02506881|3489949|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3642773|NCT02506881|3489950|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3642774|NCT02506881|3489946|B5||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
3642775|NCT02506881|3489947|B4||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3642776|NCT02506881|3489948|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3642777|NCT02506881|3489949|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3642778|NCT02506881|3489950|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3642779|NCT02506881|3489946|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642780|NCT02506881|3489947|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642781|NCT02506881|3489948|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642782|NCT02506881|3489949|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642783|NCT02506881|3489950|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642784|NCT02506660|3489987|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3642785|NCT02506660|3489988|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3642786|NCT02506660|3489989|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3642787|NCT02506660|3489987|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|114|114.0||||||
3642788|NCT02506660|3489988|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3642789|NCT02506660|3489989|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3642790|NCT02506660|3489987|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3642791|NCT02506660|3489988|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3642792|NCT02506660|3489989|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3642793|NCT02506660|3489987|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3642794|NCT02506660|3489988|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3642795|NCT02506660|3489989|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3642796|NCT02506660|3489987|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3642797|NCT02506660|3489988|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3642798|NCT02506660|3489989|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3642799|NCT02506660|3489987|B3|||Age||years|Mean|48.3|48.3|Standard Deviation|14.2|14.2|||
3642800|NCT02506660|3489988|B2|||Age||years|Mean|49.9|49.9|Standard Deviation|13.6|13.6|||
3642801|NCT02506660|3489989|B1|||Age||years|Mean|46.7|46.7|Standard Deviation|14.6|14.6|||
3642802|NCT02506309|3490008|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3642803|NCT02506309|3490009|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3642804|NCT02506309|3490010|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3642805|NCT02506309|3490008|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3642806|NCT02506309|3490009|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3642807|NCT02506309|3490010|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3642808|NCT02506309|3490008|B3|||Age||years|Mean|63.3|63.3|Standard Deviation|10.5|10.5|||
3642809|NCT02506309|3490009|B2|||Age||years|Mean|62.3|62.3|Standard Deviation|10.3|10.3|||
3642810|NCT02506309|3490010|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|10.6|10.6|||
3642811|NCT02506257|3490023|B5||Male|Gender||Participants|Count of Participants|42|42.0||||||
3642812|NCT02506257|3490024|B4||Male|Gender||Participants|Count of Participants|7|7.0||||||
3642813|NCT02506257|3490025|B3||Male|Gender||Participants|Count of Participants|10|10.0||||||
3642814|NCT02506257|3490026|B2||Male|Gender||Participants|Count of Participants|13|13.0||||||
3642815|NCT02506257|3490027|B1||Male|Gender||Participants|Count of Participants|12|12.0||||||
3642816|NCT02506257|3490023|B5||Female|Gender||Participants|Count of Participants|48|48.0||||||
3642817|NCT02506257|3490024|B4||Female|Gender||Participants|Count of Participants|2|2.0||||||
3642818|NCT02506257|3490025|B3||Female|Gender||Participants|Count of Participants|17|17.0||||||
3642819|NCT02506257|3490026|B2||Female|Gender||Participants|Count of Participants|15|15.0||||||
3642820|NCT02506257|3490027|B1||Female|Gender||Participants|Count of Participants|14|14.0||||||
3642821|NCT02506257|3490023|B5|||Age||years|Mean|29.6|29.6|Standard Deviation|10.1|10.1|||
3642822|NCT02506257|3490024|B4|||Age||years|Mean|25.7|25.7|Standard Deviation|4.6|4.6|||
3642823|NCT02506257|3490025|B3|||Age||years|Mean|30.4|30.4|Standard Deviation|10.3|10.3|||
3642824|NCT02506257|3490026|B2|||Age||years|Mean|29.4|29.4|Standard Deviation|8.7|8.7|||
3642825|NCT02506257|3490027|B1|||Age||years|Mean|30.5|30.5|Standard Deviation|12.5|12.5|||
3642826|NCT02506101|3490060|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3642827|NCT02506101|3490062|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3642828|NCT02506101|3490060|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3642829|NCT02506101|3490061|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3642830|NCT02506101|3490062|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3642831|NCT02506101|3490060|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3642832|NCT02506101|3490061|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3642833|NCT02506101|3490062|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3642834|NCT02506101|3490060|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3642835|NCT02506101|3490061|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3642836|NCT02506101|3490062|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3642837|NCT02506101|3490060|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3642838|NCT02506101|3490061|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3642839|NCT02506101|3490062|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3642840|NCT02506101|3490060|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642841|NCT02506101|3490061|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642842|NCT02506101|3490062|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642843|NCT02505945|3490077|B3|United States||Region of Enrollment||participants|Number|152|152.0||||||
3642844|NCT02505945|3490078|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
3642845|NCT02505945|3490079|B1|United States||Region of Enrollment||participants|Number|102|102.0||||||
3642846|NCT02505945|3490077|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642847|NCT02505945|3490078|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642848|NCT02505945|3490079|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642849|NCT02505945|3490077|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3642850|NCT02505945|3490078|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3642851|NCT02505945|3490079|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3642852|NCT02505945|3490077|B3||White|Race (NIH/OMB)||Participants|Count of Participants|141|141.0||||||
3642853|NCT02505945|3490078|B2||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3642854|NCT02505945|3490079|B1||White|Race (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
3642855|NCT02505945|3490077|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3642856|NCT02505945|3490078|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3642857|NCT02505945|3490079|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3642858|NCT02505945|3490077|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642859|NCT02505945|3490078|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642860|NCT02505945|3490079|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642861|NCT02505945|3490077|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3642862|NCT02505945|3490078|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642863|NCT02505945|3490079|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3642864|NCT02505945|3490077|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642865|NCT02505945|3490078|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642866|NCT02505945|3490079|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642867|NCT02505945|3490077|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642868|NCT02505945|3490078|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642869|NCT02505945|3490079|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642870|NCT02505945|3490077|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
3642871|NCT02505945|3490078|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3642872|NCT02505945|3490079|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3642873|NCT02505945|3490077|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3642874|NCT02505945|3490078|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3642875|NCT02505945|3490079|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3642876|NCT02505945|3490077|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3642877|NCT02505945|3490078|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3642878|NCT02505945|3490079|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3642879|NCT02505945|3490077|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3642880|NCT02505945|3490078|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3642881|NCT02505945|3490079|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3642882|NCT02505945|3490077|B3|||Age||years|Mean|46.9|46.9|Standard Deviation|13.4|13.4|||
3642883|NCT02505945|3490078|B2|||Age||years|Mean|47.8|47.8|Standard Deviation|13.1|13.1|||
3642884|NCT02505945|3490079|B1|||Age||years|Mean|46.4|46.4|Standard Deviation|13.7|13.7|||
3642885|NCT02505334|3490088|B3|||Glycosylated haemoglobin (HbA1c)||Percentage (%) of HbA1c|Mean|8.12|8.12|Standard Deviation|0.95|0.95|||
3642886|NCT02505334|3490089|B2|||Glycosylated haemoglobin (HbA1c)||Percentage (%) of HbA1c|Mean|8.10|8.1|Standard Deviation|0.87|0.87|||
3642887|NCT02505334|3490090|B1|||Glycosylated haemoglobin (HbA1c)||Percentage (%) of HbA1c|Mean|8.14|8.14|Standard Deviation|1.02|1.02|||
3642888|NCT02505334|3490088|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642889|NCT02505334|3490089|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642890|NCT02505334|3490090|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642891|NCT02505334|3490088|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642892|NCT02505334|3490089|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642893|NCT02505334|3490090|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642894|NCT02505334|3490088|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642895|NCT02505334|3490089|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642896|NCT02505334|3490090|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642897|NCT02505334|3490088|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642898|NCT02505334|3490089|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642899|NCT02505334|3490090|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642900|NCT02505334|3490088|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642901|NCT02505334|3490089|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642902|NCT02505334|3490090|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642903|NCT02505334|3490088|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|466|466.0||||||
3642904|NCT02505334|3490089|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|233|233.0||||||
3642905|NCT02505334|3490090|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|233|233.0||||||
3642906|NCT02505334|3490088|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642907|NCT02505334|3490089|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642908|NCT02505334|3490090|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642909|NCT02505334|3490088|B3||Male|Sex: Female, Male||Participants|Count of Participants|321|321.0||||||
3642910|NCT02505334|3490089|B2||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3642911|NCT02505334|3490090|B1||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3642912|NCT02505334|3490088|B3||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3642913|NCT02505334|3490089|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3642914|NCT02505334|3490090|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3642915|NCT02505334|3490088|B3|||Age||Years|Mean|55.01|55.01|Standard Deviation|10.43|10.43|||
3642916|NCT02505334|3490089|B2|||Age||Years|Mean|54.96|54.96|Standard Deviation|10.61|10.61|||
3642917|NCT02505334|3490090|B1|||Age||Years|Mean|55.07|55.07|Standard Deviation|10.27|10.27|||
3642918|NCT02504931|3490216|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
3642919|NCT02504931|3490217|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
3642920|NCT02504931|3490218|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
3642921|NCT02504931|3490216|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
3642922|NCT02504931|3490217|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
3642923|NCT02504931|3490218|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
3642924|NCT02504931|3490216|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3642925|NCT02504931|3490217|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3642926|NCT02504931|3490218|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3642927|NCT02504931|3490216|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642928|NCT02504931|3490217|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642929|NCT02504931|3490218|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642930|NCT02504931|3490216|B3||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3642931|NCT02504931|3490217|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3642932|NCT02504931|3490218|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3642933|NCT02504931|3490216|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3642934|NCT02504931|3490217|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3642935|NCT02504931|3490218|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3642936|NCT02504931|3490216|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642937|NCT02504931|3490217|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642938|NCT02504931|3490218|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642939|NCT02504931|3490216|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642940|NCT02504931|3490217|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642941|NCT02504931|3490218|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642942|NCT02504931|3490216|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642943|NCT02504931|3490217|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642944|NCT02504931|3490218|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642945|NCT02504931|3490216|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642946|NCT02504931|3490217|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642947|NCT02504931|3490218|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642948|NCT02504931|3490216|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3642949|NCT02504931|3490217|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3642950|NCT02504931|3490218|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3642951|NCT02504931|3490216|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3642952|NCT02504931|3490217|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3642953|NCT02504931|3490218|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3642954|NCT02504931|3490216|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3642955|NCT02504931|3490217|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3642956|NCT02504931|3490218|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3642957|NCT02504931|3490216|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3642958|NCT02504931|3490217|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3642959|NCT02504931|3490218|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3642960|NCT02504931|3490216|B3|||Age||years|Mean|40.5|40.5|Standard Deviation|12.7|12.7|||
3642961|NCT02504931|3490217|B2|||Age||years|Mean|41.2|41.2|Standard Deviation|12.2|12.2|||
3642962|NCT02504931|3490218|B1|||Age||years|Mean|39.9|39.9|Standard Deviation|13.4|13.4|||
3642963|NCT02504827|3490227|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3642964|NCT02504827|3490227|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642965|NCT02504827|3490227|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642966|NCT02504827|3490227|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3642967|NCT02504827|3490227|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642968|NCT02504827|3490227|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642969|NCT02504827|3490227|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642970|NCT02504827|3490227|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642971|NCT02504827|3490227|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3642972|NCT02504827|3490227|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3642973|NCT02504827|3490227|B1|||Age||years|Mean|33.1|33.1|Standard Deviation|11|11.0|||
3642974|NCT02504827|3490227|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3642975|NCT02504827|3490227|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3642976|NCT02504827|3490227|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3642977|NCT02504775|3490232|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3642978|NCT02504775|3490232|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3642979|NCT02504775|3490232|B1|||Age||Years|Mean|30.8|30.8|Standard Deviation|10.4|10.4|||
3642980|NCT02504723|3490245|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3642981|NCT02504723|3490245|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3642982|NCT02504723|3490246|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3642983|NCT02504723|3490247|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3642984|NCT02504723|3490245|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3642985|NCT02504723|3490246|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3642986|NCT02504723|3490247|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3642987|NCT02504723|3490245|B3|||Age||years|Mean|56.39|56.39|Standard Deviation|11.45|11.45|||
3642988|NCT02504723|3490246|B2|||Age||years|Mean|56.26|56.26|Standard Deviation|12.08|12.08|||
3642989|NCT02504723|3490247|B1|||Age||years|Mean|56.52|56.52|Standard Deviation|10.87|10.87|||
3642990|NCT02504541|3490260|B1|United States||Region of Enrollment||participants|Number|133|133.0||||||
3642991|NCT02504541|3490260|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3642992|NCT02504541|3490260|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642993|NCT02504541|3490260|B1||White|Race (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
3642994|NCT02504541|3490260|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3642995|NCT02504541|3490260|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642996|NCT02504541|3490260|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3642997|NCT02504541|3490260|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642998|NCT02504541|3490260|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3642999|NCT02504541|3490260|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|116|116.0||||||
3643000|NCT02504541|3490260|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3643001|NCT02504541|3490260|B1||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3643002|NCT02504541|3490260|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3643003|NCT02504541|3490260|B1|||Age||years|Mean|54.5|54.5|Standard Deviation|10.30|10.3|||
3643004|NCT02504502|3490264|B3||Missing|Access to Child's Record|How many times did you access your child's health information online through the MyGeisinger website or app in the last 12 months?|Participants|Count of Participants|2|2.0||||||
3643005|NCT02504502|3490265|B2||Missing|Access to Child's Record|How many times did you access your child's health information online through the MyGeisinger website or app in the last 12 months?|Participants|Count of Participants|1|1.0||||||
3643006|NCT02504502|3490266|B1||Missing|Access to Child's Record|How many times did you access your child's health information online through the MyGeisinger website or app in the last 12 months?|Participants|Count of Participants|1|1.0||||||
3643007|NCT02504502|3490264|B3||10 or more times|Access to Child's Record|How many times did you access your child's health information online through the MyGeisinger website or app in the last 12 months?|Participants|Count of Participants|7|7.0||||||
3643008|NCT02504502|3490265|B2||10 or more times|Access to Child's Record|How many times did you access your child's health information online through the MyGeisinger website or app in the last 12 months?|Participants|Count of Participants|3|3.0||||||
3643009|NCT02504502|3490266|B1||10 or more times|Access to Child's Record|How many times did you access your child's health information online through the MyGeisinger website or app in the last 12 months?|Participants|Count of Participants|4|4.0||||||
3643010|NCT02504502|3490264|B3||6-9 times|Access to Child's Record|How many times did you access your child's health information online through the MyGeisinger website or app in the last 12 months?|Participants|Count of Participants|2|2.0||||||
3643011|NCT02504502|3490265|B2||6-9 times|Access to Child's Record|How many times did you access your child's health information online through the MyGeisinger website or app in the last 12 months?|Participants|Count of Participants|2|2.0||||||
3643012|NCT02504502|3490266|B1||6-9 times|Access to Child's Record|How many times did you access your child's health information online through the MyGeisinger website or app in the last 12 months?|Participants|Count of Participants|0|0.0||||||
3643013|NCT02504502|3490264|B3||3-5 times|Access to Child's Record|How many times did you access your child's health information online through the MyGeisinger website or app in the last 12 months?|Participants|Count of Participants|8|8.0||||||
3643014|NCT02504502|3490265|B2||3-5 times|Access to Child's Record|How many times did you access your child's health information online through the MyGeisinger website or app in the last 12 months?|Participants|Count of Participants|3|3.0||||||
3643015|NCT02504502|3490266|B1||3-5 times|Access to Child's Record|How many times did you access your child's health information online through the MyGeisinger website or app in the last 12 months?|Participants|Count of Participants|5|5.0||||||
3643016|NCT02504502|3490264|B3||1-2 times|Access to Child's Record|How many times did you access your child's health information online through the MyGeisinger website or app in the last 12 months?|Participants|Count of Participants|4|4.0||||||
3643017|NCT02504502|3490265|B2||1-2 times|Access to Child's Record|How many times did you access your child's health information online through the MyGeisinger website or app in the last 12 months?|Participants|Count of Participants|2|2.0||||||
3643018|NCT02504502|3490266|B1||1-2 times|Access to Child's Record|How many times did you access your child's health information online through the MyGeisinger website or app in the last 12 months?|Participants|Count of Participants|2|2.0||||||
3643019|NCT02504502|3490264|B3||None|Access to Child's Record|How many times did you access your child's health information online through the MyGeisinger website or app in the last 12 months?|Participants|Count of Participants|29|29.0||||||
3643020|NCT02504502|3490265|B2||None|Access to Child's Record|How many times did you access your child's health information online through the MyGeisinger website or app in the last 12 months?|Participants|Count of Participants|17|17.0||||||
3643021|NCT02504502|3490266|B1||None|Access to Child's Record|How many times did you access your child's health information online through the MyGeisinger website or app in the last 12 months?|Participants|Count of Participants|12|12.0||||||
3643022|NCT02504502|3490264|B3||Missing|Numeracy|In general, how easy or hard do you find it to understand medical statistics|Participants|Count of Participants|1|1.0||||||
3643023|NCT02504502|3490265|B2||Missing|Numeracy|In general, how easy or hard do you find it to understand medical statistics|Participants|Count of Participants|1|1.0||||||
3643024|NCT02504502|3490266|B1||Missing|Numeracy|In general, how easy or hard do you find it to understand medical statistics|Participants|Count of Participants|0|0.0||||||
3643025|NCT02504502|3490264|B3||Very Hard|Numeracy|In general, how easy or hard do you find it to understand medical statistics|Participants|Count of Participants|0|0.0||||||
3643026|NCT02504502|3490265|B2||Very Hard|Numeracy|In general, how easy or hard do you find it to understand medical statistics|Participants|Count of Participants|0|0.0||||||
3643027|NCT02504502|3490266|B1||Very Hard|Numeracy|In general, how easy or hard do you find it to understand medical statistics|Participants|Count of Participants|0|0.0||||||
3643028|NCT02504502|3490264|B3||Hard|Numeracy|In general, how easy or hard do you find it to understand medical statistics|Participants|Count of Participants|15|15.0||||||
3643029|NCT02504502|3490265|B2||Hard|Numeracy|In general, how easy or hard do you find it to understand medical statistics|Participants|Count of Participants|9|9.0||||||
3643030|NCT02504502|3490266|B1||Hard|Numeracy|In general, how easy or hard do you find it to understand medical statistics|Participants|Count of Participants|6|6.0||||||
3643031|NCT02504502|3490264|B3||Easy|Numeracy|In general, how easy or hard do you find it to understand medical statistics|Participants|Count of Participants|25|25.0||||||
3643032|NCT02504502|3490265|B2||Easy|Numeracy|In general, how easy or hard do you find it to understand medical statistics|Participants|Count of Participants|12|12.0||||||
3643033|NCT02504502|3490266|B1||Easy|Numeracy|In general, how easy or hard do you find it to understand medical statistics|Participants|Count of Participants|13|13.0||||||
3643034|NCT02504502|3490264|B3||Very Easy|Numeracy|In general, how easy or hard do you find it to understand medical statistics|Participants|Count of Participants|11|11.0||||||
3643035|NCT02504502|3490265|B2||Very Easy|Numeracy|In general, how easy or hard do you find it to understand medical statistics|Participants|Count of Participants|6|6.0||||||
3643036|NCT02504502|3490266|B1||Very Easy|Numeracy|In general, how easy or hard do you find it to understand medical statistics|Participants|Count of Participants|5|5.0||||||
3643037|NCT02504502|3490264|B3||Missing|Health Literacy|How confident are you filling out forms by yourself?|Participants|Count of Participants|1|1.0||||||
3643038|NCT02504502|3490265|B2||Missing|Health Literacy|How confident are you filling out forms by yourself?|Participants|Count of Participants|1|1.0||||||
3643039|NCT02504502|3490266|B1||Missing|Health Literacy|How confident are you filling out forms by yourself?|Participants|Count of Participants|0|0.0||||||
3643125|NCT02504502|3490265|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643040|NCT02504502|3490264|B3||Always|Health Literacy|How confident are you filling out forms by yourself?|Participants|Count of Participants|29|29.0||||||
3643041|NCT02504502|3490265|B2||Always|Health Literacy|How confident are you filling out forms by yourself?|Participants|Count of Participants|15|15.0||||||
3643042|NCT02504502|3490266|B1||Always|Health Literacy|How confident are you filling out forms by yourself?|Participants|Count of Participants|14|14.0||||||
3643043|NCT02504502|3490264|B3||Often|Health Literacy|How confident are you filling out forms by yourself?|Participants|Count of Participants|6|6.0||||||
3643044|NCT02504502|3490265|B2||Often|Health Literacy|How confident are you filling out forms by yourself?|Participants|Count of Participants|4|4.0||||||
3643045|NCT02504502|3490266|B1||Often|Health Literacy|How confident are you filling out forms by yourself?|Participants|Count of Participants|2|2.0||||||
3643046|NCT02504502|3490264|B3||Sometimes|Health Literacy|How confident are you filling out forms by yourself?|Participants|Count of Participants|9|9.0||||||
3643047|NCT02504502|3490265|B2||Sometimes|Health Literacy|How confident are you filling out forms by yourself?|Participants|Count of Participants|4|4.0||||||
3643048|NCT02504502|3490266|B1||Sometimes|Health Literacy|How confident are you filling out forms by yourself?|Participants|Count of Participants|5|5.0||||||
3643049|NCT02504502|3490264|B3||Occasionally|Health Literacy|How confident are you filling out forms by yourself?|Participants|Count of Participants|6|6.0||||||
3643050|NCT02504502|3490265|B2||Occasionally|Health Literacy|How confident are you filling out forms by yourself?|Participants|Count of Participants|4|4.0||||||
3643051|NCT02504502|3490266|B1||Occasionally|Health Literacy|How confident are you filling out forms by yourself?|Participants|Count of Participants|2|2.0||||||
3643052|NCT02504502|3490264|B3||Never|Health Literacy|How confident are you filling out forms by yourself?|Participants|Count of Participants|1|1.0||||||
3643053|NCT02504502|3490265|B2||Never|Health Literacy|How confident are you filling out forms by yourself?|Participants|Count of Participants|0|0.0||||||
3643054|NCT02504502|3490266|B1||Never|Health Literacy|How confident are you filling out forms by yourself?|Participants|Count of Participants|1|1.0||||||
3643055|NCT02504502|3490264|B3||Missing|Income|Total household income|Participants|Count of Participants|2|2.0||||||
3643056|NCT02504502|3490265|B2||Missing|Income|Total household income|Participants|Count of Participants|2|2.0||||||
3643057|NCT02504502|3490266|B1||Missing|Income|Total household income|Participants|Count of Participants|0|0.0||||||
3643058|NCT02504502|3490264|B3||$200,000 or above|Income|Total household income|Participants|Count of Participants|3|3.0||||||
3643059|NCT02504502|3490265|B2||$200,000 or above|Income|Total household income|Participants|Count of Participants|0|0.0||||||
3643060|NCT02504502|3490266|B1||$200,000 or above|Income|Total household income|Participants|Count of Participants|3|3.0||||||
3643061|NCT02504502|3490264|B3||$150,000 to $199,999|Income|Total household income|Participants|Count of Participants|5|5.0||||||
3643062|NCT02504502|3490265|B2||$150,000 to $199,999|Income|Total household income|Participants|Count of Participants|2|2.0||||||
3643063|NCT02504502|3490266|B1||$150,000 to $199,999|Income|Total household income|Participants|Count of Participants|3|3.0||||||
3643064|NCT02504502|3490264|B3||$90,000 to $149,999|Income|Total household income|Participants|Count of Participants|5|5.0||||||
3643065|NCT02504502|3490265|B2||$90,000 to $149,999|Income|Total household income|Participants|Count of Participants|2|2.0||||||
3643066|NCT02504502|3490266|B1||$90,000 to $149,999|Income|Total household income|Participants|Count of Participants|3|3.0||||||
3643067|NCT02504502|3490264|B3||$60,000 to $89,999|Income|Total household income|Participants|Count of Participants|18|18.0||||||
3643068|NCT02504502|3490265|B2||$60,000 to $89,999|Income|Total household income|Participants|Count of Participants|14|14.0||||||
3643069|NCT02504502|3490266|B1||$60,000 to $89,999|Income|Total household income|Participants|Count of Participants|4|4.0||||||
3643070|NCT02504502|3490264|B3||$45,000 to $59,999|Income|Total household income|Participants|Count of Participants|8|8.0||||||
3643071|NCT02504502|3490265|B2||$45,000 to $59,999|Income|Total household income|Participants|Count of Participants|2|2.0||||||
3643072|NCT02504502|3490266|B1||$45,000 to $59,999|Income|Total household income|Participants|Count of Participants|6|6.0||||||
3643073|NCT02504502|3490264|B3||$30,000 to $44,999|Income|Total household income|Participants|Count of Participants|6|6.0||||||
3643074|NCT02504502|3490265|B2||$30,000 to $44,999|Income|Total household income|Participants|Count of Participants|4|4.0||||||
3643075|NCT02504502|3490266|B1||$30,000 to $44,999|Income|Total household income|Participants|Count of Participants|2|2.0||||||
3643076|NCT02504502|3490264|B3||$15,000 to $29,999|Income|Total household income|Participants|Count of Participants|4|4.0||||||
3643077|NCT02504502|3490265|B2||$15,000 to $29,999|Income|Total household income|Participants|Count of Participants|1|1.0||||||
3643078|NCT02504502|3490266|B1||$15,000 to $29,999|Income|Total household income|Participants|Count of Participants|3|3.0||||||
3643079|NCT02504502|3490264|B3||Less than $15,000|Income|Total household income|Participants|Count of Participants|1|1.0||||||
3643080|NCT02504502|3490265|B2||Less than $15,000|Income|Total household income|Participants|Count of Participants|1|1.0||||||
3643081|NCT02504502|3490266|B1||Less than $15,000|Income|Total household income|Participants|Count of Participants|0|0.0||||||
3643082|NCT02504502|3490264|B3||Doctor or other professional degree|Education|Highest level of education completed by participant|Participants|Count of Participants|1|1.0||||||
3643083|NCT02504502|3490265|B2||Doctor or other professional degree|Education|Highest level of education completed by participant|Participants|Count of Participants|0|0.0||||||
3643084|NCT02504502|3490266|B1||Doctor or other professional degree|Education|Highest level of education completed by participant|Participants|Count of Participants|1|1.0||||||
3643085|NCT02504502|3490264|B3||Master's degree|Education|Highest level of education completed by participant|Participants|Count of Participants|8|8.0||||||
3643086|NCT02504502|3490265|B2||Master's degree|Education|Highest level of education completed by participant|Participants|Count of Participants|4|4.0||||||
3643087|NCT02504502|3490266|B1||Master's degree|Education|Highest level of education completed by participant|Participants|Count of Participants|4|4.0||||||
3643088|NCT02504502|3490264|B3||Bachelor's degree or equivalent|Education|Highest level of education completed by participant|Participants|Count of Participants|9|9.0||||||
3643089|NCT02504502|3490265|B2||Bachelor's degree or equivalent|Education|Highest level of education completed by participant|Participants|Count of Participants|6|6.0||||||
3643090|NCT02504502|3490266|B1||Bachelor's degree or equivalent|Education|Highest level of education completed by participant|Participants|Count of Participants|3|3.0||||||
3643091|NCT02504502|3490264|B3||Some college|Education|Highest level of education completed by participant|Participants|Count of Participants|13|13.0||||||
3643092|NCT02504502|3490265|B2||Some college|Education|Highest level of education completed by participant|Participants|Count of Participants|6|6.0||||||
3643093|NCT02504502|3490266|B1||Some college|Education|Highest level of education completed by participant|Participants|Count of Participants|7|7.0||||||
3643094|NCT02504502|3490264|B3||Post high school training other than college|Education|Highest level of education completed by participant|Participants|Count of Participants|7|7.0||||||
3643095|NCT02504502|3490265|B2||Post high school training other than college|Education|Highest level of education completed by participant|Participants|Count of Participants|5|5.0||||||
3643096|NCT02504502|3490266|B1||Post high school training other than college|Education|Highest level of education completed by participant|Participants|Count of Participants|2|2.0||||||
3643097|NCT02504502|3490264|B3||High school graduate or GED|Education|Highest level of education completed by participant|Participants|Count of Participants|10|10.0||||||
3643098|NCT02504502|3490265|B2||High school graduate or GED|Education|Highest level of education completed by participant|Participants|Count of Participants|7|7.0||||||
3643099|NCT02504502|3490266|B1||High school graduate or GED|Education|Highest level of education completed by participant|Participants|Count of Participants|3|3.0||||||
3643100|NCT02504502|3490264|B3||Some high school (9-12)|Education|Highest level of education completed by participant|Participants|Count of Participants|4|4.0||||||
3643101|NCT02504502|3490265|B2||Some high school (9-12)|Education|Highest level of education completed by participant|Participants|Count of Participants|0|0.0||||||
3643102|NCT02504502|3490266|B1||Some high school (9-12)|Education|Highest level of education completed by participant|Participants|Count of Participants|4|4.0||||||
3643103|NCT02504502|3490264|B3||Non-Causal Variant Result|Child's WGS Result|Child's result after Whole Genome Sequencing (WGS). Results are either Causal Variant (CV) found or non-Causal Variant (NCV) found. CV indicates a positive result for the child (a genetic cause for the developmental delay). NCV indicates results were negative (no genetic cause or diagnosis for the child after sequencing).|Participants|Count of Participants|45|45.0||||||
3643104|NCT02504502|3490265|B2||Non-Causal Variant Result|Child's WGS Result|Child's result after Whole Genome Sequencing (WGS). Results are either Causal Variant (CV) found or non-Causal Variant (NCV) found. CV indicates a positive result for the child (a genetic cause for the developmental delay). NCV indicates results were negative (no genetic cause or diagnosis for the child after sequencing).|Participants|Count of Participants|25|25.0||||||
3643105|NCT02504502|3490266|B1||Non-Causal Variant Result|Child's WGS Result|Child's result after Whole Genome Sequencing (WGS). Results are either Causal Variant (CV) found or non-Causal Variant (NCV) found. CV indicates a positive result for the child (a genetic cause for the developmental delay). NCV indicates results were negative (no genetic cause or diagnosis for the child after sequencing).|Participants|Count of Participants|20|20.0||||||
3643106|NCT02504502|3490264|B3||Causal Variant Result|Child's WGS Result|Child's result after Whole Genome Sequencing (WGS). Results are either Causal Variant (CV) found or non-Causal Variant (NCV) found. CV indicates a positive result for the child (a genetic cause for the developmental delay). NCV indicates results were negative (no genetic cause or diagnosis for the child after sequencing).|Participants|Count of Participants|7|7.0||||||
3643107|NCT02504502|3490265|B2||Causal Variant Result|Child's WGS Result|Child's result after Whole Genome Sequencing (WGS). Results are either Causal Variant (CV) found or non-Causal Variant (NCV) found. CV indicates a positive result for the child (a genetic cause for the developmental delay). NCV indicates results were negative (no genetic cause or diagnosis for the child after sequencing).|Participants|Count of Participants|3|3.0||||||
3643108|NCT02504502|3490266|B1||Causal Variant Result|Child's WGS Result|Child's result after Whole Genome Sequencing (WGS). Results are either Causal Variant (CV) found or non-Causal Variant (NCV) found. CV indicates a positive result for the child (a genetic cause for the developmental delay). NCV indicates results were negative (no genetic cause or diagnosis for the child after sequencing).|Participants|Count of Participants|4|4.0||||||
3643109|NCT02504502|3490264|B3|United States||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
3643110|NCT02504502|3490265|B2|United States||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3643111|NCT02504502|3490266|B1|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3643112|NCT02504502|3490264|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3643113|NCT02504502|3490265|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3643114|NCT02504502|3490266|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3643115|NCT02504502|3490264|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643116|NCT02504502|3490265|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643117|NCT02504502|3490266|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643118|NCT02504502|3490264|B3||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3643119|NCT02504502|3490265|B2||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3643120|NCT02504502|3490266|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3643121|NCT02504502|3490264|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643122|NCT02504502|3490265|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643123|NCT02504502|3490266|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643124|NCT02504502|3490264|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643126|NCT02504502|3490266|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643127|NCT02504502|3490264|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643128|NCT02504502|3490265|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643129|NCT02504502|3490266|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643130|NCT02504502|3490264|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643131|NCT02504502|3490265|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643132|NCT02504502|3490266|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643133|NCT02504502|3490264|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3643134|NCT02504502|3490265|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643135|NCT02504502|3490266|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3643136|NCT02504502|3490264|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3643137|NCT02504502|3490265|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3643138|NCT02504502|3490266|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3643139|NCT02504502|3490264|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3643140|NCT02504502|3490265|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3643141|NCT02504502|3490266|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643142|NCT02504502|3490264|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3643143|NCT02504502|3490265|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3643144|NCT02504502|3490266|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3643145|NCT02504502|3490264|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3643146|NCT02504502|3490265|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3643147|NCT02504502|3490266|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3643148|NCT02504502|3490264|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3643149|NCT02504502|3490265|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3643150|NCT02504502|3490266|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3643151|NCT02504502|3490264|B3||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3643152|NCT02504502|3490265|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3643153|NCT02504502|3490266|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3643154|NCT02504502|3490264|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3643155|NCT02504502|3490265|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3643156|NCT02504502|3490266|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3643157|NCT02504424|3490273|B1|||Body Mass Index||lbs/in2|Mean|24.5|24.5|Standard Deviation|3.57|3.57|||
3643158|NCT02504424|3490273|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3643159|NCT02504424|3490273|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3643160|NCT02504424|3490273|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3643161|NCT02504424|3490273|B1||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3643162|NCT02504424|3490273|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3643163|NCT02504424|3490273|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643164|NCT02504424|3490273|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3643165|NCT02504424|3490273|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643166|NCT02504424|3490273|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643167|NCT02504424|3490273|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3643168|NCT02504424|3490273|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3643169|NCT02504424|3490273|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3643170|NCT02504424|3490273|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3643171|NCT02504424|3490273|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3643172|NCT02504424|3490273|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3643173|NCT02504424|3490273|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3643174|NCT02504320|3490278|B5|Check-in (n=19, 19, 20, 20)||Estimated Glomerular Filtration Rate (eGFR)|eGFR is calculated using the Cockcroft-Gault formula.|mL/min|Mean|114.82|114.82|Standard Deviation|11.987|11.987|||
3643175|NCT02504320|3490279|B4|Check-in (n=19, 19, 20, 20)||Estimated Glomerular Filtration Rate (eGFR)|eGFR is calculated using the Cockcroft-Gault formula.|mL/min|Mean|116.55|116.55|Standard Deviation|12.845|12.845|||
3643176|NCT02504320|3490280|B3|Check-in (n=19, 19, 20, 20)||Estimated Glomerular Filtration Rate (eGFR)|eGFR is calculated using the Cockcroft-Gault formula.|mL/min|Mean|112.00|112.0|Standard Deviation|10.964|10.964|||
3643177|NCT02504320|3490281|B2|Check-in (n=19, 19, 20, 20)||Estimated Glomerular Filtration Rate (eGFR)|eGFR is calculated using the Cockcroft-Gault formula.|mL/min|Mean|115.26|115.26|Standard Deviation|12.229|12.229|||
3643178|NCT02504320|3490282|B1|Check-in (n=19, 19, 20, 20)||Estimated Glomerular Filtration Rate (eGFR)|eGFR is calculated using the Cockcroft-Gault formula.|mL/min|Mean|115.53|115.53|Standard Deviation|12.294|12.294|||
3643229|NCT02504320|3490278|B5|Is an Ex-smoker||Smoking Classification||Participants|Count of Participants|20|20.0||||||
3643179|NCT02504320|3490278|B5|Screening (n=19, 19, 19, 20)||Estimated Glomerular Filtration Rate (eGFR)|eGFR is calculated using the Cockcroft-Gault formula.|mL/min|Mean|111.61|111.61|Standard Deviation|12.211|12.211|||
3643180|NCT02504320|3490279|B4|Screening (n=19, 19, 19, 20)||Estimated Glomerular Filtration Rate (eGFR)|eGFR is calculated using the Cockcroft-Gault formula.|mL/min|Mean|114.00|114.0|Standard Deviation|13.377|13.377|||
3643181|NCT02504320|3490280|B3|Screening (n=19, 19, 19, 20)||Estimated Glomerular Filtration Rate (eGFR)|eGFR is calculated using the Cockcroft-Gault formula.|mL/min|Mean|108.05|108.05|Standard Deviation|11.664|11.664|||
3643182|NCT02504320|3490281|B2|Screening (n=19, 19, 19, 20)||Estimated Glomerular Filtration Rate (eGFR)|eGFR is calculated using the Cockcroft-Gault formula.|mL/min|Mean|112.84|112.84|Standard Deviation|11.987|11.987|||
3643183|NCT02504320|3490282|B1|Screening (n=19, 19, 19, 20)||Estimated Glomerular Filtration Rate (eGFR)|eGFR is calculated using the Cockcroft-Gault formula.|mL/min|Mean|111.42|111.42|Standard Deviation|11.815|11.815|||
3643184|NCT02504320|3490278|B5|Postmenopausal||Female Reproductive Status||Participants|Count of Participants|2|2.0||||||
3643185|NCT02504320|3490279|B4|Postmenopausal||Female Reproductive Status||Participants|Count of Participants|0|0.0||||||
3643186|NCT02504320|3490280|B3|Postmenopausal||Female Reproductive Status||Participants|Count of Participants|1|1.0||||||
3643187|NCT02504320|3490281|B2|Postmenopausal||Female Reproductive Status||Participants|Count of Participants|0|0.0||||||
3643188|NCT02504320|3490282|B1|Postmenopausal||Female Reproductive Status||Participants|Count of Participants|1|1.0||||||
3643189|NCT02504320|3490278|B5|Surgically Sterile||Female Reproductive Status||Participants|Count of Participants|5|5.0||||||
3643190|NCT02504320|3490279|B4|Surgically Sterile||Female Reproductive Status||Participants|Count of Participants|2|2.0||||||
3643191|NCT02504320|3490280|B3|Surgically Sterile||Female Reproductive Status||Participants|Count of Participants|0|0.0||||||
3643192|NCT02504320|3490281|B2|Surgically Sterile||Female Reproductive Status||Participants|Count of Participants|1|1.0||||||
3643193|NCT02504320|3490282|B1|Surgically Sterile||Female Reproductive Status||Participants|Count of Participants|2|2.0||||||
3643194|NCT02504320|3490278|B5|Female of Childbearing Potential||Female Reproductive Status||Participants|Count of Participants|36|36.0||||||
3643195|NCT02504320|3490279|B4|Female of Childbearing Potential||Female Reproductive Status||Participants|Count of Participants|12|12.0||||||
3643196|NCT02504320|3490280|B3|Female of Childbearing Potential||Female Reproductive Status||Participants|Count of Participants|8|8.0||||||
3643197|NCT02504320|3490281|B2|Female of Childbearing Potential||Female Reproductive Status||Participants|Count of Participants|9|9.0||||||
3643198|NCT02504320|3490282|B1|Female of Childbearing Potential||Female Reproductive Status||Participants|Count of Participants|7|7.0||||||
3643199|NCT02504320|3490278|B5|Not Applicable (Participant is Male)||Female Reproductive Status||Participants|Count of Participants|35|35.0||||||
3643200|NCT02504320|3490279|B4|Not Applicable (Participant is Male)||Female Reproductive Status||Participants|Count of Participants|6|6.0||||||
3643201|NCT02504320|3490280|B3|Not Applicable (Participant is Male)||Female Reproductive Status||Participants|Count of Participants|11|11.0||||||
3643202|NCT02504320|3490281|B2|Not Applicable (Participant is Male)||Female Reproductive Status||Participants|Count of Participants|9|9.0||||||
3643203|NCT02504320|3490282|B1|Not Applicable (Participant is Male)||Female Reproductive Status||Participants|Count of Participants|9|9.0||||||
3643204|NCT02504320|3490278|B5|No||Xanthine/Caffeine Consumption||Participants|Count of Participants|27|27.0||||||
3643205|NCT02504320|3490279|B4|No||Xanthine/Caffeine Consumption||Participants|Count of Participants|6|6.0||||||
3643206|NCT02504320|3490280|B3|No||Xanthine/Caffeine Consumption||Participants|Count of Participants|8|8.0||||||
3643207|NCT02504320|3490281|B2|No||Xanthine/Caffeine Consumption||Participants|Count of Participants|6|6.0||||||
3643208|NCT02504320|3490282|B1|No||Xanthine/Caffeine Consumption||Participants|Count of Participants|7|7.0||||||
3643209|NCT02504320|3490278|B5|Yes||Xanthine/Caffeine Consumption||Participants|Count of Participants|51|51.0||||||
3643210|NCT02504320|3490279|B4|Yes||Xanthine/Caffeine Consumption||Participants|Count of Participants|14|14.0||||||
3643211|NCT02504320|3490280|B3|Yes||Xanthine/Caffeine Consumption||Participants|Count of Participants|12|12.0||||||
3643212|NCT02504320|3490281|B2|Yes||Xanthine/Caffeine Consumption||Participants|Count of Participants|13|13.0||||||
3643213|NCT02504320|3490282|B1|Yes||Xanthine/Caffeine Consumption||Participants|Count of Participants|12|12.0||||||
3643214|NCT02504320|3490278|B5|Is an Ex-drinker||Alcohol Classification||Participants|Count of Participants|28|28.0||||||
3643215|NCT02504320|3490279|B4|Is an Ex-drinker||Alcohol Classification||Participants|Count of Participants|9|9.0||||||
3643216|NCT02504320|3490280|B3|Is an Ex-drinker||Alcohol Classification||Participants|Count of Participants|8|8.0||||||
3643217|NCT02504320|3490281|B2|Is an Ex-drinker||Alcohol Classification||Participants|Count of Participants|4|4.0||||||
3643218|NCT02504320|3490282|B1|Is an Ex-drinker||Alcohol Classification||Participants|Count of Participants|7|7.0||||||
3643219|NCT02504320|3490278|B5|Is a Current Drinker||Alcohol Classification||Participants|Count of Participants|27|27.0||||||
3643220|NCT02504320|3490279|B4|Is a Current Drinker||Alcohol Classification||Participants|Count of Participants|4|4.0||||||
3643221|NCT02504320|3490280|B3|Is a Current Drinker||Alcohol Classification||Participants|Count of Participants|6|6.0||||||
3643222|NCT02504320|3490281|B2|Is a Current Drinker||Alcohol Classification||Participants|Count of Participants|9|9.0||||||
3643223|NCT02504320|3490282|B1|Is a Current Drinker||Alcohol Classification||Participants|Count of Participants|8|8.0||||||
3643224|NCT02504320|3490278|B5|Has Never Drunk||Alcohol Classification||Participants|Count of Participants|23|23.0||||||
3643225|NCT02504320|3490279|B4|Has Never Drunk||Alcohol Classification||Participants|Count of Participants|7|7.0||||||
3643226|NCT02504320|3490280|B3|Has Never Drunk||Alcohol Classification||Participants|Count of Participants|6|6.0||||||
3643227|NCT02504320|3490281|B2|Has Never Drunk||Alcohol Classification||Participants|Count of Participants|6|6.0||||||
3643228|NCT02504320|3490282|B1|Has Never Drunk||Alcohol Classification||Participants|Count of Participants|4|4.0||||||
3643230|NCT02504320|3490279|B4|Is an Ex-smoker||Smoking Classification||Participants|Count of Participants|2|2.0||||||
3643231|NCT02504320|3490280|B3|Is an Ex-smoker||Smoking Classification||Participants|Count of Participants|7|7.0||||||
3643232|NCT02504320|3490281|B2|Is an Ex-smoker||Smoking Classification||Participants|Count of Participants|5|5.0||||||
3643233|NCT02504320|3490282|B1|Is an Ex-smoker||Smoking Classification||Participants|Count of Participants|6|6.0||||||
3643234|NCT02504320|3490278|B5|Is a Current Smoker||Smoking Classification||Participants|Count of Participants|0|0.0||||||
3643235|NCT02504320|3490279|B4|Is a Current Smoker||Smoking Classification||Participants|Count of Participants|0|0.0||||||
3643236|NCT02504320|3490280|B3|Is a Current Smoker||Smoking Classification||Participants|Count of Participants|0|0.0||||||
3643237|NCT02504320|3490281|B2|Is a Current Smoker||Smoking Classification||Participants|Count of Participants|0|0.0||||||
3643238|NCT02504320|3490282|B1|Is a Current Smoker||Smoking Classification||Participants|Count of Participants|0|0.0||||||
3643239|NCT02504320|3490278|B5|Has Never Smoked||Smoking Classification||Participants|Count of Participants|58|58.0||||||
3643240|NCT02504320|3490279|B4|Has Never Smoked||Smoking Classification||Participants|Count of Participants|18|18.0||||||
3643241|NCT02504320|3490280|B3|Has Never Smoked||Smoking Classification||Participants|Count of Participants|13|13.0||||||
3643242|NCT02504320|3490281|B2|Has Never Smoked||Smoking Classification||Participants|Count of Participants|14|14.0||||||
3643243|NCT02504320|3490282|B1|Has Never Smoked||Smoking Classification||Participants|Count of Participants|13|13.0||||||
3643244|NCT02504320|3490278|B5|||Body Mass Index (BMI)||kg/m^2|Mean|25.83|25.83|Standard Deviation|2.878|2.878|||
3643245|NCT02504320|3490279|B4|||Body Mass Index (BMI)||kg/m^2|Mean|25.28|25.28|Standard Deviation|2.802|2.802|||
3643246|NCT02504320|3490280|B3|||Body Mass Index (BMI)||kg/m^2|Mean|25.29|25.29|Standard Deviation|3.168|3.168|||
3643247|NCT02504320|3490281|B2|||Body Mass Index (BMI)||kg/m^2|Mean|26.98|26.98|Standard Deviation|2.722|2.722|||
3643248|NCT02504320|3490282|B1|||Body Mass Index (BMI)||kg/m^2|Mean|25.84|25.84|Standard Deviation|2.663|2.663|||
3643249|NCT02504320|3490278|B5|||Weight||kg|Mean|73.17|73.17|Standard Deviation|12.273|12.273|||
3643250|NCT02504320|3490279|B4|||Weight||kg|Mean|69.72|69.72|Standard Deviation|11.015|11.015|||
3643251|NCT02504320|3490280|B3|||Weight||kg|Mean|71.22|71.22|Standard Deviation|12.350|12.35|||
3643252|NCT02504320|3490281|B2|||Weight||kg|Mean|79.05|79.05|Standard Deviation|11.846|11.846|||
3643253|NCT02504320|3490282|B1|||Weight||kg|Mean|72.98|72.98|Standard Deviation|12.685|12.685|||
3643254|NCT02504320|3490278|B5|||Height||cm|Mean|167.9|167.9|Standard Deviation|9.71|9.71|||
3643255|NCT02504320|3490279|B4|||Height||cm|Mean|165.7|165.7|Standard Deviation|6.67|6.67|||
3643256|NCT02504320|3490280|B3|||Height||cm|Mean|167.5|167.5|Standard Deviation|9.70|9.7|||
3643257|NCT02504320|3490281|B2|||Height||cm|Mean|171.1|171.1|Standard Deviation|11.75|11.75|||
3643258|NCT02504320|3490282|B1|||Height||cm|Mean|167.6|167.6|Standard Deviation|10.13|10.13|||
3643259|NCT02504320|3490278|B5|United States||Region of Enrollment||Participants|Count of Participants|78|78.0||||||
3643260|NCT02504320|3490279|B4|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3643261|NCT02504320|3490280|B3|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3643262|NCT02504320|3490281|B2|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3643263|NCT02504320|3490282|B1|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3643264|NCT02504320|3490278|B5|Multiracial||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3643265|NCT02504320|3490279|B4|Multiracial||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3643266|NCT02504320|3490280|B3|Multiracial||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3643267|NCT02504320|3490281|B2|Multiracial||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3643268|NCT02504320|3490282|B1|Multiracial||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3643269|NCT02504320|3490278|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|53|53.0||||||
3643270|NCT02504320|3490279|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3643271|NCT02504320|3490280|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3643272|NCT02504320|3490281|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3643273|NCT02504320|3490282|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3643274|NCT02504320|3490278|B5|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3643275|NCT02504320|3490279|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3643276|NCT02504320|3490280|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3643277|NCT02504320|3490281|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3643278|NCT02504320|3490282|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3643279|NCT02504320|3490278|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3643280|NCT02504320|3490279|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3643281|NCT02504320|3490280|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3643282|NCT02504320|3490281|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3643283|NCT02504320|3490282|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3643284|NCT02504320|3490278|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
3643285|NCT02504320|3490279|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3643286|NCT02504320|3490280|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3643287|NCT02504320|3490281|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3643288|NCT02504320|3490282|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3643289|NCT02504320|3490278|B5|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
3643290|NCT02504320|3490279|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3643291|NCT02504320|3490280|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3643292|NCT02504320|3490281|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3643293|NCT02504320|3490282|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3643294|NCT02504320|3490278|B5||Male|Gender||Participants|Count of Participants|35|35.0||||||
3643295|NCT02504320|3490279|B4||Male|Gender||Participants|Count of Participants|6|6.0||||||
3643296|NCT02504320|3490280|B3||Male|Gender||Participants|Count of Participants|11|11.0||||||
3643297|NCT02504320|3490281|B2||Male|Gender||Participants|Count of Participants|9|9.0||||||
3643298|NCT02504320|3490282|B1||Male|Gender||Participants|Count of Participants|9|9.0||||||
3643299|NCT02504320|3490278|B5||Female|Gender||Participants|Count of Participants|43|43.0||||||
3643300|NCT02504320|3490279|B4||Female|Gender||Participants|Count of Participants|14|14.0||||||
3643301|NCT02504320|3490280|B3||Female|Gender||Participants|Count of Participants|9|9.0||||||
3643302|NCT02504320|3490281|B2||Female|Gender||Participants|Count of Participants|10|10.0||||||
3643303|NCT02504320|3490282|B1||Female|Gender||Participants|Count of Participants|10|10.0||||||
3643304|NCT02504320|3490278|B5|||Age||years|Mean|31.9|31.9|Standard Deviation|7.70|7.7|||
3643305|NCT02504320|3490279|B4|||Age||years|Mean|31.2|31.2|Standard Deviation|7.78|7.78|||
3643306|NCT02504320|3490280|B3|||Age||years|Mean|34.0|34.0|Standard Deviation|8.87|8.87|||
3643307|NCT02504320|3490281|B2|||Age||years|Mean|30.7|30.7|Standard Deviation|6.51|6.51|||
3643308|NCT02504320|3490282|B1|||Age||years|Mean|31.7|31.7|Standard Deviation|7.56|7.56|||
3643309|NCT02504294|3490303|B3||Male|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
3643310|NCT02504294|3490304|B2||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3643311|NCT02504294|3490305|B1||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3643312|NCT02504294|3490303|B3||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3643313|NCT02504294|3490304|B2||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3643314|NCT02504294|3490305|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3643315|NCT02504294|3490303|B3|||Age||Years|Mean|59.9|59.9|Standard Deviation|14.09|14.09|||
3643316|NCT02504294|3490304|B2|||Age||Years|Mean|59.3|59.3|Standard Deviation|14.23|14.23|||
3643317|NCT02504294|3490305|B1|||Age||Years|Mean|60.5|60.5|Standard Deviation|13.96|13.96|||
3643318|NCT02504099|3490314|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3643319|NCT02504099|3490314|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3643320|NCT02504099|3490314|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|1.53|1.53|||
3643321|NCT02504073|3490322|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3643322|NCT02504073|3490322|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3643323|NCT02504073|3490322|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3643324|NCT02504073|3490322|B1||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3643325|NCT02504073|3490322|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3643326|NCT02503982|3490328|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3643327|NCT02503982|3490328|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3643328|NCT02503982|3490328|B1|||Age||years|Median|7.3|7.3|Inter-Quartile Range|||2.2|11.6|
3643329|NCT02503982|3490328|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3643330|NCT02503982|3490328|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3643331|NCT02503982|3490328|B1||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
3643332|NCT02503865|3490332|B4||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3643333|NCT02503865|3490333|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3643334|NCT02503865|3490334|B2||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3643335|NCT02503865|3490335|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3643336|NCT02503865|3490332|B4||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3643337|NCT02503865|3490333|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3643338|NCT02503865|3490334|B2||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3643339|NCT02503865|3490335|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3643340|NCT02503865|3490332|B4|Age||Age, Customized||years|Mean|47.3|47.3|Standard Deviation|12.9|12.9|||
3643341|NCT02503865|3490333|B3|Age||Age, Customized||years|Mean|47.7|47.7|Standard Deviation|12.3|12.3|||
3643342|NCT02503865|3490334|B2|Age||Age, Customized||years|Mean|47.4|47.4|Standard Deviation|12.8|12.8|||
3643343|NCT02503865|3490335|B1|Age||Age, Customized||years|Mean|46.5|46.5|Standard Deviation|13.6|13.6|||
3643344|NCT02503787|3490357|B1|||Average Overall Pain|Self reported daily average overall pain score 5 days prior to baseline. The question is scored 0-10 (0=no pain; 10=pain as bad as can be).|units on a scale|Mean|7.5|7.5|Standard Deviation|0.9|0.9|||
3643345|NCT02503787|3490357|B1|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3643346|NCT02503787|3490357|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3643347|NCT02503787|3490357|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3643348|NCT02503787|3490357|B1|||Age||years|Mean|56.0|56.0|Standard Deviation|11.9|11.9|||
3643349|NCT02503254|3490364|B3|> 0.6 to ≤ 1 mg||International Organization for Standardization (ISO) nicotine level||Participants|Count of Participants|14|14.0||||||
3643350|NCT02503254|3490365|B2|> 0.6 to ≤ 1 mg||International Organization for Standardization (ISO) nicotine level||Participants|Count of Participants|5|5.0||||||
3643351|NCT02503254|3490366|B1|> 0.6 to ≤ 1 mg||International Organization for Standardization (ISO) nicotine level||Participants|Count of Participants|9|9.0||||||
3643352|NCT02503254|3490364|B3|≤ 0.6 mg||International Organization for Standardization (ISO) nicotine level||Participants|Count of Participants|66|66.0||||||
3643353|NCT02503254|3490365|B2|≤ 0.6 mg||International Organization for Standardization (ISO) nicotine level||Participants|Count of Participants|34|34.0||||||
3643354|NCT02503254|3490366|B1|≤ 0.6 mg||International Organization for Standardization (ISO) nicotine level||Participants|Count of Participants|32|32.0||||||
3643355|NCT02503254|3490364|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3643356|NCT02503254|3490365|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3643357|NCT02503254|3490366|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3643358|NCT02503254|3490364|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3643359|NCT02503254|3490365|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3643360|NCT02503254|3490366|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3643361|NCT02503254|3490364|B3|||Age||years|Mean|33.5|33.5|Standard Deviation|10.66|10.66|||
3643362|NCT02503254|3490365|B2|||Age||years|Mean|32.7|32.7|Standard Deviation|10.97|10.97|||
3643363|NCT02503254|3490366|B1|||Age||years|Mean|34.1|34.1|Standard Deviation|10.45|10.45|||
3643364|NCT02503215|3490380|B1|Brazil||Region of Enrollment||participants|Number|14|14.0||||||
3643365|NCT02503215|3490380|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643366|NCT02503215|3490380|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3643367|NCT02503215|3490380|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3643368|NCT02503215|3490380|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3643369|NCT02503215|3490380|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643370|NCT02503215|3490380|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3643371|NCT02503215|3490380|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643372|NCT02503215|3490380|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643373|NCT02503215|3490380|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3643374|NCT02503215|3490380|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3643375|NCT02503215|3490380|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3643376|NCT02503215|3490380|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3643377|NCT02503215|3490380|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3643378|NCT02503215|3490380|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3643379|NCT02503215|3490380|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3643380|NCT02503202|3490386|B6||Male|Sex: Female, Male||Participants|Count of Participants|560|560.0||||||
3643381|NCT02503202|3490387|B5||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3643382|NCT02503202|3490388|B4||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3643383|NCT02503202|3490389|B3||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3643384|NCT02503202|3490390|B2||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3643385|NCT02503202|3490391|B1||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3643386|NCT02503202|3490386|B6||Female|Sex: Female, Male||Participants|Count of Participants|637|637.0||||||
3643387|NCT02503202|3490387|B5||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3643388|NCT02503202|3490388|B4||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3643389|NCT02503202|3490389|B3||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3643390|NCT02503202|3490390|B2||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3643391|NCT02503202|3490391|B1||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3643392|NCT02503202|3490386|B6|||Age||Years|Mean|41.3|41.3|Standard Deviation|13.1|13.1|||
3643393|NCT02503202|3490387|B5|||Age||Years|Mean|41.1|41.1|Standard Deviation|13.7|13.7|||
3643394|NCT02503202|3490388|B4|||Age||Years|Mean|41.7|41.7|Standard Deviation|13.4|13.4|||
3643395|NCT02503202|3490389|B3|||Age||Years|Mean|40.9|40.9|Standard Deviation|13.1|13.1|||
3643396|NCT02503202|3490390|B2|||Age||Years|Mean|41.5|41.5|Standard Deviation|12.4|12.4|||
3643397|NCT02503202|3490391|B1|||Age||Years|Mean|41.3|41.3|Standard Deviation|13.4|13.4|||
3643398|NCT02503085|3490437|B1|||Body Mass Index (BMI)||kg/m²|Mean|24.07|24.07|Standard Deviation|1.884|1.884|||
3643399|NCT02503085|3490437|B1|||Height||m|Mean|1.711|1.711|Standard Deviation|0.1000|0.1|||
3643400|NCT02503085|3490437|B1|||Weight||kg|Mean|70.88|70.88|Standard Deviation|10.909|10.909|||
3643401|NCT02503085|3490437|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3643402|NCT02503085|3490437|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3643403|NCT02503085|3490437|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3643404|NCT02503085|3490437|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3643405|NCT02503085|3490437|B1|||Age||years|Mean|31.46|31.46|Standard Deviation|8.660|8.66|||
3643406|NCT02502864|3490479|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3643407|NCT02502864|3490479|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643408|NCT02502864|3490479|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643409|NCT02502864|3490479|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3643410|NCT02502864|3490479|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643411|NCT02502864|3490479|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643412|NCT02502864|3490479|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643413|NCT02502864|3490479|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643414|NCT02502864|3490479|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643415|NCT02502864|3490479|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3643416|NCT02502864|3490479|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3643417|NCT02502864|3490479|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3643418|NCT02502864|3490479|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3643419|NCT02502864|3490479|B1|||Age||years|Mean|72|72.0|Full Range|||66.0|85.0|
3643420|NCT02502734|3490488|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|59|59.0||||||
3643421|NCT02502734|3490488|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3643422|NCT02502734|3490488|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3643423|NCT02502734|3490488|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3643424|NCT02502734|3490488|B1|||Age||Years|Mean|8.7|8.7|Standard Deviation|1.53|1.53|||
3643425|NCT02502526|3490497|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643426|NCT02502526|3490498|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643427|NCT02502526|3490499|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643428|NCT02502526|3490500|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643429|NCT02502526|3490497|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3643430|NCT02502526|3490498|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3643431|NCT02502526|3490499|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3643432|NCT02502526|3490500|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3643433|NCT02502526|3490497|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
3643434|NCT02502526|3490498|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3643435|NCT02502526|3490499|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3643436|NCT02502526|3490500|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3643437|NCT02502526|3490497|B4||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3643438|NCT02502526|3490498|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3643439|NCT02502526|3490499|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3643440|NCT02502526|3490500|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3643441|NCT02502526|3490497|B4||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3643442|NCT02502526|3490498|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3643443|NCT02502526|3490499|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3643444|NCT02502526|3490500|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3643445|NCT02502526|3490497|B4|||Age||years|Mean|71.1|71.1|Standard Deviation|9.2|9.2|||
3643446|NCT02502526|3490498|B3|||Age||years|Mean|73.4|73.4|Standard Deviation|9.6|9.6|||
3643447|NCT02502526|3490499|B2|||Age||years|Mean|70.3|70.3|Standard Deviation|9.2|9.2|||
3643448|NCT02502526|3490500|B1|||Age||years|Mean|69.6|69.6|Standard Deviation|8.4|8.4|||
3643449|NCT02502487|3490515|B4|Repeat cystoscopy||Cystoscopy history||participants|Number|79|79.0||||||
3643450|NCT02502487|3490516|B3|Repeat cystoscopy||Cystoscopy history||participants|Number|25|25.0||||||
3643451|NCT02502487|3490517|B2|Repeat cystoscopy||Cystoscopy history||participants|Number|28|28.0||||||
3643452|NCT02502487|3490518|B1|Repeat cystoscopy||Cystoscopy history||participants|Number|26|26.0||||||
3643453|NCT02502487|3490515|B4|First-time cystoscopy||Cystoscopy history||participants|Number|179|179.0||||||
3643454|NCT02502487|3490516|B3|First-time cystoscopy||Cystoscopy history||participants|Number|61|61.0||||||
3643455|NCT02502487|3490517|B2|First-time cystoscopy||Cystoscopy history||participants|Number|58|58.0||||||
3643456|NCT02502487|3490518|B1|First-time cystoscopy||Cystoscopy history||participants|Number|60|60.0||||||
3643457|NCT02502487|3490515|B4|||Duration of cystoscopy||min|Mean|3.5|3.5|Standard Deviation|0.6|0.6|||
3643458|NCT02502487|3490516|B3|||Duration of cystoscopy||min|Mean|3.4|3.4|Standard Deviation|0.5|0.5|||
3643459|NCT02502487|3490517|B2|||Duration of cystoscopy||min|Mean|3.5|3.5|Standard Deviation|0.5|0.5|||
3643460|NCT02502487|3490518|B1|||Duration of cystoscopy||min|Mean|3.5|3.5|Standard Deviation|0.6|0.6|||
3643461|NCT02502487|3490515|B4|||Body mass index||Kg/m^2|Mean|23.8|23.8|Standard Deviation|2.7|2.7|||
3643462|NCT02502487|3490516|B3|||Body mass index||Kg/m^2|Mean|23.6|23.6|Standard Deviation|2.7|2.7|||
3643463|NCT02502487|3490517|B2|||Body mass index||Kg/m^2|Mean|24.2|24.2|Standard Deviation|3.0|3.0|||
3643464|NCT02502487|3490518|B1|||Body mass index||Kg/m^2|Mean|23.8|23.8|Standard Deviation|2.4|2.4|||
3643465|NCT02502487|3490515|B4|||Height||cm|Mean|167.9|167.9|Standard Deviation|5.8|5.8|||
3643466|NCT02502487|3490516|B3|||Height||cm|Mean|167.8|167.8|Standard Deviation|6.4|6.4|||
3643467|NCT02502487|3490517|B2|||Height||cm|Mean|168.7|168.7|Standard Deviation|5.5|5.5|||
3643468|NCT02502487|3490518|B1|||Height||cm|Mean|167.3|167.3|Standard Deviation|5.6|5.6|||
3643469|NCT02502487|3490515|B4|||Body weight||Kg|Mean|67.3|67.3|Standard Deviation|8.9|8.9|||
3643470|NCT02502487|3490516|B3|||Body weight||Kg|Mean|66.4|66.4|Standard Deviation|8.9|8.9|||
3643471|NCT02502487|3490517|B2|||Body weight||Kg|Mean|68.8|68.8|Standard Deviation|9.6|9.6|||
3643472|NCT02502487|3490518|B1|||Body weight||Kg|Mean|66.8|66.8|Standard Deviation|8.2|8.2|||
3643473|NCT02502487|3490515|B4|Male||Sex/Gender, Customized||participants|Number|258|258.0||||||
3643474|NCT02502487|3490516|B3|Male||Sex/Gender, Customized||participants|Number|86|86.0||||||
3643475|NCT02502487|3490517|B2|Male||Sex/Gender, Customized||participants|Number|86|86.0||||||
3643476|NCT02502487|3490518|B1|Male||Sex/Gender, Customized||participants|Number|86|86.0||||||
3643477|NCT02502487|3490515|B4|||Age||years|Mean|53.0|53.0|Standard Deviation|12.2|12.2|||
3643478|NCT02502487|3490516|B3|||Age||years|Mean|53.5|53.5|Standard Deviation|12.0|12.0|||
3643479|NCT02502487|3490517|B2|||Age||years|Mean|52.1|52.1|Standard Deviation|13.0|13.0|||
3643480|NCT02502487|3490518|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|11.5|11.5|||
3643481|NCT02502149|3490588|B1|Not reported||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3643482|NCT02502149|3490588|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3643483|NCT02502149|3490588|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3643484|NCT02502149|3490588|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3643485|NCT02502149|3490588|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3643486|NCT02502149|3490588|B1|||Age||years|Mean|30.8|30.8|Standard Deviation|12.78|12.78|||
3643487|NCT02502071|3490711|B1|||Type 1 Diabetes Duration||years|Mean|20.2|20.2|Standard Deviation|9.3|9.3|||
3643488|NCT02502071|3490711|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643489|NCT02502071|3490711|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3643490|NCT02502071|3490711|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643491|NCT02502071|3490711|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3643492|NCT02502071|3490711|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3643493|NCT02502071|3490711|B1|||Age||years|Mean|33.6|33.6|Standard Deviation|8.5|8.5|||
3643494|NCT02501629|3490716|B3|||Oral Corticosteroid (OCS) Dose at Baseline|The patient’s previous OCS was standardized to an equivalent dose and regimen of prednisone to the nearest 2.5 mg daily. Prior to study, the dose was adjusted to identify the minimal effective OCS dose to control asthma symptoms without change to background asthma medications (non-OCS).|mg|Mean|10.37|10.37|Standard Deviation|6.604|6.604|||
3643495|NCT02501629|3490717|B2|||Oral Corticosteroid (OCS) Dose at Baseline|The patient’s previous OCS was standardized to an equivalent dose and regimen of prednisone to the nearest 2.5 mg daily. Prior to study, the dose was adjusted to identify the minimal effective OCS dose to control asthma symptoms without change to background asthma medications (non-OCS).|mg|Mean|10.37|10.37|Standard Deviation|6.807|6.807|||
3643496|NCT02501629|3490718|B1|||Oral Corticosteroid (OCS) Dose at Baseline|The patient’s previous OCS was standardized to an equivalent dose and regimen of prednisone to the nearest 2.5 mg daily. Prior to study, the dose was adjusted to identify the minimal effective OCS dose to control asthma symptoms without change to background asthma medications (non-OCS).|mg|Mean|10.37|10.37|Standard Deviation|6.435|6.435|||
3643497|NCT02501629|3490716|B3||Other|Region Group||Participants|Count of Participants|53|53.0||||||
3643498|NCT02501629|3490717|B2||Other|Region Group||Participants|Count of Participants|32|32.0||||||
3643499|NCT02501629|3490718|B1||Other|Region Group||Participants|Count of Participants|21|21.0||||||
3643500|NCT02501629|3490716|B3||Europe|Region Group||Participants|Count of Participants|105|105.0||||||
3643501|NCT02501629|3490717|B2||Europe|Region Group||Participants|Count of Participants|47|47.0||||||
3643502|NCT02501629|3490718|B1||Europe|Region Group||Participants|Count of Participants|58|58.0||||||
3643503|NCT02501629|3490716|B3||US/Canada|Region Group||Participants|Count of Participants|19|19.0||||||
3643504|NCT02501629|3490717|B2||US/Canada|Region Group||Participants|Count of Participants|9|9.0||||||
3643505|NCT02501629|3490718|B1||US/Canada|Region Group||Participants|Count of Participants|10|10.0||||||
3643506|NCT02501629|3490716|B3|||Body Mass Index||kg/m^2|Mean|29.625|29.625|Standard Deviation|7.2067|7.2067|||
3643507|NCT02501629|3490717|B2|||Body Mass Index||kg/m^2|Mean|29.389|29.389|Standard Deviation|8.0105|8.0105|||
3643508|NCT02501629|3490718|B1|||Body Mass Index||kg/m^2|Mean|29.859|29.859|Standard Deviation|6.3499|6.3499|||
3643509|NCT02501629|3490716|B3|||Weight||kg|Mean|81.14|81.14|Standard Deviation|20.202|20.202|||
3643510|NCT02501629|3490717|B2|||Weight||kg|Mean|79.58|79.58|Standard Deviation|21.390|21.39|||
3643511|NCT02501629|3490718|B1|||Weight||kg|Mean|82.69|82.69|Standard Deviation|18.949|18.949|||
3643512|NCT02501629|3490716|B3||>=65 years|Age Group||Participants|Count of Participants|39|39.0||||||
3643513|NCT02501629|3490717|B2||>=65 years|Age Group||Participants|Count of Participants|25|25.0||||||
3643514|NCT02501629|3490718|B1||>=65 years|Age Group||Participants|Count of Participants|14|14.0||||||
3643515|NCT02501629|3490716|B3||18 to <65 years|Age Group||Participants|Count of Participants|137|137.0||||||
3643516|NCT02501629|3490717|B2||18 to <65 years|Age Group||Participants|Count of Participants|63|63.0||||||
3643517|NCT02501629|3490718|B1||18 to <65 years|Age Group||Participants|Count of Participants|74|74.0||||||
3643518|NCT02501629|3490716|B3||12 to <18 years|Age Group||Participants|Count of Participants|1|1.0||||||
3643519|NCT02501629|3490717|B2||12 to <18 years|Age Group||Participants|Count of Participants|0|0.0||||||
3643520|NCT02501629|3490718|B1||12 to <18 years|Age Group||Participants|Count of Participants|1|1.0||||||
3643521|NCT02501629|3490716|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3643522|NCT02501629|3490717|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3643523|NCT02501629|3490718|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3643524|NCT02501629|3490716|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3643525|NCT02501629|3490717|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3643526|NCT02501629|3490718|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3643527|NCT02501629|3490716|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3643528|NCT02501629|3490717|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3643529|NCT02501629|3490718|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3643530|NCT02501629|3490716|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3643531|NCT02501629|3490717|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3643532|NCT02501629|3490718|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3643533|NCT02501629|3490716|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3643534|NCT02501629|3490717|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3643535|NCT02501629|3490718|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3643536|NCT02501629|3490716|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|152|152.0||||||
3643537|NCT02501629|3490717|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|72|72.0||||||
3643538|NCT02501629|3490718|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|80|80.0||||||
3643539|NCT02501629|3490716|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3643540|NCT02501629|3490717|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3643541|NCT02501629|3490718|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3643542|NCT02501629|3490716|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|137|137.0||||||
3643543|NCT02501629|3490717|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3643544|NCT02501629|3490718|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3643545|NCT02501629|3490716|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3643546|NCT02501629|3490717|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3643547|NCT02501629|3490718|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3643548|NCT02501629|3490716|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3643549|NCT02501629|3490717|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3643550|NCT02501629|3490718|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3643551|NCT02501629|3490716|B3||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3643552|NCT02501629|3490717|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3643553|NCT02501629|3490718|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3643554|NCT02501629|3490716|B3|||Age||years|Mean|54.3|54.3|Standard Deviation|12.38|12.38|||
3643555|NCT02501629|3490717|B2|||Age||years|Mean|55.5|55.5|Standard Deviation|12.72|12.72|||
3643556|NCT02501629|3490718|B1|||Age||years|Mean|53.1|53.1|Standard Deviation|11.99|11.99|||
3643557|NCT02501590|3490741|B3|Israel||Region of Enrollment||participants|Number|48|48.0||||||
3643558|NCT02501590|3490742|B2|Israel||Region of Enrollment||participants|Number|35|35.0||||||
3643559|NCT02501590|3490743|B1|Israel||Region of Enrollment||participants|Number|13|13.0||||||
3643560|NCT02501590|3490741|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3643561|NCT02501590|3490741|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3643562|NCT02501590|3490742|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3643563|NCT02501590|3490743|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3643564|NCT02501590|3490741|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3643565|NCT02501590|3490742|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3643566|NCT02501590|3490743|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3643567|NCT02501590|3490741|B3|||Age||years|Mean|5.4|5.4|Standard Deviation|0.45|0.45|||
3643568|NCT02501590|3490742|B2|||Age||years|Mean|5.9|5.9|Standard Deviation|0.4|0.4|||
3643569|NCT02501590|3490743|B1|||Age||years|Mean|4.9|4.9|Standard Deviation|0.5|0.5|||
3643570|NCT02501590|3490741|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3643571|NCT02501590|3490742|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3643572|NCT02501590|3490743|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3643573|NCT02501590|3490741|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3643574|NCT02501590|3490742|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3643575|NCT02501590|3490743|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3643576|NCT02501590|3490741|B3||<=18 years|Age||Participants|Count of Participants|48|48.0||||||
3643577|NCT02501590|3490742|B2||<=18 years|Age||Participants|Count of Participants|35|35.0||||||
3643578|NCT02501590|3490743|B1||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
3643579|NCT02500979|3490750|B3|||Baseline Insulin||U/day|Mean|37.36|37.36|Standard Deviation|10.725|10.725|||
3643580|NCT02500979|3490751|B2|||Baseline Insulin||U/day|Mean|36.58|36.58|Standard Deviation|8.920|8.92|||
3643581|NCT02500979|3490752|B1|||Baseline Insulin||U/day|Mean|38.14|38.14|Standard Deviation|12.525|12.525|||
3643582|NCT02500979|3490750|B3|||Baseline C-peptide||nmol/L|Mean|0.030|0.03|Standard Deviation|0.0100|0.01|||
3643583|NCT02500979|3490751|B2|||Baseline C-peptide||nmol/L|Mean|0.030|0.03|Standard Deviation|0.0141|0.0141|||
3643584|NCT02500979|3490752|B1|||Baseline C-peptide||nmol/L|Mean|0.030|0.03|Standard Deviation|0|0.0|||
3643585|NCT02500979|3490750|B3|||Baseline A1c||%|Mean|8.03|8.03|Standard Deviation|0.506|0.506|||
3643586|NCT02500979|3490751|B2|||Baseline A1c||%|Mean|8.21|8.21|Standard Deviation|0.574|0.574|||
3643587|NCT02500979|3490752|B1|||Baseline A1c||%|Mean|7.84|7.84|Standard Deviation|0.356|0.356|||
3643588|NCT02500979|3490750|B3|||Baseline Fasting Glucose||mmol/L|Mean|8.35|8.35|Standard Deviation|2.928|2.928|||
3643589|NCT02500979|3490751|B2|||Baseline Fasting Glucose||mmol/L|Mean|8.15|8.15|Standard Deviation|3.149|3.149|||
3643590|NCT02500979|3490752|B1|||Baseline Fasting Glucose||mmol/L|Mean|8.57|8.57|Standard Deviation|2.767|2.767|||
3643591|NCT02500979|3490750|B3|≥90 mL/min||Renal Status Category||Participants|Count of Participants|14|14.0||||||
3643592|NCT02500979|3490751|B2|≥90 mL/min||Renal Status Category||Participants|Count of Participants|8|8.0||||||
3643593|NCT02500979|3490752|B1|≥90 mL/min||Renal Status Category||Participants|Count of Participants|6|6.0||||||
3643594|NCT02500979|3490750|B3|≥60 to <90 mL/min||Renal Status Category||Participants|Count of Participants|16|16.0||||||
3643595|NCT02500979|3490751|B2|≥60 to <90 mL/min||Renal Status Category||Participants|Count of Participants|8|8.0||||||
3643596|NCT02500979|3490752|B1|≥60 to <90 mL/min||Renal Status Category||Participants|Count of Participants|8|8.0||||||
3643597|NCT02500979|3490750|B3|≥30 to <60 mL/min||Renal Status Category||Participants|Count of Participants|2|2.0||||||
3643598|NCT02500979|3490751|B2|≥30 to <60 mL/min||Renal Status Category||Participants|Count of Participants|0|0.0||||||
3643599|NCT02500979|3490752|B1|≥30 to <60 mL/min||Renal Status Category||Participants|Count of Participants|2|2.0||||||
3643600|NCT02500979|3490750|B3|<30 mL/min||Renal Status Category||Participants|Count of Participants|0|0.0||||||
3643601|NCT02500979|3490751|B2|<30 mL/min||Renal Status Category||Participants|Count of Participants|0|0.0||||||
3643602|NCT02500979|3490752|B1|<30 mL/min||Renal Status Category||Participants|Count of Participants|0|0.0||||||
3643603|NCT02500979|3490750|B3|Both||Current Administration of Insulin|Subject's usual method of insulin administration - either multiple daily injections (MDI) or continuous subcutaneous infusion of insulin (CSII), or both.|Participants|Count of Participants|2|2.0||||||
3643604|NCT02500979|3490751|B2|Both||Current Administration of Insulin|Subject's usual method of insulin administration - either multiple daily injections (MDI) or continuous subcutaneous infusion of insulin (CSII), or both.|Participants|Count of Participants|0|0.0||||||
3643605|NCT02500979|3490752|B1|Both||Current Administration of Insulin|Subject's usual method of insulin administration - either multiple daily injections (MDI) or continuous subcutaneous infusion of insulin (CSII), or both.|Participants|Count of Participants|2|2.0||||||
3643606|NCT02500979|3490750|B3|MDI||Current Administration of Insulin|Subject's usual method of insulin administration - either multiple daily injections (MDI) or continuous subcutaneous infusion of insulin (CSII), or both.|Participants|Count of Participants|9|9.0||||||
3643607|NCT02500979|3490751|B2|MDI||Current Administration of Insulin|Subject's usual method of insulin administration - either multiple daily injections (MDI) or continuous subcutaneous infusion of insulin (CSII), or both.|Participants|Count of Participants|5|5.0||||||
3643608|NCT02500979|3490752|B1|MDI||Current Administration of Insulin|Subject's usual method of insulin administration - either multiple daily injections (MDI) or continuous subcutaneous infusion of insulin (CSII), or both.|Participants|Count of Participants|4|4.0||||||
3643609|NCT02500979|3490750|B3|CSII||Current Administration of Insulin|Subject's usual method of insulin administration - either multiple daily injections (MDI) or continuous subcutaneous infusion of insulin (CSII), or both.|Participants|Count of Participants|21|21.0||||||
3643610|NCT02500979|3490751|B2|CSII||Current Administration of Insulin|Subject's usual method of insulin administration - either multiple daily injections (MDI) or continuous subcutaneous infusion of insulin (CSII), or both.|Participants|Count of Participants|11|11.0||||||
3643611|NCT02500979|3490752|B1|CSII||Current Administration of Insulin|Subject's usual method of insulin administration - either multiple daily injections (MDI) or continuous subcutaneous infusion of insulin (CSII), or both.|Participants|Count of Participants|10|10.0||||||
3643612|NCT02500979|3490750|B3|||Duration of Diabetes||Years|Mean|24.88|24.88|Standard Deviation|12.249|12.249|||
3643613|NCT02500979|3490751|B2|||Duration of Diabetes||Years|Mean|21.94|21.94|Standard Deviation|10.866|10.866|||
3643614|NCT02500979|3490752|B1|||Duration of Diabetes||Years|Mean|27.81|27.81|Standard Deviation|13.177|13.177|||
3643615|NCT02500979|3490750|B3|||Body Mass Index||kg/m^2|Mean|24.95|24.95|Standard Deviation|2.579|2.579|||
3643616|NCT02500979|3490751|B2|||Body Mass Index||kg/m^2|Mean|24.52|24.52|Standard Deviation|2.341|2.341|||
3643617|NCT02500979|3490752|B1|||Body Mass Index||kg/m^2|Mean|25.38|25.38|Standard Deviation|2.806|2.806|||
3643618|NCT02500979|3490750|B3|||Height||cm|Mean|167.86|167.86|Standard Deviation|7.236|7.236|||
3643619|NCT02500979|3490751|B2|||Height||cm|Mean|167.31|167.31|Standard Deviation|7.684|7.684|||
3643620|NCT02500979|3490752|B1|||Height||cm|Mean|168.41|168.41|Standard Deviation|6.966|6.966|||
3643621|NCT02500979|3490750|B3|||Weight||kg|Mean|70.38|70.38|Standard Deviation|8.949|8.949|||
3643622|NCT02500979|3490751|B2|||Weight||kg|Mean|68.73|68.73|Standard Deviation|8.859|8.859|||
3643623|NCT02500979|3490752|B1|||Weight||kg|Mean|72.03|72.03|Standard Deviation|9.012|9.012|||
3643624|NCT02500979|3490750|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643625|NCT02500979|3490751|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643626|NCT02500979|3490752|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643627|NCT02500979|3490750|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643628|NCT02500979|3490751|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643629|NCT02500979|3490752|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643630|NCT02500979|3490750|B3||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3643631|NCT02500979|3490751|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3643632|NCT02500979|3490752|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3643633|NCT02500979|3490750|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3643634|NCT02500979|3490751|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643635|NCT02500979|3490752|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3643636|NCT02500979|3490750|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643637|NCT02500979|3490751|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643638|NCT02500979|3490752|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643639|NCT02500979|3490750|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3643640|NCT02500979|3490751|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3643641|NCT02500979|3490752|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643642|NCT02500979|3490750|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643643|NCT02500979|3490751|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643644|NCT02500979|3490752|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643645|NCT02500979|3490750|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643646|NCT02500979|3490751|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643647|NCT02500979|3490752|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643648|NCT02500979|3490750|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3643649|NCT02500979|3490751|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3643650|NCT02500979|3490752|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3643651|NCT02500979|3490750|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3643652|NCT02500979|3490751|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3643653|NCT02500979|3490752|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643654|NCT02500979|3490750|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3643655|NCT02500979|3490751|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3643656|NCT02500979|3490752|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3643657|NCT02500979|3490750|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3643658|NCT02500979|3490751|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3643659|NCT02500979|3490752|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3643660|NCT02500979|3490750|B3|||Age||Years|Mean|42.0|42.0|Standard Deviation|13.92|13.92|||
3643661|NCT02500979|3490751|B2|||Age||Years|Mean|38.9|38.9|Standard Deviation|12.68|12.68|||
3643662|NCT02500979|3490752|B1|||Age||Years|Mean|45.1|45.1|Standard Deviation|14.83|14.83|||
3643663|NCT02500979|3490750|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3643664|NCT02500979|3490751|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3643665|NCT02500979|3490752|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3643666|NCT02500979|3490750|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3643667|NCT02500979|3490751|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3643668|NCT02500979|3490752|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3643669|NCT02500979|3490750|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3643670|NCT02500979|3490751|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3643671|NCT02500979|3490752|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3643672|NCT02500836|3490787|B4|United States||Region of Enrollment||participants|Number|646|646.0||||||
3643673|NCT02500836|3490788|B3|United States||Region of Enrollment||participants|Number|128|128.0||||||
3643674|NCT02500836|3490789|B2|United States||Region of Enrollment||participants|Number|259|259.0||||||
3643675|NCT02500836|3490790|B1|United States||Region of Enrollment||participants|Number|259|259.0||||||
3643676|NCT02500836|3490787|B4||Male|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
3643677|NCT02500836|3490788|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3643678|NCT02500836|3490789|B2||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3643679|NCT02500836|3490790|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3643680|NCT02500836|3490787|B4||Female|Sex: Female, Male||Participants|Count of Participants|393|393.0||||||
3643681|NCT02500836|3490788|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3643682|NCT02500836|3490789|B2||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3643683|NCT02500836|3490790|B1||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3643684|NCT02500836|3490787|B4|||Age||years|Mean|37.57|37.57|Standard Deviation|12.92|12.92|||
3643685|NCT02500836|3490788|B3|||Age||years|Mean|36.01|36.01|Standard Deviation|12.34|12.34|||
3643686|NCT02500836|3490789|B2|||Age||years|Mean|37.50|37.5|Standard Deviation|12.76|12.76|||
3643687|NCT02500836|3490790|B1|||Age||years|Mean|38.42|38.42|Standard Deviation|13.34|13.34|||
3643688|NCT02500758|3490801|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3643689|NCT02500758|3490802|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3643690|NCT02500758|3490803|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3643691|NCT02500758|3490801|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3643692|NCT02500758|3490802|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3643693|NCT02500758|3490803|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3643694|NCT02500758|3490801|B3|||Age||years|Mean|24.83|24.83|Standard Deviation|5.25|5.25|||
3643695|NCT02500758|3490802|B2|||Age||years|Mean|24.62|24.62|Standard Deviation|3.82|3.82|||
3643696|NCT02500758|3490803|B1|||Age||years|Mean|25.02|25.02|Standard Deviation|2.05|2.05|||
3643697|NCT02500706|3490812|B4|||Glycosylated hemoglobin (HbA1c)||percentage of HbA1c|Mean|7.42|7.42|Standard Deviation|0.70|0.7|||
3643698|NCT02500706|3490813|B3|||Glycosylated hemoglobin (HbA1c)||percentage of HbA1c|Mean|7.41|7.41|Standard Deviation|0.79|0.79|||
3643699|NCT02500706|3490814|B2|||Glycosylated hemoglobin (HbA1c)||percentage of HbA1c|Mean|7.40|7.4|Standard Deviation|0.60|0.6|||
3643700|NCT02500706|3490815|B1|||Glycosylated hemoglobin (HbA1c)||percentage of HbA1c|Mean|7.46|7.46|Standard Deviation|0.68|0.68|||
3643701|NCT02500706|3490812|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643702|NCT02500706|3490813|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643703|NCT02500706|3490814|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643704|NCT02500706|3490815|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643705|NCT02500706|3490812|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643706|NCT02500706|3490813|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643707|NCT02500706|3490814|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643708|NCT02500706|3490815|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643709|NCT02500706|3490812|B4||White|Race (NIH/OMB)||Participants|Count of Participants|623|623.0||||||
3643710|NCT02500706|3490813|B3||White|Race (NIH/OMB)||Participants|Count of Participants|198|198.0||||||
3643711|NCT02500706|3490814|B2||White|Race (NIH/OMB)||Participants|Count of Participants|206|206.0||||||
3643712|NCT02500706|3490815|B1||White|Race (NIH/OMB)||Participants|Count of Participants|219|219.0||||||
3643713|NCT02500706|3490812|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3643714|NCT02500706|3490813|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3643715|NCT02500706|3490814|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3643716|NCT02500706|3490815|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3643717|NCT02500706|3490812|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643718|NCT02500706|3490813|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643719|NCT02500706|3490814|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643720|NCT02500706|3490815|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643721|NCT02500706|3490812|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|384|384.0||||||
3643722|NCT02500706|3490813|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|137|137.0||||||
3643723|NCT02500706|3490814|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
3643724|NCT02500706|3490815|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|116|116.0||||||
3643725|NCT02500706|3490812|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3643726|NCT02500706|3490813|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3643727|NCT02500706|3490814|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643728|NCT02500706|3490815|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3643729|NCT02500706|3490812|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643730|NCT02500706|3490813|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643731|NCT02500706|3490814|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643732|NCT02500706|3490815|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643733|NCT02500706|3490812|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|992|992.0||||||
3643734|NCT02500706|3490813|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|330|330.0||||||
3643735|NCT02500706|3490814|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|333|333.0||||||
3643736|NCT02500706|3490815|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|329|329.0||||||
3643737|NCT02500706|3490812|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3643738|NCT02500706|3490813|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3643739|NCT02500706|3490814|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3643740|NCT02500706|3490815|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3643741|NCT02500706|3490812|B4||Male|Sex: Female, Male||Participants|Count of Participants|549|549.0||||||
3643742|NCT02500706|3490813|B3||Male|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
3643743|NCT02500706|3490814|B2||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
3643744|NCT02500706|3490815|B1||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3643745|NCT02500706|3490812|B4||Female|Sex: Female, Male||Participants|Count of Participants|476|476.0||||||
3643746|NCT02500706|3490813|B3||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3643747|NCT02500706|3490814|B2||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3643748|NCT02500706|3490815|B1||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3643749|NCT02500706|3490812|B4|||Age||years|Mean|41.09|41.09|Standard Deviation|14.40|14.4|||
3643750|NCT02500706|3490813|B3|||Age||years|Mean|40.77|40.77|Standard Deviation|14.22|14.22|||
3643751|NCT02500706|3490814|B2|||Age||years|Mean|41.02|41.02|Standard Deviation|14.59|14.59|||
3643752|NCT02500706|3490815|B1|||Age||years|Mean|41.48|41.48|Standard Deviation|14.42|14.42|||
3643753|NCT02500628|3490969|B3|United States||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
3643754|NCT02500628|3490970|B2|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3643755|NCT02500628|3490971|B1|United States||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
3643756|NCT02500628|3490969|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3643757|NCT02500628|3490969|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3643758|NCT02500628|3490970|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3643759|NCT02500628|3490971|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3643760|NCT02500628|3490969|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3643761|NCT02500628|3490970|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3643762|NCT02500628|3490971|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3643763|NCT02500628|3490969|B3|||Age||years|Mean|47.1|47.1|Standard Deviation|12.32|12.32|||
3643764|NCT02500628|3490970|B2|||Age||years|Mean|47.61|47.61|Standard Deviation|11.9|11.9|||
3643765|NCT02500628|3490971|B1|||Age||years|Mean|46.71|46.71|Standard Deviation|12.15|12.15|||
3643766|NCT02500628|3490969|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3643767|NCT02500628|3490970|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3643768|NCT02500628|3490971|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3643769|NCT02500628|3490969|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3643770|NCT02500628|3490970|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3643771|NCT02500628|3490971|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3643772|NCT02500628|3490969|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3643773|NCT02500628|3490970|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3643774|NCT02500628|3490971|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3643775|NCT02500537|3490982|B3|||FEV1 Score (thoracic)||percent|Mean|82.2|82.2|Standard Deviation|20.41|20.41|||
3643776|NCT02500537|3490983|B2|||FEV1 Score (thoracic)||percent|Mean|82.2|82.2|Standard Deviation|20.41|20.41|||
3643777|NCT02500537|3490982|B3|||Body Mass Index (BMI)||kg/m2|Mean|36.4|36.4|Standard Deviation|10.73|10.73|||
3643778|NCT02500537|3490983|B2|||Body Mass Index (BMI)||kg/m2|Mean|27.9|27.9|Standard Deviation|5.87|5.87|||
3643779|NCT02500537|3490984|B1|||Body Mass Index (BMI)||kg/m2|Mean|44.3|44.3|Standard Deviation|7.06|7.06|||
3643780|NCT02500537|3490982|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3643781|NCT02500537|3490983|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3643782|NCT02500537|3490984|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3643783|NCT02500537|3490982|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3643784|NCT02500537|3490983|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3643785|NCT02500537|3490984|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3643786|NCT02500537|3490982|B3|||Age||years|Mean|52.7|52.7|Standard Deviation|15.52|15.52|||
3643787|NCT02500537|3490983|B2|||Age||years|Mean|64.6|64.6|Standard Deviation|9.7|9.7|||
3643788|NCT02500537|3490984|B1|||Age||years|Mean|44.9|44.9|Standard Deviation|13.56|13.56|||
3643789|NCT02500368|3491003|B1||Male|Gender||Participants|Count of Participants|13|13.0||||||
3643790|NCT02500368|3491003|B1||Female|Gender||Participants|Count of Participants|28|28.0||||||
3643791|NCT02500368|3491003|B1|||Age||years|Median|24|24.0|Full Range|||19.0|55.0|
3643792|NCT02500056|3491052|B3|||Elective operation||participants|Number|128|128.0||||||
3643793|NCT02500056|3491053|B2|||Elective operation||participants|Number|65|65.0||||||
3643794|NCT02500056|3491054|B1|||Elective operation||participants|Number|63|63.0||||||
3643795|NCT02500056|3491052|B3|||Reducible inguinal hernia||participants|Number|128|128.0||||||
3643796|NCT02500056|3491053|B2|||Reducible inguinal hernia||participants|Number|65|65.0||||||
3643797|NCT02500056|3491054|B1|||Reducible inguinal hernia||participants|Number|63|63.0||||||
3643798|NCT02500056|3491052|B3|||Primary inguinal hernia||participants|Number|128|128.0||||||
3643799|NCT02500056|3491053|B2|||Primary inguinal hernia||participants|Number|65|65.0||||||
3643800|NCT02500056|3491054|B1|||Primary inguinal hernia||participants|Number|63|63.0||||||
3643801|NCT02500056|3491052|B3|||Unilateral inguinal hernia||participants|Number|128|128.0||||||
3643802|NCT02500056|3491053|B2|||Unilateral inguinal hernia||participants|Number|65|65.0||||||
3643803|NCT02500056|3491054|B1|||Unilateral inguinal hernia||participants|Number|63|63.0||||||
3643804|NCT02500056|3491052|B3|Male||Sex/Gender, Customized|Gender (male + female)|participants|Number|115|115.0||||||
3643805|NCT02500056|3491053|B2|Male||Sex/Gender, Customized|Gender (male + female)|participants|Number|55|55.0||||||
3643806|NCT02500056|3491054|B1|Male||Sex/Gender, Customized|Gender (male + female)|participants|Number|60|60.0||||||
3643807|NCT02500056|3491052|B3|Female||Sex/Gender, Customized|Gender (male + female)|participants|Number|13|13.0||||||
3643808|NCT02500056|3491053|B2|Female||Sex/Gender, Customized|Gender (male + female)|participants|Number|10|10.0||||||
3643809|NCT02500056|3491054|B1|Female||Sex/Gender, Customized|Gender (male + female)|participants|Number|3|3.0||||||
3643810|NCT02500056|3491052|B3|>=18 years||Age, Customized|>=18 years|participants|Number|128|128.0||||||
3643811|NCT02500056|3491053|B2|>=18 years||Age, Customized|>=18 years|participants|Number|65|65.0||||||
3643812|NCT02500056|3491054|B1|>=18 years||Age, Customized|>=18 years|participants|Number|63|63.0||||||
3643813|NCT02499952|3491065|B1|Non Pulmonary Visceral Metastasis||Metastatic Site(s)|The overall count of metastatic location(s). Subjects may have metastasis at multiple locations.|participants|Number|5|5.0||||||
3643814|NCT02499952|3491065|B1|Pulmonary||Metastatic Site(s)|The overall count of metastatic location(s). Subjects may have metastasis at multiple locations.|participants|Number|9|9.0||||||
3643815|NCT02499952|3491065|B1|Retroperitoneum||Metastatic Site(s)|The overall count of metastatic location(s). Subjects may have metastasis at multiple locations.|participants|Number|5|5.0||||||
3643816|NCT02499952|3491065|B1||ECOG 1|ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0-5 that describes a patient's level of functioning where 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Dead|Participants|Count of Participants|7|7.0||||||
3643817|NCT02499952|3491065|B1||ECOG 0|ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0-5 that describes a patient's level of functioning where 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Dead|Participants|Count of Participants|5|5.0||||||
3643818|NCT02499952|3491065|B1|6||Number of Previous Chemotherapy Regimens||Participants|Count of Participants|1|1.0||||||
3643819|NCT02499952|3491065|B1|5||Number of Previous Chemotherapy Regimens||Participants|Count of Participants|1|1.0||||||
3643820|NCT02499952|3491065|B1|4||Number of Previous Chemotherapy Regimens||Participants|Count of Participants|2|2.0||||||
3643821|NCT02499952|3491065|B1|3||Number of Previous Chemotherapy Regimens||Participants|Count of Participants|7|7.0||||||
3643822|NCT02499952|3491065|B1|2||Number of Previous Chemotherapy Regimens||Participants|Count of Participants|0|0.0||||||
3643823|NCT02499952|3491065|B1|1||Number of Previous Chemotherapy Regimens||Participants|Count of Participants|1|1.0||||||
3643824|NCT02499952|3491065|B1||Yolk sac tumor|Predominant Histology||Participants|Count of Participants|3|3.0||||||
3643825|NCT02499952|3491065|B1||Teratoma|Predominant Histology||Participants|Count of Participants|1|1.0||||||
3643826|NCT02499952|3491065|B1||Embryonal carcinoma|Predominant Histology||Participants|Count of Participants|5|5.0||||||
3643827|NCT02499952|3491065|B1||Choriocarcinoma|Predominant Histology||Participants|Count of Participants|3|3.0||||||
3643828|NCT02499952|3491065|B1||Nonseminoma|Tumor Histology||Participants|Count of Participants|12|12.0||||||
3643829|NCT02499952|3491065|B1||Seminoma|Tumor Histology||Participants|Count of Participants|0|0.0||||||
3643830|NCT02499952|3491065|B1||Mediastinum|Location Of Primary Tumor||Participants|Count of Participants|1|1.0||||||
3643831|NCT02499952|3491065|B1||Retroperitoneum|Location Of Primary Tumor||Participants|Count of Participants|0|0.0||||||
3643832|NCT02499952|3491065|B1||Testis|Location Of Primary Tumor||Participants|Count of Participants|11|11.0||||||
3643833|NCT02499952|3491065|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3643834|NCT02499952|3491065|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643835|NCT02499952|3491065|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643836|NCT02499952|3491065|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3643837|NCT02499952|3491065|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3643838|NCT02499952|3491065|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643839|NCT02499952|3491065|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643840|NCT02499952|3491065|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643841|NCT02499952|3491065|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643842|NCT02499952|3491065|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3643843|NCT02499952|3491065|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643844|NCT02499952|3491065|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3643845|NCT02499952|3491065|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3643846|NCT02499952|3491065|B1|||Age||years|Median|38|38.0|Full Range|||27.0|55.0|
3643847|NCT02499952|3491065|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3643848|NCT02499952|3491065|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3643849|NCT02499952|3491065|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3643850|NCT02499900|3491072|B3|||Height||cm|Mean|169.0|169.0|Standard Deviation|8.91|8.91|||
3643851|NCT02499900|3491073|B2|||Height||cm|Mean|169.4|169.4|Standard Deviation|8.56|8.56|||
3643852|NCT02499900|3491074|B1|||Height||cm|Mean|168.6|168.6|Standard Deviation|9.24|9.24|||
3643853|NCT02499900|3491072|B3|||Body Mass Index||kg/m^2|Mean|24.78|24.78|Standard Deviation|5.079|5.079|||
3643854|NCT02499900|3491073|B2|||Body Mass Index||kg/m^2|Mean|24.93|24.93|Standard Deviation|4.879|4.879|||
3643855|NCT02499900|3491074|B1|||Body Mass Index||kg/m^2|Mean|24.62|24.62|Standard Deviation|5.272|5.272|||
3643856|NCT02499900|3491072|B3|||Weight||kg|Mean|71.17|71.17|Standard Deviation|16.373|16.373|||
3643857|NCT02499900|3491073|B2|||Weight||kg|Mean|71.85|71.85|Standard Deviation|16.265|16.265|||
3643858|NCT02499900|3491074|B1|||Weight||kg|Mean|70.49|70.49|Standard Deviation|16.471|16.471|||
3643859|NCT02499900|3491072|B3||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3643860|NCT02499900|3491073|B2||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3643861|NCT02499900|3491074|B1||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3643862|NCT02499900|3491072|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|122|122.0||||||
3643863|NCT02499900|3491073|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|63|63.0||||||
3643864|NCT02499900|3491074|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|59|59.0||||||
3643865|NCT02499900|3491072|B3||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3643866|NCT02499900|3491073|B2||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3643867|NCT02499900|3491074|B1||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3643868|NCT02499900|3491072|B3||American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3643869|NCT02499900|3491073|B2||American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3643870|NCT02499900|3491074|B1||American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3643871|NCT02499900|3491072|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3643872|NCT02499900|3491073|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3643873|NCT02499900|3491074|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3643874|NCT02499900|3491072|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3643875|NCT02499900|3491073|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3643876|NCT02499900|3491074|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3643877|NCT02499900|3491072|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|722|722.0||||||
3643878|NCT02499900|3491073|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|359|359.0||||||
3643879|NCT02499900|3491074|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|363|363.0||||||
3643880|NCT02499900|3491072|B3||Male|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
3643881|NCT02499900|3491073|B2||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3643882|NCT02499900|3491074|B1||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3643883|NCT02499900|3491072|B3||Female|Sex: Female, Male||Participants|Count of Participants|595|595.0||||||
3643884|NCT02499900|3491073|B2||Female|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
3643885|NCT02499900|3491074|B1||Female|Sex: Female, Male||Participants|Count of Participants|307|307.0||||||
3643886|NCT02499900|3491072|B3|||Age||years|Mean|40.5|40.5|Standard Deviation|10.91|10.91|||
3643887|NCT02499900|3491073|B2|||Age||years|Mean|41.0|41.0|Standard Deviation|11.15|11.15|||
3643888|NCT02499900|3491074|B1|||Age||years|Mean|40.1|40.1|Standard Deviation|10.67|10.67|||
3643889|NCT02499692|3491095|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3643890|NCT02499692|3491095|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3643891|NCT02499692|3491095|B1|||Age||years|Mean|58.92|58.92|Standard Deviation|8.74|8.74|||
3643892|NCT02499575|3491104|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3643893|NCT02499575|3491106|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3643894|NCT02499575|3491104|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3643895|NCT02499575|3491106|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3643896|NCT02499575|3491104|B3|Age||Age, Customized||years|Number|62|62.0||||||
3643897|NCT02499575|3491106|B1|Age||Age, Customized||years|Number|62|62.0||||||
3643898|NCT02499029|3491117|B3|PCL-M||Post Traumatic Stress Disorder (PTSD)|"PTSD was measured using the CAPS IV and the PCL-M.~The CAPS IV measures seventeen symptoms based on intensity and frequency. Intensity and frequency scores are summed to create a severity score. Severity scores are summed to get a total score. A higher total score indicates a higher severity of PTSD symptoms. The full range for CAPS IV is 0-136.~The PCL-M is a seventeen question self-report, scored on a scale from 1 to 5, with possible scores from 17 to 85. The scores are summed to get a total score. A higher total indicates a higher severity of PTSD symptoms."|units on a scale|Mean|44.5|44.5|Standard Deviation|16.5|16.5|||
3643899|NCT02499029|3491118|B2|PCL-M||Post Traumatic Stress Disorder (PTSD)|"PTSD was measured using the CAPS IV and the PCL-M.~The CAPS IV measures seventeen symptoms based on intensity and frequency. Intensity and frequency scores are summed to create a severity score. Severity scores are summed to get a total score. A higher total score indicates a higher severity of PTSD symptoms. The full range for CAPS IV is 0-136.~The PCL-M is a seventeen question self-report, scored on a scale from 1 to 5, with possible scores from 17 to 85. The scores are summed to get a total score. A higher total indicates a higher severity of PTSD symptoms."|units on a scale|Mean|43.4|43.4|Standard Deviation|18.6|18.6|||
3643941|NCT02498821|3491133|B2||Very urgent (STAT)|Urgency of PICC Order||Participants|Count of Participants|0|0.0||||||
3644264|NCT02497235|3491502|B1|Hispanic or Latino||Ethnicity||participants|Number|1|1.0||||||
3643900|NCT02499029|3491119|B1|PCL-M||Post Traumatic Stress Disorder (PTSD)|"PTSD was measured using the CAPS IV and the PCL-M.~The CAPS IV measures seventeen symptoms based on intensity and frequency. Intensity and frequency scores are summed to create a severity score. Severity scores are summed to get a total score. A higher total score indicates a higher severity of PTSD symptoms. The full range for CAPS IV is 0-136.~The PCL-M is a seventeen question self-report, scored on a scale from 1 to 5, with possible scores from 17 to 85. The scores are summed to get a total score. A higher total indicates a higher severity of PTSD symptoms."|units on a scale|Mean|45.7|45.7|Standard Deviation|14.6|14.6|||
3643901|NCT02499029|3491117|B3|CAPS IV||Post Traumatic Stress Disorder (PTSD)|"PTSD was measured using the CAPS IV and the PCL-M.~The CAPS IV measures seventeen symptoms based on intensity and frequency. Intensity and frequency scores are summed to create a severity score. Severity scores are summed to get a total score. A higher total score indicates a higher severity of PTSD symptoms. The full range for CAPS IV is 0-136.~The PCL-M is a seventeen question self-report, scored on a scale from 1 to 5, with possible scores from 17 to 85. The scores are summed to get a total score. A higher total indicates a higher severity of PTSD symptoms."|units on a scale|Mean|63.8|63.8|Standard Deviation|22.6|22.6|||
3643902|NCT02499029|3491118|B2|CAPS IV||Post Traumatic Stress Disorder (PTSD)|"PTSD was measured using the CAPS IV and the PCL-M.~The CAPS IV measures seventeen symptoms based on intensity and frequency. Intensity and frequency scores are summed to create a severity score. Severity scores are summed to get a total score. A higher total score indicates a higher severity of PTSD symptoms. The full range for CAPS IV is 0-136.~The PCL-M is a seventeen question self-report, scored on a scale from 1 to 5, with possible scores from 17 to 85. The scores are summed to get a total score. A higher total indicates a higher severity of PTSD symptoms."|units on a scale|Mean|68.6|68.6|Standard Deviation|23.7|23.7|||
3643903|NCT02499029|3491119|B1|CAPS IV||Post Traumatic Stress Disorder (PTSD)|"PTSD was measured using the CAPS IV and the PCL-M.~The CAPS IV measures seventeen symptoms based on intensity and frequency. Intensity and frequency scores are summed to create a severity score. Severity scores are summed to get a total score. A higher total score indicates a higher severity of PTSD symptoms. The full range for CAPS IV is 0-136.~The PCL-M is a seventeen question self-report, scored on a scale from 1 to 5, with possible scores from 17 to 85. The scores are summed to get a total score. A higher total indicates a higher severity of PTSD symptoms."|units on a scale|Mean|58.8|58.8|Standard Deviation|21.2|21.2|||
3643904|NCT02499029|3491117|B3|Opioid||Substance Use Disorder (SUD)||Participants|Count of Participants|1|1.0||||||
3643905|NCT02499029|3491118|B2|Opioid||Substance Use Disorder (SUD)||Participants|Count of Participants|1|1.0||||||
3643906|NCT02499029|3491119|B1|Opioid||Substance Use Disorder (SUD)||Participants|Count of Participants|0|0.0||||||
3643907|NCT02499029|3491117|B3|Cocaine||Substance Use Disorder (SUD)||Participants|Count of Participants|20|20.0||||||
3643908|NCT02499029|3491118|B2|Cocaine||Substance Use Disorder (SUD)||Participants|Count of Participants|9|9.0||||||
3643909|NCT02499029|3491119|B1|Cocaine||Substance Use Disorder (SUD)||Participants|Count of Participants|11|11.0||||||
3643910|NCT02499029|3491117|B3|Alcohol||Substance Use Disorder (SUD)||Participants|Count of Participants|22|22.0||||||
3643911|NCT02499029|3491118|B2|Alcohol||Substance Use Disorder (SUD)||Participants|Count of Participants|12|12.0||||||
3643912|NCT02499029|3491119|B1|Alcohol||Substance Use Disorder (SUD)||Participants|Count of Participants|10|10.0||||||
3643913|NCT02499029|3491117|B3|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3643914|NCT02499029|3491118|B2|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3643915|NCT02499029|3491119|B1|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3643916|NCT02499029|3491117|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3643917|NCT02499029|3491118|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3643918|NCT02499029|3491119|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3643919|NCT02499029|3491117|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3643920|NCT02499029|3491118|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3643921|NCT02499029|3491119|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3643922|NCT02499029|3491117|B3|||Age||years|Mean|49.0|49.0|Standard Deviation|8.2|8.2|||
3643923|NCT02499029|3491118|B2|||Age||years|Mean|49.9|49.9|Standard Deviation|8.1|8.1|||
3643924|NCT02499029|3491119|B1|||Age||years|Mean|48.2|48.2|Standard Deviation|8.6|8.6|||
3643925|NCT02499029|3491117|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3643926|NCT02499029|3491118|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3643927|NCT02499029|3491119|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3643928|NCT02499029|3491117|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3643929|NCT02499029|3491118|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3643930|NCT02499029|3491119|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3643931|NCT02499029|3491117|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3643932|NCT02499029|3491118|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3643933|NCT02499029|3491119|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3643934|NCT02498821|3491132|B3||Not urgent|Urgency of PICC Order||Participants|Count of Participants|91|91.0||||||
3643935|NCT02498821|3491133|B2||Not urgent|Urgency of PICC Order||Participants|Count of Participants|54|54.0||||||
3643936|NCT02498821|3491134|B1||Not urgent|Urgency of PICC Order||Participants|Count of Participants|37|37.0||||||
3643937|NCT02498821|3491132|B3||Greater urgency than normal|Urgency of PICC Order||Participants|Count of Participants|29|29.0||||||
3643938|NCT02498821|3491133|B2||Greater urgency than normal|Urgency of PICC Order||Participants|Count of Participants|6|6.0||||||
3643939|NCT02498821|3491134|B1||Greater urgency than normal|Urgency of PICC Order||Participants|Count of Participants|23|23.0||||||
3643940|NCT02498821|3491132|B3||Very urgent (STAT)|Urgency of PICC Order||Participants|Count of Participants|0|0.0||||||
3643942|NCT02498821|3491134|B1||Very urgent (STAT)|Urgency of PICC Order||Participants|Count of Participants|0|0.0||||||
3643943|NCT02498821|3491132|B3|United States||Region of Enrollment||participants|Number|120|120.0||||||
3643944|NCT02498821|3491133|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
3643945|NCT02498821|3491134|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
3643946|NCT02498821|3491132|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3643947|NCT02498821|3491133|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3643948|NCT02498821|3491134|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3643949|NCT02498821|3491132|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3643950|NCT02498821|3491133|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3643951|NCT02498821|3491134|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3643952|NCT02498821|3491132|B3|||Age||years|Mean|58.985|58.985|Full Range|||23.0|93.0|
3643953|NCT02498821|3491133|B2|||Age||years|Mean|61.75|61.75|Full Range|||25.0|93.0|
3643954|NCT02498821|3491134|B1|||Age||years|Mean|56.22|56.22|Full Range|||23.0|88.0|
3643955|NCT02498769|3491162|B3|United States||Region of Enrollment||participants|Number|130|130.0||||||
3643956|NCT02498769|3491163|B2|United States||Region of Enrollment||participants|Number|67|67.0||||||
3643957|NCT02498769|3491164|B1|United States||Region of Enrollment||participants|Number|63|63.0||||||
3643958|NCT02498769|3491162|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3643959|NCT02498769|3491163|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643960|NCT02498769|3491164|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3643961|NCT02498769|3491162|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643962|NCT02498769|3491163|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643963|NCT02498769|3491164|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643964|NCT02498769|3491162|B3||White|Race (NIH/OMB)||Participants|Count of Participants|112|112.0||||||
3643965|NCT02498769|3491163|B2||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3643966|NCT02498769|3491164|B1||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3643967|NCT02498769|3491162|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3643968|NCT02498769|3491163|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3643969|NCT02498769|3491164|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3643970|NCT02498769|3491162|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643971|NCT02498769|3491163|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643972|NCT02498769|3491164|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643973|NCT02498769|3491162|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643974|NCT02498769|3491163|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643975|NCT02498769|3491164|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643976|NCT02498769|3491162|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3643977|NCT02498769|3491163|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3643978|NCT02498769|3491164|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643979|NCT02498769|3491162|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643980|NCT02498769|3491163|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643981|NCT02498769|3491164|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643982|NCT02498769|3491162|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
3643983|NCT02498769|3491163|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3643984|NCT02498769|3491164|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3643985|NCT02498769|3491162|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3643986|NCT02498769|3491163|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643987|NCT02498769|3491164|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3643988|NCT02498769|3491162|B3||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3643989|NCT02498769|3491163|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3643990|NCT02498769|3491164|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3643991|NCT02498769|3491162|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3643992|NCT02498769|3491163|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3643993|NCT02498769|3491164|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3643994|NCT02498769|3491162|B3|||Age||years|Mean|67.0|67.0|Standard Deviation|8.9|8.9|||
3643995|NCT02498769|3491163|B2|||Age||years|Mean|67.5|67.5|Standard Deviation|9.1|9.1|||
3643996|NCT02498769|3491164|B1|||Age||years|Mean|66.5|66.5|Standard Deviation|8.6|8.6|||
3643997|NCT02498678|3491177|B3|2||ASA physical status|"- A normal healthy patient~- A patient with mild systemic disease"|participants|Number|15|15.0||||||
3643998|NCT02498678|3491178|B2|2||ASA physical status|"- A normal healthy patient~- A patient with mild systemic disease"|participants|Number|5|5.0||||||
3644102|NCT02497781|3491402|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3643999|NCT02498678|3491179|B1|2||ASA physical status|"- A normal healthy patient~- A patient with mild systemic disease"|participants|Number|10|10.0||||||
3644000|NCT02498678|3491177|B3|1||ASA physical status|"- A normal healthy patient~- A patient with mild systemic disease"|participants|Number|33|33.0||||||
3644001|NCT02498678|3491178|B2|1||ASA physical status|"- A normal healthy patient~- A patient with mild systemic disease"|participants|Number|18|18.0||||||
3644002|NCT02498678|3491179|B1|1||ASA physical status|"- A normal healthy patient~- A patient with mild systemic disease"|participants|Number|15|15.0||||||
3644003|NCT02498678|3491177|B3|||Growth chart percentiles||percentile|Mean|41.3|41.3|Standard Deviation|24.9|24.9|||
3644004|NCT02498678|3491178|B2|||Growth chart percentiles||percentile|Mean|44.6|44.6|Standard Deviation|22.2|22.2|||
3644005|NCT02498678|3491179|B1|||Growth chart percentiles||percentile|Mean|38.5|38.5|Standard Deviation|27|27.0|||
3644006|NCT02498678|3491177|B3|||Body mass index||kilogram per square meter|Mean|16.5|16.5|Standard Deviation|5.56|5.56|||
3644007|NCT02498678|3491178|B2|||Body mass index||kilogram per square meter|Mean|15.7|15.7|Standard Deviation|1.3|1.3|||
3644008|NCT02498678|3491179|B1|||Body mass index||kilogram per square meter|Mean|17.2|17.2|Standard Deviation|7.6|7.6|||
3644009|NCT02498678|3491177|B3|Brazil||Region of Enrollment||participants|Number|48|48.0||||||
3644010|NCT02498678|3491178|B2|Brazil||Region of Enrollment||participants|Number|23|23.0||||||
3644011|NCT02498678|3491179|B1|Brazil||Region of Enrollment||participants|Number|25|25.0||||||
3644012|NCT02498678|3491177|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3644013|NCT02498678|3491178|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3644014|NCT02498678|3491179|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3644015|NCT02498678|3491177|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3644016|NCT02498678|3491178|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3644017|NCT02498678|3491179|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3644018|NCT02498678|3491177|B3|||Age||years|Mean|6.2|6.2|Standard Deviation|2.6|2.6|||
3644019|NCT02498678|3491178|B2|||Age||years|Mean|5.6|5.6|Standard Deviation|2.35|2.35|||
3644020|NCT02498678|3491179|B1|||Age||years|Mean|6.8|6.8|Standard Deviation|2.7|2.7|||
3644021|NCT02498652|3491194|B3|United States||Region of Enrollment||Participants|Number|41|41.0||||||
3644022|NCT02498652|3491195|B2|United States||Region of Enrollment||Participants|Number|21|21.0||||||
3644023|NCT02498652|3491196|B1|United States||Region of Enrollment||Participants|Number|20|20.0||||||
3644024|NCT02498652|3491194|B3|Female||Sex/Gender, Customized||Participants|Number|40|40.0||||||
3644025|NCT02498652|3491195|B2|Female||Sex/Gender, Customized||Participants|Number|21|21.0||||||
3644026|NCT02498652|3491196|B1|Female||Sex/Gender, Customized||Participants|Number|19|19.0||||||
3644027|NCT02498652|3491194|B3|Male||Sex/Gender, Customized||Participants|Number|1|1.0||||||
3644028|NCT02498652|3491195|B2|Male||Sex/Gender, Customized||Participants|Number|0|0.0||||||
3644029|NCT02498652|3491196|B1|Male||Sex/Gender, Customized||Participants|Number|1|1.0||||||
3644030|NCT02498652|3491194|B3|||Age||Years|Mean|49|49.0|Standard Deviation|11.7|11.7|||
3644031|NCT02498652|3491195|B2|||Age||Years|Mean|48|48.0|Standard Deviation|10.9|10.9|||
3644032|NCT02498652|3491196|B1|||Age||Years|Mean|50|50.0|Standard Deviation|12.7|12.7|||
3644033|NCT02498522|3491296|B3|Egypt||Region of Enrollment||participants|Number|166|166.0||||||
3644034|NCT02498522|3491297|B2|Egypt||Region of Enrollment||participants|Number|83|83.0||||||
3644035|NCT02498522|3491298|B1|Egypt||Region of Enrollment||participants|Number|83|83.0||||||
3644036|NCT02498522|3491296|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3644037|NCT02498522|3491297|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3644038|NCT02498522|3491298|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3644039|NCT02498522|3491296|B3||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3644040|NCT02498522|3491297|B2||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3644041|NCT02498522|3491298|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3644042|NCT02498522|3491296|B3|||Age||years|Mean|30.1|30.1|Standard Deviation|1.7|1.7|||
3644043|NCT02498522|3491297|B2|||Age||years|Mean|30.1|30.1|Standard Deviation|1.9|1.9|||
3644044|NCT02498522|3491298|B1|||Age||years|Mean|30.2|30.2|Standard Deviation|1.6|1.6|||
3644045|NCT02498522|3491296|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3644046|NCT02498522|3491297|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3644047|NCT02498522|3491298|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3644048|NCT02498522|3491296|B3||Between 18 and 65 years|Age||Participants|Count of Participants|166|166.0||||||
3644049|NCT02498522|3491297|B2||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
3644050|NCT02498522|3491298|B1||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
3644051|NCT02498522|3491296|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3644052|NCT02498522|3491297|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3644053|NCT02498522|3491298|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3644054|NCT02497976|3491305|B3|||O'Leary Sant Symptom and Problem Index|Subjects rated the presence and extent of IC/BPS symptoms by completing the O'Leary-Sant Interstitial Cystitis Symptom Index and the O’Leary-Sant Interstitial Cystitis Problem Index (ICPI) at baseline and at weeks 2, 4, 10, and 18. Lubeck et al validated ICSI as a valid measure of change in treatment outcome studies. Propert et al validated the ICSI as responsive to change in IC/BPS symptoms and was recommended as secondary endpoints in clinical trials. No urinary symptoms would have a score of 0. The most severe symptoms would be a maximum of 35. Normal patients have a value of 7 or less.|units on a scale|Mean|26.8|26.8|Standard Deviation|5.1|5.1|||
3644055|NCT02497976|3491306|B2|||O'Leary Sant Symptom and Problem Index|Subjects rated the presence and extent of IC/BPS symptoms by completing the O'Leary-Sant Interstitial Cystitis Symptom Index and the O’Leary-Sant Interstitial Cystitis Problem Index (ICPI) at baseline and at weeks 2, 4, 10, and 18. Lubeck et al validated ICSI as a valid measure of change in treatment outcome studies. Propert et al validated the ICSI as responsive to change in IC/BPS symptoms and was recommended as secondary endpoints in clinical trials. No urinary symptoms would have a score of 0. The most severe symptoms would be a maximum of 35. Normal patients have a value of 7 or less.|units on a scale|Mean|26.7|26.7|Standard Deviation|4.8|4.8|||
3644056|NCT02497976|3491307|B1|||O'Leary Sant Symptom and Problem Index|Subjects rated the presence and extent of IC/BPS symptoms by completing the O'Leary-Sant Interstitial Cystitis Symptom Index and the O’Leary-Sant Interstitial Cystitis Problem Index (ICPI) at baseline and at weeks 2, 4, 10, and 18. Lubeck et al validated ICSI as a valid measure of change in treatment outcome studies. Propert et al validated the ICSI as responsive to change in IC/BPS symptoms and was recommended as secondary endpoints in clinical trials. No urinary symptoms would have a score of 0. The most severe symptoms would be a maximum of 35. Normal patients have a value of 7 or less.|units on a scale|Mean|26.8|26.8|Standard Deviation|5.2|5.2|||
3644057|NCT02497976|3491305|B3|United States||Region of Enrollment||Count of participants|Number|42|42.0||||||
3644058|NCT02497976|3491306|B2|United States||Region of Enrollment||Count of participants|Number|14|14.0||||||
3644059|NCT02497976|3491307|B1|United States||Region of Enrollment||Count of participants|Number|28|28.0||||||
3644060|NCT02497976|3491305|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644061|NCT02497976|3491306|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644062|NCT02497976|3491307|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644063|NCT02497976|3491305|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3644064|NCT02497976|3491306|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644065|NCT02497976|3491307|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3644066|NCT02497976|3491305|B3||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3644067|NCT02497976|3491306|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3644068|NCT02497976|3491307|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3644069|NCT02497976|3491305|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3644070|NCT02497976|3491306|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644071|NCT02497976|3491307|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3644072|NCT02497976|3491305|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644073|NCT02497976|3491306|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644074|NCT02497976|3491307|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644075|NCT02497976|3491305|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644076|NCT02497976|3491306|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644077|NCT02497976|3491307|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644078|NCT02497976|3491305|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3644079|NCT02497976|3491306|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3644080|NCT02497976|3491307|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3644081|NCT02497976|3491305|B3||Male|Sex: Female, Male|Only females between the age of 18 to 65.|Participants|Count of Participants|0|0.0||||||
3644082|NCT02497976|3491306|B2||Male|Sex: Female, Male|Only females between the age of 18 to 65.|Participants|Count of Participants|0|0.0||||||
3644083|NCT02497976|3491307|B1||Male|Sex: Female, Male|Only females between the age of 18 to 65.|Participants|Count of Participants|0|0.0||||||
3644084|NCT02497976|3491305|B3||Female|Sex: Female, Male|Only females between the age of 18 to 65.|Participants|Count of Participants|42|42.0||||||
3644085|NCT02497976|3491306|B2||Female|Sex: Female, Male|Only females between the age of 18 to 65.|Participants|Count of Participants|14|14.0||||||
3644086|NCT02497976|3491307|B1||Female|Sex: Female, Male|Only females between the age of 18 to 65.|Participants|Count of Participants|28|28.0||||||
3644087|NCT02497976|3491305|B3|||Age||years|Median|47.9|47.9|Standard Deviation|10.8|10.8|||
3644088|NCT02497976|3491306|B2|||Age||years|Median|49.9|49.9|Standard Deviation|10.7|10.7|||
3644089|NCT02497976|3491307|B1|||Age||years|Median|46.9|46.9|Standard Deviation|12.7|12.7|||
3644090|NCT02497937|3491324|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3644091|NCT02497937|3491324|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3644092|NCT02497937|3491324|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3644093|NCT02497937|3491324|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3644094|NCT02497937|3491324|B1|||Age||Years|Mean|67.7|67.7|Standard Deviation|12.90|12.9|||
3644095|NCT02497781|3491401|B3|||Height||centimeters|Mean|108.7|108.7|Standard Deviation|35.03|35.03|||
3644096|NCT02497781|3491402|B2|||Height||centimeters|Mean|108.9|108.9|Standard Deviation|37.16|37.16|||
3644097|NCT02497781|3491403|B1|||Height||centimeters|Mean|108.7|108.7|Standard Deviation|34.40|34.4|||
3644098|NCT02497781|3491401|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3644099|NCT02497781|3491402|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644100|NCT02497781|3491403|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3644101|NCT02497781|3491401|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644103|NCT02497781|3491403|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644104|NCT02497781|3491401|B3||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3644105|NCT02497781|3491402|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3644106|NCT02497781|3491403|B1||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3644107|NCT02497781|3491401|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644108|NCT02497781|3491402|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644109|NCT02497781|3491403|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644110|NCT02497781|3491401|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644111|NCT02497781|3491402|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644112|NCT02497781|3491403|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644113|NCT02497781|3491401|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3644114|NCT02497781|3491402|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3644115|NCT02497781|3491403|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3644116|NCT02497781|3491401|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3644117|NCT02497781|3491402|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644118|NCT02497781|3491403|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3644119|NCT02497781|3491401|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644120|NCT02497781|3491402|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644121|NCT02497781|3491403|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644122|NCT02497781|3491401|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3644123|NCT02497781|3491402|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3644124|NCT02497781|3491403|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3644125|NCT02497781|3491401|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3644126|NCT02497781|3491402|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644127|NCT02497781|3491403|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3644128|NCT02497781|3491401|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3644129|NCT02497781|3491402|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3644130|NCT02497781|3491403|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3644131|NCT02497781|3491401|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3644132|NCT02497781|3491402|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3644133|NCT02497781|3491403|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3644134|NCT02497781|3491401|B3|||Age||years|Mean|6.12|6.12|Standard Deviation|5.743|5.743|||
3644135|NCT02497781|3491402|B2|||Age||years|Mean|6.19|6.19|Standard Deviation|6.072|6.072|||
3644136|NCT02497781|3491403|B1|||Age||years|Mean|6.08|6.08|Standard Deviation|5.647|5.647|||
3644137|NCT02497755|3491465|B3||Some college|Education||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3644138|NCT02497755|3491466|B2||Some college|Education||Participants|Count of Participants|NA|||||||Not assessed
3644139|NCT02497755|3491467|B1||Some college|Education||Participants|Count of Participants|3|3.0||||||
3644140|NCT02497755|3491465|B3||High school/GED|Education||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3644141|NCT02497755|3491466|B2||High school/GED|Education||Participants|Count of Participants|NA|||||||Not assessed
3644142|NCT02497755|3491467|B1||High school/GED|Education||Participants|Count of Participants|1|1.0||||||
3644143|NCT02497755|3491465|B3||Graduate or professional degree|Education||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3644144|NCT02497755|3491466|B2||Graduate or professional degree|Education||Participants|Count of Participants|NA|||||||Not assessed
3644145|NCT02497755|3491467|B1||Graduate or professional degree|Education||Participants|Count of Participants|3|3.0||||||
3644146|NCT02497755|3491465|B3||Bachelor's degree|Education||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3644147|NCT02497755|3491466|B2||Bachelor's degree|Education||Participants|Count of Participants|NA|||||||Not assessed
3644148|NCT02497755|3491467|B1||Bachelor's degree|Education||Participants|Count of Participants|10|10.0||||||
3644149|NCT02497755|3491465|B3||Unable to work|Employment Status||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3644150|NCT02497755|3491466|B2||Unable to work|Employment Status||Participants|Count of Participants|NA|||||||Not assessed
3644151|NCT02497755|3491467|B1||Unable to work|Employment Status||Participants|Count of Participants|2|2.0||||||
3644152|NCT02497755|3491465|B3||Student|Employment Status||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3644153|NCT02497755|3491466|B2||Student|Employment Status||Participants|Count of Participants|NA|||||||Not assessed
3644154|NCT02497755|3491467|B1||Student|Employment Status||Participants|Count of Participants|3|3.0||||||
3644155|NCT02497755|3491465|B3||Not working by choice|Employment Status||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3644263|NCT02497235|3491501|B2|Hispanic or Latino||Ethnicity||participants|Number|2|2.0||||||
3644156|NCT02497755|3491466|B2||Not working by choice|Employment Status||Participants|Count of Participants|NA|||||||Not assessed
3644157|NCT02497755|3491467|B1||Not working by choice|Employment Status||Participants|Count of Participants|1|1.0||||||
3644158|NCT02497755|3491465|B3||Full time paid employment|Employment Status||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3644159|NCT02497755|3491466|B2||Full time paid employment|Employment Status||Participants|Count of Participants|NA|||||||Not assessed
3644160|NCT02497755|3491467|B1||Full time paid employment|Employment Status||Participants|Count of Participants|11|11.0||||||
3644161|NCT02497755|3491465|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
3644162|NCT02497755|3491466|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3644163|NCT02497755|3491467|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3644164|NCT02497755|3491465|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3644165|NCT02497755|3491466|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Not assessed
3644166|NCT02497755|3491467|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644167|NCT02497755|3491465|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3644168|NCT02497755|3491466|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Not assessed
3644169|NCT02497755|3491467|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644170|NCT02497755|3491465|B3||White|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3644171|NCT02497755|3491466|B2||White|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Not assessed
3644172|NCT02497755|3491467|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3644173|NCT02497755|3491465|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3644174|NCT02497755|3491466|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Not assessed
3644175|NCT02497755|3491467|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3644176|NCT02497755|3491465|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3644177|NCT02497755|3491466|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Not assessed
3644178|NCT02497755|3491467|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644179|NCT02497755|3491465|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3644180|NCT02497755|3491466|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Not assessed
3644181|NCT02497755|3491467|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644182|NCT02497755|3491465|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3644183|NCT02497755|3491466|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Not assessed
3644184|NCT02497755|3491467|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644185|NCT02497755|3491465|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3644186|NCT02497755|3491466|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|NA|||||||Not assessed
3644187|NCT02497755|3491467|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644188|NCT02497755|3491465|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3644189|NCT02497755|3491466|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|NA|||||||Not assessed
3644190|NCT02497755|3491467|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3644191|NCT02497755|3491465|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3644192|NCT02497755|3491466|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|NA|||||||Not assessed
3644193|NCT02497755|3491467|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644194|NCT02497755|3491465|B3||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3644195|NCT02497755|3491466|B2||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Not assessed
3644196|NCT02497755|3491467|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3644197|NCT02497755|3491465|B3||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3644198|NCT02497755|3491466|B2||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Not assessed
3644199|NCT02497755|3491467|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3644200|NCT02497755|3491465|B3||>=65 years|Age||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3644201|NCT02497755|3491466|B2||>=65 years|Age||Participants|Count of Participants|NA|||||||Not assessed
3644202|NCT02497755|3491467|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3644203|NCT02497755|3491465|B3||Between 18 and 65 years|Age||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3644204|NCT02497755|3491466|B2||Between 18 and 65 years|Age||Participants|Count of Participants|NA|||||||Not assessed
3644205|NCT02497755|3491467|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3644206|NCT02497755|3491465|B3||<=18 years|Age||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3644207|NCT02497755|3491466|B2||<=18 years|Age||Participants|Count of Participants|NA|||||||Not assessed
3644208|NCT02497755|3491467|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3644209|NCT02497391|3491481|B1|Singapore||Region of Enrollment||Participants|Count of Participants|95|95.0||||||
3644210|NCT02497391|3491481|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644211|NCT02497391|3491481|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644212|NCT02497391|3491481|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3644213|NCT02497391|3491481|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644214|NCT02497391|3491481|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644215|NCT02497391|3491481|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
3644216|NCT02497391|3491481|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644217|NCT02497391|3491481|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644218|NCT02497391|3491481|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3644219|NCT02497391|3491481|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644220|NCT02497391|3491481|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3644221|NCT02497391|3491481|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3644222|NCT02497391|3491481|B1|||Age||years|Mean|40.1|40.1|Standard Deviation|10.9|10.9|||
3644223|NCT02497235|3491497|B6|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|26.79|26.79|Standard Deviation|3.212|3.212|||
3644224|NCT02497235|3491498|B5|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|24.95|24.95|Standard Deviation|4.275|4.275|||
3644225|NCT02497235|3491499|B4|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|26.87|26.87|Standard Deviation|1.593|1.593|||
3644226|NCT02497235|3491500|B3|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|25.46|25.46|Standard Deviation|5.327|5.327|||
3644227|NCT02497235|3491501|B2|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|28.37|28.37|Standard Deviation|2.157|2.157|||
3644228|NCT02497235|3491502|B1|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|29.22|29.22|Standard Deviation|0.789|0.789|||
3644229|NCT02497235|3491497|B6|||Weight||kilogram (kg)|Mean|86.06|86.06|Standard Deviation|13.009|13.009|||
3644230|NCT02497235|3491498|B5|||Weight||kilogram (kg)|Mean|84.83|84.83|Standard Deviation|23.692|23.692|||
3644231|NCT02497235|3491499|B4|||Weight||kilogram (kg)|Mean|87.05|87.05|Standard Deviation|5.162|5.162|||
3644232|NCT02497235|3491500|B3|||Weight||kilogram (kg)|Mean|79.40|79.4|Standard Deviation|12.869|12.869|||
3644233|NCT02497235|3491501|B2|||Weight||kilogram (kg)|Mean|93.60|93.6|Standard Deviation|10.748|10.748|||
3644234|NCT02497235|3491502|B1|||Weight||kilogram (kg)|Mean|86.05|86.05|Standard Deviation|7.283|7.283|||
3644235|NCT02497235|3491497|B6|||Height||centimeter (cm)|Mean|179.0|179.0|Standard Deviation|8.69|8.69|||
3644236|NCT02497235|3491498|B5|||Height||centimeter (cm)|Mean|183.0|183.0|Standard Deviation|16.09|16.09|||
3644237|NCT02497235|3491499|B4|||Height||centimeter (cm)|Mean|180.0|180.0|Standard Deviation|0.00|0.0|||
3644238|NCT02497235|3491500|B3|||Height||centimeter (cm)|Mean|177.0|177.0|Standard Deviation|4.24|4.24|||
3644239|NCT02497235|3491501|B2|||Height||centimeter (cm)|Mean|181.5|181.5|Standard Deviation|3.54|3.54|||
3644240|NCT02497235|3491502|B1|||Height||centimeter (cm)|Mean|171.5|171.5|Standard Deviation|4.95|4.95|||
3644241|NCT02497235|3491497|B6|White||Race||participants|Number|5|5.0||||||
3644242|NCT02497235|3491498|B5|White||Race||participants|Number|2|2.0||||||
3644243|NCT02497235|3491499|B4|White||Race||participants|Number|2|2.0||||||
3644244|NCT02497235|3491500|B3|White||Race||participants|Number|0|0.0||||||
3644245|NCT02497235|3491501|B2|White||Race||participants|Number|1|1.0||||||
3644246|NCT02497235|3491502|B1|White||Race||participants|Number|0|0.0||||||
3644247|NCT02497235|3491497|B6|Black or African American||Race||participants|Number|6|6.0||||||
3644248|NCT02497235|3491498|B5|Black or African American||Race||participants|Number|1|1.0||||||
3644249|NCT02497235|3491499|B4|Black or African American||Race||participants|Number|0|0.0||||||
3644250|NCT02497235|3491500|B3|Black or African American||Race||participants|Number|2|2.0||||||
3644251|NCT02497235|3491501|B2|Black or African American||Race||participants|Number|1|1.0||||||
3644252|NCT02497235|3491502|B1|Black or African American||Race||participants|Number|2|2.0||||||
3644253|NCT02497235|3491497|B6|Not Hispanic or Latino||Ethnicity||participants|Number|7|7.0||||||
3644254|NCT02497235|3491498|B5|Not Hispanic or Latino||Ethnicity||participants|Number|2|2.0||||||
3644255|NCT02497235|3491499|B4|Not Hispanic or Latino||Ethnicity||participants|Number|2|2.0||||||
3644256|NCT02497235|3491500|B3|Not Hispanic or Latino||Ethnicity||participants|Number|2|2.0||||||
3644257|NCT02497235|3491501|B2|Not Hispanic or Latino||Ethnicity||participants|Number|0|0.0||||||
3644258|NCT02497235|3491502|B1|Not Hispanic or Latino||Ethnicity||participants|Number|1|1.0||||||
3644259|NCT02497235|3491497|B6|Hispanic or Latino||Ethnicity||participants|Number|4|4.0||||||
3644260|NCT02497235|3491498|B5|Hispanic or Latino||Ethnicity||participants|Number|1|1.0||||||
3644261|NCT02497235|3491499|B4|Hispanic or Latino||Ethnicity||participants|Number|0|0.0||||||
3644262|NCT02497235|3491500|B3|Hispanic or Latino||Ethnicity||participants|Number|0|0.0||||||
3644265|NCT02497235|3491497|B6|United States||Region of Enrollment||participants|Number|11|11.0||||||
3644266|NCT02497235|3491498|B5|United States||Region of Enrollment||participants|Number|3|3.0||||||
3644267|NCT02497235|3491499|B4|United States||Region of Enrollment||participants|Number|2|2.0||||||
3644268|NCT02497235|3491500|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3644269|NCT02497235|3491501|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3644270|NCT02497235|3491502|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3644271|NCT02497235|3491497|B6|Male||Sex/Gender, Customized||participants|Number|11|11.0||||||
3644272|NCT02497235|3491498|B5|Male||Sex/Gender, Customized||participants|Number|3|3.0||||||
3644273|NCT02497235|3491499|B4|Male||Sex/Gender, Customized||participants|Number|2|2.0||||||
3644274|NCT02497235|3491500|B3|Male||Sex/Gender, Customized||participants|Number|2|2.0||||||
3644275|NCT02497235|3491501|B2|Male||Sex/Gender, Customized||participants|Number|2|2.0||||||
3644276|NCT02497235|3491502|B1|Male||Sex/Gender, Customized||participants|Number|2|2.0||||||
3644277|NCT02497235|3491497|B6|||Age||years|Mean|38.4|38.4|Standard Deviation|8.48|8.48|||
3644278|NCT02497235|3491498|B5|||Age||years|Mean|36.7|36.7|Standard Deviation|6.11|6.11|||
3644279|NCT02497235|3491499|B4|||Age||years|Mean|48.5|48.5|Standard Deviation|2.12|2.12|||
3644280|NCT02497235|3491500|B3|||Age||years|Mean|42.0|42.0|Standard Deviation|2.83|2.83|||
3644281|NCT02497235|3491501|B2|||Age||years|Mean|25.5|25.5|Standard Deviation|2.12|2.12|||
3644282|NCT02497235|3491502|B1|||Age||years|Mean|40.0|40.0|Standard Deviation|7.07|7.07|||
3644283|NCT02497040|3491536|B4|Turkey||Region of Enrollment||participants|Number|90|90.0||||||
3644284|NCT02497040|3491537|B3|Turkey||Region of Enrollment||participants|Number|30|30.0||||||
3644285|NCT02497040|3491538|B2|Turkey||Region of Enrollment||participants|Number|30|30.0||||||
3644286|NCT02497040|3491539|B1|Turkey||Region of Enrollment||participants|Number|30|30.0||||||
3644287|NCT02497040|3491536|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3644288|NCT02497040|3491537|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3644289|NCT02497040|3491538|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3644290|NCT02497040|3491539|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3644291|NCT02497040|3491536|B4||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3644292|NCT02497040|3491537|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3644293|NCT02497040|3491538|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3644294|NCT02497040|3491539|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3644295|NCT02497040|3491536|B4||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3644296|NCT02497040|3491537|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3644297|NCT02497040|3491538|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3644298|NCT02497040|3491539|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3644299|NCT02497040|3491536|B4||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
3644300|NCT02497040|3491537|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3644301|NCT02497040|3491538|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3644302|NCT02497040|3491539|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3644303|NCT02497040|3491536|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3644304|NCT02497040|3491537|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3644305|NCT02497040|3491538|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3644306|NCT02497040|3491539|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3644307|NCT02496702|3491549|B3|||BMI||kg/m^2|Mean|26.16|26.16|Standard Deviation|4.80|4.8|||
3644308|NCT02496702|3491550|B2|||BMI||kg/m^2|Mean|26.16|26.16|Standard Deviation|4.45|4.45|||
3644309|NCT02496702|3491551|B1|||BMI||kg/m^2|Mean|26.17|26.17|Standard Deviation|5.21|5.21|||
3644310|NCT02496702|3491549|B3|||Weight||kg|Mean|69.73|69.73|Standard Deviation|13.25|13.25|||
3644311|NCT02496702|3491550|B2|||Weight||kg|Mean|71.13|71.13|Standard Deviation|13.34|13.34|||
3644312|NCT02496702|3491551|B1|||Weight||kg|Mean|68.33|68.33|Standard Deviation|13.22|13.22|||
3644313|NCT02496702|3491549|B3|||Height||cm|Mean|1.63|1.63|Full Range|||1.47|1.88|
3644314|NCT02496702|3491550|B2|||Height||cm|Mean|1.65|1.65|Full Range|||1.49|1.88|
3644315|NCT02496702|3491551|B1|||Height||cm|Mean|1.62|1.62|Full Range|||1.47|1.78|
3644316|NCT02496702|3491549|B3|||Line Walk||Steps|Mean|2.93|2.93|Standard Deviation|3.56|3.56|||
3644317|NCT02496702|3491550|B2|||Line Walk||Steps|Mean|3.50|3.5|Standard Deviation|2.49|2.49|||
3644318|NCT02496702|3491551|B1|||Line Walk||Steps|Mean|2.37|2.37|Standard Deviation|4.36|4.36|||
3644319|NCT02496702|3491549|B3|||6 Minute Walking Test||Meters|Mean|238.73|238.73|Standard Deviation|83.12|83.12|||
3644320|NCT02496702|3491550|B2|||6 Minute Walking Test||Meters|Mean|237.18|237.18|Standard Deviation|94.77|94.77|||
3644321|NCT02496702|3491551|B1|||6 Minute Walking Test||Meters|Mean|240.28|240.28|Standard Deviation|71.21|71.21|||
3644322|NCT02496702|3491549|B3|||Chair Stand||Chair stands per 30 seconds|Mean|9|9.0|Standard Deviation|4.17|4.17|||
3644323|NCT02496702|3491550|B2|||Chair Stand||Chair stands per 30 seconds|Mean|8.77|8.77|Standard Deviation|3.91|3.91|||
3644324|NCT02496702|3491551|B1|||Chair Stand||Chair stands per 30 seconds|Mean|9.23|9.23|Standard Deviation|4.47|4.47|||
3644325|NCT02496702|3491549|B3|||Timed Up and Go||Seconds|Mean|12.80|12.8|Standard Deviation|7.96|7.96|||
3644326|NCT02496702|3491550|B2|||Timed Up and Go||Seconds|Mean|13.35|13.35|Standard Deviation|10.10|10.1|||
3644327|NCT02496702|3491551|B1|||Timed Up and Go||Seconds|Mean|12.24|12.24|Standard Deviation|5.13|5.13|||
3644328|NCT02496702|3491549|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3644329|NCT02496702|3491550|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3644330|NCT02496702|3491551|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3644331|NCT02496702|3491549|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3644332|NCT02496702|3491550|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3644333|NCT02496702|3491551|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3644334|NCT02496702|3491549|B3|||Age||years|Mean|82.73|82.73|Standard Deviation|6.57|6.57|||
3644335|NCT02496702|3491550|B2|||Age||years|Mean|82.37|82.37|Standard Deviation|6.61|6.61|||
3644336|NCT02496702|3491551|B1|||Age||years|Mean|83.14|83.14|Standard Deviation|6.69|6.69|||
3644337|NCT02496533|3491572|B3|United States||Region of Enrollment||participants|Number|217|217.0||||||
3644338|NCT02496533|3491573|B2|United States||Region of Enrollment||participants|Number|112|112.0||||||
3644339|NCT02496533|3491574|B1|United States||Region of Enrollment||participants|Number|105|105.0||||||
3644340|NCT02496533|3491572|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3644341|NCT02496533|3491573|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3644342|NCT02496533|3491574|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3644343|NCT02496533|3491572|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644344|NCT02496533|3491573|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644345|NCT02496533|3491574|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644346|NCT02496533|3491572|B3||White|Race (NIH/OMB)||Participants|Count of Participants|161|161.0||||||
3644347|NCT02496533|3491573|B2||White|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
3644348|NCT02496533|3491574|B1||White|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3644349|NCT02496533|3491572|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3644350|NCT02496533|3491573|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3644351|NCT02496533|3491574|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3644352|NCT02496533|3491572|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644353|NCT02496533|3491573|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644354|NCT02496533|3491574|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644355|NCT02496533|3491572|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644356|NCT02496533|3491573|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644357|NCT02496533|3491574|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644358|NCT02496533|3491572|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644359|NCT02496533|3491573|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644360|NCT02496533|3491574|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644361|NCT02496533|3491572|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3644362|NCT02496533|3491573|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3644363|NCT02496533|3491574|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644364|NCT02496533|3491572|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|204|204.0||||||
3644365|NCT02496533|3491573|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
3644366|NCT02496533|3491574|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3644367|NCT02496533|3491572|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3644368|NCT02496533|3491573|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3644369|NCT02496533|3491574|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3644370|NCT02496533|3491572|B3||Male|Gender||Participants|Count of Participants|128|128.0||||||
3644371|NCT02496533|3491573|B2||Male|Gender||Participants|Count of Participants|66|66.0||||||
3644372|NCT02496533|3491574|B1||Male|Gender||Participants|Count of Participants|62|62.0||||||
3644373|NCT02496533|3491572|B3||Female|Gender||Participants|Count of Participants|89|89.0||||||
3644374|NCT02496533|3491573|B2||Female|Gender||Participants|Count of Participants|46|46.0||||||
3644375|NCT02496533|3491574|B1||Female|Gender||Participants|Count of Participants|43|43.0||||||
3644376|NCT02496533|3491572|B3|Age ≥18 years||Age, Customized||participants|Number|217|217.0||||||
3644377|NCT02496533|3491573|B2|Age ≥18 years||Age, Customized||participants|Number|112|112.0||||||
3644378|NCT02496533|3491574|B1|Age ≥18 years||Age, Customized||participants|Number|105|105.0||||||
3644379|NCT02496221|3491587|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3644380|NCT02496221|3491587|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
3644381|NCT02496221|3491587|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3644382|NCT02496221|3491587|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3644383|NCT02496221|3491587|B1|||Age||Years|Mean|35.8|35.8|Standard Deviation|9.33|9.33|||
3644384|NCT02496039|3491622|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644385|NCT02496039|3491622|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644386|NCT02496039|3491622|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3644387|NCT02496039|3491622|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3644388|NCT02496039|3491622|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644389|NCT02496039|3491622|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644390|NCT02496039|3491622|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644391|NCT02496039|3491622|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3644392|NCT02496039|3491622|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3644393|NCT02496039|3491622|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3644394|NCT02496039|3491622|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3644395|NCT02496039|3491622|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3644396|NCT02496000|3491634|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3644397|NCT02496000|3491635|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3644398|NCT02496000|3491636|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644399|NCT02496000|3491637|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644400|NCT02496000|3491634|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644401|NCT02496000|3491635|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644402|NCT02496000|3491636|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644403|NCT02496000|3491637|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644404|NCT02496000|3491634|B4||White|Race (NIH/OMB)||Participants|Count of Participants|158|158.0||||||
3644405|NCT02496000|3491635|B3||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3644406|NCT02496000|3491636|B2||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3644407|NCT02496000|3491637|B1||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3644408|NCT02496000|3491634|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3644409|NCT02496000|3491635|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3644410|NCT02496000|3491636|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3644411|NCT02496000|3491637|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3644412|NCT02496000|3491634|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3644413|NCT02496000|3491635|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644414|NCT02496000|3491636|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3644415|NCT02496000|3491637|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3644416|NCT02496000|3491634|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3644417|NCT02496000|3491635|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3644418|NCT02496000|3491636|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3644419|NCT02496000|3491637|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3644420|NCT02496000|3491634|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644421|NCT02496000|3491635|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644422|NCT02496000|3491636|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644423|NCT02496000|3491637|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644424|NCT02496000|3491634|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644425|NCT02496000|3491635|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644426|NCT02496000|3491636|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644427|NCT02496000|3491637|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644428|NCT02496000|3491634|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
3644429|NCT02496000|3491635|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3644430|NCT02496000|3491636|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3644431|NCT02496000|3491637|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3644432|NCT02496000|3491634|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3644433|NCT02496000|3491635|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3644434|NCT02496000|3491636|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3644435|NCT02496000|3491637|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3644436|NCT02496000|3491634|B4||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3644437|NCT02496000|3491635|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3644438|NCT02496000|3491636|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3644439|NCT02496000|3491637|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3644440|NCT02496000|3491634|B4||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3644441|NCT02496000|3491635|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3644442|NCT02496000|3491636|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3644443|NCT02496000|3491637|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3644444|NCT02496000|3491634|B4|||Age||years|Mean|57.92|57.92|Standard Deviation|8.69|8.69|||
3644445|NCT02496000|3491635|B3|||Age||years|Mean|57.25|57.25|Standard Deviation|8.786|8.786|||
3644446|NCT02496000|3491636|B2|||Age||years|Mean|57.89|57.89|Standard Deviation|8.021|8.021|||
3644447|NCT02496000|3491637|B1|||Age||years|Mean|58.61|58.61|Standard Deviation|9.203|9.203|||
3644448|NCT02495948|3491648|B1||Male|Gender||Participants|Count of Participants|37|37.0||||||
3644449|NCT02495948|3491648|B1||Female|Gender||Participants|Count of Participants|130|130.0||||||
3644450|NCT02495948|3491648|B1|||Age||years|Mean|31.9|31.9|Standard Deviation|9.01|9.01|||
3644451|NCT02495831|3491656|B1|Switzerland||Region of Enrollment||participants|Number|23|23.0||||||
3644452|NCT02495831|3491656|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644453|NCT02495831|3491656|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644454|NCT02495831|3491656|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3644455|NCT02495831|3491656|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644456|NCT02495831|3491656|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644457|NCT02495831|3491656|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644458|NCT02495831|3491656|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644459|NCT02495831|3491656|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3644460|NCT02495831|3491656|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3644461|NCT02495831|3491656|B1|||Age||years|Mean|41.6|41.6|Standard Deviation|9.1|9.1|||
3644462|NCT02495831|3491656|B1||>=65 years|Age|healthy volunteers, both sexes, 22-55 years old inclusive|Participants|Count of Participants|0|0.0||||||
3644463|NCT02495831|3491656|B1||Between 18 and 65 years|Age|healthy volunteers, both sexes, 22-55 years old inclusive|Participants|Count of Participants|23|23.0||||||
3644464|NCT02495831|3491656|B1||<=18 years|Age|healthy volunteers, both sexes, 22-55 years old inclusive|Participants|Count of Participants|0|0.0||||||
3644465|NCT02495623|3491671|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3644466|NCT02495623|3491672|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3644467|NCT02495623|3491673|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3644468|NCT02495623|3491674|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3644469|NCT02495623|3491671|B4||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3644470|NCT02495623|3491672|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3644471|NCT02495623|3491673|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3644472|NCT02495623|3491674|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3644473|NCT02495623|3491671|B4|||Age||years|Mean|44.6|44.6|Standard Deviation|8.78|8.78|||
3644474|NCT02495623|3491672|B3|||Age||years|Mean|46.4|46.4|Standard Deviation|10.29|10.29|||
3644475|NCT02495623|3491673|B2|||Age||years|Mean|44.7|44.7|Standard Deviation|9.54|9.54|||
3644476|NCT02495623|3491674|B1|||Age||years|Mean|42.6|42.6|Standard Deviation|6.01|6.01|||
3644477|NCT02495259|3491684|B4|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3644478|NCT02495259|3491685|B3|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3644479|NCT02495259|3491686|B2|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3644480|NCT02495259|3491687|B1|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3644481|NCT02495259|3491684|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3644482|NCT02495259|3491685|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644483|NCT02495259|3491686|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3644484|NCT02495259|3491687|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644485|NCT02495259|3491684|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644486|NCT02495259|3491685|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644487|NCT02495259|3491686|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644488|NCT02495259|3491687|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644489|NCT02495259|3491684|B4||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3644490|NCT02495259|3491685|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3644491|NCT02495259|3491686|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3644492|NCT02495259|3491687|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3644493|NCT02495259|3491684|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3644494|NCT02495259|3491685|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3644495|NCT02495259|3491686|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3644496|NCT02495259|3491687|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3644497|NCT02495259|3491684|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644498|NCT02495259|3491685|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644499|NCT02495259|3491686|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644500|NCT02495259|3491687|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644501|NCT02495259|3491684|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644502|NCT02495259|3491685|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644503|NCT02495259|3491686|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644504|NCT02495259|3491687|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644505|NCT02495259|3491684|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644506|NCT02495259|3491685|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644507|NCT02495259|3491686|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644508|NCT02495259|3491687|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644509|NCT02495259|3491684|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3644510|NCT02495259|3491685|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3644511|NCT02495259|3491686|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3644512|NCT02495259|3491687|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3644513|NCT02495259|3491684|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3644514|NCT02495259|3491685|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3644515|NCT02495259|3491686|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3644516|NCT02495259|3491687|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3644517|NCT02495259|3491684|B4||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3644518|NCT02495259|3491685|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3644519|NCT02495259|3491686|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3644520|NCT02495259|3491687|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3644521|NCT02495259|3491684|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3644522|NCT02495259|3491685|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3644523|NCT02495259|3491686|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3644524|NCT02495259|3491687|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3644525|NCT02495259|3491684|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3644526|NCT02495259|3491685|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3644527|NCT02495259|3491686|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3644528|NCT02495259|3491687|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3644529|NCT02495038|3491712|B4|Korea, Republic of||Region of Enrollment||participants|Number|81|81.0||||||
3644530|NCT02495038|3491713|B3|Korea, Republic of||Region of Enrollment||participants|Number|27|27.0||||||
3644531|NCT02495038|3491714|B2|Korea, Republic of||Region of Enrollment||participants|Number|27|27.0||||||
3644532|NCT02495038|3491715|B1|Korea, Republic of||Region of Enrollment||participants|Number|27|27.0||||||
3644533|NCT02495038|3491712|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3644534|NCT02495038|3491713|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3644535|NCT02495038|3491714|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3644536|NCT02495038|3491715|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3644537|NCT02495038|3491712|B4||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3644538|NCT02495038|3491713|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3644539|NCT02495038|3491714|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3644540|NCT02495038|3491715|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3644541|NCT02495038|3491712|B4|||Age||years|Mean|49.1|49.1|Standard Deviation|9.4|9.4|||
3644542|NCT02495038|3491713|B3|||Age||years|Mean|49.3|49.3|Standard Deviation|9.4|9.4|||
3644543|NCT02495038|3491714|B2|||Age||years|Mean|50.3|50.3|Standard Deviation|8.0|8.0|||
3644544|NCT02495038|3491715|B1|||Age||years|Mean|47.9|47.9|Standard Deviation|10.7|10.7|||
3644545|NCT02494713|3491752|B1|5||ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status scale measures level of functioning. The scale ranges from 0 to 5, with 0 indicating the highest level of functioning and 5 the lowest.|Participants|Count of Participants|0|0.0||||||
3644546|NCT02494713|3491752|B1|4||ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status scale measures level of functioning. The scale ranges from 0 to 5, with 0 indicating the highest level of functioning and 5 the lowest.|Participants|Count of Participants|0|0.0||||||
3644547|NCT02494713|3491752|B1|3||ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status scale measures level of functioning. The scale ranges from 0 to 5, with 0 indicating the highest level of functioning and 5 the lowest.|Participants|Count of Participants|0|0.0||||||
3644548|NCT02494713|3491752|B1|2||ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status scale measures level of functioning. The scale ranges from 0 to 5, with 0 indicating the highest level of functioning and 5 the lowest.|Participants|Count of Participants|0|0.0||||||
3644549|NCT02494713|3491752|B1|1||ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status scale measures level of functioning. The scale ranges from 0 to 5, with 0 indicating the highest level of functioning and 5 the lowest.|Participants|Count of Participants|0|0.0||||||
3644609|NCT02493855|3491825|B3||Mutli Race|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3644610|NCT02493855|3491826|B2||Mutli Race|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3644550|NCT02494713|3491752|B1|0||ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status scale measures level of functioning. The scale ranges from 0 to 5, with 0 indicating the highest level of functioning and 5 the lowest.|Participants|Count of Participants|4|4.0||||||
3644551|NCT02494713|3491752|B1|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3644552|NCT02494713|3491752|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3644553|NCT02494713|3491752|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3644554|NCT02494713|3491752|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3644555|NCT02494713|3491752|B1|||Age||years|Median|58|58.0|Full Range|||49.0|73.0|
3644556|NCT02494596|3491769|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3644557|NCT02494596|3491769|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3644558|NCT02494596|3491769|B1|||Age||years|Mean|60.9|60.9|Standard Deviation|9.10|9.1|||
3644559|NCT02494440|3491796|B1|Egypt||Region of Enrollment||participants|Number|90|90.0||||||
3644560|NCT02494440|3491796|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3644561|NCT02494440|3491796|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3644562|NCT02494440|3491796|B1|||Age||years|Mean|28.1|28.1|Standard Deviation|4.7|4.7|||
3644563|NCT02494440|3491796|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3644564|NCT02494440|3491796|B1||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
3644565|NCT02494440|3491796|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3644566|NCT02494323|3491802|B1|Israel||Region of Enrollment||participants|Number|70|70.0||||||
3644567|NCT02494323|3491802|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3644568|NCT02494323|3491802|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3644569|NCT02494323|3491802|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|14.83|14.83|||
3644570|NCT02494323|3491802|B1||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
3644571|NCT02494323|3491802|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3644572|NCT02494323|3491802|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3644573|NCT02494206|3491807|B1|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3644574|NCT02494206|3491807|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644575|NCT02494206|3491807|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644576|NCT02494206|3491807|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3644577|NCT02494206|3491807|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644578|NCT02494206|3491807|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644579|NCT02494206|3491807|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644580|NCT02494206|3491807|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644581|NCT02494206|3491807|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644582|NCT02494206|3491807|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3644583|NCT02494206|3491807|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644584|NCT02494206|3491807|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3644585|NCT02494206|3491807|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3644586|NCT02494206|3491807|B1|||Age||years|Median|59|59.0|Full Range|||36.0|63.0|
3644587|NCT02494076|3491811|B3|United States||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
3644588|NCT02494076|3491812|B2|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3644589|NCT02494076|3491813|B1|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3644590|NCT02494076|3491811|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3644591|NCT02494076|3491812|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3644592|NCT02494076|3491813|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3644593|NCT02494076|3491811|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3644594|NCT02494076|3491812|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3644595|NCT02494076|3491813|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3644596|NCT02494076|3491811|B3|||Age||years|Mean|7.8|7.8|Standard Deviation|4.3|4.3|||
3644597|NCT02494076|3491812|B2|||Age||years|Mean|6.9|6.9|Standard Deviation|4.1|4.1|||
3644598|NCT02494076|3491813|B1|||Age||years|Mean|8.7|8.7|Standard Deviation|4.3|4.3|||
3644599|NCT02494076|3491811|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3644600|NCT02494076|3491812|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3644601|NCT02494076|3491813|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3644602|NCT02494076|3491811|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3644603|NCT02494076|3491812|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3644604|NCT02494076|3491813|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3644605|NCT02494076|3491811|B3||<=18 years|Age||Participants|Count of Participants|52|52.0||||||
3644606|NCT02494076|3491812|B2||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
3644607|NCT02494076|3491813|B1||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
3644608|NCT02493855|3491824|B4||Mutli Race|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3644611|NCT02493855|3491827|B1||Mutli Race|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3644612|NCT02493855|3491824|B4||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3644613|NCT02493855|3491825|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3644614|NCT02493855|3491826|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3644615|NCT02493855|3491827|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3644616|NCT02493855|3491824|B4||American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3644617|NCT02493855|3491825|B3||American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3644618|NCT02493855|3491826|B2||American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3644619|NCT02493855|3491827|B1||American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3644620|NCT02493855|3491824|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3644621|NCT02493855|3491825|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3644622|NCT02493855|3491826|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3644623|NCT02493855|3491827|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3644624|NCT02493855|3491824|B4||Black of African American|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3644625|NCT02493855|3491825|B3||Black of African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3644626|NCT02493855|3491826|B2||Black of African American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3644627|NCT02493855|3491827|B1||Black of African American|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3644628|NCT02493855|3491824|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3644629|NCT02493855|3491825|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3644630|NCT02493855|3491826|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3644631|NCT02493855|3491827|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3644632|NCT02493855|3491824|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3644633|NCT02493855|3491825|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3644634|NCT02493855|3491826|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3644635|NCT02493855|3491827|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3644636|NCT02493855|3491824|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3644637|NCT02493855|3491825|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3644638|NCT02493855|3491826|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3644639|NCT02493855|3491827|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3644640|NCT02493855|3491824|B4||≥ 65 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3644641|NCT02493855|3491825|B3||≥ 65 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3644642|NCT02493855|3491826|B2||≥ 65 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3644643|NCT02493855|3491827|B1||≥ 65 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3644644|NCT02493855|3491824|B4||≥ 55 - 65 years|Age, Customized||Participants|Count of Participants|10|10.0||||||
3644645|NCT02493855|3491825|B3||≥ 55 - 65 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
3644646|NCT02493855|3491826|B2||≥ 55 - 65 years|Age, Customized||Participants|Count of Participants|5|5.0||||||
3644647|NCT02493855|3491827|B1||≥ 55 - 65 years|Age, Customized||Participants|Count of Participants|4|4.0||||||
3644648|NCT02493855|3491824|B4||< 55 years|Age, Customized||Participants|Count of Participants|36|36.0||||||
3644649|NCT02493855|3491825|B3||< 55 years|Age, Customized||Participants|Count of Participants|5|5.0||||||
3644650|NCT02493855|3491826|B2||< 55 years|Age, Customized||Participants|Count of Participants|14|14.0||||||
3644651|NCT02493855|3491827|B1||< 55 years|Age, Customized||Participants|Count of Participants|17|17.0||||||
3644652|NCT02493855|3491824|B4|||Age||years|Mean|44.3|44.3|Standard Deviation|12.88|12.88|||
3644653|NCT02493855|3491825|B3|||Age||years|Mean|36.7|36.7|Standard Deviation|15.79|15.79|||
3644654|NCT02493855|3491826|B2|||Age||years|Mean|46.0|46.0|Standard Deviation|12.78|12.78|||
3644655|NCT02493855|3491827|B1|||Age||years|Mean|44.9|44.9|Standard Deviation|11.96|11.96|||
3644656|NCT02493777|3491837|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3644657|NCT02493777|3491838|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3644658|NCT02493777|3491839|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3644659|NCT02493777|3491837|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3644660|NCT02493777|3491838|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3644661|NCT02493777|3491839|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3644662|NCT02493777|3491837|B3|||Age||Years|Mean|9.4|9.4|Standard Deviation|1.63|1.63|||
3644663|NCT02493777|3491838|B2|||Age||Years|Mean|9.3|9.3|Standard Deviation|1.68|1.68|||
3644664|NCT02493777|3491839|B1|||Age||Years|Mean|9.6|9.6|Standard Deviation|1.58|1.58|||
3644665|NCT02493517|3491848|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644666|NCT02493517|3491849|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644667|NCT02493517|3491850|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644668|NCT02493517|3491848|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644669|NCT02493517|3491849|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644670|NCT02493517|3491850|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644671|NCT02493517|3491848|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644672|NCT02493517|3491849|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644673|NCT02493517|3491850|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644674|NCT02493517|3491848|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644675|NCT02493517|3491849|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644676|NCT02493517|3491850|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644677|NCT02493517|3491848|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644678|NCT02493517|3491849|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644679|NCT02493517|3491850|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644680|NCT02493517|3491848|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
3644681|NCT02493517|3491849|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3644682|NCT02493517|3491850|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3644683|NCT02493517|3491848|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644684|NCT02493517|3491849|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644685|NCT02493517|3491850|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644686|NCT02493517|3491848|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3644687|NCT02493517|3491849|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3644688|NCT02493517|3491850|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3644689|NCT02493517|3491848|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3644690|NCT02493517|3491849|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3644691|NCT02493517|3491850|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3644692|NCT02493517|3491848|B3|||Age||years|Mean|39.4|39.4|Standard Deviation|11.9|11.9|||
3644693|NCT02493517|3491849|B2|||Age||years|Mean|40.8|40.8|Standard Deviation|12.6|12.6|||
3644694|NCT02493517|3491850|B1|||Age||years|Mean|37.9|37.9|Standard Deviation|11.2|11.2|||
3644695|NCT02493127|3491873|B3|Maximum grip strength||Grip strength of both hands|Three grip strength measurements were recorded with the Dynamometer and the mean and maximum grip strength was calculated and reported.|pounds|Mean|78|78.0|Standard Deviation|31|31.0|||
3644696|NCT02493127|3491874|B2|Maximum grip strength||Grip strength of both hands|Three grip strength measurements were recorded with the Dynamometer and the mean and maximum grip strength was calculated and reported.|pounds|Mean|81|81.0|Standard Deviation|33|33.0|||
3644697|NCT02493127|3491875|B1|Maximum grip strength||Grip strength of both hands|Three grip strength measurements were recorded with the Dynamometer and the mean and maximum grip strength was calculated and reported.|pounds|Mean|73|73.0|Standard Deviation|28|28.0|||
3644698|NCT02493127|3491873|B3|Mean grip strength||Grip strength of both hands|Three grip strength measurements were recorded with the Dynamometer and the mean and maximum grip strength was calculated and reported.|pounds|Mean|68|68.0|Standard Deviation|30|30.0|||
3644699|NCT02493127|3491874|B2|Mean grip strength||Grip strength of both hands|Three grip strength measurements were recorded with the Dynamometer and the mean and maximum grip strength was calculated and reported.|pounds|Mean|68|68.0|Standard Deviation|30|30.0|||
3644700|NCT02493127|3491875|B1|Mean grip strength||Grip strength of both hands|Three grip strength measurements were recorded with the Dynamometer and the mean and maximum grip strength was calculated and reported.|pounds|Mean|59|59.0|Standard Deviation|23|23.0|||
3644701|NCT02493127|3491873|B3|Maximum grip strength||Grip Strength of non-affected hand|Three grip strength measurements were recorded with the Dynamometer and the mean and maximum grip strength was calculated and reported.|pounds|Mean|76|76.0|Standard Deviation|33|33.0|||
3644702|NCT02493127|3491874|B2|Maximum grip strength||Grip Strength of non-affected hand|Three grip strength measurements were recorded with the Dynamometer and the mean and maximum grip strength was calculated and reported.|pounds|Mean|79|79.0|Standard Deviation|33|33.0|||
3644703|NCT02493127|3491875|B1|Maximum grip strength||Grip Strength of non-affected hand|Three grip strength measurements were recorded with the Dynamometer and the mean and maximum grip strength was calculated and reported.|pounds|Mean|72|72.0|Standard Deviation|30|30.0|||
3644704|NCT02493127|3491873|B3|Mean grip strength||Grip Strength of non-affected hand|Three grip strength measurements were recorded with the Dynamometer and the mean and maximum grip strength was calculated and reported.|pounds|Mean|71|71.0|Standard Deviation|30|30.0|||
3644705|NCT02493127|3491874|B2|Mean grip strength||Grip Strength of non-affected hand|Three grip strength measurements were recorded with the Dynamometer and the mean and maximum grip strength was calculated and reported.|pounds|Mean|75|75.0|Standard Deviation|32|32.0|||
3644706|NCT02493127|3491875|B1|Mean grip strength||Grip Strength of non-affected hand|Three grip strength measurements were recorded with the Dynamometer and the mean and maximum grip strength was calculated and reported.|pounds|Mean|67|67.0|Standard Deviation|28|28.0|||
3644707|NCT02493127|3491873|B3|Maximum grip strength||Grip Strength affected hand|Three grip strength measurements were recorded with the Dynamometer and the mean and maximum grip strength was calculated and reported.|pounds|Mean|60|60.0|Standard Deviation|29|29.0|||
3644708|NCT02493127|3491874|B2|Maximum grip strength||Grip Strength affected hand|Three grip strength measurements were recorded with the Dynamometer and the mean and maximum grip strength was calculated and reported.|pounds|Mean|66|66.0|Standard Deviation|32|32.0|||
3644762|NCT02493036|3491897|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3644709|NCT02493127|3491875|B1|Maximum grip strength||Grip Strength affected hand|Three grip strength measurements were recorded with the Dynamometer and the mean and maximum grip strength was calculated and reported.|pounds|Mean|56|56.0|Standard Deviation|25|25.0|||
3644710|NCT02493127|3491873|B3|Mean grip strength||Grip Strength affected hand|Three grip strength measurements were recorded with the Dynamometer and the mean and maximum grip strength was calculated and reported.|pounds|Mean|57|57.0|Standard Deviation|28|28.0|||
3644711|NCT02493127|3491874|B2|Mean grip strength||Grip Strength affected hand|Three grip strength measurements were recorded with the Dynamometer and the mean and maximum grip strength was calculated and reported.|pounds|Mean|62|62.0|Standard Deviation|32|32.0|||
3644712|NCT02493127|3491875|B1|Mean grip strength||Grip Strength affected hand|Three grip strength measurements were recorded with the Dynamometer and the mean and maximum grip strength was calculated and reported.|pounds|Mean|52|52.0|Standard Deviation|24|24.0|||
3644713|NCT02493127|3491873|B3|United States||Region of Enrollment||participants|Number|120|120.0||||||
3644714|NCT02493127|3491874|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
3644715|NCT02493127|3491875|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
3644716|NCT02493127|3491873|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3644717|NCT02493127|3491874|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3644718|NCT02493127|3491875|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3644719|NCT02493127|3491873|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644720|NCT02493127|3491874|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644721|NCT02493127|3491875|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644722|NCT02493127|3491873|B3||White|Race (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
3644723|NCT02493127|3491874|B2||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3644724|NCT02493127|3491875|B1||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3644725|NCT02493127|3491873|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3644726|NCT02493127|3491874|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3644727|NCT02493127|3491875|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3644728|NCT02493127|3491873|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3644729|NCT02493127|3491874|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3644730|NCT02493127|3491875|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644731|NCT02493127|3491873|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3644732|NCT02493127|3491874|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3644733|NCT02493127|3491875|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644734|NCT02493127|3491873|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644735|NCT02493127|3491874|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644736|NCT02493127|3491875|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644737|NCT02493127|3491873|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644738|NCT02493127|3491874|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644739|NCT02493127|3491875|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644740|NCT02493127|3491873|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|116|116.0||||||
3644741|NCT02493127|3491874|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3644742|NCT02493127|3491875|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3644743|NCT02493127|3491873|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3644744|NCT02493127|3491874|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3644745|NCT02493127|3491875|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3644746|NCT02493127|3491873|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3644747|NCT02493127|3491874|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3644748|NCT02493127|3491875|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3644749|NCT02493127|3491873|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3644750|NCT02493127|3491874|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3644751|NCT02493127|3491875|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3644752|NCT02493127|3491873|B3|||Age||years|Mean|53|53.0|Standard Deviation|16|16.0|||
3644753|NCT02493127|3491874|B2|||Age||years|Mean|51|51.0|Standard Deviation|16|16.0|||
3644754|NCT02493127|3491875|B1|||Age||years|Mean|55|55.0|Standard Deviation|16|16.0|||
3644755|NCT02493088|3491888|B1|France||Region of Enrollment||participants|Number|11|11.0||||||
3644756|NCT02493088|3491888|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3644757|NCT02493088|3491888|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3644758|NCT02493088|3491888|B1|||Age||years|Median|28|28.0|Inter-Quartile Range|||18.0|47.0|
3644759|NCT02493036|3491894|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3644760|NCT02493036|3491895|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3644761|NCT02493036|3491896|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3644763|NCT02493036|3491894|B4||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3644764|NCT02493036|3491895|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3644765|NCT02493036|3491896|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3644766|NCT02493036|3491897|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3644767|NCT02493036|3491894|B4|||Age||years|Mean|44.0|44.0|Standard Deviation|8.79|8.79|||
3644768|NCT02493036|3491895|B3|||Age||years|Mean|46.4|46.4|Standard Deviation|11.16|11.16|||
3644769|NCT02493036|3491896|B2|||Age||years|Mean|42.6|42.6|Standard Deviation|6.30|6.3|||
3644770|NCT02493036|3491897|B1|||Age||years|Mean|43.4|43.4|Standard Deviation|8.67|8.67|||
3644771|NCT02492984|3491907|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3644772|NCT02492984|3491908|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3644773|NCT02492984|3491909|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3644774|NCT02492984|3491907|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3644775|NCT02492984|3491908|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3644776|NCT02492984|3491909|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3644777|NCT02492984|3491907|B3|||Age||years|Mean|9.5|9.5|Standard Deviation|9.0|9.0|||
3644778|NCT02492984|3491908|B2|||Age||years|Mean|21.0|21.0|Standard Deviation|15.0|15.0|||
3644779|NCT02492984|3491909|B1|||Age||years|Mean|7.2|7.2|Standard Deviation|4.8|4.8|||
3644780|NCT02492958|3491930|B5||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3644781|NCT02492958|3491931|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3644782|NCT02492958|3491932|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3644783|NCT02492958|3491933|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3644784|NCT02492958|3491934|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3644785|NCT02492958|3491930|B5||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3644786|NCT02492958|3491931|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3644787|NCT02492958|3491932|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3644788|NCT02492958|3491933|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3644789|NCT02492958|3491934|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3644790|NCT02492958|3491930|B5||>=65 years|Age||Participants|Count of Participants|68|68.0||||||
3644791|NCT02492958|3491931|B4||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
3644792|NCT02492958|3491932|B3||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
3644793|NCT02492958|3491933|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3644794|NCT02492958|3491934|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3644795|NCT02492958|3491930|B5||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
3644796|NCT02492958|3491931|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3644797|NCT02492958|3491932|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3644798|NCT02492958|3491933|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3644799|NCT02492958|3491934|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3644800|NCT02492958|3491930|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3644801|NCT02492958|3491931|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||3.6|3.6|||
3644802|NCT02492958|3491932|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||4.2|4.2|||
3644803|NCT02492958|3491933|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||12.1|12.1|||
3644804|NCT02492958|3491934|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||12.2|12.2|||
3644805|NCT02492880|3492023|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3644806|NCT02492880|3492023|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644807|NCT02492880|3492023|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3644808|NCT02492880|3492023|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3644809|NCT02492880|3492023|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3644810|NCT02492880|3492023|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3644811|NCT02492880|3492023|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3644812|NCT02492880|3492023|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3644813|NCT02492880|3492023|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3644814|NCT02492841|3492027|B4|Mandibular Second molar||Tooth||Participants|Count of Participants|19|19.0||||||
3644815|NCT02492841|3492028|B3|Mandibular Second molar||Tooth||Participants|Count of Participants|6|6.0||||||
3644816|NCT02492841|3492029|B2|Mandibular Second molar||Tooth||Participants|Count of Participants|6|6.0||||||
3644817|NCT02492841|3492030|B1|Mandibular Second molar||Tooth||Participants|Count of Participants|7|7.0||||||
3644818|NCT02492841|3492027|B4|Mandibular First molar||Tooth||Participants|Count of Participants|104|104.0||||||
3644819|NCT02492841|3492028|B3|Mandibular First molar||Tooth||Participants|Count of Participants|36|36.0||||||
3644820|NCT02492841|3492029|B2|Mandibular First molar||Tooth||Participants|Count of Participants|36|36.0||||||
3644821|NCT02492841|3492030|B1|Mandibular First molar||Tooth||Participants|Count of Participants|32|32.0||||||
3644822|NCT02492841|3492027|B4|Maxillary Second molar||Tooth||Participants|Count of Participants|2|2.0||||||
3644823|NCT02492841|3492028|B3|Maxillary Second molar||Tooth||Participants|Count of Participants|1|1.0||||||
3644824|NCT02492841|3492029|B2|Maxillary Second molar||Tooth||Participants|Count of Participants|0|0.0||||||
3644825|NCT02492841|3492030|B1|Maxillary Second molar||Tooth||Participants|Count of Participants|1|1.0||||||
3644826|NCT02492841|3492027|B4|Maxillary First molar||Tooth||Participants|Count of Participants|44|44.0||||||
3644827|NCT02492841|3492028|B3|Maxillary First molar||Tooth||Participants|Count of Participants|17|17.0||||||
3644828|NCT02492841|3492029|B2|Maxillary First molar||Tooth||Participants|Count of Participants|11|11.0||||||
3644829|NCT02492841|3492030|B1|Maxillary First molar||Tooth||Participants|Count of Participants|16|16.0||||||
3644830|NCT02492841|3492027|B4||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3644831|NCT02492841|3492028|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3644832|NCT02492841|3492029|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3644833|NCT02492841|3492030|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3644834|NCT02492841|3492027|B4||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3644835|NCT02492841|3492028|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3644836|NCT02492841|3492029|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3644837|NCT02492841|3492030|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3644838|NCT02492841|3492027|B4|||Age||years|Mean|11.44|11.44|Standard Deviation|2.44|2.44|||
3644839|NCT02492841|3492028|B3|||Age||years|Mean|11.22|11.22|Standard Deviation|2.34|2.34|||
3644840|NCT02492841|3492029|B2|||Age||years|Mean|11.64|11.64|Standard Deviation|2.65|2.65|||
3644841|NCT02492841|3492030|B1|||Age||years|Mean|11.51|11.51|Standard Deviation|2.34|2.34|||
3644842|NCT02492763|3492043|B5|||Body Weight||Kilograms|Mean|89.3|89.3|Standard Deviation|18.5|18.5|||
3644843|NCT02492763|3492044|B4|||Body Weight||Kilograms|Mean|92.4|92.4|Standard Deviation|16.5|16.5|||
3644844|NCT02492763|3492045|B3|||Body Weight||Kilograms|Mean|90.2|90.2|Standard Deviation|19.0|19.0|||
3644845|NCT02492763|3492046|B2|||Body Weight||Kilograms|Mean|89.4|89.4|Standard Deviation|20.0|20.0|||
3644846|NCT02492763|3492047|B1|||Body Weight||Kilograms|Mean|85.4|85.4|Standard Deviation|18.1|18.1|||
3644847|NCT02492763|3492043|B5|||Hemoglobin A1C||Percent|Mean|8.54|8.54|Standard Deviation|0.87|0.87|||
3644848|NCT02492763|3492044|B4|||Hemoglobin A1C||Percent|Mean|8.72|8.72|Standard Deviation|1.03|1.03|||
3644849|NCT02492763|3492045|B3|||Hemoglobin A1C||Percent|Mean|8.46|8.46|Standard Deviation|0.83|0.83|||
3644850|NCT02492763|3492046|B2|||Hemoglobin A1C||Percent|Mean|8.43|8.43|Standard Deviation|0.78|0.78|||
3644851|NCT02492763|3492047|B1|||Hemoglobin A1C||Percent|Mean|8.54|8.54|Standard Deviation|0.82|0.82|||
3644852|NCT02492763|3492043|B5|||Diastolic Blood Pressure (DBP)||mm Hg|Mean|77.7|77.7|Standard Deviation|7.0|7.0|||
3644853|NCT02492763|3492044|B4|||Diastolic Blood Pressure (DBP)||mm Hg|Mean|78.9|78.9|Standard Deviation|5.7|5.7|||
3644854|NCT02492763|3492045|B3|||Diastolic Blood Pressure (DBP)||mm Hg|Mean|77.6|77.6|Standard Deviation|8.3|8.3|||
3644855|NCT02492763|3492046|B2|||Diastolic Blood Pressure (DBP)||mm Hg|Mean|77.9|77.9|Standard Deviation|7.4|7.4|||
3644856|NCT02492763|3492047|B1|||Diastolic Blood Pressure (DBP)||mm Hg|Mean|76.6|76.6|Standard Deviation|6.3|6.3|||
3644857|NCT02492763|3492043|B5|||Systolic Blood Pressure (SBP)||mm Hg|Mean|125.5|125.5|Standard Deviation|12.0|12.0|||
3644858|NCT02492763|3492044|B4|||Systolic Blood Pressure (SBP)||mm Hg|Mean|126.3|126.3|Standard Deviation|11.0|11.0|||
3644859|NCT02492763|3492045|B3|||Systolic Blood Pressure (SBP)||mm Hg|Mean|124.6|124.6|Standard Deviation|14.3|14.3|||
3644860|NCT02492763|3492046|B2|||Systolic Blood Pressure (SBP)||mm Hg|Mean|126.0|126.0|Standard Deviation|12.0|12.0|||
3644861|NCT02492763|3492047|B1|||Systolic Blood Pressure (SBP)||mm Hg|Mean|125.1|125.1|Standard Deviation|10.8|10.8|||
3644862|NCT02492763|3492043|B5|||Fasting Triglycerides||mg/dL|Mean|165.5|165.5|Standard Deviation|92.5|92.5|||
3644863|NCT02492763|3492044|B4|||Fasting Triglycerides||mg/dL|Mean|154.0|154.0|Standard Deviation|89.5|89.5|||
3644864|NCT02492763|3492045|B3|||Fasting Triglycerides||mg/dL|Mean|168.7|168.7|Standard Deviation|96.1|96.1|||
3644865|NCT02492763|3492046|B2|||Fasting Triglycerides||mg/dL|Mean|167.1|167.1|Standard Deviation|79.5|79.5|||
3644866|NCT02492763|3492047|B1|||Fasting Triglycerides||mg/dL|Mean|171.5|171.5|Standard Deviation|104.6|104.6|||
3644867|NCT02492763|3492043|B5|||Fasting High Density Lipoprotein (HDL) Cholesterol||mg/dL|Mean|44.8|44.8|Standard Deviation|12.1|12.1|||
3644868|NCT02492763|3492044|B4|||Fasting High Density Lipoprotein (HDL) Cholesterol||mg/dL|Mean|46.8|46.8|Standard Deviation|13.8|13.8|||
3644869|NCT02492763|3492045|B3|||Fasting High Density Lipoprotein (HDL) Cholesterol||mg/dL|Mean|43.1|43.1|Standard Deviation|12.0|12.0|||
3644870|NCT02492763|3492046|B2|||Fasting High Density Lipoprotein (HDL) Cholesterol||mg/dL|Mean|41.7|41.7|Standard Deviation|9.5|9.5|||
3644871|NCT02492763|3492047|B1|||Fasting High Density Lipoprotein (HDL) Cholesterol||mg/dL|Mean|47.4|47.4|Standard Deviation|12.3|12.3|||
3644872|NCT02492763|3492043|B5|||Fasting Low Density Lipoprotein (LDL) Cholesterol||mg/dL|Mean|98.2|98.2|Standard Deviation|33.9|33.9|||
3644873|NCT02492763|3492044|B4|||Fasting Low Density Lipoprotein (LDL) Cholesterol||mg/dL|Mean|93.0|93.0|Standard Deviation|29.5|29.5|||
3644874|NCT02492763|3492045|B3|||Fasting Low Density Lipoprotein (LDL) Cholesterol||mg/dL|Mean|100.5|100.5|Standard Deviation|42.8|42.8|||
3644875|NCT02492763|3492046|B2|||Fasting Low Density Lipoprotein (LDL) Cholesterol||mg/dL|Mean|95.6|95.6|Standard Deviation|33.8|33.8|||
3644876|NCT02492763|3492047|B1|||Fasting Low Density Lipoprotein (LDL) Cholesterol||mg/dL|Mean|103.3|103.3|Standard Deviation|28.1|28.1|||
3644877|NCT02492763|3492043|B5|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|176.4|176.4|Standard Deviation|43.9|43.9|||
3644878|NCT02492763|3492044|B4|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|187.5|187.5|Standard Deviation|44.9|44.9|||
3644879|NCT02492763|3492045|B3|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|172.0|172.0|Standard Deviation|39.2|39.2|||
3644880|NCT02492763|3492046|B2|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|175.0|175.0|Standard Deviation|49.5|49.5|||
3644881|NCT02492763|3492047|B1|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|171.4|171.4|Standard Deviation|41.0|41.0|||
3644882|NCT02492763|3492043|B5|||Heart Rate||Beats/minute|Mean|73.3|73.3|Standard Deviation|8.8|8.8|||
3644883|NCT02492763|3492044|B4|||Heart Rate||Beats/minute|Mean|74.7|74.7|Standard Deviation|8.9|8.9|||
3644884|NCT02492763|3492045|B3|||Heart Rate||Beats/minute|Mean|73.8|73.8|Standard Deviation|8.6|8.6|||
3644885|NCT02492763|3492046|B2|||Heart Rate||Beats/minute|Mean|72.2|72.2|Standard Deviation|9.9|9.9|||
3644886|NCT02492763|3492047|B1|||Heart Rate||Beats/minute|Mean|72.5|72.5|Standard Deviation|7.7|7.7|||
3644887|NCT02492763|3492043|B5|>=30 kg/m^2||Body Mass Index (BMI)|Number of participants with a BMI <30 kg/m^2 or BMI>=30 kg/m^2|Participants|Number|114|114.0||||||
3644888|NCT02492763|3492044|B4|>=30 kg/m^2||Body Mass Index (BMI)|Number of participants with a BMI <30 kg/m^2 or BMI>=30 kg/m^2|Participants|Number|28|28.0||||||
3644889|NCT02492763|3492045|B3|>=30 kg/m^2||Body Mass Index (BMI)|Number of participants with a BMI <30 kg/m^2 or BMI>=30 kg/m^2|Participants|Number|28|28.0||||||
3644890|NCT02492763|3492046|B2|>=30 kg/m^2||Body Mass Index (BMI)|Number of participants with a BMI <30 kg/m^2 or BMI>=30 kg/m^2|Participants|Number|30|30.0||||||
3644891|NCT02492763|3492047|B1|>=30 kg/m^2||Body Mass Index (BMI)|Number of participants with a BMI <30 kg/m^2 or BMI>=30 kg/m^2|Participants|Number|28|28.0||||||
3644892|NCT02492763|3492043|B5|<30 kg/m^2||Body Mass Index (BMI)|Number of participants with a BMI <30 kg/m^2 or BMI>=30 kg/m^2|Participants|Number|62|62.0||||||
3644893|NCT02492763|3492044|B4|<30 kg/m^2||Body Mass Index (BMI)|Number of participants with a BMI <30 kg/m^2 or BMI>=30 kg/m^2|Participants|Number|15|15.0||||||
3644894|NCT02492763|3492045|B3|<30 kg/m^2||Body Mass Index (BMI)|Number of participants with a BMI <30 kg/m^2 or BMI>=30 kg/m^2|Participants|Number|15|15.0||||||
3644895|NCT02492763|3492046|B2|<30 kg/m^2||Body Mass Index (BMI)|Number of participants with a BMI <30 kg/m^2 or BMI>=30 kg/m^2|Participants|Number|14|14.0||||||
3644896|NCT02492763|3492047|B1|<30 kg/m^2||Body Mass Index (BMI)|Number of participants with a BMI <30 kg/m^2 or BMI>=30 kg/m^2|Participants|Number|18|18.0||||||
3644897|NCT02492763|3492043|B5|No||Antihyperglycemic agent (AHA) Washout Status|AHA washout status (yes/no). The trial included an 8-week AHA washout period for participants taking a AHA.|Participants|Number|156|156.0||||||
3644898|NCT02492763|3492044|B4|No||Antihyperglycemic agent (AHA) Washout Status|AHA washout status (yes/no). The trial included an 8-week AHA washout period for participants taking a AHA.|Participants|Number|38|38.0||||||
3644899|NCT02492763|3492045|B3|No||Antihyperglycemic agent (AHA) Washout Status|AHA washout status (yes/no). The trial included an 8-week AHA washout period for participants taking a AHA.|Participants|Number|38|38.0||||||
3644900|NCT02492763|3492046|B2|No||Antihyperglycemic agent (AHA) Washout Status|AHA washout status (yes/no). The trial included an 8-week AHA washout period for participants taking a AHA.|Participants|Number|39|39.0||||||
3644901|NCT02492763|3492047|B1|No||Antihyperglycemic agent (AHA) Washout Status|AHA washout status (yes/no). The trial included an 8-week AHA washout period for participants taking a AHA.|Participants|Number|41|41.0||||||
3644902|NCT02492763|3492043|B5|Yes||Antihyperglycemic agent (AHA) Washout Status|AHA washout status (yes/no). The trial included an 8-week AHA washout period for participants taking a AHA.|Participants|Number|20|20.0||||||
3644903|NCT02492763|3492044|B4|Yes||Antihyperglycemic agent (AHA) Washout Status|AHA washout status (yes/no). The trial included an 8-week AHA washout period for participants taking a AHA.|Participants|Number|5|5.0||||||
3644904|NCT02492763|3492045|B3|Yes||Antihyperglycemic agent (AHA) Washout Status|AHA washout status (yes/no). The trial included an 8-week AHA washout period for participants taking a AHA.|Participants|Number|5|5.0||||||
3644905|NCT02492763|3492046|B2|Yes||Antihyperglycemic agent (AHA) Washout Status|AHA washout status (yes/no). The trial included an 8-week AHA washout period for participants taking a AHA.|Participants|Number|5|5.0||||||
3644906|NCT02492763|3492047|B1|Yes||Antihyperglycemic agent (AHA) Washout Status|AHA washout status (yes/no). The trial included an 8-week AHA washout period for participants taking a AHA.|Participants|Number|5|5.0||||||
3644907|NCT02492763|3492043|B5|>=8.5%||Hemoglobin A1C Classification by Levels|Hemoglobin A1C classification by levels: <8.5% or >=8.5%|Participants|Number|85|85.0||||||
3644908|NCT02492763|3492044|B4|>=8.5%||Hemoglobin A1C Classification by Levels|Hemoglobin A1C classification by levels: <8.5% or >=8.5%|Participants|Number|22|22.0||||||
3644909|NCT02492763|3492045|B3|>=8.5%||Hemoglobin A1C Classification by Levels|Hemoglobin A1C classification by levels: <8.5% or >=8.5%|Participants|Number|19|19.0||||||
3644910|NCT02492763|3492046|B2|>=8.5%||Hemoglobin A1C Classification by Levels|Hemoglobin A1C classification by levels: <8.5% or >=8.5%|Participants|Number|20|20.0||||||
3644911|NCT02492763|3492047|B1|>=8.5%||Hemoglobin A1C Classification by Levels|Hemoglobin A1C classification by levels: <8.5% or >=8.5%|Participants|Number|24|24.0||||||
3644912|NCT02492763|3492043|B5|<8.5%||Hemoglobin A1C Classification by Levels|Hemoglobin A1C classification by levels: <8.5% or >=8.5%|Participants|Number|91|91.0||||||
3644913|NCT02492763|3492044|B4|<8.5%||Hemoglobin A1C Classification by Levels|Hemoglobin A1C classification by levels: <8.5% or >=8.5%|Participants|Number|21|21.0||||||
3644914|NCT02492763|3492045|B3|<8.5%||Hemoglobin A1C Classification by Levels|Hemoglobin A1C classification by levels: <8.5% or >=8.5%|Participants|Number|24|24.0||||||
3644915|NCT02492763|3492046|B2|<8.5%||Hemoglobin A1C Classification by Levels|Hemoglobin A1C classification by levels: <8.5% or >=8.5%|Participants|Number|24|24.0||||||
3644916|NCT02492763|3492047|B1|<8.5%||Hemoglobin A1C Classification by Levels|Hemoglobin A1C classification by levels: <8.5% or >=8.5%|Participants|Number|22|22.0||||||
3644917|NCT02492763|3492043|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644918|NCT02492763|3492044|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644919|NCT02492763|3492045|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644920|NCT02492763|3492046|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644921|NCT02492763|3492047|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644922|NCT02492763|3492043|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3644923|NCT02492763|3492044|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3644924|NCT02492763|3492045|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3644925|NCT02492763|3492046|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3644926|NCT02492763|3492047|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3644927|NCT02492763|3492043|B5||White|Race (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
3644928|NCT02492763|3492044|B4||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3644929|NCT02492763|3492045|B3||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3644930|NCT02492763|3492046|B2||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3644931|NCT02492763|3492047|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3644932|NCT02492763|3492043|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3644933|NCT02492763|3492044|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3644934|NCT02492763|3492045|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3644935|NCT02492763|3492046|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3644936|NCT02492763|3492047|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3644937|NCT02492763|3492043|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644938|NCT02492763|3492044|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644939|NCT02492763|3492045|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644940|NCT02492763|3492046|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644941|NCT02492763|3492047|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644942|NCT02492763|3492043|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3644943|NCT02492763|3492044|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3644944|NCT02492763|3492045|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3644945|NCT02492763|3492046|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3644946|NCT02492763|3492047|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3644947|NCT02492763|3492043|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3644948|NCT02492763|3492044|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3644949|NCT02492763|3492045|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3644950|NCT02492763|3492046|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3644951|NCT02492763|3492047|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3644952|NCT02492763|3492043|B5||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3644953|NCT02492763|3492044|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3644954|NCT02492763|3492045|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3644955|NCT02492763|3492046|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3644956|NCT02492763|3492047|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3644957|NCT02492763|3492043|B5||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3644958|NCT02492763|3492044|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3644959|NCT02492763|3492045|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3644960|NCT02492763|3492046|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3644961|NCT02492763|3492047|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3644962|NCT02492763|3492043|B5|||Age||Years|Mean|53.2|53.2|Standard Deviation|8.8|8.8|||
3644963|NCT02492763|3492044|B4|||Age||Years|Mean|52.9|52.9|Standard Deviation|9.4|9.4|||
3644964|NCT02492763|3492045|B3|||Age||Years|Mean|51.5|51.5|Standard Deviation|10.1|10.1|||
3644965|NCT02492763|3492046|B2|||Age||Years|Mean|54.2|54.2|Standard Deviation|7.9|7.9|||
3644966|NCT02492763|3492047|B1|||Age||Years|Mean|54.0|54.0|Standard Deviation|7.6|7.6|||
3644967|NCT02492451|3492104|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3644968|NCT02492451|3492105|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3644969|NCT02492451|3492106|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3644970|NCT02492451|3492107|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3644971|NCT02492451|3492104|B4||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3644972|NCT02492451|3492105|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3644973|NCT02492451|3492106|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3644974|NCT02492451|3492107|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3644975|NCT02492451|3492104|B4|||Age||years|Mean|28.64|28.64|Standard Deviation|5.17|5.17|||
3644976|NCT02492451|3492105|B3|||Age||years|Mean|29.95|29.95|Standard Deviation|5.44|5.44|||
3644977|NCT02492451|3492106|B2|||Age||years|Mean|28.13|28.13|Standard Deviation|4.41|4.41|||
3644978|NCT02492451|3492107|B1|||Age||years|Mean|27.85|27.85|Standard Deviation|5.45|5.45|||
3644979|NCT02492165|3492117|B5|Vietnam||Region of Enrollment||Participants|Number|250|250.0||||||
3644980|NCT02492165|3492118|B4|Vietnam||Region of Enrollment||Participants|Number|30|30.0||||||
3644981|NCT02492165|3492119|B3|Vietnam||Region of Enrollment||Participants|Number|60|60.0||||||
3644982|NCT02492165|3492120|B2|Vietnam||Region of Enrollment||Participants|Number|60|60.0||||||
3644983|NCT02492165|3492121|B1|Vietnam||Region of Enrollment||Participants|Number|100|100.0||||||
3644984|NCT02492165|3492117|B5||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3644985|NCT02492165|3492118|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3644986|NCT02492165|3492119|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3644987|NCT02492165|3492120|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3644988|NCT02492165|3492121|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3644989|NCT02492165|3492117|B5||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3644990|NCT02492165|3492118|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3644991|NCT02492165|3492119|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3644992|NCT02492165|3492120|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3644993|NCT02492165|3492121|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3644994|NCT02492165|3492117|B5|Age Continuous||Age||Years|Mean|15.75|15.75|Standard Deviation|3.375|3.375|||
3644995|NCT02492165|3492118|B4|Age Continuous||Age||Years|Mean|38.7|38.7|Standard Deviation|10.0|10.0|||
3644996|NCT02492165|3492119|B3|Age Continuous||Age||Years|Mean|13.9|13.9|Standard Deviation|1.4|1.4|||
3644997|NCT02492165|3492120|B2|Age Continuous||Age||Years|Mean|8.7|8.7|Standard Deviation|1.5|1.5|||
3644998|NCT02492165|3492121|B1|Age Continuous||Age||Years|Mean|0.7|0.7|Standard Deviation|0.6|0.6|||
3644999|NCT02492165|3492117|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3645000|NCT02492165|3492118|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3645001|NCT02492165|3492119|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3645002|NCT02492165|3492120|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3645003|NCT02492165|3492121|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3645004|NCT02492165|3492117|B5||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3645005|NCT02492165|3492118|B4||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3645006|NCT02492165|3492119|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3645007|NCT02492165|3492120|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3645008|NCT02492165|3492121|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3645009|NCT02492165|3492117|B5||<=18 years|Age||Participants|Count of Participants|220|220.0||||||
3645010|NCT02492165|3492118|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3645011|NCT02492165|3492119|B3||<=18 years|Age||Participants|Count of Participants|60|60.0||||||
3645012|NCT02492165|3492120|B2||<=18 years|Age||Participants|Count of Participants|60|60.0||||||
3645013|NCT02492165|3492121|B1||<=18 years|Age||Participants|Count of Participants|100|100.0||||||
3645014|NCT02491944|3492146|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645015|NCT02491944|3492146|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645016|NCT02491944|3492146|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3645017|NCT02491944|3492146|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645018|NCT02491944|3492146|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645019|NCT02491944|3492146|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3645020|NCT02491944|3492146|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645021|NCT02491944|3492146|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3645022|NCT02491944|3492146|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3645023|NCT02491944|3492146|B1|||Age||Years|Mean|34.8|34.8|Standard Deviation|13.29|13.29|||
3645024|NCT02491892|3492166|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3645025|NCT02491892|3492167|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3645026|NCT02491892|3492168|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3645027|NCT02491892|3492166|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3645028|NCT02491892|3492167|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3645029|NCT02491892|3492168|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3645030|NCT02491892|3492166|B3|||Age||years|Mean|54.4|54.4|Standard Deviation|9.42|9.42|||
3645031|NCT02491892|3492167|B2|||Age||years|Mean|53.5|53.5|Standard Deviation|8.72|8.72|||
3645032|NCT02491892|3492168|B1|||Age||years|Mean|55.3|55.3|Standard Deviation|10.04|10.04|||
3645033|NCT02491463|3492213|B5|Geographic ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3645034|NCT02491463|3492214|B4|Geographic ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3645035|NCT02491463|3492215|B3|Geographic ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3645036|NCT02491463|3492216|B2|Geographic ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3645037|NCT02491463|3492217|B1|Geographic ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3645038|NCT02491463|3492213|B5|Geographic ancestry|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|64|64.0||||||
3645039|NCT02491463|3492214|B4|Geographic ancestry|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3645040|NCT02491463|3492215|B3|Geographic ancestry|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3645041|NCT02491463|3492216|B2|Geographic ancestry|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3645042|NCT02491463|3492217|B1|Geographic ancestry|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3645043|NCT02491463|3492213|B5|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3645044|NCT02491463|3492214|B4|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3645045|NCT02491463|3492215|B3|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3645046|NCT02491463|3492216|B2|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3645047|NCT02491463|3492217|B1|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3645048|NCT02491463|3492213|B5|Geographic ancestry|Asian - Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3645049|NCT02491463|3492214|B4|Geographic ancestry|Asian - Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3645050|NCT02491463|3492215|B3|Geographic ancestry|Asian - Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3645051|NCT02491463|3492216|B2|Geographic ancestry|Asian - Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3645052|NCT02491463|3492217|B1|Geographic ancestry|Asian - Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3645053|NCT02491463|3492213|B5|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3645054|NCT02491463|3492214|B4|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3645055|NCT02491463|3492215|B3|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3645056|NCT02491463|3492216|B2|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3645057|NCT02491463|3492217|B1|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3645058|NCT02491463|3492213|B5|Geographic ancestry|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3645059|NCT02491463|3492214|B4|Geographic ancestry|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3645060|NCT02491463|3492215|B3|Geographic ancestry|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3645061|NCT02491463|3492216|B2|Geographic ancestry|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3645062|NCT02491463|3492217|B1|Geographic ancestry|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3645063|NCT02491463|3492213|B5||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3645064|NCT02491463|3492214|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3645065|NCT02491463|3492215|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3645066|NCT02491463|3492216|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3645067|NCT02491463|3492217|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3645068|NCT02491463|3492213|B5||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3645069|NCT02491463|3492214|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3645070|NCT02491463|3492215|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3645071|NCT02491463|3492216|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3645072|NCT02491463|3492217|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3645073|NCT02491463|3492213|B5|||Age||Years|Mean|30.8|30.8|Standard Deviation|8.3|8.3|||
3645074|NCT02491463|3492214|B4|||Age||Years|Mean|29.5|29.5|Standard Deviation|7.6|7.6|||
3645075|NCT02491463|3492215|B3|||Age||Years|Mean|31.3|31.3|Standard Deviation|8.6|8.6|||
3645076|NCT02491463|3492216|B2|||Age||Years|Mean|30.6|30.6|Standard Deviation|8.7|8.7|||
3645077|NCT02491463|3492217|B1|||Age||Years|Mean|32.9|32.9|Standard Deviation|8.2|8.2|||
3645078|NCT02491411|3492306|B1|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3645079|NCT02491411|3492306|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645080|NCT02491411|3492306|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645081|NCT02491411|3492306|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3645082|NCT02491411|3492306|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3645083|NCT02491411|3492306|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645084|NCT02491411|3492306|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645085|NCT02491411|3492306|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645086|NCT02491411|3492306|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3645087|NCT02491411|3492306|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645088|NCT02491411|3492306|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645089|NCT02491411|3492306|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3645090|NCT02491411|3492306|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3645091|NCT02491411|3492306|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3645092|NCT02491411|3492306|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3645093|NCT02491411|3492306|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3645094|NCT02491073|3492316|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
3645095|NCT02491073|3492317|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
3645096|NCT02491073|3492318|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
3645097|NCT02491073|3492316|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3645098|NCT02491073|3492317|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3645099|NCT02491073|3492318|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3645100|NCT02491073|3492316|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645101|NCT02491073|3492317|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645102|NCT02491073|3492318|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645103|NCT02491073|3492316|B3||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3645104|NCT02491073|3492317|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3645105|NCT02491073|3492318|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3645106|NCT02491073|3492316|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3645107|NCT02491073|3492317|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3645108|NCT02491073|3492318|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3645109|NCT02491073|3492316|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645110|NCT02491073|3492317|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645111|NCT02491073|3492318|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645112|NCT02491073|3492316|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3645113|NCT02491073|3492317|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3645114|NCT02491073|3492318|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645115|NCT02491073|3492316|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3645116|NCT02491073|3492317|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3645117|NCT02491073|3492318|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645118|NCT02491073|3492316|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645119|NCT02491073|3492317|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645120|NCT02491073|3492318|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645121|NCT02491073|3492316|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3645122|NCT02491073|3492317|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3645123|NCT02491073|3492318|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3645124|NCT02491073|3492316|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3645125|NCT02491073|3492317|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3645126|NCT02491073|3492318|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3645127|NCT02491073|3492316|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3645128|NCT02491073|3492317|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3645129|NCT02491073|3492318|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3645130|NCT02491073|3492316|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3645131|NCT02491073|3492317|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3645132|NCT02491073|3492318|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3645133|NCT02491073|3492316|B3|>65 Years||Age, Customized||participants|Number|4|4.0||||||
3645134|NCT02491073|3492317|B2|>65 Years||Age, Customized||participants|Number|2|2.0||||||
3645135|NCT02491073|3492318|B1|>65 Years||Age, Customized||participants|Number|2|2.0||||||
3645136|NCT02491073|3492316|B3|40-65 Years||Age, Customized||participants|Number|26|26.0||||||
3645137|NCT02491073|3492317|B2|40-65 Years||Age, Customized||participants|Number|13|13.0||||||
3645138|NCT02491073|3492318|B1|40-65 Years||Age, Customized||participants|Number|13|13.0||||||
3645139|NCT02491073|3492316|B3|18-39 Years||Age, Customized||participants|Number|32|32.0||||||
3645140|NCT02491073|3492317|B2|18-39 Years||Age, Customized||participants|Number|16|16.0||||||
3645141|NCT02491073|3492318|B1|18-39 Years||Age, Customized||participants|Number|16|16.0||||||
3645142|NCT02491073|3492316|B3|<18 years of age||Age, Customized||participants|Number|0|0.0||||||
3645143|NCT02491073|3492317|B2|<18 years of age||Age, Customized||participants|Number|0|0.0||||||
3645144|NCT02491073|3492318|B1|<18 years of age||Age, Customized||participants|Number|0|0.0||||||
3645145|NCT02491073|3492316|B3|||Age||years|Mean|41.8|41.8|Standard Deviation|14.68|14.68|||
3645146|NCT02491073|3492317|B2|||Age||years|Mean|41.7|41.7|Standard Deviation|14.64|14.64|||
3645147|NCT02491073|3492318|B1|||Age||years|Mean|41.8|41.8|Standard Deviation|14.95|14.95|||
3645148|NCT02491073|3492316|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3645149|NCT02491073|3492317|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3645150|NCT02491073|3492318|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3645151|NCT02491073|3492316|B3||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
3645152|NCT02491073|3492317|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3645153|NCT02491073|3492318|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3645154|NCT02491073|3492316|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3645155|NCT02491073|3492317|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3645156|NCT02491073|3492318|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3645157|NCT02490670|3492345|B3|Mexico||Region of Enrollment||participants|Number|28|28.0||||||
3645158|NCT02490670|3492346|B2|Mexico||Region of Enrollment||participants|Number|14|14.0||||||
3645159|NCT02490670|3492347|B1|Mexico||Region of Enrollment||participants|Number|14|14.0||||||
3645160|NCT02490670|3492345|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645161|NCT02490670|3492346|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645162|NCT02490670|3492347|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645163|NCT02490670|3492345|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645164|NCT02490670|3492346|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645165|NCT02490670|3492347|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645166|NCT02490670|3492345|B3||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3645167|NCT02490670|3492346|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3645168|NCT02490670|3492347|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3645169|NCT02490670|3492345|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645170|NCT02490670|3492346|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645171|NCT02490670|3492347|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645172|NCT02490670|3492345|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645173|NCT02490670|3492346|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645174|NCT02490670|3492347|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645175|NCT02490670|3492345|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645176|NCT02490670|3492346|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645177|NCT02490670|3492347|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645178|NCT02490670|3492345|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645179|NCT02490670|3492346|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645180|NCT02490670|3492347|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645181|NCT02490670|3492345|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645182|NCT02490670|3492346|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645183|NCT02490670|3492347|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645184|NCT02490670|3492345|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645185|NCT02490670|3492346|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645186|NCT02490670|3492347|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645187|NCT02490670|3492345|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3645188|NCT02490670|3492346|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3645189|NCT02490670|3492347|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3645190|NCT02490670|3492345|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3645191|NCT02490670|3492346|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3645192|NCT02490670|3492347|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3645193|NCT02490670|3492345|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3645194|NCT02490670|3492346|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3645195|NCT02490670|3492347|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3645196|NCT02490670|3492345|B3|||Age||Years|Mean|27.18|27.18|Standard Deviation|8.63|8.63|||
3645197|NCT02490670|3492346|B2|||Age||Years|Mean|25.36|25.36|Standard Deviation|7.07|7.07|||
3645198|NCT02490670|3492347|B1|||Age||Years|Mean|29.0|29.0|Standard Deviation|9.88|9.88|||
3645199|NCT02490475|3492356|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3645200|NCT02490475|3492357|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3645201|NCT02490475|3492358|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3645202|NCT02490475|3492359|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3645203|NCT02490475|3492360|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3645204|NCT02490475|3492356|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3645205|NCT02490475|3492357|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3645206|NCT02490475|3492358|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3645207|NCT02490475|3492359|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3645208|NCT02490475|3492360|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3645209|NCT02490475|3492356|B5|||Age||years|Mean|55.6|55.6|Standard Deviation|12.55|12.55|||
3645210|NCT02490475|3492357|B4|||Age||years|Mean|45.0|45.0|Standard Deviation|20.21|20.21|||
3645211|NCT02490475|3492358|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|6.06|6.06|||
3645212|NCT02490475|3492359|B2|||Age||years|Mean|62.5|62.5|Standard Deviation|9.19|9.19|||
3645213|NCT02490475|3492360|B1|||Age||years|Mean|58.2|58.2|Standard Deviation|5.38|5.38|||
3645214|NCT02490293|3492439|B3|Korea, Republic of||Region of Enrollment||participants|Number|188|188.0||||||
3645215|NCT02490293|3492440|B2|Korea, Republic of||Region of Enrollment||participants|Number|95|95.0||||||
3645216|NCT02490293|3492441|B1|Korea, Republic of||Region of Enrollment||participants|Number|93|93.0||||||
3645217|NCT02490293|3492439|B3||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3645218|NCT02490293|3492440|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3645219|NCT02490293|3492441|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3645220|NCT02490293|3492439|B3||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3645221|NCT02490293|3492440|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3645222|NCT02490293|3492441|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3645223|NCT02490293|3492439|B3|||Age||years|Mean|52.0|52.0|Standard Deviation|15.1|15.1|||
3645224|NCT02490293|3492440|B2|||Age||years|Mean|52.0|52.0|Standard Deviation|15.0|15.0|||
3645225|NCT02490293|3492441|B1|||Age||years|Mean|52.1|52.1|Standard Deviation|15.3|15.3|||
3645226|NCT02490293|3492439|B3||>=65 years|Age|"Count of Participants, is available as an option in the drop down menu to more accurately describe the Measure Type in some cases."|Participants|Count of Participants|20|20.0||||||
3645227|NCT02490293|3492440|B2||>=65 years|Age|"Count of Participants, is available as an option in the drop down menu to more accurately describe the Measure Type in some cases."|Participants|Count of Participants|10|10.0||||||
3645228|NCT02490293|3492441|B1||>=65 years|Age|"Count of Participants, is available as an option in the drop down menu to more accurately describe the Measure Type in some cases."|Participants|Count of Participants|10|10.0||||||
3645229|NCT02490293|3492439|B3||Between 18 and 65 years|Age|"Count of Participants, is available as an option in the drop down menu to more accurately describe the Measure Type in some cases."|Participants|Count of Participants|168|168.0||||||
3645230|NCT02490293|3492440|B2||Between 18 and 65 years|Age|"Count of Participants, is available as an option in the drop down menu to more accurately describe the Measure Type in some cases."|Participants|Count of Participants|85|85.0||||||
3645231|NCT02490293|3492441|B1||Between 18 and 65 years|Age|"Count of Participants, is available as an option in the drop down menu to more accurately describe the Measure Type in some cases."|Participants|Count of Participants|83|83.0||||||
3645232|NCT02490293|3492439|B3||<=18 years|Age|"Count of Participants, is available as an option in the drop down menu to more accurately describe the Measure Type in some cases."|Participants|Count of Participants|0|0.0||||||
3645233|NCT02490293|3492440|B2||<=18 years|Age|"Count of Participants, is available as an option in the drop down menu to more accurately describe the Measure Type in some cases."|Participants|Count of Participants|0|0.0||||||
3645234|NCT02490293|3492441|B1||<=18 years|Age|"Count of Participants, is available as an option in the drop down menu to more accurately describe the Measure Type in some cases."|Participants|Count of Participants|0|0.0||||||
3645235|NCT02489968|3492450|B3||Male|Sex: Female, Male||Participants|Count of Participants|633|633.0||||||
3645236|NCT02489968|3492451|B2||Male|Sex: Female, Male||Participants|Count of Participants|309|309.0||||||
3645237|NCT02489968|3492452|B1||Male|Sex: Female, Male||Participants|Count of Participants|324|324.0||||||
3645238|NCT02489968|3492450|B3||Female|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
3645239|NCT02489968|3492451|B2||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3645240|NCT02489968|3492452|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3645241|NCT02489968|3492450|B3|||Age||Years|Mean|57.2|57.2|Standard Deviation|10.1|10.1|||
3645242|NCT02489968|3492451|B2|||Age||Years|Mean|57.5|57.5|Standard Deviation|10.0|10.0|||
3645243|NCT02489968|3492452|B1|||Age||Years|Mean|56.8|56.8|Standard Deviation|10.2|10.2|||
3645244|NCT02489799|3492469|B3||Other|Primary Diagnosis||Participants|Count of Participants|5|5.0||||||
3645245|NCT02489799|3492470|B2||Other|Primary Diagnosis||Participants|Count of Participants|2|2.0||||||
3645246|NCT02489799|3492471|B1||Other|Primary Diagnosis||Participants|Count of Participants|3|3.0||||||
3645247|NCT02489799|3492469|B3||Sarcoma|Primary Diagnosis||Participants|Count of Participants|13|13.0||||||
3645248|NCT02489799|3492470|B2||Sarcoma|Primary Diagnosis||Participants|Count of Participants|6|6.0||||||
3645249|NCT02489799|3492471|B1||Sarcoma|Primary Diagnosis||Participants|Count of Participants|7|7.0||||||
3645250|NCT02489799|3492469|B3||Gynecological Cancers|Primary Diagnosis||Participants|Count of Participants|12|12.0||||||
3645251|NCT02489799|3492470|B2||Gynecological Cancers|Primary Diagnosis||Participants|Count of Participants|6|6.0||||||
3645252|NCT02489799|3492471|B1||Gynecological Cancers|Primary Diagnosis||Participants|Count of Participants|6|6.0||||||
3645253|NCT02489799|3492469|B3||Hepatobiliary and other Gastrointestinal Cancer|Primary Diagnosis||Participants|Count of Participants|25|25.0||||||
3645254|NCT02489799|3492470|B2||Hepatobiliary and other Gastrointestinal Cancer|Primary Diagnosis||Participants|Count of Participants|16|16.0||||||
3645255|NCT02489799|3492471|B1||Hepatobiliary and other Gastrointestinal Cancer|Primary Diagnosis||Participants|Count of Participants|9|9.0||||||
3645256|NCT02489799|3492469|B3||Colon Cancer|Primary Diagnosis||Participants|Count of Participants|8|8.0||||||
3645257|NCT02489799|3492470|B2||Colon Cancer|Primary Diagnosis||Participants|Count of Participants|3|3.0||||||
3645258|NCT02489799|3492471|B1||Colon Cancer|Primary Diagnosis||Participants|Count of Participants|5|5.0||||||
3645259|NCT02489799|3492469|B3||Pancreatic Cancer|Primary Diagnosis||Participants|Count of Participants|29|29.0||||||
3645260|NCT02489799|3492470|B2||Pancreatic Cancer|Primary Diagnosis||Participants|Count of Participants|14|14.0||||||
3645261|NCT02489799|3492471|B1||Pancreatic Cancer|Primary Diagnosis||Participants|Count of Participants|15|15.0||||||
3645262|NCT02489799|3492469|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645263|NCT02489799|3492470|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645264|NCT02489799|3492471|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645265|NCT02489799|3492469|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3645266|NCT02489799|3492470|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3645267|NCT02489799|3492471|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645268|NCT02489799|3492469|B3||White|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3645269|NCT02489799|3492470|B2||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3645270|NCT02489799|3492471|B1||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3645271|NCT02489799|3492469|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3645272|NCT02489799|3492470|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3645273|NCT02489799|3492471|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3645274|NCT02489799|3492469|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645275|NCT02489799|3492470|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645276|NCT02489799|3492471|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645277|NCT02489799|3492469|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3645278|NCT02489799|3492470|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3645279|NCT02489799|3492471|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3645280|NCT02489799|3492469|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645281|NCT02489799|3492470|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645282|NCT02489799|3492471|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645283|NCT02489799|3492469|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645284|NCT02489799|3492470|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645285|NCT02489799|3492471|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645286|NCT02489799|3492469|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
3645287|NCT02489799|3492470|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3645288|NCT02489799|3492471|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3645289|NCT02489799|3492469|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3645290|NCT02489799|3492470|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3645291|NCT02489799|3492471|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3645292|NCT02489799|3492469|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3645293|NCT02489799|3492470|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3645294|NCT02489799|3492471|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3645295|NCT02489799|3492469|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3645296|NCT02489799|3492470|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3645297|NCT02489799|3492471|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3645298|NCT02489799|3492469|B3|||Age||years|Mean|60.4|60.4|Standard Deviation|12.7|12.7|||
3645299|NCT02489799|3492470|B2|||Age||years|Mean|59.5|59.5|Standard Deviation|12.4|12.4|||
3645300|NCT02489799|3492471|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|13.0|13.0|||
3645301|NCT02489500|3492496|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3645302|NCT02489500|3492497|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645303|NCT02489500|3492498|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3645304|NCT02489500|3492496|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645305|NCT02489500|3492497|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645306|NCT02489500|3492498|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645307|NCT02489500|3492496|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3645308|NCT02489500|3492497|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645309|NCT02489500|3492498|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3645310|NCT02489500|3492496|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3645311|NCT02489500|3492497|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3645312|NCT02489500|3492498|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645313|NCT02489500|3492496|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645314|NCT02489500|3492497|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645315|NCT02489500|3492498|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645316|NCT02489500|3492496|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645317|NCT02489500|3492497|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645318|NCT02489500|3492498|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645319|NCT02489500|3492496|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645320|NCT02489500|3492497|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645321|NCT02489500|3492498|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645322|NCT02489500|3492496|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645323|NCT02489500|3492497|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645324|NCT02489500|3492498|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645325|NCT02489500|3492496|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3645326|NCT02489500|3492497|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3645327|NCT02489500|3492498|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3645328|NCT02489500|3492496|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645329|NCT02489500|3492497|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645330|NCT02489500|3492498|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645331|NCT02489500|3492496|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3645332|NCT02489500|3492497|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3645333|NCT02489500|3492498|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3645334|NCT02489500|3492496|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3645335|NCT02489500|3492497|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3645336|NCT02489500|3492498|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3645337|NCT02489500|3492496|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3645338|NCT02489500|3492497|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3645339|NCT02489500|3492498|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3645340|NCT02489500|3492496|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3645341|NCT02489500|3492497|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3645342|NCT02489500|3492498|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3645343|NCT02489500|3492496|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3645344|NCT02489500|3492497|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3645345|NCT02489500|3492498|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3645346|NCT02489110|3492511|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645347|NCT02489110|3492512|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645348|NCT02489110|3492513|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645349|NCT02489110|3492511|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645350|NCT02489110|3492512|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645351|NCT02489110|3492513|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645352|NCT02489110|3492511|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|150|150.0||||||
3645353|NCT02489110|3492512|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3645354|NCT02489110|3492513|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3645355|NCT02489110|3492511|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3645356|NCT02489110|3492512|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3645357|NCT02489110|3492513|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3645358|NCT02489110|3492511|B3||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3645359|NCT02489110|3492512|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3645360|NCT02489110|3492513|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3645361|NCT02489110|3492511|B3|||Age||years|Mean|52.9|52.9|Standard Deviation|10.4|10.4|||
3645362|NCT02489110|3492512|B2|||Age||years|Mean|51.5|51.5|Standard Deviation|9.4|9.4|||
3645363|NCT02489110|3492513|B1|||Age||years|Mean|54.2|54.2|Standard Deviation|11.2|11.2|||
3645364|NCT02488980|3492522|B4|Kenya||Region of Enrollment||participants|Number|300|300.0||||||
3645365|NCT02488980|3492523|B3|Kenya||Region of Enrollment||participants|Number|99|99.0||||||
3645366|NCT02488980|3492524|B2|Kenya||Region of Enrollment||participants|Number|102|102.0||||||
3645367|NCT02488980|3492525|B1|Kenya||Region of Enrollment||participants|Number|99|99.0||||||
3645368|NCT02488980|3492522|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645369|NCT02488980|3492523|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645370|NCT02488980|3492524|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645371|NCT02488980|3492525|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645372|NCT02488980|3492522|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645373|NCT02488980|3492523|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645374|NCT02488980|3492524|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645375|NCT02488980|3492525|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645376|NCT02488980|3492522|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645377|NCT02488980|3492523|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645378|NCT02488980|3492524|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645379|NCT02488980|3492525|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645380|NCT02488980|3492522|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|300|300.0||||||
3645381|NCT02488980|3492523|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3645382|NCT02488980|3492524|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
3645383|NCT02488980|3492525|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3645384|NCT02488980|3492522|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645385|NCT02488980|3492523|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645386|NCT02488980|3492524|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645387|NCT02488980|3492525|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645388|NCT02488980|3492522|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645389|NCT02488980|3492523|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645390|NCT02488980|3492524|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645391|NCT02488980|3492525|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645392|NCT02488980|3492522|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645393|NCT02488980|3492523|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645394|NCT02488980|3492524|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645395|NCT02488980|3492525|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645396|NCT02488980|3492522|B4||Male|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
3645397|NCT02488980|3492523|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3645398|NCT02488980|3492524|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3645399|NCT02488980|3492525|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3645400|NCT02488980|3492522|B4||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3645401|NCT02488980|3492523|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3645402|NCT02488980|3492524|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3645403|NCT02488980|3492525|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3645404|NCT02488980|3492522|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3645405|NCT02488980|3492523|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3645406|NCT02488980|3492524|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3645407|NCT02488980|3492525|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3645408|NCT02488980|3492522|B4||Between 18 and 65 years|Age||Participants|Count of Participants|295|295.0||||||
3645409|NCT02488980|3492523|B3||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
3645410|NCT02488980|3492524|B2||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
3645411|NCT02488980|3492525|B1||Between 18 and 65 years|Age||Participants|Count of Participants|98|98.0||||||
3645412|NCT02488980|3492522|B4||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3645413|NCT02488980|3492523|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3645414|NCT02488980|3492524|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3645415|NCT02488980|3492525|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3645416|NCT02488915|3492544|B1||Other|Most Proximal occlusion location||Participants|Count of Participants|9|9.0||||||
3645417|NCT02488915|3492544|B1||M2 middle cerebral artery|Most Proximal occlusion location||Participants|Count of Participants|57|57.0||||||
3645418|NCT02488915|3492544|B1||M1 middle cerebral artery|Most Proximal occlusion location||Participants|Count of Participants|126|126.0||||||
3645419|NCT02488915|3492544|B1||Internal carotid artery Terminus (L or T-type)|Most Proximal occlusion location||Participants|Count of Participants|25|25.0||||||
3645420|NCT02488915|3492544|B1||Internal carotid artery|Most Proximal occlusion location||Participants|Count of Participants|10|10.0||||||
3645421|NCT02488915|3492544|B1|Current or ex-smoker||Medical History||Participants|Count of Participants|56|56.0||||||
3645422|NCT02488915|3492544|B1|Dyslipidaemia||Medical History||Participants|Count of Participants|98|98.0||||||
3645423|NCT02488915|3492544|B1|Diabetes Mellitus||Medical History||Participants|Count of Participants|45|45.0||||||
3645424|NCT02488915|3492544|B1|Hypertension||Medical History||Participants|Count of Participants|155|155.0||||||
3645425|NCT02488915|3492544|B1|Atrial Fibrillation||Medical History||Participants|Count of Participants|90|90.0||||||
3645426|NCT02488915|3492544|B1|Previous MI/CAD||Medical History||Participants|Count of Participants|45|45.0||||||
3645427|NCT02488915|3492544|B1|Previous Stroke/TIA||Medical History||Participants|Count of Participants|43|43.0||||||
3645428|NCT02488915|3492544|B1|||BMI||kg per square meter|Mean|28.7|28.7|Standard Deviation|6|6.0|||
3645429|NCT02488915|3492544|B1||mRS 2|Pre-stroke Modified Rankin Scale (mRS)|"mRS is a scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. mRS scores range from 0 to 6:~mRS 0 = No symptoms.~mRS 1 = No significant disability.~mRS 2 = Slight disability.~mRS 3 = Moderate disability.~mRS 4 = Moderately severe disability.~mRS 5 = Severe disability.~mRS 6 = Dead."|Participants|Count of Participants|1|1.0||||||
3645430|NCT02488915|3492544|B1||mRS 1|Pre-stroke Modified Rankin Scale (mRS)|"mRS is a scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. mRS scores range from 0 to 6:~mRS 0 = No symptoms.~mRS 1 = No significant disability.~mRS 2 = Slight disability.~mRS 3 = Moderate disability.~mRS 4 = Moderately severe disability.~mRS 5 = Severe disability.~mRS 6 = Dead."|Participants|Count of Participants|49|49.0||||||
3645431|NCT02488915|3492544|B1||mRS 0|Pre-stroke Modified Rankin Scale (mRS)|"mRS is a scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. mRS scores range from 0 to 6:~mRS 0 = No symptoms.~mRS 1 = No significant disability.~mRS 2 = Slight disability.~mRS 3 = Moderate disability.~mRS 4 = Moderately severe disability.~mRS 5 = Severe disability.~mRS 6 = Dead."|Participants|Count of Participants|177|177.0||||||
3645432|NCT02488915|3492544|B1|||National Institutes of Health Stroke Scale (NIHSS) Score|The NIHSS is a 15-item neurologic examination stroke scale used to evaluate the effect of acute cerebral infarction on the levels of consciousness, language, neglect, visual-field loss, extraocular movement, motor strength, ataxia, dysarthria, and sensory loss. NIHSS scores range from 0 – 42. A score of 0 indicates no stroke symptoms. Higher scores indicate incremental levels of neurological impairment.|Scores on a scale|Mean|15.8|15.8|Standard Deviation|5|5.0|||
3645433|NCT02488915|3492544|B1|Switzerland||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3645434|NCT02488915|3492544|B1|France||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3645435|NCT02488915|3492544|B1|Spain||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3645436|NCT02488915|3492544|B1|Germany||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
3645437|NCT02488915|3492544|B1|Ireland||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3645438|NCT02488915|3492544|B1|United States||Region of Enrollment||Participants|Count of Participants|101|101.0||||||
3645439|NCT02488915|3492544|B1|Belgium||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3645440|NCT02488915|3492544|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645441|NCT02488915|3492544|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3645442|NCT02488915|3492544|B1||White|Race (NIH/OMB)||Participants|Count of Participants|206|206.0||||||
3645443|NCT02488915|3492544|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3645444|NCT02488915|3492544|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645445|NCT02488915|3492544|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3645446|NCT02488915|3492544|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3645447|NCT02488915|3492544|B1||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3645448|NCT02488915|3492544|B1||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3645449|NCT02488915|3492544|B1|||Age||years|Mean|68|68.0|Standard Deviation|13|13.0|||
3645450|NCT02488681|3492560|B1|United States||Region of Enrollment||participants|Number|276|276.0||||||
3645451|NCT02488681|3492560|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3645452|NCT02488681|3492560|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645453|NCT02488681|3492560|B1||White|Race (NIH/OMB)||Participants|Count of Participants|248|248.0||||||
3645454|NCT02488681|3492560|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3645455|NCT02488681|3492560|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645456|NCT02488681|3492560|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3645457|NCT02488681|3492560|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3645458|NCT02488681|3492560|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3645459|NCT02488681|3492560|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|264|264.0||||||
3645460|NCT02488681|3492560|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3645461|NCT02488681|3492560|B1||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3645462|NCT02488681|3492560|B1||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3645463|NCT02488681|3492560|B1|||Age||years|Mean|76.1|76.1|Standard Deviation|11.9|11.9|||
3645464|NCT02488317|3492564|B3|United States||Region of Enrollment||participants|Number|140|140.0||||||
3645465|NCT02488317|3492565|B2|United States||Region of Enrollment||participants|Number|70|70.0||||||
3645466|NCT02488317|3492566|B1|United States||Region of Enrollment||participants|Number|70|70.0||||||
3645467|NCT02488317|3492564|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3645468|NCT02488317|3492565|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3645469|NCT02488317|3492566|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3645470|NCT02488317|3492564|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3645471|NCT02488317|3492565|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3645472|NCT02488317|3492566|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3645473|NCT02488317|3492564|B3|||Age||years|Mean|59.30|59.3|Standard Deviation|14.31|14.31|||
3645474|NCT02488317|3492565|B2|||Age||years|Mean|59.44|59.44|Standard Deviation|14.16|14.16|||
3645475|NCT02488317|3492566|B1|||Age||years|Mean|59.16|59.16|Standard Deviation|14.59|14.59|||
3645476|NCT02488317|3492564|B3||>=65 years|Age||Participants|Count of Participants|52|52.0||||||
3645477|NCT02488317|3492565|B2||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3645478|NCT02488317|3492566|B1||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
3645479|NCT02488317|3492564|B3||Between 18 and 65 years|Age||Participants|Count of Participants|88|88.0||||||
3645480|NCT02488317|3492565|B2||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3645481|NCT02488317|3492566|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
3645482|NCT02488317|3492564|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3645483|NCT02488317|3492565|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3645484|NCT02488317|3492566|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3645485|NCT02488070|3492581|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3645486|NCT02488070|3492581|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3645487|NCT02488070|3492581|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3645488|NCT02488070|3492581|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3645489|NCT02488070|3492581|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3645490|NCT02488070|3492581|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3645491|NCT02488018|3492589|B1|||Blood glucose level (mmol/L)|Participants with a blood glucose level of <7 mmol/L after fasting (0 time)|Participant|Number|10|10.0||||||
3645492|NCT02488018|3492589|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
3645493|NCT02488018|3492589|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
3645494|NCT02488018|3492589|B1|||Age||years|Mean|21.60|21.6|Standard Deviation|1.17|1.17|||
3645495|NCT02488018|3492589|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3645496|NCT02488018|3492589|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3645497|NCT02488018|3492589|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3645498|NCT02487979|3492593|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3645499|NCT02487979|3492593|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3645500|NCT02487979|3492593|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645501|NCT02487979|3492593|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645502|NCT02487979|3492593|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3645503|NCT02487979|3492593|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3645504|NCT02487979|3492593|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645505|NCT02487979|3492593|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645506|NCT02487979|3492593|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645507|NCT02487979|3492593|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645508|NCT02487979|3492593|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3645509|NCT02487979|3492593|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3645510|NCT02487979|3492593|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3645511|NCT02487979|3492593|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3645512|NCT02487979|3492593|B1|||Age||years|Mean|20.09|20.09|Standard Deviation|5.30|5.3|||
3645513|NCT02487771|3492603|B3|United States||Region of Enrollment||Participants|Count of Participants|190|190.0||||||
3645514|NCT02487771|3492604|B2|United States||Region of Enrollment||Participants|Count of Participants|99|99.0||||||
3645515|NCT02487771|3492605|B1|United States||Region of Enrollment||Participants|Count of Participants|91|91.0||||||
3645516|NCT02487771|3492603|B3|Not Black||Race/Ethnicity, Customized||Participants|Count of Participants|124|124.0||||||
3645517|NCT02487771|3492604|B2|Not Black||Race/Ethnicity, Customized||Participants|Count of Participants|66|66.0||||||
3645518|NCT02487771|3492605|B1|Not Black||Race/Ethnicity, Customized||Participants|Count of Participants|58|58.0||||||
3645519|NCT02487771|3492603|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|66|66.0||||||
3645520|NCT02487771|3492604|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3645521|NCT02487771|3492605|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3645522|NCT02487771|3492603|B3|Not Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|171|171.0||||||
3645523|NCT02487771|3492604|B2|Not Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|90|90.0||||||
3645524|NCT02487771|3492605|B1|Not Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|81|81.0||||||
3645525|NCT02487771|3492603|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3645526|NCT02487771|3492604|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3645527|NCT02487771|3492605|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3645528|NCT02487771|3492603|B3||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3645529|NCT02487771|3492604|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3645530|NCT02487771|3492605|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3645531|NCT02487771|3492603|B3||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3645532|NCT02487771|3492604|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3645533|NCT02487771|3492605|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3645534|NCT02487771|3492603|B3|||Age||years|Mean|2.01|2.01|Standard Deviation|0.03|0.03|||
3645535|NCT02487771|3492604|B2|||Age||years|Mean|2.01|2.01|Standard Deviation|0.03|0.03|||
3645536|NCT02487771|3492605|B1|||Age||years|Mean|2.01|2.01|Standard Deviation|0.03|0.03|||
3645537|NCT02487498|3492756|B1||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
3645538|NCT02487498|3492756|B1||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3645539|NCT02487498|3492756|B1|||Age||Years|Mean|63.9|63.9|Standard Deviation|8.30|8.3|||
3645540|NCT02487446|3492780|B1||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
3645541|NCT02487446|3492780|B1||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3645542|NCT02487446|3492780|B1|||Age||Years|Mean|64.1|64.1|Standard Deviation|8.21|8.21|||
3645543|NCT02487303|3492804|B4|United States||Region of Enrollment||participants|Number|141|141.0||||||
3645544|NCT02487303|3492805|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
3645545|NCT02487303|3492806|B2|United States||Region of Enrollment||participants|Number|47|47.0||||||
3645546|NCT02487303|3492807|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
3645547|NCT02487303|3492804|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3645548|NCT02487303|3492805|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645549|NCT02487303|3492806|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3645550|NCT02487303|3492807|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645551|NCT02487303|3492804|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645552|NCT02487303|3492805|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645553|NCT02487303|3492806|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645554|NCT02487303|3492807|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645555|NCT02487303|3492804|B4||White|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3645556|NCT02487303|3492805|B3||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3645557|NCT02487303|3492806|B2||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3645558|NCT02487303|3492807|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3645559|NCT02487303|3492804|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3645560|NCT02487303|3492805|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3645561|NCT02487303|3492806|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3645562|NCT02487303|3492807|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3645563|NCT02487303|3492804|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645564|NCT02487303|3492805|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645565|NCT02487303|3492806|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645566|NCT02487303|3492807|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645567|NCT02487303|3492804|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3645568|NCT02487303|3492805|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645569|NCT02487303|3492806|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645570|NCT02487303|3492807|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3645571|NCT02487303|3492804|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645572|NCT02487303|3492805|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645573|NCT02487303|3492806|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645574|NCT02487303|3492807|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645575|NCT02487303|3492804|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3645576|NCT02487303|3492805|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3645577|NCT02487303|3492806|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3645578|NCT02487303|3492807|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3645579|NCT02487303|3492804|B4||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3645580|NCT02487303|3492805|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3645581|NCT02487303|3492806|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3645582|NCT02487303|3492807|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3645583|NCT02487303|3492804|B4|||Age||years|Mean|30.1|30.1|Full Range|||18.0|49.0|
3645584|NCT02487303|3492805|B3|||Age||years|Mean|31.2|31.2|Full Range|||18.0|49.0|
3645585|NCT02487303|3492806|B2|||Age||years|Mean|30.5|30.5|Full Range|||21.0|43.0|
3645586|NCT02487303|3492807|B1|||Age||years|Mean|28.7|28.7|Full Range|||19.0|44.0|
3645587|NCT02487303|3492804|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3645588|NCT02487303|3492805|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3645589|NCT02487303|3492806|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3645590|NCT02487303|3492807|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3645591|NCT02487303|3492804|B4||Between 18 and 65 years|Age||Participants|Count of Participants|141|141.0||||||
3645592|NCT02487303|3492805|B3||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3645593|NCT02487303|3492806|B2||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3645594|NCT02487303|3492807|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3645595|NCT02487303|3492804|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3645596|NCT02487303|3492805|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3645597|NCT02487303|3492806|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3645598|NCT02487303|3492807|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3645599|NCT02487199|3492826|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3645600|NCT02487199|3492827|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3645601|NCT02487199|3492828|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3645602|NCT02487199|3492826|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3645603|NCT02487199|3492827|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3645604|NCT02487199|3492828|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3645605|NCT02487199|3492826|B3|||Age||years|Mean|54.5|54.5|Standard Deviation|10.84|10.84|||
3645606|NCT02487199|3492827|B2|||Age||years|Mean|53.6|53.6|Standard Deviation|14.08|14.08|||
3645607|NCT02487199|3492828|B1|||Age||years|Mean|54.8|54.8|Standard Deviation|10.00|10.0|||
3645608|NCT02487030|3492841|B8|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|121|121.0||||||
3645609|NCT02487030|3492842|B7|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|6|6.0||||||
3645610|NCT02487030|3492843|B6|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|21|21.0||||||
3645611|NCT02487030|3492844|B5|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|20|20.0||||||
3645612|NCT02487030|3492845|B4|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|14|14.0||||||
3645613|NCT02487030|3492846|B3|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|18|18.0||||||
3645614|NCT02487030|3492847|B2|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|16|16.0||||||
3645615|NCT02487030|3492848|B1|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|26|26.0||||||
3645616|NCT02487030|3492841|B8|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|134|134.0||||||
3645617|NCT02487030|3492842|B7|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|5|5.0||||||
3645618|NCT02487030|3492843|B6|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|17|17.0||||||
3645619|NCT02487030|3492844|B5|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|16|16.0||||||
3645620|NCT02487030|3492845|B4|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|28|28.0||||||
3645621|NCT02487030|3492846|B3|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|25|25.0||||||
3645622|NCT02487030|3492847|B2|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|26|26.0||||||
3645623|NCT02487030|3492848|B1|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|17|17.0||||||
3645624|NCT02487030|3492841|B8|||HCV RNA||log10 IU/mL)|Mean|5.8|5.8|Standard Deviation|0.79|0.79|||
3645625|NCT02487030|3492842|B7|||HCV RNA||log10 IU/mL)|Mean|6.2|6.2|Standard Deviation|0.59|0.59|||
3645626|NCT02487030|3492843|B6|||HCV RNA||log10 IU/mL)|Mean|5.8|5.8|Standard Deviation|1.04|1.04|||
3645627|NCT02487030|3492844|B5|||HCV RNA||log10 IU/mL)|Mean|5.8|5.8|Standard Deviation|1.10|1.1|||
3645628|NCT02487030|3492845|B4|||HCV RNA||log10 IU/mL)|Mean|5.8|5.8|Standard Deviation|0.66|0.66|||
3645629|NCT02487030|3492846|B3|||HCV RNA||log10 IU/mL)|Mean|5.7|5.7|Standard Deviation|0.69|0.69|||
3645630|NCT02487030|3492847|B2|||HCV RNA||log10 IU/mL)|Mean|5.6|5.6|Standard Deviation|0.63|0.63|||
3645631|NCT02487030|3492848|B1|||HCV RNA||log10 IU/mL)|Mean|6.0|6.0|Standard Deviation|0.64|0.64|||
3645632|NCT02487030|3492841|B8|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|47|47.0||||||
3645633|NCT02487030|3492842|B7|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|3|3.0||||||
3645634|NCT02487030|3492843|B6|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|9|9.0||||||
3645635|NCT02487030|3492844|B5|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|7|7.0||||||
3645636|NCT02487030|3492845|B4|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|8|8.0||||||
3645637|NCT02487030|3492846|B3|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|6|6.0||||||
3645638|NCT02487030|3492847|B2|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|11|11.0||||||
3645639|NCT02487030|3492848|B1|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|3|3.0||||||
3645640|NCT02487030|3492841|B8|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|158|158.0||||||
3645641|NCT02487030|3492842|B7|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|8|8.0||||||
3645642|NCT02487030|3492843|B6|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|21|21.0||||||
3645643|NCT02487030|3492844|B5|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|24|24.0||||||
3645644|NCT02487030|3492845|B4|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|25|25.0||||||
3645645|NCT02487030|3492846|B3|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|26|26.0||||||
3645646|NCT02487030|3492847|B2|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|26|26.0||||||
3645647|NCT02487030|3492848|B1|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|28|28.0||||||
3645648|NCT02487030|3492841|B8|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|53|53.0||||||
3645649|NCT02487030|3492842|B7|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|0|0.0||||||
3645707|NCT02486939|3492892|B1|||Height||Centimeters|Mean|162.1|162.1|Standard Deviation|8.7|8.7|||
3645650|NCT02487030|3492843|B6|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|8|8.0||||||
3645651|NCT02487030|3492844|B5|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|8|8.0||||||
3645652|NCT02487030|3492845|B4|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|9|9.0||||||
3645653|NCT02487030|3492846|B3|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|11|11.0||||||
3645654|NCT02487030|3492847|B2|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|5|5.0||||||
3645655|NCT02487030|3492848|B1|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|12|12.0||||||
3645656|NCT02487030|3492841|B8|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|255|255.0||||||
3645657|NCT02487030|3492842|B7|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3645658|NCT02487030|3492843|B6|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
3645659|NCT02487030|3492844|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3645660|NCT02487030|3492845|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3645661|NCT02487030|3492846|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
3645662|NCT02487030|3492847|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3645663|NCT02487030|3492848|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
3645664|NCT02487030|3492841|B8|White||Race/Ethnicity, Customized||Participants|Count of Participants|255|255.0||||||
3645665|NCT02487030|3492842|B7|White||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3645666|NCT02487030|3492843|B6|White||Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
3645667|NCT02487030|3492844|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3645668|NCT02487030|3492845|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3645669|NCT02487030|3492846|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
3645670|NCT02487030|3492847|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3645671|NCT02487030|3492848|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
3645672|NCT02487030|3492841|B8||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3645673|NCT02487030|3492842|B7||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3645674|NCT02487030|3492843|B6||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3645675|NCT02487030|3492844|B5||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3645676|NCT02487030|3492845|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3645677|NCT02487030|3492846|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3645678|NCT02487030|3492847|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3645679|NCT02487030|3492848|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3645680|NCT02487030|3492841|B8||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3645681|NCT02487030|3492842|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3645682|NCT02487030|3492843|B6||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3645683|NCT02487030|3492844|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3645684|NCT02487030|3492845|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3645685|NCT02487030|3492846|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3645686|NCT02487030|3492847|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3645687|NCT02487030|3492848|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3645688|NCT02487030|3492841|B8|||Age||years|Mean|50.0|50.0|Standard Deviation|12.5|12.5|||
3645689|NCT02487030|3492842|B7|||Age||years|Mean|48|48.0|Standard Deviation|16.3|16.3|||
3645690|NCT02487030|3492843|B6|||Age||years|Mean|51|51.0|Standard Deviation|10.1|10.1|||
3645691|NCT02487030|3492844|B5|||Age||years|Mean|49|49.0|Standard Deviation|11.8|11.8|||
3645692|NCT02487030|3492845|B4|||Age||years|Mean|46|46.0|Standard Deviation|12.1|12.1|||
3645693|NCT02487030|3492846|B3|||Age||years|Mean|49|49.0|Standard Deviation|13.0|13.0|||
3645694|NCT02487030|3492847|B2|||Age||years|Mean|49|49.0|Standard Deviation|12.2|12.2|||
3645695|NCT02487030|3492848|B1|||Age||years|Mean|53|53.0|Standard Deviation|13.9|13.9|||
3645696|NCT02486952|3492885|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3645697|NCT02486952|3492885|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3645698|NCT02486952|3492885|B1|||Age||years|Median|58|58.0|Full Range|||19.0|83.0|
3645699|NCT02486939|3492890|B3|||BMI (Body Mass Index)||"kg/m^2"|Mean|27.09|27.09|Standard Deviation|6.823|6.823|||
3645700|NCT02486939|3492891|B2|||BMI (Body Mass Index)||"kg/m^2"|Mean|31.06|31.06|Standard Deviation|7.238|7.238|||
3645701|NCT02486939|3492892|B1|||BMI (Body Mass Index)||"kg/m^2"|Mean|24.73|24.73|Standard Deviation|5.287|5.287|||
3645702|NCT02486939|3492890|B3|||Weight||Kilograms|Mean|75.58|75.58|Standard Deviation|23.599|23.599|||
3645703|NCT02486939|3492891|B2|||Weight||Kilograms|Mean|92.19|92.19|Standard Deviation|21.593|21.593|||
3645704|NCT02486939|3492892|B1|||Weight||Kilograms|Mean|65.58|65.58|Standard Deviation|17.604|17.604|||
3645705|NCT02486939|3492890|B3|||Height||Centimeters|Mean|165.9|165.9|Standard Deviation|10.83|10.83|||
3645706|NCT02486939|3492891|B2|||Height||Centimeters|Mean|172.2|172.2|Standard Deviation|10.71|10.71|||
3645708|NCT02486939|3492890|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3645709|NCT02486939|3492891|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3645710|NCT02486939|3492892|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3645711|NCT02486939|3492890|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3645712|NCT02486939|3492891|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3645713|NCT02486939|3492892|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645714|NCT02486939|3492890|B3||White|Race (NIH/OMB)||Participants|Count of Participants|158|158.0||||||
3645715|NCT02486939|3492891|B2||White|Race (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
3645716|NCT02486939|3492892|B1||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3645717|NCT02486939|3492890|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645718|NCT02486939|3492891|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645719|NCT02486939|3492892|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645720|NCT02486939|3492890|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645721|NCT02486939|3492891|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645722|NCT02486939|3492892|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645723|NCT02486939|3492890|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|176|176.0||||||
3645724|NCT02486939|3492891|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3645725|NCT02486939|3492892|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
3645726|NCT02486939|3492890|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645727|NCT02486939|3492891|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645728|NCT02486939|3492892|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645729|NCT02486939|3492890|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645730|NCT02486939|3492891|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645731|NCT02486939|3492892|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645732|NCT02486939|3492890|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|350|350.0||||||
3645733|NCT02486939|3492891|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
3645734|NCT02486939|3492892|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|222|222.0||||||
3645735|NCT02486939|3492890|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3645736|NCT02486939|3492891|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3645737|NCT02486939|3492892|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3645738|NCT02486939|3492890|B3||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3645739|NCT02486939|3492891|B2||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3645740|NCT02486939|3492892|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3645741|NCT02486939|3492890|B3||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3645742|NCT02486939|3492891|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3645743|NCT02486939|3492892|B1||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
3645744|NCT02486939|3492890|B3|||Age||years|Mean|49.9|49.9|Standard Deviation|12.36|12.36|||
3645745|NCT02486939|3492891|B2|||Age||years|Mean|45.9|45.9|Standard Deviation|13.2|13.2|||
3645746|NCT02486939|3492892|B1|||Age||years|Mean|52.2|52.2|Standard Deviation|11.28|11.28|||
3645747|NCT02486796|3492901|B3|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3645748|NCT02486796|3492902|B2|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3645749|NCT02486796|3492903|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3645750|NCT02486796|3492901|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645751|NCT02486796|3492902|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645752|NCT02486796|3492903|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645753|NCT02486796|3492901|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645754|NCT02486796|3492902|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645755|NCT02486796|3492903|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645756|NCT02486796|3492901|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3645757|NCT02486796|3492902|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3645758|NCT02486796|3492903|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3645759|NCT02486796|3492901|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645760|NCT02486796|3492902|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645761|NCT02486796|3492903|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645762|NCT02486796|3492901|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645763|NCT02486796|3492902|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645932|NCT02484911|3493151|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3645764|NCT02486796|3492903|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645765|NCT02486796|3492901|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645766|NCT02486796|3492902|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645767|NCT02486796|3492903|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645768|NCT02486796|3492901|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645769|NCT02486796|3492902|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645770|NCT02486796|3492903|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645771|NCT02486796|3492901|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645772|NCT02486796|3492902|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645773|NCT02486796|3492903|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645774|NCT02486796|3492901|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3645775|NCT02486796|3492902|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3645776|NCT02486796|3492903|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3645777|NCT02486796|3492901|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645778|NCT02486796|3492902|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645779|NCT02486796|3492903|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645780|NCT02486796|3492901|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3645781|NCT02486796|3492902|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3645782|NCT02486796|3492903|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3645783|NCT02486796|3492901|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3645784|NCT02486796|3492902|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3645785|NCT02486796|3492903|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3645786|NCT02486796|3492901|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3645787|NCT02486796|3492902|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3645788|NCT02486796|3492903|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3645789|NCT02486796|3492901|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3645790|NCT02486796|3492902|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3645791|NCT02486796|3492903|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3645792|NCT02486796|3492901|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3645793|NCT02486796|3492902|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3645794|NCT02486796|3492903|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3645795|NCT02486757|3492916|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3645796|NCT02486757|3492916|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3645797|NCT02486757|3492916|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3645798|NCT02486757|3492916|B1|||Age||years|Mean|14.9|14.9|Standard Deviation|1.5|1.5|||
3645799|NCT02486757|3492916|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3645800|NCT02486757|3492916|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3645801|NCT02486757|3492916|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3645802|NCT02486627|3492920|B3|Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3645803|NCT02486627|3492921|B2|Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3645804|NCT02486627|3492922|B1|Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3645805|NCT02486627|3492920|B3|Other Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3645806|NCT02486627|3492921|B2|Other Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3645807|NCT02486627|3492922|B1|Other Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3645808|NCT02486627|3492920|B3|Native Hawaiin/Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3645809|NCT02486627|3492921|B2|Native Hawaiin/Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3645810|NCT02486627|3492922|B1|Native Hawaiin/Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3645811|NCT02486627|3492920|B3|American Indian or Native American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3645812|NCT02486627|3492921|B2|American Indian or Native American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3645813|NCT02486627|3492922|B1|American Indian or Native American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3645814|NCT02486627|3492920|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3645815|NCT02486627|3492921|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3645816|NCT02486627|3492922|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3645817|NCT02486627|3492920|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3645818|NCT02486627|3492921|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3645819|NCT02486627|3492922|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3645820|NCT02486627|3492920|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|606|606.0||||||
3645821|NCT02486627|3492921|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|302|302.0||||||
3645822|NCT02486627|3492922|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|304|304.0||||||
3645823|NCT02486627|3492920|B3||Male|Sex: Female, Male||Participants|Count of Participants|289|289.0||||||
3645824|NCT02486627|3492921|B2||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3645825|NCT02486627|3492922|B1||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3645826|NCT02486627|3492920|B3||Female|Sex: Female, Male||Participants|Count of Participants|320|320.0||||||
3645827|NCT02486627|3492921|B2||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3645828|NCT02486627|3492922|B1||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3645829|NCT02486627|3492920|B3|||Age||years|Mean|58.6|58.6|Standard Deviation|17.95|17.95|||
3645830|NCT02486627|3492921|B2|||Age||years|Mean|59|59.0|Standard Deviation|17.62|17.62|||
3645831|NCT02486627|3492922|B1|||Age||years|Mean|58.2|58.2|Standard Deviation|18.29|18.29|||
3645832|NCT02485925|3492940|B1|Others: Hui Nationality||Race/Ethnicity, Customized|Race/Ethnicity categories related to Chinese are used since the study was conducted in China|Participants|Number|2|2.0||||||
3645833|NCT02485925|3492940|B1|Han Nationality||Race/Ethnicity, Customized|Race/Ethnicity categories related to Chinese are used since the study was conducted in China|Participants|Number|198|198.0||||||
3645834|NCT02485925|3492940|B1||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3645835|NCT02485925|3492940|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3645836|NCT02485925|3492940|B1|||Age||Years|Mean|61.2|61.2|Standard Deviation|9.25|9.25|||
3645837|NCT02485561|3492948|B4|||Any prior colorectal cancer screening|Receipt of any colorectal screening test (i.e., home stool blood test, sigmoidoscopy, colonoscopy)|Participants|Count of Participants|153|153.0||||||
3645838|NCT02485561|3492949|B3|||Any prior colorectal cancer screening|Receipt of any colorectal screening test (i.e., home stool blood test, sigmoidoscopy, colonoscopy)|Participants|Count of Participants|51|51.0||||||
3645839|NCT02485561|3492950|B2|||Any prior colorectal cancer screening|Receipt of any colorectal screening test (i.e., home stool blood test, sigmoidoscopy, colonoscopy)|Participants|Count of Participants|57|57.0||||||
3645840|NCT02485561|3492951|B1|||Any prior colorectal cancer screening|Receipt of any colorectal screening test (i.e., home stool blood test, sigmoidoscopy, colonoscopy)|Participants|Count of Participants|45|45.0||||||
3645841|NCT02485561|3492948|B4|Other race||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3645842|NCT02485561|3492949|B3|Other race||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3645843|NCT02485561|3492950|B2|Other race||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3645844|NCT02485561|3492951|B1|Other race||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3645845|NCT02485561|3492948|B4|African American/Black||Race/Ethnicity, Customized||Participants|Count of Participants|77|77.0||||||
3645846|NCT02485561|3492949|B3|African American/Black||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3645847|NCT02485561|3492950|B2|African American/Black||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3645848|NCT02485561|3492951|B1|African American/Black||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3645849|NCT02485561|3492948|B4|Caucasian/White||Race/Ethnicity, Customized||Participants|Count of Participants|377|377.0||||||
3645850|NCT02485561|3492949|B3|Caucasian/White||Race/Ethnicity, Customized||Participants|Count of Participants|128|128.0||||||
3645851|NCT02485561|3492950|B2|Caucasian/White||Race/Ethnicity, Customized||Participants|Count of Participants|126|126.0||||||
3645852|NCT02485561|3492951|B1|Caucasian/White||Race/Ethnicity, Customized||Participants|Count of Participants|123|123.0||||||
3645853|NCT02485561|3492948|B4||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3645854|NCT02485561|3492949|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3645855|NCT02485561|3492950|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3645856|NCT02485561|3492951|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3645857|NCT02485561|3492948|B4||Female|Sex: Female, Male||Participants|Count of Participants|334|334.0||||||
3645858|NCT02485561|3492949|B3||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3645859|NCT02485561|3492950|B2||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3645860|NCT02485561|3492951|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3645861|NCT02485561|3492948|B4|||Age||years|Mean|57.4|57.4|Standard Deviation|6.2|6.2|||
3645862|NCT02485561|3492949|B3|||Age||years|Mean|57.4|57.4|Standard Deviation|6.2|6.2|||
3645863|NCT02485561|3492950|B2|||Age||years|Mean|57.8|57.8|Standard Deviation|6.6|6.6|||
3645864|NCT02485561|3492951|B1|||Age||years|Mean|57.1|57.1|Standard Deviation|5.8|5.8|||
3645865|NCT02485483|3492988|B3||Male|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
3645866|NCT02485483|3492989|B2||Male|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
3645867|NCT02485483|3492990|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3645868|NCT02485483|3492988|B3||Female|Sex: Female, Male||Participants|Count of Participants|982|982.0||||||
3645869|NCT02485483|3492989|B2||Female|Sex: Female, Male||Participants|Count of Participants|764|764.0||||||
3645870|NCT02485483|3492990|B1||Female|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
3645871|NCT02485483|3492988|B3|||Age||years|Mean|60.7|60.7|Standard Deviation|12.9|12.9|||
3645872|NCT02485483|3492989|B2|||Age||years|Mean|61.0|61.0|Standard Deviation|12.9|12.9|||
3645873|NCT02485483|3492990|B1|||Age||years|Mean|59.4|59.4|Standard Deviation|13.0|13.0|||
3645874|NCT02485353|3493006|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3645875|NCT02485353|3493006|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645876|NCT02485353|3493006|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3645877|NCT02485353|3493006|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645878|NCT02485353|3493006|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645879|NCT02485353|3493006|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645880|NCT02485353|3493006|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645881|NCT02485353|3493006|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3645882|NCT02485353|3493006|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645883|NCT02485353|3493006|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3645884|NCT02485353|3493006|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3645885|NCT02485353|3493006|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3645886|NCT02485353|3493006|B1|||Age||years|Mean|72.9|72.9|Standard Deviation|1.03|1.03|||
3645887|NCT02485353|3493006|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3645888|NCT02485353|3493006|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3645889|NCT02485353|3493006|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3645890|NCT02485301|3493011|B3|Geographic ancestry|Asian - South East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3645891|NCT02485301|3493012|B2|Geographic ancestry|Asian - South East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3645892|NCT02485301|3493013|B1|Geographic ancestry|Asian - South East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3645893|NCT02485301|3493011|B3|Geographic ancestry|Asian - Japanese heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3645894|NCT02485301|3493012|B2|Geographic ancestry|Asian - Japanese heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3645895|NCT02485301|3493013|B1|Geographic ancestry|Asian - Japanese heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3645896|NCT02485301|3493011|B3|Geographic ancestry|American Indian or Alaskan native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3645897|NCT02485301|3493012|B2|Geographic ancestry|American Indian or Alaskan native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3645898|NCT02485301|3493013|B1|Geographic ancestry|American Indian or Alaskan native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3645899|NCT02485301|3493011|B3|Geographic ancestry|African heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|3006|3006.0||||||
3645900|NCT02485301|3493012|B2|Geographic ancestry|African heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|1501|1501.0||||||
3645901|NCT02485301|3493013|B1|Geographic ancestry|African heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|1505|1505.0||||||
3645902|NCT02485301|3493011|B3|Male||Sex/Gender, Customized||Participants|Count of Participants|1626|1626.0||||||
3645903|NCT02485301|3493012|B2|Male||Sex/Gender, Customized||Participants|Count of Participants|814|814.0||||||
3645904|NCT02485301|3493013|B1|Male||Sex/Gender, Customized||Participants|Count of Participants|812|812.0||||||
3645905|NCT02485301|3493011|B3|Female||Sex/Gender, Customized||Participants|Count of Participants|1387|1387.0||||||
3645906|NCT02485301|3493012|B2|Female||Sex/Gender, Customized||Participants|Count of Participants|690|690.0||||||
3645907|NCT02485301|3493013|B1|Female||Sex/Gender, Customized||Participants|Count of Participants|697|697.0||||||
3645908|NCT02485301|3493011|B3|||Age||Years|Mean|32.7|32.7|Standard Deviation|12.57|12.57|||
3645909|NCT02485301|3493012|B2|||Age||Years|Mean|33.0|33.0|Standard Deviation|12.43|12.43|||
3645910|NCT02485301|3493013|B1|||Age||Years|Mean|32.4|32.4|Standard Deviation|12.71|12.71|||
3645911|NCT02485158|3493064|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3645912|NCT02485158|3493064|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3645913|NCT02485158|3493064|B1|||Age||years|Mean|24.6|24.6|Standard Deviation|2.8|2.8|||
3645914|NCT02484911|3493151|B3|NO||History of drinking||participants|Number|90|90.0||||||
3645915|NCT02484911|3493152|B2|NO||History of drinking||participants|Number|49|49.0||||||
3645916|NCT02484911|3493153|B1|NO||History of drinking||participants|Number|41|41.0||||||
3645917|NCT02484911|3493151|B3|YES||History of drinking||participants|Number|24|24.0||||||
3645918|NCT02484911|3493152|B2|YES||History of drinking||participants|Number|9|9.0||||||
3645919|NCT02484911|3493153|B1|YES||History of drinking||participants|Number|15|15.0||||||
3645920|NCT02484911|3493151|B3|China||Region of Enrollment||participants|Number|114|114.0||||||
3645921|NCT02484911|3493152|B2|China||Region of Enrollment||participants|Number|56|56.0||||||
3645922|NCT02484911|3493153|B1|China||Region of Enrollment||participants|Number|56|56.0||||||
3645923|NCT02484911|3493151|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3645924|NCT02484911|3493152|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3645925|NCT02484911|3493153|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3645926|NCT02484911|3493151|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3645927|NCT02484911|3493152|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3645928|NCT02484911|3493153|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3645929|NCT02484911|3493151|B3|||Age||years|Mean|54.18|54.18|Standard Deviation|10.24|10.24|||
3645930|NCT02484911|3493152|B2|||Age||years|Mean|52.98|52.98|Standard Deviation|10.81|10.81|||
3645931|NCT02484911|3493153|B1|||Age||years|Mean|55.43|55.43|Standard Deviation|9.55|9.55|||
3645933|NCT02484911|3493152|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3645934|NCT02484911|3493153|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3645935|NCT02484911|3493151|B3||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
3645936|NCT02484911|3493152|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3645937|NCT02484911|3493153|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3645938|NCT02484911|3493151|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3645939|NCT02484911|3493152|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3645940|NCT02484911|3493153|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3645941|NCT02484898|3493182|B1|United States||Region of Enrollment||participants|Number|200|200.0||||||
3645942|NCT02484898|3493182|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3645943|NCT02484898|3493182|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3645944|NCT02484898|3493182|B1|||Age||years|Mean|73.6|73.6|Standard Deviation|11.1|11.1|||
3645945|NCT02484729|3493186|B11|Male||Sex/Gender, Customized||Participants|Number|70|70.0||||||
3645946|NCT02484729|3493187|B10|Male||Sex/Gender, Customized||Participants|Number|8|8.0||||||
3645947|NCT02484729|3493188|B9|Male||Sex/Gender, Customized||Participants|Number|6|6.0||||||
3645948|NCT02484729|3493189|B8|Male||Sex/Gender, Customized||Participants|Number|6|6.0||||||
3645949|NCT02484729|3493190|B7|Male||Sex/Gender, Customized||Participants|Number|5|5.0||||||
3645950|NCT02484729|3493191|B6|Male||Sex/Gender, Customized||Participants|Number|6|6.0||||||
3645951|NCT02484729|3493192|B5|Male||Sex/Gender, Customized||Participants|Number|5|5.0||||||
3645952|NCT02484729|3493193|B4|Male||Sex/Gender, Customized||Participants|Number|6|6.0||||||
3645953|NCT02484729|3493194|B3|Male||Sex/Gender, Customized||Participants|Number|6|6.0||||||
3645954|NCT02484729|3493195|B2|Male||Sex/Gender, Customized||Participants|Number|6|6.0||||||
3645955|NCT02484729|3493196|B1|Male||Sex/Gender, Customized||Participants|Number|16|16.0||||||
3645956|NCT02484729|3493186|B11|||Age||Years|Mean|33|33.0|Standard Deviation|9|9.0|||
3645957|NCT02484729|3493187|B10|||Age||Years|Mean|35|35.0|Standard Deviation|9|9.0|||
3645958|NCT02484729|3493188|B9|||Age||Years|Mean|38|38.0|Standard Deviation|11|11.0|||
3645959|NCT02484729|3493189|B8|||Age||Years|Mean|32|32.0|Standard Deviation|8|8.0|||
3645960|NCT02484729|3493190|B7|||Age||Years|Mean|30|30.0|Standard Deviation|6|6.0|||
3645961|NCT02484729|3493191|B6|||Age||Years|Mean|33|33.0|Standard Deviation|9|9.0|||
3645962|NCT02484729|3493192|B5|||Age||Years|Mean|32|32.0|Standard Deviation|10|10.0|||
3645963|NCT02484729|3493193|B4|||Age||Years|Mean|36|36.0|Standard Deviation|10|10.0|||
3645964|NCT02484729|3493194|B3|||Age||Years|Mean|30|30.0|Standard Deviation|9|9.0|||
3645965|NCT02484729|3493195|B2|||Age||Years|Mean|32|32.0|Standard Deviation|11|11.0|||
3645966|NCT02484729|3493196|B1|||Age||Years|Mean|30|30.0|Standard Deviation|6|6.0|||
3645967|NCT02483975|3493401|B3|Multiple- Black or African American and White||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3645968|NCT02483975|3493402|B2|Multiple- Black or African American and White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3645969|NCT02483975|3493403|B1|Multiple- Black or African American and White||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3645970|NCT02483975|3493401|B3|Multiple- Asian-Japanese Heritage and White||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3645971|NCT02483975|3493402|B2|Multiple- Asian-Japanese Heritage and White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3645972|NCT02483975|3493403|B1|Multiple- Asian-Japanese Heritage and White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3645973|NCT02483975|3493401|B3|Multiple-East Asian Heritage & African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3645974|NCT02483975|3493402|B2|Multiple-East Asian Heritage & African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3645975|NCT02483975|3493403|B1|Multiple-East Asian Heritage & African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3645976|NCT02483975|3493401|B3|Multiple-American Indian or Alaskan native & white||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3645977|NCT02483975|3493402|B2|Multiple-American Indian or Alaskan native & white||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3645978|NCT02483975|3493403|B1|Multiple-American Indian or Alaskan native & white||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3645979|NCT02483975|3493401|B3|White- White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|42|42.0||||||
3645980|NCT02483975|3493402|B2|White- White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
3645981|NCT02483975|3493403|B1|White- White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
3645982|NCT02483975|3493401|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|61|61.0||||||
3645983|NCT02483975|3493402|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
3645984|NCT02483975|3493403|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
3645985|NCT02483975|3493401|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645986|NCT02483975|3493402|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645987|NCT02483975|3493403|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3645988|NCT02483975|3493401|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3645989|NCT02483975|3493402|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3645990|NCT02483975|3493403|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3645991|NCT02483975|3493401|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3645992|NCT02483975|3493402|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3645993|NCT02483975|3493403|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3645994|NCT02483975|3493401|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3645995|NCT02483975|3493402|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3645996|NCT02483975|3493403|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3645997|NCT02483975|3493401|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3645998|NCT02483975|3493402|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3645999|NCT02483975|3493403|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3646000|NCT02483975|3493401|B3|Overall study||Age||Years|Mean|8.4|8.4|Standard Deviation|1.97|1.97|||
3646001|NCT02483975|3493402|B2|Overall study||Age||Years|Mean|8.4|8.4|Standard Deviation|2.00|2.0|||
3646002|NCT02483975|3493403|B1|Overall study||Age||Years|Mean|8.4|8.4|Standard Deviation|1.97|1.97|||
3646003|NCT02483611|3493418|B4|Brazil||Region of Enrollment||participants|Number|47|47.0||||||
3646004|NCT02483611|3493419|B3|Brazil||Region of Enrollment||participants|Number|15|15.0||||||
3646005|NCT02483611|3493420|B2|Brazil||Region of Enrollment||participants|Number|16|16.0||||||
3646006|NCT02483611|3493421|B1|Brazil||Region of Enrollment||participants|Number|16|16.0||||||
3646007|NCT02483611|3493418|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3646008|NCT02483611|3493419|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3646009|NCT02483611|3493420|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3646010|NCT02483611|3493421|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3646011|NCT02483611|3493418|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3646012|NCT02483611|3493419|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3646013|NCT02483611|3493420|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3646014|NCT02483611|3493421|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3646015|NCT02483611|3493418|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3646016|NCT02483611|3493419|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3646017|NCT02483611|3493420|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3646018|NCT02483611|3493421|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3646019|NCT02483611|3493418|B4||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3646020|NCT02483611|3493419|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3646021|NCT02483611|3493420|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3646022|NCT02483611|3493421|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3646023|NCT02483611|3493418|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3646024|NCT02483611|3493419|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3646025|NCT02483611|3493420|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3646026|NCT02483611|3493421|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3646027|NCT02483585|3493518|B3|||Monthly Migraine Days|A migraine day was any calendar day in which the participant experienced a qualified migraine headache (onset, continuation, or recurrence of the migraine headache). A qualified migraine headache was defined either as a migraine without aura or a migraine with aura. Monthly migraine days were calculated as the number of migraine days in the 4-week baseline phase.|days|Mean|8.26|8.26|Standard Deviation|2.62|2.62|||
3646028|NCT02483585|3493519|B2|||Monthly Migraine Days|A migraine day was any calendar day in which the participant experienced a qualified migraine headache (onset, continuation, or recurrence of the migraine headache). A qualified migraine headache was defined either as a migraine without aura or a migraine with aura. Monthly migraine days were calculated as the number of migraine days in the 4-week baseline phase.|days|Mean|8.14|8.14|Standard Deviation|2.65|2.65|||
3646029|NCT02483585|3493520|B1|||Monthly Migraine Days|A migraine day was any calendar day in which the participant experienced a qualified migraine headache (onset, continuation, or recurrence of the migraine headache). A qualified migraine headache was defined either as a migraine without aura or a migraine with aura. Monthly migraine days were calculated as the number of migraine days in the 4-week baseline phase.|days|Mean|8.38|8.38|Standard Deviation|2.60|2.6|||
3646030|NCT02483585|3493518|B3|||Disease Duration of Migraine With or Without Aura||years|Mean|20.86|20.86|Standard Deviation|12.37|12.37|||
3646031|NCT02483585|3493519|B2|||Disease Duration of Migraine With or Without Aura||years|Mean|21.70|21.7|Standard Deviation|12.62|12.62|||
3646032|NCT02483585|3493520|B1|||Disease Duration of Migraine With or Without Aura||years|Mean|20.03|20.03|Standard Deviation|12.08|12.08|||
3646033|NCT02483585|3493518|B3||No prior / current migraine prophylactic treatment|Treatment Status with Migraine Prophylactic Medication||Participants|Count of Participants|303|303.0||||||
3646034|NCT02483585|3493519|B2||No prior / current migraine prophylactic treatment|Treatment Status with Migraine Prophylactic Medication||Participants|Count of Participants|150|150.0||||||
3646035|NCT02483585|3493520|B1||No prior / current migraine prophylactic treatment|Treatment Status with Migraine Prophylactic Medication||Participants|Count of Participants|153|153.0||||||
3646036|NCT02483585|3493518|B3||Prior migraine prophylactic treatment only|Treatment Status with Migraine Prophylactic Medication||Participants|Count of Participants|239|239.0||||||
3646037|NCT02483585|3493519|B2||Prior migraine prophylactic treatment only|Treatment Status with Migraine Prophylactic Medication||Participants|Count of Participants|119|119.0||||||
3646038|NCT02483585|3493520|B1||Prior migraine prophylactic treatment only|Treatment Status with Migraine Prophylactic Medication||Participants|Count of Participants|120|120.0||||||
3646039|NCT02483585|3493518|B3||Current migraine prophylactic medication treatment|Treatment Status with Migraine Prophylactic Medication||Participants|Count of Participants|35|35.0||||||
3646040|NCT02483585|3493519|B2||Current migraine prophylactic medication treatment|Treatment Status with Migraine Prophylactic Medication||Participants|Count of Participants|17|17.0||||||
3646041|NCT02483585|3493520|B1||Current migraine prophylactic medication treatment|Treatment Status with Migraine Prophylactic Medication||Participants|Count of Participants|18|18.0||||||
3646042|NCT02483585|3493518|B3||Other|Region||Participants|Count of Participants|239|239.0||||||
3646043|NCT02483585|3493519|B2||Other|Region||Participants|Count of Participants|118|118.0||||||
3646044|NCT02483585|3493520|B1||Other|Region||Participants|Count of Participants|121|121.0||||||
3646045|NCT02483585|3493518|B3||North America|Region||Participants|Count of Participants|338|338.0||||||
3646046|NCT02483585|3493519|B2||North America|Region||Participants|Count of Participants|168|168.0||||||
3646047|NCT02483585|3493520|B1||North America|Region||Participants|Count of Participants|170|170.0||||||
3646048|NCT02483585|3493518|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3646049|NCT02483585|3493519|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3646050|NCT02483585|3493520|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3646051|NCT02483585|3493518|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|518|518.0||||||
3646052|NCT02483585|3493519|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|259|259.0||||||
3646053|NCT02483585|3493520|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|259|259.0||||||
3646054|NCT02483585|3493518|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3646055|NCT02483585|3493519|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3646056|NCT02483585|3493520|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3646057|NCT02483585|3493518|B3||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3646058|NCT02483585|3493519|B2||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3646059|NCT02483585|3493520|B1||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3646060|NCT02483585|3493518|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
3646061|NCT02483585|3493519|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3646062|NCT02483585|3493520|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3646063|NCT02483585|3493518|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3646064|NCT02483585|3493519|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3646065|NCT02483585|3493520|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3646066|NCT02483585|3493518|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3646067|NCT02483585|3493519|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3646068|NCT02483585|3493520|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3646069|NCT02483585|3493518|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646070|NCT02483585|3493519|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646071|NCT02483585|3493520|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646072|NCT02483585|3493518|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|520|520.0||||||
3646073|NCT02483585|3493519|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|263|263.0||||||
3646074|NCT02483585|3493520|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|257|257.0||||||
3646075|NCT02483585|3493518|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3646076|NCT02483585|3493519|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3646077|NCT02483585|3493520|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3646078|NCT02483585|3493518|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3646079|NCT02483585|3493519|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3646080|NCT02483585|3493520|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3646081|NCT02483585|3493518|B3||Female|Sex: Female, Male||Participants|Count of Participants|492|492.0||||||
3646082|NCT02483585|3493519|B2||Female|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
3646083|NCT02483585|3493520|B1||Female|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
3646084|NCT02483585|3493518|B3||65 - 74 years|Age, Customized||Participants|Count of Participants|4|4.0||||||
3646085|NCT02483585|3493519|B2||65 - 74 years|Age, Customized||Participants|Count of Participants|3|3.0||||||
3646086|NCT02483585|3493520|B1||65 - 74 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
3646087|NCT02483585|3493518|B3||18 - 64 years|Age, Customized||Participants|Count of Participants|573|573.0||||||
3646088|NCT02483585|3493519|B2||18 - 64 years|Age, Customized||Participants|Count of Participants|283|283.0||||||
3646089|NCT02483585|3493520|B1||18 - 64 years|Age, Customized||Participants|Count of Participants|290|290.0||||||
3646090|NCT02483585|3493518|B3|||Age||years|Mean|42.3|42.3|Standard Deviation|11.4|11.4|||
3646091|NCT02483585|3493519|B2|||Age||years|Mean|42.3|42.3|Standard Deviation|11.4|11.4|||
3646092|NCT02483585|3493520|B1|||Age||years|Mean|42.2|42.2|Standard Deviation|11.5|11.5|||
3646093|NCT02482935|3493541|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3646094|NCT02482935|3493541|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646095|NCT02482935|3493541|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646096|NCT02482935|3493541|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3646097|NCT02482935|3493541|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3646098|NCT02482935|3493541|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646099|NCT02482935|3493541|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3646100|NCT02482935|3493541|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646101|NCT02482935|3493541|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646102|NCT02482935|3493541|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3646103|NCT02482935|3493541|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3646104|NCT02482935|3493541|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3646105|NCT02482935|3493541|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3646106|NCT02482935|3493541|B1|||Age||years|Mean|49.1|49.1|Standard Deviation|11.5|11.5|||
3646107|NCT02482870|3493552|B1|||Interincisor distance, Continuous||cm|Median|3.3|3.3|Inter-Quartile Range|||2.7|4.1|
3646108|NCT02482870|3493552|B1|||Sternomental distance, Continuous||cm|Median|10.9|10.9|Inter-Quartile Range|||9.6|12.3|
3646109|NCT02482870|3493552|B1|||Thyromental distance, Continuous||cm|Median|6.2|6.2|Inter-Quartile Range|||5.3|7.3|
3646110|NCT02482870|3493552|B1||2 - A patient with mild systemic disease|American Society of Anesthesiologists score, Categorical|"American Society of Anesthesiologists score is a widely used grading system for preoperative health of the surgical patients.~It is based on five classes (I to V):~I-a completely healthy fit patient.~II-patient has mild systemic disease.~III-patient has severe systemic disease that is not incapacitating.~IV-patient has incapacitating disease that is a constant threat to life.~V-a moribund patient, not expected to live 24 hour w/out surgery. E-designates emergency surgery (added after roman literal like IIE)."|Participants|Count of Participants|196|196.0||||||
3646111|NCT02482870|3493552|B1||1 - A normal healthy patient|American Society of Anesthesiologists score, Categorical|"American Society of Anesthesiologists score is a widely used grading system for preoperative health of the surgical patients.~It is based on five classes (I to V):~I-a completely healthy fit patient.~II-patient has mild systemic disease.~III-patient has severe systemic disease that is not incapacitating.~IV-patient has incapacitating disease that is a constant threat to life.~V-a moribund patient, not expected to live 24 hour w/out surgery. E-designates emergency surgery (added after roman literal like IIE)."|Participants|Count of Participants|192|192.0||||||
3646112|NCT02482870|3493552|B1||4 - Soft palate not visible at all|Mallampati class, Categorical|Mallampati class is used to indirectly assess the distance between the base of the tongue and the roof of the mouth, to predict how difficult an intubation will be.|Participants|Count of Participants|89|89.0||||||
3646113|NCT02482870|3493552|B1||3 - Soft palate, base of uvula visible|Mallampati class, Categorical|Mallampati class is used to indirectly assess the distance between the base of the tongue and the roof of the mouth, to predict how difficult an intubation will be.|Participants|Count of Participants|107|107.0||||||
3646114|NCT02482870|3493552|B1||2 - Soft palate, fauces, uvula visible|Mallampati class, Categorical|Mallampati class is used to indirectly assess the distance between the base of the tongue and the roof of the mouth, to predict how difficult an intubation will be.|Participants|Count of Participants|113|113.0||||||
3646115|NCT02482870|3493552|B1||1 - Soft palate, fauces, uvula, pillars visible|Mallampati class, Categorical|Mallampati class is used to indirectly assess the distance between the base of the tongue and the roof of the mouth, to predict how difficult an intubation will be.|Participants|Count of Participants|79|79.0||||||
3646116|NCT02482870|3493552|B1||0 - Ability to see any part of the epiglottis|Mallampati class, Categorical|Mallampati class is used to indirectly assess the distance between the base of the tongue and the roof of the mouth, to predict how difficult an intubation will be.|Participants|Count of Participants|0|0.0||||||
3646117|NCT02482870|3493552|B1||1 - History of snoring|History of snoring, Categorical||Participants|Count of Participants|142|142.0||||||
3646118|NCT02482870|3493552|B1||0 - No history of snoring|History of snoring, Categorical||Participants|Count of Participants|246|246.0||||||
3646119|NCT02482870|3493552|B1||1 - History of obstructive sleep apnea|History of obstructive sleep apnea, Categorical||Participants|Count of Participants|96|96.0||||||
3646120|NCT02482870|3493552|B1||0 - No history of obstructive sleep apnea|History of obstructive sleep apnea, Categorical||Participants|Count of Participants|292|292.0||||||
3646121|NCT02482870|3493552|B1|||Body mass index, Continuous||kg/m^2|Median|26.9|26.9|Inter-Quartile Range|||24.3|30.9|
3646122|NCT02482870|3493552|B1|||Weight, Continuous||kg|Median|80|80.0|Inter-Quartile Range|||70.0|88.0|
3646123|NCT02482870|3493552|B1|||Height, Continuous||cm|Median|171|171.0|Inter-Quartile Range|||165.0|175.0|
3646124|NCT02482870|3493552|B1||Male|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
3646125|NCT02482870|3493552|B1||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3646126|NCT02482870|3493552|B1|||Age||years|Median|48.5|48.5|Inter-Quartile Range|||37.0|55.0|
3646127|NCT02482805|3493567|B4|||Peak SUDS during exposure|Peak Subjective Units of Distress Scale (SUDS) is the maximum amount of fear experienced rated on a 0 to 100 point scale, where 0 indicates no anxiety and 100 indicates the maximum level of anxiety.|units on a scale|Mean|77.16|77.16|Standard Deviation|13.85|13.85|||
3646128|NCT02482805|3493568|B3|||Peak SUDS during exposure|Peak Subjective Units of Distress Scale (SUDS) is the maximum amount of fear experienced rated on a 0 to 100 point scale, where 0 indicates no anxiety and 100 indicates the maximum level of anxiety.|units on a scale|Mean|77.50|77.5|Standard Deviation|11.20|11.2|||
3646129|NCT02482805|3493569|B2|||Peak SUDS during exposure|Peak Subjective Units of Distress Scale (SUDS) is the maximum amount of fear experienced rated on a 0 to 100 point scale, where 0 indicates no anxiety and 100 indicates the maximum level of anxiety.|units on a scale|Mean|77.74|77.74|Standard Deviation|15.03|15.03|||
3646130|NCT02482805|3493570|B1|||Peak SUDS during exposure|Peak Subjective Units of Distress Scale (SUDS) is the maximum amount of fear experienced rated on a 0 to 100 point scale, where 0 indicates no anxiety and 100 indicates the maximum level of anxiety.|units on a scale|Mean|76.31|76.31|Standard Deviation|14.86|14.86|||
3646131|NCT02482805|3493567|B4|||LSAS-performance|The Liebowitz Social Anxiety Scale (LSAS) - Performance Subscale is a subscale of a common measure of social anxiety symptom severity. This subscale consists of only 13 (of the total 24) items related to performance situations. Participants rate both their fear (0 to 3) and avoidance (0 to 3) of these 13 situations, where higher scores indicate worse social anxiety severity. The minimum possible score on this subscale is 0 and the maximum possible score is 78.|units on a scale|Mean|37.27|37.27|Standard Deviation|11.96|11.96|||
3646132|NCT02482805|3493568|B3|||LSAS-performance|The Liebowitz Social Anxiety Scale (LSAS) - Performance Subscale is a subscale of a common measure of social anxiety symptom severity. This subscale consists of only 13 (of the total 24) items related to performance situations. Participants rate both their fear (0 to 3) and avoidance (0 to 3) of these 13 situations, where higher scores indicate worse social anxiety severity. The minimum possible score on this subscale is 0 and the maximum possible score is 78.|units on a scale|Mean|37.85|37.85|Standard Deviation|10.16|10.16|||
3646133|NCT02482805|3493569|B2|||LSAS-performance|The Liebowitz Social Anxiety Scale (LSAS) - Performance Subscale is a subscale of a common measure of social anxiety symptom severity. This subscale consists of only 13 (of the total 24) items related to performance situations. Participants rate both their fear (0 to 3) and avoidance (0 to 3) of these 13 situations, where higher scores indicate worse social anxiety severity. The minimum possible score on this subscale is 0 and the maximum possible score is 78.|units on a scale|Mean|36.19|36.19|Standard Deviation|10.92|10.92|||
3646134|NCT02482805|3493570|B1|||LSAS-performance|The Liebowitz Social Anxiety Scale (LSAS) - Performance Subscale is a subscale of a common measure of social anxiety symptom severity. This subscale consists of only 13 (of the total 24) items related to performance situations. Participants rate both their fear (0 to 3) and avoidance (0 to 3) of these 13 situations, where higher scores indicate worse social anxiety severity. The minimum possible score on this subscale is 0 and the maximum possible score is 78.|units on a scale|Mean|37.96|37.96|Standard Deviation|14.39|14.39|||
3646135|NCT02482805|3493567|B4|United States||Region of Enrollment||Participants|Count of Participants|73|73.0||||||
3646136|NCT02482805|3493568|B3|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3646137|NCT02482805|3493569|B2|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3646138|NCT02482805|3493570|B1|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3646139|NCT02482805|3493567|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3646140|NCT02482805|3493568|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3646141|NCT02482805|3493569|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3646142|NCT02482805|3493570|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3646143|NCT02482805|3493567|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646144|NCT02482805|3493568|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646145|NCT02482805|3493569|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646146|NCT02482805|3493570|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646147|NCT02482805|3493567|B4||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3646148|NCT02482805|3493568|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3646149|NCT02482805|3493569|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3646150|NCT02482805|3493570|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3646151|NCT02482805|3493567|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3646152|NCT02482805|3493568|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3646153|NCT02482805|3493569|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3646154|NCT02482805|3493570|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3646155|NCT02482805|3493567|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646156|NCT02482805|3493568|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646157|NCT02482805|3493569|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646158|NCT02482805|3493570|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646159|NCT02482805|3493567|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3646160|NCT02482805|3493568|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3646161|NCT02482805|3493569|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3646162|NCT02482805|3493570|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3646163|NCT02482805|3493567|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646164|NCT02482805|3493568|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646165|NCT02482805|3493569|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646166|NCT02482805|3493570|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646167|NCT02482805|3493567|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3646168|NCT02482805|3493568|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3646169|NCT02482805|3493569|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3646170|NCT02482805|3493570|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3646171|NCT02482805|3493567|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3646172|NCT02482805|3493568|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3646173|NCT02482805|3493569|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3646174|NCT02482805|3493570|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3646175|NCT02482805|3493567|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3646176|NCT02482805|3493568|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3646177|NCT02482805|3493569|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3646178|NCT02482805|3493570|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3646179|NCT02482805|3493567|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3646180|NCT02482805|3493568|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3646181|NCT02482805|3493569|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3646182|NCT02482805|3493570|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3646183|NCT02482805|3493567|B4||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3646184|NCT02482805|3493568|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3646185|NCT02482805|3493569|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3646186|NCT02482805|3493570|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3646187|NCT02482805|3493567|B4|||Age||years|Mean|25.66|25.66|Standard Deviation|7.48|7.48|||
3646188|NCT02482805|3493568|B3|||Age||years|Mean|24.60|24.6|Standard Deviation|5.83|5.83|||
3646189|NCT02482805|3493569|B2|||Age||years|Mean|25.26|25.26|Standard Deviation|8.99|8.99|||
3646190|NCT02482805|3493570|B1|||Age||years|Mean|26.88|26.88|Standard Deviation|6.99|6.99|||
3646191|NCT02482571|3493586|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3646192|NCT02482571|3493586|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3646193|NCT02482571|3493586|B1|||Age||years|Mean|25.4|25.4|Standard Deviation|5.9|5.9|||
3646194|NCT02482428|3493593|B6||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3646195|NCT02482428|3493594|B5||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3646196|NCT02482428|3493595|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3646197|NCT02482428|3493596|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3646198|NCT02482428|3493597|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3646199|NCT02482428|3493598|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3646200|NCT02482428|3493593|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3646201|NCT02482428|3493594|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3646202|NCT02482428|3493595|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3646203|NCT02482428|3493596|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3646204|NCT02482428|3493597|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3646205|NCT02482428|3493598|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3646206|NCT02482428|3493593|B6|||Age||years|Mean|35.3|35.3|Standard Deviation|9.31|9.31|||
3646207|NCT02482428|3493594|B5|||Age||years|Mean|36.0|36.0|Standard Deviation|9.59|9.59|||
3646208|NCT02482428|3493595|B4|||Age||years|Mean|38.1|38.1|Standard Deviation|9.62|9.62|||
3646209|NCT02482428|3493596|B3|||Age||years|Mean|35.2|35.2|Standard Deviation|6.75|6.75|||
3646210|NCT02482428|3493597|B2|||Age||years|Mean|33.3|33.3|Standard Deviation|9.31|9.31|||
3646211|NCT02482428|3493598|B1|||Age||years|Mean|35.2|35.2|Standard Deviation|10.15|10.15|||
3646212|NCT02482298|3493622|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646213|NCT02482298|3493623|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646214|NCT02482298|3493624|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646215|NCT02482298|3493625|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646216|NCT02482298|3493622|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3646217|NCT02482298|3493623|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646218|NCT02482298|3493624|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3646219|NCT02482298|3493625|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646220|NCT02482298|3493622|B4||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3646221|NCT02482298|3493623|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3646222|NCT02482298|3493624|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3646223|NCT02482298|3493625|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3646224|NCT02482298|3493622|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3646225|NCT02482298|3493623|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3646226|NCT02482298|3493624|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3646227|NCT02482298|3493625|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3646228|NCT02482298|3493622|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646229|NCT02482298|3493623|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646230|NCT02482298|3493624|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646231|NCT02482298|3493625|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646232|NCT02482298|3493622|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646233|NCT02482298|3493623|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646234|NCT02482298|3493624|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646235|NCT02482298|3493625|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646236|NCT02482298|3493622|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646237|NCT02482298|3493623|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646238|NCT02482298|3493624|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646239|NCT02482298|3493625|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646240|NCT02482298|3493622|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3646241|NCT02482298|3493623|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3646242|NCT02482298|3493624|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3646243|NCT02482298|3493625|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3646244|NCT02482298|3493622|B4||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3646245|NCT02482298|3493623|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3646246|NCT02482298|3493624|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3646247|NCT02482298|3493625|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3646248|NCT02482298|3493622|B4|||Age||Years|Mean|22.2|22.2|Standard Deviation|3.35|3.35|18.0|30.0|
3646249|NCT02482298|3493623|B3|||Age||Years|Mean|23.2|23.2|Standard Deviation|3.69|3.69|18.0|30.0|
3646250|NCT02482298|3493624|B2|||Age||Years|Mean|21.9|21.9|Standard Deviation|2.72|2.72|18.0|28.0|
3646251|NCT02482298|3493625|B1|||Age||Years|Mean|21.6|21.6|Standard Deviation|3.42|3.42|18.0|30.0|
3646252|NCT02482129|3493647|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3646253|NCT02482129|3493648|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3646254|NCT02482129|3493649|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3646255|NCT02482129|3493647|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3646256|NCT02482129|3493648|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3646257|NCT02482129|3493649|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3646258|NCT02482129|3493647|B3|||Age||years|Mean|54.5|54.5|Standard Deviation|16.71|16.71|||
3646259|NCT02482129|3493648|B2|||Age||years|Mean|55.6|55.6|Standard Deviation|16.02|16.02|||
3646260|NCT02482129|3493649|B1|||Age||years|Mean|54.1|54.1|Standard Deviation|17.20|17.2|||
3646261|NCT02481934|3493677|B1|Spain||Region of Enrollment||participants|Number|5|5.0||||||
3646262|NCT02481934|3493677|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3646263|NCT02481934|3493677|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3646264|NCT02481934|3493677|B1|||Age||years|Median|62|62.0|Inter-Quartile Range|||61.0|72.0|
3646265|NCT02481375|3493682|B5|Cambodia||Region of Enrollment||Participants|Count of Participants|809|809.0||||||
3646266|NCT02481375|3493683|B4|Cambodia||Region of Enrollment||Participants|Count of Participants|200|200.0||||||
3646267|NCT02481375|3493684|B3|Cambodia||Region of Enrollment||Participants|Count of Participants|201|201.0||||||
3646268|NCT02481375|3493685|B2|Cambodia||Region of Enrollment||Participants|Count of Participants|202|202.0||||||
3646269|NCT02481375|3493686|B1|Cambodia||Region of Enrollment||Participants|Count of Participants|206|206.0||||||
3646270|NCT02481375|3493682|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3646271|NCT02481375|3493683|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3646272|NCT02481375|3493684|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3646273|NCT02481375|3493685|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3646274|NCT02481375|3493686|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3646275|NCT02481375|3493682|B5||Female|Sex: Female, Male||Participants|Count of Participants|809|809.0||||||
3646276|NCT02481375|3493683|B4||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
3646277|NCT02481375|3493684|B3||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3646278|NCT02481375|3493685|B2||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3646279|NCT02481375|3493686|B1||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
3646280|NCT02481375|3493682|B5|||Age||years|Mean|30|30.0|Standard Deviation|8|8.0|||
3646281|NCT02481375|3493683|B4|||Age||years|Mean|30|30.0|Standard Deviation|8|8.0|||
3646282|NCT02481375|3493684|B3|||Age||years|Mean|31|31.0|Standard Deviation|8|8.0|||
3646283|NCT02481375|3493685|B2|||Age||years|Mean|30|30.0|Standard Deviation|8|8.0|||
3646284|NCT02481375|3493686|B1|||Age||years|Mean|30|30.0|Standard Deviation|8|8.0|||
3646285|NCT02481219|3493699|B3|United States||Region of Enrollment||participants|Number|122|122.0||||||
3646286|NCT02481219|3493700|B2|United States||Region of Enrollment||participants|Number|62|62.0||||||
3646287|NCT02481219|3493701|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
3646288|NCT02481219|3493699|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3646289|NCT02481219|3493700|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3646290|NCT02481219|3493701|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3646291|NCT02481219|3493699|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3646292|NCT02481219|3493700|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3646293|NCT02481219|3493701|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3646294|NCT02481219|3493699|B3|||Age||years|Median|53|53.0|Full Range|||50.0|68.0|
3646295|NCT02481219|3493700|B2|||Age||years|Median|53|53.0|Full Range|||50.0|68.0|
3646296|NCT02481219|3493701|B1|||Age||years|Median|53|53.0|Full Range|||50.0|67.0|
3646297|NCT02481219|3493699|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3646298|NCT02481219|3493700|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3646299|NCT02481219|3493701|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3646300|NCT02481219|3493699|B3||Between 18 and 65 years|Age||Participants|Count of Participants|114|114.0||||||
3646301|NCT02481219|3493700|B2||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
3646302|NCT02481219|3493701|B1||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3646303|NCT02481219|3493699|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3646304|NCT02481219|3493700|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3646305|NCT02481219|3493701|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3646306|NCT02481141|3493718|B3|Bahrain||Region of Enrollment||participants|Number|50|50.0||||||
3646307|NCT02481141|3493719|B2|Bahrain||Region of Enrollment||participants|Number|15|15.0||||||
3646308|NCT02481141|3493720|B1|Bahrain||Region of Enrollment||participants|Number|35|35.0||||||
3646309|NCT02481141|3493718|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3646310|NCT02481141|3493719|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3646311|NCT02481141|3493720|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3646312|NCT02481141|3493718|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3646313|NCT02481141|3493719|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3646314|NCT02481141|3493720|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3646315|NCT02481141|3493718|B3|||Age||years|Mean|52.2|52.2|Standard Deviation|6.07|6.07|||
3646316|NCT02481141|3493719|B2|||Age||years|Mean|51.9|51.9|Standard Deviation|5.07|5.07|||
3646317|NCT02481141|3493720|B1|||Age||years|Mean|52.4|52.4|Standard Deviation|6.51|6.51|||
3646318|NCT02481141|3493718|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3646319|NCT02481141|3493719|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3646320|NCT02481141|3493720|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3646321|NCT02481141|3493718|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
3646322|NCT02481141|3493719|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3646323|NCT02481141|3493720|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3646324|NCT02481141|3493718|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3646325|NCT02481141|3493719|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3646326|NCT02481141|3493720|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3646327|NCT02481050|3493773|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3646328|NCT02481050|3493773|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646329|NCT02481050|3493773|B1||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3646330|NCT02481050|3493773|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3646331|NCT02481050|3493773|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646332|NCT02481050|3493773|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3646333|NCT02481050|3493773|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3646334|NCT02481050|3493773|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3646335|NCT02481050|3493773|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3646336|NCT02481050|3493773|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3646337|NCT02481050|3493773|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3646338|NCT02481050|3493773|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3646339|NCT02481050|3493773|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|9.08|9.08|||
3646340|NCT02480998|3493782|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3646341|NCT02480998|3493783|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3646342|NCT02480998|3493784|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3646343|NCT02480998|3493782|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3646344|NCT02480998|3493783|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3646345|NCT02480998|3493784|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3646346|NCT02480998|3493782|B3|||Age||years|Mean|27.10|27.1|Standard Deviation|7.50|7.5|||
3646347|NCT02480998|3493783|B2|||Age||years|Mean|27.75|27.75|Standard Deviation|8.48|8.48|||
3646348|NCT02480998|3493784|B1|||Age||years|Mean|26.77|26.77|Standard Deviation|7.01|7.01|||
3646349|NCT02480712|3493793|B1|Non TDF Containing Regimens||Serum Creatinine||mg/dL|Mean|1.02|1.02|Standard Deviation|0.255|0.255|||
3646350|NCT02480712|3493793|B1|Non-Boosted TDF Containing Regimens||Serum Creatinine||mg/dL|Mean|0.98|0.98|Standard Deviation|1.44|1.44|||
3646351|NCT02480712|3493793|B1|Boosted TDF Containing Regimens||Serum Creatinine||mg/dL|Mean|1.02|1.02|Standard Deviation|0.194|0.194|||
3646352|NCT02480712|3493793|B1|Non TDF Containing Regimens|HIV RNA ≥ 50 copies/mL|HIV RNA category||Participants|Count of Participants|1|1.0||||||
3646353|NCT02480712|3493793|B1|Non TDF Containing Regimens|HIV RNA < 50 copies/mL|HIV RNA category||Participants|Count of Participants|14|14.0||||||
3646354|NCT02480712|3493793|B1|Non-Boosted TDF Containing Regimens|HIV RNA ≥ 50 copies/mL|HIV RNA category||Participants|Count of Participants|0|0.0||||||
3646355|NCT02480712|3493793|B1|Non-Boosted TDF Containing Regimens|HIV RNA < 50 copies/mL|HIV RNA category||Participants|Count of Participants|35|35.0||||||
3646356|NCT02480712|3493793|B1|Boosted TDF Containing Regimens|HIV RNA ≥ 50 copies/mL|HIV RNA category||Participants|Count of Participants|1|1.0||||||
3646357|NCT02480712|3493793|B1|Boosted TDF Containing Regimens|HIV RNA < 50 copies/mL|HIV RNA category||Participants|Count of Participants|55|55.0||||||
3646358|NCT02480712|3493793|B1||≥ 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|78|78.0||||||
3646359|NCT02480712|3493793|B1||< 800,000 IU/mL|HCV RNA Category||Participants|Count of Participants|28|28.0||||||
3646360|NCT02480712|3493793|B1|||HCV RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.57|0.57|||
3646361|NCT02480712|3493793|B1||TT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|30|30.0||||||
3646362|NCT02480712|3493793|B1||CT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|52|52.0||||||
3646363|NCT02480712|3493793|B1||CC|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|24|24.0||||||
3646364|NCT02480712|3493793|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|91|91.0||||||
3646365|NCT02480712|3493793|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3646366|NCT02480712|3493793|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3646367|NCT02480712|3493793|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3646368|NCT02480712|3493793|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|54|54.0||||||
3646369|NCT02480712|3493793|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
3646370|NCT02480712|3493793|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3646371|NCT02480712|3493793|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3646372|NCT02480712|3493793|B1|||Age||years|Mean|54|54.0|Standard Deviation|9.0|9.0|||
3646373|NCT02480621|3493810|B3|44C||OTA Fracture Classification|The number of participants within each ankle fracture classification using the groupings provided by the Orthopaedic Trauma Association (OTA) (i.e., 44A, 44B, 44C) was determined. The numbering indicates the anatomic location of the fractures (i.e., 44 designates fractures of the tibia and/or fibula malleoli [ankle]). The lettering indicates the relative location of the fracture in regards to the location of the syndesmotic joint connecting the tibia and fibula such that A indicates fractures below this joint, B indicates fractures involving the joint, and C indicate fractures above the joint.|Participants|Count of Participants|21|21.0||||||
3646374|NCT02480621|3493811|B2|44C||OTA Fracture Classification|The number of participants within each ankle fracture classification using the groupings provided by the Orthopaedic Trauma Association (OTA) (i.e., 44A, 44B, 44C) was determined. The numbering indicates the anatomic location of the fractures (i.e., 44 designates fractures of the tibia and/or fibula malleoli [ankle]). The lettering indicates the relative location of the fracture in regards to the location of the syndesmotic joint connecting the tibia and fibula such that A indicates fractures below this joint, B indicates fractures involving the joint, and C indicate fractures above the joint.|Participants|Count of Participants|10|10.0||||||
3646375|NCT02480621|3493812|B1|44C||OTA Fracture Classification|The number of participants within each ankle fracture classification using the groupings provided by the Orthopaedic Trauma Association (OTA) (i.e., 44A, 44B, 44C) was determined. The numbering indicates the anatomic location of the fractures (i.e., 44 designates fractures of the tibia and/or fibula malleoli [ankle]). The lettering indicates the relative location of the fracture in regards to the location of the syndesmotic joint connecting the tibia and fibula such that A indicates fractures below this joint, B indicates fractures involving the joint, and C indicate fractures above the joint.|Participants|Count of Participants|11|11.0||||||
3646376|NCT02480621|3493810|B3|44B||OTA Fracture Classification|The number of participants within each ankle fracture classification using the groupings provided by the Orthopaedic Trauma Association (OTA) (i.e., 44A, 44B, 44C) was determined. The numbering indicates the anatomic location of the fractures (i.e., 44 designates fractures of the tibia and/or fibula malleoli [ankle]). The lettering indicates the relative location of the fracture in regards to the location of the syndesmotic joint connecting the tibia and fibula such that A indicates fractures below this joint, B indicates fractures involving the joint, and C indicate fractures above the joint.|Participants|Count of Participants|35|35.0||||||
3646377|NCT02480621|3493811|B2|44B||OTA Fracture Classification|The number of participants within each ankle fracture classification using the groupings provided by the Orthopaedic Trauma Association (OTA) (i.e., 44A, 44B, 44C) was determined. The numbering indicates the anatomic location of the fractures (i.e., 44 designates fractures of the tibia and/or fibula malleoli [ankle]). The lettering indicates the relative location of the fracture in regards to the location of the syndesmotic joint connecting the tibia and fibula such that A indicates fractures below this joint, B indicates fractures involving the joint, and C indicate fractures above the joint.|Participants|Count of Participants|19|19.0||||||
3646378|NCT02480621|3493812|B1|44B||OTA Fracture Classification|The number of participants within each ankle fracture classification using the groupings provided by the Orthopaedic Trauma Association (OTA) (i.e., 44A, 44B, 44C) was determined. The numbering indicates the anatomic location of the fractures (i.e., 44 designates fractures of the tibia and/or fibula malleoli [ankle]). The lettering indicates the relative location of the fracture in regards to the location of the syndesmotic joint connecting the tibia and fibula such that A indicates fractures below this joint, B indicates fractures involving the joint, and C indicate fractures above the joint.|Participants|Count of Participants|16|16.0||||||
3646410|NCT02480582|3493819|B1|||Three factor Eating Questionnaire - Hunger subscale|Susceptibility to hunger Scale range: 0-13 Higher scores indicate worse outcome|units on a scale|Mean|6.1|6.1|Standard Deviation|3.2|3.2|||
3646379|NCT02480621|3493810|B3|44A||OTA Fracture Classification|The number of participants within each ankle fracture classification using the groupings provided by the Orthopaedic Trauma Association (OTA) (i.e., 44A, 44B, 44C) was determined. The numbering indicates the anatomic location of the fractures (i.e., 44 designates fractures of the tibia and/or fibula malleoli [ankle]). The lettering indicates the relative location of the fracture in regards to the location of the syndesmotic joint connecting the tibia and fibula such that A indicates fractures below this joint, B indicates fractures involving the joint, and C indicate fractures above the joint.|Participants|Count of Participants|20|20.0||||||
3646380|NCT02480621|3493811|B2|44A||OTA Fracture Classification|The number of participants within each ankle fracture classification using the groupings provided by the Orthopaedic Trauma Association (OTA) (i.e., 44A, 44B, 44C) was determined. The numbering indicates the anatomic location of the fractures (i.e., 44 designates fractures of the tibia and/or fibula malleoli [ankle]). The lettering indicates the relative location of the fracture in regards to the location of the syndesmotic joint connecting the tibia and fibula such that A indicates fractures below this joint, B indicates fractures involving the joint, and C indicate fractures above the joint.|Participants|Count of Participants|8|8.0||||||
3646381|NCT02480621|3493812|B1|44A||OTA Fracture Classification|The number of participants within each ankle fracture classification using the groupings provided by the Orthopaedic Trauma Association (OTA) (i.e., 44A, 44B, 44C) was determined. The numbering indicates the anatomic location of the fractures (i.e., 44 designates fractures of the tibia and/or fibula malleoli [ankle]). The lettering indicates the relative location of the fracture in regards to the location of the syndesmotic joint connecting the tibia and fibula such that A indicates fractures below this joint, B indicates fractures involving the joint, and C indicate fractures above the joint.|Participants|Count of Participants|12|12.0||||||
3646382|NCT02480621|3493810|B3|||Charlson Comorbidity Index (CCI)|The CCI is a validated index used to quantitatively measure the number and severity of a patient's co-morbid illnesses. A specific grading chart for the various types and severity of illnesses is used that ranges from 0 points (i.e., no active disease process) to 6 points (i.e., most severe active disease process). Each illness is assigned a point value according to the scale, and the presence and severity of each illness are summed for an individual patient. A score of 0 indicates no active co-morbid illnesses within a patient, whereas a score >0 suggests 1 or more active disease processes.|units on a scale|Mean|0.88|0.88|Full Range|||0.0|5.0|
3646383|NCT02480621|3493811|B2|||Charlson Comorbidity Index (CCI)|The CCI is a validated index used to quantitatively measure the number and severity of a patient's co-morbid illnesses. A specific grading chart for the various types and severity of illnesses is used that ranges from 0 points (i.e., no active disease process) to 6 points (i.e., most severe active disease process). Each illness is assigned a point value according to the scale, and the presence and severity of each illness are summed for an individual patient. A score of 0 indicates no active co-morbid illnesses within a patient, whereas a score >0 suggests 1 or more active disease processes.|units on a scale|Mean|0.8|0.8|Full Range|||0.0|5.0|
3646384|NCT02480621|3493812|B1|||Charlson Comorbidity Index (CCI)|The CCI is a validated index used to quantitatively measure the number and severity of a patient's co-morbid illnesses. A specific grading chart for the various types and severity of illnesses is used that ranges from 0 points (i.e., no active disease process) to 6 points (i.e., most severe active disease process). Each illness is assigned a point value according to the scale, and the presence and severity of each illness are summed for an individual patient. A score of 0 indicates no active co-morbid illnesses within a patient, whereas a score >0 suggests 1 or more active disease processes.|units on a scale|Mean|0.9|0.9|Full Range|||0.0|3.0|
3646385|NCT02480621|3493810|B3|||Body Mass Index (BMI)||kilogram per meter squared|Mean|29.5|29.5|Full Range|||17.9|48.1|
3646386|NCT02480621|3493811|B2|||Body Mass Index (BMI)||kilogram per meter squared|Mean|29.4|29.4|Full Range|||17.9|48.1|
3646387|NCT02480621|3493812|B1|||Body Mass Index (BMI)||kilogram per meter squared|Mean|29.7|29.7|Full Range|||19.1|42.0|
3646388|NCT02480621|3493810|B3|United States||Region of Enrollment||Participants|Count of Participants|76|76.0||||||
3646389|NCT02480621|3493811|B2|United States||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3646390|NCT02480621|3493812|B1|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3646391|NCT02480621|3493810|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3646392|NCT02480621|3493811|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3646393|NCT02480621|3493812|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3646394|NCT02480621|3493810|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3646395|NCT02480621|3493811|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3646396|NCT02480621|3493812|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3646397|NCT02480621|3493810|B3|||Age||years|Mean|42|42.0|Full Range|||19.0|81.0|
3646398|NCT02480621|3493811|B2|||Age||years|Mean|41.9|41.9|Full Range|||19.0|81.0|
3646399|NCT02480621|3493812|B1|||Age||years|Mean|42.6|42.6|Full Range|||19.0|69.0|
3646400|NCT02480621|3493810|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3646401|NCT02480621|3493811|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3646402|NCT02480621|3493812|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3646403|NCT02480621|3493810|B3||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
3646404|NCT02480621|3493811|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3646405|NCT02480621|3493812|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3646406|NCT02480621|3493810|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3646407|NCT02480621|3493811|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3646408|NCT02480621|3493812|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3646409|NCT02480582|3493819|B1|||Binge Eating Scale|Binge eating scale Scale range: 0-46 Higher scores indicate worse outcome|units on a scale|Mean|10.1|10.1|Standard Deviation|5.7|5.7|||
3646470|NCT02480166|3493872|B4|||Albumin||g/dL|Mean|4.0|4.0|Standard Deviation|0.7|0.7|||
3646411|NCT02480582|3493819|B1|||Three Factor Eating Questionnaire - Disinhibition subscale|Disinhibition of restraint Scale range: 0-16 Higher scores indicate worse outcome|units on a scale|Mean|7.6|7.6|Standard Deviation|2.8|2.8|||
3646412|NCT02480582|3493819|B1|||Three Factor Eating Questionnaire - Restraint subscale|Cognitive restraint over eating. Scale range: 0-21 Higher values indicate greater restraint over eating|units on a scale|Mean|9.4|9.4|Standard Deviation|4.8|4.8|||
3646413|NCT02480582|3493819|B1|||Body Fat Percentage||%|Mean|26.0|26.0|Standard Deviation|6.7|6.7|||
3646414|NCT02480582|3493819|B1|||Fat Free Mass||kg|Mean|43.0|43.0|Standard Deviation|4.1|4.1|||
3646415|NCT02480582|3493819|B1|||Fat Mass||kg|Mean|15.4|15.4|Standard Deviation|5.0|5.0|||
3646416|NCT02480582|3493819|B1|||Waist||cm|Mean|73.5|73.5|Standard Deviation|5.6|5.6|||
3646417|NCT02480582|3493819|B1|||BMI||kg/m^2|Mean|22.0|22.0|Standard Deviation|2.0|2.0|||
3646418|NCT02480582|3493819|B1|||Weight||kg|Mean|58.5|58.5|Standard Deviation|6.1|6.1|||
3646419|NCT02480582|3493819|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3646420|NCT02480582|3493819|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3646421|NCT02480582|3493819|B1|||Age||Years|Median|26.0|26.0|Standard Deviation|7.9|7.9|||
3646422|NCT02480439|3493844|B4|||Body Mass Index||kg/m^2|Mean|26.23|26.23|Standard Deviation|2.393|2.393|||
3646423|NCT02480439|3493845|B3|||Body Mass Index||kg/m^2|Mean|27.68|27.68|Standard Deviation|1.709|1.709|||
3646424|NCT02480439|3493846|B2|||Body Mass Index||kg/m^2|Mean|26.24|26.24|Standard Deviation|2.349|2.349|||
3646425|NCT02480439|3493847|B1|||Body Mass Index||kg/m^2|Mean|24.76|24.76|Standard Deviation|2.350|2.35|||
3646426|NCT02480439|3493844|B4|||Weight||kg|Mean|76.33|76.33|Standard Deviation|13.219|13.219|||
3646427|NCT02480439|3493845|B3|||Weight||kg|Mean|81.41|81.41|Standard Deviation|7.596|7.596|||
3646428|NCT02480439|3493846|B2|||Weight||kg|Mean|70.11|70.11|Standard Deviation|9.447|9.447|||
3646429|NCT02480439|3493847|B1|||Weight||kg|Mean|77.46|77.46|Standard Deviation|18.762|18.762|||
3646430|NCT02480439|3493844|B4|||Height||cm|Mean|170.1|170.1|Standard Deviation|11.18|11.18|||
3646431|NCT02480439|3493845|B3|||Height||cm|Mean|171.4|171.4|Standard Deviation|4.98|4.98|||
3646432|NCT02480439|3493846|B2|||Height||cm|Mean|163.4|163.4|Standard Deviation|11.07|11.07|||
3646433|NCT02480439|3493847|B1|||Height||cm|Mean|175.6|175.6|Standard Deviation|13.22|13.22|||
3646434|NCT02480439|3493844|B4|United States||Region of Enrollment||participants|Number|24|24.0||||||
3646435|NCT02480439|3493845|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3646436|NCT02480439|3493846|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3646437|NCT02480439|3493847|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3646438|NCT02480439|3493844|B4|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3646439|NCT02480439|3493845|B3|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3646440|NCT02480439|3493846|B2|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3646441|NCT02480439|3493847|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3646442|NCT02480439|3493844|B4|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3646443|NCT02480439|3493845|B3|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3646444|NCT02480439|3493846|B2|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3646445|NCT02480439|3493847|B1|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3646446|NCT02480439|3493844|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3646447|NCT02480439|3493845|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3646448|NCT02480439|3493846|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3646449|NCT02480439|3493847|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3646450|NCT02480439|3493844|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3646451|NCT02480439|3493845|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3646452|NCT02480439|3493846|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3646453|NCT02480439|3493847|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3646454|NCT02480439|3493844|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3646455|NCT02480439|3493845|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3646456|NCT02480439|3493846|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3646457|NCT02480439|3493847|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3646458|NCT02480439|3493844|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3646459|NCT02480439|3493845|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3646460|NCT02480439|3493846|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3646461|NCT02480439|3493847|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3646462|NCT02480439|3493844|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3646463|NCT02480439|3493845|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3646464|NCT02480439|3493846|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3646465|NCT02480439|3493847|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3646466|NCT02480439|3493844|B4|||Age||years|Mean|33.7|33.7|Standard Deviation|9.51|9.51|||
3646467|NCT02480439|3493845|B3|||Age||years|Mean|34.4|34.4|Standard Deviation|9.91|9.91|||
3646468|NCT02480439|3493846|B2|||Age||years|Mean|35.3|35.3|Standard Deviation|11.00|11.0|||
3646469|NCT02480439|3493847|B1|||Age||years|Mean|31.4|31.4|Standard Deviation|8.26|8.26|||
3646471|NCT02480166|3493873|B3|||Albumin||g/dL|Mean|3.5|3.5|Standard Deviation|1.5|1.5|||
3646472|NCT02480166|3493874|B2|||Albumin||g/dL|Mean|4.0|4.0|Standard Deviation|0.7|0.7|||
3646473|NCT02480166|3493875|B1|||Albumin||g/dL|Mean|4.3|4.3|Standard Deviation|0.4|0.4|||
3646474|NCT02480166|3493872|B4|||Alanine Aminotransferase (ALT)|ALT is an enzyme that is secreted by the liver into the blood. Main storage of this enzyme is in the liver and elevated levels of ALT in the blood may indicate liver inflammation or damage. Normal range for ALT is typically between 7-56 U/L.|U/L|Median|59|59.0|Inter-Quartile Range|||36.0|76.0|
3646475|NCT02480166|3493873|B3|||Alanine Aminotransferase (ALT)|ALT is an enzyme that is secreted by the liver into the blood. Main storage of this enzyme is in the liver and elevated levels of ALT in the blood may indicate liver inflammation or damage. Normal range for ALT is typically between 7-56 U/L.|U/L|Median|33|33.0|Inter-Quartile Range|||21.0|41.0|
3646476|NCT02480166|3493874|B2|||Alanine Aminotransferase (ALT)|ALT is an enzyme that is secreted by the liver into the blood. Main storage of this enzyme is in the liver and elevated levels of ALT in the blood may indicate liver inflammation or damage. Normal range for ALT is typically between 7-56 U/L.|U/L|Median|68|68.0|Inter-Quartile Range|||46.0|105.0|
3646477|NCT02480166|3493875|B1|||Alanine Aminotransferase (ALT)|ALT is an enzyme that is secreted by the liver into the blood. Main storage of this enzyme is in the liver and elevated levels of ALT in the blood may indicate liver inflammation or damage. Normal range for ALT is typically between 7-56 U/L.|U/L|Median|44|44.0|Inter-Quartile Range|||31.0|59.0|
3646478|NCT02480166|3493872|B4|||Aspartate Aminotransferase (AST)|AST is an enzyme that is secreted from the liver and can be found in liver, heart, muscle tissue, pancreas and kidneys. Elevated levels of AST may indicate inflammation or liver damage. Normal range for AST is typically 10-40 U/L.|U/L|Median|39|39.0|Inter-Quartile Range|||29.0|69.0|
3646479|NCT02480166|3493873|B3|||Aspartate Aminotransferase (AST)|AST is an enzyme that is secreted from the liver and can be found in liver, heart, muscle tissue, pancreas and kidneys. Elevated levels of AST may indicate inflammation or liver damage. Normal range for AST is typically 10-40 U/L.|U/L|Median|28|28.0|Inter-Quartile Range|||21.0|34.0|
3646480|NCT02480166|3493874|B2|||Aspartate Aminotransferase (AST)|AST is an enzyme that is secreted from the liver and can be found in liver, heart, muscle tissue, pancreas and kidneys. Elevated levels of AST may indicate inflammation or liver damage. Normal range for AST is typically 10-40 U/L.|U/L|Median|48|48.0|Inter-Quartile Range|||33.0|95.0|
3646481|NCT02480166|3493875|B1|||Aspartate Aminotransferase (AST)|AST is an enzyme that is secreted from the liver and can be found in liver, heart, muscle tissue, pancreas and kidneys. Elevated levels of AST may indicate inflammation or liver damage. Normal range for AST is typically 10-40 U/L.|U/L|Median|36|36.0|Inter-Quartile Range|||27.0|44.0|
3646482|NCT02480166|3493872|B4|||Total bilirubin||mg/dL|Mean|0.7|0.7|Standard Deviation|0.3|0.3|||
3646483|NCT02480166|3493873|B3|||Total bilirubin||mg/dL|Mean|0.9|0.9|Standard Deviation|0.1|0.1|||
3646484|NCT02480166|3493874|B2|||Total bilirubin||mg/dL|Mean|0.8|0.8|Standard Deviation|0.4|0.4|||
3646485|NCT02480166|3493875|B1|||Total bilirubin||mg/dL|Mean|0.7|0.7|Standard Deviation|0.1|0.1|||
3646486|NCT02480166|3493872|B4|||International Normalized Ratio (INR)|The INR is based on the ratio of the patient's prothrombin time and the normal mean prothrombin time. The normal range for a healthy person who is not on anticoagulant therapy is 0.8-1.2, while higher values are targeted for people on anticoagulant therapy.|ratio|Mean|1.0|1.0|Standard Deviation|0.1|0.1|||
3646487|NCT02480166|3493873|B3|||International Normalized Ratio (INR)|The INR is based on the ratio of the patient's prothrombin time and the normal mean prothrombin time. The normal range for a healthy person who is not on anticoagulant therapy is 0.8-1.2, while higher values are targeted for people on anticoagulant therapy.|ratio|Mean|1.0|1.0|Standard Deviation|0.0|0.0|||
3646488|NCT02480166|3493874|B2|||International Normalized Ratio (INR)|The INR is based on the ratio of the patient's prothrombin time and the normal mean prothrombin time. The normal range for a healthy person who is not on anticoagulant therapy is 0.8-1.2, while higher values are targeted for people on anticoagulant therapy.|ratio|Mean|1.0|1.0|Standard Deviation|0.1|0.1|||
3646489|NCT02480166|3493875|B1|||International Normalized Ratio (INR)|The INR is based on the ratio of the patient's prothrombin time and the normal mean prothrombin time. The normal range for a healthy person who is not on anticoagulant therapy is 0.8-1.2, while higher values are targeted for people on anticoagulant therapy.|ratio|Mean|1.0|1.0|Standard Deviation|0.2|0.2|||
3646490|NCT02480166|3493872|B4|||Creatinine||mg/dL|Mean|0.8|0.8|Standard Deviation|0.2|0.2|||
3646491|NCT02480166|3493873|B3|||Creatinine||mg/dL|Mean|0.9|0.9|Standard Deviation|0.1|0.1|||
3646492|NCT02480166|3493874|B2|||Creatinine||mg/dL|Mean|0.9|0.9|Standard Deviation|0.2|0.2|||
3646493|NCT02480166|3493875|B1|||Creatinine||mg/dL|Mean|0.8|0.8|Standard Deviation|0.1|0.1|||
3646494|NCT02480166|3493872|B4|||Platelets||K/uL|Median|201|201.0|Inter-Quartile Range|||151.0|223.0|
3646495|NCT02480166|3493873|B3|||Platelets||K/uL|Median|201|201.0|Inter-Quartile Range|||189.0|225.0|
3646496|NCT02480166|3493874|B2|||Platelets||K/uL|Median|181|181.0|Inter-Quartile Range|||133.0|223.0|
3646497|NCT02480166|3493875|B1|||Platelets||K/uL|Median|213|213.0|Inter-Quartile Range|||186.0|240.0|
3646498|NCT02480166|3493872|B4|||Hemoglobin||g/dL|Mean|14.2|14.2|Standard Deviation|1.5|1.5|||
3646499|NCT02480166|3493873|B3|||Hemoglobin||g/dL|Mean|14.8|14.8|Standard Deviation|1.1|1.1|||
3646500|NCT02480166|3493874|B2|||Hemoglobin||g/dL|Mean|14.2|14.2|Standard Deviation|1.6|1.6|||
3646501|NCT02480166|3493875|B1|||Hemoglobin||g/dL|Mean|14.3|14.3|Standard Deviation|1.3|1.3|||
3646502|NCT02480166|3493872|B4|||White Blood Cell Count (WBC)||K/uL|Mean|5.8|5.8|Standard Deviation|1.8|1.8|||
3646503|NCT02480166|3493873|B3|||White Blood Cell Count (WBC)||K/uL|Mean|5.3|5.3|Standard Deviation|0.5|0.5|||
3646504|NCT02480166|3493874|B2|||White Blood Cell Count (WBC)||K/uL|Mean|6.0|6.0|Standard Deviation|2.1|2.1|||
3646505|NCT02480166|3493875|B1|||White Blood Cell Count (WBC)||K/uL|Mean|5.5|5.5|Standard Deviation|1.4|1.4|||
3646506|NCT02480166|3493872|B4|||log10 HCV RNA||log10 (IU/ml)|Mean|6.5|6.5|Standard Deviation|0.7|0.7|||
3646507|NCT02480166|3493873|B3|||log10 HCV RNA||log10 (IU/ml)|Mean|7.2|7.2|Standard Deviation|0.3|0.3|||
3646508|NCT02480166|3493874|B2|||log10 HCV RNA||log10 (IU/ml)|Mean|6.5|6.5|Standard Deviation|0.6|0.6|||
3646509|NCT02480166|3493875|B1|||log10 HCV RNA||log10 (IU/ml)|Mean|6.2|6.2|Standard Deviation|0.8|0.8|||
3646510|NCT02480166|3493872|B4|||MELD, cirrhotics only|The Model for End-Stage Liver Disease (MELD) Score uses the patient's values for serum bilirubin, serum creatinine, and the international normalized ratio for prothrombin time (INR) to predict survival. It is calculated according to the following formula: MELD = 3.78×ln[serum bilirubin (mg/dL)] + 11.2×ln[INR] + 9.57×ln[serum creatinine (mg/dL)] + 6.43. The total possible range for MELD scores is 6 (less ill) to 40 (gravely ill).|units on a scale|Mean|6.9|6.9|Standard Deviation|1.6|1.6|||
3646511|NCT02480166|3493873|B3|||MELD, cirrhotics only|The Model for End-Stage Liver Disease (MELD) Score uses the patient's values for serum bilirubin, serum creatinine, and the international normalized ratio for prothrombin time (INR) to predict survival. It is calculated according to the following formula: MELD = 3.78×ln[serum bilirubin (mg/dL)] + 11.2×ln[INR] + 9.57×ln[serum creatinine (mg/dL)] + 6.43. The total possible range for MELD scores is 6 (less ill) to 40 (gravely ill).|units on a scale|Mean|0|0.0|Standard Deviation|0|0.0|||
3646512|NCT02480166|3493874|B2|||MELD, cirrhotics only|The Model for End-Stage Liver Disease (MELD) Score uses the patient's values for serum bilirubin, serum creatinine, and the international normalized ratio for prothrombin time (INR) to predict survival. It is calculated according to the following formula: MELD = 3.78×ln[serum bilirubin (mg/dL)] + 11.2×ln[INR] + 9.57×ln[serum creatinine (mg/dL)] + 6.43. The total possible range for MELD scores is 6 (less ill) to 40 (gravely ill).|units on a scale|Mean|6.9|6.9|Standard Deviation|1.6|1.6|||
3646513|NCT02480166|3493875|B1|||MELD, cirrhotics only|The Model for End-Stage Liver Disease (MELD) Score uses the patient's values for serum bilirubin, serum creatinine, and the international normalized ratio for prothrombin time (INR) to predict survival. It is calculated according to the following formula: MELD = 3.78×ln[serum bilirubin (mg/dL)] + 11.2×ln[INR] + 9.57×ln[serum creatinine (mg/dL)] + 6.43. The total possible range for MELD scores is 6 (less ill) to 40 (gravely ill).|units on a scale|Mean|0|0.0|Standard Deviation|0|0.0|||
3646514|NCT02480166|3493872|B4|||Proton Pump Inhibitor (PPI) usage||Participants|Count of Participants|12|12.0||||||
3646515|NCT02480166|3493873|B3|||Proton Pump Inhibitor (PPI) usage||Participants|Count of Participants|0|0.0||||||
3646516|NCT02480166|3493874|B2|||Proton Pump Inhibitor (PPI) usage||Participants|Count of Participants|9|9.0||||||
3646517|NCT02480166|3493875|B1|||Proton Pump Inhibitor (PPI) usage||Participants|Count of Participants|3|3.0||||||
3646518|NCT02480166|3493872|B4|||Prior Treatment||Participants|Count of Participants|15|15.0||||||
3646519|NCT02480166|3493873|B3|||Prior Treatment||Participants|Count of Participants|0|0.0||||||
3646520|NCT02480166|3493874|B2|||Prior Treatment||Participants|Count of Participants|15|15.0||||||
3646521|NCT02480166|3493875|B1|||Prior Treatment||Participants|Count of Participants|0|0.0||||||
3646522|NCT02480166|3493872|B4|||Hepatocellular Carcinoma||Participants|Count of Participants|3|3.0||||||
3646523|NCT02480166|3493873|B3|||Hepatocellular Carcinoma||Participants|Count of Participants|0|0.0||||||
3646524|NCT02480166|3493874|B2|||Hepatocellular Carcinoma||Participants|Count of Participants|3|3.0||||||
3646525|NCT02480166|3493875|B1|||Hepatocellular Carcinoma||Participants|Count of Participants|0|0.0||||||
3646526|NCT02480166|3493872|B4|||Decompensated Cirrhosis|Decompensated cirrhosis is defined as presence/history of variceal bleeding, hepatic encephalopathy, or ascites at baseline.|Participants|Count of Participants|2|2.0||||||
3646527|NCT02480166|3493873|B3|||Decompensated Cirrhosis|Decompensated cirrhosis is defined as presence/history of variceal bleeding, hepatic encephalopathy, or ascites at baseline.|Participants|Count of Participants|0|0.0||||||
3646528|NCT02480166|3493874|B2|||Decompensated Cirrhosis|Decompensated cirrhosis is defined as presence/history of variceal bleeding, hepatic encephalopathy, or ascites at baseline.|Participants|Count of Participants|2|2.0||||||
3646529|NCT02480166|3493875|B1|||Decompensated Cirrhosis|Decompensated cirrhosis is defined as presence/history of variceal bleeding, hepatic encephalopathy, or ascites at baseline.|Participants|Count of Participants|0|0.0||||||
3646530|NCT02480166|3493872|B4|||Baseline Cirrhosis||Participants|Count of Participants|27|27.0||||||
3646531|NCT02480166|3493873|B3|||Baseline Cirrhosis||Participants|Count of Participants|0|0.0||||||
3646532|NCT02480166|3493874|B2|||Baseline Cirrhosis||Participants|Count of Participants|27|27.0||||||
3646533|NCT02480166|3493875|B1|||Baseline Cirrhosis||Participants|Count of Participants|0|0.0||||||
3646534|NCT02480166|3493872|B4|m||HCV Genotype SubType||Participants|Count of Participants|2|2.0||||||
3646535|NCT02480166|3493873|B3|m||HCV Genotype SubType||Participants|Count of Participants|0|0.0||||||
3646536|NCT02480166|3493874|B2|m||HCV Genotype SubType||Participants|Count of Participants|2|2.0||||||
3646537|NCT02480166|3493875|B1|m||HCV Genotype SubType||Participants|Count of Participants|0|0.0||||||
3646538|NCT02480166|3493872|B4|c||HCV Genotype SubType||Participants|Count of Participants|1|1.0||||||
3646539|NCT02480166|3493873|B3|c||HCV Genotype SubType||Participants|Count of Participants|0|0.0||||||
3646540|NCT02480166|3493874|B2|c||HCV Genotype SubType||Participants|Count of Participants|0|0.0||||||
3646541|NCT02480166|3493875|B1|c||HCV Genotype SubType||Participants|Count of Participants|1|1.0||||||
3646542|NCT02480166|3493872|B4|c-l||HCV Genotype SubType||Participants|Count of Participants|25|25.0||||||
3646543|NCT02480166|3493873|B3|c-l||HCV Genotype SubType||Participants|Count of Participants|2|2.0||||||
3646544|NCT02480166|3493874|B2|c-l||HCV Genotype SubType||Participants|Count of Participants|15|15.0||||||
3646545|NCT02480166|3493875|B1|c-l||HCV Genotype SubType||Participants|Count of Participants|8|8.0||||||
3646546|NCT02480166|3493872|B4|a/b||HCV Genotype SubType||Participants|Count of Participants|13|13.0||||||
3646547|NCT02480166|3493873|B3|a/b||HCV Genotype SubType||Participants|Count of Participants|2|2.0||||||
3646548|NCT02480166|3493874|B2|a/b||HCV Genotype SubType||Participants|Count of Participants|9|9.0||||||
3646549|NCT02480166|3493875|B1|a/b||HCV Genotype SubType||Participants|Count of Participants|2|2.0||||||
3646550|NCT02480166|3493872|B4|Chronic Obstructive Pulmonary Disease (COPD)||Comorbidities||Participants|Count of Participants|1|1.0||||||
3646610|NCT02480153|3493890|B1|||Age||years|Mean|51.5|51.5|Standard Deviation|13.6|13.6|||
3646551|NCT02480166|3493873|B3|Chronic Obstructive Pulmonary Disease (COPD)||Comorbidities||Participants|Count of Participants|0|0.0||||||
3646552|NCT02480166|3493874|B2|Chronic Obstructive Pulmonary Disease (COPD)||Comorbidities||Participants|Count of Participants|1|1.0||||||
3646553|NCT02480166|3493875|B1|Chronic Obstructive Pulmonary Disease (COPD)||Comorbidities||Participants|Count of Participants|0|0.0||||||
3646554|NCT02480166|3493872|B4|Coronary Artery Disease (CAD)||Comorbidities||Participants|Count of Participants|1|1.0||||||
3646555|NCT02480166|3493873|B3|Coronary Artery Disease (CAD)||Comorbidities||Participants|Count of Participants|0|0.0||||||
3646556|NCT02480166|3493874|B2|Coronary Artery Disease (CAD)||Comorbidities||Participants|Count of Participants|1|1.0||||||
3646557|NCT02480166|3493875|B1|Coronary Artery Disease (CAD)||Comorbidities||Participants|Count of Participants|0|0.0||||||
3646558|NCT02480166|3493872|B4|Hyperlipidemia||Comorbidities||Participants|Count of Participants|9|9.0||||||
3646559|NCT02480166|3493873|B3|Hyperlipidemia||Comorbidities||Participants|Count of Participants|0|0.0||||||
3646560|NCT02480166|3493874|B2|Hyperlipidemia||Comorbidities||Participants|Count of Participants|6|6.0||||||
3646561|NCT02480166|3493875|B1|Hyperlipidemia||Comorbidities||Participants|Count of Participants|3|3.0||||||
3646562|NCT02480166|3493872|B4|Hypertension||Comorbidities||Participants|Count of Participants|15|15.0||||||
3646563|NCT02480166|3493873|B3|Hypertension||Comorbidities||Participants|Count of Participants|0|0.0||||||
3646564|NCT02480166|3493874|B2|Hypertension||Comorbidities||Participants|Count of Participants|10|10.0||||||
3646565|NCT02480166|3493875|B1|Hypertension||Comorbidities||Participants|Count of Participants|5|5.0||||||
3646566|NCT02480166|3493872|B4|Diabetes||Comorbidities||Participants|Count of Participants|7|7.0||||||
3646567|NCT02480166|3493873|B3|Diabetes||Comorbidities||Participants|Count of Participants|0|0.0||||||
3646568|NCT02480166|3493874|B2|Diabetes||Comorbidities||Participants|Count of Participants|6|6.0||||||
3646569|NCT02480166|3493875|B1|Diabetes||Comorbidities||Participants|Count of Participants|1|1.0||||||
3646570|NCT02480166|3493872|B4|||BMI||kg/m^2|Mean|23.6|23.6|Standard Deviation|3.3|3.3|||
3646571|NCT02480166|3493873|B3|||BMI||kg/m^2|Mean|24.1|24.1|Standard Deviation|3.6|3.6|||
3646572|NCT02480166|3493874|B2|||BMI||kg/m^2|Mean|24.2|24.2|Standard Deviation|2.7|2.7|||
3646573|NCT02480166|3493875|B1|||BMI||kg/m^2|Mean|22.4|22.4|Standard Deviation|4.2|4.2|||
3646574|NCT02480166|3493872|B4|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3646575|NCT02480166|3493873|B3|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3646576|NCT02480166|3493874|B2|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3646577|NCT02480166|3493875|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3646578|NCT02480166|3493872|B4||Other Asian|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3646579|NCT02480166|3493873|B3||Other Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3646580|NCT02480166|3493874|B2||Other Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3646581|NCT02480166|3493875|B1||Other Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3646582|NCT02480166|3493872|B4||Cambodian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3646583|NCT02480166|3493873|B3||Cambodian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3646584|NCT02480166|3493874|B2||Cambodian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3646585|NCT02480166|3493875|B1||Cambodian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3646586|NCT02480166|3493872|B4||Vietnamese|Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
3646587|NCT02480166|3493873|B3||Vietnamese|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3646588|NCT02480166|3493874|B2||Vietnamese|Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3646589|NCT02480166|3493875|B1||Vietnamese|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3646590|NCT02480166|3493872|B4||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3646591|NCT02480166|3493873|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3646592|NCT02480166|3493874|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3646593|NCT02480166|3493875|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3646594|NCT02480166|3493872|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3646595|NCT02480166|3493873|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3646596|NCT02480166|3493874|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3646597|NCT02480166|3493875|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3646598|NCT02480166|3493872|B4|||Age||years|Mean|59|59.0|Standard Deviation|10|10.0|||
3646599|NCT02480166|3493873|B3|||Age||years|Mean|54|54.0|Standard Deviation|10|10.0|||
3646600|NCT02480166|3493874|B2|||Age||years|Mean|60|60.0|Standard Deviation|12|12.0|||
3646601|NCT02480166|3493875|B1|||Age||years|Mean|57|57.0|Standard Deviation|8|8.0|||
3646602|NCT02480153|3493888|B3||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3646603|NCT02480153|3493889|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3646604|NCT02480153|3493890|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3646605|NCT02480153|3493888|B3||Female|Sex: Female, Male||Participants|Count of Participants|470|470.0||||||
3646606|NCT02480153|3493889|B2||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
3646607|NCT02480153|3493890|B1||Female|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
3646608|NCT02480153|3493888|B3|||Age||years|Mean|52.5|52.5|Standard Deviation|13.2|13.2|||
3646609|NCT02480153|3493889|B2|||Age||years|Mean|53.5|53.5|Standard Deviation|12.9|12.9|||
3646611|NCT02480010|3493897|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3646612|NCT02480010|3493898|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3646613|NCT02480010|3493899|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3646614|NCT02480010|3493897|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3646615|NCT02480010|3493898|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3646616|NCT02480010|3493899|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3646617|NCT02480010|3493897|B3|||Age||years|Mean|71.0|71.0|Standard Deviation|6.74|6.74|||
3646618|NCT02480010|3493898|B2|||Age||years|Mean|71.2|71.2|Standard Deviation|6.01|6.01|||
3646619|NCT02480010|3493899|B1|||Age||years|Mean|70.8|70.8|Standard Deviation|7.45|7.45|||
3646620|NCT02479763|3493944|B3|Class III; A patient with severe systemic disease||American Society of Anesthesiologists (ASA) physical status, Categorical|The ASA physical status classification system is a system for assessing the fitness of patients before surgery. There are six classes depending on status of patients. While ASA class I is a normal healthy patient, ASA class VI is a declared brain-dead patient.|participants|Number|44|44.0||||||
3646621|NCT02479763|3493945|B2|Class III; A patient with severe systemic disease||American Society of Anesthesiologists (ASA) physical status, Categorical|The ASA physical status classification system is a system for assessing the fitness of patients before surgery. There are six classes depending on status of patients. While ASA class I is a normal healthy patient, ASA class VI is a declared brain-dead patient.|participants|Number|18|18.0||||||
3646622|NCT02479763|3493946|B1|Class III; A patient with severe systemic disease||American Society of Anesthesiologists (ASA) physical status, Categorical|The ASA physical status classification system is a system for assessing the fitness of patients before surgery. There are six classes depending on status of patients. While ASA class I is a normal healthy patient, ASA class VI is a declared brain-dead patient.|participants|Number|26|26.0||||||
3646623|NCT02479763|3493944|B3|Class II; A patient with mild systemic disease||American Society of Anesthesiologists (ASA) physical status, Categorical|The ASA physical status classification system is a system for assessing the fitness of patients before surgery. There are six classes depending on status of patients. While ASA class I is a normal healthy patient, ASA class VI is a declared brain-dead patient.|participants|Number|44|44.0||||||
3646624|NCT02479763|3493945|B2|Class II; A patient with mild systemic disease||American Society of Anesthesiologists (ASA) physical status, Categorical|The ASA physical status classification system is a system for assessing the fitness of patients before surgery. There are six classes depending on status of patients. While ASA class I is a normal healthy patient, ASA class VI is a declared brain-dead patient.|participants|Number|23|23.0||||||
3646625|NCT02479763|3493946|B1|Class II; A patient with mild systemic disease||American Society of Anesthesiologists (ASA) physical status, Categorical|The ASA physical status classification system is a system for assessing the fitness of patients before surgery. There are six classes depending on status of patients. While ASA class I is a normal healthy patient, ASA class VI is a declared brain-dead patient.|participants|Number|21|21.0||||||
3646626|NCT02479763|3493944|B3|Class I; A normal healthy patient||American Society of Anesthesiologists (ASA) physical status, Categorical|The ASA physical status classification system is a system for assessing the fitness of patients before surgery. There are six classes depending on status of patients. While ASA class I is a normal healthy patient, ASA class VI is a declared brain-dead patient.|participants|Number|12|12.0||||||
3646627|NCT02479763|3493945|B2|Class I; A normal healthy patient||American Society of Anesthesiologists (ASA) physical status, Categorical|The ASA physical status classification system is a system for assessing the fitness of patients before surgery. There are six classes depending on status of patients. While ASA class I is a normal healthy patient, ASA class VI is a declared brain-dead patient.|participants|Number|9|9.0||||||
3646628|NCT02479763|3493946|B1|Class I; A normal healthy patient||American Society of Anesthesiologists (ASA) physical status, Categorical|The ASA physical status classification system is a system for assessing the fitness of patients before surgery. There are six classes depending on status of patients. While ASA class I is a normal healthy patient, ASA class VI is a declared brain-dead patient.|participants|Number|3|3.0||||||
3646629|NCT02479763|3493944|B3|||BMI (kg/m^2), Continuous||kg/m^2|Mean|25.1|25.1|Standard Deviation|4.1|4.1|||
3646630|NCT02479763|3493945|B2|||BMI (kg/m^2), Continuous||kg/m^2|Mean|24.6|24.6|Standard Deviation|3.7|3.7|||
3646631|NCT02479763|3493946|B1|||BMI (kg/m^2), Continuous||kg/m^2|Mean|25.5|25.5|Standard Deviation|4.4|4.4|||
3646632|NCT02479763|3493944|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3646633|NCT02479763|3493945|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3646634|NCT02479763|3493946|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3646635|NCT02479763|3493944|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3646636|NCT02479763|3493945|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3646637|NCT02479763|3493946|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3646638|NCT02479763|3493944|B3|||Age||years|Mean|61.3|61.3|Standard Deviation|11.4|11.4|||
3646639|NCT02479763|3493945|B2|||Age||years|Mean|61.1|61.1|Standard Deviation|11.8|11.8|||
3646640|NCT02479763|3493946|B1|||Age||years|Mean|61.4|61.4|Standard Deviation|11.0|11.0|||
3646641|NCT02479412|3493953|B10||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3646642|NCT02479412|3493954|B9||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3646643|NCT02479412|3493955|B8||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3646644|NCT02479412|3493956|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3646645|NCT02479412|3493957|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3646646|NCT02479412|3493958|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3646647|NCT02479412|3493959|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3646648|NCT02479412|3493960|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3646649|NCT02479412|3493961|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3646650|NCT02479412|3493962|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3646651|NCT02479412|3493953|B10||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3646652|NCT02479412|3493954|B9||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3646653|NCT02479412|3493955|B8||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3646654|NCT02479412|3493956|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3646655|NCT02479412|3493957|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3646656|NCT02479412|3493958|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3646657|NCT02479412|3493959|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3646658|NCT02479412|3493960|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3646659|NCT02479412|3493961|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3646660|NCT02479412|3493962|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3646661|NCT02479412|3493953|B10|Age (years)||Age||Years|Mean|51|51.0|Standard Deviation|12|12.0|||
3646662|NCT02479412|3493954|B9|Age (years)||Age||Years|Mean|46|46.0|Standard Deviation|13|13.0|||
3646663|NCT02479412|3493955|B8|Age (years)||Age||Years|Mean|55|55.0|Standard Deviation|14|14.0|||
3646664|NCT02479412|3493956|B7|Age (years)||Age||Years|Mean|48|48.0|Standard Deviation|14|14.0|||
3646665|NCT02479412|3493957|B6|Age (years)||Age||Years|Mean|55|55.0|Standard Deviation|9|9.0|||
3646666|NCT02479412|3493958|B5|Age (years)||Age||Years|Mean|49|49.0|Standard Deviation|7|7.0|||
3646667|NCT02479412|3493959|B4|Age (years)||Age||Years|Mean|50|50.0|Standard Deviation|17|17.0|||
3646668|NCT02479412|3493960|B3|Age (years)||Age||Years|Mean|56|56.0|Standard Deviation|10|10.0|||
3646669|NCT02479412|3493961|B2|Age (years)||Age||Years|Mean|50|50.0|Standard Deviation|10|10.0|||
3646670|NCT02479412|3493962|B1|Age (years)||Age||Years|Mean|49|49.0|Standard Deviation|14|14.0|||
3646671|NCT02479139|3494041|B7||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3646672|NCT02479139|3494042|B6||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3646673|NCT02479139|3494043|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3646674|NCT02479139|3494044|B4||Male|Sex: Female, Male||Participants|Count of Participants|07|7.0||||||
3646675|NCT02479139|3494045|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3646676|NCT02479139|3494046|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3646677|NCT02479139|3494047|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3646678|NCT02479139|3494041|B7||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3646679|NCT02479139|3494042|B6||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3646680|NCT02479139|3494043|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3646681|NCT02479139|3494044|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3646682|NCT02479139|3494045|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3646683|NCT02479139|3494046|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3646684|NCT02479139|3494047|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3646685|NCT02479139|3494041|B7|>50 years||Age, Customized||participants|Number|6|6.0||||||
3646686|NCT02479139|3494042|B6|>50 years||Age, Customized||participants|Number|1|1.0||||||
3646687|NCT02479139|3494043|B5|>50 years||Age, Customized||participants|Number|1|1.0||||||
3646688|NCT02479139|3494044|B4|>50 years||Age, Customized||participants|Number|0|0.0||||||
3646689|NCT02479139|3494045|B3|>50 years||Age, Customized||participants|Number|1|1.0||||||
3646690|NCT02479139|3494046|B2|>50 years||Age, Customized||participants|Number|0|0.0||||||
3646691|NCT02479139|3494047|B1|>50 years||Age, Customized||participants|Number|3|3.0||||||
3646692|NCT02479139|3494041|B7|36 to 50 years||Age, Customized||participants|Number|37|37.0||||||
3646693|NCT02479139|3494042|B6|36 to 50 years||Age, Customized||participants|Number|7|7.0||||||
3646694|NCT02479139|3494043|B5|36 to 50 years||Age, Customized||participants|Number|8|8.0||||||
3646695|NCT02479139|3494044|B4|36 to 50 years||Age, Customized||participants|Number|5|5.0||||||
3646696|NCT02479139|3494045|B3|36 to 50 years||Age, Customized||participants|Number|8|8.0||||||
3646697|NCT02479139|3494046|B2|36 to 50 years||Age, Customized||participants|Number|4|4.0||||||
3646698|NCT02479139|3494047|B1|36 to 50 years||Age, Customized||participants|Number|5|5.0||||||
3646699|NCT02479139|3494041|B7|18 to 35 years||Age, Customized||participants|Number|102|102.0||||||
3646700|NCT02479139|3494042|B6|18 to 35 years||Age, Customized||participants|Number|17|17.0||||||
3646701|NCT02479139|3494043|B5|18 to 35 years||Age, Customized||participants|Number|13|13.0||||||
3646702|NCT02479139|3494044|B4|18 to 35 years||Age, Customized||participants|Number|16|16.0||||||
3646703|NCT02479139|3494045|B3|18 to 35 years||Age, Customized||participants|Number|19|19.0||||||
3646704|NCT02479139|3494046|B2|18 to 35 years||Age, Customized||participants|Number|18|18.0||||||
3646705|NCT02479139|3494047|B1|18 to 35 years||Age, Customized||participants|Number|19|19.0||||||
3646706|NCT02479139|3494041|B7|||Age||years|Mean|31.79|31.79|Standard Deviation|9.46|9.46|||
3646707|NCT02479139|3494042|B6|||Age||years|Mean|32.64|32.64|Standard Deviation|10.55|10.55|||
3646708|NCT02479139|3494043|B5|||Age||years|Mean|32.36|32.36|Standard Deviation|9.56|9.56|||
3646709|NCT02479139|3494044|B4|||Age||years|Mean|30.48|30.48|Standard Deviation|6.90|6.9|||
3646710|NCT02479139|3494045|B3|||Age||years|Mean|32.50|32.5|Standard Deviation|9.86|9.86|||
3646711|NCT02479139|3494046|B2|||Age||years|Mean|30.18|30.18|Standard Deviation|6.70|6.7|||
3646712|NCT02479139|3494047|B1|||Age||years|Mean|32.15|32.15|Standard Deviation|11.83|11.83|||
3646713|NCT02478671|3494078|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3646714|NCT02478671|3494078|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3646715|NCT02478671|3494078|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3646716|NCT02478671|3494078|B1|||Age||years|Mean|25|25.0|Full Range|||24.0|26.0|
3646717|NCT02478671|3494078|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3646718|NCT02478671|3494078|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3646719|NCT02478671|3494078|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3646720|NCT02478632|3494083|B3|White||Race/Ethnicity, Customized||Participants|Number|84|84.0||||||
3646721|NCT02478632|3494084|B2|White||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
3646722|NCT02478632|3494085|B1|White||Race/Ethnicity, Customized||Participants|Number|44|44.0||||||
3646723|NCT02478632|3494083|B3|Black / African American||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
3646724|NCT02478632|3494084|B2|Black / African American||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3646725|NCT02478632|3494085|B1|Black / African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3646726|NCT02478632|3494083|B3|Asian- Japanese/East Asian (EA)/ South EA heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3646727|NCT02478632|3494084|B2|Asian- Japanese/East Asian (EA)/ South EA heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3646728|NCT02478632|3494085|B1|Asian- Japanese/East Asian (EA)/ South EA heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3646729|NCT02478632|3494083|B3|Asian- Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3646730|NCT02478632|3494084|B2|Asian- Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3646731|NCT02478632|3494085|B1|Asian- Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3646732|NCT02478632|3494083|B3|American Indian/ Alaska native Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3646733|NCT02478632|3494084|B2|American Indian/ Alaska native Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3646734|NCT02478632|3494085|B1|American Indian/ Alaska native Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3646735|NCT02478632|3494083|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3646736|NCT02478632|3494084|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3646737|NCT02478632|3494085|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3646738|NCT02478632|3494083|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3646739|NCT02478632|3494084|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3646740|NCT02478632|3494085|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3646741|NCT02478632|3494083|B3|||Age||Years|Mean|43.7|43.7|Standard Deviation|10.73|10.73|||
3646742|NCT02478632|3494084|B2|||Age||Years|Mean|44.8|44.8|Standard Deviation|10.66|10.66|||
3646743|NCT02478632|3494085|B1|||Age||Years|Mean|42.6|42.6|Standard Deviation|10.80|10.8|||
3646744|NCT02478580|3494100|B3|United States||Region of Enrollment||participants|Number|67|67.0||||||
3646745|NCT02478580|3494101|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
3646746|NCT02478580|3494102|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
3646747|NCT02478580|3494100|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3646748|NCT02478580|3494101|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3646749|NCT02478580|3494102|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3646750|NCT02478580|3494100|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3646751|NCT02478580|3494101|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3646752|NCT02478580|3494102|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3646753|NCT02478580|3494100|B3|||Age||years|Mean|53.7|53.7|Standard Deviation|11.8|11.8|||
3646754|NCT02478580|3494101|B2|||Age||years|Mean|54.7|54.7|Standard Deviation|10.8|10.8|||
3646755|NCT02478580|3494102|B1|||Age||years|Mean|51.7|51.7|Standard Deviation|12.7|12.7|||
3646756|NCT02478372|3494111|B3|||Body Mass Index|Weight (kilogrammes) divided by height squared (meters)|kilogrammes per meter squared|Mean|31|31.0|Standard Deviation|8|8.0|||
3646757|NCT02478372|3494112|B2|||Body Mass Index|Weight (kilogrammes) divided by height squared (meters)|kilogrammes per meter squared|Mean|31|31.0|Standard Deviation|8|8.0|||
3646758|NCT02478372|3494113|B1|||Body Mass Index|Weight (kilogrammes) divided by height squared (meters)|kilogrammes per meter squared|Mean|31|31.0|Standard Deviation|8|8.0|||
3646759|NCT02478372|3494111|B3|United Kingdom||Region of Enrollment||participants|Number|242|242.0||||||
3646760|NCT02478372|3494112|B2|United Kingdom||Region of Enrollment||participants|Number|121|121.0||||||
3646761|NCT02478372|3494113|B1|United Kingdom||Region of Enrollment||participants|Number|121|121.0||||||
3646762|NCT02478372|3494111|B3||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3646763|NCT02478372|3494112|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3646764|NCT02478372|3494113|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3646765|NCT02478372|3494111|B3||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3646766|NCT02478372|3494112|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3646767|NCT02478372|3494113|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3646768|NCT02478372|3494111|B3|||Age||years|Mean|67|67.0|Standard Deviation|7.6|7.6|||
3646769|NCT02478372|3494112|B2|||Age||years|Mean|68|68.0|Standard Deviation|11|11.0|||
3646770|NCT02478372|3494113|B1|||Age||years|Mean|66|66.0|Standard Deviation|10|10.0|||
3646771|NCT02478164|3494136|B1||70|Baseline Karnofsky performance status (KPS)|'Karnofsky Performance Status' (KPS) scale: 100 = Normal; no complaints; no evidence of disease; 90 = Able to carry on normal activity; minor signs or symptoms of disease; 80 = Normal activity with effort; some sign or symptoms of disease; 70 = Cares for self; unable to carry on normal activity or do active work.|Participants|Count of Participants|3|3.0||||||
3646772|NCT02478164|3494136|B1||80|Baseline Karnofsky performance status (KPS)|'Karnofsky Performance Status' (KPS) scale: 100 = Normal; no complaints; no evidence of disease; 90 = Able to carry on normal activity; minor signs or symptoms of disease; 80 = Normal activity with effort; some sign or symptoms of disease; 70 = Cares for self; unable to carry on normal activity or do active work.|Participants|Count of Participants|8|8.0||||||
3646773|NCT02478164|3494136|B1||90|Baseline Karnofsky performance status (KPS)|'Karnofsky Performance Status' (KPS) scale: 100 = Normal; no complaints; no evidence of disease; 90 = Able to carry on normal activity; minor signs or symptoms of disease; 80 = Normal activity with effort; some sign or symptoms of disease; 70 = Cares for self; unable to carry on normal activity or do active work.|Participants|Count of Participants|4|4.0||||||
3646774|NCT02478164|3494136|B1||100|Baseline Karnofsky performance status (KPS)|'Karnofsky Performance Status' (KPS) scale: 100 = Normal; no complaints; no evidence of disease; 90 = Able to carry on normal activity; minor signs or symptoms of disease; 80 = Normal activity with effort; some sign or symptoms of disease; 70 = Cares for self; unable to carry on normal activity or do active work.|Participants|Count of Participants|0|0.0||||||
3646775|NCT02478164|3494136|B1||First relapse|Number of Prior Relapses||Participants|Count of Participants|0|0.0||||||
3646776|NCT02478164|3494136|B1||Fourth relapse|Number of Prior Relapses||Participants|Count of Participants|1|1.0||||||
3646777|NCT02478164|3494136|B1||Third relapse|Number of Prior Relapses||Participants|Count of Participants|4|4.0||||||
3646778|NCT02478164|3494136|B1||Second relapse|Number of Prior Relapses||Participants|Count of Participants|10|10.0||||||
3646779|NCT02478164|3494136|B1|||Current Tumor Diagnosis||Participants|Count of Participants|15|15.0||||||
3646780|NCT02478164|3494136|B1||Glioblastoma Multiforme|Initial Glioma Diagnosis||Participants|Count of Participants|12|12.0||||||
3646781|NCT02478164|3494136|B1||Oligodendroglioma|Initial Glioma Diagnosis||Participants|Count of Participants|1|1.0||||||
3646782|NCT02478164|3494136|B1||Astrocytoma|Initial Glioma Diagnosis||Participants|Count of Participants|1|1.0||||||
3646783|NCT02478164|3494136|B1||Anaplastic Oligodendroglioma|Initial Glioma Diagnosis||Participants|Count of Participants|1|1.0||||||
3646784|NCT02478164|3494136|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646785|NCT02478164|3494136|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3646786|NCT02478164|3494136|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3646787|NCT02478164|3494136|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646788|NCT02478164|3494136|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646789|NCT02478164|3494136|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3646790|NCT02478164|3494136|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646791|NCT02478164|3494136|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3646792|NCT02478164|3494136|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3646793|NCT02478164|3494136|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646794|NCT02478164|3494136|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3646795|NCT02478164|3494136|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3646796|NCT02478164|3494136|B1|||Age||years|Median|62|62.0|Full Range|||28.0|75.0|
3646797|NCT02477709|3494143|B1|Mean Baseline Diastolic BP||BP|Blood Pressure|mmHg|Mean|77|77.0|Full Range|||60.0|92.0|
3646798|NCT02477709|3494143|B1|Mean Baseline Systolic BP||BP|Blood Pressure|mmHg|Mean|122|122.0|Full Range|||100.0|132.0|
3646799|NCT02477709|3494143|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3646800|NCT02477709|3494143|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646801|NCT02477709|3494143|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646802|NCT02477709|3494143|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3646803|NCT02477709|3494143|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3646804|NCT02477709|3494143|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646805|NCT02477709|3494143|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646806|NCT02477709|3494143|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646807|NCT02477709|3494143|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646808|NCT02477709|3494143|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3646809|NCT02477709|3494143|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3646810|NCT02477709|3494143|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3646811|NCT02477709|3494143|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3646812|NCT02477709|3494143|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3646813|NCT02477709|3494143|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3646814|NCT02477709|3494143|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3646815|NCT02477605|3494147|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3646816|NCT02477605|3494148|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3646817|NCT02477605|3494149|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3646818|NCT02477605|3494147|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3646819|NCT02477605|3494148|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3646820|NCT02477605|3494149|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3646821|NCT02477605|3494147|B3|||Age||years|Mean|66.4|66.4|Standard Deviation|11.57|11.57|||
3646822|NCT02477605|3494148|B2|||Age||years|Mean|67.0|67.0|Standard Deviation|11.65|11.65|||
3646823|NCT02477605|3494149|B1|||Age||years|Mean|65.8|65.8|Standard Deviation|11.55|11.55|||
3646824|NCT02477527|3494164|B1|United States||Region of Enrollment|Private practice office located in Tampa, Florida.|participants|Number|27|27.0||||||
3646825|NCT02477527|3494164|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646826|NCT02477527|3494164|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646827|NCT02477527|3494164|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3646828|NCT02477527|3494164|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3646829|NCT02477527|3494164|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646830|NCT02477527|3494164|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646831|NCT02477527|3494164|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3646832|NCT02477527|3494164|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646833|NCT02477527|3494164|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3646834|NCT02477527|3494164|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3646835|NCT02477527|3494164|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3646836|NCT02477527|3494164|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3646837|NCT02477527|3494164|B1|||Age|Age of participants in years at time of enrollment|years|Mean|48.5|48.5|Standard Deviation|5|5.0|||
3646838|NCT02477332|3494172|B7||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3646839|NCT02477332|3494173|B6||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3646840|NCT02477332|3494174|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3646841|NCT02477332|3494175|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3646842|NCT02477332|3494176|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3646843|NCT02477332|3494177|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3646844|NCT02477332|3494178|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3646845|NCT02477332|3494172|B7||Female|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
3646846|NCT02477332|3494173|B6||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3646847|NCT02477332|3494174|B5||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3646848|NCT02477332|3494175|B4||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3646849|NCT02477332|3494176|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3646850|NCT02477332|3494177|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3646851|NCT02477332|3494178|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3646852|NCT02477332|3494172|B7|||Age||years|Mean|43.3|43.3|Standard Deviation|12.49|12.49|||
3646853|NCT02477332|3494173|B6|||Age||years|Mean|42.4|42.4|Standard Deviation|14.54|14.54|||
3646854|NCT02477332|3494174|B5|||Age||years|Mean|45.4|45.4|Standard Deviation|11.22|11.22|||
3646855|NCT02477332|3494175|B4|||Age||years|Mean|41.8|41.8|Standard Deviation|13.06|13.06|||
3646856|NCT02477332|3494176|B3|||Age||years|Mean|42.9|42.9|Standard Deviation|10.51|10.51|||
3646857|NCT02477332|3494177|B2|||Age||years|Mean|44.3|44.3|Standard Deviation|12.38|12.38|||
3646858|NCT02477332|3494178|B1|||Age||years|Mean|44.1|44.1|Standard Deviation|14.36|14.36|||
3646859|NCT02477332|3494172|B7||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3646860|NCT02477332|3494173|B6||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3646861|NCT02477332|3494174|B5||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3646862|NCT02477332|3494175|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3646863|NCT02477332|3494176|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3646864|NCT02477332|3494177|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3646865|NCT02477332|3494178|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3646866|NCT02477332|3494172|B7||Between 18 and 65 years|Age||Participants|Count of Participants|360|360.0||||||
3646867|NCT02477332|3494173|B6||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3646868|NCT02477332|3494174|B5||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3646869|NCT02477332|3494175|B4||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
3646870|NCT02477332|3494176|B3||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
3646871|NCT02477332|3494177|B2||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
3646872|NCT02477332|3494178|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3646873|NCT02477332|3494172|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3646874|NCT02477332|3494173|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3646875|NCT02477332|3494174|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3646876|NCT02477332|3494175|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3646877|NCT02477332|3494176|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3646878|NCT02477332|3494177|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3646879|NCT02477332|3494178|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3646880|NCT02477020|3494257|B3|Not applicable (Male participant)||Female Reproductive Status||participants|Number|132|132.0||||||
3646881|NCT02477020|3494258|B2|Not applicable (Male participant)||Female Reproductive Status||participants|Number|65|65.0||||||
3646882|NCT02477020|3494259|B1|Not applicable (Male participant)||Female Reproductive Status||participants|Number|67|67.0||||||
3646883|NCT02477020|3494257|B3|Female of Childbearing Potential||Female Reproductive Status||participants|Number|14|14.0||||||
3646884|NCT02477020|3494258|B2|Female of Childbearing Potential||Female Reproductive Status||participants|Number|8|8.0||||||
3646885|NCT02477020|3494259|B1|Female of Childbearing Potential||Female Reproductive Status||participants|Number|6|6.0||||||
3646886|NCT02477020|3494257|B3|Surgically Sterile||Female Reproductive Status||participants|Number|7|7.0||||||
3646887|NCT02477020|3494258|B2|Surgically Sterile||Female Reproductive Status||participants|Number|6|6.0||||||
3646888|NCT02477020|3494259|B1|Surgically Sterile||Female Reproductive Status||participants|Number|1|1.0||||||
3646889|NCT02477020|3494257|B3|Postmenopausal||Female Reproductive Status||participants|Number|11|11.0||||||
3646890|NCT02477020|3494258|B2|Postmenopausal||Female Reproductive Status||participants|Number|4|4.0||||||
3646891|NCT02477020|3494259|B1|Postmenopausal||Female Reproductive Status||participants|Number|7|7.0||||||
3646892|NCT02477020|3494257|B3|No||Consume Caffeine||participants|Number|17|17.0||||||
3646893|NCT02477020|3494258|B2|No||Consume Caffeine||participants|Number|9|9.0||||||
3646894|NCT02477020|3494259|B1|No||Consume Caffeine||participants|Number|8|8.0||||||
3646895|NCT02477020|3494257|B3|Yes||Consume Caffeine||participants|Number|147|147.0||||||
3646896|NCT02477020|3494258|B2|Yes||Consume Caffeine||participants|Number|74|74.0||||||
3646897|NCT02477020|3494259|B1|Yes||Consume Caffeine||participants|Number|73|73.0||||||
3646898|NCT02477020|3494257|B3|Is an ex-drinker||Alcohol Classification||participants|Number|64|64.0||||||
3646899|NCT02477020|3494258|B2|Is an ex-drinker||Alcohol Classification||participants|Number|31|31.0||||||
3646900|NCT02477020|3494259|B1|Is an ex-drinker||Alcohol Classification||participants|Number|33|33.0||||||
3646901|NCT02477020|3494257|B3|Is a current drinker||Alcohol Classification||participants|Number|52|52.0||||||
3646902|NCT02477020|3494258|B2|Is a current drinker||Alcohol Classification||participants|Number|31|31.0||||||
3646903|NCT02477020|3494259|B1|Is a current drinker||Alcohol Classification||participants|Number|21|21.0||||||
3646904|NCT02477020|3494257|B3|Has never drunk||Alcohol Classification||participants|Number|48|48.0||||||
3646905|NCT02477020|3494258|B2|Has never drunk||Alcohol Classification||participants|Number|21|21.0||||||
3646906|NCT02477020|3494259|B1|Has never drunk||Alcohol Classification||participants|Number|27|27.0||||||
3646907|NCT02477020|3494257|B3|Is an ex-smoker||Smoking Classification||participants|Number|10|10.0||||||
3646908|NCT02477020|3494258|B2|Is an ex-smoker||Smoking Classification||participants|Number|3|3.0||||||
3646909|NCT02477020|3494259|B1|Is an ex-smoker||Smoking Classification||participants|Number|7|7.0||||||
3646910|NCT02477020|3494257|B3|Is a current smoker||Smoking Classification||participants|Number|140|140.0||||||
3646911|NCT02477020|3494258|B2|Is a current smoker||Smoking Classification||participants|Number|73|73.0||||||
3646912|NCT02477020|3494259|B1|Is a current smoker||Smoking Classification||participants|Number|67|67.0||||||
3646913|NCT02477020|3494257|B3|Has never smoked||Smoking Classification||participants|Number|14|14.0||||||
3646914|NCT02477020|3494258|B2|Has never smoked||Smoking Classification||participants|Number|7|7.0||||||
3646915|NCT02477020|3494259|B1|Has never smoked||Smoking Classification||participants|Number|7|7.0||||||
3646916|NCT02477020|3494257|B3|||Body Mass Index (BMI)|BMI = Weight (kg)/height (m^2)|kg/m^2|Mean|27.50|27.5|Standard Deviation|4.329|4.329|||
3646917|NCT02477020|3494258|B2|||Body Mass Index (BMI)|BMI = Weight (kg)/height (m^2)|kg/m^2|Mean|27.17|27.17|Standard Deviation|4.231|4.231|||
3646918|NCT02477020|3494259|B1|||Body Mass Index (BMI)|BMI = Weight (kg)/height (m^2)|kg/m^2|Mean|27.84|27.84|Standard Deviation|4.427|4.427|||
3646919|NCT02477020|3494257|B3|||Weight||kg|Mean|84.52|84.52|Standard Deviation|16.075|16.075|||
3646920|NCT02477020|3494258|B2|||Weight||kg|Mean|82.46|82.46|Standard Deviation|15.480|15.48|||
3646921|NCT02477020|3494259|B1|||Weight||kg|Mean|86.64|86.64|Standard Deviation|16.490|16.49|||
3646922|NCT02477020|3494257|B3|||Height||cm|Mean|175.2|175.2|Standard Deviation|9.23|9.23|||
3646923|NCT02477020|3494258|B2|||Height||cm|Mean|174.3|174.3|Standard Deviation|9.41|9.41|||
3646924|NCT02477020|3494259|B1|||Height||cm|Mean|176.1|176.1|Standard Deviation|9.02|9.02|||
3646925|NCT02477020|3494257|B3|United States||Region of Enrollment||participants|Number|164|164.0||||||
3646926|NCT02477020|3494258|B2|United States||Region of Enrollment||participants|Number|83|83.0||||||
3646927|NCT02477020|3494259|B1|United States||Region of Enrollment||participants|Number|81|81.0||||||
3646928|NCT02477020|3494257|B3|Multiracial||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3646929|NCT02477020|3494258|B2|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3646930|NCT02477020|3494259|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3646931|NCT02477020|3494257|B3|White||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
3646932|NCT02477020|3494258|B2|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3646933|NCT02477020|3494259|B1|White||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
3646934|NCT02477020|3494257|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|108|108.0||||||
3646935|NCT02477020|3494258|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
3646936|NCT02477020|3494259|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
3646937|NCT02477020|3494257|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3646938|NCT02477020|3494258|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3646939|NCT02477020|3494259|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3646940|NCT02477020|3494257|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3646941|NCT02477020|3494258|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3646942|NCT02477020|3494259|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3646943|NCT02477020|3494257|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3646944|NCT02477020|3494258|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3646945|NCT02477020|3494259|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3646946|NCT02477020|3494257|B3|Non-Hispanic and Latino||Race/Ethnicity, Customized||participants|Number|144|144.0||||||
3646947|NCT02477020|3494258|B2|Non-Hispanic and Latino||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
3646948|NCT02477020|3494259|B1|Non-Hispanic and Latino||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
3646949|NCT02477020|3494257|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3646950|NCT02477020|3494258|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3646951|NCT02477020|3494259|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3646952|NCT02477020|3494257|B3||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3646953|NCT02477020|3494258|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3646954|NCT02477020|3494259|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3646955|NCT02477020|3494257|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3646956|NCT02477020|3494258|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3646957|NCT02477020|3494259|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3646958|NCT02477020|3494257|B3|51 - 65 years||Age, Customized||participants|Number|45|45.0||||||
3646959|NCT02477020|3494258|B2|51 - 65 years||Age, Customized||participants|Number|26|26.0||||||
3646960|NCT02477020|3494259|B1|51 - 65 years||Age, Customized||participants|Number|19|19.0||||||
3646961|NCT02477020|3494257|B3|18 - 50 years||Age, Customized||participants|Number|119|119.0||||||
3646962|NCT02477020|3494258|B2|18 - 50 years||Age, Customized||participants|Number|57|57.0||||||
3646963|NCT02477020|3494259|B1|18 - 50 years||Age, Customized||participants|Number|62|62.0||||||
3646964|NCT02477020|3494257|B3|||Age||years|Mean|41.8|41.8|Standard Deviation|10.38|10.38|||
3646965|NCT02477020|3494258|B2|||Age||years|Mean|42.3|42.3|Standard Deviation|10.36|10.36|||
3646966|NCT02477020|3494259|B1|||Age||years|Mean|41.2|41.2|Standard Deviation|10.44|10.44|||
3646967|NCT02476994|3494288|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646968|NCT02476994|3494289|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646969|NCT02476994|3494290|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646970|NCT02476994|3494288|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646971|NCT02476994|3494289|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646972|NCT02476994|3494290|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646973|NCT02476994|3494288|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3646974|NCT02476994|3494289|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646975|NCT02476994|3494290|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3646976|NCT02476994|3494288|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646977|NCT02476994|3494289|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646978|NCT02476994|3494290|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646979|NCT02476994|3494288|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646980|NCT02476994|3494289|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646981|NCT02476994|3494290|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646982|NCT02476994|3494288|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646983|NCT02476994|3494289|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646984|NCT02476994|3494290|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646985|NCT02476994|3494288|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646986|NCT02476994|3494289|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646987|NCT02476994|3494290|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3646988|NCT02476994|3494288|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3646989|NCT02476994|3494289|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3646990|NCT02476994|3494290|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3646991|NCT02476994|3494288|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3646992|NCT02476994|3494289|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3646993|NCT02476994|3494290|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3646994|NCT02476994|3494288|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3646995|NCT02476994|3494289|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3646996|NCT02476994|3494290|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3646997|NCT02476994|3494288|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3646998|NCT02476994|3494289|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3646999|NCT02476994|3494290|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3647000|NCT02476994|3494288|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3647001|NCT02476994|3494289|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3647002|NCT02476994|3494290|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3647003|NCT02476890|3494317|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3647004|NCT02476890|3494318|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3647005|NCT02476890|3494319|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3647006|NCT02476890|3494320|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3647007|NCT02476890|3494321|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3647008|NCT02476890|3494317|B5||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3647009|NCT02476890|3494318|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3647010|NCT02476890|3494319|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3647011|NCT02476890|3494320|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3647012|NCT02476890|3494321|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3647013|NCT02476890|3494317|B5|||Age||years|Mean|53.3|53.3|Standard Deviation|14.0|14.0|||
3647014|NCT02476890|3494318|B4|||Age||years|Mean|60.6|60.6|Standard Deviation|8.58|8.58|||
3647015|NCT02476890|3494319|B3|||Age||years|Mean|61.6|61.6|Standard Deviation|9.15|9.15|||
3647016|NCT02476890|3494320|B2|||Age||years|Mean|35.7|35.7|Standard Deviation|6.09|6.09|||
3647017|NCT02476890|3494321|B1|||Age||years|Mean|40.0|40.0|Standard Deviation|10.79|10.79|||
3647018|NCT02476617|3494360|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3647019|NCT02476617|3494360|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3647020|NCT02476617|3494360|B1|||Age||years|Mean|44.8|44.8|Standard Deviation|12.61|12.61|||
3647021|NCT02476565|3494364|B3|||Body Mass Index (BMI)||kg/m2|Mean|27.7|27.7|Standard Deviation|8.1|8.1|||
3647022|NCT02476565|3494365|B2|||Body Mass Index (BMI)||kg/m2|Mean|27.3|27.3|Standard Deviation|8.3|8.3|||
3647023|NCT02476565|3494366|B1|||Body Mass Index (BMI)||kg/m2|Mean|28.3|28.3|Standard Deviation|8.0|8.0|||
3647024|NCT02476565|3494364|B3|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3647025|NCT02476565|3494365|B2|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3647026|NCT02476565|3494366|B1|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3647027|NCT02476565|3494364|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3647028|NCT02476565|3494364|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3647029|NCT02476565|3494365|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3647030|NCT02476565|3494366|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3647031|NCT02476565|3494364|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3647032|NCT02476565|3494365|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3647033|NCT02476565|3494366|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3647034|NCT02476565|3494364|B3|||Age||years|Mean|56|56.0|Standard Deviation|14|14.0|||
3647035|NCT02476565|3494365|B2|||Age||years|Mean|58|58.0|Standard Deviation|14|14.0|||
3647036|NCT02476565|3494366|B1|||Age||years|Mean|54|54.0|Standard Deviation|15|15.0|||
3647037|NCT02476422|3494387|B3||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3647038|NCT02476422|3494388|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3647039|NCT02476422|3494389|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3647040|NCT02476422|3494387|B3||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
3647041|NCT02476422|3494388|B2||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3647042|NCT02476422|3494389|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3647043|NCT02476422|3494387|B3|||Age||Years|Mean|24.8|24.8|Standard Deviation|5.66|5.66|||
3647044|NCT02476422|3494388|B2|||Age||Years|Mean|24.7|24.7|Standard Deviation|6.11|6.11|||
3647045|NCT02476422|3494389|B1|||Age||Years|Mean|24.9|24.9|Standard Deviation|5.21|5.21|||
3647046|NCT02476175|3494420|B1|Canada||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3647047|NCT02476175|3494420|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3647048|NCT02476175|3494420|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3647049|NCT02476175|3494420|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3647050|NCT02476175|3494420|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3647051|NCT02476175|3494420|B1||<=18 years|Age||Participants|Count of Participants|35|35.0||||||
3647052|NCT02476032|3494428|B4|||Verbal Rating Scale|"Verbal Rating Scale 0-10 Measurement of Participant's Perception of Pain~0 = No pain 1-3 = Mild Pain 4-6 = Moderate Pain 7-10 = Severe Pain"|units on a scale|Mean|5.5|5.5|Standard Deviation|1.9|1.9|||
3647053|NCT02476032|3494429|B3|||Verbal Rating Scale|"Verbal Rating Scale 0-10 Measurement of Participant's Perception of Pain~0 = No pain 1-3 = Mild Pain 4-6 = Moderate Pain 7-10 = Severe Pain"|units on a scale|Mean|5.8|5.8|Standard Deviation|2.1|2.1|||
3647054|NCT02476032|3494430|B2|||Verbal Rating Scale|"Verbal Rating Scale 0-10 Measurement of Participant's Perception of Pain~0 = No pain 1-3 = Mild Pain 4-6 = Moderate Pain 7-10 = Severe Pain"|units on a scale|Mean|6.5|6.5|Standard Deviation|1.8|1.8|||
3647102|NCT02476032|3494430|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3647055|NCT02476032|3494431|B1|||Verbal Rating Scale|"Verbal Rating Scale 0-10 Measurement of Participant's Perception of Pain~0 = No pain 1-3 = Mild Pain 4-6 = Moderate Pain 7-10 = Severe Pain"|units on a scale|Mean|4.3|4.3|Standard Deviation|1.9|1.9|||
3647056|NCT02476032|3494428|B4|||Schiff Air Scale|"Schiff Air Scale 0-3 Measurement of Dentinal Hypersensitivity~0 Tooth/Patient did not respond to the air stimulus~Tooth/Patient responded to the air stimulus but did not request discontinuation of the stimulus~Tooth/Patient responded to the air stimulus and request discontinuation or moved from the stimulus~Tooth/Patient responded to the air stimulus, considered the stimulus painful, and requested discontinuation of the stimulus"|units on a scale|Mean|1.9|1.9|Standard Deviation|0.83|0.83|||
3647057|NCT02476032|3494429|B3|||Schiff Air Scale|"Schiff Air Scale 0-3 Measurement of Dentinal Hypersensitivity~0 Tooth/Patient did not respond to the air stimulus~Tooth/Patient responded to the air stimulus but did not request discontinuation of the stimulus~Tooth/Patient responded to the air stimulus and request discontinuation or moved from the stimulus~Tooth/Patient responded to the air stimulus, considered the stimulus painful, and requested discontinuation of the stimulus"|units on a scale|Mean|2.0|2.0|Standard Deviation|0.9|0.9|||
3647058|NCT02476032|3494430|B2|||Schiff Air Scale|"Schiff Air Scale 0-3 Measurement of Dentinal Hypersensitivity~0 Tooth/Patient did not respond to the air stimulus~Tooth/Patient responded to the air stimulus but did not request discontinuation of the stimulus~Tooth/Patient responded to the air stimulus and request discontinuation or moved from the stimulus~Tooth/Patient responded to the air stimulus, considered the stimulus painful, and requested discontinuation of the stimulus"|units on a scale|Mean|2.3|2.3|Standard Deviation|0.8|0.8|||
3647059|NCT02476032|3494431|B1|||Schiff Air Scale|"Schiff Air Scale 0-3 Measurement of Dentinal Hypersensitivity~0 Tooth/Patient did not respond to the air stimulus~Tooth/Patient responded to the air stimulus but did not request discontinuation of the stimulus~Tooth/Patient responded to the air stimulus and request discontinuation or moved from the stimulus~Tooth/Patient responded to the air stimulus, considered the stimulus painful, and requested discontinuation of the stimulus"|units on a scale|Mean|1.4|1.4|Standard Deviation|0.8|0.8|||
3647060|NCT02476032|3494428|B4|United States||Region of Enrollment||participants|Number|60|60.0||||||
3647061|NCT02476032|3494429|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3647062|NCT02476032|3494430|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3647063|NCT02476032|3494431|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3647064|NCT02476032|3494428|B4|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3647065|NCT02476032|3494429|B3|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3647066|NCT02476032|3494430|B2|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3647067|NCT02476032|3494431|B1|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3647068|NCT02476032|3494428|B4|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3647069|NCT02476032|3494429|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3647070|NCT02476032|3494430|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3647071|NCT02476032|3494431|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3647072|NCT02476032|3494428|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3647073|NCT02476032|3494429|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3647074|NCT02476032|3494430|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3647075|NCT02476032|3494431|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3647076|NCT02476032|3494428|B4|African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3647077|NCT02476032|3494429|B3|African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3647078|NCT02476032|3494430|B2|African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3647079|NCT02476032|3494431|B1|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3647080|NCT02476032|3494428|B4|White||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
3647081|NCT02476032|3494429|B3|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3647082|NCT02476032|3494430|B2|White||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3647083|NCT02476032|3494431|B1|White||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3647084|NCT02476032|3494428|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3647085|NCT02476032|3494429|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3647086|NCT02476032|3494430|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3647087|NCT02476032|3494431|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3647088|NCT02476032|3494428|B4||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3647089|NCT02476032|3494429|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3647090|NCT02476032|3494430|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3647091|NCT02476032|3494431|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3647092|NCT02476032|3494428|B4|||Age||years|Mean|43.8|43.8|Standard Deviation|14.5|14.5|||
3647093|NCT02476032|3494429|B3|||Age||years|Mean|40.3|40.3|Standard Deviation|15.4|15.4|||
3647094|NCT02476032|3494430|B2|||Age||years|Mean|47.3|47.3|Standard Deviation|12.0|12.0|||
3647095|NCT02476032|3494431|B1|||Age||years|Mean|43.8|43.8|Standard Deviation|16.1|16.1|||
3647096|NCT02476032|3494428|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3647097|NCT02476032|3494429|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3647098|NCT02476032|3494430|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3647099|NCT02476032|3494431|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3647100|NCT02476032|3494428|B4||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3647101|NCT02476032|3494429|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3647103|NCT02476032|3494431|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3647104|NCT02476032|3494428|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3647105|NCT02476032|3494429|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3647106|NCT02476032|3494430|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3647107|NCT02476032|3494431|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3647108|NCT02475980|3494444|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3647109|NCT02475980|3494444|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3647110|NCT02475980|3494444|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3647111|NCT02475980|3494444|B1|||Age||years|Mean|15.85|15.85|Standard Deviation|1.675|1.675|||
3647112|NCT02475980|3494444|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3647113|NCT02475980|3494444|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3647114|NCT02475980|3494444|B1||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
3647115|NCT02475733|3494453|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3647116|NCT02475733|3494454|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3647117|NCT02475733|3494455|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647118|NCT02475733|3494453|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647119|NCT02475733|3494454|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647120|NCT02475733|3494455|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647121|NCT02475733|3494453|B3||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3647122|NCT02475733|3494454|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3647123|NCT02475733|3494455|B1||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3647124|NCT02475733|3494453|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647125|NCT02475733|3494454|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647126|NCT02475733|3494455|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647127|NCT02475733|3494453|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647128|NCT02475733|3494454|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647129|NCT02475733|3494455|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647130|NCT02475733|3494453|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3647131|NCT02475733|3494454|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3647132|NCT02475733|3494455|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3647133|NCT02475733|3494453|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3647134|NCT02475733|3494454|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647135|NCT02475733|3494455|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3647136|NCT02475733|3494453|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647137|NCT02475733|3494454|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647138|NCT02475733|3494455|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647139|NCT02475733|3494453|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3647140|NCT02475733|3494454|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3647141|NCT02475733|3494455|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3647142|NCT02475733|3494453|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3647143|NCT02475733|3494454|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3647144|NCT02475733|3494455|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3647145|NCT02475733|3494453|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3647146|NCT02475733|3494454|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3647147|NCT02475733|3494455|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3647148|NCT02475733|3494453|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3647149|NCT02475733|3494454|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3647150|NCT02475733|3494455|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3647151|NCT02475733|3494453|B3|||Age||years|Mean|10.2|10.2|Standard Deviation|3.71|3.71|||
3647152|NCT02475733|3494454|B2|||Age||years|Mean|9.7|9.7|Standard Deviation|3.97|3.97|||
3647153|NCT02475733|3494455|B1|||Age||years|Mean|10.4|10.4|Standard Deviation|3.64|3.64|||
3647154|NCT02475564|3494511|B3|||Prolactin||ng/mL|Mean|13.13|13.13|Standard Deviation|6.5|6.5|||
3647155|NCT02475564|3494512|B2|||Prolactin||ng/mL|Mean|14.27|14.27|Standard Deviation|6.6|6.6|||
3647156|NCT02475564|3494513|B1|||Prolactin||ng/mL|Mean|12.65|12.65|Standard Deviation|5.9|5.9|||
3647157|NCT02475564|3494511|B3|||CA-125||UI/mL|Median|17.04|17.04|Full Range|||3.3|123.6|
3647158|NCT02475564|3494512|B2|||CA-125||UI/mL|Median|18.7|18.7|Full Range|||5.7|123.6|
3647159|NCT02475564|3494513|B1|||CA-125||UI/mL|Median|14.1|14.1|Full Range|||3.3|49.5|
3647216|NCT02475031|3494550|B1|United States||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3647217|NCT02475031|3494548|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3647160|NCT02475564|3494511|B3|||Baseline pain levels (Visual Analog Scale - VAS) day 1|A 10 cm slide ruler, marked at regular intervals in millimeters, was used for measuring pain intensity on a Visual Analog Scale. The scale had scores ranging continuously from 0 (no pain) to 10 (worst imaginable pain).|units on a scale|Mean|5.6|5.6|Standard Deviation|2.3|2.3|||
3647161|NCT02475564|3494512|B2|||Baseline pain levels (Visual Analog Scale - VAS) day 1|A 10 cm slide ruler, marked at regular intervals in millimeters, was used for measuring pain intensity on a Visual Analog Scale. The scale had scores ranging continuously from 0 (no pain) to 10 (worst imaginable pain).|units on a scale|Mean|5.7|5.7|Standard Deviation|2|2.0|||
3647162|NCT02475564|3494513|B1|||Baseline pain levels (Visual Analog Scale - VAS) day 1|A 10 cm slide ruler, marked at regular intervals in millimeters, was used for measuring pain intensity on a Visual Analog Scale. The scale had scores ranging continuously from 0 (no pain) to 10 (worst imaginable pain).|units on a scale|Mean|5.4|5.4|Standard Deviation|2.6|2.6|||
3647163|NCT02475564|3494511|B3|Brazil||Region of Enrollment||participants|Number|44|44.0||||||
3647164|NCT02475564|3494512|B2|Brazil||Region of Enrollment||participants|Number|22|22.0||||||
3647165|NCT02475564|3494513|B1|Brazil||Region of Enrollment||participants|Number|22|22.0||||||
3647166|NCT02475564|3494511|B3|black||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3647167|NCT02475564|3494512|B2|black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3647168|NCT02475564|3494513|B1|black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3647169|NCT02475564|3494511|B3|white||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3647170|NCT02475564|3494512|B2|white||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3647171|NCT02475564|3494513|B1|white||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3647172|NCT02475564|3494511|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3647173|NCT02475564|3494512|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3647174|NCT02475564|3494513|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3647175|NCT02475564|3494511|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3647176|NCT02475564|3494512|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3647177|NCT02475564|3494513|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3647178|NCT02475564|3494511|B3|||Age||years|Mean|33.9|33.9|Standard Deviation|7.1|7.1|||
3647179|NCT02475564|3494512|B2|||Age||years|Mean|32.4|32.4|Standard Deviation|7|7.0|||
3647180|NCT02475564|3494513|B1|||Age||years|Mean|35.4|35.4|Standard Deviation|7.1|7.1|||
3647181|NCT02475395|3494524|B3|United States||Region of Enrollment||participants|Number|272|272.0||||||
3647182|NCT02475395|3494525|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3647183|NCT02475395|3494526|B1|United States||Region of Enrollment||participants|Number|258|258.0||||||
3647184|NCT02475395|3494524|B3||Male|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
3647185|NCT02475395|3494525|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3647186|NCT02475395|3494526|B1||Male|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
3647187|NCT02475395|3494524|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3647188|NCT02475395|3494525|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3647189|NCT02475395|3494526|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3647190|NCT02475395|3494524|B3|||Age||years|Median|34|34.0|Inter-Quartile Range|||27.0|39.0|
3647191|NCT02475395|3494525|B2|||Age||years|Median|33|33.0|Inter-Quartile Range|||27.5|35.5|
3647192|NCT02475395|3494526|B1|||Age||years|Median|34|34.0|Inter-Quartile Range|||27.0|40.0|
3647193|NCT02475395|3494524|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3647194|NCT02475395|3494525|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3647195|NCT02475395|3494526|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3647196|NCT02475395|3494524|B3||Between 18 and 65 years|Age||Participants|Count of Participants|272|272.0||||||
3647197|NCT02475395|3494525|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3647198|NCT02475395|3494526|B1||Between 18 and 65 years|Age||Participants|Count of Participants|258|258.0||||||
3647199|NCT02475395|3494524|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3647200|NCT02475395|3494525|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3647201|NCT02475395|3494526|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3647202|NCT02475278|3494537|B1|||Body Mass Index (BMI)||kg/m^2|Mean|26.88|26.88|Standard Deviation|4.025|4.025|||
3647203|NCT02475278|3494537|B1|||Weight||kg|Mean|79.08|79.08|Standard Deviation|13.864|13.864|||
3647204|NCT02475278|3494537|B1|||Height||cm|Mean|171.42|171.42|Standard Deviation|9.115|9.115|||
3647205|NCT02475278|3494537|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3647206|NCT02475278|3494537|B1|White||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3647207|NCT02475278|3494537|B1|Black Or African American||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3647208|NCT02475278|3494537|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647209|NCT02475278|3494537|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3647210|NCT02475278|3494537|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3647211|NCT02475278|3494537|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3647212|NCT02475278|3494537|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3647213|NCT02475278|3494537|B1|||Age||years|Mean|30.8|30.8|Standard Deviation|9.28|9.28|||
3647214|NCT02475031|3494548|B3|United States||Region of Enrollment||Participants|Count of Participants|70|70.0||||||
3647215|NCT02475031|3494549|B2|United States||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3647218|NCT02475031|3494549|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3647219|NCT02475031|3494550|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3647220|NCT02475031|3494548|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3647221|NCT02475031|3494549|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3647222|NCT02475031|3494550|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3647223|NCT02475031|3494548|B3|||Age||years|Mean|41.09|41.09|Standard Deviation|11.16|11.16|||
3647224|NCT02475031|3494549|B2|||Age||years|Mean|39.91|39.91|Standard Deviation|10.21|10.21|||
3647225|NCT02475031|3494550|B1|||Age||years|Mean|42.26|42.26|Standard Deviation|12.07|12.07|||
3647226|NCT02475031|3494548|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3647227|NCT02475031|3494549|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3647228|NCT02475031|3494550|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3647229|NCT02475031|3494548|B3||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
3647230|NCT02475031|3494549|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3647231|NCT02475031|3494550|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3647232|NCT02475031|3494548|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3647233|NCT02475031|3494549|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3647234|NCT02475031|3494550|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3647235|NCT02474901|3494565|B3|United States||Region of Enrollment||participants|Number|101|101.0||||||
3647236|NCT02474901|3494566|B2|United States||Region of Enrollment||participants|Number|56|56.0||||||
3647237|NCT02474901|3494567|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
3647238|NCT02474901|3494565|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3647239|NCT02474901|3494566|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3647240|NCT02474901|3494567|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3647241|NCT02474901|3494565|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647242|NCT02474901|3494566|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647243|NCT02474901|3494567|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647244|NCT02474901|3494565|B3||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3647245|NCT02474901|3494566|B2||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3647246|NCT02474901|3494567|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3647247|NCT02474901|3494565|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3647248|NCT02474901|3494566|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3647249|NCT02474901|3494567|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3647250|NCT02474901|3494565|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647251|NCT02474901|3494566|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647252|NCT02474901|3494567|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647253|NCT02474901|3494565|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647254|NCT02474901|3494566|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647255|NCT02474901|3494567|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647256|NCT02474901|3494565|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647257|NCT02474901|3494566|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647258|NCT02474901|3494567|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647259|NCT02474901|3494565|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647260|NCT02474901|3494566|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647261|NCT02474901|3494567|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647262|NCT02474901|3494565|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
3647263|NCT02474901|3494566|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3647264|NCT02474901|3494567|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3647265|NCT02474901|3494565|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3647266|NCT02474901|3494566|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3647267|NCT02474901|3494567|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3647268|NCT02474901|3494565|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3647269|NCT02474901|3494566|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3647270|NCT02474901|3494567|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3647271|NCT02474901|3494565|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3647272|NCT02474901|3494566|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3647273|NCT02474901|3494567|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3647274|NCT02474901|3494565|B3|||Age||years|Median|12|12.0|Inter-Quartile Range|||8.0|18.0|
3647275|NCT02474901|3494566|B2|||Age||years|Median|10|10.0|Inter-Quartile Range|||7.0|14.0|
3647276|NCT02474901|3494567|B1|||Age||years|Median|18|18.0|Inter-Quartile Range|||10.0|23.0|
3647277|NCT02474901|3494565|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3647278|NCT02474901|3494566|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3647279|NCT02474901|3494567|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3647280|NCT02474901|3494565|B3||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
3647281|NCT02474901|3494566|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3647282|NCT02474901|3494567|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3647283|NCT02474901|3494565|B3||<=18 years|Age||Participants|Count of Participants|32|32.0||||||
3647284|NCT02474901|3494566|B2||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
3647285|NCT02474901|3494567|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
3647286|NCT02474589|3494582|B3|United States||Region of Enrollment||participants|Number|449|449.0||||||
3647287|NCT02474589|3494583|B2|United States||Region of Enrollment||participants|Number|90|90.0||||||
3647288|NCT02474589|3494584|B1|United States||Region of Enrollment||participants|Number|359|359.0||||||
3647289|NCT02474589|3494582|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3647290|NCT02474589|3494583|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647291|NCT02474589|3494584|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3647292|NCT02474589|3494582|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647293|NCT02474589|3494583|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647294|NCT02474589|3494584|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647295|NCT02474589|3494582|B3||White|Race (NIH/OMB)||Participants|Count of Participants|311|311.0||||||
3647296|NCT02474589|3494583|B2||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3647297|NCT02474589|3494584|B1||White|Race (NIH/OMB)||Participants|Count of Participants|249|249.0||||||
3647298|NCT02474589|3494582|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|127|127.0||||||
3647299|NCT02474589|3494583|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3647300|NCT02474589|3494584|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
3647301|NCT02474589|3494582|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3647302|NCT02474589|3494583|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3647303|NCT02474589|3494584|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3647304|NCT02474589|3494582|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3647305|NCT02474589|3494583|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3647306|NCT02474589|3494584|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3647307|NCT02474589|3494582|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3647308|NCT02474589|3494583|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647309|NCT02474589|3494584|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3647310|NCT02474589|3494582|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3647311|NCT02474589|3494583|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647312|NCT02474589|3494584|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3647313|NCT02474589|3494582|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|400|400.0||||||
3647314|NCT02474589|3494583|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3647315|NCT02474589|3494584|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|315|315.0||||||
3647316|NCT02474589|3494582|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3647317|NCT02474589|3494583|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3647318|NCT02474589|3494584|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3647319|NCT02474589|3494582|B3||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3647320|NCT02474589|3494583|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3647321|NCT02474589|3494584|B1||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3647322|NCT02474589|3494582|B3||Female|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
3647323|NCT02474589|3494583|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3647324|NCT02474589|3494584|B1||Female|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
3647325|NCT02474589|3494582|B3|||Age||years|Mean|40.7|40.7|Standard Deviation|15.70|15.7|||
3647326|NCT02474589|3494583|B2|||Age||years|Mean|41.9|41.9|Standard Deviation|15.85|15.85|||
3647327|NCT02474589|3494584|B1|||Age||years|Mean|40.4|40.4|Standard Deviation|15.67|15.67|||
3647328|NCT02474498|3494591|B4|||Relative horizontal clinical attachment level (RHCAL)||mm|Mean|5.41|5.41|Standard Deviation|0.77|0.77|||
3647329|NCT02474498|3494592|B3|||Relative horizontal clinical attachment level (RHCAL)||mm|Mean|5.5|5.5|Standard Deviation|0.76|0.76|||
3647330|NCT02474498|3494593|B2|||Relative horizontal clinical attachment level (RHCAL)||mm|Mean|5.64|5.64|Standard Deviation|0.93|0.93|||
3647331|NCT02474498|3494594|B1|||Relative horizontal clinical attachment level (RHCAL)||mm|Mean|5.08|5.08|Standard Deviation|0.49|0.49|||
3647332|NCT02474498|3494591|B4|||Relative vertical clinical attachment level (RVCAL)||mm|Mean|14.36|14.36|Standard Deviation|1.46|1.46|||
3647516|NCT02473718|3494696|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3647333|NCT02474498|3494592|B3|||Relative vertical clinical attachment level (RVCAL)||mm|Mean|14.07|14.07|Standard Deviation|1.44|1.44|||
3647334|NCT02474498|3494593|B2|||Relative vertical clinical attachment level (RVCAL)||mm|Mean|14.64|14.64|Standard Deviation|1.22|1.22|||
3647335|NCT02474498|3494594|B1|||Relative vertical clinical attachment level (RVCAL)||mm|Mean|14.38|14.38|Standard Deviation|1.76|1.76|||
3647336|NCT02474498|3494591|B4|||Relative gingival margin position (RGMP)||mm|Mean|9.60|9.6|Standard Deviation|1.09|1.09|||
3647337|NCT02474498|3494592|B3|||Relative gingival margin position (RGMP)||mm|Mean|9.43|9.43|Standard Deviation|1.34|1.34|||
3647338|NCT02474498|3494593|B2|||Relative gingival margin position (RGMP)||mm|Mean|9.57|9.57|Standard Deviation|1.09|1.09|||
3647339|NCT02474498|3494594|B1|||Relative gingival margin position (RGMP)||mm|Mean|10.15|10.15|Standard Deviation|0.9|0.9|||
3647340|NCT02474498|3494591|B4|||Probing depth (PD)||mm|Mean|4.87|4.87|Standard Deviation|0.64|0.64|||
3647341|NCT02474498|3494592|B3|||Probing depth (PD)||mm|Mean|4.79|4.79|Standard Deviation|0.7|0.7|||
3647342|NCT02474498|3494593|B2|||Probing depth (PD)||mm|Mean|4.93|4.93|Standard Deviation|0.73|0.73|||
3647343|NCT02474498|3494594|B1|||Probing depth (PD)||mm|Mean|4.92|4.92|Standard Deviation|0.49|0.49|||
3647344|NCT02474498|3494591|B4|||Bleeding on probing (BOP)||Percent of surfaces with bleeding|Mean|9.36|9.36|Standard Deviation|2.61|2.61|||
3647345|NCT02474498|3494592|B3|||Bleeding on probing (BOP)||Percent of surfaces with bleeding|Mean|8.69|8.69|Standard Deviation|1.84|1.84|||
3647346|NCT02474498|3494593|B2|||Bleeding on probing (BOP)||Percent of surfaces with bleeding|Mean|9.68|9.68|Standard Deviation|2.76|2.76|||
3647347|NCT02474498|3494594|B1|||Bleeding on probing (BOP)||Percent of surfaces with bleeding|Mean|9.67|9.67|Standard Deviation|3.1|3.1|||
3647348|NCT02474498|3494591|B4|||Plaque index (PI)||Percent of surfaces with plaque|Mean|14.17|14.17|Standard Deviation|3.28|3.28|||
3647349|NCT02474498|3494592|B3|||Plaque index (PI)||Percent of surfaces with plaque|Mean|13.54|13.54|Standard Deviation|2.99|2.99|||
3647350|NCT02474498|3494593|B2|||Plaque index (PI)||Percent of surfaces with plaque|Mean|14.36|14.36|Standard Deviation|3.1|3.1|||
3647351|NCT02474498|3494594|B1|||Plaque index (PI)||Percent of surfaces with plaque|Mean|14.57|14.57|Standard Deviation|3.83|3.83|||
3647352|NCT02474498|3494591|B4||Male|Sex/Gender, Customized||Participants|Count of Participants|14|14.0||||||
3647353|NCT02474498|3494592|B3||Male|Sex/Gender, Customized||Participants|Count of Participants|5|5.0||||||
3647354|NCT02474498|3494593|B2||Male|Sex/Gender, Customized||Participants|Count of Participants|4|4.0||||||
3647355|NCT02474498|3494594|B1||Male|Sex/Gender, Customized||Participants|Count of Participants|5|5.0||||||
3647356|NCT02474498|3494591|B4||Female|Sex/Gender, Customized||Participants|Count of Participants|27|27.0||||||
3647357|NCT02474498|3494592|B3||Female|Sex/Gender, Customized||Participants|Count of Participants|8|8.0||||||
3647358|NCT02474498|3494593|B2||Female|Sex/Gender, Customized||Participants|Count of Participants|10|10.0||||||
3647359|NCT02474498|3494594|B1||Female|Sex/Gender, Customized||Participants|Count of Participants|9|9.0||||||
3647360|NCT02474498|3494591|B4|||Age, Customized||Years|Mean|53.80|53.8|Standard Deviation|5.92|5.92|||
3647361|NCT02474498|3494592|B3|||Age, Customized||Years|Mean|54.57|54.57|Standard Deviation|5.63|5.63|||
3647362|NCT02474498|3494593|B2|||Age, Customized||Years|Mean|53.14|53.14|Standard Deviation|5.92|5.92|||
3647363|NCT02474498|3494594|B1|||Age, Customized||Years|Mean|53.69|53.69|Standard Deviation|6.58|6.58|||
3647364|NCT02474498|3494591|B4||>=65 years|Age, Customized|Potential patients were selected from those referred to the Graduate Clinic of the Piracicaba Dental School. All patients received a complete periodontal examination, including anamnesis, a full-mouth periodontal probing, and radiographic examination.|Participants|Count of Participants|0|0.0||||||
3647365|NCT02474498|3494592|B3||>=65 years|Age, Customized|Potential patients were selected from those referred to the Graduate Clinic of the Piracicaba Dental School. All patients received a complete periodontal examination, including anamnesis, a full-mouth periodontal probing, and radiographic examination.|Participants|Count of Participants|0|0.0||||||
3647366|NCT02474498|3494593|B2||>=65 years|Age, Customized|Potential patients were selected from those referred to the Graduate Clinic of the Piracicaba Dental School. All patients received a complete periodontal examination, including anamnesis, a full-mouth periodontal probing, and radiographic examination.|Participants|Count of Participants|0|0.0||||||
3647367|NCT02474498|3494594|B1||>=65 years|Age, Customized|Potential patients were selected from those referred to the Graduate Clinic of the Piracicaba Dental School. All patients received a complete periodontal examination, including anamnesis, a full-mouth periodontal probing, and radiographic examination.|Participants|Count of Participants|0|0.0||||||
3647368|NCT02474498|3494591|B4||Between 18 and 65 years|Age, Customized|Potential patients were selected from those referred to the Graduate Clinic of the Piracicaba Dental School. All patients received a complete periodontal examination, including anamnesis, a full-mouth periodontal probing, and radiographic examination.|Participants|Count of Participants|41|41.0||||||
3647369|NCT02474498|3494592|B3||Between 18 and 65 years|Age, Customized|Potential patients were selected from those referred to the Graduate Clinic of the Piracicaba Dental School. All patients received a complete periodontal examination, including anamnesis, a full-mouth periodontal probing, and radiographic examination.|Participants|Count of Participants|13|13.0||||||
3647370|NCT02474498|3494593|B2||Between 18 and 65 years|Age, Customized|Potential patients were selected from those referred to the Graduate Clinic of the Piracicaba Dental School. All patients received a complete periodontal examination, including anamnesis, a full-mouth periodontal probing, and radiographic examination.|Participants|Count of Participants|14|14.0||||||
3647371|NCT02474498|3494594|B1||Between 18 and 65 years|Age, Customized|Potential patients were selected from those referred to the Graduate Clinic of the Piracicaba Dental School. All patients received a complete periodontal examination, including anamnesis, a full-mouth periodontal probing, and radiographic examination.|Participants|Count of Participants|14|14.0||||||
3647466|NCT02473718|3494698|B1|||Presence of diastolic heart failure||Participants|Count of Participants|4|4.0||||||
3647467|NCT02473718|3494696|B3|||Presence of systolic heart failure||Participants|Count of Participants|9|9.0||||||
3647372|NCT02474498|3494591|B4||<=18 years|Age, Customized|Potential patients were selected from those referred to the Graduate Clinic of the Piracicaba Dental School. All patients received a complete periodontal examination, including anamnesis, a full-mouth periodontal probing, and radiographic examination.|Participants|Count of Participants|0|0.0||||||
3647373|NCT02474498|3494592|B3||<=18 years|Age, Customized|Potential patients were selected from those referred to the Graduate Clinic of the Piracicaba Dental School. All patients received a complete periodontal examination, including anamnesis, a full-mouth periodontal probing, and radiographic examination.|Participants|Count of Participants|0|0.0||||||
3647374|NCT02474498|3494593|B2||<=18 years|Age, Customized|Potential patients were selected from those referred to the Graduate Clinic of the Piracicaba Dental School. All patients received a complete periodontal examination, including anamnesis, a full-mouth periodontal probing, and radiographic examination.|Participants|Count of Participants|0|0.0||||||
3647375|NCT02474498|3494594|B1||<=18 years|Age, Customized|Potential patients were selected from those referred to the Graduate Clinic of the Piracicaba Dental School. All patients received a complete periodontal examination, including anamnesis, a full-mouth periodontal probing, and radiographic examination.|Participants|Count of Participants|0|0.0||||||
3647376|NCT02474407|3494613|B1|United States||Region of Enrollment||Participants|Count of Participants|78|78.0||||||
3647377|NCT02474407|3494613|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3647378|NCT02474407|3494613|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647379|NCT02474407|3494613|B1||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3647380|NCT02474407|3494613|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3647381|NCT02474407|3494613|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647382|NCT02474407|3494613|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3647383|NCT02474407|3494613|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3647384|NCT02474407|3494613|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647385|NCT02474407|3494613|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3647386|NCT02474407|3494613|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3647387|NCT02474407|3494613|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3647388|NCT02474407|3494613|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3647389|NCT02474407|3494613|B1|||Age||years|Mean|41.4|41.4|Standard Deviation|13.52|13.52|||
3647390|NCT02474407|3494613|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3647391|NCT02474407|3494613|B1||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
3647392|NCT02474407|3494613|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3647393|NCT02474082|3494642|B3||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3647394|NCT02474082|3494643|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3647395|NCT02474082|3494644|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3647396|NCT02474082|3494642|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3647397|NCT02474082|3494643|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3647398|NCT02474082|3494644|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3647399|NCT02474082|3494642|B3|||Age||years|Mean|42.8|42.8|Standard Deviation|13.7|13.7|||
3647400|NCT02474082|3494643|B2|||Age||years|Mean|42.4|42.4|Standard Deviation|13.2|13.2|||
3647401|NCT02474082|3494644|B1|||Age||years|Mean|43.2|43.2|Standard Deviation|14.2|14.2|||
3647402|NCT02474082|3494642|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3647403|NCT02474082|3494643|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3647404|NCT02474082|3494644|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3647405|NCT02474082|3494642|B3||Between 18 and 65 years|Age||Participants|Count of Participants|188|188.0||||||
3647406|NCT02474082|3494643|B2||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
3647407|NCT02474082|3494644|B1||Between 18 and 65 years|Age||Participants|Count of Participants|98|98.0||||||
3647408|NCT02474082|3494642|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3647409|NCT02474082|3494643|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3647410|NCT02474082|3494644|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3647411|NCT02473991|3494679|B1|||Height||Meter|Mean|1.7|1.7|Standard Deviation|.07|0.07|||
3647412|NCT02473991|3494679|B1|||weight||kg|Mean|78|78.0|Standard Deviation|12|12.0|||
3647413|NCT02473991|3494679|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3647414|NCT02473991|3494679|B1||Female|Sex: Female, Male||Participants|Count of Participants|395|395.0||||||
3647415|NCT02473991|3494679|B1|||Age|the age of participant was between 20 years and 30 years|years|Mean|25|25.0|Standard Deviation|3|3.0|||
3647416|NCT02473783|3494685|B3|||serotonin transporter (SERT) binding potential over right basal ganglion|Binding potential (BP) is a ratio of specific to non-displaceable binding (BP = (target region (right basal ganglion) － cerebellum) / cerebellum)|ratio|Mean|0.68|0.68|Standard Deviation|0.86|0.86|||
3647417|NCT02473783|3494686|B2|||serotonin transporter (SERT) binding potential over right basal ganglion|Binding potential (BP) is a ratio of specific to non-displaceable binding (BP = (target region (right basal ganglion) － cerebellum) / cerebellum)|ratio|Mean|0.94|0.94|Standard Deviation|1.32|1.32|||
3647418|NCT02473783|3494687|B1|||serotonin transporter (SERT) binding potential over right basal ganglion|Binding potential (BP) is a ratio of specific to non-displaceable binding (BP = (target region (right basal ganglion) － cerebellum) / cerebellum)|ratio|Mean|0.52|0.52|Standard Deviation|0.28|0.28|||
3647468|NCT02473718|3494697|B2|||Presence of systolic heart failure||Participants|Count of Participants|5|5.0||||||
3647419|NCT02473783|3494685|B3|||Hamilton Depression Rating Scale (HAMD) total score|The questionnaire is designed for adults and is used to rate the severity of their depression by probing mood, feelings of guilt, suicide ideation, insomnia, agitation or retardation, anxiety, weight loss, and somatic symptoms. The patient is rated by a clinician on 17 items scored either on a 3-point or 5-point Likert-type scale. The range of the total score (summed) is from 0 to 52.The higher total score suggests the more severe depression.|units on a scale|Mean|22.90|22.9|Full Range|||18.0|30.0|
3647420|NCT02473783|3494686|B2|||Hamilton Depression Rating Scale (HAMD) total score|The questionnaire is designed for adults and is used to rate the severity of their depression by probing mood, feelings of guilt, suicide ideation, insomnia, agitation or retardation, anxiety, weight loss, and somatic symptoms. The patient is rated by a clinician on 17 items scored either on a 3-point or 5-point Likert-type scale. The range of the total score (summed) is from 0 to 52.The higher total score suggests the more severe depression.|units on a scale|Mean|NA||Full Range|||0.0|0.0|We did not measure HAMD scores of Healthy control group.
3647421|NCT02473783|3494687|B1|||Hamilton Depression Rating Scale (HAMD) total score|The questionnaire is designed for adults and is used to rate the severity of their depression by probing mood, feelings of guilt, suicide ideation, insomnia, agitation or retardation, anxiety, weight loss, and somatic symptoms. The patient is rated by a clinician on 17 items scored either on a 3-point or 5-point Likert-type scale. The range of the total score (summed) is from 0 to 52.The higher total score suggests the more severe depression.|units on a scale|Mean|22.90|22.9|Full Range|||18.0|30.0|
3647422|NCT02473783|3494685|B3|Taiwan||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3647423|NCT02473783|3494686|B2|Taiwan||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3647424|NCT02473783|3494687|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3647425|NCT02473783|3494685|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647426|NCT02473783|3494686|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647427|NCT02473783|3494687|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647428|NCT02473783|3494685|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647429|NCT02473783|3494686|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647430|NCT02473783|3494687|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647431|NCT02473783|3494685|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647432|NCT02473783|3494686|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647433|NCT02473783|3494687|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647434|NCT02473783|3494685|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647435|NCT02473783|3494686|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647436|NCT02473783|3494687|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647437|NCT02473783|3494685|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647438|NCT02473783|3494686|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647439|NCT02473783|3494687|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647440|NCT02473783|3494685|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3647441|NCT02473783|3494686|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3647442|NCT02473783|3494687|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3647443|NCT02473783|3494685|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647444|NCT02473783|3494686|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647445|NCT02473783|3494687|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647446|NCT02473783|3494685|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3647447|NCT02473783|3494686|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3647448|NCT02473783|3494687|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3647449|NCT02473783|3494685|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3647450|NCT02473783|3494686|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3647451|NCT02473783|3494687|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3647452|NCT02473783|3494685|B3|||Age||years|Mean|37.32|37.32|Standard Deviation|12.38|12.38|||
3647453|NCT02473783|3494686|B2|||Age||years|Mean|36.35|36.35|Standard Deviation|12.72|12.72|||
3647454|NCT02473783|3494687|B1|||Age||years|Mean|38.15|38.15|Standard Deviation|12.35|12.35|||
3647455|NCT02473718|3494696|B3|||Presence of end-stage liver disease||Participants|Count of Participants|20|20.0||||||
3647456|NCT02473718|3494697|B2|||Presence of end-stage liver disease||Participants|Count of Participants|7|7.0||||||
3647457|NCT02473718|3494698|B1|||Presence of end-stage liver disease||Participants|Count of Participants|13|13.0||||||
3647458|NCT02473718|3494696|B3|||Presence of active malignancy||Participants|Count of Participants|26|26.0||||||
3647459|NCT02473718|3494697|B2|||Presence of active malignancy||Participants|Count of Participants|10|10.0||||||
3647460|NCT02473718|3494698|B1|||Presence of active malignancy||Participants|Count of Participants|16|16.0||||||
3647461|NCT02473718|3494696|B3|||Presence of chronic kidney disease||Participants|Count of Participants|9|9.0||||||
3647462|NCT02473718|3494697|B2|||Presence of chronic kidney disease||Participants|Count of Participants|3|3.0||||||
3647463|NCT02473718|3494698|B1|||Presence of chronic kidney disease||Participants|Count of Participants|6|6.0||||||
3647464|NCT02473718|3494696|B3|||Presence of diastolic heart failure||Participants|Count of Participants|8|8.0||||||
3647465|NCT02473718|3494697|B2|||Presence of diastolic heart failure||Participants|Count of Participants|4|4.0||||||
3647469|NCT02473718|3494698|B1|||Presence of systolic heart failure||Participants|Count of Participants|4|4.0||||||
3647470|NCT02473718|3494696|B3|||Presence of diabetes mellitus||Participants|Count of Participants|22|22.0||||||
3647471|NCT02473718|3494697|B2|||Presence of diabetes mellitus||Participants|Count of Participants|10|10.0||||||
3647472|NCT02473718|3494698|B1|||Presence of diabetes mellitus||Participants|Count of Participants|12|12.0||||||
3647473|NCT02473718|3494696|B3|||Presence of hyperlipidemia||Participants|Count of Participants|20|20.0||||||
3647474|NCT02473718|3494697|B2|||Presence of hyperlipidemia||Participants|Count of Participants|10|10.0||||||
3647475|NCT02473718|3494698|B1|||Presence of hyperlipidemia||Participants|Count of Participants|10|10.0||||||
3647476|NCT02473718|3494696|B3|||Presence of hypertension||Participants|Count of Participants|33|33.0||||||
3647477|NCT02473718|3494697|B2|||Presence of hypertension||Participants|Count of Participants|19|19.0||||||
3647478|NCT02473718|3494698|B1|||Presence of hypertension||Participants|Count of Participants|14|14.0||||||
3647479|NCT02473718|3494696|B3|||Presence of COPD||Participants|Count of Participants|12|12.0||||||
3647480|NCT02473718|3494697|B2|||Presence of COPD||Participants|Count of Participants|7|7.0||||||
3647481|NCT02473718|3494698|B1|||Presence of COPD||Participants|Count of Participants|5|5.0||||||
3647482|NCT02473718|3494696|B3|||Presence of ARDS||Participants|Count of Participants|51|51.0||||||
3647483|NCT02473718|3494697|B2|||Presence of ARDS||Participants|Count of Participants|25|25.0||||||
3647484|NCT02473718|3494698|B1|||Presence of ARDS||Participants|Count of Participants|26|26.0||||||
3647485|NCT02473718|3494696|B3|||Intubation status||Participants|Count of Participants|59|59.0||||||
3647486|NCT02473718|3494697|B2|||Intubation status||Participants|Count of Participants|31|31.0||||||
3647487|NCT02473718|3494698|B1|||Intubation status||Participants|Count of Participants|28|28.0||||||
3647488|NCT02473718|3494696|B3|||BMI||kg/m^2|Median|32.33|32.33|Inter-Quartile Range|||24.84|37.85|
3647489|NCT02473718|3494697|B2|||BMI||kg/m^2|Median|31.13|31.13|Inter-Quartile Range|||25.98|37.41|
3647490|NCT02473718|3494698|B1|||BMI||kg/m^2|Median|32.62|32.62|Inter-Quartile Range|||24.37|37.85|
3647491|NCT02473718|3494696|B3|||SOFA score|Sequential organ failure assessment (SOFA) score is a severity of illness scoring system. An integer score from 0 to 24 is calculated based on physiologic parameters at the time of admission. Higher scores correspond to more severe disease and an increasing risk of death.|units on a scale|Median|13|13.0|Inter-Quartile Range|||11.0|15.0|
3647492|NCT02473718|3494697|B2|||SOFA score|Sequential organ failure assessment (SOFA) score is a severity of illness scoring system. An integer score from 0 to 24 is calculated based on physiologic parameters at the time of admission. Higher scores correspond to more severe disease and an increasing risk of death.|units on a scale|Median|12|12.0|Inter-Quartile Range|||11.0|15.0|
3647493|NCT02473718|3494698|B1|||SOFA score|Sequential organ failure assessment (SOFA) score is a severity of illness scoring system. An integer score from 0 to 24 is calculated based on physiologic parameters at the time of admission. Higher scores correspond to more severe disease and an increasing risk of death.|units on a scale|Median|13|13.0|Inter-Quartile Range|||11.0|15.0|
3647494|NCT02473718|3494696|B3|||APACHE II score|Acute Physiology And Chronic Health Evaluation II (APACHE II) score is a severity of illness scoring system. An integer score from 0 to 71 is calculated based on physiologic parameters within the first 24 hours of admission to the ICU. Higher scores correspond to more severe disease and an increasing risk of death.|units on a scale|Median|25|25.0|Inter-Quartile Range|||21.5|29.5|
3647495|NCT02473718|3494697|B2|||APACHE II score|Acute Physiology And Chronic Health Evaluation II (APACHE II) score is a severity of illness scoring system. An integer score from 0 to 71 is calculated based on physiologic parameters within the first 24 hours of admission to the ICU. Higher scores correspond to more severe disease and an increasing risk of death.|units on a scale|Median|26|26.0|Inter-Quartile Range|||20.5|30.0|
3647496|NCT02473718|3494698|B1|||APACHE II score|Acute Physiology And Chronic Health Evaluation II (APACHE II) score is a severity of illness scoring system. An integer score from 0 to 71 is calculated based on physiologic parameters within the first 24 hours of admission to the ICU. Higher scores correspond to more severe disease and an increasing risk of death.|units on a scale|Median|25|25.0|Inter-Quartile Range|||22.0|28.5|
3647497|NCT02473718|3494696|B3|United States||Region of Enrollment||Participants|Count of Participants|82|82.0||||||
3647498|NCT02473718|3494697|B2|United States||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3647499|NCT02473718|3494698|B1|United States||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3647500|NCT02473718|3494696|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3647501|NCT02473718|3494696|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3647502|NCT02473718|3494697|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3647503|NCT02473718|3494698|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3647504|NCT02473718|3494696|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3647505|NCT02473718|3494697|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3647506|NCT02473718|3494698|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3647507|NCT02473718|3494696|B3|||Age||years|Median|58|58.0|Inter-Quartile Range|||51.0|66.0|
3647508|NCT02473718|3494697|B2|||Age||years|Median|60|60.0|Inter-Quartile Range|||50.0|68.0|
3647509|NCT02473718|3494698|B1|||Age||years|Median|58|58.0|Inter-Quartile Range|||45.0|65.0|
3647510|NCT02473718|3494696|B3||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3647511|NCT02473718|3494697|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3647512|NCT02473718|3494698|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3647513|NCT02473718|3494696|B3||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
3647514|NCT02473718|3494697|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3647515|NCT02473718|3494698|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3647517|NCT02473718|3494697|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3647518|NCT02473718|3494698|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3647519|NCT02473640|3494719|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3647520|NCT02473640|3494719|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647521|NCT02473640|3494719|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3647522|NCT02473640|3494719|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647523|NCT02473640|3494719|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647524|NCT02473640|3494719|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647525|NCT02473640|3494719|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647526|NCT02473640|3494719|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3647527|NCT02473640|3494719|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3647528|NCT02473640|3494719|B1|||Age||years|Mean|45.1|45.1|Standard Deviation|16.4|16.4|||
3647529|NCT02473510|3494747|B3||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3647530|NCT02473510|3494748|B2||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3647531|NCT02473510|3494749|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3647532|NCT02473510|3494747|B3||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3647533|NCT02473510|3494748|B2||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3647534|NCT02473510|3494749|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3647535|NCT02473510|3494747|B3|||Age||Years|Mean|31.9|31.9|Standard Deviation|9.4|9.4|||
3647536|NCT02473510|3494748|B2|||Age||Years|Mean|32.3|32.3|Standard Deviation|9.5|9.5|||
3647537|NCT02473510|3494749|B1|||Age||Years|Mean|30.2|30.2|Standard Deviation|9.2|9.2|||
3647538|NCT02473471|3494764|B1|||Upper incisor inclination|The angle between the maxillary plane and the axis of the maxillary incisors.|Degree|Mean|119.94|119.94|Standard Deviation|7.53|7.53|||
3647539|NCT02473471|3494764|B1|||Lower anterior facial height(LAFH)||mm|Mean|55.67|55.67|Standard Deviation|1.81|1.81|||
3647540|NCT02473471|3494764|B1|||Maxillary mandibular plane angle|The angle formed between the Maxillary Plane and Mandibular Plane.|Degree|Mean|28.9|28.9|Standard Deviation|4.27|4.27|||
3647541|NCT02473471|3494764|B1|||A point to B Point Angle (ANB)|A point- Nasion-B point (ANB) indicates the skeletal relationship between the maxilla and mandible.|Degree|Mean|5.5|5.5|Standard Deviation|2.69|2.69|||
3647542|NCT02473471|3494764|B1|||Sella-Nasion to B Point Angle (SNB)|Sella-Nasion-B point (SNB) indicates the horizontal position of the mandible relative to the cranial base.|Degree|Mean|76.5|76.5|Standard Deviation|3.85|3.85|||
3647543|NCT02473471|3494764|B1|||Sella-Nasion to A Point Angle (SNA)|Sella-Nasion-A point (SNA) indicates the horizontal position of the maxilla relative to the cranial base.|Degree|Mean|81.9|81.9|Standard Deviation|4.07|4.07|||
3647544|NCT02473471|3494764|B1|Jordan||Region of Enrollment||participants|Number|35|35.0||||||
3647545|NCT02473471|3494764|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3647546|NCT02473471|3494764|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3647547|NCT02473471|3494764|B1|||Age||years|Mean|19.26|19.26|Standard Deviation|2.48|2.48|||
3647548|NCT02473445|3494795|B1||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3647549|NCT02473445|3494795|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3647550|NCT02473445|3494795|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3647551|NCT02473445|3494795|B1||Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3647552|NCT02473445|3494795|B1||Black of African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3647553|NCT02473445|3494795|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3647554|NCT02473445|3494795|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3647555|NCT02473445|3494795|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647556|NCT02473445|3494795|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3647557|NCT02473445|3494795|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647558|NCT02473445|3494795|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3647559|NCT02473445|3494795|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3647560|NCT02473445|3494795|B1|||Age||years|Mean|10.8|10.8|Standard Deviation|4.5|4.5|||
3647561|NCT02473367|3494801|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3647562|NCT02473367|3494801|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3647563|NCT02473367|3494801|B1|||Age||Years|Mean|49.8|49.8|Standard Deviation|9.8|9.8|||
3647564|NCT02472977|3494819|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647565|NCT02472977|3494820|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647566|NCT02472977|3494821|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647567|NCT02472977|3494822|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647568|NCT02472977|3494819|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647569|NCT02472977|3494820|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647570|NCT02472977|3494821|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647571|NCT02472977|3494822|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647572|NCT02472977|3494819|B4||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3647573|NCT02472977|3494820|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3647574|NCT02472977|3494821|B2||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3647575|NCT02472977|3494822|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3647576|NCT02472977|3494819|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3647577|NCT02472977|3494820|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3647578|NCT02472977|3494821|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3647579|NCT02472977|3494822|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647580|NCT02472977|3494819|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647581|NCT02472977|3494820|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647582|NCT02472977|3494821|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647583|NCT02472977|3494822|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647584|NCT02472977|3494819|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647585|NCT02472977|3494820|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647586|NCT02472977|3494821|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647587|NCT02472977|3494822|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647588|NCT02472977|3494819|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647589|NCT02472977|3494820|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647590|NCT02472977|3494821|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647591|NCT02472977|3494822|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647592|NCT02472977|3494819|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3647593|NCT02472977|3494820|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647594|NCT02472977|3494821|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3647595|NCT02472977|3494822|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647596|NCT02472977|3494819|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3647597|NCT02472977|3494820|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3647598|NCT02472977|3494821|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3647599|NCT02472977|3494822|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3647600|NCT02472977|3494819|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3647601|NCT02472977|3494820|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3647602|NCT02472977|3494821|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3647603|NCT02472977|3494822|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647604|NCT02472977|3494819|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3647605|NCT02472977|3494820|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3647606|NCT02472977|3494821|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3647607|NCT02472977|3494822|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3647608|NCT02472977|3494819|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3647609|NCT02472977|3494820|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3647610|NCT02472977|3494821|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3647611|NCT02472977|3494822|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3647612|NCT02472977|3494819|B4|||Age||years|Mean|61.7|61.7|Standard Deviation|8.94|8.94|||
3647613|NCT02472977|3494820|B3|||Age||years|Mean|60.1|60.1|Standard Deviation|14.13|14.13|||
3647614|NCT02472977|3494821|B2|||Age||years|Mean|61.9|61.9|Standard Deviation|7.93|7.93|||
3647615|NCT02472977|3494822|B1|||Age||years|Mean|63.3|63.3|Standard Deviation|5.05|5.05|||
3647616|NCT02472964|3494847|B3|Ukraine||Region of Enrollment||participants|Number|52|52.0||||||
3647617|NCT02472964|3494848|B2|Ukraine||Region of Enrollment||participants|Number|24|24.0||||||
3647618|NCT02472964|3494849|B1|Ukraine||Region of Enrollment||participants|Number|28|28.0||||||
3647619|NCT02472964|3494847|B3|Thailand||Region of Enrollment||participants|Number|39|39.0||||||
3647620|NCT02472964|3494848|B2|Thailand||Region of Enrollment||participants|Number|16|16.0||||||
3647621|NCT02472964|3494849|B1|Thailand||Region of Enrollment||participants|Number|23|23.0||||||
3647622|NCT02472964|3494847|B3|South Africa||Region of Enrollment||participants|Number|11|11.0||||||
3647623|NCT02472964|3494848|B2|South Africa||Region of Enrollment||participants|Number|8|8.0||||||
3647624|NCT02472964|3494849|B1|South Africa||Region of Enrollment||participants|Number|3|3.0||||||
3647625|NCT02472964|3494847|B3|Slovakia||Region of Enrollment||participants|Number|3|3.0||||||
3647626|NCT02472964|3494848|B2|Slovakia||Region of Enrollment||participants|Number|2|2.0||||||
3647627|NCT02472964|3494849|B1|Slovakia||Region of Enrollment||participants|Number|1|1.0||||||
3647628|NCT02472964|3494847|B3|Serbia||Region of Enrollment||participants|Number|5|5.0||||||
3647629|NCT02472964|3494848|B2|Serbia||Region of Enrollment||participants|Number|3|3.0||||||
3647630|NCT02472964|3494849|B1|Serbia||Region of Enrollment||participants|Number|2|2.0||||||
3647631|NCT02472964|3494847|B3|Russia||Region of Enrollment||participants|Number|144|144.0||||||
3647632|NCT02472964|3494848|B2|Russia||Region of Enrollment||participants|Number|71|71.0||||||
3647633|NCT02472964|3494849|B1|Russia||Region of Enrollment||participants|Number|73|73.0||||||
3647634|NCT02472964|3494847|B3|Romania||Region of Enrollment||participants|Number|8|8.0||||||
3647635|NCT02472964|3494848|B2|Romania||Region of Enrollment||participants|Number|3|3.0||||||
3647636|NCT02472964|3494849|B1|Romania||Region of Enrollment||participants|Number|5|5.0||||||
3647637|NCT02472964|3494847|B3|Poland||Region of Enrollment||participants|Number|19|19.0||||||
3647638|NCT02472964|3494848|B2|Poland||Region of Enrollment||participants|Number|13|13.0||||||
3647639|NCT02472964|3494849|B1|Poland||Region of Enrollment||participants|Number|6|6.0||||||
3647640|NCT02472964|3494847|B3|Philippines||Region of Enrollment||participants|Number|48|48.0||||||
3647641|NCT02472964|3494848|B2|Philippines||Region of Enrollment||participants|Number|30|30.0||||||
3647642|NCT02472964|3494849|B1|Philippines||Region of Enrollment||participants|Number|18|18.0||||||
3647643|NCT02472964|3494847|B3|Latvia||Region of Enrollment||participants|Number|6|6.0||||||
3647644|NCT02472964|3494848|B2|Latvia||Region of Enrollment||participants|Number|4|4.0||||||
3647645|NCT02472964|3494849|B1|Latvia||Region of Enrollment||participants|Number|2|2.0||||||
3647646|NCT02472964|3494847|B3|India||Region of Enrollment||participants|Number|55|55.0||||||
3647647|NCT02472964|3494848|B2|India||Region of Enrollment||participants|Number|24|24.0||||||
3647648|NCT02472964|3494849|B1|India||Region of Enrollment||participants|Number|31|31.0||||||
3647649|NCT02472964|3494847|B3|Hungary||Region of Enrollment||participants|Number|13|13.0||||||
3647650|NCT02472964|3494848|B2|Hungary||Region of Enrollment||participants|Number|5|5.0||||||
3647651|NCT02472964|3494849|B1|Hungary||Region of Enrollment||participants|Number|8|8.0||||||
3647652|NCT02472964|3494847|B3|Georgia||Region of Enrollment||participants|Number|49|49.0||||||
3647653|NCT02472964|3494848|B2|Georgia||Region of Enrollment||participants|Number|26|26.0||||||
3647654|NCT02472964|3494849|B1|Georgia||Region of Enrollment||participants|Number|23|23.0||||||
3647655|NCT02472964|3494847|B3|Czechia||Region of Enrollment||participants|Number|1|1.0||||||
3647656|NCT02472964|3494848|B2|Czechia||Region of Enrollment||participants|Number|0|0.0||||||
3647657|NCT02472964|3494849|B1|Czechia||Region of Enrollment||participants|Number|1|1.0||||||
3647658|NCT02472964|3494847|B3|Chile||Region of Enrollment||participants|Number|5|5.0||||||
3647659|NCT02472964|3494848|B2|Chile||Region of Enrollment||participants|Number|1|1.0||||||
3647660|NCT02472964|3494849|B1|Chile||Region of Enrollment||participants|Number|4|4.0||||||
3647661|NCT02472964|3494847|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647662|NCT02472964|3494848|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647663|NCT02472964|3494849|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647664|NCT02472964|3494847|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647665|NCT02472964|3494848|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647666|NCT02472964|3494849|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647667|NCT02472964|3494847|B3||White|Race (NIH/OMB)||Participants|Count of Participants|313|313.0||||||
3647668|NCT02472964|3494848|B2||White|Race (NIH/OMB)||Participants|Count of Participants|159|159.0||||||
3647669|NCT02472964|3494849|B1||White|Race (NIH/OMB)||Participants|Count of Participants|154|154.0||||||
3647670|NCT02472964|3494847|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3647671|NCT02472964|3494848|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3647672|NCT02472964|3494849|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3647673|NCT02472964|3494847|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647674|NCT02472964|3494848|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647675|NCT02472964|3494849|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647676|NCT02472964|3494847|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|142|142.0||||||
3647677|NCT02472964|3494848|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3647678|NCT02472964|3494849|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3647679|NCT02472964|3494847|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647680|NCT02472964|3494848|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647681|NCT02472964|3494849|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647682|NCT02472964|3494847|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3647683|NCT02472964|3494848|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3647684|NCT02472964|3494849|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3647685|NCT02472964|3494847|B3||Female|Sex: Female, Male||Participants|Count of Participants|458|458.0||||||
3647686|NCT02472964|3494848|B2||Female|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
3647687|NCT02472964|3494849|B1||Female|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
3647688|NCT02472964|3494847|B3|>/= 50years of age||Age, Customized||Participants|Count of Participants|298|298.0||||||
3647689|NCT02472964|3494848|B2|>/= 50years of age||Age, Customized||Participants|Count of Participants|156|156.0||||||
3647690|NCT02472964|3494849|B1|>/= 50years of age||Age, Customized||Participants|Count of Participants|142|142.0||||||
3647691|NCT02472964|3494847|B3|< 50years of age||Age, Customized||Participants|Count of Participants|160|160.0||||||
3647692|NCT02472964|3494848|B2|< 50years of age||Age, Customized||Participants|Count of Participants|74|74.0||||||
3647693|NCT02472964|3494849|B1|< 50years of age||Age, Customized||Participants|Count of Participants|86|86.0||||||
3647694|NCT02472886|3494856|B4|Yes||Cirrhosis Status||Participants|Count of Participants|10|10.0||||||
3647695|NCT02472886|3494857|B3|Yes||Cirrhosis Status||Participants|Count of Participants|10|10.0||||||
3647696|NCT02472886|3494858|B2|Yes||Cirrhosis Status||Participants|Count of Participants|0|0.0||||||
3647697|NCT02472886|3494859|B1|Yes||Cirrhosis Status||Participants|Count of Participants|0|0.0||||||
3647698|NCT02472886|3494856|B4|No||Cirrhosis Status||Participants|Count of Participants|143|143.0||||||
3647699|NCT02472886|3494857|B3|No||Cirrhosis Status||Participants|Count of Participants|17|17.0||||||
3647700|NCT02472886|3494858|B2|No||Cirrhosis Status||Participants|Count of Participants|59|59.0||||||
3647701|NCT02472886|3494859|B1|No||Cirrhosis Status||Participants|Count of Participants|67|67.0||||||
3647702|NCT02472886|3494856|B4|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|93|93.0||||||
3647703|NCT02472886|3494857|B3|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|19|19.0||||||
3647704|NCT02472886|3494858|B2|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|36|36.0||||||
3647705|NCT02472886|3494859|B1|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|38|38.0||||||
3647706|NCT02472886|3494856|B4|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|60|60.0||||||
3647707|NCT02472886|3494857|B3|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|8|8.0||||||
3647708|NCT02472886|3494858|B2|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|23|23.0||||||
3647709|NCT02472886|3494859|B1|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|29|29.0||||||
3647710|NCT02472886|3494856|B4|||HCV RNA||log10 IU/mL|Mean|6.0|6.0|Standard Deviation|0.66|0.66|||
3647711|NCT02472886|3494857|B3|||HCV RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.67|0.67|||
3647712|NCT02472886|3494858|B2|||HCV RNA||log10 IU/mL|Mean|6.1|6.1|Standard Deviation|0.54|0.54|||
3647713|NCT02472886|3494859|B1|||HCV RNA||log10 IU/mL|Mean|5.9|5.9|Standard Deviation|0.72|0.72|||
3647714|NCT02472886|3494856|B4|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|20|20.0||||||
3647715|NCT02472886|3494857|B3|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|2|2.0||||||
3647716|NCT02472886|3494858|B2|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|9|9.0||||||
3647717|NCT02472886|3494859|B1|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|9|9.0||||||
3647718|NCT02472886|3494856|B4|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|100|100.0||||||
3647719|NCT02472886|3494857|B3|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|18|18.0||||||
3647720|NCT02472886|3494858|B2|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|41|41.0||||||
3647721|NCT02472886|3494859|B1|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|41|41.0||||||
3647722|NCT02472886|3494856|B4|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|33|33.0||||||
3647723|NCT02472886|3494857|B3|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|7|7.0||||||
3647724|NCT02472886|3494858|B2|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|9|9.0||||||
3647725|NCT02472886|3494859|B1|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|17|17.0||||||
3647726|NCT02472886|3494856|B4|Estonia||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3647727|NCT02472886|3494857|B3|Estonia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3647728|NCT02472886|3494858|B2|Estonia||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3647729|NCT02472886|3494859|B1|Estonia||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3647730|NCT02472886|3494856|B4|Russian Federation||Region of Enrollment||Participants|Count of Participants|135|135.0||||||
3647731|NCT02472886|3494857|B3|Russian Federation||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3647732|NCT02472886|3494858|B2|Russian Federation||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
3647733|NCT02472886|3494859|B1|Russian Federation||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
3647734|NCT02472886|3494856|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|153|153.0||||||
3647735|NCT02472886|3494857|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3647736|NCT02472886|3494858|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|59|59.0||||||
3647737|NCT02472886|3494859|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|67|67.0||||||
3647738|NCT02472886|3494856|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3647739|NCT02472886|3494857|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3647740|NCT02472886|3494858|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3647741|NCT02472886|3494859|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3647742|NCT02472886|3494856|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|152|152.0||||||
3647743|NCT02472886|3494857|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3647744|NCT02472886|3494858|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|59|59.0||||||
3647745|NCT02472886|3494859|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|66|66.0||||||
3647746|NCT02472886|3494856|B4||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3647747|NCT02472886|3494857|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3647748|NCT02472886|3494858|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3647749|NCT02472886|3494859|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3647750|NCT02472886|3494856|B4||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3647751|NCT02472886|3494857|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3647752|NCT02472886|3494858|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3647753|NCT02472886|3494859|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3647754|NCT02472886|3494856|B4|||Age||years|Mean|40|40.0|Standard Deviation|11.1|11.1|||
3647755|NCT02472886|3494857|B3|||Age||years|Mean|47|47.0|Standard Deviation|11.2|11.2|||
3647756|NCT02472886|3494858|B2|||Age||years|Mean|34|34.0|Standard Deviation|5.5|5.5|||
3647757|NCT02472886|3494859|B1|||Age||years|Mean|42|42.0|Standard Deviation|12.6|12.6|||
3647758|NCT02472847|3494887|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3647759|NCT02472847|3494888|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3647760|NCT02472847|3494889|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647761|NCT02472847|3494887|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3647762|NCT02472847|3494888|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3647763|NCT02472847|3494889|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3647764|NCT02472847|3494887|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3647765|NCT02472847|3494888|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3647766|NCT02472847|3494889|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3647767|NCT02472847|3494887|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3647768|NCT02472847|3494888|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3647769|NCT02472847|3494889|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3647770|NCT02472847|3494887|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3647771|NCT02472847|3494888|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647772|NCT02472847|3494889|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3647773|NCT02472847|3494887|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3647774|NCT02472847|3494888|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3647775|NCT02472847|3494889|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3647776|NCT02472847|3494887|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3647777|NCT02472847|3494888|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3647778|NCT02472847|3494889|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647779|NCT02472847|3494887|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647780|NCT02472847|3494888|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647781|NCT02472847|3494889|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647782|NCT02472847|3494887|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3647783|NCT02472847|3494888|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3647784|NCT02472847|3494889|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3647785|NCT02472847|3494887|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3647786|NCT02472847|3494888|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3647787|NCT02472847|3494889|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3647788|NCT02472847|3494887|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3647789|NCT02472847|3494888|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3647790|NCT02472847|3494889|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3647791|NCT02472847|3494887|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3647792|NCT02472847|3494888|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3647793|NCT02472847|3494889|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3647794|NCT02472847|3494887|B3|21-45 Years||Age, Customized|Between 21-45 years|participants|Number|50|50.0||||||
3647795|NCT02472847|3494888|B2|21-45 Years||Age, Customized|Between 21-45 years|participants|Number|26|26.0||||||
3647796|NCT02472847|3494889|B1|21-45 Years||Age, Customized|Between 21-45 years|participants|Number|24|24.0||||||
3647797|NCT02472756|3494896|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3647798|NCT02472756|3494896|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3647799|NCT02472756|3494896|B1|||Age||years|Median|55|55.0|Full Range|||40.0|78.0|
3647800|NCT02472522|3494919|B3|||Duration of surgery||Minutes|Mean|50.06|50.06|Standard Deviation|4.14|4.14|||
3647801|NCT02472522|3494920|B2|||Duration of surgery||Minutes|Mean|50.00|50.0|Standard Deviation|4.35|4.35|||
3647802|NCT02472522|3494921|B1|||Duration of surgery||Minutes|Mean|50.12|50.12|Standard Deviation|3.97|3.97|||
3647803|NCT02472522|3494919|B3|||Height of the patients||Centimeters|Mean|158.13|158.13|Standard Deviation|11.57|11.57|||
3647804|NCT02472522|3494920|B2|||Height of the patients||Centimeters|Mean|157.36|157.36|Standard Deviation|15.77|15.77|||
3647805|NCT02472522|3494921|B1|||Height of the patients||Centimeters|Mean|158.90|158.9|Standard Deviation|4.53|4.53|||
3647806|NCT02472522|3494919|B3|||Weight||Kilograms|Mean|64.88|64.88|Standard Deviation|6.78|6.78|||
3647807|NCT02472522|3494920|B2|||Weight||Kilograms|Mean|65.68|65.68|Standard Deviation|7.49|7.49|||
3647808|NCT02472522|3494921|B1|||Weight||Kilograms|Mean|64.08|64.08|Standard Deviation|5.96|5.96|||
3647809|NCT02472522|3494919|B3|India||Region of Enrollment||participants|Number|100|100.0||||||
3647810|NCT02472522|3494920|B2|India||Region of Enrollment||participants|Number|50|50.0||||||
3647811|NCT02472522|3494921|B1|India||Region of Enrollment||participants|Number|50|50.0||||||
3647812|NCT02472522|3494919|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3647813|NCT02472522|3494920|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3647814|NCT02472522|3494921|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3647815|NCT02472522|3494919|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3647816|NCT02472522|3494920|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3647817|NCT02472522|3494921|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3647818|NCT02472522|3494919|B3|||Age||Years|Mean|28.34|28.34|Standard Deviation|4.57|4.57|||
3647819|NCT02472522|3494920|B2|||Age||Years|Mean|28.66|28.66|Standard Deviation|4.53|4.53|||
3647820|NCT02472522|3494921|B1|||Age||Years|Mean|28.02|28.02|Standard Deviation|4.64|4.64|||
3647821|NCT02472405|3494952|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3647822|NCT02472405|3494952|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3647823|NCT02472405|3494952|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3647824|NCT02472405|3494952|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3647825|NCT02472405|3494952|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3647826|NCT02472366|3494958|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3647827|NCT02472366|3494959|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3647828|NCT02472366|3494960|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3647829|NCT02472366|3494958|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3647830|NCT02472366|3494959|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3647831|NCT02472366|3494960|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3647832|NCT02472366|3494958|B3|||Age||years|Mean|63.04|63.04|Standard Deviation|10.398|10.398|||
3647833|NCT02472366|3494959|B2|||Age||years|Mean|60.87|60.87|Standard Deviation|11.006|11.006|||
3647834|NCT02472366|3494960|B1|||Age||years|Mean|66.65|66.65|Standard Deviation|9.014|9.014|||
3647835|NCT02471755|3494975|B3|||E2||pmol/l|Median|65.77|65.77|Inter-Quartile Range|||38.57|103.39|
3647836|NCT02471755|3494976|B2|||E2||pmol/l|Median|51.38|51.38|Inter-Quartile Range|||37.56|92.18|
3647837|NCT02471755|3494977|B1|||E2||pmol/l|Median|73.73|73.73|Inter-Quartile Range|||42.03|110.54|
3647838|NCT02471755|3494975|B3|||FSH/LH||ratio|Median|1.42|1.42|Inter-Quartile Range|||0.99|1.67|
3647839|NCT02471755|3494976|B2|||FSH/LH||ratio|Median|1.44|1.44|Inter-Quartile Range|||1.11|1.69|
3647840|NCT02471755|3494977|B1|||FSH/LH||ratio|Median|1.38|1.38|Inter-Quartile Range|||0.9|1.67|
3647841|NCT02471755|3494975|B3|||LH||mIU/ml|Median|32.89|32.89|Inter-Quartile Range|||21.34|38.75|
3647842|NCT02471755|3494976|B2|||LH||mIU/ml|Median|32.89|32.89|Inter-Quartile Range|||22.26|37.5|
3647843|NCT02471755|3494977|B1|||LH||mIU/ml|Median|33.08|33.08|Inter-Quartile Range|||20.92|43.21|
3647844|NCT02471755|3494975|B3|||FSH||mIU/ml|Median|44.12|44.12|Inter-Quartile Range|||35.72|49.28|
3647845|NCT02471755|3494976|B2|||FSH||mIU/ml|Median|44.47|44.47|Inter-Quartile Range|||36.13|48.59|
3647846|NCT02471755|3494977|B1|||FSH||mIU/ml|Median|42.85|42.85|Inter-Quartile Range|||31.16|51.96|
3647847|NCT02471755|3494975|B3|||Menopause Rating Scale|The MRS is composed of 11 items to assess menopausal symptoms, and each item is graded from 0 (no symptoms) to 4 (very severe symptoms). As a result, the scores of the MRS range from 0 to 44, with higher scores indicating more severe symptoms.|Scores on a scale|Median|16.00|16.0|Inter-Quartile Range|||11.5|19.5|
3647848|NCT02471755|3494976|B2|||Menopause Rating Scale|The MRS is composed of 11 items to assess menopausal symptoms, and each item is graded from 0 (no symptoms) to 4 (very severe symptoms). As a result, the scores of the MRS range from 0 to 44, with higher scores indicating more severe symptoms.|Scores on a scale|Median|15.00|15.0|Inter-Quartile Range|||11.0|19.5|
3647849|NCT02471755|3494977|B1|||Menopause Rating Scale|The MRS is composed of 11 items to assess menopausal symptoms, and each item is graded from 0 (no symptoms) to 4 (very severe symptoms). As a result, the scores of the MRS range from 0 to 44, with higher scores indicating more severe symptoms.|Scores on a scale|Median|17.50|17.5|Inter-Quartile Range|||12.25|19.75|
3647850|NCT02471755|3494975|B3|||24 h Hot Flash Score|Hot flash scores are calculated as (hot flash frequency x severity)/7, with severity scores ranging from 1=mild 2=moderate to 3=severe.|Scores on a scale|Median|7.71|7.71|Inter-Quartile Range|||5.15|12.22|
3647851|NCT02471755|3494976|B2|||24 h Hot Flash Score|Hot flash scores are calculated as (hot flash frequency x severity)/7, with severity scores ranging from 1=mild 2=moderate to 3=severe.|Scores on a scale|Median|7.26|7.26|Inter-Quartile Range|||5.31|11.93|
3647852|NCT02471755|3494977|B1|||24 h Hot Flash Score|Hot flash scores are calculated as (hot flash frequency x severity)/7, with severity scores ranging from 1=mild 2=moderate to 3=severe.|Scores on a scale|Median|8.07|8.07|Inter-Quartile Range|||4.78|12.5|
3647853|NCT02471755|3494975|B3|No||Ever Received Drug Therapy||participants|Number|83|83.0||||||
3647854|NCT02471755|3494976|B2|No||Ever Received Drug Therapy||participants|Number|44|44.0||||||
3647855|NCT02471755|3494977|B1|No||Ever Received Drug Therapy||participants|Number|39|39.0||||||
3647856|NCT02471755|3494975|B3|Yes||Ever Received Drug Therapy||participants|Number|6|6.0||||||
3647857|NCT02471755|3494976|B2|Yes||Ever Received Drug Therapy||participants|Number|1|1.0||||||
3647858|NCT02471755|3494977|B1|Yes||Ever Received Drug Therapy||participants|Number|5|5.0||||||
3647859|NCT02471755|3494975|B3|Late stage||Menopausal Stage|According to different cycle lengths, MT can be divided into two stages: early MT (>7 days different from normal) and late MT (≥60 days, 2 skipped cycles, 1 interval of amenorrhea).|participants|Number|48|48.0||||||
3647860|NCT02471755|3494976|B2|Late stage||Menopausal Stage|According to different cycle lengths, MT can be divided into two stages: early MT (>7 days different from normal) and late MT (≥60 days, 2 skipped cycles, 1 interval of amenorrhea).|participants|Number|21|21.0||||||
3647861|NCT02471755|3494977|B1|Late stage||Menopausal Stage|According to different cycle lengths, MT can be divided into two stages: early MT (>7 days different from normal) and late MT (≥60 days, 2 skipped cycles, 1 interval of amenorrhea).|participants|Number|27|27.0||||||
3647862|NCT02471755|3494975|B3|Early stage||Menopausal Stage|According to different cycle lengths, MT can be divided into two stages: early MT (>7 days different from normal) and late MT (≥60 days, 2 skipped cycles, 1 interval of amenorrhea).|participants|Number|41|41.0||||||
3647863|NCT02471755|3494976|B2|Early stage||Menopausal Stage|According to different cycle lengths, MT can be divided into two stages: early MT (>7 days different from normal) and late MT (≥60 days, 2 skipped cycles, 1 interval of amenorrhea).|participants|Number|24|24.0||||||
3647864|NCT02471755|3494977|B1|Early stage||Menopausal Stage|According to different cycle lengths, MT can be divided into two stages: early MT (>7 days different from normal) and late MT (≥60 days, 2 skipped cycles, 1 interval of amenorrhea).|participants|Number|17|17.0||||||
3647865|NCT02471755|3494975|B3|||Menopausal Course||month|Median|16.00|16.0|Inter-Quartile Range|||12.0|21.0|
3647866|NCT02471755|3494976|B2|||Menopausal Course||month|Median|16.00|16.0|Inter-Quartile Range|||12.5|24.0|
3647867|NCT02471755|3494977|B1|||Menopausal Course||month|Median|16.00|16.0|Inter-Quartile Range|||12.0|18.0|
3647868|NCT02471755|3494975|B3|||Height||cm|Mean|159.44|159.44|Standard Deviation|3.85|3.85|||
3647869|NCT02471755|3494976|B2|||Height||cm|Mean|159.49|159.49|Standard Deviation|3.88|3.88|||
3647870|NCT02471755|3494977|B1|||Height||cm|Mean|159.39|159.39|Standard Deviation|3.87|3.87|||
3647871|NCT02471755|3494975|B3|||Weight||Kg|Mean|57.84|57.84|Standard Deviation|6.87|6.87|||
3647872|NCT02471755|3494976|B2|||Weight||Kg|Mean|57.66|57.66|Standard Deviation|7.95|7.95|||
3647873|NCT02471755|3494977|B1|||Weight||Kg|Mean|58.02|58.02|Standard Deviation|5.66|5.66|||
3647874|NCT02471755|3494975|B3|Tertiary education||Educational Level||participants|Number|30|30.0||||||
3647875|NCT02471755|3494976|B2|Tertiary education||Educational Level||participants|Number|19|19.0||||||
3647876|NCT02471755|3494977|B1|Tertiary education||Educational Level||participants|Number|11|11.0||||||
3647877|NCT02471755|3494975|B3|Secondary education||Educational Level||participants|Number|58|58.0||||||
3647878|NCT02471755|3494976|B2|Secondary education||Educational Level||participants|Number|25|25.0||||||
3647879|NCT02471755|3494977|B1|Secondary education||Educational Level||participants|Number|33|33.0||||||
3647880|NCT02471755|3494975|B3|Preliminary education||Educational Level||participants|Number|1|1.0||||||
3647881|NCT02471755|3494976|B2|Preliminary education||Educational Level||participants|Number|1|1.0||||||
3647882|NCT02471755|3494977|B1|Preliminary education||Educational Level||participants|Number|0|0.0||||||
3647883|NCT02471755|3494975|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3647884|NCT02471755|3494976|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3647885|NCT02471755|3494977|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3647886|NCT02471755|3494975|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3647887|NCT02471755|3494976|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3647888|NCT02471755|3494977|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3647889|NCT02471755|3494975|B3|||Age||years|Mean|50.84|50.84|Standard Deviation|4.10|4.1|||
3647890|NCT02471755|3494976|B2|||Age||years|Mean|50.69|50.69|Standard Deviation|3.79|3.79|||
3647891|NCT02471755|3494977|B1|||Age||years|Mean|51.05|51.05|Standard Deviation|4.41|4.41|||
3647892|NCT02471612|3494994|B1|India||Region of Enrollment||participants|Number|157|157.0||||||
3647893|NCT02471612|3494994|B1||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3647894|NCT02471612|3494994|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3647895|NCT02471612|3494994|B1|> 80years||Age, Customized|All patients above 18 years age were included in the study|participants|Number|3|3.0||||||
3647896|NCT02471612|3494994|B1|61-80 years||Age, Customized|All patients above 18 years age were included in the study|participants|Number|38|38.0||||||
3647897|NCT02471612|3494994|B1|41-60 years||Age, Customized|All patients above 18 years age were included in the study|participants|Number|60|60.0||||||
3647898|NCT02471612|3494994|B1|21-40 years||Age, Customized|All patients above 18 years age were included in the study|participants|Number|45|45.0||||||
3647899|NCT02471612|3494994|B1|18- 20 years||Age, Customized|All patients above 18 years age were included in the study|participants|Number|11|11.0||||||
3647900|NCT02471326|3495011|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3647901|NCT02471326|3495011|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647902|NCT02471326|3495011|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3647903|NCT02471326|3495011|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3647904|NCT02471326|3495011|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647905|NCT02471326|3495011|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647906|NCT02471326|3495011|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647907|NCT02471326|3495011|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3647908|NCT02471326|3495011|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3647909|NCT02471326|3495011|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3647910|NCT02471326|3495011|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3647911|NCT02471326|3495011|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3647912|NCT02471326|3495011|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3647913|NCT02471326|3495011|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3647914|NCT02471326|3495011|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3647915|NCT02471183|3495016|B1||ERAs and sCG stimulator|PAH-specific therapy at baseline|"Number of patients receiving any of the following oral PAH background medication for at least 90 days prior to study treatment with selexipag:~Endothelin Receptor Antagonists (ERAs) or Phosphodiesterase-5 (PDE5) inhibitor or Soluble guanylate cyclase (sGC) stimulator or a combination of these therapeutic classes"|Participants|Count of Participants|4|4.0||||||
3647916|NCT02471183|3495016|B1||ERAs and PDE-5|PAH-specific therapy at baseline|"Number of patients receiving any of the following oral PAH background medication for at least 90 days prior to study treatment with selexipag:~Endothelin Receptor Antagonists (ERAs) or Phosphodiesterase-5 (PDE5) inhibitor or Soluble guanylate cyclase (sGC) stimulator or a combination of these therapeutic classes"|Participants|Count of Participants|19|19.0||||||
3647917|NCT02471183|3495016|B1||ERAs alone|PAH-specific therapy at baseline|"Number of patients receiving any of the following oral PAH background medication for at least 90 days prior to study treatment with selexipag:~Endothelin Receptor Antagonists (ERAs) or Phosphodiesterase-5 (PDE5) inhibitor or Soluble guanylate cyclase (sGC) stimulator or a combination of these therapeutic classes"|Participants|Count of Participants|4|4.0||||||
3647918|NCT02471183|3495016|B1||PDE5-inhibitors alone|PAH-specific therapy at baseline|"Number of patients receiving any of the following oral PAH background medication for at least 90 days prior to study treatment with selexipag:~Endothelin Receptor Antagonists (ERAs) or Phosphodiesterase-5 (PDE5) inhibitor or Soluble guanylate cyclase (sGC) stimulator or a combination of these therapeutic classes"|Participants|Count of Participants|7|7.0||||||
3647919|NCT02471183|3495016|B1||> 54 mcg q.i.d.|Treprostinil stable dose|This corresponds to the daily stable dose of inhaled treprostinil before initiation of selexipag based on the prescribed dose within 30 days before the intiation of selexipag (Day 1). The stable dose of treprostinil is expressed in mcg q.i.d., which is the number of breaths per 4 treatment session per day x 6 mcg|Participants|Count of Participants|12|12.0||||||
3647920|NCT02471183|3495016|B1||54 mcg q.i.d.|Treprostinil stable dose|This corresponds to the daily stable dose of inhaled treprostinil before initiation of selexipag based on the prescribed dose within 30 days before the intiation of selexipag (Day 1). The stable dose of treprostinil is expressed in mcg q.i.d., which is the number of breaths per 4 treatment session per day x 6 mcg|Participants|Count of Participants|20|20.0||||||
3647921|NCT02471183|3495016|B1||< 54 mcg q.i.d.|Treprostinil stable dose|This corresponds to the daily stable dose of inhaled treprostinil before initiation of selexipag based on the prescribed dose within 30 days before the intiation of selexipag (Day 1). The stable dose of treprostinil is expressed in mcg q.i.d., which is the number of breaths per 4 treatment session per day x 6 mcg|Participants|Count of Participants|2|2.0||||||
3647922|NCT02471183|3495016|B1|||Time since initial inhaled treprostinil|This is the time elapsed since initiation of treatment with inhaled treprostinil and before starting the study drug selexipag.|Months|Median|37.8|37.8|Full Range|||4.4|135.2|
3647923|NCT02471183|3495016|B1||FC IV|World Health Organization Functional class (WHO FC)|"The World Health Organization (WHO) defines 4 classes to classify the functional status of patients with pulmonary hypertension:~Class I (FC I): No limitation of physical activity; Class II (FC II): Slight limitation of physical activity; Class IIII (FC III): Marked limitation of physical activity; Class IV (FC IV): Inability to carry out any physical activity without symptoms.~Number of subjects in each WHO FC category before the first study drug administration is reported here."|Participants|Count of Participants|0|0.0||||||
3647924|NCT02471183|3495016|B1||FC III|World Health Organization Functional class (WHO FC)|"The World Health Organization (WHO) defines 4 classes to classify the functional status of patients with pulmonary hypertension:~Class I (FC I): No limitation of physical activity; Class II (FC II): Slight limitation of physical activity; Class IIII (FC III): Marked limitation of physical activity; Class IV (FC IV): Inability to carry out any physical activity without symptoms.~Number of subjects in each WHO FC category before the first study drug administration is reported here."|Participants|Count of Participants|9|9.0||||||
3647925|NCT02471183|3495016|B1||FC II|World Health Organization Functional class (WHO FC)|"The World Health Organization (WHO) defines 4 classes to classify the functional status of patients with pulmonary hypertension:~Class I (FC I): No limitation of physical activity; Class II (FC II): Slight limitation of physical activity; Class IIII (FC III): Marked limitation of physical activity; Class IV (FC IV): Inability to carry out any physical activity without symptoms.~Number of subjects in each WHO FC category before the first study drug administration is reported here."|Participants|Count of Participants|25|25.0||||||
3647926|NCT02471183|3495016|B1||FC I|World Health Organization Functional class (WHO FC)|"The World Health Organization (WHO) defines 4 classes to classify the functional status of patients with pulmonary hypertension:~Class I (FC I): No limitation of physical activity; Class II (FC II): Slight limitation of physical activity; Class IIII (FC III): Marked limitation of physical activity; Class IV (FC IV): Inability to carry out any physical activity without symptoms.~Number of subjects in each WHO FC category before the first study drug administration is reported here."|Participants|Count of Participants|0|0.0||||||
3647927|NCT02471183|3495016|B1||Associated PAH|Etiology of pulmonary arterial hypertension (PAH)|"Patients included in the study had a diagnosis of PAH belonging to one of the following categories at screening:~Idiopathic PAH~Heritable PAH~Drug or toxin induced PAH~PAH associated with connective tissue disease or HIV infection or congenital heart disease"|Participants|Count of Participants|10|10.0||||||
3648003|NCT02470390|3495113|B3|||Age||years|Mean|41.2|41.2|Standard Deviation|11.65|11.65|||
3648004|NCT02470390|3495114|B2|||Age||years|Mean|43.0|43.0|Standard Deviation|9.50|9.5|||
3648005|NCT02470390|3495115|B1|||Age||years|Mean|39.0|39.0|Standard Deviation|14.38|14.38|||
3647928|NCT02471183|3495016|B1||Drug or toxin induced|Etiology of pulmonary arterial hypertension (PAH)|"Patients included in the study had a diagnosis of PAH belonging to one of the following categories at screening:~Idiopathic PAH~Heritable PAH~Drug or toxin induced PAH~PAH associated with connective tissue disease or HIV infection or congenital heart disease"|Participants|Count of Participants|5|5.0||||||
3647929|NCT02471183|3495016|B1||Heritable|Etiology of pulmonary arterial hypertension (PAH)|"Patients included in the study had a diagnosis of PAH belonging to one of the following categories at screening:~Idiopathic PAH~Heritable PAH~Drug or toxin induced PAH~PAH associated with connective tissue disease or HIV infection or congenital heart disease"|Participants|Count of Participants|0|0.0||||||
3647930|NCT02471183|3495016|B1||Idiopathic|Etiology of pulmonary arterial hypertension (PAH)|"Patients included in the study had a diagnosis of PAH belonging to one of the following categories at screening:~Idiopathic PAH~Heritable PAH~Drug or toxin induced PAH~PAH associated with connective tissue disease or HIV infection or congenital heart disease"|Participants|Count of Participants|19|19.0||||||
3647931|NCT02471183|3495016|B1|Race categories as per protocol|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3647932|NCT02471183|3495016|B1|Race categories as per protocol|White|Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3647933|NCT02471183|3495016|B1|Race categories as per protocol|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3647934|NCT02471183|3495016|B1|Race categories as per protocol|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3647935|NCT02471183|3495016|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3647936|NCT02471183|3495016|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3647937|NCT02471183|3495016|B1|Age categories as per protocol|>= 75 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
3647938|NCT02471183|3495016|B1|Age categories as per protocol|>65 years and <75 years|Age, Customized||Participants|Count of Participants|5|5.0||||||
3647939|NCT02471183|3495016|B1|Age categories as per protocol|<= 65 years|Age, Customized||Participants|Count of Participants|28|28.0||||||
3647940|NCT02470949|3495031|B1|||BMI||kg/m^2|Mean|22.8|22.8|Standard Deviation|2.8|2.8|||
3647941|NCT02470949|3495031|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3647942|NCT02470949|3495031|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3647943|NCT02470949|3495031|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3647944|NCT02470949|3495031|B1|||Age||years|Mean|22.3|22.3|Standard Deviation|1.6|1.6|||
3647945|NCT02470494|3495042|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
3647946|NCT02470494|3495042|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3647947|NCT02470494|3495042|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3647948|NCT02470494|3495042|B1|||Age||years|Mean|68.5|68.5|Standard Deviation|10.0|10.0|||
3647949|NCT02470494|3495042|B1||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
3647950|NCT02470494|3495042|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3647951|NCT02470494|3495042|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3647952|NCT02470429|3495050|B3|||Tear Film Break-up Time (TFBUT)|TFBUT is defined as the time elapsed from the last blink until 1 or more dry spots appeared in the precorneal tear film.|seconds|Mean|3.39|3.39|Standard Deviation|2.115|2.115|||
3647953|NCT02470429|3495051|B2|||Tear Film Break-up Time (TFBUT)|TFBUT is defined as the time elapsed from the last blink until 1 or more dry spots appeared in the precorneal tear film.|seconds|Mean|3.58|3.58|Standard Deviation|2.222|2.222|||
3647954|NCT02470429|3495052|B1|||Tear Film Break-up Time (TFBUT)|TFBUT is defined as the time elapsed from the last blink until 1 or more dry spots appeared in the precorneal tear film.|seconds|Mean|3.20|3.2|Standard Deviation|2.010|2.01|||
3647955|NCT02470429|3495050|B3|Treatment Inconvenience||IDEEL Treatment Score|The IDEEL (Impact of dry eye on everyday life) is 10-question patient-reported outcome questionnaire that assesses the subject's general satisfaction with treatment use (Treatment Effectiveness and Treatment Inconvenience). A resultant overall 0-100 treatment satisfaction score was calculated separately for Treatment Effectiveness and Treatment Inconvenience, with higher scores indicating greater satisfaction and less treatment-related bother.|units on a scale|Mean|82.67|82.67|Standard Deviation|17.712|17.712|||
3647956|NCT02470429|3495051|B2|Treatment Inconvenience||IDEEL Treatment Score|The IDEEL (Impact of dry eye on everyday life) is 10-question patient-reported outcome questionnaire that assesses the subject's general satisfaction with treatment use (Treatment Effectiveness and Treatment Inconvenience). A resultant overall 0-100 treatment satisfaction score was calculated separately for Treatment Effectiveness and Treatment Inconvenience, with higher scores indicating greater satisfaction and less treatment-related bother.|units on a scale|Mean|81.90|81.9|Standard Deviation|17.829|17.829|||
3647957|NCT02470429|3495052|B1|Treatment Inconvenience||IDEEL Treatment Score|The IDEEL (Impact of dry eye on everyday life) is 10-question patient-reported outcome questionnaire that assesses the subject's general satisfaction with treatment use (Treatment Effectiveness and Treatment Inconvenience). A resultant overall 0-100 treatment satisfaction score was calculated separately for Treatment Effectiveness and Treatment Inconvenience, with higher scores indicating greater satisfaction and less treatment-related bother.|units on a scale|Mean|83.42|83.42|Standard Deviation|17.749|17.749|||
3647958|NCT02470429|3495050|B3|Treatment Effectiveness||IDEEL Treatment Score|The IDEEL (Impact of dry eye on everyday life) is 10-question patient-reported outcome questionnaire that assesses the subject's general satisfaction with treatment use (Treatment Effectiveness and Treatment Inconvenience). A resultant overall 0-100 treatment satisfaction score was calculated separately for Treatment Effectiveness and Treatment Inconvenience, with higher scores indicating greater satisfaction and less treatment-related bother.|units on a scale|Mean|51.80|51.8|Standard Deviation|28.979|28.979|||
3648006|NCT02469961|3495142|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3648007|NCT02469961|3495143|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3648008|NCT02469961|3495144|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3647959|NCT02470429|3495051|B2|Treatment Effectiveness||IDEEL Treatment Score|The IDEEL (Impact of dry eye on everyday life) is 10-question patient-reported outcome questionnaire that assesses the subject's general satisfaction with treatment use (Treatment Effectiveness and Treatment Inconvenience). A resultant overall 0-100 treatment satisfaction score was calculated separately for Treatment Effectiveness and Treatment Inconvenience, with higher scores indicating greater satisfaction and less treatment-related bother.|units on a scale|Mean|51.56|51.56|Standard Deviation|28.641|28.641|||
3647960|NCT02470429|3495052|B1|Treatment Effectiveness||IDEEL Treatment Score|The IDEEL (Impact of dry eye on everyday life) is 10-question patient-reported outcome questionnaire that assesses the subject's general satisfaction with treatment use (Treatment Effectiveness and Treatment Inconvenience). A resultant overall 0-100 treatment satisfaction score was calculated separately for Treatment Effectiveness and Treatment Inconvenience, with higher scores indicating greater satisfaction and less treatment-related bother.|units on a scale|Mean|52.04|52.04|Standard Deviation|29.602|29.602|||
3647961|NCT02470429|3495050|B3|||Total Ocular Surface Staining (TOSS) Score|The TOSS score is a cumulative cornea and conjunctival staining score. After instilling ophthalmic dye in the eye, the investigator graded 3 areas of the ocular surface for dryness on a scale from 0 to 5, where 0=Absent and 5=Severe. The 3 scores were summed for a resultant overall 0-15 score.|units on a scale|Mean|5.12|5.12|Standard Deviation|1.264|1.264|||
3647962|NCT02470429|3495051|B2|||Total Ocular Surface Staining (TOSS) Score|The TOSS score is a cumulative cornea and conjunctival staining score. After instilling ophthalmic dye in the eye, the investigator graded 3 areas of the ocular surface for dryness on a scale from 0 to 5, where 0=Absent and 5=Severe. The 3 scores were summed for a resultant overall 0-15 score.|units on a scale|Mean|4.98|4.98|Standard Deviation|1.090|1.09|||
3647963|NCT02470429|3495052|B1|||Total Ocular Surface Staining (TOSS) Score|The TOSS score is a cumulative cornea and conjunctival staining score. After instilling ophthalmic dye in the eye, the investigator graded 3 areas of the ocular surface for dryness on a scale from 0 to 5, where 0=Absent and 5=Severe. The 3 scores were summed for a resultant overall 0-15 score.|units on a scale|Mean|5.26|5.26|Standard Deviation|1.411|1.411|||
3647964|NCT02470429|3495050|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3647965|NCT02470429|3495051|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3647966|NCT02470429|3495052|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3647967|NCT02470429|3495050|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3647968|NCT02470429|3495051|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3647969|NCT02470429|3495052|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3647970|NCT02470429|3495050|B3|||Age||years|Mean|59.2|59.2|Standard Deviation|13.49|13.49|||
3647971|NCT02470429|3495051|B2|||Age||years|Mean|56.7|56.7|Standard Deviation|14.29|14.29|||
3647972|NCT02470429|3495052|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|12.29|12.29|||
3647973|NCT02470403|3495066|B6||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3647974|NCT02470403|3495067|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3647975|NCT02470403|3495068|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3647976|NCT02470403|3495069|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3647977|NCT02470403|3495070|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3647978|NCT02470403|3495071|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3647979|NCT02470403|3495066|B6||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3647980|NCT02470403|3495067|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3647981|NCT02470403|3495068|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3647982|NCT02470403|3495069|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3647983|NCT02470403|3495070|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3647984|NCT02470403|3495071|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3647985|NCT02470403|3495066|B6|Part 2 (NA, NA, 40,43,10,93)||Age||Years|Mean|41.6|41.6|Standard Deviation|10.44|10.44|||
3647986|NCT02470403|3495067|B5|Part 2 (NA, NA, 40,43,10,93)||Age||Years|Mean|43.4|43.4|Standard Deviation|12.39|12.39|||
3647987|NCT02470403|3495068|B4|Part 2 (NA, NA, 40,43,10,93)||Age||Years|Mean|39.9|39.9|Standard Deviation|11.22|11.22|||
3647988|NCT02470403|3495069|B3|Part 2 (NA, NA, 40,43,10,93)||Age||Years|Mean|42.9|42.9|Standard Deviation|8.96|8.96|||
3647989|NCT02470403|3495070|B2|Part 2 (NA, NA, 40,43,10,93)||Age||Years|Mean|NA||Standard Deviation|NA||||This arm is not for Part 2
3647990|NCT02470403|3495071|B1|Part 2 (NA, NA, 40,43,10,93)||Age||Years|Mean|NA||Standard Deviation|NA||||This arm is not for Part 2
3647991|NCT02470403|3495066|B6|Part 1 (44, 44, NA,NA,NA,88)||Age||Years|Mean|40.2|40.2|Standard Deviation|11.54|11.54|||
3647992|NCT02470403|3495067|B5|Part 1 (44, 44, NA,NA,NA,88)||Age||Years|Mean|NA||Standard Deviation|NA||||This arm is not for Part 1
3647993|NCT02470403|3495068|B4|Part 1 (44, 44, NA,NA,NA,88)||Age||Years|Mean|NA||Standard Deviation|NA||||This arm is not for Part 1
3647994|NCT02470403|3495069|B3|Part 1 (44, 44, NA,NA,NA,88)||Age||Years|Mean|NA||Standard Deviation|NA||||This arm is not for Part 1
3647995|NCT02470403|3495070|B2|Part 1 (44, 44, NA,NA,NA,88)||Age||Years|Mean|41.3|41.3|Standard Deviation|11.07|11.07|||
3647996|NCT02470403|3495071|B1|Part 1 (44, 44, NA,NA,NA,88)||Age||Years|Mean|39.0|39.0|Standard Deviation|12.01|12.01|||
3647997|NCT02470390|3495113|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3647998|NCT02470390|3495114|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3647999|NCT02470390|3495115|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3648000|NCT02470390|3495113|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3648001|NCT02470390|3495114|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3648002|NCT02470390|3495115|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3648009|NCT02469961|3495142|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3648010|NCT02469961|3495143|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3648011|NCT02469961|3495144|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3648012|NCT02469961|3495142|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3648013|NCT02469961|3495143|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3648014|NCT02469961|3495144|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3648015|NCT02469961|3495142|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3648016|NCT02469961|3495143|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3648017|NCT02469961|3495144|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3648018|NCT02469961|3495142|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3648019|NCT02469961|3495143|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3648020|NCT02469961|3495144|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3648021|NCT02469701|3495157|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3648022|NCT02469701|3495157|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3648023|NCT02469701|3495157|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648024|NCT02469701|3495157|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3648025|NCT02469701|3495157|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648026|NCT02469701|3495157|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648027|NCT02469701|3495157|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648028|NCT02469701|3495157|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648029|NCT02469701|3495157|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3648030|NCT02469701|3495157|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3648031|NCT02469701|3495157|B1|||Age||years|Mean|64.6|64.6|Full Range|||52.0|75.0|
3648032|NCT02469701|3495157|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3648033|NCT02469701|3495157|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3648034|NCT02469701|3495157|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3648035|NCT02469597|3495161|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3648036|NCT02469597|3495162|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3648037|NCT02469597|3495163|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3648038|NCT02469597|3495161|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3648039|NCT02469597|3495162|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3648040|NCT02469597|3495163|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3648041|NCT02469597|3495161|B3|||Age||months|Mean|7.9|7.9|Standard Deviation|6.2|6.2|||
3648042|NCT02469597|3495162|B2|||Age||months|Mean|8.1|8.1|Standard Deviation|6.8|6.8|||
3648043|NCT02469597|3495163|B1|||Age||months|Mean|7.7|7.7|Standard Deviation|5.5|5.5|||
3648044|NCT02469597|3495161|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3648045|NCT02469597|3495162|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3648046|NCT02469597|3495163|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3648047|NCT02469597|3495161|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3648048|NCT02469597|3495162|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3648049|NCT02469597|3495163|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3648050|NCT02469597|3495161|B3||<=18 years|Age||Participants|Count of Participants|46|46.0||||||
3648051|NCT02469597|3495162|B2||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
3648052|NCT02469597|3495163|B1||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
3648053|NCT02469415|3495180|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3648054|NCT02469415|3495180|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648055|NCT02469415|3495180|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3648056|NCT02469415|3495180|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648057|NCT02469415|3495180|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3648058|NCT02469415|3495180|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3648059|NCT02469415|3495180|B1|||Age||years|Median|52|52.0|Full Range|||52.0|69.0|
3648060|NCT02469415|3495180|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3648061|NCT02469415|3495180|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3648062|NCT02469415|3495180|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3648063|NCT02469298|3495184|B5|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3648064|NCT02469298|3495185|B4|Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3648065|NCT02469298|3495186|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3648066|NCT02469298|3495187|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3648067|NCT02469298|3495188|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3648068|NCT02469298|3495184|B5|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
3648069|NCT02469298|3495185|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3648070|NCT02469298|3495186|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
3648071|NCT02469298|3495187|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3648072|NCT02469298|3495188|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3648073|NCT02469298|3495184|B5|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3648074|NCT02469298|3495185|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3648075|NCT02469298|3495186|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3648076|NCT02469298|3495187|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3648077|NCT02469298|3495188|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3648078|NCT02469298|3495184|B5|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3648079|NCT02469298|3495185|B4|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3648080|NCT02469298|3495186|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3648081|NCT02469298|3495187|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3648082|NCT02469298|3495188|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3648083|NCT02469298|3495184|B5|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3648084|NCT02469298|3495185|B4|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3648085|NCT02469298|3495186|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3648086|NCT02469298|3495187|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3648087|NCT02469298|3495188|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3648088|NCT02469298|3495184|B5|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3648089|NCT02469298|3495185|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3648090|NCT02469298|3495186|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3648091|NCT02469298|3495187|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3648092|NCT02469298|3495188|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3648093|NCT02469298|3495184|B5|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3648094|NCT02469298|3495185|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3648095|NCT02469298|3495186|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3648096|NCT02469298|3495187|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3648097|NCT02469298|3495188|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3648098|NCT02469298|3495184|B5||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3648099|NCT02469298|3495185|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3648100|NCT02469298|3495186|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3648101|NCT02469298|3495187|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3648102|NCT02469298|3495188|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3648103|NCT02469298|3495184|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3648104|NCT02469298|3495185|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3648105|NCT02469298|3495186|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3648106|NCT02469298|3495187|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3648107|NCT02469298|3495188|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3648108|NCT02469298|3495184|B5|||Age||Years|Mean|38.6|38.6|Standard Deviation|12.04|12.04|||
3648109|NCT02469298|3495185|B4|||Age||Years|Mean|36.3|36.3|Standard Deviation|9.83|9.83|||
3648110|NCT02469298|3495186|B3|||Age||Years|Mean|42.6|42.6|Standard Deviation|11.53|11.53|||
3648111|NCT02469298|3495187|B2|||Age||Years|Mean|33.4|33.4|Standard Deviation|11.56|11.56|||
3648112|NCT02469298|3495188|B1|||Age||Years|Mean|37.9|37.9|Standard Deviation|13.40|13.4|||
3648113|NCT02469246|3495329|B3|||Spine BMD||g/cm^2|Mean|NA||Standard Deviation|NA||||Total was not calculated for baseline spine BMD.
3648114|NCT02469246|3495330|B2|||Spine BMD||g/cm^2|Mean|1.121|1.121|Standard Deviation|0.1838|0.1838|||
3648115|NCT02469246|3495331|B1|||Spine BMD||g/cm^2|Mean|1.130|1.13|Standard Deviation|0.1885|0.1885|||
3648116|NCT02469246|3495329|B3|||Hip Bone Mineral Density (BMD)||g/cm^2|Mean|NA||Standard Deviation|NA||||Total was not calculated for baseline hip BMD.
3648117|NCT02469246|3495330|B2|||Hip Bone Mineral Density (BMD)||g/cm^2|Mean|1.000|1.0|Standard Deviation|0.1459|0.1459|||
3648118|NCT02469246|3495331|B1|||Hip Bone Mineral Density (BMD)||g/cm^2|Mean|1.006|1.006|Standard Deviation|0.1555|0.1555|||
3648119|NCT02469246|3495329|B3||Unknown|HIV Disease Status||Participants|Count of Participants|2|2.0||||||
3648120|NCT02469246|3495330|B2||Unknown|HIV Disease Status||Participants|Count of Participants|1|1.0||||||
3648121|NCT02469246|3495331|B1||Unknown|HIV Disease Status||Participants|Count of Participants|1|1.0||||||
3648122|NCT02469246|3495329|B3||AIDS|HIV Disease Status||Participants|Count of Participants|97|97.0||||||
3648123|NCT02469246|3495330|B2||AIDS|HIV Disease Status||Participants|Count of Participants|50|50.0||||||
3648124|NCT02469246|3495331|B1||AIDS|HIV Disease Status||Participants|Count of Participants|47|47.0||||||
3648289|NCT02468830|3495399|B1|Canada||Region of Enrollment||participants|Number|58|58.0||||||
3648125|NCT02469246|3495329|B3||Symptomatic HIV Infection|HIV Disease Status||Participants|Count of Participants|55|55.0||||||
3648126|NCT02469246|3495330|B2||Symptomatic HIV Infection|HIV Disease Status||Participants|Count of Participants|24|24.0||||||
3648127|NCT02469246|3495331|B1||Symptomatic HIV Infection|HIV Disease Status||Participants|Count of Participants|31|31.0||||||
3648128|NCT02469246|3495329|B3||Asymptomatic|HIV Disease Status||Participants|Count of Participants|402|402.0||||||
3648129|NCT02469246|3495330|B2||Asymptomatic|HIV Disease Status||Participants|Count of Participants|201|201.0||||||
3648130|NCT02469246|3495331|B1||Asymptomatic|HIV Disease Status||Participants|Count of Participants|201|201.0||||||
3648131|NCT02469246|3495329|B3||≥ 500 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|425|425.0||||||
3648132|NCT02469246|3495330|B2||≥ 500 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|221|221.0||||||
3648133|NCT02469246|3495331|B1||≥ 500 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|204|204.0||||||
3648134|NCT02469246|3495329|B3||≥ 350 to < 500 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|94|94.0||||||
3648135|NCT02469246|3495330|B2||≥ 350 to < 500 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|38|38.0||||||
3648136|NCT02469246|3495331|B1||≥ 350 to < 500 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|56|56.0||||||
3648137|NCT02469246|3495329|B3||≥ 200 to < 350 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|36|36.0||||||
3648138|NCT02469246|3495330|B2||≥ 200 to < 350 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|16|16.0||||||
3648139|NCT02469246|3495331|B1||≥ 200 to < 350 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|20|20.0||||||
3648140|NCT02469246|3495329|B3||≥ 50 to < 200 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|0|0.0||||||
3648141|NCT02469246|3495330|B2||≥ 50 to < 200 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|0|0.0||||||
3648142|NCT02469246|3495331|B1||≥ 50 to < 200 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|0|0.0||||||
3648143|NCT02469246|3495329|B3||< 50 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|1|1.0||||||
3648144|NCT02469246|3495330|B2||< 50 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|1|1.0||||||
3648145|NCT02469246|3495331|B1||< 50 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|0|0.0||||||
3648146|NCT02469246|3495329|B3|||CD4 Cell Count||cells/µL|Mean|715|715.0|Standard Deviation|287.3|287.3|||
3648147|NCT02469246|3495330|B2|||CD4 Cell Count||cells/µL|Mean|727|727.0|Standard Deviation|275.2|275.2|||
3648148|NCT02469246|3495331|B1|||CD4 Cell Count||cells/µL|Mean|703|703.0|Standard Deviation|298.7|298.7|||
3648149|NCT02469246|3495329|B3||≥ 50 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|5|5.0||||||
3648150|NCT02469246|3495330|B2||≥ 50 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|3|3.0||||||
3648151|NCT02469246|3495331|B1||≥ 50 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|2|2.0||||||
3648152|NCT02469246|3495329|B3||< 50 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|551|551.0||||||
3648153|NCT02469246|3495330|B2||< 50 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|273|273.0||||||
3648154|NCT02469246|3495331|B1||< 50 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|278|278.0||||||
3648155|NCT02469246|3495329|B3|United States||Region of Enrollment||Participants|Count of Participants|206|206.0||||||
3648156|NCT02469246|3495330|B2|United States||Region of Enrollment||Participants|Count of Participants|101|101.0||||||
3648157|NCT02469246|3495331|B1|United States||Region of Enrollment||Participants|Count of Participants|105|105.0||||||
3648158|NCT02469246|3495329|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|109|109.0||||||
3648159|NCT02469246|3495330|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|59|59.0||||||
3648160|NCT02469246|3495331|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3648161|NCT02469246|3495329|B3|Sweden||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3648162|NCT02469246|3495330|B2|Sweden||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3648163|NCT02469246|3495331|B1|Sweden||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3648164|NCT02469246|3495329|B3|Spain||Region of Enrollment||Participants|Count of Participants|66|66.0||||||
3648165|NCT02469246|3495330|B2|Spain||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3648166|NCT02469246|3495331|B1|Spain||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3648167|NCT02469246|3495329|B3|Italy||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
3648168|NCT02469246|3495330|B2|Italy||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3648169|NCT02469246|3495331|B1|Italy||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3648170|NCT02469246|3495329|B3|Ireland||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3648171|NCT02469246|3495330|B2|Ireland||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3648172|NCT02469246|3495331|B1|Ireland||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3648173|NCT02469246|3495329|B3|Germany||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3648174|NCT02469246|3495330|B2|Germany||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3648175|NCT02469246|3495331|B1|Germany||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3648176|NCT02469246|3495329|B3|France||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3648177|NCT02469246|3495330|B2|France||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3648178|NCT02469246|3495331|B1|France||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3648179|NCT02469246|3495329|B3|Denmark||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3648180|NCT02469246|3495330|B2|Denmark||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3648181|NCT02469246|3495331|B1|Denmark||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3648182|NCT02469246|3495329|B3|Canada||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3648183|NCT02469246|3495330|B2|Canada||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3648184|NCT02469246|3495331|B1|Canada||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3648185|NCT02469246|3495329|B3|Belgium||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3648186|NCT02469246|3495330|B2|Belgium||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3648187|NCT02469246|3495331|B1|Belgium||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3648188|NCT02469246|3495329|B3||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3648189|NCT02469246|3495330|B2||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3648190|NCT02469246|3495331|B1||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3648191|NCT02469246|3495329|B3||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|521|521.0||||||
3648192|NCT02469246|3495330|B2||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|257|257.0||||||
3648193|NCT02469246|3495331|B1||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|264|264.0||||||
3648194|NCT02469246|3495329|B3||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
3648195|NCT02469246|3495330|B2||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3648196|NCT02469246|3495331|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3648197|NCT02469246|3495329|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3648198|NCT02469246|3495330|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3648199|NCT02469246|3495331|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3648200|NCT02469246|3495329|B3||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3648201|NCT02469246|3495330|B2||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3648202|NCT02469246|3495331|B1||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3648203|NCT02469246|3495329|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|404|404.0||||||
3648204|NCT02469246|3495330|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|199|199.0||||||
3648205|NCT02469246|3495331|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|205|205.0||||||
3648206|NCT02469246|3495329|B3||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3648207|NCT02469246|3495330|B2||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3648208|NCT02469246|3495331|B1||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3648209|NCT02469246|3495329|B3||Black|Race/Ethnicity, Customized||Participants|Count of Participants|130|130.0||||||
3648210|NCT02469246|3495330|B2||Black|Race/Ethnicity, Customized||Participants|Count of Participants|66|66.0||||||
3648211|NCT02469246|3495331|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|64|64.0||||||
3648212|NCT02469246|3495329|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3648213|NCT02469246|3495330|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3648214|NCT02469246|3495331|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3648215|NCT02469246|3495329|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3648216|NCT02469246|3495330|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3648217|NCT02469246|3495331|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3648218|NCT02469246|3495329|B3||Male|Sex: Female, Male||Participants|Count of Participants|455|455.0||||||
3648219|NCT02469246|3495330|B2||Male|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
3648220|NCT02469246|3495331|B1||Male|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
3648221|NCT02469246|3495329|B3||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3648222|NCT02469246|3495330|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3648223|NCT02469246|3495331|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3648224|NCT02469246|3495329|B3|||Age||years|Mean|51|51.0|Standard Deviation|9.3|9.3|||
3648225|NCT02469246|3495330|B2|||Age||years|Mean|51|51.0|Standard Deviation|9.3|9.3|||
3648226|NCT02469246|3495331|B1|||Age||years|Mean|51|51.0|Standard Deviation|9.4|9.4|||
3648227|NCT02469168|3495348|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3648228|NCT02469168|3495350|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3648229|NCT02469168|3495348|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648230|NCT02469168|3495350|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648231|NCT02469168|3495348|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648232|NCT02469168|3495350|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648233|NCT02469168|3495348|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3648234|NCT02469168|3495350|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3648235|NCT02469168|3495348|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648236|NCT02469168|3495350|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648237|NCT02469168|3495348|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648238|NCT02469168|3495350|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648239|NCT02469168|3495348|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648240|NCT02469168|3495350|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648241|NCT02469168|3495348|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648242|NCT02469168|3495350|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648243|NCT02469168|3495348|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3648244|NCT02469168|3495350|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3648245|NCT02469168|3495348|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3648246|NCT02469168|3495350|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3648247|NCT02469168|3495348|B3|||Age||years|Mean|29|29.0|Standard Deviation|0|0.0|||
3648248|NCT02469168|3495350|B1|||Age||years|Mean|29|29.0|Standard Deviation|0|0.0|||
3648249|NCT02469116|3495359|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3648250|NCT02469116|3495359|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3648251|NCT02469116|3495359|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3648252|NCT02469116|3495359|B1|||Age||years|Median|62|62.0|Full Range|||44.0|84.0|
3648253|NCT02469064|3495369|B3|Colombia||Region of Enrollment||Participants|Count of Participants|126|126.0||||||
3648254|NCT02469064|3495370|B2|Colombia||Region of Enrollment||Participants|Count of Participants|64|64.0||||||
3648255|NCT02469064|3495371|B1|Colombia||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
3648256|NCT02469064|3495369|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3648257|NCT02469064|3495370|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3648258|NCT02469064|3495371|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3648259|NCT02469064|3495369|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3648260|NCT02469064|3495370|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3648261|NCT02469064|3495371|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3648262|NCT02469064|3495369|B3|||Age||years|Median|62|62.0|Inter-Quartile Range|||44.0|71.0|
3648263|NCT02469064|3495370|B2|||Age||years|Median|64|64.0|Inter-Quartile Range|||47.0|72.0|
3648264|NCT02469064|3495371|B1|||Age||years|Median|61|61.0|Inter-Quartile Range|||40.0|70.0|
3648265|NCT02468934|3495380|B1||Other|Reason for Total Knee Arthroplasty (TKA)|The reason that each subject was scheduled to undergo a primary unilateral total knee arthroplasty (also known as total knee replacement).|Participants|Count of Participants|0|0.0||||||
3648266|NCT02468934|3495380|B1||Post-Traumatic Arthritis|Reason for Total Knee Arthroplasty (TKA)|The reason that each subject was scheduled to undergo a primary unilateral total knee arthroplasty (also known as total knee replacement).|Participants|Count of Participants|0|0.0||||||
3648267|NCT02468934|3495380|B1||Trauma|Reason for Total Knee Arthroplasty (TKA)|The reason that each subject was scheduled to undergo a primary unilateral total knee arthroplasty (also known as total knee replacement).|Participants|Count of Participants|0|0.0||||||
3648268|NCT02468934|3495380|B1||Rheumatoid Arthritis|Reason for Total Knee Arthroplasty (TKA)|The reason that each subject was scheduled to undergo a primary unilateral total knee arthroplasty (also known as total knee replacement).|Participants|Count of Participants|0|0.0||||||
3648269|NCT02468934|3495380|B1||Osteoarthritis|Reason for Total Knee Arthroplasty (TKA)|The reason that each subject was scheduled to undergo a primary unilateral total knee arthroplasty (also known as total knee replacement).|Participants|Count of Participants|24|24.0||||||
3648270|NCT02468934|3495380|B1|Right Leg||Affected Leg||Participants|Count of Participants|14|14.0||||||
3648271|NCT02468934|3495380|B1|Left Leg||Affected Leg||Participants|Count of Participants|10|10.0||||||
3648272|NCT02468934|3495380|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3648273|NCT02468934|3495380|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648274|NCT02468934|3495380|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648275|NCT02468934|3495380|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3648276|NCT02468934|3495380|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3648277|NCT02468934|3495380|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648278|NCT02468934|3495380|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3648279|NCT02468934|3495380|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648280|NCT02468934|3495380|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648281|NCT02468934|3495380|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3648282|NCT02468934|3495380|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3648283|NCT02468934|3495380|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3648284|NCT02468934|3495380|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3648285|NCT02468934|3495380|B1|||Age||years|Mean|67.9|67.9|Standard Deviation|8.7|8.7|||
3648286|NCT02468934|3495380|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3648287|NCT02468934|3495380|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3648288|NCT02468934|3495380|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3648290|NCT02468830|3495399|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3648291|NCT02468830|3495399|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3648292|NCT02468830|3495399|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3648293|NCT02468830|3495399|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3648294|NCT02468830|3495399|B1||<=18 years|Age||Participants|Count of Participants|58|58.0||||||
3648295|NCT02468700|3495407|B3||Green|Iris Color||Participants|Count of Participants|3|3.0||||||
3648296|NCT02468700|3495408|B2||Green|Iris Color||Participants|Count of Participants|1|1.0||||||
3648297|NCT02468700|3495409|B1||Green|Iris Color||Participants|Count of Participants|2|2.0||||||
3648298|NCT02468700|3495407|B3||Hazel|Iris Color||Participants|Count of Participants|10|10.0||||||
3648299|NCT02468700|3495408|B2||Hazel|Iris Color||Participants|Count of Participants|3|3.0||||||
3648300|NCT02468700|3495409|B1||Hazel|Iris Color||Participants|Count of Participants|7|7.0||||||
3648301|NCT02468700|3495407|B3||Brown|Iris Color||Participants|Count of Participants|15|15.0||||||
3648302|NCT02468700|3495408|B2||Brown|Iris Color||Participants|Count of Participants|7|7.0||||||
3648303|NCT02468700|3495409|B1||Brown|Iris Color||Participants|Count of Participants|8|8.0||||||
3648304|NCT02468700|3495407|B3||Blue|Iris Color||Participants|Count of Participants|15|15.0||||||
3648305|NCT02468700|3495408|B2||Blue|Iris Color||Participants|Count of Participants|10|10.0||||||
3648306|NCT02468700|3495409|B1||Blue|Iris Color||Participants|Count of Participants|5|5.0||||||
3648307|NCT02468700|3495407|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3648308|NCT02468700|3495408|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3648309|NCT02468700|3495409|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648310|NCT02468700|3495407|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648311|NCT02468700|3495408|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648312|NCT02468700|3495409|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648313|NCT02468700|3495407|B3||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3648314|NCT02468700|3495408|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3648315|NCT02468700|3495409|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3648316|NCT02468700|3495407|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3648317|NCT02468700|3495408|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648318|NCT02468700|3495409|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3648319|NCT02468700|3495407|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648320|NCT02468700|3495408|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648321|NCT02468700|3495409|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648322|NCT02468700|3495407|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648323|NCT02468700|3495408|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648324|NCT02468700|3495409|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648325|NCT02468700|3495407|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648326|NCT02468700|3495408|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648327|NCT02468700|3495409|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648328|NCT02468700|3495407|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648329|NCT02468700|3495408|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648330|NCT02468700|3495409|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648331|NCT02468700|3495407|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3648332|NCT02468700|3495408|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3648333|NCT02468700|3495409|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3648334|NCT02468700|3495407|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3648335|NCT02468700|3495408|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3648336|NCT02468700|3495409|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3648337|NCT02468700|3495407|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3648338|NCT02468700|3495408|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3648339|NCT02468700|3495409|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3648340|NCT02468700|3495407|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3648341|NCT02468700|3495408|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3648342|NCT02468700|3495409|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3648343|NCT02468700|3495407|B3|||Age||years|Mean|62.4|62.4|Full Range|||41.0|84.0|
3648344|NCT02468700|3495408|B2|||Age||years|Mean|62.5|62.5|Full Range|||46.0|77.0|
3648345|NCT02468700|3495409|B1|||Age||years|Mean|62.3|62.3|Full Range|||41.0|84.0|
3648346|NCT02468583|3495422|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3648347|NCT02468583|3495423|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3648348|NCT02468583|3495424|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3648349|NCT02468583|3495422|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3648350|NCT02468583|3495423|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3648351|NCT02468583|3495424|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3648352|NCT02468583|3495422|B3|||Age||years|Mean|42|42.0|Full Range|||36.0|49.0|
3648353|NCT02468583|3495423|B2|||Age||years|Mean|40|40.0|Full Range|||37.0|47.0|
3648354|NCT02468583|3495424|B1|||Age||years|Mean|43|43.0|Full Range|||36.0|49.0|
3648355|NCT02468414|3495461|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648356|NCT02468414|3495462|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648357|NCT02468414|3495463|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648358|NCT02468414|3495461|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648359|NCT02468414|3495462|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648360|NCT02468414|3495463|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648361|NCT02468414|3495461|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3648362|NCT02468414|3495462|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648363|NCT02468414|3495463|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3648364|NCT02468414|3495461|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648365|NCT02468414|3495462|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648366|NCT02468414|3495463|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648367|NCT02468414|3495461|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648368|NCT02468414|3495462|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648369|NCT02468414|3495463|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648370|NCT02468414|3495461|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648371|NCT02468414|3495462|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648372|NCT02468414|3495463|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648373|NCT02468414|3495461|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648374|NCT02468414|3495462|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648375|NCT02468414|3495463|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648376|NCT02468414|3495461|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3648377|NCT02468414|3495462|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3648378|NCT02468414|3495463|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3648379|NCT02468414|3495461|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3648380|NCT02468414|3495462|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3648381|NCT02468414|3495463|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3648382|NCT02468414|3495461|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3648383|NCT02468414|3495462|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3648384|NCT02468414|3495463|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3648385|NCT02468414|3495461|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3648386|NCT02468414|3495462|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3648387|NCT02468414|3495463|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3648388|NCT02468414|3495461|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3648389|NCT02468414|3495462|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3648390|NCT02468414|3495463|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3648391|NCT02468154|3495470|B3|||pain killer (opioid)||participants|Number|8|8.0||||||
3648392|NCT02468154|3495471|B2|||pain killer (opioid)||participants|Number|4|4.0||||||
3648393|NCT02468154|3495472|B1|||pain killer (opioid)||participants|Number|4|4.0||||||
3648394|NCT02468154|3495470|B3|||under the knee cast||participants|Number|17|17.0||||||
3648395|NCT02468154|3495471|B2|||under the knee cast||participants|Number|8|8.0||||||
3648396|NCT02468154|3495472|B1|||under the knee cast||participants|Number|9|9.0||||||
3648397|NCT02468154|3495470|B3|||over the knee cast||participants|Number|27|27.0||||||
3648398|NCT02468154|3495471|B2|||over the knee cast||participants|Number|16|16.0||||||
3648399|NCT02468154|3495472|B1|||over the knee cast||participants|Number|11|11.0||||||
3648400|NCT02468154|3495470|B3|||spica cast||participants|Number|13|13.0||||||
3648401|NCT02468154|3495471|B2|||spica cast||participants|Number|4|4.0||||||
3648402|NCT02468154|3495472|B1|||spica cast||participants|Number|9|9.0||||||
3648403|NCT02468154|3495470|B3|||bone surgical intervention (vs soft tissue surgical intervention)||participants|Number|43|43.0||||||
3648404|NCT02468154|3495471|B2|||bone surgical intervention (vs soft tissue surgical intervention)||participants|Number|21|21.0||||||
3648405|NCT02468154|3495472|B1|||bone surgical intervention (vs soft tissue surgical intervention)||participants|Number|22|22.0||||||
3648406|NCT02468154|3495470|B3|Italy||Region of Enrollment||participants|Number|57|57.0||||||
3648407|NCT02468154|3495471|B2|Italy||Region of Enrollment||participants|Number|28|28.0||||||
3648408|NCT02468154|3495472|B1|Italy||Region of Enrollment||participants|Number|29|29.0||||||
3648409|NCT02468154|3495470|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3648410|NCT02468154|3495471|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3648411|NCT02468154|3495472|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3648412|NCT02468154|3495470|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3648413|NCT02468154|3495471|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3648414|NCT02468154|3495472|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3648415|NCT02468154|3495470|B3|||Age||years|Mean|10.5|10.5|Standard Deviation|3.84|3.84|||
3648416|NCT02468154|3495471|B2|||Age||years|Mean|10.5|10.5|Standard Deviation|3.72|3.72|||
3648417|NCT02468154|3495472|B1|||Age||years|Mean|10.4|10.4|Standard Deviation|3.96|3.96|||
3648418|NCT02467777|3495485|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3648419|NCT02467777|3495486|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
3648420|NCT02467777|3495487|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
3648421|NCT02467777|3495485|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3648422|NCT02467777|3495486|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3648423|NCT02467777|3495487|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3648424|NCT02467777|3495485|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3648425|NCT02467777|3495486|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3648426|NCT02467777|3495487|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3648427|NCT02467777|3495485|B3|||Age||years|Mean|51.6|51.6|Standard Deviation|14.41|14.41|||
3648428|NCT02467777|3495486|B2|||Age||years|Mean|50.4|50.4|Standard Deviation|16.15|16.15|||
3648429|NCT02467777|3495487|B1|||Age||years|Mean|53|53.0|Standard Deviation|11.52|11.52|||
3648430|NCT02467777|3495485|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3648431|NCT02467777|3495486|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3648432|NCT02467777|3495487|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3648433|NCT02467777|3495485|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3648434|NCT02467777|3495486|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3648435|NCT02467777|3495487|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3648436|NCT02467777|3495485|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3648437|NCT02467777|3495486|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3648438|NCT02467777|3495487|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3648439|NCT02467491|3495494|B1|||Short Portable Mental Status Questionnaire score|The Short Portable Mental Status Questionnaire is made of 8 questions which explore the cognitive function of the subject. Possible scores range from 0 to 8 with lower scores indicating better cognitive function.|units on a scale|Mean|0.08|0.08|Standard Deviation|0.3|0.3|||
3648440|NCT02467491|3495494|B1|||Rapid Assessment of Physical Activity (RAPA) score|"The Rapid Assessment of Physical Activity (RAPA) questionnaire is a questionnaire made of 7 questions that ask about the amount and intensity of physical activity during the week. Minimum score is 0 and maximum score is 7 as described below:~Sedentary: score 1 Under-active: score 2 Under-active regular–light activities: score 3 Under-active regular: score 4 or 5 Active: score 6 or 7"|units on a scale|Mean|4.08|4.08|Standard Deviation|1.44|1.44|||
3648441|NCT02467491|3495494|B1|||Short Physical Performance Battery score (SPPB)|The SPPB is a common measure of physical performance in older adults. The test is comprised of timed measures of standing balance in three positions (side by side position, semi tandem position, tandem position), walking speed over 4 meters, and time to stand up and sit down 5 times in a chair, as quickly as possible. Each of the 3 performance measures are assigned a score ranging from 0 to 4, with 4 indicating the highest level of performance and 0 the inability to complete the test. A summary score was created by adding each performance score and ranges from 0-12.|units on a scale|Mean|8.2|8.2|Standard Deviation|1.2|1.2|||
3648442|NCT02467491|3495494|B1|||Body Mass Index (BMI)||kg/m^2|Mean|22.5|22.5|Standard Deviation|2.9|2.9|||
3648443|NCT02467491|3495494|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3648444|NCT02467491|3495494|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648445|NCT02467491|3495494|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648446|NCT02467491|3495494|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3648447|NCT02467491|3495494|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648448|NCT02467491|3495494|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648449|NCT02467491|3495494|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648450|NCT02467491|3495494|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648451|NCT02467491|3495494|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648452|NCT02467491|3495494|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3648453|NCT02467491|3495494|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648454|NCT02467491|3495494|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3648455|NCT02467491|3495494|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3648456|NCT02467491|3495494|B1|||Age||years|Mean|80.5|80.5|Standard Deviation|4.2|4.2|||
3648457|NCT02467075|3495503|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3648458|NCT02467075|3495504|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3648459|NCT02467075|3495503|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648460|NCT02467075|3495504|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648461|NCT02467075|3495505|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648462|NCT02467075|3495503|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648463|NCT02467075|3495504|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648464|NCT02467075|3495505|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648465|NCT02467075|3495503|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3648466|NCT02467075|3495504|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3648467|NCT02467075|3495505|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648468|NCT02467075|3495503|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648469|NCT02467075|3495504|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648470|NCT02467075|3495505|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648471|NCT02467075|3495503|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648472|NCT02467075|3495504|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648473|NCT02467075|3495505|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648474|NCT02467075|3495503|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648475|NCT02467075|3495504|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648476|NCT02467075|3495505|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648477|NCT02467075|3495503|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648478|NCT02467075|3495504|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648479|NCT02467075|3495505|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648480|NCT02467075|3495503|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3648481|NCT02467075|3495504|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3648482|NCT02467075|3495505|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3648483|NCT02467075|3495503|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3648484|NCT02467075|3495504|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3648485|NCT02467075|3495505|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3648486|NCT02467075|3495503|B3|||Age||years|Mean|84|84.0|Full Range|||||
3648487|NCT02467075|3495504|B2|||Age||years|Mean|84|84.0|Full Range|||||
3648488|NCT02467075|3495503|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3648489|NCT02467075|3495504|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3648490|NCT02467075|3495505|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3648491|NCT02467075|3495503|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3648492|NCT02467075|3495504|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3648493|NCT02467075|3495505|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3648494|NCT02467075|3495503|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3648495|NCT02467075|3495504|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3648496|NCT02467075|3495505|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3648497|NCT02466659|3495522|B3|||IXT Control Score at distance|"IXT control score: referring to the Pediatric eye disease investigator group (PEDIG).~PEDIG scale of control for IXT 1-5 is defined as the following:~5 = Constant exotropia~4 = exotropia > 50% of the 30-sec period before dissociation~3 = exotropia < 50% of the 30-sec period before dissociation~2 = No exotropia unless dissociated, recovers in > 5 sec~1 = No exotropia unless dissociated, recovers in 1-5 sec~0 = No exotropia unless dissociated, recovers in < 1 sec (phoria)~Not Applicable = No exotropia present"|units on a scale|Mean|3.5|3.5|Standard Deviation|.92|0.92|||
3648498|NCT02466659|3495523|B2|||IXT Control Score at distance|"IXT control score: referring to the Pediatric eye disease investigator group (PEDIG).~PEDIG scale of control for IXT 1-5 is defined as the following:~5 = Constant exotropia~4 = exotropia > 50% of the 30-sec period before dissociation~3 = exotropia < 50% of the 30-sec period before dissociation~2 = No exotropia unless dissociated, recovers in > 5 sec~1 = No exotropia unless dissociated, recovers in 1-5 sec~0 = No exotropia unless dissociated, recovers in < 1 sec (phoria)~Not Applicable = No exotropia present"|units on a scale|Mean|2.67|2.67|Standard Deviation|.57|0.57|||
3648499|NCT02466659|3495524|B1|||IXT Control Score at distance|"IXT control score: referring to the Pediatric eye disease investigator group (PEDIG).~PEDIG scale of control for IXT 1-5 is defined as the following:~5 = Constant exotropia~4 = exotropia > 50% of the 30-sec period before dissociation~3 = exotropia < 50% of the 30-sec period before dissociation~2 = No exotropia unless dissociated, recovers in > 5 sec~1 = No exotropia unless dissociated, recovers in 1-5 sec~0 = No exotropia unless dissociated, recovers in < 1 sec (phoria)~Not Applicable = No exotropia present"|units on a scale|Mean|4|4.0|Standard Deviation|.71|0.71|||
3648500|NCT02466659|3495522|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648501|NCT02466659|3495523|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648502|NCT02466659|3495524|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648503|NCT02466659|3495522|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648504|NCT02466659|3495523|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648505|NCT02466659|3495524|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648506|NCT02466659|3495522|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3648507|NCT02466659|3495523|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3648508|NCT02466659|3495524|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3648509|NCT02466659|3495522|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648510|NCT02466659|3495523|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648511|NCT02466659|3495524|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648512|NCT02466659|3495522|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648513|NCT02466659|3495523|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648514|NCT02466659|3495524|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648515|NCT02466659|3495522|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648516|NCT02466659|3495523|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648517|NCT02466659|3495524|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648518|NCT02466659|3495522|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648519|NCT02466659|3495523|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648520|NCT02466659|3495524|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648521|NCT02466659|3495522|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3648522|NCT02466659|3495523|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3648523|NCT02466659|3495524|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3648524|NCT02466659|3495522|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3648525|NCT02466659|3495523|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3648526|NCT02466659|3495524|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3648527|NCT02466659|3495522|B3|||Age||Year|Mean|5.91|5.91|Standard Deviation|2.68|2.68|||
3648528|NCT02466659|3495523|B2|||Age||Year|Mean|6.24|6.24|Standard Deviation|4.17|4.17|||
3648529|NCT02466659|3495524|B1|||Age||Year|Mean|5.7|5.7|Standard Deviation|1.94|1.94|||
3648530|NCT02466425|3495533|B3||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3648531|NCT02466425|3495534|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3648532|NCT02466425|3495535|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3648533|NCT02466425|3495533|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3648534|NCT02466425|3495534|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3648535|NCT02466425|3495535|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3648536|NCT02466425|3495533|B3|||Age||Years|Mean|12.5|12.5|Standard Deviation|3.24|3.24|||
3648537|NCT02466425|3495534|B2|||Age||Years|Mean|12.4|12.4|Standard Deviation|3.25|3.25|||
3648538|NCT02466425|3495535|B1|||Age||Years|Mean|12.5|12.5|Standard Deviation|3.24|3.24|||
3648539|NCT02466412|3495544|B3|> 0.6 to ≤ 1 mg||International Organization for Standardization (ISO) nicotine Yield||Participants|Count of Participants|25|25.0||||||
3648540|NCT02466412|3495545|B2|> 0.6 to ≤ 1 mg||International Organization for Standardization (ISO) nicotine Yield||Participants|Count of Participants|13|13.0||||||
3648541|NCT02466412|3495546|B1|> 0.6 to ≤ 1 mg||International Organization for Standardization (ISO) nicotine Yield||Participants|Count of Participants|12|12.0||||||
3648542|NCT02466412|3495544|B3|≤ 0.6 mg||International Organization for Standardization (ISO) nicotine Yield||Participants|Count of Participants|22|22.0||||||
3648543|NCT02466412|3495545|B2|≤ 0.6 mg||International Organization for Standardization (ISO) nicotine Yield||Participants|Count of Participants|11|11.0||||||
3648544|NCT02466412|3495546|B1|≤ 0.6 mg||International Organization for Standardization (ISO) nicotine Yield||Participants|Count of Participants|11|11.0||||||
3648545|NCT02466412|3495544|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3648546|NCT02466412|3495545|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3648547|NCT02466412|3495546|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3648548|NCT02466412|3495544|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3648549|NCT02466412|3495545|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3648550|NCT02466412|3495546|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3648551|NCT02466412|3495544|B3|||Age||years|Mean|42.6|42.6|Standard Deviation|10.86|10.86|||
3648552|NCT02466412|3495545|B2|||Age||years|Mean|40.7|40.7|Standard Deviation|11.48|11.48|||
3648553|NCT02466412|3495546|B1|||Age||years|Mean|44.7|44.7|Standard Deviation|10.03|10.03|||
3648554|NCT02466230|3495556|B1|||Patient Health Questionnaire - 9 (PHQ-9)|Self-rated scale of symptoms of depression. Nine items with a maximum score of 27. Higher score means more severe depression (0-4 = None; 5-9 = Mild; 10-14 = Moderate; 15-19 = Severe; 20 and higher = Very Severe).|units on a scale|Mean|14.3|14.3|Standard Deviation|8.4|8.4|||
3648555|NCT02466230|3495556|B1|||Hamilton Depression Rating Scale|The Hamilton Depression Rating Scale is 24 items with total scores ranging from 0-76. Higher scores indicate greater severity of depression. (0-7 = None; 8-13 = Mild; 14-18 = Moderate; 19-23 = Severe; 23 and higher = very severe). Total scores are reported with no subscales.|units on a scale|Mean|27.6|27.6|Standard Deviation|6.5|6.5|||
3648556|NCT02466230|3495556|B1|United States||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3648557|NCT02466230|3495556|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648558|NCT02466230|3495556|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648559|NCT02466230|3495556|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3648560|NCT02466230|3495556|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3648561|NCT02466230|3495556|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648562|NCT02466230|3495556|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648563|NCT02466230|3495556|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648564|NCT02466230|3495556|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648565|NCT02466230|3495556|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3648566|NCT02466230|3495556|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3648567|NCT02466230|3495556|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3648568|NCT02466230|3495556|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3648569|NCT02466230|3495556|B1|||Age||years|Mean|41.9|41.9|Standard Deviation|15.8|15.8|||
3648570|NCT02465931|3495561|B3|||Stanford Binet 5 verbal IQ (intelligence quotient) score||percentage|Mean|68.2|68.2|Standard Deviation|17.8|17.8|||
3648571|NCT02465931|3495562|B2|||Stanford Binet 5 verbal IQ (intelligence quotient) score||percentage|Mean|69.48|69.48|Standard Deviation|16.37|16.37|||
3648572|NCT02465931|3495563|B1|||Stanford Binet 5 verbal IQ (intelligence quotient) score||percentage|Mean|65.67|65.67|Standard Deviation|17.26|17.26|||
3648573|NCT02465931|3495561|B3|United States||Region of Enrollment||participants|Number|89|89.0||||||
3648574|NCT02465931|3495562|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
3648575|NCT02465931|3495563|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
3648576|NCT02465931|3495561|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3648577|NCT02465931|3495562|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3648578|NCT02465931|3495563|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3648579|NCT02465931|3495561|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3648580|NCT02465931|3495562|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648581|NCT02465931|3495563|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3648582|NCT02465931|3495561|B3||White|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3648583|NCT02465931|3495562|B2||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3648584|NCT02465931|3495563|B1||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3648585|NCT02465931|3495561|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3648586|NCT02465931|3495562|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3648587|NCT02465931|3495563|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3648588|NCT02465931|3495561|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3648589|NCT02465931|3495562|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3648590|NCT02465931|3495563|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648591|NCT02465931|3495561|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648592|NCT02465931|3495562|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648593|NCT02465931|3495563|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648594|NCT02465931|3495561|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648595|NCT02465931|3495562|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648596|NCT02465931|3495563|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648597|NCT02465931|3495561|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648598|NCT02465931|3495562|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648599|NCT02465931|3495563|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648600|NCT02465931|3495561|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3648601|NCT02465931|3495562|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3648602|NCT02465931|3495563|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3648603|NCT02465931|3495561|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3648604|NCT02465931|3495562|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3648605|NCT02465931|3495563|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3648606|NCT02465931|3495561|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3648607|NCT02465931|3495562|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3648608|NCT02465931|3495563|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3648609|NCT02465931|3495561|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3648610|NCT02465931|3495562|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3648611|NCT02465931|3495563|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3648612|NCT02465931|3495561|B3|||Age||years|Mean|21.21|21.21|Standard Deviation|7.27|7.27|||
3648613|NCT02465931|3495562|B2|||Age||years|Mean|21.27|21.27|Standard Deviation|7.50|7.5|||
3648614|NCT02465931|3495563|B1|||Age||years|Mean|21.16|21.16|Standard Deviation|7.11|7.11|||
3648615|NCT02465931|3495561|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3648616|NCT02465931|3495562|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3648617|NCT02465931|3495563|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3648618|NCT02465931|3495561|B3||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3648619|NCT02465931|3495562|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3648620|NCT02465931|3495563|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3648621|NCT02465931|3495561|B3||<=18 years|Age||Participants|Count of Participants|35|35.0||||||
3648622|NCT02465931|3495562|B2||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
3648623|NCT02465931|3495563|B1||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
3648624|NCT02465866|3495570|B1|||Body Mass Index (BMI)||kg/m²|Mean|25.43|25.43|Standard Deviation|2.80|2.8|||
3648625|NCT02465866|3495570|B1|||Weight||kg|Mean|67.83|67.83|Standard Deviation|10.72|10.72|||
3648626|NCT02465866|3495570|B1|||Height||cm|Mean|163.15|163.15|Standard Deviation|10.49|10.49|||
3648627|NCT02465866|3495570|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3648628|NCT02465866|3495570|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3648629|NCT02465866|3495570|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3648630|NCT02465866|3495570|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3648631|NCT02465866|3495570|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648632|NCT02465866|3495570|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648633|NCT02465866|3495570|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3648634|NCT02465866|3495570|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3648635|NCT02465866|3495570|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648636|NCT02465866|3495570|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648637|NCT02465866|3495570|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3648638|NCT02465866|3495570|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648639|NCT02465866|3495570|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3648640|NCT02465866|3495570|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3648641|NCT02465866|3495570|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3648642|NCT02465866|3495570|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3648643|NCT02465866|3495570|B1|||Age||years|Mean|52.85|52.85|Standard Deviation|17.71|17.71|||
3648644|NCT02465866|3495570|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3648645|NCT02465866|3495570|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3648646|NCT02465866|3495570|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3648647|NCT02465632|3495643|B4||Male|Sex: Female, Male||Participants|Count of Participants|413|413.0||||||
3648648|NCT02465632|3495644|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3648649|NCT02465632|3495645|B2||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3648650|NCT02465632|3495646|B1||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3648651|NCT02465632|3495643|B4||Female|Sex: Female, Male||Participants|Count of Participants|660|660.0||||||
3648652|NCT02465632|3495644|B3||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3648653|NCT02465632|3495645|B2||Female|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
3648654|NCT02465632|3495646|B1||Female|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
3648655|NCT02465632|3495643|B4|||Age||years|Mean|22.6|22.6|Standard Deviation|7.6|7.6|||
3648656|NCT02465632|3495644|B3|||Age||years|Mean|22.6|22.6|Standard Deviation|7.5|7.5|||
3648657|NCT02465632|3495645|B2|||Age||years|Mean|22.3|22.3|Standard Deviation|7.6|7.6|||
3648658|NCT02465632|3495646|B1|||Age||years|Mean|22.8|22.8|Standard Deviation|7.7|7.7|||
3648659|NCT02465489|3495659|B1|Canada||Region of Enrollment||participants|Number|20|20.0||||||
3648660|NCT02465489|3495659|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3648661|NCT02465489|3495659|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3648662|NCT02465489|3495659|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3648663|NCT02465489|3495659|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3648664|NCT02465489|3495659|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3648665|NCT02465463|3495686|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648666|NCT02465463|3495687|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648667|NCT02465463|3495688|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648668|NCT02465463|3495686|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648669|NCT02465463|3495687|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648670|NCT02465463|3495688|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648671|NCT02465463|3495686|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3648672|NCT02465463|3495687|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3648673|NCT02465463|3495688|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3648674|NCT02465463|3495686|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648675|NCT02465463|3495687|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648676|NCT02465463|3495688|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648677|NCT02465463|3495686|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648678|NCT02465463|3495687|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648679|NCT02465463|3495688|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648680|NCT02465463|3495686|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648681|NCT02465463|3495687|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648682|NCT02465463|3495688|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648683|NCT02465463|3495686|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648684|NCT02465463|3495687|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648685|NCT02465463|3495688|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648686|NCT02465463|3495686|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3648687|NCT02465463|3495687|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3648688|NCT02465463|3495688|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3648689|NCT02465463|3495686|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3648690|NCT02465463|3495687|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3648691|NCT02465463|3495688|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3648692|NCT02465463|3495686|B3|||Age||years|Mean|59.13|59.13|Standard Deviation|5.6|5.6|||
3648693|NCT02465463|3495687|B2|||Age||years|Mean|61.75|61.75|Standard Deviation|7.20|7.2|||
3648694|NCT02465463|3495688|B1|||Age||years|Mean|56.25|56.25|Standard Deviation|9.34|9.34|||
3648695|NCT02465450|3495705|B4|||BMI||kg/m^2|Mean|22.751|22.751|Standard Deviation|3.5381|3.5381|||
3648696|NCT02465450|3495706|B3|||BMI||kg/m^2|Mean|22.608|22.608|Standard Deviation|3.4672|3.4672|||
3648697|NCT02465450|3495707|B2|||BMI||kg/m^2|Mean|22.976|22.976|Standard Deviation|3.4182|3.4182|||
3648698|NCT02465450|3495708|B1|||BMI||kg/m^2|Mean|22.735|22.735|Standard Deviation|3.8582|3.8582|||
3648699|NCT02465450|3495705|B4|||Weight||kg|Mean|65.03|65.03|Standard Deviation|12.467|12.467|||
3648700|NCT02465450|3495706|B3|||Weight||kg|Mean|63.81|63.81|Standard Deviation|11.806|11.806|||
3648701|NCT02465450|3495707|B2|||Weight||kg|Mean|64.71|64.71|Standard Deviation|11.032|11.032|||
3648702|NCT02465450|3495708|B1|||Weight||kg|Mean|66.98|66.98|Standard Deviation|14.648|14.648|||
3648703|NCT02465450|3495705|B4|||Height||cm|Mean|168.86|168.86|Standard Deviation|9.259|9.259|||
3648704|NCT02465450|3495706|B3|||Height||cm|Mean|167.82|167.82|Standard Deviation|8.866|8.866|||
3648705|NCT02465450|3495707|B2|||Height||cm|Mean|167.75|167.75|Standard Deviation|9.192|9.192|||
3648706|NCT02465450|3495708|B1|||Height||cm|Mean|171.30|171.3|Standard Deviation|9.724|9.724|||
3648707|NCT02465450|3495705|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3648708|NCT02465450|3495706|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3648709|NCT02465450|3495707|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648710|NCT02465450|3495708|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648711|NCT02465450|3495705|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648712|NCT02465450|3495706|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648713|NCT02465450|3495707|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648714|NCT02465450|3495708|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648715|NCT02465450|3495705|B4||White|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3648716|NCT02465450|3495706|B3||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3648717|NCT02465450|3495707|B2||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3648718|NCT02465450|3495708|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3648719|NCT02465450|3495705|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3648720|NCT02465450|3495706|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3648721|NCT02465450|3495707|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648722|NCT02465450|3495708|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3648723|NCT02465450|3495705|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648724|NCT02465450|3495706|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648725|NCT02465450|3495707|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648726|NCT02465450|3495708|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648727|NCT02465450|3495705|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648728|NCT02465450|3495706|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648729|NCT02465450|3495707|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648730|NCT02465450|3495708|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648731|NCT02465450|3495705|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648732|NCT02465450|3495706|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648733|NCT02465450|3495707|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648734|NCT02465450|3495708|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648735|NCT02465450|3495705|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648736|NCT02465450|3495706|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648737|NCT02465450|3495707|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648738|NCT02465450|3495708|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648739|NCT02465450|3495705|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3648740|NCT02465450|3495706|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3648741|NCT02465450|3495707|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3648742|NCT02465450|3495708|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3648743|NCT02465450|3495705|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3648744|NCT02465450|3495706|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648745|NCT02465450|3495707|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3648746|NCT02465450|3495708|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648747|NCT02465450|3495705|B4||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3648748|NCT02465450|3495706|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3648749|NCT02465450|3495707|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3648750|NCT02465450|3495708|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3648751|NCT02465450|3495705|B4||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3648752|NCT02465450|3495706|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3648753|NCT02465450|3495707|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3648754|NCT02465450|3495708|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3648755|NCT02465450|3495705|B4|||Age||years|Mean|28.4|28.4|Standard Deviation|8.81|8.81|||
3648756|NCT02465450|3495706|B3|||Age||years|Mean|29.2|29.2|Standard Deviation|8.55|8.55|||
3648757|NCT02465450|3495707|B2|||Age||years|Mean|28.8|28.8|Standard Deviation|10.40|10.4|||
3648758|NCT02465450|3495708|B1|||Age||years|Mean|26.9|26.9|Standard Deviation|7.66|7.66|||
3648759|NCT02465450|3495705|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3648760|NCT02465450|3495706|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3648761|NCT02465450|3495707|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3648762|NCT02465450|3495708|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3648763|NCT02465450|3495705|B4||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
3648764|NCT02465450|3495706|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3648765|NCT02465450|3495707|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3648766|NCT02465450|3495708|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3648767|NCT02465450|3495705|B4||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3648768|NCT02465450|3495706|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3648769|NCT02465450|3495707|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3648770|NCT02465450|3495708|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3648771|NCT02465437|3495733|B5|||Baseline FVC % Predicted||percent predicted|Mean|84.33|84.33|Standard Deviation|12.185|12.185|||
3648772|NCT02465437|3495734|B4|||Baseline FVC % Predicted||percent predicted|Mean|79.61|79.61|Standard Deviation|10.286|10.286|||
3648773|NCT02465437|3495735|B3|||Baseline FVC % Predicted||percent predicted|Mean|80.10|80.1|Standard Deviation|15.993|15.993|||
3648774|NCT02465437|3495736|B2|||Baseline FVC % Predicted||percent predicted|Mean|93.79|93.79|Standard Deviation|11.740|11.74|||
3648775|NCT02465437|3495737|B1|||Baseline FVC % Predicted||percent predicted|Mean|84.15|84.15|Standard Deviation|9.044|9.044|||
3648776|NCT02465437|3495733|B5|||Baseline HAQ-DI|Health Assessment Questionnaire - Disability Index includes 8 sections: dressing, arising, eating, walking, hygiene, reach, grip, and activities. There are two or three questions for each section. Scoring within each section is from 0 (without any difficulty) to 3 (unable to do). The eight scores of the eight sections are summed and divided by 8. If one section is not completed by a subject, the summed score is divided by 7. As such, maximum scores can vary with a min of 0. The result is the DI, the disability index or functional disability index. Higher scores indicate worse symptomology.|units on a scale|Mean|1.26|1.26|Standard Deviation|0.809|0.809|||
3648777|NCT02465437|3495734|B4|||Baseline HAQ-DI|Health Assessment Questionnaire - Disability Index includes 8 sections: dressing, arising, eating, walking, hygiene, reach, grip, and activities. There are two or three questions for each section. Scoring within each section is from 0 (without any difficulty) to 3 (unable to do). The eight scores of the eight sections are summed and divided by 8. If one section is not completed by a subject, the summed score is divided by 7. As such, maximum scores can vary with a min of 0. The result is the DI, the disability index or functional disability index. Higher scores indicate worse symptomology.|units on a scale|Mean|1.51|1.51|Standard Deviation|0.793|0.793|||
3648778|NCT02465437|3495735|B3|||Baseline HAQ-DI|Health Assessment Questionnaire - Disability Index includes 8 sections: dressing, arising, eating, walking, hygiene, reach, grip, and activities. There are two or three questions for each section. Scoring within each section is from 0 (without any difficulty) to 3 (unable to do). The eight scores of the eight sections are summed and divided by 8. If one section is not completed by a subject, the summed score is divided by 7. As such, maximum scores can vary with a min of 0. The result is the DI, the disability index or functional disability index. Higher scores indicate worse symptomology.|units on a scale|Mean|0.83|0.83|Standard Deviation|0.890|0.89|||
3648805|NCT02465437|3495737|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3648806|NCT02465437|3495733|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3648779|NCT02465437|3495736|B2|||Baseline HAQ-DI|Health Assessment Questionnaire - Disability Index includes 8 sections: dressing, arising, eating, walking, hygiene, reach, grip, and activities. There are two or three questions for each section. Scoring within each section is from 0 (without any difficulty) to 3 (unable to do). The eight scores of the eight sections are summed and divided by 8. If one section is not completed by a subject, the summed score is divided by 7. As such, maximum scores can vary with a min of 0. The result is the DI, the disability index or functional disability index. Higher scores indicate worse symptomology.|units on a scale|Mean|1.49|1.49|Standard Deviation|0.697|0.697|||
3648780|NCT02465437|3495737|B1|||Baseline HAQ-DI|Health Assessment Questionnaire - Disability Index includes 8 sections: dressing, arising, eating, walking, hygiene, reach, grip, and activities. There are two or three questions for each section. Scoring within each section is from 0 (without any difficulty) to 3 (unable to do). The eight scores of the eight sections are summed and divided by 8. If one section is not completed by a subject, the summed score is divided by 7. As such, maximum scores can vary with a min of 0. The result is the DI, the disability index or functional disability index. Higher scores indicate worse symptomology.|units on a scale|Mean|1.07|1.07|Standard Deviation|0.745|0.745|||
3648781|NCT02465437|3495733|B5|||Baseline Modified Rodnan Skin Score (mRSS)|The mRSS is an evaluation of patient’s skin thickness by clinical palpation using a 0–3 scale; 0 = normal skin; 1 = mild thickness; 2 = moderate thickness; 3 = severe thickness with inability to pinch the skin into a fold for each of 17 surface anatomic areas of the body: face, anterior chest, abdomen, and, with right and left sides of the body separately evaluated, the fingers, forearms, upper arms, thighs, lower legs, dorsum of hands and feet. Individual values are summed and defined as the total skin score. Lowest score of 0 and maximum of 51 with higher scores indicate worse symptomology.|units on a scale|Mean|24.5|24.5|Standard Deviation|10.60|10.6|||
3648782|NCT02465437|3495734|B4|||Baseline Modified Rodnan Skin Score (mRSS)|The mRSS is an evaluation of patient’s skin thickness by clinical palpation using a 0–3 scale; 0 = normal skin; 1 = mild thickness; 2 = moderate thickness; 3 = severe thickness with inability to pinch the skin into a fold for each of 17 surface anatomic areas of the body: face, anterior chest, abdomen, and, with right and left sides of the body separately evaluated, the fingers, forearms, upper arms, thighs, lower legs, dorsum of hands and feet. Individual values are summed and defined as the total skin score. Lowest score of 0 and maximum of 51 with higher scores indicate worse symptomology.|units on a scale|Mean|26.2|26.2|Standard Deviation|11.12|11.12|||
3648783|NCT02465437|3495735|B3|||Baseline Modified Rodnan Skin Score (mRSS)|The mRSS is an evaluation of patient’s skin thickness by clinical palpation using a 0–3 scale; 0 = normal skin; 1 = mild thickness; 2 = moderate thickness; 3 = severe thickness with inability to pinch the skin into a fold for each of 17 surface anatomic areas of the body: face, anterior chest, abdomen, and, with right and left sides of the body separately evaluated, the fingers, forearms, upper arms, thighs, lower legs, dorsum of hands and feet. Individual values are summed and defined as the total skin score. Lowest score of 0 and maximum of 51 with higher scores indicate worse symptomology.|units on a scale|Mean|22.3|22.3|Standard Deviation|10.16|10.16|||
3648784|NCT02465437|3495736|B2|||Baseline Modified Rodnan Skin Score (mRSS)|The mRSS is an evaluation of patient’s skin thickness by clinical palpation using a 0–3 scale; 0 = normal skin; 1 = mild thickness; 2 = moderate thickness; 3 = severe thickness with inability to pinch the skin into a fold for each of 17 surface anatomic areas of the body: face, anterior chest, abdomen, and, with right and left sides of the body separately evaluated, the fingers, forearms, upper arms, thighs, lower legs, dorsum of hands and feet. Individual values are summed and defined as the total skin score. Lowest score of 0 and maximum of 51 with higher scores indicate worse symptomology.|units on a scale|Mean|26.7|26.7|Standard Deviation|12.03|12.03|||
3648785|NCT02465437|3495737|B1|||Baseline Modified Rodnan Skin Score (mRSS)|The mRSS is an evaluation of patient’s skin thickness by clinical palpation using a 0–3 scale; 0 = normal skin; 1 = mild thickness; 2 = moderate thickness; 3 = severe thickness with inability to pinch the skin into a fold for each of 17 surface anatomic areas of the body: face, anterior chest, abdomen, and, with right and left sides of the body separately evaluated, the fingers, forearms, upper arms, thighs, lower legs, dorsum of hands and feet. Individual values are summed and defined as the total skin score. Lowest score of 0 and maximum of 51 with higher scores indicate worse symptomology.|units on a scale|Mean|21.6|21.6|Standard Deviation|9.29|9.29|||
3648786|NCT02465437|3495733|B5|United States||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3648787|NCT02465437|3495734|B4|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3648788|NCT02465437|3495735|B3|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3648789|NCT02465437|3495736|B2|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3648790|NCT02465437|3495737|B1|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3648791|NCT02465437|3495733|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648792|NCT02465437|3495734|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648793|NCT02465437|3495735|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648794|NCT02465437|3495736|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648795|NCT02465437|3495737|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648796|NCT02465437|3495733|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648797|NCT02465437|3495734|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648798|NCT02465437|3495735|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648799|NCT02465437|3495736|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648800|NCT02465437|3495737|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648801|NCT02465437|3495733|B5||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3648802|NCT02465437|3495734|B4||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3648803|NCT02465437|3495735|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3648804|NCT02465437|3495736|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3648807|NCT02465437|3495734|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648808|NCT02465437|3495735|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648809|NCT02465437|3495736|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3648810|NCT02465437|3495737|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3648811|NCT02465437|3495733|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648812|NCT02465437|3495734|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648813|NCT02465437|3495735|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648814|NCT02465437|3495736|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648815|NCT02465437|3495737|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648816|NCT02465437|3495733|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3648817|NCT02465437|3495734|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3648818|NCT02465437|3495735|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648819|NCT02465437|3495736|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648820|NCT02465437|3495737|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3648821|NCT02465437|3495733|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3648822|NCT02465437|3495734|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648823|NCT02465437|3495735|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3648824|NCT02465437|3495736|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648825|NCT02465437|3495737|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648826|NCT02465437|3495733|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3648827|NCT02465437|3495734|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648828|NCT02465437|3495735|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3648829|NCT02465437|3495736|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648830|NCT02465437|3495737|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648831|NCT02465437|3495733|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3648832|NCT02465437|3495734|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3648833|NCT02465437|3495735|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3648834|NCT02465437|3495736|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3648835|NCT02465437|3495737|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3648836|NCT02465437|3495733|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3648837|NCT02465437|3495734|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3648838|NCT02465437|3495735|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3648839|NCT02465437|3495736|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3648840|NCT02465437|3495737|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3648841|NCT02465437|3495733|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3648842|NCT02465437|3495734|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3648843|NCT02465437|3495735|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3648844|NCT02465437|3495736|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3648845|NCT02465437|3495737|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3648846|NCT02465437|3495733|B5||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3648847|NCT02465437|3495734|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3648848|NCT02465437|3495735|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3648849|NCT02465437|3495736|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3648850|NCT02465437|3495737|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3648851|NCT02465437|3495733|B5|||Age||years|Mean|47.9|47.9|Standard Deviation|10.57|10.57|||
3648852|NCT02465437|3495734|B4|||Age||years|Mean|46.5|46.5|Standard Deviation|11.05|11.05|||
3648853|NCT02465437|3495735|B3|||Age||years|Mean|49.1|49.1|Standard Deviation|14.57|14.57|||
3648854|NCT02465437|3495736|B2|||Age||years|Mean|47.2|47.2|Standard Deviation|4.63|4.63|||
3648855|NCT02465437|3495737|B1|||Age||years|Mean|49.7|49.7|Standard Deviation|10.75|10.75|||
3648856|NCT02465437|3495733|B5||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3648857|NCT02465437|3495734|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3648858|NCT02465437|3495735|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3648859|NCT02465437|3495736|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3648860|NCT02465437|3495737|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3648861|NCT02465437|3495733|B5||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3648862|NCT02465437|3495734|B4||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3648863|NCT02465437|3495735|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3648864|NCT02465437|3495736|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3648865|NCT02465437|3495737|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3648866|NCT02465437|3495733|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3648867|NCT02465437|3495734|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3648868|NCT02465437|3495735|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3648869|NCT02465437|3495736|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3648870|NCT02465437|3495737|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3648871|NCT02465372|3495758|B3||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
3648872|NCT02465372|3495759|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3648873|NCT02465372|3495760|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3648874|NCT02465372|3495758|B3||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3648875|NCT02465372|3495759|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3648876|NCT02465372|3495760|B1||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3648877|NCT02465372|3495758|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3648878|NCT02465372|3495759|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3648879|NCT02465372|3495760|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3648880|NCT02465372|3495758|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3648881|NCT02465372|3495759|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3648882|NCT02465372|3495760|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3648883|NCT02465372|3495758|B3||<=18 years|Age||Participants|Count of Participants|380|380.0||||||
3648884|NCT02465372|3495759|B2||<=18 years|Age||Participants|Count of Participants|153|153.0||||||
3648885|NCT02465372|3495760|B1||<=18 years|Age||Participants|Count of Participants|227|227.0||||||
3648886|NCT02465216|3495771|B6|||BMI||kg/m2|Mean|20.9|20.9|Standard Deviation|3.39|3.39|||
3648887|NCT02465216|3495772|B5|||BMI||kg/m2|Mean|21.4|21.4|Standard Deviation|1.94|1.94|||
3648888|NCT02465216|3495773|B4|||BMI||kg/m2|Mean|21.4|21.4|Standard Deviation|4.92|4.92|||
3648889|NCT02465216|3495774|B3|||BMI||kg/m2|Mean|19.6|19.6|Standard Deviation|2.38|2.38|||
3648890|NCT02465216|3495775|B2|||BMI||kg/m2|Mean|22.8|22.8|Standard Deviation|5.4|5.4|||
3648891|NCT02465216|3495776|B1|||BMI||kg/m2|Mean|20.6|20.6|Standard Deviation|2.32|2.32|||
3648892|NCT02465216|3495771|B6|South Africa||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3648893|NCT02465216|3495772|B5|South Africa||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3648894|NCT02465216|3495773|B4|South Africa||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3648895|NCT02465216|3495774|B3|South Africa||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3648896|NCT02465216|3495775|B2|South Africa||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3648897|NCT02465216|3495776|B1|South Africa||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3648898|NCT02465216|3495771|B6|Black African||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3648899|NCT02465216|3495772|B5|Black African||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3648900|NCT02465216|3495773|B4|Black African||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3648901|NCT02465216|3495774|B3|Black African||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3648902|NCT02465216|3495775|B2|Black African||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3648903|NCT02465216|3495776|B1|Black African||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3648904|NCT02465216|3495771|B6|African Mixed Race||Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
3648905|NCT02465216|3495772|B5|African Mixed Race||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3648906|NCT02465216|3495773|B4|African Mixed Race||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3648907|NCT02465216|3495774|B3|African Mixed Race||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3648908|NCT02465216|3495775|B2|African Mixed Race||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3648909|NCT02465216|3495776|B1|African Mixed Race||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3648910|NCT02465216|3495771|B6||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3648911|NCT02465216|3495772|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3648912|NCT02465216|3495773|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3648913|NCT02465216|3495774|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3648914|NCT02465216|3495775|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3648915|NCT02465216|3495776|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3648916|NCT02465216|3495771|B6||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3648917|NCT02465216|3495772|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3648918|NCT02465216|3495773|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3648919|NCT02465216|3495774|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3648920|NCT02465216|3495775|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3648921|NCT02465216|3495776|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3648922|NCT02465216|3495771|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3648923|NCT02465216|3495772|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3648924|NCT02465216|3495773|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3648925|NCT02465216|3495774|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3648926|NCT02465216|3495775|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3648927|NCT02465216|3495776|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3648928|NCT02465216|3495771|B6||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3648929|NCT02465216|3495772|B5||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3648930|NCT02465216|3495773|B4||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3648931|NCT02465216|3495774|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3648932|NCT02465216|3495775|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3648933|NCT02465216|3495776|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3648934|NCT02465216|3495771|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3648935|NCT02465216|3495772|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3648936|NCT02465216|3495773|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3648937|NCT02465216|3495774|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3648938|NCT02465216|3495775|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3648939|NCT02465216|3495776|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3648940|NCT02465203|3495792|B4|||Baseline HCV RNA Load (log10 IU/mL)||log10 IU/mL|Mean|6.26|6.26|Standard Deviation|1.0959|1.0959|||
3648941|NCT02465203|3495793|B3|||Baseline HCV RNA Load (log10 IU/mL)||log10 IU/mL|Mean|6.17|6.17|Standard Deviation|1.1974|1.1974|||
3648942|NCT02465203|3495794|B2|||Baseline HCV RNA Load (log10 IU/mL)||log10 IU/mL|Mean|6.19|6.19|Standard Deviation|0.5171|0.5171|||
3648943|NCT02465203|3495795|B1|||Baseline HCV RNA Load (log10 IU/mL)||log10 IU/mL|Mean|6.32|6.32|Standard Deviation|1.3375|1.3375|||
3648944|NCT02465203|3495792|B4|||BMI|Body Mass Index|kg/m^2|Mean|26.06|26.06|Standard Deviation|3.89|3.89|||
3648945|NCT02465203|3495793|B3|||BMI|Body Mass Index|kg/m^2|Mean|26.24|26.24|Standard Deviation|4.12|4.12|||
3648946|NCT02465203|3495794|B2|||BMI|Body Mass Index|kg/m^2|Mean|25.54|25.54|Standard Deviation|4.08|4.08|||
3648947|NCT02465203|3495795|B1|||BMI|Body Mass Index|kg/m^2|Mean|26.35|26.35|Standard Deviation|3.76|3.76|||
3648948|NCT02465203|3495792|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3648949|NCT02465203|3495793|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3648950|NCT02465203|3495794|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3648951|NCT02465203|3495795|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3648952|NCT02465203|3495792|B4|Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3648953|NCT02465203|3495793|B3|Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3648954|NCT02465203|3495794|B2|Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3648955|NCT02465203|3495795|B1|Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3648956|NCT02465203|3495792|B4|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3648957|NCT02465203|3495793|B3|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3648958|NCT02465203|3495794|B2|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3648959|NCT02465203|3495795|B1|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3648960|NCT02465203|3495792|B4|Asian||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3648961|NCT02465203|3495793|B3|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3648962|NCT02465203|3495794|B2|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3648963|NCT02465203|3495795|B1|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3648964|NCT02465203|3495792|B4|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3648965|NCT02465203|3495793|B3|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3648966|NCT02465203|3495794|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3648967|NCT02465203|3495795|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3648968|NCT02465203|3495792|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
3648969|NCT02465203|3495793|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3648970|NCT02465203|3495794|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3648971|NCT02465203|3495795|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
3648972|NCT02465203|3495792|B4||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3648973|NCT02465203|3495793|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3648974|NCT02465203|3495794|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3648975|NCT02465203|3495795|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3648976|NCT02465203|3495792|B4||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3648977|NCT02465203|3495793|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3648978|NCT02465203|3495794|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3648979|NCT02465203|3495795|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3648980|NCT02465203|3495792|B4|||Age||years|Mean|52.3|52.3|Standard Deviation|10.06|10.06|||
3648981|NCT02465203|3495793|B3|||Age||years|Mean|46.5|46.5|Standard Deviation|7.88|7.88|||
3648982|NCT02465203|3495794|B2|||Age||years|Mean|53.8|53.8|Standard Deviation|10.57|10.57|||
3648983|NCT02465203|3495795|B1|||Age||years|Mean|52.7|52.7|Standard Deviation|9.86|9.86|||
3648984|NCT02465099|3495808|B3|United States||Region of Enrollment||participants|Number|64|64.0||||||
3648985|NCT02465099|3495809|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3648986|NCT02465099|3495810|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
3648987|NCT02465099|3495808|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3648988|NCT02465099|3495809|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3648989|NCT02465099|3495810|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3648990|NCT02465099|3495808|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648991|NCT02465099|3495809|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648992|NCT02465099|3495810|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3648993|NCT02465099|3495808|B3||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3648994|NCT02465099|3495809|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3648995|NCT02465099|3495810|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3648996|NCT02465099|3495808|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3648997|NCT02465099|3495809|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3648998|NCT02465099|3495810|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3648999|NCT02465099|3495808|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649000|NCT02465099|3495809|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649001|NCT02465099|3495810|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649002|NCT02465099|3495808|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3649003|NCT02465099|3495809|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649004|NCT02465099|3495810|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3649005|NCT02465099|3495808|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649006|NCT02465099|3495809|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649007|NCT02465099|3495810|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649008|NCT02465099|3495808|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3649009|NCT02465099|3495809|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3649010|NCT02465099|3495810|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3649011|NCT02465099|3495808|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3649012|NCT02465099|3495809|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3649013|NCT02465099|3495810|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3649014|NCT02465099|3495808|B3|||Age||years|Mean|14.9|14.9|Standard Deviation|2.43|2.43|||
3649015|NCT02465099|3495809|B2|||Age||years|Mean|14.5|14.5|Standard Deviation|1.84|1.84|||
3649016|NCT02465099|3495810|B1|||Age||years|Mean|15.1|15.1|Standard Deviation|2.64|2.64|||
3649017|NCT02465073|3495817|B4|United States||Region of Enrollment||participants|Number|45|45.0||||||
3649018|NCT02465073|3495818|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
3649019|NCT02465073|3495819|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3649020|NCT02465073|3495820|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3649021|NCT02465073|3495817|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3649022|NCT02465073|3495818|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3649023|NCT02465073|3495819|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3649024|NCT02465073|3495820|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3649025|NCT02465073|3495817|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3649026|NCT02465073|3495818|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3649027|NCT02465073|3495819|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3649028|NCT02465073|3495820|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3649029|NCT02465073|3495817|B4|||Age||years|Mean|60|60.0|Full Range|||23.0|76.0|
3649030|NCT02465073|3495818|B3|||Age||years|Mean|60|60.0|Full Range|||23.0|76.0|
3649031|NCT02465073|3495819|B2|||Age||years|Mean|63|63.0|Full Range|||39.0|72.0|
3649032|NCT02465073|3495820|B1|||Age||years|Mean|57|57.0|Full Range|||31.0|67.0|
3649033|NCT02465073|3495817|B4||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3649034|NCT02465073|3495818|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3649035|NCT02465073|3495819|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3649036|NCT02465073|3495820|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3649037|NCT02465073|3495817|B4||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3649038|NCT02465073|3495818|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3649039|NCT02465073|3495819|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3649040|NCT02465073|3495820|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3649041|NCT02465073|3495817|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3649042|NCT02465073|3495818|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3649043|NCT02465073|3495819|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3649044|NCT02465073|3495820|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3649045|NCT02464176|3495830|B4|||BMI||kg/m^2|Median|29.3|29.3|Inter-Quartile Range|||25.45|34.05|
3649046|NCT02464176|3495831|B3|||BMI||kg/m^2|Median|28.3|28.3|Inter-Quartile Range|||22.7|34.2|
3649047|NCT02464176|3495832|B2|||BMI||kg/m^2|Median|29.3|29.3|Inter-Quartile Range|||25.6|32.6|
3649048|NCT02464176|3495833|B1|||BMI||kg/m^2|Median|29.8|29.8|Inter-Quartile Range|||25.5|36.1|
3649049|NCT02464176|3495830|B4|United States||Region of Enrollment||participants|Number|115|115.0||||||
3649050|NCT02464176|3495831|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
3649051|NCT02464176|3495832|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
3649052|NCT02464176|3495833|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3649053|NCT02464176|3495830|B4||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3649054|NCT02464176|3495831|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3649055|NCT02464176|3495832|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3649056|NCT02464176|3495833|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3649057|NCT02464176|3495830|B4||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3649058|NCT02464176|3495831|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3649059|NCT02464176|3495832|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3649060|NCT02464176|3495833|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3649061|NCT02464176|3495830|B4|||Age||years|Median|63|63.0|Inter-Quartile Range|||57.0|71.0|
3649062|NCT02464176|3495831|B3|||Age||years|Median|66|66.0|Inter-Quartile Range|||62.0|72.0|
3649063|NCT02464176|3495832|B2|||Age||years|Median|63|63.0|Inter-Quartile Range|||56.0|71.0|
3649064|NCT02464176|3495833|B1|||Age||years|Median|61|61.0|Inter-Quartile Range|||51.0|68.0|
3649065|NCT02464176|3495830|B4||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
3649066|NCT02464176|3495831|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3649067|NCT02464176|3495832|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3649068|NCT02464176|3495833|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3649069|NCT02464176|3495830|B4||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
3649070|NCT02464176|3495831|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3649071|NCT02464176|3495832|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3649072|NCT02464176|3495833|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3649073|NCT02464176|3495830|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3649074|NCT02464176|3495831|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3649075|NCT02464176|3495832|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3649076|NCT02464176|3495833|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3649077|NCT02464163|3495852|B5||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3649078|NCT02464163|3495853|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3649079|NCT02464163|3495854|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3649080|NCT02464163|3495855|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3649081|NCT02464163|3495856|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3649082|NCT02464163|3495852|B5||Female|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
3649083|NCT02464163|3495853|B4||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3649084|NCT02464163|3495854|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3649085|NCT02464163|3495855|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3649086|NCT02464163|3495856|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3649087|NCT02464163|3495852|B5|Age, Categorical|>=65 Years|Age, Customized||Participants|Count of Participants|201|201.0||||||
3649088|NCT02464163|3495853|B4|Age, Categorical|>=65 Years|Age, Customized||Participants|Count of Participants|52|52.0||||||
3649089|NCT02464163|3495854|B3|Age, Categorical|>=65 Years|Age, Customized||Participants|Count of Participants|50|50.0||||||
3649090|NCT02464163|3495855|B2|Age, Categorical|>=65 Years|Age, Customized||Participants|Count of Participants|49|49.0||||||
3649091|NCT02464163|3495856|B1|Age, Categorical|>=65 Years|Age, Customized||Participants|Count of Participants|50|50.0||||||
3649092|NCT02464163|3495852|B5|Age, Categorical|<65 Years|Age, Customized||Participants|Count of Participants|181|181.0||||||
3649093|NCT02464163|3495853|B4|Age, Categorical|<65 Years|Age, Customized||Participants|Count of Participants|42|42.0||||||
3649094|NCT02464163|3495854|B3|Age, Categorical|<65 Years|Age, Customized||Participants|Count of Participants|49|49.0||||||
3649095|NCT02464163|3495855|B2|Age, Categorical|<65 Years|Age, Customized||Participants|Count of Participants|45|45.0||||||
3649096|NCT02464163|3495856|B1|Age, Categorical|<65 Years|Age, Customized||Participants|Count of Participants|45|45.0||||||
3649097|NCT02463981|3495881|B3|China||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3649098|NCT02463981|3495882|B2|China||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3649099|NCT02463981|3495883|B1|China||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3649100|NCT02463981|3495881|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3649101|NCT02463981|3495882|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3649102|NCT02463981|3495883|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3649103|NCT02463981|3495881|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3649104|NCT02463981|3495882|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3649105|NCT02463981|3495883|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3649106|NCT02463981|3495881|B3|||Age||years|Mean|21.95|21.95|Standard Deviation|0.4|0.4|||
3649107|NCT02463981|3495882|B2|||Age||years|Mean|21.7|21.7|Standard Deviation|0.5|0.5|||
3649108|NCT02463981|3495883|B1|||Age||years|Mean|22.2|22.2|Standard Deviation|0.3|0.3|||
3649109|NCT02463409|3495892|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3649110|NCT02463409|3495892|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649111|NCT02463409|3495892|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649112|NCT02463409|3495892|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3649113|NCT02463409|3495892|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649114|NCT02463409|3495892|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649115|NCT02463409|3495892|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649116|NCT02463409|3495892|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649117|NCT02463409|3495892|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3649118|NCT02463409|3495892|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3649119|NCT02463409|3495892|B1|||Age||years|Mean|14.4|14.4|Standard Deviation|3.1|3.1|||
3649120|NCT02463331|3495898|B3||Male|Gender||Participants|Count of Participants|12|12.0||||||
3649121|NCT02463331|3495899|B2||Male|Gender||Participants|Count of Participants|7|7.0||||||
3649122|NCT02463331|3495900|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
3649123|NCT02463331|3495898|B3||Female|Gender||Participants|Count of Participants|45|45.0||||||
3649124|NCT02463331|3495899|B2||Female|Gender||Participants|Count of Participants|24|24.0||||||
3649125|NCT02463331|3495900|B1||Female|Gender||Participants|Count of Participants|21|21.0||||||
3649126|NCT02463331|3495898|B3|||Age||years|Mean|37.28|37.28|Standard Deviation|16.84|16.84|||
3649127|NCT02463331|3495899|B2|||Age||years|Mean|37.23|37.23|Standard Deviation|17.63|17.63|||
3649128|NCT02463331|3495900|B1|||Age||years|Mean|37.54|37.54|Standard Deviation|15.99|15.99|||
3649129|NCT02463227|3495909|B1|||CD4 Cell Count||cells/mm^3|Median|896|896.0|Inter-Quartile Range|||579.0|1053.0|
3649130|NCT02463227|3495909|B1|= 50600 copies/mL||HIV-1 RNA|The categories < 20 copies/mL and < 40 copies/mL are mutually exclusive. These categories represent results below the limit of detection from different assays used to assess HIV-1 RNA.|Participants|Count of Participants|1|1.0||||||
3649131|NCT02463227|3495909|B1|= 40 copies/mL||HIV-1 RNA|The categories < 20 copies/mL and < 40 copies/mL are mutually exclusive. These categories represent results below the limit of detection from different assays used to assess HIV-1 RNA.|Participants|Count of Participants|1|1.0||||||
3649132|NCT02463227|3495909|B1|< 40 copies/mL||HIV-1 RNA|The categories < 20 copies/mL and < 40 copies/mL are mutually exclusive. These categories represent results below the limit of detection from different assays used to assess HIV-1 RNA.|Participants|Count of Participants|2|2.0||||||
3649133|NCT02463227|3495909|B1|< 20 copies/mL||HIV-1 RNA|The categories < 20 copies/mL and < 40 copies/mL are mutually exclusive. These categories represent results below the limit of detection from different assays used to assess HIV-1 RNA.|Participants|Count of Participants|10|10.0||||||
3649134|NCT02463227|3495909|B1|||BMI||kg/m^2|Median|28.3|28.3|Inter-Quartile Range|||25.4|31.3|
3649135|NCT02463227|3495909|B1|||Weight||kilograms|Median|86|86.0|Inter-Quartile Range|||77.0|102.0|
3649136|NCT02463227|3495909|B1|Previously||Intravenous Drug History||Participants|Count of Participants|1|1.0||||||
3649137|NCT02463227|3495909|B1|Never||Intravenous Drug History||Participants|Count of Participants|13|13.0||||||
3649138|NCT02463227|3495909|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3649139|NCT02463227|3495909|B1|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3649140|NCT02463227|3495909|B1|Black Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3649141|NCT02463227|3495909|B1|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3649142|NCT02463227|3495909|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3649143|NCT02463227|3495909|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3649144|NCT02463227|3495909|B1|50+ years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3649145|NCT02463227|3495909|B1|40-49 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
3649146|NCT02463227|3495909|B1|30-39 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
3649147|NCT02463227|3495909|B1|18-29 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3649148|NCT02463227|3495909|B1|||Age||years|Median|38|38.0|Inter-Quartile Range|||34.0|44.0|
3649149|NCT02463097|3495917|B1|Israel||Region of Enrollment||participants|Number|12|12.0||||||
3649150|NCT02463097|3495917|B1|United States||Region of Enrollment||participants|Number|112|112.0||||||
3649151|NCT02463097|3495917|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3649152|NCT02463097|3495917|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3649153|NCT02463097|3495917|B1|||Age||years|Mean|37.8|37.8|Standard Deviation|16.46|16.46|||
3649154|NCT02463097|3495917|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3649155|NCT02463097|3495917|B1||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
3649156|NCT02463097|3495917|B1||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
3649157|NCT02463071|3495923|B4|No||established CVD||Participants|Number|338|338.0||||||
3649158|NCT02463071|3495924|B3|No||established CVD||Participants|Number|67|67.0||||||
3649159|NCT02463071|3495925|B2|No||established CVD||Participants|Number|141|141.0||||||
3649160|NCT02463071|3495926|B1|No||established CVD||Participants|Number|130|130.0||||||
3649161|NCT02463071|3495923|B4|Yes||established CVD||Participants|Number|44|44.0||||||
3649162|NCT02463071|3495924|B3|Yes||established CVD||Participants|Number|9|9.0||||||
3649163|NCT02463071|3495925|B2|Yes||established CVD||Participants|Number|13|13.0||||||
3649164|NCT02463071|3495926|B1|Yes||established CVD||Participants|Number|22|22.0||||||
3649165|NCT02463071|3495923|B4|No||Diabetes||Participants|Number|225|225.0||||||
3649166|NCT02463071|3495924|B3|No||Diabetes||Participants|Number|47|47.0||||||
3649167|NCT02463071|3495925|B2|No||Diabetes||Participants|Number|86|86.0||||||
3649168|NCT02463071|3495926|B1|No||Diabetes||Participants|Number|92|92.0||||||
3649169|NCT02463071|3495923|B4|Yes||Diabetes||Participants|Number|157|157.0||||||
3649170|NCT02463071|3495924|B3|Yes||Diabetes||Participants|Number|29|29.0||||||
3649171|NCT02463071|3495925|B2|Yes||Diabetes||Participants|Number|68|68.0||||||
3649172|NCT02463071|3495926|B1|Yes||Diabetes||Participants|Number|60|60.0||||||
3649173|NCT02463071|3495923|B4|No||Hypertension||Participants|Number|138|138.0||||||
3649174|NCT02463071|3495924|B3|No||Hypertension||Participants|Number|32|32.0||||||
3649175|NCT02463071|3495925|B2|No||Hypertension||Participants|Number|51|51.0||||||
3649176|NCT02463071|3495926|B1|No||Hypertension||Participants|Number|55|55.0||||||
3649177|NCT02463071|3495923|B4|Yes||Hypertension||Participants|Number|244|244.0||||||
3649178|NCT02463071|3495924|B3|Yes||Hypertension||Participants|Number|44|44.0||||||
3649179|NCT02463071|3495925|B2|Yes||Hypertension||Participants|Number|103|103.0||||||
3649180|NCT02463071|3495926|B1|Yes||Hypertension||Participants|Number|97|97.0||||||
3649181|NCT02463071|3495923|B4|>= 40 mg/dL||Baseline HDL-C||Participants|Number|265|265.0||||||
3649182|NCT02463071|3495924|B3|>= 40 mg/dL||Baseline HDL-C||Participants|Number|54|54.0||||||
3649183|NCT02463071|3495925|B2|>= 40 mg/dL||Baseline HDL-C||Participants|Number|102|102.0||||||
3649184|NCT02463071|3495926|B1|>= 40 mg/dL||Baseline HDL-C||Participants|Number|109|109.0||||||
3649185|NCT02463071|3495923|B4|< 40 mg/dL||Baseline HDL-C||Participants|Number|117|117.0||||||
3649186|NCT02463071|3495924|B3|< 40 mg/dL||Baseline HDL-C||Participants|Number|22|22.0||||||
3649187|NCT02463071|3495925|B2|< 40 mg/dL||Baseline HDL-C||Participants|Number|52|52.0||||||
3649188|NCT02463071|3495926|B1|< 40 mg/dL||Baseline HDL-C||Participants|Number|43|43.0||||||
3649189|NCT02463071|3495923|B4|>= 140 mg/dL||Baseline LDL-C||Participants|Number|41|41.0||||||
3649190|NCT02463071|3495924|B3|>= 140 mg/dL||Baseline LDL-C||Participants|Number|10|10.0||||||
3649191|NCT02463071|3495925|B2|>= 140 mg/dL||Baseline LDL-C||Participants|Number|13|13.0||||||
3649192|NCT02463071|3495926|B1|>= 140 mg/dL||Baseline LDL-C||Participants|Number|18|18.0||||||
3649193|NCT02463071|3495923|B4|< 140 mg/dL||Baseline LDL-C||Participants|Number|341|341.0||||||
3649194|NCT02463071|3495924|B3|< 140 mg/dL||Baseline LDL-C||Participants|Number|66|66.0||||||
3649195|NCT02463071|3495925|B2|< 140 mg/dL||Baseline LDL-C||Participants|Number|141|141.0||||||
3649196|NCT02463071|3495926|B1|< 140 mg/dL||Baseline LDL-C||Participants|Number|134|134.0||||||
3649197|NCT02463071|3495923|B4|No||Concurrent use of statin||Participants|Number|187|187.0||||||
3649198|NCT02463071|3495924|B3|No||Concurrent use of statin||Participants|Number|38|38.0||||||
3649199|NCT02463071|3495925|B2|No||Concurrent use of statin||Participants|Number|76|76.0||||||
3649200|NCT02463071|3495926|B1|No||Concurrent use of statin||Participants|Number|73|73.0||||||
3649201|NCT02463071|3495923|B4|Yes||Concurrent use of statin||Participants|Number|195|195.0||||||
3649202|NCT02463071|3495924|B3|Yes||Concurrent use of statin||Participants|Number|38|38.0||||||
3649203|NCT02463071|3495925|B2|Yes||Concurrent use of statin||Participants|Number|78|78.0||||||
3649204|NCT02463071|3495926|B1|Yes||Concurrent use of statin||Participants|Number|79|79.0||||||
3649205|NCT02463071|3495923|B4|>= 300 mg/dL||Baseline triglyceride||Participants|Number|59|59.0||||||
3649206|NCT02463071|3495924|B3|>= 300 mg/dL||Baseline triglyceride||Participants|Number|12|12.0||||||
3649207|NCT02463071|3495925|B2|>= 300 mg/dL||Baseline triglyceride||Participants|Number|27|27.0||||||
3649208|NCT02463071|3495926|B1|>= 300 mg/dL||Baseline triglyceride||Participants|Number|20|20.0||||||
3649209|NCT02463071|3495923|B4|< 300 mg/dL||Baseline triglyceride||Participants|Number|323|323.0||||||
3649210|NCT02463071|3495924|B3|< 300 mg/dL||Baseline triglyceride||Participants|Number|64|64.0||||||
3649211|NCT02463071|3495925|B2|< 300 mg/dL||Baseline triglyceride||Participants|Number|127|127.0||||||
3649212|NCT02463071|3495926|B1|< 300 mg/dL||Baseline triglyceride||Participants|Number|132|132.0||||||
3649213|NCT02463071|3495923|B4|||Height||cm|Mean|166.8|166.8|Standard Deviation|8.0|8.0|||
3649214|NCT02463071|3495924|B3|||Height||cm|Mean|166.4|166.4|Standard Deviation|9.0|9.0|||
3649215|NCT02463071|3495925|B2|||Height||cm|Mean|167.6|167.6|Standard Deviation|7.7|7.7|||
3649216|NCT02463071|3495926|B1|||Height||cm|Mean|166.1|166.1|Standard Deviation|7.8|7.8|||
3649217|NCT02463071|3495923|B4|||BMI||kg/m2|Mean|26.9|26.9|Standard Deviation|4.0|4.0|||
3649218|NCT02463071|3495924|B3|||BMI||kg/m2|Mean|26.8|26.8|Standard Deviation|3.9|3.9|||
3649219|NCT02463071|3495925|B2|||BMI||kg/m2|Mean|26.9|26.9|Standard Deviation|4.0|4.0|||
3649220|NCT02463071|3495926|B1|||BMI||kg/m2|Mean|26.9|26.9|Standard Deviation|4.0|4.0|||
3649221|NCT02463071|3495923|B4|||Weight||kg|Mean|75.0|75.0|Standard Deviation|13.4|13.4|||
3649222|NCT02463071|3495924|B3|||Weight||kg|Mean|74.4|74.4|Standard Deviation|13.2|13.2|||
3649223|NCT02463071|3495925|B2|||Weight||kg|Mean|75.8|75.8|Standard Deviation|14.1|14.1|||
3649224|NCT02463071|3495926|B1|||Weight||kg|Mean|74.5|74.5|Standard Deviation|12.8|12.8|||
3649225|NCT02463071|3495923|B4|Asian||Race/Ethnicity, Customized||Participants|Number|382|382.0||||||
3649226|NCT02463071|3495924|B3|Asian||Race/Ethnicity, Customized||Participants|Number|76|76.0||||||
3649227|NCT02463071|3495925|B2|Asian||Race/Ethnicity, Customized||Participants|Number|154|154.0||||||
3649228|NCT02463071|3495926|B1|Asian||Race/Ethnicity, Customized||Participants|Number|152|152.0||||||
3649229|NCT02463071|3495923|B4||Male|Sex: Female, Male||Participants|Count of Participants|299|299.0||||||
3649230|NCT02463071|3495924|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3649231|NCT02463071|3495925|B2||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3649232|NCT02463071|3495926|B1||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3649233|NCT02463071|3495923|B4||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3649234|NCT02463071|3495924|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3649235|NCT02463071|3495925|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3649236|NCT02463071|3495926|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3649237|NCT02463071|3495923|B4|||Age||Years|Mean|56.9|56.9|Standard Deviation|10.7|10.7|||
3649238|NCT02463071|3495924|B3|||Age||Years|Mean|57.4|57.4|Standard Deviation|10.9|10.9|||
3649239|NCT02463071|3495925|B2|||Age||Years|Mean|56.5|56.5|Standard Deviation|11.2|11.2|||
3649240|NCT02463071|3495926|B1|||Age||Years|Mean|56.9|56.9|Standard Deviation|10.1|10.1|||
3649241|NCT02462720|3495954|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649242|NCT02462720|3495954|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649243|NCT02462720|3495954|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3649244|NCT02462720|3495954|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3649245|NCT02462720|3495954|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649246|NCT02462720|3495954|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3649247|NCT02462720|3495954|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649248|NCT02462720|3495954|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3649249|NCT02462720|3495954|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3649250|NCT02462720|3495954|B1|||Age||years|Mean|50.9|50.9|Standard Deviation|11.86|11.86|||
3649251|NCT02462473|3495965|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3649252|NCT02462473|3495965|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3649253|NCT02462473|3495965|B1|||Age||years|Mean|46.2|46.2|Standard Deviation|13.15|13.15|||
3649254|NCT02462473|3495965|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3649255|NCT02462473|3495965|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3649256|NCT02462473|3495965|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3649257|NCT02462291|3495976|B3|Italy||Region of Enrollment||participants|Number|163|163.0||||||
3649258|NCT02462291|3495977|B2|Italy||Region of Enrollment||participants|Number|81|81.0||||||
3649259|NCT02462291|3495978|B1|Italy||Region of Enrollment||participants|Number|82|82.0||||||
3649260|NCT02462291|3495976|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3649261|NCT02462291|3495977|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3649262|NCT02462291|3495978|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3649263|NCT02462291|3495976|B3||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3649264|NCT02462291|3495977|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3649265|NCT02462291|3495978|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3649266|NCT02462291|3495976|B3|||Age||years|Mean|77|77.0|Standard Deviation|7|7.0|||
3649267|NCT02462291|3495977|B2|||Age||years|Mean|78|78.0|Standard Deviation|5|5.0|||
3649268|NCT02462291|3495978|B1|||Age||years|Mean|76|76.0|Standard Deviation|4|4.0|||
3649269|NCT02462148|3496017|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3649270|NCT02462148|3496018|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3649271|NCT02462148|3496019|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3649272|NCT02462148|3496020|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3649273|NCT02462148|3496017|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649274|NCT02462148|3496018|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649275|NCT02462148|3496019|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649276|NCT02462148|3496020|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649277|NCT02462148|3496017|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649278|NCT02462148|3496018|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649279|NCT02462148|3496019|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649280|NCT02462148|3496020|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649281|NCT02462148|3496017|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649282|NCT02462148|3496018|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649283|NCT02462148|3496019|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649284|NCT02462148|3496020|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649285|NCT02462148|3496017|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649286|NCT02462148|3496018|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649287|NCT02462148|3496019|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649288|NCT02462148|3496020|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649289|NCT02462148|3496017|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649290|NCT02462148|3496018|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649291|NCT02462148|3496019|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649292|NCT02462148|3496020|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649293|NCT02462148|3496017|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649294|NCT02462148|3496018|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649295|NCT02462148|3496019|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649296|NCT02462148|3496020|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649297|NCT02462148|3496017|B4||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3649298|NCT02462148|3496018|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3649299|NCT02462148|3496019|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3649300|NCT02462148|3496020|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3649301|NCT02462148|3496017|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3649302|NCT02462148|3496018|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3649303|NCT02462148|3496019|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3649304|NCT02462148|3496020|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3649305|NCT02462148|3496017|B4|||Age||years|Mean|62.7|62.7|Standard Deviation|8.9|8.9|||
3649306|NCT02462148|3496018|B3|||Age||years|Mean|59.2|59.2|Standard Deviation|9.1|9.1|||
3649307|NCT02462148|3496019|B2|||Age||years|Mean|63.3|63.3|Standard Deviation|8.9|8.9|||
3649308|NCT02462148|3496020|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|8.7|8.7|||
3649309|NCT02462148|3496017|B4||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
3649310|NCT02462148|3496018|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3649311|NCT02462148|3496019|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3649312|NCT02462148|3496020|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3649313|NCT02462148|3496017|B4||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3649314|NCT02462148|3496018|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3649315|NCT02462148|3496019|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3649316|NCT02462148|3496020|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3649317|NCT02462148|3496017|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3649318|NCT02462148|3496018|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3649319|NCT02462148|3496019|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3649320|NCT02462148|3496020|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3649321|NCT02462057|3496045|B6|Female||Sex/Gender, Customized||Participants|Count of Participants|729|729.0||||||
3649322|NCT02462057|3496046|B5|Female||Sex/Gender, Customized||Participants|Count of Participants|146|146.0||||||
3649323|NCT02462057|3496047|B4|Female||Sex/Gender, Customized||Participants|Count of Participants|134|134.0||||||
3649324|NCT02462057|3496048|B3|Female||Sex/Gender, Customized||Participants|Count of Participants|152|152.0||||||
3649325|NCT02462057|3496049|B2|Female||Sex/Gender, Customized||Participants|Count of Participants|152|152.0||||||
3649326|NCT02462057|3496050|B1|Female||Sex/Gender, Customized||Participants|Count of Participants|145|145.0||||||
3649327|NCT02462057|3496045|B6|||Age||years|Mean|55.4|55.4|Standard Deviation|10.6|10.6|||
3649328|NCT02462057|3496046|B5|||Age||years|Mean|56|56.0|Standard Deviation|10.6|10.6|||
3649329|NCT02462057|3496047|B4|||Age||years|Mean|55.4|55.4|Standard Deviation|10|10.0|||
3649330|NCT02462057|3496048|B3|||Age||years|Mean|55|55.0|Standard Deviation|10.8|10.8|||
3649331|NCT02462057|3496049|B2|||Age||years|Mean|55.2|55.2|Standard Deviation|10.7|10.7|||
3649332|NCT02462057|3496050|B1|||Age||years|Mean|55.9|55.9|Standard Deviation|10.9|10.9|||
3649333|NCT02461992|3496066|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3649334|NCT02461992|3496066|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3649335|NCT02461992|3496066|B1|Greater than or equal to 65 years||Age, Customized||participants|Number|0|0.0||||||
3649336|NCT02461992|3496066|B1|45 to 64 years||Age, Customized||participants|Number|3|3.0||||||
3649337|NCT02461992|3496066|B1|18 to 44 years||Age, Customized||participants|Number|2|2.0||||||
3649338|NCT02461992|3496066|B1|12 to 17 years||Age, Customized||participants|Number|5|5.0||||||
3649339|NCT02461992|3496066|B1|6 to 11 years||Age, Customized||participants|Number|3|3.0||19.6|19.6|||
3649340|NCT02461966|3496083|B4|Egypt||Region of Enrollment||participants|Number|300|300.0||||||
3649341|NCT02461966|3496084|B3|Egypt||Region of Enrollment||participants|Number|60|60.0||||||
3649342|NCT02461966|3496085|B2|Egypt||Region of Enrollment||participants|Number|80|80.0||||||
3649343|NCT02461966|3496086|B1|Egypt||Region of Enrollment||participants|Number|160|160.0||||||
3649344|NCT02461966|3496083|B4||Male|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
3649345|NCT02461966|3496084|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3649346|NCT02461966|3496085|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3649347|NCT02461966|3496086|B1||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3649348|NCT02461966|3496083|B4||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3649349|NCT02461966|3496084|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3649350|NCT02461966|3496085|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3649351|NCT02461966|3496086|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3649352|NCT02461966|3496083|B4|Age||Age||years|Mean|45|45.0|Standard Deviation|23.04|23.04|||
3649353|NCT02461966|3496084|B3|Age||Age||years|Mean|27.80|27.8|Standard Deviation|5.06|5.06|||
3649354|NCT02461966|3496085|B2|Age||Age||years|Mean|50.00|50.0|Standard Deviation|8.72|8.72|||
3649355|NCT02461966|3496086|B1|Age||Age||years|Mean|58.58|58.58|Standard Deviation|9.58|9.58|||
3649356|NCT02461966|3496083|B4||>=65 years|Age|Age, categorical numerical|Participants|Count of Participants|66|66.0||||||
3649357|NCT02461966|3496084|B3||>=65 years|Age|Age, categorical numerical|Participants|Count of Participants|21|21.0||||||
3649358|NCT02461966|3496085|B2||>=65 years|Age|Age, categorical numerical|Participants|Count of Participants|17|17.0||||||
3649359|NCT02461966|3496086|B1||>=65 years|Age|Age, categorical numerical|Participants|Count of Participants|28|28.0||||||
3649360|NCT02461966|3496083|B4||Between 18 and 65 years|Age|Age, categorical numerical|Participants|Count of Participants|234|234.0||||||
3649361|NCT02461966|3496084|B3||Between 18 and 65 years|Age|Age, categorical numerical|Participants|Count of Participants|39|39.0||||||
3649362|NCT02461966|3496085|B2||Between 18 and 65 years|Age|Age, categorical numerical|Participants|Count of Participants|63|63.0||||||
3649363|NCT02461966|3496086|B1||Between 18 and 65 years|Age|Age, categorical numerical|Participants|Count of Participants|132|132.0||||||
3649364|NCT02461966|3496083|B4||<=18 years|Age|Age, categorical numerical|Participants|Count of Participants|0|0.0||||||
3649365|NCT02461966|3496084|B3||<=18 years|Age|Age, categorical numerical|Participants|Count of Participants|0|0.0||||||
3649366|NCT02461966|3496085|B2||<=18 years|Age|Age, categorical numerical|Participants|Count of Participants|0|0.0||||||
3649367|NCT02461966|3496086|B1||<=18 years|Age|Age, categorical numerical|Participants|Count of Participants|0|0.0||||||
3649368|NCT02461693|3496096|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3649369|NCT02461693|3496097|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3649370|NCT02461693|3496098|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3649371|NCT02461693|3496096|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649372|NCT02461693|3496097|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649373|NCT02461693|3496098|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649374|NCT02461693|3496096|B3||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3649375|NCT02461693|3496097|B2||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3649376|NCT02461693|3496098|B1||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3649377|NCT02461693|3496096|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
3649378|NCT02461693|3496097|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3649379|NCT02461693|3496098|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3649380|NCT02461693|3496096|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649381|NCT02461693|3496097|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649382|NCT02461693|3496098|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649383|NCT02461693|3496096|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3649384|NCT02461693|3496097|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3649385|NCT02461693|3496098|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3649386|NCT02461693|3496096|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649387|NCT02461693|3496097|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649388|NCT02461693|3496098|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649389|NCT02461693|3496096|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3649390|NCT02461693|3496097|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3649391|NCT02461693|3496098|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3649392|NCT02461693|3496096|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|159|159.0||||||
3649393|NCT02461693|3496097|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3649394|NCT02461693|3496098|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3649395|NCT02461693|3496096|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3649396|NCT02461693|3496097|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3649397|NCT02461693|3496098|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3649398|NCT02461693|3496096|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3649399|NCT02461693|3496097|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3649400|NCT02461693|3496098|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3649401|NCT02461693|3496096|B3||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3649402|NCT02461693|3496097|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3649403|NCT02461693|3496098|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3649404|NCT02461693|3496096|B3|||Age||years|Mean|31.79|31.79|Standard Deviation|12.91|12.91|||
3649405|NCT02461693|3496097|B2|||Age||years|Mean|29.75|29.75|Standard Deviation|11.39|11.39|||
3649406|NCT02461693|3496098|B1|||Age||years|Mean|33.83|33.83|Standard Deviation|14.02|14.02|||
3649407|NCT02461589|3496111|B11|||Diastolic blood pressure||mmHg|Mean|81.11|81.11|Standard Deviation|7.96|7.96|||
3649408|NCT02461589|3496112|B10|||Diastolic blood pressure||mmHg|Mean|81.89|81.89|Standard Deviation|8.40|8.4|||
3649409|NCT02461589|3496113|B9|||Diastolic blood pressure||mmHg|Mean|80.98|80.98|Standard Deviation|8.00|8.0|||
3649410|NCT02461589|3496114|B8|||Diastolic blood pressure||mmHg|Mean|80.66|80.66|Standard Deviation|7.62|7.62|||
3649411|NCT02461589|3496115|B7|||Diastolic blood pressure||mmHg|Mean|82.98|82.98|Standard Deviation|6.94|6.94|||
3649412|NCT02461589|3496116|B6|||Diastolic blood pressure||mmHg|Mean|81.28|81.28|Standard Deviation|6.90|6.9|||
3649413|NCT02461589|3496117|B5|||Diastolic blood pressure||mmHg|Mean|81.83|81.83|Standard Deviation|6.98|6.98|||
3649414|NCT02461589|3496118|B4|||Diastolic blood pressure||mmHg|Mean|81.41|81.41|Standard Deviation|8.05|8.05|||
3649415|NCT02461589|3496119|B3|||Diastolic blood pressure||mmHg|Mean|80.48|80.48|Standard Deviation|8.87|8.87|||
3649416|NCT02461589|3496120|B2|||Diastolic blood pressure||mmHg|Mean|79.71|79.71|Standard Deviation|8.56|8.56|||
3649417|NCT02461589|3496121|B1|||Diastolic blood pressure||mmHg|Mean|80.06|80.06|Standard Deviation|8.90|8.9|||
3649418|NCT02461589|3496111|B11|||Systolic blood pressure||mmHg|Mean|132.43|132.43|Standard Deviation|13.10|13.1|||
3649419|NCT02461589|3496112|B10|||Systolic blood pressure||mmHg|Mean|132.70|132.7|Standard Deviation|12.74|12.74|||
3649420|NCT02461589|3496113|B9|||Systolic blood pressure||mmHg|Mean|132.17|132.17|Standard Deviation|14.26|14.26|||
3649421|NCT02461589|3496114|B8|||Systolic blood pressure||mmHg|Mean|131.02|131.02|Standard Deviation|11.86|11.86|||
3649422|NCT02461589|3496115|B7|||Systolic blood pressure||mmHg|Mean|134.20|134.2|Standard Deviation|12.73|12.73|||
3649423|NCT02461589|3496116|B6|||Systolic blood pressure||mmHg|Mean|132.41|132.41|Standard Deviation|12.37|12.37|||
3649424|NCT02461589|3496117|B5|||Systolic blood pressure||mmHg|Mean|134.02|134.02|Standard Deviation|11.30|11.3|||
3649425|NCT02461589|3496118|B4|||Systolic blood pressure||mmHg|Mean|132.08|132.08|Standard Deviation|11.69|11.69|||
3649426|NCT02461589|3496119|B3|||Systolic blood pressure||mmHg|Mean|131.34|131.34|Standard Deviation|12.55|12.55|||
3649427|NCT02461589|3496120|B2|||Systolic blood pressure||mmHg|Mean|130.97|130.97|Standard Deviation|14.92|14.92|||
3649428|NCT02461589|3496121|B1|||Systolic blood pressure||mmHg|Mean|133.70|133.7|Standard Deviation|15.14|15.14|||
3649429|NCT02461589|3496111|B11|||Body weight||kg|Mean|94.28|94.28|Standard Deviation|17.61|17.61|||
3649430|NCT02461589|3496112|B10|||Body weight||kg|Mean|95.29|95.29|Standard Deviation|15.43|15.43|||
3649431|NCT02461589|3496113|B9|||Body weight||kg|Mean|93.98|93.98|Standard Deviation|17.75|17.75|||
3649432|NCT02461589|3496114|B8|||Body weight||kg|Mean|93.40|93.4|Standard Deviation|19.34|19.34|||
3649433|NCT02461589|3496115|B7|||Body weight||kg|Mean|96.67|96.67|Standard Deviation|18.28|18.28|||
3649434|NCT02461589|3496116|B6|||Body weight||kg|Mean|92.68|92.68|Standard Deviation|16.46|16.46|||
3649435|NCT02461589|3496117|B5|||Body weight||kg|Mean|92.25|92.25|Standard Deviation|17.48|17.48|||
3649436|NCT02461589|3496118|B4|||Body weight||kg|Mean|94.82|94.82|Standard Deviation|17.84|17.84|||
3649437|NCT02461589|3496119|B3|||Body weight||kg|Mean|98.07|98.07|Standard Deviation|17.92|17.92|||
3649438|NCT02461589|3496120|B2|||Body weight||kg|Mean|92.40|92.4|Standard Deviation|17.20|17.2|||
3649439|NCT02461589|3496121|B1|||Body weight||kg|Mean|93.44|93.44|Standard Deviation|18.27|18.27|||
3649440|NCT02461589|3496111|B11|||Fasting plasma glucose||mmol/L|Mean|9.45|9.45|Standard Deviation|2.59|2.59|||
3649441|NCT02461589|3496112|B10|||Fasting plasma glucose||mmol/L|Mean|9.82|9.82|Standard Deviation|2.66|2.66|||
3649442|NCT02461589|3496113|B9|||Fasting plasma glucose||mmol/L|Mean|9.67|9.67|Standard Deviation|2.98|2.98|||
3649443|NCT02461589|3496114|B8|||Fasting plasma glucose||mmol/L|Mean|9.18|9.18|Standard Deviation|2.45|2.45|||
3649444|NCT02461589|3496115|B7|||Fasting plasma glucose||mmol/L|Mean|9.91|9.91|Standard Deviation|2.70|2.7|||
3649445|NCT02461589|3496116|B6|||Fasting plasma glucose||mmol/L|Mean|9.34|9.34|Standard Deviation|2.33|2.33|||
3649446|NCT02461589|3496117|B5|||Fasting plasma glucose||mmol/L|Mean|9.32|9.32|Standard Deviation|2.54|2.54|||
3649447|NCT02461589|3496118|B4|||Fasting plasma glucose||mmol/L|Mean|9.67|9.67|Standard Deviation|2.56|2.56|||
3649448|NCT02461589|3496119|B3|||Fasting plasma glucose||mmol/L|Mean|9.20|9.2|Standard Deviation|2.28|2.28|||
3649449|NCT02461589|3496120|B2|||Fasting plasma glucose||mmol/L|Mean|8.97|8.97|Standard Deviation|2.22|2.22|||
3649450|NCT02461589|3496121|B1|||Fasting plasma glucose||mmol/L|Mean|9.26|9.26|Standard Deviation|2.60|2.6|||
3649451|NCT02461589|3496111|B11|||HbA1c (glycosylated haemoglobin)||percentage of HbA1c|Mean|8.06|8.06|Standard Deviation|0.84|0.84|||
3649452|NCT02461589|3496112|B10|||HbA1c (glycosylated haemoglobin)||percentage of HbA1c|Mean|8.10|8.1|Standard Deviation|0.91|0.91|||
3649453|NCT02461589|3496113|B9|||HbA1c (glycosylated haemoglobin)||percentage of HbA1c|Mean|8.12|8.12|Standard Deviation|0.87|0.87|||
3649454|NCT02461589|3496114|B8|||HbA1c (glycosylated haemoglobin)||percentage of HbA1c|Mean|8.07|8.07|Standard Deviation|0.85|0.85|||
3649455|NCT02461589|3496115|B7|||HbA1c (glycosylated haemoglobin)||percentage of HbA1c|Mean|8.14|8.14|Standard Deviation|0.87|0.87|||
3649456|NCT02461589|3496116|B6|||HbA1c (glycosylated haemoglobin)||percentage of HbA1c|Mean|8.12|8.12|Standard Deviation|0.81|0.81|||
3649457|NCT02461589|3496117|B5|||HbA1c (glycosylated haemoglobin)||percentage of HbA1c|Mean|8.06|8.06|Standard Deviation|0.86|0.86|||
3649458|NCT02461589|3496118|B4|||HbA1c (glycosylated haemoglobin)||percentage of HbA1c|Mean|8.23|8.23|Standard Deviation|0.80|0.8|||
3649581|NCT02460978|3496288|B2|Asian||Race/Ethnicity, Customized||Participants|Number|44|44.0||||||
3649459|NCT02461589|3496119|B3|||HbA1c (glycosylated haemoglobin)||percentage of HbA1c|Mean|7.96|7.96|Standard Deviation|0.82|0.82|||
3649460|NCT02461589|3496120|B2|||HbA1c (glycosylated haemoglobin)||percentage of HbA1c|Mean|7.91|7.91|Standard Deviation|0.83|0.83|||
3649461|NCT02461589|3496121|B1|||HbA1c (glycosylated haemoglobin)||percentage of HbA1c|Mean|7.87|7.87|Standard Deviation|0.71|0.71|||
3649462|NCT02461589|3496111|B11||Male|Sex: Female, Male||Participants|Count of Participants|379|379.0||||||
3649463|NCT02461589|3496112|B10||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3649464|NCT02461589|3496113|B9||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3649465|NCT02461589|3496114|B8||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3649466|NCT02461589|3496115|B7||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3649467|NCT02461589|3496116|B6||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3649468|NCT02461589|3496117|B5||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3649469|NCT02461589|3496118|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3649470|NCT02461589|3496119|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3649471|NCT02461589|3496120|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3649472|NCT02461589|3496121|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3649473|NCT02461589|3496111|B11||Female|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
3649474|NCT02461589|3496112|B10||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3649475|NCT02461589|3496113|B9||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3649476|NCT02461589|3496114|B8||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3649477|NCT02461589|3496115|B7||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3649478|NCT02461589|3496116|B6||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3649479|NCT02461589|3496117|B5||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3649480|NCT02461589|3496118|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3649481|NCT02461589|3496119|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3649482|NCT02461589|3496120|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3649483|NCT02461589|3496121|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3649484|NCT02461589|3496111|B11|||Age||years|Mean|56.67|56.67|Standard Deviation|9.94|9.94|||
3649485|NCT02461589|3496112|B10|||Age||years|Mean|54.81|54.81|Standard Deviation|9.70|9.7|||
3649486|NCT02461589|3496113|B9|||Age||years|Mean|57.08|57.08|Standard Deviation|9.25|9.25|||
3649487|NCT02461589|3496114|B8|||Age||years|Mean|55.82|55.82|Standard Deviation|9.19|9.19|||
3649488|NCT02461589|3496115|B7|||Age||years|Mean|53.73|53.73|Standard Deviation|11.35|11.35|||
3649489|NCT02461589|3496116|B6|||Age||years|Mean|59.45|59.45|Standard Deviation|9.77|9.77|||
3649490|NCT02461589|3496117|B5|||Age||years|Mean|57.20|57.2|Standard Deviation|10.78|10.78|||
3649491|NCT02461589|3496118|B4|||Age||years|Mean|54.76|54.76|Standard Deviation|9.66|9.66|||
3649492|NCT02461589|3496119|B3|||Age||years|Mean|58.37|58.37|Standard Deviation|9.58|9.58|||
3649493|NCT02461589|3496120|B2|||Age||years|Mean|57.51|57.51|Standard Deviation|10.0|10.0|||
3649494|NCT02461589|3496121|B1|||Age||years|Mean|57.53|57.53|Standard Deviation|9.8|9.8|||
3649495|NCT02461563|3496182|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3649496|NCT02461563|3496183|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3649497|NCT02461563|3496184|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3649498|NCT02461563|3496185|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3649499|NCT02461563|3496186|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3649500|NCT02461563|3496182|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3649501|NCT02461563|3496183|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3649502|NCT02461563|3496184|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3649503|NCT02461563|3496185|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3649504|NCT02461563|3496186|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3649505|NCT02461563|3496182|B5|||Age||Years|Mean|41.0|41.0|Standard Deviation|7.6|7.6|||
3649506|NCT02461563|3496183|B4|||Age||Years|Mean|46.0|46.0|Standard Deviation|7.0|7.0|||
3649507|NCT02461563|3496184|B3|||Age||Years|Mean|39.0|39.0|Standard Deviation|3.0|3.0|||
3649508|NCT02461563|3496185|B2|||Age||Years|Mean|39.7|39.7|Standard Deviation|11.0|11.0|||
3649509|NCT02461563|3496186|B1|||Age||Years|Mean|39.3|39.3|Standard Deviation|9.3|9.3|||
3649510|NCT02461550|3496223|B1|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3649511|NCT02461550|3496223|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649512|NCT02461550|3496223|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649513|NCT02461550|3496223|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3649514|NCT02461550|3496223|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649515|NCT02461550|3496223|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649516|NCT02461550|3496223|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649517|NCT02461550|3496223|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649518|NCT02461550|3496223|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649519|NCT02461550|3496223|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3649520|NCT02461550|3496223|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649521|NCT02461550|3496223|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3649522|NCT02461550|3496223|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3649523|NCT02461550|3496223|B1|||Age||years|Median|42|42.0|Full Range|||35.0|48.0|
3649524|NCT02461433|3496227|B3|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3649525|NCT02461433|3496228|B2|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3649526|NCT02461433|3496229|B1|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3649527|NCT02461433|3496227|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3649528|NCT02461433|3496228|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3649529|NCT02461433|3496229|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3649530|NCT02461433|3496227|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3649531|NCT02461433|3496228|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3649532|NCT02461433|3496229|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3649533|NCT02461433|3496227|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3649534|NCT02461433|3496228|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3649535|NCT02461433|3496229|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3649536|NCT02461433|3496227|B3|||Age||years|Mean|39.5|39.5|Full Range|||34.0|45.0|
3649537|NCT02461433|3496228|B2|||Age||years|Mean|45|45.0|Full Range|||45.0|45.0|
3649538|NCT02461433|3496229|B1|||Age||years|Mean|34|34.0|Full Range|||34.0|34.0|
3649539|NCT02461290|3496256|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3649540|NCT02461290|3496256|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3649541|NCT02461290|3496256|B1|||Age||years|Mean|55.8|55.8|Standard Deviation|10.8|10.8|||
3649542|NCT02461134|3496263|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3649543|NCT02461134|3496263|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3649544|NCT02461134|3496263|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3649545|NCT02461134|3496263|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3649546|NCT02461134|3496263|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3649547|NCT02460991|3496269|B3|||Age||years|Mean|63|63.0|Full Range|||56.0|70.0|
3649548|NCT02460991|3496270|B2|||Age||years|Mean|63|63.0|Full Range|||56.0|70.0|
3649549|NCT02460991|3496269|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3649550|NCT02460991|3496270|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3649551|NCT02460991|3496269|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649552|NCT02460991|3496270|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649553|NCT02460991|3496269|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649554|NCT02460991|3496270|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649555|NCT02460991|3496269|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3649556|NCT02460991|3496270|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3649557|NCT02460991|3496269|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3649558|NCT02460991|3496270|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3649559|NCT02460991|3496269|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649560|NCT02460991|3496270|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649561|NCT02460991|3496269|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649562|NCT02460991|3496270|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649563|NCT02460991|3496269|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649564|NCT02460991|3496270|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649565|NCT02460991|3496269|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3649566|NCT02460991|3496270|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3649567|NCT02460991|3496269|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3649568|NCT02460991|3496270|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3649569|NCT02460991|3496269|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3649570|NCT02460991|3496270|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3649571|NCT02460991|3496269|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3649572|NCT02460991|3496270|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3649573|NCT02460991|3496269|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3649574|NCT02460991|3496270|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3649575|NCT02460978|3496286|B4|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3649576|NCT02460978|3496287|B3|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3649577|NCT02460978|3496288|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3649578|NCT02460978|3496289|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3649579|NCT02460978|3496286|B4|Asian||Race/Ethnicity, Customized||Participants|Number|160|160.0||||||
3649580|NCT02460978|3496287|B3|Asian||Race/Ethnicity, Customized||Participants|Number|59|59.0||||||
3649582|NCT02460978|3496289|B1|Asian||Race/Ethnicity, Customized||Participants|Number|57|57.0||||||
3649583|NCT02460978|3496286|B4|Black or African-American||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3649584|NCT02460978|3496287|B3|Black or African-American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3649585|NCT02460978|3496288|B2|Black or African-American||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3649586|NCT02460978|3496289|B1|Black or African-American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3649587|NCT02460978|3496286|B4|White||Race/Ethnicity, Customized||Participants|Number|637|637.0||||||
3649588|NCT02460978|3496287|B3|White||Race/Ethnicity, Customized||Participants|Number|208|208.0||||||
3649589|NCT02460978|3496288|B2|White||Race/Ethnicity, Customized||Participants|Number|219|219.0||||||
3649590|NCT02460978|3496289|B1|White||Race/Ethnicity, Customized||Participants|Number|210|210.0||||||
3649591|NCT02460978|3496286|B4||Male|Sex: Female, Male||Participants|Count of Participants|358|358.0||||||
3649592|NCT02460978|3496287|B3||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3649593|NCT02460978|3496288|B2||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3649594|NCT02460978|3496289|B1||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3649595|NCT02460978|3496286|B4||Female|Sex: Female, Male||Participants|Count of Participants|455|455.0||||||
3649596|NCT02460978|3496287|B3||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3649597|NCT02460978|3496288|B2||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3649598|NCT02460978|3496289|B1||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3649599|NCT02460978|3496286|B4|||Age||Years|Mean|42.7|42.7|Standard Deviation|13.29|13.29|||
3649600|NCT02460978|3496287|B3|||Age||Years|Mean|43.0|43.0|Standard Deviation|13.73|13.73|||
3649601|NCT02460978|3496288|B2|||Age||Years|Mean|42.4|42.4|Standard Deviation|12.80|12.8|||
3649602|NCT02460978|3496289|B1|||Age||Years|Mean|42.7|42.7|Standard Deviation|13.35|13.35|||
3649603|NCT02460822|3496317|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3649604|NCT02460822|3496317|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3649605|NCT02460822|3496317|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3649606|NCT02460822|3496317|B1|||Age||years|Mean|55.9|55.9|Standard Deviation|9.6|9.6|||
3649607|NCT02460458|3496326|B1|Spain||Region of Enrollment||participants|Number|10|10.0||||||
3649608|NCT02460458|3496326|B1|Iran, Islamic Republic of||Region of Enrollment||participants|Number|120|120.0||||||
3649609|NCT02460458|3496326|B1|Germany||Region of Enrollment||participants|Number|18|18.0||||||
3649610|NCT02460458|3496326|B1|France||Region of Enrollment||participants|Number|13|13.0||||||
3649611|NCT02460458|3496326|B1|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3649612|NCT02460458|3496326|B1|Italy||Region of Enrollment||participants|Number|60|60.0||||||
3649613|NCT02460458|3496326|B1|Finland||Region of Enrollment||participants|Number|9|9.0||||||
3649614|NCT02460458|3496326|B1|Hungary||Region of Enrollment||participants|Number|16|16.0||||||
3649615|NCT02460458|3496326|B1|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
3649616|NCT02460458|3496326|B1|Netherlands||Region of Enrollment||participants|Number|9|9.0||||||
3649617|NCT02460458|3496326|B1||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3649618|NCT02460458|3496326|B1||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3649619|NCT02460458|3496326|B1|||Age||years|Mean|30.13534|30.13534|Standard Deviation|18.22409|18.22409|||
3649620|NCT02460458|3496326|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3649621|NCT02460458|3496326|B1||Between 18 and 65 years|Age||Participants|Count of Participants|179|179.0||||||
3649622|NCT02460458|3496326|B1||<=18 years|Age||Participants|Count of Participants|76|76.0||||||
3649623|NCT02460380|3496332|B3|United States||Region of Enrollment||Participants|Count of Participants|53|53.0||||||
3649624|NCT02460380|3496333|B2|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3649625|NCT02460380|3496334|B1|United States||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3649626|NCT02460380|3496332|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649627|NCT02460380|3496333|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649628|NCT02460380|3496334|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649629|NCT02460380|3496332|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3649630|NCT02460380|3496333|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3649631|NCT02460380|3496334|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3649632|NCT02460380|3496332|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3649633|NCT02460380|3496333|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3649634|NCT02460380|3496334|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3649635|NCT02460380|3496332|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3649636|NCT02460380|3496333|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3649637|NCT02460380|3496334|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3649638|NCT02460380|3496332|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3649639|NCT02460380|3496333|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3649640|NCT02460380|3496334|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3649641|NCT02460380|3496332|B3|||Age||years|Mean|30.2|30.2|Standard Deviation|6.8|6.8|||
3649642|NCT02460380|3496333|B2|||Age||years|Mean|29.6|29.6|Standard Deviation|7.6|7.6|||
3649643|NCT02460380|3496334|B1|||Age||years|Mean|30.5|30.5|Standard Deviation|6.4|6.4|||
3649644|NCT02460159|3496355|B3||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3649645|NCT02460159|3496356|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3649646|NCT02460159|3496357|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3649647|NCT02460159|3496355|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3649648|NCT02460159|3496356|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3649649|NCT02460159|3496357|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3649650|NCT02460159|3496355|B3|||Age||years|Mean|58.3|58.3|Standard Deviation|12.4|12.4|||
3649651|NCT02460159|3496356|B2|||Age||years|Mean|61.6|61.6|Standard Deviation|10.9|10.9|||
3649652|NCT02460159|3496357|B1|||Age||years|Mean|57.8|57.8|Standard Deviation|12.6|12.6|||
3649653|NCT02459418|3496386|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3649654|NCT02459418|3496387|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3649655|NCT02459418|3496388|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3649656|NCT02459418|3496386|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3649657|NCT02459418|3496387|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3649658|NCT02459418|3496388|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3649659|NCT02459418|3496386|B3|||Age||years|Mean|28.0|28.0|Full Range|||18.0|39.0|
3649660|NCT02459418|3496387|B2|||Age||years|Mean|28.1|28.1|Full Range|||18.0|37.0|
3649661|NCT02459418|3496388|B1|||Age||years|Mean|27.8|27.8|Full Range|||18.0|39.0|
3649662|NCT02459418|3496386|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3649663|NCT02459418|3496387|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3649664|NCT02459418|3496388|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3649665|NCT02459418|3496386|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3649666|NCT02459418|3496387|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3649667|NCT02459418|3496388|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3649668|NCT02459418|3496386|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3649669|NCT02459418|3496387|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3649670|NCT02459418|3496388|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3649671|NCT02459093|3496409|B3||Any labor|Cesarean delivery with labor||Participants|Count of Participants|89|89.0||||||
3649672|NCT02459093|3496410|B2||Any labor|Cesarean delivery with labor||Participants|Count of Participants|50|50.0||||||
3649673|NCT02459093|3496411|B1||Any labor|Cesarean delivery with labor||Participants|Count of Participants|39|39.0||||||
3649674|NCT02459093|3496409|B3||Scheduled or no labor|Cesarean delivery with labor||Participants|Count of Participants|431|431.0||||||
3649675|NCT02459093|3496410|B2||Scheduled or no labor|Cesarean delivery with labor||Participants|Count of Participants|207|207.0||||||
3649676|NCT02459093|3496411|B1||Scheduled or no labor|Cesarean delivery with labor||Participants|Count of Participants|224|224.0||||||
3649677|NCT02459093|3496409|B3||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3649678|NCT02459093|3496410|B2||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3649679|NCT02459093|3496411|B1||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3649680|NCT02459093|3496409|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3649681|NCT02459093|3496410|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3649682|NCT02459093|3496411|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3649683|NCT02459093|3496409|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3649684|NCT02459093|3496410|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3649685|NCT02459093|3496411|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3649686|NCT02459093|3496409|B3||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|258|258.0||||||
3649687|NCT02459093|3496410|B2||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|130|130.0||||||
3649688|NCT02459093|3496411|B1||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|128|128.0||||||
3649689|NCT02459093|3496409|B3||African American|Race/Ethnicity, Customized||Participants|Count of Participants|125|125.0||||||
3649690|NCT02459093|3496410|B2||African American|Race/Ethnicity, Customized||Participants|Count of Participants|61|61.0||||||
3649691|NCT02459093|3496411|B1||African American|Race/Ethnicity, Customized||Participants|Count of Participants|64|64.0||||||
3649692|NCT02459093|3496409|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
3649693|NCT02459093|3496410|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3649694|NCT02459093|3496411|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3649695|NCT02459093|3496409|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3649696|NCT02459093|3496410|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3649697|NCT02459093|3496411|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3649698|NCT02459093|3496409|B3||Female|Sex: Female, Male||Participants|Count of Participants|520|520.0||||||
3649699|NCT02459093|3496410|B2||Female|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
3649700|NCT02459093|3496411|B1||Female|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
3649701|NCT02459093|3496409|B3|||Age||years|Mean|31.3|31.3|Standard Deviation|5.4|5.4|||
3649702|NCT02459093|3496410|B2|||Age||years|Mean|31.2|31.2|Standard Deviation|5.4|5.4|||
3649703|NCT02459093|3496411|B1|||Age||years|Mean|31.4|31.4|Standard Deviation|5.4|5.4|||
3649704|NCT02459080|3496420|B4|Former Smoker||Smoking Status||Participants|Count of Participants|318|318.0||||||
3649705|NCT02459080|3496421|B3|Former Smoker||Smoking Status||Participants|Count of Participants|106|106.0||||||
3649706|NCT02459080|3496422|B2|Former Smoker||Smoking Status||Participants|Count of Participants|102|102.0||||||
3649707|NCT02459080|3496423|B1|Former Smoker||Smoking Status||Participants|Count of Participants|110|110.0||||||
3649708|NCT02459080|3496420|B4|Current Smoker||Smoking Status||Participants|Count of Participants|301|301.0||||||
3649709|NCT02459080|3496421|B3|Current Smoker||Smoking Status||Participants|Count of Participants|103|103.0||||||
3649710|NCT02459080|3496422|B2|Current Smoker||Smoking Status||Participants|Count of Participants|96|96.0||||||
3649711|NCT02459080|3496423|B1|Current Smoker||Smoking Status||Participants|Count of Participants|102|102.0||||||
3649712|NCT02459080|3496420|B4|United States||Region of Enrollment||participants|Number|619|619.0||||||
3649713|NCT02459080|3496421|B3|United States||Region of Enrollment||participants|Number|209|209.0||||||
3649714|NCT02459080|3496422|B2|United States||Region of Enrollment||participants|Number|198|198.0||||||
3649715|NCT02459080|3496423|B1|United States||Region of Enrollment||participants|Number|212|212.0||||||
3649716|NCT02459080|3496420|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649717|NCT02459080|3496421|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649718|NCT02459080|3496422|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649719|NCT02459080|3496423|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649720|NCT02459080|3496420|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3649721|NCT02459080|3496421|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3649722|NCT02459080|3496422|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3649723|NCT02459080|3496423|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3649724|NCT02459080|3496420|B4||White|Race (NIH/OMB)||Participants|Count of Participants|564|564.0||||||
3649725|NCT02459080|3496421|B3||White|Race (NIH/OMB)||Participants|Count of Participants|191|191.0||||||
3649726|NCT02459080|3496422|B2||White|Race (NIH/OMB)||Participants|Count of Participants|179|179.0||||||
3649727|NCT02459080|3496423|B1||White|Race (NIH/OMB)||Participants|Count of Participants|194|194.0||||||
3649728|NCT02459080|3496420|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3649729|NCT02459080|3496421|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3649730|NCT02459080|3496422|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3649731|NCT02459080|3496423|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3649732|NCT02459080|3496420|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649733|NCT02459080|3496421|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649734|NCT02459080|3496422|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649735|NCT02459080|3496423|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649736|NCT02459080|3496420|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3649737|NCT02459080|3496421|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649738|NCT02459080|3496422|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3649739|NCT02459080|3496423|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3649740|NCT02459080|3496420|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649741|NCT02459080|3496421|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649742|NCT02459080|3496422|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649743|NCT02459080|3496423|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649744|NCT02459080|3496420|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3649745|NCT02459080|3496421|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3649746|NCT02459080|3496422|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3649747|NCT02459080|3496423|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3649748|NCT02459080|3496420|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|595|595.0||||||
3649749|NCT02459080|3496421|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|204|204.0||||||
3649750|NCT02459080|3496422|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|186|186.0||||||
3649751|NCT02459080|3496423|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|205|205.0||||||
3649752|NCT02459080|3496420|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3649753|NCT02459080|3496421|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3649754|NCT02459080|3496422|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3649755|NCT02459080|3496423|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3649756|NCT02459080|3496420|B4||Male|Sex: Female, Male||Participants|Count of Participants|317|317.0||||||
3649757|NCT02459080|3496421|B3||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3649758|NCT02459080|3496422|B2||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3649759|NCT02459080|3496423|B1||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3649760|NCT02459080|3496420|B4||Female|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
3649761|NCT02459080|3496421|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3649762|NCT02459080|3496422|B2||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3649763|NCT02459080|3496423|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3649764|NCT02459080|3496420|B4|||Age||years|Mean|64.1|64.1|Standard Deviation|8.87|8.87|||
3649765|NCT02459080|3496421|B3|||Age||years|Mean|64.3|64.3|Standard Deviation|9.12|9.12|||
3649766|NCT02459080|3496422|B2|||Age||years|Mean|64.2|64.2|Standard Deviation|8.60|8.6|||
3649767|NCT02459080|3496423|B1|||Age||years|Mean|63.7|63.7|Standard Deviation|8.90|8.9|||
3649768|NCT02459080|3496420|B4||>=65 years|Age||Participants|Count of Participants|307|307.0||||||
3649769|NCT02459080|3496421|B3||>=65 years|Age||Participants|Count of Participants|105|105.0||||||
3649770|NCT02459080|3496422|B2||>=65 years|Age||Participants|Count of Participants|102|102.0||||||
3649771|NCT02459080|3496423|B1||>=65 years|Age||Participants|Count of Participants|100|100.0||||||
3649772|NCT02459080|3496420|B4||Between 18 and 65 years|Age||Participants|Count of Participants|312|312.0||||||
3649773|NCT02459080|3496421|B3||Between 18 and 65 years|Age||Participants|Count of Participants|104|104.0||||||
3649774|NCT02459080|3496422|B2||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
3649775|NCT02459080|3496423|B1||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
3649776|NCT02459080|3496420|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3649777|NCT02459080|3496421|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3649778|NCT02459080|3496422|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3649779|NCT02459080|3496423|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3649780|NCT02458768|3496448|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3649781|NCT02458768|3496449|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3649782|NCT02458768|3496450|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3649783|NCT02458768|3496448|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3649784|NCT02458768|3496449|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3649785|NCT02458768|3496450|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3649786|NCT02458768|3496448|B3|||Age||years|Mean|33.21|33.21|Standard Deviation|3.12|3.12|||
3649787|NCT02458768|3496449|B2|||Age||years|Mean|33.39|33.39|Standard Deviation|3.19|3.19|||
3649788|NCT02458768|3496450|B1|||Age||years|Mean|33.05|33.05|Standard Deviation|3.09|3.09|||
3649789|NCT02458365|3496457|B3|United States||Region of Enrollment||participants|Number|3901|3901.0||||||
3649790|NCT02458365|3496458|B2|United States||Region of Enrollment||participants|Number|1901|1901.0||||||
3649791|NCT02458365|3496459|B1|United States||Region of Enrollment||participants|Number|2000|2000.0||||||
3649792|NCT02458365|3496457|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|379|379.0||||||
3649793|NCT02458365|3496458|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|178|178.0||||||
3649794|NCT02458365|3496459|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|201|201.0||||||
3649795|NCT02458365|3496457|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|159|159.0||||||
3649796|NCT02458365|3496458|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3649797|NCT02458365|3496459|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3649798|NCT02458365|3496457|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3060|3060.0||||||
3649799|NCT02458365|3496458|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1447|1447.0||||||
3649800|NCT02458365|3496459|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1613|1613.0||||||
3649801|NCT02458365|3496457|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|161|161.0||||||
3649802|NCT02458365|3496458|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
3649803|NCT02458365|3496459|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3649804|NCT02458365|3496457|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3649805|NCT02458365|3496458|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3649806|NCT02458365|3496459|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3649807|NCT02458365|3496457|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3649808|NCT02458365|3496458|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3649809|NCT02458365|3496459|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3649810|NCT02458365|3496457|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3649811|NCT02458365|3496458|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3649812|NCT02458365|3496459|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3649813|NCT02458365|3496457|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649814|NCT02458365|3496458|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649815|NCT02458365|3496459|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649816|NCT02458365|3496457|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3497|3497.0||||||
3649817|NCT02458365|3496458|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1715|1715.0||||||
3649818|NCT02458365|3496459|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1782|1782.0||||||
3649819|NCT02458365|3496457|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|404|404.0||||||
3649820|NCT02458365|3496458|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|186|186.0||||||
3649821|NCT02458365|3496459|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|218|218.0||||||
3649822|NCT02458365|3496457|B3||Male|Sex: Female, Male||Participants|Count of Participants|1885|1885.0||||||
3649823|NCT02458365|3496458|B2||Male|Sex: Female, Male||Participants|Count of Participants|913|913.0||||||
3649824|NCT02458365|3496459|B1||Male|Sex: Female, Male||Participants|Count of Participants|972|972.0||||||
3649825|NCT02458365|3496457|B3||Female|Sex: Female, Male||Participants|Count of Participants|2016|2016.0||||||
3649826|NCT02458365|3496458|B2||Female|Sex: Female, Male||Participants|Count of Participants|988|988.0||||||
3649827|NCT02458365|3496459|B1||Female|Sex: Female, Male||Participants|Count of Participants|1028|1028.0||||||
3649828|NCT02458365|3496457|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3649829|NCT02458365|3496458|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3649830|NCT02458365|3496459|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3649831|NCT02458365|3496457|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3649832|NCT02458365|3496458|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3649833|NCT02458365|3496459|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3649834|NCT02458365|3496457|B3||<=18 years|Age||Participants|Count of Participants|3882|3882.0||||||
3649835|NCT02458365|3496458|B2||<=18 years|Age||Participants|Count of Participants|1893|1893.0||||||
3649836|NCT02458365|3496459|B1||<=18 years|Age||Participants|Count of Participants|1989|1989.0||||||
3649837|NCT02458287|3496480|B5||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3649838|NCT02458287|3496481|B4||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3649839|NCT02458287|3496482|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3649840|NCT02458287|3496483|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3649841|NCT02458287|3496484|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3649842|NCT02458287|3496480|B5||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3649843|NCT02458287|3496481|B4||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3649844|NCT02458287|3496482|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3649845|NCT02458287|3496483|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3649846|NCT02458287|3496484|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3649847|NCT02458287|3496480|B5|||Age||years|Mean|60|60.0|Standard Deviation|10.9|10.9|||
3649848|NCT02458287|3496481|B4|||Age||years|Mean|59.9|59.9|Standard Deviation|10.1|10.1|||
3649849|NCT02458287|3496482|B3|||Age||years|Mean|61|61.0|Standard Deviation|9.7|9.7|||
3649850|NCT02458287|3496483|B2|||Age||years|Mean|58.9|58.9|Standard Deviation|11.5|11.5|||
3649851|NCT02458287|3496484|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|12|12.0|||
3649852|NCT02457793|3496532|B7||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3649853|NCT02457793|3496533|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3649854|NCT02457793|3496534|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3649855|NCT02457793|3496535|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3649856|NCT02457793|3496536|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3649857|NCT02457793|3496537|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3649858|NCT02457793|3496538|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3649859|NCT02457793|3496532|B7||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3649860|NCT02457793|3496533|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3649861|NCT02457793|3496534|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3649862|NCT02457793|3496535|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3649863|NCT02457793|3496536|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3649864|NCT02457793|3496537|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3649865|NCT02457793|3496538|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3649866|NCT02457793|3496532|B7|||Age||Years|Mean|54.6|54.6|Standard Deviation|10.7|10.7|||
3649867|NCT02457793|3496533|B6|||Age||Years|Mean|59.7|59.7|Standard Deviation|11.5|11.5|||
3649868|NCT02457793|3496534|B5|||Age||Years|Mean|52.3|52.3|Standard Deviation|5.6|5.6|||
3649869|NCT02457793|3496535|B4|||Age||Years|Mean|51.6|51.6|Standard Deviation|14.2|14.2|||
3649870|NCT02457793|3496536|B3|||Age||Years|Mean|57.3|57.3|Standard Deviation|11.0|11.0|||
3649871|NCT02457793|3496537|B2|||Age||Years|Mean|53.0|53.0|Standard Deviation|11.5|11.5|||
3649872|NCT02457793|3496538|B1|||Age||Years|Mean|48.0|48.0|Standard Deviation|9999|9999.0|||
3649873|NCT02457728|3496683|B1|Austria||Region of Enrollment||participants|Number|34|34.0||||||
3649874|NCT02457728|3496683|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3649875|NCT02457728|3496683|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3649876|NCT02457728|3496683|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3649877|NCT02457728|3496683|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3649878|NCT02457728|3496683|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3649879|NCT02457611|3496687|B1|||CD4 Counts||cells/uL|Mean|675|675.0|Standard Deviation|251.3|251.3|||
3649880|NCT02457611|3496687|B1|>= 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|12|12.0||||||
3649881|NCT02457611|3496687|B1|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|14|14.0||||||
3649882|NCT02457611|3496687|B1|||HCV RNA||log10 IU/mL|Mean|5.4|5.4|Standard Deviation|1.60|1.6|||
3649883|NCT02457611|3496687|B1|Genotype 4||HCV Genotype||Participants|Count of Participants|7|7.0||||||
3649884|NCT02457611|3496687|B1|Genotype 1a||HCV Genotype||Participants|Count of Participants|19|19.0||||||
3649885|NCT02457611|3496687|B1|TT||IL28b Status||Participants|Count of Participants|3|3.0||||||
3649886|NCT02457611|3496687|B1|CT||IL28b Status||Participants|Count of Participants|11|11.0||||||
3649887|NCT02457611|3496687|B1|CC||IL28b Status||Participants|Count of Participants|12|12.0||||||
3649888|NCT02457611|3496687|B1|Germany||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3649889|NCT02457611|3496687|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3649890|NCT02457611|3496687|B1|Not Disclosed||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3649891|NCT02457611|3496687|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3649892|NCT02457611|3496687|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3649893|NCT02457611|3496687|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3649894|NCT02457611|3496687|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3649895|NCT02457611|3496687|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3649896|NCT02457611|3496687|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3649897|NCT02457611|3496687|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3649898|NCT02457611|3496687|B1|||Age||years|Mean|41|41.0|Standard Deviation|8.8|8.8|||
3649899|NCT02457546|3496699|B3|Non-Hispanic||Ethnicity||Participants|Count of Participants|229|229.0||||||
3649900|NCT02457546|3496700|B2|Non-Hispanic||Ethnicity||Participants|Count of Participants|117|117.0||||||
3649901|NCT02457546|3496701|B1|Non-Hispanic||Ethnicity||Participants|Count of Participants|112|112.0||||||
3649902|NCT02457546|3496699|B3|Hispanic||Ethnicity||Participants|Count of Participants|5|5.0||||||
3649903|NCT02457546|3496700|B2|Hispanic||Ethnicity||Participants|Count of Participants|3|3.0||||||
3649904|NCT02457546|3496701|B1|Hispanic||Ethnicity||Participants|Count of Participants|2|2.0||||||
3649905|NCT02457546|3496699|B3|Morbidly Obese||BMI (Grouped)|Description: Underweight: < 18.5 kg/m^2, normal weight: 18.5 - < 25kg kg/m^2, Overweigh: 25 - < 30 kg/m^2, Obese: 30 - < 40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participants|Count of Participants|4|4.0||||||
3649906|NCT02457546|3496700|B2|Morbidly Obese||BMI (Grouped)|Description: Underweight: < 18.5 kg/m^2, normal weight: 18.5 - < 25kg kg/m^2, Overweigh: 25 - < 30 kg/m^2, Obese: 30 - < 40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participants|Count of Participants|0|0.0||||||
3649907|NCT02457546|3496701|B1|Morbidly Obese||BMI (Grouped)|Description: Underweight: < 18.5 kg/m^2, normal weight: 18.5 - < 25kg kg/m^2, Overweigh: 25 - < 30 kg/m^2, Obese: 30 - < 40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participants|Count of Participants|4|4.0||||||
3649908|NCT02457546|3496699|B3|Obese||BMI (Grouped)|Description: Underweight: < 18.5 kg/m^2, normal weight: 18.5 - < 25kg kg/m^2, Overweigh: 25 - < 30 kg/m^2, Obese: 30 - < 40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participants|Count of Participants|61|61.0||||||
3649909|NCT02457546|3496700|B2|Obese||BMI (Grouped)|Description: Underweight: < 18.5 kg/m^2, normal weight: 18.5 - < 25kg kg/m^2, Overweigh: 25 - < 30 kg/m^2, Obese: 30 - < 40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participants|Count of Participants|34|34.0||||||
3649910|NCT02457546|3496701|B1|Obese||BMI (Grouped)|Description: Underweight: < 18.5 kg/m^2, normal weight: 18.5 - < 25kg kg/m^2, Overweigh: 25 - < 30 kg/m^2, Obese: 30 - < 40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participants|Count of Participants|27|27.0||||||
3649911|NCT02457546|3496699|B3|Overweight||BMI (Grouped)|Description: Underweight: < 18.5 kg/m^2, normal weight: 18.5 - < 25kg kg/m^2, Overweigh: 25 - < 30 kg/m^2, Obese: 30 - < 40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participants|Count of Participants|84|84.0||||||
3649912|NCT02457546|3496700|B2|Overweight||BMI (Grouped)|Description: Underweight: < 18.5 kg/m^2, normal weight: 18.5 - < 25kg kg/m^2, Overweigh: 25 - < 30 kg/m^2, Obese: 30 - < 40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participants|Count of Participants|39|39.0||||||
3649913|NCT02457546|3496701|B1|Overweight||BMI (Grouped)|Description: Underweight: < 18.5 kg/m^2, normal weight: 18.5 - < 25kg kg/m^2, Overweigh: 25 - < 30 kg/m^2, Obese: 30 - < 40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participants|Count of Participants|45|45.0||||||
3649914|NCT02457546|3496699|B3|Normal||BMI (Grouped)|Description: Underweight: < 18.5 kg/m^2, normal weight: 18.5 - < 25kg kg/m^2, Overweigh: 25 - < 30 kg/m^2, Obese: 30 - < 40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participants|Count of Participants|83|83.0||||||
3649915|NCT02457546|3496700|B2|Normal||BMI (Grouped)|Description: Underweight: < 18.5 kg/m^2, normal weight: 18.5 - < 25kg kg/m^2, Overweigh: 25 - < 30 kg/m^2, Obese: 30 - < 40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participants|Count of Participants|46|46.0||||||
3649916|NCT02457546|3496701|B1|Normal||BMI (Grouped)|Description: Underweight: < 18.5 kg/m^2, normal weight: 18.5 - < 25kg kg/m^2, Overweigh: 25 - < 30 kg/m^2, Obese: 30 - < 40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participants|Count of Participants|37|37.0||||||
3649917|NCT02457546|3496699|B3|Underweight||BMI (Grouped)|Description: Underweight: < 18.5 kg/m^2, normal weight: 18.5 - < 25kg kg/m^2, Overweigh: 25 - < 30 kg/m^2, Obese: 30 - < 40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participants|Count of Participants|2|2.0||||||
3649918|NCT02457546|3496700|B2|Underweight||BMI (Grouped)|Description: Underweight: < 18.5 kg/m^2, normal weight: 18.5 - < 25kg kg/m^2, Overweigh: 25 - < 30 kg/m^2, Obese: 30 - < 40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participants|Count of Participants|1|1.0||||||
3649919|NCT02457546|3496701|B1|Underweight||BMI (Grouped)|Description: Underweight: < 18.5 kg/m^2, normal weight: 18.5 - < 25kg kg/m^2, Overweigh: 25 - < 30 kg/m^2, Obese: 30 - < 40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participants|Count of Participants|1|1.0||||||
3649920|NCT02457546|3496699|B3|||BMI||kg/m^2|Mean|27.2|27.2|Standard Deviation|5.5|5.5|||
3649921|NCT02457546|3496700|B2|||BMI||kg/m^2|Mean|26.9|26.9|Standard Deviation|5.0|5.0|||
3649922|NCT02457546|3496701|B1|||BMI||kg/m^2|Mean|27.5|27.5|Standard Deviation|6.0|6.0|||
3649923|NCT02457546|3496699|B3|Other||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3649924|NCT02457546|3496700|B2|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3649925|NCT02457546|3496701|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3649926|NCT02457546|3496699|B3|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3649927|NCT02457546|3496700|B2|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3649928|NCT02457546|3496701|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3649929|NCT02457546|3496699|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3649930|NCT02457546|3496700|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3649931|NCT02457546|3496701|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3649932|NCT02457546|3496699|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3649933|NCT02457546|3496700|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3649934|NCT02457546|3496701|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3649935|NCT02457546|3496699|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
3649936|NCT02457546|3496700|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3649937|NCT02457546|3496701|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3649938|NCT02457546|3496699|B3|White/Caucasian||Race/Ethnicity, Customized||Participants|Number|203|203.0||||||
3649939|NCT02457546|3496700|B2|White/Caucasian||Race/Ethnicity, Customized||Participants|Number|101|101.0||||||
3649940|NCT02457546|3496701|B1|White/Caucasian||Race/Ethnicity, Customized||Participants|Number|102|102.0||||||
3649941|NCT02457546|3496699|B3||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3649942|NCT02457546|3496700|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3649943|NCT02457546|3496701|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3649944|NCT02457546|3496699|B3||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3649945|NCT02457546|3496700|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3649946|NCT02457546|3496701|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3649947|NCT02457546|3496699|B3|||Age||years|Mean|54.7|54.7|Standard Deviation|15.0|15.0|||
3649948|NCT02457546|3496700|B2|||Age||years|Mean|56.0|56.0|Standard Deviation|15.0|15.0|||
3649949|NCT02457546|3496701|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|14.9|14.9|||
3649950|NCT02457260|3496710|B4|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3649951|NCT02457260|3496711|B3|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3649952|NCT02457260|3496712|B2|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3649953|NCT02457260|3496713|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3649954|NCT02457260|3496710|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649955|NCT02457260|3496711|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649956|NCT02457260|3496712|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649957|NCT02457260|3496713|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649958|NCT02457260|3496710|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649959|NCT02457260|3496711|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649960|NCT02457260|3496712|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649961|NCT02457260|3496713|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649962|NCT02457260|3496710|B4||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3649963|NCT02457260|3496711|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3649964|NCT02457260|3496712|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3649965|NCT02457260|3496713|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3649966|NCT02457260|3496710|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649967|NCT02457260|3496711|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649968|NCT02457260|3496712|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649969|NCT02457260|3496713|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649970|NCT02457260|3496710|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649971|NCT02457260|3496711|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649972|NCT02457260|3496712|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649973|NCT02457260|3496713|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649974|NCT02457260|3496710|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649975|NCT02457260|3496711|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649976|NCT02457260|3496712|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649977|NCT02457260|3496713|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649978|NCT02457260|3496710|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649979|NCT02457260|3496711|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649980|NCT02457260|3496712|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649981|NCT02457260|3496713|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3649982|NCT02457260|3496710|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3649983|NCT02457260|3496711|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3649984|NCT02457260|3496712|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3649985|NCT02457260|3496713|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3649986|NCT02457260|3496710|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3649987|NCT02457260|3496711|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3649988|NCT02457260|3496712|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3649989|NCT02457260|3496713|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3649990|NCT02457260|3496710|B4||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3649991|NCT02457260|3496711|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3649992|NCT02457260|3496712|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3649993|NCT02457260|3496713|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3649994|NCT02457260|3496710|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3649995|NCT02457260|3496711|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3649996|NCT02457260|3496712|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3649997|NCT02457260|3496713|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3649998|NCT02457260|3496710|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3649999|NCT02457260|3496711|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3650000|NCT02457260|3496712|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3650001|NCT02457260|3496713|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3650002|NCT02457247|3496753|B5|No||History of Fractures in the Last 10 Years||participants|Number|240|240.0||||||
3650003|NCT02457247|3496754|B4|No||History of Fractures in the Last 10 Years||participants|Number|62|62.0||||||
3650004|NCT02457247|3496755|B3|No||History of Fractures in the Last 10 Years||participants|Number|61|61.0||||||
3650005|NCT02457247|3496756|B2|No||History of Fractures in the Last 10 Years||participants|Number|60|60.0||||||
3650006|NCT02457247|3496757|B1|No||History of Fractures in the Last 10 Years||participants|Number|57|57.0||||||
3650007|NCT02457247|3496753|B5|Yes||History of Fractures in the Last 10 Years||participants|Number|36|36.0||||||
3650008|NCT02457247|3496754|B4|Yes||History of Fractures in the Last 10 Years||participants|Number|8|8.0||||||
3650009|NCT02457247|3496755|B3|Yes||History of Fractures in the Last 10 Years||participants|Number|7|7.0||||||
3650010|NCT02457247|3496756|B2|Yes||History of Fractures in the Last 10 Years||participants|Number|10|10.0||||||
3650011|NCT02457247|3496757|B1|Yes||History of Fractures in the Last 10 Years||participants|Number|11|11.0||||||
3650012|NCT02457247|3496753|B5|No||History of Osteopenia||participants|Number|247|247.0||||||
3650013|NCT02457247|3496754|B4|No||History of Osteopenia||participants|Number|58|58.0||||||
3650014|NCT02457247|3496755|B3|No||History of Osteopenia||participants|Number|61|61.0||||||
3650015|NCT02457247|3496756|B2|No||History of Osteopenia||participants|Number|67|67.0||||||
3650016|NCT02457247|3496757|B1|No||History of Osteopenia||participants|Number|61|61.0||||||
3650017|NCT02457247|3496753|B5|Yes||History of Osteopenia||participants|Number|29|29.0||||||
3650018|NCT02457247|3496754|B4|Yes||History of Osteopenia||participants|Number|12|12.0||||||
3650019|NCT02457247|3496755|B3|Yes||History of Osteopenia||participants|Number|7|7.0||||||
3650020|NCT02457247|3496756|B2|Yes||History of Osteopenia||participants|Number|3|3.0||||||
3650021|NCT02457247|3496757|B1|Yes||History of Osteopenia||participants|Number|7|7.0||||||
3650022|NCT02457247|3496753|B5|No||History of Osteoporosis||participants|Number|220|220.0||||||
3650023|NCT02457247|3496754|B4|No||History of Osteoporosis||participants|Number|46|46.0||||||
3650024|NCT02457247|3496755|B3|No||History of Osteoporosis||participants|Number|40|40.0||||||
3650025|NCT02457247|3496756|B2|No||History of Osteoporosis||participants|Number|67|67.0||||||
3650026|NCT02457247|3496757|B1|No||History of Osteoporosis||participants|Number|67|67.0||||||
3650027|NCT02457247|3496753|B5|Yes||History of Osteoporosis||participants|Number|56|56.0||||||
3650028|NCT02457247|3496754|B4|Yes||History of Osteoporosis||participants|Number|24|24.0||||||
3650029|NCT02457247|3496755|B3|Yes||History of Osteoporosis||participants|Number|28|28.0||||||
3650030|NCT02457247|3496756|B2|Yes||History of Osteoporosis||participants|Number|3|3.0||||||
3650031|NCT02457247|3496757|B1|Yes||History of Osteoporosis||participants|Number|1|1.0||||||
3650032|NCT02457247|3496753|B5|Current Drinker||Alcohol Status||participants|Number|208|208.0||||||
3650033|NCT02457247|3496754|B4|Current Drinker||Alcohol Status||participants|Number|56|56.0||||||
3650034|NCT02457247|3496755|B3|Current Drinker||Alcohol Status||participants|Number|53|53.0||||||
3650035|NCT02457247|3496756|B2|Current Drinker||Alcohol Status||participants|Number|46|46.0||||||
3650036|NCT02457247|3496757|B1|Current Drinker||Alcohol Status||participants|Number|53|53.0||||||
3650037|NCT02457247|3496753|B5|Ex-drinker||Alcohol Status||participants|Number|21|21.0||||||
3650038|NCT02457247|3496754|B4|Ex-drinker||Alcohol Status||participants|Number|2|2.0||||||
3650039|NCT02457247|3496755|B3|Ex-drinker||Alcohol Status||participants|Number|5|5.0||||||
3650040|NCT02457247|3496756|B2|Ex-drinker||Alcohol Status||participants|Number|10|10.0||||||
3650041|NCT02457247|3496757|B1|Ex-drinker||Alcohol Status||participants|Number|4|4.0||||||
3650042|NCT02457247|3496753|B5|Never Drank||Alcohol Status||participants|Number|47|47.0||||||
3650043|NCT02457247|3496754|B4|Never Drank||Alcohol Status||participants|Number|12|12.0||||||
3650044|NCT02457247|3496755|B3|Never Drank||Alcohol Status||participants|Number|10|10.0||||||
3650045|NCT02457247|3496756|B2|Never Drank||Alcohol Status||participants|Number|14|14.0||||||
3650046|NCT02457247|3496757|B1|Never Drank||Alcohol Status||participants|Number|11|11.0||||||
3650047|NCT02457247|3496753|B5|Current Smoker||Smoking Status||participants|Number|34|34.0||||||
3650048|NCT02457247|3496754|B4|Current Smoker||Smoking Status||participants|Number|11|11.0||||||
3650049|NCT02457247|3496755|B3|Current Smoker||Smoking Status||participants|Number|9|9.0||||||
3650050|NCT02457247|3496756|B2|Current Smoker||Smoking Status||participants|Number|6|6.0||||||
3650051|NCT02457247|3496757|B1|Current Smoker||Smoking Status||participants|Number|8|8.0||||||
3650052|NCT02457247|3496753|B5|Ex-smoker||Smoking Status||participants|Number|107|107.0||||||
3650053|NCT02457247|3496754|B4|Ex-smoker||Smoking Status||participants|Number|24|24.0||||||
3650054|NCT02457247|3496755|B3|Ex-smoker||Smoking Status||participants|Number|18|18.0||||||
3650055|NCT02457247|3496756|B2|Ex-smoker||Smoking Status||participants|Number|33|33.0||||||
3650056|NCT02457247|3496757|B1|Ex-smoker||Smoking Status||participants|Number|32|32.0||||||
3650057|NCT02457247|3496753|B5|Never Smoked||Smoking Status||participants|Number|135|135.0||||||
3650058|NCT02457247|3496754|B4|Never Smoked||Smoking Status||participants|Number|35|35.0||||||
3650059|NCT02457247|3496755|B3|Never Smoked||Smoking Status||participants|Number|41|41.0||||||
3650060|NCT02457247|3496756|B2|Never Smoked||Smoking Status||participants|Number|31|31.0||||||
3650061|NCT02457247|3496757|B1|Never Smoked||Smoking Status||participants|Number|28|28.0||||||
3650062|NCT02457247|3496753|B5|Missing||BMI Categorical||participants|Number|3|3.0||||||
3650063|NCT02457247|3496754|B4|Missing||BMI Categorical||participants|Number|0|0.0||||||
3650064|NCT02457247|3496755|B3|Missing||BMI Categorical||participants|Number|0|0.0||||||
3650065|NCT02457247|3496756|B2|Missing||BMI Categorical||participants|Number|0|0.0||||||
3650066|NCT02457247|3496757|B1|Missing||BMI Categorical||participants|Number|3|3.0||||||
3650067|NCT02457247|3496753|B5|≥30 kg/m^2||BMI Categorical||participants|Number|75|75.0||||||
3650068|NCT02457247|3496754|B4|≥30 kg/m^2||BMI Categorical||participants|Number|16|16.0||||||
3650069|NCT02457247|3496755|B3|≥30 kg/m^2||BMI Categorical||participants|Number|11|11.0||||||
3650070|NCT02457247|3496756|B2|≥30 kg/m^2||BMI Categorical||participants|Number|24|24.0||||||
3650071|NCT02457247|3496757|B1|≥30 kg/m^2||BMI Categorical||participants|Number|24|24.0||||||
3650072|NCT02457247|3496753|B5|25 to <30 kg/m^2||BMI Categorical||participants|Number|113|113.0||||||
3650073|NCT02457247|3496754|B4|25 to <30 kg/m^2||BMI Categorical||participants|Number|27|27.0||||||
3650074|NCT02457247|3496755|B3|25 to <30 kg/m^2||BMI Categorical||participants|Number|27|27.0||||||
3650075|NCT02457247|3496756|B2|25 to <30 kg/m^2||BMI Categorical||participants|Number|29|29.0||||||
3650076|NCT02457247|3496757|B1|25 to <30 kg/m^2||BMI Categorical||participants|Number|30|30.0||||||
3650077|NCT02457247|3496753|B5|<25 kg/m^2||BMI Categorical||participants|Number|85|85.0||||||
3650078|NCT02457247|3496754|B4|<25 kg/m^2||BMI Categorical||participants|Number|27|27.0||||||
3650079|NCT02457247|3496755|B3|<25 kg/m^2||BMI Categorical||participants|Number|30|30.0||||||
3650080|NCT02457247|3496756|B2|<25 kg/m^2||BMI Categorical||participants|Number|17|17.0||||||
3650081|NCT02457247|3496757|B1|<25 kg/m^2||BMI Categorical||participants|Number|11|11.0||||||
3650082|NCT02457247|3496753|B5|||Body Mass Index (BMI)|BMI data is available for 65, 70, 68 and 70 participants, respectively.|kg/m^2|Mean|NA||Standard Deviation|NA||17.39|55.52|Test Group 1 and Test Group 2 were analyzed separately for their respective region (UK and Germany, respectively); therefore, Total Mean and Standard Deviation are not available.
3650083|NCT02457247|3496754|B4|||Body Mass Index (BMI)|BMI data is available for 65, 70, 68 and 70 participants, respectively.|kg/m^2|Mean|27.002|27.002|Standard Deviation|5.1081|5.1081|17.96|46.48|
3650084|NCT02457247|3496755|B3|||Body Mass Index (BMI)|BMI data is available for 65, 70, 68 and 70 participants, respectively.|kg/m^2|Mean|26.478|26.478|Standard Deviation|4.2362|4.2362|19.94|39.45|
3650085|NCT02457247|3496756|B2|||Body Mass Index (BMI)|BMI data is available for 65, 70, 68 and 70 participants, respectively.|kg/m^2|Mean|29.588|29.588|Standard Deviation|6.5710|6.571|19.92|55.52|
3650086|NCT02457247|3496757|B1|||Body Mass Index (BMI)|BMI data is available for 65, 70, 68 and 70 participants, respectively.|kg/m^2|Mean|29.157|29.157|Standard Deviation|4.7766|4.7766|17.39|39.92|
3650087|NCT02457247|3496753|B5|||Weight||kg|Mean|NA||Standard Deviation|NA||41.9|172.5|Test Group 1 and Test Group 2 were analyzed separately for their respective region (UK and Germany, respectively); therefore, Total Mean and Standard Deviation are not available.
3650088|NCT02457247|3496754|B4|||Weight||kg|Mean|73.61|73.61|Standard Deviation|16.340|16.34|41.9|125.0|
3650089|NCT02457247|3496755|B3|||Weight||kg|Mean|71.44|71.44|Standard Deviation|13.799|13.799|53.0|114.4|
3650090|NCT02457247|3496756|B2|||Weight||kg|Mean|81.72|81.72|Standard Deviation|23.559|23.559|54.5|172.5|
3650091|NCT02457247|3496757|B1|||Weight||kg|Mean|78.92|78.92|Standard Deviation|15.383|15.383|46.2|110.0|
3650092|NCT02457247|3496753|B5|||Height|Height data is available for 65, 70, 68 and 70 participants, respectively.|cm|Mean|NA||Standard Deviation|NA||148.0|188.0|Test Group 1 and Test Group 2 were analyzed separately for their respective region (UK and Germany, respectively); therefore, Total Mean and Standard Deviation are not available.
3650093|NCT02457247|3496754|B4|||Height|Height data is available for 65, 70, 68 and 70 participants, respectively.|cm|Mean|164.8|164.8|Standard Deviation|7.78|7.78|150.0|186.0|
3650094|NCT02457247|3496755|B3|||Height|Height data is available for 65, 70, 68 and 70 participants, respectively.|cm|Mean|164.0|164.0|Standard Deviation|7.73|7.73|148.0|186.0|
3650095|NCT02457247|3496756|B2|||Height|Height data is available for 65, 70, 68 and 70 participants, respectively.|cm|Mean|165.4|165.4|Standard Deviation|8.95|8.95|150.0|188.0|
3650096|NCT02457247|3496757|B1|||Height|Height data is available for 65, 70, 68 and 70 participants, respectively.|cm|Mean|164.4|164.4|Standard Deviation|7.44|7.44|150.0|183.0|
3650097|NCT02457247|3496753|B5|Germany||Region of Enrollment||participants|Number|138|138.0||||||
3650098|NCT02457247|3496754|B4|Germany||Region of Enrollment||participants|Number|70|70.0||||||
3650099|NCT02457247|3496755|B3|Germany||Region of Enrollment||participants|Number|68|68.0||||||
3650100|NCT02457247|3496756|B2|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3650101|NCT02457247|3496757|B1|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3650102|NCT02457247|3496753|B5|United Kingdom||Region of Enrollment||participants|Number|138|138.0||||||
3650103|NCT02457247|3496754|B4|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3650104|NCT02457247|3496755|B3|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3650105|NCT02457247|3496756|B2|United Kingdom||Region of Enrollment||participants|Number|70|70.0||||||
3650106|NCT02457247|3496757|B1|United Kingdom||Region of Enrollment||participants|Number|68|68.0||||||
3650107|NCT02457247|3496753|B5|White||Race/Ethnicity, Customized||participants|Number|270|270.0||||||
3650108|NCT02457247|3496754|B4|White||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
3650109|NCT02457247|3496755|B3|White||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
3650110|NCT02457247|3496756|B2|White||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
3650111|NCT02457247|3496757|B1|White||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
3650112|NCT02457247|3496753|B5|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3650113|NCT02457247|3496754|B4|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3650114|NCT02457247|3496755|B3|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3650115|NCT02457247|3496756|B2|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3650116|NCT02457247|3496757|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3650117|NCT02457247|3496753|B5|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3650118|NCT02457247|3496754|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3650119|NCT02457247|3496755|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3650120|NCT02457247|3496756|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3650121|NCT02457247|3496757|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3650122|NCT02457247|3496753|B5||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3650123|NCT02457247|3496754|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3650124|NCT02457247|3496755|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3650125|NCT02457247|3496756|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3650126|NCT02457247|3496757|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3650127|NCT02457247|3496753|B5||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3650128|NCT02457247|3496754|B4||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3650129|NCT02457247|3496755|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3650130|NCT02457247|3496756|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3650131|NCT02457247|3496757|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3650132|NCT02457247|3496753|B5|85 Years and Over||Age, Customized||participants|Number|3|3.0||||||
3650133|NCT02457247|3496754|B4|85 Years and Over||Age, Customized||participants|Number|0|0.0||||||
3650134|NCT02457247|3496755|B3|85 Years and Over||Age, Customized||participants|Number|2|2.0||||||
3650135|NCT02457247|3496756|B2|85 Years and Over||Age, Customized||participants|Number|1|1.0||||||
3650136|NCT02457247|3496757|B1|85 Years and Over||Age, Customized||participants|Number|0|0.0||||||
3650137|NCT02457247|3496753|B5|From 65-84 Years||Age, Customized||participants|Number|254|254.0||||||
3650138|NCT02457247|3496754|B4|From 65-84 Years||Age, Customized||participants|Number|59|59.0||||||
3650139|NCT02457247|3496755|B3|From 65-84 Years||Age, Customized||participants|Number|58|58.0||||||
3650140|NCT02457247|3496756|B2|From 65-84 Years||Age, Customized||participants|Number|69|69.0||||||
3650141|NCT02457247|3496757|B1|From 65-84 Years||Age, Customized||participants|Number|68|68.0||||||
3650142|NCT02457247|3496753|B5|Adults (18-64 Years)||Age, Customized||participants|Number|19|19.0||||||
3650143|NCT02457247|3496754|B4|Adults (18-64 Years)||Age, Customized||participants|Number|11|11.0||||||
3650144|NCT02457247|3496755|B3|Adults (18-64 Years)||Age, Customized||participants|Number|8|8.0||||||
3650145|NCT02457247|3496756|B2|Adults (18-64 Years)||Age, Customized||participants|Number|0|0.0||||||
3650146|NCT02457247|3496757|B1|Adults (18-64 Years)||Age, Customized||participants|Number|0|0.0||||||
3650147|NCT02457247|3496753|B5|≥65 years||Age, Customized||participants|Number|257|257.0||||||
3650148|NCT02457247|3496754|B4|≥65 years||Age, Customized||participants|Number|59|59.0||||||
3650149|NCT02457247|3496755|B3|≥65 years||Age, Customized||participants|Number|60|60.0||||||
3650150|NCT02457247|3496756|B2|≥65 years||Age, Customized||participants|Number|70|70.0||||||
3650151|NCT02457247|3496757|B1|≥65 years||Age, Customized||participants|Number|68|68.0||||||
3650152|NCT02457247|3496753|B5|<65 years||Age, Customized||participants|Number|19|19.0||||||
3650153|NCT02457247|3496754|B4|<65 years||Age, Customized||participants|Number|11|11.0||||||
3650154|NCT02457247|3496755|B3|<65 years||Age, Customized||participants|Number|8|8.0||||||
3650155|NCT02457247|3496756|B2|<65 years||Age, Customized||participants|Number|0|0.0||||||
3650156|NCT02457247|3496757|B1|<65 years||Age, Customized||participants|Number|0|0.0||||||
3650313|NCT02455518|3496844|B4||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3650157|NCT02457247|3496753|B5|||Age||years|Mean|NA||Standard Deviation|NA||36.0|85.0|Test Group 1 and Test Group 2 were analyzed separately for their respective region (UK and Germany, respectively); therefore, Total Mean and Standard Deviation are not available.
3650158|NCT02457247|3496754|B4|||Age||years|Mean|69.9|69.9|Standard Deviation|7.03|7.03|46.0|84.0|
3650159|NCT02457247|3496755|B3|||Age||years|Mean|70.9|70.9|Standard Deviation|7.37|7.37|36.0|85.0|
3650160|NCT02457247|3496756|B2|||Age||years|Mean|70.8|70.8|Standard Deviation|4.94|4.94|65.0|85.0|
3650161|NCT02457247|3496757|B1|||Age||years|Mean|70.9|70.9|Standard Deviation|7.37|7.37|65.0|80.0|
3650162|NCT02457182|3496780|B3|Other||Race||participants|Number|3|3.0||||||
3650163|NCT02457182|3496781|B2|Other||Race||participants|Number|3|3.0||||||
3650164|NCT02457182|3496782|B1|Other||Race||participants|Number|0|0.0||||||
3650165|NCT02457182|3496780|B3|Caucasian||Race||participants|Number|14|14.0||||||
3650166|NCT02457182|3496781|B2|Caucasian||Race||participants|Number|5|5.0||||||
3650167|NCT02457182|3496782|B1|Caucasian||Race||participants|Number|9|9.0||||||
3650168|NCT02457182|3496780|B3|Asian||Race||participants|Number|1|1.0||||||
3650169|NCT02457182|3496781|B2|Asian||Race||participants|Number|1|1.0||||||
3650170|NCT02457182|3496782|B1|Asian||Race||participants|Number|0|0.0||||||
3650171|NCT02457182|3496780|B3|American Indian/Alaskan Native||Race||participants|Number|2|2.0||||||
3650172|NCT02457182|3496781|B2|American Indian/Alaskan Native||Race||participants|Number|2|2.0||||||
3650173|NCT02457182|3496782|B1|American Indian/Alaskan Native||Race||participants|Number|0|0.0||||||
3650174|NCT02457182|3496780|B3|||BMI (kg/m^2)||kg/m^2|Mean|27.1|27.1|Standard Deviation|7.3|7.3|||
3650175|NCT02457182|3496781|B2|||BMI (kg/m^2)||kg/m^2|Mean|26.4|26.4|Standard Deviation|6.0|6.0|||
3650176|NCT02457182|3496782|B1|||BMI (kg/m^2)||kg/m^2|Mean|28.0|28.0|Standard Deviation|9.2|9.2|||
3650177|NCT02457182|3496780|B3|||Time with IC symptoms||years|Mean|9.2|9.2|Standard Deviation|8.3|8.3|||
3650178|NCT02457182|3496781|B2|||Time with IC symptoms||years|Mean|8.9|8.9|Standard Deviation|7.1|7.1|||
3650179|NCT02457182|3496782|B1|||Time with IC symptoms||years|Mean|9.6|9.6|Standard Deviation|9.9|9.9|||
3650180|NCT02457182|3496780|B3|||Time with IC diagnosis||years|Mean|4.3|4.3|Standard Deviation|4.96|4.96|||
3650181|NCT02457182|3496781|B2|||Time with IC diagnosis||years|Mean|3.85|3.85|Standard Deviation|5.1|5.1|||
3650182|NCT02457182|3496782|B1|||Time with IC diagnosis||years|Mean|5.0|5.0|Standard Deviation|5.3|5.3|||
3650183|NCT02457182|3496780|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3650184|NCT02457182|3496781|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3650185|NCT02457182|3496782|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3650186|NCT02457182|3496780|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3650187|NCT02457182|3496781|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3650188|NCT02457182|3496782|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3650189|NCT02457182|3496780|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3650190|NCT02457182|3496781|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3650191|NCT02457182|3496782|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3650192|NCT02457182|3496780|B3|||Age||years|Mean|45.3|45.3|Standard Deviation|14.1|14.1|||
3650193|NCT02457182|3496781|B2|||Age||years|Mean|44.4|44.4|Standard Deviation|13.9|13.9|||
3650194|NCT02457182|3496782|B1|||Age||years|Mean|46.3|46.3|Standard Deviation|15.2|15.2|||
3650195|NCT02457065|3496799|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3650196|NCT02457065|3496799|B3|unknown||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3650197|NCT02457065|3496799|B3|unknown||Age, Customized||Participants|Count of Participants|0|0.0||||||
3650198|NCT02456740|3496810|B4|||Monthly Migraine Days|A migraine day was any calendar day in which the participant experienced a qualified migraine headache (onset, continuation, or recurrence of the migraine headache). A qualified migraine headache was defined either as a migraine without aura or a migraine with aura. Monthly migraine days were calculated as the number of migraine days in the 4-week baseline phase.|migraine days/month|Mean|8.29|8.29|Standard Deviation|2.48|2.48|||
3650199|NCT02456740|3496811|B3|||Monthly Migraine Days|A migraine day was any calendar day in which the participant experienced a qualified migraine headache (onset, continuation, or recurrence of the migraine headache). A qualified migraine headache was defined either as a migraine without aura or a migraine with aura. Monthly migraine days were calculated as the number of migraine days in the 4-week baseline phase.|migraine days/month|Mean|8.34|8.34|Standard Deviation|2.48|2.48|||
3650200|NCT02456740|3496812|B2|||Monthly Migraine Days|A migraine day was any calendar day in which the participant experienced a qualified migraine headache (onset, continuation, or recurrence of the migraine headache). A qualified migraine headache was defined either as a migraine without aura or a migraine with aura. Monthly migraine days were calculated as the number of migraine days in the 4-week baseline phase.|migraine days/month|Mean|8.29|8.29|Standard Deviation|2.47|2.47|||
3650201|NCT02456740|3496813|B1|||Monthly Migraine Days|A migraine day was any calendar day in which the participant experienced a qualified migraine headache (onset, continuation, or recurrence of the migraine headache). A qualified migraine headache was defined either as a migraine without aura or a migraine with aura. Monthly migraine days were calculated as the number of migraine days in the 4-week baseline phase.|migraine days/month|Mean|8.23|8.23|Standard Deviation|2.51|2.51|||
3650202|NCT02456740|3496810|B4||No prior / current migraine prophylactic treatment|Treatment Status with Migraine Prophylactic Medication||Participants|Count of Participants|576|576.0||||||
3650203|NCT02456740|3496811|B3||No prior / current migraine prophylactic treatment|Treatment Status with Migraine Prophylactic Medication||Participants|Count of Participants|192|192.0||||||
3650204|NCT02456740|3496812|B2||No prior / current migraine prophylactic treatment|Treatment Status with Migraine Prophylactic Medication||Participants|Count of Participants|192|192.0||||||
3650205|NCT02456740|3496813|B1||No prior / current migraine prophylactic treatment|Treatment Status with Migraine Prophylactic Medication||Participants|Count of Participants|192|192.0||||||
3650206|NCT02456740|3496810|B4||Prior migraine prophylactic treatment only|Treatment Status with Migraine Prophylactic Medication||Participants|Count of Participants|358|358.0||||||
3650207|NCT02456740|3496811|B3||Prior migraine prophylactic treatment only|Treatment Status with Migraine Prophylactic Medication||Participants|Count of Participants|120|120.0||||||
3650208|NCT02456740|3496812|B2||Prior migraine prophylactic treatment only|Treatment Status with Migraine Prophylactic Medication||Participants|Count of Participants|119|119.0||||||
3650209|NCT02456740|3496813|B1||Prior migraine prophylactic treatment only|Treatment Status with Migraine Prophylactic Medication||Participants|Count of Participants|119|119.0||||||
3650210|NCT02456740|3496810|B4||Current migraine prophylactic treatment|Treatment Status with Migraine Prophylactic Medication||Participants|Count of Participants|21|21.0||||||
3650211|NCT02456740|3496811|B3||Current migraine prophylactic treatment|Treatment Status with Migraine Prophylactic Medication||Participants|Count of Participants|7|7.0||||||
3650212|NCT02456740|3496812|B2||Current migraine prophylactic treatment|Treatment Status with Migraine Prophylactic Medication||Participants|Count of Participants|6|6.0||||||
3650213|NCT02456740|3496813|B1||Current migraine prophylactic treatment|Treatment Status with Migraine Prophylactic Medication||Participants|Count of Participants|8|8.0||||||
3650214|NCT02456740|3496810|B4||Other|Region||Participants|Count of Participants|478|478.0||||||
3650215|NCT02456740|3496811|B3||Other|Region||Participants|Count of Participants|159|159.0||||||
3650216|NCT02456740|3496812|B2||Other|Region||Participants|Count of Participants|158|158.0||||||
3650217|NCT02456740|3496813|B1||Other|Region||Participants|Count of Participants|161|161.0||||||
3650218|NCT02456740|3496810|B4||North America|Region||Participants|Count of Participants|477|477.0||||||
3650219|NCT02456740|3496811|B3||North America|Region||Participants|Count of Participants|160|160.0||||||
3650220|NCT02456740|3496812|B2||North America|Region||Participants|Count of Participants|159|159.0||||||
3650221|NCT02456740|3496813|B1||North America|Region||Participants|Count of Participants|158|158.0||||||
3650222|NCT02456740|3496810|B4||Other|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3650223|NCT02456740|3496811|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3650224|NCT02456740|3496812|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3650225|NCT02456740|3496813|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3650226|NCT02456740|3496810|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|851|851.0||||||
3650227|NCT02456740|3496811|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|293|293.0||||||
3650228|NCT02456740|3496812|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|281|281.0||||||
3650229|NCT02456740|3496813|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|277|277.0||||||
3650230|NCT02456740|3496810|B4||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3650231|NCT02456740|3496811|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3650232|NCT02456740|3496812|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3650233|NCT02456740|3496813|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3650234|NCT02456740|3496810|B4||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3650235|NCT02456740|3496811|B3||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3650236|NCT02456740|3496812|B2||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3650237|NCT02456740|3496813|B1||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3650238|NCT02456740|3496810|B4||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|66|66.0||||||
3650239|NCT02456740|3496811|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3650240|NCT02456740|3496812|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3650241|NCT02456740|3496813|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3650242|NCT02456740|3496810|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3650243|NCT02456740|3496811|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3650244|NCT02456740|3496812|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3650245|NCT02456740|3496813|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3650246|NCT02456740|3496810|B4||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3650247|NCT02456740|3496811|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3650248|NCT02456740|3496812|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3650249|NCT02456740|3496813|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3650250|NCT02456740|3496810|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650251|NCT02456740|3496811|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650252|NCT02456740|3496812|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650253|NCT02456740|3496813|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650254|NCT02456740|3496810|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|875|875.0||||||
3650255|NCT02456740|3496811|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|297|297.0||||||
3650256|NCT02456740|3496812|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|291|291.0||||||
3650257|NCT02456740|3496813|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|287|287.0||||||
3650258|NCT02456740|3496810|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3650259|NCT02456740|3496811|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3650260|NCT02456740|3496812|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3650261|NCT02456740|3496813|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3650262|NCT02456740|3496810|B4||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3650263|NCT02456740|3496811|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3650264|NCT02456740|3496812|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3650265|NCT02456740|3496813|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3650266|NCT02456740|3496810|B4||Female|Sex: Female, Male||Participants|Count of Participants|814|814.0||||||
3650267|NCT02456740|3496811|B3||Female|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
3650268|NCT02456740|3496812|B2||Female|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
3650269|NCT02456740|3496813|B1||Female|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
3650270|NCT02456740|3496810|B4||65 - 74 years|Age, Customized||Participants|Count of Participants|4|4.0||||||
3650271|NCT02456740|3496811|B3||65 - 74 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
3650272|NCT02456740|3496812|B2||65 - 74 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3650273|NCT02456740|3496813|B1||65 - 74 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
3650274|NCT02456740|3496810|B4||18 - 64 years|Age, Customized||Participants|Count of Participants|951|951.0||||||
3650275|NCT02456740|3496811|B3||18 - 64 years|Age, Customized||Participants|Count of Participants|317|317.0||||||
3650276|NCT02456740|3496812|B2||18 - 64 years|Age, Customized||Participants|Count of Participants|317|317.0||||||
3650277|NCT02456740|3496813|B1||18 - 64 years|Age, Customized||Participants|Count of Participants|317|317.0||||||
3650278|NCT02456740|3496810|B4|||Age||years|Mean|40.9|40.9|Standard Deviation|11.2|11.2|||
3650279|NCT02456740|3496811|B3|||Age||years|Mean|40.4|40.4|Standard Deviation|11.1|11.1|||
3650280|NCT02456740|3496812|B2|||Age||years|Mean|41.1|41.1|Standard Deviation|11.3|11.3|||
3650281|NCT02456740|3496813|B1|||Age||years|Mean|41.3|41.3|Standard Deviation|11.2|11.2|||
3650282|NCT02455518|3496843|B5|United States||Region of Enrollment||participants|Number|411|411.0||||||
3650283|NCT02455518|3496844|B4|United States||Region of Enrollment||participants|Number|101|101.0||||||
3650284|NCT02455518|3496845|B3|United States||Region of Enrollment||participants|Number|103|103.0||||||
3650285|NCT02455518|3496846|B2|United States||Region of Enrollment||participants|Number|103|103.0||||||
3650286|NCT02455518|3496847|B1|United States||Region of Enrollment||participants|Number|104|104.0||||||
3650287|NCT02455518|3496843|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3650288|NCT02455518|3496844|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3650289|NCT02455518|3496845|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3650290|NCT02455518|3496846|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3650291|NCT02455518|3496847|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3650292|NCT02455518|3496843|B5|East Asian/Asian||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3650293|NCT02455518|3496844|B4|East Asian/Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3650294|NCT02455518|3496845|B3|East Asian/Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3650295|NCT02455518|3496846|B2|East Asian/Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3650296|NCT02455518|3496847|B1|East Asian/Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3650297|NCT02455518|3496843|B5|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3650298|NCT02455518|3496844|B4|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3650299|NCT02455518|3496845|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3650300|NCT02455518|3496846|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3650301|NCT02455518|3496847|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3650302|NCT02455518|3496843|B5|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|122|122.0||||||
3650303|NCT02455518|3496844|B4|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3650304|NCT02455518|3496845|B3|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3650305|NCT02455518|3496846|B2|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3650306|NCT02455518|3496847|B1|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3650307|NCT02455518|3496843|B5|Latino||Race/Ethnicity, Customized||Participants|Count of Participants|247|247.0||||||
3650308|NCT02455518|3496844|B4|Latino||Race/Ethnicity, Customized||Participants|Count of Participants|62|62.0||||||
3650309|NCT02455518|3496845|B3|Latino||Race/Ethnicity, Customized||Participants|Count of Participants|58|58.0||||||
3650310|NCT02455518|3496846|B2|Latino||Race/Ethnicity, Customized||Participants|Count of Participants|65|65.0||||||
3650311|NCT02455518|3496847|B1|Latino||Race/Ethnicity, Customized||Participants|Count of Participants|62|62.0||||||
3650312|NCT02455518|3496843|B5||Male|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
3650314|NCT02455518|3496845|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3650315|NCT02455518|3496846|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3650316|NCT02455518|3496847|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3650317|NCT02455518|3496843|B5||Female|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
3650318|NCT02455518|3496844|B4||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3650319|NCT02455518|3496845|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3650320|NCT02455518|3496846|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3650321|NCT02455518|3496847|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3650322|NCT02455518|3496843|B5|||Age||years|Mean|37|37.0|Standard Deviation|12|12.0|||
3650323|NCT02455518|3496844|B4|||Age||years|Mean|37|37.0|Standard Deviation|11|11.0|||
3650324|NCT02455518|3496845|B3|||Age||years|Mean|37|37.0|Standard Deviation|12|12.0|||
3650325|NCT02455518|3496846|B2|||Age||years|Mean|37|37.0|Standard Deviation|13|13.0|||
3650326|NCT02455518|3496847|B1|||Age||years|Mean|37|37.0|Standard Deviation|12|12.0|||
3650327|NCT02455388|3496864|B3|||Body Mass Index||kg/m^2|Mean|20.0|20.0|Standard Deviation|4.4|4.4|||
3650328|NCT02455388|3496865|B2|||Body Mass Index||kg/m^2|Mean|20.0|20.0|Standard Deviation|4.5|4.5|||
3650329|NCT02455388|3496866|B1|||Body Mass Index||kg/m^2|Mean|20.2|20.2|Standard Deviation|2.1|2.1|||
3650330|NCT02455388|3496864|B3|United States||Region of Enrollment||participants|Number|358|358.0||||||
3650331|NCT02455388|3496865|B2|United States||Region of Enrollment||participants|Number|326|326.0||||||
3650332|NCT02455388|3496866|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
3650333|NCT02455388|3496864|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3650334|NCT02455388|3496865|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3650335|NCT02455388|3496866|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650336|NCT02455388|3496864|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650337|NCT02455388|3496865|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650338|NCT02455388|3496866|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650339|NCT02455388|3496864|B3||White|Race (NIH/OMB)||Participants|Count of Participants|345|345.0||||||
3650340|NCT02455388|3496865|B2||White|Race (NIH/OMB)||Participants|Count of Participants|313|313.0||||||
3650341|NCT02455388|3496866|B1||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3650342|NCT02455388|3496864|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3650343|NCT02455388|3496865|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3650344|NCT02455388|3496866|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650345|NCT02455388|3496864|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650346|NCT02455388|3496865|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650347|NCT02455388|3496866|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650348|NCT02455388|3496864|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3650349|NCT02455388|3496865|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3650350|NCT02455388|3496866|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650351|NCT02455388|3496864|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650352|NCT02455388|3496865|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650353|NCT02455388|3496866|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650354|NCT02455388|3496864|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3650355|NCT02455388|3496865|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3650356|NCT02455388|3496866|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3650357|NCT02455388|3496864|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|334|334.0||||||
3650358|NCT02455388|3496865|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|303|303.0||||||
3650359|NCT02455388|3496866|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3650360|NCT02455388|3496864|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3650361|NCT02455388|3496865|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3650362|NCT02455388|3496866|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650363|NCT02455388|3496864|B3||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3650364|NCT02455388|3496865|B2||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
3650365|NCT02455388|3496866|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3650366|NCT02455388|3496864|B3||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3650367|NCT02455388|3496865|B2||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3650368|NCT02455388|3496866|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3650369|NCT02455388|3496864|B3|||Age||years|Mean|12.6|12.6|Standard Deviation|3.3|3.3|||
3650370|NCT02455388|3496865|B2|||Age||years|Mean|12|12.0|Standard Deviation|3|3.0|||
3650371|NCT02455388|3496866|B1|||Age||years|Mean|15.3|15.3|Standard Deviation|1.6|1.6|||
3650372|NCT02455388|3496864|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3650373|NCT02455388|3496865|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3650374|NCT02455388|3496866|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3650375|NCT02455388|3496864|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3650376|NCT02455388|3496865|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3650377|NCT02455388|3496866|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3650378|NCT02455388|3496864|B3||<=18 years|Age||Participants|Count of Participants|358|358.0||||||
3650379|NCT02455388|3496865|B2||<=18 years|Age||Participants|Count of Participants|326|326.0||||||
3650380|NCT02455388|3496866|B1||<=18 years|Age||Participants|Count of Participants|32|32.0||||||
3650381|NCT02455050|3496875|B5||Male|Gender||Participants|Count of Participants|21|21.0||||||
3650382|NCT02455050|3496876|B4||Male|Gender||Participants|Count of Participants|4|4.0||||||
3650383|NCT02455050|3496877|B3||Male|Gender||Participants|Count of Participants|7|7.0||||||
3650384|NCT02455050|3496878|B2||Male|Gender||Participants|Count of Participants|4|4.0||||||
3650385|NCT02455050|3496879|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
3650386|NCT02455050|3496875|B5||Female|Gender||Participants|Count of Participants|58|58.0||||||
3650387|NCT02455050|3496876|B4||Female|Gender||Participants|Count of Participants|16|16.0||||||
3650388|NCT02455050|3496877|B3||Female|Gender||Participants|Count of Participants|13|13.0||||||
3650389|NCT02455050|3496878|B2||Female|Gender||Participants|Count of Participants|15|15.0||||||
3650390|NCT02455050|3496879|B1||Female|Gender||Participants|Count of Participants|14|14.0||||||
3650391|NCT02455050|3496875|B5|||Age||years|Mean|42.95|42.95|Standard Deviation|14.45|14.45|||
3650392|NCT02455050|3496876|B4|||Age||years|Mean|45.05|45.05|Standard Deviation|17.05|17.05|||
3650393|NCT02455050|3496877|B3|||Age||years|Mean|40.70|40.7|Standard Deviation|11.65|11.65|||
3650394|NCT02455050|3496878|B2|||Age||years|Mean|41.79|41.79|Standard Deviation|15.86|15.86|||
3650395|NCT02455050|3496879|B1|||Age||years|Mean|44.20|44.2|Standard Deviation|13.41|13.41|||
3650396|NCT02454959|3496946|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3650397|NCT02454959|3496946|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3650398|NCT02454959|3496946|B1|||Age||Years|Mean|62.5|62.5|Standard Deviation|8.7|8.7|||
3650399|NCT02454933|3496964|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650400|NCT02454933|3496965|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650401|NCT02454933|3496966|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650402|NCT02454933|3496964|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650403|NCT02454933|3496965|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650404|NCT02454933|3496966|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650405|NCT02454933|3496964|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3650406|NCT02454933|3496965|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3650407|NCT02454933|3496966|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3650408|NCT02454933|3496964|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650409|NCT02454933|3496965|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650410|NCT02454933|3496966|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650411|NCT02454933|3496964|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650412|NCT02454933|3496965|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650413|NCT02454933|3496966|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650414|NCT02454933|3496964|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3650415|NCT02454933|3496965|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3650416|NCT02454933|3496966|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3650417|NCT02454933|3496964|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650418|NCT02454933|3496965|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650419|NCT02454933|3496966|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650420|NCT02454933|3496964|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650421|NCT02454933|3496965|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650422|NCT02454933|3496966|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650423|NCT02454933|3496964|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3650424|NCT02454933|3496965|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3650425|NCT02454933|3496966|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3650426|NCT02454933|3496964|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3650427|NCT02454933|3496965|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650428|NCT02454933|3496966|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3650429|NCT02454933|3496964|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3650430|NCT02454933|3496965|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3650431|NCT02454933|3496966|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3650432|NCT02454933|3496964|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3650433|NCT02454933|3496965|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3650434|NCT02454933|3496966|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3650435|NCT02454933|3496964|B3|||Age||years|Mean|60.3|60.3|Standard Deviation|10.9|10.9|||
3650436|NCT02454933|3496965|B2|||Age||years|Mean|57.6|57.6|Standard Deviation|11.2|11.2|||
3650437|NCT02454933|3496966|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|10.6|10.6|||
3650438|NCT02454608|3496972|B4|United States||Region of Enrollment||participants|Number|49|49.0||||||
3650439|NCT02454608|3496973|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
3650440|NCT02454608|3496974|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3650441|NCT02454608|3496975|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3650442|NCT02454608|3496972|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650443|NCT02454608|3496973|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650444|NCT02454608|3496974|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650445|NCT02454608|3496975|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650446|NCT02454608|3496972|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3650447|NCT02454608|3496973|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3650448|NCT02454608|3496974|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3650449|NCT02454608|3496975|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3650450|NCT02454608|3496972|B4||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3650451|NCT02454608|3496973|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3650452|NCT02454608|3496974|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3650453|NCT02454608|3496975|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3650454|NCT02454608|3496972|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3650455|NCT02454608|3496973|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3650456|NCT02454608|3496974|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650457|NCT02454608|3496975|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3650458|NCT02454608|3496972|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650459|NCT02454608|3496973|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650460|NCT02454608|3496974|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650461|NCT02454608|3496975|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650462|NCT02454608|3496972|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3650463|NCT02454608|3496973|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3650464|NCT02454608|3496974|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3650465|NCT02454608|3496975|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650466|NCT02454608|3496972|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650467|NCT02454608|3496973|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650468|NCT02454608|3496974|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650469|NCT02454608|3496975|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650470|NCT02454608|3496972|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3650471|NCT02454608|3496973|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3650472|NCT02454608|3496974|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3650473|NCT02454608|3496975|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3650474|NCT02454608|3496972|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3650475|NCT02454608|3496973|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3650476|NCT02454608|3496974|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3650477|NCT02454608|3496975|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3650478|NCT02454608|3496972|B4|||Age||years|Mean|48.7|48.7|Standard Deviation|12.8|12.8|||
3650479|NCT02454608|3496973|B3|||Age||years|Mean|47.8|47.8|Standard Deviation|11.7|11.7|||
3650480|NCT02454608|3496974|B2|||Age||years|Mean|48.4|48.4|Standard Deviation|11.3|11.3|||
3650481|NCT02454608|3496975|B1|||Age||years|Mean|49.1|49.1|Standard Deviation|14.7|14.7|||
3650482|NCT02454296|3496998|B3|United States||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3650483|NCT02454296|3496999|B2|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3650484|NCT02454296|3497000|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3650485|NCT02454296|3496998|B3|Hispanic/Latina||Race/Ethnicity, Customized|Participants were allowed to mark more than one race|Participants|Count of Participants|2|2.0||||||
3650486|NCT02454296|3496999|B2|Hispanic/Latina||Race/Ethnicity, Customized|Participants were allowed to mark more than one race|Participants|Count of Participants|1|1.0||||||
3650487|NCT02454296|3497000|B1|Hispanic/Latina||Race/Ethnicity, Customized|Participants were allowed to mark more than one race|Participants|Count of Participants|1|1.0||||||
3650548|NCT02454283|3497011|B3|||Pacemaker||participants|Number|1|1.0||||||
3650488|NCT02454296|3496998|B3|Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized|Participants were allowed to mark more than one race|Participants|Count of Participants|20|20.0||||||
3650489|NCT02454296|3496999|B2|Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized|Participants were allowed to mark more than one race|Participants|Count of Participants|10|10.0||||||
3650490|NCT02454296|3497000|B1|Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized|Participants were allowed to mark more than one race|Participants|Count of Participants|10|10.0||||||
3650491|NCT02454296|3496998|B3|Asian||Race/Ethnicity, Customized|Participants were allowed to mark more than one race|Participants|Count of Participants|14|14.0||||||
3650492|NCT02454296|3496999|B2|Asian||Race/Ethnicity, Customized|Participants were allowed to mark more than one race|Participants|Count of Participants|9|9.0||||||
3650493|NCT02454296|3497000|B1|Asian||Race/Ethnicity, Customized|Participants were allowed to mark more than one race|Participants|Count of Participants|5|5.0||||||
3650494|NCT02454296|3496998|B3|Black/African American||Race/Ethnicity, Customized|Participants were allowed to mark more than one race|Participants|Count of Participants|1|1.0||||||
3650495|NCT02454296|3496999|B2|Black/African American||Race/Ethnicity, Customized|Participants were allowed to mark more than one race|Participants|Count of Participants|0|0.0||||||
3650496|NCT02454296|3497000|B1|Black/African American||Race/Ethnicity, Customized|Participants were allowed to mark more than one race|Participants|Count of Participants|1|1.0||||||
3650497|NCT02454296|3496998|B3|White/Caucasian||Race/Ethnicity, Customized|Participants were allowed to mark more than one race|Participants|Count of Participants|12|12.0||||||
3650498|NCT02454296|3496999|B2|White/Caucasian||Race/Ethnicity, Customized|Participants were allowed to mark more than one race|Participants|Count of Participants|7|7.0||||||
3650499|NCT02454296|3497000|B1|White/Caucasian||Race/Ethnicity, Customized|Participants were allowed to mark more than one race|Participants|Count of Participants|5|5.0||||||
3650500|NCT02454296|3496998|B3|Females||Sex/Gender, Customized||Participants|Count of Participants|41|41.0||||||
3650501|NCT02454296|3496999|B2|Females||Sex/Gender, Customized||Participants|Count of Participants|21|21.0||||||
3650502|NCT02454296|3497000|B1|Females||Sex/Gender, Customized||Participants|Count of Participants|20|20.0||||||
3650503|NCT02454296|3496998|B3|||Age||years|Mean|27.85|27.85|Standard Deviation|6.77|6.77|||
3650504|NCT02454296|3496999|B2|||Age||years|Mean|29.81|29.81|Standard Deviation|6.92|6.92|||
3650505|NCT02454296|3497000|B1|||Age||years|Mean|25.80|25.8|Standard Deviation|6.12|6.12|||
3650506|NCT02454283|3497011|B3|||Other anticoagulant||participants|Number|14|14.0||||||
3650507|NCT02454283|3497012|B2|||Other anticoagulant||participants|Number|3|3.0||||||
3650508|NCT02454283|3497013|B1|||Other anticoagulant||participants|Number|11|11.0||||||
3650509|NCT02454283|3497011|B3|||Non vitamin K antagonist||participants|Number|6|6.0||||||
3650510|NCT02454283|3497012|B2|||Non vitamin K antagonist||participants|Number|2|2.0||||||
3650511|NCT02454283|3497013|B1|||Non vitamin K antagonist||participants|Number|4|4.0||||||
3650512|NCT02454283|3497011|B3|||Warfarin||participants|Number|4|4.0||||||
3650513|NCT02454283|3497012|B2|||Warfarin||participants|Number|1|1.0||||||
3650514|NCT02454283|3497013|B1|||Warfarin||participants|Number|3|3.0||||||
3650515|NCT02454283|3497011|B3|||Aspirin||participants|Number|7|7.0||||||
3650516|NCT02454283|3497012|B2|||Aspirin||participants|Number|2|2.0||||||
3650517|NCT02454283|3497013|B1|||Aspirin||participants|Number|5|5.0||||||
3650518|NCT02454283|3497011|B3|||Prior catheter ablation of AF||participants|Number|1|1.0||||||
3650519|NCT02454283|3497012|B2|||Prior catheter ablation of AF||participants|Number|0|0.0||||||
3650520|NCT02454283|3497013|B1|||Prior catheter ablation of AF||participants|Number|1|1.0||||||
3650521|NCT02454283|3497011|B3|||Prior antiarrhythmic drug therapy||participants|Number|2|2.0||||||
3650522|NCT02454283|3497012|B2|||Prior antiarrhythmic drug therapy||participants|Number|2|2.0||||||
3650523|NCT02454283|3497013|B1|||Prior antiarrhythmic drug therapy||participants|Number|0|0.0||||||
3650524|NCT02454283|3497011|B3|||Prior revascularization (PCI or CABG)||participants|Number|4|4.0||||||
3650525|NCT02454283|3497012|B2|||Prior revascularization (PCI or CABG)||participants|Number|2|2.0||||||
3650526|NCT02454283|3497013|B1|||Prior revascularization (PCI or CABG)||participants|Number|2|2.0||||||
3650527|NCT02454283|3497011|B3|||Ischemic heart disease||participants|Number|6|6.0||||||
3650528|NCT02454283|3497012|B2|||Ischemic heart disease||participants|Number|3|3.0||||||
3650529|NCT02454283|3497013|B1|||Ischemic heart disease||participants|Number|3|3.0||||||
3650530|NCT02454283|3497011|B3|||Aortic regurgitation||participants|Number|5|5.0||||||
3650531|NCT02454283|3497012|B2|||Aortic regurgitation||participants|Number|1|1.0||||||
3650532|NCT02454283|3497013|B1|||Aortic regurgitation||participants|Number|4|4.0||||||
3650533|NCT02454283|3497011|B3|||Aortic stenosis||participants|Number|1|1.0||||||
3650534|NCT02454283|3497012|B2|||Aortic stenosis||participants|Number|0|0.0||||||
3650535|NCT02454283|3497013|B1|||Aortic stenosis||participants|Number|1|1.0||||||
3650536|NCT02454283|3497011|B3|||Mitral regurgitation||participants|Number|14|14.0||||||
3650537|NCT02454283|3497012|B2|||Mitral regurgitation||participants|Number|4|4.0||||||
3650538|NCT02454283|3497013|B1|||Mitral regurgitation||participants|Number|10|10.0||||||
3650539|NCT02454283|3497011|B3|||Mitral stenosis||participants|Number|0|0.0||||||
3650540|NCT02454283|3497012|B2|||Mitral stenosis||participants|Number|0|0.0||||||
3650541|NCT02454283|3497013|B1|||Mitral stenosis||participants|Number|0|0.0||||||
3650542|NCT02454283|3497011|B3|||LVEF, mean||%|Mean|54.6|54.6|Standard Deviation|9.7|9.7|||
3650543|NCT02454283|3497012|B2|||LVEF, mean||%|Mean|55.1|55.1|Standard Deviation|12.4|12.4|||
3650544|NCT02454283|3497013|B1|||LVEF, mean||%|Mean|54.3|54.3|Standard Deviation|8.4|8.4|||
3650545|NCT02454283|3497011|B3|||Heart failure||participants|Number|7|7.0||||||
3650546|NCT02454283|3497012|B2|||Heart failure||participants|Number|2|2.0||||||
3650547|NCT02454283|3497013|B1|||Heart failure||participants|Number|5|5.0||||||
3650550|NCT02454283|3497013|B1|||Pacemaker||participants|Number|1|1.0||||||
3650551|NCT02454283|3497011|B3|||Prior stroke||participants|Number|2|2.0||||||
3650552|NCT02454283|3497012|B2|||Prior stroke||participants|Number|2|2.0||||||
3650553|NCT02454283|3497013|B1|||Prior stroke||participants|Number|0|0.0||||||
3650554|NCT02454283|3497011|B3|||Hypothyroidism||participants|Number|3|3.0||||||
3650555|NCT02454283|3497012|B2|||Hypothyroidism||participants|Number|0|0.0||||||
3650556|NCT02454283|3497013|B1|||Hypothyroidism||participants|Number|3|3.0||||||
3650557|NCT02454283|3497011|B3|||Hyperthyroidism||participants|Number|1|1.0||||||
3650558|NCT02454283|3497012|B2|||Hyperthyroidism||participants|Number|0|0.0||||||
3650559|NCT02454283|3497013|B1|||Hyperthyroidism||participants|Number|1|1.0||||||
3650560|NCT02454283|3497011|B3|||COPD||participants|Number|3|3.0||||||
3650561|NCT02454283|3497012|B2|||COPD||participants|Number|1|1.0||||||
3650562|NCT02454283|3497013|B1|||COPD||participants|Number|2|2.0||||||
3650563|NCT02454283|3497011|B3|||Hyperlipidemia||participants|Number|14|14.0||||||
3650564|NCT02454283|3497012|B2|||Hyperlipidemia||participants|Number|6|6.0||||||
3650565|NCT02454283|3497013|B1|||Hyperlipidemia||participants|Number|8|8.0||||||
3650566|NCT02454283|3497011|B3|||Diabetes mellitus||participants|Number|4|4.0||||||
3650567|NCT02454283|3497012|B2|||Diabetes mellitus||participants|Number|0|0.0||||||
3650568|NCT02454283|3497013|B1|||Diabetes mellitus||participants|Number|4|4.0||||||
3650569|NCT02454283|3497011|B3|||Hypertension||participants|Number|27|27.0||||||
3650570|NCT02454283|3497012|B2|||Hypertension||participants|Number|11|11.0||||||
3650571|NCT02454283|3497013|B1|||Hypertension||participants|Number|16|16.0||||||
3650572|NCT02454283|3497011|B3|||Prior AF/AFL||participants|Number|23|23.0||||||
3650573|NCT02454283|3497012|B2|||Prior AF/AFL||participants|Number|7|7.0||||||
3650574|NCT02454283|3497013|B1|||Prior AF/AFL||participants|Number|16|16.0||||||
3650575|NCT02454283|3497011|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3650576|NCT02454283|3497012|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3650577|NCT02454283|3497013|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3650578|NCT02454283|3497011|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3650579|NCT02454283|3497012|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3650580|NCT02454283|3497013|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3650581|NCT02454283|3497011|B3|||Age||years|Mean|67.7|67.7|Standard Deviation|10.0|10.0|||
3650582|NCT02454283|3497012|B2|||Age||years|Mean|66.9|66.9|Standard Deviation|11.3|11.3|||
3650583|NCT02454283|3497013|B1|||Age||years|Mean|68.1|68.1|Standard Deviation|9.3|9.3|||
3650584|NCT02454127|3497022|B5|United States||Region of Enrollment||participants|Number|160|160.0||||||
3650585|NCT02454127|3497023|B4|United States||Region of Enrollment||participants|Number|40|40.0||||||
3650586|NCT02454127|3497024|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3650587|NCT02454127|3497025|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
3650588|NCT02454127|3497026|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3650589|NCT02454127|3497022|B5||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3650590|NCT02454127|3497023|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3650591|NCT02454127|3497024|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3650592|NCT02454127|3497025|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3650593|NCT02454127|3497026|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3650594|NCT02454127|3497022|B5||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3650595|NCT02454127|3497023|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3650596|NCT02454127|3497024|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3650597|NCT02454127|3497025|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3650598|NCT02454127|3497026|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3650599|NCT02454127|3497022|B5|||Age||years|Mean|49|49.0|Standard Deviation|11|11.0|||
3650600|NCT02454127|3497023|B4|||Age||years|Mean|49|49.0|Standard Deviation|12|12.0|||
3650601|NCT02454127|3497024|B3|||Age||years|Mean|49|49.0|Standard Deviation|10|10.0|||
3650602|NCT02454127|3497025|B2|||Age||years|Mean|51|51.0|Standard Deviation|9|9.0|||
3650603|NCT02454127|3497026|B1|||Age||years|Mean|47|47.0|Standard Deviation|12|12.0|||
3650604|NCT02454101|3497067|B3|Egypt||Region of Enrollment||participants|Number|288|288.0||||||
3650605|NCT02454101|3497068|B2|Egypt||Region of Enrollment||participants|Number|143|143.0||||||
3650606|NCT02454101|3497069|B1|Egypt||Region of Enrollment||participants|Number|145|145.0||||||
3650607|NCT02454101|3497067|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3650608|NCT02454101|3497068|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3650609|NCT02454101|3497069|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3650610|NCT02454101|3497067|B3||Female|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
3650611|NCT02454101|3497068|B2||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3650612|NCT02454101|3497069|B1||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3650613|NCT02454101|3497067|B3|||Age||years|Mean|22.4|22.4|Standard Deviation|1.7|1.7|||
3650614|NCT02454101|3497068|B2|||Age||years|Mean|22.4|22.4|Standard Deviation|1.78|1.78|||
3650615|NCT02454101|3497069|B1|||Age||years|Mean|22.42|22.42|Standard Deviation|1.67|1.67|||
3650616|NCT02453841|3497092|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3650617|NCT02453841|3497092|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3650618|NCT02453841|3497092|B1|||Age||years|Mean|7|7.0|Standard Deviation|4|4.0|||
3650619|NCT02453841|3497092|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3650620|NCT02453841|3497092|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3650621|NCT02453841|3497092|B1||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
3650622|NCT02453581|3497099|B1|Australia||Region of Enrollment||participants|Number|24|24.0||||||
3650623|NCT02453581|3497099|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650624|NCT02453581|3497099|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650625|NCT02453581|3497099|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3650626|NCT02453581|3497099|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650627|NCT02453581|3497099|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650628|NCT02453581|3497099|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650629|NCT02453581|3497099|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650630|NCT02453581|3497099|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3650631|NCT02453581|3497099|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3650632|NCT02453581|3497099|B1|41 - 45 Years||Age, Customized||participants|Number|0|0.0||||||
3650633|NCT02453581|3497099|B1|31 - 40 Years||Age, Customized||participants|Number|3|3.0||||||
3650634|NCT02453581|3497099|B1|18 - 30 Years||Age, Customized||participants|Number|21|21.0||||||
3650635|NCT02453347|3497121|B1|United States||Region of Enrollment|Region from which participants are enrolled|participants|Number|6|6.0||||||
3650636|NCT02453347|3497121|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3650637|NCT02453347|3497121|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3650638|NCT02453347|3497121|B1|||Age||years|Mean|38.5|38.5|Standard Deviation|8.57|8.57|||
3650639|NCT02453347|3497121|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3650640|NCT02453347|3497121|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3650641|NCT02453347|3497121|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3650642|NCT02453321|3497134|B4|United States||Region of Enrollment||participants|Number|62|62.0||||||
3650643|NCT02453321|3497135|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
3650644|NCT02453321|3497136|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
3650645|NCT02453321|3497137|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3650646|NCT02453321|3497134|B4|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3650647|NCT02453321|3497134|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3650648|NCT02453321|3497135|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3650649|NCT02453321|3497136|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3650650|NCT02453321|3497137|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3650651|NCT02453321|3497134|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3650652|NCT02453321|3497135|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3650653|NCT02453321|3497136|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3650654|NCT02453321|3497137|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3650655|NCT02453321|3497134|B4|||Age||years|Mean|66.2|66.2|Standard Deviation|5.8|5.8|||
3650656|NCT02453321|3497135|B3|||Age||years|Mean|66.5|66.5|Standard Deviation|6.8|6.8|||
3650657|NCT02453321|3497136|B2|||Age||years|Mean|67.0|67.0|Standard Deviation|5.1|5.1|||
3650658|NCT02453321|3497137|B1|||Age||years|Mean|65.4|65.4|Standard Deviation|5.5|5.5|||
3650659|NCT02453321|3497134|B4||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
3650660|NCT02453321|3497135|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3650661|NCT02453321|3497136|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3650662|NCT02453321|3497137|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3650663|NCT02453321|3497134|B4||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3650664|NCT02453321|3497135|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3650665|NCT02453321|3497136|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3650666|NCT02453321|3497137|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3650667|NCT02453321|3497134|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3650668|NCT02453321|3497135|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3650669|NCT02453321|3497136|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3650670|NCT02453321|3497137|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3650671|NCT02452944|3497156|B3|ASA II||American Society of Anesthesiologists physical status (ASA)|ASA class I: a normal healthy patient ASA class II: a patient with mild systemic disease|participants|Number|44|44.0||||||
3650672|NCT02452944|3497157|B2|ASA II||American Society of Anesthesiologists physical status (ASA)|ASA class I: a normal healthy patient ASA class II: a patient with mild systemic disease|participants|Number|20|20.0||||||
3650673|NCT02452944|3497158|B1|ASA II||American Society of Anesthesiologists physical status (ASA)|ASA class I: a normal healthy patient ASA class II: a patient with mild systemic disease|participants|Number|24|24.0||||||
3650674|NCT02452944|3497156|B3|ASA I||American Society of Anesthesiologists physical status (ASA)|ASA class I: a normal healthy patient ASA class II: a patient with mild systemic disease|participants|Number|18|18.0||||||
3650675|NCT02452944|3497157|B2|ASA I||American Society of Anesthesiologists physical status (ASA)|ASA class I: a normal healthy patient ASA class II: a patient with mild systemic disease|participants|Number|11|11.0||||||
3650676|NCT02452944|3497158|B1|ASA I||American Society of Anesthesiologists physical status (ASA)|ASA class I: a normal healthy patient ASA class II: a patient with mild systemic disease|participants|Number|7|7.0||||||
3650677|NCT02452944|3497156|B3|||Weight (kg)||kg|Mean|62.5|62.5|Standard Deviation|10.7|10.7|||
3650678|NCT02452944|3497157|B2|||Weight (kg)||kg|Mean|63.1|63.1|Standard Deviation|10.2|10.2|||
3650679|NCT02452944|3497158|B1|||Weight (kg)||kg|Mean|61.9|61.9|Standard Deviation|11.3|11.3|||
3650680|NCT02452944|3497156|B3|||Height (cm)||cm|Mean|165.2|165.2|Standard Deviation|7.0|7.0|||
3650681|NCT02452944|3497157|B2|||Height (cm)||cm|Mean|166.3|166.3|Standard Deviation|6.3|6.3|||
3650682|NCT02452944|3497158|B1|||Height (cm)||cm|Mean|164.1|164.1|Standard Deviation|7.6|7.6|||
3650683|NCT02452944|3497156|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3650684|NCT02452944|3497157|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3650685|NCT02452944|3497158|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3650686|NCT02452944|3497156|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3650687|NCT02452944|3497157|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3650688|NCT02452944|3497158|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3650689|NCT02452944|3497156|B3|||Age||years|Mean|69.2|69.2|Standard Deviation|12.3|12.3|||
3650690|NCT02452944|3497157|B2|||Age||years|Mean|70|70.0|Standard Deviation|11|11.0|||
3650691|NCT02452944|3497158|B1|||Age||years|Mean|68|68.0|Standard Deviation|14|14.0|||
3650692|NCT02452892|3497167|B5|Other||Race/Ethnicity, Customized|White, Black or African American, Asian|Participants|Count of Participants|1|1.0||||||
3650693|NCT02452892|3497168|B4|Other||Race/Ethnicity, Customized|White, Black or African American, Asian|Participants|Count of Participants|0|0.0||||||
3650694|NCT02452892|3497169|B3|Other||Race/Ethnicity, Customized|White, Black or African American, Asian|Participants|Count of Participants|1|1.0||||||
3650695|NCT02452892|3497170|B2|Other||Race/Ethnicity, Customized|White, Black or African American, Asian|Participants|Count of Participants|0|0.0||||||
3650696|NCT02452892|3497171|B1|Other||Race/Ethnicity, Customized|White, Black or African American, Asian|Participants|Count of Participants|0|0.0||||||
3650697|NCT02452892|3497167|B5|Asian||Race/Ethnicity, Customized|White, Black or African American, Asian|Participants|Count of Participants|6|6.0||||||
3650698|NCT02452892|3497168|B4|Asian||Race/Ethnicity, Customized|White, Black or African American, Asian|Participants|Count of Participants|0|0.0||||||
3650699|NCT02452892|3497169|B3|Asian||Race/Ethnicity, Customized|White, Black or African American, Asian|Participants|Count of Participants|2|2.0||||||
3650700|NCT02452892|3497170|B2|Asian||Race/Ethnicity, Customized|White, Black or African American, Asian|Participants|Count of Participants|3|3.0||||||
3650701|NCT02452892|3497171|B1|Asian||Race/Ethnicity, Customized|White, Black or African American, Asian|Participants|Count of Participants|1|1.0||||||
3650702|NCT02452892|3497167|B5|Black or African American||Race/Ethnicity, Customized|White, Black or African American, Asian|Participants|Count of Participants|29|29.0||||||
3650703|NCT02452892|3497168|B4|Black or African American||Race/Ethnicity, Customized|White, Black or African American, Asian|Participants|Count of Participants|0|0.0||||||
3650704|NCT02452892|3497169|B3|Black or African American||Race/Ethnicity, Customized|White, Black or African American, Asian|Participants|Count of Participants|11|11.0||||||
3650705|NCT02452892|3497170|B2|Black or African American||Race/Ethnicity, Customized|White, Black or African American, Asian|Participants|Count of Participants|9|9.0||||||
3650706|NCT02452892|3497171|B1|Black or African American||Race/Ethnicity, Customized|White, Black or African American, Asian|Participants|Count of Participants|9|9.0||||||
3650707|NCT02452892|3497167|B5|White||Race/Ethnicity, Customized|White, Black or African American, Asian|Participants|Count of Participants|86|86.0||||||
3650708|NCT02452892|3497168|B4|White||Race/Ethnicity, Customized|White, Black or African American, Asian|Participants|Count of Participants|0|0.0||||||
3650709|NCT02452892|3497169|B3|White||Race/Ethnicity, Customized|White, Black or African American, Asian|Participants|Count of Participants|27|27.0||||||
3650710|NCT02452892|3497170|B2|White||Race/Ethnicity, Customized|White, Black or African American, Asian|Participants|Count of Participants|28|28.0||||||
3650711|NCT02452892|3497171|B1|White||Race/Ethnicity, Customized|White, Black or African American, Asian|Participants|Count of Participants|31|31.0||||||
3650712|NCT02452892|3497167|B5||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3650713|NCT02452892|3497168|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3650714|NCT02452892|3497169|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3650715|NCT02452892|3497170|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3650716|NCT02452892|3497171|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3650717|NCT02452892|3497167|B5||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3650718|NCT02452892|3497168|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3650719|NCT02452892|3497169|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3650720|NCT02452892|3497170|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3650721|NCT02452892|3497171|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3650722|NCT02452892|3497167|B5||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3650723|NCT02452892|3497168|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3650724|NCT02452892|3497169|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3650725|NCT02452892|3497170|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3650726|NCT02452892|3497171|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3650727|NCT02452892|3497167|B5||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
3650728|NCT02452892|3497168|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3650729|NCT02452892|3497169|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3650730|NCT02452892|3497170|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3650731|NCT02452892|3497171|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3650732|NCT02452892|3497167|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3650733|NCT02452892|3497168|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3650734|NCT02452892|3497169|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3650735|NCT02452892|3497170|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3650736|NCT02452892|3497171|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3650737|NCT02452528|3497203|B3|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3650738|NCT02452528|3497204|B2|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3650739|NCT02452528|3497205|B1|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3650740|NCT02452528|3497203|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650741|NCT02452528|3497204|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650742|NCT02452528|3497205|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650743|NCT02452528|3497203|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650744|NCT02452528|3497204|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650745|NCT02452528|3497205|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650746|NCT02452528|3497203|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3650747|NCT02452528|3497204|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3650748|NCT02452528|3497205|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650749|NCT02452528|3497203|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3650750|NCT02452528|3497204|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650751|NCT02452528|3497205|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3650752|NCT02452528|3497203|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650753|NCT02452528|3497204|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650754|NCT02452528|3497205|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650755|NCT02452528|3497203|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3650756|NCT02452528|3497204|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3650757|NCT02452528|3497205|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3650758|NCT02452528|3497203|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650759|NCT02452528|3497204|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650760|NCT02452528|3497205|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650761|NCT02452528|3497203|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650762|NCT02452528|3497204|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650763|NCT02452528|3497205|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650764|NCT02452528|3497203|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3650765|NCT02452528|3497204|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3650766|NCT02452528|3497205|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3650767|NCT02452528|3497203|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650768|NCT02452528|3497204|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650769|NCT02452528|3497205|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650770|NCT02452528|3497203|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3650771|NCT02452528|3497204|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3650772|NCT02452528|3497205|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3650773|NCT02452528|3497203|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3650774|NCT02452528|3497204|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3650775|NCT02452528|3497205|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3650776|NCT02452528|3497203|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3650777|NCT02452528|3497204|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3650778|NCT02452528|3497205|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3650779|NCT02452528|3497203|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3650780|NCT02452528|3497204|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3650781|NCT02452528|3497205|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3650782|NCT02452528|3497203|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3650783|NCT02452528|3497204|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3650784|NCT02452528|3497205|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3650785|NCT02452346|3497238|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3650786|NCT02452346|3497238|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3650787|NCT02452346|3497238|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650788|NCT02452346|3497238|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3650789|NCT02452346|3497238|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650790|NCT02452346|3497238|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650791|NCT02452346|3497238|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650792|NCT02452346|3497238|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650793|NCT02452346|3497238|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3650794|NCT02452346|3497238|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3650795|NCT02452346|3497238|B1|||Age||years|Median|72|72.0|Full Range|||61.0|80.0|
3650796|NCT02452346|3497238|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3650797|NCT02452346|3497238|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3650798|NCT02452346|3497238|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3650799|NCT02452320|3497244|B3|||BMI||kg/m^2|Mean|46.9|46.9|Standard Deviation|7.8|7.8|||
3650800|NCT02452320|3497245|B2|||BMI||kg/m^2|Mean|46.6|46.6|Standard Deviation|7.7|7.7|||
3650801|NCT02452320|3497246|B1|||BMI||kg/m^2|Mean|47.3|47.3|Standard Deviation|7.9|7.9|||
3650802|NCT02452320|3497244|B3|||Weight (kg)||kg|Mean|128.8|128.8|Standard Deviation|26.3|26.3|||
3650803|NCT02452320|3497245|B2|||Weight (kg)||kg|Mean|127.5|127.5|Standard Deviation|25.4|25.4|||
3650804|NCT02452320|3497246|B1|||Weight (kg)||kg|Mean|130|130.0|Standard Deviation|27.1|27.1|||
3650805|NCT02452320|3497244|B3|||Height (cm)||cm|Mean|165.2|165.2|Standard Deviation|10|10.0|||
3650806|NCT02452320|3497245|B2|||Height (cm)||cm|Mean|165.5|165.5|Standard Deviation|9.2|9.2|||
3650807|NCT02452320|3497246|B1|||Height (cm)||cm|Mean|164.8|164.8|Standard Deviation|10.8|10.8|||
3650808|NCT02452320|3497244|B3|United States||Region of Enrollment||participants|Number|127|127.0||||||
3650809|NCT02452320|3497245|B2|United States||Region of Enrollment||participants|Number|63|63.0||||||
3650810|NCT02452320|3497246|B1|United States||Region of Enrollment||participants|Number|64|64.0||||||
3650811|NCT02452320|3497244|B3|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3650812|NCT02452320|3497245|B2|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3650813|NCT02452320|3497246|B1|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3650814|NCT02452320|3497244|B3|More than one race||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3650815|NCT02452320|3497245|B2|More than one race||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3650816|NCT02452320|3497246|B1|More than one race||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3650817|NCT02452320|3497244|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3650818|NCT02452320|3497245|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3650819|NCT02452320|3497246|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3650820|NCT02452320|3497244|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|45|45.0||||||
3650821|NCT02452320|3497245|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3650822|NCT02452320|3497246|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3650823|NCT02452320|3497244|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3650824|NCT02452320|3497245|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3650825|NCT02452320|3497246|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3650826|NCT02452320|3497244|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3650827|NCT02452320|3497245|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3650828|NCT02452320|3497246|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3650829|NCT02452320|3497244|B3|||Age||years|Mean|40.7|40.7|Standard Deviation|12.2|12.2|||
3650830|NCT02452320|3497245|B2|||Age||years|Mean|42.2|42.2|Standard Deviation|12.2|12.2|||
3650831|NCT02452320|3497246|B1|||Age||years|Mean|39.1|39.1|Standard Deviation|12.2|12.2|||
3650832|NCT02452047|3497257|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650833|NCT02452047|3497258|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650834|NCT02452047|3497259|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650835|NCT02452047|3497260|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650836|NCT02452047|3497257|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3650837|NCT02452047|3497258|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650838|NCT02452047|3497259|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650839|NCT02452047|3497260|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3650840|NCT02452047|3497257|B4||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3650841|NCT02452047|3497258|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3650842|NCT02452047|3497259|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3650843|NCT02452047|3497260|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3650844|NCT02452047|3497257|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3650845|NCT02452047|3497258|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650846|NCT02452047|3497259|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3650847|NCT02452047|3497260|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650848|NCT02452047|3497257|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650849|NCT02452047|3497258|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650850|NCT02452047|3497259|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650851|NCT02452047|3497260|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650852|NCT02452047|3497257|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650853|NCT02452047|3497258|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650854|NCT02452047|3497259|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650855|NCT02452047|3497260|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650856|NCT02452047|3497257|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3650857|NCT02452047|3497258|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650858|NCT02452047|3497259|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650859|NCT02452047|3497260|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3650860|NCT02452047|3497257|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3650861|NCT02452047|3497258|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3650862|NCT02452047|3497259|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3650863|NCT02452047|3497260|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3650864|NCT02452047|3497257|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3650865|NCT02452047|3497258|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3650866|NCT02452047|3497259|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3650867|NCT02452047|3497260|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3650868|NCT02452047|3497257|B4|||Age||Years|Mean|57.9|57.9|Standard Deviation|16.4|16.4|||
3650869|NCT02452047|3497258|B3|||Age||Years|Mean|50.0|50.0|Standard Deviation|23.1|23.1|||
3650870|NCT02452047|3497259|B2|||Age||Years|Mean|62.8|62.8|Standard Deviation|14.9|14.9|||
3650871|NCT02452047|3497260|B1|||Age||Years|Mean|56.1|56.1|Standard Deviation|16.5|16.5|||
3650872|NCT02451917|3497321|B3|||Diastolic Blood Pressure||mmHg|Mean|76|76.0|Standard Deviation|12|12.0|||
3650873|NCT02451917|3497322|B2|||Diastolic Blood Pressure||mmHg|Mean|75|75.0|Standard Deviation|13|13.0|||
3650874|NCT02451917|3497323|B1|||Diastolic Blood Pressure||mmHg|Mean|79|79.0|Standard Deviation|12|12.0|||
3650875|NCT02451917|3497321|B3|||Systolic Blood Pressure||mmHg|Mean|141|141.0|Standard Deviation|20|20.0|||
3650876|NCT02451917|3497322|B2|||Systolic Blood Pressure||mmHg|Mean|136|136.0|Standard Deviation|18|18.0|||
3650877|NCT02451917|3497323|B1|||Systolic Blood Pressure||mmHg|Mean|147|147.0|Standard Deviation|22|22.0|||
3650878|NCT02451917|3497321|B3|||BMI||kg/m²|Mean|29.6|29.6|Standard Deviation|4.6|4.6|||
3650879|NCT02451917|3497322|B2|||BMI||kg/m²|Mean|30.4|30.4|Standard Deviation|4.3|4.3|||
3650880|NCT02451917|3497323|B1|||BMI||kg/m²|Mean|28.6|28.6|Standard Deviation|4.8|4.8|||
3650881|NCT02451917|3497321|B3|||Body weight||kg|Mean|79.2|79.2|Standard Deviation|15.3|15.3|||
3650882|NCT02451917|3497322|B2|||Body weight||kg|Mean|82.6|82.6|Standard Deviation|17.4|17.4|||
3650883|NCT02451917|3497323|B1|||Body weight||kg|Mean|75.4|75.4|Standard Deviation|11.9|11.9|||
3650884|NCT02451917|3497321|B3|||Duration of Diabetes||years|Mean|19.1|19.1|Standard Deviation|9.4|9.4|||
3650885|NCT02451917|3497322|B2|||Duration of Diabetes||years|Mean|19.2|19.2|Standard Deviation|7.0|7.0|||
3650886|NCT02451917|3497323|B1|||Duration of Diabetes||years|Mean|19.0|19.0|Standard Deviation|11.7|11.7|||
3650887|NCT02451917|3497321|B3|Brazil||Region of Enrollment||participants|Number|34|34.0||||||
3650888|NCT02451917|3497322|B2|Brazil||Region of Enrollment||participants|Number|18|18.0||||||
3650889|NCT02451917|3497323|B1|Brazil||Region of Enrollment||participants|Number|16|16.0||||||
3650890|NCT02451917|3497321|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3650891|NCT02451917|3497322|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3650892|NCT02451917|3497323|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3650893|NCT02451917|3497321|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3650894|NCT02451917|3497322|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3650895|NCT02451917|3497323|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3650896|NCT02451917|3497321|B3|||Age||years|Mean|61.4|61.4|Standard Deviation|7.9|7.9|||
3650897|NCT02451917|3497322|B2|||Age||years|Mean|60.1|60.1|Standard Deviation|8.7|8.7|||
3650898|NCT02451917|3497323|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|7.0|7.0|||
3650899|NCT02451358|3497342|B5|India||Region of Enrollment||participants|Number|396|396.0||||||
3650900|NCT02451358|3497343|B4|India||Region of Enrollment||participants|Number|100|100.0||||||
3650901|NCT02451358|3497344|B3|India||Region of Enrollment||participants|Number|99|99.0||||||
3650902|NCT02451358|3497345|B2|India||Region of Enrollment||participants|Number|98|98.0||||||
3650903|NCT02451358|3497346|B1|India||Region of Enrollment||participants|Number|99|99.0||||||
3650904|NCT02451358|3497342|B5|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3650905|NCT02451358|3497342|B5||Male|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
3650906|NCT02451358|3497343|B4||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3650907|NCT02451358|3497344|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3650908|NCT02451358|3497345|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3650909|NCT02451358|3497346|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3650910|NCT02451358|3497342|B5||Female|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
3650911|NCT02451358|3497343|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3650912|NCT02451358|3497344|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3650913|NCT02451358|3497345|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3650914|NCT02451358|3497346|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3650915|NCT02451358|3497342|B5|||Age||years|Mean|16.6|16.6|Standard Deviation|21.2|21.2|||
3650916|NCT02451358|3497343|B4|||Age||years|Mean|48.5|48.5|Standard Deviation|18.8|18.8|||
3650917|NCT02451358|3497344|B3|||Age||years|Mean|11.7|11.7|Standard Deviation|2.2|2.2|||
3650918|NCT02451358|3497345|B2|||Age||years|Mean|4.9|4.9|Standard Deviation|1.5|1.5|||
3650919|NCT02451358|3497346|B1|||Age||years|Mean|1.0|1.0|Standard Deviation|0.8|0.8|||
3650920|NCT02451150|3497371|B3|Secondary Hypertension||Types of Hypertension||participants|Number|5|5.0||||||
3650921|NCT02451150|3497372|B2|Secondary Hypertension||Types of Hypertension||participants|Number|2|2.0||||||
3650922|NCT02451150|3497373|B1|Secondary Hypertension||Types of Hypertension||participants|Number|3|3.0||||||
3650923|NCT02451150|3497371|B3|Essential Hypertension||Types of Hypertension||participants|Number|1|1.0||||||
3650924|NCT02451150|3497372|B2|Essential Hypertension||Types of Hypertension||participants|Number|1|1.0||||||
3650925|NCT02451150|3497373|B1|Essential Hypertension||Types of Hypertension||participants|Number|0|0.0||||||
3650926|NCT02451150|3497371|B3|||Disease Duration||years|Mean|2.47|2.47|Standard Deviation|2.717|2.717|||
3650927|NCT02451150|3497372|B2|||Disease Duration||years|Mean|4.17|4.17|Standard Deviation|2.994|2.994|||
3650928|NCT02451150|3497373|B1|||Disease Duration||years|Mean|0.77|0.77|Standard Deviation|0.907|0.907|||
3650929|NCT02451150|3497371|B3|No||Caffeine Classification||participants|Number|6|6.0||||||
3650930|NCT02451150|3497372|B2|No||Caffeine Classification||participants|Number|3|3.0||||||
3650931|NCT02451150|3497373|B1|No||Caffeine Classification||participants|Number|3|3.0||||||
3650932|NCT02451150|3497371|B3|Yes||Caffeine Classification||participants|Number|0|0.0||||||
3650933|NCT02451150|3497372|B2|Yes||Caffeine Classification||participants|Number|0|0.0||||||
3650934|NCT02451150|3497373|B1|Yes||Caffeine Classification||participants|Number|0|0.0||||||
3650935|NCT02451150|3497371|B3|||Body Mass Index (BMI)||kg/m^2|Mean|20.35|20.35|Standard Deviation|5.035|5.035|||
3650936|NCT02451150|3497372|B2|||Body Mass Index (BMI)||kg/m^2|Mean|24.77|24.77|Standard Deviation|2.108|2.108|||
3650937|NCT02451150|3497373|B1|||Body Mass Index (BMI)||kg/m^2|Mean|15.93|15.93|Standard Deviation|0.651|0.651|||
3650938|NCT02451150|3497371|B3|||Weight||kg|Mean|46.72|46.72|Standard Deviation|21.386|21.386|||
3650939|NCT02451150|3497372|B2|||Weight||kg|Mean|65.90|65.9|Standard Deviation|2.955|2.955|||
3650940|NCT02451150|3497373|B1|||Weight||kg|Mean|27.53|27.53|Standard Deviation|5.537|5.537|||
3650941|NCT02451150|3497371|B3|≥50.0 kg||Weight Categorical||participants|Number|3|3.0||||||
3650942|NCT02451150|3497372|B2|≥50.0 kg||Weight Categorical||participants|Number|3|3.0||||||
3650943|NCT02451150|3497373|B1|≥50.0 kg||Weight Categorical||participants|Number|0|0.0||||||
3650944|NCT02451150|3497371|B3|<50.0 kg||Weight Categorical||participants|Number|3|3.0||||||
3650945|NCT02451150|3497372|B2|<50.0 kg||Weight Categorical||participants|Number|0|0.0||||||
3650946|NCT02451150|3497373|B1|<50.0 kg||Weight Categorical||participants|Number|3|3.0||||||
3650947|NCT02451150|3497371|B3|||Height||cm|Mean|147.2|147.2|Standard Deviation|19.49|19.49|||
3650948|NCT02451150|3497372|B2|||Height||cm|Mean|163.3|163.3|Standard Deviation|7.37|7.37|||
3650949|NCT02451150|3497373|B1|||Height||cm|Mean|131.0|131.0|Standard Deviation|10.54|10.54|||
3650950|NCT02451150|3497371|B3|Japan||Region of Enrollment||participants|Number|6|6.0||||||
3650951|NCT02451150|3497372|B2|Japan||Region of Enrollment||participants|Number|3|3.0||||||
3650952|NCT02451150|3497373|B1|Japan||Region of Enrollment||participants|Number|3|3.0||||||
3650953|NCT02451150|3497371|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3650954|NCT02451150|3497372|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3650955|NCT02451150|3497373|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3650956|NCT02451150|3497371|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3650957|NCT02451150|3497372|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3650958|NCT02451150|3497373|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3650959|NCT02451150|3497371|B3|||Age||years|Mean|11.3|11.3|Standard Deviation|2.58|2.58|||
3650960|NCT02451150|3497372|B2|||Age||years|Mean|13.7|13.7|Standard Deviation|0.58|0.58|||
3650961|NCT02451150|3497373|B1|||Age||years|Mean|9.0|9.0|Standard Deviation|0.00|0.0|||
3650962|NCT02450799|3497424|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3650963|NCT02450799|3497425|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3650964|NCT02450799|3497426|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3650965|NCT02450799|3497427|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3650966|NCT02450799|3497424|B4||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3650967|NCT02450799|3497425|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3650968|NCT02450799|3497426|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3650969|NCT02450799|3497427|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3650970|NCT02450799|3497424|B4|>90 years||Age, Customized||subjects|Number|8|8.0||||||
3650971|NCT02450799|3497425|B3|>90 years||Age, Customized||subjects|Number|4|4.0||||||
3650972|NCT02450799|3497426|B2|>90 years||Age, Customized||subjects|Number|0|0.0||||||
3650973|NCT02450799|3497427|B1|>90 years||Age, Customized||subjects|Number|4|4.0||||||
3650974|NCT02450799|3497424|B4|≥80 and ≤89 years||Age, Customized||subjects|Number|33|33.0||||||
3650975|NCT02450799|3497425|B3|≥80 and ≤89 years||Age, Customized||subjects|Number|9|9.0||||||
3650976|NCT02450799|3497426|B2|≥80 and ≤89 years||Age, Customized||subjects|Number|12|12.0||||||
3650977|NCT02450799|3497427|B1|≥80 and ≤89 years||Age, Customized||subjects|Number|12|12.0||||||
3650978|NCT02450799|3497424|B4|≥70 and ≤79 years||Age, Customized||subjects|Number|45|45.0||||||
3650979|NCT02450799|3497425|B3|≥70 and ≤79 years||Age, Customized||subjects|Number|11|11.0||||||
3650980|NCT02450799|3497426|B2|≥70 and ≤79 years||Age, Customized||subjects|Number|21|21.0||||||
3650981|NCT02450799|3497427|B1|≥70 and ≤79 years||Age, Customized||subjects|Number|13|13.0||||||
3650982|NCT02450799|3497424|B4|<70 years||Age, Customized||subjects|Number|12|12.0||||||
3650983|NCT02450799|3497425|B3|<70 years||Age, Customized||subjects|Number|6|6.0||||||
3650984|NCT02450799|3497426|B2|<70 years||Age, Customized||subjects|Number|4|4.0||||||
3650985|NCT02450799|3497427|B1|<70 years||Age, Customized||subjects|Number|2|2.0||||||
3650986|NCT02450747|3497440|B1|Canada||Region of Enrollment||Participants|Number|39|39.0||||||
3650987|NCT02450747|3497440|B1|White||Race/Ethnicity, Customized||Participants|Number|33|33.0||||||
3650988|NCT02450747|3497440|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3650989|NCT02450747|3497440|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3650990|NCT02450747|3497440|B1|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3650991|NCT02450747|3497440|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3650992|NCT02450747|3497440|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3650993|NCT02450747|3497440|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3650994|NCT02450747|3497440|B1|||Age||Years|Mean|54.5|54.5|Standard Deviation|7.05|7.05|||
3650995|NCT02450591|3497449|B1|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3650996|NCT02450591|3497449|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650997|NCT02450591|3497449|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3650998|NCT02450591|3497449|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3650999|NCT02450591|3497449|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651000|NCT02450591|3497449|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651001|NCT02450591|3497449|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3651002|NCT02450591|3497449|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3651003|NCT02450591|3497449|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651004|NCT02450591|3497449|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3651005|NCT02450591|3497449|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651006|NCT02450591|3497449|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3651007|NCT02450591|3497449|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3651008|NCT02450591|3497449|B1|||Age||years|Median|61|61.0|Full Range|||55.0|65.0|
3651009|NCT02450539|3497453|B3||1|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Participants were stratified at randomization according to the following: Eastern Cooperative Oncology Group (ECOG) PS (0 vs. 1); number of prior therapies (received only platinum-based therapy vs. platinum-based therapy plus immune checkpoint inhibitor) and time since initiation of first line therapy (<=9 months vs >9 months). The ECOG Performance Status:0 - Fully active, able to carry on all pre-disease performance without restriction,1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature.|Participants|Count of Participants|130|130.0||||||
3651010|NCT02450539|3497454|B2||1|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Participants were stratified at randomization according to the following: Eastern Cooperative Oncology Group (ECOG) PS (0 vs. 1); number of prior therapies (received only platinum-based therapy vs. platinum-based therapy plus immune checkpoint inhibitor) and time since initiation of first line therapy (<=9 months vs >9 months). The ECOG Performance Status:0 - Fully active, able to carry on all pre-disease performance without restriction,1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature.|Participants|Count of Participants|46|46.0||||||
3651011|NCT02450539|3497455|B1||1|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Participants were stratified at randomization according to the following: Eastern Cooperative Oncology Group (ECOG) PS (0 vs. 1); number of prior therapies (received only platinum-based therapy vs. platinum-based therapy plus immune checkpoint inhibitor) and time since initiation of first line therapy (<=9 months vs >9 months). The ECOG Performance Status:0 - Fully active, able to carry on all pre-disease performance without restriction,1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature.|Participants|Count of Participants|84|84.0||||||
3651057|NCT02450539|3497453|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651012|NCT02450539|3497453|B3||0|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Participants were stratified at randomization according to the following: Eastern Cooperative Oncology Group (ECOG) PS (0 vs. 1); number of prior therapies (received only platinum-based therapy vs. platinum-based therapy plus immune checkpoint inhibitor) and time since initiation of first line therapy (<=9 months vs >9 months). The ECOG Performance Status:0 - Fully active, able to carry on all pre-disease performance without restriction,1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature.|Participants|Count of Participants|29|29.0||||||
3651013|NCT02450539|3497454|B2||0|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Participants were stratified at randomization according to the following: Eastern Cooperative Oncology Group (ECOG) PS (0 vs. 1); number of prior therapies (received only platinum-based therapy vs. platinum-based therapy plus immune checkpoint inhibitor) and time since initiation of first line therapy (<=9 months vs >9 months). The ECOG Performance Status:0 - Fully active, able to carry on all pre-disease performance without restriction,1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature.|Participants|Count of Participants|7|7.0||||||
3651014|NCT02450539|3497455|B1||0|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Participants were stratified at randomization according to the following: Eastern Cooperative Oncology Group (ECOG) PS (0 vs. 1); number of prior therapies (received only platinum-based therapy vs. platinum-based therapy plus immune checkpoint inhibitor) and time since initiation of first line therapy (<=9 months vs >9 months). The ECOG Performance Status:0 - Fully active, able to carry on all pre-disease performance without restriction,1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature.|Participants|Count of Participants|22|22.0||||||
3651015|NCT02450539|3497453|B3|Germany||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3651016|NCT02450539|3497454|B2|Germany||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3651017|NCT02450539|3497455|B1|Germany||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3651018|NCT02450539|3497453|B3|France||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3651019|NCT02450539|3497454|B2|France||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3651020|NCT02450539|3497455|B1|France||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3651021|NCT02450539|3497453|B3|Australia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3651022|NCT02450539|3497454|B2|Australia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3651023|NCT02450539|3497455|B1|Australia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3651024|NCT02450539|3497453|B3|Italy||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3651025|NCT02450539|3497454|B2|Italy||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3651026|NCT02450539|3497455|B1|Italy||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3651027|NCT02450539|3497453|B3|Poland||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3651028|NCT02450539|3497454|B2|Poland||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3651029|NCT02450539|3497455|B1|Poland||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3651030|NCT02450539|3497453|B3|Taiwan||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3651031|NCT02450539|3497454|B2|Taiwan||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3651032|NCT02450539|3497455|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3651033|NCT02450539|3497453|B3|South Korea||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3651034|NCT02450539|3497454|B2|South Korea||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3651035|NCT02450539|3497455|B1|South Korea||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3651036|NCT02450539|3497453|B3|Spain||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3651037|NCT02450539|3497454|B2|Spain||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3651038|NCT02450539|3497455|B1|Spain||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3651039|NCT02450539|3497453|B3|Russia||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3651040|NCT02450539|3497454|B2|Russia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3651041|NCT02450539|3497455|B1|Russia||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3651042|NCT02450539|3497453|B3|Ukraine||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3651043|NCT02450539|3497454|B2|Ukraine||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3651044|NCT02450539|3497455|B1|Ukraine||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3651045|NCT02450539|3497453|B3|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3651046|NCT02450539|3497454|B2|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3651047|NCT02450539|3497455|B1|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3651048|NCT02450539|3497453|B3|Hungary||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3651049|NCT02450539|3497454|B2|Hungary||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3651050|NCT02450539|3497455|B1|Hungary||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3651051|NCT02450539|3497453|B3|Romania||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3651052|NCT02450539|3497454|B2|Romania||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3651053|NCT02450539|3497455|B1|Romania||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3651054|NCT02450539|3497453|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651055|NCT02450539|3497454|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651056|NCT02450539|3497455|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651058|NCT02450539|3497454|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651059|NCT02450539|3497455|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651060|NCT02450539|3497453|B3||White|Race (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
3651061|NCT02450539|3497454|B2||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3651062|NCT02450539|3497455|B1||White|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3651063|NCT02450539|3497453|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651064|NCT02450539|3497454|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651065|NCT02450539|3497455|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651066|NCT02450539|3497453|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651067|NCT02450539|3497454|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651068|NCT02450539|3497455|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651069|NCT02450539|3497453|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3651070|NCT02450539|3497454|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3651071|NCT02450539|3497455|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3651072|NCT02450539|3497453|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651073|NCT02450539|3497454|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651074|NCT02450539|3497455|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651075|NCT02450539|3497453|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3651076|NCT02450539|3497454|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3651077|NCT02450539|3497455|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3651078|NCT02450539|3497453|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
3651079|NCT02450539|3497454|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3651080|NCT02450539|3497455|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3651081|NCT02450539|3497453|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3651082|NCT02450539|3497454|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3651083|NCT02450539|3497455|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3651084|NCT02450539|3497453|B3||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3651085|NCT02450539|3497454|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3651086|NCT02450539|3497455|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3651087|NCT02450539|3497453|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3651088|NCT02450539|3497454|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3651089|NCT02450539|3497455|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3651090|NCT02450539|3497453|B3|||Age||years|Mean|63.5|63.5|Standard Deviation|7.6|7.6|||
3651091|NCT02450539|3497454|B2|||Age||years|Mean|64.5|64.5|Standard Deviation|7.1|7.1|||
3651092|NCT02450539|3497455|B1|||Age||years|Mean|63.1|63.1|Standard Deviation|7.8|7.8|||
3651093|NCT02450383|3497476|B3|||Peri-implant mucosa thickness at 1 mm||millimeters|Mean|3.0|3.0|Standard Deviation|1.3|1.3|||
3651094|NCT02450383|3497477|B2|||Peri-implant mucosa thickness at 1 mm||millimeters|Mean|2.85|2.85|Standard Deviation|1.40|1.4|||
3651095|NCT02450383|3497478|B1|||Peri-implant mucosa thickness at 1 mm||millimeters|Mean|3.05|3.05|Standard Deviation|1.28|1.28|||
3651096|NCT02450383|3497476|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3651097|NCT02450383|3497477|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3651098|NCT02450383|3497478|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3651099|NCT02450383|3497476|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3651100|NCT02450383|3497477|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3651101|NCT02450383|3497478|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3651102|NCT02450383|3497476|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3651103|NCT02450383|3497477|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3651104|NCT02450383|3497478|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3651105|NCT02450383|3497476|B3|||Age||years|Mean|55.5|55.5|Standard Deviation|11.5|11.5|||
3651106|NCT02450383|3497477|B2|||Age||years|Mean|59.7|59.7|Standard Deviation|10.9|10.9|||
3651107|NCT02450383|3497478|B1|||Age||years|Mean|51.2|51.2|Standard Deviation|11.0|11.0|||
3651108|NCT02450383|3497476|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3651109|NCT02450383|3497477|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3651110|NCT02450383|3497478|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3651111|NCT02450383|3497476|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3651112|NCT02450383|3497477|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3651113|NCT02450383|3497478|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3651114|NCT02450383|3497476|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3651115|NCT02450383|3497477|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3651116|NCT02450383|3497478|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3651117|NCT02449915|3497491|B3|United States||Region of Enrollment||Participants|Count of Participants|64|64.0||||||
3651118|NCT02449915|3497492|B2|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3651119|NCT02449915|3497493|B1|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3651120|NCT02449915|3497491|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651121|NCT02449915|3497492|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651122|NCT02449915|3497493|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651123|NCT02449915|3497491|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3651124|NCT02449915|3497492|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3651125|NCT02449915|3497493|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3651126|NCT02449915|3497491|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3651127|NCT02449915|3497492|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3651128|NCT02449915|3497493|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651129|NCT02449915|3497491|B3|Female only||Sex/Gender, Customized||Participants|Count of Participants|64|64.0||||||
3651130|NCT02449915|3497492|B2|Female only||Sex/Gender, Customized||Participants|Count of Participants|31|31.0||||||
3651131|NCT02449915|3497493|B1|Female only||Sex/Gender, Customized||Participants|Count of Participants|33|33.0||||||
3651132|NCT02449915|3497491|B3|||Age||years|Median|62|62.0|Inter-Quartile Range|||55.3|68.0|
3651133|NCT02449915|3497492|B2|||Age||years|Median|61|61.0|Inter-Quartile Range|||54.0|70.0|
3651134|NCT02449915|3497493|B1|||Age||years|Median|64|64.0|Inter-Quartile Range|||57.0|68.0|
3651135|NCT02449902|3497500|B3|||BMI (kg/m^2)||kg/m^2|Mean|26.8|26.8|Standard Deviation|3.6|3.6|||
3651136|NCT02449902|3497501|B2|||BMI (kg/m^2)||kg/m^2|Mean|27.2|27.2|Standard Deviation|3.3|3.3|||
3651137|NCT02449902|3497502|B1|||BMI (kg/m^2)||kg/m^2|Mean|26.4|26.4|Standard Deviation|3.9|3.9|||
3651138|NCT02449902|3497500|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3651139|NCT02449902|3497501|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
3651140|NCT02449902|3497502|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3651141|NCT02449902|3497500|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651142|NCT02449902|3497501|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651143|NCT02449902|3497502|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651144|NCT02449902|3497500|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651145|NCT02449902|3497501|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651146|NCT02449902|3497502|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651147|NCT02449902|3497500|B3||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3651148|NCT02449902|3497501|B2||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3651149|NCT02449902|3497502|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3651150|NCT02449902|3497500|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3651151|NCT02449902|3497501|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3651152|NCT02449902|3497502|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3651153|NCT02449902|3497500|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651154|NCT02449902|3497501|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651155|NCT02449902|3497502|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651156|NCT02449902|3497500|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3651157|NCT02449902|3497501|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651158|NCT02449902|3497502|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3651159|NCT02449902|3497500|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651160|NCT02449902|3497501|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651161|NCT02449902|3497502|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651162|NCT02449902|3497500|B3|Female||Sex/Gender, Customized||participants|Number|50|50.0||||||
3651163|NCT02449902|3497501|B2|Female||Sex/Gender, Customized||participants|Number|26|26.0||||||
3651164|NCT02449902|3497502|B1|Female||Sex/Gender, Customized||participants|Number|24|24.0||||||
3651165|NCT02449902|3497500|B3|||Age||years|Mean|62.3|62.3|Standard Deviation|6.4|6.4|||
3651166|NCT02449902|3497501|B2|||Age||years|Mean|62.3|62.3|Standard Deviation|7.0|7.0|||
3651167|NCT02449902|3497502|B1|||Age||years|Mean|62.4|62.4|Standard Deviation|5.7|5.7|||
3651168|NCT02449798|3497527|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3651169|NCT02449798|3497527|B1|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3651170|NCT02449798|3497527|B1|Latino||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3651171|NCT02449798|3497527|B1|Black||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
3651172|NCT02449798|3497527|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
3651173|NCT02449798|3497527|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3651174|NCT02449798|3497527|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3651175|NCT02449798|3497527|B1|||Age||Year|Mean|56.5|56.5|Standard Deviation|19.06|19.06|||
3651176|NCT02449356|3497539|B3|China||Region of Enrollment||participants|Number|60|60.0||||||
3651177|NCT02449356|3497540|B2|China||Region of Enrollment||participants|Number|30|30.0||||||
3651178|NCT02449356|3497541|B1|China||Region of Enrollment||participants|Number|30|30.0||||||
3651179|NCT02449356|3497539|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3651180|NCT02449356|3497540|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3651181|NCT02449356|3497541|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3651182|NCT02449356|3497539|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3651183|NCT02449356|3497540|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3651184|NCT02449356|3497541|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3651185|NCT02449356|3497539|B3|||Age||yr|Mean|48|48.0|Standard Deviation|6|6.0|||
3651186|NCT02449356|3497540|B2|||Age||yr|Mean|47|47.0|Standard Deviation|6|6.0|||
3651187|NCT02449356|3497541|B1|||Age||yr|Mean|49|49.0|Standard Deviation|5|5.0|||
3651188|NCT02449356|3497539|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3651189|NCT02449356|3497540|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3651190|NCT02449356|3497541|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3651191|NCT02449356|3497539|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3651192|NCT02449356|3497540|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3651193|NCT02449356|3497541|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3651194|NCT02449356|3497539|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3651195|NCT02449356|3497540|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3651196|NCT02449356|3497541|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3651197|NCT02449291|3497558|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3651198|NCT02449291|3497559|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3651199|NCT02449291|3497560|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3651200|NCT02449291|3497561|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3651201|NCT02449291|3497558|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651202|NCT02449291|3497559|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651203|NCT02449291|3497560|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651204|NCT02449291|3497561|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651205|NCT02449291|3497558|B4||White|Race (NIH/OMB)||Participants|Count of Participants|456|456.0||||||
3651206|NCT02449291|3497559|B3||White|Race (NIH/OMB)||Participants|Count of Participants|151|151.0||||||
3651207|NCT02449291|3497560|B2||White|Race (NIH/OMB)||Participants|Count of Participants|152|152.0||||||
3651208|NCT02449291|3497561|B1||White|Race (NIH/OMB)||Participants|Count of Participants|153|153.0||||||
3651209|NCT02449291|3497558|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3651210|NCT02449291|3497559|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3651211|NCT02449291|3497560|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3651212|NCT02449291|3497561|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3651213|NCT02449291|3497558|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651214|NCT02449291|3497559|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651215|NCT02449291|3497560|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651216|NCT02449291|3497561|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651217|NCT02449291|3497558|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3651218|NCT02449291|3497559|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3651219|NCT02449291|3497560|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3651220|NCT02449291|3497561|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3651221|NCT02449291|3497558|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3651222|NCT02449291|3497559|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651223|NCT02449291|3497560|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651224|NCT02449291|3497561|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3651225|NCT02449291|3497558|B4||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3651226|NCT02449291|3497559|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3651227|NCT02449291|3497560|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3651228|NCT02449291|3497561|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3651229|NCT02449291|3497558|B4||Female|Sex: Female, Male||Participants|Count of Participants|427|427.0||||||
3651230|NCT02449291|3497559|B3||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3651231|NCT02449291|3497560|B2||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3651232|NCT02449291|3497561|B1||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3651233|NCT02449291|3497558|B4|||Age||years|Mean|46.1|46.1|Full Range|||18.0|82.0|
3651234|NCT02449291|3497559|B3|||Age||years|Mean|46.5|46.5|Full Range|||19.0|79.0|
3651235|NCT02449291|3497560|B2|||Age||years|Mean|47.4|47.4|Full Range|||19.0|82.0|
3651236|NCT02449291|3497561|B1|||Age||years|Mean|44.2|44.2|Full Range|||18.0|76.0|
3651237|NCT02449044|3497598|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3651238|NCT02449044|3497598|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3651239|NCT02449044|3497598|B1|||Age||Years|Mean|64.6|64.6|Standard Deviation|15.0|15.0|||
3651240|NCT02449018|3497617|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3651241|NCT02449018|3497618|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3651242|NCT02449018|3497619|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3651243|NCT02449018|3497617|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3651244|NCT02449018|3497618|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3651245|NCT02449018|3497619|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3651246|NCT02449018|3497617|B3|||Age||Years|Mean|64.0|64.0|Standard Deviation|6.89|6.89|||
3651247|NCT02449018|3497618|B2|||Age||Years|Mean|64.9|64.9|Standard Deviation|7.55|7.55|||
3651248|NCT02449018|3497619|B1|||Age||Years|Mean|63.6|63.6|Standard Deviation|6.61|6.61|||
3651249|NCT02448914|3497647|B1|Sweden||Region of Enrollment||participants|Number|11|11.0||||||
3651250|NCT02448914|3497647|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3651251|NCT02448914|3497647|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3651252|NCT02448914|3497647|B1|||Age||years|Mean|69.5|69.5|Full Range|||63.0|76.0|
3651253|NCT02448914|3497647|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3651254|NCT02448914|3497647|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3651255|NCT02448914|3497647|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3651256|NCT02448862|3497664|B3|Korea, Republic of||Region of Enrollment||participants|Number|10575|10575.0||||||
3651257|NCT02448862|3497665|B2|Korea, Republic of||Region of Enrollment||participants|Number|6050|6050.0||||||
3651258|NCT02448862|3497666|B1|Korea, Republic of||Region of Enrollment||participants|Number|4525|4525.0||||||
3651259|NCT02448862|3497664|B3||Male|Sex: Female, Male||Participants|Count of Participants|4700|4700.0||||||
3651260|NCT02448862|3497665|B2||Male|Sex: Female, Male||Participants|Count of Participants|2344|2344.0||||||
3651261|NCT02448862|3497666|B1||Male|Sex: Female, Male||Participants|Count of Participants|2356|2356.0||||||
3651262|NCT02448862|3497664|B3||Female|Sex: Female, Male||Participants|Count of Participants|5875|5875.0||||||
3651263|NCT02448862|3497665|B2||Female|Sex: Female, Male||Participants|Count of Participants|3706|3706.0||||||
3651264|NCT02448862|3497666|B1||Female|Sex: Female, Male||Participants|Count of Participants|2169|2169.0||||||
3651265|NCT02448862|3497664|B3|||Age||years|Mean|57.8|57.8|Standard Deviation|5.2|5.2|||
3651266|NCT02448862|3497665|B2|||Age||years|Mean|31.7|31.7|Standard Deviation|5.8|5.8|||
3651267|NCT02448862|3497666|B1|||Age||years|Mean|74.8|74.8|Standard Deviation|4.4|4.4|||
3651268|NCT02448862|3497664|B3||>=65 years|Age||Participants|Count of Participants|4525|4525.0||||||
3651269|NCT02448862|3497665|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3651270|NCT02448862|3497666|B1||>=65 years|Age||Participants|Count of Participants|4525|4525.0||||||
3651271|NCT02448862|3497664|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6050|6050.0||||||
3651272|NCT02448862|3497665|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6050|6050.0||||||
3651273|NCT02448862|3497666|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3651274|NCT02448862|3497664|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3651275|NCT02448862|3497665|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3651276|NCT02448862|3497666|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3651277|NCT02448810|3497681|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3651278|NCT02448810|3497682|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651279|NCT02448810|3497683|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651280|NCT02448810|3497684|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651281|NCT02448810|3497685|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651282|NCT02448810|3497686|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3651283|NCT02448810|3497687|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651284|NCT02448810|3497688|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651285|NCT02448810|3497689|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651286|NCT02448810|3497681|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651287|NCT02448810|3497682|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651288|NCT02448810|3497683|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651289|NCT02448810|3497684|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651290|NCT02448810|3497685|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651291|NCT02448810|3497686|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651292|NCT02448810|3497687|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651293|NCT02448810|3497688|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651294|NCT02448810|3497689|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651295|NCT02448810|3497681|B9||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3651296|NCT02448810|3497682|B8||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3651297|NCT02448810|3497683|B7||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3651298|NCT02448810|3497684|B6||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3651299|NCT02448810|3497685|B5||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3651300|NCT02448810|3497686|B4||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3651301|NCT02448810|3497687|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3651302|NCT02448810|3497688|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3651303|NCT02448810|3497689|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3651304|NCT02448810|3497681|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3651305|NCT02448810|3497682|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3651306|NCT02448810|3497683|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651307|NCT02448810|3497684|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651308|NCT02448810|3497685|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3651309|NCT02448810|3497686|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651310|NCT02448810|3497687|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651311|NCT02448810|3497688|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651312|NCT02448810|3497689|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3651313|NCT02448810|3497681|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651314|NCT02448810|3497682|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651315|NCT02448810|3497683|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651316|NCT02448810|3497684|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651317|NCT02448810|3497685|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651318|NCT02448810|3497686|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651319|NCT02448810|3497687|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651320|NCT02448810|3497688|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651321|NCT02448810|3497689|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651322|NCT02448810|3497681|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3651323|NCT02448810|3497682|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651324|NCT02448810|3497683|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651325|NCT02448810|3497684|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3651326|NCT02448810|3497685|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3651327|NCT02448810|3497686|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651328|NCT02448810|3497687|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651329|NCT02448810|3497688|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651330|NCT02448810|3497689|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651331|NCT02448810|3497681|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651332|NCT02448810|3497682|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651333|NCT02448810|3497683|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651334|NCT02448810|3497684|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651335|NCT02448810|3497685|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651336|NCT02448810|3497686|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651337|NCT02448810|3497687|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651338|NCT02448810|3497688|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651339|NCT02448810|3497689|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651340|NCT02448810|3497681|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651341|NCT02448810|3497682|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651342|NCT02448810|3497683|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651343|NCT02448810|3497684|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651344|NCT02448810|3497685|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651345|NCT02448810|3497686|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651346|NCT02448810|3497687|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651347|NCT02448810|3497688|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651348|NCT02448810|3497689|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651349|NCT02448810|3497681|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3651350|NCT02448810|3497682|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3651351|NCT02448810|3497683|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3651352|NCT02448810|3497684|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3651353|NCT02448810|3497685|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3651354|NCT02448810|3497686|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3651355|NCT02448810|3497687|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3651356|NCT02448810|3497688|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3651357|NCT02448810|3497689|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3651358|NCT02448810|3497681|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3651359|NCT02448810|3497682|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651360|NCT02448810|3497683|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3651361|NCT02448810|3497684|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3651362|NCT02448810|3497685|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3651363|NCT02448810|3497686|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3651364|NCT02448810|3497687|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651365|NCT02448810|3497688|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3651366|NCT02448810|3497689|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651367|NCT02448810|3497681|B9||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3651368|NCT02448810|3497682|B8||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3651369|NCT02448810|3497683|B7||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3651370|NCT02448810|3497684|B6||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3651371|NCT02448810|3497685|B5||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3651372|NCT02448810|3497686|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3651373|NCT02448810|3497687|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3651374|NCT02448810|3497688|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3651375|NCT02448810|3497689|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3651376|NCT02448810|3497681|B9||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3651377|NCT02448810|3497682|B8||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3651378|NCT02448810|3497683|B7||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3651379|NCT02448810|3497684|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3651380|NCT02448810|3497685|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3651381|NCT02448810|3497686|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3651382|NCT02448810|3497687|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3651383|NCT02448810|3497688|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3651384|NCT02448810|3497689|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3651385|NCT02448810|3497681|B9||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
3651386|NCT02448810|3497682|B8||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3651387|NCT02448810|3497683|B7||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3651388|NCT02448810|3497684|B6||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3651389|NCT02448810|3497685|B5||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3651390|NCT02448810|3497686|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3651391|NCT02448810|3497687|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3651392|NCT02448810|3497688|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3651393|NCT02448810|3497689|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3651394|NCT02448810|3497681|B9||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
3651395|NCT02448810|3497682|B8||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3651396|NCT02448810|3497683|B7||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3651397|NCT02448810|3497684|B6||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3651398|NCT02448810|3497685|B5||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3651399|NCT02448810|3497686|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3651400|NCT02448810|3497687|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3651401|NCT02448810|3497688|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3651402|NCT02448810|3497689|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3651403|NCT02448810|3497681|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3651404|NCT02448810|3497682|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3651405|NCT02448810|3497683|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3651406|NCT02448810|3497684|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3651407|NCT02448810|3497685|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3651408|NCT02448810|3497686|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3651409|NCT02448810|3497687|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3651410|NCT02448810|3497688|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3651411|NCT02448810|3497689|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3651412|NCT02448563|3497762|B5|No||Breastfeeding||participants|Number|21|21.0||||||
3651413|NCT02448563|3497763|B4|No||Breastfeeding||participants|Number|7|7.0||||||
3651414|NCT02448563|3497764|B3|No||Breastfeeding||participants|Number|6|6.0||||||
3651415|NCT02448563|3497765|B2|No||Breastfeeding||participants|Number|4|4.0||||||
3651416|NCT02448563|3497766|B1|No||Breastfeeding||participants|Number|4|4.0||||||
3651417|NCT02448563|3497762|B5|Yes||Breastfeeding||participants|Number|41|41.0||||||
3651418|NCT02448563|3497763|B4|Yes||Breastfeeding||participants|Number|4|4.0||||||
3651419|NCT02448563|3497764|B3|Yes||Breastfeeding||participants|Number|13|13.0||||||
3651420|NCT02448563|3497765|B2|Yes||Breastfeeding||participants|Number|12|12.0||||||
3651421|NCT02448563|3497766|B1|Yes||Breastfeeding||participants|Number|12|12.0||||||
3651422|NCT02448563|3497762|B5|||Waist circumference||centimeters|Mean|108.6|108.6|Standard Deviation|14.6|14.6|||
3651423|NCT02448563|3497763|B4|||Waist circumference||centimeters|Mean|109.5|109.5|Standard Deviation|8.3|8.3|||
3651424|NCT02448563|3497764|B3|||Waist circumference||centimeters|Mean|109.6|109.6|Standard Deviation|14.8|14.8|||
3651425|NCT02448563|3497765|B2|||Waist circumference||centimeters|Mean|108.1|108.1|Standard Deviation|13.8|13.8|||
3651426|NCT02448563|3497766|B1|||Waist circumference||centimeters|Mean|107.3|107.3|Standard Deviation|18.3|18.3|||
3651427|NCT02448563|3497762|B5|||Body mass index (BMI)||kg/m^2|Mean|35.0|35.0|Standard Deviation|6.5|6.5|||
3651428|NCT02448563|3497763|B4|||Body mass index (BMI)||kg/m^2|Mean|34.1|34.1|Standard Deviation|3.6|3.6|||
3651429|NCT02448563|3497764|B3|||Body mass index (BMI)||kg/m^2|Mean|34.8|34.8|Standard Deviation|6.1|6.1|||
3651430|NCT02448563|3497765|B2|||Body mass index (BMI)||kg/m^2|Mean|35.6|35.6|Standard Deviation|6.4|6.4|||
3651431|NCT02448563|3497766|B1|||Body mass index (BMI)||kg/m^2|Mean|35.2|35.2|Standard Deviation|8.8|8.8|||
3651432|NCT02448563|3497762|B5|||Weight||kilograms|Mean|94.3|94.3|Standard Deviation|18.9|18.9|||
3651433|NCT02448563|3497763|B4|||Weight||kilograms|Mean|93.2|93.2|Standard Deviation|12.1|12.1|||
3651434|NCT02448563|3497764|B3|||Weight||kilograms|Mean|92.3|92.3|Standard Deviation|17.9|17.9|||
3651435|NCT02448563|3497765|B2|||Weight||kilograms|Mean|100.5|100.5|Standard Deviation|19.8|19.8|||
3651436|NCT02448563|3497766|B1|||Weight||kilograms|Mean|91.4|91.4|Standard Deviation|22.8|22.8|||
3651437|NCT02448563|3497762|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651438|NCT02448563|3497763|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651439|NCT02448563|3497764|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651440|NCT02448563|3497765|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651441|NCT02448563|3497766|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651442|NCT02448563|3497762|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651443|NCT02448563|3497763|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651444|NCT02448563|3497764|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651445|NCT02448563|3497765|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651446|NCT02448563|3497766|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651447|NCT02448563|3497762|B5||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651448|NCT02448563|3497763|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651449|NCT02448563|3497764|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651450|NCT02448563|3497765|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651451|NCT02448563|3497766|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651452|NCT02448563|3497762|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3651453|NCT02448563|3497763|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3651454|NCT02448563|3497764|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3651455|NCT02448563|3497765|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3651456|NCT02448563|3497766|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3651457|NCT02448563|3497762|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651458|NCT02448563|3497763|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651459|NCT02448563|3497764|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651460|NCT02448563|3497765|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651461|NCT02448563|3497766|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651462|NCT02448563|3497762|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651463|NCT02448563|3497763|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651464|NCT02448563|3497764|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651465|NCT02448563|3497765|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651466|NCT02448563|3497766|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651467|NCT02448563|3497762|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651468|NCT02448563|3497763|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651469|NCT02448563|3497764|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651470|NCT02448563|3497765|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651471|NCT02448563|3497766|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651472|NCT02448563|3497762|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3651473|NCT02448563|3497763|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3651474|NCT02448563|3497764|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3651475|NCT02448563|3497765|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3651476|NCT02448563|3497766|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3651477|NCT02448563|3497762|B5||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3651478|NCT02448563|3497763|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3651479|NCT02448563|3497764|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3651480|NCT02448563|3497765|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3651481|NCT02448563|3497766|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3651482|NCT02448563|3497762|B5|||Age||years|Mean|30.6|30.6|Standard Deviation|6.2|6.2|||
3651483|NCT02448563|3497763|B4|||Age||years|Mean|32.6|32.6|Standard Deviation|5.3|5.3|||
3651484|NCT02448563|3497764|B3|||Age||years|Mean|30.5|30.5|Standard Deviation|6.6|6.6|||
3651485|NCT02448563|3497765|B2|||Age||years|Mean|30.3|30.3|Standard Deviation|7.4|7.4|||
3651486|NCT02448563|3497766|B1|||Age||years|Mean|29.5|29.5|Standard Deviation|5.1|5.1|||
3651487|NCT02448537|3497786|B4|United States||Region of Enrollment||participants|Number|42|42.0||||||
3651488|NCT02448537|3497787|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3651489|NCT02448537|3497788|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3651490|NCT02448537|3497789|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3651491|NCT02448537|3497786|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3651492|NCT02448537|3497787|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3651493|NCT02448537|3497788|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3651494|NCT02448537|3497789|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3651495|NCT02448537|3497786|B4|More Than One Race||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3651496|NCT02448537|3497787|B3|More Than One Race||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3651497|NCT02448537|3497788|B2|More Than One Race||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3651498|NCT02448537|3497789|B1|More Than One Race||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3651499|NCT02448537|3497786|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3651500|NCT02448537|3497787|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3651501|NCT02448537|3497788|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3651502|NCT02448537|3497789|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3651503|NCT02448537|3497786|B4|Black or African-American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3651504|NCT02448537|3497787|B3|Black or African-American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3651505|NCT02448537|3497788|B2|Black or African-American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3651506|NCT02448537|3497789|B1|Black or African-American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3651507|NCT02448537|3497786|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3651508|NCT02448537|3497787|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3651509|NCT02448537|3497788|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3651510|NCT02448537|3497789|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3651511|NCT02448537|3497786|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3651512|NCT02448537|3497787|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3651513|NCT02448537|3497788|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3651514|NCT02448537|3497789|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651515|NCT02448537|3497786|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3651516|NCT02448537|3497787|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3651517|NCT02448537|3497788|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3651518|NCT02448537|3497789|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3651519|NCT02448537|3497786|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3651520|NCT02448537|3497787|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651521|NCT02448537|3497788|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3651522|NCT02448537|3497789|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3651523|NCT02448537|3497786|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3651524|NCT02448537|3497787|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3651525|NCT02448537|3497788|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3651526|NCT02448537|3497789|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3651527|NCT02448537|3497786|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3651528|NCT02448537|3497787|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3651529|NCT02448537|3497788|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3651530|NCT02448537|3497789|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3651531|NCT02448537|3497786|B4|||Age||years|Median|51.9|51.9|Full Range|||29.6|74.5|
3651532|NCT02448537|3497787|B3|||Age||years|Median|55.3|55.3|Full Range|||30.0|71.7|
3651533|NCT02448537|3497788|B2|||Age||years|Median|44.2|44.2|Full Range|||29.6|74.5|
3651534|NCT02448537|3497789|B1|||Age||years|Median|52.6|52.6|Full Range|||31.8|74.2|
3651535|NCT02448368|3497805|B3|United States||Region of Enrollment||Participants|Number|35|35.0||||||
3651536|NCT02448368|3497806|B2|United States||Region of Enrollment||Participants|Number|15|15.0||||||
3651537|NCT02448368|3497807|B1|United States||Region of Enrollment||Participants|Number|20|20.0||||||
3651538|NCT02448368|3497805|B3|Female||Sex/Gender, Customized||Participants|Number|0|0.0||||||
3651539|NCT02448368|3497806|B2|Female||Sex/Gender, Customized||Participants|Number|0|0.0||||||
3651540|NCT02448368|3497807|B1|Female||Sex/Gender, Customized||Participants|Number|0|0.0||||||
3651541|NCT02448368|3497805|B3|Male||Sex/Gender, Customized||Participants|Number|35|35.0||||||
3651542|NCT02448368|3497806|B2|Male||Sex/Gender, Customized||Participants|Number|15|15.0||||||
3651543|NCT02448368|3497807|B1|Male||Sex/Gender, Customized||Participants|Number|20|20.0||||||
3651544|NCT02448368|3497805|B3|||Age||Years|Mean|38|38.0|Standard Deviation|10.45|10.45|||
3651545|NCT02448368|3497806|B2|||Age||Years|Mean|41|41.0|Standard Deviation|12.0|12.0|||
3651546|NCT02448368|3497807|B1|||Age||Years|Mean|35|35.0|Standard Deviation|8.9|8.9|||
3651547|NCT02447952|3497894|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
3651548|NCT02447952|3497894|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3651549|NCT02447952|3497894|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3651550|NCT02447952|3497894|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3651551|NCT02447952|3497894|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3651552|NCT02447952|3497894|B1|||Age||Years|Mean|53.1|53.1|Standard Deviation|9.93|9.93|||
3651553|NCT02447848|3497946|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3651554|NCT02447848|3497946|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3651555|NCT02447848|3497946|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3651556|NCT02447848|3497946|B1||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
3651557|NCT02447848|3497946|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3651558|NCT02447458|3497952|B7|Ex-smoker||Smoking Classification||participants|Number|2|2.0||||||
3651559|NCT02447458|3497953|B6|Ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3651560|NCT02447458|3497954|B5|Ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3651561|NCT02447458|3497955|B4|Ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3651562|NCT02447458|3497956|B3|Ex-smoker||Smoking Classification||participants|Number|2|2.0||||||
3651563|NCT02447458|3497957|B2|Ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3651564|NCT02447458|3497958|B1|Ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3651565|NCT02447458|3497952|B7|Current smoker||Smoking Classification||participants|Number|0|0.0||||||
3651566|NCT02447458|3497953|B6|Current smoker||Smoking Classification||participants|Number|0|0.0||||||
3651567|NCT02447458|3497954|B5|Current smoker||Smoking Classification||participants|Number|0|0.0||||||
3651568|NCT02447458|3497955|B4|Current smoker||Smoking Classification||participants|Number|0|0.0||||||
3651569|NCT02447458|3497956|B3|Current smoker||Smoking Classification||participants|Number|0|0.0||||||
3651570|NCT02447458|3497957|B2|Current smoker||Smoking Classification||participants|Number|0|0.0||||||
3651571|NCT02447458|3497958|B1|Current smoker||Smoking Classification||participants|Number|0|0.0||||||
3651572|NCT02447458|3497952|B7|Never smoked||Smoking Classification||participants|Number|37|37.0||||||
3651573|NCT02447458|3497953|B6|Never smoked||Smoking Classification||participants|Number|10|10.0||||||
3651574|NCT02447458|3497954|B5|Never smoked||Smoking Classification||participants|Number|6|6.0||||||
3651575|NCT02447458|3497955|B4|Never smoked||Smoking Classification||participants|Number|6|6.0||||||
3651576|NCT02447458|3497956|B3|Never smoked||Smoking Classification||participants|Number|4|4.0||||||
3651577|NCT02447458|3497957|B2|Never smoked||Smoking Classification||participants|Number|6|6.0||||||
3651578|NCT02447458|3497958|B1|Never smoked||Smoking Classification||participants|Number|5|5.0||||||
3651579|NCT02447458|3497952|B7|No||Caffeine Consumption||participants|Number|29|29.0||||||
3651580|NCT02447458|3497953|B6|No||Caffeine Consumption||participants|Number|7|7.0||||||
3651581|NCT02447458|3497954|B5|No||Caffeine Consumption||participants|Number|6|6.0||||||
3651582|NCT02447458|3497955|B4|No||Caffeine Consumption||participants|Number|3|3.0||||||
3651583|NCT02447458|3497956|B3|No||Caffeine Consumption||participants|Number|4|4.0||||||
3651584|NCT02447458|3497957|B2|No||Caffeine Consumption||participants|Number|5|5.0||||||
3651585|NCT02447458|3497958|B1|No||Caffeine Consumption||participants|Number|4|4.0||||||
3651586|NCT02447458|3497952|B7|Yes||Caffeine Consumption||participants|Number|10|10.0||||||
3651587|NCT02447458|3497953|B6|Yes||Caffeine Consumption||participants|Number|3|3.0||||||
3651588|NCT02447458|3497954|B5|Yes||Caffeine Consumption||participants|Number|0|0.0||||||
3651589|NCT02447458|3497955|B4|Yes||Caffeine Consumption||participants|Number|3|3.0||||||
3651590|NCT02447458|3497956|B3|Yes||Caffeine Consumption||participants|Number|2|2.0||||||
3651591|NCT02447458|3497957|B2|Yes||Caffeine Consumption||participants|Number|1|1.0||||||
3651592|NCT02447458|3497958|B1|Yes||Caffeine Consumption||participants|Number|1|1.0||||||
3651593|NCT02447458|3497952|B7|||Body Mass Index (BMI)||kg/m^2|Mean|26.54|26.54|Standard Deviation|2.587|2.587|||
3651594|NCT02447458|3497953|B6|||Body Mass Index (BMI)||kg/m^2|Mean|27.22|27.22|Standard Deviation|3.251|3.251|||
3651595|NCT02447458|3497954|B5|||Body Mass Index (BMI)||kg/m^2|Mean|25.16|25.16|Standard Deviation|2.329|2.329|||
3651596|NCT02447458|3497955|B4|||Body Mass Index (BMI)||kg/m^2|Mean|25.01|25.01|Standard Deviation|1.811|1.811|||
3651597|NCT02447458|3497956|B3|||Body Mass Index (BMI)||kg/m^2|Mean|27.18|27.18|Standard Deviation|2.293|2.293|||
3651598|NCT02447458|3497957|B2|||Body Mass Index (BMI)||kg/m^2|Mean|27.56|27.56|Standard Deviation|2.127|2.127|||
3651599|NCT02447458|3497958|B1|||Body Mass Index (BMI)||kg/m^2|Mean|26.65|26.65|Standard Deviation|2.643|2.643|||
3651600|NCT02447458|3497952|B7|||Weight||kg|Mean|79.44|79.44|Standard Deviation|10.498|10.498|||
3651601|NCT02447458|3497953|B6|||Weight||kg|Mean|82.58|82.58|Standard Deviation|7.420|7.42|||
3651602|NCT02447458|3497954|B5|||Weight||kg|Mean|75.87|75.87|Standard Deviation|10.016|10.016|||
3651603|NCT02447458|3497955|B4|||Weight||kg|Mean|72.22|72.22|Standard Deviation|7.165|7.165|||
3651604|NCT02447458|3497956|B3|||Weight||kg|Mean|83.67|83.67|Standard Deviation|15.871|15.871|||
3651605|NCT02447458|3497957|B2|||Weight||kg|Mean|81.98|81.98|Standard Deviation|8.538|8.538|||
3651606|NCT02447458|3497958|B1|||Weight||kg|Mean|78.00|78.0|Standard Deviation|12.900|12.9|||
3651607|NCT02447458|3497952|B7|||Height||cm|Mean|172.9|172.9|Standard Deviation|9.14|9.14|||
3651608|NCT02447458|3497953|B6|||Height||cm|Mean|174.9|174.9|Standard Deviation|13.08|13.08|||
3651609|NCT02447458|3497954|B5|||Height||cm|Mean|173.3|173.3|Standard Deviation|6.09|6.09|||
3651610|NCT02447458|3497955|B4|||Height||cm|Mean|169.8|169.8|Standard Deviation|5.71|5.71|||
3651611|NCT02447458|3497956|B3|||Height||cm|Mean|174.7|174.7|Standard Deviation|10.42|10.42|||
3651612|NCT02447458|3497957|B2|||Height||cm|Mean|172.3|172.3|Standard Deviation|5.47|5.47|||
3651613|NCT02447458|3497958|B1|||Height||cm|Mean|170.8|170.8|Standard Deviation|10.64|10.64|||
3651614|NCT02447458|3497952|B7|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3651615|NCT02447458|3497953|B6|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3651616|NCT02447458|3497954|B5|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3651617|NCT02447458|3497955|B4|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3651618|NCT02447458|3497956|B3|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3651619|NCT02447458|3497957|B2|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3651620|NCT02447458|3497958|B1|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3651621|NCT02447458|3497952|B7|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3651622|NCT02447458|3497953|B6|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3651623|NCT02447458|3497954|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3651624|NCT02447458|3497955|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3651625|NCT02447458|3497956|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3651626|NCT02447458|3497957|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3651627|NCT02447458|3497958|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3651628|NCT02447458|3497952|B7|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3651629|NCT02447458|3497953|B6|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3651630|NCT02447458|3497954|B5|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3651631|NCT02447458|3497955|B4|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3651632|NCT02447458|3497956|B3|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3651633|NCT02447458|3497957|B2|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3651634|NCT02447458|3497958|B1|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3651635|NCT02447458|3497952|B7|Black or African American||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3651636|NCT02447458|3497953|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3651637|NCT02447458|3497954|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3651638|NCT02447458|3497955|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3651639|NCT02447458|3497956|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3651640|NCT02447458|3497957|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3651641|NCT02447458|3497958|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3651642|NCT02447458|3497952|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3651643|NCT02447458|3497953|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3651644|NCT02447458|3497954|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3651645|NCT02447458|3497955|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3651646|NCT02447458|3497956|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3651647|NCT02447458|3497957|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3651648|NCT02447458|3497958|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3651649|NCT02447458|3497952|B7||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3651650|NCT02447458|3497953|B6||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3651651|NCT02447458|3497954|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3651652|NCT02447458|3497955|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3651653|NCT02447458|3497956|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3651654|NCT02447458|3497957|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3651655|NCT02447458|3497958|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3651656|NCT02447458|3497952|B7||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3651657|NCT02447458|3497953|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3651658|NCT02447458|3497954|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3651659|NCT02447458|3497955|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3651660|NCT02447458|3497956|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3651661|NCT02447458|3497957|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3651662|NCT02447458|3497958|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3651663|NCT02447458|3497952|B7|||Age||Years|Mean|33.7|33.7|Standard Deviation|9.10|9.1|||
3651664|NCT02447458|3497953|B6|||Age||Years|Mean|32.8|32.8|Standard Deviation|6.32|6.32|||
3651665|NCT02447458|3497954|B5|||Age||Years|Mean|30.0|30.0|Standard Deviation|8.39|8.39|||
3651666|NCT02447458|3497955|B4|||Age||Years|Mean|32.3|32.3|Standard Deviation|11.78|11.78|||
3651667|NCT02447458|3497956|B3|||Age||Years|Mean|41.2|41.2|Standard Deviation|10.42|10.42|||
3651668|NCT02447458|3497957|B2|||Age||Years|Mean|30.3|30.3|Standard Deviation|6.50|6.5|||
3651669|NCT02447458|3497958|B1|||Age||Years|Mean|36.8|36.8|Standard Deviation|10.43|10.43|||
3651670|NCT02447432|3498059|B3|Asian-South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|320|320.0||||||
3651671|NCT02447432|3498060|B2|Asian-South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|160|160.0||||||
3651672|NCT02447432|3498061|B1|Asian-South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|160|160.0||||||
3651673|NCT02447432|3498059|B3||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3651674|NCT02447432|3498060|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3651675|NCT02447432|3498061|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3651676|NCT02447432|3498059|B3||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3651677|NCT02447432|3498060|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3651678|NCT02447432|3498061|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3651679|NCT02447432|3498059|B3|||Age||Weeks|Mean|6.8|6.8|Standard Deviation|1.3|1.3|||
3651680|NCT02447432|3498060|B2|||Age||Weeks|Mean|6.8|6.8|Standard Deviation|1.2|1.2|||
3651681|NCT02447432|3498061|B1|||Age||Weeks|Mean|6.9|6.9|Standard Deviation|1.3|1.3|||
3651682|NCT02447328|3498094|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3651683|NCT02447328|3498094|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3651684|NCT02447328|3498094|B1|Age||Age||years|Mean|56.6|56.6|Standard Deviation|9.34|9.34|||
3651685|NCT02447133|3498098|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3651686|NCT02447133|3498098|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
3651687|NCT02447133|3498098|B1||Female|Gender||Participants|Count of Participants|7|7.0||||||
3651688|NCT02447133|3498098|B1|||Age||years|Mean|43.17|43.17|Standard Deviation|13.48|13.48|||
3651689|NCT02447133|3498098|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3651690|NCT02447133|3498098|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3651691|NCT02447133|3498098|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3651692|NCT02447029|3498104|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3651693|NCT02447029|3498105|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3651694|NCT02447029|3498106|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3651695|NCT02447029|3498104|B3||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3651696|NCT02447029|3498105|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3651697|NCT02447029|3498106|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3651698|NCT02447029|3498104|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3651699|NCT02447029|3498105|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3651700|NCT02447029|3498106|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3651701|NCT02447029|3498104|B3||Between 18 and 65 years|Age||Participants|Count of Participants|137|137.0||||||
3651702|NCT02447029|3498105|B2||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
3651703|NCT02447029|3498106|B1||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
3651704|NCT02447029|3498104|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3651705|NCT02447029|3498105|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3651706|NCT02447029|3498106|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3651707|NCT02446990|3498125|B3||Male|Sex: Female, Male||Participants|Count of Participants|13839|13839.0||||||
3651708|NCT02446990|3498126|B2||Male|Sex: Female, Male||Participants|Count of Participants|6890|6890.0||||||
3651709|NCT02446990|3498127|B1||Male|Sex: Female, Male||Participants|Count of Participants|6949|6949.0||||||
3651710|NCT02446990|3498125|B3||Female|Sex: Female, Male||Participants|Count of Participants|5263|5263.0||||||
3651711|NCT02446990|3498126|B2||Female|Sex: Female, Male||Participants|Count of Participants|2662|2662.0||||||
3651712|NCT02446990|3498127|B1||Female|Sex: Female, Male||Participants|Count of Participants|2601|2601.0||||||
3651713|NCT02446990|3498125|B3|||Age||years|Mean|65|65.0|Standard Deviation|7.2|7.2|||
3651714|NCT02446990|3498126|B2|||Age||years|Mean|65|65.0|Standard Deviation|7.3|7.3|||
3651715|NCT02446990|3498127|B1|||Age||years|Mean|65|65.0|Standard Deviation|7.2|7.2|||
3651716|NCT02446990|3498125|B3||>=65 years|Age||Participants|Count of Participants|8897|8897.0||||||
3651717|NCT02446990|3498126|B2||>=65 years|Age||Participants|Count of Participants|4456|4456.0||||||
3651718|NCT02446990|3498127|B1||>=65 years|Age||Participants|Count of Participants|4441|4441.0||||||
3651719|NCT02446990|3498125|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10205|10205.0||||||
3651720|NCT02446990|3498126|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5096|5096.0||||||
3651721|NCT02446990|3498127|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5109|5109.0||||||
3651722|NCT02446990|3498125|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3651723|NCT02446990|3498126|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3651724|NCT02446990|3498127|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3651725|NCT02446743|3498160|B3|Race/Ethinicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|291|291.0||||||
3651726|NCT02446743|3498161|B2|Race/Ethinicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|152|152.0||||||
3651727|NCT02446743|3498162|B1|Race/Ethinicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|139|139.0||||||
3651728|NCT02446743|3498160|B3|Race/Ethinicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|172|172.0||||||
3651729|NCT02446743|3498161|B2|Race/Ethinicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|74|74.0||||||
3651730|NCT02446743|3498162|B1|Race/Ethinicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|98|98.0||||||
3651731|NCT02446743|3498160|B3|Race/Ethinicity|Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3651732|NCT02446743|3498161|B2|Race/Ethinicity|Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3651733|NCT02446743|3498162|B1|Race/Ethinicity|Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3651734|NCT02446743|3498160|B3|Race/Ethinicity|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3651735|NCT02446743|3498161|B2|Race/Ethinicity|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3651736|NCT02446743|3498162|B1|Race/Ethinicity|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3651737|NCT02446743|3498160|B3|Race/Ethinicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3651738|NCT02446743|3498161|B2|Race/Ethinicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3651739|NCT02446743|3498162|B1|Race/Ethinicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3651740|NCT02446743|3498160|B3|Race/Ethinicity|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3651741|NCT02446743|3498161|B2|Race/Ethinicity|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3651742|NCT02446743|3498162|B1|Race/Ethinicity|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3651743|NCT02446743|3498160|B3||Male|Sex: Female, Male||Participants|Count of Participants|270|270.0||||||
3651744|NCT02446743|3498161|B2||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3651745|NCT02446743|3498162|B1||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3651746|NCT02446743|3498160|B3||Female|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
3651747|NCT02446743|3498161|B2||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3651748|NCT02446743|3498162|B1||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3651749|NCT02446743|3498160|B3|||Age||years|Mean|19.7|19.7|Standard Deviation|2.56|2.56|||
3651750|NCT02446743|3498161|B2|||Age||years|Mean|20.0|20.0|Standard Deviation|2.69|2.69|||
3651751|NCT02446743|3498162|B1|||Age||years|Mean|19.5|19.5|Standard Deviation|2.42|2.42|||
3651752|NCT02446717|3498313|B6||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3651753|NCT02446717|3498314|B5||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3651754|NCT02446717|3498315|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3651755|NCT02446717|3498316|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3651756|NCT02446717|3498317|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3651757|NCT02446717|3498318|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3651758|NCT02446717|3498313|B6||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3651759|NCT02446717|3498314|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3651760|NCT02446717|3498315|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3651761|NCT02446717|3498316|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3651762|NCT02446717|3498317|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3651763|NCT02446717|3498318|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3651764|NCT02446717|3498313|B6|||Age||years|Mean|55.9|55.9|Standard Deviation|7.88|7.88|||
3651765|NCT02446717|3498314|B5|||Age||years|Mean|55.6|55.6|Standard Deviation|8.31|8.31|||
3651766|NCT02446717|3498315|B4|||Age||years|Mean|55.6|55.6|Standard Deviation|8.57|8.57|||
3651767|NCT02446717|3498316|B3|||Age||years|Mean|58.5|58.5|Standard Deviation|6.56|6.56|||
3651768|NCT02446717|3498317|B2|||Age||years|Mean|55.2|55.2|Standard Deviation|6.29|6.29|||
3651769|NCT02446717|3498318|B1|||Age||years|Mean|53.5|53.5|Standard Deviation|9.16|9.16|||
3651770|NCT02446613|3498349|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651771|NCT02446613|3498350|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651772|NCT02446613|3498351|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651773|NCT02446613|3498349|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651774|NCT02446613|3498350|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651775|NCT02446613|3498351|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651776|NCT02446613|3498349|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3651777|NCT02446613|3498350|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3651778|NCT02446613|3498351|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3651779|NCT02446613|3498349|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651780|NCT02446613|3498350|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651781|NCT02446613|3498351|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651782|NCT02446613|3498349|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651783|NCT02446613|3498350|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651784|NCT02446613|3498351|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651785|NCT02446613|3498349|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3651786|NCT02446613|3498350|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651787|NCT02446613|3498351|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3651788|NCT02446613|3498349|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3651789|NCT02446613|3498350|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651790|NCT02446613|3498351|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3651791|NCT02446613|3498349|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3651792|NCT02446613|3498350|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3651793|NCT02446613|3498351|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3651794|NCT02446613|3498349|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3651795|NCT02446613|3498350|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3651796|NCT02446613|3498351|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3651797|NCT02446613|3498349|B3|||Age||Years|Mean|40.8|40.8|Standard Deviation|11.90|11.9|||
3651798|NCT02446613|3498350|B2|||Age||Years|Mean|40.4|40.4|Standard Deviation|12.02|12.02|||
3651799|NCT02446613|3498351|B1|||Age||Years|Mean|41.3|41.3|Standard Deviation|12.82|12.82|||
3651800|NCT02446496|3498374|B1|Oriental||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
3651801|NCT02446496|3498374|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3651802|NCT02446496|3498374|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3651803|NCT02446496|3498374|B1|||Age||Years|Mean|26.46|26.46|Standard Deviation|7.68|7.68|||
3651804|NCT02446483|3498386|B1|Egypt||Region of Enrollment||Participants|Number|60|60.0||||||
3651805|NCT02446483|3498386|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3651806|NCT02446483|3498386|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3651807|NCT02446483|3498386|B1|||Age||Years|Mean|30.72|30.72|Standard Deviation|9.01|9.01|||
3651808|NCT02446171|3498399|B5||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3651809|NCT02446171|3498400|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3651810|NCT02446171|3498401|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3651811|NCT02446171|3498402|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3651812|NCT02446171|3498403|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3651813|NCT02446171|3498399|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3651814|NCT02446171|3498400|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3651815|NCT02446171|3498401|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3651816|NCT02446171|3498402|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3651817|NCT02446171|3498403|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3651818|NCT02446171|3498399|B5|||Age||years|Mean|44|44.0|Standard Deviation|10|10.0|||
3651819|NCT02446171|3498400|B4|||Age||years|Mean|44|44.0|Standard Deviation|8|8.0|||
3651820|NCT02446171|3498401|B3|||Age||years|Mean|45|45.0|Standard Deviation|8|8.0|||
3651821|NCT02446171|3498402|B2|||Age||years|Mean|42|42.0|Standard Deviation|11|11.0|||
3651822|NCT02446171|3498403|B1|||Age||years|Mean|44|44.0|Standard Deviation|12|12.0|||
3651823|NCT02446015|3498475|B3|Inconvenience||IDEEL Treatment Satisfaction Scores|The IDEEL is 10-question patient-reported outcome questionnaire that assesses the subject's general satisfaction with treatment use (Treatment Effectiveness and Treatment Inconvenience). A resultant overall 0-100 treatment satisfaction score was calculated separately for Treatment Effectiveness and Treatment Inconvenience, with higher scores indicating greater satisfaction and less treatment-related bother.|units on a scale|Mean|84.15|84.15|Standard Deviation|14.520|14.52|||
3651853|NCT02445807|3498489|B3||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
3651824|NCT02446015|3498476|B2|Inconvenience||IDEEL Treatment Satisfaction Scores|The IDEEL is 10-question patient-reported outcome questionnaire that assesses the subject's general satisfaction with treatment use (Treatment Effectiveness and Treatment Inconvenience). A resultant overall 0-100 treatment satisfaction score was calculated separately for Treatment Effectiveness and Treatment Inconvenience, with higher scores indicating greater satisfaction and less treatment-related bother.|units on a scale|Mean|84.03|84.03|Standard Deviation|14.189|14.189|||
3651825|NCT02446015|3498477|B1|Inconvenience||IDEEL Treatment Satisfaction Scores|The IDEEL is 10-question patient-reported outcome questionnaire that assesses the subject's general satisfaction with treatment use (Treatment Effectiveness and Treatment Inconvenience). A resultant overall 0-100 treatment satisfaction score was calculated separately for Treatment Effectiveness and Treatment Inconvenience, with higher scores indicating greater satisfaction and less treatment-related bother.|units on a scale|Mean|84.38|84.38|Standard Deviation|15.329|15.329|||
3651826|NCT02446015|3498475|B3|Effectiveness||IDEEL Treatment Satisfaction Scores|The IDEEL is 10-question patient-reported outcome questionnaire that assesses the subject's general satisfaction with treatment use (Treatment Effectiveness and Treatment Inconvenience). A resultant overall 0-100 treatment satisfaction score was calculated separately for Treatment Effectiveness and Treatment Inconvenience, with higher scores indicating greater satisfaction and less treatment-related bother.|units on a scale|Mean|57.41|57.41|Standard Deviation|20.419|20.419|||
3651827|NCT02446015|3498476|B2|Effectiveness||IDEEL Treatment Satisfaction Scores|The IDEEL is 10-question patient-reported outcome questionnaire that assesses the subject's general satisfaction with treatment use (Treatment Effectiveness and Treatment Inconvenience). A resultant overall 0-100 treatment satisfaction score was calculated separately for Treatment Effectiveness and Treatment Inconvenience, with higher scores indicating greater satisfaction and less treatment-related bother.|units on a scale|Mean|57.54|57.54|Standard Deviation|20.428|20.428|||
3651828|NCT02446015|3498477|B1|Effectiveness||IDEEL Treatment Satisfaction Scores|The IDEEL is 10-question patient-reported outcome questionnaire that assesses the subject's general satisfaction with treatment use (Treatment Effectiveness and Treatment Inconvenience). A resultant overall 0-100 treatment satisfaction score was calculated separately for Treatment Effectiveness and Treatment Inconvenience, with higher scores indicating greater satisfaction and less treatment-related bother.|units on a scale|Mean|57.17|57.17|Standard Deviation|20.708|20.708|||
3651829|NCT02446015|3498475|B3|||Impact of Dry Eye on Everyday Life Symptom-Bother (IDEEL SB) Score|The IDEEL SB module is a 20 question patient reported outcome questionnaire that assesses the subject's symptoms of dry eye. An overall resultant calculated score ranges from 0 to 100, with higher scores indicating greater symptom bother.|units on a scale|Mean|45.50|45.5|Standard Deviation|10.372|10.372|||
3651830|NCT02446015|3498476|B2|||Impact of Dry Eye on Everyday Life Symptom-Bother (IDEEL SB) Score|The IDEEL SB module is a 20 question patient reported outcome questionnaire that assesses the subject's symptoms of dry eye. An overall resultant calculated score ranges from 0 to 100, with higher scores indicating greater symptom bother.|units on a scale|Mean|46.75|46.75|Standard Deviation|9.854|9.854|||
3651831|NCT02446015|3498477|B1|||Impact of Dry Eye on Everyday Life Symptom-Bother (IDEEL SB) Score|The IDEEL SB module is a 20 question patient reported outcome questionnaire that assesses the subject's symptoms of dry eye. An overall resultant calculated score ranges from 0 to 100, with higher scores indicating greater symptom bother.|units on a scale|Mean|43.20|43.2|Standard Deviation|11.049|11.049|||
3651832|NCT02446015|3498475|B3|||Total Ocular Surface Staining (TOSS) Score|"The TOSS score is a cumulative cornea and conjunctival staining score. After instilling ophthalmic dye in the eye, the investigator graded three areas of the ocular surface for dryness on a scale from 0 to 5, where 0 is Absent and 5 is Severe. The three scores were summed for a resultant overall 0-15 score."|units on a scale|Mean|5.0|5.0|Standard Deviation|1.14|1.14|||
3651833|NCT02446015|3498476|B2|||Total Ocular Surface Staining (TOSS) Score|"The TOSS score is a cumulative cornea and conjunctival staining score. After instilling ophthalmic dye in the eye, the investigator graded three areas of the ocular surface for dryness on a scale from 0 to 5, where 0 is Absent and 5 is Severe. The three scores were summed for a resultant overall 0-15 score."|units on a scale|Mean|5.0|5.0|Standard Deviation|1.07|1.07|||
3651834|NCT02446015|3498477|B1|||Total Ocular Surface Staining (TOSS) Score|"The TOSS score is a cumulative cornea and conjunctival staining score. After instilling ophthalmic dye in the eye, the investigator graded three areas of the ocular surface for dryness on a scale from 0 to 5, where 0 is Absent and 5 is Severe. The three scores were summed for a resultant overall 0-15 score."|units on a scale|Mean|5.1|5.1|Standard Deviation|1.28|1.28|||
3651835|NCT02446015|3498475|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3651836|NCT02446015|3498476|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3651837|NCT02446015|3498477|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3651838|NCT02446015|3498475|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3651839|NCT02446015|3498476|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3651840|NCT02446015|3498477|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3651841|NCT02446015|3498475|B3|||Age||years|Mean|50.4|50.4|Standard Deviation|17.7|17.7|||
3651842|NCT02446015|3498476|B2|||Age||years|Mean|52.2|52.2|Standard Deviation|18.1|18.1|||
3651843|NCT02446015|3498477|B1|||Age||years|Mean|47.2|47.2|Standard Deviation|16.6|16.6|||
3651844|NCT02445807|3498489|B3|United States||Region of Enrollment||participants|Number|265|265.0||||||
3651845|NCT02445807|3498490|B2|United States||Region of Enrollment||participants|Number|89|89.0||||||
3651846|NCT02445807|3498491|B1|United States||Region of Enrollment||participants|Number|176|176.0||||||
3651847|NCT02445807|3498489|B3||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3651848|NCT02445807|3498490|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3651849|NCT02445807|3498491|B1||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3651850|NCT02445807|3498489|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3651851|NCT02445807|3498490|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3651852|NCT02445807|3498491|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3651854|NCT02445807|3498490|B2||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3651855|NCT02445807|3498491|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3651856|NCT02445807|3498489|B3||Between 18 and 65 years|Age||Participants|Count of Participants|222|222.0||||||
3651857|NCT02445807|3498490|B2||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
3651858|NCT02445807|3498491|B1||Between 18 and 65 years|Age||Participants|Count of Participants|152|152.0||||||
3651859|NCT02445807|3498489|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3651860|NCT02445807|3498490|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3651861|NCT02445807|3498491|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3651862|NCT02445755|3498502|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3651863|NCT02445755|3498502|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651864|NCT02445755|3498502|B1||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3651865|NCT02445755|3498502|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3651866|NCT02445755|3498502|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3651867|NCT02445755|3498502|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3651868|NCT02445755|3498502|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651869|NCT02445755|3498502|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3651870|NCT02445755|3498502|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3651871|NCT02445755|3498502|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3651872|NCT02445755|3498502|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3651873|NCT02445755|3498502|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3651874|NCT02445755|3498502|B1|||Age|Gestational Age (GA) in weeks|Weeks|Mean|38|38.0|Standard Deviation|1.25|1.25|||
3651875|NCT02445573|3498509|B3|||International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) score|The International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) was a brief and robust measure for evaluating the symptoms and impact of urinary incontinence.It was used to assess the influence of urinary incontinence on quality of life during the past 4 weeks retrospectively. It contained three items on frequency, amount of leakage, and overall impact on quality of life, and a fourth, non-scored item for the assessment of type of incontinence. A total score was summed by the scores of the first three items, ranging from 0 to 21. A higher value indicates increased severity.|units on a scale|Mean|8.94|8.94|Standard Deviation|4.37|4.37|||
3651876|NCT02445573|3498510|B2|||International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) score|The International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) was a brief and robust measure for evaluating the symptoms and impact of urinary incontinence.It was used to assess the influence of urinary incontinence on quality of life during the past 4 weeks retrospectively. It contained three items on frequency, amount of leakage, and overall impact on quality of life, and a fourth, non-scored item for the assessment of type of incontinence. A total score was summed by the scores of the first three items, ranging from 0 to 21. A higher value indicates increased severity.|units on a scale|Mean|8.80|8.8|Standard Deviation|4.54|4.54|||
3651877|NCT02445573|3498511|B1|||International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) score|The International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) was a brief and robust measure for evaluating the symptoms and impact of urinary incontinence.It was used to assess the influence of urinary incontinence on quality of life during the past 4 weeks retrospectively. It contained three items on frequency, amount of leakage, and overall impact on quality of life, and a fourth, non-scored item for the assessment of type of incontinence. A total score was summed by the scores of the first three items, ranging from 0 to 21. A higher value indicates increased severity.|units on a scale|Mean|9.08|9.08|Standard Deviation|4.24|4.24|||
3651878|NCT02445573|3498509|B3|||72-hour incontinence episode frequency (IEF)|Number of stress urinary incontinence episodes was collected over the last 72 hours (i.e.,in the last three days) of the week for baseline assessment.|episodes|Median|5.00|5.0|Inter-Quartile Range|||2.0|9.0|
3651879|NCT02445573|3498510|B2|||72-hour incontinence episode frequency (IEF)|Number of stress urinary incontinence episodes was collected over the last 72 hours (i.e.,in the last three days) of the week for baseline assessment.|episodes|Median|5.00|5.0|Inter-Quartile Range|||1.25|9.0|
3651880|NCT02445573|3498511|B1|||72-hour incontinence episode frequency (IEF)|Number of stress urinary incontinence episodes was collected over the last 72 hours (i.e.,in the last three days) of the week for baseline assessment.|episodes|Median|4.00|4.0|Inter-Quartile Range|||2.0|6.75|
3651881|NCT02445573|3498509|B3|||Urine leakage measured by 1-hour pad test||g|Median|4.90|4.9|Inter-Quartile Range|||2.3|16.2|
3651882|NCT02445573|3498510|B2|||Urine leakage measured by 1-hour pad test||g|Median|4.60|4.6|Inter-Quartile Range|||2.3|16.7|
3651883|NCT02445573|3498511|B1|||Urine leakage measured by 1-hour pad test||g|Median|5.30|5.3|Inter-Quartile Range|||2.33|16.0|
3651884|NCT02445573|3498509|B3|Severe (≥50 g)||Severity of SUI rated by amount of urine leakage measured by 1-hour pad test||participants|Number|2|2.0||||||
3651885|NCT02445573|3498510|B2|Severe (≥50 g)||Severity of SUI rated by amount of urine leakage measured by 1-hour pad test||participants|Number|2|2.0||||||
3651886|NCT02445573|3498511|B1|Severe (≥50 g)||Severity of SUI rated by amount of urine leakage measured by 1-hour pad test||participants|Number|0|0.0||||||
3651887|NCT02445573|3498509|B3|Moderate (10-49.9 g)||Severity of SUI rated by amount of urine leakage measured by 1-hour pad test||participants|Number|22|22.0||||||
3651888|NCT02445573|3498510|B2|Moderate (10-49.9 g)||Severity of SUI rated by amount of urine leakage measured by 1-hour pad test||participants|Number|6|6.0||||||
3651889|NCT02445573|3498511|B1|Moderate (10-49.9 g)||Severity of SUI rated by amount of urine leakage measured by 1-hour pad test||participants|Number|16|16.0||||||
3651955|NCT02445573|3498511|B1|Preliminary education and below||Educational level||participants|Number|2|2.0||||||
3651890|NCT02445573|3498509|B3|Mild (1.1-9.9 g)||Severity of SUI rated by amount of urine leakage measured by 1-hour pad test||participants|Number|56|56.0||||||
3651891|NCT02445573|3498510|B2|Mild (1.1-9.9 g)||Severity of SUI rated by amount of urine leakage measured by 1-hour pad test||participants|Number|32|32.0||||||
3651892|NCT02445573|3498511|B1|Mild (1.1-9.9 g)||Severity of SUI rated by amount of urine leakage measured by 1-hour pad test||participants|Number|24|24.0||||||
3651893|NCT02445573|3498509|B3|no||Ever received SUI treatment||participants|Number|72|72.0||||||
3651894|NCT02445573|3498510|B2|no||Ever received SUI treatment||participants|Number|38|38.0||||||
3651895|NCT02445573|3498511|B1|no||Ever received SUI treatment||participants|Number|34|34.0||||||
3651896|NCT02445573|3498509|B3|yes||Ever received SUI treatment||participants|Number|8|8.0||||||
3651897|NCT02445573|3498510|B2|yes||Ever received SUI treatment||participants|Number|2|2.0||||||
3651898|NCT02445573|3498511|B1|yes||Ever received SUI treatment||participants|Number|6|6.0||||||
3651899|NCT02445573|3498509|B3|||Duration of disease||years|Median|5.00|5.0|Inter-Quartile Range|||2.67|8.32|
3651900|NCT02445573|3498510|B2|||Duration of disease||years|Median|5.00|5.0|Inter-Quartile Range|||2.37|8.07|
3651901|NCT02445573|3498511|B1|||Duration of disease||years|Median|5.04|5.04|Inter-Quartile Range|||2.54|8.81|
3651902|NCT02445573|3498509|B3|||BMI||kg/m^2|Median|23.13|23.13|Inter-Quartile Range|||21.66|24.63|
3651903|NCT02445573|3498510|B2|||BMI||kg/m^2|Median|22.70|22.7|Inter-Quartile Range|||21.47|24.28|
3651904|NCT02445573|3498511|B1|||BMI||kg/m^2|Median|23.44|23.44|Inter-Quartile Range|||22.09|25.53|
3651905|NCT02445573|3498509|B3|no||Hysterectomy||participants|Number|75|75.0||||||
3651906|NCT02445573|3498510|B2|no||Hysterectomy||participants|Number|38|38.0||||||
3651907|NCT02445573|3498511|B1|no||Hysterectomy||participants|Number|37|37.0||||||
3651908|NCT02445573|3498509|B3|yes||Hysterectomy||participants|Number|5|5.0||||||
3651909|NCT02445573|3498510|B2|yes||Hysterectomy||participants|Number|2|2.0||||||
3651910|NCT02445573|3498511|B1|yes||Hysterectomy||participants|Number|3|3.0||||||
3651911|NCT02445573|3498509|B3|no||Menopause||participants|Number|19|19.0||||||
3651912|NCT02445573|3498510|B2|no||Menopause||participants|Number|10|10.0||||||
3651913|NCT02445573|3498511|B1|no||Menopause||participants|Number|9|9.0||||||
3651914|NCT02445573|3498509|B3|yes||Menopause||participants|Number|61|61.0||||||
3651915|NCT02445573|3498510|B2|yes||Menopause||participants|Number|30|30.0||||||
3651916|NCT02445573|3498511|B1|yes||Menopause||participants|Number|31|31.0||||||
3651917|NCT02445573|3498509|B3|no||Number of cesarean||participants|Number|80|80.0||||||
3651918|NCT02445573|3498510|B2|no||Number of cesarean||participants|Number|40|40.0||||||
3651919|NCT02445573|3498511|B1|no||Number of cesarean||participants|Number|40|40.0||||||
3651920|NCT02445573|3498509|B3|yes||Number of cesarean||participants|Number|0|0.0||||||
3651921|NCT02445573|3498510|B2|yes||Number of cesarean||participants|Number|0|0.0||||||
3651922|NCT02445573|3498511|B1|yes||Number of cesarean||participants|Number|0|0.0||||||
3651923|NCT02445573|3498509|B3|||Number of vaginal delivery||vaginal delivery|Median|1.00|1.0|Inter-Quartile Range|||1.0|2.0|
3651924|NCT02445573|3498510|B2|||Number of vaginal delivery||vaginal delivery|Median|1.00|1.0|Inter-Quartile Range|||1.0|2.0|
3651925|NCT02445573|3498511|B1|||Number of vaginal delivery||vaginal delivery|Median|1.00|1.0|Inter-Quartile Range|||1.0|2.0|
3651926|NCT02445573|3498509|B3|||Initial childbearing age||years|Mean|24.19|24.19|Standard Deviation|2.91|2.91|||
3651927|NCT02445573|3498510|B2|||Initial childbearing age||years|Mean|23.71|23.71|Standard Deviation|2.84|2.84|||
3651928|NCT02445573|3498511|B1|||Initial childbearing age||years|Mean|24.65|24.65|Standard Deviation|2.94|2.94|||
3651929|NCT02445573|3498509|B3|≥3||Number of births||participants|Number|12|12.0||||||
3651930|NCT02445573|3498510|B2|≥3||Number of births||participants|Number|6|6.0||||||
3651931|NCT02445573|3498511|B1|≥3||Number of births||participants|Number|6|6.0||||||
3651932|NCT02445573|3498509|B3|2||Number of births||participants|Number|16|16.0||||||
3651933|NCT02445573|3498510|B2|2||Number of births||participants|Number|7|7.0||||||
3651934|NCT02445573|3498511|B1|2||Number of births||participants|Number|9|9.0||||||
3651935|NCT02445573|3498509|B3|1||Number of births||participants|Number|50|50.0||||||
3651936|NCT02445573|3498510|B2|1||Number of births||participants|Number|25|25.0||||||
3651937|NCT02445573|3498511|B1|1||Number of births||participants|Number|25|25.0||||||
3651938|NCT02445573|3498509|B3|0||Number of births||participants|Number|2|2.0||||||
3651939|NCT02445573|3498510|B2|0||Number of births||participants|Number|2|2.0||||||
3651940|NCT02445573|3498511|B1|0||Number of births||participants|Number|0|0.0||||||
3651941|NCT02445573|3498509|B3|no||Childbearing||participants|Number|2|2.0||||||
3651942|NCT02445573|3498510|B2|no||Childbearing||participants|Number|2|2.0||||||
3651943|NCT02445573|3498511|B1|no||Childbearing||participants|Number|0|0.0||||||
3651944|NCT02445573|3498509|B3|yes||Childbearing||participants|Number|78|78.0||||||
3651945|NCT02445573|3498510|B2|yes||Childbearing||participants|Number|38|38.0||||||
3651946|NCT02445573|3498511|B1|yes||Childbearing||participants|Number|40|40.0||||||
3651947|NCT02445573|3498509|B3|Tertiary education||Educational level||participants|Number|22|22.0||||||
3651948|NCT02445573|3498510|B2|Tertiary education||Educational level||participants|Number|14|14.0||||||
3651949|NCT02445573|3498511|B1|Tertiary education||Educational level||participants|Number|8|8.0||||||
3651950|NCT02445573|3498509|B3|Secondary education||Educational level||participants|Number|51|51.0||||||
3651951|NCT02445573|3498510|B2|Secondary education||Educational level||participants|Number|21|21.0||||||
3651952|NCT02445573|3498511|B1|Secondary education||Educational level||participants|Number|30|30.0||||||
3651953|NCT02445573|3498509|B3|Preliminary education and below||Educational level||participants|Number|7|7.0||||||
3651954|NCT02445573|3498510|B2|Preliminary education and below||Educational level||participants|Number|5|5.0||||||
3651956|NCT02445573|3498509|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3651957|NCT02445573|3498510|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3651958|NCT02445573|3498511|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3651959|NCT02445573|3498509|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3651960|NCT02445573|3498510|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3651961|NCT02445573|3498511|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3651962|NCT02445573|3498509|B3|||Age||years|Mean|58.60|58.6|Standard Deviation|8.07|8.07|||
3651963|NCT02445573|3498510|B2|||Age||years|Mean|57.97|57.97|Standard Deviation|8.42|8.42|||
3651964|NCT02445573|3498511|B1|||Age||years|Mean|59.05|59.05|Standard Deviation|7.91|7.91|||
3651965|NCT02445326|3498526|B3||Green|Iris Color||Participants|Count of Participants|9|9.0||||||
3651966|NCT02445326|3498527|B2||Green|Iris Color||Participants|Count of Participants|5|5.0||||||
3651967|NCT02445326|3498528|B1||Green|Iris Color||Participants|Count of Participants|4|4.0||||||
3651968|NCT02445326|3498526|B3||Hazel|Iris Color||Participants|Count of Participants|1|1.0||||||
3651969|NCT02445326|3498527|B2||Hazel|Iris Color||Participants|Count of Participants|0|0.0||||||
3651970|NCT02445326|3498528|B1||Hazel|Iris Color||Participants|Count of Participants|1|1.0||||||
3651971|NCT02445326|3498526|B3||Brown|Iris Color||Participants|Count of Participants|58|58.0||||||
3651972|NCT02445326|3498527|B2||Brown|Iris Color||Participants|Count of Participants|32|32.0||||||
3651973|NCT02445326|3498528|B1||Brown|Iris Color||Participants|Count of Participants|26|26.0||||||
3651974|NCT02445326|3498526|B3||Blue|Iris Color||Participants|Count of Participants|5|5.0||||||
3651975|NCT02445326|3498527|B2||Blue|Iris Color||Participants|Count of Participants|1|1.0||||||
3651976|NCT02445326|3498528|B1||Blue|Iris Color||Participants|Count of Participants|4|4.0||||||
3651977|NCT02445326|3498526|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3651978|NCT02445326|3498527|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3651979|NCT02445326|3498528|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3651980|NCT02445326|3498526|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3651981|NCT02445326|3498527|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3651982|NCT02445326|3498528|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651983|NCT02445326|3498526|B3||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3651984|NCT02445326|3498527|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3651985|NCT02445326|3498528|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3651986|NCT02445326|3498526|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3651987|NCT02445326|3498527|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3651988|NCT02445326|3498528|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3651989|NCT02445326|3498526|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651990|NCT02445326|3498527|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651991|NCT02445326|3498528|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651992|NCT02445326|3498526|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3651993|NCT02445326|3498527|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3651994|NCT02445326|3498528|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3651995|NCT02445326|3498526|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651996|NCT02445326|3498527|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651997|NCT02445326|3498528|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3651998|NCT02445326|3498526|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3651999|NCT02445326|3498527|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3652000|NCT02445326|3498528|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3652001|NCT02445326|3498526|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3652002|NCT02445326|3498527|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3652003|NCT02445326|3498528|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3652004|NCT02445326|3498526|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3652005|NCT02445326|3498527|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3652006|NCT02445326|3498528|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3652007|NCT02445326|3498526|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3652008|NCT02445326|3498527|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3652009|NCT02445326|3498528|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3652010|NCT02445326|3498526|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3652011|NCT02445326|3498527|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3652012|NCT02445326|3498528|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3652013|NCT02445326|3498526|B3|||Age||years|Mean|37|37.0|Full Range|||18.0|66.0|
3652014|NCT02445326|3498527|B2|||Age||years|Mean|36.3|36.3|Full Range|||18.0|62.0|
3652015|NCT02445326|3498528|B1|||Age||years|Mean|38.2|38.2|Full Range|||19.0|66.0|
3652016|NCT02445287|3498545|B3|Gender Unknown (not collected)||Sex/Gender, Customized|gender not collected for human subjects or cadaveric specimens|participants|Number|48|48.0||||||
3652017|NCT02445287|3498546|B2|Gender Unknown (not collected)||Sex/Gender, Customized|gender not collected for human subjects or cadaveric specimens|participants|Number|13|13.0||||||
3652018|NCT02445287|3498547|B1|Gender Unknown (not collected)||Sex/Gender, Customized|gender not collected for human subjects or cadaveric specimens|participants|Number|35|35.0||||||
3652019|NCT02445287|3498545|B3|18 years or older||Age, Customized||participants|Number|48|48.0||||||
3652020|NCT02445287|3498546|B2|18 years or older||Age, Customized||participants|Number|13|13.0||||||
3652021|NCT02445287|3498547|B1|18 years or older||Age, Customized||participants|Number|35|35.0||||||
3652022|NCT02445196|3498561|B3|United States||Region of Enrollment||Participants|Count of Participants|120|120.0||||||
3652023|NCT02445196|3498562|B2|United States||Region of Enrollment||Participants|Count of Participants|58|58.0||||||
3652024|NCT02445196|3498563|B1|United States||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
3652025|NCT02445196|3498561|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3652026|NCT02445196|3498562|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3652027|NCT02445196|3498563|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3652028|NCT02445196|3498561|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3652029|NCT02445196|3498562|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3652030|NCT02445196|3498563|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3652031|NCT02445196|3498561|B3|||Age||years|Mean|39.28|39.28|Standard Deviation|14.59|14.59|||
3652032|NCT02445196|3498562|B2|||Age||years|Mean|39.12|39.12|Standard Deviation|14.08|14.08|||
3652033|NCT02445196|3498563|B1|||Age||years|Mean|39.43|39.43|Standard Deviation|15.16|15.16|||
3652034|NCT02445196|3498561|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3652035|NCT02445196|3498562|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3652036|NCT02445196|3498563|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3652037|NCT02445196|3498561|B3||Between 18 and 65 years|Age||Participants|Count of Participants|115|115.0||||||
3652038|NCT02445196|3498562|B2||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
3652039|NCT02445196|3498563|B1||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3652040|NCT02445196|3498561|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3652041|NCT02445196|3498562|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3652042|NCT02445196|3498563|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3652043|NCT02444936|3498577|B3|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3652044|NCT02444936|3498578|B2|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3652045|NCT02444936|3498579|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3652046|NCT02444936|3498577|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652047|NCT02444936|3498578|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652048|NCT02444936|3498579|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652049|NCT02444936|3498577|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652050|NCT02444936|3498578|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652051|NCT02444936|3498579|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652052|NCT02444936|3498577|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3652053|NCT02444936|3498578|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3652054|NCT02444936|3498579|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3652055|NCT02444936|3498577|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3652056|NCT02444936|3498578|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3652057|NCT02444936|3498579|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652058|NCT02444936|3498577|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652059|NCT02444936|3498578|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652060|NCT02444936|3498579|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652061|NCT02444936|3498577|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652062|NCT02444936|3498578|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652063|NCT02444936|3498579|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652064|NCT02444936|3498577|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652065|NCT02444936|3498578|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652066|NCT02444936|3498579|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652067|NCT02444936|3498577|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3652068|NCT02444936|3498578|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3652069|NCT02444936|3498579|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3652070|NCT02444936|3498577|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3652071|NCT02444936|3498578|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3652072|NCT02444936|3498579|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3652073|NCT02444936|3498577|B3|||Age||years|Mean|64.7|64.7|Standard Deviation|8.3|8.3|||
3652074|NCT02444936|3498578|B2|||Age||years|Mean|64|64.0|Standard Deviation|9.8|9.8|||
3652075|NCT02444936|3498579|B1|||Age||years|Mean|65.7|65.7|Standard Deviation|6.6|6.6|||
3652076|NCT02444936|3498577|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3652077|NCT02444936|3498578|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3652078|NCT02444936|3498579|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3652079|NCT02444936|3498577|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3652080|NCT02444936|3498578|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3652081|NCT02444936|3498579|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3652082|NCT02444936|3498577|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3652083|NCT02444936|3498578|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3652084|NCT02444936|3498579|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3652085|NCT02444715|3498586|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3652086|NCT02444715|3498587|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3652087|NCT02444715|3498588|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3652088|NCT02444715|3498586|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3652089|NCT02444715|3498587|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3652090|NCT02444715|3498588|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3652091|NCT02444715|3498586|B3|||Age||years|Mean|60.2|60.2|Standard Deviation|11.6|11.6|||
3652092|NCT02444715|3498587|B2|||Age||years|Mean|60.7|60.7|Standard Deviation|11.3|11.3|||
3652093|NCT02444715|3498588|B1|||Age||years|Mean|59.6|59.6|Standard Deviation|12.1|12.1|||
3652094|NCT02444533|3498618|B3|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3652095|NCT02444533|3498619|B2|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3652096|NCT02444533|3498620|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3652097|NCT02444533|3498618|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3652098|NCT02444533|3498619|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3652099|NCT02444533|3498620|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3652100|NCT02444533|3498618|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3652101|NCT02444533|3498619|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3652102|NCT02444533|3498620|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3652103|NCT02444533|3498618|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3652104|NCT02444533|3498619|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3652105|NCT02444533|3498620|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3652106|NCT02444533|3498618|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3652107|NCT02444533|3498619|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3652108|NCT02444533|3498620|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3652109|NCT02444533|3498618|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3652110|NCT02444533|3498619|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3652111|NCT02444533|3498620|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3652112|NCT02444182|3498635|B3|Kuwait||Region of Enrollment||participants|Number|108|108.0||||||
3652113|NCT02444182|3498636|B2|Kuwait||Region of Enrollment||participants|Number|54|54.0||||||
3652114|NCT02444182|3498637|B1|Kuwait||Region of Enrollment||participants|Number|54|54.0||||||
3652115|NCT02444182|3498635|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652116|NCT02444182|3498636|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652117|NCT02444182|3498637|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652118|NCT02444182|3498635|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
3652119|NCT02444182|3498636|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3652120|NCT02444182|3498637|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3652121|NCT02444182|3498635|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652122|NCT02444182|3498636|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652123|NCT02444182|3498637|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652124|NCT02444182|3498635|B3||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3652125|NCT02444182|3498636|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3652126|NCT02444182|3498637|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3652127|NCT02444182|3498635|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3652128|NCT02444182|3498636|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3652129|NCT02444182|3498637|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3652130|NCT02444182|3498635|B3|||Age|school children in 7‒9th grades (aged 13-15 years)|years|Mean|14|14.0|Standard Deviation|1|1.0|||
3652131|NCT02444182|3498636|B2|||Age|school children in 7‒9th grades (aged 13-15 years)|years|Mean|14|14.0|Standard Deviation|1|1.0|||
3652132|NCT02444182|3498637|B1|||Age|school children in 7‒9th grades (aged 13-15 years)|years|Mean|14|14.0|Standard Deviation|1|1.0|||
3652133|NCT02444143|3498646|B3|||Adjusted Body Weight||kg|Mean|92.1|92.1|Standard Deviation|18.7|18.7|||
3652134|NCT02444143|3498647|B2|||Adjusted Body Weight||kg|Mean|97.5|97.5|Standard Deviation|17.9|17.9|||
3652135|NCT02444143|3498648|B1|||Adjusted Body Weight||kg|Mean|86.7|86.7|Standard Deviation|19.5|19.5|||
3652136|NCT02444143|3498646|B3|||Ideal Body Weight||kg|Mean|69.75|69.75|Standard Deviation|12.55|12.55|||
3652137|NCT02444143|3498647|B2|||Ideal Body Weight||kg|Mean|71.5|71.5|Standard Deviation|11.8|11.8|||
3652138|NCT02444143|3498648|B1|||Ideal Body Weight||kg|Mean|68|68.0|Standard Deviation|13.3|13.3|||
3652139|NCT02444143|3498646|B3|||Weight at Transplant||kg|Mean|126.6|126.6|Standard Deviation|30.35|30.35|||
3652140|NCT02444143|3498647|B2|||Weight at Transplant||kg|Mean|136.4|136.4|Standard Deviation|30.5|30.5|||
3652141|NCT02444143|3498648|B1|||Weight at Transplant||kg|Mean|116.8|116.8|Standard Deviation|30.2|30.2|||
3652142|NCT02444143|3498646|B3|||Body Mass Index at Transplant||kg/m2|Mean|40.8|40.8|Standard Deviation|6|6.0|||
3652143|NCT02444143|3498647|B2|||Body Mass Index at Transplant||kg/m2|Mean|43.4|43.4|Standard Deviation|6.8|6.8|||
3652144|NCT02444143|3498648|B1|||Body Mass Index at Transplant||kg/m2|Mean|38.2|38.2|Standard Deviation|5.2|5.2|||
3652145|NCT02444143|3498646|B3|||Hospital stay in days||days|Median|6.75|6.75|Full Range|||5.5|19.0|
3652146|NCT02444143|3498647|B2|||Hospital stay in days||days|Median|6.5|6.5|Full Range|||5.0|17.0|
3652147|NCT02444143|3498648|B1|||Hospital stay in days||days|Median|7|7.0|Full Range|||6.0|21.0|
3652148|NCT02444143|3498646|B3||Other|Cause of End Stage Renal Disease||Participants|Count of Participants|4|4.0||||||
3652149|NCT02444143|3498647|B2||Other|Cause of End Stage Renal Disease||Participants|Count of Participants|3|3.0||||||
3652150|NCT02444143|3498648|B1||Other|Cause of End Stage Renal Disease||Participants|Count of Participants|1|1.0||||||
3652151|NCT02444143|3498646|B3||DM + HTN|Cause of End Stage Renal Disease||Participants|Count of Participants|7|7.0||||||
3652152|NCT02444143|3498647|B2||DM + HTN|Cause of End Stage Renal Disease||Participants|Count of Participants|3|3.0||||||
3652153|NCT02444143|3498648|B1||DM + HTN|Cause of End Stage Renal Disease||Participants|Count of Participants|4|4.0||||||
3652154|NCT02444143|3498646|B3||diabetes mellitus (DM)|Cause of End Stage Renal Disease||Participants|Count of Participants|2|2.0||||||
3652155|NCT02444143|3498647|B2||diabetes mellitus (DM)|Cause of End Stage Renal Disease||Participants|Count of Participants|0|0.0||||||
3652156|NCT02444143|3498648|B1||diabetes mellitus (DM)|Cause of End Stage Renal Disease||Participants|Count of Participants|2|2.0||||||
3652157|NCT02444143|3498646|B3||hypertension (HTN)|Cause of End Stage Renal Disease||Participants|Count of Participants|7|7.0||||||
3652158|NCT02444143|3498647|B2||hypertension (HTN)|Cause of End Stage Renal Disease||Participants|Count of Participants|4|4.0||||||
3652159|NCT02444143|3498648|B1||hypertension (HTN)|Cause of End Stage Renal Disease||Participants|Count of Participants|3|3.0||||||
3652160|NCT02444143|3498646|B3|||Duration of Pre-transplant dialysis||days|Mean|50.8|50.8|Standard Deviation|41.7|41.7|||
3652161|NCT02444143|3498647|B2|||Duration of Pre-transplant dialysis||days|Mean|55.8|55.8|Standard Deviation|46.8|46.8|||
3652162|NCT02444143|3498648|B1|||Duration of Pre-transplant dialysis||days|Mean|45.8|45.8|Standard Deviation|36.6|36.6|||
3652163|NCT02444143|3498646|B3||Living-related|Donor Type||Participants|Count of Participants|8|8.0||||||
3652164|NCT02444143|3498647|B2||Living-related|Donor Type||Participants|Count of Participants|2|2.0||||||
3652165|NCT02444143|3498648|B1||Living-related|Donor Type||Participants|Count of Participants|6|6.0||||||
3652166|NCT02444143|3498646|B3||Living-unrelated|Donor Type||Participants|Count of Participants|7|7.0||||||
3652167|NCT02444143|3498647|B2||Living-unrelated|Donor Type||Participants|Count of Participants|5|5.0||||||
3652168|NCT02444143|3498648|B1||Living-unrelated|Donor Type||Participants|Count of Participants|2|2.0||||||
3652169|NCT02444143|3498646|B3||Deceased|Donor Type||Participants|Count of Participants|5|5.0||||||
3652170|NCT02444143|3498647|B2||Deceased|Donor Type||Participants|Count of Participants|3|3.0||||||
3652171|NCT02444143|3498648|B1||Deceased|Donor Type||Participants|Count of Participants|2|2.0||||||
3652172|NCT02444143|3498646|B3|||Body Mass Index greater than or equal to 30 on Post Operative Day 0||Participants|Count of Participants|20|20.0||||||
3652173|NCT02444143|3498647|B2|||Body Mass Index greater than or equal to 30 on Post Operative Day 0||Participants|Count of Participants|10|10.0||||||
3652174|NCT02444143|3498648|B1|||Body Mass Index greater than or equal to 30 on Post Operative Day 0||Participants|Count of Participants|10|10.0||||||
3652175|NCT02444143|3498646|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3652176|NCT02444143|3498647|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3652177|NCT02444143|3498648|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3652178|NCT02444143|3498646|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3652179|NCT02444143|3498647|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3652180|NCT02444143|3498648|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652181|NCT02444143|3498646|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652182|NCT02444143|3498647|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652183|NCT02444143|3498648|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652184|NCT02444143|3498646|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3652185|NCT02444143|3498647|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3652186|NCT02444143|3498648|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3652187|NCT02444143|3498646|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3652188|NCT02444143|3498647|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3652189|NCT02444143|3498648|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3652190|NCT02444143|3498646|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652191|NCT02444143|3498647|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652192|NCT02444143|3498648|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652193|NCT02444143|3498646|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652194|NCT02444143|3498647|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652195|NCT02444143|3498648|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652196|NCT02444143|3498646|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652197|NCT02444143|3498647|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652198|NCT02444143|3498648|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652199|NCT02444143|3498646|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652200|NCT02444143|3498647|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652201|NCT02444143|3498648|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652202|NCT02444143|3498646|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3652203|NCT02444143|3498647|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3652204|NCT02444143|3498648|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3652205|NCT02444143|3498646|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3652206|NCT02444143|3498647|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3652207|NCT02444143|3498648|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652208|NCT02444143|3498646|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3652209|NCT02444143|3498647|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3652210|NCT02444143|3498648|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3652211|NCT02444143|3498646|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3652212|NCT02444143|3498647|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3652213|NCT02444143|3498648|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3652214|NCT02444143|3498646|B3|||Age||years|Mean|54|54.0|Standard Deviation|11.45|11.45|||
3652215|NCT02444143|3498647|B2|||Age||years|Mean|47.7|47.7|Standard Deviation|14.3|14.3|||
3652216|NCT02444143|3498648|B1|||Age||years|Mean|60.3|60.3|Standard Deviation|8.6|8.6|||
3652217|NCT02443883|3498657|B5|Russia||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3652218|NCT02443883|3498658|B4|Russia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3652219|NCT02443883|3498659|B3|Russia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3652220|NCT02443883|3498660|B2|Russia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3652221|NCT02443883|3498661|B1|Russia||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3652222|NCT02443883|3498657|B5|France||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3652223|NCT02443883|3498658|B4|France||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3652224|NCT02443883|3498659|B3|France||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3652225|NCT02443883|3498660|B2|France||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3652226|NCT02443883|3498661|B1|France||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3652227|NCT02443883|3498657|B5|Australia||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3652228|NCT02443883|3498658|B4|Australia||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3652229|NCT02443883|3498659|B3|Australia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3652230|NCT02443883|3498660|B2|Australia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3652231|NCT02443883|3498661|B1|Australia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3652232|NCT02443883|3498657|B5|Slovakia||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3652233|NCT02443883|3498658|B4|Slovakia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3652234|NCT02443883|3498659|B3|Slovakia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3652235|NCT02443883|3498660|B2|Slovakia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3652236|NCT02443883|3498661|B1|Slovakia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3652237|NCT02443883|3498657|B5|United Kingdom||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3652238|NCT02443883|3498658|B4|United Kingdom||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3652239|NCT02443883|3498659|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3652240|NCT02443883|3498660|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3652241|NCT02443883|3498661|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3652242|NCT02443883|3498657|B5|Poland||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3652243|NCT02443883|3498658|B4|Poland||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3652244|NCT02443883|3498659|B3|Poland||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3652245|NCT02443883|3498660|B2|Poland||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3652246|NCT02443883|3498661|B1|Poland||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3652247|NCT02443883|3498657|B5|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3652248|NCT02443883|3498658|B4|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3652249|NCT02443883|3498659|B3|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3652250|NCT02443883|3498660|B2|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3652251|NCT02443883|3498661|B1|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3652252|NCT02443883|3498657|B5|Hungary||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3652253|NCT02443883|3498658|B4|Hungary||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3652254|NCT02443883|3498659|B3|Hungary||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3652255|NCT02443883|3498660|B2|Hungary||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3652256|NCT02443883|3498661|B1|Hungary||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3652257|NCT02443883|3498657|B5|Turkey||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3652258|NCT02443883|3498658|B4|Turkey||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3652259|NCT02443883|3498659|B3|Turkey||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3652260|NCT02443883|3498660|B2|Turkey||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3652261|NCT02443883|3498661|B1|Turkey||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3652262|NCT02443883|3498657|B5|Romania||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3652263|NCT02443883|3498658|B4|Romania||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3652264|NCT02443883|3498659|B3|Romania||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3652265|NCT02443883|3498660|B2|Romania||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3652266|NCT02443883|3498661|B1|Romania||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3652267|NCT02443883|3498657|B5|Argentina||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3652268|NCT02443883|3498658|B4|Argentina||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3652269|NCT02443883|3498659|B3|Argentina||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3652270|NCT02443883|3498660|B2|Argentina||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3652271|NCT02443883|3498661|B1|Argentina||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3652272|NCT02443883|3498657|B5|New Zealand||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3652273|NCT02443883|3498658|B4|New Zealand||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3652274|NCT02443883|3498659|B3|New Zealand||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3652275|NCT02443883|3498660|B2|New Zealand||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3652276|NCT02443883|3498661|B1|New Zealand||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3652277|NCT02443883|3498657|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3652278|NCT02443883|3498658|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3652279|NCT02443883|3498659|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3652280|NCT02443883|3498660|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652281|NCT02443883|3498661|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3652282|NCT02443883|3498657|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3652283|NCT02443883|3498658|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3652284|NCT02443883|3498659|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3652285|NCT02443883|3498660|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3652286|NCT02443883|3498661|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3652287|NCT02443883|3498657|B5||White|Race (NIH/OMB)||Participants|Count of Participants|135|135.0||||||
3652288|NCT02443883|3498658|B4||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3652289|NCT02443883|3498659|B3||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3652290|NCT02443883|3498660|B2||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3652291|NCT02443883|3498661|B1||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3652292|NCT02443883|3498657|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652293|NCT02443883|3498658|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652294|NCT02443883|3498659|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652295|NCT02443883|3498660|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652296|NCT02443883|3498661|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652297|NCT02443883|3498657|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652298|NCT02443883|3498658|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652299|NCT02443883|3498659|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652300|NCT02443883|3498660|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652301|NCT02443883|3498661|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652302|NCT02443883|3498657|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3652303|NCT02443883|3498658|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3652304|NCT02443883|3498659|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652305|NCT02443883|3498660|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652306|NCT02443883|3498661|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3652307|NCT02443883|3498657|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652308|NCT02443883|3498658|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652309|NCT02443883|3498659|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652310|NCT02443883|3498660|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652311|NCT02443883|3498661|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652312|NCT02443883|3498657|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3652313|NCT02443883|3498658|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3652314|NCT02443883|3498659|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3652315|NCT02443883|3498660|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3652316|NCT02443883|3498661|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3652317|NCT02443883|3498657|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
3652318|NCT02443883|3498658|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3652319|NCT02443883|3498659|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3652320|NCT02443883|3498660|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3652321|NCT02443883|3498661|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3652322|NCT02443883|3498657|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3652323|NCT02443883|3498658|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3652324|NCT02443883|3498659|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3652325|NCT02443883|3498660|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3652326|NCT02443883|3498661|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3652327|NCT02443883|3498657|B5||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3652328|NCT02443883|3498658|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3652329|NCT02443883|3498659|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3652330|NCT02443883|3498660|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3652331|NCT02443883|3498661|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3652332|NCT02443883|3498657|B5||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3652333|NCT02443883|3498658|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3652334|NCT02443883|3498659|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3652335|NCT02443883|3498660|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3652336|NCT02443883|3498661|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3652337|NCT02443883|3498657|B5|||Age||years|Mean|58.5|58.5|Standard Deviation|12.4|12.4|||
3652338|NCT02443883|3498658|B4|||Age||years|Mean|56.2|56.2|Standard Deviation|12.9|12.9|||
3652339|NCT02443883|3498659|B3|||Age||years|Mean|60.5|60.5|Standard Deviation|12.3|12.3|||
3652340|NCT02443883|3498660|B2|||Age||years|Mean|58.7|58.7|Standard Deviation|10.4|10.4|||
3652341|NCT02443883|3498661|B1|||Age||years|Mean|58.5|58.5|Standard Deviation|14.0|14.0|||
3652342|NCT02443792|3498682|B3|South Africa||Region of Enrollment||participants|Number|75|75.0||||||
3652343|NCT02443792|3498683|B2|South Africa||Region of Enrollment||participants|Number|25|25.0||||||
3652344|NCT02443792|3498684|B1|South Africa||Region of Enrollment||participants|Number|50|50.0||||||
3652345|NCT02443792|3498682|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3652346|NCT02443792|3498683|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3652347|NCT02443792|3498684|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3652348|NCT02443792|3498682|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3652349|NCT02443792|3498683|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3652350|NCT02443792|3498684|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3652351|NCT02443792|3498682|B3|Age 36+||Age, Customized||participants|Number|39|39.0||||||
3652352|NCT02443792|3498683|B2|Age 36+||Age, Customized||participants|Number|11|11.0||||||
3652353|NCT02443792|3498684|B1|Age 36+||Age, Customized||participants|Number|28|28.0||||||
3652354|NCT02443792|3498682|B3|Age 26-35||Age, Customized||participants|Number|31|31.0||||||
3652355|NCT02443792|3498683|B2|Age 26-35||Age, Customized||participants|Number|12|12.0||||||
3652356|NCT02443792|3498684|B1|Age 26-35||Age, Customized||participants|Number|19|19.0||||||
3652357|NCT02443792|3498682|B3|Age 18-25||Age, Customized||participants|Number|5|5.0||||||
3652358|NCT02443792|3498683|B2|Age 18-25||Age, Customized||participants|Number|2|2.0||||||
3652359|NCT02443792|3498684|B1|Age 18-25||Age, Customized||participants|Number|3|3.0||||||
3652360|NCT02443740|3498699|B5||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3652361|NCT02443740|3498700|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3652362|NCT02443740|3498701|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3652363|NCT02443740|3498702|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3652364|NCT02443740|3498703|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3652365|NCT02443740|3498699|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3652366|NCT02443740|3498700|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3652367|NCT02443740|3498701|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3652368|NCT02443740|3498702|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3652369|NCT02443740|3498703|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3652370|NCT02443740|3498699|B5|||Age||years|Mean|38.9|38.9|Standard Deviation|9.2|9.2|||
3652371|NCT02443740|3498700|B4|||Age||years|Mean|38.5|38.5|Standard Deviation|11.2|11.2|||
3652372|NCT02443740|3498701|B3|||Age||years|Mean|44.5|44.5|Standard Deviation|6.0|6.0|||
3652373|NCT02443740|3498702|B2|||Age||years|Mean|41.3|41.3|Standard Deviation|6.3|6.3|||
3652374|NCT02443740|3498703|B1|||Age||years|Mean|32.7|32.7|Standard Deviation|10.2|10.2|||
3652375|NCT02443571|3498892|B4|Italy||Region of Enrollment||Participants|Count of Participants|88|88.0||||||
3652376|NCT02443571|3498893|B3|Italy||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3652377|NCT02443571|3498894|B2|Italy||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3652378|NCT02443571|3498895|B1|Italy||Region of Enrollment||Participants|Count of Participants|88|88.0||||||
3652379|NCT02443571|3498892|B4|Norway||Region of Enrollment||Participants|Count of Participants|458|458.0||||||
3652380|NCT02443571|3498893|B3|Norway||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3652381|NCT02443571|3498894|B2|Norway||Region of Enrollment||Participants|Count of Participants|85|85.0||||||
3652382|NCT02443571|3498895|B1|Norway||Region of Enrollment||Participants|Count of Participants|371|371.0||||||
3652383|NCT02443571|3498892|B4|United States||Region of Enrollment||Participants|Count of Participants|168|168.0||||||
3652384|NCT02443571|3498893|B3|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3652385|NCT02443571|3498894|B2|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3652386|NCT02443571|3498895|B1|United States||Region of Enrollment||Participants|Count of Participants|137|137.0||||||
3652387|NCT02443571|3498892|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|480|480.0||||||
3652388|NCT02443571|3498893|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3652389|NCT02443571|3498894|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3652390|NCT02443571|3498895|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|382|382.0||||||
3652391|NCT02443571|3498892|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3652392|NCT02443571|3498893|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652393|NCT02443571|3498894|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652394|NCT02443571|3498895|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3652395|NCT02443571|3498892|B4||White|Race (NIH/OMB)||Participants|Count of Participants|203|203.0||||||
3652396|NCT02443571|3498893|B3||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3652397|NCT02443571|3498894|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652398|NCT02443571|3498895|B1||White|Race (NIH/OMB)||Participants|Count of Participants|186|186.0||||||
3652399|NCT02443571|3498892|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3652400|NCT02443571|3498893|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3652401|NCT02443571|3498894|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652402|NCT02443571|3498895|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3652403|NCT02443571|3498892|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652404|NCT02443571|3498893|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652405|NCT02443571|3498894|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652406|NCT02443571|3498895|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652407|NCT02443571|3498892|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3652408|NCT02443571|3498893|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652409|NCT02443571|3498894|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652410|NCT02443571|3498895|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3652411|NCT02443571|3498892|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652412|NCT02443571|3498893|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652413|NCT02443571|3498894|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652414|NCT02443571|3498895|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652415|NCT02443571|3498892|B4||Male|Sex: Female, Male||Participants|Count of Participants|698|698.0||||||
3652416|NCT02443571|3498893|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3652417|NCT02443571|3498894|B2||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3652418|NCT02443571|3498895|B1||Male|Sex: Female, Male||Participants|Count of Participants|596|596.0||||||
3652419|NCT02443571|3498892|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3652420|NCT02443571|3498893|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3652421|NCT02443571|3498894|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3652422|NCT02443571|3498895|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3652423|NCT02443571|3498892|B4|||Age||Years|Mean|66|66.0|Full Range|||34.0|90.0|
3652424|NCT02443571|3498893|B3|||Age||Years|Mean|61|61.0|Full Range|||34.0|89.0|
3652425|NCT02443571|3498894|B2|||Age||Years|Mean|65|65.0|Full Range|||44.0|88.0|
3652426|NCT02443571|3498895|B1|||Age||Years|Mean|67|67.0|Full Range|||42.0|90.0|
3652427|NCT02443402|3498907|B3|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3652428|NCT02443402|3498908|B2|United States||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3652429|NCT02443402|3498909|B1|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3652430|NCT02443402|3498907|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3652431|NCT02443402|3498908|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3652432|NCT02443402|3498909|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3652433|NCT02443402|3498907|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3652434|NCT02443402|3498908|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3652435|NCT02443402|3498909|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3652436|NCT02443402|3498907|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3652437|NCT02443402|3498908|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3652438|NCT02443402|3498909|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3652439|NCT02443402|3498907|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3652440|NCT02443402|3498908|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3652441|NCT02443402|3498909|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3652442|NCT02443402|3498907|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3652443|NCT02443402|3498908|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3652444|NCT02443402|3498909|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3652445|NCT02443402|3498907|B3|||Age||years|Mean|64|64.0|Standard Deviation|9.9|9.9|||
3652446|NCT02443402|3498908|B2|||Age||years|Mean|64|64.0|Standard Deviation|9|9.0|||
3652447|NCT02443402|3498909|B1|||Age||years|Mean|64|64.0|Standard Deviation|11|11.0|||
3652448|NCT02443103|3498970|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3652449|NCT02443103|3498970|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652450|NCT02443103|3498970|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3652451|NCT02443103|3498970|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3652452|NCT02443103|3498970|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652453|NCT02443103|3498970|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652454|NCT02443103|3498970|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652455|NCT02443103|3498970|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3652456|NCT02443103|3498970|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3652457|NCT02443103|3498970|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652458|NCT02443103|3498970|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3652459|NCT02443103|3498970|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3652460|NCT02443103|3498970|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|2.45|2.45|||
3652461|NCT02443103|3498970|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3652462|NCT02443103|3498970|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3652463|NCT02443103|3498970|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3652464|NCT02442830|3498975|B3||Symptomatic anemia|Type of bleeding at admission||Participants|Count of Participants|7|7.0||||||
3652465|NCT02442830|3498976|B2||Symptomatic anemia|Type of bleeding at admission||Participants|Count of Participants|2|2.0||||||
3652466|NCT02442830|3498977|B1||Symptomatic anemia|Type of bleeding at admission||Participants|Count of Participants|5|5.0||||||
3652467|NCT02442830|3498975|B3||Hematochezia|Type of bleeding at admission||Participants|Count of Participants|20|20.0||||||
3652468|NCT02442830|3498976|B2||Hematochezia|Type of bleeding at admission||Participants|Count of Participants|9|9.0||||||
3652469|NCT02442830|3498977|B1||Hematochezia|Type of bleeding at admission||Participants|Count of Participants|11|11.0||||||
3652470|NCT02442830|3498975|B3||Melena|Type of bleeding at admission||Participants|Count of Participants|60|60.0||||||
3652471|NCT02442830|3498976|B2||Melena|Type of bleeding at admission||Participants|Count of Participants|34|34.0||||||
3652472|NCT02442830|3498977|B1||Melena|Type of bleeding at admission||Participants|Count of Participants|26|26.0||||||
3652473|NCT02442830|3498975|B3|United States||Region of Enrollment||Participants|Count of Participants|87|87.0||||||
3652474|NCT02442830|3498976|B2|United States||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3652475|NCT02442830|3498977|B1|United States||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3652476|NCT02442830|3498975|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3652477|NCT02442830|3498976|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3652478|NCT02442830|3498977|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3652479|NCT02442830|3498975|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652480|NCT02442830|3498976|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652481|NCT02442830|3498977|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652482|NCT02442830|3498975|B3||White|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3652483|NCT02442830|3498976|B2||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3652484|NCT02442830|3498977|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3652485|NCT02442830|3498975|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3652486|NCT02442830|3498976|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3652487|NCT02442830|3498977|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3652488|NCT02442830|3498975|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652489|NCT02442830|3498976|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652490|NCT02442830|3498977|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652491|NCT02442830|3498975|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652492|NCT02442830|3498976|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652493|NCT02442830|3498977|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652494|NCT02442830|3498975|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652495|NCT02442830|3498976|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652496|NCT02442830|3498977|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652497|NCT02442830|3498975|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652498|NCT02442830|3498976|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652499|NCT02442830|3498977|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652500|NCT02442830|3498975|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3652501|NCT02442830|3498976|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3652502|NCT02442830|3498977|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3652503|NCT02442830|3498975|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3652504|NCT02442830|3498976|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3652505|NCT02442830|3498977|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3652506|NCT02442830|3498975|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3652507|NCT02442830|3498976|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3652508|NCT02442830|3498977|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3652509|NCT02442830|3498975|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3652510|NCT02442830|3498976|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3652511|NCT02442830|3498977|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3652512|NCT02442830|3498975|B3|||Age||years|Mean|68.7|68.7|Standard Deviation|14.7|14.7|||
3652513|NCT02442830|3498976|B2|||Age||years|Mean|70.4|70.4|Standard Deviation|16.4|16.4|||
3652514|NCT02442830|3498977|B1|||Age||years|Mean|67.0|67.0|Standard Deviation|12.6|12.6|||
3652515|NCT02442830|3498975|B3||>=65 years|Age||Participants|Count of Participants|53|53.0||||||
3652516|NCT02442830|3498976|B2||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
3652517|NCT02442830|3498977|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3652518|NCT02442830|3498975|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3652519|NCT02442830|3498976|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3652520|NCT02442830|3498977|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3652521|NCT02442830|3498975|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3652522|NCT02442830|3498976|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3652523|NCT02442830|3498977|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3652524|NCT02442804|3498986|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
3652525|NCT02442804|3498987|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3652526|NCT02442804|3498988|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3652527|NCT02442804|3498986|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652528|NCT02442804|3498987|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652529|NCT02442804|3498988|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652530|NCT02442804|3498986|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3652531|NCT02442804|3498987|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3652532|NCT02442804|3498988|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3652533|NCT02442804|3498986|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3652534|NCT02442804|3498987|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3652535|NCT02442804|3498988|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3652536|NCT02442804|3498986|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3652537|NCT02442804|3498987|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3652538|NCT02442804|3498988|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3652539|NCT02442804|3498986|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652540|NCT02442804|3498987|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652541|NCT02442804|3498988|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652542|NCT02442804|3498986|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3652543|NCT02442804|3498987|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3652544|NCT02442804|3498988|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652545|NCT02442804|3498986|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652546|NCT02442804|3498987|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652547|NCT02442804|3498988|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652548|NCT02442804|3498986|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3652549|NCT02442804|3498987|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3652550|NCT02442804|3498988|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3652551|NCT02442804|3498986|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3652552|NCT02442804|3498987|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3652553|NCT02442804|3498988|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3652554|NCT02442804|3498986|B3|||Age||years|Mean|58.88|58.88|Standard Deviation|13.11|13.11|||
3652555|NCT02442804|3498987|B2|||Age||years|Mean|59.63|59.63|Standard Deviation|13.48|13.48|||
3652556|NCT02442804|3498988|B1|||Age||years|Mean|58.13|58.13|Standard Deviation|13.62|13.62|||
3652557|NCT02442700|3499017|B3|No TDF in backbone||Antiretroviral regimens combined with ATV/r||participants|Number|9|9.0||||||
3652558|NCT02442700|3499018|B2|No TDF in backbone||Antiretroviral regimens combined with ATV/r||participants|Number|4|4.0||||||
3652559|NCT02442700|3499019|B1|No TDF in backbone||Antiretroviral regimens combined with ATV/r||participants|Number|5|5.0||||||
3652560|NCT02442700|3499017|B3|TDF + other NRTIs (exclude FTC/3TC)||Antiretroviral regimens combined with ATV/r||participants|Number|4|4.0||||||
3652561|NCT02442700|3499018|B2|TDF + other NRTIs (exclude FTC/3TC)||Antiretroviral regimens combined with ATV/r||participants|Number|2|2.0||||||
3652562|NCT02442700|3499019|B1|TDF + other NRTIs (exclude FTC/3TC)||Antiretroviral regimens combined with ATV/r||participants|Number|2|2.0||||||
3652563|NCT02442700|3499017|B3|TDF + FTC/3TC||Antiretroviral regimens combined with ATV/r||participants|Number|11|11.0||||||
3652564|NCT02442700|3499018|B2|TDF + FTC/3TC||Antiretroviral regimens combined with ATV/r||participants|Number|6|6.0||||||
3652565|NCT02442700|3499019|B1|TDF + FTC/3TC||Antiretroviral regimens combined with ATV/r||participants|Number|5|5.0||||||
3652566|NCT02442700|3499017|B3|||Duration of ATV/r use||months|Median|36|36.0|Inter-Quartile Range|||24.0|48.0|
3652567|NCT02442700|3499018|B2|||Duration of ATV/r use||months|Median|36|36.0|Inter-Quartile Range|||24.0|36.0|
3652568|NCT02442700|3499019|B1|||Duration of ATV/r use||months|Median|42|42.0|Inter-Quartile Range|||30.0|54.0|
3652569|NCT02442700|3499017|B3|||HIV viral load <40 copies/mL||participants|Number|23|23.0||||||
3652570|NCT02442700|3499018|B2|||HIV viral load <40 copies/mL||participants|Number|11|11.0||||||
3652571|NCT02442700|3499019|B1|||HIV viral load <40 copies/mL||participants|Number|12|12.0||||||
3652572|NCT02442700|3499017|B3|||Baseline CD4 cell counts||cells/mm3|Mean|680|680.0|Standard Deviation|189|189.0|||
3652573|NCT02442700|3499018|B2|||Baseline CD4 cell counts||cells/mm3|Mean|718.1|718.1|Standard Deviation|181.2|181.2|||
3652574|NCT02442700|3499019|B1|||Baseline CD4 cell counts||cells/mm3|Mean|641.9|641.9|Standard Deviation|196.5|196.5|||
3652575|NCT02442700|3499017|B3|||Baseline Fasting blood sugar||mg/dL|Mean|98.9|98.9|Standard Deviation|10.2|10.2|||
3652576|NCT02442700|3499018|B2|||Baseline Fasting blood sugar||mg/dL|Mean|97.1|97.1|Standard Deviation|10.5|10.5|||
3652577|NCT02442700|3499019|B1|||Baseline Fasting blood sugar||mg/dL|Mean|100.8|100.8|Standard Deviation|10.1|10.1|||
3652578|NCT02442700|3499017|B3|||Baseline Creatinine||mg/dL|Mean|0.9|0.9|Standard Deviation|0.2|0.2|||
3652579|NCT02442700|3499018|B2|||Baseline Creatinine||mg/dL|Mean|0.9|0.9|Standard Deviation|0.2|0.2|||
3652580|NCT02442700|3499019|B1|||Baseline Creatinine||mg/dL|Mean|0.9|0.9|Standard Deviation|0.2|0.2|||
3652581|NCT02442700|3499017|B3|> or equal to 2||Cardiovascular risk factors||participants|Number|6|6.0||||||
3652582|NCT02442700|3499018|B2|> or equal to 2||Cardiovascular risk factors||participants|Number|1|1.0||||||
3652583|NCT02442700|3499019|B1|> or equal to 2||Cardiovascular risk factors||participants|Number|5|5.0||||||
3652584|NCT02442700|3499017|B3|<2||Cardiovascular risk factors||participants|Number|18|18.0||||||
3652585|NCT02442700|3499018|B2|<2||Cardiovascular risk factors||participants|Number|11|11.0||||||
3652586|NCT02442700|3499019|B1|<2||Cardiovascular risk factors||participants|Number|7|7.0||||||
3652587|NCT02442700|3499017|B3|Others||Underlying conditions||participants|Number|2|2.0||||||
3652588|NCT02442700|3499018|B2|Others||Underlying conditions||participants|Number|0|0.0||||||
3652589|NCT02442700|3499019|B1|Others||Underlying conditions||participants|Number|2|2.0||||||
3652590|NCT02442700|3499017|B3|Chronic hepatitis B and C virus infection||Underlying conditions||participants|Number|4|4.0||||||
3652591|NCT02442700|3499018|B2|Chronic hepatitis B and C virus infection||Underlying conditions||participants|Number|2|2.0||||||
3652592|NCT02442700|3499019|B1|Chronic hepatitis B and C virus infection||Underlying conditions||participants|Number|2|2.0||||||
3652593|NCT02442700|3499017|B3|Dyslipidemia||Underlying conditions||participants|Number|6|6.0||||||
3652594|NCT02442700|3499018|B2|Dyslipidemia||Underlying conditions||participants|Number|2|2.0||||||
3652595|NCT02442700|3499019|B1|Dyslipidemia||Underlying conditions||participants|Number|4|4.0||||||
3652596|NCT02442700|3499017|B3|No||Underlying conditions||participants|Number|12|12.0||||||
3652597|NCT02442700|3499018|B2|No||Underlying conditions||participants|Number|8|8.0||||||
3652598|NCT02442700|3499019|B1|No||Underlying conditions||participants|Number|4|4.0||||||
3652599|NCT02442700|3499017|B3|||Body mass index||kg/m2|Mean|23.2|23.2|Standard Deviation|3.1|3.1|||
3652600|NCT02442700|3499018|B2|||Body mass index||kg/m2|Mean|22.5|22.5|Standard Deviation|3.4|3.4|||
3652601|NCT02442700|3499019|B1|||Body mass index||kg/m2|Mean|23.8|23.8|Standard Deviation|2.7|2.7|||
3652602|NCT02442700|3499017|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3652603|NCT02442700|3499018|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3652604|NCT02442700|3499019|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3652605|NCT02442700|3499017|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3652606|NCT02442700|3499018|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3652607|NCT02442700|3499019|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3652608|NCT02442700|3499017|B3|||Age||years|Mean|48.1|48.1|Standard Deviation|1.8|1.8|||
3652609|NCT02442700|3499018|B2|||Age||years|Mean|46.7|46.7|Standard Deviation|6.8|6.8|||
3652610|NCT02442700|3499019|B1|||Age||years|Mean|49.6|49.6|Standard Deviation|10.6|10.6|||
3652611|NCT02442349|3499028|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3652612|NCT02442349|3499028|B1|White||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3652613|NCT02442349|3499028|B1|Asian||Race/Ethnicity, Customized||Participants|Number|168|168.0||||||
3652614|NCT02442349|3499028|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3652615|NCT02442349|3499028|B1||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3652616|NCT02442349|3499028|B1|>=75 Years||Age, Customized||Participants|Number|9|9.0||||||
3652617|NCT02442349|3499028|B1|>=65-<75 Years||Age, Customized||Participants|Number|45|45.0||||||
3652618|NCT02442349|3499028|B1|>=50-<65 Years||Age, Customized||Participants|Number|79|79.0||||||
3652619|NCT02442349|3499028|B1|<50 Years||Age, Customized||Participants|Number|38|38.0||||||
3652620|NCT02442349|3499028|B1|||Age||Years|Mean|58.3|58.3|Standard Deviation|10.81|10.81|||
3652621|NCT02442310|3499033|B1|Canada||Region of Enrollment||participants|Number|20|20.0||||||
3652622|NCT02442310|3499033|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3652623|NCT02442310|3499033|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3652624|NCT02442310|3499033|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3652625|NCT02442310|3499033|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3652626|NCT02442310|3499033|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3652627|NCT02442284|3499055|B1||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3652628|NCT02442284|3499055|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3652629|NCT02442284|3499055|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|5.90|5.9|||
3652630|NCT02442271|3499062|B1||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3652631|NCT02442271|3499062|B1||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3652632|NCT02442271|3499062|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|10.34|10.34|||
3652633|NCT02442206|3499086|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652634|NCT02442206|3499087|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652635|NCT02442206|3499088|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652636|NCT02442206|3499086|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652637|NCT02442206|3499087|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652638|NCT02442206|3499088|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652639|NCT02442206|3499086|B3||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3652640|NCT02442206|3499087|B2||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3652641|NCT02442206|3499088|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3652642|NCT02442206|3499086|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652643|NCT02442206|3499087|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652644|NCT02442206|3499088|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652645|NCT02442206|3499086|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652646|NCT02442206|3499087|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652647|NCT02442206|3499088|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652648|NCT02442206|3499086|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652649|NCT02442206|3499087|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652650|NCT02442206|3499088|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652651|NCT02442206|3499086|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652652|NCT02442206|3499087|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652653|NCT02442206|3499088|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652654|NCT02442206|3499086|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3652655|NCT02442206|3499087|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3652656|NCT02442206|3499088|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3652657|NCT02442206|3499086|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3652658|NCT02442206|3499087|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3652659|NCT02442206|3499088|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3652660|NCT02442206|3499086|B3|||Age||Years|Mean|63.9|63.9|Standard Deviation|7.83|7.83|||
3652661|NCT02442206|3499087|B2|||Age||Years|Mean|63.8|63.8|Standard Deviation|7.80|7.8|||
3652662|NCT02442206|3499088|B1|||Age||Years|Mean|64.1|64.1|Standard Deviation|8.00|8.0|||
3652663|NCT02441946|3499118|B4|||KI67 at Baseline|Tumor tissue collected through a core biopsy at baseline and at the end of cycle 1 was used to determine Ki67 expression. Ki67 expression is defined as the percent of cells staining positive by validated central assay.|Percent Cells Positive|Median|25.40|25.4|Standard Deviation|12.90|12.9|||
3652664|NCT02441946|3499119|B3|||KI67 at Baseline|Tumor tissue collected through a core biopsy at baseline and at the end of cycle 1 was used to determine Ki67 expression. Ki67 expression is defined as the percent of cells staining positive by validated central assay.|Percent Cells Positive|Median|25.40|25.4|Standard Deviation|12.40|12.4|||
3652665|NCT02441946|3499120|B2|||KI67 at Baseline|Tumor tissue collected through a core biopsy at baseline and at the end of cycle 1 was used to determine Ki67 expression. Ki67 expression is defined as the percent of cells staining positive by validated central assay.|Percent Cells Positive|Median|25.00|25.0|Standard Deviation|12.16|12.16|||
3652666|NCT02441946|3499121|B1|||KI67 at Baseline|Tumor tissue collected through a core biopsy at baseline and at the end of cycle 1 was used to determine Ki67 expression. Ki67 expression is defined as the percent of cells staining positive by validated central assay.|Percent Cells Positive|Median|25.80|25.8|Standard Deviation|14.18|14.18|||
3652667|NCT02441946|3499118|B4||Unreported|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|2|2.0||||||
3652668|NCT02441946|3499119|B3||Unreported|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|1|1.0||||||
3652669|NCT02441946|3499120|B2||Unreported|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|1|1.0||||||
3652670|NCT02441946|3499121|B1||Unreported|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|0|0.0||||||
3652671|NCT02441946|3499118|B4||1 (Restricted, able to do light sedentary work)|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|20|20.0||||||
3652672|NCT02441946|3499119|B3||1 (Restricted, able to do light sedentary work)|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|10|10.0||||||
3652673|NCT02441946|3499120|B2||1 (Restricted, able to do light sedentary work)|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|5|5.0||||||
3652674|NCT02441946|3499121|B1||1 (Restricted, able to do light sedentary work)|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|5|5.0||||||
3652675|NCT02441946|3499118|B4||0 (Fully Active)|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|202|202.0||||||
3652676|NCT02441946|3499119|B3||0 (Fully Active)|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|63|63.0||||||
3652677|NCT02441946|3499120|B2||0 (Fully Active)|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|70|70.0||||||
3652678|NCT02441946|3499121|B1||0 (Fully Active)|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|69|69.0||||||
3652679|NCT02441946|3499118|B4|Spain||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3652680|NCT02441946|3499119|B3|Spain||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3652681|NCT02441946|3499120|B2|Spain||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3652682|NCT02441946|3499121|B1|Spain||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3652683|NCT02441946|3499118|B4|Germany||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3652684|NCT02441946|3499119|B3|Germany||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3652685|NCT02441946|3499120|B2|Germany||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3652686|NCT02441946|3499121|B1|Germany||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3652687|NCT02441946|3499118|B4|Italy||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3652688|NCT02441946|3499119|B3|Italy||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3652689|NCT02441946|3499120|B2|Italy||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3652690|NCT02441946|3499121|B1|Italy||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3652691|NCT02441946|3499118|B4|South Korea||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3652692|NCT02441946|3499119|B3|South Korea||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3652693|NCT02441946|3499120|B2|South Korea||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3652694|NCT02441946|3499121|B1|South Korea||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3652695|NCT02441946|3499118|B4|Taiwan||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3652696|NCT02441946|3499119|B3|Taiwan||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3652697|NCT02441946|3499120|B2|Taiwan||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3652698|NCT02441946|3499121|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3652699|NCT02441946|3499118|B4|United States||Region of Enrollment||Participants|Count of Participants|80|80.0||||||
3652700|NCT02441946|3499119|B3|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3652701|NCT02441946|3499120|B2|United States||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3652702|NCT02441946|3499121|B1|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3652703|NCT02441946|3499118|B4|Belgium||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3652704|NCT02441946|3499119|B3|Belgium||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3652705|NCT02441946|3499120|B2|Belgium||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3652706|NCT02441946|3499121|B1|Belgium||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3652707|NCT02441946|3499118|B4|Netherlands||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3652708|NCT02441946|3499119|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3652709|NCT02441946|3499120|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3652710|NCT02441946|3499121|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3652711|NCT02441946|3499118|B4|Austria||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3652712|NCT02441946|3499119|B3|Austria||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3652713|NCT02441946|3499120|B2|Austria||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3652714|NCT02441946|3499121|B1|Austria||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3652715|NCT02441946|3499118|B4|Canada||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3652716|NCT02441946|3499119|B3|Canada||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3652717|NCT02441946|3499120|B2|Canada||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3652718|NCT02441946|3499121|B1|Canada||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3652719|NCT02441946|3499118|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3652720|NCT02441946|3499119|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652721|NCT02441946|3499120|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652722|NCT02441946|3499121|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3652723|NCT02441946|3499118|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3652724|NCT02441946|3499119|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3652725|NCT02441946|3499120|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3652726|NCT02441946|3499121|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3652727|NCT02441946|3499118|B4||White|Race (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
3652728|NCT02441946|3499119|B3||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3652729|NCT02441946|3499120|B2||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3652730|NCT02441946|3499121|B1||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3652731|NCT02441946|3499118|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3652732|NCT02441946|3499119|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3652733|NCT02441946|3499120|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3652734|NCT02441946|3499121|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3652735|NCT02441946|3499118|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3652736|NCT02441946|3499119|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652737|NCT02441946|3499120|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3652738|NCT02441946|3499121|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652739|NCT02441946|3499118|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3652740|NCT02441946|3499119|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3652741|NCT02441946|3499120|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3652742|NCT02441946|3499121|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3652743|NCT02441946|3499118|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652744|NCT02441946|3499119|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652745|NCT02441946|3499120|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652746|NCT02441946|3499121|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652747|NCT02441946|3499118|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3652748|NCT02441946|3499119|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3652749|NCT02441946|3499120|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3652750|NCT02441946|3499121|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3652751|NCT02441946|3499118|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|182|182.0||||||
3652752|NCT02441946|3499119|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3652753|NCT02441946|3499120|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3652754|NCT02441946|3499121|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3652755|NCT02441946|3499118|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3652756|NCT02441946|3499119|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3652757|NCT02441946|3499120|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3652758|NCT02441946|3499121|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3652759|NCT02441946|3499118|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3652760|NCT02441946|3499119|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3652761|NCT02441946|3499120|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3652762|NCT02441946|3499121|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3652763|NCT02441946|3499118|B4||Female|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
3652764|NCT02441946|3499119|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3652765|NCT02441946|3499120|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3652766|NCT02441946|3499121|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3652767|NCT02441946|3499118|B4|||Age||years|Mean|64.2|64.2|Standard Deviation|8.2|8.2|||
3652768|NCT02441946|3499119|B3|||Age||years|Mean|64.9|64.9|Standard Deviation|8.4|8.4|||
3652769|NCT02441946|3499120|B2|||Age||years|Mean|63.8|63.8|Standard Deviation|7.9|7.9|||
3652770|NCT02441946|3499121|B1|||Age||years|Mean|63.9|63.9|Standard Deviation|8.4|8.4|||
3652771|NCT02441517|3499135|B1|No||Any Prior Disease-Related Surgeries||Participants|Count of Participants|2|2.0||||||
3652772|NCT02441517|3499135|B1|Yes||Any Prior Disease-Related Surgeries||Participants|Count of Participants|2|2.0||||||
3652773|NCT02441517|3499135|B1|No||Any Prior Radiotherapy||Participants|Count of Participants|2|2.0||||||
3652774|NCT02441517|3499135|B1|Yes||Any Prior Radiotherapy||Participants|Count of Participants|2|2.0||||||
3652775|NCT02441517|3499135|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652776|NCT02441517|3499135|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652777|NCT02441517|3499135|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3652778|NCT02441517|3499135|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652779|NCT02441517|3499135|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652780|NCT02441517|3499135|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3652781|NCT02441517|3499135|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652782|NCT02441517|3499135|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652783|NCT02441517|3499135|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3652784|NCT02441517|3499135|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3652785|NCT02441517|3499135|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3652786|NCT02441517|3499135|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3652787|NCT02441517|3499135|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3652788|NCT02441517|3499135|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3652789|NCT02441517|3499135|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3652790|NCT02441218|3499145|B3|No||Beta-blocker intake at randomization||participants|Number|685|685.0||||||
3652791|NCT02441218|3499146|B2|No||Beta-blocker intake at randomization||participants|Number|341|341.0||||||
3652792|NCT02441218|3499147|B1|No||Beta-blocker intake at randomization||participants|Number|344|344.0||||||
3652793|NCT02441218|3499145|B3|Yes||Beta-blocker intake at randomization||participants|Number|5820|5820.0||||||
3652794|NCT02441218|3499146|B2|Yes||Beta-blocker intake at randomization||participants|Number|2923|2923.0||||||
3652795|NCT02441218|3499147|B1|Yes||Beta-blocker intake at randomization||participants|Number|2897|2897.0||||||
3652796|NCT02441218|3499145|B3||Male|Sex: Female, Male||Participants|Count of Participants|4970|4970.0||||||
3652797|NCT02441218|3499146|B2||Male|Sex: Female, Male||Participants|Count of Participants|2508|2508.0||||||
3652798|NCT02441218|3499147|B1||Male|Sex: Female, Male||Participants|Count of Participants|2462|2462.0||||||
3652799|NCT02441218|3499145|B3||Female|Sex: Female, Male||Participants|Count of Participants|1535|1535.0||||||
3652800|NCT02441218|3499146|B2||Female|Sex: Female, Male||Participants|Count of Participants|756|756.0||||||
3652801|NCT02441218|3499147|B1||Female|Sex: Female, Male||Participants|Count of Participants|779|779.0||||||
3652802|NCT02441218|3499145|B3|||Age||years|Mean|60.4|60.4|Standard Deviation|11.4|11.4|||
3652803|NCT02441218|3499146|B2|||Age||years|Mean|60.1|60.1|Standard Deviation|11.5|11.5|||
3652804|NCT02441218|3499147|B1|||Age||years|Mean|60.7|60.7|Standard Deviation|11.2|11.2|||
3652805|NCT02441179|3499172|B3|Chile||Region of Enrollment||participants|Number|33|33.0||||||
3652806|NCT02441179|3499173|B2|Chile||Region of Enrollment||participants|Number|16|16.0||||||
3652807|NCT02441179|3499174|B1|Chile||Region of Enrollment||participants|Number|17|17.0||||||
3652808|NCT02441179|3499172|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3652809|NCT02441179|3499173|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3652810|NCT02441179|3499174|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3652811|NCT02441179|3499172|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3652812|NCT02441179|3499173|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3652813|NCT02441179|3499174|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3652814|NCT02441179|3499172|B3|||Age||years|Mean|41|41.0|Standard Deviation|17|17.0|||
3652815|NCT02441179|3499173|B2|||Age||years|Mean|42|42.0|Standard Deviation|17|17.0|||
3652816|NCT02441179|3499174|B1|||Age||years|Mean|41|41.0|Standard Deviation|17|17.0|||
3652817|NCT02441114|3499193|B1|Korea, Republic of||Region of Enrollment||participants|Number|10|10.0||||||
3652818|NCT02441114|3499193|B1||Male|Gender||Participants|Count of Participants|10|10.0||||||
3652819|NCT02441114|3499193|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3652820|NCT02441114|3499193|B1|||Age||years|Mean|26.8|26.8|Standard Deviation|4.9|4.9|||
3652821|NCT02441114|3499193|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3652822|NCT02441114|3499193|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3652823|NCT02441114|3499193|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3652824|NCT02440659|3499199|B3|United States||Region of Enrollment||participants|Number|1960|1960.0||||||
3652825|NCT02440659|3499200|B2|United States||Region of Enrollment||participants|Number|614|614.0||||||
3652826|NCT02440659|3499201|B1|United States||Region of Enrollment||participants|Number|1346|1346.0||||||
3652827|NCT02440659|3499199|B3|Male||Sex/Gender, Customized||participants|Number|1097|1097.0||||||
3652828|NCT02440659|3499200|B2|Male||Sex/Gender, Customized||participants|Number|331|331.0||||||
3652829|NCT02440659|3499201|B1|Male||Sex/Gender, Customized||participants|Number|766|766.0||||||
3652830|NCT02440659|3499199|B3|Female||Sex/Gender, Customized||participants|Number|853|853.0||||||
3652831|NCT02440659|3499200|B2|Female||Sex/Gender, Customized||participants|Number|282|282.0||||||
3652832|NCT02440659|3499201|B1|Female||Sex/Gender, Customized||participants|Number|571|571.0||||||
3652833|NCT02440659|3499199|B3|||Age||years|Mean|62.06|62.06|Standard Deviation|14.66|14.66|||
3652834|NCT02440659|3499200|B2|||Age||years|Mean|59.90|59.9|Standard Deviation|14.92|14.92|||
3652835|NCT02440659|3499201|B1|||Age||years|Mean|63.04|63.04|Standard Deviation|14.44|14.44|||
3652836|NCT02440659|3499199|B3|>=65 years||Age, Customized||participants|Number|878|878.0||||||
3652837|NCT02440659|3499200|B2|>=65 years||Age, Customized||participants|Number|229|229.0||||||
3652838|NCT02440659|3499201|B1|>=65 years||Age, Customized||participants|Number|649|649.0||||||
3652839|NCT02440659|3499199|B3|Between 18 and 65 years||Age, Customized||participants|Number|1070|1070.0||||||
3652840|NCT02440659|3499200|B2|Between 18 and 65 years||Age, Customized||participants|Number|384|384.0||||||
3652841|NCT02440659|3499201|B1|Between 18 and 65 years||Age, Customized||participants|Number|686|686.0||||||
3652842|NCT02440659|3499199|B3|<=18 years||Age, Customized||participants|Number|0|0.0||||||
3652843|NCT02440659|3499200|B2|<=18 years||Age, Customized||participants|Number|0|0.0||||||
3652844|NCT02440659|3499201|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
3652845|NCT02440633|3499208|B1|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3652846|NCT02440633|3499208|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3652847|NCT02440633|3499208|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3652848|NCT02440633|3499208|B1|||Age||years|Mean|42.0|42.0|Standard Deviation|4.8|4.8|||
3652849|NCT02440633|3499208|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3652850|NCT02440633|3499208|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3652851|NCT02440633|3499208|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3652852|NCT02440451|3499217|B1|Portugal||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3652853|NCT02440451|3499217|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652854|NCT02440451|3499217|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652855|NCT02440451|3499217|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3652856|NCT02440451|3499217|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652857|NCT02440451|3499217|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652858|NCT02440451|3499217|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652859|NCT02440451|3499217|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652860|NCT02440451|3499217|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3652861|NCT02440451|3499217|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652862|NCT02440451|3499217|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652863|NCT02440451|3499217|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3652864|NCT02440451|3499217|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3652865|NCT02440451|3499217|B1|||Age||years|Mean|19.92|19.92|Full Range|||16.83|29.0|
3652866|NCT02440308|3499221|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3652867|NCT02440308|3499221|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3652868|NCT02440308|3499221|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3652869|NCT02440308|3499221|B1|||Age||years|Median|73.3|73.3|Full Range|||60.8|83.1|
3652870|NCT02440308|3499221|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3652871|NCT02440308|3499221|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3652872|NCT02440308|3499221|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3652873|NCT02439879|3499226|B3|||TSS|Total Symptoms Score TSS, which is a summation of the presence, severity,and duration of lancinating pain, burning pain, prickling, and asleep numbness. Each of these is a positive neuropathic sensory symptom. Scoring: total score 0–14.64. Any increase in the score means a worsening of symptoms|units on a scale|Mean|3.45|3.45|Standard Deviation|2|2.0|||
3652930|NCT02439164|3499244|B3||high school|education||Participants|Count of Participants|10|10.0||||||
3652931|NCT02439164|3499245|B2||high school|education||Participants|Count of Participants|2|2.0||||||
3652932|NCT02439164|3499246|B1||high school|education||Participants|Count of Participants|8|8.0||||||
3652874|NCT02439879|3499227|B2|||TSS|Total Symptoms Score TSS, which is a summation of the presence, severity,and duration of lancinating pain, burning pain, prickling, and asleep numbness. Each of these is a positive neuropathic sensory symptom. Scoring: total score 0–14.64. Any increase in the score means a worsening of symptoms|units on a scale|Mean|3.23|3.23|Standard Deviation|2.07|2.07|||
3652875|NCT02439879|3499228|B1|||TSS|Total Symptoms Score TSS, which is a summation of the presence, severity,and duration of lancinating pain, burning pain, prickling, and asleep numbness. Each of these is a positive neuropathic sensory symptom. Scoring: total score 0–14.64. Any increase in the score means a worsening of symptoms|units on a scale|Mean|3.7|3.7|Standard Deviation|1.97|1.97|||
3652876|NCT02439879|3499226|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3652877|NCT02439879|3499227|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3652878|NCT02439879|3499228|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3652879|NCT02439879|3499226|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3652880|NCT02439879|3499227|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3652881|NCT02439879|3499228|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3652882|NCT02439879|3499226|B3|||Age||years|Mean|58.4|58.4|Standard Deviation|10.5|10.5|||
3652883|NCT02439879|3499227|B2|||Age||years|Mean|59|59.0|Standard Deviation|11|11.0|||
3652884|NCT02439879|3499228|B1|||Age||years|Mean|57.5|57.5|Standard Deviation|10|10.0|||
3652885|NCT02439814|3499235|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
3652886|NCT02439814|3499236|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3652887|NCT02439814|3499237|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3652888|NCT02439814|3499235|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652889|NCT02439814|3499236|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652890|NCT02439814|3499237|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652891|NCT02439814|3499235|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652892|NCT02439814|3499236|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652893|NCT02439814|3499237|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652894|NCT02439814|3499235|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3652895|NCT02439814|3499236|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3652896|NCT02439814|3499237|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3652897|NCT02439814|3499235|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3652898|NCT02439814|3499236|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3652899|NCT02439814|3499237|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3652900|NCT02439814|3499235|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652901|NCT02439814|3499236|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652902|NCT02439814|3499237|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652903|NCT02439814|3499235|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652904|NCT02439814|3499236|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652905|NCT02439814|3499237|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652906|NCT02439814|3499235|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652907|NCT02439814|3499236|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652908|NCT02439814|3499237|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652909|NCT02439814|3499235|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3652910|NCT02439814|3499236|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3652911|NCT02439814|3499237|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3652912|NCT02439814|3499235|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3652913|NCT02439814|3499236|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3652914|NCT02439814|3499237|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3652915|NCT02439814|3499235|B3|||Age||Years|Mean|26|26.0|Full Range|||19.0|49.0|
3652916|NCT02439814|3499236|B2|||Age||Years|Mean|25.6|25.6|Full Range|||19.0|36.0|
3652917|NCT02439814|3499237|B1|||Age||Years|Mean|26.4|26.4|Full Range|||19.0|49.0|
3652918|NCT02439814|3499235|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3652919|NCT02439814|3499236|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3652920|NCT02439814|3499237|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3652921|NCT02439814|3499235|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3652922|NCT02439814|3499236|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3652923|NCT02439814|3499237|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3652924|NCT02439814|3499235|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3652925|NCT02439814|3499236|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3652926|NCT02439814|3499237|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3652927|NCT02439164|3499244|B3||college|education||Participants|Count of Participants|13|13.0||||||
3652928|NCT02439164|3499245|B2||college|education||Participants|Count of Participants|10|10.0||||||
3652929|NCT02439164|3499246|B1||college|education||Participants|Count of Participants|3|3.0||||||
3652933|NCT02439164|3499244|B3||middle school|education||Participants|Count of Participants|4|4.0||||||
3652934|NCT02439164|3499245|B2||middle school|education||Participants|Count of Participants|2|2.0||||||
3652935|NCT02439164|3499246|B1||middle school|education||Participants|Count of Participants|2|2.0||||||
3652936|NCT02439164|3499244|B3||primary school|education||Participants|Count of Participants|5|5.0||||||
3652937|NCT02439164|3499245|B2||primary school|education||Participants|Count of Participants|3|3.0||||||
3652938|NCT02439164|3499246|B1||primary school|education||Participants|Count of Participants|2|2.0||||||
3652939|NCT02439164|3499244|B3|||weight||kg|Mean|70.7|70.7|Standard Deviation|21.1|21.1|||
3652940|NCT02439164|3499245|B2|||weight||kg|Mean|75.8|75.8|Standard Deviation|5.1|5.1|||
3652941|NCT02439164|3499246|B1|||weight||kg|Mean|64.9|64.9|Standard Deviation|14.0|14.0|||
3652942|NCT02439164|3499244|B3|China||Region of Enrollment||participants|Number|32|32.0||||||
3652943|NCT02439164|3499245|B2|China||Region of Enrollment||participants|Number|17|17.0||||||
3652944|NCT02439164|3499246|B1|China||Region of Enrollment||participants|Number|15|15.0||||||
3652945|NCT02439164|3499244|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652946|NCT02439164|3499245|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652947|NCT02439164|3499246|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652948|NCT02439164|3499244|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652949|NCT02439164|3499245|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652950|NCT02439164|3499246|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652951|NCT02439164|3499244|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652952|NCT02439164|3499245|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652953|NCT02439164|3499246|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652954|NCT02439164|3499244|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652955|NCT02439164|3499245|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652956|NCT02439164|3499246|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652957|NCT02439164|3499244|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652958|NCT02439164|3499245|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652959|NCT02439164|3499246|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652960|NCT02439164|3499244|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3652961|NCT02439164|3499245|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3652962|NCT02439164|3499246|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3652963|NCT02439164|3499244|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652964|NCT02439164|3499245|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652965|NCT02439164|3499246|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3652966|NCT02439164|3499244|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3652967|NCT02439164|3499245|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3652968|NCT02439164|3499246|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3652969|NCT02439164|3499244|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3652970|NCT02439164|3499245|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3652971|NCT02439164|3499246|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3652972|NCT02439164|3499244|B3|||Age||years old|Mean|40|40.0|Standard Deviation|9|9.0|||
3652973|NCT02439164|3499245|B2|||Age||years old|Mean|35|35.0|Standard Deviation|7|7.0|||
3652974|NCT02439164|3499246|B1|||Age||years old|Mean|46|46.0|Standard Deviation|9|9.0|||
3652975|NCT02439138|3499260|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3652976|NCT02439138|3499260|B1||Male|Gender||Participants|Count of Participants|4|4.0||||||
3652977|NCT02439138|3499260|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
3652978|NCT02439138|3499260|B1|||Age||years|Median|66|66.0|Full Range|||57.0|80.0|
3652979|NCT02439138|3499260|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3652980|NCT02439138|3499260|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3652981|NCT02439138|3499260|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3652982|NCT02438813|3499271|B1||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3652983|NCT02438813|3499271|B1||Female|Sex: Female, Male||Participants|Count of Participants|883|883.0||||||
3652984|NCT02438813|3499271|B1|>65 years||Age, Customized||participants|Number|108|108.0||||||
3652985|NCT02438813|3499271|B1|51 to 65 years||Age, Customized||participants|Number|413|413.0||||||
3652986|NCT02438813|3499271|B1|31 to 50 years||Age, Customized||participants|Number|427|427.0||||||
3652987|NCT02438813|3499271|B1|18 to 30 years||Age, Customized||participants|Number|81|81.0||||||
3652988|NCT02438813|3499271|B1|||Age||years|Mean|49.9|49.9|Standard Deviation|12.30|12.3|||
3652989|NCT02438787|3499320|B4|UNITED STATES||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3652990|NCT02438787|3499321|B3|UNITED STATES||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3652991|NCT02438787|3499322|B2|UNITED STATES||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3652992|NCT02438787|3499323|B1|UNITED STATES||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3652993|NCT02438787|3499320|B4|UNITED KINGDOM||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3652994|NCT02438787|3499321|B3|UNITED KINGDOM||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3652995|NCT02438787|3499322|B2|UNITED KINGDOM||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3652996|NCT02438787|3499323|B1|UNITED KINGDOM||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3652997|NCT02438787|3499320|B4|UKRAINE||Region of Enrollment||Participants|Count of Participants|66|66.0||||||
3652998|NCT02438787|3499321|B3|UKRAINE||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3652999|NCT02438787|3499322|B2|UKRAINE||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3653000|NCT02438787|3499323|B1|UKRAINE||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3653001|NCT02438787|3499320|B4|TAIWAN||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3653002|NCT02438787|3499321|B3|TAIWAN||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3653003|NCT02438787|3499322|B2|TAIWAN||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3653004|NCT02438787|3499323|B1|TAIWAN||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3653005|NCT02438787|3499320|B4|SPAIN||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3653006|NCT02438787|3499321|B3|SPAIN||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3653007|NCT02438787|3499322|B2|SPAIN||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3653008|NCT02438787|3499323|B1|SPAIN||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3653009|NCT02438787|3499320|B4|SOUTH KOREA||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3653010|NCT02438787|3499321|B3|SOUTH KOREA||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3653011|NCT02438787|3499322|B2|SOUTH KOREA||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3653012|NCT02438787|3499323|B1|SOUTH KOREA||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3653013|NCT02438787|3499320|B4|RUSSIAN FEDERATION||Region of Enrollment||Participants|Count of Participants|69|69.0||||||
3653014|NCT02438787|3499321|B3|RUSSIAN FEDERATION||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3653015|NCT02438787|3499322|B2|RUSSIAN FEDERATION||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3653016|NCT02438787|3499323|B1|RUSSIAN FEDERATION||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3653017|NCT02438787|3499320|B4|PORTUGAL||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3653018|NCT02438787|3499321|B3|PORTUGAL||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3653019|NCT02438787|3499322|B2|PORTUGAL||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3653020|NCT02438787|3499323|B1|PORTUGAL||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3653021|NCT02438787|3499320|B4|POLAND||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3653022|NCT02438787|3499321|B3|POLAND||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3653023|NCT02438787|3499322|B2|POLAND||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3653024|NCT02438787|3499323|B1|POLAND||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3653025|NCT02438787|3499320|B4|MEXICO||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3653026|NCT02438787|3499321|B3|MEXICO||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3653027|NCT02438787|3499322|B2|MEXICO||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3653028|NCT02438787|3499323|B1|MEXICO||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3653029|NCT02438787|3499320|B4|HUNGARY||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3653030|NCT02438787|3499321|B3|HUNGARY||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3653031|NCT02438787|3499322|B2|HUNGARY||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3653032|NCT02438787|3499323|B1|HUNGARY||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3653033|NCT02438787|3499320|B4|GERMANY||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3653034|NCT02438787|3499321|B3|GERMANY||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3653035|NCT02438787|3499322|B2|GERMANY||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3653036|NCT02438787|3499323|B1|GERMANY||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3653037|NCT02438787|3499320|B4|FRANCE||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3653038|NCT02438787|3499321|B3|FRANCE||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3653039|NCT02438787|3499322|B2|FRANCE||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3653040|NCT02438787|3499323|B1|FRANCE||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3653041|NCT02438787|3499320|B4|CZECH REPUBLIC||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3653042|NCT02438787|3499321|B3|CZECH REPUBLIC||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3653043|NCT02438787|3499322|B2|CZECH REPUBLIC||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3653044|NCT02438787|3499323|B1|CZECH REPUBLIC||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3653045|NCT02438787|3499320|B4|CANADA||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3653046|NCT02438787|3499321|B3|CANADA||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3653047|NCT02438787|3499322|B2|CANADA||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3653048|NCT02438787|3499323|B1|CANADA||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3653049|NCT02438787|3499320|B4|BULGARIA||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3653105|NCT02438787|3499320|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3653050|NCT02438787|3499321|B3|BULGARIA||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3653051|NCT02438787|3499322|B2|BULGARIA||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3653052|NCT02438787|3499323|B1|BULGARIA||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3653053|NCT02438787|3499320|B4|BRAZIL||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3653054|NCT02438787|3499321|B3|BRAZIL||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3653055|NCT02438787|3499322|B2|BRAZIL||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3653056|NCT02438787|3499323|B1|BRAZIL||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3653057|NCT02438787|3499320|B4|BELGIUM||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3653058|NCT02438787|3499321|B3|BELGIUM||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3653059|NCT02438787|3499322|B2|BELGIUM||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3653060|NCT02438787|3499323|B1|BELGIUM||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3653061|NCT02438787|3499320|B4|ARGENTINA||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3653062|NCT02438787|3499321|B3|ARGENTINA||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3653063|NCT02438787|3499322|B2|ARGENTINA||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3653064|NCT02438787|3499323|B1|ARGENTINA||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3653065|NCT02438787|3499320|B4|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|225|225.0||||||
3653066|NCT02438787|3499321|B3|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|73|73.0||||||
3653067|NCT02438787|3499322|B2|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|75|75.0||||||
3653068|NCT02438787|3499323|B1|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|77|77.0||||||
3653069|NCT02438787|3499320|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3653070|NCT02438787|3499321|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3653071|NCT02438787|3499322|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3653072|NCT02438787|3499323|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3653073|NCT02438787|3499320|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3653074|NCT02438787|3499321|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3653075|NCT02438787|3499322|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3653076|NCT02438787|3499323|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3653077|NCT02438787|3499320|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3653078|NCT02438787|3499321|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3653079|NCT02438787|3499322|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3653080|NCT02438787|3499323|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3653081|NCT02438787|3499320|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
3653082|NCT02438787|3499321|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3653083|NCT02438787|3499322|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3653084|NCT02438787|3499323|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3653085|NCT02438787|3499320|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3653086|NCT02438787|3499321|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3653087|NCT02438787|3499322|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3653088|NCT02438787|3499323|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3653089|NCT02438787|3499320|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653090|NCT02438787|3499321|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653091|NCT02438787|3499322|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653092|NCT02438787|3499323|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653093|NCT02438787|3499320|B4||White|Race (NIH/OMB)||Participants|Count of Participants|250|250.0||||||
3653094|NCT02438787|3499321|B3||White|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3653095|NCT02438787|3499322|B2||White|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3653096|NCT02438787|3499323|B1||White|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3653097|NCT02438787|3499320|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3653098|NCT02438787|3499321|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653099|NCT02438787|3499322|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3653100|NCT02438787|3499323|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3653101|NCT02438787|3499320|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653102|NCT02438787|3499321|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653103|NCT02438787|3499322|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653104|NCT02438787|3499323|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653106|NCT02438787|3499321|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3653107|NCT02438787|3499322|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3653108|NCT02438787|3499323|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3653109|NCT02438787|3499320|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653110|NCT02438787|3499321|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653111|NCT02438787|3499322|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653112|NCT02438787|3499323|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653113|NCT02438787|3499320|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3653114|NCT02438787|3499321|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3653115|NCT02438787|3499322|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3653116|NCT02438787|3499323|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3653117|NCT02438787|3499320|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|270|270.0||||||
3653118|NCT02438787|3499321|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3653119|NCT02438787|3499322|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3653120|NCT02438787|3499323|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3653121|NCT02438787|3499320|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3653122|NCT02438787|3499321|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3653123|NCT02438787|3499322|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3653124|NCT02438787|3499323|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3653125|NCT02438787|3499320|B4||Male|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
3653126|NCT02438787|3499321|B3||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3653127|NCT02438787|3499322|B2||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3653128|NCT02438787|3499323|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3653129|NCT02438787|3499320|B4||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3653130|NCT02438787|3499321|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3653131|NCT02438787|3499322|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3653132|NCT02438787|3499323|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3653133|NCT02438787|3499320|B4|||Age||years|Mean|41.2|41.2|Standard Deviation|11.33|11.33|||
3653134|NCT02438787|3499321|B3|||Age||years|Mean|41.5|41.5|Standard Deviation|11.02|11.02|||
3653135|NCT02438787|3499322|B2|||Age||years|Mean|41.4|41.4|Standard Deviation|11.33|11.33|||
3653136|NCT02438787|3499323|B1|||Age||years|Mean|40.8|40.8|Standard Deviation|11.72|11.72|||
3653137|NCT02438540|3499368|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3653138|NCT02438540|3499369|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3653139|NCT02438540|3499370|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3653140|NCT02438540|3499368|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3653141|NCT02438540|3499369|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3653142|NCT02438540|3499370|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3653143|NCT02438540|3499368|B3|Mean age||Age, Customized|Patients between 20 and 65 years old of either gender|years|Mean|41.3|41.3|Standard Deviation|3.0|3.0|||
3653144|NCT02438540|3499369|B2|Mean age||Age, Customized|Patients between 20 and 65 years old of either gender|years|Mean|40.5|40.5|Standard Deviation|2.6|2.6|||
3653145|NCT02438540|3499370|B1|Mean age||Age, Customized|Patients between 20 and 65 years old of either gender|years|Mean|42.2|42.2|Standard Deviation|3.5|3.5|||
3653146|NCT02438280|3499411|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
3653147|NCT02438280|3499412|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3653148|NCT02438280|3499413|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3653149|NCT02438280|3499411|B3|Canada||Region of Enrollment||participants|Number|11|11.0||||||
3653150|NCT02438280|3499412|B2|Canada||Region of Enrollment||participants|Number|3|3.0||||||
3653151|NCT02438280|3499413|B1|Canada||Region of Enrollment||participants|Number|8|8.0||||||
3653152|NCT02438280|3499411|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3653153|NCT02438280|3499411|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3653154|NCT02438280|3499412|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3653155|NCT02438280|3499413|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3653156|NCT02438280|3499411|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3653157|NCT02438280|3499412|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3653158|NCT02438280|3499413|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3653159|NCT02438280|3499411|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3653160|NCT02438280|3499412|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3653161|NCT02438280|3499413|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3653162|NCT02438280|3499411|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3653163|NCT02438280|3499412|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3653164|NCT02438280|3499413|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3653165|NCT02438280|3499411|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3653166|NCT02438280|3499412|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3653167|NCT02438280|3499413|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3653168|NCT02438137|3499422|B3|Monocyte Chemoattractant Protein-1||Baseline cytokine levels (log-transformed values)||pg/ml|Mean|2.619|2.619|Standard Deviation|0.153|0.153|||
3653169|NCT02438137|3499423|B2|Monocyte Chemoattractant Protein-1||Baseline cytokine levels (log-transformed values)||pg/ml|Mean|2.593|2.593|Standard Deviation|0.210|0.21|||
3653170|NCT02438137|3499424|B1|Monocyte Chemoattractant Protein-1||Baseline cytokine levels (log-transformed values)||pg/ml|Mean|2.632|2.632|Standard Deviation|0.118|0.118|||
3653171|NCT02438137|3499422|B3|Interleukin-10||Baseline cytokine levels (log-transformed values)||pg/ml|Mean|0.530|0.53|Standard Deviation|0.496|0.496|||
3653172|NCT02438137|3499423|B2|Interleukin-10||Baseline cytokine levels (log-transformed values)||pg/ml|Mean|0.392|0.392|Standard Deviation|0.294|0.294|||
3653173|NCT02438137|3499424|B1|Interleukin-10||Baseline cytokine levels (log-transformed values)||pg/ml|Mean|0.596|0.596|Standard Deviation|0.558|0.558|||
3653174|NCT02438137|3499422|B3|Tissue Necrosis Factor-alpha||Baseline cytokine levels (log-transformed values)||pg/ml|Mean|0.957|0.957|Standard Deviation|0.257|0.257|||
3653175|NCT02438137|3499423|B2|Tissue Necrosis Factor-alpha||Baseline cytokine levels (log-transformed values)||pg/ml|Mean|1.009|1.009|Standard Deviation|0.354|0.354|||
3653176|NCT02438137|3499424|B1|Tissue Necrosis Factor-alpha||Baseline cytokine levels (log-transformed values)||pg/ml|Mean|0.933|0.933|Standard Deviation|0.195|0.195|||
3653177|NCT02438137|3499422|B3|Interleukin-6||Baseline cytokine levels (log-transformed values)||pg/ml|Mean|0.372|0.372|Standard Deviation|0.325|0.325|||
3653178|NCT02438137|3499423|B2|Interleukin-6||Baseline cytokine levels (log-transformed values)||pg/ml|Mean|0.300|0.3|Standard Deviation|0.249|0.249|||
3653179|NCT02438137|3499424|B1|Interleukin-6||Baseline cytokine levels (log-transformed values)||pg/ml|Mean|0.406|0.406|Standard Deviation|0.354|0.354|||
3653180|NCT02438137|3499422|B3|||Respiratory Disturbance Index (RDI)|The RDI represents the total number of apneas, hypopneas and respiratory-related arousals per hour of sleep.|respiratory events/hour|Mean|34|34.0|Standard Deviation|25.1|25.1|||
3653181|NCT02438137|3499423|B2|||Respiratory Disturbance Index (RDI)|The RDI represents the total number of apneas, hypopneas and respiratory-related arousals per hour of sleep.|respiratory events/hour|Mean|29.0|29.0|Standard Deviation|16.9|16.9|||
3653182|NCT02438137|3499424|B1|||Respiratory Disturbance Index (RDI)|The RDI represents the total number of apneas, hypopneas and respiratory-related arousals per hour of sleep.|respiratory events/hour|Mean|36.4|36.4|Standard Deviation|28|28.0|||
3653183|NCT02438137|3499422|B3|United States||Region of Enrollment||participants|Number|65|65.0||||||
3653184|NCT02438137|3499423|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
3653185|NCT02438137|3499424|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
3653186|NCT02438137|3499422|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3653187|NCT02438137|3499423|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3653188|NCT02438137|3499424|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3653189|NCT02438137|3499422|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3653190|NCT02438137|3499423|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3653191|NCT02438137|3499424|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3653192|NCT02438137|3499422|B3|||Age||years|Mean|50.2|50.2|Standard Deviation|12|12.0|||
3653193|NCT02438137|3499423|B2|||Age||years|Mean|52.5|52.5|Standard Deviation|12.4|12.4|||
3653194|NCT02438137|3499424|B1|||Age||years|Mean|49.1|49.1|Standard Deviation|11.7|11.7|||
3653195|NCT02437903|3499433|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3653196|NCT02437903|3499433|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653197|NCT02437903|3499433|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653198|NCT02437903|3499433|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3653199|NCT02437903|3499433|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653200|NCT02437903|3499433|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653201|NCT02437903|3499433|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653202|NCT02437903|3499433|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653203|NCT02437903|3499433|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653204|NCT02437903|3499433|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3653205|NCT02437903|3499433|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3653206|NCT02437903|3499433|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3653207|NCT02437903|3499433|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3653208|NCT02437903|3499433|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3653209|NCT02437903|3499433|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3653210|NCT02437903|3499433|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3653211|NCT02437864|3499441|B3|||Body Mass Index (BMI)||kg/m^2|Median|16.4|16.4|Inter-Quartile Range|||14.8|18.1|
3653212|NCT02437864|3499442|B2|||Body Mass Index (BMI)||kg/m^2|Median|16.3|16.3|Inter-Quartile Range|||14.9|18.1|
3653213|NCT02437864|3499443|B1|||Body Mass Index (BMI)||kg/m^2|Median|16.6|16.6|Inter-Quartile Range|||14.7|18.0|
3653214|NCT02437864|3499441|B3|||Height||centimeters|Median|92.5|92.5|Inter-Quartile Range|||76.0|110.9|
3653333|NCT02437487|3499467|B2|||Age||years|Mean|66.1|66.1|Standard Deviation|14.02|14.02|||
3653215|NCT02437864|3499442|B2|||Height||centimeters|Median|89.3|89.3|Inter-Quartile Range|||73.0|107.8|
3653216|NCT02437864|3499443|B1|||Height||centimeters|Median|95.3|95.3|Inter-Quartile Range|||78.5|113.0|
3653217|NCT02437864|3499441|B3|||Weight||kilograms|Median|13.6|13.6|Inter-Quartile Range|||10.0|18.4|
3653218|NCT02437864|3499442|B2|||Weight||kilograms|Median|13.4|13.4|Inter-Quartile Range|||9.3|17.5|
3653219|NCT02437864|3499443|B1|||Weight||kilograms|Median|13.9|13.9|Inter-Quartile Range|||10.4|19.0|
3653220|NCT02437864|3499441|B3|United States||Region of Enrollment||participants|Number|356|356.0||||||
3653221|NCT02437864|3499442|B2|United States||Region of Enrollment||participants|Number|160|160.0||||||
3653222|NCT02437864|3499443|B1|United States||Region of Enrollment||participants|Number|196|196.0||||||
3653223|NCT02437864|3499441|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3653224|NCT02437864|3499441|B3||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3653225|NCT02437864|3499442|B2||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3653226|NCT02437864|3499443|B1||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3653227|NCT02437864|3499441|B3||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3653228|NCT02437864|3499442|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3653229|NCT02437864|3499443|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3653230|NCT02437864|3499441|B3|||Age||years|Median|3|3.0|Inter-Quartile Range|||1.4|5.0|
3653231|NCT02437864|3499442|B2|||Age||years|Median|2|2.0|Inter-Quartile Range|||1.2|4.0|
3653232|NCT02437864|3499443|B1|||Age||years|Median|3|3.0|Inter-Quartile Range|||1.5|5.0|
3653233|NCT02437864|3499441|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3653234|NCT02437864|3499442|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3653235|NCT02437864|3499443|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3653236|NCT02437864|3499441|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3653237|NCT02437864|3499442|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3653238|NCT02437864|3499443|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3653239|NCT02437864|3499441|B3||<=18 years|Age||Participants|Count of Participants|356|356.0||||||
3653240|NCT02437864|3499442|B2||<=18 years|Age||Participants|Count of Participants|160|160.0||||||
3653241|NCT02437864|3499443|B1||<=18 years|Age||Participants|Count of Participants|196|196.0||||||
3653242|NCT02437513|3499458|B1|Germany||Region of Enrollment||participants|Number|2|2.0||||||
3653243|NCT02437513|3499458|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3653244|NCT02437513|3499458|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3653245|NCT02437513|3499458|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3653246|NCT02437513|3499458|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3653247|NCT02437513|3499458|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3653248|NCT02437487|3499466|B3||Unknown|Albumin < 2.5 mg/dL||Participants|Count of Participants|58|58.0||||||
3653249|NCT02437487|3499467|B2||Unknown|Albumin < 2.5 mg/dL||Participants|Count of Participants|20|20.0||||||
3653250|NCT02437487|3499468|B1||Unknown|Albumin < 2.5 mg/dL||Participants|Count of Participants|38|38.0||||||
3653251|NCT02437487|3499466|B3||No|Albumin < 2.5 mg/dL||Participants|Count of Participants|28|28.0||||||
3653252|NCT02437487|3499467|B2||No|Albumin < 2.5 mg/dL||Participants|Count of Participants|8|8.0||||||
3653253|NCT02437487|3499468|B1||No|Albumin < 2.5 mg/dL||Participants|Count of Participants|20|20.0||||||
3653254|NCT02437487|3499466|B3||Yes|Albumin < 2.5 mg/dL||Participants|Count of Participants|3|3.0||||||
3653255|NCT02437487|3499467|B2||Yes|Albumin < 2.5 mg/dL||Participants|Count of Participants|2|2.0||||||
3653256|NCT02437487|3499468|B1||Yes|Albumin < 2.5 mg/dL||Participants|Count of Participants|1|1.0||||||
3653257|NCT02437487|3499466|B3||Unknown|White Blood Cells Category||Participants|Count of Participants|61|61.0||||||
3653258|NCT02437487|3499467|B2||Unknown|White Blood Cells Category||Participants|Count of Participants|21|21.0||||||
3653259|NCT02437487|3499468|B1||Unknown|White Blood Cells Category||Participants|Count of Participants|40|40.0||||||
3653260|NCT02437487|3499466|B3||15,001 or more|White Blood Cells Category||Participants|Count of Participants|0|0.0||||||
3653261|NCT02437487|3499467|B2||15,001 or more|White Blood Cells Category||Participants|Count of Participants|0|0.0||||||
3653262|NCT02437487|3499468|B1||15,001 or more|White Blood Cells Category||Participants|Count of Participants|0|0.0||||||
3653263|NCT02437487|3499466|B3||12,001 to 15,000|White Blood Cells Category||Participants|Count of Participants|3|3.0||||||
3653264|NCT02437487|3499467|B2||12,001 to 15,000|White Blood Cells Category||Participants|Count of Participants|2|2.0||||||
3653265|NCT02437487|3499468|B1||12,001 to 15,000|White Blood Cells Category||Participants|Count of Participants|1|1.0||||||
3653266|NCT02437487|3499466|B3||less than 12,000|White Blood Cells Category||Participants|Count of Participants|25|25.0||||||
3653267|NCT02437487|3499467|B2||less than 12,000|White Blood Cells Category||Participants|Count of Participants|7|7.0||||||
3653268|NCT02437487|3499468|B1||less than 12,000|White Blood Cells Category||Participants|Count of Participants|18|18.0||||||
3653269|NCT02437487|3499466|B3||Unknown|Stool Frequency||Participants|Count of Participants|4|4.0||||||
3653270|NCT02437487|3499467|B2||Unknown|Stool Frequency||Participants|Count of Participants|2|2.0||||||
3653271|NCT02437487|3499468|B1||Unknown|Stool Frequency||Participants|Count of Participants|2|2.0||||||
3653272|NCT02437487|3499466|B3||10 or more per day|Stool Frequency||Participants|Count of Participants|19|19.0||||||
3653273|NCT02437487|3499467|B2||10 or more per day|Stool Frequency||Participants|Count of Participants|8|8.0||||||
3653274|NCT02437487|3499468|B1||10 or more per day|Stool Frequency||Participants|Count of Participants|11|11.0||||||
3653275|NCT02437487|3499466|B3||6-9 per day|Stool Frequency||Participants|Count of Participants|22|22.0||||||
3653276|NCT02437487|3499467|B2||6-9 per day|Stool Frequency||Participants|Count of Participants|8|8.0||||||
3653277|NCT02437487|3499468|B1||6-9 per day|Stool Frequency||Participants|Count of Participants|14|14.0||||||
3653278|NCT02437487|3499466|B3||4-5 per day|Stool Frequency||Participants|Count of Participants|39|39.0||||||
3653279|NCT02437487|3499467|B2||4-5 per day|Stool Frequency||Participants|Count of Participants|12|12.0||||||
3653280|NCT02437487|3499468|B1||4-5 per day|Stool Frequency||Participants|Count of Participants|27|27.0||||||
3653281|NCT02437487|3499466|B3||3 per day|Stool Frequency||Participants|Count of Participants|5|5.0||||||
3653282|NCT02437487|3499467|B2||3 per day|Stool Frequency||Participants|Count of Participants|0|0.0||||||
3653283|NCT02437487|3499468|B1||3 per day|Stool Frequency||Participants|Count of Participants|5|5.0||||||
3653284|NCT02437487|3499466|B3||0-2 per day|Stool Frequency||Participants|Count of Participants|0|0.0||||||
3653285|NCT02437487|3499467|B2||0-2 per day|Stool Frequency||Participants|Count of Participants|0|0.0||||||
3653286|NCT02437487|3499468|B1||0-2 per day|Stool Frequency||Participants|Count of Participants|0|0.0||||||
3653287|NCT02437487|3499466|B3||5 or more|Number of Previous CDI Episodes||Participants|Count of Participants|15|15.0||||||
3653288|NCT02437487|3499467|B2||5 or more|Number of Previous CDI Episodes||Participants|Count of Participants|5|5.0||||||
3653289|NCT02437487|3499468|B1||5 or more|Number of Previous CDI Episodes||Participants|Count of Participants|10|10.0||||||
3653290|NCT02437487|3499466|B3||4|Number of Previous CDI Episodes||Participants|Count of Participants|26|26.0||||||
3653291|NCT02437487|3499467|B2||4|Number of Previous CDI Episodes||Participants|Count of Participants|5|5.0||||||
3653292|NCT02437487|3499468|B1||4|Number of Previous CDI Episodes||Participants|Count of Participants|21|21.0||||||
3653293|NCT02437487|3499466|B3||3|Number of Previous CDI Episodes||Participants|Count of Participants|48|48.0||||||
3653294|NCT02437487|3499467|B2||3|Number of Previous CDI Episodes||Participants|Count of Participants|20|20.0||||||
3653295|NCT02437487|3499468|B1||3|Number of Previous CDI Episodes||Participants|Count of Participants|28|28.0||||||
3653296|NCT02437487|3499466|B3||2|Number of Previous CDI Episodes||Participants|Count of Participants|0|0.0||||||
3653297|NCT02437487|3499467|B2||2|Number of Previous CDI Episodes||Participants|Count of Participants|0|0.0||||||
3653298|NCT02437487|3499468|B1||2|Number of Previous CDI Episodes||Participants|Count of Participants|0|0.0||||||
3653299|NCT02437487|3499466|B3||1|Number of Previous CDI Episodes||Participants|Count of Participants|0|0.0||||||
3653300|NCT02437487|3499467|B2||1|Number of Previous CDI Episodes||Participants|Count of Participants|0|0.0||||||
3653301|NCT02437487|3499468|B1||1|Number of Previous CDI Episodes||Participants|Count of Participants|0|0.0||||||
3653302|NCT02437487|3499466|B3|||Body Mass Index (kg/m2)||kg/m^2|Mean|27.70|27.7|Standard Deviation|6.150|6.15|||
3653303|NCT02437487|3499467|B2|||Body Mass Index (kg/m2)||kg/m^2|Mean|27.65|27.65|Standard Deviation|5.744|5.744|||
3653304|NCT02437487|3499468|B1|||Body Mass Index (kg/m2)||kg/m^2|Mean|27.72|27.72|Standard Deviation|6.402|6.402|||
3653305|NCT02437487|3499466|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653306|NCT02437487|3499467|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653307|NCT02437487|3499468|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653308|NCT02437487|3499466|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653309|NCT02437487|3499467|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653310|NCT02437487|3499468|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653311|NCT02437487|3499466|B3||White|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3653312|NCT02437487|3499467|B2||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3653313|NCT02437487|3499468|B1||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3653314|NCT02437487|3499466|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3653315|NCT02437487|3499467|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3653316|NCT02437487|3499468|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3653317|NCT02437487|3499466|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3653318|NCT02437487|3499467|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653319|NCT02437487|3499468|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3653320|NCT02437487|3499466|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653321|NCT02437487|3499467|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653322|NCT02437487|3499468|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653323|NCT02437487|3499466|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3653324|NCT02437487|3499467|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653325|NCT02437487|3499468|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3653326|NCT02437487|3499466|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3653327|NCT02437487|3499467|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3653328|NCT02437487|3499468|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3653329|NCT02437487|3499466|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3653330|NCT02437487|3499467|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3653331|NCT02437487|3499468|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3653332|NCT02437487|3499466|B3|||Age||years|Mean|64.5|64.5|Standard Deviation|15.74|15.74|||
3653334|NCT02437487|3499468|B1|||Age||years|Mean|63.7|63.7|Standard Deviation|16.60|16.6|||
3653335|NCT02437487|3499466|B3||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
3653336|NCT02437487|3499467|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3653337|NCT02437487|3499468|B1||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
3653338|NCT02437487|3499466|B3||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
3653339|NCT02437487|3499467|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3653340|NCT02437487|3499468|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3653341|NCT02437487|3499466|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3653342|NCT02437487|3499467|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3653343|NCT02437487|3499468|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3653344|NCT02437409|3499483|B1|Germany||Region of Enrollment||participants|Number|100|100.0||||||
3653345|NCT02437409|3499483|B1||Male|Sex: Female, Male|Gender|Participants|Count of Participants|45|45.0||||||
3653346|NCT02437409|3499483|B1||Female|Sex: Female, Male|Gender|Participants|Count of Participants|55|55.0||||||
3653347|NCT02437409|3499483|B1|||Age||years|Mean|68.3|68.3|Standard Deviation|13.8|13.8|||
3653348|NCT02437344|3499492|B1|||baseline opioid use (morphine equivalents)||morphine eq, in mg|Mean|297.7|297.7|Standard Deviation|113.2|113.2|||
3653349|NCT02437344|3499492|B1|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3653350|NCT02437344|3499492|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653351|NCT02437344|3499492|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653352|NCT02437344|3499492|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3653353|NCT02437344|3499492|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3653354|NCT02437344|3499492|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653355|NCT02437344|3499492|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653356|NCT02437344|3499492|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653357|NCT02437344|3499492|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3653358|NCT02437344|3499492|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3653359|NCT02437344|3499492|B1|||Age||years|Mean|37.8|37.8|Standard Deviation|12.3|12.3|||
3653360|NCT02437344|3499492|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3653361|NCT02437344|3499492|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3653362|NCT02437344|3499492|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3653363|NCT02437305|3499496|B3|None of these||Skin reaction to the sun||participants|Number|14|14.0||||||
3653364|NCT02437305|3499497|B2|None of these||Skin reaction to the sun||participants|Number|5|5.0||||||
3653365|NCT02437305|3499498|B1|None of these||Skin reaction to the sun||participants|Number|9|9.0||||||
3653366|NCT02437305|3499496|B3|Never burn/always tan||Skin reaction to the sun||participants|Number|36|36.0||||||
3653367|NCT02437305|3499497|B2|Never burn/always tan||Skin reaction to the sun||participants|Number|19|19.0||||||
3653368|NCT02437305|3499498|B1|Never burn/always tan||Skin reaction to the sun||participants|Number|17|17.0||||||
3653369|NCT02437305|3499496|B3|Rarely burn/usually tan||Skin reaction to the sun||participants|Number|42|42.0||||||
3653370|NCT02437305|3499497|B2|Rarely burn/usually tan||Skin reaction to the sun||participants|Number|24|24.0||||||
3653371|NCT02437305|3499498|B1|Rarely burn/usually tan||Skin reaction to the sun||participants|Number|18|18.0||||||
3653372|NCT02437305|3499496|B3|Usually burn/rarely tan||Skin reaction to the sun||participants|Number|4|4.0||||||
3653373|NCT02437305|3499497|B2|Usually burn/rarely tan||Skin reaction to the sun||participants|Number|1|1.0||||||
3653374|NCT02437305|3499498|B1|Usually burn/rarely tan||Skin reaction to the sun||participants|Number|3|3.0||||||
3653375|NCT02437305|3499496|B3|Always burn/never tan||Skin reaction to the sun||participants|Number|4|4.0||||||
3653376|NCT02437305|3499497|B2|Always burn/never tan||Skin reaction to the sun||participants|Number|1|1.0||||||
3653377|NCT02437305|3499498|B1|Always burn/never tan||Skin reaction to the sun||participants|Number|3|3.0||||||
3653378|NCT02437305|3499496|B3|No||Family history of skin cancer||participants|Number|93|93.0||||||
3653379|NCT02437305|3499497|B2|No||Family history of skin cancer||participants|Number|44|44.0||||||
3653380|NCT02437305|3499498|B1|No||Family history of skin cancer||participants|Number|49|49.0||||||
3653381|NCT02437305|3499496|B3|Yes||Family history of skin cancer||participants|Number|7|7.0||||||
3653382|NCT02437305|3499497|B2|Yes||Family history of skin cancer||participants|Number|6|6.0||||||
3653383|NCT02437305|3499498|B1|Yes||Family history of skin cancer||participants|Number|1|1.0||||||
3653384|NCT02437305|3499496|B3|No||Personal history of skin cancer||participants|Number|98|98.0||||||
3653385|NCT02437305|3499497|B2|No||Personal history of skin cancer||participants|Number|49|49.0||||||
3653386|NCT02437305|3499498|B1|No||Personal history of skin cancer||participants|Number|49|49.0||||||
3653387|NCT02437305|3499496|B3|Yes||Personal history of skin cancer||participants|Number|2|2.0||||||
3653388|NCT02437305|3499497|B2|Yes||Personal history of skin cancer||participants|Number|1|1.0||||||
3653389|NCT02437305|3499498|B1|Yes||Personal history of skin cancer||participants|Number|1|1.0||||||
3653390|NCT02437305|3499496|B3|Graduate/professional||Education||participants|Number|38|38.0||||||
3653391|NCT02437305|3499497|B2|Graduate/professional||Education||participants|Number|17|17.0||||||
3653392|NCT02437305|3499498|B1|Graduate/professional||Education||participants|Number|21|21.0||||||
3653393|NCT02437305|3499496|B3|College graduate||Education||participants|Number|31|31.0||||||
3653394|NCT02437305|3499497|B2|College graduate||Education||participants|Number|17|17.0||||||
3653395|NCT02437305|3499498|B1|College graduate||Education||participants|Number|14|14.0||||||
3653396|NCT02437305|3499496|B3|Some college/technical school||Education||participants|Number|23|23.0||||||
3653397|NCT02437305|3499497|B2|Some college/technical school||Education||participants|Number|11|11.0||||||
3653398|NCT02437305|3499498|B1|Some college/technical school||Education||participants|Number|12|12.0||||||
3653399|NCT02437305|3499496|B3|High school||Education||participants|Number|6|6.0||||||
3653400|NCT02437305|3499497|B2|High school||Education||participants|Number|4|4.0||||||
3653401|NCT02437305|3499498|B1|High school||Education||participants|Number|2|2.0||||||
3653402|NCT02437305|3499496|B3|<12 years||Education||participants|Number|2|2.0||||||
3653403|NCT02437305|3499497|B2|<12 years||Education||participants|Number|1|1.0||||||
3653404|NCT02437305|3499498|B1|<12 years||Education||participants|Number|1|1.0||||||
3653405|NCT02437305|3499496|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3653406|NCT02437305|3499497|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3653407|NCT02437305|3499498|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3653408|NCT02437305|3499496|B3|American Indian and Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3653409|NCT02437305|3499497|B2|American Indian and Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3653410|NCT02437305|3499498|B1|American Indian and Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3653411|NCT02437305|3499496|B3|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3653412|NCT02437305|3499497|B2|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3653413|NCT02437305|3499498|B1|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3653414|NCT02437305|3499496|B3|African American||Race/Ethnicity, Customized||participants|Number|78|78.0||||||
3653415|NCT02437305|3499497|B2|African American||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
3653416|NCT02437305|3499498|B1|African American||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
3653417|NCT02437305|3499496|B3||Male|Gender||Participants|Count of Participants|15|15.0||||||
3653418|NCT02437305|3499497|B2||Male|Gender||Participants|Count of Participants|7|7.0||||||
3653419|NCT02437305|3499498|B1||Male|Gender||Participants|Count of Participants|8|8.0||||||
3653420|NCT02437305|3499496|B3||Female|Gender||Participants|Count of Participants|85|85.0||||||
3653421|NCT02437305|3499497|B2||Female|Gender||Participants|Count of Participants|43|43.0||||||
3653422|NCT02437305|3499498|B1||Female|Gender||Participants|Count of Participants|42|42.0||||||
3653423|NCT02437305|3499496|B3|76+||Age, Customized||participants|Number|2|2.0||||||
3653424|NCT02437305|3499497|B2|76+||Age, Customized||participants|Number|2|2.0||||||
3653425|NCT02437305|3499498|B1|76+||Age, Customized||participants|Number|0|0.0||||||
3653426|NCT02437305|3499496|B3|51-75||Age, Customized||participants|Number|35|35.0||||||
3653427|NCT02437305|3499497|B2|51-75||Age, Customized||participants|Number|14|14.0||||||
3653428|NCT02437305|3499498|B1|51-75||Age, Customized||participants|Number|21|21.0||||||
3653429|NCT02437305|3499496|B3|26-50||Age, Customized||participants|Number|55|55.0||||||
3653430|NCT02437305|3499497|B2|26-50||Age, Customized||participants|Number|29|29.0||||||
3653431|NCT02437305|3499498|B1|26-50||Age, Customized||participants|Number|26|26.0||||||
3653432|NCT02437305|3499496|B3|18-25||Age, Customized||participants|Number|8|8.0||||||
3653433|NCT02437305|3499497|B2|18-25||Age, Customized||participants|Number|5|5.0||||||
3653434|NCT02437305|3499498|B1|18-25||Age, Customized||participants|Number|3|3.0||||||
3653435|NCT02437253|3499507|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3653436|NCT02437253|3499508|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3653437|NCT02437253|3499509|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3653438|NCT02437253|3499507|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653439|NCT02437253|3499508|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653440|NCT02437253|3499509|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653441|NCT02437253|3499507|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653442|NCT02437253|3499508|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653443|NCT02437253|3499509|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653444|NCT02437253|3499507|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3653445|NCT02437253|3499508|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3653446|NCT02437253|3499509|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3653447|NCT02437253|3499507|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653448|NCT02437253|3499508|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653449|NCT02437253|3499509|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653450|NCT02437253|3499507|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653451|NCT02437253|3499508|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653452|NCT02437253|3499509|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653453|NCT02437253|3499507|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653454|NCT02437253|3499508|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653455|NCT02437253|3499509|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653569|NCT02437162|3499524|B4|||Age||years|Mean|39|39.0|Standard Deviation|11.04|11.04|||
3653456|NCT02437253|3499507|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653457|NCT02437253|3499508|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653458|NCT02437253|3499509|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653459|NCT02437253|3499507|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3653460|NCT02437253|3499508|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3653461|NCT02437253|3499509|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3653462|NCT02437253|3499507|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3653463|NCT02437253|3499508|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3653464|NCT02437253|3499509|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3653465|NCT02437253|3499507|B3|||Age||years|Mean|10.5|10.5|Full Range|||6.0|15.0|
3653466|NCT02437253|3499508|B2|||Age||years|Mean|6|6.0|Full Range|||6.0|6.0|
3653467|NCT02437253|3499509|B1|||Age||years|Mean|15|15.0|Full Range|||15.0|15.0|
3653468|NCT02437253|3499507|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3653469|NCT02437253|3499508|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3653470|NCT02437253|3499509|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3653471|NCT02437253|3499507|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3653472|NCT02437253|3499508|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3653473|NCT02437253|3499509|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3653474|NCT02437253|3499507|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3653475|NCT02437253|3499508|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3653476|NCT02437253|3499509|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3653477|NCT02437162|3499524|B4|Czech Republic||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3653478|NCT02437162|3499525|B3|Czech Republic||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3653479|NCT02437162|3499526|B2|Czech Republic||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3653480|NCT02437162|3499527|B1|Czech Republic||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3653481|NCT02437162|3499524|B4|Taiwan, Province Of China||Region of Enrollment||Participants|Count of Participants|67|67.0||||||
3653482|NCT02437162|3499525|B3|Taiwan, Province Of China||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3653483|NCT02437162|3499526|B2|Taiwan, Province Of China||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3653484|NCT02437162|3499527|B1|Taiwan, Province Of China||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3653485|NCT02437162|3499524|B4|Korea, Democratic People'S Republic Of||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3653486|NCT02437162|3499525|B3|Korea, Democratic People'S Republic Of||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3653487|NCT02437162|3499526|B2|Korea, Democratic People'S Republic Of||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3653488|NCT02437162|3499527|B1|Korea, Democratic People'S Republic Of||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3653489|NCT02437162|3499524|B4|Russia||Region of Enrollment||Participants|Count of Participants|101|101.0||||||
3653490|NCT02437162|3499525|B3|Russia||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3653491|NCT02437162|3499526|B2|Russia||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
3653492|NCT02437162|3499527|B1|Russia||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3653493|NCT02437162|3499524|B4|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3653494|NCT02437162|3499525|B3|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3653495|NCT02437162|3499526|B2|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3653496|NCT02437162|3499527|B1|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3653497|NCT02437162|3499524|B4|Ukraine||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
3653498|NCT02437162|3499525|B3|Ukraine||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3653499|NCT02437162|3499526|B2|Ukraine||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3653500|NCT02437162|3499527|B1|Ukraine||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3653501|NCT02437162|3499524|B4|Poland||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3653502|NCT02437162|3499525|B3|Poland||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3653503|NCT02437162|3499526|B2|Poland||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3653504|NCT02437162|3499527|B1|Poland||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3653505|NCT02437162|3499524|B4|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|247|247.0||||||
3653506|NCT02437162|3499525|B3|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|81|81.0||||||
3653507|NCT02437162|3499526|B2|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|84|84.0||||||
3653508|NCT02437162|3499527|B1|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|82|82.0||||||
3653509|NCT02437162|3499524|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3653510|NCT02437162|3499525|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3653511|NCT02437162|3499526|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3653512|NCT02437162|3499527|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3653513|NCT02437162|3499524|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3653514|NCT02437162|3499525|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3653515|NCT02437162|3499526|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3653516|NCT02437162|3499527|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3653517|NCT02437162|3499524|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|93|93.0||||||
3653518|NCT02437162|3499525|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3653519|NCT02437162|3499526|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3653520|NCT02437162|3499527|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3653521|NCT02437162|3499524|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653522|NCT02437162|3499525|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653523|NCT02437162|3499526|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653524|NCT02437162|3499527|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653525|NCT02437162|3499524|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653526|NCT02437162|3499525|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653527|NCT02437162|3499526|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653528|NCT02437162|3499527|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653529|NCT02437162|3499524|B4||White|Race (NIH/OMB)||Participants|Count of Participants|252|252.0||||||
3653530|NCT02437162|3499525|B3||White|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3653531|NCT02437162|3499526|B2||White|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3653532|NCT02437162|3499527|B1||White|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
3653533|NCT02437162|3499524|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3653534|NCT02437162|3499525|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3653535|NCT02437162|3499526|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653536|NCT02437162|3499527|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653537|NCT02437162|3499524|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653538|NCT02437162|3499525|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653539|NCT02437162|3499526|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653540|NCT02437162|3499527|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653541|NCT02437162|3499524|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
3653542|NCT02437162|3499525|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3653543|NCT02437162|3499526|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3653544|NCT02437162|3499527|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3653545|NCT02437162|3499524|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653546|NCT02437162|3499525|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653547|NCT02437162|3499526|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653548|NCT02437162|3499527|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653549|NCT02437162|3499524|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653550|NCT02437162|3499525|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653551|NCT02437162|3499526|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653552|NCT02437162|3499527|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653553|NCT02437162|3499524|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|341|341.0||||||
3653554|NCT02437162|3499525|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
3653555|NCT02437162|3499526|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|116|116.0||||||
3653556|NCT02437162|3499527|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|112|112.0||||||
3653557|NCT02437162|3499524|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3653558|NCT02437162|3499525|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3653559|NCT02437162|3499526|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653560|NCT02437162|3499527|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3653561|NCT02437162|3499524|B4||Male|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
3653562|NCT02437162|3499525|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3653563|NCT02437162|3499526|B2||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3653564|NCT02437162|3499527|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3653565|NCT02437162|3499524|B4||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3653566|NCT02437162|3499525|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3653567|NCT02437162|3499526|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3653568|NCT02437162|3499527|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3653570|NCT02437162|3499525|B3|||Age||years|Mean|39.5|39.5|Standard Deviation|11.32|11.32|||
3653571|NCT02437162|3499526|B2|||Age||years|Mean|39.2|39.2|Standard Deviation|10.5|10.5|||
3653572|NCT02437162|3499527|B1|||Age||years|Mean|38.3|38.3|Standard Deviation|11.35|11.35|||
3653573|NCT02436811|3499647|B4|Brazil||Region of Enrollment||participants|Number|180|180.0||||||
3653574|NCT02436811|3499648|B3|Brazil||Region of Enrollment||participants|Number|60|60.0||||||
3653575|NCT02436811|3499649|B2|Brazil||Region of Enrollment||participants|Number|60|60.0||||||
3653576|NCT02436811|3499650|B1|Brazil||Region of Enrollment||participants|Number|60|60.0||||||
3653577|NCT02436811|3499647|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3653578|NCT02436811|3499648|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3653579|NCT02436811|3499649|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3653580|NCT02436811|3499650|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3653581|NCT02436811|3499647|B4||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3653582|NCT02436811|3499648|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3653583|NCT02436811|3499649|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3653584|NCT02436811|3499650|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3653585|NCT02436811|3499647|B4|||Age||years|Mean|26.22|26.22|Standard Deviation|6.24|6.24|||
3653586|NCT02436811|3499648|B3|||Age||years|Mean|25.58|25.58|Standard Deviation|6.59|6.59|||
3653587|NCT02436811|3499649|B2|||Age||years|Mean|26.32|26.32|Standard Deviation|6.19|6.19|||
3653588|NCT02436811|3499650|B1|||Age||years|Mean|26.60|26.6|Standard Deviation|5.74|5.74|||
3653589|NCT02436811|3499647|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3653590|NCT02436811|3499648|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3653591|NCT02436811|3499649|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3653592|NCT02436811|3499650|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3653593|NCT02436811|3499647|B4||Between 18 and 65 years|Age||Participants|Count of Participants|148|148.0||||||
3653594|NCT02436811|3499648|B3||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3653595|NCT02436811|3499649|B2||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
3653596|NCT02436811|3499650|B1||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
3653597|NCT02436811|3499647|B4||<=18 years|Age||Participants|Count of Participants|32|32.0||||||
3653598|NCT02436811|3499648|B3||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
3653599|NCT02436811|3499649|B2||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
3653600|NCT02436811|3499650|B1||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
3653601|NCT02436577|3499660|B7||Male|Gender||Participants|Count of Participants|42|42.0||||||
3653602|NCT02436577|3499661|B6||Male|Gender||Participants|Count of Participants|7|7.0||||||
3653603|NCT02436577|3499662|B5||Male|Gender||Participants|Count of Participants|7|7.0||||||
3653604|NCT02436577|3499663|B4||Male|Gender||Participants|Count of Participants|7|7.0||||||
3653605|NCT02436577|3499664|B3||Male|Gender||Participants|Count of Participants|7|7.0||||||
3653606|NCT02436577|3499665|B2||Male|Gender||Participants|Count of Participants|7|7.0||||||
3653607|NCT02436577|3499666|B1||Male|Gender||Participants|Count of Participants|7|7.0||||||
3653608|NCT02436577|3499660|B7||Female|Gender||Participants|Count of Participants|0|0.0||||||
3653609|NCT02436577|3499661|B6||Female|Gender||Participants|Count of Participants|0|0.0||||||
3653610|NCT02436577|3499662|B5||Female|Gender||Participants|Count of Participants|0|0.0||||||
3653611|NCT02436577|3499663|B4||Female|Gender||Participants|Count of Participants|0|0.0||||||
3653612|NCT02436577|3499664|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
3653613|NCT02436577|3499665|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
3653614|NCT02436577|3499666|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3653615|NCT02436577|3499660|B7|||Age||years|Mean|31|31.0|Standard Deviation|7|7.0|||
3653616|NCT02436577|3499661|B6|||Age||years|Mean|29|29.0|Standard Deviation|8|8.0|||
3653617|NCT02436577|3499662|B5|||Age||years|Mean|31|31.0|Standard Deviation|7|7.0|||
3653618|NCT02436577|3499663|B4|||Age||years|Mean|32|32.0|Standard Deviation|8|8.0|||
3653619|NCT02436577|3499664|B3|||Age||years|Mean|32|32.0|Standard Deviation|9|9.0|||
3653620|NCT02436577|3499665|B2|||Age||years|Mean|32|32.0|Standard Deviation|3|3.0|||
3653621|NCT02436577|3499666|B1|||Age||years|Mean|28|28.0|Standard Deviation|6|6.0|||
3653622|NCT02436330|3499724|B3|||Baseline BMI z-score||z-score|Mean|2.2|2.2|Full Range|||1.27|2.96|
3653623|NCT02436330|3499725|B2|||Baseline BMI z-score||z-score|Mean|2.2|2.2|Full Range|||1.27|2.96|
3653624|NCT02436330|3499726|B1|||Baseline BMI z-score||z-score|Mean|2.2|2.2|Full Range|||1.43|2.86|
3653625|NCT02436330|3499724|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653626|NCT02436330|3499725|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653627|NCT02436330|3499726|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653628|NCT02436330|3499724|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653629|NCT02436330|3499725|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653630|NCT02436330|3499726|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653631|NCT02436330|3499724|B3||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3653632|NCT02436330|3499725|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3653633|NCT02436330|3499726|B1||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3653634|NCT02436330|3499724|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3653635|NCT02436330|3499725|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3653636|NCT02436330|3499726|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3653637|NCT02436330|3499724|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653638|NCT02436330|3499725|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653639|NCT02436330|3499726|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653640|NCT02436330|3499724|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3653641|NCT02436330|3499725|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3653642|NCT02436330|3499726|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3653643|NCT02436330|3499724|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653644|NCT02436330|3499725|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653645|NCT02436330|3499726|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653646|NCT02436330|3499724|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3653647|NCT02436330|3499725|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3653648|NCT02436330|3499726|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3653649|NCT02436330|3499724|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3653650|NCT02436330|3499725|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3653651|NCT02436330|3499726|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3653652|NCT02436330|3499724|B3|||Age|Obese and overweight children (BMI greater than or equal to 85th percentile) ages 8 years through 12 years were enrolled.|years|Mean|10.1|10.1|Standard Deviation|1.3|1.3|||
3653653|NCT02436330|3499725|B2|||Age|Obese and overweight children (BMI greater than or equal to 85th percentile) ages 8 years through 12 years were enrolled.|years|Mean|10.1|10.1|Standard Deviation|1.1|1.1|||
3653654|NCT02436330|3499726|B1|||Age|Obese and overweight children (BMI greater than or equal to 85th percentile) ages 8 years through 12 years were enrolled.|years|Mean|10.0|10.0|Standard Deviation|1.2|1.2|||
3653655|NCT02436304|3499769|B4||Male|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
3653656|NCT02436304|3499770|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3653657|NCT02436304|3499771|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3653658|NCT02436304|3499772|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3653659|NCT02436304|3499769|B4||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3653660|NCT02436304|3499770|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3653661|NCT02436304|3499771|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3653662|NCT02436304|3499772|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3653663|NCT02436304|3499769|B4|||Age||years|Mean|2.5|2.5|Standard Deviation|2.20|2.2|||
3653664|NCT02436304|3499770|B3|||Age||years|Mean|2.6|2.6|Standard Deviation|2.31|2.31|||
3653665|NCT02436304|3499771|B2|||Age||years|Mean|2.8|2.8|Standard Deviation|2.31|2.31|||
3653666|NCT02436304|3499772|B1|||Age||years|Mean|2.3|2.3|Standard Deviation|2.05|2.05|||
3653667|NCT02436031|3499789|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3653668|NCT02436031|3499789|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3653669|NCT02436031|3499789|B1|||Age||years|Median|55|55.0|Inter-Quartile Range|||49.0|62.0|
3653670|NCT02435966|3499800|B4|||Range of Motion (Neck): Inclination Rigth||degrees|Mean|47.77|47.77|Standard Deviation|12.40|12.4|||
3653671|NCT02435966|3499801|B3|||Range of Motion (Neck): Inclination Rigth||degrees|Mean|45.63|45.63|Standard Deviation|6.78|6.78|||
3653672|NCT02435966|3499802|B2|||Range of Motion (Neck): Inclination Rigth||degrees|Mean|49.03|49.03|Standard Deviation|13.09|13.09|||
3653673|NCT02435966|3499803|B1|||Range of Motion (Neck): Inclination Rigth||degrees|Mean|47.72|47.72|Standard Deviation|14.28|14.28|||
3653674|NCT02435966|3499800|B4|||Range of Motion (Neck): Inclination Left||degrees|Mean|54.09|54.09|Standard Deviation|10.39|10.39|||
3653675|NCT02435966|3499801|B3|||Range of Motion (Neck): Inclination Left||degrees|Mean|52.43|52.43|Standard Deviation|8.44|8.44|||
3653676|NCT02435966|3499802|B2|||Range of Motion (Neck): Inclination Left||degrees|Mean|55.43|55.43|Standard Deviation|10.99|10.99|||
3653677|NCT02435966|3499803|B1|||Range of Motion (Neck): Inclination Left||degrees|Mean|53.63|53.63|Standard Deviation|10.83|10.83|||
3653678|NCT02435966|3499800|B4|||Range of Motion (Neck): Extension||degrees|Mean|55.38|55.38|Standard Deviation|12.50|12.5|||
3653679|NCT02435966|3499801|B3|||Range of Motion (Neck): Extension||degrees|Mean|59.66|59.66|Standard Deviation|9.30|9.3|||
3653680|NCT02435966|3499802|B2|||Range of Motion (Neck): Extension||degrees|Mean|55.67|55.67|Standard Deviation|11.54|11.54|||
3653681|NCT02435966|3499803|B1|||Range of Motion (Neck): Extension||degrees|Mean|52.31|52.31|Standard Deviation|14.56|14.56|||
3653682|NCT02435966|3499800|B4|||Range of Motion (Neck): Flexion||degrees|Mean|68.00|68.0|Standard Deviation|11.56|11.56|||
3653683|NCT02435966|3499801|B3|||Range of Motion (Neck): Flexion||degrees|Mean|65.96|65.96|Standard Deviation|8.82|8.82|||
3653684|NCT02435966|3499802|B2|||Range of Motion (Neck): Flexion||degrees|Mean|69.24|69.24|Standard Deviation|11.05|11.05|||
3653685|NCT02435966|3499803|B1|||Range of Motion (Neck): Flexion||degrees|Mean|67.89|67.89|Standard Deviation|13.53|13.53|||
3653686|NCT02435966|3499800|B4|||Range of Motion (Neck): Rotation Rigth||degrees|Mean|76.24|76.24|Standard Deviation|15.49|15.49|||
3653687|NCT02435966|3499801|B3|||Range of Motion (Neck): Rotation Rigth||degrees|Mean|78.20|78.2|Standard Deviation|11.21|11.21|||
3653688|NCT02435966|3499802|B2|||Range of Motion (Neck): Rotation Rigth||degrees|Mean|74.60|74.6|Standard Deviation|15.31|15.31|||
3653689|NCT02435966|3499803|B1|||Range of Motion (Neck): Rotation Rigth||degrees|Mean|74.27|74.27|Standard Deviation|18.10|18.1|||
3653690|NCT02435966|3499800|B4|||Range of Motion (Neck): Rotation Left||degrees|Mean|74.09|74.09|Standard Deviation|14.23|14.23|||
3653691|NCT02435966|3499801|B3|||Range of Motion (Neck): Rotation Left||degrees|Mean|78.20|78.2|Standard Deviation|11.21|11.21|||
3653692|NCT02435966|3499802|B2|||Range of Motion (Neck): Rotation Left||degrees|Mean|73.81|73.81|Standard Deviation|11.82|11.82|||
3653693|NCT02435966|3499803|B1|||Range of Motion (Neck): Rotation Left||degrees|Mean|71.78|71.78|Standard Deviation|17.73|17.73|||
3653694|NCT02435966|3499800|B4|||Pressure Pain Threshold at the most active trigger point||kg/cm2|Mean|1.82|1.82|Standard Deviation|0.45|0.45|||
3653695|NCT02435966|3499801|B3|||Pressure Pain Threshold at the most active trigger point||kg/cm2|Mean|1.83|1.83|Standard Deviation|0.43|0.43|||
3653696|NCT02435966|3499802|B2|||Pressure Pain Threshold at the most active trigger point||kg/cm2|Mean|1.88|1.88|Standard Deviation|0.52|0.52|||
3653697|NCT02435966|3499803|B1|||Pressure Pain Threshold at the most active trigger point||kg/cm2|Mean|1.75|1.75|Standard Deviation|0.37|0.37|||
3653698|NCT02435966|3499800|B4|||Visual Analogue Scale||units on a scale|Mean|6.44|6.44|Standard Deviation|1.46|1.46|||
3653699|NCT02435966|3499801|B3|||Visual Analogue Scale||units on a scale|Mean|6.57|6.57|Standard Deviation|1.33|1.33|||
3653700|NCT02435966|3499802|B2|||Visual Analogue Scale||units on a scale|Mean|6.17|6.17|Standard Deviation|1.60|1.6|||
3653701|NCT02435966|3499803|B1|||Visual Analogue Scale||units on a scale|Mean|6.66|6.66|Standard Deviation|1.37|1.37|||
3653702|NCT02435966|3499800|B4||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3653703|NCT02435966|3499801|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3653704|NCT02435966|3499802|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3653705|NCT02435966|3499803|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3653706|NCT02435966|3499800|B4||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3653707|NCT02435966|3499801|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3653708|NCT02435966|3499802|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3653709|NCT02435966|3499803|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3653710|NCT02435966|3499800|B4|||Age||years|Mean|34.62|34.62|Standard Deviation|8.51|8.51|||
3653711|NCT02435966|3499801|B3|||Age||years|Mean|31.37|31.37|Standard Deviation|9.33|9.33|||
3653712|NCT02435966|3499802|B2|||Age||years|Mean|34.64|34.64|Standard Deviation|8.88|8.88|||
3653713|NCT02435966|3499803|B1|||Age||years|Mean|34.13|34.13|Standard Deviation|7.64|7.64|||
3653714|NCT02435836|3499813|B1||Male|Sex: Female, Male||Participants|Count of Participants|367|367.0||||||
3653715|NCT02435836|3499813|B1||Female|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
3653716|NCT02435836|3499813|B1|||Age||Years|Mean|37.5|37.5|Standard Deviation|11.0|11.0|||
3653717|NCT02435524|3499829|B5|Burkina Faso||Region of Enrollment||participants|Number|4541|4541.0||||||
3653718|NCT02435524|3499830|B4|Burkina Faso||Region of Enrollment||participants|Number|1161|1161.0||||||
3653719|NCT02435524|3499831|B3|Burkina Faso||Region of Enrollment||participants|Number|1092|1092.0||||||
3653720|NCT02435524|3499832|B2|Burkina Faso||Region of Enrollment||participants|Number|1177|1177.0||||||
3653721|NCT02435524|3499833|B1|Burkina Faso||Region of Enrollment||participants|Number|1111|1111.0||||||
3653722|NCT02435524|3499829|B5|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3653723|NCT02435524|3499829|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3653724|NCT02435524|3499830|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3653725|NCT02435524|3499831|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3653726|NCT02435524|3499832|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3653727|NCT02435524|3499833|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3653728|NCT02435524|3499829|B5||Female|Sex: Female, Male||Participants|Count of Participants|4541|4541.0||||||
3653729|NCT02435524|3499830|B4||Female|Sex: Female, Male||Participants|Count of Participants|1161|1161.0||||||
3653730|NCT02435524|3499831|B3||Female|Sex: Female, Male||Participants|Count of Participants|1092|1092.0||||||
3653731|NCT02435524|3499832|B2||Female|Sex: Female, Male||Participants|Count of Participants|1177|1177.0||||||
3653732|NCT02435524|3499833|B1||Female|Sex: Female, Male||Participants|Count of Participants|1111|1111.0||||||
3653733|NCT02435524|3499829|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3653734|NCT02435524|3499830|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3653735|NCT02435524|3499831|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3653736|NCT02435524|3499832|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3653737|NCT02435524|3499833|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3653738|NCT02435524|3499829|B5||Between 18 and 65 years|Age||Participants|Count of Participants|4357|4357.0||||||
3653739|NCT02435524|3499830|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1118|1118.0||||||
3653740|NCT02435524|3499831|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1039|1039.0||||||
3653741|NCT02435524|3499832|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1128|1128.0||||||
3653742|NCT02435524|3499833|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1072|1072.0||||||
3653743|NCT02435524|3499829|B5||<=18 years|Age||Participants|Count of Participants|184|184.0||||||
3653744|NCT02435524|3499830|B4||<=18 years|Age||Participants|Count of Participants|43|43.0||||||
3653745|NCT02435524|3499831|B3||<=18 years|Age||Participants|Count of Participants|53|53.0||||||
3653746|NCT02435524|3499832|B2||<=18 years|Age||Participants|Count of Participants|49|49.0||||||
3653747|NCT02435524|3499833|B1||<=18 years|Age||Participants|Count of Participants|39|39.0||||||
3653748|NCT02435277|3499840|B5|Prior taken metformin: Had abdominal side effects||Previous Metformin experience||Participants|Count of Participants|7|7.0||||||
3653749|NCT02435277|3499841|B4|Prior taken metformin: Had abdominal side effects||Previous Metformin experience||Participants|Count of Participants|1|1.0||||||
3653750|NCT02435277|3499842|B3|Prior taken metformin: Had abdominal side effects||Previous Metformin experience||Participants|Count of Participants|1|1.0||||||
3653751|NCT02435277|3499843|B2|Prior taken metformin: Had abdominal side effects||Previous Metformin experience||Participants|Count of Participants|4|4.0||||||
3653752|NCT02435277|3499844|B1|Prior taken metformin: Had abdominal side effects||Previous Metformin experience||Participants|Count of Participants|1|1.0||||||
3653753|NCT02435277|3499840|B5|Prior taken metformin: No Abdominal side effects||Previous Metformin experience||Participants|Count of Participants|35|35.0||||||
3653754|NCT02435277|3499841|B4|Prior taken metformin: No Abdominal side effects||Previous Metformin experience||Participants|Count of Participants|8|8.0||||||
3653755|NCT02435277|3499842|B3|Prior taken metformin: No Abdominal side effects||Previous Metformin experience||Participants|Count of Participants|7|7.0||||||
3653756|NCT02435277|3499843|B2|Prior taken metformin: No Abdominal side effects||Previous Metformin experience||Participants|Count of Participants|11|11.0||||||
3653757|NCT02435277|3499844|B1|Prior taken metformin: No Abdominal side effects||Previous Metformin experience||Participants|Count of Participants|9|9.0||||||
3653758|NCT02435277|3499840|B5|No Previous Experience||Previous Metformin experience||Participants|Count of Participants|8|8.0||||||
3653759|NCT02435277|3499841|B4|No Previous Experience||Previous Metformin experience||Participants|Count of Participants|2|2.0||||||
3653760|NCT02435277|3499842|B3|No Previous Experience||Previous Metformin experience||Participants|Count of Participants|3|3.0||||||
3653761|NCT02435277|3499843|B2|No Previous Experience||Previous Metformin experience||Participants|Count of Participants|1|1.0||||||
3653762|NCT02435277|3499844|B1|No Previous Experience||Previous Metformin experience||Participants|Count of Participants|2|2.0||||||
3653763|NCT02435277|3499840|B5|||Haemoglobin A1c (HbA1c)||%|Mean|7.79|7.79|Standard Deviation|0.661|0.661|||
3653764|NCT02435277|3499841|B4|||Haemoglobin A1c (HbA1c)||%|Mean|7.92|7.92|Standard Deviation|0.645|0.645|||
3653765|NCT02435277|3499842|B3|||Haemoglobin A1c (HbA1c)||%|Mean|7.84|7.84|Standard Deviation|0.545|0.545|||
3653766|NCT02435277|3499843|B2|||Haemoglobin A1c (HbA1c)||%|Mean|7.83|7.83|Standard Deviation|0.769|0.769|||
3653767|NCT02435277|3499844|B1|||Haemoglobin A1c (HbA1c)||%|Mean|7.56|7.56|Standard Deviation|0.644|0.644|||
3653768|NCT02435277|3499840|B5|||Fasting Plasma Glucose||mg/dL|Mean|168.2|168.2|Standard Deviation|38.00|38.0|||
3653769|NCT02435277|3499841|B4|||Fasting Plasma Glucose||mg/dL|Mean|177.1|177.1|Standard Deviation|53.67|53.67|||
3653770|NCT02435277|3499842|B3|||Fasting Plasma Glucose||mg/dL|Mean|179.2|179.2|Standard Deviation|36.04|36.04|||
3653771|NCT02435277|3499843|B2|||Fasting Plasma Glucose||mg/dL|Mean|150.5|150.5|Standard Deviation|26.78|26.78|||
3653772|NCT02435277|3499844|B1|||Fasting Plasma Glucose||mg/dL|Mean|173.5|173.5|Standard Deviation|31.13|31.13|||
3653773|NCT02435277|3499840|B5|||Body Mass Index (BMI)||(kg/m^2|Mean|31.606|31.606|Standard Deviation|5.4597|5.4597|||
3653774|NCT02435277|3499841|B4|||Body Mass Index (BMI)||(kg/m^2|Mean|32.677|32.677|Standard Deviation|5.3808|5.3808|||
3653775|NCT02435277|3499842|B3|||Body Mass Index (BMI)||(kg/m^2|Mean|28.627|28.627|Standard Deviation|4.5195|4.5195|||
3653776|NCT02435277|3499843|B2|||Body Mass Index (BMI)||(kg/m^2|Mean|31.647|31.647|Standard Deviation|6.3242|6.3242|||
3653777|NCT02435277|3499844|B1|||Body Mass Index (BMI)||(kg/m^2|Mean|33.298|33.298|Standard Deviation|4.4952|4.4952|||
3653778|NCT02435277|3499840|B5|||Weight||kg|Mean|90.782|90.782|Standard Deviation|18.8230|18.823|||
3653779|NCT02435277|3499841|B4|||Weight||kg|Mean|90.500|90.5|Standard Deviation|18.4163|18.4163|||
3653780|NCT02435277|3499842|B3|||Weight||kg|Mean|87.497|87.497|Standard Deviation|21.2259|21.2259|||
3653781|NCT02435277|3499843|B2|||Weight||kg|Mean|91.314|91.314|Standard Deviation|18.7664|18.7664|||
3653782|NCT02435277|3499844|B1|||Weight||kg|Mean|93.343|93.343|Standard Deviation|19.0179|19.0179|||
3653783|NCT02435277|3499840|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653784|NCT02435277|3499841|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653785|NCT02435277|3499842|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653786|NCT02435277|3499843|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653787|NCT02435277|3499844|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653788|NCT02435277|3499840|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653789|NCT02435277|3499841|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653790|NCT02435277|3499842|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653791|NCT02435277|3499843|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653792|NCT02435277|3499844|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653793|NCT02435277|3499840|B5||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3653794|NCT02435277|3499841|B4||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3653795|NCT02435277|3499842|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3653796|NCT02435277|3499843|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3653797|NCT02435277|3499844|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3653798|NCT02435277|3499840|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3653799|NCT02435277|3499841|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3653800|NCT02435277|3499842|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3653801|NCT02435277|3499843|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3653802|NCT02435277|3499844|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3653803|NCT02435277|3499840|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653804|NCT02435277|3499841|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653805|NCT02435277|3499842|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653806|NCT02435277|3499843|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653807|NCT02435277|3499844|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653808|NCT02435277|3499840|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653809|NCT02435277|3499841|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653810|NCT02435277|3499842|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653811|NCT02435277|3499843|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653812|NCT02435277|3499844|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653813|NCT02435277|3499840|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3653814|NCT02435277|3499841|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653815|NCT02435277|3499842|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653816|NCT02435277|3499843|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3653817|NCT02435277|3499844|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653818|NCT02435277|3499840|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653819|NCT02435277|3499841|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653820|NCT02435277|3499842|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653821|NCT02435277|3499843|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653822|NCT02435277|3499844|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653823|NCT02435277|3499840|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3653824|NCT02435277|3499841|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3653825|NCT02435277|3499842|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3653826|NCT02435277|3499843|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3653827|NCT02435277|3499844|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3653828|NCT02435277|3499840|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3653829|NCT02435277|3499841|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3653830|NCT02435277|3499842|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3653831|NCT02435277|3499843|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3653832|NCT02435277|3499844|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3653833|NCT02435277|3499840|B5||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3653834|NCT02435277|3499841|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3653835|NCT02435277|3499842|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3653836|NCT02435277|3499843|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3653837|NCT02435277|3499844|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3653838|NCT02435277|3499840|B5||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3653839|NCT02435277|3499841|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3653840|NCT02435277|3499842|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3653841|NCT02435277|3499843|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3653842|NCT02435277|3499844|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3653843|NCT02435277|3499840|B5|||Age||years|Mean|56.9|56.9|Standard Deviation|9.52|9.52|||
3653844|NCT02435277|3499841|B4|||Age||years|Mean|60.5|60.5|Standard Deviation|8.77|8.77|||
3653845|NCT02435277|3499842|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|9.01|9.01|||
3653846|NCT02435277|3499843|B2|||Age||years|Mean|56.1|56.1|Standard Deviation|8.24|8.24|||
3653847|NCT02435277|3499844|B1|||Age||years|Mean|51.8|51.8|Standard Deviation|10.81|10.81|||
3653848|NCT02435277|3499840|B5||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3653849|NCT02435277|3499841|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3653850|NCT02435277|3499842|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3653851|NCT02435277|3499843|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3653852|NCT02435277|3499844|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3653853|NCT02435277|3499840|B5||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3653854|NCT02435277|3499841|B4||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3653855|NCT02435277|3499842|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3653856|NCT02435277|3499843|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3653857|NCT02435277|3499844|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3653858|NCT02435277|3499840|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3653859|NCT02435277|3499841|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3653860|NCT02435277|3499842|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3653861|NCT02435277|3499843|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3653862|NCT02435277|3499844|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3653863|NCT02435147|3499861|B1|||Total Femur Bone Mineral Density|Total femur bone mineral density is measured in g/cm^2 and is dependent on factors such as an individual's age, height, weight, and ethnicity.|g/cm^2|Mean|0.746|0.746|Standard Deviation|0.079|0.079|||
3653864|NCT02435147|3499861|B1|||Femoral Neck Bone Mineral Density|Femoral neck bone mineral density is measured in g/cm^2 and is dependent on such factors as an individual's age, height, weight and ethnicity.|g/cm^2|Mean|0.717|0.717|Standard Deviation|0.070|0.07|||
3653865|NCT02435147|3499861|B1|||Lumbar Spine Bone Mineral Density|Lumbar bone mineral density is measured in g/cm^2 and is dependent on such factors such as an individual's age, height, weight and ethnicity.|g/cm^2|Mean|0.931|0.931|Standard Deviation|0.132|0.132|||
3653866|NCT02435147|3499861|B1|||Femur Strength Index|Femur strength index (FSI) is a measure of femoral bone density, structure and strength obtained from DXA measurements using modern software. FSI provides an index for hip strength by combining bone mineral density, femur geometry, age, height, and weight.This index is not anchored in definite values, but rather is derived from the following equation: Hip Strength Index= strength/stress where, strength=185-0.34 (age-45); Age>45 years. Stress=moment*y/CSM I+ force/CSA. Higher values indicate greater hip strength.|units on a scale|Mean|1.291|1.291|Standard Deviation|0.287|0.287|||
3653867|NCT02435147|3499861|B1|||Trabecular Bone Score|"Trabecular Bone Score (TBS) is an index for bone micro-architecture extracted from anterior-posterior spine dual-energy X-ray absorptiometry (DXA) images. TBS quantifies local variations in pixel intensities and is derived from the experimental variogram obtained from the gray levels of a DXA image. As noted in the Journal of Bone Mineral Research Volume 29, Issue 3, March 2014, pages 518-530, TBS> or = 1.350 is considered to be normal; TBS between 1.200 and 1.350 is considered to be consistent with partially degraded microarchitecture, and TBS </=1.200 defines degraded microarchitecture."|units on a scale|Mean|1.257|1.257|Standard Deviation|0.09|0.09|||
3653868|NCT02435147|3499861|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
3653869|NCT02435147|3499861|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653870|NCT02435147|3499861|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653871|NCT02435147|3499861|B1||White|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3653872|NCT02435147|3499861|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653873|NCT02435147|3499861|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653874|NCT02435147|3499861|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653875|NCT02435147|3499861|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653876|NCT02435147|3499861|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3653877|NCT02435147|3499861|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3653878|NCT02435147|3499861|B1|||Age||years|Mean|71.6|71.6|Standard Deviation|9.71|9.71|||
3653879|NCT02434939|3499866|B3|Admitted||status||participants|Number|23|23.0||||||
3653880|NCT02434939|3499867|B2|Admitted||status||participants|Number|12|12.0||||||
3653881|NCT02434939|3499868|B1|Admitted||status||participants|Number|11|11.0||||||
3653882|NCT02434939|3499866|B3|discharged||status||participants|Number|217|217.0||||||
3653883|NCT02434939|3499867|B2|discharged||status||participants|Number|108|108.0||||||
3653884|NCT02434939|3499868|B1|discharged||status||participants|Number|109|109.0||||||
3653885|NCT02434939|3499866|B3|others||site of pain||participants|Number|24|24.0||||||
3653886|NCT02434939|3499867|B2|others||site of pain||participants|Number|12|12.0||||||
3653887|NCT02434939|3499868|B1|others||site of pain||participants|Number|12|12.0||||||
3653888|NCT02434939|3499866|B3|chest||site of pain||participants|Number|53|53.0||||||
3653889|NCT02434939|3499867|B2|chest||site of pain||participants|Number|23|23.0||||||
3653890|NCT02434939|3499868|B1|chest||site of pain||participants|Number|30|30.0||||||
3653891|NCT02434939|3499866|B3|back||site of pain||participants|Number|45|45.0||||||
3653892|NCT02434939|3499867|B2|back||site of pain||participants|Number|27|27.0||||||
3653893|NCT02434939|3499868|B1|back||site of pain||participants|Number|18|18.0||||||
3653894|NCT02434939|3499866|B3|Extremity||site of pain||participants|Number|118|118.0||||||
3653895|NCT02434939|3499867|B2|Extremity||site of pain||participants|Number|58|58.0||||||
3653896|NCT02434939|3499868|B1|Extremity||site of pain||participants|Number|60|60.0||||||
3653897|NCT02434939|3499866|B3|||Hemoglobin (Hb)||g/dl|Mean|8|8.0|Standard Deviation|3.4|3.4|||
3653898|NCT02434939|3499867|B2|||Hemoglobin (Hb)||g/dl|Mean|8.3|8.3|Standard Deviation|5.3|5.3|||
3653899|NCT02434939|3499868|B1|||Hemoglobin (Hb)||g/dl|Mean|7.6|7.6|Standard Deviation|1.4|1.4|||
3653900|NCT02434939|3499866|B3|||Glasgow Coma Scale.(GCS)|GCS measures level of consciousness of a patient on a scale of 3(unresponsive even to deep stimulation) to 15 ( fully conscious and alert)|units on a scale|Mean|15|15.0|Standard Deviation|0|0.0|||
3653901|NCT02434939|3499867|B2|||Glasgow Coma Scale.(GCS)|GCS measures level of consciousness of a patient on a scale of 3(unresponsive even to deep stimulation) to 15 ( fully conscious and alert)|units on a scale|Mean|15|15.0|Standard Deviation|0|0.0|||
3653902|NCT02434939|3499868|B1|||Glasgow Coma Scale.(GCS)|GCS measures level of consciousness of a patient on a scale of 3(unresponsive even to deep stimulation) to 15 ( fully conscious and alert)|units on a scale|Mean|15|15.0|Standard Deviation|0|0.0|||
3653903|NCT02434939|3499866|B3|||respiratory rate||breaths/minute|Mean|24.2|24.2|Standard Deviation|5.8|5.8|||
3653904|NCT02434939|3499867|B2|||respiratory rate||breaths/minute|Mean|24.5|24.5|Standard Deviation|6.4|6.4|||
3653905|NCT02434939|3499868|B1|||respiratory rate||breaths/minute|Mean|23.8|23.8|Standard Deviation|5.2|5.2|||
3653906|NCT02434939|3499866|B3|||SPO2||percentage of oxygen saturation|Mean|94.3|94.3|Standard Deviation|4.1|4.1|||
3653907|NCT02434939|3499867|B2|||SPO2||percentage of oxygen saturation|Mean|94.7|94.7|Standard Deviation|3.4|3.4|||
3653908|NCT02434939|3499868|B1|||SPO2||percentage of oxygen saturation|Mean|93.9|93.9|Standard Deviation|4.8|4.8|||
3653909|NCT02434939|3499866|B3|||Heart rate||bpm|Mean|97.3|97.3|Standard Deviation|16.8|16.8|||
3653910|NCT02434939|3499867|B2|||Heart rate||bpm|Mean|98.8|98.8|Standard Deviation|17.8|17.8|||
3653911|NCT02434939|3499868|B1|||Heart rate||bpm|Mean|95.8|95.8|Standard Deviation|15.8|15.8|||
3653912|NCT02434939|3499866|B3|diastolic||blood pressure||mmHg|Mean|65|65.0|Standard Deviation|13.2|13.2|||
3653913|NCT02434939|3499867|B2|diastolic||blood pressure||mmHg|Mean|65.2|65.2|Standard Deviation|14.1|14.1|||
3653914|NCT02434939|3499868|B1|diastolic||blood pressure||mmHg|Mean|64.7|64.7|Standard Deviation|12.3|12.3|||
3653915|NCT02434939|3499866|B3|systolic||blood pressure||mmHg|Mean|114.4|114.4|Standard Deviation|14.9|14.9|||
3653916|NCT02434939|3499867|B2|systolic||blood pressure||mmHg|Mean|115.2|115.2|Standard Deviation|15.7|15.7|||
3653917|NCT02434939|3499868|B1|systolic||blood pressure||mmHg|Mean|113.7|113.7|Standard Deviation|14.0|14.0|||
3653918|NCT02434939|3499866|B3|||Temperature||oC|Mean|36.8|36.8|Standard Deviation|0.8|0.8|||
3653919|NCT02434939|3499867|B2|||Temperature||oC|Mean|36.8|36.8|Standard Deviation|0.74|0.74|||
3653920|NCT02434939|3499868|B1|||Temperature||oC|Mean|36.7|36.7|Standard Deviation|0.86|0.86|||
3653921|NCT02434939|3499866|B3|||Numerical Rating Scale (NRS) pain score|The NRS was used to measure a patient's subjective level of pain on a scale from 0 (representing no pain at all) to 10 (the worst pain imaginable)|units on a scale|Mean|9.1|9.1|Standard Deviation|1.1|1.1|||
3653922|NCT02434939|3499867|B2|||Numerical Rating Scale (NRS) pain score|The NRS was used to measure a patient's subjective level of pain on a scale from 0 (representing no pain at all) to 10 (the worst pain imaginable)|units on a scale|Mean|9.2|9.2|Standard Deviation|1.0|1.0|||
3653923|NCT02434939|3499868|B1|||Numerical Rating Scale (NRS) pain score|The NRS was used to measure a patient's subjective level of pain on a scale from 0 (representing no pain at all) to 10 (the worst pain imaginable)|units on a scale|Mean|8.9|8.9|Standard Deviation|1.2|1.2|||
3653924|NCT02434939|3499866|B3|no prior medication||Medication||participants|Number|167|167.0||||||
3653925|NCT02434939|3499867|B2|no prior medication||Medication||participants|Number|78|78.0||||||
3653926|NCT02434939|3499868|B1|no prior medication||Medication||participants|Number|89|89.0||||||
3653927|NCT02434939|3499866|B3|prior medication||Medication||participants|Number|73|73.0||||||
3653928|NCT02434939|3499867|B2|prior medication||Medication||participants|Number|42|42.0||||||
3653929|NCT02434939|3499868|B1|prior medication||Medication||participants|Number|31|31.0||||||
3653930|NCT02434939|3499866|B3|||Weight||kgs|Mean|30.4|30.4|Standard Deviation|12.1|12.1|||
3653931|NCT02434939|3499867|B2|||Weight||kgs|Mean|30.0|30.0|Standard Deviation|12.2|12.2|||
3653932|NCT02434939|3499868|B1|||Weight||kgs|Mean|30.8|30.8|Standard Deviation|11.9|11.9|||
3653933|NCT02434939|3499866|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3653934|NCT02434939|3499867|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3653935|NCT02434939|3499868|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3653936|NCT02434939|3499866|B3||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3653937|NCT02434939|3499867|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3653938|NCT02434939|3499868|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3653939|NCT02434939|3499866|B3|||Age||years|Mean|11.8|11.8|Standard Deviation|3.5|3.5|||
3653940|NCT02434939|3499867|B2|||Age||years|Mean|11.8|11.8|Standard Deviation|3.6|3.6|||
3653941|NCT02434939|3499868|B1|||Age||years|Mean|11.8|11.8|Standard Deviation|3.4|3.4|||
3653942|NCT02434523|3499881|B3|||Reflux Symptom Index (RSI) Score||severity on Likert-type scale|Mean|22|22.0|Standard Deviation|9|9.0|||
3653943|NCT02434523|3499882|B2|||Reflux Symptom Index (RSI) Score||severity on Likert-type scale|Mean|24|24.0|Standard Deviation|10|10.0|||
3653944|NCT02434523|3499883|B1|||Reflux Symptom Index (RSI) Score||severity on Likert-type scale|Mean|19|19.0|Standard Deviation|10|10.0|||
3653945|NCT02434523|3499881|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3653946|NCT02434523|3499882|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3653947|NCT02434523|3499883|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3653948|NCT02434523|3499881|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3653949|NCT02434523|3499882|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3653950|NCT02434523|3499883|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3653951|NCT02434523|3499881|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3653952|NCT02434523|3499882|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3653953|NCT02434523|3499883|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3653954|NCT02434523|3499881|B3|||Age||years|Mean|48|48.0|Standard Deviation|15|15.0|||
3653955|NCT02434523|3499882|B2|||Age||years|Mean|50|50.0|Standard Deviation|14|14.0|||
3653956|NCT02434523|3499883|B1|||Age||years|Mean|45|45.0|Standard Deviation|15|15.0|||
3653957|NCT02434523|3499881|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3653958|NCT02434523|3499882|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3653959|NCT02434523|3499883|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3653960|NCT02434523|3499881|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3653961|NCT02434523|3499882|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3653962|NCT02434523|3499883|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3653963|NCT02434523|3499881|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3653964|NCT02434523|3499882|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3653965|NCT02434523|3499883|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3653966|NCT02434497|3499896|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3653967|NCT02434497|3499896|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3653968|NCT02434497|3499896|B1|||Age||years|Mean|10.6|10.6|Standard Deviation|2.83|2.83|||
3653969|NCT02434471|3499996|B1|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3653970|NCT02434471|3499996|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653971|NCT02434471|3499996|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653972|NCT02434471|3499996|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3653973|NCT02434471|3499996|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3653974|NCT02434471|3499996|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653975|NCT02434471|3499996|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653976|NCT02434471|3499996|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653977|NCT02434471|3499996|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653978|NCT02434471|3499996|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3653979|NCT02434471|3499996|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653980|NCT02434471|3499996|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3653981|NCT02434471|3499996|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3653982|NCT02434471|3499996|B1|||Age||years|Mean|57.94|57.94|Standard Deviation|12.7|12.7|||
3653983|NCT02434146|3500003|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3653984|NCT02434146|3500003|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653985|NCT02434146|3500003|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653986|NCT02434146|3500003|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3653987|NCT02434146|3500003|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3653988|NCT02434146|3500003|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653989|NCT02434146|3500003|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653990|NCT02434146|3500003|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653991|NCT02434146|3500003|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653992|NCT02434146|3500003|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3653993|NCT02434146|3500003|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3653994|NCT02434146|3500003|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3653995|NCT02434146|3500003|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3653996|NCT02434146|3500003|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3653997|NCT02434146|3500003|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3653998|NCT02434146|3500003|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3653999|NCT02433834|3500015|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3654000|NCT02433834|3500015|B1||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3654001|NCT02433834|3500015|B1|||Age||Years|Mean|46.0|46.0|Standard Deviation|13.8|13.8|||
3654002|NCT02433496|3500073|B4|||Proportion with co-prescribed benzodiazepines||proportion of patients|Number|0.072|0.072||||||
3654003|NCT02433496|3500075|B2|||Proportion with co-prescribed benzodiazepines||proportion of patients|Number|0.055|0.055||||||
3654004|NCT02433496|3500076|B1|||Proportion with co-prescribed benzodiazepines||proportion of patients|Number|0.08|0.08||||||
3654005|NCT02433496|3500073|B4|||Proportion with MEDD >120 mg||proportion of patients|Number|0.190|0.19||||||
3654006|NCT02433496|3500075|B2|||Proportion with MEDD >120 mg||proportion of patients|Number|0.137|0.137||||||
3654007|NCT02433496|3500076|B1|||Proportion with MEDD >120 mg||proportion of patients|Number|0.215|0.215||||||
3654008|NCT02433496|3500073|B4|||Average morphine equivalent daily dose (MEDD)||milligram|Mean|72.5|72.5|Standard Deviation|16.9|16.9|||
3654009|NCT02433496|3500075|B2|||Average morphine equivalent daily dose (MEDD)||milligram|Mean|58.8|58.8|Standard Deviation|10.1|10.1|||
3654010|NCT02433496|3500076|B1|||Average morphine equivalent daily dose (MEDD)||milligram|Mean|86.3|86.3|Standard Deviation|18.7|18.7|||
3654011|NCT02433496|3500073|B4|||Proportion with treatment agreement||proportion of patients|Number|0.409|0.409||||||
3654012|NCT02433496|3500075|B2|||Proportion with treatment agreement||proportion of patients|Number|0.368|0.368||||||
3654013|NCT02433496|3500076|B1|||Proportion with treatment agreement||proportion of patients|Number|0.428|0.428||||||
3654014|NCT02433496|3500073|B4|||Proportion with urine drug screen||proportion of patients|Number|0.391|0.391||||||
3654015|NCT02433496|3500075|B2|||Proportion with urine drug screen||proportion of patients|Number|0.374|0.374||||||
3654016|NCT02433496|3500076|B1|||Proportion with urine drug screen||proportion of patients|Number|0.399|0.399||||||
3654017|NCT02433496|3500073|B4|||Proportion with mental health screen||proportion of patients|Number|0.224|0.224||||||
3654018|NCT02433496|3500075|B2|||Proportion with mental health screen||proportion of patients|Number|0.220|0.22||||||
3654019|NCT02433496|3500076|B1|||Proportion with mental health screen||proportion of patients|Number|0.226|0.226||||||
3654020|NCT02433496|3500073|B4|||Proportion of patients with consistent opioid Rx||proportion of patients|Number|0.013|0.013||||||
3654021|NCT02433496|3500075|B2|||Proportion of patients with consistent opioid Rx||proportion of patients|Number|0.014|0.014||||||
3654022|NCT02433496|3500076|B1|||Proportion of patients with consistent opioid Rx||proportion of patients|Number|0.013|0.013||||||
3654023|NCT02433496|3500073|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6287|6287.0||||||
3654024|NCT02433496|3500074|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1121|1121.0||||||
3654025|NCT02433496|3500075|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1597|1597.0||||||
3654026|NCT02433496|3500076|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3569|3569.0||||||
3654027|NCT02433496|3500073|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654028|NCT02433496|3500074|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654029|NCT02433496|3500075|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654030|NCT02433496|3500076|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654031|NCT02433496|3500073|B4||White|Race (NIH/OMB)||Participants|Count of Participants|44482|44482.0||||||
3654032|NCT02433496|3500074|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8525|8525.0||||||
3654033|NCT02433496|3500075|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11126|11126.0||||||
3654034|NCT02433496|3500076|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24831|24831.0||||||
3654035|NCT02433496|3500073|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1095|1095.0||||||
3654036|NCT02433496|3500074|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3654037|NCT02433496|3500075|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|306|306.0||||||
3654038|NCT02433496|3500076|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|720|720.0||||||
3654039|NCT02433496|3500073|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654040|NCT02433496|3500074|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654041|NCT02433496|3500075|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654042|NCT02433496|3500076|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654043|NCT02433496|3500073|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1002|1002.0||||||
3654044|NCT02433496|3500074|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3654045|NCT02433496|3500075|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|213|213.0||||||
3654046|NCT02433496|3500076|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|720|720.0||||||
3654047|NCT02433496|3500073|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|266|266.0||||||
3654048|NCT02433496|3500074|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3654049|NCT02433496|3500075|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3654050|NCT02433496|3500076|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|150|150.0||||||
3654051|NCT02433496|3500073|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654052|NCT02433496|3500074|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654053|NCT02433496|3500075|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654054|NCT02433496|3500076|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654055|NCT02433496|3500073|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51893|51893.0||||||
3654056|NCT02433496|3500074|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9587|9587.0||||||
3654057|NCT02433496|3500075|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12976|12976.0||||||
3654058|NCT02433496|3500076|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29330|29330.0||||||
3654059|NCT02433496|3500073|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1239|1239.0||||||
3654060|NCT02433496|3500074|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|246|246.0||||||
3654061|NCT02433496|3500075|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|333|333.0||||||
3654062|NCT02433496|3500076|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|660|660.0||||||
3654063|NCT02433496|3500073|B4||Male|Sex: Female, Male||Participants|Count of Participants|27888|27888.0||||||
3654064|NCT02433496|3500074|B3||Male|Sex: Female, Male||Participants|Count of Participants|5329|5329.0||||||
3654065|NCT02433496|3500075|B2||Male|Sex: Female, Male||Participants|Count of Participants|6694|6694.0||||||
3654066|NCT02433496|3500076|B1||Male|Sex: Female, Male||Participants|Count of Participants|15865|15865.0||||||
3654067|NCT02433496|3500073|B4||Female|Sex: Female, Male||Participants|Count of Participants|25244|25244.0||||||
3654068|NCT02433496|3500074|B3||Female|Sex: Female, Male||Participants|Count of Participants|4504|4504.0||||||
3654069|NCT02433496|3500075|B2||Female|Sex: Female, Male||Participants|Count of Participants|6615|6615.0||||||
3654070|NCT02433496|3500076|B1||Female|Sex: Female, Male||Participants|Count of Participants|14125|14125.0||||||
3654071|NCT02433496|3500073|B4|Age of participants|>= 18 years old|Age, Customized||Participants|Count of Participants|53132|53132.0||||||
3654072|NCT02433496|3500074|B3|Age of participants|>= 18 years old|Age, Customized||Participants|Count of Participants|9833|9833.0||||||
3654073|NCT02433496|3500075|B2|Age of participants|>= 18 years old|Age, Customized||Participants|Count of Participants|13309|13309.0||||||
3654074|NCT02433496|3500076|B1|Age of participants|>= 18 years old|Age, Customized||Participants|Count of Participants|29990|29990.0||||||
3654075|NCT02433496|3500073|B4|Age of participants|< 18 years old|Age, Customized||Participants|Count of Participants|0|0.0||||||
3654076|NCT02433496|3500074|B3|Age of participants|< 18 years old|Age, Customized||Participants|Count of Participants|0|0.0||||||
3654077|NCT02433496|3500075|B2|Age of participants|< 18 years old|Age, Customized||Participants|Count of Participants|0|0.0||||||
3654078|NCT02433496|3500076|B1|Age of participants|< 18 years old|Age, Customized||Participants|Count of Participants|0|0.0||||||
3654079|NCT02433483|3500108|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654080|NCT02433483|3500108|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654081|NCT02433483|3500108|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3654082|NCT02433483|3500108|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654083|NCT02433483|3500108|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654084|NCT02433483|3500108|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654085|NCT02433483|3500108|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654086|NCT02433483|3500108|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3654087|NCT02433483|3500108|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3654088|NCT02433483|3500108|B1|||Age||years|Mean|7.45|7.45|Full Range|||2.66|12.29|
3654089|NCT02433366|3500120|B3||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3654090|NCT02433366|3500121|B2||Male|Sex: Female, Male||Participants|Count of Participants|432|432.0||||||
3654091|NCT02433366|3500122|B1||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Information about physicians gender is not available
3654092|NCT02433366|3500120|B3||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3654093|NCT02433366|3500121|B2||Female|Sex: Female, Male||Participants|Count of Participants|370|370.0||||||
3654094|NCT02433366|3500122|B1||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Information about physicians gender is not available
3654095|NCT02433366|3500120|B3|≥ 75 years||Age, Customized||Participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3654096|NCT02433366|3500121|B2|≥ 75 years||Age, Customized||Participants|Number|322|322.0||||||
3654097|NCT02433366|3500122|B1|≥ 75 years||Age, Customized||Participants|Number|NA|||||||Information about physicians age is not available
3654098|NCT02433366|3500120|B3|<75 years||Age, Customized||Participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3654099|NCT02433366|3500121|B2|<75 years||Age, Customized||Participants|Number|480|480.0||||||
3654100|NCT02433366|3500122|B1|<75 years||Age, Customized||Participants|Number|NA|||||||Information about physicians age is not available
3654101|NCT02433340|3500131|B5||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3654102|NCT02433340|3500132|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3654103|NCT02433340|3500133|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3654104|NCT02433340|3500134|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3654105|NCT02433340|3500135|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3654106|NCT02433340|3500131|B5||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3654107|NCT02433340|3500132|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3654108|NCT02433340|3500133|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3654109|NCT02433340|3500134|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3654110|NCT02433340|3500135|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3654111|NCT02433340|3500131|B5|>= 65 years||Age, Customized||Participants|Count of Participants|38|38.0||||||
3654112|NCT02433340|3500132|B4|>= 65 years||Age, Customized||Participants|Count of Participants|9|9.0||||||
3654113|NCT02433340|3500133|B3|>= 65 years||Age, Customized||Participants|Count of Participants|10|10.0||||||
3654114|NCT02433340|3500134|B2|>= 65 years||Age, Customized||Participants|Count of Participants|8|8.0||||||
3654115|NCT02433340|3500135|B1|>= 65 years||Age, Customized||Participants|Count of Participants|11|11.0||||||
3654116|NCT02433340|3500131|B5|40 to < 65 years||Age, Customized||Participants|Count of Participants|99|99.0||||||
3654117|NCT02433340|3500132|B4|40 to < 65 years||Age, Customized||Participants|Count of Participants|26|26.0||||||
3654118|NCT02433340|3500133|B3|40 to < 65 years||Age, Customized||Participants|Count of Participants|22|22.0||||||
3654119|NCT02433340|3500134|B2|40 to < 65 years||Age, Customized||Participants|Count of Participants|24|24.0||||||
3654120|NCT02433340|3500135|B1|40 to < 65 years||Age, Customized||Participants|Count of Participants|27|27.0||||||
3654121|NCT02433340|3500131|B5|< 40 years||Age, Customized||Participants|Count of Participants|21|21.0||||||
3654122|NCT02433340|3500132|B4|< 40 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
3654123|NCT02433340|3500133|B3|< 40 years||Age, Customized||Participants|Count of Participants|7|7.0||||||
3654124|NCT02433340|3500134|B2|< 40 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
3654125|NCT02433340|3500135|B1|< 40 years||Age, Customized||Participants|Count of Participants|4|4.0||||||
3654172|NCT02432287|3501039|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3654173|NCT02432287|3501037|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3654174|NCT02432287|3501038|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3654126|NCT02432300|3501030|B1|||Trait Anxiety (State Trait Anxiety Inventory)|The STAI is a self-report measure of state and trait anxiety (20 items each). The trait anxiety subscale was the variable of interest for this study. Higher scores indicate more trait or state anxiety. Scores for each scale range from 20-80 (higher scores indicated higher anxiety). The raw scores were converted into T scores using age and gender norms provided by the STAI authors. A T score of 50 represents the mean. A difference of 10 from the mean indicates a difference of 1 standard deviation. Higher T scores still indicated higher anxiety. We reported T scores for trait anxiety.|T score|Mean|68.38|68.38|Standard Deviation|11.45|11.45|||
3654127|NCT02432300|3501030|B1|||PHQ 9 (Depression)|The PHQ-9 is a subjective measure of depression. There are 9 items describing problems associated with depression, and participants must rate how often they have been bothered by the problems in the last 2 weeks on a 0-3 scale. The scores are summed for a total depression score, ranging from 0-27, which higher scores indicating greater depression.|units on a scale|Mean|10.77|10.77|Standard Deviation|4.82|4.82|||
3654128|NCT02432300|3501030|B1|||Levels of Emotional Awareness Scale|Participants must respond how they think they would feel and how another person would feel in response to a hypothetical scenario. The more discrete emotions (e.g., bad vs sad) receive higher points, as well as blended emotions (e.g. sad and angry). There are 10 items on this measure. The minimum score for each item is 0 and the max score for each item is 5. The item scores are summed to calculate a total score. Thus, the total scores range from 0-50; 0=lowest awareness and 50=highest awareness. A computerized scoring system and parallel forms were used.|units on a scale|Mean|36.92|36.92|Standard Deviation|7.88|7.88|||
3654129|NCT02432300|3501030|B1|||Toronto Alexithymia Scale|Measures emotional awareness (difficulty identifying feelings), difficulty describing feelings, and externally oriented thinking. The full scale range is 20-100 (higher scores indicate higher alexithymia). Subscales are summed to compute a total score Scores between 52 and 60 indicate moderate alexithymia; scores 61 and higher indicate high alexithymia.|units on a scale|Mean|61.54|61.54|Standard Deviation|7.26|7.26|||
3654130|NCT02432300|3501030|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654131|NCT02432300|3501030|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654132|NCT02432300|3501030|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3654133|NCT02432300|3501030|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654134|NCT02432300|3501030|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654135|NCT02432300|3501030|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654136|NCT02432300|3501030|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654137|NCT02432300|3501030|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3654138|NCT02432300|3501030|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3654139|NCT02432300|3501030|B1|||Age||years|Mean|46.12|46.12|Standard Deviation|11.41|11.41|||
3654140|NCT02432287|3501037|B3|||Aspirin therapy||Participants|Count of Participants|5|5.0||||||
3654141|NCT02432287|3501038|B2|||Aspirin therapy||Participants|Count of Participants|3|3.0||||||
3654142|NCT02432287|3501039|B1|||Aspirin therapy||Participants|Count of Participants|2|2.0||||||
3654143|NCT02432287|3501037|B3|||Statin therapy||Participants|Count of Participants|6|6.0||||||
3654144|NCT02432287|3501038|B2|||Statin therapy||Participants|Count of Participants|3|3.0||||||
3654145|NCT02432287|3501039|B1|||Statin therapy||Participants|Count of Participants|3|3.0||||||
3654146|NCT02432287|3501037|B3|||Antihypertensive therapy||Participants|Count of Participants|11|11.0||||||
3654147|NCT02432287|3501038|B2|||Antihypertensive therapy||Participants|Count of Participants|6|6.0||||||
3654148|NCT02432287|3501039|B1|||Antihypertensive therapy||Participants|Count of Participants|5|5.0||||||
3654149|NCT02432287|3501037|B3|||2-hour glucose||mg/dL|Mean|162|162.0|Standard Deviation|21|21.0|||
3654150|NCT02432287|3501038|B2|||2-hour glucose||mg/dL|Mean|171|171.0|Standard Deviation|24|24.0|||
3654151|NCT02432287|3501039|B1|||2-hour glucose||mg/dL|Mean|153|153.0|Standard Deviation|13|13.0|||
3654152|NCT02432287|3501037|B3|||Fasting glucose||mg/dL|Mean|105|105.0|Standard Deviation|12|12.0|||
3654153|NCT02432287|3501038|B2|||Fasting glucose||mg/dL|Mean|102|102.0|Standard Deviation|10|10.0|||
3654154|NCT02432287|3501039|B1|||Fasting glucose||mg/dL|Mean|108|108.0|Standard Deviation|13|13.0|||
3654155|NCT02432287|3501037|B3|||Weight||kg|Mean|87|87.0|Standard Deviation|16|16.0|||
3654156|NCT02432287|3501038|B2|||Weight||kg|Mean|89|89.0|Standard Deviation|17|17.0|||
3654157|NCT02432287|3501039|B1|||Weight||kg|Mean|84|84.0|Standard Deviation|14|14.0|||
3654158|NCT02432287|3501037|B3|||BMI||kg/m^2|Mean|30|30.0|Standard Deviation|4.3|4.3|||
3654159|NCT02432287|3501038|B2|||BMI||kg/m^2|Mean|32|32.0|Standard Deviation|4.4|4.4|||
3654160|NCT02432287|3501039|B1|||BMI||kg/m^2|Mean|28|28.0|Standard Deviation|3.1|3.1|||
3654161|NCT02432287|3501037|B3|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3654162|NCT02432287|3501038|B2|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3654163|NCT02432287|3501039|B1|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3654164|NCT02432287|3501037|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654165|NCT02432287|3501038|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654166|NCT02432287|3501039|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654167|NCT02432287|3501037|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654168|NCT02432287|3501038|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654169|NCT02432287|3501039|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654170|NCT02432287|3501037|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3654171|NCT02432287|3501038|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3654175|NCT02432287|3501039|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3654176|NCT02432287|3501037|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654177|NCT02432287|3501038|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654178|NCT02432287|3501039|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654179|NCT02432287|3501037|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654180|NCT02432287|3501038|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654181|NCT02432287|3501039|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654182|NCT02432287|3501037|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654183|NCT02432287|3501038|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654184|NCT02432287|3501039|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654185|NCT02432287|3501037|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3654186|NCT02432287|3501038|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3654187|NCT02432287|3501039|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3654188|NCT02432287|3501037|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3654189|NCT02432287|3501038|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3654190|NCT02432287|3501039|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3654191|NCT02432287|3501037|B3|||Age||years|Mean|71|71.0|Standard Deviation|6.4|6.4|||
3654192|NCT02432287|3501038|B2|||Age||years|Mean|74|74.0|Standard Deviation|5.4|5.4|||
3654193|NCT02432287|3501039|B1|||Age||years|Mean|69|69.0|Standard Deviation|6.7|6.7|||
3654194|NCT02432105|3501048|B4||Male|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
3654195|NCT02432105|3501049|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3654196|NCT02432105|3501050|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3654197|NCT02432105|3501051|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3654198|NCT02432105|3501048|B4||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3654199|NCT02432105|3501049|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3654200|NCT02432105|3501050|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3654201|NCT02432105|3501051|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3654202|NCT02432105|3501048|B4|||Age||years|Mean|2.2|2.2|Standard Deviation|1.78|1.78|||
3654203|NCT02432105|3501049|B3|||Age||years|Mean|2.2|2.2|Standard Deviation|1.92|1.92|||
3654204|NCT02432105|3501050|B2|||Age||years|Mean|2.1|2.1|Standard Deviation|1.59|1.59|||
3654205|NCT02432105|3501051|B1|||Age||years|Mean|2.2|2.2|Standard Deviation|1.82|1.82|||
3654206|NCT02432040|3501068|B3|||DLQI score|Dermatology Life Quality Index (DLQI) is a 10-item self-administered questionnaire designed to evaluate the quality of life of patients with skin diseases. Items are scored on a 4-point scale, with higher scores indicating a greater impairment in the quality of life. The total score is interpreted as follows: 0-1=no effect on patient’s life, 2-5=mild effect, 6-10=moderate effect, 11-20=very large effect, and 21-30=extremely large effect.|units on a scale|Mean|10.29|10.29|Standard Deviation|5.96|5.96|||
3654207|NCT02432040|3501069|B2|||DLQI score|Dermatology Life Quality Index (DLQI) is a 10-item self-administered questionnaire designed to evaluate the quality of life of patients with skin diseases. Items are scored on a 4-point scale, with higher scores indicating a greater impairment in the quality of life. The total score is interpreted as follows: 0-1=no effect on patient’s life, 2-5=mild effect, 6-10=moderate effect, 11-20=very large effect, and 21-30=extremely large effect.|units on a scale|Mean|9.07|9.07|Standard Deviation|5.84|5.84|||
3654208|NCT02432040|3501070|B1|||DLQI score|Dermatology Life Quality Index (DLQI) is a 10-item self-administered questionnaire designed to evaluate the quality of life of patients with skin diseases. Items are scored on a 4-point scale, with higher scores indicating a greater impairment in the quality of life. The total score is interpreted as follows: 0-1=no effect on patient’s life, 2-5=mild effect, 6-10=moderate effect, 11-20=very large effect, and 21-30=extremely large effect.|units on a scale|Mean|11.50|11.5|Standard Deviation|6.04|6.04|||
3654209|NCT02432040|3501068|B3|||High-sensitivity C-reactive protein (hsCRP)||nmol/L|Mean|51.54|51.54|Standard Deviation|89.31|89.31|||
3654210|NCT02432040|3501069|B2|||High-sensitivity C-reactive protein (hsCRP)||nmol/L|Mean|39.62|39.62|Standard Deviation|44.67|44.67|||
3654211|NCT02432040|3501070|B1|||High-sensitivity C-reactive protein (hsCRP)||nmol/L|Mean|63.46|63.46|Standard Deviation|119.43|119.43|||
3654212|NCT02432040|3501068|B3|||HDL-cholesterol||mg/dL|Mean|46.34|46.34|Standard Deviation|12.67|12.67|||
3654213|NCT02432040|3501069|B2|||HDL-cholesterol||mg/dL|Mean|46.56|46.56|Standard Deviation|13.13|13.13|||
3654214|NCT02432040|3501070|B1|||HDL-cholesterol||mg/dL|Mean|46.13|46.13|Standard Deviation|12.68|12.68|||
3654215|NCT02432040|3501068|B3|||LDL-cholesterol||mg/dL|Mean|127.69|127.69|Standard Deviation|28.78|28.78|||
3654216|NCT02432040|3501069|B2|||LDL-cholesterol||mg/dL|Mean|129.49|129.49|Standard Deviation|29.11|29.11|||
3654217|NCT02432040|3501070|B1|||LDL-cholesterol||mg/dL|Mean|125.88|125.88|Standard Deviation|29.42|29.42|||
3654218|NCT02432040|3501068|B3|||Triglycerides||mg/dL|Mean|119.50|119.5|Standard Deviation|45.29|45.29|||
3654219|NCT02432040|3501069|B2|||Triglycerides||mg/dL|Mean|112.27|112.27|Standard Deviation|45.37|45.37|||
3654220|NCT02432040|3501070|B1|||Triglycerides||mg/dL|Mean|126.73|126.73|Standard Deviation|45.71|45.71|||
3654221|NCT02432040|3501068|B3|||Total cholesterol||mg/dL|Mean|195.37|195.37|Standard Deviation|35.11|35.11|||
3654222|NCT02432040|3501069|B2|||Total cholesterol||mg/dL|Mean|197.73|197.73|Standard Deviation|36.52|36.52|||
3654223|NCT02432040|3501070|B1|||Total cholesterol||mg/dL|Mean|193.02|193.02|Standard Deviation|34.85|34.85|||
3654224|NCT02432040|3501068|B3|||PASI score|Psoriasis Area and Severity Index involves grading psoriatic plaques based on erythema (E), infiltration (I), desquamation (D). Severity is graded from 0-4 for each criteria (0 – none, 1 – slight, 2 – moderate, 3 – severe, and 4 – very severe). The body is divided into 4 regions, head, upper extremities, trunk, and lower extremities, and for each region, the surface area involvement is graded on a 0-6 scale (0 – 0% involvement, 1 - <10%, 2 – 10-<30%, 3 – 30-<50%, 4 – 50-<70%, 5 – 70-<90%, 6 – 90-100%).The highest potential PASI score is 72, with higher PASI scores indicating worse psoriasis.|units on a scale|Mean|5.56|5.56|Standard Deviation|2.61|2.61|||
3654225|NCT02432040|3501069|B2|||PASI score|Psoriasis Area and Severity Index involves grading psoriatic plaques based on erythema (E), infiltration (I), desquamation (D). Severity is graded from 0-4 for each criteria (0 – none, 1 – slight, 2 – moderate, 3 – severe, and 4 – very severe). The body is divided into 4 regions, head, upper extremities, trunk, and lower extremities, and for each region, the surface area involvement is graded on a 0-6 scale (0 – 0% involvement, 1 - <10%, 2 – 10-<30%, 3 – 30-<50%, 4 – 50-<70%, 5 – 70-<90%, 6 – 90-100%).The highest potential PASI score is 72, with higher PASI scores indicating worse psoriasis.|units on a scale|Mean|5.63|5.63|Standard Deviation|2.52|2.52|||
3654226|NCT02432040|3501070|B1|||PASI score|Psoriasis Area and Severity Index involves grading psoriatic plaques based on erythema (E), infiltration (I), desquamation (D). Severity is graded from 0-4 for each criteria (0 – none, 1 – slight, 2 – moderate, 3 – severe, and 4 – very severe). The body is divided into 4 regions, head, upper extremities, trunk, and lower extremities, and for each region, the surface area involvement is graded on a 0-6 scale (0 – 0% involvement, 1 - <10%, 2 – 10-<30%, 3 – 30-<50%, 4 – 50-<70%, 5 – 70-<90%, 6 – 90-100%).The highest potential PASI score is 72, with higher PASI scores indicating worse psoriasis.|units on a scale|Mean|5.49|5.49|Standard Deviation|2.78|2.78|||
3654227|NCT02432040|3501068|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3654228|NCT02432040|3501069|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3654229|NCT02432040|3501070|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3654230|NCT02432040|3501068|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3654231|NCT02432040|3501069|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3654232|NCT02432040|3501070|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3654233|NCT02432040|3501068|B3|||Age||Years|Mean|41|41.0|Standard Deviation|11.48|11.48|||
3654234|NCT02432040|3501069|B2|||Age||Years|Mean|40.71|40.71|Standard Deviation|12.00|12.0|||
3654235|NCT02432040|3501070|B1|||Age||Years|Mean|41.29|41.29|Standard Deviation|11.38|11.38|||
3654236|NCT02431754|3501091|B3|No||Current Smoking Habit||participants|Number|137|137.0||||||
3654237|NCT02431754|3501092|B2|No||Current Smoking Habit||participants|Number|66|66.0||||||
3654238|NCT02431754|3501093|B1|No||Current Smoking Habit||participants|Number|71|71.0||||||
3654239|NCT02431754|3501091|B3|Yes||Current Smoking Habit||participants|Number|34|34.0||||||
3654240|NCT02431754|3501092|B2|Yes||Current Smoking Habit||participants|Number|20|20.0||||||
3654241|NCT02431754|3501093|B1|Yes||Current Smoking Habit||participants|Number|14|14.0||||||
3654242|NCT02431754|3501091|B3|Japan||Region of Enrollment||Participants|Count of Participants|171|171.0||||||
3654243|NCT02431754|3501092|B2|Japan||Region of Enrollment||Participants|Count of Participants|86|86.0||||||
3654244|NCT02431754|3501093|B1|Japan||Region of Enrollment||Participants|Count of Participants|85|85.0||||||
3654245|NCT02431754|3501091|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654246|NCT02431754|3501092|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654247|NCT02431754|3501093|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654248|NCT02431754|3501091|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654249|NCT02431754|3501092|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654250|NCT02431754|3501093|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654251|NCT02431754|3501091|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654252|NCT02431754|3501092|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654253|NCT02431754|3501093|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654254|NCT02431754|3501091|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654255|NCT02431754|3501092|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654256|NCT02431754|3501093|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654257|NCT02431754|3501091|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654258|NCT02431754|3501092|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654259|NCT02431754|3501093|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654260|NCT02431754|3501091|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|171|171.0||||||
3654261|NCT02431754|3501092|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
3654262|NCT02431754|3501093|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3654263|NCT02431754|3501091|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654264|NCT02431754|3501092|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654265|NCT02431754|3501093|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654266|NCT02431754|3501091|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654267|NCT02431754|3501092|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654268|NCT02431754|3501093|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654269|NCT02431754|3501091|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|171|171.0||||||
3654270|NCT02431754|3501092|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
3654271|NCT02431754|3501093|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3654272|NCT02431754|3501091|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654273|NCT02431754|3501092|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654274|NCT02431754|3501093|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654275|NCT02431754|3501091|B3||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3654276|NCT02431754|3501092|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3654277|NCT02431754|3501093|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3654278|NCT02431754|3501091|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3654279|NCT02431754|3501092|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3654280|NCT02431754|3501093|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3654281|NCT02431754|3501091|B3|||Age||years|Mean|61.7|61.7|Standard Deviation|6.0|6.0|||
3654282|NCT02431754|3501092|B2|||Age||years|Mean|62.0|62.0|Standard Deviation|5.8|5.8|||
3654283|NCT02431754|3501093|B1|||Age||years|Mean|61.4|61.4|Standard Deviation|6.2|6.2|||
3654284|NCT02431741|3501112|B1|||Presence of bleeding from tumor||participants|Number|14|14.0||||||
3654285|NCT02431741|3501112|B1|||Presence of malodour||participants|Number|14|14.0||||||
3654286|NCT02431741|3501112|B1|||Exudate handling|chronic wound exudate handling|participants|Number|14|14.0||||||
3654287|NCT02431741|3501112|B1|||Pain during dressing changes||participants|Number|14|14.0||||||
3654288|NCT02431741|3501112|B1|||Infections in the wound at baseline|inclusion criteria is exuding malignant wound in need for antimicrobial treatment|participants|Number|14|14.0||||||
3654289|NCT02431741|3501112|B1|Czech Republic||Region of Enrollment||participants|Number|14|14.0||||||
3654290|NCT02431741|3501112|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3654291|NCT02431741|3501112|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3654292|NCT02431741|3501112|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3654293|NCT02431741|3501112|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3654294|NCT02431741|3501112|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3654295|NCT02431598|3501116|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
3654296|NCT02431598|3501116|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3654297|NCT02431598|3501116|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3654298|NCT02431598|3501116|B1|||Age||years|Mean|32|32.0|Standard Deviation|7.5|7.5|||
3654299|NCT02431468|3501145|B4|||Mini Mental State Exam version 2 (MMSE-2) baseline score 10-15|For this study, subjects were stratified at randomization by Mini Mental State Exam version 2 (MMSE-2) scores 4-9 (severe cognitive impairment) and 10-15 (moderately severe impairment)|Participants|Count of Participants|84|84.0||||||
3654300|NCT02431468|3501146|B3|||Mini Mental State Exam version 2 (MMSE-2) baseline score 10-15|For this study, subjects were stratified at randomization by Mini Mental State Exam version 2 (MMSE-2) scores 4-9 (severe cognitive impairment) and 10-15 (moderately severe impairment)|Participants|Count of Participants|29|29.0||||||
3654301|NCT02431468|3501147|B2|||Mini Mental State Exam version 2 (MMSE-2) baseline score 10-15|For this study, subjects were stratified at randomization by Mini Mental State Exam version 2 (MMSE-2) scores 4-9 (severe cognitive impairment) and 10-15 (moderately severe impairment)|Participants|Count of Participants|27|27.0||||||
3654302|NCT02431468|3501148|B1|||Mini Mental State Exam version 2 (MMSE-2) baseline score 10-15|For this study, subjects were stratified at randomization by Mini Mental State Exam version 2 (MMSE-2) scores 4-9 (severe cognitive impairment) and 10-15 (moderately severe impairment)|Participants|Count of Participants|28|28.0||||||
3654303|NCT02431468|3501145|B4|||Mini Mental State Exam-version 2 (MMSE-2) baseline scores 4-9|ion, language, and praxis on a scale of 0-30. Lower scores indicate greater cognitive impairment. For this study, subjects were stratified at randomization based on Mini Mental State Exam version 2 (MMSE-2) scores 4-9 (severe cognitive impairment) and 10-15 (moderately severe impairment).|Participants|Count of Participants|57|57.0||||||
3654304|NCT02431468|3501146|B3|||Mini Mental State Exam-version 2 (MMSE-2) baseline scores 4-9|ion, language, and praxis on a scale of 0-30. Lower scores indicate greater cognitive impairment. For this study, subjects were stratified at randomization based on Mini Mental State Exam version 2 (MMSE-2) scores 4-9 (severe cognitive impairment) and 10-15 (moderately severe impairment).|Participants|Count of Participants|19|19.0||||||
3654305|NCT02431468|3501147|B2|||Mini Mental State Exam-version 2 (MMSE-2) baseline scores 4-9|ion, language, and praxis on a scale of 0-30. Lower scores indicate greater cognitive impairment. For this study, subjects were stratified at randomization based on Mini Mental State Exam version 2 (MMSE-2) scores 4-9 (severe cognitive impairment) and 10-15 (moderately severe impairment).|Participants|Count of Participants|20|20.0||||||
3654306|NCT02431468|3501148|B1|||Mini Mental State Exam-version 2 (MMSE-2) baseline scores 4-9|ion, language, and praxis on a scale of 0-30. Lower scores indicate greater cognitive impairment. For this study, subjects were stratified at randomization based on Mini Mental State Exam version 2 (MMSE-2) scores 4-9 (severe cognitive impairment) and 10-15 (moderately severe impairment).|Participants|Count of Participants|18|18.0||||||
3654307|NCT02431468|3501145|B4|United States||Region of Enrollment||participants|Number|141|141.0||||||
3654308|NCT02431468|3501146|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
3654309|NCT02431468|3501147|B2|United States||Region of Enrollment||participants|Number|47|47.0||||||
3654310|NCT02431468|3501148|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
3654311|NCT02431468|3501145|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3654312|NCT02431468|3501146|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3654313|NCT02431468|3501147|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3654314|NCT02431468|3501148|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3654315|NCT02431468|3501145|B4|African American||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3654316|NCT02431468|3501146|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3654317|NCT02431468|3501147|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3654318|NCT02431468|3501148|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3654319|NCT02431468|3501145|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|133|133.0||||||
3654320|NCT02431468|3501146|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|45|45.0||||||
3654321|NCT02431468|3501147|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
3654322|NCT02431468|3501148|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3654323|NCT02431468|3501145|B4||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3654324|NCT02431468|3501146|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3654325|NCT02431468|3501147|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3654326|NCT02431468|3501148|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3654327|NCT02431468|3501145|B4||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3654328|NCT02431468|3501146|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3654329|NCT02431468|3501147|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3654330|NCT02431468|3501148|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3654331|NCT02431468|3501145|B4|||Age||years|Mean|71.7|71.7|Standard Deviation|7.94|7.94|||
3654332|NCT02431468|3501146|B3|||Age||years|Mean|73.5|73.5|Standard Deviation|7.68|7.68|||
3654333|NCT02431468|3501147|B2|||Age||years|Mean|70.2|70.2|Standard Deviation|7.53|7.53|||
3654334|NCT02431468|3501148|B1|||Age||years|Mean|71.2|71.2|Standard Deviation|8.40|8.4|||
3654335|NCT02431455|3501170|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3654336|NCT02431455|3501171|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3654337|NCT02431455|3501172|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3654338|NCT02431455|3501170|B3||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3654339|NCT02431455|3501171|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3654340|NCT02431455|3501172|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3654341|NCT02431455|3501170|B3|||Age||years|Mean|45.6|45.6|Standard Deviation|11.7|11.7|||
3654342|NCT02431455|3501171|B2|||Age||years|Mean|45.9|45.9|Standard Deviation|11.1|11.1|||
3654343|NCT02431455|3501172|B1|||Age||years|Mean|45.2|45.2|Standard Deviation|12.4|12.4|||
3654344|NCT02431299|3501185|B3|||Brief COPE Inventory Maladaptive Coping Subscale|This is a consumer rated assessment of adaptive coping skills. This is derived from the 28 item, full scale. The scale uses a 1-4 Likert scale, indicating the frequency of using different coping strategies. There are 14 subscales, each calculated by summing 2 items. The range on each subscale is 2 - 8. The 14 subscales are further combined into 2 larger scales - maladaptive and adaptive coping. Maladaptive coping is calculated by averaging the responses from 6 out of the 14 subscales. Higher scores indicate worse outcomes (i.e. higher use of maladaptive coping strategies).|units on a scale|Mean|4.46|4.46|Standard Deviation|1.2|1.2|||
3654345|NCT02431299|3501186|B2|||Brief COPE Inventory Maladaptive Coping Subscale|This is a consumer rated assessment of adaptive coping skills. This is derived from the 28 item, full scale. The scale uses a 1-4 Likert scale, indicating the frequency of using different coping strategies. There are 14 subscales, each calculated by summing 2 items. The range on each subscale is 2 - 8. The 14 subscales are further combined into 2 larger scales - maladaptive and adaptive coping. Maladaptive coping is calculated by averaging the responses from 6 out of the 14 subscales. Higher scores indicate worse outcomes (i.e. higher use of maladaptive coping strategies).|units on a scale|Mean|NA||Standard Deviation|NA||||Data not collected for clinicians
3654346|NCT02431299|3501187|B1|||Brief COPE Inventory Maladaptive Coping Subscale|This is a consumer rated assessment of adaptive coping skills. This is derived from the 28 item, full scale. The scale uses a 1-4 Likert scale, indicating the frequency of using different coping strategies. There are 14 subscales, each calculated by summing 2 items. The range on each subscale is 2 - 8. The 14 subscales are further combined into 2 larger scales - maladaptive and adaptive coping. Maladaptive coping is calculated by averaging the responses from 6 out of the 14 subscales. Higher scores indicate worse outcomes (i.e. higher use of maladaptive coping strategies).|units on a scale|Mean|4.46|4.46|Standard Deviation|1.2|1.2|||
3654347|NCT02431299|3501185|B3|||Brief COPE Inventory Adaptive Coping Subscale|This is a consumer rated assessment of adaptive coping skills. This is derived from the 28 item, full scale. The scale uses a 1-4 Likert scale, indicating the frequency of using different coping strategies. There are 14 subscales, each calculated by summing 2 items. The range on each subscale is 2 - 8. The 14 subscales are further combined into 2 larger scales - maladaptive and adaptive coping. Adaptive coping is calculated by averaging the responses from 8 out of the 14 subscales. Higher scores indicate better outcomes (i.e. higher use of adaptive coping strategies).|units on a scale|Mean|5.64|5.64|Standard Deviation|1.4|1.4|||
3654348|NCT02431299|3501186|B2|||Brief COPE Inventory Adaptive Coping Subscale|This is a consumer rated assessment of adaptive coping skills. This is derived from the 28 item, full scale. The scale uses a 1-4 Likert scale, indicating the frequency of using different coping strategies. There are 14 subscales, each calculated by summing 2 items. The range on each subscale is 2 - 8. The 14 subscales are further combined into 2 larger scales - maladaptive and adaptive coping. Adaptive coping is calculated by averaging the responses from 8 out of the 14 subscales. Higher scores indicate better outcomes (i.e. higher use of adaptive coping strategies).|units on a scale|Mean|NA||Standard Deviation|NA||||Data not collected for clinicians
3654349|NCT02431299|3501187|B1|||Brief COPE Inventory Adaptive Coping Subscale|This is a consumer rated assessment of adaptive coping skills. This is derived from the 28 item, full scale. The scale uses a 1-4 Likert scale, indicating the frequency of using different coping strategies. There are 14 subscales, each calculated by summing 2 items. The range on each subscale is 2 - 8. The 14 subscales are further combined into 2 larger scales - maladaptive and adaptive coping. Adaptive coping is calculated by averaging the responses from 8 out of the 14 subscales. Higher scores indicate better outcomes (i.e. higher use of adaptive coping strategies).|units on a scale|Mean|5.64|5.64|Standard Deviation|1.4|1.4|||
3654350|NCT02431299|3501185|B3|||UNCOPE|"This measure is a consumer rated substance abuse screener consisting of 6 yes or no questions. A response of yes is assigned a value of 1. The total number of yes responses are summed and a score of greater than 4 indicates likelihood of substance abuse. Higher scores mean worse outcomes for this scale (i.e. the higher the score, the greater the likelihood of substance abuse issues)."|units on a scale|Mean|1.88|1.88|Standard Deviation|.13|0.13|||
3654351|NCT02431299|3501186|B2|||UNCOPE|"This measure is a consumer rated substance abuse screener consisting of 6 yes or no questions. A response of yes is assigned a value of 1. The total number of yes responses are summed and a score of greater than 4 indicates likelihood of substance abuse. Higher scores mean worse outcomes for this scale (i.e. the higher the score, the greater the likelihood of substance abuse issues)."|units on a scale|Mean|NA||Standard Deviation|NA||||Data not collected for clinicians
3654352|NCT02431299|3501187|B1|||UNCOPE|"This measure is a consumer rated substance abuse screener consisting of 6 yes or no questions. A response of yes is assigned a value of 1. The total number of yes responses are summed and a score of greater than 4 indicates likelihood of substance abuse. Higher scores mean worse outcomes for this scale (i.e. the higher the score, the greater the likelihood of substance abuse issues)."|units on a scale|Mean|1.88|1.88|Standard Deviation|.13|0.13|||
3654353|NCT02431299|3501185|B3|||Medication Adherence Rating Scale|"This is a consumer rated scale assessing medication adherence. This is a 10 item scale with each question rated as yes or no. A yes is assigned a value of 1. The scale ranges from 0 (no yes responses) to 10 (all yes responses endorsed). The total number of yes responses is totaled to create a summary score. The mean score is calculated based on averaging the summary scores for the entire consumer sample. Higher scores mean better outcomes for medication adherence."|units on a scale|Mean|2.45|2.45|Standard Deviation|.12|0.12|||
3654354|NCT02431299|3501186|B2|||Medication Adherence Rating Scale|"This is a consumer rated scale assessing medication adherence. This is a 10 item scale with each question rated as yes or no. A yes is assigned a value of 1. The scale ranges from 0 (no yes responses) to 10 (all yes responses endorsed). The total number of yes responses is totaled to create a summary score. The mean score is calculated based on averaging the summary scores for the entire consumer sample. Higher scores mean better outcomes for medication adherence."|units on a scale|Mean|NA||Standard Deviation|NA||||Data not collected for clinicians
3654355|NCT02431299|3501187|B1|||Medication Adherence Rating Scale|"This is a consumer rated scale assessing medication adherence. This is a 10 item scale with each question rated as yes or no. A yes is assigned a value of 1. The scale ranges from 0 (no yes responses) to 10 (all yes responses endorsed). The total number of yes responses is totaled to create a summary score. The mean score is calculated based on averaging the summary scores for the entire consumer sample. Higher scores mean better outcomes for medication adherence."|units on a scale|Mean|2.45|2.45|Standard Deviation|.12|0.12|||
3654356|NCT02431299|3501185|B3|||Adult State Hope Scale|"This is a consumer rated measure that assesses the level of goal related hope a consumer possesses. This version is a 6 item measure, with each item rated on a 4 point scale (range 1-4, with 1 being Definitely False and 4 being Definitely True). A summary score is calculated by summing all 6 items. Higher scores represent better outcomes (i.e. higher goal related hope). These summary scores were then averages to calculate a mean score for our sample."|units on a scale|Mean|18.8|18.8|Standard Deviation|3.7|3.7|||
3654357|NCT02431299|3501186|B2|||Adult State Hope Scale|"This is a consumer rated measure that assesses the level of goal related hope a consumer possesses. This version is a 6 item measure, with each item rated on a 4 point scale (range 1-4, with 1 being Definitely False and 4 being Definitely True). A summary score is calculated by summing all 6 items. Higher scores represent better outcomes (i.e. higher goal related hope). These summary scores were then averages to calculate a mean score for our sample."|units on a scale|Mean|NA||Standard Deviation|NA||||Data not collected for clinicians
3654358|NCT02431299|3501187|B1|||Adult State Hope Scale|"This is a consumer rated measure that assesses the level of goal related hope a consumer possesses. This version is a 6 item measure, with each item rated on a 4 point scale (range 1-4, with 1 being Definitely False and 4 being Definitely True). A summary score is calculated by summing all 6 items. Higher scores represent better outcomes (i.e. higher goal related hope). These summary scores were then averages to calculate a mean score for our sample."|units on a scale|Mean|18.8|18.8|Standard Deviation|3.7|3.7|||
3654359|NCT02431299|3501185|B3|||Multidimensional Scale of Perceived Social Support|This scale is a consumer rated assessment of perceived social support systems. There are 12 items each rated on a 7 point Likert scale (ranging from 1-7). A mean score is calculated from all 12 items. Higher scores represent better outcomes (i.e. higher levels of perceived social support).|units on a scale|Mean|4.94|4.94|Standard Deviation|1.7|1.7|||
3654360|NCT02431299|3501186|B2|||Multidimensional Scale of Perceived Social Support|This scale is a consumer rated assessment of perceived social support systems. There are 12 items each rated on a 7 point Likert scale (ranging from 1-7). A mean score is calculated from all 12 items. Higher scores represent better outcomes (i.e. higher levels of perceived social support).|units on a scale|Mean|NA||Standard Deviation|NA||||Data not collected for clinicians
3654361|NCT02431299|3501187|B1|||Multidimensional Scale of Perceived Social Support|This scale is a consumer rated assessment of perceived social support systems. There are 12 items each rated on a 7 point Likert scale (ranging from 1-7). A mean score is calculated from all 12 items. Higher scores represent better outcomes (i.e. higher levels of perceived social support).|units on a scale|Mean|4.94|4.94|Standard Deviation|1.7|1.7|||
3654362|NCT02431299|3501185|B3|||Working Alliance Inventory Short Form|This is a consumer rated scale indicated working alliance between consumer and clinician. The scale has 12 items, rated on a 7 point Likert style scale (ranging from 1-7). The total score provided a mean score of all 12 items. Better working alliance is indicated by a higher score.|units on a scale|Mean|5.65|5.65|Standard Deviation|1.0|1.0|||
3654363|NCT02431299|3501186|B2|||Working Alliance Inventory Short Form|This is a consumer rated scale indicated working alliance between consumer and clinician. The scale has 12 items, rated on a 7 point Likert style scale (ranging from 1-7). The total score provided a mean score of all 12 items. Better working alliance is indicated by a higher score.|units on a scale|Mean|NA||Standard Deviation|NA||||Data not collected for clinicians
3654364|NCT02431299|3501187|B1|||Working Alliance Inventory Short Form|This is a consumer rated scale indicated working alliance between consumer and clinician. The scale has 12 items, rated on a 7 point Likert style scale (ranging from 1-7). The total score provided a mean score of all 12 items. Better working alliance is indicated by a higher score.|units on a scale|Mean|5.65|5.65|Standard Deviation|1.0|1.0|||
3654365|NCT02431299|3501185|B3|||Illness Management and Recovery Scale|This measure is designed to assess consumer-rated illness self management skills. This scale is based on a 15 items, each rated on a 5 point Likert scale, ranging from 1 to 5. Higher numbers of this scale represent better outcomes. A mean score of all 15 items is provided as the primary outcome score for this scale.|units on a scale|Mean|3.55|3.55|Standard Deviation|.6|0.6|||
3654366|NCT02431299|3501186|B2|||Illness Management and Recovery Scale|This measure is designed to assess consumer-rated illness self management skills. This scale is based on a 15 items, each rated on a 5 point Likert scale, ranging from 1 to 5. Higher numbers of this scale represent better outcomes. A mean score of all 15 items is provided as the primary outcome score for this scale.|units on a scale|Mean|NA||Standard Deviation|NA||||Data not collected for clinicians
3654367|NCT02431299|3501187|B1|||Illness Management and Recovery Scale|This measure is designed to assess consumer-rated illness self management skills. This scale is based on a 15 items, each rated on a 5 point Likert scale, ranging from 1 to 5. Higher numbers of this scale represent better outcomes. A mean score of all 15 items is provided as the primary outcome score for this scale.|units on a scale|Mean|3.55|3.55|Standard Deviation|.6|0.6|||
3654368|NCT02431299|3501185|B3|United States||Region of Enrollment|Every attempt was made to collect this information from all participants, however this data was missing in some instances. Data was collected via self-report, and thus if the question was omitted by the participant the data was not available for analyses.|participants|Number|298|298.0||||||
3654369|NCT02431299|3501186|B2|United States||Region of Enrollment|Every attempt was made to collect this information from all participants, however this data was missing in some instances. Data was collected via self-report, and thus if the question was omitted by the participant the data was not available for analyses.|participants|Number|62|62.0||||||
3654370|NCT02431299|3501187|B1|United States||Region of Enrollment|Every attempt was made to collect this information from all participants, however this data was missing in some instances. Data was collected via self-report, and thus if the question was omitted by the participant the data was not available for analyses.|participants|Number|236|236.0||||||
3654371|NCT02431299|3501185|B3|Male||Gender|Every attempt was made to collect this information from all participants, however this data was missing in some instances. Data was collected via self-report, and thus if the question was omitted by the participant the data was not available for analyses.|participants|Number|149|149.0||||||
3654372|NCT02431299|3501186|B2|Male||Gender|Every attempt was made to collect this information from all participants, however this data was missing in some instances. Data was collected via self-report, and thus if the question was omitted by the participant the data was not available for analyses.|participants|Number|21|21.0||||||
3654373|NCT02431299|3501187|B1|Male||Gender|Every attempt was made to collect this information from all participants, however this data was missing in some instances. Data was collected via self-report, and thus if the question was omitted by the participant the data was not available for analyses.|participants|Number|128|128.0||||||
3654374|NCT02431299|3501185|B3|Female||Gender|Every attempt was made to collect this information from all participants, however this data was missing in some instances. Data was collected via self-report, and thus if the question was omitted by the participant the data was not available for analyses.|participants|Number|131|131.0||||||
3654375|NCT02431299|3501186|B2|Female||Gender|Every attempt was made to collect this information from all participants, however this data was missing in some instances. Data was collected via self-report, and thus if the question was omitted by the participant the data was not available for analyses.|participants|Number|41|41.0||||||
3654376|NCT02431299|3501187|B1|Female||Gender|Every attempt was made to collect this information from all participants, however this data was missing in some instances. Data was collected via self-report, and thus if the question was omitted by the participant the data was not available for analyses.|participants|Number|90|90.0||||||
3654377|NCT02431299|3501185|B3||>=65 years|Age|Every attempt was made to collect this information from all participants, however this data was missing in some instances. Data was collected via self-report, and thus if the question was omitted by the participant the data was not available for analyses.|Participants|Count of Participants|6|6.0||||||
3654378|NCT02431299|3501186|B2||>=65 years|Age|Every attempt was made to collect this information from all participants, however this data was missing in some instances. Data was collected via self-report, and thus if the question was omitted by the participant the data was not available for analyses.|Participants|Count of Participants|1|1.0||||||
3654379|NCT02431299|3501187|B1||>=65 years|Age|Every attempt was made to collect this information from all participants, however this data was missing in some instances. Data was collected via self-report, and thus if the question was omitted by the participant the data was not available for analyses.|Participants|Count of Participants|5|5.0||||||
3654380|NCT02431299|3501185|B3||Between 18 and 65 years|Age|Every attempt was made to collect this information from all participants, however this data was missing in some instances. Data was collected via self-report, and thus if the question was omitted by the participant the data was not available for analyses.|Participants|Count of Participants|292|292.0||||||
3654381|NCT02431299|3501186|B2||Between 18 and 65 years|Age|Every attempt was made to collect this information from all participants, however this data was missing in some instances. Data was collected via self-report, and thus if the question was omitted by the participant the data was not available for analyses.|Participants|Count of Participants|61|61.0||||||
3654382|NCT02431299|3501187|B1||Between 18 and 65 years|Age|Every attempt was made to collect this information from all participants, however this data was missing in some instances. Data was collected via self-report, and thus if the question was omitted by the participant the data was not available for analyses.|Participants|Count of Participants|231|231.0||||||
3654383|NCT02431299|3501185|B3||<=18 years|Age|Every attempt was made to collect this information from all participants, however this data was missing in some instances. Data was collected via self-report, and thus if the question was omitted by the participant the data was not available for analyses.|Participants|Count of Participants|0|0.0||||||
3654384|NCT02431299|3501186|B2||<=18 years|Age|Every attempt was made to collect this information from all participants, however this data was missing in some instances. Data was collected via self-report, and thus if the question was omitted by the participant the data was not available for analyses.|Participants|Count of Participants|0|0.0||||||
3654385|NCT02431299|3501187|B1||<=18 years|Age|Every attempt was made to collect this information from all participants, however this data was missing in some instances. Data was collected via self-report, and thus if the question was omitted by the participant the data was not available for analyses.|Participants|Count of Participants|0|0.0||||||
3654386|NCT02431247|3501201|B3|United States||Region of Enrollment||Participants|Count of Participants|133|133.0||||||
3654387|NCT02431247|3501202|B2|United States||Region of Enrollment||Participants|Count of Participants|67|67.0||||||
3654388|NCT02431247|3501203|B1|United States||Region of Enrollment||Participants|Count of Participants|66|66.0||||||
3654389|NCT02431247|3501201|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3654390|NCT02431247|3501202|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3654391|NCT02431247|3501203|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3654392|NCT02431247|3501201|B3|Spain||Region of Enrollment||Participants|Count of Participants|137|137.0||||||
3654393|NCT02431247|3501202|B2|Spain||Region of Enrollment||Participants|Count of Participants|55|55.0||||||
3654394|NCT02431247|3501203|B1|Spain||Region of Enrollment||Participants|Count of Participants|82|82.0||||||
3654395|NCT02431247|3501201|B3|Russia||Region of Enrollment||Participants|Count of Participants|86|86.0||||||
3654396|NCT02431247|3501202|B2|Russia||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
3654397|NCT02431247|3501203|B1|Russia||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3654398|NCT02431247|3501201|B3|Poland||Region of Enrollment||Participants|Count of Participants|78|78.0||||||
3654399|NCT02431247|3501202|B2|Poland||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
3654400|NCT02431247|3501203|B1|Poland||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3654401|NCT02431247|3501201|B3|Italy||Region of Enrollment||Participants|Count of Participants|81|81.0||||||
3654402|NCT02431247|3501202|B2|Italy||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3654403|NCT02431247|3501203|B1|Italy||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3654404|NCT02431247|3501201|B3|Germany||Region of Enrollment||Participants|Count of Participants|88|88.0||||||
3654405|NCT02431247|3501202|B2|Germany||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3654406|NCT02431247|3501203|B1|Germany||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
3654407|NCT02431247|3501201|B3|France||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3654408|NCT02431247|3501202|B2|France||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3654409|NCT02431247|3501203|B1|France||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3654410|NCT02431247|3501201|B3|Canada||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3654411|NCT02431247|3501202|B2|Canada||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3654412|NCT02431247|3501203|B1|Canada||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3654413|NCT02431247|3501201|B3|Belgium||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3654414|NCT02431247|3501202|B2|Belgium||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3654415|NCT02431247|3501203|B1|Belgium||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3654416|NCT02431247|3501201|B3|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|518|518.0||||||
3654417|NCT02431247|3501202|B2|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|260|260.0||||||
3654418|NCT02431247|3501203|B1|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|258|258.0||||||
3654419|NCT02431247|3501201|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
3654420|NCT02431247|3501202|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3654421|NCT02431247|3501203|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3654422|NCT02431247|3501201|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|79|79.0||||||
3654423|NCT02431247|3501202|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
3654424|NCT02431247|3501203|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
3654425|NCT02431247|3501201|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|80|80.0||||||
3654426|NCT02431247|3501202|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3654427|NCT02431247|3501203|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3654428|NCT02431247|3501201|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3654429|NCT02431247|3501202|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3654430|NCT02431247|3501203|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3654431|NCT02431247|3501201|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3654432|NCT02431247|3501202|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3654433|NCT02431247|3501203|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3654434|NCT02431247|3501201|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3654435|NCT02431247|3501202|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3654436|NCT02431247|3501203|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3654437|NCT02431247|3501201|B3||White|Race (NIH/OMB)||Participants|Count of Participants|600|600.0||||||
3654438|NCT02431247|3501202|B2||White|Race (NIH/OMB)||Participants|Count of Participants|300|300.0||||||
3654439|NCT02431247|3501203|B1||White|Race (NIH/OMB)||Participants|Count of Participants|300|300.0||||||
3654440|NCT02431247|3501201|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3654441|NCT02431247|3501202|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3654442|NCT02431247|3501203|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3654443|NCT02431247|3501201|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654444|NCT02431247|3501202|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654445|NCT02431247|3501203|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654446|NCT02431247|3501201|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3654447|NCT02431247|3501202|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3654448|NCT02431247|3501203|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3654449|NCT02431247|3501201|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3654450|NCT02431247|3501202|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3654451|NCT02431247|3501203|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3654452|NCT02431247|3501201|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3654453|NCT02431247|3501202|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3654454|NCT02431247|3501203|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3654455|NCT02431247|3501201|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|626|626.0||||||
3654456|NCT02431247|3501202|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|316|316.0||||||
3654457|NCT02431247|3501203|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|310|310.0||||||
3654458|NCT02431247|3501201|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3654459|NCT02431247|3501202|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3654460|NCT02431247|3501203|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3654461|NCT02431247|3501201|B3||Male|Sex: Female, Male||Participants|Count of Participants|640|640.0||||||
3654462|NCT02431247|3501202|B2||Male|Sex: Female, Male||Participants|Count of Participants|322|322.0||||||
3654463|NCT02431247|3501203|B1||Male|Sex: Female, Male||Participants|Count of Participants|318|318.0||||||
3654464|NCT02431247|3501201|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3654465|NCT02431247|3501202|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3654466|NCT02431247|3501203|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3654467|NCT02431247|3501201|B3|||Age||years|Mean|35.3|35.3|Standard Deviation|10.08|10.08|||
3654468|NCT02431247|3501202|B2|||Age||years|Mean|35.1|35.1|Standard Deviation|9.99|9.99|||
3654469|NCT02431247|3501203|B1|||Age||years|Mean|35.6|35.6|Standard Deviation|10.17|10.17|||
3654470|NCT02430870|3501258|B9|||Duration of Type 2 Diabetes Mellitus (T2DM)|Applies only to Part 1 only, participants with T2DM.|years|Mean|10.5|10.5|Standard Deviation|4.99|4.99|||
3654471|NCT02430870|3501259|B8|||Duration of Type 2 Diabetes Mellitus (T2DM)|Applies only to Part 1 only, participants with T2DM.|years|Mean|NA||Standard Deviation|NA||||Not Applicable: Healthy Participant
3654472|NCT02430870|3501260|B7|||Duration of Type 2 Diabetes Mellitus (T2DM)|Applies only to Part 1 only, participants with T2DM.|years|Mean|NA||Standard Deviation|NA||||Not Applicable: Healthy Participant
3654473|NCT02430870|3501261|B6|||Duration of Type 2 Diabetes Mellitus (T2DM)|Applies only to Part 1 only, participants with T2DM.|years|Mean|NA||Standard Deviation|NA||||Not Applicable: Healthy Participant
3654474|NCT02430870|3501262|B5|||Duration of Type 2 Diabetes Mellitus (T2DM)|Applies only to Part 1 only, participants with T2DM.|years|Mean|NA||Standard Deviation|NA||||Not Applicable: Healthy Participant
3654475|NCT02430870|3501263|B4|||Duration of Type 2 Diabetes Mellitus (T2DM)|Applies only to Part 1 only, participants with T2DM.|years|Mean|NA||Standard Deviation|NA||||Not Applicable: Healthy Participant
3654476|NCT02430870|3501264|B3|||Duration of Type 2 Diabetes Mellitus (T2DM)|Applies only to Part 1 only, participants with T2DM.|years|Mean|9.0|9.0|Standard Deviation|3.37|3.37|||
3654477|NCT02430870|3501265|B2|||Duration of Type 2 Diabetes Mellitus (T2DM)|Applies only to Part 1 only, participants with T2DM.|years|Mean|9.3|9.3|Standard Deviation|5.16|5.16|||
3654478|NCT02430870|3501266|B1|||Duration of Type 2 Diabetes Mellitus (T2DM)|Applies only to Part 1 only, participants with T2DM.|years|Mean|12.7|12.7|Standard Deviation|5.68|5.68|||
3654479|NCT02430870|3501258|B9|||Metformin Dose|Applies only to Part 1 only, participants with T2DM.|mg|Mean|1512.5|1512.5|Standard Deviation|615.49|615.49|||
3654480|NCT02430870|3501259|B8|||Metformin Dose|Applies only to Part 1 only, participants with T2DM.|mg|Mean|NA||Standard Deviation|NA||||Not Applicable: Healthy Participant
3654481|NCT02430870|3501260|B7|||Metformin Dose|Applies only to Part 1 only, participants with T2DM.|mg|Mean|NA||Standard Deviation|NA||||Not Applicable: Healthy Participant
3654482|NCT02430870|3501261|B6|||Metformin Dose|Applies only to Part 1 only, participants with T2DM.|mg|Mean|NA||Standard Deviation|NA||||Not Applicable: Healthy Participant
3654676|NCT02430532|3501347|B1|20 to 29 years||Age, Customized||participants|Number|0|0.0||||||
3654483|NCT02430870|3501262|B5|||Metformin Dose|Applies only to Part 1 only, participants with T2DM.|mg|Mean|NA||Standard Deviation|NA||||Not Applicable: Healthy Participant
3654484|NCT02430870|3501263|B4|||Metformin Dose|Applies only to Part 1 only, participants with T2DM.|mg|Mean|NA||Standard Deviation|NA||||Not Applicable: Healthy Participant
3654485|NCT02430870|3501264|B3|||Metformin Dose|Applies only to Part 1 only, participants with T2DM.|mg|Mean|1812.5|1812.5|Standard Deviation|645.98|645.98|||
3654486|NCT02430870|3501265|B2|||Metformin Dose|Applies only to Part 1 only, participants with T2DM.|mg|Mean|1400.0|1400.0|Standard Deviation|709.93|709.93|||
3654487|NCT02430870|3501266|B1|||Metformin Dose|Applies only to Part 1 only, participants with T2DM.|mg|Mean|1425.0|1425.0|Standard Deviation|534.56|534.56|||
3654488|NCT02430870|3501258|B9|||Body Mass Index (BMI)|Data presented for study Part 2 only. BMI data for study Part 1 is reported in a separate baseline measure.|kg/m^2|Mean|22.16|22.16|Standard Deviation|2.072|2.072|||
3654489|NCT02430870|3501259|B8|||Body Mass Index (BMI)|Data presented for study Part 2 only. BMI data for study Part 1 is reported in a separate baseline measure.|kg/m^2|Mean|21.34|21.34|Standard Deviation|2.215|2.215|||
3654490|NCT02430870|3501260|B7|||Body Mass Index (BMI)|Data presented for study Part 2 only. BMI data for study Part 1 is reported in a separate baseline measure.|kg/m^2|Mean|23.13|23.13|Standard Deviation|2.234|2.234|||
3654491|NCT02430870|3501261|B6|||Body Mass Index (BMI)|Data presented for study Part 2 only. BMI data for study Part 1 is reported in a separate baseline measure.|kg/m^2|Mean|21.33|21.33|Standard Deviation|1.983|1.983|||
3654492|NCT02430870|3501262|B5|||Body Mass Index (BMI)|Data presented for study Part 2 only. BMI data for study Part 1 is reported in a separate baseline measure.|kg/m^2|Mean|22.70|22.7|Standard Deviation|1.531|1.531|||
3654493|NCT02430870|3501263|B4|||Body Mass Index (BMI)|Data presented for study Part 2 only. BMI data for study Part 1 is reported in a separate baseline measure.|kg/m^2|Mean|22.58|22.58|Standard Deviation|2.207|2.207|||
3654494|NCT02430870|3501264|B3|||Body Mass Index (BMI)|Data presented for study Part 2 only. BMI data for study Part 1 is reported in a separate baseline measure.|kg/m^2|Mean|NA||Standard Deviation|NA||||Reported in a separate baseline measure.
3654495|NCT02430870|3501265|B2|||Body Mass Index (BMI)|Data presented for study Part 2 only. BMI data for study Part 1 is reported in a separate baseline measure.|kg/m^2|Mean|NA||Standard Deviation|NA||||Reported in a separate baseline measure.
3654496|NCT02430870|3501266|B1|||Body Mass Index (BMI)|Data presented for study Part 2 only. BMI data for study Part 1 is reported in a separate baseline measure.|kg/m^2|Mean|NA||Standard Deviation|NA||||Reported in a separate baseline measure.
3654497|NCT02430870|3501258|B9|||Body Mass Index (BMI)|Data presented for study Part 1 only. BMI data for study Part 2 is reported in a separate baseline measure.|kg/m^2|Mean|30.09|30.09|Standard Deviation|3.587|3.587|||
3654498|NCT02430870|3501259|B8|||Body Mass Index (BMI)|Data presented for study Part 1 only. BMI data for study Part 2 is reported in a separate baseline measure.|kg/m^2|Mean|NA||Standard Deviation|NA||||Reported in a separate baseline measure.
3654499|NCT02430870|3501260|B7|||Body Mass Index (BMI)|Data presented for study Part 1 only. BMI data for study Part 2 is reported in a separate baseline measure.|kg/m^2|Mean|NA||Standard Deviation|NA||||Reported in a separate baseline measure.
3654500|NCT02430870|3501261|B6|||Body Mass Index (BMI)|Data presented for study Part 1 only. BMI data for study Part 2 is reported in a separate baseline measure.|kg/m^2|Mean|NA||Standard Deviation|NA||||Reported in a separate baseline measure.
3654501|NCT02430870|3501262|B5|||Body Mass Index (BMI)|Data presented for study Part 1 only. BMI data for study Part 2 is reported in a separate baseline measure.|kg/m^2|Mean|NA||Standard Deviation|NA||||Reported in a separate baseline measure.
3654502|NCT02430870|3501263|B4|||Body Mass Index (BMI)|Data presented for study Part 1 only. BMI data for study Part 2 is reported in a separate baseline measure.|kg/m^2|Mean|NA||Standard Deviation|NA||||Reported in a separate baseline measure.
3654503|NCT02430870|3501264|B3|||Body Mass Index (BMI)|Data presented for study Part 1 only. BMI data for study Part 2 is reported in a separate baseline measure.|kg/m^2|Mean|30.00|30.0|Standard Deviation|4.146|4.146|||
3654504|NCT02430870|3501265|B2|||Body Mass Index (BMI)|Data presented for study Part 1 only. BMI data for study Part 2 is reported in a separate baseline measure.|kg/m^2|Mean|29.12|29.12|Standard Deviation|4.599|4.599|||
3654505|NCT02430870|3501266|B1|||Body Mass Index (BMI)|Data presented for study Part 1 only. BMI data for study Part 2 is reported in a separate baseline measure.|kg/m^2|Mean|31.12|31.12|Standard Deviation|2.176|2.176|||
3654506|NCT02430870|3501258|B9|||Weight|Data presented for study Part 2 only. Weight data for study Part 1 is reported in a separate baseline measure.|kg|Mean|62.45|62.45|Standard Deviation|10.248|10.248|||
3654507|NCT02430870|3501259|B8|||Weight|Data presented for study Part 2 only. Weight data for study Part 1 is reported in a separate baseline measure.|kg|Mean|58.40|58.4|Standard Deviation|10.206|10.206|||
3654508|NCT02430870|3501260|B7|||Weight|Data presented for study Part 2 only. Weight data for study Part 1 is reported in a separate baseline measure.|kg|Mean|64.47|64.47|Standard Deviation|11.585|11.585|||
3654509|NCT02430870|3501261|B6|||Weight|Data presented for study Part 2 only. Weight data for study Part 1 is reported in a separate baseline measure.|kg|Mean|57.82|57.82|Standard Deviation|6.421|6.421|||
3654510|NCT02430870|3501262|B5|||Weight|Data presented for study Part 2 only. Weight data for study Part 1 is reported in a separate baseline measure.|kg|Mean|65.40|65.4|Standard Deviation|12.236|12.236|||
3654511|NCT02430870|3501263|B4|||Weight|Data presented for study Part 2 only. Weight data for study Part 1 is reported in a separate baseline measure.|kg|Mean|67.52|67.52|Standard Deviation|9.055|9.055|||
3654512|NCT02430870|3501264|B3|||Weight|Data presented for study Part 2 only. Weight data for study Part 1 is reported in a separate baseline measure.|kg|Mean|NA||Standard Deviation|NA||||Reported in a separate baseline measure.
3654513|NCT02430870|3501265|B2|||Weight|Data presented for study Part 2 only. Weight data for study Part 1 is reported in a separate baseline measure.|kg|Mean|NA||Standard Deviation|NA||||Reported in a separate baseline measure.
3654514|NCT02430870|3501266|B1|||Weight|Data presented for study Part 2 only. Weight data for study Part 1 is reported in a separate baseline measure.|kg|Mean|NA||Standard Deviation|NA||||Reported in a separate baseline measure.
3654515|NCT02430870|3501258|B9|||Weight|Data presented for study Part 1 only. Weight data for study Part 2 is reported in a separate baseline measure.|kg|Mean|83.09|83.09|Standard Deviation|14.895|14.895|||
3654516|NCT02430870|3501259|B8|||Weight|Data presented for study Part 1 only. Weight data for study Part 2 is reported in a separate baseline measure.|kg|Mean|NA||Standard Deviation|NA||||Reported in a separate baseline measure.
3654517|NCT02430870|3501260|B7|||Weight|Data presented for study Part 1 only. Weight data for study Part 2 is reported in a separate baseline measure.|kg|Mean|NA||Standard Deviation|NA||||Reported in a separate baseline measure.
3654518|NCT02430870|3501261|B6|||Weight|Data presented for study Part 1 only. Weight data for study Part 2 is reported in a separate baseline measure.|kg|Mean|NA||Standard Deviation|NA||||Reported in a separate baseline measure.
3654519|NCT02430870|3501262|B5|||Weight|Data presented for study Part 1 only. Weight data for study Part 2 is reported in a separate baseline measure.|kg|Mean|NA||Standard Deviation|NA||||Reported in a separate baseline measure.
3654520|NCT02430870|3501263|B4|||Weight|Data presented for study Part 1 only. Weight data for study Part 2 is reported in a separate baseline measure.|kg|Mean|NA||Standard Deviation|NA||||Reported in a separate baseline measure.
3654521|NCT02430870|3501264|B3|||Weight|Data presented for study Part 1 only. Weight data for study Part 2 is reported in a separate baseline measure.|kg|Mean|73.38|73.38|Standard Deviation|17.068|17.068|||
3654522|NCT02430870|3501265|B2|||Weight|Data presented for study Part 1 only. Weight data for study Part 2 is reported in a separate baseline measure.|kg|Mean|81.22|81.22|Standard Deviation|17.359|17.359|||
3654523|NCT02430870|3501266|B1|||Weight|Data presented for study Part 1 only. Weight data for study Part 2 is reported in a separate baseline measure.|kg|Mean|91.45|91.45|Standard Deviation|5.082|5.082|||
3654524|NCT02430870|3501258|B9|||Height|Data presented for study Part 2 only. Height data for study Part 1 is reported in a separate baseline measure.|cm|Mean|167.3|167.3|Standard Deviation|8.66|8.66|||
3654525|NCT02430870|3501259|B8|||Height|Data presented for study Part 2 only. Height data for study Part 1 is reported in a separate baseline measure.|cm|Mean|164.9|164.9|Standard Deviation|8.43|8.43|||
3654526|NCT02430870|3501260|B7|||Height|Data presented for study Part 2 only. Height data for study Part 1 is reported in a separate baseline measure.|cm|Mean|166.3|166.3|Standard Deviation|8.19|8.19|||
3654527|NCT02430870|3501261|B6|||Height|Data presented for study Part 2 only. Height data for study Part 1 is reported in a separate baseline measure.|cm|Mean|164.5|164.5|Standard Deviation|6.57|6.57|||
3654528|NCT02430870|3501262|B5|||Height|Data presented for study Part 2 only. Height data for study Part 1 is reported in a separate baseline measure.|cm|Mean|169.0|169.0|Standard Deviation|13.02|13.02|||
3654529|NCT02430870|3501263|B4|||Height|Data presented for study Part 2 only. Height data for study Part 1 is reported in a separate baseline measure.|cm|Mean|172.7|172.7|Standard Deviation|5.32|5.32|||
3654530|NCT02430870|3501264|B3|||Height|Data presented for study Part 2 only. Height data for study Part 1 is reported in a separate baseline measure.|cm|Mean|NA||Standard Deviation|NA||||Reported in a separate baseline measure.
3654531|NCT02430870|3501265|B2|||Height|Data presented for study Part 2 only. Height data for study Part 1 is reported in a separate baseline measure.|cm|Mean|NA||Standard Deviation|NA||||Reported in a separate baseline measure.
3654532|NCT02430870|3501266|B1|||Height|Data presented for study Part 2 only. Height data for study Part 1 is reported in a separate baseline measure.|cm|Mean|NA||Standard Deviation|NA||||Reported in a separate baseline measure.
3654533|NCT02430870|3501258|B9|||Height|Data presented for study Part 1 only. Height data for study Part 2 is reported in a separate baseline measure.|cm|Mean|165.6|165.6|Standard Deviation|9.75|9.75|||
3654534|NCT02430870|3501259|B8|||Height|Data presented for study Part 1 only. Height data for study Part 2 is reported in a separate baseline measure.|cm|Mean|NA||Standard Deviation|NA||||Reported in a separate baseline measure.
3654535|NCT02430870|3501260|B7|||Height|Data presented for study Part 1 only. Height data for study Part 2 is reported in a separate baseline measure.|cm|Mean|NA||Standard Deviation|NA||||Reported in a separate baseline measure.
3654536|NCT02430870|3501261|B6|||Height|Data presented for study Part 1 only. Height data for study Part 2 is reported in a separate baseline measure.|cm|Mean|NA||Standard Deviation|NA||||Reported in a separate baseline measure.
3654537|NCT02430870|3501262|B5|||Height|Data presented for study Part 1 only. Height data for study Part 2 is reported in a separate baseline measure.|cm|Mean|NA||Standard Deviation|NA||||Reported in a separate baseline measure.
3654538|NCT02430870|3501263|B4|||Height|Data presented for study Part 1 only. Height data for study Part 2 is reported in a separate baseline measure.|cm|Mean|NA||Standard Deviation|NA||||Reported in a separate baseline measure.
3654539|NCT02430870|3501264|B3|||Height|Data presented for study Part 1 only. Height data for study Part 2 is reported in a separate baseline measure.|cm|Mean|155.5|155.5|Standard Deviation|8.70|8.7|||
3654540|NCT02430870|3501265|B2|||Height|Data presented for study Part 1 only. Height data for study Part 2 is reported in a separate baseline measure.|cm|Mean|166.3|166.3|Standard Deviation|9.95|9.95|||
3654541|NCT02430870|3501266|B1|||Height|Data presented for study Part 1 only. Height data for study Part 2 is reported in a separate baseline measure.|cm|Mean|171.5|171.5|Standard Deviation|4.09|4.09|||
3654542|NCT02430870|3501258|B9|United States||Region of Enrollment|Data presented for study Part 2 only. Region of enrollment data for study Part 1 is reported in a separate baseline measure.|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3654543|NCT02430870|3501259|B8|United States||Region of Enrollment|Data presented for study Part 2 only. Region of enrollment data for study Part 1 is reported in a separate baseline measure.|participants|Number|8|8.0||9.82|9.82|||
3654544|NCT02430870|3501260|B7|United States||Region of Enrollment|Data presented for study Part 2 only. Region of enrollment data for study Part 1 is reported in a separate baseline measure.|participants|Number|6|6.0||4.10|4.1|||
3654545|NCT02430870|3501261|B6|United States||Region of Enrollment|Data presented for study Part 2 only. Region of enrollment data for study Part 1 is reported in a separate baseline measure.|participants|Number|6|6.0||12.48|12.48|||
3654546|NCT02430870|3501262|B5|United States||Region of Enrollment|Data presented for study Part 2 only. Region of enrollment data for study Part 1 is reported in a separate baseline measure.|participants|Number|6|6.0||10.45|10.45|||
3654547|NCT02430870|3501263|B4|United States||Region of Enrollment|Data presented for study Part 2 only. Region of enrollment data for study Part 1 is reported in a separate baseline measure.|participants|Number|6|6.0||9.63|9.63|||
3654548|NCT02430870|3501264|B3|United States||Region of Enrollment|Data presented for study Part 2 only. Region of enrollment data for study Part 1 is reported in a separate baseline measure.|participants|Number|NA|||NA||||Reported in a separate baseline measure.
3654549|NCT02430870|3501265|B2|United States||Region of Enrollment|Data presented for study Part 2 only. Region of enrollment data for study Part 1 is reported in a separate baseline measure.|participants|Number|NA|||NA||||Reported in a separate baseline measure.
3654550|NCT02430870|3501266|B1|United States||Region of Enrollment|Data presented for study Part 2 only. Region of enrollment data for study Part 1 is reported in a separate baseline measure.|participants|Number|NA|||NA||||Reported in a separate baseline measure.
3654551|NCT02430870|3501258|B9|United States||Region of Enrollment|Data presented for study Part 1 only. Region of enrollment data for study Part 2 is reported in a separate baseline measure.|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3654552|NCT02430870|3501259|B8|United States||Region of Enrollment|Data presented for study Part 1 only. Region of enrollment data for study Part 2 is reported in a separate baseline measure.|participants|Number|NA|||||||Reported in a separate baseline measure.
3654553|NCT02430870|3501260|B7|United States||Region of Enrollment|Data presented for study Part 1 only. Region of enrollment data for study Part 2 is reported in a separate baseline measure.|participants|Number|NA|||||||Reported in a separate baseline measure.
3654554|NCT02430870|3501261|B6|United States||Region of Enrollment|Data presented for study Part 1 only. Region of enrollment data for study Part 2 is reported in a separate baseline measure.|participants|Number|NA|||||||Reported in a separate baseline measure.
3654555|NCT02430870|3501262|B5|United States||Region of Enrollment|Data presented for study Part 1 only. Region of enrollment data for study Part 2 is reported in a separate baseline measure.|participants|Number|NA|||||||Reported in a separate baseline measure.
3654556|NCT02430870|3501263|B4|United States||Region of Enrollment|Data presented for study Part 1 only. Region of enrollment data for study Part 2 is reported in a separate baseline measure.|participants|Number|NA|||||||Reported in a separate baseline measure.
3654557|NCT02430870|3501264|B3|United States||Region of Enrollment|Data presented for study Part 1 only. Region of enrollment data for study Part 2 is reported in a separate baseline measure.|participants|Number|4|4.0||||||
3654558|NCT02430870|3501265|B2|United States||Region of Enrollment|Data presented for study Part 1 only. Region of enrollment data for study Part 2 is reported in a separate baseline measure.|participants|Number|6|6.0||||||
3654559|NCT02430870|3501266|B1|United States||Region of Enrollment|Data presented for study Part 1 only. Region of enrollment data for study Part 2 is reported in a separate baseline measure.|participants|Number|6|6.0||||||
3654560|NCT02430870|3501258|B9|Asian||Race/Ethnicity, Customized|Data presented for study Part 2 only. Race data for study Part 1 is reported in a separate baseline measure.|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3654561|NCT02430870|3501259|B8|Asian||Race/Ethnicity, Customized|Data presented for study Part 2 only. Race data for study Part 1 is reported in a separate baseline measure.|participants|Number|8|8.0||NA||||
3654562|NCT02430870|3501260|B7|Asian||Race/Ethnicity, Customized|Data presented for study Part 2 only. Race data for study Part 1 is reported in a separate baseline measure.|participants|Number|6|6.0||NA||||
3654563|NCT02430870|3501261|B6|Asian||Race/Ethnicity, Customized|Data presented for study Part 2 only. Race data for study Part 1 is reported in a separate baseline measure.|participants|Number|6|6.0||NA||||
3654564|NCT02430870|3501262|B5|Asian||Race/Ethnicity, Customized|Data presented for study Part 2 only. Race data for study Part 1 is reported in a separate baseline measure.|participants|Number|6|6.0||NA||||
3654565|NCT02430870|3501263|B4|Asian||Race/Ethnicity, Customized|Data presented for study Part 2 only. Race data for study Part 1 is reported in a separate baseline measure.|participants|Number|6|6.0||NA||||
3654566|NCT02430870|3501264|B3|Asian||Race/Ethnicity, Customized|Data presented for study Part 2 only. Race data for study Part 1 is reported in a separate baseline measure.|participants|Number|NA|||645.98|645.98|||Reported in a separate baseline measure.
3654567|NCT02430870|3501265|B2|Asian||Race/Ethnicity, Customized|Data presented for study Part 2 only. Race data for study Part 1 is reported in a separate baseline measure.|participants|Number|NA|||709.93|709.93|||Reported in a separate baseline measure.
3654568|NCT02430870|3501266|B1|Asian||Race/Ethnicity, Customized|Data presented for study Part 2 only. Race data for study Part 1 is reported in a separate baseline measure.|participants|Number|NA|||534.56|534.56|||Reported in a separate baseline measure.
3654569|NCT02430870|3501258|B9|White||Race/Ethnicity, Customized|Data presented for study Part 1 only. Race data for study Part 2 is reported in a separate baseline measure.|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3654570|NCT02430870|3501259|B8|White||Race/Ethnicity, Customized|Data presented for study Part 1 only. Race data for study Part 2 is reported in a separate baseline measure.|participants|Number|NA|||NA||19.0|24.8|Reported in a separate baseline measure.
3654571|NCT02430870|3501260|B7|White||Race/Ethnicity, Customized|Data presented for study Part 1 only. Race data for study Part 2 is reported in a separate baseline measure.|participants|Number|NA|||NA||20.2|26.3|Reported in a separate baseline measure.
3654572|NCT02430870|3501261|B6|White||Race/Ethnicity, Customized|Data presented for study Part 1 only. Race data for study Part 2 is reported in a separate baseline measure.|participants|Number|NA|||NA||18.7|23.8|Reported in a separate baseline measure.
3654573|NCT02430870|3501262|B5|White||Race/Ethnicity, Customized|Data presented for study Part 1 only. Race data for study Part 2 is reported in a separate baseline measure.|participants|Number|NA|||NA||20.3|25.1|Reported in a separate baseline measure.
3654574|NCT02430870|3501263|B4|White||Race/Ethnicity, Customized|Data presented for study Part 1 only. Race data for study Part 2 is reported in a separate baseline measure.|participants|Number|NA|||NA||19.5|24.9|Reported in a separate baseline measure.
3654575|NCT02430870|3501264|B3|White||Race/Ethnicity, Customized|Data presented for study Part 1 only. Race data for study Part 2 is reported in a separate baseline measure.|participants|Number|4|4.0||4.146|4.146|24.3|33.7|
3654576|NCT02430870|3501265|B2|White||Race/Ethnicity, Customized|Data presented for study Part 1 only. Race data for study Part 2 is reported in a separate baseline measure.|participants|Number|6|6.0||4.599|4.599|22.9|34.4|
3654677|NCT02430532|3501345|B3|< 20 years||Age, Customized||participants|Number|0|0.0||||||
3654577|NCT02430870|3501266|B1|White||Race/Ethnicity, Customized|Data presented for study Part 1 only. Race data for study Part 2 is reported in a separate baseline measure.|participants|Number|6|6.0||2.176|2.176|27.2|33.9|
3654578|NCT02430870|3501258|B9|Non-Hispanic and Latino||Race/Ethnicity, Customized|Data presented for study Part 2 only. Ethnicity data for study Part 1 is reported in a separate baseline measure.|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3654579|NCT02430870|3501259|B8|Non-Hispanic and Latino||Race/Ethnicity, Customized|Data presented for study Part 2 only. Ethnicity data for study Part 1 is reported in a separate baseline measure.|participants|Number|8|8.0||NA||46.8|77.7|
3654580|NCT02430870|3501260|B7|Non-Hispanic and Latino||Race/Ethnicity, Customized|Data presented for study Part 2 only. Ethnicity data for study Part 1 is reported in a separate baseline measure.|participants|Number|6|6.0||NA||52.4|81.3|
3654581|NCT02430870|3501261|B6|Non-Hispanic and Latino||Race/Ethnicity, Customized|Data presented for study Part 2 only. Ethnicity data for study Part 1 is reported in a separate baseline measure.|participants|Number|6|6.0||NA||47.9|65.2|
3654582|NCT02430870|3501262|B5|Non-Hispanic and Latino||Race/Ethnicity, Customized|Data presented for study Part 2 only. Ethnicity data for study Part 1 is reported in a separate baseline measure.|participants|Number|6|6.0||NA||49.4|77.7|
3654583|NCT02430870|3501263|B4|Non-Hispanic and Latino||Race/Ethnicity, Customized|Data presented for study Part 2 only. Ethnicity data for study Part 1 is reported in a separate baseline measure.|participants|Number|6|6.0||NA||55.0|77.5|
3654584|NCT02430870|3501264|B3|Non-Hispanic and Latino||Race/Ethnicity, Customized|Data presented for study Part 2 only. Ethnicity data for study Part 1 is reported in a separate baseline measure.|participants|Number|NA|||17.068|17.068|54.0|89.5|Reported in a separate baseline measure.
3654585|NCT02430870|3501265|B2|Non-Hispanic and Latino||Race/Ethnicity, Customized|Data presented for study Part 2 only. Ethnicity data for study Part 1 is reported in a separate baseline measure.|participants|Number|NA|||17.359|17.359|56.4|94.6|Reported in a separate baseline measure.
3654586|NCT02430870|3501266|B1|Non-Hispanic and Latino||Race/Ethnicity, Customized|Data presented for study Part 2 only. Ethnicity data for study Part 1 is reported in a separate baseline measure.|participants|Number|NA|||5.082|5.082|83.3|98.6|Reported in a separate baseline measure.
3654587|NCT02430870|3501258|B9|Non-Hispanic and Latino||Race/Ethnicity, Customized|Data presented for study Part 1 only. Ethnicity data for study Part 2 is reported in a separate baseline measure.|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3654588|NCT02430870|3501259|B8|Non-Hispanic and Latino||Race/Ethnicity, Customized|Data presented for study Part 1 only. Ethnicity data for study Part 2 is reported in a separate baseline measure.|participants|Number|NA|||||||Reported in a separate baseline measure.
3654589|NCT02430870|3501260|B7|Non-Hispanic and Latino||Race/Ethnicity, Customized|Data presented for study Part 1 only. Ethnicity data for study Part 2 is reported in a separate baseline measure.|participants|Number|NA|||||||Reported in a separate baseline measure.
3654590|NCT02430870|3501261|B6|Non-Hispanic and Latino||Race/Ethnicity, Customized|Data presented for study Part 1 only. Ethnicity data for study Part 2 is reported in a separate baseline measure.|participants|Number|NA|||||||Reported in a separate baseline measure.
3654591|NCT02430870|3501262|B5|Non-Hispanic and Latino||Race/Ethnicity, Customized|Data presented for study Part 1 only. Ethnicity data for study Part 2 is reported in a separate baseline measure.|participants|Number|NA|||||||Reported in a separate baseline measure.
3654592|NCT02430870|3501263|B4|Non-Hispanic and Latino||Race/Ethnicity, Customized|Data presented for study Part 1 only. Ethnicity data for study Part 2 is reported in a separate baseline measure.|participants|Number|NA|||||||Reported in a separate baseline measure.
3654593|NCT02430870|3501264|B3|Non-Hispanic and Latino||Race/Ethnicity, Customized|Data presented for study Part 1 only. Ethnicity data for study Part 2 is reported in a separate baseline measure.|participants|Number|0|0.0||||||
3654594|NCT02430870|3501265|B2|Non-Hispanic and Latino||Race/Ethnicity, Customized|Data presented for study Part 1 only. Ethnicity data for study Part 2 is reported in a separate baseline measure.|participants|Number|1|1.0||||||
3654595|NCT02430870|3501266|B1|Non-Hispanic and Latino||Race/Ethnicity, Customized|Data presented for study Part 1 only. Ethnicity data for study Part 2 is reported in a separate baseline measure.|participants|Number|0|0.0||||||
3654596|NCT02430870|3501258|B9|Hispanic or Latino||Race/Ethnicity, Customized|Data presented for study Part 1 only. Ethnicity data for study Part 2 is reported in a separate baseline measure.|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3654597|NCT02430870|3501259|B8|Hispanic or Latino||Race/Ethnicity, Customized|Data presented for study Part 1 only. Ethnicity data for study Part 2 is reported in a separate baseline measure.|participants|Number|NA|||NA||0.0|0.0|Reported in a separate baseline measure.
3654598|NCT02430870|3501260|B7|Hispanic or Latino||Race/Ethnicity, Customized|Data presented for study Part 1 only. Ethnicity data for study Part 2 is reported in a separate baseline measure.|participants|Number|NA|||NA||0.0|0.0|Reported in a separate baseline measure.
3654599|NCT02430870|3501261|B6|Hispanic or Latino||Race/Ethnicity, Customized|Data presented for study Part 1 only. Ethnicity data for study Part 2 is reported in a separate baseline measure.|participants|Number|NA|||NA||0.0|0.0|Reported in a separate baseline measure.
3654600|NCT02430870|3501262|B5|Hispanic or Latino||Race/Ethnicity, Customized|Data presented for study Part 1 only. Ethnicity data for study Part 2 is reported in a separate baseline measure.|participants|Number|NA|||NA||0.0|0.0|Reported in a separate baseline measure.
3654601|NCT02430870|3501263|B4|Hispanic or Latino||Race/Ethnicity, Customized|Data presented for study Part 1 only. Ethnicity data for study Part 2 is reported in a separate baseline measure.|participants|Number|NA|||NA||0.0|0.0|Reported in a separate baseline measure.
3654602|NCT02430870|3501264|B3|Hispanic or Latino||Race/Ethnicity, Customized|Data presented for study Part 1 only. Ethnicity data for study Part 2 is reported in a separate baseline measure.|participants|Number|4|4.0||8.70|8.7|147.0|163.0|
3654603|NCT02430870|3501265|B2|Hispanic or Latino||Race/Ethnicity, Customized|Data presented for study Part 1 only. Ethnicity data for study Part 2 is reported in a separate baseline measure.|participants|Number|5|5.0||9.95|9.95|155.0|179.0|
3654604|NCT02430870|3501266|B1|Hispanic or Latino||Race/Ethnicity, Customized|Data presented for study Part 1 only. Ethnicity data for study Part 2 is reported in a separate baseline measure.|participants|Number|6|6.0||4.09|4.09|165.0|176.0|
3654605|NCT02430870|3501258|B9||Male|Sex: Female, Male|Data presented for study Part 2 only. Gender data for study Part 1 is reported in a separate baseline measure.|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3654606|NCT02430870|3501259|B8||Male|Sex: Female, Male|Data presented for study Part 2 only. Gender data for study Part 1 is reported in a separate baseline measure.|Participants|Count of Participants|3|3.0||||||
3654607|NCT02430870|3501260|B7||Male|Sex: Female, Male|Data presented for study Part 2 only. Gender data for study Part 1 is reported in a separate baseline measure.|Participants|Count of Participants|3|3.0||||||
3654608|NCT02430870|3501261|B6||Male|Sex: Female, Male|Data presented for study Part 2 only. Gender data for study Part 1 is reported in a separate baseline measure.|Participants|Count of Participants|3|3.0||||||
3654609|NCT02430870|3501262|B5||Male|Sex: Female, Male|Data presented for study Part 2 only. Gender data for study Part 1 is reported in a separate baseline measure.|Participants|Count of Participants|3|3.0||||||
3654610|NCT02430870|3501263|B4||Male|Sex: Female, Male|Data presented for study Part 2 only. Gender data for study Part 1 is reported in a separate baseline measure.|Participants|Count of Participants|5|5.0||||||
3654611|NCT02430870|3501264|B3||Male|Sex: Female, Male|Data presented for study Part 2 only. Gender data for study Part 1 is reported in a separate baseline measure.|Participants|Count of Participants|NA|||||||Reported in a separate baseline measure.
3654612|NCT02430870|3501265|B2||Male|Sex: Female, Male|Data presented for study Part 2 only. Gender data for study Part 1 is reported in a separate baseline measure.|Participants|Count of Participants|NA|||||||Reported in a separate baseline measure.
3654613|NCT02430870|3501266|B1||Male|Sex: Female, Male|Data presented for study Part 2 only. Gender data for study Part 1 is reported in a separate baseline measure.|Participants|Count of Participants|NA|||||||Reported in a separate baseline measure.
3654614|NCT02430870|3501258|B9||Female|Sex: Female, Male|Data presented for study Part 2 only. Gender data for study Part 1 is reported in a separate baseline measure.|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3654615|NCT02430870|3501259|B8||Female|Sex: Female, Male|Data presented for study Part 2 only. Gender data for study Part 1 is reported in a separate baseline measure.|Participants|Count of Participants|5|5.0||||||
3654616|NCT02430870|3501260|B7||Female|Sex: Female, Male|Data presented for study Part 2 only. Gender data for study Part 1 is reported in a separate baseline measure.|Participants|Count of Participants|3|3.0||||||
3654617|NCT02430870|3501261|B6||Female|Sex: Female, Male|Data presented for study Part 2 only. Gender data for study Part 1 is reported in a separate baseline measure.|Participants|Count of Participants|3|3.0||||||
3654618|NCT02430870|3501262|B5||Female|Sex: Female, Male|Data presented for study Part 2 only. Gender data for study Part 1 is reported in a separate baseline measure.|Participants|Count of Participants|3|3.0||||||
3654619|NCT02430870|3501263|B4||Female|Sex: Female, Male|Data presented for study Part 2 only. Gender data for study Part 1 is reported in a separate baseline measure.|Participants|Count of Participants|1|1.0||||||
3654620|NCT02430870|3501264|B3||Female|Sex: Female, Male|Data presented for study Part 2 only. Gender data for study Part 1 is reported in a separate baseline measure.|Participants|Count of Participants|NA|||||||Reported in a separate baseline measure.
3654621|NCT02430870|3501265|B2||Female|Sex: Female, Male|Data presented for study Part 2 only. Gender data for study Part 1 is reported in a separate baseline measure.|Participants|Count of Participants|NA|||||||Reported in a separate baseline measure.
3654622|NCT02430870|3501266|B1||Female|Sex: Female, Male|Data presented for study Part 2 only. Gender data for study Part 1 is reported in a separate baseline measure.|Participants|Count of Participants|NA|||||||Reported in a separate baseline measure.
3654623|NCT02430870|3501258|B9||Male|Sex: Female, Male|Data presented for study Part 1 only. Gender data for study Part 2 is reported in a separate baseline measure.|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3654624|NCT02430870|3501259|B8||Male|Sex: Female, Male|Data presented for study Part 1 only. Gender data for study Part 2 is reported in a separate baseline measure.|Participants|Count of Participants|NA|||||||Reported in a separate baseline measure.
3654625|NCT02430870|3501260|B7||Male|Sex: Female, Male|Data presented for study Part 1 only. Gender data for study Part 2 is reported in a separate baseline measure.|Participants|Count of Participants|NA|||||||Reported in a separate baseline measure.
3654626|NCT02430870|3501261|B6||Male|Sex: Female, Male|Data presented for study Part 1 only. Gender data for study Part 2 is reported in a separate baseline measure.|Participants|Count of Participants|NA|||||||Reported in a separate baseline measure.
3654627|NCT02430870|3501262|B5||Male|Sex: Female, Male|Data presented for study Part 1 only. Gender data for study Part 2 is reported in a separate baseline measure.|Participants|Count of Participants|NA|||||||Reported in a separate baseline measure.
3654628|NCT02430870|3501263|B4||Male|Sex: Female, Male|Data presented for study Part 1 only. Gender data for study Part 2 is reported in a separate baseline measure.|Participants|Count of Participants|NA|||||||Reported in a separate baseline measure.
3654629|NCT02430870|3501264|B3||Male|Sex: Female, Male|Data presented for study Part 1 only. Gender data for study Part 2 is reported in a separate baseline measure.|Participants|Count of Participants|0|0.0||||||
3654630|NCT02430870|3501265|B2||Male|Sex: Female, Male|Data presented for study Part 1 only. Gender data for study Part 2 is reported in a separate baseline measure.|Participants|Count of Participants|3|3.0||||||
3654631|NCT02430870|3501266|B1||Male|Sex: Female, Male|Data presented for study Part 1 only. Gender data for study Part 2 is reported in a separate baseline measure.|Participants|Count of Participants|6|6.0||||||
3654632|NCT02430870|3501258|B9||Female|Sex: Female, Male|Data presented for study Part 1 only. Gender data for study Part 2 is reported in a separate baseline measure.|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3654633|NCT02430870|3501259|B8||Female|Sex: Female, Male|Data presented for study Part 1 only. Gender data for study Part 2 is reported in a separate baseline measure.|Participants|Count of Participants|NA|||||||Reported in a separate baseline measure.
3654634|NCT02430870|3501260|B7||Female|Sex: Female, Male|Data presented for study Part 1 only. Gender data for study Part 2 is reported in a separate baseline measure.|Participants|Count of Participants|NA|||||||Reported in a separate baseline measure.
3654678|NCT02430532|3501346|B2|< 20 years||Age, Customized||participants|Number|0|0.0||||||
3654635|NCT02430870|3501261|B6||Female|Sex: Female, Male|Data presented for study Part 1 only. Gender data for study Part 2 is reported in a separate baseline measure.|Participants|Count of Participants|NA|||||||Reported in a separate baseline measure.
3654636|NCT02430870|3501262|B5||Female|Sex: Female, Male|Data presented for study Part 1 only. Gender data for study Part 2 is reported in a separate baseline measure.|Participants|Count of Participants|NA|||||||Reported in a separate baseline measure.
3654637|NCT02430870|3501263|B4||Female|Sex: Female, Male|Data presented for study Part 1 only. Gender data for study Part 2 is reported in a separate baseline measure.|Participants|Count of Participants|NA|||||||Reported in a separate baseline measure.
3654638|NCT02430870|3501264|B3||Female|Sex: Female, Male|Data presented for study Part 1 only. Gender data for study Part 2 is reported in a separate baseline measure.|Participants|Count of Participants|4|4.0||||||
3654639|NCT02430870|3501265|B2||Female|Sex: Female, Male|Data presented for study Part 1 only. Gender data for study Part 2 is reported in a separate baseline measure.|Participants|Count of Participants|3|3.0||||||
3654640|NCT02430870|3501266|B1||Female|Sex: Female, Male|Data presented for study Part 1 only. Gender data for study Part 2 is reported in a separate baseline measure.|Participants|Count of Participants|0|0.0||||||
3654641|NCT02430870|3501258|B9|||Age|Data presented for study Part 2 only. Age data for study Part 1 is reported in a separate baseline measure.|years|Mean|34.8|34.8|Standard Deviation|9.26|9.26|||
3654642|NCT02430870|3501259|B8|||Age|Data presented for study Part 2 only. Age data for study Part 1 is reported in a separate baseline measure.|years|Mean|35.3|35.3|Standard Deviation|9.82|9.82|||
3654643|NCT02430870|3501260|B7|||Age|Data presented for study Part 2 only. Age data for study Part 1 is reported in a separate baseline measure.|years|Mean|33.0|33.0|Standard Deviation|4.10|4.1|||
3654644|NCT02430870|3501261|B6|||Age|Data presented for study Part 2 only. Age data for study Part 1 is reported in a separate baseline measure.|years|Mean|32.2|32.2|Standard Deviation|12.48|12.48|||
3654645|NCT02430870|3501262|B5|||Age|Data presented for study Part 2 only. Age data for study Part 1 is reported in a separate baseline measure.|years|Mean|36.0|36.0|Standard Deviation|10.45|10.45|||
3654646|NCT02430870|3501263|B4|||Age|Data presented for study Part 2 only. Age data for study Part 1 is reported in a separate baseline measure.|years|Mean|37.3|37.3|Standard Deviation|9.63|9.63|||
3654647|NCT02430870|3501264|B3|||Age|Data presented for study Part 2 only. Age data for study Part 1 is reported in a separate baseline measure.|years|Mean|NA||Standard Deviation|NA||||Reported in a separate baseline measure.
3654648|NCT02430870|3501265|B2|||Age|Data presented for study Part 2 only. Age data for study Part 1 is reported in a separate baseline measure.|years|Mean|NA||Standard Deviation|NA||||Reported in a separate baseline measure.
3654649|NCT02430870|3501266|B1|||Age|Data presented for study Part 2 only. Age data for study Part 1 is reported in a separate baseline measure.|years|Mean|NA||Standard Deviation|NA||||Reported in a separate baseline measure.
3654650|NCT02430870|3501258|B9|||Age|Data presented for study Part 1 only. Age data for study Part 2 is reported in a separate baseline measure.|years|Mean|55.0|55.0|Standard Deviation|7.08|7.08|21.0|64.0|
3654651|NCT02430870|3501259|B8|||Age|Data presented for study Part 1 only. Age data for study Part 2 is reported in a separate baseline measure.|years|Mean|NA||Standard Deviation|NA||21.0|53.0|Reported in a separate baseline measure.
3654652|NCT02430870|3501260|B7|||Age|Data presented for study Part 1 only. Age data for study Part 2 is reported in a separate baseline measure.|years|Mean|NA||Standard Deviation|NA||30.0|41.0|Reported in a separate baseline measure.
3654653|NCT02430870|3501261|B6|||Age|Data presented for study Part 1 only. Age data for study Part 2 is reported in a separate baseline measure.|years|Mean|NA||Standard Deviation|NA||21.0|54.0|Reported in a separate baseline measure.
3654654|NCT02430870|3501262|B5|||Age|Data presented for study Part 1 only. Age data for study Part 2 is reported in a separate baseline measure.|years|Mean|NA||Standard Deviation|NA||26.0|54.0|Reported in a separate baseline measure.
3654655|NCT02430870|3501263|B4|||Age|Data presented for study Part 1 only. Age data for study Part 2 is reported in a separate baseline measure.|years|Mean|NA||Standard Deviation|NA||26.0|51.0|Reported in a separate baseline measure.
3654656|NCT02430870|3501264|B3|||Age|Data presented for study Part 1 only. Age data for study Part 2 is reported in a separate baseline measure.|years|Mean|54.5|54.5|Standard Deviation|7.77|7.77|43.0|60.0|
3654657|NCT02430870|3501265|B2|||Age|Data presented for study Part 1 only. Age data for study Part 2 is reported in a separate baseline measure.|years|Mean|55.0|55.0|Standard Deviation|7.01|7.01|46.0|64.0|
3654658|NCT02430870|3501266|B1|||Age|Data presented for study Part 1 only. Age data for study Part 2 is reported in a separate baseline measure.|years|Mean|55.3|55.3|Standard Deviation|8.04|8.04|46.0|64.0|
3654659|NCT02430532|3501345|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3654660|NCT02430532|3501346|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3654661|NCT02430532|3501347|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3654662|NCT02430532|3501345|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3654663|NCT02430532|3501346|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3654664|NCT02430532|3501347|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3654665|NCT02430532|3501345|B3|>= 50 years||Age, Customized||participants|Number|35|35.0||||||
3654666|NCT02430532|3501346|B2|>= 50 years||Age, Customized||participants|Number|16|16.0||||||
3654667|NCT02430532|3501347|B1|>= 50 years||Age, Customized||participants|Number|19|19.0||||||
3654668|NCT02430532|3501345|B3|40 to 49 years||Age, Customized||participants|Number|18|18.0||||||
3654669|NCT02430532|3501346|B2|40 to 49 years||Age, Customized||participants|Number|8|8.0||||||
3654670|NCT02430532|3501347|B1|40 to 49 years||Age, Customized||participants|Number|10|10.0||||||
3654671|NCT02430532|3501345|B3|30 to 39 years||Age, Customized||participants|Number|5|5.0||||||
3654672|NCT02430532|3501346|B2|30 to 39 years||Age, Customized||participants|Number|4|4.0||||||
3654673|NCT02430532|3501347|B1|30 to 39 years||Age, Customized||participants|Number|1|1.0||||||
3654674|NCT02430532|3501345|B3|20 to 29 years||Age, Customized||participants|Number|0|0.0||||||
3654675|NCT02430532|3501346|B2|20 to 29 years||Age, Customized||participants|Number|0|0.0||||||
3654679|NCT02430532|3501347|B1|< 20 years||Age, Customized||participants|Number|0|0.0||||||
3654680|NCT02430532|3501345|B3|||Age||years|Mean|50.2|50.2|Standard Deviation|7.33|7.33|||
3654681|NCT02430532|3501346|B2|||Age||years|Mean|49.6|49.6|Standard Deviation|8.05|8.05|||
3654682|NCT02430532|3501347|B1|||Age||years|Mean|50.7|50.7|Standard Deviation|6.67|6.67|||
3654683|NCT02430389|3501362|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3654684|NCT02430389|3501363|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3654685|NCT02430389|3501364|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3654686|NCT02430389|3501362|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3654687|NCT02430389|3501363|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3654688|NCT02430389|3501364|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3654689|NCT02430389|3501362|B3|||Age||years|Mean|56.5|56.5|Standard Deviation|10.3|10.3|||
3654690|NCT02430389|3501363|B2|||Age||years|Mean|51.7|51.7|Standard Deviation|4.8|4.8|||
3654691|NCT02430389|3501364|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|12.2|12.2|||
3654692|NCT02430311|3501373|B3|||Body mass index||kg/m2|Mean|23.85|23.85|Standard Deviation|3.857|3.857|||
3654693|NCT02430311|3501374|B2|||Body mass index||kg/m2|Mean|23.78|23.78|Standard Deviation|3.599|3.599|||
3654694|NCT02430311|3501375|B1|||Body mass index||kg/m2|Mean|23.91|23.91|Standard Deviation|4.144|4.144|||
3654695|NCT02430311|3501373|B3|||Weight||kg|Mean|63.1|63.1|Standard Deviation|9.71|9.71|||
3654696|NCT02430311|3501374|B2|||Weight||kg|Mean|60.9|60.9|Standard Deviation|8.71|8.71|||
3654697|NCT02430311|3501375|B1|||Weight||kg|Mean|64.8|64.8|Standard Deviation|10.35|10.35|||
3654698|NCT02430311|3501373|B3|||Height||cm|Mean|162.8|162.8|Standard Deviation|6.04|6.04|||
3654699|NCT02430311|3501374|B2|||Height||cm|Mean|160.3|160.3|Standard Deviation|4.81|4.81|||
3654700|NCT02430311|3501375|B1|||Height||cm|Mean|164.9|164.9|Standard Deviation|6.25|6.25|||
3654701|NCT02430311|3501373|B3|Chinese||Race/Ethnicity, Customized||Participants|Number|36|36.0||||||
3654702|NCT02430311|3501374|B2|Chinese||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
3654703|NCT02430311|3501375|B1|Chinese||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
3654704|NCT02430311|3501373|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3654705|NCT02430311|3501374|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3654706|NCT02430311|3501375|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3654707|NCT02430311|3501373|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3654708|NCT02430311|3501374|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3654709|NCT02430311|3501375|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3654710|NCT02430311|3501373|B3|≥75 years||Age, Customized||Participants|Number|0|0.0||||||
3654711|NCT02430311|3501374|B2|≥75 years||Age, Customized||Participants|Number|0|0.0||||||
3654712|NCT02430311|3501375|B1|≥75 years||Age, Customized||Participants|Number|0|0.0||||||
3654713|NCT02430311|3501373|B3|≥65 <75 years||Age, Customized||Participants|Number|1|1.0||||||
3654714|NCT02430311|3501374|B2|≥65 <75 years||Age, Customized||Participants|Number|1|1.0||||||
3654715|NCT02430311|3501375|B1|≥65 <75 years||Age, Customized||Participants|Number|0|0.0||||||
3654716|NCT02430311|3501373|B3|≥50 <65 years||Age, Customized||Participants|Number|15|15.0||||||
3654717|NCT02430311|3501374|B2|≥50 <65 years||Age, Customized||Participants|Number|6|6.0||||||
3654718|NCT02430311|3501375|B1|≥50 <65 years||Age, Customized||Participants|Number|9|9.0||||||
3654719|NCT02430311|3501373|B3|<50 years||Age, Customized||Participants|Number|20|20.0||||||
3654720|NCT02430311|3501374|B2|<50 years||Age, Customized||Participants|Number|9|9.0||||||
3654721|NCT02430311|3501375|B1|<50 years||Age, Customized||Participants|Number|11|11.0||||||
3654722|NCT02430311|3501373|B3|||Age||years|Mean|48.4|48.4|Standard Deviation|9.92|9.92|||
3654723|NCT02430311|3501374|B2|||Age||years|Mean|49.3|49.3|Standard Deviation|9.49|9.49|||
3654724|NCT02430311|3501375|B1|||Age||years|Mean|47.7|47.7|Standard Deviation|10.43|10.43|||
3654725|NCT02430090|3501409|B4|Turkey||Region of Enrollment||participants|Number|45|45.0||||||
3654726|NCT02430090|3501410|B3|Turkey||Region of Enrollment||participants|Number|15|15.0||||||
3654727|NCT02430090|3501411|B2|Turkey||Region of Enrollment||participants|Number|15|15.0||||||
3654728|NCT02430090|3501412|B1|Turkey||Region of Enrollment||participants|Number|15|15.0||||||
3654729|NCT02430090|3501409|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654730|NCT02430090|3501410|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654731|NCT02430090|3501411|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654732|NCT02430090|3501412|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654733|NCT02430090|3501409|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654734|NCT02430090|3501410|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654735|NCT02430090|3501411|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654736|NCT02430090|3501412|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654737|NCT02430090|3501409|B4||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3654738|NCT02430090|3501410|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3654739|NCT02430090|3501411|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3654740|NCT02430090|3501412|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3654741|NCT02430090|3501409|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654742|NCT02430090|3501410|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654743|NCT02430090|3501411|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654744|NCT02430090|3501412|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654745|NCT02430090|3501409|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654746|NCT02430090|3501410|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654747|NCT02430090|3501411|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654748|NCT02430090|3501412|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654749|NCT02430090|3501409|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654750|NCT02430090|3501410|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654751|NCT02430090|3501411|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654752|NCT02430090|3501412|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654753|NCT02430090|3501409|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654754|NCT02430090|3501410|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654755|NCT02430090|3501411|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654756|NCT02430090|3501412|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654757|NCT02430090|3501409|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3654758|NCT02430090|3501410|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3654759|NCT02430090|3501411|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3654760|NCT02430090|3501412|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3654761|NCT02430090|3501409|B4||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3654762|NCT02430090|3501410|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3654763|NCT02430090|3501411|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3654764|NCT02430090|3501412|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3654765|NCT02430090|3501409|B4|||Age||years|Mean|26.9|26.9|Standard Deviation|7.5|7.5|||
3654766|NCT02430090|3501410|B3|||Age||years|Mean|27.4|27.4|Standard Deviation|7.1|7.1|||
3654767|NCT02430090|3501411|B2|||Age||years|Mean|25.5|25.5|Standard Deviation|5.2|5.2|||
3654768|NCT02430090|3501412|B1|||Age||years|Mean|27.8|27.8|Standard Deviation|7.4|7.4|||
3654769|NCT02429791|3501422|B3|African American/African H. and Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3654770|NCT02429791|3501423|B2|African American/African H. and Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3654771|NCT02429791|3501424|B1|African American/African H. and Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3654772|NCT02429791|3501422|B3|American Indian or Alaska Native and white||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3654773|NCT02429791|3501423|B2|American Indian or Alaska Native and white||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3654774|NCT02429791|3501424|B1|American Indian or Alaska Native and white||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3654775|NCT02429791|3501422|B3|White||Race/Ethnicity, Customized||Participants|Number|386|386.0||||||
3654776|NCT02429791|3501423|B2|White||Race/Ethnicity, Customized||Participants|Number|188|188.0||||||
3654777|NCT02429791|3501424|B1|White||Race/Ethnicity, Customized||Participants|Number|198|198.0||||||
3654778|NCT02429791|3501422|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3654779|NCT02429791|3501423|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3654780|NCT02429791|3501424|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3654781|NCT02429791|3501422|B3|Black/African American||Race/Ethnicity, Customized||Participants|Number|51|51.0||||||
3654782|NCT02429791|3501423|B2|Black/African American||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
3654783|NCT02429791|3501424|B1|Black/African American||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
3654784|NCT02429791|3501422|B3|Japanese/East Asian (EA) Heritage (H.)/South EA H.||Race/Ethnicity, Customized||Participants|Number|59|59.0||||||
3654785|NCT02429791|3501423|B2|Japanese/East Asian (EA) Heritage (H.)/South EA H.||Race/Ethnicity, Customized||Participants|Number|34|34.0||||||
3654786|NCT02429791|3501424|B1|Japanese/East Asian (EA) Heritage (H.)/South EA H.||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
3654787|NCT02429791|3501422|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3654788|NCT02429791|3501423|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3654789|NCT02429791|3501424|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3654790|NCT02429791|3501422|B3||Male|Sex: Female, Male||Participants|Count of Participants|399|399.0||||||
3654791|NCT02429791|3501423|B2||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
3654792|NCT02429791|3501424|B1||Male|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
3654793|NCT02429791|3501422|B3||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3654794|NCT02429791|3501423|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3654795|NCT02429791|3501424|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3654796|NCT02429791|3501422|B3|||Age||Years|Mean|43.6|43.6|Standard Deviation|10.84|10.84|||
3654797|NCT02429791|3501423|B2|||Age||Years|Mean|43.6|43.6|Standard Deviation|10.76|10.76|||
3654798|NCT02429791|3501424|B1|||Age||Years|Mean|43.6|43.6|Standard Deviation|10.93|10.93|||
3654799|NCT02429258|3501495|B3|||Hemoglobin A1c (HbA1c)||Percentage|Mean|8.34|8.34|Standard Deviation|0.794|0.794|||
3654800|NCT02429258|3501496|B2|||Hemoglobin A1c (HbA1c)||Percentage|Mean|8.37|8.37|Standard Deviation|0.810|0.81|||
3654801|NCT02429258|3501497|B1|||Hemoglobin A1c (HbA1c)||Percentage|Mean|8.31|8.31|Standard Deviation|0.785|0.785|||
3654802|NCT02429258|3501495|B3|||BMI||kg/m^2|Mean|33.8|33.8|Standard Deviation|5.75|5.75|||
3654803|NCT02429258|3501496|B2|||BMI||kg/m^2|Mean|33.2|33.2|Standard Deviation|5.59|5.59|||
3654804|NCT02429258|3501497|B1|||BMI||kg/m^2|Mean|34.3|34.3|Standard Deviation|5.92|5.92|||
3654805|NCT02429258|3501495|B3|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3654806|NCT02429258|3501496|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3654807|NCT02429258|3501497|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3654808|NCT02429258|3501495|B3|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3654809|NCT02429258|3501496|B2|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3654810|NCT02429258|3501497|B1|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3654811|NCT02429258|3501495|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3654812|NCT02429258|3501496|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3654813|NCT02429258|3501497|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3654814|NCT02429258|3501495|B3|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3654815|NCT02429258|3501496|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3654816|NCT02429258|3501497|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3654817|NCT02429258|3501495|B3|American Indian and Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3654818|NCT02429258|3501496|B2|American Indian and Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3654819|NCT02429258|3501497|B1|American Indian and Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3654820|NCT02429258|3501495|B3|White||Race/Ethnicity, Customized||Participants|Number|75|75.0||||||
3654821|NCT02429258|3501496|B2|White||Race/Ethnicity, Customized||Participants|Number|36|36.0||||||
3654822|NCT02429258|3501497|B1|White||Race/Ethnicity, Customized||Participants|Number|39|39.0||||||
3654823|NCT02429258|3501495|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
3654824|NCT02429258|3501496|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3654825|NCT02429258|3501497|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3654826|NCT02429258|3501495|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3654827|NCT02429258|3501496|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3654828|NCT02429258|3501497|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3654829|NCT02429258|3501495|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3654830|NCT02429258|3501496|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3654831|NCT02429258|3501497|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3654832|NCT02429258|3501495|B3|||Age||Years|Mean|56.9|56.9|Standard Deviation|8.47|8.47|||
3654833|NCT02429258|3501496|B2|||Age||Years|Mean|56.8|56.8|Standard Deviation|9.71|9.71|||
3654834|NCT02429258|3501497|B1|||Age||Years|Mean|56.9|56.9|Standard Deviation|7.11|7.11|||
3654835|NCT02428699|3501524|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654836|NCT02428699|3501524|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3654837|NCT02428699|3501524|B1||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3654838|NCT02428699|3501524|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3654839|NCT02428699|3501524|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654840|NCT02428699|3501524|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3654841|NCT02428699|3501524|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654842|NCT02428699|3501524|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654843|NCT02428699|3501524|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3654844|NCT02428699|3501524|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654845|NCT02428699|3501524|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3654846|NCT02428699|3501524|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3654847|NCT02428699|3501524|B1|||Age||Years|Mean|29.1|29.1|Standard Deviation|7.62|7.62|||
3654848|NCT02428478|3501553|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3654849|NCT02428478|3501553|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3654850|NCT02428478|3501553|B1|||Age||years|Median|27.5|27.5|Inter-Quartile Range|||24.0|39.5|
3654851|NCT02428413|3501562|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3654852|NCT02428413|3501563|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3654853|NCT02428413|3501564|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3654854|NCT02428413|3501562|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3654855|NCT02428413|3501563|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3654856|NCT02428413|3501564|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3654857|NCT02428413|3501562|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3654858|NCT02428413|3501563|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3654859|NCT02428413|3501564|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3654860|NCT02428413|3501562|B3||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
3654861|NCT02428413|3501563|B2||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3654862|NCT02428413|3501564|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3654863|NCT02428413|3501562|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3654864|NCT02428413|3501563|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3654865|NCT02428413|3501564|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3654866|NCT02428231|3501577|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3654867|NCT02428231|3501578|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3654868|NCT02428231|3501579|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3654869|NCT02428231|3501577|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3654870|NCT02428231|3501578|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3654871|NCT02428231|3501579|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3654872|NCT02428231|3501577|B3|||Age||years|Mean|44.0|44.0|Standard Deviation|11.45|11.45|||
3654873|NCT02428231|3501578|B2|||Age||years|Mean|42.5|42.5|Standard Deviation|11.12|11.12|||
3654874|NCT02428231|3501579|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|11.77|11.77|||
3654875|NCT02427984|3501594|B4||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3654876|NCT02427984|3501595|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3654877|NCT02427984|3501596|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3654878|NCT02427984|3501597|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3654879|NCT02427984|3501594|B4||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3654880|NCT02427984|3501595|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3654881|NCT02427984|3501596|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3654882|NCT02427984|3501597|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3654883|NCT02427984|3501594|B4||>=65 years|Age||Participants|Count of Participants|52|52.0||||||
3654884|NCT02427984|3501595|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3654885|NCT02427984|3501596|B2||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3654886|NCT02427984|3501597|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3654887|NCT02427984|3501594|B4||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3654888|NCT02427984|3501595|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3654889|NCT02427984|3501596|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3654890|NCT02427984|3501597|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3654891|NCT02427984|3501594|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3654892|NCT02427984|3501595|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3654893|NCT02427984|3501596|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3654894|NCT02427984|3501597|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3654895|NCT02427750|3501613|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3654896|NCT02427750|3501614|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3654897|NCT02427750|3501615|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3654898|NCT02427750|3501613|B3||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3654899|NCT02427750|3501614|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3654900|NCT02427750|3501615|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3654901|NCT02427750|3501613|B3|||Age||years|Mean|50.7|50.7|Standard Deviation|20.8|20.8|||
3654902|NCT02427750|3501614|B2|||Age||years|Mean|69.3|69.3|Standard Deviation|6.9|6.9|||
3654903|NCT02427750|3501615|B1|||Age||years|Mean|32.1|32.1|Standard Deviation|11.0|11.0|||
3654904|NCT02427607|3501639|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3654905|NCT02427607|3501639|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3654906|NCT02427607|3501639|B1|||Age||Years|Mean|35.3|35.3|Standard Deviation|19.20|19.2|||
3654907|NCT02427477|3501643|B3|United States||Region of Enrollment||participants|Number|120|120.0||||||
3654908|NCT02427477|3501644|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
3654909|NCT02427477|3501645|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
3654910|NCT02427477|3501643|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654911|NCT02427477|3501644|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654912|NCT02427477|3501645|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654913|NCT02427477|3501643|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654914|NCT02427477|3501644|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654915|NCT02427477|3501645|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654916|NCT02427477|3501643|B3||White|Race (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3654917|NCT02427477|3501644|B2||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3654918|NCT02427477|3501645|B1||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3654919|NCT02427477|3501643|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3654920|NCT02427477|3501644|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3654921|NCT02427477|3501645|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3654922|NCT02427477|3501643|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654923|NCT02427477|3501644|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654924|NCT02427477|3501645|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654925|NCT02427477|3501643|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3654926|NCT02427477|3501644|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3654927|NCT02427477|3501645|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3654928|NCT02427477|3501643|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3654929|NCT02427477|3501644|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3654930|NCT02427477|3501645|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3654931|NCT02427477|3501643|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3654932|NCT02427477|3501644|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3654933|NCT02427477|3501645|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3654934|NCT02427477|3501643|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3654935|NCT02427477|3501644|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3654936|NCT02427477|3501645|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3654937|NCT02427477|3501643|B3|||Age||years|Mean|28.0|28.0|Standard Deviation|5.60|5.6|||
3654938|NCT02427477|3501644|B2|||Age||years|Mean|27.6|27.6|Standard Deviation|4.97|4.97|||
3654939|NCT02427477|3501645|B1|||Age||years|Mean|28.6|28.6|Standard Deviation|6.14|6.14|||
3654940|NCT02427399|3501654|B6|||Mean Number of Medical Appointments||appointments|Mean|9.5|9.5|Standard Deviation|20.7|20.7|||
3654941|NCT02427399|3501655|B5|||Mean Number of Medical Appointments||appointments|Mean|8.8|8.8|Standard Deviation|16.9|16.9|||
3654942|NCT02427399|3501656|B4|||Mean Number of Medical Appointments||appointments|Mean|9.2|9.2|Standard Deviation|19.6|19.6|||
3654943|NCT02427399|3501657|B3|||Mean Number of Medical Appointments||appointments|Mean|7.4|7.4|Standard Deviation|10.7|10.7|||
3654944|NCT02427399|3501658|B2|||Mean Number of Medical Appointments||appointments|Mean|11.8|11.8|Standard Deviation|30.2|30.2|||
3654945|NCT02427399|3501659|B1|||Mean Number of Medical Appointments||appointments|Mean|10.5|10.5|Standard Deviation|21.3|21.3|||
3654946|NCT02427399|3501654|B6|||Insured||participants|Number|899|899.0||||||
3654947|NCT02427399|3501655|B5|||Insured||participants|Number|179|179.0||||||
3654948|NCT02427399|3501656|B4|||Insured||participants|Number|181|181.0||||||
3654949|NCT02427399|3501657|B3|||Insured||participants|Number|188|188.0||||||
3654950|NCT02427399|3501658|B2|||Insured||participants|Number|175|175.0||||||
3654951|NCT02427399|3501659|B1|||Insured||participants|Number|176|176.0||||||
3654952|NCT02427399|3501654|B6|Unknown||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3654953|NCT02427399|3501655|B5|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3654954|NCT02427399|3501656|B4|Unknown||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3654955|NCT02427399|3501657|B3|Unknown||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3654956|NCT02427399|3501658|B2|Unknown||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3654957|NCT02427399|3501659|B1|Unknown||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3654958|NCT02427399|3501654|B6|Other||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
3654959|NCT02427399|3501655|B5|Other||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3654960|NCT02427399|3501656|B4|Other||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3654961|NCT02427399|3501657|B3|Other||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3654962|NCT02427399|3501658|B2|Other||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3654963|NCT02427399|3501659|B1|Other||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3654964|NCT02427399|3501654|B6|Multiracial||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3654965|NCT02427399|3501655|B5|Multiracial||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3654966|NCT02427399|3501656|B4|Multiracial||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3654967|NCT02427399|3501657|B3|Multiracial||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3654968|NCT02427399|3501658|B2|Multiracial||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3654969|NCT02427399|3501659|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3654970|NCT02427399|3501654|B6|Hispanic||Race/Ethnicity, Customized||participants|Number|75|75.0||||||
3654971|NCT02427399|3501655|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3654972|NCT02427399|3501656|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3654973|NCT02427399|3501657|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3654974|NCT02427399|3501658|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3654975|NCT02427399|3501659|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3654976|NCT02427399|3501654|B6|Black||Race/Ethnicity, Customized||participants|Number|78|78.0||||||
3654977|NCT02427399|3501655|B5|Black||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3654978|NCT02427399|3501656|B4|Black||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3654979|NCT02427399|3501657|B3|Black||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3654980|NCT02427399|3501658|B2|Black||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3654981|NCT02427399|3501659|B1|Black||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3654982|NCT02427399|3501654|B6|Asian||Race/Ethnicity, Customized||participants|Number|105|105.0||||||
3654983|NCT02427399|3501655|B5|Asian||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3654984|NCT02427399|3501656|B4|Asian||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3654985|NCT02427399|3501657|B3|Asian||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3654986|NCT02427399|3501658|B2|Asian||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3654987|NCT02427399|3501659|B1|Asian||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3654988|NCT02427399|3501654|B6|White||Race/Ethnicity, Customized||participants|Number|655|655.0||||||
3654989|NCT02427399|3501655|B5|White||Race/Ethnicity, Customized||participants|Number|130|130.0||||||
3654990|NCT02427399|3501656|B4|White||Race/Ethnicity, Customized||participants|Number|133|133.0||||||
3654991|NCT02427399|3501657|B3|White||Race/Ethnicity, Customized||participants|Number|133|133.0||||||
3654992|NCT02427399|3501658|B2|White||Race/Ethnicity, Customized||participants|Number|136|136.0||||||
3654993|NCT02427399|3501659|B1|White||Race/Ethnicity, Customized||participants|Number|123|123.0||||||
3654994|NCT02427399|3501654|B6|Trans/FTM||Sex/Gender, Customized||participants|Number|62|62.0||||||
3654995|NCT02427399|3501655|B5|Trans/FTM||Sex/Gender, Customized||participants|Number|12|12.0||||||
3654996|NCT02427399|3501656|B4|Trans/FTM||Sex/Gender, Customized||participants|Number|14|14.0||||||
3654997|NCT02427399|3501657|B3|Trans/FTM||Sex/Gender, Customized||participants|Number|11|11.0||||||
3654998|NCT02427399|3501658|B2|Trans/FTM||Sex/Gender, Customized||participants|Number|9|9.0||||||
3654999|NCT02427399|3501659|B1|Trans/FTM||Sex/Gender, Customized||participants|Number|16|16.0||||||
3655000|NCT02427399|3501654|B6|Female||Sex/Gender, Customized||participants|Number|963|963.0||||||
3655001|NCT02427399|3501655|B5|Female||Sex/Gender, Customized||participants|Number|193|193.0||||||
3655002|NCT02427399|3501656|B4|Female||Sex/Gender, Customized||participants|Number|188|188.0||||||
3655003|NCT02427399|3501657|B3|Female||Sex/Gender, Customized||participants|Number|197|197.0||||||
3655004|NCT02427399|3501658|B2|Female||Sex/Gender, Customized||participants|Number|195|195.0||||||
3655005|NCT02427399|3501659|B1|Female||Sex/Gender, Customized||participants|Number|190|190.0||||||
3655006|NCT02427399|3501654|B6|||Age||years|Mean|30.1|30.1|Standard Deviation|10.7|10.7|||
3655007|NCT02427399|3501655|B5|||Age||years|Mean|29.9|29.9|Standard Deviation|10.0|10.0|||
3655008|NCT02427399|3501656|B4|||Age||years|Mean|29.5|29.5|Standard Deviation|10.3|10.3|||
3655009|NCT02427399|3501657|B3|||Age||years|Mean|29.7|29.7|Standard Deviation|10.9|10.9|||
3655010|NCT02427399|3501658|B2|||Age||years|Mean|30.7|30.7|Standard Deviation|11.3|11.3|||
3655011|NCT02427399|3501659|B1|||Age||years|Mean|30.5|30.5|Standard Deviation|10.8|10.8|||
3655012|NCT02426541|3501685|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655013|NCT02426541|3501686|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655014|NCT02426541|3501687|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655015|NCT02426541|3501685|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655016|NCT02426541|3501686|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655017|NCT02426541|3501687|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655018|NCT02426541|3501685|B3||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3655019|NCT02426541|3501686|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3655020|NCT02426541|3501687|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3655021|NCT02426541|3501685|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655022|NCT02426541|3501686|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655023|NCT02426541|3501687|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655024|NCT02426541|3501685|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655025|NCT02426541|3501686|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655026|NCT02426541|3501687|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655027|NCT02426541|3501685|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655028|NCT02426541|3501686|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655029|NCT02426541|3501687|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655030|NCT02426541|3501685|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655031|NCT02426541|3501686|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655032|NCT02426541|3501687|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655033|NCT02426541|3501685|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3655034|NCT02426541|3501686|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3655035|NCT02426541|3501687|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3655036|NCT02426541|3501685|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3655037|NCT02426541|3501686|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3655038|NCT02426541|3501687|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3655039|NCT02426541|3501685|B3|||Age|Age of participant|years|Mean|61.0|61.0|Standard Deviation|7.9|7.9|||
3655040|NCT02426541|3501686|B2|||Age|Age of participant|years|Mean|59.9|59.9|Standard Deviation|7.4|7.4|||
3655041|NCT02426541|3501687|B1|||Age|Age of participant|years|Mean|62.1|62.1|Standard Deviation|8.4|8.4|||
3655042|NCT02425956|3501698|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3655043|NCT02425956|3501698|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3655044|NCT02425956|3501698|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3655045|NCT02425956|3501698|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3655046|NCT02425956|3501698|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3655047|NCT02425826|3501703|B3|Unknown||Ethnicity||participants|Number|1|1.0||||||
3655048|NCT02425826|3501704|B2|Unknown||Ethnicity||participants|Number|1|1.0||||||
3655049|NCT02425826|3501705|B1|Unknown||Ethnicity||participants|Number|0|0.0||||||
3655050|NCT02425826|3501703|B3|Not Hispanic or Latino||Ethnicity||participants|Number|203|203.0||||||
3655051|NCT02425826|3501704|B2|Not Hispanic or Latino||Ethnicity||participants|Number|134|134.0||||||
3655052|NCT02425826|3501705|B1|Not Hispanic or Latino||Ethnicity||participants|Number|69|69.0||||||
3655053|NCT02425826|3501703|B3|Hispanic or Latino||Ethnicity||participants|Number|17|17.0||||||
3655054|NCT02425826|3501704|B2|Hispanic or Latino||Ethnicity||participants|Number|13|13.0||||||
3655055|NCT02425826|3501705|B1|Hispanic or Latino||Ethnicity||participants|Number|4|4.0||||||
3655056|NCT02425826|3501703|B3|||Duration of Psoriasis|The difference between participants enrolled (148) in the apremilast group and treated (147) lies in one participant, who was randomized in error.|years|Mean|15.64|15.64|Standard Deviation|13.684|13.684|||
3655057|NCT02425826|3501704|B2|||Duration of Psoriasis|The difference between participants enrolled (148) in the apremilast group and treated (147) lies in one participant, who was randomized in error.|years|Mean|17.02|17.02|Standard Deviation|14.138|14.138|||
3655058|NCT02425826|3501705|B1|||Duration of Psoriasis|The difference between participants enrolled (148) in the apremilast group and treated (147) lies in one participant, who was randomized in error.|years|Mean|12.85|12.85|Standard Deviation|12.350|12.35|||
3655059|NCT02425826|3501703|B3|||Product of BSA and sPGA|For each participant, the product of BSA and sPGA were calculated as BSA value multiplied by the sPGA score (BSA*sPGA), measured as the total psoriasis severity index. The ranges for BSA* sPGA scores were from 15 to 40% for the placebo and apremilast arms respectively. Those in the study who had a baseline BSA in the range of 5-10% and a sPGA score of 3 or 4 were enrolled. Those with a higher psoriasis severity index represented worse outcomes. The difference between participants enrolled (148) in the apremilast group and treated (147) lies in one participant, who was randomized in error.|psoriasis severity index|Mean|21.7|21.7|Standard Deviation|5.40|5.4|||
3655060|NCT02425826|3501704|B2|||Product of BSA and sPGA|For each participant, the product of BSA and sPGA were calculated as BSA value multiplied by the sPGA score (BSA*sPGA), measured as the total psoriasis severity index. The ranges for BSA* sPGA scores were from 15 to 40% for the placebo and apremilast arms respectively. Those in the study who had a baseline BSA in the range of 5-10% and a sPGA score of 3 or 4 were enrolled. Those with a higher psoriasis severity index represented worse outcomes. The difference between participants enrolled (148) in the apremilast group and treated (147) lies in one participant, who was randomized in error.|psoriasis severity index|Mean|21.8|21.8|Standard Deviation|5.17|5.17|||
3655061|NCT02425826|3501705|B1|||Product of BSA and sPGA|For each participant, the product of BSA and sPGA were calculated as BSA value multiplied by the sPGA score (BSA*sPGA), measured as the total psoriasis severity index. The ranges for BSA* sPGA scores were from 15 to 40% for the placebo and apremilast arms respectively. Those in the study who had a baseline BSA in the range of 5-10% and a sPGA score of 3 or 4 were enrolled. Those with a higher psoriasis severity index represented worse outcomes. The difference between participants enrolled (148) in the apremilast group and treated (147) lies in one participant, who was randomized in error.|psoriasis severity index|Mean|21.6|21.6|Standard Deviation|5.87|5.87|||
3655062|NCT02425826|3501703|B3|Missing||Static Physician’s Global Assessment (sPGA) Score|The Static Physician’s Global Assessment (sPGA) is the assessment by the investigator of the overall disease severity at the time of evaluation. The National Psoriasis Foundation Psoriasis Score version of a static PGA is calculated by averaging the total body erythema, induration, and desquamation scores. Erythema (E), induration (I), and desquamation (D) are scored on a 6-point scale, ranging from 0 (clear) to 5 (very severe), with an overall sPGA calculated as (E + I + D)/3. Scores for each assessment are rounded to the nearest whole number to result in the final score.|Participants|Number|1|1.0||||||
3655063|NCT02425826|3501704|B2|Missing||Static Physician’s Global Assessment (sPGA) Score|The Static Physician’s Global Assessment (sPGA) is the assessment by the investigator of the overall disease severity at the time of evaluation. The National Psoriasis Foundation Psoriasis Score version of a static PGA is calculated by averaging the total body erythema, induration, and desquamation scores. Erythema (E), induration (I), and desquamation (D) are scored on a 6-point scale, ranging from 0 (clear) to 5 (very severe), with an overall sPGA calculated as (E + I + D)/3. Scores for each assessment are rounded to the nearest whole number to result in the final score.|Participants|Number|1|1.0||||||
3655064|NCT02425826|3501705|B1|Missing||Static Physician’s Global Assessment (sPGA) Score|The Static Physician’s Global Assessment (sPGA) is the assessment by the investigator of the overall disease severity at the time of evaluation. The National Psoriasis Foundation Psoriasis Score version of a static PGA is calculated by averaging the total body erythema, induration, and desquamation scores. Erythema (E), induration (I), and desquamation (D) are scored on a 6-point scale, ranging from 0 (clear) to 5 (very severe), with an overall sPGA calculated as (E + I + D)/3. Scores for each assessment are rounded to the nearest whole number to result in the final score.|Participants|Number|0|0.0||||||
3655065|NCT02425826|3501703|B3|5 = Very Severe||Static Physician’s Global Assessment (sPGA) Score|The Static Physician’s Global Assessment (sPGA) is the assessment by the investigator of the overall disease severity at the time of evaluation. The National Psoriasis Foundation Psoriasis Score version of a static PGA is calculated by averaging the total body erythema, induration, and desquamation scores. Erythema (E), induration (I), and desquamation (D) are scored on a 6-point scale, ranging from 0 (clear) to 5 (very severe), with an overall sPGA calculated as (E + I + D)/3. Scores for each assessment are rounded to the nearest whole number to result in the final score.|Participants|Number|0|0.0||||||
3655066|NCT02425826|3501704|B2|5 = Very Severe||Static Physician’s Global Assessment (sPGA) Score|The Static Physician’s Global Assessment (sPGA) is the assessment by the investigator of the overall disease severity at the time of evaluation. The National Psoriasis Foundation Psoriasis Score version of a static PGA is calculated by averaging the total body erythema, induration, and desquamation scores. Erythema (E), induration (I), and desquamation (D) are scored on a 6-point scale, ranging from 0 (clear) to 5 (very severe), with an overall sPGA calculated as (E + I + D)/3. Scores for each assessment are rounded to the nearest whole number to result in the final score.|Participants|Number|0|0.0||||||
3655067|NCT02425826|3501705|B1|5 = Very Severe||Static Physician’s Global Assessment (sPGA) Score|The Static Physician’s Global Assessment (sPGA) is the assessment by the investigator of the overall disease severity at the time of evaluation. The National Psoriasis Foundation Psoriasis Score version of a static PGA is calculated by averaging the total body erythema, induration, and desquamation scores. Erythema (E), induration (I), and desquamation (D) are scored on a 6-point scale, ranging from 0 (clear) to 5 (very severe), with an overall sPGA calculated as (E + I + D)/3. Scores for each assessment are rounded to the nearest whole number to result in the final score.|Participants|Number|0|0.0||||||
3655068|NCT02425826|3501703|B3|4 =Severe||Static Physician’s Global Assessment (sPGA) Score|The Static Physician’s Global Assessment (sPGA) is the assessment by the investigator of the overall disease severity at the time of evaluation. The National Psoriasis Foundation Psoriasis Score version of a static PGA is calculated by averaging the total body erythema, induration, and desquamation scores. Erythema (E), induration (I), and desquamation (D) are scored on a 6-point scale, ranging from 0 (clear) to 5 (very severe), with an overall sPGA calculated as (E + I + D)/3. Scores for each assessment are rounded to the nearest whole number to result in the final score.|Participants|Number|6|6.0||||||
3655069|NCT02425826|3501704|B2|4 =Severe||Static Physician’s Global Assessment (sPGA) Score|The Static Physician’s Global Assessment (sPGA) is the assessment by the investigator of the overall disease severity at the time of evaluation. The National Psoriasis Foundation Psoriasis Score version of a static PGA is calculated by averaging the total body erythema, induration, and desquamation scores. Erythema (E), induration (I), and desquamation (D) are scored on a 6-point scale, ranging from 0 (clear) to 5 (very severe), with an overall sPGA calculated as (E + I + D)/3. Scores for each assessment are rounded to the nearest whole number to result in the final score.|Participants|Number|3|3.0||||||
3655070|NCT02425826|3501705|B1|4 =Severe||Static Physician’s Global Assessment (sPGA) Score|The Static Physician’s Global Assessment (sPGA) is the assessment by the investigator of the overall disease severity at the time of evaluation. The National Psoriasis Foundation Psoriasis Score version of a static PGA is calculated by averaging the total body erythema, induration, and desquamation scores. Erythema (E), induration (I), and desquamation (D) are scored on a 6-point scale, ranging from 0 (clear) to 5 (very severe), with an overall sPGA calculated as (E + I + D)/3. Scores for each assessment are rounded to the nearest whole number to result in the final score.|Participants|Number|3|3.0||||||
3655071|NCT02425826|3501703|B3|3 = Moderate||Static Physician’s Global Assessment (sPGA) Score|The Static Physician’s Global Assessment (sPGA) is the assessment by the investigator of the overall disease severity at the time of evaluation. The National Psoriasis Foundation Psoriasis Score version of a static PGA is calculated by averaging the total body erythema, induration, and desquamation scores. Erythema (E), induration (I), and desquamation (D) are scored on a 6-point scale, ranging from 0 (clear) to 5 (very severe), with an overall sPGA calculated as (E + I + D)/3. Scores for each assessment are rounded to the nearest whole number to result in the final score.|Participants|Number|214|214.0||||||
3655072|NCT02425826|3501704|B2|3 = Moderate||Static Physician’s Global Assessment (sPGA) Score|The Static Physician’s Global Assessment (sPGA) is the assessment by the investigator of the overall disease severity at the time of evaluation. The National Psoriasis Foundation Psoriasis Score version of a static PGA is calculated by averaging the total body erythema, induration, and desquamation scores. Erythema (E), induration (I), and desquamation (D) are scored on a 6-point scale, ranging from 0 (clear) to 5 (very severe), with an overall sPGA calculated as (E + I + D)/3. Scores for each assessment are rounded to the nearest whole number to result in the final score.|Participants|Number|144|144.0||||||
3655073|NCT02425826|3501705|B1|3 = Moderate||Static Physician’s Global Assessment (sPGA) Score|The Static Physician’s Global Assessment (sPGA) is the assessment by the investigator of the overall disease severity at the time of evaluation. The National Psoriasis Foundation Psoriasis Score version of a static PGA is calculated by averaging the total body erythema, induration, and desquamation scores. Erythema (E), induration (I), and desquamation (D) are scored on a 6-point scale, ranging from 0 (clear) to 5 (very severe), with an overall sPGA calculated as (E + I + D)/3. Scores for each assessment are rounded to the nearest whole number to result in the final score.|Participants|Number|70|70.0||||||
3655074|NCT02425826|3501703|B3|2 = Mild||Static Physician’s Global Assessment (sPGA) Score|The Static Physician’s Global Assessment (sPGA) is the assessment by the investigator of the overall disease severity at the time of evaluation. The National Psoriasis Foundation Psoriasis Score version of a static PGA is calculated by averaging the total body erythema, induration, and desquamation scores. Erythema (E), induration (I), and desquamation (D) are scored on a 6-point scale, ranging from 0 (clear) to 5 (very severe), with an overall sPGA calculated as (E + I + D)/3. Scores for each assessment are rounded to the nearest whole number to result in the final score.|Participants|Number|0|0.0||||||
3655075|NCT02425826|3501704|B2|2 = Mild||Static Physician’s Global Assessment (sPGA) Score|The Static Physician’s Global Assessment (sPGA) is the assessment by the investigator of the overall disease severity at the time of evaluation. The National Psoriasis Foundation Psoriasis Score version of a static PGA is calculated by averaging the total body erythema, induration, and desquamation scores. Erythema (E), induration (I), and desquamation (D) are scored on a 6-point scale, ranging from 0 (clear) to 5 (very severe), with an overall sPGA calculated as (E + I + D)/3. Scores for each assessment are rounded to the nearest whole number to result in the final score.|Participants|Number|0|0.0||||||
3655076|NCT02425826|3501705|B1|2 = Mild||Static Physician’s Global Assessment (sPGA) Score|The Static Physician’s Global Assessment (sPGA) is the assessment by the investigator of the overall disease severity at the time of evaluation. The National Psoriasis Foundation Psoriasis Score version of a static PGA is calculated by averaging the total body erythema, induration, and desquamation scores. Erythema (E), induration (I), and desquamation (D) are scored on a 6-point scale, ranging from 0 (clear) to 5 (very severe), with an overall sPGA calculated as (E + I + D)/3. Scores for each assessment are rounded to the nearest whole number to result in the final score.|Participants|Number|0|0.0||||||
3655077|NCT02425826|3501703|B3|1 = Almost Clear||Static Physician’s Global Assessment (sPGA) Score|The Static Physician’s Global Assessment (sPGA) is the assessment by the investigator of the overall disease severity at the time of evaluation. The National Psoriasis Foundation Psoriasis Score version of a static PGA is calculated by averaging the total body erythema, induration, and desquamation scores. Erythema (E), induration (I), and desquamation (D) are scored on a 6-point scale, ranging from 0 (clear) to 5 (very severe), with an overall sPGA calculated as (E + I + D)/3. Scores for each assessment are rounded to the nearest whole number to result in the final score.|Participants|Number|0|0.0||||||
3655078|NCT02425826|3501704|B2|1 = Almost Clear||Static Physician’s Global Assessment (sPGA) Score|The Static Physician’s Global Assessment (sPGA) is the assessment by the investigator of the overall disease severity at the time of evaluation. The National Psoriasis Foundation Psoriasis Score version of a static PGA is calculated by averaging the total body erythema, induration, and desquamation scores. Erythema (E), induration (I), and desquamation (D) are scored on a 6-point scale, ranging from 0 (clear) to 5 (very severe), with an overall sPGA calculated as (E + I + D)/3. Scores for each assessment are rounded to the nearest whole number to result in the final score.|Participants|Number|0|0.0||||||
3655079|NCT02425826|3501705|B1|1 = Almost Clear||Static Physician’s Global Assessment (sPGA) Score|The Static Physician’s Global Assessment (sPGA) is the assessment by the investigator of the overall disease severity at the time of evaluation. The National Psoriasis Foundation Psoriasis Score version of a static PGA is calculated by averaging the total body erythema, induration, and desquamation scores. Erythema (E), induration (I), and desquamation (D) are scored on a 6-point scale, ranging from 0 (clear) to 5 (very severe), with an overall sPGA calculated as (E + I + D)/3. Scores for each assessment are rounded to the nearest whole number to result in the final score.|Participants|Number|0|0.0||||||
3655080|NCT02425826|3501703|B3|||Body Surface Area (BSA)|Body Surface Area (BSA) is a measurement of involved skin. The overall BSA affected by psoriasis is estimated based on the palm area of the participant’s hand (entire palmar surface or “handprint”), which equates to approximately 1% of total body surface area.|percent affected|Mean|7.2|7.2|Standard Deviation|1.66|1.66|||
3655081|NCT02425826|3501704|B2|||Body Surface Area (BSA)|Body Surface Area (BSA) is a measurement of involved skin. The overall BSA affected by psoriasis is estimated based on the palm area of the participant’s hand (entire palmar surface or “handprint”), which equates to approximately 1% of total body surface area.|percent affected|Mean|7.2|7.2|Standard Deviation|1.61|1.61|||
3655082|NCT02425826|3501705|B1|||Body Surface Area (BSA)|Body Surface Area (BSA) is a measurement of involved skin. The overall BSA affected by psoriasis is estimated based on the palm area of the participant’s hand (entire palmar surface or “handprint”), which equates to approximately 1% of total body surface area.|percent affected|Mean|7.1|7.1|Standard Deviation|1.75|1.75|||
3655083|NCT02425826|3501703|B3||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3655084|NCT02425826|3501704|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3655085|NCT02425826|3501705|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3655086|NCT02425826|3501703|B3||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3655087|NCT02425826|3501704|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3655088|NCT02425826|3501705|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3655089|NCT02425826|3501703|B3|||Age||years|Mean|49.4|49.4|Standard Deviation|14.89|14.89|||
3655090|NCT02425826|3501704|B2|||Age||years|Mean|48.6|48.6|Standard Deviation|15.41|15.41|||
3655091|NCT02425826|3501705|B1|||Age||years|Mean|51.1|51.1|Standard Deviation|13.74|13.74|||
3655092|NCT02425826|3501703|B3||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
3655093|NCT02425826|3501704|B2||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
3655094|NCT02425826|3501705|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3655095|NCT02425826|3501703|B3||Between 18 and 65 years|Age||Participants|Count of Participants|180|180.0||||||
3655096|NCT02425826|3501704|B2||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
3655097|NCT02425826|3501705|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3655098|NCT02425826|3501703|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3655099|NCT02425826|3501704|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3655100|NCT02425826|3501705|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3655101|NCT02425449|3501740|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3655102|NCT02425449|3501741|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3655103|NCT02425449|3501742|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3655104|NCT02425449|3501743|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3655105|NCT02425449|3501744|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3655106|NCT02425449|3501740|B6||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3655107|NCT02425449|3501741|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3655108|NCT02425449|3501742|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3655109|NCT02425449|3501743|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3655110|NCT02425449|3501744|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3655111|NCT02425449|3501740|B6|||Age||years|Mean|36.9|36.9|Standard Deviation|8.4|8.4|||
3655112|NCT02425449|3501741|B5|||Age||years|Mean|36.2|36.2|Standard Deviation|12.8|12.8|||
3655113|NCT02425449|3501742|B4|||Age||years|Mean|37.4|37.4|Standard Deviation|6.2|6.2|||
3655114|NCT02425449|3501743|B3|||Age||years|Mean|38.4|38.4|Standard Deviation|11.1|11.1|||
3655115|NCT02425449|3501744|B2|||Age||years|Mean|35.3|35.3|Standard Deviation|6.7|6.7|||
3655116|NCT02425111|3501761|B1|||Number of Participants with Endoscopic Remission|Endoscopic remission is defined as a simple endoscopic score for Crohn's Disease (SES-CD) score of ≤4.|Participants|Count of Participants|3|3.0||||||
3655117|NCT02425111|3501761|B1|N/A (Participant is a Male)||Female Reproductive Status||Participants|Count of Participants|52|52.0||||||
3655118|NCT02425111|3501761|B1|Female of Childbearing Potential||Female Reproductive Status||Participants|Count of Participants|34|34.0||||||
3655119|NCT02425111|3501761|B1|Surgically Sterile||Female Reproductive Status||Participants|Count of Participants|9|9.0||||||
3655120|NCT02425111|3501761|B1|Postmenopausal||Female Reproductive Status||Participants|Count of Participants|6|6.0||||||
3655121|NCT02425111|3501761|B1|Participant is an ex-smoker||Smoking Classification||Participants|Count of Participants|22|22.0||||||
3655122|NCT02425111|3501761|B1|Participant is a current smoker||Smoking Classification||Participants|Count of Participants|33|33.0||||||
3655123|NCT02425111|3501761|B1|Participant has never smoked||Smoking Classification||Participants|Count of Participants|46|46.0||||||
3655124|NCT02425111|3501761|B1|||Body Mass Index (BMI)|Body Mass Index = weight (kg)/[height (m)^2]|kg/m^2|Mean|24.71|24.71|Standard Deviation|5.365|5.365|||
3655125|NCT02425111|3501761|B1|||Weight||kg|Mean|73.94|73.94|Standard Deviation|18.795|18.795|||
3655126|NCT02425111|3501761|B1|||Height||cm|Mean|172.5|172.5|Standard Deviation|9.81|9.81|||
3655127|NCT02425111|3501761|B1|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3655128|NCT02425111|3501761|B1|Poland||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3655129|NCT02425111|3501761|B1|Italy||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3655130|NCT02425111|3501761|B1|Hungary||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3655131|NCT02425111|3501761|B1|France||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3655132|NCT02425111|3501761|B1|Czech Republic||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3655133|NCT02425111|3501761|B1|Canada||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3655134|NCT02425111|3501761|B1|Belgium||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3655135|NCT02425111|3501761|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|98|98.0||||||
3655136|NCT02425111|3501761|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3655137|NCT02425111|3501761|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3655138|NCT02425111|3501761|B1|Not Collected||Race/Ethnicity, Customized|Ethnicity was collected only in the United States.|Participants|Count of Participants|68|68.0||||||
3655139|NCT02425111|3501761|B1|Non-Hispanic and Latino||Race/Ethnicity, Customized|Ethnicity was collected only in the United States.|Participants|Count of Participants|32|32.0||||||
3655140|NCT02425111|3501761|B1|Hispanic or Latino||Race/Ethnicity, Customized|Ethnicity was collected only in the United States.|Participants|Count of Participants|1|1.0||||||
3655141|NCT02425111|3501761|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3655142|NCT02425111|3501761|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3655143|NCT02425111|3501761|B1|||Age||years|Mean|38.0|38.0|Standard Deviation|14.00|14.0|||
3655144|NCT02424734|3501780|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655145|NCT02424734|3501781|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655146|NCT02424734|3501782|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655147|NCT02424734|3501783|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655148|NCT02424734|3501780|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655149|NCT02424734|3501781|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655150|NCT02424734|3501782|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655151|NCT02424734|3501783|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655152|NCT02424734|3501780|B4||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3655153|NCT02424734|3501781|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3655154|NCT02424734|3501782|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3655155|NCT02424734|3501783|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3655156|NCT02424734|3501780|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655157|NCT02424734|3501781|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655158|NCT02424734|3501782|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655159|NCT02424734|3501783|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655160|NCT02424734|3501780|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655161|NCT02424734|3501781|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655162|NCT02424734|3501782|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655163|NCT02424734|3501783|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655164|NCT02424734|3501780|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3655165|NCT02424734|3501781|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655166|NCT02424734|3501782|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655167|NCT02424734|3501783|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3655168|NCT02424734|3501780|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655169|NCT02424734|3501781|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655170|NCT02424734|3501782|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655171|NCT02424734|3501783|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655172|NCT02424734|3501780|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655173|NCT02424734|3501781|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655174|NCT02424734|3501782|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655175|NCT02424734|3501783|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655176|NCT02424734|3501780|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3655177|NCT02424734|3501781|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3655178|NCT02424734|3501782|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3655179|NCT02424734|3501783|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3655180|NCT02424734|3501780|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3655181|NCT02424734|3501781|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655182|NCT02424734|3501782|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3655183|NCT02424734|3501783|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655184|NCT02424734|3501780|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3655185|NCT02424734|3501781|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3655186|NCT02424734|3501782|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3655187|NCT02424734|3501783|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3655188|NCT02424734|3501780|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3655189|NCT02424734|3501781|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3655190|NCT02424734|3501782|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3655191|NCT02424734|3501783|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3655192|NCT02424734|3501780|B4|||Age||days|Mean|30.3|30.3|Standard Deviation|14.78|14.78|||
3655193|NCT02424734|3501781|B3|||Age||days|Mean|15.5|15.5|Standard Deviation|4.95|4.95|||
3655194|NCT02424734|3501782|B2|||Age||days|Mean|22.0|22.0|Standard Deviation|3.81|3.81|||
3655195|NCT02424734|3501783|B1|||Age||days|Mean|48.0|48.0|Standard Deviation|4.69|4.69|||
3655196|NCT02424591|3501802|B3||III|American Society of Anesthesiologists Physical Status Score|"The American Society of Anesthesiologists Physical Status Score is assigned by the anesthesiologist at the time of providing care, based on the following definitions:~ASA I - A normal healthy patient ASA II - A patient with mild systemic disease ASA III - A patient with severe systemic disease ASA IV - A patient with severe systemic disease that is a constant threat to life ASA V - A moribund patient who is not expected to survive without the operation ASA VI - A declared brain-dead patient whose organs are being removed for donor purposes"|Participants|Count of Participants|21|21.0||||||
3655197|NCT02424591|3501803|B2||III|American Society of Anesthesiologists Physical Status Score|"The American Society of Anesthesiologists Physical Status Score is assigned by the anesthesiologist at the time of providing care, based on the following definitions:~ASA I - A normal healthy patient ASA II - A patient with mild systemic disease ASA III - A patient with severe systemic disease ASA IV - A patient with severe systemic disease that is a constant threat to life ASA V - A moribund patient who is not expected to survive without the operation ASA VI - A declared brain-dead patient whose organs are being removed for donor purposes"|Participants|Count of Participants|11|11.0||||||
3655198|NCT02424591|3501804|B1||III|American Society of Anesthesiologists Physical Status Score|"The American Society of Anesthesiologists Physical Status Score is assigned by the anesthesiologist at the time of providing care, based on the following definitions:~ASA I - A normal healthy patient ASA II - A patient with mild systemic disease ASA III - A patient with severe systemic disease ASA IV - A patient with severe systemic disease that is a constant threat to life ASA V - A moribund patient who is not expected to survive without the operation ASA VI - A declared brain-dead patient whose organs are being removed for donor purposes"|Participants|Count of Participants|10|10.0||||||
3655199|NCT02424591|3501802|B3||II|American Society of Anesthesiologists Physical Status Score|"The American Society of Anesthesiologists Physical Status Score is assigned by the anesthesiologist at the time of providing care, based on the following definitions:~ASA I - A normal healthy patient ASA II - A patient with mild systemic disease ASA III - A patient with severe systemic disease ASA IV - A patient with severe systemic disease that is a constant threat to life ASA V - A moribund patient who is not expected to survive without the operation ASA VI - A declared brain-dead patient whose organs are being removed for donor purposes"|Participants|Count of Participants|18|18.0||||||
3655200|NCT02424591|3501803|B2||II|American Society of Anesthesiologists Physical Status Score|"The American Society of Anesthesiologists Physical Status Score is assigned by the anesthesiologist at the time of providing care, based on the following definitions:~ASA I - A normal healthy patient ASA II - A patient with mild systemic disease ASA III - A patient with severe systemic disease ASA IV - A patient with severe systemic disease that is a constant threat to life ASA V - A moribund patient who is not expected to survive without the operation ASA VI - A declared brain-dead patient whose organs are being removed for donor purposes"|Participants|Count of Participants|8|8.0||||||
3655201|NCT02424591|3501804|B1||II|American Society of Anesthesiologists Physical Status Score|"The American Society of Anesthesiologists Physical Status Score is assigned by the anesthesiologist at the time of providing care, based on the following definitions:~ASA I - A normal healthy patient ASA II - A patient with mild systemic disease ASA III - A patient with severe systemic disease ASA IV - A patient with severe systemic disease that is a constant threat to life ASA V - A moribund patient who is not expected to survive without the operation ASA VI - A declared brain-dead patient whose organs are being removed for donor purposes"|Participants|Count of Participants|10|10.0||||||
3655246|NCT02424578|3501817|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3655247|NCT02424578|3501815|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655202|NCT02424591|3501802|B3||I|American Society of Anesthesiologists Physical Status Score|"The American Society of Anesthesiologists Physical Status Score is assigned by the anesthesiologist at the time of providing care, based on the following definitions:~ASA I - A normal healthy patient ASA II - A patient with mild systemic disease ASA III - A patient with severe systemic disease ASA IV - A patient with severe systemic disease that is a constant threat to life ASA V - A moribund patient who is not expected to survive without the operation ASA VI - A declared brain-dead patient whose organs are being removed for donor purposes"|Participants|Count of Participants|1|1.0||||||
3655203|NCT02424591|3501803|B2||I|American Society of Anesthesiologists Physical Status Score|"The American Society of Anesthesiologists Physical Status Score is assigned by the anesthesiologist at the time of providing care, based on the following definitions:~ASA I - A normal healthy patient ASA II - A patient with mild systemic disease ASA III - A patient with severe systemic disease ASA IV - A patient with severe systemic disease that is a constant threat to life ASA V - A moribund patient who is not expected to survive without the operation ASA VI - A declared brain-dead patient whose organs are being removed for donor purposes"|Participants|Count of Participants|1|1.0||||||
3655204|NCT02424591|3501804|B1||I|American Society of Anesthesiologists Physical Status Score|"The American Society of Anesthesiologists Physical Status Score is assigned by the anesthesiologist at the time of providing care, based on the following definitions:~ASA I - A normal healthy patient ASA II - A patient with mild systemic disease ASA III - A patient with severe systemic disease ASA IV - A patient with severe systemic disease that is a constant threat to life ASA V - A moribund patient who is not expected to survive without the operation ASA VI - A declared brain-dead patient whose organs are being removed for donor purposes"|Participants|Count of Participants|0|0.0||||||
3655205|NCT02424591|3501802|B3|||Visual Analog Scale (VAS) Pain Score|The Visual Analog Scale is a way to measure pain, with zero being no pain at all and 10 being the most terrible pain.|points|Median|6|6.0|Inter-Quartile Range|||3.0|8.0|
3655206|NCT02424591|3501803|B2|||Visual Analog Scale (VAS) Pain Score|The Visual Analog Scale is a way to measure pain, with zero being no pain at all and 10 being the most terrible pain.|points|Median|3.5|3.5|Inter-Quartile Range|||2.8|7.0|
3655207|NCT02424591|3501804|B1|||Visual Analog Scale (VAS) Pain Score|The Visual Analog Scale is a way to measure pain, with zero being no pain at all and 10 being the most terrible pain.|points|Median|7|7.0|Inter-Quartile Range|||5.0|8.0|
3655208|NCT02424591|3501802|B3|||Prior Back Surgery||Participants|Count of Participants|24|24.0||||||
3655209|NCT02424591|3501803|B2|||Prior Back Surgery||Participants|Count of Participants|13|13.0||||||
3655210|NCT02424591|3501804|B1|||Prior Back Surgery||Participants|Count of Participants|11|11.0||||||
3655211|NCT02424591|3501802|B3|||Preoperative Opioid Use||Participants|Count of Participants|17|17.0||||||
3655212|NCT02424591|3501803|B2|||Preoperative Opioid Use||Participants|Count of Participants|8|8.0||||||
3655213|NCT02424591|3501804|B1|||Preoperative Opioid Use||Participants|Count of Participants|9|9.0||||||
3655214|NCT02424591|3501802|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3655215|NCT02424591|3501803|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3655216|NCT02424591|3501804|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3655217|NCT02424591|3501802|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3655218|NCT02424591|3501803|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3655219|NCT02424591|3501804|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3655220|NCT02424591|3501802|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3655221|NCT02424591|3501803|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3655222|NCT02424591|3501804|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3655223|NCT02424591|3501802|B3|||Age||years|Median|65|65.0|Inter-Quartile Range|||54.0|72.0|
3655224|NCT02424591|3501803|B2|||Age||years|Median|65|65.0|Inter-Quartile Range|||53.0|72.0|
3655225|NCT02424591|3501804|B1|||Age||years|Median|65|65.0|Inter-Quartile Range|||56.0|72.0|
3655226|NCT02424578|3501815|B3||>/=35 kg|Weight Group||Participants|Count of Participants|23|23.0||||||
3655227|NCT02424578|3501816|B2||>/=35 kg|Weight Group||Participants|Count of Participants|15|15.0||||||
3655228|NCT02424578|3501817|B1||>/=35 kg|Weight Group||Participants|Count of Participants|8|8.0||||||
3655229|NCT02424578|3501815|B3||>/=18 to <35 kg|Weight Group||Participants|Count of Participants|7|7.0||||||
3655230|NCT02424578|3501816|B2||>/=18 to <35 kg|Weight Group||Participants|Count of Participants|0|0.0||||||
3655231|NCT02424578|3501817|B1||>/=18 to <35 kg|Weight Group||Participants|Count of Participants|7|7.0||||||
3655232|NCT02424578|3501815|B3|||Weight||kg|Mean|57.34|57.34|Standard Deviation|24.693|24.693|||
3655233|NCT02424578|3501816|B2|||Weight||kg|Mean|74.44|74.44|Standard Deviation|18.974|18.974|||
3655234|NCT02424578|3501817|B1|||Weight||kg|Mean|40.20|40.2|Standard Deviation|16.628|16.628|||
3655235|NCT02424578|3501815|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3655236|NCT02424578|3501816|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3655237|NCT02424578|3501817|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3655238|NCT02424578|3501815|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3655239|NCT02424578|3501816|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3655240|NCT02424578|3501817|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655241|NCT02424578|3501815|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3655242|NCT02424578|3501816|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3655243|NCT02424578|3501817|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3655244|NCT02424578|3501815|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3655245|NCT02424578|3501816|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3655248|NCT02424578|3501816|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655249|NCT02424578|3501817|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655250|NCT02424578|3501815|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655251|NCT02424578|3501816|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655252|NCT02424578|3501817|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655253|NCT02424578|3501815|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655254|NCT02424578|3501816|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655255|NCT02424578|3501817|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655256|NCT02424578|3501815|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655257|NCT02424578|3501816|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655258|NCT02424578|3501817|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655259|NCT02424578|3501815|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3655260|NCT02424578|3501816|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3655261|NCT02424578|3501817|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3655262|NCT02424578|3501815|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655263|NCT02424578|3501816|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655264|NCT02424578|3501817|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655265|NCT02424578|3501815|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3655266|NCT02424578|3501816|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3655267|NCT02424578|3501817|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3655268|NCT02424578|3501815|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3655269|NCT02424578|3501816|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3655270|NCT02424578|3501817|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3655271|NCT02424578|3501815|B3|||Age||years|Mean|11.6|11.6|Standard Deviation|3.05|3.05|||
3655272|NCT02424578|3501816|B2|||Age||years|Mean|14.1|14.1|Standard Deviation|1.51|1.51|||
3655273|NCT02424578|3501817|B1|||Age||years|Mean|9.0|9.0|Standard Deviation|1.69|1.69|||
3655274|NCT02424578|3501815|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3655275|NCT02424578|3501816|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3655276|NCT02424578|3501817|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3655277|NCT02424578|3501815|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3655278|NCT02424578|3501816|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3655279|NCT02424578|3501817|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3655280|NCT02424578|3501815|B3||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
3655281|NCT02424578|3501816|B2||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
3655282|NCT02424578|3501817|B1||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
3655283|NCT02424565|3501824|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655284|NCT02424565|3501824|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655285|NCT02424565|3501824|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655286|NCT02424565|3501824|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655287|NCT02424565|3501824|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655288|NCT02424565|3501824|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3655289|NCT02424565|3501824|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655290|NCT02424565|3501824|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3655291|NCT02424565|3501824|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3655292|NCT02424565|3501824|B1|||Age||Years|Mean|49.9|49.9|Standard Deviation|8.0|8.0|||
3655293|NCT02424357|3501831|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3655294|NCT02424357|3501832|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3655295|NCT02424357|3501833|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3655296|NCT02424357|3501831|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3655297|NCT02424357|3501832|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3655298|NCT02424357|3501833|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3655299|NCT02424357|3501831|B3|||Age||years|Mean|47.6|47.6|Standard Deviation|17.3|17.3|||
3655300|NCT02424357|3501832|B2|||Age||years|Mean|46.6|46.6|Standard Deviation|18.1|18.1|||
3655301|NCT02424357|3501833|B1|||Age||years|Mean|48.5|48.5|Standard Deviation|16.8|16.8|||
3655302|NCT02424344|3501842|B3||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3655303|NCT02424344|3501843|B2||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3655304|NCT02424344|3501844|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3655305|NCT02424344|3501842|B3||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3655306|NCT02424344|3501843|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3655307|NCT02424344|3501844|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3655308|NCT02424344|3501842|B3|||Age||Years|Mean|62.3|62.3|Standard Deviation|7.8|7.8|||
3655309|NCT02424344|3501843|B2|||Age||Years|Mean|62.1|62.1|Standard Deviation|7.7|7.7|||
3655310|NCT02424344|3501844|B1|||Age||Years|Mean|62.6|62.6|Standard Deviation|7.9|7.9|||
3655311|NCT02424149|3501855|B3|||Surgical procedure performed: prolapse repair with laparoscopic hysterectomy|Number of study participants who underwent surgical repair of pelvic organ prolapse with a concomitant laparoscopic hysterectomy.|participants|Number|13|13.0||||||
3655312|NCT02424149|3501856|B2|||Surgical procedure performed: prolapse repair with laparoscopic hysterectomy|Number of study participants who underwent surgical repair of pelvic organ prolapse with a concomitant laparoscopic hysterectomy.|participants|Number|6|6.0||||||
3655313|NCT02424149|3501857|B1|||Surgical procedure performed: prolapse repair with laparoscopic hysterectomy|Number of study participants who underwent surgical repair of pelvic organ prolapse with a concomitant laparoscopic hysterectomy.|participants|Number|7|7.0||||||
3655314|NCT02424149|3501855|B3|||Surgical procedure performed: prolapse repair with abdominal hysterectomy|Number of study participants who underwent surgical repair of pelvic organ prolapse with a concomitant abdominal hysterectomy.|participants|Number|2|2.0||||||
3655315|NCT02424149|3501856|B2|||Surgical procedure performed: prolapse repair with abdominal hysterectomy|Number of study participants who underwent surgical repair of pelvic organ prolapse with a concomitant abdominal hysterectomy.|participants|Number|1|1.0||||||
3655316|NCT02424149|3501857|B1|||Surgical procedure performed: prolapse repair with abdominal hysterectomy|Number of study participants who underwent surgical repair of pelvic organ prolapse with a concomitant abdominal hysterectomy.|participants|Number|1|1.0||||||
3655317|NCT02424149|3501855|B3|||Surgical procedure performed: prolapse repair with vaginal hysterectomy|Number of study participants who underwent surgical repair of pelvic organ prolapse with a concomitant vaginal hysterectomy.|participants|Number|45|45.0||||||
3655318|NCT02424149|3501856|B2|||Surgical procedure performed: prolapse repair with vaginal hysterectomy|Number of study participants who underwent surgical repair of pelvic organ prolapse with a concomitant vaginal hysterectomy.|participants|Number|18|18.0||||||
3655319|NCT02424149|3501857|B1|||Surgical procedure performed: prolapse repair with vaginal hysterectomy|Number of study participants who underwent surgical repair of pelvic organ prolapse with a concomitant vaginal hysterectomy.|participants|Number|27|27.0||||||
3655320|NCT02424149|3501855|B3|||Surgical procedure performed: prolapse repair without hysterectomy|Subjects who underwent surgical treatment of pelvic organ prolapse without a concomitant hysterectomy.|participants|Number|41|41.0||||||
3655321|NCT02424149|3501856|B2|||Surgical procedure performed: prolapse repair without hysterectomy|Subjects who underwent surgical treatment of pelvic organ prolapse without a concomitant hysterectomy.|participants|Number|25|25.0||||||
3655322|NCT02424149|3501857|B1|||Surgical procedure performed: prolapse repair without hysterectomy|Subjects who underwent surgical treatment of pelvic organ prolapse without a concomitant hysterectomy.|participants|Number|16|16.0||||||
3655323|NCT02424149|3501855|B3|||Surgical procedure performed: concomitant incontinence procedure|Number of participants who underwent an incontinence procedure in addition to surgery for pelvic organ prolapse|participants|Number|42|42.0||||||
3655324|NCT02424149|3501856|B2|||Surgical procedure performed: concomitant incontinence procedure|Number of participants who underwent an incontinence procedure in addition to surgery for pelvic organ prolapse|participants|Number|21|21.0||||||
3655325|NCT02424149|3501857|B1|||Surgical procedure performed: concomitant incontinence procedure|Number of participants who underwent an incontinence procedure in addition to surgery for pelvic organ prolapse|participants|Number|21|21.0||||||
3655326|NCT02424149|3501855|B3|||Stage II or greater prolapse: posterior|Pelvic organ prolapse is assessed by physical exam using the Pelvic Organ Prolpase Quantification scale. The results of the exam findings are then classified into prolapse stages which range from 0 (no prolapse ) to IV (complete prolapse). Each compartment (anterior / bladder, apical / uterus / vaginal cuff, and posterior / rectum) is assigned a stage.|participants|Number|72|72.0||||||
3655327|NCT02424149|3501856|B2|||Stage II or greater prolapse: posterior|Pelvic organ prolapse is assessed by physical exam using the Pelvic Organ Prolpase Quantification scale. The results of the exam findings are then classified into prolapse stages which range from 0 (no prolapse ) to IV (complete prolapse). Each compartment (anterior / bladder, apical / uterus / vaginal cuff, and posterior / rectum) is assigned a stage.|participants|Number|34|34.0||||||
3655328|NCT02424149|3501857|B1|||Stage II or greater prolapse: posterior|Pelvic organ prolapse is assessed by physical exam using the Pelvic Organ Prolpase Quantification scale. The results of the exam findings are then classified into prolapse stages which range from 0 (no prolapse ) to IV (complete prolapse). Each compartment (anterior / bladder, apical / uterus / vaginal cuff, and posterior / rectum) is assigned a stage.|participants|Number|38|38.0||||||
3655329|NCT02424149|3501855|B3|||Stage II or greater prolapse: apical|Pelvic organ prolapse is assessed by physical exam using the Pelvic Organ Prolpase Quantification scale. The results of the exam findings are then classified into prolapse stages which range from 0 (no prolapse ) to IV (complete prolapse). Each compartment (anterior / bladder, apical / uterus / vaginal cuff, and posterior / rectum) is assigned a stage.|participants|Number|43|43.0||||||
3655330|NCT02424149|3501856|B2|||Stage II or greater prolapse: apical|Pelvic organ prolapse is assessed by physical exam using the Pelvic Organ Prolpase Quantification scale. The results of the exam findings are then classified into prolapse stages which range from 0 (no prolapse ) to IV (complete prolapse). Each compartment (anterior / bladder, apical / uterus / vaginal cuff, and posterior / rectum) is assigned a stage.|participants|Number|24|24.0||||||
3655331|NCT02424149|3501857|B1|||Stage II or greater prolapse: apical|Pelvic organ prolapse is assessed by physical exam using the Pelvic Organ Prolpase Quantification scale. The results of the exam findings are then classified into prolapse stages which range from 0 (no prolapse ) to IV (complete prolapse). Each compartment (anterior / bladder, apical / uterus / vaginal cuff, and posterior / rectum) is assigned a stage.|participants|Number|19|19.0||||||
3655379|NCT02424097|3501874|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3655380|NCT02424097|3501872|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3655381|NCT02424097|3501873|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3655332|NCT02424149|3501855|B3|||Stage II or greater prolapse: anterior|Pelvic organ prolapse is assessed by physical exam using the Pelvic Organ Prolpase Quantification scale. The results of the exam findings are then classified into prolapse stages which range from 0 (no prolapse ) to IV (complete prolapse). Each compartment (anterior / bladder, apical / uterus / vaginal cuff, and posterior / rectum) is assigned a stage.|participants|Number|92|92.0||||||
3655333|NCT02424149|3501856|B2|||Stage II or greater prolapse: anterior|Pelvic organ prolapse is assessed by physical exam using the Pelvic Organ Prolpase Quantification scale. The results of the exam findings are then classified into prolapse stages which range from 0 (no prolapse ) to IV (complete prolapse). Each compartment (anterior / bladder, apical / uterus / vaginal cuff, and posterior / rectum) is assigned a stage.|participants|Number|46|46.0||||||
3655334|NCT02424149|3501857|B1|||Stage II or greater prolapse: anterior|Pelvic organ prolapse is assessed by physical exam using the Pelvic Organ Prolpase Quantification scale. The results of the exam findings are then classified into prolapse stages which range from 0 (no prolapse ) to IV (complete prolapse). Each compartment (anterior / bladder, apical / uterus / vaginal cuff, and posterior / rectum) is assigned a stage.|participants|Number|46|46.0||||||
3655335|NCT02424149|3501855|B3|||Surgical indication: incontinence||participants|Number|35|35.0||||||
3655336|NCT02424149|3501856|B2|||Surgical indication: incontinence||participants|Number|14|14.0||||||
3655337|NCT02424149|3501857|B1|||Surgical indication: incontinence||participants|Number|21|21.0||||||
3655338|NCT02424149|3501855|B3|||Surgical indication: prolapse||participants|Number|100|100.0||||||
3655339|NCT02424149|3501856|B2|||Surgical indication: prolapse||participants|Number|49|49.0||||||
3655340|NCT02424149|3501857|B1|||Surgical indication: prolapse||participants|Number|51|51.0||||||
3655341|NCT02424149|3501855|B3|||History of urinary tract surgery||participants|Number|15|15.0||||||
3655342|NCT02424149|3501856|B2|||History of urinary tract surgery||participants|Number|9|9.0||||||
3655343|NCT02424149|3501857|B1|||History of urinary tract surgery||participants|Number|6|6.0||||||
3655344|NCT02424149|3501855|B3|||History or prolapse surgery||participants|Number|19|19.0||||||
3655345|NCT02424149|3501856|B2|||History or prolapse surgery||participants|Number|12|12.0||||||
3655346|NCT02424149|3501857|B1|||History or prolapse surgery||participants|Number|7|7.0||||||
3655347|NCT02424149|3501855|B3|||Serum creatinine||mg/dL|Mean|0.65|0.65|Standard Deviation|0.32|0.32|||
3655348|NCT02424149|3501856|B2|||Serum creatinine||mg/dL|Mean|0.63|0.63|Standard Deviation|0.35|0.35|||
3655349|NCT02424149|3501857|B1|||Serum creatinine||mg/dL|Mean|0.66|0.66|Standard Deviation|0.28|0.28|||
3655350|NCT02424149|3501855|B3|||Charlson comorbidity index|The Charlson co-morbidity index is a scale used in longitudinal studies to estimate relative risk of death from prognostic clinical covariates. Age and comorbidities are evaluated to produce a score. Minimum score is zero, there is no maximum score. Zero is predicts no risk of death based on age and comorbidities.|scale score|Mean|2.13|2.13|Standard Deviation|1.3|1.3|||
3655351|NCT02424149|3501856|B2|||Charlson comorbidity index|The Charlson co-morbidity index is a scale used in longitudinal studies to estimate relative risk of death from prognostic clinical covariates. Age and comorbidities are evaluated to produce a score. Minimum score is zero, there is no maximum score. Zero is predicts no risk of death based on age and comorbidities.|scale score|Mean|2.31|2.31|Standard Deviation|1.1|1.1|||
3655352|NCT02424149|3501857|B1|||Charlson comorbidity index|The Charlson co-morbidity index is a scale used in longitudinal studies to estimate relative risk of death from prognostic clinical covariates. Age and comorbidities are evaluated to produce a score. Minimum score is zero, there is no maximum score. Zero is predicts no risk of death based on age and comorbidities.|scale score|Mean|1.96|1.96|Standard Deviation|1.5|1.5|||
3655353|NCT02424149|3501855|B3|United States||Region of Enrollment||participants|Number|104|104.0||||||
3655354|NCT02424149|3501856|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
3655355|NCT02424149|3501857|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
3655356|NCT02424149|3501855|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3655357|NCT02424149|3501856|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3655358|NCT02424149|3501857|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3655359|NCT02424149|3501855|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3655360|NCT02424149|3501856|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3655361|NCT02424149|3501857|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3655362|NCT02424149|3501855|B3|||Age||years|Mean|60.19|60.19|Standard Deviation|10.89|10.89|||
3655363|NCT02424149|3501856|B2|||Age||years|Mean|62.7|62.7|Standard Deviation|9.8|9.8|||
3655364|NCT02424149|3501857|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|11.3|11.3|||
3655365|NCT02424097|3501872|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3655366|NCT02424097|3501873|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3655367|NCT02424097|3501874|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3655368|NCT02424097|3501872|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3655369|NCT02424097|3501873|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3655370|NCT02424097|3501874|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3655371|NCT02424097|3501872|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3655372|NCT02424097|3501873|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3655373|NCT02424097|3501874|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3655374|NCT02424097|3501872|B3|||Age||years|Mean|16.1|16.1|Standard Deviation|3.8|3.8|||
3655375|NCT02424097|3501873|B2|||Age||years|Mean|16.5|16.5|Standard Deviation|3.8|3.8|||
3655376|NCT02424097|3501874|B1|||Age||years|Mean|15.1|15.1|Standard Deviation|3.8|3.8|||
3655377|NCT02424097|3501872|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3655378|NCT02424097|3501873|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3655382|NCT02424097|3501874|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3655383|NCT02424097|3501872|B3||<=18 years|Age||Participants|Count of Participants|34|34.0||||||
3655384|NCT02424097|3501873|B2||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
3655385|NCT02424097|3501874|B1||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
3655386|NCT02423993|3501883|B5|Russian Federation||Region of Enrollment||participants|Number|77|77.0||||||
3655387|NCT02423993|3501884|B4|Russian Federation||Region of Enrollment||participants|Number|19|19.0||||||
3655388|NCT02423993|3501885|B3|Russian Federation||Region of Enrollment||participants|Number|23|23.0||||||
3655389|NCT02423993|3501886|B2|Russian Federation||Region of Enrollment||participants|Number|16|16.0||||||
3655390|NCT02423993|3501887|B1|Russian Federation||Region of Enrollment||participants|Number|19|19.0||||||
3655391|NCT02423993|3501883|B5||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3655392|NCT02423993|3501884|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3655393|NCT02423993|3501885|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3655394|NCT02423993|3501886|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3655395|NCT02423993|3501887|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3655396|NCT02423993|3501883|B5||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3655397|NCT02423993|3501884|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3655398|NCT02423993|3501885|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3655399|NCT02423993|3501886|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3655400|NCT02423993|3501887|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3655401|NCT02423993|3501883|B5|||Age||years|Median|26.5|26.5|Inter-Quartile Range|||24.0|36.0|
3655402|NCT02423993|3501884|B4|||Age||years|Median|23|23.0|Inter-Quartile Range|||19.0|28.0|
3655403|NCT02423993|3501885|B3|||Age||years|Median|27|27.0|Inter-Quartile Range|||25.0|35.0|
3655404|NCT02423993|3501886|B2|||Age||years|Median|33|33.0|Inter-Quartile Range|||25.0|36.0|
3655405|NCT02423993|3501887|B1|||Age||years|Median|29.5|29.5|Inter-Quartile Range|||29.0|36.0|
3655406|NCT02423993|3501883|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3655407|NCT02423993|3501884|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3655408|NCT02423993|3501885|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3655409|NCT02423993|3501886|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3655410|NCT02423993|3501887|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3655411|NCT02423993|3501883|B5||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
3655412|NCT02423993|3501884|B4||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3655413|NCT02423993|3501885|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3655414|NCT02423993|3501886|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3655415|NCT02423993|3501887|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3655416|NCT02423993|3501883|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3655417|NCT02423993|3501884|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3655418|NCT02423993|3501885|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3655419|NCT02423993|3501886|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3655420|NCT02423993|3501887|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3655421|NCT02423980|3501920|B1|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3655422|NCT02423980|3501920|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655423|NCT02423980|3501920|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655424|NCT02423980|3501920|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3655425|NCT02423980|3501920|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655426|NCT02423980|3501920|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655427|NCT02423980|3501920|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3655428|NCT02423980|3501920|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655429|NCT02423980|3501920|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655430|NCT02423980|3501920|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3655431|NCT02423980|3501920|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3655432|NCT02423980|3501920|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3655433|NCT02423980|3501920|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3655434|NCT02423980|3501920|B1|||Age||years|Median|42|42.0|Full Range|||23.0|59.0|
3655435|NCT02423798|3501930|B1|Europe||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3655436|NCT02423798|3501930|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3655437|NCT02423798|3501930|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3655438|NCT02423798|3501930|B1|||Age||Years|Mean|40.6|40.6|Standard Deviation|13.3|13.3|||
3655439|NCT02423577|3501936|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|79|79.0||||||
3655440|NCT02423577|3501937|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3655441|NCT02423577|3501938|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|53|53.0||||||
3655442|NCT02423577|3501936|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655443|NCT02423577|3501937|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655444|NCT02423577|3501938|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655445|NCT02423577|3501936|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3655446|NCT02423577|3501937|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3655447|NCT02423577|3501938|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3655448|NCT02423577|3501936|B3||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3655449|NCT02423577|3501937|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3655450|NCT02423577|3501938|B1||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3655451|NCT02423577|3501936|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3655452|NCT02423577|3501937|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655453|NCT02423577|3501938|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3655454|NCT02423577|3501936|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3655455|NCT02423577|3501937|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3655456|NCT02423577|3501938|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655457|NCT02423577|3501936|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3655458|NCT02423577|3501937|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3655459|NCT02423577|3501938|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3655460|NCT02423577|3501936|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655461|NCT02423577|3501937|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655462|NCT02423577|3501938|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655463|NCT02423577|3501936|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655464|NCT02423577|3501937|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655465|NCT02423577|3501938|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655466|NCT02423577|3501936|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3655467|NCT02423577|3501937|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3655468|NCT02423577|3501938|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3655469|NCT02423577|3501936|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3655470|NCT02423577|3501937|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3655471|NCT02423577|3501938|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3655472|NCT02423577|3501936|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3655473|NCT02423577|3501937|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3655474|NCT02423577|3501938|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3655475|NCT02423577|3501936|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3655476|NCT02423577|3501937|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3655477|NCT02423577|3501938|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3655478|NCT02423577|3501936|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3655479|NCT02423577|3501937|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3655480|NCT02423577|3501938|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3655481|NCT02423577|3501936|B3||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
3655482|NCT02423577|3501937|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3655483|NCT02423577|3501938|B1||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
3655484|NCT02423577|3501936|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3655485|NCT02423577|3501937|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3655486|NCT02423577|3501938|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3655487|NCT02423447|3501945|B1|||Basline Pulmonary Function (FEV1)||Liters|Mean|2.42|2.42|Standard Deviation|20.28|20.28|||
3655488|NCT02423447|3501945|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3655489|NCT02423447|3501945|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3655490|NCT02423447|3501945|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3655491|NCT02423447|3501945|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3655492|NCT02423447|3501945|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3655493|NCT02423408|3501960|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3655494|NCT02423408|3501961|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3655495|NCT02423408|3501962|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3655496|NCT02423408|3501960|B3||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3655497|NCT02423408|3501961|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3655498|NCT02423408|3501962|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3655499|NCT02423408|3501960|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3655500|NCT02423408|3501961|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3655501|NCT02423408|3501962|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3655502|NCT02423408|3501960|B3||Between 18 and 65 years|Age||Participants|Count of Participants|165|165.0||||||
3655503|NCT02423408|3501961|B2||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
3655504|NCT02423408|3501962|B1||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
3655505|NCT02423408|3501960|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3655506|NCT02423408|3501961|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3655507|NCT02423408|3501962|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3655508|NCT02423317|3501975|B3|||Weight||Kg|Mean|16.2|16.2|Standard Deviation|3.2|3.2|||
3655509|NCT02423317|3501976|B2|||Weight||Kg|Mean|16.5|16.5|Standard Deviation|3.87|3.87|||
3655510|NCT02423317|3501977|B1|||Weight||Kg|Mean|15.9|15.9|Standard Deviation|2.53|2.53|||
3655511|NCT02423317|3501975|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3655512|NCT02423317|3501976|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3655513|NCT02423317|3501977|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3655514|NCT02423317|3501975|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3655515|NCT02423317|3501976|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3655516|NCT02423317|3501977|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3655517|NCT02423317|3501975|B3|||Age||years|Mean|5.775|5.775|Standard Deviation|2.21|2.21|||
3655518|NCT02423317|3501976|B2|||Age||years|Mean|6.15|6.15|Standard Deviation|2.64|2.64|||
3655519|NCT02423317|3501977|B1|||Age||years|Mean|5.4|5.4|Standard Deviation|1.78|1.78|||
3655520|NCT02423291|3501996|B1|Italy||Region of Enrollment||participants|Number|15|15.0||||||
3655521|NCT02423291|3501996|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3655522|NCT02423291|3501996|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3655523|NCT02423291|3501996|B1|||Age||years|Mean|37|37.0|Standard Deviation|18.63|18.63|||
3655524|NCT02423291|3501996|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3655525|NCT02423291|3501996|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3655526|NCT02423291|3501996|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3655527|NCT02423200|3502000|B3|United States||Region of Enrollment||count of participants|Number|9|9.0||||||
3655528|NCT02423200|3502001|B2|United States||Region of Enrollment||count of participants|Number|1|1.0||||||
3655529|NCT02423200|3502002|B1|United States||Region of Enrollment||count of participants|Number|8|8.0||||||
3655530|NCT02423200|3502000|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3655531|NCT02423200|3502001|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3655532|NCT02423200|3502002|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3655533|NCT02423200|3502000|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3655534|NCT02423200|3502001|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3655535|NCT02423200|3502002|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3655536|NCT02423200|3502000|B3|||Age||years|Median|71|71.0|Full Range|||66.0|74.0|
3655537|NCT02423200|3502001|B2|||Age||years|Median|68|68.0|Full Range|||68.0|68.0|
3655538|NCT02423200|3502002|B1|||Age||years|Median|71|71.0|Full Range|||66.0|74.0|
3655539|NCT02423109|3502011|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3655540|NCT02423109|3502011|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3655541|NCT02423109|3502011|B1|||Age||years|Mean|24|24.0|Standard Deviation|5|5.0|||
3655542|NCT02422940|3502020|B3|United States||Region of Enrollment||Participants|Count of Participants|277|277.0||||||
3655543|NCT02422940|3502021|B2|United States||Region of Enrollment||Participants|Count of Participants|133|133.0||||||
3655544|NCT02422940|3502022|B1|United States||Region of Enrollment||Participants|Count of Participants|144|144.0||||||
3655545|NCT02422940|3502020|B3|Canada||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3655546|NCT02422940|3502021|B2|Canada||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3655547|NCT02422940|3502022|B1|Canada||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3655548|NCT02422940|3502020|B3||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
3655549|NCT02422940|3502021|B2||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3655550|NCT02422940|3502022|B1||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3655551|NCT02422940|3502020|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3655552|NCT02422940|3502021|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3655553|NCT02422940|3502022|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3655554|NCT02422940|3502020|B3|||Age||years|Mean|63.3|63.3|Standard Deviation|10.67|10.67|||
3655555|NCT02422940|3502021|B2|||Age||years|Mean|64.6|64.6|Standard Deviation|10.32|10.32|||
3655556|NCT02422940|3502022|B1|||Age||years|Mean|62.1|62.1|Standard Deviation|10.87|10.87|||
3655557|NCT02422940|3502020|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3655558|NCT02422940|3502021|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3655559|NCT02422940|3502022|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3655560|NCT02422940|3502020|B3||Between 18 and 65 years|Age||Participants|Count of Participants|294|294.0||||||
3655561|NCT02422940|3502021|B2||Between 18 and 65 years|Age||Participants|Count of Participants|142|142.0||||||
3655562|NCT02422940|3502022|B1||Between 18 and 65 years|Age||Participants|Count of Participants|152|152.0||||||
3655563|NCT02422940|3502020|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3655564|NCT02422940|3502021|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3655565|NCT02422940|3502022|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3655566|NCT02422797|3502043|B3|African American/ African H. and White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3655567|NCT02422797|3502044|B2|African American/ African H. and White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3655568|NCT02422797|3502045|B1|African American/ African H. and White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3655569|NCT02422797|3502043|B3|White||Race/Ethnicity, Customized||Participants|Number|433|433.0||||||
3655570|NCT02422797|3502044|B2|White||Race/Ethnicity, Customized||Participants|Number|210|210.0||||||
3655571|NCT02422797|3502045|B1|White||Race/Ethnicity, Customized||Participants|Number|223|223.0||||||
3655572|NCT02422797|3502043|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3655573|NCT02422797|3502044|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3655574|NCT02422797|3502045|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3655575|NCT02422797|3502043|B3|Black/African American||Race/Ethnicity, Customized||Participants|Number|33|33.0||||||
3655576|NCT02422797|3502044|B2|Black/African American||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
3655577|NCT02422797|3502045|B1|Black/African American||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
3655578|NCT02422797|3502043|B3|Japanese/East Asian (EA) Heritage (H.)/South EA H.||Race/Ethnicity, Customized||Participants|Number|28|28.0||||||
3655579|NCT02422797|3502044|B2|Japanese/East Asian (EA) Heritage (H.)/South EA H.||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
3655580|NCT02422797|3502045|B1|Japanese/East Asian (EA) Heritage (H.)/South EA H.||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
3655581|NCT02422797|3502043|B3|Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3655582|NCT02422797|3502044|B2|Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3655583|NCT02422797|3502045|B1|Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3655584|NCT02422797|3502043|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
3655585|NCT02422797|3502044|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3655586|NCT02422797|3502045|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3655587|NCT02422797|3502043|B3||Male|Sex: Female, Male||Participants|Count of Participants|397|397.0||||||
3655588|NCT02422797|3502044|B2||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
3655589|NCT02422797|3502045|B1||Male|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
3655590|NCT02422797|3502043|B3||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3655591|NCT02422797|3502044|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3655592|NCT02422797|3502045|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3655593|NCT02422797|3502043|B3|||Age||Years|Mean|43.3|43.3|Standard Deviation|10.52|10.52|||
3655594|NCT02422797|3502044|B2|||Age||Years|Mean|43.2|43.2|Standard Deviation|9.64|9.64|||
3655595|NCT02422797|3502045|B1|||Age||Years|Mean|43.3|43.3|Standard Deviation|11.34|11.34|||
3655596|NCT02422615|3502116|B3|Unkown||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3655597|NCT02422615|3502117|B2|Unkown||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3655598|NCT02422615|3502118|B1|Unkown||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3655599|NCT02422615|3502116|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3655600|NCT02422615|3502117|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3655601|NCT02422615|3502118|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3655602|NCT02422615|3502116|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3655603|NCT02422615|3502117|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3655604|NCT02422615|3502118|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3655605|NCT02422615|3502116|B3|Native American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3655606|NCT02422615|3502117|B2|Native American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3655607|NCT02422615|3502118|B1|Native American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3655608|NCT02422615|3502116|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|63|63.0||||||
3655609|NCT02422615|3502117|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3655610|NCT02422615|3502118|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|45|45.0||||||
3655611|NCT02422615|3502116|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|619|619.0||||||
3655612|NCT02422615|3502117|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|213|213.0||||||
3655613|NCT02422615|3502118|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|406|406.0||||||
3655614|NCT02422615|3502116|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3655615|NCT02422615|3502117|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3655616|NCT02422615|3502118|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3655617|NCT02422615|3502116|B3||Female|Sex: Female, Male||Participants|Count of Participants|726|726.0||||||
3655618|NCT02422615|3502117|B2||Female|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
3655619|NCT02422615|3502118|B1||Female|Sex: Female, Male||Participants|Count of Participants|484|484.0||||||
3655620|NCT02422615|3502116|B3|||Age||Years|Mean|63.2|63.2|Standard Deviation|10.05|10.05|||
3655621|NCT02422615|3502117|B2|||Age||Years|Mean|62.8|62.8|Standard Deviation|10.59|10.59|||
3655622|NCT02422615|3502118|B1|||Age||Years|Mean|63.4|63.4|Standard Deviation|9.78|9.78|||
3655623|NCT02422446|3502125|B3|||Triglycerides||mg/dl|Mean|199|199.0|Full Range|||177.0|221.0|
3655624|NCT02422446|3502126|B2|||Triglycerides||mg/dl|Mean|177|177.0|Full Range|||177.0|177.0|
3655625|NCT02422446|3502127|B1|||Triglycerides||mg/dl|Mean|221|221.0|Full Range|||221.0|221.0|
3655626|NCT02422446|3502125|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655627|NCT02422446|3502126|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655628|NCT02422446|3502127|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655629|NCT02422446|3502125|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655630|NCT02422446|3502126|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655631|NCT02422446|3502127|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655632|NCT02422446|3502125|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3655633|NCT02422446|3502126|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3655634|NCT02422446|3502127|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3655635|NCT02422446|3502125|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655636|NCT02422446|3502126|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655637|NCT02422446|3502127|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655638|NCT02422446|3502125|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655639|NCT02422446|3502126|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655640|NCT02422446|3502127|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655641|NCT02422446|3502125|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655642|NCT02422446|3502126|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655643|NCT02422446|3502127|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655644|NCT02422446|3502125|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655645|NCT02422446|3502126|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655646|NCT02422446|3502127|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655647|NCT02422446|3502125|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3655648|NCT02422446|3502126|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3655649|NCT02422446|3502127|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3655650|NCT02422446|3502125|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3655651|NCT02422446|3502126|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3655652|NCT02422446|3502127|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3655653|NCT02422446|3502125|B3|||Age||years|Mean|63|63.0|Full Range|||57.0|69.0|
3655654|NCT02422446|3502126|B2|||Age||years|Mean|57|57.0|Full Range|||57.0|57.0|
3655655|NCT02422446|3502127|B1|||Age||years|Mean|69|69.0|Full Range|||69.0|69.0|
3655656|NCT02422303|3502134|B3|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3655657|NCT02422303|3502135|B2|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3655658|NCT02422303|3502136|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3655659|NCT02422303|3502134|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3655660|NCT02422303|3502135|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3655661|NCT02422303|3502136|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3655662|NCT02422303|3502134|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3655663|NCT02422303|3502135|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3655664|NCT02422303|3502136|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3655665|NCT02422303|3502134|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3655666|NCT02422303|3502135|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3655667|NCT02422303|3502136|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3655668|NCT02422303|3502134|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3655669|NCT02422303|3502135|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3655670|NCT02422303|3502136|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3655671|NCT02422303|3502134|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3655672|NCT02422303|3502135|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3655673|NCT02422303|3502136|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3655674|NCT02421419|3502143|B4|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3655675|NCT02421419|3502144|B3|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3655676|NCT02421419|3502145|B2|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3655677|NCT02421419|3502146|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3655678|NCT02421419|3502143|B4|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3655679|NCT02421419|3502143|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3655680|NCT02421419|3502144|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3655681|NCT02421419|3502145|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3655682|NCT02421419|3502146|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3655683|NCT02421419|3502143|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3655684|NCT02421419|3502144|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3655685|NCT02421419|3502145|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3655686|NCT02421419|3502146|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3655687|NCT02421419|3502143|B4||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3655688|NCT02421419|3502144|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3655689|NCT02421419|3502145|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3655690|NCT02421419|3502146|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3655691|NCT02421419|3502143|B4||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3655692|NCT02421419|3502144|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3655693|NCT02421419|3502145|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3655694|NCT02421419|3502146|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3655695|NCT02421419|3502143|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3655696|NCT02421419|3502144|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3655697|NCT02421419|3502145|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3655698|NCT02421419|3502146|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3655699|NCT02421211|3502165|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3655700|NCT02421211|3502166|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3655701|NCT02421211|3502167|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3655702|NCT02421211|3502165|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3655703|NCT02421211|3502166|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3655704|NCT02421211|3502167|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3655705|NCT02421211|3502165|B3|||Age||years|Median|51|51.0|Full Range|||25.0|70.0|
3655706|NCT02421211|3502166|B2|||Age||years|Median|51|51.0|Full Range|||26.0|62.0|
3655707|NCT02421211|3502167|B1|||Age||years|Median|50.5|50.5|Full Range|||25.0|70.0|
3655708|NCT02421146|3502212|B5|United States||Region of Enrollment||participants|Number|12|12.0||||||
3655709|NCT02421146|3502213|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
3655710|NCT02421146|3502214|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3655711|NCT02421146|3502215|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3655712|NCT02421146|3502216|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3655713|NCT02421146|3502212|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3655714|NCT02421146|3502213|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3655715|NCT02421146|3502214|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3655716|NCT02421146|3502215|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3655717|NCT02421146|3502216|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3655718|NCT02421146|3502212|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3655719|NCT02421146|3502213|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3655720|NCT02421146|3502214|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3655721|NCT02421146|3502215|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3655722|NCT02421146|3502216|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3655723|NCT02421146|3502212|B5|||Age||years|Mean|34.8|34.8|Full Range|||25.0|51.0|
3655724|NCT02421146|3502213|B4|||Age||years|Mean|38.3|38.3|Full Range|||31.0|45.0|
3655725|NCT02421146|3502214|B3|||Age||years|Mean|40.7|40.7|Full Range|||31.0|51.0|
3655726|NCT02421146|3502215|B2|||Age||years|Mean|29.5|29.5|Full Range|||25.0|36.0|
3655727|NCT02421146|3502216|B1|||Age||years|Mean|31|31.0|Full Range|||26.0|36.0|
3655728|NCT02421146|3502212|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3655729|NCT02421146|3502213|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3655730|NCT02421146|3502214|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3655731|NCT02421146|3502215|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3655732|NCT02421146|3502216|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3655733|NCT02421146|3502212|B5||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3655734|NCT02421146|3502213|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3655735|NCT02421146|3502214|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3655736|NCT02421146|3502215|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3655737|NCT02421146|3502216|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3655738|NCT02421146|3502212|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3655739|NCT02421146|3502213|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3655740|NCT02421146|3502214|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3655741|NCT02421146|3502215|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3655742|NCT02421146|3502216|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3655743|NCT02421120|3502233|B1|||Creatinine Clearance||milliliters per minute|Mean|117.7|117.7|Full Range|||62.0|197.0|
3655744|NCT02421120|3502233|B1|||Height||centimeters|Mean|161.8|161.8|Standard Deviation|8.29|8.29|||
3655745|NCT02421120|3502233|B1|||Weight||kilograms|Mean|53.2|53.2|Standard Deviation|8.2|8.2|||
3655746|NCT02421120|3502233|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3655747|NCT02421120|3502233|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655748|NCT02421120|3502233|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655749|NCT02421120|3502233|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3655750|NCT02421120|3502233|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655751|NCT02421120|3502233|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655752|NCT02421120|3502233|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655753|NCT02421120|3502233|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655754|NCT02421120|3502233|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3655755|NCT02421120|3502233|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3655756|NCT02421120|3502233|B1|||Age||years|Mean|25.4|25.4|Full Range|||18.0|53.0|
3655757|NCT02420951|3502241|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3655758|NCT02420951|3502242|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3655759|NCT02420951|3502243|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3655760|NCT02420951|3502241|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3655761|NCT02420951|3502242|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3655762|NCT02420951|3502243|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3655763|NCT02420951|3502241|B3|||Age||years|Mean|67.7|67.7|Full Range|||50.0|81.0|
3655764|NCT02420951|3502242|B2|||Age||years|Mean|66.44|66.44|Full Range|||50.0|79.0|
3655765|NCT02420951|3502243|B1|||Age||years|Mean|68.96|68.96|Full Range|||57.0|81.0|
3655766|NCT02420951|3502241|B3||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
3655767|NCT02420951|3502242|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3655768|NCT02420951|3502243|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3655769|NCT02420951|3502241|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3655770|NCT02420951|3502242|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3655771|NCT02420951|3502243|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3655772|NCT02420951|3502241|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3655773|NCT02420951|3502242|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3655774|NCT02420951|3502243|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3655775|NCT02420873|3502260|B4|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3655776|NCT02420873|3502263|B1|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3655777|NCT02420873|3502260|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655778|NCT02420873|3502261|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655779|NCT02420873|3502262|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655780|NCT02420873|3502263|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655781|NCT02420873|3502260|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655782|NCT02420873|3502261|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655783|NCT02420873|3502262|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655784|NCT02420873|3502263|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655785|NCT02420873|3502260|B4||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3655786|NCT02420873|3502261|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655787|NCT02420873|3502262|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655788|NCT02420873|3502263|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3655789|NCT02420873|3502260|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3655790|NCT02420873|3502261|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655791|NCT02420873|3502262|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655792|NCT02420873|3502263|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3655793|NCT02420873|3502260|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655794|NCT02420873|3502261|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655795|NCT02420873|3502262|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655796|NCT02420873|3502263|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655797|NCT02420873|3502260|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3655798|NCT02420873|3502261|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655799|NCT02420873|3502262|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655800|NCT02420873|3502263|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3655801|NCT02420873|3502260|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655802|NCT02420873|3502261|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655803|NCT02420873|3502262|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655804|NCT02420873|3502263|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655805|NCT02420873|3502260|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3655806|NCT02420873|3502261|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3655807|NCT02420873|3502262|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3655808|NCT02420873|3502263|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3655809|NCT02420873|3502260|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3655810|NCT02420873|3502261|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3655811|NCT02420873|3502262|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3655812|NCT02420873|3502263|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3655813|NCT02420873|3502260|B4|||Age||years|Median|58|58.0|Full Range|||28.0|72.0|
3655814|NCT02420873|3502263|B1|||Age||years|Median|58|58.0|Full Range|||28.0|72.0|
3655815|NCT02420873|3502260|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3655816|NCT02420873|3502261|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3655817|NCT02420873|3502262|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3655818|NCT02420873|3502263|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3655819|NCT02420873|3502260|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3655820|NCT02420873|3502261|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3655821|NCT02420873|3502262|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3655822|NCT02420873|3502263|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3655823|NCT02420873|3502260|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3655824|NCT02420873|3502261|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3655825|NCT02420873|3502262|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3655826|NCT02420873|3502263|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3655827|NCT02420821|3502273|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3655828|NCT02420821|3502274|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3655829|NCT02420821|3502275|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3655830|NCT02420821|3502273|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655831|NCT02420821|3502274|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655832|NCT02420821|3502275|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655833|NCT02420821|3502273|B3||White|Race (NIH/OMB)||Participants|Count of Participants|660|660.0||||||
3655834|NCT02420821|3502274|B2||White|Race (NIH/OMB)||Participants|Count of Participants|326|326.0||||||
3655835|NCT02420821|3502275|B1||White|Race (NIH/OMB)||Participants|Count of Participants|334|334.0||||||
3655836|NCT02420821|3502273|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3655837|NCT02420821|3502274|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3655838|NCT02420821|3502275|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3655839|NCT02420821|3502273|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3655840|NCT02420821|3502274|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3655841|NCT02420821|3502275|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655842|NCT02420821|3502273|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|171|171.0||||||
3655843|NCT02420821|3502274|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3655844|NCT02420821|3502275|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3655845|NCT02420821|3502273|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3655846|NCT02420821|3502274|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3655847|NCT02420821|3502275|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3655848|NCT02420821|3502273|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
3655849|NCT02420821|3502274|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3655850|NCT02420821|3502275|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3655851|NCT02420821|3502273|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|777|777.0||||||
3655852|NCT02420821|3502274|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|391|391.0||||||
3655853|NCT02420821|3502275|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|386|386.0||||||
3655854|NCT02420821|3502273|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3655855|NCT02420821|3502274|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3655856|NCT02420821|3502275|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3655857|NCT02420821|3502273|B3||Male|Sex: Female, Male||Participants|Count of Participants|669|669.0||||||
3655858|NCT02420821|3502274|B2||Male|Sex: Female, Male||Participants|Count of Participants|317|317.0||||||
3655859|NCT02420821|3502275|B1||Male|Sex: Female, Male||Participants|Count of Participants|352|352.0||||||
3655860|NCT02420821|3502273|B3||Female|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
3655861|NCT02420821|3502274|B2||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3655862|NCT02420821|3502275|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3655863|NCT02420821|3502273|B3|||Age||years|Mean|60.7|60.7|Standard Deviation|10.2|10.2|||
3655864|NCT02420821|3502274|B2|||Age||years|Mean|61.6|61.6|Standard Deviation|10.4|10.4|||
3655865|NCT02420821|3502275|B1|||Age||years|Mean|59.9|59.9|Standard Deviation|9.9|9.9|||
3655866|NCT02420327|3502344|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
3655867|NCT02420327|3502344|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3655868|NCT02420327|3502344|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3655869|NCT02420327|3502344|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3655870|NCT02420327|3502344|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3655871|NCT02420327|3502344|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655872|NCT02420327|3502344|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3655873|NCT02420327|3502344|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655874|NCT02420327|3502344|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655875|NCT02420327|3502344|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3655876|NCT02420327|3502344|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3655877|NCT02420327|3502344|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3655878|NCT02420327|3502344|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3655879|NCT02420327|3502344|B1|||Age||years|Mean|33.3|33.3|Standard Deviation|10.5|10.5|||
3655880|NCT02420262|3502378|B3|||Body Weight||kg|Mean|87.7|87.7|Standard Deviation|16.6|16.6|||
3655881|NCT02420262|3502379|B2|||Body Weight||kg|Mean|88.2|88.2|Standard Deviation|17.2|17.2|||
3655882|NCT02420262|3502380|B1|||Body Weight||kg|Mean|87.2|87.2|Standard Deviation|16.0|16.0|||
3655883|NCT02420262|3502378|B3|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.22|8.22|Standard Deviation|0.78|0.78|||
3655884|NCT02420262|3502379|B2|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.24|8.24|Standard Deviation|0.81|0.81|||
3655885|NCT02420262|3502380|B1|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.21|8.21|Standard Deviation|0.76|0.76|||
3655886|NCT02420262|3502378|B3||Male|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
3655887|NCT02420262|3502379|B2||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3655888|NCT02420262|3502380|B1||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3655889|NCT02420262|3502378|B3||Female|Sex: Female, Male||Participants|Count of Participants|279|279.0||||||
3655890|NCT02420262|3502379|B2||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3655891|NCT02420262|3502380|B1||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3655892|NCT02420262|3502378|B3|||Age||years|Mean|58.3|58.3|Standard Deviation|8.8|8.8|||
3655893|NCT02420262|3502379|B2|||Age||years|Mean|58.0|58.0|Standard Deviation|8.6|8.6|||
3655894|NCT02420262|3502380|B1|||Age||years|Mean|58.6|58.6|Standard Deviation|9.0|9.0|||
3655895|NCT02420210|3502395|B1|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3655896|NCT02420210|3502395|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655897|NCT02420210|3502395|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655898|NCT02420210|3502395|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3655899|NCT02420210|3502395|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3655900|NCT02420210|3502395|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655901|NCT02420210|3502395|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655902|NCT02420210|3502395|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3655903|NCT02420210|3502395|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3655904|NCT02420210|3502395|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3655905|NCT02420210|3502395|B1|||Age||years|Mean|89.5|89.5|Full Range|||88.0|91.0|
3655906|NCT02420093|3502405|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
3655907|NCT02420093|3502406|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3655908|NCT02420093|3502407|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3655909|NCT02420093|3502405|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3655910|NCT02420093|3502406|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3655911|NCT02420093|3502407|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3655912|NCT02420093|3502405|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3655913|NCT02420093|3502406|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3655914|NCT02420093|3502407|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3655915|NCT02420093|3502405|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3655916|NCT02420093|3502406|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3655917|NCT02420093|3502407|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3655918|NCT02420093|3502405|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3655919|NCT02420093|3502406|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3655920|NCT02420093|3502407|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3655921|NCT02420093|3502405|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3655922|NCT02420093|3502406|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3655923|NCT02420093|3502407|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3655924|NCT02420041|3502422|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
3655925|NCT02420041|3502423|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3655926|NCT02420041|3502424|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3655927|NCT02420041|3502422|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3655928|NCT02420041|3502423|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3655929|NCT02420041|3502424|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3655930|NCT02420041|3502422|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3655931|NCT02420041|3502423|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3655932|NCT02420041|3502424|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3655933|NCT02420041|3502422|B3|||Age||years|Mean|35.535|35.535|Standard Deviation|7.9435|7.9435|||
3655934|NCT02420041|3502423|B2|||Age||years|Mean|34.07|34.07|Standard Deviation|8.2695|8.2695|||
3655935|NCT02420041|3502424|B1|||Age||years|Mean|37|37.0|Standard Deviation|7.6175|7.6175|||
3655936|NCT02419937|3502449|B3|United States||Region of Enrollment|Demographics of study participants|Participants|Count of Participants|28|28.0||||||
3655937|NCT02419937|3502450|B2|United States||Region of Enrollment|Demographics of study participants|Participants|Count of Participants|16|16.0||||||
3655938|NCT02419937|3502451|B1|United States||Region of Enrollment|Demographics of study participants|Participants|Count of Participants|12|12.0||||||
3655939|NCT02419937|3502449|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3655940|NCT02419937|3502450|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3655941|NCT02419937|3502451|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3655942|NCT02419937|3502449|B3|Caucasian (White)||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3655943|NCT02419937|3502450|B2|Caucasian (White)||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3655944|NCT02419937|3502451|B1|Caucasian (White)||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3655945|NCT02419937|3502449|B3|African American (Black)||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3655946|NCT02419937|3502450|B2|African American (Black)||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3655947|NCT02419937|3502451|B1|African American (Black)||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3655948|NCT02419937|3502449|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3655949|NCT02419937|3502450|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3655950|NCT02419937|3502451|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3655951|NCT02419937|3502449|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3655952|NCT02419937|3502450|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3655953|NCT02419937|3502451|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3655954|NCT02419937|3502449|B3|||Age||years|Mean|69.2|69.2|Standard Deviation|9.8|9.8|||
3655955|NCT02419937|3502450|B2|||Age||years|Mean|67.7|67.7|Standard Deviation|9.5|9.5|||
3655956|NCT02419937|3502451|B1|||Age||years|Mean|70.7|70.7|Standard Deviation|10.0|10.0|||
3655957|NCT02419937|3502449|B3||>=65 years|Age|Age at the time of enrollment|Participants|Count of Participants|16|16.0||||||
3655958|NCT02419937|3502450|B2||>=65 years|Age|Age at the time of enrollment|Participants|Count of Participants|7|7.0||||||
3655959|NCT02419937|3502451|B1||>=65 years|Age|Age at the time of enrollment|Participants|Count of Participants|9|9.0||||||
3655960|NCT02419937|3502449|B3||Between 18 and 65 years|Age|Age at the time of enrollment|Participants|Count of Participants|12|12.0||||||
3655961|NCT02419937|3502450|B2||Between 18 and 65 years|Age|Age at the time of enrollment|Participants|Count of Participants|9|9.0||||||
3655962|NCT02419937|3502451|B1||Between 18 and 65 years|Age|Age at the time of enrollment|Participants|Count of Participants|3|3.0||||||
3655963|NCT02419937|3502449|B3||<=18 years|Age|Age at the time of enrollment|Participants|Count of Participants|0|0.0||||||
3655964|NCT02419937|3502450|B2||<=18 years|Age|Age at the time of enrollment|Participants|Count of Participants|0|0.0||||||
3655965|NCT02419937|3502451|B1||<=18 years|Age|Age at the time of enrollment|Participants|Count of Participants|0|0.0||||||
3655966|NCT02419755|3502458|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3655967|NCT02419755|3502459|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3655968|NCT02419755|3502460|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3655969|NCT02419755|3502458|B3||Asian and White|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3655970|NCT02419755|3502459|B2||Asian and White|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3655971|NCT02419755|3502460|B1||Asian and White|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3655972|NCT02419755|3502458|B3||South or Central American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3655973|NCT02419755|3502459|B2||South or Central American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3655974|NCT02419755|3502460|B1||South or Central American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3655975|NCT02419755|3502458|B3||Non Spanish speaking, Non Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3655976|NCT02419755|3502459|B2||Non Spanish speaking, Non Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3655977|NCT02419755|3502460|B1||Non Spanish speaking, Non Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3655978|NCT02419755|3502458|B3||Not Otherwise Specified, Spanish, Hispanic, Latino|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3655979|NCT02419755|3502459|B2||Not Otherwise Specified, Spanish, Hispanic, Latino|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3655980|NCT02419755|3502460|B1||Not Otherwise Specified, Spanish, Hispanic, Latino|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3655981|NCT02419755|3502458|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3655982|NCT02419755|3502459|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3655983|NCT02419755|3502460|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3655984|NCT02419755|3502458|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3655985|NCT02419755|3502459|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3655986|NCT02419755|3502460|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3655987|NCT02419755|3502458|B3|||Age||years|Mean|4.10869|4.10869|Standard Deviation|4.08824|4.08824|||
3655988|NCT02419755|3502459|B2|||Age||years|Mean|4.58224|4.58224|Standard Deviation|5.33903|5.33903|||
3655989|NCT02419755|3502460|B1|||Age||years|Mean|3.39836|3.39836|Standard Deviation|1.22932|1.22932|||
3655990|NCT02419612|3502485|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|399|399.0||||||
3655991|NCT02419612|3502486|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|195|195.0||||||
3655992|NCT02419612|3502487|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|204|204.0||||||
3655993|NCT02419612|3502485|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3655994|NCT02419612|3502486|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3655995|NCT02419612|3502487|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3655996|NCT02419612|3502485|B3|Native Hawaiian Or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3655997|NCT02419612|3502486|B2|Native Hawaiian Or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3655998|NCT02419612|3502487|B1|Native Hawaiian Or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3655999|NCT02419612|3502485|B3|Black Or African American||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3656000|NCT02419612|3502486|B2|Black Or African American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3656001|NCT02419612|3502487|B1|Black Or African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3656002|NCT02419612|3502485|B3|American Indian Or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3656003|NCT02419612|3502486|B2|American Indian Or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3656004|NCT02419612|3502487|B1|American Indian Or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3656005|NCT02419612|3502485|B3||Male|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
3656006|NCT02419612|3502486|B2||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3656007|NCT02419612|3502487|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3656008|NCT02419612|3502485|B3||Female|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
3656009|NCT02419612|3502486|B2||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3656010|NCT02419612|3502487|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3656011|NCT02419612|3502485|B3|||Age||Years|Mean|56.1|56.1|Standard Deviation|9.68|9.68|||
3656012|NCT02419612|3502486|B2|||Age||Years|Mean|56.1|56.1|Standard Deviation|9.23|9.23|||
3656013|NCT02419612|3502487|B1|||Age||Years|Mean|56.1|56.1|Standard Deviation|10.11|10.11|||
3656014|NCT02419573|3502502|B3|United States||Region of Enrollment||participants|Number|3000|3000.0||||||
3656015|NCT02419573|3502503|B2|United States||Region of Enrollment||participants|Number|1505|1505.0||||||
3656016|NCT02419573|3502504|B1|United States||Region of Enrollment||participants|Number|1495|1495.0||||||
3656017|NCT02419573|3502502|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|333|333.0||||||
3656018|NCT02419573|3502503|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|170|170.0||||||
3656019|NCT02419573|3502504|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|163|163.0||||||
3656020|NCT02419573|3502502|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3656021|NCT02419573|3502503|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3656022|NCT02419573|3502504|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3656023|NCT02419573|3502502|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1707|1707.0||||||
3656024|NCT02419573|3502503|B2||White|Race (NIH/OMB)||Participants|Count of Participants|903|903.0||||||
3656025|NCT02419573|3502504|B1||White|Race (NIH/OMB)||Participants|Count of Participants|804|804.0||||||
3656026|NCT02419573|3502502|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|878|878.0||||||
3656027|NCT02419573|3502503|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|385|385.0||||||
3656028|NCT02419573|3502504|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|493|493.0||||||
3656029|NCT02419573|3502502|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3656030|NCT02419573|3502503|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3656031|NCT02419573|3502504|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3656032|NCT02419573|3502502|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3656033|NCT02419573|3502503|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3656034|NCT02419573|3502504|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3656035|NCT02419573|3502502|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3656036|NCT02419573|3502503|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3656037|NCT02419573|3502504|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3656038|NCT02419573|3502502|B3||Male|Sex: Female, Male|"The gender was unknown for 1 female patient in LT and 1 male patient in LT."|Participants|Count of Participants|1826|1826.0||||||
3656039|NCT02419573|3502503|B2||Male|Sex: Female, Male|"The gender was unknown for 1 female patient in LT and 1 male patient in LT."|Participants|Count of Participants|929|929.0||||||
3656040|NCT02419573|3502504|B1||Male|Sex: Female, Male|"The gender was unknown for 1 female patient in LT and 1 male patient in LT."|Participants|Count of Participants|897|897.0||||||
3656041|NCT02419573|3502502|B3||Female|Sex: Female, Male|"The gender was unknown for 1 female patient in LT and 1 male patient in LT."|Participants|Count of Participants|1174|1174.0||||||
3656042|NCT02419573|3502503|B2||Female|Sex: Female, Male|"The gender was unknown for 1 female patient in LT and 1 male patient in LT."|Participants|Count of Participants|576|576.0||||||
3656043|NCT02419573|3502504|B1||Female|Sex: Female, Male|"The gender was unknown for 1 female patient in LT and 1 male patient in LT."|Participants|Count of Participants|598|598.0||||||
3656044|NCT02419573|3502502|B3|||Age||Years|Mean|63.1|63.1|Standard Deviation|17.0|17.0|||
3656045|NCT02419573|3502503|B2|||Age||Years|Mean|63.2|63.2|Standard Deviation|17.0|17.0|||
3656046|NCT02419573|3502504|B1|||Age||Years|Mean|63|63.0|Standard Deviation|16.9|16.9|||
3656047|NCT02419521|3502517|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
3656048|NCT02419521|3502517|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3656049|NCT02419521|3502517|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3656050|NCT02419521|3502517|B1|||Age||years|Mean|66.1|66.1|Standard Deviation|9.4|9.4|||
3656051|NCT02419521|3502517|B1||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
3656052|NCT02419521|3502517|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3656053|NCT02419521|3502517|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3656054|NCT02419508|3502529|B3|Latin America, Canada||Region of Enrollment||Participants|Count of Participants|98|98.0||||||
3656055|NCT02419508|3502530|B2|Latin America, Canada||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
3656056|NCT02419508|3502531|B1|Latin America, Canada||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3656057|NCT02419508|3502529|B3|Europe, Australia||Region of Enrollment||Participants|Count of Participants|89|89.0||||||
3656058|NCT02419508|3502530|B2|Europe, Australia||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3656059|NCT02419508|3502531|B1|Europe, Australia||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3656060|NCT02419508|3502529|B3|||Baseline Diurnal IOP|IOP (fluid pressure inside the eye) was measured using Goldmann applanation tonometry and averaged over the 09:00 AM and 11:00 AM time points. A higher IOP can be a greater risk factor for developing glaucoma or glaucoma progression (leading to optic nerve damage).|millimeters mercury (mmHg)|Mean|22.8|22.8|Standard Deviation|2.35|2.35|||
3656061|NCT02419508|3502530|B2|||Baseline Diurnal IOP|IOP (fluid pressure inside the eye) was measured using Goldmann applanation tonometry and averaged over the 09:00 AM and 11:00 AM time points. A higher IOP can be a greater risk factor for developing glaucoma or glaucoma progression (leading to optic nerve damage).|millimeters mercury (mmHg)|Mean|22.9|22.9|Standard Deviation|2.32|2.32|||
3656062|NCT02419508|3502531|B1|||Baseline Diurnal IOP|IOP (fluid pressure inside the eye) was measured using Goldmann applanation tonometry and averaged over the 09:00 AM and 11:00 AM time points. A higher IOP can be a greater risk factor for developing glaucoma or glaucoma progression (leading to optic nerve damage).|millimeters mercury (mmHg)|Mean|22.8|22.8|Standard Deviation|2.39|2.39|||
3656063|NCT02419508|3502529|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3656064|NCT02419508|3502530|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3656065|NCT02419508|3502531|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656066|NCT02419508|3502529|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
3656067|NCT02419508|3502530|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3656068|NCT02419508|3502531|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3656069|NCT02419508|3502529|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3656070|NCT02419508|3502530|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3656071|NCT02419508|3502531|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3656072|NCT02419508|3502529|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3656073|NCT02419508|3502530|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3656074|NCT02419508|3502531|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3656075|NCT02419508|3502529|B3||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3656076|NCT02419508|3502530|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3656077|NCT02419508|3502531|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3656078|NCT02419508|3502529|B3|||Age||years|Mean|67.2|67.2|Standard Deviation|11.17|11.17|||
3656079|NCT02419508|3502530|B2|||Age||years|Mean|67.9|67.9|Standard Deviation|11.65|11.65|||
3656080|NCT02419508|3502531|B1|||Age||years|Mean|66.5|66.5|Standard Deviation|10.70|10.7|||
3656081|NCT02419469|3502550|B1|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3656082|NCT02419469|3502550|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656083|NCT02419469|3502550|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656084|NCT02419469|3502550|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3656085|NCT02419469|3502550|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656086|NCT02419469|3502550|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656087|NCT02419469|3502550|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656088|NCT02419469|3502550|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656089|NCT02419469|3502550|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3656090|NCT02419469|3502550|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3656091|NCT02419469|3502550|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3656092|NCT02419469|3502550|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3656093|NCT02419469|3502550|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3656094|NCT02419313|3502554|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3656095|NCT02419313|3502554|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3656096|NCT02419313|3502554|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3656097|NCT02419313|3502554|B1|||Age||years|Mean|61.7|61.7|Full Range|||52.0|83.0|
3656098|NCT02419313|3502554|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3656099|NCT02419313|3502554|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3656100|NCT02419313|3502554|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3656101|NCT02419001|3502565|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3656102|NCT02419001|3502566|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3656103|NCT02419001|3502567|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3656104|NCT02419001|3502565|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3656105|NCT02419001|3502566|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3656106|NCT02419001|3502567|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3656107|NCT02419001|3502565|B3|||Age||years|Mean|48.5|48.5|Standard Deviation|13.8|13.8|||
3656108|NCT02419001|3502566|B2|||Age||years|Mean|57.1|57.1|Standard Deviation|11.6|11.6|||
3656109|NCT02419001|3502567|B1|||Age||years|Mean|41.3|41.3|Standard Deviation|11.9|11.9|||
3656110|NCT02418676|3502578|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3656111|NCT02418676|3502579|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3656112|NCT02418676|3502580|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3656113|NCT02418676|3502581|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3656114|NCT02418676|3502578|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3656115|NCT02418676|3502579|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3656116|NCT02418676|3502580|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3656117|NCT02418676|3502581|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3656118|NCT02418676|3502578|B4|>45 and <75 years||Age, Customized||participants|Number|15|15.0||||||
3656119|NCT02418676|3502579|B3|>45 and <75 years||Age, Customized||participants|Number|5|5.0||||||
3656120|NCT02418676|3502580|B2|>45 and <75 years||Age, Customized||participants|Number|5|5.0||||||
3656121|NCT02418676|3502581|B1|>45 and <75 years||Age, Customized||participants|Number|5|5.0||||||
3656122|NCT02418468|3502594|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3656123|NCT02418468|3502595|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3656124|NCT02418468|3502596|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3656125|NCT02418468|3502594|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3656126|NCT02418468|3502595|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3656127|NCT02418468|3502596|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3656128|NCT02418468|3502594|B3|||Age||years|Mean|66|66.0|Standard Deviation|8.2|8.2|||
3656129|NCT02418468|3502595|B2|||Age||years|Mean|68.8|68.8|Standard Deviation|14.96|14.96|||
3656130|NCT02418468|3502596|B1|||Age||years|Mean|66|66.0|Standard Deviation|7.2|7.2|||
3656131|NCT02418234|3502603|B1|IV||Stage|Each patient was staged according to NCCN guidelines (2015. v6) at the time of enrollment. Generally, Stage IV showed worse prognosis.|participants|Number|239|239.0||||||
3656132|NCT02418234|3502603|B1|IIIB||Stage|Each patient was staged according to NCCN guidelines (2015. v6) at the time of enrollment. Generally, Stage IV showed worse prognosis.|participants|Number|21|21.0||||||
3656133|NCT02418234|3502603|B1|IIIA||Stage|Each patient was staged according to NCCN guidelines (2015. v6) at the time of enrollment. Generally, Stage IV showed worse prognosis.|participants|Number|54|54.0||||||
3656134|NCT02418234|3502603|B1|China||Region of Enrollment||participants|Number|314|314.0||||||
3656135|NCT02418234|3502603|B1||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3656136|NCT02418234|3502603|B1||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
3656137|NCT02418234|3502603|B1|||Age||years|Median|63|63.0|Full Range|||32.0|89.0|
3656138|NCT02418026|3502614|B3|France||Region of Enrollment||participants|Number|79|79.0||||||
3656139|NCT02418026|3502615|B2|France||Region of Enrollment||participants|Number|35|35.0||||||
3656140|NCT02418026|3502616|B1|France||Region of Enrollment||participants|Number|44|44.0||||||
3656141|NCT02418026|3502614|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3656142|NCT02418026|3502615|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3656143|NCT02418026|3502616|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3656144|NCT02418026|3502614|B3||Female|Gender||Participants|Count of Participants|79|79.0||||||
3656145|NCT02418026|3502615|B2||Female|Gender||Participants|Count of Participants|35|35.0||||||
3656146|NCT02418026|3502616|B1||Female|Gender||Participants|Count of Participants|44|44.0||||||
3656147|NCT02418026|3502614|B3|||Age||years|Mean|30.8|30.8|Standard Deviation|5.5|5.5|||
3656148|NCT02418026|3502615|B2|||Age||years|Mean|31.2|31.2|Standard Deviation|5.3|5.3|||
3656149|NCT02418026|3502616|B1|||Age||years|Mean|30.6|30.6|Standard Deviation|5.7|5.7|||
3656150|NCT02417961|3502647|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3656151|NCT02417961|3502647|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3656152|NCT02417961|3502647|B1|||Age||years|Mean|47.6|47.6|Standard Deviation|13.19|13.19|||
3656153|NCT02417935|3502657|B3|||EuroQol 5 Dimension (EQ-5D)|The EQ-5D is a self-reported, 5-item scale used to assess the patient’s health utility (mobility, self-care, usual activities, pain and discomfort, and depression/anxiety). Scoring is on a 3-point scale.These combinations of attributes were converted into a weighted health-state Index Score according to the Japan population-based algorithm.Range of the Index score is -0.111 - 1(higher score indicates better health state).|units on a scale|Mean|0.7296|0.7296|Standard Deviation|0.1079|0.1079|||
3656154|NCT02417935|3502658|B2|||EuroQol 5 Dimension (EQ-5D)|The EQ-5D is a self-reported, 5-item scale used to assess the patient’s health utility (mobility, self-care, usual activities, pain and discomfort, and depression/anxiety). Scoring is on a 3-point scale.These combinations of attributes were converted into a weighted health-state Index Score according to the Japan population-based algorithm.Range of the Index score is -0.111 - 1(higher score indicates better health state).|units on a scale|Mean|0.7337|0.7337|Standard Deviation|0.1230|0.123|||
3656155|NCT02417935|3502659|B1|||EuroQol 5 Dimension (EQ-5D)|The EQ-5D is a self-reported, 5-item scale used to assess the patient’s health utility (mobility, self-care, usual activities, pain and discomfort, and depression/anxiety). Scoring is on a 3-point scale.These combinations of attributes were converted into a weighted health-state Index Score according to the Japan population-based algorithm.Range of the Index score is -0.111 - 1(higher score indicates better health state).|units on a scale|Mean|0.7253|0.7253|Standard Deviation|0.0903|0.0903|||
3656156|NCT02417935|3502657|B3|||Neuropathic Pain Symptom Inventory (NPSI)|NPSI questionnaire is a 12-item self-administered questionnaire that will be completed by the patient. It assesses 5 different dimensions of neuropathic pain: burning spontaneous pain, pressing spontaneous pain, paroxysmal pain, evoked pain, and paresthesias/dysesthesias. The NPSI includes 12 items: 10 descriptors of the different symptoms and 2 items for assessing the duration of spontaneous ongoing and paroxysmal pain. A total intensity score can be calculated as the sum of the scores of the 10 descriptors. (range: 0 (no pain) -100 (worst imaginable pain)).|units on a scale|Mean|31.9|31.9|Standard Deviation|16.03|16.03|||
3656157|NCT02417935|3502658|B2|||Neuropathic Pain Symptom Inventory (NPSI)|NPSI questionnaire is a 12-item self-administered questionnaire that will be completed by the patient. It assesses 5 different dimensions of neuropathic pain: burning spontaneous pain, pressing spontaneous pain, paroxysmal pain, evoked pain, and paresthesias/dysesthesias. The NPSI includes 12 items: 10 descriptors of the different symptoms and 2 items for assessing the duration of spontaneous ongoing and paroxysmal pain. A total intensity score can be calculated as the sum of the scores of the 10 descriptors. (range: 0 (no pain) -100 (worst imaginable pain)).|units on a scale|Mean|32.1|32.1|Standard Deviation|16.49|16.49|||
3656158|NCT02417935|3502659|B1|||Neuropathic Pain Symptom Inventory (NPSI)|NPSI questionnaire is a 12-item self-administered questionnaire that will be completed by the patient. It assesses 5 different dimensions of neuropathic pain: burning spontaneous pain, pressing spontaneous pain, paroxysmal pain, evoked pain, and paresthesias/dysesthesias. The NPSI includes 12 items: 10 descriptors of the different symptoms and 2 items for assessing the duration of spontaneous ongoing and paroxysmal pain. A total intensity score can be calculated as the sum of the scores of the 10 descriptors. (range: 0 (no pain) -100 (worst imaginable pain)).|units on a scale|Mean|31.8|31.8|Standard Deviation|15.60|15.6|||
3656159|NCT02417935|3502657|B3|||Beck Depression Inventory-II (BDI-II)|Beck Depression Inventory-II: BDI-II is a 21-item, participant-completed questionnaire to assess characteristics of depression. Each of the 21 items corresponding to symptoms of depression were scored on a 4-point scale ranging from 0 to 3 and was summed to give a single score. A total score of 0-13 was considered minimal range, 14-19 was mild, 20-28 was moderate, and 29-63 was severe.|units on a scale|Mean|6.5|6.5|Standard Deviation|5.66|5.66|||
3656160|NCT02417935|3502658|B2|||Beck Depression Inventory-II (BDI-II)|Beck Depression Inventory-II: BDI-II is a 21-item, participant-completed questionnaire to assess characteristics of depression. Each of the 21 items corresponding to symptoms of depression were scored on a 4-point scale ranging from 0 to 3 and was summed to give a single score. A total score of 0-13 was considered minimal range, 14-19 was mild, 20-28 was moderate, and 29-63 was severe.|units on a scale|Mean|6.8|6.8|Standard Deviation|5.90|5.9|||
3656161|NCT02417935|3502659|B1|||Beck Depression Inventory-II (BDI-II)|Beck Depression Inventory-II: BDI-II is a 21-item, participant-completed questionnaire to assess characteristics of depression. Each of the 21 items corresponding to symptoms of depression were scored on a 4-point scale ranging from 0 to 3 and was summed to give a single score. A total score of 0-13 was considered minimal range, 14-19 was mild, 20-28 was moderate, and 29-63 was severe.|units on a scale|Mean|6.2|6.2|Standard Deviation|5.41|5.41|||
3656206|NCT02417935|3502659|B1|Average Pain Score||Numeric Rating Scale (NRS)|24-hour average pain, night pain & 24-hour worst pain severity scores were recorded on an 11-point NRS, ranging from 0 (no pain) to 10 (pain as bad as you can imagine).Weekly mean was calculated based on daily score and used for the analysis.|units on a scale|Mean|5.35|5.35|Standard Deviation|1.129|1.129|||
3656162|NCT02417935|3502657|B3|Average Interference Score||Brief Pain Inventory - Short Form (BPI-SF)|BPI Severity (BPI-S) & BPI Interference Scores (BPI-I) are self-reported scales measuring severity of pain and interference on function. Severity scores: 0 (no pain) to 10 (as bad as you can imagine) on each question assessing worst pain, least pain, and average pain in past 24 hours, and pain right now. Interference scores: 0 (does not interfere) to 10 (completely interferes) on each question assessing interference of pain in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|2.64|2.64|Standard Deviation|1.807|1.807|||
3656163|NCT02417935|3502658|B2|Average Interference Score||Brief Pain Inventory - Short Form (BPI-SF)|BPI Severity (BPI-S) & BPI Interference Scores (BPI-I) are self-reported scales measuring severity of pain and interference on function. Severity scores: 0 (no pain) to 10 (as bad as you can imagine) on each question assessing worst pain, least pain, and average pain in past 24 hours, and pain right now. Interference scores: 0 (does not interfere) to 10 (completely interferes) on each question assessing interference of pain in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|2.63|2.63|Standard Deviation|1.875|1.875|||
3656164|NCT02417935|3502659|B1|Average Interference Score||Brief Pain Inventory - Short Form (BPI-SF)|BPI Severity (BPI-S) & BPI Interference Scores (BPI-I) are self-reported scales measuring severity of pain and interference on function. Severity scores: 0 (no pain) to 10 (as bad as you can imagine) on each question assessing worst pain, least pain, and average pain in past 24 hours, and pain right now. Interference scores: 0 (does not interfere) to 10 (completely interferes) on each question assessing interference of pain in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|2.66|2.66|Standard Deviation|1.744|1.744|||
3656165|NCT02417935|3502657|B3|Enjoyment of Life||Brief Pain Inventory - Short Form (BPI-SF)|BPI Severity (BPI-S) & BPI Interference Scores (BPI-I) are self-reported scales measuring severity of pain and interference on function. Severity scores: 0 (no pain) to 10 (as bad as you can imagine) on each question assessing worst pain, least pain, and average pain in past 24 hours, and pain right now. Interference scores: 0 (does not interfere) to 10 (completely interferes) on each question assessing interference of pain in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|2.5|2.5|Standard Deviation|2.25|2.25|||
3656166|NCT02417935|3502658|B2|Enjoyment of Life||Brief Pain Inventory - Short Form (BPI-SF)|BPI Severity (BPI-S) & BPI Interference Scores (BPI-I) are self-reported scales measuring severity of pain and interference on function. Severity scores: 0 (no pain) to 10 (as bad as you can imagine) on each question assessing worst pain, least pain, and average pain in past 24 hours, and pain right now. Interference scores: 0 (does not interfere) to 10 (completely interferes) on each question assessing interference of pain in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|2.5|2.5|Standard Deviation|2.24|2.24|||
3656167|NCT02417935|3502659|B1|Enjoyment of Life||Brief Pain Inventory - Short Form (BPI-SF)|BPI Severity (BPI-S) & BPI Interference Scores (BPI-I) are self-reported scales measuring severity of pain and interference on function. Severity scores: 0 (no pain) to 10 (as bad as you can imagine) on each question assessing worst pain, least pain, and average pain in past 24 hours, and pain right now. Interference scores: 0 (does not interfere) to 10 (completely interferes) on each question assessing interference of pain in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|2.6|2.6|Standard Deviation|2.27|2.27|||
3656168|NCT02417935|3502657|B3|Sleep||Brief Pain Inventory - Short Form (BPI-SF)|BPI Severity (BPI-S) & BPI Interference Scores (BPI-I) are self-reported scales measuring severity of pain and interference on function. Severity scores: 0 (no pain) to 10 (as bad as you can imagine) on each question assessing worst pain, least pain, and average pain in past 24 hours, and pain right now. Interference scores: 0 (does not interfere) to 10 (completely interferes) on each question assessing interference of pain in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|2.8|2.8|Standard Deviation|2.38|2.38|||
3656169|NCT02417935|3502658|B2|Sleep||Brief Pain Inventory - Short Form (BPI-SF)|BPI Severity (BPI-S) & BPI Interference Scores (BPI-I) are self-reported scales measuring severity of pain and interference on function. Severity scores: 0 (no pain) to 10 (as bad as you can imagine) on each question assessing worst pain, least pain, and average pain in past 24 hours, and pain right now. Interference scores: 0 (does not interfere) to 10 (completely interferes) on each question assessing interference of pain in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|2.8|2.8|Standard Deviation|2.37|2.37|||
3656170|NCT02417935|3502659|B1|Sleep||Brief Pain Inventory - Short Form (BPI-SF)|BPI Severity (BPI-S) & BPI Interference Scores (BPI-I) are self-reported scales measuring severity of pain and interference on function. Severity scores: 0 (no pain) to 10 (as bad as you can imagine) on each question assessing worst pain, least pain, and average pain in past 24 hours, and pain right now. Interference scores: 0 (does not interfere) to 10 (completely interferes) on each question assessing interference of pain in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|2.7|2.7|Standard Deviation|2.39|2.39|||
3656171|NCT02417935|3502657|B3|Relations With Other People||Brief Pain Inventory - Short Form (BPI-SF)|BPI Severity (BPI-S) & BPI Interference Scores (BPI-I) are self-reported scales measuring severity of pain and interference on function. Severity scores: 0 (no pain) to 10 (as bad as you can imagine) on each question assessing worst pain, least pain, and average pain in past 24 hours, and pain right now. Interference scores: 0 (does not interfere) to 10 (completely interferes) on each question assessing interference of pain in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|1.4|1.4|Standard Deviation|1.80|1.8|||
3656207|NCT02417935|3502657|B3|Japan||Region of Enrollment||Participants|Count of Participants|303|303.0||||||
3656208|NCT02417935|3502658|B2|Japan||Region of Enrollment||Participants|Count of Participants|152|152.0||||||
3656209|NCT02417935|3502659|B1|Japan||Region of Enrollment||Participants|Count of Participants|151|151.0||||||
3656210|NCT02417935|3502657|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656172|NCT02417935|3502658|B2|Relations With Other People||Brief Pain Inventory - Short Form (BPI-SF)|BPI Severity (BPI-S) & BPI Interference Scores (BPI-I) are self-reported scales measuring severity of pain and interference on function. Severity scores: 0 (no pain) to 10 (as bad as you can imagine) on each question assessing worst pain, least pain, and average pain in past 24 hours, and pain right now. Interference scores: 0 (does not interfere) to 10 (completely interferes) on each question assessing interference of pain in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|1.4|1.4|Standard Deviation|1.81|1.81|||
3656173|NCT02417935|3502659|B1|Relations With Other People||Brief Pain Inventory - Short Form (BPI-SF)|BPI Severity (BPI-S) & BPI Interference Scores (BPI-I) are self-reported scales measuring severity of pain and interference on function. Severity scores: 0 (no pain) to 10 (as bad as you can imagine) on each question assessing worst pain, least pain, and average pain in past 24 hours, and pain right now. Interference scores: 0 (does not interfere) to 10 (completely interferes) on each question assessing interference of pain in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|1.4|1.4|Standard Deviation|1.81|1.81|||
3656174|NCT02417935|3502657|B3|Normal Work||Brief Pain Inventory - Short Form (BPI-SF)|BPI Severity (BPI-S) & BPI Interference Scores (BPI-I) are self-reported scales measuring severity of pain and interference on function. Severity scores: 0 (no pain) to 10 (as bad as you can imagine) on each question assessing worst pain, least pain, and average pain in past 24 hours, and pain right now. Interference scores: 0 (does not interfere) to 10 (completely interferes) on each question assessing interference of pain in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|2.6|2.6|Standard Deviation|2.26|2.26|||
3656175|NCT02417935|3502658|B2|Normal Work||Brief Pain Inventory - Short Form (BPI-SF)|BPI Severity (BPI-S) & BPI Interference Scores (BPI-I) are self-reported scales measuring severity of pain and interference on function. Severity scores: 0 (no pain) to 10 (as bad as you can imagine) on each question assessing worst pain, least pain, and average pain in past 24 hours, and pain right now. Interference scores: 0 (does not interfere) to 10 (completely interferes) on each question assessing interference of pain in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|2.6|2.6|Standard Deviation|2.41|2.41|||
3656176|NCT02417935|3502659|B1|Normal Work||Brief Pain Inventory - Short Form (BPI-SF)|BPI Severity (BPI-S) & BPI Interference Scores (BPI-I) are self-reported scales measuring severity of pain and interference on function. Severity scores: 0 (no pain) to 10 (as bad as you can imagine) on each question assessing worst pain, least pain, and average pain in past 24 hours, and pain right now. Interference scores: 0 (does not interfere) to 10 (completely interferes) on each question assessing interference of pain in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|2.6|2.6|Standard Deviation|2.11|2.11|||
3656177|NCT02417935|3502657|B3|Walking Ability||Brief Pain Inventory - Short Form (BPI-SF)|BPI Severity (BPI-S) & BPI Interference Scores (BPI-I) are self-reported scales measuring severity of pain and interference on function. Severity scores: 0 (no pain) to 10 (as bad as you can imagine) on each question assessing worst pain, least pain, and average pain in past 24 hours, and pain right now. Interference scores: 0 (does not interfere) to 10 (completely interferes) on each question assessing interference of pain in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|2.8|2.8|Standard Deviation|2.39|2.39|||
3656178|NCT02417935|3502658|B2|Walking Ability||Brief Pain Inventory - Short Form (BPI-SF)|BPI Severity (BPI-S) & BPI Interference Scores (BPI-I) are self-reported scales measuring severity of pain and interference on function. Severity scores: 0 (no pain) to 10 (as bad as you can imagine) on each question assessing worst pain, least pain, and average pain in past 24 hours, and pain right now. Interference scores: 0 (does not interfere) to 10 (completely interferes) on each question assessing interference of pain in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|2.8|2.8|Standard Deviation|2.51|2.51|||
3656179|NCT02417935|3502659|B1|Walking Ability||Brief Pain Inventory - Short Form (BPI-SF)|BPI Severity (BPI-S) & BPI Interference Scores (BPI-I) are self-reported scales measuring severity of pain and interference on function. Severity scores: 0 (no pain) to 10 (as bad as you can imagine) on each question assessing worst pain, least pain, and average pain in past 24 hours, and pain right now. Interference scores: 0 (does not interfere) to 10 (completely interferes) on each question assessing interference of pain in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|2.9|2.9|Standard Deviation|2.28|2.28|||
3656180|NCT02417935|3502657|B3|Mood||Brief Pain Inventory - Short Form (BPI-SF)|BPI Severity (BPI-S) & BPI Interference Scores (BPI-I) are self-reported scales measuring severity of pain and interference on function. Severity scores: 0 (no pain) to 10 (as bad as you can imagine) on each question assessing worst pain, least pain, and average pain in past 24 hours, and pain right now. Interference scores: 0 (does not interfere) to 10 (completely interferes) on each question assessing interference of pain in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|3.1|3.1|Standard Deviation|2.28|2.28|||
3656181|NCT02417935|3502658|B2|Mood||Brief Pain Inventory - Short Form (BPI-SF)|BPI Severity (BPI-S) & BPI Interference Scores (BPI-I) are self-reported scales measuring severity of pain and interference on function. Severity scores: 0 (no pain) to 10 (as bad as you can imagine) on each question assessing worst pain, least pain, and average pain in past 24 hours, and pain right now. Interference scores: 0 (does not interfere) to 10 (completely interferes) on each question assessing interference of pain in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|2.9|2.9|Standard Deviation|2.23|2.23|||
3656211|NCT02417935|3502658|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656212|NCT02417935|3502659|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656213|NCT02417935|3502657|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656214|NCT02417935|3502658|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656182|NCT02417935|3502659|B1|Mood||Brief Pain Inventory - Short Form (BPI-SF)|BPI Severity (BPI-S) & BPI Interference Scores (BPI-I) are self-reported scales measuring severity of pain and interference on function. Severity scores: 0 (no pain) to 10 (as bad as you can imagine) on each question assessing worst pain, least pain, and average pain in past 24 hours, and pain right now. Interference scores: 0 (does not interfere) to 10 (completely interferes) on each question assessing interference of pain in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|3.3|3.3|Standard Deviation|2.32|2.32|||
3656183|NCT02417935|3502657|B3|General Activity||Brief Pain Inventory - Short Form (BPI-SF)|BPI Severity (BPI-S) & BPI Interference Scores (BPI-I) are self-reported scales measuring severity of pain and interference on function. Severity scores: 0 (no pain) to 10 (as bad as you can imagine) on each question assessing worst pain, least pain, and average pain in past 24 hours, and pain right now. Interference scores: 0 (does not interfere) to 10 (completely interferes) on each question assessing interference of pain in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|3.3|3.3|Standard Deviation|2.18|2.18|||
3656184|NCT02417935|3502658|B2|General Activity||Brief Pain Inventory - Short Form (BPI-SF)|BPI Severity (BPI-S) & BPI Interference Scores (BPI-I) are self-reported scales measuring severity of pain and interference on function. Severity scores: 0 (no pain) to 10 (as bad as you can imagine) on each question assessing worst pain, least pain, and average pain in past 24 hours, and pain right now. Interference scores: 0 (does not interfere) to 10 (completely interferes) on each question assessing interference of pain in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|3.4|3.4|Standard Deviation|2.21|2.21|||
3656185|NCT02417935|3502659|B1|General Activity||Brief Pain Inventory - Short Form (BPI-SF)|BPI Severity (BPI-S) & BPI Interference Scores (BPI-I) are self-reported scales measuring severity of pain and interference on function. Severity scores: 0 (no pain) to 10 (as bad as you can imagine) on each question assessing worst pain, least pain, and average pain in past 24 hours, and pain right now. Interference scores: 0 (does not interfere) to 10 (completely interferes) on each question assessing interference of pain in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|3.1|3.1|Standard Deviation|2.14|2.14|||
3656186|NCT02417935|3502657|B3|Pain Right Now||Brief Pain Inventory - Short Form (BPI-SF)|BPI Severity (BPI-S) & BPI Interference Scores (BPI-I) are self-reported scales measuring severity of pain and interference on function. Severity scores: 0 (no pain) to 10 (as bad as you can imagine) on each question assessing worst pain, least pain, and average pain in past 24 hours, and pain right now. Interference scores: 0 (does not interfere) to 10 (completely interferes) on each question assessing interference of pain in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|4.9|4.9|Standard Deviation|1.59|1.59|||
3656187|NCT02417935|3502658|B2|Pain Right Now||Brief Pain Inventory - Short Form (BPI-SF)|BPI Severity (BPI-S) & BPI Interference Scores (BPI-I) are self-reported scales measuring severity of pain and interference on function. Severity scores: 0 (no pain) to 10 (as bad as you can imagine) on each question assessing worst pain, least pain, and average pain in past 24 hours, and pain right now. Interference scores: 0 (does not interfere) to 10 (completely interferes) on each question assessing interference of pain in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|4.9|4.9|Standard Deviation|1.58|1.58|||
3656188|NCT02417935|3502659|B1|Pain Right Now||Brief Pain Inventory - Short Form (BPI-SF)|BPI Severity (BPI-S) & BPI Interference Scores (BPI-I) are self-reported scales measuring severity of pain and interference on function. Severity scores: 0 (no pain) to 10 (as bad as you can imagine) on each question assessing worst pain, least pain, and average pain in past 24 hours, and pain right now. Interference scores: 0 (does not interfere) to 10 (completely interferes) on each question assessing interference of pain in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|4.9|4.9|Standard Deviation|1.60|1.6|||
3656189|NCT02417935|3502657|B3|Average Pain||Brief Pain Inventory - Short Form (BPI-SF)|BPI Severity (BPI-S) & BPI Interference Scores (BPI-I) are self-reported scales measuring severity of pain and interference on function. Severity scores: 0 (no pain) to 10 (as bad as you can imagine) on each question assessing worst pain, least pain, and average pain in past 24 hours, and pain right now. Interference scores: 0 (does not interfere) to 10 (completely interferes) on each question assessing interference of pain in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|5.3|5.3|Standard Deviation|1.19|1.19|||
3656190|NCT02417935|3502658|B2|Average Pain||Brief Pain Inventory - Short Form (BPI-SF)|BPI Severity (BPI-S) & BPI Interference Scores (BPI-I) are self-reported scales measuring severity of pain and interference on function. Severity scores: 0 (no pain) to 10 (as bad as you can imagine) on each question assessing worst pain, least pain, and average pain in past 24 hours, and pain right now. Interference scores: 0 (does not interfere) to 10 (completely interferes) on each question assessing interference of pain in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|5.3|5.3|Standard Deviation|1.17|1.17|||
3656191|NCT02417935|3502659|B1|Average Pain||Brief Pain Inventory - Short Form (BPI-SF)|BPI Severity (BPI-S) & BPI Interference Scores (BPI-I) are self-reported scales measuring severity of pain and interference on function. Severity scores: 0 (no pain) to 10 (as bad as you can imagine) on each question assessing worst pain, least pain, and average pain in past 24 hours, and pain right now. Interference scores: 0 (does not interfere) to 10 (completely interferes) on each question assessing interference of pain in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|5.3|5.3|Standard Deviation|1.21|1.21|||
3656215|NCT02417935|3502659|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656216|NCT02417935|3502657|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656217|NCT02417935|3502658|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656218|NCT02417935|3502659|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656324|NCT02416973|3502794|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
3656192|NCT02417935|3502657|B3|Least Pain||Brief Pain Inventory - Short Form (BPI-SF)|BPI Severity (BPI-S) & BPI Interference Scores (BPI-I) are self-reported scales measuring severity of pain and interference on function. Severity scores: 0 (no pain) to 10 (as bad as you can imagine) on each question assessing worst pain, least pain, and average pain in past 24 hours, and pain right now. Interference scores: 0 (does not interfere) to 10 (completely interferes) on each question assessing interference of pain in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|3.9|3.9|Standard Deviation|1.72|1.72|||
3656193|NCT02417935|3502658|B2|Least Pain||Brief Pain Inventory - Short Form (BPI-SF)|BPI Severity (BPI-S) & BPI Interference Scores (BPI-I) are self-reported scales measuring severity of pain and interference on function. Severity scores: 0 (no pain) to 10 (as bad as you can imagine) on each question assessing worst pain, least pain, and average pain in past 24 hours, and pain right now. Interference scores: 0 (does not interfere) to 10 (completely interferes) on each question assessing interference of pain in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|3.9|3.9|Standard Deviation|1.70|1.7|||
3656194|NCT02417935|3502659|B1|Least Pain||Brief Pain Inventory - Short Form (BPI-SF)|BPI Severity (BPI-S) & BPI Interference Scores (BPI-I) are self-reported scales measuring severity of pain and interference on function. Severity scores: 0 (no pain) to 10 (as bad as you can imagine) on each question assessing worst pain, least pain, and average pain in past 24 hours, and pain right now. Interference scores: 0 (does not interfere) to 10 (completely interferes) on each question assessing interference of pain in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|3.8|3.8|Standard Deviation|1.74|1.74|||
3656195|NCT02417935|3502657|B3|Worst Pain||Brief Pain Inventory - Short Form (BPI-SF)|BPI Severity (BPI-S) & BPI Interference Scores (BPI-I) are self-reported scales measuring severity of pain and interference on function. Severity scores: 0 (no pain) to 10 (as bad as you can imagine) on each question assessing worst pain, least pain, and average pain in past 24 hours, and pain right now. Interference scores: 0 (does not interfere) to 10 (completely interferes) on each question assessing interference of pain in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|6.3|6.3|Standard Deviation|1.35|1.35|||
3656196|NCT02417935|3502658|B2|Worst Pain||Brief Pain Inventory - Short Form (BPI-SF)|BPI Severity (BPI-S) & BPI Interference Scores (BPI-I) are self-reported scales measuring severity of pain and interference on function. Severity scores: 0 (no pain) to 10 (as bad as you can imagine) on each question assessing worst pain, least pain, and average pain in past 24 hours, and pain right now. Interference scores: 0 (does not interfere) to 10 (completely interferes) on each question assessing interference of pain in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|6.3|6.3|Standard Deviation|1.24|1.24|||
3656197|NCT02417935|3502659|B1|Worst Pain||Brief Pain Inventory - Short Form (BPI-SF)|BPI Severity (BPI-S) & BPI Interference Scores (BPI-I) are self-reported scales measuring severity of pain and interference on function. Severity scores: 0 (no pain) to 10 (as bad as you can imagine) on each question assessing worst pain, least pain, and average pain in past 24 hours, and pain right now. Interference scores: 0 (does not interfere) to 10 (completely interferes) on each question assessing interference of pain in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|6.3|6.3|Standard Deviation|1.45|1.45|||
3656198|NCT02417935|3502657|B3|Worst Pain Score||Numeric Rating Scale (NRS)|24-hour average pain, night pain & 24-hour worst pain severity scores were recorded on an 11-point NRS, ranging from 0 (no pain) to 10 (pain as bad as you can imagine).Weekly mean was calculated based on daily score and used for the analysis.|units on a scale|Mean|6.23|6.23|Standard Deviation|1.273|1.273|||
3656199|NCT02417935|3502658|B2|Worst Pain Score||Numeric Rating Scale (NRS)|24-hour average pain, night pain & 24-hour worst pain severity scores were recorded on an 11-point NRS, ranging from 0 (no pain) to 10 (pain as bad as you can imagine).Weekly mean was calculated based on daily score and used for the analysis.|units on a scale|Mean|6.22|6.22|Standard Deviation|1.237|1.237|||
3656200|NCT02417935|3502659|B1|Worst Pain Score||Numeric Rating Scale (NRS)|24-hour average pain, night pain & 24-hour worst pain severity scores were recorded on an 11-point NRS, ranging from 0 (no pain) to 10 (pain as bad as you can imagine).Weekly mean was calculated based on daily score and used for the analysis.|units on a scale|Mean|6.25|6.25|Standard Deviation|1.311|1.311|||
3656201|NCT02417935|3502657|B3|Night Pain Score||Numeric Rating Scale (NRS)|24-hour average pain, night pain & 24-hour worst pain severity scores were recorded on an 11-point NRS, ranging from 0 (no pain) to 10 (pain as bad as you can imagine).Weekly mean was calculated based on daily score and used for the analysis.|units on a scale|Mean|4.76|4.76|Standard Deviation|1.759|1.759|||
3656202|NCT02417935|3502658|B2|Night Pain Score||Numeric Rating Scale (NRS)|24-hour average pain, night pain & 24-hour worst pain severity scores were recorded on an 11-point NRS, ranging from 0 (no pain) to 10 (pain as bad as you can imagine).Weekly mean was calculated based on daily score and used for the analysis.|units on a scale|Mean|4.92|4.92|Standard Deviation|1.650|1.65|||
3656203|NCT02417935|3502659|B1|Night Pain Score||Numeric Rating Scale (NRS)|24-hour average pain, night pain & 24-hour worst pain severity scores were recorded on an 11-point NRS, ranging from 0 (no pain) to 10 (pain as bad as you can imagine).Weekly mean was calculated based on daily score and used for the analysis.|units on a scale|Mean|4.61|4.61|Standard Deviation|1.855|1.855|||
3656204|NCT02417935|3502657|B3|Average Pain Score||Numeric Rating Scale (NRS)|24-hour average pain, night pain & 24-hour worst pain severity scores were recorded on an 11-point NRS, ranging from 0 (no pain) to 10 (pain as bad as you can imagine).Weekly mean was calculated based on daily score and used for the analysis.|units on a scale|Mean|5.37|5.37|Standard Deviation|1.102|1.102|||
3656205|NCT02417935|3502658|B2|Average Pain Score||Numeric Rating Scale (NRS)|24-hour average pain, night pain & 24-hour worst pain severity scores were recorded on an 11-point NRS, ranging from 0 (no pain) to 10 (pain as bad as you can imagine).Weekly mean was calculated based on daily score and used for the analysis.|units on a scale|Mean|5.38|5.38|Standard Deviation|1.079|1.079|||
3656219|NCT02417935|3502657|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656220|NCT02417935|3502658|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656221|NCT02417935|3502659|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656222|NCT02417935|3502657|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656223|NCT02417935|3502658|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656224|NCT02417935|3502659|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656225|NCT02417935|3502657|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|303|303.0||||||
3656226|NCT02417935|3502658|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|152|152.0||||||
3656227|NCT02417935|3502659|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|151|151.0||||||
3656228|NCT02417935|3502657|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656229|NCT02417935|3502658|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656230|NCT02417935|3502659|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656231|NCT02417935|3502657|B3||Male|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
3656232|NCT02417935|3502658|B2||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3656233|NCT02417935|3502659|B1||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3656234|NCT02417935|3502657|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3656235|NCT02417935|3502658|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3656236|NCT02417935|3502659|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3656237|NCT02417935|3502657|B3|||Age||years|Mean|59.6|59.6|Standard Deviation|9.03|9.03|||
3656238|NCT02417935|3502658|B2|||Age||years|Mean|59.3|59.3|Standard Deviation|8.16|8.16|||
3656239|NCT02417935|3502659|B1|||Age||years|Mean|60.0|60.0|Standard Deviation|9.84|9.84|||
3656240|NCT02417753|3502684|B1|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3656241|NCT02417753|3502684|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656242|NCT02417753|3502684|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656243|NCT02417753|3502684|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656244|NCT02417753|3502684|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3656245|NCT02417753|3502684|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656246|NCT02417753|3502684|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656247|NCT02417753|3502684|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656248|NCT02417753|3502684|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656249|NCT02417753|3502684|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3656250|NCT02417753|3502684|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656251|NCT02417753|3502684|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3656252|NCT02417753|3502684|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3656253|NCT02417753|3502684|B1|||Age||years|Mean|60.4|60.4|Standard Deviation|0|0.0|||
3656254|NCT02417753|3502684|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3656255|NCT02417753|3502684|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3656256|NCT02417753|3502684|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3656257|NCT02417532|3502694|B1|Australia||Region of Enrollment||participants|Number|44|44.0||||||
3656258|NCT02417532|3502694|B1|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
3656259|NCT02417532|3502694|B1|New Zealand||Region of Enrollment||participants|Number|3|3.0||||||
3656260|NCT02417532|3502694|B1||Male|Gender||Participants|Count of Participants|37|37.0||||||
3656261|NCT02417532|3502694|B1||Female|Gender||Participants|Count of Participants|19|19.0||||||
3656262|NCT02417532|3502694|B1|||Age||years|Mean|39.8|39.8|Full Range|||18.0|75.0|
3656263|NCT02417532|3502694|B1||>=65 years|Age|Age - from date of birth record|Participants|Count of Participants|1|1.0||||||
3656264|NCT02417532|3502694|B1||Between 18 and 65 years|Age|Age - from date of birth record|Participants|Count of Participants|50|50.0||||||
3656265|NCT02417532|3502694|B1||<=18 years|Age|Age - from date of birth record|Participants|Count of Participants|1|1.0||||||
3656266|NCT02417376|3502705|B3|India||Region of Enrollment||participants|Number|70|70.0||||||
3656267|NCT02417376|3502706|B2|India||Region of Enrollment||participants|Number|35|35.0||||||
3656268|NCT02417376|3502707|B1|India||Region of Enrollment||participants|Number|35|35.0||||||
3656269|NCT02417376|3502705|B3||Male|Gender||Participants|Count of Participants|49|49.0||||||
3656270|NCT02417376|3502706|B2||Male|Gender||Participants|Count of Participants|26|26.0||||||
3656271|NCT02417376|3502707|B1||Male|Gender||Participants|Count of Participants|23|23.0||||||
3656272|NCT02417376|3502705|B3||Female|Gender||Participants|Count of Participants|21|21.0||||||
3656273|NCT02417376|3502706|B2||Female|Gender||Participants|Count of Participants|9|9.0||||||
3656274|NCT02417376|3502707|B1||Female|Gender||Participants|Count of Participants|12|12.0||||||
3656275|NCT02417376|3502705|B3|||Age||years|Mean|60.30|60.3|Standard Deviation|9.56|9.56|||
3656276|NCT02417376|3502706|B2|||Age||years|Mean|60.21|60.21|Standard Deviation|9.23|9.23|||
3656277|NCT02417376|3502707|B1|||Age||years|Mean|60.43|60.43|Standard Deviation|10.31|10.31|||
3656278|NCT02417233|3502752|B4|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3656279|NCT02417233|3502753|B3|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3656280|NCT02417233|3502754|B2|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3656281|NCT02417233|3502755|B1|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3656282|NCT02417233|3502752|B4|Colored||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3656283|NCT02417233|3502753|B3|Colored||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3656284|NCT02417233|3502754|B2|Colored||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3656285|NCT02417233|3502755|B1|Colored||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3656286|NCT02417233|3502752|B4|Black||Race/Ethnicity, Customized||Participants|Count of Participants|749|749.0||||||
3656287|NCT02417233|3502753|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|295|295.0||||||
3656288|NCT02417233|3502754|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|288|288.0||||||
3656289|NCT02417233|3502755|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|166|166.0||||||
3656290|NCT02417233|3502752|B4||Male|Sex: Female, Male||Participants|Count of Participants|460|460.0||||||
3656291|NCT02417233|3502753|B3||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
3656292|NCT02417233|3502754|B2||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
3656293|NCT02417233|3502755|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3656294|NCT02417233|3502752|B4||Female|Sex: Female, Male||Participants|Count of Participants|292|292.0||||||
3656295|NCT02417233|3502753|B3||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3656296|NCT02417233|3502754|B2||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3656297|NCT02417233|3502755|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3656298|NCT02417233|3502752|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3656299|NCT02417233|3502753|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3656300|NCT02417233|3502754|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3656301|NCT02417233|3502755|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3656302|NCT02417233|3502752|B4||Between 18 and 65 years|Age||Participants|Count of Participants|750|750.0||||||
3656303|NCT02417233|3502753|B3||Between 18 and 65 years|Age||Participants|Count of Participants|294|294.0||||||
3656304|NCT02417233|3502754|B2||Between 18 and 65 years|Age||Participants|Count of Participants|289|289.0||||||
3656305|NCT02417233|3502755|B1||Between 18 and 65 years|Age||Participants|Count of Participants|167|167.0||||||
3656306|NCT02417233|3502752|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3656307|NCT02417233|3502753|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3656308|NCT02417233|3502754|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3656309|NCT02417233|3502755|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3656310|NCT02417129|3502780|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3656311|NCT02417129|3502780|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
3656312|NCT02417129|3502780|B1|||Age||Years|Mean|45.5|45.5|Standard Deviation|3.54|3.54|||
3656313|NCT02416973|3502791|B4|||PainDETECT Questionnaire|PainDETECT Questionniare (PD-q): a self-reported assessment designed to identify the presence of a neuropathic pain component in subjects with back pain. This was completed by the subject and scored by the research personnel at the Enrollment Visit. Subjects assessment current pain, strongest pain, average pain, areas of pain, course of pain and symptoms (such as burning, tingling, numbness and sensitivity). The scale ranged from 0 to 38 defined as follows: score 0-12 = neuropathic pain component unlikely; 13-18 = result is ambiguous; 19-38 = neuropathic pain component is likely.|units on a scale|Mean|15.8|15.8|Full Range|||2.0|28.0|
3656314|NCT02416973|3502792|B3|||PainDETECT Questionnaire|PainDETECT Questionniare (PD-q): a self-reported assessment designed to identify the presence of a neuropathic pain component in subjects with back pain. This was completed by the subject and scored by the research personnel at the Enrollment Visit. Subjects assessment current pain, strongest pain, average pain, areas of pain, course of pain and symptoms (such as burning, tingling, numbness and sensitivity). The scale ranged from 0 to 38 defined as follows: score 0-12 = neuropathic pain component unlikely; 13-18 = result is ambiguous; 19-38 = neuropathic pain component is likely.|units on a scale|Mean|16.1|16.1|Full Range|||2.0|27.0|
3656315|NCT02416973|3502793|B2|||PainDETECT Questionnaire|PainDETECT Questionniare (PD-q): a self-reported assessment designed to identify the presence of a neuropathic pain component in subjects with back pain. This was completed by the subject and scored by the research personnel at the Enrollment Visit. Subjects assessment current pain, strongest pain, average pain, areas of pain, course of pain and symptoms (such as burning, tingling, numbness and sensitivity). The scale ranged from 0 to 38 defined as follows: score 0-12 = neuropathic pain component unlikely; 13-18 = result is ambiguous; 19-38 = neuropathic pain component is likely.|units on a scale|Mean|14.5|14.5|Full Range|||7.0|19.0|
3656316|NCT02416973|3502794|B1|||PainDETECT Questionnaire|PainDETECT Questionniare (PD-q): a self-reported assessment designed to identify the presence of a neuropathic pain component in subjects with back pain. This was completed by the subject and scored by the research personnel at the Enrollment Visit. Subjects assessment current pain, strongest pain, average pain, areas of pain, course of pain and symptoms (such as burning, tingling, numbness and sensitivity). The scale ranged from 0 to 38 defined as follows: score 0-12 = neuropathic pain component unlikely; 13-18 = result is ambiguous; 19-38 = neuropathic pain component is likely.|units on a scale|Mean|16.6|16.6|Full Range|||4.0|28.0|
3656317|NCT02416973|3502791|B4|United States||Region of Enrollment||participants|Number|41|41.0||||||
3656318|NCT02416973|3502792|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
3656319|NCT02416973|3502793|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3656320|NCT02416973|3502794|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3656321|NCT02416973|3502791|B4||Male|Gender||Participants|Count of Participants|20|20.0||||||
3656322|NCT02416973|3502792|B3||Male|Gender||Participants|Count of Participants|7|7.0||||||
3656323|NCT02416973|3502793|B2||Male|Gender||Participants|Count of Participants|8|8.0||||||
3656325|NCT02416973|3502791|B4||Female|Gender||Participants|Count of Participants|21|21.0||||||
3656326|NCT02416973|3502792|B3||Female|Gender||Participants|Count of Participants|7|7.0||||||
3656327|NCT02416973|3502793|B2||Female|Gender||Participants|Count of Participants|5|5.0||||||
3656328|NCT02416973|3502794|B1||Female|Gender||Participants|Count of Participants|9|9.0||||||
3656329|NCT02416973|3502791|B4|||Age||years|Mean|51.83|51.83|Full Range|||28.0|81.0|
3656330|NCT02416973|3502792|B3|||Age||years|Mean|50.2|50.2|Full Range|||30.0|74.0|
3656331|NCT02416973|3502793|B2|||Age||years|Mean|54.9|54.9|Full Range|||30.0|81.0|
3656332|NCT02416973|3502794|B1|||Age||years|Mean|50.6|50.6|Full Range|||28.0|70.0|
3656333|NCT02416934|3502804|B3|United States||Region of Enrollment|The Dysphagia Short Questionnaire: An Instrument for Evaluation of Dysphagia (DSQ) and Bazaz Dysphagia Scale (Bazaz) were administered in person at baseline and Day 1, via phone call Day 2, Week 1,2; 1,3, 6 months, and 1 year.|participants|Number|64|64.0||||||
3656334|NCT02416934|3502805|B2|United States||Region of Enrollment|The Dysphagia Short Questionnaire: An Instrument for Evaluation of Dysphagia (DSQ) and Bazaz Dysphagia Scale (Bazaz) were administered in person at baseline and Day 1, via phone call Day 2, Week 1,2; 1,3, 6 months, and 1 year.|participants|Number|31|31.0||||||
3656335|NCT02416934|3502806|B1|United States||Region of Enrollment|The Dysphagia Short Questionnaire: An Instrument for Evaluation of Dysphagia (DSQ) and Bazaz Dysphagia Scale (Bazaz) were administered in person at baseline and Day 1, via phone call Day 2, Week 1,2; 1,3, 6 months, and 1 year.|participants|Number|33|33.0||||||
3656336|NCT02416934|3502804|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3656337|NCT02416934|3502805|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3656338|NCT02416934|3502806|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3656339|NCT02416934|3502804|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3656340|NCT02416934|3502805|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3656341|NCT02416934|3502806|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3656342|NCT02416934|3502804|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3656343|NCT02416934|3502805|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3656344|NCT02416934|3502806|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3656345|NCT02416934|3502804|B3||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
3656346|NCT02416934|3502805|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3656347|NCT02416934|3502806|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3656348|NCT02416934|3502804|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3656349|NCT02416934|3502805|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3656350|NCT02416934|3502806|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3656351|NCT02416180|3502817|B1|White - Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3656352|NCT02416180|3502817|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|106|106.0||||||
3656353|NCT02416180|3502817|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3656354|NCT02416180|3502817|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3656355|NCT02416180|3502817|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3656356|NCT02416180|3502817|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3656357|NCT02416180|3502817|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3656358|NCT02416180|3502817|B1|||Age||Years|Mean|45.6|45.6|Standard Deviation|16.76|16.76|||
3656359|NCT02415959|3502824|B6|Spain||Region of Enrollment||participants|Number|20|20.0||||||
3656360|NCT02415959|3502825|B5|Spain||Region of Enrollment||participants|Number|4|4.0||||||
3656361|NCT02415959|3502826|B4|Spain||Region of Enrollment||participants|Number|4|4.0||||||
3656362|NCT02415959|3502827|B3|Spain||Region of Enrollment||participants|Number|4|4.0||||||
3656363|NCT02415959|3502828|B2|Spain||Region of Enrollment||participants|Number|4|4.0||||||
3656364|NCT02415959|3502829|B1|Spain||Region of Enrollment||participants|Number|4|4.0||||||
3656365|NCT02415959|3502824|B6|Poland||Region of Enrollment||participants|Number|30|30.0||||||
3656366|NCT02415959|3502825|B5|Poland||Region of Enrollment||participants|Number|6|6.0||||||
3656367|NCT02415959|3502826|B4|Poland||Region of Enrollment||participants|Number|6|6.0||||||
3656368|NCT02415959|3502827|B3|Poland||Region of Enrollment||participants|Number|6|6.0||||||
3656369|NCT02415959|3502828|B2|Poland||Region of Enrollment||participants|Number|6|6.0||||||
3656370|NCT02415959|3502829|B1|Poland||Region of Enrollment||participants|Number|6|6.0||||||
3656371|NCT02415959|3502824|B6|Czech Republic||Region of Enrollment||participants|Number|5|5.0||||||
3656372|NCT02415959|3502825|B5|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
3656373|NCT02415959|3502826|B4|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
3656374|NCT02415959|3502827|B3|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
3656375|NCT02415959|3502828|B2|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
3656376|NCT02415959|3502829|B1|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
3656377|NCT02415959|3502824|B6|Hungary||Region of Enrollment||participants|Number|15|15.0||||||
3656378|NCT02415959|3502825|B5|Hungary||Region of Enrollment||participants|Number|3|3.0||||||
3656379|NCT02415959|3502826|B4|Hungary||Region of Enrollment||participants|Number|3|3.0||||||
3656380|NCT02415959|3502827|B3|Hungary||Region of Enrollment||participants|Number|3|3.0||||||
3656381|NCT02415959|3502828|B2|Hungary||Region of Enrollment||participants|Number|3|3.0||||||
3656382|NCT02415959|3502829|B1|Hungary||Region of Enrollment||participants|Number|3|3.0||||||
3656383|NCT02415959|3502824|B6||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3656384|NCT02415959|3502825|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3656385|NCT02415959|3502826|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3656386|NCT02415959|3502827|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3656387|NCT02415959|3502828|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3656388|NCT02415959|3502829|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3656389|NCT02415959|3502824|B6||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3656390|NCT02415959|3502825|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3656391|NCT02415959|3502826|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3656392|NCT02415959|3502827|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3656393|NCT02415959|3502828|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3656394|NCT02415959|3502829|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3656395|NCT02415959|3502824|B6|||Age||years|Mean|22.4|22.4|Standard Deviation|7.7|7.7|||
3656396|NCT02415959|3502825|B5|||Age||years|Mean|22.6|22.6|Standard Deviation|7.1|7.1|||
3656397|NCT02415959|3502826|B4|||Age||years|Mean|19.7|19.7|Standard Deviation|8.4|8.4|||
3656398|NCT02415959|3502827|B3|||Age||years|Mean|22.0|22.0|Standard Deviation|7.3|7.3|||
3656399|NCT02415959|3502828|B2|||Age||years|Mean|22.9|22.9|Standard Deviation|8.5|8.5|||
3656400|NCT02415959|3502829|B1|||Age||years|Mean|24.7|24.7|Standard Deviation|7.6|7.6|||
3656401|NCT02415959|3502824|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3656402|NCT02415959|3502825|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3656403|NCT02415959|3502826|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3656404|NCT02415959|3502827|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3656405|NCT02415959|3502828|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3656406|NCT02415959|3502829|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3656407|NCT02415959|3502824|B6||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3656408|NCT02415959|3502825|B5||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3656409|NCT02415959|3502826|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3656410|NCT02415959|3502827|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3656411|NCT02415959|3502828|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3656412|NCT02415959|3502829|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3656413|NCT02415959|3502824|B6||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
3656414|NCT02415959|3502825|B5||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3656415|NCT02415959|3502826|B4||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
3656416|NCT02415959|3502827|B3||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3656417|NCT02415959|3502828|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3656418|NCT02415959|3502829|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3656419|NCT02415608|3502865|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3656420|NCT02415608|3502866|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3656421|NCT02415608|3502867|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3656422|NCT02415608|3502865|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656423|NCT02415608|3502866|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656424|NCT02415608|3502867|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656425|NCT02415608|3502865|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656426|NCT02415608|3502866|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656427|NCT02415608|3502867|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656428|NCT02415608|3502865|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3656429|NCT02415608|3502866|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3656430|NCT02415608|3502867|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3656431|NCT02415608|3502865|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656432|NCT02415608|3502866|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656433|NCT02415608|3502867|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656434|NCT02415608|3502865|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656435|NCT02415608|3502866|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656436|NCT02415608|3502867|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656437|NCT02415608|3502865|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656438|NCT02415608|3502866|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656439|NCT02415608|3502867|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656440|NCT02415608|3502865|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656441|NCT02415608|3502866|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656442|NCT02415608|3502867|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656443|NCT02415608|3502865|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656444|NCT02415608|3502866|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656445|NCT02415608|3502867|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656446|NCT02415608|3502865|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3656447|NCT02415608|3502866|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3656448|NCT02415608|3502867|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3656449|NCT02415608|3502865|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656450|NCT02415608|3502866|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656451|NCT02415608|3502867|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656452|NCT02415608|3502865|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3656453|NCT02415608|3502866|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3656454|NCT02415608|3502867|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3656455|NCT02415608|3502865|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3656456|NCT02415608|3502866|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3656457|NCT02415608|3502867|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3656458|NCT02415608|3502865|B3|||Age||years|Median|69.7|69.7|Full Range|||61.6|78.5|
3656459|NCT02415608|3502866|B2|||Age||years|Median|76.8|76.8|Full Range|||76.8|76.8|
3656460|NCT02415608|3502867|B1|||Age||years|Median|62.6|62.6|Full Range|||61.6|78.5|
3656461|NCT02415608|3502865|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3656462|NCT02415608|3502866|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3656463|NCT02415608|3502867|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3656464|NCT02415608|3502865|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3656465|NCT02415608|3502866|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3656466|NCT02415608|3502867|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3656467|NCT02415608|3502865|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3656468|NCT02415608|3502866|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3656469|NCT02415608|3502867|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3656470|NCT02415595|3502894|B5|Race customized|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3656471|NCT02415595|3502895|B4|Race customized|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3656472|NCT02415595|3502896|B3|Race customized|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3656473|NCT02415595|3502897|B2|Race customized|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3656474|NCT02415595|3502898|B1|Race customized|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3656475|NCT02415595|3502894|B5|Race customized|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3656476|NCT02415595|3502895|B4|Race customized|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3656477|NCT02415595|3502896|B3|Race customized|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3656478|NCT02415595|3502897|B2|Race customized|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3656479|NCT02415595|3502898|B1|Race customized|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3656480|NCT02415595|3502894|B5|Race customized|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3656481|NCT02415595|3502895|B4|Race customized|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3656482|NCT02415595|3502896|B3|Race customized|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3656483|NCT02415595|3502897|B2|Race customized|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3656484|NCT02415595|3502898|B1|Race customized|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3656485|NCT02415595|3502894|B5|Race customized|White|Race/Ethnicity, Customized||Participants|Count of Participants|158|158.0||||||
3656486|NCT02415595|3502895|B4|Race customized|White|Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3656487|NCT02415595|3502896|B3|Race customized|White|Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
3656488|NCT02415595|3502897|B2|Race customized|White|Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
3656489|NCT02415595|3502898|B1|Race customized|White|Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
3656490|NCT02415595|3502894|B5||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
3656491|NCT02415595|3502895|B4||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3656492|NCT02415595|3502896|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3656493|NCT02415595|3502897|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3656494|NCT02415595|3502898|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3656495|NCT02415595|3502894|B5||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3656496|NCT02415595|3502895|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3656497|NCT02415595|3502896|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3656498|NCT02415595|3502897|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3656499|NCT02415595|3502898|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3656500|NCT02415595|3502894|B5|||Age||Years|Mean|33.7|33.7|Standard Deviation|10.18|10.18|||
3656501|NCT02415595|3502895|B4|||Age||Years|Mean|32.9|32.9|Standard Deviation|9.35|9.35|||
3656502|NCT02415595|3502896|B3|||Age||Years|Mean|35.5|35.5|Standard Deviation|11.34|11.34|||
3656503|NCT02415595|3502897|B2|||Age||Years|Mean|34.7|34.7|Standard Deviation|11.29|11.29|||
3656504|NCT02415595|3502898|B1|||Age||Years|Mean|31.8|31.8|Standard Deviation|8.26|8.26|||
3656505|NCT02415439|3502960|B14|United States||Region of Enrollment||participants|Number|86|86.0||||||
3656506|NCT02415439|3502961|B13|United States||Region of Enrollment||participants|Number|8|8.0||||||
3656507|NCT02415439|3502962|B12|United States||Region of Enrollment||participants|Number|6|6.0||||||
3656508|NCT02415439|3502963|B11|United States||Region of Enrollment||participants|Number|6|6.0||||||
3656509|NCT02415439|3502964|B10|United States||Region of Enrollment||participants|Number|6|6.0||||||
3656510|NCT02415439|3502965|B9|United States||Region of Enrollment||participants|Number|6|6.0||||||
3656511|NCT02415439|3502966|B8|United States||Region of Enrollment||participants|Number|12|12.0||||||
3656512|NCT02415439|3502967|B7|United States||Region of Enrollment||participants|Number|6|6.0||||||
3656513|NCT02415439|3502968|B6|United States||Region of Enrollment||participants|Number|6|6.0||||||
3656514|NCT02415439|3502969|B5|United States||Region of Enrollment||participants|Number|6|6.0||||||
3656515|NCT02415439|3502970|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
3656516|NCT02415439|3502971|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3656517|NCT02415439|3502972|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3656518|NCT02415439|3502973|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3656519|NCT02415439|3502960|B14||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3656520|NCT02415439|3502961|B13||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3656521|NCT02415439|3502962|B12||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3656522|NCT02415439|3502963|B11||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3656523|NCT02415439|3502964|B10||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3656524|NCT02415439|3502965|B9||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3656525|NCT02415439|3502966|B8||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3656526|NCT02415439|3502967|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3656527|NCT02415439|3502968|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3656528|NCT02415439|3502969|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3656529|NCT02415439|3502970|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3656530|NCT02415439|3502971|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3656531|NCT02415439|3502972|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3656532|NCT02415439|3502973|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3656533|NCT02415439|3502960|B14||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3656534|NCT02415439|3502961|B13||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3656535|NCT02415439|3502962|B12||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3656536|NCT02415439|3502963|B11||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3656537|NCT02415439|3502964|B10||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3656538|NCT02415439|3502965|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3656539|NCT02415439|3502966|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3656540|NCT02415439|3502967|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3656541|NCT02415439|3502968|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3656542|NCT02415439|3502969|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3656543|NCT02415439|3502970|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3656544|NCT02415439|3502971|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3656545|NCT02415439|3502972|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3656546|NCT02415439|3502973|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3656547|NCT02415439|3502960|B14||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3656548|NCT02415439|3502961|B13||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3656549|NCT02415439|3502962|B12||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3656550|NCT02415439|3502963|B11||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3656551|NCT02415439|3502964|B10||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3656552|NCT02415439|3502965|B9||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3656553|NCT02415439|3502966|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3656554|NCT02415439|3502967|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3656555|NCT02415439|3502968|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3656556|NCT02415439|3502969|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3656557|NCT02415439|3502970|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3656558|NCT02415439|3502971|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3656559|NCT02415439|3502972|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3656560|NCT02415439|3502973|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3656561|NCT02415439|3502960|B14||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
3656562|NCT02415439|3502961|B13||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3656563|NCT02415439|3502962|B12||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3656564|NCT02415439|3502963|B11||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3656565|NCT02415439|3502964|B10||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3656566|NCT02415439|3502965|B9||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3656567|NCT02415439|3502966|B8||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3656568|NCT02415439|3502967|B7||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3656569|NCT02415439|3502968|B6||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3656570|NCT02415439|3502969|B5||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3656571|NCT02415439|3502970|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3656572|NCT02415439|3502971|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3656573|NCT02415439|3502972|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3656574|NCT02415439|3502973|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3656575|NCT02415439|3502960|B14||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3656576|NCT02415439|3502961|B13||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3656577|NCT02415439|3502962|B12||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3656578|NCT02415439|3502963|B11||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3656579|NCT02415439|3502964|B10||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3656580|NCT02415439|3502965|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3656581|NCT02415439|3502966|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3656582|NCT02415439|3502967|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3656583|NCT02415439|3502968|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3656584|NCT02415439|3502969|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3656585|NCT02415439|3502970|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3656586|NCT02415439|3502971|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3656587|NCT02415439|3502972|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3656588|NCT02415439|3502973|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3656589|NCT02415166|3503039|B5|United States||Region of Enrollment||participants|Number|6|6.0||||||
3656590|NCT02415166|3503043|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3656591|NCT02415166|3503039|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3656592|NCT02415166|3503043|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3656593|NCT02415166|3503039|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3656594|NCT02415166|3503043|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3656595|NCT02415166|3503039|B5|||Age||years|Mean|35|35.0|Standard Deviation|6|6.0|||
3656596|NCT02415166|3503043|B1|||Age||years|Mean|35|35.0|Standard Deviation|6|6.0|||
3656597|NCT02415166|3503039|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3656598|NCT02415166|3503043|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3656599|NCT02415166|3503039|B5||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3656600|NCT02415166|3503043|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3656601|NCT02415166|3503039|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3656602|NCT02415166|3503043|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3656603|NCT02415127|3503072|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3656604|NCT02415127|3503073|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3656605|NCT02415127|3503074|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3656606|NCT02415127|3503072|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3656607|NCT02415127|3503073|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3656608|NCT02415127|3503074|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3656609|NCT02415127|3503072|B3|||Age||years|Mean|16.3|16.3|Standard Deviation|4.08|4.08|||
3656610|NCT02415127|3503073|B2|||Age||years|Mean|16.1|16.1|Standard Deviation|3.75|3.75|||
3656611|NCT02415127|3503074|B1|||Age||years|Mean|16.5|16.5|Standard Deviation|4.41|4.41|||
3656612|NCT02414958|3503089|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656613|NCT02414958|3503090|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656614|NCT02414958|3503091|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656615|NCT02414958|3503092|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656616|NCT02414958|3503089|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3656617|NCT02414958|3503090|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656618|NCT02414958|3503091|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656619|NCT02414958|3503092|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3656620|NCT02414958|3503089|B4||White|Race (NIH/OMB)||Participants|Count of Participants|687|687.0||||||
3656621|NCT02414958|3503090|B3||White|Race (NIH/OMB)||Participants|Count of Participants|230|230.0||||||
3656622|NCT02414958|3503091|B2||White|Race (NIH/OMB)||Participants|Count of Participants|230|230.0||||||
3656623|NCT02414958|3503092|B1||White|Race (NIH/OMB)||Participants|Count of Participants|227|227.0||||||
3656624|NCT02414958|3503089|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3656625|NCT02414958|3503090|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3656626|NCT02414958|3503091|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3656627|NCT02414958|3503092|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3656628|NCT02414958|3503089|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3656629|NCT02414958|3503090|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656630|NCT02414958|3503091|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3656631|NCT02414958|3503092|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656632|NCT02414958|3503089|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3656633|NCT02414958|3503090|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3656634|NCT02414958|3503091|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3656635|NCT02414958|3503092|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3656636|NCT02414958|3503089|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656637|NCT02414958|3503090|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656638|NCT02414958|3503091|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656639|NCT02414958|3503092|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656640|NCT02414958|3503089|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656641|NCT02414958|3503090|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656642|NCT02414958|3503091|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656643|NCT02414958|3503092|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656644|NCT02414958|3503089|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|713|713.0||||||
3656645|NCT02414958|3503090|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|238|238.0||||||
3656646|NCT02414958|3503091|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|239|239.0||||||
3656647|NCT02414958|3503092|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|236|236.0||||||
3656648|NCT02414958|3503089|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3656649|NCT02414958|3503090|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3656650|NCT02414958|3503091|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3656651|NCT02414958|3503092|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3656652|NCT02414958|3503089|B4||Male|Sex: Female, Male||Participants|Count of Participants|341|341.0||||||
3656653|NCT02414958|3503090|B3||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3656654|NCT02414958|3503091|B2||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3656655|NCT02414958|3503092|B1||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3656656|NCT02414958|3503089|B4||Female|Sex: Female, Male||Participants|Count of Participants|389|389.0||||||
3656657|NCT02414958|3503090|B3||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3656658|NCT02414958|3503091|B2||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3656659|NCT02414958|3503092|B1||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3656660|NCT02414958|3503089|B4|||Age||Years|Mean|45.0|45.0|Standard Deviation|13.4|13.4|||
3656661|NCT02414958|3503090|B3|||Age||Years|Mean|45.3|45.3|Standard Deviation|14.0|14.0|||
3656662|NCT02414958|3503091|B2|||Age||Years|Mean|45.7|45.7|Standard Deviation|12.5|12.5|||
3656663|NCT02414958|3503092|B1|||Age||Years|Mean|44.2|44.2|Standard Deviation|13.6|13.6|||
3656664|NCT02414854|3503123|B5|Low||ICS Dose Level||Participants|Count of Participants|15|15.0||||||
3656665|NCT02414854|3503124|B4|Low||ICS Dose Level||Participants|Count of Participants|7|7.0||||||
3656666|NCT02414854|3503125|B3|Low||ICS Dose Level||Participants|Count of Participants|3|3.0||||||
3656667|NCT02414854|3503126|B2|Low||ICS Dose Level||Participants|Count of Participants|4|4.0||||||
3656668|NCT02414854|3503127|B1|Low||ICS Dose Level||Participants|Count of Participants|1|1.0||||||
3656669|NCT02414854|3503123|B5|Medium||ICS Dose Level||Participants|Count of Participants|908|908.0||||||
3656670|NCT02414854|3503124|B4|Medium||ICS Dose Level||Participants|Count of Participants|303|303.0||||||
3656671|NCT02414854|3503125|B3|Medium||ICS Dose Level||Participants|Count of Participants|151|151.0||||||
3656672|NCT02414854|3503126|B2|Medium||ICS Dose Level||Participants|Count of Participants|310|310.0||||||
3656673|NCT02414854|3503127|B1|Medium||ICS Dose Level||Participants|Count of Participants|144|144.0||||||
3656674|NCT02414854|3503123|B5|High||ICS Dose Level||Participants|Count of Participants|979|979.0||||||
3656675|NCT02414854|3503124|B4|High||ICS Dose Level||Participants|Count of Participants|323|323.0||||||
3656676|NCT02414854|3503125|B3|High||ICS Dose Level||Participants|Count of Participants|167|167.0||||||
3656677|NCT02414854|3503126|B2|High||ICS Dose Level||Participants|Count of Participants|317|317.0||||||
3656678|NCT02414854|3503127|B1|High||ICS Dose Level||Participants|Count of Participants|172|172.0||||||
3656679|NCT02414854|3503123|B5|>=0.3 Giga/L||Blood Eosinophil Group||Participants|Count of Participants|831|831.0||||||
3656680|NCT02414854|3503124|B4|>=0.3 Giga/L||Blood Eosinophil Group||Participants|Count of Participants|277|277.0||||||
3656681|NCT02414854|3503125|B3|>=0.3 Giga/L||Blood Eosinophil Group||Participants|Count of Participants|142|142.0||||||
3656682|NCT02414854|3503126|B2|>=0.3 Giga/L||Blood Eosinophil Group||Participants|Count of Participants|264|264.0||||||
3656683|NCT02414854|3503127|B1|>=0.3 Giga/L||Blood Eosinophil Group||Participants|Count of Participants|148|148.0||||||
3656684|NCT02414854|3503123|B5|>=0.15 - <0.3 Giga/L||Blood Eosinophil Group||Participants|Count of Participants|527|527.0||||||
3656685|NCT02414854|3503124|B4|>=0.15 - <0.3 Giga/L||Blood Eosinophil Group||Participants|Count of Participants|175|175.0||||||
3656686|NCT02414854|3503125|B3|>=0.15 - <0.3 Giga/L||Blood Eosinophil Group||Participants|Count of Participants|95|95.0||||||
3656687|NCT02414854|3503126|B2|>=0.15 - <0.3 Giga/L||Blood Eosinophil Group||Participants|Count of Participants|173|173.0||||||
3656688|NCT02414854|3503127|B1|>=0.15 - <0.3 Giga/L||Blood Eosinophil Group||Participants|Count of Participants|84|84.0||||||
3656689|NCT02414854|3503123|B5|<0.15 Giga/L||Blood Eosinophil Group||Participants|Count of Participants|542|542.0||||||
3656690|NCT02414854|3503124|B4|<0.15 Giga/L||Blood Eosinophil Group||Participants|Count of Participants|181|181.0||||||
3656691|NCT02414854|3503125|B3|<0.15 Giga/L||Blood Eosinophil Group||Participants|Count of Participants|83|83.0||||||
3656692|NCT02414854|3503126|B2|<0.15 Giga/L||Blood Eosinophil Group||Participants|Count of Participants|193|193.0||||||
3656693|NCT02414854|3503127|B1|<0.15 Giga/L||Blood Eosinophil Group||Participants|Count of Participants|85|85.0||||||
3656694|NCT02414854|3503123|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3656695|NCT02414854|3503124|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3656696|NCT02414854|3503125|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3656697|NCT02414854|3503126|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3656698|NCT02414854|3503127|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3656699|NCT02414854|3503123|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3656700|NCT02414854|3503124|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3656701|NCT02414854|3503125|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3656702|NCT02414854|3503126|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3656703|NCT02414854|3503127|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3656704|NCT02414854|3503123|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3656705|NCT02414854|3503124|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3656706|NCT02414854|3503125|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3656707|NCT02414854|3503126|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3656708|NCT02414854|3503127|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3656709|NCT02414854|3503123|B5|Asian/Oriental||Race/Ethnicity, Customized||Participants|Count of Participants|223|223.0||||||
3656710|NCT02414854|3503124|B4|Asian/Oriental||Race/Ethnicity, Customized||Participants|Count of Participants|79|79.0||||||
3656711|NCT02414854|3503125|B3|Asian/Oriental||Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3656712|NCT02414854|3503126|B2|Asian/Oriental||Race/Ethnicity, Customized||Participants|Count of Participants|78|78.0||||||
3656713|NCT02414854|3503127|B1|Asian/Oriental||Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3656714|NCT02414854|3503123|B5|Black/of African descent||Race/Ethnicity, Customized||Participants|Count of Participants|80|80.0||||||
3656715|NCT02414854|3503124|B4|Black/of African descent||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3656716|NCT02414854|3503125|B3|Black/of African descent||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3656717|NCT02414854|3503126|B2|Black/of African descent||Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3656718|NCT02414854|3503127|B1|Black/of African descent||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3656719|NCT02414854|3503123|B5|Caucasian/White||Race/Ethnicity, Customized||Participants|Count of Participants|1577|1577.0||||||
3656720|NCT02414854|3503124|B4|Caucasian/White||Race/Ethnicity, Customized||Participants|Count of Participants|529|529.0||||||
3656721|NCT02414854|3503125|B3|Caucasian/White||Race/Ethnicity, Customized||Participants|Count of Participants|273|273.0||||||
3656722|NCT02414854|3503126|B2|Caucasian/White||Race/Ethnicity, Customized||Participants|Count of Participants|510|510.0||||||
3656723|NCT02414854|3503127|B1|Caucasian/White||Race/Ethnicity, Customized||Participants|Count of Participants|265|265.0||||||
3656724|NCT02414854|3503123|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656725|NCT02414854|3503124|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656726|NCT02414854|3503125|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656727|NCT02414854|3503126|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656728|NCT02414854|3503127|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656729|NCT02414854|3503123|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1412|1412.0||||||
3656730|NCT02414854|3503124|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|474|474.0||||||
3656731|NCT02414854|3503125|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|242|242.0||||||
3656732|NCT02414854|3503126|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|460|460.0||||||
3656733|NCT02414854|3503127|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|236|236.0||||||
3656734|NCT02414854|3503123|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|490|490.0||||||
3656735|NCT02414854|3503124|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|159|159.0||||||
3656736|NCT02414854|3503125|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3656737|NCT02414854|3503126|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|171|171.0||||||
3656738|NCT02414854|3503127|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
3656739|NCT02414854|3503123|B5||Male|Sex: Female, Male||Participants|Count of Participants|705|705.0||||||
3656740|NCT02414854|3503124|B4||Male|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
3656741|NCT02414854|3503125|B3||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3656742|NCT02414854|3503126|B2||Male|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
3656743|NCT02414854|3503127|B1||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3656744|NCT02414854|3503123|B5||Female|Sex: Female, Male||Participants|Count of Participants|1197|1197.0||||||
3656745|NCT02414854|3503124|B4||Female|Sex: Female, Male||Participants|Count of Participants|394|394.0||||||
3656746|NCT02414854|3503125|B3||Female|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
3656747|NCT02414854|3503126|B2||Female|Sex: Female, Male||Participants|Count of Participants|387|387.0||||||
3656748|NCT02414854|3503127|B1||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
3656749|NCT02414854|3503123|B5|From 65-84 years||Age, Customized||Participants|Count of Participants|251|251.0||||||
3656750|NCT02414854|3503124|B4|From 65-84 years||Age, Customized||Participants|Count of Participants|83|83.0||||||
3656751|NCT02414854|3503125|B3|From 65-84 years||Age, Customized||Participants|Count of Participants|40|40.0||||||
3656752|NCT02414854|3503126|B2|From 65-84 years||Age, Customized||Participants|Count of Participants|85|85.0||||||
3656753|NCT02414854|3503127|B1|From 65-84 years||Age, Customized||Participants|Count of Participants|43|43.0||||||
3656754|NCT02414854|3503123|B5|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|1544|1544.0||||||
3656755|NCT02414854|3503124|B4|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|516|516.0||||||
3656756|NCT02414854|3503125|B3|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|263|263.0||||||
3656757|NCT02414854|3503126|B2|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|512|512.0||||||
3656758|NCT02414854|3503127|B1|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|253|253.0||||||
3656759|NCT02414854|3503123|B5|Adolescents (12-17 years)||Age, Customized||Participants|Count of Participants|107|107.0||||||
3656760|NCT02414854|3503124|B4|Adolescents (12-17 years)||Age, Customized||Participants|Count of Participants|34|34.0||||||
3656761|NCT02414854|3503125|B3|Adolescents (12-17 years)||Age, Customized||Participants|Count of Participants|18|18.0||||||
3656762|NCT02414854|3503126|B2|Adolescents (12-17 years)||Age, Customized||Participants|Count of Participants|34|34.0||||||
3656763|NCT02414854|3503127|B1|Adolescents (12-17 years)||Age, Customized||Participants|Count of Participants|21|21.0||||||
3656764|NCT02414854|3503123|B5|||Age||years|Mean|47.9|47.9|Standard Deviation|15.3|15.3|||
3656765|NCT02414854|3503124|B4|||Age||years|Mean|47.7|47.7|Standard Deviation|15.6|15.6|||
3656766|NCT02414854|3503125|B3|||Age||years|Mean|48.2|48.2|Standard Deviation|14.7|14.7|||
3656767|NCT02414854|3503126|B2|||Age||years|Mean|47.9|47.9|Standard Deviation|15.3|15.3|||
3656768|NCT02414854|3503127|B1|||Age||years|Mean|48.2|48.2|Standard Deviation|15.6|15.6|||
3656769|NCT02414828|3503292|B5|No - History of Smoking||History of Smoking||participants|Number|21|21.0||||||
3656770|NCT02414828|3503293|B4|No - History of Smoking||History of Smoking||participants|Number|11|11.0||||||
3656771|NCT02414828|3503294|B3|No - History of Smoking||History of Smoking||participants|Number|6|6.0||||||
3656772|NCT02414828|3503295|B2|No - History of Smoking||History of Smoking||participants|Number|4|4.0||||||
3656773|NCT02414828|3503296|B1|No - History of Smoking||History of Smoking||participants|Number|0|0.0||||||
3656774|NCT02414828|3503292|B5|Yes - History of smoking||History of Smoking||participants|Number|51|51.0||||||
3656775|NCT02414828|3503293|B4|Yes - History of smoking||History of Smoking||participants|Number|20|20.0||||||
3656776|NCT02414828|3503294|B3|Yes - History of smoking||History of Smoking||participants|Number|14|14.0||||||
3656777|NCT02414828|3503295|B2|Yes - History of smoking||History of Smoking||participants|Number|6|6.0||||||
3656778|NCT02414828|3503296|B1|Yes - History of smoking||History of Smoking||participants|Number|11|11.0||||||
3656779|NCT02414828|3503292|B5|Post TB Treatment||TB Treatment Status|"On TB Treatment stratum started TB treatment between 1 and 4 months prior to Study Day 0. The Post TB Treatment stratum started TB treatment at least 12 months prior to Study Day 0"|participants|Number|36|36.0||||||
3656780|NCT02414828|3503293|B4|Post TB Treatment||TB Treatment Status|"On TB Treatment stratum started TB treatment between 1 and 4 months prior to Study Day 0. The Post TB Treatment stratum started TB treatment at least 12 months prior to Study Day 0"|participants|Number|15|15.0||||||
3656781|NCT02414828|3503294|B3|Post TB Treatment||TB Treatment Status|"On TB Treatment stratum started TB treatment between 1 and 4 months prior to Study Day 0. The Post TB Treatment stratum started TB treatment at least 12 months prior to Study Day 0"|participants|Number|10|10.0||||||
3656782|NCT02414828|3503295|B2|Post TB Treatment||TB Treatment Status|"On TB Treatment stratum started TB treatment between 1 and 4 months prior to Study Day 0. The Post TB Treatment stratum started TB treatment at least 12 months prior to Study Day 0"|participants|Number|5|5.0||||||
3656839|NCT02414204|3503360|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656840|NCT02414204|3503358|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656783|NCT02414828|3503296|B1|Post TB Treatment||TB Treatment Status|"On TB Treatment stratum started TB treatment between 1 and 4 months prior to Study Day 0. The Post TB Treatment stratum started TB treatment at least 12 months prior to Study Day 0"|participants|Number|6|6.0||||||
3656784|NCT02414828|3503292|B5|On TB Treatment||TB Treatment Status|"On TB Treatment stratum started TB treatment between 1 and 4 months prior to Study Day 0. The Post TB Treatment stratum started TB treatment at least 12 months prior to Study Day 0"|participants|Number|36|36.0||||||
3656785|NCT02414828|3503293|B4|On TB Treatment||TB Treatment Status|"On TB Treatment stratum started TB treatment between 1 and 4 months prior to Study Day 0. The Post TB Treatment stratum started TB treatment at least 12 months prior to Study Day 0"|participants|Number|16|16.0||||||
3656786|NCT02414828|3503294|B3|On TB Treatment||TB Treatment Status|"On TB Treatment stratum started TB treatment between 1 and 4 months prior to Study Day 0. The Post TB Treatment stratum started TB treatment at least 12 months prior to Study Day 0"|participants|Number|10|10.0||||||
3656787|NCT02414828|3503295|B2|On TB Treatment||TB Treatment Status|"On TB Treatment stratum started TB treatment between 1 and 4 months prior to Study Day 0. The Post TB Treatment stratum started TB treatment at least 12 months prior to Study Day 0"|participants|Number|5|5.0||||||
3656788|NCT02414828|3503296|B1|On TB Treatment||TB Treatment Status|"On TB Treatment stratum started TB treatment between 1 and 4 months prior to Study Day 0. The Post TB Treatment stratum started TB treatment at least 12 months prior to Study Day 0"|participants|Number|5|5.0||||||
3656789|NCT02414828|3503292|B5|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3656790|NCT02414828|3503293|B4|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3656791|NCT02414828|3503294|B3|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3656792|NCT02414828|3503295|B2|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3656793|NCT02414828|3503296|B1|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3656794|NCT02414828|3503292|B5|Coloured||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
3656795|NCT02414828|3503293|B4|Coloured||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3656796|NCT02414828|3503294|B3|Coloured||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3656797|NCT02414828|3503295|B2|Coloured||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3656798|NCT02414828|3503296|B1|Coloured||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3656799|NCT02414828|3503292|B5|Black||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3656800|NCT02414828|3503293|B4|Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3656801|NCT02414828|3503294|B3|Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3656802|NCT02414828|3503295|B2|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3656803|NCT02414828|3503296|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3656804|NCT02414828|3503292|B5|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3656805|NCT02414828|3503293|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3656806|NCT02414828|3503294|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3656807|NCT02414828|3503295|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3656808|NCT02414828|3503296|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3656809|NCT02414828|3503292|B5||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3656810|NCT02414828|3503293|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3656811|NCT02414828|3503294|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3656812|NCT02414828|3503295|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3656813|NCT02414828|3503296|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3656814|NCT02414828|3503292|B5||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3656815|NCT02414828|3503293|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3656816|NCT02414828|3503294|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3656817|NCT02414828|3503295|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3656818|NCT02414828|3503296|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3656819|NCT02414828|3503292|B5|41-45 years||Age, Customized||years|Number|10|10.0||||||
3656820|NCT02414828|3503293|B4|41-45 years||Age, Customized||years|Number|2|2.0||||||
3656821|NCT02414828|3503294|B3|41-45 years||Age, Customized||years|Number|4|4.0||||||
3656822|NCT02414828|3503295|B2|41-45 years||Age, Customized||years|Number|3|3.0||||||
3656823|NCT02414828|3503296|B1|41-45 years||Age, Customized||years|Number|1|1.0||||||
3656824|NCT02414828|3503292|B5|31-40 years||Age, Customized||years|Number|20|20.0||||||
3656825|NCT02414828|3503293|B4|31-40 years||Age, Customized||years|Number|9|9.0||||||
3656826|NCT02414828|3503294|B3|31-40 years||Age, Customized||years|Number|5|5.0||||||
3656827|NCT02414828|3503295|B2|31-40 years||Age, Customized||years|Number|2|2.0||||||
3656828|NCT02414828|3503296|B1|31-40 years||Age, Customized||years|Number|4|4.0||||||
3656829|NCT02414828|3503292|B5|18-30 years||Age, Customized||years|Number|42|42.0||||||
3656830|NCT02414828|3503293|B4|18-30 years||Age, Customized||years|Number|20|20.0||||||
3656831|NCT02414828|3503294|B3|18-30 years||Age, Customized||years|Number|11|11.0||||||
3656832|NCT02414828|3503295|B2|18-30 years||Age, Customized||years|Number|5|5.0||||||
3656833|NCT02414828|3503296|B1|18-30 years||Age, Customized||years|Number|6|6.0||||||
3656834|NCT02414633|3503337|B1||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3656835|NCT02414633|3503337|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3656836|NCT02414633|3503337|B1|||Age||years|Mean|49.1|49.1|Standard Deviation|11.3|11.3|||
3656837|NCT02414204|3503358|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656838|NCT02414204|3503359|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656841|NCT02414204|3503359|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656842|NCT02414204|3503360|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656843|NCT02414204|3503358|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656844|NCT02414204|3503359|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656845|NCT02414204|3503360|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656846|NCT02414204|3503358|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3656847|NCT02414204|3503359|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3656848|NCT02414204|3503360|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3656849|NCT02414204|3503358|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656850|NCT02414204|3503359|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656851|NCT02414204|3503360|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656852|NCT02414204|3503358|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656853|NCT02414204|3503359|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656854|NCT02414204|3503360|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656855|NCT02414204|3503358|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656856|NCT02414204|3503359|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656857|NCT02414204|3503360|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656858|NCT02414204|3503358|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3656859|NCT02414204|3503359|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3656860|NCT02414204|3503360|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3656861|NCT02414204|3503358|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3656862|NCT02414204|3503359|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3656863|NCT02414204|3503360|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3656864|NCT02414204|3503358|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3656865|NCT02414204|3503359|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3656866|NCT02414204|3503360|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3656867|NCT02414204|3503358|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3656868|NCT02414204|3503359|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3656869|NCT02414204|3503360|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3656870|NCT02414204|3503358|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3656871|NCT02414204|3503359|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3656872|NCT02414204|3503360|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3656873|NCT02414152|3503369|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656874|NCT02414152|3503369|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656875|NCT02414152|3503369|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3656876|NCT02414152|3503369|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656877|NCT02414152|3503369|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656878|NCT02414152|3503369|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656879|NCT02414152|3503369|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656880|NCT02414152|3503369|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656881|NCT02414152|3503369|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3656882|NCT02414152|3503369|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656883|NCT02414152|3503369|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3656884|NCT02414152|3503369|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3656885|NCT02414152|3503369|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3656886|NCT02414152|3503369|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3656887|NCT02414152|3503369|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3656888|NCT02413918|3503373|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3656889|NCT02413918|3503373|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3656890|NCT02413918|3503373|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3656891|NCT02413918|3503373|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3656892|NCT02413918|3503373|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3656893|NCT02413879|3503380|B1|Steroid or other immunosuppressant within 1 month||Medical History||Participants|Count of Participants|30|30.0||||||
3656894|NCT02413879|3503380|B1|History of Smoking||Medical History||Participants|Count of Participants|46|46.0||||||
3656895|NCT02413879|3503380|B1|Diabetes||Medical History||Participants|Count of Participants|19|19.0||||||
3656896|NCT02413879|3503380|B1|Hypertension||Medical History||Participants|Count of Participants|46|46.0||||||
3656897|NCT02413879|3503380|B1|Colorectal Cancer||Medical History||Participants|Count of Participants|33|33.0||||||
3656898|NCT02413879|3503380|B1|IBD||Medical History||Participants|Count of Participants|14|14.0||||||
3656899|NCT02413879|3503380|B1|||BMI||kg/m^2|Mean|29.0|29.0|Standard Deviation|5.8|5.8|||
3656900|NCT02413879|3503380|B1|United States||Region of Enrollment||participants|Number|86|86.0||||||
3656901|NCT02413879|3503380|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3656902|NCT02413879|3503380|B1|White||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
3656903|NCT02413879|3503380|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3656904|NCT02413879|3503380|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3656905|NCT02413879|3503380|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3656906|NCT02413879|3503380|B1|||Age||years|Mean|62.4|62.4|Standard Deviation|13.2|13.2|||
3656907|NCT02413684|3503386|B1|||Weight||kilograms|Mean|94.5|94.5|Inter-Quartile Range|||54.5|160.0|
3656908|NCT02413684|3503386|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3656909|NCT02413684|3503386|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656910|NCT02413684|3503386|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656911|NCT02413684|3503386|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3656912|NCT02413684|3503386|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3656913|NCT02413684|3503386|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656914|NCT02413684|3503386|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3656915|NCT02413684|3503386|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3656916|NCT02413684|3503386|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656917|NCT02413684|3503386|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3656918|NCT02413684|3503386|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656919|NCT02413684|3503386|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3656920|NCT02413684|3503386|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3656921|NCT02413684|3503386|B1|||Age||years|Mean|49.98|49.98|Standard Deviation|13.26|13.26|||
3656922|NCT02413684|3503386|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3656923|NCT02413684|3503386|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3656924|NCT02413684|3503386|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3656925|NCT02413593|3503396|B1|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|76|76.0||||||
3656926|NCT02413593|3503396|B1|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|35|35.0||||||
3656927|NCT02413593|3503396|B1|||HCV RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.66|0.66|||
3656928|NCT02413593|3503396|B1|Missing||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|2|2.0||||||
3656929|NCT02413593|3503396|B1|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|13|13.0||||||
3656930|NCT02413593|3503396|B1|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|56|56.0||||||
3656931|NCT02413593|3503396|B1|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|40|40.0||||||
3656932|NCT02413593|3503396|B1|Missing||Cirrhosis Status||Participants|Count of Participants|2|2.0||||||
3656933|NCT02413593|3503396|B1|Present||Cirrhosis Status||Participants|Count of Participants|39|39.0||||||
3656934|NCT02413593|3503396|B1|Absent||Cirrhosis Status||Participants|Count of Participants|70|70.0||||||
3656935|NCT02413593|3503396|B1|Genotype 3b||HCV Genotype||Participants|Count of Participants|3|3.0||||||
3656936|NCT02413593|3503396|B1|Genotype 3a||HCV Genotype||Participants|Count of Participants|105|105.0||||||
3656937|NCT02413593|3503396|B1|Genotype 3 (no confirmed subtype)||HCV Genotype||Participants|Count of Participants|3|3.0||||||
3656938|NCT02413593|3503396|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656939|NCT02413593|3503396|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3656940|NCT02413593|3503396|B1||White|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3656941|NCT02413593|3503396|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3656942|NCT02413593|3503396|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656943|NCT02413593|3503396|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3656944|NCT02413593|3503396|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3656945|NCT02413593|3503396|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656946|NCT02413593|3503396|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
3656947|NCT02413593|3503396|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3656948|NCT02413593|3503396|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3656949|NCT02413593|3503396|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3656950|NCT02413593|3503396|B1|||Age||years|Mean|48|48.0|Standard Deviation|10.7|10.7|||
3656951|NCT02413489|3503405|B4|||CD38 expression value|The expression levels of CD38 were used to do diagnosis of MCL, DLBCL, or FL and measurable disease.|Percentage of CD38 expression|Mean|71.9|71.9|Standard Deviation|16.66|16.66|||
3656952|NCT02413489|3503406|B3|||CD38 expression value|The expression levels of CD38 were used to do diagnosis of MCL, DLBCL, or FL and measurable disease.|Percentage of CD38 expression|Mean|64|64.0|Standard Deviation|8.22|8.22|||
3656953|NCT02413489|3503407|B2|||CD38 expression value|The expression levels of CD38 were used to do diagnosis of MCL, DLBCL, or FL and measurable disease.|Percentage of CD38 expression|Mean|70.3|70.3|Standard Deviation|16.78|16.78|||
3656954|NCT02413489|3503408|B1|||CD38 expression value|The expression levels of CD38 were used to do diagnosis of MCL, DLBCL, or FL and measurable disease.|Percentage of CD38 expression|Mean|76.3|76.3|Standard Deviation|18.07|18.07|||
3656955|NCT02413489|3503405|B4|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3656956|NCT02413489|3503406|B3|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3656957|NCT02413489|3503407|B2|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3656958|NCT02413489|3503408|B1|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3656959|NCT02413489|3503405|B4|Turkey||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3656960|NCT02413489|3503406|B3|Turkey||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3656961|NCT02413489|3503407|B2|Turkey||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3656962|NCT02413489|3503408|B1|Turkey||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3656963|NCT02413489|3503405|B4|Republic of Korea||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3656964|NCT02413489|3503406|B3|Republic of Korea||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3656965|NCT02413489|3503407|B2|Republic of Korea||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3656966|NCT02413489|3503408|B1|Republic of Korea||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3656967|NCT02413489|3503405|B4|Netherlands||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3656968|NCT02413489|3503406|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3656969|NCT02413489|3503407|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3656970|NCT02413489|3503408|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3656971|NCT02413489|3503405|B4|France||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3656972|NCT02413489|3503406|B3|France||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3656973|NCT02413489|3503407|B2|France||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3656974|NCT02413489|3503408|B1|France||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3656975|NCT02413489|3503405|B4|Belgium||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3656976|NCT02413489|3503406|B3|Belgium||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3656977|NCT02413489|3503407|B2|Belgium||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3656978|NCT02413489|3503408|B1|Belgium||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3656979|NCT02413489|3503405|B4|Australia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3656980|NCT02413489|3503406|B3|Australia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3656981|NCT02413489|3503407|B2|Australia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3656982|NCT02413489|3503408|B1|Australia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3656983|NCT02413489|3503405|B4||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3656984|NCT02413489|3503406|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3656985|NCT02413489|3503407|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3656986|NCT02413489|3503408|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3656987|NCT02413489|3503405|B4||Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3656988|NCT02413489|3503406|B3||Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3656989|NCT02413489|3503407|B2||Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3656990|NCT02413489|3503408|B1||Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3656991|NCT02413489|3503405|B4||Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3656992|NCT02413489|3503406|B3||Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3656993|NCT02413489|3503407|B2||Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3656994|NCT02413489|3503408|B1||Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3656995|NCT02413489|3503405|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3656996|NCT02413489|3503406|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3656997|NCT02413489|3503407|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3656998|NCT02413489|3503408|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3656999|NCT02413489|3503405|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3657000|NCT02413489|3503406|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3657001|NCT02413489|3503407|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3657002|NCT02413489|3503408|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3657003|NCT02413489|3503405|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3657004|NCT02413489|3503406|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3657005|NCT02413489|3503407|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657006|NCT02413489|3503408|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3657007|NCT02413489|3503405|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3657008|NCT02413489|3503406|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3657009|NCT02413489|3503407|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3657010|NCT02413489|3503408|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3657011|NCT02413489|3503405|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3657012|NCT02413489|3503406|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3657013|NCT02413489|3503407|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3657014|NCT02413489|3503408|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657015|NCT02413489|3503405|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3657016|NCT02413489|3503406|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3657017|NCT02413489|3503407|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3657018|NCT02413489|3503408|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3657019|NCT02413489|3503405|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3657020|NCT02413489|3503406|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3657021|NCT02413489|3503407|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3657022|NCT02413489|3503408|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3657023|NCT02413489|3503405|B4|||Age||years|Mean|63.8|63.8|Standard Deviation|10.45|10.45|||
3657024|NCT02413489|3503406|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|6.69|6.69|||
3657025|NCT02413489|3503407|B2|||Age||years|Mean|62.3|62.3|Standard Deviation|9.77|9.77|||
3657026|NCT02413489|3503408|B1|||Age||years|Mean|66.7|66.7|Standard Deviation|11.88|11.88|||
3657027|NCT02413489|3503405|B4||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3657028|NCT02413489|3503406|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3657029|NCT02413489|3503407|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3657030|NCT02413489|3503408|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3657031|NCT02413489|3503405|B4||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3657032|NCT02413489|3503406|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3657033|NCT02413489|3503407|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3657034|NCT02413489|3503408|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3657035|NCT02413489|3503405|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3657036|NCT02413489|3503406|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3657037|NCT02413489|3503407|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3657038|NCT02413489|3503408|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3657039|NCT02413398|3503430|B3|||Urine Albumin-to-Creatinine Ratio (UACR)||mg/g|Mean|236.78|236.78|Standard Deviation|678.81|678.81|||
3657040|NCT02413398|3503431|B2|||Urine Albumin-to-Creatinine Ratio (UACR)||mg/g|Mean|246.52|246.52|Standard Deviation|775.49|775.49|||
3657041|NCT02413398|3503432|B1|||Urine Albumin-to-Creatinine Ratio (UACR)||mg/g|Mean|226.91|226.91|Standard Deviation|566.67|566.67|||
3657042|NCT02413398|3503430|B3|||Estimated Glomular Filtration Rate (eGFR)||mL/min/1.73 m^2|Mean|51.7|51.7|Standard Deviation|3.9|3.9|||
3657043|NCT02413398|3503431|B2|||Estimated Glomular Filtration Rate (eGFR)||mL/min/1.73 m^2|Mean|51.6|51.6|Standard Deviation|3.8|3.8|||
3657044|NCT02413398|3503432|B1|||Estimated Glomular Filtration Rate (eGFR)||mL/min/1.73 m^2|Mean|51.8|51.8|Standard Deviation|4.1|4.1|||
3657045|NCT02413398|3503430|B3|||Body Mass Index||kg/m^2|Mean|32.1|32.1|Standard Deviation|4.9|4.9|||
3657046|NCT02413398|3503431|B2|||Body Mass Index||kg/m^2|Mean|31.6|31.6|Standard Deviation|5.0|5.0|||
3657047|NCT02413398|3503432|B1|||Body Mass Index||kg/m^2|Mean|32.6|32.6|Standard Deviation|4.7|4.7|||
3657048|NCT02413398|3503430|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|281|281.0||||||
3657049|NCT02413398|3503431|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|140|140.0||||||
3657050|NCT02413398|3503432|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|141|141.0||||||
3657051|NCT02413398|3503430|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3657052|NCT02413398|3503431|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3657053|NCT02413398|3503432|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3657054|NCT02413398|3503430|B3||Black Or African American|Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3657055|NCT02413398|3503431|B2||Black Or African American|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3657056|NCT02413398|3503432|B1||Black Or African American|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3657057|NCT02413398|3503430|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3657058|NCT02413398|3503431|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3657059|NCT02413398|3503432|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3657060|NCT02413398|3503430|B3||American Indian Or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3657061|NCT02413398|3503431|B2||American Indian Or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3657062|NCT02413398|3503432|B1||American Indian Or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3657063|NCT02413398|3503430|B3||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3657064|NCT02413398|3503431|B2||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3657065|NCT02413398|3503432|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3657066|NCT02413398|3503430|B3||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3657067|NCT02413398|3503431|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3657068|NCT02413398|3503432|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3657069|NCT02413398|3503430|B3||>= 65 Years|Age, Customized||Participants|Count of Participants|211|211.0||||||
3657070|NCT02413398|3503431|B2||>= 65 Years|Age, Customized||Participants|Count of Participants|115|115.0||||||
3657071|NCT02413398|3503432|B1||>= 65 Years|Age, Customized||Participants|Count of Participants|96|96.0||||||
3657072|NCT02413398|3503430|B3||< 65 Years|Age, Customized||Participants|Count of Participants|110|110.0||||||
3657073|NCT02413398|3503431|B2||< 65 Years|Age, Customized||Participants|Count of Participants|46|46.0||||||
3657074|NCT02413398|3503432|B1||< 65 Years|Age, Customized||Participants|Count of Participants|64|64.0||||||
3657075|NCT02413398|3503430|B3|||Age||Years|Mean|65.8|65.8|Standard Deviation|6.36|6.36|||
3657076|NCT02413398|3503431|B2|||Age||Years|Mean|66.2|66.2|Standard Deviation|6.49|6.49|||
3657077|NCT02413398|3503432|B1|||Age||Years|Mean|65.3|65.3|Standard Deviation|6.22|6.22|||
3657078|NCT02413346|3503445|B3||Male|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
3657079|NCT02413346|3503446|B2||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3657080|NCT02413346|3503447|B1||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3657081|NCT02413346|3503445|B3||Female|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
3657082|NCT02413346|3503446|B2||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3657083|NCT02413346|3503447|B1||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3657084|NCT02413346|3503445|B3|≥18 years||Age, Customized||participants|Number|188|188.0||||||
3657085|NCT02413346|3503446|B2|≥18 years||Age, Customized||participants|Number|92|92.0||||||
3657086|NCT02413346|3503447|B1|≥18 years||Age, Customized||participants|Number|96|96.0||||||
3657087|NCT02413346|3503445|B3|≥12 and <18 years||Age, Customized||participants|Number|290|290.0||||||
3657088|NCT02413346|3503446|B2|≥12 and <18 years||Age, Customized||participants|Number|152|152.0||||||
3657089|NCT02413346|3503447|B1|≥12 and <18 years||Age, Customized||participants|Number|138|138.0||||||
3657090|NCT02413346|3503445|B3|≥9 and <12 years||Age, Customized||participants|Number|5|5.0||||||
3657091|NCT02413346|3503446|B2|≥9 and <12 years||Age, Customized||participants|Number|3|3.0||||||
3657092|NCT02413346|3503447|B1|≥9 and <12 years||Age, Customized||participants|Number|2|2.0||||||
3657093|NCT02413333|3503454|B5||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3657094|NCT02413333|3503455|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3657095|NCT02413333|3503456|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3657096|NCT02413333|3503457|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3657097|NCT02413333|3503458|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3657098|NCT02413333|3503454|B5||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3657099|NCT02413333|3503455|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3657100|NCT02413333|3503456|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3657101|NCT02413333|3503457|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3657102|NCT02413333|3503458|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3657103|NCT02413333|3503454|B5|≥65 years||Age, Customized||participants|Number|1|1.0||||||
3657104|NCT02413333|3503455|B4|≥65 years||Age, Customized||participants|Number|0|0.0||||||
3657105|NCT02413333|3503456|B3|≥65 years||Age, Customized||participants|Number|0|0.0||||||
3657106|NCT02413333|3503457|B2|≥65 years||Age, Customized||participants|Number|1|1.0||||||
3657107|NCT02413333|3503458|B1|≥65 years||Age, Customized||participants|Number|0|0.0||||||
3657108|NCT02413333|3503454|B5|18-64 years||Age, Customized||participants|Number|131|131.0||||||
3657109|NCT02413333|3503455|B4|18-64 years||Age, Customized||participants|Number|1|1.0||||||
3657110|NCT02413333|3503456|B3|18-64 years||Age, Customized||participants|Number|1|1.0||||||
3657111|NCT02413333|3503457|B2|18-64 years||Age, Customized||participants|Number|64|64.0||||||
3657112|NCT02413333|3503458|B1|18-64 years||Age, Customized||participants|Number|65|65.0||||||
3657113|NCT02413333|3503454|B5|||Age||years|Mean|36.7|36.7|Standard Deviation|11.4|11.4|||
3657114|NCT02413333|3503455|B4|||Age||years|Mean|38.0|38.0|Standard Deviation|NA||||Single data point
3657115|NCT02413333|3503456|B3|||Age||years|Mean|42.0|42.0|Standard Deviation|NA||||Single data point
3657116|NCT02413333|3503457|B2|||Age||years|Mean|35.7|35.7|Standard Deviation|11.8|11.8|||
3657117|NCT02413333|3503458|B1|||Age||years|Mean|37.7|37.7|Standard Deviation|11.2|11.2|||
3657118|NCT02413294|3503467|B1||Evening type|Morningness/Eveningness Questionnaire||Participants|Count of Participants|1|1.0||||||
3657119|NCT02413294|3503467|B1||Intermediate type|Morningness/Eveningness Questionnaire||Participants|Count of Participants|8|8.0||||||
3657120|NCT02413294|3503467|B1||Morning type|Morningness/Eveningness Questionnaire||Participants|Count of Participants|2|2.0||||||
3657121|NCT02413294|3503467|B1|After 2 wks sleep tracking/prior to intervention 3||Insomnia Severity Index|"The Insomnia Severity Index measures insomnia severity on a scale from 0 to 28. A score of 15 or higher is indicative of clinical insomnia.~Data for all 11 participants is provided at two baseline time points:~prior to wearing a monitor at all, and after two weeks of wearing a monitoring device, prior to use of ReTimer glasses"|units on a scale|Mean|11.86|11.86|Standard Deviation|5.51|5.51|||
3657122|NCT02413294|3503467|B1|Initial baseline measurement||Insomnia Severity Index|"The Insomnia Severity Index measures insomnia severity on a scale from 0 to 28. A score of 15 or higher is indicative of clinical insomnia.~Data for all 11 participants is provided at two baseline time points:~prior to wearing a monitor at all, and after two weeks of wearing a monitoring device, prior to use of ReTimer glasses"|units on a scale|Mean|13.09|13.09|Standard Deviation|4.85|4.85|||
3657123|NCT02413294|3503467|B1|After 2 wks sleep tracking/prior to intervention||Pittsburgh Sleep Quality Index|The Pittsburgh Sleep Quality Index is a validated scale which measures self-reported sleep quality based on a wide variety of questions (duration, quality, disturbances, medication, etc.) and converts them to a scale which ranges from 0 to 21 where 6 or higher denotes poor sleep quality.|units on a scale|Mean|7.6|7.6|Standard Deviation|3.7|3.7|||
3657124|NCT02413294|3503467|B1|Baseline||Pittsburgh Sleep Quality Index|The Pittsburgh Sleep Quality Index is a validated scale which measures self-reported sleep quality based on a wide variety of questions (duration, quality, disturbances, medication, etc.) and converts them to a scale which ranges from 0 to 21 where 6 or higher denotes poor sleep quality.|units on a scale|Mean|8.3|8.3|Standard Deviation|4.1|4.1|||
3657125|NCT02413294|3503467|B1|After 2 wks sleep tracking/prior to intervention||Patient Health Questionnaire-9|The PHQ-9 Depression Scale is a validated scale ranging from 0 to 27 with higher numbers representing greater severity of depressive symptoms, based on 9 questions with each question on a scale of 0 - 3.|units on a scale|Mean|3.7|3.7|Standard Deviation|3.2|3.2|||
3657126|NCT02413294|3503467|B1|Baseline||Patient Health Questionnaire-9|The PHQ-9 Depression Scale is a validated scale ranging from 0 to 27 with higher numbers representing greater severity of depressive symptoms, based on 9 questions with each question on a scale of 0 - 3.|units on a scale|Mean|5.6|5.6|Standard Deviation|3.9|3.9|||
3657127|NCT02413294|3503467|B1|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3657128|NCT02413294|3503467|B1|Asian American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3657129|NCT02413294|3503467|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3657130|NCT02413294|3503467|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3657131|NCT02413294|3503467|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3657132|NCT02413294|3503467|B1|||Age||years|Mean|66.6|66.6|Standard Deviation|1.5|1.5|||
3657133|NCT02413229|3503485|B9|> 5 Years||Time Patient has Suffered from Symptoms||Participants|Count of Participants|83|83.0||||||
3657134|NCT02413229|3503486|B8|> 5 Years||Time Patient has Suffered from Symptoms||Participants|Count of Participants|5|5.0||||||
3657135|NCT02413229|3503487|B7|> 5 Years||Time Patient has Suffered from Symptoms||Participants|Count of Participants|19|19.0||||||
3657136|NCT02413229|3503488|B6|> 5 Years||Time Patient has Suffered from Symptoms||Participants|Count of Participants|6|6.0||||||
3657137|NCT02413229|3503489|B5|> 5 Years||Time Patient has Suffered from Symptoms||Participants|Count of Participants|12|12.0||||||
3657138|NCT02413229|3503490|B4|> 5 Years||Time Patient has Suffered from Symptoms||Participants|Count of Participants|4|4.0||||||
3657139|NCT02413229|3503491|B3|> 5 Years||Time Patient has Suffered from Symptoms||Participants|Count of Participants|16|16.0||||||
3657140|NCT02413229|3503492|B2|> 5 Years||Time Patient has Suffered from Symptoms||Participants|Count of Participants|8|8.0||||||
3657141|NCT02413229|3503493|B1|> 5 Years||Time Patient has Suffered from Symptoms||Participants|Count of Participants|13|13.0||||||
3657142|NCT02413229|3503485|B9|> 3 Years And <= 5 Years||Time Patient has Suffered from Symptoms||Participants|Count of Participants|21|21.0||||||
3657143|NCT02413229|3503486|B8|> 3 Years And <= 5 Years||Time Patient has Suffered from Symptoms||Participants|Count of Participants|4|4.0||||||
3657144|NCT02413229|3503487|B7|> 3 Years And <= 5 Years||Time Patient has Suffered from Symptoms||Participants|Count of Participants|2|2.0||||||
3657145|NCT02413229|3503488|B6|> 3 Years And <= 5 Years||Time Patient has Suffered from Symptoms||Participants|Count of Participants|1|1.0||||||
3657146|NCT02413229|3503489|B5|> 3 Years And <= 5 Years||Time Patient has Suffered from Symptoms||Participants|Count of Participants|3|3.0||||||
3657147|NCT02413229|3503490|B4|> 3 Years And <= 5 Years||Time Patient has Suffered from Symptoms||Participants|Count of Participants|1|1.0||||||
3657148|NCT02413229|3503491|B3|> 3 Years And <= 5 Years||Time Patient has Suffered from Symptoms||Participants|Count of Participants|6|6.0||||||
3657149|NCT02413229|3503492|B2|> 3 Years And <= 5 Years||Time Patient has Suffered from Symptoms||Participants|Count of Participants|0|0.0||||||
3657150|NCT02413229|3503493|B1|> 3 Years And <= 5 Years||Time Patient has Suffered from Symptoms||Participants|Count of Participants|4|4.0||||||
3657151|NCT02413229|3503485|B9|> 1 Year And <= 3 Years||Time Patient has Suffered from Symptoms||Participants|Count of Participants|29|29.0||||||
3657152|NCT02413229|3503486|B8|> 1 Year And <= 3 Years||Time Patient has Suffered from Symptoms||Participants|Count of Participants|3|3.0||||||
3657153|NCT02413229|3503487|B7|> 1 Year And <= 3 Years||Time Patient has Suffered from Symptoms||Participants|Count of Participants|3|3.0||||||
3657154|NCT02413229|3503488|B6|> 1 Year And <= 3 Years||Time Patient has Suffered from Symptoms||Participants|Count of Participants|4|4.0||||||
3657155|NCT02413229|3503489|B5|> 1 Year And <= 3 Years||Time Patient has Suffered from Symptoms||Participants|Count of Participants|6|6.0||||||
3657156|NCT02413229|3503490|B4|> 1 Year And <= 3 Years||Time Patient has Suffered from Symptoms||Participants|Count of Participants|4|4.0||||||
3657157|NCT02413229|3503491|B3|> 1 Year And <= 3 Years||Time Patient has Suffered from Symptoms||Participants|Count of Participants|3|3.0||||||
3657158|NCT02413229|3503492|B2|> 1 Year And <= 3 Years||Time Patient has Suffered from Symptoms||Participants|Count of Participants|3|3.0||||||
3657159|NCT02413229|3503493|B1|> 1 Year And <= 3 Years||Time Patient has Suffered from Symptoms||Participants|Count of Participants|3|3.0||||||
3657160|NCT02413229|3503485|B9|6 to 12 Months||Time Patient has Suffered from Symptoms||Participants|Count of Participants|10|10.0||||||
3657161|NCT02413229|3503486|B8|6 to 12 Months||Time Patient has Suffered from Symptoms||Participants|Count of Participants|2|2.0||||||
3657162|NCT02413229|3503487|B7|6 to 12 Months||Time Patient has Suffered from Symptoms||Participants|Count of Participants|1|1.0||||||
3657163|NCT02413229|3503488|B6|6 to 12 Months||Time Patient has Suffered from Symptoms||Participants|Count of Participants|1|1.0||||||
3657164|NCT02413229|3503489|B5|6 to 12 Months||Time Patient has Suffered from Symptoms||Participants|Count of Participants|1|1.0||||||
3657165|NCT02413229|3503490|B4|6 to 12 Months||Time Patient has Suffered from Symptoms||Participants|Count of Participants|2|2.0||||||
3657166|NCT02413229|3503491|B3|6 to 12 Months||Time Patient has Suffered from Symptoms||Participants|Count of Participants|1|1.0||||||
3657167|NCT02413229|3503492|B2|6 to 12 Months||Time Patient has Suffered from Symptoms||Participants|Count of Participants|1|1.0||||||
3657168|NCT02413229|3503493|B1|6 to 12 Months||Time Patient has Suffered from Symptoms||Participants|Count of Participants|1|1.0||||||
3657169|NCT02413229|3503485|B9|3 to 6 Months||Time Patient has Suffered from Symptoms||Participants|Count of Participants|2|2.0||||||
3657170|NCT02413229|3503486|B8|3 to 6 Months||Time Patient has Suffered from Symptoms||Participants|Count of Participants|1|1.0||||||
3657171|NCT02413229|3503487|B7|3 to 6 Months||Time Patient has Suffered from Symptoms||Participants|Count of Participants|0|0.0||||||
3657172|NCT02413229|3503488|B6|3 to 6 Months||Time Patient has Suffered from Symptoms||Participants|Count of Participants|0|0.0||||||
3657173|NCT02413229|3503489|B5|3 to 6 Months||Time Patient has Suffered from Symptoms||Participants|Count of Participants|0|0.0||||||
3657174|NCT02413229|3503490|B4|3 to 6 Months||Time Patient has Suffered from Symptoms||Participants|Count of Participants|0|0.0||||||
3657175|NCT02413229|3503491|B3|3 to 6 Months||Time Patient has Suffered from Symptoms||Participants|Count of Participants|0|0.0||||||
3657176|NCT02413229|3503492|B2|3 to 6 Months||Time Patient has Suffered from Symptoms||Participants|Count of Participants|0|0.0||||||
3657177|NCT02413229|3503493|B1|3 to 6 Months||Time Patient has Suffered from Symptoms||Participants|Count of Participants|1|1.0||||||
3657178|NCT02413229|3503485|B9|< 3 Months||Time Patient has Suffered from Symptoms||Participants|Count of Participants|3|3.0||||||
3657179|NCT02413229|3503486|B8|< 3 Months||Time Patient has Suffered from Symptoms||Participants|Count of Participants|0|0.0||||||
3657180|NCT02413229|3503487|B7|< 3 Months||Time Patient has Suffered from Symptoms||Participants|Count of Participants|0|0.0||||||
3657181|NCT02413229|3503488|B6|< 3 Months||Time Patient has Suffered from Symptoms||Participants|Count of Participants|0|0.0||||||
3657182|NCT02413229|3503489|B5|< 3 Months||Time Patient has Suffered from Symptoms||Participants|Count of Participants|0|0.0||||||
3657183|NCT02413229|3503490|B4|< 3 Months||Time Patient has Suffered from Symptoms||Participants|Count of Participants|1|1.0||||||
3657184|NCT02413229|3503491|B3|< 3 Months||Time Patient has Suffered from Symptoms||Participants|Count of Participants|0|0.0||||||
3657185|NCT02413229|3503492|B2|< 3 Months||Time Patient has Suffered from Symptoms||Participants|Count of Participants|0|0.0||||||
3657186|NCT02413229|3503493|B1|< 3 Months||Time Patient has Suffered from Symptoms||Participants|Count of Participants|2|2.0||||||
3657187|NCT02413229|3503485|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3657188|NCT02413229|3503486|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657189|NCT02413229|3503487|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657190|NCT02413229|3503488|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3657191|NCT02413229|3503489|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657192|NCT02413229|3503490|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657193|NCT02413229|3503491|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657194|NCT02413229|3503492|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657195|NCT02413229|3503493|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3657196|NCT02413229|3503485|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657197|NCT02413229|3503486|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657198|NCT02413229|3503487|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657199|NCT02413229|3503488|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657200|NCT02413229|3503489|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657201|NCT02413229|3503490|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657202|NCT02413229|3503491|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657203|NCT02413229|3503492|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657204|NCT02413229|3503493|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657205|NCT02413229|3503485|B9||White|Race (NIH/OMB)||Participants|Count of Participants|137|137.0||||||
3657206|NCT02413229|3503486|B8||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3657207|NCT02413229|3503487|B7||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3657208|NCT02413229|3503488|B6||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3657209|NCT02413229|3503489|B5||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3657210|NCT02413229|3503490|B4||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3657211|NCT02413229|3503491|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3657212|NCT02413229|3503492|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3657213|NCT02413229|3503493|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3657214|NCT02413229|3503485|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3657215|NCT02413229|3503486|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657216|NCT02413229|3503487|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3657217|NCT02413229|3503488|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657218|NCT02413229|3503489|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657219|NCT02413229|3503490|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3657220|NCT02413229|3503491|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657221|NCT02413229|3503492|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3657222|NCT02413229|3503493|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657223|NCT02413229|3503485|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657224|NCT02413229|3503486|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657225|NCT02413229|3503487|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657226|NCT02413229|3503488|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657227|NCT02413229|3503489|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657228|NCT02413229|3503490|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657229|NCT02413229|3503491|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657230|NCT02413229|3503492|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657231|NCT02413229|3503493|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657232|NCT02413229|3503485|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3657233|NCT02413229|3503486|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657234|NCT02413229|3503487|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3657235|NCT02413229|3503488|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657236|NCT02413229|3503489|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657237|NCT02413229|3503490|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3657238|NCT02413229|3503491|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3657239|NCT02413229|3503492|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3657240|NCT02413229|3503493|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657241|NCT02413229|3503485|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657242|NCT02413229|3503486|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657243|NCT02413229|3503487|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657244|NCT02413229|3503488|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657245|NCT02413229|3503489|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657246|NCT02413229|3503490|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657247|NCT02413229|3503491|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657248|NCT02413229|3503492|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657249|NCT02413229|3503493|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657250|NCT02413229|3503485|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657251|NCT02413229|3503486|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657252|NCT02413229|3503487|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657253|NCT02413229|3503488|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657254|NCT02413229|3503489|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657255|NCT02413229|3503490|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657256|NCT02413229|3503491|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657257|NCT02413229|3503492|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657258|NCT02413229|3503493|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657259|NCT02413229|3503485|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3657260|NCT02413229|3503486|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3657261|NCT02413229|3503487|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3657262|NCT02413229|3503488|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3657263|NCT02413229|3503489|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3657264|NCT02413229|3503490|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3657265|NCT02413229|3503491|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3657266|NCT02413229|3503492|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3657267|NCT02413229|3503493|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3657268|NCT02413229|3503485|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3657269|NCT02413229|3503486|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3657270|NCT02413229|3503487|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3657271|NCT02413229|3503488|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3657272|NCT02413229|3503489|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3657273|NCT02413229|3503490|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3657274|NCT02413229|3503491|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3657275|NCT02413229|3503492|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3657276|NCT02413229|3503493|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3657277|NCT02413229|3503485|B9||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3657278|NCT02413229|3503486|B8||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3657279|NCT02413229|3503487|B7||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3657280|NCT02413229|3503488|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3657281|NCT02413229|3503489|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3657282|NCT02413229|3503490|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3657283|NCT02413229|3503491|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3657284|NCT02413229|3503492|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3657285|NCT02413229|3503493|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3657286|NCT02413229|3503485|B9||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3657287|NCT02413229|3503486|B8||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3657288|NCT02413229|3503487|B7||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3657289|NCT02413229|3503488|B6||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3657290|NCT02413229|3503489|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3657291|NCT02413229|3503490|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3657292|NCT02413229|3503491|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3657293|NCT02413229|3503492|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3657294|NCT02413229|3503493|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3657295|NCT02413229|3503485|B9|> 75||Age, Customized||Participants|Count of Participants|3|3.0||||||
3657296|NCT02413229|3503486|B8|> 75||Age, Customized||Participants|Count of Participants|0|0.0||||||
3657297|NCT02413229|3503487|B7|> 75||Age, Customized||Participants|Count of Participants|2|2.0||||||
3657298|NCT02413229|3503488|B6|> 75||Age, Customized||Participants|Count of Participants|0|0.0||||||
3657299|NCT02413229|3503489|B5|> 75||Age, Customized||Participants|Count of Participants|0|0.0||||||
3657300|NCT02413229|3503490|B4|> 75||Age, Customized||Participants|Count of Participants|1|1.0||||||
3657301|NCT02413229|3503491|B3|> 75||Age, Customized||Participants|Count of Participants|0|0.0||||||
3657302|NCT02413229|3503492|B2|> 75||Age, Customized||Participants|Count of Participants|0|0.0||||||
3657303|NCT02413229|3503493|B1|> 75||Age, Customized||Participants|Count of Participants|0|0.0||||||
3657304|NCT02413229|3503485|B9|65 - 75||Age, Customized||Participants|Count of Participants|19|19.0||||||
3657305|NCT02413229|3503486|B8|65 - 75||Age, Customized||Participants|Count of Participants|1|1.0||||||
3657306|NCT02413229|3503487|B7|65 - 75||Age, Customized||Participants|Count of Participants|4|4.0||||||
3657307|NCT02413229|3503488|B6|65 - 75||Age, Customized||Participants|Count of Participants|1|1.0||||||
3657308|NCT02413229|3503489|B5|65 - 75||Age, Customized||Participants|Count of Participants|4|4.0||||||
3657309|NCT02413229|3503490|B4|65 - 75||Age, Customized||Participants|Count of Participants|0|0.0||||||
3657310|NCT02413229|3503491|B3|65 - 75||Age, Customized||Participants|Count of Participants|3|3.0||||||
3657311|NCT02413229|3503492|B2|65 - 75||Age, Customized||Participants|Count of Participants|3|3.0||||||
3657312|NCT02413229|3503493|B1|65 - 75||Age, Customized||Participants|Count of Participants|3|3.0||||||
3657313|NCT02413229|3503485|B9|41 - 64||Age, Customized||Participants|Count of Participants|76|76.0||||||
3657314|NCT02413229|3503486|B8|41 - 64||Age, Customized||Participants|Count of Participants|4|4.0||||||
3657315|NCT02413229|3503487|B7|41 - 64||Age, Customized||Participants|Count of Participants|13|13.0||||||
3657316|NCT02413229|3503488|B6|41 - 64||Age, Customized||Participants|Count of Participants|5|5.0||||||
3657317|NCT02413229|3503489|B5|41 - 64||Age, Customized||Participants|Count of Participants|14|14.0||||||
3657318|NCT02413229|3503490|B4|41 - 64||Age, Customized||Participants|Count of Participants|5|5.0||||||
3657319|NCT02413229|3503491|B3|41 - 64||Age, Customized||Participants|Count of Participants|18|18.0||||||
3657320|NCT02413229|3503492|B2|41 - 64||Age, Customized||Participants|Count of Participants|4|4.0||||||
3657321|NCT02413229|3503493|B1|41 - 64||Age, Customized||Participants|Count of Participants|13|13.0||||||
3657322|NCT02413229|3503485|B9|18 - 40||Age, Customized||Participants|Count of Participants|45|45.0||||||
3657323|NCT02413229|3503486|B8|18 - 40||Age, Customized||Participants|Count of Participants|10|10.0||||||
3657324|NCT02413229|3503487|B7|18 - 40||Age, Customized||Participants|Count of Participants|5|5.0||||||
3657325|NCT02413229|3503488|B6|18 - 40||Age, Customized||Participants|Count of Participants|6|6.0||||||
3657326|NCT02413229|3503489|B5|18 - 40||Age, Customized||Participants|Count of Participants|4|4.0||||||
3657327|NCT02413229|3503490|B4|18 - 40||Age, Customized||Participants|Count of Participants|5|5.0||||||
3657328|NCT02413229|3503491|B3|18 - 40||Age, Customized||Participants|Count of Participants|5|5.0||||||
3657329|NCT02413229|3503492|B2|18 - 40||Age, Customized||Participants|Count of Participants|4|4.0||||||
3657330|NCT02413229|3503493|B1|18 - 40||Age, Customized||Participants|Count of Participants|6|6.0||||||
3657331|NCT02413229|3503485|B9|< 18||Age, Customized||Participants|Count of Participants|5|5.0||||||
3657332|NCT02413229|3503486|B8|< 18||Age, Customized||Participants|Count of Participants|0|0.0||||||
3657333|NCT02413229|3503487|B7|< 18||Age, Customized||Participants|Count of Participants|1|1.0||||||
3657334|NCT02413229|3503488|B6|< 18||Age, Customized||Participants|Count of Participants|0|0.0||||||
3657335|NCT02413229|3503489|B5|< 18||Age, Customized||Participants|Count of Participants|0|0.0||||||
3657336|NCT02413229|3503490|B4|< 18||Age, Customized||Participants|Count of Participants|1|1.0||||||
3657337|NCT02413229|3503491|B3|< 18||Age, Customized||Participants|Count of Participants|0|0.0||||||
3657338|NCT02413229|3503492|B2|< 18||Age, Customized||Participants|Count of Participants|1|1.0||||||
3657339|NCT02413229|3503493|B1|< 18||Age, Customized||Participants|Count of Participants|2|2.0||||||
3657340|NCT02413203|3503518|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3657341|NCT02413203|3503519|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3657342|NCT02413203|3503520|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3657343|NCT02413203|3503518|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3657344|NCT02413203|3503519|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3657345|NCT02413203|3503520|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3657346|NCT02413203|3503518|B3|||Age||years|Mean|32.1|32.1|Standard Deviation|8.6|8.6|||
3657347|NCT02413203|3503519|B2|||Age||years|Mean|30|30.0|Standard Deviation|9|9.0|||
3657348|NCT02413203|3503520|B1|||Age||years|Mean|32.2|32.2|Standard Deviation|8.6|8.6|||
3657349|NCT02413034|3503541|B3|Spain||Region of Enrollment||participants|Number|28|28.0||||||
3657350|NCT02413034|3503542|B2|Spain||Region of Enrollment||participants|Number|14|14.0||||||
3657351|NCT02413034|3503543|B1|Spain||Region of Enrollment||participants|Number|14|14.0||||||
3657352|NCT02413034|3503541|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3657353|NCT02413034|3503542|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3657354|NCT02413034|3503543|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3657355|NCT02413034|3503541|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3657356|NCT02413034|3503542|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3657357|NCT02413034|3503543|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3657358|NCT02413034|3503541|B3|||Age||years|Mean|74|74.0|Standard Deviation|15|15.0|||
3657359|NCT02413034|3503542|B2|||Age||years|Mean|75|75.0|Standard Deviation|12|12.0|||
3657360|NCT02413034|3503543|B1|||Age||years|Mean|74|74.0|Standard Deviation|12|12.0|||
3657361|NCT02413034|3503541|B3||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3657362|NCT02413034|3503542|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3657363|NCT02413034|3503543|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3657364|NCT02413034|3503541|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3657365|NCT02413034|3503542|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3657366|NCT02413034|3503543|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3657367|NCT02413034|3503541|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3657368|NCT02413034|3503542|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3657369|NCT02413034|3503543|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3657370|NCT02412878|3503552|B3||No|Stratification Factor: Refractory to Bortezomib Treatment|"Participants were classified as refractory to bortezomib in prior regimens if the data collected on prior multiple myeloma therapy indicated that any of the following criteria were met:~Best Response to any regimen containing bortezomib was stable disease or progressive disease.~Reason bortezomib was stopped was progression in any regimen.~Date of relapse/progression was after start date and within 60 days after stop date of bortezomib in any regimen."|Participants|Count of Participants|302|302.0||||||
3657371|NCT02412878|3503553|B2||No|Stratification Factor: Refractory to Bortezomib Treatment|"Participants were classified as refractory to bortezomib in prior regimens if the data collected on prior multiple myeloma therapy indicated that any of the following criteria were met:~Best Response to any regimen containing bortezomib was stable disease or progressive disease.~Reason bortezomib was stopped was progression in any regimen.~Date of relapse/progression was after start date and within 60 days after stop date of bortezomib in any regimen."|Participants|Count of Participants|152|152.0||||||
3657372|NCT02412878|3503554|B1||No|Stratification Factor: Refractory to Bortezomib Treatment|"Participants were classified as refractory to bortezomib in prior regimens if the data collected on prior multiple myeloma therapy indicated that any of the following criteria were met:~Best Response to any regimen containing bortezomib was stable disease or progressive disease.~Reason bortezomib was stopped was progression in any regimen.~Date of relapse/progression was after start date and within 60 days after stop date of bortezomib in any regimen."|Participants|Count of Participants|150|150.0||||||
3657373|NCT02412878|3503552|B3||Yes|Stratification Factor: Refractory to Bortezomib Treatment|"Participants were classified as refractory to bortezomib in prior regimens if the data collected on prior multiple myeloma therapy indicated that any of the following criteria were met:~Best Response to any regimen containing bortezomib was stable disease or progressive disease.~Reason bortezomib was stopped was progression in any regimen.~Date of relapse/progression was after start date and within 60 days after stop date of bortezomib in any regimen."|Participants|Count of Participants|176|176.0||||||
3657374|NCT02412878|3503553|B2||Yes|Stratification Factor: Refractory to Bortezomib Treatment|"Participants were classified as refractory to bortezomib in prior regimens if the data collected on prior multiple myeloma therapy indicated that any of the following criteria were met:~Best Response to any regimen containing bortezomib was stable disease or progressive disease.~Reason bortezomib was stopped was progression in any regimen.~Date of relapse/progression was after start date and within 60 days after stop date of bortezomib in any regimen."|Participants|Count of Participants|88|88.0||||||
3657375|NCT02412878|3503554|B1||Yes|Stratification Factor: Refractory to Bortezomib Treatment|"Participants were classified as refractory to bortezomib in prior regimens if the data collected on prior multiple myeloma therapy indicated that any of the following criteria were met:~Best Response to any regimen containing bortezomib was stable disease or progressive disease.~Reason bortezomib was stopped was progression in any regimen.~Date of relapse/progression was after start date and within 60 days after stop date of bortezomib in any regimen."|Participants|Count of Participants|88|88.0||||||
3657376|NCT02412878|3503552|B3||Stage 2 or 3|Stratification Factor: International Staging System (ISS) stage|"The International Staging System (ISS) for myeloma was published by the International Myeloma Working Group:~Stage I: β2-microglobulin (β2M) < 3.5 mg/L, albumin >= 3.5 g/dL~Stage II: β2M < 3.5 mg/L and albumin < 3.5 g/dL; or β2M 3.5 mg/L - 5.5 mg/L irrespective of the serum albumin~Stage III: β2M ≥ 5.5 mg/L"|Participants|Count of Participants|278|278.0||||||
3657377|NCT02412878|3503553|B2||Stage 2 or 3|Stratification Factor: International Staging System (ISS) stage|"The International Staging System (ISS) for myeloma was published by the International Myeloma Working Group:~Stage I: β2-microglobulin (β2M) < 3.5 mg/L, albumin >= 3.5 g/dL~Stage II: β2M < 3.5 mg/L and albumin < 3.5 g/dL; or β2M 3.5 mg/L - 5.5 mg/L irrespective of the serum albumin~Stage III: β2M ≥ 5.5 mg/L"|Participants|Count of Participants|140|140.0||||||
3657378|NCT02412878|3503554|B1||Stage 2 or 3|Stratification Factor: International Staging System (ISS) stage|"The International Staging System (ISS) for myeloma was published by the International Myeloma Working Group:~Stage I: β2-microglobulin (β2M) < 3.5 mg/L, albumin >= 3.5 g/dL~Stage II: β2M < 3.5 mg/L and albumin < 3.5 g/dL; or β2M 3.5 mg/L - 5.5 mg/L irrespective of the serum albumin~Stage III: β2M ≥ 5.5 mg/L"|Participants|Count of Participants|138|138.0||||||
3657379|NCT02412878|3503552|B3||Stage 1|Stratification Factor: International Staging System (ISS) stage|"The International Staging System (ISS) for myeloma was published by the International Myeloma Working Group:~Stage I: β2-microglobulin (β2M) < 3.5 mg/L, albumin >= 3.5 g/dL~Stage II: β2M < 3.5 mg/L and albumin < 3.5 g/dL; or β2M 3.5 mg/L - 5.5 mg/L irrespective of the serum albumin~Stage III: β2M ≥ 5.5 mg/L"|Participants|Count of Participants|200|200.0||||||
3657380|NCT02412878|3503553|B2||Stage 1|Stratification Factor: International Staging System (ISS) stage|"The International Staging System (ISS) for myeloma was published by the International Myeloma Working Group:~Stage I: β2-microglobulin (β2M) < 3.5 mg/L, albumin >= 3.5 g/dL~Stage II: β2M < 3.5 mg/L and albumin < 3.5 g/dL; or β2M 3.5 mg/L - 5.5 mg/L irrespective of the serum albumin~Stage III: β2M ≥ 5.5 mg/L"|Participants|Count of Participants|100|100.0||||||
3657381|NCT02412878|3503554|B1||Stage 1|Stratification Factor: International Staging System (ISS) stage|"The International Staging System (ISS) for myeloma was published by the International Myeloma Working Group:~Stage I: β2-microglobulin (β2M) < 3.5 mg/L, albumin >= 3.5 g/dL~Stage II: β2M < 3.5 mg/L and albumin < 3.5 g/dL; or β2M 3.5 mg/L - 5.5 mg/L irrespective of the serum albumin~Stage III: β2M ≥ 5.5 mg/L"|Participants|Count of Participants|100|100.0||||||
3657382|NCT02412878|3503552|B3||2 (Ambulatory but unable to work)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|1|1.0||||||
3657383|NCT02412878|3503553|B2||2 (Ambulatory but unable to work)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|1|1.0||||||
3657384|NCT02412878|3503554|B1||2 (Ambulatory but unable to work)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|0|0.0||||||
3657385|NCT02412878|3503552|B3||1 (Restrictive but ambulatory)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|241|241.0||||||
3657386|NCT02412878|3503553|B2||1 (Restrictive but ambulatory)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|121|121.0||||||
3657387|NCT02412878|3503554|B1||1 (Restrictive but ambulatory)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|120|120.0||||||
3657388|NCT02412878|3503552|B3||0 (Fully active)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|236|236.0||||||
3657438|NCT02412761|3503569|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3657389|NCT02412878|3503553|B2||0 (Fully active)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|118|118.0||||||
3657390|NCT02412878|3503554|B1||0 (Fully active)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|118|118.0||||||
3657391|NCT02412878|3503552|B3||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3657392|NCT02412878|3503553|B2||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3657393|NCT02412878|3503554|B1||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3657394|NCT02412878|3503552|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3657395|NCT02412878|3503553|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3657396|NCT02412878|3503554|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3657397|NCT02412878|3503552|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|402|402.0||||||
3657398|NCT02412878|3503553|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|200|200.0||||||
3657399|NCT02412878|3503554|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|202|202.0||||||
3657400|NCT02412878|3503552|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3657401|NCT02412878|3503553|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3657402|NCT02412878|3503554|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3657403|NCT02412878|3503552|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|45|45.0||||||
3657404|NCT02412878|3503553|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3657405|NCT02412878|3503554|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3657406|NCT02412878|3503552|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3657407|NCT02412878|3503553|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3657408|NCT02412878|3503554|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3657409|NCT02412878|3503552|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|461|461.0||||||
3657410|NCT02412878|3503553|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|235|235.0||||||
3657411|NCT02412878|3503554|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|226|226.0||||||
3657412|NCT02412878|3503552|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3657413|NCT02412878|3503553|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3657414|NCT02412878|3503554|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3657415|NCT02412878|3503552|B3||Male|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
3657416|NCT02412878|3503553|B2||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3657417|NCT02412878|3503554|B1||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3657418|NCT02412878|3503552|B3||Female|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
3657419|NCT02412878|3503553|B2||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3657420|NCT02412878|3503554|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3657421|NCT02412878|3503552|B3||≥ 85 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
3657422|NCT02412878|3503553|B2||≥ 85 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
3657423|NCT02412878|3503554|B1||≥ 85 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3657424|NCT02412878|3503552|B3||75 - 84 years|Age, Customized||Participants|Count of Participants|77|77.0||||||
3657425|NCT02412878|3503553|B2||75 - 84 years|Age, Customized||Participants|Count of Participants|45|45.0||||||
3657426|NCT02412878|3503554|B1||75 - 84 years|Age, Customized||Participants|Count of Participants|32|32.0||||||
3657427|NCT02412878|3503552|B3||65 - 74 years|Age, Customized||Participants|Count of Participants|192|192.0||||||
3657428|NCT02412878|3503553|B2||65 - 74 years|Age, Customized||Participants|Count of Participants|90|90.0||||||
3657429|NCT02412878|3503554|B1||65 - 74 years|Age, Customized||Participants|Count of Participants|102|102.0||||||
3657430|NCT02412878|3503552|B3||18 - 64 years|Age, Customized||Participants|Count of Participants|208|208.0||||||
3657431|NCT02412878|3503553|B2||18 - 64 years|Age, Customized||Participants|Count of Participants|104|104.0||||||
3657432|NCT02412878|3503554|B1||18 - 64 years|Age, Customized||Participants|Count of Participants|104|104.0||||||
3657433|NCT02412878|3503552|B3|||Age||years|Median|66.0|66.0|Full Range|||35.0|85.0|
3657434|NCT02412878|3503553|B2|||Age||years|Median|66.0|66.0|Full Range|||39.0|85.0|
3657435|NCT02412878|3503554|B1|||Age||years|Median|66.0|66.0|Full Range|||35.0|83.0|
3657436|NCT02412761|3503569|B1|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3657437|NCT02412761|3503569|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3657439|NCT02412761|3503569|B1|||Age||years|Median|14|14.0|Full Range|||9.0|19.0|
3657440|NCT02412657|3503582|B4|Canada||Region of Enrollment||participants|Number|69|69.0||||||
3657441|NCT02412657|3503583|B3|Canada||Region of Enrollment||participants|Number|22|22.0||||||
3657442|NCT02412657|3503584|B2|Canada||Region of Enrollment||participants|Number|23|23.0||||||
3657443|NCT02412657|3503585|B1|Canada||Region of Enrollment||participants|Number|24|24.0||||||
3657444|NCT02412657|3503582|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3657445|NCT02412657|3503583|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3657446|NCT02412657|3503584|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3657447|NCT02412657|3503585|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3657448|NCT02412657|3503582|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3657449|NCT02412657|3503583|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3657450|NCT02412657|3503584|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3657451|NCT02412657|3503585|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3657452|NCT02412657|3503582|B4|||Age||years|Mean|53|53.0|Inter-Quartile Range|||33.0|73.0|
3657453|NCT02412657|3503583|B3|||Age||years|Mean|55|55.0|Inter-Quartile Range|||51.0|58.0|
3657454|NCT02412657|3503584|B2|||Age||years|Mean|54|54.0|Inter-Quartile Range|||50.0|59.0|
3657455|NCT02412657|3503585|B1|||Age||years|Mean|49|49.0|Inter-Quartile Range|||44.0|54.0|
3657456|NCT02412501|3503595|B1|||BMI||kg/m2|Mean|29.0|29.0|Standard Deviation|6.5|6.5|||
3657457|NCT02412501|3503595|B1|Japan||Region of Enrollment||participants|Number|15|15.0||||||
3657458|NCT02412501|3503595|B1|United States||Region of Enrollment||participants|Number|86|86.0||||||
3657459|NCT02412501|3503595|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3657460|NCT02412501|3503595|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3657461|NCT02412501|3503595|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3657462|NCT02412501|3503595|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|82|82.0||||||
3657463|NCT02412501|3503595|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3657464|NCT02412501|3503595|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3657465|NCT02412501|3503595|B1|||Age||Years|Mean|67.3|67.3|Standard Deviation|9.6|9.6|||
3657466|NCT02412501|3503595|B1||>=65 years|Age||Participants|Count of Participants|70|70.0||||||
3657467|NCT02412501|3503595|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3657468|NCT02412501|3503595|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3657469|NCT02412436|3503604|B1|RIF, INH, and ethambutol||TB Treatment|Participants were expected to be on the continuation phase of TB treatment for the length of study follow-up.|Participants|Count of Participants|10|10.0||||||
3657470|NCT02412436|3503604|B1|RIF and INH||TB Treatment|Participants were expected to be on the continuation phase of TB treatment for the length of study follow-up.|Participants|Count of Participants|52|52.0||||||
3657471|NCT02412436|3503604|B1|||CD4+ Cell Count||cells/mm^3|Median|407|407.0|Inter-Quartile Range|||209.0|644.0|
3657472|NCT02412436|3503604|B1|=> 400 copies/mL||HIV RNA||Participants|Count of Participants|9|9.0||||||
3657473|NCT02412436|3503604|B1|< 400 copies/mL||HIV RNA||Participants|Count of Participants|52|52.0||||||
3657474|NCT02412436|3503604|B1|EFV + more than two NRTIs||HIV Antiretroviral Therapy|HIV antiretroviral therapy was classified according to the two types of regimens allowed by the protocol.|Participants|Count of Participants|0|0.0||||||
3657475|NCT02412436|3503604|B1|EFV + two NRTIs||HIV Antiretroviral Therapy|HIV antiretroviral therapy was classified according to the two types of regimens allowed by the protocol.|Participants|Count of Participants|62|62.0||||||
3657476|NCT02412436|3503604|B1|||Body Mass Index (BMI)||kg/m^2|Median|20.8|20.8|Inter-Quartile Range|||18.9|24.9|
3657477|NCT02412436|3503604|B1|South Africa||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3657478|NCT02412436|3503604|B1|Kenya||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3657479|NCT02412436|3503604|B1|Zimbabwe||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3657480|NCT02412436|3503604|B1|Botswana||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3657481|NCT02412436|3503604|B1|Black African||Race/Ethnicity, Customized||Participants|Count of Participants|62|62.0||||||
3657482|NCT02412436|3503604|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3657483|NCT02412436|3503604|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3657484|NCT02412436|3503604|B1|40-49 years||Age, Customized||Participants|Count of Participants|13|13.0||||||
3657485|NCT02412436|3503604|B1|30-39 years||Age, Customized||Participants|Count of Participants|25|25.0||||||
3657486|NCT02412436|3503604|B1|20-29 years||Age, Customized||Participants|Count of Participants|24|24.0||||||
3657487|NCT02412436|3503604|B1|||Age||years|Median|32|32.0|Inter-Quartile Range|||27.0|37.0|
3657488|NCT02411929|3503616|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3657489|NCT02411929|3503616|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3657490|NCT02411929|3503616|B1|||Age||Years|Mean|41.0|41.0|Standard Deviation|11.5|11.5|||
3657491|NCT02411747|3503646|B3|Not surgical/not desided||Future interest for surgical specility||participants|Number|13|13.0||||||
3657492|NCT02411747|3503647|B2|Not surgical/not desided||Future interest for surgical specility||participants|Number|7|7.0||||||
3657493|NCT02411747|3503648|B1|Not surgical/not desided||Future interest for surgical specility||participants|Number|6|6.0||||||
3657494|NCT02411747|3503646|B3|Surgical||Future interest for surgical specility||participants|Number|19|19.0||||||
3657875|NCT02410291|3503920|B2||Male|Gender||Participants|Count of Participants|29|29.0||||||
3657495|NCT02411747|3503647|B2|Surgical||Future interest for surgical specility||participants|Number|9|9.0||||||
3657496|NCT02411747|3503648|B1|Surgical||Future interest for surgical specility||participants|Number|10|10.0||||||
3657497|NCT02411747|3503646|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3657498|NCT02411747|3503647|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3657499|NCT02411747|3503648|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3657500|NCT02411747|3503646|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3657501|NCT02411747|3503647|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3657502|NCT02411747|3503648|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3657503|NCT02411747|3503646|B3|||Age||years|Mean|26|26.0|Full Range|||24.0|31.0|
3657504|NCT02411747|3503647|B2|||Age||years|Mean|26|26.0|Full Range|||24.0|31.0|
3657505|NCT02411747|3503648|B1|||Age||years|Mean|26|26.0|Full Range|||25.0|30.0|
3657506|NCT02411747|3503646|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3657507|NCT02411747|3503647|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3657508|NCT02411747|3503648|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3657509|NCT02411747|3503646|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3657510|NCT02411747|3503647|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3657511|NCT02411747|3503648|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3657512|NCT02411747|3503646|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3657513|NCT02411747|3503647|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3657514|NCT02411747|3503648|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3657515|NCT02411643|3503655|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3657516|NCT02411643|3503655|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3657517|NCT02411643|3503655|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3657518|NCT02411643|3503655|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3657519|NCT02411643|3503655|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3657520|NCT02411643|3503655|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3657521|NCT02411578|3503662|B3|||Duration of Type 1 Diabetes||years|Mean|23.4|23.4|Standard Deviation|14.8|14.8|||
3657522|NCT02411578|3503663|B2|||Duration of Type 1 Diabetes||years|Mean|22.5|22.5|Standard Deviation|15.8|15.8|||
3657523|NCT02411578|3503664|B1|||Duration of Type 1 Diabetes||years|Mean|24.8|24.8|Standard Deviation|14.2|14.2|||
3657524|NCT02411578|3503662|B3|||Hemoglobin A1c||%|Mean|7.2|7.2|Standard Deviation|0.8|0.8|||
3657525|NCT02411578|3503663|B2|||Hemoglobin A1c||%|Mean|7.4|7.4|Standard Deviation|0.9|0.9|||
3657526|NCT02411578|3503664|B1|||Hemoglobin A1c||%|Mean|6.9|6.9|Standard Deviation|0.6|0.6|||
3657527|NCT02411578|3503662|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657528|NCT02411578|3503663|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657529|NCT02411578|3503664|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657530|NCT02411578|3503662|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657531|NCT02411578|3503663|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657532|NCT02411578|3503664|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657533|NCT02411578|3503662|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3657534|NCT02411578|3503663|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3657535|NCT02411578|3503664|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3657536|NCT02411578|3503662|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657537|NCT02411578|3503663|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657538|NCT02411578|3503664|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657539|NCT02411578|3503662|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657540|NCT02411578|3503663|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657541|NCT02411578|3503664|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657542|NCT02411578|3503662|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657543|NCT02411578|3503663|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657544|NCT02411578|3503664|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657545|NCT02411578|3503662|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657546|NCT02411578|3503663|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657547|NCT02411578|3503664|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657548|NCT02411578|3503662|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657549|NCT02411578|3503663|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657550|NCT02411578|3503664|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657551|NCT02411578|3503662|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3657552|NCT02411578|3503663|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3657553|NCT02411578|3503664|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3657554|NCT02411578|3503662|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657555|NCT02411578|3503663|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657556|NCT02411578|3503664|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657557|NCT02411578|3503662|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3657558|NCT02411578|3503663|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3657559|NCT02411578|3503664|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3657560|NCT02411578|3503662|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3657561|NCT02411578|3503663|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3657562|NCT02411578|3503664|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3657563|NCT02411578|3503662|B3|||Age||years|Mean|38.6|38.6|Standard Deviation|11.0|11.0|||
3657564|NCT02411578|3503663|B2|||Age||years|Mean|36.9|36.9|Standard Deviation|12.2|12.2|||
3657565|NCT02411578|3503664|B1|||Age||years|Mean|41.5|41.5|Standard Deviation|9.1|9.1|||
3657566|NCT02411539|3503705|B3|||Cell-associated HIV-1 RNA/DNA Ratio||log10 ratio|Median|-1.45|-1.45|Inter-Quartile Range|||-1.63|-1.17|
3657567|NCT02411539|3503706|B2|||Cell-associated HIV-1 RNA/DNA Ratio||log10 ratio|Median|-1.51|-1.51|Inter-Quartile Range|||-1.69|-1.3|
3657568|NCT02411539|3503707|B1|||Cell-associated HIV-1 RNA/DNA Ratio||log10 ratio|Median|-1.35|-1.35|Inter-Quartile Range|||-1.63|-1.02|
3657569|NCT02411539|3503705|B3|> 90 mL/min||Creatinine clearance, categorical|Categorization of the average results from the screening and entry visits|Participants|Count of Participants|27|27.0||||||
3657570|NCT02411539|3503706|B2|> 90 mL/min||Creatinine clearance, categorical|Categorization of the average results from the screening and entry visits|Participants|Count of Participants|11|11.0||||||
3657571|NCT02411539|3503707|B1|> 90 mL/min||Creatinine clearance, categorical|Categorization of the average results from the screening and entry visits|Participants|Count of Participants|16|16.0||||||
3657572|NCT02411539|3503705|B3|50 - 90 mL/min||Creatinine clearance, categorical|Categorization of the average results from the screening and entry visits|Participants|Count of Participants|13|13.0||||||
3657573|NCT02411539|3503706|B2|50 - 90 mL/min||Creatinine clearance, categorical|Categorization of the average results from the screening and entry visits|Participants|Count of Participants|9|9.0||||||
3657574|NCT02411539|3503707|B1|50 - 90 mL/min||Creatinine clearance, categorical|Categorization of the average results from the screening and entry visits|Participants|Count of Participants|4|4.0||||||
3657575|NCT02411539|3503705|B3|>= 500 cells/mm^3||CD4+ T-Cell Count, categorical|Categorization of the average results from the screening and entry visits|Participants|Count of Participants|33|33.0||||||
3657576|NCT02411539|3503706|B2|>= 500 cells/mm^3||CD4+ T-Cell Count, categorical|Categorization of the average results from the screening and entry visits|Participants|Count of Participants|16|16.0||||||
3657577|NCT02411539|3503707|B1|>= 500 cells/mm^3||CD4+ T-Cell Count, categorical|Categorization of the average results from the screening and entry visits|Participants|Count of Participants|17|17.0||||||
3657578|NCT02411539|3503705|B3|350 - <500 cells/mm^3||CD4+ T-Cell Count, categorical|Categorization of the average results from the screening and entry visits|Participants|Count of Participants|5|5.0||||||
3657579|NCT02411539|3503706|B2|350 - <500 cells/mm^3||CD4+ T-Cell Count, categorical|Categorization of the average results from the screening and entry visits|Participants|Count of Participants|2|2.0||||||
3657580|NCT02411539|3503707|B1|350 - <500 cells/mm^3||CD4+ T-Cell Count, categorical|Categorization of the average results from the screening and entry visits|Participants|Count of Participants|3|3.0||||||
3657581|NCT02411539|3503705|B3|200 - <350 cells/mm^3||CD4+ T-Cell Count, categorical|Categorization of the average results from the screening and entry visits|Participants|Count of Participants|2|2.0||||||
3657582|NCT02411539|3503706|B2|200 - <350 cells/mm^3||CD4+ T-Cell Count, categorical|Categorization of the average results from the screening and entry visits|Participants|Count of Participants|2|2.0||||||
3657583|NCT02411539|3503707|B1|200 - <350 cells/mm^3||CD4+ T-Cell Count, categorical|Categorization of the average results from the screening and entry visits|Participants|Count of Participants|0|0.0||||||
3657584|NCT02411539|3503705|B3|>= 40 copies/mL||Plasma HIV-1 RNA, categorical|Categorization of the result from the entry visit|Participants|Count of Participants|0|0.0||||||
3657585|NCT02411539|3503706|B2|>= 40 copies/mL||Plasma HIV-1 RNA, categorical|Categorization of the result from the entry visit|Participants|Count of Participants|0|0.0||||||
3657586|NCT02411539|3503707|B1|>= 40 copies/mL||Plasma HIV-1 RNA, categorical|Categorization of the result from the entry visit|Participants|Count of Participants|0|0.0||||||
3657587|NCT02411539|3503705|B3|< 40 copies/mL||Plasma HIV-1 RNA, categorical|Categorization of the result from the entry visit|Participants|Count of Participants|40|40.0||||||
3657588|NCT02411539|3503706|B2|< 40 copies/mL||Plasma HIV-1 RNA, categorical|Categorization of the result from the entry visit|Participants|Count of Participants|20|20.0||||||
3657589|NCT02411539|3503707|B1|< 40 copies/mL||Plasma HIV-1 RNA, categorical|Categorization of the result from the entry visit|Participants|Count of Participants|20|20.0||||||
3657590|NCT02411539|3503705|B3|Obese (30+ kg/m^2)||BMI, categorical|Categories from entry visit|Participants|Count of Participants|8|8.0||||||
3657591|NCT02411539|3503706|B2|Obese (30+ kg/m^2)||BMI, categorical|Categories from entry visit|Participants|Count of Participants|3|3.0||||||
3657592|NCT02411539|3503707|B1|Obese (30+ kg/m^2)||BMI, categorical|Categories from entry visit|Participants|Count of Participants|5|5.0||||||
3657593|NCT02411539|3503705|B3|Overweight (25 - <30 kg/m^2)||BMI, categorical|Categories from entry visit|Participants|Count of Participants|16|16.0||||||
3657594|NCT02411539|3503706|B2|Overweight (25 - <30 kg/m^2)||BMI, categorical|Categories from entry visit|Participants|Count of Participants|6|6.0||||||
3657595|NCT02411539|3503707|B1|Overweight (25 - <30 kg/m^2)||BMI, categorical|Categories from entry visit|Participants|Count of Participants|10|10.0||||||
3657596|NCT02411539|3503705|B3|Normal (18 - <25 kg/m^2)||BMI, categorical|Categories from entry visit|Participants|Count of Participants|15|15.0||||||
3657597|NCT02411539|3503706|B2|Normal (18 - <25 kg/m^2)||BMI, categorical|Categories from entry visit|Participants|Count of Participants|11|11.0||||||
3657598|NCT02411539|3503707|B1|Normal (18 - <25 kg/m^2)||BMI, categorical|Categories from entry visit|Participants|Count of Participants|4|4.0||||||
3657599|NCT02411539|3503705|B3|Underweight (<18 kg/m^2)||BMI, categorical|Categories from entry visit|Participants|Count of Participants|1|1.0||||||
3657600|NCT02411539|3503706|B2|Underweight (<18 kg/m^2)||BMI, categorical|Categories from entry visit|Participants|Count of Participants|0|0.0||||||
3657601|NCT02411539|3503707|B1|Underweight (<18 kg/m^2)||BMI, categorical|Categories from entry visit|Participants|Count of Participants|1|1.0||||||
3657602|NCT02411539|3503705|B3|Previously||IV drug history, categorical||Participants|Count of Participants|3|3.0||||||
3657603|NCT02411539|3503706|B2|Previously||IV drug history, categorical||Participants|Count of Participants|2|2.0||||||
3657604|NCT02411539|3503707|B1|Previously||IV drug history, categorical||Participants|Count of Participants|1|1.0||||||
3657605|NCT02411539|3503705|B3|Never||IV drug history, categorical||Participants|Count of Participants|37|37.0||||||
3657606|NCT02411539|3503706|B2|Never||IV drug history, categorical||Participants|Count of Participants|18|18.0||||||
3657607|NCT02411539|3503707|B1|Never||IV drug history, categorical||Participants|Count of Participants|19|19.0||||||
3657608|NCT02411539|3503705|B3|Hispanic (regardless of race)||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3657609|NCT02411539|3503706|B2|Hispanic (regardless of race)||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3657610|NCT02411539|3503707|B1|Hispanic (regardless of race)||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3657611|NCT02411539|3503705|B3|Black non-hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3657612|NCT02411539|3503706|B2|Black non-hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3657613|NCT02411539|3503707|B1|Black non-hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3657614|NCT02411539|3503705|B3|White non-hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3657615|NCT02411539|3503706|B2|White non-hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3657616|NCT02411539|3503707|B1|White non-hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3657617|NCT02411539|3503705|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3657618|NCT02411539|3503706|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3657619|NCT02411539|3503707|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3657620|NCT02411539|3503705|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3657621|NCT02411539|3503706|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3657622|NCT02411539|3503707|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3657623|NCT02411539|3503705|B3|50+ years||Age, Customized|Age at enrollment, categorized|Participants|Count of Participants|24|24.0||||||
3657624|NCT02411539|3503706|B2|50+ years||Age, Customized|Age at enrollment, categorized|Participants|Count of Participants|15|15.0||||||
3657625|NCT02411539|3503707|B1|50+ years||Age, Customized|Age at enrollment, categorized|Participants|Count of Participants|9|9.0||||||
3657626|NCT02411539|3503705|B3|40-49 years||Age, Customized|Age at enrollment, categorized|Participants|Count of Participants|6|6.0||||||
3657627|NCT02411539|3503706|B2|40-49 years||Age, Customized|Age at enrollment, categorized|Participants|Count of Participants|2|2.0||||||
3657628|NCT02411539|3503707|B1|40-49 years||Age, Customized|Age at enrollment, categorized|Participants|Count of Participants|4|4.0||||||
3657629|NCT02411539|3503705|B3|30-39 years||Age, Customized|Age at enrollment, categorized|Participants|Count of Participants|5|5.0||||||
3657630|NCT02411539|3503706|B2|30-39 years||Age, Customized|Age at enrollment, categorized|Participants|Count of Participants|1|1.0||||||
3657631|NCT02411539|3503707|B1|30-39 years||Age, Customized|Age at enrollment, categorized|Participants|Count of Participants|4|4.0||||||
3657632|NCT02411539|3503705|B3|18-29 years||Age, Customized|Age at enrollment, categorized|Participants|Count of Participants|5|5.0||||||
3657633|NCT02411539|3503706|B2|18-29 years||Age, Customized|Age at enrollment, categorized|Participants|Count of Participants|2|2.0||||||
3657634|NCT02411539|3503707|B1|18-29 years||Age, Customized|Age at enrollment, categorized|Participants|Count of Participants|3|3.0||||||
3657635|NCT02411539|3503705|B3|||Age||years|Mean|48|48.0|Standard Deviation|12|12.0|||
3657636|NCT02411539|3503706|B2|||Age||years|Mean|52|52.0|Standard Deviation|11|11.0|||
3657637|NCT02411539|3503707|B1|||Age||years|Mean|44|44.0|Standard Deviation|12|12.0|||
3657638|NCT02411461|3503783|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657639|NCT02411461|3503784|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657640|NCT02411461|3503785|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657641|NCT02411461|3503786|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657642|NCT02411461|3503783|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657643|NCT02411461|3503784|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657644|NCT02411461|3503785|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657645|NCT02411461|3503786|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657646|NCT02411461|3503783|B4||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3657647|NCT02411461|3503784|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3657648|NCT02411461|3503785|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3657649|NCT02411461|3503786|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3657650|NCT02411461|3503783|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657651|NCT02411461|3503784|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657652|NCT02411461|3503785|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657653|NCT02411461|3503786|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657654|NCT02411461|3503783|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657655|NCT02411461|3503784|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657656|NCT02411461|3503785|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657657|NCT02411461|3503786|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657658|NCT02411461|3503783|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657659|NCT02411461|3503784|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657660|NCT02411461|3503785|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657661|NCT02411461|3503786|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657662|NCT02411461|3503783|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657663|NCT02411461|3503784|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657664|NCT02411461|3503785|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657665|NCT02411461|3503786|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657666|NCT02411461|3503783|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3657667|NCT02411461|3503784|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3657668|NCT02411461|3503785|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3657669|NCT02411461|3503786|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3657670|NCT02411461|3503783|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3657671|NCT02411461|3503784|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3657672|NCT02411461|3503785|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3657673|NCT02411461|3503786|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3657674|NCT02411461|3503783|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3657675|NCT02411461|3503784|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3657676|NCT02411461|3503785|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3657677|NCT02411461|3503786|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3657678|NCT02411461|3503783|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3657679|NCT02411461|3503784|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3657680|NCT02411461|3503785|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3657681|NCT02411461|3503786|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3657682|NCT02411461|3503783|B4||<=18 years|Age||Participants|Count of Participants|39|39.0||||||
3657683|NCT02411461|3503784|B3||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
3657684|NCT02411461|3503785|B2||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
3657685|NCT02411461|3503786|B1||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
3657686|NCT02411292|3503796|B1|||Length of chemoprophylaxis||days|Mean|10.3|10.3|Full Range|||1.0|40.0|
3657687|NCT02411292|3503796|B1|||Length of hospital stay||days|Mean|7.6|7.6|Full Range|||3.0|39.0|
3657688|NCT02411292|3503796|B1|||Total body surface area surgically injured||percentage of total body surface area|Mean|6.1|6.1|Full Range|||1.0|13.0|
3657689|NCT02411292|3503796|B1|||Length of operation||minutes|Mean|281|281.0|Full Range|||23.0|996.0|
3657690|NCT02411292|3503796|B1||Lower extremity|Location of primary operation||Participants|Count of Participants|30|30.0||||||
3657691|NCT02411292|3503796|B1||Upper extremity|Location of primary operation||Participants|Count of Participants|2|2.0||||||
3657692|NCT02411292|3503796|B1||Back including pressure ulcers|Location of primary operation||Participants|Count of Participants|26|26.0||||||
3657693|NCT02411292|3503796|B1||Chest, nonbreast|Location of primary operation||Participants|Count of Participants|5|5.0||||||
3657694|NCT02411292|3503796|B1||Breast|Location of primary operation||Participants|Count of Participants|29|29.0||||||
3657695|NCT02411292|3503796|B1||Head and neck|Location of primary operation||Participants|Count of Participants|2|2.0||||||
3657696|NCT02411292|3503796|B1|||Caprini Score|"The Caprini risk score is a risk assessment tool for the occurrence of venous thromboembolism (VTE) among surgical patients. The Caprini risk score includes 40 factors, each ascribed points ranging from 1 to 5. The Caprini score is calculated by adding the scores of all factors present in the patient. The minimum possible score is 0. The maximum score for men is 85. The maximum score for women is 88. The Caprini score is interpreted in the following way:~Score 0-1: Low risk of VTE~Score 2: Moderate of VTE~Score 3-4: High risk of VTE~Score ≥ 5: Highest risk for VTE"|scores on a scale|Median|7|7.0|Full Range|||2.0|15.0|
3657697|NCT02411292|3503796|B1|||Current smoker||Participants|Count of Participants|14|14.0||||||
3657698|NCT02411292|3503796|B1|||Creatinine||mg/dL|Mean|0.82|0.82|Full Range|||0.34|1.52|
3657699|NCT02411292|3503796|B1|||Number of patients receiving treatment for Diabetes||Participants|Count of Participants|8|8.0||||||
3657700|NCT02411292|3503796|B1|||Gross weight||lbs|Mean|184|184.0|Full Range|||94.0|320.0|
3657701|NCT02411292|3503796|B1|||Body Mass Index||kg/m^2|Mean|28.6|28.6|Full Range|||17.0|49.8|
3657702|NCT02411292|3503796|B1|United States||Region of Enrollment||participants|Number|94|94.0||||||
3657703|NCT02411292|3503796|B1|Ethnicity|Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3657704|NCT02411292|3503796|B1|Ethnicity|Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3657705|NCT02411292|3503796|B1|Ethnicity|Native American or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3657706|NCT02411292|3503796|B1|Ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3657707|NCT02411292|3503796|B1|Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|79|79.0||||||
3657708|NCT02411292|3503796|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3657709|NCT02411292|3503796|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3657710|NCT02411292|3503796|B1|||Age||years|Mean|52.6|52.6|Full Range|||21.0|88.0|
3657711|NCT02411201|3503802|B1|France||Region of Enrollment||participants|Number|4|4.0||||||
3657712|NCT02411201|3503802|B1|Poland||Region of Enrollment||participants|Number|29|29.0||||||
3657713|NCT02411201|3503802|B1|Hungary||Region of Enrollment||participants|Number|9|9.0||||||
3657714|NCT02411201|3503802|B1|Austria||Region of Enrollment||participants|Number|3|3.0||||||
3657715|NCT02411201|3503802|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3657716|NCT02411201|3503802|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3657717|NCT02411201|3503802|B1|>3 months to <24 months||Age, Customized||Participants|Count of Participants|31|31.0||||||
3657718|NCT02411201|3503802|B1|1 to 3 months||Age, Customized||Participants|Count of Participants|9|9.0||||||
3657719|NCT02411201|3503802|B1|<1 month||Age, Customized||Participants|Count of Participants|5|5.0||||||
3657720|NCT02411201|3503802|B1|||Age||months|Mean|9.9|9.9|Standard Deviation|7.4|7.4|||
3657721|NCT02411110|3503813|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3657722|NCT02411110|3503814|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3657723|NCT02411110|3503815|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3657724|NCT02411110|3503813|B3||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3657725|NCT02411110|3503814|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3657726|NCT02411110|3503815|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3657727|NCT02411110|3503813|B3|≥ 40 Years||Age, Customized||participants|Number|82|82.0||||||
3657728|NCT02411110|3503814|B2|≥ 40 Years||Age, Customized||participants|Number|42|42.0||||||
3657729|NCT02411110|3503815|B1|≥ 40 Years||Age, Customized||participants|Number|40|40.0||||||
3657730|NCT02411110|3503813|B3|< 40 Years||Age, Customized||participants|Number|49|49.0||||||
3657731|NCT02411110|3503814|B2|< 40 Years||Age, Customized||participants|Number|24|24.0||||||
3657732|NCT02411110|3503815|B1|< 40 Years||Age, Customized||participants|Number|25|25.0||||||
3657733|NCT02411110|3503813|B3|||Age||years|Mean|46.37|46.37|Standard Deviation|13.73|13.73|||
3657734|NCT02411110|3503814|B2|||Age||years|Mean|44.20|44.2|Standard Deviation|12.65|12.65|||
3657735|NCT02411110|3503815|B1|||Age||years|Mean|48.58|48.58|Standard Deviation|14.50|14.5|||
3657736|NCT02410967|3503824|B3|United States||Region of Enrollment||Participants|Count of Participants|53|53.0||||||
3657737|NCT02410967|3503825|B2|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3657738|NCT02410967|3503826|B1|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3657739|NCT02410967|3503824|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3657740|NCT02410967|3503825|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3657741|NCT02410967|3503826|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657742|NCT02410967|3503824|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3657743|NCT02410967|3503825|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3657744|NCT02410967|3503826|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657745|NCT02410967|3503824|B3||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3657746|NCT02410967|3503825|B2||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3657747|NCT02410967|3503826|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3657748|NCT02410967|3503824|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3657749|NCT02410967|3503825|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657750|NCT02410967|3503826|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3657751|NCT02410967|3503824|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657752|NCT02410967|3503825|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657753|NCT02410967|3503826|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657754|NCT02410967|3503824|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3657755|NCT02410967|3503825|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3657756|NCT02410967|3503826|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657757|NCT02410967|3503824|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657758|NCT02410967|3503825|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657759|NCT02410967|3503826|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657760|NCT02410967|3503824|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3657761|NCT02410967|3503825|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657762|NCT02410967|3503826|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3657763|NCT02410967|3503824|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3657764|NCT02410967|3503825|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3657765|NCT02410967|3503826|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3657766|NCT02410967|3503824|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3657767|NCT02410967|3503825|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3657768|NCT02410967|3503826|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3657769|NCT02410967|3503824|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3657770|NCT02410967|3503825|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3657771|NCT02410967|3503826|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3657772|NCT02410967|3503824|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3657773|NCT02410967|3503825|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3657774|NCT02410967|3503826|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3657775|NCT02410967|3503824|B3|||Age||years|Mean|9.27|9.27|Standard Deviation|2.61|2.61|||
3657776|NCT02410967|3503825|B2|||Age||years|Mean|8.85|8.85|Standard Deviation|2.53|2.53|||
3657777|NCT02410967|3503826|B1|||Age||years|Mean|9.67|9.67|Standard Deviation|2.68|2.68|||
3657778|NCT02410967|3503824|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3657779|NCT02410967|3503825|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3657780|NCT02410967|3503826|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3657781|NCT02410967|3503824|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3657782|NCT02410967|3503825|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3657783|NCT02410967|3503826|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3657784|NCT02410967|3503824|B3||<=18 years|Age||Participants|Count of Participants|53|53.0||||||
3657785|NCT02410967|3503825|B2||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
3657786|NCT02410967|3503826|B1||<=18 years|Age||Participants|Count of Participants|27|27.0||||||
3657787|NCT02410824|3503843|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
3657788|NCT02410824|3503843|B1|Canada||Region of Enrollment||participants|Number|21|21.0||||||
3657789|NCT02410824|3503843|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3657790|NCT02410824|3503843|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3657791|NCT02410824|3503843|B1|||Age||years|Mean|26|26.0|Standard Deviation|9|9.0|||
3657792|NCT02410551|3503876|B1|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3657793|NCT02410551|3503876|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657794|NCT02410551|3503876|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657795|NCT02410551|3503876|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3657796|NCT02410551|3503876|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657797|NCT02410551|3503876|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657798|NCT02410551|3503876|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657799|NCT02410551|3503876|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657800|NCT02410551|3503876|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657801|NCT02410551|3503876|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3657802|NCT02410551|3503876|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3657803|NCT02410551|3503876|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3657804|NCT02410551|3503876|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3657805|NCT02410551|3503876|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3657806|NCT02410551|3503876|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3657807|NCT02410551|3503876|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3657808|NCT02410343|3503881|B3||Missing|Prior Treatment for Growth-Hormone Deficiency||Participants|Count of Participants|11|11.0||||||
3657809|NCT02410343|3503882|B2||Missing|Prior Treatment for Growth-Hormone Deficiency||Participants|Count of Participants|7|7.0||||||
3657810|NCT02410343|3503883|B1||Missing|Prior Treatment for Growth-Hormone Deficiency||Participants|Count of Participants|4|4.0||||||
3657811|NCT02410343|3503881|B3||No|Prior Treatment for Growth-Hormone Deficiency||Participants|Count of Participants|0|0.0||||||
3657812|NCT02410343|3503882|B2||No|Prior Treatment for Growth-Hormone Deficiency||Participants|Count of Participants|0|0.0||||||
3657813|NCT02410343|3503883|B1||No|Prior Treatment for Growth-Hormone Deficiency||Participants|Count of Participants|0|0.0||||||
3657814|NCT02410343|3503881|B3||Yes|Prior Treatment for Growth-Hormone Deficiency||Participants|Count of Participants|3|3.0||||||
3657815|NCT02410343|3503882|B2||Yes|Prior Treatment for Growth-Hormone Deficiency||Participants|Count of Participants|1|1.0||||||
3657816|NCT02410343|3503883|B1||Yes|Prior Treatment for Growth-Hormone Deficiency||Participants|Count of Participants|2|2.0||||||
3657817|NCT02410343|3503881|B3||Other|Cause of Growth-Hormone Deficiency||Participants|Count of Participants|7|7.0||||||
3657818|NCT02410343|3503882|B2||Other|Cause of Growth-Hormone Deficiency||Participants|Count of Participants|4|4.0||||||
3657819|NCT02410343|3503883|B1||Other|Cause of Growth-Hormone Deficiency||Participants|Count of Participants|3|3.0||||||
3657820|NCT02410343|3503881|B3||Idiopathic|Cause of Growth-Hormone Deficiency||Participants|Count of Participants|1|1.0||||||
3657821|NCT02410343|3503882|B2||Idiopathic|Cause of Growth-Hormone Deficiency||Participants|Count of Participants|1|1.0||||||
3657822|NCT02410343|3503883|B1||Idiopathic|Cause of Growth-Hormone Deficiency||Participants|Count of Participants|0|0.0||||||
3657823|NCT02410343|3503881|B3||Non-secreting pituitary adenoma|Cause of Growth-Hormone Deficiency||Participants|Count of Participants|5|5.0||||||
3657824|NCT02410343|3503882|B2||Non-secreting pituitary adenoma|Cause of Growth-Hormone Deficiency||Participants|Count of Participants|2|2.0||||||
3657825|NCT02410343|3503883|B1||Non-secreting pituitary adenoma|Cause of Growth-Hormone Deficiency||Participants|Count of Participants|3|3.0||||||
3657826|NCT02410343|3503881|B3||Secreting pituitary adenoma|Cause of Growth-Hormone Deficiency||Participants|Count of Participants|1|1.0||||||
3657827|NCT02410343|3503882|B2||Secreting pituitary adenoma|Cause of Growth-Hormone Deficiency||Participants|Count of Participants|1|1.0||||||
3657828|NCT02410343|3503883|B1||Secreting pituitary adenoma|Cause of Growth-Hormone Deficiency||Participants|Count of Participants|0|0.0||||||
3657829|NCT02410343|3503881|B3||Childhood (<18 years)|Growth-Hormone Deficiency Onset||Participants|Count of Participants|2|2.0||||||
3657830|NCT02410343|3503882|B2||Childhood (<18 years)|Growth-Hormone Deficiency Onset||Participants|Count of Participants|1|1.0||||||
3657831|NCT02410343|3503883|B1||Childhood (<18 years)|Growth-Hormone Deficiency Onset||Participants|Count of Participants|1|1.0||||||
3657832|NCT02410343|3503881|B3||Adult (>+18 years)|Growth-Hormone Deficiency Onset||Participants|Count of Participants|12|12.0||||||
3657833|NCT02410343|3503882|B2||Adult (>+18 years)|Growth-Hormone Deficiency Onset||Participants|Count of Participants|7|7.0||||||
3657834|NCT02410343|3503883|B1||Adult (>+18 years)|Growth-Hormone Deficiency Onset||Participants|Count of Participants|5|5.0||||||
3657835|NCT02410343|3503881|B3|||Duration of Growth-Hormone Deficiency Diagnosis||years|Mean|10.318|10.318|Standard Deviation|11.2932|11.2932|||
3657836|NCT02410343|3503882|B2|||Duration of Growth-Hormone Deficiency Diagnosis||years|Mean|11.104|11.104|Standard Deviation|13.1631|13.1631|||
3657837|NCT02410343|3503883|B1|||Duration of Growth-Hormone Deficiency Diagnosis||years|Mean|9.270|9.27|Standard Deviation|9.3120|9.312|||
3657838|NCT02410343|3503881|B3|||Insulin-like Growth Factor 1 Standard Deviation Score|IGF-1 SDS represents the standard deviation from a 'normal' population.|standard deviations|Mean|-1.66|-1.66|Standard Deviation|0.789|0.789|||
3657839|NCT02410343|3503882|B2|||Insulin-like Growth Factor 1 Standard Deviation Score|IGF-1 SDS represents the standard deviation from a 'normal' population.|standard deviations|Mean|-1.40|-1.4|Standard Deviation|0.545|0.545|||
3657840|NCT02410343|3503883|B1|||Insulin-like Growth Factor 1 Standard Deviation Score|IGF-1 SDS represents the standard deviation from a 'normal' population.|standard deviations|Mean|-2.00|-2.0|Standard Deviation|0.978|0.978|||
3657841|NCT02410343|3503881|B3|||Body Mass Index||kg/m^2|Mean|26.998|26.998|Standard Deviation|4.6280|4.628|||
3657842|NCT02410343|3503882|B2|||Body Mass Index||kg/m^2|Mean|27.716|27.716|Standard Deviation|3.3512|3.3512|||
3657843|NCT02410343|3503883|B1|||Body Mass Index||kg/m^2|Mean|26.040|26.04|Standard Deviation|6.1675|6.1675|||
3657844|NCT02410343|3503881|B3|||Height||cm|Mean|172.257|172.257|Standard Deviation|8.8362|8.8362|||
3657845|NCT02410343|3503882|B2|||Height||cm|Mean|170.130|170.13|Standard Deviation|8.5363|8.5363|||
3657846|NCT02410343|3503883|B1|||Height||cm|Mean|175.093|175.093|Standard Deviation|9.1702|9.1702|||
3657847|NCT02410343|3503881|B3|||Weight||kg|Mean|80.669|80.669|Standard Deviation|17.9137|17.9137|||
3657848|NCT02410343|3503882|B2|||Weight||kg|Mean|80.448|80.448|Standard Deviation|13.3406|13.3406|||
3657849|NCT02410343|3503883|B1|||Weight||kg|Mean|80.963|80.963|Standard Deviation|24.1867|24.1867|||
3657850|NCT02410343|3503881|B3||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3657851|NCT02410343|3503882|B2||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3657852|NCT02410343|3503883|B1||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3657853|NCT02410343|3503881|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3657854|NCT02410343|3503882|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3657855|NCT02410343|3503883|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3657856|NCT02410343|3503881|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3657857|NCT02410343|3503882|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3657858|NCT02410343|3503883|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3657859|NCT02410343|3503881|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3657860|NCT02410343|3503882|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3657861|NCT02410343|3503883|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3657862|NCT02410343|3503881|B3||>=40 years|Age, Customized||Participants|Count of Participants|12|12.0||||||
3657863|NCT02410343|3503882|B2||>=40 years|Age, Customized||Participants|Count of Participants|7|7.0||||||
3657864|NCT02410343|3503883|B1||>=40 years|Age, Customized||Participants|Count of Participants|5|5.0||||||
3657865|NCT02410343|3503881|B3||<40 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
3657866|NCT02410343|3503882|B2||<40 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
3657867|NCT02410343|3503883|B1||<40 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
3657868|NCT02410343|3503881|B3|||Age||years|Mean|53.4|53.4|Standard Deviation|15.66|15.66|||
3657869|NCT02410343|3503882|B2|||Age||years|Mean|56.4|56.4|Standard Deviation|17.70|17.7|||
3657870|NCT02410343|3503883|B1|||Age||years|Mean|49.3|49.3|Standard Deviation|12.86|12.86|||
3657871|NCT02410291|3503919|B3|Canada||Region of Enrollment||participants|Number|58|58.0||||||
3657872|NCT02410291|3503920|B2|Canada||Region of Enrollment||participants|Number|29|29.0||||||
3657873|NCT02410291|3503921|B1|Canada||Region of Enrollment||participants|Number|29|29.0||||||
3657874|NCT02410291|3503919|B3||Male|Gender||Participants|Count of Participants|58|58.0||||||
3657876|NCT02410291|3503921|B1||Male|Gender||Participants|Count of Participants|29|29.0||||||
3657877|NCT02410291|3503919|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
3657878|NCT02410291|3503920|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
3657879|NCT02410291|3503921|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3657880|NCT02410291|3503919|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3657881|NCT02410291|3503920|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3657882|NCT02410291|3503921|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3657883|NCT02410291|3503919|B3||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3657884|NCT02410291|3503920|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3657885|NCT02410291|3503921|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3657886|NCT02410291|3503919|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3657887|NCT02410291|3503920|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3657888|NCT02410291|3503921|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3657889|NCT02410278|3503928|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3657890|NCT02410278|3503928|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3657891|NCT02410278|3503929|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3657892|NCT02410278|3503930|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3657893|NCT02410278|3503928|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3657894|NCT02410278|3503929|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3657895|NCT02410278|3503930|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3657896|NCT02410278|3503928|B3|||Age||years|Mean|44.29|44.29|Standard Deviation|11.63|11.63|||
3657897|NCT02410278|3503929|B2|||Age||years|Mean|44.88|44.88|Standard Deviation|10.39|10.39|||
3657898|NCT02410278|3503930|B1|||Age||years|Mean|43.63|43.63|Standard Deviation|13.00|13.0|||
3657899|NCT02410252|3503957|B1||Unemployed|Employment Status of Caregivers||Participants|Count of Participants|5|5.0||||||
3657900|NCT02410252|3503957|B1||Homemaker|Employment Status of Caregivers||Participants|Count of Participants|6|6.0||||||
3657901|NCT02410252|3503957|B1||Employed, part time|Employment Status of Caregivers||Participants|Count of Participants|3|3.0||||||
3657902|NCT02410252|3503957|B1||Employed, full time|Employment Status of Caregivers||Participants|Count of Participants|5|5.0||||||
3657903|NCT02410252|3503957|B1|||Age of Caregivers||years|Mean|41|41.0|Standard Deviation|8|8.0|||
3657904|NCT02410252|3503957|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3657905|NCT02410252|3503957|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3657906|NCT02410252|3503957|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657907|NCT02410252|3503957|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3657908|NCT02410252|3503957|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657909|NCT02410252|3503957|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657910|NCT02410252|3503957|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3657911|NCT02410252|3503957|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657912|NCT02410252|3503957|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3657913|NCT02410252|3503957|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3657914|NCT02410252|3503957|B1|||Age||years|Mean|8|8.0|Standard Deviation|5|5.0|||
3657915|NCT02410213|3503963|B1|Russia||Region of Enrollment||participants|Number|5|5.0||||||
3657916|NCT02410213|3503963|B1|Poland||Region of Enrollment||participants|Number|30|30.0||||||
3657917|NCT02410213|3503963|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657918|NCT02410213|3503963|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657919|NCT02410213|3503963|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3657920|NCT02410213|3503963|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657921|NCT02410213|3503963|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657922|NCT02410213|3503963|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657923|NCT02410213|3503963|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657924|NCT02410213|3503963|B1|Cohort 2 (FCM at 15 mg/kg to a maximum of 750mg|Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3657925|NCT02410213|3503963|B1|Cohort 2 (FCM at 15 mg/kg to a maximum of 750mg|Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3657926|NCT02410213|3503963|B1|Cohort 1 (FCM at 7.5 mg/kg to a maximum of 750mg)|Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3657927|NCT02410213|3503963|B1|Cohort 1 (FCM at 7.5 mg/kg to a maximum of 750mg)|Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3657928|NCT02410213|3503963|B1|Cohort 2 (FCM at 15 mg/kg to a maximum of 750mg)||Age||years|Mean|10.3|10.3|Standard Deviation|5.77|5.77|||
3657929|NCT02410213|3503963|B1|Cohort 1 (FCM at 7.5 mg/kg to a maximum of 750mg)||Age||years|Mean|9.1|9.1|Standard Deviation|6.13|6.13|||
3657930|NCT02410200|3503970|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3657931|NCT02410200|3503970|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3657932|NCT02410200|3503970|B1|||Age||years|Mean|15.8|15.8|Standard Deviation|1.18|1.18|||
3657933|NCT02410018|3503981|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3657934|NCT02410018|3503982|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3657935|NCT02410018|3503983|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3657936|NCT02410018|3503981|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3657937|NCT02410018|3503982|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3657938|NCT02410018|3503983|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3657939|NCT02410018|3503981|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3657940|NCT02410018|3503982|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3657941|NCT02410018|3503983|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3657942|NCT02410018|3503981|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3657943|NCT02410018|3503982|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3657944|NCT02410018|3503983|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3657945|NCT02410018|3503981|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3657946|NCT02410018|3503982|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3657947|NCT02410018|3503983|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3657948|NCT02410018|3503981|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3657949|NCT02410018|3503982|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3657950|NCT02410018|3503983|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3657951|NCT02409927|3504004|B1|Canada||Region of Enrollment||participants|Number|10|10.0||||||
3657952|NCT02409927|3504004|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3657953|NCT02409927|3504004|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3657954|NCT02409927|3504004|B1|||Age||years|Median|31|31.0|Standard Deviation|3|3.0|||
3657955|NCT02409927|3504004|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3657956|NCT02409927|3504004|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3657957|NCT02409927|3504004|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3657958|NCT02409784|3504012|B1|Canada||Region of Enrollment||participants|Number|10|10.0||||||
3657959|NCT02409784|3504012|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3657960|NCT02409784|3504012|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3657961|NCT02409784|3504012|B1|||Age||years|Mean|34|34.0|Standard Deviation|15|15.0|||
3657962|NCT02409784|3504012|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3657963|NCT02409784|3504012|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3657964|NCT02409784|3504012|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3657965|NCT02409732|3504020|B1|Prefer not to answer||Income||participants|Number|6|6.0||||||
3657966|NCT02409732|3504020|B1|>$100,000||Income||participants|Number|4|4.0||||||
3657967|NCT02409732|3504020|B1|$76,000-100,000||Income||participants|Number|4|4.0||||||
3657968|NCT02409732|3504020|B1|$51,000-75,000||Income||participants|Number|4|4.0||||||
3657969|NCT02409732|3504020|B1|$26,000-50,000||Income||participants|Number|1|1.0||||||
3657970|NCT02409732|3504020|B1|$10,000-25,000||Income||participants|Number|1|1.0||||||
3657971|NCT02409732|3504020|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3657972|NCT02409732|3504020|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657973|NCT02409732|3504020|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657974|NCT02409732|3504020|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3657975|NCT02409732|3504020|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657976|NCT02409732|3504020|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657977|NCT02409732|3504020|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657978|NCT02409732|3504020|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657979|NCT02409732|3504020|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3657980|NCT02409732|3504020|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3657981|NCT02409732|3504020|B1|||Age||years|Median|65|65.0|Standard Deviation|19|19.0|||
3657982|NCT02409459|3504028|B3|||IRLS score per Arm/Group|"‘International Restless Legs Syndrome Study Group Rating Scale’ (IRLS) The IRLS is composed of 10 items. It gives a global score for all 10 items that is most commonly used as an overall severity score. 9 of the 10 items investigate two dimensions of the RLS severity. Item 3 is part of the diagnostic criteria and does not belong to any of the two dimensions. It is used for the total score for overall RLS severity.~Symptom severity subscale: 0-24 Impact on daily living subscale: 0-12 Global score: 0-40 For all scores, higher score = higher symptom impact."|units on a scale|Mean|14.8|14.8|Standard Deviation|14.04|14.04|||
3657983|NCT02409459|3504029|B2|||IRLS score per Arm/Group|"‘International Restless Legs Syndrome Study Group Rating Scale’ (IRLS) The IRLS is composed of 10 items. It gives a global score for all 10 items that is most commonly used as an overall severity score. 9 of the 10 items investigate two dimensions of the RLS severity. Item 3 is part of the diagnostic criteria and does not belong to any of the two dimensions. It is used for the total score for overall RLS severity.~Symptom severity subscale: 0-24 Impact on daily living subscale: 0-12 Global score: 0-40 For all scores, higher score = higher symptom impact."|units on a scale|Mean|13.4|13.4|Standard Deviation|13.16|13.16|||
3658037|NCT02409355|3504050|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658038|NCT02409355|3504051|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3658039|NCT02409355|3504049|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3657984|NCT02409459|3504030|B1|||IRLS score per Arm/Group|"‘International Restless Legs Syndrome Study Group Rating Scale’ (IRLS) The IRLS is composed of 10 items. It gives a global score for all 10 items that is most commonly used as an overall severity score. 9 of the 10 items investigate two dimensions of the RLS severity. Item 3 is part of the diagnostic criteria and does not belong to any of the two dimensions. It is used for the total score for overall RLS severity.~Symptom severity subscale: 0-24 Impact on daily living subscale: 0-12 Global score: 0-40 For all scores, higher score = higher symptom impact."|units on a scale|Mean|16.3|16.3|Standard Deviation|14.9|14.9|||
3657985|NCT02409459|3504028|B3||Yes|History of drug allergy||Participants|Count of Participants|43|43.0||||||
3657986|NCT02409459|3504029|B2||Yes|History of drug allergy||Participants|Count of Participants|20|20.0||||||
3657987|NCT02409459|3504030|B1||Yes|History of drug allergy||Participants|Count of Participants|23|23.0||||||
3657988|NCT02409459|3504028|B3||No|History of drug allergy||Participants|Count of Participants|38|38.0||||||
3657989|NCT02409459|3504029|B2||No|History of drug allergy||Participants|Count of Participants|21|21.0||||||
3657990|NCT02409459|3504030|B1||No|History of drug allergy||Participants|Count of Participants|17|17.0||||||
3657991|NCT02409459|3504028|B3||Yes|History of iron intolerance||Participants|Count of Participants|9|9.0||||||
3657992|NCT02409459|3504029|B2||Yes|History of iron intolerance||Participants|Count of Participants|6|6.0||||||
3657993|NCT02409459|3504030|B1||Yes|History of iron intolerance||Participants|Count of Participants|3|3.0||||||
3657994|NCT02409459|3504028|B3||No|History of iron intolerance||Participants|Count of Participants|72|72.0||||||
3657995|NCT02409459|3504029|B2||No|History of iron intolerance||Participants|Count of Participants|35|35.0||||||
3657996|NCT02409459|3504030|B1||No|History of iron intolerance||Participants|Count of Participants|37|37.0||||||
3657997|NCT02409459|3504028|B3|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3657998|NCT02409459|3504029|B2|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3657999|NCT02409459|3504030|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3658000|NCT02409459|3504028|B3|Race|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3658001|NCT02409459|3504029|B2|Race|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3658002|NCT02409459|3504030|B1|Race|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3658003|NCT02409459|3504028|B3|Race|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|63|63.0||||||
3658004|NCT02409459|3504029|B2|Race|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3658005|NCT02409459|3504030|B1|Race|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3658006|NCT02409459|3504028|B3|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3658007|NCT02409459|3504029|B2|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3658008|NCT02409459|3504030|B1|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3658009|NCT02409459|3504028|B3|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3658010|NCT02409459|3504029|B2|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3658011|NCT02409459|3504030|B1|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3658012|NCT02409459|3504028|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3658013|NCT02409459|3504029|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3658014|NCT02409459|3504030|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3658015|NCT02409459|3504028|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3658016|NCT02409459|3504029|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3658017|NCT02409459|3504030|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3658018|NCT02409459|3504028|B3|||Age||years|Mean|43|43.0|Standard Deviation|10.97|10.97|||
3658019|NCT02409459|3504029|B2|||Age||years|Mean|41|41.0|Standard Deviation|11.07|11.07|||
3658020|NCT02409459|3504030|B1|||Age||years|Mean|44|44.0|Standard Deviation|10.85|10.85|||
3658021|NCT02409355|3504049|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658022|NCT02409355|3504050|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658023|NCT02409355|3504051|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658024|NCT02409355|3504049|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658025|NCT02409355|3504050|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658026|NCT02409355|3504051|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658027|NCT02409355|3504049|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3658028|NCT02409355|3504050|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3658029|NCT02409355|3504051|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3658030|NCT02409355|3504049|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658031|NCT02409355|3504050|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658032|NCT02409355|3504051|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658033|NCT02409355|3504049|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658034|NCT02409355|3504050|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658035|NCT02409355|3504051|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658036|NCT02409355|3504049|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3658040|NCT02409355|3504050|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658041|NCT02409355|3504051|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658042|NCT02409355|3504049|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658043|NCT02409355|3504050|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658044|NCT02409355|3504051|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658045|NCT02409355|3504049|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3658046|NCT02409355|3504050|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3658047|NCT02409355|3504051|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3658048|NCT02409355|3504049|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658049|NCT02409355|3504050|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658050|NCT02409355|3504051|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658051|NCT02409355|3504049|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3658052|NCT02409355|3504050|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3658053|NCT02409355|3504051|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3658054|NCT02409355|3504049|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3658055|NCT02409355|3504050|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3658056|NCT02409355|3504051|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3658057|NCT02409355|3504049|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3658058|NCT02409355|3504050|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3658059|NCT02409355|3504051|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3658060|NCT02409355|3504049|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3658061|NCT02409355|3504050|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3658062|NCT02409355|3504051|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3658063|NCT02409355|3504049|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3658064|NCT02409355|3504050|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3658065|NCT02409355|3504051|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3658066|NCT02408692|3504058|B4|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3658067|NCT02408692|3504059|B3|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3658068|NCT02408692|3504060|B2|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3658069|NCT02408692|3504061|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3658070|NCT02408692|3504058|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3658071|NCT02408692|3504059|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3658072|NCT02408692|3504060|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3658073|NCT02408692|3504061|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3658074|NCT02408692|3504058|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3658075|NCT02408692|3504059|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3658076|NCT02408692|3504060|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3658077|NCT02408692|3504061|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3658078|NCT02408692|3504058|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3658079|NCT02408692|3504059|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3658080|NCT02408692|3504060|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3658081|NCT02408692|3504061|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3658082|NCT02408692|3504058|B4||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3658083|NCT02408692|3504059|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3658084|NCT02408692|3504060|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3658085|NCT02408692|3504061|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3658086|NCT02408692|3504058|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3658087|NCT02408692|3504059|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3658088|NCT02408692|3504060|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3658089|NCT02408692|3504061|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3658090|NCT02408263|3504074|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3658091|NCT02408263|3504074|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3658092|NCT02408263|3504074|B1|||Age||years|Mean|64.1|64.1|Standard Deviation|8.7|8.7|||
3658093|NCT02408068|3504081|B1|United Kingdom||Region of Enrollment||participants|Number|18|18.0||||||
3658094|NCT02408068|3504081|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3658095|NCT02408068|3504081|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3658096|NCT02408068|3504081|B1|||Age||years|Mean|34.0|34.0|Standard Deviation|9.73|9.73|||
3658097|NCT02408068|3504081|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3658098|NCT02408068|3504081|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3658099|NCT02408068|3504081|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3658100|NCT02407704|3504109|B5|||Montgomery Asberg Depression Rating Scale|The Montgomery Asberg Depression Rating Scale measures depression severity. Scores can range from 0 to 60, with higher scores indicating higher levels of depression severity.|units on a scale|Mean|23.73|23.73|Standard Deviation|4.23|4.23|||
3658101|NCT02407704|3504110|B4|||Montgomery Asberg Depression Rating Scale|The Montgomery Asberg Depression Rating Scale measures depression severity. Scores can range from 0 to 60, with higher scores indicating higher levels of depression severity.|units on a scale|Mean|25.60|25.6|Standard Deviation|4.55|4.55|||
3658102|NCT02407704|3504111|B3|||Montgomery Asberg Depression Rating Scale|The Montgomery Asberg Depression Rating Scale measures depression severity. Scores can range from 0 to 60, with higher scores indicating higher levels of depression severity.|units on a scale|Mean|21.80|21.8|Standard Deviation|5.81|5.81|||
3658103|NCT02407704|3504112|B2|||Montgomery Asberg Depression Rating Scale|The Montgomery Asberg Depression Rating Scale measures depression severity. Scores can range from 0 to 60, with higher scores indicating higher levels of depression severity.|units on a scale|Mean|24.33|24.33|Standard Deviation|3.51|3.51|||
3658104|NCT02407704|3504113|B1|||Montgomery Asberg Depression Rating Scale|The Montgomery Asberg Depression Rating Scale measures depression severity. Scores can range from 0 to 60, with higher scores indicating higher levels of depression severity.|units on a scale|Mean|27.00|27.0|Standard Deviation|0.71|0.71|||
3658105|NCT02407704|3504109|B5|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3658106|NCT02407704|3504110|B4|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3658107|NCT02407704|3504111|B3|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3658108|NCT02407704|3504112|B2|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3658109|NCT02407704|3504113|B1|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3658110|NCT02407704|3504109|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658111|NCT02407704|3504110|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658112|NCT02407704|3504111|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658113|NCT02407704|3504112|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658114|NCT02407704|3504113|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658115|NCT02407704|3504109|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3658116|NCT02407704|3504110|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658117|NCT02407704|3504111|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3658118|NCT02407704|3504112|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658119|NCT02407704|3504113|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658120|NCT02407704|3504109|B5||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3658121|NCT02407704|3504110|B4||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3658122|NCT02407704|3504111|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3658123|NCT02407704|3504112|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3658124|NCT02407704|3504113|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3658125|NCT02407704|3504109|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3658126|NCT02407704|3504110|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3658127|NCT02407704|3504111|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3658128|NCT02407704|3504112|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658129|NCT02407704|3504113|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3658130|NCT02407704|3504109|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658131|NCT02407704|3504110|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658132|NCT02407704|3504111|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658133|NCT02407704|3504112|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658134|NCT02407704|3504113|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658135|NCT02407704|3504109|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658136|NCT02407704|3504110|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658137|NCT02407704|3504111|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658138|NCT02407704|3504112|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658139|NCT02407704|3504113|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658140|NCT02407704|3504109|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658141|NCT02407704|3504110|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658142|NCT02407704|3504111|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658143|NCT02407704|3504112|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658144|NCT02407704|3504113|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658145|NCT02407704|3504109|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658146|NCT02407704|3504110|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658147|NCT02407704|3504111|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658148|NCT02407704|3504112|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658149|NCT02407704|3504113|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658150|NCT02407704|3504109|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3658151|NCT02407704|3504110|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3658152|NCT02407704|3504111|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3658153|NCT02407704|3504112|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3658154|NCT02407704|3504113|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3658155|NCT02407704|3504109|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3658156|NCT02407704|3504110|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658157|NCT02407704|3504111|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3658158|NCT02407704|3504112|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658159|NCT02407704|3504113|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658160|NCT02407704|3504109|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3658161|NCT02407704|3504110|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3658162|NCT02407704|3504111|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3658163|NCT02407704|3504112|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3658164|NCT02407704|3504113|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3658165|NCT02407704|3504109|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3658166|NCT02407704|3504110|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3658167|NCT02407704|3504111|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3658168|NCT02407704|3504112|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3658169|NCT02407704|3504113|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3658170|NCT02407704|3504109|B5||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3658171|NCT02407704|3504110|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3658172|NCT02407704|3504111|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3658173|NCT02407704|3504112|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3658174|NCT02407704|3504113|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3658175|NCT02407704|3504109|B5||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3658176|NCT02407704|3504110|B4||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3658177|NCT02407704|3504111|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3658178|NCT02407704|3504112|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3658179|NCT02407704|3504113|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3658180|NCT02407704|3504109|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3658181|NCT02407704|3504110|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3658182|NCT02407704|3504111|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3658183|NCT02407704|3504112|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3658184|NCT02407704|3504113|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3658185|NCT02406937|3504150|B4|China||Region of Enrollment||participants|Number|176|176.0||||||
3658186|NCT02406937|3504151|B3|China||Region of Enrollment||participants|Number|58|58.0||||||
3658187|NCT02406937|3504152|B2|China||Region of Enrollment||participants|Number|59|59.0||||||
3658188|NCT02406937|3504153|B1|China||Region of Enrollment||participants|Number|59|59.0||||||
3658189|NCT02406937|3504150|B4||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3658190|NCT02406937|3504151|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3658191|NCT02406937|3504152|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3658192|NCT02406937|3504153|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3658193|NCT02406937|3504150|B4||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3658194|NCT02406937|3504151|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3658195|NCT02406937|3504152|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3658196|NCT02406937|3504153|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3658197|NCT02406937|3504150|B4|||Age||Days|Mean|57.9|57.9|Standard Deviation|18.6|18.6|||
3658198|NCT02406937|3504151|B3|||Age||Days|Mean|59.8|59.8|Standard Deviation|20.5|20.5|||
3658199|NCT02406937|3504152|B2|||Age||Days|Mean|58.4|58.4|Standard Deviation|17.0|17.0|||
3658200|NCT02406937|3504153|B1|||Age||Days|Mean|55.5|55.5|Standard Deviation|18.3|18.3|||
3658201|NCT02406612|3504211|B3|||Ankle-Brachial Index (ABI)||Ratio|Mean|1.0|1.0|Standard Deviation|0.1|0.1|||
3658202|NCT02406612|3504212|B2|||Ankle-Brachial Index (ABI)||Ratio|Mean|1.0|1.0|Standard Deviation|0.2|0.2|||
3658203|NCT02406612|3504213|B1|||Ankle-Brachial Index (ABI)||Ratio|Mean|1.1|1.1|Standard Deviation|0.1|0.1|||
3658204|NCT02406612|3504211|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3658205|NCT02406612|3504212|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3658206|NCT02406612|3504213|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3658207|NCT02406612|3504211|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658208|NCT02406612|3504212|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658209|NCT02406612|3504213|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658210|NCT02406612|3504211|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658211|NCT02406612|3504212|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658212|NCT02406612|3504213|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658213|NCT02406612|3504211|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658214|NCT02406612|3504212|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658215|NCT02406612|3504213|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658216|NCT02406612|3504211|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658217|NCT02406612|3504212|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658218|NCT02406612|3504213|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658219|NCT02406612|3504211|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658220|NCT02406612|3504212|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658221|NCT02406612|3504213|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658222|NCT02406612|3504211|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658223|NCT02406612|3504212|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658224|NCT02406612|3504213|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658225|NCT02406612|3504211|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3658226|NCT02406612|3504212|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3658227|NCT02406612|3504213|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3658228|NCT02406612|3504211|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3658229|NCT02406612|3504212|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3658230|NCT02406612|3504213|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3658231|NCT02406612|3504211|B3|||Age||years|Mean|65.1|65.1|Standard Deviation|12.4|12.4|||
3658232|NCT02406612|3504212|B2|||Age||years|Mean|66.3|66.3|Standard Deviation|11.8|11.8|||
3658233|NCT02406612|3504213|B1|||Age||years|Mean|64.1|64.1|Standard Deviation|13|13.0|||
3658234|NCT02406586|3504226|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3658235|NCT02406586|3504227|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3658236|NCT02406586|3504228|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3658237|NCT02406586|3504229|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3658238|NCT02406586|3504226|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3658239|NCT02406586|3504227|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3658240|NCT02406586|3504228|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3658241|NCT02406586|3504229|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3658242|NCT02406586|3504226|B4|||Age||years|Mean|37.5|37.5|Standard Deviation|10|10.0|||
3658243|NCT02406586|3504227|B3|||Age||years|Mean|37.5|37.5|Standard Deviation|8|8.0|||
3658244|NCT02406586|3504228|B2|||Age||years|Mean|41|41.0|Standard Deviation|11|11.0|||
3658245|NCT02406586|3504229|B1|||Age||years|Mean|34|34.0|Standard Deviation|11|11.0|||
3658246|NCT02406495|3504284|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3658247|NCT02406495|3504284|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3658248|NCT02406495|3504284|B1|||Age||years|Mean|23.92|23.92|Standard Deviation|5.43|5.43|||
3658249|NCT02406443|3504323|B3|||HbA1c (%)||Percentage|Mean|7.2|7.2|Standard Deviation|0.8|0.8|||
3658250|NCT02406443|3504324|B2|||HbA1c (%)||Percentage|Mean|7.31|7.31|Standard Deviation|0.84|0.84|||
3658251|NCT02406443|3504325|B1|||HbA1c (%)||Percentage|Mean|7.18|7.18|Standard Deviation|0.97|0.97|||
3658252|NCT02406443|3504323|B3|||Diabetes Duration||years|Median|8.0|8.0|Inter-Quartile Range|||4.0|10.0|
3658253|NCT02406443|3504324|B2|||Diabetes Duration||years|Median|8.5|8.5|Inter-Quartile Range|||5.5|14.0|
3658254|NCT02406443|3504325|B1|||Diabetes Duration||years|Median|6.0|6.0|Inter-Quartile Range|||3.0|10.0|
3658255|NCT02406443|3504323|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3658256|NCT02406443|3504324|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3658257|NCT02406443|3504325|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3658258|NCT02406443|3504323|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3658259|NCT02406443|3504324|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3658260|NCT02406443|3504325|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3658261|NCT02406443|3504323|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|8.1|8.1|||
3658262|NCT02406443|3504324|B2|||Age||years|Mean|59.3|59.3|Standard Deviation|8.8|8.8|||
3658263|NCT02406443|3504325|B1|||Age||years|Mean|60.4|60.4|Standard Deviation|7.6|7.6|||
3658264|NCT02406248|3504344|B1||Not hispanic or latino|Race/Ethnicity, Customized||Participants|Count of Participants|108|108.0||||||
3658265|NCT02406248|3504344|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|108|108.0||||||
3658266|NCT02406248|3504344|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3658267|NCT02406248|3504344|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3658268|NCT02406248|3504344|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|12.12|12.12|||
3658269|NCT02405429|3504352|B1|||Body Weight at Time of Study||grams|Median|2235|2235.0|Full Range|||1160.0|4205.0|
3658270|NCT02405429|3504352|B1|||Gestational Age||weeks|Median|34|34.0|Full Range|||25.0|40.0|
3658271|NCT02405429|3504352|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
3658272|NCT02405429|3504352|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3658273|NCT02405429|3504352|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3658274|NCT02405429|3504352|B1|||Age||days|Median|11|11.0|Full Range|||1.0|78.0|
3658275|NCT02405429|3504352|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3658276|NCT02405429|3504352|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3658277|NCT02405429|3504352|B1||<=18 years|Age||Participants|Count of Participants|49|49.0||||||
3658278|NCT02405390|3504360|B3|Rotation Left||Head Motion in degrees|The primary measure was the degree of head motion which were maximum angles achieved with extension, flexion and rotation|participants|Mean|6.40|6.4|Standard Deviation|5.76|5.76|||
3658279|NCT02405390|3504361|B2|Rotation Left||Head Motion in degrees|The primary measure was the degree of head motion which were maximum angles achieved with extension, flexion and rotation|participants|Mean|6.5|6.5|Standard Deviation|7.0|7.0|||
3658280|NCT02405390|3504362|B1|Rotation Left||Head Motion in degrees|The primary measure was the degree of head motion which were maximum angles achieved with extension, flexion and rotation|participants|Mean|6.2|6.2|Standard Deviation|4.4|4.4|||
3658281|NCT02405390|3504360|B3|Rotation Right||Head Motion in degrees|The primary measure was the degree of head motion which were maximum angles achieved with extension, flexion and rotation|participants|Mean|8.48|8.48|Standard Deviation|7.02|7.02|||
3658282|NCT02405390|3504361|B2|Rotation Right||Head Motion in degrees|The primary measure was the degree of head motion which were maximum angles achieved with extension, flexion and rotation|participants|Mean|7.9|7.9|Standard Deviation|6.6|6.6|||
3658283|NCT02405390|3504362|B1|Rotation Right||Head Motion in degrees|The primary measure was the degree of head motion which were maximum angles achieved with extension, flexion and rotation|participants|Mean|9.1|9.1|Standard Deviation|7.6|7.6|||
3658284|NCT02405390|3504360|B3|Flexion||Head Motion in degrees|The primary measure was the degree of head motion which were maximum angles achieved with extension, flexion and rotation|participants|Mean|8.95|8.95|Standard Deviation|6.9|6.9|||
3658285|NCT02405390|3504361|B2|Flexion||Head Motion in degrees|The primary measure was the degree of head motion which were maximum angles achieved with extension, flexion and rotation|participants|Mean|8.3|8.3|Standard Deviation|5.8|5.8|||
3658286|NCT02405390|3504362|B1|Flexion||Head Motion in degrees|The primary measure was the degree of head motion which were maximum angles achieved with extension, flexion and rotation|participants|Mean|9.6|9.6|Standard Deviation|8.0|8.0|||
3658287|NCT02405390|3504360|B3|Extension||Head Motion in degrees|The primary measure was the degree of head motion which were maximum angles achieved with extension, flexion and rotation|participants|Mean|17.05|17.05|Standard Deviation|10.18|10.18|||
3658288|NCT02405390|3504361|B2|Extension||Head Motion in degrees|The primary measure was the degree of head motion which were maximum angles achieved with extension, flexion and rotation|participants|Mean|16.5|16.5|Standard Deviation|9.5|9.5|||
3658289|NCT02405390|3504362|B1|Extension||Head Motion in degrees|The primary measure was the degree of head motion which were maximum angles achieved with extension, flexion and rotation|participants|Mean|17.7|17.7|Standard Deviation|11.1|11.1|||
3658290|NCT02405390|3504360|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3658291|NCT02405390|3504361|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3658292|NCT02405390|3504362|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3658293|NCT02405390|3504360|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3658294|NCT02405390|3504361|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3658295|NCT02405390|3504362|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3658296|NCT02405390|3504360|B3|||Age||years|Mean|4.04|4.04|Standard Deviation|1.8|1.8|||
3658297|NCT02405390|3504361|B2|||Age||years|Mean|4.07|4.07|Standard Deviation|1.9|1.9|||
3658298|NCT02405390|3504362|B1|||Age||years|Mean|4.0|4.0|Standard Deviation|1.8|1.8|||
3658299|NCT02405091|3504371|B4|||Baseline AIMS Dyskinesia Total Score|The AIMS Total Dyskinesia Score rates a total of 7 items, rating involuntary movement from 0 (no dyskinesia) to 4 (severe dyskinesia). Items 1 through 7 include facial and oral movements (Items 1-4), extremity movements (Items 5-6), and trunk movements (Item 7). The AIMS dyskinesia total score for Items 1-7 ranges from 0 to 28; a higher score reflects increased severity.|score on a scale|Mean|14.6|14.6|Standard Deviation|4.8|4.8|||
3658300|NCT02405091|3504372|B3|||Baseline AIMS Dyskinesia Total Score|The AIMS Total Dyskinesia Score rates a total of 7 items, rating involuntary movement from 0 (no dyskinesia) to 4 (severe dyskinesia). Items 1 through 7 include facial and oral movements (Items 1-4), extremity movements (Items 5-6), and trunk movements (Item 7). The AIMS dyskinesia total score for Items 1-7 ranges from 0 to 28; a higher score reflects increased severity.|score on a scale|Mean|12.8|12.8|Standard Deviation|4.6|4.6|||
3658301|NCT02405091|3504373|B2|||Baseline AIMS Dyskinesia Total Score|The AIMS Total Dyskinesia Score rates a total of 7 items, rating involuntary movement from 0 (no dyskinesia) to 4 (severe dyskinesia). Items 1 through 7 include facial and oral movements (Items 1-4), extremity movements (Items 5-6), and trunk movements (Item 7). The AIMS dyskinesia total score for Items 1-7 ranges from 0 to 28; a higher score reflects increased severity.|score on a scale|Mean|15.0|15.0|Standard Deviation|4.5|4.5|||
3658302|NCT02405091|3504374|B1|||Baseline AIMS Dyskinesia Total Score|The AIMS Total Dyskinesia Score rates a total of 7 items, rating involuntary movement from 0 (no dyskinesia) to 4 (severe dyskinesia). Items 1 through 7 include facial and oral movements (Items 1-4), extremity movements (Items 5-6), and trunk movements (Item 7). The AIMS dyskinesia total score for Items 1-7 ranges from 0 to 28; a higher score reflects increased severity.|score on a scale|Mean|14.2|14.2|Standard Deviation|5.5|5.5|||
3658344|NCT02405091|3504372|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3658345|NCT02405091|3504373|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|74|74.0||||||
3658303|NCT02405091|3504371|B4|||Screening BPRS Total Score|The Brief Psychiatric Rating Scale (BPRS) is a clinician-rated tool designed to assess the severity of psychopathology in participants with schizophrenia and other psychotic disorders (Overall and Gorham, 1962, 1988). The severity of each of the 18 items of the BPRS is rated on a scale of 1 (not present) to 7 (extremely severe) (total score range: 18 to 126). Higher scores represent greater symptom severity.|score on a scale|Mean|27.9|27.9|Full Range|||18.0|47.0|
3658304|NCT02405091|3504372|B3|||Screening BPRS Total Score|The Brief Psychiatric Rating Scale (BPRS) is a clinician-rated tool designed to assess the severity of psychopathology in participants with schizophrenia and other psychotic disorders (Overall and Gorham, 1962, 1988). The severity of each of the 18 items of the BPRS is rated on a scale of 1 (not present) to 7 (extremely severe) (total score range: 18 to 126). Higher scores represent greater symptom severity.|score on a scale|Mean|28.4|28.4|Full Range|||19.0|45.0|
3658305|NCT02405091|3504373|B2|||Screening BPRS Total Score|The Brief Psychiatric Rating Scale (BPRS) is a clinician-rated tool designed to assess the severity of psychopathology in participants with schizophrenia and other psychotic disorders (Overall and Gorham, 1962, 1988). The severity of each of the 18 items of the BPRS is rated on a scale of 1 (not present) to 7 (extremely severe) (total score range: 18 to 126). Higher scores represent greater symptom severity.|score on a scale|Mean|27.3|27.3|Full Range|||18.0|45.0|
3658306|NCT02405091|3504374|B1|||Screening BPRS Total Score|The Brief Psychiatric Rating Scale (BPRS) is a clinician-rated tool designed to assess the severity of psychopathology in participants with schizophrenia and other psychotic disorders (Overall and Gorham, 1962, 1988). The severity of each of the 18 items of the BPRS is rated on a scale of 1 (not present) to 7 (extremely severe) (total score range: 18 to 126). Higher scores represent greater symptom severity.|score on a scale|Mean|29.2|29.2|Full Range|||19.0|47.0|
3658307|NCT02405091|3504371|B4|||Age at Tardive Dyskinesia Diagnosis||years|Mean|48.4|48.4|Full Range|||16.0|73.0|
3658308|NCT02405091|3504372|B3|||Age at Tardive Dyskinesia Diagnosis||years|Mean|44.3|44.3|Full Range|||20.0|66.0|
3658309|NCT02405091|3504373|B2|||Age at Tardive Dyskinesia Diagnosis||years|Mean|49.2|49.2|Full Range|||16.0|69.0|
3658310|NCT02405091|3504374|B1|||Age at Tardive Dyskinesia Diagnosis||years|Mean|47.8|47.8|Full Range|||24.0|73.0|
3658311|NCT02405091|3504371|B4|Age at Mood Disorder Diagnosis||Age at Diagnosis||years|Mean|36.8|36.8|Full Range|||11.0|62.0|
3658312|NCT02405091|3504372|B3|Age at Mood Disorder Diagnosis||Age at Diagnosis||years|Mean|28.3|28.3|Full Range|||11.0|62.0|
3658313|NCT02405091|3504373|B2|Age at Mood Disorder Diagnosis||Age at Diagnosis||years|Mean|36.9|36.9|Full Range|||14.0|55.0|
3658314|NCT02405091|3504374|B1|Age at Mood Disorder Diagnosis||Age at Diagnosis||years|Mean|40.6|40.6|Full Range|||32.0|50.0|
3658315|NCT02405091|3504371|B4|Age at Schizophrenia/Schizoaffective Diagnosis||Age at Diagnosis||years|Mean|28.8|28.8|Full Range|||9.0|63.0|
3658316|NCT02405091|3504372|B3|Age at Schizophrenia/Schizoaffective Diagnosis||Age at Diagnosis||years|Mean|26.2|26.2|Full Range|||17.0|45.0|
3658317|NCT02405091|3504373|B2|Age at Schizophrenia/Schizoaffective Diagnosis||Age at Diagnosis||years|Mean|28.0|28.0|Full Range|||9.0|63.0|
3658318|NCT02405091|3504374|B1|Age at Schizophrenia/Schizoaffective Diagnosis||Age at Diagnosis||years|Mean|30.9|30.9|Full Range|||14.0|59.0|
3658319|NCT02405091|3504371|B4||Mood disorder|Primary Psychiatric Diagnosis||Participants|Count of Participants|44|44.0||||||
3658320|NCT02405091|3504372|B3||Mood disorder|Primary Psychiatric Diagnosis||Participants|Count of Participants|5|5.0||||||
3658321|NCT02405091|3504373|B2||Mood disorder|Primary Psychiatric Diagnosis||Participants|Count of Participants|31|31.0||||||
3658322|NCT02405091|3504374|B1||Mood disorder|Primary Psychiatric Diagnosis||Participants|Count of Participants|8|8.0||||||
3658323|NCT02405091|3504371|B4||Schizophrenia/schizoaffective|Primary Psychiatric Diagnosis||Participants|Count of Participants|119|119.0||||||
3658324|NCT02405091|3504372|B3||Schizophrenia/schizoaffective|Primary Psychiatric Diagnosis||Participants|Count of Participants|6|6.0||||||
3658325|NCT02405091|3504373|B2||Schizophrenia/schizoaffective|Primary Psychiatric Diagnosis||Participants|Count of Participants|76|76.0||||||
3658326|NCT02405091|3504374|B1||Schizophrenia/schizoaffective|Primary Psychiatric Diagnosis||Participants|Count of Participants|37|37.0||||||
3658327|NCT02405091|3504371|B4|||BMI at Screening||kg/m^2|Mean|28.53|28.53|Full Range|||18.0|41.7|
3658328|NCT02405091|3504372|B3|||BMI at Screening||kg/m^2|Mean|27.45|27.45|Full Range|||22.2|33.3|
3658329|NCT02405091|3504373|B2|||BMI at Screening||kg/m^2|Mean|28.95|28.95|Full Range|||18.6|41.7|
3658330|NCT02405091|3504374|B1|||BMI at Screening||kg/m^2|Mean|27.80|27.8|Full Range|||18.0|40.8|
3658331|NCT02405091|3504371|B4|Other: Mulatto||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3658332|NCT02405091|3504372|B3|Other: Mulatto||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3658333|NCT02405091|3504373|B2|Other: Mulatto||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3658334|NCT02405091|3504374|B1|Other: Mulatto||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3658335|NCT02405091|3504371|B4|Other: Latina||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3658336|NCT02405091|3504372|B3|Other: Latina||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3658337|NCT02405091|3504373|B2|Other: Latina||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3658338|NCT02405091|3504374|B1|Other: Latina||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3658339|NCT02405091|3504371|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3658340|NCT02405091|3504372|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3658341|NCT02405091|3504373|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3658342|NCT02405091|3504374|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3658343|NCT02405091|3504371|B4|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|110|110.0||||||
3658346|NCT02405091|3504374|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3658347|NCT02405091|3504371|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
3658348|NCT02405091|3504372|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3658349|NCT02405091|3504373|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3658350|NCT02405091|3504374|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3658351|NCT02405091|3504371|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3658352|NCT02405091|3504372|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3658353|NCT02405091|3504373|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3658354|NCT02405091|3504374|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3658355|NCT02405091|3504371|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658356|NCT02405091|3504372|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658357|NCT02405091|3504373|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658358|NCT02405091|3504374|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658359|NCT02405091|3504371|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
3658360|NCT02405091|3504372|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3658361|NCT02405091|3504373|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3658362|NCT02405091|3504374|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3658363|NCT02405091|3504371|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3658364|NCT02405091|3504372|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3658365|NCT02405091|3504373|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3658366|NCT02405091|3504374|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3658367|NCT02405091|3504371|B4||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3658368|NCT02405091|3504372|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3658369|NCT02405091|3504373|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3658370|NCT02405091|3504374|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3658371|NCT02405091|3504371|B4||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3658372|NCT02405091|3504372|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3658373|NCT02405091|3504373|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3658374|NCT02405091|3504374|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3658375|NCT02405091|3504371|B4|||Age||years|Mean|57.4|57.4|Full Range|||30.0|82.0|
3658376|NCT02405091|3504372|B3|||Age||years|Mean|56.3|56.3|Full Range|||42.0|69.0|
3658377|NCT02405091|3504373|B2|||Age||years|Mean|57.8|57.8|Full Range|||32.0|82.0|
3658378|NCT02405091|3504374|B1|||Age||years|Mean|56.8|56.8|Full Range|||30.0|80.0|
3658379|NCT02404649|3504397|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3658380|NCT02404649|3504398|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3658381|NCT02404649|3504399|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3658382|NCT02404649|3504397|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3658383|NCT02404649|3504398|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3658384|NCT02404649|3504399|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3658385|NCT02404649|3504397|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3658386|NCT02404649|3504398|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3658387|NCT02404649|3504399|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3658388|NCT02404649|3504397|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3658389|NCT02404649|3504398|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3658390|NCT02404649|3504399|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3658391|NCT02404649|3504397|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3658392|NCT02404649|3504398|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3658393|NCT02404649|3504399|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3658394|NCT02404649|3504397|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3658395|NCT02404649|3504398|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3658396|NCT02404649|3504399|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3658397|NCT02404545|3504406|B3|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3658398|NCT02404545|3504407|B2|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3658399|NCT02404545|3504408|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3658400|NCT02404545|3504406|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658401|NCT02404545|3504407|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658402|NCT02404545|3504408|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658403|NCT02404545|3504406|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3658404|NCT02404545|3504407|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3658405|NCT02404545|3504408|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658406|NCT02404545|3504406|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3658407|NCT02404545|3504407|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3658408|NCT02404545|3504408|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3658409|NCT02404545|3504406|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3658410|NCT02404545|3504407|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3658411|NCT02404545|3504408|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3658412|NCT02404545|3504406|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658413|NCT02404545|3504407|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658414|NCT02404545|3504408|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658415|NCT02404545|3504406|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658416|NCT02404545|3504407|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658417|NCT02404545|3504408|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658418|NCT02404545|3504406|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658419|NCT02404545|3504407|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658420|NCT02404545|3504408|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658421|NCT02404545|3504406|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658422|NCT02404545|3504407|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658423|NCT02404545|3504408|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658424|NCT02404545|3504406|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3658425|NCT02404545|3504407|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3658426|NCT02404545|3504408|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3658427|NCT02404545|3504406|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3658428|NCT02404545|3504407|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3658429|NCT02404545|3504408|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3658430|NCT02404545|3504406|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3658431|NCT02404545|3504407|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3658432|NCT02404545|3504408|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3658433|NCT02404545|3504406|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3658434|NCT02404545|3504407|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3658435|NCT02404545|3504408|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3658436|NCT02404545|3504406|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3658437|NCT02404545|3504407|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3658438|NCT02404545|3504408|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3658439|NCT02404545|3504406|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3658440|NCT02404545|3504407|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3658441|NCT02404545|3504408|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3658442|NCT02404545|3504406|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3658443|NCT02404545|3504407|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3658444|NCT02404545|3504408|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3658445|NCT02404532|3504416|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3658446|NCT02404532|3504416|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3658447|NCT02404532|3504416|B1|||Age||years|Mean|43.0|43.0|Standard Deviation|15.2|15.2|||
3658448|NCT02404532|3504416|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3658449|NCT02404532|3504416|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3658450|NCT02404532|3504416|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3658451|NCT02404493|3504426|B3|USA||Region of Enrollment||participants|Number|23|23.0||||||
3658452|NCT02404493|3504427|B2|USA||Region of Enrollment||participants|Number|6|6.0||||||
3658453|NCT02404493|3504428|B1|USA||Region of Enrollment||participants|Number|17|17.0||||||
3658454|NCT02404493|3504426|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3658455|NCT02404493|3504427|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3658456|NCT02404493|3504428|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3658457|NCT02404493|3504426|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3658458|NCT02404493|3504427|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3658459|NCT02404493|3504428|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3658460|NCT02404493|3504426|B3|||Age||months|Mean|22.0|22.0|Standard Deviation|9.72|9.72|||
3658461|NCT02404493|3504427|B2|||Age||months|Mean|22.5|22.5|Standard Deviation|10.78|10.78|||
3658462|NCT02404493|3504428|B1|||Age||months|Mean|21.8|21.8|Standard Deviation|9.66|9.66|||
3658463|NCT02404389|3504669|B6||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3658464|NCT02404389|3504670|B5||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3658465|NCT02404389|3504671|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3658466|NCT02404389|3504672|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3658467|NCT02404389|3504673|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3658468|NCT02404389|3504674|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3658469|NCT02404389|3504669|B6||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3658470|NCT02404389|3504670|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3658471|NCT02404389|3504671|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3658472|NCT02404389|3504672|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3658473|NCT02404389|3504673|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3658474|NCT02404389|3504674|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3658475|NCT02404389|3504669|B6|||Age||years|Mean|68.5|68.5|Standard Deviation|5.61|5.61|||
3658476|NCT02404389|3504670|B5|||Age||years|Mean|68.6|68.6|Standard Deviation|5.61|5.61|||
3658477|NCT02404389|3504671|B4|||Age||years|Mean|70.2|70.2|Standard Deviation|4.32|4.32|||
3658478|NCT02404389|3504672|B3|||Age||years|Mean|68.3|68.3|Standard Deviation|6.66|6.66|||
3658479|NCT02404389|3504673|B2|||Age||years|Mean|68.6|68.6|Standard Deviation|6.25|6.25|||
3658480|NCT02404389|3504674|B1|||Age||years|Mean|67.7|67.7|Standard Deviation|5.23|5.23|||
3658481|NCT02404103|3504714|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
3658482|NCT02404103|3504715|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3658483|NCT02404103|3504716|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3658484|NCT02404103|3504714|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658485|NCT02404103|3504715|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658486|NCT02404103|3504716|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658487|NCT02404103|3504714|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658488|NCT02404103|3504715|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658489|NCT02404103|3504716|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658490|NCT02404103|3504714|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3658491|NCT02404103|3504715|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3658492|NCT02404103|3504716|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3658493|NCT02404103|3504714|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3658494|NCT02404103|3504715|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3658495|NCT02404103|3504716|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3658496|NCT02404103|3504714|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658497|NCT02404103|3504715|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658498|NCT02404103|3504716|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658499|NCT02404103|3504714|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658500|NCT02404103|3504715|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658501|NCT02404103|3504716|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658502|NCT02404103|3504714|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658503|NCT02404103|3504715|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658504|NCT02404103|3504716|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658505|NCT02404103|3504714|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3658506|NCT02404103|3504715|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3658507|NCT02404103|3504716|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3658508|NCT02404103|3504714|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3658509|NCT02404103|3504715|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3658510|NCT02404103|3504716|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3658511|NCT02404103|3504714|B3|||Age||years|Mean|10.5|10.5|Standard Deviation|3.2|3.2|||
3658512|NCT02404103|3504715|B2|||Age||years|Mean|11.1|11.1|Standard Deviation|2.9|2.9|||
3658513|NCT02404103|3504716|B1|||Age||years|Mean|10.1|10.1|Standard Deviation|3.8|3.8|||
3658514|NCT02403999|3504737|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658515|NCT02403999|3504738|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658516|NCT02403999|3504739|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658517|NCT02403999|3504740|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658518|NCT02403999|3504737|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658519|NCT02403999|3504738|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658520|NCT02403999|3504739|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658521|NCT02403999|3504740|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658522|NCT02403999|3504737|B4||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3658523|NCT02403999|3504738|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3658524|NCT02403999|3504739|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3658525|NCT02403999|3504740|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3658526|NCT02403999|3504737|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658527|NCT02403999|3504738|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658528|NCT02403999|3504739|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658529|NCT02403999|3504740|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658530|NCT02403999|3504737|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658531|NCT02403999|3504738|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658532|NCT02403999|3504739|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658533|NCT02403999|3504740|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658534|NCT02403999|3504737|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3658535|NCT02403999|3504738|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658536|NCT02403999|3504739|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658537|NCT02403999|3504740|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3658538|NCT02403999|3504737|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658539|NCT02403999|3504738|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658540|NCT02403999|3504739|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658541|NCT02403999|3504740|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658542|NCT02403999|3504737|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3658543|NCT02403999|3504738|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3658544|NCT02403999|3504739|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3658545|NCT02403999|3504740|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3658546|NCT02403999|3504737|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3658547|NCT02403999|3504738|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3658548|NCT02403999|3504739|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3658549|NCT02403999|3504740|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3658550|NCT02403999|3504737|B4|||Age||Months|Mean|10.0|10.0|Standard Deviation|4.51|4.51|||
3658551|NCT02403999|3504738|B3|||Age||Months|Mean|10.1|10.1|Standard Deviation|3.86|3.86|||
3658552|NCT02403999|3504739|B2|||Age||Months|Mean|10.9|10.9|Standard Deviation|4.20|4.2|||
3658553|NCT02403999|3504740|B1|||Age||Months|Mean|9.0|9.0|Standard Deviation|5.62|5.62|||
3658554|NCT02403895|3504753|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3658555|NCT02403895|3504753|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3658556|NCT02403895|3504753|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3658557|NCT02403895|3504753|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3658558|NCT02403895|3504753|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3658559|NCT02403830|3504766|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658560|NCT02403830|3504766|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658561|NCT02403830|3504766|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3658562|NCT02403830|3504766|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3658563|NCT02403830|3504766|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658564|NCT02403830|3504766|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3658565|NCT02403830|3504766|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658566|NCT02403830|3504766|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3658567|NCT02403830|3504766|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3658568|NCT02403830|3504766|B1|||Age||years|Mean|62|62.0|Standard Deviation|9|9.0|||
3658569|NCT02403674|3504777|B3|||Baseline fasting high-density lipoprotein cholesterol (HDL-C)|Participants fasted for ≥8 hours prior to HDL-C measurement on Day 1.|mg/dL|Mean|41.67|41.67|Standard Deviation|12.38|12.38|||
3658570|NCT02403674|3504778|B2|||Baseline fasting high-density lipoprotein cholesterol (HDL-C)|Participants fasted for ≥8 hours prior to HDL-C measurement on Day 1.|mg/dL|Mean|41.44|41.44|Standard Deviation|13.08|13.08|||
3658571|NCT02403674|3504779|B1|||Baseline fasting high-density lipoprotein cholesterol (HDL-C)|Participants fasted for ≥8 hours prior to HDL-C measurement on Day 1.|mg/dL|Mean|41.90|41.9|Standard Deviation|11.67|11.67|||
3658572|NCT02403674|3504777|B3|||Baseline fasting triglycerides|Participants fasted for ≥8 hour prior to triglycerides measurement on Day 1.|mg/dL|Mean|122.04|122.04|Standard Deviation|82.84|82.84|||
3658573|NCT02403674|3504778|B2|||Baseline fasting triglycerides|Participants fasted for ≥8 hour prior to triglycerides measurement on Day 1.|mg/dL|Mean|123.23|123.23|Standard Deviation|82.73|82.73|||
3658574|NCT02403674|3504779|B1|||Baseline fasting triglycerides|Participants fasted for ≥8 hour prior to triglycerides measurement on Day 1.|mg/dL|Mean|120.85|120.85|Standard Deviation|83.06|83.06|||
3658575|NCT02403674|3504777|B3|||Baseline fasting cholesterol|Participants fasted for ≥8 hours prior to cholesterol measurement on Day 1.|mg/dL|Mean|156.68|156.68|Standard Deviation|36.45|36.45|||
3658576|NCT02403674|3504778|B2|||Baseline fasting cholesterol|Participants fasted for ≥8 hours prior to cholesterol measurement on Day 1.|mg/dL|Mean|156.07|156.07|Standard Deviation|36.51|36.51|||
3658577|NCT02403674|3504779|B1|||Baseline fasting cholesterol|Participants fasted for ≥8 hours prior to cholesterol measurement on Day 1.|mg/dL|Mean|157.29|157.29|Standard Deviation|36.43|36.43|||
3658578|NCT02403674|3504777|B3|||Baseline fasting non-high-density lipoprotein cholesterol (non-HDL-C)|Participants fasted for ≥8 hours prior to non-HDL-C measurement on Day 1.|mg/dL|Mean|115.01|115.01|Standard Deviation|34.09|34.09|||
3658579|NCT02403674|3504778|B2|||Baseline fasting non-high-density lipoprotein cholesterol (non-HDL-C)|Participants fasted for ≥8 hours prior to non-HDL-C measurement on Day 1.|mg/dL|Mean|114.63|114.63|Standard Deviation|33.55|33.55|||
3658580|NCT02403674|3504779|B1|||Baseline fasting non-high-density lipoprotein cholesterol (non-HDL-C)|Participants fasted for ≥8 hours prior to non-HDL-C measurement on Day 1.|mg/dL|Mean|115.39|115.39|Standard Deviation|34.67|34.67|||
3658581|NCT02403674|3504777|B3|||Baseline fasting low-density lipoprotein cholesterol (LDL-C)|Participants fasted for ≥8 hours prior to LDL-C measurement on Day 1.|mg/dL|Mean|91.27|91.27|Standard Deviation|31.48|31.48|||
3658582|NCT02403674|3504778|B2|||Baseline fasting low-density lipoprotein cholesterol (LDL-C)|Participants fasted for ≥8 hours prior to LDL-C measurement on Day 1.|mg/dL|Mean|90.47|90.47|Standard Deviation|30.64|30.64|||
3658583|NCT02403674|3504779|B1|||Baseline fasting low-density lipoprotein cholesterol (LDL-C)|Participants fasted for ≥8 hours prior to LDL-C measurement on Day 1.|mg/dL|Mean|92.08|92.08|Standard Deviation|32.32|32.32|||
3658584|NCT02403674|3504777|B3|||Baseline cluster of differentiation 4 (CD4) cell counts||cells/mm^3|Mean|425.2|425.2|Standard Deviation|214.3|214.3|||
3658585|NCT02403674|3504778|B2|||Baseline cluster of differentiation 4 (CD4) cell counts||cells/mm^3|Mean|415.5|415.5|Standard Deviation|210.6|210.6|||
3658586|NCT02403674|3504779|B1|||Baseline cluster of differentiation 4 (CD4) cell counts||cells/mm^3|Mean|434.9|434.9|Standard Deviation|217.9|217.9|||
3658587|NCT02403674|3504777|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658588|NCT02403674|3504778|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658589|NCT02403674|3504779|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658590|NCT02403674|3504777|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
3658591|NCT02403674|3504778|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3658592|NCT02403674|3504779|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3658593|NCT02403674|3504777|B3||White|Race (NIH/OMB)||Participants|Count of Participants|347|347.0||||||
3658594|NCT02403674|3504778|B2||White|Race (NIH/OMB)||Participants|Count of Participants|170|170.0||||||
3658595|NCT02403674|3504779|B1||White|Race (NIH/OMB)||Participants|Count of Participants|177|177.0||||||
3658596|NCT02403674|3504777|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|135|135.0||||||
3658597|NCT02403674|3504778|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3658598|NCT02403674|3504779|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3658599|NCT02403674|3504777|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658600|NCT02403674|3504778|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658601|NCT02403674|3504779|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658602|NCT02403674|3504777|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
3658603|NCT02403674|3504778|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3658604|NCT02403674|3504779|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3658605|NCT02403674|3504777|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3658606|NCT02403674|3504778|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3658607|NCT02403674|3504779|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3658608|NCT02403674|3504777|B3||Male|Sex: Female, Male||Participants|Count of Participants|616|616.0||||||
3658609|NCT02403674|3504778|B2||Male|Sex: Female, Male||Participants|Count of Participants|311|311.0||||||
3658610|NCT02403674|3504779|B1||Male|Sex: Female, Male||Participants|Count of Participants|305|305.0||||||
3658611|NCT02403674|3504777|B3||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3658612|NCT02403674|3504778|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3658613|NCT02403674|3504779|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3658614|NCT02403674|3504777|B3|||Age||Years|Mean|33.1|33.1|Standard Deviation|10.2|10.2|||
3658615|NCT02403674|3504778|B2|||Age||Years|Mean|32.7|32.7|Standard Deviation|9.9|9.9|||
3658616|NCT02403674|3504779|B1|||Age||Years|Mean|33.6|33.6|Standard Deviation|10.5|10.5|||
3658617|NCT02403206|3504819|B3||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3658618|NCT02403206|3504820|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3658619|NCT02403206|3504821|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3658620|NCT02403206|3504819|B3||Female|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
3658621|NCT02403206|3504820|B2||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3658622|NCT02403206|3504821|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3658623|NCT02403206|3504819|B3|||Age||years|Mean|65.6|65.6|Standard Deviation|12.8|12.8|||
3658624|NCT02403206|3504820|B2|||Age||years|Mean|66.4|66.4|Standard Deviation|11.9|11.9|||
3658625|NCT02403206|3504821|B1|||Age||years|Mean|64.9|64.9|Standard Deviation|13.6|13.6|||
3658626|NCT02403180|3504831|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3658627|NCT02403180|3504832|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3658628|NCT02403180|3504833|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3658629|NCT02403180|3504831|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3658630|NCT02403180|3504832|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3658631|NCT02403180|3504833|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3658632|NCT02403180|3504831|B3|61-65 years||Age, Customized||participants|Number|2|2.0||||||
3658633|NCT02403180|3504832|B2|61-65 years||Age, Customized||participants|Number|1|1.0||||||
3658634|NCT02403180|3504833|B1|61-65 years||Age, Customized||participants|Number|1|1.0||||||
3658635|NCT02403180|3504831|B3|51-60 years||Age, Customized||participants|Number|33|33.0||||||
3658636|NCT02403180|3504832|B2|51-60 years||Age, Customized||participants|Number|13|13.0||||||
3658637|NCT02403180|3504833|B1|51-60 years||Age, Customized||participants|Number|20|20.0||||||
3658638|NCT02403180|3504831|B3|41-50 years||Age, Customized||participants|Number|35|35.0||||||
3658639|NCT02403180|3504832|B2|41-50 years||Age, Customized||participants|Number|20|20.0||||||
3658640|NCT02403180|3504833|B1|41-50 years||Age, Customized||participants|Number|15|15.0||||||
3658641|NCT02403180|3504831|B3|||Age||years|Mean|51.1|51.1|Standard Deviation|4.32|4.32|||
3658642|NCT02403180|3504832|B2|||Age||years|Mean|50.4|50.4|Standard Deviation|3.88|3.88|||
3658643|NCT02403180|3504833|B1|||Age||years|Mean|51.7|51.7|Standard Deviation|4.67|4.67|||
3658644|NCT02403154|3504842|B5|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3658645|NCT02403154|3504842|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3658646|NCT02403154|3504843|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3658647|NCT02403154|3504844|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3658648|NCT02403154|3504845|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3658649|NCT02403154|3504846|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3658650|NCT02403154|3504842|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3658651|NCT02403154|3504843|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3658652|NCT02403154|3504844|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3658653|NCT02403154|3504845|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3658654|NCT02403154|3504846|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3658655|NCT02403154|3504842|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3658656|NCT02403154|3504843|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3658657|NCT02403154|3504844|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3658658|NCT02403154|3504845|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3658659|NCT02403154|3504846|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3658660|NCT02403154|3504842|B5||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3658661|NCT02403154|3504843|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3658662|NCT02403154|3504844|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3658663|NCT02403154|3504845|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3658664|NCT02403154|3504846|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3658665|NCT02403154|3504842|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3658666|NCT02403154|3504843|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3658667|NCT02403154|3504844|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3658668|NCT02403154|3504845|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3658669|NCT02403154|3504846|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3658670|NCT02402933|3504863|B1|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3658671|NCT02402933|3504863|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658672|NCT02402933|3504863|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658673|NCT02402933|3504863|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3658674|NCT02402933|3504863|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3658675|NCT02402933|3504863|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658676|NCT02402933|3504863|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658677|NCT02402933|3504863|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658678|NCT02402933|3504863|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3658679|NCT02402933|3504863|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3658680|NCT02402933|3504863|B1|||Age||years|Mean|11.7|11.7|Standard Deviation|3.73|3.73|||
3658681|NCT02402764|3504870|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3658682|NCT02402764|3504870|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3658683|NCT02402764|3504870|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3658684|NCT02402764|3504870|B1|||Age||years|Median|60|60.0|Full Range|||44.0|71.0|
3658685|NCT02402764|3504870|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3658686|NCT02402764|3504870|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3658687|NCT02402764|3504870|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3658688|NCT02402322|3504878|B4|Spain||Region of Enrollment||participants|Number|77|77.0||||||
3658689|NCT02402322|3504879|B3|Spain||Region of Enrollment||participants|Number|25|25.0||||||
3658690|NCT02402322|3504880|B2|Spain||Region of Enrollment||participants|Number|25|25.0||||||
3658691|NCT02402322|3504881|B1|Spain||Region of Enrollment||participants|Number|27|27.0||||||
3658692|NCT02402322|3504878|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3658693|NCT02402322|3504879|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3658694|NCT02402322|3504880|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3658695|NCT02402322|3504881|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3658696|NCT02402322|3504878|B4||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3658697|NCT02402322|3504879|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3658698|NCT02402322|3504880|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3658699|NCT02402322|3504881|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3658700|NCT02402322|3504878|B4|||Age||years|Mean|40.7|40.7|Standard Deviation|9.3|9.3|||
3658701|NCT02402322|3504879|B3|||Age||years|Mean|44.6|44.6|Standard Deviation|10.3|10.3|||
3658702|NCT02402322|3504880|B2|||Age||years|Mean|38.2|38.2|Standard Deviation|7.8|7.8|||
3658703|NCT02402322|3504881|B1|||Age||years|Mean|39.4|39.4|Standard Deviation|8.5|8.5|||
3658704|NCT02402296|3504915|B3|Egypt||Region of Enrollment||participants|Number|30|30.0||||||
3658705|NCT02402296|3504916|B2|Egypt||Region of Enrollment||participants|Number|15|15.0||||||
3658706|NCT02402296|3504917|B1|Egypt||Region of Enrollment||participants|Number|15|15.0||||||
3658707|NCT02402296|3504915|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3658708|NCT02402296|3504916|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3658709|NCT02402296|3504917|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3658710|NCT02402296|3504915|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3658711|NCT02402296|3504916|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3658712|NCT02402296|3504917|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3658713|NCT02402296|3504915|B3|||Age||years|Mean|24.7|24.7|Standard Deviation|2.11|2.11|||
3658714|NCT02402296|3504916|B2|||Age||years|Mean|25|25.0|Standard Deviation|1.94|1.94|||
3658715|NCT02402296|3504917|B1|||Age||years|Mean|24.4|24.4|Standard Deviation|2.37|2.37|||
3658716|NCT02402296|3504915|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3658717|NCT02402296|3504916|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3658718|NCT02402296|3504917|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3658719|NCT02402296|3504915|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3658720|NCT02402296|3504916|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3658721|NCT02402296|3504917|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3658722|NCT02402296|3504915|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3658723|NCT02402296|3504916|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3658724|NCT02402296|3504917|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3658725|NCT02402166|3504930|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3658726|NCT02402166|3504930|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3658727|NCT02402166|3504930|B1|||Age||years|Mean|4.7|4.7|Standard Deviation|0.48|0.48|||
3658728|NCT02402153|3504951|B1|||Blood pressure (diastolic)||mmHg|Mean|79|79.0|Full Range|||65.0|102.0|
3658729|NCT02402153|3504951|B1|||Blood pressure (systolic)||mmHg|Mean|123|123.0|Full Range|||105.0|168.0|
3658730|NCT02402153|3504951|B1|||Height||Centimeter|Mean|175.7|175.7|Full Range|||153.5|205.0|
3658731|NCT02402153|3504951|B1|||Weight||Kg|Mean|87|87.0|Full Range|||63.0|126.3|
3658732|NCT02402153|3504951|B1|Denmark||Region of Enrollment||participants|Number|18|18.0||||||
3658733|NCT02402153|3504951|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658734|NCT02402153|3504951|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658735|NCT02402153|3504951|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3658736|NCT02402153|3504951|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658737|NCT02402153|3504951|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658738|NCT02402153|3504951|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658739|NCT02402153|3504951|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658740|NCT02402153|3504951|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3658741|NCT02402153|3504951|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3658742|NCT02402153|3504951|B1|||Age||years|Mean|37|37.0|Full Range|||25.0|49.0|
3658743|NCT02402127|3504961|B7||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3658744|NCT02402127|3504962|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3658745|NCT02402127|3504963|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3658746|NCT02402127|3504964|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3658747|NCT02402127|3504965|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3658748|NCT02402127|3504966|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3658749|NCT02402127|3504967|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3658750|NCT02402127|3504961|B7||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3658751|NCT02402127|3504962|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3658752|NCT02402127|3504963|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3658753|NCT02402127|3504964|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3658754|NCT02402127|3504965|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3658755|NCT02402127|3504966|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3658756|NCT02402127|3504967|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3658757|NCT02402127|3504961|B7|≥65 years||Age, Customized||participants|Number|0|0.0||||||
3658758|NCT02402127|3504962|B6|≥65 years||Age, Customized||participants|Number|0|0.0||||||
3658759|NCT02402127|3504963|B5|≥65 years||Age, Customized||participants|Number|0|0.0||||||
3658760|NCT02402127|3504964|B4|≥65 years||Age, Customized||participants|Number|0|0.0||||||
3658761|NCT02402127|3504965|B3|≥65 years||Age, Customized||participants|Number|0|0.0||||||
3658762|NCT02402127|3504966|B2|≥65 years||Age, Customized||participants|Number|0|0.0||||||
3658763|NCT02402127|3504967|B1|≥65 years||Age, Customized||participants|Number|0|0.0||||||
3658764|NCT02402127|3504961|B7|18-64 years||Age, Customized||participants|Number|24|24.0||||||
3658765|NCT02402127|3504962|B6|18-64 years||Age, Customized||participants|Number|4|4.0||||||
3658766|NCT02402127|3504963|B5|18-64 years||Age, Customized||participants|Number|4|4.0||||||
3658767|NCT02402127|3504964|B4|18-64 years||Age, Customized||participants|Number|4|4.0||||||
3658768|NCT02402127|3504965|B3|18-64 years||Age, Customized||participants|Number|4|4.0||||||
3658769|NCT02402127|3504966|B2|18-64 years||Age, Customized||participants|Number|4|4.0||||||
3658770|NCT02402127|3504967|B1|18-64 years||Age, Customized||participants|Number|4|4.0||||||
3658771|NCT02402127|3504961|B7|||Age||years|Mean|30.0|30.0|Standard Deviation|6.9|6.9|||
3658772|NCT02402127|3504962|B6|||Age||years|Mean|24.3|24.3|Standard Deviation|2.4|2.4|||
3658773|NCT02402127|3504963|B5|||Age||years|Mean|26.3|26.3|Standard Deviation|6.2|6.2|||
3658774|NCT02402127|3504964|B4|||Age||years|Mean|35.3|35.3|Standard Deviation|4.6|4.6|||
3658775|NCT02402127|3504965|B3|||Age||years|Mean|33.0|33.0|Standard Deviation|7.3|7.3|||
3658776|NCT02402127|3504966|B2|||Age||years|Mean|27.5|27.5|Standard Deviation|4.0|4.0|||
3658777|NCT02402127|3504967|B1|||Age||years|Mean|34.0|34.0|Standard Deviation|9.6|9.6|||
3658778|NCT02401867|3504983|B1|Assay not collected||Self-Collected Vaginal HPV DNA (Current)||Participants|Count of Participants|3|3.0||||||
3658779|NCT02401867|3504983|B1|Negative||Self-Collected Vaginal HPV DNA (Current)||Participants|Count of Participants|126|126.0||||||
3658780|NCT02401867|3504983|B1|Positive||Self-Collected Vaginal HPV DNA (Current)||Participants|Count of Participants|21|21.0||||||
3658781|NCT02401867|3504983|B1|Assay not collected||Provider-Collected Cervical HPV DNA (Current)||Participants|Count of Participants|9|9.0||||||
3658782|NCT02401867|3504983|B1|Assay could not be tested||Provider-Collected Cervical HPV DNA (Current)||Participants|Count of Participants|9|9.0||||||
3658783|NCT02401867|3504983|B1|Negative||Provider-Collected Cervical HPV DNA (Current)||Participants|Count of Participants|111|111.0||||||
3658784|NCT02401867|3504983|B1|Positive||Provider-Collected Cervical HPV DNA (Current)||Participants|Count of Participants|21|21.0||||||
3658785|NCT02401867|3504983|B1|Assay not collected||Provider-Collected Cervical Cytology (Current)||Participants|Count of Participants|3|3.0||||||
3658786|NCT02401867|3504983|B1|Assay could not be tested||Provider-Collected Cervical Cytology (Current)||Participants|Count of Participants|27|27.0||||||
3658787|NCT02401867|3504983|B1|Normal||Provider-Collected Cervical Cytology (Current)||Participants|Count of Participants|111|111.0||||||
3658788|NCT02401867|3504983|B1|Abnormal||Provider-Collected Cervical Cytology (Current)||Participants|Count of Participants|9|9.0||||||
3658789|NCT02401867|3504983|B1|Prefer Not to Answer||HIV Status - Lifetime||Participants|Count of Participants|1|1.0||||||
3658790|NCT02401867|3504983|B1|Don't Know||HIV Status - Lifetime||Participants|Count of Participants|28|28.0||||||
3658791|NCT02401867|3504983|B1|Negative||HIV Status - Lifetime||Participants|Count of Participants|120|120.0||||||
3658792|NCT02401867|3504983|B1|Positive||HIV Status - Lifetime||Participants|Count of Participants|1|1.0||||||
3658793|NCT02401867|3504983|B1|Prefer Not to Answer||Diagnosed with HPV - Lifetime||Participants|Count of Participants|1|1.0||||||
3658794|NCT02401867|3504983|B1|Don't Know||Diagnosed with HPV - Lifetime||Participants|Count of Participants|3|3.0||||||
3658795|NCT02401867|3504983|B1|No||Diagnosed with HPV - Lifetime||Participants|Count of Participants|135|135.0||||||
3658796|NCT02401867|3504983|B1|Yes||Diagnosed with HPV - Lifetime||Participants|Count of Participants|11|11.0||||||
3658797|NCT02401867|3504983|B1|No||Diagnosed with Genital Warts - Lifetime||Participants|Count of Participants|146|146.0||||||
3658798|NCT02401867|3504983|B1|Yes||Diagnosed with Genital Warts - Lifetime||Participants|Count of Participants|4|4.0||||||
3658799|NCT02401867|3504983|B1|No||Diagnosed with Genital Herpes - Lifetime||Participants|Count of Participants|145|145.0||||||
3658800|NCT02401867|3504983|B1|Yes||Diagnosed with Genital Herpes - Lifetime||Participants|Count of Participants|5|5.0||||||
3658801|NCT02401867|3504983|B1|No||Diagnosed with Hepatitis C - Lifetime||Participants|Count of Participants|149|149.0||||||
3658802|NCT02401867|3504983|B1|Yes||Diagnosed with Hepatitis C - Lifetime||Participants|Count of Participants|1|1.0||||||
3658803|NCT02401867|3504983|B1|No||Diagnosed with Trichomoniasis - Lifetime||Participants|Count of Participants|144|144.0||||||
3658804|NCT02401867|3504983|B1|Yes||Diagnosed with Trichomoniasis - Lifetime||Participants|Count of Participants|6|6.0||||||
3658805|NCT02401867|3504983|B1|No||Diagnosed with Syphilis - Lifetime||Participants|Count of Participants|149|149.0||||||
3658806|NCT02401867|3504983|B1|Yes||Diagnosed with Syphilis - Lifetime||Participants|Count of Participants|1|1.0||||||
3658807|NCT02401867|3504983|B1|No||Diagnosed with Gonorrhea - Lifetime||Participants|Count of Participants|145|145.0||||||
3658808|NCT02401867|3504983|B1|Yes||Diagnosed with Gonorrhea - Lifetime||Participants|Count of Participants|5|5.0||||||
3658809|NCT02401867|3504983|B1|No||Diagnosed with Chlamydia - Lifetime||Participants|Count of Participants|142|142.0||||||
3658810|NCT02401867|3504983|B1|Yes||Diagnosed with Chlamydia - Lifetime||Participants|Count of Participants|8|8.0||||||
3658811|NCT02401867|3504983|B1|United States||Region of Enrollment||participants|Number|150|150.0||||||
3658812|NCT02401867|3504983|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3658813|NCT02401867|3504983|B1|Not Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|133|133.0||||||
3658814|NCT02401867|3504983|B1|Yes, Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3658815|NCT02401867|3504983|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3658816|NCT02401867|3504983|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3658817|NCT02401867|3504983|B1||White|Race (NIH/OMB)||Participants|Count of Participants|112|112.0||||||
3658818|NCT02401867|3504983|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3658819|NCT02401867|3504983|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3658820|NCT02401867|3504983|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3658821|NCT02401867|3504983|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658822|NCT02401867|3504983|B1|Trans Masculine/ Male to Female||Sex/Gender, Customized||Participants|Count of Participants|150|150.0||||||
3658823|NCT02401867|3504983|B1|||Age||years|Mean|27.49|27.49|Standard Deviation|5.74|5.74|||
3658824|NCT02401867|3504983|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3658825|NCT02401867|3504983|B1||Between 18 and 65 years|Age||Participants|Count of Participants|150|150.0||||||
3658826|NCT02401867|3504983|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3658827|NCT02401555|3504988|B4|United States||Region of Enrollment||participants|Number|419|419.0||||||
3658828|NCT02401555|3504989|B3|United States||Region of Enrollment||participants|Number|120|120.0||||||
3658829|NCT02401555|3504990|B2|United States||Region of Enrollment||participants|Number|212|212.0||||||
3658830|NCT02401555|3504991|B1|United States||Region of Enrollment||participants|Number|87|87.0||||||
3658831|NCT02401555|3504988|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3658832|NCT02401555|3504989|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658833|NCT02401555|3504990|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3658834|NCT02401555|3504991|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3658835|NCT02401555|3504988|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3658836|NCT02401555|3504989|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3658837|NCT02401555|3504990|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3658838|NCT02401555|3504991|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3658839|NCT02401555|3504988|B4||White|Race (NIH/OMB)||Participants|Count of Participants|220|220.0||||||
3658840|NCT02401555|3504989|B3||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3658841|NCT02401555|3504990|B2||White|Race (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
3658842|NCT02401555|3504991|B1||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3658843|NCT02401555|3504988|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
3658844|NCT02401555|3504989|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3658845|NCT02401555|3504990|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3658846|NCT02401555|3504991|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3658847|NCT02401555|3504988|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3658848|NCT02401555|3504989|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658849|NCT02401555|3504990|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3658850|NCT02401555|3504991|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3658851|NCT02401555|3504988|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3658852|NCT02401555|3504989|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3658853|NCT02401555|3504990|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3658854|NCT02401555|3504991|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3658855|NCT02401555|3504988|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3658856|NCT02401555|3504989|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658857|NCT02401555|3504990|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3658858|NCT02401555|3504991|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658859|NCT02401555|3504988|B4||Male|Sex: Female, Male||Participants|Count of Participants|323|323.0||||||
3658860|NCT02401555|3504989|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3658861|NCT02401555|3504990|B2||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3658862|NCT02401555|3504991|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3658863|NCT02401555|3504988|B4||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3658864|NCT02401555|3504989|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3658865|NCT02401555|3504990|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3658866|NCT02401555|3504991|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3658867|NCT02401555|3504988|B4||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3658868|NCT02401555|3504989|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3658869|NCT02401555|3504990|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3658870|NCT02401555|3504991|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3658871|NCT02401555|3504988|B4||Between 18 and 65 years|Age||Participants|Count of Participants|406|406.0||||||
3658872|NCT02401555|3504989|B3||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
3658873|NCT02401555|3504990|B2||Between 18 and 65 years|Age||Participants|Count of Participants|201|201.0||||||
3658874|NCT02401555|3504991|B1||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
3658875|NCT02401555|3504988|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3658876|NCT02401555|3504989|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3658877|NCT02401555|3504990|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3658878|NCT02401555|3504991|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3658879|NCT02401529|3505001|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3658880|NCT02401529|3505002|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3658881|NCT02401529|3505003|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3658882|NCT02401529|3505001|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3658883|NCT02401529|3505002|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3658884|NCT02401529|3505003|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3658885|NCT02401529|3505001|B3|||Age||years|Mean|8.6|8.6|Full Range|||5.0|19.0|
3658886|NCT02401529|3505002|B2|||Age||years|Mean|8.7|8.7|Full Range|||5.0|17.0|
3658887|NCT02401529|3505003|B1|||Age||years|Mean|8.5|8.5|Full Range|||5.0|19.0|
3658888|NCT02401464|3505028|B5|Had no caffeine consumption||Caffeine Classification||participants|Number|36|36.0||||||
3658889|NCT02401464|3505029|B4|Had no caffeine consumption||Caffeine Classification||participants|Number|8|8.0||||||
3658890|NCT02401464|3505030|B3|Had no caffeine consumption||Caffeine Classification||participants|Number|7|7.0||||||
3658891|NCT02401464|3505031|B2|Had no caffeine consumption||Caffeine Classification||participants|Number|10|10.0||||||
3658892|NCT02401464|3505032|B1|Had no caffeine consumption||Caffeine Classification||participants|Number|11|11.0||||||
3658893|NCT02401464|3505028|B5|Had caffeine consumption||Caffeine Classification||participants|Number|16|16.0||||||
3658894|NCT02401464|3505029|B4|Had caffeine consumption||Caffeine Classification||participants|Number|5|5.0||||||
3658895|NCT02401464|3505030|B3|Had caffeine consumption||Caffeine Classification||participants|Number|6|6.0||||||
3658896|NCT02401464|3505031|B2|Had caffeine consumption||Caffeine Classification||participants|Number|3|3.0||||||
3658897|NCT02401464|3505032|B1|Had caffeine consumption||Caffeine Classification||participants|Number|2|2.0||||||
3658898|NCT02401464|3505028|B5|Never drank||Alcohol classification||participants|Number|37|37.0||||||
3658899|NCT02401464|3505029|B4|Never drank||Alcohol classification||participants|Number|10|10.0||||||
3658900|NCT02401464|3505030|B3|Never drank||Alcohol classification||participants|Number|8|8.0||||||
3658901|NCT02401464|3505031|B2|Never drank||Alcohol classification||participants|Number|8|8.0||||||
3658902|NCT02401464|3505032|B1|Never drank||Alcohol classification||participants|Number|11|11.0||||||
3658903|NCT02401464|3505028|B5|Drank a few days per month||Alcohol classification||participants|Number|10|10.0||||||
3658904|NCT02401464|3505029|B4|Drank a few days per month||Alcohol classification||participants|Number|3|3.0||||||
3658905|NCT02401464|3505030|B3|Drank a few days per month||Alcohol classification||participants|Number|3|3.0||||||
3658906|NCT02401464|3505031|B2|Drank a few days per month||Alcohol classification||participants|Number|3|3.0||||||
3658907|NCT02401464|3505032|B1|Drank a few days per month||Alcohol classification||participants|Number|1|1.0||||||
3658908|NCT02401464|3505028|B5|Drank a few days per week||Alcohol classification||participants|Number|5|5.0||||||
3658909|NCT02401464|3505029|B4|Drank a few days per week||Alcohol classification||participants|Number|0|0.0||||||
3658910|NCT02401464|3505030|B3|Drank a few days per week||Alcohol classification||participants|Number|2|2.0||||||
3658911|NCT02401464|3505031|B2|Drank a few days per week||Alcohol classification||participants|Number|2|2.0||||||
3658912|NCT02401464|3505032|B1|Drank a few days per week||Alcohol classification||participants|Number|1|1.0||||||
3658913|NCT02401464|3505028|B5|Ex-smoker||Smoking classification||participants|Number|19|19.0||||||
3658914|NCT02401464|3505029|B4|Ex-smoker||Smoking classification||participants|Number|4|4.0||||||
3658915|NCT02401464|3505030|B3|Ex-smoker||Smoking classification||participants|Number|5|5.0||||||
3658916|NCT02401464|3505031|B2|Ex-smoker||Smoking classification||participants|Number|4|4.0||||||
3658917|NCT02401464|3505032|B1|Ex-smoker||Smoking classification||participants|Number|6|6.0||||||
3658918|NCT02401464|3505028|B5|Current smoker||Smoking classification||participants|Number|2|2.0||||||
3658919|NCT02401464|3505029|B4|Current smoker||Smoking classification||participants|Number|1|1.0||||||
3658920|NCT02401464|3505030|B3|Current smoker||Smoking classification||participants|Number|1|1.0||||||
3658921|NCT02401464|3505031|B2|Current smoker||Smoking classification||participants|Number|0|0.0||||||
3658922|NCT02401464|3505032|B1|Current smoker||Smoking classification||participants|Number|0|0.0||||||
3658923|NCT02401464|3505028|B5|Never smoked||Smoking classification||participants|Number|31|31.0||||||
3658924|NCT02401464|3505029|B4|Never smoked||Smoking classification||participants|Number|8|8.0||||||
3658925|NCT02401464|3505030|B3|Never smoked||Smoking classification||participants|Number|7|7.0||||||
3658926|NCT02401464|3505031|B2|Never smoked||Smoking classification||participants|Number|9|9.0||||||
3658927|NCT02401464|3505032|B1|Never smoked||Smoking classification||participants|Number|7|7.0||||||
3658928|NCT02401464|3505028|B5|Male||Sex/Gender, Customized||participants|Number|52|52.0||||||
3658929|NCT02401464|3505029|B4|Male||Sex/Gender, Customized||participants|Number|13|13.0||||||
3658930|NCT02401464|3505030|B3|Male||Sex/Gender, Customized||participants|Number|13|13.0||||||
3658931|NCT02401464|3505031|B2|Male||Sex/Gender, Customized||participants|Number|13|13.0||||||
3658932|NCT02401464|3505032|B1|Male||Sex/Gender, Customized||participants|Number|13|13.0||||||
3658933|NCT02401464|3505028|B5|||Age||years|Mean|26.308|26.308|Standard Deviation|4.16|4.16|||
3658934|NCT02401464|3505029|B4|||Age||years|Mean|27.4|27.4|Standard Deviation|5.71|5.71|||
3658935|NCT02401464|3505030|B3|||Age||years|Mean|26.6|26.6|Standard Deviation|4.07|4.07|||
3658936|NCT02401464|3505031|B2|||Age||years|Mean|25.9|25.9|Standard Deviation|4.11|4.11|||
3658937|NCT02401464|3505032|B1|||Age||years|Mean|25.3|25.3|Standard Deviation|2.21|2.21|||
3658938|NCT02401412|3505069|B3|||BMI||kg/m2|Mean|25.6|25.6|Standard Deviation|5.8|5.8|||
3658939|NCT02401412|3505070|B2|||BMI||kg/m2|Mean|26.4|26.4|Standard Deviation|5.8|5.8|||
3658940|NCT02401412|3505071|B1|||BMI||kg/m2|Mean|24.8|24.8|Standard Deviation|5.8|5.8|||
3658941|NCT02401412|3505069|B3|Europe||Region of Enrollment||participants|Number|17|17.0||||||
3658942|NCT02401412|3505070|B2|Europe||Region of Enrollment||participants|Number|9|9.0||||||
3658943|NCT02401412|3505071|B1|Europe||Region of Enrollment||participants|Number|8|8.0||||||
3658944|NCT02401412|3505069|B3|United States||Region of Enrollment||participants|Number|109|109.0||||||
3658945|NCT02401412|3505070|B2|United States||Region of Enrollment||participants|Number|53|53.0||||||
3658946|NCT02401412|3505071|B1|United States||Region of Enrollment||participants|Number|56|56.0||||||
3658947|NCT02401412|3505069|B3|Canada||Region of Enrollment||participants|Number|27|27.0||||||
3658948|NCT02401412|3505070|B2|Canada||Region of Enrollment||participants|Number|12|12.0||||||
3658949|NCT02401412|3505071|B1|Canada||Region of Enrollment||participants|Number|15|15.0||||||
3658950|NCT02401412|3505069|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3658951|NCT02401412|3505069|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3658952|NCT02401412|3505070|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3658953|NCT02401412|3505071|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3658954|NCT02401412|3505069|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3658955|NCT02401412|3505070|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3658956|NCT02401412|3505071|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3658957|NCT02401412|3505069|B3|||Age||years|Mean|56.3|56.3|Standard Deviation|15.3|15.3|||
3658958|NCT02401412|3505070|B2|||Age||years|Mean|57.2|57.2|Standard Deviation|15.2|15.2|||
3658959|NCT02401412|3505071|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|24.8|24.8|||
3658960|NCT02401256|3505080|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658961|NCT02401256|3505080|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3658962|NCT02401256|3505080|B1||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3658963|NCT02401256|3505080|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3658964|NCT02401256|3505080|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658965|NCT02401256|3505080|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3658966|NCT02401256|3505080|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658967|NCT02401256|3505080|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3658968|NCT02401256|3505080|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3658969|NCT02401256|3505080|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3658970|NCT02401256|3505080|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3658971|NCT02401256|3505080|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3658972|NCT02401256|3505080|B1|||Age||years|Mean|25.5|25.5|Standard Deviation|6.9|6.9|||
3658973|NCT02401230|3505086|B4|United States||Region of Enrollment||participants|Number|60|60.0||||||
3658974|NCT02401230|3505087|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
3658975|NCT02401230|3505088|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3658976|NCT02401230|3505089|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3658977|NCT02401230|3505086|B4|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3658978|NCT02401230|3505086|B4||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3658979|NCT02401230|3505087|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3658980|NCT02401230|3505088|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3658981|NCT02401230|3505089|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3658982|NCT02401230|3505086|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3658983|NCT02401230|3505087|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3658984|NCT02401230|3505088|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3658985|NCT02401230|3505089|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3658986|NCT02401230|3505086|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3658987|NCT02401230|3505087|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3658988|NCT02401230|3505088|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3658989|NCT02401230|3505089|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3658990|NCT02401230|3505086|B4||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3658991|NCT02401230|3505087|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3658992|NCT02401230|3505088|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3658993|NCT02401230|3505089|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3658994|NCT02401230|3505086|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3658995|NCT02401230|3505087|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3658996|NCT02401230|3505088|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3658997|NCT02401230|3505089|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3658998|NCT02401022|3505124|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3658999|NCT02401022|3505125|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3659000|NCT02401022|3505126|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659001|NCT02401022|3505124|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3659002|NCT02401022|3505125|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3659003|NCT02401022|3505126|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3659004|NCT02401022|3505124|B3||White|Race (NIH/OMB)||Participants|Count of Participants|151|151.0||||||
3659005|NCT02401022|3505125|B2||White|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
3659006|NCT02401022|3505126|B1||White|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3659007|NCT02401022|3505124|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3659008|NCT02401022|3505125|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3659009|NCT02401022|3505126|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3659010|NCT02401022|3505124|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659011|NCT02401022|3505125|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659012|NCT02401022|3505126|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659013|NCT02401022|3505124|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3659014|NCT02401022|3505125|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3659015|NCT02401022|3505126|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3659016|NCT02401022|3505124|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3659017|NCT02401022|3505125|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659018|NCT02401022|3505126|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3659019|NCT02401022|3505124|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3659020|NCT02401022|3505125|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3659021|NCT02401022|3505126|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3659022|NCT02401022|3505124|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|188|188.0||||||
3659023|NCT02401022|3505125|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
3659024|NCT02401022|3505126|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3659025|NCT02401022|3505124|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3659026|NCT02401022|3505125|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3659027|NCT02401022|3505126|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3659028|NCT02401022|3505124|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3659029|NCT02401022|3505125|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3659030|NCT02401022|3505126|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3659031|NCT02401022|3505124|B3||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
3659032|NCT02401022|3505125|B2||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3659033|NCT02401022|3505126|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3659034|NCT02401022|3505124|B3|||Age||years|Mean|47.8|47.8|Standard Deviation|9.47|9.47|||
3659035|NCT02401022|3505125|B2|||Age||years|Mean|47.3|47.3|Standard Deviation|9.63|9.63|||
3659036|NCT02401022|3505126|B1|||Age||years|Mean|48.3|48.3|Standard Deviation|9.34|9.34|||
3659037|NCT02400996|3505133|B1|India||Region of Enrollment||participants|Number|40|40.0||||||
3659038|NCT02400996|3505133|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3659039|NCT02400996|3505133|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3659040|NCT02400996|3505133|B1|||Age||years|Mean|48.6|48.6|Standard Deviation|15.52|15.52|||
3659041|NCT02400749|3505137|B3|||Palmoplantar Psoriasis Surface Area (PPPSA)|The surface affected by psoriasis on palms and soles is estimated as a percentage of the total surface of palms and soles. Each palm represents 20% and each sole 30%. PPPSA values range from 0% (no psoriasis on palms and soles) to 100% (all palms and soles covered by psoriasis).|units on a scale|Mean|34.3|34.3|Standard Deviation|0.2|0.2|||
3659061|NCT02400749|3505139|B1|||BMI||kg/m^2|Mean|31.1|31.1|Standard Deviation|5.5|5.5|||
3659062|NCT02400749|3505137|B3|||Weight||kg|Mean|87.6|87.6|Standard Deviation|18.4|18.4|||
3659063|NCT02400749|3505138|B2|||Weight||kg|Mean|88.3|88.3|Standard Deviation|19.8|19.8|||
3659042|NCT02400749|3505138|B2|||Palmoplantar Psoriasis Surface Area (PPPSA)|The surface affected by psoriasis on palms and soles is estimated as a percentage of the total surface of palms and soles. Each palm represents 20% and each sole 30%. PPPSA values range from 0% (no psoriasis on palms and soles) to 100% (all palms and soles covered by psoriasis).|units on a scale|Mean|30.5|30.5|Standard Deviation|18.3|18.3|||
3659043|NCT02400749|3505139|B1|||Palmoplantar Psoriasis Surface Area (PPPSA)|The surface affected by psoriasis on palms and soles is estimated as a percentage of the total surface of palms and soles. Each palm represents 20% and each sole 30%. PPPSA values range from 0% (no psoriasis on palms and soles) to 100% (all palms and soles covered by psoriasis).|units on a scale|Mean|38.1|38.1|Standard Deviation|23.4|23.4|||
3659044|NCT02400749|3505137|B3|||Palmoplantar Psoriasis Area Severity Index (PPPASI)|"The PPPASI is a scale that can vary from 0 to 72.~Erythema (E), induration (I), and desquamation (D) are evaluated on a scale of 0 to 4 while area is evaluated on a scale of 0 to 6. The combined score of each of these features, for the right (R) and left (L) palms and soles, gives a PPPASI score from 0 (absence of disease) to 72 (most severe palmoplantar psoriasis possible).~PPPASI = (E + I + D)Area X 0.2 (R palm) + (E + I + D) Area X 0.2 (L palm) + (E + I + D) Area X 0.3 (R sole) + (E + I + D) Area X 0.3 (L sole)"|units on a scale|Mean|17.1|17.1|Standard Deviation|10.1|10.1|||
3659045|NCT02400749|3505138|B2|||Palmoplantar Psoriasis Area Severity Index (PPPASI)|"The PPPASI is a scale that can vary from 0 to 72.~Erythema (E), induration (I), and desquamation (D) are evaluated on a scale of 0 to 4 while area is evaluated on a scale of 0 to 6. The combined score of each of these features, for the right (R) and left (L) palms and soles, gives a PPPASI score from 0 (absence of disease) to 72 (most severe palmoplantar psoriasis possible).~PPPASI = (E + I + D)Area X 0.2 (R palm) + (E + I + D) Area X 0.2 (L palm) + (E + I + D) Area X 0.3 (R sole) + (E + I + D) Area X 0.3 (L sole)"|units on a scale|Mean|15.6|15.6|Standard Deviation|8.5|8.5|||
3659046|NCT02400749|3505139|B1|||Palmoplantar Psoriasis Area Severity Index (PPPASI)|"The PPPASI is a scale that can vary from 0 to 72.~Erythema (E), induration (I), and desquamation (D) are evaluated on a scale of 0 to 4 while area is evaluated on a scale of 0 to 6. The combined score of each of these features, for the right (R) and left (L) palms and soles, gives a PPPASI score from 0 (absence of disease) to 72 (most severe palmoplantar psoriasis possible).~PPPASI = (E + I + D)Area X 0.2 (R palm) + (E + I + D) Area X 0.2 (L palm) + (E + I + D) Area X 0.3 (R sole) + (E + I + D) Area X 0.3 (L sole)"|units on a scale|Mean|18.7|18.7|Standard Deviation|11.3|11.3|||
3659047|NCT02400749|3505137|B3|||Palmoplantar Psoriasis Physician Global Assessment (PPPGA)|The PPPGA is a zero to five, 6-point scale that evaluates the severity of palmoplantar psoriasis (score 0 [Clear]; score 1 [Almost clear]; score 2 [Mild]; score 3 [Moderate]; score 4 [Severe]; score 5 [Very severe]).|units on a scale|Mean|3.4|3.4|Standard Deviation|0.6|0.6|||
3659048|NCT02400749|3505138|B2|||Palmoplantar Psoriasis Physician Global Assessment (PPPGA)|The PPPGA is a zero to five, 6-point scale that evaluates the severity of palmoplantar psoriasis (score 0 [Clear]; score 1 [Almost clear]; score 2 [Mild]; score 3 [Moderate]; score 4 [Severe]; score 5 [Very severe]).|units on a scale|Mean|3.4|3.4|Standard Deviation|0.6|0.6|||
3659049|NCT02400749|3505139|B1|||Palmoplantar Psoriasis Physician Global Assessment (PPPGA)|The PPPGA is a zero to five, 6-point scale that evaluates the severity of palmoplantar psoriasis (score 0 [Clear]; score 1 [Almost clear]; score 2 [Mild]; score 3 [Moderate]; score 4 [Severe]; score 5 [Very severe]).|units on a scale|Mean|3.4|3.4|Standard Deviation|0.5|0.5|||
3659050|NCT02400749|3505137|B3||Score 5|Palmoplantar Psoriasis Physician Global Assessment (PPPGA)|The PPPGA is a zero to five, 6-point scale that evaluates the severity of palmoplantar psoriasis (score 0 [Clear]; score 1 [Almost clear]; score 2 [Mild]; score 3 [Moderate]; score 4 [Severe]; score 5 [Very severe]).|Participants|Count of Participants|3|3.0||||||
3659051|NCT02400749|3505138|B2||Score 5|Palmoplantar Psoriasis Physician Global Assessment (PPPGA)|The PPPGA is a zero to five, 6-point scale that evaluates the severity of palmoplantar psoriasis (score 0 [Clear]; score 1 [Almost clear]; score 2 [Mild]; score 3 [Moderate]; score 4 [Severe]; score 5 [Very severe]).|Participants|Count of Participants|2|2.0||||||
3659052|NCT02400749|3505139|B1||Score 5|Palmoplantar Psoriasis Physician Global Assessment (PPPGA)|The PPPGA is a zero to five, 6-point scale that evaluates the severity of palmoplantar psoriasis (score 0 [Clear]; score 1 [Almost clear]; score 2 [Mild]; score 3 [Moderate]; score 4 [Severe]; score 5 [Very severe]).|Participants|Count of Participants|1|1.0||||||
3659053|NCT02400749|3505137|B3||Score 4|Palmoplantar Psoriasis Physician Global Assessment (PPPGA)|The PPPGA is a zero to five, 6-point scale that evaluates the severity of palmoplantar psoriasis (score 0 [Clear]; score 1 [Almost clear]; score 2 [Mild]; score 3 [Moderate]; score 4 [Severe]; score 5 [Very severe]).|Participants|Count of Participants|35|35.0||||||
3659054|NCT02400749|3505138|B2||Score 4|Palmoplantar Psoriasis Physician Global Assessment (PPPGA)|The PPPGA is a zero to five, 6-point scale that evaluates the severity of palmoplantar psoriasis (score 0 [Clear]; score 1 [Almost clear]; score 2 [Mild]; score 3 [Moderate]; score 4 [Severe]; score 5 [Very severe]).|Participants|Count of Participants|16|16.0||||||
3659055|NCT02400749|3505139|B1||Score 4|Palmoplantar Psoriasis Physician Global Assessment (PPPGA)|The PPPGA is a zero to five, 6-point scale that evaluates the severity of palmoplantar psoriasis (score 0 [Clear]; score 1 [Almost clear]; score 2 [Mild]; score 3 [Moderate]; score 4 [Severe]; score 5 [Very severe]).|Participants|Count of Participants|19|19.0||||||
3659056|NCT02400749|3505137|B3||Score 3|Palmoplantar Psoriasis Physician Global Assessment (PPPGA)|The PPPGA is a zero to five, 6-point scale that evaluates the severity of palmoplantar psoriasis (score 0 [Clear]; score 1 [Almost clear]; score 2 [Mild]; score 3 [Moderate]; score 4 [Severe]; score 5 [Very severe]).|Participants|Count of Participants|62|62.0||||||
3659057|NCT02400749|3505138|B2||Score 3|Palmoplantar Psoriasis Physician Global Assessment (PPPGA)|The PPPGA is a zero to five, 6-point scale that evaluates the severity of palmoplantar psoriasis (score 0 [Clear]; score 1 [Almost clear]; score 2 [Mild]; score 3 [Moderate]; score 4 [Severe]; score 5 [Very severe]).|Participants|Count of Participants|32|32.0||||||
3659058|NCT02400749|3505139|B1||Score 3|Palmoplantar Psoriasis Physician Global Assessment (PPPGA)|The PPPGA is a zero to five, 6-point scale that evaluates the severity of palmoplantar psoriasis (score 0 [Clear]; score 1 [Almost clear]; score 2 [Mild]; score 3 [Moderate]; score 4 [Severe]; score 5 [Very severe]).|Participants|Count of Participants|30|30.0||||||
3659059|NCT02400749|3505137|B3|||BMI||kg/m^2|Mean|31.0|31.0|Standard Deviation|6.0|6.0|||
3659060|NCT02400749|3505138|B2|||BMI||kg/m^2|Mean|31.0|31.0|Standard Deviation|6.6|6.6|||
3659064|NCT02400749|3505139|B1|||Weight||kg|Mean|86.9|86.9|Standard Deviation|17.1|17.1|||
3659065|NCT02400749|3505137|B3||Present|Smoking Status||Participants|Count of Participants|33|33.0||||||
3659066|NCT02400749|3505138|B2||Present|Smoking Status||Participants|Count of Participants|13|13.0||||||
3659067|NCT02400749|3505139|B1||Present|Smoking Status||Participants|Count of Participants|20|20.0||||||
3659068|NCT02400749|3505137|B3||Past|Smoking Status||Participants|Count of Participants|36|36.0||||||
3659069|NCT02400749|3505138|B2||Past|Smoking Status||Participants|Count of Participants|18|18.0||||||
3659070|NCT02400749|3505139|B1||Past|Smoking Status||Participants|Count of Participants|18|18.0||||||
3659071|NCT02400749|3505137|B3||Never|Smoking Status||Participants|Count of Participants|31|31.0||||||
3659072|NCT02400749|3505138|B2||Never|Smoking Status||Participants|Count of Participants|19|19.0||||||
3659073|NCT02400749|3505139|B1||Never|Smoking Status||Participants|Count of Participants|12|12.0||||||
3659074|NCT02400749|3505137|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|100|100.0||||||
3659075|NCT02400749|3505138|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
3659076|NCT02400749|3505139|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
3659077|NCT02400749|3505137|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3659078|NCT02400749|3505138|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3659079|NCT02400749|3505139|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3659080|NCT02400749|3505137|B3||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|92|92.0||||||
3659081|NCT02400749|3505138|B2||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
3659082|NCT02400749|3505139|B1||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|45|45.0||||||
3659083|NCT02400749|3505137|B3||Black|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3659084|NCT02400749|3505138|B2||Black|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3659085|NCT02400749|3505139|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3659086|NCT02400749|3505137|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3659087|NCT02400749|3505138|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3659088|NCT02400749|3505139|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3659089|NCT02400749|3505137|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3659090|NCT02400749|3505138|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3659091|NCT02400749|3505139|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3659092|NCT02400749|3505137|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3659093|NCT02400749|3505138|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3659094|NCT02400749|3505139|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3659095|NCT02400749|3505137|B3|||Age||years|Mean|55.1|55.1|Standard Deviation|11.5|11.5|||
3659096|NCT02400749|3505138|B2|||Age||years|Mean|53.6|53.6|Standard Deviation|13.5|13.5|||
3659097|NCT02400749|3505139|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|8.6|8.6|||
3659098|NCT02400710|3505154|B3|||PTSD Checklist-Specific|Measures the 17 symptoms of PTSD according to the DSM-IV criteria. Each symptom is measured on a 5-point scale ranging from 1-5, with higher numbers equating to more severe symptoms. Measures range is 17-85. The mean provided is for the total score of all symptoms added together.|units on a scale|Mean|53.5|53.5|Standard Deviation|12.0|12.0|||
3659099|NCT02400710|3505155|B2|||PTSD Checklist-Specific|Measures the 17 symptoms of PTSD according to the DSM-IV criteria. Each symptom is measured on a 5-point scale ranging from 1-5, with higher numbers equating to more severe symptoms. Measures range is 17-85. The mean provided is for the total score of all symptoms added together.|units on a scale|Mean|56.0|56.0|Standard Deviation|15.3|15.3|||
3659100|NCT02400710|3505156|B1|||PTSD Checklist-Specific|Measures the 17 symptoms of PTSD according to the DSM-IV criteria. Each symptom is measured on a 5-point scale ranging from 1-5, with higher numbers equating to more severe symptoms. Measures range is 17-85. The mean provided is for the total score of all symptoms added together.|units on a scale|Mean|51.0|51.0|Standard Deviation|7.7|7.7|||
3659101|NCT02400710|3505154|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3659102|NCT02400710|3505155|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3659103|NCT02400710|3505156|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3659104|NCT02400710|3505154|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659105|NCT02400710|3505155|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659106|NCT02400710|3505156|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659107|NCT02400710|3505154|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659108|NCT02400710|3505155|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659109|NCT02400710|3505156|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659110|NCT02400710|3505154|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3659111|NCT02400710|3505155|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3659112|NCT02400710|3505156|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3659113|NCT02400710|3505154|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3659114|NCT02400710|3505155|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3659115|NCT02400710|3505156|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3659116|NCT02400710|3505154|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659117|NCT02400710|3505155|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659118|NCT02400710|3505156|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659119|NCT02400710|3505154|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659120|NCT02400710|3505155|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659121|NCT02400710|3505156|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659122|NCT02400710|3505154|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3659123|NCT02400710|3505155|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3659124|NCT02400710|3505156|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3659125|NCT02400710|3505154|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659126|NCT02400710|3505155|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659127|NCT02400710|3505156|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659128|NCT02400710|3505154|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3659129|NCT02400710|3505155|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3659130|NCT02400710|3505156|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3659131|NCT02400710|3505154|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3659132|NCT02400710|3505155|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3659133|NCT02400710|3505156|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659134|NCT02400710|3505154|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3659135|NCT02400710|3505155|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3659136|NCT02400710|3505156|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3659137|NCT02400710|3505154|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3659138|NCT02400710|3505155|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3659139|NCT02400710|3505156|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3659140|NCT02400710|3505154|B3|||Age||years|Mean|41.9|41.9|Standard Deviation|11.9|11.9|||
3659141|NCT02400710|3505155|B2|||Age||years|Mean|42.8|42.8|Standard Deviation|15.4|15.4|||
3659142|NCT02400710|3505156|B1|||Age||years|Mean|41.0|41.0|Standard Deviation|7.8|7.8|||
3659143|NCT02400580|3505165|B3|United States||Region of Enrollment||participants|Number|183|183.0||||||
3659144|NCT02400580|3505166|B2|United States||Region of Enrollment||participants|Number|92|92.0||||||
3659145|NCT02400580|3505167|B1|United States||Region of Enrollment||participants|Number|91|91.0||||||
3659146|NCT02400580|3505165|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3659147|NCT02400580|3505165|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3659148|NCT02400580|3505166|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3659149|NCT02400580|3505167|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3659150|NCT02400580|3505165|B3||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3659151|NCT02400580|3505166|B2||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3659152|NCT02400580|3505167|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3659153|NCT02400580|3505165|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3659154|NCT02400580|3505166|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3659155|NCT02400580|3505167|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3659156|NCT02400580|3505165|B3||Between 18 and 65 years|Age||Participants|Count of Participants|183|183.0||||||
3659157|NCT02400580|3505166|B2||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
3659158|NCT02400580|3505167|B1||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
3659159|NCT02400580|3505165|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3659160|NCT02400580|3505166|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3659161|NCT02400580|3505167|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3659162|NCT02400346|3505184|B1|Estonia||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3659163|NCT02400346|3505184|B1|Germany||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3659164|NCT02400346|3505184|B1|Poland||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3659165|NCT02400346|3505184|B1|Finland||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3659166|NCT02400346|3505184|B1|United States||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
3659167|NCT02400346|3505184|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659168|NCT02400346|3505184|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659169|NCT02400346|3505184|B1||White|Race (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
3659170|NCT02400346|3505184|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3659171|NCT02400346|3505184|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659172|NCT02400346|3505184|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659173|NCT02400346|3505184|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659174|NCT02400346|3505184|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3659175|NCT02400346|3505184|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3659176|NCT02400346|3505184|B1|||Age||years|Mean|71.4|71.4|Standard Deviation|5.3|5.3|||
3659177|NCT02400333|3505188|B5||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3659178|NCT02400333|3505189|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3659179|NCT02400333|3505190|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3659180|NCT02400333|3505191|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3659181|NCT02400333|3505192|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3659182|NCT02400333|3505188|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3659183|NCT02400333|3505189|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3659184|NCT02400333|3505190|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3659185|NCT02400333|3505191|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3659186|NCT02400333|3505192|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3659187|NCT02400333|3505188|B5|||Age||years|Mean|42|42.0|Standard Deviation|12|12.0|||
3659188|NCT02400333|3505189|B4|||Age||years|Mean|40|40.0|Standard Deviation|13|13.0|||
3659189|NCT02400333|3505190|B3|||Age||years|Mean|42|42.0|Standard Deviation|13|13.0|||
3659190|NCT02400333|3505191|B2|||Age||years|Mean|44|44.0|Standard Deviation|12|12.0|||
3659191|NCT02400333|3505192|B1|||Age||years|Mean|42|42.0|Standard Deviation|12|12.0|||
3659192|NCT02399345|3505253|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3659193|NCT02399345|3505253|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3659194|NCT02399345|3505253|B1|||Age||years|Mean|46.4|46.4|Standard Deviation|11.30|11.3|||
3659195|NCT02399163|3505259|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659196|NCT02399163|3505259|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3659197|NCT02399163|3505259|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3659198|NCT02399163|3505259|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3659199|NCT02399163|3505259|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659200|NCT02399163|3505259|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659201|NCT02399163|3505259|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659202|NCT02399163|3505259|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3659203|NCT02399163|3505259|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3659204|NCT02399163|3505259|B1|||Age||Years|Mean|64.1|64.1|Standard Deviation|10.45|10.45|||
3659205|NCT02399111|3505283|B5||Male|Gender||Participants|Count of Participants|6|6.0||||||
3659206|NCT02399111|3505284|B4||Male|Gender||Participants|Count of Participants|0|0.0||||||
3659207|NCT02399111|3505285|B3||Male|Gender||Participants|Count of Participants|4|4.0||||||
3659208|NCT02399111|3505286|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3659209|NCT02399111|3505287|B1||Male|Gender||Participants|Count of Participants|2|2.0||||||
3659210|NCT02399111|3505283|B5||Female|Gender||Participants|Count of Participants|3|3.0||||||
3659211|NCT02399111|3505284|B4||Female|Gender||Participants|Count of Participants|0|0.0||||||
3659212|NCT02399111|3505285|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
3659213|NCT02399111|3505286|B2||Female|Gender||Participants|Count of Participants|1|1.0||||||
3659214|NCT02399111|3505287|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
3659215|NCT02399111|3505283|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3659216|NCT02399111|3505284|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3659217|NCT02399111|3505285|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3659218|NCT02399111|3505286|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3659219|NCT02399111|3505287|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3659220|NCT02399111|3505283|B5||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3659221|NCT02399111|3505284|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3659222|NCT02399111|3505285|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3659223|NCT02399111|3505286|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3659224|NCT02399111|3505287|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3659225|NCT02399111|3505283|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3659226|NCT02399111|3505284|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3659227|NCT02399111|3505285|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3659228|NCT02399111|3505286|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3659229|NCT02399111|3505287|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3659230|NCT02398227|3505304|B3|||Clinician-Administered PTSD Scale (CAPS)|Clinical Interview assessing symptoms of Posttraumatic Stress Disorder (PTSD) scores can range from 0 to 136 with higher scores reflecting greater PTSD severity|units on a scale|Mean|75.06|75.06|Standard Deviation|21.14|21.14|||
3659231|NCT02398227|3505305|B2|||Clinician-Administered PTSD Scale (CAPS)|Clinical Interview assessing symptoms of Posttraumatic Stress Disorder (PTSD) scores can range from 0 to 136 with higher scores reflecting greater PTSD severity|units on a scale|Mean|77.82|77.82|Standard Deviation|21.12|21.12|||
3659288|NCT02397915|3505315|B1|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3659232|NCT02398227|3505306|B1|||Clinician-Administered PTSD Scale (CAPS)|Clinical Interview assessing symptoms of Posttraumatic Stress Disorder (PTSD) scores can range from 0 to 136 with higher scores reflecting greater PTSD severity|units on a scale|Mean|72.11|72.11|Standard Deviation|20.87|20.87|||
3659233|NCT02398227|3505304|B3|United States||Region of Enrollment||participants|Number|172|172.0||||||
3659234|NCT02398227|3505305|B2|United States||Region of Enrollment||participants|Number|89|89.0||||||
3659235|NCT02398227|3505306|B1|United States||Region of Enrollment||participants|Number|83|83.0||||||
3659236|NCT02398227|3505304|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659237|NCT02398227|3505305|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659238|NCT02398227|3505306|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659239|NCT02398227|3505304|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3659240|NCT02398227|3505305|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3659241|NCT02398227|3505306|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3659242|NCT02398227|3505304|B3||White|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3659243|NCT02398227|3505305|B2||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3659244|NCT02398227|3505306|B1||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3659245|NCT02398227|3505304|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
3659246|NCT02398227|3505305|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3659247|NCT02398227|3505306|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3659248|NCT02398227|3505304|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659249|NCT02398227|3505305|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659250|NCT02398227|3505306|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659251|NCT02398227|3505304|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659252|NCT02398227|3505305|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659253|NCT02398227|3505306|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659254|NCT02398227|3505304|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3659255|NCT02398227|3505305|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659256|NCT02398227|3505306|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3659257|NCT02398227|3505304|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659258|NCT02398227|3505305|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659259|NCT02398227|3505306|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659260|NCT02398227|3505304|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
3659261|NCT02398227|3505305|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3659262|NCT02398227|3505306|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3659263|NCT02398227|3505304|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3659264|NCT02398227|3505305|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3659265|NCT02398227|3505306|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3659266|NCT02398227|3505304|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3659267|NCT02398227|3505305|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3659268|NCT02398227|3505306|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3659269|NCT02398227|3505304|B3||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3659270|NCT02398227|3505305|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3659271|NCT02398227|3505306|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3659272|NCT02398227|3505304|B3|||Age||Years|Mean|35.13|35.13|Full Range|||19.0|59.0|
3659273|NCT02398227|3505305|B2|||Age||Years|Mean|36|36.0|Full Range|||19.0|59.0|
3659274|NCT02398227|3505306|B1|||Age||Years|Mean|34.5|34.5|Full Range|||19.0|59.0|
3659275|NCT02398227|3505304|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3659276|NCT02398227|3505305|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3659277|NCT02398227|3505306|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3659278|NCT02398227|3505304|B3||Between 18 and 65 years|Age||Participants|Count of Participants|172|172.0||||||
3659279|NCT02398227|3505305|B2||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
3659280|NCT02398227|3505306|B1||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
3659281|NCT02398227|3505304|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3659282|NCT02398227|3505305|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3659283|NCT02398227|3505306|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3659284|NCT02397915|3505315|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3659285|NCT02397915|3505315|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|217|217.0||||||
3659286|NCT02397915|3505315|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3659287|NCT02397915|3505315|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3659289|NCT02397915|3505315|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
3659290|NCT02397915|3505315|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|49|49.0||||||
3659291|NCT02397915|3505315|B1||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3659292|NCT02397915|3505315|B1||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
3659293|NCT02397915|3505315|B1|||Age||Years|Mean|40.4|40.4|Standard Deviation|13.64|13.64|||
3659294|NCT02397785|3505368|B3||No|History of Sexual Abuse||Participants|Count of Participants|44|44.0||||||
3659295|NCT02397785|3505369|B2||No|History of Sexual Abuse||Participants|Count of Participants|25|25.0||||||
3659296|NCT02397785|3505370|B1||No|History of Sexual Abuse||Participants|Count of Participants|19|19.0||||||
3659297|NCT02397785|3505368|B3||Yes|History of Sexual Abuse||Participants|Count of Participants|14|14.0||||||
3659298|NCT02397785|3505369|B2||Yes|History of Sexual Abuse||Participants|Count of Participants|9|9.0||||||
3659299|NCT02397785|3505370|B1||Yes|History of Sexual Abuse||Participants|Count of Participants|5|5.0||||||
3659300|NCT02397785|3505368|B3||No|History of Depression||Participants|Count of Participants|28|28.0||||||
3659301|NCT02397785|3505369|B2||No|History of Depression||Participants|Count of Participants|13|13.0||||||
3659302|NCT02397785|3505370|B1||No|History of Depression||Participants|Count of Participants|15|15.0||||||
3659303|NCT02397785|3505368|B3||Yes|History of Depression||Participants|Count of Participants|30|30.0||||||
3659304|NCT02397785|3505369|B2||Yes|History of Depression||Participants|Count of Participants|21|21.0||||||
3659305|NCT02397785|3505370|B1||Yes|History of Depression||Participants|Count of Participants|9|9.0||||||
3659306|NCT02397785|3505368|B3||No|History of Pelvic Floor Physical Therapy||Participants|Count of Participants|45|45.0||||||
3659307|NCT02397785|3505369|B2||No|History of Pelvic Floor Physical Therapy||Participants|Count of Participants|25|25.0||||||
3659308|NCT02397785|3505370|B1||No|History of Pelvic Floor Physical Therapy||Participants|Count of Participants|20|20.0||||||
3659309|NCT02397785|3505368|B3||Yes|History of Pelvic Floor Physical Therapy||Participants|Count of Participants|13|13.0||||||
3659310|NCT02397785|3505369|B2||Yes|History of Pelvic Floor Physical Therapy||Participants|Count of Participants|9|9.0||||||
3659311|NCT02397785|3505370|B1||Yes|History of Pelvic Floor Physical Therapy||Participants|Count of Participants|4|4.0||||||
3659312|NCT02397785|3505368|B3||No|Endometriosis||Participants|Count of Participants|32|32.0||||||
3659313|NCT02397785|3505369|B2||No|Endometriosis||Participants|Count of Participants|16|16.0||||||
3659314|NCT02397785|3505370|B1||No|Endometriosis||Participants|Count of Participants|16|16.0||||||
3659315|NCT02397785|3505368|B3||Yes|Endometriosis||Participants|Count of Participants|26|26.0||||||
3659316|NCT02397785|3505369|B2||Yes|Endometriosis||Participants|Count of Participants|18|18.0||||||
3659317|NCT02397785|3505370|B1||Yes|Endometriosis||Participants|Count of Participants|8|8.0||||||
3659318|NCT02397785|3505368|B3|||Pain Duration||years|Mean|8.5|8.5|Standard Deviation|10.3|10.3|||
3659319|NCT02397785|3505369|B2|||Pain Duration||years|Mean|11.0|11.0|Standard Deviation|12.6|12.6|||
3659320|NCT02397785|3505370|B1|||Pain Duration||years|Mean|4.9|4.9|Standard Deviation|3.4|3.4|||
3659321|NCT02397785|3505368|B3||Post-Menopausal|Menopausal Status||Participants|Count of Participants|7|7.0||||||
3659322|NCT02397785|3505369|B2||Post-Menopausal|Menopausal Status||Participants|Count of Participants|4|4.0||||||
3659323|NCT02397785|3505370|B1||Post-Menopausal|Menopausal Status||Participants|Count of Participants|3|3.0||||||
3659324|NCT02397785|3505368|B3||Pre-Menopausal|Menopausal Status||Participants|Count of Participants|51|51.0||||||
3659325|NCT02397785|3505369|B2||Pre-Menopausal|Menopausal Status||Participants|Count of Participants|30|30.0||||||
3659326|NCT02397785|3505370|B1||Pre-Menopausal|Menopausal Status||Participants|Count of Participants|21|21.0||||||
3659327|NCT02397785|3505368|B3|||Vaginal Parity||number|Mean|1.3|1.3|Standard Deviation|1.2|1.2|||
3659328|NCT02397785|3505369|B2|||Vaginal Parity||number|Mean|1.1|1.1|Standard Deviation|1.3|1.3|||
3659329|NCT02397785|3505370|B1|||Vaginal Parity||number|Mean|1.8|1.8|Standard Deviation|1.2|1.2|||
3659330|NCT02397785|3505368|B3||>=2|Total Parity||Participants|Count of Participants|15|15.0||||||
3659331|NCT02397785|3505369|B2||>=2|Total Parity||Participants|Count of Participants|10|10.0||||||
3659332|NCT02397785|3505370|B1||>=2|Total Parity||Participants|Count of Participants|5|5.0||||||
3659333|NCT02397785|3505368|B3||1|Total Parity||Participants|Count of Participants|8|8.0||||||
3659334|NCT02397785|3505369|B2||1|Total Parity||Participants|Count of Participants|6|6.0||||||
3659335|NCT02397785|3505370|B1||1|Total Parity||Participants|Count of Participants|2|2.0||||||
3659336|NCT02397785|3505368|B3||0|Total Parity||Participants|Count of Participants|35|35.0||||||
3659337|NCT02397785|3505369|B2||0|Total Parity||Participants|Count of Participants|18|18.0||||||
3659338|NCT02397785|3505370|B1||0|Total Parity||Participants|Count of Participants|17|17.0||||||
3659339|NCT02397785|3505368|B3||Graduate/Professional Degree|Highest Education Level Completed||Participants|Count of Participants|13|13.0||||||
3659340|NCT02397785|3505369|B2||Graduate/Professional Degree|Highest Education Level Completed||Participants|Count of Participants|7|7.0||||||
3659341|NCT02397785|3505370|B1||Graduate/Professional Degree|Highest Education Level Completed||Participants|Count of Participants|6|6.0||||||
3659342|NCT02397785|3505368|B3||College|Highest Education Level Completed||Participants|Count of Participants|29|29.0||||||
3659343|NCT02397785|3505369|B2||College|Highest Education Level Completed||Participants|Count of Participants|18|18.0||||||
3659344|NCT02397785|3505370|B1||College|Highest Education Level Completed||Participants|Count of Participants|11|11.0||||||
3659345|NCT02397785|3505368|B3||High School / GED|Highest Education Level Completed||Participants|Count of Participants|15|15.0||||||
3659346|NCT02397785|3505369|B2||High School / GED|Highest Education Level Completed||Participants|Count of Participants|9|9.0||||||
3659347|NCT02397785|3505370|B1||High School / GED|Highest Education Level Completed||Participants|Count of Participants|6|6.0||||||
3659348|NCT02397785|3505368|B3||< High School|Highest Education Level Completed||Participants|Count of Participants|1|1.0||||||
3659349|NCT02397785|3505369|B2||< High School|Highest Education Level Completed||Participants|Count of Participants|0|0.0||||||
3659350|NCT02397785|3505370|B1||< High School|Highest Education Level Completed||Participants|Count of Participants|1|1.0||||||
3659351|NCT02397785|3505368|B3||>$100,000|Annual Household Income||Participants|Count of Participants|12|12.0||||||
3659352|NCT02397785|3505369|B2||>$100,000|Annual Household Income||Participants|Count of Participants|9|9.0||||||
3659353|NCT02397785|3505370|B1||>$100,000|Annual Household Income||Participants|Count of Participants|3|3.0||||||
3659354|NCT02397785|3505368|B3||$75,001-$100,000|Annual Household Income||Participants|Count of Participants|6|6.0||||||
3659355|NCT02397785|3505369|B2||$75,001-$100,000|Annual Household Income||Participants|Count of Participants|5|5.0||||||
3659356|NCT02397785|3505370|B1||$75,001-$100,000|Annual Household Income||Participants|Count of Participants|1|1.0||||||
3659357|NCT02397785|3505368|B3||$50,001-$75,000|Annual Household Income||Participants|Count of Participants|15|15.0||||||
3659358|NCT02397785|3505369|B2||$50,001-$75,000|Annual Household Income||Participants|Count of Participants|7|7.0||||||
3659359|NCT02397785|3505370|B1||$50,001-$75,000|Annual Household Income||Participants|Count of Participants|8|8.0||||||
3659360|NCT02397785|3505368|B3||$25,001-$50,000|Annual Household Income||Participants|Count of Participants|12|12.0||||||
3659361|NCT02397785|3505369|B2||$25,001-$50,000|Annual Household Income||Participants|Count of Participants|8|8.0||||||
3659362|NCT02397785|3505370|B1||$25,001-$50,000|Annual Household Income||Participants|Count of Participants|4|4.0||||||
3659363|NCT02397785|3505368|B3||<$25,000|Annual Household Income||Participants|Count of Participants|13|13.0||||||
3659364|NCT02397785|3505369|B2||<$25,000|Annual Household Income||Participants|Count of Participants|5|5.0||||||
3659365|NCT02397785|3505370|B1||<$25,000|Annual Household Income||Participants|Count of Participants|8|8.0||||||
3659366|NCT02397785|3505368|B3||Unemployed|Employment Status||Participants|Count of Participants|12|12.0||||||
3659367|NCT02397785|3505369|B2||Unemployed|Employment Status||Participants|Count of Participants|7|7.0||||||
3659368|NCT02397785|3505370|B1||Unemployed|Employment Status||Participants|Count of Participants|5|5.0||||||
3659369|NCT02397785|3505368|B3||Employed|Employment Status||Participants|Count of Participants|46|46.0||||||
3659370|NCT02397785|3505369|B2||Employed|Employment Status||Participants|Count of Participants|27|27.0||||||
3659371|NCT02397785|3505370|B1||Employed|Employment Status||Participants|Count of Participants|19|19.0||||||
3659372|NCT02397785|3505368|B3|||BMI||kg/m^2|Mean|27.6|27.6|Standard Deviation|6.0|6.0|||
3659373|NCT02397785|3505369|B2|||BMI||kg/m^2|Mean|28.1|28.1|Standard Deviation|6.3|6.3|||
3659374|NCT02397785|3505370|B1|||BMI||kg/m^2|Mean|27.0|27.0|Standard Deviation|5.8|5.8|||
3659375|NCT02397785|3505368|B3|United States||Region of Enrollment||Participants|Count of Participants|58|58.0||||||
3659376|NCT02397785|3505369|B2|United States||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3659377|NCT02397785|3505370|B1|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3659378|NCT02397785|3505368|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659379|NCT02397785|3505369|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659380|NCT02397785|3505370|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659381|NCT02397785|3505368|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659382|NCT02397785|3505369|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659383|NCT02397785|3505370|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659384|NCT02397785|3505368|B3||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3659385|NCT02397785|3505369|B2||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3659386|NCT02397785|3505370|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3659387|NCT02397785|3505368|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3659388|NCT02397785|3505369|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3659389|NCT02397785|3505370|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3659390|NCT02397785|3505368|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659391|NCT02397785|3505369|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659392|NCT02397785|3505370|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659393|NCT02397785|3505368|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3659394|NCT02397785|3505369|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659395|NCT02397785|3505370|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3659396|NCT02397785|3505368|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659397|NCT02397785|3505369|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659398|NCT02397785|3505370|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659399|NCT02397785|3505368|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3659400|NCT02397785|3505369|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3659401|NCT02397785|3505370|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3659402|NCT02397785|3505368|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3659403|NCT02397785|3505369|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3659404|NCT02397785|3505370|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3659405|NCT02397785|3505368|B3|||Age||years|Mean|33.2|33.2|Standard Deviation|10.0|10.0|||
3659406|NCT02397785|3505369|B2|||Age||years|Mean|33.8|33.8|Standard Deviation|10.5|10.5|||
3659407|NCT02397785|3505370|B1|||Age||years|Mean|32.3|32.3|Standard Deviation|9.5|9.5|||
3659408|NCT02397694|3505415|B3||≥ 500|CD4 Cell Count Category (/μL)||Participants|Count of Participants|41|41.0||||||
3659409|NCT02397694|3505416|B2||≥ 500|CD4 Cell Count Category (/μL)||Participants|Count of Participants|16|16.0||||||
3659410|NCT02397694|3505417|B1||≥ 500|CD4 Cell Count Category (/μL)||Participants|Count of Participants|25|25.0||||||
3659411|NCT02397694|3505415|B3||≥ 350 to < 500|CD4 Cell Count Category (/μL)||Participants|Count of Participants|26|26.0||||||
3659412|NCT02397694|3505416|B2||≥ 350 to < 500|CD4 Cell Count Category (/μL)||Participants|Count of Participants|6|6.0||||||
3659413|NCT02397694|3505417|B1||≥ 350 to < 500|CD4 Cell Count Category (/μL)||Participants|Count of Participants|20|20.0||||||
3659414|NCT02397694|3505415|B3||≥ 200 to < 350|CD4 Cell Count Category (/μL)||Participants|Count of Participants|25|25.0||||||
3659415|NCT02397694|3505416|B2||≥ 200 to < 350|CD4 Cell Count Category (/μL)||Participants|Count of Participants|8|8.0||||||
3659416|NCT02397694|3505417|B1||≥ 200 to < 350|CD4 Cell Count Category (/μL)||Participants|Count of Participants|17|17.0||||||
3659417|NCT02397694|3505415|B3||< 200|CD4 Cell Count Category (/μL)||Participants|Count of Participants|6|6.0||||||
3659418|NCT02397694|3505416|B2||< 200|CD4 Cell Count Category (/μL)||Participants|Count of Participants|3|3.0||||||
3659419|NCT02397694|3505417|B1||< 200|CD4 Cell Count Category (/μL)||Participants|Count of Participants|3|3.0||||||
3659420|NCT02397694|3505415|B3|||CD4 Cell Count (/μL)||cells/μL|Mean|483|483.0|Standard Deviation|220.3|220.3|||
3659421|NCT02397694|3505416|B2|||CD4 Cell Count (/μL)||cells/μL|Mean|507|507.0|Standard Deviation|271.0|271.0|||
3659422|NCT02397694|3505417|B1|||CD4 Cell Count (/μL)||cells/μL|Mean|471|471.0|Standard Deviation|190.9|190.9|||
3659423|NCT02397694|3505415|B3||> 400,000|HIV-1 RNA category (copies/mL)||Participants|Count of Participants|5|5.0||||||
3659424|NCT02397694|3505416|B2||> 400,000|HIV-1 RNA category (copies/mL)||Participants|Count of Participants|1|1.0||||||
3659425|NCT02397694|3505417|B1||> 400,000|HIV-1 RNA category (copies/mL)||Participants|Count of Participants|4|4.0||||||
3659426|NCT02397694|3505415|B3||> 100,000 to ≤ 400,000|HIV-1 RNA category (copies/mL)||Participants|Count of Participants|12|12.0||||||
3659427|NCT02397694|3505416|B2||> 100,000 to ≤ 400,000|HIV-1 RNA category (copies/mL)||Participants|Count of Participants|6|6.0||||||
3659428|NCT02397694|3505417|B1||> 100,000 to ≤ 400,000|HIV-1 RNA category (copies/mL)||Participants|Count of Participants|6|6.0||||||
3659429|NCT02397694|3505415|B3||≤ 100,000|HIV-1 RNA category (copies/mL)||Participants|Count of Participants|81|81.0||||||
3659430|NCT02397694|3505416|B2||≤ 100,000|HIV-1 RNA category (copies/mL)||Participants|Count of Participants|26|26.0||||||
3659431|NCT02397694|3505417|B1||≤ 100,000|HIV-1 RNA category (copies/mL)||Participants|Count of Participants|55|55.0||||||
3659432|NCT02397694|3505415|B3|||HIV-1 RNA||log10 copies/mL|Mean|4.39|4.39|Standard Deviation|0.795|0.795|||
3659433|NCT02397694|3505416|B2|||HIV-1 RNA||log10 copies/mL|Mean|4.38|4.38|Standard Deviation|0.866|0.866|||
3659434|NCT02397694|3505417|B1|||HIV-1 RNA||log10 copies/mL|Mean|4.39|4.39|Standard Deviation|0.764|0.764|||
3659435|NCT02397694|3505415|B3||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|83|83.0||||||
3659436|NCT02397694|3505416|B2||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3659437|NCT02397694|3505417|B1||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|54|54.0||||||
3659438|NCT02397694|3505415|B3||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3659439|NCT02397694|3505416|B2||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3659440|NCT02397694|3505417|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3659441|NCT02397694|3505415|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3659442|NCT02397694|3505416|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3659443|NCT02397694|3505417|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3659444|NCT02397694|3505415|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|56|56.0||||||
3659445|NCT02397694|3505416|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3659446|NCT02397694|3505417|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
3659447|NCT02397694|3505415|B3||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3659448|NCT02397694|3505416|B2||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3659449|NCT02397694|3505417|B1||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3659450|NCT02397694|3505415|B3||Black|Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3659451|NCT02397694|3505416|B2||Black|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3659452|NCT02397694|3505417|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3659453|NCT02397694|3505415|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3659454|NCT02397694|3505416|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3659455|NCT02397694|3505417|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3659456|NCT02397694|3505415|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3659629|NCT02396147|3505543|B3|White||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
3659457|NCT02397694|3505416|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3659458|NCT02397694|3505417|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3659459|NCT02397694|3505415|B3||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3659460|NCT02397694|3505416|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3659461|NCT02397694|3505417|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3659462|NCT02397694|3505415|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3659463|NCT02397694|3505416|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3659464|NCT02397694|3505417|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3659465|NCT02397694|3505415|B3|||Age||years|Mean|35|35.0|Standard Deviation|12.1|12.1|||
3659466|NCT02397694|3505416|B2|||Age||years|Mean|38|38.0|Standard Deviation|12.9|12.9|||
3659467|NCT02397694|3505417|B1|||Age||years|Mean|34|34.0|Standard Deviation|11.4|11.4|||
3659468|NCT02397655|3505456|B1|China||Region of Enrollment||participants|Number|10711|10711.0||||||
3659469|NCT02397655|3505456|B1||Male|Sex: Female, Male||Participants|Count of Participants|7083|7083.0||||||
3659470|NCT02397655|3505456|B1||Female|Sex: Female, Male||Participants|Count of Participants|3628|3628.0||||||
3659471|NCT02397655|3505456|B1|||Age||years|Mean|64.1|64.1|Standard Deviation|10.9|10.9|||
3659472|NCT02397564|3505460|B1|United States||Region of Enrollment|Patients enrolled in a consecutive order from our surgical log book.|participants|Number|20|20.0||||||
3659473|NCT02397564|3505460|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3659474|NCT02397564|3505460|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3659475|NCT02397564|3505460|B1|||Age||years|Mean|46|46.0|Full Range|||28.0|79.0|
3659476|NCT02397564|3505460|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3659477|NCT02397564|3505460|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3659478|NCT02397564|3505460|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3659479|NCT02397122|3505465|B3|Turkey||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3659480|NCT02397122|3505466|B2|Turkey||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3659481|NCT02397122|3505467|B1|Turkey||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3659482|NCT02397122|3505465|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3659483|NCT02397122|3505466|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3659484|NCT02397122|3505467|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3659485|NCT02397122|3505465|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3659486|NCT02397122|3505466|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3659487|NCT02397122|3505467|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3659488|NCT02397122|3505465|B3|||Age||years|Mean|40.72|40.72|Standard Deviation|7.18|7.18|||
3659489|NCT02397122|3505466|B2|||Age||years|Mean|39.65|39.65|Standard Deviation|6.46|6.46|||
3659490|NCT02397122|3505467|B1|||Age||years|Mean|41.80|41.8|Standard Deviation|7.85|7.85|||
3659491|NCT02397122|3505465|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3659492|NCT02397122|3505466|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3659493|NCT02397122|3505467|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3659494|NCT02397122|3505465|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3659495|NCT02397122|3505466|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3659496|NCT02397122|3505467|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3659497|NCT02397122|3505465|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3659498|NCT02397122|3505466|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3659499|NCT02397122|3505467|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3659500|NCT02396537|3505484|B3|United States||Region of Enrollment||participants|Number|76|76.0||||||
3659501|NCT02396537|3505485|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
3659502|NCT02396537|3505486|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3659503|NCT02396537|3505484|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3659504|NCT02396537|3505485|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659505|NCT02396537|3505486|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3659506|NCT02396537|3505484|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3659507|NCT02396537|3505485|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659508|NCT02396537|3505486|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3659509|NCT02396537|3505484|B3||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3659510|NCT02396537|3505485|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3659511|NCT02396537|3505486|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3659512|NCT02396537|3505484|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3659513|NCT02396537|3505485|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3659514|NCT02396537|3505486|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3659515|NCT02396537|3505484|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659516|NCT02396537|3505485|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659517|NCT02396537|3505486|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659518|NCT02396537|3505484|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659519|NCT02396537|3505485|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659520|NCT02396537|3505486|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659521|NCT02396537|3505484|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659522|NCT02396537|3505485|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659523|NCT02396537|3505486|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659524|NCT02396537|3505484|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659525|NCT02396537|3505485|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659526|NCT02396537|3505486|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659527|NCT02396537|3505484|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3659528|NCT02396537|3505485|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3659529|NCT02396537|3505486|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3659530|NCT02396537|3505484|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3659531|NCT02396537|3505485|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659532|NCT02396537|3505486|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3659533|NCT02396537|3505484|B3||Male|Gender||Participants|Count of Participants|44|44.0||||||
3659534|NCT02396537|3505485|B2||Male|Gender||Participants|Count of Participants|23|23.0||||||
3659535|NCT02396537|3505486|B1||Male|Gender||Participants|Count of Participants|21|21.0||||||
3659536|NCT02396537|3505484|B3||Female|Gender||Participants|Count of Participants|32|32.0||||||
3659537|NCT02396537|3505485|B2||Female|Gender||Participants|Count of Participants|13|13.0||||||
3659538|NCT02396537|3505486|B1||Female|Gender||Participants|Count of Participants|19|19.0||||||
3659539|NCT02396537|3505484|B3|||Age||years|Median|8|8.0|Inter-Quartile Range|||7.0|10.0|
3659540|NCT02396537|3505485|B2|||Age||years|Median|9|9.0|Inter-Quartile Range|||7.0|10.0|
3659541|NCT02396537|3505486|B1|||Age||years|Median|8|8.0|Inter-Quartile Range|||7.0|10.0|
3659542|NCT02396420|3505493|B1|||Use of other BPH treatments||Participants|Count of Participants|0|0.0||||||
3659543|NCT02396420|3505493|B1|||Use of other medications or supplements [to treat BPH]||Participants|Count of Participants|1|1.0||||||
3659544|NCT02396420|3505493|B1|||Use of alpha adrenergic blockers||Participants|Count of Participants|2|2.0||||||
3659545|NCT02396420|3505493|B1|||Use of 5 alpha reductase inhibitors||Participants|Count of Participants|1|1.0||||||
3659546|NCT02396420|3505493|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3659547|NCT02396420|3505493|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659548|NCT02396420|3505493|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659549|NCT02396420|3505493|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3659550|NCT02396420|3505493|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659551|NCT02396420|3505493|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659552|NCT02396420|3505493|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659553|NCT02396420|3505493|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659554|NCT02396420|3505493|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659555|NCT02396420|3505493|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3659556|NCT02396420|3505493|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659557|NCT02396420|3505493|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3659558|NCT02396420|3505493|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3659559|NCT02396420|3505493|B1|||Age||years|Mean|67.5|67.5|Full Range|||66.0|69.0|
3659560|NCT02396420|3505493|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3659561|NCT02396420|3505493|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3659562|NCT02396420|3505493|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3659563|NCT02396316|3505513|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3659564|NCT02396316|3505514|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3659565|NCT02396316|3505515|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3659566|NCT02396316|3505513|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3659567|NCT02396316|3505514|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3659568|NCT02396316|3505515|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3659569|NCT02396316|3505513|B3|||Age||Years|Mean|67.1|67.1|Standard Deviation|13.1|13.1|||
3659570|NCT02396316|3505514|B2|||Age||Years|Mean|66.2|66.2|Standard Deviation|13.7|13.7|||
3659571|NCT02396316|3505515|B1|||Age||Years|Mean|68.1|68.1|Standard Deviation|12.7|12.7|||
3659572|NCT02396160|3505526|B3|||4 symptoms|number of participants reporting meeting 4 symptom criteria per day|participants|Number|41|41.0||||||
3659573|NCT02396160|3505527|B2|||4 symptoms|number of participants reporting meeting 4 symptom criteria per day|participants|Number|23|23.0||||||
3659574|NCT02396160|3505528|B1|||4 symptoms|number of participants reporting meeting 4 symptom criteria per day|participants|Number|18|18.0||||||
3659575|NCT02396160|3505526|B3|||3 symptoms|number of participants reporting meeting 3 symptom criteria per day|participants|Number|62|62.0||||||
3659576|NCT02396160|3505527|B2|||3 symptoms|number of participants reporting meeting 3 symptom criteria per day|participants|Number|29|29.0||||||
3659577|NCT02396160|3505528|B1|||3 symptoms|number of participants reporting meeting 3 symptom criteria per day|participants|Number|33|33.0||||||
3659578|NCT02396160|3505526|B3|||2 symptoms|number of participants reporting meeting 2 symptom criteria per day|participants|Number|47|47.0||||||
3659579|NCT02396160|3505527|B2|||2 symptoms|number of participants reporting meeting 2 symptom criteria per day|participants|Number|23|23.0||||||
3659580|NCT02396160|3505528|B1|||2 symptoms|number of participants reporting meeting 2 symptom criteria per day|participants|Number|24|24.0||||||
3659581|NCT02396160|3505526|B3|||Any incontinence|number of participants ≥1 any incontinence episodes per day|participants|Number|78|78.0||||||
3659582|NCT02396160|3505527|B2|||Any incontinence|number of participants ≥1 any incontinence episodes per day|participants|Number|43|43.0||||||
3659583|NCT02396160|3505528|B1|||Any incontinence|number of participants ≥1 any incontinence episodes per day|participants|Number|35|35.0||||||
3659584|NCT02396160|3505526|B3|||Stress incontinence|number of participants ≥1 stress incontinent episodes per day|participants|Number|21|21.0||||||
3659585|NCT02396160|3505527|B2|||Stress incontinence|number of participants ≥1 stress incontinent episodes per day|participants|Number|10|10.0||||||
3659586|NCT02396160|3505528|B1|||Stress incontinence|number of participants ≥1 stress incontinent episodes per day|participants|Number|11|11.0||||||
3659587|NCT02396160|3505526|B3|||Urge incontinence|number of participants ≥1 urge incontinent episode per day|participants|Number|69|69.0||||||
3659588|NCT02396160|3505527|B2|||Urge incontinence|number of participants ≥1 urge incontinent episode per day|participants|Number|35|35.0||||||
3659589|NCT02396160|3505528|B1|||Urge incontinence|number of participants ≥1 urge incontinent episode per day|participants|Number|34|34.0||||||
3659590|NCT02396160|3505526|B3|||Urgency|number of participants ≥2 urgency micturitions per day|participants|Number|124|124.0||||||
3659591|NCT02396160|3505527|B2|||Urgency|number of participants ≥2 urgency micturitions per day|participants|Number|62|62.0||||||
3659592|NCT02396160|3505528|B1|||Urgency|number of participants ≥2 urgency micturitions per day|participants|Number|62|62.0||||||
3659593|NCT02396160|3505526|B3|||Night urinary frequency|number of participants ≥2 nocturnal micturitions per night|participants|Number|131|131.0||||||
3659594|NCT02396160|3505527|B2|||Night urinary frequency|number of participants ≥2 nocturnal micturitions per night|participants|Number|61|61.0||||||
3659595|NCT02396160|3505528|B1|||Night urinary frequency|number of participants ≥2 nocturnal micturitions per night|participants|Number|70|70.0||||||
3659596|NCT02396160|3505526|B3|||Day urinary frequency|number of participants ≥10 daytime micturitions per day|participants|Number|107|107.0||||||
3659597|NCT02396160|3505527|B2|||Day urinary frequency|number of participants ≥10 daytime micturitions per day|participants|Number|57|57.0||||||
3659598|NCT02396160|3505528|B1|||Day urinary frequency|number of participants ≥10 daytime micturitions per day|participants|Number|50|50.0||||||
3659599|NCT02396160|3505526|B3|||Weight||kg|Mean|79.82|79.82|Standard Deviation|20.81|20.81|||
3659600|NCT02396160|3505527|B2|||Weight||kg|Mean|79.73|79.73|Standard Deviation|22.74|22.74|||
3659601|NCT02396160|3505528|B1|||Weight||kg|Mean|79.90|79.9|Standard Deviation|18.78|18.78|||
3659602|NCT02396160|3505526|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3659603|NCT02396160|3505527|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3659604|NCT02396160|3505528|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3659605|NCT02396160|3505526|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3659606|NCT02396160|3505527|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3659607|NCT02396160|3505528|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3659608|NCT02396160|3505526|B3|||Age||years|Mean|63.23|63.23|Standard Deviation|13.03|13.03|||
3659609|NCT02396160|3505527|B2|||Age||years|Mean|62.26|62.26|Standard Deviation|13.87|13.87|||
3659610|NCT02396160|3505528|B1|||Age||years|Mean|64.21|64.21|Standard Deviation|12.11|12.11|||
3659611|NCT02396147|3505543|B3|||Body Mass Index||kg/m^2|Mean|27.230|27.23|Standard Deviation|3.2074|3.2074|||
3659612|NCT02396147|3505544|B2|||Body Mass Index||kg/m^2|Mean|27.148|27.148|Standard Deviation|3.6504|3.6504|||
3659613|NCT02396147|3505545|B1|||Body Mass Index||kg/m^2|Mean|27.311|27.311|Standard Deviation|2.7624|2.7624|||
3659614|NCT02396147|3505543|B3|||Height||cm|Mean|174.8|174.8|Standard Deviation|8.54|8.54|||
3659615|NCT02396147|3505544|B2|||Height||cm|Mean|175.4|175.4|Standard Deviation|6.79|6.79|||
3659616|NCT02396147|3505545|B1|||Height||cm|Mean|174.3|174.3|Standard Deviation|10.10|10.1|||
3659617|NCT02396147|3505543|B3|||Weight||kg|Mean|83.38|83.38|Standard Deviation|12.729|12.729|||
3659618|NCT02396147|3505544|B2|||Weight||kg|Mean|83.69|83.69|Standard Deviation|13.678|13.678|||
3659619|NCT02396147|3505545|B1|||Weight||kg|Mean|83.07|83.07|Standard Deviation|11.957|11.957|||
3659620|NCT02396147|3505543|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
3659621|NCT02396147|3505544|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
3659622|NCT02396147|3505545|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3659623|NCT02396147|3505543|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3659624|NCT02396147|3505544|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3659625|NCT02396147|3505545|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3659626|NCT02396147|3505543|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3659627|NCT02396147|3505544|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3659628|NCT02396147|3505545|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3659630|NCT02396147|3505544|B2|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3659631|NCT02396147|3505545|B1|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3659632|NCT02396147|3505543|B3|Multiple||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3659633|NCT02396147|3505544|B2|Multiple||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3659634|NCT02396147|3505545|B1|Multiple||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3659635|NCT02396147|3505543|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3659636|NCT02396147|3505544|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3659637|NCT02396147|3505545|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3659638|NCT02396147|3505543|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3659639|NCT02396147|3505544|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3659640|NCT02396147|3505545|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3659641|NCT02396147|3505543|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3659642|NCT02396147|3505544|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3659643|NCT02396147|3505545|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3659644|NCT02396147|3505543|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3659645|NCT02396147|3505544|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3659646|NCT02396147|3505545|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3659647|NCT02396147|3505543|B3|||Age||years|Mean|38.9|38.9|Standard Deviation|10.78|10.78|||
3659648|NCT02396147|3505544|B2|||Age||years|Mean|38.8|38.8|Standard Deviation|10.08|10.08|||
3659649|NCT02396147|3505545|B1|||Age||years|Mean|39.0|39.0|Standard Deviation|11.62|11.62|||
3659650|NCT02395822|3505614|B1|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3659651|NCT02395822|3505614|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3659652|NCT02395822|3505614|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659653|NCT02395822|3505614|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3659654|NCT02395822|3505614|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659655|NCT02395822|3505614|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659656|NCT02395822|3505614|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659657|NCT02395822|3505614|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659658|NCT02395822|3505614|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3659659|NCT02395822|3505614|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3659660|NCT02395822|3505614|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659661|NCT02395822|3505614|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3659662|NCT02395822|3505614|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3659663|NCT02395822|3505614|B1|||Age||Years|Mean|57|57.0|Standard Deviation|14|14.0|||
3659664|NCT02395822|3505614|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3659665|NCT02395822|3505614|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3659666|NCT02395822|3505614|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3659667|NCT02395653|3505622|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3659668|NCT02395653|3505622|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3659669|NCT02395653|3505622|B1|||Age||years|Mean|14.7|14.7|Standard Deviation|1.54|1.54|||
3659670|NCT02395536|3505629|B3|||Renal dysfunction||Participants|Count of Participants|21|21.0||||||
3659671|NCT02395536|3505630|B2|||Renal dysfunction||Participants|Count of Participants|14|14.0||||||
3659672|NCT02395536|3505631|B1|||Renal dysfunction||Participants|Count of Participants|7|7.0||||||
3659673|NCT02395536|3505629|B3|||Diabetes||Participants|Count of Participants|96|96.0||||||
3659674|NCT02395536|3505630|B2|||Diabetes||Participants|Count of Participants|53|53.0||||||
3659675|NCT02395536|3505631|B1|||Diabetes||Participants|Count of Participants|43|43.0||||||
3659676|NCT02395536|3505629|B3|||Persistent/permanent atrial fibrillation||Participants|Count of Participants|28|28.0||||||
3659677|NCT02395536|3505630|B2|||Persistent/permanent atrial fibrillation||Participants|Count of Participants|14|14.0||||||
3659678|NCT02395536|3505631|B1|||Persistent/permanent atrial fibrillation||Participants|Count of Participants|14|14.0||||||
3659679|NCT02395536|3505629|B3|||Paroxysmal atrial fibrillation||Participants|Count of Participants|149|149.0||||||
3659680|NCT02395536|3505630|B2|||Paroxysmal atrial fibrillation||Participants|Count of Participants|68|68.0||||||
3659681|NCT02395536|3505631|B1|||Paroxysmal atrial fibrillation||Participants|Count of Participants|81|81.0||||||
3659682|NCT02395536|3505629|B3|||Unexplained syncope||Participants|Count of Participants|124|124.0||||||
3659683|NCT02395536|3505630|B2|||Unexplained syncope||Participants|Count of Participants|76|76.0||||||
3659684|NCT02395536|3505631|B1|||Unexplained syncope||Participants|Count of Participants|48|48.0||||||
3659685|NCT02395536|3505629|B3|||Prior stroke or transient ischemic attack||Participants|Count of Participants|127|127.0||||||
3659686|NCT02395536|3505630|B2|||Prior stroke or transient ischemic attack||Participants|Count of Participants|58|58.0||||||
3659687|NCT02395536|3505631|B1|||Prior stroke or transient ischemic attack||Participants|Count of Participants|69|69.0||||||
3659688|NCT02395536|3505629|B3|||Myocardial infarction||Participants|Count of Participants|23|23.0||||||
3659689|NCT02395536|3505630|B2|||Myocardial infarction||Participants|Count of Participants|10|10.0||||||
3659690|NCT02395536|3505631|B1|||Myocardial infarction||Participants|Count of Participants|13|13.0||||||
3659691|NCT02395536|3505629|B3|||Hypertension||Participants|Count of Participants|308|308.0||||||
3659692|NCT02395536|3505630|B2|||Hypertension||Participants|Count of Participants|146|146.0||||||
3659693|NCT02395536|3505631|B1|||Hypertension||Participants|Count of Participants|162|162.0||||||
3659694|NCT02395536|3505629|B3|||Congestive heart failure||Participants|Count of Participants|14|14.0||||||
3659695|NCT02395536|3505630|B2|||Congestive heart failure||Participants|Count of Participants|9|9.0||||||
3659696|NCT02395536|3505631|B1|||Congestive heart failure||Participants|Count of Participants|5|5.0||||||
3659697|NCT02395536|3505629|B3|||Cardiomyopathy||Participants|Count of Participants|17|17.0||||||
3659698|NCT02395536|3505630|B2|||Cardiomyopathy||Participants|Count of Participants|8|8.0||||||
3659699|NCT02395536|3505631|B1|||Cardiomyopathy||Participants|Count of Participants|9|9.0||||||
3659700|NCT02395536|3505629|B3|||Body mass index (kg/m^2)||kg/m^2|Mean|30.0|30.0|Standard Deviation|7.3|7.3|||
3659701|NCT02395536|3505630|B2|||Body mass index (kg/m^2)||kg/m^2|Mean|29.6|29.6|Standard Deviation|7.1|7.1|||
3659702|NCT02395536|3505631|B1|||Body mass index (kg/m^2)||kg/m^2|Mean|30.3|30.3|Standard Deviation|7.5|7.5|||
3659703|NCT02395536|3505629|B3|United States||Region of Enrollment||participants|Number|482|482.0||||||
3659704|NCT02395536|3505630|B2|United States||Region of Enrollment||participants|Number|231|231.0||||||
3659705|NCT02395536|3505631|B1|United States||Region of Enrollment||participants|Number|251|251.0||||||
3659706|NCT02395536|3505629|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3659707|NCT02395536|3505629|B3||Male|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
3659708|NCT02395536|3505630|B2||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3659709|NCT02395536|3505631|B1||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3659710|NCT02395536|3505629|B3||Female|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
3659711|NCT02395536|3505630|B2||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3659712|NCT02395536|3505631|B1||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3659713|NCT02395536|3505629|B3|||Age||years|Mean|64.1|64.1|Standard Deviation|14.4|14.4|||
3659714|NCT02395536|3505630|B2|||Age||years|Mean|63.9|63.9|Standard Deviation|14.9|14.9|||
3659715|NCT02395536|3505631|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|14.0|14.0|||
3659716|NCT02395302|3505638|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3659717|NCT02395302|3505638|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3659718|NCT02395302|3505638|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3659719|NCT02395302|3505638|B1|||Age||years|Mean|61.9|61.9|Standard Deviation|13.8|13.8|||
3659720|NCT02395185|3505642|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
3659721|NCT02395185|3505642|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3659722|NCT02395185|3505642|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3659723|NCT02395185|3505642|B1|||Age||days|Mean|17.9|17.9|Standard Deviation|20.5|20.5|||
3659724|NCT02395185|3505642|B1|>=65 years||Age, Customized||participants|Number|0|0.0||||||
3659725|NCT02395185|3505642|B1|Between 18 and 65 years||Age, Customized||participants|Number|0|0.0||||||
3659726|NCT02395185|3505642|B1|<=18 years||Age, Customized||participants|Number|33|33.0||||||
3659727|NCT02395172|3505656|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3659728|NCT02395172|3505657|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3659729|NCT02395172|3505658|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3659730|NCT02395172|3505656|B3||Not collected at the site|Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3659731|NCT02395172|3505657|B2||Not collected at the site|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3659732|NCT02395172|3505658|B1||Not collected at the site|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3659733|NCT02395172|3505656|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|535|535.0||||||
3659734|NCT02395172|3505657|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|262|262.0||||||
3659735|NCT02395172|3505658|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|273|273.0||||||
3659736|NCT02395172|3505656|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3659737|NCT02395172|3505657|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3659738|NCT02395172|3505658|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3659739|NCT02395172|3505656|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3659740|NCT02395172|3505657|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3659741|NCT02395172|3505658|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3659742|NCT02395172|3505656|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|216|216.0||||||
3659743|NCT02395172|3505657|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|114|114.0||||||
3659744|NCT02395172|3505658|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|102|102.0||||||
3659745|NCT02395172|3505656|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3659746|NCT02395172|3505657|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3659747|NCT02395172|3505658|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3659748|NCT02395172|3505656|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3659749|NCT02395172|3505657|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3659750|NCT02395172|3505658|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3659751|NCT02395172|3505656|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|604|604.0||||||
3659752|NCT02395172|3505657|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|307|307.0||||||
3659753|NCT02395172|3505658|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|297|297.0||||||
3659754|NCT02395172|3505656|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
3659755|NCT02395172|3505657|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3659756|NCT02395172|3505658|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3659757|NCT02395172|3505656|B3||Male|Sex: Female, Male||Participants|Count of Participants|542|542.0||||||
3659758|NCT02395172|3505657|B2||Male|Sex: Female, Male||Participants|Count of Participants|273|273.0||||||
3659759|NCT02395172|3505658|B1||Male|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
3659760|NCT02395172|3505656|B3||Female|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
3659761|NCT02395172|3505657|B2||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3659762|NCT02395172|3505658|B1||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3659763|NCT02395172|3505656|B3|||Age||years|Mean|62.7|62.7|Standard Deviation|9.81|9.81|||
3659764|NCT02395172|3505657|B2|||Age||years|Mean|62.5|62.5|Standard Deviation|9.65|9.65|||
3659765|NCT02395172|3505658|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|9.99|9.99|||
3659766|NCT02395133|3505694|B5|||Total Hospital Anxiety Depression Scale (HADS)|The HADS is a fourteen item scale. Seven of the items relate to anxiety and seven relate to depression. Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 (no symptoms) and 21 (severe symptoms) for either anxiety or depression. Cut-offs for identifying psychiatric distress has been reported as 7 to 8 for possible presence, 10 to 11 for probable presence, and 14 to 15 for severe anxiety or depression.|units on a scale|Mean|6.6|6.6|Standard Deviation|6.53|6.53|||
3659767|NCT02395133|3505695|B4|||Total Hospital Anxiety Depression Scale (HADS)|The HADS is a fourteen item scale. Seven of the items relate to anxiety and seven relate to depression. Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 (no symptoms) and 21 (severe symptoms) for either anxiety or depression. Cut-offs for identifying psychiatric distress has been reported as 7 to 8 for possible presence, 10 to 11 for probable presence, and 14 to 15 for severe anxiety or depression.|units on a scale|Mean|6.4|6.4|Standard Deviation|5.94|5.94|||
3659768|NCT02395133|3505696|B3|||Total Hospital Anxiety Depression Scale (HADS)|The HADS is a fourteen item scale. Seven of the items relate to anxiety and seven relate to depression. Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 (no symptoms) and 21 (severe symptoms) for either anxiety or depression. Cut-offs for identifying psychiatric distress has been reported as 7 to 8 for possible presence, 10 to 11 for probable presence, and 14 to 15 for severe anxiety or depression.|units on a scale|Mean|7.3|7.3|Standard Deviation|7.53|7.53|||
3659769|NCT02395133|3505697|B2|||Total Hospital Anxiety Depression Scale (HADS)|The HADS is a fourteen item scale. Seven of the items relate to anxiety and seven relate to depression. Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 (no symptoms) and 21 (severe symptoms) for either anxiety or depression. Cut-offs for identifying psychiatric distress has been reported as 7 to 8 for possible presence, 10 to 11 for probable presence, and 14 to 15 for severe anxiety or depression.|units on a scale|Mean|7.1|7.1|Standard Deviation|6.87|6.87|||
3659770|NCT02395133|3505698|B1|||Total Hospital Anxiety Depression Scale (HADS)|The HADS is a fourteen item scale. Seven of the items relate to anxiety and seven relate to depression. Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 (no symptoms) and 21 (severe symptoms) for either anxiety or depression. Cut-offs for identifying psychiatric distress has been reported as 7 to 8 for possible presence, 10 to 11 for probable presence, and 14 to 15 for severe anxiety or depression.|units on a scale|Mean|5.9|5.9|Standard Deviation|6.36|6.36|||
3659771|NCT02395133|3505694|B5|||Dermatology Life Quality Index (DLQI) Score|The DLQI is a 10-item, validated questionnaire used in clinical practice and clinical trials to assess the impact of AD disease symptoms and treatment on quality of life (QOL). The 10 questions assessed QOL over the past week, with an overall scoring of 0 (absent disease) to 30 (severe disease); a high score indicative of a poor QOL.|units on a scale|Mean|3.3|3.3|Standard Deviation|4.06|4.06|||
3659772|NCT02395133|3505695|B4|||Dermatology Life Quality Index (DLQI) Score|The DLQI is a 10-item, validated questionnaire used in clinical practice and clinical trials to assess the impact of AD disease symptoms and treatment on quality of life (QOL). The 10 questions assessed QOL over the past week, with an overall scoring of 0 (absent disease) to 30 (severe disease); a high score indicative of a poor QOL.|units on a scale|Mean|3.4|3.4|Standard Deviation|4.21|4.21|||
3659773|NCT02395133|3505696|B3|||Dermatology Life Quality Index (DLQI) Score|The DLQI is a 10-item, validated questionnaire used in clinical practice and clinical trials to assess the impact of AD disease symptoms and treatment on quality of life (QOL). The 10 questions assessed QOL over the past week, with an overall scoring of 0 (absent disease) to 30 (severe disease); a high score indicative of a poor QOL.|units on a scale|Mean|3.2|3.2|Standard Deviation|3.93|3.93|||
3659774|NCT02395133|3505697|B2|||Dermatology Life Quality Index (DLQI) Score|The DLQI is a 10-item, validated questionnaire used in clinical practice and clinical trials to assess the impact of AD disease symptoms and treatment on quality of life (QOL). The 10 questions assessed QOL over the past week, with an overall scoring of 0 (absent disease) to 30 (severe disease); a high score indicative of a poor QOL.|units on a scale|Mean|3.0|3.0|Standard Deviation|3.76|3.76|||
3659816|NCT02395133|3505694|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3659817|NCT02395133|3505695|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3659775|NCT02395133|3505698|B1|||Dermatology Life Quality Index (DLQI) Score|The DLQI is a 10-item, validated questionnaire used in clinical practice and clinical trials to assess the impact of AD disease symptoms and treatment on quality of life (QOL). The 10 questions assessed QOL over the past week, with an overall scoring of 0 (absent disease) to 30 (severe disease); a high score indicative of a poor QOL.|units on a scale|Mean|3.4|3.4|Standard Deviation|4.25|4.25|||
3659776|NCT02395133|3505694|B5|||Patient Oriented Eczema Measure (POEM)|The POEM was a 7-item questionnaire that assessed disease symptoms (dryness,itching, flaking, cracking, sleep loss, bleeding and weeping) with a scoring system of 0 (absent disease) to 28 (severe disease) (high score indicative of poor quality of life [QOL]).|units on a scale|Mean|6.3|6.3|Standard Deviation|5.40|5.4|||
3659777|NCT02395133|3505695|B4|||Patient Oriented Eczema Measure (POEM)|The POEM was a 7-item questionnaire that assessed disease symptoms (dryness,itching, flaking, cracking, sleep loss, bleeding and weeping) with a scoring system of 0 (absent disease) to 28 (severe disease) (high score indicative of poor quality of life [QOL]).|units on a scale|Mean|6.4|6.4|Standard Deviation|5.30|5.3|||
3659778|NCT02395133|3505696|B3|||Patient Oriented Eczema Measure (POEM)|The POEM was a 7-item questionnaire that assessed disease symptoms (dryness,itching, flaking, cracking, sleep loss, bleeding and weeping) with a scoring system of 0 (absent disease) to 28 (severe disease) (high score indicative of poor quality of life [QOL]).|units on a scale|Mean|6.1|6.1|Standard Deviation|5.11|5.11|||
3659779|NCT02395133|3505697|B2|||Patient Oriented Eczema Measure (POEM)|The POEM was a 7-item questionnaire that assessed disease symptoms (dryness,itching, flaking, cracking, sleep loss, bleeding and weeping) with a scoring system of 0 (absent disease) to 28 (severe disease) (high score indicative of poor quality of life [QOL]).|units on a scale|Mean|6.8|6.8|Standard Deviation|5.88|5.88|||
3659780|NCT02395133|3505698|B1|||Patient Oriented Eczema Measure (POEM)|The POEM was a 7-item questionnaire that assessed disease symptoms (dryness,itching, flaking, cracking, sleep loss, bleeding and weeping) with a scoring system of 0 (absent disease) to 28 (severe disease) (high score indicative of poor quality of life [QOL]).|units on a scale|Mean|6.1|6.1|Standard Deviation|5.43|5.43|||
3659781|NCT02395133|3505694|B5|||SCORing Atopic Dermatitis (SCORAD) Score|SCORAD was a clinical tool for assessing the severity of AD developed by the European Task Force on Atopic Dermatitis (Severity scoring of atopic dermatitis: the SCORAD index). Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology (Basel) 186 (1): 23–31. 1993. Extent and intensity of eczema as well as subjective signs (insomnia, etc.) were assessed and scored. Total score ranges from 0 (absent disease) to 103 (severe disease).|units on a scale|Mean|17.1|17.1|Standard Deviation|10.18|10.18|||
3659782|NCT02395133|3505695|B4|||SCORing Atopic Dermatitis (SCORAD) Score|SCORAD was a clinical tool for assessing the severity of AD developed by the European Task Force on Atopic Dermatitis (Severity scoring of atopic dermatitis: the SCORAD index). Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology (Basel) 186 (1): 23–31. 1993. Extent and intensity of eczema as well as subjective signs (insomnia, etc.) were assessed and scored. Total score ranges from 0 (absent disease) to 103 (severe disease).|units on a scale|Mean|17.1|17.1|Standard Deviation|10.49|10.49|||
3659783|NCT02395133|3505696|B3|||SCORing Atopic Dermatitis (SCORAD) Score|SCORAD was a clinical tool for assessing the severity of AD developed by the European Task Force on Atopic Dermatitis (Severity scoring of atopic dermatitis: the SCORAD index). Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology (Basel) 186 (1): 23–31. 1993. Extent and intensity of eczema as well as subjective signs (insomnia, etc.) were assessed and scored. Total score ranges from 0 (absent disease) to 103 (severe disease).|units on a scale|Mean|17.5|17.5|Standard Deviation|10.59|10.59|||
3659784|NCT02395133|3505697|B2|||SCORing Atopic Dermatitis (SCORAD) Score|SCORAD was a clinical tool for assessing the severity of AD developed by the European Task Force on Atopic Dermatitis (Severity scoring of atopic dermatitis: the SCORAD index). Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology (Basel) 186 (1): 23–31. 1993. Extent and intensity of eczema as well as subjective signs (insomnia, etc.) were assessed and scored. Total score ranges from 0 (absent disease) to 103 (severe disease).|units on a scale|Mean|17.1|17.1|Standard Deviation|9.41|9.41|||
3659785|NCT02395133|3505698|B1|||SCORing Atopic Dermatitis (SCORAD) Score|SCORAD was a clinical tool for assessing the severity of AD developed by the European Task Force on Atopic Dermatitis (Severity scoring of atopic dermatitis: the SCORAD index). Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology (Basel) 186 (1): 23–31. 1993. Extent and intensity of eczema as well as subjective signs (insomnia, etc.) were assessed and scored. Total score ranges from 0 (absent disease) to 103 (severe disease).|units on a scale|Mean|16.8|16.8|Standard Deviation|10.03|10.03|||
3659786|NCT02395133|3505694|B5|||Body Surface Area (BSA) Involvement with AD|Body surface area affected by AD was assessed for each section of the body (the possible highest score for each region was: head and neck [9%], anterior trunk [18%], back [18%], upper limbs [18%], lower limbs [36%], and genitals [1%]). It was reported as a percentage of all major body sections combined.|percentage of body surface area|Mean|8.2|8.2|Standard Deviation|9.18|9.18|||
3659787|NCT02395133|3505695|B4|||Body Surface Area (BSA) Involvement with AD|Body surface area affected by AD was assessed for each section of the body (the possible highest score for each region was: head and neck [9%], anterior trunk [18%], back [18%], upper limbs [18%], lower limbs [36%], and genitals [1%]). It was reported as a percentage of all major body sections combined.|percentage of body surface area|Mean|7.9|7.9|Standard Deviation|9.02|9.02|||
3659788|NCT02395133|3505696|B3|||Body Surface Area (BSA) Involvement with AD|Body surface area affected by AD was assessed for each section of the body (the possible highest score for each region was: head and neck [9%], anterior trunk [18%], back [18%], upper limbs [18%], lower limbs [36%], and genitals [1%]). It was reported as a percentage of all major body sections combined.|percentage of body surface area|Mean|9.3|9.3|Standard Deviation|10.51|10.51|||
3659789|NCT02395133|3505697|B2|||Body Surface Area (BSA) Involvement with AD|Body surface area affected by AD was assessed for each section of the body (the possible highest score for each region was: head and neck [9%], anterior trunk [18%], back [18%], upper limbs [18%], lower limbs [36%], and genitals [1%]). It was reported as a percentage of all major body sections combined.|percentage of body surface area|Mean|7.9|7.9|Standard Deviation|9.04|9.04|||
3659818|NCT02395133|3505696|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3659819|NCT02395133|3505697|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3659790|NCT02395133|3505698|B1|||Body Surface Area (BSA) Involvement with AD|Body surface area affected by AD was assessed for each section of the body (the possible highest score for each region was: head and neck [9%], anterior trunk [18%], back [18%], upper limbs [18%], lower limbs [36%], and genitals [1%]). It was reported as a percentage of all major body sections combined.|percentage of body surface area|Mean|8.1|8.1|Standard Deviation|8.21|8.21|||
3659791|NCT02395133|3505694|B5|||Weekly Average of Peak Daily Pruritus Numerical Rating Scale (NRS)|Pruritus NRS scale is an assessment tool that is used to report the intensity of participant’s pruritus (itch), both maximum and average intensity, during a 24-hour recall period. Participants were asked the following question: how would a participant rate his itch at the worst moment during the previous 24 hours (for maximum itch intensity on a scale of 0 – 10 [0= no itch; 10= worst itch imaginable]).|units on a scale|Mean|2.8|2.8|Standard Deviation|2.08|2.08|||
3659792|NCT02395133|3505695|B4|||Weekly Average of Peak Daily Pruritus Numerical Rating Scale (NRS)|Pruritus NRS scale is an assessment tool that is used to report the intensity of participant’s pruritus (itch), both maximum and average intensity, during a 24-hour recall period. Participants were asked the following question: how would a participant rate his itch at the worst moment during the previous 24 hours (for maximum itch intensity on a scale of 0 – 10 [0= no itch; 10= worst itch imaginable]).|units on a scale|Mean|2.8|2.8|Standard Deviation|1.92|1.92|||
3659793|NCT02395133|3505696|B3|||Weekly Average of Peak Daily Pruritus Numerical Rating Scale (NRS)|Pruritus NRS scale is an assessment tool that is used to report the intensity of participant’s pruritus (itch), both maximum and average intensity, during a 24-hour recall period. Participants were asked the following question: how would a participant rate his itch at the worst moment during the previous 24 hours (for maximum itch intensity on a scale of 0 – 10 [0= no itch; 10= worst itch imaginable]).|units on a scale|Mean|3.1|3.1|Standard Deviation|2.16|2.16|||
3659794|NCT02395133|3505697|B2|||Weekly Average of Peak Daily Pruritus Numerical Rating Scale (NRS)|Pruritus NRS scale is an assessment tool that is used to report the intensity of participant’s pruritus (itch), both maximum and average intensity, during a 24-hour recall period. Participants were asked the following question: how would a participant rate his itch at the worst moment during the previous 24 hours (for maximum itch intensity on a scale of 0 – 10 [0= no itch; 10= worst itch imaginable]).|units on a scale|Mean|2.7|2.7|Standard Deviation|2.27|2.27|||
3659795|NCT02395133|3505698|B1|||Weekly Average of Peak Daily Pruritus Numerical Rating Scale (NRS)|Pruritus NRS scale is an assessment tool that is used to report the intensity of participant’s pruritus (itch), both maximum and average intensity, during a 24-hour recall period. Participants were asked the following question: how would a participant rate his itch at the worst moment during the previous 24 hours (for maximum itch intensity on a scale of 0 – 10 [0= no itch; 10= worst itch imaginable]).|units on a scale|Mean|2.8|2.8|Standard Deviation|2.11|2.11|||
3659796|NCT02395133|3505694|B5|||Eczema Area and Severity Index (EASI) Score|The EASI score was used to measure the severity and extent of atopic dermatitis (AD) and measured erythema, infiltration, excoriation and lichenification on 4 anatomic regions of the body: head, trunk, upper and lower extremities. The total EASI score range from 0 (minimum) to 72 (maximum) points,with the higher scores reflecting the worse severity of AD.|units on a scale|Mean|2.6|2.6|Standard Deviation|2.78|2.78|||
3659797|NCT02395133|3505695|B4|||Eczema Area and Severity Index (EASI) Score|The EASI score was used to measure the severity and extent of atopic dermatitis (AD) and measured erythema, infiltration, excoriation and lichenification on 4 anatomic regions of the body: head, trunk, upper and lower extremities. The total EASI score range from 0 (minimum) to 72 (maximum) points,with the higher scores reflecting the worse severity of AD.|units on a scale|Mean|2.6|2.6|Standard Deviation|2.92|2.92|||
3659798|NCT02395133|3505696|B3|||Eczema Area and Severity Index (EASI) Score|The EASI score was used to measure the severity and extent of atopic dermatitis (AD) and measured erythema, infiltration, excoriation and lichenification on 4 anatomic regions of the body: head, trunk, upper and lower extremities. The total EASI score range from 0 (minimum) to 72 (maximum) points,with the higher scores reflecting the worse severity of AD.|units on a scale|Mean|2.8|2.8|Standard Deviation|3.31|3.31|||
3659799|NCT02395133|3505697|B2|||Eczema Area and Severity Index (EASI) Score|The EASI score was used to measure the severity and extent of atopic dermatitis (AD) and measured erythema, infiltration, excoriation and lichenification on 4 anatomic regions of the body: head, trunk, upper and lower extremities. The total EASI score range from 0 (minimum) to 72 (maximum) points,with the higher scores reflecting the worse severity of AD.|units on a scale|Mean|2.3|2.3|Standard Deviation|2.33|2.33|||
3659800|NCT02395133|3505698|B1|||Eczema Area and Severity Index (EASI) Score|The EASI score was used to measure the severity and extent of atopic dermatitis (AD) and measured erythema, infiltration, excoriation and lichenification on 4 anatomic regions of the body: head, trunk, upper and lower extremities. The total EASI score range from 0 (minimum) to 72 (maximum) points,with the higher scores reflecting the worse severity of AD.|units on a scale|Mean|2.5|2.5|Standard Deviation|2.31|2.31|||
3659801|NCT02395133|3505694|B5|Europe||Region of Enrollment||participants|Number|172|172.0||||||
3659802|NCT02395133|3505695|B4|Europe||Region of Enrollment||participants|Number|69|69.0||||||
3659803|NCT02395133|3505696|B3|Europe||Region of Enrollment||participants|Number|36|36.0||||||
3659804|NCT02395133|3505697|B2|Europe||Region of Enrollment||participants|Number|34|34.0||||||
3659805|NCT02395133|3505698|B1|Europe||Region of Enrollment||participants|Number|33|33.0||||||
3659806|NCT02395133|3505694|B5|Japan||Region of Enrollment||participants|Number|58|58.0||||||
3659807|NCT02395133|3505695|B4|Japan||Region of Enrollment||participants|Number|23|23.0||||||
3659808|NCT02395133|3505696|B3|Japan||Region of Enrollment||participants|Number|12|12.0||||||
3659809|NCT02395133|3505697|B2|Japan||Region of Enrollment||participants|Number|11|11.0||||||
3659810|NCT02395133|3505698|B1|Japan||Region of Enrollment||participants|Number|12|12.0||||||
3659811|NCT02395133|3505694|B5|North America||Region of Enrollment||participants|Number|192|192.0||||||
3659812|NCT02395133|3505695|B4|North America||Region of Enrollment||participants|Number|77|77.0||||||
3659813|NCT02395133|3505696|B3|North America||Region of Enrollment||participants|Number|38|38.0||||||
3659814|NCT02395133|3505697|B2|North America||Region of Enrollment||participants|Number|39|39.0||||||
3659815|NCT02395133|3505698|B1|North America||Region of Enrollment||participants|Number|38|38.0||||||
3659820|NCT02395133|3505698|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3659821|NCT02395133|3505694|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659822|NCT02395133|3505695|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659823|NCT02395133|3505696|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659824|NCT02395133|3505697|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659825|NCT02395133|3505698|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659826|NCT02395133|3505694|B5||White|Race (NIH/OMB)||Participants|Count of Participants|298|298.0||||||
3659827|NCT02395133|3505695|B4||White|Race (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
3659828|NCT02395133|3505696|B3||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3659829|NCT02395133|3505697|B2||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3659830|NCT02395133|3505698|B1||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3659831|NCT02395133|3505694|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3659832|NCT02395133|3505695|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3659833|NCT02395133|3505696|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3659834|NCT02395133|3505697|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3659835|NCT02395133|3505698|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3659836|NCT02395133|3505694|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659837|NCT02395133|3505695|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659838|NCT02395133|3505696|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659839|NCT02395133|3505697|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659840|NCT02395133|3505698|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659841|NCT02395133|3505694|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3659842|NCT02395133|3505695|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3659843|NCT02395133|3505696|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3659844|NCT02395133|3505697|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3659845|NCT02395133|3505698|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3659846|NCT02395133|3505694|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659847|NCT02395133|3505695|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659848|NCT02395133|3505696|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659849|NCT02395133|3505697|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659850|NCT02395133|3505698|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659851|NCT02395133|3505694|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3659852|NCT02395133|3505695|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3659853|NCT02395133|3505696|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659854|NCT02395133|3505697|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659855|NCT02395133|3505698|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3659856|NCT02395133|3505694|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|396|396.0||||||
3659857|NCT02395133|3505695|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|155|155.0||||||
3659858|NCT02395133|3505696|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3659859|NCT02395133|3505697|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
3659860|NCT02395133|3505698|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3659861|NCT02395133|3505694|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3659862|NCT02395133|3505695|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3659863|NCT02395133|3505696|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3659864|NCT02395133|3505697|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3659865|NCT02395133|3505698|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3659866|NCT02395133|3505694|B5||Male|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
3659867|NCT02395133|3505695|B4||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3659868|NCT02395133|3505696|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3659869|NCT02395133|3505697|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3659870|NCT02395133|3505698|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3659871|NCT02395133|3505694|B5||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
3659872|NCT02395133|3505695|B4||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3659873|NCT02395133|3505696|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3659874|NCT02395133|3505697|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3659875|NCT02395133|3505698|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3659876|NCT02395133|3505694|B5|||Age||years|Mean|38.2|38.2|Standard Deviation|14.46|14.46|||
3659877|NCT02395133|3505695|B4|||Age||years|Mean|38.5|38.5|Standard Deviation|13.94|13.94|||
3659878|NCT02395133|3505696|B3|||Age||years|Mean|38.5|38.5|Standard Deviation|16.76|16.76|||
3659879|NCT02395133|3505697|B2|||Age||years|Mean|37.3|37.3|Standard Deviation|13.98|13.98|||
3659880|NCT02395133|3505698|B1|||Age||years|Mean|38.1|38.1|Standard Deviation|13.64|13.64|||
3659881|NCT02395055|3505787|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3659882|NCT02395055|3505788|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3659883|NCT02395055|3505789|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3659884|NCT02395055|3505787|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3659885|NCT02395055|3505788|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3659886|NCT02395055|3505789|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3659887|NCT02395055|3505787|B3|||Age||years|Median|25|25.0|Inter-Quartile Range|||22.0|30.0|
3659888|NCT02395055|3505788|B2|||Age||years|Median|25.5|25.5|Inter-Quartile Range|||22.0|29.0|
3659889|NCT02395055|3505789|B1|||Age||years|Median|24.5|24.5|Inter-Quartile Range|||22.0|30.5|
3659890|NCT02395055|3505787|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3659891|NCT02395055|3505788|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3659892|NCT02395055|3505789|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3659893|NCT02395055|3505787|B3||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
3659894|NCT02395055|3505788|B2||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3659895|NCT02395055|3505789|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3659896|NCT02395055|3505787|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3659897|NCT02395055|3505788|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3659898|NCT02395055|3505789|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3659899|NCT02395042|3505800|B4|||Daily Average Bladder Pain Numeric Rating Scale (NRS)|The participant recorded their daily bladder pain score over the previous 24-hour period on a 7-day pain assessment tool as measured by an NRS on an 11-point scale where 0=no pain to 10=worst pain imaginable. The daily pain scores over the 7-day period were averaged.|score on a scale|Mean|5.7|5.7|Full Range|||3.2|9.3|
3659900|NCT02395042|3505801|B3|||Daily Average Bladder Pain Numeric Rating Scale (NRS)|The participant recorded their daily bladder pain score over the previous 24-hour period on a 7-day pain assessment tool as measured by an NRS on an 11-point scale where 0=no pain to 10=worst pain imaginable. The daily pain scores over the 7-day period were averaged.|score on a scale|Mean|5.6|5.6|Full Range|||4.1|7.8|
3659901|NCT02395042|3505802|B2|||Daily Average Bladder Pain Numeric Rating Scale (NRS)|The participant recorded their daily bladder pain score over the previous 24-hour period on a 7-day pain assessment tool as measured by an NRS on an 11-point scale where 0=no pain to 10=worst pain imaginable. The daily pain scores over the 7-day period were averaged.|score on a scale|Mean|5.5|5.5|Full Range|||3.2|9.3|
3659902|NCT02395042|3505803|B1|||Daily Average Bladder Pain Numeric Rating Scale (NRS)|The participant recorded their daily bladder pain score over the previous 24-hour period on a 7-day pain assessment tool as measured by an NRS on an 11-point scale where 0=no pain to 10=worst pain imaginable. The daily pain scores over the 7-day period were averaged.|score on a scale|Mean|6.0|6.0|Full Range|||4.3|8.0|
3659903|NCT02395042|3505800|B4|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3659904|NCT02395042|3505801|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3659905|NCT02395042|3505802|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3659906|NCT02395042|3505803|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3659907|NCT02395042|3505800|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3659908|NCT02395042|3505801|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3659909|NCT02395042|3505802|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3659910|NCT02395042|3505803|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3659911|NCT02395042|3505800|B4|Black||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3659912|NCT02395042|3505801|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3659913|NCT02395042|3505802|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3659914|NCT02395042|3505803|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3659915|NCT02395042|3505800|B4|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|53|53.0||||||
3659916|NCT02395042|3505801|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3659917|NCT02395042|3505802|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3659918|NCT02395042|3505803|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3659919|NCT02395042|3505800|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3659920|NCT02395042|3505801|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3659921|NCT02395042|3505802|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3659922|NCT02395042|3505803|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3659923|NCT02395042|3505800|B4||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3659924|NCT02395042|3505801|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3659925|NCT02395042|3505802|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3659926|NCT02395042|3505803|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3659927|NCT02395042|3505800|B4|||Age||years|Mean|56.73|56.73|Standard Deviation|12.93|12.93|||
3659928|NCT02395042|3505801|B3|||Age||years|Mean|57.31|57.31|Standard Deviation|14.25|14.25|||
3659929|NCT02395042|3505802|B2|||Age||years|Mean|57.65|57.65|Standard Deviation|12.76|12.76|||
3659930|NCT02395042|3505803|B1|||Age||years|Mean|53.58|53.58|Standard Deviation|12.09|12.09|||
3659931|NCT02394925|3505822|B1|United Kingdom||Region of Enrollment||participants|Number|62|62.0||||||
3659932|NCT02394925|3505822|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
3659933|NCT02394925|3505822|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3659934|NCT02394925|3505822|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659935|NCT02394925|3505822|B1||White|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3659936|NCT02394925|3505822|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3659937|NCT02394925|3505822|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659938|NCT02394925|3505822|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3659939|NCT02394925|3505822|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3659940|NCT02394925|3505822|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3659941|NCT02394925|3505822|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3659942|NCT02394925|3505822|B1|||Age||years|Mean|49.9|49.9|Standard Deviation|6.13|6.13|||
3659943|NCT02394912|3505826|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3659944|NCT02394912|3505826|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3659945|NCT02394912|3505826|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3659946|NCT02394912|3505826|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3659947|NCT02394912|3505826|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3659948|NCT02394912|3505826|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3659949|NCT02394808|3505830|B1|India||Region of Enrollment||participants|Number|54|54.0||||||
3659950|NCT02394808|3505830|B1|Asian||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
3659951|NCT02394808|3505830|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3659952|NCT02394808|3505830|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3659953|NCT02394808|3505830|B1|||Age||years|Mean|25.83|25.83|Standard Deviation|4.621|4.621|||
3659954|NCT02394756|3505839|B1|Canada||Region of Enrollment||participants|Number|42|42.0||||||
3659955|NCT02394756|3505839|B1|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3659956|NCT02394756|3505839|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3659957|NCT02394756|3505839|B1|Asian||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3659958|NCT02394756|3505839|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3659959|NCT02394756|3505839|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3659960|NCT02394756|3505839|B1|||Age||years|Mean|24.0|24.0|Standard Deviation|4.74|4.74|||
3659961|NCT02394665|3505855|B4|United States||Region of Enrollment||participants|Number|1|1.0||||||
3659962|NCT02394665|3505858|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3659963|NCT02394665|3505855|B4||Male|Gender||Participants|Count of Participants|1|1.0||||||
3659964|NCT02394665|3505856|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3659965|NCT02394665|3505857|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3659966|NCT02394665|3505858|B1||Male|Gender||Participants|Count of Participants|1|1.0||||||
3659967|NCT02394665|3505855|B4||Female|Gender||Participants|Count of Participants|0|0.0||||||
3659968|NCT02394665|3505856|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
3659969|NCT02394665|3505857|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
3659970|NCT02394665|3505858|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3659971|NCT02394665|3505855|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3659972|NCT02394665|3505856|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3659973|NCT02394665|3505857|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3659974|NCT02394665|3505858|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3659975|NCT02394665|3505855|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3659976|NCT02394665|3505856|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3659977|NCT02394665|3505857|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3659978|NCT02394665|3505858|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3659979|NCT02394665|3505855|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3659980|NCT02394665|3505856|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3659981|NCT02394665|3505857|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3659982|NCT02394665|3505858|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3659983|NCT02394600|3505880|B3|Canada||Region of Enrollment||Participants|Count of Participants|93|93.0||||||
3659984|NCT02394600|3505881|B2|Canada||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
3659985|NCT02394600|3505882|B1|Canada||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
3659986|NCT02394600|3505880|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3659987|NCT02394600|3505881|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3659988|NCT02394600|3505882|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3659989|NCT02394600|3505880|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3659990|NCT02394600|3505881|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3659991|NCT02394600|3505882|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3659992|NCT02394600|3505880|B3|||Age||years|Mean|38.03|38.03|Full Range|||18.0|65.0|
3659993|NCT02394600|3505881|B2|||Age||years|Mean|38.17|38.17|Full Range|||22.0|58.75|
3659994|NCT02394600|3505882|B1|||Age||years|Mean|37.89|37.89|Full Range|||18.0|65.0|
3659995|NCT02394600|3505880|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3659996|NCT02394600|3505881|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3659997|NCT02394600|3505882|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3659998|NCT02394600|3505880|B3||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
3659999|NCT02394600|3505881|B2||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
3660000|NCT02394600|3505882|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3660001|NCT02394600|3505880|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3660002|NCT02394600|3505881|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3660003|NCT02394600|3505882|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3660004|NCT02394457|3505891|B3|||Neck Stiffness|measure describes number of patients who reported positive for neck stiffness|participants|Number|20|20.0||||||
3660005|NCT02394457|3505892|B2|||Neck Stiffness|measure describes number of patients who reported positive for neck stiffness|participants|Number|10|10.0||||||
3660006|NCT02394457|3505893|B1|||Neck Stiffness|measure describes number of patients who reported positive for neck stiffness|participants|Number|10|10.0||||||
3660007|NCT02394457|3505891|B3|||Nausea/Vomiting|measure describes number of patients who reported positive for nausea/vomiting|participants|Number|21|21.0||||||
3660008|NCT02394457|3505892|B2|||Nausea/Vomiting|measure describes number of patients who reported positive for nausea/vomiting|participants|Number|11|11.0||||||
3660009|NCT02394457|3505893|B1|||Nausea/Vomiting|measure describes number of patients who reported positive for nausea/vomiting|participants|Number|10|10.0||||||
3660010|NCT02394457|3505891|B3|||Positional Headache|measure to obtain headache history was considered positive if the patient reported any previous diagnosis of recurrent headaches or previous post dural headache|participants|Number|25|25.0||||||
3660011|NCT02394457|3505892|B2|||Positional Headache|measure to obtain headache history was considered positive if the patient reported any previous diagnosis of recurrent headaches or previous post dural headache|participants|Number|11|11.0||||||
3660012|NCT02394457|3505893|B1|||Positional Headache|measure to obtain headache history was considered positive if the patient reported any previous diagnosis of recurrent headaches or previous post dural headache|participants|Number|14|14.0||||||
3660013|NCT02394457|3505891|B3|||Function|self-reported function scores were 1-10 with 10 representing the greatest impairment to function|units on a scale|Mean|7.29|7.29|Full Range|||1.0|10.0|
3660014|NCT02394457|3505892|B2|||Function|self-reported function scores were 1-10 with 10 representing the greatest impairment to function|units on a scale|Mean|7.17|7.17|Full Range|||1.0|10.0|
3660015|NCT02394457|3505893|B1|||Function|self-reported function scores were 1-10 with 10 representing the greatest impairment to function|units on a scale|Mean|7.4|7.4|Full Range|||1.0|10.0|
3660016|NCT02394457|3505891|B3|||Pain|Pain was measured 1-10 scale with 10 representing the highest level of pain, number reported was the mean|units on a scale|Number|17.03|17.03||||||
3660017|NCT02394457|3505892|B2|||Pain|Pain was measured 1-10 scale with 10 representing the highest level of pain, number reported was the mean|units on a scale|Number|8.50|8.5||||||
3660018|NCT02394457|3505893|B1|||Pain|Pain was measured 1-10 scale with 10 representing the highest level of pain, number reported was the mean|units on a scale|Number|8.53|8.53||||||
3660019|NCT02394457|3505891|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3660020|NCT02394457|3505892|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3660021|NCT02394457|3505893|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3660022|NCT02394457|3505891|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3660023|NCT02394457|3505892|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3660024|NCT02394457|3505893|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3660025|NCT02394457|3505891|B3|||Age||years|Mean|28.05|28.05|Full Range|||18.0|65.0|
3660026|NCT02394457|3505892|B2|||Age||years|Mean|26.9|26.9|Full Range|||18.0|65.0|
3660027|NCT02394457|3505893|B1|||Age||years|Mean|29.2|29.2|Full Range|||18.0|65.0|
3660028|NCT02393950|3505910|B3|Germany||Region of Enrollment||participants|Number|18|18.0||||||
3660029|NCT02393950|3505911|B2|Germany||Region of Enrollment||participants|Number|9|9.0||||||
3660030|NCT02393950|3505912|B1|Germany||Region of Enrollment||participants|Number|9|9.0||||||
3660031|NCT02393950|3505910|B3||Male|Gender||Participants|Count of Participants|18|18.0||||||
3660032|NCT02393950|3505911|B2||Male|Gender||Participants|Count of Participants|9|9.0||||||
3660033|NCT02393950|3505912|B1||Male|Gender||Participants|Count of Participants|9|9.0||||||
3660034|NCT02393950|3505910|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
3660035|NCT02393950|3505911|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
3660036|NCT02393950|3505912|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3660037|NCT02393950|3505910|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3660038|NCT02393950|3505911|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3660039|NCT02393950|3505912|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3660040|NCT02393950|3505910|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3660041|NCT02393950|3505911|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3660042|NCT02393950|3505912|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3660043|NCT02393950|3505910|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3660044|NCT02393950|3505911|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3660045|NCT02393950|3505912|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3660046|NCT02393677|3505978|B3|India||Region of Enrollment||participants|Number|80|80.0||||||
3660047|NCT02393677|3505979|B2|India||Region of Enrollment||participants|Number|40|40.0||||||
3660048|NCT02393677|3505980|B1|India||Region of Enrollment||participants|Number|40|40.0||||||
3660049|NCT02393677|3505978|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3660050|NCT02393677|3505979|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3660051|NCT02393677|3505980|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3660052|NCT02393677|3505978|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3660053|NCT02393677|3505979|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3660054|NCT02393677|3505980|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3660055|NCT02393677|3505978|B3|||Age||years|Mean|34.86|34.86|Standard Deviation|11.2|11.2|||
3660056|NCT02393677|3505979|B2|||Age||years|Mean|34.52|34.52|Standard Deviation|12.8|12.8|||
3660057|NCT02393677|3505980|B1|||Age||years|Mean|35.2|35.2|Standard Deviation|9.6|9.6|||
3660058|NCT02393547|3505987|B1|||Waist Circumference||cm|Mean|102.1|102.1|Standard Deviation|16.0|16.0|||
3660059|NCT02393547|3505987|B1|||Body Mass Index||units on a scale -- kg/m^2|Mean|30.4|30.4|Standard Deviation|4.5|4.5|||
3660060|NCT02393547|3505987|B1|||Weight||kg|Mean|90.3|90.3|Standard Deviation|26.2|26.2|||
3660061|NCT02393547|3505987|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660062|NCT02393547|3505987|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660063|NCT02393547|3505987|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3660064|NCT02393547|3505987|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660065|NCT02393547|3505987|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660066|NCT02393547|3505987|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660067|NCT02393547|3505987|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660068|NCT02393547|3505987|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660069|NCT02393547|3505987|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3660070|NCT02393547|3505987|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3660071|NCT02393547|3505987|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3660072|NCT02393547|3505987|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3660073|NCT02393547|3505987|B1|||Age||years|Mean|41.7|41.7|Standard Deviation|11.4|11.4|||
3660074|NCT02393547|3505987|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3660075|NCT02393547|3505987|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3660076|NCT02393547|3505987|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3660077|NCT02393209|3505994|B3|||Body Surface Area|Body Surface Area (m^2) = Square root [height (cm) * weight (kg) / 3600].|m^2|Mean|1.839|1.839|Standard Deviation|0.2084|0.2084|||
3660078|NCT02393209|3505995|B2|||Body Surface Area|Body Surface Area (m^2) = Square root [height (cm) * weight (kg) / 3600].|m^2|Mean|1.865|1.865|Standard Deviation|0.1231|0.1231|||
3660079|NCT02393209|3505996|B1|||Body Surface Area|Body Surface Area (m^2) = Square root [height (cm) * weight (kg) / 3600].|m^2|Mean|1.805|1.805|Standard Deviation|0.2987|0.2987|||
3660080|NCT02393209|3505994|B3|||Weight||kg|Mean|71.31|71.31|Standard Deviation|15.093|15.093|||
3660081|NCT02393209|3505995|B2|||Weight||kg|Mean|72.69|72.69|Standard Deviation|9.157|9.157|||
3660082|NCT02393209|3505996|B1|||Weight||kg|Mean|69.48|69.48|Standard Deviation|21.630|21.63|||
3660083|NCT02393209|3505994|B3|||Height||cm|Mean|172.34|172.34|Standard Deviation|5.810|5.81|||
3660084|NCT02393209|3505995|B2|||Height||cm|Mean|172.95|172.95|Standard Deviation|6.102|6.102|||
3660085|NCT02393209|3505996|B1|||Height||cm|Mean|171.53|171.53|Standard Deviation|5.854|5.854|||
3660086|NCT02393209|3505994|B3|Not reported||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3660087|NCT02393209|3505995|B2|Not reported||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3660088|NCT02393209|3505996|B1|Not reported||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3660089|NCT02393209|3505994|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3660090|NCT02393209|3505995|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3660091|NCT02393209|3505996|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3660092|NCT02393209|3505994|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3660093|NCT02393209|3505995|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3660094|NCT02393209|3505996|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3660095|NCT02393209|3505994|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3660096|NCT02393209|3505995|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3660097|NCT02393209|3505996|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3660098|NCT02393209|3505994|B3|Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3660099|NCT02393209|3505995|B2|Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3660100|NCT02393209|3505996|B1|Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3660101|NCT02393209|3505994|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3660102|NCT02393209|3505995|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3660103|NCT02393209|3505996|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3660104|NCT02393209|3505994|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3660105|NCT02393209|3505995|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3660106|NCT02393209|3505996|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3660107|NCT02393209|3505994|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3660108|NCT02393209|3505995|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3660109|NCT02393209|3505996|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3660110|NCT02393209|3505994|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3660111|NCT02393209|3505995|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3660112|NCT02393209|3505996|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3660113|NCT02393209|3505994|B3|||Age||years|Mean|62.9|62.9|Standard Deviation|9.75|9.75|||
3660114|NCT02393209|3505995|B2|||Age||years|Mean|62.1|62.1|Standard Deviation|11.32|11.32|||
3660115|NCT02393209|3505996|B1|||Age||years|Mean|64.0|64.0|Standard Deviation|8.10|8.1|||
3660116|NCT02392806|3506055|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3660117|NCT02392806|3506056|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3660118|NCT02392806|3506057|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3660119|NCT02392806|3506055|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3660120|NCT02392806|3506056|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3660121|NCT02392806|3506057|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3660122|NCT02392806|3506055|B3|||Age||Weeks Gestational Age|Mean|25.7|25.7|Standard Deviation|1.7|1.7|||
3660123|NCT02392806|3506056|B2|||Age||Weeks Gestational Age|Mean|25.4|25.4|Standard Deviation|1.4|1.4|||
3660124|NCT02392806|3506057|B1|||Age||Weeks Gestational Age|Mean|26.0|26.0|Standard Deviation|2.0|2.0|||
3660125|NCT02392767|3506066|B3|Germany||Region of Enrollment||participants|Number|25|25.0||||||
3660126|NCT02392767|3506067|B2|Germany||Region of Enrollment||participants|Number|13|13.0||||||
3660127|NCT02392767|3506068|B1|Germany||Region of Enrollment||participants|Number|12|12.0||||||
3660128|NCT02392767|3506066|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3660129|NCT02392767|3506067|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3660130|NCT02392767|3506068|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3660131|NCT02392767|3506066|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3660132|NCT02392767|3506067|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3660133|NCT02392767|3506068|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3660134|NCT02392767|3506066|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3660135|NCT02392767|3506067|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3660136|NCT02392767|3506068|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3660137|NCT02392767|3506066|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3660138|NCT02392767|3506067|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3660139|NCT02392767|3506068|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3660140|NCT02392767|3506066|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3660141|NCT02392767|3506067|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3660142|NCT02392767|3506068|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3660143|NCT02392624|3506085|B4|Ethnicity: Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3660144|NCT02392624|3506086|B3|Ethnicity: Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3660145|NCT02392624|3506087|B2|Ethnicity: Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3660146|NCT02392624|3506088|B1|Ethnicity: Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3660147|NCT02392624|3506085|B4|Ethnicity: Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|161|161.0||||||
3660148|NCT02392624|3506086|B3|Ethnicity: Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
3660149|NCT02392624|3506087|B2|Ethnicity: Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
3660150|NCT02392624|3506088|B1|Ethnicity: Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
3660151|NCT02392624|3506085|B4|Ethnicity: Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
3660152|NCT02392624|3506086|B3|Ethnicity: Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3660153|NCT02392624|3506087|B2|Ethnicity: Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3660154|NCT02392624|3506088|B1|Ethnicity: Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3660155|NCT02392624|3506085|B4|Race: Mixed/Unknown||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3660156|NCT02392624|3506086|B3|Race: Mixed/Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3660157|NCT02392624|3506087|B2|Race: Mixed/Unknown||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3660158|NCT02392624|3506088|B1|Race: Mixed/Unknown||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3660159|NCT02392624|3506085|B4|Race: White||Race/Ethnicity, Customized||participants|Number|168|168.0||||||
3660160|NCT02392624|3506086|B3|Race: White||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
3660161|NCT02392624|3506087|B2|Race: White||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
3660162|NCT02392624|3506088|B1|Race: White||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
3660163|NCT02392624|3506085|B4|Race: Black or African American||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3660164|NCT02392624|3506086|B3|Race: Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3660165|NCT02392624|3506087|B2|Race: Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3660166|NCT02392624|3506088|B1|Race: Black or African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3660167|NCT02392624|3506085|B4|Race: Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3660168|NCT02392624|3506086|B3|Race: Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3660169|NCT02392624|3506087|B2|Race: Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3660170|NCT02392624|3506088|B1|Race: Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3660171|NCT02392624|3506085|B4|Race: American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3660172|NCT02392624|3506086|B3|Race: American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3660173|NCT02392624|3506087|B2|Race: American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3660174|NCT02392624|3506088|B1|Race: American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3660175|NCT02392624|3506085|B4||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3660176|NCT02392624|3506086|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3660177|NCT02392624|3506087|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3660178|NCT02392624|3506088|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3660179|NCT02392624|3506085|B4||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3660180|NCT02392624|3506086|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3660181|NCT02392624|3506087|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3660182|NCT02392624|3506088|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3660183|NCT02392624|3506085|B4|||Age||years|Mean|44.6|44.6|Standard Deviation|14.46|14.46|||
3660184|NCT02392624|3506086|B3|||Age||years|Mean|48.5|48.5|Standard Deviation|13.22|13.22|||
3660185|NCT02392624|3506087|B2|||Age||years|Mean|43.1|43.1|Standard Deviation|14.68|14.68|||
3660186|NCT02392624|3506088|B1|||Age||years|Mean|43.5|43.5|Standard Deviation|14.76|14.76|||
3660187|NCT02392494|3506103|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3660188|NCT02392494|3506104|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3660189|NCT02392494|3506105|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3660190|NCT02392494|3506106|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3660191|NCT02392494|3506103|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3660192|NCT02392494|3506104|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3660193|NCT02392494|3506105|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3660194|NCT02392494|3506106|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3660195|NCT02392494|3506103|B4|||Age||years|Mean|47.4|47.4|Standard Deviation|9.3|9.3|||
3660196|NCT02392494|3506104|B3|||Age||years|Mean|49.7|49.7|Standard Deviation|2.5|2.5|||
3660197|NCT02392494|3506105|B2|||Age||years|Mean|44.0|44.0|Standard Deviation|8.0|8.0|||
3660198|NCT02392494|3506106|B1|||Age||years|Mean|48.7|48.7|Standard Deviation|15.7|15.7|||
3660199|NCT02392481|3506123|B5||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3660200|NCT02392481|3506124|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3660201|NCT02392481|3506125|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3660202|NCT02392481|3506126|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3660203|NCT02392481|3506127|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3660204|NCT02392481|3506123|B5||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3660205|NCT02392481|3506124|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3660206|NCT02392481|3506125|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3660207|NCT02392481|3506126|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3660208|NCT02392481|3506127|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3660209|NCT02392481|3506123|B5|||Age||Years|Mean|44.8|44.8|Standard Deviation|14.2|14.2|||
3660210|NCT02392481|3506124|B4|||Age||Years|Mean|50.2|50.2|Standard Deviation|13.6|13.6|||
3660211|NCT02392481|3506125|B3|||Age||Years|Mean|44.9|44.9|Standard Deviation|12.6|12.6|||
3660212|NCT02392481|3506126|B2|||Age||Years|Mean|36.1|36.1|Standard Deviation|13.5|13.5|||
3660213|NCT02392481|3506127|B1|||Age||Years|Mean|40.3|40.3|Standard Deviation|14.6|14.6|||
3660214|NCT02392403|3506152|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3660215|NCT02392403|3506152|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3660216|NCT02392403|3506152|B1|||Age||years|Mean|61|61.0|Standard Deviation|15|15.0|||
3660217|NCT02392403|3506152|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3660218|NCT02392403|3506152|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3660219|NCT02392403|3506152|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3660220|NCT02392377|3506164|B3|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3660221|NCT02392377|3506165|B2|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3660222|NCT02392377|3506164|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660223|NCT02392377|3506165|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660224|NCT02392377|3506166|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660225|NCT02392377|3506164|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660226|NCT02392377|3506165|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660227|NCT02392377|3506166|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660228|NCT02392377|3506164|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3660229|NCT02392377|3506165|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3660230|NCT02392377|3506166|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660231|NCT02392377|3506164|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660232|NCT02392377|3506165|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660233|NCT02392377|3506166|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660234|NCT02392377|3506164|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660235|NCT02392377|3506165|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660236|NCT02392377|3506166|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660237|NCT02392377|3506164|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660238|NCT02392377|3506165|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660239|NCT02392377|3506166|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660240|NCT02392377|3506164|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660241|NCT02392377|3506165|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660242|NCT02392377|3506166|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660243|NCT02392377|3506164|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660244|NCT02392377|3506165|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660245|NCT02392377|3506166|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660246|NCT02392377|3506164|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3660247|NCT02392377|3506165|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3660248|NCT02392377|3506166|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660249|NCT02392377|3506164|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660250|NCT02392377|3506165|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660251|NCT02392377|3506166|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660252|NCT02392377|3506164|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3660253|NCT02392377|3506165|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3660254|NCT02392377|3506166|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3660255|NCT02392377|3506164|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3660256|NCT02392377|3506165|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3660257|NCT02392377|3506166|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3660258|NCT02392377|3506164|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3660259|NCT02392377|3506165|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3660260|NCT02392377|3506166|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3660261|NCT02392377|3506164|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3660262|NCT02392377|3506165|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3660263|NCT02392377|3506166|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3660264|NCT02392377|3506164|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3660265|NCT02392377|3506165|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3660266|NCT02392377|3506166|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3660267|NCT02392247|3506191|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3660268|NCT02392247|3506191|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3660269|NCT02392247|3506191|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660270|NCT02392247|3506191|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3660271|NCT02392247|3506191|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3660272|NCT02392247|3506191|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660273|NCT02392247|3506191|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3660274|NCT02392247|3506191|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660275|NCT02392247|3506191|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3660276|NCT02392247|3506191|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3660277|NCT02392247|3506191|B1|||Age||years|Mean|60|60.0|Standard Deviation|14|14.0|||
3660278|NCT02392247|3506191|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3660279|NCT02392247|3506191|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3660280|NCT02392247|3506191|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3660281|NCT02392234|3506196|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3660282|NCT02392234|3506197|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660283|NCT02392234|3506198|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3660284|NCT02392234|3506199|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660285|NCT02392234|3506200|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660286|NCT02392234|3506201|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3660287|NCT02392234|3506202|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660288|NCT02392234|3506196|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660289|NCT02392234|3506197|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660290|NCT02392234|3506198|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660291|NCT02392234|3506199|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660292|NCT02392234|3506200|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660293|NCT02392234|3506201|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660294|NCT02392234|3506202|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660295|NCT02392234|3506196|B7||White|Race (NIH/OMB)||Participants|Count of Participants|241|241.0||||||
3660296|NCT02392234|3506197|B6||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3660297|NCT02392234|3506198|B5||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3660298|NCT02392234|3506199|B4||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3660299|NCT02392234|3506200|B3||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3660300|NCT02392234|3506201|B2||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3660301|NCT02392234|3506202|B1||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3660302|NCT02392234|3506196|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3660303|NCT02392234|3506197|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3660304|NCT02392234|3506198|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660305|NCT02392234|3506199|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660306|NCT02392234|3506200|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660307|NCT02392234|3506201|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660308|NCT02392234|3506202|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3660309|NCT02392234|3506196|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660310|NCT02392234|3506197|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660311|NCT02392234|3506198|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660312|NCT02392234|3506199|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660313|NCT02392234|3506200|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660314|NCT02392234|3506201|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660315|NCT02392234|3506202|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660316|NCT02392234|3506196|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660317|NCT02392234|3506197|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660318|NCT02392234|3506198|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660319|NCT02392234|3506199|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660320|NCT02392234|3506200|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660321|NCT02392234|3506201|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660322|NCT02392234|3506202|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660323|NCT02392234|3506196|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3660324|NCT02392234|3506197|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3660325|NCT02392234|3506198|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660326|NCT02392234|3506199|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660327|NCT02392234|3506200|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660328|NCT02392234|3506201|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660329|NCT02392234|3506202|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660330|NCT02392234|3506196|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3660331|NCT02392234|3506197|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660332|NCT02392234|3506198|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3660333|NCT02392234|3506199|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660334|NCT02392234|3506200|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660335|NCT02392234|3506201|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660336|NCT02392234|3506202|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660337|NCT02392234|3506196|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|237|237.0||||||
3660338|NCT02392234|3506197|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3660339|NCT02392234|3506198|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3660340|NCT02392234|3506199|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3660341|NCT02392234|3506200|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3660342|NCT02392234|3506201|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3660343|NCT02392234|3506202|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3660344|NCT02392234|3506196|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3660345|NCT02392234|3506197|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3660346|NCT02392234|3506198|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3660347|NCT02392234|3506199|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3660348|NCT02392234|3506200|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3660349|NCT02392234|3506201|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660350|NCT02392234|3506202|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3660351|NCT02392234|3506196|B7||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3660352|NCT02392234|3506197|B6||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3660353|NCT02392234|3506198|B5||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3660354|NCT02392234|3506199|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3660355|NCT02392234|3506200|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3660356|NCT02392234|3506201|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3660357|NCT02392234|3506202|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3660358|NCT02392234|3506196|B7||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3660359|NCT02392234|3506197|B6||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3660360|NCT02392234|3506198|B5||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3660361|NCT02392234|3506199|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3660362|NCT02392234|3506200|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3660363|NCT02392234|3506201|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3660364|NCT02392234|3506202|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3660365|NCT02392234|3506196|B7||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3660366|NCT02392234|3506197|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3660367|NCT02392234|3506198|B5||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3660368|NCT02392234|3506199|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3660369|NCT02392234|3506200|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3660370|NCT02392234|3506201|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3660371|NCT02392234|3506202|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3660372|NCT02392234|3506196|B7||Between 18 and 65 years|Age||Participants|Count of Participants|212|212.0||||||
3660373|NCT02392234|3506197|B6||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3660374|NCT02392234|3506198|B5||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3660375|NCT02392234|3506199|B4||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3660376|NCT02392234|3506200|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3660377|NCT02392234|3506201|B2||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3660378|NCT02392234|3506202|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3660379|NCT02392234|3506196|B7||<=18 years|Age||Participants|Count of Participants|34|34.0||||||
3660380|NCT02392234|3506197|B6||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3660381|NCT02392234|3506198|B5||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3660382|NCT02392234|3506199|B4||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3660383|NCT02392234|3506200|B3||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
3660384|NCT02392234|3506201|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3660385|NCT02392234|3506202|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3660386|NCT02392208|3506229|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660387|NCT02392208|3506229|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660388|NCT02392208|3506229|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3660389|NCT02392208|3506229|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3660390|NCT02392208|3506229|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660391|NCT02392208|3506229|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660392|NCT02392208|3506229|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660393|NCT02392208|3506229|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660394|NCT02392208|3506229|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3660395|NCT02392208|3506229|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660396|NCT02392208|3506229|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3660397|NCT02392208|3506229|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3660398|NCT02392208|3506229|B1|||Age||years|Mean|47|47.0|Standard Deviation|20|20.0|||
3660399|NCT02392000|3506239|B1|||WatchPAT Behavioral Intention|The minimum for this subscale score is 2. The maximum for this subscale score is 14. Higher scores indicate greater behavioral intention to use the WatchPAT. These scores are from the Usability Survey which is given only at the baseline and used to predict later tech use. Also, because this predictor is measured at baseline to predict initiation of tech use, we can use the complete, enrolled sample of 38, even if individuals are withdrawn later for apnea.|units on a scale|Mean|12.6|12.6|Standard Deviation|2.2|2.2|||
3660400|NCT02392000|3506239|B1|||WatchPAT Perceived Usefulness|The minimum for this subscale score is 3. The maximum for this subscale score is 21. Higher scores indicate greater perceived usefulness of the WatchPAT. These scores are from the Usability Survey which is given only at the baseline and used to predict later tech use. Also, because this predictor is measured at baseline to predict initiation of tech use, we can use the complete, enrolled sample of 38, even if individuals are withdrawn later for apnea.|units on a scale|Mean|16.3|16.3|Standard Deviation|3.3|3.3|||
3660401|NCT02392000|3506239|B1|||WatchPAT Perceived Ease of Use|The minimum for this subscale score is 3. The maximum for this subscale score is 21. Higher scores indicate greater perceived ease of use of the WatchPAT. These scores are from the Usability Survey which is given only at the baseline and used to predict later tech use. Also, because this predictor is measured at baseline to predict initiation of tech use, we can use the complete, enrolled sample of 38, even if individuals are withdrawn later for apnea.|units on a scale|Mean|16.7|16.7|Standard Deviation|3.4|3.4|||
3660402|NCT02392000|3506239|B1|||WatchPAT Intrinsic Motivation|The minimum for this subscale score is 3. The maximum for this subscale score is 21. Higher scores indicate greater intrinsic motivation to use the WatchPAT. These scores are from the Usability Survey which is given only at the baseline and used to predict later tech use. Also, because this predictor is measured at baseline to predict initiation of tech use, we can use the complete, enrolled sample of 38, even if individuals are withdrawn later for apnea.|units on a scale|Mean|13.9|13.9|Standard Deviation|3.8|3.8|||
3660403|NCT02392000|3506239|B1|||CBT-i Coach Behavioral Intention|The minimum for this subscale score is 2. The maximum for this subscale score is 14. Higher scores indicate greater behavioral intention to use the CBT-i Coach app. These scores are from the Usability Survey which is given only at the baseline and used to predict later tech use. Also, because this predictor is measured at baseline to predict initiation of tech use, we can use the complete, enrolled sample of 38, even if individuals are withdrawn later for apnea.|units on a scale|Mean|12.5|12.5|Standard Deviation|2.1|2.1|||
3660404|NCT02392000|3506239|B1|||CBT-i Coach Perceived Usefulness|The minimum for this subscale score is 3. The maximum for this subscale score is 21. Higher scores indicate greater perceived usefulness of the CBT-i Coach app. These scores are from the Usability Survey which is given only at the baseline and used to predict later tech use. Also, because this predictor is measured at baseline to predict initiation of tech use, we can use the complete, enrolled sample of 38, even if individuals are withdrawn later for apnea.|units on a scale|Mean|15.9|15.9|Standard Deviation|3.0|3.0|||
3660405|NCT02392000|3506239|B1|||CBT-i Coach Perceived Ease of Use|The minimum for this subscale score is 3. The maximum for this subscale score is 21. Higher scores indicate greater perceived ease of use of the CBT-i Coach app. These scores are from the Usability Survey which is given only at the baseline and used to predict later tech use. Also, because this predictor is measured at baseline to predict initiation of tech use, we can use the complete, enrolled sample of 38, even if individuals are withdrawn later for apnea.|units on a scale|Mean|16.1|16.1|Standard Deviation|2.9|2.9|||
3660406|NCT02392000|3506239|B1|||CBT-i Coach App Intrinsic Motivation|The minimum for this subscale score is 3. The maximum for this subscale score is 21. Higher scores indicate greater intrinsic motivation to use the CBT-i Coach app. These scores are from the Usability Survey which is given only at the baseline and used to predict later tech use. Also, because this predictor is measured at baseline to predict initiation of tech use, we can use the complete, enrolled sample of 38, even if individuals are withdrawn later for apnea.|units on a scale|Mean|14.7|14.7|Standard Deviation|3.2|3.2|||
3660407|NCT02392000|3506239|B1|||Usability Healthcare Need|The minimum for this subscale score is 0. The maximum for this subscale score is 4. Higher scores indicate greater health care need. These scores are from the Usability Survey which is given only at the baseline and used to predict later tech use. Also, because this predictor is measured at baseline to predict initiation of tech use, we can use the complete, enrolled sample of 38, even if individuals are withdrawn later for apnea.|units on a scale|Mean|1.3|1.3|Standard Deviation|1.0|1.0|||
3660408|NCT02392000|3506239|B1|||Usability Information Seeking Preferences|The minimum for this subscale score is 4. The maximum for this subscale score is 28. Higher scores indicate greater preference for seeking information. These scores are from the Usability Survey which is given only at the baseline and used to predict later tech use. Also, because this predictor is measured at baseline to predict initiation of tech use, we can use the complete, enrolled sample of 38, even if individuals are withdrawn later for apnea.|units on a scale|Mean|21.8|21.8|Standard Deviation|4.4|4.4|||
3660409|NCT02392000|3506239|B1|||Usability Internet Dependence|The minimum for this subscale score is 4. The maximum for this subscale score is 28. Higher scores indicate greater internet dependence. These scores are from the Usability Survey which is given only at the baseline and used to predict later tech use. Also, because this predictor is measured at baseline to predict initiation of tech use, we can use the complete, enrolled sample of 38, even if individuals are withdrawn later for apnea.|units on a scale|Mean|19.5|19.5|Standard Deviation|5.6|5.6|||
3660449|NCT02391584|3506260|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660450|NCT02391584|3506261|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660451|NCT02391584|3506262|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660410|NCT02392000|3506239|B1|||Usability Health Knowledge|The minimum for this subscale score is 2. The maximum for this subscale score is 14. Higher scores indicate greater health knowledge. These scores are from the Usability Survey which is given only at the baseline and used to predict later tech use. Also, because this predictor is measured at baseline to predict initiation of tech use, we can use the complete, enrolled sample of 38, even if individuals are withdrawn later for apnea.|units on a scale|Mean|8.0|8.0|Standard Deviation|2.4|2.4|||
3660411|NCT02392000|3506239|B1|||Usability Satisfaction with Care|The minimum for this subscale score is 3. The maximum for this subscale score is 21. Higher scores indicate greater satisfaction with their medical care. These scores are from the Usability Survey which is given only at the baseline and used to predict later tech use. Also, because this predictor is measured at baseline to predict initiation of tech use, we can use the complete, enrolled sample of 38, even if individuals are withdrawn later for apnea.|units on a scale|Mean|14.6|14.6|Standard Deviation|3.1|3.1|||
3660412|NCT02392000|3506239|B1|||Weight||pounds|Mean|195.9|195.9|Standard Deviation|40.5|40.5|||
3660413|NCT02392000|3506239|B1|||Height||inches|Mean|68.6|68.6|Standard Deviation|3.8|3.8|||
3660414|NCT02392000|3506239|B1|United States||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
3660415|NCT02392000|3506239|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3660416|NCT02392000|3506239|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3660417|NCT02392000|3506239|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3660418|NCT02392000|3506239|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3660419|NCT02392000|3506239|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660420|NCT02392000|3506239|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660421|NCT02392000|3506239|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660422|NCT02392000|3506239|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660423|NCT02392000|3506239|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3660424|NCT02392000|3506239|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3660425|NCT02392000|3506239|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3660426|NCT02392000|3506239|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3660427|NCT02392000|3506239|B1|||Age||years|Mean|44.3|44.3|Standard Deviation|10.9|10.9|||
3660428|NCT02391714|3506247|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
3660429|NCT02391714|3506248|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
3660430|NCT02391714|3506249|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3660431|NCT02391714|3506247|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3660432|NCT02391714|3506248|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3660433|NCT02391714|3506249|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3660434|NCT02391714|3506247|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3660435|NCT02391714|3506248|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3660436|NCT02391714|3506249|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3660437|NCT02391714|3506247|B3|||Age||years|Mean|25.62|25.62|Full Range|||13.0|41.0|
3660438|NCT02391714|3506248|B2|||Age||years|Mean|24.93|24.93|Full Range|||13.0|41.0|
3660439|NCT02391714|3506249|B1|||Age||years|Mean|26.3|26.3|Full Range|||17.0|40.0|
3660440|NCT02391584|3506260|B3|||Baseline mean overall ETDQ-7 score|The 7-item Eustachian Tube Dysfunction Questionnaire (ETDQ-7) is a validated patient-reported tool measuring ETD symptoms and severity. The 7 items are: pressure in the ears, pain in the ears, a feeling that ears are clogged or underwater, ear symptoms when you have a cold of sinusitis, cracking or popping sounds in the ear, ringing in the ears, and a feeling that your hearing is muffled. Each item is rated from 1 (no problem) to 7 (severe problem) and a mean is calculated for the overall score (range from 1-7). Scores of 1-2 indicate no to mild symptoms, 3-5 moderate, and 6-7 severe symptoms.|units on a scale|Mean|4.7|4.7|Standard Deviation|0.9|0.9|||
3660441|NCT02391584|3506261|B2|||Baseline mean overall ETDQ-7 score|The 7-item Eustachian Tube Dysfunction Questionnaire (ETDQ-7) is a validated patient-reported tool measuring ETD symptoms and severity. The 7 items are: pressure in the ears, pain in the ears, a feeling that ears are clogged or underwater, ear symptoms when you have a cold of sinusitis, cracking or popping sounds in the ear, ringing in the ears, and a feeling that your hearing is muffled. Each item is rated from 1 (no problem) to 7 (severe problem) and a mean is calculated for the overall score (range from 1-7). Scores of 1-2 indicate no to mild symptoms, 3-5 moderate, and 6-7 severe symptoms.|units on a scale|Mean|5.0|5.0|Standard Deviation|0.8|0.8|||
3660442|NCT02391584|3506262|B1|||Baseline mean overall ETDQ-7 score|The 7-item Eustachian Tube Dysfunction Questionnaire (ETDQ-7) is a validated patient-reported tool measuring ETD symptoms and severity. The 7 items are: pressure in the ears, pain in the ears, a feeling that ears are clogged or underwater, ear symptoms when you have a cold of sinusitis, cracking or popping sounds in the ear, ringing in the ears, and a feeling that your hearing is muffled. Each item is rated from 1 (no problem) to 7 (severe problem) and a mean is calculated for the overall score (range from 1-7). Scores of 1-2 indicate no to mild symptoms, 3-5 moderate, and 6-7 severe symptoms.|units on a scale|Mean|4.6|4.6|Standard Deviation|1.1|1.1|||
3660443|NCT02391584|3506260|B3|||Duration of ETD (years)||years|Mean|12.6|12.6|Standard Deviation|17.0|17.0|||
3660444|NCT02391584|3506261|B2|||Duration of ETD (years)||years|Mean|13.0|13.0|Standard Deviation|17.3|17.3|||
3660445|NCT02391584|3506262|B1|||Duration of ETD (years)||years|Mean|12.2|12.2|Standard Deviation|17.0|17.0|||
3660446|NCT02391584|3506260|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
3660447|NCT02391584|3506261|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
3660448|NCT02391584|3506262|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
3660452|NCT02391584|3506260|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3660453|NCT02391584|3506261|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3660454|NCT02391584|3506262|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3660455|NCT02391584|3506260|B3||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3660456|NCT02391584|3506261|B2||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3660457|NCT02391584|3506262|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3660458|NCT02391584|3506260|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660459|NCT02391584|3506261|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660460|NCT02391584|3506262|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660461|NCT02391584|3506260|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660462|NCT02391584|3506261|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660463|NCT02391584|3506262|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660464|NCT02391584|3506260|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660465|NCT02391584|3506261|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660466|NCT02391584|3506262|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660467|NCT02391584|3506260|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660468|NCT02391584|3506261|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660469|NCT02391584|3506262|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660470|NCT02391584|3506260|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3660471|NCT02391584|3506261|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3660472|NCT02391584|3506262|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3660473|NCT02391584|3506260|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3660474|NCT02391584|3506261|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3660475|NCT02391584|3506262|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3660476|NCT02391584|3506260|B3|||Age||years|Mean|49.4|49.4|Standard Deviation|15.6|15.6|||
3660477|NCT02391584|3506261|B2|||Age||years|Mean|46.6|46.6|Standard Deviation|15.7|15.7|||
3660478|NCT02391584|3506262|B1|||Age||years|Mean|52.0|52.0|Standard Deviation|15.4|15.4|||
3660479|NCT02391311|3506278|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
3660480|NCT02391311|3506279|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3660481|NCT02391311|3506280|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3660482|NCT02391311|3506278|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660483|NCT02391311|3506279|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660484|NCT02391311|3506280|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660485|NCT02391311|3506278|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660486|NCT02391311|3506279|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660487|NCT02391311|3506280|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660488|NCT02391311|3506278|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3660489|NCT02391311|3506279|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3660490|NCT02391311|3506280|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3660491|NCT02391311|3506278|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3660492|NCT02391311|3506279|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3660493|NCT02391311|3506280|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3660494|NCT02391311|3506278|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660495|NCT02391311|3506279|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660496|NCT02391311|3506280|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660497|NCT02391311|3506278|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660498|NCT02391311|3506279|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660499|NCT02391311|3506280|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660500|NCT02391311|3506278|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660501|NCT02391311|3506279|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660502|NCT02391311|3506280|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660503|NCT02391311|3506278|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3660504|NCT02391311|3506279|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3660505|NCT02391311|3506280|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3660506|NCT02391311|3506278|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3660507|NCT02391311|3506279|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3660508|NCT02391311|3506280|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3660509|NCT02391311|3506278|B3|||Age||years|Mean|55.82|55.82|Full Range|||51.0|71.0|
3660510|NCT02391311|3506279|B2|||Age||years|Mean|56|56.0|Full Range|||52.0|63.0|
3660511|NCT02391311|3506280|B1|||Age||years|Mean|55.63|55.63|Full Range|||51.0|71.0|
3660512|NCT02391116|3506289|B1|Per protocol set|Not Available|DLBCL / Cell of Origin (COO) Subtype||Participants|Count of Participants|0|0.0||||||
3660513|NCT02391116|3506289|B1|Per protocol set|Unclassifiable|DLBCL / Cell of Origin (COO) Subtype||Participants|Count of Participants|2|2.0||||||
3660514|NCT02391116|3506289|B1|Per protocol set|Germinal center B-cell-like (GCB)|DLBCL / Cell of Origin (COO) Subtype||Participants|Count of Participants|22|22.0||||||
3660515|NCT02391116|3506289|B1|Per protocol set|Activated B-cell-like (ABC)|DLBCL / Cell of Origin (COO) Subtype||Participants|Count of Participants|16|16.0||||||
3660516|NCT02391116|3506289|B1|Full analysis set|Not Available|DLBCL / Cell of Origin (COO) Subtype||Participants|Count of Participants|15|15.0||||||
3660517|NCT02391116|3506289|B1|Full analysis set|Unclassifiable|DLBCL / Cell of Origin (COO) Subtype||Participants|Count of Participants|3|3.0||||||
3660518|NCT02391116|3506289|B1|Full analysis set|Germinal center B-cell-like (GCB)|DLBCL / Cell of Origin (COO) Subtype||Participants|Count of Participants|30|30.0||||||
3660519|NCT02391116|3506289|B1|Full analysis set|Activated B-cell-like (ABC)|DLBCL / Cell of Origin (COO) Subtype||Participants|Count of Participants|19|19.0||||||
3660520|NCT02391116|3506289|B1|Per protocol set|Not Available|CD79b Status||Participants|Count of Participants|0|0.0||||||
3660521|NCT02391116|3506289|B1|Per protocol set|CD79b Wild-type|CD79b Status||Participants|Count of Participants|32|32.0||||||
3660522|NCT02391116|3506289|B1|Per protocol set|CD79b Mutant|CD79b Status||Participants|Count of Participants|8|8.0||||||
3660523|NCT02391116|3506289|B1|Full analysis set|Not Available|CD79b Status||Participants|Count of Participants|13|13.0||||||
3660524|NCT02391116|3506289|B1|Full analysis set|CD79b Wild-type|CD79b Status||Participants|Count of Participants|45|45.0||||||
3660525|NCT02391116|3506289|B1|Full analysis set|CD79b Mutant|CD79b Status||Participants|Count of Participants|9|9.0||||||
3660526|NCT02391116|3506289|B1|Per protocol set|Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3660527|NCT02391116|3506289|B1|Per protocol set|Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3660528|NCT02391116|3506289|B1|Full analysis set|Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3660529|NCT02391116|3506289|B1|Full analysis set|Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3660530|NCT02391116|3506289|B1|Per protocol set||Age||Years|Mean|69.2|69.2|Standard Deviation|12.2|12.2|||
3660531|NCT02391116|3506289|B1|Full analysis set||Age||Years|Mean|65.3|65.3|Standard Deviation|14.5|14.5|||
3660532|NCT02391038|3506342|B1|1||Eastern Cooperative Oncology Group (ECOG) Therapy|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|4|4.0||||||
3660533|NCT02391038|3506342|B1|0||Eastern Cooperative Oncology Group (ECOG) Therapy|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|8|8.0||||||
3660534|NCT02391038|3506342|B1|Without prior radiation therapy||Participants With Prior Radiation Therapy||participants|Number|10|10.0||||||
3660535|NCT02391038|3506342|B1|With prior radiation therapy||Participants With Prior Radiation Therapy||participants|Number|2|2.0||||||
3660536|NCT02391038|3506342|B1|||Participants With Prior Anticancer Therapy||participants|Number|12|12.0||||||
3660537|NCT02391038|3506342|B1|Without Surgical History||Participants With Surgical History||participants|Number|4|4.0||||||
3660538|NCT02391038|3506342|B1|With Surgical History||Participants With Surgical History||participants|Number|8|8.0||||||
3660539|NCT02391038|3506342|B1|||Participants With Prior Medical Condition||participants|Number|12|12.0||||||
3660540|NCT02391038|3506342|B1|Moderately differentiated and descending colon||Histological classification|Histological classification included moderately differentiated adenocarcinoma (colon and rectal cancer); intestinal type adenocarcinoma (gastric cancer); adenocarcinoma with lymphovascular invasion; invasive ductal carcinoma of the pancreas, moderately differentiated ductal adenocarcinoma, adenocarcinoma not otherwise specified, tubular adenocarcinoma, and moderately differentiated adenocarcinoma of the transverse and descending colon.|participants|Number|1|1.0||||||
3660541|NCT02391038|3506342|B1|Tubular adenocarcinoma||Histological classification|Histological classification included moderately differentiated adenocarcinoma (colon and rectal cancer); intestinal type adenocarcinoma (gastric cancer); adenocarcinoma with lymphovascular invasion; invasive ductal carcinoma of the pancreas, moderately differentiated ductal adenocarcinoma, adenocarcinoma not otherwise specified, tubular adenocarcinoma, and moderately differentiated adenocarcinoma of the transverse and descending colon.|participants|Number|1|1.0||||||
3660542|NCT02391038|3506342|B1|Adenocarcinoma not otherwise specified||Histological classification|Histological classification included moderately differentiated adenocarcinoma (colon and rectal cancer); intestinal type adenocarcinoma (gastric cancer); adenocarcinoma with lymphovascular invasion; invasive ductal carcinoma of the pancreas, moderately differentiated ductal adenocarcinoma, adenocarcinoma not otherwise specified, tubular adenocarcinoma, and moderately differentiated adenocarcinoma of the transverse and descending colon.|participants|Number|1|1.0||||||
3660543|NCT02391038|3506342|B1|Moderately differentiated ductal adenocarcinoma||Histological classification|Histological classification included moderately differentiated adenocarcinoma (colon and rectal cancer); intestinal type adenocarcinoma (gastric cancer); adenocarcinoma with lymphovascular invasion; invasive ductal carcinoma of the pancreas, moderately differentiated ductal adenocarcinoma, adenocarcinoma not otherwise specified, tubular adenocarcinoma, and moderately differentiated adenocarcinoma of the transverse and descending colon.|participants|Number|1|1.0||||||
3660583|NCT02390557|3506459|B3|Wave 2|Hispanics|Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
3660584|NCT02390557|3506460|B2|Wave 2|Hispanics|Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
3660544|NCT02391038|3506342|B1|Invasive ductal carcinoma of the pancreas||Histological classification|Histological classification included moderately differentiated adenocarcinoma (colon and rectal cancer); intestinal type adenocarcinoma (gastric cancer); adenocarcinoma with lymphovascular invasion; invasive ductal carcinoma of the pancreas, moderately differentiated ductal adenocarcinoma, adenocarcinoma not otherwise specified, tubular adenocarcinoma, and moderately differentiated adenocarcinoma of the transverse and descending colon.|participants|Number|1|1.0||||||
3660545|NCT02391038|3506342|B1|Lymphovascular invasion||Histological classification|Histological classification included moderately differentiated adenocarcinoma (colon and rectal cancer); intestinal type adenocarcinoma (gastric cancer); adenocarcinoma with lymphovascular invasion; invasive ductal carcinoma of the pancreas, moderately differentiated ductal adenocarcinoma, adenocarcinoma not otherwise specified, tubular adenocarcinoma, and moderately differentiated adenocarcinoma of the transverse and descending colon.|participants|Number|1|1.0||||||
3660546|NCT02391038|3506342|B1|Gastric cancer||Histological classification|Histological classification included moderately differentiated adenocarcinoma (colon and rectal cancer); intestinal type adenocarcinoma (gastric cancer); adenocarcinoma with lymphovascular invasion; invasive ductal carcinoma of the pancreas, moderately differentiated ductal adenocarcinoma, adenocarcinoma not otherwise specified, tubular adenocarcinoma, and moderately differentiated adenocarcinoma of the transverse and descending colon.|participants|Number|2|2.0||||||
3660547|NCT02391038|3506342|B1|Rectal cancer||Histological classification|Histological classification included moderately differentiated adenocarcinoma (colon and rectal cancer); intestinal type adenocarcinoma (gastric cancer); adenocarcinoma with lymphovascular invasion; invasive ductal carcinoma of the pancreas, moderately differentiated ductal adenocarcinoma, adenocarcinoma not otherwise specified, tubular adenocarcinoma, and moderately differentiated adenocarcinoma of the transverse and descending colon.|participants|Number|2|2.0||||||
3660548|NCT02391038|3506342|B1|Colon cancer||Histological classification|Histological classification included moderately differentiated adenocarcinoma (colon and rectal cancer); intestinal type adenocarcinoma (gastric cancer); adenocarcinoma with lymphovascular invasion; invasive ductal carcinoma of the pancreas, moderately differentiated ductal adenocarcinoma, adenocarcinoma not otherwise specified, tubular adenocarcinoma, and moderately differentiated adenocarcinoma of the transverse and descending colon.|participants|Number|2|2.0||||||
3660549|NCT02391038|3506342|B1|Korea, Republic of||Region of Enrollment||participants|Number|7|7.0||||||
3660550|NCT02391038|3506342|B1|Taiwan||Region of Enrollment||participants|Number|1|1.0||||||
3660551|NCT02391038|3506342|B1|Japan||Region of Enrollment||participants|Number|4|4.0||||||
3660552|NCT02391038|3506342|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660553|NCT02391038|3506342|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660554|NCT02391038|3506342|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660555|NCT02391038|3506342|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660556|NCT02391038|3506342|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660557|NCT02391038|3506342|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3660558|NCT02391038|3506342|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660559|NCT02391038|3506342|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3660560|NCT02391038|3506342|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3660561|NCT02391038|3506342|B1|Between 45 to 78 years||Age, Customized||participants|Number|12|12.0||||||
3660562|NCT02390557|3506458|B4|Wave 2|Severe Mental Illness|Disability Type||Participants|Count of Participants|187|187.0||||||
3660563|NCT02390557|3506459|B3|Wave 2|Severe Mental Illness|Disability Type||Participants|Count of Participants|71|71.0||||||
3660564|NCT02390557|3506460|B2|Wave 2|Severe Mental Illness|Disability Type||Participants|Count of Participants|75|75.0||||||
3660565|NCT02390557|3506461|B1|Wave 2|Severe Mental Illness|Disability Type||Participants|Count of Participants|41|41.0||||||
3660566|NCT02390557|3506458|B4|Wave 2|Significant Physical Disability|Disability Type||Participants|Count of Participants|128|128.0||||||
3660567|NCT02390557|3506459|B3|Wave 2|Significant Physical Disability|Disability Type||Participants|Count of Participants|41|41.0||||||
3660568|NCT02390557|3506460|B2|Wave 2|Significant Physical Disability|Disability Type||Participants|Count of Participants|40|40.0||||||
3660569|NCT02390557|3506461|B1|Wave 2|Significant Physical Disability|Disability Type||Participants|Count of Participants|47|47.0||||||
3660570|NCT02390557|3506458|B4|Wave 1|Severe Mental Illness|Disability Type||Participants|Count of Participants|276|276.0||||||
3660571|NCT02390557|3506459|B3|Wave 1|Severe Mental Illness|Disability Type||Participants|Count of Participants|84|84.0||||||
3660572|NCT02390557|3506460|B2|Wave 1|Severe Mental Illness|Disability Type||Participants|Count of Participants|92|92.0||||||
3660573|NCT02390557|3506461|B1|Wave 1|Severe Mental Illness|Disability Type||Participants|Count of Participants|100|100.0||||||
3660574|NCT02390557|3506458|B4|Wave 1|Significant Physical Disability|Disability Type||Participants|Count of Participants|175|175.0||||||
3660575|NCT02390557|3506459|B3|Wave 1|Significant Physical Disability|Disability Type||Participants|Count of Participants|51|51.0||||||
3660576|NCT02390557|3506460|B2|Wave 1|Significant Physical Disability|Disability Type||Participants|Count of Participants|64|64.0||||||
3660577|NCT02390557|3506461|B1|Wave 1|Significant Physical Disability|Disability Type||Participants|Count of Participants|60|60.0||||||
3660578|NCT02390557|3506458|B4|Wave 2|Other|Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3660579|NCT02390557|3506459|B3|Wave 2|Other|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3660580|NCT02390557|3506460|B2|Wave 2|Other|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3660581|NCT02390557|3506461|B1|Wave 2|Other|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3660582|NCT02390557|3506458|B4|Wave 2|Hispanics|Race/Ethnicity, Customized||Participants|Count of Participants|107|107.0||||||
3660867|NCT02389829|3506564|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3660585|NCT02390557|3506461|B1|Wave 2|Hispanics|Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3660586|NCT02390557|3506458|B4|Wave 2|Black|Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
3660587|NCT02390557|3506459|B3|Wave 2|Black|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3660588|NCT02390557|3506460|B2|Wave 2|Black|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3660589|NCT02390557|3506461|B1|Wave 2|Black|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3660590|NCT02390557|3506458|B4|Wave 2|White|Race/Ethnicity, Customized||Participants|Count of Participants|129|129.0||||||
3660591|NCT02390557|3506459|B3|Wave 2|White|Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
3660592|NCT02390557|3506460|B2|Wave 2|White|Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
3660593|NCT02390557|3506461|B1|Wave 2|White|Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3660594|NCT02390557|3506458|B4|Wave 1|Other|Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3660595|NCT02390557|3506459|B3|Wave 1|Other|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3660596|NCT02390557|3506460|B2|Wave 1|Other|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3660597|NCT02390557|3506461|B1|Wave 1|Other|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3660598|NCT02390557|3506458|B4|Wave 1|Hispanics|Race/Ethnicity, Customized||Participants|Count of Participants|149|149.0||||||
3660599|NCT02390557|3506459|B3|Wave 1|Hispanics|Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
3660600|NCT02390557|3506460|B2|Wave 1|Hispanics|Race/Ethnicity, Customized||Participants|Count of Participants|53|53.0||||||
3660601|NCT02390557|3506461|B1|Wave 1|Hispanics|Race/Ethnicity, Customized||Participants|Count of Participants|53|53.0||||||
3660602|NCT02390557|3506458|B4|Wave 1|Black|Race/Ethnicity, Customized||Participants|Count of Participants|59|59.0||||||
3660603|NCT02390557|3506459|B3|Wave 1|Black|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3660604|NCT02390557|3506460|B2|Wave 1|Black|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3660605|NCT02390557|3506461|B1|Wave 1|Black|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3660606|NCT02390557|3506458|B4|Wave 1|White|Race/Ethnicity, Customized||Participants|Count of Participants|203|203.0||||||
3660607|NCT02390557|3506459|B3|Wave 1|White|Race/Ethnicity, Customized||Participants|Count of Participants|53|53.0||||||
3660608|NCT02390557|3506460|B2|Wave 1|White|Race/Ethnicity, Customized||Participants|Count of Participants|63|63.0||||||
3660609|NCT02390557|3506461|B1|Wave 1|White|Race/Ethnicity, Customized||Participants|Count of Participants|87|87.0||||||
3660610|NCT02390557|3506458|B4|Wave 2|Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3660611|NCT02390557|3506459|B3|Wave 2|Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3660612|NCT02390557|3506460|B2|Wave 2|Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3660613|NCT02390557|3506461|B1|Wave 2|Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3660614|NCT02390557|3506458|B4|Wave 2|Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3660615|NCT02390557|3506459|B3|Wave 2|Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3660616|NCT02390557|3506460|B2|Wave 2|Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3660617|NCT02390557|3506461|B1|Wave 2|Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3660618|NCT02390557|3506458|B4|Wave 1|Male|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
3660619|NCT02390557|3506459|B3|Wave 1|Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3660620|NCT02390557|3506460|B2|Wave 1|Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3660621|NCT02390557|3506461|B1|Wave 1|Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3660622|NCT02390557|3506458|B4|Wave 1|Female|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
3660623|NCT02390557|3506459|B3|Wave 1|Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3660624|NCT02390557|3506460|B2|Wave 1|Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3660625|NCT02390557|3506461|B1|Wave 1|Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3660626|NCT02390557|3506458|B4|Wave 2|>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3660627|NCT02390557|3506459|B3|Wave 2|>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3660628|NCT02390557|3506460|B2|Wave 2|>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3660629|NCT02390557|3506461|B1|Wave 2|>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3660630|NCT02390557|3506458|B4|Wave 2|Between 18 and 65 years|Age||Participants|Count of Participants|315|315.0||||||
3660631|NCT02390557|3506459|B3|Wave 2|Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
3660632|NCT02390557|3506460|B2|Wave 2|Between 18 and 65 years|Age||Participants|Count of Participants|115|115.0||||||
3660633|NCT02390557|3506461|B1|Wave 2|Between 18 and 65 years|Age||Participants|Count of Participants|88|88.0||||||
3660634|NCT02390557|3506458|B4|Wave 2|<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3660635|NCT02390557|3506459|B3|Wave 2|<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3660636|NCT02390557|3506460|B2|Wave 2|<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3660637|NCT02390557|3506461|B1|Wave 2|<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3660638|NCT02390557|3506458|B4|Wave 1|>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3660639|NCT02390557|3506459|B3|Wave 1|>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3660640|NCT02390557|3506460|B2|Wave 1|>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3660641|NCT02390557|3506461|B1|Wave 1|>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3660642|NCT02390557|3506458|B4|Wave 1|Between 18 and 65 years|Age||Participants|Count of Participants|451|451.0||||||
3660643|NCT02390557|3506459|B3|Wave 1|Between 18 and 65 years|Age||Participants|Count of Participants|135|135.0||||||
3660644|NCT02390557|3506460|B2|Wave 1|Between 18 and 65 years|Age||Participants|Count of Participants|156|156.0||||||
3660645|NCT02390557|3506461|B1|Wave 1|Between 18 and 65 years|Age||Participants|Count of Participants|160|160.0||||||
3660646|NCT02390557|3506458|B4|Wave 1|<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3660647|NCT02390557|3506459|B3|Wave 1|<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3660648|NCT02390557|3506460|B2|Wave 1|<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3660649|NCT02390557|3506461|B1|Wave 1|<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3660650|NCT02390219|3506471|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3660651|NCT02390219|3506471|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3660652|NCT02390219|3506471|B1|||Age||years|Mean|32.1|32.1|Standard Deviation|9|9.0|||
3660653|NCT02390167|3506481|B1|United States||Region of Enrollment||participants|Number|376|376.0||||||
3660654|NCT02390167|3506481|B1|Race Unknown or Not Reported||Race/Ethnicity, Customized||Number of responses|Number|9|9.0||||||
3660655|NCT02390167|3506481|B1|White||Race/Ethnicity, Customized||Number of responses|Number|292|292.0||||||
3660656|NCT02390167|3506481|B1|Black or African American||Race/Ethnicity, Customized||Number of responses|Number|52|52.0||||||
3660657|NCT02390167|3506481|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Number of responses|Number|2|2.0||||||
3660658|NCT02390167|3506481|B1|Asian||Race/Ethnicity, Customized||Number of responses|Number|23|23.0||||||
3660659|NCT02390167|3506481|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Number of responses|Number|7|7.0||||||
3660660|NCT02390167|3506481|B1|Ethnicity Unknown or Not Reported||Race/Ethnicity, Customized||Number of responses|Number|5|5.0||||||
3660661|NCT02390167|3506481|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Number of responses|Number|321|321.0||||||
3660662|NCT02390167|3506481|B1|Hispanic/Latino||Race/Ethnicity, Customized||Number of responses|Number|50|50.0||||||
3660663|NCT02390167|3506481|B1||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3660664|NCT02390167|3506481|B1||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3660665|NCT02390167|3506481|B1|||Age||years|Mean|52.1|52.1|Full Range|||18.0|81.0|
3660666|NCT02389881|3506500|B8|Not Applicable (Participant is Male)||Reproductive Status||Participants|Count of Participants|28|28.0||||||
3660667|NCT02389881|3506501|B7|Not Applicable (Participant is Male)||Reproductive Status||Participants|Count of Participants|0|0.0||||||
3660668|NCT02389881|3506502|B6|Not Applicable (Participant is Male)||Reproductive Status||Participants|Count of Participants|8|8.0||||||
3660669|NCT02389881|3506503|B5|Not Applicable (Participant is Male)||Reproductive Status||Participants|Count of Participants|4|4.0||||||
3660670|NCT02389881|3506504|B4|Not Applicable (Participant is Male)||Reproductive Status||Participants|Count of Participants|4|4.0||||||
3660671|NCT02389881|3506505|B3|Not Applicable (Participant is Male)||Reproductive Status||Participants|Count of Participants|4|4.0||||||
3660672|NCT02389881|3506506|B2|Not Applicable (Participant is Male)||Reproductive Status||Participants|Count of Participants|4|4.0||||||
3660673|NCT02389881|3506507|B1|Not Applicable (Participant is Male)||Reproductive Status||Participants|Count of Participants|4|4.0||||||
3660674|NCT02389881|3506500|B8|Female of Childbearing Potential||Reproductive Status||Participants|Count of Participants|0|0.0||||||
3660675|NCT02389881|3506501|B7|Female of Childbearing Potential||Reproductive Status||Participants|Count of Participants|0|0.0||||||
3660676|NCT02389881|3506502|B6|Female of Childbearing Potential||Reproductive Status||Participants|Count of Participants|0|0.0||||||
3660677|NCT02389881|3506503|B5|Female of Childbearing Potential||Reproductive Status||Participants|Count of Participants|0|0.0||||||
3660678|NCT02389881|3506504|B4|Female of Childbearing Potential||Reproductive Status||Participants|Count of Participants|0|0.0||||||
3660679|NCT02389881|3506505|B3|Female of Childbearing Potential||Reproductive Status||Participants|Count of Participants|0|0.0||||||
3660680|NCT02389881|3506506|B2|Female of Childbearing Potential||Reproductive Status||Participants|Count of Participants|0|0.0||||||
3660681|NCT02389881|3506507|B1|Female of Childbearing Potential||Reproductive Status||Participants|Count of Participants|0|0.0||||||
3660682|NCT02389881|3506500|B8|Surgically Sterile||Reproductive Status||Participants|Count of Participants|7|7.0||||||
3660683|NCT02389881|3506501|B7|Surgically Sterile||Reproductive Status||Participants|Count of Participants|0|0.0||||||
3660684|NCT02389881|3506502|B6|Surgically Sterile||Reproductive Status||Participants|Count of Participants|0|0.0||||||
3660685|NCT02389881|3506503|B5|Surgically Sterile||Reproductive Status||Participants|Count of Participants|2|2.0||||||
3660686|NCT02389881|3506504|B4|Surgically Sterile||Reproductive Status||Participants|Count of Participants|0|0.0||||||
3660687|NCT02389881|3506505|B3|Surgically Sterile||Reproductive Status||Participants|Count of Participants|2|2.0||||||
3660688|NCT02389881|3506506|B2|Surgically Sterile||Reproductive Status||Participants|Count of Participants|2|2.0||||||
3660689|NCT02389881|3506507|B1|Surgically Sterile||Reproductive Status||Participants|Count of Participants|1|1.0||||||
3660690|NCT02389881|3506500|B8|Postmenopausal||Reproductive Status||Participants|Count of Participants|5|5.0||||||
3660691|NCT02389881|3506501|B7|Postmenopausal||Reproductive Status||Participants|Count of Participants|2|2.0||||||
3660692|NCT02389881|3506502|B6|Postmenopausal||Reproductive Status||Participants|Count of Participants|0|0.0||||||
3660693|NCT02389881|3506503|B5|Postmenopausal||Reproductive Status||Participants|Count of Participants|0|0.0||||||
3660694|NCT02389881|3506504|B4|Postmenopausal||Reproductive Status||Participants|Count of Participants|2|2.0||||||
3660695|NCT02389881|3506505|B3|Postmenopausal||Reproductive Status||Participants|Count of Participants|0|0.0||||||
3660696|NCT02389881|3506506|B2|Postmenopausal||Reproductive Status||Participants|Count of Participants|0|0.0||||||
3660697|NCT02389881|3506507|B1|Postmenopausal||Reproductive Status||Participants|Count of Participants|1|1.0||||||
3660698|NCT02389881|3506500|B8|Ex-drinker||Alcohol Consumption||Participants|Count of Participants|7|7.0||||||
3660699|NCT02389881|3506501|B7|Ex-drinker||Alcohol Consumption||Participants|Count of Participants|0|0.0||||||
3660700|NCT02389881|3506502|B6|Ex-drinker||Alcohol Consumption||Participants|Count of Participants|2|2.0||||||
3660701|NCT02389881|3506503|B5|Ex-drinker||Alcohol Consumption||Participants|Count of Participants|0|0.0||||||
3660702|NCT02389881|3506504|B4|Ex-drinker||Alcohol Consumption||Participants|Count of Participants|0|0.0||||||
3660703|NCT02389881|3506505|B3|Ex-drinker||Alcohol Consumption||Participants|Count of Participants|3|3.0||||||
3660704|NCT02389881|3506506|B2|Ex-drinker||Alcohol Consumption||Participants|Count of Participants|1|1.0||||||
3660705|NCT02389881|3506507|B1|Ex-drinker||Alcohol Consumption||Participants|Count of Participants|1|1.0||||||
3660706|NCT02389881|3506500|B8|Current Drinker||Alcohol Consumption||Participants|Count of Participants|13|13.0||||||
3660707|NCT02389881|3506501|B7|Current Drinker||Alcohol Consumption||Participants|Count of Participants|0|0.0||||||
3660708|NCT02389881|3506502|B6|Current Drinker||Alcohol Consumption||Participants|Count of Participants|3|3.0||||||
3660709|NCT02389881|3506503|B5|Current Drinker||Alcohol Consumption||Participants|Count of Participants|2|2.0||||||
3660710|NCT02389881|3506504|B4|Current Drinker||Alcohol Consumption||Participants|Count of Participants|3|3.0||||||
3660711|NCT02389881|3506505|B3|Current Drinker||Alcohol Consumption||Participants|Count of Participants|3|3.0||||||
3660712|NCT02389881|3506506|B2|Current Drinker||Alcohol Consumption||Participants|Count of Participants|0|0.0||||||
3660713|NCT02389881|3506507|B1|Current Drinker||Alcohol Consumption||Participants|Count of Participants|2|2.0||||||
3660714|NCT02389881|3506500|B8|Never Drunk||Alcohol Consumption||Participants|Count of Participants|20|20.0||||||
3660715|NCT02389881|3506501|B7|Never Drunk||Alcohol Consumption||Participants|Count of Participants|2|2.0||||||
3660716|NCT02389881|3506502|B6|Never Drunk||Alcohol Consumption||Participants|Count of Participants|3|3.0||||||
3660717|NCT02389881|3506503|B5|Never Drunk||Alcohol Consumption||Participants|Count of Participants|4|4.0||||||
3660718|NCT02389881|3506504|B4|Never Drunk||Alcohol Consumption||Participants|Count of Participants|3|3.0||||||
3660719|NCT02389881|3506505|B3|Never Drunk||Alcohol Consumption||Participants|Count of Participants|0|0.0||||||
3660720|NCT02389881|3506506|B2|Never Drunk||Alcohol Consumption||Participants|Count of Participants|5|5.0||||||
3660721|NCT02389881|3506507|B1|Never Drunk||Alcohol Consumption||Participants|Count of Participants|3|3.0||||||
3660722|NCT02389881|3506500|B8|No||Caffeine Consumption||Participants|Count of Participants|20|20.0||||||
3660723|NCT02389881|3506501|B7|No||Caffeine Consumption||Participants|Count of Participants|1|1.0||||||
3660724|NCT02389881|3506502|B6|No||Caffeine Consumption||Participants|Count of Participants|5|5.0||||||
3660725|NCT02389881|3506503|B5|No||Caffeine Consumption||Participants|Count of Participants|2|2.0||||||
3660726|NCT02389881|3506504|B4|No||Caffeine Consumption||Participants|Count of Participants|1|1.0||||||
3660727|NCT02389881|3506505|B3|No||Caffeine Consumption||Participants|Count of Participants|4|4.0||||||
3660728|NCT02389881|3506506|B2|No||Caffeine Consumption||Participants|Count of Participants|3|3.0||||||
3660729|NCT02389881|3506507|B1|No||Caffeine Consumption||Participants|Count of Participants|4|4.0||||||
3660730|NCT02389881|3506500|B8|Yes||Caffeine Consumption||Participants|Count of Participants|20|20.0||||||
3660731|NCT02389881|3506501|B7|Yes||Caffeine Consumption||Participants|Count of Participants|1|1.0||||||
3660732|NCT02389881|3506502|B6|Yes||Caffeine Consumption||Participants|Count of Participants|3|3.0||||||
3660733|NCT02389881|3506503|B5|Yes||Caffeine Consumption||Participants|Count of Participants|4|4.0||||||
3660734|NCT02389881|3506504|B4|Yes||Caffeine Consumption||Participants|Count of Participants|5|5.0||||||
3660735|NCT02389881|3506505|B3|Yes||Caffeine Consumption||Participants|Count of Participants|2|2.0||||||
3660736|NCT02389881|3506506|B2|Yes||Caffeine Consumption||Participants|Count of Participants|3|3.0||||||
3660737|NCT02389881|3506507|B1|Yes||Caffeine Consumption||Participants|Count of Participants|2|2.0||||||
3660738|NCT02389881|3506500|B8|Current Smoker||Smoking Classification||Participants|Count of Participants|6|6.0||||||
3660739|NCT02389881|3506501|B7|Current Smoker||Smoking Classification||Participants|Count of Participants|0|0.0||||||
3660740|NCT02389881|3506502|B6|Current Smoker||Smoking Classification||Participants|Count of Participants|1|1.0||||||
3660741|NCT02389881|3506503|B5|Current Smoker||Smoking Classification||Participants|Count of Participants|1|1.0||||||
3660742|NCT02389881|3506504|B4|Current Smoker||Smoking Classification||Participants|Count of Participants|2|2.0||||||
3660743|NCT02389881|3506505|B3|Current Smoker||Smoking Classification||Participants|Count of Participants|2|2.0||||||
3660744|NCT02389881|3506506|B2|Current Smoker||Smoking Classification||Participants|Count of Participants|0|0.0||||||
3660745|NCT02389881|3506507|B1|Current Smoker||Smoking Classification||Participants|Count of Participants|0|0.0||||||
3660746|NCT02389881|3506500|B8|Never Smoked||Smoking Classification||Participants|Count of Participants|34|34.0||||||
3660747|NCT02389881|3506501|B7|Never Smoked||Smoking Classification||Participants|Count of Participants|2|2.0||||||
3660748|NCT02389881|3506502|B6|Never Smoked||Smoking Classification||Participants|Count of Participants|7|7.0||||||
3660749|NCT02389881|3506503|B5|Never Smoked||Smoking Classification||Participants|Count of Participants|5|5.0||||||
3660750|NCT02389881|3506504|B4|Never Smoked||Smoking Classification||Participants|Count of Participants|4|4.0||||||
3660751|NCT02389881|3506505|B3|Never Smoked||Smoking Classification||Participants|Count of Participants|4|4.0||||||
3660752|NCT02389881|3506506|B2|Never Smoked||Smoking Classification||Participants|Count of Participants|6|6.0||||||
3660753|NCT02389881|3506507|B1|Never Smoked||Smoking Classification||Participants|Count of Participants|6|6.0||||||
3660868|NCT02389829|3506562|B3||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3660754|NCT02389881|3506500|B8|||Body Mass Index (BMI)||kg/m^2|Mean|26.36|26.36|Standard Deviation|2.416|2.416|||
3660755|NCT02389881|3506501|B7|||Body Mass Index (BMI)||kg/m^2|Mean|28.60|28.6|Standard Deviation|1.697|1.697|||
3660756|NCT02389881|3506502|B6|||Body Mass Index (BMI)||kg/m^2|Mean|25.66|25.66|Standard Deviation|2.942|2.942|||
3660757|NCT02389881|3506503|B5|||Body Mass Index (BMI)||kg/m^2|Mean|25.17|25.17|Standard Deviation|3.463|3.463|||
3660758|NCT02389881|3506504|B4|||Body Mass Index (BMI)||kg/m^2|Mean|27.48|27.48|Standard Deviation|1.094|1.094|||
3660759|NCT02389881|3506505|B3|||Body Mass Index (BMI)||kg/m^2|Mean|27.68|27.68|Standard Deviation|1.451|1.451|||
3660760|NCT02389881|3506506|B2|||Body Mass Index (BMI)||kg/m^2|Mean|25.80|25.8|Standard Deviation|2.392|2.392|||
3660761|NCT02389881|3506507|B1|||Body Mass Index (BMI)||kg/m^2|Mean|25.87|25.87|Standard Deviation|1.742|1.742|||
3660762|NCT02389881|3506500|B8|||Weight||kg|Mean|78.23|78.23|Standard Deviation|11.322|11.322|||
3660763|NCT02389881|3506501|B7|||Weight||kg|Mean|68.35|68.35|Standard Deviation|5.869|5.869|||
3660764|NCT02389881|3506502|B6|||Weight||kg|Mean|79.63|79.63|Standard Deviation|9.721|9.721|||
3660765|NCT02389881|3506503|B5|||Weight||kg|Mean|74.17|74.17|Standard Deviation|15.687|15.687|||
3660766|NCT02389881|3506504|B4|||Weight||kg|Mean|83.08|83.08|Standard Deviation|10.778|10.778|||
3660767|NCT02389881|3506505|B3|||Weight||kg|Mean|83.55|83.55|Standard Deviation|12.902|12.902|||
3660768|NCT02389881|3506506|B2|||Weight||kg|Mean|75.63|75.63|Standard Deviation|10.397|10.397|||
3660769|NCT02389881|3506507|B1|||Weight||kg|Mean|76.15|76.15|Standard Deviation|9.291|9.291|||
3660770|NCT02389881|3506500|B8|||Height||cm|Mean|172.0|172.0|Standard Deviation|9.45|9.45|||
3660771|NCT02389881|3506501|B7|||Height||cm|Mean|154.5|154.5|Standard Deviation|2.12|2.12|||
3660772|NCT02389881|3506502|B6|||Height||cm|Mean|176.1|176.1|Standard Deviation|4.52|4.52|||
3660773|NCT02389881|3506503|B5|||Height||cm|Mean|171.0|171.0|Standard Deviation|9.42|9.42|||
3660774|NCT02389881|3506504|B4|||Height||cm|Mean|173.7|173.7|Standard Deviation|12.21|12.21|||
3660775|NCT02389881|3506505|B3|||Height||cm|Mean|173.2|173.2|Standard Deviation|10.23|10.23|||
3660776|NCT02389881|3506506|B2|||Height||cm|Mean|171.0|171.0|Standard Deviation|7.95|7.95|||
3660777|NCT02389881|3506507|B1|||Height||cm|Mean|171.5|171.5|Standard Deviation|10.17|10.17|||
3660778|NCT02389881|3506500|B8|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3660779|NCT02389881|3506501|B7|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3660780|NCT02389881|3506502|B6|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3660781|NCT02389881|3506503|B5|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3660782|NCT02389881|3506504|B4|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3660783|NCT02389881|3506505|B3|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3660784|NCT02389881|3506506|B2|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3660785|NCT02389881|3506507|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3660786|NCT02389881|3506500|B8|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3660787|NCT02389881|3506501|B7|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3660788|NCT02389881|3506502|B6|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3660789|NCT02389881|3506503|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3660790|NCT02389881|3506504|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3660791|NCT02389881|3506505|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3660792|NCT02389881|3506506|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3660793|NCT02389881|3506507|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3660794|NCT02389881|3506500|B8|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3660795|NCT02389881|3506501|B7|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3660796|NCT02389881|3506502|B6|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3660797|NCT02389881|3506503|B5|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3660798|NCT02389881|3506504|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3660799|NCT02389881|3506505|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3660800|NCT02389881|3506506|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3660801|NCT02389881|3506507|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3660802|NCT02389881|3506500|B8|More than one race||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3660803|NCT02389881|3506501|B7|More than one race||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3660804|NCT02389881|3506502|B6|More than one race||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3660805|NCT02389881|3506503|B5|More than one race||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3660806|NCT02389881|3506504|B4|More than one race||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3660807|NCT02389881|3506505|B3|More than one race||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3660808|NCT02389881|3506506|B2|More than one race||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3660809|NCT02389881|3506507|B1|More than one race||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3660810|NCT02389881|3506500|B8|White||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3660811|NCT02389881|3506501|B7|White||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3660812|NCT02389881|3506502|B6|White||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3660813|NCT02389881|3506503|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3660814|NCT02389881|3506504|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3660815|NCT02389881|3506505|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3660816|NCT02389881|3506506|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3660817|NCT02389881|3506507|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3660818|NCT02389881|3506500|B8|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3660819|NCT02389881|3506501|B7|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3660820|NCT02389881|3506502|B6|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3660821|NCT02389881|3506503|B5|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3660822|NCT02389881|3506504|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3660823|NCT02389881|3506505|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3660824|NCT02389881|3506506|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3660825|NCT02389881|3506507|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3660826|NCT02389881|3506500|B8|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3660827|NCT02389881|3506501|B7|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3660828|NCT02389881|3506502|B6|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3660829|NCT02389881|3506503|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3660830|NCT02389881|3506504|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3660831|NCT02389881|3506505|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3660832|NCT02389881|3506506|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3660833|NCT02389881|3506507|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3660834|NCT02389881|3506500|B8||Male|Gender||Participants|Count of Participants|28|28.0||||||
3660835|NCT02389881|3506501|B7||Male|Gender||Participants|Count of Participants|0|0.0||||||
3660836|NCT02389881|3506502|B6||Male|Gender||Participants|Count of Participants|8|8.0||||||
3660837|NCT02389881|3506503|B5||Male|Gender||Participants|Count of Participants|4|4.0||||||
3660838|NCT02389881|3506504|B4||Male|Gender||Participants|Count of Participants|4|4.0||||||
3660839|NCT02389881|3506505|B3||Male|Gender||Participants|Count of Participants|4|4.0||||||
3660840|NCT02389881|3506506|B2||Male|Gender||Participants|Count of Participants|4|4.0||||||
3660841|NCT02389881|3506507|B1||Male|Gender||Participants|Count of Participants|4|4.0||||||
3660842|NCT02389881|3506500|B8||Female|Gender||Participants|Count of Participants|12|12.0||||||
3660843|NCT02389881|3506501|B7||Female|Gender||Participants|Count of Participants|2|2.0||||||
3660844|NCT02389881|3506502|B6||Female|Gender||Participants|Count of Participants|0|0.0||||||
3660845|NCT02389881|3506503|B5||Female|Gender||Participants|Count of Participants|2|2.0||||||
3660846|NCT02389881|3506504|B4||Female|Gender||Participants|Count of Participants|2|2.0||||||
3660847|NCT02389881|3506505|B3||Female|Gender||Participants|Count of Participants|2|2.0||||||
3660848|NCT02389881|3506506|B2||Female|Gender||Participants|Count of Participants|2|2.0||||||
3660849|NCT02389881|3506507|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
3660850|NCT02389881|3506500|B8|||Age||years|Mean|46.6|46.6|Standard Deviation|15.56|15.56|||
3660851|NCT02389881|3506501|B7|||Age||years|Mean|72.5|72.5|Standard Deviation|2.12|2.12|||
3660852|NCT02389881|3506502|B6|||Age||years|Mean|40.9|40.9|Standard Deviation|13.67|13.67|||
3660853|NCT02389881|3506503|B5|||Age||years|Mean|41.0|41.0|Standard Deviation|15.39|15.39|||
3660854|NCT02389881|3506504|B4|||Age||years|Mean|68.2|68.2|Standard Deviation|1.83|1.83|||
3660855|NCT02389881|3506505|B3|||Age||years|Mean|42.2|42.2|Standard Deviation|11.23|11.23|||
3660856|NCT02389881|3506506|B2|||Age||years|Mean|36.2|36.2|Standard Deviation|11.65|11.65|||
3660857|NCT02389881|3506507|B1|||Age||years|Mean|44.3|44.3|Standard Deviation|6.77|6.77|||
3660858|NCT02389829|3506562|B3|||Duration of headache Prior to Study||Hours|Median|48|48.0|Inter-Quartile Range|||24.0|96.0|
3660859|NCT02389829|3506563|B2|||Duration of headache Prior to Study||Hours|Median|72|72.0|Inter-Quartile Range|||24.0|96.0|
3660860|NCT02389829|3506564|B1|||Duration of headache Prior to Study||Hours|Median|48|48.0|Inter-Quartile Range|||24.0|96.0|
3660861|NCT02389829|3506562|B3|United States||Region of Enrollment||Participants|Count of Participants|127|127.0||||||
3660862|NCT02389829|3506563|B2|United States||Region of Enrollment||Participants|Count of Participants|63|63.0||||||
3660863|NCT02389829|3506564|B1|United States||Region of Enrollment||Participants|Count of Participants|64|64.0||||||
3660864|NCT02389829|3506562|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3660865|NCT02389829|3506562|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3660866|NCT02389829|3506563|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3660869|NCT02389829|3506563|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3660870|NCT02389829|3506564|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3660871|NCT02389829|3506562|B3|||Age||years|Mean|34|34.0|Standard Deviation|10|10.0|||
3660872|NCT02389829|3506563|B2|||Age||years|Mean|32|32.0|Standard Deviation|9|9.0|||
3660873|NCT02389829|3506564|B1|||Age||years|Mean|35|35.0|Standard Deviation|11|11.0|||
3660874|NCT02389738|3506577|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3660875|NCT02389738|3506577|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3660876|NCT02389738|3506577|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3660877|NCT02389738|3506577|B1|||Age||years|Mean|51|51.0|Full Range|||32.0|68.0|
3660878|NCT02389738|3506577|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3660879|NCT02389738|3506577|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3660880|NCT02389738|3506577|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3660881|NCT02389621|3506581|B3||Missing|Baseline Platelet Count||Participants|Count of Participants|2|2.0||||||
3660882|NCT02389621|3506582|B2||Missing|Baseline Platelet Count||Participants|Count of Participants|1|1.0||||||
3660883|NCT02389621|3506583|B1||Missing|Baseline Platelet Count||Participants|Count of Participants|1|1.0||||||
3660884|NCT02389621|3506581|B3||≥ 35 × 10⁹/L|Baseline Platelet Count||Participants|Count of Participants|139|139.0||||||
3660885|NCT02389621|3506582|B2||≥ 35 × 10⁹/L|Baseline Platelet Count||Participants|Count of Participants|68|68.0||||||
3660886|NCT02389621|3506583|B1||≥ 35 × 10⁹/L|Baseline Platelet Count||Participants|Count of Participants|71|71.0||||||
3660887|NCT02389621|3506581|B3||< 35 × 10⁹/L|Baseline Platelet Count||Participants|Count of Participants|74|74.0||||||
3660888|NCT02389621|3506582|B2||< 35 × 10⁹/L|Baseline Platelet Count||Participants|Count of Participants|38|38.0||||||
3660889|NCT02389621|3506583|B1||< 35 × 10⁹/L|Baseline Platelet Count||Participants|Count of Participants|36|36.0||||||
3660890|NCT02389621|3506581|B3||Other|Planned Invasive Procedure||Participants|Count of Participants|203|203.0||||||
3660891|NCT02389621|3506582|B2||Other|Planned Invasive Procedure||Participants|Count of Participants|102|102.0||||||
3660892|NCT02389621|3506583|B1||Other|Planned Invasive Procedure||Participants|Count of Participants|101|101.0||||||
3660893|NCT02389621|3506581|B3||Liver ablation/ coagulation|Planned Invasive Procedure||Participants|Count of Participants|12|12.0||||||
3660894|NCT02389621|3506582|B2||Liver ablation/ coagulation|Planned Invasive Procedure||Participants|Count of Participants|5|5.0||||||
3660895|NCT02389621|3506583|B1||Liver ablation/ coagulation|Planned Invasive Procedure||Participants|Count of Participants|7|7.0||||||
3660896|NCT02389621|3506581|B3||Not provided|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3660897|NCT02389621|3506582|B2||Not provided|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3660898|NCT02389621|3506583|B1||Not provided|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3660899|NCT02389621|3506581|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3660900|NCT02389621|3506582|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3660901|NCT02389621|3506583|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3660902|NCT02389621|3506581|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|171|171.0||||||
3660903|NCT02389621|3506582|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|86|86.0||||||
3660904|NCT02389621|3506583|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|85|85.0||||||
3660905|NCT02389621|3506581|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3660906|NCT02389621|3506582|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3660907|NCT02389621|3506583|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3660908|NCT02389621|3506581|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3660909|NCT02389621|3506582|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3660910|NCT02389621|3506583|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3660911|NCT02389621|3506581|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3660912|NCT02389621|3506582|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3660913|NCT02389621|3506583|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3660914|NCT02389621|3506581|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3660915|NCT02389621|3506582|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3660916|NCT02389621|3506583|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3660917|NCT02389621|3506581|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3660918|NCT02389621|3506582|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660919|NCT02389621|3506583|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3660920|NCT02389621|3506581|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|188|188.0||||||
3660921|NCT02389621|3506582|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3660922|NCT02389621|3506583|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
3660923|NCT02389621|3506581|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3661039|NCT02388997|3506722|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3660924|NCT02389621|3506582|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3660925|NCT02389621|3506583|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3660926|NCT02389621|3506581|B3||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3660927|NCT02389621|3506582|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3660928|NCT02389621|3506583|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3660929|NCT02389621|3506581|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3660930|NCT02389621|3506582|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3660931|NCT02389621|3506583|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3660932|NCT02389621|3506581|B3|||Age||years|Mean|55.7|55.7|Standard Deviation|11.3|11.3|||
3660933|NCT02389621|3506582|B2|||Age||years|Mean|56.1|56.1|Standard Deviation|11.0|11.0|||
3660934|NCT02389621|3506583|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|11.6|11.6|||
3660935|NCT02389452|3506614|B1|||Body Mass Index||kilogram per square meter|Mean|27.66|27.66|Standard Deviation|4.477|4.477|||
3660936|NCT02389452|3506614|B1|||Height||centimeters|Mean|160.11|160.11|Standard Deviation|8.836|8.836|||
3660937|NCT02389452|3506614|B1|||Weight||kilograms|Mean|70.72|70.72|Standard Deviation|11.526|11.526|||
3660938|NCT02389452|3506614|B1||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3660939|NCT02389452|3506614|B1||Female|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
3660940|NCT02389452|3506614|B1|||Age|Number of participants analysed for this parameter were 392.|years|Mean|57.6|57.6|Standard Deviation|9.80|9.8|||
3660941|NCT02389374|3506632|B4|Bangladesh||Region of Enrollment||participants|Number|181|181.0||||||
3660942|NCT02389374|3506633|B3|Bangladesh||Region of Enrollment||participants|Number|11|11.0||||||
3660943|NCT02389374|3506634|B2|Bangladesh||Region of Enrollment||participants|Number|115|115.0||||||
3660944|NCT02389374|3506635|B1|Bangladesh||Region of Enrollment||participants|Number|55|55.0||||||
3660945|NCT02389374|3506632|B4||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3660946|NCT02389374|3506633|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3660947|NCT02389374|3506634|B2||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3660948|NCT02389374|3506635|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3660949|NCT02389374|3506632|B4||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3660950|NCT02389374|3506633|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3660951|NCT02389374|3506634|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3660952|NCT02389374|3506635|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3660953|NCT02389374|3506632|B4|||Age||years|Median|20|20.0|Inter-Quartile Range|||11.0|28.0|
3660954|NCT02389374|3506633|B3|||Age||years|Median|14|14.0|Inter-Quartile Range|||7.0|26.0|
3660955|NCT02389374|3506634|B2|||Age||years|Median|22|22.0|Inter-Quartile Range|||14.0|30.0|
3660956|NCT02389374|3506635|B1|||Age||years|Median|18|18.0|Inter-Quartile Range|||11.0|27.0|
3660957|NCT02389361|3506667|B3|Belgium||Region of Enrollment||participants|Number|51|51.0||||||
3660958|NCT02389361|3506668|B2|Belgium||Region of Enrollment||participants|Number|27|27.0||||||
3660959|NCT02389361|3506669|B1|Belgium||Region of Enrollment||participants|Number|24|24.0||||||
3660960|NCT02389361|3506667|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3660961|NCT02389361|3506668|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3660962|NCT02389361|3506669|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3660963|NCT02389361|3506667|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3660964|NCT02389361|3506668|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3660965|NCT02389361|3506669|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3660966|NCT02389361|3506667|B3|||Age||years|Mean|57.19|57.19|Standard Deviation|15.29|15.29|||
3660967|NCT02389361|3506668|B2|||Age||years|Mean|62.41|62.41|Standard Deviation|14.51|14.51|||
3660968|NCT02389361|3506669|B1|||Age||years|Mean|57.08|57.08|Standard Deviation|16.42|16.42|||
3660969|NCT02389361|3506667|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3660970|NCT02389361|3506668|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3660971|NCT02389361|3506669|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3660972|NCT02389361|3506667|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3660973|NCT02389361|3506668|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3660974|NCT02389361|3506669|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3660975|NCT02389361|3506667|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3660976|NCT02389361|3506668|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3660977|NCT02389361|3506669|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3660978|NCT02389088|3506676|B1|||Phase II - Estradiol||pmol/L|Mean|195.7|195.7|Standard Deviation|97.4|97.4|||
3660979|NCT02389088|3506676|B1|17-OH Progesterone||Phase II - Testosterone, Androstenedione, 17-OH Progesterone||nmol/L|Mean|53.3|53.3|Standard Deviation|43.7|43.7|||
3660980|NCT02389088|3506676|B1|Androstenedione||Phase II - Testosterone, Androstenedione, 17-OH Progesterone||nmol/L|Mean|5.5|5.5|Standard Deviation|1.6|1.6|||
3660981|NCT02389088|3506676|B1|Testosterone||Phase II - Testosterone, Androstenedione, 17-OH Progesterone||nmol/L|Mean|1.3|1.3|Standard Deviation|0.4|0.4|||
3660982|NCT02389088|3506676|B1|FSH||Phase II - LH, FSH||IU/L|Mean|4.7|4.7|Standard Deviation|1.3|1.3|||
3660983|NCT02389088|3506676|B1|LH||Phase II - LH, FSH||IU/L|Mean|8.6|8.6|Standard Deviation|4.4|4.4|||
3660984|NCT02389088|3506676|B1|||Phase I - Estradiol||pmol/L|Mean|180.4|180.4|Standard Deviation|25.5|25.5|||
3660985|NCT02389088|3506676|B1|17-OH Progesterone||Phase I - Testosterone, Androstenedione, 17-OH Progesterone||nmol/L|Mean|47.3|47.3|Standard Deviation|24.6|24.6|||
3660986|NCT02389088|3506676|B1|Androstenedione||Phase I - Testosterone, Androstenedione, 17-OH Progesterone||nmol/L|Mean|5.29|5.29|Standard Deviation|1.3|1.3|||
3660987|NCT02389088|3506676|B1|Testosterone||Phase I - Testosterone, Androstenedione, 17-OH Progesterone||nmol/L|Mean|1.34|1.34|Standard Deviation|0.3|0.3|||
3660988|NCT02389088|3506676|B1|FSH||Phase I - LH, FSH||IU/L|Mean|5.1|5.1|Standard Deviation|1.03|1.03|||
3660989|NCT02389088|3506676|B1|LH||Phase I - LH, FSH||IU/L|Mean|9.5|9.5|Standard Deviation|4.04|4.04|||
3660990|NCT02389088|3506676|B1|United States||Region of Enrollment|San Diego|participants|Number|9|9.0||||||
3660991|NCT02389088|3506676|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660992|NCT02389088|3506676|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3660993|NCT02389088|3506676|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3660994|NCT02389088|3506676|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3660995|NCT02389088|3506676|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660996|NCT02389088|3506676|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660997|NCT02389088|3506676|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3660998|NCT02389088|3506676|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3660999|NCT02389088|3506676|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3661000|NCT02389088|3506676|B1|||Age||years|Mean|26|26.0|Standard Deviation|1.2|1.2|||
3661001|NCT02388997|3506720|B3|||Negative serum neutralizing antibody to rhinovirus-16||Participants|Count of Participants|30|30.0||||||
3661002|NCT02388997|3506721|B2|||Negative serum neutralizing antibody to rhinovirus-16||Participants|Count of Participants|15|15.0||||||
3661003|NCT02388997|3506722|B1|||Negative serum neutralizing antibody to rhinovirus-16||Participants|Count of Participants|15|15.0||||||
3661004|NCT02388997|3506720|B3|||Total serum IgE level (IU/ml)||IU/ml|Geometric Mean|252|252.0|Full Range|||133.0|529.0|
3661005|NCT02388997|3506721|B2|||Total serum IgE level (IU/ml)||IU/ml|Geometric Mean|266|266.0|Full Range|||140.0|529.0|
3661006|NCT02388997|3506722|B1|||Total serum IgE level (IU/ml)||IU/ml|Geometric Mean|238|238.0|Full Range|||133.0|493.0|
3661007|NCT02388997|3506720|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661008|NCT02388997|3506721|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661009|NCT02388997|3506722|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661010|NCT02388997|3506720|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3661011|NCT02388997|3506721|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3661012|NCT02388997|3506722|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661013|NCT02388997|3506720|B3||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3661014|NCT02388997|3506721|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3661015|NCT02388997|3506722|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3661016|NCT02388997|3506720|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3661017|NCT02388997|3506721|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3661018|NCT02388997|3506722|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3661019|NCT02388997|3506720|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3661020|NCT02388997|3506721|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661021|NCT02388997|3506722|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3661022|NCT02388997|3506720|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3661023|NCT02388997|3506721|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3661024|NCT02388997|3506722|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3661025|NCT02388997|3506720|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661026|NCT02388997|3506721|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661027|NCT02388997|3506722|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661028|NCT02388997|3506720|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661029|NCT02388997|3506721|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661030|NCT02388997|3506722|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661031|NCT02388997|3506720|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3661032|NCT02388997|3506721|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3661033|NCT02388997|3506722|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3661034|NCT02388997|3506720|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3661035|NCT02388997|3506721|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3661036|NCT02388997|3506722|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661037|NCT02388997|3506720|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3661038|NCT02388997|3506721|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3661040|NCT02388997|3506720|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3661041|NCT02388997|3506721|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3661042|NCT02388997|3506722|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3661043|NCT02388997|3506720|B3|||Age||years|Mean|21.6|21.6|Full Range|||18.0|33.0|
3661044|NCT02388997|3506721|B2|||Age||years|Mean|22.8|22.8|Full Range|||18.0|33.0|
3661045|NCT02388997|3506722|B1|||Age||years|Mean|20.4|20.4|Full Range|||18.0|28.0|
3661046|NCT02388932|3506741|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3661047|NCT02388932|3506741|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661048|NCT02388932|3506741|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661049|NCT02388932|3506741|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3661050|NCT02388932|3506741|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661051|NCT02388932|3506741|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661052|NCT02388932|3506741|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661053|NCT02388932|3506741|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661054|NCT02388932|3506741|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661055|NCT02388932|3506741|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3661056|NCT02388932|3506741|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661057|NCT02388932|3506741|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3661058|NCT02388932|3506741|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3661059|NCT02388932|3506741|B1|||Age||years|Mean|84|84.0|Standard Deviation|14|14.0|||
3661060|NCT02388815|3506750|B1|United Kingdom||Region of Enrollment||participants|Number|89|89.0||||||
3661061|NCT02388815|3506750|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3661062|NCT02388815|3506750|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3661063|NCT02388815|3506750|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3661064|NCT02388815|3506750|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3661065|NCT02388815|3506750|B1||<=18 years|Age||Participants|Count of Participants|89|89.0||||||
3661066|NCT02388776|3506754|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3661067|NCT02388776|3506754|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3661068|NCT02388776|3506754|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3661069|NCT02388776|3506754|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3661070|NCT02388776|3506754|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3661071|NCT02388763|3506759|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3661072|NCT02388763|3506759|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3661073|NCT02388763|3506759|B1|||Age||years|Mean|33.8|33.8|Standard Deviation|9.71|9.71|||
3661074|NCT02388568|3506771|B3|||Height||cm|Mean|167.2|167.2|Standard Deviation|9.1|9.1|||
3661075|NCT02388568|3506772|B2|||Height||cm|Mean|165.7|165.7|Standard Deviation|9.4|9.4|||
3661076|NCT02388568|3506773|B1|||Height||cm|Mean|168.8|168.8|Standard Deviation|8.6|8.6|||
3661077|NCT02388568|3506771|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3661078|NCT02388568|3506772|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3661079|NCT02388568|3506773|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3661080|NCT02388568|3506771|B3|Multiracial or other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3661081|NCT02388568|3506772|B2|Multiracial or other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3661082|NCT02388568|3506773|B1|Multiracial or other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3661083|NCT02388568|3506771|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3661084|NCT02388568|3506772|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3661085|NCT02388568|3506773|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3661086|NCT02388568|3506771|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3661087|NCT02388568|3506772|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3661088|NCT02388568|3506773|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3661089|NCT02388568|3506771|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|94|94.0||||||
3661090|NCT02388568|3506772|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|45|45.0||||||
3661091|NCT02388568|3506773|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|49|49.0||||||
3661092|NCT02388568|3506771|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3661093|NCT02388568|3506772|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3661094|NCT02388568|3506773|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3661095|NCT02388568|3506771|B3||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3661096|NCT02388568|3506772|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3661097|NCT02388568|3506773|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3661098|NCT02388568|3506771|B3|||Age||years|Mean|46.1|46.1|Standard Deviation|10.1|10.1|||
3661099|NCT02388568|3506772|B2|||Age||years|Mean|47.7|47.7|Standard Deviation|9.8|9.8|||
3661100|NCT02388568|3506773|B1|||Age||years|Mean|45.4|45.4|Standard Deviation|10.5|10.5|||
3661101|NCT02388347|3506790|B6||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3661102|NCT02388347|3506791|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3661103|NCT02388347|3506792|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3661104|NCT02388347|3506793|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3661105|NCT02388347|3506794|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3661106|NCT02388347|3506795|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3661107|NCT02388347|3506790|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3661108|NCT02388347|3506791|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3661109|NCT02388347|3506792|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3661110|NCT02388347|3506793|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3661111|NCT02388347|3506794|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3661112|NCT02388347|3506795|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3661113|NCT02388347|3506790|B6|||Age||Years|Mean|34.6|34.6|Standard Deviation|10.2|10.2|||
3661114|NCT02388347|3506791|B5|||Age||Years|Mean|32.0|32.0|Standard Deviation|14.0|14.0|||
3661115|NCT02388347|3506792|B4|||Age||Years|Mean|32.8|32.8|Standard Deviation|9.7|9.7|||
3661116|NCT02388347|3506793|B3|||Age||Years|Mean|32.8|32.8|Standard Deviation|11.5|11.5|||
3661117|NCT02388347|3506794|B2|||Age||Years|Mean|38.2|38.2|Standard Deviation|7.1|7.1|||
3661118|NCT02388347|3506795|B1|||Age||Years|Mean|36.4|36.4|Standard Deviation|9.9|9.9|||
3661119|NCT02388321|3506864|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
3661120|NCT02388321|3506865|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3661121|NCT02388321|3506866|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3661122|NCT02388321|3506864|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3661123|NCT02388321|3506865|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3661124|NCT02388321|3506866|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3661125|NCT02388321|3506864|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3661126|NCT02388321|3506865|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3661127|NCT02388321|3506866|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3661128|NCT02388321|3506864|B3|||Age||years|Mean|9.7|9.7|Standard Deviation|2.7|2.7|||
3661129|NCT02388321|3506865|B2|||Age||years|Mean|9.6|9.6|Standard Deviation|2.9|2.9|||
3661130|NCT02388321|3506866|B1|||Age||years|Mean|9.8|9.8|Standard Deviation|2.5|2.5|||
3661131|NCT02388295|3506875|B4|TSPO- Low Affinity Binding||Genotype|Translocator Protein binding (TSPO) : genotype (affinity for binding); Low Affinity Binding was exclusionary|Participants|Number|0|0.0||||||
3661132|NCT02388295|3506876|B3|TSPO- Low Affinity Binding||Genotype|Translocator Protein binding (TSPO) : genotype (affinity for binding); Low Affinity Binding was exclusionary|Participants|Number|0|0.0||||||
3661133|NCT02388295|3506877|B2|TSPO- Low Affinity Binding||Genotype|Translocator Protein binding (TSPO) : genotype (affinity for binding); Low Affinity Binding was exclusionary|Participants|Number|0|0.0||||||
3661134|NCT02388295|3506878|B1|TSPO- Low Affinity Binding||Genotype|Translocator Protein binding (TSPO) : genotype (affinity for binding); Low Affinity Binding was exclusionary|Participants|Number|0|0.0||||||
3661135|NCT02388295|3506875|B4|TSPO - Mixed affinity binding||Genotype|Translocator Protein binding (TSPO) : genotype (affinity for binding); Low Affinity Binding was exclusionary|Participants|Number|20|20.0||||||
3661136|NCT02388295|3506876|B3|TSPO - Mixed affinity binding||Genotype|Translocator Protein binding (TSPO) : genotype (affinity for binding); Low Affinity Binding was exclusionary|Participants|Number|4|4.0||||||
3661137|NCT02388295|3506877|B2|TSPO - Mixed affinity binding||Genotype|Translocator Protein binding (TSPO) : genotype (affinity for binding); Low Affinity Binding was exclusionary|Participants|Number|9|9.0||||||
3661138|NCT02388295|3506878|B1|TSPO - Mixed affinity binding||Genotype|Translocator Protein binding (TSPO) : genotype (affinity for binding); Low Affinity Binding was exclusionary|Participants|Number|7|7.0||||||
3661139|NCT02388295|3506875|B4|TSPO - High Affinity Binding||Genotype|Translocator Protein binding (TSPO) : genotype (affinity for binding); Low Affinity Binding was exclusionary|Participants|Number|38|38.0||||||
3661140|NCT02388295|3506876|B3|TSPO - High Affinity Binding||Genotype|Translocator Protein binding (TSPO) : genotype (affinity for binding); Low Affinity Binding was exclusionary|Participants|Number|16|16.0||||||
3661141|NCT02388295|3506877|B2|TSPO - High Affinity Binding||Genotype|Translocator Protein binding (TSPO) : genotype (affinity for binding); Low Affinity Binding was exclusionary|Participants|Number|10|10.0||||||
3661142|NCT02388295|3506878|B1|TSPO - High Affinity Binding||Genotype|Translocator Protein binding (TSPO) : genotype (affinity for binding); Low Affinity Binding was exclusionary|Participants|Number|12|12.0||||||
3661143|NCT02388295|3506875|B4|Probable MSA||Diagnostic Category|Diagnostic Category for Multiple System Atropy (MSA); Possible or Probable were the eligible categories|Participants|Number|45|45.0||||||
3661144|NCT02388295|3506876|B3|Probable MSA||Diagnostic Category|Diagnostic Category for Multiple System Atropy (MSA); Possible or Probable were the eligible categories|Participants|Number|12|12.0||||||
3661145|NCT02388295|3506877|B2|Probable MSA||Diagnostic Category|Diagnostic Category for Multiple System Atropy (MSA); Possible or Probable were the eligible categories|Participants|Number|15|15.0||||||
3661146|NCT02388295|3506878|B1|Probable MSA||Diagnostic Category|Diagnostic Category for Multiple System Atropy (MSA); Possible or Probable were the eligible categories|Participants|Number|18|18.0||||||
3661197|NCT02388295|3506877|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661147|NCT02388295|3506875|B4|Possible MSA||Diagnostic Category|Diagnostic Category for Multiple System Atropy (MSA); Possible or Probable were the eligible categories|Participants|Number|13|13.0||||||
3661148|NCT02388295|3506876|B3|Possible MSA||Diagnostic Category|Diagnostic Category for Multiple System Atropy (MSA); Possible or Probable were the eligible categories|Participants|Number|8|8.0||||||
3661149|NCT02388295|3506877|B2|Possible MSA||Diagnostic Category|Diagnostic Category for Multiple System Atropy (MSA); Possible or Probable were the eligible categories|Participants|Number|4|4.0||||||
3661150|NCT02388295|3506878|B1|Possible MSA||Diagnostic Category|Diagnostic Category for Multiple System Atropy (MSA); Possible or Probable were the eligible categories|Participants|Number|1|1.0||||||
3661151|NCT02388295|3506875|B4|MSA - C||Multiple System Atropy Subtype|Multiple System Atropy (MSA) Subtype, Parkinsonian (P) or Cerebellar (C)|Participants|Number|34|34.0||||||
3661152|NCT02388295|3506876|B3|MSA - C||Multiple System Atropy Subtype|Multiple System Atropy (MSA) Subtype, Parkinsonian (P) or Cerebellar (C)|Participants|Number|13|13.0||||||
3661153|NCT02388295|3506877|B2|MSA - C||Multiple System Atropy Subtype|Multiple System Atropy (MSA) Subtype, Parkinsonian (P) or Cerebellar (C)|Participants|Number|9|9.0||||||
3661154|NCT02388295|3506878|B1|MSA - C||Multiple System Atropy Subtype|Multiple System Atropy (MSA) Subtype, Parkinsonian (P) or Cerebellar (C)|Participants|Number|12|12.0||||||
3661155|NCT02388295|3506875|B4|MSA - P||Multiple System Atropy Subtype|Multiple System Atropy (MSA) Subtype, Parkinsonian (P) or Cerebellar (C)|Participants|Number|24|24.0||||||
3661156|NCT02388295|3506876|B3|MSA - P||Multiple System Atropy Subtype|Multiple System Atropy (MSA) Subtype, Parkinsonian (P) or Cerebellar (C)|Participants|Number|7|7.0||||||
3661157|NCT02388295|3506877|B2|MSA - P||Multiple System Atropy Subtype|Multiple System Atropy (MSA) Subtype, Parkinsonian (P) or Cerebellar (C)|Participants|Number|10|10.0||||||
3661158|NCT02388295|3506878|B1|MSA - P||Multiple System Atropy Subtype|Multiple System Atropy (MSA) Subtype, Parkinsonian (P) or Cerebellar (C)|Participants|Number|7|7.0||||||
3661159|NCT02388295|3506875|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3661160|NCT02388295|3506876|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3661161|NCT02388295|3506877|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3661162|NCT02388295|3506878|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3661163|NCT02388295|3506875|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661164|NCT02388295|3506876|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661165|NCT02388295|3506877|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661166|NCT02388295|3506878|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661167|NCT02388295|3506875|B4||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3661168|NCT02388295|3506876|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3661169|NCT02388295|3506877|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3661170|NCT02388295|3506878|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3661171|NCT02388295|3506875|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3661172|NCT02388295|3506876|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661173|NCT02388295|3506877|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661174|NCT02388295|3506878|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3661175|NCT02388295|3506875|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661176|NCT02388295|3506876|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661177|NCT02388295|3506877|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661178|NCT02388295|3506878|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661179|NCT02388295|3506875|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3661180|NCT02388295|3506876|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3661181|NCT02388295|3506877|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3661182|NCT02388295|3506878|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661183|NCT02388295|3506875|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661184|NCT02388295|3506876|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661185|NCT02388295|3506877|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661186|NCT02388295|3506878|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661187|NCT02388295|3506875|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3661188|NCT02388295|3506876|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3661189|NCT02388295|3506877|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3661190|NCT02388295|3506878|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3661191|NCT02388295|3506875|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3661192|NCT02388295|3506876|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3661193|NCT02388295|3506877|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3661194|NCT02388295|3506878|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3661195|NCT02388295|3506875|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3661196|NCT02388295|3506876|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661198|NCT02388295|3506878|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3661199|NCT02388295|3506875|B4||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3661200|NCT02388295|3506876|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3661201|NCT02388295|3506877|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3661202|NCT02388295|3506878|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3661203|NCT02388295|3506875|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3661204|NCT02388295|3506876|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3661205|NCT02388295|3506877|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3661206|NCT02388295|3506878|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3661207|NCT02388295|3506875|B4|||Age||Years|Mean|59|59.0|Standard Deviation|7.5|7.5|||
3661208|NCT02388295|3506876|B3|||Age||Years|Mean|58.0|58.0|Standard Deviation|8.5|8.5|||
3661209|NCT02388295|3506877|B2|||Age||Years|Mean|59.9|59.9|Standard Deviation|6.1|6.1|||
3661210|NCT02388295|3506878|B1|||Age||Years|Mean|59.3|59.3|Standard Deviation|7.9|7.9|||
3661211|NCT02388269|3506894|B5|United Kingdom||Region of Enrollment||Participants|Count of Participants|81|81.0||||||
3661212|NCT02388269|3506895|B4|United Kingdom||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3661213|NCT02388269|3506896|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3661214|NCT02388269|3506897|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3661215|NCT02388269|3506898|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3661216|NCT02388269|3506894|B5|other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3661217|NCT02388269|3506895|B4|other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3661218|NCT02388269|3506896|B3|other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3661219|NCT02388269|3506897|B2|other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3661220|NCT02388269|3506898|B1|other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3661221|NCT02388269|3506894|B5|asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3661222|NCT02388269|3506895|B4|asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3661223|NCT02388269|3506896|B3|asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3661224|NCT02388269|3506897|B2|asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3661225|NCT02388269|3506898|B1|asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3661226|NCT02388269|3506894|B5|black||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3661227|NCT02388269|3506895|B4|black||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3661228|NCT02388269|3506896|B3|black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3661229|NCT02388269|3506897|B2|black||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3661230|NCT02388269|3506898|B1|black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3661231|NCT02388269|3506894|B5|white||Race/Ethnicity, Customized||Participants|Count of Participants|70|70.0||||||
3661232|NCT02388269|3506895|B4|white||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3661233|NCT02388269|3506896|B3|white||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3661234|NCT02388269|3506897|B2|white||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3661235|NCT02388269|3506898|B1|white||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3661236|NCT02388269|3506894|B5||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3661237|NCT02388269|3506895|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3661238|NCT02388269|3506896|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3661239|NCT02388269|3506897|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3661240|NCT02388269|3506898|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3661241|NCT02388269|3506894|B5||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3661242|NCT02388269|3506895|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3661243|NCT02388269|3506896|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3661244|NCT02388269|3506897|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3661245|NCT02388269|3506898|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3661246|NCT02388269|3506894|B5|||Age||years|Mean|38.9|38.9|Standard Deviation|14.4|14.4|||
3661247|NCT02388269|3506895|B4|||Age||years|Mean|41.1|41.1|Standard Deviation|16.84|16.84|||
3661248|NCT02388269|3506896|B3|||Age||years|Mean|40.1|40.1|Standard Deviation|13.78|13.78|||
3661249|NCT02388269|3506897|B2|||Age||years|Mean|33.9|33.9|Standard Deviation|12.01|12.01|||
3661250|NCT02388269|3506898|B1|||Age||years|Mean|40.6|40.6|Standard Deviation|14.39|14.39|||
3661251|NCT02388191|3506930|B3|||Expected pain for IUD insertion|"This measure asked the following:~On a scale of 0 to 10, where 0 is no anxiety and 10 is the most anxious you could be, how anxious are you about the IUD placement?.~Participants were then able to circle any whole number from 0-10 to indicate their answer."|units on a scale|Median|49.3|49.3|Inter-Quartile Range|||29.0|61.3|
3661252|NCT02388191|3506931|B2|||Expected pain for IUD insertion|"This measure asked the following:~On a scale of 0 to 10, where 0 is no anxiety and 10 is the most anxious you could be, how anxious are you about the IUD placement?.~Participants were then able to circle any whole number from 0-10 to indicate their answer."|units on a scale|Median|50.3|50.3|Inter-Quartile Range|||28.8|62.0|
3661337|NCT02387996|3506951|B1|||Age||Years|Mean|65.0|65.0|Standard Deviation|9.38|9.38|||
3661253|NCT02388191|3506932|B1|||Expected pain for IUD insertion|"This measure asked the following:~On a scale of 0 to 10, where 0 is no anxiety and 10 is the most anxious you could be, how anxious are you about the IUD placement?.~Participants were then able to circle any whole number from 0-10 to indicate their answer."|units on a scale|Median|45.5|45.5|Inter-Quartile Range|||32.0|60.0|
3661254|NCT02388191|3506930|B3|||Baseline pain tolerance, self report|"This measure asked the following:~How would you rate your pain tolerance (ability to handle pain) in general?. Response choices included: Very low (not much at all), Low, Moderate, High, or Very High (Can tolerate a lot of pain). Patients were asked to check the box of the choice that was correct for them.~Conversions to numerical values were as follows:~Very low = 1 Low = 2 Moderate = 3 High = 4 Very high = 5"|units on a scale|Median|3|3.0|Inter-Quartile Range|||3.0|4.0|
3661255|NCT02388191|3506931|B2|||Baseline pain tolerance, self report|"This measure asked the following:~How would you rate your pain tolerance (ability to handle pain) in general?. Response choices included: Very low (not much at all), Low, Moderate, High, or Very High (Can tolerate a lot of pain). Patients were asked to check the box of the choice that was correct for them.~Conversions to numerical values were as follows:~Very low = 1 Low = 2 Moderate = 3 High = 4 Very high = 5"|units on a scale|Median|4|4.0|Inter-Quartile Range|||3.0|4.0|
3661256|NCT02388191|3506932|B1|||Baseline pain tolerance, self report|"This measure asked the following:~How would you rate your pain tolerance (ability to handle pain) in general?. Response choices included: Very low (not much at all), Low, Moderate, High, or Very High (Can tolerate a lot of pain). Patients were asked to check the box of the choice that was correct for them.~Conversions to numerical values were as follows:~Very low = 1 Low = 2 Moderate = 3 High = 4 Very high = 5"|units on a scale|Median|3|3.0|Inter-Quartile Range|||3.0|4.0|
3661257|NCT02388191|3506930|B3|||Baseline anxiety, self-report|"This measure asked the following:~On a scale of 0 to 10, where 0 is no anxiety and 10 is the most anxious you could be, how have you been feeling in the past week?.~Participants were then able to circle any whole number from 0-10 to indicate their answer."|units on a scale|Median|3.5|3.5|Inter-Quartile Range|||2.0|5.0|
3661258|NCT02388191|3506931|B2|||Baseline anxiety, self-report|"This measure asked the following:~On a scale of 0 to 10, where 0 is no anxiety and 10 is the most anxious you could be, how have you been feeling in the past week?.~Participants were then able to circle any whole number from 0-10 to indicate their answer."|units on a scale|Median|4|4.0|Inter-Quartile Range|||2.0|5.0|
3661259|NCT02388191|3506932|B1|||Baseline anxiety, self-report|"This measure asked the following:~On a scale of 0 to 10, where 0 is no anxiety and 10 is the most anxious you could be, how have you been feeling in the past week?.~Participants were then able to circle any whole number from 0-10 to indicate their answer."|units on a scale|Median|3|3.0|Inter-Quartile Range|||2.0|5.0|
3661260|NCT02388191|3506930|B3|||Baseline sadness, self-report|"This measure asked the following:~How sad have you felt in the past week on a scale of 0-10, where 0 is not sad at all and 10 is the most sad ever.~Participants were then able to circle any whole number from 0-10 to indicate their answer."|units on a scale|Median|2|2.0|Inter-Quartile Range|||1.0|4.0|
3661261|NCT02388191|3506931|B2|||Baseline sadness, self-report|"This measure asked the following:~How sad have you felt in the past week on a scale of 0-10, where 0 is not sad at all and 10 is the most sad ever.~Participants were then able to circle any whole number from 0-10 to indicate their answer."|units on a scale|Median|3|3.0|Inter-Quartile Range|||1.0|4.0|
3661262|NCT02388191|3506932|B1|||Baseline sadness, self-report|"This measure asked the following:~How sad have you felt in the past week on a scale of 0-10, where 0 is not sad at all and 10 is the most sad ever.~Participants were then able to circle any whole number from 0-10 to indicate their answer."|units on a scale|Median|2|2.0|Inter-Quartile Range|||1.0|3.0|
3661263|NCT02388191|3506930|B3|||Baseline stress, self-report|"This measure asked the following:~How stressed have you felt in the past week on a scale of 0-10, where 0 is not stressed at all and 10 is the most stressed ever.~Participants were then able to circle any whole number from 0-10 to indicate their answer."|units on a scale|Median|4|4.0|Inter-Quartile Range|||3.0|6.0|
3661264|NCT02388191|3506931|B2|||Baseline stress, self-report|"This measure asked the following:~How stressed have you felt in the past week on a scale of 0-10, where 0 is not stressed at all and 10 is the most stressed ever.~Participants were then able to circle any whole number from 0-10 to indicate their answer."|units on a scale|Median|4|4.0|Inter-Quartile Range|||3.0|6.0|
3661265|NCT02388191|3506932|B1|||Baseline stress, self-report|"This measure asked the following:~How stressed have you felt in the past week on a scale of 0-10, where 0 is not stressed at all and 10 is the most stressed ever.~Participants were then able to circle any whole number from 0-10 to indicate their answer."|units on a scale|Median|4|4.0|Inter-Quartile Range|||3.0|6.0|
3661266|NCT02388191|3506930|B3|||Diagnosed with depression (yes)||Participants|Count of Participants|25|25.0||||||
3661267|NCT02388191|3506931|B2|||Diagnosed with depression (yes)||Participants|Count of Participants|11|11.0||||||
3661268|NCT02388191|3506932|B1|||Diagnosed with depression (yes)||Participants|Count of Participants|14|14.0||||||
3661269|NCT02388191|3506930|B3|||Diagnosed with chronic pain condition (yes)||Participants|Count of Participants|3|3.0||||||
3661270|NCT02388191|3506931|B2|||Diagnosed with chronic pain condition (yes)||Participants|Count of Participants|1|1.0||||||
3661271|NCT02388191|3506932|B1|||Diagnosed with chronic pain condition (yes)||Participants|Count of Participants|2|2.0||||||
3661272|NCT02388191|3506930|B3|Other||Highest level of education||Participants|Count of Participants|2|2.0||||||
3661273|NCT02388191|3506931|B2|Other||Highest level of education||Participants|Count of Participants|2|2.0||||||
3661274|NCT02388191|3506932|B1|Other||Highest level of education||Participants|Count of Participants|0|0.0||||||
3661275|NCT02388191|3506930|B3|Graduate or professional school||Highest level of education||Participants|Count of Participants|14|14.0||||||
3661276|NCT02388191|3506931|B2|Graduate or professional school||Highest level of education||Participants|Count of Participants|9|9.0||||||
3661277|NCT02388191|3506932|B1|Graduate or professional school||Highest level of education||Participants|Count of Participants|5|5.0||||||
3661278|NCT02388191|3506930|B3|4 year college or Bachelor's degree||Highest level of education||Participants|Count of Participants|45|45.0||||||
3661279|NCT02388191|3506931|B2|4 year college or Bachelor's degree||Highest level of education||Participants|Count of Participants|22|22.0||||||
3661280|NCT02388191|3506932|B1|4 year college or Bachelor's degree||Highest level of education||Participants|Count of Participants|23|23.0||||||
3661281|NCT02388191|3506930|B3|Some college or 2 year college||Highest level of education||Participants|Count of Participants|48|48.0||||||
3661282|NCT02388191|3506931|B2|Some college or 2 year college||Highest level of education||Participants|Count of Participants|23|23.0||||||
3661283|NCT02388191|3506932|B1|Some college or 2 year college||Highest level of education||Participants|Count of Participants|25|25.0||||||
3661284|NCT02388191|3506930|B3|High school or high school equivalency||Highest level of education||Participants|Count of Participants|9|9.0||||||
3661285|NCT02388191|3506931|B2|High school or high school equivalency||Highest level of education||Participants|Count of Participants|4|4.0||||||
3661286|NCT02388191|3506932|B1|High school or high school equivalency||Highest level of education||Participants|Count of Participants|5|5.0||||||
3661287|NCT02388191|3506930|B3|Other||Marital status||Participants|Count of Participants|9|9.0||||||
3661288|NCT02388191|3506931|B2|Other||Marital status||Participants|Count of Participants|5|5.0||||||
3661289|NCT02388191|3506932|B1|Other||Marital status||Participants|Count of Participants|4|4.0||||||
3661290|NCT02388191|3506930|B3|Single||Marital status||Participants|Count of Participants|105|105.0||||||
3661291|NCT02388191|3506931|B2|Single||Marital status||Participants|Count of Participants|54|54.0||||||
3661292|NCT02388191|3506932|B1|Single||Marital status||Participants|Count of Participants|51|51.0||||||
3661293|NCT02388191|3506930|B3|Married||Marital status||Participants|Count of Participants|4|4.0||||||
3661294|NCT02388191|3506931|B2|Married||Marital status||Participants|Count of Participants|1|1.0||||||
3661295|NCT02388191|3506932|B1|Married||Marital status||Participants|Count of Participants|3|3.0||||||
3661296|NCT02388191|3506930|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3661297|NCT02388191|3506931|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3661298|NCT02388191|3506932|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3661299|NCT02388191|3506930|B3|Multiracial||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3661300|NCT02388191|3506931|B2|Multiracial||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3661301|NCT02388191|3506932|B1|Multiracial||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3661302|NCT02388191|3506930|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3661303|NCT02388191|3506931|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3661304|NCT02388191|3506932|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3661305|NCT02388191|3506930|B3|White or European American||Race/Ethnicity, Customized||Participants|Count of Participants|93|93.0||||||
3661306|NCT02388191|3506931|B2|White or European American||Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
3661307|NCT02388191|3506932|B1|White or European American||Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
3661308|NCT02388191|3506930|B3|African American or black||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3661309|NCT02388191|3506931|B2|African American or black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3661310|NCT02388191|3506932|B1|African American or black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3661311|NCT02388191|3506930|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3661312|NCT02388191|3506931|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3661313|NCT02388191|3506932|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3661314|NCT02388191|3506930|B3||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3661315|NCT02388191|3506931|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3661316|NCT02388191|3506932|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3661317|NCT02388191|3506930|B3|||Age||years|Mean|23.86|23.86|Standard Deviation|4.1|4.1|||
3661318|NCT02388191|3506931|B2|||Age||years|Mean|24.3|24.3|Standard Deviation|4.2|4.2|||
3661319|NCT02388191|3506932|B1|||Age||years|Mean|23.2|23.2|Standard Deviation|3.9|3.9|||
3661320|NCT02388074|3506947|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3661321|NCT02388074|3506947|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3661322|NCT02388074|3506947|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3661323|NCT02388074|3506947|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3661324|NCT02388074|3506947|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3661325|NCT02387996|3506951|B1|Not Reported||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3661326|NCT02387996|3506951|B1|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3661327|NCT02387996|3506951|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3661328|NCT02387996|3506951|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3661329|NCT02387996|3506951|B1|Asian||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
3661330|NCT02387996|3506951|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3661331|NCT02387996|3506951|B1|White||Race/Ethnicity, Customized||Participants|Number|231|231.0||||||
3661332|NCT02387996|3506951|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|112|112.0||||||
3661333|NCT02387996|3506951|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|156|156.0||||||
3661334|NCT02387996|3506951|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3661335|NCT02387996|3506951|B1||Male|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
3661336|NCT02387996|3506951|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3661338|NCT02387983|3506962|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3661339|NCT02387983|3506962|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3661340|NCT02387983|3506962|B1|||Age||Years|Mean|42.7|42.7|Standard Deviation|11.8|11.8|||
3661341|NCT02387801|3506974|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3661342|NCT02387801|3506975|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3661343|NCT02387801|3506976|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3661344|NCT02387801|3506974|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661345|NCT02387801|3506975|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661346|NCT02387801|3506976|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661347|NCT02387801|3506974|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661348|NCT02387801|3506975|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661349|NCT02387801|3506976|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661350|NCT02387801|3506974|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3661351|NCT02387801|3506975|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3661352|NCT02387801|3506976|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3661353|NCT02387801|3506974|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3661354|NCT02387801|3506975|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3661355|NCT02387801|3506976|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3661356|NCT02387801|3506974|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661357|NCT02387801|3506975|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661358|NCT02387801|3506976|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661359|NCT02387801|3506974|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3661360|NCT02387801|3506975|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661361|NCT02387801|3506976|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3661362|NCT02387801|3506974|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661363|NCT02387801|3506975|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661364|NCT02387801|3506976|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661365|NCT02387801|3506974|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661366|NCT02387801|3506975|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661367|NCT02387801|3506976|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661368|NCT02387801|3506974|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3661369|NCT02387801|3506975|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3661370|NCT02387801|3506976|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3661371|NCT02387801|3506974|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3661372|NCT02387801|3506975|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3661373|NCT02387801|3506976|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3661374|NCT02387801|3506974|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3661375|NCT02387801|3506975|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3661376|NCT02387801|3506976|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3661377|NCT02387801|3506974|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3661378|NCT02387801|3506975|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3661379|NCT02387801|3506976|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3661380|NCT02387801|3506974|B3|||Age||years|Mean|48.5|48.5|Standard Deviation|12.03|12.03|||
3661381|NCT02387801|3506975|B2|||Age||years|Mean|55.2|55.2|Standard Deviation|7.39|7.39|||
3661382|NCT02387801|3506976|B1|||Age||years|Mean|41.8|41.8|Standard Deviation|12.54|12.54|||
3661383|NCT02387749|3506995|B1|Egypt||Region of Enrollment||participants|Number|10|10.0||||||
3661384|NCT02387749|3506995|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3661385|NCT02387749|3506995|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3661386|NCT02387749|3506995|B1|||Age||years|Mean|41.20|41.2|Standard Deviation|4.59|4.59|||
3661387|NCT02387749|3506995|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3661388|NCT02387749|3506995|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3661389|NCT02387749|3506995|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3661390|NCT02387710|3507004|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3661391|NCT02387710|3507004|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3661392|NCT02387710|3507004|B1|||Age||years|Median|58|58.0|Inter-Quartile Range|||51.0|63.0|
3661393|NCT02387580|3507015|B7|United Kingdom||Region of Enrollment||participants|Number|48|48.0||||||
3661394|NCT02387580|3507016|B6|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3661395|NCT02387580|3507017|B5|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3661396|NCT02387580|3507018|B4|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3661397|NCT02387580|3507019|B3|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3661398|NCT02387580|3507020|B2|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3661399|NCT02387580|3507021|B1|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3661400|NCT02387580|3507015|B7||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3661401|NCT02387580|3507016|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3661402|NCT02387580|3507017|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3661403|NCT02387580|3507018|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3661404|NCT02387580|3507019|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3661405|NCT02387580|3507020|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3661406|NCT02387580|3507021|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3661407|NCT02387580|3507015|B7||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3661408|NCT02387580|3507016|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3661409|NCT02387580|3507017|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3661410|NCT02387580|3507018|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3661411|NCT02387580|3507019|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3661412|NCT02387580|3507020|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3661413|NCT02387580|3507021|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3661414|NCT02387580|3507015|B7|||Age||years|Mean|32.1|32.1|Standard Deviation|10.5|10.5|||
3661415|NCT02387580|3507016|B6|||Age||years|Mean|30.1|30.1|Standard Deviation|7.0|7.0|||
3661416|NCT02387580|3507017|B5|||Age||years|Mean|31.3|31.3|Standard Deviation|12.9|12.9|||
3661417|NCT02387580|3507018|B4|||Age||years|Mean|32.0|32.0|Standard Deviation|12.9|12.9|||
3661418|NCT02387580|3507019|B3|||Age||years|Mean|34.9|34.9|Standard Deviation|9.8|9.8|||
3661419|NCT02387580|3507020|B2|||Age||years|Mean|34.5|34.5|Standard Deviation|12.7|12.7|||
3661420|NCT02387580|3507021|B1|||Age||years|Mean|30|30.0|Standard Deviation|8.9|8.9|||
3661421|NCT02387554|3507058|B5|Korea, Republic of||Region of Enrollment||participants|Number|33|33.0||||||
3661422|NCT02387554|3507059|B4|Korea, Republic of||Region of Enrollment||participants|Number|8|8.0||||||
3661423|NCT02387554|3507060|B3|Korea, Republic of||Region of Enrollment||participants|Number|8|8.0||||||
3661424|NCT02387554|3507061|B2|Korea, Republic of||Region of Enrollment||participants|Number|7|7.0||||||
3661425|NCT02387554|3507062|B1|Korea, Republic of||Region of Enrollment||participants|Number|10|10.0||||||
3661426|NCT02387554|3507058|B5||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3661427|NCT02387554|3507059|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3661428|NCT02387554|3507060|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3661429|NCT02387554|3507061|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3661430|NCT02387554|3507062|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3661431|NCT02387554|3507058|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3661432|NCT02387554|3507059|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3661433|NCT02387554|3507060|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3661434|NCT02387554|3507061|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3661435|NCT02387554|3507062|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3661436|NCT02387554|3507058|B5|||Age||years|Mean|26.06|26.06|Standard Deviation|4.07|4.07|||
3661437|NCT02387554|3507059|B4|||Age||years|Mean|24.88|24.88|Standard Deviation|4.05|4.05|||
3661438|NCT02387554|3507060|B3|||Age||years|Mean|26.00|26.0|Standard Deviation|3.93|3.93|||
3661439|NCT02387554|3507061|B2|||Age||years|Mean|26.43|26.43|Standard Deviation|4.89|4.89|||
3661440|NCT02387554|3507062|B1|||Age||years|Mean|26.70|26.7|Standard Deviation|4.06|4.06|||
3661441|NCT02387502|3507075|B4|||Thyromental distance||cm|Mean|6.21|6.21|Standard Deviation|0.41|0.41|||
3661442|NCT02387502|3507076|B3|||Thyromental distance||cm|Mean|6.28|6.28|Standard Deviation|0.44|0.44|||
3661443|NCT02387502|3507077|B2|||Thyromental distance||cm|Mean|6.16|6.16|Standard Deviation|0.40|0.4|||
3661444|NCT02387502|3507078|B1|||Thyromental distance||cm|Mean|6.19|6.19|Standard Deviation|0.40|0.4|||
3661445|NCT02387502|3507075|B4|||Mallampati grade|"The Mallampati classification is based on the structures visualized with maximal mouth opening and tongue protrusion in the sitting position.~Class I: Soft palate, uvula, fauces, pillars visible. Class II: Soft palate, uvula, fauces visible. Class III: Soft palate, base of uvula visible. Class IV: Only hard palate visible."|units on a scale|Median|2|2.0|Inter-Quartile Range|||1.0|2.0|
3661446|NCT02387502|3507076|B3|||Mallampati grade|"The Mallampati classification is based on the structures visualized with maximal mouth opening and tongue protrusion in the sitting position.~Class I: Soft palate, uvula, fauces, pillars visible. Class II: Soft palate, uvula, fauces visible. Class III: Soft palate, base of uvula visible. Class IV: Only hard palate visible."|units on a scale|Median|1|1.0|Inter-Quartile Range|||1.0|2.0|
3661447|NCT02387502|3507077|B2|||Mallampati grade|"The Mallampati classification is based on the structures visualized with maximal mouth opening and tongue protrusion in the sitting position.~Class I: Soft palate, uvula, fauces, pillars visible. Class II: Soft palate, uvula, fauces visible. Class III: Soft palate, base of uvula visible. Class IV: Only hard palate visible."|units on a scale|Median|2|2.0|Inter-Quartile Range|||1.0|2.0|
3661448|NCT02387502|3507078|B1|||Mallampati grade|"The Mallampati classification is based on the structures visualized with maximal mouth opening and tongue protrusion in the sitting position.~Class I: Soft palate, uvula, fauces, pillars visible. Class II: Soft palate, uvula, fauces visible. Class III: Soft palate, base of uvula visible. Class IV: Only hard palate visible."|units on a scale|Median|2|2.0|Inter-Quartile Range|||1.0|2.0|
3661449|NCT02387502|3507075|B4|||BMI||kg/m^2|Mean|22.29|22.29|Standard Deviation|1.10|1.1|||
3661450|NCT02387502|3507076|B3|||BMI||kg/m^2|Mean|22.03|22.03|Standard Deviation|1.13|1.13|||
3661451|NCT02387502|3507077|B2|||BMI||kg/m^2|Mean|22.43|22.43|Standard Deviation|1.07|1.07|||
3661452|NCT02387502|3507078|B1|||BMI||kg/m^2|Mean|22.41|22.41|Standard Deviation|1.11|1.11|||
3661453|NCT02387502|3507075|B4|||Weight||Kg|Mean|58.30|58.3|Standard Deviation|6.05|6.05|||
3661454|NCT02387502|3507076|B3|||Weight||Kg|Mean|57.62|57.62|Standard Deviation|5.65|5.65|||
3661455|NCT02387502|3507077|B2|||Weight||Kg|Mean|58.62|58.62|Standard Deviation|6.46|6.46|||
3661456|NCT02387502|3507078|B1|||Weight||Kg|Mean|58.65|58.65|Standard Deviation|6.03|6.03|||
3661457|NCT02387502|3507075|B4||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3661458|NCT02387502|3507076|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3661459|NCT02387502|3507077|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3661460|NCT02387502|3507078|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3661461|NCT02387502|3507075|B4||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3661462|NCT02387502|3507076|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3661463|NCT02387502|3507077|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3661464|NCT02387502|3507078|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3661465|NCT02387502|3507075|B4|||Age||years|Mean|37.88|37.88|Standard Deviation|9.88|9.88|||
3661466|NCT02387502|3507076|B3|||Age||years|Mean|35.47|35.47|Standard Deviation|10.10|10.1|||
3661467|NCT02387502|3507077|B2|||Age||years|Mean|38.82|38.82|Standard Deviation|9.62|9.62|||
3661468|NCT02387502|3507078|B1|||Age||years|Mean|39.35|39.35|Standard Deviation|9.92|9.92|||
3661469|NCT02387502|3507075|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3661470|NCT02387502|3507076|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3661471|NCT02387502|3507077|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3661472|NCT02387502|3507078|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3661473|NCT02387502|3507075|B4||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
3661474|NCT02387502|3507076|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3661475|NCT02387502|3507077|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3661476|NCT02387502|3507078|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3661477|NCT02387502|3507075|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3661478|NCT02387502|3507076|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3661479|NCT02387502|3507077|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3661480|NCT02387502|3507078|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3661481|NCT02387476|3507088|B3|||BMI<= 35 kg/m^2||kg/m^2|Mean|30.43|30.43|Standard Deviation|3.242|3.242|||
3661482|NCT02387476|3507089|B2|||BMI<= 35 kg/m^2||kg/m^2|Mean|29.89|29.89|Standard Deviation|3.543|3.543|||
3661483|NCT02387476|3507090|B1|||BMI<= 35 kg/m^2||kg/m^2|Mean|30.91|30.91|Standard Deviation|2.961|2.961|||
3661484|NCT02387476|3507088|B3|||Apnea-Hypopnea Index >= 5/hr||events/hour|Mean|26.1|26.1|Standard Deviation|17.403|17.403|||
3661485|NCT02387476|3507089|B2|||Apnea-Hypopnea Index >= 5/hr||events/hour|Mean|28.8|28.8|Standard Deviation|19.571|19.571|||
3661486|NCT02387476|3507090|B1|||Apnea-Hypopnea Index >= 5/hr||events/hour|Mean|23.6|23.6|Standard Deviation|15.317|15.317|||
3661487|NCT02387476|3507088|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3661488|NCT02387476|3507089|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3661489|NCT02387476|3507090|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3661490|NCT02387476|3507088|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3661491|NCT02387476|3507089|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3661492|NCT02387476|3507090|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3661493|NCT02387476|3507088|B3|Age|age less than 70 years old|Age, Customized||Participants|Count of Participants|0|0.0||||||
3661494|NCT02387476|3507089|B2|Age|age less than 70 years old|Age, Customized||Participants|Count of Participants|0|0.0||||||
3661495|NCT02387476|3507090|B1|Age|age less than 70 years old|Age, Customized||Participants|Count of Participants|0|0.0||||||
3661496|NCT02387476|3507088|B3|Age|age between 18-70 years old|Age, Customized||Participants|Count of Participants|36|36.0||||||
3661497|NCT02387476|3507089|B2|Age|age between 18-70 years old|Age, Customized||Participants|Count of Participants|17|17.0||||||
3661498|NCT02387476|3507090|B1|Age|age between 18-70 years old|Age, Customized||Participants|Count of Participants|19|19.0||||||
3661499|NCT02387476|3507088|B3|Age|age less than 18 years old|Age, Customized||Participants|Count of Participants|0|0.0||||||
3661500|NCT02387476|3507089|B2|Age|age less than 18 years old|Age, Customized||Participants|Count of Participants|0|0.0||||||
3661501|NCT02387476|3507090|B1|Age|age less than 18 years old|Age, Customized||Participants|Count of Participants|0|0.0||||||
3661502|NCT02387268|3507117|B1|Israel||Region of Enrollment||participants|Number|10|10.0||||||
3661503|NCT02387268|3507117|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3661504|NCT02387268|3507117|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3661505|NCT02387268|3507117|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|13|13.0|||
3661506|NCT02387268|3507117|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3661507|NCT02387268|3507117|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3661508|NCT02387268|3507117|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3661509|NCT02386098|3507122|B6||Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3661510|NCT02386098|3507126|B2||Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3661511|NCT02386098|3507127|B1||Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3661512|NCT02386098|3507122|B6||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3661513|NCT02386098|3507126|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3661514|NCT02386098|3507127|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3661515|NCT02386098|3507122|B6||Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3661516|NCT02386098|3507126|B2||Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3661517|NCT02386098|3507127|B1||Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3661518|NCT02386098|3507122|B6||White|Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3661519|NCT02386098|3507126|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3661520|NCT02386098|3507127|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3661521|NCT02386098|3507122|B6||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3661522|NCT02386098|3507126|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3661523|NCT02386098|3507127|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3661524|NCT02386098|3507122|B6||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3661525|NCT02386098|3507126|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3661526|NCT02386098|3507127|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3661527|NCT02386098|3507122|B6|||Age||Years|Mean|40.7|40.7|Standard Deviation|11.70|11.7|||
3661528|NCT02386098|3507126|B2|||Age||Years|Mean|41.7|41.7|Standard Deviation|12.06|12.06|||
3661529|NCT02386098|3507127|B1|||Age||Years|Mean|39.8|39.8|Standard Deviation|11.45|11.45|||
3661530|NCT02385526|3507208|B4|United States||Region of Enrollment||participants|Number|62|62.0||||||
3661531|NCT02385526|3507209|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3661532|NCT02385526|3507210|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3661533|NCT02385526|3507211|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3661534|NCT02385526|3507208|B4|Race/Ethnicity|Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3661535|NCT02385526|3507209|B3|Race/Ethnicity|Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3661536|NCT02385526|3507210|B2|Race/Ethnicity|Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3661537|NCT02385526|3507211|B1|Race/Ethnicity|Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3661538|NCT02385526|3507208|B4|Race/Ethnicity|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3661539|NCT02385526|3507209|B3|Race/Ethnicity|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3661540|NCT02385526|3507210|B2|Race/Ethnicity|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3661541|NCT02385526|3507211|B1|Race/Ethnicity|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3661542|NCT02385526|3507208|B4|Race/Ethnicity|White Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|45|45.0||||||
3661543|NCT02385526|3507209|B3|Race/Ethnicity|White Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3661544|NCT02385526|3507210|B2|Race/Ethnicity|White Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3661545|NCT02385526|3507211|B1|Race/Ethnicity|White Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3661546|NCT02385526|3507208|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3661547|NCT02385526|3507209|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3661548|NCT02385526|3507210|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3661549|NCT02385526|3507211|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3661550|NCT02385526|3507208|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3661551|NCT02385526|3507209|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3661552|NCT02385526|3507210|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3661553|NCT02385526|3507211|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3661554|NCT02385526|3507208|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3661555|NCT02385526|3507209|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3661556|NCT02385526|3507210|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3661557|NCT02385526|3507211|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3661558|NCT02385526|3507208|B4||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
3661559|NCT02385526|3507209|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3661560|NCT02385526|3507210|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3661561|NCT02385526|3507211|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3661562|NCT02385526|3507208|B4||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3661563|NCT02385526|3507209|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3661564|NCT02385526|3507210|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3661565|NCT02385526|3507211|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3661566|NCT02385084|3507221|B1|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3661567|NCT02385084|3507221|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661568|NCT02385084|3507221|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661569|NCT02385084|3507221|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3661570|NCT02385084|3507221|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3661571|NCT02385084|3507221|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661572|NCT02385084|3507221|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661573|NCT02385084|3507221|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661574|NCT02385084|3507221|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661575|NCT02385084|3507221|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3661576|NCT02385084|3507221|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3661577|NCT02385084|3507221|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3661578|NCT02385084|3507221|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3661579|NCT02385084|3507221|B1|||Age||years|Mean|44.4|44.4|Standard Deviation|13.0|13.0|||
3661580|NCT02384538|3507237|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3661581|NCT02384538|3507238|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3661582|NCT02384538|3507239|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3661583|NCT02384538|3507237|B3||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3661584|NCT02384538|3507238|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3661585|NCT02384538|3507239|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3661586|NCT02384538|3507237|B3|||Age||years|Mean|65.7|65.7|Standard Deviation|7.700|7.7|||
3661587|NCT02384538|3507238|B2|||Age||years|Mean|65.7|65.7|Standard Deviation|8.132|8.132|||
3661588|NCT02384538|3507239|B1|||Age||years|Mean|65.8|65.8|Standard Deviation|7.325|7.325|||
3661589|NCT02384460|3507258|B3|Junctional non-Herlitz||EB type||Participants|Count of Participants|32|32.0||||||
3661590|NCT02384460|3507259|B2|Junctional non-Herlitz||EB type||Participants|Count of Participants|17|17.0||||||
3661591|NCT02384460|3507260|B1|Junctional non-Herlitz||EB type||Participants|Count of Participants|15|15.0||||||
3661592|NCT02384460|3507258|B3|Recessive dystrophic||EB type||Participants|Count of Participants|119|119.0||||||
3661593|NCT02384460|3507259|B2|Recessive dystrophic||EB type||Participants|Count of Participants|62|62.0||||||
3661594|NCT02384460|3507260|B1|Recessive dystrophic||EB type||Participants|Count of Participants|57|57.0||||||
3661595|NCT02384460|3507258|B3|Simplex||EB type||Participants|Count of Participants|18|18.0||||||
3661596|NCT02384460|3507259|B2|Simplex||EB type||Participants|Count of Participants|8|8.0||||||
3661597|NCT02384460|3507260|B1|Simplex||EB type||Participants|Count of Participants|10|10.0||||||
3661598|NCT02384460|3507258|B3|Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3661599|NCT02384460|3507259|B2|Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3661600|NCT02384460|3507260|B1|Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3661601|NCT02384460|3507258|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3661602|NCT02384460|3507259|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3661603|NCT02384460|3507260|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3661604|NCT02384460|3507258|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3661605|NCT02384460|3507259|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3661606|NCT02384460|3507260|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3661607|NCT02384460|3507258|B3|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3661608|NCT02384460|3507259|B2|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3661609|NCT02384460|3507260|B1|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3661610|NCT02384460|3507258|B3|White/Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|141|141.0||||||
3661611|NCT02384460|3507259|B2|White/Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|72|72.0||||||
3661612|NCT02384460|3507260|B1|White/Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|69|69.0||||||
3661613|NCT02384460|3507258|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3661614|NCT02384460|3507259|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3661615|NCT02384460|3507260|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3661616|NCT02384460|3507258|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3661617|NCT02384460|3507259|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3661618|NCT02384460|3507260|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3661619|NCT02384460|3507258|B3|||Age||years|Mean|13.9|13.9|Standard Deviation|13.09|13.09|||
3661620|NCT02384460|3507259|B2|||Age||years|Mean|13.9|13.9|Standard Deviation|13.12|13.12|||
3661621|NCT02384460|3507260|B1|||Age||years|Mean|13.8|13.8|Standard Deviation|13.15|13.15|||
3661622|NCT02384096|3507279|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3661623|NCT02384096|3507280|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3661624|NCT02384096|3507281|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3661625|NCT02384096|3507279|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3661626|NCT02384096|3507280|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3661627|NCT02384096|3507281|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3661628|NCT02384096|3507279|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3661629|NCT02384096|3507280|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3661630|NCT02384096|3507281|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3661631|NCT02384096|3507279|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3661632|NCT02384096|3507280|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3661633|NCT02384096|3507281|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3661634|NCT02384096|3507279|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3661635|NCT02384096|3507280|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3661636|NCT02384096|3507281|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3661637|NCT02384096|3507279|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3661638|NCT02384096|3507280|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3661639|NCT02384096|3507281|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3661640|NCT02384070|3507287|B4|United States||Region of Enrollment||participants|Number|300|300.0||||||
3661641|NCT02384070|3507288|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
3661642|NCT02384070|3507289|B2|United States||Region of Enrollment||participants|Number|100|100.0||||||
3661643|NCT02384070|3507290|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
3661644|NCT02384070|3507287|B4||Male|Gender||Participants|Count of Participants|188|188.0||||||
3661645|NCT02384070|3507288|B3||Male|Gender||Participants|Count of Participants|65|65.0||||||
3661646|NCT02384070|3507289|B2||Male|Gender||Participants|Count of Participants|61|61.0||||||
3661647|NCT02384070|3507290|B1||Male|Gender||Participants|Count of Participants|62|62.0||||||
3661648|NCT02384070|3507287|B4||Female|Gender||Participants|Count of Participants|112|112.0||||||
3661649|NCT02384070|3507288|B3||Female|Gender||Participants|Count of Participants|35|35.0||||||
3661650|NCT02384070|3507289|B2||Female|Gender||Participants|Count of Participants|39|39.0||||||
3661651|NCT02384070|3507290|B1||Female|Gender||Participants|Count of Participants|38|38.0||||||
3661652|NCT02384070|3507287|B4|||Age||Years|Mean|64|64.0|Standard Deviation|3|3.0|||
3661653|NCT02384070|3507288|B3|||Age||Years|Mean|63|63.0|Standard Deviation|8|8.0|||
3661654|NCT02384070|3507289|B2|||Age||Years|Mean|65|65.0|Standard Deviation|10|10.0|||
3661655|NCT02384070|3507290|B1|||Age||Years|Mean|62|62.0|Standard Deviation|9|9.0|||
3661656|NCT02383862|3507306|B3|||PROMIS Fatigue T-score|The 4-item PROMIS subscale for fatigue assesses the extent to which patients experience problems with fatigue over the past 7 days using a 5-point Likert scale. The fatigue subscale provides a raw score, ranging from 4 to 20. Raw scores are converted to T-scores using the PROMIS conversion tables. Higher scores reflect greater fatigue.|T-score|Mean|57.0|57.0|Standard Deviation|10.0|10.0|||
3661657|NCT02383862|3507307|B2|||PROMIS Fatigue T-score|The 4-item PROMIS subscale for fatigue assesses the extent to which patients experience problems with fatigue over the past 7 days using a 5-point Likert scale. The fatigue subscale provides a raw score, ranging from 4 to 20. Raw scores are converted to T-scores using the PROMIS conversion tables. Higher scores reflect greater fatigue.|T-score|Mean|57.2|57.2|Standard Deviation|9.9|9.9|||
3661658|NCT02383862|3507308|B1|||PROMIS Fatigue T-score|The 4-item PROMIS subscale for fatigue assesses the extent to which patients experience problems with fatigue over the past 7 days using a 5-point Likert scale. The fatigue subscale provides a raw score, ranging from 4 to 20. Raw scores are converted to T-scores using the PROMIS conversion tables. Higher scores reflect greater fatigue.|T-score|Mean|56.8|56.8|Standard Deviation|10.1|10.1|||
3661659|NCT02383862|3507306|B3|||PROMIS Depression T-score|The 4-item PROMIS subscale for depression assesses the extent to which patients experience depressive symptoms over the past 7 days using a 5-point Likert scale. The depression subscale provides a raw score, ranging from 4 to 20. Raw scores are converted to T-scores using the PROMIS conversion tables. Higher scores reflect greater depression.|T-score|Mean|55.9|55.9|Standard Deviation|9.8|9.8|||
3661660|NCT02383862|3507307|B2|||PROMIS Depression T-score|The 4-item PROMIS subscale for depression assesses the extent to which patients experience depressive symptoms over the past 7 days using a 5-point Likert scale. The depression subscale provides a raw score, ranging from 4 to 20. Raw scores are converted to T-scores using the PROMIS conversion tables. Higher scores reflect greater depression.|T-score|Mean|56.0|56.0|Standard Deviation|9.1|9.1|||
3661661|NCT02383862|3507308|B1|||PROMIS Depression T-score|The 4-item PROMIS subscale for depression assesses the extent to which patients experience depressive symptoms over the past 7 days using a 5-point Likert scale. The depression subscale provides a raw score, ranging from 4 to 20. Raw scores are converted to T-scores using the PROMIS conversion tables. Higher scores reflect greater depression.|T-score|Mean|55.8|55.8|Standard Deviation|10.4|10.4|||
3661662|NCT02383862|3507306|B3|||PROMIS Anxiety T-score|The 4-item PROMIS subscale for anxiety assesses the extent to which patients experience anxiety symptoms over the past 7 days using a 5-point Likert scale. The anxiety subscale provides a raw score, ranging from 4 to 20. Raw scores are converted to T-scores using the PROMIS conversion tables. Higher scores reflect greater anxiety.|T-score|Mean|59.1|59.1|Standard Deviation|9.4|9.4|||
3661663|NCT02383862|3507307|B2|||PROMIS Anxiety T-score|The 4-item PROMIS subscale for anxiety assesses the extent to which patients experience anxiety symptoms over the past 7 days using a 5-point Likert scale. The anxiety subscale provides a raw score, ranging from 4 to 20. Raw scores are converted to T-scores using the PROMIS conversion tables. Higher scores reflect greater anxiety.|T-score|Mean|59.2|59.2|Standard Deviation|8.7|8.7|||
3661693|NCT02383862|3507307|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661694|NCT02383862|3507308|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3661664|NCT02383862|3507308|B1|||PROMIS Anxiety T-score|The 4-item PROMIS subscale for anxiety assesses the extent to which patients experience anxiety symptoms over the past 7 days using a 5-point Likert scale. The anxiety subscale provides a raw score, ranging from 4 to 20. Raw scores are converted to T-scores using the PROMIS conversion tables. Higher scores reflect greater anxiety.|T-score|Mean|59.0|59.0|Standard Deviation|10.1|10.1|||
3661665|NCT02383862|3507306|B3|||PROMIS Pain T-score|The 4-item PROMIS subscale for pain assesses the extent to which patients experience problems with pain over the past 7 days using a 5-point Likert scale. The pain subscale provides a raw score, ranging from 4 to 20. Raw scores are converted to T-scores using the PROMIS conversion tables. Higher scores reflect greater pain.|T-score|Mean|61.5|61.5|Standard Deviation|9.4|9.4|||
3661666|NCT02383862|3507307|B2|||PROMIS Pain T-score|The 4-item PROMIS subscale for pain assesses the extent to which patients experience problems with pain over the past 7 days using a 5-point Likert scale. The pain subscale provides a raw score, ranging from 4 to 20. Raw scores are converted to T-scores using the PROMIS conversion tables. Higher scores reflect greater pain.|T-score|Mean|61.4|61.4|Standard Deviation|9.5|9.5|||
3661667|NCT02383862|3507308|B1|||PROMIS Pain T-score|The 4-item PROMIS subscale for pain assesses the extent to which patients experience problems with pain over the past 7 days using a 5-point Likert scale. The pain subscale provides a raw score, ranging from 4 to 20. Raw scores are converted to T-scores using the PROMIS conversion tables. Higher scores reflect greater pain.|T-score|Mean|61.5|61.5|Standard Deviation|9.3|9.3|||
3661668|NCT02383862|3507306|B3|||PROMIS Sleep T-score|The 4-item PROMIS subscale for sleep assesses the extent to which patients experience problems with sleep over the past 7 days using a 5-point Likert scale. The sleep subscale provides a raw score, ranging from 4 to 20. Raw scores are converted to T-scores using the PROMIS conversion tables. Higher scores reflect more severe sleep problems.|T-score|Mean|58.2|58.2|Standard Deviation|9.0|9.0|||
3661669|NCT02383862|3507307|B2|||PROMIS Sleep T-score|The 4-item PROMIS subscale for sleep assesses the extent to which patients experience problems with sleep over the past 7 days using a 5-point Likert scale. The sleep subscale provides a raw score, ranging from 4 to 20. Raw scores are converted to T-scores using the PROMIS conversion tables. Higher scores reflect more severe sleep problems.|T-score|Mean|58.1|58.1|Standard Deviation|8.7|8.7|||
3661670|NCT02383862|3507308|B1|||PROMIS Sleep T-score|The 4-item PROMIS subscale for sleep assesses the extent to which patients experience problems with sleep over the past 7 days using a 5-point Likert scale. The sleep subscale provides a raw score, ranging from 4 to 20. Raw scores are converted to T-scores using the PROMIS conversion tables. Higher scores reflect more severe sleep problems.|T-score|Mean|58.3|58.3|Standard Deviation|9.4|9.4|||
3661671|NCT02383862|3507306|B3|||PROMIS Composite T-score|The 20-item PROMIS questionnaire (composed of 4-item scales for each of the 5 SPADE symptoms) assesses the extent to which patients experience problems with SPADE symptoms over the past 7 days using a 5-point Likert scale. Each PROMIS scale provides a raw score, ranging from 4 to 20. Raw scores are converted to T-scores using the PROMIS conversion tables. The composite PROMIS T-score is the sum of the 5 symptom T-scores divided by 5. Higher scores reflect greater symptom severity.|T-score|Mean|58.3|58.3|Standard Deviation|7.0|7.0|||
3661672|NCT02383862|3507307|B2|||PROMIS Composite T-score|The 20-item PROMIS questionnaire (composed of 4-item scales for each of the 5 SPADE symptoms) assesses the extent to which patients experience problems with SPADE symptoms over the past 7 days using a 5-point Likert scale. Each PROMIS scale provides a raw score, ranging from 4 to 20. Raw scores are converted to T-scores using the PROMIS conversion tables. The composite PROMIS T-score is the sum of the 5 symptom T-scores divided by 5. Higher scores reflect greater symptom severity.|T-score|Mean|58.4|58.4|Standard Deviation|6.4|6.4|||
3661673|NCT02383862|3507308|B1|||PROMIS Composite T-score|The 20-item PROMIS questionnaire (composed of 4-item scales for each of the 5 SPADE symptoms) assesses the extent to which patients experience problems with SPADE symptoms over the past 7 days using a 5-point Likert scale. Each PROMIS scale provides a raw score, ranging from 4 to 20. Raw scores are converted to T-scores using the PROMIS conversion tables. The composite PROMIS T-score is the sum of the 5 symptom T-scores divided by 5. Higher scores reflect greater symptom severity.|T-score|Mean|58.3|58.3|Standard Deviation|7.6|7.6|||
3661674|NCT02383862|3507306|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3661675|NCT02383862|3507307|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3661676|NCT02383862|3507308|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3661677|NCT02383862|3507306|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3661678|NCT02383862|3507307|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3661679|NCT02383862|3507308|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3661680|NCT02383862|3507306|B3||White|Race (NIH/OMB)||Participants|Count of Participants|135|135.0||||||
3661681|NCT02383862|3507307|B2||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3661682|NCT02383862|3507308|B1||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3661683|NCT02383862|3507306|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|148|148.0||||||
3661684|NCT02383862|3507307|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3661685|NCT02383862|3507308|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3661686|NCT02383862|3507306|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661687|NCT02383862|3507307|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661688|NCT02383862|3507308|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661689|NCT02383862|3507306|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3661690|NCT02383862|3507307|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3661691|NCT02383862|3507308|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3661692|NCT02383862|3507306|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3661754|NCT02383472|3507376|B3|PTSD||Psychiatric hx||Participants|Count of Participants|1|1.0||||||
3661695|NCT02383862|3507306|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3661696|NCT02383862|3507307|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3661697|NCT02383862|3507308|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3661698|NCT02383862|3507306|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|243|243.0||||||
3661699|NCT02383862|3507307|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
3661700|NCT02383862|3507308|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
3661701|NCT02383862|3507306|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3661702|NCT02383862|3507307|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3661703|NCT02383862|3507308|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3661704|NCT02383862|3507306|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3661705|NCT02383862|3507307|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3661706|NCT02383862|3507308|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3661707|NCT02383862|3507306|B3||Female|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
3661708|NCT02383862|3507307|B2||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3661709|NCT02383862|3507308|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3661710|NCT02383862|3507306|B3|||Age||years|Mean|49.4|49.4|Standard Deviation|14.4|14.4|||
3661711|NCT02383862|3507307|B2|||Age||years|Mean|48.2|48.2|Standard Deviation|14.7|14.7|||
3661712|NCT02383862|3507308|B1|||Age||years|Mean|50.5|50.5|Standard Deviation|14.1|14.1|||
3661713|NCT02383758|3507340|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3661714|NCT02383758|3507341|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3661715|NCT02383758|3507342|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3661716|NCT02383758|3507340|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3661717|NCT02383758|3507340|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3661718|NCT02383758|3507341|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3661719|NCT02383758|3507342|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3661720|NCT02383758|3507340|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3661721|NCT02383758|3507341|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3661722|NCT02383758|3507342|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3661723|NCT02383758|3507340|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3661724|NCT02383758|3507341|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3661725|NCT02383758|3507342|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3661726|NCT02383758|3507340|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3661727|NCT02383758|3507341|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3661728|NCT02383758|3507342|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3661729|NCT02383758|3507340|B3||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
3661730|NCT02383758|3507341|B2||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
3661731|NCT02383758|3507342|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
3661732|NCT02383719|3507355|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3661733|NCT02383719|3507355|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3661734|NCT02383719|3507355|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3661735|NCT02383719|3507355|B1|||Age||years|Mean|62|62.0|Standard Deviation|11|11.0|||
3661736|NCT02383472|3507376|B3|Amnesia||Injury characteristics||Participants|Count of Participants|18|18.0||||||
3661737|NCT02383472|3507377|B2|Amnesia||Injury characteristics||Participants|Count of Participants|10|10.0||||||
3661738|NCT02383472|3507378|B1|Amnesia||Injury characteristics||Participants|Count of Participants|8|8.0||||||
3661739|NCT02383472|3507376|B3|Loss of Consciousness||Injury characteristics||Participants|Count of Participants|6|6.0||||||
3661740|NCT02383472|3507377|B2|Loss of Consciousness||Injury characteristics||Participants|Count of Participants|3|3.0||||||
3661741|NCT02383472|3507378|B1|Loss of Consciousness||Injury characteristics||Participants|Count of Participants|3|3.0||||||
3661742|NCT02383472|3507376|B3|Sport-related concussion||Injury characteristics||Participants|Count of Participants|36|36.0||||||
3661743|NCT02383472|3507377|B2|Sport-related concussion||Injury characteristics||Participants|Count of Participants|22|22.0||||||
3661744|NCT02383472|3507378|B1|Sport-related concussion||Injury characteristics||Participants|Count of Participants|14|14.0||||||
3661745|NCT02383472|3507376|B3|||Prior Concussions||Concussions|Mean|2.5|2.5|Full Range|||1.0|10.0|
3661746|NCT02383472|3507377|B2|||Prior Concussions||Concussions|Mean|2|2.0|Full Range|||1.0|6.0|
3661747|NCT02383472|3507378|B1|||Prior Concussions||Concussions|Mean|3.5|3.5|Full Range|||1.0|10.0|
3661748|NCT02383472|3507376|B3|Learning Disability||Neurodevelopmental Diagnosis||Participants|Count of Participants|3|3.0||||||
3661749|NCT02383472|3507377|B2|Learning Disability||Neurodevelopmental Diagnosis||Participants|Count of Participants|2|2.0||||||
3661750|NCT02383472|3507378|B1|Learning Disability||Neurodevelopmental Diagnosis||Participants|Count of Participants|1|1.0||||||
3661751|NCT02383472|3507376|B3|ADHD||Neurodevelopmental Diagnosis||Participants|Count of Participants|7|7.0||||||
3661752|NCT02383472|3507377|B2|ADHD||Neurodevelopmental Diagnosis||Participants|Count of Participants|2|2.0||||||
3661753|NCT02383472|3507378|B1|ADHD||Neurodevelopmental Diagnosis||Participants|Count of Participants|5|5.0||||||
3661755|NCT02383472|3507377|B2|PTSD||Psychiatric hx||Participants|Count of Participants|0|0.0||||||
3661756|NCT02383472|3507378|B1|PTSD||Psychiatric hx||Participants|Count of Participants|1|1.0||||||
3661757|NCT02383472|3507376|B3|Depression||Psychiatric hx||Participants|Count of Participants|3|3.0||||||
3661758|NCT02383472|3507377|B2|Depression||Psychiatric hx||Participants|Count of Participants|3|3.0||||||
3661759|NCT02383472|3507378|B1|Depression||Psychiatric hx||Participants|Count of Participants|0|0.0||||||
3661760|NCT02383472|3507376|B3|Anxiety||Psychiatric hx||Participants|Count of Participants|1|1.0||||||
3661761|NCT02383472|3507377|B2|Anxiety||Psychiatric hx||Participants|Count of Participants|0|0.0||||||
3661762|NCT02383472|3507378|B1|Anxiety||Psychiatric hx||Participants|Count of Participants|1|1.0||||||
3661763|NCT02383472|3507376|B3|Undefined||Psychiatric hx||Participants|Count of Participants|36|36.0||||||
3661764|NCT02383472|3507377|B2|Undefined||Psychiatric hx||Participants|Count of Participants|22|22.0||||||
3661765|NCT02383472|3507378|B1|Undefined||Psychiatric hx||Participants|Count of Participants|14|14.0||||||
3661766|NCT02383472|3507376|B3|||Migraine Headache||Participants|Count of Participants|9|9.0||||||
3661767|NCT02383472|3507377|B2|||Migraine Headache||Participants|Count of Participants|7|7.0||||||
3661768|NCT02383472|3507378|B1|||Migraine Headache||Participants|Count of Participants|2|2.0||||||
3661769|NCT02383472|3507376|B3|||Participants taking stimulant medications||Participants|Count of Participants|24|24.0||||||
3661770|NCT02383472|3507377|B2|||Participants taking stimulant medications||Participants|Count of Participants|14|14.0||||||
3661771|NCT02383472|3507378|B1|||Participants taking stimulant medications||Participants|Count of Participants|10|10.0||||||
3661772|NCT02383472|3507376|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661773|NCT02383472|3507377|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661774|NCT02383472|3507378|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661775|NCT02383472|3507376|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661776|NCT02383472|3507377|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661777|NCT02383472|3507378|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661778|NCT02383472|3507376|B3||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3661779|NCT02383472|3507377|B2||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3661780|NCT02383472|3507378|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3661781|NCT02383472|3507376|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3661782|NCT02383472|3507377|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3661783|NCT02383472|3507378|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661784|NCT02383472|3507376|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661785|NCT02383472|3507377|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661786|NCT02383472|3507378|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661787|NCT02383472|3507376|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661788|NCT02383472|3507377|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661789|NCT02383472|3507378|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661790|NCT02383472|3507376|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661791|NCT02383472|3507377|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661792|NCT02383472|3507378|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3661793|NCT02383472|3507376|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3661794|NCT02383472|3507377|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3661795|NCT02383472|3507378|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3661796|NCT02383472|3507376|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3661797|NCT02383472|3507377|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3661798|NCT02383472|3507378|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3661799|NCT02383472|3507376|B3|||Age||years|Mean|21.35|21.35|Standard Deviation|13.19|13.19|||
3661800|NCT02383472|3507377|B2|||Age||years|Mean|21.21|21.21|Standard Deviation|13.25|13.25|||
3661801|NCT02383472|3507378|B1|||Age||years|Mean|21.55|21.55|Standard Deviation|13.12|13.12|||
3661802|NCT02383420|3507393|B4|Unknown||Sex/Gender, Customized||participants|Number|21|21.0||||||
3661803|NCT02383420|3507394|B3|Unknown||Sex/Gender, Customized||participants|Number|3|3.0||||||
3661804|NCT02383420|3507395|B2|Unknown||Sex/Gender, Customized||participants|Number|10|10.0||||||
3661805|NCT02383420|3507396|B1|Unknown||Sex/Gender, Customized||participants|Number|8|8.0||||||
3661806|NCT02383420|3507393|B4|21 years and older||Age, Customized||participants|Number|21|21.0||||||
3661807|NCT02383420|3507394|B3|21 years and older||Age, Customized||participants|Number|3|3.0||||||
3661808|NCT02383420|3507395|B2|21 years and older||Age, Customized||participants|Number|10|10.0||||||
3661809|NCT02383420|3507396|B1|21 years and older||Age, Customized||participants|Number|8|8.0||||||
3661810|NCT02382913|3507406|B11||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3661811|NCT02382913|3507407|B10||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3661812|NCT02382913|3507408|B9||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3661813|NCT02382913|3507409|B8||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3661814|NCT02382913|3507410|B7||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3661815|NCT02382913|3507411|B6||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3661816|NCT02382913|3507412|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3661817|NCT02382913|3507413|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3661818|NCT02382913|3507414|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3661819|NCT02382913|3507415|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3661820|NCT02382913|3507416|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3661821|NCT02382913|3507406|B11||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
3661822|NCT02382913|3507407|B10||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3661823|NCT02382913|3507408|B9||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3661824|NCT02382913|3507409|B8||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3661825|NCT02382913|3507410|B7||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3661826|NCT02382913|3507411|B6||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3661827|NCT02382913|3507412|B5||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3661828|NCT02382913|3507413|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3661829|NCT02382913|3507414|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3661830|NCT02382913|3507415|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3661831|NCT02382913|3507416|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3661832|NCT02382913|3507406|B11|||Age||years|Mean|30.3|30.3|Standard Deviation|5.6|5.6|||
3661833|NCT02382913|3507407|B10|||Age||years|Mean|31.5|31.5|Standard Deviation|6.7|6.7|||
3661834|NCT02382913|3507408|B9|||Age||years|Mean|31.3|31.3|Standard Deviation|5.9|5.9|||
3661835|NCT02382913|3507409|B8|||Age||years|Mean|30.1|30.1|Standard Deviation|4.6|4.6|||
3661836|NCT02382913|3507410|B7|||Age||years|Mean|28.2|28.2|Standard Deviation|4.4|4.4|||
3661837|NCT02382913|3507411|B6|||Age||years|Mean|30|30.0|Standard Deviation|5.6|5.6|||
3661838|NCT02382913|3507412|B5|||Age||years|Mean|30.9|30.9|Standard Deviation|5.7|5.7|||
3661839|NCT02382913|3507413|B4|||Age||years|Mean|31.3|31.3|Standard Deviation|6.3|6.3|||
3661840|NCT02382913|3507414|B3|||Age||years|Mean|30.3|30.3|Standard Deviation|6.4|6.4|||
3661841|NCT02382913|3507415|B2|||Age||years|Mean|29.5|29.5|Standard Deviation|4.9|4.9|||
3661842|NCT02382913|3507416|B1|||Age||years|Mean|30.2|30.2|Standard Deviation|5.7|5.7|||
3661843|NCT02382744|3507461|B3|Amputation||Type of surgery||participants|Number|1|1.0||||||
3661844|NCT02382744|3507462|B2|Amputation||Type of surgery||participants|Number|1|1.0||||||
3661845|NCT02382744|3507463|B1|Amputation||Type of surgery||participants|Number|0|0.0||||||
3661846|NCT02382744|3507461|B3|Tendon repair/transfer||Type of surgery||participants|Number|6|6.0||||||
3661847|NCT02382744|3507462|B2|Tendon repair/transfer||Type of surgery||participants|Number|2|2.0||||||
3661848|NCT02382744|3507463|B1|Tendon repair/transfer||Type of surgery||participants|Number|4|4.0||||||
3661849|NCT02382744|3507461|B3|Fracture fixation||Type of surgery||participants|Number|8|8.0||||||
3661850|NCT02382744|3507462|B2|Fracture fixation||Type of surgery||participants|Number|3|3.0||||||
3661851|NCT02382744|3507463|B1|Fracture fixation||Type of surgery||participants|Number|5|5.0||||||
3661852|NCT02382744|3507461|B3|Mass/hardware removal||Type of surgery||participants|Number|12|12.0||||||
3661853|NCT02382744|3507462|B2|Mass/hardware removal||Type of surgery||participants|Number|3|3.0||||||
3661854|NCT02382744|3507463|B1|Mass/hardware removal||Type of surgery||participants|Number|9|9.0||||||
3661855|NCT02382744|3507461|B3|Arthroscopy/debridement||Type of surgery||participants|Number|14|14.0||||||
3661856|NCT02382744|3507462|B2|Arthroscopy/debridement||Type of surgery||participants|Number|7|7.0||||||
3661857|NCT02382744|3507463|B1|Arthroscopy/debridement||Type of surgery||participants|Number|7|7.0||||||
3661858|NCT02382744|3507461|B3|Foot/ankle joint reconstruction/fusion/arthrodesis||Type of surgery||participants|Number|39|39.0||||||
3661859|NCT02382744|3507462|B2|Foot/ankle joint reconstruction/fusion/arthrodesis||Type of surgery||participants|Number|24|24.0||||||
3661860|NCT02382744|3507463|B1|Foot/ankle joint reconstruction/fusion/arthrodesis||Type of surgery||participants|Number|15|15.0||||||
3661861|NCT02382744|3507461|B3|III to V||American Society of Anesthesiologists (ASA) physical status|"ASA I: A normal healthy patient ASA II: A patient with mild systemic disease ASA III: A patient with severe systemic disease ASA IV: A patient with severe systemic disease that is a constant threat to life ASA V: A moribund patient who is not expected to survive without the operation~(For reference, see https://www.asahq.org/resources/clinical-information/asa-physical-status-classification-system)"|participants|Number|10|10.0||||||
3661862|NCT02382744|3507462|B2|III to V||American Society of Anesthesiologists (ASA) physical status|"ASA I: A normal healthy patient ASA II: A patient with mild systemic disease ASA III: A patient with severe systemic disease ASA IV: A patient with severe systemic disease that is a constant threat to life ASA V: A moribund patient who is not expected to survive without the operation~(For reference, see https://www.asahq.org/resources/clinical-information/asa-physical-status-classification-system)"|participants|Number|7|7.0||||||
3661863|NCT02382744|3507463|B1|III to V||American Society of Anesthesiologists (ASA) physical status|"ASA I: A normal healthy patient ASA II: A patient with mild systemic disease ASA III: A patient with severe systemic disease ASA IV: A patient with severe systemic disease that is a constant threat to life ASA V: A moribund patient who is not expected to survive without the operation~(For reference, see https://www.asahq.org/resources/clinical-information/asa-physical-status-classification-system)"|participants|Number|3|3.0||||||
3661912|NCT02382640|3507498|B2|Is a current drinker||Alcohol classification||participants|Number|1|1.0||||||
3661913|NCT02382640|3507499|B1|Is a current drinker||Alcohol classification||participants|Number|4|4.0||||||
3661914|NCT02382640|3507495|B5|Has never drunk||Alcohol classification||participants|Number|15|15.0||||||
3661864|NCT02382744|3507461|B3|I or II||American Society of Anesthesiologists (ASA) physical status|"ASA I: A normal healthy patient ASA II: A patient with mild systemic disease ASA III: A patient with severe systemic disease ASA IV: A patient with severe systemic disease that is a constant threat to life ASA V: A moribund patient who is not expected to survive without the operation~(For reference, see https://www.asahq.org/resources/clinical-information/asa-physical-status-classification-system)"|participants|Number|70|70.0||||||
3661865|NCT02382744|3507462|B2|I or II||American Society of Anesthesiologists (ASA) physical status|"ASA I: A normal healthy patient ASA II: A patient with mild systemic disease ASA III: A patient with severe systemic disease ASA IV: A patient with severe systemic disease that is a constant threat to life ASA V: A moribund patient who is not expected to survive without the operation~(For reference, see https://www.asahq.org/resources/clinical-information/asa-physical-status-classification-system)"|participants|Number|33|33.0||||||
3661866|NCT02382744|3507463|B1|I or II||American Society of Anesthesiologists (ASA) physical status|"ASA I: A normal healthy patient ASA II: A patient with mild systemic disease ASA III: A patient with severe systemic disease ASA IV: A patient with severe systemic disease that is a constant threat to life ASA V: A moribund patient who is not expected to survive without the operation~(For reference, see https://www.asahq.org/resources/clinical-information/asa-physical-status-classification-system)"|participants|Number|37|37.0||||||
3661867|NCT02382744|3507461|B3|||Body Mass Index||kg/m^2|Mean|25|25.0|Standard Deviation|4|4.0|||
3661868|NCT02382744|3507462|B2|||Body Mass Index||kg/m^2|Mean|25|25.0|Standard Deviation|4|4.0|||
3661869|NCT02382744|3507463|B1|||Body Mass Index||kg/m^2|Mean|26|26.0|Standard Deviation|3|3.0|||
3661870|NCT02382744|3507461|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3661871|NCT02382744|3507462|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3661872|NCT02382744|3507463|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3661873|NCT02382744|3507461|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3661874|NCT02382744|3507462|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3661875|NCT02382744|3507463|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3661876|NCT02382744|3507461|B3|||Age||years|Mean|52|52.0|Standard Deviation|15|15.0|||
3661877|NCT02382744|3507462|B2|||Age||years|Mean|53|53.0|Standard Deviation|14|14.0|||
3661878|NCT02382744|3507463|B1|||Age||years|Mean|50|50.0|Standard Deviation|15|15.0|||
3661879|NCT02382640|3507495|B5|N/A (participant is male)||Female reproductive status||participants|Number|15|15.0||||||
3661880|NCT02382640|3507496|B4|N/A (participant is male)||Female reproductive status||participants|Number|3|3.0||||||
3661881|NCT02382640|3507497|B3|N/A (participant is male)||Female reproductive status||participants|Number|4|4.0||||||
3661882|NCT02382640|3507498|B2|N/A (participant is male)||Female reproductive status||participants|Number|4|4.0||||||
3661883|NCT02382640|3507499|B1|N/A (participant is male)||Female reproductive status||participants|Number|4|4.0||||||
3661884|NCT02382640|3507495|B5|Surgically sterile||Female reproductive status||participants|Number|4|4.0||||||
3661885|NCT02382640|3507496|B4|Surgically sterile||Female reproductive status||participants|Number|2|2.0||||||
3661886|NCT02382640|3507497|B3|Surgically sterile||Female reproductive status||participants|Number|1|1.0||||||
3661887|NCT02382640|3507498|B2|Surgically sterile||Female reproductive status||participants|Number|0|0.0||||||
3661888|NCT02382640|3507499|B1|Surgically sterile||Female reproductive status||participants|Number|1|1.0||||||
3661889|NCT02382640|3507495|B5|Female of childbearing potential||Female reproductive status||participants|Number|17|17.0||||||
3661890|NCT02382640|3507496|B4|Female of childbearing potential||Female reproductive status||participants|Number|4|4.0||||||
3661891|NCT02382640|3507497|B3|Female of childbearing potential||Female reproductive status||participants|Number|4|4.0||||||
3661892|NCT02382640|3507498|B2|Female of childbearing potential||Female reproductive status||participants|Number|5|5.0||||||
3661893|NCT02382640|3507499|B1|Female of childbearing potential||Female reproductive status||participants|Number|4|4.0||||||
3661894|NCT02382640|3507495|B5|Had no xanthine/caffeine consumption||Xanthine/caffeine consumption||participants|Number|18|18.0||||||
3661895|NCT02382640|3507496|B4|Had no xanthine/caffeine consumption||Xanthine/caffeine consumption||participants|Number|4|4.0||||||
3661896|NCT02382640|3507497|B3|Had no xanthine/caffeine consumption||Xanthine/caffeine consumption||participants|Number|6|6.0||||||
3661897|NCT02382640|3507498|B2|Had no xanthine/caffeine consumption||Xanthine/caffeine consumption||participants|Number|4|4.0||||||
3661898|NCT02382640|3507499|B1|Had no xanthine/caffeine consumption||Xanthine/caffeine consumption||participants|Number|4|4.0||||||
3661899|NCT02382640|3507495|B5|Had xanthine/caffeine consumption||Xanthine/caffeine consumption||participants|Number|18|18.0||||||
3661900|NCT02382640|3507496|B4|Had xanthine/caffeine consumption||Xanthine/caffeine consumption||participants|Number|5|5.0||||||
3661901|NCT02382640|3507497|B3|Had xanthine/caffeine consumption||Xanthine/caffeine consumption||participants|Number|3|3.0||||||
3661902|NCT02382640|3507498|B2|Had xanthine/caffeine consumption||Xanthine/caffeine consumption||participants|Number|5|5.0||||||
3661903|NCT02382640|3507499|B1|Had xanthine/caffeine consumption||Xanthine/caffeine consumption||participants|Number|5|5.0||||||
3661904|NCT02382640|3507495|B5|Is an ex-drinker||Alcohol classification||participants|Number|13|13.0||||||
3661905|NCT02382640|3507496|B4|Is an ex-drinker||Alcohol classification||participants|Number|3|3.0||||||
3661906|NCT02382640|3507497|B3|Is an ex-drinker||Alcohol classification||participants|Number|3|3.0||||||
3661907|NCT02382640|3507498|B2|Is an ex-drinker||Alcohol classification||participants|Number|4|4.0||||||
3661908|NCT02382640|3507499|B1|Is an ex-drinker||Alcohol classification||participants|Number|3|3.0||||||
3661909|NCT02382640|3507495|B5|Is a current drinker||Alcohol classification||participants|Number|8|8.0||||||
3661910|NCT02382640|3507496|B4|Is a current drinker||Alcohol classification||participants|Number|2|2.0||||||
3661911|NCT02382640|3507497|B3|Is a current drinker||Alcohol classification||participants|Number|1|1.0||||||
3661915|NCT02382640|3507496|B4|Has never drunk||Alcohol classification||participants|Number|4|4.0||||||
3661916|NCT02382640|3507497|B3|Has never drunk||Alcohol classification||participants|Number|5|5.0||||||
3661917|NCT02382640|3507498|B2|Has never drunk||Alcohol classification||participants|Number|4|4.0||||||
3661918|NCT02382640|3507499|B1|Has never drunk||Alcohol classification||participants|Number|2|2.0||||||
3661919|NCT02382640|3507495|B5|Is an ex-smoker||Smoking classification||participants|Number|3|3.0||||||
3661920|NCT02382640|3507496|B4|Is an ex-smoker||Smoking classification||participants|Number|1|1.0||||||
3661921|NCT02382640|3507497|B3|Is an ex-smoker||Smoking classification||participants|Number|1|1.0||||||
3661922|NCT02382640|3507498|B2|Is an ex-smoker||Smoking classification||participants|Number|0|0.0||||||
3661923|NCT02382640|3507499|B1|Is an ex-smoker||Smoking classification||participants|Number|1|1.0||||||
3661924|NCT02382640|3507495|B5|Has never smoked||Smoking classification||participants|Number|33|33.0||||||
3661925|NCT02382640|3507496|B4|Has never smoked||Smoking classification||participants|Number|8|8.0||||||
3661926|NCT02382640|3507497|B3|Has never smoked||Smoking classification||participants|Number|8|8.0||||||
3661927|NCT02382640|3507498|B2|Has never smoked||Smoking classification||participants|Number|9|9.0||||||
3661928|NCT02382640|3507499|B1|Has never smoked||Smoking classification||participants|Number|8|8.0||||||
3661929|NCT02382640|3507495|B5|Multiracial||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3661930|NCT02382640|3507496|B4|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3661931|NCT02382640|3507497|B3|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3661932|NCT02382640|3507498|B2|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3661933|NCT02382640|3507499|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3661934|NCT02382640|3507495|B5|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3661935|NCT02382640|3507496|B4|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3661936|NCT02382640|3507497|B3|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3661937|NCT02382640|3507498|B2|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3661938|NCT02382640|3507499|B1|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3661939|NCT02382640|3507495|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3661940|NCT02382640|3507496|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3661941|NCT02382640|3507497|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3661942|NCT02382640|3507498|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3661943|NCT02382640|3507499|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3661944|NCT02382640|3507495|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3661945|NCT02382640|3507496|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3661946|NCT02382640|3507497|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3661947|NCT02382640|3507498|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3661948|NCT02382640|3507499|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3661949|NCT02382640|3507495|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3661950|NCT02382640|3507496|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3661951|NCT02382640|3507497|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3661952|NCT02382640|3507498|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3661953|NCT02382640|3507499|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3661954|NCT02382640|3507495|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3661955|NCT02382640|3507496|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3661956|NCT02382640|3507497|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3661957|NCT02382640|3507498|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3661958|NCT02382640|3507499|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3661959|NCT02382640|3507495|B5||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3661960|NCT02382640|3507496|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3661961|NCT02382640|3507497|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3661962|NCT02382640|3507498|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3661963|NCT02382640|3507499|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3661964|NCT02382640|3507495|B5|||Age||years|Mean|35.0|35.0|Standard Deviation|10.36|10.36|||
3661965|NCT02382640|3507496|B4|||Age||years|Mean|35.8|35.8|Standard Deviation|11.38|11.38|||
3661966|NCT02382640|3507497|B3|||Age||years|Mean|31.7|31.7|Standard Deviation|9.18|9.18|||
3661967|NCT02382640|3507498|B2|||Age||years|Mean|34.7|34.7|Standard Deviation|13.42|13.42|||
3661968|NCT02382640|3507499|B1|||Age||years|Mean|37.8|37.8|Standard Deviation|7.36|7.36|||
3661969|NCT02382133|3507540|B1|United States||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
3661970|NCT02382133|3507540|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3661971|NCT02382133|3507540|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3661972|NCT02382133|3507540|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|16.1|16.1|||
3661973|NCT02382133|3507540|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3661974|NCT02382133|3507540|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3661975|NCT02382133|3507540|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3661976|NCT02382016|3507545|B3|||Pulmonary vascular resistance (PVR) at baseline (calculated)||dyn*sec/cm5|Mean|537.2|537.2|Standard Deviation|178.4|178.4|||
3661977|NCT02382016|3507546|B2|||Pulmonary vascular resistance (PVR) at baseline (calculated)||dyn*sec/cm5|Mean|521.7|521.7|Standard Deviation|163.3|163.3|||
3661978|NCT02382016|3507547|B1|||Pulmonary vascular resistance (PVR) at baseline (calculated)||dyn*sec/cm5|Mean|552.4|552.4|Standard Deviation|192.8|192.8|||
3661979|NCT02382016|3507545|B3|||Time since PAH diagnosis||months|Median|10|10.0|Inter-Quartile Range|||2.0|36.0|
3661980|NCT02382016|3507546|B2|||Time since PAH diagnosis||months|Median|12|12.0|Inter-Quartile Range|||1.0|37.0|
3661981|NCT02382016|3507547|B1|||Time since PAH diagnosis||months|Median|7|7.0|Inter-Quartile Range|||2.0|33.0|
3661982|NCT02382016|3507545|B3|||Time since portal hypertension diagnosis||months|Median|25|25.0|Inter-Quartile Range|||5.0|76.0|
3661983|NCT02382016|3507546|B2|||Time since portal hypertension diagnosis||months|Median|31|31.0|Inter-Quartile Range|||4.0|69.0|
3661984|NCT02382016|3507547|B1|||Time since portal hypertension diagnosis||months|Median|23|23.0|Inter-Quartile Range|||5.0|80.0|
3661985|NCT02382016|3507545|B3|||Body Mass Index (BMI) at baseline||kg/m2|Mean|29.17|29.17|Standard Deviation|4.41|4.41|||
3661986|NCT02382016|3507546|B2|||Body Mass Index (BMI) at baseline||kg/m2|Mean|29.33|29.33|Standard Deviation|4.04|4.04|||
3661987|NCT02382016|3507547|B1|||Body Mass Index (BMI) at baseline||kg/m2|Mean|29.01|29.01|Standard Deviation|4.79|4.79|||
3661988|NCT02382016|3507545|B3|No||Pulmonary arterial hypertension (PAH)-specific therapy|As per randomization stratification, 63.5% of patients were receiving a pulmonary arterial hypertension (PAH)-specific therapy at baseline.|Participants|Count of Participants|31|31.0||||||
3661989|NCT02382016|3507546|B2|No||Pulmonary arterial hypertension (PAH)-specific therapy|As per randomization stratification, 63.5% of patients were receiving a pulmonary arterial hypertension (PAH)-specific therapy at baseline.|Participants|Count of Participants|15|15.0||||||
3661990|NCT02382016|3507547|B1|No||Pulmonary arterial hypertension (PAH)-specific therapy|As per randomization stratification, 63.5% of patients were receiving a pulmonary arterial hypertension (PAH)-specific therapy at baseline.|Participants|Count of Participants|16|16.0||||||
3661991|NCT02382016|3507545|B3|Yes||Pulmonary arterial hypertension (PAH)-specific therapy|As per randomization stratification, 63.5% of patients were receiving a pulmonary arterial hypertension (PAH)-specific therapy at baseline.|Participants|Count of Participants|54|54.0||||||
3661992|NCT02382016|3507546|B2|Yes||Pulmonary arterial hypertension (PAH)-specific therapy|As per randomization stratification, 63.5% of patients were receiving a pulmonary arterial hypertension (PAH)-specific therapy at baseline.|Participants|Count of Participants|27|27.0||||||
3661993|NCT02382016|3507547|B1|Yes||Pulmonary arterial hypertension (PAH)-specific therapy|As per randomization stratification, 63.5% of patients were receiving a pulmonary arterial hypertension (PAH)-specific therapy at baseline.|Participants|Count of Participants|27|27.0||||||
3661994|NCT02382016|3507545|B3|Latin America||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3661995|NCT02382016|3507546|B2|Latin America||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3661996|NCT02382016|3507547|B1|Latin America||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3661997|NCT02382016|3507545|B3|North America||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3661998|NCT02382016|3507546|B2|North America||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3661999|NCT02382016|3507547|B1|North America||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3662000|NCT02382016|3507545|B3|Europe||Region of Enrollment||Participants|Count of Participants|57|57.0||||||
3662001|NCT02382016|3507546|B2|Europe||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3662002|NCT02382016|3507547|B1|Europe||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3662003|NCT02382016|3507545|B3|Not Applicable||Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
3662004|NCT02382016|3507546|B2|Not Applicable||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3662005|NCT02382016|3507547|B1|Not Applicable||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3662006|NCT02382016|3507545|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3662007|NCT02382016|3507546|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3662008|NCT02382016|3507547|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3662009|NCT02382016|3507545|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
3662010|NCT02382016|3507546|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3662011|NCT02382016|3507547|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3662012|NCT02382016|3507545|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3662013|NCT02382016|3507546|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3662014|NCT02382016|3507547|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3662015|NCT02382016|3507545|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3662016|NCT02382016|3507546|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3662017|NCT02382016|3507547|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3662018|NCT02382016|3507545|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3662019|NCT02382016|3507546|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3662020|NCT02382016|3507547|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3662021|NCT02382016|3507545|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3662022|NCT02382016|3507546|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3662183|NCT02381288|3507606|B4|||Height||cm|Mean|174.6|174.6|Standard Deviation|6.77|6.77|||
3662023|NCT02382016|3507547|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3662024|NCT02382016|3507545|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3662025|NCT02382016|3507546|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3662026|NCT02382016|3507547|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3662027|NCT02382016|3507545|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3662028|NCT02382016|3507546|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3662029|NCT02382016|3507547|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3662030|NCT02382016|3507545|B3|||Age||years|Mean|58.5|58.5|Standard Deviation|9.1|9.1|||
3662031|NCT02382016|3507546|B2|||Age||years|Mean|59.0|59.0|Standard Deviation|9.5|9.5|||
3662032|NCT02382016|3507547|B1|||Age||years|Mean|58.0|58.0|Standard Deviation|8.7|8.7|||
3662033|NCT02382016|3507545|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3662034|NCT02382016|3507546|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3662035|NCT02382016|3507547|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3662036|NCT02382016|3507545|B3||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
3662037|NCT02382016|3507546|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3662038|NCT02382016|3507547|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3662039|NCT02382016|3507545|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3662040|NCT02382016|3507546|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3662041|NCT02382016|3507547|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3662042|NCT02381795|3507570|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662043|NCT02381795|3507570|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662044|NCT02381795|3507570|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3662045|NCT02381795|3507570|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662046|NCT02381795|3507570|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662047|NCT02381795|3507570|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662048|NCT02381795|3507570|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662049|NCT02381795|3507570|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3662050|NCT02381795|3507570|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3662051|NCT02381795|3507570|B1|||Age||years|Mean|42.3|42.3|Standard Deviation|13.58|13.58|||
3662052|NCT02381678|3507574|B1|Time for cross clamp||The time for Extracorporeal Circulation and Cross Clamp in surgery||minutes|Mean|89.5|89.5|Standard Deviation|40.2|40.2|||
3662053|NCT02381678|3507574|B1|Time for Extracorporeal Circulation||The time for Extracorporeal Circulation and Cross Clamp in surgery||minutes|Mean|137.9|137.9|Standard Deviation|66.6|66.6|||
3662054|NCT02381678|3507574|B1|Radiofrequency Ablation||The concomitant surgery||participants|Number|4|4.0||||||
3662055|NCT02381678|3507574|B1|Tricuspid valvuloplasty||The concomitant surgery||participants|Number|75|75.0||||||
3662056|NCT02381678|3507574|B1|Left Atrial Reduction||The concomitant surgery||participants|Number|5|5.0||||||
3662057|NCT02381678|3507574|B1|Coronary Artery Bypass Grafting||The concomitant surgery||participants|Number|41|41.0||||||
3662058|NCT02381678|3507574|B1|Triple Valves Replacement||The numbers of valves implanted simultaneously||participants|Number|3|3.0||||||
3662059|NCT02381678|3507574|B1|Double Valves Replacement||The numbers of valves implanted simultaneously||participants|Number|48|48.0||||||
3662060|NCT02381678|3507574|B1|Single Valve Replacement||The numbers of valves implanted simultaneously||participants|Number|174|174.0||||||
3662061|NCT02381678|3507574|B1|Not Known||Preoperative Classification of NYHA assessment|"The criteria for NYHA assessment listed below:~Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. no shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20–100 m).~Comfortable only at rest. Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|14|14.0||||||
3662062|NCT02381678|3507574|B1|Class IV||Preoperative Classification of NYHA assessment|"The criteria for NYHA assessment listed below:~Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. no shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20–100 m).~Comfortable only at rest. Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|31|31.0||||||
3662063|NCT02381678|3507574|B1|Class III||Preoperative Classification of NYHA assessment|"The criteria for NYHA assessment listed below:~Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. no shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20–100 m).~Comfortable only at rest. Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|96|96.0||||||
3662173|NCT02381288|3507606|B4|||Baseline Body Mass Index (BMI)||kg/m^2|Mean|30.0|30.0|Standard Deviation|6.5|6.5|||
3662174|NCT02381288|3507607|B3|||Baseline Body Mass Index (BMI)||kg/m^2|Mean|33.3|33.3|Standard Deviation|4.2|4.2|||
3662175|NCT02381288|3507608|B2|||Baseline Body Mass Index (BMI)||kg/m^2|Mean|33.9|33.9|Standard Deviation|5.2|5.2|||
3662184|NCT02381288|3507607|B3|||Height||cm|Mean|172.4|172.4|Standard Deviation|7.80|7.8|||
3662064|NCT02381678|3507574|B1|Class II||Preoperative Classification of NYHA assessment|"The criteria for NYHA assessment listed below:~Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. no shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20–100 m).~Comfortable only at rest. Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|79|79.0||||||
3662065|NCT02381678|3507574|B1|Class I||Preoperative Classification of NYHA assessment|"The criteria for NYHA assessment listed below:~Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. no shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20–100 m).~Comfortable only at rest. Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|5|5.0||||||
3662066|NCT02381678|3507574|B1|Miscellaneous||Etiology of subjects||participants|Number|26|26.0||||||
3662067|NCT02381678|3507574|B1|Ischemic||Etiology of subjects||participants|Number|18|18.0||||||
3662068|NCT02381678|3507574|B1|Endocardititis||Etiology of subjects||participants|Number|6|6.0||||||
3662069|NCT02381678|3507574|B1|Degenerated||Etiology of subjects||participants|Number|51|51.0||||||
3662070|NCT02381678|3507574|B1|Rheumatic||Etiology of subjects||participants|Number|124|124.0||||||
3662071|NCT02381678|3507574|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3662072|NCT02381678|3507574|B1||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3662073|NCT02381678|3507574|B1|||Age||years|Mean|63|63.0|Full Range|||16.0|78.0|
3662074|NCT02381418|3507582|B1|Australia||Region of Enrollment||participants|Number|120|120.0||||||
3662075|NCT02381418|3507582|B1||Male|Gender||Participants|Count of Participants|62|62.0||||||
3662076|NCT02381418|3507582|B1||Female|Gender||Participants|Count of Participants|58|58.0||||||
3662077|NCT02381418|3507582|B1|elderly adult (>=61 year old)||Age||years|Mean|71.5|71.5|Full Range|||61.0|88.0|
3662078|NCT02381418|3507582|B1|adult (18-60 year old)||Age||years|Mean|41.2|41.2|Full Range|||18.0|60.0|
3662079|NCT02381418|3507582|B1||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
3662080|NCT02381418|3507582|B1||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
3662081|NCT02381418|3507582|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3662082|NCT02381392|3507588|B3||Missing data|Mental status||Participants|Count of Participants|2|2.0||||||
3662083|NCT02381392|3507589|B2||Missing data|Mental status||Participants|Count of Participants|1|1.0||||||
3662084|NCT02381392|3507590|B1||Missing data|Mental status||Participants|Count of Participants|1|1.0||||||
3662085|NCT02381392|3507588|B3||Cooperative|Mental status||Participants|Count of Participants|6|6.0||||||
3662086|NCT02381392|3507589|B2||Cooperative|Mental status||Participants|Count of Participants|3|3.0||||||
3662087|NCT02381392|3507590|B1||Cooperative|Mental status||Participants|Count of Participants|3|3.0||||||
3662088|NCT02381392|3507588|B3||Combative|Mental status||Participants|Count of Participants|15|15.0||||||
3662089|NCT02381392|3507589|B2||Combative|Mental status||Participants|Count of Participants|8|8.0||||||
3662090|NCT02381392|3507590|B1||Combative|Mental status||Participants|Count of Participants|7|7.0||||||
3662091|NCT02381392|3507588|B3||Missing data|Dehydration status||Participants|Count of Participants|2|2.0||||||
3662092|NCT02381392|3507589|B2||Missing data|Dehydration status||Participants|Count of Participants|2|2.0||||||
3662093|NCT02381392|3507590|B1||Missing data|Dehydration status||Participants|Count of Participants|0|0.0||||||
3662094|NCT02381392|3507588|B3||Moderate|Dehydration status||Participants|Count of Participants|1|1.0||||||
3662095|NCT02381392|3507589|B2||Moderate|Dehydration status||Participants|Count of Participants|1|1.0||||||
3662096|NCT02381392|3507590|B1||Moderate|Dehydration status||Participants|Count of Participants|0|0.0||||||
3662097|NCT02381392|3507588|B3||Mild|Dehydration status||Participants|Count of Participants|14|14.0||||||
3662098|NCT02381392|3507589|B2||Mild|Dehydration status||Participants|Count of Participants|5|5.0||||||
3662099|NCT02381392|3507590|B1||Mild|Dehydration status||Participants|Count of Participants|9|9.0||||||
3662100|NCT02381392|3507588|B3||None|Dehydration status||Participants|Count of Participants|6|6.0||||||
3662101|NCT02381392|3507589|B2||None|Dehydration status||Participants|Count of Participants|4|4.0||||||
3662102|NCT02381392|3507590|B1||None|Dehydration status||Participants|Count of Participants|2|2.0||||||
3662103|NCT02381392|3507588|B3||V|Fitzpatrick skin color|"The Fitzpatrick scale is a numerical classification schema for human skin color. Patients are graded as follows:~Type I always burns, never tans (pale white; blond / red hair; blue eyes; freckles).~Type II usually burns, tans minimally (white; fair; blond / red hair; blue, green, or hazel eyes) Type III sometimes mild burn, tans uniformly (cream white; fair with any hair or eye color) Type IV burns minimally, always tans well (moderate brown) Type V very rarely burns, tans very easily (dark brown)"|Participants|Count of Participants|1|1.0||||||
3662104|NCT02381392|3507589|B2||V|Fitzpatrick skin color|"The Fitzpatrick scale is a numerical classification schema for human skin color. Patients are graded as follows:~Type I always burns, never tans (pale white; blond / red hair; blue eyes; freckles).~Type II usually burns, tans minimally (white; fair; blond / red hair; blue, green, or hazel eyes) Type III sometimes mild burn, tans uniformly (cream white; fair with any hair or eye color) Type IV burns minimally, always tans well (moderate brown) Type V very rarely burns, tans very easily (dark brown)"|Participants|Count of Participants|0|0.0||||||
3662176|NCT02381288|3507609|B1|||Baseline Body Mass Index (BMI)||kg/m^2|Mean|30.7|30.7|Standard Deviation|4.3|4.3|||
3662177|NCT02381288|3507605|B5|||Weight||kg|Mean|95.5|95.5|Standard Deviation|16.8|16.8|||
3662178|NCT02381288|3507606|B4|||Weight||kg|Mean|91.5|91.5|Standard Deviation|21.5|21.5|||
3662179|NCT02381288|3507607|B3|||Weight||kg|Mean|99.4|99.4|Standard Deviation|17.3|17.3|||
3662105|NCT02381392|3507590|B1||V|Fitzpatrick skin color|"The Fitzpatrick scale is a numerical classification schema for human skin color. Patients are graded as follows:~Type I always burns, never tans (pale white; blond / red hair; blue eyes; freckles).~Type II usually burns, tans minimally (white; fair; blond / red hair; blue, green, or hazel eyes) Type III sometimes mild burn, tans uniformly (cream white; fair with any hair or eye color) Type IV burns minimally, always tans well (moderate brown) Type V very rarely burns, tans very easily (dark brown)"|Participants|Count of Participants|1|1.0||||||
3662106|NCT02381392|3507588|B3||IV|Fitzpatrick skin color|"The Fitzpatrick scale is a numerical classification schema for human skin color. Patients are graded as follows:~Type I always burns, never tans (pale white; blond / red hair; blue eyes; freckles).~Type II usually burns, tans minimally (white; fair; blond / red hair; blue, green, or hazel eyes) Type III sometimes mild burn, tans uniformly (cream white; fair with any hair or eye color) Type IV burns minimally, always tans well (moderate brown) Type V very rarely burns, tans very easily (dark brown)"|Participants|Count of Participants|3|3.0||||||
3662107|NCT02381392|3507589|B2||IV|Fitzpatrick skin color|"The Fitzpatrick scale is a numerical classification schema for human skin color. Patients are graded as follows:~Type I always burns, never tans (pale white; blond / red hair; blue eyes; freckles).~Type II usually burns, tans minimally (white; fair; blond / red hair; blue, green, or hazel eyes) Type III sometimes mild burn, tans uniformly (cream white; fair with any hair or eye color) Type IV burns minimally, always tans well (moderate brown) Type V very rarely burns, tans very easily (dark brown)"|Participants|Count of Participants|2|2.0||||||
3662108|NCT02381392|3507590|B1||IV|Fitzpatrick skin color|"The Fitzpatrick scale is a numerical classification schema for human skin color. Patients are graded as follows:~Type I always burns, never tans (pale white; blond / red hair; blue eyes; freckles).~Type II usually burns, tans minimally (white; fair; blond / red hair; blue, green, or hazel eyes) Type III sometimes mild burn, tans uniformly (cream white; fair with any hair or eye color) Type IV burns minimally, always tans well (moderate brown) Type V very rarely burns, tans very easily (dark brown)"|Participants|Count of Participants|1|1.0||||||
3662109|NCT02381392|3507588|B3||III|Fitzpatrick skin color|"The Fitzpatrick scale is a numerical classification schema for human skin color. Patients are graded as follows:~Type I always burns, never tans (pale white; blond / red hair; blue eyes; freckles).~Type II usually burns, tans minimally (white; fair; blond / red hair; blue, green, or hazel eyes) Type III sometimes mild burn, tans uniformly (cream white; fair with any hair or eye color) Type IV burns minimally, always tans well (moderate brown) Type V very rarely burns, tans very easily (dark brown)"|Participants|Count of Participants|13|13.0||||||
3662110|NCT02381392|3507589|B2||III|Fitzpatrick skin color|"The Fitzpatrick scale is a numerical classification schema for human skin color. Patients are graded as follows:~Type I always burns, never tans (pale white; blond / red hair; blue eyes; freckles).~Type II usually burns, tans minimally (white; fair; blond / red hair; blue, green, or hazel eyes) Type III sometimes mild burn, tans uniformly (cream white; fair with any hair or eye color) Type IV burns minimally, always tans well (moderate brown) Type V very rarely burns, tans very easily (dark brown)"|Participants|Count of Participants|8|8.0||||||
3662111|NCT02381392|3507590|B1||III|Fitzpatrick skin color|"The Fitzpatrick scale is a numerical classification schema for human skin color. Patients are graded as follows:~Type I always burns, never tans (pale white; blond / red hair; blue eyes; freckles).~Type II usually burns, tans minimally (white; fair; blond / red hair; blue, green, or hazel eyes) Type III sometimes mild burn, tans uniformly (cream white; fair with any hair or eye color) Type IV burns minimally, always tans well (moderate brown) Type V very rarely burns, tans very easily (dark brown)"|Participants|Count of Participants|5|5.0||||||
3662112|NCT02381392|3507588|B3||II|Fitzpatrick skin color|"The Fitzpatrick scale is a numerical classification schema for human skin color. Patients are graded as follows:~Type I always burns, never tans (pale white; blond / red hair; blue eyes; freckles).~Type II usually burns, tans minimally (white; fair; blond / red hair; blue, green, or hazel eyes) Type III sometimes mild burn, tans uniformly (cream white; fair with any hair or eye color) Type IV burns minimally, always tans well (moderate brown) Type V very rarely burns, tans very easily (dark brown)"|Participants|Count of Participants|6|6.0||||||
3662113|NCT02381392|3507589|B2||II|Fitzpatrick skin color|"The Fitzpatrick scale is a numerical classification schema for human skin color. Patients are graded as follows:~Type I always burns, never tans (pale white; blond / red hair; blue eyes; freckles).~Type II usually burns, tans minimally (white; fair; blond / red hair; blue, green, or hazel eyes) Type III sometimes mild burn, tans uniformly (cream white; fair with any hair or eye color) Type IV burns minimally, always tans well (moderate brown) Type V very rarely burns, tans very easily (dark brown)"|Participants|Count of Participants|2|2.0||||||
3662114|NCT02381392|3507590|B1||II|Fitzpatrick skin color|"The Fitzpatrick scale is a numerical classification schema for human skin color. Patients are graded as follows:~Type I always burns, never tans (pale white; blond / red hair; blue eyes; freckles).~Type II usually burns, tans minimally (white; fair; blond / red hair; blue, green, or hazel eyes) Type III sometimes mild burn, tans uniformly (cream white; fair with any hair or eye color) Type IV burns minimally, always tans well (moderate brown) Type V very rarely burns, tans very easily (dark brown)"|Participants|Count of Participants|4|4.0||||||
3662115|NCT02381392|3507588|B3||I|Fitzpatrick skin color|"The Fitzpatrick scale is a numerical classification schema for human skin color. Patients are graded as follows:~Type I always burns, never tans (pale white; blond / red hair; blue eyes; freckles).~Type II usually burns, tans minimally (white; fair; blond / red hair; blue, green, or hazel eyes) Type III sometimes mild burn, tans uniformly (cream white; fair with any hair or eye color) Type IV burns minimally, always tans well (moderate brown) Type V very rarely burns, tans very easily (dark brown)"|Participants|Count of Participants|0|0.0||||||
3662116|NCT02381392|3507589|B2||I|Fitzpatrick skin color|"The Fitzpatrick scale is a numerical classification schema for human skin color. Patients are graded as follows:~Type I always burns, never tans (pale white; blond / red hair; blue eyes; freckles).~Type II usually burns, tans minimally (white; fair; blond / red hair; blue, green, or hazel eyes) Type III sometimes mild burn, tans uniformly (cream white; fair with any hair or eye color) Type IV burns minimally, always tans well (moderate brown) Type V very rarely burns, tans very easily (dark brown)"|Participants|Count of Participants|0|0.0||||||
3662180|NCT02381288|3507608|B2|||Weight||kg|Mean|101.6|101.6|Standard Deviation|11.3|11.3|||
3662181|NCT02381288|3507609|B1|||Weight||kg|Mean|93.0|93.0|Standard Deviation|16.6|16.6|||
3662182|NCT02381288|3507605|B5|||Height||cm|Mean|173.5|173.5|Standard Deviation|6.05|6.05|||
3662117|NCT02381392|3507590|B1||I|Fitzpatrick skin color|"The Fitzpatrick scale is a numerical classification schema for human skin color. Patients are graded as follows:~Type I always burns, never tans (pale white; blond / red hair; blue eyes; freckles).~Type II usually burns, tans minimally (white; fair; blond / red hair; blue, green, or hazel eyes) Type III sometimes mild burn, tans uniformly (cream white; fair with any hair or eye color) Type IV burns minimally, always tans well (moderate brown) Type V very rarely burns, tans very easily (dark brown)"|Participants|Count of Participants|0|0.0||||||
3662118|NCT02381392|3507588|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
3662119|NCT02381392|3507589|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3662120|NCT02381392|3507590|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3662121|NCT02381392|3507588|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3662122|NCT02381392|3507588|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3662123|NCT02381392|3507589|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3662124|NCT02381392|3507590|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3662125|NCT02381392|3507588|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3662126|NCT02381392|3507589|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3662127|NCT02381392|3507590|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3662128|NCT02381392|3507588|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3662129|NCT02381392|3507589|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3662130|NCT02381392|3507590|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3662131|NCT02381392|3507588|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3662132|NCT02381392|3507589|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3662133|NCT02381392|3507590|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3662134|NCT02381392|3507588|B3||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
3662135|NCT02381392|3507589|B2||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
3662136|NCT02381392|3507590|B1||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
3662137|NCT02381288|3507605|B5|No||Caffeine Consumption||participants|Number|5|5.0||||||
3662138|NCT02381288|3507606|B4|No||Caffeine Consumption||participants|Number|1|1.0||||||
3662139|NCT02381288|3507607|B3|No||Caffeine Consumption||participants|Number|2|2.0||||||
3662140|NCT02381288|3507608|B2|No||Caffeine Consumption||participants|Number|0|0.0||||||
3662141|NCT02381288|3507609|B1|No||Caffeine Consumption||participants|Number|2|2.0||||||
3662142|NCT02381288|3507605|B5|Yes||Caffeine Consumption||participants|Number|12|12.0||||||
3662143|NCT02381288|3507606|B4|Yes||Caffeine Consumption||participants|Number|4|4.0||||||
3662144|NCT02381288|3507607|B3|Yes||Caffeine Consumption||participants|Number|3|3.0||||||
3662145|NCT02381288|3507608|B2|Yes||Caffeine Consumption||participants|Number|2|2.0||||||
3662146|NCT02381288|3507609|B1|Yes||Caffeine Consumption||participants|Number|3|3.0||||||
3662147|NCT02381288|3507605|B5|Participant is an ex-drinker||Alcohol Classification||participants|Number|3|3.0||||||
3662148|NCT02381288|3507606|B4|Participant is an ex-drinker||Alcohol Classification||participants|Number|0|0.0||||||
3662149|NCT02381288|3507607|B3|Participant is an ex-drinker||Alcohol Classification||participants|Number|2|2.0||||||
3662150|NCT02381288|3507608|B2|Participant is an ex-drinker||Alcohol Classification||participants|Number|0|0.0||||||
3662151|NCT02381288|3507609|B1|Participant is an ex-drinker||Alcohol Classification||participants|Number|1|1.0||||||
3662152|NCT02381288|3507605|B5|Participant is a current drinker||Alcohol Classification||participants|Number|12|12.0||||||
3662153|NCT02381288|3507606|B4|Participant is a current drinker||Alcohol Classification||participants|Number|5|5.0||||||
3662154|NCT02381288|3507607|B3|Participant is a current drinker||Alcohol Classification||participants|Number|3|3.0||||||
3662155|NCT02381288|3507608|B2|Participant is a current drinker||Alcohol Classification||participants|Number|1|1.0||||||
3662156|NCT02381288|3507609|B1|Participant is a current drinker||Alcohol Classification||participants|Number|3|3.0||||||
3662157|NCT02381288|3507605|B5|Participant has never drunk||Alcohol Classification||participants|Number|2|2.0||||||
3662158|NCT02381288|3507606|B4|Participant has never drunk||Alcohol Classification||participants|Number|0|0.0||||||
3662159|NCT02381288|3507607|B3|Participant has never drunk||Alcohol Classification||participants|Number|0|0.0||||||
3662160|NCT02381288|3507608|B2|Participant has never drunk||Alcohol Classification||participants|Number|1|1.0||||||
3662161|NCT02381288|3507609|B1|Participant has never drunk||Alcohol Classification||participants|Number|1|1.0||||||
3662162|NCT02381288|3507605|B5|Participant is an ex-smoker||Smoking Classification||participants|Number|6|6.0||||||
3662163|NCT02381288|3507606|B4|Participant is an ex-smoker||Smoking Classification||participants|Number|1|1.0||||||
3662164|NCT02381288|3507607|B3|Participant is an ex-smoker||Smoking Classification||participants|Number|2|2.0||||||
3662165|NCT02381288|3507608|B2|Participant is an ex-smoker||Smoking Classification||participants|Number|1|1.0||||||
3662166|NCT02381288|3507609|B1|Participant is an ex-smoker||Smoking Classification||participants|Number|2|2.0||||||
3662167|NCT02381288|3507605|B5|Participant has never smoked||Smoking Classification||participants|Number|11|11.0||||||
3662168|NCT02381288|3507606|B4|Participant has never smoked||Smoking Classification||participants|Number|4|4.0||||||
3662169|NCT02381288|3507607|B3|Participant has never smoked||Smoking Classification||participants|Number|3|3.0||||||
3662170|NCT02381288|3507608|B2|Participant has never smoked||Smoking Classification||participants|Number|1|1.0||||||
3662171|NCT02381288|3507609|B1|Participant has never smoked||Smoking Classification||participants|Number|3|3.0||||||
3662172|NCT02381288|3507605|B5|||Baseline Body Mass Index (BMI)||kg/m^2|Mean|31.6|31.6|Standard Deviation|4.9|4.9|||
3662185|NCT02381288|3507608|B2|||Height||cm|Mean|173.5|173.5|Standard Deviation|3.54|3.54|||
3662186|NCT02381288|3507609|B1|||Height||cm|Mean|173.6|173.6|Standard Deviation|5.81|5.81|||
3662187|NCT02381288|3507605|B5|United States||Region of Enrollment||participants|Number|17|17.0||||||
3662188|NCT02381288|3507606|B4|United States||Region of Enrollment||participants|Number|5|5.0||||||
3662189|NCT02381288|3507607|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3662190|NCT02381288|3507608|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3662191|NCT02381288|3507609|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3662192|NCT02381288|3507605|B5|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3662193|NCT02381288|3507606|B4|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3662194|NCT02381288|3507607|B3|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3662195|NCT02381288|3507608|B2|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3662196|NCT02381288|3507609|B1|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3662197|NCT02381288|3507605|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3662198|NCT02381288|3507606|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3662199|NCT02381288|3507607|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3662200|NCT02381288|3507608|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3662201|NCT02381288|3507609|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3662202|NCT02381288|3507605|B5|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3662203|NCT02381288|3507606|B4|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3662204|NCT02381288|3507607|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3662205|NCT02381288|3507608|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3662206|NCT02381288|3507609|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3662207|NCT02381288|3507605|B5|Non-Hispanic and Latino||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3662208|NCT02381288|3507606|B4|Non-Hispanic and Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3662209|NCT02381288|3507607|B3|Non-Hispanic and Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3662210|NCT02381288|3507608|B2|Non-Hispanic and Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3662211|NCT02381288|3507609|B1|Non-Hispanic and Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3662212|NCT02381288|3507605|B5||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3662213|NCT02381288|3507606|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3662214|NCT02381288|3507607|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3662215|NCT02381288|3507608|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3662216|NCT02381288|3507609|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3662217|NCT02381288|3507605|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3662218|NCT02381288|3507606|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3662219|NCT02381288|3507607|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3662220|NCT02381288|3507608|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3662221|NCT02381288|3507609|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3662222|NCT02381288|3507605|B5|||Age||years|Mean|67.1|67.1|Standard Deviation|6.54|6.54|||
3662223|NCT02381288|3507606|B4|||Age||years|Mean|65.2|65.2|Standard Deviation|1.48|1.48|||
3662224|NCT02381288|3507607|B3|||Age||years|Mean|70.6|70.6|Standard Deviation|9.32|9.32|||
3662225|NCT02381288|3507608|B2|||Age||years|Mean|71.0|71.0|Standard Deviation|11.31|11.31|||
3662226|NCT02381288|3507609|B1|||Age||years|Mean|64.0|64.0|Standard Deviation|3.24|3.24|||
3662227|NCT02380742|3507639|B3|Mean electronic form||Baseline VAS scores|The Visual Analogue Scale (VAS) consists of a 10-cm-long straight line, scaled from 0 to 10 (0 = no pain and 10 = severe pain) without numerical values on the scale, except for 0 and 10.|units on a scale|Mean|0.52|0.52|Standard Deviation|0.60|0.6|||
3662228|NCT02380742|3507640|B2|Mean electronic form||Baseline VAS scores|The Visual Analogue Scale (VAS) consists of a 10-cm-long straight line, scaled from 0 to 10 (0 = no pain and 10 = severe pain) without numerical values on the scale, except for 0 and 10.|units on a scale|Mean|0.52|0.52|Standard Deviation|0.51|0.51|||
3662229|NCT02380742|3507641|B1|Mean electronic form||Baseline VAS scores|The Visual Analogue Scale (VAS) consists of a 10-cm-long straight line, scaled from 0 to 10 (0 = no pain and 10 = severe pain) without numerical values on the scale, except for 0 and 10.|units on a scale|Mean|0.51|0.51|Standard Deviation|0.69|0.69|||
3662230|NCT02380742|3507639|B3|Mean paper form||Baseline VAS scores|The Visual Analogue Scale (VAS) consists of a 10-cm-long straight line, scaled from 0 to 10 (0 = no pain and 10 = severe pain) without numerical values on the scale, except for 0 and 10.|units on a scale|Mean|0.26|0.26|Standard Deviation|0.61|0.61|||
3662231|NCT02380742|3507640|B2|Mean paper form||Baseline VAS scores|The Visual Analogue Scale (VAS) consists of a 10-cm-long straight line, scaled from 0 to 10 (0 = no pain and 10 = severe pain) without numerical values on the scale, except for 0 and 10.|units on a scale|Mean|0.23|0.23|Standard Deviation|0.48|0.48|||
3662232|NCT02380742|3507641|B1|Mean paper form||Baseline VAS scores|The Visual Analogue Scale (VAS) consists of a 10-cm-long straight line, scaled from 0 to 10 (0 = no pain and 10 = severe pain) without numerical values on the scale, except for 0 and 10.|units on a scale|Mean|0.29|0.29|Standard Deviation|0.73|0.73|||
3662233|NCT02380742|3507639|B3|Very satisfied||Pessary satisfaction||participants|Number|41|41.0||||||
3662234|NCT02380742|3507640|B2|Very satisfied||Pessary satisfaction||participants|Number|19|19.0||||||
3662235|NCT02380742|3507641|B1|Very satisfied||Pessary satisfaction||participants|Number|22|22.0||||||
3662236|NCT02380742|3507639|B3|Somewhat satisfied||Pessary satisfaction||participants|Number|10|10.0||||||
3662237|NCT02380742|3507640|B2|Somewhat satisfied||Pessary satisfaction||participants|Number|6|6.0||||||
3662238|NCT02380742|3507641|B1|Somewhat satisfied||Pessary satisfaction||participants|Number|4|4.0||||||
3662239|NCT02380742|3507639|B3|Neutral||Pessary satisfaction||participants|Number|1|1.0||||||
3662240|NCT02380742|3507640|B2|Neutral||Pessary satisfaction||participants|Number|0|0.0||||||
3662241|NCT02380742|3507641|B1|Neutral||Pessary satisfaction||participants|Number|1|1.0||||||
3662242|NCT02380742|3507639|B3|Somewhat dissatisfied||Pessary satisfaction||participants|Number|1|1.0||||||
3662243|NCT02380742|3507640|B2|Somewhat dissatisfied||Pessary satisfaction||participants|Number|1|1.0||||||
3662244|NCT02380742|3507641|B1|Somewhat dissatisfied||Pessary satisfaction||participants|Number|0|0.0||||||
3662245|NCT02380742|3507639|B3|Dissatisfied||Pessary satisfaction||participants|Number|0|0.0||||||
3662246|NCT02380742|3507640|B2|Dissatisfied||Pessary satisfaction||participants|Number|0|0.0||||||
3662247|NCT02380742|3507641|B1|Dissatisfied||Pessary satisfaction||participants|Number|0|0.0||||||
3662248|NCT02380742|3507639|B3|Yes||Tobacco use||participants|Number|3|3.0||||||
3662249|NCT02380742|3507640|B2|Yes||Tobacco use||participants|Number|2|2.0||||||
3662250|NCT02380742|3507641|B1|Yes||Tobacco use||participants|Number|1|1.0||||||
3662251|NCT02380742|3507639|B3|No||Tobacco use||participants|Number|50|50.0||||||
3662252|NCT02380742|3507640|B2|No||Tobacco use||participants|Number|24|24.0||||||
3662253|NCT02380742|3507641|B1|No||Tobacco use||participants|Number|26|26.0||||||
3662254|NCT02380742|3507639|B3|Not applicable||Pain with intercourse||participants|Number|32|32.0||||||
3662255|NCT02380742|3507640|B2|Not applicable||Pain with intercourse||participants|Number|17|17.0||||||
3662256|NCT02380742|3507641|B1|Not applicable||Pain with intercourse||participants|Number|15|15.0||||||
3662257|NCT02380742|3507639|B3|Yes||Pain with intercourse||participants|Number|0|0.0||||||
3662258|NCT02380742|3507640|B2|Yes||Pain with intercourse||participants|Number|0|0.0||||||
3662259|NCT02380742|3507641|B1|Yes||Pain with intercourse||participants|Number|0|0.0||||||
3662260|NCT02380742|3507639|B3|No||Pain with intercourse||participants|Number|21|21.0||||||
3662261|NCT02380742|3507640|B2|No||Pain with intercourse||participants|Number|9|9.0||||||
3662262|NCT02380742|3507641|B1|No||Pain with intercourse||participants|Number|12|12.0||||||
3662263|NCT02380742|3507639|B3|Yes||Sexually active||participants|Number|4|4.0||||||
3662264|NCT02380742|3507640|B2|Yes||Sexually active||participants|Number|0|0.0||||||
3662265|NCT02380742|3507641|B1|Yes||Sexually active||participants|Number|4|4.0||||||
3662266|NCT02380742|3507639|B3|No||Sexually active||participants|Number|49|49.0||||||
3662267|NCT02380742|3507640|B2|No||Sexually active||participants|Number|26|26.0||||||
3662268|NCT02380742|3507641|B1|No||Sexually active||participants|Number|23|23.0||||||
3662269|NCT02380742|3507639|B3|Yes||Prior hysterectomy||participants|Number|18|18.0||||||
3662270|NCT02380742|3507640|B2|Yes||Prior hysterectomy||participants|Number|7|7.0||||||
3662271|NCT02380742|3507641|B1|Yes||Prior hysterectomy||participants|Number|11|11.0||||||
3662272|NCT02380742|3507639|B3|No||Prior hysterectomy||participants|Number|35|35.0||||||
3662273|NCT02380742|3507640|B2|No||Prior hysterectomy||participants|Number|19|19.0||||||
3662274|NCT02380742|3507641|B1|No||Prior hysterectomy||participants|Number|16|16.0||||||
3662275|NCT02380742|3507639|B3|||Mean age at menopause (SD)||years|Mean|48.88|48.88|Standard Deviation|6.33|6.33|||
3662276|NCT02380742|3507640|B2|||Mean age at menopause (SD)||years|Mean|49.10|49.1|Standard Deviation|6.85|6.85|||
3662277|NCT02380742|3507641|B1|||Mean age at menopause (SD)||years|Mean|48.67|48.67|Standard Deviation|5.92|5.92|||
3662278|NCT02380742|3507639|B3|Postmenopausal||Menopausal status||participants|Number|53|53.0||||||
3662279|NCT02380742|3507640|B2|Postmenopausal||Menopausal status||participants|Number|26|26.0||||||
3662280|NCT02380742|3507641|B1|Postmenopausal||Menopausal status||participants|Number|27|27.0||||||
3662281|NCT02380742|3507639|B3|Premenopausal||Menopausal status||participants|Number|0|0.0||||||
3662282|NCT02380742|3507640|B2|Premenopausal||Menopausal status||participants|Number|0|0.0||||||
3662283|NCT02380742|3507641|B1|Premenopausal||Menopausal status||participants|Number|0|0.0||||||
3662284|NCT02380742|3507639|B3|Yes||Weekly topical estrogen||participants|Number|17|17.0||||||
3662285|NCT02380742|3507640|B2|Yes||Weekly topical estrogen||participants|Number|10|10.0||||||
3662286|NCT02380742|3507641|B1|Yes||Weekly topical estrogen||participants|Number|7|7.0||||||
3662287|NCT02380742|3507639|B3|No||Weekly topical estrogen||participants|Number|36|36.0||||||
3662288|NCT02380742|3507640|B2|No||Weekly topical estrogen||participants|Number|16|16.0||||||
3662289|NCT02380742|3507641|B1|No||Weekly topical estrogen||participants|Number|20|20.0||||||
3662290|NCT02380742|3507639|B3|Yes||Vaginal erosions||participants|Number|5|5.0||||||
3662291|NCT02380742|3507640|B2|Yes||Vaginal erosions||participants|Number|3|3.0||||||
3662292|NCT02380742|3507641|B1|Yes||Vaginal erosions||participants|Number|2|2.0||||||
3662293|NCT02380742|3507639|B3|No||Vaginal erosions||participants|Number|48|48.0||||||
3662294|NCT02380742|3507640|B2|No||Vaginal erosions||participants|Number|23|23.0||||||
3662295|NCT02380742|3507641|B1|No||Vaginal erosions||participants|Number|25|25.0||||||
3662296|NCT02380742|3507639|B3|Incontinence dish with support||Type of pessary||participants|Number|10|10.0||||||
3662297|NCT02380742|3507640|B2|Incontinence dish with support||Type of pessary||participants|Number|5|5.0||||||
3662298|NCT02380742|3507641|B1|Incontinence dish with support||Type of pessary||participants|Number|5|5.0||||||
3662299|NCT02380742|3507639|B3|Incontinence dish||Type of pessary||participants|Number|8|8.0||||||
3662300|NCT02380742|3507640|B2|Incontinence dish||Type of pessary||participants|Number|4|4.0||||||
3662301|NCT02380742|3507641|B1|Incontinence dish||Type of pessary||participants|Number|4|4.0||||||
3662302|NCT02380742|3507639|B3|Incontinence ring||Type of pessary||participants|Number|3|3.0||||||
3662303|NCT02380742|3507640|B2|Incontinence ring||Type of pessary||participants|Number|1|1.0||||||
3662304|NCT02380742|3507641|B1|Incontinence ring||Type of pessary||participants|Number|2|2.0||||||
3662305|NCT02380742|3507639|B3|Ring with support||Type of pessary||participants|Number|23|23.0||||||
3662306|NCT02380742|3507640|B2|Ring with support||Type of pessary||participants|Number|10|10.0||||||
3662307|NCT02380742|3507641|B1|Ring with support||Type of pessary||participants|Number|13|13.0||||||
3662308|NCT02380742|3507639|B3|Ring||Type of pessary||participants|Number|4|4.0||||||
3662309|NCT02380742|3507640|B2|Ring||Type of pessary||participants|Number|1|1.0||||||
3662310|NCT02380742|3507641|B1|Ring||Type of pessary||participants|Number|3|3.0||||||
3662311|NCT02380742|3507639|B3|Gelhorn||Type of pessary||participants|Number|5|5.0||||||
3662312|NCT02380742|3507640|B2|Gelhorn||Type of pessary||participants|Number|5|5.0||||||
3662313|NCT02380742|3507641|B1|Gelhorn||Type of pessary||participants|Number|0|0.0||||||
3662314|NCT02380742|3507639|B3|Prolapse & Incontinence||Reason for pessary||participants|Number|16|16.0||||||
3662315|NCT02380742|3507640|B2|Prolapse & Incontinence||Reason for pessary||participants|Number|10|10.0||||||
3662316|NCT02380742|3507641|B1|Prolapse & Incontinence||Reason for pessary||participants|Number|6|6.0||||||
3662317|NCT02380742|3507639|B3|Incontinence||Reason for pessary||participants|Number|8|8.0||||||
3662318|NCT02380742|3507640|B2|Incontinence||Reason for pessary||participants|Number|1|1.0||||||
3662319|NCT02380742|3507641|B1|Incontinence||Reason for pessary||participants|Number|7|7.0||||||
3662320|NCT02380742|3507639|B3|Prolapse||Reason for pessary||participants|Number|29|29.0||||||
3662321|NCT02380742|3507640|B2|Prolapse||Reason for pessary||participants|Number|15|15.0||||||
3662322|NCT02380742|3507641|B1|Prolapse||Reason for pessary||participants|Number|14|14.0||||||
3662323|NCT02380742|3507639|B3|||Median pessary size (IQR)||mm|Median|70|70.0|Inter-Quartile Range|||64.0|76.0|
3662324|NCT02380742|3507640|B2|||Median pessary size (IQR)||mm|Median|70|70.0|Inter-Quartile Range|||65.0|76.0|
3662325|NCT02380742|3507641|B1|||Median pessary size (IQR)||mm|Median|70|70.0|Inter-Quartile Range|||64.0|76.0|
3662326|NCT02380742|3507639|B3|||Median pessary months (IQR)||months|Median|15|15.0|Inter-Quartile Range|||6.0|26.0|
3662327|NCT02380742|3507640|B2|||Median pessary months (IQR)||months|Median|14|14.0|Inter-Quartile Range|||5.0|32.0|
3662328|NCT02380742|3507641|B1|||Median pessary months (IQR)||months|Median|18|18.0|Inter-Quartile Range|||6.0|26.0|
3662329|NCT02380742|3507639|B3|||Median parity (range)||number of viable pregnancies|Median|3|3.0|Inter-Quartile Range|||2.0|4.0|
3662330|NCT02380742|3507640|B2|||Median parity (range)||number of viable pregnancies|Median|3|3.0|Inter-Quartile Range|||2.0|4.0|
3662331|NCT02380742|3507641|B1|||Median parity (range)||number of viable pregnancies|Median|3|3.0|Inter-Quartile Range|||2.0|4.0|
3662332|NCT02380742|3507639|B3|||Median gravidity (IQR)||number of pregnancies|Median|3|3.0|Inter-Quartile Range|||2.0|4.0|
3662333|NCT02380742|3507640|B2|||Median gravidity (IQR)||number of pregnancies|Median|3|3.0|Inter-Quartile Range|||2.0|4.0|
3662334|NCT02380742|3507641|B1|||Median gravidity (IQR)||number of pregnancies|Median|3|3.0|Inter-Quartile Range|||2.0|4.0|
3662335|NCT02380742|3507639|B3|||BMI, Continuous||kg/m^2|Mean|28.78|28.78|Standard Deviation|6.30|6.3|||
3662336|NCT02380742|3507640|B2|||BMI, Continuous||kg/m^2|Mean|29.47|29.47|Standard Deviation|6.59|6.59|||
3662337|NCT02380742|3507641|B1|||BMI, Continuous||kg/m^2|Mean|28.11|28.11|Standard Deviation|6.06|6.06|||
3662338|NCT02380742|3507639|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3662339|NCT02380742|3507640|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3662340|NCT02380742|3507641|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3662341|NCT02380742|3507639|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662342|NCT02380742|3507640|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662343|NCT02380742|3507641|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662344|NCT02380742|3507639|B3||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3662345|NCT02380742|3507640|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3662346|NCT02380742|3507641|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3662347|NCT02380742|3507639|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3662348|NCT02380742|3507640|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3662349|NCT02380742|3507641|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662350|NCT02380742|3507639|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662351|NCT02380742|3507640|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662352|NCT02380742|3507641|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662353|NCT02380742|3507639|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662354|NCT02380742|3507640|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662355|NCT02380742|3507641|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662356|NCT02380742|3507639|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662357|NCT02380742|3507640|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662358|NCT02380742|3507641|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662359|NCT02380742|3507639|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3662360|NCT02380742|3507640|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662361|NCT02380742|3507641|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3662362|NCT02380742|3507639|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3662363|NCT02380742|3507640|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3662364|NCT02380742|3507641|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3662365|NCT02380742|3507639|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3662366|NCT02380742|3507640|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3662367|NCT02380742|3507641|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3662368|NCT02380742|3507639|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3662369|NCT02380742|3507640|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3662370|NCT02380742|3507641|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3662371|NCT02380742|3507639|B3||Female|Gender||Participants|Count of Participants|53|53.0||||||
3662372|NCT02380742|3507640|B2||Female|Gender||Participants|Count of Participants|26|26.0||||||
3662373|NCT02380742|3507641|B1||Female|Gender||Participants|Count of Participants|27|27.0||||||
3662374|NCT02380742|3507639|B3|||Age||years|Mean|77.76|77.76|Standard Deviation|9.49|9.49|||
3662375|NCT02380742|3507640|B2|||Age||years|Mean|79.95|79.95|Standard Deviation|8.01|8.01|||
3662376|NCT02380742|3507641|B1|||Age||years|Mean|75.64|75.64|Standard Deviation|10.43|10.43|||
3662377|NCT02380287|3507654|B9||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3662378|NCT02380287|3507655|B8||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3662379|NCT02380287|3507656|B7||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3662380|NCT02380287|3507657|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3662381|NCT02380287|3507658|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3662382|NCT02380287|3507659|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3662383|NCT02380287|3507660|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3662384|NCT02380287|3507661|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3662385|NCT02380287|3507662|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3662386|NCT02380287|3507654|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3662387|NCT02380287|3507655|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3662388|NCT02380287|3507656|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3662389|NCT02380287|3507657|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3662390|NCT02380287|3507658|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3662391|NCT02380287|3507659|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3662392|NCT02380287|3507660|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3662393|NCT02380287|3507661|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3662394|NCT02380287|3507662|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3662395|NCT02380287|3507654|B9||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3662396|NCT02380287|3507655|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3662397|NCT02380287|3507656|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3662398|NCT02380287|3507657|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3662399|NCT02380287|3507658|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3662400|NCT02380287|3507659|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3662401|NCT02380287|3507660|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3662402|NCT02380287|3507661|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3662403|NCT02380287|3507662|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3662404|NCT02380287|3507654|B9||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3662405|NCT02380287|3507655|B8||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3662406|NCT02380287|3507656|B7||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3662407|NCT02380287|3507657|B6||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3662408|NCT02380287|3507658|B5||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3662409|NCT02380287|3507659|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3662410|NCT02380287|3507660|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3662411|NCT02380287|3507661|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3662412|NCT02380287|3507662|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3662413|NCT02380287|3507654|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3662414|NCT02380287|3507655|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3662415|NCT02380287|3507656|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3662416|NCT02380287|3507657|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3662417|NCT02380287|3507658|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3662418|NCT02380287|3507659|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3662419|NCT02380287|3507660|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3662420|NCT02380287|3507661|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3662421|NCT02380287|3507662|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3662422|NCT02380261|3507680|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3662423|NCT02380261|3507680|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3662424|NCT02380261|3507680|B1|Age 18-70||Age, Customized||participants|Number|35|35.0||||||
3662425|NCT02380248|3507685|B1|||Corneal Staining|Corneal staining was assessed by the Investigator through slit-lamp examination and reported on a scale of 0-3, where 0=normal (no staining) and 3=severe (numerous coalescent macropunctate areas and/or patches), for the 5 quadrants of each eye. The scores at each visit were summed by eye for each subject. The overall corneal staining score for the subject at each visit was then computed as the average of the sum from both eyes. Thus, the overall scores ranged between 0-15 with higher scores reflecting more damage to the corneal surface.|units on a scale|Mean|5.7|5.7|Standard Deviation|2.12|2.12|||
3662426|NCT02380248|3507685|B1||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3662427|NCT02380248|3507685|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3662428|NCT02380248|3507685|B1|||Age||years|Mean|41.1|41.1|Standard Deviation|13.43|13.43|||
3662429|NCT02379923|3507690|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3662430|NCT02379923|3507690|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662431|NCT02379923|3507690|B1||White|Race (NIH/OMB)||Participants|Count of Participants|142|142.0||||||
3662432|NCT02379923|3507690|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3662433|NCT02379923|3507690|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3662434|NCT02379923|3507690|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3662435|NCT02379923|3507690|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3662436|NCT02379923|3507690|B1||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3662437|NCT02379923|3507690|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3662438|NCT02379923|3507690|B1|||Age||years|Mean|65.5|65.5|Standard Deviation|10.8|10.8|||
3662439|NCT02379637|3507704|B3|||Body mass index||kg/m^2|Mean|26.8|26.8|Standard Deviation|4.53|4.53|||
3662440|NCT02379637|3507705|B2|||Body mass index||kg/m^2|Mean|27.3|27.3|Standard Deviation|4.59|4.59|||
3662441|NCT02379637|3507706|B1|||Body mass index||kg/m^2|Mean|26.3|26.3|Standard Deviation|4.49|4.49|||
3662442|NCT02379637|3507704|B3|Canada||Region of Enrollment||participants|Number|70|70.0||||||
3662443|NCT02379637|3507705|B2|Canada||Region of Enrollment||participants|Number|35|35.0||||||
3662444|NCT02379637|3507706|B1|Canada||Region of Enrollment||participants|Number|35|35.0||||||
3662445|NCT02379637|3507704|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3662446|NCT02379637|3507705|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3662447|NCT02379637|3507706|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3662448|NCT02379637|3507704|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3662449|NCT02379637|3507705|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3662450|NCT02379637|3507706|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3662451|NCT02379637|3507704|B3|||Age||years|Mean|33.5|33.5|Standard Deviation|11.94|11.94|||
3662452|NCT02379637|3507705|B2|||Age||years|Mean|34|34.0|Standard Deviation|12.9|12.9|||
3662453|NCT02379637|3507706|B1|||Age||years|Mean|33|33.0|Standard Deviation|11.06|11.06|||
3662454|NCT02379221|3507740|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
3662455|NCT02379221|3507740|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3662456|NCT02379221|3507740|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3662457|NCT02379221|3507740|B1|||Age||years|Mean|53|53.0|Full Range|||22.0|81.0|
3662458|NCT02379221|3507740|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3662459|NCT02379221|3507740|B1||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
3662460|NCT02379221|3507740|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3662461|NCT02379091|3507755|B5|Participant is an ex-smoker||Smoking classification||Participants|Count of Participants|15|15.0||||||
3662462|NCT02379091|3507756|B4|Participant is an ex-smoker||Smoking classification||Participants|Count of Participants|4|4.0||||||
3662463|NCT02379091|3507757|B3|Participant is an ex-smoker||Smoking classification||Participants|Count of Participants|2|2.0||||||
3662464|NCT02379091|3507758|B2|Participant is an ex-smoker||Smoking classification||Participants|Count of Participants|4|4.0||||||
3662465|NCT02379091|3507759|B1|Participant is an ex-smoker||Smoking classification||Participants|Count of Participants|5|5.0||||||
3662466|NCT02379091|3507755|B5|Participant is a current smoker||Smoking classification||Participants|Count of Participants|22|22.0||||||
3662467|NCT02379091|3507756|B4|Participant is a current smoker||Smoking classification||Participants|Count of Participants|6|6.0||||||
3662468|NCT02379091|3507757|B3|Participant is a current smoker||Smoking classification||Participants|Count of Participants|5|5.0||||||
3662469|NCT02379091|3507758|B2|Participant is a current smoker||Smoking classification||Participants|Count of Participants|5|5.0||||||
3662470|NCT02379091|3507759|B1|Participant is a current smoker||Smoking classification||Participants|Count of Participants|6|6.0||||||
3662471|NCT02379091|3507755|B5|Participant has never smoked||Smoking classification||Participants|Count of Participants|71|71.0||||||
3662472|NCT02379091|3507756|B4|Participant has never smoked||Smoking classification||Participants|Count of Participants|18|18.0||||||
3662473|NCT02379091|3507757|B3|Participant has never smoked||Smoking classification||Participants|Count of Participants|18|18.0||||||
3662474|NCT02379091|3507758|B2|Participant has never smoked||Smoking classification||Participants|Count of Participants|19|19.0||||||
3662475|NCT02379091|3507759|B1|Participant has never smoked||Smoking classification||Participants|Count of Participants|16|16.0||||||
3662476|NCT02379091|3507755|B5|>= 30 kg/m^2||BMI Categories||Participants|Count of Participants|23|23.0||||||
3662477|NCT02379091|3507756|B4|>= 30 kg/m^2||BMI Categories||Participants|Count of Participants|6|6.0||||||
3662478|NCT02379091|3507757|B3|>= 30 kg/m^2||BMI Categories||Participants|Count of Participants|9|9.0||||||
3662479|NCT02379091|3507758|B2|>= 30 kg/m^2||BMI Categories||Participants|Count of Participants|5|5.0||||||
3662480|NCT02379091|3507759|B1|>= 30 kg/m^2||BMI Categories||Participants|Count of Participants|3|3.0||||||
3662481|NCT02379091|3507755|B5|< 30 kg/m^2||BMI Categories||Participants|Count of Participants|85|85.0||||||
3662482|NCT02379091|3507756|B4|< 30 kg/m^2||BMI Categories||Participants|Count of Participants|22|22.0||||||
3662483|NCT02379091|3507757|B3|< 30 kg/m^2||BMI Categories||Participants|Count of Participants|16|16.0||||||
3662484|NCT02379091|3507758|B2|< 30 kg/m^2||BMI Categories||Participants|Count of Participants|23|23.0||||||
3662485|NCT02379091|3507759|B1|< 30 kg/m^2||BMI Categories||Participants|Count of Participants|24|24.0||||||
3662486|NCT02379091|3507755|B5|||Body Mass Index (BMI)||kg/m^2|Mean|25.41|25.41|Standard Deviation|5.741|5.741|||
3662487|NCT02379091|3507756|B4|||Body Mass Index (BMI)||kg/m^2|Mean|25.92|25.92|Standard Deviation|6.313|6.313|||
3662488|NCT02379091|3507757|B3|||Body Mass Index (BMI)||kg/m^2|Mean|27.16|27.16|Standard Deviation|5.605|5.605|||
3662489|NCT02379091|3507758|B2|||Body Mass Index (BMI)||kg/m^2|Mean|24.91|24.91|Standard Deviation|5.210|5.21|||
3662490|NCT02379091|3507759|B1|||Body Mass Index (BMI)||kg/m^2|Mean|23.75|23.75|Standard Deviation|5.542|5.542|||
3662491|NCT02379091|3507755|B5|||Weight||kg|Mean|70.64|70.64|Standard Deviation|17.499|17.499|||
3662492|NCT02379091|3507756|B4|||Weight||kg|Mean|72.23|72.23|Standard Deviation|19.168|19.168|||
3662493|NCT02379091|3507757|B3|||Weight||kg|Mean|76.56|76.56|Standard Deviation|18.660|18.66|||
3662494|NCT02379091|3507758|B2|||Weight||kg|Mean|70.28|70.28|Standard Deviation|15.911|15.911|||
3662495|NCT02379091|3507759|B1|||Weight||kg|Mean|63.89|63.89|Standard Deviation|14.511|14.511|||
3662496|NCT02379091|3507755|B5|||Height||cm|Mean|166.5|166.5|Standard Deviation|8.78|8.78|||
3662497|NCT02379091|3507756|B4|||Height||cm|Mean|166.5|166.5|Standard Deviation|9.24|9.24|||
3662498|NCT02379091|3507757|B3|||Height||cm|Mean|167.4|167.4|Standard Deviation|8.36|8.36|||
3662499|NCT02379091|3507758|B2|||Height||cm|Mean|167.7|167.7|Standard Deviation|6.65|6.65|||
3662500|NCT02379091|3507759|B1|||Height||cm|Mean|164.3|164.3|Standard Deviation|10.51|10.51|||
3662501|NCT02379091|3507755|B5|United Kingdom||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3662502|NCT02379091|3507756|B4|United Kingdom||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3662503|NCT02379091|3507757|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3662504|NCT02379091|3507758|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3662505|NCT02379091|3507759|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3662506|NCT02379091|3507755|B5|Spain||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3662507|NCT02379091|3507756|B4|Spain||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3662508|NCT02379091|3507757|B3|Spain||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3662509|NCT02379091|3507758|B2|Spain||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3662510|NCT02379091|3507759|B1|Spain||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3662511|NCT02379091|3507755|B5|Russia||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3662512|NCT02379091|3507756|B4|Russia||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3662513|NCT02379091|3507757|B3|Russia||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3662514|NCT02379091|3507758|B2|Russia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3662515|NCT02379091|3507759|B1|Russia||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3662516|NCT02379091|3507755|B5|Poland||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3662517|NCT02379091|3507756|B4|Poland||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3662518|NCT02379091|3507757|B3|Poland||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3662519|NCT02379091|3507758|B2|Poland||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3662520|NCT02379091|3507759|B1|Poland||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3662521|NCT02379091|3507755|B5|Japan||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3662522|NCT02379091|3507756|B4|Japan||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3662523|NCT02379091|3507757|B3|Japan||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3662524|NCT02379091|3507758|B2|Japan||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3662525|NCT02379091|3507759|B1|Japan||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3662526|NCT02379091|3507755|B5|Czech Republic||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3662527|NCT02379091|3507756|B4|Czech Republic||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3662528|NCT02379091|3507757|B3|Czech Republic||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3662529|NCT02379091|3507758|B2|Czech Republic||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3662530|NCT02379091|3507759|B1|Czech Republic||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3662531|NCT02379091|3507755|B5|Bulgaria||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3662532|NCT02379091|3507756|B4|Bulgaria||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3663263|NCT02375724|3508322|B2|||Age||Years|Mean|62.0|62.0|Standard Deviation|9.1|9.1|||
3662533|NCT02379091|3507757|B3|Bulgaria||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3662534|NCT02379091|3507758|B2|Bulgaria||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3662535|NCT02379091|3507759|B1|Bulgaria||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3662536|NCT02379091|3507755|B5|Multiracial||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3662537|NCT02379091|3507756|B4|Multiracial||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3662538|NCT02379091|3507757|B3|Multiracial||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3662539|NCT02379091|3507758|B2|Multiracial||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3662540|NCT02379091|3507759|B1|Multiracial||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3662541|NCT02379091|3507755|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|89|89.0||||||
3662542|NCT02379091|3507756|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3662543|NCT02379091|3507757|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3662544|NCT02379091|3507758|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3662545|NCT02379091|3507759|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3662546|NCT02379091|3507755|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3662547|NCT02379091|3507756|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3662548|NCT02379091|3507757|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3662549|NCT02379091|3507758|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3662550|NCT02379091|3507759|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3662551|NCT02379091|3507755|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3662552|NCT02379091|3507756|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3662553|NCT02379091|3507757|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3662554|NCT02379091|3507758|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3662555|NCT02379091|3507759|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3662556|NCT02379091|3507755|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3662557|NCT02379091|3507756|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3662558|NCT02379091|3507757|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3662559|NCT02379091|3507758|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3662560|NCT02379091|3507759|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3662561|NCT02379091|3507755|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3662562|NCT02379091|3507756|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662563|NCT02379091|3507757|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3662564|NCT02379091|3507758|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3662565|NCT02379091|3507759|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3662566|NCT02379091|3507755|B5||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3662567|NCT02379091|3507756|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3662568|NCT02379091|3507757|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3662569|NCT02379091|3507758|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3662570|NCT02379091|3507759|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3662571|NCT02379091|3507755|B5||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3662572|NCT02379091|3507756|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3662573|NCT02379091|3507757|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3662574|NCT02379091|3507758|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3662575|NCT02379091|3507759|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3662576|NCT02379091|3507755|B5|>= 75 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
3662577|NCT02379091|3507756|B4|>= 75 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3662578|NCT02379091|3507757|B3|>= 75 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3662579|NCT02379091|3507758|B2|>= 75 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3662580|NCT02379091|3507759|B1|>= 75 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
3662581|NCT02379091|3507755|B5|65 to 74 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
3662582|NCT02379091|3507756|B4|65 to 74 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
3662583|NCT02379091|3507757|B3|65 to 74 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3662584|NCT02379091|3507758|B2|65 to 74 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3662585|NCT02379091|3507759|B1|65 to 74 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3662586|NCT02379091|3507755|B5|45 to 64 years||Age, Customized||Participants|Count of Participants|67|67.0||||||
3662587|NCT02379091|3507756|B4|45 to 64 years||Age, Customized||Participants|Count of Participants|19|19.0||||||
3662588|NCT02379091|3507757|B3|45 to 64 years||Age, Customized||Participants|Count of Participants|17|17.0||||||
3662589|NCT02379091|3507758|B2|45 to 64 years||Age, Customized||Participants|Count of Participants|16|16.0||||||
3662590|NCT02379091|3507759|B1|45 to 64 years||Age, Customized||Participants|Count of Participants|15|15.0||||||
3662591|NCT02379091|3507755|B5|< 45 years||Age, Customized||Participants|Count of Participants|34|34.0||||||
3662592|NCT02379091|3507756|B4|< 45 years||Age, Customized||Participants|Count of Participants|7|7.0||||||
3662593|NCT02379091|3507757|B3|< 45 years||Age, Customized||Participants|Count of Participants|7|7.0||||||
3662594|NCT02379091|3507758|B2|< 45 years||Age, Customized||Participants|Count of Participants|11|11.0||||||
3662595|NCT02379091|3507759|B1|< 45 years||Age, Customized||Participants|Count of Participants|9|9.0||||||
3662596|NCT02379091|3507755|B5|||Age||years|Mean|48.4|48.4|Standard Deviation|12.02|12.02|||
3662597|NCT02379091|3507756|B4|||Age||years|Mean|51.3|51.3|Standard Deviation|14.13|14.13|||
3662598|NCT02379091|3507757|B3|||Age||years|Mean|49.0|49.0|Standard Deviation|9.60|9.6|||
3662599|NCT02379091|3507758|B2|||Age||years|Mean|46.1|46.1|Standard Deviation|10.07|10.07|||
3662600|NCT02379091|3507759|B1|||Age||years|Mean|47.2|47.2|Standard Deviation|13.45|13.45|||
3662601|NCT02378961|3507798|B5|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|84|84.0||||||
3662602|NCT02378961|3507799|B4|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|22|22.0||||||
3662603|NCT02378961|3507800|B3|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|24|24.0||||||
3662604|NCT02378961|3507801|B2|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|19|19.0||||||
3662605|NCT02378961|3507802|B1|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|19|19.0||||||
3662606|NCT02378961|3507798|B5|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|44|44.0||||||
3662607|NCT02378961|3507799|B4|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|7|7.0||||||
3662608|NCT02378961|3507800|B3|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|12|12.0||||||
3662609|NCT02378961|3507801|B2|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|11|11.0||||||
3662610|NCT02378961|3507802|B1|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|14|14.0||||||
3662611|NCT02378961|3507798|B5|||HCV RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.72|0.72|||
3662612|NCT02378961|3507799|B4|||HCV RNA||log10 IU/mL|Mean|6.4|6.4|Standard Deviation|0.57|0.57|||
3662613|NCT02378961|3507800|B3|||HCV RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.72|0.72|||
3662614|NCT02378961|3507801|B2|||HCV RNA||log10 IU/mL|Mean|6.1|6.1|Standard Deviation|0.66|0.66|||
3662615|NCT02378961|3507802|B1|||HCV RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.86|0.86|||
3662616|NCT02378961|3507798|B5|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|17|17.0||||||
3662617|NCT02378961|3507799|B4|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|2|2.0||||||
3662618|NCT02378961|3507800|B3|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|5|5.0||||||
3662619|NCT02378961|3507801|B2|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|4|4.0||||||
3662620|NCT02378961|3507802|B1|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|6|6.0||||||
3662621|NCT02378961|3507798|B5|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|62|62.0||||||
3662622|NCT02378961|3507799|B4|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|17|17.0||||||
3662623|NCT02378961|3507800|B3|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|15|15.0||||||
3662624|NCT02378961|3507801|B2|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|15|15.0||||||
3662625|NCT02378961|3507802|B1|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|15|15.0||||||
3662626|NCT02378961|3507798|B5|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|47|47.0||||||
3662627|NCT02378961|3507799|B4|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|10|10.0||||||
3662628|NCT02378961|3507800|B3|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|15|15.0||||||
3662629|NCT02378961|3507801|B2|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|11|11.0||||||
3662630|NCT02378961|3507802|B1|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|11|11.0||||||
3662631|NCT02378961|3507798|B5|United States||Region of Enrollment||participants|Number|121|121.0||||||
3662632|NCT02378961|3507799|B4|United States||Region of Enrollment||participants|Number|29|29.0||||||
3662633|NCT02378961|3507800|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
3662634|NCT02378961|3507801|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
3662635|NCT02378961|3507802|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
3662636|NCT02378961|3507798|B5|New Zealand||Region of Enrollment||participants|Number|7|7.0||||||
3662637|NCT02378961|3507799|B4|New Zealand||Region of Enrollment||participants|Number|0|0.0||||||
3662638|NCT02378961|3507800|B3|New Zealand||Region of Enrollment||participants|Number|2|2.0||||||
3662639|NCT02378961|3507801|B2|New Zealand||Region of Enrollment||participants|Number|4|4.0||||||
3662640|NCT02378961|3507802|B1|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
3662641|NCT02378961|3507798|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|111|111.0||||||
3662642|NCT02378961|3507799|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3662643|NCT02378961|3507800|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3662644|NCT02378961|3507801|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3662645|NCT02378961|3507802|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3662646|NCT02378961|3507798|B5|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3662647|NCT02378961|3507799|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3662648|NCT02378961|3507800|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3662649|NCT02378961|3507801|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3662650|NCT02378961|3507802|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3662651|NCT02378961|3507798|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3662652|NCT02378961|3507799|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3662653|NCT02378961|3507800|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3662654|NCT02378961|3507801|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3662655|NCT02378961|3507802|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3662656|NCT02378961|3507798|B5|Native India or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3662657|NCT02378961|3507799|B4|Native India or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3662658|NCT02378961|3507800|B3|Native India or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3662659|NCT02378961|3507801|B2|Native India or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3662660|NCT02378961|3507802|B1|Native India or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3662661|NCT02378961|3507798|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3662662|NCT02378961|3507799|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3662663|NCT02378961|3507800|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3662664|NCT02378961|3507801|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3662665|NCT02378961|3507802|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3662666|NCT02378961|3507798|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3662667|NCT02378961|3507799|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3662668|NCT02378961|3507800|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3662669|NCT02378961|3507801|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3662670|NCT02378961|3507802|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3662671|NCT02378961|3507798|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|103|103.0||||||
3662672|NCT02378961|3507799|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3662673|NCT02378961|3507800|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3662674|NCT02378961|3507801|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3662675|NCT02378961|3507802|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3662676|NCT02378961|3507798|B5|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3662677|NCT02378961|3507799|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3662678|NCT02378961|3507800|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3662679|NCT02378961|3507801|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3662680|NCT02378961|3507802|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3662681|NCT02378961|3507798|B5||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3662682|NCT02378961|3507799|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3662683|NCT02378961|3507800|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3662684|NCT02378961|3507801|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3662685|NCT02378961|3507802|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3662686|NCT02378961|3507798|B5||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3662687|NCT02378961|3507799|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3662688|NCT02378961|3507800|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3662689|NCT02378961|3507801|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3662690|NCT02378961|3507802|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3662691|NCT02378961|3507798|B5|||Age||years|Mean|56|56.0|Standard Deviation|9.3|9.3|||
3662692|NCT02378961|3507799|B4|||Age||years|Mean|58|58.0|Standard Deviation|7.0|7.0|||
3662693|NCT02378961|3507800|B3|||Age||years|Mean|57|57.0|Standard Deviation|8.3|8.3|||
3662694|NCT02378961|3507801|B2|||Age||years|Mean|56|56.0|Standard Deviation|8.3|8.3|||
3662695|NCT02378961|3507802|B1|||Age||years|Mean|53|53.0|Standard Deviation|12.0|12.0|||
3662696|NCT02378935|3507835|B8|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|147|147.0||||||
3662697|NCT02378935|3507836|B7|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|8|8.0||||||
3662698|NCT02378935|3507837|B6|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|16|16.0||||||
3663264|NCT02375724|3508323|B1|||Age||Years|Mean|62.0|62.0|Standard Deviation|8.4|8.4|||
3662699|NCT02378935|3507838|B5|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|25|25.0||||||
3662700|NCT02378935|3507839|B4|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|25|25.0||||||
3662701|NCT02378935|3507840|B3|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|19|19.0||||||
3662702|NCT02378935|3507841|B2|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|26|26.0||||||
3662703|NCT02378935|3507842|B1|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|28|28.0||||||
3662704|NCT02378935|3507835|B8|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|58|58.0||||||
3662705|NCT02378935|3507836|B7|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|0|0.0||||||
3662706|NCT02378935|3507837|B6|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|16|16.0||||||
3662707|NCT02378935|3507838|B5|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|6|6.0||||||
3662708|NCT02378935|3507839|B4|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|6|6.0||||||
3662709|NCT02378935|3507840|B3|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|14|14.0||||||
3662710|NCT02378935|3507841|B2|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|10|10.0||||||
3662711|NCT02378935|3507842|B1|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|6|6.0||||||
3662712|NCT02378935|3507835|B8|||HCV RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.60|0.6|||
3662713|NCT02378935|3507836|B7|||HCV RNA||log10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.38|0.38|||
3662714|NCT02378935|3507837|B6|||HCV RNA||log10 IU/mL|Mean|6.0|6.0|Standard Deviation|0.61|0.61|||
3662715|NCT02378935|3507838|B5|||HCV RNA||log10 IU/mL|Mean|6.4|6.4|Standard Deviation|0.77|0.77|||
3662716|NCT02378935|3507839|B4|||HCV RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.47|0.47|||
3662717|NCT02378935|3507840|B3|||HCV RNA||log10 IU/mL|Mean|6.0|6.0|Standard Deviation|0.59|0.59|||
3662718|NCT02378935|3507841|B2|||HCV RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.55|0.55|||
3662719|NCT02378935|3507842|B1|||HCV RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.51|0.51|||
3662720|NCT02378935|3507835|B8|Missing||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|4|4.0||||||
3662721|NCT02378935|3507836|B7|Missing||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|0|0.0||||||
3662722|NCT02378935|3507837|B6|Missing||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|0|0.0||||||
3662723|NCT02378935|3507838|B5|Missing||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|1|1.0||||||
3662724|NCT02378935|3507839|B4|Missing||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|1|1.0||||||
3662725|NCT02378935|3507840|B3|Missing||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|0|0.0||||||
3662726|NCT02378935|3507841|B2|Missing||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|2|2.0||||||
3662727|NCT02378935|3507842|B1|Missing||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|0|0.0||||||
3662728|NCT02378935|3507835|B8|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|40|40.0||||||
3662729|NCT02378935|3507836|B7|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|2|2.0||||||
3662730|NCT02378935|3507837|B6|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|7|7.0||||||
3662731|NCT02378935|3507838|B5|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|7|7.0||||||
3662732|NCT02378935|3507839|B4|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|6|6.0||||||
3662733|NCT02378935|3507840|B3|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|7|7.0||||||
3662734|NCT02378935|3507841|B2|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|4|4.0||||||
3662735|NCT02378935|3507842|B1|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|7|7.0||||||
3662736|NCT02378935|3507835|B8|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|110|110.0||||||
3662737|NCT02378935|3507836|B7|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|3|3.0||||||
3662738|NCT02378935|3507837|B6|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|21|21.0||||||
3662739|NCT02378935|3507838|B5|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|19|19.0||||||
3662740|NCT02378935|3507839|B4|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|12|12.0||||||
3662741|NCT02378935|3507840|B3|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|19|19.0||||||
3662742|NCT02378935|3507841|B2|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|21|21.0||||||
3662743|NCT02378935|3507842|B1|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|15|15.0||||||
3662744|NCT02378935|3507835|B8|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|51|51.0||||||
3662745|NCT02378935|3507836|B7|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|3|3.0||||||
3662746|NCT02378935|3507837|B6|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|4|4.0||||||
3662747|NCT02378935|3507838|B5|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|4|4.0||||||
3662748|NCT02378935|3507839|B4|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|12|12.0||||||
3662749|NCT02378935|3507840|B3|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|7|7.0||||||
3662750|NCT02378935|3507841|B2|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|9|9.0||||||
3662751|NCT02378935|3507842|B1|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|12|12.0||||||
3662752|NCT02378935|3507835|B8|New Zealand||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3662753|NCT02378935|3507836|B7|New Zealand||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3662754|NCT02378935|3507837|B6|New Zealand||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3662755|NCT02378935|3507838|B5|New Zealand||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3662756|NCT02378935|3507839|B4|New Zealand||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3662757|NCT02378935|3507840|B3|New Zealand||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3662758|NCT02378935|3507841|B2|New Zealand||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3662759|NCT02378935|3507842|B1|New Zealand||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3662760|NCT02378935|3507835|B8|United States||Region of Enrollment||Participants|Count of Participants|198|198.0||||||
3662761|NCT02378935|3507836|B7|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3662762|NCT02378935|3507837|B6|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3662763|NCT02378935|3507838|B5|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3662764|NCT02378935|3507839|B4|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3662765|NCT02378935|3507840|B3|United States||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3662766|NCT02378935|3507841|B2|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3662767|NCT02378935|3507842|B1|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3662768|NCT02378935|3507835|B8|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|163|163.0||||||
3662769|NCT02378935|3507836|B7|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3662770|NCT02378935|3507837|B6|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3662771|NCT02378935|3507838|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3662772|NCT02378935|3507839|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3662773|NCT02378935|3507840|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3662774|NCT02378935|3507841|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3662775|NCT02378935|3507842|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3662776|NCT02378935|3507835|B8|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3662777|NCT02378935|3507836|B7|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3662778|NCT02378935|3507837|B6|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3662779|NCT02378935|3507838|B5|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3662780|NCT02378935|3507839|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3662781|NCT02378935|3507840|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3662782|NCT02378935|3507841|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3662783|NCT02378935|3507842|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3662784|NCT02378935|3507835|B8|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3662785|NCT02378935|3507836|B7|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3662786|NCT02378935|3507837|B6|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3662787|NCT02378935|3507838|B5|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3662788|NCT02378935|3507839|B4|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3662789|NCT02378935|3507840|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3662790|NCT02378935|3507841|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3662791|NCT02378935|3507842|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3662792|NCT02378935|3507835|B8|White||Race/Ethnicity, Customized||Participants|Count of Participants|175|175.0||||||
3662793|NCT02378935|3507836|B7|White||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3662794|NCT02378935|3507837|B6|White||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3662795|NCT02378935|3507838|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3662796|NCT02378935|3507839|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3662797|NCT02378935|3507840|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3662798|NCT02378935|3507841|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3662799|NCT02378935|3507842|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3662800|NCT02378935|3507835|B8|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3662801|NCT02378935|3507836|B7|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3662802|NCT02378935|3507837|B6|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3662803|NCT02378935|3507838|B5|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3662804|NCT02378935|3507839|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3662805|NCT02378935|3507840|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3662806|NCT02378935|3507841|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3662807|NCT02378935|3507842|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3662808|NCT02378935|3507835|B8||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3662809|NCT02378935|3507836|B7||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3662810|NCT02378935|3507837|B6||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3662811|NCT02378935|3507838|B5||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3662812|NCT02378935|3507839|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3662813|NCT02378935|3507840|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3662814|NCT02378935|3507841|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3662815|NCT02378935|3507842|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3662816|NCT02378935|3507835|B8||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3662817|NCT02378935|3507836|B7||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3662818|NCT02378935|3507837|B6||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3662819|NCT02378935|3507838|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3662820|NCT02378935|3507839|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3662821|NCT02378935|3507840|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3662822|NCT02378935|3507841|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3662823|NCT02378935|3507842|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3662824|NCT02378935|3507835|B8|||Age||years|Mean|56|56.0|Standard Deviation|9.8|9.8|||
3662825|NCT02378935|3507836|B7|||Age||years|Mean|5.7|5.7|Standard Deviation|5.9|5.9|||
3662826|NCT02378935|3507837|B6|||Age||years|Mean|59|59.0|Standard Deviation|6.5|6.5|||
3662827|NCT02378935|3507838|B5|||Age||years|Mean|57|57.0|Standard Deviation|7.8|7.8|||
3662828|NCT02378935|3507839|B4|||Age||years|Mean|59|59.0|Standard Deviation|6.7|6.7|||
3662829|NCT02378935|3507840|B3|||Age||years|Mean|58|58.0|Standard Deviation|7.2|7.2|||
3662830|NCT02378935|3507841|B2|||Age||years|Mean|51|51.0|Standard Deviation|14.3|14.3|||
3662831|NCT02378935|3507842|B1|||Age||years|Mean|53|53.0|Standard Deviation|11.5|11.5|||
3662832|NCT02378753|3507899|B3|Sierra Leone||Region of Enrollment||Participants|Count of Participants|8004|8004.0||||||
3662833|NCT02378753|3507900|B2|Sierra Leone||Region of Enrollment||Participants|Count of Participants|3821|3821.0||||||
3662834|NCT02378753|3507901|B1|Sierra Leone||Region of Enrollment||Participants|Count of Participants|4183|4183.0||||||
3662835|NCT02378753|3507899|B3||Male|Sex: Female, Male||Participants|Count of Participants|5244|5244.0||||||
3662836|NCT02378753|3507900|B2||Male|Sex: Female, Male||Participants|Count of Participants|2628|2628.0||||||
3662837|NCT02378753|3507901|B1||Male|Sex: Female, Male||Participants|Count of Participants|2616|2616.0||||||
3662838|NCT02378753|3507899|B3||Female|Sex: Female, Male||Participants|Count of Participants|3407|3407.0||||||
3662839|NCT02378753|3507900|B2||Female|Sex: Female, Male||Participants|Count of Participants|1704|1704.0||||||
3662840|NCT02378753|3507901|B1||Female|Sex: Female, Male||Participants|Count of Participants|1703|1703.0||||||
3662841|NCT02378753|3507899|B3|||Age||years|Median|30.7|30.7|Full Range|||18.0|79.5|
3662842|NCT02378753|3507900|B2|||Age||years|Median|31.0|31.0|Full Range|||18.0|79.5|
3662843|NCT02378753|3507901|B1|||Age||years|Median|30.5|30.5|Full Range|||18.1|78.0|
3662844|NCT02378662|3507920|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662845|NCT02378662|3507921|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662846|NCT02378662|3507922|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662847|NCT02378662|3507920|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662848|NCT02378662|3507921|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662849|NCT02378662|3507922|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662850|NCT02378662|3507920|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3662851|NCT02378662|3507921|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662852|NCT02378662|3507922|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3662853|NCT02378662|3507920|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662854|NCT02378662|3507921|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662855|NCT02378662|3507922|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662856|NCT02378662|3507920|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662857|NCT02378662|3507921|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662858|NCT02378662|3507922|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662859|NCT02378662|3507920|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3662860|NCT02378662|3507921|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662861|NCT02378662|3507922|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3662862|NCT02378662|3507920|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662863|NCT02378662|3507921|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662864|NCT02378662|3507922|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662865|NCT02378662|3507920|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3662866|NCT02378662|3507921|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3662867|NCT02378662|3507922|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3662868|NCT02378662|3507920|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3662869|NCT02378662|3507921|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3662870|NCT02378662|3507922|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3662871|NCT02378662|3507920|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3662872|NCT02378662|3507921|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3662873|NCT02378662|3507922|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3662874|NCT02378662|3507920|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3662875|NCT02378662|3507921|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3662876|NCT02378662|3507922|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3662877|NCT02378662|3507920|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3662878|NCT02378662|3507921|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3662879|NCT02378662|3507922|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3662880|NCT02378506|3507929|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3662881|NCT02378506|3507929|B1||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
3662882|NCT02378506|3507929|B1|||Age||years|Mean|54.2|54.2|Standard Deviation|12.89|12.89|||
3662883|NCT02378220|3507946|B3|AVERAGE PHARMACOGENETIC RISK||OASIS Metrics|"OASIS (Outcome and Assessment Information Set) Score represents an outcome measure in home health at an individual patient level to plan care, measure quality, and calculate reimbursement. On an overall scale of 0 to 3, a lower number represents a better outcome.~Average Pharmacogenetic Risk score estimates individual patient risk of having at least one significant adverse drug event due to genetic variation. Total range is 0 to 100, representing percentage, where a larger number indicates a higher risk."|Scores on a scale|Mean|33.75|33.75|Full Range|||0.0|73.0|
3662884|NCT02378220|3507947|B2|AVERAGE PHARMACOGENETIC RISK||OASIS Metrics|"OASIS (Outcome and Assessment Information Set) Score represents an outcome measure in home health at an individual patient level to plan care, measure quality, and calculate reimbursement. On an overall scale of 0 to 3, a lower number represents a better outcome.~Average Pharmacogenetic Risk score estimates individual patient risk of having at least one significant adverse drug event due to genetic variation. Total range is 0 to 100, representing percentage, where a larger number indicates a higher risk."|Scores on a scale|Mean|33.2|33.2|Full Range|||0.0|63.0|
3662885|NCT02378220|3507948|B1|AVERAGE PHARMACOGENETIC RISK||OASIS Metrics|"OASIS (Outcome and Assessment Information Set) Score represents an outcome measure in home health at an individual patient level to plan care, measure quality, and calculate reimbursement. On an overall scale of 0 to 3, a lower number represents a better outcome.~Average Pharmacogenetic Risk score estimates individual patient risk of having at least one significant adverse drug event due to genetic variation. Total range is 0 to 100, representing percentage, where a larger number indicates a higher risk."|Scores on a scale|Mean|34.3|34.3|Full Range|||0.0|73.0|
3662886|NCT02378220|3507946|B3|OVERALL OASIS SCORE||OASIS Metrics|"OASIS (Outcome and Assessment Information Set) Score represents an outcome measure in home health at an individual patient level to plan care, measure quality, and calculate reimbursement. On an overall scale of 0 to 3, a lower number represents a better outcome.~Average Pharmacogenetic Risk score estimates individual patient risk of having at least one significant adverse drug event due to genetic variation. Total range is 0 to 100, representing percentage, where a larger number indicates a higher risk."|Scores on a scale|Mean|1.63|1.63|Full Range|||0.0|3.0|
3662887|NCT02378220|3507947|B2|OVERALL OASIS SCORE||OASIS Metrics|"OASIS (Outcome and Assessment Information Set) Score represents an outcome measure in home health at an individual patient level to plan care, measure quality, and calculate reimbursement. On an overall scale of 0 to 3, a lower number represents a better outcome.~Average Pharmacogenetic Risk score estimates individual patient risk of having at least one significant adverse drug event due to genetic variation. Total range is 0 to 100, representing percentage, where a larger number indicates a higher risk."|Scores on a scale|Mean|1.64|1.64|Full Range|||0.0|3.0|
3662888|NCT02378220|3507948|B1|OVERALL OASIS SCORE||OASIS Metrics|"OASIS (Outcome and Assessment Information Set) Score represents an outcome measure in home health at an individual patient level to plan care, measure quality, and calculate reimbursement. On an overall scale of 0 to 3, a lower number represents a better outcome.~Average Pharmacogenetic Risk score estimates individual patient risk of having at least one significant adverse drug event due to genetic variation. Total range is 0 to 100, representing percentage, where a larger number indicates a higher risk."|Scores on a scale|Mean|1.63|1.63|Full Range|||0.0|3.0|
3662889|NCT02378220|3507946|B3|United States||Region of Enrollment||participants|Number|110|110.0||||||
3662890|NCT02378220|3507947|B2|United States||Region of Enrollment||participants|Number|57|57.0||||||
3662891|NCT02378220|3507948|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
3662892|NCT02378220|3507946|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662893|NCT02378220|3507947|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662894|NCT02378220|3507948|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662895|NCT02378220|3507946|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662896|NCT02378220|3507947|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662897|NCT02378220|3507948|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662898|NCT02378220|3507946|B3||White|Race (NIH/OMB)||Participants|Count of Participants|109|109.0||||||
3662899|NCT02378220|3507947|B2||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3662900|NCT02378220|3507948|B1||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3662901|NCT02378220|3507946|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3662902|NCT02378220|3507947|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662903|NCT02378220|3507948|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3662904|NCT02378220|3507946|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662905|NCT02378220|3507947|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662906|NCT02378220|3507948|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662907|NCT02378220|3507946|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662908|NCT02378220|3507947|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662909|NCT02378220|3507948|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662910|NCT02378220|3507946|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662911|NCT02378220|3507947|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662912|NCT02378220|3507948|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662913|NCT02378220|3507946|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3662914|NCT02378220|3507947|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3662915|NCT02378220|3507948|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3662916|NCT02378220|3507946|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3662917|NCT02378220|3507947|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3662918|NCT02378220|3507948|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3662919|NCT02378220|3507946|B3|||Age|Baseline data was extracted from patient charts & manually entered into the study database.Study pharmacist reviewed DDIs, DGIs, and cumulative drug and/or gene interactions in the tested group using the YouScript generated reports and CDST to provide drug therapy recommendations to clinicians, after which prescriptions were altered at clinician discretion. Patients in the untested group were screened for DDIs using standard drug information resources (Lexicomp) with recommendations acted on according to clinician judgment. Time to change therapy was similar to those in the tested group.|years|Mean|75.6|75.6|Standard Deviation|10.7|10.7|||
3662920|NCT02378220|3507947|B2|||Age|Baseline data was extracted from patient charts & manually entered into the study database.Study pharmacist reviewed DDIs, DGIs, and cumulative drug and/or gene interactions in the tested group using the YouScript generated reports and CDST to provide drug therapy recommendations to clinicians, after which prescriptions were altered at clinician discretion. Patients in the untested group were screened for DDIs using standard drug information resources (Lexicomp) with recommendations acted on according to clinician judgment. Time to change therapy was similar to those in the tested group.|years|Mean|76.5|76.5|Standard Deviation|9.4|9.4|||
3662921|NCT02378220|3507948|B1|||Age|Baseline data was extracted from patient charts & manually entered into the study database.Study pharmacist reviewed DDIs, DGIs, and cumulative drug and/or gene interactions in the tested group using the YouScript generated reports and CDST to provide drug therapy recommendations to clinicians, after which prescriptions were altered at clinician discretion. Patients in the untested group were screened for DDIs using standard drug information resources (Lexicomp) with recommendations acted on according to clinician judgment. Time to change therapy was similar to those in the tested group.|years|Mean|74.6|74.6|Standard Deviation|11.9|11.9|||
3662922|NCT02378220|3507946|B3||>=65 years|Age||Participants|Count of Participants|90|90.0||||||
3662923|NCT02378220|3507947|B2||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
3662924|NCT02378220|3507948|B1||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
3662925|NCT02378220|3507946|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3662926|NCT02378220|3507947|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3662927|NCT02378220|3507948|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3662928|NCT02378220|3507946|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3662929|NCT02378220|3507947|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3662930|NCT02378220|3507948|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3662931|NCT02377921|3507979|B3|||Percent of Predicted Distance Walked in 6MWT|The total distance walked (meters) in a 6-minute period was measured, and the percent predicted distance based on normative data for age and gender was estimated. Predicted Six-Minute Walk Test Distance (meters) = 868.8 - (2.99 x Age) – (74.7 x Sex), where Age is baseline age in years, and Sex = 0 for males, and 1 for females.|percentage of predicted meters|Mean|49.92|49.92|Standard Deviation|15.097|15.097|||
3662932|NCT02377921|3507980|B2|||Percent of Predicted Distance Walked in 6MWT|The total distance walked (meters) in a 6-minute period was measured, and the percent predicted distance based on normative data for age and gender was estimated. Predicted Six-Minute Walk Test Distance (meters) = 868.8 - (2.99 x Age) – (74.7 x Sex), where Age is baseline age in years, and Sex = 0 for males, and 1 for females.|percentage of predicted meters|Mean|49.87|49.87|Standard Deviation|14.823|14.823|||
3663003|NCT02377466|3508004|B3|Asian-East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3662933|NCT02377921|3507981|B1|||Percent of Predicted Distance Walked in 6MWT|The total distance walked (meters) in a 6-minute period was measured, and the percent predicted distance based on normative data for age and gender was estimated. Predicted Six-Minute Walk Test Distance (meters) = 868.8 - (2.99 x Age) – (74.7 x Sex), where Age is baseline age in years, and Sex = 0 for males, and 1 for females.|percentage of predicted meters|Mean|49.97|49.97|Standard Deviation|15.521|15.521|||
3662934|NCT02377921|3507979|B3|||Distance Walked in 6-Minute Walk Test (6MWT)|The total distance walked (meters) in a 6-minute period was measured.|meters|Mean|364.2|364.2|Standard Deviation|111.95|111.95|||
3662935|NCT02377921|3507980|B2|||Distance Walked in 6-Minute Walk Test (6MWT)|The total distance walked (meters) in a 6-minute period was measured.|meters|Mean|361.2|361.2|Standard Deviation|109.87|109.87|||
3662936|NCT02377921|3507981|B1|||Distance Walked in 6-Minute Walk Test (6MWT)|The total distance walked (meters) in a 6-minute period was measured.|meters|Mean|367.0|367.0|Standard Deviation|115.07|115.07|||
3662937|NCT02377921|3507979|B3|||Lifts in Weighted Arm Lift Test|Upper extremity function was assessed using a weighted arm lift test performed bilaterally. The number of times the subject can raise a 1 kg weight above the head in a 30-second period was recorded.|arm lifts|Mean|29.33|29.33|Standard Deviation|10.137|10.137|||
3662938|NCT02377921|3507980|B2|||Lifts in Weighted Arm Lift Test|Upper extremity function was assessed using a weighted arm lift test performed bilaterally. The number of times the subject can raise a 1 kg weight above the head in a 30-second period was recorded.|arm lifts|Mean|28.18|28.18|Standard Deviation|9.824|9.824|||
3662939|NCT02377921|3507981|B1|||Lifts in Weighted Arm Lift Test|Upper extremity function was assessed using a weighted arm lift test performed bilaterally. The number of times the subject can raise a 1 kg weight above the head in a 30-second period was recorded.|arm lifts|Mean|30.50|30.5|Standard Deviation|10.452|10.452|||
3662940|NCT02377921|3507979|B3|||Stands in Sit-to-Stand Test|Lower extremity function was assessed using a sit-to-stand test. The number of times the participant can rise from a seated to a standing position in a 30-second period was recorded.|stands|Mean|12.48|12.48|Standard Deviation|4.185|4.185|||
3662941|NCT02377921|3507980|B2|||Stands in Sit-to-Stand Test|Lower extremity function was assessed using a sit-to-stand test. The number of times the participant can rise from a seated to a standing position in a 30-second period was recorded.|stands|Mean|12.58|12.58|Standard Deviation|4.316|4.316|||
3662942|NCT02377921|3507981|B1|||Stands in Sit-to-Stand Test|Lower extremity function was assessed using a sit-to-stand test. The number of times the participant can rise from a seated to a standing position in a 30-second period was recorded.|stands|Mean|12.38|12.38|Standard Deviation|4.103|4.103|||
3662943|NCT02377921|3507979|B3|||Glucosamine (UDP-N-acetyl)-2-epimerase Myopathy Functional Activities Scale(GNEM-FAS) Mobility Score|Lower extremity use and function was assessed using the Mobility domain of the GNEM-FAS instrument a disease specific measure developed to assess the functional impact of changes in muscle strength on mobility (reflective of the lower extremities). This mobility score ranges from 0 to 40 with higher scores representing greater mobility.|units on a scale|Mean|26.31|26.31|Standard Deviation|6.990|6.99|||
3662944|NCT02377921|3507980|B2|||Glucosamine (UDP-N-acetyl)-2-epimerase Myopathy Functional Activities Scale(GNEM-FAS) Mobility Score|Lower extremity use and function was assessed using the Mobility domain of the GNEM-FAS instrument a disease specific measure developed to assess the functional impact of changes in muscle strength on mobility (reflective of the lower extremities). This mobility score ranges from 0 to 40 with higher scores representing greater mobility.|units on a scale|Mean|26.23|26.23|Standard Deviation|6.403|6.403|||
3662945|NCT02377921|3507981|B1|||Glucosamine (UDP-N-acetyl)-2-epimerase Myopathy Functional Activities Scale(GNEM-FAS) Mobility Score|Lower extremity use and function was assessed using the Mobility domain of the GNEM-FAS instrument a disease specific measure developed to assess the functional impact of changes in muscle strength on mobility (reflective of the lower extremities). This mobility score ranges from 0 to 40 with higher scores representing greater mobility.|units on a scale|Mean|26.38|26.38|Standard Deviation|7.581|7.581|||
3662946|NCT02377921|3507979|B3|||Lower Extremity Composite (LEC) Score|Muscle strength based on MVIC against a dynamometer was measured bilaterally in the following lower extremity muscle groups: knee flexors, hip flexors, hip extensors, hip abductors and hip adductors. The LEC is derived from the sum of the average of the right and left total force values (measured in kg).|kg|Mean|54.33|54.33|Standard Deviation|36.378|36.378|||
3662947|NCT02377921|3507980|B2|||Lower Extremity Composite (LEC) Score|Muscle strength based on MVIC against a dynamometer was measured bilaterally in the following lower extremity muscle groups: knee flexors, hip flexors, hip extensors, hip abductors and hip adductors. The LEC is derived from the sum of the average of the right and left total force values (measured in kg).|kg|Mean|55.17|55.17|Standard Deviation|39.324|39.324|||
3662948|NCT02377921|3507981|B1|||Lower Extremity Composite (LEC) Score|Muscle strength based on MVIC against a dynamometer was measured bilaterally in the following lower extremity muscle groups: knee flexors, hip flexors, hip extensors, hip abductors and hip adductors. The LEC is derived from the sum of the average of the right and left total force values (measured in kg).|kg|Mean|53.52|53.52|Standard Deviation|33.751|33.751|||
3662949|NCT02377921|3507979|B3|||Muscle Strength in the Knee Extensors|Lower extremity muscle strength in the knee extensors was measured by dynamometry. Bilateral total force was defined as the average of the right and left force values (measured in kg).|kg|Mean|26.59|26.59|Standard Deviation|8.951|8.951|||
3662950|NCT02377921|3507980|B2|||Muscle Strength in the Knee Extensors|Lower extremity muscle strength in the knee extensors was measured by dynamometry. Bilateral total force was defined as the average of the right and left force values (measured in kg).|kg|Mean|26.65|26.65|Standard Deviation|8.969|8.969|||
3662951|NCT02377921|3507981|B1|||Muscle Strength in the Knee Extensors|Lower extremity muscle strength in the knee extensors was measured by dynamometry. Bilateral total force was defined as the average of the right and left force values (measured in kg).|kg|Mean|26.53|26.53|Standard Deviation|9.035|9.035|||
3662952|NCT02377921|3507979|B3|||Upper Extremity Composite (UEC) Score|Muscle strength based on the maximum voluntary isometric contraction (MVIC) against a dynamometer was measured bilaterally in the following upper extremity muscle groups: gross grip, shoulder abductors, elbow flexors, and elbow extensors. The UEC is derived from the sum of the average of the right and left total force values (measured in kg).|kg|Mean|56.14|56.14|Standard Deviation|27.954|27.954|||
3662953|NCT02377921|3507980|B2|||Upper Extremity Composite (UEC) Score|Muscle strength based on the maximum voluntary isometric contraction (MVIC) against a dynamometer was measured bilaterally in the following upper extremity muscle groups: gross grip, shoulder abductors, elbow flexors, and elbow extensors. The UEC is derived from the sum of the average of the right and left total force values (measured in kg).|kg|Mean|56.31|56.31|Standard Deviation|29.287|29.287|||
3662954|NCT02377921|3507981|B1|||Upper Extremity Composite (UEC) Score|Muscle strength based on the maximum voluntary isometric contraction (MVIC) against a dynamometer was measured bilaterally in the following upper extremity muscle groups: gross grip, shoulder abductors, elbow flexors, and elbow extensors. The UEC is derived from the sum of the average of the right and left total force values (measured in kg).|kg|Mean|55.99|55.99|Standard Deviation|26.950|26.95|||
3662955|NCT02377921|3507979|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3662956|NCT02377921|3507980|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3662957|NCT02377921|3507981|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3662958|NCT02377921|3507979|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662959|NCT02377921|3507980|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662960|NCT02377921|3507981|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662961|NCT02377921|3507979|B3||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3662962|NCT02377921|3507980|B2||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3662963|NCT02377921|3507981|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3662964|NCT02377921|3507979|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662965|NCT02377921|3507980|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662966|NCT02377921|3507981|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662967|NCT02377921|3507979|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662968|NCT02377921|3507980|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662969|NCT02377921|3507981|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662970|NCT02377921|3507979|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3662971|NCT02377921|3507980|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3662972|NCT02377921|3507981|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3662973|NCT02377921|3507979|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662974|NCT02377921|3507980|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662975|NCT02377921|3507981|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3662976|NCT02377921|3507979|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3662977|NCT02377921|3507980|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3662978|NCT02377921|3507981|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3662979|NCT02377921|3507979|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3662980|NCT02377921|3507980|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3662981|NCT02377921|3507981|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3662982|NCT02377921|3507979|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3662983|NCT02377921|3507980|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3662984|NCT02377921|3507981|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3662985|NCT02377921|3507979|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3662986|NCT02377921|3507980|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3662987|NCT02377921|3507981|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3662988|NCT02377921|3507979|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3662989|NCT02377921|3507980|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3662990|NCT02377921|3507981|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3662991|NCT02377921|3507979|B3|||Age||years|Mean|35.0|35.0|Standard Deviation|8.29|8.29|||
3662992|NCT02377921|3507980|B2|||Age||years|Mean|36.2|36.2|Standard Deviation|8.59|8.59|||
3662993|NCT02377921|3507981|B1|||Age||years|Mean|33.8|33.8|Standard Deviation|7.91|7.91|||
3662994|NCT02377466|3508004|B3|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3662995|NCT02377466|3508005|B2|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3662996|NCT02377466|3508006|B1|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3662997|NCT02377466|3508004|B3|Asian-South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3662998|NCT02377466|3508005|B2|Asian-South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3662999|NCT02377466|3508006|B1|Asian-South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3663000|NCT02377466|3508004|B3|Asian-Japanese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3663001|NCT02377466|3508005|B2|Asian-Japanese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3663002|NCT02377466|3508006|B1|Asian-Japanese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3663004|NCT02377466|3508005|B2|Asian-East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3663005|NCT02377466|3508006|B1|Asian-East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3663006|NCT02377466|3508004|B3|Asian-Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3663007|NCT02377466|3508005|B2|Asian-Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3663008|NCT02377466|3508006|B1|Asian-Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3663009|NCT02377466|3508004|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3663010|NCT02377466|3508005|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3663011|NCT02377466|3508006|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3663012|NCT02377466|3508004|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3663013|NCT02377466|3508005|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3663014|NCT02377466|3508006|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3663015|NCT02377466|3508004|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3663016|NCT02377466|3508005|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3663017|NCT02377466|3508006|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3663018|NCT02377466|3508004|B3|||Age||Years|Mean|27.0|27.0|Standard Deviation|6.63|6.63|||
3663019|NCT02377466|3508005|B2|||Age||Years|Mean|27.7|27.7|Standard Deviation|6.73|6.73|||
3663020|NCT02377466|3508006|B1|||Age||Years|Mean|26.5|26.5|Standard Deviation|6.78|6.78|||
3663021|NCT02377427|3508123|B3||B or Af Am and White-White/Caucasian/European Her.|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3663022|NCT02377427|3508124|B2||B or Af Am and White-White/Caucasian/European Her.|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3663023|NCT02377427|3508125|B1||B or Af Am and White-White/Caucasian/European Her.|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3663024|NCT02377427|3508123|B3||White/Caucasian/European Her.|Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3663025|NCT02377427|3508124|B2||White/Caucasian/European Her.|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3663026|NCT02377427|3508125|B1||White/Caucasian/European Her.|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3663027|NCT02377427|3508123|B3||Black or African American (B or Af Am)|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3663028|NCT02377427|3508124|B2||Black or African American (B or Af Am)|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3663029|NCT02377427|3508125|B1||Black or African American (B or Af Am)|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3663030|NCT02377427|3508123|B3||Japanese Her.|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3663031|NCT02377427|3508124|B2||Japanese Her.|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3663032|NCT02377427|3508125|B1||Japanese Her.|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3663033|NCT02377427|3508123|B3||Central/South Asian Heritage (Her.)|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3663034|NCT02377427|3508124|B2||Central/South Asian Heritage (Her.)|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3663035|NCT02377427|3508125|B1||Central/South Asian Heritage (Her.)|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3663036|NCT02377427|3508123|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3663037|NCT02377427|3508124|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3663038|NCT02377427|3508125|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3663039|NCT02377427|3508123|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3663040|NCT02377427|3508124|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3663041|NCT02377427|3508125|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3663042|NCT02377427|3508123|B3|||Age||Years|Mean|8.6|8.6|Standard Deviation|1.89|1.89|||
3663043|NCT02377427|3508124|B2|||Age||Years|Mean|10.0|10.0|Standard Deviation|1.33|1.33|||
3663044|NCT02377427|3508125|B1|||Age||Years|Mean|8.0|8.0|Standard Deviation|1.79|1.79|||
3663045|NCT02376998|3508189|B1|Italy||Region of Enrollment||participants|Number|11|11.0||||||
3663046|NCT02376998|3508189|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3663047|NCT02376998|3508189|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3663048|NCT02376998|3508189|B1|||Age||years|Mean|36.9|36.9|Full Range|||18.0|53.0|
3663049|NCT02376933|3508193|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3663050|NCT02376933|3508193|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3663051|NCT02376933|3508193|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3663052|NCT02376933|3508193|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3663053|NCT02376933|3508193|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3663054|NCT02376933|3508193|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3663055|NCT02376530|3508200|B5|||Body Mass Index (BMI)||Kg/m^2|Mean|31.0|31.0|Standard Deviation|8.2|8.2|||
3663056|NCT02376530|3508201|B4|||Body Mass Index (BMI)||Kg/m^2|Mean|31.3|31.3|Standard Deviation|8.7|8.7|||
3663057|NCT02376530|3508202|B3|||Body Mass Index (BMI)||Kg/m^2|Mean|30.9|30.9|Standard Deviation|8.2|8.2|||
3663058|NCT02376530|3508203|B2|||Body Mass Index (BMI)||Kg/m^2|Mean|30.8|30.8|Standard Deviation|7.9|7.9|||
3663059|NCT02376530|3508204|B1|||Body Mass Index (BMI)||Kg/m^2|Mean|31.0|31.0|Standard Deviation|8.0|8.0|||
3663060|NCT02376530|3508200|B5|United States||Region of Enrollment||participants|Number|788|788.0||||||
3663061|NCT02376530|3508201|B4|United States||Region of Enrollment||participants|Number|197|197.0||||||
3663062|NCT02376530|3508202|B3|United States||Region of Enrollment||participants|Number|197|197.0||||||
3663063|NCT02376530|3508203|B2|United States||Region of Enrollment||participants|Number|198|198.0||||||
3663064|NCT02376530|3508204|B1|United States||Region of Enrollment||participants|Number|196|196.0||||||
3663065|NCT02376530|3508200|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3663066|NCT02376530|3508201|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3663067|NCT02376530|3508202|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3663068|NCT02376530|3508203|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3663069|NCT02376530|3508204|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3663070|NCT02376530|3508200|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3663071|NCT02376530|3508201|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3663072|NCT02376530|3508202|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3663073|NCT02376530|3508203|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3663074|NCT02376530|3508204|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3663075|NCT02376530|3508200|B5||White|Race (NIH/OMB)||Participants|Count of Participants|555|555.0||||||
3663076|NCT02376530|3508201|B4||White|Race (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
3663077|NCT02376530|3508202|B3||White|Race (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
3663078|NCT02376530|3508203|B2||White|Race (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
3663079|NCT02376530|3508204|B1||White|Race (NIH/OMB)||Participants|Count of Participants|135|135.0||||||
3663080|NCT02376530|3508200|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|169|169.0||||||
3663081|NCT02376530|3508201|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3663082|NCT02376530|3508202|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3663083|NCT02376530|3508203|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3663084|NCT02376530|3508204|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3663085|NCT02376530|3508200|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3663086|NCT02376530|3508201|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3663087|NCT02376530|3508202|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663088|NCT02376530|3508203|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3663089|NCT02376530|3508204|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663090|NCT02376530|3508200|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3663091|NCT02376530|3508201|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3663092|NCT02376530|3508202|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3663093|NCT02376530|3508203|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3663094|NCT02376530|3508204|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3663095|NCT02376530|3508200|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3663096|NCT02376530|3508201|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3663097|NCT02376530|3508202|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3663098|NCT02376530|3508203|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3663099|NCT02376530|3508204|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3663100|NCT02376530|3508200|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3663101|NCT02376530|3508201|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3663102|NCT02376530|3508202|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3663103|NCT02376530|3508203|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3663104|NCT02376530|3508204|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3663105|NCT02376530|3508200|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|746|746.0||||||
3663106|NCT02376530|3508201|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|185|185.0||||||
3663107|NCT02376530|3508202|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|188|188.0||||||
3663108|NCT02376530|3508203|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|185|185.0||||||
3663109|NCT02376530|3508204|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|188|188.0||||||
3663110|NCT02376530|3508200|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3663111|NCT02376530|3508201|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3663112|NCT02376530|3508202|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3663113|NCT02376530|3508203|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3663114|NCT02376530|3508204|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3663115|NCT02376530|3508200|B5||Male|Gender||Participants|Count of Participants|0|0.0||||||
3663116|NCT02376530|3508201|B4||Male|Gender||Participants|Count of Participants|0|0.0||||||
3663117|NCT02376530|3508202|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3663118|NCT02376530|3508203|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3663119|NCT02376530|3508204|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3663120|NCT02376530|3508200|B5||Female|Gender||Participants|Count of Participants|788|788.0||||||
3663121|NCT02376530|3508201|B4||Female|Gender||Participants|Count of Participants|197|197.0||||||
3663122|NCT02376530|3508202|B3||Female|Gender||Participants|Count of Participants|197|197.0||||||
3663123|NCT02376530|3508203|B2||Female|Gender||Participants|Count of Participants|198|198.0||||||
3663124|NCT02376530|3508204|B1||Female|Gender||Participants|Count of Participants|196|196.0||||||
3663125|NCT02376530|3508200|B5|||Age||years|Mean|42.4|42.4|Standard Deviation|8.4|8.4|||
3663126|NCT02376530|3508201|B4|||Age||years|Mean|41.6|41.6|Standard Deviation|7.8|7.8|||
3663127|NCT02376530|3508202|B3|||Age||years|Mean|42.4|42.4|Standard Deviation|8.2|8.2|||
3663128|NCT02376530|3508203|B2|||Age||years|Mean|42.5|42.5|Standard Deviation|8.8|8.8|||
3663129|NCT02376530|3508204|B1|||Age||years|Mean|43.1|43.1|Standard Deviation|8.6|8.6|||
3663130|NCT02376257|3508217|B4|||Digits backwards|The examiner reads a list of digits and asks that each digit be read backwards. After correct scores, longer lists of digits are then provided. The total number of correct trials is recorded with higher scores indicating better performance. Scores can range from 0 to 16.|Number of correct trials|Mean|9.6|9.6|Standard Deviation|2.8|2.8|||
3663131|NCT02376257|3508218|B3|||Digits backwards|The examiner reads a list of digits and asks that each digit be read backwards. After correct scores, longer lists of digits are then provided. The total number of correct trials is recorded with higher scores indicating better performance. Scores can range from 0 to 16.|Number of correct trials|Mean|11.3|11.3|Standard Deviation|2.5|2.5|||
3663132|NCT02376257|3508219|B2|||Digits backwards|The examiner reads a list of digits and asks that each digit be read backwards. After correct scores, longer lists of digits are then provided. The total number of correct trials is recorded with higher scores indicating better performance. Scores can range from 0 to 16.|Number of correct trials|Mean|9.5|9.5|Standard Deviation|2.5|2.5|||
3663133|NCT02376257|3508220|B1|||Digits backwards|The examiner reads a list of digits and asks that each digit be read backwards. After correct scores, longer lists of digits are then provided. The total number of correct trials is recorded with higher scores indicating better performance. Scores can range from 0 to 16.|Number of correct trials|Mean|8.3|8.3|Standard Deviation|2.7|2.7|||
3663134|NCT02376257|3508217|B4|||Immediate Memory measured by the Hopkins Verbal Learning Task|The Hopkins Verbal Learning Test (HVLT) consists of a 12-item word list, composed of four words from each of the three semantic categories. The patient’s free recall of the list is recorded. The same procedure is repeated for two more trials. The total recall score for the last trial was used as the baseline score and ranged from a minimum of zero to a maximum of 12 correct answers.|number of correctly recalled words|Mean|9.2|9.2|Standard Deviation|1.4|1.4|||
3663135|NCT02376257|3508218|B3|||Immediate Memory measured by the Hopkins Verbal Learning Task|The Hopkins Verbal Learning Test (HVLT) consists of a 12-item word list, composed of four words from each of the three semantic categories. The patient’s free recall of the list is recorded. The same procedure is repeated for two more trials. The total recall score for the last trial was used as the baseline score and ranged from a minimum of zero to a maximum of 12 correct answers.|number of correctly recalled words|Mean|9.6|9.6|Standard Deviation|1.7|1.7|||
3663136|NCT02376257|3508219|B2|||Immediate Memory measured by the Hopkins Verbal Learning Task|The Hopkins Verbal Learning Test (HVLT) consists of a 12-item word list, composed of four words from each of the three semantic categories. The patient’s free recall of the list is recorded. The same procedure is repeated for two more trials. The total recall score for the last trial was used as the baseline score and ranged from a minimum of zero to a maximum of 12 correct answers.|number of correctly recalled words|Mean|9.6|9.6|Standard Deviation|1.1|1.1|||
3663137|NCT02376257|3508220|B1|||Immediate Memory measured by the Hopkins Verbal Learning Task|The Hopkins Verbal Learning Test (HVLT) consists of a 12-item word list, composed of four words from each of the three semantic categories. The patient’s free recall of the list is recorded. The same procedure is repeated for two more trials. The total recall score for the last trial was used as the baseline score and ranged from a minimum of zero to a maximum of 12 correct answers.|number of correctly recalled words|Mean|8.5|8.5|Standard Deviation|1.3|1.3|||
3663138|NCT02376257|3508217|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3663139|NCT02376257|3508218|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3663140|NCT02376257|3508219|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663141|NCT02376257|3508220|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3663142|NCT02376257|3508217|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663143|NCT02376257|3508218|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663144|NCT02376257|3508219|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663145|NCT02376257|3508220|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663146|NCT02376257|3508217|B4||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3663147|NCT02376257|3508218|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3663148|NCT02376257|3508219|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3663149|NCT02376257|3508220|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3663150|NCT02376257|3508217|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3663151|NCT02376257|3508218|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3663152|NCT02376257|3508219|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3663153|NCT02376257|3508220|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3663154|NCT02376257|3508217|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663155|NCT02376257|3508218|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663156|NCT02376257|3508219|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663157|NCT02376257|3508220|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663158|NCT02376257|3508217|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3663159|NCT02376257|3508218|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3663160|NCT02376257|3508219|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3663161|NCT02376257|3508220|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3663162|NCT02376257|3508217|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663163|NCT02376257|3508218|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663164|NCT02376257|3508219|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663165|NCT02376257|3508220|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663166|NCT02376257|3508217|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663167|NCT02376257|3508218|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663168|NCT02376257|3508219|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663169|NCT02376257|3508220|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663170|NCT02376257|3508217|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3663171|NCT02376257|3508218|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3663172|NCT02376257|3508219|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3663173|NCT02376257|3508220|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3663174|NCT02376257|3508217|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3663175|NCT02376257|3508218|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3663176|NCT02376257|3508219|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663177|NCT02376257|3508220|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3663178|NCT02376257|3508217|B4|Transgender||Sex/Gender, Customized||Participants|Count of Participants|2|2.0||||||
3663179|NCT02376257|3508218|B3|Transgender||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3663180|NCT02376257|3508219|B2|Transgender||Sex/Gender, Customized||Participants|Count of Participants|1|1.0||||||
3663181|NCT02376257|3508220|B1|Transgender||Sex/Gender, Customized||Participants|Count of Participants|1|1.0||||||
3663182|NCT02376257|3508217|B4|Female||Sex/Gender, Customized||Participants|Count of Participants|20|20.0||||||
3663183|NCT02376257|3508218|B3|Female||Sex/Gender, Customized||Participants|Count of Participants|7|7.0||||||
3663184|NCT02376257|3508219|B2|Female||Sex/Gender, Customized||Participants|Count of Participants|6|6.0||||||
3663185|NCT02376257|3508220|B1|Female||Sex/Gender, Customized||Participants|Count of Participants|7|7.0||||||
3663186|NCT02376257|3508217|B4|Male||Sex/Gender, Customized||Participants|Count of Participants|14|14.0||||||
3663187|NCT02376257|3508218|B3|Male||Sex/Gender, Customized||Participants|Count of Participants|4|4.0||||||
3663188|NCT02376257|3508219|B2|Male||Sex/Gender, Customized||Participants|Count of Participants|5|5.0||||||
3663189|NCT02376257|3508220|B1|Male||Sex/Gender, Customized||Participants|Count of Participants|5|5.0||||||
3663190|NCT02376257|3508217|B4|||Age||years|Mean|29.9|29.9|Standard Deviation|11.7|11.7|||
3663191|NCT02376257|3508218|B3|||Age||years|Mean|27.7|27.7|Standard Deviation|10.8|10.8|||
3663192|NCT02376257|3508219|B2|||Age||years|Mean|26.4|26.4|Standard Deviation|8.1|8.1|||
3663193|NCT02376257|3508220|B1|||Age||years|Mean|34.9|34.9|Standard Deviation|14.0|14.0|||
3663194|NCT02376257|3508217|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3663195|NCT02376257|3508218|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3663196|NCT02376257|3508219|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3663197|NCT02376257|3508220|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3663198|NCT02376257|3508217|B4||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3663199|NCT02376257|3508218|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3663200|NCT02376257|3508219|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3663201|NCT02376257|3508220|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3663202|NCT02376257|3508217|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3663203|NCT02376257|3508218|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3663204|NCT02376257|3508219|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3663205|NCT02376257|3508220|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3663206|NCT02376166|3508251|B1|||One-way driving time to study center||minutes|Median|71|71.0|Full Range|||12.0|147.0|
3663207|NCT02376166|3508251|B1|||One-way driving distance to study center||miles|Median|63.2|63.2|Full Range|||2.4|146.0|
3663208|NCT02376166|3508251|B1|||Baseline PSA||ng/mL|Median|4.1|4.1|Full Range|||0.52|31.7|
3663209|NCT02376166|3508251|B1|||Years from local therapy to study enrollment||years|Median|5.9|5.9|Full Range|||1.2|16.0|
3663210|NCT02376166|3508251|B1|Radiation therapy||Primary Treatment||Participants|Count of Participants|3|3.0||||||
3663211|NCT02376166|3508251|B1|Radical prostatectomy||Primary Treatment||Participants|Count of Participants|12|12.0||||||
3663212|NCT02376166|3508251|B1|||Gleason Score|A system of grading prostate cancer tissue based on how it looks under a microscope. Gleason scores range from 2 to 10 and indicate how likely it is that a tumor will spread. A low Gleason score means the cancer tissue is similar to normal prostate tissue and the tumor is less likely to spread; a high Gleason score means the cancer tissue is very different from normal and the tumor is more likely to spread.|units on a scale|Median|7|7.0|Full Range|||6.0|9.0|
3663213|NCT02376166|3508251|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3663214|NCT02376166|3508251|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3663215|NCT02376166|3508251|B1|||Age||years|Median|68|68.0|Full Range|||57.0|83.0|
3663216|NCT02375971|3508276|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3663217|NCT02375971|3508277|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3663218|NCT02375971|3508278|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3663219|NCT02375971|3508279|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3663220|NCT02375971|3508276|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663221|NCT02375971|3508277|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663222|NCT02375971|3508278|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663223|NCT02375971|3508279|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663224|NCT02375971|3508276|B4||White|Race (NIH/OMB)||Participants|Count of Participants|133|133.0||||||
3663225|NCT02375971|3508277|B3||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3663226|NCT02375971|3508278|B2||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3663227|NCT02375971|3508279|B1||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3663228|NCT02375971|3508276|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3663229|NCT02375971|3508277|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3663230|NCT02375971|3508278|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3663231|NCT02375971|3508279|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663232|NCT02375971|3508276|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663233|NCT02375971|3508277|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663234|NCT02375971|3508278|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663235|NCT02375971|3508279|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663236|NCT02375971|3508276|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3663237|NCT02375971|3508277|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3663238|NCT02375971|3508278|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3663239|NCT02375971|3508279|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3663240|NCT02375971|3508276|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663241|NCT02375971|3508277|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663242|NCT02375971|3508278|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663243|NCT02375971|3508279|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663244|NCT02375971|3508276|B4||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3663245|NCT02375971|3508277|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3663246|NCT02375971|3508278|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3663247|NCT02375971|3508279|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3663248|NCT02375971|3508276|B4||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3663249|NCT02375971|3508277|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3663250|NCT02375971|3508278|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3663251|NCT02375971|3508279|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3663252|NCT02375971|3508276|B4|||Age|Gestational age at birth (weeks)|Weeks|Mean|26.1|26.1|Standard Deviation|2.48|2.48|||
3663253|NCT02375971|3508277|B3|||Age|Gestational age at birth (weeks)|Weeks|Mean|26.2|26.2|Standard Deviation|2.59|2.59|||
3663254|NCT02375971|3508278|B2|||Age|Gestational age at birth (weeks)|Weeks|Mean|26.5|26.5|Standard Deviation|2.57|2.57|||
3663255|NCT02375971|3508279|B1|||Age|Gestational age at birth (weeks)|Weeks|Mean|25.8|25.8|Standard Deviation|2.25|2.25|||
3663256|NCT02375724|3508321|B3||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3663257|NCT02375724|3508322|B2||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3663258|NCT02375724|3508323|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3663259|NCT02375724|3508321|B3||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3663260|NCT02375724|3508322|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3663261|NCT02375724|3508323|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3663262|NCT02375724|3508321|B3|||Age||Years|Mean|62.0|62.0|Standard Deviation|8.7|8.7|||
3663265|NCT02375373|3508334|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3663266|NCT02375373|3508334|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3663267|NCT02375373|3508334|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3663268|NCT02375373|3508334|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3663269|NCT02375373|3508334|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3663270|NCT02375373|3508334|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3663271|NCT02375347|3508338|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3663272|NCT02375347|3508338|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3663273|NCT02375347|3508338|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663274|NCT02375347|3508338|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3663275|NCT02375347|3508338|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3663276|NCT02375347|3508338|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663277|NCT02375347|3508338|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3663278|NCT02375347|3508338|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663279|NCT02375347|3508338|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3663280|NCT02375347|3508338|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3663281|NCT02375347|3508338|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3663282|NCT02375347|3508338|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3663283|NCT02375347|3508338|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3663284|NCT02374957|3508342|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663285|NCT02374957|3508343|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663286|NCT02374957|3508344|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663287|NCT02374957|3508342|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663288|NCT02374957|3508343|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663289|NCT02374957|3508344|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663290|NCT02374957|3508342|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3663291|NCT02374957|3508343|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3663292|NCT02374957|3508344|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3663293|NCT02374957|3508342|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3663294|NCT02374957|3508343|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3663295|NCT02374957|3508344|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3663296|NCT02374957|3508342|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663297|NCT02374957|3508343|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663298|NCT02374957|3508344|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663299|NCT02374957|3508342|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3663300|NCT02374957|3508343|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3663301|NCT02374957|3508344|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663302|NCT02374957|3508342|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663303|NCT02374957|3508343|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663304|NCT02374957|3508344|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663305|NCT02374957|3508342|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3663306|NCT02374957|3508343|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3663307|NCT02374957|3508344|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3663308|NCT02374957|3508342|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3663309|NCT02374957|3508343|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3663310|NCT02374957|3508344|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3663311|NCT02374957|3508342|B3|||Age||years|Mean|63.37|63.37|Full Range|||43.0|82.0|
3663312|NCT02374957|3508343|B2|||Age||years|Mean|63.11|63.11|Full Range|||43.0|73.0|
3663313|NCT02374957|3508344|B1|||Age||years|Mean|63.60|63.6|Full Range|||52.0|82.0|
3663314|NCT02374957|3508342|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3663315|NCT02374957|3508343|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3663316|NCT02374957|3508344|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3663317|NCT02374957|3508342|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3663318|NCT02374957|3508343|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3663319|NCT02374957|3508344|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3663320|NCT02374957|3508342|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3663321|NCT02374957|3508343|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3663322|NCT02374957|3508344|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3663323|NCT02374593|3508371|B3|United States||Region of Enrollment||participants|Number|66|66.0||||||
3663324|NCT02374593|3508372|B2|United States||Region of Enrollment||participants|Number|44|44.0||||||
3663325|NCT02374593|3508373|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3663326|NCT02374593|3508371|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3663327|NCT02374593|3508372|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3663328|NCT02374593|3508373|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3663329|NCT02374593|3508371|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3663330|NCT02374593|3508372|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3663331|NCT02374593|3508373|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3663332|NCT02374593|3508371|B3|||Age||weeks|Mean|1|1.0|Full Range|||0.0|2.0|
3663333|NCT02374593|3508372|B2|||Age||weeks|Mean|1|1.0|Full Range|||0.0|2.0|
3663334|NCT02374593|3508373|B1|||Age||weeks|Mean|1|1.0|Full Range|||0.0|2.0|
3663335|NCT02374398|3508384|B5|United States||Region of Enrollment||participants|Number|121|121.0||||||
3663336|NCT02374398|3508385|B4|United States||Region of Enrollment||participants|Number|32|32.0||||||
3663337|NCT02374398|3508386|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
3663338|NCT02374398|3508387|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
3663339|NCT02374398|3508388|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3663340|NCT02374398|3508384|B5||Male|Gender||Participants|Count of Participants|55|55.0||||||
3663341|NCT02374398|3508385|B4||Male|Gender||Participants|Count of Participants|14|14.0||||||
3663342|NCT02374398|3508386|B3||Male|Gender||Participants|Count of Participants|13|13.0||||||
3663343|NCT02374398|3508387|B2||Male|Gender||Participants|Count of Participants|14|14.0||||||
3663344|NCT02374398|3508388|B1||Male|Gender||Participants|Count of Participants|14|14.0||||||
3663345|NCT02374398|3508384|B5||Female|Gender||Participants|Count of Participants|66|66.0||||||
3663346|NCT02374398|3508385|B4||Female|Gender||Participants|Count of Participants|18|18.0||||||
3663347|NCT02374398|3508386|B3||Female|Gender||Participants|Count of Participants|16|16.0||||||
3663348|NCT02374398|3508387|B2||Female|Gender||Participants|Count of Participants|17|17.0||||||
3663349|NCT02374398|3508388|B1||Female|Gender||Participants|Count of Participants|15|15.0||||||
3663350|NCT02374398|3508384|B5|||Age||years|Mean|63.6|63.6|Standard Deviation|8.9|8.9|||
3663351|NCT02374398|3508385|B4|||Age||years|Mean|62.9|62.9|Standard Deviation|8.4|8.4|||
3663352|NCT02374398|3508386|B3|||Age||years|Mean|61.1|61.1|Standard Deviation|10.5|10.5|||
3663353|NCT02374398|3508387|B2|||Age||years|Mean|64.8|64.8|Standard Deviation|8.0|8.0|||
3663354|NCT02374398|3508388|B1|||Age||years|Mean|65.7|65.7|Standard Deviation|8.6|8.6|||
3663355|NCT02374346|3508417|B1|Greece||Region of Enrollment||participants|Number|446|446.0||||||
3663356|NCT02374346|3508417|B1||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3663357|NCT02374346|3508417|B1||Female|Sex: Female, Male||Participants|Count of Participants|321|321.0||||||
3663358|NCT02374346|3508417|B1|||Age||years|Mean|42.8|42.8|Full Range|||19.0|87.0|
3663359|NCT02374346|3508417|B1||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
3663360|NCT02374346|3508417|B1||Between 18 and 65 years|Age||Participants|Count of Participants|396|396.0||||||
3663361|NCT02374346|3508417|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3663362|NCT02374164|3508423|B4|Check-in||Estimated Glomerular Filtration Rate (eGFR)|eGFR is calculated using the Cockcroft-Gault formula.|mL/min|Mean|133.36|133.36|Standard Deviation|19.509|19.509|||
3663363|NCT02374164|3508424|B3|Check-in||Estimated Glomerular Filtration Rate (eGFR)|eGFR is calculated using the Cockcroft-Gault formula.|mL/min|Mean|135.95|135.95|Standard Deviation|19.147|19.147|||
3663364|NCT02374164|3508425|B2|Check-in||Estimated Glomerular Filtration Rate (eGFR)|eGFR is calculated using the Cockcroft-Gault formula.|mL/min|Mean|132.71|132.71|Standard Deviation|13.999|13.999|||
3663365|NCT02374164|3508426|B1|Check-in||Estimated Glomerular Filtration Rate (eGFR)|eGFR is calculated using the Cockcroft-Gault formula.|mL/min|Mean|131.43|131.43|Standard Deviation|25.231|25.231|||
3663366|NCT02374164|3508423|B4|Screening||Estimated Glomerular Filtration Rate (eGFR)|eGFR is calculated using the Cockcroft-Gault formula.|mL/min|Mean|124.88|124.88|Standard Deviation|16.920|16.92|||
3663367|NCT02374164|3508424|B3|Screening||Estimated Glomerular Filtration Rate (eGFR)|eGFR is calculated using the Cockcroft-Gault formula.|mL/min|Mean|125.87|125.87|Standard Deviation|15.280|15.28|||
3663368|NCT02374164|3508425|B2|Screening||Estimated Glomerular Filtration Rate (eGFR)|eGFR is calculated using the Cockcroft-Gault formula.|mL/min|Mean|125.41|125.41|Standard Deviation|13.025|13.025|||
3663369|NCT02374164|3508426|B1|Screening||Estimated Glomerular Filtration Rate (eGFR)|eGFR is calculated using the Cockcroft-Gault formula.|mL/min|Mean|123.38|123.38|Standard Deviation|22.449|22.449|||
3663370|NCT02374164|3508423|B4|No||Xanthine/Caffeine Consumption||participants|Number|14|14.0||||||
3663371|NCT02374164|3508424|B3|No||Xanthine/Caffeine Consumption||participants|Number|5|5.0||||||
3663372|NCT02374164|3508425|B2|No||Xanthine/Caffeine Consumption||participants|Number|5|5.0||||||
3663373|NCT02374164|3508426|B1|No||Xanthine/Caffeine Consumption||participants|Number|4|4.0||||||
3663374|NCT02374164|3508423|B4|Yes||Xanthine/Caffeine Consumption||participants|Number|22|22.0||||||
3663375|NCT02374164|3508424|B3|Yes||Xanthine/Caffeine Consumption||participants|Number|7|7.0||||||
3663376|NCT02374164|3508425|B2|Yes||Xanthine/Caffeine Consumption||participants|Number|7|7.0||||||
3663377|NCT02374164|3508426|B1|Yes||Xanthine/Caffeine Consumption||participants|Number|8|8.0||||||
3663378|NCT02374164|3508423|B4|Is an Ex-Drinker||Alcohol Classification||participants|Number|6|6.0||||||
3663379|NCT02374164|3508424|B3|Is an Ex-Drinker||Alcohol Classification||participants|Number|2|2.0||||||
3663380|NCT02374164|3508425|B2|Is an Ex-Drinker||Alcohol Classification||participants|Number|2|2.0||||||
3663381|NCT02374164|3508426|B1|Is an Ex-Drinker||Alcohol Classification||participants|Number|2|2.0||||||
3663382|NCT02374164|3508423|B4|Is a Current Drinker||Alcohol Classification||participants|Number|18|18.0||||||
3663383|NCT02374164|3508424|B3|Is a Current Drinker||Alcohol Classification||participants|Number|6|6.0||||||
3663384|NCT02374164|3508425|B2|Is a Current Drinker||Alcohol Classification||participants|Number|5|5.0||||||
3663385|NCT02374164|3508426|B1|Is a Current Drinker||Alcohol Classification||participants|Number|7|7.0||||||
3663386|NCT02374164|3508423|B4|Has Never Drunk||Alcohol Classification||participants|Number|12|12.0||||||
3663387|NCT02374164|3508424|B3|Has Never Drunk||Alcohol Classification||participants|Number|4|4.0||||||
3663388|NCT02374164|3508425|B2|Has Never Drunk||Alcohol Classification||participants|Number|5|5.0||||||
3663389|NCT02374164|3508426|B1|Has Never Drunk||Alcohol Classification||participants|Number|3|3.0||||||
3663390|NCT02374164|3508423|B4|Is an Ex-Smoker||Smoking Classification||participants|Number|6|6.0||||||
3663391|NCT02374164|3508424|B3|Is an Ex-Smoker||Smoking Classification||participants|Number|2|2.0||||||
3663392|NCT02374164|3508425|B2|Is an Ex-Smoker||Smoking Classification||participants|Number|0|0.0||||||
3663393|NCT02374164|3508426|B1|Is an Ex-Smoker||Smoking Classification||participants|Number|4|4.0||||||
3663394|NCT02374164|3508423|B4|Is a Current Smoker||Smoking Classification||participants|Number|0|0.0||||||
3663395|NCT02374164|3508424|B3|Is a Current Smoker||Smoking Classification||participants|Number|0|0.0||||||
3663396|NCT02374164|3508425|B2|Is a Current Smoker||Smoking Classification||participants|Number|0|0.0||||||
3663397|NCT02374164|3508426|B1|Is a Current Smoker||Smoking Classification||participants|Number|0|0.0||||||
3663398|NCT02374164|3508423|B4|Has Never Smoked||Smoking Classification||participants|Number|30|30.0||||||
3663399|NCT02374164|3508424|B3|Has Never Smoked||Smoking Classification||participants|Number|10|10.0||||||
3663400|NCT02374164|3508425|B2|Has Never Smoked||Smoking Classification||participants|Number|12|12.0||||||
3663401|NCT02374164|3508426|B1|Has Never Smoked||Smoking Classification||participants|Number|8|8.0||||||
3663402|NCT02374164|3508423|B4|Surgically Sterile||Female Reproductive Status||participants|Number|4|4.0||||||
3663403|NCT02374164|3508424|B3|Surgically Sterile||Female Reproductive Status||participants|Number|0|0.0||||||
3663404|NCT02374164|3508425|B2|Surgically Sterile||Female Reproductive Status||participants|Number|3|3.0||||||
3663405|NCT02374164|3508426|B1|Surgically Sterile||Female Reproductive Status||participants|Number|1|1.0||||||
3663406|NCT02374164|3508423|B4|Female of Childbearing Potential||Female Reproductive Status||participants|Number|15|15.0||||||
3663407|NCT02374164|3508424|B3|Female of Childbearing Potential||Female Reproductive Status||participants|Number|7|7.0||||||
3663408|NCT02374164|3508425|B2|Female of Childbearing Potential||Female Reproductive Status||participants|Number|3|3.0||||||
3663409|NCT02374164|3508426|B1|Female of Childbearing Potential||Female Reproductive Status||participants|Number|5|5.0||||||
3663410|NCT02374164|3508423|B4|N/A (Participant is Male)||Female Reproductive Status||participants|Number|17|17.0||||||
3663411|NCT02374164|3508424|B3|N/A (Participant is Male)||Female Reproductive Status||participants|Number|5|5.0||||||
3663412|NCT02374164|3508425|B2|N/A (Participant is Male)||Female Reproductive Status||participants|Number|6|6.0||||||
3663413|NCT02374164|3508426|B1|N/A (Participant is Male)||Female Reproductive Status||participants|Number|6|6.0||||||
3663414|NCT02374164|3508423|B4|||Body Mass Index (BMI)||kg/m^2|Mean|25.67|25.67|Standard Deviation|2.376|2.376|||
3663415|NCT02374164|3508424|B3|||Body Mass Index (BMI)||kg/m^2|Mean|25.03|25.03|Standard Deviation|2.878|2.878|||
3663416|NCT02374164|3508425|B2|||Body Mass Index (BMI)||kg/m^2|Mean|25.76|25.76|Standard Deviation|2.321|2.321|||
3663417|NCT02374164|3508426|B1|||Body Mass Index (BMI)||kg/m^2|Mean|26.21|26.21|Standard Deviation|1.880|1.88|||
3663418|NCT02374164|3508423|B4|||Weight||kg|Mean|72.13|72.13|Standard Deviation|9.335|9.335|||
3663419|NCT02374164|3508424|B3|||Weight||kg|Mean|69.10|69.1|Standard Deviation|8.169|8.169|||
3663420|NCT02374164|3508425|B2|||Weight||kg|Mean|73.35|73.35|Standard Deviation|8.867|8.867|||
3663421|NCT02374164|3508426|B1|||Weight||kg|Mean|73.95|73.95|Standard Deviation|10.802|10.802|||
3663422|NCT02374164|3508423|B4|||Height||cm|Mean|167.6|167.6|Standard Deviation|10.08|10.08|||
3663423|NCT02374164|3508424|B3|||Height||cm|Mean|166.6|166.6|Standard Deviation|12.35|12.35|||
3663424|NCT02374164|3508425|B2|||Height||cm|Mean|168.8|168.8|Standard Deviation|9.98|9.98|||
3663425|NCT02374164|3508426|B1|||Height||cm|Mean|167.6|167.6|Standard Deviation|8.27|8.27|||
3663426|NCT02374164|3508423|B4|United States||Region of Enrollment||participants|Number|36|36.0||||||
3663427|NCT02374164|3508424|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3663428|NCT02374164|3508425|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3663429|NCT02374164|3508426|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3663430|NCT02374164|3508423|B4|White||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3663431|NCT02374164|3508424|B3|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3663432|NCT02374164|3508425|B2|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3663433|NCT02374164|3508426|B1|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3663434|NCT02374164|3508423|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3663435|NCT02374164|3508424|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3663436|NCT02374164|3508425|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3663437|NCT02374164|3508426|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3663438|NCT02374164|3508423|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3663439|NCT02374164|3508424|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3663440|NCT02374164|3508425|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3663441|NCT02374164|3508426|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3663442|NCT02374164|3508423|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3663443|NCT02374164|3508424|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3663444|NCT02374164|3508425|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3663445|NCT02374164|3508426|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3663446|NCT02374164|3508423|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3663447|NCT02374164|3508424|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3663448|NCT02374164|3508425|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3663449|NCT02374164|3508426|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3663450|NCT02374164|3508423|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3663451|NCT02374164|3508424|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3663452|NCT02374164|3508425|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3663453|NCT02374164|3508426|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3663454|NCT02374164|3508423|B4|||Age||years|Mean|31.8|31.8|Standard Deviation|7.05|7.05|||
3663455|NCT02374164|3508424|B3|||Age||years|Mean|29.1|29.1|Standard Deviation|5.35|5.35|||
3663456|NCT02374164|3508425|B2|||Age||years|Mean|35.0|35.0|Standard Deviation|6.32|6.32|||
3663457|NCT02374164|3508426|B1|||Age||years|Mean|31.3|31.3|Standard Deviation|8.37|8.37|||
3663458|NCT02374099|3508445|B3|||Duration of Prior Hormonal Anti-Cancer Therapy||Months|Mean|33.64|33.64|Standard Deviation|22.097|22.097|||
3663459|NCT02374099|3508446|B2|||Duration of Prior Hormonal Anti-Cancer Therapy||Months|Mean|35.84|35.84|Standard Deviation|27.409|27.409|||
3663460|NCT02374099|3508447|B1|||Duration of Prior Hormonal Anti-Cancer Therapy||Months|Mean|31.39|31.39|Standard Deviation|14.830|14.83|||
3663461|NCT02374099|3508445|B3|||Time from Primary Diagnosis of Breast Cancer to Study Randomization||months|Mean|107.19|107.19|Standard Deviation|74.037|74.037|||
3663462|NCT02374099|3508446|B2|||Time from Primary Diagnosis of Breast Cancer to Study Randomization||months|Mean|95.57|95.57|Standard Deviation|76.434|76.434|||
3663463|NCT02374099|3508447|B1|||Time from Primary Diagnosis of Breast Cancer to Study Randomization||months|Mean|119.05|119.05|Standard Deviation|70.322|70.322|||
3663464|NCT02374099|3508445|B3|Missing||Histology of Primary Diagnosis||Participants|Number|3|3.0||||||
3663465|NCT02374099|3508446|B2|Missing||Histology of Primary Diagnosis||Participants|Number|1|1.0||||||
3663466|NCT02374099|3508447|B1|Missing||Histology of Primary Diagnosis||Participants|Number|2|2.0||||||
3663467|NCT02374099|3508445|B3|Other, Not specified||Histology of Primary Diagnosis||Participants|Number|6|6.0||||||
3663468|NCT02374099|3508446|B2|Other, Not specified||Histology of Primary Diagnosis||Participants|Number|2|2.0||||||
3663469|NCT02374099|3508447|B1|Other, Not specified||Histology of Primary Diagnosis||Participants|Number|4|4.0||||||
3663470|NCT02374099|3508445|B3|Lobular Carcinoma||Histology of Primary Diagnosis||Participants|Number|19|19.0||||||
3663471|NCT02374099|3508446|B2|Lobular Carcinoma||Histology of Primary Diagnosis||Participants|Number|12|12.0||||||
3663472|NCT02374099|3508447|B1|Lobular Carcinoma||Histology of Primary Diagnosis||Participants|Number|7|7.0||||||
3663473|NCT02374099|3508445|B3|Ductal (Scirrhous Carcinoma)||Histology of Primary Diagnosis||Participants|Number|75|75.0||||||
3663474|NCT02374099|3508446|B2|Ductal (Scirrhous Carcinoma)||Histology of Primary Diagnosis||Participants|Number|38|38.0||||||
3663475|NCT02374099|3508447|B1|Ductal (Scirrhous Carcinoma)||Histology of Primary Diagnosis||Participants|Number|37|37.0||||||
3663476|NCT02374099|3508445|B3||3 = Limited Self Care|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|0|0.0||||||
3663477|NCT02374099|3508446|B2||3 = Limited Self Care|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|0|0.0||||||
3663478|NCT02374099|3508447|B1||3 = Limited Self Care|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|0|0.0||||||
3663479|NCT02374099|3508445|B3||2 = = Ambulatory but unable to work|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|0|0.0||||||
3663509|NCT02374099|3508445|B3||From 65-84 years|Age, Customized||Participants|Count of Participants|43|43.0||||||
3663510|NCT02374099|3508446|B2||From 65-84 years|Age, Customized||Participants|Count of Participants|24|24.0||||||
3663511|NCT02374099|3508447|B1||From 65-84 years|Age, Customized||Participants|Count of Participants|19|19.0||||||
3663480|NCT02374099|3508446|B2||2 = = Ambulatory but unable to work|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|0|0.0||||||
3663481|NCT02374099|3508447|B1||2 = = Ambulatory but unable to work|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|0|0.0||||||
3663482|NCT02374099|3508445|B3||1 = Restrictive but ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|40|40.0||||||
3663483|NCT02374099|3508446|B2||1 = Restrictive but ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|28|28.0||||||
3663484|NCT02374099|3508447|B1||1 = Restrictive but ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|12|12.0||||||
3663485|NCT02374099|3508445|B3||0 = Fully Active|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|57|57.0||||||
3663486|NCT02374099|3508446|B2||0 = Fully Active|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|21|21.0||||||
3663487|NCT02374099|3508447|B1||0 = Fully Active|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|36|36.0||||||
3663488|NCT02374099|3508445|B3||Not Collected or Reported|Race||Participants|Count of Participants|22|22.0||||||
3663489|NCT02374099|3508446|B2||Not Collected or Reported|Race||Participants|Count of Participants|9|9.0||||||
3663490|NCT02374099|3508447|B1||Not Collected or Reported|Race||Participants|Count of Participants|13|13.0||||||
3663491|NCT02374099|3508445|B3||American Indian/Alaska Native|Race||Participants|Count of Participants|1|1.0||||||
3663492|NCT02374099|3508446|B2||American Indian/Alaska Native|Race||Participants|Count of Participants|0|0.0||||||
3663493|NCT02374099|3508447|B1||American Indian/Alaska Native|Race||Participants|Count of Participants|1|1.0||||||
3663494|NCT02374099|3508445|B3||Asian|Race||Participants|Count of Participants|1|1.0||||||
3663495|NCT02374099|3508446|B2||Asian|Race||Participants|Count of Participants|1|1.0||||||
3663496|NCT02374099|3508447|B1||Asian|Race||Participants|Count of Participants|0|0.0||||||
3663497|NCT02374099|3508445|B3||White|Race||Participants|Count of Participants|73|73.0||||||
3663498|NCT02374099|3508446|B2||White|Race||Participants|Count of Participants|39|39.0||||||
3663499|NCT02374099|3508447|B1||White|Race||Participants|Count of Participants|34|34.0||||||
3663500|NCT02374099|3508445|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3663501|NCT02374099|3508446|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3663502|NCT02374099|3508447|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3663503|NCT02374099|3508445|B3||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3663504|NCT02374099|3508446|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3663505|NCT02374099|3508447|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3663506|NCT02374099|3508445|B3||85 years and over|Age, Customized||Participants|Count of Participants|0|0.0||||||
3663507|NCT02374099|3508446|B2||85 years and over|Age, Customized||Participants|Count of Participants|0|0.0||||||
3663508|NCT02374099|3508447|B1||85 years and over|Age, Customized||Participants|Count of Participants|0|0.0||||||
3663512|NCT02374099|3508445|B3||Adults (18-64 years)|Age, Customized||Participants|Count of Participants|54|54.0||||||
3663513|NCT02374099|3508446|B2||Adults (18-64 years)|Age, Customized||Participants|Count of Participants|25|25.0||||||
3663514|NCT02374099|3508447|B1||Adults (18-64 years)|Age, Customized||Participants|Count of Participants|29|29.0||||||
3663515|NCT02374099|3508445|B3||Adolescents (12-17 years)|Age, Customized||Participants|Count of Participants|0|0.0||||||
3663516|NCT02374099|3508446|B2||Adolescents (12-17 years)|Age, Customized||Participants|Count of Participants|0|0.0||||||
3663517|NCT02374099|3508447|B1||Adolescents (12-17 years)|Age, Customized||Participants|Count of Participants|0|0.0||||||
3663518|NCT02374099|3508445|B3||Children (2-11 years)|Age, Customized||Participants|Count of Participants|0|0.0||||||
3663519|NCT02374099|3508446|B2||Children (2-11 years)|Age, Customized||Participants|Count of Participants|0|0.0||||||
3663520|NCT02374099|3508447|B1||Children (2-11 years)|Age, Customized||Participants|Count of Participants|0|0.0||||||
3663521|NCT02374099|3508445|B3||Infants and toddlers (28 days-23 months)|Age, Customized||Participants|Count of Participants|0|0.0||||||
3663522|NCT02374099|3508446|B2||Infants and toddlers (28 days-23 months)|Age, Customized||Participants|Count of Participants|0|0.0||||||
3663523|NCT02374099|3508447|B1||Infants and toddlers (28 days-23 months)|Age, Customized||Participants|Count of Participants|0|0.0||||||
3663524|NCT02374099|3508445|B3||Newborns (0-27 days)|Age, Customized||Participants|Count of Participants|0|0.0||||||
3663525|NCT02374099|3508446|B2||Newborns (0-27 days)|Age, Customized||Participants|Count of Participants|0|0.0||||||
3663526|NCT02374099|3508447|B1||Newborns (0-27 days)|Age, Customized||Participants|Count of Participants|0|0.0||||||
3663527|NCT02374099|3508445|B3||Preterm newborn infants (gestational age < 37 wks)|Age, Customized||Participants|Count of Participants|0|0.0||||||
3663528|NCT02374099|3508446|B2||Preterm newborn infants (gestational age < 37 wks)|Age, Customized||Participants|Count of Participants|0|0.0||||||
3663529|NCT02374099|3508447|B1||Preterm newborn infants (gestational age < 37 wks)|Age, Customized||Participants|Count of Participants|0|0.0||||||
3663530|NCT02374099|3508445|B3||In utero|Age, Customized||Participants|Count of Participants|0|0.0||||||
3663531|NCT02374099|3508446|B2||In utero|Age, Customized||Participants|Count of Participants|0|0.0||||||
3663532|NCT02374099|3508447|B1||In utero|Age, Customized||Participants|Count of Participants|0|0.0||||||
3663533|NCT02374099|3508445|B3|||Age||years|Mean|62.7|62.7|Standard Deviation|10.46|10.46|||
3663534|NCT02374099|3508446|B2|||Age||years|Mean|62.9|62.9|Standard Deviation|10.03|10.03|||
3663535|NCT02374099|3508447|B1|||Age||years|Mean|62.6|62.6|Standard Deviation|10.99|10.99|||
3663536|NCT02374060|3508464|B4|||Concomitant systemic medication||Participants|Count of Participants|70|70.0||||||
3663537|NCT02374060|3508465|B3|||Concomitant systemic medication||Participants|Count of Participants|23|23.0||||||
3663538|NCT02374060|3508466|B2|||Concomitant systemic medication||Participants|Count of Participants|23|23.0||||||
3663539|NCT02374060|3508467|B1|||Concomitant systemic medication||Participants|Count of Participants|24|24.0||||||
3663540|NCT02374060|3508464|B4|||Retinal thickness at the center subfield||um|Median|462|462.0|Full Range|||236.0|1300.0|
3663541|NCT02374060|3508465|B3|||Retinal thickness at the center subfield||um|Median|449|449.0|Full Range|||243.0|1300.0|
3663542|NCT02374060|3508466|B2|||Retinal thickness at the center subfield||um|Median|485|485.0|Full Range|||236.0|824.0|
3663543|NCT02374060|3508467|B1|||Retinal thickness at the center subfield||um|Median|438|438.0|Full Range|||278.0|922.0|
3663544|NCT02374060|3508464|B4|||Visual acuity|Participants' visual acuity was measured by certified examiners with best refractive correction in place.Participants were challenged with reading letters on lines of the standard ETDRS eye chart (5 letters per line). Lines became smaller as participants progressed from the top to the bottom of the chart. Participants read down the chart until no more meaningful readings could be made and were scored by how many letters could be correctly identified. More letters read is associated with higher visual acuity.|Standard letters|Median|64|64.0|Full Range|||13.0|91.0|
3663545|NCT02374060|3508465|B3|||Visual acuity|Participants' visual acuity was measured by certified examiners with best refractive correction in place.Participants were challenged with reading letters on lines of the standard ETDRS eye chart (5 letters per line). Lines became smaller as participants progressed from the top to the bottom of the chart. Participants read down the chart until no more meaningful readings could be made and were scored by how many letters could be correctly identified. More letters read is associated with higher visual acuity.|Standard letters|Median|64|64.0|Full Range|||23.0|86.0|
3663546|NCT02374060|3508466|B2|||Visual acuity|Participants' visual acuity was measured by certified examiners with best refractive correction in place.Participants were challenged with reading letters on lines of the standard ETDRS eye chart (5 letters per line). Lines became smaller as participants progressed from the top to the bottom of the chart. Participants read down the chart until no more meaningful readings could be made and were scored by how many letters could be correctly identified. More letters read is associated with higher visual acuity.|Standard letters|Median|63|63.0|Full Range|||13.0|88.0|
3663547|NCT02374060|3508467|B1|||Visual acuity|Participants' visual acuity was measured by certified examiners with best refractive correction in place.Participants were challenged with reading letters on lines of the standard ETDRS eye chart (5 letters per line). Lines became smaller as participants progressed from the top to the bottom of the chart. Participants read down the chart until no more meaningful readings could be made and were scored by how many letters could be correctly identified. More letters read is associated with higher visual acuity.|Standard letters|Median|68|68.0|Full Range|||25.0|91.0|
3663548|NCT02374060|3508464|B4|||Intraocular pressure||mm Hg|Median|14|14.0|Full Range|||6.0|22.0|
3663549|NCT02374060|3508465|B3|||Intraocular pressure||mm Hg|Median|13|13.0|Full Range|||6.0|20.0|
3663550|NCT02374060|3508466|B2|||Intraocular pressure||mm Hg|Median|14|14.0|Full Range|||7.0|21.0|
3663551|NCT02374060|3508467|B1|||Intraocular pressure||mm Hg|Median|14|14.0|Full Range|||6.0|22.0|
3663552|NCT02374060|3508464|B4|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3663553|NCT02374060|3508465|B3|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3663554|NCT02374060|3508466|B2|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3663555|NCT02374060|3508467|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3663556|NCT02374060|3508464|B4|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
3663557|NCT02374060|3508465|B3|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3663558|NCT02374060|3508466|B2|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3663559|NCT02374060|3508467|B1|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3663560|NCT02374060|3508464|B4|Race|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3663561|NCT02374060|3508465|B3|Race|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3663562|NCT02374060|3508466|B2|Race|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3663563|NCT02374060|3508467|B1|Race|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3663564|NCT02374060|3508464|B4|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|122|122.0||||||
3663565|NCT02374060|3508465|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
3663566|NCT02374060|3508466|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
3663567|NCT02374060|3508467|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
3663568|NCT02374060|3508464|B4||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3663569|NCT02374060|3508465|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3663570|NCT02374060|3508466|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3663571|NCT02374060|3508467|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3663572|NCT02374060|3508464|B4||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3663573|NCT02374060|3508465|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3663574|NCT02374060|3508466|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3663575|NCT02374060|3508467|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3663576|NCT02374060|3508464|B4|||Age||years|Median|55|55.0|Full Range|||18.0|87.0|
3663577|NCT02374060|3508465|B3|||Age||years|Median|55|55.0|Full Range|||19.0|85.0|
3663578|NCT02374060|3508466|B2|||Age||years|Median|56|56.0|Full Range|||18.0|86.0|
3663579|NCT02374060|3508467|B1|||Age||years|Median|55|55.0|Full Range|||22.0|87.0|
3663580|NCT02373202|3508519|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3663581|NCT02373202|3508520|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3663582|NCT02373202|3508521|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3663583|NCT02373202|3508522|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3663584|NCT02373202|3508523|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3663585|NCT02373202|3508519|B5||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3663586|NCT02373202|3508520|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3663587|NCT02373202|3508521|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3663588|NCT02373202|3508522|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3663589|NCT02373202|3508523|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3663590|NCT02373202|3508519|B5|||Age||years|Mean|55.6|55.6|Standard Deviation|12.1|12.1|||
3663591|NCT02373202|3508520|B4|||Age||years|Mean|52.5|52.5|Standard Deviation|10.3|10.3|||
3663592|NCT02373202|3508521|B3|||Age||years|Mean|54.4|54.4|Standard Deviation|13.8|13.8|||
3663593|NCT02373202|3508522|B2|||Age||years|Mean|63.3|63.3|Standard Deviation|10.6|10.6|||
3663594|NCT02373202|3508523|B1|||Age||years|Mean|56.3|56.3|Standard Deviation|10.9|10.9|||
3663595|NCT02372396|3508576|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
3663596|NCT02372396|3508577|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3663597|NCT02372396|3508578|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3663598|NCT02372396|3508576|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663599|NCT02372396|3508577|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663600|NCT02372396|3508578|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663601|NCT02372396|3508576|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3663602|NCT02372396|3508577|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3663603|NCT02372396|3508578|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663604|NCT02372396|3508576|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3663605|NCT02372396|3508577|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3663606|NCT02372396|3508578|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3663607|NCT02372396|3508576|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3663608|NCT02372396|3508577|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3663609|NCT02372396|3508578|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3663610|NCT02372396|3508576|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3663611|NCT02372396|3508577|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663612|NCT02372396|3508578|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3663613|NCT02372396|3508576|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3663614|NCT02372396|3508577|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3663615|NCT02372396|3508578|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3663616|NCT02372396|3508576|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663617|NCT02372396|3508577|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663618|NCT02372396|3508578|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663619|NCT02372396|3508576|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663620|NCT02372396|3508577|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663621|NCT02372396|3508578|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663622|NCT02372396|3508576|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3663623|NCT02372396|3508577|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3663624|NCT02372396|3508578|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3663625|NCT02372396|3508576|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3663626|NCT02372396|3508577|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3663627|NCT02372396|3508578|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3663628|NCT02372396|3508576|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3663629|NCT02372396|3508577|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3663630|NCT02372396|3508578|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3663631|NCT02372396|3508576|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3663632|NCT02372396|3508577|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3663633|NCT02372396|3508578|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3663634|NCT02372396|3508576|B3|||Age||years|Mean|49.11|49.11|Standard Deviation|14.5|14.5|||
3663635|NCT02372396|3508577|B2|||Age||years|Mean|52.7|52.7|Standard Deviation|11.4|11.4|||
3663636|NCT02372396|3508578|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|16.6|16.6|||
3663637|NCT02372344|3508585|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663638|NCT02372344|3508585|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663639|NCT02372344|3508585|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663640|NCT02372344|3508585|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663641|NCT02372344|3508585|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663642|NCT02372344|3508585|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3663643|NCT02372344|3508585|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663644|NCT02372344|3508585|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3663645|NCT02372344|3508585|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3663646|NCT02372344|3508585|B1|||Age||years|Mean|31.0|31.0|Standard Deviation|7.4|7.4|||
3663647|NCT02372097|3508601|B3|Caffeine Non-Consumer||Caffeine Classification||participants|Number|18|18.0||||||
3663648|NCT02372097|3508602|B2|Caffeine Non-Consumer||Caffeine Classification||participants|Number|10|10.0||||||
3663649|NCT02372097|3508603|B1|Caffeine Non-Consumer||Caffeine Classification||participants|Number|8|8.0||||||
3663650|NCT02372097|3508601|B3|Caffeine Consumer||Caffeine Classification||participants|Number|6|6.0||||||
3663651|NCT02372097|3508602|B2|Caffeine Consumer||Caffeine Classification||participants|Number|2|2.0||||||
3663652|NCT02372097|3508603|B1|Caffeine Consumer||Caffeine Classification||participants|Number|4|4.0||||||
3663653|NCT02372097|3508601|B3|Never Drunk||Alcohol Classification||participants|Number|6|6.0||||||
3663654|NCT02372097|3508602|B2|Never Drunk||Alcohol Classification||participants|Number|3|3.0||||||
3663655|NCT02372097|3508603|B1|Never Drunk||Alcohol Classification||participants|Number|3|3.0||||||
3663656|NCT02372097|3508601|B3|Drinks a Few Days per Month||Alcohol Classification||participants|Number|11|11.0||||||
3663657|NCT02372097|3508602|B2|Drinks a Few Days per Month||Alcohol Classification||participants|Number|4|4.0||||||
3663658|NCT02372097|3508603|B1|Drinks a Few Days per Month||Alcohol Classification||participants|Number|7|7.0||||||
3663659|NCT02372097|3508601|B3|Drinks a Few Days per Week||Alcohol Classification||participants|Number|7|7.0||||||
3663660|NCT02372097|3508602|B2|Drinks a Few Days per Week||Alcohol Classification||participants|Number|5|5.0||||||
3663661|NCT02372097|3508603|B1|Drinks a Few Days per Week||Alcohol Classification||participants|Number|2|2.0||||||
3663662|NCT02372097|3508601|B3|Ex-Smoker||Smoking Classification||participants|Number|1|1.0||||||
3663663|NCT02372097|3508602|B2|Ex-Smoker||Smoking Classification||participants|Number|1|1.0||||||
3663664|NCT02372097|3508603|B1|Ex-Smoker||Smoking Classification||participants|Number|0|0.0||||||
3663665|NCT02372097|3508601|B3|Current Smoker||Smoking Classification||participants|Number|9|9.0||||||
3663666|NCT02372097|3508602|B2|Current Smoker||Smoking Classification||participants|Number|4|4.0||||||
3663667|NCT02372097|3508603|B1|Current Smoker||Smoking Classification||participants|Number|5|5.0||||||
3663668|NCT02372097|3508601|B3|Never Smoked||Smoking Classification||participants|Number|14|14.0||||||
3663669|NCT02372097|3508602|B2|Never Smoked||Smoking Classification||participants|Number|7|7.0||||||
3663670|NCT02372097|3508603|B1|Never Smoked||Smoking Classification||participants|Number|7|7.0||||||
3663994|NCT02370602|3509012|B6|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
3663671|NCT02372097|3508601|B3|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|21.37|21.37|Standard Deviation|1.894|1.894|||
3663672|NCT02372097|3508602|B2|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|21.05|21.05|Standard Deviation|1.948|1.948|||
3663673|NCT02372097|3508603|B1|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|21.69|21.69|Standard Deviation|1.866|1.866|||
3663674|NCT02372097|3508601|B3|||Weight||kilogram (kg)|Mean|63.65|63.65|Standard Deviation|7.972|7.972|||
3663675|NCT02372097|3508602|B2|||Weight||kilogram (kg)|Mean|62.79|62.79|Standard Deviation|6.087|6.087|||
3663676|NCT02372097|3508603|B1|||Weight||kilogram (kg)|Mean|64.51|64.51|Standard Deviation|9.707|9.707|||
3663677|NCT02372097|3508601|B3|||Height||centimeter (cm)|Mean|172.4|172.4|Standard Deviation|7.06|7.06|||
3663678|NCT02372097|3508602|B2|||Height||centimeter (cm)|Mean|172.8|172.8|Standard Deviation|7.48|7.48|||
3663679|NCT02372097|3508603|B1|||Height||centimeter (cm)|Mean|172.0|172.0|Standard Deviation|6.93|6.93|||
3663680|NCT02372097|3508601|B3|Japan||Region of Enrollment||participants|Number|24|24.0||||||
3663681|NCT02372097|3508602|B2|Japan||Region of Enrollment||participants|Number|12|12.0||||||
3663682|NCT02372097|3508603|B1|Japan||Region of Enrollment||participants|Number|12|12.0||||||
3663683|NCT02372097|3508601|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3663684|NCT02372097|3508602|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3663685|NCT02372097|3508603|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3663686|NCT02372097|3508601|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3663687|NCT02372097|3508602|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3663688|NCT02372097|3508603|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3663689|NCT02372097|3508601|B3|||Age||Years|Mean|23.0|23.0|Standard Deviation|2.93|2.93|||
3663690|NCT02372097|3508602|B2|||Age||Years|Mean|22.3|22.3|Standard Deviation|3.17|3.17|||
3663691|NCT02372097|3508603|B1|||Age||Years|Mean|23.7|23.7|Standard Deviation|2.64|2.64|||
3663692|NCT02372071|3508630|B1|African or Bedouin (Dark Skin tone)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3663693|NCT02372071|3508630|B1|Caucasian (White or Tan skin tone))||Race/Ethnicity, Customized||participants|Number|93|93.0||||||
3663694|NCT02372071|3508630|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3663695|NCT02372071|3508630|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3663696|NCT02372071|3508630|B1|35<=Gestational Age [weeks]||Age, Customized|Age ( = Gestational age + Chronological age)|Weeks|Mean|38.9|38.9|Standard Deviation|1.8|1.8|||
3663697|NCT02372071|3508630|B1|24<=Gestational Age [weeks]<35||Age, Customized|Age ( = Gestational age + Chronological age)|Weeks|Mean|33.2|33.2|Standard Deviation|2.0|2.0|||
3663698|NCT02372058|3508635|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3663699|NCT02372058|3508635|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663700|NCT02372058|3508635|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3663701|NCT02372058|3508635|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3663702|NCT02372058|3508635|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663703|NCT02372058|3508635|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3663704|NCT02372058|3508635|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3663705|NCT02372058|3508635|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3663706|NCT02372058|3508635|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3663707|NCT02372058|3508635|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3663708|NCT02372058|3508635|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3663709|NCT02372058|3508635|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3663710|NCT02372058|3508635|B1|||Age||Hours since birth|Mean|43.5|43.5|Standard Deviation|19.75|19.75|||
3663711|NCT02371876|3508641|B1|United States||Region of Enrollment||participants|Number|134|134.0||||||
3663712|NCT02371876|3508641|B1|Unknown or Not Reported||Race/Ethnicity, Customized|Subjects provided more than one choice for Race. Therefore, the apparent frequency total for Race was different from the number of subjects.|participants|Number|2|2.0||||||
3663713|NCT02371876|3508641|B1|More than one race||Race/Ethnicity, Customized|Subjects provided more than one choice for Race. Therefore, the apparent frequency total for Race was different from the number of subjects.|participants|Number|3|3.0||||||
3663714|NCT02371876|3508641|B1|White||Race/Ethnicity, Customized|Subjects provided more than one choice for Race. Therefore, the apparent frequency total for Race was different from the number of subjects.|participants|Number|112|112.0||||||
3663715|NCT02371876|3508641|B1|Black or African American||Race/Ethnicity, Customized|Subjects provided more than one choice for Race. Therefore, the apparent frequency total for Race was different from the number of subjects.|participants|Number|14|14.0||||||
3663716|NCT02371876|3508641|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Subjects provided more than one choice for Race. Therefore, the apparent frequency total for Race was different from the number of subjects.|participants|Number|2|2.0||||||
3663717|NCT02371876|3508641|B1|Asian||Race/Ethnicity, Customized|Subjects provided more than one choice for Race. Therefore, the apparent frequency total for Race was different from the number of subjects.|participants|Number|4|4.0||||||
3663718|NCT02371876|3508641|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Subjects provided more than one choice for Race. Therefore, the apparent frequency total for Race was different from the number of subjects.|participants|Number|3|3.0||||||
3663719|NCT02371876|3508641|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3663720|NCT02371876|3508641|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
3663721|NCT02371876|3508641|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3663722|NCT02371876|3508641|B1||Male|Gender||Participants|Count of Participants|64|64.0||||||
3663723|NCT02371876|3508641|B1||Female|Gender||Participants|Count of Participants|70|70.0||||||
3663724|NCT02371876|3508641|B1|||Age||years|Mean|54.0|54.0|Full Range|||18.0|77.0|
3663725|NCT02371850|3508651|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3663726|NCT02371850|3508651|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3663727|NCT02371850|3508651|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3663728|NCT02371850|3508651|B1|||Age||years|Mean|29|29.0|Standard Deviation|6.41|6.41|||
3663729|NCT02371850|3508651|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3663730|NCT02371850|3508651|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3663731|NCT02371850|3508651|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3663732|NCT02371759|3508656|B9|||Intraoral Neuropathy||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3663733|NCT02371759|3508657|B8|||Intraoral Neuropathy||Participants|Count of Participants|NA|||||||Available only for diabetic participants
3663734|NCT02371759|3508658|B7|||Intraoral Neuropathy||Participants|Count of Participants|NA|||||||Available only for diabetic participants
3663735|NCT02371759|3508659|B6|||Intraoral Neuropathy||Participants|Count of Participants|NA|||||||Available only for diabetic participants
3663736|NCT02371759|3508660|B5|||Intraoral Neuropathy||Participants|Count of Participants|NA|||||||Available only for diabetic participants
3663737|NCT02371759|3508661|B4|||Intraoral Neuropathy||Participants|Count of Participants|18|18.0||||||
3663738|NCT02371759|3508662|B3|||Intraoral Neuropathy||Participants|Count of Participants|17|17.0||||||
3663739|NCT02371759|3508663|B2|||Intraoral Neuropathy||Participants|Count of Participants|16|16.0||||||
3663740|NCT02371759|3508664|B1|||Intraoral Neuropathy||Participants|Count of Participants|14|14.0||||||
3663741|NCT02371759|3508656|B9|||Peripheral Neuropathy||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3663742|NCT02371759|3508657|B8|||Peripheral Neuropathy||Participants|Count of Participants|NA|||||||Available only for diabetic participants
3663743|NCT02371759|3508658|B7|||Peripheral Neuropathy||Participants|Count of Participants|NA|||||||Available only for diabetic participants
3663744|NCT02371759|3508659|B6|||Peripheral Neuropathy||Participants|Count of Participants|NA|||||||Available only for diabetic participants
3663745|NCT02371759|3508660|B5|||Peripheral Neuropathy||Participants|Count of Participants|NA|||||||Available only for diabetic participants
3663746|NCT02371759|3508661|B4|||Peripheral Neuropathy||Participants|Count of Participants|10|10.0||||||
3663747|NCT02371759|3508662|B3|||Peripheral Neuropathy||Participants|Count of Participants|12|12.0||||||
3663748|NCT02371759|3508663|B2|||Peripheral Neuropathy||Participants|Count of Participants|12|12.0||||||
3663749|NCT02371759|3508664|B1|||Peripheral Neuropathy||Participants|Count of Participants|9|9.0||||||
3663750|NCT02371759|3508656|B9|||Coronary Artery Disease||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3663751|NCT02371759|3508657|B8|||Coronary Artery Disease||Participants|Count of Participants|NA|||||||Available only for diabetic participants
3663752|NCT02371759|3508658|B7|||Coronary Artery Disease||Participants|Count of Participants|NA|||||||Available only for diabetic participants
3663753|NCT02371759|3508659|B6|||Coronary Artery Disease||Participants|Count of Participants|NA|||||||Available only for diabetic participants
3663754|NCT02371759|3508660|B5|||Coronary Artery Disease||Participants|Count of Participants|NA|||||||Available only for diabetic participants
3663755|NCT02371759|3508661|B4|||Coronary Artery Disease||Participants|Count of Participants|13|13.0||||||
3663756|NCT02371759|3508662|B3|||Coronary Artery Disease||Participants|Count of Participants|14|14.0||||||
3663757|NCT02371759|3508663|B2|||Coronary Artery Disease||Participants|Count of Participants|14|14.0||||||
3663758|NCT02371759|3508664|B1|||Coronary Artery Disease||Participants|Count of Participants|12|12.0||||||
3663759|NCT02371759|3508656|B9|||Hypertension||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3663760|NCT02371759|3508657|B8|||Hypertension||Participants|Count of Participants|NA|||||||Available only for diabetic participants
3663761|NCT02371759|3508658|B7|||Hypertension||Participants|Count of Participants|NA|||||||Available only for diabetic participants
3663762|NCT02371759|3508659|B6|||Hypertension||Participants|Count of Participants|NA|||||||Available only for diabetic participants
3663763|NCT02371759|3508660|B5|||Hypertension||Participants|Count of Participants|NA|||||||Available only for diabetic participants
3663764|NCT02371759|3508661|B4|||Hypertension||Participants|Count of Participants|17|17.0||||||
3663765|NCT02371759|3508662|B3|||Hypertension||Participants|Count of Participants|19|19.0||||||
3663766|NCT02371759|3508663|B2|||Hypertension||Participants|Count of Participants|26|26.0||||||
3663767|NCT02371759|3508664|B1|||Hypertension||Participants|Count of Participants|16|16.0||||||
3663768|NCT02371759|3508656|B9|||Number of participants on insulin therapy||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3663769|NCT02371759|3508657|B8|||Number of participants on insulin therapy||Participants|Count of Participants|NA|||||||Available only for diabetic participants
3663770|NCT02371759|3508658|B7|||Number of participants on insulin therapy||Participants|Count of Participants|NA|||||||Available only for diabetic participants
3663771|NCT02371759|3508659|B6|||Number of participants on insulin therapy||Participants|Count of Participants|NA|||||||Available only for diabetic participants
3663772|NCT02371759|3508660|B5|||Number of participants on insulin therapy||Participants|Count of Participants|NA|||||||Available only for diabetic participants
3663773|NCT02371759|3508661|B4|||Number of participants on insulin therapy||Participants|Count of Participants|4|4.0||||||
3663774|NCT02371759|3508662|B3|||Number of participants on insulin therapy||Participants|Count of Participants|8|8.0||||||
3663775|NCT02371759|3508663|B2|||Number of participants on insulin therapy||Participants|Count of Participants|4|4.0||||||
3663776|NCT02371759|3508664|B1|||Number of participants on insulin therapy||Participants|Count of Participants|2|2.0||||||
3663777|NCT02371759|3508656|B9|||Number of participants on OHA therapy||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3663778|NCT02371759|3508657|B8|||Number of participants on OHA therapy||Participants|Count of Participants|NA|||||||Available only for diabetic participants
3663779|NCT02371759|3508658|B7|||Number of participants on OHA therapy||Participants|Count of Participants|NA|||||||Available only for diabetic participants
3663780|NCT02371759|3508659|B6|||Number of participants on OHA therapy||Participants|Count of Participants|NA|||||||Available only for diabetic participants
3663781|NCT02371759|3508660|B5|||Number of participants on OHA therapy||Participants|Count of Participants|NA|||||||Available only for diabetic participants
3663782|NCT02371759|3508661|B4|||Number of participants on OHA therapy||Participants|Count of Participants|30|30.0||||||
3663783|NCT02371759|3508662|B3|||Number of participants on OHA therapy||Participants|Count of Participants|30|30.0||||||
3663784|NCT02371759|3508663|B2|||Number of participants on OHA therapy||Participants|Count of Participants|29|29.0||||||
3663785|NCT02371759|3508664|B1|||Number of participants on OHA therapy||Participants|Count of Participants|28|28.0||||||
3663786|NCT02371759|3508656|B9|||Number of participants with modified diet||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3663787|NCT02371759|3508657|B8|||Number of participants with modified diet||Participants|Count of Participants|NA|||||||Available only for diabetic participants
3663788|NCT02371759|3508658|B7|||Number of participants with modified diet||Participants|Count of Participants|NA|||||||Available only for diabetic participants
3663789|NCT02371759|3508659|B6|||Number of participants with modified diet||Participants|Count of Participants|NA|||||||Available only for diabetic participants
3663790|NCT02371759|3508660|B5|||Number of participants with modified diet||Participants|Count of Participants|NA|||||||Available only for diabetic participants
3663791|NCT02371759|3508661|B4|||Number of participants with modified diet||Participants|Count of Participants|30|30.0||||||
3663792|NCT02371759|3508662|B3|||Number of participants with modified diet||Participants|Count of Participants|31|31.0||||||
3663793|NCT02371759|3508663|B2|||Number of participants with modified diet||Participants|Count of Participants|30|30.0||||||
3663794|NCT02371759|3508664|B1|||Number of participants with modified diet||Participants|Count of Participants|22|22.0||||||
3663795|NCT02371759|3508656|B9|||Glycosilated Hemoglobin||percents|Mean|NA||Standard Deviation|NA||||Available only for diabetic participants
3663796|NCT02371759|3508657|B8|||Glycosilated Hemoglobin||percents|Mean|NA||Standard Deviation|NA||||Available only for diabetic participants
3663797|NCT02371759|3508658|B7|||Glycosilated Hemoglobin||percents|Mean|NA||Standard Deviation|NA||||Available only for diabetic participants
3663798|NCT02371759|3508659|B6|||Glycosilated Hemoglobin||percents|Mean|NA||Standard Deviation|NA||||Available only for diabetic participants
3663799|NCT02371759|3508660|B5|||Glycosilated Hemoglobin||percents|Mean|NA||Standard Deviation|NA||||Available only for diabetic participants
3663800|NCT02371759|3508661|B4|||Glycosilated Hemoglobin||percents|Mean|7.97|7.97|Standard Deviation|1.50|1.5|||
3663801|NCT02371759|3508662|B3|||Glycosilated Hemoglobin||percents|Mean|7.63|7.63|Standard Deviation|1.72|1.72|||
3663802|NCT02371759|3508663|B2|||Glycosilated Hemoglobin||percents|Mean|7.55|7.55|Standard Deviation|2.53|2.53|||
3663803|NCT02371759|3508664|B1|||Glycosilated Hemoglobin||percents|Mean|7.42|7.42|Standard Deviation|1.25|1.25|||
3663804|NCT02371759|3508656|B9|||Duration of Diabetes||years|Mean|NA||Standard Deviation|NA||||Available only for diabetic participants
3663805|NCT02371759|3508657|B8|||Duration of Diabetes||years|Mean|NA||Standard Deviation|NA||||Available only for diabetic participants
3663806|NCT02371759|3508658|B7|||Duration of Diabetes||years|Mean|NA||Standard Deviation|NA||||Available only for diabetic participants
3663807|NCT02371759|3508659|B6|||Duration of Diabetes||years|Mean|NA||Standard Deviation|NA||||Available only for diabetic participants
3663808|NCT02371759|3508660|B5|||Duration of Diabetes||years|Mean|NA||Standard Deviation|NA||||Available only for diabetic participants
3663809|NCT02371759|3508661|B4|||Duration of Diabetes||years|Mean|9.27|9.27|Standard Deviation|6.09|6.09|||
3663810|NCT02371759|3508662|B3|||Duration of Diabetes||years|Mean|9.77|9.77|Standard Deviation|7.62|7.62|||
3663811|NCT02371759|3508663|B2|||Duration of Diabetes||years|Mean|9.57|9.57|Standard Deviation|5.51|5.51|||
3663812|NCT02371759|3508664|B1|||Duration of Diabetes||years|Mean|6.83|6.83|Standard Deviation|4.59|4.59|||
3663813|NCT02371759|3508656|B9|||Fasting Plasma Glucose|Available only for diabetic participants|milimoles per liter|Mean|NA||Standard Deviation|NA||||Available only for diabetic participants
3663814|NCT02371759|3508657|B8|||Fasting Plasma Glucose|Available only for diabetic participants|milimoles per liter|Mean|NA||Standard Deviation|NA||||Available only for diabetic participants
3663815|NCT02371759|3508658|B7|||Fasting Plasma Glucose|Available only for diabetic participants|milimoles per liter|Mean|NA||Standard Deviation|NA||||Available only for diabetic participants
3663816|NCT02371759|3508659|B6|||Fasting Plasma Glucose|Available only for diabetic participants|milimoles per liter|Mean|NA||Standard Deviation|NA||||Available only for diabetic participants
3663817|NCT02371759|3508660|B5|||Fasting Plasma Glucose|Available only for diabetic participants|milimoles per liter|Mean|NA||Standard Deviation|NA||||Available only for diabetic participants
3663818|NCT02371759|3508661|B4|||Fasting Plasma Glucose|Available only for diabetic participants|milimoles per liter|Mean|8.35|8.35|Standard Deviation|2.49|2.49|||
3663819|NCT02371759|3508662|B3|||Fasting Plasma Glucose|Available only for diabetic participants|milimoles per liter|Mean|9.66|9.66|Standard Deviation|4.02|4.02|||
3663820|NCT02371759|3508663|B2|||Fasting Plasma Glucose|Available only for diabetic participants|milimoles per liter|Mean|7.55|7.55|Standard Deviation|2.53|2.53|||
3663821|NCT02371759|3508664|B1|||Fasting Plasma Glucose|Available only for diabetic participants|milimoles per liter|Mean|8.12|8.12|Standard Deviation|3.01|3.01|||
3663822|NCT02371759|3508656|B9|||Body Mass||kilograms|Mean|76.90|76.9|Standard Deviation|8.42|8.42|||
3663823|NCT02371759|3508657|B8|||Body Mass||kilograms|Mean|71.59|71.59|Standard Deviation|7.81|7.81|||
3663824|NCT02371759|3508658|B7|||Body Mass||kilograms|Mean|71.01|71.01|Standard Deviation|12.08|12.08|||
3663825|NCT02371759|3508659|B6|||Body Mass||kilograms|Mean|74.59|74.59|Standard Deviation|9.64|9.64|||
3663826|NCT02371759|3508660|B5|||Body Mass||kilograms|Mean|79.50|79.5|Standard Deviation|15.22|15.22|||
3663827|NCT02371759|3508661|B4|||Body Mass||kilograms|Mean|79.45|79.45|Standard Deviation|17.34|17.34|||
3663828|NCT02371759|3508662|B3|||Body Mass||kilograms|Mean|85.84|85.84|Standard Deviation|14.76|14.76|||
3663829|NCT02371759|3508663|B2|||Body Mass||kilograms|Mean|75.03|75.03|Standard Deviation|11.53|11.53|||
3663830|NCT02371759|3508664|B1|||Body Mass||kilograms|Mean|78.72|78.72|Standard Deviation|11.19|11.19|||
3663831|NCT02371759|3508656|B9|Serbia||Region of Enrollment||participants|Number|220|220.0||||||
3663832|NCT02371759|3508657|B8|Serbia||Region of Enrollment||participants|Number|24|24.0||||||
3663833|NCT02371759|3508658|B7|Serbia||Region of Enrollment||participants|Number|25|25.0||||||
3663834|NCT02371759|3508659|B6|Serbia||Region of Enrollment||participants|Number|25|25.0||||||
3663835|NCT02371759|3508660|B5|Serbia||Region of Enrollment||participants|Number|24|24.0||||||
3663836|NCT02371759|3508661|B4|Serbia||Region of Enrollment||participants|Number|31|31.0||||||
3663837|NCT02371759|3508662|B3|Serbia||Region of Enrollment||participants|Number|33|33.0||||||
3663838|NCT02371759|3508663|B2|Serbia||Region of Enrollment||participants|Number|31|31.0||||||
3663839|NCT02371759|3508664|B1|Serbia||Region of Enrollment||participants|Number|32|32.0||||||
3663840|NCT02371759|3508656|B9||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3663841|NCT02371759|3508657|B8||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3663842|NCT02371759|3508658|B7||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3663843|NCT02371759|3508659|B6||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3663844|NCT02371759|3508660|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3663845|NCT02371759|3508661|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3663846|NCT02371759|3508662|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3663847|NCT02371759|3508663|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3663848|NCT02371759|3508664|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3663849|NCT02371759|3508656|B9||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3663850|NCT02371759|3508657|B8||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3663851|NCT02371759|3508658|B7||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3663852|NCT02371759|3508659|B6||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3663853|NCT02371759|3508660|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3663854|NCT02371759|3508661|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3663855|NCT02371759|3508662|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3663856|NCT02371759|3508663|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3663857|NCT02371759|3508664|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3663858|NCT02371759|3508656|B9||>=65 years|Age|Age between 18 and 65 years|Participants|Count of Participants|0|0.0||||||
3663859|NCT02371759|3508657|B8||>=65 years|Age|Age between 18 and 65 years|Participants|Count of Participants|0|0.0||||||
3663860|NCT02371759|3508658|B7||>=65 years|Age|Age between 18 and 65 years|Participants|Count of Participants|0|0.0||||||
3663861|NCT02371759|3508659|B6||>=65 years|Age|Age between 18 and 65 years|Participants|Count of Participants|0|0.0||||||
3663862|NCT02371759|3508660|B5||>=65 years|Age|Age between 18 and 65 years|Participants|Count of Participants|0|0.0||||||
3663863|NCT02371759|3508661|B4||>=65 years|Age|Age between 18 and 65 years|Participants|Count of Participants|0|0.0||||||
3663864|NCT02371759|3508662|B3||>=65 years|Age|Age between 18 and 65 years|Participants|Count of Participants|0|0.0||||||
3663865|NCT02371759|3508663|B2||>=65 years|Age|Age between 18 and 65 years|Participants|Count of Participants|0|0.0||||||
3663866|NCT02371759|3508664|B1||>=65 years|Age|Age between 18 and 65 years|Participants|Count of Participants|0|0.0||||||
3663867|NCT02371759|3508656|B9||Between 18 and 65 years|Age|Age between 18 and 65 years|Participants|Count of Participants|220|220.0||||||
3663868|NCT02371759|3508657|B8||Between 18 and 65 years|Age|Age between 18 and 65 years|Participants|Count of Participants|24|24.0||||||
3663869|NCT02371759|3508658|B7||Between 18 and 65 years|Age|Age between 18 and 65 years|Participants|Count of Participants|25|25.0||||||
3663870|NCT02371759|3508659|B6||Between 18 and 65 years|Age|Age between 18 and 65 years|Participants|Count of Participants|25|25.0||||||
3663871|NCT02371759|3508660|B5||Between 18 and 65 years|Age|Age between 18 and 65 years|Participants|Count of Participants|24|24.0||||||
3663872|NCT02371759|3508661|B4||Between 18 and 65 years|Age|Age between 18 and 65 years|Participants|Count of Participants|31|31.0||||||
3663873|NCT02371759|3508662|B3||Between 18 and 65 years|Age|Age between 18 and 65 years|Participants|Count of Participants|32|32.0||||||
3663874|NCT02371759|3508663|B2||Between 18 and 65 years|Age|Age between 18 and 65 years|Participants|Count of Participants|30|30.0||||||
3663875|NCT02371759|3508664|B1||Between 18 and 65 years|Age|Age between 18 and 65 years|Participants|Count of Participants|29|29.0||||||
3663876|NCT02371759|3508656|B9||<=18 years|Age|Age between 18 and 65 years|Participants|Count of Participants|0|0.0||||||
3663877|NCT02371759|3508657|B8||<=18 years|Age|Age between 18 and 65 years|Participants|Count of Participants|0|0.0||||||
3663878|NCT02371759|3508658|B7||<=18 years|Age|Age between 18 and 65 years|Participants|Count of Participants|0|0.0||||||
3663879|NCT02371759|3508659|B6||<=18 years|Age|Age between 18 and 65 years|Participants|Count of Participants|0|0.0||||||
3663880|NCT02371759|3508660|B5||<=18 years|Age|Age between 18 and 65 years|Participants|Count of Participants|0|0.0||||||
3663881|NCT02371759|3508661|B4||<=18 years|Age|Age between 18 and 65 years|Participants|Count of Participants|0|0.0||||||
3663882|NCT02371759|3508662|B3||<=18 years|Age|Age between 18 and 65 years|Participants|Count of Participants|0|0.0||||||
3663883|NCT02371759|3508663|B2||<=18 years|Age|Age between 18 and 65 years|Participants|Count of Participants|0|0.0||||||
3663884|NCT02371759|3508664|B1||<=18 years|Age|Age between 18 and 65 years|Participants|Count of Participants|0|0.0||||||
3663885|NCT02371616|3508881|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3663886|NCT02371616|3508882|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3663887|NCT02371616|3508883|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3663888|NCT02371616|3508881|B3||Female|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
3663889|NCT02371616|3508882|B2||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3663890|NCT02371616|3508883|B1||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3663891|NCT02371616|3508881|B3|||Age||years|Mean|41.9|41.9|Standard Deviation|9.89|9.89|||
3663892|NCT02371616|3508882|B2|||Age||years|Mean|42.5|42.5|Standard Deviation|9.43|9.43|||
3663893|NCT02371616|3508883|B1|||Age||years|Mean|41.1|41.1|Standard Deviation|10.33|10.33|||
3663894|NCT02371395|3508896|B1|Brazil||Region of Enrollment||Participants|Count of Participants|1000|1000.0||||||
3663895|NCT02371395|3508896|B1||Male|Sex: Female, Male||Participants|Count of Participants|449|449.0||||||
3663896|NCT02371395|3508896|B1||Female|Sex: Female, Male||Participants|Count of Participants|551|551.0||||||
3663897|NCT02371395|3508896|B1|||Age||years|Median|29.5|29.5|Full Range|||7.0|88.0|
3663898|NCT02370914|3508900|B1|||Sport Concussion Assessment Tool- Second Edition (SCAT 2)|SCAT 2 was used to perform baseline testing in the athletes before the football season began. Of these, 9 without a concussion during the season, elected to have an additional recording done at the end of the year. If an athletic sustained an impact and sideline physicians or trainers regarded the impact as a concussion, the athlete had SCAT2 testing performed and JMD testing.The scale is based on total symptoms and symptoms severity score, with 0 being the least severe and 132 being the most severe. In other words, the higher the the score value, the worse the condition. Score range is 0-132.|units on a scale|Mean|82.5|82.5|Standard Deviation|10.2|10.2|||
3663899|NCT02370914|3508900|B1|United States||Region of Enrollment||participants|Number|82|82.0||||||
3663900|NCT02370914|3508900|B1|Males||Sex/Gender, Customized||participants|Number|82|82.0||||||
3663901|NCT02370914|3508900|B1|||Age||years|Mean|15.3|15.3|Standard Deviation|1.33|1.33|||
3663902|NCT02370914|3508900|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3663903|NCT02370914|3508900|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3663904|NCT02370914|3508900|B1||<=18 years|Age||Participants|Count of Participants|80|80.0||||||
3663905|NCT02370667|3508904|B4|Canada||Region of Enrollment||participants|Number|31|31.0||||||
3663906|NCT02370667|3508905|B3|Canada||Region of Enrollment||participants|Number|10|10.0||||||
3663907|NCT02370667|3508906|B2|Canada||Region of Enrollment||participants|Number|11|11.0||||||
3663908|NCT02370667|3508907|B1|Canada||Region of Enrollment||participants|Number|10|10.0||||||
3663909|NCT02370667|3508904|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3663910|NCT02370667|3508905|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3663911|NCT02370667|3508906|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3663912|NCT02370667|3508907|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3663913|NCT02370667|3508904|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3663914|NCT02370667|3508905|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3663915|NCT02370667|3508906|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3663916|NCT02370667|3508907|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3663917|NCT02370667|3508904|B4|||Age||years|Mean|66.7|66.7|Standard Deviation|8.5|8.5|||
3663918|NCT02370667|3508905|B3|||Age||years|Mean|71.1|71.1|Standard Deviation|9.3|9.3|||
3663919|NCT02370667|3508906|B2|||Age||years|Mean|63.7|63.7|Standard Deviation|8.9|8.9|||
3663920|NCT02370667|3508907|B1|||Age||years|Mean|65.5|65.5|Standard Deviation|5.6|5.6|||
3663921|NCT02370615|3508971|B3|No caffeine consumption||Caffeine Classification||participants|Number|20|20.0||||||
3663922|NCT02370615|3508972|B2|No caffeine consumption||Caffeine Classification||participants|Number|12|12.0||||||
3663923|NCT02370615|3508973|B1|No caffeine consumption||Caffeine Classification||participants|Number|8|8.0||||||
3663924|NCT02370615|3508971|B3|Caffeine consumption||Caffeine Classification||participants|Number|13|13.0||||||
3663925|NCT02370615|3508972|B2|Caffeine consumption||Caffeine Classification||participants|Number|6|6.0||||||
3663926|NCT02370615|3508973|B1|Caffeine consumption||Caffeine Classification||participants|Number|7|7.0||||||
3663927|NCT02370615|3508971|B3|Does not drink||Alcohol Classification||participants|Number|16|16.0||||||
3663928|NCT02370615|3508972|B2|Does not drink||Alcohol Classification||participants|Number|11|11.0||||||
3663929|NCT02370615|3508973|B1|Does not drink||Alcohol Classification||participants|Number|5|5.0||||||
3663930|NCT02370615|3508971|B3|Drinks a few days per month||Alcohol Classification||participants|Number|10|10.0||||||
3663931|NCT02370615|3508972|B2|Drinks a few days per month||Alcohol Classification||participants|Number|5|5.0||||||
3663932|NCT02370615|3508973|B1|Drinks a few days per month||Alcohol Classification||participants|Number|5|5.0||||||
3663933|NCT02370615|3508971|B3|Drinks a few days per week||Alcohol Classification||participants|Number|7|7.0||||||
3663934|NCT02370615|3508972|B2|Drinks a few days per week||Alcohol Classification||participants|Number|2|2.0||||||
3663935|NCT02370615|3508973|B1|Drinks a few days per week||Alcohol Classification||participants|Number|5|5.0||||||
3663936|NCT02370615|3508971|B3|Ex-smoker||Smoking Classification||participants|Number|7|7.0||||||
3663937|NCT02370615|3508972|B2|Ex-smoker||Smoking Classification||participants|Number|5|5.0||||||
3663938|NCT02370615|3508973|B1|Ex-smoker||Smoking Classification||participants|Number|2|2.0||||||
3663939|NCT02370615|3508971|B3|Current smoker||Smoking Classification||participants|Number|2|2.0||||||
3663940|NCT02370615|3508972|B2|Current smoker||Smoking Classification||participants|Number|1|1.0||||||
3663941|NCT02370615|3508973|B1|Current smoker||Smoking Classification||participants|Number|1|1.0||||||
3663942|NCT02370615|3508971|B3|Never smoked||Smoking Classification||participants|Number|24|24.0||||||
3663943|NCT02370615|3508972|B2|Never smoked||Smoking Classification||participants|Number|12|12.0||||||
3663944|NCT02370615|3508973|B1|Never smoked||Smoking Classification||participants|Number|12|12.0||||||
3663945|NCT02370615|3508971|B3|Male||Sex/Gender, Customized||participants|Number|33|33.0||||||
3663946|NCT02370615|3508972|B2|Male||Sex/Gender, Customized||participants|Number|18|18.0||||||
3663947|NCT02370615|3508973|B1|Male||Sex/Gender, Customized||participants|Number|15|15.0||||||
3663948|NCT02370615|3508971|B3|||Age||years|Mean|26.0|26.0|Standard Deviation|4.30|4.3|||
3663949|NCT02370615|3508972|B2|||Age||years|Mean|25.3|25.3|Standard Deviation|4.44|4.44|||
3663950|NCT02370615|3508973|B1|||Age||years|Mean|26.8|26.8|Standard Deviation|4.11|4.11|||
3663951|NCT02370602|3509011|B7|Ex-smoker||Smoking Classification||participants|Number|2|2.0||||||
3663952|NCT02370602|3509012|B6|Ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3663953|NCT02370602|3509013|B5|Ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3663954|NCT02370602|3509014|B4|Ex-smoker||Smoking Classification||participants|Number|2|2.0||||||
3663955|NCT02370602|3509015|B3|Ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3663956|NCT02370602|3509016|B2|Ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3663957|NCT02370602|3509017|B1|Ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3663958|NCT02370602|3509011|B7|Current smoker||Smoking Classification||participants|Number|0|0.0||||||
3663959|NCT02370602|3509012|B6|Current smoker||Smoking Classification||participants|Number|0|0.0||||||
3663960|NCT02370602|3509013|B5|Current smoker||Smoking Classification||participants|Number|0|0.0||||||
3663961|NCT02370602|3509014|B4|Current smoker||Smoking Classification||participants|Number|0|0.0||||||
3663962|NCT02370602|3509015|B3|Current smoker||Smoking Classification||participants|Number|0|0.0||||||
3663963|NCT02370602|3509016|B2|Current smoker||Smoking Classification||participants|Number|0|0.0||||||
3663964|NCT02370602|3509017|B1|Current smoker||Smoking Classification||participants|Number|0|0.0||||||
3663965|NCT02370602|3509011|B7|Never smoked||Smoking Classification||participants|Number|11|11.0||||||
3663966|NCT02370602|3509012|B6|Never smoked||Smoking Classification||participants|Number|2|2.0||||||
3663967|NCT02370602|3509013|B5|Never smoked||Smoking Classification||participants|Number|3|3.0||||||
3663968|NCT02370602|3509014|B4|Never smoked||Smoking Classification||participants|Number|1|1.0||||||
3663969|NCT02370602|3509015|B3|Never smoked||Smoking Classification||participants|Number|2|2.0||||||
3663970|NCT02370602|3509016|B2|Never smoked||Smoking Classification||participants|Number|2|2.0||||||
3663971|NCT02370602|3509017|B1|Never smoked||Smoking Classification||participants|Number|1|1.0||||||
3663972|NCT02370602|3509011|B7|||Body Mass Index (BMI)||kg/m^2|Mean|26.04|26.04|Standard Deviation|2.883|2.883|||
3663973|NCT02370602|3509012|B6|||Body Mass Index (BMI)||kg/m^2|Mean|25.80|25.8|Standard Deviation|2.701|2.701|||
3663974|NCT02370602|3509013|B5|||Body Mass Index (BMI)||kg/m^2|Mean|25.86|25.86|Standard Deviation|4.584|4.584|||
3663975|NCT02370602|3509014|B4|||Body Mass Index (BMI)||kg/m^2|Mean|27.27|27.27|Standard Deviation|3.267|3.267|||
3663976|NCT02370602|3509015|B3|||Body Mass Index (BMI)||kg/m^2|Mean|27.92|27.92|Standard Deviation|1.089|1.089|||
3663977|NCT02370602|3509016|B2|||Body Mass Index (BMI)||kg/m^2|Mean|23.47|23.47|Standard Deviation|1.117|1.117|||
3663978|NCT02370602|3509017|B1|||Body Mass Index (BMI)||kg/m^2|Mean|24.78|24.78|Standard Deviation|NA||||Standard deviation can not be calculated for 1 participant.
3663979|NCT02370602|3509011|B7|||Weight||kg|Mean|83.51|83.51|Standard Deviation|8.233|8.233|||
3663980|NCT02370602|3509012|B6|||Weight||kg|Mean|80.65|80.65|Standard Deviation|4.596|4.596|||
3663981|NCT02370602|3509013|B5|||Weight||kg|Mean|83.27|83.27|Standard Deviation|15.938|15.938|||
3663982|NCT02370602|3509014|B4|||Weight||kg|Mean|85.90|85.9|Standard Deviation|3.651|3.651|||
3663983|NCT02370602|3509015|B3|||Weight||kg|Mean|90.50|90.5|Standard Deviation|4.950|4.95|||
3663984|NCT02370602|3509016|B2|||Weight||kg|Mean|76.40|76.4|Standard Deviation|0.566|0.566|||
3663985|NCT02370602|3509017|B1|||Weight||kg|Mean|83.00|83.0|Standard Deviation|NA||||Standard deviation can not be calculated for 1 participant.
3663986|NCT02370602|3509011|B7|||Height||cm|Mean|179.2|179.2|Standard Deviation|5.20|5.2|||
3663987|NCT02370602|3509012|B6|||Height||cm|Mean|177.0|177.0|Standard Deviation|4.24|4.24|||
3663988|NCT02370602|3509013|B5|||Height||cm|Mean|179.3|179.3|Standard Deviation|7.51|7.51|||
3663989|NCT02370602|3509014|B4|||Height||cm|Mean|178.0|178.0|Standard Deviation|8.19|8.19|||
3663990|NCT02370602|3509015|B3|||Height||cm|Mean|180.0|180.0|Standard Deviation|1.41|1.41|||
3663991|NCT02370602|3509016|B2|||Height||cm|Mean|180.5|180.5|Standard Deviation|4.95|4.95|||
3663992|NCT02370602|3509017|B1|||Height||cm|Mean|183.0|183.0|Standard Deviation|NA||||Standard deviation can not be calculated for 1 participant.
3663993|NCT02370602|3509011|B7|Sweden||Region of Enrollment||participants|Number|13|13.0||||||
3663995|NCT02370602|3509013|B5|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
3663996|NCT02370602|3509014|B4|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
3663997|NCT02370602|3509015|B3|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
3663998|NCT02370602|3509016|B2|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
3663999|NCT02370602|3509017|B1|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
3664000|NCT02370602|3509011|B7|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3664001|NCT02370602|3509012|B6|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3664002|NCT02370602|3509013|B5|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3664003|NCT02370602|3509014|B4|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3664004|NCT02370602|3509015|B3|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3664005|NCT02370602|3509016|B2|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3664006|NCT02370602|3509017|B1|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3664007|NCT02370602|3509011|B7||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3664008|NCT02370602|3509012|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3664009|NCT02370602|3509013|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3664010|NCT02370602|3509014|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3664011|NCT02370602|3509015|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3664012|NCT02370602|3509016|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3664013|NCT02370602|3509017|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3664014|NCT02370602|3509011|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3664015|NCT02370602|3509012|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3664016|NCT02370602|3509013|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3664017|NCT02370602|3509014|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3664018|NCT02370602|3509015|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3664019|NCT02370602|3509016|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3664020|NCT02370602|3509017|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3664021|NCT02370602|3509011|B7|||Age||years|Mean|29.2|29.2|Standard Deviation|6.08|6.08|||
3664022|NCT02370602|3509012|B6|||Age||years|Mean|27.0|27.0|Standard Deviation|1.41|1.41|||
3664023|NCT02370602|3509013|B5|||Age||years|Mean|26.7|26.7|Standard Deviation|3.51|3.51|||
3664024|NCT02370602|3509014|B4|||Age||years|Mean|37.7|37.7|Standard Deviation|7.09|7.09|||
3664025|NCT02370602|3509015|B3|||Age||years|Mean|26.5|26.5|Standard Deviation|0.71|0.71|||
3664026|NCT02370602|3509016|B2|||Age||years|Mean|27.5|27.5|Standard Deviation|4.95|4.95|||
3664027|NCT02370602|3509017|B1|||Age||years|Mean|24.0|24.0|Standard Deviation|NA||||Standard deviation can not be calculated for 1 participant.
3664028|NCT02370537|3509113|B4||Male|Gender||Participants|Count of Participants|182|182.0||||||
3664029|NCT02370537|3509114|B3||Male|Gender||Participants|Count of Participants|160|160.0||||||
3664030|NCT02370537|3509115|B2||Male|Gender||Participants|Count of Participants|11|11.0||||||
3664031|NCT02370537|3509116|B1||Male|Gender||Participants|Count of Participants|11|11.0||||||
3664032|NCT02370537|3509113|B4||Female|Gender||Participants|Count of Participants|133|133.0||||||
3664033|NCT02370537|3509114|B3||Female|Gender||Participants|Count of Participants|123|123.0||||||
3664034|NCT02370537|3509115|B2||Female|Gender||Participants|Count of Participants|5|5.0||||||
3664035|NCT02370537|3509116|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
3664036|NCT02370537|3509113|B4|Over 85 years||Age, Customized||Participants|Number|0|0.0||||||
3664037|NCT02370537|3509114|B3|Over 85 years||Age, Customized||Participants|Number|0|0.0||||||
3664038|NCT02370537|3509115|B2|Over 85 years||Age, Customized||Participants|Number|0|0.0||||||
3664039|NCT02370537|3509116|B1|Over 85 years||Age, Customized||Participants|Number|0|0.0||||||
3664040|NCT02370537|3509113|B4|From 65 - 84 years||Age, Customized||Participants|Number|122|122.0||||||
3664041|NCT02370537|3509114|B3|From 65 - 84 years||Age, Customized||Participants|Number|112|112.0||||||
3664042|NCT02370537|3509115|B2|From 65 - 84 years||Age, Customized||Participants|Number|5|5.0||||||
3664043|NCT02370537|3509116|B1|From 65 - 84 years||Age, Customized||Participants|Number|5|5.0||||||
3664044|NCT02370537|3509113|B4|From 18 - 64 years||Age, Customized||Participants|Number|193|193.0||||||
3664045|NCT02370537|3509114|B3|From 18 - 64 years||Age, Customized||Participants|Number|171|171.0||||||
3664046|NCT02370537|3509115|B2|From 18 - 64 years||Age, Customized||Participants|Number|11|11.0||||||
3664047|NCT02370537|3509116|B1|From 18 - 64 years||Age, Customized||Participants|Number|11|11.0||||||
3664048|NCT02370498|3509165|B3||≥6 months|Time To Progression (TTP) on first-line therapy||Participants|Count of Participants|224|224.0||||||
3664049|NCT02370498|3509166|B2||≥6 months|Time To Progression (TTP) on first-line therapy||Participants|Count of Participants|114|114.0||||||
3664050|NCT02370498|3509167|B1||≥6 months|Time To Progression (TTP) on first-line therapy||Participants|Count of Participants|110|110.0||||||
3664051|NCT02370498|3509165|B3||<6 months|Time To Progression (TTP) on first-line therapy||Participants|Count of Participants|368|368.0||||||
3664052|NCT02370498|3509166|B2||<6 months|Time To Progression (TTP) on first-line therapy||Participants|Count of Participants|182|182.0||||||
3664053|NCT02370498|3509167|B1||<6 months|Time To Progression (TTP) on first-line therapy||Participants|Count of Participants|186|186.0||||||
3664054|NCT02370498|3509165|B3|Unknown||PD-L1 Status||Participants|Count of Participants|2|2.0||||||
3664055|NCT02370498|3509166|B2|Unknown||PD-L1 Status||Participants|Count of Participants|1|1.0||||||
3664056|NCT02370498|3509167|B1|Unknown||PD-L1 Status||Participants|Count of Participants|1|1.0||||||
3664057|NCT02370498|3509165|B3|Negative||PD-L1 Status||Participants|Count of Participants|195|195.0||||||
3664058|NCT02370498|3509166|B2|Negative||PD-L1 Status||Participants|Count of Participants|96|96.0||||||
3664059|NCT02370498|3509167|B1|Negative||PD-L1 Status||Participants|Count of Participants|99|99.0||||||
3664060|NCT02370498|3509165|B3|Positive||PD-L1 Status||Participants|Count of Participants|395|395.0||||||
3664061|NCT02370498|3509166|B2|Positive||PD-L1 Status||Participants|Count of Participants|199|199.0||||||
3664062|NCT02370498|3509167|B1|Positive||PD-L1 Status||Participants|Count of Participants|196|196.0||||||
3664063|NCT02370498|3509165|B3|Rest of World||Region of Enrollment||Participants|Number|38|38.0||||||
3664064|NCT02370498|3509166|B2|Rest of World||Region of Enrollment||Participants|Number|20|20.0||||||
3664065|NCT02370498|3509167|B1|Rest of World||Region of Enrollment||Participants|Number|18|18.0||||||
3664066|NCT02370498|3509165|B3|Asia||Region of Enrollment||Participants|Number|177|177.0||||||
3664067|NCT02370498|3509166|B2|Asia||Region of Enrollment||Participants|Number|89|89.0||||||
3664068|NCT02370498|3509167|B1|Asia||Region of Enrollment||Participants|Number|88|88.0||||||
3664069|NCT02370498|3509165|B3|Europe/Israel/North America/Australia||Region of Enrollment||Participants|Number|377|377.0||||||
3664070|NCT02370498|3509166|B2|Europe/Israel/North America/Australia||Region of Enrollment||Participants|Number|187|187.0||||||
3664071|NCT02370498|3509167|B1|Europe/Israel/North America/Australia||Region of Enrollment||Participants|Number|190|190.0||||||
3664072|NCT02370498|3509165|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664073|NCT02370498|3509166|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664074|NCT02370498|3509167|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664075|NCT02370498|3509165|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3664076|NCT02370498|3509166|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3664077|NCT02370498|3509167|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3664078|NCT02370498|3509165|B3||White|Race (NIH/OMB)||Participants|Count of Participants|391|391.0||||||
3664079|NCT02370498|3509166|B2||White|Race (NIH/OMB)||Participants|Count of Participants|198|198.0||||||
3664080|NCT02370498|3509167|B1||White|Race (NIH/OMB)||Participants|Count of Participants|193|193.0||||||
3664081|NCT02370498|3509165|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3664082|NCT02370498|3509166|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3664083|NCT02370498|3509167|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3664084|NCT02370498|3509165|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664085|NCT02370498|3509166|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664086|NCT02370498|3509167|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664087|NCT02370498|3509165|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|184|184.0||||||
3664088|NCT02370498|3509166|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3664089|NCT02370498|3509167|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
3664090|NCT02370498|3509165|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3664091|NCT02370498|3509166|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3664092|NCT02370498|3509167|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3664093|NCT02370498|3509165|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664094|NCT02370498|3509166|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664095|NCT02370498|3509167|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664096|NCT02370498|3509165|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|541|541.0||||||
3664097|NCT02370498|3509166|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|272|272.0||||||
3664098|NCT02370498|3509167|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|269|269.0||||||
3664099|NCT02370498|3509165|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3664100|NCT02370498|3509166|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3664101|NCT02370498|3509167|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3664102|NCT02370498|3509165|B3||Male|Sex: Female, Male||Participants|Count of Participants|410|410.0||||||
3664103|NCT02370498|3509166|B2||Male|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
3664104|NCT02370498|3509167|B1||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3664105|NCT02370498|3509165|B3||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3664106|NCT02370498|3509166|B2||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3664107|NCT02370498|3509167|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3664108|NCT02370498|3509165|B3|||Age||Years|Mean|60.2|60.2|Standard Deviation|11.9|11.9|||
3664109|NCT02370498|3509166|B2|||Age||Years|Mean|59.6|59.6|Standard Deviation|11.7|11.7|||
3664110|NCT02370498|3509167|B1|||Age||Years|Mean|60.7|60.7|Standard Deviation|12.0|12.0|||
3664111|NCT02370420|3509220|B3|||Visual Analog Scale (VAS)|We used the Visual Analog Scale (VAS) to measure global pain on all patients. The scale used consisted on a 10 cm line divided in 10 equal parts. According to this, the possible values ranged from 0 (zero) to 10. The highest score (10) represented the highest level of pain.|cm|Mean|7.03|7.03|Standard Deviation|2.34|2.34|||
3664112|NCT02370420|3509221|B2|||Visual Analog Scale (VAS)|We used the Visual Analog Scale (VAS) to measure global pain on all patients. The scale used consisted on a 10 cm line divided in 10 equal parts. According to this, the possible values ranged from 0 (zero) to 10. The highest score (10) represented the highest level of pain.|cm|Mean|6.46|6.46|Standard Deviation|2.47|2.47|||
3664113|NCT02370420|3509222|B1|||Visual Analog Scale (VAS)|We used the Visual Analog Scale (VAS) to measure global pain on all patients. The scale used consisted on a 10 cm line divided in 10 equal parts. According to this, the possible values ranged from 0 (zero) to 10. The highest score (10) represented the highest level of pain.|cm|Mean|7.06|7.06|Standard Deviation|2.21|2.21|||
3664114|NCT02370420|3509220|B3|||Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)|We used the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index to assess the overall clinical effectiveness of the two treatments. This index is composed by three categories: pain, articular stiffness, and functional limitation. The survey consists of 24 elements ranged from 0 (zero) to 4, with a higher value indicating a worst outcome. Thus, a reported value can range from 0 to 96. The values displayed correspond to the total WOMAC values integrated by the summatory of the three categories.|units on a scale|Mean|41.13|41.13|Standard Deviation|17.75|17.75|||
3664115|NCT02370420|3509221|B2|||Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)|We used the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index to assess the overall clinical effectiveness of the two treatments. This index is composed by three categories: pain, articular stiffness, and functional limitation. The survey consists of 24 elements ranged from 0 (zero) to 4, with a higher value indicating a worst outcome. Thus, a reported value can range from 0 to 96. The values displayed correspond to the total WOMAC values integrated by the summatory of the three categories.|units on a scale|Mean|41|41.0|Standard Deviation|16.50|16.5|||
3664116|NCT02370420|3509222|B1|||Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)|We used the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index to assess the overall clinical effectiveness of the two treatments. This index is composed by three categories: pain, articular stiffness, and functional limitation. The survey consists of 24 elements ranged from 0 (zero) to 4, with a higher value indicating a worst outcome. Thus, a reported value can range from 0 to 96. The values displayed correspond to the total WOMAC values integrated by the summatory of the three categories.|units on a scale|Mean|41.27|41.27|Standard Deviation|19|19.0|||
3664117|NCT02370420|3509220|B3|||Physical Component of the Short Form-12 of the Health Survey (SF-12)|"We used the Spanish (México) version of the Short Form-12 of the Health Survey (SF-12) to assess the quality of life of the patient. This survey evaluates 2 main components: one physical and one mental, and each one is composed by 4 elements. The total value displayed represents the summatory of all the elements evaluated by the survey in the physical component.~A higher value indicates a better quality of life. The scores range from 0 to 100. The data obtained with the SF-12 has been developed, tested and validated by Quality Metric Incorporated."|units on a scale|Mean|35.43|35.43|Standard Deviation|8.18|8.18|||
3664118|NCT02370420|3509221|B2|||Physical Component of the Short Form-12 of the Health Survey (SF-12)|"We used the Spanish (México) version of the Short Form-12 of the Health Survey (SF-12) to assess the quality of life of the patient. This survey evaluates 2 main components: one physical and one mental, and each one is composed by 4 elements. The total value displayed represents the summatory of all the elements evaluated by the survey in the physical component.~A higher value indicates a better quality of life. The scores range from 0 to 100. The data obtained with the SF-12 has been developed, tested and validated by Quality Metric Incorporated."|units on a scale|Mean|37.25|37.25|Standard Deviation|7.19|7.19|||
3664119|NCT02370420|3509222|B1|||Physical Component of the Short Form-12 of the Health Survey (SF-12)|"We used the Spanish (México) version of the Short Form-12 of the Health Survey (SF-12) to assess the quality of life of the patient. This survey evaluates 2 main components: one physical and one mental, and each one is composed by 4 elements. The total value displayed represents the summatory of all the elements evaluated by the survey in the physical component.~A higher value indicates a better quality of life. The scores range from 0 to 100. The data obtained with the SF-12 has been developed, tested and validated by Quality Metric Incorporated."|units on a scale|Mean|33.61|33.61|Standard Deviation|9.14|9.14|||
3664120|NCT02370420|3509220|B3|Mexico||Region of Enrollment||participants|Number|30|30.0||||||
3664121|NCT02370420|3509221|B2|Mexico||Region of Enrollment||participants|Number|15|15.0||||||
3664122|NCT02370420|3509222|B1|Mexico||Region of Enrollment||participants|Number|15|15.0||||||
3664123|NCT02370420|3509220|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3664124|NCT02370420|3509221|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3664125|NCT02370420|3509222|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3664126|NCT02370420|3509220|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3664127|NCT02370420|3509221|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3664128|NCT02370420|3509222|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3664129|NCT02370420|3509220|B3|||Age||years|Mean|56.61|56.61|Standard Deviation|10.93|10.93|||
3664130|NCT02370420|3509221|B2|||Age||years|Mean|58.77|58.77|Standard Deviation|11.19|11.19|||
3664131|NCT02370420|3509222|B1|||Age||years|Mean|54.46|54.46|Standard Deviation|10.68|10.68|||
3664132|NCT02370420|3509220|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3664133|NCT02370420|3509221|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3664134|NCT02370420|3509222|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3664135|NCT02370420|3509220|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3664136|NCT02370420|3509221|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3664137|NCT02370420|3509222|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3664138|NCT02370420|3509220|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3664139|NCT02370420|3509221|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3664140|NCT02370420|3509222|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3664141|NCT02370407|3509233|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3664142|NCT02370407|3509234|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3664143|NCT02370407|3509235|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3664144|NCT02370407|3509233|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3664145|NCT02370407|3509234|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3664146|NCT02370407|3509235|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3664147|NCT02370407|3509233|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3664148|NCT02370407|3509234|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3664149|NCT02370407|3509235|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3664150|NCT02370407|3509233|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3664151|NCT02370407|3509234|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3664152|NCT02370407|3509235|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3664153|NCT02370407|3509233|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3664154|NCT02370407|3509234|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3664155|NCT02370407|3509235|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3664156|NCT02370394|3509258|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3664157|NCT02370394|3509259|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3664158|NCT02370394|3509260|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3664159|NCT02370394|3509258|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3664160|NCT02370394|3509259|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3664161|NCT02370394|3509260|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3664162|NCT02370394|3509258|B3|||Age||years|Mean|27.64|27.64|Full Range|||18.0|37.0|
3664163|NCT02370394|3509259|B2|||Age||years|Mean|28.32|28.32|Full Range|||18.0|36.0|
3664164|NCT02370394|3509260|B1|||Age||years|Mean|27.03|27.03|Full Range|||18.0|37.0|
3664165|NCT02370394|3509258|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3664166|NCT02370394|3509259|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3664167|NCT02370394|3509260|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3664168|NCT02370394|3509258|B3||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3664169|NCT02370394|3509259|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3664170|NCT02370394|3509260|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3664171|NCT02370394|3509258|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3664172|NCT02370394|3509259|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3664173|NCT02370394|3509260|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3664174|NCT02370121|3509275|B3|||Insulin sensitivity|Insulin sensitivity was calculated with Matsuda index [10,000 / √glucose 0' x insulin 0') (mean glucose oral glucose tolerance test (OGTT) x mean insulin OGTT)].|unitless|Mean|3.6|3.6|Standard Deviation|1.5|1.5|||
3664175|NCT02370121|3509276|B2|||Insulin sensitivity|Insulin sensitivity was calculated with Matsuda index [10,000 / √glucose 0' x insulin 0') (mean glucose oral glucose tolerance test (OGTT) x mean insulin OGTT)].|unitless|Mean|3.8|3.8|Standard Deviation|1.1|1.1|||
3664176|NCT02370121|3509277|B1|||Insulin sensitivity|Insulin sensitivity was calculated with Matsuda index [10,000 / √glucose 0' x insulin 0') (mean glucose oral glucose tolerance test (OGTT) x mean insulin OGTT)].|unitless|Mean|3.3|3.3|Standard Deviation|1.9|1.9|||
3664177|NCT02370121|3509275|B3|||First phase of insulin secretion|First phase of insulin secretion was estimated using the Stumvoll index (1283+ 1.829 x insulin 30' - 138.7 x glucose 30' + 3.772 x insulin 0').|unitless|Mean|1431|1431.0|Standard Deviation|596|596.0|||
3664178|NCT02370121|3509276|B2|||First phase of insulin secretion|First phase of insulin secretion was estimated using the Stumvoll index (1283+ 1.829 x insulin 30' - 138.7 x glucose 30' + 3.772 x insulin 0').|unitless|Mean|1458|1458.0|Standard Deviation|510|510.0|||
3664179|NCT02370121|3509277|B1|||First phase of insulin secretion|First phase of insulin secretion was estimated using the Stumvoll index (1283+ 1.829 x insulin 30' - 138.7 x glucose 30' + 3.772 x insulin 0').|unitless|Mean|1403|1403.0|Standard Deviation|682|682.0|||
3664180|NCT02370121|3509275|B3|||Total insulin secretion|Total insulin secretion was calculated with the insulinogenic index (ΔABC insulin / ΔABC glucose).|unitless|Mean|0.59|0.59|Standard Deviation|0.57|0.57|||
3664181|NCT02370121|3509276|B2|||Total insulin secretion|Total insulin secretion was calculated with the insulinogenic index (ΔABC insulin / ΔABC glucose).|unitless|Mean|0.57|0.57|Standard Deviation|0.24|0.24|||
3664182|NCT02370121|3509277|B1|||Total insulin secretion|Total insulin secretion was calculated with the insulinogenic index (ΔABC insulin / ΔABC glucose).|unitless|Mean|0.61|0.61|Standard Deviation|0.33|0.33|||
3664183|NCT02370121|3509275|B3|||Area under the curve of insulin (AUCI)|The estimation for AUCI was calculated from parameters obtained during the 2 hours oral glucose tolerant test (OGTT) with 75 g dextrose by trapezoidal integration. The value was expressed on pmol/L/min.|pmol/L/min|Mean|62970|62970.0|Standard Deviation|32307|32307.0|||
3664184|NCT02370121|3509276|B2|||Area under the curve of insulin (AUCI)|The estimation for AUCI was calculated from parameters obtained during the 2 hours oral glucose tolerant test (OGTT) with 75 g dextrose by trapezoidal integration. The value was expressed on pmol/L/min.|pmol/L/min|Mean|61626|61626.0|Standard Deviation|29700|29700.0|||
3664185|NCT02370121|3509277|B1|||Area under the curve of insulin (AUCI)|The estimation for AUCI was calculated from parameters obtained during the 2 hours oral glucose tolerant test (OGTT) with 75 g dextrose by trapezoidal integration. The value was expressed on pmol/L/min.|pmol/L/min|Mean|64314|64314.0|Standard Deviation|34914|34914.0|||
3664186|NCT02370121|3509275|B3|||Area under the curve of glucose (AUCG)|The estimation for AUCG was calculated from parameters obtained during the 2 hours oral glucose tolerant test (OGTT) with 75 g dextrose by trapezoidal integration. The value was expressed mmol/L/min.|mmol/L/min|Mean|976|976.0|Standard Deviation|168|168.0|||
3664187|NCT02370121|3509276|B2|||Area under the curve of glucose (AUCG)|The estimation for AUCG was calculated from parameters obtained during the 2 hours oral glucose tolerant test (OGTT) with 75 g dextrose by trapezoidal integration. The value was expressed mmol/L/min.|mmol/L/min|Mean|979|979.0|Standard Deviation|182|182.0|||
3664188|NCT02370121|3509277|B1|||Area under the curve of glucose (AUCG)|The estimation for AUCG was calculated from parameters obtained during the 2 hours oral glucose tolerant test (OGTT) with 75 g dextrose by trapezoidal integration. The value was expressed mmol/L/min.|mmol/L/min|Mean|972|972.0|Standard Deviation|154|154.0|||
3664189|NCT02370121|3509275|B3|||2-hour postload plasma glucose (2-h PG)|The blood sample for determining of 2-h PG, was taken two hours after the ingestion of the drink with 75 g dextrose and was evaluated by spectrophotometry method. The value was expressed on mmol/L.|mmol/L|Mean|7.67|7.67|Standard Deviation|184|184.0|||
3664190|NCT02370121|3509276|B2|||2-hour postload plasma glucose (2-h PG)|The blood sample for determining of 2-h PG, was taken two hours after the ingestion of the drink with 75 g dextrose and was evaluated by spectrophotometry method. The value was expressed on mmol/L.|mmol/L|Mean|7.61|7.61|Standard Deviation|1.89|1.89|||
3664191|NCT02370121|3509277|B1|||2-hour postload plasma glucose (2-h PG)|The blood sample for determining of 2-h PG, was taken two hours after the ingestion of the drink with 75 g dextrose and was evaluated by spectrophotometry method. The value was expressed on mmol/L.|mmol/L|Mean|7.72|7.72|Standard Deviation|1.78|1.78|||
3664192|NCT02370121|3509275|B3|||Fasting plasma glucose (FPG)|The blood sample for determining of FPG, was taken after an overnight fast and was evaluated by spectrophotometry method. The value was expressed on mmol/L.|mmol/L|Mean|5.09|5.09|Standard Deviation|0.58|0.58|||
3664193|NCT02370121|3509276|B2|||Fasting plasma glucose (FPG)|The blood sample for determining of FPG, was taken after an overnight fast and was evaluated by spectrophotometry method. The value was expressed on mmol/L.|mmol/L|Mean|5.22|5.22|Standard Deviation|0.72|0.72|||
3664194|NCT02370121|3509277|B1|||Fasting plasma glucose (FPG)|The blood sample for determining of FPG, was taken after an overnight fast and was evaluated by spectrophotometry method. The value was expressed on mmol/L.|mmol/L|Mean|4.97|4.97|Standard Deviation|0.44|0.44|||
3664195|NCT02370121|3509275|B3|||Very-low density lipoprotein (VLDL)|The blood sample for determining the VLDL, was taken after an overnight fast and was calculated as triglycerides/5 . The value was expressed on mmol/L.|mmol/L|Mean|0.49|0.49|Standard Deviation|0.16|0.16|||
3664196|NCT02370121|3509276|B2|||Very-low density lipoprotein (VLDL)|The blood sample for determining the VLDL, was taken after an overnight fast and was calculated as triglycerides/5 . The value was expressed on mmol/L.|mmol/L|Mean|0.45|0.45|Standard Deviation|0.15|0.15|||
3664197|NCT02370121|3509277|B1|||Very-low density lipoprotein (VLDL)|The blood sample for determining the VLDL, was taken after an overnight fast and was calculated as triglycerides/5 . The value was expressed on mmol/L.|mmol/L|Mean|0.54|0.54|Standard Deviation|0.17|0.17|||
3664198|NCT02370121|3509275|B3|||Low-density lipoprotein cholesterol (LDL-C)|The blood sample for determining of LDL-C, was taken after an overnight fast and was calculated by Friedewald formula. The value was expressed on mmol/L.|mmol/L|Mean|2.15|2.15|Standard Deviation|0.52|0.52|||
3664199|NCT02370121|3509276|B2|||Low-density lipoprotein cholesterol (LDL-C)|The blood sample for determining of LDL-C, was taken after an overnight fast and was calculated by Friedewald formula. The value was expressed on mmol/L.|mmol/L|Mean|2.48|2.48|Standard Deviation|0.93|0.93|||
3664200|NCT02370121|3509277|B1|||Low-density lipoprotein cholesterol (LDL-C)|The blood sample for determining of LDL-C, was taken after an overnight fast and was calculated by Friedewald formula. The value was expressed on mmol/L.|mmol/L|Mean|2.12|2.12|Standard Deviation|0.59|0.59|||
3664201|NCT02370121|3509275|B3|||high-density lipoprotein cholesterol (HDL-C)|The blood sample for determining of HDL-C, was taken after an overnight fast and was evaluated by colorimetric method. The value was expressed on mmol/L.|mmol/L|Mean|1.04|1.04|Standard Deviation|0.22|0.22|||
3664202|NCT02370121|3509276|B2|||high-density lipoprotein cholesterol (HDL-C)|The blood sample for determining of HDL-C, was taken after an overnight fast and was evaluated by colorimetric method. The value was expressed on mmol/L.|mmol/L|Mean|1.11|1.11|Standard Deviation|0.18|0.18|||
3664203|NCT02370121|3509277|B1|||high-density lipoprotein cholesterol (HDL-C)|The blood sample for determining of HDL-C, was taken after an overnight fast and was evaluated by colorimetric method. The value was expressed on mmol/L.|mmol/L|Mean|1.00|1.0|Standard Deviation|0.23|0.23|||
3664204|NCT02370121|3509275|B3|||Total cholesterol (TC)|The blood sample for determining of TC, was taken after an overnight fast and was evaluated by spectrophotometry method. The value was expressed on mmol/L.|mmol/L|Mean|4.59|4.59|Standard Deviation|0.63|0.63|||
3664205|NCT02370121|3509276|B2|||Total cholesterol (TC)|The blood sample for determining of TC, was taken after an overnight fast and was evaluated by spectrophotometry method. The value was expressed on mmol/L.|mmol/L|Mean|4.60|4.6|Standard Deviation|1.06|1.06|||
3664206|NCT02370121|3509277|B1|||Total cholesterol (TC)|The blood sample for determining of TC, was taken after an overnight fast and was evaluated by spectrophotometry method. The value was expressed on mmol/L.|mmol/L|Mean|4.53|4.53|Standard Deviation|0.52|0.52|||
3664207|NCT02370121|3509275|B3|||Triglycerides (TGs)|The blood sample for determining of TGs, was taken after an overnight fast and was evaluated by spectrophotometry method. The value was expressed on mmol/L.|mmol/L|Mean|2.69|2.69|Standard Deviation|0.90|0.9|||
3664208|NCT02370121|3509276|B2|||Triglycerides (TGs)|The blood sample for determining of TGs, was taken after an overnight fast and was evaluated by spectrophotometry method. The value was expressed on mmol/L.|mmol/L|Mean|2.37|2.37|Standard Deviation|1.03|1.03|||
3664209|NCT02370121|3509277|B1|||Triglycerides (TGs)|The blood sample for determining of TGs, was taken after an overnight fast and was evaluated by spectrophotometry method. The value was expressed on mmol/L.|mmol/L|Mean|2.91|2.91|Standard Deviation|0.93|0.93|||
3664210|NCT02370121|3509275|B3|||Diastolic blood pressure (DBP)|The DBP was evaluated with a digital sphygmomanometer with the subject sited down on a chair after a resting period of 5 minutes on three occasions. The mean of the three measures was considered as the value of DBP. The value was expressed on mmHg.|mmHg|Mean|81|81.0|Standard Deviation|6|6.0|||
3664251|NCT02369848|3509316|B1||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3664252|NCT02369848|3509316|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664211|NCT02370121|3509276|B2|||Diastolic blood pressure (DBP)|The DBP was evaluated with a digital sphygmomanometer with the subject sited down on a chair after a resting period of 5 minutes on three occasions. The mean of the three measures was considered as the value of DBP. The value was expressed on mmHg.|mmHg|Mean|79|79.0|Standard Deviation|5|5.0|||
3664212|NCT02370121|3509277|B1|||Diastolic blood pressure (DBP)|The DBP was evaluated with a digital sphygmomanometer with the subject sited down on a chair after a resting period of 5 minutes on three occasions. The mean of the three measures was considered as the value of DBP. The value was expressed on mmHg.|mmHg|Mean|81|81.0|Standard Deviation|7|7.0|||
3664213|NCT02370121|3509275|B3|||Systolic blood pressure (SBP)|The SBP was evaluated with a digital sphygmomanometer with the subject sited down on a chair after a resting period of 5 minutes on three occasions. The mean of the three measures was considered as the value of SBP. The value was expressed on mmHg.|mmHg|Mean|122|122.0|Standard Deviation|15|15.0|||
3664214|NCT02370121|3509276|B2|||Systolic blood pressure (SBP)|The SBP was evaluated with a digital sphygmomanometer with the subject sited down on a chair after a resting period of 5 minutes on three occasions. The mean of the three measures was considered as the value of SBP. The value was expressed on mmHg.|mmHg|Mean|121|121.0|Standard Deviation|10|10.0|||
3664215|NCT02370121|3509277|B1|||Systolic blood pressure (SBP)|The SBP was evaluated with a digital sphygmomanometer with the subject sited down on a chair after a resting period of 5 minutes on three occasions. The mean of the three measures was considered as the value of SBP. The value was expressed on mmHg.|mmHg|Mean|123|123.0|Standard Deviation|11|11.0|||
3664216|NCT02370121|3509275|B3|||Waist circumference (WC)|The WC was evaluated after an overnight fast with a flexible tape in the midpoint between the lowest rib and the iliac crest and is expressed in centimeters.|cm|Mean|98|98.0|Standard Deviation|14|14.0|||
3664217|NCT02370121|3509276|B2|||Waist circumference (WC)|The WC was evaluated after an overnight fast with a flexible tape in the midpoint between the lowest rib and the iliac crest and is expressed in centimeters.|cm|Mean|99|99.0|Standard Deviation|10|10.0|||
3664218|NCT02370121|3509277|B1|||Waist circumference (WC)|The WC was evaluated after an overnight fast with a flexible tape in the midpoint between the lowest rib and the iliac crest and is expressed in centimeters.|cm|Mean|98|98.0|Standard Deviation|14|14.0|||
3664219|NCT02370121|3509275|B3|||Body mass index (BMI)|The BMI was calculated by the square of the body height, and is universally expressed in units of kg/m2, resulting from mass in kilograms and height in metres.|kg/m^2|Mean|30.56|30.56|Standard Deviation|2.98|2.98|||
3664220|NCT02370121|3509276|B2|||Body mass index (BMI)|The BMI was calculated by the square of the body height, and is universally expressed in units of kg/m2, resulting from mass in kilograms and height in metres.|kg/m^2|Mean|31.24|31.24|Standard Deviation|2.55|2.55|||
3664221|NCT02370121|3509277|B1|||Body mass index (BMI)|The BMI was calculated by the square of the body height, and is universally expressed in units of kg/m2, resulting from mass in kilograms and height in metres.|kg/m^2|Mean|30.29|30.29|Standard Deviation|3.21|3.21|||
3664222|NCT02370121|3509275|B3|||Body weight (BW)|The BW was evaluated after an overnight fast, through a bioimpedance digital scale results are reported in kilograms with a decimal.|kg|Mean|80.2|80.2|Standard Deviation|15.4|15.4|||
3664223|NCT02370121|3509276|B2|||Body weight (BW)|The BW was evaluated after an overnight fast, through a bioimpedance digital scale results are reported in kilograms with a decimal.|kg|Mean|81.3|81.3|Standard Deviation|10.6|10.6|||
3664224|NCT02370121|3509277|B1|||Body weight (BW)|The BW was evaluated after an overnight fast, through a bioimpedance digital scale results are reported in kilograms with a decimal.|kg|Mean|78.8|78.8|Standard Deviation|16.1|16.1|||
3664225|NCT02370121|3509275|B3|Mexico||Region of Enrollment||participants|Number|24|24.0||||||
3664226|NCT02370121|3509276|B2|Mexico||Region of Enrollment||participants|Number|12|12.0||||||
3664227|NCT02370121|3509277|B1|Mexico||Region of Enrollment||participants|Number|12|12.0||||||
3664228|NCT02370121|3509275|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664229|NCT02370121|3509276|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664230|NCT02370121|3509277|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664231|NCT02370121|3509275|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664232|NCT02370121|3509276|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664233|NCT02370121|3509277|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664234|NCT02370121|3509275|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3664235|NCT02370121|3509276|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3664236|NCT02370121|3509277|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3664237|NCT02370121|3509275|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3664238|NCT02370121|3509276|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3664239|NCT02370121|3509277|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3664240|NCT02370121|3509275|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3664241|NCT02370121|3509276|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3664242|NCT02370121|3509277|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3664243|NCT02370121|3509275|B3|||Age||years|Mean|42|42.0|Standard Deviation|4|4.0|||
3664244|NCT02370121|3509276|B2|||Age||years|Mean|43|43.0|Standard Deviation|1|1.0|||
3664245|NCT02370121|3509277|B1|||Age||years|Mean|41|41.0|Standard Deviation|4|4.0|||
3664246|NCT02369848|3509316|B1|Germany||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3664247|NCT02369848|3509316|B1|Austria||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3664248|NCT02369848|3509316|B1|New Zealand||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3664249|NCT02369848|3509316|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3664250|NCT02369848|3509316|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664253|NCT02369848|3509316|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664254|NCT02369848|3509316|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664255|NCT02369848|3509316|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664256|NCT02369848|3509316|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3664257|NCT02369848|3509316|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3664258|NCT02369848|3509316|B1||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
3664259|NCT02369848|3509316|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3664260|NCT02369848|3509316|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3664261|NCT02369796|3509330|B6|No||Caffeine Consumption||participants|Number|1|1.0||||||
3664262|NCT02369796|3509331|B5|No||Caffeine Consumption||participants|Number|0|0.0||||||
3664263|NCT02369796|3509332|B4|No||Caffeine Consumption||participants|Number|1|1.0||||||
3664264|NCT02369796|3509333|B3|No||Caffeine Consumption||participants|Number|0|0.0||||||
3664265|NCT02369796|3509334|B2|No||Caffeine Consumption||participants|Number|0|0.0||||||
3664266|NCT02369796|3509335|B1|No||Caffeine Consumption||participants|Number|0|0.0||||||
3664267|NCT02369796|3509330|B6|Yes||Caffeine Consumption||participants|Number|14|14.0||||||
3664268|NCT02369796|3509331|B5|Yes||Caffeine Consumption||participants|Number|3|3.0||||||
3664269|NCT02369796|3509332|B4|Yes||Caffeine Consumption||participants|Number|2|2.0||||||
3664270|NCT02369796|3509333|B3|Yes||Caffeine Consumption||participants|Number|3|3.0||||||
3664271|NCT02369796|3509334|B2|Yes||Caffeine Consumption||participants|Number|3|3.0||||||
3664272|NCT02369796|3509335|B1|Yes||Caffeine Consumption||participants|Number|3|3.0||||||
3664273|NCT02369796|3509330|B6|Is an ex-drinker||Alcohol Classification||participants|Number|4|4.0||||||
3664274|NCT02369796|3509331|B5|Is an ex-drinker||Alcohol Classification||participants|Number|1|1.0||||||
3664275|NCT02369796|3509332|B4|Is an ex-drinker||Alcohol Classification||participants|Number|1|1.0||||||
3664276|NCT02369796|3509333|B3|Is an ex-drinker||Alcohol Classification||participants|Number|1|1.0||||||
3664277|NCT02369796|3509334|B2|Is an ex-drinker||Alcohol Classification||participants|Number|1|1.0||||||
3664278|NCT02369796|3509335|B1|Is an ex-drinker||Alcohol Classification||participants|Number|0|0.0||||||
3664279|NCT02369796|3509330|B6|Is current drinker||Alcohol Classification||participants|Number|10|10.0||||||
3664280|NCT02369796|3509331|B5|Is current drinker||Alcohol Classification||participants|Number|2|2.0||||||
3664281|NCT02369796|3509332|B4|Is current drinker||Alcohol Classification||participants|Number|2|2.0||||||
3664282|NCT02369796|3509333|B3|Is current drinker||Alcohol Classification||participants|Number|1|1.0||||||
3664283|NCT02369796|3509334|B2|Is current drinker||Alcohol Classification||participants|Number|2|2.0||||||
3664284|NCT02369796|3509335|B1|Is current drinker||Alcohol Classification||participants|Number|3|3.0||||||
3664285|NCT02369796|3509330|B6|Has never drunk||Alcohol Classification||participants|Number|1|1.0||||||
3664286|NCT02369796|3509331|B5|Has never drunk||Alcohol Classification||participants|Number|0|0.0||||||
3664287|NCT02369796|3509332|B4|Has never drunk||Alcohol Classification||participants|Number|0|0.0||||||
3664288|NCT02369796|3509333|B3|Has never drunk||Alcohol Classification||participants|Number|1|1.0||||||
3664289|NCT02369796|3509334|B2|Has never drunk||Alcohol Classification||participants|Number|0|0.0||||||
3664290|NCT02369796|3509335|B1|Has never drunk||Alcohol Classification||participants|Number|0|0.0||||||
3664291|NCT02369796|3509330|B6|Is an ex-smoker||Smoking Classification||participants|Number|9|9.0||||||
3664292|NCT02369796|3509331|B5|Is an ex-smoker||Smoking Classification||participants|Number|2|2.0||||||
3664293|NCT02369796|3509332|B4|Is an ex-smoker||Smoking Classification||participants|Number|2|2.0||||||
3664294|NCT02369796|3509333|B3|Is an ex-smoker||Smoking Classification||participants|Number|2|2.0||||||
3664295|NCT02369796|3509334|B2|Is an ex-smoker||Smoking Classification||participants|Number|3|3.0||||||
3664296|NCT02369796|3509335|B1|Is an ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3664297|NCT02369796|3509330|B6|Is current smoker||Smoking Classification||participants|Number|1|1.0||||||
3664298|NCT02369796|3509331|B5|Is current smoker||Smoking Classification||participants|Number|0|0.0||||||
3664299|NCT02369796|3509332|B4|Is current smoker||Smoking Classification||participants|Number|0|0.0||||||
3664300|NCT02369796|3509333|B3|Is current smoker||Smoking Classification||participants|Number|1|1.0||||||
3664301|NCT02369796|3509334|B2|Is current smoker||Smoking Classification||participants|Number|0|0.0||||||
3664302|NCT02369796|3509335|B1|Is current smoker||Smoking Classification||participants|Number|0|0.0||||||
3664303|NCT02369796|3509330|B6|Has never smoked||Smoking Classification||participants|Number|5|5.0||||||
3664304|NCT02369796|3509331|B5|Has never smoked||Smoking Classification||participants|Number|1|1.0||||||
3664305|NCT02369796|3509332|B4|Has never smoked||Smoking Classification||participants|Number|1|1.0||||||
3664306|NCT02369796|3509333|B3|Has never smoked||Smoking Classification||participants|Number|0|0.0||||||
3664307|NCT02369796|3509334|B2|Has never smoked||Smoking Classification||participants|Number|0|0.0||||||
3664308|NCT02369796|3509335|B1|Has never smoked||Smoking Classification||participants|Number|3|3.0||||||
3664309|NCT02369796|3509330|B6|||Body Mass Index||kg/m^2|Mean|36|36.0|Standard Deviation|4|4.0|||
3664310|NCT02369796|3509331|B5|||Body Mass Index||kg/m^2|Mean|34|34.0|Standard Deviation|4|4.0|||
3664311|NCT02369796|3509332|B4|||Body Mass Index||kg/m^2|Mean|36|36.0|Standard Deviation|2|2.0|||
3664312|NCT02369796|3509333|B3|||Body Mass Index||kg/m^2|Mean|36|36.0|Standard Deviation|2|2.0|||
3664313|NCT02369796|3509334|B2|||Body Mass Index||kg/m^2|Mean|37|37.0|Standard Deviation|1|1.0|||
3664314|NCT02369796|3509335|B1|||Body Mass Index||kg/m^2|Mean|36|36.0|Standard Deviation|8|8.0|||
3664315|NCT02369796|3509330|B6|||Weight||kg|Mean|112|112.0|Standard Deviation|19|19.0|||
3664316|NCT02369796|3509331|B5|||Weight||kg|Mean|110|110.0|Standard Deviation|26|26.0|||
3664317|NCT02369796|3509332|B4|||Weight||kg|Mean|115|115.0|Standard Deviation|7|7.0|||
3664318|NCT02369796|3509333|B3|||Weight||kg|Mean|119|119.0|Standard Deviation|26|26.0|||
3664319|NCT02369796|3509334|B2|||Weight||kg|Mean|113|113.0|Standard Deviation|10|10.0|||
3664320|NCT02369796|3509335|B1|||Weight||kg|Mean|104|104.0|Standard Deviation|30|30.0|||
3664321|NCT02369796|3509330|B6|||Height||cm|Mean|176|176.0|Standard Deviation|10|10.0|||
3664322|NCT02369796|3509331|B5|||Height||cm|Mean|178|178.0|Standard Deviation|12|12.0|||
3664323|NCT02369796|3509332|B4|||Height||cm|Mean|178|178.0|Standard Deviation|6|6.0|||
3664324|NCT02369796|3509333|B3|||Height||cm|Mean|181|181.0|Standard Deviation|18|18.0|||
3664325|NCT02369796|3509334|B2|||Height||cm|Mean|174|174.0|Standard Deviation|6|6.0|||
3664326|NCT02369796|3509335|B1|||Height||cm|Mean|168|168.0|Standard Deviation|7|7.0|||
3664327|NCT02369796|3509330|B6|United Kingdom||Region of Enrollment||participants|Number|15|15.0||||||
3664328|NCT02369796|3509331|B5|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3664329|NCT02369796|3509332|B4|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3664330|NCT02369796|3509333|B3|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3664331|NCT02369796|3509334|B2|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3664332|NCT02369796|3509335|B1|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3664333|NCT02369796|3509330|B6|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3664334|NCT02369796|3509331|B5|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3664335|NCT02369796|3509332|B4|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3664336|NCT02369796|3509333|B3|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3664337|NCT02369796|3509334|B2|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3664338|NCT02369796|3509335|B1|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3664339|NCT02369796|3509330|B6|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3664340|NCT02369796|3509331|B5|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3664341|NCT02369796|3509332|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3664342|NCT02369796|3509333|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3664343|NCT02369796|3509334|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3664344|NCT02369796|3509335|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3664345|NCT02369796|3509330|B6||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3664346|NCT02369796|3509331|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3664347|NCT02369796|3509332|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3664348|NCT02369796|3509333|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3664349|NCT02369796|3509334|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3664350|NCT02369796|3509335|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3664351|NCT02369796|3509330|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3664352|NCT02369796|3509331|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3664353|NCT02369796|3509332|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3664354|NCT02369796|3509333|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3664355|NCT02369796|3509334|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3664356|NCT02369796|3509335|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3664357|NCT02369796|3509330|B6|||Age||years|Mean|50.8|50.8|Standard Deviation|9.04|9.04|||
3664358|NCT02369796|3509331|B5|||Age||years|Mean|45.0|45.0|Standard Deviation|19.16|19.16|||
3664359|NCT02369796|3509332|B4|||Age||years|Mean|56.0|56.0|Standard Deviation|3.61|3.61|||
3664360|NCT02369796|3509333|B3|||Age||years|Mean|51.7|51.7|Standard Deviation|3.79|3.79|||
3664361|NCT02369796|3509334|B2|||Age||years|Mean|50.7|50.7|Standard Deviation|4.62|4.62|||
3664362|NCT02369796|3509335|B1|||Age||years|Mean|50.7|50.7|Standard Deviation|8.02|8.02|||
3664363|NCT02369510|3509378|B4|||Pre-op Heart Rate (HR)||beats per minute|Mean|82|82.0|Standard Deviation|10|10.0|||
3664364|NCT02369510|3509379|B3|||Pre-op Heart Rate (HR)||beats per minute|Mean|78|78.0|Standard Deviation|10|10.0|||
3664365|NCT02369510|3509380|B2|||Pre-op Heart Rate (HR)||beats per minute|Mean|85|85.0|Standard Deviation|9|9.0|||
3664366|NCT02369510|3509381|B1|||Pre-op Heart Rate (HR)||beats per minute|Mean|82|82.0|Standard Deviation|10|10.0|||
3664367|NCT02369510|3509378|B4|||Pre-op Diastolic Blood Pressure (DBP)||mmHg|Mean|70|70.0|Standard Deviation|10|10.0|||
3664368|NCT02369510|3509379|B3|||Pre-op Diastolic Blood Pressure (DBP)||mmHg|Mean|66|66.0|Standard Deviation|8|8.0|||
3664369|NCT02369510|3509380|B2|||Pre-op Diastolic Blood Pressure (DBP)||mmHg|Mean|70|70.0|Standard Deviation|9|9.0|||
3664370|NCT02369510|3509381|B1|||Pre-op Diastolic Blood Pressure (DBP)||mmHg|Mean|70|70.0|Standard Deviation|11|11.0|||
3664371|NCT02369510|3509378|B4|||Pre-op Systolic Blood Pressure (SBP)||mmHg|Mean|117|117.0|Standard Deviation|11|11.0|||
3664372|NCT02369510|3509379|B3|||Pre-op Systolic Blood Pressure (SBP)||mmHg|Mean|115|115.0|Standard Deviation|11|11.0|||
3664373|NCT02369510|3509380|B2|||Pre-op Systolic Blood Pressure (SBP)||mmHg|Mean|119|119.0|Standard Deviation|10|10.0|||
3664374|NCT02369510|3509381|B1|||Pre-op Systolic Blood Pressure (SBP)||mmHg|Mean|116|116.0|Standard Deviation|12|12.0|||
3664375|NCT02369510|3509378|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3664376|NCT02369510|3509379|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3664377|NCT02369510|3509380|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3664378|NCT02369510|3509381|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3664379|NCT02369510|3509378|B4||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3664380|NCT02369510|3509379|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3664381|NCT02369510|3509380|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3664382|NCT02369510|3509381|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3664383|NCT02369510|3509378|B4|||Age||years|Mean|34|34.0|Standard Deviation|4.73|4.73|||
3664384|NCT02369510|3509379|B3|||Age||years|Mean|34|34.0|Standard Deviation|5.12|5.12|||
3664385|NCT02369510|3509380|B2|||Age||years|Mean|34|34.0|Standard Deviation|5.19|5.19|||
3664386|NCT02369510|3509381|B1|||Age||years|Mean|35|35.0|Standard Deviation|3.86|3.86|||
3664387|NCT02369341|3509412|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3664388|NCT02369341|3509413|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3664389|NCT02369341|3509414|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3664390|NCT02369341|3509412|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3664391|NCT02369341|3509413|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3664392|NCT02369341|3509414|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3664393|NCT02369341|3509412|B3|||Age||Years|Mean|53.3|53.3|Standard Deviation|16.4|16.4|||
3664394|NCT02369341|3509413|B2|||Age||Years|Mean|67.2|67.2|Standard Deviation|6.0|6.0|||
3664395|NCT02369341|3509414|B1|||Age||Years|Mean|40.8|40.8|Standard Deviation|12.2|12.2|||
3664396|NCT02368457|3509469|B3|||Exposed bone||mm^2|Mean|12.5|12.5|Standard Deviation|10|10.0|||
3664397|NCT02368457|3509470|B2|||Exposed bone||mm^2|Mean|15|15.0|Standard Deviation|10|10.0|||
3664398|NCT02368457|3509471|B1|||Exposed bone||mm^2|Mean|10|10.0|Standard Deviation|10|10.0|||
3664399|NCT02368457|3509469|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3664400|NCT02368457|3509470|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3664401|NCT02368457|3509471|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3664402|NCT02368457|3509469|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3664403|NCT02368457|3509470|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3664404|NCT02368457|3509471|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3664405|NCT02368457|3509469|B3|||Age||years|Mean|56|56.0|Standard Deviation|10|10.0|||
3664406|NCT02368457|3509470|B2|||Age||years|Mean|55|55.0|Standard Deviation|10|10.0|||
3664407|NCT02368457|3509471|B1|||Age||years|Mean|57|57.0|Standard Deviation|10|10.0|||
3664408|NCT02368314|3509480|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3664409|NCT02368314|3509481|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3664410|NCT02368314|3509482|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3664411|NCT02368314|3509480|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3664412|NCT02368314|3509481|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3664413|NCT02368314|3509482|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3664414|NCT02368314|3509480|B3|||Age||years|Median|58.00|58.0|Inter-Quartile Range|||53.0|64.0|
3664415|NCT02368314|3509481|B2|||Age||years|Median|60.00|60.0|Inter-Quartile Range|||53.0|65.0|
3664416|NCT02368314|3509482|B1|||Age||years|Median|57.50|57.5|Inter-Quartile Range|||53.0|63.5|
3664417|NCT02368210|3509493|B3|United States||Region of Enrollment||Participants|Count of Participants|151|151.0||||||
3664418|NCT02368210|3509494|B2|United States||Region of Enrollment||Participants|Count of Participants|76|76.0||||||
3664419|NCT02368210|3509495|B1|United States||Region of Enrollment||Participants|Count of Participants|75|75.0||||||
3664420|NCT02368210|3509493|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664421|NCT02368210|3509494|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664422|NCT02368210|3509495|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664423|NCT02368210|3509493|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664424|NCT02368210|3509494|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664425|NCT02368210|3509495|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664426|NCT02368210|3509493|B3||White|Race (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
3664427|NCT02368210|3509494|B2||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3664428|NCT02368210|3509495|B1||White|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3664429|NCT02368210|3509493|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3664430|NCT02368210|3509494|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3664431|NCT02368210|3509495|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3664432|NCT02368210|3509493|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3664433|NCT02368210|3509494|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3664434|NCT02368210|3509495|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664435|NCT02368210|3509493|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3664436|NCT02368210|3509494|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3664437|NCT02368210|3509495|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3664438|NCT02368210|3509493|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664439|NCT02368210|3509494|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664440|NCT02368210|3509495|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664441|NCT02368210|3509493|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664442|NCT02368210|3509494|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664443|NCT02368210|3509495|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664444|NCT02368210|3509493|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
3664445|NCT02368210|3509494|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3664446|NCT02368210|3509495|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3664447|NCT02368210|3509493|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3664448|NCT02368210|3509494|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3664449|NCT02368210|3509495|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3664450|NCT02368210|3509493|B3||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3664451|NCT02368210|3509494|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3664452|NCT02368210|3509495|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3664453|NCT02368210|3509493|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3664454|NCT02368210|3509494|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3664455|NCT02368210|3509495|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3664456|NCT02368210|3509493|B3|||Age||years|Mean|54.5|54.5|Standard Deviation|14.00|14.0|||
3664457|NCT02368210|3509494|B2|||Age||years|Mean|55.1|55.1|Standard Deviation|13.86|13.86|||
3664458|NCT02368210|3509495|B1|||Age||years|Mean|54.0|54.0|Standard Deviation|14.22|14.22|||
3664459|NCT02368093|3509512|B3|Taiwan||Region of Enrollment|Ethnicity of participants|participants|Number|48|48.0||||||
3664460|NCT02368093|3509513|B2|Taiwan||Region of Enrollment|Ethnicity of participants|participants|Number|24|24.0||||||
3664461|NCT02368093|3509514|B1|Taiwan||Region of Enrollment|Ethnicity of participants|participants|Number|24|24.0||||||
3664462|NCT02368093|3509512|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3664463|NCT02368093|3509513|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3664464|NCT02368093|3509514|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3664465|NCT02368093|3509512|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3664466|NCT02368093|3509513|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3664467|NCT02368093|3509514|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3664468|NCT02368093|3509512|B3|||Age||years|Mean|52.5|52.5|Standard Deviation|11.0|11.0|||
3664469|NCT02368093|3509513|B2|||Age||years|Mean|52.8|52.8|Standard Deviation|10.5|10.5|||
3664470|NCT02368093|3509514|B1|||Age||years|Mean|52.2|52.2|Standard Deviation|11.6|11.6|||
3664471|NCT02367911|3509521|B3|United States||Region of Enrollment||Participants|Count of Participants|144|144.0||||||
3664472|NCT02367911|3509522|B2|United States||Region of Enrollment||Participants|Count of Participants|73|73.0||||||
3664473|NCT02367911|3509523|B1|United States||Region of Enrollment||Participants|Count of Participants|71|71.0||||||
3664474|NCT02367911|3509521|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|132|132.0||||||
3664475|NCT02367911|3509522|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|64|64.0||||||
3664476|NCT02367911|3509523|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|68|68.0||||||
3664477|NCT02367911|3509521|B3|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3664478|NCT02367911|3509522|B2|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3664479|NCT02367911|3509523|B1|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3664480|NCT02367911|3509521|B3|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3664481|NCT02367911|3509522|B2|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3664482|NCT02367911|3509523|B1|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3664483|NCT02367911|3509521|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664484|NCT02367911|3509522|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664485|NCT02367911|3509523|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664486|NCT02367911|3509521|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|135|135.0||||||
3664487|NCT02367911|3509522|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3664488|NCT02367911|3509523|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3664489|NCT02367911|3509521|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3664490|NCT02367911|3509522|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3664491|NCT02367911|3509523|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3664492|NCT02367911|3509521|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3664493|NCT02367911|3509522|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3664494|NCT02367911|3509523|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3664495|NCT02367911|3509521|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3664496|NCT02367911|3509522|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3664497|NCT02367911|3509523|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3664498|NCT02367911|3509521|B3|||Age||years|Mean|52.2|52.2|Standard Deviation|13.55|13.55|||
3664499|NCT02367911|3509522|B2|||Age||years|Mean|52.0|52.0|Standard Deviation|13.75|13.75|||
3664500|NCT02367911|3509523|B1|||Age||years|Mean|52.4|52.4|Standard Deviation|13.44|13.44|||
3664501|NCT02367885|3509532|B4|Antipyretics not administered||Administration of Antipyretics||participants|Number|95|95.0||||||
3664502|NCT02367885|3509533|B3|Antipyretics not administered||Administration of Antipyretics||participants|Number|32|32.0||||||
3664503|NCT02367885|3509534|B2|Antipyretics not administered||Administration of Antipyretics||participants|Number|32|32.0||||||
3664504|NCT02367885|3509535|B1|Antipyretics not administered||Administration of Antipyretics||participants|Number|31|31.0||||||
3664505|NCT02367885|3509532|B4|Antipyretics administered||Administration of Antipyretics||participants|Number|4|4.0||||||
3664506|NCT02367885|3509533|B3|Antipyretics administered||Administration of Antipyretics||participants|Number|1|1.0||||||
3664507|NCT02367885|3509534|B2|Antipyretics administered||Administration of Antipyretics||participants|Number|1|1.0||||||
3664508|NCT02367885|3509535|B1|Antipyretics administered||Administration of Antipyretics||participants|Number|2|2.0||||||
3664509|NCT02367885|3509532|B4|Infection did not occur||Influenza Infection within 5 years||participants|Number|74|74.0||||||
3664510|NCT02367885|3509533|B3|Infection did not occur||Influenza Infection within 5 years||participants|Number|26|26.0||||||
3664511|NCT02367885|3509534|B2|Infection did not occur||Influenza Infection within 5 years||participants|Number|17|17.0||||||
3664512|NCT02367885|3509535|B1|Infection did not occur||Influenza Infection within 5 years||participants|Number|31|31.0||||||
3664513|NCT02367885|3509532|B4|Infection occurred||Influenza Infection within 5 years||participants|Number|25|25.0||||||
3664514|NCT02367885|3509533|B3|Infection occurred||Influenza Infection within 5 years||participants|Number|7|7.0||||||
3664515|NCT02367885|3509534|B2|Infection occurred||Influenza Infection within 5 years||participants|Number|16|16.0||||||
3664516|NCT02367885|3509535|B1|Infection occurred||Influenza Infection within 5 years||participants|Number|2|2.0||||||
3664517|NCT02367885|3509532|B4|>=40 Titer||Hemagglutination Inhibition (HI) (Egg-derived) - B Titer at Day 1 (Pre-vaccination)|Number of participants with values of HI antibody titer for B strain pre-vaccination at Day 1 were reported.|participants|Number|7|7.0||||||
3664518|NCT02367885|3509533|B3|>=40 Titer||Hemagglutination Inhibition (HI) (Egg-derived) - B Titer at Day 1 (Pre-vaccination)|Number of participants with values of HI antibody titer for B strain pre-vaccination at Day 1 were reported.|participants|Number|7|7.0||||||
3664519|NCT02367885|3509534|B2|>=40 Titer||Hemagglutination Inhibition (HI) (Egg-derived) - B Titer at Day 1 (Pre-vaccination)|Number of participants with values of HI antibody titer for B strain pre-vaccination at Day 1 were reported.|participants|Number|0|0.0||||||
3664520|NCT02367885|3509535|B1|>=40 Titer||Hemagglutination Inhibition (HI) (Egg-derived) - B Titer at Day 1 (Pre-vaccination)|Number of participants with values of HI antibody titer for B strain pre-vaccination at Day 1 were reported.|participants|Number|0|0.0||||||
3664521|NCT02367885|3509532|B4|<40 Titer||Hemagglutination Inhibition (HI) (Egg-derived) - B Titer at Day 1 (Pre-vaccination)|Number of participants with values of HI antibody titer for B strain pre-vaccination at Day 1 were reported.|participants|Number|92|92.0||||||
3664522|NCT02367885|3509533|B3|<40 Titer||Hemagglutination Inhibition (HI) (Egg-derived) - B Titer at Day 1 (Pre-vaccination)|Number of participants with values of HI antibody titer for B strain pre-vaccination at Day 1 were reported.|participants|Number|26|26.0||||||
3664523|NCT02367885|3509534|B2|<40 Titer||Hemagglutination Inhibition (HI) (Egg-derived) - B Titer at Day 1 (Pre-vaccination)|Number of participants with values of HI antibody titer for B strain pre-vaccination at Day 1 were reported.|participants|Number|33|33.0||||||
3664524|NCT02367885|3509535|B1|<40 Titer||Hemagglutination Inhibition (HI) (Egg-derived) - B Titer at Day 1 (Pre-vaccination)|Number of participants with values of HI antibody titer for B strain pre-vaccination at Day 1 were reported.|participants|Number|33|33.0||||||
3664525|NCT02367885|3509532|B4|>=40 Titer||Hemagglutination Inhibition (HI) (Egg-derived) - A/H3N2 Titer at Day 1 (Pre-vaccination)|Number of participants with values of HI antibody titer for A/H3N2 strain pre-vaccination at Day 1 were reported.|participants|Number|42|42.0||||||
3664526|NCT02367885|3509533|B3|>=40 Titer||Hemagglutination Inhibition (HI) (Egg-derived) - A/H3N2 Titer at Day 1 (Pre-vaccination)|Number of participants with values of HI antibody titer for A/H3N2 strain pre-vaccination at Day 1 were reported.|participants|Number|18|18.0||||||
3664527|NCT02367885|3509534|B2|>=40 Titer||Hemagglutination Inhibition (HI) (Egg-derived) - A/H3N2 Titer at Day 1 (Pre-vaccination)|Number of participants with values of HI antibody titer for A/H3N2 strain pre-vaccination at Day 1 were reported.|participants|Number|17|17.0||||||
3664528|NCT02367885|3509535|B1|>=40 Titer||Hemagglutination Inhibition (HI) (Egg-derived) - A/H3N2 Titer at Day 1 (Pre-vaccination)|Number of participants with values of HI antibody titer for A/H3N2 strain pre-vaccination at Day 1 were reported.|participants|Number|7|7.0||||||
3664529|NCT02367885|3509532|B4|<40 Titer||Hemagglutination Inhibition (HI) (Egg-derived) - A/H3N2 Titer at Day 1 (Pre-vaccination)|Number of participants with values of HI antibody titer for A/H3N2 strain pre-vaccination at Day 1 were reported.|participants|Number|57|57.0||||||
3664530|NCT02367885|3509533|B3|<40 Titer||Hemagglutination Inhibition (HI) (Egg-derived) - A/H3N2 Titer at Day 1 (Pre-vaccination)|Number of participants with values of HI antibody titer for A/H3N2 strain pre-vaccination at Day 1 were reported.|participants|Number|15|15.0||||||
3664531|NCT02367885|3509534|B2|<40 Titer||Hemagglutination Inhibition (HI) (Egg-derived) - A/H3N2 Titer at Day 1 (Pre-vaccination)|Number of participants with values of HI antibody titer for A/H3N2 strain pre-vaccination at Day 1 were reported.|participants|Number|16|16.0||||||
3664577|NCT02367872|3509605|B6|||Estimated Glomerular Filtration Rate (eGFR)||mL/min/1.73 m^2|Mean|115.2|115.2|Standard Deviation|14.55|14.55|||
3664532|NCT02367885|3509535|B1|<40 Titer||Hemagglutination Inhibition (HI) (Egg-derived) - A/H3N2 Titer at Day 1 (Pre-vaccination)|Number of participants with values of HI antibody titer for A/H3N2 strain pre-vaccination at Day 1 were reported.|participants|Number|26|26.0||||||
3664533|NCT02367885|3509532|B4|Greater Than or Equal to (>=) 40 Titer||Hemagglutination Inhibition (HI) (Egg-derived) - A/H1N1 Titer at Day 1(Pre-vaccination)|Number of participants with values of HI antibody titer for A/H1N1 strain pre-vaccination at Day 1 were reported.|participants|Number|48|48.0||||||
3664534|NCT02367885|3509533|B3|Greater Than or Equal to (>=) 40 Titer||Hemagglutination Inhibition (HI) (Egg-derived) - A/H1N1 Titer at Day 1(Pre-vaccination)|Number of participants with values of HI antibody titer for A/H1N1 strain pre-vaccination at Day 1 were reported.|participants|Number|19|19.0||||||
3664535|NCT02367885|3509534|B2|Greater Than or Equal to (>=) 40 Titer||Hemagglutination Inhibition (HI) (Egg-derived) - A/H1N1 Titer at Day 1(Pre-vaccination)|Number of participants with values of HI antibody titer for A/H1N1 strain pre-vaccination at Day 1 were reported.|participants|Number|27|27.0||||||
3664536|NCT02367885|3509535|B1|Greater Than or Equal to (>=) 40 Titer||Hemagglutination Inhibition (HI) (Egg-derived) - A/H1N1 Titer at Day 1(Pre-vaccination)|Number of participants with values of HI antibody titer for A/H1N1 strain pre-vaccination at Day 1 were reported.|participants|Number|2|2.0||||||
3664537|NCT02367885|3509532|B4|Less Than (<) 40 Titer||Hemagglutination Inhibition (HI) (Egg-derived) - A/H1N1 Titer at Day 1(Pre-vaccination)|Number of participants with values of HI antibody titer for A/H1N1 strain pre-vaccination at Day 1 were reported.|participants|Number|51|51.0||||||
3664538|NCT02367885|3509533|B3|Less Than (<) 40 Titer||Hemagglutination Inhibition (HI) (Egg-derived) - A/H1N1 Titer at Day 1(Pre-vaccination)|Number of participants with values of HI antibody titer for A/H1N1 strain pre-vaccination at Day 1 were reported.|participants|Number|14|14.0||||||
3664539|NCT02367885|3509534|B2|Less Than (<) 40 Titer||Hemagglutination Inhibition (HI) (Egg-derived) - A/H1N1 Titer at Day 1(Pre-vaccination)|Number of participants with values of HI antibody titer for A/H1N1 strain pre-vaccination at Day 1 were reported.|participants|Number|6|6.0||||||
3664540|NCT02367885|3509535|B1|Less Than (<) 40 Titer||Hemagglutination Inhibition (HI) (Egg-derived) - A/H1N1 Titer at Day 1(Pre-vaccination)|Number of participants with values of HI antibody titer for A/H1N1 strain pre-vaccination at Day 1 were reported.|participants|Number|31|31.0||||||
3664541|NCT02367885|3509532|B4|Japan||Region of Enrollment||participants|Number|99|99.0||||||
3664542|NCT02367885|3509533|B3|Japan||Region of Enrollment||participants|Number|33|33.0||||||
3664543|NCT02367885|3509534|B2|Japan||Region of Enrollment||participants|Number|33|33.0||||||
3664544|NCT02367885|3509535|B1|Japan||Region of Enrollment||participants|Number|33|33.0||||||
3664545|NCT02367885|3509532|B4||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3664546|NCT02367885|3509533|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3664547|NCT02367885|3509534|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3664548|NCT02367885|3509535|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3664549|NCT02367885|3509532|B4||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3664550|NCT02367885|3509533|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3664551|NCT02367885|3509534|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3664552|NCT02367885|3509535|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3664553|NCT02367885|3509532|B4|13-19 Years||Age, Customized||participants|Number|33|33.0||||||
3664554|NCT02367885|3509533|B3|13-19 Years||Age, Customized||participants|Number|33|33.0||||||
3664555|NCT02367885|3509534|B2|13-19 Years||Age, Customized||participants|Number|0|0.0||||||
3664556|NCT02367885|3509535|B1|13-19 Years||Age, Customized||participants|Number|0|0.0||||||
3664557|NCT02367885|3509532|B4|3-12 Years||Age, Customized||participants|Number|33|33.0||||||
3664558|NCT02367885|3509533|B3|3-12 Years||Age, Customized||participants|Number|0|0.0||||||
3664559|NCT02367885|3509534|B2|3-12 Years||Age, Customized||participants|Number|33|33.0||||||
3664560|NCT02367885|3509535|B1|3-12 Years||Age, Customized||participants|Number|0|0.0||||||
3664561|NCT02367885|3509532|B4|6-35 Months||Age, Customized||participants|Number|33|33.0||||||
3664562|NCT02367885|3509533|B3|6-35 Months||Age, Customized||participants|Number|0|0.0||||||
3664563|NCT02367885|3509534|B2|6-35 Months||Age, Customized||participants|Number|0|0.0||||||
3664564|NCT02367885|3509535|B1|6-35 Months||Age, Customized||participants|Number|33|33.0||||||
3664565|NCT02367872|3509602|B9|||Alpha1 Acid Glycoprotein (AGP)||milligram per deciliter (mg/dL)|Mean|66.15|66.15|Standard Deviation|26.757|26.757|||
3664566|NCT02367872|3509603|B8|||Alpha1 Acid Glycoprotein (AGP)||milligram per deciliter (mg/dL)|Mean|41.12|41.12|Standard Deviation|20.282|20.282|||
3664567|NCT02367872|3509604|B7|||Alpha1 Acid Glycoprotein (AGP)||milligram per deciliter (mg/dL)|Mean|51.18|51.18|Standard Deviation|16.328|16.328|||
3664568|NCT02367872|3509605|B6|||Alpha1 Acid Glycoprotein (AGP)||milligram per deciliter (mg/dL)|Mean|55.80|55.8|Standard Deviation|17.694|17.694|||
3664569|NCT02367872|3509606|B5|||Alpha1 Acid Glycoprotein (AGP)||milligram per deciliter (mg/dL)|Mean|82.77|82.77|Standard Deviation|7.104|7.104|||
3664570|NCT02367872|3509607|B4|||Alpha1 Acid Glycoprotein (AGP)||milligram per deciliter (mg/dL)|Mean|114.45|114.45|Standard Deviation|25.029|25.029|||
3664571|NCT02367872|3509608|B3|||Alpha1 Acid Glycoprotein (AGP)||milligram per deciliter (mg/dL)|Mean|70.30|70.3|Standard Deviation|14.936|14.936|||
3664572|NCT02367872|3509609|B2|||Alpha1 Acid Glycoprotein (AGP)||milligram per deciliter (mg/dL)|Mean|48.65|48.65|Standard Deviation|4.809|4.809|||
3664573|NCT02367872|3509610|B1|||Alpha1 Acid Glycoprotein (AGP)||milligram per deciliter (mg/dL)|Mean|64.97|64.97|Standard Deviation|12.065|12.065|||
3664574|NCT02367872|3509602|B9|||Estimated Glomerular Filtration Rate (eGFR)||mL/min/1.73 m^2|Mean|72.6|72.6|Standard Deviation|43.41|43.41|||
3664575|NCT02367872|3509603|B8|||Estimated Glomerular Filtration Rate (eGFR)||mL/min/1.73 m^2|Mean|100.8|100.8|Standard Deviation|16.49|16.49|||
3664576|NCT02367872|3509604|B7|||Estimated Glomerular Filtration Rate (eGFR)||mL/min/1.73 m^2|Mean|93.7|93.7|Standard Deviation|21.63|21.63|||
3664791|NCT02367391|3509845|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664578|NCT02367872|3509606|B5|||Estimated Glomerular Filtration Rate (eGFR)||mL/min/1.73 m^2|Mean|4.5|4.5|Standard Deviation|0.55|0.55|||
3664579|NCT02367872|3509607|B4|||Estimated Glomerular Filtration Rate (eGFR)||mL/min/1.73 m^2|Mean|16.3|16.3|Standard Deviation|7.61|7.61|||
3664580|NCT02367872|3509608|B3|||Estimated Glomerular Filtration Rate (eGFR)||mL/min/1.73 m^2|Mean|54.8|54.8|Standard Deviation|9.50|9.5|||
3664581|NCT02367872|3509609|B2|||Estimated Glomerular Filtration Rate (eGFR)||mL/min/1.73 m^2|Mean|80.7|80.7|Standard Deviation|17.70|17.7|||
3664582|NCT02367872|3509610|B1|||Estimated Glomerular Filtration Rate (eGFR)||mL/min/1.73 m^2|Mean|114.8|114.8|Standard Deviation|26.03|26.03|||
3664583|NCT02367872|3509602|B9||No|Caffeine Classification|Participants who were answered Yes or No for a question “Take Caffeine in Daily Life?” were reported.|Participants|Count of Participants|10|10.0||||||
3664584|NCT02367872|3509603|B8||No|Caffeine Classification|Participants who were answered Yes or No for a question “Take Caffeine in Daily Life?” were reported.|Participants|Count of Participants|4|4.0||||||
3664585|NCT02367872|3509604|B7||No|Caffeine Classification|Participants who were answered Yes or No for a question “Take Caffeine in Daily Life?” were reported.|Participants|Count of Participants|3|3.0||||||
3664586|NCT02367872|3509605|B6||No|Caffeine Classification|Participants who were answered Yes or No for a question “Take Caffeine in Daily Life?” were reported.|Participants|Count of Participants|0|0.0||||||
3664587|NCT02367872|3509606|B5||No|Caffeine Classification|Participants who were answered Yes or No for a question “Take Caffeine in Daily Life?” were reported.|Participants|Count of Participants|1|1.0||||||
3664588|NCT02367872|3509607|B4||No|Caffeine Classification|Participants who were answered Yes or No for a question “Take Caffeine in Daily Life?” were reported.|Participants|Count of Participants|0|0.0||||||
3664589|NCT02367872|3509608|B3||No|Caffeine Classification|Participants who were answered Yes or No for a question “Take Caffeine in Daily Life?” were reported.|Participants|Count of Participants|1|1.0||||||
3664590|NCT02367872|3509609|B2||No|Caffeine Classification|Participants who were answered Yes or No for a question “Take Caffeine in Daily Life?” were reported.|Participants|Count of Participants|0|0.0||||||
3664591|NCT02367872|3509610|B1||No|Caffeine Classification|Participants who were answered Yes or No for a question “Take Caffeine in Daily Life?” were reported.|Participants|Count of Participants|1|1.0||||||
3664592|NCT02367872|3509602|B9||Yes|Caffeine Classification|Participants who were answered Yes or No for a question “Take Caffeine in Daily Life?” were reported.|Participants|Count of Participants|38|38.0||||||
3664593|NCT02367872|3509603|B8||Yes|Caffeine Classification|Participants who were answered Yes or No for a question “Take Caffeine in Daily Life?” were reported.|Participants|Count of Participants|2|2.0||||||
3664594|NCT02367872|3509604|B7||Yes|Caffeine Classification|Participants who were answered Yes or No for a question “Take Caffeine in Daily Life?” were reported.|Participants|Count of Participants|3|3.0||||||
3664595|NCT02367872|3509605|B6||Yes|Caffeine Classification|Participants who were answered Yes or No for a question “Take Caffeine in Daily Life?” were reported.|Participants|Count of Participants|6|6.0||||||
3664596|NCT02367872|3509606|B5||Yes|Caffeine Classification|Participants who were answered Yes or No for a question “Take Caffeine in Daily Life?” were reported.|Participants|Count of Participants|5|5.0||||||
3664597|NCT02367872|3509607|B4||Yes|Caffeine Classification|Participants who were answered Yes or No for a question “Take Caffeine in Daily Life?” were reported.|Participants|Count of Participants|6|6.0||||||
3664598|NCT02367872|3509608|B3||Yes|Caffeine Classification|Participants who were answered Yes or No for a question “Take Caffeine in Daily Life?” were reported.|Participants|Count of Participants|5|5.0||||||
3664599|NCT02367872|3509609|B2||Yes|Caffeine Classification|Participants who were answered Yes or No for a question “Take Caffeine in Daily Life?” were reported.|Participants|Count of Participants|6|6.0||||||
3664600|NCT02367872|3509610|B1||Yes|Caffeine Classification|Participants who were answered Yes or No for a question “Take Caffeine in Daily Life?” were reported.|Participants|Count of Participants|5|5.0||||||
3664601|NCT02367872|3509602|B9||Never drinks|Alcohol Classification||Participants|Count of Participants|26|26.0||||||
3664602|NCT02367872|3509603|B8||Never drinks|Alcohol Classification||Participants|Count of Participants|4|4.0||||||
3664603|NCT02367872|3509604|B7||Never drinks|Alcohol Classification||Participants|Count of Participants|4|4.0||||||
3664604|NCT02367872|3509605|B6||Never drinks|Alcohol Classification||Participants|Count of Participants|2|2.0||||||
3664605|NCT02367872|3509606|B5||Never drinks|Alcohol Classification||Participants|Count of Participants|5|5.0||||||
3664606|NCT02367872|3509607|B4||Never drinks|Alcohol Classification||Participants|Count of Participants|3|3.0||||||
3664607|NCT02367872|3509608|B3||Never drinks|Alcohol Classification||Participants|Count of Participants|4|4.0||||||
3664608|NCT02367872|3509609|B2||Never drinks|Alcohol Classification||Participants|Count of Participants|2|2.0||||||
3664609|NCT02367872|3509610|B1||Never drinks|Alcohol Classification||Participants|Count of Participants|2|2.0||||||
3664610|NCT02367872|3509602|B9||Drinks a few days per month|Alcohol Classification||Participants|Count of Participants|7|7.0||||||
3664611|NCT02367872|3509603|B8||Drinks a few days per month|Alcohol Classification||Participants|Count of Participants|0|0.0||||||
3664612|NCT02367872|3509604|B7||Drinks a few days per month|Alcohol Classification||Participants|Count of Participants|1|1.0||||||
3664613|NCT02367872|3509605|B6||Drinks a few days per month|Alcohol Classification||Participants|Count of Participants|1|1.0||||||
3664614|NCT02367872|3509606|B5||Drinks a few days per month|Alcohol Classification||Participants|Count of Participants|1|1.0||||||
3664615|NCT02367872|3509607|B4||Drinks a few days per month|Alcohol Classification||Participants|Count of Participants|0|0.0||||||
3664616|NCT02367872|3509608|B3||Drinks a few days per month|Alcohol Classification||Participants|Count of Participants|1|1.0||||||
3664617|NCT02367872|3509609|B2||Drinks a few days per month|Alcohol Classification||Participants|Count of Participants|2|2.0||||||
3664618|NCT02367872|3509610|B1||Drinks a few days per month|Alcohol Classification||Participants|Count of Participants|1|1.0||||||
3664619|NCT02367872|3509602|B9||Drinks a few days per week|Alcohol Classification||Participants|Count of Participants|9|9.0||||||
3664620|NCT02367872|3509603|B8||Drinks a few days per week|Alcohol Classification||Participants|Count of Participants|2|2.0||||||
3664621|NCT02367872|3509604|B7||Drinks a few days per week|Alcohol Classification||Participants|Count of Participants|1|1.0||||||
3664622|NCT02367872|3509605|B6||Drinks a few days per week|Alcohol Classification||Participants|Count of Participants|1|1.0||||||
3664623|NCT02367872|3509606|B5||Drinks a few days per week|Alcohol Classification||Participants|Count of Participants|0|0.0||||||
3664624|NCT02367872|3509607|B4||Drinks a few days per week|Alcohol Classification||Participants|Count of Participants|1|1.0||||||
3664625|NCT02367872|3509608|B3||Drinks a few days per week|Alcohol Classification||Participants|Count of Participants|0|0.0||||||
3664626|NCT02367872|3509609|B2||Drinks a few days per week|Alcohol Classification||Participants|Count of Participants|2|2.0||||||
3664627|NCT02367872|3509610|B1||Drinks a few days per week|Alcohol Classification||Participants|Count of Participants|2|2.0||||||
3664628|NCT02367872|3509602|B9||Drinks every day|Alcohol Classification||Participants|Count of Participants|6|6.0||||||
3664629|NCT02367872|3509603|B8||Drinks every day|Alcohol Classification||Participants|Count of Participants|0|0.0||||||
3664630|NCT02367872|3509604|B7||Drinks every day|Alcohol Classification||Participants|Count of Participants|0|0.0||||||
3664631|NCT02367872|3509605|B6||Drinks every day|Alcohol Classification||Participants|Count of Participants|2|2.0||||||
3664632|NCT02367872|3509606|B5||Drinks every day|Alcohol Classification||Participants|Count of Participants|0|0.0||||||
3664633|NCT02367872|3509607|B4||Drinks every day|Alcohol Classification||Participants|Count of Participants|2|2.0||||||
3664634|NCT02367872|3509608|B3||Drinks every day|Alcohol Classification||Participants|Count of Participants|1|1.0||||||
3664635|NCT02367872|3509609|B2||Drinks every day|Alcohol Classification||Participants|Count of Participants|0|0.0||||||
3664636|NCT02367872|3509610|B1||Drinks every day|Alcohol Classification||Participants|Count of Participants|1|1.0||||||
3664637|NCT02367872|3509602|B9||Ex-smoker|Smoking Classification||Participants|Count of Participants|18|18.0||||||
3664638|NCT02367872|3509603|B8||Ex-smoker|Smoking Classification||Participants|Count of Participants|1|1.0||||||
3664639|NCT02367872|3509604|B7||Ex-smoker|Smoking Classification||Participants|Count of Participants|2|2.0||||||
3664640|NCT02367872|3509605|B6||Ex-smoker|Smoking Classification||Participants|Count of Participants|3|3.0||||||
3664641|NCT02367872|3509606|B5||Ex-smoker|Smoking Classification||Participants|Count of Participants|2|2.0||||||
3664642|NCT02367872|3509607|B4||Ex-smoker|Smoking Classification||Participants|Count of Participants|4|4.0||||||
3664643|NCT02367872|3509608|B3||Ex-smoker|Smoking Classification||Participants|Count of Participants|1|1.0||||||
3664644|NCT02367872|3509609|B2||Ex-smoker|Smoking Classification||Participants|Count of Participants|1|1.0||||||
3664645|NCT02367872|3509610|B1||Ex-smoker|Smoking Classification||Participants|Count of Participants|4|4.0||||||
3664646|NCT02367872|3509602|B9||Current smoker|Smoking Classification||Participants|Count of Participants|10|10.0||||||
3664647|NCT02367872|3509603|B8||Current smoker|Smoking Classification||Participants|Count of Participants|4|4.0||||||
3664648|NCT02367872|3509604|B7||Current smoker|Smoking Classification||Participants|Count of Participants|1|1.0||||||
3664649|NCT02367872|3509605|B6||Current smoker|Smoking Classification||Participants|Count of Participants|1|1.0||||||
3664650|NCT02367872|3509606|B5||Current smoker|Smoking Classification||Participants|Count of Participants|1|1.0||||||
3664651|NCT02367872|3509607|B4||Current smoker|Smoking Classification||Participants|Count of Participants|0|0.0||||||
3664652|NCT02367872|3509608|B3||Current smoker|Smoking Classification||Participants|Count of Participants|2|2.0||||||
3664653|NCT02367872|3509609|B2||Current smoker|Smoking Classification||Participants|Count of Participants|1|1.0||||||
3664654|NCT02367872|3509610|B1||Current smoker|Smoking Classification||Participants|Count of Participants|0|0.0||||||
3664655|NCT02367872|3509602|B9||Never smoked|Smoking Classification||Participants|Count of Participants|20|20.0||||||
3664656|NCT02367872|3509603|B8||Never smoked|Smoking Classification||Participants|Count of Participants|1|1.0||||||
3664657|NCT02367872|3509604|B7||Never smoked|Smoking Classification||Participants|Count of Participants|3|3.0||||||
3664658|NCT02367872|3509605|B6||Never smoked|Smoking Classification||Participants|Count of Participants|2|2.0||||||
3664659|NCT02367872|3509606|B5||Never smoked|Smoking Classification||Participants|Count of Participants|3|3.0||||||
3664660|NCT02367872|3509607|B4||Never smoked|Smoking Classification||Participants|Count of Participants|2|2.0||||||
3664661|NCT02367872|3509608|B3||Never smoked|Smoking Classification||Participants|Count of Participants|3|3.0||||||
3664662|NCT02367872|3509609|B2||Never smoked|Smoking Classification||Participants|Count of Participants|4|4.0||||||
3664663|NCT02367872|3509610|B1||Never smoked|Smoking Classification||Participants|Count of Participants|2|2.0||||||
3664664|NCT02367872|3509602|B9|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|23.96|23.96|Standard Deviation|3.303|3.303|||
3664665|NCT02367872|3509603|B8|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|26.03|26.03|Standard Deviation|5.581|5.581|||
3664666|NCT02367872|3509604|B7|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|25.33|25.33|Standard Deviation|3.389|3.389|||
3664667|NCT02367872|3509605|B6|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|24.03|24.03|Standard Deviation|2.935|2.935|||
3664668|NCT02367872|3509606|B5|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|23.62|23.62|Standard Deviation|3.242|3.242|||
3664669|NCT02367872|3509607|B4|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|22.22|22.22|Standard Deviation|2.588|2.588|||
3664670|NCT02367872|3509608|B3|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|24.88|24.88|Standard Deviation|2.082|2.082|||
3664671|NCT02367872|3509609|B2|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|22.12|22.12|Standard Deviation|2.289|2.289|||
3664672|NCT02367872|3509610|B1|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|23.42|23.42|Standard Deviation|2.807|2.807|||
3664673|NCT02367872|3509602|B9|||Weight||kilogram (kg)|Mean|62.70|62.7|Standard Deviation|11.674|11.674|||
3664674|NCT02367872|3509603|B8|||Weight||kilogram (kg)|Mean|69.73|69.73|Standard Deviation|23.171|23.171|||
3664675|NCT02367872|3509604|B7|||Weight||kilogram (kg)|Mean|65.08|65.08|Standard Deviation|11.760|11.76|||
3664676|NCT02367872|3509605|B6|||Weight||kilogram (kg)|Mean|62.25|62.25|Standard Deviation|6.275|6.275|||
3664677|NCT02367872|3509606|B5|||Weight||kilogram (kg)|Mean|60.83|60.83|Standard Deviation|6.982|6.982|||
3664678|NCT02367872|3509607|B4|||Weight||kilogram (kg)|Mean|56.48|56.48|Standard Deviation|9.392|9.392|||
3664679|NCT02367872|3509608|B3|||Weight||kilogram (kg)|Mean|69.87|69.87|Standard Deviation|5.654|5.654|||
3664680|NCT02367872|3509609|B2|||Weight||kilogram (kg)|Mean|59.80|59.8|Standard Deviation|11.726|11.726|||
3664681|NCT02367872|3509610|B1|||Weight||kilogram (kg)|Mean|57.58|57.58|Standard Deviation|6.328|6.328|||
3664682|NCT02367872|3509602|B9|||Height||centimeter (cm)|Mean|161.4|161.4|Standard Deviation|8.54|8.54|||
3664683|NCT02367872|3509603|B8|||Height||centimeter (cm)|Mean|161.5|161.5|Standard Deviation|11.40|11.4|||
3664684|NCT02367872|3509604|B7|||Height||centimeter (cm)|Mean|160.0|160.0|Standard Deviation|10.20|10.2|||
3664685|NCT02367872|3509605|B6|||Height||centimeter (cm)|Mean|161.2|161.2|Standard Deviation|5.64|5.64|||
3664686|NCT02367872|3509606|B5|||Height||centimeter (cm)|Mean|160.8|160.8|Standard Deviation|5.56|5.56|||
3664687|NCT02367872|3509607|B4|||Height||centimeter (cm)|Mean|159.0|159.0|Standard Deviation|8.63|8.63|||
3664688|NCT02367872|3509608|B3|||Height||centimeter (cm)|Mean|167.7|167.7|Standard Deviation|5.32|5.32|||
3664689|NCT02367872|3509609|B2|||Height||centimeter (cm)|Mean|163.7|163.7|Standard Deviation|9.18|9.18|||
3664690|NCT02367872|3509610|B1|||Height||centimeter (cm)|Mean|157.3|157.3|Standard Deviation|10.91|10.91|||
3664691|NCT02367872|3509602|B9|Japan||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
3664692|NCT02367872|3509603|B8|Japan||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3664693|NCT02367872|3509604|B7|Japan||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3664694|NCT02367872|3509605|B6|Japan||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3664695|NCT02367872|3509606|B5|Japan||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3664696|NCT02367872|3509607|B4|Japan||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3664697|NCT02367872|3509608|B3|Japan||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3664698|NCT02367872|3509609|B2|Japan||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3664699|NCT02367872|3509610|B1|Japan||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3664700|NCT02367872|3509602|B9||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3664701|NCT02367872|3509603|B8||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3664702|NCT02367872|3509604|B7||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3664703|NCT02367872|3509605|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3664704|NCT02367872|3509606|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3664705|NCT02367872|3509607|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3664706|NCT02367872|3509608|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3664707|NCT02367872|3509609|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3664708|NCT02367872|3509610|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3664709|NCT02367872|3509602|B9||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3664710|NCT02367872|3509603|B8||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3664711|NCT02367872|3509604|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3664712|NCT02367872|3509605|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3664713|NCT02367872|3509606|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3664714|NCT02367872|3509607|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3664715|NCT02367872|3509608|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3664716|NCT02367872|3509609|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3664717|NCT02367872|3509610|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3664718|NCT02367872|3509602|B9|||Age||years|Mean|65.0|65.0|Standard Deviation|8.23|8.23|||
3664719|NCT02367872|3509603|B8|||Age||years|Mean|61.5|61.5|Standard Deviation|8.96|8.96|||
3664720|NCT02367872|3509604|B7|||Age||years|Mean|61.0|61.0|Standard Deviation|10.41|10.41|||
3664721|NCT02367872|3509605|B6|||Age||years|Mean|61.0|61.0|Standard Deviation|5.73|5.73|||
3664722|NCT02367872|3509606|B5|||Age||years|Mean|71.2|71.2|Standard Deviation|6.91|6.91|||
3664723|NCT02367872|3509607|B4|||Age||years|Mean|69.5|69.5|Standard Deviation|5.89|5.89|||
3664724|NCT02367872|3509608|B3|||Age||years|Mean|70.2|70.2|Standard Deviation|5.53|5.53|||
3664725|NCT02367872|3509609|B2|||Age||years|Mean|59.7|59.7|Standard Deviation|8.94|8.94|||
3664726|NCT02367872|3509610|B1|||Age||years|Mean|66.3|66.3|Standard Deviation|5.61|5.61|||
3664727|NCT02367729|3509770|B3|United States||Region of Enrollment||Participants|Count of Participants|104|104.0||||||
3664728|NCT02367729|3509771|B2|United States||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
3664729|NCT02367729|3509772|B1|United States||Region of Enrollment||Participants|Count of Participants|57|57.0||||||
3664730|NCT02367729|3509770|B3|Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3664731|NCT02367729|3509771|B2|Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3664732|NCT02367729|3509772|B1|Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3664733|NCT02367729|3509770|B3|Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3664734|NCT02367729|3509771|B2|Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3664735|NCT02367729|3509772|B1|Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3664736|NCT02367729|3509770|B3|Ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3664737|NCT02367729|3509771|B2|Ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3664738|NCT02367729|3509772|B1|Ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3664739|NCT02367729|3509770|B3|Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|93|93.0||||||
3664740|NCT02367729|3509771|B2|Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
3664741|NCT02367729|3509772|B1|Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|49|49.0||||||
3664742|NCT02367729|3509770|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3664743|NCT02367729|3509771|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3664744|NCT02367729|3509772|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3664745|NCT02367729|3509770|B3||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3664746|NCT02367729|3509771|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3664747|NCT02367729|3509772|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3664748|NCT02367729|3509770|B3|||Age||years|Median|15.3|15.3|Inter-Quartile Range|||13.7|16.6|
3664749|NCT02367729|3509771|B2|||Age||years|Median|15.6|15.6|Inter-Quartile Range|||14.7|17.2|
3664750|NCT02367729|3509772|B1|||Age||years|Median|15.3|15.3|Inter-Quartile Range|||13.5|16.6|
3664751|NCT02367521|3509789|B3|||Months Depressed Since Injury||months|Mean|39.47|39.47|Standard Deviation|39.51|39.51|||
3664752|NCT02367521|3509790|B2|||Months Depressed Since Injury||months|Mean|39.6|39.6|Standard Deviation|36.1|36.1|||
3664753|NCT02367521|3509791|B1|||Months Depressed Since Injury||months|Mean|39.4|39.4|Standard Deviation|43|43.0|||
3664754|NCT02367521|3509789|B3|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3664755|NCT02367521|3509790|B2|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3664756|NCT02367521|3509791|B1|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3664757|NCT02367521|3509789|B3|Non-White||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3664758|NCT02367521|3509790|B2|Non-White||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3664759|NCT02367521|3509791|B1|Non-White||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3664760|NCT02367521|3509789|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3664761|NCT02367521|3509790|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3664762|NCT02367521|3509791|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3664763|NCT02367521|3509789|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3664764|NCT02367521|3509790|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3664765|NCT02367521|3509791|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3664766|NCT02367521|3509789|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3664767|NCT02367521|3509790|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3664768|NCT02367521|3509791|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3664769|NCT02367521|3509789|B3|||Age||years|Mean|40|40.0|Standard Deviation|14.4|14.4|||
3664770|NCT02367521|3509790|B2|||Age||years|Mean|39.8|39.8|Standard Deviation|14.2|14.2|||
3664771|NCT02367521|3509791|B1|||Age||years|Mean|40.2|40.2|Standard Deviation|14.6|14.6|||
3664772|NCT02367391|3509844|B3|United States||Region of Enrollment||participants|Number|150|150.0||||||
3664773|NCT02367391|3509845|B2|United States||Region of Enrollment||participants|Number|76|76.0||||||
3664774|NCT02367391|3509846|B1|United States||Region of Enrollment||participants|Number|74|74.0||||||
3664775|NCT02367391|3509844|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3664776|NCT02367391|3509845|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3664777|NCT02367391|3509846|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3664778|NCT02367391|3509844|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664779|NCT02367391|3509845|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664780|NCT02367391|3509846|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664781|NCT02367391|3509844|B3||White|Race (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
3664782|NCT02367391|3509845|B2||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3664783|NCT02367391|3509846|B1||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3664784|NCT02367391|3509844|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3664785|NCT02367391|3509845|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3664786|NCT02367391|3509846|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3664787|NCT02367391|3509844|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664788|NCT02367391|3509845|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664789|NCT02367391|3509846|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664790|NCT02367391|3509844|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3664792|NCT02367391|3509846|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3664793|NCT02367391|3509844|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664794|NCT02367391|3509845|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664795|NCT02367391|3509846|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664796|NCT02367391|3509844|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3664797|NCT02367391|3509845|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3664798|NCT02367391|3509846|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3664799|NCT02367391|3509844|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3664800|NCT02367391|3509845|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3664801|NCT02367391|3509846|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3664802|NCT02367391|3509844|B3|||Age||years|Mean|45.5|45.5|Standard Deviation|11.9|11.9|||
3664803|NCT02367391|3509845|B2|||Age||years|Mean|44.5|44.5|Standard Deviation|11.6|11.6|||
3664804|NCT02367391|3509846|B1|||Age||years|Mean|46.6|46.6|Standard Deviation|12.3|12.3|||
3664805|NCT02367170|3509865|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3664806|NCT02367170|3509866|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3664807|NCT02367170|3509867|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3664808|NCT02367170|3509865|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3664809|NCT02367170|3509866|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3664810|NCT02367170|3509867|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3664811|NCT02367170|3509865|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3664812|NCT02367170|3509866|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3664813|NCT02367170|3509867|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3664814|NCT02367170|3509865|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3664815|NCT02367170|3509866|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3664816|NCT02367170|3509867|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3664817|NCT02367170|3509865|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3664818|NCT02367170|3509866|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3664819|NCT02367170|3509867|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3664820|NCT02367131|3509878|B1||Male|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
3664821|NCT02367131|3509878|B1||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3664822|NCT02367131|3509878|B1|||Age||Years|Mean|71.8|71.8|Standard Deviation|5.5|5.5|||
3664823|NCT02367066|3509884|B3|||HbA1c|Percentage of glycosylated hemoglobin, DCCT|%|Mean|9.40|9.4|Standard Deviation|1.06|1.06|||
3664824|NCT02367066|3509885|B2|||HbA1c|Percentage of glycosylated hemoglobin, DCCT|%|Mean|9.30|9.3|Standard Deviation|0.88|0.88|||
3664825|NCT02367066|3509886|B1|||HbA1c|Percentage of glycosylated hemoglobin, DCCT|%|Mean|9.50|9.5|Standard Deviation|1.24|1.24|||
3664826|NCT02367066|3509884|B3|||Current Metformin Daily Dose||mg|Mean|1830.00|1830.0|Standard Deviation|427.78|427.78|||
3664827|NCT02367066|3509885|B2|||Current Metformin Daily Dose||mg|Mean|1895.00|1895.0|Standard Deviation|390.48|390.48|||
3664828|NCT02367066|3509886|B1|||Current Metformin Daily Dose||mg|Mean|1765.00|1765.0|Standard Deviation|473.78|473.78|||
3664829|NCT02367066|3509884|B3|||T2DM disease duration||Years|Mean|9.50|9.5|Standard Deviation|4.61|4.61|||
3664830|NCT02367066|3509885|B2|||T2DM disease duration||Years|Mean|8.60|8.6|Standard Deviation|5.02|5.02|||
3664831|NCT02367066|3509886|B1|||T2DM disease duration||Years|Mean|10.30|10.3|Standard Deviation|4.24|4.24|||
3664832|NCT02367066|3509884|B3|||Body Mass Index||kg/m2|Mean|31.63|31.63|Standard Deviation|4.47|4.47|||
3664833|NCT02367066|3509885|B2|||Body Mass Index||kg/m2|Mean|32.13|32.13|Standard Deviation|5.37|5.37|||
3664834|NCT02367066|3509886|B1|||Body Mass Index||kg/m2|Mean|31.13|31.13|Standard Deviation|3.58|3.58|||
3664835|NCT02367066|3509884|B3|||Height||cm|Mean|165.80|165.8|Standard Deviation|11.41|11.41|||
3664836|NCT02367066|3509885|B2|||Height||cm|Mean|164.90|164.9|Standard Deviation|12.59|12.59|||
3664837|NCT02367066|3509886|B1|||Height||cm|Mean|166.80|166.8|Standard Deviation|10.70|10.7|||
3664838|NCT02367066|3509884|B3|||Weight||kg|Mean|87.44|87.44|Standard Deviation|19.14|19.14|||
3664839|NCT02367066|3509885|B2|||Weight||kg|Mean|87.59|87.59|Standard Deviation|20.36|20.36|||
3664840|NCT02367066|3509886|B1|||Weight||kg|Mean|87.28|87.28|Standard Deviation|18.95|18.95|||
3664841|NCT02367066|3509884|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664842|NCT02367066|3509885|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664843|NCT02367066|3509886|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664844|NCT02367066|3509884|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664845|NCT02367066|3509885|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664846|NCT02367066|3509886|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664847|NCT02367066|3509884|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3664848|NCT02367066|3509885|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3664849|NCT02367066|3509886|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3664850|NCT02367066|3509884|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3664910|NCT02366767|3509976|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3664851|NCT02367066|3509885|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3664852|NCT02367066|3509886|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3664853|NCT02367066|3509884|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3664854|NCT02367066|3509885|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3664855|NCT02367066|3509886|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664856|NCT02367066|3509884|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664857|NCT02367066|3509885|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664858|NCT02367066|3509886|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664859|NCT02367066|3509884|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664860|NCT02367066|3509885|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664861|NCT02367066|3509886|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664862|NCT02367066|3509884|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664863|NCT02367066|3509885|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664864|NCT02367066|3509886|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664865|NCT02367066|3509884|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3664866|NCT02367066|3509885|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3664867|NCT02367066|3509886|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3664868|NCT02367066|3509884|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3664869|NCT02367066|3509885|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3664870|NCT02367066|3509886|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3664871|NCT02367066|3509884|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3664872|NCT02367066|3509885|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3664873|NCT02367066|3509886|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3664874|NCT02367066|3509884|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3664875|NCT02367066|3509885|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3664876|NCT02367066|3509886|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3664877|NCT02367066|3509884|B3|||Age||Years|Mean|54.00|54.0|Standard Deviation|7.86|7.86|||
3664878|NCT02367066|3509885|B2|||Age||Years|Mean|54.80|54.8|Standard Deviation|6.80|6.8|||
3664879|NCT02367066|3509886|B1|||Age||Years|Mean|53.10|53.1|Standard Deviation|9.10|9.1|||
3664880|NCT02366936|3509945|B1|||Birth weight||g|Mean|975|975.0|Full Range|||590.0|1430.0|
3664881|NCT02366936|3509945|B1|||Gestational age||weeks|Mean|27|27.0|Full Range|||25.0|30.0|
3664882|NCT02366936|3509945|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
3664883|NCT02366936|3509945|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664884|NCT02366936|3509945|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3664885|NCT02366936|3509945|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3664886|NCT02366936|3509945|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3664887|NCT02366936|3509945|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664888|NCT02366936|3509945|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664889|NCT02366936|3509945|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664890|NCT02366936|3509945|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3664891|NCT02366936|3509945|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3664892|NCT02366936|3509945|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3664893|NCT02366936|3509945|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3664894|NCT02366936|3509945|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3664895|NCT02366936|3509945|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3664896|NCT02366936|3509945|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3664897|NCT02366936|3509945|B1||<=18 years|Age||Participants|Count of Participants|32|32.0||||||
3664898|NCT02366923|3509950|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3664899|NCT02366923|3509950|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3664900|NCT02366923|3509950|B1|||Age||years|Median|25|25.0|Full Range|||18.0|63.0|
3664901|NCT02366923|3509950|B1|||Age||years|Mean|27.1|27.1|Standard Deviation|9.9|9.9|||
3664902|NCT02366910|3509963|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3664903|NCT02366910|3509963|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3664904|NCT02366910|3509963|B1|||Age||years|Median|24|24.0|Full Range|||20.0|62.0|
3664905|NCT02366910|3509963|B1|||Age||years|Mean|26.9|26.9|Standard Deviation|10.1|10.1|||
3664906|NCT02366767|3509975|B3|||Hemoglobin A1c||%|Mean|8.6|8.6|Standard Deviation|1.5|1.5|||
3664907|NCT02366767|3509976|B2|||Hemoglobin A1c||%|Mean|8.6|8.6|Standard Deviation|1.05|1.05|||
3664908|NCT02366767|3509977|B1|||Hemoglobin A1c||%|Mean|8.5|8.5|Standard Deviation|1.9|1.9|||
3664909|NCT02366767|3509975|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
3664911|NCT02366767|3509977|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3664912|NCT02366767|3509975|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3664913|NCT02366767|3509976|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3664914|NCT02366767|3509977|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3664915|NCT02366767|3509975|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3664916|NCT02366767|3509976|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3664917|NCT02366767|3509977|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3664918|NCT02366767|3509975|B3|||Age||years|Mean|18.6|18.6|Standard Deviation|3.7|3.7|||
3664919|NCT02366767|3509976|B2|||Age||years|Mean|17.7|17.7|Standard Deviation|2.2|2.2|||
3664920|NCT02366767|3509977|B1|||Age||years|Mean|19.4|19.4|Standard Deviation|4.7|4.7|||
3664921|NCT02366689|3509988|B4|United States||Region of Enrollment||participants|Number|179|179.0||||||
3664922|NCT02366689|3509989|B3|United States||Region of Enrollment||participants|Number|61|61.0||||||
3664923|NCT02366689|3509990|B2|United States||Region of Enrollment||participants|Number|58|58.0||||||
3664924|NCT02366689|3509991|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
3664925|NCT02366689|3509988|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3664926|NCT02366689|3509989|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3664927|NCT02366689|3509990|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3664928|NCT02366689|3509991|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3664929|NCT02366689|3509988|B4||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3664930|NCT02366689|3509989|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3664931|NCT02366689|3509990|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3664932|NCT02366689|3509991|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3664933|NCT02366689|3509988|B4|||Age||years|Mean|49.08|49.08|Standard Deviation|12.49|12.49|||
3664934|NCT02366689|3509989|B3|||Age||years|Mean|48.51|48.51|Standard Deviation|12.90|12.9|||
3664935|NCT02366689|3509990|B2|||Age||years|Mean|48.65|48.65|Standard Deviation|12.84|12.84|||
3664936|NCT02366689|3509991|B1|||Age||years|Mean|50.09|50.09|Standard Deviation|11.72|11.72|||
3664937|NCT02366663|3510016|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3664938|NCT02366663|3510017|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3664939|NCT02366663|3510018|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3664940|NCT02366663|3510016|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3664941|NCT02366663|3510017|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3664942|NCT02366663|3510018|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3664943|NCT02366663|3510016|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3664944|NCT02366663|3510017|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3664945|NCT02366663|3510018|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3664946|NCT02366663|3510016|B3|||Age||years|Median|66|66.0|Full Range|||48.0|71.0|
3664947|NCT02366663|3510017|B2|||Age||years|Median|48|48.0|Full Range|||48.0|48.0|
3664948|NCT02366663|3510018|B1|||Age||years|Median|69|69.0|Full Range|||66.0|71.0|
3664949|NCT02366663|3510016|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3664950|NCT02366663|3510017|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3664951|NCT02366663|3510018|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3664952|NCT02366663|3510016|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3664953|NCT02366663|3510017|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3664954|NCT02366663|3510018|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3664955|NCT02366663|3510016|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3664956|NCT02366663|3510017|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3664957|NCT02366663|3510018|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3664958|NCT02366637|3510045|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3664959|NCT02366637|3510045|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3664960|NCT02366637|3510045|B1|||Age||years|Mean|62.0|62.0|Standard Deviation|6.5|6.5|||
3664961|NCT02366338|3510070|B4|Turkey||Region of Enrollment||participants|Number|148|148.0||||||
3664962|NCT02366338|3510071|B3|Turkey||Region of Enrollment||participants|Number|36|36.0||||||
3664963|NCT02366338|3510072|B2|Turkey||Region of Enrollment||participants|Number|39|39.0||||||
3664964|NCT02366338|3510073|B1|Turkey||Region of Enrollment||participants|Number|73|73.0||||||
3664965|NCT02366338|3510070|B4||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3664966|NCT02366338|3510071|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3664967|NCT02366338|3510072|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3664968|NCT02366338|3510073|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3664969|NCT02366338|3510070|B4||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3664970|NCT02366338|3510071|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3664971|NCT02366338|3510072|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3664972|NCT02366338|3510073|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3664973|NCT02366338|3510070|B4|||Age||years|Mean|71|71.0|Standard Deviation|9|9.0|||
3664974|NCT02366338|3510071|B3|||Age||years|Mean|72|72.0|Standard Deviation|8|8.0|||
3664975|NCT02366338|3510072|B2|||Age||years|Mean|69|69.0|Standard Deviation|9|9.0|||
3664976|NCT02366338|3510073|B1|||Age||years|Mean|72|72.0|Standard Deviation|9|9.0|||
3664977|NCT02366195|3510083|B1|||Log2(Intratumoral Cluster of Differentiation 8-positive (CD8+) Cell Density)|CD8+ cell density was assessed from tumor biopsy samples using CD8-specific immunohistochemistry.|CD8+ cells/mm²|Mean|8.041|8.041|Standard Deviation|1.903|1.903|||
3664978|NCT02366195|3510083|B1||1 (Restricted but ambulatory)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|24|24.0||||||
3664979|NCT02366195|3510083|B1||0 (Fully active, no restrictions)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|87|87.0||||||
3664980|NCT02366195|3510083|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3664981|NCT02366195|3510083|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|111|111.0||||||
3664982|NCT02366195|3510083|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3664983|NCT02366195|3510083|B1||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3664984|NCT02366195|3510083|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3664985|NCT02366195|3510083|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3664986|NCT02366195|3510083|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3664987|NCT02366195|3510083|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664988|NCT02366195|3510083|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
3664989|NCT02366195|3510083|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3664990|NCT02366195|3510083|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3664991|NCT02366195|3510083|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3664992|NCT02366195|3510083|B1|||Age||years|Mean|65.7|65.7|Standard Deviation|15.1|15.1|||
3664993|NCT02365714|3510101|B1|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3664994|NCT02365714|3510101|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664995|NCT02365714|3510101|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664996|NCT02365714|3510101|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664997|NCT02365714|3510101|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3664998|NCT02365714|3510101|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3664999|NCT02365714|3510101|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665000|NCT02365714|3510101|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665001|NCT02365714|3510101|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3665002|NCT02365714|3510101|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3665003|NCT02365714|3510101|B1|||Age||years|Median|59|59.0|Full Range|||55.0|63.0|
3665004|NCT02365688|3510107|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3665005|NCT02365688|3510107|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3665006|NCT02365688|3510107|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3665007|NCT02365688|3510107|B1|||Age||years|Mean|58|58.0|Full Range|||24.0|77.0|
3665008|NCT02365636|3510111|B4||Homozygous common allele (negative, GG)|R1150W Polymorphism Status|Patients who carry the R1150W polymorphism have a nucleotide containing adenine (A) instead of guanine (G) in the rs6746030 single nucleotide polymorphism in the SCN9A gene. This change causes an arginine to tryptophan amino acid residue change at position 1150 in the alpha subunit of the voltage-gated sodium channel NaV1.7. Those who carry the R1150W polymorphism may be heterozygous (GA) or homozygous (AA) for the minor allele. This R1150W polymorphism in the SCN9A gene may affect pain perception (Reimann et al 2010).|Participants|Count of Participants|233|233.0||||||
3665009|NCT02365636|3510112|B3||Homozygous common allele (negative, GG)|R1150W Polymorphism Status|Patients who carry the R1150W polymorphism have a nucleotide containing adenine (A) instead of guanine (G) in the rs6746030 single nucleotide polymorphism in the SCN9A gene. This change causes an arginine to tryptophan amino acid residue change at position 1150 in the alpha subunit of the voltage-gated sodium channel NaV1.7. Those who carry the R1150W polymorphism may be heterozygous (GA) or homozygous (AA) for the minor allele. This R1150W polymorphism in the SCN9A gene may affect pain perception (Reimann et al 2010).|Participants|Count of Participants|78|78.0||||||
3665010|NCT02365636|3510113|B2||Homozygous common allele (negative, GG)|R1150W Polymorphism Status|Patients who carry the R1150W polymorphism have a nucleotide containing adenine (A) instead of guanine (G) in the rs6746030 single nucleotide polymorphism in the SCN9A gene. This change causes an arginine to tryptophan amino acid residue change at position 1150 in the alpha subunit of the voltage-gated sodium channel NaV1.7. Those who carry the R1150W polymorphism may be heterozygous (GA) or homozygous (AA) for the minor allele. This R1150W polymorphism in the SCN9A gene may affect pain perception (Reimann et al 2010).|Participants|Count of Participants|73|73.0||||||
3665011|NCT02365636|3510114|B1||Homozygous common allele (negative, GG)|R1150W Polymorphism Status|Patients who carry the R1150W polymorphism have a nucleotide containing adenine (A) instead of guanine (G) in the rs6746030 single nucleotide polymorphism in the SCN9A gene. This change causes an arginine to tryptophan amino acid residue change at position 1150 in the alpha subunit of the voltage-gated sodium channel NaV1.7. Those who carry the R1150W polymorphism may be heterozygous (GA) or homozygous (AA) for the minor allele. This R1150W polymorphism in the SCN9A gene may affect pain perception (Reimann et al 2010).|Participants|Count of Participants|82|82.0||||||
3665012|NCT02365636|3510111|B4||Heterozygous (positive, AG)|R1150W Polymorphism Status|Patients who carry the R1150W polymorphism have a nucleotide containing adenine (A) instead of guanine (G) in the rs6746030 single nucleotide polymorphism in the SCN9A gene. This change causes an arginine to tryptophan amino acid residue change at position 1150 in the alpha subunit of the voltage-gated sodium channel NaV1.7. Those who carry the R1150W polymorphism may be heterozygous (GA) or homozygous (AA) for the minor allele. This R1150W polymorphism in the SCN9A gene may affect pain perception (Reimann et al 2010).|Participants|Count of Participants|64|64.0||||||
3665013|NCT02365636|3510112|B3||Heterozygous (positive, AG)|R1150W Polymorphism Status|Patients who carry the R1150W polymorphism have a nucleotide containing adenine (A) instead of guanine (G) in the rs6746030 single nucleotide polymorphism in the SCN9A gene. This change causes an arginine to tryptophan amino acid residue change at position 1150 in the alpha subunit of the voltage-gated sodium channel NaV1.7. Those who carry the R1150W polymorphism may be heterozygous (GA) or homozygous (AA) for the minor allele. This R1150W polymorphism in the SCN9A gene may affect pain perception (Reimann et al 2010).|Participants|Count of Participants|22|22.0||||||
3665014|NCT02365636|3510113|B2||Heterozygous (positive, AG)|R1150W Polymorphism Status|Patients who carry the R1150W polymorphism have a nucleotide containing adenine (A) instead of guanine (G) in the rs6746030 single nucleotide polymorphism in the SCN9A gene. This change causes an arginine to tryptophan amino acid residue change at position 1150 in the alpha subunit of the voltage-gated sodium channel NaV1.7. Those who carry the R1150W polymorphism may be heterozygous (GA) or homozygous (AA) for the minor allele. This R1150W polymorphism in the SCN9A gene may affect pain perception (Reimann et al 2010).|Participants|Count of Participants|25|25.0||||||
3665015|NCT02365636|3510114|B1||Heterozygous (positive, AG)|R1150W Polymorphism Status|Patients who carry the R1150W polymorphism have a nucleotide containing adenine (A) instead of guanine (G) in the rs6746030 single nucleotide polymorphism in the SCN9A gene. This change causes an arginine to tryptophan amino acid residue change at position 1150 in the alpha subunit of the voltage-gated sodium channel NaV1.7. Those who carry the R1150W polymorphism may be heterozygous (GA) or homozygous (AA) for the minor allele. This R1150W polymorphism in the SCN9A gene may affect pain perception (Reimann et al 2010).|Participants|Count of Participants|17|17.0||||||
3665016|NCT02365636|3510111|B4||Homozygous minor allele (positive, AA)|R1150W Polymorphism Status|Patients who carry the R1150W polymorphism have a nucleotide containing adenine (A) instead of guanine (G) in the rs6746030 single nucleotide polymorphism in the SCN9A gene. This change causes an arginine to tryptophan amino acid residue change at position 1150 in the alpha subunit of the voltage-gated sodium channel NaV1.7. Those who carry the R1150W polymorphism may be heterozygous (GA) or homozygous (AA) for the minor allele. This R1150W polymorphism in the SCN9A gene may affect pain perception (Reimann et al 2010).|Participants|Count of Participants|3|3.0||||||
3665017|NCT02365636|3510112|B3||Homozygous minor allele (positive, AA)|R1150W Polymorphism Status|Patients who carry the R1150W polymorphism have a nucleotide containing adenine (A) instead of guanine (G) in the rs6746030 single nucleotide polymorphism in the SCN9A gene. This change causes an arginine to tryptophan amino acid residue change at position 1150 in the alpha subunit of the voltage-gated sodium channel NaV1.7. Those who carry the R1150W polymorphism may be heterozygous (GA) or homozygous (AA) for the minor allele. This R1150W polymorphism in the SCN9A gene may affect pain perception (Reimann et al 2010).|Participants|Count of Participants|0|0.0||||||
3665018|NCT02365636|3510113|B2||Homozygous minor allele (positive, AA)|R1150W Polymorphism Status|Patients who carry the R1150W polymorphism have a nucleotide containing adenine (A) instead of guanine (G) in the rs6746030 single nucleotide polymorphism in the SCN9A gene. This change causes an arginine to tryptophan amino acid residue change at position 1150 in the alpha subunit of the voltage-gated sodium channel NaV1.7. Those who carry the R1150W polymorphism may be heterozygous (GA) or homozygous (AA) for the minor allele. This R1150W polymorphism in the SCN9A gene may affect pain perception (Reimann et al 2010).|Participants|Count of Participants|2|2.0||||||
3665019|NCT02365636|3510114|B1||Homozygous minor allele (positive, AA)|R1150W Polymorphism Status|Patients who carry the R1150W polymorphism have a nucleotide containing adenine (A) instead of guanine (G) in the rs6746030 single nucleotide polymorphism in the SCN9A gene. This change causes an arginine to tryptophan amino acid residue change at position 1150 in the alpha subunit of the voltage-gated sodium channel NaV1.7. Those who carry the R1150W polymorphism may be heterozygous (GA) or homozygous (AA) for the minor allele. This R1150W polymorphism in the SCN9A gene may affect pain perception (Reimann et al 2010).|Participants|Count of Participants|1|1.0||||||
3665020|NCT02365636|3510111|B4|||Body Mass Index||kg/m^2|Mean|27.62|27.62|Standard Deviation|3.580|3.58|||
3665021|NCT02365636|3510112|B3|||Body Mass Index||kg/m^2|Mean|28.15|28.15|Standard Deviation|3.798|3.798|||
3665022|NCT02365636|3510113|B2|||Body Mass Index||kg/m^2|Mean|27.30|27.3|Standard Deviation|3.452|3.452|||
3665023|NCT02365636|3510114|B1|||Body Mass Index||kg/m^2|Mean|27.42|27.42|Standard Deviation|3.457|3.457|||
3665024|NCT02365636|3510111|B4|||Height||cm|Mean|167.04|167.04|Standard Deviation|9.668|9.668|||
3665025|NCT02365636|3510112|B3|||Height||cm|Mean|165.82|165.82|Standard Deviation|10.355|10.355|||
3665026|NCT02365636|3510113|B2|||Height||cm|Mean|168.03|168.03|Standard Deviation|8.203|8.203|||
3665027|NCT02365636|3510114|B1|||Height||cm|Mean|167.27|167.27|Standard Deviation|10.258|10.258|||
3665028|NCT02365636|3510111|B4|||Weight||kg|Mean|77.43|77.43|Standard Deviation|14.066|14.066|||
3665029|NCT02365636|3510112|B3|||Weight||kg|Mean|77.86|77.86|Standard Deviation|15.111|15.111|||
3665030|NCT02365636|3510113|B2|||Weight||kg|Mean|77.41|77.41|Standard Deviation|13.383|13.383|||
3665031|NCT02365636|3510114|B1|||Weight||kg|Mean|77.02|77.02|Standard Deviation|13.775|13.775|||
3665032|NCT02365636|3510111|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3665033|NCT02365636|3510112|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3665034|NCT02365636|3510113|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3665035|NCT02365636|3510114|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3665036|NCT02365636|3510111|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3665037|NCT02365636|3510112|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3665038|NCT02365636|3510113|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3665039|NCT02365636|3510114|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3665040|NCT02365636|3510111|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3665041|NCT02365636|3510112|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3665042|NCT02365636|3510113|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3665043|NCT02365636|3510114|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3665044|NCT02365636|3510111|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
3665045|NCT02365636|3510112|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3665046|NCT02365636|3510113|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3665047|NCT02365636|3510114|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3665048|NCT02365636|3510111|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|250|250.0||||||
3665049|NCT02365636|3510112|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|90|90.0||||||
3665050|NCT02365636|3510113|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|79|79.0||||||
3665051|NCT02365636|3510114|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|81|81.0||||||
3665052|NCT02365636|3510111|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3665053|NCT02365636|3510112|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665054|NCT02365636|3510113|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665055|NCT02365636|3510114|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3665056|NCT02365636|3510111|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
3665057|NCT02365636|3510112|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3665058|NCT02365636|3510113|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3665059|NCT02365636|3510114|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3665060|NCT02365636|3510111|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|179|179.0||||||
3665061|NCT02365636|3510112|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3665062|NCT02365636|3510113|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3665063|NCT02365636|3510114|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3665064|NCT02365636|3510111|B4||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3665065|NCT02365636|3510112|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3665066|NCT02365636|3510113|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3665067|NCT02365636|3510114|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3665068|NCT02365636|3510111|B4||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3665069|NCT02365636|3510112|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3665070|NCT02365636|3510113|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3665071|NCT02365636|3510114|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3665072|NCT02365636|3510111|B4|||Age||years|Mean|57.8|57.8|Standard Deviation|16.09|16.09|||
3665073|NCT02365636|3510112|B3|||Age||years|Mean|58.6|58.6|Standard Deviation|15.80|15.8|||
3665074|NCT02365636|3510113|B2|||Age||years|Mean|57.6|57.6|Standard Deviation|16.61|16.61|||
3665075|NCT02365636|3510114|B1|||Age||years|Mean|57.2|57.2|Standard Deviation|15.99|15.99|||
3665076|NCT02365558|3510160|B1|United States||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3665077|NCT02365558|3510160|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665078|NCT02365558|3510160|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665079|NCT02365558|3510160|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3665080|NCT02365558|3510160|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3665081|NCT02365558|3510160|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665082|NCT02365558|3510160|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3665083|NCT02365558|3510160|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665084|NCT02365558|3510160|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665085|NCT02365558|3510160|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3665086|NCT02365558|3510160|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3665087|NCT02365558|3510160|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3665088|NCT02365558|3510160|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3665089|NCT02365558|3510160|B1|||Age||Years|Mean|40.9|40.9|Standard Deviation|10.6|10.6|||
3665090|NCT02365519|3510172|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3665091|NCT02365519|3510173|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3665092|NCT02365519|3510174|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3665093|NCT02365519|3510172|B3||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3665094|NCT02365519|3510173|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3665095|NCT02365519|3510174|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3665096|NCT02365519|3510172|B3|||Age||years|Mean|60.3|60.3|Standard Deviation|13.78|13.78|||
3665097|NCT02365519|3510173|B2|||Age||years|Mean|58.8|58.8|Standard Deviation|14.48|14.48|||
3665098|NCT02365519|3510174|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|13.05|13.05|||
3665099|NCT02365298|3510197|B1|Canada||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3665100|NCT02365298|3510197|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3665101|NCT02365298|3510197|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3665102|NCT02365298|3510197|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3665103|NCT02365298|3510197|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3665104|NCT02365298|3510197|B1|||Age||years|Mean|23.3|23.3|Standard Deviation|4.79|4.79|||
3665105|NCT02364999|3510227|B3|OTHER||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3665106|NCT02364999|3510228|B2|OTHER||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3665107|NCT02364999|3510229|B1|OTHER||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3665108|NCT02364999|3510227|B3|ASIAN||Race/Ethnicity, Customized||Participants|Count of Participants|76|76.0||||||
3665109|NCT02364999|3510228|B2|ASIAN||Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3665110|NCT02364999|3510229|B1|ASIAN||Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3665111|NCT02364999|3510227|B3|BLACK||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3665112|NCT02364999|3510228|B2|BLACK||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3665113|NCT02364999|3510229|B1|BLACK||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3665114|NCT02364999|3510227|B3|WHITE||Race/Ethnicity, Customized||Participants|Count of Participants|638|638.0||||||
3665115|NCT02364999|3510228|B2|WHITE||Race/Ethnicity, Customized||Participants|Count of Participants|319|319.0||||||
3665116|NCT02364999|3510229|B1|WHITE||Race/Ethnicity, Customized||Participants|Count of Participants|319|319.0||||||
3665117|NCT02364999|3510227|B3|Male||Sex/Gender, Customized||Participants|Count of Participants|467|467.0||||||
3665118|NCT02364999|3510228|B2|Male||Sex/Gender, Customized||Participants|Count of Participants|230|230.0||||||
3665119|NCT02364999|3510229|B1|Male||Sex/Gender, Customized||Participants|Count of Participants|237|237.0||||||
3665120|NCT02364999|3510227|B3|Female||Sex/Gender, Customized||Participants|Count of Participants|252|252.0||||||
3665121|NCT02364999|3510228|B2|Female||Sex/Gender, Customized||Participants|Count of Participants|131|131.0||||||
3665122|NCT02364999|3510229|B1|Female||Sex/Gender, Customized||Participants|Count of Participants|121|121.0||||||
3665123|NCT02364999|3510227|B3|>= 65 years||Age, Customized||Participants|Count of Participants|263|263.0||||||
3665124|NCT02364999|3510228|B2|>= 65 years||Age, Customized||Participants|Count of Participants|122|122.0||||||
3665125|NCT02364999|3510229|B1|>= 65 years||Age, Customized||Participants|Count of Participants|141|141.0||||||
3665126|NCT02364999|3510227|B3|45-64 years||Age, Customized||Participants|Count of Participants|420|420.0||||||
3665127|NCT02364999|3510228|B2|45-64 years||Age, Customized||Participants|Count of Participants|222|222.0||||||
3665128|NCT02364999|3510229|B1|45-64 years||Age, Customized||Participants|Count of Participants|198|198.0||||||
3665129|NCT02364999|3510227|B3|18-44 years||Age, Customized||Participants|Count of Participants|36|36.0||||||
3665130|NCT02364999|3510228|B2|18-44 years||Age, Customized||Participants|Count of Participants|17|17.0||||||
3665131|NCT02364999|3510229|B1|18-44 years||Age, Customized||Participants|Count of Participants|19|19.0||||||
3665132|NCT02364999|3510227|B3|||Age||years|Mean|61.3|61.3|Standard Deviation|9.2|9.2|||
3665133|NCT02364999|3510228|B2|||Age||years|Mean|60.9|60.9|Standard Deviation|8.9|8.9|||
3665134|NCT02364999|3510229|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|9.5|9.5|||
3665135|NCT02364778|3510253|B3|||Triglyceride||mg/dL|Median|102|102.0|Inter-Quartile Range|||63.0|151.0|
3665136|NCT02364778|3510254|B2|||Triglyceride||mg/dL|Median|84|84.0|Inter-Quartile Range|||61.0|151.0|
3665137|NCT02364778|3510255|B1|||Triglyceride||mg/dL|Median|107|107.0|Inter-Quartile Range|||85.0|152.0|
3665138|NCT02364778|3510253|B3|||LDL cholesterol||mg/dL|Median|72|72.0|Inter-Quartile Range|||57.0|92.0|
3665139|NCT02364778|3510254|B2|||LDL cholesterol||mg/dL|Median|73|73.0|Inter-Quartile Range|||58.0|92.0|
3665140|NCT02364778|3510255|B1|||LDL cholesterol||mg/dL|Median|72|72.0|Inter-Quartile Range|||59.0|86.0|
3665141|NCT02364778|3510253|B3|||HDL cholesterol||mg/dL|Median|41|41.0|Inter-Quartile Range|||32.0|52.0|
3665142|NCT02364778|3510254|B2|||HDL cholesterol||mg/dL|Median|40|40.0|Inter-Quartile Range|||32.0|52.0|
3665143|NCT02364778|3510255|B1|||HDL cholesterol||mg/dL|Median|41|41.0|Inter-Quartile Range|||36.0|42.0|
3665144|NCT02364778|3510253|B3|||Total cholesterol||mg/dL|Median|136|136.0|Inter-Quartile Range|||127.0|179.0|
3665145|NCT02364778|3510254|B2|||Total cholesterol||mg/dL|Median|136|136.0|Inter-Quartile Range|||127.0|168.0|
3665146|NCT02364778|3510255|B1|||Total cholesterol||mg/dL|Median|136|136.0|Inter-Quartile Range|||127.0|167.0|
3665147|NCT02364778|3510253|B3|Ticagrelor||Antiplatelet therapy||participants|Number|4|4.0||||||
3665148|NCT02364778|3510254|B2|Ticagrelor||Antiplatelet therapy||participants|Number|2|2.0||||||
3665149|NCT02364778|3510255|B1|Ticagrelor||Antiplatelet therapy||participants|Number|2|2.0||||||
3665150|NCT02364778|3510253|B3|Prasugrel||Antiplatelet therapy||participants|Number|4|4.0||||||
3665151|NCT02364778|3510254|B2|Prasugrel||Antiplatelet therapy||participants|Number|1|1.0||||||
3665152|NCT02364778|3510255|B1|Prasugrel||Antiplatelet therapy||participants|Number|3|3.0||||||
3665153|NCT02364778|3510253|B3|Clopidogrel||Antiplatelet therapy||participants|Number|22|22.0||||||
3665154|NCT02364778|3510254|B2|Clopidogrel||Antiplatelet therapy||participants|Number|17|17.0||||||
3665155|NCT02364778|3510255|B1|Clopidogrel||Antiplatelet therapy||participants|Number|5|5.0||||||
3665156|NCT02364778|3510253|B3|no||Statin use||participants|Number|6|6.0||||||
3665157|NCT02364778|3510254|B2|no||Statin use||participants|Number|4|4.0||||||
3665158|NCT02364778|3510255|B1|no||Statin use||participants|Number|2|2.0||||||
3665159|NCT02364778|3510253|B3|yes||Statin use||participants|Number|24|24.0||||||
3665160|NCT02364778|3510254|B2|yes||Statin use||participants|Number|16|16.0||||||
3665161|NCT02364778|3510255|B1|yes||Statin use||participants|Number|8|8.0||||||
3665162|NCT02364778|3510253|B3|no||CCS angina grade III or IV|Canadian Cardiovascular Society (CCS)|participants|Number|4|4.0||||||
3665163|NCT02364778|3510254|B2|no||CCS angina grade III or IV|Canadian Cardiovascular Society (CCS)|participants|Number|2|2.0||||||
3665164|NCT02364778|3510255|B1|no||CCS angina grade III or IV|Canadian Cardiovascular Society (CCS)|participants|Number|2|2.0||||||
3665165|NCT02364778|3510253|B3|yes||CCS angina grade III or IV|Canadian Cardiovascular Society (CCS)|participants|Number|26|26.0||||||
3665166|NCT02364778|3510254|B2|yes||CCS angina grade III or IV|Canadian Cardiovascular Society (CCS)|participants|Number|18|18.0||||||
3665167|NCT02364778|3510255|B1|yes||CCS angina grade III or IV|Canadian Cardiovascular Society (CCS)|participants|Number|8|8.0||||||
3665168|NCT02364778|3510253|B3|no||Prior MI|Prior myocardial infarction history|participants|Number|26|26.0||||||
3665169|NCT02364778|3510254|B2|no||Prior MI|Prior myocardial infarction history|participants|Number|17|17.0||||||
3665170|NCT02364778|3510255|B1|no||Prior MI|Prior myocardial infarction history|participants|Number|9|9.0||||||
3665171|NCT02364778|3510253|B3|yes||Prior MI|Prior myocardial infarction history|participants|Number|4|4.0||||||
3665172|NCT02364778|3510254|B2|yes||Prior MI|Prior myocardial infarction history|participants|Number|3|3.0||||||
3665173|NCT02364778|3510255|B1|yes||Prior MI|Prior myocardial infarction history|participants|Number|1|1.0||||||
3665174|NCT02364778|3510253|B3|||BMI||kg/m^2|Mean|30.3|30.3|Standard Deviation|1.6|1.6|||
3665175|NCT02364778|3510254|B2|||BMI||kg/m^2|Mean|31.5|31.5|Standard Deviation|2.2|2.2|||
3665176|NCT02364778|3510255|B1|||BMI||kg/m^2|Mean|27.8|27.8|Standard Deviation|2.0|2.0|||
3665177|NCT02364778|3510253|B3|no||Current smoking||participants|Number|26|26.0||||||
3665178|NCT02364778|3510254|B2|no||Current smoking||participants|Number|18|18.0||||||
3665179|NCT02364778|3510255|B1|no||Current smoking||participants|Number|8|8.0||||||
3665180|NCT02364778|3510253|B3|yes||Current smoking||participants|Number|4|4.0||||||
3665181|NCT02364778|3510254|B2|yes||Current smoking||participants|Number|2|2.0||||||
3665182|NCT02364778|3510255|B1|yes||Current smoking||participants|Number|2|2.0||||||
3665183|NCT02364778|3510253|B3|no||Diabetes mellitus||participants|Number|17|17.0||||||
3665184|NCT02364778|3510254|B2|no||Diabetes mellitus||participants|Number|12|12.0||||||
3665185|NCT02364778|3510255|B1|no||Diabetes mellitus||participants|Number|5|5.0||||||
3665186|NCT02364778|3510253|B3|yes||Diabetes mellitus||participants|Number|13|13.0||||||
3665187|NCT02364778|3510254|B2|yes||Diabetes mellitus||participants|Number|8|8.0||||||
3665188|NCT02364778|3510255|B1|yes||Diabetes mellitus||participants|Number|5|5.0||||||
3665189|NCT02364778|3510253|B3|no||Dyslipidemia||participants|Number|2|2.0||||||
3665190|NCT02364778|3510254|B2|no||Dyslipidemia||participants|Number|1|1.0||||||
3665191|NCT02364778|3510255|B1|no||Dyslipidemia||participants|Number|1|1.0||||||
3665192|NCT02364778|3510253|B3|yes||Dyslipidemia||participants|Number|28|28.0||||||
3665193|NCT02364778|3510254|B2|yes||Dyslipidemia||participants|Number|19|19.0||||||
3665194|NCT02364778|3510255|B1|yes||Dyslipidemia||participants|Number|9|9.0||||||
3665195|NCT02364778|3510253|B3|no||Hypertension||participants|Number|6|6.0||||||
3665196|NCT02364778|3510254|B2|no||Hypertension||participants|Number|5|5.0||||||
3665197|NCT02364778|3510255|B1|no||Hypertension||participants|Number|1|1.0||||||
3665198|NCT02364778|3510253|B3|yes||Hypertension||participants|Number|24|24.0||||||
3665199|NCT02364778|3510254|B2|yes||Hypertension||participants|Number|15|15.0||||||
3665200|NCT02364778|3510255|B1|yes||Hypertension||participants|Number|9|9.0||||||
3665201|NCT02364778|3510253|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3665202|NCT02364778|3510254|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3665203|NCT02364778|3510255|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3665204|NCT02364778|3510253|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3665205|NCT02364778|3510254|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3665206|NCT02364778|3510255|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3665207|NCT02364778|3510253|B3|||Age||years|Mean|63.6|63.6|Standard Deviation|1.8|1.8|||
3665208|NCT02364778|3510254|B2|||Age||years|Mean|63.1|63.1|Standard Deviation|2.2|2.2|||
3665209|NCT02364778|3510255|B1|||Age||years|Mean|64.8|64.8|Standard Deviation|2.5|2.5|||
3665210|NCT02364700|3510267|B1|||Dynamometry|Dynamometer is a valid and reliable assessment of grip strength (impairment) measured in kilograms.|kilograms|Mean|7.96|7.96|Standard Deviation|6.24|6.24|||
3665247|NCT02364037|3510281|B2||Neutral|Participant feelings about becoming pregnant in next 12 months||Participants|Count of Participants|101|101.0||||||
3665248|NCT02364037|3510282|B1||Neutral|Participant feelings about becoming pregnant in next 12 months||Participants|Count of Participants|102|102.0||||||
3665361|NCT02363946|3510305|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3665211|NCT02364700|3510267|B1|||Stroke Impact Scale-Hand Subscale|"The Stroke Impact Scale is a stroke-specific questionnaire evaluating quality of life in stroke survivors over eight domains. Each domain is scored independently on an ordinal scale ranging from 0 to a maximum of 5. Only the Hand sub-score (SIS-H) was used in this study. Scores for each domain are transformed and range from 0-100.~Formula for scoring domains:~Transformed Scale = [(Actual raw score - lowest possible raw score) / Possible raw score] * 100"|units on a scale|Mean|11.50|11.5|Standard Deviation|4.91|4.91|||
3665212|NCT02364700|3510267|B1|||Stroke Upper Limb Capacity Scale (SULCS)|The SULCS was developed to measure the capacity of the affected upper limb after stroke. Each of the 10 items arranged in a hierarchical order is assigned a score of 0 (unable to complete) or 1 (able to complete the task) with a maximum score of 10.|units on a scale|Mean|5.33|5.33|Standard Deviation|2.15|2.15|||
3665213|NCT02364700|3510267|B1|||Fugl-Meyer Assessment (FMA)|The FMA is a widely-used performance-based measure of impairment for nine upper extremity movements. It examines flexor and extensor synergy patterns, movements out of synergy patterns, wrist and hand movements, as well as strength and coordination of fine motor movements. Scores range from 0-66, with 66 being the highest score possible. For this study, the three reflex items were omitted from the final score because it is considered a separate construct from motor impairment making the maximum score 60.|units on a scale|Mean|20.75|20.75|Standard Deviation|7.90|7.9|||
3665214|NCT02364700|3510267|B1|||Arm Motor Ability Test (AMAT)|Performance-based measure to assess ability of participant to perform everyday functional upper extremity tasks unilaterally or bilaterally. Scoring is based on a 0-5 ordinal scale, with 0 being no ability and 5 being normal arm ability (highest score). It is comprised on 10 functional tasks. The total score is the average of scores on individual task items combined.|units on a scale|Mean|2.13|2.13|Standard Deviation|.50|0.5|||
3665215|NCT02364700|3510267|B1|||Box and Blocks|This is a performance-based assessment of unilateral gross manual dexterity of the upper extremity in adults after stroke. The total score is the number of 2.5cc blocks successfully transferred with the affected hand from one box to another in one minute.|number of blocks|Mean|5.67|5.67|Standard Deviation|10.36|10.36|||
3665216|NCT02364700|3510267|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3665217|NCT02364700|3510267|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3665218|NCT02364700|3510267|B1|||Age||years|Mean|57.1|57.1|Standard Deviation|10.2|10.2|||
3665219|NCT02364180|3510276|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3665220|NCT02364180|3510276|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3665221|NCT02364180|3510276|B1|||Age||years|Mean|63|63.0|Full Range|||18.0|89.0|
3665222|NCT02364037|3510280|B3||Nothing|Contraceptive method used immediately prior to enrollment visit||Participants|Count of Participants|372|372.0||||||
3665223|NCT02364037|3510281|B2||Nothing|Contraceptive method used immediately prior to enrollment visit||Participants|Count of Participants|206|206.0||||||
3665224|NCT02364037|3510282|B1||Nothing|Contraceptive method used immediately prior to enrollment visit||Participants|Count of Participants|166|166.0||||||
3665225|NCT02364037|3510280|B3||Other|Contraceptive method used immediately prior to enrollment visit||Participants|Count of Participants|34|34.0||||||
3665226|NCT02364037|3510281|B2||Other|Contraceptive method used immediately prior to enrollment visit||Participants|Count of Participants|15|15.0||||||
3665227|NCT02364037|3510282|B1||Other|Contraceptive method used immediately prior to enrollment visit||Participants|Count of Participants|19|19.0||||||
3665228|NCT02364037|3510280|B3||Condoms|Contraceptive method used immediately prior to enrollment visit||Participants|Count of Participants|123|123.0||||||
3665229|NCT02364037|3510281|B2||Condoms|Contraceptive method used immediately prior to enrollment visit||Participants|Count of Participants|77|77.0||||||
3665230|NCT02364037|3510282|B1||Condoms|Contraceptive method used immediately prior to enrollment visit||Participants|Count of Participants|46|46.0||||||
3665231|NCT02364037|3510280|B3||Contraceptive Pills/Patch/Ring|Contraceptive method used immediately prior to enrollment visit||Participants|Count of Participants|104|104.0||||||
3665232|NCT02364037|3510281|B2||Contraceptive Pills/Patch/Ring|Contraceptive method used immediately prior to enrollment visit||Participants|Count of Participants|37|37.0||||||
3665233|NCT02364037|3510282|B1||Contraceptive Pills/Patch/Ring|Contraceptive method used immediately prior to enrollment visit||Participants|Count of Participants|67|67.0||||||
3665234|NCT02364037|3510280|B3||Depot Medroxyprogesterone Acetate (DMPA)|Contraceptive method used immediately prior to enrollment visit||Participants|Count of Participants|310|310.0||||||
3665235|NCT02364037|3510281|B2||Depot Medroxyprogesterone Acetate (DMPA)|Contraceptive method used immediately prior to enrollment visit||Participants|Count of Participants|125|125.0||||||
3665236|NCT02364037|3510282|B1||Depot Medroxyprogesterone Acetate (DMPA)|Contraceptive method used immediately prior to enrollment visit||Participants|Count of Participants|185|185.0||||||
3665237|NCT02364037|3510280|B3||IUD/Implant|Contraceptive method used immediately prior to enrollment visit||Participants|Count of Participants|65|65.0||||||
3665238|NCT02364037|3510281|B2||IUD/Implant|Contraceptive method used immediately prior to enrollment visit||Participants|Count of Participants|46|46.0||||||
3665239|NCT02364037|3510282|B1||IUD/Implant|Contraceptive method used immediately prior to enrollment visit||Participants|Count of Participants|19|19.0||||||
3665240|NCT02364037|3510280|B3||Unsure|Participant feelings about becoming pregnant in next 12 months||Participants|Count of Participants|81|81.0||||||
3665241|NCT02364037|3510281|B2||Unsure|Participant feelings about becoming pregnant in next 12 months||Participants|Count of Participants|52|52.0||||||
3665242|NCT02364037|3510282|B1||Unsure|Participant feelings about becoming pregnant in next 12 months||Participants|Count of Participants|29|29.0||||||
3665243|NCT02364037|3510280|B3||Pleased|Participant feelings about becoming pregnant in next 12 months||Participants|Count of Participants|109|109.0||||||
3665244|NCT02364037|3510281|B2||Pleased|Participant feelings about becoming pregnant in next 12 months||Participants|Count of Participants|60|60.0||||||
3665245|NCT02364037|3510282|B1||Pleased|Participant feelings about becoming pregnant in next 12 months||Participants|Count of Participants|49|49.0||||||
3665246|NCT02364037|3510280|B3||Neutral|Participant feelings about becoming pregnant in next 12 months||Participants|Count of Participants|203|203.0||||||
3665249|NCT02364037|3510280|B3||Upset|Participant feelings about becoming pregnant in next 12 months||Participants|Count of Participants|615|615.0||||||
3665250|NCT02364037|3510281|B2||Upset|Participant feelings about becoming pregnant in next 12 months||Participants|Count of Participants|293|293.0||||||
3665251|NCT02364037|3510282|B1||Upset|Participant feelings about becoming pregnant in next 12 months||Participants|Count of Participants|322|322.0||||||
3665252|NCT02364037|3510280|B3||Missing|Insurance Status||Participants|Count of Participants|2|2.0||||||
3665253|NCT02364037|3510281|B2||Missing|Insurance Status||Participants|Count of Participants|1|1.0||||||
3665254|NCT02364037|3510282|B1||Missing|Insurance Status||Participants|Count of Participants|1|1.0||||||
3665255|NCT02364037|3510280|B3||Commercial|Insurance Status||Participants|Count of Participants|152|152.0||||||
3665256|NCT02364037|3510281|B2||Commercial|Insurance Status||Participants|Count of Participants|82|82.0||||||
3665257|NCT02364037|3510282|B1||Commercial|Insurance Status||Participants|Count of Participants|70|70.0||||||
3665258|NCT02364037|3510280|B3||Public|Insurance Status||Participants|Count of Participants|585|585.0||||||
3665259|NCT02364037|3510281|B2||Public|Insurance Status||Participants|Count of Participants|274|274.0||||||
3665260|NCT02364037|3510282|B1||Public|Insurance Status||Participants|Count of Participants|311|311.0||||||
3665261|NCT02364037|3510280|B3||None|Insurance Status||Participants|Count of Participants|269|269.0||||||
3665262|NCT02364037|3510281|B2||None|Insurance Status||Participants|Count of Participants|149|149.0||||||
3665263|NCT02364037|3510282|B1||None|Insurance Status||Participants|Count of Participants|120|120.0||||||
3665264|NCT02364037|3510280|B3||Missing|Unintended Pregnancy||Participants|Count of Participants|3|3.0||||||
3665265|NCT02364037|3510281|B2||Missing|Unintended Pregnancy||Participants|Count of Participants|2|2.0||||||
3665266|NCT02364037|3510282|B1||Missing|Unintended Pregnancy||Participants|Count of Participants|1|1.0||||||
3665267|NCT02364037|3510280|B3||Never pregnant|Unintended Pregnancy||Participants|Count of Participants|278|278.0||||||
3665268|NCT02364037|3510281|B2||Never pregnant|Unintended Pregnancy||Participants|Count of Participants|135|135.0||||||
3665269|NCT02364037|3510282|B1||Never pregnant|Unintended Pregnancy||Participants|Count of Participants|143|143.0||||||
3665270|NCT02364037|3510280|B3||No prior pregnancy was unintended|Unintended Pregnancy||Participants|Count of Participants|248|248.0||||||
3665271|NCT02364037|3510281|B2||No prior pregnancy was unintended|Unintended Pregnancy||Participants|Count of Participants|147|147.0||||||
3665272|NCT02364037|3510282|B1||No prior pregnancy was unintended|Unintended Pregnancy||Participants|Count of Participants|101|101.0||||||
3665273|NCT02364037|3510280|B3||At least one prior pregnancy was unintended|Unintended Pregnancy||Participants|Count of Participants|479|479.0||||||
3665274|NCT02364037|3510281|B2||At least one prior pregnancy was unintended|Unintended Pregnancy||Participants|Count of Participants|222|222.0||||||
3665275|NCT02364037|3510282|B1||At least one prior pregnancy was unintended|Unintended Pregnancy||Participants|Count of Participants|257|257.0||||||
3665276|NCT02364037|3510280|B3||3+|Parity|Number of times a participant has given birth|Participants|Count of Participants|216|216.0||||||
3665277|NCT02364037|3510281|B2||3+|Parity|Number of times a participant has given birth|Participants|Count of Participants|120|120.0||||||
3665278|NCT02364037|3510282|B1||3+|Parity|Number of times a participant has given birth|Participants|Count of Participants|96|96.0||||||
3665279|NCT02364037|3510280|B3||1-2|Parity|Number of times a participant has given birth|Participants|Count of Participants|466|466.0||||||
3665280|NCT02364037|3510281|B2||1-2|Parity|Number of times a participant has given birth|Participants|Count of Participants|221|221.0||||||
3665281|NCT02364037|3510282|B1||1-2|Parity|Number of times a participant has given birth|Participants|Count of Participants|245|245.0||||||
3665282|NCT02364037|3510280|B3||0|Parity|Number of times a participant has given birth|Participants|Count of Participants|326|326.0||||||
3665283|NCT02364037|3510281|B2||0|Parity|Number of times a participant has given birth|Participants|Count of Participants|165|165.0||||||
3665284|NCT02364037|3510282|B1||0|Parity|Number of times a participant has given birth|Participants|Count of Participants|161|161.0||||||
3665285|NCT02364037|3510280|B3||Unknown or Not Reported|Federal Poverty Level||Participants|Count of Participants|5|5.0||||||
3665286|NCT02364037|3510281|B2||Unknown or Not Reported|Federal Poverty Level||Participants|Count of Participants|3|3.0||||||
3665287|NCT02364037|3510282|B1||Unknown or Not Reported|Federal Poverty Level||Participants|Count of Participants|2|2.0||||||
3665288|NCT02364037|3510280|B3||>=201% FPL|Federal Poverty Level||Participants|Count of Participants|40|40.0||||||
3665289|NCT02364037|3510281|B2||>=201% FPL|Federal Poverty Level||Participants|Count of Participants|24|24.0||||||
3665290|NCT02364037|3510282|B1||>=201% FPL|Federal Poverty Level||Participants|Count of Participants|16|16.0||||||
3665291|NCT02364037|3510280|B3||101%-200% FPL|Federal Poverty Level||Participants|Count of Participants|197|197.0||||||
3665292|NCT02364037|3510281|B2||101%-200% FPL|Federal Poverty Level||Participants|Count of Participants|95|95.0||||||
3665293|NCT02364037|3510282|B1||101%-200% FPL|Federal Poverty Level||Participants|Count of Participants|102|102.0||||||
3665294|NCT02364037|3510280|B3||<=100% FPL|Federal Poverty Level||Participants|Count of Participants|766|766.0||||||
3665295|NCT02364037|3510281|B2||<=100% FPL|Federal Poverty Level||Participants|Count of Participants|384|384.0||||||
3665296|NCT02364037|3510282|B1||<=100% FPL|Federal Poverty Level||Participants|Count of Participants|382|382.0||||||
3665297|NCT02364037|3510280|B3||Separated/Divorced/Widowed|Marital Status||Participants|Count of Participants|56|56.0||||||
3665298|NCT02364037|3510281|B2||Separated/Divorced/Widowed|Marital Status||Participants|Count of Participants|33|33.0||||||
3665299|NCT02364037|3510282|B1||Separated/Divorced/Widowed|Marital Status||Participants|Count of Participants|23|23.0||||||
3665300|NCT02364037|3510280|B3||Married/Living with Partner|Marital Status||Participants|Count of Participants|217|217.0||||||
3665301|NCT02364037|3510281|B2||Married/Living with Partner|Marital Status||Participants|Count of Participants|132|132.0||||||
3665302|NCT02364037|3510282|B1||Married/Living with Partner|Marital Status||Participants|Count of Participants|85|85.0||||||
3665303|NCT02364037|3510280|B3||Never Married|Marital Status||Participants|Count of Participants|735|735.0||||||
3665304|NCT02364037|3510281|B2||Never Married|Marital Status||Participants|Count of Participants|341|341.0||||||
3665305|NCT02364037|3510282|B1||Never Married|Marital Status||Participants|Count of Participants|394|394.0||||||
3665306|NCT02364037|3510280|B3||=>College Degree|Education||Participants|Count of Participants|70|70.0||||||
3665307|NCT02364037|3510281|B2||=>College Degree|Education||Participants|Count of Participants|38|38.0||||||
3665308|NCT02364037|3510282|B1||=>College Degree|Education||Participants|Count of Participants|32|32.0||||||
3665309|NCT02364037|3510280|B3||Some College|Education||Participants|Count of Participants|276|276.0||||||
3665310|NCT02364037|3510281|B2||Some College|Education||Participants|Count of Participants|123|123.0||||||
3665311|NCT02364037|3510282|B1||Some College|Education||Participants|Count of Participants|153|153.0||||||
3665312|NCT02364037|3510280|B3||=<High School|Education||Participants|Count of Participants|662|662.0||||||
3665313|NCT02364037|3510281|B2||=<High School|Education||Participants|Count of Participants|345|345.0||||||
3665314|NCT02364037|3510282|B1||=<High School|Education||Participants|Count of Participants|317|317.0||||||
3665315|NCT02364037|3510280|B3|United States||Region of Enrollment||Participants|Count of Participants|1008|1008.0||||||
3665316|NCT02364037|3510281|B2|United States||Region of Enrollment||Participants|Count of Participants|506|506.0||||||
3665317|NCT02364037|3510282|B1|United States||Region of Enrollment||Participants|Count of Participants|502|502.0||||||
3665318|NCT02364037|3510280|B3|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|59|59.0||||||
3665319|NCT02364037|3510281|B2|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3665320|NCT02364037|3510282|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3665321|NCT02364037|3510280|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|255|255.0||||||
3665322|NCT02364037|3510281|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|159|159.0||||||
3665323|NCT02364037|3510282|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|96|96.0||||||
3665324|NCT02364037|3510280|B3|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|694|694.0||||||
3665325|NCT02364037|3510281|B2|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|320|320.0||||||
3665326|NCT02364037|3510282|B1|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|374|374.0||||||
3665327|NCT02364037|3510280|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3665328|NCT02364037|3510281|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3665329|NCT02364037|3510282|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3665330|NCT02364037|3510280|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|899|899.0||||||
3665331|NCT02364037|3510281|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|439|439.0||||||
3665332|NCT02364037|3510282|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|460|460.0||||||
3665333|NCT02364037|3510280|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
3665334|NCT02364037|3510281|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3665335|NCT02364037|3510282|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3665336|NCT02364037|3510280|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3665337|NCT02364037|3510281|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3665338|NCT02364037|3510282|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3665339|NCT02364037|3510280|B3||Female|Sex: Female, Male||Participants|Count of Participants|1008|1008.0||||||
3665340|NCT02364037|3510281|B2||Female|Sex: Female, Male||Participants|Count of Participants|506|506.0||||||
3665341|NCT02364037|3510282|B1||Female|Sex: Female, Male||Participants|Count of Participants|502|502.0||||||
3665342|NCT02364037|3510280|B3|Age|>=20 years old|Age, Customized||Participants|Count of Participants|828|828.0||||||
3665343|NCT02364037|3510281|B2|Age|>=20 years old|Age, Customized||Participants|Count of Participants|414|414.0||||||
3665344|NCT02364037|3510282|B1|Age|>=20 years old|Age, Customized||Participants|Count of Participants|414|414.0||||||
3665345|NCT02364037|3510280|B3|Age|<20 years old|Age, Customized||Participants|Count of Participants|180|180.0||||||
3665346|NCT02364037|3510281|B2|Age|<20 years old|Age, Customized||Participants|Count of Participants|92|92.0||||||
3665347|NCT02364037|3510282|B1|Age|<20 years old|Age, Customized||Participants|Count of Participants|88|88.0||||||
3665348|NCT02364037|3510280|B3|||Age||years|Mean|26.1|26.1|Standard Deviation|7.0|7.0|||
3665349|NCT02364037|3510281|B2|||Age||years|Mean|26.8|26.8|Standard Deviation|7.4|7.4|||
3665350|NCT02364037|3510282|B1|||Age||years|Mean|25.3|25.3|Standard Deviation|6.5|6.5|||
3665351|NCT02363946|3510295|B14||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3665352|NCT02363946|3510296|B13||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3665353|NCT02363946|3510297|B12||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3665354|NCT02363946|3510298|B11||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3665355|NCT02363946|3510299|B10||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3665356|NCT02363946|3510300|B9||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3665357|NCT02363946|3510301|B8||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3665358|NCT02363946|3510302|B7||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3665359|NCT02363946|3510303|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3665360|NCT02363946|3510304|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3665362|NCT02363946|3510306|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3665363|NCT02363946|3510307|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3665364|NCT02363946|3510308|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3665365|NCT02363946|3510295|B14||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3665366|NCT02363946|3510296|B13||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3665367|NCT02363946|3510297|B12||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3665368|NCT02363946|3510298|B11||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3665369|NCT02363946|3510299|B10||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3665370|NCT02363946|3510300|B9||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3665371|NCT02363946|3510301|B8||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3665372|NCT02363946|3510302|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3665373|NCT02363946|3510303|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3665374|NCT02363946|3510304|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3665375|NCT02363946|3510305|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3665376|NCT02363946|3510306|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3665377|NCT02363946|3510307|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3665378|NCT02363946|3510308|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3665379|NCT02363946|3510295|B14|||Age||years|Mean|33.4|33.4|Standard Deviation|14.3|14.3|||
3665380|NCT02363946|3510296|B13|||Age||years|Mean|58.8|58.8|Standard Deviation|9.0|9.0|||
3665381|NCT02363946|3510297|B12|||Age||years|Mean|64.3|64.3|Standard Deviation|3.8|3.8|||
3665382|NCT02363946|3510298|B11|||Age||years|Mean|59.0|59.0|Standard Deviation|1.8|1.8|||
3665383|NCT02363946|3510299|B10|||Age||years|Mean|25.4|25.4|Standard Deviation|4.8|4.8|||
3665384|NCT02363946|3510300|B9|||Age||years|Mean|25.0|25.0|Standard Deviation|1.8|1.8|||
3665385|NCT02363946|3510301|B8|||Age||years|Mean|26.0|26.0|Standard Deviation|5.0|5.0|||
3665386|NCT02363946|3510302|B7|||Age||years|Mean|32.5|32.5|Standard Deviation|15.3|15.3|||
3665387|NCT02363946|3510303|B6|||Age||years|Mean|23.8|23.8|Standard Deviation|4.1|4.1|||
3665388|NCT02363946|3510304|B5|||Age||years|Mean|32.3|32.3|Standard Deviation|5.6|5.6|||
3665389|NCT02363946|3510305|B4|||Age||years|Mean|29.5|29.5|Standard Deviation|10.7|10.7|||
3665390|NCT02363946|3510306|B3|||Age||years|Mean|30.0|30.0|Standard Deviation|7.8|7.8|||
3665391|NCT02363946|3510307|B2|||Age||years|Mean|25.0|25.0|Standard Deviation|4.5|4.5|||
3665392|NCT02363946|3510308|B1|||Age||years|Mean|39.0|39.0|Standard Deviation|9.8|9.8|||
3665393|NCT02363933|3510506|B1|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3665394|NCT02363933|3510506|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665395|NCT02363933|3510506|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665396|NCT02363933|3510506|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3665397|NCT02363933|3510506|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665398|NCT02363933|3510506|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665399|NCT02363933|3510506|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665400|NCT02363933|3510506|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665401|NCT02363933|3510506|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665402|NCT02363933|3510506|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3665403|NCT02363933|3510506|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665404|NCT02363933|3510506|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3665405|NCT02363933|3510506|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3665406|NCT02363933|3510506|B1|||Age||years|Mean|45.0|45.0|Standard Deviation|9.1|9.1|||
3665407|NCT02363933|3510506|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3665408|NCT02363933|3510506|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3665409|NCT02363933|3510506|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3665410|NCT02363907|3510511|B1|||CGM Experience Level||years|Mean|0.2|0.2|Standard Deviation|0.4|0.4|||
3665411|NCT02363907|3510511|B1|||Baseline A1C||percent|Mean|8.6|8.6|Standard Deviation|1.3|1.3|||
3665412|NCT02363907|3510511|B1|||Duration of diabetes||years|Mean|4.3|4.3|Standard Deviation|3.1|3.1|||
3665413|NCT02363907|3510511|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3665414|NCT02363907|3510511|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3665415|NCT02363907|3510511|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665416|NCT02363907|3510511|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3665417|NCT02363907|3510511|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665418|NCT02363907|3510511|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665419|NCT02363907|3510511|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665420|NCT02363907|3510511|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665421|NCT02363907|3510511|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665422|NCT02363907|3510511|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3665423|NCT02363907|3510511|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3665424|NCT02363907|3510511|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3665425|NCT02363907|3510511|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3665426|NCT02363907|3510511|B1|||Age||years|Mean|12.1|12.1|Standard Deviation|4.0|4.0|||
3665427|NCT02363478|3510515|B1|Greece||Region of Enrollment||participants|Number|22|22.0||||||
3665428|NCT02363478|3510515|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3665429|NCT02363478|3510515|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3665430|NCT02363478|3510515|B1|||Age||years|Mean|52.5|52.5|Standard Deviation|11.6|11.6|||
3665431|NCT02363439|3510522|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3665432|NCT02363439|3510522|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665433|NCT02363439|3510522|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665434|NCT02363439|3510522|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3665435|NCT02363439|3510522|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665436|NCT02363439|3510522|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665437|NCT02363439|3510522|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665438|NCT02363439|3510522|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665439|NCT02363439|3510522|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3665440|NCT02363439|3510522|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3665441|NCT02363439|3510522|B1|||Age||years|Median|65|65.0|Full Range|||48.0|82.0|
3665442|NCT02363270|3510526|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
3665443|NCT02363270|3510527|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
3665444|NCT02363270|3510528|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3665445|NCT02363270|3510526|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3665446|NCT02363270|3510527|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3665447|NCT02363270|3510528|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3665448|NCT02363270|3510526|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3665449|NCT02363270|3510527|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3665450|NCT02363270|3510528|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3665451|NCT02363270|3510526|B3|||Age||years|Mean|44.40|44.4|Standard Deviation|13.67|13.67|||
3665452|NCT02363270|3510527|B2|||Age||years|Mean|43.56|43.56|Standard Deviation|12.32|12.32|||
3665453|NCT02363270|3510528|B1|||Age||years|Mean|45.25|45.25|Standard Deviation|15.12|15.12|||
3665454|NCT02363270|3510526|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3665455|NCT02363270|3510527|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3665456|NCT02363270|3510528|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3665457|NCT02363270|3510526|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
3665458|NCT02363270|3510527|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3665459|NCT02363270|3510528|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3665460|NCT02363270|3510526|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3665461|NCT02363270|3510527|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3665462|NCT02363270|3510528|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3665463|NCT02362789|3510535|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3665464|NCT02362789|3510536|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3665465|NCT02362789|3510537|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3665466|NCT02362789|3510535|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
3665467|NCT02362789|3510536|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3665468|NCT02362789|3510537|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
3665469|NCT02362789|3510535|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3665470|NCT02362789|3510536|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3665471|NCT02362789|3510537|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3665472|NCT02362789|3510535|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3665473|NCT02362789|3510536|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3665474|NCT02362789|3510537|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3665475|NCT02362789|3510535|B3|>=65||Age, Customized||Participants|Count of Participants|7|7.0||||||
3665476|NCT02362789|3510536|B2|>=65||Age, Customized||Participants|Count of Participants|2|2.0||||||
3665477|NCT02362789|3510537|B1|>=65||Age, Customized||Participants|Count of Participants|5|5.0||||||
3665478|NCT02362789|3510535|B3|<65||Age, Customized||Participants|Count of Participants|73|73.0||||||
3665479|NCT02362789|3510536|B2|<65||Age, Customized||Participants|Count of Participants|36|36.0||||||
3665480|NCT02362789|3510537|B1|<65||Age, Customized||Participants|Count of Participants|37|37.0||||||
3665481|NCT02362503|3510546|B4|Race customized|White and African descent|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3665482|NCT02362503|3510547|B3|Race customized|White and African descent|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3665483|NCT02362503|3510548|B2|Race customized|White and African descent|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3665484|NCT02362503|3510549|B1|Race customized|White and African descent|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3665485|NCT02362503|3510546|B4|Race customized|Brown|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3665486|NCT02362503|3510547|B3|Race customized|Brown|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3665487|NCT02362503|3510548|B2|Race customized|Brown|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3665488|NCT02362503|3510549|B1|Race customized|Brown|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3665489|NCT02362503|3510546|B4|Race customized|Mulatto|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3665490|NCT02362503|3510547|B3|Race customized|Mulatto|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3665491|NCT02362503|3510548|B2|Race customized|Mulatto|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3665492|NCT02362503|3510549|B1|Race customized|Mulatto|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3665493|NCT02362503|3510546|B4|Race customized|North African|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3665494|NCT02362503|3510547|B3|Race customized|North African|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3665495|NCT02362503|3510548|B2|Race customized|North African|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3665496|NCT02362503|3510549|B1|Race customized|North African|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3665497|NCT02362503|3510546|B4|Race customized|Mestizo|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3665498|NCT02362503|3510547|B3|Race customized|Mestizo|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3665499|NCT02362503|3510548|B2|Race customized|Mestizo|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3665500|NCT02362503|3510549|B1|Race customized|Mestizo|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3665501|NCT02362503|3510546|B4|Race customized|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3665502|NCT02362503|3510547|B3|Race customized|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3665503|NCT02362503|3510548|B2|Race customized|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3665504|NCT02362503|3510549|B1|Race customized|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3665505|NCT02362503|3510546|B4|Race customized|Mixed|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3665506|NCT02362503|3510547|B3|Race customized|Mixed|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3665507|NCT02362503|3510548|B2|Race customized|Mixed|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3665508|NCT02362503|3510549|B1|Race customized|Mixed|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3665509|NCT02362503|3510546|B4|Race customized|White|Race/Ethnicity, Customized||Participants|Count of Participants|257|257.0||||||
3665510|NCT02362503|3510547|B3|Race customized|White|Race/Ethnicity, Customized||Participants|Count of Participants|73|73.0||||||
3665511|NCT02362503|3510548|B2|Race customized|White|Race/Ethnicity, Customized||Participants|Count of Participants|137|137.0||||||
3665512|NCT02362503|3510549|B1|Race customized|White|Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
3665513|NCT02362503|3510546|B4|Race customized|Native Hawaiian or other Pacific islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3665514|NCT02362503|3510547|B3|Race customized|Native Hawaiian or other Pacific islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3665515|NCT02362503|3510548|B2|Race customized|Native Hawaiian or other Pacific islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3665516|NCT02362503|3510549|B1|Race customized|Native Hawaiian or other Pacific islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3665517|NCT02362503|3510546|B4|Race customized|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3665518|NCT02362503|3510547|B3|Race customized|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3665519|NCT02362503|3510548|B2|Race customized|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3665520|NCT02362503|3510549|B1|Race customized|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3665521|NCT02362503|3510546|B4|Race customized|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3665522|NCT02362503|3510547|B3|Race customized|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3665523|NCT02362503|3510548|B2|Race customized|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3665524|NCT02362503|3510549|B1|Race customized|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3665525|NCT02362503|3510546|B4|Race customized|African American/African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|83|83.0||||||
3665526|NCT02362503|3510547|B3|Race customized|African American/African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3665527|NCT02362503|3510548|B2|Race customized|African American/African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3665528|NCT02362503|3510549|B1|Race customized|African American/African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3665529|NCT02362503|3510546|B4||Male|Sex: Female, Male||Participants|Count of Participants|289|289.0||||||
3665530|NCT02362503|3510547|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3665531|NCT02362503|3510548|B2||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3665532|NCT02362503|3510549|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3665533|NCT02362503|3510546|B4||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3665534|NCT02362503|3510547|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3665535|NCT02362503|3510548|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3665536|NCT02362503|3510549|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3665537|NCT02362503|3510546|B4|||Age||Years|Mean|45.6|45.6|Standard Deviation|12.20|12.2|||
3665538|NCT02362503|3510547|B3|||Age||Years|Mean|48.1|48.1|Standard Deviation|11.53|11.53|||
3665539|NCT02362503|3510548|B2|||Age||Years|Mean|45.2|45.2|Standard Deviation|12.72|12.72|||
3665540|NCT02362503|3510549|B1|||Age||Years|Mean|43.0|43.0|Standard Deviation|11.02|11.02|||
3665541|NCT02362412|3510576|B1|||HAMILTON DEPRESSION SCALE (HAM-D17) TOTAL SCORE|The HAM-D17 is a clinician-rated 17-item scale for assessing the severity of depression symptoms. The scores for each item range from 0 to 4 or 0 to 2, where 0 represents no symptoms. The rating is based on the past 7 days prior to the time of assessment. The total score ranges from 0 to 52 with lower scores indicating less depressive symptoms.|UNITS ON A SCALE|Mean|14.5|14.5|Standard Deviation|6.4|6.4|||
3665542|NCT02362412|3510576|B1|||MONTGOMERY-ASBERG DEPRESSION RATING SCALE (MADRS) TOTAL SCORE|The MADRS is a 10-item scale to measure the severity of depressive episodes, where each item is rated on a scale from 0 to 6. The MADRS total score ranges from 0 to 60 with lower scores indicating less depressive symptoms|UNITS ON A SCALE|Mean|19.8|19.8|Standard Deviation|8.6|8.6|||
3665543|NCT02362412|3510576|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3665544|NCT02362412|3510576|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3665545|NCT02362412|3510576|B1|||Age||Years|Mean|39.7|39.7|Standard Deviation|10.3|10.3|||
3665546|NCT02362373|3510603|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3665547|NCT02362373|3510603|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3665548|NCT02362373|3510603|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3665549|NCT02362373|3510603|B1|||Age||years|Mean|28|28.0|Standard Deviation|6.2|6.2|||
3665550|NCT02362373|3510603|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3665551|NCT02362373|3510603|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3665552|NCT02362373|3510603|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3665553|NCT02362360|3510611|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3665554|NCT02362360|3510611|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3665555|NCT02362360|3510611|B1|||Age||years|Mean|70.9|70.9|Standard Deviation|9.5|9.5|||
3665556|NCT02362321|3510618|B3|Canada||Region of Enrollment||participants|Number|20|20.0||||||
3665557|NCT02362321|3510619|B2|Canada||Region of Enrollment||participants|Number|10|10.0||||||
3665558|NCT02362321|3510620|B1|Canada||Region of Enrollment||participants|Number|10|10.0||||||
3665559|NCT02362321|3510618|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3665560|NCT02362321|3510619|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3665561|NCT02362321|3510620|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3665562|NCT02362321|3510618|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3665563|NCT02362321|3510619|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3665564|NCT02362321|3510620|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3665565|NCT02362321|3510618|B3|||Age||years|Mean|70.9|70.9|Standard Deviation|9.2|9.2|||
3665566|NCT02362321|3510619|B2|||Age||years|Mean|69.4|69.4|Standard Deviation|8.8|8.8|||
3665567|NCT02362321|3510620|B1|||Age||years|Mean|72.3|72.3|Standard Deviation|6.3|6.3|||
3665568|NCT02362321|3510618|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3665569|NCT02362321|3510619|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3665570|NCT02362321|3510620|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3665571|NCT02362321|3510618|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3665572|NCT02362321|3510619|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3665573|NCT02362321|3510620|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3665574|NCT02362321|3510618|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3665575|NCT02362321|3510619|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3665576|NCT02362321|3510620|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3665577|NCT02361736|3510627|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3665578|NCT02361736|3510628|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3665579|NCT02361736|3510629|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3665580|NCT02361736|3510627|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3665581|NCT02361736|3510628|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3665582|NCT02361736|3510629|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3665583|NCT02361736|3510627|B3|||Age||age|Mean|76.2|76.2|Standard Deviation|7.7|7.7|||
3665584|NCT02361736|3510628|B2|||Age||age|Mean|75.9|75.9|Standard Deviation|7.5|7.5|||
3665585|NCT02361736|3510629|B1|||Age||age|Mean|76.4|76.4|Standard Deviation|8.1|8.1|||
3665586|NCT02361580|3510648|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
3665587|NCT02361580|3510649|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3665588|NCT02361580|3510650|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3665589|NCT02361580|3510648|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3665590|NCT02361580|3510649|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3665591|NCT02361580|3510650|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3665592|NCT02361580|3510648|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3665593|NCT02361580|3510649|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3665594|NCT02361580|3510650|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3665595|NCT02361580|3510648|B3|||Age||years|Mean|52|52.0|Standard Deviation|16|16.0|||
3665596|NCT02361580|3510649|B2|||Age||years|Mean|54|54.0|Standard Deviation|10|10.0|||
3665597|NCT02361580|3510650|B1|||Age||years|Mean|51|51.0|Standard Deviation|19|19.0|||
3665598|NCT02361580|3510648|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3665599|NCT02361580|3510649|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3665600|NCT02361580|3510650|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3665601|NCT02361580|3510648|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3665602|NCT02361580|3510649|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3665603|NCT02361580|3510650|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3665604|NCT02361580|3510648|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3665605|NCT02361580|3510649|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3665606|NCT02361580|3510650|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3665607|NCT02361216|3510661|B3|Australia||Region of Enrollment||participants|Number|80|80.0||||||
3665608|NCT02361216|3510662|B2|Australia||Region of Enrollment||participants|Number|20|20.0||||||
3665609|NCT02361216|3510663|B1|Australia||Region of Enrollment||participants|Number|60|60.0||||||
3665610|NCT02361216|3510661|B3|Canada||Region of Enrollment||participants|Number|247|247.0||||||
3665611|NCT02361216|3510662|B2|Canada||Region of Enrollment||participants|Number|59|59.0||||||
3665612|NCT02361216|3510663|B1|Canada||Region of Enrollment||participants|Number|188|188.0||||||
3665613|NCT02361216|3510661|B3|United States||Region of Enrollment||participants|Number|402|402.0||||||
3665614|NCT02361216|3510662|B2|United States||Region of Enrollment||participants|Number|98|98.0||||||
3665615|NCT02361216|3510663|B1|United States||Region of Enrollment||participants|Number|304|304.0||||||
3665616|NCT02361216|3510661|B3||Male|Sex: Female, Male||Participants|Count of Participants|535|535.0||||||
3665617|NCT02361216|3510662|B2||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3665618|NCT02361216|3510663|B1||Male|Sex: Female, Male||Participants|Count of Participants|403|403.0||||||
3665619|NCT02361216|3510661|B3||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
3665620|NCT02361216|3510662|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3665621|NCT02361216|3510663|B1||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3665622|NCT02361216|3510661|B3|||Age||years|Median|68|68.0|Full Range|||38.0|91.0|
3665623|NCT02361216|3510662|B2|||Age||years|Median|69|69.0|Full Range|||45.0|91.0|
3665624|NCT02361216|3510663|B1|||Age||years|Median|68|68.0|Full Range|||38.0|91.0|
3665625|NCT02360995|3510676|B4|United States||Region of Enrollment||participants|Number|129|129.0||||||
3665626|NCT02360995|3510677|B3|United States||Region of Enrollment||participants|Number|43|43.0||||||
3665627|NCT02360995|3510678|B2|United States||Region of Enrollment||participants|Number|43|43.0||||||
3665628|NCT02360995|3510679|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
3665629|NCT02360995|3510676|B4||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3665630|NCT02360995|3510677|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3665631|NCT02360995|3510678|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3665632|NCT02360995|3510679|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3665633|NCT02360995|3510676|B4||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3665634|NCT02360995|3510677|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3665635|NCT02360995|3510678|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3665636|NCT02360995|3510679|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3665637|NCT02360995|3510676|B4|||Age||years|Mean|44.47|44.47|Standard Deviation|15.26|15.26|||
3665638|NCT02360995|3510677|B3|||Age||years|Mean|44.39|44.39|Standard Deviation|13.68|13.68|||
3665639|NCT02360995|3510678|B2|||Age||years|Mean|44.90|44.9|Standard Deviation|15.51|15.51|||
3665640|NCT02360995|3510679|B1|||Age||years|Mean|44.68|44.68|Standard Deviation|16.85|16.85|||
3665641|NCT02360774|3510704|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
3665642|NCT02360774|3510705|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3665643|NCT02360774|3510706|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3665644|NCT02360774|3510704|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665645|NCT02360774|3510705|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665646|NCT02360774|3510706|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665647|NCT02360774|3510704|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3665648|NCT02360774|3510705|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3665649|NCT02360774|3510706|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3665650|NCT02360774|3510704|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3665651|NCT02360774|3510705|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3665652|NCT02360774|3510706|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3665653|NCT02360774|3510704|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3665654|NCT02360774|3510705|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3665655|NCT02360774|3510706|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3665656|NCT02360774|3510704|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665657|NCT02360774|3510705|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665658|NCT02360774|3510706|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665659|NCT02360774|3510704|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665660|NCT02360774|3510705|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665661|NCT02360774|3510706|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665662|NCT02360774|3510704|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665663|NCT02360774|3510705|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665664|NCT02360774|3510706|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665665|NCT02360774|3510704|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665666|NCT02360774|3510705|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665667|NCT02360774|3510706|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665668|NCT02360774|3510704|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3665669|NCT02360774|3510705|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3665670|NCT02360774|3510706|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3665671|NCT02360774|3510704|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3665672|NCT02360774|3510705|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3665673|NCT02360774|3510706|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3665674|NCT02360774|3510704|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3665675|NCT02360774|3510705|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3665676|NCT02360774|3510706|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3665677|NCT02360774|3510704|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3665678|NCT02360774|3510705|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3665679|NCT02360774|3510706|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3665680|NCT02360774|3510704|B3|||Age||years|Mean|59.3|59.3|Standard Deviation|9.1|9.1|||
3665681|NCT02360774|3510705|B2|||Age||years|Mean|61.8|61.8|Standard Deviation|2.9|2.9|||
3665682|NCT02360774|3510706|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|1.98|1.98|||
3665683|NCT02360774|3510704|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3665684|NCT02360774|3510705|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3665685|NCT02360774|3510706|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3665686|NCT02360774|3510704|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3665687|NCT02360774|3510705|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3665688|NCT02360774|3510706|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3665689|NCT02360774|3510704|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3665690|NCT02360774|3510705|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3665691|NCT02360774|3510706|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3665692|NCT02360475|3510719|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3665693|NCT02360475|3510720|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3665694|NCT02360475|3510721|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3665695|NCT02360475|3510722|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3665696|NCT02360475|3510723|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3665697|NCT02360475|3510719|B5|White-Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|431|431.0||||||
3665698|NCT02360475|3510720|B4|White-Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|108|108.0||||||
3665699|NCT02360475|3510721|B3|White-Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|97|97.0||||||
3665700|NCT02360475|3510722|B2|White-Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|114|114.0||||||
3665701|NCT02360475|3510723|B1|White-Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|112|112.0||||||
3665702|NCT02360475|3510719|B5|White-Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3665703|NCT02360475|3510720|B4|White-Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3665704|NCT02360475|3510721|B3|White-Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3665705|NCT02360475|3510722|B2|White-Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3665706|NCT02360475|3510723|B1|White-Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3665707|NCT02360475|3510719|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3665708|NCT02360475|3510720|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3665709|NCT02360475|3510721|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3665710|NCT02360475|3510722|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3665711|NCT02360475|3510723|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3665712|NCT02360475|3510719|B5|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3665713|NCT02360475|3510720|B4|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3665714|NCT02360475|3510721|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3665715|NCT02360475|3510722|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3665716|NCT02360475|3510723|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3665717|NCT02360475|3510719|B5|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3665718|NCT02360475|3510720|B4|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3665719|NCT02360475|3510721|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3665720|NCT02360475|3510722|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3665721|NCT02360475|3510723|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3665722|NCT02360475|3510719|B5|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3665723|NCT02360475|3510720|B4|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3665724|NCT02360475|3510721|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3665725|NCT02360475|3510722|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3665726|NCT02360475|3510723|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3665727|NCT02360475|3510719|B5|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3665728|NCT02360475|3510720|B4|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3665729|NCT02360475|3510721|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3665730|NCT02360475|3510722|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3665731|NCT02360475|3510723|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3665732|NCT02360475|3510719|B5|African Heritage / African American||Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3665733|NCT02360475|3510720|B4|African Heritage / African American||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3665734|NCT02360475|3510721|B3|African Heritage / African American||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3665735|NCT02360475|3510722|B2|African Heritage / African American||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3665736|NCT02360475|3510723|B1|African Heritage / African American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3665737|NCT02360475|3510719|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3665738|NCT02360475|3510720|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3665739|NCT02360475|3510721|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3665740|NCT02360475|3510722|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3665741|NCT02360475|3510723|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3665742|NCT02360475|3510719|B5||Female|Sex: Female, Male||Participants|Count of Participants|500|500.0||||||
3665743|NCT02360475|3510720|B4||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3665744|NCT02360475|3510721|B3||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3665745|NCT02360475|3510722|B2||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3665746|NCT02360475|3510723|B1||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3665747|NCT02360475|3510719|B5|||Age||Years|Mean|29.25|29.25|Standard Deviation|7.73|7.73|||
3665748|NCT02360475|3510720|B4|||Age||Years|Mean|29.2|29.2|Standard Deviation|7.9|7.9|||
3665749|NCT02360475|3510721|B3|||Age||Years|Mean|29.1|29.1|Standard Deviation|7.4|7.4|||
3665750|NCT02360475|3510722|B2|||Age||Years|Mean|29.5|29.5|Standard Deviation|8.2|8.2|||
3665751|NCT02360475|3510723|B1|||Age||Years|Mean|29.2|29.2|Standard Deviation|7.5|7.5|||
3665752|NCT02360228|3510784|B4|||Brief Assessment of Cognition in Schizophrenia|"The Brief Assessment of Cognition in Schizophrenia (BACS) is a battery of cognitive assessments assessing verbal memory and learning, working memory, motor function, verbal fluency, speed of processing, and executive function. Higher scores indicate better cognitive performance.~Verbal Memory: Score out of 75~Digit Sequencing: Score out of 28~Token Motor: Score out of 100~Fluency: No score limit~Symbol Coding: Score out of 110~Tower of London: Score out of 22~Reported score is the mean of these 6 subtests. Healthy controls (Keefe et al., 2006) scored 45.6 as a comparison."|units on a scale|Mean|35.91|35.91|Standard Deviation|7.87|7.87|||
3665773|NCT02360228|3510785|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665753|NCT02360228|3510785|B3|||Brief Assessment of Cognition in Schizophrenia|"The Brief Assessment of Cognition in Schizophrenia (BACS) is a battery of cognitive assessments assessing verbal memory and learning, working memory, motor function, verbal fluency, speed of processing, and executive function. Higher scores indicate better cognitive performance.~Verbal Memory: Score out of 75~Digit Sequencing: Score out of 28~Token Motor: Score out of 100~Fluency: No score limit~Symbol Coding: Score out of 110~Tower of London: Score out of 22~Reported score is the mean of these 6 subtests. Healthy controls (Keefe et al., 2006) scored 45.6 as a comparison."|units on a scale|Mean|38.93|38.93|Standard Deviation|7.17|7.17|||
3665754|NCT02360228|3510786|B2|||Brief Assessment of Cognition in Schizophrenia|"The Brief Assessment of Cognition in Schizophrenia (BACS) is a battery of cognitive assessments assessing verbal memory and learning, working memory, motor function, verbal fluency, speed of processing, and executive function. Higher scores indicate better cognitive performance.~Verbal Memory: Score out of 75~Digit Sequencing: Score out of 28~Token Motor: Score out of 100~Fluency: No score limit~Symbol Coding: Score out of 110~Tower of London: Score out of 22~Reported score is the mean of these 6 subtests. Healthy controls (Keefe et al., 2006) scored 45.6 as a comparison."|units on a scale|Mean|38.26|38.26|Standard Deviation|9.01|9.01|||
3665755|NCT02360228|3510787|B1|||Brief Assessment of Cognition in Schizophrenia|"The Brief Assessment of Cognition in Schizophrenia (BACS) is a battery of cognitive assessments assessing verbal memory and learning, working memory, motor function, verbal fluency, speed of processing, and executive function. Higher scores indicate better cognitive performance.~Verbal Memory: Score out of 75~Digit Sequencing: Score out of 28~Token Motor: Score out of 100~Fluency: No score limit~Symbol Coding: Score out of 110~Tower of London: Score out of 22~Reported score is the mean of these 6 subtests. Healthy controls (Keefe et al., 2006) scored 45.6 as a comparison."|units on a scale|Mean|31.21|31.21|Standard Deviation|5.68|5.68|||
3665756|NCT02360228|3510784|B4|||Positive and Negative Syndrome Scale|The Positive and Negative Syndrome Scale (PANSS) is a clinical measure assessing the positive, negative, and general symptoms of psychosis. There are 30 items (7 positive, 7 negative, and 16 general). The score for each item ranges from 1 (absent) to 7 (extreme) and the PANSS total score ranges from 30 to 210, with higher scores indicating more severe symptoms.|units on a scale|Mean|56.05|56.05|Standard Deviation|11.27|11.27|||
3665757|NCT02360228|3510785|B3|||Positive and Negative Syndrome Scale|The Positive and Negative Syndrome Scale (PANSS) is a clinical measure assessing the positive, negative, and general symptoms of psychosis. There are 30 items (7 positive, 7 negative, and 16 general). The score for each item ranges from 1 (absent) to 7 (extreme) and the PANSS total score ranges from 30 to 210, with higher scores indicating more severe symptoms.|units on a scale|Mean|57.00|57.0|Standard Deviation|11.60|11.6|||
3665758|NCT02360228|3510786|B2|||Positive and Negative Syndrome Scale|The Positive and Negative Syndrome Scale (PANSS) is a clinical measure assessing the positive, negative, and general symptoms of psychosis. There are 30 items (7 positive, 7 negative, and 16 general). The score for each item ranges from 1 (absent) to 7 (extreme) and the PANSS total score ranges from 30 to 210, with higher scores indicating more severe symptoms.|units on a scale|Mean|58.86|58.86|Standard Deviation|14.66|14.66|||
3665759|NCT02360228|3510787|B1|||Positive and Negative Syndrome Scale|The Positive and Negative Syndrome Scale (PANSS) is a clinical measure assessing the positive, negative, and general symptoms of psychosis. There are 30 items (7 positive, 7 negative, and 16 general). The score for each item ranges from 1 (absent) to 7 (extreme) and the PANSS total score ranges from 30 to 210, with higher scores indicating more severe symptoms.|units on a scale|Mean|52.75|52.75|Standard Deviation|7.74|7.74|||
3665760|NCT02360228|3510784|B4|||Auditory Hallucination Rating Scale|The Auditory Hallucination Rating Scale (AHRS) measures the severity of auditory hallucinations in the past week. The scale assesses frequency, duration, location, loudness, belief of origin of voices, negative content, distress, disruption to life, and control over voices. All items are measured on a scale of 0 to 4, with a total possible score of 44. Higher scores indicate higher severity of auditory hallucinations.|units on a scale|Mean|24.59|24.59|Standard Deviation|5.47|5.47|||
3665761|NCT02360228|3510785|B3|||Auditory Hallucination Rating Scale|The Auditory Hallucination Rating Scale (AHRS) measures the severity of auditory hallucinations in the past week. The scale assesses frequency, duration, location, loudness, belief of origin of voices, negative content, distress, disruption to life, and control over voices. All items are measured on a scale of 0 to 4, with a total possible score of 44. Higher scores indicate higher severity of auditory hallucinations.|units on a scale|Mean|24.71|24.71|Standard Deviation|5.91|5.91|||
3665762|NCT02360228|3510786|B2|||Auditory Hallucination Rating Scale|The Auditory Hallucination Rating Scale (AHRS) measures the severity of auditory hallucinations in the past week. The scale assesses frequency, duration, location, loudness, belief of origin of voices, negative content, distress, disruption to life, and control over voices. All items are measured on a scale of 0 to 4, with a total possible score of 44. Higher scores indicate higher severity of auditory hallucinations.|units on a scale|Mean|23.00|23.0|Standard Deviation|6.90|6.9|||
3665763|NCT02360228|3510787|B1|||Auditory Hallucination Rating Scale|The Auditory Hallucination Rating Scale (AHRS) measures the severity of auditory hallucinations in the past week. The scale assesses frequency, duration, location, loudness, belief of origin of voices, negative content, distress, disruption to life, and control over voices. All items are measured on a scale of 0 to 4, with a total possible score of 44. Higher scores indicate higher severity of auditory hallucinations.|units on a scale|Mean|25.88|25.88|Standard Deviation|3.80|3.8|||
3665764|NCT02360228|3510784|B4|United States||Region of Enrollment||participants|Number|22|22.0||||||
3665765|NCT02360228|3510785|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
3665766|NCT02360228|3510786|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3665767|NCT02360228|3510787|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3665768|NCT02360228|3510784|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665769|NCT02360228|3510785|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665770|NCT02360228|3510786|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665771|NCT02360228|3510787|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665772|NCT02360228|3510784|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665774|NCT02360228|3510786|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665775|NCT02360228|3510787|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665776|NCT02360228|3510784|B4||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3665777|NCT02360228|3510785|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3665778|NCT02360228|3510786|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3665779|NCT02360228|3510787|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3665780|NCT02360228|3510784|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3665781|NCT02360228|3510785|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3665782|NCT02360228|3510786|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3665783|NCT02360228|3510787|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3665784|NCT02360228|3510784|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665785|NCT02360228|3510785|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665786|NCT02360228|3510786|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665787|NCT02360228|3510787|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665788|NCT02360228|3510784|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3665789|NCT02360228|3510785|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3665790|NCT02360228|3510786|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665791|NCT02360228|3510787|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665792|NCT02360228|3510784|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665793|NCT02360228|3510785|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665794|NCT02360228|3510786|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665795|NCT02360228|3510787|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665796|NCT02360228|3510784|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3665797|NCT02360228|3510785|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3665798|NCT02360228|3510786|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665799|NCT02360228|3510787|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665800|NCT02360228|3510784|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3665801|NCT02360228|3510785|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3665802|NCT02360228|3510786|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3665803|NCT02360228|3510787|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3665804|NCT02360228|3510784|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665805|NCT02360228|3510785|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665806|NCT02360228|3510786|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665807|NCT02360228|3510787|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665808|NCT02360228|3510784|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3665809|NCT02360228|3510785|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3665810|NCT02360228|3510786|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3665811|NCT02360228|3510787|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3665812|NCT02360228|3510784|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3665813|NCT02360228|3510785|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3665814|NCT02360228|3510786|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3665815|NCT02360228|3510787|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3665816|NCT02360228|3510784|B4|||Age||years|Mean|38.86|38.86|Standard Deviation|12.19|12.19|||
3665817|NCT02360228|3510785|B3|||Age||years|Mean|38.86|38.86|Standard Deviation|10.01|10.01|||
3665818|NCT02360228|3510786|B2|||Age||years|Mean|29.75|29.75|Standard Deviation|10.97|10.97|||
3665819|NCT02360228|3510787|B1|||Age||years|Mean|47|47.0|Standard Deviation|9.72|9.72|||
3665820|NCT02360124|3510815|B4|China||Region of Enrollment||participants|Number|323|323.0||||||
3665821|NCT02360124|3510816|B3|China||Region of Enrollment||participants|Number|108|108.0||||||
3665822|NCT02360124|3510817|B2|China||Region of Enrollment||participants|Number|107|107.0||||||
3665823|NCT02360124|3510818|B1|China||Region of Enrollment||participants|Number|108|108.0||||||
3665824|NCT02360124|3510815|B4|Chinese||Race/Ethnicity, Customized||participants|Number|323|323.0||||||
3665825|NCT02360124|3510816|B3|Chinese||Race/Ethnicity, Customized||participants|Number|108|108.0||||||
3665826|NCT02360124|3510817|B2|Chinese||Race/Ethnicity, Customized||participants|Number|107|107.0||||||
3665827|NCT02360124|3510818|B1|Chinese||Race/Ethnicity, Customized||participants|Number|108|108.0||||||
3665828|NCT02360124|3510815|B4||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3665829|NCT02360124|3510816|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3665830|NCT02360124|3510817|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3665831|NCT02360124|3510818|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3665832|NCT02360124|3510815|B4||Female|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
3665833|NCT02360124|3510816|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3665834|NCT02360124|3510817|B2||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3665835|NCT02360124|3510818|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3665836|NCT02360124|3510815|B4|||Age||years|Mean|72.1|72.1|Standard Deviation|6.2|6.2|||
3665837|NCT02360124|3510816|B3|||Age||years|Mean|72.7|72.7|Standard Deviation|5.8|5.8|||
3665838|NCT02360124|3510817|B2|||Age||years|Mean|72.4|72.4|Standard Deviation|6.2|6.2|||
3665839|NCT02360124|3510818|B1|||Age||years|Mean|71.1|71.1|Standard Deviation|6.7|6.7|||
3665840|NCT02360124|3510815|B4||>=65 years|Age||Participants|Count of Participants|279|279.0||||||
3665841|NCT02360124|3510816|B3||>=65 years|Age||Participants|Count of Participants|99|99.0||||||
3665842|NCT02360124|3510817|B2||>=65 years|Age||Participants|Count of Participants|95|95.0||||||
3665843|NCT02360124|3510818|B1||>=65 years|Age||Participants|Count of Participants|85|85.0||||||
3665844|NCT02360124|3510815|B4||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3665845|NCT02360124|3510816|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3665846|NCT02360124|3510817|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3665847|NCT02360124|3510818|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3665848|NCT02360124|3510815|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3665849|NCT02360124|3510816|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3665850|NCT02360124|3510817|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3665851|NCT02360124|3510818|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3665852|NCT02360111|3510831|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3665853|NCT02360111|3510831|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665854|NCT02360111|3510831|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665855|NCT02360111|3510831|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3665856|NCT02360111|3510831|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665857|NCT02360111|3510831|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665858|NCT02360111|3510831|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665859|NCT02360111|3510831|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665860|NCT02360111|3510831|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3665861|NCT02360111|3510831|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3665862|NCT02360111|3510831|B1|||Age||years|Median|70|70.0|Full Range|||64.0|73.0|
3665863|NCT02360059|3510839|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3665864|NCT02360059|3510841|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3665865|NCT02360059|3510839|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3665866|NCT02360059|3510841|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3665867|NCT02360059|3510839|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3665868|NCT02360059|3510841|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3665869|NCT02360059|3510839|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3665870|NCT02360059|3510841|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3665871|NCT02360059|3510839|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3665872|NCT02360059|3510841|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3665873|NCT02360059|3510839|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3665874|NCT02360059|3510841|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3665875|NCT02359955|3510848|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3665876|NCT02359955|3510849|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3665877|NCT02359955|3510850|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3665878|NCT02359955|3510848|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3665879|NCT02359955|3510849|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3665880|NCT02359955|3510850|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3665881|NCT02359955|3510848|B3|||Age||years|Mean|58.65|58.65|Standard Deviation|5.5|5.5|||
3665882|NCT02359955|3510849|B2|||Age||years|Mean|58.4|58.4|Standard Deviation|5.29|5.29|||
3665883|NCT02359955|3510850|B1|||Age||years|Mean|58.9|58.9|Standard Deviation|5.9|5.9|||
3665884|NCT02359955|3510848|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3665885|NCT02359955|3510849|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3665886|NCT02359955|3510850|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3665887|NCT02359955|3510848|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3665888|NCT02359955|3510849|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3665889|NCT02359955|3510850|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3665890|NCT02359955|3510848|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3665891|NCT02359955|3510849|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3665892|NCT02359955|3510850|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3665893|NCT02359903|3510900|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3665894|NCT02359903|3510901|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3665895|NCT02359903|3510902|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3665896|NCT02359903|3510900|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3665897|NCT02359903|3510901|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3665898|NCT02359903|3510902|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3665899|NCT02359903|3510900|B3|||Age||years|Median|38|38.0|Inter-Quartile Range|||33.0|53.0|
3665900|NCT02359903|3510901|B2|||Age||years|Median|38|38.0|Inter-Quartile Range|||35.0|55.0|
3665901|NCT02359903|3510902|B1|||Age||years|Median|38|38.0|Inter-Quartile Range|||32.0|51.0|
3665902|NCT02359890|3510911|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3665903|NCT02359890|3510911|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665904|NCT02359890|3510911|B1||White|Race (NIH/OMB)||Participants|Count of Participants|159|159.0||||||
3665905|NCT02359890|3510911|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3665906|NCT02359890|3510911|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3665907|NCT02359890|3510911|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3665908|NCT02359890|3510911|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665909|NCT02359890|3510911|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3665910|NCT02359890|3510911|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|155|155.0||||||
3665911|NCT02359890|3510911|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3665912|NCT02359890|3510911|B1||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3665913|NCT02359890|3510911|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3665914|NCT02359890|3510911|B1|Age (Years)||Age||Years|Mean|62.7|62.7|Standard Deviation|10.44|10.44|||
3665915|NCT02359877|3510918|B5||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3665916|NCT02359877|3510919|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3665917|NCT02359877|3510920|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3665918|NCT02359877|3510921|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3665919|NCT02359877|3510922|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3665920|NCT02359877|3510918|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3665921|NCT02359877|3510919|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3665922|NCT02359877|3510920|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3665923|NCT02359877|3510921|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3665924|NCT02359877|3510922|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3665925|NCT02359877|3510918|B5|||Age||years|Median|23|23.0|Inter-Quartile Range|||21.0|26.0|
3665926|NCT02359877|3510919|B4|||Age||years|Median|21|21.0|Inter-Quartile Range|||20.0|31.0|
3665927|NCT02359877|3510920|B3|||Age||years|Median|23|23.0|Inter-Quartile Range|||21.0|26.0|
3665928|NCT02359877|3510921|B2|||Age||years|Median|23|23.0|Inter-Quartile Range|||21.0|26.0|
3665929|NCT02359877|3510922|B1|||Age||years|Median|23|23.0|Inter-Quartile Range|||21.0|26.0|
3665930|NCT02359877|3510918|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3665931|NCT02359877|3510919|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3665932|NCT02359877|3510920|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3665933|NCT02359877|3510921|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3665934|NCT02359877|3510922|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3665935|NCT02359877|3510918|B5||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
3665936|NCT02359877|3510919|B4||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3665937|NCT02359877|3510920|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3665938|NCT02359877|3510921|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3665939|NCT02359877|3510922|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3665940|NCT02359877|3510918|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3665941|NCT02359877|3510919|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3665942|NCT02359877|3510920|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3665943|NCT02359877|3510921|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3665944|NCT02359877|3510922|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3665945|NCT02359851|3510975|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3665946|NCT02359851|3510975|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665947|NCT02359851|3510975|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665948|NCT02359851|3510975|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3665949|NCT02359851|3510975|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665950|NCT02359851|3510975|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665951|NCT02359851|3510975|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665952|NCT02359851|3510975|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3665953|NCT02359851|3510975|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3665954|NCT02359851|3510975|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3665955|NCT02359851|3510975|B1|||Age||Years|Mean|61|61.0|Standard Deviation|16.7332|16.7332|||
3665956|NCT02359851|3510975|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3665957|NCT02359851|3510975|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3665958|NCT02359851|3510975|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3665959|NCT02359435|3510983|B3|Taiwan||Region of Enrollment||participants|Number|440|440.0||||||
3665960|NCT02359435|3510984|B2|Taiwan||Region of Enrollment||participants|Number|220|220.0||||||
3665961|NCT02359435|3510985|B1|Taiwan||Region of Enrollment||participants|Number|220|220.0||||||
3665962|NCT02359435|3510983|B3||Male|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
3665963|NCT02359435|3510984|B2||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3665964|NCT02359435|3510985|B1||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3665965|NCT02359435|3510983|B3||Female|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
3665966|NCT02359435|3510984|B2||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3665967|NCT02359435|3510985|B1||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3665968|NCT02359435|3510983|B3|||Age||years|Mean|52.83|52.83|Standard Deviation|12.58|12.58|||
3665969|NCT02359435|3510984|B2|||Age||years|Mean|53.4|53.4|Standard Deviation|12.2|12.2|||
3665970|NCT02359435|3510985|B1|||Age||years|Mean|52.6|52.6|Standard Deviation|12.9|12.9|||
3665971|NCT02359435|3510983|B3||>=65 years|Age||Participants|Count of Participants|133|133.0||||||
3665972|NCT02359435|3510984|B2||>=65 years|Age||Participants|Count of Participants|67|67.0||||||
3665973|NCT02359435|3510985|B1||>=65 years|Age||Participants|Count of Participants|66|66.0||||||
3665974|NCT02359435|3510983|B3||Between 18 and 65 years|Age||Participants|Count of Participants|307|307.0||||||
3665975|NCT02359435|3510984|B2||Between 18 and 65 years|Age||Participants|Count of Participants|153|153.0||||||
3665976|NCT02359435|3510985|B1||Between 18 and 65 years|Age||Participants|Count of Participants|154|154.0||||||
3665977|NCT02359435|3510983|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3665978|NCT02359435|3510984|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3665979|NCT02359435|3510985|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3665980|NCT02359305|3510992|B3|United States||Region of Enrollment||participants|Number|68|68.0||||||
3665981|NCT02359305|3510993|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
3665982|NCT02359305|3510994|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
3665983|NCT02359305|3510992|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3665984|NCT02359305|3510993|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3665985|NCT02359305|3510994|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3665986|NCT02359305|3510992|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3665987|NCT02359305|3510993|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3665988|NCT02359305|3510994|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3665989|NCT02359305|3510992|B3|||Age||days|Mean|36|36.0|Standard Deviation|15.5|15.5|||
3665990|NCT02359305|3510993|B2|||Age||days|Mean|37.8|37.8|Standard Deviation|16.5|16.5|||
3665991|NCT02359305|3510994|B1|||Age||days|Mean|34.2|34.2|Standard Deviation|14.5|14.5|||
3665992|NCT02359305|3510992|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3665993|NCT02359305|3510993|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3665994|NCT02359305|3510994|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3665995|NCT02359305|3510992|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3665996|NCT02359305|3510993|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3665997|NCT02359305|3510994|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3665998|NCT02359305|3510992|B3||<=18 years|Age||Participants|Count of Participants|68|68.0||||||
3665999|NCT02359305|3510993|B2||<=18 years|Age||Participants|Count of Participants|34|34.0||||||
3666000|NCT02359305|3510994|B1||<=18 years|Age||Participants|Count of Participants|34|34.0||||||
3666001|NCT02359110|3511005|B3|||BMI||kg/m2|Mean|29.8|29.8|Standard Deviation|7.4|7.4|||
3666002|NCT02359110|3511006|B2|||BMI||kg/m2|Mean|30.0|30.0|Standard Deviation|7.7|7.7|||
3666003|NCT02359110|3511007|B1|||BMI||kg/m2|Mean|29.5|29.5|Standard Deviation|7.2|7.2|||
3666004|NCT02359110|3511005|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3666005|NCT02359110|3511006|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3666006|NCT02359110|3511007|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3666007|NCT02359110|3511005|B3||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3666008|NCT02359110|3511006|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3666009|NCT02359110|3511007|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3666010|NCT02359110|3511005|B3|||Age||years|Mean|39.9|39.9|Standard Deviation|9.5|9.5|||
3666011|NCT02359110|3511006|B2|||Age||years|Mean|39.5|39.5|Standard Deviation|9.4|9.4|||
3666012|NCT02359110|3511007|B1|||Age||years|Mean|40.4|40.4|Standard Deviation|9.8|9.8|||
3666013|NCT02359058|3511018|B4|Japan||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3666014|NCT02359058|3511019|B3|Japan||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3666015|NCT02359058|3511020|B2|Japan||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3666016|NCT02359058|3511021|B1|Japan||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3666017|NCT02359058|3511018|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666018|NCT02359058|3511019|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666019|NCT02359058|3511020|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666020|NCT02359058|3511021|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666021|NCT02359058|3511018|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666022|NCT02359058|3511019|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666023|NCT02359058|3511020|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666024|NCT02359058|3511021|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666025|NCT02359058|3511018|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666026|NCT02359058|3511019|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666027|NCT02359058|3511020|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666028|NCT02359058|3511021|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666029|NCT02359058|3511018|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666030|NCT02359058|3511019|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666031|NCT02359058|3511020|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666032|NCT02359058|3511021|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666033|NCT02359058|3511018|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666034|NCT02359058|3511019|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666035|NCT02359058|3511020|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666036|NCT02359058|3511021|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666037|NCT02359058|3511018|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3666038|NCT02359058|3511019|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3666039|NCT02359058|3511020|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3666040|NCT02359058|3511021|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3666041|NCT02359058|3511018|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666042|NCT02359058|3511019|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666043|NCT02359058|3511020|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666044|NCT02359058|3511021|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666045|NCT02359058|3511018|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3666046|NCT02359058|3511019|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3666047|NCT02359058|3511020|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3666048|NCT02359058|3511021|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3666049|NCT02359058|3511018|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666050|NCT02359058|3511019|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666051|NCT02359058|3511020|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666052|NCT02359058|3511021|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666053|NCT02359058|3511018|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666054|NCT02359058|3511019|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666055|NCT02359058|3511020|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666056|NCT02359058|3511021|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666057|NCT02359058|3511018|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3666058|NCT02359058|3511019|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3666059|NCT02359058|3511020|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3666060|NCT02359058|3511021|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3666061|NCT02359058|3511018|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3666062|NCT02359058|3511019|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3666063|NCT02359058|3511020|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3666064|NCT02359058|3511021|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3666065|NCT02359058|3511018|B4|||Age||years|Mean|60.2|60.2|Standard Deviation|8.30|8.3|||
3666066|NCT02359058|3511019|B3|||Age||years|Mean|62.7|62.7|Standard Deviation|6.98|6.98|||
3666067|NCT02359058|3511020|B2|||Age||years|Mean|60.3|60.3|Standard Deviation|7.06|7.06|||
3666068|NCT02359058|3511021|B1|||Age||years|Mean|57.5|57.5|Standard Deviation|10.93|10.93|||
3666069|NCT02359045|3511044|B3|Male||Sex/Gender, Customized||Participants|Number|77|77.0||||||
3666070|NCT02359045|3511045|B2|Male||Sex/Gender, Customized||Participants|Number|37|37.0||||||
3666071|NCT02359045|3511046|B1|Male||Sex/Gender, Customized||Participants|Number|40|40.0||||||
3666072|NCT02359045|3511044|B3|Female||Sex/Gender, Customized||Participants|Number|5|5.0||||||
3666073|NCT02359045|3511045|B2|Female||Sex/Gender, Customized||Participants|Number|5|5.0||||||
3666074|NCT02359045|3511046|B1|Female||Sex/Gender, Customized||Participants|Number|0|0.0||||||
3666075|NCT02359045|3511044|B3|||Age||Years|Mean|37.9|37.9|Standard Deviation|9.97|9.97|||
3666076|NCT02359045|3511045|B2|||Age||Years|Mean|37.1|37.1|Standard Deviation|9.97|9.97|||
3666077|NCT02359045|3511046|B1|||Age||Years|Mean|38.7|38.7|Standard Deviation|9.97|9.97|||
3666078|NCT02358876|3511280|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
3666079|NCT02358876|3511280|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3666080|NCT02358876|3511280|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3666081|NCT02358876|3511280|B1|||Age||years|Mean|62.6|62.6|Standard Deviation|6.4|6.4|||
3666082|NCT02358863|3511284|B1|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3666083|NCT02358863|3511284|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3666084|NCT02358863|3511284|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3666085|NCT02358863|3511284|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3666086|NCT02358863|3511284|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3666087|NCT02358863|3511284|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3666088|NCT02358668|3511288|B4|||Standard deviation|Standard deviation on continuous glucose monitoring system|mmol/L|Mean|1.09|1.09|Standard Deviation|0.43|0.43|||
3666089|NCT02358668|3511289|B3|||Standard deviation|Standard deviation on continuous glucose monitoring system|mmol/L|Mean|1.18|1.18|Standard Deviation|0.59|0.59|||
3666090|NCT02358668|3511290|B2|||Standard deviation|Standard deviation on continuous glucose monitoring system|mmol/L|Mean|1.19|1.19|Standard Deviation|0.44|0.44|||
3666091|NCT02358668|3511291|B1|||Standard deviation|Standard deviation on continuous glucose monitoring system|mmol/L|Mean|0.93|0.93|Standard Deviation|0.28|0.28|||
3666092|NCT02358668|3511288|B4|||Percentage coefficient of variation|Percentage coefficient of variation on continuous glucose monitoring system|%|Mean|17.46|17.46|Standard Deviation|6.20|6.2|||
3666093|NCT02358668|3511289|B3|||Percentage coefficient of variation|Percentage coefficient of variation on continuous glucose monitoring system|%|Mean|18.00|18.0|Standard Deviation|7.60|7.6|||
3666094|NCT02358668|3511290|B2|||Percentage coefficient of variation|Percentage coefficient of variation on continuous glucose monitoring system|%|Mean|19.07|19.07|Standard Deviation|6.61|6.61|||
3666095|NCT02358668|3511291|B1|||Percentage coefficient of variation|Percentage coefficient of variation on continuous glucose monitoring system|%|Mean|15.49|15.49|Standard Deviation|4.43|4.43|||
3666096|NCT02358668|3511288|B4|||Mean amplitude of glucose excursion|Mean amplitude of glucose excursion on continuous glucose monitoring system|mmol/L|Mean|2.55|2.55|Standard Deviation|1.63|1.63|||
3666097|NCT02358668|3511289|B3|||Mean amplitude of glucose excursion|Mean amplitude of glucose excursion on continuous glucose monitoring system|mmol/L|Mean|3.21|3.21|Standard Deviation|3.16|3.16|||
3666098|NCT02358668|3511290|B2|||Mean amplitude of glucose excursion|Mean amplitude of glucose excursion on continuous glucose monitoring system|mmol/L|Mean|2.68|2.68|Standard Deviation|1.01|1.01|||
3666099|NCT02358668|3511291|B1|||Mean amplitude of glucose excursion|Mean amplitude of glucose excursion on continuous glucose monitoring system|mmol/L|Mean|2.06|2.06|Standard Deviation|0.69|0.69|||
3666100|NCT02358668|3511288|B4|||Mean post-meal maximum glucose|Mean post-meal maximum glucose on continuous glucose monitoring system|mmol/L|Mean|7.88|7.88|Standard Deviation|1.09|1.09|||
3666101|NCT02358668|3511289|B3|||Mean post-meal maximum glucose|Mean post-meal maximum glucose on continuous glucose monitoring system|mmol/L|Mean|8.07|8.07|Standard Deviation|1.00|1.0|||
3666102|NCT02358668|3511290|B2|||Mean post-meal maximum glucose|Mean post-meal maximum glucose on continuous glucose monitoring system|mmol/L|Mean|8.20|8.2|Standard Deviation|1.31|1.31|||
3666103|NCT02358668|3511291|B1|||Mean post-meal maximum glucose|Mean post-meal maximum glucose on continuous glucose monitoring system|mmol/L|Mean|7.45|7.45|Standard Deviation|0.75|0.75|||
3666104|NCT02358668|3511288|B4|||Mean blood glucose|Mean blood glucose on continuous glucose monitoring system|mmol/L|Mean|6.18|6.18|Standard Deviation|0.56|0.56|||
3666105|NCT02358668|3511289|B3|||Mean blood glucose|Mean blood glucose on continuous glucose monitoring system|mmol/L|Mean|6.45|6.45|Standard Deviation|0.54|0.54|||
3666106|NCT02358668|3511290|B2|||Mean blood glucose|Mean blood glucose on continuous glucose monitoring system|mmol/L|Mean|6.20|6.2|Standard Deviation|0.63|0.63|||
3666107|NCT02358668|3511291|B1|||Mean blood glucose|Mean blood glucose on continuous glucose monitoring system|mmol/L|Mean|6.01|6.01|Standard Deviation|0.45|0.45|||
3666108|NCT02358668|3511288|B4|||72 hour AUC-180|Area under curve for glucose levels >180 mg/dL on continuous glucose monitoring system|mmol/L*hour|Mean|1.39|1.39|Standard Deviation|4.17|4.17|||
3666109|NCT02358668|3511289|B3|||72 hour AUC-180|Area under curve for glucose levels >180 mg/dL on continuous glucose monitoring system|mmol/L*hour|Mean|2.73|2.73|Standard Deviation|7.64|7.64|||
3666110|NCT02358668|3511290|B2|||72 hour AUC-180|Area under curve for glucose levels >180 mg/dL on continuous glucose monitoring system|mmol/L*hour|Mean|1.71|1.71|Standard Deviation|3.35|3.35|||
3666111|NCT02358668|3511291|B1|||72 hour AUC-180|Area under curve for glucose levels >180 mg/dL on continuous glucose monitoring system|mmol/L*hour|Mean|0.40|0.4|Standard Deviation|1.85|1.85|||
3666112|NCT02358668|3511288|B4|||3-hour post-prandial glucose AUC|3-hour post-prandial glucose incremental area under curve on continuous glucose monitoring system|mmol/L*hour|Mean|19.68|19.68|Standard Deviation|2.25|2.25|||
3666113|NCT02358668|3511289|B3|||3-hour post-prandial glucose AUC|3-hour post-prandial glucose incremental area under curve on continuous glucose monitoring system|mmol/L*hour|Mean|20.20|20.2|Standard Deviation|2.20|2.2|||
3666114|NCT02358668|3511290|B2|||3-hour post-prandial glucose AUC|3-hour post-prandial glucose incremental area under curve on continuous glucose monitoring system|mmol/L*hour|Mean|20.20|20.2|Standard Deviation|2.59|2.59|||
3666115|NCT02358668|3511291|B1|||3-hour post-prandial glucose AUC|3-hour post-prandial glucose incremental area under curve on continuous glucose monitoring system|mmol/L*hour|Mean|18.90|18.9|Standard Deviation|1.69|1.69|||
3666170|NCT02358668|3511290|B2|||Body weight||kg|Mean|71.0|71.0|Standard Deviation|16.2|16.2|||
3666116|NCT02358668|3511288|B4|||2-hour post-prandial glucose AUC|2-hour post-prandial glucose incremental area under curve on continuous glucose monitoring system|mmol/L*hour|Mean|13.22|13.22|Standard Deviation|1.59|1.59|||
3666117|NCT02358668|3511289|B3|||2-hour post-prandial glucose AUC|2-hour post-prandial glucose incremental area under curve on continuous glucose monitoring system|mmol/L*hour|Mean|13.49|13.49|Standard Deviation|1.43|1.43|||
3666118|NCT02358668|3511290|B2|||2-hour post-prandial glucose AUC|2-hour post-prandial glucose incremental area under curve on continuous glucose monitoring system|mmol/L*hour|Mean|13.64|13.64|Standard Deviation|1.87|1.87|||
3666119|NCT02358668|3511291|B1|||2-hour post-prandial glucose AUC|2-hour post-prandial glucose incremental area under curve on continuous glucose monitoring system|mmol/L*hour|Mean|12.68|12.68|Standard Deviation|1.21|1.21|||
3666120|NCT02358668|3511288|B4|||1-hour post-prandial glucose AUC|1-hour post-prandial glucose incremental area under curve on continuous glucose monitoring system|mmol/L*hour|Mean|6.12|6.12|Standard Deviation|0.65|0.65|||
3666121|NCT02358668|3511289|B3|||1-hour post-prandial glucose AUC|1-hour post-prandial glucose incremental area under curve on continuous glucose monitoring system|mmol/L*hour|Mean|6.33|6.33|Standard Deviation|0.64|0.64|||
3666122|NCT02358668|3511290|B2|||1-hour post-prandial glucose AUC|1-hour post-prandial glucose incremental area under curve on continuous glucose monitoring system|mmol/L*hour|Mean|6.22|6.22|Standard Deviation|0.72|0.72|||
3666123|NCT02358668|3511291|B1|||1-hour post-prandial glucose AUC|1-hour post-prandial glucose incremental area under curve on continuous glucose monitoring system|mmol/L*hour|Mean|5.91|5.91|Standard Deviation|0.53|0.53|||
3666124|NCT02358668|3511288|B4|||Normal glucose tolerance||participants|Number|18|18.0||||||
3666125|NCT02358668|3511289|B3|||Normal glucose tolerance||participants|Number|3|3.0||||||
3666126|NCT02358668|3511290|B2|||Normal glucose tolerance||participants|Number|8|8.0||||||
3666127|NCT02358668|3511291|B1|||Normal glucose tolerance||participants|Number|7|7.0||||||
3666128|NCT02358668|3511288|B4|||Impaired fasting glucose and impaired glucose tolerance||participants|Number|15|15.0||||||
3666129|NCT02358668|3511289|B3|||Impaired fasting glucose and impaired glucose tolerance||participants|Number|4|4.0||||||
3666130|NCT02358668|3511290|B2|||Impaired fasting glucose and impaired glucose tolerance||participants|Number|7|7.0||||||
3666131|NCT02358668|3511291|B1|||Impaired fasting glucose and impaired glucose tolerance||participants|Number|4|4.0||||||
3666132|NCT02358668|3511288|B4|||Impaired glucose tolerance||participants|Number|23|23.0||||||
3666133|NCT02358668|3511289|B3|||Impaired glucose tolerance||participants|Number|5|5.0||||||
3666134|NCT02358668|3511290|B2|||Impaired glucose tolerance||participants|Number|8|8.0||||||
3666135|NCT02358668|3511291|B1|||Impaired glucose tolerance||participants|Number|10|10.0||||||
3666136|NCT02358668|3511288|B4|||Impaired fasting glucose||participants|Number|4|4.0||||||
3666137|NCT02358668|3511289|B3|||Impaired fasting glucose||participants|Number|0|0.0||||||
3666138|NCT02358668|3511290|B2|||Impaired fasting glucose||participants|Number|1|1.0||||||
3666139|NCT02358668|3511291|B1|||Impaired fasting glucose||participants|Number|3|3.0||||||
3666140|NCT02358668|3511288|B4|||Total cholesterol||mmol/L|Mean|5.0|5.0|Standard Deviation|1.0|1.0|||
3666141|NCT02358668|3511289|B3|||Total cholesterol||mmol/L|Mean|5.3|5.3|Standard Deviation|0.8|0.8|||
3666142|NCT02358668|3511290|B2|||Total cholesterol||mmol/L|Mean|4.9|4.9|Standard Deviation|1.0|1.0|||
3666143|NCT02358668|3511291|B1|||Total cholesterol||mmol/L|Mean|4.9|4.9|Standard Deviation|1.1|1.1|||
3666144|NCT02358668|3511288|B4|||HbA1c|Glycated hemoglobin|%|Mean|6.0|6.0|Standard Deviation|0.3|0.3|||
3666145|NCT02358668|3511289|B3|||HbA1c|Glycated hemoglobin|%|Mean|6.1|6.1|Standard Deviation|0.3|0.3|||
3666146|NCT02358668|3511290|B2|||HbA1c|Glycated hemoglobin|%|Mean|6.0|6.0|Standard Deviation|0.3|0.3|||
3666147|NCT02358668|3511291|B1|||HbA1c|Glycated hemoglobin|%|Mean|6.0|6.0|Standard Deviation|0.3|0.3|||
3666148|NCT02358668|3511288|B4|||Fructosamine||umol/L|Mean|272.1|272.1|Standard Deviation|19.9|19.9|||
3666149|NCT02358668|3511289|B3|||Fructosamine||umol/L|Mean|278.9|278.9|Standard Deviation|22.0|22.0|||
3666150|NCT02358668|3511290|B2|||Fructosamine||umol/L|Mean|272.2|272.2|Standard Deviation|20.2|20.2|||
3666151|NCT02358668|3511291|B1|||Fructosamine||umol/L|Mean|268.5|268.5|Standard Deviation|18.3|18.3|||
3666152|NCT02358668|3511288|B4|||Diastolic blood pressure||mmHg|Mean|78.9|78.9|Standard Deviation|7.0|7.0|||
3666153|NCT02358668|3511289|B3|||Diastolic blood pressure||mmHg|Mean|80.4|80.4|Standard Deviation|7.3|7.3|||
3666154|NCT02358668|3511290|B2|||Diastolic blood pressure||mmHg|Mean|78.7|78.7|Standard Deviation|7.2|7.2|||
3666155|NCT02358668|3511291|B1|||Diastolic blood pressure||mmHg|Mean|78.4|78.4|Standard Deviation|6.8|6.8|||
3666156|NCT02358668|3511288|B4|||Systolic blood pressure||mmHg|Mean|124.0|124.0|Standard Deviation|13.8|13.8|||
3666157|NCT02358668|3511289|B3|||Systolic blood pressure||mmHg|Mean|127.8|127.8|Standard Deviation|8.7|8.7|||
3666158|NCT02358668|3511290|B2|||Systolic blood pressure||mmHg|Mean|125.4|125.4|Standard Deviation|16.2|16.2|||
3666159|NCT02358668|3511291|B1|||Systolic blood pressure||mmHg|Mean|121.7|121.7|Standard Deviation|13.2|13.2|||
3666160|NCT02358668|3511288|B4|||Waist circumference||cm|Mean|91.8|91.8|Standard Deviation|13.5|13.5|||
3666161|NCT02358668|3511289|B3|||Waist circumference||cm|Mean|88.0|88.0|Standard Deviation|15.7|15.7|||
3666162|NCT02358668|3511290|B2|||Waist circumference||cm|Mean|90.6|90.6|Standard Deviation|9.1|9.1|||
3666163|NCT02358668|3511291|B1|||Waist circumference||cm|Mean|95.0|95.0|Standard Deviation|15.6|15.6|||
3666164|NCT02358668|3511288|B4|||Body mass index||kg/m2|Mean|27.0|27.0|Standard Deviation|5.0|5.0|||
3666165|NCT02358668|3511289|B3|||Body mass index||kg/m2|Mean|25.1|25.1|Standard Deviation|4.3|4.3|||
3666166|NCT02358668|3511290|B2|||Body mass index||kg/m2|Mean|26.9|26.9|Standard Deviation|4.4|4.4|||
3666167|NCT02358668|3511291|B1|||Body mass index||kg/m2|Mean|28.0|28.0|Standard Deviation|5.8|5.8|||
3666168|NCT02358668|3511288|B4|||Body weight||kg|Mean|70.9|70.9|Standard Deviation|17.4|17.4|||
3666169|NCT02358668|3511289|B3|||Body weight||kg|Mean|63.9|63.9|Standard Deviation|20.0|20.0|||
3666171|NCT02358668|3511291|B1|||Body weight||kg|Mean|74.2|74.2|Standard Deviation|16.9|16.9|||
3666172|NCT02358668|3511288|B4|Hong Kong||Region of Enrollment||participants|Number|60|60.0||||||
3666173|NCT02358668|3511289|B3|Hong Kong||Region of Enrollment||participants|Number|12|12.0||||||
3666174|NCT02358668|3511290|B2|Hong Kong||Region of Enrollment||participants|Number|24|24.0||||||
3666175|NCT02358668|3511291|B1|Hong Kong||Region of Enrollment||participants|Number|24|24.0||||||
3666176|NCT02358668|3511288|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3666177|NCT02358668|3511289|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3666178|NCT02358668|3511290|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3666179|NCT02358668|3511291|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3666180|NCT02358668|3511288|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3666181|NCT02358668|3511289|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3666182|NCT02358668|3511290|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3666183|NCT02358668|3511291|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3666184|NCT02358668|3511288|B4|||Age||years|Mean|56.4|56.4|Standard Deviation|9.1|9.1|||
3666185|NCT02358668|3511289|B3|||Age||years|Mean|57.1|57.1|Standard Deviation|10.9|10.9|||
3666186|NCT02358668|3511290|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|8.5|8.5|||
3666187|NCT02358668|3511291|B1|||Age||years|Mean|54.1|54.1|Standard Deviation|8.6|8.6|||
3666188|NCT02358473|3511433|B1|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3666189|NCT02358473|3511433|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3666190|NCT02358473|3511433|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3666191|NCT02358473|3511433|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3666192|NCT02358473|3511433|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3666193|NCT02358473|3511433|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3666194|NCT02358044|3511442|B3||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3666195|NCT02358044|3511443|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3666196|NCT02358044|3511444|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3666197|NCT02358044|3511442|B3||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3666198|NCT02358044|3511443|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3666199|NCT02358044|3511444|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3666200|NCT02358044|3511442|B3|||Age||years|Mean|47.9|47.9|Standard Deviation|12.4|12.4|||
3666201|NCT02358044|3511443|B2|||Age||years|Mean|48.2|48.2|Standard Deviation|12.4|12.4|||
3666202|NCT02358044|3511444|B1|||Age||years|Mean|47.6|47.6|Standard Deviation|12.4|12.4|||
3666203|NCT02357940|3511461|B3|USA||Region of Enrollment||participants|Number|41|41.0||||||
3666204|NCT02357940|3511462|B2|USA||Region of Enrollment||participants|Number|32|32.0||||||
3666205|NCT02357940|3511463|B1|USA||Region of Enrollment||participants|Number|9|9.0||||||
3666206|NCT02357940|3511461|B3||Male|Gender||Participants|Count of Participants|22|22.0||||||
3666207|NCT02357940|3511462|B2||Male|Gender||Participants|Count of Participants|19|19.0||||||
3666208|NCT02357940|3511463|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
3666209|NCT02357940|3511461|B3||Female|Gender||Participants|Count of Participants|19|19.0||||||
3666210|NCT02357940|3511462|B2||Female|Gender||Participants|Count of Participants|13|13.0||||||
3666211|NCT02357940|3511463|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
3666212|NCT02357940|3511461|B3|||Age||months|Mean|105.6|105.6|Standard Deviation|169.8|169.8|||
3666213|NCT02357940|3511462|B2|||Age||months|Mean|22.8|22.8|Standard Deviation|8.89|8.89|||
3666214|NCT02357940|3511463|B1|||Age||months|Mean|400.0|400.0|Standard Deviation|137.5|137.5|||
3666215|NCT02357901|3511588|B4|Other||Drug use history||Participants|Count of Participants|9|9.0||||||
3666216|NCT02357901|3511589|B3|Other||Drug use history||Participants|Count of Participants|1|1.0||||||
3666217|NCT02357901|3511590|B2|Other||Drug use history||Participants|Count of Participants|6|6.0||||||
3666218|NCT02357901|3511591|B1|Other||Drug use history||Participants|Count of Participants|2|2.0||||||
3666219|NCT02357901|3511588|B4|Phencyclidine||Drug use history||Participants|Count of Participants|3|3.0||||||
3666220|NCT02357901|3511589|B3|Phencyclidine||Drug use history||Participants|Count of Participants|1|1.0||||||
3666221|NCT02357901|3511590|B2|Phencyclidine||Drug use history||Participants|Count of Participants|2|2.0||||||
3666222|NCT02357901|3511591|B1|Phencyclidine||Drug use history||Participants|Count of Participants|0|0.0||||||
3666223|NCT02357901|3511588|B4|Benzodiazepines||Drug use history||Participants|Count of Participants|58|58.0||||||
3666224|NCT02357901|3511589|B3|Benzodiazepines||Drug use history||Participants|Count of Participants|13|13.0||||||
3666225|NCT02357901|3511590|B2|Benzodiazepines||Drug use history||Participants|Count of Participants|20|20.0||||||
3666226|NCT02357901|3511591|B1|Benzodiazepines||Drug use history||Participants|Count of Participants|25|25.0||||||
3666227|NCT02357901|3511588|B4|Buprenorphine||Drug use history||Participants|Count of Participants|42|42.0||||||
3666228|NCT02357901|3511589|B3|Buprenorphine||Drug use history||Participants|Count of Participants|6|6.0||||||
3666229|NCT02357901|3511590|B2|Buprenorphine||Drug use history||Participants|Count of Participants|16|16.0||||||
3666230|NCT02357901|3511591|B1|Buprenorphine||Drug use history||Participants|Count of Participants|20|20.0||||||
3666231|NCT02357901|3511588|B4|Barbiturates||Drug use history||Participants|Count of Participants|4|4.0||||||
3666232|NCT02357901|3511589|B3|Barbiturates||Drug use history||Participants|Count of Participants|0|0.0||||||
3666233|NCT02357901|3511590|B2|Barbiturates||Drug use history||Participants|Count of Participants|1|1.0||||||
3666234|NCT02357901|3511591|B1|Barbiturates||Drug use history||Participants|Count of Participants|3|3.0||||||
3666235|NCT02357901|3511588|B4|Cannabinoids||Drug use history||Participants|Count of Participants|261|261.0||||||
3666236|NCT02357901|3511589|B3|Cannabinoids||Drug use history||Participants|Count of Participants|53|53.0||||||
3666237|NCT02357901|3511590|B2|Cannabinoids||Drug use history||Participants|Count of Participants|95|95.0||||||
3666238|NCT02357901|3511591|B1|Cannabinoids||Drug use history||Participants|Count of Participants|113|113.0||||||
3666239|NCT02357901|3511588|B4|Methadone||Drug use history||Participants|Count of Participants|44|44.0||||||
3666240|NCT02357901|3511589|B3|Methadone||Drug use history||Participants|Count of Participants|5|5.0||||||
3666241|NCT02357901|3511590|B2|Methadone||Drug use history||Participants|Count of Participants|14|14.0||||||
3666242|NCT02357901|3511591|B1|Methadone||Drug use history||Participants|Count of Participants|25|25.0||||||
3666243|NCT02357901|3511588|B4|Amphetamines/ Methamphetamine||Drug use history||Participants|Count of Participants|101|101.0||||||
3666244|NCT02357901|3511589|B3|Amphetamines/ Methamphetamine||Drug use history||Participants|Count of Participants|19|19.0||||||
3666245|NCT02357901|3511590|B2|Amphetamines/ Methamphetamine||Drug use history||Participants|Count of Participants|29|29.0||||||
3666246|NCT02357901|3511591|B1|Amphetamines/ Methamphetamine||Drug use history||Participants|Count of Participants|53|53.0||||||
3666247|NCT02357901|3511588|B4|Cocaine||Drug use history||Participants|Count of Participants|216|216.0||||||
3666248|NCT02357901|3511589|B3|Cocaine||Drug use history||Participants|Count of Participants|42|42.0||||||
3666249|NCT02357901|3511590|B2|Cocaine||Drug use history||Participants|Count of Participants|80|80.0||||||
3666250|NCT02357901|3511591|B1|Cocaine||Drug use history||Participants|Count of Participants|94|94.0||||||
3666251|NCT02357901|3511588|B4|Opioids||Drug use history||Participants|Count of Participants|504|504.0||||||
3666252|NCT02357901|3511589|B3|Opioids||Drug use history||Participants|Count of Participants|100|100.0||||||
3666253|NCT02357901|3511590|B2|Opioids||Drug use history||Participants|Count of Participants|201|201.0||||||
3666254|NCT02357901|3511591|B1|Opioids||Drug use history||Participants|Count of Participants|203|203.0||||||
3666255|NCT02357901|3511588|B4||No|Alcohol use||Participants|Count of Participants|103|103.0||||||
3666256|NCT02357901|3511589|B3||No|Alcohol use||Participants|Count of Participants|19|19.0||||||
3666257|NCT02357901|3511590|B2||No|Alcohol use||Participants|Count of Participants|41|41.0||||||
3666258|NCT02357901|3511591|B1||No|Alcohol use||Participants|Count of Participants|43|43.0||||||
3666259|NCT02357901|3511588|B4||Yes|Alcohol use||Participants|Count of Participants|401|401.0||||||
3666260|NCT02357901|3511589|B3||Yes|Alcohol use||Participants|Count of Participants|81|81.0||||||
3666261|NCT02357901|3511590|B2||Yes|Alcohol use||Participants|Count of Participants|160|160.0||||||
3666262|NCT02357901|3511591|B1||Yes|Alcohol use||Participants|Count of Participants|160|160.0||||||
3666263|NCT02357901|3511588|B4||No|Caffeine use||Participants|Count of Participants|37|37.0||||||
3666264|NCT02357901|3511589|B3||No|Caffeine use||Participants|Count of Participants|5|5.0||||||
3666265|NCT02357901|3511590|B2||No|Caffeine use||Participants|Count of Participants|16|16.0||||||
3666266|NCT02357901|3511591|B1||No|Caffeine use||Participants|Count of Participants|16|16.0||||||
3666267|NCT02357901|3511588|B4||Yes|Caffeine use||Participants|Count of Participants|467|467.0||||||
3666268|NCT02357901|3511589|B3||Yes|Caffeine use||Participants|Count of Participants|95|95.0||||||
3666269|NCT02357901|3511590|B2||Yes|Caffeine use||Participants|Count of Participants|185|185.0||||||
3666270|NCT02357901|3511591|B1||Yes|Caffeine use||Participants|Count of Participants|187|187.0||||||
3666271|NCT02357901|3511588|B4||No|Tobacco use||Participants|Count of Participants|38|38.0||||||
3666272|NCT02357901|3511589|B3||No|Tobacco use||Participants|Count of Participants|7|7.0||||||
3666273|NCT02357901|3511590|B2||No|Tobacco use||Participants|Count of Participants|15|15.0||||||
3666274|NCT02357901|3511591|B1||No|Tobacco use||Participants|Count of Participants|16|16.0||||||
3666275|NCT02357901|3511588|B4||Yes|Tobacco use||Participants|Count of Participants|466|466.0||||||
3666276|NCT02357901|3511589|B3||Yes|Tobacco use||Participants|Count of Participants|93|93.0||||||
3666277|NCT02357901|3511590|B2||Yes|Tobacco use||Participants|Count of Participants|186|186.0||||||
3666278|NCT02357901|3511591|B1||Yes|Tobacco use||Participants|Count of Participants|187|187.0||||||
3666279|NCT02357901|3511588|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666280|NCT02357901|3511589|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666281|NCT02357901|3511590|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666282|NCT02357901|3511591|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666283|NCT02357901|3511588|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3666284|NCT02357901|3511589|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3666285|NCT02357901|3511590|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3666286|NCT02357901|3511591|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3666287|NCT02357901|3511588|B4||White|Race (NIH/OMB)||Participants|Count of Participants|362|362.0||||||
3666288|NCT02357901|3511589|B3||White|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3666289|NCT02357901|3511590|B2||White|Race (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
3666290|NCT02357901|3511591|B1||White|Race (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
3666291|NCT02357901|3511588|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
3666292|NCT02357901|3511589|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3666350|NCT02357459|3511652|B4||Female|Sex: Female, Male||Participants|Count of Participants|296|296.0||||||
3666293|NCT02357901|3511590|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3666294|NCT02357901|3511591|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3666295|NCT02357901|3511588|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666296|NCT02357901|3511589|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666297|NCT02357901|3511590|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666298|NCT02357901|3511591|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666299|NCT02357901|3511588|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666300|NCT02357901|3511589|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666301|NCT02357901|3511590|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666302|NCT02357901|3511591|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666303|NCT02357901|3511588|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3666304|NCT02357901|3511589|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3666305|NCT02357901|3511590|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3666306|NCT02357901|3511591|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3666307|NCT02357901|3511588|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666308|NCT02357901|3511589|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666309|NCT02357901|3511590|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666310|NCT02357901|3511591|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666311|NCT02357901|3511588|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|463|463.0||||||
3666312|NCT02357901|3511589|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
3666313|NCT02357901|3511590|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|183|183.0||||||
3666314|NCT02357901|3511591|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|190|190.0||||||
3666315|NCT02357901|3511588|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3666316|NCT02357901|3511589|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3666317|NCT02357901|3511590|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3666318|NCT02357901|3511591|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3666319|NCT02357901|3511588|B4||Male|Sex: Female, Male||Participants|Count of Participants|336|336.0||||||
3666320|NCT02357901|3511589|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3666321|NCT02357901|3511590|B2||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3666322|NCT02357901|3511591|B1||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3666323|NCT02357901|3511588|B4||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3666324|NCT02357901|3511589|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3666325|NCT02357901|3511590|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3666326|NCT02357901|3511591|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3666327|NCT02357901|3511588|B4||>= 60 years|Age, Customized||Participants|Count of Participants|17|17.0||||||
3666328|NCT02357901|3511589|B3||>= 60 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
3666329|NCT02357901|3511590|B2||>= 60 years|Age, Customized||Participants|Count of Participants|8|8.0||||||
3666330|NCT02357901|3511591|B1||>= 60 years|Age, Customized||Participants|Count of Participants|7|7.0||||||
3666331|NCT02357901|3511588|B4||>=45 to <60 years|Age, Customized||Participants|Count of Participants|147|147.0||||||
3666332|NCT02357901|3511589|B3||>=45 to <60 years|Age, Customized||Participants|Count of Participants|30|30.0||||||
3666333|NCT02357901|3511590|B2||>=45 to <60 years|Age, Customized||Participants|Count of Participants|53|53.0||||||
3666334|NCT02357901|3511591|B1||>=45 to <60 years|Age, Customized||Participants|Count of Participants|64|64.0||||||
3666335|NCT02357901|3511588|B4||>=30 to <45 years|Age, Customized||Participants|Count of Participants|228|228.0||||||
3666336|NCT02357901|3511589|B3||>=30 to <45 years|Age, Customized||Participants|Count of Participants|45|45.0||||||
3666337|NCT02357901|3511590|B2||>=30 to <45 years|Age, Customized||Participants|Count of Participants|95|95.0||||||
3666338|NCT02357901|3511591|B1||>=30 to <45 years|Age, Customized||Participants|Count of Participants|88|88.0||||||
3666339|NCT02357901|3511588|B4||>=18 to <30 years|Age, Customized||Participants|Count of Participants|112|112.0||||||
3666340|NCT02357901|3511589|B3||>=18 to <30 years|Age, Customized||Participants|Count of Participants|23|23.0||||||
3666341|NCT02357901|3511590|B2||>=18 to <30 years|Age, Customized||Participants|Count of Participants|45|45.0||||||
3666342|NCT02357901|3511591|B1||>=18 to <30 years|Age, Customized||Participants|Count of Participants|44|44.0||||||
3666343|NCT02357485|3511644|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3666344|NCT02357485|3511644|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3666345|NCT02357485|3511644|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|5.9|5.9|||
3666346|NCT02357459|3511652|B4||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3666347|NCT02357459|3511653|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3666348|NCT02357459|3511654|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3666349|NCT02357459|3511655|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3666351|NCT02357459|3511653|B3||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3666352|NCT02357459|3511654|B2||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3666353|NCT02357459|3511655|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3666354|NCT02357459|3511652|B4|||Age||years|Mean|62.1|62.1|Standard Deviation|9.49|9.49|||
3666355|NCT02357459|3511653|B3|||Age||years|Mean|62.3|62.3|Standard Deviation|10.08|10.08|||
3666356|NCT02357459|3511654|B2|||Age||years|Mean|62.4|62.4|Standard Deviation|8.89|8.89|||
3666357|NCT02357459|3511655|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|9.52|9.52|||
3666358|NCT02357342|3511699|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3666359|NCT02357342|3511700|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3666360|NCT02357342|3511701|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3666361|NCT02357342|3511699|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3666362|NCT02357342|3511700|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3666363|NCT02357342|3511701|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3666364|NCT02357342|3511699|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3666365|NCT02357342|3511700|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3666366|NCT02357342|3511701|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3666367|NCT02357342|3511699|B3||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
3666368|NCT02357342|3511700|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3666369|NCT02357342|3511701|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3666370|NCT02357342|3511699|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3666371|NCT02357342|3511700|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3666372|NCT02357342|3511701|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3666373|NCT02357342|3511699|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3666374|NCT02357342|3511700|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3666375|NCT02357342|3511701|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3666376|NCT02357264|3511712|B3|United States||Region of Enrollment||participants|Number|186|186.0||||||
3666377|NCT02357264|3511713|B2|United States||Region of Enrollment||participants|Number|130|130.0||||||
3666378|NCT02357264|3511714|B1|United States||Region of Enrollment||participants|Number|56|56.0||||||
3666379|NCT02357264|3511712|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3666380|NCT02357264|3511713|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3666381|NCT02357264|3511714|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3666382|NCT02357264|3511712|B3||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
3666383|NCT02357264|3511713|B2||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3666384|NCT02357264|3511714|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3666385|NCT02357264|3511712|B3|||Age||years|Mean|31.2|31.2|Standard Deviation|5.89|5.89|||
3666386|NCT02357264|3511713|B2|||Age||years|Mean|31.1|31.1|Standard Deviation|5.90|5.9|||
3666387|NCT02357264|3511714|B1|||Age||years|Mean|31.3|31.3|Standard Deviation|5.93|5.93|||
3666388|NCT02357173|3511721|B4|United States||Region of Enrollment||participants|Number|68|68.0||||||
3666389|NCT02357173|3511722|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
3666390|NCT02357173|3511723|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
3666391|NCT02357173|3511724|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3666392|NCT02357173|3511721|B4|Race|Multiracial|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3666393|NCT02357173|3511722|B3|Race|Multiracial|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3666394|NCT02357173|3511723|B2|Race|Multiracial|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3666395|NCT02357173|3511724|B1|Race|Multiracial|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3666396|NCT02357173|3511721|B4|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3666397|NCT02357173|3511722|B3|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3666398|NCT02357173|3511723|B2|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3666399|NCT02357173|3511724|B1|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3666400|NCT02357173|3511721|B4|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
3666401|NCT02357173|3511722|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3666402|NCT02357173|3511723|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3666403|NCT02357173|3511724|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3666404|NCT02357173|3511721|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3666405|NCT02357173|3511722|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3666406|NCT02357173|3511723|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3666407|NCT02357173|3511724|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3666408|NCT02357173|3511721|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3666409|NCT02357173|3511722|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3666410|NCT02357173|3511723|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3666411|NCT02357173|3511724|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3666412|NCT02357173|3511721|B4|||Age||years|Mean|42.2|42.2|Standard Deviation|13.6|13.6|||
3666413|NCT02357173|3511722|B3|||Age||years|Mean|42.3|42.3|Standard Deviation|14.2|14.2|||
3666414|NCT02357173|3511723|B2|||Age||years|Mean|40.9|40.9|Standard Deviation|12.3|12.3|||
3666415|NCT02357173|3511724|B1|||Age||years|Mean|43.3|43.3|Standard Deviation|14.4|14.4|||
3666416|NCT02356900|3511743|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
3666417|NCT02356900|3511744|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3666418|NCT02356900|3511745|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3666419|NCT02356900|3511743|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666420|NCT02356900|3511744|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666421|NCT02356900|3511745|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666422|NCT02356900|3511743|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3666423|NCT02356900|3511744|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666424|NCT02356900|3511745|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3666425|NCT02356900|3511743|B3||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3666426|NCT02356900|3511744|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3666427|NCT02356900|3511745|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3666428|NCT02356900|3511743|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3666429|NCT02356900|3511744|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3666430|NCT02356900|3511745|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666431|NCT02356900|3511743|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666432|NCT02356900|3511744|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666433|NCT02356900|3511745|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666434|NCT02356900|3511743|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666435|NCT02356900|3511744|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666436|NCT02356900|3511745|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666437|NCT02356900|3511743|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666438|NCT02356900|3511744|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666439|NCT02356900|3511745|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666440|NCT02356900|3511743|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666441|NCT02356900|3511744|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666442|NCT02356900|3511745|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666443|NCT02356900|3511743|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3666444|NCT02356900|3511744|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3666445|NCT02356900|3511745|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3666446|NCT02356900|3511743|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3666447|NCT02356900|3511744|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3666448|NCT02356900|3511745|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666449|NCT02356900|3511743|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3666450|NCT02356900|3511744|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3666451|NCT02356900|3511745|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3666452|NCT02356900|3511743|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3666453|NCT02356900|3511744|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3666454|NCT02356900|3511745|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3666455|NCT02356900|3511743|B3|||Age||years|Mean|25.4|25.4|Standard Deviation|4.6|4.6|||
3666456|NCT02356900|3511744|B2|||Age||years|Mean|25.9|25.9|Standard Deviation|4.8|4.8|||
3666457|NCT02356900|3511745|B1|||Age||years|Mean|25.0|25.0|Standard Deviation|4.5|4.5|||
3666458|NCT02356783|3511764|B3|United States||Region of Enrollment||count of participants|Number|29|29.0||||||
3666459|NCT02356783|3511765|B2|United States||Region of Enrollment||count of participants|Number|14|14.0||||||
3666460|NCT02356783|3511766|B1|United States||Region of Enrollment||count of participants|Number|15|15.0||||||
3666461|NCT02356783|3511764|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3666462|NCT02356783|3511765|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3666463|NCT02356783|3511766|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3666464|NCT02356783|3511764|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3666465|NCT02356783|3511765|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3666466|NCT02356783|3511766|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3666467|NCT02356783|3511764|B3|||Age||years|Mean|53.3|53.3|Standard Deviation|14.5|14.5|||
3666468|NCT02356783|3511765|B2|||Age||years|Mean|51.5|51.5|Standard Deviation|12.9|12.9|||
3666469|NCT02356783|3511766|B1|||Age||years|Mean|54.9|54.9|Standard Deviation|16.2|16.2|||
3666470|NCT02356588|3511775|B3||Male|Gender||Participants|Count of Participants|52|52.0||||||
3666471|NCT02356588|3511776|B2||Male|Gender||Participants|Count of Participants|18|18.0||||||
3666472|NCT02356588|3511777|B1||Male|Gender||Participants|Count of Participants|34|34.0||||||
3666473|NCT02356588|3511775|B3||Female|Gender||Participants|Count of Participants|109|109.0||||||
3666474|NCT02356588|3511776|B2||Female|Gender||Participants|Count of Participants|36|36.0||||||
3666475|NCT02356588|3511777|B1||Female|Gender||Participants|Count of Participants|73|73.0||||||
3666476|NCT02356588|3511775|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3666477|NCT02356588|3511776|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3666478|NCT02356588|3511777|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3666479|NCT02356588|3511775|B3||Between 18 and 65 years|Age||Participants|Count of Participants|159|159.0||||||
3666480|NCT02356588|3511776|B2||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
3666481|NCT02356588|3511777|B1||Between 18 and 65 years|Age||Participants|Count of Participants|106|106.0||||||
3666482|NCT02356588|3511775|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3666483|NCT02356588|3511776|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3666484|NCT02356588|3511777|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3666485|NCT02356562|3511810|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3666486|NCT02356562|3511811|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3666487|NCT02356562|3511812|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3666488|NCT02356562|3511810|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3666489|NCT02356562|3511811|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3666490|NCT02356562|3511812|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3666491|NCT02356562|3511810|B3|||Age||years|Mean|NA||Standard Deviation|NA||||Per protocol, data from Parts 1 and 2 were not combined for analysis.
3666492|NCT02356562|3511811|B2|||Age||years|Mean|65.3|65.3|Standard Deviation|9.60|9.6|||
3666493|NCT02356562|3511812|B1|||Age||years|Mean|58.0|58.0|Standard Deviation|6.41|6.41|||
3666494|NCT02356471|3511823|B1|United States||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3666495|NCT02356471|3511823|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3666496|NCT02356471|3511823|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666497|NCT02356471|3511823|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3666498|NCT02356471|3511823|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3666499|NCT02356471|3511823|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666500|NCT02356471|3511823|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666501|NCT02356471|3511823|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666502|NCT02356471|3511823|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666503|NCT02356471|3511823|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3666504|NCT02356471|3511823|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666505|NCT02356471|3511823|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3666506|NCT02356471|3511823|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3666507|NCT02356471|3511823|B1|||Age||years|Mean|70.99|70.99|Standard Deviation|5.28|5.28|||
3666508|NCT02356471|3511823|B1||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
3666509|NCT02356471|3511823|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3666510|NCT02356471|3511823|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3666511|NCT02356107|3511836|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666512|NCT02356107|3511836|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666513|NCT02356107|3511836|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3666514|NCT02356107|3511836|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666515|NCT02356107|3511836|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666516|NCT02356107|3511836|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666517|NCT02356107|3511836|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666518|NCT02356107|3511836|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666519|NCT02356107|3511836|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3666520|NCT02356107|3511836|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666521|NCT02356107|3511836|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3666522|NCT02356107|3511836|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3666523|NCT02356107|3511836|B1|||Age||years|Mean|34|34.0|Standard Deviation|11.6|11.6|||
3666524|NCT02356107|3511836|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3666525|NCT02356107|3511836|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3666526|NCT02356107|3511836|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3666527|NCT02355977|3511840|B4|China||Region of Enrollment||participants|Number|70|70.0||||||
3666528|NCT02355977|3511841|B3|China||Region of Enrollment||participants|Number|23|23.0||||||
3666529|NCT02355977|3511842|B2|China||Region of Enrollment||participants|Number|26|26.0||||||
3666530|NCT02355977|3511843|B1|China||Region of Enrollment||participants|Number|21|21.0||||||
3666531|NCT02355977|3511840|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666532|NCT02355977|3511841|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666533|NCT02355977|3511842|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666534|NCT02355977|3511843|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666535|NCT02355977|3511840|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3666536|NCT02355977|3511841|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3666537|NCT02355977|3511842|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3666538|NCT02355977|3511843|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3666539|NCT02355977|3511840|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666540|NCT02355977|3511841|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666541|NCT02355977|3511842|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666542|NCT02355977|3511843|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666543|NCT02355977|3511840|B4||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3666544|NCT02355977|3511841|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3666545|NCT02355977|3511842|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3666546|NCT02355977|3511843|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3666547|NCT02355977|3511840|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3666548|NCT02355977|3511841|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3666549|NCT02355977|3511842|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3666550|NCT02355977|3511843|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3666551|NCT02355977|3511840|B4|||Age||years|Mean|49|49.0|Standard Deviation|13|13.0|||
3666552|NCT02355977|3511841|B3|||Age||years|Mean|49|49.0|Standard Deviation|11|11.0|||
3666553|NCT02355977|3511842|B2|||Age||years|Mean|50|50.0|Standard Deviation|13|13.0|||
3666554|NCT02355977|3511843|B1|||Age||years|Mean|47|47.0|Standard Deviation|15|15.0|||
3666555|NCT02355977|3511840|B4||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3666556|NCT02355977|3511841|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3666557|NCT02355977|3511842|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3666558|NCT02355977|3511843|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3666559|NCT02355977|3511840|B4||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
3666560|NCT02355977|3511841|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3666561|NCT02355977|3511842|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3666562|NCT02355977|3511843|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3666563|NCT02355977|3511840|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3666564|NCT02355977|3511841|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3666565|NCT02355977|3511842|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3666566|NCT02355977|3511843|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3666567|NCT02355743|3511859|B1|||Central venous access devices in prior 6 months||central venous access devices|Median|2|2.0|Inter-Quartile Range|||1.8|3.3|
3666568|NCT02355743|3511859|B1|||Lifetime number of central venous access devices||central venous access devices|Median|6.5|6.5|Inter-Quartile Range|||3.0|14.0|
3666569|NCT02355743|3511859|B1|||Hospitalizations in prior 6 months||hospitalizations|Mean|3|3.0|Inter-Quartile Range|||1.8|4.5|
3666570|NCT02355743|3511859|B1|||Central venous access device associated infections in prior 6 months||infections|Median|2|2.0|Inter-Quartile Range|||0.8|2.5|
3666571|NCT02355743|3511859|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666572|NCT02355743|3511859|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666573|NCT02355743|3511859|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3666574|NCT02355743|3511859|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3666575|NCT02355743|3511859|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666576|NCT02355743|3511859|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3666577|NCT02355743|3511859|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666578|NCT02355743|3511859|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666579|NCT02355743|3511859|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3666580|NCT02355743|3511859|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3666581|NCT02355743|3511859|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3666582|NCT02355743|3511859|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3666583|NCT02355743|3511859|B1|||Age||years|Median|4.4|4.4|Full Range|||1.4|11.9|
3666584|NCT02355691|3511865|B3||Home|Discharge location||Participants|Count of Participants|11|11.0||||||
3666585|NCT02355691|3511866|B2||Home|Discharge location||Participants|Count of Participants|6|6.0||||||
3666586|NCT02355691|3511867|B1||Home|Discharge location||Participants|Count of Participants|5|5.0||||||
3666587|NCT02355691|3511865|B3||Skilled Nursing Facility|Discharge location||Participants|Count of Participants|5|5.0||||||
3666588|NCT02355691|3511866|B2||Skilled Nursing Facility|Discharge location||Participants|Count of Participants|3|3.0||||||
3666589|NCT02355691|3511867|B1||Skilled Nursing Facility|Discharge location||Participants|Count of Participants|2|2.0||||||
3666590|NCT02355691|3511865|B3|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3666591|NCT02355691|3511866|B2|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3666592|NCT02355691|3511867|B1|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3666593|NCT02355691|3511865|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666594|NCT02355691|3511866|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666595|NCT02355691|3511867|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666596|NCT02355691|3511865|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666597|NCT02355691|3511866|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666598|NCT02355691|3511867|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666599|NCT02355691|3511865|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3666600|NCT02355691|3511866|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3666601|NCT02355691|3511867|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3666602|NCT02355691|3511865|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3666603|NCT02355691|3511866|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3666604|NCT02355691|3511867|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3666605|NCT02355691|3511865|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666606|NCT02355691|3511866|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666607|NCT02355691|3511867|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666608|NCT02355691|3511865|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666609|NCT02355691|3511866|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666610|NCT02355691|3511867|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666611|NCT02355691|3511865|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666612|NCT02355691|3511866|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666613|NCT02355691|3511867|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666614|NCT02355691|3511865|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3666615|NCT02355691|3511866|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3666616|NCT02355691|3511867|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3666617|NCT02355691|3511865|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3666618|NCT02355691|3511866|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3666619|NCT02355691|3511867|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3666620|NCT02355691|3511865|B3|||Age||years|Mean|56.2|56.2|Full Range|||44.0|73.0|
3666621|NCT02355691|3511866|B2|||Age||years|Mean|57.6|57.6|Full Range|||44.0|73.0|
3666622|NCT02355691|3511867|B1|||Age||years|Mean|54.6|54.6|Full Range|||50.0|64.0|
3666623|NCT02355691|3511865|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3666624|NCT02355691|3511866|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3666625|NCT02355691|3511867|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3666626|NCT02355691|3511865|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3666627|NCT02355691|3511866|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3666628|NCT02355691|3511867|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3666629|NCT02355691|3511865|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3666630|NCT02355691|3511866|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3666631|NCT02355691|3511867|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3666632|NCT02355275|3511876|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3666633|NCT02355275|3511876|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3666634|NCT02355275|3511876|B1|||Age||years|Mean|41.5|41.5|Full Range|||24.0|63.0|
3666635|NCT02355158|3511881|B1|United States||Region of Enrollment||participants|Number|197|197.0||||||
3666636|NCT02355158|3511881|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666637|NCT02355158|3511881|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666638|NCT02355158|3511881|B1||White|Race (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
3666639|NCT02355158|3511881|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3666640|NCT02355158|3511881|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666641|NCT02355158|3511881|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3666642|NCT02355158|3511881|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666643|NCT02355158|3511881|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666644|NCT02355158|3511881|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|157|157.0||||||
3666645|NCT02355158|3511881|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3666646|NCT02355158|3511881|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3666647|NCT02355158|3511881|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3666648|NCT02355158|3511881|B1|||Age||years|Mean|61.1|61.1|Standard Deviation|10.9|10.9|||
3666649|NCT02355028|3511885|B3|||Choroidal Neovascularization (CNV) Size|CNV (creation of new blood vessels in the choroid layer of the eye) size as measured by FA assessment and reported in millimeters squared.|mm^2|Mean|6.9|6.9|Standard Deviation|5.33|5.33|||
3666650|NCT02355028|3511886|B2|||Choroidal Neovascularization (CNV) Size|CNV (creation of new blood vessels in the choroid layer of the eye) size as measured by FA assessment and reported in millimeters squared.|mm^2|Mean|7.7|7.7|Standard Deviation|5.72|5.72|||
3666651|NCT02355028|3511887|B1|||Choroidal Neovascularization (CNV) Size|CNV (creation of new blood vessels in the choroid layer of the eye) size as measured by FA assessment and reported in millimeters squared.|mm^2|Mean|6.0|6.0|Standard Deviation|4.79|4.79|||
3666652|NCT02355028|3511885|B3|||Total Lesion Size|The total neovascular lesion size was measured by fluorescein angiography (FA) assessment and reported in millimeters squared.|mm^2|Mean|7.0|7.0|Standard Deviation|5.31|5.31|||
3666653|NCT02355028|3511886|B2|||Total Lesion Size|The total neovascular lesion size was measured by fluorescein angiography (FA) assessment and reported in millimeters squared.|mm^2|Mean|7.8|7.8|Standard Deviation|5.74|5.74|||
3666654|NCT02355028|3511887|B1|||Total Lesion Size|The total neovascular lesion size was measured by fluorescein angiography (FA) assessment and reported in millimeters squared.|mm^2|Mean|6.1|6.1|Standard Deviation|4.73|4.73|||
3666655|NCT02355028|3511885|B3|||Pigment Epithelial Detachment – Foveal Involvement (PEDfi) Thickness|The thickness of pigment epithelial detachment involving the fovea was measured using SD-OCT and reported in micrometers.|μm|Mean|72.4|72.4|Standard Deviation|96.39|96.39|||
3666656|NCT02355028|3511886|B2|||Pigment Epithelial Detachment – Foveal Involvement (PEDfi) Thickness|The thickness of pigment epithelial detachment involving the fovea was measured using SD-OCT and reported in micrometers.|μm|Mean|82.6|82.6|Standard Deviation|100.07|100.07|||
3666657|NCT02355028|3511887|B1|||Pigment Epithelial Detachment – Foveal Involvement (PEDfi) Thickness|The thickness of pigment epithelial detachment involving the fovea was measured using SD-OCT and reported in micrometers.|μm|Mean|60.9|60.9|Standard Deviation|92.26|92.26|||
3666658|NCT02355028|3511885|B3|||Subretinal Fluid-Foveal Involvement (SRFfi) Thickness|The thickness of subretinal fluid involving the fovea was measured using SD-OCT and reported in micrometers.|μm|Mean|32.4|32.4|Standard Deviation|54.87|54.87|||
3666659|NCT02355028|3511886|B2|||Subretinal Fluid-Foveal Involvement (SRFfi) Thickness|The thickness of subretinal fluid involving the fovea was measured using SD-OCT and reported in micrometers.|μm|Mean|25.0|25.0|Standard Deviation|50.76|50.76|||
3666660|NCT02355028|3511887|B1|||Subretinal Fluid-Foveal Involvement (SRFfi) Thickness|The thickness of subretinal fluid involving the fovea was measured using SD-OCT and reported in micrometers.|μm|Mean|40.7|40.7|Standard Deviation|58.81|58.81|||
3666661|NCT02355028|3511885|B3|||Lesion Thickness|The thickness of the neovascular lesion was measured using SD-OCT and reported in micrometers.|μm|Mean|33.8|33.8|Standard Deviation|72.99|72.99|||
3666662|NCT02355028|3511886|B2|||Lesion Thickness|The thickness of the neovascular lesion was measured using SD-OCT and reported in micrometers.|μm|Mean|45.8|45.8|Standard Deviation|92.83|92.83|||
3666663|NCT02355028|3511887|B1|||Lesion Thickness|The thickness of the neovascular lesion was measured using SD-OCT and reported in micrometers.|μm|Mean|20.3|20.3|Standard Deviation|37.90|37.9|||
3666664|NCT02355028|3511885|B3|||Central Subfield Thickness Neuro-Retina (CSFTnr)|The thickness of the neuro-retina, at the level of the central subfield, was measured using SD-OCT and reported in micrometers.|μm|Mean|240.5|240.5|Standard Deviation|64.17|64.17|||
3666665|NCT02355028|3511886|B2|||Central Subfield Thickness Neuro-Retina (CSFTnr)|The thickness of the neuro-retina, at the level of the central subfield, was measured using SD-OCT and reported in micrometers.|μm|Mean|239.0|239.0|Standard Deviation|75.87|75.87|||
3666666|NCT02355028|3511887|B1|||Central Subfield Thickness Neuro-Retina (CSFTnr)|The thickness of the neuro-retina, at the level of the central subfield, was measured using SD-OCT and reported in micrometers.|μm|Mean|242.2|242.2|Standard Deviation|48.95|48.95|||
3666667|NCT02355028|3511885|B3|||Best-corrected visual acuity (BCVA)|Measurement of best corrected (with spectacles or other visual corrective devices) visual acuity was conducted in each eye individually using Early Treatment Diabetic Retinopathy Study (ETDRS) charts and reported in number of letters read correctly.|letters|Mean|70.9|70.9|Standard Deviation|9.09|9.09|||
3666668|NCT02355028|3511886|B2|||Best-corrected visual acuity (BCVA)|Measurement of best corrected (with spectacles or other visual corrective devices) visual acuity was conducted in each eye individually using Early Treatment Diabetic Retinopathy Study (ETDRS) charts and reported in number of letters read correctly.|letters|Mean|70.5|70.5|Standard Deviation|8.87|8.87|||
3666669|NCT02355028|3511887|B1|||Best-corrected visual acuity (BCVA)|Measurement of best corrected (with spectacles or other visual corrective devices) visual acuity was conducted in each eye individually using Early Treatment Diabetic Retinopathy Study (ETDRS) charts and reported in number of letters read correctly.|letters|Mean|71.2|71.2|Standard Deviation|9.45|9.45|||
3666670|NCT02355028|3511885|B3|||Central Subfield Thickness Total (CSFTtot)|The thickness of the retina was measured using spectral domain-optical coherence tomography (SD-OCT) and reported in micrometers.|μm|Mean|363.4|363.4|Standard Deviation|112.29|112.29|||
3666671|NCT02355028|3511886|B2|||Central Subfield Thickness Total (CSFTtot)|The thickness of the retina was measured using spectral domain-optical coherence tomography (SD-OCT) and reported in micrometers.|μm|Mean|374.9|374.9|Standard Deviation|116.98|116.98|||
3666672|NCT02355028|3511887|B1|||Central Subfield Thickness Total (CSFTtot)|The thickness of the retina was measured using spectral domain-optical coherence tomography (SD-OCT) and reported in micrometers.|μm|Mean|350.5|350.5|Standard Deviation|107.09|107.09|||
3666673|NCT02355028|3511885|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3666674|NCT02355028|3511886|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3666675|NCT02355028|3511887|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3666676|NCT02355028|3511885|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3666677|NCT02355028|3511886|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3666678|NCT02355028|3511887|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3666679|NCT02355028|3511885|B3|||Age||years|Mean|77.1|77.1|Standard Deviation|7.80|7.8|||
3666680|NCT02355028|3511886|B2|||Age||years|Mean|76.8|76.8|Standard Deviation|7.94|7.94|||
3666681|NCT02355028|3511887|B1|||Age||years|Mean|77.3|77.3|Standard Deviation|7.74|7.74|||
3666682|NCT02354976|3511921|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|75|75.0||||||
3666683|NCT02354976|3511922|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3666684|NCT02354976|3511923|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3666685|NCT02354976|3511924|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3666686|NCT02354976|3511921|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3666687|NCT02354976|3511922|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3666688|NCT02354976|3511923|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3666689|NCT02354976|3511924|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3666690|NCT02354976|3511921|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3666691|NCT02354976|3511922|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3666692|NCT02354976|3511923|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3666693|NCT02354976|3511924|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3666694|NCT02354976|3511921|B4||Male|Sex/Gender, Customized||Participants|Count of Participants|45|45.0||||||
3666695|NCT02354976|3511922|B3||Male|Sex/Gender, Customized||Participants|Count of Participants|14|14.0||||||
3666696|NCT02354976|3511923|B2||Male|Sex/Gender, Customized||Participants|Count of Participants|15|15.0||||||
3666697|NCT02354976|3511924|B1||Male|Sex/Gender, Customized||Participants|Count of Participants|16|16.0||||||
3666698|NCT02354976|3511921|B4||Female|Sex/Gender, Customized||Participants|Count of Participants|33|33.0||||||
3666699|NCT02354976|3511922|B3||Female|Sex/Gender, Customized||Participants|Count of Participants|12|12.0||||||
3666700|NCT02354976|3511923|B2||Female|Sex/Gender, Customized||Participants|Count of Participants|12|12.0||||||
3666701|NCT02354976|3511924|B1||Female|Sex/Gender, Customized||Participants|Count of Participants|9|9.0||||||
3666702|NCT02354976|3511921|B4|>=65||Age, Customized||Participants|Count of Participants|26|26.0||||||
3666703|NCT02354976|3511922|B3|>=65||Age, Customized||Participants|Count of Participants|10|10.0||||||
3666704|NCT02354976|3511923|B2|>=65||Age, Customized||Participants|Count of Participants|10|10.0||||||
3666705|NCT02354976|3511924|B1|>=65||Age, Customized||Participants|Count of Participants|6|6.0||||||
3666706|NCT02354976|3511921|B4|>=50 - <65||Age, Customized||Participants|Count of Participants|45|45.0||||||
3666707|NCT02354976|3511922|B3|>=50 - <65||Age, Customized||Participants|Count of Participants|15|15.0||||||
3666708|NCT02354976|3511923|B2|>=50 - <65||Age, Customized||Participants|Count of Participants|14|14.0||||||
3666709|NCT02354976|3511924|B1|>=50 - <65||Age, Customized||Participants|Count of Participants|16|16.0||||||
3666710|NCT02354976|3511921|B4|<50||Age, Customized||Participants|Count of Participants|7|7.0||||||
3666711|NCT02354976|3511922|B3|<50||Age, Customized||Participants|Count of Participants|1|1.0||||||
3666712|NCT02354976|3511923|B2|<50||Age, Customized||Participants|Count of Participants|3|3.0||||||
3666713|NCT02354976|3511924|B1|<50||Age, Customized||Participants|Count of Participants|3|3.0||||||
3666714|NCT02354976|3511921|B4|||Age||Years|Mean|60.8|60.8|Standard Deviation|7.73|7.73|44.0|74.0|
3666715|NCT02354976|3511922|B3|||Age||Years|Mean|60.8|60.8|Standard Deviation|7.85|7.85|45.0|72.0|
3666716|NCT02354976|3511923|B2|||Age||Years|Mean|61.7|61.7|Standard Deviation|7.78|7.78|46.0|74.0|
3666717|NCT02354976|3511924|B1|||Age||Years|Mean|60.0|60.0|Standard Deviation|7.79|7.79|44.0|74.0|
3666718|NCT02354924|3511935|B3|Taiwan||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3666719|NCT02354924|3511936|B2|Taiwan||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3666720|NCT02354924|3511937|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3666721|NCT02354924|3511935|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3666722|NCT02354924|3511936|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3666723|NCT02354924|3511937|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3666724|NCT02354924|3511935|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3666725|NCT02354924|3511936|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3666726|NCT02354924|3511937|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3666727|NCT02354924|3511935|B3|||Age||years|Mean|34.87|34.87|Standard Deviation|6.13|6.13|||
3666728|NCT02354924|3511936|B2|||Age||years|Mean|36.30|36.3|Standard Deviation|5.53|5.53|||
3666729|NCT02354924|3511937|B1|||Age||years|Mean|34.15|34.15|Standard Deviation|6.44|6.44|||
3666730|NCT02354924|3511935|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3666731|NCT02354924|3511936|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3666732|NCT02354924|3511937|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3666733|NCT02354924|3511935|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3666734|NCT02354924|3511936|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3666735|NCT02354924|3511937|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3666736|NCT02354924|3511935|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3666737|NCT02354924|3511936|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3666738|NCT02354924|3511937|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3666739|NCT02354833|3511948|B3|United States||Region of Enrollment||participants|Number|81|81.0||||||
3666740|NCT02354833|3511949|B2|United States||Region of Enrollment||participants|Number|43|43.0||||||
3666741|NCT02354833|3511950|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
3666742|NCT02354833|3511948|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3666743|NCT02354833|3511949|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3666744|NCT02354833|3511950|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3666745|NCT02354833|3511948|B3||Female|Gender||Participants|Count of Participants|81|81.0||||||
3666746|NCT02354833|3511949|B2||Female|Gender||Participants|Count of Participants|43|43.0||||||
3666747|NCT02354833|3511950|B1||Female|Gender||Participants|Count of Participants|38|38.0||||||
3666748|NCT02354833|3511948|B3|||Age||years|Mean|30.15|30.15|Standard Deviation|6.2|6.2|||
3666749|NCT02354833|3511949|B2|||Age||years|Mean|31.2|31.2|Standard Deviation|6.8|6.8|||
3666750|NCT02354833|3511950|B1|||Age||years|Mean|29.1|29.1|Standard Deviation|5.6|5.6|||
3666751|NCT02354833|3511948|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3666752|NCT02354833|3511949|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3666753|NCT02354833|3511950|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3666754|NCT02354833|3511948|B3||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
3666755|NCT02354833|3511949|B2||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
3666756|NCT02354833|3511950|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3666757|NCT02354833|3511948|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3666758|NCT02354833|3511949|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3666759|NCT02354833|3511950|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3666760|NCT02354599|3511963|B7|Had no caffeine consumption||Caffeine Classification||participants|Number|19|19.0||||||
3666761|NCT02354599|3511964|B6|Had no caffeine consumption||Caffeine Classification||participants|Number|3|3.0||||||
3666762|NCT02354599|3511965|B5|Had no caffeine consumption||Caffeine Classification||participants|Number|0|0.0||||||
3666763|NCT02354599|3511966|B4|Had no caffeine consumption||Caffeine Classification||participants|Number|4|4.0||||||
3666764|NCT02354599|3511967|B3|Had no caffeine consumption||Caffeine Classification||participants|Number|5|5.0||||||
3666765|NCT02354599|3511968|B2|Had no caffeine consumption||Caffeine Classification||participants|Number|3|3.0||||||
3666766|NCT02354599|3511969|B1|Had no caffeine consumption||Caffeine Classification||participants|Number|4|4.0||||||
3666767|NCT02354599|3511963|B7|Had caffeine consumption||Caffeine Classification||participants|Number|13|13.0||||||
3666768|NCT02354599|3511964|B6|Had caffeine consumption||Caffeine Classification||participants|Number|3|3.0||||||
3666769|NCT02354599|3511965|B5|Had caffeine consumption||Caffeine Classification||participants|Number|2|2.0||||||
3666770|NCT02354599|3511966|B4|Had caffeine consumption||Caffeine Classification||participants|Number|2|2.0||||||
3666771|NCT02354599|3511967|B3|Had caffeine consumption||Caffeine Classification||participants|Number|1|1.0||||||
3666772|NCT02354599|3511968|B2|Had caffeine consumption||Caffeine Classification||participants|Number|3|3.0||||||
3666773|NCT02354599|3511969|B1|Had caffeine consumption||Caffeine Classification||participants|Number|2|2.0||||||
3666774|NCT02354599|3511963|B7|Never drank||Alcohol Classification||participants|Number|14|14.0||||||
3666775|NCT02354599|3511964|B6|Never drank||Alcohol Classification||participants|Number|2|2.0||||||
3666776|NCT02354599|3511965|B5|Never drank||Alcohol Classification||participants|Number|0|0.0||||||
3666777|NCT02354599|3511966|B4|Never drank||Alcohol Classification||participants|Number|2|2.0||||||
3666778|NCT02354599|3511967|B3|Never drank||Alcohol Classification||participants|Number|2|2.0||||||
3666779|NCT02354599|3511968|B2|Never drank||Alcohol Classification||participants|Number|4|4.0||||||
3666780|NCT02354599|3511969|B1|Never drank||Alcohol Classification||participants|Number|4|4.0||||||
3666781|NCT02354599|3511963|B7|Drank a few days per month||Alcohol Classification||participants|Number|12|12.0||||||
3666782|NCT02354599|3511964|B6|Drank a few days per month||Alcohol Classification||participants|Number|2|2.0||||||
3666783|NCT02354599|3511965|B5|Drank a few days per month||Alcohol Classification||participants|Number|2|2.0||||||
3666784|NCT02354599|3511966|B4|Drank a few days per month||Alcohol Classification||participants|Number|3|3.0||||||
3666785|NCT02354599|3511967|B3|Drank a few days per month||Alcohol Classification||participants|Number|3|3.0||||||
3666786|NCT02354599|3511968|B2|Drank a few days per month||Alcohol Classification||participants|Number|2|2.0||||||
3666787|NCT02354599|3511969|B1|Drank a few days per month||Alcohol Classification||participants|Number|0|0.0||||||
3666788|NCT02354599|3511963|B7|Drank a few days per week||Alcohol Classification||participants|Number|6|6.0||||||
3666789|NCT02354599|3511964|B6|Drank a few days per week||Alcohol Classification||participants|Number|2|2.0||||||
3666790|NCT02354599|3511965|B5|Drank a few days per week||Alcohol Classification||participants|Number|0|0.0||||||
3666791|NCT02354599|3511966|B4|Drank a few days per week||Alcohol Classification||participants|Number|1|1.0||||||
3666792|NCT02354599|3511967|B3|Drank a few days per week||Alcohol Classification||participants|Number|1|1.0||||||
3666793|NCT02354599|3511968|B2|Drank a few days per week||Alcohol Classification||participants|Number|0|0.0||||||
3666794|NCT02354599|3511969|B1|Drank a few days per week||Alcohol Classification||participants|Number|2|2.0||||||
3666795|NCT02354599|3511963|B7|Ex-smoker||Smoking Classification||participants|Number|11|11.0||||||
3666796|NCT02354599|3511964|B6|Ex-smoker||Smoking Classification||participants|Number|1|1.0||||||
3666797|NCT02354599|3511965|B5|Ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3666798|NCT02354599|3511966|B4|Ex-smoker||Smoking Classification||participants|Number|4|4.0||||||
3666799|NCT02354599|3511967|B3|Ex-smoker||Smoking Classification||participants|Number|1|1.0||||||
3666800|NCT02354599|3511968|B2|Ex-smoker||Smoking Classification||participants|Number|3|3.0||||||
3666801|NCT02354599|3511969|B1|Ex-smoker||Smoking Classification||participants|Number|2|2.0||||||
3666802|NCT02354599|3511963|B7|Never Smoked||Smoking Classification||participants|Number|21|21.0||||||
3666803|NCT02354599|3511964|B6|Never Smoked||Smoking Classification||participants|Number|5|5.0||||||
3666804|NCT02354599|3511965|B5|Never Smoked||Smoking Classification||participants|Number|2|2.0||||||
3666805|NCT02354599|3511966|B4|Never Smoked||Smoking Classification||participants|Number|2|2.0||||||
3666806|NCT02354599|3511967|B3|Never Smoked||Smoking Classification||participants|Number|5|5.0||||||
3666807|NCT02354599|3511968|B2|Never Smoked||Smoking Classification||participants|Number|3|3.0||||||
3666808|NCT02354599|3511969|B1|Never Smoked||Smoking Classification||participants|Number|4|4.0||||||
3666809|NCT02354599|3511963|B7|Male||Sex/Gender, Customized||participants|Number|32|32.0||||||
3666810|NCT02354599|3511964|B6|Male||Sex/Gender, Customized||participants|Number|6|6.0||||||
3666811|NCT02354599|3511965|B5|Male||Sex/Gender, Customized||participants|Number|2|2.0||||||
3666812|NCT02354599|3511966|B4|Male||Sex/Gender, Customized||participants|Number|6|6.0||||||
3666813|NCT02354599|3511967|B3|Male||Sex/Gender, Customized||participants|Number|6|6.0||||||
3666814|NCT02354599|3511968|B2|Male||Sex/Gender, Customized||participants|Number|6|6.0||||||
3666815|NCT02354599|3511969|B1|Male||Sex/Gender, Customized||participants|Number|6|6.0||||||
3666816|NCT02354599|3511963|B7|||Age||years|Mean|28.2|28.2|Standard Deviation|7.56|7.56|||
3666817|NCT02354599|3511964|B6|||Age||years|Mean|36.0|36.0|Standard Deviation|6.29|6.29|||
3666818|NCT02354599|3511965|B5|||Age||years|Mean|28.0|28.0|Standard Deviation|7.07|7.07|||
3666819|NCT02354599|3511966|B4|||Age||years|Mean|24.2|24.2|Standard Deviation|6.85|6.85|||
3666820|NCT02354599|3511967|B3|||Age||years|Mean|26.5|26.5|Standard Deviation|7.79|7.79|||
3666821|NCT02354599|3511968|B2|||Age||years|Mean|26.0|26.0|Standard Deviation|4.05|4.05|||
3666822|NCT02354599|3511969|B1|||Age||years|Mean|28.2|28.2|Standard Deviation|8.89|8.89|||
3666823|NCT02354443|3512044|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3666824|NCT02354443|3512044|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666825|NCT02354443|3512044|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666826|NCT02354443|3512044|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3666827|NCT02354443|3512044|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666828|NCT02354443|3512044|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666829|NCT02354443|3512044|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666830|NCT02354443|3512044|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666831|NCT02354443|3512044|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666832|NCT02354443|3512044|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3666833|NCT02354443|3512044|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666834|NCT02354443|3512044|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3666835|NCT02354443|3512044|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3666836|NCT02354443|3512044|B1|||Age||Years|Mean|1.0|1.0|Standard Deviation|||||
3666837|NCT02354417|3512048|B1|||Weight (kg)||kg|Mean|73.4|73.4|Standard Deviation|28.8|28.8|||
3666838|NCT02354417|3512048|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3666839|NCT02354417|3512048|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3666840|NCT02354417|3512048|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666841|NCT02354417|3512048|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3666842|NCT02354417|3512048|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3666843|NCT02354417|3512048|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666844|NCT02354417|3512048|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666845|NCT02354417|3512048|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666846|NCT02354417|3512048|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666847|NCT02354417|3512048|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3666848|NCT02354417|3512048|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3666849|NCT02354417|3512048|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3666850|NCT02354417|3512048|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3666851|NCT02354417|3512048|B1|||Age||Years|Mean|15.7|15.7|Standard Deviation|3.2|3.2|||
3666852|NCT02354235|3512052|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3666853|NCT02354235|3512053|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3666854|NCT02354235|3512054|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3666855|NCT02354235|3512052|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3666856|NCT02354235|3512053|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3666857|NCT02354235|3512054|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3666858|NCT02354235|3512052|B3||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
3666859|NCT02354235|3512053|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3666860|NCT02354235|3512054|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3666861|NCT02354235|3512052|B3||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
3666862|NCT02354235|3512053|B2||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3666863|NCT02354235|3512054|B1||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
3666864|NCT02354235|3512052|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3666865|NCT02354235|3512053|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3666866|NCT02354235|3512054|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3666867|NCT02354222|3512069|B3||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3666868|NCT02354222|3512070|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3666869|NCT02354222|3512071|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3666870|NCT02354222|3512069|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3666871|NCT02354222|3512070|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3666872|NCT02354222|3512071|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3666873|NCT02354222|3512069|B3||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
3666874|NCT02354222|3512070|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3666875|NCT02354222|3512071|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3666876|NCT02354222|3512069|B3||Between 18 and 65 years|Age||Participants|Count of Participants|127|127.0||||||
3666877|NCT02354222|3512070|B2||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
3666878|NCT02354222|3512071|B1||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
3666879|NCT02354222|3512069|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3666880|NCT02354222|3512070|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3666881|NCT02354222|3512071|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3666882|NCT02353871|3512086|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3666883|NCT02353871|3512087|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3666884|NCT02353871|3512088|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3666885|NCT02353871|3512086|B3|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3666886|NCT02353871|3512087|B2|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3666887|NCT02353871|3512088|B1|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3666888|NCT02353871|3512086|B3|Caucasian/White||Race/Ethnicity, Customized||Participants|Count of Participants|183|183.0||||||
3666889|NCT02353871|3512087|B2|Caucasian/White||Race/Ethnicity, Customized||Participants|Count of Participants|59|59.0||||||
3666890|NCT02353871|3512088|B1|Caucasian/White||Race/Ethnicity, Customized||Participants|Count of Participants|124|124.0||||||
3666891|NCT02353871|3512086|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666892|NCT02353871|3512087|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666893|NCT02353871|3512088|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666894|NCT02353871|3512086|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|185|185.0||||||
3666895|NCT02353871|3512087|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3666896|NCT02353871|3512088|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
3666897|NCT02353871|3512086|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666898|NCT02353871|3512087|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666899|NCT02353871|3512088|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666900|NCT02353871|3512086|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3666901|NCT02353871|3512087|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3666902|NCT02353871|3512088|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3666903|NCT02353871|3512086|B3||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3666904|NCT02353871|3512087|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3666905|NCT02353871|3512088|B1||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3666906|NCT02353871|3512086|B3|||Age||Years|Mean|47.8|47.8|Standard Deviation|9.52|9.52|||
3666907|NCT02353871|3512087|B2|||Age||Years|Mean|48.0|48.0|Standard Deviation|9.09|9.09|||
3666908|NCT02353871|3512088|B1|||Age||Years|Mean|47.7|47.7|Standard Deviation|9.75|9.75|||
3666909|NCT02353754|3512109|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3666910|NCT02353754|3512111|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3666911|NCT02353754|3512109|B3|Male||Sex/Gender, Customized||participants|Number|0|0.0||||||
3666912|NCT02353754|3512111|B1|Male||Sex/Gender, Customized||participants|Number|0|0.0||||||
3666913|NCT02353754|3512109|B3|Female||Sex/Gender, Customized||participants|Number|12|12.0||||||
3666914|NCT02353754|3512111|B1|Female||Sex/Gender, Customized||participants|Number|12|12.0||||||
3666915|NCT02353754|3512109|B3|||Age||years|Mean|32.2|32.2|Standard Deviation|4.71|4.71|||
3666916|NCT02353754|3512111|B1|||Age||years|Mean|32.2|32.2|Standard Deviation|4.71|4.71|||
3666917|NCT02353754|3512109|B3|>=65 years||Age||participants|Number|0|0.0||||||
3666918|NCT02353754|3512111|B1|>=65 years||Age||participants|Number|0|0.0||||||
3666919|NCT02353754|3512109|B3|Between 18 and 65 years||Age||participants|Number|12|12.0||||||
3666920|NCT02353754|3512111|B1|Between 18 and 65 years||Age||participants|Number|12|12.0||||||
3666921|NCT02353754|3512109|B3|<=18 years||Age||participants|Number|0|0.0||||||
3666922|NCT02353754|3512111|B1|<=18 years||Age||participants|Number|0|0.0||||||
3666923|NCT02353572|3512122|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3666924|NCT02353572|3512122|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666925|NCT02353572|3512122|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666926|NCT02353572|3512122|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3666927|NCT02353572|3512122|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3666928|NCT02353572|3512122|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666929|NCT02353572|3512122|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666930|NCT02353572|3512122|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666931|NCT02353572|3512122|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3666932|NCT02353572|3512122|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3666933|NCT02353572|3512122|B1|||Age||Years|Mean|62.3|62.3|Standard Deviation|5.0|5.0|||
3666934|NCT02353572|3512122|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3666935|NCT02353572|3512122|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3666936|NCT02353572|3512122|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3666937|NCT02353468|3512126|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3666938|NCT02353468|3512126|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666939|NCT02353468|3512126|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666940|NCT02353468|3512126|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666941|NCT02353468|3512126|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3666942|NCT02353468|3512126|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666943|NCT02353468|3512126|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666944|NCT02353468|3512126|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666945|NCT02353468|3512126|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3666946|NCT02353468|3512126|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3666947|NCT02353468|3512126|B1|||Age||Years|Mean|54.3|54.3|Standard Deviation|3.8|3.8|||
3666948|NCT02353468|3512126|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3666949|NCT02353468|3512126|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3666950|NCT02353468|3512126|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3666951|NCT02353442|3512130|B3|Brazil||Region of Enrollment||participants|Number|59|59.0||||||
3666952|NCT02353442|3512131|B2|Brazil||Region of Enrollment||participants|Number|31|31.0||||||
3666953|NCT02353442|3512132|B1|Brazil||Region of Enrollment||participants|Number|28|28.0||||||
3666954|NCT02353442|3512130|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3666955|NCT02353442|3512131|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3666956|NCT02353442|3512132|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3666957|NCT02353442|3512130|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3666958|NCT02353442|3512131|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3666959|NCT02353442|3512132|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3666960|NCT02353442|3512130|B3|||Age||years|Mean|40.63|40.63|Standard Deviation|12.46|12.46|||
3666961|NCT02353442|3512131|B2|||Age||years|Mean|41.18|41.18|Standard Deviation|12.84|12.84|||
3666962|NCT02353442|3512132|B1|||Age||years|Mean|40.08|40.08|Standard Deviation|12.08|12.08|||
3666963|NCT02353442|3512130|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3666964|NCT02353442|3512131|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3666965|NCT02353442|3512132|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3666966|NCT02353442|3512130|B3||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
3666967|NCT02353442|3512131|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3666968|NCT02353442|3512132|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3666969|NCT02353442|3512130|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3666970|NCT02353442|3512131|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3666971|NCT02353442|3512132|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3666972|NCT02353299|3512147|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
3666973|NCT02353299|3512147|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3666974|NCT02353299|3512147|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666975|NCT02353299|3512147|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3666976|NCT02353299|3512147|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3666977|NCT02353299|3512147|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666978|NCT02353299|3512147|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3666979|NCT02353299|3512147|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666980|NCT02353299|3512147|B1|male||Sex/Gender, Customized||Participants|Count of Participants|52|52.0||||||
3666981|NCT02353299|3512147|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3666982|NCT02353299|3512147|B1||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3666983|NCT02353299|3512147|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3666984|NCT02352844|3512184|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3666985|NCT02352844|3512184|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3666986|NCT02352844|3512184|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666987|NCT02352844|3512184|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3666988|NCT02352844|3512184|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666989|NCT02352844|3512184|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666990|NCT02352844|3512184|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666991|NCT02352844|3512184|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666992|NCT02352844|3512184|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666993|NCT02352844|3512184|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3666994|NCT02352844|3512184|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3666995|NCT02352844|3512184|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3666996|NCT02352844|3512184|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3666997|NCT02352844|3512184|B1|||Age||years|Median|65|65.0|Full Range|||40.0|86.0|
3666998|NCT02352831|3512190|B3|||Baseline CA19-9||U/mL|Mean|1255|1255.0|Full Range|||1.0|8803.0|
3666999|NCT02352831|3512191|B2|||Baseline CA19-9||U/mL|Mean|2061.73|2061.73|Full Range|||19.7|8803.0|
3667000|NCT02352831|3512192|B1|||Baseline CA19-9||U/mL|Mean|331.22|331.22|Full Range|||1.0|1697.9|
3667001|NCT02352831|3512190|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
3667002|NCT02352831|3512191|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3667003|NCT02352831|3512192|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3667004|NCT02352831|3512190|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667005|NCT02352831|3512191|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667006|NCT02352831|3512192|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667007|NCT02352831|3512190|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667008|NCT02352831|3512191|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667009|NCT02352831|3512192|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667010|NCT02352831|3512190|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3667011|NCT02352831|3512191|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3667012|NCT02352831|3512192|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3667013|NCT02352831|3512190|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3667014|NCT02352831|3512191|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3667015|NCT02352831|3512192|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667016|NCT02352831|3512190|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667017|NCT02352831|3512191|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667018|NCT02352831|3512192|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667019|NCT02352831|3512190|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667020|NCT02352831|3512191|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667021|NCT02352831|3512192|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667022|NCT02352831|3512190|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667023|NCT02352831|3512191|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667024|NCT02352831|3512192|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667025|NCT02352831|3512190|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667026|NCT02352831|3512191|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667027|NCT02352831|3512192|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667028|NCT02352831|3512190|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3667029|NCT02352831|3512191|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3667030|NCT02352831|3512192|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3667031|NCT02352831|3512190|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667032|NCT02352831|3512191|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667033|NCT02352831|3512192|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667034|NCT02352831|3512190|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3667035|NCT02352831|3512191|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3667036|NCT02352831|3512192|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3667037|NCT02352831|3512190|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3667038|NCT02352831|3512191|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3667039|NCT02352831|3512192|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3667040|NCT02352831|3512190|B3|||Age||years|Median|66|66.0|Full Range|||42.0|76.0|
3667041|NCT02352831|3512191|B2|||Age||years|Median|69.5|69.5|Full Range|||51.0|76.0|
3667042|NCT02352831|3512192|B1|||Age||years|Median|60.5|60.5|Full Range|||42.0|73.0|
3667043|NCT02352779|3512210|B4||No|Previous Treatment - Hormone Therapy||Participants|Count of Participants|80|80.0||||||
3667044|NCT02352779|3512211|B3||No|Previous Treatment - Hormone Therapy||Participants|Count of Participants|24|24.0||||||
3667045|NCT02352779|3512212|B2||No|Previous Treatment - Hormone Therapy||Participants|Count of Participants|29|29.0||||||
3667046|NCT02352779|3512213|B1||No|Previous Treatment - Hormone Therapy||Participants|Count of Participants|27|27.0||||||
3667047|NCT02352779|3512210|B4||Yes|Previous Treatment - Hormone Therapy||Participants|Count of Participants|17|17.0||||||
3667048|NCT02352779|3512211|B3||Yes|Previous Treatment - Hormone Therapy||Participants|Count of Participants|9|9.0||||||
3667049|NCT02352779|3512212|B2||Yes|Previous Treatment - Hormone Therapy||Participants|Count of Participants|6|6.0||||||
3667050|NCT02352779|3512213|B1||Yes|Previous Treatment - Hormone Therapy||Participants|Count of Participants|2|2.0||||||
3667051|NCT02352779|3512210|B4||No|Previous Treatment - Radiation||Participants|Count of Participants|25|25.0||||||
3667052|NCT02352779|3512211|B3||No|Previous Treatment - Radiation||Participants|Count of Participants|8|8.0||||||
3667053|NCT02352779|3512212|B2||No|Previous Treatment - Radiation||Participants|Count of Participants|7|7.0||||||
3667054|NCT02352779|3512213|B1||No|Previous Treatment - Radiation||Participants|Count of Participants|10|10.0||||||
3667055|NCT02352779|3512210|B4||Yes|Previous Treatment - Radiation||Participants|Count of Participants|72|72.0||||||
3667056|NCT02352779|3512211|B3||Yes|Previous Treatment - Radiation||Participants|Count of Participants|25|25.0||||||
3667057|NCT02352779|3512212|B2||Yes|Previous Treatment - Radiation||Participants|Count of Participants|28|28.0||||||
3667058|NCT02352779|3512213|B1||Yes|Previous Treatment - Radiation||Participants|Count of Participants|19|19.0||||||
3667059|NCT02352779|3512210|B4||No|Previous Treatment - Chemotherapy||Participants|Count of Participants|48|48.0||||||
3667060|NCT02352779|3512211|B3||No|Previous Treatment - Chemotherapy||Participants|Count of Participants|16|16.0||||||
3667061|NCT02352779|3512212|B2||No|Previous Treatment - Chemotherapy||Participants|Count of Participants|16|16.0||||||
3667062|NCT02352779|3512213|B1||No|Previous Treatment - Chemotherapy||Participants|Count of Participants|16|16.0||||||
3667063|NCT02352779|3512210|B4||Yes|Previous Treatment - Chemotherapy||Participants|Count of Participants|49|49.0||||||
3667064|NCT02352779|3512211|B3||Yes|Previous Treatment - Chemotherapy||Participants|Count of Participants|17|17.0||||||
3667065|NCT02352779|3512212|B2||Yes|Previous Treatment - Chemotherapy||Participants|Count of Participants|19|19.0||||||
3667066|NCT02352779|3512213|B1||Yes|Previous Treatment - Chemotherapy||Participants|Count of Participants|13|13.0||||||
3667067|NCT02352779|3512210|B4||No|Previous Treatment - Surgery||Participants|Count of Participants|3|3.0||||||
3667068|NCT02352779|3512211|B3||No|Previous Treatment - Surgery||Participants|Count of Participants|0|0.0||||||
3667069|NCT02352779|3512212|B2||No|Previous Treatment - Surgery||Participants|Count of Participants|2|2.0||||||
3667070|NCT02352779|3512213|B1||No|Previous Treatment - Surgery||Participants|Count of Participants|1|1.0||||||
3667071|NCT02352779|3512210|B4||Yes|Previous Treatment - Surgery||Participants|Count of Participants|94|94.0||||||
3667072|NCT02352779|3512211|B3||Yes|Previous Treatment - Surgery||Participants|Count of Participants|33|33.0||||||
3667073|NCT02352779|3512212|B2||Yes|Previous Treatment - Surgery||Participants|Count of Participants|33|33.0||||||
3667074|NCT02352779|3512213|B1||Yes|Previous Treatment - Surgery||Participants|Count of Participants|28|28.0||||||
3667075|NCT02352779|3512210|B4||Unemployed|Employment Status (Current)||Participants|Count of Participants|26|26.0||||||
3667076|NCT02352779|3512211|B3||Unemployed|Employment Status (Current)||Participants|Count of Participants|11|11.0||||||
3667077|NCT02352779|3512212|B2||Unemployed|Employment Status (Current)||Participants|Count of Participants|11|11.0||||||
3667078|NCT02352779|3512213|B1||Unemployed|Employment Status (Current)||Participants|Count of Participants|4|4.0||||||
3667079|NCT02352779|3512210|B4||Home Maker|Employment Status (Current)||Participants|Count of Participants|18|18.0||||||
3667080|NCT02352779|3512211|B3||Home Maker|Employment Status (Current)||Participants|Count of Participants|9|9.0||||||
3667081|NCT02352779|3512212|B2||Home Maker|Employment Status (Current)||Participants|Count of Participants|3|3.0||||||
3667082|NCT02352779|3512213|B1||Home Maker|Employment Status (Current)||Participants|Count of Participants|6|6.0||||||
3667083|NCT02352779|3512210|B4||Self Employed|Employment Status (Current)||Participants|Count of Participants|6|6.0||||||
3667084|NCT02352779|3512211|B3||Self Employed|Employment Status (Current)||Participants|Count of Participants|0|0.0||||||
3667085|NCT02352779|3512212|B2||Self Employed|Employment Status (Current)||Participants|Count of Participants|3|3.0||||||
3667086|NCT02352779|3512213|B1||Self Employed|Employment Status (Current)||Participants|Count of Participants|3|3.0||||||
3667087|NCT02352779|3512210|B4||Employment outside the house|Employment Status (Current)||Participants|Count of Participants|47|47.0||||||
3667088|NCT02352779|3512211|B3||Employment outside the house|Employment Status (Current)||Participants|Count of Participants|13|13.0||||||
3667089|NCT02352779|3512212|B2||Employment outside the house|Employment Status (Current)||Participants|Count of Participants|18|18.0||||||
3667090|NCT02352779|3512213|B1||Employment outside the house|Employment Status (Current)||Participants|Count of Participants|16|16.0||||||
3667091|NCT02352779|3512210|B4||Widowed|Marital Status||Participants|Count of Participants|10|10.0||||||
3667092|NCT02352779|3512211|B3||Widowed|Marital Status||Participants|Count of Participants|3|3.0||||||
3667093|NCT02352779|3512212|B2||Widowed|Marital Status||Participants|Count of Participants|4|4.0||||||
3667094|NCT02352779|3512213|B1||Widowed|Marital Status||Participants|Count of Participants|3|3.0||||||
3667095|NCT02352779|3512210|B4||Single|Marital Status||Participants|Count of Participants|9|9.0||||||
3667096|NCT02352779|3512211|B3||Single|Marital Status||Participants|Count of Participants|2|2.0||||||
3667097|NCT02352779|3512212|B2||Single|Marital Status||Participants|Count of Participants|4|4.0||||||
3667098|NCT02352779|3512213|B1||Single|Marital Status||Participants|Count of Participants|3|3.0||||||
3667099|NCT02352779|3512210|B4||Divorced|Marital Status||Participants|Count of Participants|12|12.0||||||
3667100|NCT02352779|3512211|B3||Divorced|Marital Status||Participants|Count of Participants|0|0.0||||||
3667101|NCT02352779|3512212|B2||Divorced|Marital Status||Participants|Count of Participants|7|7.0||||||
3667102|NCT02352779|3512213|B1||Divorced|Marital Status||Participants|Count of Participants|5|5.0||||||
3667103|NCT02352779|3512210|B4||Long Term, Committed SO|Marital Status||Participants|Count of Participants|5|5.0||||||
3667104|NCT02352779|3512211|B3||Long Term, Committed SO|Marital Status||Participants|Count of Participants|3|3.0||||||
3667105|NCT02352779|3512212|B2||Long Term, Committed SO|Marital Status||Participants|Count of Participants|0|0.0||||||
3667106|NCT02352779|3512213|B1||Long Term, Committed SO|Marital Status||Participants|Count of Participants|2|2.0||||||
3667107|NCT02352779|3512210|B4||Married|Marital Status||Participants|Count of Participants|61|61.0||||||
3667108|NCT02352779|3512211|B3||Married|Marital Status||Participants|Count of Participants|25|25.0||||||
3667109|NCT02352779|3512212|B2||Married|Marital Status||Participants|Count of Participants|20|20.0||||||
3667110|NCT02352779|3512213|B1||Married|Marital Status||Participants|Count of Participants|16|16.0||||||
3667111|NCT02352779|3512210|B4||No HS Degree or GED|Education Level||Participants|Count of Participants|1|1.0||||||
3667112|NCT02352779|3512211|B3||No HS Degree or GED|Education Level||Participants|Count of Participants|1|1.0||||||
3667113|NCT02352779|3512212|B2||No HS Degree or GED|Education Level||Participants|Count of Participants|0|0.0||||||
3667114|NCT02352779|3512213|B1||No HS Degree or GED|Education Level||Participants|Count of Participants|0|0.0||||||
3667115|NCT02352779|3512210|B4||HS / GED Degree|Education Level||Participants|Count of Participants|36|36.0||||||
3667116|NCT02352779|3512211|B3||HS / GED Degree|Education Level||Participants|Count of Participants|14|14.0||||||
3667117|NCT02352779|3512212|B2||HS / GED Degree|Education Level||Participants|Count of Participants|12|12.0||||||
3667118|NCT02352779|3512213|B1||HS / GED Degree|Education Level||Participants|Count of Participants|10|10.0||||||
3667119|NCT02352779|3512210|B4||2 or 4 year Degree / Some college|Education Level||Participants|Count of Participants|45|45.0||||||
3667120|NCT02352779|3512211|B3||2 or 4 year Degree / Some college|Education Level||Participants|Count of Participants|14|14.0||||||
3667121|NCT02352779|3512212|B2||2 or 4 year Degree / Some college|Education Level||Participants|Count of Participants|18|18.0||||||
3667122|NCT02352779|3512213|B1||2 or 4 year Degree / Some college|Education Level||Participants|Count of Participants|13|13.0||||||
3667123|NCT02352779|3512210|B4||Graduate Degree|Education Level||Participants|Count of Participants|15|15.0||||||
3667124|NCT02352779|3512211|B3||Graduate Degree|Education Level||Participants|Count of Participants|4|4.0||||||
3667125|NCT02352779|3512212|B2||Graduate Degree|Education Level||Participants|Count of Participants|5|5.0||||||
3667126|NCT02352779|3512213|B1||Graduate Degree|Education Level||Participants|Count of Participants|6|6.0||||||
3667127|NCT02352779|3512210|B4|||Karnofsky Performance Status (KPS)|The Karnofsky Performance Scale (KPS) Index allows patients to be classified as to their functional impairment. Essentially as used in oncology, the KPS is a measure of time to death. A higher score is favorable. There are 3 general categories which are broken down into 11 specific criteria. Scale range is from 0 (Dead) to 100 (Normal, no complaints, no evidence of disease). The scale increases in units of 10.|Karnofsky Performance Scale|Mean|91.03|91.03|Standard Deviation|6.69|6.69|||
3667128|NCT02352779|3512211|B3|||Karnofsky Performance Status (KPS)|The Karnofsky Performance Scale (KPS) Index allows patients to be classified as to their functional impairment. Essentially as used in oncology, the KPS is a measure of time to death. A higher score is favorable. There are 3 general categories which are broken down into 11 specific criteria. Scale range is from 0 (Dead) to 100 (Normal, no complaints, no evidence of disease). The scale increases in units of 10.|Karnofsky Performance Scale|Mean|89.70|89.7|Standard Deviation|7.70|7.7|||
3667129|NCT02352779|3512212|B2|||Karnofsky Performance Status (KPS)|The Karnofsky Performance Scale (KPS) Index allows patients to be classified as to their functional impairment. Essentially as used in oncology, the KPS is a measure of time to death. A higher score is favorable. There are 3 general categories which are broken down into 11 specific criteria. Scale range is from 0 (Dead) to 100 (Normal, no complaints, no evidence of disease). The scale increases in units of 10.|Karnofsky Performance Scale|Mean|92.00|92.0|Standard Deviation|6.32|6.32|||
3667130|NCT02352779|3512213|B1|||Karnofsky Performance Status (KPS)|The Karnofsky Performance Scale (KPS) Index allows patients to be classified as to their functional impairment. Essentially as used in oncology, the KPS is a measure of time to death. A higher score is favorable. There are 3 general categories which are broken down into 11 specific criteria. Scale range is from 0 (Dead) to 100 (Normal, no complaints, no evidence of disease). The scale increases in units of 10.|Karnofsky Performance Scale|Mean|91.38|91.38|Standard Deviation|5.81|5.81|||
3667131|NCT02352779|3512210|B4|||BMI|"Body Mass Index (BMI) is a person's weight in kilograms divided by the square of height in meters. Values below 18.5 represent Underweight, 18.5 to 24.9 represent Normal or Healthy Weight, 25.0 to 29.9 represent Overweight and 30.0 and above represent Obese."|kg/m^2|Mean|31.76|31.76|Standard Deviation|7.34|7.34|||
3667132|NCT02352779|3512211|B3|||BMI|"Body Mass Index (BMI) is a person's weight in kilograms divided by the square of height in meters. Values below 18.5 represent Underweight, 18.5 to 24.9 represent Normal or Healthy Weight, 25.0 to 29.9 represent Overweight and 30.0 and above represent Obese."|kg/m^2|Mean|32.64|32.64|Standard Deviation|8.17|8.17|||
3667186|NCT02352779|3512213|B1|||Age||years|Mean|60.62|60.62|Standard Deviation|11.10|11.1|||
3667133|NCT02352779|3512212|B2|||BMI|"Body Mass Index (BMI) is a person's weight in kilograms divided by the square of height in meters. Values below 18.5 represent Underweight, 18.5 to 24.9 represent Normal or Healthy Weight, 25.0 to 29.9 represent Overweight and 30.0 and above represent Obese."|kg/m^2|Mean|32.31|32.31|Standard Deviation|7.45|7.45|||
3667134|NCT02352779|3512213|B1|||BMI|"Body Mass Index (BMI) is a person's weight in kilograms divided by the square of height in meters. Values below 18.5 represent Underweight, 18.5 to 24.9 represent Normal or Healthy Weight, 25.0 to 29.9 represent Overweight and 30.0 and above represent Obese."|kg/m^2|Mean|30.11|30.11|Standard Deviation|6.07|6.07|||
3667135|NCT02352779|3512210|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667136|NCT02352779|3512211|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667137|NCT02352779|3512212|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667138|NCT02352779|3512213|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667139|NCT02352779|3512210|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667140|NCT02352779|3512211|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667141|NCT02352779|3512212|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667142|NCT02352779|3512213|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667143|NCT02352779|3512210|B4||White|Race (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3667144|NCT02352779|3512211|B3||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3667145|NCT02352779|3512212|B2||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3667146|NCT02352779|3512213|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3667147|NCT02352779|3512210|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3667148|NCT02352779|3512211|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667149|NCT02352779|3512212|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3667150|NCT02352779|3512213|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3667151|NCT02352779|3512210|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667152|NCT02352779|3512211|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667153|NCT02352779|3512212|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667154|NCT02352779|3512213|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667155|NCT02352779|3512210|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3667156|NCT02352779|3512211|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667157|NCT02352779|3512212|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667158|NCT02352779|3512213|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3667159|NCT02352779|3512210|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667160|NCT02352779|3512211|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667161|NCT02352779|3512212|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667162|NCT02352779|3512213|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667163|NCT02352779|3512210|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3667164|NCT02352779|3512211|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667165|NCT02352779|3512212|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667166|NCT02352779|3512213|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3667167|NCT02352779|3512210|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3667168|NCT02352779|3512211|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3667169|NCT02352779|3512212|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3667170|NCT02352779|3512213|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3667171|NCT02352779|3512210|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667172|NCT02352779|3512211|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667173|NCT02352779|3512212|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667174|NCT02352779|3512213|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667175|NCT02352779|3512210|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3667176|NCT02352779|3512211|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3667177|NCT02352779|3512212|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3667178|NCT02352779|3512213|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3667179|NCT02352779|3512210|B4||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3667180|NCT02352779|3512211|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3667181|NCT02352779|3512212|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3667182|NCT02352779|3512213|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3667183|NCT02352779|3512210|B4|||Age||years|Mean|59.66|59.66|Standard Deviation|10.40|10.4|||
3667184|NCT02352779|3512211|B3|||Age||years|Mean|58.03|58.03|Standard Deviation|10.94|10.94|||
3667185|NCT02352779|3512212|B2|||Age||years|Mean|60.40|60.4|Standard Deviation|9.35|9.35|||
3667187|NCT02352363|3512223|B3|||Spirometry FEV1/FVC||Ratio %|Mean|77.3|77.3|Standard Deviation|6.32|6.32|||
3667188|NCT02352363|3512224|B2|||Spirometry FEV1/FVC||Ratio %|Mean|76.8|76.8|Standard Deviation|6.50|6.5|||
3667189|NCT02352363|3512225|B1|||Spirometry FEV1/FVC||Ratio %|Mean|77.6|77.6|Standard Deviation|6.23|6.23|||
3667190|NCT02352363|3512223|B3|||Spirometry FVC||Liters|Mean|3.675|3.675|Standard Deviation|0.9622|0.9622|||
3667191|NCT02352363|3512224|B2|||Spirometry FVC||Liters|Mean|3.696|3.696|Standard Deviation|1.0497|1.0497|||
3667192|NCT02352363|3512225|B1|||Spirometry FVC||Liters|Mean|3.665|3.665|Standard Deviation|0.9203|0.9203|||
3667193|NCT02352363|3512223|B3|||Spirometry FEV1||Liters|Mean|2.841|2.841|Standard Deviation|0.7831|0.7831|||
3667194|NCT02352363|3512224|B2|||Spirometry FEV1||Liters|Mean|2.838|2.838|Standard Deviation|0.853|0.853|||
3667195|NCT02352363|3512225|B1|||Spirometry FEV1||Liters|Mean|2.842|2.842|Standard Deviation|0.7538|0.7538|||
3667196|NCT02352363|3512223|B3|Germany||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3667197|NCT02352363|3512224|B2|Germany||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3667198|NCT02352363|3512225|B1|Germany||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3667199|NCT02352363|3512223|B3|Serbia||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3667200|NCT02352363|3512224|B2|Serbia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3667201|NCT02352363|3512225|B1|Serbia||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3667202|NCT02352363|3512223|B3|France||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3667203|NCT02352363|3512224|B2|France||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3667204|NCT02352363|3512225|B1|France||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3667205|NCT02352363|3512223|B3|Israel||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3667206|NCT02352363|3512224|B2|Israel||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3667207|NCT02352363|3512225|B1|Israel||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3667208|NCT02352363|3512223|B3|Poland||Region of Enrollment||Participants|Count of Participants|93|93.0||||||
3667209|NCT02352363|3512224|B2|Poland||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3667210|NCT02352363|3512225|B1|Poland||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
3667211|NCT02352363|3512223|B3|Belgium||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3667212|NCT02352363|3512224|B2|Belgium||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3667213|NCT02352363|3512225|B1|Belgium||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3667214|NCT02352363|3512223|B3|Austria||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3667215|NCT02352363|3512224|B2|Austria||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3667216|NCT02352363|3512225|B1|Austria||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3667217|NCT02352363|3512223|B3|Spain||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3667218|NCT02352363|3512224|B2|Spain||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3667219|NCT02352363|3512225|B1|Spain||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3667220|NCT02352363|3512223|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3667221|NCT02352363|3512224|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3667222|NCT02352363|3512225|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3667223|NCT02352363|3512223|B3|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3667224|NCT02352363|3512224|B2|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3667225|NCT02352363|3512225|B1|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3667226|NCT02352363|3512223|B3|Czechia||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
3667227|NCT02352363|3512224|B2|Czechia||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3667228|NCT02352363|3512225|B1|Czechia||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3667229|NCT02352363|3512223|B3|Hungary||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3667230|NCT02352363|3512224|B2|Hungary||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3667231|NCT02352363|3512225|B1|Hungary||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3667232|NCT02352363|3512223|B3|Romania||Region of Enrollment||Participants|Count of Participants|89|89.0||||||
3667233|NCT02352363|3512224|B2|Romania||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3667234|NCT02352363|3512225|B1|Romania||Region of Enrollment||Participants|Count of Participants|55|55.0||||||
3667235|NCT02352363|3512223|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3667236|NCT02352363|3512224|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3667237|NCT02352363|3512225|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3667238|NCT02352363|3512223|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|391|391.0||||||
3667239|NCT02352363|3512224|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
3667240|NCT02352363|3512225|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|267|267.0||||||
3667241|NCT02352363|3512223|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3667242|NCT02352363|3512224|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667243|NCT02352363|3512225|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3667244|NCT02352363|3512223|B3||Male|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
3667245|NCT02352363|3512224|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3667246|NCT02352363|3512225|B1||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3667247|NCT02352363|3512223|B3||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
3667248|NCT02352363|3512224|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3667249|NCT02352363|3512225|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3667250|NCT02352363|3512223|B3|||Age||years|Mean|63.8|63.8|Standard Deviation|8.33|8.33|||
3667251|NCT02352363|3512224|B2|||Age||years|Mean|64.2|64.2|Standard Deviation|7.88|7.88|||
3667252|NCT02352363|3512225|B1|||Age||years|Mean|63.6|63.6|Standard Deviation|8.54|8.54|||
3667253|NCT02352363|3512223|B3||>=65 years|Age||Participants|Count of Participants|202|202.0||||||
3667254|NCT02352363|3512224|B2||>=65 years|Age||Participants|Count of Participants|68|68.0||||||
3667255|NCT02352363|3512225|B1||>=65 years|Age||Participants|Count of Participants|134|134.0||||||
3667256|NCT02352363|3512223|B3||Between 18 and 65 years|Age||Participants|Count of Participants|196|196.0||||||
3667257|NCT02352363|3512224|B2||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
3667258|NCT02352363|3512225|B1||Between 18 and 65 years|Age||Participants|Count of Participants|137|137.0||||||
3667259|NCT02352363|3512223|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3667260|NCT02352363|3512224|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3667261|NCT02352363|3512225|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3667262|NCT02352298|3512238|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
3667263|NCT02352298|3512238|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3667264|NCT02352298|3512238|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3667265|NCT02352298|3512238|B1|||Age||years|Mean|41.44|41.44|Full Range|||20.0|66.0|
3667266|NCT02352298|3512238|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3667267|NCT02352298|3512238|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3667268|NCT02352298|3512238|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3667269|NCT02351960|3512243|B3|Abnormal but not Clinically Significant||12-Lead Electrocardiogram (ECG)||participants|Number|100|100.0||||||
3667270|NCT02351960|3512244|B2|Abnormal but not Clinically Significant||12-Lead Electrocardiogram (ECG)||participants|Number|33|33.0||||||
3667271|NCT02351960|3512245|B1|Abnormal but not Clinically Significant||12-Lead Electrocardiogram (ECG)||participants|Number|67|67.0||||||
3667272|NCT02351960|3512243|B3|Within Normal Limits||12-Lead Electrocardiogram (ECG)||participants|Number|196|196.0||||||
3667273|NCT02351960|3512244|B2|Within Normal Limits||12-Lead Electrocardiogram (ECG)||participants|Number|55|55.0||||||
3667274|NCT02351960|3512245|B1|Within Normal Limits||12-Lead Electrocardiogram (ECG)||participants|Number|141|141.0||||||
3667275|NCT02351960|3512243|B3|Ex-smoker||Smoking History||participants|Number|40|40.0||||||
3667276|NCT02351960|3512244|B2|Ex-smoker||Smoking History||participants|Number|16|16.0||||||
3667277|NCT02351960|3512245|B1|Ex-smoker||Smoking History||participants|Number|24|24.0||||||
3667278|NCT02351960|3512243|B3|Current Smoker||Smoking History||participants|Number|26|26.0||||||
3667279|NCT02351960|3512244|B2|Current Smoker||Smoking History||participants|Number|11|11.0||||||
3667280|NCT02351960|3512245|B1|Current Smoker||Smoking History||participants|Number|15|15.0||||||
3667281|NCT02351960|3512243|B3|Never Smoked||Smoking History||participants|Number|230|230.0||||||
3667282|NCT02351960|3512244|B2|Never Smoked||Smoking History||participants|Number|61|61.0||||||
3667283|NCT02351960|3512245|B1|Never Smoked||Smoking History||participants|Number|169|169.0||||||
3667284|NCT02351960|3512243|B3|≥30 kg/m^2||BMI categories||participants|Number|16|16.0||||||
3667285|NCT02351960|3512244|B2|≥30 kg/m^2||BMI categories||participants|Number|9|9.0||||||
3667286|NCT02351960|3512245|B1|≥30 kg/m^2||BMI categories||participants|Number|7|7.0||||||
3667287|NCT02351960|3512243|B3|25-<30 kg/m^2||BMI categories||participants|Number|76|76.0||||||
3667288|NCT02351960|3512244|B2|25-<30 kg/m^2||BMI categories||participants|Number|33|33.0||||||
3667289|NCT02351960|3512245|B1|25-<30 kg/m^2||BMI categories||participants|Number|43|43.0||||||
3667290|NCT02351960|3512243|B3|<25 kg/m^2||BMI categories||participants|Number|204|204.0||||||
3667291|NCT02351960|3512244|B2|<25 kg/m^2||BMI categories||participants|Number|46|46.0||||||
3667292|NCT02351960|3512245|B1|<25 kg/m^2||BMI categories||participants|Number|158|158.0||||||
3667293|NCT02351960|3512243|B3|||Body Mass Index|Body Mass Index = weight (kg)/[height (m)^2].|kg/m^2|Mean|24.05|24.05|Standard Deviation|3.732|3.732|||
3667294|NCT02351960|3512244|B2|||Body Mass Index|Body Mass Index = weight (kg)/[height (m)^2].|kg/m^2|Mean|25.11|25.11|Standard Deviation|4.160|4.16|||
3667295|NCT02351960|3512245|B1|||Body Mass Index|Body Mass Index = weight (kg)/[height (m)^2].|kg/m^2|Mean|23.00|23.0|Standard Deviation|3.305|3.305|||
3667296|NCT02351960|3512243|B3|||Height||cm|Mean|163.25|163.25|Standard Deviation|9.04|9.04|||
3667297|NCT02351960|3512244|B2|||Height||cm|Mean|165.0|165.0|Standard Deviation|9.65|9.65|||
3667298|NCT02351960|3512245|B1|||Height||cm|Mean|161.5|161.5|Standard Deviation|8.43|8.43|||
3667299|NCT02351960|3512243|B3|||Weight||kg|Mean|64.55|64.55|Standard Deviation|13.302|13.302|||
3667300|NCT02351960|3512244|B2|||Weight||kg|Mean|68.84|68.84|Standard Deviation|14.986|14.986|||
3667301|NCT02351960|3512245|B1|||Weight||kg|Mean|60.26|60.26|Standard Deviation|11.619|11.619|||
3667302|NCT02351960|3512243|B3|Taiwan, Province Of China||Region of Enrollment||participants|Number|70|70.0||||||
3667303|NCT02351960|3512244|B2|Taiwan, Province Of China||Region of Enrollment||participants|Number|70|70.0||||||
3667304|NCT02351960|3512245|B1|Taiwan, Province Of China||Region of Enrollment||participants|Number|0|0.0||||||
3667305|NCT02351960|3512243|B3|Korea, Republic Of||Region of Enrollment||participants|Number|207|207.0||||||
3667306|NCT02351960|3512244|B2|Korea, Republic Of||Region of Enrollment||participants|Number|12|12.0||||||
3667307|NCT02351960|3512245|B1|Korea, Republic Of||Region of Enrollment||participants|Number|195|195.0||||||
3667308|NCT02351960|3512243|B3|Hong Kong||Region of Enrollment||participants|Number|19|19.0||||||
3667309|NCT02351960|3512244|B2|Hong Kong||Region of Enrollment||participants|Number|6|6.0||||||
3667310|NCT02351960|3512245|B1|Hong Kong||Region of Enrollment||participants|Number|13|13.0||||||
3667311|NCT02351960|3512243|B3|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3667312|NCT02351960|3512244|B2|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3667313|NCT02351960|3512245|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3667314|NCT02351960|3512243|B3|Asian||Race/Ethnicity, Customized||participants|Number|295|295.0||||||
3667315|NCT02351960|3512244|B2|Asian||Race/Ethnicity, Customized||participants|Number|87|87.0||||||
3667316|NCT02351960|3512245|B1|Asian||Race/Ethnicity, Customized||participants|Number|208|208.0||||||
3667317|NCT02351960|3512243|B3||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
3667318|NCT02351960|3512244|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3667319|NCT02351960|3512245|B1||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3667320|NCT02351960|3512243|B3||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3667321|NCT02351960|3512244|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3667322|NCT02351960|3512245|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3667323|NCT02351960|3512243|B3|≥65 years||Age, Customized||participants|Number|63|63.0||||||
3667324|NCT02351960|3512244|B2|≥65 years||Age, Customized||participants|Number|17|17.0||||||
3667325|NCT02351960|3512245|B1|≥65 years||Age, Customized||participants|Number|46|46.0||||||
3667326|NCT02351960|3512243|B3|45-<65 years||Age, Customized||participants|Number|144|144.0||||||
3667327|NCT02351960|3512244|B2|45-<65 years||Age, Customized||participants|Number|42|42.0||||||
3667328|NCT02351960|3512245|B1|45-<65 years||Age, Customized||participants|Number|102|102.0||||||
3667329|NCT02351960|3512243|B3|<45 years||Age, Customized||participants|Number|89|89.0||||||
3667330|NCT02351960|3512244|B2|<45 years||Age, Customized||participants|Number|29|29.0||||||
3667331|NCT02351960|3512245|B1|<45 years||Age, Customized||participants|Number|60|60.0||||||
3667332|NCT02351960|3512243|B3|||Age||years|Mean|52.6|52.6|Standard Deviation|13.06|13.06|||
3667333|NCT02351960|3512244|B2|||Age||years|Mean|51.7|51.7|Standard Deviation|12.51|12.51|||
3667334|NCT02351960|3512245|B1|||Age||years|Mean|53.6|53.6|Standard Deviation|13.62|13.62|||
3667335|NCT02351934|3512265|B3|United States||Region of Enrollment||Participants|Count of Participants|123|123.0||||||
3667336|NCT02351934|3512266|B2|United States||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
3667337|NCT02351934|3512267|B1|United States||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
3667338|NCT02351934|3512265|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3667339|NCT02351934|3512266|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3667340|NCT02351934|3512267|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3667341|NCT02351934|3512265|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3667342|NCT02351934|3512266|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3667343|NCT02351934|3512267|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3667344|NCT02351934|3512265|B3|||Age||years|Median|59|59.0|Inter-Quartile Range|||42.0|68.0|
3667345|NCT02351934|3512266|B2|||Age||years|Median|61|61.0|Inter-Quartile Range|||45.0|68.0|
3667346|NCT02351934|3512267|B1|||Age||years|Median|57|57.0|Inter-Quartile Range|||42.0|68.0|
3667347|NCT02351817|3512284|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3667348|NCT02351817|3512284|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3667349|NCT02351817|3512284|B1|||Age||years|Mean|57.0|57.0|Standard Deviation|9.5|9.5|||
3667350|NCT02351505|3512292|B1|United States||Region of Enrollment||patients|Number|1|1.0||||||
3667351|NCT02351505|3512292|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667352|NCT02351505|3512292|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667353|NCT02351505|3512292|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3667354|NCT02351505|3512292|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667355|NCT02351505|3512292|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667356|NCT02351505|3512292|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667357|NCT02351505|3512292|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667358|NCT02351505|3512292|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667359|NCT02351505|3512292|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3667360|NCT02351505|3512292|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667361|NCT02351505|3512292|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3667362|NCT02351505|3512292|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3667363|NCT02351505|3512292|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3667364|NCT02351505|3512292|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3667365|NCT02351505|3512292|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3667366|NCT02351037|3512303|B4|United States||Region of Enrollment||participants|Number|36|36.0||||||
3667367|NCT02351037|3512304|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3667368|NCT02351037|3512305|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
3667369|NCT02351037|3512306|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3667370|NCT02351037|3512303|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667371|NCT02351037|3512304|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667372|NCT02351037|3512305|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667373|NCT02351037|3512306|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667374|NCT02351037|3512303|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667375|NCT02351037|3512304|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667376|NCT02351037|3512305|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667377|NCT02351037|3512306|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667378|NCT02351037|3512303|B4||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3667379|NCT02351037|3512304|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3667380|NCT02351037|3512305|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3667381|NCT02351037|3512306|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3667382|NCT02351037|3512303|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3667383|NCT02351037|3512304|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667384|NCT02351037|3512305|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3667385|NCT02351037|3512306|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3667386|NCT02351037|3512303|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667387|NCT02351037|3512304|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667388|NCT02351037|3512305|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667389|NCT02351037|3512306|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667390|NCT02351037|3512303|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3667391|NCT02351037|3512304|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667392|NCT02351037|3512305|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3667393|NCT02351037|3512306|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667394|NCT02351037|3512303|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667395|NCT02351037|3512304|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667396|NCT02351037|3512305|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667397|NCT02351037|3512306|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667398|NCT02351037|3512303|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667399|NCT02351037|3512304|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667400|NCT02351037|3512305|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667401|NCT02351037|3512306|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667402|NCT02351037|3512303|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3667403|NCT02351037|3512304|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3667404|NCT02351037|3512305|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3667405|NCT02351037|3512306|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3667406|NCT02351037|3512303|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3667407|NCT02351037|3512304|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3667408|NCT02351037|3512305|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3667409|NCT02351037|3512306|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3667410|NCT02351037|3512303|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3667411|NCT02351037|3512304|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3667412|NCT02351037|3512305|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3667413|NCT02351037|3512306|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3667414|NCT02351037|3512303|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3667415|NCT02351037|3512304|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3667416|NCT02351037|3512305|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3667417|NCT02351037|3512306|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3667418|NCT02351037|3512303|B4|||Age||years|Mean|67|67.0|Standard Deviation|11.1|11.1|||
3667419|NCT02351037|3512304|B3|||Age||years|Mean|58|58.0|Standard Deviation|12.4|12.4|||
3667420|NCT02351037|3512305|B2|||Age||years|Mean|70|70.0|Standard Deviation|9.1|9.1|||
3667421|NCT02351037|3512306|B1|||Age||years|Mean|67|67.0|Standard Deviation|11.7|11.7|||
3667422|NCT02351037|3512303|B4||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3667423|NCT02351037|3512304|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3667424|NCT02351037|3512305|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3667425|NCT02351037|3512306|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3667426|NCT02351037|3512303|B4||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3667427|NCT02351037|3512304|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3667428|NCT02351037|3512305|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3667429|NCT02351037|3512306|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3667430|NCT02351037|3512303|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3667431|NCT02351037|3512304|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3667432|NCT02351037|3512305|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3667433|NCT02351037|3512306|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3667434|NCT02350881|3512316|B1|Italy||Region of Enrollment||participants|Number|64|64.0||||||
3667435|NCT02350881|3512316|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3667436|NCT02350881|3512316|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3667437|NCT02350881|3512316|B1|||Age||years|Mean|59.8|59.8|Full Range|||45.0|77.0|
3667438|NCT02350777|3512344|B3|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3667439|NCT02350777|3512345|B2|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3667440|NCT02350777|3512346|B1|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3667441|NCT02350777|3512344|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667442|NCT02350777|3512345|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667443|NCT02350777|3512346|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667444|NCT02350777|3512344|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667445|NCT02350777|3512345|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667446|NCT02350777|3512346|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667447|NCT02350777|3512344|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3667448|NCT02350777|3512345|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3667449|NCT02350777|3512346|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3667450|NCT02350777|3512344|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667451|NCT02350777|3512345|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667452|NCT02350777|3512346|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667453|NCT02350777|3512344|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667454|NCT02350777|3512345|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667455|NCT02350777|3512346|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667456|NCT02350777|3512344|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3667457|NCT02350777|3512345|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3667458|NCT02350777|3512346|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667459|NCT02350777|3512344|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667460|NCT02350777|3512345|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667461|NCT02350777|3512346|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667462|NCT02350777|3512344|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667463|NCT02350777|3512345|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667464|NCT02350777|3512346|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667465|NCT02350777|3512344|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3667466|NCT02350777|3512345|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3667467|NCT02350777|3512346|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3667468|NCT02350777|3512344|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667469|NCT02350777|3512345|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667470|NCT02350777|3512346|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667471|NCT02350777|3512344|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3667472|NCT02350777|3512345|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3667473|NCT02350777|3512346|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3667474|NCT02350777|3512344|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3667475|NCT02350777|3512345|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3667476|NCT02350777|3512346|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3667477|NCT02350777|3512344|B3|||Age||years|Mean|52|52.0|Full Range|||45.0|58.0|
3667478|NCT02350777|3512345|B2|||Age||years|Mean|50|50.0|Full Range|||45.0|55.0|
3667479|NCT02350777|3512346|B1|||Age||years|Mean|54|54.0|Full Range|||50.0|58.0|
3667480|NCT02350569|3512353|B1|Yes||Prior HCV Treatment||Participants|Count of Participants|7|7.0||||||
3667481|NCT02350569|3512353|B1|No||Prior HCV Treatment||Participants|Count of Participants|9|9.0||||||
3667482|NCT02350569|3512353|B1|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|6|6.0||||||
3667483|NCT02350569|3512353|B1|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|10|10.0||||||
3667484|NCT02350569|3512353|B1|||HCV RNA||log10 IU/mL|Mean|5.6|5.6|Standard Deviation|0.75|0.75|||
3667485|NCT02350569|3512353|B1|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|2|2.0||||||
3667486|NCT02350569|3512353|B1|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|9|9.0||||||
3667487|NCT02350569|3512353|B1|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|5|5.0||||||
3667488|NCT02350569|3512353|B1|Genotype 1b||HCV Genotype||Participants|Count of Participants|5|5.0||||||
3667489|NCT02350569|3512353|B1|Genotype 1a||HCV Genotype||Participants|Count of Participants|11|11.0||||||
3667490|NCT02350569|3512353|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667491|NCT02350569|3512353|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667492|NCT02350569|3512353|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3667493|NCT02350569|3512353|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3667494|NCT02350569|3512353|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667495|NCT02350569|3512353|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3667496|NCT02350569|3512353|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667497|NCT02350569|3512353|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667498|NCT02350569|3512353|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3667499|NCT02350569|3512353|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3667500|NCT02350569|3512353|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3667501|NCT02350569|3512353|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3667502|NCT02350569|3512353|B1|||Age||years|Mean|59|59.0|Standard Deviation|5.1|5.1|||
3667503|NCT02349711|3512363|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3667504|NCT02349711|3512364|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3667505|NCT02349711|3512365|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3667506|NCT02349711|3512363|B3||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3667507|NCT02349711|3512364|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3667508|NCT02349711|3512365|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3667509|NCT02349711|3512363|B3|||Age||years|Mean|26.8|26.8|Standard Deviation|12.0|12.0|||
3667510|NCT02349711|3512364|B2|||Age||years|Mean|26.0|26.0|Standard Deviation|10.8|10.8|||
3667511|NCT02349711|3512365|B1|||Age||years|Mean|27.6|27.6|Standard Deviation|13.1|13.1|||
3667512|NCT02349685|3512378|B4|Korea, Republic of||Region of Enrollment||participants|Number|219|219.0||||||
3667513|NCT02349685|3512379|B3|Korea, Republic of||Region of Enrollment||participants|Number|41|41.0||||||
3667514|NCT02349685|3512380|B2|Korea, Republic of||Region of Enrollment||participants|Number|89|89.0||||||
3667515|NCT02349685|3512381|B1|Korea, Republic of||Region of Enrollment||participants|Number|89|89.0||||||
3667516|NCT02349685|3512378|B4||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3667517|NCT02349685|3512379|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3667518|NCT02349685|3512380|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3667519|NCT02349685|3512381|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3667520|NCT02349685|3512378|B4||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3667521|NCT02349685|3512379|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3667522|NCT02349685|3512380|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3667523|NCT02349685|3512381|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3667524|NCT02349685|3512378|B4|||Age||years|Mean|54.5|54.5|Full Range|||18.0|75.0|
3667525|NCT02349685|3512379|B3|||Age||years|Mean|54.5|54.5|Full Range|||29.0|75.0|
3667526|NCT02349685|3512380|B2|||Age||years|Mean|59.2|59.2|Full Range|||25.0|75.0|
3667527|NCT02349685|3512381|B1|||Age||years|Mean|55.7|55.7|Full Range|||18.0|74.0|
3667528|NCT02349685|3512378|B4||>=65 years|Age||Participants|Count of Participants|91|91.0||||||
3667529|NCT02349685|3512379|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3667530|NCT02349685|3512380|B2||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
3667531|NCT02349685|3512381|B1||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
3667532|NCT02349685|3512378|B4||Between 18 and 65 years|Age||Participants|Count of Participants|128|128.0||||||
3667533|NCT02349685|3512379|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3667534|NCT02349685|3512380|B2||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3667535|NCT02349685|3512381|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3667536|NCT02349685|3512378|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3667537|NCT02349685|3512379|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3667538|NCT02349685|3512380|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3667539|NCT02349685|3512381|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3667540|NCT02349646|3512394|B1|Germany||Region of Enrollment||participants|Number|33|33.0||||||
3667541|NCT02349646|3512394|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667542|NCT02349646|3512394|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667543|NCT02349646|3512394|B1||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3667544|NCT02349646|3512394|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667545|NCT02349646|3512394|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667546|NCT02349646|3512394|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667547|NCT02349646|3512394|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667548|NCT02349646|3512394|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3667549|NCT02349646|3512394|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3667550|NCT02349646|3512394|B1|||Age||years|Mean|51|51.0|Full Range|||25.0|82.0|
3667551|NCT02349542|3512399|B1|||Body Mass Index||kilograms per meters-squared|Mean|30.7|30.7|Full Range|||27.0|34.9|
3667552|NCT02349542|3512399|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3667553|NCT02349542|3512399|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3667554|NCT02349542|3512399|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3667555|NCT02349542|3512399|B1|||Age||years|Mean|60|60.0|Full Range|||57.0|64.0|
3667556|NCT02349451|3512404|B5||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3667557|NCT02349451|3512405|B4||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3667558|NCT02349451|3512406|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3667559|NCT02349451|3512407|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3667560|NCT02349451|3512408|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3667561|NCT02349451|3512404|B5||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3667562|NCT02349451|3512405|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3667563|NCT02349451|3512406|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3667564|NCT02349451|3512407|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3667565|NCT02349451|3512408|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3667566|NCT02349451|3512404|B5|||Age||years|Mean|49.4|49.4|Standard Deviation|12.87|12.87|||
3667567|NCT02349451|3512405|B4|||Age||years|Mean|47.4|47.4|Standard Deviation|13.77|13.77|||
3667568|NCT02349451|3512406|B3|||Age||years|Mean|51.0|51.0|Standard Deviation|12.39|12.39|||
3667569|NCT02349451|3512407|B2|||Age||years|Mean|50.5|50.5|Standard Deviation|12.03|12.03|||
3667570|NCT02349451|3512408|B1|||Age||years|Mean|47.7|47.7|Standard Deviation|13.67|13.67|||
3667571|NCT02349438|3512447|B1|Australia||Region of Enrollment||participants|Number|21|21.0||||||
3667572|NCT02349438|3512447|B1|White||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3667573|NCT02349438|3512447|B1|Asian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3667574|NCT02349438|3512447|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3667575|NCT02349438|3512447|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3667576|NCT02349438|3512447|B1|||Age||years|Mean|23.1|23.1|Standard Deviation|5.43|5.43|||
3667577|NCT02349360|3512458|B3|United States||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3667578|NCT02349360|3512459|B2|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3667579|NCT02349360|3512460|B1|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3667580|NCT02349360|3512458|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3667581|NCT02349360|3512459|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3667582|NCT02349360|3512460|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3667583|NCT02349360|3512458|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3667584|NCT02349360|3512459|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3667585|NCT02349360|3512460|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3667586|NCT02349360|3512458|B3|||Age||years|Median|21|21.0|Full Range|||18.0|48.0|
3667587|NCT02349360|3512459|B2|||Age||years|Median|21|21.0|Full Range|||18.0|48.0|
3667588|NCT02349360|3512460|B1|||Age||years|Median|23|23.0|Full Range|||18.0|36.0|
3667589|NCT02349360|3512458|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3667590|NCT02349360|3512459|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3667591|NCT02349360|3512460|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3667592|NCT02349360|3512458|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3667593|NCT02349360|3512459|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3667594|NCT02349360|3512460|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3667595|NCT02349360|3512458|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3667596|NCT02349360|3512459|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3667597|NCT02349360|3512460|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3667598|NCT02349295|3512469|B4|Spain||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3667599|NCT02349295|3512470|B3|Spain||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3667600|NCT02349295|3512471|B2|Spain||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3667601|NCT02349295|3512472|B1|Spain||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3667602|NCT02349295|3512469|B4|Germany||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3667603|NCT02349295|3512470|B3|Germany||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3667604|NCT02349295|3512471|B2|Germany||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3667605|NCT02349295|3512472|B1|Germany||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3667606|NCT02349295|3512469|B4|France||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3667607|NCT02349295|3512470|B3|France||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3667608|NCT02349295|3512471|B2|France||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3667609|NCT02349295|3512472|B1|France||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3667610|NCT02349295|3512469|B4|Australia||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3667611|NCT02349295|3512470|B3|Australia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3667612|NCT02349295|3512471|B2|Australia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3667613|NCT02349295|3512472|B1|Australia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3667614|NCT02349295|3512469|B4|United Kingdom||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3667615|NCT02349295|3512470|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3667616|NCT02349295|3512471|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3667617|NCT02349295|3512472|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3667618|NCT02349295|3512469|B4|Italy||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3667619|NCT02349295|3512470|B3|Italy||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3667620|NCT02349295|3512471|B2|Italy||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3667621|NCT02349295|3512472|B1|Italy||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3667622|NCT02349295|3512469|B4|Poland||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3667623|NCT02349295|3512470|B3|Poland||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3667624|NCT02349295|3512471|B2|Poland||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3667625|NCT02349295|3512472|B1|Poland||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3667626|NCT02349295|3512469|B4|Taiwan||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3667627|NCT02349295|3512470|B3|Taiwan||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3667628|NCT02349295|3512471|B2|Taiwan||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3667629|NCT02349295|3512472|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3667630|NCT02349295|3512469|B4|United States||Region of Enrollment||Participants|Count of Participants|188|188.0||||||
3667631|NCT02349295|3512470|B3|United States||Region of Enrollment||Participants|Count of Participants|63|63.0||||||
3667632|NCT02349295|3512471|B2|United States||Region of Enrollment||Participants|Count of Participants|65|65.0||||||
3667633|NCT02349295|3512472|B1|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3667634|NCT02349295|3512469|B4|Czechia||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3667635|NCT02349295|3512470|B3|Czechia||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3667636|NCT02349295|3512471|B2|Czechia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3667637|NCT02349295|3512472|B1|Czechia||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3667638|NCT02349295|3512469|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3667639|NCT02349295|3512470|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3667640|NCT02349295|3512471|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667641|NCT02349295|3512472|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667642|NCT02349295|3512469|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3667643|NCT02349295|3512470|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3667644|NCT02349295|3512471|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3667645|NCT02349295|3512472|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3667646|NCT02349295|3512469|B4||White|Race (NIH/OMB)||Participants|Count of Participants|332|332.0||||||
3667647|NCT02349295|3512470|B3||White|Race (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
3667648|NCT02349295|3512471|B2||White|Race (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
3667649|NCT02349295|3512472|B1||White|Race (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
3667650|NCT02349295|3512469|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3667651|NCT02349295|3512470|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3667652|NCT02349295|3512471|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3667653|NCT02349295|3512472|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3667654|NCT02349295|3512469|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3667655|NCT02349295|3512470|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667656|NCT02349295|3512471|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3667657|NCT02349295|3512472|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667658|NCT02349295|3512469|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3667659|NCT02349295|3512470|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3667660|NCT02349295|3512471|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3667661|NCT02349295|3512472|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3667662|NCT02349295|3512469|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667663|NCT02349295|3512470|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667664|NCT02349295|3512471|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667665|NCT02349295|3512472|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667666|NCT02349295|3512469|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3667667|NCT02349295|3512470|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3667668|NCT02349295|3512471|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3667669|NCT02349295|3512472|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3667670|NCT02349295|3512469|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|324|324.0||||||
3667671|NCT02349295|3512470|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|109|109.0||||||
3667672|NCT02349295|3512471|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|109|109.0||||||
3667673|NCT02349295|3512472|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
3667674|NCT02349295|3512469|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3667675|NCT02349295|3512470|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3667676|NCT02349295|3512471|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3667677|NCT02349295|3512472|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3667678|NCT02349295|3512469|B4||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3667679|NCT02349295|3512470|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3667680|NCT02349295|3512471|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3667681|NCT02349295|3512472|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3667682|NCT02349295|3512469|B4||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
3667683|NCT02349295|3512470|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3667684|NCT02349295|3512471|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3667685|NCT02349295|3512472|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3667686|NCT02349295|3512469|B4|||Age||years|Mean|51.9|51.9|Standard Deviation|12.00|12.0|||
3667687|NCT02349295|3512470|B3|||Age||years|Mean|51.7|51.7|Standard Deviation|11.85|11.85|||
3667688|NCT02349295|3512471|B2|||Age||years|Mean|52.6|52.6|Standard Deviation|13.57|13.57|||
3667689|NCT02349295|3512472|B1|||Age||years|Mean|51.5|51.5|Standard Deviation|10.39|10.39|||
3667690|NCT02349152|3512550|B3|United States||Region of Enrollment||participants|Number|106|106.0||||||
3667691|NCT02349152|3512551|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
3667692|NCT02349152|3512552|B1|United States||Region of Enrollment||participants|Number|54|54.0||||||
3667693|NCT02349152|3512550|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3667694|NCT02349152|3512550|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3667695|NCT02349152|3512551|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3667696|NCT02349152|3512552|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3667697|NCT02349152|3512550|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3667698|NCT02349152|3512551|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3667699|NCT02349152|3512552|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3667700|NCT02349152|3512550|B3|||Age||years|Mean|70.5|70.5|Full Range|||32.0|86.0|
3667701|NCT02349152|3512551|B2|||Age||years|Mean|71.0|71.0|Full Range|||46.0|86.0|
3667702|NCT02349152|3512552|B1|||Age||years|Mean|70.0|70.0|Full Range|||32.0|84.0|
3667703|NCT02349061|3512577|B3|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3667704|NCT02349061|3512578|B2|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3667705|NCT02349061|3512579|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3667706|NCT02349061|3512577|B3|Taiwan, Province Of China||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3667707|NCT02349061|3512578|B2|Taiwan, Province Of China||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3667708|NCT02349061|3512579|B1|Taiwan, Province Of China||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3667709|NCT02349061|3512577|B3|Spain||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3667710|NCT02349061|3512578|B2|Spain||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3667711|NCT02349061|3512579|B1|Spain||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3667712|NCT02349061|3512577|B3|Poland||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3667713|NCT02349061|3512578|B2|Poland||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3667714|NCT02349061|3512579|B1|Poland||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3667715|NCT02349061|3512577|B3|Mexico||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3667716|NCT02349061|3512578|B2|Mexico||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3667717|NCT02349061|3512579|B1|Mexico||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3667718|NCT02349061|3512577|B3|Hungary||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3667719|NCT02349061|3512578|B2|Hungary||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3667720|NCT02349061|3512579|B1|Hungary||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3667721|NCT02349061|3512577|B3|Germany||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3667722|NCT02349061|3512578|B2|Germany||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3667723|NCT02349061|3512579|B1|Germany||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3667724|NCT02349061|3512577|B3|Australia||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3667725|NCT02349061|3512578|B2|Australia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3667726|NCT02349061|3512579|B1|Australia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3667727|NCT02349061|3512577|B3|Argentina||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3667728|NCT02349061|3512578|B2|Argentina||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3667729|NCT02349061|3512579|B1|Argentina||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3667730|NCT02349061|3512577|B3||White Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
3667731|NCT02349061|3512578|B2||White Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3667732|NCT02349061|3512579|B1||White Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3667733|NCT02349061|3512577|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3667734|NCT02349061|3512578|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3667735|NCT02349061|3512579|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3667736|NCT02349061|3512577|B3||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3667737|NCT02349061|3512578|B2||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3667738|NCT02349061|3512579|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3667739|NCT02349061|3512577|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3667740|NCT02349061|3512578|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3667741|NCT02349061|3512579|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3667742|NCT02349061|3512577|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3667743|NCT02349061|3512578|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3667744|NCT02349061|3512579|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3667745|NCT02349061|3512577|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3667746|NCT02349061|3512578|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3667747|NCT02349061|3512579|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667748|NCT02349061|3512577|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3667749|NCT02349061|3512578|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3667750|NCT02349061|3512579|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3667751|NCT02349061|3512577|B3||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3667752|NCT02349061|3512578|B2||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3667753|NCT02349061|3512579|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3667754|NCT02349061|3512577|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3667755|NCT02349061|3512578|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3667756|NCT02349061|3512579|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3667757|NCT02349061|3512577|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667758|NCT02349061|3512578|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667759|NCT02349061|3512579|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667760|NCT02349061|3512577|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3667761|NCT02349061|3512578|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3667762|NCT02349061|3512579|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3667763|NCT02349061|3512577|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3667764|NCT02349061|3512578|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3667765|NCT02349061|3512579|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667766|NCT02349061|3512577|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667767|NCT02349061|3512578|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667768|NCT02349061|3512579|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667769|NCT02349061|3512577|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3667770|NCT02349061|3512578|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3667771|NCT02349061|3512579|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3667772|NCT02349061|3512577|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3667773|NCT02349061|3512578|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3667774|NCT02349061|3512579|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3667775|NCT02349061|3512577|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3667776|NCT02349061|3512578|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3667777|NCT02349061|3512579|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3667778|NCT02349061|3512577|B3||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3667779|NCT02349061|3512578|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3667780|NCT02349061|3512579|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3667781|NCT02349061|3512577|B3|||Age||years|Mean|41.3|41.3|Standard Deviation|11.62|11.62|||
3667782|NCT02349061|3512578|B2|||Age||years|Mean|40|40.0|Standard Deviation|11.95|11.95|||
3667783|NCT02349061|3512579|B1|||Age||years|Mean|43.1|43.1|Standard Deviation|11.03|11.03|||
3667784|NCT02349048|3512586|B3|USA||Region of Enrollment||participants|Number|59|59.0||||||
3667785|NCT02349048|3512587|B2|USA||Region of Enrollment||participants|Number|9|9.0||||||
3667786|NCT02349048|3512588|B1|USA||Region of Enrollment||participants|Number|50|50.0||||||
3667787|NCT02349048|3512586|B3|CAN||Region of Enrollment||participants|Number|9|9.0||||||
3667788|NCT02349048|3512587|B2|CAN||Region of Enrollment||participants|Number|0|0.0||||||
3667789|NCT02349048|3512588|B1|CAN||Region of Enrollment||participants|Number|9|9.0||||||
3667790|NCT02349048|3512586|B3||Male|Gender||Participants|Count of Participants|31|31.0||||||
3667791|NCT02349048|3512587|B2||Male|Gender||Participants|Count of Participants|4|4.0||||||
3667792|NCT02349048|3512588|B1||Male|Gender||Participants|Count of Participants|27|27.0||||||
3667793|NCT02349048|3512586|B3||Female|Gender||Participants|Count of Participants|37|37.0||||||
3667794|NCT02349048|3512587|B2||Female|Gender||Participants|Count of Participants|5|5.0||||||
3667795|NCT02349048|3512588|B1||Female|Gender||Participants|Count of Participants|32|32.0||||||
3667796|NCT02349048|3512586|B3|||Age||years|Median|50.5|50.5|Full Range|||18.0|64.0|
3667797|NCT02349048|3512587|B2|||Age||years|Median|56|56.0|Full Range|||52.0|64.0|
3667798|NCT02349048|3512588|B1|||Age||years|Median|47|47.0|Full Range|||18.0|63.0|
3667799|NCT02348918|3512609|B10|United States||Region of Enrollment||Participants|Count of Participants|218|218.0||||||
3667800|NCT02348918|3512610|B9|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3667801|NCT02348918|3512611|B8|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3667802|NCT02348918|3512612|B7|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3667803|NCT02348918|3512613|B6|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3667804|NCT02348918|3512614|B5|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3667805|NCT02348918|3512615|B4|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3667806|NCT02348918|3512616|B3|United States||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3667807|NCT02348918|3512617|B2|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3667808|NCT02348918|3512618|B1|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3667809|NCT02348918|3512609|B10|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3667810|NCT02348918|3512610|B9|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3667811|NCT02348918|3512611|B8|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3667812|NCT02348918|3512612|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3667813|NCT02348918|3512613|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3667814|NCT02348918|3512614|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3667815|NCT02348918|3512615|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3667816|NCT02348918|3512616|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3667817|NCT02348918|3512617|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3667818|NCT02348918|3512618|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3667819|NCT02348918|3512609|B10|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3667820|NCT02348918|3512610|B9|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3667821|NCT02348918|3512611|B8|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3667822|NCT02348918|3512612|B7|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3667823|NCT02348918|3512613|B6|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3667824|NCT02348918|3512614|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3667825|NCT02348918|3512615|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3667826|NCT02348918|3512616|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3667827|NCT02348918|3512617|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3667828|NCT02348918|3512618|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3667829|NCT02348918|3512609|B10|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3667830|NCT02348918|3512610|B9|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3667831|NCT02348918|3512611|B8|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3667832|NCT02348918|3512612|B7|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3667833|NCT02348918|3512613|B6|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3667834|NCT02348918|3512614|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3667835|NCT02348918|3512615|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3667836|NCT02348918|3512616|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3667837|NCT02348918|3512617|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3667838|NCT02348918|3512618|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3667839|NCT02348918|3512609|B10|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3667840|NCT02348918|3512610|B9|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3667841|NCT02348918|3512611|B8|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3667842|NCT02348918|3512612|B7|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3667843|NCT02348918|3512613|B6|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3667844|NCT02348918|3512614|B5|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3667845|NCT02348918|3512615|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3667846|NCT02348918|3512616|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3667847|NCT02348918|3512617|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3667848|NCT02348918|3512618|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3667849|NCT02348918|3512609|B10|white||Race/Ethnicity, Customized||Participants|Count of Participants|181|181.0||||||
3667850|NCT02348918|3512610|B9|white||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3667851|NCT02348918|3512611|B8|white||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3667852|NCT02348918|3512612|B7|white||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3667853|NCT02348918|3512613|B6|white||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3667854|NCT02348918|3512614|B5|white||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3667855|NCT02348918|3512615|B4|white||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3667856|NCT02348918|3512616|B3|white||Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
3667857|NCT02348918|3512617|B2|white||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3667858|NCT02348918|3512618|B1|white||Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3667859|NCT02348918|3512609|B10||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3667860|NCT02348918|3512610|B9||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3667861|NCT02348918|3512611|B8||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3667862|NCT02348918|3512612|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3667863|NCT02348918|3512613|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3667864|NCT02348918|3512614|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3667865|NCT02348918|3512615|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3667866|NCT02348918|3512616|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3667867|NCT02348918|3512617|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3667868|NCT02348918|3512618|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3667869|NCT02348918|3512609|B10||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3667870|NCT02348918|3512610|B9||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3667871|NCT02348918|3512611|B8||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3667872|NCT02348918|3512612|B7||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3667873|NCT02348918|3512613|B6||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3667874|NCT02348918|3512614|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3667875|NCT02348918|3512615|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3667876|NCT02348918|3512616|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3667877|NCT02348918|3512617|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3667878|NCT02348918|3512618|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3667879|NCT02348918|3512609|B10|||Age||years|Mean|62.3|62.3|Standard Deviation|9.35|9.35|||
3667880|NCT02348918|3512610|B9|||Age||years|Mean|62.1|62.1|Standard Deviation|9.35|9.35|||
3667881|NCT02348918|3512611|B8|||Age||years|Mean|60.5|60.5|Standard Deviation|8.29|8.29|||
3667882|NCT02348918|3512612|B7|||Age||years|Mean|60.1|60.1|Standard Deviation|10.92|10.92|||
3667883|NCT02348918|3512613|B6|||Age||years|Mean|65.5|65.5|Standard Deviation|9.41|9.41|||
3667884|NCT02348918|3512614|B5|||Age||years|Mean|67.1|67.1|Standard Deviation|10.47|10.47|||
3667885|NCT02348918|3512615|B4|||Age||years|Mean|60.3|60.3|Standard Deviation|8.83|8.83|||
3667886|NCT02348918|3512616|B3|||Age||years|Mean|63.8|63.8|Standard Deviation|9.45|9.45|||
3667887|NCT02348918|3512617|B2|||Age||years|Mean|61|61.0|Standard Deviation|9.91|9.91|||
3667888|NCT02348918|3512618|B1|||Age||years|Mean|62.9|62.9|Standard Deviation|9.05|9.05|||
3667889|NCT02348918|3512609|B10||>=65 years|Age||Participants|Count of Participants|83|83.0||||||
3667890|NCT02348918|3512610|B9||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3667891|NCT02348918|3512611|B8||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3667892|NCT02348918|3512612|B7||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3667893|NCT02348918|3512613|B6||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3667894|NCT02348918|3512614|B5||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3667895|NCT02348918|3512615|B4||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3667896|NCT02348918|3512616|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3667897|NCT02348918|3512617|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3667898|NCT02348918|3512618|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3667899|NCT02348918|3512609|B10||Between 18 and 65 years|Age||Participants|Count of Participants|135|135.0||||||
3667900|NCT02348918|3512610|B9||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3667901|NCT02348918|3512611|B8||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3667902|NCT02348918|3512612|B7||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3667903|NCT02348918|3512613|B6||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3667904|NCT02348918|3512614|B5||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3667905|NCT02348918|3512615|B4||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3667906|NCT02348918|3512616|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3667907|NCT02348918|3512617|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3667908|NCT02348918|3512618|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3667909|NCT02348918|3512609|B10||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3667910|NCT02348918|3512610|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3667911|NCT02348918|3512611|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3667912|NCT02348918|3512612|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3667913|NCT02348918|3512613|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3667914|NCT02348918|3512614|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3667915|NCT02348918|3512615|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3667916|NCT02348918|3512616|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3667917|NCT02348918|3512617|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3667918|NCT02348918|3512618|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3667919|NCT02348723|3512646|B3||Male|Sex: Female, Male||Participants|Count of Participants|502|502.0||||||
3667920|NCT02348723|3512647|B2||Male|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
3667921|NCT02348723|3512648|B1||Male|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
3667922|NCT02348723|3512646|B3||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3667923|NCT02348723|3512647|B2||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3667924|NCT02348723|3512648|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3667925|NCT02348723|3512646|B3|||Age||years|Mean|59.3|59.3|Standard Deviation|10.30|10.3|||
3667926|NCT02348723|3512647|B2|||Age||years|Mean|59.4|59.4|Standard Deviation|10.29|10.29|||
3667927|NCT02348723|3512648|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|10.33|10.33|||
3667928|NCT02348658|3512661|B1|Caffeine Non-Consumer||Caffeine Classification||participants|Number|11|11.0||||||
3667929|NCT02348658|3512661|B1|Caffeine Consumer||Caffeine Classification||participants|Number|1|1.0||||||
3667930|NCT02348658|3512661|B1|Had Never Drunk||Alcohol Classification||participants|Number|5|5.0||||||
3667931|NCT02348658|3512661|B1|Drinks a few Days per Month||Alcohol Classification||participants|Number|7|7.0||||||
3667932|NCT02348658|3512661|B1|Ex-Smoker||Smoking Classification||participants|Number|3|3.0||||||
3667933|NCT02348658|3512661|B1|Current Smoker||Smoking Classification||participants|Number|3|3.0||||||
3667934|NCT02348658|3512661|B1|Never Smoked||Smoking Classification||participants|Number|6|6.0||||||
3667935|NCT02348658|3512661|B1|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|20.85|20.85|Standard Deviation|1.499|1.499|||
3667936|NCT02348658|3512661|B1|||Weight||kilogram (kg)|Mean|61.18|61.18|Standard Deviation|5.548|5.548|||
3667937|NCT02348658|3512661|B1|||Height||centimeter (cm)|Mean|171.3|171.3|Standard Deviation|6.03|6.03|||
3667938|NCT02348658|3512661|B1|Japan||Region of Enrollment||participants|Number|12|12.0||||||
3667939|NCT02348658|3512661|B1|Male||Sex/Gender, Customized||participants|Number|12|12.0||||||
3667940|NCT02348658|3512661|B1|||Age||years|Mean|22.2|22.2|Standard Deviation|3.54|3.54|||
3667941|NCT02348359|3512696|B5|||Best corrected visual acuity||Number of letters|Mean|71.0|71.0|Standard Deviation|11.83|11.83|||
3667942|NCT02348359|3512697|B4|||Best corrected visual acuity||Number of letters|Mean|68.8|68.8|Standard Deviation|12.43|12.43|||
3667943|NCT02348359|3512698|B3|||Best corrected visual acuity||Number of letters|Mean|71.9|71.9|Standard Deviation|13.17|13.17|||
3667944|NCT02348359|3512699|B2|||Best corrected visual acuity||Number of letters|Mean|71.2|71.2|Standard Deviation|12.17|12.17|||
3667945|NCT02348359|3512700|B1|||Best corrected visual acuity||Number of letters|Mean|72.3|72.3|Standard Deviation|9.41|9.41|||
3667946|NCT02348359|3512696|B5|United States||Region of Enrollment||participants|Number|157|157.0||||||
3667947|NCT02348359|3512697|B4|United States||Region of Enrollment||participants|Number|39|39.0||||||
3667948|NCT02348359|3512698|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
3667949|NCT02348359|3512699|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
3667950|NCT02348359|3512700|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3667951|NCT02348359|3512696|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667952|NCT02348359|3512697|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667953|NCT02348359|3512698|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667954|NCT02348359|3512699|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667955|NCT02348359|3512700|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667956|NCT02348359|3512696|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3667957|NCT02348359|3512697|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667958|NCT02348359|3512698|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667959|NCT02348359|3512699|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3667960|NCT02348359|3512700|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667961|NCT02348359|3512696|B5||White|Race (NIH/OMB)||Participants|Count of Participants|154|154.0||||||
3667962|NCT02348359|3512697|B4||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3667963|NCT02348359|3512698|B3||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3667964|NCT02348359|3512699|B2||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3667965|NCT02348359|3512700|B1||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3667966|NCT02348359|3512696|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667967|NCT02348359|3512697|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667968|NCT02348359|3512698|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667969|NCT02348359|3512699|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667970|NCT02348359|3512700|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667971|NCT02348359|3512696|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667972|NCT02348359|3512697|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667973|NCT02348359|3512698|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667974|NCT02348359|3512699|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667975|NCT02348359|3512700|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667976|NCT02348359|3512696|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3667977|NCT02348359|3512697|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3667978|NCT02348359|3512698|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3667979|NCT02348359|3512699|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667980|NCT02348359|3512700|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667981|NCT02348359|3512696|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667982|NCT02348359|3512697|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667983|NCT02348359|3512698|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667984|NCT02348359|3512699|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667985|NCT02348359|3512700|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3667986|NCT02348359|3512696|B5||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3667987|NCT02348359|3512697|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3667988|NCT02348359|3512698|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3667989|NCT02348359|3512699|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3667990|NCT02348359|3512700|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3667991|NCT02348359|3512696|B5||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3667992|NCT02348359|3512697|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3667993|NCT02348359|3512698|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3667994|NCT02348359|3512699|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3667995|NCT02348359|3512700|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3667996|NCT02348359|3512696|B5|||Age||years|Mean|75.0|75.0|Standard Deviation|7.95|7.95|||
3667997|NCT02348359|3512697|B4|||Age||years|Mean|75.9|75.9|Standard Deviation|7.65|7.65|||
3667998|NCT02348359|3512698|B3|||Age||years|Mean|75.0|75.0|Standard Deviation|7.63|7.63|||
3667999|NCT02348359|3512699|B2|||Age||years|Mean|73.5|73.5|Standard Deviation|8.33|8.33|||
3668000|NCT02348359|3512700|B1|||Age||years|Mean|75.7|75.7|Standard Deviation|8.23|8.23|||
3668001|NCT02347774|3512713|B4|||Forced expiratory volume in one second (FEV1)||liters|Least Squares Mean|1.3365|1.3365|Standard Deviation|0.51414|0.51414|||
3668002|NCT02347774|3512714|B3|||Forced expiratory volume in one second (FEV1)||liters|Least Squares Mean|1.13355|1.13355|Standard Deviation|0.48612|0.48612|||
3668003|NCT02347774|3512715|B2|||Forced expiratory volume in one second (FEV1)||liters|Least Squares Mean|1.3232|1.3232|Standard Deviation|0.50179|0.50179|||
3668004|NCT02347774|3512716|B1|||Forced expiratory volume in one second (FEV1)||liters|Least Squares Mean|1.3506|1.3506|Standard Deviation|0.55380|0.5538|||
3668005|NCT02347774|3512713|B4|background LABA use = no||Background long-acting beta(2) agonist (LABA) use||participants|Number|435|435.0||||||
3668006|NCT02347774|3512714|B3|background LABA use = no||Background long-acting beta(2) agonist (LABA) use||participants|Number|143|143.0||||||
3668007|NCT02347774|3512715|B2|background LABA use = no||Background long-acting beta(2) agonist (LABA) use||participants|Number|145|145.0||||||
3668008|NCT02347774|3512716|B1|background LABA use = no||Background long-acting beta(2) agonist (LABA) use||participants|Number|147|147.0||||||
3668009|NCT02347774|3512713|B4|background LABA use = yes||Background long-acting beta(2) agonist (LABA) use||participants|Number|205|205.0||||||
3668010|NCT02347774|3512714|B3|background LABA use = yes||Background long-acting beta(2) agonist (LABA) use||participants|Number|69|69.0||||||
3668011|NCT02347774|3512715|B2|background LABA use = yes||Background long-acting beta(2) agonist (LABA) use||participants|Number|69|69.0||||||
3668012|NCT02347774|3512716|B1|background LABA use = yes||Background long-acting beta(2) agonist (LABA) use||participants|Number|67|67.0||||||
3668013|NCT02347774|3512713|B4|hypertension||Cardiovascular risk (low/high) and categories for high cardiovascular risk||participants|Number|372|372.0||||||
3668014|NCT02347774|3512714|B3|hypertension||Cardiovascular risk (low/high) and categories for high cardiovascular risk||participants|Number|125|125.0||||||
3668015|NCT02347774|3512715|B2|hypertension||Cardiovascular risk (low/high) and categories for high cardiovascular risk||participants|Number|123|123.0||||||
3668016|NCT02347774|3512716|B1|hypertension||Cardiovascular risk (low/high) and categories for high cardiovascular risk||participants|Number|124|124.0||||||
3668017|NCT02347774|3512713|B4|heart failure||Cardiovascular risk (low/high) and categories for high cardiovascular risk||participants|Number|14|14.0||||||
3668018|NCT02347774|3512714|B3|heart failure||Cardiovascular risk (low/high) and categories for high cardiovascular risk||participants|Number|6|6.0||||||
3668019|NCT02347774|3512715|B2|heart failure||Cardiovascular risk (low/high) and categories for high cardiovascular risk||participants|Number|4|4.0||||||
3668020|NCT02347774|3512716|B1|heart failure||Cardiovascular risk (low/high) and categories for high cardiovascular risk||participants|Number|4|4.0||||||
3668021|NCT02347774|3512713|B4|clinically significant arrhythmia||Cardiovascular risk (low/high) and categories for high cardiovascular risk||participants|Number|19|19.0||||||
3668022|NCT02347774|3512714|B3|clinically significant arrhythmia||Cardiovascular risk (low/high) and categories for high cardiovascular risk||participants|Number|6|6.0||||||
3668023|NCT02347774|3512715|B2|clinically significant arrhythmia||Cardiovascular risk (low/high) and categories for high cardiovascular risk||participants|Number|7|7.0||||||
3668024|NCT02347774|3512716|B1|clinically significant arrhythmia||Cardiovascular risk (low/high) and categories for high cardiovascular risk||participants|Number|8|8.0||||||
3668025|NCT02347774|3512713|B4|peripheral arterial disease||Cardiovascular risk (low/high) and categories for high cardiovascular risk||participants|Number|33|33.0||||||
3668026|NCT02347774|3512714|B3|peripheral arterial disease||Cardiovascular risk (low/high) and categories for high cardiovascular risk||participants|Number|17|17.0||||||
3668027|NCT02347774|3512715|B2|peripheral arterial disease||Cardiovascular risk (low/high) and categories for high cardiovascular risk||participants|Number|9|9.0||||||
3668028|NCT02347774|3512716|B1|peripheral arterial disease||Cardiovascular risk (low/high) and categories for high cardiovascular risk||participants|Number|7|7.0||||||
3668029|NCT02347774|3512713|B4|cerebrovascular disease||Cardiovascular risk (low/high) and categories for high cardiovascular risk||participants|Number|27|27.0||||||
3668030|NCT02347774|3512714|B3|cerebrovascular disease||Cardiovascular risk (low/high) and categories for high cardiovascular risk||participants|Number|9|9.0||||||
3668031|NCT02347774|3512715|B2|cerebrovascular disease||Cardiovascular risk (low/high) and categories for high cardiovascular risk||participants|Number|8|8.0||||||
3668032|NCT02347774|3512716|B1|cerebrovascular disease||Cardiovascular risk (low/high) and categories for high cardiovascular risk||participants|Number|10|10.0||||||
3668033|NCT02347774|3512713|B4|ischemic heart disease||Cardiovascular risk (low/high) and categories for high cardiovascular risk||participants|Number|64|64.0||||||
3668034|NCT02347774|3512714|B3|ischemic heart disease||Cardiovascular risk (low/high) and categories for high cardiovascular risk||participants|Number|20|20.0||||||
3668035|NCT02347774|3512715|B2|ischemic heart disease||Cardiovascular risk (low/high) and categories for high cardiovascular risk||participants|Number|24|24.0||||||
3668036|NCT02347774|3512716|B1|ischemic heart disease||Cardiovascular risk (low/high) and categories for high cardiovascular risk||participants|Number|20|20.0||||||
3668037|NCT02347774|3512713|B4|high cardiovascular risk||Cardiovascular risk (low/high) and categories for high cardiovascular risk||participants|Number|406|406.0||||||
3668038|NCT02347774|3512714|B3|high cardiovascular risk||Cardiovascular risk (low/high) and categories for high cardiovascular risk||participants|Number|136|136.0||||||
3668039|NCT02347774|3512715|B2|high cardiovascular risk||Cardiovascular risk (low/high) and categories for high cardiovascular risk||participants|Number|136|136.0||||||
3668040|NCT02347774|3512716|B1|high cardiovascular risk||Cardiovascular risk (low/high) and categories for high cardiovascular risk||participants|Number|134|134.0||||||
3668041|NCT02347774|3512713|B4|low cardiovascular risk||Cardiovascular risk (low/high) and categories for high cardiovascular risk||participants|Number|234|234.0||||||
3668042|NCT02347774|3512714|B3|low cardiovascular risk||Cardiovascular risk (low/high) and categories for high cardiovascular risk||participants|Number|76|76.0||||||
3668043|NCT02347774|3512715|B2|low cardiovascular risk||Cardiovascular risk (low/high) and categories for high cardiovascular risk||participants|Number|78|78.0||||||
3668044|NCT02347774|3512716|B1|low cardiovascular risk||Cardiovascular risk (low/high) and categories for high cardiovascular risk||participants|Number|80|80.0||||||
3668045|NCT02347774|3512713|B4|United States||Region of Enrollment||Participants|Count of Participants|640|640.0||||||
3668046|NCT02347774|3512714|B3|United States||Region of Enrollment||Participants|Count of Participants|212|212.0||||||
3668047|NCT02347774|3512715|B2|United States||Region of Enrollment||Participants|Count of Participants|214|214.0||||||
3668048|NCT02347774|3512716|B1|United States||Region of Enrollment||Participants|Count of Participants|214|214.0||||||
3668049|NCT02347774|3512713|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668050|NCT02347774|3512714|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668051|NCT02347774|3512715|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668052|NCT02347774|3512716|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668053|NCT02347774|3512713|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3668054|NCT02347774|3512714|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668055|NCT02347774|3512715|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3668056|NCT02347774|3512716|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668057|NCT02347774|3512713|B4||White|Race (NIH/OMB)||Participants|Count of Participants|565|565.0||||||
3668058|NCT02347774|3512714|B3||White|Race (NIH/OMB)||Participants|Count of Participants|192|192.0||||||
3668059|NCT02347774|3512715|B2||White|Race (NIH/OMB)||Participants|Count of Participants|185|185.0||||||
3668060|NCT02347774|3512716|B1||White|Race (NIH/OMB)||Participants|Count of Participants|188|188.0||||||
3668061|NCT02347774|3512713|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3668062|NCT02347774|3512714|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3668063|NCT02347774|3512715|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3668064|NCT02347774|3512716|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3668065|NCT02347774|3512713|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3668066|NCT02347774|3512714|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3668067|NCT02347774|3512715|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668068|NCT02347774|3512716|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668069|NCT02347774|3512713|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668070|NCT02347774|3512714|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668071|NCT02347774|3512715|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668072|NCT02347774|3512716|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668073|NCT02347774|3512713|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3668074|NCT02347774|3512714|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668075|NCT02347774|3512715|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3668076|NCT02347774|3512716|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668077|NCT02347774|3512713|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668078|NCT02347774|3512714|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668079|NCT02347774|3512715|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668080|NCT02347774|3512716|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668081|NCT02347774|3512713|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|632|632.0||||||
3668082|NCT02347774|3512714|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|209|209.0||||||
3668083|NCT02347774|3512715|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|212|212.0||||||
3668084|NCT02347774|3512716|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|211|211.0||||||
3668085|NCT02347774|3512713|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3668086|NCT02347774|3512714|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3668087|NCT02347774|3512715|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3668088|NCT02347774|3512716|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3668089|NCT02347774|3512713|B4||Male|Sex: Female, Male||Participants|Count of Participants|375|375.0||||||
3668090|NCT02347774|3512714|B3||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3668091|NCT02347774|3512715|B2||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3668092|NCT02347774|3512716|B1||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3668093|NCT02347774|3512713|B4||Female|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
3668094|NCT02347774|3512714|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3668095|NCT02347774|3512715|B2||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3668096|NCT02347774|3512716|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3668097|NCT02347774|3512713|B4|||Age||years|Mean|63.3|63.3|Standard Deviation|9.04|9.04|||
3668098|NCT02347774|3512714|B3|||Age||years|Mean|63.7|63.7|Standard Deviation|9.26|9.26|||
3668099|NCT02347774|3512715|B2|||Age||years|Mean|63.6|63.6|Standard Deviation|8.66|8.66|||
3668100|NCT02347774|3512716|B1|||Age||years|Mean|62.6|62.6|Standard Deviation|9.20|9.2|||
3668101|NCT02347774|3512713|B4||>=65 years|Age||Participants|Count of Participants|301|301.0||||||
3668102|NCT02347774|3512714|B3||>=65 years|Age||Participants|Count of Participants|101|101.0||||||
3668103|NCT02347774|3512715|B2||>=65 years|Age||Participants|Count of Participants|105|105.0||||||
3668104|NCT02347774|3512716|B1||>=65 years|Age||Participants|Count of Participants|95|95.0||||||
3668105|NCT02347774|3512713|B4||Between 18 and 65 years|Age||Participants|Count of Participants|339|339.0||||||
3668106|NCT02347774|3512714|B3||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
3668180|NCT02347761|3512774|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668107|NCT02347774|3512715|B2||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
3668108|NCT02347774|3512716|B1||Between 18 and 65 years|Age||Participants|Count of Participants|119|119.0||||||
3668109|NCT02347774|3512713|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3668110|NCT02347774|3512714|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3668111|NCT02347774|3512715|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3668112|NCT02347774|3512716|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3668113|NCT02347761|3512771|B4|||Forced expiratory volume in one second (FEV1)|spirometry was performed according to internationally accepted standards. Baseline FEV1 is defined as the mean of the two dose values at 45 and 15 minutes prior to first dose.|liters|Mean|1.3325|1.3325|Standard Deviation|0.50297|0.50297|||
3668114|NCT02347761|3512772|B3|||Forced expiratory volume in one second (FEV1)|spirometry was performed according to internationally accepted standards. Baseline FEV1 is defined as the mean of the two dose values at 45 and 15 minutes prior to first dose.|liters|Mean|1.3122|1.3122|Standard Deviation|0.47511|0.47511|||
3668115|NCT02347761|3512773|B2|||Forced expiratory volume in one second (FEV1)|spirometry was performed according to internationally accepted standards. Baseline FEV1 is defined as the mean of the two dose values at 45 and 15 minutes prior to first dose.|liters|Mean|1.3108|1.3108|Standard Deviation|0.50243|0.50243|||
3668116|NCT02347761|3512774|B1|||Forced expiratory volume in one second (FEV1)|spirometry was performed according to internationally accepted standards. Baseline FEV1 is defined as the mean of the two dose values at 45 and 15 minutes prior to first dose.|liters|Mean|1.3745|1.3745|Standard Deviation|0.52957|0.52957|||
3668117|NCT02347761|3512771|B4|background LABA use =no||background long-acting beta(2) agonist (LABA) use|"background LABA [+/- ICS] use was stratified as yes or no where the continuation of background therapy, in approximately 30% of the study population, required the subject to be on a stable dose of the medication for 4 weeks prior to study entry."|Participants|Count of Participants|456|456.0||||||
3668118|NCT02347761|3512772|B3|background LABA use =no||background long-acting beta(2) agonist (LABA) use|"background LABA [+/- ICS] use was stratified as yes or no where the continuation of background therapy, in approximately 30% of the study population, required the subject to be on a stable dose of the medication for 4 weeks prior to study entry."|Participants|Count of Participants|155|155.0||||||
3668119|NCT02347761|3512773|B2|background LABA use =no||background long-acting beta(2) agonist (LABA) use|"background LABA [+/- ICS] use was stratified as yes or no where the continuation of background therapy, in approximately 30% of the study population, required the subject to be on a stable dose of the medication for 4 weeks prior to study entry."|Participants|Count of Participants|151|151.0||||||
3668120|NCT02347761|3512774|B1|background LABA use =no||background long-acting beta(2) agonist (LABA) use|"background LABA [+/- ICS] use was stratified as yes or no where the continuation of background therapy, in approximately 30% of the study population, required the subject to be on a stable dose of the medication for 4 weeks prior to study entry."|Participants|Count of Participants|150|150.0||||||
3668121|NCT02347761|3512771|B4|background LABA use =yes||background long-acting beta(2) agonist (LABA) use|"background LABA [+/- ICS] use was stratified as yes or no where the continuation of background therapy, in approximately 30% of the study population, required the subject to be on a stable dose of the medication for 4 weeks prior to study entry."|Participants|Count of Participants|197|197.0||||||
3668122|NCT02347761|3512772|B3|background LABA use =yes||background long-acting beta(2) agonist (LABA) use|"background LABA [+/- ICS] use was stratified as yes or no where the continuation of background therapy, in approximately 30% of the study population, required the subject to be on a stable dose of the medication for 4 weeks prior to study entry."|Participants|Count of Participants|63|63.0||||||
3668123|NCT02347761|3512773|B2|background LABA use =yes||background long-acting beta(2) agonist (LABA) use|"background LABA [+/- ICS] use was stratified as yes or no where the continuation of background therapy, in approximately 30% of the study population, required the subject to be on a stable dose of the medication for 4 weeks prior to study entry."|Participants|Count of Participants|66|66.0||||||
3668124|NCT02347761|3512774|B1|background LABA use =yes||background long-acting beta(2) agonist (LABA) use|"background LABA [+/- ICS] use was stratified as yes or no where the continuation of background therapy, in approximately 30% of the study population, required the subject to be on a stable dose of the medication for 4 weeks prior to study entry."|Participants|Count of Participants|68|68.0||||||
3668125|NCT02347761|3512771|B4|hyertension||cardiovascular risk (low/high) and categories for high caridovascular risk|Cardiovascular risk was stratified as low versus high risk where the high risk stratum was defined as any participant with a pre-existing diagnosis of ischemic heart cardiovascular risk disease, cerebrovascular disease, peripheral arterial disease, hypertension, clinically significant arrhythmia or heart failure.|Participants|Count of Participants|393|393.0||||||
3668126|NCT02347761|3512772|B3|hyertension||cardiovascular risk (low/high) and categories for high caridovascular risk|Cardiovascular risk was stratified as low versus high risk where the high risk stratum was defined as any participant with a pre-existing diagnosis of ischemic heart cardiovascular risk disease, cerebrovascular disease, peripheral arterial disease, hypertension, clinically significant arrhythmia or heart failure.|Participants|Count of Participants|138|138.0||||||
3668127|NCT02347761|3512773|B2|hyertension||cardiovascular risk (low/high) and categories for high caridovascular risk|Cardiovascular risk was stratified as low versus high risk where the high risk stratum was defined as any participant with a pre-existing diagnosis of ischemic heart cardiovascular risk disease, cerebrovascular disease, peripheral arterial disease, hypertension, clinically significant arrhythmia or heart failure.|Participants|Count of Participants|128|128.0||||||
3668128|NCT02347761|3512774|B1|hyertension||cardiovascular risk (low/high) and categories for high caridovascular risk|Cardiovascular risk was stratified as low versus high risk where the high risk stratum was defined as any participant with a pre-existing diagnosis of ischemic heart cardiovascular risk disease, cerebrovascular disease, peripheral arterial disease, hypertension, clinically significant arrhythmia or heart failure.|Participants|Count of Participants|127|127.0||||||
3668176|NCT02347761|3512774|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3668177|NCT02347761|3512771|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3668178|NCT02347761|3512772|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3668129|NCT02347761|3512771|B4|heart failure||cardiovascular risk (low/high) and categories for high caridovascular risk|Cardiovascular risk was stratified as low versus high risk where the high risk stratum was defined as any participant with a pre-existing diagnosis of ischemic heart cardiovascular risk disease, cerebrovascular disease, peripheral arterial disease, hypertension, clinically significant arrhythmia or heart failure.|Participants|Count of Participants|24|24.0||||||
3668130|NCT02347761|3512772|B3|heart failure||cardiovascular risk (low/high) and categories for high caridovascular risk|Cardiovascular risk was stratified as low versus high risk where the high risk stratum was defined as any participant with a pre-existing diagnosis of ischemic heart cardiovascular risk disease, cerebrovascular disease, peripheral arterial disease, hypertension, clinically significant arrhythmia or heart failure.|Participants|Count of Participants|8|8.0||||||
3668131|NCT02347761|3512773|B2|heart failure||cardiovascular risk (low/high) and categories for high caridovascular risk|Cardiovascular risk was stratified as low versus high risk where the high risk stratum was defined as any participant with a pre-existing diagnosis of ischemic heart cardiovascular risk disease, cerebrovascular disease, peripheral arterial disease, hypertension, clinically significant arrhythmia or heart failure.|Participants|Count of Participants|7|7.0||||||
3668132|NCT02347761|3512774|B1|heart failure||cardiovascular risk (low/high) and categories for high caridovascular risk|Cardiovascular risk was stratified as low versus high risk where the high risk stratum was defined as any participant with a pre-existing diagnosis of ischemic heart cardiovascular risk disease, cerebrovascular disease, peripheral arterial disease, hypertension, clinically significant arrhythmia or heart failure.|Participants|Count of Participants|9|9.0||||||
3668133|NCT02347761|3512771|B4|clinically significant arrhythmia||cardiovascular risk (low/high) and categories for high caridovascular risk|Cardiovascular risk was stratified as low versus high risk where the high risk stratum was defined as any participant with a pre-existing diagnosis of ischemic heart cardiovascular risk disease, cerebrovascular disease, peripheral arterial disease, hypertension, clinically significant arrhythmia or heart failure.|Participants|Count of Participants|22|22.0||||||
3668134|NCT02347761|3512772|B3|clinically significant arrhythmia||cardiovascular risk (low/high) and categories for high caridovascular risk|Cardiovascular risk was stratified as low versus high risk where the high risk stratum was defined as any participant with a pre-existing diagnosis of ischemic heart cardiovascular risk disease, cerebrovascular disease, peripheral arterial disease, hypertension, clinically significant arrhythmia or heart failure.|Participants|Count of Participants|2|2.0||||||
3668135|NCT02347761|3512773|B2|clinically significant arrhythmia||cardiovascular risk (low/high) and categories for high caridovascular risk|Cardiovascular risk was stratified as low versus high risk where the high risk stratum was defined as any participant with a pre-existing diagnosis of ischemic heart cardiovascular risk disease, cerebrovascular disease, peripheral arterial disease, hypertension, clinically significant arrhythmia or heart failure.|Participants|Count of Participants|13|13.0||||||
3668136|NCT02347761|3512774|B1|clinically significant arrhythmia||cardiovascular risk (low/high) and categories for high caridovascular risk|Cardiovascular risk was stratified as low versus high risk where the high risk stratum was defined as any participant with a pre-existing diagnosis of ischemic heart cardiovascular risk disease, cerebrovascular disease, peripheral arterial disease, hypertension, clinically significant arrhythmia or heart failure.|Participants|Count of Participants|7|7.0||||||
3668137|NCT02347761|3512771|B4|peripheral arterial disease||cardiovascular risk (low/high) and categories for high caridovascular risk|Cardiovascular risk was stratified as low versus high risk where the high risk stratum was defined as any participant with a pre-existing diagnosis of ischemic heart cardiovascular risk disease, cerebrovascular disease, peripheral arterial disease, hypertension, clinically significant arrhythmia or heart failure.|Participants|Count of Participants|37|37.0||||||
3668138|NCT02347761|3512772|B3|peripheral arterial disease||cardiovascular risk (low/high) and categories for high caridovascular risk|Cardiovascular risk was stratified as low versus high risk where the high risk stratum was defined as any participant with a pre-existing diagnosis of ischemic heart cardiovascular risk disease, cerebrovascular disease, peripheral arterial disease, hypertension, clinically significant arrhythmia or heart failure.|Participants|Count of Participants|14|14.0||||||
3668139|NCT02347761|3512773|B2|peripheral arterial disease||cardiovascular risk (low/high) and categories for high caridovascular risk|Cardiovascular risk was stratified as low versus high risk where the high risk stratum was defined as any participant with a pre-existing diagnosis of ischemic heart cardiovascular risk disease, cerebrovascular disease, peripheral arterial disease, hypertension, clinically significant arrhythmia or heart failure.|Participants|Count of Participants|13|13.0||||||
3668140|NCT02347761|3512774|B1|peripheral arterial disease||cardiovascular risk (low/high) and categories for high caridovascular risk|Cardiovascular risk was stratified as low versus high risk where the high risk stratum was defined as any participant with a pre-existing diagnosis of ischemic heart cardiovascular risk disease, cerebrovascular disease, peripheral arterial disease, hypertension, clinically significant arrhythmia or heart failure.|Participants|Count of Participants|10|10.0||||||
3668141|NCT02347761|3512771|B4|cerebrovascular disease||cardiovascular risk (low/high) and categories for high caridovascular risk|Cardiovascular risk was stratified as low versus high risk where the high risk stratum was defined as any participant with a pre-existing diagnosis of ischemic heart cardiovascular risk disease, cerebrovascular disease, peripheral arterial disease, hypertension, clinically significant arrhythmia or heart failure.|Participants|Count of Participants|37|37.0||||||
3668142|NCT02347761|3512772|B3|cerebrovascular disease||cardiovascular risk (low/high) and categories for high caridovascular risk|Cardiovascular risk was stratified as low versus high risk where the high risk stratum was defined as any participant with a pre-existing diagnosis of ischemic heart cardiovascular risk disease, cerebrovascular disease, peripheral arterial disease, hypertension, clinically significant arrhythmia or heart failure.|Participants|Count of Participants|14|14.0||||||
3668143|NCT02347761|3512773|B2|cerebrovascular disease||cardiovascular risk (low/high) and categories for high caridovascular risk|Cardiovascular risk was stratified as low versus high risk where the high risk stratum was defined as any participant with a pre-existing diagnosis of ischemic heart cardiovascular risk disease, cerebrovascular disease, peripheral arterial disease, hypertension, clinically significant arrhythmia or heart failure.|Participants|Count of Participants|13|13.0||||||
3668179|NCT02347761|3512773|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3668144|NCT02347761|3512774|B1|cerebrovascular disease||cardiovascular risk (low/high) and categories for high caridovascular risk|Cardiovascular risk was stratified as low versus high risk where the high risk stratum was defined as any participant with a pre-existing diagnosis of ischemic heart cardiovascular risk disease, cerebrovascular disease, peripheral arterial disease, hypertension, clinically significant arrhythmia or heart failure.|Participants|Count of Participants|10|10.0||||||
3668145|NCT02347761|3512771|B4|high cardiovascular risk||cardiovascular risk (low/high) and categories for high caridovascular risk|Cardiovascular risk was stratified as low versus high risk where the high risk stratum was defined as any participant with a pre-existing diagnosis of ischemic heart cardiovascular risk disease, cerebrovascular disease, peripheral arterial disease, hypertension, clinically significant arrhythmia or heart failure.|Participants|Count of Participants|422|422.0||||||
3668146|NCT02347761|3512772|B3|high cardiovascular risk||cardiovascular risk (low/high) and categories for high caridovascular risk|Cardiovascular risk was stratified as low versus high risk where the high risk stratum was defined as any participant with a pre-existing diagnosis of ischemic heart cardiovascular risk disease, cerebrovascular disease, peripheral arterial disease, hypertension, clinically significant arrhythmia or heart failure.|Participants|Count of Participants|142|142.0||||||
3668147|NCT02347761|3512773|B2|high cardiovascular risk||cardiovascular risk (low/high) and categories for high caridovascular risk|Cardiovascular risk was stratified as low versus high risk where the high risk stratum was defined as any participant with a pre-existing diagnosis of ischemic heart cardiovascular risk disease, cerebrovascular disease, peripheral arterial disease, hypertension, clinically significant arrhythmia or heart failure.|Participants|Count of Participants|139|139.0||||||
3668148|NCT02347761|3512774|B1|high cardiovascular risk||cardiovascular risk (low/high) and categories for high caridovascular risk|Cardiovascular risk was stratified as low versus high risk where the high risk stratum was defined as any participant with a pre-existing diagnosis of ischemic heart cardiovascular risk disease, cerebrovascular disease, peripheral arterial disease, hypertension, clinically significant arrhythmia or heart failure.|Participants|Count of Participants|141|141.0||||||
3668149|NCT02347761|3512771|B4|low cardiovascular risk||cardiovascular risk (low/high) and categories for high caridovascular risk|Cardiovascular risk was stratified as low versus high risk where the high risk stratum was defined as any participant with a pre-existing diagnosis of ischemic heart cardiovascular risk disease, cerebrovascular disease, peripheral arterial disease, hypertension, clinically significant arrhythmia or heart failure.|Participants|Count of Participants|231|231.0||||||
3668150|NCT02347761|3512772|B3|low cardiovascular risk||cardiovascular risk (low/high) and categories for high caridovascular risk|Cardiovascular risk was stratified as low versus high risk where the high risk stratum was defined as any participant with a pre-existing diagnosis of ischemic heart cardiovascular risk disease, cerebrovascular disease, peripheral arterial disease, hypertension, clinically significant arrhythmia or heart failure.|Participants|Count of Participants|76|76.0||||||
3668151|NCT02347761|3512773|B2|low cardiovascular risk||cardiovascular risk (low/high) and categories for high caridovascular risk|Cardiovascular risk was stratified as low versus high risk where the high risk stratum was defined as any participant with a pre-existing diagnosis of ischemic heart cardiovascular risk disease, cerebrovascular disease, peripheral arterial disease, hypertension, clinically significant arrhythmia or heart failure.|Participants|Count of Participants|78|78.0||||||
3668152|NCT02347761|3512774|B1|low cardiovascular risk||cardiovascular risk (low/high) and categories for high caridovascular risk|Cardiovascular risk was stratified as low versus high risk where the high risk stratum was defined as any participant with a pre-existing diagnosis of ischemic heart cardiovascular risk disease, cerebrovascular disease, peripheral arterial disease, hypertension, clinically significant arrhythmia or heart failure.|Participants|Count of Participants|77|77.0||||||
3668153|NCT02347761|3512771|B4|United States||Region of Enrollment||Participants|Count of Participants|653|653.0||||||
3668154|NCT02347761|3512772|B3|United States||Region of Enrollment||Participants|Count of Participants|218|218.0||||||
3668155|NCT02347761|3512773|B2|United States||Region of Enrollment||Participants|Count of Participants|217|217.0||||||
3668156|NCT02347761|3512774|B1|United States||Region of Enrollment||Participants|Count of Participants|218|218.0||||||
3668157|NCT02347761|3512771|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668158|NCT02347761|3512772|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668159|NCT02347761|3512773|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668160|NCT02347761|3512774|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668161|NCT02347761|3512771|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668162|NCT02347761|3512772|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668163|NCT02347761|3512773|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668164|NCT02347761|3512774|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668165|NCT02347761|3512771|B4||White|Race (NIH/OMB)||Participants|Count of Participants|594|594.0||||||
3668166|NCT02347761|3512772|B3||White|Race (NIH/OMB)||Participants|Count of Participants|196|196.0||||||
3668167|NCT02347761|3512773|B2||White|Race (NIH/OMB)||Participants|Count of Participants|200|200.0||||||
3668168|NCT02347761|3512774|B1||White|Race (NIH/OMB)||Participants|Count of Participants|198|198.0||||||
3668169|NCT02347761|3512771|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3668170|NCT02347761|3512772|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3668171|NCT02347761|3512773|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3668172|NCT02347761|3512774|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3668173|NCT02347761|3512771|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3668174|NCT02347761|3512772|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668175|NCT02347761|3512773|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668181|NCT02347761|3512771|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3668182|NCT02347761|3512772|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3668183|NCT02347761|3512773|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3668184|NCT02347761|3512774|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3668185|NCT02347761|3512771|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668186|NCT02347761|3512772|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668187|NCT02347761|3512773|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668188|NCT02347761|3512774|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668189|NCT02347761|3512771|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|634|634.0||||||
3668190|NCT02347761|3512772|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|212|212.0||||||
3668191|NCT02347761|3512773|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|210|210.0||||||
3668192|NCT02347761|3512774|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|212|212.0||||||
3668193|NCT02347761|3512771|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3668194|NCT02347761|3512772|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3668195|NCT02347761|3512773|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3668196|NCT02347761|3512774|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3668197|NCT02347761|3512771|B4||Male|Sex: Female, Male||Participants|Count of Participants|349|349.0||||||
3668198|NCT02347761|3512772|B3||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3668199|NCT02347761|3512773|B2||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3668200|NCT02347761|3512774|B1||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3668201|NCT02347761|3512771|B4||Female|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
3668202|NCT02347761|3512772|B3||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3668203|NCT02347761|3512773|B2||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3668204|NCT02347761|3512774|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3668205|NCT02347761|3512771|B4|||Age||years|Mean|63.1|63.1|Standard Deviation|8.42|8.42|||
3668206|NCT02347761|3512772|B3|||Age||years|Mean|63.7|63.7|Standard Deviation|8.37|8.37|||
3668207|NCT02347761|3512773|B2|||Age||years|Mean|63.1|63.1|Standard Deviation|8.78|8.78|||
3668208|NCT02347761|3512774|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|8.09|8.09|||
3668209|NCT02347761|3512771|B4||>=65 years|Age||Participants|Count of Participants|287|287.0||||||
3668210|NCT02347761|3512772|B3||>=65 years|Age||Participants|Count of Participants|109|109.0||||||
3668211|NCT02347761|3512773|B2||>=65 years|Age||Participants|Count of Participants|95|95.0||||||
3668212|NCT02347761|3512774|B1||>=65 years|Age||Participants|Count of Participants|83|83.0||||||
3668213|NCT02347761|3512771|B4||Between 18 and 65 years|Age||Participants|Count of Participants|366|366.0||||||
3668214|NCT02347761|3512772|B3||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
3668215|NCT02347761|3512773|B2||Between 18 and 65 years|Age||Participants|Count of Participants|122|122.0||||||
3668216|NCT02347761|3512774|B1||Between 18 and 65 years|Age||Participants|Count of Participants|135|135.0||||||
3668217|NCT02347761|3512771|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3668218|NCT02347761|3512772|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3668219|NCT02347761|3512773|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3668220|NCT02347761|3512774|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3668221|NCT02347657|3512835|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3668222|NCT02347657|3512836|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3668223|NCT02347657|3512837|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668224|NCT02347657|3512835|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668225|NCT02347657|3512836|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668226|NCT02347657|3512837|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668227|NCT02347657|3512835|B3||White|Race (NIH/OMB)||Participants|Count of Participants|499|499.0||||||
3668228|NCT02347657|3512836|B2||White|Race (NIH/OMB)||Participants|Count of Participants|245|245.0||||||
3668229|NCT02347657|3512837|B1||White|Race (NIH/OMB)||Participants|Count of Participants|254|254.0||||||
3668230|NCT02347657|3512835|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3668231|NCT02347657|3512836|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3668232|NCT02347657|3512837|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668233|NCT02347657|3512835|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668234|NCT02347657|3512836|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668235|NCT02347657|3512837|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668236|NCT02347657|3512835|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3668237|NCT02347657|3512836|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668238|NCT02347657|3512837|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3668239|NCT02347657|3512835|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668240|NCT02347657|3512836|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668241|NCT02347657|3512837|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668242|NCT02347657|3512835|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3668243|NCT02347657|3512836|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3668244|NCT02347657|3512837|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3668245|NCT02347657|3512835|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|484|484.0||||||
3668246|NCT02347657|3512836|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|234|234.0||||||
3668247|NCT02347657|3512837|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|250|250.0||||||
3668248|NCT02347657|3512835|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3668249|NCT02347657|3512836|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3668250|NCT02347657|3512837|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3668251|NCT02347657|3512835|B3||Male|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
3668252|NCT02347657|3512836|B2||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3668253|NCT02347657|3512837|B1||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3668254|NCT02347657|3512835|B3||Female|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
3668255|NCT02347657|3512836|B2||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3668256|NCT02347657|3512837|B1||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3668257|NCT02347657|3512835|B3|||Age||years|Mean|26.3|26.3|Standard Deviation|10.4|10.4|||
3668258|NCT02347657|3512836|B2|||Age||years|Mean|26.9|26.9|Standard Deviation|11.2|11.2|||
3668259|NCT02347657|3512837|B1|||Age||years|Mean|25.7|25.7|Standard Deviation|9.5|9.5|||
3668260|NCT02347605|3512863|B7|United States||Region of Enrollment||participants|Number|56|56.0||||||
3668261|NCT02347605|3512864|B6|United States||Region of Enrollment||participants|Number|9|9.0||||||
3668262|NCT02347605|3512865|B5|United States||Region of Enrollment||participants|Number|9|9.0||||||
3668263|NCT02347605|3512866|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
3668264|NCT02347605|3512867|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3668265|NCT02347605|3512868|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3668266|NCT02347605|3512869|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3668267|NCT02347605|3512863|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3668268|NCT02347605|3512864|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668269|NCT02347605|3512865|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668270|NCT02347605|3512866|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3668271|NCT02347605|3512867|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668272|NCT02347605|3512868|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668273|NCT02347605|3512869|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668274|NCT02347605|3512863|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3668275|NCT02347605|3512864|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668276|NCT02347605|3512865|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668277|NCT02347605|3512866|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3668278|NCT02347605|3512867|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3668279|NCT02347605|3512868|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3668280|NCT02347605|3512869|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668281|NCT02347605|3512863|B7||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3668282|NCT02347605|3512864|B6||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3668283|NCT02347605|3512865|B5||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3668284|NCT02347605|3512866|B4||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3668285|NCT02347605|3512867|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3668286|NCT02347605|3512868|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3668287|NCT02347605|3512869|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3668288|NCT02347605|3512863|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3668289|NCT02347605|3512864|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3668290|NCT02347605|3512865|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3668291|NCT02347605|3512866|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3668292|NCT02347605|3512867|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668293|NCT02347605|3512868|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3668294|NCT02347605|3512869|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3668295|NCT02347605|3512863|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668296|NCT02347605|3512864|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668297|NCT02347605|3512865|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668298|NCT02347605|3512866|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668299|NCT02347605|3512867|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668300|NCT02347605|3512868|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668301|NCT02347605|3512869|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668302|NCT02347605|3512863|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668303|NCT02347605|3512864|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668304|NCT02347605|3512865|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668305|NCT02347605|3512866|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668306|NCT02347605|3512867|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668307|NCT02347605|3512868|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668308|NCT02347605|3512869|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668309|NCT02347605|3512863|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3668310|NCT02347605|3512864|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3668311|NCT02347605|3512865|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668312|NCT02347605|3512866|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3668313|NCT02347605|3512867|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668314|NCT02347605|3512868|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668315|NCT02347605|3512869|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668316|NCT02347605|3512863|B7||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3668317|NCT02347605|3512864|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3668318|NCT02347605|3512865|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3668319|NCT02347605|3512866|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3668320|NCT02347605|3512867|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3668321|NCT02347605|3512868|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3668322|NCT02347605|3512869|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3668323|NCT02347605|3512863|B7||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3668324|NCT02347605|3512864|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3668325|NCT02347605|3512865|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3668326|NCT02347605|3512866|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3668327|NCT02347605|3512867|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3668328|NCT02347605|3512868|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3668329|NCT02347605|3512869|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3668330|NCT02347605|3512863|B7|||Age||years|Mean|43.1|43.1|Standard Deviation|13.0|13.0|||
3668331|NCT02347605|3512864|B6|||Age||years|Mean|48.7|48.7|Standard Deviation|11.6|11.6|||
3668332|NCT02347605|3512865|B5|||Age||years|Mean|48.6|48.6|Standard Deviation|12.3|12.3|||
3668333|NCT02347605|3512866|B4|||Age||years|Mean|37|37.0|Standard Deviation|12.1|12.1|||
3668334|NCT02347605|3512867|B3|||Age||years|Mean|40.1|40.1|Standard Deviation|16.6|16.6|||
3668335|NCT02347605|3512868|B2|||Age||years|Mean|45.9|45.9|Standard Deviation|11.6|11.6|||
3668336|NCT02347605|3512869|B1|||Age||years|Mean|39.1|39.1|Standard Deviation|12.1|12.1|||
3668337|NCT02347488|3512885|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3668338|NCT02347488|3512885|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3668339|NCT02347488|3512885|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3668340|NCT02347488|3512885|B1|||Age||years|Mean|55.4|55.4|Full Range|||22.0|86.0|
3668341|NCT02347189|3512895|B1|Spain||Region of Enrollment||participants|Number|3|3.0||||||
3668342|NCT02347189|3512895|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3668343|NCT02347189|3512895|B1|Austria||Region of Enrollment||participants|Number|4|4.0||||||
3668344|NCT02347189|3512895|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
3668345|NCT02347189|3512895|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3668346|NCT02347189|3512895|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3668347|NCT02347189|3512895|B1|||Age||years|Mean|15.2|15.2|Standard Deviation|6.3|6.3|||
3668348|NCT02347176|3512899|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668349|NCT02347176|3512900|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668350|NCT02347176|3512901|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668351|NCT02347176|3512902|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668352|NCT02347176|3512903|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668353|NCT02347176|3512899|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3668354|NCT02347176|3512900|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3668355|NCT02347176|3512901|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668356|NCT02347176|3512902|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3668357|NCT02347176|3512903|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3668358|NCT02347176|3512899|B5||White|Race (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
3668359|NCT02347176|3512900|B4||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3668360|NCT02347176|3512901|B3||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3668361|NCT02347176|3512902|B2||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3668362|NCT02347176|3512903|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3668363|NCT02347176|3512899|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3668364|NCT02347176|3512900|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3668365|NCT02347176|3512901|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3668366|NCT02347176|3512902|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3668367|NCT02347176|3512903|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3668368|NCT02347176|3512899|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3668369|NCT02347176|3512900|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668370|NCT02347176|3512901|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668371|NCT02347176|3512902|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668372|NCT02347176|3512903|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3668373|NCT02347176|3512899|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3668374|NCT02347176|3512900|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3668375|NCT02347176|3512901|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3668376|NCT02347176|3512902|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3668377|NCT02347176|3512903|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3668378|NCT02347176|3512899|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3668379|NCT02347176|3512900|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668380|NCT02347176|3512901|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668381|NCT02347176|3512902|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3668382|NCT02347176|3512903|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668383|NCT02347176|3512899|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668384|NCT02347176|3512900|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668385|NCT02347176|3512901|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668386|NCT02347176|3512902|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668387|NCT02347176|3512903|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668388|NCT02347176|3512899|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|193|193.0||||||
3668389|NCT02347176|3512900|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3668390|NCT02347176|3512901|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3668391|NCT02347176|3512902|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3668392|NCT02347176|3512903|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3668393|NCT02347176|3512899|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3668394|NCT02347176|3512900|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3668395|NCT02347176|3512901|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3668396|NCT02347176|3512902|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3668397|NCT02347176|3512903|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3668398|NCT02347176|3512899|B5||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3668399|NCT02347176|3512900|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3668400|NCT02347176|3512901|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3668401|NCT02347176|3512902|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3668402|NCT02347176|3512903|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3668403|NCT02347176|3512899|B5||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3668404|NCT02347176|3512900|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3668405|NCT02347176|3512901|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3668406|NCT02347176|3512902|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3668407|NCT02347176|3512903|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3668408|NCT02347176|3512899|B5|||Age||Years|Mean|37.8|37.8|Standard Deviation|14.5|14.5|||
3668409|NCT02347176|3512900|B4|||Age||Years|Mean|35.7|35.7|Standard Deviation|14.6|14.6|||
3668410|NCT02347176|3512901|B3|||Age||Years|Mean|37.1|37.1|Standard Deviation|14.0|14.0|||
3668411|NCT02347176|3512902|B2|||Age||Years|Mean|39.1|39.1|Standard Deviation|15.1|15.1|||
3668412|NCT02347176|3512903|B1|||Age||Years|Mean|39.4|39.4|Standard Deviation|14.5|14.5|||
3668413|NCT02347124|3512952|B3|||Last dental visit > 1 year ago||Participants|Count of Participants|576|576.0||||||
3668414|NCT02347124|3512953|B2|||Last dental visit > 1 year ago||Participants|Count of Participants|282|282.0||||||
3668415|NCT02347124|3512954|B1|||Last dental visit > 1 year ago||Participants|Count of Participants|294|294.0||||||
3668416|NCT02347124|3512952|B3|||Cigarettes per day||cigarettes|Mean|19.1|19.1|Standard Deviation|9.7|9.7|||
3668417|NCT02347124|3512953|B2|||Cigarettes per day||cigarettes|Mean|19.3|19.3|Standard Deviation|9.7|9.7|||
3668418|NCT02347124|3512954|B1|||Cigarettes per day||cigarettes|Mean|18.9|18.9|Standard Deviation|9.5|9.5|||
3668419|NCT02347124|3512952|B3|United States||Region of Enrollment||Participants|Count of Participants|718|718.0||||||
3668420|NCT02347124|3512953|B2|United States||Region of Enrollment||Participants|Count of Participants|358|358.0||||||
3668421|NCT02347124|3512954|B1|United States||Region of Enrollment||Participants|Count of Participants|360|360.0||||||
3668422|NCT02347124|3512952|B3|Don't Know or Refused||Race/Ethnicity, Customized|"Subjects were asked: Which of the following categories best describe your race? (may indicate all that apply).~Categories offered were: White, Black or African-American, Native Hawaiian or Other Pacific Islander, American Indian, Other, Don't Know, Refused"|Participants|Count of Participants|4|4.0||||||
3668423|NCT02347124|3512953|B2|Don't Know or Refused||Race/Ethnicity, Customized|"Subjects were asked: Which of the following categories best describe your race? (may indicate all that apply).~Categories offered were: White, Black or African-American, Native Hawaiian or Other Pacific Islander, American Indian, Other, Don't Know, Refused"|Participants|Count of Participants|2|2.0||||||
3668424|NCT02347124|3512954|B1|Don't Know or Refused||Race/Ethnicity, Customized|"Subjects were asked: Which of the following categories best describe your race? (may indicate all that apply).~Categories offered were: White, Black or African-American, Native Hawaiian or Other Pacific Islander, American Indian, Other, Don't Know, Refused"|Participants|Count of Participants|2|2.0||||||
3668425|NCT02347124|3512952|B3|Other or multi-racial||Race/Ethnicity, Customized|"Subjects were asked: Which of the following categories best describe your race? (may indicate all that apply).~Categories offered were: White, Black or African-American, Native Hawaiian or Other Pacific Islander, American Indian, Other, Don't Know, Refused"|Participants|Count of Participants|89|89.0||||||
3668426|NCT02347124|3512953|B2|Other or multi-racial||Race/Ethnicity, Customized|"Subjects were asked: Which of the following categories best describe your race? (may indicate all that apply).~Categories offered were: White, Black or African-American, Native Hawaiian or Other Pacific Islander, American Indian, Other, Don't Know, Refused"|Participants|Count of Participants|52|52.0||||||
3668427|NCT02347124|3512954|B1|Other or multi-racial||Race/Ethnicity, Customized|"Subjects were asked: Which of the following categories best describe your race? (may indicate all that apply).~Categories offered were: White, Black or African-American, Native Hawaiian or Other Pacific Islander, American Indian, Other, Don't Know, Refused"|Participants|Count of Participants|37|37.0||||||
3668428|NCT02347124|3512952|B3|Black||Race/Ethnicity, Customized|"Subjects were asked: Which of the following categories best describe your race? (may indicate all that apply).~Categories offered were: White, Black or African-American, Native Hawaiian or Other Pacific Islander, American Indian, Other, Don't Know, Refused"|Participants|Count of Participants|208|208.0||||||
3668429|NCT02347124|3512953|B2|Black||Race/Ethnicity, Customized|"Subjects were asked: Which of the following categories best describe your race? (may indicate all that apply).~Categories offered were: White, Black or African-American, Native Hawaiian or Other Pacific Islander, American Indian, Other, Don't Know, Refused"|Participants|Count of Participants|95|95.0||||||
3668430|NCT02347124|3512954|B1|Black||Race/Ethnicity, Customized|"Subjects were asked: Which of the following categories best describe your race? (may indicate all that apply).~Categories offered were: White, Black or African-American, Native Hawaiian or Other Pacific Islander, American Indian, Other, Don't Know, Refused"|Participants|Count of Participants|113|113.0||||||
3668431|NCT02347124|3512952|B3|White||Race/Ethnicity, Customized|"Subjects were asked: Which of the following categories best describe your race? (may indicate all that apply).~Categories offered were: White, Black or African-American, Native Hawaiian or Other Pacific Islander, American Indian, Other, Don't Know, Refused"|Participants|Count of Participants|417|417.0||||||
3668432|NCT02347124|3512953|B2|White||Race/Ethnicity, Customized|"Subjects were asked: Which of the following categories best describe your race? (may indicate all that apply).~Categories offered were: White, Black or African-American, Native Hawaiian or Other Pacific Islander, American Indian, Other, Don't Know, Refused"|Participants|Count of Participants|209|209.0||||||
3668433|NCT02347124|3512954|B1|White||Race/Ethnicity, Customized|"Subjects were asked: Which of the following categories best describe your race? (may indicate all that apply).~Categories offered were: White, Black or African-American, Native Hawaiian or Other Pacific Islander, American Indian, Other, Don't Know, Refused"|Participants|Count of Participants|208|208.0||||||
3668434|NCT02347124|3512952|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668435|NCT02347124|3512953|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668436|NCT02347124|3512954|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668437|NCT02347124|3512952|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|697|697.0||||||
3668438|NCT02347124|3512953|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|342|342.0||||||
3668439|NCT02347124|3512954|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|355|355.0||||||
3668440|NCT02347124|3512952|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3668441|NCT02347124|3512953|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3668442|NCT02347124|3512954|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3668443|NCT02347124|3512952|B3||Male|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
3668444|NCT02347124|3512953|B2||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3668445|NCT02347124|3512954|B1||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3668446|NCT02347124|3512952|B3||Female|Sex: Female, Male||Participants|Count of Participants|443|443.0||||||
3668447|NCT02347124|3512953|B2||Female|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
3668448|NCT02347124|3512954|B1||Female|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
3668449|NCT02347124|3512952|B3|||Age||years|Mean|44.3|44.3|Standard Deviation|12.2|12.2|||
3668450|NCT02347124|3512953|B2|||Age||years|Mean|44.1|44.1|Standard Deviation|12.2|12.2|||
3668451|NCT02347124|3512954|B1|||Age||years|Mean|44.5|44.5|Standard Deviation|12.2|12.2|||
3668452|NCT02347085|3512989|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3668453|NCT02347085|3512989|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3668454|NCT02347085|3512989|B1|||Age||Years|Mean|61.3|61.3|Standard Deviation|9.2|9.2|||
3668455|NCT02347072|3513011|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3668456|NCT02347072|3513011|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3668457|NCT02347072|3513011|B1|||Age||Years|Mean|61.8|61.8|Standard Deviation|9.1|9.1|||
3668458|NCT02346877|3513043|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3668459|NCT02346877|3513045|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3668460|NCT02346877|3513043|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3668461|NCT02346877|3513045|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3668462|NCT02346877|3513043|B3|||Age||years|Mean|57.1|57.1|Standard Deviation|10.1|10.1|||
3668463|NCT02346877|3513045|B1|||Age||years|Mean|57.1|57.1|Standard Deviation|10.1|10.1|||
3668464|NCT02346721|3513056|B1|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|81|81.0||||||
3668465|NCT02346721|3513056|B1|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|30|30.0||||||
3668466|NCT02346721|3513056|B1|||HCV RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.55|0.55|||
3668467|NCT02346721|3513056|B1|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|25|25.0||||||
3668468|NCT02346721|3513056|B1|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|50|50.0||||||
3668469|NCT02346721|3513056|B1|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|36|36.0||||||
3668470|NCT02346721|3513056|B1|Puerto Rico||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3668471|NCT02346721|3513056|B1|Hong Kong||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3668472|NCT02346721|3513056|B1|Germany||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3668473|NCT02346721|3513056|B1|France||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3668474|NCT02346721|3513056|B1|Italy||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3668475|NCT02346721|3513056|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3668476|NCT02346721|3513056|B1|China||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3668477|NCT02346721|3513056|B1|United States||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3668478|NCT02346721|3513056|B1|Belgium||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3668479|NCT02346721|3513056|B1|Canada||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3668480|NCT02346721|3513056|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|106|106.0||||||
3668481|NCT02346721|3513056|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3668482|NCT02346721|3513056|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3668483|NCT02346721|3513056|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3668484|NCT02346721|3513056|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3668485|NCT02346721|3513056|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|85|85.0||||||
3668486|NCT02346721|3513056|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3668487|NCT02346721|3513056|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3668488|NCT02346721|3513056|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3668489|NCT02346721|3513056|B1|||Age||years|Mean|54|54.0|Standard Deviation|10.4|10.4|||
3668490|NCT02346643|3513065|B1|Sweden||Region of Enrollment||participants|Number|41|41.0||||||
3668491|NCT02346643|3513065|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668492|NCT02346643|3513065|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668493|NCT02346643|3513065|B1||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3668494|NCT02346643|3513065|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668495|NCT02346643|3513065|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668496|NCT02346643|3513065|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668497|NCT02346643|3513065|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668498|NCT02346643|3513065|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3668499|NCT02346643|3513065|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3668500|NCT02346643|3513065|B1|||Age||years|Mean|47|47.0|Full Range|||20.0|77.0|
3668501|NCT02346240|3513070|B5||Other/mixed|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3668502|NCT02346240|3513071|B4||Other/mixed|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3668503|NCT02346240|3513072|B3||Other/mixed|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3668504|NCT02346240|3513073|B2||Other/mixed|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3668505|NCT02346240|3513074|B1||Other/mixed|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3668506|NCT02346240|3513070|B5||White|Race/Ethnicity, Customized||Participants|Count of Participants|540|540.0||||||
3668507|NCT02346240|3513071|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|162|162.0||||||
3668508|NCT02346240|3513072|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|158|158.0||||||
3668509|NCT02346240|3513073|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|163|163.0||||||
3668510|NCT02346240|3513074|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|57|57.0||||||
3668511|NCT02346240|3513070|B5||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3668512|NCT02346240|3513071|B4||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3668513|NCT02346240|3513072|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3668514|NCT02346240|3513073|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3668515|NCT02346240|3513074|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3668516|NCT02346240|3513070|B5||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3668517|NCT02346240|3513071|B4||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3668518|NCT02346240|3513072|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3668519|NCT02346240|3513073|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3668520|NCT02346240|3513074|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3668521|NCT02346240|3513070|B5||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3668522|NCT02346240|3513071|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3668523|NCT02346240|3513072|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3668524|NCT02346240|3513073|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3668525|NCT02346240|3513074|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3668526|NCT02346240|3513070|B5||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3668527|NCT02346240|3513071|B4||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3668528|NCT02346240|3513072|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3668529|NCT02346240|3513073|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3668530|NCT02346240|3513074|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3668531|NCT02346240|3513070|B5||Male|Sex: Female, Male||Participants|Count of Participants|381|381.0||||||
3668532|NCT02346240|3513071|B4||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3668533|NCT02346240|3513072|B3||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3668534|NCT02346240|3513073|B2||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3668535|NCT02346240|3513074|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3668536|NCT02346240|3513070|B5||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
3668537|NCT02346240|3513071|B4||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3668538|NCT02346240|3513072|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3668539|NCT02346240|3513073|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3668540|NCT02346240|3513074|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3668541|NCT02346240|3513070|B5|||Age||years|Mean|45.7|45.7|Standard Deviation|13.3|13.3|||
3668542|NCT02346240|3513071|B4|||Age||years|Mean|45.4|45.4|Standard Deviation|12.4|12.4|||
3668543|NCT02346240|3513072|B3|||Age||years|Mean|46.7|46.7|Standard Deviation|13.5|13.5|||
3668544|NCT02346240|3513073|B2|||Age||years|Mean|44.6|44.6|Standard Deviation|14.1|14.1|||
3668545|NCT02346240|3513074|B1|||Age||years|Mean|46.5|46.5|Standard Deviation|12.5|12.5|||
3668546|NCT02346240|3513070|B5||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
3668547|NCT02346240|3513071|B4||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3668548|NCT02346240|3513072|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3668549|NCT02346240|3513073|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3668550|NCT02346240|3513074|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3668551|NCT02346240|3513070|B5||Between 18 and 65 years|Age||Participants|Count of Participants|519|519.0||||||
3668552|NCT02346240|3513071|B4||Between 18 and 65 years|Age||Participants|Count of Participants|156|156.0||||||
3668553|NCT02346240|3513072|B3||Between 18 and 65 years|Age||Participants|Count of Participants|153|153.0||||||
3668554|NCT02346240|3513073|B2||Between 18 and 65 years|Age||Participants|Count of Participants|157|157.0||||||
3668555|NCT02346240|3513074|B1||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
3668556|NCT02346240|3513070|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3668557|NCT02346240|3513071|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3668558|NCT02346240|3513072|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3668559|NCT02346240|3513073|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3668560|NCT02346240|3513074|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3668561|NCT02345720|3513130|B1|United Kingdom||Region of Enrollment||Participants|Number|20|20.0||||||
3668562|NCT02345720|3513130|B1|Asian||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
3668563|NCT02345720|3513130|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3668564|NCT02345720|3513130|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3668565|NCT02345720|3513130|B1|||Age||Years|Mean|50.6|50.6|Standard Deviation|6.85|6.85|||
3668566|NCT02345642|3513136|B3|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3668567|NCT02345642|3513137|B2|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3668568|NCT02345642|3513138|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3668569|NCT02345642|3513136|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3668570|NCT02345642|3513137|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3668571|NCT02345642|3513138|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3668572|NCT02345642|3513136|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3668573|NCT02345642|3513137|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3668574|NCT02345642|3513138|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3668575|NCT02345642|3513136|B3|||Age||years|Mean|46.65|46.65|Full Range|||21.0|70.0|
3668576|NCT02345642|3513137|B2|||Age||years|Mean|64.6|64.6|Full Range|||55.0|70.0|
3668577|NCT02345642|3513138|B1|||Age||years|Mean|28.7|28.7|Full Range|||21.0|43.0|
3668578|NCT02345642|3513136|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3668579|NCT02345642|3513137|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3668580|NCT02345642|3513138|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3668581|NCT02345642|3513136|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3668582|NCT02345642|3513137|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3668583|NCT02345642|3513138|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3668584|NCT02345642|3513136|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3668585|NCT02345642|3513137|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3668586|NCT02345642|3513138|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3668587|NCT02345460|3513145|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3668588|NCT02345460|3513145|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668589|NCT02345460|3513145|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668590|NCT02345460|3513145|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3668591|NCT02345460|3513145|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668592|NCT02345460|3513145|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668593|NCT02345460|3513145|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668594|NCT02345460|3513145|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668595|NCT02345460|3513145|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668596|NCT02345460|3513145|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3668597|NCT02345460|3513145|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668598|NCT02345460|3513145|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3668599|NCT02345460|3513145|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3668600|NCT02345460|3513145|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3668601|NCT02345460|3513145|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3668602|NCT02345460|3513145|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3668603|NCT02345330|3513169|B1|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3668604|NCT02345330|3513169|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3668605|NCT02345330|3513169|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3668606|NCT02345330|3513169|B1|||Age||years|Mean|52.8|52.8|Standard Deviation|4.50|4.5|||
3668607|NCT02345252|3513179|B3|||CD4 Cell Count||cells/μL|Mean|709|709.0|Standard Deviation|271.7|271.7|||
3668608|NCT02345252|3513180|B2|||CD4 Cell Count||cells/μL|Mean|707|707.0|Standard Deviation|264.7|264.7|||
3668609|NCT02345252|3513181|B1|||CD4 Cell Count||cells/μL|Mean|711|711.0|Standard Deviation|278.9|278.9|||
3668610|NCT02345252|3513179|B3|≥ 50 copies/mL||HIV-1 RNA Categories||Participants|Count of Participants|11|11.0||||||
3668611|NCT02345252|3513180|B2|≥ 50 copies/mL||HIV-1 RNA Categories||Participants|Count of Participants|2|2.0||||||
3668612|NCT02345252|3513181|B1|≥ 50 copies/mL||HIV-1 RNA Categories||Participants|Count of Participants|9|9.0||||||
3668613|NCT02345252|3513179|B3|< 50 copies/mL||HIV-1 RNA Categories||Participants|Count of Participants|619|619.0||||||
3668614|NCT02345252|3513180|B2|< 50 copies/mL||HIV-1 RNA Categories||Participants|Count of Participants|312|312.0||||||
3668615|NCT02345252|3513181|B1|< 50 copies/mL||HIV-1 RNA Categories||Participants|Count of Participants|307|307.0||||||
3668616|NCT02345252|3513179|B3|Spain||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3668617|NCT02345252|3513180|B2|Spain||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3668618|NCT02345252|3513181|B1|Spain||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3668619|NCT02345252|3513179|B3|Germany||Region of Enrollment||Participants|Count of Participants|57|57.0||||||
3668620|NCT02345252|3513180|B2|Germany||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3668621|NCT02345252|3513181|B1|Germany||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3668622|NCT02345252|3513179|B3|Switzerland||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3668623|NCT02345252|3513180|B2|Switzerland||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3668624|NCT02345252|3513181|B1|Switzerland||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3668625|NCT02345252|3513179|B3|France||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3668626|NCT02345252|3513180|B2|France||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3668627|NCT02345252|3513181|B1|France||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3668628|NCT02345252|3513179|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3668629|NCT02345252|3513180|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3668630|NCT02345252|3513181|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3668631|NCT02345252|3513179|B3|Italy||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3668632|NCT02345252|3513180|B2|Italy||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3668633|NCT02345252|3513181|B1|Italy||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3668634|NCT02345252|3513179|B3|United States||Region of Enrollment||Participants|Count of Participants|448|448.0||||||
3668635|NCT02345252|3513180|B2|United States||Region of Enrollment||Participants|Count of Participants|226|226.0||||||
3668636|NCT02345252|3513181|B1|United States||Region of Enrollment||Participants|Count of Participants|222|222.0||||||
3668637|NCT02345252|3513179|B3|Belgium||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3668638|NCT02345252|3513180|B2|Belgium||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3668639|NCT02345252|3513181|B1|Belgium||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3668640|NCT02345252|3513179|B3|Sweden||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3668641|NCT02345252|3513180|B2|Sweden||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3668642|NCT02345252|3513181|B1|Sweden||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3668643|NCT02345252|3513179|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3668644|NCT02345252|3513180|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3668645|NCT02345252|3513181|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3668646|NCT02345252|3513179|B3|Canada||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3668647|NCT02345252|3513180|B2|Canada||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3668648|NCT02345252|3513181|B1|Canada||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3668649|NCT02345252|3513179|B3|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3668650|NCT02345252|3513180|B2|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3668651|NCT02345252|3513181|B1|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3668652|NCT02345252|3513179|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|536|536.0||||||
3668653|NCT02345252|3513180|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|261|261.0||||||
3668654|NCT02345252|3513181|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|275|275.0||||||
3668655|NCT02345252|3513179|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|93|93.0||||||
3668656|NCT02345252|3513180|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|53|53.0||||||
3668657|NCT02345252|3513181|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3668658|NCT02345252|3513179|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3668659|NCT02345252|3513180|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3668660|NCT02345252|3513181|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3668661|NCT02345252|3513179|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|473|473.0||||||
3668662|NCT02345252|3513180|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|235|235.0||||||
3668663|NCT02345252|3513181|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|238|238.0||||||
3668664|NCT02345252|3513179|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3668665|NCT02345252|3513180|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3668666|NCT02345252|3513181|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3668667|NCT02345252|3513179|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|119|119.0||||||
3668668|NCT02345252|3513180|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|54|54.0||||||
3668669|NCT02345252|3513181|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|65|65.0||||||
3668670|NCT02345252|3513179|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3668671|NCT02345252|3513180|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3668672|NCT02345252|3513181|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3668673|NCT02345252|3513179|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3668674|NCT02345252|3513180|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3668675|NCT02345252|3513181|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3668676|NCT02345252|3513179|B3||Male|Sex: Female, Male||Participants|Count of Participants|564|564.0||||||
3668677|NCT02345252|3513180|B2||Male|Sex: Female, Male||Participants|Count of Participants|289|289.0||||||
3668678|NCT02345252|3513181|B1||Male|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
3668679|NCT02345252|3513179|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3668680|NCT02345252|3513180|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3668681|NCT02345252|3513181|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3668682|NCT02345252|3513179|B3|||Age||years|Mean|45|45.0|Standard Deviation|10.3|10.3|||
3668683|NCT02345252|3513180|B2|||Age||years|Mean|44|44.0|Standard Deviation|10.2|10.2|||
3668684|NCT02345252|3513181|B1|||Age||years|Mean|45|45.0|Standard Deviation|10.4|10.4|||
3668685|NCT02345226|3513196|B3|||CD4 Cell Count||cells//uL|Mean|700|700.0|Standard Deviation|278.4|278.4|||
3668686|NCT02345226|3513197|B2|||CD4 Cell Count||cells//uL|Mean|688|688.0|Standard Deviation|263.5|263.5|||
3668687|NCT02345226|3513198|B1|||CD4 Cell Count||cells//uL|Mean|711|711.0|Standard Deviation|292.3|292.3|||
3668688|NCT02345226|3513196|B3|≥ 50 copies/mL||HIV-1 RNA Categories||Participants|Count of Participants|13|13.0||||||
3668689|NCT02345226|3513197|B2|≥ 50 copies/mL||HIV-1 RNA Categories||Participants|Count of Participants|5|5.0||||||
3668690|NCT02345226|3513198|B1|≥ 50 copies/mL||HIV-1 RNA Categories||Participants|Count of Participants|8|8.0||||||
3668691|NCT02345226|3513196|B3|< 50 copies/mL||HIV-1 RNA Categories||Participants|Count of Participants|862|862.0||||||
3668692|NCT02345226|3513197|B2|< 50 copies/mL||HIV-1 RNA Categories||Participants|Count of Participants|432|432.0||||||
3668693|NCT02345226|3513198|B1|< 50 copies/mL||HIV-1 RNA Categories||Participants|Count of Participants|430|430.0||||||
3668694|NCT02345226|3513196|B3|Spain||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3668695|NCT02345226|3513197|B2|Spain||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3668696|NCT02345226|3513198|B1|Spain||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3668697|NCT02345226|3513196|B3|Germany||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3668698|NCT02345226|3513197|B2|Germany||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3668699|NCT02345226|3513198|B1|Germany||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3668700|NCT02345226|3513196|B3|Switzerland||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3668701|NCT02345226|3513197|B2|Switzerland||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3668702|NCT02345226|3513198|B1|Switzerland||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3668703|NCT02345226|3513196|B3|France||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3668704|NCT02345226|3513197|B2|France||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3668705|NCT02345226|3513198|B1|France||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3668706|NCT02345226|3513196|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3668707|NCT02345226|3513197|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3668708|NCT02345226|3513198|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3668709|NCT02345226|3513196|B3|United States||Region of Enrollment||Participants|Count of Participants|696|696.0||||||
3668710|NCT02345226|3513197|B2|United States||Region of Enrollment||Participants|Count of Participants|345|345.0||||||
3668711|NCT02345226|3513198|B1|United States||Region of Enrollment||Participants|Count of Participants|351|351.0||||||
3668712|NCT02345226|3513196|B3|Belgium||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3668713|NCT02345226|3513197|B2|Belgium||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3668714|NCT02345226|3513198|B1|Belgium||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3668715|NCT02345226|3513196|B3|Canada||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3668716|NCT02345226|3513197|B2|Canada||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3668717|NCT02345226|3513198|B1|Canada||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3668718|NCT02345226|3513196|B3|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3668719|NCT02345226|3513197|B2|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3668720|NCT02345226|3513198|B1|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3668721|NCT02345226|3513196|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|717|717.0||||||
3668722|NCT02345226|3513197|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|359|359.0||||||
3668723|NCT02345226|3513198|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|358|358.0||||||
3668724|NCT02345226|3513196|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|157|157.0||||||
3668725|NCT02345226|3513197|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|78|78.0||||||
3668726|NCT02345226|3513198|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|79|79.0||||||
3668727|NCT02345226|3513196|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3668728|NCT02345226|3513197|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3668729|NCT02345226|3513198|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3668730|NCT02345226|3513196|B3|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3668731|NCT02345226|3513197|B2|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3668732|NCT02345226|3513198|B1|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3668733|NCT02345226|3513196|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|583|583.0||||||
3668734|NCT02345226|3513197|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|292|292.0||||||
3668735|NCT02345226|3513198|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|291|291.0||||||
3668736|NCT02345226|3513196|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3668737|NCT02345226|3513197|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3668738|NCT02345226|3513198|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3668739|NCT02345226|3513196|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|238|238.0||||||
3668740|NCT02345226|3513197|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|120|120.0||||||
3668741|NCT02345226|3513198|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|118|118.0||||||
3668742|NCT02345226|3513196|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3668743|NCT02345226|3513197|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3668744|NCT02345226|3513198|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3668745|NCT02345226|3513196|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3668746|NCT02345226|3513197|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3668747|NCT02345226|3513198|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3668748|NCT02345226|3513196|B3||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3668749|NCT02345226|3513197|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3668750|NCT02345226|3513198|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3668751|NCT02345226|3513196|B3||Female|Sex: Female, Male||Participants|Count of Participants|763|763.0||||||
3668752|NCT02345226|3513197|B2||Female|Sex: Female, Male||Participants|Count of Participants|390|390.0||||||
3668753|NCT02345226|3513198|B1||Female|Sex: Female, Male||Participants|Count of Participants|373|373.0||||||
3668754|NCT02345226|3513196|B3|||Age||Years|Mean|48|48.0|Standard Deviation|10.1|10.1|||
3668755|NCT02345226|3513197|B2|||Age||Years|Mean|47|47.0|Standard Deviation|10.5|10.5|||
3668756|NCT02345226|3513198|B1|||Age||Years|Mean|48|48.0|Standard Deviation|9.8|9.8|||
3668757|NCT02345161|3513215|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|125|125.0||||||
3668758|NCT02345161|3513216|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|62|62.0||||||
3668759|NCT02345161|3513217|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|63|63.0||||||
3668760|NCT02345161|3513215|B3|White-White/Caucasina/Euorpean Heritage||Race/Ethnicity, Customized||Participants|Number|1530|1530.0||||||
3668761|NCT02345161|3513216|B2|White-White/Caucasina/Euorpean Heritage||Race/Ethnicity, Customized||Participants|Number|759|759.0||||||
3668762|NCT02345161|3513217|B1|White-White/Caucasina/Euorpean Heritage||Race/Ethnicity, Customized||Participants|Number|771|771.0||||||
3668763|NCT02345161|3513215|B3|White-Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
3668764|NCT02345161|3513216|B2|White-Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3668765|NCT02345161|3513217|B1|White-Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3668766|NCT02345161|3513215|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3668767|NCT02345161|3513216|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3668768|NCT02345161|3513217|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3668769|NCT02345161|3513215|B3|Asian-South East Asian Heritag||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3668770|NCT02345161|3513216|B2|Asian-South East Asian Heritag||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3668771|NCT02345161|3513217|B1|Asian-South East Asian Heritag||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3668772|NCT02345161|3513215|B3|Asian-East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|104|104.0||||||
3668773|NCT02345161|3513216|B2|Asian-East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|49|49.0||||||
3668774|NCT02345161|3513217|B1|Asian-East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|55|55.0||||||
3668775|NCT02345161|3513215|B3|Amrican Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
3668776|NCT02345161|3513216|B2|Amrican Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
3668777|NCT02345161|3513217|B1|Amrican Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
3668778|NCT02345161|3513215|B3||Male|Sex: Female, Male||Participants|Count of Participants|1341|1341.0||||||
3668779|NCT02345161|3513216|B2||Male|Sex: Female, Male||Participants|Count of Participants|663|663.0||||||
3668780|NCT02345161|3513217|B1||Male|Sex: Female, Male||Participants|Count of Participants|678|678.0||||||
3668781|NCT02345161|3513215|B3||Female|Sex: Female, Male||Participants|Count of Participants|469|469.0||||||
3668782|NCT02345161|3513216|B2||Female|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
3668783|NCT02345161|3513217|B1||Female|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
3668784|NCT02345161|3513215|B3|||Age||Years|Mean|63.9|63.9|Standard Deviation|8.64|8.64|||
3668785|NCT02345161|3513216|B2|||Age||Years|Mean|63.7|63.7|Standard Deviation|8.71|8.71|||
3668786|NCT02345161|3513217|B1|||Age||Years|Mean|64.2|64.2|Standard Deviation|8.56|8.56|||
3668833|NCT02344745|3513338|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3668834|NCT02344745|3513339|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3668787|NCT02345031|3513320|B3|||QuickSIN SNR-50 Score (dB)|The QuickSIN test measures the level of signal compared to the noise that is required to achieve 50% recognition and were administered in a sound booth at 70-dB HL binaurally. It is reported in decibels (dB).|decibels (dB)|Mean|7.06|7.06|Standard Deviation|1.965|1.965|||
3668788|NCT02345031|3513321|B2|||QuickSIN SNR-50 Score (dB)|The QuickSIN test measures the level of signal compared to the noise that is required to achieve 50% recognition and were administered in a sound booth at 70-dB HL binaurally. It is reported in decibels (dB).|decibels (dB)|Mean|7.11|7.11|Standard Deviation|1.991|1.991|||
3668789|NCT02345031|3513322|B1|||QuickSIN SNR-50 Score (dB)|The QuickSIN test measures the level of signal compared to the noise that is required to achieve 50% recognition and were administered in a sound booth at 70-dB HL binaurally. It is reported in decibels (dB).|decibels (dB)|Mean|7.00|7.0|Standard Deviation|1.963|1.963|||
3668790|NCT02345031|3513320|B3|United States||Region of Enrollment||Participants|Count of Participants|78|78.0||||||
3668791|NCT02345031|3513321|B2|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3668792|NCT02345031|3513322|B1|United States||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
3668793|NCT02345031|3513320|B3|Ethnicity|Not Hispanic Or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|75|75.0||||||
3668794|NCT02345031|3513321|B2|Ethnicity|Not Hispanic Or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
3668795|NCT02345031|3513322|B1|Ethnicity|Not Hispanic Or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3668796|NCT02345031|3513320|B3|Ethnicity|Hispanic Or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3668797|NCT02345031|3513321|B2|Ethnicity|Hispanic Or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3668798|NCT02345031|3513322|B1|Ethnicity|Hispanic Or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3668799|NCT02345031|3513320|B3|Race|Black/African-American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3668800|NCT02345031|3513321|B2|Race|Black/African-American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3668801|NCT02345031|3513322|B1|Race|Black/African-American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3668802|NCT02345031|3513320|B3|Race|White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|74|74.0||||||
3668803|NCT02345031|3513321|B2|Race|White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
3668804|NCT02345031|3513322|B1|Race|White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3668805|NCT02345031|3513320|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3668806|NCT02345031|3513321|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3668807|NCT02345031|3513322|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3668808|NCT02345031|3513320|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3668809|NCT02345031|3513321|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3668810|NCT02345031|3513322|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3668811|NCT02345031|3513320|B3||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
3668812|NCT02345031|3513321|B2||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
3668813|NCT02345031|3513322|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3668814|NCT02345031|3513320|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3668815|NCT02345031|3513321|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3668816|NCT02345031|3513322|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3668817|NCT02345031|3513320|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3668818|NCT02345031|3513321|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3668819|NCT02345031|3513322|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3668820|NCT02344745|3513337|B3|||Pain|Pain was measured on the Wong Baker scale from 0-10. Higher values indicate more pain.|units on a scale|Median|0|0.0|Full Range|||0.0|5.0|
3668821|NCT02344745|3513338|B2|||Pain|Pain was measured on the Wong Baker scale from 0-10. Higher values indicate more pain.|units on a scale|Median|0|0.0|Full Range|||0.0|4.0|
3668822|NCT02344745|3513339|B1|||Pain|Pain was measured on the Wong Baker scale from 0-10. Higher values indicate more pain.|units on a scale|Median|0|0.0|Full Range|||0.0|5.0|
3668823|NCT02344745|3513337|B3|||Anxiety|Anxiety was measured using a visual analogue scale, from 0-10 cm. All measurements were rounded to the nearest 0.5 cm. Since all participants had baseline anxiety, the lowest score recorded was 1. Higher values indicate more anxiety.|cm|Median|5|5.0|Full Range|||1.0|10.0|
3668824|NCT02344745|3513338|B2|||Anxiety|Anxiety was measured using a visual analogue scale, from 0-10 cm. All measurements were rounded to the nearest 0.5 cm. Since all participants had baseline anxiety, the lowest score recorded was 1. Higher values indicate more anxiety.|cm|Median|5|5.0|Full Range|||1.0|10.0|
3668825|NCT02344745|3513339|B1|||Anxiety|Anxiety was measured using a visual analogue scale, from 0-10 cm. All measurements were rounded to the nearest 0.5 cm. Since all participants had baseline anxiety, the lowest score recorded was 1. Higher values indicate more anxiety.|cm|Median|4|4.0|Full Range|||1.0|9.0|
3668826|NCT02344745|3513337|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668827|NCT02344745|3513338|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668828|NCT02344745|3513339|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668829|NCT02344745|3513337|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3668830|NCT02344745|3513338|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3668831|NCT02344745|3513339|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3668832|NCT02344745|3513337|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
3668835|NCT02344745|3513337|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3668836|NCT02344745|3513338|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3668837|NCT02344745|3513339|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3668838|NCT02344745|3513337|B3||Female|Gender||Participants|Count of Participants|78|78.0||||||
3668839|NCT02344745|3513338|B2||Female|Gender||Participants|Count of Participants|40|40.0||||||
3668840|NCT02344745|3513339|B1||Female|Gender||Participants|Count of Participants|38|38.0||||||
3668841|NCT02344745|3513337|B3|||Age||years|Mean|48.5|48.5|Standard Deviation|7.9|7.9|||
3668842|NCT02344745|3513338|B2|||Age||years|Mean|49.0|49.0|Standard Deviation|8.0|8.0|||
3668843|NCT02344745|3513339|B1|||Age||years|Mean|48.0|48.0|Standard Deviation|7.5|7.5|||
3668844|NCT02344628|3513352|B3|Ghana||Region of Enrollment||participants|Number|400|400.0||||||
3668845|NCT02344628|3513353|B2|Ghana||Region of Enrollment||participants|Number|201|201.0||||||
3668846|NCT02344628|3513354|B1|Ghana||Region of Enrollment||participants|Number|199|199.0||||||
3668847|NCT02344628|3513352|B3|Papua New Guinea||Region of Enrollment||participants|Number|183|183.0||||||
3668848|NCT02344628|3513353|B2|Papua New Guinea||Region of Enrollment||participants|Number|91|91.0||||||
3668849|NCT02344628|3513354|B1|Papua New Guinea||Region of Enrollment||participants|Number|92|92.0||||||
3668850|NCT02344628|3513352|B3||Male|Sex: Female, Male||Participants|Count of Participants|412|412.0||||||
3668851|NCT02344628|3513353|B2||Male|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
3668852|NCT02344628|3513354|B1||Male|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
3668853|NCT02344628|3513352|B3||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3668854|NCT02344628|3513353|B2||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3668855|NCT02344628|3513354|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3668856|NCT02344628|3513352|B3|||Age||years|Median|10|10.0|Inter-Quartile Range|||8.0|12.0|
3668857|NCT02344628|3513353|B2|||Age||years|Median|10|10.0|Inter-Quartile Range|||8.0|12.0|
3668858|NCT02344628|3513354|B1|||Age||years|Median|10|10.0|Inter-Quartile Range|||8.0|12.0|
3668859|NCT02344407|3513365|B4|||Positive antibody response||Participants|Count of Participants|60|60.0||||||
3668860|NCT02344407|3513366|B3|||Positive antibody response||Participants|Count of Participants|26|26.0||||||
3668861|NCT02344407|3513367|B2|||Positive antibody response||Participants|Count of Participants|18|18.0||||||
3668862|NCT02344407|3513368|B1|||Positive antibody response||Participants|Count of Participants|16|16.0||||||
3668863|NCT02344407|3513365|B4|||IgG antibody level (EU/mL)||EU/mL|Median|78|78.0|Inter-Quartile Range|||47.0|139.0|
3668864|NCT02344407|3513366|B3|||IgG antibody level (EU/mL)||EU/mL|Median|79|79.0|Inter-Quartile Range|||50.0|148.0|
3668865|NCT02344407|3513367|B2|||IgG antibody level (EU/mL)||EU/mL|Median|81|81.0|Inter-Quartile Range|||49.0|141.0|
3668866|NCT02344407|3513368|B1|||IgG antibody level (EU/mL)||EU/mL|Median|75|75.0|Inter-Quartile Range|||44.0|135.0|
3668867|NCT02344407|3513365|B4|||Syphilis positive||Participants|Count of Participants|77|77.0||||||
3668868|NCT02344407|3513366|B3|||Syphilis positive||Participants|Count of Participants|25|25.0||||||
3668869|NCT02344407|3513367|B2|||Syphilis positive||Participants|Count of Participants|22|22.0||||||
3668870|NCT02344407|3513368|B1|||Syphilis positive||Participants|Count of Participants|30|30.0||||||
3668871|NCT02344407|3513365|B4|||HIV Positive||Participants|Count of Participants|78|78.0||||||
3668872|NCT02344407|3513366|B3|||HIV Positive||Participants|Count of Participants|31|31.0||||||
3668873|NCT02344407|3513367|B2|||HIV Positive||Participants|Count of Participants|22|22.0||||||
3668874|NCT02344407|3513368|B1|||HIV Positive||Participants|Count of Participants|25|25.0||||||
3668875|NCT02344407|3513365|B4|||Work involves contact with persons with Ebola||Participants|Count of Participants|69|69.0||||||
3668876|NCT02344407|3513366|B3|||Work involves contact with persons with Ebola||Participants|Count of Participants|22|22.0||||||
3668877|NCT02344407|3513367|B2|||Work involves contact with persons with Ebola||Participants|Count of Participants|25|25.0||||||
3668878|NCT02344407|3513368|B1|||Work involves contact with persons with Ebola||Participants|Count of Participants|22|22.0||||||
3668879|NCT02344407|3513365|B4|||Contact past month with someone who had Ebola||Participants|Count of Participants|11|11.0||||||
3668880|NCT02344407|3513366|B3|||Contact past month with someone who had Ebola||Participants|Count of Participants|5|5.0||||||
3668881|NCT02344407|3513367|B2|||Contact past month with someone who had Ebola||Participants|Count of Participants|5|5.0||||||
3668882|NCT02344407|3513368|B1|||Contact past month with someone who had Ebola||Participants|Count of Participants|1|1.0||||||
3668883|NCT02344407|3513365|B4|Liberia||Region of Enrollment||participants|Number|1500|1500.0||||||
3668884|NCT02344407|3513366|B3|Liberia||Region of Enrollment||participants|Number|500|500.0||||||
3668885|NCT02344407|3513367|B2|Liberia||Region of Enrollment||participants|Number|500|500.0||||||
3668886|NCT02344407|3513368|B1|Liberia||Region of Enrollment||participants|Number|500|500.0||||||
3668887|NCT02344407|3513365|B4||Male|Sex: Female, Male||Participants|Count of Participants|951|951.0||||||
3668888|NCT02344407|3513366|B3||Male|Sex: Female, Male||Participants|Count of Participants|323|323.0||||||
3668889|NCT02344407|3513367|B2||Male|Sex: Female, Male||Participants|Count of Participants|313|313.0||||||
3668890|NCT02344407|3513368|B1||Male|Sex: Female, Male||Participants|Count of Participants|315|315.0||||||
3668891|NCT02344407|3513365|B4||Female|Sex: Female, Male||Participants|Count of Participants|549|549.0||||||
3668892|NCT02344407|3513366|B3||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
3668893|NCT02344407|3513367|B2||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
3668894|NCT02344407|3513368|B1||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
3668895|NCT02344407|3513365|B4|||Age||years|Median|30|30.0|Inter-Quartile Range|||24.0|38.0|
3668896|NCT02344407|3513366|B3|||Age||years|Median|30|30.0|Inter-Quartile Range|||24.0|39.0|
3668897|NCT02344407|3513367|B2|||Age||years|Median|29|29.0|Inter-Quartile Range|||24.0|36.0|
3668898|NCT02344407|3513368|B1|||Age||years|Median|30|30.0|Inter-Quartile Range|||25.0|38.0|
3668899|NCT02344342|3513381|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3668900|NCT02344342|3513382|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668901|NCT02344342|3513383|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3668902|NCT02344342|3513384|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668903|NCT02344342|3513385|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3668904|NCT02344342|3513381|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668905|NCT02344342|3513382|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668906|NCT02344342|3513383|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668907|NCT02344342|3513384|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668908|NCT02344342|3513385|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668909|NCT02344342|3513381|B5||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3668910|NCT02344342|3513382|B4||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3668911|NCT02344342|3513383|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3668912|NCT02344342|3513384|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3668913|NCT02344342|3513385|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3668914|NCT02344342|3513381|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3668915|NCT02344342|3513382|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3668916|NCT02344342|3513383|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3668917|NCT02344342|3513384|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3668918|NCT02344342|3513385|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3668919|NCT02344342|3513381|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668920|NCT02344342|3513382|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668921|NCT02344342|3513383|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668922|NCT02344342|3513384|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668923|NCT02344342|3513385|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668924|NCT02344342|3513381|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668925|NCT02344342|3513382|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668926|NCT02344342|3513383|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668927|NCT02344342|3513384|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668928|NCT02344342|3513385|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668929|NCT02344342|3513381|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668930|NCT02344342|3513382|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668931|NCT02344342|3513383|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668932|NCT02344342|3513384|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668933|NCT02344342|3513385|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3668934|NCT02344342|3513381|B5||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3668935|NCT02344342|3513382|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3668936|NCT02344342|3513383|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3668937|NCT02344342|3513384|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3668938|NCT02344342|3513385|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3668939|NCT02344342|3513381|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3668940|NCT02344342|3513382|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3668941|NCT02344342|3513383|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3668942|NCT02344342|3513384|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3668943|NCT02344342|3513385|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3668944|NCT02344342|3513381|B5||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3668945|NCT02344342|3513382|B4||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3668946|NCT02344342|3513383|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3668947|NCT02344342|3513384|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3668948|NCT02344342|3513385|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3668949|NCT02344342|3513381|B5||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3668950|NCT02344342|3513382|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3668951|NCT02344342|3513383|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3668952|NCT02344342|3513384|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3668953|NCT02344342|3513385|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3668954|NCT02344342|3513381|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3668955|NCT02344342|3513382|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3668956|NCT02344342|3513383|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3668957|NCT02344342|3513384|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3668958|NCT02344342|3513385|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3668959|NCT02344251|3513410|B3|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3668960|NCT02344251|3513411|B2|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3668961|NCT02344251|3513412|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3668962|NCT02344251|3513410|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3668963|NCT02344251|3513411|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3668964|NCT02344251|3513412|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3668965|NCT02344251|3513410|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3668966|NCT02344251|3513411|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3668967|NCT02344251|3513412|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3668968|NCT02344251|3513410|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3668969|NCT02344251|3513411|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3668970|NCT02344251|3513412|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3668971|NCT02344251|3513410|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3668972|NCT02344251|3513411|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3668973|NCT02344251|3513412|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3668974|NCT02344251|3513410|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3668975|NCT02344251|3513411|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3668976|NCT02344251|3513412|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3668977|NCT02344238|3513421|B4|United States||Region of Enrollment||participants|Number|60|60.0||||||
3668978|NCT02344238|3513422|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3668979|NCT02344238|3513423|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3668980|NCT02344238|3513424|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3668981|NCT02344238|3513421|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3668982|NCT02344238|3513422|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3668983|NCT02344238|3513423|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3668984|NCT02344238|3513424|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3668985|NCT02344238|3513421|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3668986|NCT02344238|3513422|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3668987|NCT02344238|3513423|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3668988|NCT02344238|3513424|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3668989|NCT02344238|3513421|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3668990|NCT02344238|3513422|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3668991|NCT02344238|3513423|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3668992|NCT02344238|3513424|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3668993|NCT02344238|3513421|B4||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3668994|NCT02344238|3513422|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3668995|NCT02344238|3513423|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3668996|NCT02344238|3513424|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3668997|NCT02344238|3513421|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3668998|NCT02344238|3513422|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3668999|NCT02344238|3513423|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3669000|NCT02344238|3513424|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3669001|NCT02344004|3513435|B3|||Prior nebulized IV amikacin|Subjects who had received prior nebulized IV amikacin|Participants|Count of Participants|39|39.0||||||
3669002|NCT02344004|3513436|B2|||Prior nebulized IV amikacin|Subjects who had received prior nebulized IV amikacin|Participants|Count of Participants|15|15.0||||||
3669003|NCT02344004|3513437|B1|||Prior nebulized IV amikacin|Subjects who had received prior nebulized IV amikacin|Participants|Count of Participants|24|24.0||||||
3669004|NCT02344004|3513435|B3||COPD and bronchiectasis|Underlying lung disease|COPD was derived from the medical history data.|Participants|Count of Participants|40|40.0||||||
3669005|NCT02344004|3513436|B2||COPD and bronchiectasis|Underlying lung disease|COPD was derived from the medical history data.|Participants|Count of Participants|18|18.0||||||
3669006|NCT02344004|3513437|B1||COPD and bronchiectasis|Underlying lung disease|COPD was derived from the medical history data.|Participants|Count of Participants|22|22.0||||||
3669007|NCT02344004|3513435|B3||Bronchiectasis only|Underlying lung disease|COPD was derived from the medical history data.|Participants|Count of Participants|210|210.0||||||
3669008|NCT02344004|3513436|B2||Bronchiectasis only|Underlying lung disease|COPD was derived from the medical history data.|Participants|Count of Participants|64|64.0||||||
3669009|NCT02344004|3513437|B1||Bronchiectasis only|Underlying lung disease|COPD was derived from the medical history data.|Participants|Count of Participants|146|146.0||||||
3669010|NCT02344004|3513435|B3||COPD only|Underlying lung disease|COPD was derived from the medical history data.|Participants|Count of Participants|48|48.0||||||
3669011|NCT02344004|3513436|B2||COPD only|Underlying lung disease|COPD was derived from the medical history data.|Participants|Count of Participants|19|19.0||||||
3669012|NCT02344004|3513437|B1||COPD only|Underlying lung disease|COPD was derived from the medical history data.|Participants|Count of Participants|29|29.0||||||
3669013|NCT02344004|3513435|B3||Not a current smoker|Smoking status (includes e-cigarettes)||Participants|Count of Participants|300|300.0||||||
3669014|NCT02344004|3513436|B2||Not a current smoker|Smoking status (includes e-cigarettes)||Participants|Count of Participants|102|102.0||||||
3669015|NCT02344004|3513437|B1||Not a current smoker|Smoking status (includes e-cigarettes)||Participants|Count of Participants|198|198.0||||||
3669016|NCT02344004|3513435|B3||Current smoker|Smoking status (includes e-cigarettes)||Participants|Count of Participants|36|36.0||||||
3669017|NCT02344004|3513436|B2||Current smoker|Smoking status (includes e-cigarettes)||Participants|Count of Participants|10|10.0||||||
3669018|NCT02344004|3513437|B1||Current smoker|Smoking status (includes e-cigarettes)||Participants|Count of Participants|26|26.0||||||
3669019|NCT02344004|3513435|B3||Off treatment for at least 3 months|Multidrug regimen prior to enrollment||Participants|Count of Participants|34|34.0||||||
3669020|NCT02344004|3513436|B2||Off treatment for at least 3 months|Multidrug regimen prior to enrollment||Participants|Count of Participants|11|11.0||||||
3669021|NCT02344004|3513437|B1||Off treatment for at least 3 months|Multidrug regimen prior to enrollment||Participants|Count of Participants|23|23.0||||||
3669022|NCT02344004|3513435|B3||On treatment|Multidrug regimen prior to enrollment||Participants|Count of Participants|302|302.0||||||
3669023|NCT02344004|3513436|B2||On treatment|Multidrug regimen prior to enrollment||Participants|Count of Participants|101|101.0||||||
3669024|NCT02344004|3513437|B1||On treatment|Multidrug regimen prior to enrollment||Participants|Count of Participants|201|201.0||||||
3669025|NCT02344004|3513435|B3||Rest of World|Region||Participants|Count of Participants|127|127.0||||||
3669026|NCT02344004|3513436|B2||Rest of World|Region||Participants|Count of Participants|44|44.0||||||
3669027|NCT02344004|3513437|B1||Rest of World|Region||Participants|Count of Participants|83|83.0||||||
3669028|NCT02344004|3513435|B3||Japan|Region||Participants|Count of Participants|48|48.0||||||
3669029|NCT02344004|3513436|B2||Japan|Region||Participants|Count of Participants|14|14.0||||||
3669030|NCT02344004|3513437|B1||Japan|Region||Participants|Count of Participants|34|34.0||||||
3669031|NCT02344004|3513435|B3||Asia (excluding Japan)|Region||Participants|Count of Participants|20|20.0||||||
3669032|NCT02344004|3513436|B2||Asia (excluding Japan)|Region||Participants|Count of Participants|6|6.0||||||
3669033|NCT02344004|3513437|B1||Asia (excluding Japan)|Region||Participants|Count of Participants|14|14.0||||||
3669034|NCT02344004|3513435|B3||United States of America|Region||Participants|Count of Participants|141|141.0||||||
3669035|NCT02344004|3513436|B2||United States of America|Region||Participants|Count of Participants|48|48.0||||||
3669036|NCT02344004|3513437|B1||United States of America|Region||Participants|Count of Participants|93|93.0||||||
3669037|NCT02344004|3513435|B3||Naturally Sterile|If not childbearing potential, specify||Participants|Count of Participants|0|0.0||||||
3669038|NCT02344004|3513436|B2||Naturally Sterile|If not childbearing potential, specify||Participants|Count of Participants|0|0.0||||||
3669039|NCT02344004|3513437|B1||Naturally Sterile|If not childbearing potential, specify||Participants|Count of Participants|0|0.0||||||
3669040|NCT02344004|3513435|B3||Surgically Sterile|If not childbearing potential, specify||Participants|Count of Participants|50|50.0||||||
3669041|NCT02344004|3513436|B2||Surgically Sterile|If not childbearing potential, specify||Participants|Count of Participants|12|12.0||||||
3669042|NCT02344004|3513437|B1||Surgically Sterile|If not childbearing potential, specify||Participants|Count of Participants|38|38.0||||||
3669043|NCT02344004|3513435|B3||Postmenopausal|If not childbearing potential, specify||Participants|Count of Participants|164|164.0||||||
3669044|NCT02344004|3513436|B2||Postmenopausal|If not childbearing potential, specify||Participants|Count of Participants|50|50.0||||||
3669045|NCT02344004|3513437|B1||Postmenopausal|If not childbearing potential, specify||Participants|Count of Participants|114|114.0||||||
3669046|NCT02344004|3513435|B3||No|If female, is subject of childbearing potential?||Participants|Count of Participants|214|214.0||||||
3669047|NCT02344004|3513436|B2||No|If female, is subject of childbearing potential?||Participants|Count of Participants|62|62.0||||||
3669048|NCT02344004|3513437|B1||No|If female, is subject of childbearing potential?||Participants|Count of Participants|152|152.0||||||
3669049|NCT02344004|3513435|B3||Yes|If female, is subject of childbearing potential?||Participants|Count of Participants|19|19.0||||||
3669050|NCT02344004|3513436|B2||Yes|If female, is subject of childbearing potential?||Participants|Count of Participants|6|6.0||||||
3669051|NCT02344004|3513437|B1||Yes|If female, is subject of childbearing potential?||Participants|Count of Participants|13|13.0||||||
3669052|NCT02344004|3513435|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3669053|NCT02344004|3513436|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3669054|NCT02344004|3513437|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3669055|NCT02344004|3513435|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3669056|NCT02344004|3513436|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669057|NCT02344004|3513437|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3669058|NCT02344004|3513435|B3||White|Race (NIH/OMB)||Participants|Count of Participants|235|235.0||||||
3669059|NCT02344004|3513436|B2||White|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3669060|NCT02344004|3513437|B1||White|Race (NIH/OMB)||Participants|Count of Participants|158|158.0||||||
3669061|NCT02344004|3513435|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3669062|NCT02344004|3513436|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3669063|NCT02344004|3513437|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3669064|NCT02344004|3513435|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3669065|NCT02344004|3513436|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669066|NCT02344004|3513437|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3669067|NCT02344004|3513435|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3669068|NCT02344004|3513436|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3669069|NCT02344004|3513437|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3669070|NCT02344004|3513435|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3669071|NCT02344004|3513436|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3669072|NCT02344004|3513437|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669073|NCT02344004|3513435|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3669074|NCT02344004|3513436|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3669075|NCT02344004|3513437|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3669076|NCT02344004|3513435|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|313|313.0||||||
3669077|NCT02344004|3513436|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
3669078|NCT02344004|3513437|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|211|211.0||||||
3669079|NCT02344004|3513435|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3669080|NCT02344004|3513436|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3669081|NCT02344004|3513437|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3669082|NCT02344004|3513435|B3||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3669083|NCT02344004|3513436|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3669084|NCT02344004|3513437|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3669085|NCT02344004|3513435|B3||Female|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
3669086|NCT02344004|3513436|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3669087|NCT02344004|3513437|B1||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3669088|NCT02344004|3513435|B3|||Age||years|Mean|64.7|64.7|Standard Deviation|9.77|9.77|||
3669089|NCT02344004|3513436|B2|||Age||years|Mean|64.9|64.9|Standard Deviation|10.16|10.16|||
3669090|NCT02344004|3513437|B1|||Age||years|Mean|64.6|64.6|Standard Deviation|9.59|9.59|||
3669091|NCT02343627|3513450|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669092|NCT02343627|3513451|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669093|NCT02343627|3513452|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669094|NCT02343627|3513450|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3669095|NCT02343627|3513451|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3669096|NCT02343627|3513452|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3669097|NCT02343627|3513450|B3||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3669098|NCT02343627|3513451|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3669099|NCT02343627|3513452|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3669100|NCT02343627|3513450|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3669101|NCT02343627|3513451|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3669102|NCT02343627|3513452|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3669103|NCT02343627|3513450|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669104|NCT02343627|3513451|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669105|NCT02343627|3513452|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669106|NCT02343627|3513450|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669107|NCT02343627|3513451|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669108|NCT02343627|3513452|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669109|NCT02343627|3513450|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669110|NCT02343627|3513451|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669111|NCT02343627|3513452|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669112|NCT02343627|3513450|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3669113|NCT02343627|3513451|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3669114|NCT02343627|3513452|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3669115|NCT02343627|3513450|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3669116|NCT02343627|3513451|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3669117|NCT02343627|3513452|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3669118|NCT02343627|3513450|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3669119|NCT02343627|3513451|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3669120|NCT02343627|3513452|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3669121|NCT02343627|3513450|B3||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3669122|NCT02343627|3513451|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3669123|NCT02343627|3513452|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3669124|NCT02343627|3513450|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3669125|NCT02343627|3513451|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3669126|NCT02343627|3513452|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3669127|NCT02343380|3513459|B3|||fasting Resting Metabolic rate||Kcal/min|Mean|1543.5|1543.5|Standard Deviation|244.7|244.7|||
3669128|NCT02343380|3513460|B2|||fasting Resting Metabolic rate||Kcal/min|Mean|1540.0|1540.0|Standard Deviation|235.0|235.0|||
3669129|NCT02343380|3513461|B1|||fasting Resting Metabolic rate||Kcal/min|Mean|1545.0|1545.0|Standard Deviation|266.8|266.8|||
3669130|NCT02343380|3513459|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3669131|NCT02343380|3513460|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3669132|NCT02343380|3513461|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3669133|NCT02343380|3513459|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3669134|NCT02343380|3513460|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3669135|NCT02343380|3513461|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3669136|NCT02343380|3513459|B3|||Age||years|Mean|27.6|27.6|Standard Deviation|3.4|3.4|||
3669137|NCT02343380|3513460|B2|||Age||years|Mean|27.4|27.4|Standard Deviation|3.6|3.6|||
3669138|NCT02343380|3513461|B1|||Age||years|Mean|27.9|27.9|Standard Deviation|3.3|3.3|||
3669139|NCT02343263|3513478|B4|||study closed for administrative reasons||Participants|Count of Participants|9|9.0||||||
3669140|NCT02343263|3513479|B3|||study closed for administrative reasons||Participants|Count of Participants|1|1.0||||||
3669141|NCT02343263|3513480|B2|||study closed for administrative reasons||Participants|Count of Participants|3|3.0||||||
3669142|NCT02343263|3513481|B1|||study closed for administrative reasons||Participants|Count of Participants|5|5.0||||||
3669143|NCT02343263|3513478|B4|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3669144|NCT02343263|3513479|B3|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3669145|NCT02343263|3513480|B2|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3669146|NCT02343263|3513481|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3669147|NCT02343263|3513478|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3669148|NCT02343263|3513479|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669149|NCT02343263|3513480|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3669150|NCT02343263|3513481|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669151|NCT02343263|3513478|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669152|NCT02343263|3513479|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669153|NCT02343263|3513480|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669154|NCT02343263|3513481|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669155|NCT02343263|3513478|B4||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3669156|NCT02343263|3513479|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3669157|NCT02343263|3513480|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3669158|NCT02343263|3513481|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3669159|NCT02343263|3513478|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3669160|NCT02343263|3513479|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669161|NCT02343263|3513480|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669162|NCT02343263|3513481|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3669163|NCT02343263|3513478|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669164|NCT02343263|3513479|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669165|NCT02343263|3513480|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669166|NCT02343263|3513481|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669167|NCT02343263|3513478|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669168|NCT02343263|3513479|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669169|NCT02343263|3513480|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669170|NCT02343263|3513481|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669171|NCT02343263|3513478|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669172|NCT02343263|3513479|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669173|NCT02343263|3513480|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669174|NCT02343263|3513481|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669175|NCT02343263|3513478|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3669176|NCT02343263|3513479|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3669177|NCT02343263|3513480|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3669178|NCT02343263|3513481|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3669179|NCT02343263|3513478|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3669180|NCT02343263|3513479|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3669181|NCT02343263|3513480|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3669182|NCT02343263|3513481|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3669183|NCT02343263|3513478|B4|||Age||years|Mean|5.6|5.6|Standard Deviation|2.3|2.3|||
3669184|NCT02343263|3513479|B3|||Age||years|Mean|8|8.0|Standard Deviation|0|0.0|||
3669185|NCT02343263|3513480|B2|||Age||years|Mean|3.7|3.7|Standard Deviation|2.9|2.9|||
3669186|NCT02343263|3513481|B1|||Age||years|Mean|6.2|6.2|Standard Deviation|1.8|1.8|||
3669187|NCT02343263|3513478|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3669188|NCT02343263|3513479|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3669189|NCT02343263|3513480|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3669190|NCT02343263|3513481|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3669191|NCT02343263|3513478|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3669192|NCT02343263|3513479|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3669193|NCT02343263|3513480|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3669194|NCT02343263|3513481|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3669195|NCT02343263|3513478|B4||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
3669196|NCT02343263|3513479|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3669197|NCT02343263|3513480|B2||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3669198|NCT02343263|3513481|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3669199|NCT02343159|3513509|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3669200|NCT02343159|3513510|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3669201|NCT02343159|3513511|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3669202|NCT02343159|3513512|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3669203|NCT02343159|3513509|B4||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3669204|NCT02343159|3513510|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3669205|NCT02343159|3513511|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3669206|NCT02343159|3513512|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3669207|NCT02343159|3513509|B4|> 50 Years||Age, Customized||Participants|Number|22|22.0||||||
3669208|NCT02343159|3513510|B3|> 50 Years||Age, Customized||Participants|Number|10|10.0||||||
3669209|NCT02343159|3513511|B2|> 50 Years||Age, Customized||Participants|Number|7|7.0||||||
3669210|NCT02343159|3513512|B1|> 50 Years||Age, Customized||Participants|Number|5|5.0||||||
3669211|NCT02343159|3513509|B4|18 - 50 Years||Age, Customized||Participants|Number|57|57.0||||||
3669212|NCT02343159|3513510|B3|18 - 50 Years||Age, Customized||Participants|Number|17|17.0||||||
3669213|NCT02343159|3513511|B2|18 - 50 Years||Age, Customized||Participants|Number|19|19.0||||||
3669214|NCT02343159|3513512|B1|18 - 50 Years||Age, Customized||Participants|Number|21|21.0||||||
3669215|NCT02343081|3513539|B3|||Body Mass Index||kg/m^2|Mean|27.26|27.26|Standard Deviation|2.82|2.82|||
3669216|NCT02343081|3513540|B2|||Body Mass Index||kg/m^2|Mean|28.46|28.46|Standard Deviation|2.72|2.72|||
3669217|NCT02343081|3513541|B1|||Body Mass Index||kg/m^2|Mean|26.03|26.03|Standard Deviation|2.01|2.01|||
3669218|NCT02343081|3513539|B3|||Body Surface, Continuous||m^2|Mean|1.92|1.92|Standard Deviation|0.19|0.19|||
3669219|NCT02343081|3513540|B2|||Body Surface, Continuous||m^2|Mean|1.95|1.95|Standard Deviation|0.16|0.16|||
3669220|NCT02343081|3513541|B1|||Body Surface, Continuous||m^2|Mean|1.89|1.89|Standard Deviation|0.22|0.22|||
3669221|NCT02343081|3513539|B3|||Weight, Continuous||kg|Mean|79.40|79.4|Standard Deviation|12.00|12.0|||
3669222|NCT02343081|3513540|B2|||Weight, Continuous||kg|Mean|81.12|81.12|Standard Deviation|10.78|10.78|||
3669223|NCT02343081|3513541|B1|||Weight, Continuous||kg|Mean|78.87|78.87|Standard Deviation|14.20|14.2|||
3669224|NCT02343081|3513539|B3|||Height||cm|Mean|170.00|170.0|Standard Deviation|8.00|8.0|||
3669225|NCT02343081|3513540|B2|||Height||cm|Mean|173.37|173.37|Standard Deviation|8.65|8.65|||
3669226|NCT02343081|3513541|B1|||Height||cm|Mean|169|169.0|Standard Deviation|9.53|9.53|||
3669227|NCT02343081|3513539|B3|Argentina||Region of Enrollment||participants|Number|16|16.0||||||
3669228|NCT02343081|3513540|B2|Argentina||Region of Enrollment||participants|Number|8|8.0||||||
3669229|NCT02343081|3513541|B1|Argentina||Region of Enrollment||participants|Number|8|8.0||||||
3669230|NCT02343081|3513539|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3669231|NCT02343081|3513540|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3669232|NCT02343081|3513541|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3669233|NCT02343081|3513539|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3669234|NCT02343081|3513540|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3669235|NCT02343081|3513541|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3669236|NCT02343081|3513539|B3|||Age||Years|Mean|48.44|48.44|Standard Deviation|14.5|14.5|||
3669237|NCT02343081|3513540|B2|||Age||Years|Mean|39.75|39.75|Standard Deviation|14.5|14.5|||
3669238|NCT02343081|3513541|B1|||Age||Years|Mean|53.75|53.75|Standard Deviation|9.35|9.35|||
3669239|NCT02343003|3513556|B3|United States||Region of Enrollment||participants|Number|151|151.0||||||
3669240|NCT02343003|3513557|B2|United States||Region of Enrollment||participants|Number|75|75.0||||||
3669241|NCT02343003|3513558|B1|United States||Region of Enrollment||participants|Number|76|76.0||||||
3669242|NCT02343003|3513556|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3669243|NCT02343003|3513557|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3669244|NCT02343003|3513558|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3669245|NCT02343003|3513556|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3669246|NCT02343003|3513557|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3669247|NCT02343003|3513558|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3669248|NCT02343003|3513556|B3|||Age||years|Mean|64.6|64.6|Standard Deviation|12.5|12.5|||
3669249|NCT02343003|3513557|B2|||Age||years|Mean|66.1|66.1|Standard Deviation|13.1|13.1|||
3669250|NCT02343003|3513558|B1|||Age||years|Mean|63|63.0|Standard Deviation|11.9|11.9|||
3669251|NCT02343003|3513556|B3||>=65 years|Age||Participants|Count of Participants|76|76.0||||||
3669252|NCT02343003|3513557|B2||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
3669253|NCT02343003|3513558|B1||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
3669254|NCT02343003|3513556|B3||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
3669255|NCT02343003|3513557|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3669256|NCT02343003|3513558|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3669257|NCT02343003|3513556|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3669258|NCT02343003|3513557|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3669259|NCT02343003|3513558|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3669260|NCT02342743|3513575|B1|||Acute medication use (total number) - all categories||medications|Mean|26.33|26.33|Standard Deviation|30.25|30.25|||
3669261|NCT02342743|3513575|B1|||Average headache intensity|Headache intensity is defined on a scale from 0 (no pain) to 3 (maximum pain)|units on a scale|Mean|1.98|1.98|Standard Deviation|0.44|0.44|||
3669262|NCT02342743|3513575|B1|||Cumulative hours of headache on headache days||hours|Mean|249.64|249.64|Standard Deviation|124.29|124.29|||
3669263|NCT02342743|3513575|B1|||Number of migraine days||days|Mean|19.02|19.02|Standard Deviation|6.36|6.36|||
3669264|NCT02342743|3513575|B1|||Number of moderate/severe headache days||days|Mean|16.07|16.07|Standard Deviation|7.65|7.65|||
3669265|NCT02342743|3513575|B1|||Number of headache days||days|Mean|22.55|22.55|Standard Deviation|5.38|5.38|||
3669266|NCT02342743|3513575|B1|||Number of headache episodes||episodes|Mean|22.66|22.66|Standard Deviation|5.35|5.35|||
3669267|NCT02342743|3513575|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3669268|NCT02342743|3513575|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3669269|NCT02342743|3513575|B1|||Age||years|Mean|40.45|40.45|Standard Deviation|13.12|13.12|||
3669270|NCT02342704|3513586|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3669271|NCT02342704|3513587|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3669272|NCT02342704|3513588|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3669273|NCT02342704|3513586|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3669274|NCT02342704|3513587|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3669275|NCT02342704|3513588|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3669276|NCT02342704|3513586|B3|||Age||years|Mean|36.53|36.53|Standard Deviation|8.887|8.887|||
3669277|NCT02342704|3513587|B2|||Age||years|Mean|34.87|34.87|Standard Deviation|8.731|8.731|||
3669278|NCT02342704|3513588|B1|||Age||years|Mean|38.19|38.19|Standard Deviation|8.811|8.811|||
3669279|NCT02342678|3513615|B3|Patient Perception of Bladder Condition||Urinary Symptom Questionnaire Scores||Scores on Scale|Mean|3.4|3.4|Standard Deviation|1.0|1.0|||
3669280|NCT02342678|3513616|B2|Patient Perception of Bladder Condition||Urinary Symptom Questionnaire Scores||Scores on Scale|Mean|3.3|3.3|Standard Deviation|1.1|1.1|||
3669281|NCT02342678|3513617|B1|Patient Perception of Bladder Condition||Urinary Symptom Questionnaire Scores||Scores on Scale|Mean|3.4|3.4|Standard Deviation|1.0|1.0|||
3669282|NCT02342678|3513615|B3|Urogenital Distress Inventory-6||Urinary Symptom Questionnaire Scores||Scores on Scale|Mean|35.5|35.5|Standard Deviation|17.8|17.8|||
3669283|NCT02342678|3513616|B2|Urogenital Distress Inventory-6||Urinary Symptom Questionnaire Scores||Scores on Scale|Mean|36.5|36.5|Standard Deviation|19.5|19.5|||
3669284|NCT02342678|3513617|B1|Urogenital Distress Inventory-6||Urinary Symptom Questionnaire Scores||Scores on Scale|Mean|34.5|34.5|Standard Deviation|16.4|16.4|||
3669285|NCT02342678|3513615|B3|Incontinence Impact Questionnaire||Urinary Symptom Questionnaire Scores||Scores on Scale|Mean|125.9|125.9|Standard Deviation|87.0|87.0|||
3669286|NCT02342678|3513616|B2|Incontinence Impact Questionnaire||Urinary Symptom Questionnaire Scores||Scores on Scale|Mean|133.9|133.9|Standard Deviation|92.3|92.3|||
3669287|NCT02342678|3513617|B1|Incontinence Impact Questionnaire||Urinary Symptom Questionnaire Scores||Scores on Scale|Mean|117.9|117.9|Standard Deviation|82.1|82.1|||
3669288|NCT02342678|3513615|B3|Stress Incontinence||Incontinence Frequency||Episodes per day|Mean|1.0|1.0|Standard Deviation|1.4|1.4|||
3669289|NCT02342678|3513616|B2|Stress Incontinence||Incontinence Frequency||Episodes per day|Mean|0.7|0.7|Standard Deviation|1.1|1.1|||
3669290|NCT02342678|3513617|B1|Stress Incontinence||Incontinence Frequency||Episodes per day|Mean|1.4|1.4|Standard Deviation|1.5|1.5|||
3669291|NCT02342678|3513615|B3|Urgency Incontinence||Incontinence Frequency||Episodes per day|Mean|2.2|2.2|Standard Deviation|2.1|2.1|||
3669292|NCT02342678|3513616|B2|Urgency Incontinence||Incontinence Frequency||Episodes per day|Mean|2.3|2.3|Standard Deviation|2.3|2.3|||
3669293|NCT02342678|3513617|B1|Urgency Incontinence||Incontinence Frequency||Episodes per day|Mean|2.1|2.1|Standard Deviation|1.8|1.8|||
3669294|NCT02342678|3513615|B3|Total Incontinence||Incontinence Frequency||Episodes per day|Mean|3.5|3.5|Standard Deviation|2.0|2.0|||
3669295|NCT02342678|3513616|B2|Total Incontinence||Incontinence Frequency||Episodes per day|Mean|3.1|3.1|Standard Deviation|2.3|2.3|||
3669296|NCT02342678|3513617|B1|Total Incontinence||Incontinence Frequency||Episodes per day|Mean|3.8|3.8|Standard Deviation|1.6|1.6|||
3669297|NCT02342678|3513615|B3|United States||Region of Enrollment||participants|Number|56|56.0||||||
3669298|NCT02342678|3513616|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
3669299|NCT02342678|3513617|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
3669300|NCT02342678|3513615|B3|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3669301|NCT02342678|3513616|B2|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3669302|NCT02342678|3513617|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3669303|NCT02342678|3513615|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3669304|NCT02342678|3513616|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3669305|NCT02342678|3513617|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3669306|NCT02342678|3513615|B3|Asian/Asian-American||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3669307|NCT02342678|3513616|B2|Asian/Asian-American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3669308|NCT02342678|3513617|B1|Asian/Asian-American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3669309|NCT02342678|3513615|B3|Latina White||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3669310|NCT02342678|3513616|B2|Latina White||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3669311|NCT02342678|3513617|B1|Latina White||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3669312|NCT02342678|3513615|B3|Non-Latina White||Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
3669313|NCT02342678|3513616|B2|Non-Latina White||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3669314|NCT02342678|3513617|B1|Non-Latina White||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3669315|NCT02342678|3513615|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3669316|NCT02342678|3513616|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3669317|NCT02342678|3513617|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3669318|NCT02342678|3513615|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3669319|NCT02342678|3513616|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3669320|NCT02342678|3513617|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3669321|NCT02342678|3513615|B3||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
3669322|NCT02342678|3513616|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3669323|NCT02342678|3513617|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3669324|NCT02342678|3513615|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3669325|NCT02342678|3513616|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3669326|NCT02342678|3513617|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3669327|NCT02342678|3513615|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3669328|NCT02342678|3513616|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3669329|NCT02342678|3513617|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3669330|NCT02342561|3513638|B1|Both groups combined||Bacterial growth prior disinfection (colony forming unit/cm^2, Log10 transformed)||Log10 CFU/cm^2|Median|2.97|2.97|Inter-Quartile Range|||2.74|3.43|
3669331|NCT02342561|3513638|B1|Control knees (no drape knees)||Bacterial growth prior disinfection (colony forming unit/cm^2, Log10 transformed)||Log10 CFU/cm^2|Median|2.91|2.91|Inter-Quartile Range|||2.76|3.19|
3669332|NCT02342561|3513638|B1|Intervention knees (Draped Knees)||Bacterial growth prior disinfection (colony forming unit/cm^2, Log10 transformed)||Log10 CFU/cm^2|Median|2.99|2.99|Inter-Quartile Range|||2.62|3.52|
3669333|NCT02342561|3513638|B1|Denmark||Region of Enrollment||participants|Number|20|20.0||||||
3669334|NCT02342561|3513638|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669335|NCT02342561|3513638|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669336|NCT02342561|3513638|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3669337|NCT02342561|3513638|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669338|NCT02342561|3513638|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669339|NCT02342561|3513638|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669340|NCT02342561|3513638|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669341|NCT02342561|3513638|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3669342|NCT02342561|3513638|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3669343|NCT02342561|3513638|B1|||Age|Age of study participant on intervention date|years|Mean|67.8|67.8|Standard Deviation|9.7|9.7|||
3669344|NCT02342548|3513646|B4|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3669345|NCT02342548|3513647|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3669346|NCT02342548|3513648|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3669347|NCT02342548|3513649|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3669348|NCT02342548|3513646|B4|White||Race/Ethnicity, Customized||participants|Number|184|184.0||||||
3669349|NCT02342548|3513647|B3|White||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
3669350|NCT02342548|3513648|B2|White||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
3669351|NCT02342548|3513649|B1|White||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
3669352|NCT02342548|3513646|B4||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3669353|NCT02342548|3513647|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3669354|NCT02342548|3513648|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3669355|NCT02342548|3513649|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3669356|NCT02342548|3513646|B4||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3669357|NCT02342548|3513647|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3669358|NCT02342548|3513648|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3669359|NCT02342548|3513649|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3669360|NCT02342548|3513646|B4|||Age||years|Mean|49.9|49.9|Standard Deviation|9.1|9.1|||
3669361|NCT02342548|3513647|B3|||Age||years|Mean|51.3|51.3|Standard Deviation|9.4|9.4|||
3669362|NCT02342548|3513648|B2|||Age||years|Mean|48.4|48.4|Standard Deviation|8.6|8.6|||
3669363|NCT02342548|3513649|B1|||Age||years|Mean|50.2|50.2|Standard Deviation|9.4|9.4|||
3669364|NCT02342535|3513689|B1|United States||Region of Enrollment|Majority participants from the Rogers Park neighborhood of Chicago and the neighboring suburbs in Illinois.|participants|Number|68|68.0||||||
3669365|NCT02342535|3513689|B1|South Asian||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
3669366|NCT02342535|3513689|B1|Male Child||Sex/Gender, Customized||participants|Number|21|21.0||||||
3669367|NCT02342535|3513689|B1|Female Child||Sex/Gender, Customized||participants|Number|17|17.0||||||
3669368|NCT02342535|3513689|B1|Female Parent||Sex/Gender, Customized||participants|Number|30|30.0||||||
3669369|NCT02342535|3513689|B1|||Age|Participants were enrolled into the study from November 2014 to February 2015. The average age of mothers was 40 (SD±5) years.|years|Mean|40|40.0|Standard Deviation|5|5.0|||
3669370|NCT02342418|3513693|B3|||Body Mass Index||kilogram per square meter|Median|36.1|36.1|Full Range|||25.4|51.8|
3669371|NCT02342418|3513694|B2|||Body Mass Index||kilogram per square meter|Median|27.4|27.4|Full Range|||25.4|29.1|
3669372|NCT02342418|3513695|B1|||Body Mass Index||kilogram per square meter|Median|43.5|43.5|Full Range|||40.4|51.8|
3669373|NCT02342418|3513693|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3669374|NCT02342418|3513694|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3669375|NCT02342418|3513695|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3669376|NCT02342418|3513693|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3669377|NCT02342418|3513694|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3669378|NCT02342418|3513695|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3669379|NCT02342418|3513693|B3|||Age||years|Median|37|37.0|Full Range|||24.0|50.0|
3669380|NCT02342418|3513694|B2|||Age||years|Median|37|37.0|Full Range|||24.0|46.0|
3669381|NCT02342418|3513695|B1|||Age||years|Median|38|38.0|Full Range|||26.0|50.0|
3669382|NCT02342288|3513704|B3|United States||Region of Enrollment||participants|Number|52|52.0||||||
3669383|NCT02342288|3513705|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
3669384|NCT02342288|3513706|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3669385|NCT02342288|3513704|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3669386|NCT02342288|3513705|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3669387|NCT02342288|3513706|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3669388|NCT02342288|3513704|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669389|NCT02342288|3513705|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669390|NCT02342288|3513706|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669391|NCT02342288|3513704|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669392|NCT02342288|3513705|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669393|NCT02342288|3513706|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669394|NCT02342288|3513704|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669395|NCT02342288|3513705|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669396|NCT02342288|3513706|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669397|NCT02342288|3513704|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669398|NCT02342288|3513705|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669399|NCT02342288|3513706|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669400|NCT02342288|3513704|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669401|NCT02342288|3513705|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669402|NCT02342288|3513706|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669403|NCT02342288|3513704|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669404|NCT02342288|3513705|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669405|NCT02342288|3513706|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669406|NCT02342288|3513704|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3669407|NCT02342288|3513705|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3669408|NCT02342288|3513706|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3669409|NCT02342288|3513704|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3669410|NCT02342288|3513705|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3669411|NCT02342288|3513706|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3669412|NCT02342288|3513704|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3669413|NCT02342288|3513705|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3669414|NCT02342288|3513706|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3669415|NCT02342288|3513704|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3669416|NCT02342288|3513705|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3669417|NCT02342288|3513706|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3669418|NCT02342288|3513704|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3669419|NCT02342288|3513705|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3669420|NCT02342288|3513706|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3669421|NCT02342223|3513713|B1||Male|Gender||Participants|Count of Participants|20|20.0||||||
3669422|NCT02342223|3513713|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3669423|NCT02342223|3513713|B1|||Age||years|Mean|57|57.0|Standard Deviation|10|10.0|||
3669424|NCT02342197|3513722|B3|||Duration of infertility||years|Mean|5.4|5.4|Standard Deviation|0.1|0.1|||
3669425|NCT02342197|3513723|B2|||Duration of infertility||years|Mean|5.7|5.7|Standard Deviation|1.5|1.5|||
3669426|NCT02342197|3513724|B1|||Duration of infertility||years|Mean|5.1|5.1|Standard Deviation|1.5|1.5|||
3669427|NCT02342197|3513722|B3|||Day 3 FSH (IU/L)||IU/L|Mean|7.8|7.8|Standard Deviation|0.1|0.1|||
3669428|NCT02342197|3513723|B2|||Day 3 FSH (IU/L)||IU/L|Mean|7.6|7.6|Standard Deviation|1.1|1.1|||
3669429|NCT02342197|3513724|B1|||Day 3 FSH (IU/L)||IU/L|Mean|8|8.0|Standard Deviation|1.1|1.1|||
3669430|NCT02342197|3513722|B3|||BMI (kg/m2)||kg / m2|Mean|30.5|30.5|Standard Deviation|0.2|0.2|||
3669431|NCT02342197|3513723|B2|||BMI (kg/m2)||kg / m2|Mean|31|31.0|Standard Deviation|1.8|1.8|||
3669432|NCT02342197|3513724|B1|||BMI (kg/m2)||kg / m2|Mean|30|30.0|Standard Deviation|2.5|2.5|||
3669433|NCT02342197|3513722|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3669434|NCT02342197|3513723|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3669435|NCT02342197|3513724|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3669436|NCT02342197|3513722|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3669437|NCT02342197|3513723|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3669438|NCT02342197|3513724|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3669439|NCT02342197|3513722|B3|||Age||years|Mean|37.2|37.2|Standard Deviation|0.1|0.1|||
3669440|NCT02342197|3513723|B2|||Age||years|Mean|37.1|37.1|Standard Deviation|1.5|1.5|||
3669441|NCT02342197|3513724|B1|||Age||years|Mean|37.4|37.4|Standard Deviation|1.5|1.5|||
3669442|NCT02341859|3513731|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3669443|NCT02341859|3513731|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3669444|NCT02341859|3513731|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3669445|NCT02341859|3513731|B1|||Age||years|Median|22|22.0|Full Range|||19.0|44.0|
3669446|NCT02341859|3513731|B1|||Age||years|Mean|24.3|24.3|Standard Deviation|5.84|5.84|||
3669447|NCT02341482|3513885|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3669448|NCT02341482|3513885|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3669449|NCT02341482|3513885|B1|||Age||years|Mean|42.5|42.5|Standard Deviation|8.5|8.5|||
3669450|NCT02341417|3513911|B4|Day 1 of cinacalcet treatment baseline||Calcium Phosphorus Product (Ca x P)||mg²/dL²|Median|56.81|56.81|Inter-Quartile Range|||48.03|62.24|
3669451|NCT02341417|3513912|B3|Day 1 of cinacalcet treatment baseline||Calcium Phosphorus Product (Ca x P)||mg²/dL²|Median|98.90|98.9|Inter-Quartile Range|||98.9|98.9|
3669452|NCT02341417|3513913|B2|Day 1 of cinacalcet treatment baseline||Calcium Phosphorus Product (Ca x P)||mg²/dL²|Median|57.98|57.98|Inter-Quartile Range|||47.47|62.25|
3669453|NCT02341417|3513914|B1|Day 1 of cinacalcet treatment baseline||Calcium Phosphorus Product (Ca x P)||mg²/dL²|Median|54.42|54.42|Inter-Quartile Range|||48.59|58.82|
3669454|NCT02341417|3513911|B4|Extension study baseline||Calcium Phosphorus Product (Ca x P)||mg²/dL²|Median|56.71|56.71|Inter-Quartile Range|||50.11|65.06|
3669455|NCT02341417|3513912|B3|Extension study baseline||Calcium Phosphorus Product (Ca x P)||mg²/dL²|Median|82.28|82.28|Inter-Quartile Range|||82.28|82.28|
3669456|NCT02341417|3513913|B2|Extension study baseline||Calcium Phosphorus Product (Ca x P)||mg²/dL²|Median|57.80|57.8|Inter-Quartile Range|||50.94|65.65|
3669457|NCT02341417|3513914|B1|Extension study baseline||Calcium Phosphorus Product (Ca x P)||mg²/dL²|Median|54.42|54.42|Inter-Quartile Range|||48.59|58.82|
3669458|NCT02341417|3513911|B4|Day 1 of cinacalcet treatment baseline||Serum Phosphorus|Phosphorus levels are reported for the extension study baseline and also for baseline relative to day 1 of cinacalcet treatment (equivalent to baseline of extension study for participants who received SOC alone in parent study 20130356; transferred from parent study for all other participants).|mg/dL|Median|5.74|5.74|Inter-Quartile Range|||4.87|6.32|
3669459|NCT02341417|3513912|B3|Day 1 of cinacalcet treatment baseline||Serum Phosphorus|Phosphorus levels are reported for the extension study baseline and also for baseline relative to day 1 of cinacalcet treatment (equivalent to baseline of extension study for participants who received SOC alone in parent study 20130356; transferred from parent study for all other participants).|mg/dL|Median|9.00|9.0|Inter-Quartile Range|||9.0|9.0|
3669460|NCT02341417|3513913|B2|Day 1 of cinacalcet treatment baseline||Serum Phosphorus|Phosphorus levels are reported for the extension study baseline and also for baseline relative to day 1 of cinacalcet treatment (equivalent to baseline of extension study for participants who received SOC alone in parent study 20130356; transferred from parent study for all other participants).|mg/dL|Median|5.75|5.75|Inter-Quartile Range|||4.88|6.13|
3669461|NCT02341417|3513914|B1|Day 1 of cinacalcet treatment baseline||Serum Phosphorus|Phosphorus levels are reported for the extension study baseline and also for baseline relative to day 1 of cinacalcet treatment (equivalent to baseline of extension study for participants who received SOC alone in parent study 20130356; transferred from parent study for all other participants).|mg/dL|Median|5.57|5.57|Inter-Quartile Range|||4.86|6.19|
3669462|NCT02341417|3513911|B4|Extension study baseline||Serum Phosphorus|Phosphorus levels are reported for the extension study baseline and also for baseline relative to day 1 of cinacalcet treatment (equivalent to baseline of extension study for participants who received SOC alone in parent study 20130356; transferred from parent study for all other participants).|mg/dL|Median|5.85|5.85|Inter-Quartile Range|||5.23|6.58|
3669463|NCT02341417|3513912|B3|Extension study baseline||Serum Phosphorus|Phosphorus levels are reported for the extension study baseline and also for baseline relative to day 1 of cinacalcet treatment (equivalent to baseline of extension study for participants who received SOC alone in parent study 20130356; transferred from parent study for all other participants).|mg/dL|Median|8.08|8.08|Inter-Quartile Range|||8.08|8.08|
3669464|NCT02341417|3513913|B2|Extension study baseline||Serum Phosphorus|Phosphorus levels are reported for the extension study baseline and also for baseline relative to day 1 of cinacalcet treatment (equivalent to baseline of extension study for participants who received SOC alone in parent study 20130356; transferred from parent study for all other participants).|mg/dL|Median|6.05|6.05|Inter-Quartile Range|||5.31|6.67|
3669465|NCT02341417|3513914|B1|Extension study baseline||Serum Phosphorus|Phosphorus levels are reported for the extension study baseline and also for baseline relative to day 1 of cinacalcet treatment (equivalent to baseline of extension study for participants who received SOC alone in parent study 20130356; transferred from parent study for all other participants).|mg/dL|Median|5.57|5.57|Inter-Quartile Range|||4.86|6.19|
3669466|NCT02341417|3513911|B4|Day 1 of cinacalcet treatment baseline||Ionized Calcium||mmol/L|Median|1.215|1.215|Inter-Quartile Range|||1.125|1.26|
3669467|NCT02341417|3513912|B3|Day 1 of cinacalcet treatment baseline||Ionized Calcium||mmol/L|Median|1.340|1.34|Inter-Quartile Range|||1.34|1.34|
3669468|NCT02341417|3513913|B2|Day 1 of cinacalcet treatment baseline||Ionized Calcium||mmol/L|Median|1.225|1.225|Inter-Quartile Range|||1.14|1.27|
3669469|NCT02341417|3513914|B1|Day 1 of cinacalcet treatment baseline||Ionized Calcium||mmol/L|Median|1.130|1.13|Inter-Quartile Range|||1.11|1.23|
3669470|NCT02341417|3513911|B4|Extension study baseline||Ionized Calcium||mmol/L|Median|1.140|1.14|Inter-Quartile Range|||1.11|1.26|
3669471|NCT02341417|3513912|B3|Extension study baseline||Ionized Calcium||mmol/L|Median|1.390|1.39|Inter-Quartile Range|||1.39|1.39|
3669472|NCT02341417|3513913|B2|Extension study baseline||Ionized Calcium||mmol/L|Median|1.145|1.145|Inter-Quartile Range|||1.1|1.28|
3669473|NCT02341417|3513914|B1|Extension study baseline||Ionized Calcium||mmol/L|Median|1.130|1.13|Inter-Quartile Range|||1.11|1.23|
3669474|NCT02341417|3513911|B4|Day 1 of cinacalcet treatment baseline||Corrected Total Serum Calcium|"Total serum calcium was corrected using the following formula if the serum albumin was < 4 g/dL:~Corrected total serum calcium (mg/dL) = measured total serum calcium (mg/dL) + 0.8 (4.0 – serum albumin (g/dL)) Corrected calcium levels are reported for the extension study baseline and also for baseline relative to day 1 of cinacalcet treatment (equivalent to baseline of extension study for participants who received SOC alone in parent study 20130356; transferred from parent study for all other participants)."|mg/dL|Median|9.80|9.8|Inter-Quartile Range|||9.45|10.19|
3669475|NCT02341417|3513912|B3|Day 1 of cinacalcet treatment baseline||Corrected Total Serum Calcium|"Total serum calcium was corrected using the following formula if the serum albumin was < 4 g/dL:~Corrected total serum calcium (mg/dL) = measured total serum calcium (mg/dL) + 0.8 (4.0 – serum albumin (g/dL)) Corrected calcium levels are reported for the extension study baseline and also for baseline relative to day 1 of cinacalcet treatment (equivalent to baseline of extension study for participants who received SOC alone in parent study 20130356; transferred from parent study for all other participants)."|mg/dL|Median|10.90|10.9|Inter-Quartile Range|||10.9|10.9|
3669476|NCT02341417|3513913|B2|Day 1 of cinacalcet treatment baseline||Corrected Total Serum Calcium|"Total serum calcium was corrected using the following formula if the serum albumin was < 4 g/dL:~Corrected total serum calcium (mg/dL) = measured total serum calcium (mg/dL) + 0.8 (4.0 – serum albumin (g/dL)) Corrected calcium levels are reported for the extension study baseline and also for baseline relative to day 1 of cinacalcet treatment (equivalent to baseline of extension study for participants who received SOC alone in parent study 20130356; transferred from parent study for all other participants)."|mg/dL|Median|9.86|9.86|Inter-Quartile Range|||9.58|10.18|
3669477|NCT02341417|3513914|B1|Day 1 of cinacalcet treatment baseline||Corrected Total Serum Calcium|"Total serum calcium was corrected using the following formula if the serum albumin was < 4 g/dL:~Corrected total serum calcium (mg/dL) = measured total serum calcium (mg/dL) + 0.8 (4.0 – serum albumin (g/dL)) Corrected calcium levels are reported for the extension study baseline and also for baseline relative to day 1 of cinacalcet treatment (equivalent to baseline of extension study for participants who received SOC alone in parent study 20130356; transferred from parent study for all other participants)."|mg/dL|Median|9.56|9.56|Inter-Quartile Range|||9.4|10.0|
3669478|NCT02341417|3513911|B4|Extension study baseline||Corrected Total Serum Calcium|"Total serum calcium was corrected using the following formula if the serum albumin was < 4 g/dL:~Corrected total serum calcium (mg/dL) = measured total serum calcium (mg/dL) + 0.8 (4.0 – serum albumin (g/dL)) Corrected calcium levels are reported for the extension study baseline and also for baseline relative to day 1 of cinacalcet treatment (equivalent to baseline of extension study for participants who received SOC alone in parent study 20130356; transferred from parent study for all other participants)."|mg/dL|Median|9.80|9.8|Inter-Quartile Range|||9.36|10.18|
3669503|NCT02341417|3513912|B3||Black (or African American)|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3669504|NCT02341417|3513913|B2||Black (or African American)|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3669479|NCT02341417|3513912|B3|Extension study baseline||Corrected Total Serum Calcium|"Total serum calcium was corrected using the following formula if the serum albumin was < 4 g/dL:~Corrected total serum calcium (mg/dL) = measured total serum calcium (mg/dL) + 0.8 (4.0 – serum albumin (g/dL)) Corrected calcium levels are reported for the extension study baseline and also for baseline relative to day 1 of cinacalcet treatment (equivalent to baseline of extension study for participants who received SOC alone in parent study 20130356; transferred from parent study for all other participants)."|mg/dL|Median|10.29|10.29|Inter-Quartile Range|||10.29|10.29|
3669480|NCT02341417|3513913|B2|Extension study baseline||Corrected Total Serum Calcium|"Total serum calcium was corrected using the following formula if the serum albumin was < 4 g/dL:~Corrected total serum calcium (mg/dL) = measured total serum calcium (mg/dL) + 0.8 (4.0 – serum albumin (g/dL)) Corrected calcium levels are reported for the extension study baseline and also for baseline relative to day 1 of cinacalcet treatment (equivalent to baseline of extension study for participants who received SOC alone in parent study 20130356; transferred from parent study for all other participants)."|mg/dL|Median|9.93|9.93|Inter-Quartile Range|||9.02|10.16|
3669481|NCT02341417|3513914|B1|Extension study baseline||Corrected Total Serum Calcium|"Total serum calcium was corrected using the following formula if the serum albumin was < 4 g/dL:~Corrected total serum calcium (mg/dL) = measured total serum calcium (mg/dL) + 0.8 (4.0 – serum albumin (g/dL)) Corrected calcium levels are reported for the extension study baseline and also for baseline relative to day 1 of cinacalcet treatment (equivalent to baseline of extension study for participants who received SOC alone in parent study 20130356; transferred from parent study for all other participants)."|mg/dL|Median|9.56|9.56|Inter-Quartile Range|||9.4|10.0|
3669482|NCT02341417|3513911|B4|Day 1 of cinacalcet treatment baseline||Intact Parathyroid Hormone (iPTH)|Intact parathyroid hormone levels are reported for the extension study baseline and also for baseline relative to day 1 of cinacalcet treatment (equivalent to baseline of extension study for participants who received SOC alone in parent study 20130356; transferred from parent study for all other participants).|pg/mL|Median|980.56|980.56|Inter-Quartile Range|||639.85|1530.03|
3669483|NCT02341417|3513912|B3|Day 1 of cinacalcet treatment baseline||Intact Parathyroid Hormone (iPTH)|Intact parathyroid hormone levels are reported for the extension study baseline and also for baseline relative to day 1 of cinacalcet treatment (equivalent to baseline of extension study for participants who received SOC alone in parent study 20130356; transferred from parent study for all other participants).|pg/mL|Median|992.60|992.6|Inter-Quartile Range|||992.6|992.6|
3669484|NCT02341417|3513913|B2|Day 1 of cinacalcet treatment baseline||Intact Parathyroid Hormone (iPTH)|Intact parathyroid hormone levels are reported for the extension study baseline and also for baseline relative to day 1 of cinacalcet treatment (equivalent to baseline of extension study for participants who received SOC alone in parent study 20130356; transferred from parent study for all other participants).|pg/mL|Median|798.10|798.1|Inter-Quartile Range|||622.36|1360.95|
3669485|NCT02341417|3513914|B1|Day 1 of cinacalcet treatment baseline||Intact Parathyroid Hormone (iPTH)|Intact parathyroid hormone levels are reported for the extension study baseline and also for baseline relative to day 1 of cinacalcet treatment (equivalent to baseline of extension study for participants who received SOC alone in parent study 20130356; transferred from parent study for all other participants).|pg/mL|Median|1432.69|1432.69|Inter-Quartile Range|||800.19|1695.48|
3669486|NCT02341417|3513911|B4|Extension study baseline||Intact Parathyroid Hormone (iPTH)|Intact parathyroid hormone levels are reported for the extension study baseline and also for baseline relative to day 1 of cinacalcet treatment (equivalent to baseline of extension study for participants who received SOC alone in parent study 20130356; transferred from parent study for all other participants).|pg/mL|Median|1047.41|1047.41|Inter-Quartile Range|||583.37|1530.03|
3669487|NCT02341417|3513912|B3|Extension study baseline||Intact Parathyroid Hormone (iPTH)|Intact parathyroid hormone levels are reported for the extension study baseline and also for baseline relative to day 1 of cinacalcet treatment (equivalent to baseline of extension study for participants who received SOC alone in parent study 20130356; transferred from parent study for all other participants).|pg/mL|Median|907.74|907.74|Inter-Quartile Range|||907.74|907.74|
3669488|NCT02341417|3513913|B2|Extension study baseline||Intact Parathyroid Hormone (iPTH)|Intact parathyroid hormone levels are reported for the extension study baseline and also for baseline relative to day 1 of cinacalcet treatment (equivalent to baseline of extension study for participants who received SOC alone in parent study 20130356; transferred from parent study for all other participants).|pg/mL|Median|1001.35|1001.35|Inter-Quartile Range|||525.76|1292.08|
3669489|NCT02341417|3513914|B1|Extension study baseline||Intact Parathyroid Hormone (iPTH)|Intact parathyroid hormone levels are reported for the extension study baseline and also for baseline relative to day 1 of cinacalcet treatment (equivalent to baseline of extension study for participants who received SOC alone in parent study 20130356; transferred from parent study for all other participants).|pg/mL|Median|1432.69|1432.69|Inter-Quartile Range|||800.19|1695.48|
3669490|NCT02341417|3513911|B4||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3669491|NCT02341417|3513912|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3669492|NCT02341417|3513913|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3669493|NCT02341417|3513914|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3669494|NCT02341417|3513911|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3669495|NCT02341417|3513912|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3669496|NCT02341417|3513913|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3669497|NCT02341417|3513914|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3669498|NCT02341417|3513911|B4||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3669499|NCT02341417|3513912|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3669500|NCT02341417|3513913|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3669501|NCT02341417|3513914|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3669502|NCT02341417|3513911|B4||Black (or African American)|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3669505|NCT02341417|3513914|B1||Black (or African American)|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3669506|NCT02341417|3513911|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3669507|NCT02341417|3513912|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3669508|NCT02341417|3513913|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3669509|NCT02341417|3513914|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3669510|NCT02341417|3513911|B4||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3669511|NCT02341417|3513912|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3669512|NCT02341417|3513913|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3669513|NCT02341417|3513914|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3669514|NCT02341417|3513911|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669515|NCT02341417|3513912|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669516|NCT02341417|3513913|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669517|NCT02341417|3513914|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669518|NCT02341417|3513911|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3669519|NCT02341417|3513912|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3669520|NCT02341417|3513913|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3669521|NCT02341417|3513914|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3669522|NCT02341417|3513911|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3669523|NCT02341417|3513912|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669524|NCT02341417|3513913|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669525|NCT02341417|3513914|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3669526|NCT02341417|3513911|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3669527|NCT02341417|3513912|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3669528|NCT02341417|3513913|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3669529|NCT02341417|3513914|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3669530|NCT02341417|3513911|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3669531|NCT02341417|3513912|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3669532|NCT02341417|3513913|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3669533|NCT02341417|3513914|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3669534|NCT02341417|3513911|B4||12 to ≤ 18 years|Age, Customized|One participants in the 20130356 SOC group was 17 years old at the time of enrollment of parent study and had turned 18 at the time of enrollment of Study 20140159.|Participants|Count of Participants|17|17.0||||||
3669535|NCT02341417|3513912|B3||12 to ≤ 18 years|Age, Customized|One participants in the 20130356 SOC group was 17 years old at the time of enrollment of parent study and had turned 18 at the time of enrollment of Study 20140159.|Participants|Count of Participants|0|0.0||||||
3669536|NCT02341417|3513913|B2||12 to ≤ 18 years|Age, Customized|One participants in the 20130356 SOC group was 17 years old at the time of enrollment of parent study and had turned 18 at the time of enrollment of Study 20140159.|Participants|Count of Participants|8|8.0||||||
3669537|NCT02341417|3513914|B1||12 to ≤ 18 years|Age, Customized|One participants in the 20130356 SOC group was 17 years old at the time of enrollment of parent study and had turned 18 at the time of enrollment of Study 20140159.|Participants|Count of Participants|9|9.0||||||
3669538|NCT02341417|3513911|B4||6 to < 12 years|Age, Customized|One participants in the 20130356 SOC group was 17 years old at the time of enrollment of parent study and had turned 18 at the time of enrollment of Study 20140159.|Participants|Count of Participants|10|10.0||||||
3669539|NCT02341417|3513912|B3||6 to < 12 years|Age, Customized|One participants in the 20130356 SOC group was 17 years old at the time of enrollment of parent study and had turned 18 at the time of enrollment of Study 20140159.|Participants|Count of Participants|0|0.0||||||
3669540|NCT02341417|3513913|B2||6 to < 12 years|Age, Customized|One participants in the 20130356 SOC group was 17 years old at the time of enrollment of parent study and had turned 18 at the time of enrollment of Study 20140159.|Participants|Count of Participants|6|6.0||||||
3669541|NCT02341417|3513914|B1||6 to < 12 years|Age, Customized|One participants in the 20130356 SOC group was 17 years old at the time of enrollment of parent study and had turned 18 at the time of enrollment of Study 20140159.|Participants|Count of Participants|4|4.0||||||
3669542|NCT02341417|3513911|B4||2 to < 6 years|Age, Customized|One participants in the 20130356 SOC group was 17 years old at the time of enrollment of parent study and had turned 18 at the time of enrollment of Study 20140159.|Participants|Count of Participants|1|1.0||||||
3669543|NCT02341417|3513912|B3||2 to < 6 years|Age, Customized|One participants in the 20130356 SOC group was 17 years old at the time of enrollment of parent study and had turned 18 at the time of enrollment of Study 20140159.|Participants|Count of Participants|1|1.0||||||
3669544|NCT02341417|3513913|B2||2 to < 6 years|Age, Customized|One participants in the 20130356 SOC group was 17 years old at the time of enrollment of parent study and had turned 18 at the time of enrollment of Study 20140159.|Participants|Count of Participants|0|0.0||||||
3669545|NCT02341417|3513914|B1||2 to < 6 years|Age, Customized|One participants in the 20130356 SOC group was 17 years old at the time of enrollment of parent study and had turned 18 at the time of enrollment of Study 20140159.|Participants|Count of Participants|0|0.0||||||
3669597|NCT02340962|3513976|B2|||Age||years|Mean|54.0|54.0|Standard Deviation|11.91|11.91|||
3669546|NCT02341417|3513911|B4||28 days to < 2 years|Age, Customized|One participants in the 20130356 SOC group was 17 years old at the time of enrollment of parent study and had turned 18 at the time of enrollment of Study 20140159.|Participants|Count of Participants|0|0.0||||||
3669547|NCT02341417|3513912|B3||28 days to < 2 years|Age, Customized|One participants in the 20130356 SOC group was 17 years old at the time of enrollment of parent study and had turned 18 at the time of enrollment of Study 20140159.|Participants|Count of Participants|0|0.0||||||
3669548|NCT02341417|3513913|B2||28 days to < 2 years|Age, Customized|One participants in the 20130356 SOC group was 17 years old at the time of enrollment of parent study and had turned 18 at the time of enrollment of Study 20140159.|Participants|Count of Participants|0|0.0||||||
3669549|NCT02341417|3513914|B1||28 days to < 2 years|Age, Customized|One participants in the 20130356 SOC group was 17 years old at the time of enrollment of parent study and had turned 18 at the time of enrollment of Study 20140159.|Participants|Count of Participants|0|0.0||||||
3669550|NCT02341417|3513911|B4|||Age||years|Median|14.0|14.0|Full Range|||2.0|18.0|
3669551|NCT02341417|3513912|B3|||Age||years|Median|2.0|2.0|Full Range|||2.0|2.0|
3669552|NCT02341417|3513913|B2|||Age||years|Median|14.0|14.0|Full Range|||7.0|17.0|
3669553|NCT02341417|3513914|B1|||Age||years|Median|14.0|14.0|Full Range|||9.0|18.0|
3669554|NCT02341144|3513958|B3|||Body mass index (BMI) percentile|body mass index (BMI) percentile: weight (kg) divided by height (m) relative to other children in the US of the same age and sex|percentile|Median|61.2|61.2|Full Range|||3.0|99.0|
3669555|NCT02341144|3513959|B2|||Body mass index (BMI) percentile|body mass index (BMI) percentile: weight (kg) divided by height (m) relative to other children in the US of the same age and sex|percentile|Median|77|77.0|Full Range|||5.0|98.0|
3669556|NCT02341144|3513960|B1|||Body mass index (BMI) percentile|body mass index (BMI) percentile: weight (kg) divided by height (m) relative to other children in the US of the same age and sex|percentile|Median|57|57.0|Full Range|||3.0|99.0|
3669557|NCT02341144|3513958|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3669558|NCT02341144|3513959|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3669559|NCT02341144|3513960|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3669560|NCT02341144|3513958|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3669561|NCT02341144|3513959|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3669562|NCT02341144|3513960|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3669563|NCT02341144|3513958|B3|||Age||years|Median|6.2|6.2|Full Range|||3.2|17.2|
3669564|NCT02341144|3513959|B2|||Age||years|Median|6.2|6.2|Full Range|||4.1|17.2|
3669565|NCT02341144|3513960|B1|||Age||years|Median|6.2|6.2|Full Range|||3.2|15.4|
3669566|NCT02340962|3513975|B3|||Weight||kilogram|Mean|63.4|63.4|Standard Deviation|11.49|11.49|||
3669567|NCT02340962|3513976|B2|||Weight||kilogram|Mean|64.0|64.0|Standard Deviation|9.11|9.11|||
3669568|NCT02340962|3513977|B1|||Weight||kilogram|Mean|62.8|62.8|Standard Deviation|13.69|13.69|||
3669569|NCT02340962|3513975|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669570|NCT02340962|3513976|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669571|NCT02340962|3513977|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669572|NCT02340962|3513975|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669573|NCT02340962|3513976|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669574|NCT02340962|3513977|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669575|NCT02340962|3513975|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669576|NCT02340962|3513976|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669577|NCT02340962|3513977|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669578|NCT02340962|3513975|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669579|NCT02340962|3513976|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669580|NCT02340962|3513977|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669581|NCT02340962|3513975|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669582|NCT02340962|3513976|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669583|NCT02340962|3513977|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669584|NCT02340962|3513975|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3669585|NCT02340962|3513976|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3669586|NCT02340962|3513977|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3669587|NCT02340962|3513975|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669588|NCT02340962|3513976|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669589|NCT02340962|3513977|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669590|NCT02340962|3513975|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3669591|NCT02340962|3513976|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3669592|NCT02340962|3513977|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3669593|NCT02340962|3513975|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3669594|NCT02340962|3513976|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3669595|NCT02340962|3513977|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3669596|NCT02340962|3513975|B3|||Age||years|Mean|52.3|52.3|Standard Deviation|11.21|11.21|||
3669598|NCT02340962|3513977|B1|||Age||years|Mean|50.8|50.8|Standard Deviation|10.76|10.76|||
3669599|NCT02340715|3513998|B1||Male|Sex: Female, Male|Enrollment open to both genders.|Participants|Count of Participants|73|73.0||||||
3669600|NCT02340715|3513998|B1||Female|Sex: Female, Male|Enrollment open to both genders.|Participants|Count of Participants|85|85.0||||||
3669601|NCT02340715|3513998|B1||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
3669602|NCT02340715|3513998|B1||Between 18 and 65 years|Age||Participants|Count of Participants|114|114.0||||||
3669603|NCT02340715|3513998|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3669604|NCT02340676|3514002|B1||Severe|Chronic Graft-versus-Host Disease (cGVHD)||Participants|Count of Participants|5|5.0||||||
3669605|NCT02340676|3514002|B1||Moderate|Chronic Graft-versus-Host Disease (cGVHD)||Participants|Count of Participants|19|19.0||||||
3669606|NCT02340676|3514002|B1||Mild|Chronic Graft-versus-Host Disease (cGVHD)||Participants|Count of Participants|1|1.0||||||
3669607|NCT02340676|3514002|B1|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3669608|NCT02340676|3514002|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669609|NCT02340676|3514002|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669610|NCT02340676|3514002|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3669611|NCT02340676|3514002|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669612|NCT02340676|3514002|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669613|NCT02340676|3514002|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3669614|NCT02340676|3514002|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669615|NCT02340676|3514002|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3669616|NCT02340676|3514002|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3669617|NCT02340676|3514002|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669618|NCT02340676|3514002|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3669619|NCT02340676|3514002|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3669620|NCT02340676|3514002|B1|||Age||years|Median|62|62.0|Full Range|||34.0|76.0|
3669621|NCT02340676|3514002|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3669622|NCT02340676|3514002|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3669623|NCT02340676|3514002|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3669624|NCT02340663|3514013|B3|4 - 7 nights / week||Bruxing Self-report|4-point scale reflecting frequency of nights bruxing per week or per month|Participants|Count of Participants|27|27.0||||||
3669625|NCT02340663|3514014|B2|4 - 7 nights / week||Bruxing Self-report|4-point scale reflecting frequency of nights bruxing per week or per month|Participants|Count of Participants|14|14.0||||||
3669626|NCT02340663|3514015|B1|4 - 7 nights / week||Bruxing Self-report|4-point scale reflecting frequency of nights bruxing per week or per month|Participants|Count of Participants|13|13.0||||||
3669627|NCT02340663|3514013|B3|1 -3 nights / week||Bruxing Self-report|4-point scale reflecting frequency of nights bruxing per week or per month|Participants|Count of Participants|29|29.0||||||
3669628|NCT02340663|3514014|B2|1 -3 nights / week||Bruxing Self-report|4-point scale reflecting frequency of nights bruxing per week or per month|Participants|Count of Participants|14|14.0||||||
3669629|NCT02340663|3514015|B1|1 -3 nights / week||Bruxing Self-report|4-point scale reflecting frequency of nights bruxing per week or per month|Participants|Count of Participants|15|15.0||||||
3669630|NCT02340663|3514013|B3|1-3 nights / month||Bruxing Self-report|4-point scale reflecting frequency of nights bruxing per week or per month|Participants|Count of Participants|10|10.0||||||
3669631|NCT02340663|3514014|B2|1-3 nights / month||Bruxing Self-report|4-point scale reflecting frequency of nights bruxing per week or per month|Participants|Count of Participants|4|4.0||||||
3669632|NCT02340663|3514015|B1|1-3 nights / month||Bruxing Self-report|4-point scale reflecting frequency of nights bruxing per week or per month|Participants|Count of Participants|6|6.0||||||
3669633|NCT02340663|3514013|B3|< 1 night / month||Bruxing Self-report|4-point scale reflecting frequency of nights bruxing per week or per month|Participants|Count of Participants|1|1.0||||||
3669634|NCT02340663|3514014|B2|< 1 night / month||Bruxing Self-report|4-point scale reflecting frequency of nights bruxing per week or per month|Participants|Count of Participants|0|0.0||||||
3669635|NCT02340663|3514015|B1|< 1 night / month||Bruxing Self-report|4-point scale reflecting frequency of nights bruxing per week or per month|Participants|Count of Participants|1|1.0||||||
3669636|NCT02340663|3514013|B3|United States||Region of Enrollment||Participants|Count of Participants|67|67.0||||||
3669637|NCT02340663|3514014|B2|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3669638|NCT02340663|3514015|B1|United States||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3669639|NCT02340663|3514013|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669640|NCT02340663|3514014|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669641|NCT02340663|3514015|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669642|NCT02340663|3514013|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3669643|NCT02340663|3514014|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3669644|NCT02340663|3514015|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669645|NCT02340663|3514013|B3||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3669646|NCT02340663|3514014|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3669647|NCT02340663|3514015|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3669648|NCT02340663|3514013|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3669649|NCT02340663|3514014|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3669650|NCT02340663|3514015|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3669651|NCT02340663|3514013|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669652|NCT02340663|3514014|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669653|NCT02340663|3514015|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669654|NCT02340663|3514013|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3669655|NCT02340663|3514014|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3669656|NCT02340663|3514015|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3669657|NCT02340663|3514013|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3669658|NCT02340663|3514014|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3669659|NCT02340663|3514015|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669660|NCT02340663|3514013|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3669661|NCT02340663|3514014|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3669662|NCT02340663|3514015|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3669663|NCT02340663|3514013|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3669664|NCT02340663|3514014|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3669665|NCT02340663|3514015|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3669666|NCT02340663|3514013|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3669667|NCT02340663|3514014|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3669668|NCT02340663|3514015|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3669669|NCT02340663|3514013|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3669670|NCT02340663|3514014|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3669671|NCT02340663|3514015|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3669672|NCT02340663|3514013|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3669673|NCT02340663|3514014|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3669674|NCT02340663|3514015|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3669675|NCT02340663|3514013|B3|||Age||Years|Mean|25.5|25.5|Standard Deviation|3.55|3.55|||
3669676|NCT02340663|3514014|B2|||Age||Years|Mean|25.4|25.4|Standard Deviation|3.83|3.83|||
3669677|NCT02340663|3514015|B1|||Age||Years|Mean|25.5|25.5|Standard Deviation|3.33|3.33|||
3669678|NCT02340663|3514013|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3669679|NCT02340663|3514014|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3669680|NCT02340663|3514015|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3669681|NCT02340663|3514013|B3||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
3669682|NCT02340663|3514014|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3669683|NCT02340663|3514015|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3669684|NCT02340663|3514013|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3669685|NCT02340663|3514014|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3669686|NCT02340663|3514015|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3669687|NCT02340520|3514072|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3669688|NCT02340520|3514072|B1|White Non-Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3669689|NCT02340520|3514072|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3669690|NCT02340520|3514072|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3669691|NCT02340520|3514072|B1|||Age||years|Mean|67.4|67.4|Standard Deviation|8.2|8.2|||
3669692|NCT02340338|3514077|B8|||Safety and Immunogenicity assessment.|Initial screening of antibody titers of participants of all groups since high titers were among exclusion criteria. For this reason, all patients included were assessed for antibody titers at that time point.|participants|Number|46|46.0||||||
3669693|NCT02340338|3514078|B7|||Safety and Immunogenicity assessment.|Initial screening of antibody titers of participants of all groups since high titers were among exclusion criteria. For this reason, all patients included were assessed for antibody titers at that time point.|participants|Number|12|12.0||||||
3669694|NCT02340338|3514079|B6|||Safety and Immunogenicity assessment.|Initial screening of antibody titers of participants of all groups since high titers were among exclusion criteria. For this reason, all patients included were assessed for antibody titers at that time point.|participants|Number|9|9.0||||||
3669695|NCT02340338|3514080|B5|||Safety and Immunogenicity assessment.|Initial screening of antibody titers of participants of all groups since high titers were among exclusion criteria. For this reason, all patients included were assessed for antibody titers at that time point.|participants|Number|9|9.0||||||
3669696|NCT02340338|3514081|B4|||Safety and Immunogenicity assessment.|Initial screening of antibody titers of participants of all groups since high titers were among exclusion criteria. For this reason, all patients included were assessed for antibody titers at that time point.|participants|Number|9|9.0||||||
3669756|NCT02340104|3514113|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3669697|NCT02340338|3514082|B3|||Safety and Immunogenicity assessment.|Initial screening of antibody titers of participants of all groups since high titers were among exclusion criteria. For this reason, all patients included were assessed for antibody titers at that time point.|participants|Number|3|3.0||||||
3669698|NCT02340338|3514083|B2|||Safety and Immunogenicity assessment.|Initial screening of antibody titers of participants of all groups since high titers were among exclusion criteria. For this reason, all patients included were assessed for antibody titers at that time point.|participants|Number|2|2.0||||||
3669699|NCT02340338|3514084|B1|||Safety and Immunogenicity assessment.|Initial screening of antibody titers of participants of all groups since high titers were among exclusion criteria. For this reason, all patients included were assessed for antibody titers at that time point.|participants|Number|2|2.0||||||
3669700|NCT02340338|3514077|B8|Austria||Region of Enrollment||participants|Number|46|46.0||||||
3669701|NCT02340338|3514078|B7|Austria||Region of Enrollment||participants|Number|12|12.0||||||
3669702|NCT02340338|3514079|B6|Austria||Region of Enrollment||participants|Number|9|9.0||||||
3669703|NCT02340338|3514080|B5|Austria||Region of Enrollment||participants|Number|9|9.0||||||
3669704|NCT02340338|3514081|B4|Austria||Region of Enrollment||participants|Number|9|9.0||||||
3669705|NCT02340338|3514082|B3|Austria||Region of Enrollment||participants|Number|3|3.0||||||
3669706|NCT02340338|3514083|B2|Austria||Region of Enrollment||participants|Number|2|2.0||||||
3669707|NCT02340338|3514084|B1|Austria||Region of Enrollment||participants|Number|2|2.0||||||
3669708|NCT02340338|3514077|B8||Male|Gender||Participants|Count of Participants|19|19.0||||||
3669709|NCT02340338|3514078|B7||Male|Gender||Participants|Count of Participants|6|6.0||||||
3669710|NCT02340338|3514079|B6||Male|Gender||Participants|Count of Participants|2|2.0||||||
3669711|NCT02340338|3514080|B5||Male|Gender||Participants|Count of Participants|3|3.0||||||
3669712|NCT02340338|3514081|B4||Male|Gender||Participants|Count of Participants|5|5.0||||||
3669713|NCT02340338|3514082|B3||Male|Gender||Participants|Count of Participants|1|1.0||||||
3669714|NCT02340338|3514083|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3669715|NCT02340338|3514084|B1||Male|Gender||Participants|Count of Participants|2|2.0||||||
3669716|NCT02340338|3514077|B8||Female|Gender||Participants|Count of Participants|27|27.0||||||
3669717|NCT02340338|3514078|B7||Female|Gender||Participants|Count of Participants|6|6.0||||||
3669718|NCT02340338|3514079|B6||Female|Gender||Participants|Count of Participants|7|7.0||||||
3669719|NCT02340338|3514080|B5||Female|Gender||Participants|Count of Participants|6|6.0||||||
3669720|NCT02340338|3514081|B4||Female|Gender||Participants|Count of Participants|4|4.0||||||
3669721|NCT02340338|3514082|B3||Female|Gender||Participants|Count of Participants|2|2.0||||||
3669722|NCT02340338|3514083|B2||Female|Gender||Participants|Count of Participants|2|2.0||||||
3669723|NCT02340338|3514084|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3669724|NCT02340338|3514077|B8|||Age||years|Mean|34.0|34.0|Standard Deviation|9.7|9.7|||
3669725|NCT02340338|3514078|B7|||Age||years|Mean|34.4|34.4|Standard Deviation|8.5|8.5|||
3669726|NCT02340338|3514079|B6|||Age||years|Mean|27.7|27.7|Standard Deviation|7.2|7.2|||
3669727|NCT02340338|3514080|B5|||Age||years|Mean|33.7|33.7|Standard Deviation|11.7|11.7|||
3669728|NCT02340338|3514081|B4|||Age||years|Mean|36.2|36.2|Standard Deviation|10.9|10.9|||
3669729|NCT02340338|3514082|B3|||Age||years|Mean|36.3|36.3|Standard Deviation|5.1|5.1|||
3669730|NCT02340338|3514083|B2|||Age||years|Mean|37.5|37.5|Standard Deviation|13.4|13.4|||
3669731|NCT02340338|3514084|B1|||Age||years|Mean|44.0|44.0|Standard Deviation|9.9|9.9|||
3669732|NCT02340338|3514077|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3669733|NCT02340338|3514078|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3669734|NCT02340338|3514079|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3669735|NCT02340338|3514080|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3669736|NCT02340338|3514081|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3669737|NCT02340338|3514082|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3669738|NCT02340338|3514083|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3669739|NCT02340338|3514084|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3669740|NCT02340338|3514077|B8||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
3669741|NCT02340338|3514078|B7||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3669742|NCT02340338|3514079|B6||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3669743|NCT02340338|3514080|B5||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3669744|NCT02340338|3514081|B4||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3669745|NCT02340338|3514082|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3669746|NCT02340338|3514083|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3669747|NCT02340338|3514084|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3669748|NCT02340338|3514077|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3669749|NCT02340338|3514078|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3669750|NCT02340338|3514079|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3669751|NCT02340338|3514080|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3669752|NCT02340338|3514081|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3669753|NCT02340338|3514082|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3669754|NCT02340338|3514083|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3669755|NCT02340338|3514084|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3669757|NCT02340104|3514113|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669758|NCT02340104|3514113|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669759|NCT02340104|3514113|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3669760|NCT02340104|3514113|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669761|NCT02340104|3514113|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669762|NCT02340104|3514113|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669763|NCT02340104|3514113|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669764|NCT02340104|3514113|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3669765|NCT02340104|3514113|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3669766|NCT02340104|3514113|B1|||Age||years|Mean|42.8|42.8|Standard Deviation|17.2|17.2|||
3669767|NCT02340000|3514118|B3|||Day 0 SNOT-16 mean item score|Ratings on a scale from 0=none to 3=severe of 16 sinusitis-related symptoms. Total score can range from 0 to 48 (with 48 the most severe possible)|units on a scale|Mean|1.94|1.94|Standard Deviation|.55|0.55|||
3669768|NCT02340000|3514119|B2|||Day 0 SNOT-16 mean item score|Ratings on a scale from 0=none to 3=severe of 16 sinusitis-related symptoms. Total score can range from 0 to 48 (with 48 the most severe possible)|units on a scale|Mean|1.99|1.99|Standard Deviation|.55|0.55|||
3669769|NCT02340000|3514120|B1|||Day 0 SNOT-16 mean item score|Ratings on a scale from 0=none to 3=severe of 16 sinusitis-related symptoms. Total score can range from 0 to 48 (with 48 the most severe possible)|units on a scale|Mean|1.89|1.89|Standard Deviation|.56|0.56|||
3669770|NCT02340000|3514118|B3|||Sinusitis category 3|double sickening|Participants|Count of Participants|74|74.0||||||
3669771|NCT02340000|3514119|B2|||Sinusitis category 3|double sickening|Participants|Count of Participants|34|34.0||||||
3669772|NCT02340000|3514120|B1|||Sinusitis category 3|double sickening|Participants|Count of Participants|40|40.0||||||
3669773|NCT02340000|3514118|B3|||Sinusitis category 2|Severe symptoms (most severe of the 3 categories)|Participants|Count of Participants|37|37.0||||||
3669774|NCT02340000|3514119|B2|||Sinusitis category 2|Severe symptoms (most severe of the 3 categories)|Participants|Count of Participants|19|19.0||||||
3669775|NCT02340000|3514120|B1|||Sinusitis category 2|Severe symptoms (most severe of the 3 categories)|Participants|Count of Participants|18|18.0||||||
3669776|NCT02340000|3514118|B3|||Sinusitis category 1|Duration greater than or equal to 10 days|Participants|Count of Participants|204|204.0||||||
3669777|NCT02340000|3514119|B2|||Sinusitis category 1|Duration greater than or equal to 10 days|Participants|Count of Participants|103|103.0||||||
3669778|NCT02340000|3514120|B1|||Sinusitis category 1|Duration greater than or equal to 10 days|Participants|Count of Participants|101|101.0||||||
3669779|NCT02340000|3514118|B3|||Days of illness|Clinician indicated the number of days the patient had been sick prior to the office visit.|days|Mean|14.5|14.5|Standard Deviation|8.4|8.4|||
3669780|NCT02340000|3514119|B2|||Days of illness|Clinician indicated the number of days the patient had been sick prior to the office visit.|days|Mean|14.3|14.3|Standard Deviation|8.1|8.1|||
3669781|NCT02340000|3514120|B1|||Days of illness|Clinician indicated the number of days the patient had been sick prior to the office visit.|days|Mean|14.8|14.8|Standard Deviation|8.8|8.8|||
3669782|NCT02340000|3514118|B3|||History of sinusitis||Participants|Count of Participants|123|123.0||||||
3669783|NCT02340000|3514119|B2|||History of sinusitis||Participants|Count of Participants|60|60.0||||||
3669784|NCT02340000|3514120|B1|||History of sinusitis||Participants|Count of Participants|63|63.0||||||
3669785|NCT02340000|3514118|B3|||Heart disease||Participants|Count of Participants|19|19.0||||||
3669786|NCT02340000|3514119|B2|||Heart disease||Participants|Count of Participants|8|8.0||||||
3669787|NCT02340000|3514120|B1|||Heart disease||Participants|Count of Participants|11|11.0||||||
3669788|NCT02340000|3514118|B3|||Diabetes||Participants|Count of Participants|31|31.0||||||
3669789|NCT02340000|3514119|B2|||Diabetes||Participants|Count of Participants|15|15.0||||||
3669790|NCT02340000|3514120|B1|||Diabetes||Participants|Count of Participants|16|16.0||||||
3669791|NCT02340000|3514118|B3|||allergic rhinitis||Participants|Count of Participants|162|162.0||||||
3669792|NCT02340000|3514119|B2|||allergic rhinitis||Participants|Count of Participants|80|80.0||||||
3669793|NCT02340000|3514120|B1|||allergic rhinitis||Participants|Count of Participants|82|82.0||||||
3669794|NCT02340000|3514118|B3|||COPD/asthma||Participants|Count of Participants|59|59.0||||||
3669795|NCT02340000|3514119|B2|||COPD/asthma||Participants|Count of Participants|30|30.0||||||
3669796|NCT02340000|3514120|B1|||COPD/asthma||Participants|Count of Participants|29|29.0||||||
3669797|NCT02340000|3514118|B3|||Active tobacco use||Participants|Count of Participants|39|39.0||||||
3669798|NCT02340000|3514119|B2|||Active tobacco use||Participants|Count of Participants|20|20.0||||||
3669799|NCT02340000|3514120|B1|||Active tobacco use||Participants|Count of Participants|19|19.0||||||
3669800|NCT02340000|3514118|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3669801|NCT02340000|3514118|B3||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3669802|NCT02340000|3514119|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3669803|NCT02340000|3514120|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3669804|NCT02340000|3514118|B3||Female|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
3669805|NCT02340000|3514119|B2||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3669806|NCT02340000|3514120|B1||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3669807|NCT02340000|3514118|B3|||Age||years|Mean|46.9|46.9|Standard Deviation|15.4|15.4|||
3669808|NCT02340000|3514119|B2|||Age||years|Mean|45.9|45.9|Standard Deviation|14.8|14.8|||
3669809|NCT02340000|3514120|B1|||Age||years|Mean|48.0|48.0|Standard Deviation|15.9|15.9|||
3669810|NCT02339909|3514148|B4|United Kingdom||Region of Enrollment||participants|Number|1051|1051.0||||||
3669811|NCT02339909|3514149|B3|United Kingdom||Region of Enrollment||participants|Number|304|304.0||||||
3669812|NCT02339909|3514150|B2|United Kingdom||Region of Enrollment||participants|Number|312|312.0||||||
3669813|NCT02339909|3514151|B1|United Kingdom||Region of Enrollment||participants|Number|435|435.0||||||
3669814|NCT02339909|3514148|B4||Male|Sex: Female, Male||Participants|Count of Participants|609|609.0||||||
3669815|NCT02339909|3514149|B3||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
3669816|NCT02339909|3514150|B2||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
3669817|NCT02339909|3514151|B1||Male|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
3669818|NCT02339909|3514148|B4||Female|Sex: Female, Male||Participants|Count of Participants|442|442.0||||||
3669819|NCT02339909|3514149|B3||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3669820|NCT02339909|3514150|B2||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3669821|NCT02339909|3514151|B1||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3669822|NCT02339909|3514148|B4|Over 65 years||Age, Customized||Participants|Count of Participants|473|473.0||||||
3669823|NCT02339909|3514149|B3|Over 65 years||Age, Customized||Participants|Count of Participants|128|128.0||||||
3669824|NCT02339909|3514150|B2|Over 65 years||Age, Customized||Participants|Count of Participants|139|139.0||||||
3669825|NCT02339909|3514151|B1|Over 65 years||Age, Customized||Participants|Count of Participants|206|206.0||||||
3669826|NCT02339909|3514148|B4|16-65 years||Age, Customized||Participants|Count of Participants|578|578.0||||||
3669827|NCT02339909|3514149|B3|16-65 years||Age, Customized||Participants|Count of Participants|176|176.0||||||
3669828|NCT02339909|3514150|B2|16-65 years||Age, Customized||Participants|Count of Participants|173|173.0||||||
3669829|NCT02339909|3514151|B1|16-65 years||Age, Customized||Participants|Count of Participants|229|229.0||||||
3669830|NCT02339831|3514164|B3|||SF-36 Physical Health Score|Short form 36 is a patient reported outcome survey used to asses physical health. The scale is 0-100. Lower scores indicate more disability and higher scores indicate less disability.|units on a scale|Mean|35.0|35.0|Standard Deviation|6.6|6.6|||
3669831|NCT02339831|3514165|B2|||SF-36 Physical Health Score|Short form 36 is a patient reported outcome survey used to asses physical health. The scale is 0-100. Lower scores indicate more disability and higher scores indicate less disability.|units on a scale|Mean|35.0|35.0|Standard Deviation|6.8|6.8|||
3669832|NCT02339831|3514166|B1|||SF-36 Physical Health Score|Short form 36 is a patient reported outcome survey used to asses physical health. The scale is 0-100. Lower scores indicate more disability and higher scores indicate less disability.|units on a scale|Mean|35.1|35.1|Standard Deviation|6.3|6.3|||
3669833|NCT02339831|3514164|B3|||Sit-to-Stand Test|"After one demonstration of the sit-to-stand test, standing up from a seated position without support, two tests were timed and the better value recorded.The patient was directed to sit with his/her back against the chair and arms crossed in front. Time started when timer said Go."|seconds|Mean|3.39|3.39|Standard Deviation|1.34|1.34|||
3669834|NCT02339831|3514165|B2|||Sit-to-Stand Test|"After one demonstration of the sit-to-stand test, standing up from a seated position without support, two tests were timed and the better value recorded.The patient was directed to sit with his/her back against the chair and arms crossed in front. Time started when timer said Go."|seconds|Mean|3.40|3.4|Standard Deviation|1.48|1.48|||
3669835|NCT02339831|3514166|B1|||Sit-to-Stand Test|"After one demonstration of the sit-to-stand test, standing up from a seated position without support, two tests were timed and the better value recorded.The patient was directed to sit with his/her back against the chair and arms crossed in front. Time started when timer said Go."|seconds|Mean|3.37|3.37|Standard Deviation|1.18|1.18|||
3669836|NCT02339831|3514164|B3|||WOMAC|Western Ontario and McMaster Universities Arthritis Index is measured on a scale of 0-68. Higher scores on the WOMAC indicate worse pain, stiffness, and functional limitations.|units on a scale|Mean|65.7|65.7|Standard Deviation|17.7|17.7|||
3669837|NCT02339831|3514165|B2|||WOMAC|Western Ontario and McMaster Universities Arthritis Index is measured on a scale of 0-68. Higher scores on the WOMAC indicate worse pain, stiffness, and functional limitations.|units on a scale|Mean|67.1|67.1|Standard Deviation|20.3|20.3|||
3669838|NCT02339831|3514166|B1|||WOMAC|Western Ontario and McMaster Universities Arthritis Index is measured on a scale of 0-68. Higher scores on the WOMAC indicate worse pain, stiffness, and functional limitations.|units on a scale|Mean|64.1|64.1|Standard Deviation|14.9|14.9|||
3669839|NCT02339831|3514164|B3|||Knee Society Score|Knee society score is an objective patient reported outcome survey to measure a patient’s functional ability before and after knee arthroplasty. It is measured on a scale of 1-100. A score between 80-100 indicated excellent functioning, a score between 70-79 indicates good functioning, a score between 60-69 indicates fair functioning, and a score below 60 indicates poor functioning.|units on a scale|Mean|54.7|54.7|Standard Deviation|17.8|17.8|||
3669840|NCT02339831|3514165|B2|||Knee Society Score|Knee society score is an objective patient reported outcome survey to measure a patient’s functional ability before and after knee arthroplasty. It is measured on a scale of 1-100. A score between 80-100 indicated excellent functioning, a score between 70-79 indicates good functioning, a score between 60-69 indicates fair functioning, and a score below 60 indicates poor functioning.|units on a scale|Mean|49.3|49.3|Standard Deviation|14.9|14.9|||
3669841|NCT02339831|3514166|B1|||Knee Society Score|Knee society score is an objective patient reported outcome survey to measure a patient’s functional ability before and after knee arthroplasty. It is measured on a scale of 1-100. A score between 80-100 indicated excellent functioning, a score between 70-79 indicates good functioning, a score between 60-69 indicates fair functioning, and a score below 60 indicates poor functioning.|units on a scale|Mean|56.0|56.0|Standard Deviation|13.7|13.7|||
3669842|NCT02339831|3514164|B3|||SF-36 Mental Health Score|Short form 36 mental health score. The scale is measured from 0-100. 0 is the lowest or worst possible level of functioning and 100 is the highest or best possible level of functioning.|units on a scale|Mean|43.3|43.3|Standard Deviation|7.8|7.8|||
3669875|NCT02339584|3514189|B3|||Age||years|Mean|52.4|52.4|Standard Deviation|16.25|16.25|||
3669843|NCT02339831|3514165|B2|||SF-36 Mental Health Score|Short form 36 mental health score. The scale is measured from 0-100. 0 is the lowest or worst possible level of functioning and 100 is the highest or best possible level of functioning.|units on a scale|Mean|43.2|43.2|Standard Deviation|8.1|8.1|||
3669844|NCT02339831|3514166|B1|||SF-36 Mental Health Score|Short form 36 mental health score. The scale is measured from 0-100. 0 is the lowest or worst possible level of functioning and 100 is the highest or best possible level of functioning.|units on a scale|Mean|43.4|43.4|Standard Deviation|7.5|7.5|||
3669845|NCT02339831|3514164|B3|||Knee Flexion|Knee-flexion was measured using an 8-inch goniometer.|degrees|Mean|112.6|112.6|Standard Deviation|12.8|12.8|||
3669846|NCT02339831|3514165|B2|||Knee Flexion|Knee-flexion was measured using an 8-inch goniometer.|degrees|Mean|111.6|111.6|Standard Deviation|12.8|12.8|||
3669847|NCT02339831|3514166|B1|||Knee Flexion|Knee-flexion was measured using an 8-inch goniometer.|degrees|Mean|113.8|113.8|Standard Deviation|12.8|12.8|||
3669848|NCT02339831|3514164|B3|||Balance|Biodex Balance Machine Score. The system consists of a multiaxial standing platform with a maximum tilt of 20 degrees. All participants were tested on level 8, and a balance index was calculated using the time and deviation (in degrees) on the platform relative to a neutral position. The normal range for adults 54-71 is 1.79 – 3.35. Lower values indicate better/greater stability.|units on a scale|Mean|3.62|3.62|Standard Deviation|1.53|1.53|||
3669849|NCT02339831|3514165|B2|||Balance|Biodex Balance Machine Score. The system consists of a multiaxial standing platform with a maximum tilt of 20 degrees. All participants were tested on level 8, and a balance index was calculated using the time and deviation (in degrees) on the platform relative to a neutral position. The normal range for adults 54-71 is 1.79 – 3.35. Lower values indicate better/greater stability.|units on a scale|Mean|3.62|3.62|Standard Deviation|1.39|1.39|||
3669850|NCT02339831|3514166|B1|||Balance|Biodex Balance Machine Score. The system consists of a multiaxial standing platform with a maximum tilt of 20 degrees. All participants were tested on level 8, and a balance index was calculated using the time and deviation (in degrees) on the platform relative to a neutral position. The normal range for adults 54-71 is 1.79 – 3.35. Lower values indicate better/greater stability.|units on a scale|Mean|3.61|3.61|Standard Deviation|1.69|1.69|||
3669851|NCT02339831|3514164|B3|||Quadriceps Strength||newton meter|Mean|11.8|11.8|Standard Deviation|4.7|4.7|||
3669852|NCT02339831|3514165|B2|||Quadriceps Strength||newton meter|Mean|11.2|11.2|Standard Deviation|4.7|4.7|||
3669853|NCT02339831|3514166|B1|||Quadriceps Strength||newton meter|Mean|12.4|12.4|Standard Deviation|4.7|4.7|||
3669854|NCT02339831|3514164|B3|||Kinesthesia|Kinesthesia was measured by recording the angle of the flexed knee and documenting how close the patient was able to reproduce the angle with closed eyes. The differences were recorded in degrees using an 8-inch goniometer.|degrees|Mean|3.7|3.7|Standard Deviation|3.0|3.0|||
3669855|NCT02339831|3514165|B2|||Kinesthesia|Kinesthesia was measured by recording the angle of the flexed knee and documenting how close the patient was able to reproduce the angle with closed eyes. The differences were recorded in degrees using an 8-inch goniometer.|degrees|Mean|4.24|4.24|Standard Deviation|3.34|3.34|||
3669856|NCT02339831|3514166|B1|||Kinesthesia|Kinesthesia was measured by recording the angle of the flexed knee and documenting how close the patient was able to reproduce the angle with closed eyes. The differences were recorded in degrees using an 8-inch goniometer.|degrees|Mean|3.20|3.2|Standard Deviation|2.64|2.64|||
3669857|NCT02339831|3514164|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3669858|NCT02339831|3514165|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3669859|NCT02339831|3514166|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3669860|NCT02339831|3514164|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3669861|NCT02339831|3514165|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3669862|NCT02339831|3514166|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3669863|NCT02339831|3514164|B3|||Age||years|Median|63.2|63.2|Standard Deviation|9.0|9.0|||
3669864|NCT02339831|3514165|B2|||Age||years|Median|64.7|64.7|Standard Deviation|9.2|9.2|||
3669865|NCT02339831|3514166|B1|||Age||years|Median|61.5|61.5|Standard Deviation|8.8|8.8|||
3669866|NCT02339584|3514189|B3|||Mean Diurnal Intraocular Pressure (IOP)|IOP (fluid pressure inside the eye) was assessed using Goldmann applanation tonometry and reported in millimeters mercury (mmHg). Diurnal IOP was defined as the average of the three timepoints measured: 9 AM, +2 Hrs and +7Hrs. Baseline was the average of the values for 2 eligibility visits. If one of the values was missing, the other non-missing value was taken as the baseline. Only one eye (study eye) contributed to the analysis.|mmHg|Mean|24.61|24.61|Standard Deviation|2.657|2.657|||
3669867|NCT02339584|3514190|B2|||Mean Diurnal Intraocular Pressure (IOP)|IOP (fluid pressure inside the eye) was assessed using Goldmann applanation tonometry and reported in millimeters mercury (mmHg). Diurnal IOP was defined as the average of the three timepoints measured: 9 AM, +2 Hrs and +7Hrs. Baseline was the average of the values for 2 eligibility visits. If one of the values was missing, the other non-missing value was taken as the baseline. Only one eye (study eye) contributed to the analysis.|mmHg|Mean|24.59|24.59|Standard Deviation|2.660|2.66|||
3669868|NCT02339584|3514191|B1|||Mean Diurnal Intraocular Pressure (IOP)|IOP (fluid pressure inside the eye) was assessed using Goldmann applanation tonometry and reported in millimeters mercury (mmHg). Diurnal IOP was defined as the average of the three timepoints measured: 9 AM, +2 Hrs and +7Hrs. Baseline was the average of the values for 2 eligibility visits. If one of the values was missing, the other non-missing value was taken as the baseline. Only one eye (study eye) contributed to the analysis.|mmHg|Mean|24.62|24.62|Standard Deviation|2.661|2.661|||
3669869|NCT02339584|3514189|B3||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3669870|NCT02339584|3514190|B2||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3669871|NCT02339584|3514191|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3669872|NCT02339584|3514189|B3||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
3669873|NCT02339584|3514190|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3669874|NCT02339584|3514191|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3669876|NCT02339584|3514190|B2|||Age||years|Mean|52.6|52.6|Standard Deviation|16.25|16.25|||
3669877|NCT02339584|3514191|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|16.29|16.29|||
3669878|NCT02339506|3514198|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3669879|NCT02339506|3514198|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669880|NCT02339506|3514198|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3669881|NCT02339506|3514198|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3669882|NCT02339506|3514198|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669883|NCT02339506|3514198|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3669884|NCT02339506|3514198|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669885|NCT02339506|3514198|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669886|NCT02339506|3514198|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3669887|NCT02339506|3514198|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3669888|NCT02339506|3514198|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3669889|NCT02339506|3514198|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3669890|NCT02339506|3514198|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3669891|NCT02339506|3514198|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3669892|NCT02339506|3514198|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3669893|NCT02339389|3514205|B1|United States||Region of Enrollment||participants|Number|57|57.0||||||
3669894|NCT02339389|3514205|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3669895|NCT02339389|3514205|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3669896|NCT02339389|3514205|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3669897|NCT02339389|3514205|B1||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
3669898|NCT02339389|3514205|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3669899|NCT02339285|3514210|B4|||Clinical Global Impression (CGI)|"Values reported on Item 1 Severity of Illness on the Clinical Global Impressions scale. Patients are scored on a likert scale, with 1 = Normal, not at all ill to 7 = Among the most extremely ill patients."|units on a scale|Mean|3.88|3.88|Standard Deviation|0.79|0.79|||
3669900|NCT02339285|3514211|B3|||Clinical Global Impression (CGI)|"Values reported on Item 1 Severity of Illness on the Clinical Global Impressions scale. Patients are scored on a likert scale, with 1 = Normal, not at all ill to 7 = Among the most extremely ill patients."|units on a scale|Mean|3.73|3.73|Standard Deviation|0.79|0.79|||
3669901|NCT02339285|3514212|B2|||Clinical Global Impression (CGI)|"Values reported on Item 1 Severity of Illness on the Clinical Global Impressions scale. Patients are scored on a likert scale, with 1 = Normal, not at all ill to 7 = Among the most extremely ill patients."|units on a scale|Mean|3.82|3.82|Standard Deviation|0.60|0.6|||
3669902|NCT02339285|3514213|B1|||Clinical Global Impression (CGI)|"Values reported on Item 1 Severity of Illness on the Clinical Global Impressions scale. Patients are scored on a likert scale, with 1 = Normal, not at all ill to 7 = Among the most extremely ill patients."|units on a scale|Mean|4.10|4.1|Standard Deviation|0.99|0.99|||
3669903|NCT02339285|3514210|B4|||Montreal Cognitive Assessment (MoCA)|A basic assessment of cognition. Total score is ranges from 0 to 30 points, with higher values indicating better cognition.|units on a scale|Mean|27.75|27.75|Standard Deviation|2.00|2.0|||
3669904|NCT02339285|3514211|B3|||Montreal Cognitive Assessment (MoCA)|A basic assessment of cognition. Total score is ranges from 0 to 30 points, with higher values indicating better cognition.|units on a scale|Mean|27.82|27.82|Standard Deviation|2.48|2.48|||
3669905|NCT02339285|3514212|B2|||Montreal Cognitive Assessment (MoCA)|A basic assessment of cognition. Total score is ranges from 0 to 30 points, with higher values indicating better cognition.|units on a scale|Mean|27.27|27.27|Standard Deviation|1.62|1.62|||
3669906|NCT02339285|3514213|B1|||Montreal Cognitive Assessment (MoCA)|A basic assessment of cognition. Total score is ranges from 0 to 30 points, with higher values indicating better cognition.|units on a scale|Mean|28.20|28.2|Standard Deviation|1.99|1.99|||
3669907|NCT02339285|3514210|B4|||Beck Depression Inventory (BDI)|The BDI is a self-administered questionnaire that measures the occurrence and severity of current depressive symptoms. Total scores range from 0-63 with higher scores indicating higher feelings of being depressed.|units on a scale|Mean|27.03|27.03|Standard Deviation|8.10|8.1|||
3669908|NCT02339285|3514211|B3|||Beck Depression Inventory (BDI)|The BDI is a self-administered questionnaire that measures the occurrence and severity of current depressive symptoms. Total scores range from 0-63 with higher scores indicating higher feelings of being depressed.|units on a scale|Mean|26.18|26.18|Standard Deviation|9.74|9.74|||
3669909|NCT02339285|3514212|B2|||Beck Depression Inventory (BDI)|The BDI is a self-administered questionnaire that measures the occurrence and severity of current depressive symptoms. Total scores range from 0-63 with higher scores indicating higher feelings of being depressed.|units on a scale|Mean|28.27|28.27|Standard Deviation|8.81|8.81|||
3669910|NCT02339285|3514213|B1|||Beck Depression Inventory (BDI)|The BDI is a self-administered questionnaire that measures the occurrence and severity of current depressive symptoms. Total scores range from 0-63 with higher scores indicating higher feelings of being depressed.|units on a scale|Mean|26.60|26.6|Standard Deviation|5.58|5.58|||
3669911|NCT02339285|3514210|B4|||Hamilton Depression Rating Scale (HDRS)|The HDRS is a clinician-administered depression assessment and consists of 17 items with a total score range from 0 to 54. Higher scores indicate more depressive symptoms.|units on a scale|Mean|15.63|15.63|Standard Deviation|4.94|4.94|||
3669912|NCT02339285|3514211|B3|||Hamilton Depression Rating Scale (HDRS)|The HDRS is a clinician-administered depression assessment and consists of 17 items with a total score range from 0 to 54. Higher scores indicate more depressive symptoms.|units on a scale|Mean|14.55|14.55|Standard Deviation|6.12|6.12|||
3669913|NCT02339285|3514212|B2|||Hamilton Depression Rating Scale (HDRS)|The HDRS is a clinician-administered depression assessment and consists of 17 items with a total score range from 0 to 54. Higher scores indicate more depressive symptoms.|units on a scale|Mean|14.64|14.64|Standard Deviation|3.53|3.53|||
3669914|NCT02339285|3514213|B1|||Hamilton Depression Rating Scale (HDRS)|The HDRS is a clinician-administered depression assessment and consists of 17 items with a total score range from 0 to 54. Higher scores indicate more depressive symptoms.|units on a scale|Mean|17.90|17.9|Standard Deviation|4.51|4.51|||
3669915|NCT02339285|3514210|B4|||Montgomery-Asberg Depression Rating Scale (MADRS)|The MADRS is a 10-item scale to measure the severity of depressive episodes, where each item is rated on a scale from 0 to 6. The MADRS total score ranges from 0 to 60 with lower scores indicating less depressive symptoms.|units on a scale|Mean|26.03|26.03|Standard Deviation|6.39|6.39|||
3669916|NCT02339285|3514211|B3|||Montgomery-Asberg Depression Rating Scale (MADRS)|The MADRS is a 10-item scale to measure the severity of depressive episodes, where each item is rated on a scale from 0 to 6. The MADRS total score ranges from 0 to 60 with lower scores indicating less depressive symptoms.|units on a scale|Mean|24.55|24.55|Standard Deviation|5.18|5.18|||
3669917|NCT02339285|3514212|B2|||Montgomery-Asberg Depression Rating Scale (MADRS)|The MADRS is a 10-item scale to measure the severity of depressive episodes, where each item is rated on a scale from 0 to 6. The MADRS total score ranges from 0 to 60 with lower scores indicating less depressive symptoms.|units on a scale|Mean|25.00|25.0|Standard Deviation|7.21|7.21|||
3669918|NCT02339285|3514213|B1|||Montgomery-Asberg Depression Rating Scale (MADRS)|The MADRS is a 10-item scale to measure the severity of depressive episodes, where each item is rated on a scale from 0 to 6. The MADRS total score ranges from 0 to 60 with lower scores indicating less depressive symptoms.|units on a scale|Mean|28.80|28.8|Standard Deviation|6.36|6.36|||
3669919|NCT02339285|3514210|B4|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3669920|NCT02339285|3514211|B3|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3669921|NCT02339285|3514212|B2|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3669922|NCT02339285|3514213|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3669923|NCT02339285|3514210|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669924|NCT02339285|3514211|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669925|NCT02339285|3514212|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669926|NCT02339285|3514213|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669927|NCT02339285|3514210|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669928|NCT02339285|3514211|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669929|NCT02339285|3514212|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669930|NCT02339285|3514213|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669931|NCT02339285|3514210|B4||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3669932|NCT02339285|3514211|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3669933|NCT02339285|3514212|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3669934|NCT02339285|3514213|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3669935|NCT02339285|3514210|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669936|NCT02339285|3514211|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669937|NCT02339285|3514212|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669938|NCT02339285|3514213|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669939|NCT02339285|3514210|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669940|NCT02339285|3514211|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669941|NCT02339285|3514212|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669942|NCT02339285|3514213|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669943|NCT02339285|3514210|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3669944|NCT02339285|3514211|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669945|NCT02339285|3514212|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3669946|NCT02339285|3514213|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669947|NCT02339285|3514210|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3669948|NCT02339285|3514211|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669949|NCT02339285|3514212|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669950|NCT02339285|3514213|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3669951|NCT02339285|3514210|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3669952|NCT02339285|3514211|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3669953|NCT02339285|3514212|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3669954|NCT02339285|3514213|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3669955|NCT02339285|3514210|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3669956|NCT02339285|3514211|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3669957|NCT02339285|3514212|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3669958|NCT02339285|3514213|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3669959|NCT02339285|3514210|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669960|NCT02339285|3514211|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669961|NCT02339285|3514212|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669962|NCT02339285|3514213|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3669963|NCT02339285|3514210|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3669964|NCT02339285|3514211|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3669965|NCT02339285|3514212|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3669966|NCT02339285|3514213|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3669967|NCT02339285|3514210|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3669968|NCT02339285|3514211|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3669969|NCT02339285|3514212|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3669970|NCT02339285|3514213|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3669971|NCT02339285|3514210|B4|||Age||years|Mean|36.69|36.69|Standard Deviation|13.08|13.08|||
3669972|NCT02339285|3514211|B3|||Age||years|Mean|38.36|38.36|Standard Deviation|13.54|13.54|||
3669973|NCT02339285|3514212|B2|||Age||years|Mean|35.36|35.36|Standard Deviation|11.56|11.56|||
3669974|NCT02339285|3514213|B1|||Age||years|Mean|36.30|36.3|Standard Deviation|15.22|15.22|||
3669975|NCT02339246|3514241|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
3669976|NCT02339246|3514242|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3669977|NCT02339246|3514243|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3669978|NCT02339246|3514241|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3669979|NCT02339246|3514242|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3669980|NCT02339246|3514243|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3669981|NCT02339246|3514241|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3669982|NCT02339246|3514242|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3669983|NCT02339246|3514243|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3669984|NCT02339246|3514241|B3|||Age||years|Mean|48.3|48.3|Standard Deviation|12.11|12.11|||
3669985|NCT02339246|3514242|B2|||Age||years|Mean|46.3|46.3|Standard Deviation|13.30|13.3|||
3669986|NCT02339246|3514243|B1|||Age||years|Mean|50.1|50.1|Standard Deviation|11.00|11.0|||
3669987|NCT02339246|3514241|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3669988|NCT02339246|3514242|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3669989|NCT02339246|3514243|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3669990|NCT02339246|3514241|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3669991|NCT02339246|3514242|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3669992|NCT02339246|3514243|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3669993|NCT02339246|3514241|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3669994|NCT02339246|3514242|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3669995|NCT02339246|3514243|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3669996|NCT02339155|3514259|B3|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3669997|NCT02339155|3514260|B2|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3669998|NCT02339155|3514261|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3669999|NCT02339155|3514259|B3|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3670000|NCT02339155|3514260|B2|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3670001|NCT02339155|3514261|B1|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3670002|NCT02339155|3514259|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3670003|NCT02339155|3514260|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3670004|NCT02339155|3514261|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3670005|NCT02339155|3514259|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3670006|NCT02339155|3514260|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3670007|NCT02339155|3514261|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3670008|NCT02339155|3514259|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|117|117.0||||||
3670009|NCT02339155|3514260|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|56|56.0||||||
3670010|NCT02339155|3514261|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|61|61.0||||||
3670011|NCT02339155|3514259|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|437|437.0||||||
3670012|NCT02339155|3514260|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|222|222.0||||||
3670013|NCT02339155|3514261|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|215|215.0||||||
3670014|NCT02339155|3514259|B3||Male|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
3670015|NCT02339155|3514260|B2||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3670016|NCT02339155|3514261|B1||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3670017|NCT02339155|3514259|B3||Female|Sex: Female, Male||Participants|Count of Participants|292|292.0||||||
3670018|NCT02339155|3514260|B2||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3670019|NCT02339155|3514261|B1||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3670020|NCT02339155|3514259|B3|||Age||Years|Mean|36.2|36.2|Standard Deviation|12.42|12.42|||
3670021|NCT02339155|3514260|B2|||Age||Years|Mean|36.0|36.0|Standard Deviation|12.06|12.06|||
3670022|NCT02339155|3514261|B1|||Age||Years|Mean|36.3|36.3|Standard Deviation|12.78|12.78|||
3670023|NCT02339038|3514288|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670024|NCT02339038|3514288|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670025|NCT02339038|3514288|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3670026|NCT02339038|3514288|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|578|578.0||||||
3670027|NCT02339038|3514288|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670028|NCT02339038|3514288|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670029|NCT02339038|3514288|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3670030|NCT02339038|3514288|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670031|NCT02339038|3514288|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|589|589.0||||||
3670032|NCT02339038|3514288|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3670033|NCT02339038|3514288|B1||Male|Sex: Female, Male||Participants|Count of Participants|416|416.0||||||
3670034|NCT02339038|3514288|B1||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3670035|NCT02339038|3514288|B1||>=65 years|Age||Participants|Count of Participants|78|78.0||||||
3670036|NCT02339038|3514288|B1||Between 18 and 65 years|Age||Participants|Count of Participants|522|522.0||||||
3670037|NCT02339038|3514288|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3670038|NCT02338843|3514292|B3|Other||Cause of Shock||Participants|Count of Participants|10|10.0||||||
3670039|NCT02338843|3514293|B2|Other||Cause of Shock||Participants|Count of Participants|4|4.0||||||
3670040|NCT02338843|3514294|B1|Other||Cause of Shock||Participants|Count of Participants|6|6.0||||||
3670041|NCT02338843|3514292|B3|Vasoplegia||Cause of Shock||Participants|Count of Participants|19|19.0||||||
3670042|NCT02338843|3514293|B2|Vasoplegia||Cause of Shock||Participants|Count of Participants|9|9.0||||||
3670043|NCT02338843|3514294|B1|Vasoplegia||Cause of Shock||Participants|Count of Participants|10|10.0||||||
3670044|NCT02338843|3514292|B3|Pancreatitis||Cause of Shock||Participants|Count of Participants|2|2.0||||||
3670045|NCT02338843|3514293|B2|Pancreatitis||Cause of Shock||Participants|Count of Participants|2|2.0||||||
3670046|NCT02338843|3514294|B1|Pancreatitis||Cause of Shock||Participants|Count of Participants|0|0.0||||||
3670047|NCT02338843|3514292|B3|Other, potentially sepsis||Cause of Shock||Participants|Count of Participants|31|31.0||||||
3670048|NCT02338843|3514293|B2|Other, potentially sepsis||Cause of Shock||Participants|Count of Participants|11|11.0||||||
3670049|NCT02338843|3514294|B1|Other, potentially sepsis||Cause of Shock||Participants|Count of Participants|20|20.0||||||
3670050|NCT02338843|3514292|B3|Sepsis||Cause of Shock||Participants|Count of Participants|259|259.0||||||
3670051|NCT02338843|3514293|B2|Sepsis||Cause of Shock||Participants|Count of Participants|132|132.0||||||
3670052|NCT02338843|3514294|B1|Sepsis||Cause of Shock||Participants|Count of Participants|127|127.0||||||
3670053|NCT02338843|3514292|B3|||Vasopressor Dose||mcg/kg/min|Median|0.34|0.34|Inter-Quartile Range|||0.23|0.56|
3670054|NCT02338843|3514293|B2|||Vasopressor Dose||mcg/kg/min|Median|0.34|0.34|Inter-Quartile Range|||0.23|0.56|
3670055|NCT02338843|3514294|B1|||Vasopressor Dose||mcg/kg/min|Median|0.33|0.33|Inter-Quartile Range|||0.23|0.56|
3670056|NCT02338843|3514292|B3|||APACHE II Score|The Acute Physiology and Chronic Health Evaluation (APACHE II) is a severity score and mortality estimation tool developed from a large sample of ICU patients in the United States. The APACHE II score is made of 12 physiological variables and 2 disease-related variables. The APACHE II score ranges from 0 to 71 points, with higher scores correlating to worse outcomes.|points|Median|28|28.0|Inter-Quartile Range|||22.0|33.0|
3670057|NCT02338843|3514293|B2|||APACHE II Score|The Acute Physiology and Chronic Health Evaluation (APACHE II) is a severity score and mortality estimation tool developed from a large sample of ICU patients in the United States. The APACHE II score is made of 12 physiological variables and 2 disease-related variables. The APACHE II score ranges from 0 to 71 points, with higher scores correlating to worse outcomes.|points|Median|29|29.0|Inter-Quartile Range|||22.0|34.0|
3670058|NCT02338843|3514294|B1|||APACHE II Score|The Acute Physiology and Chronic Health Evaluation (APACHE II) is a severity score and mortality estimation tool developed from a large sample of ICU patients in the United States. The APACHE II score is made of 12 physiological variables and 2 disease-related variables. The APACHE II score ranges from 0 to 71 points, with higher scores correlating to worse outcomes.|points|Median|27|27.0|Inter-Quartile Range|||22.0|33.0|
3670059|NCT02338843|3514292|B3|||Mean Arterial Pressure (MAP)||mmHg|Median|66.3|66.3|Inter-Quartile Range|||63.7|68.7|
3670060|NCT02338843|3514293|B2|||Mean Arterial Pressure (MAP)||mmHg|Median|66.3|66.3|Inter-Quartile Range|||63.0|68.3|
3670061|NCT02338843|3514294|B1|||Mean Arterial Pressure (MAP)||mmHg|Median|66.3|66.3|Inter-Quartile Range|||63.7|69.0|
3670062|NCT02338843|3514292|B3|BMI < 30||Body Mass Index (BMI)||Participants|Count of Participants|176|176.0||||||
3670063|NCT02338843|3514293|B2|BMI < 30||Body Mass Index (BMI)||Participants|Count of Participants|84|84.0||||||
3670064|NCT02338843|3514294|B1|BMI < 30||Body Mass Index (BMI)||Participants|Count of Participants|92|92.0||||||
3670065|NCT02338843|3514292|B3|BMI ≥ 30||Body Mass Index (BMI)||Participants|Count of Participants|140|140.0||||||
3670066|NCT02338843|3514293|B2|BMI ≥ 30||Body Mass Index (BMI)||Participants|Count of Participants|71|71.0||||||
3670067|NCT02338843|3514294|B1|BMI ≥ 30||Body Mass Index (BMI)||Participants|Count of Participants|69|69.0||||||
3670068|NCT02338843|3514292|B3|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3670069|NCT02338843|3514293|B2|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3670070|NCT02338843|3514294|B1|Germany||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3670071|NCT02338843|3514292|B3|France||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3670072|NCT02338843|3514293|B2|France||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3670073|NCT02338843|3514294|B1|France||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3670074|NCT02338843|3514292|B3|Australia||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
3670075|NCT02338843|3514293|B2|Australia||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3670076|NCT02338843|3514294|B1|Australia||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3670077|NCT02338843|3514292|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3670078|NCT02338843|3514293|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3670079|NCT02338843|3514294|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3670080|NCT02338843|3514292|B3|Finland||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3670081|NCT02338843|3514293|B2|Finland||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3670082|NCT02338843|3514294|B1|Finland||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3670083|NCT02338843|3514292|B3|United States||Region of Enrollment||Participants|Count of Participants|200|200.0||||||
3670084|NCT02338843|3514293|B2|United States||Region of Enrollment||Participants|Count of Participants|110|110.0||||||
3670085|NCT02338843|3514294|B1|United States||Region of Enrollment||Participants|Count of Participants|90|90.0||||||
3670086|NCT02338843|3514292|B3|Belgium||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3670087|NCT02338843|3514293|B2|Belgium||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3670088|NCT02338843|3514294|B1|Belgium||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3670089|NCT02338843|3514292|B3|Canada||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3670090|NCT02338843|3514293|B2|Canada||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3670091|NCT02338843|3514294|B1|Canada||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3670092|NCT02338843|3514292|B3|New Zealand||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3670093|NCT02338843|3514293|B2|New Zealand||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3670094|NCT02338843|3514294|B1|New Zealand||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3670095|NCT02338843|3514292|B3||Male|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
3670096|NCT02338843|3514293|B2||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3670097|NCT02338843|3514294|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3670098|NCT02338843|3514292|B3||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3670099|NCT02338843|3514293|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3670100|NCT02338843|3514294|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3670101|NCT02338843|3514292|B3|||Age||years|Median|64|64.0|Inter-Quartile Range|||52.0|75.0|
3670102|NCT02338843|3514293|B2|||Age||years|Median|65|65.0|Inter-Quartile Range|||53.0|75.0|
3670103|NCT02338843|3514294|B1|||Age||years|Median|63|63.0|Inter-Quartile Range|||52.0|75.0|
3670104|NCT02338713|3514301|B1|||Number of Participants who were Postmenopausal||participants|Number|14|14.0||||||
3670105|NCT02338713|3514301|B1|Had no Consumption||Xanthine/Caffeine Consumption||participants|Number|6|6.0||||||
3670106|NCT02338713|3514301|B1|Had Consumption||Xanthine/Caffeine Consumption||participants|Number|21|21.0||||||
3670107|NCT02338713|3514301|B1|Current Drinker (less than 5 units per day)||Alcohol classification||participants|Number|5|5.0||||||
3670108|NCT02338713|3514301|B1|Never Drunk||Alcohol classification||participants|Number|22|22.0||||||
3670109|NCT02338713|3514301|B1|Ex-Smoker||Smoking classification||participants|Number|9|9.0||||||
3670110|NCT02338713|3514301|B1|Current Smoker||Smoking classification||participants|Number|0|0.0||||||
3670111|NCT02338713|3514301|B1|Never Smoked||Smoking classification||participants|Number|18|18.0||||||
3670112|NCT02338713|3514301|B1|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|24.49|24.49|Standard Deviation|2.594|2.594|||
3670113|NCT02338713|3514301|B1|||Weight||kilogram (kg)|Mean|68.0|68.0|Standard Deviation|11.088|11.088|||
3670114|NCT02338713|3514301|B1|||Height||centimeter (cm)|Mean|166.3|166.3|Standard Deviation|9.16|9.16|||
3670115|NCT02338713|3514301|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670116|NCT02338713|3514301|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670117|NCT02338713|3514301|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3670118|NCT02338713|3514301|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670119|NCT02338713|3514301|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670120|NCT02338713|3514301|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670121|NCT02338713|3514301|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670122|NCT02338713|3514301|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3670123|NCT02338713|3514301|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3670124|NCT02338713|3514301|B1|||Age||years|Mean|59.0|59.0|Standard Deviation|6.34|6.34|||
3670125|NCT02338492|3514323|B1||Distal|Impending Bone Fracture Characteristics - Location||Participants|Count of Participants|1|1.0||||||
3670126|NCT02338492|3514323|B1||Diaphyseal|Impending Bone Fracture Characteristics - Location||Participants|Count of Participants|9|9.0||||||
3670127|NCT02338492|3514323|B1||Proximal|Impending Bone Fracture Characteristics - Location||Participants|Count of Participants|22|22.0||||||
3670128|NCT02338492|3514323|B1||Right Humerus|Impending Bone Fracture Characteristics - Location of Target Fracture||Participants|Count of Participants|18|18.0||||||
3670129|NCT02338492|3514323|B1||Left Humerus|Impending Bone Fracture Characteristics - Location of Target Fracture||Participants|Count of Participants|14|14.0||||||
3670130|NCT02338492|3514323|B1||Type I|Actual Bone Fracture Characteristics - Gustilo Grading of Soft Tissue|Soft tissue grading. It ranges from Type I (wound < 1 cm) to Type III C (vascular injury requiring vascular repair), with the wound damage getting more severe as the type increases. A closed fracture does not have any soft tissue damage. The grading system considers the energy of the injury, the wound size, amount of soft tissue damage, contamination, fracture pattern, periosteal stripping, skin coverage, neovascular injury and antibiotic use.|Participants|Count of Participants|3|3.0||||||
3670131|NCT02338492|3514323|B1||Closed Fracture|Actual Bone Fracture Characteristics - Gustilo Grading of Soft Tissue|Soft tissue grading. It ranges from Type I (wound < 1 cm) to Type III C (vascular injury requiring vascular repair), with the wound damage getting more severe as the type increases. A closed fracture does not have any soft tissue damage. The grading system considers the energy of the injury, the wound size, amount of soft tissue damage, contamination, fracture pattern, periosteal stripping, skin coverage, neovascular injury and antibiotic use.|Participants|Count of Participants|46|46.0||||||
3670132|NCT02338492|3514323|B1||Unknown|Actual Bone Fracture Characteristics - AO Classification|Classification system of fractures. 11 is the proximal humerus, 12 is the humeral shaft, and 13 is the distal humerus. For the proximal humerus, A is an extra-articular unifocal fracture, B is an extra-articular bifocal fracture and C is an articular fracture. For the humeral shaft, A is a simple fracture, B is a wedge fracture and C is a complex fracture. For the distal humerus, A is an extra articular fracture, B is partial articular fracture and C is a complete articular fracture. These are further classified as 1, 2, 3 with the higher number indicating a more complex fracture.|Participants|Count of Participants|1|1.0||||||
3670133|NCT02338492|3514323|B1||NA|Actual Bone Fracture Characteristics - AO Classification|Classification system of fractures. 11 is the proximal humerus, 12 is the humeral shaft, and 13 is the distal humerus. For the proximal humerus, A is an extra-articular unifocal fracture, B is an extra-articular bifocal fracture and C is an articular fracture. For the humeral shaft, A is a simple fracture, B is a wedge fracture and C is a complex fracture. For the distal humerus, A is an extra articular fracture, B is partial articular fracture and C is a complete articular fracture. These are further classified as 1, 2, 3 with the higher number indicating a more complex fracture.|Participants|Count of Participants|1|1.0||||||
3670134|NCT02338492|3514323|B1||12-C3|Actual Bone Fracture Characteristics - AO Classification|Classification system of fractures. 11 is the proximal humerus, 12 is the humeral shaft, and 13 is the distal humerus. For the proximal humerus, A is an extra-articular unifocal fracture, B is an extra-articular bifocal fracture and C is an articular fracture. For the humeral shaft, A is a simple fracture, B is a wedge fracture and C is a complex fracture. For the distal humerus, A is an extra articular fracture, B is partial articular fracture and C is a complete articular fracture. These are further classified as 1, 2, 3 with the higher number indicating a more complex fracture.|Participants|Count of Participants|1|1.0||||||
3670135|NCT02338492|3514323|B1||12-B2|Actual Bone Fracture Characteristics - AO Classification|Classification system of fractures. 11 is the proximal humerus, 12 is the humeral shaft, and 13 is the distal humerus. For the proximal humerus, A is an extra-articular unifocal fracture, B is an extra-articular bifocal fracture and C is an articular fracture. For the humeral shaft, A is a simple fracture, B is a wedge fracture and C is a complex fracture. For the distal humerus, A is an extra articular fracture, B is partial articular fracture and C is a complete articular fracture. These are further classified as 1, 2, 3 with the higher number indicating a more complex fracture.|Participants|Count of Participants|7|7.0||||||
3670136|NCT02338492|3514323|B1||12-B1|Actual Bone Fracture Characteristics - AO Classification|Classification system of fractures. 11 is the proximal humerus, 12 is the humeral shaft, and 13 is the distal humerus. For the proximal humerus, A is an extra-articular unifocal fracture, B is an extra-articular bifocal fracture and C is an articular fracture. For the humeral shaft, A is a simple fracture, B is a wedge fracture and C is a complex fracture. For the distal humerus, A is an extra articular fracture, B is partial articular fracture and C is a complete articular fracture. These are further classified as 1, 2, 3 with the higher number indicating a more complex fracture.|Participants|Count of Participants|3|3.0||||||
3670137|NCT02338492|3514323|B1||12-A3|Actual Bone Fracture Characteristics - AO Classification|Classification system of fractures. 11 is the proximal humerus, 12 is the humeral shaft, and 13 is the distal humerus. For the proximal humerus, A is an extra-articular unifocal fracture, B is an extra-articular bifocal fracture and C is an articular fracture. For the humeral shaft, A is a simple fracture, B is a wedge fracture and C is a complex fracture. For the distal humerus, A is an extra articular fracture, B is partial articular fracture and C is a complete articular fracture. These are further classified as 1, 2, 3 with the higher number indicating a more complex fracture.|Participants|Count of Participants|5|5.0||||||
3670138|NCT02338492|3514323|B1||12-A2|Actual Bone Fracture Characteristics - AO Classification|Classification system of fractures. 11 is the proximal humerus, 12 is the humeral shaft, and 13 is the distal humerus. For the proximal humerus, A is an extra-articular unifocal fracture, B is an extra-articular bifocal fracture and C is an articular fracture. For the humeral shaft, A is a simple fracture, B is a wedge fracture and C is a complex fracture. For the distal humerus, A is an extra articular fracture, B is partial articular fracture and C is a complete articular fracture. These are further classified as 1, 2, 3 with the higher number indicating a more complex fracture.|Participants|Count of Participants|12|12.0||||||
3670177|NCT02338336|3514337|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3670178|NCT02338336|3514338|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3670179|NCT02338336|3514339|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3670180|NCT02338336|3514337|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670139|NCT02338492|3514323|B1||12-A1|Actual Bone Fracture Characteristics - AO Classification|Classification system of fractures. 11 is the proximal humerus, 12 is the humeral shaft, and 13 is the distal humerus. For the proximal humerus, A is an extra-articular unifocal fracture, B is an extra-articular bifocal fracture and C is an articular fracture. For the humeral shaft, A is a simple fracture, B is a wedge fracture and C is a complex fracture. For the distal humerus, A is an extra articular fracture, B is partial articular fracture and C is a complete articular fracture. These are further classified as 1, 2, 3 with the higher number indicating a more complex fracture.|Participants|Count of Participants|7|7.0||||||
3670140|NCT02338492|3514323|B1||11-A3|Actual Bone Fracture Characteristics - AO Classification|Classification system of fractures. 11 is the proximal humerus, 12 is the humeral shaft, and 13 is the distal humerus. For the proximal humerus, A is an extra-articular unifocal fracture, B is an extra-articular bifocal fracture and C is an articular fracture. For the humeral shaft, A is a simple fracture, B is a wedge fracture and C is a complex fracture. For the distal humerus, A is an extra articular fracture, B is partial articular fracture and C is a complete articular fracture. These are further classified as 1, 2, 3 with the higher number indicating a more complex fracture.|Participants|Count of Participants|5|5.0||||||
3670141|NCT02338492|3514323|B1||11-A2|Actual Bone Fracture Characteristics - AO Classification|Classification system of fractures. 11 is the proximal humerus, 12 is the humeral shaft, and 13 is the distal humerus. For the proximal humerus, A is an extra-articular unifocal fracture, B is an extra-articular bifocal fracture and C is an articular fracture. For the humeral shaft, A is a simple fracture, B is a wedge fracture and C is a complex fracture. For the distal humerus, A is an extra articular fracture, B is partial articular fracture and C is a complete articular fracture. These are further classified as 1, 2, 3 with the higher number indicating a more complex fracture.|Participants|Count of Participants|6|6.0||||||
3670142|NCT02338492|3514323|B1||11-A1|Actual Bone Fracture Characteristics - AO Classification|Classification system of fractures. 11 is the proximal humerus, 12 is the humeral shaft, and 13 is the distal humerus. For the proximal humerus, A is an extra-articular unifocal fracture, B is an extra-articular bifocal fracture and C is an articular fracture. For the humeral shaft, A is a simple fracture, B is a wedge fracture and C is a complex fracture. For the distal humerus, A is an extra articular fracture, B is partial articular fracture and C is a complete articular fracture. These are further classified as 1, 2, 3 with the higher number indicating a more complex fracture.|Participants|Count of Participants|1|1.0||||||
3670143|NCT02338492|3514323|B1||Distal|Actual Bone Fracture Characteristics - Location||Participants|Count of Participants|4|4.0||||||
3670144|NCT02338492|3514323|B1||Diaphyseal|Actual Bone Fracture Characteristics - Location||Participants|Count of Participants|20|20.0||||||
3670145|NCT02338492|3514323|B1||Proximal|Actual Bone Fracture Characteristics - Location||Participants|Count of Participants|25|25.0||||||
3670146|NCT02338492|3514323|B1||Right Humerus|Actual Bone Fracture Characteristics - Location of Target Fracture||Participants|Count of Participants|25|25.0||||||
3670147|NCT02338492|3514323|B1||Left Humerus|Actual Bone Fracture Characteristics - Location of Target Fracture||Participants|Count of Participants|24|24.0||||||
3670148|NCT02338492|3514323|B1|United States||Region of Enrollment||Participants|Count of Participants|81|81.0||||||
3670149|NCT02338492|3514323|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3670150|NCT02338492|3514323|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3670151|NCT02338492|3514323|B1||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3670152|NCT02338492|3514323|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3670153|NCT02338492|3514323|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670154|NCT02338492|3514323|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3670155|NCT02338492|3514323|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670156|NCT02338492|3514323|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3670157|NCT02338492|3514323|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3670158|NCT02338492|3514323|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3670159|NCT02338492|3514323|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3670160|NCT02338492|3514323|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3670161|NCT02338492|3514323|B1|||Age||years|Mean|63.9|63.9|Standard Deviation|11.91|11.91|||
3670162|NCT02338336|3514337|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3670163|NCT02338336|3514338|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3670164|NCT02338336|3514339|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3670165|NCT02338336|3514337|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670166|NCT02338336|3514338|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670167|NCT02338336|3514339|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670168|NCT02338336|3514337|B3||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3670169|NCT02338336|3514338|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3670170|NCT02338336|3514339|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3670171|NCT02338336|3514337|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3670172|NCT02338336|3514338|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3670173|NCT02338336|3514339|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3670174|NCT02338336|3514337|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670175|NCT02338336|3514338|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670176|NCT02338336|3514339|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670181|NCT02338336|3514338|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670182|NCT02338336|3514339|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670183|NCT02338336|3514337|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3670184|NCT02338336|3514338|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3670185|NCT02338336|3514339|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3670186|NCT02338336|3514337|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3670187|NCT02338336|3514338|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3670188|NCT02338336|3514339|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3670189|NCT02338336|3514337|B3|||Age||years|Mean|34.3|34.3|Standard Deviation|11.59|11.59|||
3670190|NCT02338336|3514338|B2|||Age||years|Mean|34.5|34.5|Standard Deviation|12.65|12.65|||
3670191|NCT02338336|3514339|B1|||Age||years|Mean|34.0|34.0|Standard Deviation|10.58|10.58|||
3670192|NCT02338076|3514350|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3670193|NCT02338076|3514350|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3670194|NCT02338076|3514350|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3670195|NCT02338076|3514350|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3670196|NCT02338076|3514350|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3670197|NCT02337959|3514365|B4|Unknown||Sex/Gender, Customized||participants|Number|24|24.0||||||
3670198|NCT02337959|3514366|B3|Unknown||Sex/Gender, Customized||participants|Number|7|7.0||||||
3670199|NCT02337959|3514367|B2|Unknown||Sex/Gender, Customized||participants|Number|7|7.0||||||
3670200|NCT02337959|3514368|B1|Unknown||Sex/Gender, Customized||participants|Number|10|10.0||||||
3670201|NCT02337959|3514365|B4|< 21 years||Age, Customized||participants|Number|3|3.0||||||
3670202|NCT02337959|3514366|B3|< 21 years||Age, Customized||participants|Number|3|3.0||||||
3670203|NCT02337959|3514367|B2|< 21 years||Age, Customized||participants|Number|0|0.0||||||
3670204|NCT02337959|3514368|B1|< 21 years||Age, Customized||participants|Number|0|0.0||||||
3670205|NCT02337959|3514365|B4|21 years and older||Age, Customized||participants|Number|21|21.0||||||
3670206|NCT02337959|3514366|B3|21 years and older||Age, Customized||participants|Number|4|4.0||||||
3670207|NCT02337959|3514367|B2|21 years and older||Age, Customized||participants|Number|7|7.0||||||
3670208|NCT02337959|3514368|B1|21 years and older||Age, Customized||participants|Number|10|10.0||||||
3670209|NCT02337907|3514378|B7||Unknown or Not Reported|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|0|0.0||||||
3670210|NCT02337907|3514379|B6||Unknown or Not Reported|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|0|0.0||||||
3670211|NCT02337907|3514380|B5||Unknown or Not Reported|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|0|0.0||||||
3670212|NCT02337907|3514381|B4||Unknown or Not Reported|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|0|0.0||||||
3670213|NCT02337907|3514382|B3||Unknown or Not Reported|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|0|0.0||||||
3670214|NCT02337907|3514383|B2||Unknown or Not Reported|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|0|0.0||||||
3670215|NCT02337907|3514384|B1||Unknown or Not Reported|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|0|0.0||||||
3670216|NCT02337907|3514378|B7||More than one race|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|0|0.0||||||
3670217|NCT02337907|3514379|B6||More than one race|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|0|0.0||||||
3670218|NCT02337907|3514380|B5||More than one race|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|0|0.0||||||
3670219|NCT02337907|3514381|B4||More than one race|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|0|0.0||||||
3670220|NCT02337907|3514382|B3||More than one race|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|0|0.0||||||
3670221|NCT02337907|3514383|B2||More than one race|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|0|0.0||||||
3670222|NCT02337907|3514384|B1||More than one race|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|0|0.0||||||
3670223|NCT02337907|3514378|B7||White|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|324|324.0||||||
3670224|NCT02337907|3514379|B6||White|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|5|5.0||||||
3670225|NCT02337907|3514380|B5||White|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|103|103.0||||||
3670226|NCT02337907|3514381|B4||White|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|55|55.0||||||
3670227|NCT02337907|3514382|B3||White|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|54|54.0||||||
3670228|NCT02337907|3514383|B2||White|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|53|53.0||||||
3670229|NCT02337907|3514384|B1||White|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|54|54.0||||||
3670230|NCT02337907|3514378|B7||Black or African American|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|3|3.0||||||
3670231|NCT02337907|3514379|B6||Black or African American|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|0|0.0||||||
3670232|NCT02337907|3514380|B5||Black or African American|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|3|3.0||||||
3670233|NCT02337907|3514381|B4||Black or African American|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|0|0.0||||||
3670234|NCT02337907|3514382|B3||Black or African American|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|0|0.0||||||
3670235|NCT02337907|3514383|B2||Black or African American|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|0|0.0||||||
3670236|NCT02337907|3514384|B1||Black or African American|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|0|0.0||||||
3670237|NCT02337907|3514378|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|0|0.0||||||
3670238|NCT02337907|3514379|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|0|0.0||||||
3670239|NCT02337907|3514380|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|0|0.0||||||
3670240|NCT02337907|3514381|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|0|0.0||||||
3670241|NCT02337907|3514382|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|0|0.0||||||
3670242|NCT02337907|3514383|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|0|0.0||||||
3670243|NCT02337907|3514384|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|0|0.0||||||
3670244|NCT02337907|3514378|B7||Asian|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|2|2.0||||||
3670245|NCT02337907|3514379|B6||Asian|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|0|0.0||||||
3670246|NCT02337907|3514380|B5||Asian|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|0|0.0||||||
3670247|NCT02337907|3514381|B4||Asian|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|0|0.0||||||
3670248|NCT02337907|3514382|B3||Asian|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|1|1.0||||||
3670249|NCT02337907|3514383|B2||Asian|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|0|0.0||||||
3670250|NCT02337907|3514384|B1||Asian|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|1|1.0||||||
3670251|NCT02337907|3514378|B7||American Indian or Alaska Native|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|0|0.0||||||
3670252|NCT02337907|3514379|B6||American Indian or Alaska Native|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|0|0.0||||||
3670253|NCT02337907|3514380|B5||American Indian or Alaska Native|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|0|0.0||||||
3670254|NCT02337907|3514381|B4||American Indian or Alaska Native|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|0|0.0||||||
3670255|NCT02337907|3514382|B3||American Indian or Alaska Native|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|0|0.0||||||
3670256|NCT02337907|3514383|B2||American Indian or Alaska Native|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|0|0.0||||||
3670257|NCT02337907|3514384|B1||American Indian or Alaska Native|Race (NIH/OMB)|Number of subjects is categorized for race data.|Participants|Count of Participants|0|0.0||||||
3670258|NCT02337907|3514378|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)|Number of subjects is categorized for ethnicity data.|Participants|Count of Participants|0|0.0||||||
3670259|NCT02337907|3514379|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)|Number of subjects is categorized for ethnicity data.|Participants|Count of Participants|0|0.0||||||
3670260|NCT02337907|3514380|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)|Number of subjects is categorized for ethnicity data.|Participants|Count of Participants|0|0.0||||||
3670261|NCT02337907|3514381|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)|Number of subjects is categorized for ethnicity data.|Participants|Count of Participants|0|0.0||||||
3670262|NCT02337907|3514382|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)|Number of subjects is categorized for ethnicity data.|Participants|Count of Participants|0|0.0||||||
3670263|NCT02337907|3514383|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)|Number of subjects is categorized for ethnicity data.|Participants|Count of Participants|0|0.0||||||
3670264|NCT02337907|3514384|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|Number of subjects is categorized for ethnicity data.|Participants|Count of Participants|0|0.0||||||
3670265|NCT02337907|3514378|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Number of subjects is categorized for ethnicity data.|Participants|Count of Participants|316|316.0||||||
3670266|NCT02337907|3514379|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Number of subjects is categorized for ethnicity data.|Participants|Count of Participants|4|4.0||||||
3670267|NCT02337907|3514380|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Number of subjects is categorized for ethnicity data.|Participants|Count of Participants|104|104.0||||||
3670268|NCT02337907|3514381|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Number of subjects is categorized for ethnicity data.|Participants|Count of Participants|53|53.0||||||
3670269|NCT02337907|3514382|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Number of subjects is categorized for ethnicity data.|Participants|Count of Participants|51|51.0||||||
3670270|NCT02337907|3514383|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Number of subjects is categorized for ethnicity data.|Participants|Count of Participants|51|51.0||||||
3670271|NCT02337907|3514384|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Number of subjects is categorized for ethnicity data.|Participants|Count of Participants|53|53.0||||||
3670272|NCT02337907|3514378|B7||Hispanic or Latino|Ethnicity (NIH/OMB)|Number of subjects is categorized for ethnicity data.|Participants|Count of Participants|13|13.0||||||
3670346|NCT02337725|3514425|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3670273|NCT02337907|3514379|B6||Hispanic or Latino|Ethnicity (NIH/OMB)|Number of subjects is categorized for ethnicity data.|Participants|Count of Participants|1|1.0||||||
3670274|NCT02337907|3514380|B5||Hispanic or Latino|Ethnicity (NIH/OMB)|Number of subjects is categorized for ethnicity data.|Participants|Count of Participants|2|2.0||||||
3670275|NCT02337907|3514381|B4||Hispanic or Latino|Ethnicity (NIH/OMB)|Number of subjects is categorized for ethnicity data.|Participants|Count of Participants|2|2.0||||||
3670276|NCT02337907|3514382|B3||Hispanic or Latino|Ethnicity (NIH/OMB)|Number of subjects is categorized for ethnicity data.|Participants|Count of Participants|4|4.0||||||
3670277|NCT02337907|3514383|B2||Hispanic or Latino|Ethnicity (NIH/OMB)|Number of subjects is categorized for ethnicity data.|Participants|Count of Participants|2|2.0||||||
3670278|NCT02337907|3514384|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|Number of subjects is categorized for ethnicity data.|Participants|Count of Participants|2|2.0||||||
3670279|NCT02337907|3514378|B7||Male|Sex: Female, Male|Number of subjects is categorized as Male or Female.|Participants|Count of Participants|166|166.0||||||
3670280|NCT02337907|3514379|B6||Male|Sex: Female, Male|Number of subjects is categorized as Male or Female.|Participants|Count of Participants|2|2.0||||||
3670281|NCT02337907|3514380|B5||Male|Sex: Female, Male|Number of subjects is categorized as Male or Female.|Participants|Count of Participants|58|58.0||||||
3670282|NCT02337907|3514381|B4||Male|Sex: Female, Male|Number of subjects is categorized as Male or Female.|Participants|Count of Participants|25|25.0||||||
3670283|NCT02337907|3514382|B3||Male|Sex: Female, Male|Number of subjects is categorized as Male or Female.|Participants|Count of Participants|29|29.0||||||
3670284|NCT02337907|3514383|B2||Male|Sex: Female, Male|Number of subjects is categorized as Male or Female.|Participants|Count of Participants|23|23.0||||||
3670285|NCT02337907|3514384|B1||Male|Sex: Female, Male|Number of subjects is categorized as Male or Female.|Participants|Count of Participants|29|29.0||||||
3670286|NCT02337907|3514378|B7||Female|Sex: Female, Male|Number of subjects is categorized as Male or Female.|Participants|Count of Participants|163|163.0||||||
3670287|NCT02337907|3514379|B6||Female|Sex: Female, Male|Number of subjects is categorized as Male or Female.|Participants|Count of Participants|3|3.0||||||
3670288|NCT02337907|3514380|B5||Female|Sex: Female, Male|Number of subjects is categorized as Male or Female.|Participants|Count of Participants|48|48.0||||||
3670289|NCT02337907|3514381|B4||Female|Sex: Female, Male|Number of subjects is categorized as Male or Female.|Participants|Count of Participants|30|30.0||||||
3670290|NCT02337907|3514382|B3||Female|Sex: Female, Male|Number of subjects is categorized as Male or Female.|Participants|Count of Participants|26|26.0||||||
3670291|NCT02337907|3514383|B2||Female|Sex: Female, Male|Number of subjects is categorized as Male or Female.|Participants|Count of Participants|30|30.0||||||
3670292|NCT02337907|3514384|B1||Female|Sex: Female, Male|Number of subjects is categorized as Male or Female.|Participants|Count of Participants|26|26.0||||||
3670293|NCT02337907|3514378|B7|||Age|Age at the time of signing informed consent form is presented.|Years|Mean|74.0|74.0|Standard Deviation|7.9|7.9|||
3670294|NCT02337907|3514379|B6|||Age|Age at the time of signing informed consent form is presented.|Years|Mean|79.6|79.6|Standard Deviation|7.0|7.0|||
3670295|NCT02337907|3514380|B5|||Age|Age at the time of signing informed consent form is presented.|Years|Mean|74.0|74.0|Standard Deviation|7.7|7.7|||
3670296|NCT02337907|3514381|B4|||Age|Age at the time of signing informed consent form is presented.|Years|Mean|74.8|74.8|Standard Deviation|9.1|9.1|||
3670297|NCT02337907|3514382|B3|||Age|Age at the time of signing informed consent form is presented.|Years|Mean|73.0|73.0|Standard Deviation|6.5|6.5|||
3670298|NCT02337907|3514383|B2|||Age|Age at the time of signing informed consent form is presented.|Years|Mean|74.2|74.2|Standard Deviation|7.8|7.8|||
3670299|NCT02337907|3514384|B1|||Age|Age at the time of signing informed consent form is presented.|Years|Mean|73.7|73.7|Standard Deviation|8.4|8.4|||
3670300|NCT02337725|3514424|B3|||MDS-UPDRS Part III Total Score|For MDS-UPDRS Part III (motor examination) scores, the scale range for Part III Total Score was 0-136, with higher scores reflecting greater severity.|Scores on a scale|Mean|27.0|27.0|Standard Deviation|12.68|12.68|||
3670301|NCT02337725|3514425|B2|||MDS-UPDRS Part III Total Score|For MDS-UPDRS Part III (motor examination) scores, the scale range for Part III Total Score was 0-136, with higher scores reflecting greater severity.|Scores on a scale|Mean|27.2|27.2|Standard Deviation|13.80|13.8|||
3670302|NCT02337725|3514426|B1|||MDS-UPDRS Part III Total Score|For MDS-UPDRS Part III (motor examination) scores, the scale range for Part III Total Score was 0-136, with higher scores reflecting greater severity.|Scores on a scale|Mean|26.8|26.8|Standard Deviation|11.59|11.59|||
3670303|NCT02337725|3514424|B3|||MDS-UPDRS Part II Total Score|For MDS-UPDRS Part II (motor experiences of daily living) scores, the scale range for Part II Total Score was 0-52, with higher scores reflecting greater severity.|Scores on a scale|Mean|7.1|7.1|Standard Deviation|5.05|5.05|||
3670304|NCT02337725|3514425|B2|||MDS-UPDRS Part II Total Score|For MDS-UPDRS Part II (motor experiences of daily living) scores, the scale range for Part II Total Score was 0-52, with higher scores reflecting greater severity.|Scores on a scale|Mean|7.2|7.2|Standard Deviation|5.47|5.47|||
3670305|NCT02337725|3514426|B1|||MDS-UPDRS Part II Total Score|For MDS-UPDRS Part II (motor experiences of daily living) scores, the scale range for Part II Total Score was 0-52, with higher scores reflecting greater severity.|Scores on a scale|Mean|7.0|7.0|Standard Deviation|4.64|4.64|||
3670306|NCT02337725|3514424|B3|||MDS-UPDRS Part I Total Score|For MDS-UPDRS Part I (non-motor experiences of daily living) scores, the scale range for Part I Total Score was 0-52, with higher scores reflecting greater severity.|Scores on a scale|Mean|5.6|5.6|Standard Deviation|3.70|3.7|||
3670307|NCT02337725|3514425|B2|||MDS-UPDRS Part I Total Score|For MDS-UPDRS Part I (non-motor experiences of daily living) scores, the scale range for Part I Total Score was 0-52, with higher scores reflecting greater severity.|Scores on a scale|Mean|5.5|5.5|Standard Deviation|3.83|3.83|||
3670308|NCT02337725|3514426|B1|||MDS-UPDRS Part I Total Score|For MDS-UPDRS Part I (non-motor experiences of daily living) scores, the scale range for Part I Total Score was 0-52, with higher scores reflecting greater severity.|Scores on a scale|Mean|5.7|5.7|Standard Deviation|3.58|3.58|||
3670309|NCT02337725|3514424|B3|||MDS-UPDRS Part II+III Total Score|Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) retains the four-scale structure with a reorganization of the various subscale; (Part I; 13 items) non-motor experiences of daily living, (Part II; 13) motor experiences of daily living, (Part III; 34) motor examination, and (Part IV; 6) motor complications. Each items had 0-4 ratings, where 0 (normal) to 4 (severe) and score for each was summed to calculate the total scores. The scale range for Part II+III Total Score was 0-188, with higher scores reflecting greater severity.|Scores on a scale|Mean|34.1|34.1|Standard Deviation|15.66|15.66|||
3670310|NCT02337725|3514425|B2|||MDS-UPDRS Part II+III Total Score|Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) retains the four-scale structure with a reorganization of the various subscale; (Part I; 13 items) non-motor experiences of daily living, (Part II; 13) motor experiences of daily living, (Part III; 34) motor examination, and (Part IV; 6) motor complications. Each items had 0-4 ratings, where 0 (normal) to 4 (severe) and score for each was summed to calculate the total scores. The scale range for Part II+III Total Score was 0-188, with higher scores reflecting greater severity.|Scores on a scale|Mean|34.4|34.4|Standard Deviation|16.95|16.95|||
3670311|NCT02337725|3514426|B1|||MDS-UPDRS Part II+III Total Score|Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) retains the four-scale structure with a reorganization of the various subscale; (Part I; 13 items) non-motor experiences of daily living, (Part II; 13) motor experiences of daily living, (Part III; 34) motor examination, and (Part IV; 6) motor complications. Each items had 0-4 ratings, where 0 (normal) to 4 (severe) and score for each was summed to calculate the total scores. The scale range for Part II+III Total Score was 0-188, with higher scores reflecting greater severity.|Scores on a scale|Mean|33.8|33.8|Standard Deviation|14.43|14.43|||
3670312|NCT02337725|3514424|B3|||Modified Hoehn & Yahr Stage|Modified Hoehn & Yahr Stage represented severity for symptoms of Parkinson's disease progress. The Stage of Modified Hoehn & Yahr were assigned from Stage 0 (Asymptomatic) to Stage 5 (Wheelchair bound or bedridden unless aided (unable to walk even if aided)).|Units on a scale|Mean|2.17|2.17|Standard Deviation|0.619|0.619|||
3670313|NCT02337725|3514425|B2|||Modified Hoehn & Yahr Stage|Modified Hoehn & Yahr Stage represented severity for symptoms of Parkinson's disease progress. The Stage of Modified Hoehn & Yahr were assigned from Stage 0 (Asymptomatic) to Stage 5 (Wheelchair bound or bedridden unless aided (unable to walk even if aided)).|Units on a scale|Mean|2.18|2.18|Standard Deviation|0.626|0.626|||
3670314|NCT02337725|3514426|B1|||Modified Hoehn & Yahr Stage|Modified Hoehn & Yahr Stage represented severity for symptoms of Parkinson's disease progress. The Stage of Modified Hoehn & Yahr were assigned from Stage 0 (Asymptomatic) to Stage 5 (Wheelchair bound or bedridden unless aided (unable to walk even if aided)).|Units on a scale|Mean|2.15|2.15|Standard Deviation|0.615|0.615|||
3670315|NCT02337725|3514424|B3|||Duration of Parkinson's Disease||years|Mean|1.76|1.76|Standard Deviation|1.644|1.644|||
3670316|NCT02337725|3514425|B2|||Duration of Parkinson's Disease||years|Mean|1.97|1.97|Standard Deviation|1.972|1.972|||
3670317|NCT02337725|3514426|B1|||Duration of Parkinson's Disease||years|Mean|1.56|1.56|Standard Deviation|1.237|1.237|||
3670318|NCT02337725|3514424|B3||After Breakfast|Timing of Study Drug Dose||Participants|Count of Participants|125|125.0||||||
3670319|NCT02337725|3514425|B2||After Breakfast|Timing of Study Drug Dose||Participants|Count of Participants|59|59.0||||||
3670320|NCT02337725|3514426|B1||After Breakfast|Timing of Study Drug Dose||Participants|Count of Participants|66|66.0||||||
3670321|NCT02337725|3514424|B3||Before Breakfast|Timing of Study Drug Dose||Participants|Count of Participants|119|119.0||||||
3670322|NCT02337725|3514425|B2||Before Breakfast|Timing of Study Drug Dose||Participants|Count of Participants|59|59.0||||||
3670323|NCT02337725|3514426|B1||Before Breakfast|Timing of Study Drug Dose||Participants|Count of Participants|60|60.0||||||
3670324|NCT02337725|3514424|B3||Ex-Smoker|Smoking Classification||Participants|Count of Participants|92|92.0||||||
3670325|NCT02337725|3514425|B2||Ex-Smoker|Smoking Classification||Participants|Count of Participants|49|49.0||||||
3670326|NCT02337725|3514426|B1||Ex-Smoker|Smoking Classification||Participants|Count of Participants|43|43.0||||||
3670327|NCT02337725|3514424|B3||Current Smoker|Smoking Classification||Participants|Count of Participants|13|13.0||||||
3670328|NCT02337725|3514425|B2||Current Smoker|Smoking Classification||Participants|Count of Participants|5|5.0||||||
3670329|NCT02337725|3514426|B1||Current Smoker|Smoking Classification||Participants|Count of Participants|8|8.0||||||
3670330|NCT02337725|3514424|B3||Never Smoked|Smoking Classification||Participants|Count of Participants|139|139.0||||||
3670331|NCT02337725|3514425|B2||Never Smoked|Smoking Classification||Participants|Count of Participants|64|64.0||||||
3670332|NCT02337725|3514426|B1||Never Smoked|Smoking Classification||Participants|Count of Participants|75|75.0||||||
3670333|NCT02337725|3514424|B3|||BMI|Body Mass Index = weight (kg)/[height (m)^2]|kg/m^2|Mean|22.56|22.56|Standard Deviation|3.031|3.031|||
3670334|NCT02337725|3514425|B2|||BMI|Body Mass Index = weight (kg)/[height (m)^2]|kg/m^2|Mean|22.78|22.78|Standard Deviation|3.303|3.303|||
3670335|NCT02337725|3514426|B1|||BMI|Body Mass Index = weight (kg)/[height (m)^2]|kg/m^2|Mean|22.35|22.35|Standard Deviation|2.752|2.752|||
3670336|NCT02337725|3514424|B3|||Weight||kg|Mean|57.42|57.42|Standard Deviation|10.997|10.997|||
3670337|NCT02337725|3514425|B2|||Weight||kg|Mean|57.91|57.91|Standard Deviation|11.803|11.803|||
3670338|NCT02337725|3514426|B1|||Weight||kg|Mean|56.97|56.97|Standard Deviation|10.218|10.218|||
3670339|NCT02337725|3514424|B3|||Height||cm|Mean|159.0|159.0|Standard Deviation|9.04|9.04|||
3670340|NCT02337725|3514425|B2|||Height||cm|Mean|158.8|158.8|Standard Deviation|8.86|8.86|||
3670341|NCT02337725|3514426|B1|||Height||cm|Mean|159.3|159.3|Standard Deviation|9.24|9.24|||
3670342|NCT02337725|3514424|B3|Japan||Region of Enrollment|All participants were enrolled in Japan.|Participants|Number|244|244.0||||||
3670343|NCT02337725|3514425|B2|Japan||Region of Enrollment|All participants were enrolled in Japan.|Participants|Number|118|118.0||||||
3670344|NCT02337725|3514426|B1|Japan||Region of Enrollment|All participants were enrolled in Japan.|Participants|Number|126|126.0||||||
3670345|NCT02337725|3514424|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3670347|NCT02337725|3514426|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3670348|NCT02337725|3514424|B3||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3670349|NCT02337725|3514425|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3670350|NCT02337725|3514426|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3670351|NCT02337725|3514424|B3|||Age||years|Mean|66.4|66.4|Standard Deviation|8.92|8.92|||
3670352|NCT02337725|3514425|B2|||Age||years|Mean|67.4|67.4|Standard Deviation|8.96|8.96|||
3670353|NCT02337725|3514426|B1|||Age||years|Mean|65.4|65.4|Standard Deviation|8.81|8.81|||
3670354|NCT02337491|3514449|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3670355|NCT02337491|3514450|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3670356|NCT02337491|3514451|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3670357|NCT02337491|3514449|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3670358|NCT02337491|3514450|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3670359|NCT02337491|3514451|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3670360|NCT02337491|3514449|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3670361|NCT02337491|3514450|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3670362|NCT02337491|3514451|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3670363|NCT02337491|3514449|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3670364|NCT02337491|3514450|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3670365|NCT02337491|3514451|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3670366|NCT02337491|3514449|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3670367|NCT02337491|3514450|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3670368|NCT02337491|3514451|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3670369|NCT02337491|3514449|B3|||Age||years|Mean|51.1|51.1|Standard Deviation|12.9|12.9|||
3670370|NCT02337491|3514450|B2|||Age||years|Mean|51.8|51.8|Standard Deviation|13.3|13.3|||
3670371|NCT02337491|3514451|B1|||Age||years|Mean|50.7|50.7|Standard Deviation|12.7|12.7|||
3670372|NCT02337062|3514466|B3|Germany||Region of Enrollment||Participants|Count of Participants|279|279.0||||||
3670373|NCT02337062|3514467|B2|Germany||Region of Enrollment||Participants|Count of Participants|139|139.0||||||
3670374|NCT02337062|3514468|B1|Germany||Region of Enrollment||Participants|Count of Participants|140|140.0||||||
3670375|NCT02337062|3514466|B3|France||Region of Enrollment||Participants|Count of Participants|164|164.0||||||
3670376|NCT02337062|3514467|B2|France||Region of Enrollment||Participants|Count of Participants|85|85.0||||||
3670377|NCT02337062|3514468|B1|France||Region of Enrollment||Participants|Count of Participants|79|79.0||||||
3670378|NCT02337062|3514466|B3|United States||Region of Enrollment||Participants|Count of Participants|704|704.0||||||
3670379|NCT02337062|3514467|B2|United States||Region of Enrollment||Participants|Count of Participants|351|351.0||||||
3670380|NCT02337062|3514468|B1|United States||Region of Enrollment||Participants|Count of Participants|353|353.0||||||
3670381|NCT02337062|3514466|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3670382|NCT02337062|3514467|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3670383|NCT02337062|3514468|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3670384|NCT02337062|3514466|B3||Female|Sex: Female, Male||Participants|Count of Participants|1109|1109.0||||||
3670385|NCT02337062|3514467|B2||Female|Sex: Female, Male||Participants|Count of Participants|557|557.0||||||
3670386|NCT02337062|3514468|B1||Female|Sex: Female, Male||Participants|Count of Participants|552|552.0||||||
3670387|NCT02337062|3514466|B3|||Age||Years|Mean|48.5|48.5|Standard Deviation|14.10|14.1|||
3670388|NCT02337062|3514467|B2|||Age||Years|Mean|48.3|48.3|Standard Deviation|13.98|13.98|||
3670389|NCT02337062|3514468|B1|||Age||Years|Mean|48.8|48.8|Standard Deviation|14.24|14.24|||
3670390|NCT02336958|3514475|B3|Germany||Region of Enrollment||participants|Number|40|40.0||||||
3670391|NCT02336958|3514476|B2|Germany||Region of Enrollment||participants|Number|20|20.0||||||
3670392|NCT02336958|3514477|B1|Germany||Region of Enrollment||participants|Number|20|20.0||||||
3670393|NCT02336958|3514475|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670394|NCT02336958|3514476|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670395|NCT02336958|3514477|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670396|NCT02336958|3514475|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670397|NCT02336958|3514476|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670398|NCT02336958|3514477|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670399|NCT02336958|3514475|B3||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3670400|NCT02336958|3514476|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3670401|NCT02336958|3514477|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3670402|NCT02336958|3514475|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670403|NCT02336958|3514476|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670404|NCT02336958|3514477|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670405|NCT02336958|3514475|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670406|NCT02336958|3514476|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670407|NCT02336958|3514477|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670408|NCT02336958|3514475|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670409|NCT02336958|3514476|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670410|NCT02336958|3514477|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670411|NCT02336958|3514475|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670412|NCT02336958|3514476|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670413|NCT02336958|3514477|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670414|NCT02336958|3514475|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3670415|NCT02336958|3514476|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3670416|NCT02336958|3514477|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3670417|NCT02336958|3514475|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3670418|NCT02336958|3514476|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3670419|NCT02336958|3514477|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3670420|NCT02336958|3514475|B3|||Age||years|Mean|71.5|71.5|Standard Deviation|8.3|8.3|||
3670421|NCT02336958|3514476|B2|||Age||years|Mean|72.2|72.2|Standard Deviation|7.7|7.7|||
3670422|NCT02336958|3514477|B1|||Age||years|Mean|70.9|70.9|Standard Deviation|9.0|9.0|||
3670423|NCT02336763|3514486|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3670424|NCT02336763|3514486|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3670425|NCT02336763|3514486|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3670426|NCT02336763|3514486|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3670427|NCT02336763|3514486|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3670428|NCT02336763|3514486|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3670429|NCT02336607|3514496|B5||Male|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
3670430|NCT02336607|3514497|B4||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3670431|NCT02336607|3514498|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3670432|NCT02336607|3514499|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3670433|NCT02336607|3514500|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3670434|NCT02336607|3514496|B5||Female|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
3670435|NCT02336607|3514497|B4||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3670436|NCT02336607|3514498|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3670437|NCT02336607|3514499|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3670438|NCT02336607|3514500|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3670439|NCT02336607|3514496|B5|||Age||Years|Mean|54.9|54.9|Standard Deviation|10.8|10.8|||
3670440|NCT02336607|3514497|B4|||Age||Years|Mean|55|55.0|Standard Deviation|11.3|11.3|||
3670441|NCT02336607|3514498|B3|||Age||Years|Mean|55.6|55.6|Standard Deviation|9.9|9.9|||
3670442|NCT02336607|3514499|B2|||Age||Years|Mean|55.2|55.2|Standard Deviation|10.7|10.7|||
3670443|NCT02336607|3514500|B1|||Age||Years|Mean|53.4|53.4|Standard Deviation|10.8|10.8|||
3670444|NCT02336594|3514557|B5|United States||Region of Enrollment||Participants|Number|15|15.0||||||
3670445|NCT02336594|3514558|B4|United States||Region of Enrollment||Participants|Number|4|4.0||||||
3670446|NCT02336594|3514559|B3|United States||Region of Enrollment||Participants|Number|4|4.0||||||
3670447|NCT02336594|3514560|B2|United States||Region of Enrollment||Participants|Number|4|4.0||||||
3670448|NCT02336594|3514561|B1|United States||Region of Enrollment||Participants|Number|3|3.0||||||
3670449|NCT02336594|3514557|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3670450|NCT02336594|3514558|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3670451|NCT02336594|3514559|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3670452|NCT02336594|3514560|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3670453|NCT02336594|3514561|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3670454|NCT02336594|3514557|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3670455|NCT02336594|3514558|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3670456|NCT02336594|3514559|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3670457|NCT02336594|3514560|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3670458|NCT02336594|3514561|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3670459|NCT02336594|3514557|B5|>=65||Age, Customized||Participants|Number|0|0.0||||||
3670460|NCT02336594|3514558|B4|>=65||Age, Customized||Participants|Number|0|0.0||||||
3670461|NCT02336594|3514559|B3|>=65||Age, Customized||Participants|Number|0|0.0||||||
3670462|NCT02336594|3514560|B2|>=65||Age, Customized||Participants|Number|0|0.0||||||
3670463|NCT02336594|3514561|B1|>=65||Age, Customized||Participants|Number|0|0.0||||||
3670464|NCT02336594|3514557|B5|<65||Age, Customized||Participants|Number|15|15.0||||||
3670465|NCT02336594|3514558|B4|<65||Age, Customized||Participants|Number|4|4.0||||||
3670466|NCT02336594|3514559|B3|<65||Age, Customized||Participants|Number|4|4.0||||||
3670467|NCT02336594|3514560|B2|<65||Age, Customized||Participants|Number|4|4.0||||||
3670468|NCT02336594|3514561|B1|<65||Age, Customized||Participants|Number|3|3.0||||||
3670469|NCT02336594|3514557|B5|||Age||Years|Mean|42|42.0|Standard Deviation|11.9|11.9|||
3670470|NCT02336594|3514558|B4|||Age||Years|Mean|42|42.0|Standard Deviation|16.0|16.0|||
3670471|NCT02336594|3514559|B3|||Age||Years|Mean|40|40.0|Standard Deviation|12.3|12.3|||
3670472|NCT02336594|3514560|B2|||Age||Years|Mean|39|39.0|Standard Deviation|9.7|9.7|||
3670473|NCT02336594|3514561|B1|||Age||Years|Mean|51|51.0|Standard Deviation|9.8|9.8|||
3670474|NCT02336438|3514604|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3670475|NCT02336438|3514604|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3670476|NCT02336438|3514604|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3670477|NCT02336438|3514604|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3670478|NCT02336438|3514604|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3670479|NCT02336438|3514604|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3670480|NCT02336425|3514613|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3670481|NCT02336425|3514614|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3670482|NCT02336425|3514615|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3670483|NCT02336425|3514616|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3670484|NCT02336425|3514617|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3670485|NCT02336425|3514613|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3670486|NCT02336425|3514614|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3670487|NCT02336425|3514615|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3670488|NCT02336425|3514616|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3670489|NCT02336425|3514617|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3670490|NCT02336425|3514613|B5|||Age||Years|Mean|49.1|49.1|Standard Deviation|8.45|8.45|||
3670491|NCT02336425|3514614|B4|||Age||Years|Mean|47.7|47.7|Standard Deviation|2.89|2.89|||
3670492|NCT02336425|3514615|B3|||Age||Years|Mean|53.7|53.7|Standard Deviation|11.59|11.59|||
3670493|NCT02336425|3514616|B2|||Age||Years|Mean|47.0|47.0|Standard Deviation|1.41|1.41|||
3670494|NCT02336425|3514617|B1|||Age||Years|Mean|46.5|46.5|Standard Deviation|16.26|16.26|||
3670495|NCT02336282|3514670|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670496|NCT02336282|3514670|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670497|NCT02336282|3514670|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3670498|NCT02336282|3514670|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3670499|NCT02336282|3514670|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670500|NCT02336282|3514670|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670501|NCT02336282|3514670|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670502|NCT02336282|3514670|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670503|NCT02336282|3514670|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3670504|NCT02336282|3514670|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3670505|NCT02336282|3514670|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3670506|NCT02336282|3514670|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3670507|NCT02336282|3514670|B1|||Age||years|Mean|38.2|38.2|Standard Deviation|9.3|9.3|||
3670508|NCT02336178|3514694|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3670509|NCT02336178|3514694|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3670510|NCT02336178|3514694|B1|||Age||years|Mean|7.8|7.8|Standard Deviation|7.2|7.2|||
3670511|NCT02335710|3514780|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3670512|NCT02335710|3514781|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3670513|NCT02335710|3514782|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3670514|NCT02335710|3514780|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3670515|NCT02335710|3514781|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3670516|NCT02335710|3514782|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3670517|NCT02335710|3514780|B3|||Age||years|Mean|67.29|67.29|Standard Deviation|9.43|9.43|||
3670518|NCT02335710|3514781|B2|||Age||years|Mean|57.44|57.44|Standard Deviation|7.15|7.15|||
3670519|NCT02335710|3514782|B1|||Age||years|Mean|69.76|69.76|Standard Deviation|8.30|8.3|||
3670520|NCT02335710|3514780|B3||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
3670521|NCT02335710|3514781|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3670522|NCT02335710|3514782|B1||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
3670523|NCT02335710|3514780|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3670524|NCT02335710|3514781|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3670525|NCT02335710|3514782|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3670526|NCT02335710|3514780|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3670527|NCT02335710|3514781|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3670528|NCT02335710|3514782|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3670529|NCT02335502|3514803|B1|Netherlands||Region of Enrollment||participants|Number|66|66.0||||||
3670530|NCT02335502|3514803|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670531|NCT02335502|3514803|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670532|NCT02335502|3514803|B1||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3670533|NCT02335502|3514803|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3670534|NCT02335502|3514803|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670535|NCT02335502|3514803|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670536|NCT02335502|3514803|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670537|NCT02335502|3514803|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3670538|NCT02335502|3514803|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3670539|NCT02335502|3514803|B1|||Age||years|Mean|52|52.0|Full Range|||30.0|80.0|
3670540|NCT02335489|3514808|B1|Belgium||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3670541|NCT02335489|3514808|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3670542|NCT02335489|3514808|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670543|NCT02335489|3514808|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3670544|NCT02335489|3514808|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670545|NCT02335489|3514808|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670546|NCT02335489|3514808|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670547|NCT02335489|3514808|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670548|NCT02335489|3514808|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3670549|NCT02335489|3514808|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3670550|NCT02335489|3514808|B1|||Age||years|Mean|54|54.0|Full Range|||25.0|81.0|
3670551|NCT02335346|3514812|B1|Japan||Region of Enrollment||participants|Number|93|93.0||||||
3670552|NCT02335346|3514812|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670553|NCT02335346|3514812|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670554|NCT02335346|3514812|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670555|NCT02335346|3514812|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670556|NCT02335346|3514812|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670557|NCT02335346|3514812|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
3670558|NCT02335346|3514812|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670559|NCT02335346|3514812|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670560|NCT02335346|3514812|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
3670561|NCT02335346|3514812|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670562|NCT02335346|3514812|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3670563|NCT02335346|3514812|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3670564|NCT02335346|3514812|B1|||Age||years|Mean|66.2|66.2|Standard Deviation|8.2|8.2|||
3670565|NCT02335216|3514824|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3670566|NCT02335216|3514824|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3670567|NCT02335216|3514824|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670568|NCT02335216|3514824|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3670569|NCT02335216|3514824|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670570|NCT02335216|3514824|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670571|NCT02335216|3514824|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670572|NCT02335216|3514824|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670573|NCT02335216|3514824|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3670574|NCT02335216|3514824|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3670575|NCT02335216|3514824|B1|||Age||years|Mean|51|51.0|Full Range|||26.0|70.0|
3670576|NCT02334982|3514829|B8|Current||Alcohol Classification||participants|Number|3|3.0||||||
3670577|NCT02334982|3514830|B7|Current||Alcohol Classification||participants|Number|0|0.0||||||
3670578|NCT02334982|3514831|B6|Current||Alcohol Classification||participants|Number|0|0.0||||||
3670579|NCT02334982|3514832|B5|Current||Alcohol Classification||participants|Number|0|0.0||||||
3670580|NCT02334982|3514833|B4|Current||Alcohol Classification||participants|Number|1|1.0||||||
3670581|NCT02334982|3514834|B3|Current||Alcohol Classification||participants|Number|2|2.0||||||
3670582|NCT02334982|3514835|B2|Current||Alcohol Classification||participants|Number|0|0.0||||||
3670583|NCT02334982|3514836|B1|Current||Alcohol Classification||participants|Number|0|0.0||||||
3670584|NCT02334982|3514829|B8|Never||Alcohol Classification||participants|Number|44|44.0||||||
3670585|NCT02334982|3514830|B7|Never||Alcohol Classification||participants|Number|12|12.0||||||
3670586|NCT02334982|3514831|B6|Never||Alcohol Classification||participants|Number|6|6.0||||||
3670587|NCT02334982|3514832|B5|Never||Alcohol Classification||participants|Number|6|6.0||||||
3670588|NCT02334982|3514833|B4|Never||Alcohol Classification||participants|Number|5|5.0||||||
3670589|NCT02334982|3514834|B3|Never||Alcohol Classification||participants|Number|4|4.0||||||
3670590|NCT02334982|3514835|B2|Never||Alcohol Classification||participants|Number|5|5.0||||||
3670591|NCT02334982|3514836|B1|Never||Alcohol Classification||participants|Number|6|6.0||||||
3670592|NCT02334982|3514829|B8|Ex-smoker||Smoking Classification||participants|Number|1|1.0||||||
3670593|NCT02334982|3514830|B7|Ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3670594|NCT02334982|3514831|B6|Ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3670595|NCT02334982|3514832|B5|Ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3670596|NCT02334982|3514833|B4|Ex-smoker||Smoking Classification||participants|Number|1|1.0||||||
3670597|NCT02334982|3514834|B3|Ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3670598|NCT02334982|3514835|B2|Ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3670599|NCT02334982|3514836|B1|Ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3670600|NCT02334982|3514829|B8|Never smoked||Smoking Classification||participants|Number|46|46.0||||||
3670601|NCT02334982|3514830|B7|Never smoked||Smoking Classification||participants|Number|12|12.0||||||
3670602|NCT02334982|3514831|B6|Never smoked||Smoking Classification||participants|Number|6|6.0||||||
3670603|NCT02334982|3514832|B5|Never smoked||Smoking Classification||participants|Number|6|6.0||||||
3670604|NCT02334982|3514833|B4|Never smoked||Smoking Classification||participants|Number|5|5.0||||||
3670605|NCT02334982|3514834|B3|Never smoked||Smoking Classification||participants|Number|6|6.0||||||
3670606|NCT02334982|3514835|B2|Never smoked||Smoking Classification||participants|Number|5|5.0||||||
3670607|NCT02334982|3514836|B1|Never smoked||Smoking Classification||participants|Number|6|6.0||||||
3670608|NCT02334982|3514829|B8|No||Caffeine Consumption||participants|Number|35|35.0||||||
3670609|NCT02334982|3514830|B7|No||Caffeine Consumption||participants|Number|7|7.0||||||
3670610|NCT02334982|3514831|B6|No||Caffeine Consumption||participants|Number|5|5.0||||||
3670611|NCT02334982|3514832|B5|No||Caffeine Consumption||participants|Number|5|5.0||||||
3670612|NCT02334982|3514833|B4|No||Caffeine Consumption||participants|Number|4|4.0||||||
3670613|NCT02334982|3514834|B3|No||Caffeine Consumption||participants|Number|4|4.0||||||
3670614|NCT02334982|3514835|B2|No||Caffeine Consumption||participants|Number|4|4.0||||||
3670615|NCT02334982|3514836|B1|No||Caffeine Consumption||participants|Number|6|6.0||||||
3670616|NCT02334982|3514829|B8|Yes||Caffeine Consumption||participants|Number|12|12.0||||||
3670617|NCT02334982|3514830|B7|Yes||Caffeine Consumption||participants|Number|5|5.0||||||
3670618|NCT02334982|3514831|B6|Yes||Caffeine Consumption||participants|Number|1|1.0||||||
3670619|NCT02334982|3514832|B5|Yes||Caffeine Consumption||participants|Number|1|1.0||||||
3670620|NCT02334982|3514833|B4|Yes||Caffeine Consumption||participants|Number|2|2.0||||||
3670621|NCT02334982|3514834|B3|Yes||Caffeine Consumption||participants|Number|2|2.0||||||
3670622|NCT02334982|3514835|B2|Yes||Caffeine Consumption||participants|Number|1|1.0||||||
3670623|NCT02334982|3514836|B1|Yes||Caffeine Consumption||participants|Number|0|0.0||||||
3670624|NCT02334982|3514829|B8|||Body Mass Index (BMI)||kg/m^2|Mean|24.93|24.93|Standard Deviation|3.074|3.074|||
3670625|NCT02334982|3514830|B7|||Body Mass Index (BMI)||kg/m^2|Mean|26.51|26.51|Standard Deviation|2.658|2.658|||
3670626|NCT02334982|3514831|B6|||Body Mass Index (BMI)||kg/m^2|Mean|23.38|23.38|Standard Deviation|2.315|2.315|||
3670627|NCT02334982|3514832|B5|||Body Mass Index (BMI)||kg/m^2|Mean|25.38|25.38|Standard Deviation|2.905|2.905|||
3670628|NCT02334982|3514833|B4|||Body Mass Index (BMI)||kg/m^2|Mean|24.68|24.68|Standard Deviation|4.260|4.26|||
3670629|NCT02334982|3514834|B3|||Body Mass Index (BMI)||kg/m^2|Mean|25.68|25.68|Standard Deviation|3.323|3.323|||
3670630|NCT02334982|3514835|B2|||Body Mass Index (BMI)||kg/m^2|Mean|26.48|26.48|Standard Deviation|2.138|2.138|||
3670631|NCT02334982|3514836|B1|||Body Mass Index (BMI)||kg/m^2|Mean|24.22|24.22|Standard Deviation|3.276|3.276|||
3670632|NCT02334982|3514829|B8|||Weight||kg|Mean|74.23|74.23|Standard Deviation|15.306|15.306|||
3670633|NCT02334982|3514830|B7|||Weight||kg|Mean|73.23|73.23|Standard Deviation|9.378|9.378|||
3670634|NCT02334982|3514831|B6|||Weight||kg|Mean|64.18|64.18|Standard Deviation|14.297|14.297|||
3670635|NCT02334982|3514832|B5|||Weight||kg|Mean|75.05|75.05|Standard Deviation|12.228|12.228|||
3670636|NCT02334982|3514833|B4|||Weight||kg|Mean|74.40|74.4|Standard Deviation|18.840|18.84|||
3670637|NCT02334982|3514834|B3|||Weight||kg|Mean|81.88|81.88|Standard Deviation|15.381|15.381|||
3670638|NCT02334982|3514835|B2|||Weight||kg|Mean|79.86|79.86|Standard Deviation|14.870|14.87|||
3670639|NCT02334982|3514836|B1|||Weight||kg|Mean|70.97|70.97|Standard Deviation|15.299|15.299|||
3670640|NCT02334982|3514829|B8|||Height||cm|Mean|171.6|171.6|Standard Deviation|9.52|9.52|||
3670641|NCT02334982|3514830|B7|||Height||cm|Mean|166.2|166.2|Standard Deviation|9.44|9.44|||
3670642|NCT02334982|3514831|B6|||Height||cm|Mean|164.7|164.7|Standard Deviation|11.74|11.74|||
3670643|NCT02334982|3514832|B5|||Height||cm|Mean|171.5|171.5|Standard Deviation|6.44|6.44|||
3670644|NCT02334982|3514833|B4|||Height||cm|Mean|172.3|172.3|Standard Deviation|8.62|8.62|||
3670645|NCT02334982|3514834|B3|||Height||cm|Mean|178.0|178.0|Standard Deviation|6.63|6.63|||
3670646|NCT02334982|3514835|B2|||Height||cm|Mean|173.2|173.2|Standard Deviation|13.22|13.22|||
3670647|NCT02334982|3514836|B1|||Height||cm|Mean|170.3|170.3|Standard Deviation|8.19|8.19|||
3670648|NCT02334982|3514829|B8|United States||Region of Enrollment||participants|Number|47|47.0||||||
3670649|NCT02334982|3514830|B7|United States||Region of Enrollment||participants|Number|12|12.0||||||
3670650|NCT02334982|3514831|B6|United States||Region of Enrollment||participants|Number|6|6.0||||||
3670651|NCT02334982|3514832|B5|United States||Region of Enrollment||participants|Number|6|6.0||||||
3670652|NCT02334982|3514833|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
3670653|NCT02334982|3514834|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3670654|NCT02334982|3514835|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3670655|NCT02334982|3514836|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3670656|NCT02334982|3514829|B8|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3670657|NCT02334982|3514830|B7|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3670658|NCT02334982|3514831|B6|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3670659|NCT02334982|3514832|B5|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3670660|NCT02334982|3514833|B4|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3670661|NCT02334982|3514834|B3|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3670662|NCT02334982|3514835|B2|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3670663|NCT02334982|3514836|B1|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3670664|NCT02334982|3514829|B8|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3670665|NCT02334982|3514830|B7|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3670666|NCT02334982|3514831|B6|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3670667|NCT02334982|3514832|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3670668|NCT02334982|3514833|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3670669|NCT02334982|3514834|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3670670|NCT02334982|3514835|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3670671|NCT02334982|3514836|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3670672|NCT02334982|3514829|B8|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3670673|NCT02334982|3514830|B7|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3670674|NCT02334982|3514831|B6|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3670675|NCT02334982|3514832|B5|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3670676|NCT02334982|3514833|B4|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3670677|NCT02334982|3514834|B3|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3670678|NCT02334982|3514835|B2|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3670679|NCT02334982|3514836|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3670680|NCT02334982|3514829|B8|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3670681|NCT02334982|3514830|B7|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3670682|NCT02334982|3514831|B6|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3670683|NCT02334982|3514832|B5|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3670684|NCT02334982|3514833|B4|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3670685|NCT02334982|3514834|B3|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3670686|NCT02334982|3514835|B2|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3670687|NCT02334982|3514836|B1|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3670688|NCT02334982|3514829|B8|Black or African American||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3670689|NCT02334982|3514830|B7|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3670690|NCT02334982|3514831|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3670691|NCT02334982|3514832|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3670692|NCT02334982|3514833|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3670693|NCT02334982|3514834|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3670694|NCT02334982|3514835|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3670695|NCT02334982|3514836|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3670696|NCT02334982|3514829|B8|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3670697|NCT02334982|3514830|B7|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3670698|NCT02334982|3514831|B6|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3670699|NCT02334982|3514832|B5|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3670700|NCT02334982|3514833|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3670701|NCT02334982|3514834|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3670702|NCT02334982|3514835|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3670703|NCT02334982|3514836|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3670704|NCT02334982|3514829|B8|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3670705|NCT02334982|3514830|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3670706|NCT02334982|3514831|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3670707|NCT02334982|3514832|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3670708|NCT02334982|3514833|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3670709|NCT02334982|3514834|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3670710|NCT02334982|3514835|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3670711|NCT02334982|3514836|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3670712|NCT02334982|3514829|B8||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3670713|NCT02334982|3514830|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3670714|NCT02334982|3514831|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3670715|NCT02334982|3514832|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3670716|NCT02334982|3514833|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3670717|NCT02334982|3514834|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3670718|NCT02334982|3514835|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3670719|NCT02334982|3514836|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3670720|NCT02334982|3514829|B8||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3670721|NCT02334982|3514830|B7||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3670722|NCT02334982|3514831|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3670723|NCT02334982|3514832|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3670724|NCT02334982|3514833|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3670725|NCT02334982|3514834|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3670726|NCT02334982|3514835|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3670727|NCT02334982|3514836|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3670728|NCT02334982|3514829|B8|||Age||years|Mean|34.9|34.9|Standard Deviation|9.43|9.43|||
3670729|NCT02334982|3514830|B7|||Age||years|Mean|31.5|31.5|Standard Deviation|6.87|6.87|||
3670730|NCT02334982|3514831|B6|||Age||years|Mean|38.5|38.5|Standard Deviation|10.63|10.63|||
3670731|NCT02334982|3514832|B5|||Age||years|Mean|24.7|24.7|Standard Deviation|3.88|3.88|||
3670732|NCT02334982|3514833|B4|||Age||years|Mean|36.5|36.5|Standard Deviation|9.27|9.27|||
3670733|NCT02334982|3514834|B3|||Age||years|Mean|40.5|40.5|Standard Deviation|8.22|8.22|||
3670734|NCT02334982|3514835|B2|||Age||years|Mean|34.0|34.0|Standard Deviation|8.66|8.66|||
3670735|NCT02334982|3514836|B1|||Age||years|Mean|34.8|34.8|Standard Deviation|9.00|9.0|||
3670736|NCT02334813|3514946|B3|Germany||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3670737|NCT02334813|3514947|B2|Germany||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3670738|NCT02334813|3514948|B1|Germany||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3670739|NCT02334813|3514946|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3670740|NCT02334813|3514946|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3670741|NCT02334813|3514947|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3670742|NCT02334813|3514948|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3670743|NCT02334813|3514946|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3670744|NCT02334813|3514947|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3670745|NCT02334813|3514948|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3670746|NCT02334813|3514946|B3|||Age||years|Median|44|44.0|Full Range|||22.0|77.0|
3670747|NCT02334813|3514947|B2|||Age||years|Median|46|46.0|Full Range|||22.0|77.0|
3670748|NCT02334813|3514948|B1|||Age||years|Median|43|43.0|Full Range|||29.0|65.0|
3670749|NCT02334800|3514955|B5||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3670750|NCT02334800|3514956|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3670751|NCT02334800|3514957|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3670752|NCT02334800|3514958|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3670753|NCT02334800|3514959|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3670754|NCT02334800|3514955|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3670755|NCT02334800|3514956|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3670756|NCT02334800|3514957|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3670757|NCT02334800|3514958|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3670758|NCT02334800|3514959|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3670759|NCT02334800|3514955|B5|||Age||years|Mean|56.6|56.6|Standard Deviation|4.5|4.5|||
3670760|NCT02334800|3514956|B4|||Age||years|Mean|57|57.0|Standard Deviation|5.3|5.3|||
3670761|NCT02334800|3514957|B3|||Age||years|Mean|57.9|57.9|Standard Deviation|4.2|4.2|||
3670762|NCT02334800|3514958|B2|||Age||years|Mean|53.9|53.9|Standard Deviation|5.1|5.1|||
3670763|NCT02334800|3514959|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|2.6|2.6|||
3670764|NCT02334787|3515052|B5|Japan||Region of Enrollment||participants|Number|32|32.0||||||
3670765|NCT02334787|3515053|B4|Japan||Region of Enrollment||participants|Number|8|8.0||||||
3670766|NCT02334787|3515054|B3|Japan||Region of Enrollment||participants|Number|8|8.0||||||
3670767|NCT02334787|3515055|B2|Japan||Region of Enrollment||participants|Number|8|8.0||||||
3670768|NCT02334787|3515056|B1|Japan||Region of Enrollment||participants|Number|8|8.0||||||
3670769|NCT02334787|3515052|B5||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3670770|NCT02334787|3515053|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3670771|NCT02334787|3515054|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3670772|NCT02334787|3515055|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3670773|NCT02334787|3515056|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3670774|NCT02334787|3515052|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3670775|NCT02334787|3515053|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3670776|NCT02334787|3515054|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3670777|NCT02334787|3515055|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3670778|NCT02334787|3515056|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3670779|NCT02334787|3515052|B5|||Age||years|Mean|30.0|30.0|Standard Deviation|6.8|6.8|||
3670780|NCT02334787|3515053|B4|||Age||years|Mean|29.5|29.5|Standard Deviation|6.3|6.3|||
3670781|NCT02334787|3515054|B3|||Age||years|Mean|30.5|30.5|Standard Deviation|6.7|6.7|||
3670782|NCT02334787|3515055|B2|||Age||years|Mean|28.3|28.3|Standard Deviation|7.6|7.6|||
3670783|NCT02334787|3515056|B1|||Age||years|Mean|31.9|31.9|Standard Deviation|7.2|7.2|||
3670784|NCT02334787|3515052|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3670785|NCT02334787|3515053|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3670786|NCT02334787|3515054|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3670787|NCT02334787|3515055|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3670788|NCT02334787|3515056|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3670789|NCT02334787|3515052|B5||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3670790|NCT02334787|3515053|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3670791|NCT02334787|3515054|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3670792|NCT02334787|3515055|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3670793|NCT02334787|3515056|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3670794|NCT02334787|3515052|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3670795|NCT02334787|3515053|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3670796|NCT02334787|3515054|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3670797|NCT02334787|3515055|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3670798|NCT02334787|3515056|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3670799|NCT02334527|3515081|B1||>=12 months|Time from prior therapy||Participants|Count of Participants|2|2.0||||||
3670800|NCT02334527|3515081|B1||6-9 months|Time from prior therapy||Participants|Count of Participants|1|1.0||||||
3670801|NCT02334527|3515081|B1||3-6 months|Time from prior therapy||Participants|Count of Participants|5|5.0||||||
3670802|NCT02334527|3515081|B1||< 3 months|Time from prior therapy||Participants|Count of Participants|4|4.0||||||
3670803|NCT02334527|3515081|B1||No|Liver Metastases||Participants|Count of Participants|12|12.0||||||
3670804|NCT02334527|3515081|B1||Yes|Liver Metastases||Participants|Count of Participants|0|0.0||||||
3670805|NCT02334527|3515081|B1||>= 10 g/dL|Hemoglobin||Participants|Count of Participants|10|10.0||||||
3670806|NCT02334527|3515081|B1||<10 g/dL|Hemoglobin||Participants|Count of Participants|2|2.0||||||
3670807|NCT02334527|3515081|B1||2|Eastern Cooperative Oncology Group (ECOG) Performance Status|"Measure Description: A scale from 0-5 to describe a patient's level of functioning in terms of selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|Participants|Count of Participants|1|1.0||||||
3670808|NCT02334527|3515081|B1||1|Eastern Cooperative Oncology Group (ECOG) Performance Status|"Measure Description: A scale from 0-5 to describe a patient's level of functioning in terms of selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|Participants|Count of Participants|6|6.0||||||
3670809|NCT02334527|3515081|B1||0|Eastern Cooperative Oncology Group (ECOG) Performance Status|"Measure Description: A scale from 0-5 to describe a patient's level of functioning in terms of selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|Participants|Count of Participants|5|5.0||||||
3670810|NCT02334527|3515081|B1||Both|Setting of prior platinum-based chemotherapy||Participants|Count of Participants|2|2.0||||||
3670811|NCT02334527|3515081|B1||Metastatic only|Setting of prior platinum-based chemotherapy||Participants|Count of Participants|2|2.0||||||
3670812|NCT02334527|3515081|B1||Perioperative only|Setting of prior platinum-based chemotherapy||Participants|Count of Participants|8|8.0||||||
3670813|NCT02334527|3515081|B1||3|Number of prior systemic therapy regiments (including immunotherapy)||Participants|Count of Participants|2|2.0||||||
3670814|NCT02334527|3515081|B1||2|Number of prior systemic therapy regiments (including immunotherapy)||Participants|Count of Participants|3|3.0||||||
3670815|NCT02334527|3515081|B1||1|Number of prior systemic therapy regiments (including immunotherapy)||Participants|Count of Participants|7|7.0||||||
3670816|NCT02334527|3515081|B1||Urethra|Primary Tumor Site||Participants|Count of Participants|1|1.0||||||
3670817|NCT02334527|3515081|B1||Upper Tract|Primary Tumor Site||Participants|Count of Participants|4|4.0||||||
3670818|NCT02334527|3515081|B1||Bladder|Primary Tumor Site||Participants|Count of Participants|7|7.0||||||
3670819|NCT02334527|3515081|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3670820|NCT02334527|3515081|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670821|NCT02334527|3515081|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670822|NCT02334527|3515081|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3670823|NCT02334527|3515081|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3670824|NCT02334527|3515081|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670825|NCT02334527|3515081|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670826|NCT02334527|3515081|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670827|NCT02334527|3515081|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670828|NCT02334527|3515081|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3670829|NCT02334527|3515081|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3670830|NCT02334527|3515081|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3670831|NCT02334527|3515081|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3670832|NCT02334527|3515081|B1|||Age||years|Median|68|68.0|Full Range|||51.0|86.0|
3670833|NCT02334384|3515090|B3|||Diameter of induration||mm|Mean|30.8|30.8|Full Range|||25.0|40.0|
3670834|NCT02334384|3515091|B2|||Diameter of induration||mm|Mean|27.5|27.5|Full Range|||25.0|30.0|
3670835|NCT02334384|3515092|B1|||Diameter of induration||mm|Mean|32.5|32.5|Full Range|||25.0|40.0|
3670836|NCT02334384|3515090|B3|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3670837|NCT02334384|3515091|B2|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3670838|NCT02334384|3515092|B1|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3670839|NCT02334384|3515090|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3670840|NCT02334384|3515090|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3670841|NCT02334384|3515091|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3670842|NCT02334384|3515092|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3670843|NCT02334384|3515090|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3670844|NCT02334384|3515091|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3670845|NCT02334384|3515092|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3670846|NCT02334384|3515090|B3|||Age||years|Median|33|33.0|Standard Deviation|12|12.0|||
3670847|NCT02334384|3515091|B2|||Age||years|Median|33|33.0|Standard Deviation|12|12.0|||
3670848|NCT02334384|3515092|B1|||Age||years|Median|33|33.0|Standard Deviation|12|12.0|||
3670849|NCT02334384|3515090|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3670850|NCT02334384|3515091|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3670851|NCT02334384|3515092|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3670852|NCT02334384|3515090|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3670853|NCT02334384|3515091|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3670854|NCT02334384|3515092|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3670855|NCT02334384|3515090|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3670856|NCT02334384|3515091|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3670857|NCT02334384|3515092|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3670858|NCT02334267|3515099|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3670859|NCT02334267|3515100|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3670860|NCT02334267|3515101|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3670861|NCT02334267|3515099|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3670862|NCT02334267|3515100|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3670863|NCT02334267|3515101|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3670864|NCT02334267|3515099|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3670865|NCT02334267|3515100|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3670866|NCT02334267|3515101|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3670867|NCT02334267|3515099|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3670868|NCT02334267|3515100|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3670869|NCT02334267|3515101|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3670870|NCT02334267|3515099|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3670871|NCT02334267|3515100|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3670872|NCT02334267|3515101|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3670873|NCT02334267|3515099|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3670874|NCT02334267|3515100|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3670875|NCT02334267|3515101|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3670876|NCT02333045|3515114|B3|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3670877|NCT02333045|3515115|B2|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3670878|NCT02333045|3515116|B1|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3670879|NCT02333045|3515114|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670880|NCT02333045|3515115|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670881|NCT02333045|3515116|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671198|NCT02332720|3515272|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3670882|NCT02333045|3515114|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670883|NCT02333045|3515115|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670884|NCT02333045|3515116|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670885|NCT02333045|3515114|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3670886|NCT02333045|3515115|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670887|NCT02333045|3515116|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3670888|NCT02333045|3515114|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3670889|NCT02333045|3515115|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3670890|NCT02333045|3515116|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670891|NCT02333045|3515114|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670892|NCT02333045|3515115|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670893|NCT02333045|3515116|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670894|NCT02333045|3515114|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670895|NCT02333045|3515115|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670896|NCT02333045|3515116|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670897|NCT02333045|3515114|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670898|NCT02333045|3515115|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670899|NCT02333045|3515116|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670900|NCT02333045|3515114|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670901|NCT02333045|3515115|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670902|NCT02333045|3515116|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670903|NCT02333045|3515114|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3670904|NCT02333045|3515115|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3670905|NCT02333045|3515116|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3670906|NCT02333045|3515114|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670907|NCT02333045|3515115|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670908|NCT02333045|3515116|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670909|NCT02333045|3515114|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3670910|NCT02333045|3515115|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3670911|NCT02333045|3515116|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3670912|NCT02333045|3515114|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3670913|NCT02333045|3515115|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3670914|NCT02333045|3515116|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3670915|NCT02333045|3515114|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3670916|NCT02333045|3515115|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3670917|NCT02333045|3515116|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3670918|NCT02333045|3515114|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3670919|NCT02333045|3515115|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3670920|NCT02333045|3515116|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3670921|NCT02333045|3515114|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3670922|NCT02333045|3515115|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3670923|NCT02333045|3515116|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3670924|NCT02332902|3515127|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3670925|NCT02332902|3515127|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3670926|NCT02332902|3515127|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3670927|NCT02332902|3515127|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3670928|NCT02332902|3515127|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3670929|NCT02332902|3515127|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3670930|NCT02332889|3515132|B1|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3670931|NCT02332889|3515132|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3670932|NCT02332889|3515132|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3670933|NCT02332889|3515132|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3670934|NCT02332889|3515132|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3670935|NCT02332889|3515132|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3670936|NCT02332876|3515136|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670937|NCT02332876|3515137|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670938|NCT02332876|3515138|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670939|NCT02332876|3515136|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3670940|NCT02332876|3515137|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3670941|NCT02332876|3515138|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3670942|NCT02332876|3515136|B3||White|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3670943|NCT02332876|3515137|B2||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3670944|NCT02332876|3515138|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3670945|NCT02332876|3515136|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3670946|NCT02332876|3515137|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3670947|NCT02332876|3515138|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3670948|NCT02332876|3515136|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3670949|NCT02332876|3515137|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3670950|NCT02332876|3515138|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670951|NCT02332876|3515136|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3670952|NCT02332876|3515137|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3670953|NCT02332876|3515138|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3670954|NCT02332876|3515136|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670955|NCT02332876|3515137|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670956|NCT02332876|3515138|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670957|NCT02332876|3515136|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670958|NCT02332876|3515137|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670959|NCT02332876|3515138|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3670960|NCT02332876|3515136|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3670961|NCT02332876|3515137|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3670962|NCT02332876|3515138|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3670963|NCT02332876|3515136|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3670964|NCT02332876|3515137|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3670965|NCT02332876|3515138|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3670966|NCT02332876|3515136|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3670967|NCT02332876|3515137|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3670968|NCT02332876|3515138|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3670969|NCT02332876|3515136|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3670970|NCT02332876|3515137|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3670971|NCT02332876|3515138|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3670972|NCT02332876|3515136|B3|||Age||years|Mean|57.2|57.2|Standard Deviation|10.36|10.36|||
3670973|NCT02332876|3515137|B2|||Age||years|Mean|56.2|56.2|Standard Deviation|9.30|9.3|||
3670974|NCT02332876|3515138|B1|||Age||years|Mean|58.2|58.2|Standard Deviation|11.37|11.37|||
3670975|NCT02332824|3515145|B7|||Trough Sitting Systolic Blood Pressure||mmHg|Mean|139.7|139.7|Standard Deviation|7.63|7.63|||
3670976|NCT02332824|3515146|B6|||Trough Sitting Systolic Blood Pressure||mmHg|Mean|140.6|140.6|Standard Deviation|7.65|7.65|||
3670977|NCT02332824|3515147|B5|||Trough Sitting Systolic Blood Pressure||mmHg|Mean|140.3|140.3|Standard Deviation|7.77|7.77|||
3670978|NCT02332824|3515148|B4|||Trough Sitting Systolic Blood Pressure||mmHg|Mean|139.0|139.0|Standard Deviation|7.64|7.64|||
3670979|NCT02332824|3515149|B3|||Trough Sitting Systolic Blood Pressure||mmHg|Mean|138.2|138.2|Standard Deviation|7.09|7.09|||
3670980|NCT02332824|3515150|B2|||Trough Sitting Systolic Blood Pressure||mmHg|Mean|139.0|139.0|Standard Deviation|8.41|8.41|||
3670981|NCT02332824|3515151|B1|||Trough Sitting Systolic Blood Pressure||mmHg|Mean|141.1|141.1|Standard Deviation|7.01|7.01|||
3670982|NCT02332824|3515145|B7|||Trough Sitting Diastolic Blood Pressure||mmHg|Mean|80.6|80.6|Standard Deviation|9.00|9.0|||
3670983|NCT02332824|3515146|B6|||Trough Sitting Diastolic Blood Pressure||mmHg|Mean|80.5|80.5|Standard Deviation|8.89|8.89|||
3670984|NCT02332824|3515147|B5|||Trough Sitting Diastolic Blood Pressure||mmHg|Mean|81.9|81.9|Standard Deviation|8.90|8.9|||
3670985|NCT02332824|3515148|B4|||Trough Sitting Diastolic Blood Pressure||mmHg|Mean|79.3|79.3|Standard Deviation|9.26|9.26|||
3670986|NCT02332824|3515149|B3|||Trough Sitting Diastolic Blood Pressure||mmHg|Mean|80.6|80.6|Standard Deviation|8.99|8.99|||
3670987|NCT02332824|3515150|B2|||Trough Sitting Diastolic Blood Pressure||mmHg|Mean|80.6|80.6|Standard Deviation|8.80|8.8|||
3670988|NCT02332824|3515151|B1|||Trough Sitting Diastolic Blood Pressure||mmHg|Mean|80.6|80.6|Standard Deviation|9.29|9.29|||
3670989|NCT02332824|3515145|B7|||Haemoglobin A1c (HbA1c)||percentage of glycated haemoglobin|Mean|7.01|7.01|Standard Deviation|0.778|0.778|||
3670990|NCT02332824|3515146|B6|||Haemoglobin A1c (HbA1c)||percentage of glycated haemoglobin|Mean|7.02|7.02|Standard Deviation|0.731|0.731|||
3670991|NCT02332824|3515147|B5|||Haemoglobin A1c (HbA1c)||percentage of glycated haemoglobin|Mean|6.90|6.9|Standard Deviation|0.834|0.834|||
3670992|NCT02332824|3515148|B4|||Haemoglobin A1c (HbA1c)||percentage of glycated haemoglobin|Mean|7.03|7.03|Standard Deviation|0.789|0.789|||
3670993|NCT02332824|3515149|B3|||Haemoglobin A1c (HbA1c)||percentage of glycated haemoglobin|Mean|7.06|7.06|Standard Deviation|0.770|0.77|||
3670994|NCT02332824|3515150|B2|||Haemoglobin A1c (HbA1c)||percentage of glycated haemoglobin|Mean|7.03|7.03|Standard Deviation|0.772|0.772|||
3670995|NCT02332824|3515151|B1|||Haemoglobin A1c (HbA1c)||percentage of glycated haemoglobin|Mean|7.02|7.02|Standard Deviation|0.789|0.789|||
3670996|NCT02332824|3515145|B7|||eGFRcreat|Male: eGFRcreat (mL/min/1.73 m^2)=194×Cr (mg/dL)^(-1.094)×age (years)^(-0.287) Female: eGFRcreat (mL/min/1.73 m^2)=194×Cr (mg/dL)^(-1.094)×age (years)^(-0.287)×0.739 Cr: serum creatinine|mL/min/1.73m^2|Mean|79.97|79.97|Standard Deviation|19.980|19.98|||
3670997|NCT02332824|3515146|B6|||eGFRcreat|Male: eGFRcreat (mL/min/1.73 m^2)=194×Cr (mg/dL)^(-1.094)×age (years)^(-0.287) Female: eGFRcreat (mL/min/1.73 m^2)=194×Cr (mg/dL)^(-1.094)×age (years)^(-0.287)×0.739 Cr: serum creatinine|mL/min/1.73m^2|Mean|83.27|83.27|Standard Deviation|22.777|22.777|||
3670998|NCT02332824|3515147|B5|||eGFRcreat|Male: eGFRcreat (mL/min/1.73 m^2)=194×Cr (mg/dL)^(-1.094)×age (years)^(-0.287) Female: eGFRcreat (mL/min/1.73 m^2)=194×Cr (mg/dL)^(-1.094)×age (years)^(-0.287)×0.739 Cr: serum creatinine|mL/min/1.73m^2|Mean|77.81|77.81|Standard Deviation|18.425|18.425|||
3670999|NCT02332824|3515148|B4|||eGFRcreat|Male: eGFRcreat (mL/min/1.73 m^2)=194×Cr (mg/dL)^(-1.094)×age (years)^(-0.287) Female: eGFRcreat (mL/min/1.73 m^2)=194×Cr (mg/dL)^(-1.094)×age (years)^(-0.287)×0.739 Cr: serum creatinine|mL/min/1.73m^2|Mean|80.51|80.51|Standard Deviation|20.292|20.292|||
3671000|NCT02332824|3515149|B3|||eGFRcreat|Male: eGFRcreat (mL/min/1.73 m^2)=194×Cr (mg/dL)^(-1.094)×age (years)^(-0.287) Female: eGFRcreat (mL/min/1.73 m^2)=194×Cr (mg/dL)^(-1.094)×age (years)^(-0.287)×0.739 Cr: serum creatinine|mL/min/1.73m^2|Mean|79.19|79.19|Standard Deviation|19.449|19.449|||
3671001|NCT02332824|3515150|B2|||eGFRcreat|Male: eGFRcreat (mL/min/1.73 m^2)=194×Cr (mg/dL)^(-1.094)×age (years)^(-0.287) Female: eGFRcreat (mL/min/1.73 m^2)=194×Cr (mg/dL)^(-1.094)×age (years)^(-0.287)×0.739 Cr: serum creatinine|mL/min/1.73m^2|Mean|81.81|81.81|Standard Deviation|19.788|19.788|||
3671002|NCT02332824|3515151|B1|||eGFRcreat|Male: eGFRcreat (mL/min/1.73 m^2)=194×Cr (mg/dL)^(-1.094)×age (years)^(-0.287) Female: eGFRcreat (mL/min/1.73 m^2)=194×Cr (mg/dL)^(-1.094)×age (years)^(-0.287)×0.739 Cr: serum creatinine|mL/min/1.73m^2|Mean|77.17|77.17|Standard Deviation|18.828|18.828|||
3671003|NCT02332824|3515145|B7|||Urine albumin/Creatinine ratio||mg/gCR|Median|100.26|100.26|Inter-Quartile Range|||55.9|179.37|
3671004|NCT02332824|3515146|B6|||Urine albumin/Creatinine ratio||mg/gCR|Median|96.33|96.33|Inter-Quartile Range|||57.48|179.26|
3671005|NCT02332824|3515147|B5|||Urine albumin/Creatinine ratio||mg/gCR|Median|86.87|86.87|Inter-Quartile Range|||53.53|153.05|
3671006|NCT02332824|3515148|B4|||Urine albumin/Creatinine ratio||mg/gCR|Median|116.43|116.43|Inter-Quartile Range|||49.92|201.16|
3671007|NCT02332824|3515149|B3|||Urine albumin/Creatinine ratio||mg/gCR|Median|96.03|96.03|Inter-Quartile Range|||58.59|174.45|
3671008|NCT02332824|3515150|B2|||Urine albumin/Creatinine ratio||mg/gCR|Median|93.45|93.45|Inter-Quartile Range|||53.92|139.41|
3671009|NCT02332824|3515151|B1|||Urine albumin/Creatinine ratio||mg/gCR|Median|119.95|119.95|Inter-Quartile Range|||65.61|214.88|
3671010|NCT02332824|3515145|B7|HMG-CoA Reductase Inhibitor - No||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|221|221.0||||||
3671011|NCT02332824|3515146|B6|HMG-CoA Reductase Inhibitor - No||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|43|43.0||||||
3671012|NCT02332824|3515147|B5|HMG-CoA Reductase Inhibitor - No||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|25|25.0||||||
3671013|NCT02332824|3515148|B4|HMG-CoA Reductase Inhibitor - No||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|37|37.0||||||
3671014|NCT02332824|3515149|B3|HMG-CoA Reductase Inhibitor - No||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|39|39.0||||||
3671015|NCT02332824|3515150|B2|HMG-CoA Reductase Inhibitor - No||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|40|40.0||||||
3671016|NCT02332824|3515151|B1|HMG-CoA Reductase Inhibitor - No||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|37|37.0||||||
3671017|NCT02332824|3515145|B7|HMG-CoA Reductase Inhibitor - Yes||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|194|194.0||||||
3671018|NCT02332824|3515146|B6|HMG-CoA Reductase Inhibitor - Yes||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|27|27.0||||||
3671019|NCT02332824|3515147|B5|HMG-CoA Reductase Inhibitor - Yes||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|44|44.0||||||
3671020|NCT02332824|3515148|B4|HMG-CoA Reductase Inhibitor - Yes||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|31|31.0||||||
3671021|NCT02332824|3515149|B3|HMG-CoA Reductase Inhibitor - Yes||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|35|35.0||||||
3671022|NCT02332824|3515150|B2|HMG-CoA Reductase Inhibitor - Yes||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|27|27.0||||||
3671023|NCT02332824|3515151|B1|HMG-CoA Reductase Inhibitor - Yes||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|30|30.0||||||
3671024|NCT02332824|3515145|B7|Anti-Diabetic Drug - No||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|25|25.0||||||
3671025|NCT02332824|3515146|B6|Anti-Diabetic Drug - No||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|4|4.0||||||
3671135|NCT02332824|3515151|B1|||Body Mass Index (BMI)|Body Mass Index = weight (kg)/[height (m)^2].|kg/m^2|Mean|25.93|25.93|Standard Deviation|4.024|4.024|||
3671026|NCT02332824|3515147|B5|Anti-Diabetic Drug - No||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|4|4.0||||||
3671027|NCT02332824|3515148|B4|Anti-Diabetic Drug - No||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|3|3.0||||||
3671028|NCT02332824|3515149|B3|Anti-Diabetic Drug - No||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|8|8.0||||||
3671029|NCT02332824|3515150|B2|Anti-Diabetic Drug - No||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|3|3.0||||||
3671030|NCT02332824|3515151|B1|Anti-Diabetic Drug - No||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|3|3.0||||||
3671031|NCT02332824|3515145|B7|Anti-Diabetic Drug - Yes||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|390|390.0||||||
3671032|NCT02332824|3515146|B6|Anti-Diabetic Drug - Yes||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|66|66.0||||||
3671033|NCT02332824|3515147|B5|Anti-Diabetic Drug - Yes||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|65|65.0||||||
3671034|NCT02332824|3515148|B4|Anti-Diabetic Drug - Yes||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|65|65.0||||||
3671035|NCT02332824|3515149|B3|Anti-Diabetic Drug - Yes||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|66|66.0||||||
3671036|NCT02332824|3515150|B2|Anti-Diabetic Drug - Yes||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|64|64.0||||||
3671037|NCT02332824|3515151|B1|Anti-Diabetic Drug - Yes||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|64|64.0||||||
3671038|NCT02332824|3515145|B7|Anti-Hypertension Drug - No||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|173|173.0||||||
3671039|NCT02332824|3515146|B6|Anti-Hypertension Drug - No||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|25|25.0||||||
3671040|NCT02332824|3515147|B5|Anti-Hypertension Drug - No||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|25|25.0||||||
3671041|NCT02332824|3515148|B4|Anti-Hypertension Drug - No||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|35|35.0||||||
3671042|NCT02332824|3515149|B3|Anti-Hypertension Drug - No||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|28|28.0||||||
3671043|NCT02332824|3515150|B2|Anti-Hypertension Drug - No||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|33|33.0||||||
3671044|NCT02332824|3515151|B1|Anti-Hypertension Drug - No||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|27|27.0||||||
3671045|NCT02332824|3515145|B7|Anti-Hypertension Drug - Yes||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|242|242.0||||||
3671046|NCT02332824|3515146|B6|Anti-Hypertension Drug - Yes||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|45|45.0||||||
3671047|NCT02332824|3515147|B5|Anti-Hypertension Drug - Yes||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|44|44.0||||||
3671048|NCT02332824|3515148|B4|Anti-Hypertension Drug - Yes||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|33|33.0||||||
3671049|NCT02332824|3515149|B3|Anti-Hypertension Drug - Yes||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|46|46.0||||||
3671050|NCT02332824|3515150|B2|Anti-Hypertension Drug - Yes||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|34|34.0||||||
3671051|NCT02332824|3515151|B1|Anti-Hypertension Drug - Yes||Restricted Medication|HMG-COA = 3-hydroxy-3-methylglutaryl Coenzyme A. Participants may also be counted in more than 1 category.|Participants|Count of Participants|40|40.0||||||
3671052|NCT02332824|3515145|B7|Potassium-Sparing Diuretic - No||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|412|412.0||||||
3671053|NCT02332824|3515146|B6|Potassium-Sparing Diuretic - No||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|69|69.0||||||
3671054|NCT02332824|3515147|B5|Potassium-Sparing Diuretic - No||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|69|69.0||||||
3671055|NCT02332824|3515148|B4|Potassium-Sparing Diuretic - No||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|67|67.0||||||
3671056|NCT02332824|3515149|B3|Potassium-Sparing Diuretic - No||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|74|74.0||||||
3671136|NCT02332824|3515145|B7|Japan||Region of Enrollment|All participants were enrolled in Japan.|participants|Number|415|415.0||||||
3671057|NCT02332824|3515150|B2|Potassium-Sparing Diuretic - No||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|66|66.0||||||
3671058|NCT02332824|3515151|B1|Potassium-Sparing Diuretic - No||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|67|67.0||||||
3671059|NCT02332824|3515145|B7|Potassium-Sparing Diuretic - Yes||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|3|3.0||||||
3671060|NCT02332824|3515146|B6|Potassium-Sparing Diuretic - Yes||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|1|1.0||||||
3671061|NCT02332824|3515147|B5|Potassium-Sparing Diuretic - Yes||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|0|0.0||||||
3671062|NCT02332824|3515148|B4|Potassium-Sparing Diuretic - Yes||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|1|1.0||||||
3671063|NCT02332824|3515149|B3|Potassium-Sparing Diuretic - Yes||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|0|0.0||||||
3671064|NCT02332824|3515150|B2|Potassium-Sparing Diuretic - Yes||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|1|1.0||||||
3671065|NCT02332824|3515151|B1|Potassium-Sparing Diuretic - Yes||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|0|0.0||||||
3671066|NCT02332824|3515145|B7|SGLT2 Inhibitor - No||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|406|406.0||||||
3671067|NCT02332824|3515146|B6|SGLT2 Inhibitor - No||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|70|70.0||||||
3671068|NCT02332824|3515147|B5|SGLT2 Inhibitor - No||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|67|67.0||||||
3671069|NCT02332824|3515148|B4|SGLT2 Inhibitor - No||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|67|67.0||||||
3671070|NCT02332824|3515149|B3|SGLT2 Inhibitor - No||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|71|71.0||||||
3671071|NCT02332824|3515150|B2|SGLT2 Inhibitor - No||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|65|65.0||||||
3671072|NCT02332824|3515151|B1|SGLT2 Inhibitor - No||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|66|66.0||||||
3671073|NCT02332824|3515145|B7|Sodium Glucose Co-transporter (SGLT2)Inhibitor-Yes||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|9|9.0||||||
3671074|NCT02332824|3515146|B6|Sodium Glucose Co-transporter (SGLT2)Inhibitor-Yes||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|0|0.0||||||
3671075|NCT02332824|3515147|B5|Sodium Glucose Co-transporter (SGLT2)Inhibitor-Yes||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|2|2.0||||||
3671076|NCT02332824|3515148|B4|Sodium Glucose Co-transporter (SGLT2)Inhibitor-Yes||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|1|1.0||||||
3671077|NCT02332824|3515149|B3|Sodium Glucose Co-transporter (SGLT2)Inhibitor-Yes||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|3|3.0||||||
3671078|NCT02332824|3515150|B2|Sodium Glucose Co-transporter (SGLT2)Inhibitor-Yes||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|2|2.0||||||
3671079|NCT02332824|3515151|B1|Sodium Glucose Co-transporter (SGLT2)Inhibitor-Yes||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|1|1.0||||||
3671080|NCT02332824|3515145|B7|RAS Inhibitor - No||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|225|225.0||||||
3671081|NCT02332824|3515146|B6|RAS Inhibitor - No||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|35|35.0||||||
3671082|NCT02332824|3515147|B5|RAS Inhibitor - No||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|33|33.0||||||
3671083|NCT02332824|3515148|B4|RAS Inhibitor - No||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|43|43.0||||||
3671084|NCT02332824|3515149|B3|RAS Inhibitor - No||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|41|41.0||||||
3671085|NCT02332824|3515150|B2|RAS Inhibitor - No||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|36|36.0||||||
3671086|NCT02332824|3515151|B1|RAS Inhibitor - No||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|37|37.0||||||
3671087|NCT02332824|3515145|B7|Renin-angiotensin system (RAS) Inhibitor - Yes||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|190|190.0||||||
3671088|NCT02332824|3515146|B6|Renin-angiotensin system (RAS) Inhibitor - Yes||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|35|35.0||||||
3671089|NCT02332824|3515147|B5|Renin-angiotensin system (RAS) Inhibitor - Yes||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|36|36.0||||||
3671090|NCT02332824|3515148|B4|Renin-angiotensin system (RAS) Inhibitor - Yes||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|25|25.0||||||
3671091|NCT02332824|3515149|B3|Renin-angiotensin system (RAS) Inhibitor - Yes||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|33|33.0||||||
3671092|NCT02332824|3515150|B2|Renin-angiotensin system (RAS) Inhibitor - Yes||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|31|31.0||||||
3671093|NCT02332824|3515151|B1|Renin-angiotensin system (RAS) Inhibitor - Yes||Previous Medication|Participants may also be counted in more than 1 category.|Participants|Count of Participants|30|30.0||||||
3671094|NCT02332824|3515145|B7|Dyslipidemia - No||Concurrent Medical Condition|Participants may also be counted in more than 1 category.|Participants|Count of Participants|118|118.0||||||
3671095|NCT02332824|3515146|B6|Dyslipidemia - No||Concurrent Medical Condition|Participants may also be counted in more than 1 category.|Participants|Count of Participants|24|24.0||||||
3671096|NCT02332824|3515147|B5|Dyslipidemia - No||Concurrent Medical Condition|Participants may also be counted in more than 1 category.|Participants|Count of Participants|13|13.0||||||
3671097|NCT02332824|3515148|B4|Dyslipidemia - No||Concurrent Medical Condition|Participants may also be counted in more than 1 category.|Participants|Count of Participants|17|17.0||||||
3671098|NCT02332824|3515149|B3|Dyslipidemia - No||Concurrent Medical Condition|Participants may also be counted in more than 1 category.|Participants|Count of Participants|16|16.0||||||
3671099|NCT02332824|3515150|B2|Dyslipidemia - No||Concurrent Medical Condition|Participants may also be counted in more than 1 category.|Participants|Count of Participants|26|26.0||||||
3671100|NCT02332824|3515151|B1|Dyslipidemia - No||Concurrent Medical Condition|Participants may also be counted in more than 1 category.|Participants|Count of Participants|22|22.0||||||
3671101|NCT02332824|3515145|B7|Dyslipidemia - Yes||Concurrent Medical Condition|Participants may also be counted in more than 1 category.|Participants|Count of Participants|297|297.0||||||
3671102|NCT02332824|3515146|B6|Dyslipidemia - Yes||Concurrent Medical Condition|Participants may also be counted in more than 1 category.|Participants|Count of Participants|46|46.0||||||
3671103|NCT02332824|3515147|B5|Dyslipidemia - Yes||Concurrent Medical Condition|Participants may also be counted in more than 1 category.|Participants|Count of Participants|56|56.0||||||
3671104|NCT02332824|3515148|B4|Dyslipidemia - Yes||Concurrent Medical Condition|Participants may also be counted in more than 1 category.|Participants|Count of Participants|51|51.0||||||
3671105|NCT02332824|3515149|B3|Dyslipidemia - Yes||Concurrent Medical Condition|Participants may also be counted in more than 1 category.|Participants|Count of Participants|58|58.0||||||
3671106|NCT02332824|3515150|B2|Dyslipidemia - Yes||Concurrent Medical Condition|Participants may also be counted in more than 1 category.|Participants|Count of Participants|41|41.0||||||
3671107|NCT02332824|3515151|B1|Dyslipidemia - Yes||Concurrent Medical Condition|Participants may also be counted in more than 1 category.|Participants|Count of Participants|45|45.0||||||
3671108|NCT02332824|3515145|B7|Hypertension - No||Concurrent Medical Condition|Participants may also be counted in more than 1 category.|Participants|Count of Participants|99|99.0||||||
3671109|NCT02332824|3515146|B6|Hypertension - No||Concurrent Medical Condition|Participants may also be counted in more than 1 category.|Participants|Count of Participants|18|18.0||||||
3671110|NCT02332824|3515147|B5|Hypertension - No||Concurrent Medical Condition|Participants may also be counted in more than 1 category.|Participants|Count of Participants|9|9.0||||||
3671111|NCT02332824|3515148|B4|Hypertension - No||Concurrent Medical Condition|Participants may also be counted in more than 1 category.|Participants|Count of Participants|20|20.0||||||
3671112|NCT02332824|3515149|B3|Hypertension - No||Concurrent Medical Condition|Participants may also be counted in more than 1 category.|Participants|Count of Participants|14|14.0||||||
3671113|NCT02332824|3515150|B2|Hypertension - No||Concurrent Medical Condition|Participants may also be counted in more than 1 category.|Participants|Count of Participants|21|21.0||||||
3671114|NCT02332824|3515151|B1|Hypertension - No||Concurrent Medical Condition|Participants may also be counted in more than 1 category.|Participants|Count of Participants|17|17.0||||||
3671115|NCT02332824|3515145|B7|Hypertension - Yes||Concurrent Medical Condition|Participants may also be counted in more than 1 category.|Participants|Count of Participants|316|316.0||||||
3671116|NCT02332824|3515146|B6|Hypertension - Yes||Concurrent Medical Condition|Participants may also be counted in more than 1 category.|Participants|Count of Participants|52|52.0||||||
3671117|NCT02332824|3515147|B5|Hypertension - Yes||Concurrent Medical Condition|Participants may also be counted in more than 1 category.|Participants|Count of Participants|60|60.0||||||
3671118|NCT02332824|3515148|B4|Hypertension - Yes||Concurrent Medical Condition|Participants may also be counted in more than 1 category.|Participants|Count of Participants|48|48.0||||||
3671119|NCT02332824|3515149|B3|Hypertension - Yes||Concurrent Medical Condition|Participants may also be counted in more than 1 category.|Participants|Count of Participants|60|60.0||||||
3671120|NCT02332824|3515150|B2|Hypertension - Yes||Concurrent Medical Condition|Participants may also be counted in more than 1 category.|Participants|Count of Participants|46|46.0||||||
3671121|NCT02332824|3515151|B1|Hypertension - Yes||Concurrent Medical Condition|Participants may also be counted in more than 1 category.|Participants|Count of Participants|50|50.0||||||
3671122|NCT02332824|3515145|B7|||Duration of Type 2 Diabetes Mellitus||years|Mean|11.19|11.19|Standard Deviation|7.450|7.45|||
3671123|NCT02332824|3515146|B6|||Duration of Type 2 Diabetes Mellitus||years|Mean|10.38|10.38|Standard Deviation|7.046|7.046|||
3671124|NCT02332824|3515147|B5|||Duration of Type 2 Diabetes Mellitus||years|Mean|10.88|10.88|Standard Deviation|7.363|7.363|||
3671125|NCT02332824|3515148|B4|||Duration of Type 2 Diabetes Mellitus||years|Mean|11.19|11.19|Standard Deviation|7.151|7.151|||
3671126|NCT02332824|3515149|B3|||Duration of Type 2 Diabetes Mellitus||years|Mean|11.06|11.06|Standard Deviation|7.708|7.708|||
3671127|NCT02332824|3515150|B2|||Duration of Type 2 Diabetes Mellitus||years|Mean|11.48|11.48|Standard Deviation|7.355|7.355|||
3671128|NCT02332824|3515151|B1|||Duration of Type 2 Diabetes Mellitus||years|Mean|12.24|12.24|Standard Deviation|8.164|8.164|||
3671129|NCT02332824|3515145|B7|||Body Mass Index (BMI)|Body Mass Index = weight (kg)/[height (m)^2].|kg/m^2|Mean|26.45|26.45|Standard Deviation|4.518|4.518|||
3671130|NCT02332824|3515146|B6|||Body Mass Index (BMI)|Body Mass Index = weight (kg)/[height (m)^2].|kg/m^2|Mean|26.60|26.6|Standard Deviation|5.483|5.483|||
3671131|NCT02332824|3515147|B5|||Body Mass Index (BMI)|Body Mass Index = weight (kg)/[height (m)^2].|kg/m^2|Mean|26.41|26.41|Standard Deviation|3.543|3.543|||
3671132|NCT02332824|3515148|B4|||Body Mass Index (BMI)|Body Mass Index = weight (kg)/[height (m)^2].|kg/m^2|Mean|26.39|26.39|Standard Deviation|4.580|4.58|||
3671133|NCT02332824|3515149|B3|||Body Mass Index (BMI)|Body Mass Index = weight (kg)/[height (m)^2].|kg/m^2|Mean|26.91|26.91|Standard Deviation|5.035|5.035|||
3671134|NCT02332824|3515150|B2|||Body Mass Index (BMI)|Body Mass Index = weight (kg)/[height (m)^2].|kg/m^2|Mean|26.41|26.41|Standard Deviation|4.208|4.208|||
3671137|NCT02332824|3515146|B6|Japan||Region of Enrollment|All participants were enrolled in Japan.|participants|Number|70|70.0||||||
3671138|NCT02332824|3515147|B5|Japan||Region of Enrollment|All participants were enrolled in Japan.|participants|Number|69|69.0||||||
3671139|NCT02332824|3515148|B4|Japan||Region of Enrollment|All participants were enrolled in Japan.|participants|Number|68|68.0||||||
3671140|NCT02332824|3515149|B3|Japan||Region of Enrollment|All participants were enrolled in Japan.|participants|Number|74|74.0||||||
3671141|NCT02332824|3515150|B2|Japan||Region of Enrollment|All participants were enrolled in Japan.|participants|Number|67|67.0||||||
3671142|NCT02332824|3515151|B1|Japan||Region of Enrollment|All participants were enrolled in Japan.|participants|Number|67|67.0||||||
3671143|NCT02332824|3515145|B7||Male|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
3671144|NCT02332824|3515146|B6||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3671145|NCT02332824|3515147|B5||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3671146|NCT02332824|3515148|B4||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3671147|NCT02332824|3515149|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3671148|NCT02332824|3515150|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3671149|NCT02332824|3515151|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3671150|NCT02332824|3515145|B7||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3671151|NCT02332824|3515146|B6||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3671152|NCT02332824|3515147|B5||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3671153|NCT02332824|3515148|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3671154|NCT02332824|3515149|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3671155|NCT02332824|3515150|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3671156|NCT02332824|3515151|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3671157|NCT02332824|3515145|B7|||Age||years|Mean|61.3|61.3|Standard Deviation|9.40|9.4|||
3671158|NCT02332824|3515146|B6|||Age||years|Mean|62.4|62.4|Standard Deviation|9.29|9.29|||
3671159|NCT02332824|3515147|B5|||Age||years|Mean|61.2|61.2|Standard Deviation|9.95|9.95|||
3671160|NCT02332824|3515148|B4|||Age||years|Mean|59.6|59.6|Standard Deviation|10.22|10.22|||
3671161|NCT02332824|3515149|B3|||Age||years|Mean|60.9|60.9|Standard Deviation|9.57|9.57|||
3671162|NCT02332824|3515150|B2|||Age||years|Mean|61.8|61.8|Standard Deviation|8.90|8.9|||
3671163|NCT02332824|3515151|B1|||Age||years|Mean|62.2|62.2|Standard Deviation|8.38|8.38|||
3671164|NCT02332798|3515194|B4||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3671165|NCT02332798|3515195|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3671166|NCT02332798|3515196|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3671167|NCT02332798|3515197|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3671168|NCT02332798|3515194|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3671169|NCT02332798|3515195|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3671170|NCT02332798|3515196|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3671171|NCT02332798|3515197|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3671172|NCT02332798|3515194|B4|||Age||years|Mean|44.3|44.3|Standard Deviation|8.1|8.1|||
3671173|NCT02332798|3515195|B3|||Age||years|Mean|45.8|45.8|Standard Deviation|10.5|10.5|||
3671174|NCT02332798|3515196|B2|||Age||years|Mean|41.6|41.6|Standard Deviation|7.5|7.5|||
3671175|NCT02332798|3515197|B1|||Age||years|Mean|45.6|45.6|Standard Deviation|5.9|5.9|||
3671176|NCT02332720|3515249|B24||Male|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
3671177|NCT02332720|3515250|B23||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3671178|NCT02332720|3515252|B21||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3671179|NCT02332720|3515253|B20||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3671180|NCT02332720|3515254|B19||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3671181|NCT02332720|3515255|B18||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3671182|NCT02332720|3515256|B17||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3671183|NCT02332720|3515257|B16||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3671184|NCT02332720|3515258|B15||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3671185|NCT02332720|3515259|B14||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3671186|NCT02332720|3515260|B13||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3671187|NCT02332720|3515261|B12||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3671188|NCT02332720|3515262|B11||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3671189|NCT02332720|3515263|B10||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3671190|NCT02332720|3515264|B9||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3671191|NCT02332720|3515265|B8||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3671192|NCT02332720|3515266|B7||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3671193|NCT02332720|3515267|B6||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3671194|NCT02332720|3515268|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3671195|NCT02332720|3515269|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3671196|NCT02332720|3515270|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3671197|NCT02332720|3515271|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3671199|NCT02332720|3515249|B24||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
3671200|NCT02332720|3515250|B23||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3671201|NCT02332720|3515252|B21||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3671202|NCT02332720|3515253|B20||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3671203|NCT02332720|3515254|B19||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3671204|NCT02332720|3515255|B18||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3671205|NCT02332720|3515256|B17||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3671206|NCT02332720|3515257|B16||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3671207|NCT02332720|3515258|B15||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3671208|NCT02332720|3515259|B14||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3671209|NCT02332720|3515260|B13||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3671210|NCT02332720|3515261|B12||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3671211|NCT02332720|3515262|B11||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3671212|NCT02332720|3515263|B10||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3671213|NCT02332720|3515264|B9||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3671214|NCT02332720|3515265|B8||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3671215|NCT02332720|3515266|B7||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3671216|NCT02332720|3515267|B6||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3671217|NCT02332720|3515268|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3671218|NCT02332720|3515269|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3671219|NCT02332720|3515270|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3671220|NCT02332720|3515271|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3671221|NCT02332720|3515272|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3671222|NCT02332720|3515249|B24|Over 64 years||Age, Customized||Participants|Number|19|19.0||||||
3671223|NCT02332720|3515250|B23|Over 64 years||Age, Customized||Participants|Number|0|0.0||||||
3671224|NCT02332720|3515252|B21|Over 64 years||Age, Customized||Participants|Number|0|0.0||||||
3671225|NCT02332720|3515253|B20|Over 64 years||Age, Customized||Participants|Number|1|1.0||||||
3671226|NCT02332720|3515254|B19|Over 64 years||Age, Customized||Participants|Number|1|1.0||||||
3671227|NCT02332720|3515255|B18|Over 64 years||Age, Customized||Participants|Number|0|0.0||||||
3671228|NCT02332720|3515256|B17|Over 64 years||Age, Customized||Participants|Number|0|0.0||||||
3671229|NCT02332720|3515257|B16|Over 64 years||Age, Customized||Participants|Number|2|2.0||||||
3671230|NCT02332720|3515258|B15|Over 64 years||Age, Customized||Participants|Number|0|0.0||||||
3671231|NCT02332720|3515259|B14|Over 64 years||Age, Customized||Participants|Number|2|2.0||||||
3671232|NCT02332720|3515260|B13|Over 64 years||Age, Customized||Participants|Number|1|1.0||||||
3671233|NCT02332720|3515261|B12|Over 64 years||Age, Customized||Participants|Number|1|1.0||||||
3671234|NCT02332720|3515262|B11|Over 64 years||Age, Customized||Participants|Number|0|0.0||||||
3671235|NCT02332720|3515263|B10|Over 64 years||Age, Customized||Participants|Number|1|1.0||||||
3671236|NCT02332720|3515264|B9|Over 64 years||Age, Customized||Participants|Number|2|2.0||||||
3671237|NCT02332720|3515265|B8|Over 64 years||Age, Customized||Participants|Number|0|0.0||||||
3671238|NCT02332720|3515266|B7|Over 64 years||Age, Customized||Participants|Number|1|1.0||||||
3671239|NCT02332720|3515267|B6|Over 64 years||Age, Customized||Participants|Number|1|1.0||||||
3671240|NCT02332720|3515268|B5|Over 64 years||Age, Customized||Participants|Number|3|3.0||||||
3671241|NCT02332720|3515269|B4|Over 64 years||Age, Customized||Participants|Number|3|3.0||||||
3671242|NCT02332720|3515270|B3|Over 64 years||Age, Customized||Participants|Number|0|0.0||||||
3671243|NCT02332720|3515271|B2|Over 64 years||Age, Customized||Participants|Number|0|0.0||||||
3671244|NCT02332720|3515272|B1|Over 64 years||Age, Customized||Participants|Number|0|0.0||||||
3671245|NCT02332720|3515249|B24|51 to 64 years||Age, Customized||Participants|Number|194|194.0||||||
3671246|NCT02332720|3515250|B23|51 to 64 years||Age, Customized||Participants|Number|3|3.0||||||
3671247|NCT02332720|3515252|B21|51 to 64 years||Age, Customized||Participants|Number|3|3.0||||||
3671248|NCT02332720|3515253|B20|51 to 64 years||Age, Customized||Participants|Number|18|18.0||||||
3671249|NCT02332720|3515254|B19|51 to 64 years||Age, Customized||Participants|Number|13|13.0||||||
3671250|NCT02332720|3515255|B18|51 to 64 years||Age, Customized||Participants|Number|9|9.0||||||
3671251|NCT02332720|3515256|B17|51 to 64 years||Age, Customized||Participants|Number|11|11.0||||||
3671252|NCT02332720|3515257|B16|51 to 64 years||Age, Customized||Participants|Number|9|9.0||||||
3671253|NCT02332720|3515258|B15|51 to 64 years||Age, Customized||Participants|Number|13|13.0||||||
3671254|NCT02332720|3515259|B14|51 to 64 years||Age, Customized||Participants|Number|4|4.0||||||
3671255|NCT02332720|3515260|B13|51 to 64 years||Age, Customized||Participants|Number|9|9.0||||||
3671256|NCT02332720|3515261|B12|51 to 64 years||Age, Customized||Participants|Number|9|9.0||||||
3671257|NCT02332720|3515262|B11|51 to 64 years||Age, Customized||Participants|Number|6|6.0||||||
3671258|NCT02332720|3515263|B10|51 to 64 years||Age, Customized||Participants|Number|7|7.0||||||
3671259|NCT02332720|3515264|B9|51 to 64 years||Age, Customized||Participants|Number|8|8.0||||||
3671260|NCT02332720|3515265|B8|51 to 64 years||Age, Customized||Participants|Number|16|16.0||||||
3671261|NCT02332720|3515266|B7|51 to 64 years||Age, Customized||Participants|Number|13|13.0||||||
3671262|NCT02332720|3515267|B6|51 to 64 years||Age, Customized||Participants|Number|16|16.0||||||
3671263|NCT02332720|3515268|B5|51 to 64 years||Age, Customized||Participants|Number|6|6.0||||||
3671264|NCT02332720|3515269|B4|51 to 64 years||Age, Customized||Participants|Number|3|3.0||||||
3671265|NCT02332720|3515270|B3|51 to 64 years||Age, Customized||Participants|Number|5|5.0||||||
3671266|NCT02332720|3515271|B2|51 to 64 years||Age, Customized||Participants|Number|8|8.0||||||
3671267|NCT02332720|3515272|B1|51 to 64 years||Age, Customized||Participants|Number|5|5.0||||||
3671268|NCT02332720|3515249|B24|36 to 50 years||Age, Customized||Participants|Number|150|150.0||||||
3671269|NCT02332720|3515250|B23|36 to 50 years||Age, Customized||Participants|Number|1|1.0||||||
3671270|NCT02332720|3515252|B21|36 to 50 years||Age, Customized||Participants|Number|3|3.0||||||
3671271|NCT02332720|3515253|B20|36 to 50 years||Age, Customized||Participants|Number|6|6.0||||||
3671272|NCT02332720|3515254|B19|36 to 50 years||Age, Customized||Participants|Number|6|6.0||||||
3671273|NCT02332720|3515255|B18|36 to 50 years||Age, Customized||Participants|Number|3|3.0||||||
3671274|NCT02332720|3515256|B17|36 to 50 years||Age, Customized||Participants|Number|4|4.0||||||
3671275|NCT02332720|3515257|B16|36 to 50 years||Age, Customized||Participants|Number|3|3.0||||||
3671276|NCT02332720|3515258|B15|36 to 50 years||Age, Customized||Participants|Number|3|3.0||||||
3671277|NCT02332720|3515259|B14|36 to 50 years||Age, Customized||Participants|Number|7|7.0||||||
3671278|NCT02332720|3515260|B13|36 to 50 years||Age, Customized||Participants|Number|6|6.0||||||
3671279|NCT02332720|3515261|B12|36 to 50 years||Age, Customized||Participants|Number|4|4.0||||||
3671280|NCT02332720|3515262|B11|36 to 50 years||Age, Customized||Participants|Number|6|6.0||||||
3671281|NCT02332720|3515263|B10|36 to 50 years||Age, Customized||Participants|Number|5|5.0||||||
3671282|NCT02332720|3515264|B9|36 to 50 years||Age, Customized||Participants|Number|5|5.0||||||
3671283|NCT02332720|3515265|B8|36 to 50 years||Age, Customized||Participants|Number|12|12.0||||||
3671284|NCT02332720|3515266|B7|36 to 50 years||Age, Customized||Participants|Number|14|14.0||||||
3671285|NCT02332720|3515267|B6|36 to 50 years||Age, Customized||Participants|Number|11|11.0||||||
3671286|NCT02332720|3515268|B5|36 to 50 years||Age, Customized||Participants|Number|4|4.0||||||
3671287|NCT02332720|3515269|B4|36 to 50 years||Age, Customized||Participants|Number|12|12.0||||||
3671288|NCT02332720|3515270|B3|36 to 50 years||Age, Customized||Participants|Number|14|14.0||||||
3671289|NCT02332720|3515271|B2|36 to 50 years||Age, Customized||Participants|Number|9|9.0||||||
3671290|NCT02332720|3515272|B1|36 to 50 years||Age, Customized||Participants|Number|12|12.0||||||
3671291|NCT02332720|3515249|B24|18 to 35 years||Age, Customized||Participants|Number|49|49.0||||||
3671292|NCT02332720|3515250|B23|18 to 35 years||Age, Customized||Participants|Number|0|0.0||||||
3671293|NCT02332720|3515252|B21|18 to 35 years||Age, Customized||Participants|Number|1|1.0||||||
3671294|NCT02332720|3515253|B20|18 to 35 years||Age, Customized||Participants|Number|0|0.0||||||
3671295|NCT02332720|3515254|B19|18 to 35 years||Age, Customized||Participants|Number|0|0.0||||||
3671296|NCT02332720|3515255|B18|18 to 35 years||Age, Customized||Participants|Number|2|2.0||||||
3671297|NCT02332720|3515256|B17|18 to 35 years||Age, Customized||Participants|Number|0|0.0||||||
3671298|NCT02332720|3515257|B16|18 to 35 years||Age, Customized||Participants|Number|0|0.0||||||
3671299|NCT02332720|3515258|B15|18 to 35 years||Age, Customized||Participants|Number|0|0.0||||||
3671300|NCT02332720|3515259|B14|18 to 35 years||Age, Customized||Participants|Number|0|0.0||||||
3671301|NCT02332720|3515260|B13|18 to 35 years||Age, Customized||Participants|Number|0|0.0||||||
3671302|NCT02332720|3515261|B12|18 to 35 years||Age, Customized||Participants|Number|1|1.0||||||
3671303|NCT02332720|3515262|B11|18 to 35 years||Age, Customized||Participants|Number|2|2.0||||||
3671304|NCT02332720|3515263|B10|18 to 35 years||Age, Customized||Participants|Number|1|1.0||||||
3671305|NCT02332720|3515264|B9|18 to 35 years||Age, Customized||Participants|Number|0|0.0||||||
3671306|NCT02332720|3515265|B8|18 to 35 years||Age, Customized||Participants|Number|7|7.0||||||
3671307|NCT02332720|3515266|B7|18 to 35 years||Age, Customized||Participants|Number|9|9.0||||||
3671308|NCT02332720|3515267|B6|18 to 35 years||Age, Customized||Participants|Number|8|8.0||||||
3671309|NCT02332720|3515268|B5|18 to 35 years||Age, Customized||Participants|Number|3|3.0||||||
3671310|NCT02332720|3515269|B4|18 to 35 years||Age, Customized||Participants|Number|4|4.0||||||
3671311|NCT02332720|3515270|B3|18 to 35 years||Age, Customized||Participants|Number|3|3.0||||||
3671312|NCT02332720|3515271|B2|18 to 35 years||Age, Customized||Participants|Number|4|4.0||||||
3671313|NCT02332720|3515272|B1|18 to 35 years||Age, Customized||Participants|Number|4|4.0||||||
3671314|NCT02332720|3515249|B24|Less than 18 years||Age, Customized||Participants|Number|0|0.0||||||
3671315|NCT02332720|3515250|B23|Less than 18 years||Age, Customized||Participants|Number|0|0.0||||||
3671316|NCT02332720|3515252|B21|Less than 18 years||Age, Customized||Participants|Number|0|0.0||||||
3671317|NCT02332720|3515253|B20|Less than 18 years||Age, Customized||Participants|Number|0|0.0||||||
3671318|NCT02332720|3515254|B19|Less than 18 years||Age, Customized||Participants|Number|0|0.0||||||
3671319|NCT02332720|3515255|B18|Less than 18 years||Age, Customized||Participants|Number|0|0.0||||||
3671320|NCT02332720|3515256|B17|Less than 18 years||Age, Customized||Participants|Number|0|0.0||||||
3671321|NCT02332720|3515257|B16|Less than 18 years||Age, Customized||Participants|Number|0|0.0||||||
3671322|NCT02332720|3515258|B15|Less than 18 years||Age, Customized||Participants|Number|0|0.0||||||
3671323|NCT02332720|3515259|B14|Less than 18 years||Age, Customized||Participants|Number|0|0.0||||||
3671324|NCT02332720|3515260|B13|Less than 18 years||Age, Customized||Participants|Number|0|0.0||||||
3671325|NCT02332720|3515261|B12|Less than 18 years||Age, Customized||Participants|Number|0|0.0||||||
3671326|NCT02332720|3515262|B11|Less than 18 years||Age, Customized||Participants|Number|0|0.0||||||
3671327|NCT02332720|3515263|B10|Less than 18 years||Age, Customized||Participants|Number|0|0.0||||||
3671328|NCT02332720|3515264|B9|Less than 18 years||Age, Customized||Participants|Number|0|0.0||||||
3671329|NCT02332720|3515265|B8|Less than 18 years||Age, Customized||Participants|Number|0|0.0||||||
3671330|NCT02332720|3515266|B7|Less than 18 years||Age, Customized||Participants|Number|0|0.0||||||
3671331|NCT02332720|3515267|B6|Less than 18 years||Age, Customized||Participants|Number|0|0.0||||||
3671332|NCT02332720|3515268|B5|Less than 18 years||Age, Customized||Participants|Number|0|0.0||||||
3671333|NCT02332720|3515269|B4|Less than 18 years||Age, Customized||Participants|Number|0|0.0||||||
3671334|NCT02332720|3515270|B3|Less than 18 years||Age, Customized||Participants|Number|0|0.0||||||
3671335|NCT02332720|3515271|B2|Less than 18 years||Age, Customized||Participants|Number|0|0.0||||||
3671336|NCT02332720|3515272|B1|Less than 18 years||Age, Customized||Participants|Number|0|0.0||||||
3671337|NCT02332707|3515412|B19||Male|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
3671338|NCT02332707|3515413|B18||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3671339|NCT02332707|3515414|B17||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3671340|NCT02332707|3515415|B16||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3671341|NCT02332707|3515416|B15||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3671342|NCT02332707|3515417|B14||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3671343|NCT02332707|3515418|B13||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3671344|NCT02332707|3515419|B12||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3671345|NCT02332707|3515420|B11||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3671346|NCT02332707|3515421|B10||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3671347|NCT02332707|3515422|B9||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3671348|NCT02332707|3515423|B8||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3671349|NCT02332707|3515424|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3671350|NCT02332707|3515425|B6||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3671351|NCT02332707|3515426|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3671352|NCT02332707|3515427|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3671353|NCT02332707|3515428|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3671354|NCT02332707|3515429|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3671355|NCT02332707|3515430|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3671356|NCT02332707|3515412|B19||Female|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
3671357|NCT02332707|3515413|B18||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3671358|NCT02332707|3515414|B17||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3671359|NCT02332707|3515415|B16||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3671360|NCT02332707|3515416|B15||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3671361|NCT02332707|3515417|B14||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3671362|NCT02332707|3515418|B13||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3671363|NCT02332707|3515419|B12||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3671364|NCT02332707|3515420|B11||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3671365|NCT02332707|3515421|B10||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3671366|NCT02332707|3515422|B9||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3671367|NCT02332707|3515423|B8||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3671368|NCT02332707|3515424|B7||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3671369|NCT02332707|3515425|B6||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3671370|NCT02332707|3515426|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3671371|NCT02332707|3515427|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3671372|NCT02332707|3515428|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3671373|NCT02332707|3515429|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3671374|NCT02332707|3515430|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3671375|NCT02332707|3515412|B19|||Age||Years|Mean|52.6|52.6|Standard Deviation|13.0|13.0|||
3671376|NCT02332707|3515413|B18|||Age||Years|Mean|51.4|51.4|Standard Deviation|10.8|10.8|||
3671377|NCT02332707|3515414|B17|||Age||Years|Mean|47.4|47.4|Standard Deviation|11.7|11.7|||
3671378|NCT02332707|3515415|B16|||Age||Years|Mean|64.0|64.0|Standard Deviation|9.3|9.3|||
3671379|NCT02332707|3515416|B15|||Age||Years|Mean|59.8|59.8|Standard Deviation|8.0|8.0|||
3671380|NCT02332707|3515417|B14|||Age||Years|Mean|61.8|61.8|Standard Deviation|6.8|6.8|||
3671381|NCT02332707|3515418|B13|||Age||Years|Mean|56.9|56.9|Standard Deviation|11.1|11.1|||
3671382|NCT02332707|3515419|B12|||Age||Years|Mean|58.8|58.8|Standard Deviation|9.6|9.6|||
3671383|NCT02332707|3515420|B11|||Age||Years|Mean|55.6|55.6|Standard Deviation|14.4|14.4|||
3671384|NCT02332707|3515421|B10|||Age||Years|Mean|49.8|49.8|Standard Deviation|13.0|13.0|||
3671385|NCT02332707|3515422|B9|||Age||Years|Mean|48.8|48.8|Standard Deviation|13.9|13.9|||
3671386|NCT02332707|3515423|B8|||Age||Years|Mean|48.3|48.3|Standard Deviation|8.8|8.8|||
3671387|NCT02332707|3515424|B7|||Age||Years|Mean|52.9|52.9|Standard Deviation|12.1|12.1|||
3671388|NCT02332707|3515425|B6|||Age||Years|Mean|46.7|46.7|Standard Deviation|13.9|13.9|||
3671389|NCT02332707|3515426|B5|||Age||Years|Mean|49.0|49.0|Standard Deviation|11.2|11.2|||
3671390|NCT02332707|3515427|B4|||Age||Years|Mean|52.6|52.6|Standard Deviation|11.6|11.6|||
3671391|NCT02332707|3515428|B3|||Age||Years|Mean|49.4|49.4|Standard Deviation|15.8|15.8|||
3671392|NCT02332707|3515429|B2|||Age||Years|Mean|45.0|45.0|Standard Deviation|14.5|14.5|||
3671393|NCT02332707|3515430|B1|||Age||Years|Mean|50.2|50.2|Standard Deviation|13.5|13.5|||
3671394|NCT02332590|3515539|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3671395|NCT02332590|3515540|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3671396|NCT02332590|3515541|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3671397|NCT02332590|3515539|B3||Female|Sex: Female, Male||Participants|Count of Participants|307|307.0||||||
3671398|NCT02332590|3515540|B2||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3671399|NCT02332590|3515541|B1||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3671400|NCT02332590|3515539|B3|||Age||years|Mean|52.2|52.2|Standard Deviation|12.3|12.3|||
3671401|NCT02332590|3515540|B2|||Age||years|Mean|50.9|50.9|Standard Deviation|12.6|12.6|||
3671402|NCT02332590|3515541|B1|||Age||years|Mean|53.6|53.6|Standard Deviation|11.9|11.9|||
3671403|NCT02332239|3515604|B3|||The Beck Depression Inventory (BDI-2)|The Beck Depression Inventory (BDI-2) is a 1996 revision of the BDI, developed in response to the DSM-IV, which changed many of the diagnostic criteria for Major Depressive Disorder. Participants were asked to rate how they have been feeling for the past two weeks. It contains 21 questions, each answer being scored on a scale value of 0 to 3. Higher total scores indicate more severe depressive symptoms. The standardized cutoffs used differ from the original: 0-13: minimal depression; 14-19: mild depression; 20-28: moderate depression; 29-63: severe depression.|units on a scale|Mean|13.51|13.51|Standard Deviation|9.33|9.33|||
3671404|NCT02332239|3515605|B2|||The Beck Depression Inventory (BDI-2)|The Beck Depression Inventory (BDI-2) is a 1996 revision of the BDI, developed in response to the DSM-IV, which changed many of the diagnostic criteria for Major Depressive Disorder. Participants were asked to rate how they have been feeling for the past two weeks. It contains 21 questions, each answer being scored on a scale value of 0 to 3. Higher total scores indicate more severe depressive symptoms. The standardized cutoffs used differ from the original: 0-13: minimal depression; 14-19: mild depression; 20-28: moderate depression; 29-63: severe depression.|units on a scale|Mean|13.41|13.41|Standard Deviation|10.10|10.1|||
3671405|NCT02332239|3515606|B1|||The Beck Depression Inventory (BDI-2)|The Beck Depression Inventory (BDI-2) is a 1996 revision of the BDI, developed in response to the DSM-IV, which changed many of the diagnostic criteria for Major Depressive Disorder. Participants were asked to rate how they have been feeling for the past two weeks. It contains 21 questions, each answer being scored on a scale value of 0 to 3. Higher total scores indicate more severe depressive symptoms. The standardized cutoffs used differ from the original: 0-13: minimal depression; 14-19: mild depression; 20-28: moderate depression; 29-63: severe depression.|units on a scale|Mean|13.60|13.6|Standard Deviation|8.59|8.59|||
3671406|NCT02332239|3515604|B3|||The Patient Health Questionnaire (PHQ-9)|The Patient Health Questionnaire (PHQ-9) is a 9-question instrument given to patients in a primary care setting to screen for the presence and severity of depression based on diagnostic criteria of depression from the Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV. It asks about the patient's experience in the last 2 weeks. Responses range from “0” (Not at all) to “3” (nearly every day). The total sum of the responses suggests varying levels of depression. Scores range from 0 to 27. A total of 10 or above is suggestive of the presence of depression.|units on a scale|Mean|9.10|9.1|Standard Deviation|3.66|3.66|||
3671407|NCT02332239|3515605|B2|||The Patient Health Questionnaire (PHQ-9)|The Patient Health Questionnaire (PHQ-9) is a 9-question instrument given to patients in a primary care setting to screen for the presence and severity of depression based on diagnostic criteria of depression from the Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV. It asks about the patient's experience in the last 2 weeks. Responses range from “0” (Not at all) to “3” (nearly every day). The total sum of the responses suggests varying levels of depression. Scores range from 0 to 27. A total of 10 or above is suggestive of the presence of depression.|units on a scale|Mean|8.78|8.78|Standard Deviation|3.49|3.49|||
3671408|NCT02332239|3515606|B1|||The Patient Health Questionnaire (PHQ-9)|The Patient Health Questionnaire (PHQ-9) is a 9-question instrument given to patients in a primary care setting to screen for the presence and severity of depression based on diagnostic criteria of depression from the Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV. It asks about the patient's experience in the last 2 weeks. Responses range from “0” (Not at all) to “3” (nearly every day). The total sum of the responses suggests varying levels of depression. Scores range from 0 to 27. A total of 10 or above is suggestive of the presence of depression.|units on a scale|Mean|9.43|9.43|Standard Deviation|3.82|3.82|||
3671409|NCT02332239|3515604|B3|||The Revised Conflict Tactics Scales (CTS-2)|The Physical Assault subscale of the Conflict Tactics Scale (CTS-2), developed by Straus et al. (1996), was used to analyze changes in past-two-month peer violence in iDOVE participants, relative to an automated health-and-safety brief intervention and text message program. There are 14 items that measure violent behavior, each scored based on how frequently the participant has experienced the behavior (0=never to 6=20+ times). Score is summed, so the minimum score possible is 14*0=0 (lowest level of violence) and the maximum score possible is 14*6=84 (highest level of violence).|units on a scale|Mean|3.88|3.88|Standard Deviation|5.22|5.22|||
3671410|NCT02332239|3515605|B2|||The Revised Conflict Tactics Scales (CTS-2)|The Physical Assault subscale of the Conflict Tactics Scale (CTS-2), developed by Straus et al. (1996), was used to analyze changes in past-two-month peer violence in iDOVE participants, relative to an automated health-and-safety brief intervention and text message program. There are 14 items that measure violent behavior, each scored based on how frequently the participant has experienced the behavior (0=never to 6=20+ times). Score is summed, so the minimum score possible is 14*0=0 (lowest level of violence) and the maximum score possible is 14*6=84 (highest level of violence).|units on a scale|Mean|2.69|2.69|Standard Deviation|2.64|2.64|||
3671438|NCT02332239|3515606|B1||Grades 9-12|School Year||Participants|Count of Participants|37|37.0||||||
3671439|NCT02332239|3515604|B3||Grades 6-8|School Year||Participants|Count of Participants|26|26.0||||||
3671440|NCT02332239|3515605|B2||Grades 6-8|School Year||Participants|Count of Participants|10|10.0||||||
3671441|NCT02332239|3515606|B1||Grades 6-8|School Year||Participants|Count of Participants|16|16.0||||||
3671411|NCT02332239|3515606|B1|||The Revised Conflict Tactics Scales (CTS-2)|The Physical Assault subscale of the Conflict Tactics Scale (CTS-2), developed by Straus et al. (1996), was used to analyze changes in past-two-month peer violence in iDOVE participants, relative to an automated health-and-safety brief intervention and text message program. There are 14 items that measure violent behavior, each scored based on how frequently the participant has experienced the behavior (0=never to 6=20+ times). Score is summed, so the minimum score possible is 14*0=0 (lowest level of violence) and the maximum score possible is 14*6=84 (highest level of violence).|units on a scale|Mean|5.07|5.07|Standard Deviation|6.72|6.72|||
3671412|NCT02332239|3515604|B3||Prefer not to answer|Sexual Orientation||Participants|Count of Participants|6|6.0||||||
3671413|NCT02332239|3515605|B2||Prefer not to answer|Sexual Orientation||Participants|Count of Participants|2|2.0||||||
3671414|NCT02332239|3515606|B1||Prefer not to answer|Sexual Orientation||Participants|Count of Participants|4|4.0||||||
3671415|NCT02332239|3515604|B3||LGBQ|Sexual Orientation||Participants|Count of Participants|21|21.0||||||
3671416|NCT02332239|3515605|B2||LGBQ|Sexual Orientation||Participants|Count of Participants|10|10.0||||||
3671417|NCT02332239|3515606|B1||LGBQ|Sexual Orientation||Participants|Count of Participants|11|11.0||||||
3671418|NCT02332239|3515604|B3||Straight|Sexual Orientation||Participants|Count of Participants|89|89.0||||||
3671419|NCT02332239|3515605|B2||Straight|Sexual Orientation||Participants|Count of Participants|46|46.0||||||
3671420|NCT02332239|3515606|B1||Straight|Sexual Orientation||Participants|Count of Participants|43|43.0||||||
3671421|NCT02332239|3515604|B3||Prefer not to answer|Socio-economic status|"Socioeconomic Status (SES) was collected using selected items from the National Study for Adolescent Health. Low SES was defined as receipt of free services (a parent or guardian who qualifies for public assistance, welfare, food stamps, disability benefits, Medicaid, Rite-care, etc., or a child who qualifies for free or reduced lunches from school). High SES was defined as not receiving free services."|Participants|Count of Participants|4|4.0||||||
3671422|NCT02332239|3515605|B2||Prefer not to answer|Socio-economic status|"Socioeconomic Status (SES) was collected using selected items from the National Study for Adolescent Health. Low SES was defined as receipt of free services (a parent or guardian who qualifies for public assistance, welfare, food stamps, disability benefits, Medicaid, Rite-care, etc., or a child who qualifies for free or reduced lunches from school). High SES was defined as not receiving free services."|Participants|Count of Participants|2|2.0||||||
3671423|NCT02332239|3515606|B1||Prefer not to answer|Socio-economic status|"Socioeconomic Status (SES) was collected using selected items from the National Study for Adolescent Health. Low SES was defined as receipt of free services (a parent or guardian who qualifies for public assistance, welfare, food stamps, disability benefits, Medicaid, Rite-care, etc., or a child who qualifies for free or reduced lunches from school). High SES was defined as not receiving free services."|Participants|Count of Participants|2|2.0||||||
3671424|NCT02332239|3515604|B3||High SES|Socio-economic status|"Socioeconomic Status (SES) was collected using selected items from the National Study for Adolescent Health. Low SES was defined as receipt of free services (a parent or guardian who qualifies for public assistance, welfare, food stamps, disability benefits, Medicaid, Rite-care, etc., or a child who qualifies for free or reduced lunches from school). High SES was defined as not receiving free services."|Participants|Count of Participants|34|34.0||||||
3671425|NCT02332239|3515605|B2||High SES|Socio-economic status|"Socioeconomic Status (SES) was collected using selected items from the National Study for Adolescent Health. Low SES was defined as receipt of free services (a parent or guardian who qualifies for public assistance, welfare, food stamps, disability benefits, Medicaid, Rite-care, etc., or a child who qualifies for free or reduced lunches from school). High SES was defined as not receiving free services."|Participants|Count of Participants|14|14.0||||||
3671426|NCT02332239|3515606|B1||High SES|Socio-economic status|"Socioeconomic Status (SES) was collected using selected items from the National Study for Adolescent Health. Low SES was defined as receipt of free services (a parent or guardian who qualifies for public assistance, welfare, food stamps, disability benefits, Medicaid, Rite-care, etc., or a child who qualifies for free or reduced lunches from school). High SES was defined as not receiving free services."|Participants|Count of Participants|20|20.0||||||
3671427|NCT02332239|3515604|B3||Low SES|Socio-economic status|"Socioeconomic Status (SES) was collected using selected items from the National Study for Adolescent Health. Low SES was defined as receipt of free services (a parent or guardian who qualifies for public assistance, welfare, food stamps, disability benefits, Medicaid, Rite-care, etc., or a child who qualifies for free or reduced lunches from school). High SES was defined as not receiving free services."|Participants|Count of Participants|78|78.0||||||
3671428|NCT02332239|3515605|B2||Low SES|Socio-economic status|"Socioeconomic Status (SES) was collected using selected items from the National Study for Adolescent Health. Low SES was defined as receipt of free services (a parent or guardian who qualifies for public assistance, welfare, food stamps, disability benefits, Medicaid, Rite-care, etc., or a child who qualifies for free or reduced lunches from school). High SES was defined as not receiving free services."|Participants|Count of Participants|42|42.0||||||
3671429|NCT02332239|3515606|B1||Low SES|Socio-economic status|"Socioeconomic Status (SES) was collected using selected items from the National Study for Adolescent Health. Low SES was defined as receipt of free services (a parent or guardian who qualifies for public assistance, welfare, food stamps, disability benefits, Medicaid, Rite-care, etc., or a child who qualifies for free or reduced lunches from school). High SES was defined as not receiving free services."|Participants|Count of Participants|36|36.0||||||
3671430|NCT02332239|3515604|B3||Not in school|School Year||Participants|Count of Participants|3|3.0||||||
3671431|NCT02332239|3515605|B2||Not in school|School Year||Participants|Count of Participants|0|0.0||||||
3671432|NCT02332239|3515606|B1||Not in school|School Year||Participants|Count of Participants|3|3.0||||||
3671433|NCT02332239|3515604|B3||College|School Year||Participants|Count of Participants|2|2.0||||||
3671434|NCT02332239|3515605|B2||College|School Year||Participants|Count of Participants|0|0.0||||||
3671435|NCT02332239|3515606|B1||College|School Year||Participants|Count of Participants|2|2.0||||||
3671436|NCT02332239|3515604|B3||Grades 9-12|School Year||Participants|Count of Participants|85|85.0||||||
3671437|NCT02332239|3515605|B2||Grades 9-12|School Year||Participants|Count of Participants|48|48.0||||||
3671442|NCT02332239|3515604|B3|United States||Region of Enrollment||participants|Number|116|116.0||||||
3671443|NCT02332239|3515605|B2|United States||Region of Enrollment||participants|Number|58|58.0||||||
3671444|NCT02332239|3515606|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
3671445|NCT02332239|3515604|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3671446|NCT02332239|3515605|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3671447|NCT02332239|3515606|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3671448|NCT02332239|3515604|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3671449|NCT02332239|3515605|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3671450|NCT02332239|3515606|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3671451|NCT02332239|3515604|B3||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3671452|NCT02332239|3515605|B2||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3671453|NCT02332239|3515606|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3671454|NCT02332239|3515604|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3671455|NCT02332239|3515605|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3671456|NCT02332239|3515606|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3671457|NCT02332239|3515604|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3671458|NCT02332239|3515605|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3671459|NCT02332239|3515606|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3671460|NCT02332239|3515604|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3671461|NCT02332239|3515605|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3671462|NCT02332239|3515606|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3671463|NCT02332239|3515604|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3671464|NCT02332239|3515605|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3671465|NCT02332239|3515606|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3671466|NCT02332239|3515604|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3671467|NCT02332239|3515605|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671468|NCT02332239|3515606|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3671469|NCT02332239|3515604|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3671470|NCT02332239|3515605|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3671471|NCT02332239|3515606|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3671472|NCT02332239|3515604|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3671473|NCT02332239|3515605|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3671474|NCT02332239|3515606|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3671475|NCT02332239|3515604|B3|Gender|Transgender, Other, Prefer not to answer|Sex/Gender, Customized||Participants|Count of Participants|2|2.0||||||
3671476|NCT02332239|3515605|B2|Gender|Transgender, Other, Prefer not to answer|Sex/Gender, Customized||Participants|Count of Participants|2|2.0||||||
3671477|NCT02332239|3515606|B1|Gender|Transgender, Other, Prefer not to answer|Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3671478|NCT02332239|3515604|B3|Gender|Male|Sex/Gender, Customized||Participants|Count of Participants|46|46.0||||||
3671479|NCT02332239|3515605|B2|Gender|Male|Sex/Gender, Customized||Participants|Count of Participants|22|22.0||||||
3671480|NCT02332239|3515606|B1|Gender|Male|Sex/Gender, Customized||Participants|Count of Participants|24|24.0||||||
3671481|NCT02332239|3515604|B3|Gender|Female|Sex/Gender, Customized||Participants|Count of Participants|68|68.0||||||
3671482|NCT02332239|3515605|B2|Gender|Female|Sex/Gender, Customized||Participants|Count of Participants|34|34.0||||||
3671483|NCT02332239|3515606|B1|Gender|Female|Sex/Gender, Customized||Participants|Count of Participants|34|34.0||||||
3671484|NCT02332239|3515604|B3|||Age||years|Mean|14.94|14.94|Standard Deviation|1.18|1.18|||
3671485|NCT02332239|3515605|B2|||Age||years|Mean|15.05|15.05|Standard Deviation|1.13|1.13|||
3671486|NCT02332239|3515606|B1|||Age||years|Mean|14.83|14.83|Standard Deviation|1.23|1.23|||
3671487|NCT02331992|3515620|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3671488|NCT02331992|3515620|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3671489|NCT02331992|3515620|B1|||Age||years|Mean|44|44.0|Full Range|||26.0|71.0|
3671490|NCT02331940|3515625|B3|Greece||Region of Enrollment||participants|Number|188|188.0||||||
3671491|NCT02331940|3515626|B2|Greece||Region of Enrollment||participants|Number|95|95.0||||||
3671492|NCT02331940|3515627|B1|Greece||Region of Enrollment||participants|Number|93|93.0||||||
3671493|NCT02331940|3515625|B3||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3671494|NCT02331940|3515626|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3671495|NCT02331940|3515627|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3671496|NCT02331940|3515625|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3671497|NCT02331940|3515626|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3671498|NCT02331940|3515627|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3671499|NCT02331940|3515625|B3|||Age||Years|Mean|54.3|54.3|Standard Deviation|11.5|11.5|||
3671500|NCT02331940|3515626|B2|||Age||Years|Mean|54.9|54.9|Standard Deviation|11.8|11.8|||
3671501|NCT02331940|3515627|B1|||Age||Years|Mean|53.7|53.7|Standard Deviation|11.3|11.3|||
3671502|NCT02331589|3515640|B3|Korea, Republic of||Region of Enrollment||participants|Number|65|65.0||||||
3671503|NCT02331589|3515641|B2|Korea, Republic of||Region of Enrollment||participants|Number|31|31.0||||||
3671504|NCT02331589|3515642|B1|Korea, Republic of||Region of Enrollment||participants|Number|34|34.0||||||
3671505|NCT02331589|3515640|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3671506|NCT02331589|3515641|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3671507|NCT02331589|3515642|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3671508|NCT02331589|3515640|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3671509|NCT02331589|3515641|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3671510|NCT02331589|3515642|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3671511|NCT02331589|3515640|B3|||Age||years|Mean|47.8|47.8|Standard Deviation|12.9|12.9|||
3671512|NCT02331589|3515641|B2|||Age||years|Mean|50.0|50.0|Standard Deviation|12.8|12.8|||
3671513|NCT02331589|3515642|B1|||Age||years|Mean|45.8|45.8|Standard Deviation|12.7|12.7|||
3671514|NCT02331589|3515640|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3671515|NCT02331589|3515641|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3671516|NCT02331589|3515642|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3671517|NCT02331589|3515640|B3||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3671518|NCT02331589|3515641|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3671519|NCT02331589|3515642|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3671520|NCT02331589|3515640|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3671521|NCT02331589|3515641|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3671522|NCT02331589|3515642|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3671523|NCT02331446|3515655|B5|No||Alcohol intake||participants|Number|18|18.0||||||
3671524|NCT02331446|3515656|B4|No||Alcohol intake||participants|Number|6|6.0||||||
3671525|NCT02331446|3515657|B3|No||Alcohol intake||participants|Number|2|2.0||||||
3671526|NCT02331446|3515658|B2|No||Alcohol intake||participants|Number|6|6.0||||||
3671527|NCT02331446|3515659|B1|No||Alcohol intake||participants|Number|4|4.0||||||
3671528|NCT02331446|3515655|B5|Sporadically||Alcohol intake||participants|Number|21|21.0||||||
3671529|NCT02331446|3515656|B4|Sporadically||Alcohol intake||participants|Number|5|5.0||||||
3671530|NCT02331446|3515657|B3|Sporadically||Alcohol intake||participants|Number|7|7.0||||||
3671531|NCT02331446|3515658|B2|Sporadically||Alcohol intake||participants|Number|4|4.0||||||
3671532|NCT02331446|3515659|B1|Sporadically||Alcohol intake||participants|Number|5|5.0||||||
3671533|NCT02331446|3515655|B5|Daily (one dose)||Alcohol intake||participants|Number|1|1.0||||||
3671534|NCT02331446|3515656|B4|Daily (one dose)||Alcohol intake||participants|Number|0|0.0||||||
3671535|NCT02331446|3515657|B3|Daily (one dose)||Alcohol intake||participants|Number|1|1.0||||||
3671536|NCT02331446|3515658|B2|Daily (one dose)||Alcohol intake||participants|Number|0|0.0||||||
3671537|NCT02331446|3515659|B1|Daily (one dose)||Alcohol intake||participants|Number|0|0.0||||||
3671538|NCT02331446|3515655|B5|Yes||Smoking||participants|Number|5|5.0||||||
3671539|NCT02331446|3515656|B4|Yes||Smoking||participants|Number|1|1.0||||||
3671540|NCT02331446|3515657|B3|Yes||Smoking||participants|Number|1|1.0||||||
3671541|NCT02331446|3515658|B2|Yes||Smoking||participants|Number|2|2.0||||||
3671542|NCT02331446|3515659|B1|Yes||Smoking||participants|Number|1|1.0||||||
3671543|NCT02331446|3515655|B5|No||Smoking||participants|Number|35|35.0||||||
3671544|NCT02331446|3515656|B4|No||Smoking||participants|Number|10|10.0||||||
3671545|NCT02331446|3515657|B3|No||Smoking||participants|Number|9|9.0||||||
3671546|NCT02331446|3515658|B2|No||Smoking||participants|Number|8|8.0||||||
3671547|NCT02331446|3515659|B1|No||Smoking||participants|Number|8|8.0||||||
3671548|NCT02331446|3515655|B5|Yes||Chronic Use of Medication|This variable refers to a chronic use of any medication.|participants|Number|37|37.0||||||
3671549|NCT02331446|3515656|B4|Yes||Chronic Use of Medication|This variable refers to a chronic use of any medication.|participants|Number|10|10.0||||||
3671550|NCT02331446|3515657|B3|Yes||Chronic Use of Medication|This variable refers to a chronic use of any medication.|participants|Number|9|9.0||||||
3671551|NCT02331446|3515658|B2|Yes||Chronic Use of Medication|This variable refers to a chronic use of any medication.|participants|Number|9|9.0||||||
3671552|NCT02331446|3515659|B1|Yes||Chronic Use of Medication|This variable refers to a chronic use of any medication.|participants|Number|9|9.0||||||
3671553|NCT02331446|3515655|B5|No||Chronic Use of Medication|This variable refers to a chronic use of any medication.|participants|Number|3|3.0||||||
3671554|NCT02331446|3515656|B4|No||Chronic Use of Medication|This variable refers to a chronic use of any medication.|participants|Number|1|1.0||||||
3671555|NCT02331446|3515657|B3|No||Chronic Use of Medication|This variable refers to a chronic use of any medication.|participants|Number|1|1.0||||||
3671556|NCT02331446|3515658|B2|No||Chronic Use of Medication|This variable refers to a chronic use of any medication.|participants|Number|1|1.0||||||
3671557|NCT02331446|3515659|B1|No||Chronic Use of Medication|This variable refers to a chronic use of any medication.|participants|Number|0|0.0||||||
3671558|NCT02331446|3515655|B5|Higher education||Educational level||participants|Number|3|3.0||||||
3671559|NCT02331446|3515656|B4|Higher education||Educational level||participants|Number|1|1.0||||||
3671560|NCT02331446|3515657|B3|Higher education||Educational level||participants|Number|0|0.0||||||
3671561|NCT02331446|3515658|B2|Higher education||Educational level||participants|Number|1|1.0||||||
3671562|NCT02331446|3515659|B1|Higher education||Educational level||participants|Number|1|1.0||||||
3671563|NCT02331446|3515655|B5|Incomplete higher education||Educational level||participants|Number|2|2.0||||||
3671564|NCT02331446|3515656|B4|Incomplete higher education||Educational level||participants|Number|2|2.0||||||
3671565|NCT02331446|3515657|B3|Incomplete higher education||Educational level||participants|Number|0|0.0||||||
3671566|NCT02331446|3515658|B2|Incomplete higher education||Educational level||participants|Number|0|0.0||||||
3671567|NCT02331446|3515659|B1|Incomplete higher education||Educational level||participants|Number|0|0.0||||||
3671568|NCT02331446|3515655|B5|High school||Educational level||participants|Number|10|10.0||||||
3671569|NCT02331446|3515656|B4|High school||Educational level||participants|Number|2|2.0||||||
3671570|NCT02331446|3515657|B3|High school||Educational level||participants|Number|4|4.0||||||
3671571|NCT02331446|3515658|B2|High school||Educational level||participants|Number|1|1.0||||||
3671572|NCT02331446|3515659|B1|High school||Educational level||participants|Number|3|3.0||||||
3671573|NCT02331446|3515655|B5|Incomplete high school||Educational level||participants|Number|4|4.0||||||
3671574|NCT02331446|3515656|B4|Incomplete high school||Educational level||participants|Number|0|0.0||||||
3671575|NCT02331446|3515657|B3|Incomplete high school||Educational level||participants|Number|2|2.0||||||
3671576|NCT02331446|3515658|B2|Incomplete high school||Educational level||participants|Number|1|1.0||||||
3671577|NCT02331446|3515659|B1|Incomplete high school||Educational level||participants|Number|1|1.0||||||
3671578|NCT02331446|3515655|B5|Primary school||Educational level||participants|Number|9|9.0||||||
3671579|NCT02331446|3515656|B4|Primary school||Educational level||participants|Number|2|2.0||||||
3671580|NCT02331446|3515657|B3|Primary school||Educational level||participants|Number|1|1.0||||||
3671581|NCT02331446|3515658|B2|Primary school||Educational level||participants|Number|3|3.0||||||
3671582|NCT02331446|3515659|B1|Primary school||Educational level||participants|Number|3|3.0||||||
3671583|NCT02331446|3515655|B5|Incomplete primary school||Educational level||participants|Number|12|12.0||||||
3671584|NCT02331446|3515656|B4|Incomplete primary school||Educational level||participants|Number|4|4.0||||||
3671585|NCT02331446|3515657|B3|Incomplete primary school||Educational level||participants|Number|3|3.0||||||
3671586|NCT02331446|3515658|B2|Incomplete primary school||Educational level||participants|Number|4|4.0||||||
3671587|NCT02331446|3515659|B1|Incomplete primary school||Educational level||participants|Number|1|1.0||||||
3671588|NCT02331446|3515655|B5|Others||Marital status||participants|Number|24|24.0||||||
3671589|NCT02331446|3515656|B4|Others||Marital status||participants|Number|10|10.0||||||
3671590|NCT02331446|3515657|B3|Others||Marital status||participants|Number|3|3.0||||||
3671591|NCT02331446|3515658|B2|Others||Marital status||participants|Number|6|6.0||||||
3671592|NCT02331446|3515659|B1|Others||Marital status||participants|Number|5|5.0||||||
3671593|NCT02331446|3515655|B5|Married||Marital status||participants|Number|16|16.0||||||
3671594|NCT02331446|3515656|B4|Married||Marital status||participants|Number|1|1.0||||||
3671595|NCT02331446|3515657|B3|Married||Marital status||participants|Number|7|7.0||||||
3671596|NCT02331446|3515658|B2|Married||Marital status||participants|Number|4|4.0||||||
3671597|NCT02331446|3515659|B1|Married||Marital status||participants|Number|4|4.0||||||
3671598|NCT02331446|3515655|B5|||Diastolic blood pressure||mmHg|Mean|76.4|76.4|Standard Deviation|10.6|10.6|||
3671599|NCT02331446|3515656|B4|||Diastolic blood pressure||mmHg|Mean|78.7|78.7|Standard Deviation|7.1|7.1|||
3671600|NCT02331446|3515657|B3|||Diastolic blood pressure||mmHg|Mean|76.0|76.0|Standard Deviation|7.0|7.0|||
3671601|NCT02331446|3515658|B2|||Diastolic blood pressure||mmHg|Mean|75.2|75.2|Standard Deviation|17.2|17.2|||
3671602|NCT02331446|3515659|B1|||Diastolic blood pressure||mmHg|Mean|74.4|74.4|Standard Deviation|8.8|8.8|||
3671603|NCT02331446|3515655|B5|||Systolic blood pressure||mmHg|Mean|120.8|120.8|Standard Deviation|14.3|14.3|||
3671604|NCT02331446|3515656|B4|||Systolic blood pressure||mmHg|Mean|121.0|121.0|Standard Deviation|14.2|14.2|||
3671605|NCT02331446|3515657|B3|||Systolic blood pressure||mmHg|Mean|121.2|121.2|Standard Deviation|12.4|12.4|||
3671606|NCT02331446|3515658|B2|||Systolic blood pressure||mmHg|Mean|118.2|118.2|Standard Deviation|20.4|20.4|||
3671607|NCT02331446|3515659|B1|||Systolic blood pressure||mmHg|Mean|119.8|119.8|Standard Deviation|6.7|6.7|||
3671608|NCT02331446|3515655|B5|||Resting heart rate||bpm|Mean|65.5|65.5|Standard Deviation|10.6|10.6|||
3671609|NCT02331446|3515656|B4|||Resting heart rate||bpm|Mean|68.1|68.1|Standard Deviation|12.1|12.1|||
3671610|NCT02331446|3515657|B3|||Resting heart rate||bpm|Mean|64.5|64.5|Standard Deviation|9.2|9.2|||
3671611|NCT02331446|3515658|B2|||Resting heart rate||bpm|Mean|64.7|64.7|Standard Deviation|13.1|13.1|||
3671612|NCT02331446|3515659|B1|||Resting heart rate||bpm|Mean|65.8|65.8|Standard Deviation|7.9|7.9|||
3671613|NCT02331446|3515655|B5|||Household Income||US$|Median|612|612.0|Inter-Quartile Range|||338.0|1015.0|
3671614|NCT02331446|3515656|B4|||Household Income||US$|Median|423|423.0|Inter-Quartile Range|||306.0|655.0|
3671615|NCT02331446|3515657|B3|||Household Income||US$|Median|867|867.0|Inter-Quartile Range|||444.0|1269.0|
3671616|NCT02331446|3515658|B2|||Household Income||US$|Median|538|538.0|Inter-Quartile Range|||338.0|846.0|
3671617|NCT02331446|3515659|B1|||Household Income||US$|Median|846|846.0|Inter-Quartile Range|||612.0|1692.0|
3671618|NCT02331446|3515655|B5|Brazil||Region of Enrollment||participants|Number|40|40.0||||||
3671619|NCT02331446|3515656|B4|Brazil||Region of Enrollment||participants|Number|11|11.0||||||
3671620|NCT02331446|3515657|B3|Brazil||Region of Enrollment||participants|Number|10|10.0||||||
3671621|NCT02331446|3515658|B2|Brazil||Region of Enrollment||participants|Number|10|10.0||||||
3671622|NCT02331446|3515659|B1|Brazil||Region of Enrollment||participants|Number|9|9.0||||||
3671623|NCT02331446|3515655|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671624|NCT02331446|3515656|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671625|NCT02331446|3515657|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671626|NCT02331446|3515658|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671627|NCT02331446|3515659|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671628|NCT02331446|3515655|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671629|NCT02331446|3515656|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671630|NCT02331446|3515657|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671631|NCT02331446|3515658|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671632|NCT02331446|3515659|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671633|NCT02331446|3515655|B5||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3671634|NCT02331446|3515656|B4||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3671635|NCT02331446|3515657|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3671636|NCT02331446|3515658|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3671637|NCT02331446|3515659|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3671638|NCT02331446|3515655|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3671639|NCT02331446|3515656|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3671640|NCT02331446|3515657|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3671641|NCT02331446|3515658|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3671642|NCT02331446|3515659|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3671643|NCT02331446|3515655|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671644|NCT02331446|3515656|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671645|NCT02331446|3515657|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671646|NCT02331446|3515658|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671647|NCT02331446|3515659|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671648|NCT02331446|3515655|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671649|NCT02331446|3515656|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671650|NCT02331446|3515657|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671651|NCT02331446|3515658|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671652|NCT02331446|3515659|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671653|NCT02331446|3515655|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671654|NCT02331446|3515656|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671655|NCT02331446|3515657|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671656|NCT02331446|3515658|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671657|NCT02331446|3515659|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671658|NCT02331446|3515655|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3671659|NCT02331446|3515656|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3671660|NCT02331446|3515657|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3671661|NCT02331446|3515658|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3671662|NCT02331446|3515659|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3671663|NCT02331446|3515655|B5||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3671664|NCT02331446|3515656|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3671665|NCT02331446|3515657|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3671666|NCT02331446|3515658|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3671667|NCT02331446|3515659|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3671668|NCT02331446|3515655|B5|||Age||years|Median|63|63.0|Inter-Quartile Range|||60.0|68.0|
3671669|NCT02331446|3515656|B4|||Age||years|Median|63|63.0|Inter-Quartile Range|||62.0|65.0|
3671670|NCT02331446|3515657|B3|||Age||years|Median|61.5|61.5|Inter-Quartile Range|||59.0|67.0|
3671671|NCT02331446|3515658|B2|||Age||years|Median|62|62.0|Inter-Quartile Range|||52.0|74.0|
3671672|NCT02331446|3515659|B1|||Age||years|Median|70|70.0|Inter-Quartile Range|||63.0|73.0|
3671673|NCT02331368|3515732|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3671674|NCT02331368|3515732|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3671675|NCT02331368|3515732|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3671676|NCT02331368|3515732|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3671677|NCT02331368|3515732|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3671678|NCT02331368|3515732|B1|||Age||years|Median|59|59.0|Full Range|||49.0|70.0|
3671679|NCT02331108|3515738|B7|United States||Region of Enrollment||participants|Number|309|309.0||||||
3671680|NCT02331108|3515739|B6|United States||Region of Enrollment||participants|Number|52|52.0||||||
3671681|NCT02331108|3515740|B5|United States||Region of Enrollment||participants|Number|52|52.0||||||
3671682|NCT02331108|3515741|B4|United States||Region of Enrollment||participants|Number|51|51.0||||||
3671683|NCT02331108|3515742|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
3671684|NCT02331108|3515743|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
3671685|NCT02331108|3515744|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
3671686|NCT02331108|3515738|B7|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3671687|NCT02331108|3515738|B7||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3671688|NCT02331108|3515739|B6||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3671689|NCT02331108|3515740|B5||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3671690|NCT02331108|3515741|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3671691|NCT02331108|3515742|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3671692|NCT02331108|3515743|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3671693|NCT02331108|3515744|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3671694|NCT02331108|3515738|B7||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3671695|NCT02331108|3515739|B6||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3671696|NCT02331108|3515740|B5||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3671697|NCT02331108|3515741|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3671698|NCT02331108|3515742|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3671699|NCT02331108|3515743|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3671700|NCT02331108|3515744|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3671701|NCT02331108|3515738|B7|||Age||years|Mean|50.0|50.0|Standard Deviation|15.3|15.3|||
3671702|NCT02331108|3515739|B6|||Age||years|Mean|66.2|66.2|Standard Deviation|7.4|7.4|||
3671703|NCT02331108|3515740|B5|||Age||years|Mean|68.2|68.2|Standard Deviation|8.4|8.4|||
3671704|NCT02331108|3515741|B4|||Age||years|Mean|40.6|40.6|Standard Deviation|9.1|9.1|||
3671705|NCT02331108|3515742|B3|||Age||years|Mean|39.0|39.0|Standard Deviation|11.2|11.2|||
3671706|NCT02331108|3515743|B2|||Age||years|Mean|43.0|43.0|Standard Deviation|8.8|8.8|||
3671707|NCT02331108|3515744|B1|||Age||years|Mean|42.8|42.8|Standard Deviation|10.1|10.1|||
3671708|NCT02331108|3515738|B7||>=65 years|Age||Participants|Count of Participants|58|58.0||||||
3671709|NCT02331108|3515739|B6||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
3671710|NCT02331108|3515740|B5||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
3671711|NCT02331108|3515741|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3671712|NCT02331108|3515742|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3671713|NCT02331108|3515743|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3671714|NCT02331108|3515744|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3671715|NCT02331108|3515738|B7||Between 18 and 65 years|Age||Participants|Count of Participants|251|251.0||||||
3671716|NCT02331108|3515739|B6||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3671717|NCT02331108|3515740|B5||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3671718|NCT02331108|3515741|B4||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3671719|NCT02331108|3515742|B3||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3671720|NCT02331108|3515743|B2||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3671721|NCT02331108|3515744|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3671722|NCT02331108|3515738|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3671723|NCT02331108|3515739|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3671724|NCT02331108|3515740|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3671725|NCT02331108|3515741|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3671726|NCT02331108|3515742|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3671727|NCT02331108|3515743|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3671728|NCT02331108|3515744|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3671729|NCT02330588|3515771|B6||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3671730|NCT02330588|3515772|B5||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3671731|NCT02330588|3515773|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3671732|NCT02330588|3515774|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3671733|NCT02330588|3515775|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3671734|NCT02330588|3515776|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3671735|NCT02330588|3515771|B6||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3671736|NCT02330588|3515772|B5||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3671737|NCT02330588|3515773|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3671738|NCT02330588|3515774|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3671739|NCT02330588|3515775|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3671740|NCT02330588|3515776|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3671741|NCT02330588|3515771|B6|||Age||years|Mean|9.9|9.9|Standard Deviation|3.4|3.4|||
3671742|NCT02330588|3515772|B5|||Age||years|Mean|10.2|10.2|Standard Deviation|2.9|2.9|||
3671743|NCT02330588|3515773|B4|||Age||years|Mean|9.6|9.6|Standard Deviation|3.5|3.5|||
3671744|NCT02330588|3515774|B3|||Age||years|Mean|10.3|10.3|Standard Deviation|3.9|3.9|||
3671745|NCT02330588|3515775|B2|||Age||years|Mean|9.7|9.7|Standard Deviation|3.2|3.2|||
3671746|NCT02330588|3515776|B1|||Age||years|Mean|9.8|9.8|Standard Deviation|3.6|3.6|||
3671747|NCT02330588|3515771|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3671748|NCT02330588|3515772|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3671749|NCT02330588|3515773|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3671750|NCT02330588|3515774|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3671751|NCT02330588|3515775|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3671752|NCT02330588|3515776|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3671753|NCT02330588|3515771|B6||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3671754|NCT02330588|3515772|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3671755|NCT02330588|3515773|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3671756|NCT02330588|3515774|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3671757|NCT02330588|3515775|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3671758|NCT02330588|3515776|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3671759|NCT02330588|3515771|B6||<=18 years|Age||Participants|Count of Participants|226|226.0||||||
3671760|NCT02330588|3515772|B5||<=18 years|Age||Participants|Count of Participants|47|47.0||||||
3671761|NCT02330588|3515773|B4||<=18 years|Age||Participants|Count of Participants|46|46.0||||||
3671762|NCT02330588|3515774|B3||<=18 years|Age||Participants|Count of Participants|46|46.0||||||
3671763|NCT02330588|3515775|B2||<=18 years|Age||Participants|Count of Participants|43|43.0||||||
3671764|NCT02330588|3515776|B1||<=18 years|Age||Participants|Count of Participants|44|44.0||||||
3671765|NCT02330523|3515805|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3671766|NCT02330523|3515806|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3671767|NCT02330523|3515807|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3671768|NCT02330523|3515805|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3671769|NCT02330523|3515806|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3671770|NCT02330523|3515807|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3671771|NCT02330523|3515805|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3671772|NCT02330523|3515806|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3671773|NCT02330523|3515807|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3671774|NCT02330523|3515805|B3|||Age||years|Mean|55.7|55.7|Standard Deviation|11.8|11.8|||
3671775|NCT02330523|3515806|B2|||Age||years|Mean|55.3|55.3|Standard Deviation|13.3|13.3|||
3671776|NCT02330523|3515807|B1|||Age||years|Mean|55.9|55.9|Standard Deviation|10.7|10.7|||
3671777|NCT02330276|3515818|B4|United States||Region of Enrollment||participants|Number|12|12.0||||||
3671778|NCT02330276|3515819|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3671779|NCT02330276|3515820|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3671780|NCT02330276|3515821|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3671781|NCT02330276|3515818|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671782|NCT02330276|3515819|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671783|NCT02330276|3515820|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671784|NCT02330276|3515821|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671785|NCT02330276|3515818|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671786|NCT02330276|3515819|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671787|NCT02330276|3515820|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671788|NCT02330276|3515821|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671789|NCT02330276|3515818|B4||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3671790|NCT02330276|3515819|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3671791|NCT02330276|3515820|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3671792|NCT02330276|3515821|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671793|NCT02330276|3515818|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3671794|NCT02330276|3515819|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671795|NCT02330276|3515820|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671796|NCT02330276|3515821|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3671797|NCT02330276|3515818|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671798|NCT02330276|3515819|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671799|NCT02330276|3515820|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671800|NCT02330276|3515821|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671801|NCT02330276|3515818|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671802|NCT02330276|3515819|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671803|NCT02330276|3515820|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671804|NCT02330276|3515821|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671805|NCT02330276|3515818|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3671806|NCT02330276|3515819|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671807|NCT02330276|3515820|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671808|NCT02330276|3515821|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3671809|NCT02330276|3515818|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3671810|NCT02330276|3515819|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3671811|NCT02330276|3515820|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3671812|NCT02330276|3515821|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3671813|NCT02330276|3515818|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3671814|NCT02330276|3515819|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3671815|NCT02330276|3515820|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3671816|NCT02330276|3515821|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3671817|NCT02330276|3515818|B4||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3671818|NCT02330276|3515819|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3671819|NCT02330276|3515820|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3671820|NCT02330276|3515821|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3671821|NCT02330276|3515818|B4||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3671822|NCT02330276|3515819|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3671823|NCT02330276|3515820|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3671824|NCT02330276|3515821|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3671825|NCT02330276|3515818|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3671826|NCT02330276|3515819|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3671827|NCT02330276|3515820|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3671828|NCT02330276|3515821|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3671829|NCT02330172|3515843|B3|Korea, Republic of||Region of Enrollment||participants|Number|44|44.0||||||
3671830|NCT02330172|3515844|B2|Korea, Republic of||Region of Enrollment||participants|Number|22|22.0||||||
3671831|NCT02330172|3515845|B1|Korea, Republic of||Region of Enrollment||participants|Number|22|22.0||||||
3671832|NCT02330172|3515843|B3|Number of South Korean participants||Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
3671833|NCT02330172|3515844|B2|Number of South Korean participants||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3671834|NCT02330172|3515845|B1|Number of South Korean participants||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3671835|NCT02330172|3515843|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3671836|NCT02330172|3515844|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3671837|NCT02330172|3515845|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3671838|NCT02330172|3515843|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3671839|NCT02330172|3515844|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3671840|NCT02330172|3515845|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3671841|NCT02330172|3515843|B3|Population from 18 years to 65 years|>=65 years|Age|From 18 years to 65 years|Participants|Count of Participants|0|0.0||||||
3671842|NCT02330172|3515844|B2|Population from 18 years to 65 years|>=65 years|Age|From 18 years to 65 years|Participants|Count of Participants|0|0.0||||||
3671843|NCT02330172|3515845|B1|Population from 18 years to 65 years|>=65 years|Age|From 18 years to 65 years|Participants|Count of Participants|0|0.0||||||
3671844|NCT02330172|3515843|B3|Population from 18 years to 65 years|Between 18 and 65 years|Age|From 18 years to 65 years|Participants|Count of Participants|44|44.0||||||
3671845|NCT02330172|3515844|B2|Population from 18 years to 65 years|Between 18 and 65 years|Age|From 18 years to 65 years|Participants|Count of Participants|22|22.0||||||
3671846|NCT02330172|3515845|B1|Population from 18 years to 65 years|Between 18 and 65 years|Age|From 18 years to 65 years|Participants|Count of Participants|22|22.0||||||
3671847|NCT02330172|3515843|B3|Population from 18 years to 65 years|<=18 years|Age|From 18 years to 65 years|Participants|Count of Participants|0|0.0||||||
3671848|NCT02330172|3515844|B2|Population from 18 years to 65 years|<=18 years|Age|From 18 years to 65 years|Participants|Count of Participants|0|0.0||||||
3671849|NCT02330172|3515845|B1|Population from 18 years to 65 years|<=18 years|Age|From 18 years to 65 years|Participants|Count of Participants|0|0.0||||||
3671850|NCT02330055|3515854|B3||Cesarean section|Delivery Type||Participants|Count of Participants|40|40.0||||||
3671851|NCT02330055|3515855|B2||Cesarean section|Delivery Type||Participants|Count of Participants|20|20.0||||||
3671852|NCT02330055|3515856|B1||Cesarean section|Delivery Type||Participants|Count of Participants|20|20.0||||||
3671853|NCT02330055|3515854|B3||Vaginal|Delivery Type||Participants|Count of Participants|40|40.0||||||
3671854|NCT02330055|3515855|B2||Vaginal|Delivery Type||Participants|Count of Participants|20|20.0||||||
3671855|NCT02330055|3515856|B1||Vaginal|Delivery Type||Participants|Count of Participants|20|20.0||||||
3671856|NCT02330055|3515854|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3671857|NCT02330055|3515855|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3671858|NCT02330055|3515856|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3671859|NCT02330055|3515854|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3671860|NCT02330055|3515855|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3671861|NCT02330055|3515856|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671862|NCT02330055|3515854|B3||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3671863|NCT02330055|3515855|B2||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3671864|NCT02330055|3515856|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3671865|NCT02330055|3515854|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3671866|NCT02330055|3515855|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3671867|NCT02330055|3515856|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3671868|NCT02330055|3515854|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671869|NCT02330055|3515855|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671870|NCT02330055|3515856|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671871|NCT02330055|3515854|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3671872|NCT02330055|3515855|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3671873|NCT02330055|3515856|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3671874|NCT02330055|3515854|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671875|NCT02330055|3515855|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671876|NCT02330055|3515856|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671877|NCT02330055|3515854|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3671878|NCT02330055|3515855|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3671879|NCT02330055|3515856|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3671880|NCT02330055|3515854|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3671881|NCT02330055|3515855|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3671882|NCT02330055|3515856|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3671883|NCT02330055|3515854|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3671884|NCT02330055|3515855|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3671885|NCT02330055|3515856|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3671886|NCT02330055|3515854|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3671887|NCT02330055|3515855|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3671888|NCT02330055|3515856|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3671889|NCT02330055|3515854|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3671890|NCT02330055|3515855|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3671891|NCT02330055|3515856|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3671892|NCT02330055|3515854|B3|||Age||years|Mean|33|33.0|Standard Deviation|5|5.0|||
3671893|NCT02330055|3515855|B2|||Age||years|Mean|32.5|32.5|Standard Deviation|5|5.0|||
3671894|NCT02330055|3515856|B1|||Age||years|Mean|34.5|34.5|Standard Deviation|5.5|5.5|||
3671895|NCT02329964|3515875|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3671896|NCT02329964|3515876|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3671897|NCT02329964|3515877|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3671898|NCT02329964|3515875|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3671899|NCT02329964|3515876|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3671900|NCT02329964|3515877|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3671901|NCT02329964|3515875|B3|||Age||years|Mean|50|50.0|Standard Deviation|13|13.0|||
3671902|NCT02329964|3515876|B2|||Age||years|Mean|52|52.0|Standard Deviation|15|15.0|||
3671903|NCT02329964|3515877|B1|||Age||years|Mean|48|48.0|Standard Deviation|12|12.0|||
3671904|NCT02329964|3515875|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3671905|NCT02329964|3515876|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3671906|NCT02329964|3515877|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3671907|NCT02329964|3515875|B3||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
3671908|NCT02329964|3515876|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3671909|NCT02329964|3515877|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3671910|NCT02329964|3515875|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3671911|NCT02329964|3515876|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3671912|NCT02329964|3515877|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3671913|NCT02329730|3515900|B5|||weight||kg|Mean|60.78|60.78|Standard Deviation|10.12|10.12|||
3671914|NCT02329730|3515901|B4|||weight||kg|Mean|59.42|59.42|Standard Deviation|11.56|11.56|||
3671915|NCT02329730|3515902|B3|||weight||kg|Mean|59.33|59.33|Standard Deviation|9.40|9.4|||
3671916|NCT02329730|3515903|B2|||weight||kg|Mean|62.15|62.15|Standard Deviation|9.83|9.83|||
3671917|NCT02329730|3515904|B1|||weight||kg|Mean|62.20|62.2|Standard Deviation|9.70|9.7|||
3671918|NCT02329730|3515900|B5|||height||cm|Mean|166.52|166.52|Standard Deviation|7.67|7.67|||
3671919|NCT02329730|3515901|B4|||height||cm|Mean|165.47|165.47|Standard Deviation|7.81|7.81|||
3671920|NCT02329730|3515902|B3|||height||cm|Mean|167.44|167.44|Standard Deviation|8.23|8.23|||
3671921|NCT02329730|3515903|B2|||height||cm|Mean|166.32|166.32|Standard Deviation|7.59|7.59|||
3671922|NCT02329730|3515904|B1|||height||cm|Mean|166.83|166.83|Standard Deviation|7.06|7.06|||
3671923|NCT02329730|3515900|B5||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3671924|NCT02329730|3515901|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3671925|NCT02329730|3515902|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3671926|NCT02329730|3515903|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3671927|NCT02329730|3515904|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3671928|NCT02329730|3515900|B5||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3671929|NCT02329730|3515901|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3671930|NCT02329730|3515902|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3671931|NCT02329730|3515903|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3671932|NCT02329730|3515904|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3671933|NCT02329730|3515900|B5|||Age||years|Mean|41.76|41.76|Standard Deviation|12.42|12.42|||
3671934|NCT02329730|3515901|B4|||Age||years|Mean|44.63|44.63|Standard Deviation|12.37|12.37|||
3671935|NCT02329730|3515902|B3|||Age||years|Mean|43.81|43.81|Standard Deviation|12.53|12.53|||
3671936|NCT02329730|3515903|B2|||Age||years|Mean|38.46|38.46|Standard Deviation|11.98|11.98|||
3671937|NCT02329730|3515904|B1|||Age||years|Mean|40.12|40.12|Standard Deviation|12.83|12.83|||
3671938|NCT02329600|3515989|B4|Egypt||Region of Enrollment||participants|Number|40|40.0||||||
3671939|NCT02329600|3515990|B3|Egypt||Region of Enrollment||participants|Number|15|15.0||||||
3671940|NCT02329600|3515991|B2|Egypt||Region of Enrollment||participants|Number|15|15.0||||||
3671941|NCT02329600|3515992|B1|Egypt||Region of Enrollment||participants|Number|10|10.0||||||
3671942|NCT02329600|3515989|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3671943|NCT02329600|3515990|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3671944|NCT02329600|3515991|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3671945|NCT02329600|3515992|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3671946|NCT02329600|3515989|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3671947|NCT02329600|3515990|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3671948|NCT02329600|3515991|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3671949|NCT02329600|3515992|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3671950|NCT02329600|3515989|B4|||Age||years|Mean|38|38.0|Standard Deviation|15.3|15.3|||
3671951|NCT02329600|3515990|B3|||Age||years|Mean|44.3|44.3|Standard Deviation|16.2|16.2|||
3671952|NCT02329600|3515991|B2|||Age||years|Mean|41.4|41.4|Standard Deviation|9.7|9.7|||
3671953|NCT02329600|3515992|B1|||Age||years|Mean|27.6|27.6|Standard Deviation|2.7|2.7|||
3671954|NCT02329600|3515989|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3671955|NCT02329600|3515990|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3671956|NCT02329600|3515991|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3671957|NCT02329600|3515992|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3671958|NCT02329600|3515989|B4||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3671959|NCT02329600|3515990|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3671960|NCT02329600|3515991|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3671961|NCT02329600|3515992|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3671962|NCT02329600|3515989|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3671963|NCT02329600|3515990|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3671964|NCT02329600|3515991|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3671965|NCT02329600|3515992|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3671966|NCT02329587|3516005|B3|||Yale-Brown Obsessive-Compulsive Scale (Y-BOCS): Total Score|The Y-BOCS is a well-known measure of obsessive-compulsive disorder (OCD) symptom severity. Total scores can range from 0-40, with higher scores corresponding to greater severity of symptoms.|units on a scale|Mean|25.08|25.08|Standard Deviation|5.04|5.04|||
3671967|NCT02329587|3516006|B2|||Yale-Brown Obsessive-Compulsive Scale (Y-BOCS): Total Score|The Y-BOCS is a well-known measure of obsessive-compulsive disorder (OCD) symptom severity. Total scores can range from 0-40, with higher scores corresponding to greater severity of symptoms.|units on a scale|Mean|25.29|25.29|Standard Deviation|4.27|4.27|||
3671968|NCT02329587|3516007|B1|||Yale-Brown Obsessive-Compulsive Scale (Y-BOCS): Total Score|The Y-BOCS is a well-known measure of obsessive-compulsive disorder (OCD) symptom severity. Total scores can range from 0-40, with higher scores corresponding to greater severity of symptoms.|units on a scale|Mean|24.80|24.8|Standard Deviation|6.50|6.5|||
3671969|NCT02329587|3516005|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3671970|NCT02329587|3516006|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671971|NCT02329587|3516007|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3671972|NCT02329587|3516005|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671973|NCT02329587|3516006|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671974|NCT02329587|3516007|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671975|NCT02329587|3516005|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3671976|NCT02329587|3516006|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3671977|NCT02329587|3516007|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3671978|NCT02329587|3516005|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671979|NCT02329587|3516006|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671980|NCT02329587|3516007|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671981|NCT02329587|3516005|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671982|NCT02329587|3516006|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671983|NCT02329587|3516007|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671984|NCT02329587|3516005|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671985|NCT02329587|3516006|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671986|NCT02329587|3516007|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671987|NCT02329587|3516005|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671988|NCT02329587|3516006|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671989|NCT02329587|3516007|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671990|NCT02329587|3516005|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671991|NCT02329587|3516006|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671992|NCT02329587|3516007|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671993|NCT02329587|3516005|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3671994|NCT02329587|3516006|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3671995|NCT02329587|3516007|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3671996|NCT02329587|3516005|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3671997|NCT02329587|3516006|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3671998|NCT02329587|3516007|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3671999|NCT02329587|3516005|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3672000|NCT02329587|3516006|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3672001|NCT02329587|3516007|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3672002|NCT02329587|3516005|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3672003|NCT02329587|3516006|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3672004|NCT02329587|3516007|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3672005|NCT02329587|3516005|B3|||Age||years|Mean|39.08|39.08|Standard Deviation|13.47|13.47|||
3672006|NCT02329587|3516006|B2|||Age||years|Mean|39.86|39.86|Standard Deviation|11.35|11.35|||
3672007|NCT02329587|3516007|B1|||Age||years|Mean|38.00|38.0|Standard Deviation|17.42|17.42|||
3672008|NCT02329431|3516024|B3|||Medicaid coverage|Target child covered by Medicaid|Participants|Count of Participants|124|124.0||||||
3672009|NCT02329431|3516025|B2|||Medicaid coverage|Target child covered by Medicaid|Participants|Count of Participants|62|62.0||||||
3672010|NCT02329431|3516026|B1|||Medicaid coverage|Target child covered by Medicaid|Participants|Count of Participants|62|62.0||||||
3672011|NCT02329431|3516024|B3|United States||Region of Enrollment||Participants|Count of Participants|172|172.0||||||
3672012|NCT02329431|3516025|B2|United States||Region of Enrollment||Participants|Count of Participants|85|85.0||||||
3672013|NCT02329431|3516026|B1|United States||Region of Enrollment||Participants|Count of Participants|87|87.0||||||
3672014|NCT02329431|3516024|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672015|NCT02329431|3516025|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672016|NCT02329431|3516026|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672017|NCT02329431|3516024|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672018|NCT02329431|3516025|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672019|NCT02329431|3516026|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672020|NCT02329431|3516024|B3||White|Race (NIH/OMB)||Participants|Count of Participants|172|172.0||||||
3672021|NCT02329431|3516025|B2||White|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3672022|NCT02329431|3516026|B1||White|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3672023|NCT02329431|3516024|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672024|NCT02329431|3516025|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672025|NCT02329431|3516026|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672026|NCT02329431|3516024|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672027|NCT02329431|3516025|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672028|NCT02329431|3516026|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672029|NCT02329431|3516024|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672030|NCT02329431|3516025|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672031|NCT02329431|3516026|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672032|NCT02329431|3516024|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672033|NCT02329431|3516025|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672034|NCT02329431|3516026|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672035|NCT02329431|3516024|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672036|NCT02329431|3516025|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672037|NCT02329431|3516026|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672038|NCT02329431|3516024|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672039|NCT02329431|3516025|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672040|NCT02329431|3516026|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672041|NCT02329431|3516024|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|172|172.0||||||
3672042|NCT02329431|3516025|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3672043|NCT02329431|3516026|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3672044|NCT02329431|3516024|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3672045|NCT02329431|3516025|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3672046|NCT02329431|3516026|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3672047|NCT02329431|3516024|B3||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3672048|NCT02329431|3516025|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3672049|NCT02329431|3516026|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3672050|NCT02329431|3516024|B3|||Age||years|Mean|35.8|35.8|Standard Deviation|6.6|6.6|||
3672051|NCT02329431|3516025|B2|||Age||years|Mean|36.4|36.4|Standard Deviation|6.3|6.3|||
3672052|NCT02329431|3516026|B1|||Age||years|Mean|35.3|35.3|Standard Deviation|6.9|6.9|||
3672053|NCT02329223|3516043|B4||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3672054|NCT02329223|3516044|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3672055|NCT02329223|3516045|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3672056|NCT02329223|3516046|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3672057|NCT02329223|3516043|B4||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3672058|NCT02329223|3516044|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3672059|NCT02329223|3516045|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3672060|NCT02329223|3516046|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3672061|NCT02329223|3516043|B4|||Age||Years|Mean|43.5|43.5|Standard Deviation|13.81|13.81|||
3672062|NCT02329223|3516044|B3|||Age||Years|Mean|42.5|42.5|Standard Deviation|14.26|14.26|||
3672063|NCT02329223|3516045|B2|||Age||Years|Mean|43.6|43.6|Standard Deviation|12.24|12.24|||
3672064|NCT02329223|3516046|B1|||Age||Years|Mean|44.6|44.6|Standard Deviation|14.86|14.86|||
3672065|NCT02329015|3516079|B3|||Cardiovascular Fitness (Pacer Test: Fitnessgram)|The Pacer test is a test of aerobic fitness wherein participants are required to run back and forth on a level surface 20 meters in length. The allowed time to successfully complete each 20 meter run is gradually increased via an audible timer. The score represents the final number of runs successfully completed within the allowed time. Values range from 1-106 with higher values representing greater levels of aerobic fitness.|Number of 20 meter laps completed|Mean|50.8|50.8|Standard Deviation|15.63|15.63|||
3672066|NCT02329015|3516080|B2|||Cardiovascular Fitness (Pacer Test: Fitnessgram)|The Pacer test is a test of aerobic fitness wherein participants are required to run back and forth on a level surface 20 meters in length. The allowed time to successfully complete each 20 meter run is gradually increased via an audible timer. The score represents the final number of runs successfully completed within the allowed time. Values range from 1-106 with higher values representing greater levels of aerobic fitness.|Number of 20 meter laps completed|Mean|52.9|52.9|Standard Deviation|17.3|17.3|||
3672067|NCT02329015|3516081|B1|||Cardiovascular Fitness (Pacer Test: Fitnessgram)|The Pacer test is a test of aerobic fitness wherein participants are required to run back and forth on a level surface 20 meters in length. The allowed time to successfully complete each 20 meter run is gradually increased via an audible timer. The score represents the final number of runs successfully completed within the allowed time. Values range from 1-106 with higher values representing greater levels of aerobic fitness.|Number of 20 meter laps completed|Mean|48|48.0|Standard Deviation|13.3|13.3|||
3672068|NCT02329015|3516079|B3|Full Price Lunch||Lunch Status|Data was not available for some participants relative to lunch status, therefore totals for each group do not equal baseline values|participants|Number|15|15.0||||||
3672069|NCT02329015|3516080|B2|Full Price Lunch||Lunch Status|Data was not available for some participants relative to lunch status, therefore totals for each group do not equal baseline values|participants|Number|8|8.0||||||
3672070|NCT02329015|3516081|B1|Full Price Lunch||Lunch Status|Data was not available for some participants relative to lunch status, therefore totals for each group do not equal baseline values|participants|Number|7|7.0||||||
3672071|NCT02329015|3516079|B3|Reduced Lunch||Lunch Status|Data was not available for some participants relative to lunch status, therefore totals for each group do not equal baseline values|participants|Number|17|17.0||||||
3672072|NCT02329015|3516080|B2|Reduced Lunch||Lunch Status|Data was not available for some participants relative to lunch status, therefore totals for each group do not equal baseline values|participants|Number|11|11.0||||||
3672073|NCT02329015|3516081|B1|Reduced Lunch||Lunch Status|Data was not available for some participants relative to lunch status, therefore totals for each group do not equal baseline values|participants|Number|6|6.0||||||
3672074|NCT02329015|3516079|B3|Free lunch||Lunch Status|Data was not available for some participants relative to lunch status, therefore totals for each group do not equal baseline values|participants|Number|71|71.0||||||
3672075|NCT02329015|3516080|B2|Free lunch||Lunch Status|Data was not available for some participants relative to lunch status, therefore totals for each group do not equal baseline values|participants|Number|40|40.0||||||
3672076|NCT02329015|3516081|B1|Free lunch||Lunch Status|Data was not available for some participants relative to lunch status, therefore totals for each group do not equal baseline values|participants|Number|31|31.0||||||
3672077|NCT02329015|3516079|B3|||Weight||pounds|Mean|128.64|128.64|Standard Deviation|23.9|23.9|||
3672078|NCT02329015|3516080|B2|||Weight||pounds|Mean|128.0|128.0|Standard Deviation|21.9|21.9|||
3672079|NCT02329015|3516081|B1|||Weight||pounds|Mean|129.5|129.5|Standard Deviation|26.6|26.6|||
3672080|NCT02329015|3516079|B3|||Height in inches||inches|Mean|56.4|56.4|Standard Deviation|5.23|5.23|||
3672081|NCT02329015|3516080|B2|||Height in inches||inches|Mean|57.5|57.5|Standard Deviation|4.9|4.9|||
3672082|NCT02329015|3516081|B1|||Height in inches||inches|Mean|54.9|54.9|Standard Deviation|5.7|5.7|||
3672083|NCT02329015|3516079|B3|||Grade Point Average Previous Academic Year|GPA was calculated as the numeric average of course scores of all courses taken by the student weighted by credit load of each course using a standard process within NYC public schools|per cent|Mean|84.34|84.34|Standard Deviation|7.81|7.81|||
3672084|NCT02329015|3516080|B2|||Grade Point Average Previous Academic Year|GPA was calculated as the numeric average of course scores of all courses taken by the student weighted by credit load of each course using a standard process within NYC public schools|per cent|Mean|83.38|83.38|Standard Deviation|7.68|7.68|||
3672085|NCT02329015|3516081|B1|||Grade Point Average Previous Academic Year|GPA was calculated as the numeric average of course scores of all courses taken by the student weighted by credit load of each course using a standard process within NYC public schools|per cent|Mean|85.62|85.62|Standard Deviation|7.9|7.9|||
3672086|NCT02329015|3516079|B3|United States||Region of Enrollment||participants|Number|112|112.0||||||
3672087|NCT02329015|3516080|B2|United States||Region of Enrollment||participants|Number|64|64.0||||||
3672088|NCT02329015|3516081|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
3672089|NCT02329015|3516079|B3|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3672090|NCT02329015|3516080|B2|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3672091|NCT02329015|3516081|B1|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3672092|NCT02329015|3516079|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
3672093|NCT02329015|3516080|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
3672094|NCT02329015|3516081|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3672095|NCT02329015|3516079|B3|Black||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3672096|NCT02329015|3516080|B2|Black||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3672097|NCT02329015|3516081|B1|Black||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3672098|NCT02329015|3516079|B3|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3672099|NCT02329015|3516080|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3672100|NCT02329015|3516081|B1|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3672101|NCT02329015|3516079|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3672102|NCT02329015|3516080|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3672103|NCT02329015|3516081|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3672104|NCT02329015|3516079|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3672105|NCT02329015|3516080|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3672106|NCT02329015|3516081|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3672107|NCT02329015|3516079|B3|||Age||years|Mean|15.3|15.3|Standard Deviation|.97|0.97|||
3672108|NCT02329015|3516080|B2|||Age||years|Mean|15.4|15.4|Standard Deviation|.98|0.98|||
3672109|NCT02329015|3516081|B1|||Age||years|Mean|15.2|15.2|Standard Deviation|.94|0.94|||
3672110|NCT02328937|3516098|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
3672111|NCT02328937|3516098|B1|White||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3672112|NCT02328937|3516098|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3672113|NCT02328937|3516098|B1|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3672114|NCT02328937|3516098|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3672115|NCT02328937|3516098|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3672116|NCT02328937|3516098|B1|||Age||years|Mean|32.9|32.9|Standard Deviation|8.71|8.71|||
3672117|NCT02328404|3516114|B3|Irrigular||Menstrual Cycle Regularity||participants|Number|51|51.0||||||
3672118|NCT02328404|3516115|B2|Irrigular||Menstrual Cycle Regularity||participants|Number|25|25.0||||||
3672119|NCT02328404|3516116|B1|Irrigular||Menstrual Cycle Regularity||participants|Number|26|26.0||||||
3672120|NCT02328404|3516114|B3|Regular||Menstrual Cycle Regularity||participants|Number|7|7.0||||||
3672121|NCT02328404|3516115|B2|Regular||Menstrual Cycle Regularity||participants|Number|4|4.0||||||
3672122|NCT02328404|3516116|B1|Regular||Menstrual Cycle Regularity||participants|Number|3|3.0||||||
3672123|NCT02328404|3516114|B3|||Body Mass Index||kg/m^2|Mean|27.33|27.33|Standard Deviation|0.23|0.23|||
3672124|NCT02328404|3516115|B2|||Body Mass Index||kg/m^2|Mean|27.33|27.33|Standard Deviation|0.30|0.3|||
3672125|NCT02328404|3516116|B1|||Body Mass Index||kg/m^2|Mean|27.33|27.33|Standard Deviation|0.16|0.16|||
3672126|NCT02328404|3516114|B3|||Sex Hormon Binding Globulin||nmol/L|Mean|84.55|84.55|Standard Deviation|13.00|13.0|||
3672127|NCT02328404|3516115|B2|||Sex Hormon Binding Globulin||nmol/L|Mean|111.2|111.2|Standard Deviation|16.7|16.7|||
3672128|NCT02328404|3516116|B1|||Sex Hormon Binding Globulin||nmol/L|Mean|57.9|57.9|Standard Deviation|9.29|9.29|||
3672129|NCT02328404|3516114|B3|||Oral Glucose Tolerance Test (1st Hour)||mmol/L|Mean|7.55|7.55|Standard Deviation|0.41|0.41|||
3672130|NCT02328404|3516115|B2|||Oral Glucose Tolerance Test (1st Hour)||mmol/L|Mean|7.7|7.7|Standard Deviation|0.48|0.48|||
3672131|NCT02328404|3516116|B1|||Oral Glucose Tolerance Test (1st Hour)||mmol/L|Mean|7.4|7.4|Standard Deviation|0.33|0.33|||
3672132|NCT02328404|3516114|B3|||C-Reactive Protien Serum Level||mg/L|Mean|5.15|5.15|Standard Deviation|0.91|0.91|||
3672133|NCT02328404|3516115|B2|||C-Reactive Protien Serum Level||mg/L|Mean|3.7|3.7|Standard Deviation|0.69|0.69|||
3672134|NCT02328404|3516116|B1|||C-Reactive Protien Serum Level||mg/L|Mean|6.6|6.6|Standard Deviation|1.13|1.13|||
3672135|NCT02328404|3516114|B3|||Fasting Blood Sugar Serum Level||mmol/L|Mean|4.83|4.83|Standard Deviation|0.04|0.04|||
3672136|NCT02328404|3516115|B2|||Fasting Blood Sugar Serum Level||mmol/L|Mean|4.9|4.9|Standard Deviation|0.07|0.07|||
3672137|NCT02328404|3516116|B1|||Fasting Blood Sugar Serum Level||mmol/L|Mean|4.7|4.7|Standard Deviation|0.07|0.07|||
3672138|NCT02328404|3516114|B3|||Fasting Insulin Serum Level||uU/ml|Mean|10.0|10.0|Standard Deviation|3.4|3.4|||
3672139|NCT02328404|3516115|B2|||Fasting Insulin Serum Level||uU/ml|Mean|9.8|9.8|Standard Deviation|2.17|2.17|||
3672140|NCT02328404|3516116|B1|||Fasting Insulin Serum Level||uU/ml|Mean|10.2|10.2|Standard Deviation|1.23|1.23|||
3672141|NCT02328404|3516114|B3|||TC / HDL-C Ratio|This indicate the Total Cholesterol to High Density Lipoprotien ratio. An optimal ratio is between 3.5-to-1. A higher ratio means a higher risk of heart disease.|Ratio|Mean|4.4|4.4|Standard Deviation|0.23|0.23|||
3672142|NCT02328404|3516115|B2|||TC / HDL-C Ratio|This indicate the Total Cholesterol to High Density Lipoprotien ratio. An optimal ratio is between 3.5-to-1. A higher ratio means a higher risk of heart disease.|Ratio|Mean|4.5|4.5|Standard Deviation|0.26|0.26|||
3672143|NCT02328404|3516116|B1|||TC / HDL-C Ratio|This indicate the Total Cholesterol to High Density Lipoprotien ratio. An optimal ratio is between 3.5-to-1. A higher ratio means a higher risk of heart disease.|Ratio|Mean|4.3|4.3|Standard Deviation|0.20|0.2|||
3672144|NCT02328404|3516114|B3|Total Cholestrol||Lipid Profile||mmol/L|Mean|5.3|5.3|Standard Deviation|0.23|0.23|||
3672145|NCT02328404|3516115|B2|Total Cholestrol||Lipid Profile||mmol/L|Mean|5.3|5.3|Standard Deviation|0.26|0.26|||
3672146|NCT02328404|3516116|B1|Total Cholestrol||Lipid Profile||mmol/L|Mean|5.3|5.3|Standard Deviation|0.20|0.2|||
3672147|NCT02328404|3516114|B3|HDL||Lipid Profile||mmol/L|Mean|1.3|1.3|Standard Deviation|0.05|0.05|||
3672148|NCT02328404|3516115|B2|HDL||Lipid Profile||mmol/L|Mean|1.3|1.3|Standard Deviation|0.04|0.04|||
3672149|NCT02328404|3516116|B1|HDL||Lipid Profile||mmol/L|Mean|1.3|1.3|Standard Deviation|0.06|0.06|||
3672150|NCT02328404|3516114|B3|LDLC||Lipid Profile||mmol/L|Mean|3.35|3.35|Standard Deviation|0.17|0.17|||
3672151|NCT02328404|3516115|B2|LDLC||Lipid Profile||mmol/L|Mean|3.4|3.4|Standard Deviation|0.19|0.19|||
3672152|NCT02328404|3516116|B1|LDLC||Lipid Profile||mmol/L|Mean|3.3|3.3|Standard Deviation|0.15|0.15|||
3672153|NCT02328404|3516114|B3|||Parathyroide Hormon Serum Level||Pg/ml|Mean|63.55|63.55|Standard Deviation|5.225|5.225|||
3672154|NCT02328404|3516115|B2|||Parathyroide Hormon Serum Level||Pg/ml|Mean|61.8|61.8|Standard Deviation|4.54|4.54|||
3672155|NCT02328404|3516116|B1|||Parathyroide Hormon Serum Level||Pg/ml|Mean|65.3|65.3|Standard Deviation|5.91|5.91|||
3672156|NCT02328404|3516114|B3|||Phosphorus Serum Level||nmol/L|Mean|1.1|1.1|Standard Deviation|0.03|0.03|||
3672157|NCT02328404|3516115|B2|||Phosphorus Serum Level||nmol/L|Mean|1.1|1.1|Standard Deviation|0.02|0.02|||
3672158|NCT02328404|3516116|B1|||Phosphorus Serum Level||nmol/L|Mean|1.1|1.1|Standard Deviation|0.03|0.03|||
3672159|NCT02328404|3516114|B3|||Calcium Serum Level||mmol/L|Mean|2.3|2.3|Standard Deviation|0.02|0.02|||
3672160|NCT02328404|3516115|B2|||Calcium Serum Level||mmol/L|Mean|2.3|2.3|Standard Deviation|0.02|0.02|||
3672161|NCT02328404|3516116|B1|||Calcium Serum Level||mmol/L|Mean|2.3|2.3|Standard Deviation|0.02|0.02|||
3672162|NCT02328404|3516114|B3|||Chromium Serum Level||ppm|Mean|0.295|0.295|Standard Deviation|0.01|0.01|||
3672163|NCT02328404|3516115|B2|||Chromium Serum Level||ppm|Mean|0.30|0.3|Standard Deviation|0.01|0.01|||
3672164|NCT02328404|3516116|B1|||Chromium Serum Level||ppm|Mean|0.29|0.29|Standard Deviation|0.01|0.01|||
3672165|NCT02328404|3516114|B3|||Total Testosteron Serum Level||nmol/L|Mean|1.95|1.95|Standard Deviation|0.16|0.16|||
3672166|NCT02328404|3516115|B2|||Total Testosteron Serum Level||nmol/L|Mean|1.8|1.8|Standard Deviation|0.15|0.15|||
3672167|NCT02328404|3516116|B1|||Total Testosteron Serum Level||nmol/L|Mean|2.1|2.1|Standard Deviation|0.17|0.17|||
3672168|NCT02328404|3516114|B3|||Progesterone Serum Level||nmol/L|Mean|7.7|7.7|Standard Deviation|2.67|2.67|||
3672169|NCT02328404|3516115|B2|||Progesterone Serum Level||nmol/L|Mean|10.7|10.7|Standard Deviation|3.48|3.48|||
3672170|NCT02328404|3516116|B1|||Progesterone Serum Level||nmol/L|Mean|5.2|5.2|Standard Deviation|1.86|1.86|||
3672171|NCT02328404|3516114|B3|||25(OH)D Serum Level||ng/ml|Mean|12.415|12.415|Standard Deviation|3.08|3.08|||
3672172|NCT02328404|3516115|B2|||25(OH)D Serum Level||ng/ml|Mean|12.37|12.37|Standard Deviation|2.91|2.91|||
3672173|NCT02328404|3516116|B1|||25(OH)D Serum Level||ng/ml|Mean|12.46|12.46|Standard Deviation|3.29|3.29|||
3672174|NCT02328404|3516114|B3|||Hirsutism Score|"The scale ranges between 0 and 36, where A score of 8 or higher was considered as androgen excess (Ferriman and Gallwey, 1961).~Hirsutism score was assessed using self-administrated Ferriman-Gallwey scoring system (Ferriman and Gallwey, 1961). Each participant answered the hirsutism test with the help of a trained nurse who was working in the same clinic. The score of each body site may range between 0 (no excessive terminal hair growth) to 4 (extensive terminal hair growth)."|units on a scale|Mean|16.65|16.65|Standard Deviation|1.025|1.025|||
3672227|NCT02327429|3516165|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3672228|NCT02327429|3516165|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3672229|NCT02327429|3516165|B1|||Age||years|Mean|66|66.0|Standard Deviation|8|8.0|||
3672175|NCT02328404|3516115|B2|||Hirsutism Score|"The scale ranges between 0 and 36, where A score of 8 or higher was considered as androgen excess (Ferriman and Gallwey, 1961).~Hirsutism score was assessed using self-administrated Ferriman-Gallwey scoring system (Ferriman and Gallwey, 1961). Each participant answered the hirsutism test with the help of a trained nurse who was working in the same clinic. The score of each body site may range between 0 (no excessive terminal hair growth) to 4 (extensive terminal hair growth)."|units on a scale|Mean|16.8|16.8|Standard Deviation|1.19|1.19|||
3672176|NCT02328404|3516116|B1|||Hirsutism Score|"The scale ranges between 0 and 36, where A score of 8 or higher was considered as androgen excess (Ferriman and Gallwey, 1961).~Hirsutism score was assessed using self-administrated Ferriman-Gallwey scoring system (Ferriman and Gallwey, 1961). Each participant answered the hirsutism test with the help of a trained nurse who was working in the same clinic. The score of each body site may range between 0 (no excessive terminal hair growth) to 4 (extensive terminal hair growth)."|units on a scale|Mean|16.5|16.5|Standard Deviation|0.86|0.86|||
3672177|NCT02328404|3516114|B3|Both are Polycystic||Ultrasound Examination||participants|Number|58|58.0||||||
3672178|NCT02328404|3516115|B2|Both are Polycystic||Ultrasound Examination||participants|Number|29|29.0||||||
3672179|NCT02328404|3516116|B1|Both are Polycystic||Ultrasound Examination||participants|Number|29|29.0||||||
3672180|NCT02328404|3516114|B3|Left or Right is Normal||Ultrasound Examination||participants|Number|0|0.0||||||
3672181|NCT02328404|3516115|B2|Left or Right is Normal||Ultrasound Examination||participants|Number|0|0.0||||||
3672182|NCT02328404|3516116|B1|Left or Right is Normal||Ultrasound Examination||participants|Number|0|0.0||||||
3672183|NCT02328404|3516114|B3|Both Overies are Normal||Ultrasound Examination||participants|Number|0|0.0||||||
3672184|NCT02328404|3516115|B2|Both Overies are Normal||Ultrasound Examination||participants|Number|0|0.0||||||
3672185|NCT02328404|3516116|B1|Both Overies are Normal||Ultrasound Examination||participants|Number|0|0.0||||||
3672186|NCT02328404|3516114|B3|Jordan||Region of Enrollment||participants|Number|58|58.0||||||
3672187|NCT02328404|3516115|B2|Jordan||Region of Enrollment||participants|Number|29|29.0||||||
3672188|NCT02328404|3516116|B1|Jordan||Region of Enrollment||participants|Number|29|29.0||||||
3672189|NCT02328404|3516114|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3672190|NCT02328404|3516115|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3672191|NCT02328404|3516116|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3672192|NCT02328404|3516114|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3672193|NCT02328404|3516115|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3672194|NCT02328404|3516116|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3672195|NCT02328404|3516114|B3|Age||Age||years|Mean|23.56|23.56|Full Range|||18.0|49.0|
3672196|NCT02328404|3516115|B2|Age||Age||years|Mean|23.56|23.56|Full Range|||18.0|49.0|
3672197|NCT02328404|3516116|B1|Age||Age||years|Mean|23.56|23.56|Full Range|||18.0|49.0|
3672198|NCT02328105|3516151|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3672199|NCT02328105|3516151|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672200|NCT02328105|3516151|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672201|NCT02328105|3516151|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3672202|NCT02328105|3516151|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3672203|NCT02328105|3516151|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672204|NCT02328105|3516151|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672205|NCT02328105|3516151|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672206|NCT02328105|3516151|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3672207|NCT02328105|3516151|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3672208|NCT02328105|3516151|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3672209|NCT02328105|3516151|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3672210|NCT02328105|3516151|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3672211|NCT02328105|3516151|B1|||Age||years|Mean|66.09|66.09|Standard Deviation|8.95|8.95|||
3672212|NCT02328105|3516151|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3672213|NCT02328105|3516151|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3672214|NCT02328105|3516151|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3672215|NCT02328040|3516156|B1|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3672216|NCT02328040|3516156|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3672217|NCT02328040|3516156|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3672218|NCT02328040|3516156|B1|||Age||years|Mean|24.1|24.1|Standard Deviation|4.7|4.7|||
3672219|NCT02328040|3516156|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3672220|NCT02328040|3516156|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3672221|NCT02328040|3516156|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3672222|NCT02327429|3516165|B1|||Acculturation score|Suinn-Lew Asian Self Identity Acculturation Scale minimum = 1, maximum = 5; lower score indicates lower acculturation|units on a scale|Mean|1.9|1.9|Standard Deviation|0.4|0.4|||
3672223|NCT02327429|3516165|B1|||Duration of diabetes||years|Mean|11|11.0|Standard Deviation|8|8.0|||
3672224|NCT02327429|3516165|B1|||Years in North America||years|Mean|21|21.0|Standard Deviation|19|19.0|||
3672225|NCT02327429|3516165|B1|||Age at Immigration||years|Mean|45|45.0|Standard Deviation|19|19.0|||
3672226|NCT02327429|3516165|B1|Canada||Region of Enrollment||participants|Number|17|17.0||||||
3672230|NCT02327325|3516185|B4||Other|Household Financial Status|"Low income defined as self-report of just meeting basic expenses or don't have enough to meet basic expenses."|Participants|Count of Participants|42|42.0||||||
3672231|NCT02327325|3516186|B3||Other|Household Financial Status|"Low income defined as self-report of just meeting basic expenses or don't have enough to meet basic expenses."|Participants|Count of Participants|13|13.0||||||
3672232|NCT02327325|3516187|B2||Other|Household Financial Status|"Low income defined as self-report of just meeting basic expenses or don't have enough to meet basic expenses."|Participants|Count of Participants|13|13.0||||||
3672233|NCT02327325|3516188|B1||Other|Household Financial Status|"Low income defined as self-report of just meeting basic expenses or don't have enough to meet basic expenses."|Participants|Count of Participants|16|16.0||||||
3672234|NCT02327325|3516185|B4||Low income|Household Financial Status|"Low income defined as self-report of just meeting basic expenses or don't have enough to meet basic expenses."|Participants|Count of Participants|16|16.0||||||
3672235|NCT02327325|3516186|B3||Low income|Household Financial Status|"Low income defined as self-report of just meeting basic expenses or don't have enough to meet basic expenses."|Participants|Count of Participants|6|6.0||||||
3672236|NCT02327325|3516187|B2||Low income|Household Financial Status|"Low income defined as self-report of just meeting basic expenses or don't have enough to meet basic expenses."|Participants|Count of Participants|6|6.0||||||
3672237|NCT02327325|3516188|B1||Low income|Household Financial Status|"Low income defined as self-report of just meeting basic expenses or don't have enough to meet basic expenses."|Participants|Count of Participants|4|4.0||||||
3672238|NCT02327325|3516185|B4||Other|Marital Status||Participants|Count of Participants|22|22.0||||||
3672239|NCT02327325|3516186|B3||Other|Marital Status||Participants|Count of Participants|4|4.0||||||
3672240|NCT02327325|3516187|B2||Other|Marital Status||Participants|Count of Participants|7|7.0||||||
3672241|NCT02327325|3516188|B1||Other|Marital Status||Participants|Count of Participants|11|11.0||||||
3672242|NCT02327325|3516185|B4||Married|Marital Status||Participants|Count of Participants|38|38.0||||||
3672243|NCT02327325|3516186|B3||Married|Marital Status||Participants|Count of Participants|16|16.0||||||
3672244|NCT02327325|3516187|B2||Married|Marital Status||Participants|Count of Participants|13|13.0||||||
3672245|NCT02327325|3516188|B1||Married|Marital Status||Participants|Count of Participants|9|9.0||||||
3672246|NCT02327325|3516185|B4||Other|Employment Status||Participants|Count of Participants|39|39.0||||||
3672247|NCT02327325|3516186|B3||Other|Employment Status||Participants|Count of Participants|14|14.0||||||
3672248|NCT02327325|3516187|B2||Other|Employment Status||Participants|Count of Participants|12|12.0||||||
3672249|NCT02327325|3516188|B1||Other|Employment Status||Participants|Count of Participants|13|13.0||||||
3672250|NCT02327325|3516185|B4||Disabled|Employment Status||Participants|Count of Participants|21|21.0||||||
3672251|NCT02327325|3516186|B3||Disabled|Employment Status||Participants|Count of Participants|6|6.0||||||
3672252|NCT02327325|3516187|B2||Disabled|Employment Status||Participants|Count of Participants|8|8.0||||||
3672253|NCT02327325|3516188|B1||Disabled|Employment Status||Participants|Count of Participants|7|7.0||||||
3672254|NCT02327325|3516185|B4||High school or technical school|Education Level||Participants|Count of Participants|29|29.0||||||
3672255|NCT02327325|3516186|B3||High school or technical school|Education Level||Participants|Count of Participants|12|12.0||||||
3672256|NCT02327325|3516187|B2||High school or technical school|Education Level||Participants|Count of Participants|10|10.0||||||
3672257|NCT02327325|3516188|B1||High school or technical school|Education Level||Participants|Count of Participants|7|7.0||||||
3672258|NCT02327325|3516185|B4||At least some college|Education Level||Participants|Count of Participants|31|31.0||||||
3672259|NCT02327325|3516186|B3||At least some college|Education Level||Participants|Count of Participants|8|8.0||||||
3672260|NCT02327325|3516187|B2||At least some college|Education Level||Participants|Count of Participants|10|10.0||||||
3672261|NCT02327325|3516188|B1||At least some college|Education Level||Participants|Count of Participants|13|13.0||||||
3672262|NCT02327325|3516185|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672263|NCT02327325|3516186|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672264|NCT02327325|3516187|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672265|NCT02327325|3516188|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672266|NCT02327325|3516185|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672267|NCT02327325|3516186|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672268|NCT02327325|3516187|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672269|NCT02327325|3516188|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672270|NCT02327325|3516185|B4||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3672271|NCT02327325|3516186|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3672272|NCT02327325|3516187|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3672273|NCT02327325|3516188|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3672274|NCT02327325|3516185|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3672275|NCT02327325|3516186|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3672276|NCT02327325|3516187|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3672277|NCT02327325|3516188|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3672278|NCT02327325|3516185|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672279|NCT02327325|3516186|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672280|NCT02327325|3516187|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672281|NCT02327325|3516188|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672282|NCT02327325|3516185|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672283|NCT02327325|3516186|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672284|NCT02327325|3516187|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672285|NCT02327325|3516188|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672286|NCT02327325|3516185|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3672287|NCT02327325|3516186|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672288|NCT02327325|3516187|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672289|NCT02327325|3516188|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3672290|NCT02327325|3516185|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672291|NCT02327325|3516186|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672292|NCT02327325|3516187|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672293|NCT02327325|3516188|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672294|NCT02327325|3516185|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3672295|NCT02327325|3516186|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3672296|NCT02327325|3516187|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3672297|NCT02327325|3516188|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3672298|NCT02327325|3516185|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3672299|NCT02327325|3516186|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672300|NCT02327325|3516187|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672301|NCT02327325|3516188|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3672302|NCT02327325|3516185|B4||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3672303|NCT02327325|3516186|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3672304|NCT02327325|3516187|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3672305|NCT02327325|3516188|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3672306|NCT02327325|3516185|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3672307|NCT02327325|3516186|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3672308|NCT02327325|3516187|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3672309|NCT02327325|3516188|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3672310|NCT02327325|3516185|B4|||Age||years|Mean|70.3|70.3|Standard Deviation|4.9|4.9|||
3672311|NCT02327325|3516186|B3|||Age||years|Mean|71.9|71.9|Standard Deviation|6.5|6.5|||
3672312|NCT02327325|3516187|B2|||Age||years|Mean|69.5|69.5|Standard Deviation|4.0|4.0|||
3672313|NCT02327325|3516188|B1|||Age||years|Mean|69.6|69.6|Standard Deviation|3.5|3.5|||
3672314|NCT02327143|3516210|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3672315|NCT02327143|3516210|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672316|NCT02327143|3516210|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672317|NCT02327143|3516210|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3672318|NCT02327143|3516210|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3672319|NCT02327143|3516210|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672320|NCT02327143|3516210|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672321|NCT02327143|3516210|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672322|NCT02327143|3516210|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672323|NCT02327143|3516210|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3672324|NCT02327143|3516210|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672325|NCT02327143|3516210|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3672326|NCT02327143|3516210|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3672327|NCT02327143|3516210|B1|||Age||years|Mean|56.00|56.0|Standard Deviation|8.00|8.0|||
3672328|NCT02327117|3516219|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3672329|NCT02327117|3516220|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3672330|NCT02327117|3516221|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3672331|NCT02327117|3516219|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3672332|NCT02327117|3516220|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3672333|NCT02327117|3516221|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3672334|NCT02327117|3516219|B3|||Age||year|Mean|66.35|66.35|Standard Deviation|6.49|6.49|||
3672335|NCT02327117|3516220|B2|||Age||year|Mean|65.66|65.66|Standard Deviation|4.97|4.97|||
3672336|NCT02327117|3516221|B1|||Age||year|Mean|67.04|67.04|Standard Deviation|8.01|8.01|||
3672337|NCT02327013|3516228|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3672338|NCT02327013|3516229|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3672339|NCT02327013|3516230|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3672340|NCT02327013|3516231|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3672341|NCT02327013|3516228|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672342|NCT02327013|3516229|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672343|NCT02327013|3516230|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672344|NCT02327013|3516231|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672345|NCT02327013|3516228|B4||White|Race (NIH/OMB)||Participants|Count of Participants|165|165.0||||||
3672346|NCT02327013|3516229|B3||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3672347|NCT02327013|3516230|B2||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3672348|NCT02327013|3516231|B1||White|Race (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
3672349|NCT02327013|3516228|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3672350|NCT02327013|3516229|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3672351|NCT02327013|3516230|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3672352|NCT02327013|3516231|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3672353|NCT02327013|3516228|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3672354|NCT02327013|3516229|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672355|NCT02327013|3516230|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3672356|NCT02327013|3516231|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3672357|NCT02327013|3516228|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3672358|NCT02327013|3516229|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3672359|NCT02327013|3516230|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3672360|NCT02327013|3516231|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3672361|NCT02327013|3516228|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672362|NCT02327013|3516229|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672363|NCT02327013|3516230|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672364|NCT02327013|3516231|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672365|NCT02327013|3516228|B4||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3672366|NCT02327013|3516229|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3672367|NCT02327013|3516230|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3672368|NCT02327013|3516231|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3672369|NCT02327013|3516228|B4||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3672370|NCT02327013|3516229|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3672371|NCT02327013|3516230|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3672372|NCT02327013|3516231|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3672373|NCT02327013|3516228|B4|||Age||years|Mean|36.9|36.9|Standard Deviation|10.2|10.2|||
3672374|NCT02327013|3516229|B3|||Age||years|Mean|37.2|37.2|Standard Deviation|10.4|10.4|||
3672375|NCT02327013|3516230|B2|||Age||years|Mean|35.8|35.8|Standard Deviation|9.6|9.6|||
3672376|NCT02327013|3516231|B1|||Age||years|Mean|37.1|37.1|Standard Deviation|10.3|10.3|||
3672377|NCT02326844|3516408|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3672378|NCT02326844|3516408|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672379|NCT02326844|3516408|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672380|NCT02326844|3516408|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3672381|NCT02326844|3516408|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3672382|NCT02326844|3516408|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672383|NCT02326844|3516408|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672384|NCT02326844|3516408|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672385|NCT02326844|3516408|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672386|NCT02326844|3516408|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3672387|NCT02326844|3516408|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672388|NCT02326844|3516408|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3672389|NCT02326844|3516408|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3672390|NCT02326844|3516408|B1|||Age||years|Mean|51.1|51.1|Standard Deviation|3.45|3.45|||
3672391|NCT02326844|3516408|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3672392|NCT02326844|3516408|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3672393|NCT02326844|3516408|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3672394|NCT02326649|3516415|B1|||Body Surface Area||meters squared|Mean|1.67|1.67|Full Range|||0.8|2.2|
3672395|NCT02326649|3516415|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3672396|NCT02326649|3516415|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3672397|NCT02326649|3516415|B1|||Age||years|Mean|18|18.0|Full Range|||7.0|30.0|
3672398|NCT02326597|3516419|B3|United States||Region of Enrollment||Participants|Count of Participants|120|120.0||||||
3672399|NCT02326597|3516420|B2|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3672400|NCT02326597|3516421|B1|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3672401|NCT02326597|3516419|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672402|NCT02326597|3516420|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672403|NCT02326597|3516421|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672404|NCT02326597|3516419|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672405|NCT02326597|3516420|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672406|NCT02326597|3516421|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672407|NCT02326597|3516419|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672408|NCT02326597|3516420|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672409|NCT02326597|3516421|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672410|NCT02326597|3516419|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
3672411|NCT02326597|3516420|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3672412|NCT02326597|3516421|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3672413|NCT02326597|3516419|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672414|NCT02326597|3516420|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672415|NCT02326597|3516421|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672416|NCT02326597|3516419|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672417|NCT02326597|3516420|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672418|NCT02326597|3516421|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672419|NCT02326597|3516419|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672420|NCT02326597|3516420|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672421|NCT02326597|3516421|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672422|NCT02326597|3516419|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3672423|NCT02326597|3516420|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3672424|NCT02326597|3516421|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3672425|NCT02326597|3516419|B3||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3672426|NCT02326597|3516420|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3672427|NCT02326597|3516421|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3672428|NCT02326597|3516419|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3672429|NCT02326597|3516420|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3672430|NCT02326597|3516421|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3672431|NCT02326597|3516419|B3||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
3672432|NCT02326597|3516420|B2||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3672433|NCT02326597|3516421|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3672434|NCT02326597|3516419|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3672435|NCT02326597|3516420|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3672436|NCT02326597|3516421|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3672437|NCT02326298|3516440|B4||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3672438|NCT02326298|3516441|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3672439|NCT02326298|3516442|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3672440|NCT02326298|3516443|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3672441|NCT02326298|3516440|B4||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3672442|NCT02326298|3516441|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3672443|NCT02326298|3516442|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3672444|NCT02326298|3516443|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3672445|NCT02326298|3516440|B4|||Age||Years|Mean|44.9|44.9|Standard Deviation|12.7|12.7|||
3672446|NCT02326298|3516441|B3|||Age||Years|Mean|43.6|43.6|Standard Deviation|12.1|12.1|||
3672447|NCT02326298|3516442|B2|||Age||Years|Mean|44.5|44.5|Standard Deviation|13.1|13.1|||
3672448|NCT02326298|3516443|B1|||Age||Years|Mean|47.9|47.9|Standard Deviation|12.8|12.8|||
3672449|NCT02326298|3516440|B4||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3672450|NCT02326298|3516441|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3672451|NCT02326298|3516442|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3672452|NCT02326298|3516443|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3672453|NCT02326298|3516440|B4||Between 18 and 65 years|Age||Participants|Count of Participants|221|221.0||||||
3672454|NCT02326298|3516441|B3||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
3672455|NCT02326298|3516442|B2||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
3672456|NCT02326298|3516443|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3672457|NCT02326298|3516440|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3672458|NCT02326298|3516441|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3672459|NCT02326298|3516442|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3672460|NCT02326298|3516443|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3672461|NCT02326272|3516472|B4||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3672462|NCT02326272|3516473|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3672463|NCT02326272|3516474|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3672464|NCT02326272|3516475|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3672465|NCT02326272|3516472|B4||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3672466|NCT02326272|3516473|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3672467|NCT02326272|3516474|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3672468|NCT02326272|3516475|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3672469|NCT02326272|3516472|B4|||Age||years|Mean|45.9|45.9|Standard Deviation|13.7|13.7|||
3672470|NCT02326272|3516473|B3|||Age||years|Mean|46.4|46.4|Standard Deviation|13.5|13.5|||
3672471|NCT02326272|3516474|B2|||Age||years|Mean|46.7|46.7|Standard Deviation|13.3|13.3|||
3672472|NCT02326272|3516475|B1|||Age||years|Mean|43.3|43.3|Standard Deviation|14.5|14.5|||
3672473|NCT02326272|3516472|B4||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3672474|NCT02326272|3516473|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3672475|NCT02326272|3516474|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3672476|NCT02326272|3516475|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3672477|NCT02326272|3516472|B4||Between 18 and 65 years|Age||Participants|Count of Participants|206|206.0||||||
3672478|NCT02326272|3516473|B3||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
3672479|NCT02326272|3516474|B2||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
3672480|NCT02326272|3516475|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
3672481|NCT02326272|3516472|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3672482|NCT02326272|3516473|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3672483|NCT02326272|3516474|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3672484|NCT02326272|3516475|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3672485|NCT02325856|3516504|B3||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3672486|NCT02325856|3516505|B2||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3672487|NCT02325856|3516506|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3672488|NCT02325856|3516504|B3||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3672489|NCT02325856|3516505|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3672490|NCT02325856|3516506|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3672491|NCT02325856|3516504|B3|||Age||years|Mean|62.4|62.4|Standard Deviation|11.8|11.8|||
3672492|NCT02325856|3516505|B2|||Age||years|Mean|62.1|62.1|Standard Deviation|11.5|11.5|||
3672493|NCT02325856|3516506|B1|||Age||years|Mean|62.7|62.7|Standard Deviation|12.1|12.1|||
3672494|NCT02325791|3516515|B5|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3672495|NCT02325791|3516516|B4|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3672496|NCT02325791|3516517|B3|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3672497|NCT02325791|3516518|B2|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3672498|NCT02325791|3516519|B1|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3672499|NCT02325791|3516515|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3672500|NCT02325791|3516516|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3672501|NCT02325791|3516517|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3672502|NCT02325791|3516518|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3672503|NCT02325791|3516519|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3672504|NCT02325791|3516515|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|1017|1017.0||||||
3672505|NCT02325791|3516516|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|326|326.0||||||
3672506|NCT02325791|3516517|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|334|334.0||||||
3672507|NCT02325791|3516518|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|338|338.0||||||
3672508|NCT02325791|3516519|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3672509|NCT02325791|3516515|B5|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|101|101.0||||||
3672510|NCT02325791|3516516|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
3672511|NCT02325791|3516517|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3672512|NCT02325791|3516518|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3672513|NCT02325791|3516519|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3672514|NCT02325791|3516515|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3672515|NCT02325791|3516516|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3672516|NCT02325791|3516517|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3672517|NCT02325791|3516518|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3672518|NCT02325791|3516519|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3672519|NCT02325791|3516515|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3672520|NCT02325791|3516516|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3672521|NCT02325791|3516517|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3672522|NCT02325791|3516518|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3672523|NCT02325791|3516519|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3672524|NCT02325791|3516515|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3672525|NCT02325791|3516516|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3672526|NCT02325791|3516517|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3672527|NCT02325791|3516518|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3672528|NCT02325791|3516519|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3672529|NCT02325791|3516515|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3672530|NCT02325791|3516516|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3672531|NCT02325791|3516517|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3672532|NCT02325791|3516518|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3672533|NCT02325791|3516519|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672534|NCT02325791|3516515|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|919|919.0||||||
3672535|NCT02325791|3516516|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|302|302.0||||||
3672536|NCT02325791|3516517|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|300|300.0||||||
3672537|NCT02325791|3516518|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|297|297.0||||||
3672538|NCT02325791|3516519|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3672539|NCT02325791|3516515|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|239|239.0||||||
3672540|NCT02325791|3516516|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3672541|NCT02325791|3516517|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
3672542|NCT02325791|3516518|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3672543|NCT02325791|3516519|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3672544|NCT02325791|3516515|B5||Male|Sex: Female, Male||Participants|Count of Participants|626|626.0||||||
3672545|NCT02325791|3516516|B4||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3672546|NCT02325791|3516517|B3||Male|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
3672547|NCT02325791|3516518|B2||Male|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
3672548|NCT02325791|3516519|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3672549|NCT02325791|3516515|B5||Female|Sex: Female, Male||Participants|Count of Participants|546|546.0||||||
3672550|NCT02325791|3516516|B4||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
3672551|NCT02325791|3516517|B3||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3672552|NCT02325791|3516518|B2||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
3672553|NCT02325791|3516519|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3672554|NCT02325791|3516515|B5|>=32 weeks & <=35 weeks 6 days||Age, Customized||Participants|Count of Participants|987|987.0||||||
3672555|NCT02325791|3516516|B4|>=32 weeks & <=35 weeks 6 days||Age, Customized||Participants|Count of Participants|322|322.0||||||
3672556|NCT02325791|3516517|B3|>=32 weeks & <=35 weeks 6 days||Age, Customized||Participants|Count of Participants|326|326.0||||||
3672557|NCT02325791|3516518|B2|>=32 weeks & <=35 weeks 6 days||Age, Customized||Participants|Count of Participants|321|321.0||||||
3672558|NCT02325791|3516519|B1|>=32 weeks & <=35 weeks 6 days||Age, Customized||Participants|Count of Participants|18|18.0||||||
3672559|NCT02325791|3516515|B5|<=31 weeks 6 days||Age, Customized||Participants|Count of Participants|185|185.0||||||
3672560|NCT02325791|3516516|B4|<=31 weeks 6 days||Age, Customized||Participants|Count of Participants|59|59.0||||||
3672561|NCT02325791|3516517|B3|<=31 weeks 6 days||Age, Customized||Participants|Count of Participants|59|59.0||||||
3672562|NCT02325791|3516518|B2|<=31 weeks 6 days||Age, Customized||Participants|Count of Participants|62|62.0||||||
3672563|NCT02325791|3516519|B1|<=31 weeks 6 days||Age, Customized||Participants|Count of Participants|5|5.0||||||
3672564|NCT02325713|3516541|B17||Male|Gender||Participants|Count of Participants|32|32.0||||||
3672565|NCT02325713|3516542|B16||Male|Gender||Participants|Count of Participants|2|2.0||||||
3672566|NCT02325713|3516543|B15||Male|Gender||Participants|Count of Participants|2|2.0||||||
3672567|NCT02325713|3516544|B14||Male|Gender||Participants|Count of Participants|2|2.0||||||
3672568|NCT02325713|3516545|B13||Male|Gender||Participants|Count of Participants|2|2.0||||||
3672569|NCT02325713|3516546|B12||Male|Gender||Participants|Count of Participants|2|2.0||||||
3672570|NCT02325713|3516547|B11||Male|Gender||Participants|Count of Participants|2|2.0||||||
3672571|NCT02325713|3516548|B10||Male|Gender||Participants|Count of Participants|2|2.0||||||
3672572|NCT02325713|3516549|B9||Male|Gender||Participants|Count of Participants|2|2.0||||||
3672573|NCT02325713|3516550|B8||Male|Gender||Participants|Count of Participants|2|2.0||||||
3672574|NCT02325713|3516551|B7||Male|Gender||Participants|Count of Participants|2|2.0||||||
3672575|NCT02325713|3516552|B6||Male|Gender||Participants|Count of Participants|2|2.0||||||
3672576|NCT02325713|3516553|B5||Male|Gender||Participants|Count of Participants|2|2.0||||||
3672577|NCT02325713|3516554|B4||Male|Gender||Participants|Count of Participants|2|2.0||||||
3672578|NCT02325713|3516555|B3||Male|Gender||Participants|Count of Participants|2|2.0||||||
3672579|NCT02325713|3516556|B2||Male|Gender||Participants|Count of Participants|2|2.0||||||
3672580|NCT02325713|3516557|B1||Male|Gender||Participants|Count of Participants|2|2.0||||||
3672581|NCT02325713|3516541|B17||Female|Gender||Participants|Count of Participants|0|0.0||||||
3672582|NCT02325713|3516542|B16||Female|Gender||Participants|Count of Participants|0|0.0||||||
3672583|NCT02325713|3516543|B15||Female|Gender||Participants|Count of Participants|0|0.0||||||
3672584|NCT02325713|3516544|B14||Female|Gender||Participants|Count of Participants|0|0.0||||||
3672585|NCT02325713|3516545|B13||Female|Gender||Participants|Count of Participants|0|0.0||||||
3672586|NCT02325713|3516546|B12||Female|Gender||Participants|Count of Participants|0|0.0||||||
3672587|NCT02325713|3516547|B11||Female|Gender||Participants|Count of Participants|0|0.0||||||
3672588|NCT02325713|3516548|B10||Female|Gender||Participants|Count of Participants|0|0.0||||||
3672589|NCT02325713|3516549|B9||Female|Gender||Participants|Count of Participants|0|0.0||||||
3672590|NCT02325713|3516550|B8||Female|Gender||Participants|Count of Participants|0|0.0||||||
3672591|NCT02325713|3516551|B7||Female|Gender||Participants|Count of Participants|0|0.0||||||
3672592|NCT02325713|3516552|B6||Female|Gender||Participants|Count of Participants|0|0.0||||||
3672593|NCT02325713|3516553|B5||Female|Gender||Participants|Count of Participants|0|0.0||||||
3672594|NCT02325713|3516554|B4||Female|Gender||Participants|Count of Participants|0|0.0||||||
3672595|NCT02325713|3516555|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
3672596|NCT02325713|3516556|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
3672597|NCT02325713|3516557|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3672598|NCT02325713|3516541|B17||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3672599|NCT02325713|3516542|B16||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3672600|NCT02325713|3516543|B15||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3672601|NCT02325713|3516544|B14||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3672602|NCT02325713|3516545|B13||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3672603|NCT02325713|3516546|B12||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3672604|NCT02325713|3516547|B11||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3672605|NCT02325713|3516548|B10||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3672606|NCT02325713|3516549|B9||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3672607|NCT02325713|3516550|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3672608|NCT02325713|3516551|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3672609|NCT02325713|3516552|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3672610|NCT02325713|3516553|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3672611|NCT02325713|3516554|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3672612|NCT02325713|3516555|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3672613|NCT02325713|3516556|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3672614|NCT02325713|3516557|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3672615|NCT02325713|3516541|B17||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3672616|NCT02325713|3516542|B16||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3672617|NCT02325713|3516543|B15||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3672618|NCT02325713|3516544|B14||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3672619|NCT02325713|3516545|B13||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3672620|NCT02325713|3516546|B12||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3672621|NCT02325713|3516547|B11||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3672622|NCT02325713|3516548|B10||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3672623|NCT02325713|3516549|B9||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3672624|NCT02325713|3516550|B8||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3672625|NCT02325713|3516551|B7||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3672626|NCT02325713|3516552|B6||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3672627|NCT02325713|3516553|B5||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3672628|NCT02325713|3516554|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3672629|NCT02325713|3516555|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3672630|NCT02325713|3516556|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3672631|NCT02325713|3516557|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3672632|NCT02325713|3516541|B17||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3672633|NCT02325713|3516542|B16||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3672634|NCT02325713|3516543|B15||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3672635|NCT02325713|3516544|B14||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3672636|NCT02325713|3516545|B13||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3672637|NCT02325713|3516546|B12||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3672638|NCT02325713|3516547|B11||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3672639|NCT02325713|3516548|B10||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3672640|NCT02325713|3516549|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3672641|NCT02325713|3516550|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3672642|NCT02325713|3516551|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3672643|NCT02325713|3516552|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3672644|NCT02325713|3516553|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3672645|NCT02325713|3516554|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3672646|NCT02325713|3516555|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3672647|NCT02325713|3516556|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3672648|NCT02325713|3516557|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3672649|NCT02325518|3516665|B3||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3672650|NCT02325518|3516666|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3672651|NCT02325518|3516667|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3672652|NCT02325518|3516665|B3||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3672653|NCT02325518|3516666|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3672654|NCT02325518|3516667|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3672655|NCT02325518|3516665|B3|||Age||years|Mean|63.7|63.7|Standard Deviation|12.0|12.0|||
3672656|NCT02325518|3516666|B2|||Age||years|Mean|64.4|64.4|Standard Deviation|12.3|12.3|||
3672657|NCT02325518|3516667|B1|||Age||years|Mean|63.1|63.1|Standard Deviation|11.8|11.8|||
3672658|NCT02324972|3516677|B3|||BMI||kg/m2|Mean|26.8|26.8|Standard Deviation|5.68|5.68|||
3672659|NCT02324972|3516678|B2|||BMI||kg/m2|Mean|27.1|27.1|Standard Deviation|5.28|5.28|||
3672660|NCT02324972|3516679|B1|||BMI||kg/m2|Mean|26.4|26.4|Standard Deviation|6.17|6.17|||
3672661|NCT02324972|3516677|B3|||Weight||kg|Mean|74.69|74.69|Standard Deviation|17.67|17.67|||
3672662|NCT02324972|3516678|B2|||Weight||kg|Mean|76.30|76.3|Standard Deviation|16.06|16.06|||
3672663|NCT02324972|3516679|B1|||Weight||kg|Mean|72.96|72.96|Standard Deviation|19.44|19.44|||
3672664|NCT02324972|3516677|B3|Canada||Region of Enrollment||participants|Number|54|54.0||||||
3672665|NCT02324972|3516678|B2|Canada||Region of Enrollment||participants|Number|28|28.0||||||
3672666|NCT02324972|3516679|B1|Canada||Region of Enrollment||participants|Number|26|26.0||||||
3672667|NCT02324972|3516677|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672668|NCT02324972|3516678|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672669|NCT02324972|3516679|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672670|NCT02324972|3516677|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3672671|NCT02324972|3516678|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3672672|NCT02324972|3516679|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672673|NCT02324972|3516677|B3||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3672674|NCT02324972|3516678|B2||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3672675|NCT02324972|3516679|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3672676|NCT02324972|3516677|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3672677|NCT02324972|3516678|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3672678|NCT02324972|3516679|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3672679|NCT02324972|3516677|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672680|NCT02324972|3516678|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672681|NCT02324972|3516679|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672682|NCT02324972|3516677|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3672683|NCT02324972|3516678|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3672684|NCT02324972|3516679|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3672685|NCT02324972|3516677|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672686|NCT02324972|3516678|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672687|NCT02324972|3516679|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672688|NCT02324972|3516677|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672689|NCT02324972|3516678|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672690|NCT02324972|3516679|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672691|NCT02324972|3516677|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3672692|NCT02324972|3516678|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3672693|NCT02324972|3516679|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3672694|NCT02324972|3516677|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3672695|NCT02324972|3516678|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672696|NCT02324972|3516679|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3672697|NCT02324972|3516677|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3672698|NCT02324972|3516678|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3672699|NCT02324972|3516679|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3672700|NCT02324972|3516677|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3672701|NCT02324972|3516678|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3672702|NCT02324972|3516679|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3672703|NCT02324972|3516677|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3672704|NCT02324972|3516678|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3672705|NCT02324972|3516679|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3672706|NCT02324972|3516677|B3||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3672707|NCT02324972|3516678|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3672708|NCT02324972|3516679|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3672709|NCT02324972|3516677|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3672710|NCT02324972|3516678|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3672711|NCT02324972|3516679|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3672712|NCT02324673|3516694|B4|United States||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
3672713|NCT02324673|3516695|B3|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3672714|NCT02324673|3516696|B2|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3672715|NCT02324673|3516697|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3672716|NCT02324673|3516694|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3672717|NCT02324673|3516695|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3672718|NCT02324673|3516696|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3672719|NCT02324673|3516697|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3672720|NCT02324673|3516694|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3672721|NCT02324673|3516695|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3672722|NCT02324673|3516696|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3672723|NCT02324673|3516697|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3672724|NCT02324673|3516694|B4||Adolescents = 12 to ≤17 years|Age, Customized||Participants|Count of Participants|18|18.0||||||
3672725|NCT02324673|3516695|B3||Adolescents = 12 to ≤17 years|Age, Customized||Participants|Count of Participants|6|6.0||||||
3672726|NCT02324673|3516696|B2||Adolescents = 12 to ≤17 years|Age, Customized||Participants|Count of Participants|6|6.0||||||
3672727|NCT02324673|3516697|B1||Adolescents = 12 to ≤17 years|Age, Customized||Participants|Count of Participants|6|6.0||||||
3672728|NCT02324673|3516694|B4||Children = 2 to <12 years|Age, Customized||Participants|Count of Participants|28|28.0||||||
3672729|NCT02324673|3516695|B3||Children = 2 to <12 years|Age, Customized||Participants|Count of Participants|10|10.0||||||
3672730|NCT02324673|3516696|B2||Children = 2 to <12 years|Age, Customized||Participants|Count of Participants|9|9.0||||||
3672731|NCT02324673|3516697|B1||Children = 2 to <12 years|Age, Customized||Participants|Count of Participants|9|9.0||||||
3672732|NCT02324673|3516694|B4||Infants = 1 to <2 years|Age, Customized||Participants|Count of Participants|15|15.0||||||
3672733|NCT02324673|3516695|B3||Infants = 1 to <2 years|Age, Customized||Participants|Count of Participants|5|5.0||||||
3672734|NCT02324673|3516696|B2||Infants = 1 to <2 years|Age, Customized||Participants|Count of Participants|5|5.0||||||
3672735|NCT02324673|3516697|B1||Infants = 1 to <2 years|Age, Customized||Participants|Count of Participants|5|5.0||||||
3672736|NCT02324673|3516694|B4|||Age||years|Mean|7.6|7.6|Standard Deviation|5.21|5.21|||
3672737|NCT02324673|3516695|B3|||Age||years|Mean|7.8|7.8|Standard Deviation|5.39|5.39|||
3672738|NCT02324673|3516696|B2|||Age||years|Mean|7.7|7.7|Standard Deviation|5.17|5.17|||
3672739|NCT02324673|3516697|B1|||Age||years|Mean|7.5|7.5|Standard Deviation|5.32|5.32|||
3672740|NCT02324660|3516800|B1|Italy||Region of Enrollment||participants|Number|137|137.0||||||
3672741|NCT02324660|3516800|B1||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3672742|NCT02324660|3516800|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3672743|NCT02324660|3516800|B1|||Age||years|Mean|65|65.0|Standard Deviation|10|10.0|||
3672744|NCT02324504|3516805|B1|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3672745|NCT02324504|3516805|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3672746|NCT02324504|3516805|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3672747|NCT02324504|3516805|B1||12-17 Years|Age, Customized||Participants|Count of Participants|23|23.0||||||
3672748|NCT02324504|3516805|B1||3-11 Years|Age, Customized||Participants|Count of Participants|14|14.0||||||
3672749|NCT02324504|3516805|B1||0-2 Years|Age, Customized||Participants|Count of Participants|23|23.0||||||
3672750|NCT02324049|3516812|B1|Overall||Overall Age at Diagnosis||Months|Median|37.0|37.0|Full Range|||12.0|77.0|
3672751|NCT02324049|3516812|B1|10.0 mg/kg||Overall Age at Diagnosis||Months|Median|25.0|25.0|Full Range|||12.0|77.0|
3672752|NCT02324049|3516812|B1|5.0 mg/kg||Overall Age at Diagnosis||Months|Median|48.0|48.0|Full Range|||18.0|57.0|
3672753|NCT02324049|3516812|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3672754|NCT02324049|3516812|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672755|NCT02324049|3516812|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3672756|NCT02324049|3516812|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672757|NCT02324049|3516812|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672758|NCT02324049|3516812|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3672759|NCT02324049|3516812|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672760|NCT02324049|3516812|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672761|NCT02324049|3516812|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3672762|NCT02324049|3516812|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3672763|NCT02324049|3516812|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3672764|NCT02324049|3516812|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3672765|NCT02324049|3516812|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3672766|NCT02324049|3516812|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3672767|NCT02324049|3516812|B1||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
3672768|NCT02323854|3516816|B1|Germany||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3672769|NCT02323854|3516816|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3672770|NCT02323854|3516816|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3672771|NCT02323854|3516816|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3672772|NCT02323854|3516816|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672773|NCT02323854|3516816|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3672774|NCT02323854|3516816|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3672775|NCT02323854|3516816|B1|Age||Age, Customized||Years|Mean|58.9|58.9|Standard Deviation|15.8|15.8|||
3672776|NCT02323048|3516822|B6|United States||Region of Enrollment||Participants|Count of Participants|87|87.0||||||
3672777|NCT02323048|3516823|B5|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3672778|NCT02323048|3516824|B4|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3672779|NCT02323048|3516825|B3|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3672780|NCT02323048|3516826|B2|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3672781|NCT02323048|3516827|B1|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3672782|NCT02323048|3516822|B6||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3672783|NCT02323048|3516823|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3672784|NCT02323048|3516824|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3672785|NCT02323048|3516825|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3672786|NCT02323048|3516826|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3672787|NCT02323048|3516827|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3672788|NCT02323048|3516822|B6||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3672789|NCT02323048|3516823|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3672790|NCT02323048|3516824|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3672791|NCT02323048|3516825|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3672792|NCT02323048|3516826|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3672793|NCT02323048|3516827|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3672794|NCT02323048|3516822|B6|||Age||years|Mean|23.8|23.8|Standard Deviation|3.7|3.7|||
3672795|NCT02323048|3516823|B5|||Age||years|Mean|24.2|24.2|Standard Deviation|3.7|3.7|||
3672796|NCT02323048|3516824|B4|||Age||years|Mean|23.3|23.3|Standard Deviation|3.0|3.0|||
3672797|NCT02323048|3516825|B3|||Age||years|Mean|22.8|22.8|Standard Deviation|2.3|2.3|||
3672798|NCT02323048|3516826|B2|||Age||years|Mean|23.9|23.9|Standard Deviation|3.3|3.3|||
3672799|NCT02323048|3516827|B1|||Age||years|Mean|24.8|24.8|Standard Deviation|5.0|5.0|||
3672800|NCT02323048|3516822|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3672801|NCT02323048|3516823|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3672802|NCT02323048|3516824|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3672803|NCT02323048|3516825|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3672804|NCT02323048|3516826|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3672805|NCT02323048|3516827|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3672806|NCT02323048|3516822|B6||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
3672807|NCT02323048|3516823|B5||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3672808|NCT02323048|3516824|B4||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3672809|NCT02323048|3516825|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3672810|NCT02323048|3516826|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3672811|NCT02323048|3516827|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3672812|NCT02323048|3516822|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3672813|NCT02323048|3516823|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3672814|NCT02323048|3516824|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3672815|NCT02323048|3516825|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3672816|NCT02323048|3516826|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3672817|NCT02323048|3516827|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3672818|NCT02322892|3516843|B3|United States||Region of Enrollment||participants|Number|64|64.0||||||
3672819|NCT02322892|3516844|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
3672820|NCT02322892|3516845|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
3672821|NCT02322892|3516843|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672822|NCT02322892|3516844|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672823|NCT02322892|3516845|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672824|NCT02322892|3516843|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672825|NCT02322892|3516844|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672826|NCT02322892|3516845|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672827|NCT02322892|3516843|B3||White|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3672828|NCT02322892|3516844|B2||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3672829|NCT02322892|3516845|B1||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3672830|NCT02322892|3516843|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3672831|NCT02322892|3516844|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672832|NCT02322892|3516845|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3672833|NCT02322892|3516843|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672834|NCT02322892|3516844|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672835|NCT02322892|3516845|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672836|NCT02322892|3516843|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672837|NCT02322892|3516844|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672838|NCT02322892|3516845|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672839|NCT02322892|3516843|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672840|NCT02322892|3516844|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672841|NCT02322892|3516845|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672842|NCT02322892|3516843|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3672843|NCT02322892|3516844|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3672844|NCT02322892|3516845|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3672845|NCT02322892|3516843|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3672846|NCT02322892|3516844|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3672847|NCT02322892|3516845|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3672848|NCT02322892|3516843|B3|||Age||years|Median|72|72.0|Inter-Quartile Range|||67.0|78.0|
3672849|NCT02322892|3516844|B2|||Age||years|Median|71|71.0|Inter-Quartile Range|||67.0|75.0|
3672850|NCT02322892|3516845|B1|||Age||years|Median|73|73.0|Inter-Quartile Range|||68.0|79.0|
3672851|NCT02322879|3516860|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3672852|NCT02322879|3516861|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3672853|NCT02322879|3516862|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3672854|NCT02322879|3516860|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672855|NCT02322879|3516861|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672856|NCT02322879|3516862|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672857|NCT02322879|3516860|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3672858|NCT02322879|3516861|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3672859|NCT02322879|3516862|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3672860|NCT02322879|3516860|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3672861|NCT02322879|3516861|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3672862|NCT02322879|3516862|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3672863|NCT02322879|3516860|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672864|NCT02322879|3516861|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672865|NCT02322879|3516862|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672866|NCT02322879|3516860|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3672867|NCT02322879|3516861|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3672868|NCT02322879|3516862|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672869|NCT02322879|3516860|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672870|NCT02322879|3516861|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672871|NCT02322879|3516862|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672872|NCT02322879|3516860|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672873|NCT02322879|3516861|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672874|NCT02322879|3516862|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672875|NCT02322879|3516860|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3672876|NCT02322879|3516861|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3672877|NCT02322879|3516862|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3672878|NCT02322879|3516860|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3672879|NCT02322879|3516861|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3672880|NCT02322879|3516862|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3672881|NCT02322879|3516860|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3672882|NCT02322879|3516861|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3672883|NCT02322879|3516862|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3672884|NCT02322879|3516860|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3672885|NCT02322879|3516861|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3672886|NCT02322879|3516862|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3672887|NCT02322879|3516860|B3|||Age||years|Mean|29.2|29.2|Full Range|||21.0|37.0|
3672888|NCT02322879|3516861|B2|||Age||years|Mean|29.8|29.8|Full Range|||24.0|37.0|
3672889|NCT02322879|3516862|B1|||Age||years|Mean|28.6|28.6|Full Range|||21.0|37.0|
3672890|NCT02322866|3516869|B3||Male|Sex: Female, Male||Participants|Count of Participants|427|427.0||||||
3672891|NCT02322866|3516870|B2||Male|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
3672892|NCT02322866|3516871|B1||Male|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
3672893|NCT02322866|3516869|B3||Female|Sex: Female, Male||Participants|Count of Participants|607|607.0||||||
3672894|NCT02322866|3516870|B2||Female|Sex: Female, Male||Participants|Count of Participants|315|315.0||||||
3672895|NCT02322866|3516871|B1||Female|Sex: Female, Male||Participants|Count of Participants|292|292.0||||||
3672896|NCT02322866|3516869|B3|≥18 years||Age, Customized||participants|Number|540|540.0||||||
3672897|NCT02322866|3516870|B2|≥18 years||Age, Customized||participants|Number|285|285.0||||||
3672898|NCT02322866|3516871|B1|≥18 years||Age, Customized||participants|Number|255|255.0||||||
3672899|NCT02322866|3516869|B3|≥12 and <18 years||Age, Customized||participants|Number|483|483.0||||||
3672900|NCT02322866|3516870|B2|≥12 and <18 years||Age, Customized||participants|Number|227|227.0||||||
3672901|NCT02322866|3516871|B1|≥12 and <18 years||Age, Customized||participants|Number|256|256.0||||||
3672902|NCT02322866|3516869|B3|≥9 and <12 years||Age, Customized||participants|Number|11|11.0||||||
3672903|NCT02322866|3516870|B2|≥9 and <12 years||Age, Customized||participants|Number|7|7.0||||||
3672904|NCT02322866|3516871|B1|≥9 and <12 years||Age, Customized||participants|Number|4|4.0||||||
3672905|NCT02322788|3516894|B1|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3672906|NCT02322788|3516894|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3672907|NCT02322788|3516894|B1|White||Race/Ethnicity, Customized||Participants|Number|57|57.0||||||
3672908|NCT02322788|3516894|B1||Male|Gender||Participants|Count of Participants|20|20.0||||||
3672909|NCT02322788|3516894|B1||Female|Gender||Participants|Count of Participants|40|40.0||||||
3672910|NCT02322788|3516894|B1|||Age||Years|Mean|31.1|31.1|Standard Deviation|12.19|12.19|||
3672911|NCT02322775|3516907|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|202|202.0||||||
3672912|NCT02322775|3516908|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|102|102.0||||||
3672913|NCT02322775|3516909|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|100|100.0||||||
3672914|NCT02322775|3516907|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3672915|NCT02322775|3516908|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3672916|NCT02322775|3516909|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3672917|NCT02322775|3516907|B3|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3672918|NCT02322775|3516908|B2|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3672919|NCT02322775|3516909|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3672920|NCT02322775|3516907|B3|White||Race/Ethnicity, Customized||Participants|Number|197|197.0||||||
3672921|NCT02322775|3516908|B2|White||Race/Ethnicity, Customized||Participants|Number|99|99.0||||||
3672922|NCT02322775|3516909|B1|White||Race/Ethnicity, Customized||Participants|Number|98|98.0||||||
3672923|NCT02322775|3516907|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3672924|NCT02322775|3516908|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3672925|NCT02322775|3516909|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3672926|NCT02322775|3516907|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3672927|NCT02322775|3516908|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3672928|NCT02322775|3516909|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3672929|NCT02322775|3516907|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3672930|NCT02322775|3516908|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3672931|NCT02322775|3516909|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3672932|NCT02322775|3516907|B3||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3672933|NCT02322775|3516908|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3672934|NCT02322775|3516909|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3672935|NCT02322775|3516907|B3|>=65-<=75 years||Age, Customized||Participants|Number|29|29.0||||||
3672936|NCT02322775|3516908|B2|>=65-<=75 years||Age, Customized||Participants|Number|15|15.0||||||
3672937|NCT02322775|3516909|B1|>=65-<=75 years||Age, Customized||Participants|Number|14|14.0||||||
3672938|NCT02322775|3516907|B3|>=50-<65 years||Age, Customized||Participants|Number|89|89.0||||||
3672939|NCT02322775|3516908|B2|>=50-<65 years||Age, Customized||Participants|Number|46|46.0||||||
3672940|NCT02322775|3516909|B1|>=50-<65 years||Age, Customized||Participants|Number|43|43.0||||||
3672941|NCT02322775|3516907|B3|>=18-<50 years||Age, Customized||Participants|Number|93|93.0||||||
3672942|NCT02322775|3516908|B2|>=18-<50 years||Age, Customized||Participants|Number|44|44.0||||||
3672943|NCT02322775|3516909|B1|>=18-<50 years||Age, Customized||Participants|Number|49|49.0||||||
3672944|NCT02322775|3516907|B3|||Age||Years|Mean|49.7|49.7|Standard Deviation|13.58|13.58|||
3672945|NCT02322775|3516908|B2|||Age||Years|Mean|51.1|51.1|Standard Deviation|12.60|12.6|||
3672946|NCT02322775|3516909|B1|||Age||Years|Mean|48.3|48.3|Standard Deviation|14.40|14.4|||
3672947|NCT02322749|3516936|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672948|NCT02322749|3516936|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672949|NCT02322749|3516936|B1||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3672950|NCT02322749|3516936|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3672951|NCT02322749|3516936|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672952|NCT02322749|3516936|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672953|NCT02322749|3516936|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672954|NCT02322749|3516936|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3672955|NCT02322749|3516936|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3672956|NCT02322749|3516936|B1|||Age||years|Mean|31|31.0|Standard Deviation|8|8.0|||
3672957|NCT02322528|3516964|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3672958|NCT02322528|3516964|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3672959|NCT02322528|3516964|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3672960|NCT02322528|3516964|B1|||Age||years|Mean|56.7|56.7|Standard Deviation|4.92|4.92|||
3672961|NCT02322229|3516969|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3672962|NCT02322229|3516969|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3672963|NCT02322229|3516969|B1|||Age||years|Mean|74.5|74.5|Standard Deviation|7.0|7.0|||
3672964|NCT02322216|3516979|B3|||Itching Score|Ocular itching was assessed by the participant on a scale from 0-4, where 0=None and 4=Incapacitating itch.|units on a scale|Mean|3.39|3.39|Standard Deviation|0.376|0.376|||
3672965|NCT02322216|3516980|B2|||Itching Score|Ocular itching was assessed by the participant on a scale from 0-4, where 0=None and 4=Incapacitating itch.|units on a scale|Mean|3.43|3.43|Standard Deviation|0.373|0.373|||
3672966|NCT02322216|3516981|B1|||Itching Score|Ocular itching was assessed by the participant on a scale from 0-4, where 0=None and 4=Incapacitating itch.|units on a scale|Mean|3.35|3.35|Standard Deviation|0.377|0.377|||
3672967|NCT02322216|3516979|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3672968|NCT02322216|3516980|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3672969|NCT02322216|3516981|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3672970|NCT02322216|3516979|B3||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3672971|NCT02322216|3516980|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3672972|NCT02322216|3516981|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3672973|NCT02322216|3516979|B3|||Age||years|Mean|32.2|32.2|Standard Deviation|13.24|13.24|||
3672974|NCT02322216|3516980|B2|||Age||years|Mean|31.9|31.9|Standard Deviation|12.79|12.79|||
3672975|NCT02322216|3516981|B1|||Age||years|Mean|32.5|32.5|Standard Deviation|13.72|13.72|||
3672976|NCT02321527|3516989|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3672977|NCT02321527|3516989|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3672978|NCT02321527|3516989|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672979|NCT02321527|3516989|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3672980|NCT02321527|3516989|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3672981|NCT02321527|3516989|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3672982|NCT02321527|3516989|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3672983|NCT02321527|3516989|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3672984|NCT02321527|3516989|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3672985|NCT02321527|3516989|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3672986|NCT02321527|3516989|B1|||Age||years|Median|62|62.0|Full Range|||37.0|73.0|
3672987|NCT02321436|3516993|B3|Thailand||Country||Participants|Number|9|9.0||||||
3672988|NCT02321436|3516994|B2|Thailand||Country||Participants|Number|4|4.0||||||
3672989|NCT02321436|3516995|B1|Thailand||Country||Participants|Number|5|5.0||||||
3672990|NCT02321436|3516993|B3|Singapore||Country||Participants|Number|14|14.0||||||
3672991|NCT02321436|3516994|B2|Singapore||Country||Participants|Number|5|5.0||||||
3672992|NCT02321436|3516995|B1|Singapore||Country||Participants|Number|9|9.0||||||
3672993|NCT02321436|3516993|B3|Philippines||Country||Participants|Number|15|15.0||||||
3672994|NCT02321436|3516994|B2|Philippines||Country||Participants|Number|4|4.0||||||
3672995|NCT02321436|3516995|B1|Philippines||Country||Participants|Number|11|11.0||||||
3672996|NCT02321436|3516993|B3|Malaysia||Country||Participants|Number|4|4.0||||||
3672997|NCT02321436|3516994|B2|Malaysia||Country||Participants|Number|1|1.0||||||
3672998|NCT02321436|3516995|B1|Malaysia||Country||Participants|Number|3|3.0||||||
3672999|NCT02321436|3516993|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673000|NCT02321436|3516994|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673001|NCT02321436|3516995|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673002|NCT02321436|3516993|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673003|NCT02321436|3516994|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673004|NCT02321436|3516995|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673005|NCT02321436|3516993|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673006|NCT02321436|3516994|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673007|NCT02321436|3516995|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673008|NCT02321436|3516993|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673009|NCT02321436|3516994|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673010|NCT02321436|3516995|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673011|NCT02321436|3516993|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673012|NCT02321436|3516994|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673013|NCT02321436|3516995|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673014|NCT02321436|3516993|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3673015|NCT02321436|3516994|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3673016|NCT02321436|3516995|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3673017|NCT02321436|3516993|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673018|NCT02321436|3516994|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673019|NCT02321436|3516995|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673020|NCT02321436|3516993|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3673021|NCT02321436|3516994|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3673022|NCT02321436|3516995|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3673023|NCT02321436|3516993|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3673024|NCT02321436|3516994|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3673025|NCT02321436|3516995|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3673026|NCT02321436|3516993|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|12.3|12.3|||
3673027|NCT02321436|3516994|B2|||Age||years|Mean|56.5|56.5|Standard Deviation|9.7|9.7|||
3673028|NCT02321436|3516995|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|13.2|13.2|||
3673029|NCT02321098|3517012|B4|Iceland||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3673030|NCT02321098|3517014|B2|Iceland||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3673031|NCT02321098|3517015|B1|Iceland||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3673032|NCT02321098|3517012|B4|Treatment Period|Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3673033|NCT02321098|3517014|B2|Treatment Period|Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3673034|NCT02321098|3517015|B1|Treatment Period|Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3673035|NCT02321098|3517012|B4|Treatment Period|Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3673036|NCT02321098|3517014|B2|Treatment Period|Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3673037|NCT02321098|3517015|B1|Treatment Period|Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3673038|NCT02321098|3517012|B4|Treatment Period||Age|Treatment period: 50 subjects are included in two arms for 12 weeks|years|Mean|54.4|54.4|Standard Deviation|12.1|12.1|||
3673039|NCT02321098|3517014|B2|Treatment Period||Age|Treatment period: 50 subjects are included in two arms for 12 weeks|years|Mean|53.7|53.7|Standard Deviation|12.5|12.5|||
3673040|NCT02321098|3517015|B1|Treatment Period||Age|Treatment period: 50 subjects are included in two arms for 12 weeks|years|Mean|55.1|55.1|Standard Deviation|12.0|12.0|||
3673041|NCT02321098|3517012|B4|Treatment period|>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3673042|NCT02321098|3517014|B2|Treatment period|>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3673043|NCT02321098|3517015|B1|Treatment period|>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3673044|NCT02321098|3517012|B4|Treatment period|Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3673045|NCT02321098|3517014|B2|Treatment period|Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3673046|NCT02321098|3517015|B1|Treatment period|Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3673047|NCT02321098|3517012|B4|Treatment period|<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3673048|NCT02321098|3517014|B2|Treatment period|<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3673049|NCT02321098|3517015|B1|Treatment period|<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3673050|NCT02320903|3517026|B4|United States||Region of Enrollment||Participants|Count of Participants|88|88.0||||||
3673051|NCT02320903|3517027|B3|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3673052|NCT02320903|3517028|B2|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3673053|NCT02320903|3517029|B1|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3673054|NCT02320903|3517026|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3673055|NCT02320903|3517027|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3673056|NCT02320903|3517028|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3673057|NCT02320903|3517029|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3673058|NCT02320903|3517026|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3673059|NCT02320903|3517027|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3673060|NCT02320903|3517028|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3673061|NCT02320903|3517029|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673062|NCT02320903|3517026|B4||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3673063|NCT02320903|3517027|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3673064|NCT02320903|3517028|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3673065|NCT02320903|3517029|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3673066|NCT02320903|3517026|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3673067|NCT02320903|3517027|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3673068|NCT02320903|3517028|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3673069|NCT02320903|3517029|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3673070|NCT02320903|3517026|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673071|NCT02320903|3517027|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673072|NCT02320903|3517028|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673073|NCT02320903|3517029|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673074|NCT02320903|3517026|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3673075|NCT02320903|3517027|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673076|NCT02320903|3517028|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673077|NCT02320903|3517029|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3673078|NCT02320903|3517026|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673079|NCT02320903|3517027|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673080|NCT02320903|3517028|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673081|NCT02320903|3517029|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673082|NCT02320903|3517026|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3673083|NCT02320903|3517027|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3673084|NCT02320903|3517028|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3673085|NCT02320903|3517029|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3673086|NCT02320903|3517026|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3673087|NCT02320903|3517027|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3673088|NCT02320903|3517028|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3673089|NCT02320903|3517029|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3673090|NCT02320903|3517026|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3673091|NCT02320903|3517027|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3673092|NCT02320903|3517028|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3673093|NCT02320903|3517029|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3673094|NCT02320903|3517026|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3673095|NCT02320903|3517027|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3673096|NCT02320903|3517028|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3673097|NCT02320903|3517029|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3673098|NCT02320903|3517026|B4||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3673099|NCT02320903|3517027|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3673100|NCT02320903|3517028|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3673101|NCT02320903|3517029|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3673102|NCT02320903|3517026|B4|Age||Age|Demographics collected only for parents and teens who completed the study (parents=16, teens=16)|Years|Mean|24.15|24.15|Standard Deviation|0|0.0|||
3673103|NCT02320903|3517027|B3|Age||Age|Demographics collected only for parents and teens who completed the study (parents=16, teens=16)|Years|Mean|14.6|14.6|Standard Deviation|1.6|1.6|||
3673201|NCT02320149|3517254|B1|≥12 and <18 Years||Age, Customized||participants|Number|241|241.0||||||
3673104|NCT02320903|3517028|B2|Age||Age|Demographics collected only for parents and teens who completed the study (parents=16, teens=16)|Years|Mean|41.7|41.7|Standard Deviation|0|0.0|||
3673105|NCT02320838|3517064|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3673106|NCT02320838|3517064|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3673107|NCT02320838|3517064|B1|||Age||years|Mean|21.4|21.4|Standard Deviation|2.3|2.3|||
3673108|NCT02320721|3517133|B3|≥75 years of age||Age Group||Participants|Count of Participants|241|241.0||||||
3673109|NCT02320721|3517134|B2|≥75 years of age||Age Group||Participants|Count of Participants|106|106.0||||||
3673110|NCT02320721|3517135|B1|≥75 years of age||Age Group||Participants|Count of Participants|135|135.0||||||
3673111|NCT02320721|3517133|B3|<75 years of age||Age Group||Participants|Count of Participants|773|773.0||||||
3673112|NCT02320721|3517134|B2|<75 years of age||Age Group||Participants|Count of Participants|400|400.0||||||
3673113|NCT02320721|3517135|B1|<75 years of age||Age Group||Participants|Count of Participants|373|373.0||||||
3673114|NCT02320721|3517133|B3|Insulin pre-treated||Randomization strata of insulin||Participants|Count of Participants|683|683.0||||||
3673115|NCT02320721|3517134|B2|Insulin pre-treated||Randomization strata of insulin||Participants|Count of Participants|341|341.0||||||
3673116|NCT02320721|3517135|B1|Insulin pre-treated||Randomization strata of insulin||Participants|Count of Participants|342|342.0||||||
3673117|NCT02320721|3517133|B3|Insulin-naive||Randomization strata of insulin||Participants|Count of Participants|331|331.0||||||
3673118|NCT02320721|3517134|B2|Insulin-naive||Randomization strata of insulin||Participants|Count of Participants|165|165.0||||||
3673119|NCT02320721|3517135|B1|Insulin-naive||Randomization strata of insulin||Participants|Count of Participants|166|166.0||||||
3673120|NCT02320721|3517133|B3|||Baseline Glycated Hemoglobin A1c (HbA1c)||percentage of HbA1c|Mean|8.21|8.21|Standard Deviation|0.91|0.91|||
3673121|NCT02320721|3517134|B2|||Baseline Glycated Hemoglobin A1c (HbA1c)||percentage of HbA1c|Mean|8.22|8.22|Standard Deviation|0.92|0.92|||
3673122|NCT02320721|3517135|B1|||Baseline Glycated Hemoglobin A1c (HbA1c)||percentage of HbA1c|Mean|8.20|8.2|Standard Deviation|0.91|0.91|||
3673123|NCT02320721|3517133|B3|||Duration of Type 2 Diabetes||years|Mean|15.32|15.32|Standard Deviation|7.93|7.93|||
3673124|NCT02320721|3517134|B2|||Duration of Type 2 Diabetes||years|Mean|15.35|15.35|Standard Deviation|7.70|7.7|||
3673125|NCT02320721|3517135|B1|||Duration of Type 2 Diabetes||years|Mean|15.29|15.29|Standard Deviation|8.17|8.17|||
3673126|NCT02320721|3517133|B3|||Body Mass Index (BMI)||kg/m^2|Mean|31.1|31.1|Standard Deviation|5.6|5.6|||
3673127|NCT02320721|3517134|B2|||Body Mass Index (BMI)||kg/m^2|Mean|31.2|31.2|Standard Deviation|5.7|5.7|||
3673128|NCT02320721|3517135|B1|||Body Mass Index (BMI)||kg/m^2|Mean|30.9|30.9|Standard Deviation|5.5|5.5|||
3673129|NCT02320721|3517133|B3||Male|Sex: Female, Male||Participants|Count of Participants|527|527.0||||||
3673130|NCT02320721|3517134|B2||Male|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
3673131|NCT02320721|3517135|B1||Male|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
3673132|NCT02320721|3517133|B3||Female|Sex: Female, Male||Participants|Count of Participants|487|487.0||||||
3673133|NCT02320721|3517134|B2||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
3673134|NCT02320721|3517135|B1||Female|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
3673135|NCT02320721|3517133|B3|||Age||years|Mean|71.0|71.0|Standard Deviation|4.9|4.9|||
3673136|NCT02320721|3517134|B2|||Age||years|Mean|70.8|70.8|Standard Deviation|4.8|4.8|||
3673137|NCT02320721|3517135|B1|||Age||years|Mean|71.1|71.1|Standard Deviation|4.9|4.9|||
3673138|NCT02320695|3517164|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
3673139|NCT02320695|3517164|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3673140|NCT02320695|3517164|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3673141|NCT02320695|3517164|B1|||Age||years|Mean|51.2|51.2|Standard Deviation|13.24|13.24|||
3673142|NCT02320487|3517191|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3673143|NCT02320487|3517191|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3673144|NCT02320487|3517191|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|10.79|10.79|||
3673145|NCT02320396|3517209|B3||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3673146|NCT02320396|3517210|B2||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3673147|NCT02320396|3517211|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3673148|NCT02320396|3517209|B3||Female|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
3673149|NCT02320396|3517210|B2||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3673150|NCT02320396|3517211|B1||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3673151|NCT02320396|3517209|B3|||Age||years|Mean|39.9|39.9|Standard Deviation|10.9|10.9|||
3673152|NCT02320396|3517210|B2|||Age||years|Mean|39.8|39.8|Standard Deviation|10.9|10.9|||
3673153|NCT02320396|3517211|B1|||Age||years|Mean|40.0|40.0|Standard Deviation|10.9|10.9|||
3673154|NCT02320227|3517242|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3673155|NCT02320227|3517242|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3673156|NCT02320227|3517242|B1|Age 22-59||Age, Customized||participants|Number|30|30.0||||||
3673157|NCT02320214|3517247|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3673158|NCT02320214|3517247|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3673159|NCT02320214|3517247|B1|24-59||Age, Customized||participants|Number|30|30.0||||||
3673202|NCT02320149|3517252|B3|≥9 and <12 Years||Age, Customized||participants|Number|10|10.0||||||
3673203|NCT02320149|3517253|B2|≥9 and <12 Years||Age, Customized||participants|Number|6|6.0||||||
3673160|NCT02320149|3517252|B3|||Investigator’s Global Assessment (IGA) Score - Face|The investigator assessed the participant’s inflammatory lesions on the face using the IGA 5-point scale. The scale ranges from 0 (best): clear, no evidence of papules or pustules to 4 (worst): severe, inflammatory lesions are more apparent, many papules/pustules, there may or may not be a few nodulocytic lesions.|score on a scale|Mean|3.1|3.1|Standard Deviation|0.4|0.4|||
3673161|NCT02320149|3517253|B2|||Investigator’s Global Assessment (IGA) Score - Face|The investigator assessed the participant’s inflammatory lesions on the face using the IGA 5-point scale. The scale ranges from 0 (best): clear, no evidence of papules or pustules to 4 (worst): severe, inflammatory lesions are more apparent, many papules/pustules, there may or may not be a few nodulocytic lesions.|score on a scale|Mean|3.2|3.2|Standard Deviation|0.4|0.4|||
3673162|NCT02320149|3517254|B1|||Investigator’s Global Assessment (IGA) Score - Face|The investigator assessed the participant’s inflammatory lesions on the face using the IGA 5-point scale. The scale ranges from 0 (best): clear, no evidence of papules or pustules to 4 (worst): severe, inflammatory lesions are more apparent, many papules/pustules, there may or may not be a few nodulocytic lesions.|score on a scale|Mean|3.1|3.1|Standard Deviation|0.4|0.4|||
3673163|NCT02320149|3517252|B3|||Inflammatory Lesion Counts|Facial area lesion counts were made at forehead, left and right cheeks, nose, and chin. Inflammatory lesion counts were defined as: papule: a solid, elevated lesion <0.5 cm in diameter with surrounding erythematous halo; pustule: an elevated lesion containing pus <0.5 cm in diameter with surrounding erythematous halo; nodule: palpable solid erythematous lesion >0.5 cm in diameter; has depth, not necessarily elevated.|lesion count|Mean|30.0|30.0|Standard Deviation|9.2|9.2|||
3673164|NCT02320149|3517253|B2|||Inflammatory Lesion Counts|Facial area lesion counts were made at forehead, left and right cheeks, nose, and chin. Inflammatory lesion counts were defined as: papule: a solid, elevated lesion <0.5 cm in diameter with surrounding erythematous halo; pustule: an elevated lesion containing pus <0.5 cm in diameter with surrounding erythematous halo; nodule: palpable solid erythematous lesion >0.5 cm in diameter; has depth, not necessarily elevated.|lesion count|Mean|30.2|30.2|Standard Deviation|9.6|9.6|||
3673165|NCT02320149|3517254|B1|||Inflammatory Lesion Counts|Facial area lesion counts were made at forehead, left and right cheeks, nose, and chin. Inflammatory lesion counts were defined as: papule: a solid, elevated lesion <0.5 cm in diameter with surrounding erythematous halo; pustule: an elevated lesion containing pus <0.5 cm in diameter with surrounding erythematous halo; nodule: palpable solid erythematous lesion >0.5 cm in diameter; has depth, not necessarily elevated.|lesion count|Mean|29.7|29.7|Standard Deviation|8.7|8.7|||
3673166|NCT02320149|3517252|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|681|681.0||||||
3673167|NCT02320149|3517253|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|342|342.0||||||
3673168|NCT02320149|3517254|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|339|339.0||||||
3673169|NCT02320149|3517252|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|287|287.0||||||
3673170|NCT02320149|3517253|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|143|143.0||||||
3673171|NCT02320149|3517254|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|144|144.0||||||
3673172|NCT02320149|3517252|B3|Multiple races||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
3673173|NCT02320149|3517253|B2|Multiple races||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3673174|NCT02320149|3517254|B1|Multiple races||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3673175|NCT02320149|3517252|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3673176|NCT02320149|3517253|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3673177|NCT02320149|3517254|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3673178|NCT02320149|3517252|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3673179|NCT02320149|3517253|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3673180|NCT02320149|3517254|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3673181|NCT02320149|3517252|B3|Asian||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
3673182|NCT02320149|3517253|B2|Asian||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3673183|NCT02320149|3517254|B1|Asian||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3673184|NCT02320149|3517252|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|159|159.0||||||
3673185|NCT02320149|3517253|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|79|79.0||||||
3673186|NCT02320149|3517254|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|80|80.0||||||
3673187|NCT02320149|3517252|B3|White||Race/Ethnicity, Customized||Participants|Number|754|754.0||||||
3673188|NCT02320149|3517253|B2|White||Race/Ethnicity, Customized||Participants|Number|377|377.0||||||
3673189|NCT02320149|3517254|B1|White||Race/Ethnicity, Customized||Participants|Number|377|377.0||||||
3673190|NCT02320149|3517252|B3||Male|Sex: Female, Male||Participants|Count of Participants|429|429.0||||||
3673191|NCT02320149|3517253|B2||Male|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
3673192|NCT02320149|3517254|B1||Male|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
3673193|NCT02320149|3517252|B3||Female|Sex: Female, Male||Participants|Count of Participants|539|539.0||||||
3673194|NCT02320149|3517253|B2||Female|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
3673195|NCT02320149|3517254|B1||Female|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
3673196|NCT02320149|3517252|B3|≥18 Years||Age, Customized||participants|Number|482|482.0||||||
3673197|NCT02320149|3517253|B2|≥18 Years||Age, Customized||participants|Number|244|244.0||||||
3673198|NCT02320149|3517254|B1|≥18 Years||Age, Customized||participants|Number|238|238.0||||||
3673199|NCT02320149|3517252|B3|≥12 and <18 Years||Age, Customized||participants|Number|476|476.0||||||
3673200|NCT02320149|3517253|B2|≥12 and <18 Years||Age, Customized||participants|Number|235|235.0||||||
3673204|NCT02320149|3517254|B1|≥9 and <12 Years||Age, Customized||participants|Number|4|4.0||||||
3673205|NCT02319824|3517293|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3673206|NCT02319824|3517293|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673207|NCT02319824|3517293|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673208|NCT02319824|3517293|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3673209|NCT02319824|3517293|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673210|NCT02319824|3517293|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673211|NCT02319824|3517293|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673212|NCT02319824|3517293|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673213|NCT02319824|3517293|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3673214|NCT02319824|3517293|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3673215|NCT02319824|3517293|B1|||Age, Customized||years|Mean|40|40.0|Full Range|||27.0|53.0|
3673216|NCT02319668|3517299|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673217|NCT02319668|3517300|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673218|NCT02319668|3517301|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673219|NCT02319668|3517299|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673220|NCT02319668|3517300|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673221|NCT02319668|3517301|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673222|NCT02319668|3517299|B3||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3673223|NCT02319668|3517300|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3673224|NCT02319668|3517301|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3673225|NCT02319668|3517299|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3673226|NCT02319668|3517300|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3673227|NCT02319668|3517301|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673228|NCT02319668|3517299|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673229|NCT02319668|3517300|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673230|NCT02319668|3517301|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673231|NCT02319668|3517299|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3673232|NCT02319668|3517300|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3673233|NCT02319668|3517301|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3673234|NCT02319668|3517299|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673235|NCT02319668|3517300|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673236|NCT02319668|3517301|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673237|NCT02319668|3517299|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673238|NCT02319668|3517300|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673239|NCT02319668|3517301|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673240|NCT02319668|3517299|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3673241|NCT02319668|3517300|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3673242|NCT02319668|3517301|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3673243|NCT02319668|3517299|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3673244|NCT02319668|3517300|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3673245|NCT02319668|3517301|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3673246|NCT02319668|3517299|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3673247|NCT02319668|3517300|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3673248|NCT02319668|3517301|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3673249|NCT02319668|3517299|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3673250|NCT02319668|3517300|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3673251|NCT02319668|3517301|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3673252|NCT02319668|3517299|B3|||Age||Years|Mean|27.9|27.9|Standard Deviation|10.50|10.5|||
3673253|NCT02319668|3517300|B2|||Age||Years|Mean|28.4|28.4|Standard Deviation|12.23|12.23|||
3673254|NCT02319668|3517301|B1|||Age||Years|Mean|27.5|27.5|Standard Deviation|8.74|8.74|||
3673255|NCT02319642|3517314|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3673256|NCT02319642|3517315|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3673257|NCT02319642|3517316|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3673258|NCT02319642|3517314|B3||Female|Sex: Female, Male||Participants|Count of Participants|293|293.0||||||
3673259|NCT02319642|3517315|B2||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
3673260|NCT02319642|3517316|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3673261|NCT02319642|3517314|B3|||Age||years|Mean|47.2|47.2|Standard Deviation|11.4|11.4|||
3673262|NCT02319642|3517315|B2|||Age||years|Mean|47.5|47.5|Standard Deviation|11.6|11.6|||
3673263|NCT02319642|3517316|B1|||Age||years|Mean|46.3|46.3|Standard Deviation|10.9|10.9|||
3673264|NCT02319642|3517314|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3673265|NCT02319642|3517315|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3673266|NCT02319642|3517316|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3673267|NCT02319642|3517314|B3||Between 18 and 65 years|Age||Participants|Count of Participants|330|330.0||||||
3673268|NCT02319642|3517315|B2||Between 18 and 65 years|Age||Participants|Count of Participants|239|239.0||||||
3673269|NCT02319642|3517316|B1||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
3673270|NCT02319642|3517314|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3673271|NCT02319642|3517315|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3673272|NCT02319642|3517316|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3673273|NCT02319525|3517335|B3|Inadequate Knowledge||Knowledge about immunosuppressives|"Patients were asked 20 true/false questions regarding lupus nephritis and immunosuppressive drugs. Patients answering at least 75% of questions correctly were considered to have adequate knowledge about immunosuppressives. Those answering fewer than 75% of questions correctly were considered to have inadequate knowledge."|participants|Number|119|119.0||||||
3673274|NCT02319525|3517336|B2|Inadequate Knowledge||Knowledge about immunosuppressives|"Patients were asked 20 true/false questions regarding lupus nephritis and immunosuppressive drugs. Patients answering at least 75% of questions correctly were considered to have adequate knowledge about immunosuppressives. Those answering fewer than 75% of questions correctly were considered to have inadequate knowledge."|participants|Number|58|58.0||||||
3673275|NCT02319525|3517337|B1|Inadequate Knowledge||Knowledge about immunosuppressives|"Patients were asked 20 true/false questions regarding lupus nephritis and immunosuppressive drugs. Patients answering at least 75% of questions correctly were considered to have adequate knowledge about immunosuppressives. Those answering fewer than 75% of questions correctly were considered to have inadequate knowledge."|participants|Number|61|61.0||||||
3673276|NCT02319525|3517335|B3|Adequate Knowledge||Knowledge about immunosuppressives|"Patients were asked 20 true/false questions regarding lupus nephritis and immunosuppressive drugs. Patients answering at least 75% of questions correctly were considered to have adequate knowledge about immunosuppressives. Those answering fewer than 75% of questions correctly were considered to have inadequate knowledge."|participants|Number|179|179.0||||||
3673277|NCT02319525|3517336|B2|Adequate Knowledge||Knowledge about immunosuppressives|"Patients were asked 20 true/false questions regarding lupus nephritis and immunosuppressive drugs. Patients answering at least 75% of questions correctly were considered to have adequate knowledge about immunosuppressives. Those answering fewer than 75% of questions correctly were considered to have inadequate knowledge."|participants|Number|89|89.0||||||
3673278|NCT02319525|3517337|B1|Adequate Knowledge||Knowledge about immunosuppressives|"Patients were asked 20 true/false questions regarding lupus nephritis and immunosuppressive drugs. Patients answering at least 75% of questions correctly were considered to have adequate knowledge about immunosuppressives. Those answering fewer than 75% of questions correctly were considered to have inadequate knowledge."|participants|Number|90|90.0||||||
3673279|NCT02319525|3517335|B3|||Decisional conflict|The Decisional Conflict Scale is a patient self-administered, validated measure of decisional conflict, a state of uncertainty about a course of action. Scores range from 0 (no decisional conflict) to 100 (extremely high decisional conflict).|units on a scale|Mean|35.4|35.4|Standard Deviation|29.72|29.72|||
3673280|NCT02319525|3517336|B2|||Decisional conflict|The Decisional Conflict Scale is a patient self-administered, validated measure of decisional conflict, a state of uncertainty about a course of action. Scores range from 0 (no decisional conflict) to 100 (extremely high decisional conflict).|units on a scale|Mean|37.48|37.48|Standard Deviation|29.85|29.85|||
3673281|NCT02319525|3517337|B1|||Decisional conflict|The Decisional Conflict Scale is a patient self-administered, validated measure of decisional conflict, a state of uncertainty about a course of action. Scores range from 0 (no decisional conflict) to 100 (extremely high decisional conflict).|units on a scale|Mean|33.37|33.37|Standard Deviation|29.55|29.55|||
3673282|NCT02319525|3517335|B3|United States||Region of Enrollment||participants|Number|298|298.0||||||
3673283|NCT02319525|3517336|B2|United States||Region of Enrollment||participants|Number|147|147.0||||||
3673284|NCT02319525|3517337|B1|United States||Region of Enrollment||participants|Number|151|151.0||||||
3673285|NCT02319525|3517335|B3|Other||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3673286|NCT02319525|3517336|B2|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3673287|NCT02319525|3517337|B1|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3673288|NCT02319525|3517335|B3|Non-Hispanic White||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
3673289|NCT02319525|3517336|B2|Non-Hispanic White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3673290|NCT02319525|3517337|B1|Non-Hispanic White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3673291|NCT02319525|3517335|B3|Non-Hispanic Black||Race/Ethnicity, Customized||participants|Number|141|141.0||||||
3673292|NCT02319525|3517336|B2|Non-Hispanic Black||Race/Ethnicity, Customized||participants|Number|71|71.0||||||
3673293|NCT02319525|3517337|B1|Non-Hispanic Black||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
3673294|NCT02319525|3517335|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|78|78.0||||||
3673295|NCT02319525|3517336|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
3673296|NCT02319525|3517337|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
3673297|NCT02319525|3517335|B3|Asian||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3673298|NCT02319525|3517336|B2|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3673299|NCT02319525|3517337|B1|Asian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3673300|NCT02319525|3517335|B3|Not answered||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3673301|NCT02319525|3517336|B2|Not answered||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3673302|NCT02319525|3517337|B1|Not answered||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3673303|NCT02319525|3517335|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3673304|NCT02319525|3517336|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3673305|NCT02319525|3517337|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3673306|NCT02319525|3517335|B3||Female|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
3673307|NCT02319525|3517336|B2||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3673308|NCT02319525|3517337|B1||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3673309|NCT02319525|3517335|B3|||Age||Years|Mean|37.3|37.3|Full Range|||19.0|69.0|
3673310|NCT02319525|3517336|B2|||Age||Years|Mean|37.6|37.6|Full Range|||19.0|66.0|
3673311|NCT02319525|3517337|B1|||Age||Years|Mean|37.1|37.1|Full Range|||19.0|69.0|
3673312|NCT02319525|3517335|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3673313|NCT02319525|3517336|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3673314|NCT02319525|3517337|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3673315|NCT02319525|3517335|B3||Between 18 and 65 years|Age||Participants|Count of Participants|294|294.0||||||
3673316|NCT02319525|3517336|B2||Between 18 and 65 years|Age||Participants|Count of Participants|146|146.0||||||
3673317|NCT02319525|3517337|B1||Between 18 and 65 years|Age||Participants|Count of Participants|148|148.0||||||
3673318|NCT02319525|3517335|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3673319|NCT02319525|3517336|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3673320|NCT02319525|3517337|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3673321|NCT02319486|3517356|B1|stage IIIa||Number of Participants||participants|Number|17|17.0||||||
3673322|NCT02319486|3517356|B1|stage II||Number of Participants||participants|Number|9|9.0||||||
3673323|NCT02319486|3517356|B1|China||Region of Enrollment||participants|Number|26|26.0||||||
3673324|NCT02319486|3517356|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3673325|NCT02319486|3517356|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3673326|NCT02319486|3517356|B1|||Age||months|Mean|2.5|2.5|Full Range|||1.5|7.5|
3673327|NCT02319317|3517362|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
3673328|NCT02319317|3517363|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
3673329|NCT02319317|3517364|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
3673330|NCT02319317|3517362|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3673331|NCT02319317|3517363|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3673332|NCT02319317|3517364|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3673333|NCT02319317|3517362|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3673334|NCT02319317|3517363|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3673335|NCT02319317|3517364|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3673336|NCT02319317|3517362|B3|||Age||years|Mean|16.98|16.98|Standard Deviation|0.35|0.35|||
3673337|NCT02319317|3517363|B2|||Age||years|Mean|16.92|16.92|Standard Deviation|0.30|0.3|||
3673338|NCT02319317|3517364|B1|||Age||years|Mean|17.04|17.04|Standard Deviation|0.39|0.39|||
3673339|NCT02319317|3517362|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3673340|NCT02319317|3517363|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3673341|NCT02319317|3517364|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3673342|NCT02319317|3517362|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3673343|NCT02319317|3517363|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3673344|NCT02319317|3517364|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3673345|NCT02319317|3517362|B3||<=18 years|Age||Participants|Count of Participants|60|60.0||||||
3673346|NCT02319317|3517363|B2||<=18 years|Age||Participants|Count of Participants|29|29.0||||||
3673347|NCT02319317|3517364|B1||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
3673348|NCT02319174|3517371|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
3673349|NCT02319174|3517371|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3673350|NCT02319174|3517371|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3673351|NCT02319174|3517371|B1|||Age||years|Median|29|29.0|Full Range|||18.0|43.0|
3673352|NCT02319148|3517377|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3673353|NCT02319148|3517378|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3673354|NCT02319148|3517379|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3673355|NCT02319148|3517380|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3673356|NCT02319148|3517377|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3673357|NCT02319148|3517378|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3673358|NCT02319148|3517379|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3673359|NCT02319148|3517380|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3673360|NCT02319148|3517377|B4|||Age||years|Mean|35.5|35.5|Standard Deviation|8.7|8.7|||
3673361|NCT02319148|3517378|B3|||Age||years|Mean|35.1|35.1|Standard Deviation|10.1|10.1|||
3673362|NCT02319148|3517379|B2|||Age||years|Mean|33.4|33.4|Standard Deviation|9.9|9.9|||
3673363|NCT02319148|3517380|B1|||Age||years|Mean|38.1|38.1|Standard Deviation|6.1|6.1|||
3673364|NCT02319044|3517443|B4|(1) Restricted activity||WHO/ECOG performance status at study entry||Participants|Count of Participants|186|186.0||||||
3673365|NCT02319044|3517444|B3|(1) Restricted activity||WHO/ECOG performance status at study entry||Participants|Count of Participants|48|48.0||||||
3673366|NCT02319044|3517445|B2|(1) Restricted activity||WHO/ECOG performance status at study entry||Participants|Count of Participants|45|45.0||||||
3673367|NCT02319044|3517446|B1|(1) Restricted activity||WHO/ECOG performance status at study entry||Participants|Count of Participants|93|93.0||||||
3673368|NCT02319044|3517443|B4|(0) Normal activity||WHO/ECOG performance status at study entry||Participants|Count of Participants|81|81.0||||||
3673369|NCT02319044|3517444|B3|(0) Normal activity||WHO/ECOG performance status at study entry||Participants|Count of Participants|19|19.0||||||
3673370|NCT02319044|3517445|B2|(0) Normal activity||WHO/ECOG performance status at study entry||Participants|Count of Participants|22|22.0||||||
3673371|NCT02319044|3517446|B1|(0) Normal activity||WHO/ECOG performance status at study entry||Participants|Count of Participants|40|40.0||||||
3673372|NCT02319044|3517443|B4||Never|Smoking/nicotine status by nicotine user||Participants|Count of Participants|43|43.0||||||
3673373|NCT02319044|3517444|B3||Never|Smoking/nicotine status by nicotine user||Participants|Count of Participants|14|14.0||||||
3673374|NCT02319044|3517445|B2||Never|Smoking/nicotine status by nicotine user||Participants|Count of Participants|9|9.0||||||
3673375|NCT02319044|3517446|B1||Never|Smoking/nicotine status by nicotine user||Participants|Count of Participants|20|20.0||||||
3673376|NCT02319044|3517443|B4||Former smoker <= 10 pack years|Smoking/nicotine status by nicotine user||Participants|Count of Participants|58|58.0||||||
3673377|NCT02319044|3517444|B3||Former smoker <= 10 pack years|Smoking/nicotine status by nicotine user||Participants|Count of Participants|12|12.0||||||
3673378|NCT02319044|3517445|B2||Former smoker <= 10 pack years|Smoking/nicotine status by nicotine user||Participants|Count of Participants|16|16.0||||||
3673379|NCT02319044|3517446|B1||Former smoker <= 10 pack years|Smoking/nicotine status by nicotine user||Participants|Count of Participants|30|30.0||||||
3673380|NCT02319044|3517443|B4||Former smoker >10 pack years|Smoking/nicotine status by nicotine user||Participants|Count of Participants|128|128.0||||||
3673381|NCT02319044|3517444|B3||Former smoker >10 pack years|Smoking/nicotine status by nicotine user||Participants|Count of Participants|34|34.0||||||
3673382|NCT02319044|3517445|B2||Former smoker >10 pack years|Smoking/nicotine status by nicotine user||Participants|Count of Participants|35|35.0||||||
3673383|NCT02319044|3517446|B1||Former smoker >10 pack years|Smoking/nicotine status by nicotine user||Participants|Count of Participants|59|59.0||||||
3673384|NCT02319044|3517443|B4||Current smoker <= 10 pack years|Smoking/nicotine status by nicotine user||Participants|Count of Participants|3|3.0||||||
3673385|NCT02319044|3517444|B3||Current smoker <= 10 pack years|Smoking/nicotine status by nicotine user||Participants|Count of Participants|1|1.0||||||
3673386|NCT02319044|3517445|B2||Current smoker <= 10 pack years|Smoking/nicotine status by nicotine user||Participants|Count of Participants|0|0.0||||||
3673387|NCT02319044|3517446|B1||Current smoker <= 10 pack years|Smoking/nicotine status by nicotine user||Participants|Count of Participants|2|2.0||||||
3673388|NCT02319044|3517443|B4||Current smoker >10 pack years|Smoking/nicotine status by nicotine user||Participants|Count of Participants|35|35.0||||||
3673389|NCT02319044|3517444|B3||Current smoker >10 pack years|Smoking/nicotine status by nicotine user||Participants|Count of Participants|6|6.0||||||
3673390|NCT02319044|3517445|B2||Current smoker >10 pack years|Smoking/nicotine status by nicotine user||Participants|Count of Participants|7|7.0||||||
3673391|NCT02319044|3517446|B1||Current smoker >10 pack years|Smoking/nicotine status by nicotine user||Participants|Count of Participants|22|22.0||||||
3673392|NCT02319044|3517443|B4||No|Use of nicotine (other than cigarettes)||Participants|Count of Participants|265|265.0||||||
3673393|NCT02319044|3517444|B3||No|Use of nicotine (other than cigarettes)||Participants|Count of Participants|67|67.0||||||
3673394|NCT02319044|3517445|B2||No|Use of nicotine (other than cigarettes)||Participants|Count of Participants|66|66.0||||||
3673395|NCT02319044|3517446|B1||No|Use of nicotine (other than cigarettes)||Participants|Count of Participants|132|132.0||||||
3673396|NCT02319044|3517443|B4||Yes|Use of nicotine (other than cigarettes)||Participants|Count of Participants|2|2.0||||||
3673397|NCT02319044|3517444|B3||Yes|Use of nicotine (other than cigarettes)||Participants|Count of Participants|0|0.0||||||
3673398|NCT02319044|3517445|B2||Yes|Use of nicotine (other than cigarettes)||Participants|Count of Participants|1|1.0||||||
3673399|NCT02319044|3517446|B1||Yes|Use of nicotine (other than cigarettes)||Participants|Count of Participants|1|1.0||||||
3673400|NCT02319044|3517443|B4||Negative|HPV status||Participants|Count of Participants|192|192.0||||||
3673401|NCT02319044|3517444|B3||Negative|HPV status||Participants|Count of Participants|49|49.0||||||
3673402|NCT02319044|3517445|B2||Negative|HPV status||Participants|Count of Participants|49|49.0||||||
3673403|NCT02319044|3517446|B1||Negative|HPV status||Participants|Count of Participants|94|94.0||||||
3673404|NCT02319044|3517443|B4||Positive|HPV status||Participants|Count of Participants|75|75.0||||||
3673405|NCT02319044|3517444|B3||Positive|HPV status||Participants|Count of Participants|18|18.0||||||
3673406|NCT02319044|3517445|B2||Positive|HPV status||Participants|Count of Participants|18|18.0||||||
3673407|NCT02319044|3517446|B1||Positive|HPV status||Participants|Count of Participants|39|39.0||||||
3673408|NCT02319044|3517443|B4||PD-L1 negative patients|Negative PD-L1 status|Programmed cell death ligand 1 status identification performed at screening|Participants|Count of Participants|267|267.0||||||
3673409|NCT02319044|3517444|B3||PD-L1 negative patients|Negative PD-L1 status|Programmed cell death ligand 1 status identification performed at screening|Participants|Count of Participants|67|67.0||||||
3673410|NCT02319044|3517445|B2||PD-L1 negative patients|Negative PD-L1 status|Programmed cell death ligand 1 status identification performed at screening|Participants|Count of Participants|67|67.0||||||
3673411|NCT02319044|3517446|B1||PD-L1 negative patients|Negative PD-L1 status|Programmed cell death ligand 1 status identification performed at screening|Participants|Count of Participants|133|133.0||||||
3673412|NCT02319044|3517443|B4|Unknown or not reported||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3673413|NCT02319044|3517444|B3|Unknown or not reported||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3673414|NCT02319044|3517445|B2|Unknown or not reported||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3673415|NCT02319044|3517446|B1|Unknown or not reported||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3673416|NCT02319044|3517443|B4|Asian ethnic group - Total||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3673417|NCT02319044|3517444|B3|Asian ethnic group - Total||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3673418|NCT02319044|3517445|B2|Asian ethnic group - Total||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3673419|NCT02319044|3517446|B1|Asian ethnic group - Total||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3673420|NCT02319044|3517443|B4|Asian ethnic group - Chinese||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3673421|NCT02319044|3517444|B3|Asian ethnic group - Chinese||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3673422|NCT02319044|3517445|B2|Asian ethnic group - Chinese||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3673423|NCT02319044|3517446|B1|Asian ethnic group - Chinese||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3673424|NCT02319044|3517443|B4|Asian ethnic group - Asian (not Chinese/Japanese)||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3673425|NCT02319044|3517444|B3|Asian ethnic group - Asian (not Chinese/Japanese)||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3673426|NCT02319044|3517445|B2|Asian ethnic group - Asian (not Chinese/Japanese)||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3673427|NCT02319044|3517446|B1|Asian ethnic group - Asian (not Chinese/Japanese)||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3673428|NCT02319044|3517443|B4|Ethnic group - Total||Race/Ethnicity, Customized||Participants|Count of Participants|256|256.0||||||
3673429|NCT02319044|3517444|B3|Ethnic group - Total||Race/Ethnicity, Customized||Participants|Count of Participants|63|63.0||||||
3673430|NCT02319044|3517445|B2|Ethnic group - Total||Race/Ethnicity, Customized||Participants|Count of Participants|66|66.0||||||
3673431|NCT02319044|3517446|B1|Ethnic group - Total||Race/Ethnicity, Customized||Participants|Count of Participants|127|127.0||||||
3673432|NCT02319044|3517443|B4|Ethnic group - Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|241|241.0||||||
3673433|NCT02319044|3517444|B3|Ethnic group - Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|58|58.0||||||
3673434|NCT02319044|3517445|B2|Ethnic group - Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|64|64.0||||||
3673435|NCT02319044|3517446|B1|Ethnic group - Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|119|119.0||||||
3673436|NCT02319044|3517443|B4|Ethnic group - Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3673437|NCT02319044|3517444|B3|Ethnic group - Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3673438|NCT02319044|3517445|B2|Ethnic group - Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3673439|NCT02319044|3517446|B1|Ethnic group - Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3673440|NCT02319044|3517443|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3673441|NCT02319044|3517444|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3673442|NCT02319044|3517445|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3673443|NCT02319044|3517446|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3673444|NCT02319044|3517443|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673445|NCT02319044|3517444|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673446|NCT02319044|3517445|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673447|NCT02319044|3517446|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673448|NCT02319044|3517443|B4||White|Race (NIH/OMB)||Participants|Count of Participants|230|230.0||||||
3673449|NCT02319044|3517444|B3||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3673450|NCT02319044|3517445|B2||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3673451|NCT02319044|3517446|B1||White|Race (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
3673452|NCT02319044|3517443|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3673453|NCT02319044|3517444|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3673454|NCT02319044|3517445|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3673455|NCT02319044|3517446|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3673456|NCT02319044|3517443|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673457|NCT02319044|3517444|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673458|NCT02319044|3517445|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673459|NCT02319044|3517446|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673460|NCT02319044|3517443|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3673461|NCT02319044|3517444|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3673462|NCT02319044|3517445|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3673463|NCT02319044|3517446|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3673464|NCT02319044|3517443|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673465|NCT02319044|3517444|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673466|NCT02319044|3517445|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673467|NCT02319044|3517446|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673468|NCT02319044|3517443|B4||Male|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
3673469|NCT02319044|3517444|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3673470|NCT02319044|3517445|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3673471|NCT02319044|3517446|B1||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3673472|NCT02319044|3517443|B4||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3673473|NCT02319044|3517444|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3673474|NCT02319044|3517445|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3673475|NCT02319044|3517446|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3673476|NCT02319044|3517443|B4|||Age||years|Median|61|61.0|Full Range|||23.0|82.0|
3673477|NCT02319044|3517444|B3|||Age||years|Median|61|61.0|Full Range|||42.0|77.0|
3673478|NCT02319044|3517445|B2|||Age||years|Median|62|62.0|Full Range|||23.0|82.0|
3673479|NCT02319044|3517446|B1|||Age||years|Median|62|62.0|Full Range|||26.0|81.0|
3673480|NCT02319044|3517443|B4||>=65 years|Age||Participants|Count of Participants|91|91.0||||||
3673481|NCT02319044|3517444|B3||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3673482|NCT02319044|3517445|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3673483|NCT02319044|3517446|B1||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
3673484|NCT02319044|3517443|B4||Between 18 and 65 years|Age||Participants|Count of Participants|176|176.0||||||
3673485|NCT02319044|3517444|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3673486|NCT02319044|3517445|B2||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
3673487|NCT02319044|3517446|B1||Between 18 and 65 years|Age||Participants|Count of Participants|88|88.0||||||
3673488|NCT02319044|3517443|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3673489|NCT02319044|3517444|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3673490|NCT02319044|3517445|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3673491|NCT02319044|3517446|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3673492|NCT02319031|3517502|B3||Male|Gender||Participants|Count of Participants|40|40.0||||||
3673493|NCT02319031|3517503|B2||Male|Gender||Participants|Count of Participants|22|22.0||||||
3673494|NCT02319031|3517504|B1||Male|Gender||Participants|Count of Participants|18|18.0||||||
3673495|NCT02319031|3517502|B3||Female|Gender||Participants|Count of Participants|10|10.0||||||
3673496|NCT02319031|3517503|B2||Female|Gender||Participants|Count of Participants|4|4.0||||||
3673497|NCT02319031|3517504|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
3673498|NCT02319031|3517502|B3|>=65||Age, Customized||participants|Number|1|1.0||||||
3673499|NCT02319031|3517503|B2|>=65||Age, Customized||participants|Number|0|0.0||||||
3673500|NCT02319031|3517504|B1|>=65||Age, Customized||participants|Number|1|1.0||||||
3673501|NCT02319031|3517502|B3|<65||Age, Customized||participants|Number|49|49.0||||||
3673502|NCT02319031|3517503|B2|<65||Age, Customized||participants|Number|26|26.0||||||
3673503|NCT02319031|3517504|B1|<65||Age, Customized||participants|Number|23|23.0||||||
3673504|NCT02319031|3517502|B3|||Age||years|Mean|54.1|54.1|Standard Deviation|6.80|6.8|||
3673505|NCT02319031|3517503|B2|||Age||years|Mean|55.0|55.0|Standard Deviation|5.75|5.75|||
3673506|NCT02319031|3517504|B1|||Age||years|Mean|53.0|53.0|Standard Deviation|7.77|7.77|||
3673507|NCT02319005|3517515|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3673508|NCT02319005|3517516|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673509|NCT02319005|3517517|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3673510|NCT02319005|3517515|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673511|NCT02319005|3517516|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673512|NCT02319005|3517517|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673513|NCT02319005|3517515|B3||White|Race (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3673514|NCT02319005|3517516|B2||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3673515|NCT02319005|3517517|B1||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3673516|NCT02319005|3517515|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
3673517|NCT02319005|3517516|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3673518|NCT02319005|3517517|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3673519|NCT02319005|3517515|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673520|NCT02319005|3517516|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673521|NCT02319005|3517517|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673522|NCT02319005|3517515|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673523|NCT02319005|3517516|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673524|NCT02319005|3517517|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673525|NCT02319005|3517515|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3673526|NCT02319005|3517516|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3673527|NCT02319005|3517517|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673528|NCT02319005|3517515|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3673529|NCT02319005|3517516|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3673530|NCT02319005|3517517|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3673531|NCT02319005|3517515|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|194|194.0||||||
3673532|NCT02319005|3517516|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3673533|NCT02319005|3517517|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
3673534|NCT02319005|3517515|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3673535|NCT02319005|3517516|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673536|NCT02319005|3517517|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3673537|NCT02319005|3517515|B3||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3673538|NCT02319005|3517516|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3673539|NCT02319005|3517517|B1||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3673540|NCT02319005|3517515|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3673541|NCT02319005|3517516|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3673542|NCT02319005|3517517|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3673543|NCT02319005|3517515|B3|||Age||years|Mean|67.8|67.8|Standard Deviation|9.40|9.4|||
3673544|NCT02319005|3517516|B2|||Age||years|Mean|66.2|66.2|Standard Deviation|9.52|9.52|||
3673545|NCT02319005|3517517|B1|||Age||years|Mean|68.6|68.6|Standard Deviation|9.28|9.28|||
3673546|NCT02318940|3517538|B3|||weight||kg|Median|10|10.0|Full Range|||3.0|113.0|
3673547|NCT02318940|3517539|B2|||weight||kg|Median|9|9.0|Full Range|||3.0|70.0|
3673548|NCT02318940|3517540|B1|||weight||kg|Median|10|10.0|Full Range|||3.0|113.0|
3673549|NCT02318940|3517538|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3673550|NCT02318940|3517539|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3673551|NCT02318940|3517540|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3673552|NCT02318940|3517538|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3673553|NCT02318940|3517539|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3673554|NCT02318940|3517540|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3673555|NCT02318940|3517538|B3|||Age||months|Median|13|13.0|Full Range|||1.0|180.0|
3673556|NCT02318940|3517539|B2|||Age||months|Median|14|14.0|Full Range|||1.0|168.0|
3673557|NCT02318940|3517540|B1|||Age||months|Median|12|12.0|Full Range|||1.0|180.0|
3673558|NCT02318901|3517553|B4|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3673559|NCT02318901|3517554|B3|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3673560|NCT02318901|3517555|B2|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3673561|NCT02318901|3517556|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3673562|NCT02318901|3517553|B4|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3673563|NCT02318901|3517553|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3673564|NCT02318901|3517554|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3673565|NCT02318901|3517555|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3673566|NCT02318901|3517556|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3673567|NCT02318901|3517553|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3673568|NCT02318901|3517554|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3673569|NCT02318901|3517555|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3673570|NCT02318901|3517556|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3673571|NCT02318901|3517553|B4|||Age||years|Mean|57|57.0|Full Range|||35.0|67.0|
3673572|NCT02318901|3517554|B3|||Age||years|Mean|58|58.0|Full Range|||35.0|67.0|
3673573|NCT02318901|3517555|B2|||Age||years|Mean|62|62.0|Full Range|||||
3673574|NCT02318901|3517556|B1|||Age||years|Mean|52|52.0|Full Range|||44.0|64.0|
3673575|NCT02318901|3517553|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3673576|NCT02318901|3517554|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3673577|NCT02318901|3517555|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3673578|NCT02318901|3517556|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3673579|NCT02318901|3517553|B4||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3673580|NCT02318901|3517554|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3673581|NCT02318901|3517555|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3673582|NCT02318901|3517556|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3673583|NCT02318901|3517553|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3673584|NCT02318901|3517554|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3673585|NCT02318901|3517555|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3673586|NCT02318901|3517556|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3673587|NCT02318797|3517566|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673588|NCT02318797|3517567|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673589|NCT02318797|3517568|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673590|NCT02318797|3517566|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3673591|NCT02318797|3517567|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3673592|NCT02318797|3517568|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3673593|NCT02318797|3517566|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1104|1104.0||||||
3673594|NCT02318797|3517567|B2||White|Race (NIH/OMB)||Participants|Count of Participants|621|621.0||||||
3673595|NCT02318797|3517568|B1||White|Race (NIH/OMB)||Participants|Count of Participants|483|483.0||||||
3673596|NCT02318797|3517566|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
3673597|NCT02318797|3517567|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3673598|NCT02318797|3517568|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3673599|NCT02318797|3517566|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673600|NCT02318797|3517567|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673601|NCT02318797|3517568|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673602|NCT02318797|3517566|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3673603|NCT02318797|3517567|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3673604|NCT02318797|3517568|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673605|NCT02318797|3517566|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3673606|NCT02318797|3517567|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3673607|NCT02318797|3517568|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3673608|NCT02318797|3517566|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673609|NCT02318797|3517567|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673610|NCT02318797|3517568|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673611|NCT02318797|3517566|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1223|1223.0||||||
3673612|NCT02318797|3517567|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|709|709.0||||||
3673613|NCT02318797|3517568|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|514|514.0||||||
3673614|NCT02318797|3517566|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3673615|NCT02318797|3517567|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3673616|NCT02318797|3517568|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3673617|NCT02318797|3517566|B3||Male|Sex: Female, Male||Participants|Count of Participants|460|460.0||||||
3673618|NCT02318797|3517567|B2||Male|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
3673619|NCT02318797|3517568|B1||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
3673620|NCT02318797|3517566|B3||Female|Sex: Female, Male||Participants|Count of Participants|769|769.0||||||
3673621|NCT02318797|3517567|B2||Female|Sex: Female, Male||Participants|Count of Participants|428|428.0||||||
3673622|NCT02318797|3517568|B1||Female|Sex: Female, Male||Participants|Count of Participants|341|341.0||||||
3673623|NCT02318797|3517566|B3|||Age||years|Mean|43.01|43.01|Full Range|||18.0|76.0|
3673624|NCT02318797|3517567|B2|||Age||years|Mean|43.47|43.47|Full Range|||19.0|72.0|
3673625|NCT02318797|3517568|B1|||Age||years|Mean|42.37|42.37|Full Range|||18.0|76.0|
3673626|NCT02318693|3517607|B3|||Hemoglobin A1C (HbA1C)|Glycosylated HbA1c is a surrogate marker of long-term glycemic control. The permissible range for study inclusion was ≥ 7.0% and < 9.0% (National Glycohemoglobin Standardization program; NGSP) at Week -2.|%|Mean|7.8|7.8|Standard Deviation|0.5|0.5|||
3673627|NCT02318693|3517608|B2|||Hemoglobin A1C (HbA1C)|Glycosylated HbA1c is a surrogate marker of long-term glycemic control. The permissible range for study inclusion was ≥ 7.0% and < 9.0% (National Glycohemoglobin Standardization program; NGSP) at Week -2.|%|Mean|7.9|7.9|Standard Deviation|0.6|0.6|||
3673628|NCT02318693|3517609|B1|||Hemoglobin A1C (HbA1C)|Glycosylated HbA1c is a surrogate marker of long-term glycemic control. The permissible range for study inclusion was ≥ 7.0% and < 9.0% (National Glycohemoglobin Standardization program; NGSP) at Week -2.|%|Mean|7.7|7.7|Standard Deviation|0.5|0.5|||
3673629|NCT02318693|3517607|B3|>5||Alcohol Consumption||Drinks/week|Number|17|17.0||||||
3673630|NCT02318693|3517608|B2|>5||Alcohol Consumption||Drinks/week|Number|8|8.0||||||
3673631|NCT02318693|3517609|B1|>5||Alcohol Consumption||Drinks/week|Number|9|9.0||||||
3673632|NCT02318693|3517607|B3|1 to 4||Alcohol Consumption||Drinks/week|Number|22|22.0||||||
3673633|NCT02318693|3517608|B2|1 to 4||Alcohol Consumption||Drinks/week|Number|13|13.0||||||
3673634|NCT02318693|3517609|B1|1 to 4||Alcohol Consumption||Drinks/week|Number|9|9.0||||||
3673635|NCT02318693|3517607|B3|0||Alcohol Consumption||Drinks/week|Number|13|13.0||||||
3673636|NCT02318693|3517608|B2|0||Alcohol Consumption||Drinks/week|Number|5|5.0||||||
3673637|NCT02318693|3517609|B1|0||Alcohol Consumption||Drinks/week|Number|8|8.0||||||
3673638|NCT02318693|3517607|B3|Never Smoked||Smoking Status||Participants|Number|15|15.0||||||
3673639|NCT02318693|3517608|B2|Never Smoked||Smoking Status||Participants|Number|7|7.0||||||
3673640|NCT02318693|3517609|B1|Never Smoked||Smoking Status||Participants|Number|8|8.0||||||
3673641|NCT02318693|3517607|B3|Ex-Smoker||Smoking Status||Participants|Number|20|20.0||||||
3673642|NCT02318693|3517608|B2|Ex-Smoker||Smoking Status||Participants|Number|10|10.0||||||
3673643|NCT02318693|3517609|B1|Ex-Smoker||Smoking Status||Participants|Number|10|10.0||||||
3673644|NCT02318693|3517607|B3|Current Smoker||Smoking Status||Participants|Number|17|17.0||||||
3673645|NCT02318693|3517608|B2|Current Smoker||Smoking Status||Participants|Number|9|9.0||||||
3673646|NCT02318693|3517609|B1|Current Smoker||Smoking Status||Participants|Number|8|8.0||||||
3673647|NCT02318693|3517607|B3|||Duration of Diabetes Mellitus||Years|Mean|8.2|8.2|Standard Deviation|5.7|5.7|||
3673648|NCT02318693|3517608|B2|||Duration of Diabetes Mellitus||Years|Mean|9.9|9.9|Standard Deviation|5.5|5.5|||
3673649|NCT02318693|3517609|B1|||Duration of Diabetes Mellitus||Years|Mean|6.4|6.4|Standard Deviation|5.4|5.4|||
3673650|NCT02318693|3517607|B3|||Body Mass Index||kg/m^2|Mean|24.5|24.5|Standard Deviation|2.6|2.6|||
3673651|NCT02318693|3517608|B2|||Body Mass Index||kg/m^2|Mean|24.6|24.6|Standard Deviation|3.0|3.0|||
3673652|NCT02318693|3517609|B1|||Body Mass Index||kg/m^2|Mean|24.4|24.4|Standard Deviation|2.1|2.1|||
3673653|NCT02318693|3517607|B3|||Height||cm|Mean|169.4|169.4|Standard Deviation|5.3|5.3|||
3673654|NCT02318693|3517608|B2|||Height||cm|Mean|169.3|169.3|Standard Deviation|5.3|5.3|||
3673655|NCT02318693|3517609|B1|||Height||cm|Mean|169.5|169.5|Standard Deviation|5.4|5.4|||
3673656|NCT02318693|3517607|B3|||Body Weight||kg|Mean|70.5|70.5|Standard Deviation|9.7|9.7|||
3673657|NCT02318693|3517608|B2|||Body Weight||kg|Mean|70.7|70.7|Standard Deviation|11.2|11.2|||
3673658|NCT02318693|3517609|B1|||Body Weight||kg|Mean|70.2|70.2|Standard Deviation|8.2|8.2|||
3673659|NCT02318693|3517607|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3673660|NCT02318693|3517608|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3673661|NCT02318693|3517609|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3673662|NCT02318693|3517607|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3673663|NCT02318693|3517608|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3673664|NCT02318693|3517609|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3673665|NCT02318693|3517607|B3|>=65 years||Age, Customized||Participants|Number|21|21.0||||||
3673666|NCT02318693|3517608|B2|>=65 years||Age, Customized||Participants|Number|10|10.0||||||
3673667|NCT02318693|3517609|B1|>=65 years||Age, Customized||Participants|Number|11|11.0||||||
3673668|NCT02318693|3517607|B3|<65 years||Age, Customized||Participants|Number|31|31.0||||||
3673669|NCT02318693|3517608|B2|<65 years||Age, Customized||Participants|Number|16|16.0||||||
3673670|NCT02318693|3517609|B1|<65 years||Age, Customized||Participants|Number|15|15.0||||||
3673671|NCT02318693|3517607|B3|||Age||Years|Mean|59.8|59.8|Standard Deviation|9.5|9.5|||
3673672|NCT02318693|3517608|B2|||Age||Years|Mean|59.5|59.5|Standard Deviation|10.7|10.7|||
3673673|NCT02318693|3517609|B1|||Age||Years|Mean|60.2|60.2|Standard Deviation|8.4|8.4|||
3673674|NCT02318667|3517624|B1|||Serum human Suppression of Tumorigenicity 2 (ST2) level|ST2, a serum biomarker, was collected at Baseline.|ng/mL|Mean|21.8|21.8|Standard Deviation|11.09|11.09|||
3673675|NCT02318667|3517624|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3673676|NCT02318667|3517624|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3673677|NCT02318667|3517624|B1|||Age||Years|Mean|34.8|34.8|Standard Deviation|12.15|12.15|||
3673678|NCT02318602|3517640|B4|United States||Region of Enrollment||participants|Number|52|52.0||||||
3673679|NCT02318602|3517641|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
3673680|NCT02318602|3517642|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
3673681|NCT02318602|3517643|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3673682|NCT02318602|3517640|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3673683|NCT02318602|3517641|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673684|NCT02318602|3517642|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3673685|NCT02318602|3517643|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3673686|NCT02318602|3517640|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673687|NCT02318602|3517641|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673688|NCT02318602|3517642|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673689|NCT02318602|3517643|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673690|NCT02318602|3517640|B4||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3673691|NCT02318602|3517641|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3673692|NCT02318602|3517642|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3673693|NCT02318602|3517643|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3673694|NCT02318602|3517640|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3673695|NCT02318602|3517641|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673696|NCT02318602|3517642|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3673697|NCT02318602|3517643|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673698|NCT02318602|3517640|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3673699|NCT02318602|3517641|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673700|NCT02318602|3517642|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3673701|NCT02318602|3517643|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673702|NCT02318602|3517640|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3673703|NCT02318602|3517641|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673704|NCT02318602|3517642|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3673705|NCT02318602|3517643|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673706|NCT02318602|3517640|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3673707|NCT02318602|3517641|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3673708|NCT02318602|3517642|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3673709|NCT02318602|3517643|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673710|NCT02318602|3517640|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673711|NCT02318602|3517641|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673712|NCT02318602|3517642|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673713|NCT02318602|3517643|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673714|NCT02318602|3517640|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3673715|NCT02318602|3517641|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3673716|NCT02318602|3517642|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3673717|NCT02318602|3517643|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3673718|NCT02318602|3517640|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3673719|NCT02318602|3517641|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3673720|NCT02318602|3517642|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3673721|NCT02318602|3517643|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3673722|NCT02318602|3517640|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3673723|NCT02318602|3517641|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3673724|NCT02318602|3517642|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3673725|NCT02318602|3517643|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3673726|NCT02318602|3517640|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3673727|NCT02318602|3517641|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3673728|NCT02318602|3517642|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3673729|NCT02318602|3517643|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3673730|NCT02318602|3517640|B4|||Age||Years|Mean|8.1|8.1|Standard Deviation|5.07|5.07|||
3673731|NCT02318602|3517641|B3|||Age||Years|Mean|13.9|13.9|Standard Deviation|1.58|1.58|||
3673732|NCT02318602|3517642|B2|||Age||Years|Mean|6.7|6.7|Standard Deviation|2.84|2.84|||
3673733|NCT02318602|3517643|B1|||Age||Years|Mean|1.00|1.0|Standard Deviation|0.00|0.0|||
3673734|NCT02318303|3517676|B8||Male|Sex: Female, Male||Participants|Count of Participants|371|371.0||||||
3673735|NCT02318303|3517677|B7||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3673736|NCT02318303|3517678|B6||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3673737|NCT02318303|3517679|B5||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3673738|NCT02318303|3517680|B4||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3673739|NCT02318303|3517681|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3673740|NCT02318303|3517682|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3673741|NCT02318303|3517683|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3673742|NCT02318303|3517676|B8||Female|Sex: Female, Male||Participants|Count of Participants|740|740.0||||||
3673743|NCT02318303|3517677|B7||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3673744|NCT02318303|3517678|B6||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3673745|NCT02318303|3517679|B5||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3673746|NCT02318303|3517680|B4||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3673747|NCT02318303|3517681|B3||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3673748|NCT02318303|3517682|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3673749|NCT02318303|3517683|B1||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3673750|NCT02318303|3517676|B8|||Age||years|Mean|43.86|43.86|Standard Deviation|13.882|13.882|||
3673751|NCT02318303|3517677|B7|||Age||years|Mean|43.49|43.49|Standard Deviation|13.868|13.868|||
3673752|NCT02318303|3517678|B6|||Age||years|Mean|44.58|44.58|Standard Deviation|13.698|13.698|||
3673753|NCT02318303|3517679|B5|||Age||years|Mean|43.44|43.44|Standard Deviation|14.128|14.128|||
3673754|NCT02318303|3517680|B4|||Age||years|Mean|41.90|41.9|Standard Deviation|12.478|12.478|||
3673755|NCT02318303|3517681|B3|||Age||years|Mean|44.40|44.4|Standard Deviation|14.312|14.312|||
3673756|NCT02318303|3517682|B2|||Age||years|Mean|43.83|43.83|Standard Deviation|13.609|13.609|||
3673757|NCT02318303|3517683|B1|||Age||years|Mean|45.35|45.35|Standard Deviation|14.951|14.951|||
3673758|NCT02317809|3517705|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3673759|NCT02317809|3517705|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3673760|NCT02317809|3517705|B1|||Age||Years|Mean|28.6|28.6|Standard Deviation|5.88|5.88|||
3673761|NCT02317744|3517756|B3|||Body Mass Index (BMI)||kg/m^2|Mean|37.3|37.3|Full Range|||30.0|49.0|
3673762|NCT02317744|3517757|B2|||Body Mass Index (BMI)||kg/m^2|Mean|40.1|40.1|Full Range|||33.0|48.0|
3673763|NCT02317744|3517758|B1|||Body Mass Index (BMI)||kg/m^2|Mean|35.0|35.0|Full Range|||30.0|49.0|
3673764|NCT02317744|3517756|B3|||Binge Eating Frequency||binge eating days (out of 28)|Mean|12.9|12.9|Full Range|||3.0|27.0|
3673765|NCT02317744|3517757|B2|||Binge Eating Frequency||binge eating days (out of 28)|Mean|9.2|9.2|Full Range|||3.0|27.0|
3673766|NCT02317744|3517758|B1|||Binge Eating Frequency||binge eating days (out of 28)|Mean|16.0|16.0|Full Range|||4.0|28.0|
3673767|NCT02317744|3517756|B3|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3673768|NCT02317744|3517757|B2|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3673769|NCT02317744|3517758|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3673770|NCT02317744|3517756|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3673771|NCT02317744|3517757|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3673772|NCT02317744|3517758|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3673773|NCT02317744|3517756|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3673774|NCT02317744|3517757|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3673775|NCT02317744|3517758|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3673776|NCT02317744|3517756|B3|||Age||years|Mean|50.4|50.4|Standard Deviation|8.8|8.8|||
3673777|NCT02317744|3517757|B2|||Age||years|Mean|49.4|49.4|Standard Deviation|10.1|10.1|||
3673778|NCT02317744|3517758|B1|||Age||years|Mean|51.2|51.2|Standard Deviation|8.0|8.0|||
3673779|NCT02317744|3517756|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3673780|NCT02317744|3517757|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3673781|NCT02317744|3517758|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3673782|NCT02317744|3517756|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3673783|NCT02317744|3517757|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3673784|NCT02317744|3517758|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3673785|NCT02317744|3517756|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3673786|NCT02317744|3517757|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3673787|NCT02317744|3517758|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3673788|NCT02317692|3517771|B3|United States||Region of Enrollment||Families|Number|61|61.0||||||
3673789|NCT02317692|3517772|B2|United States||Region of Enrollment||Families|Number|31|31.0||||||
3673790|NCT02317692|3517773|B1|United States||Region of Enrollment||Families|Number|30|30.0||||||
3673791|NCT02317692|3517771|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673792|NCT02317692|3517772|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673793|NCT02317692|3517773|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673794|NCT02317692|3517771|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673795|NCT02317692|3517772|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673796|NCT02317692|3517773|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673797|NCT02317692|3517771|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3673798|NCT02317692|3517772|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3673799|NCT02317692|3517773|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3673800|NCT02317692|3517771|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3673801|NCT02317692|3517772|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3673802|NCT02317692|3517773|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3673803|NCT02317692|3517771|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3673804|NCT02317692|3517772|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3673805|NCT02317692|3517773|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3673806|NCT02317692|3517771|B3|||Age||years|Mean|7.98|7.98|Full Range|||5.0|13.0|
3673807|NCT02317692|3517772|B2|||Age||years|Mean|7.84|7.84|Full Range|||5.0|13.0|
3673808|NCT02317692|3517773|B1|||Age||years|Mean|8.13|8.13|Full Range|||5.0|12.0|
3673809|NCT02317614|3517792|B3|||number (and percentage) of participants with an undetectable HIV viral load||Participants|Count of Participants|46|46.0||||||
3673810|NCT02317614|3517793|B2|||number (and percentage) of participants with an undetectable HIV viral load||Participants|Count of Participants|24|24.0||||||
3673811|NCT02317614|3517794|B1|||number (and percentage) of participants with an undetectable HIV viral load||Participants|Count of Participants|22|22.0||||||
3673812|NCT02317614|3517792|B3|||number (and percentage) of participants with cocaine or non-prescribed opioid use in their lifetime||Participants|Count of Participants|47|47.0||||||
3673813|NCT02317614|3517793|B2|||number (and percentage) of participants with cocaine or non-prescribed opioid use in their lifetime||Participants|Count of Participants|23|23.0||||||
3673814|NCT02317614|3517794|B1|||number (and percentage) of participants with cocaine or non-prescribed opioid use in their lifetime||Participants|Count of Participants|24|24.0||||||
3673815|NCT02317614|3517792|B3|||number (and percentage) of participants with cocaine or non-prescribed opioids in the last 30 days||Participants|Count of Participants|15|15.0||||||
3673816|NCT02317614|3517793|B2|||number (and percentage) of participants with cocaine or non-prescribed opioids in the last 30 days||Participants|Count of Participants|6|6.0||||||
3673817|NCT02317614|3517794|B1|||number (and percentage) of participants with cocaine or non-prescribed opioids in the last 30 days||Participants|Count of Participants|9|9.0||||||
3673818|NCT02317614|3517792|B3|||number (and percentage) of participants with clinical depression||Participants|Count of Participants|20|20.0||||||
3673819|NCT02317614|3517793|B2|||number (and percentage) of participants with clinical depression||Participants|Count of Participants|11|11.0||||||
3673820|NCT02317614|3517794|B1|||number (and percentage) of participants with clinical depression||Participants|Count of Participants|9|9.0||||||
3673821|NCT02317614|3517792|B3|||Test of Functional Health Literacy in Adults (TOFHLA) score|The TOFHLA has two main sections, one for reading literacy and one for numeracy. These are each scored from zero to 50 then summed for a composite score. Composite scores less than 60 indicate inadequate health literacy. Scores between 60 and 74 indicate marginal health literacy. Scores 75 and above indicate adequate health literacy.|units on a scale|Mean|82.72|82.72|Standard Deviation|13.82|13.82|||
3673822|NCT02317614|3517793|B2|||Test of Functional Health Literacy in Adults (TOFHLA) score|The TOFHLA has two main sections, one for reading literacy and one for numeracy. These are each scored from zero to 50 then summed for a composite score. Composite scores less than 60 indicate inadequate health literacy. Scores between 60 and 74 indicate marginal health literacy. Scores 75 and above indicate adequate health literacy.|units on a scale|Mean|80.28|80.28|Standard Deviation|15.27|15.27|||
3673823|NCT02317614|3517794|B1|||Test of Functional Health Literacy in Adults (TOFHLA) score|The TOFHLA has two main sections, one for reading literacy and one for numeracy. These are each scored from zero to 50 then summed for a composite score. Composite scores less than 60 indicate inadequate health literacy. Scores between 60 and 74 indicate marginal health literacy. Scores 75 and above indicate adequate health literacy.|units on a scale|Mean|85.16|85.16|Standard Deviation|12.36|12.36|||
3673824|NCT02317614|3517792|B3|||Education (years)||years|Mean|11.92|11.92|Standard Deviation|1.69|1.69|||
3673825|NCT02317614|3517793|B2|||Education (years)||years|Mean|11.88|11.88|Standard Deviation|2.13|2.13|||
3673826|NCT02317614|3517794|B1|||Education (years)||years|Mean|11.96|11.96|Standard Deviation|1.24|1.24|||
3673827|NCT02317614|3517792|B3|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3673828|NCT02317614|3517793|B2|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3673829|NCT02317614|3517794|B1|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3673830|NCT02317614|3517792|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3673831|NCT02317614|3517793|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3673832|NCT02317614|3517794|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3673833|NCT02317614|3517792|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3673834|NCT02317614|3517793|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3673835|NCT02317614|3517794|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3673836|NCT02317614|3517792|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
3673837|NCT02317614|3517793|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3673838|NCT02317614|3517794|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3673839|NCT02317614|3517792|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3673840|NCT02317614|3517793|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3673841|NCT02317614|3517794|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3673842|NCT02317614|3517792|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3673843|NCT02317614|3517793|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3673844|NCT02317614|3517794|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3673845|NCT02317614|3517792|B3|||Age||Years|Mean|53.18|53.18|Standard Deviation|9.25|9.25|||
3673846|NCT02317614|3517793|B2|||Age||Years|Mean|54|54.0|Standard Deviation|7.81|7.81|||
3673847|NCT02317614|3517794|B1|||Age||Years|Mean|52.36|52.36|Standard Deviation|10.69|10.69|||
3673848|NCT02317549|3517811|B3|Highest Score = 15-18||SOFA Distribution at Screening|SOFA (sequential organ failure assessment) is a morbidity severity score and mortality assessment tool focused on organ dysfunction and morbidity. The score is composed of 6 variables representing different organ systems (cardiovascular, coagulation, liver, neurological, renal and respiratory). The total score ranges from 0 to 24 with each variable having a point value range of 0 (normal) to 4 (high degree of dysfunction or failure). Since this system uses scoring of individual organ systems, it is able to measure either individual or combined organ dysfunction.|units on a scale|Number|0|0.0||||||
3673849|NCT02317549|3517812|B2|Highest Score = 15-18||SOFA Distribution at Screening|SOFA (sequential organ failure assessment) is a morbidity severity score and mortality assessment tool focused on organ dysfunction and morbidity. The score is composed of 6 variables representing different organ systems (cardiovascular, coagulation, liver, neurological, renal and respiratory). The total score ranges from 0 to 24 with each variable having a point value range of 0 (normal) to 4 (high degree of dysfunction or failure). Since this system uses scoring of individual organ systems, it is able to measure either individual or combined organ dysfunction.|units on a scale|Number|0|0.0||||||
3673850|NCT02317549|3517813|B1|Highest Score = 15-18||SOFA Distribution at Screening|SOFA (sequential organ failure assessment) is a morbidity severity score and mortality assessment tool focused on organ dysfunction and morbidity. The score is composed of 6 variables representing different organ systems (cardiovascular, coagulation, liver, neurological, renal and respiratory). The total score ranges from 0 to 24 with each variable having a point value range of 0 (normal) to 4 (high degree of dysfunction or failure). Since this system uses scoring of individual organ systems, it is able to measure either individual or combined organ dysfunction.|units on a scale|Number|0|0.0||||||
3673872|NCT02317549|3517811|B3|Canada||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3673873|NCT02317549|3517812|B2|Canada||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3673851|NCT02317549|3517811|B3|Highest Score = 12-14||SOFA Distribution at Screening|SOFA (sequential organ failure assessment) is a morbidity severity score and mortality assessment tool focused on organ dysfunction and morbidity. The score is composed of 6 variables representing different organ systems (cardiovascular, coagulation, liver, neurological, renal and respiratory). The total score ranges from 0 to 24 with each variable having a point value range of 0 (normal) to 4 (high degree of dysfunction or failure). Since this system uses scoring of individual organ systems, it is able to measure either individual or combined organ dysfunction.|units on a scale|Number|2|2.0||||||
3673852|NCT02317549|3517812|B2|Highest Score = 12-14||SOFA Distribution at Screening|SOFA (sequential organ failure assessment) is a morbidity severity score and mortality assessment tool focused on organ dysfunction and morbidity. The score is composed of 6 variables representing different organ systems (cardiovascular, coagulation, liver, neurological, renal and respiratory). The total score ranges from 0 to 24 with each variable having a point value range of 0 (normal) to 4 (high degree of dysfunction or failure). Since this system uses scoring of individual organ systems, it is able to measure either individual or combined organ dysfunction.|units on a scale|Number|0|0.0||||||
3673853|NCT02317549|3517813|B1|Highest Score = 12-14||SOFA Distribution at Screening|SOFA (sequential organ failure assessment) is a morbidity severity score and mortality assessment tool focused on organ dysfunction and morbidity. The score is composed of 6 variables representing different organ systems (cardiovascular, coagulation, liver, neurological, renal and respiratory). The total score ranges from 0 to 24 with each variable having a point value range of 0 (normal) to 4 (high degree of dysfunction or failure). Since this system uses scoring of individual organ systems, it is able to measure either individual or combined organ dysfunction.|units on a scale|Number|2|2.0||||||
3673854|NCT02317549|3517811|B3|Highest Score = 9-11||SOFA Distribution at Screening|SOFA (sequential organ failure assessment) is a morbidity severity score and mortality assessment tool focused on organ dysfunction and morbidity. The score is composed of 6 variables representing different organ systems (cardiovascular, coagulation, liver, neurological, renal and respiratory). The total score ranges from 0 to 24 with each variable having a point value range of 0 (normal) to 4 (high degree of dysfunction or failure). Since this system uses scoring of individual organ systems, it is able to measure either individual or combined organ dysfunction.|units on a scale|Number|5|5.0||||||
3673855|NCT02317549|3517812|B2|Highest Score = 9-11||SOFA Distribution at Screening|SOFA (sequential organ failure assessment) is a morbidity severity score and mortality assessment tool focused on organ dysfunction and morbidity. The score is composed of 6 variables representing different organ systems (cardiovascular, coagulation, liver, neurological, renal and respiratory). The total score ranges from 0 to 24 with each variable having a point value range of 0 (normal) to 4 (high degree of dysfunction or failure). Since this system uses scoring of individual organ systems, it is able to measure either individual or combined organ dysfunction.|units on a scale|Number|2|2.0||||||
3673856|NCT02317549|3517813|B1|Highest Score = 9-11||SOFA Distribution at Screening|SOFA (sequential organ failure assessment) is a morbidity severity score and mortality assessment tool focused on organ dysfunction and morbidity. The score is composed of 6 variables representing different organ systems (cardiovascular, coagulation, liver, neurological, renal and respiratory). The total score ranges from 0 to 24 with each variable having a point value range of 0 (normal) to 4 (high degree of dysfunction or failure). Since this system uses scoring of individual organ systems, it is able to measure either individual or combined organ dysfunction.|units on a scale|Number|3|3.0||||||
3673857|NCT02317549|3517811|B3|Highest Score = 6-8||SOFA Distribution at Screening|SOFA (sequential organ failure assessment) is a morbidity severity score and mortality assessment tool focused on organ dysfunction and morbidity. The score is composed of 6 variables representing different organ systems (cardiovascular, coagulation, liver, neurological, renal and respiratory). The total score ranges from 0 to 24 with each variable having a point value range of 0 (normal) to 4 (high degree of dysfunction or failure). Since this system uses scoring of individual organ systems, it is able to measure either individual or combined organ dysfunction.|units on a scale|Number|1|1.0||||||
3673858|NCT02317549|3517812|B2|Highest Score = 6-8||SOFA Distribution at Screening|SOFA (sequential organ failure assessment) is a morbidity severity score and mortality assessment tool focused on organ dysfunction and morbidity. The score is composed of 6 variables representing different organ systems (cardiovascular, coagulation, liver, neurological, renal and respiratory). The total score ranges from 0 to 24 with each variable having a point value range of 0 (normal) to 4 (high degree of dysfunction or failure). Since this system uses scoring of individual organ systems, it is able to measure either individual or combined organ dysfunction.|units on a scale|Number|1|1.0||||||
3673859|NCT02317549|3517813|B1|Highest Score = 6-8||SOFA Distribution at Screening|SOFA (sequential organ failure assessment) is a morbidity severity score and mortality assessment tool focused on organ dysfunction and morbidity. The score is composed of 6 variables representing different organ systems (cardiovascular, coagulation, liver, neurological, renal and respiratory). The total score ranges from 0 to 24 with each variable having a point value range of 0 (normal) to 4 (high degree of dysfunction or failure). Since this system uses scoring of individual organ systems, it is able to measure either individual or combined organ dysfunction.|units on a scale|Number|0|0.0||||||
3673860|NCT02317549|3517811|B3|||BMI||kg/m^2|Mean|30.30|30.3|Standard Deviation|6.05|6.05|||
3673861|NCT02317549|3517812|B2|||BMI||kg/m^2|Mean|32.54|32.54|Standard Deviation|3.45|3.45|||
3673862|NCT02317549|3517813|B1|||BMI||kg/m^2|Mean|28.96|28.96|Standard Deviation|7.21|7.21|||
3673863|NCT02317549|3517811|B3|||Height||cm|Mean|164.5|164.5|Standard Deviation|12.38|12.38|||
3673864|NCT02317549|3517812|B2|||Height||cm|Mean|157|157.0|Standard Deviation|6.08|6.08|||
3673865|NCT02317549|3517813|B1|||Height||cm|Mean|169|169.0|Standard Deviation|13.49|13.49|||
3673866|NCT02317549|3517811|B3|||Weight||kg|Mean|81.98|81.98|Standard Deviation|17.65|17.65|||
3673867|NCT02317549|3517812|B2|||Weight||kg|Mean|80.67|80.67|Standard Deviation|13.96|13.96|||
3673868|NCT02317549|3517813|B1|||Weight||kg|Mean|82.76|82.76|Standard Deviation|21.11|21.11|||
3673869|NCT02317549|3517811|B3|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3673870|NCT02317549|3517812|B2|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3673871|NCT02317549|3517813|B1|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3673874|NCT02317549|3517813|B1|Canada||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3673875|NCT02317549|3517811|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673876|NCT02317549|3517812|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673877|NCT02317549|3517813|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673878|NCT02317549|3517811|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3673879|NCT02317549|3517812|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673880|NCT02317549|3517813|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3673881|NCT02317549|3517811|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3673882|NCT02317549|3517812|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3673883|NCT02317549|3517813|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3673884|NCT02317549|3517811|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3673885|NCT02317549|3517812|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3673886|NCT02317549|3517813|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3673887|NCT02317549|3517811|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673888|NCT02317549|3517812|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673889|NCT02317549|3517813|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673890|NCT02317549|3517811|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673891|NCT02317549|3517812|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673892|NCT02317549|3517813|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673893|NCT02317549|3517811|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3673894|NCT02317549|3517812|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3673895|NCT02317549|3517813|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673896|NCT02317549|3517811|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673897|NCT02317549|3517812|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673898|NCT02317549|3517813|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673899|NCT02317549|3517811|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3673900|NCT02317549|3517812|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3673901|NCT02317549|3517813|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3673902|NCT02317549|3517811|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3673903|NCT02317549|3517812|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3673904|NCT02317549|3517813|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673905|NCT02317549|3517811|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3673906|NCT02317549|3517812|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3673907|NCT02317549|3517813|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3673908|NCT02317549|3517811|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3673909|NCT02317549|3517812|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3673910|NCT02317549|3517813|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3673911|NCT02317549|3517811|B3|||Age||years|Mean|56.23|56.23|Standard Deviation|12.07|12.07|||
3673912|NCT02317549|3517812|B2|||Age||years|Mean|63.75|63.75|Standard Deviation|2.26|2.26|||
3673913|NCT02317549|3517813|B1|||Age||years|Mean|50.59|50.59|Standard Deviation|13.75|13.75|||
3673914|NCT02317549|3517811|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3673915|NCT02317549|3517812|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3673916|NCT02317549|3517813|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3673917|NCT02317549|3517811|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3673918|NCT02317549|3517812|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3673919|NCT02317549|3517813|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3673920|NCT02317549|3517811|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3673921|NCT02317549|3517812|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3673922|NCT02317549|3517813|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3673923|NCT02317510|3517820|B3|||ASA (American Society of Anesthesiologists scores)|"The ASA score is a subjective assessment of a patient’s overall health that is based on five classes (I to V).~I- Patient is a completely healthy fit patient. II- Patient has mild systemic disease. III-Patient has severe systemic disease that is not incapacitating. IV-Patient has incapacitating disease that is a constant threat to life. V-A moribund patient who is not expected to live 24 hour with or without surgery."|units on a scale|Median|1|1.0|Full Range|||1.0|3.0|
3673924|NCT02317510|3517821|B2|||ASA (American Society of Anesthesiologists scores)|"The ASA score is a subjective assessment of a patient’s overall health that is based on five classes (I to V).~I- Patient is a completely healthy fit patient. II- Patient has mild systemic disease. III-Patient has severe systemic disease that is not incapacitating. IV-Patient has incapacitating disease that is a constant threat to life. V-A moribund patient who is not expected to live 24 hour with or without surgery."|units on a scale|Median|1|1.0|Full Range|||1.0|3.0|
3674097|NCT02316548|3517948|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673925|NCT02317510|3517822|B1|||ASA (American Society of Anesthesiologists scores)|"The ASA score is a subjective assessment of a patient’s overall health that is based on five classes (I to V).~I- Patient is a completely healthy fit patient. II- Patient has mild systemic disease. III-Patient has severe systemic disease that is not incapacitating. IV-Patient has incapacitating disease that is a constant threat to life. V-A moribund patient who is not expected to live 24 hour with or without surgery."|units on a scale|Median|1|1.0|Full Range|||1.0|2.0|
3673926|NCT02317510|3517820|B3|||BMI|BMI:Body Mass Index|kg/m^2|Median|29.55|29.55|Standard Deviation|4.14|4.14|||
3673927|NCT02317510|3517821|B2|||BMI|BMI:Body Mass Index|kg/m^2|Median|30.68|30.68|Standard Deviation|3.59|3.59|||
3673928|NCT02317510|3517822|B1|||BMI|BMI:Body Mass Index|kg/m^2|Median|28.66|28.66|Standard Deviation|4.49|4.49|||
3673929|NCT02317510|3517820|B3|Turkey||Region of Enrollment||participants|Number|49|49.0||||||
3673930|NCT02317510|3517821|B2|Turkey||Region of Enrollment||participants|Number|24|24.0||||||
3673931|NCT02317510|3517822|B1|Turkey||Region of Enrollment||participants|Number|25|25.0||||||
3673932|NCT02317510|3517820|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3673933|NCT02317510|3517821|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3673934|NCT02317510|3517822|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3673935|NCT02317510|3517820|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3673936|NCT02317510|3517821|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3673937|NCT02317510|3517822|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3673938|NCT02317510|3517820|B3|||Age||years|Median|46|46.0|Standard Deviation|13.35|13.35|||
3673939|NCT02317510|3517821|B2|||Age||years|Median|45.5|45.5|Standard Deviation|13.60|13.6|||
3673940|NCT02317510|3517822|B1|||Age||years|Median|46|46.0|Standard Deviation|13.38|13.38|||
3673941|NCT02317016|3517851|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673942|NCT02317016|3517851|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673943|NCT02317016|3517851|B1||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3673944|NCT02317016|3517851|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3673945|NCT02317016|3517851|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673946|NCT02317016|3517851|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3673947|NCT02317016|3517851|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673948|NCT02317016|3517851|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3673949|NCT02317016|3517851|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3673950|NCT02317016|3517851|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|11.37|11.37|||
3673951|NCT02316847|3517877|B3|United States||Region of Enrollment||Participants|Count of Participants|108|108.0||||||
3673952|NCT02316847|3517878|B2|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3673953|NCT02316847|3517879|B1|United States||Region of Enrollment||Participants|Count of Participants|99|99.0||||||
3673954|NCT02316847|3517877|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3673955|NCT02316847|3517878|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673956|NCT02316847|3517879|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3673957|NCT02316847|3517877|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3673958|NCT02316847|3517878|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673959|NCT02316847|3517879|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3673960|NCT02316847|3517877|B3||White|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3673961|NCT02316847|3517878|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3673962|NCT02316847|3517879|B1||White|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3673963|NCT02316847|3517877|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3673964|NCT02316847|3517878|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3673965|NCT02316847|3517879|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3673966|NCT02316847|3517877|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3673967|NCT02316847|3517878|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673968|NCT02316847|3517879|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3673969|NCT02316847|3517877|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3673970|NCT02316847|3517878|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673971|NCT02316847|3517879|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3673972|NCT02316847|3517877|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673973|NCT02316847|3517878|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673974|NCT02316847|3517879|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673975|NCT02316847|3517877|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673976|NCT02316847|3517878|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673977|NCT02316847|3517879|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3673978|NCT02316847|3517877|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3673979|NCT02316847|3517878|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3673980|NCT02316847|3517879|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
3673981|NCT02316847|3517877|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3673982|NCT02316847|3517878|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3673983|NCT02316847|3517879|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3673984|NCT02316847|3517877|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3673985|NCT02316847|3517878|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3673986|NCT02316847|3517879|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3673987|NCT02316847|3517877|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3673988|NCT02316847|3517878|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3673989|NCT02316847|3517879|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3673990|NCT02316847|3517877|B3|||Age||years|Mean|32.9|32.9|Standard Deviation|13.40|13.4|||
3673991|NCT02316847|3517878|B2|||Age||years|Mean|13.4|13.4|Standard Deviation|1.13|1.13|||
3673992|NCT02316847|3517879|B1|||Age||years|Mean|34.6|34.6|Standard Deviation|12.58|12.58|||
3673993|NCT02316847|3517877|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3673994|NCT02316847|3517878|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3673995|NCT02316847|3517879|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3673996|NCT02316847|3517877|B3||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
3673997|NCT02316847|3517878|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3673998|NCT02316847|3517879|B1||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
3673999|NCT02316847|3517877|B3||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
3674000|NCT02316847|3517878|B2||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
3674001|NCT02316847|3517879|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
3674002|NCT02316769|3517889|B3|United States||Region of Enrollment||participants|Number|66|66.0||||||
3674003|NCT02316769|3517890|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
3674004|NCT02316769|3517891|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
3674005|NCT02316769|3517889|B3|Female||Sex/Gender, Customized||participants|Number|33|33.0||||||
3674006|NCT02316769|3517890|B2|Female||Sex/Gender, Customized||participants|Number|18|18.0||||||
3674007|NCT02316769|3517891|B1|Female||Sex/Gender, Customized||participants|Number|15|15.0||||||
3674008|NCT02316769|3517889|B3|Male||Sex/Gender, Customized||participants|Number|33|33.0||||||
3674009|NCT02316769|3517890|B2|Male||Sex/Gender, Customized||participants|Number|15|15.0||||||
3674010|NCT02316769|3517891|B1|Male||Sex/Gender, Customized||participants|Number|18|18.0||||||
3674011|NCT02316769|3517889|B3|||Age||years|Mean|52|52.0|Standard Deviation|17|17.0|||
3674012|NCT02316769|3517890|B2|||Age||years|Mean|52|52.0|Standard Deviation|21|21.0|||
3674013|NCT02316769|3517891|B1|||Age||years|Mean|51|51.0|Standard Deviation|15|15.0|||
3674014|NCT02316678|3517900|B3|United States||Region of Enrollment||participants|Number|9573|9573.0||||||
3674015|NCT02316678|3517901|B2|United States||Region of Enrollment||participants|Number|7694|7694.0||||||
3674016|NCT02316678|3517902|B1|United States||Region of Enrollment||participants|Number|1879|1879.0||||||
3674017|NCT02316678|3517900|B3||Male|Sex: Female, Male||Participants|Count of Participants|3527|3527.0||||||
3674018|NCT02316678|3517901|B2||Male|Sex: Female, Male||Participants|Count of Participants|2864|2864.0||||||
3674019|NCT02316678|3517902|B1||Male|Sex: Female, Male||Participants|Count of Participants|663|663.0||||||
3674020|NCT02316678|3517900|B3||Female|Sex: Female, Male||Participants|Count of Participants|6046|6046.0||||||
3674021|NCT02316678|3517901|B2||Female|Sex: Female, Male||Participants|Count of Participants|4830|4830.0||||||
3674022|NCT02316678|3517902|B1||Female|Sex: Female, Male||Participants|Count of Participants|1216|1216.0||||||
3674023|NCT02316678|3517900|B3|||Age||years|Mean|52.6|52.6|Standard Deviation|18.6|18.6|||
3674024|NCT02316678|3517901|B2|||Age||years|Mean|53.2|53.2|Standard Deviation|18.8|18.8|||
3674025|NCT02316678|3517902|B1|||Age||years|Mean|50.1|50.1|Standard Deviation|17.7|17.7|||
3674026|NCT02316678|3517900|B3||>=65 years|Age||Participants|Count of Participants|3412|3412.0||||||
3674027|NCT02316678|3517901|B2||>=65 years|Age||Participants|Count of Participants|2856|2856.0||||||
3674028|NCT02316678|3517902|B1||>=65 years|Age||Participants|Count of Participants|556|556.0||||||
3674029|NCT02316678|3517900|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6161|6161.0||||||
3674030|NCT02316678|3517901|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4838|4838.0||||||
3674031|NCT02316678|3517902|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1323|1323.0||||||
3674032|NCT02316678|3517900|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3674033|NCT02316678|3517901|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3674034|NCT02316678|3517902|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3674035|NCT02316613|3517909|B1||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3674036|NCT02316613|3517909|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3674037|NCT02316613|3517909|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|11.2|11.2|||
3674038|NCT02316548|3517946|B3||N2|N Stage|Regional lymph nodes staging per the AJCC 7th ed. refers to the number and location of lymph nodes that contain cancer. The higher the number after the N, the more lymph nodes that contain cancer.|Participants|Count of Participants|2|2.0||||||
3674159|NCT02316366|3518060|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
3674039|NCT02316548|3517947|B2||N2|N Stage|Regional lymph nodes staging per the AJCC 7th ed. refers to the number and location of lymph nodes that contain cancer. The higher the number after the N, the more lymph nodes that contain cancer.|Participants|Count of Participants|1|1.0||||||
3674040|NCT02316548|3517948|B1||N2|N Stage|Regional lymph nodes staging per the AJCC 7th ed. refers to the number and location of lymph nodes that contain cancer. The higher the number after the N, the more lymph nodes that contain cancer.|Participants|Count of Participants|1|1.0||||||
3674041|NCT02316548|3517946|B3||N1|N Stage|Regional lymph nodes staging per the AJCC 7th ed. refers to the number and location of lymph nodes that contain cancer. The higher the number after the N, the more lymph nodes that contain cancer.|Participants|Count of Participants|5|5.0||||||
3674042|NCT02316548|3517947|B2||N1|N Stage|Regional lymph nodes staging per the AJCC 7th ed. refers to the number and location of lymph nodes that contain cancer. The higher the number after the N, the more lymph nodes that contain cancer.|Participants|Count of Participants|3|3.0||||||
3674043|NCT02316548|3517948|B1||N1|N Stage|Regional lymph nodes staging per the AJCC 7th ed. refers to the number and location of lymph nodes that contain cancer. The higher the number after the N, the more lymph nodes that contain cancer.|Participants|Count of Participants|2|2.0||||||
3674044|NCT02316548|3517946|B3||N0|N Stage|Regional lymph nodes staging per the AJCC 7th ed. refers to the number and location of lymph nodes that contain cancer. The higher the number after the N, the more lymph nodes that contain cancer.|Participants|Count of Participants|5|5.0||||||
3674045|NCT02316548|3517947|B2||N0|N Stage|Regional lymph nodes staging per the AJCC 7th ed. refers to the number and location of lymph nodes that contain cancer. The higher the number after the N, the more lymph nodes that contain cancer.|Participants|Count of Participants|2|2.0||||||
3674046|NCT02316548|3517948|B1||N0|N Stage|Regional lymph nodes staging per the AJCC 7th ed. refers to the number and location of lymph nodes that contain cancer. The higher the number after the N, the more lymph nodes that contain cancer.|Participants|Count of Participants|3|3.0||||||
3674047|NCT02316548|3517946|B3||T4b|T Stage|Tumor stage per the American Joint Committee on Cancer (AJCC) 7th ed. refers to the size and/or extent of the main tumor. The higher the number after the T, the larger the tumor or the more it has grown into nearby tissues. T's may be further divided to provide more detail, such as T3a and T3b.|Participants|Count of Participants|1|1.0||||||
3674048|NCT02316548|3517947|B2||T4b|T Stage|Tumor stage per the American Joint Committee on Cancer (AJCC) 7th ed. refers to the size and/or extent of the main tumor. The higher the number after the T, the larger the tumor or the more it has grown into nearby tissues. T's may be further divided to provide more detail, such as T3a and T3b.|Participants|Count of Participants|1|1.0||||||
3674049|NCT02316548|3517948|B1||T4b|T Stage|Tumor stage per the American Joint Committee on Cancer (AJCC) 7th ed. refers to the size and/or extent of the main tumor. The higher the number after the T, the larger the tumor or the more it has grown into nearby tissues. T's may be further divided to provide more detail, such as T3a and T3b.|Participants|Count of Participants|0|0.0||||||
3674050|NCT02316548|3517946|B3||T4a|T Stage|Tumor stage per the American Joint Committee on Cancer (AJCC) 7th ed. refers to the size and/or extent of the main tumor. The higher the number after the T, the larger the tumor or the more it has grown into nearby tissues. T's may be further divided to provide more detail, such as T3a and T3b.|Participants|Count of Participants|4|4.0||||||
3674051|NCT02316548|3517947|B2||T4a|T Stage|Tumor stage per the American Joint Committee on Cancer (AJCC) 7th ed. refers to the size and/or extent of the main tumor. The higher the number after the T, the larger the tumor or the more it has grown into nearby tissues. T's may be further divided to provide more detail, such as T3a and T3b.|Participants|Count of Participants|3|3.0||||||
3674052|NCT02316548|3517948|B1||T4a|T Stage|Tumor stage per the American Joint Committee on Cancer (AJCC) 7th ed. refers to the size and/or extent of the main tumor. The higher the number after the T, the larger the tumor or the more it has grown into nearby tissues. T's may be further divided to provide more detail, such as T3a and T3b.|Participants|Count of Participants|1|1.0||||||
3674053|NCT02316548|3517946|B3||T3b|T Stage|Tumor stage per the American Joint Committee on Cancer (AJCC) 7th ed. refers to the size and/or extent of the main tumor. The higher the number after the T, the larger the tumor or the more it has grown into nearby tissues. T's may be further divided to provide more detail, such as T3a and T3b.|Participants|Count of Participants|5|5.0||||||
3674054|NCT02316548|3517947|B2||T3b|T Stage|Tumor stage per the American Joint Committee on Cancer (AJCC) 7th ed. refers to the size and/or extent of the main tumor. The higher the number after the T, the larger the tumor or the more it has grown into nearby tissues. T's may be further divided to provide more detail, such as T3a and T3b.|Participants|Count of Participants|2|2.0||||||
3674055|NCT02316548|3517948|B1||T3b|T Stage|Tumor stage per the American Joint Committee on Cancer (AJCC) 7th ed. refers to the size and/or extent of the main tumor. The higher the number after the T, the larger the tumor or the more it has grown into nearby tissues. T's may be further divided to provide more detail, such as T3a and T3b.|Participants|Count of Participants|3|3.0||||||
3674056|NCT02316548|3517946|B3||T3a|T Stage|Tumor stage per the American Joint Committee on Cancer (AJCC) 7th ed. refers to the size and/or extent of the main tumor. The higher the number after the T, the larger the tumor or the more it has grown into nearby tissues. T's may be further divided to provide more detail, such as T3a and T3b.|Participants|Count of Participants|2|2.0||||||
3674057|NCT02316548|3517947|B2||T3a|T Stage|Tumor stage per the American Joint Committee on Cancer (AJCC) 7th ed. refers to the size and/or extent of the main tumor. The higher the number after the T, the larger the tumor or the more it has grown into nearby tissues. T's may be further divided to provide more detail, such as T3a and T3b.|Participants|Count of Participants|0|0.0||||||
3674058|NCT02316548|3517948|B1||T3a|T Stage|Tumor stage per the American Joint Committee on Cancer (AJCC) 7th ed. refers to the size and/or extent of the main tumor. The higher the number after the T, the larger the tumor or the more it has grown into nearby tissues. T's may be further divided to provide more detail, such as T3a and T3b.|Participants|Count of Participants|2|2.0||||||
3674059|NCT02316548|3517946|B3|2||Zubrod performance status|0 – Asymptomatic; 1 – Symptomatic but completely ambulatory; 2 – Symptomatic, <50% in bed during the day; 3 – Symptomatic, >50% in bed, but not bedbound; 4 – Bedbound; 5 – Death|Participants|Count of Participants|2|2.0||||||
3674098|NCT02316548|3517946|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674060|NCT02316548|3517947|B2|2||Zubrod performance status|0 – Asymptomatic; 1 – Symptomatic but completely ambulatory; 2 – Symptomatic, <50% in bed during the day; 3 – Symptomatic, >50% in bed, but not bedbound; 4 – Bedbound; 5 – Death|Participants|Count of Participants|0|0.0||||||
3674061|NCT02316548|3517948|B1|2||Zubrod performance status|0 – Asymptomatic; 1 – Symptomatic but completely ambulatory; 2 – Symptomatic, <50% in bed during the day; 3 – Symptomatic, >50% in bed, but not bedbound; 4 – Bedbound; 5 – Death|Participants|Count of Participants|2|2.0||||||
3674062|NCT02316548|3517946|B3|1||Zubrod performance status|0 – Asymptomatic; 1 – Symptomatic but completely ambulatory; 2 – Symptomatic, <50% in bed during the day; 3 – Symptomatic, >50% in bed, but not bedbound; 4 – Bedbound; 5 – Death|Participants|Count of Participants|5|5.0||||||
3674063|NCT02316548|3517947|B2|1||Zubrod performance status|0 – Asymptomatic; 1 – Symptomatic but completely ambulatory; 2 – Symptomatic, <50% in bed during the day; 3 – Symptomatic, >50% in bed, but not bedbound; 4 – Bedbound; 5 – Death|Participants|Count of Participants|3|3.0||||||
3674064|NCT02316548|3517948|B1|1||Zubrod performance status|0 – Asymptomatic; 1 – Symptomatic but completely ambulatory; 2 – Symptomatic, <50% in bed during the day; 3 – Symptomatic, >50% in bed, but not bedbound; 4 – Bedbound; 5 – Death|Participants|Count of Participants|2|2.0||||||
3674065|NCT02316548|3517946|B3|0||Zubrod performance status|0 – Asymptomatic; 1 – Symptomatic but completely ambulatory; 2 – Symptomatic, <50% in bed during the day; 3 – Symptomatic, >50% in bed, but not bedbound; 4 – Bedbound; 5 – Death|Participants|Count of Participants|5|5.0||||||
3674066|NCT02316548|3517947|B2|0||Zubrod performance status|0 – Asymptomatic; 1 – Symptomatic but completely ambulatory; 2 – Symptomatic, <50% in bed during the day; 3 – Symptomatic, >50% in bed, but not bedbound; 4 – Bedbound; 5 – Death|Participants|Count of Participants|3|3.0||||||
3674067|NCT02316548|3517948|B1|0||Zubrod performance status|0 – Asymptomatic; 1 – Symptomatic but completely ambulatory; 2 – Symptomatic, <50% in bed during the day; 3 – Symptomatic, >50% in bed, but not bedbound; 4 – Bedbound; 5 – Death|Participants|Count of Participants|2|2.0||||||
3674068|NCT02316548|3517946|B3||High Risk|Pelvic Relapse Risk Category|Intermediate risk= pT3b/pT4a/pT4b pN0-2 with negative margins and 10 or more nodes dissected. High risk = pT3a/pT3b/pT4a/pT4b pN0-2 with less than 10 nodes dissected and/or with positive margins.|Participants|Count of Participants|6|6.0||||||
3674069|NCT02316548|3517947|B2||High Risk|Pelvic Relapse Risk Category|Intermediate risk= pT3b/pT4a/pT4b pN0-2 with negative margins and 10 or more nodes dissected. High risk = pT3a/pT3b/pT4a/pT4b pN0-2 with less than 10 nodes dissected and/or with positive margins.|Participants|Count of Participants|3|3.0||||||
3674070|NCT02316548|3517948|B1||High Risk|Pelvic Relapse Risk Category|Intermediate risk= pT3b/pT4a/pT4b pN0-2 with negative margins and 10 or more nodes dissected. High risk = pT3a/pT3b/pT4a/pT4b pN0-2 with less than 10 nodes dissected and/or with positive margins.|Participants|Count of Participants|3|3.0||||||
3674071|NCT02316548|3517946|B3||Intermediate Risk|Pelvic Relapse Risk Category|Intermediate risk= pT3b/pT4a/pT4b pN0-2 with negative margins and 10 or more nodes dissected. High risk = pT3a/pT3b/pT4a/pT4b pN0-2 with less than 10 nodes dissected and/or with positive margins.|Participants|Count of Participants|6|6.0||||||
3674072|NCT02316548|3517947|B2||Intermediate Risk|Pelvic Relapse Risk Category|Intermediate risk= pT3b/pT4a/pT4b pN0-2 with negative margins and 10 or more nodes dissected. High risk = pT3a/pT3b/pT4a/pT4b pN0-2 with less than 10 nodes dissected and/or with positive margins.|Participants|Count of Participants|3|3.0||||||
3674073|NCT02316548|3517948|B1||Intermediate Risk|Pelvic Relapse Risk Category|Intermediate risk= pT3b/pT4a/pT4b pN0-2 with negative margins and 10 or more nodes dissected. High risk = pT3a/pT3b/pT4a/pT4b pN0-2 with less than 10 nodes dissected and/or with positive margins.|Participants|Count of Participants|3|3.0||||||
3674074|NCT02316548|3517946|B3||No chemotherapy|Chemotherapy||Participants|Count of Participants|3|3.0||||||
3674075|NCT02316548|3517947|B2||No chemotherapy|Chemotherapy||Participants|Count of Participants|2|2.0||||||
3674076|NCT02316548|3517948|B1||No chemotherapy|Chemotherapy||Participants|Count of Participants|1|1.0||||||
3674077|NCT02316548|3517946|B3||Neoadjuvant or adjuvant chemotherapy|Chemotherapy||Participants|Count of Participants|9|9.0||||||
3674078|NCT02316548|3517947|B2||Neoadjuvant or adjuvant chemotherapy|Chemotherapy||Participants|Count of Participants|4|4.0||||||
3674079|NCT02316548|3517948|B1||Neoadjuvant or adjuvant chemotherapy|Chemotherapy||Participants|Count of Participants|5|5.0||||||
3674080|NCT02316548|3517946|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674081|NCT02316548|3517947|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674082|NCT02316548|3517948|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674083|NCT02316548|3517946|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674084|NCT02316548|3517947|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674085|NCT02316548|3517948|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674086|NCT02316548|3517946|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3674087|NCT02316548|3517947|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3674088|NCT02316548|3517948|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3674089|NCT02316548|3517946|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3674090|NCT02316548|3517947|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3674091|NCT02316548|3517948|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674092|NCT02316548|3517946|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674093|NCT02316548|3517947|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674094|NCT02316548|3517948|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674095|NCT02316548|3517946|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674096|NCT02316548|3517947|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674099|NCT02316548|3517947|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674100|NCT02316548|3517948|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674101|NCT02316548|3517946|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674102|NCT02316548|3517947|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674103|NCT02316548|3517948|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674104|NCT02316548|3517946|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3674105|NCT02316548|3517947|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3674106|NCT02316548|3517948|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3674107|NCT02316548|3517946|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674108|NCT02316548|3517947|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674109|NCT02316548|3517948|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674110|NCT02316548|3517946|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3674111|NCT02316548|3517947|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3674112|NCT02316548|3517948|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3674113|NCT02316548|3517946|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3674114|NCT02316548|3517947|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3674115|NCT02316548|3517948|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3674116|NCT02316548|3517946|B3|||Age||years|Median|67|67.0|Full Range|||37.0|82.0|
3674117|NCT02316548|3517947|B2|||Age||years|Median|67|67.0|Full Range|||37.0|82.0|
3674118|NCT02316548|3517948|B1|||Age||years|Median|67|67.0|Full Range|||60.0|77.0|
3674119|NCT02316470|3517959|B5|Germany||Region of Enrollment||Participants|Count of Participants|106|106.0||||||
3674120|NCT02316470|3517960|B4|Germany||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3674121|NCT02316470|3517961|B3|Germany||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3674122|NCT02316470|3517962|B2|Germany||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3674123|NCT02316470|3517963|B1|Germany||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3674124|NCT02316470|3517959|B5|United States||Region of Enrollment||Participants|Count of Participants|394|394.0||||||
3674125|NCT02316470|3517960|B4|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3674126|NCT02316470|3517961|B3|United States||Region of Enrollment||Participants|Count of Participants|118|118.0||||||
3674127|NCT02316470|3517962|B2|United States||Region of Enrollment||Participants|Count of Participants|119|119.0||||||
3674128|NCT02316470|3517963|B1|United States||Region of Enrollment||Participants|Count of Participants|118|118.0||||||
3674129|NCT02316470|3517959|B5||Male|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
3674130|NCT02316470|3517960|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3674131|NCT02316470|3517961|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3674132|NCT02316470|3517962|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3674133|NCT02316470|3517963|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3674134|NCT02316470|3517959|B5||Female|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
3674135|NCT02316470|3517960|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3674136|NCT02316470|3517961|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3674137|NCT02316470|3517962|B2||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3674138|NCT02316470|3517963|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3674139|NCT02316470|3517959|B5|||Age||years|Mean|64.0|64.0|Standard Deviation|9.13|9.13|||
3674140|NCT02316470|3517960|B4|||Age||years|Mean|63.7|63.7|Standard Deviation|9.49|9.49|||
3674141|NCT02316470|3517961|B3|||Age||years|Mean|63.9|63.9|Standard Deviation|9.15|9.15|||
3674142|NCT02316470|3517962|B2|||Age||years|Mean|64.1|64.1|Standard Deviation|9.34|9.34|||
3674143|NCT02316470|3517963|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|8.86|8.86|||
3674144|NCT02316470|3517959|B5||>=65 years|Age||Participants|Count of Participants|250|250.0||||||
3674145|NCT02316470|3517960|B4||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3674146|NCT02316470|3517961|B3||>=65 years|Age||Participants|Count of Participants|75|75.0||||||
3674147|NCT02316470|3517962|B2||>=65 years|Age||Participants|Count of Participants|75|75.0||||||
3674148|NCT02316470|3517963|B1||>=65 years|Age||Participants|Count of Participants|76|76.0||||||
3674149|NCT02316470|3517959|B5||Between 18 and 65 years|Age||Participants|Count of Participants|250|250.0||||||
3674150|NCT02316470|3517960|B4||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3674151|NCT02316470|3517961|B3||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
3674152|NCT02316470|3517962|B2||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
3674153|NCT02316470|3517963|B1||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
3674154|NCT02316470|3517959|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3674155|NCT02316470|3517960|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3674156|NCT02316470|3517961|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3674157|NCT02316470|3517962|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3674158|NCT02316470|3517963|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3674160|NCT02316366|3518061|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
3674161|NCT02316366|3518062|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3674162|NCT02316366|3518060|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3674163|NCT02316366|3518061|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3674164|NCT02316366|3518062|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3674165|NCT02316366|3518060|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3674166|NCT02316366|3518061|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3674167|NCT02316366|3518062|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3674168|NCT02316366|3518060|B3|||Age||years|Mean|14|14.0|Standard Deviation|5.1|5.1|||
3674169|NCT02316366|3518061|B2|||Age||years|Mean|13.6|13.6|Standard Deviation|5.6|5.6|||
3674170|NCT02316366|3518062|B1|||Age||years|Mean|14.3|14.3|Standard Deviation|4.7|4.7|||
3674171|NCT02316353|3518077|B3|Spain||Region of Enrollment||participants|Number|4|4.0||||||
3674172|NCT02316353|3518078|B2|Spain||Region of Enrollment||participants|Number|2|2.0||||||
3674173|NCT02316353|3518079|B1|Spain||Region of Enrollment||participants|Number|2|2.0||||||
3674174|NCT02316353|3518077|B3|Germany||Region of Enrollment||participants|Number|22|22.0||||||
3674175|NCT02316353|3518078|B2|Germany||Region of Enrollment||participants|Number|9|9.0||||||
3674176|NCT02316353|3518079|B1|Germany||Region of Enrollment||participants|Number|13|13.0||||||
3674177|NCT02316353|3518077|B3|Australia||Region of Enrollment||participants|Number|3|3.0||||||
3674178|NCT02316353|3518078|B2|Australia||Region of Enrollment||participants|Number|2|2.0||||||
3674179|NCT02316353|3518079|B1|Australia||Region of Enrollment||participants|Number|1|1.0||||||
3674180|NCT02316353|3518077|B3|Israel||Region of Enrollment||participants|Number|14|14.0||||||
3674181|NCT02316353|3518078|B2|Israel||Region of Enrollment||participants|Number|8|8.0||||||
3674182|NCT02316353|3518079|B1|Israel||Region of Enrollment||participants|Number|6|6.0||||||
3674183|NCT02316353|3518077|B3|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
3674184|NCT02316353|3518078|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3674185|NCT02316353|3518079|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3674186|NCT02316353|3518077|B3|Italy||Region of Enrollment||participants|Number|4|4.0||||||
3674187|NCT02316353|3518078|B2|Italy||Region of Enrollment||participants|Number|1|1.0||||||
3674188|NCT02316353|3518079|B1|Italy||Region of Enrollment||participants|Number|3|3.0||||||
3674189|NCT02316353|3518077|B3|Czechia||Region of Enrollment||participants|Number|4|4.0||||||
3674190|NCT02316353|3518078|B2|Czechia||Region of Enrollment||participants|Number|2|2.0||||||
3674191|NCT02316353|3518079|B1|Czechia||Region of Enrollment||participants|Number|2|2.0||||||
3674192|NCT02316353|3518077|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
3674193|NCT02316353|3518078|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
3674194|NCT02316353|3518079|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3674195|NCT02316353|3518077|B3|Hungary||Region of Enrollment||participants|Number|6|6.0||||||
3674196|NCT02316353|3518078|B2|Hungary||Region of Enrollment||participants|Number|5|5.0||||||
3674197|NCT02316353|3518079|B1|Hungary||Region of Enrollment||participants|Number|1|1.0||||||
3674198|NCT02316353|3518077|B3|Romania||Region of Enrollment||participants|Number|1|1.0||||||
3674199|NCT02316353|3518078|B2|Romania||Region of Enrollment||participants|Number|0|0.0||||||
3674200|NCT02316353|3518079|B1|Romania||Region of Enrollment||participants|Number|1|1.0||||||
3674201|NCT02316353|3518077|B3|Canada||Region of Enrollment||participants|Number|12|12.0||||||
3674202|NCT02316353|3518078|B2|Canada||Region of Enrollment||participants|Number|4|4.0||||||
3674203|NCT02316353|3518079|B1|Canada||Region of Enrollment||participants|Number|8|8.0||||||
3674204|NCT02316353|3518077|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674205|NCT02316353|3518078|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674206|NCT02316353|3518079|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674207|NCT02316353|3518077|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|118|118.0||||||
3674208|NCT02316353|3518078|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3674209|NCT02316353|3518079|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3674210|NCT02316353|3518077|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3674211|NCT02316353|3518078|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3674212|NCT02316353|3518079|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3674213|NCT02316353|3518077|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3674214|NCT02316353|3518078|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3674215|NCT02316353|3518079|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3674216|NCT02316353|3518077|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3674217|NCT02316353|3518078|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3674218|NCT02316353|3518079|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3674219|NCT02316353|3518077|B3|||Age||years|Mean|40.5|40.5|Standard Deviation|15.56|15.56|||
3674220|NCT02316353|3518078|B2|||Age||years|Mean|40.3|40.3|Standard Deviation|16.26|16.26|||
3674221|NCT02316353|3518079|B1|||Age||years|Mean|40.8|40.8|Standard Deviation|14.96|14.96|||
3674222|NCT02316353|3518077|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3674223|NCT02316353|3518078|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3674224|NCT02316353|3518079|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3674225|NCT02316353|3518077|B3||Between 18 and 65 years|Age||Participants|Count of Participants|105|105.0||||||
3674226|NCT02316353|3518078|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3674227|NCT02316353|3518079|B1||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
3674228|NCT02316353|3518077|B3||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
3674229|NCT02316353|3518078|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3674230|NCT02316353|3518079|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3674231|NCT02315989|3518098|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
3674232|NCT02315989|3518098|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
3674233|NCT02315989|3518098|B1|||Age||years|Median|61.5|61.5|Full Range|||39.0|73.0|
3674234|NCT02315560|3518106|B1|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3674235|NCT02315560|3518106|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3674236|NCT02315560|3518106|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3674237|NCT02315560|3518106|B1|||Age||years|Mean|11.4|11.4|Full Range|||7.0|16.0|
3674238|NCT02315560|3518106|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3674239|NCT02315560|3518106|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3674240|NCT02315560|3518106|B1||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
3674241|NCT02315352|3518111|B3||Male|Gender||Participants|Count of Participants|24|24.0||||||
3674242|NCT02315352|3518112|B2||Male|Gender||Participants|Count of Participants|12|12.0||||||
3674243|NCT02315352|3518113|B1||Male|Gender||Participants|Count of Participants|12|12.0||||||
3674244|NCT02315352|3518111|B3||Female|Gender||Participants|Count of Participants|24|24.0||||||
3674245|NCT02315352|3518112|B2||Female|Gender||Participants|Count of Participants|12|12.0||||||
3674246|NCT02315352|3518113|B1||Female|Gender||Participants|Count of Participants|12|12.0||||||
3674247|NCT02315352|3518111|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3674248|NCT02315352|3518112|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3674249|NCT02315352|3518113|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3674250|NCT02315352|3518111|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3674251|NCT02315352|3518112|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3674252|NCT02315352|3518113|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3674253|NCT02315352|3518111|B3||<=18 years|Age||Participants|Count of Participants|48|48.0||||||
3674254|NCT02315352|3518112|B2||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
3674255|NCT02315352|3518113|B1||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
3674256|NCT02315261|3518147|B1|||Duration of surgery||minutes|Mean|192|192.0|Standard Deviation|85|85.0|||
3674257|NCT02315261|3518147|B1|Whole abdomen||Surgical site||Participants|Count of Participants|5|5.0||||||
3674258|NCT02315261|3518147|B1|Lower abdomen||Surgical site||Participants|Count of Participants|192|192.0||||||
3674259|NCT02315261|3518147|B1|Upper abdomen||Surgical site||Participants|Count of Participants|131|131.0||||||
3674260|NCT02315261|3518147|B1|Thoracic||Surgical site||Participants|Count of Participants|36|36.0||||||
3674261|NCT02315261|3518147|B1|ASA physical status IV||ASA physical classification|"The ASA physical status classification system is a system for assessing the fitness of patients before surgery. In 1963 the American Society of Anesthesiologists (ASA) adopted this category physical status classification system as~ASA physical status I: Healthy person. ASA physical status II: Mild systemic disease. ASA physical status III: Severe systemic disease. ASA physical status IV: Severe systemic disease that is a constant threat to life."|Participants|Count of Participants|2|2.0||||||
3674262|NCT02315261|3518147|B1|ASA physical status III||ASA physical classification|"The ASA physical status classification system is a system for assessing the fitness of patients before surgery. In 1963 the American Society of Anesthesiologists (ASA) adopted this category physical status classification system as~ASA physical status I: Healthy person. ASA physical status II: Mild systemic disease. ASA physical status III: Severe systemic disease. ASA physical status IV: Severe systemic disease that is a constant threat to life."|Participants|Count of Participants|94|94.0||||||
3674263|NCT02315261|3518147|B1|ASA physical status II||ASA physical classification|"The ASA physical status classification system is a system for assessing the fitness of patients before surgery. In 1963 the American Society of Anesthesiologists (ASA) adopted this category physical status classification system as~ASA physical status I: Healthy person. ASA physical status II: Mild systemic disease. ASA physical status III: Severe systemic disease. ASA physical status IV: Severe systemic disease that is a constant threat to life."|Participants|Count of Participants|215|215.0||||||
3674264|NCT02315261|3518147|B1|ASA physical status I||ASA physical classification|"The ASA physical status classification system is a system for assessing the fitness of patients before surgery. In 1963 the American Society of Anesthesiologists (ASA) adopted this category physical status classification system as~ASA physical status I: Healthy person. ASA physical status II: Mild systemic disease. ASA physical status III: Severe systemic disease. ASA physical status IV: Severe systemic disease that is a constant threat to life."|Participants|Count of Participants|53|53.0||||||
3674265|NCT02315261|3518147|B1|||Body Mass Index||kg/m^2|Mean|23.9|23.9|Standard Deviation|5.1|5.1|||
3674266|NCT02315261|3518147|B1||Male|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
3674267|NCT02315261|3518147|B1||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3674268|NCT02315261|3518147|B1|||Age||years|Mean|59|59.0|Standard Deviation|13|13.0|||
3674269|NCT02314936|3518154|B5|Weekly||Alcohol Use||Participants|Count of Participants|55|55.0||||||
3674270|NCT02314936|3518155|B4|Weekly||Alcohol Use||Participants|Count of Participants|11|11.0||||||
3674271|NCT02314936|3518156|B3|Weekly||Alcohol Use||Participants|Count of Participants|16|16.0||||||
3674272|NCT02314936|3518157|B2|Weekly||Alcohol Use||Participants|Count of Participants|16|16.0||||||
3674273|NCT02314936|3518158|B1|Weekly||Alcohol Use||Participants|Count of Participants|12|12.0||||||
3674274|NCT02314936|3518154|B5|Occasionally||Alcohol Use||Participants|Count of Participants|100|100.0||||||
3674275|NCT02314936|3518155|B4|Occasionally||Alcohol Use||Participants|Count of Participants|27|27.0||||||
3674276|NCT02314936|3518156|B3|Occasionally||Alcohol Use||Participants|Count of Participants|21|21.0||||||
3674277|NCT02314936|3518157|B2|Occasionally||Alcohol Use||Participants|Count of Participants|25|25.0||||||
3674278|NCT02314936|3518158|B1|Occasionally||Alcohol Use||Participants|Count of Participants|27|27.0||||||
3674279|NCT02314936|3518154|B5|None||Alcohol Use||Participants|Count of Participants|32|32.0||||||
3674280|NCT02314936|3518155|B4|None||Alcohol Use||Participants|Count of Participants|9|9.0||||||
3674281|NCT02314936|3518156|B3|None||Alcohol Use||Participants|Count of Participants|9|9.0||||||
3674282|NCT02314936|3518157|B2|None||Alcohol Use||Participants|Count of Participants|5|5.0||||||
3674283|NCT02314936|3518158|B1|None||Alcohol Use||Participants|Count of Participants|9|9.0||||||
3674284|NCT02314936|3518154|B5|Daily||Alcohol Use||Participants|Count of Participants|5|5.0||||||
3674285|NCT02314936|3518155|B4|Daily||Alcohol Use||Participants|Count of Participants|1|1.0||||||
3674286|NCT02314936|3518156|B3|Daily||Alcohol Use||Participants|Count of Participants|2|2.0||||||
3674287|NCT02314936|3518157|B2|Daily||Alcohol Use||Participants|Count of Participants|2|2.0||||||
3674288|NCT02314936|3518158|B1|Daily||Alcohol Use||Participants|Count of Participants|0|0.0||||||
3674289|NCT02314936|3518154|B5||Current Smoker|Smoking Status||Participants|Count of Participants|22|22.0||||||
3674290|NCT02314936|3518155|B4||Current Smoker|Smoking Status||Participants|Count of Participants|6|6.0||||||
3674291|NCT02314936|3518156|B3||Current Smoker|Smoking Status||Participants|Count of Participants|5|5.0||||||
3674292|NCT02314936|3518157|B2||Current Smoker|Smoking Status||Participants|Count of Participants|4|4.0||||||
3674293|NCT02314936|3518158|B1||Current Smoker|Smoking Status||Participants|Count of Participants|7|7.0||||||
3674294|NCT02314936|3518154|B5||Non-Smoker|Smoking Status||Participants|Count of Participants|145|145.0||||||
3674295|NCT02314936|3518155|B4||Non-Smoker|Smoking Status||Participants|Count of Participants|35|35.0||||||
3674296|NCT02314936|3518156|B3||Non-Smoker|Smoking Status||Participants|Count of Participants|40|40.0||||||
3674297|NCT02314936|3518157|B2||Non-Smoker|Smoking Status||Participants|Count of Participants|36|36.0||||||
3674298|NCT02314936|3518158|B1||Non-Smoker|Smoking Status||Participants|Count of Participants|34|34.0||||||
3674299|NCT02314936|3518154|B5||Ex-Smoker|Smoking Status||Participants|Count of Participants|25|25.0||||||
3674300|NCT02314936|3518155|B4||Ex-Smoker|Smoking Status||Participants|Count of Participants|7|7.0||||||
3674301|NCT02314936|3518156|B3||Ex-Smoker|Smoking Status||Participants|Count of Participants|3|3.0||||||
3674302|NCT02314936|3518157|B2||Ex-Smoker|Smoking Status||Participants|Count of Participants|8|8.0||||||
3674303|NCT02314936|3518158|B1||Ex-Smoker|Smoking Status||Participants|Count of Participants|7|7.0||||||
3674304|NCT02314936|3518154|B5|||Body Mass Index||kg/m^2|Mean|25.28|25.28|Standard Deviation|2.85|2.85|||
3674305|NCT02314936|3518155|B4|||Body Mass Index||kg/m^2|Mean|25.23|25.23|Standard Deviation|2.48|2.48|||
3674306|NCT02314936|3518156|B3|||Body Mass Index||kg/m^2|Mean|25.32|25.32|Standard Deviation|2.82|2.82|||
3674307|NCT02314936|3518157|B2|||Body Mass Index||kg/m^2|Mean|25.31|25.31|Standard Deviation|3.09|3.09|||
3674308|NCT02314936|3518158|B1|||Body Mass Index||kg/m^2|Mean|25.27|25.27|Standard Deviation|3.06|3.06|||
3674309|NCT02314936|3518154|B5|Western European White||Race/Ethnicity, Customized||Participants|Count of Participants|147|147.0||||||
3674310|NCT02314936|3518155|B4|Western European White||Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
3674311|NCT02314936|3518156|B3|Western European White||Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3674312|NCT02314936|3518157|B2|Western European White||Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3674313|NCT02314936|3518158|B1|Western European White||Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3674314|NCT02314936|3518154|B5|South East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3674315|NCT02314936|3518155|B4|South East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3674316|NCT02314936|3518156|B3|South East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3674317|NCT02314936|3518157|B2|South East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3674318|NCT02314936|3518158|B1|South East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3674319|NCT02314936|3518154|B5|South Asian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3674320|NCT02314936|3518155|B4|South Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3674321|NCT02314936|3518156|B3|South Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3674322|NCT02314936|3518157|B2|South Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3674323|NCT02314936|3518158|B1|South Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3674324|NCT02314936|3518154|B5|South American||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3674325|NCT02314936|3518155|B4|South American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3674326|NCT02314936|3518156|B3|South American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3674327|NCT02314936|3518157|B2|South American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3674384|NCT02314689|3518347|B1|||Age||years|Mean|22.8|22.8|Full Range|||21.0|25.0|
3674328|NCT02314936|3518158|B1|South American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3674329|NCT02314936|3518154|B5|North American Indian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3674330|NCT02314936|3518155|B4|North American Indian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3674331|NCT02314936|3518156|B3|North American Indian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3674332|NCT02314936|3518157|B2|North American Indian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3674333|NCT02314936|3518158|B1|North American Indian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3674334|NCT02314936|3518154|B5|Middle Eastern||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3674335|NCT02314936|3518155|B4|Middle Eastern||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3674336|NCT02314936|3518156|B3|Middle Eastern||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3674337|NCT02314936|3518157|B2|Middle Eastern||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3674338|NCT02314936|3518158|B1|Middle Eastern||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3674339|NCT02314936|3518154|B5|Eastern European White||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3674340|NCT02314936|3518155|B4|Eastern European White||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3674341|NCT02314936|3518156|B3|Eastern European White||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3674342|NCT02314936|3518157|B2|Eastern European White||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3674343|NCT02314936|3518158|B1|Eastern European White||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3674344|NCT02314936|3518154|B5|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3674345|NCT02314936|3518155|B4|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3674346|NCT02314936|3518156|B3|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3674347|NCT02314936|3518157|B2|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3674348|NCT02314936|3518158|B1|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3674349|NCT02314936|3518154|B5|Central American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3674350|NCT02314936|3518155|B4|Central American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3674351|NCT02314936|3518156|B3|Central American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3674352|NCT02314936|3518157|B2|Central American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3674353|NCT02314936|3518158|B1|Central American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3674354|NCT02314936|3518154|B5|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3674355|NCT02314936|3518155|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3674356|NCT02314936|3518156|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3674357|NCT02314936|3518157|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3674358|NCT02314936|3518158|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3674359|NCT02314936|3518154|B5||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3674360|NCT02314936|3518155|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3674361|NCT02314936|3518156|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3674362|NCT02314936|3518157|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3674363|NCT02314936|3518158|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3674364|NCT02314936|3518154|B5||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3674365|NCT02314936|3518155|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3674366|NCT02314936|3518156|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3674367|NCT02314936|3518157|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3674368|NCT02314936|3518158|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3674369|NCT02314936|3518154|B5|||Age||years|Mean|42.7|42.7|Standard Deviation|14.8|14.8|||
3674370|NCT02314936|3518155|B4|||Age||years|Mean|43.6|43.6|Standard Deviation|13.4|13.4|||
3674371|NCT02314936|3518156|B3|||Age||years|Mean|41.5|41.5|Standard Deviation|17.1|17.1|||
3674372|NCT02314936|3518157|B2|||Age||years|Mean|42.9|42.9|Standard Deviation|12.5|12.5|||
3674373|NCT02314936|3518158|B1|||Age||years|Mean|42.9|42.9|Standard Deviation|16.3|16.3|||
3674374|NCT02314689|3518347|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3674375|NCT02314689|3518347|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674376|NCT02314689|3518347|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674377|NCT02314689|3518347|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674378|NCT02314689|3518347|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3674379|NCT02314689|3518347|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674380|NCT02314689|3518347|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674381|NCT02314689|3518347|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674382|NCT02314689|3518347|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3674383|NCT02314689|3518347|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3674385|NCT02314637|3518351|B3||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3674386|NCT02314637|3518352|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3674387|NCT02314637|3518353|B1||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3674388|NCT02314637|3518351|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3674389|NCT02314637|3518352|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3674390|NCT02314637|3518353|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3674391|NCT02314637|3518351|B3|>=65 years||Age, Customized||participants|Number|67|67.0||||||
3674392|NCT02314637|3518352|B2|>=65 years||Age, Customized||participants|Number|24|24.0||||||
3674393|NCT02314637|3518353|B1|>=65 years||Age, Customized||participants|Number|43|43.0||||||
3674394|NCT02314637|3518351|B3|<65 years||Age, Customized||participants|Number|173|173.0||||||
3674395|NCT02314637|3518352|B2|<65 years||Age, Customized||participants|Number|65|65.0||||||
3674396|NCT02314637|3518353|B1|<65 years||Age, Customized||participants|Number|108|108.0||||||
3674397|NCT02314546|3518364|B4|ASA Class 2||American Society of Anesthesiologists Physical Status Class|ASA Class 1: A healthy patient, ASA Class 2: A patient with mild systemic disease|participants|Number|10|10.0||||||
3674398|NCT02314546|3518365|B3|ASA Class 2||American Society of Anesthesiologists Physical Status Class|ASA Class 1: A healthy patient, ASA Class 2: A patient with mild systemic disease|participants|Number|3|3.0||||||
3674399|NCT02314546|3518366|B2|ASA Class 2||American Society of Anesthesiologists Physical Status Class|ASA Class 1: A healthy patient, ASA Class 2: A patient with mild systemic disease|participants|Number|3|3.0||||||
3674400|NCT02314546|3518367|B1|ASA Class 2||American Society of Anesthesiologists Physical Status Class|ASA Class 1: A healthy patient, ASA Class 2: A patient with mild systemic disease|participants|Number|4|4.0||||||
3674401|NCT02314546|3518364|B4|ASA Class 1||American Society of Anesthesiologists Physical Status Class|ASA Class 1: A healthy patient, ASA Class 2: A patient with mild systemic disease|participants|Number|5|5.0||||||
3674402|NCT02314546|3518365|B3|ASA Class 1||American Society of Anesthesiologists Physical Status Class|ASA Class 1: A healthy patient, ASA Class 2: A patient with mild systemic disease|participants|Number|2|2.0||||||
3674403|NCT02314546|3518366|B2|ASA Class 1||American Society of Anesthesiologists Physical Status Class|ASA Class 1: A healthy patient, ASA Class 2: A patient with mild systemic disease|participants|Number|2|2.0||||||
3674404|NCT02314546|3518367|B1|ASA Class 1||American Society of Anesthesiologists Physical Status Class|ASA Class 1: A healthy patient, ASA Class 2: A patient with mild systemic disease|participants|Number|1|1.0||||||
3674405|NCT02314546|3518364|B4|United States||Region of Enrollment||participants|Number|15|15.0||||||
3674406|NCT02314546|3518365|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3674407|NCT02314546|3518366|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3674408|NCT02314546|3518367|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3674409|NCT02314546|3518364|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3674410|NCT02314546|3518365|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3674411|NCT02314546|3518366|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3674412|NCT02314546|3518367|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3674413|NCT02314546|3518364|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3674414|NCT02314546|3518365|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3674415|NCT02314546|3518366|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3674416|NCT02314546|3518367|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3674417|NCT02314546|3518364|B4|||Age||years|Mean|3.7|3.7|Standard Deviation|1.8|1.8|||
3674418|NCT02314546|3518365|B3|||Age||years|Mean|4.0|4.0|Standard Deviation|2.0|2.0|||
3674419|NCT02314546|3518366|B2|||Age||years|Mean|4.0|4.0|Standard Deviation|1.2|1.2|||
3674420|NCT02314546|3518367|B1|||Age||years|Mean|3.2|3.2|Standard Deviation|2.2|2.2|||
3674421|NCT02314520|3518395|B3||other|Diagnosis||Participants|Count of Participants|20|20.0||||||
3674422|NCT02314520|3518396|B2||other|Diagnosis||Participants|Count of Participants|11|11.0||||||
3674423|NCT02314520|3518397|B1||other|Diagnosis||Participants|Count of Participants|9|9.0||||||
3674424|NCT02314520|3518395|B3||intraventricular hemorrhage|Diagnosis||Participants|Count of Participants|1|1.0||||||
3674425|NCT02314520|3518396|B2||intraventricular hemorrhage|Diagnosis||Participants|Count of Participants|1|1.0||||||
3674426|NCT02314520|3518397|B1||intraventricular hemorrhage|Diagnosis||Participants|Count of Participants|0|0.0||||||
3674427|NCT02314520|3518395|B3||myasthenia gravis|Diagnosis||Participants|Count of Participants|1|1.0||||||
3674428|NCT02314520|3518396|B2||myasthenia gravis|Diagnosis||Participants|Count of Participants|1|1.0||||||
3674429|NCT02314520|3518397|B1||myasthenia gravis|Diagnosis||Participants|Count of Participants|0|0.0||||||
3674430|NCT02314520|3518395|B3||intraparenchymal hematoma|Diagnosis||Participants|Count of Participants|22|22.0||||||
3674431|NCT02314520|3518396|B2||intraparenchymal hematoma|Diagnosis||Participants|Count of Participants|12|12.0||||||
3674432|NCT02314520|3518397|B1||intraparenchymal hematoma|Diagnosis||Participants|Count of Participants|10|10.0||||||
3674433|NCT02314520|3518395|B3||traumatic brain injury|Diagnosis||Participants|Count of Participants|19|19.0||||||
3674434|NCT02314520|3518396|B2||traumatic brain injury|Diagnosis||Participants|Count of Participants|8|8.0||||||
3674435|NCT02314520|3518397|B1||traumatic brain injury|Diagnosis||Participants|Count of Participants|11|11.0||||||
3674436|NCT02314520|3518395|B3||subarachnoid hemorrhage|Diagnosis||Participants|Count of Participants|32|32.0||||||
3674437|NCT02314520|3518396|B2||subarachnoid hemorrhage|Diagnosis||Participants|Count of Participants|18|18.0||||||
3674438|NCT02314520|3518397|B1||subarachnoid hemorrhage|Diagnosis||Participants|Count of Participants|14|14.0||||||
3674439|NCT02314520|3518395|B3||stroke|Diagnosis||Participants|Count of Participants|57|57.0||||||
3674440|NCT02314520|3518396|B2||stroke|Diagnosis||Participants|Count of Participants|29|29.0||||||
3674441|NCT02314520|3518397|B1||stroke|Diagnosis||Participants|Count of Participants|28|28.0||||||
3674442|NCT02314520|3518395|B3|||Hemiparesis||Participants|Count of Participants|76|76.0||||||
3674443|NCT02314520|3518396|B2|||Hemiparesis||Participants|Count of Participants|38|38.0||||||
3674444|NCT02314520|3518397|B1|||Hemiparesis||Participants|Count of Participants|38|38.0||||||
3674445|NCT02314520|3518395|B3|||Glasgow Coma Scale (Total)|The Glasgow Goma Scale (GCS) gives a description of level of consciousness. Patients are assigned a minimum of 1 and maximum of 6 units on a scale for motor skills, a minimum of 1 and maximum of 5 units on a scale for verbal skills, a minimum of 1 and maximum of 4 units on a scale for eye opening function. The total GCS is a simple sum of all of the units on a scale with a minimum of 3 and maximum of 15. Higher values indicate higher neurologic function.|points|Median|10|10.0|Standard Deviation|3.8|3.8|||
3674446|NCT02314520|3518396|B2|||Glasgow Coma Scale (Total)|The Glasgow Goma Scale (GCS) gives a description of level of consciousness. Patients are assigned a minimum of 1 and maximum of 6 units on a scale for motor skills, a minimum of 1 and maximum of 5 units on a scale for verbal skills, a minimum of 1 and maximum of 4 units on a scale for eye opening function. The total GCS is a simple sum of all of the units on a scale with a minimum of 3 and maximum of 15. Higher values indicate higher neurologic function.|points|Median|10|10.0|Standard Deviation|3.6|3.6|||
3674447|NCT02314520|3518397|B1|||Glasgow Coma Scale (Total)|The Glasgow Goma Scale (GCS) gives a description of level of consciousness. Patients are assigned a minimum of 1 and maximum of 6 units on a scale for motor skills, a minimum of 1 and maximum of 5 units on a scale for verbal skills, a minimum of 1 and maximum of 4 units on a scale for eye opening function. The total GCS is a simple sum of all of the units on a scale with a minimum of 3 and maximum of 15. Higher values indicate higher neurologic function.|points|Median|9.5|9.5|Standard Deviation|4.0|4.0|||
3674448|NCT02314520|3518395|B3|United States||Region of Enrollment||Participants|Count of Participants|152|152.0||||||
3674449|NCT02314520|3518396|B2|United States||Region of Enrollment||Participants|Count of Participants|80|80.0||||||
3674450|NCT02314520|3518397|B1|United States||Region of Enrollment||Participants|Count of Participants|72|72.0||||||
3674451|NCT02314520|3518395|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3674452|NCT02314520|3518395|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3674453|NCT02314520|3518396|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3674454|NCT02314520|3518397|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3674455|NCT02314520|3518395|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3674456|NCT02314520|3518396|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3674457|NCT02314520|3518397|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3674458|NCT02314520|3518395|B3|||Age||years|Mean|61.4|61.4|Standard Deviation|15.9|15.9|||
3674459|NCT02314520|3518396|B2|||Age||years|Mean|63.3|63.3|Standard Deviation|13.6|13.6|||
3674460|NCT02314520|3518397|B1|||Age||years|Mean|59.7|59.7|Standard Deviation|18|18.0|||
3674461|NCT02314260|3518410|B1|||Apgar score at 5 minutes|"Apgar score is a method to assess the health of a newborn immediately after birth.~It is determined by evaluating the newborn baby on 5 simple criteria on a scale from 0-2, then adding the five values obtained.~The resulting Apgar score ranges from 0-10. The 5 criteria are summarized using words chosen to form a backronym (Appearance,Pulse,Grimace,Activity,Respiration).~The test is generally done at 1 & 5 minutes after birth. Scores 7 & above are normal, 4-6 fairly low,and 3 and below are critically low.A low score on the one-minute test, may indicate neonate requires medical attention"|units on a scale|Mean|8.45|8.45|Standard Deviation|1.82|1.82|||
3674462|NCT02314260|3518410|B1|||Fetal weight (kilograms)||kilograms|Mean|3.02|3.02|Standard Deviation|0.267|0.267|||
3674463|NCT02314260|3518410|B1|||rupture of membraned duration||hours|Mean|9.93|9.93|Standard Deviation|4.50|4.5|||
3674464|NCT02314260|3518410|B1|||Induction to delivery time||Hours|Mean|17.38|17.38|Standard Deviation|4.29|4.29|||
3674465|NCT02314260|3518410|B1|||Time to active Phase||Hours|Mean|11.87|11.87|Standard Deviation|3.25|3.25|||
3674466|NCT02314260|3518410|B1|||New Modified Bishop Score|"The modified bishop score, is tailored by criteria we added to incorporate cervical length into the old bishop score.~it can have a range between (-2 & 15). low scores bellow 5 are associated with failed induction , while high scores are associated with successful vaginal delivery.~there are no set cut-off value for failed induction"|units on a scale|Mean|5.28|5.28|Standard Deviation|1.88|1.88|||
3674467|NCT02314260|3518410|B1|||Cervical Length||Cm|Mean|2.06|2.06|Standard Deviation|0.56|0.56|||
3674468|NCT02314260|3518410|B1|||Bishop Score|"A score of 5 or less suggests that labour is unlikely to start without induction. A score of 9 or more indicates that labour will most likely commence spontaneously.~The score can range between (0 -13) A low Bishop's score often indicates that induction is unlikely to be successful, however there is no set value"|units on a scale|Mean|5.71|5.71|Standard Deviation|1.20|1.2|||
3674469|NCT02314260|3518410|B1|||Gestational Age||Weeks|Mean|39.70|39.7|Standard Deviation|1.50|1.5|||
3674470|NCT02314260|3518410|B1|Egypt||Region of Enrollment||participants|Number|80|80.0||||||
3674471|NCT02314260|3518410|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3674472|NCT02314260|3518410|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3674473|NCT02314260|3518410|B1|||Age||years|Mean|24.31|24.31|Standard Deviation|3.65|3.65|||
3674474|NCT02314247|3518417|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674475|NCT02314247|3518418|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674476|NCT02314247|3518419|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674477|NCT02314247|3518417|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674478|NCT02314247|3518418|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674479|NCT02314247|3518419|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674480|NCT02314247|3518417|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3674481|NCT02314247|3518418|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3674482|NCT02314247|3518419|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3674483|NCT02314247|3518417|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674484|NCT02314247|3518418|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674485|NCT02314247|3518419|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674486|NCT02314247|3518417|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674487|NCT02314247|3518418|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674488|NCT02314247|3518419|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674489|NCT02314247|3518417|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3674490|NCT02314247|3518418|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3674491|NCT02314247|3518419|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3674492|NCT02314247|3518417|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674493|NCT02314247|3518418|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674494|NCT02314247|3518419|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674495|NCT02314247|3518417|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3674496|NCT02314247|3518418|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674497|NCT02314247|3518419|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3674498|NCT02314247|3518417|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3674499|NCT02314247|3518418|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3674500|NCT02314247|3518419|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3674501|NCT02314247|3518417|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674502|NCT02314247|3518418|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674503|NCT02314247|3518419|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674504|NCT02314247|3518417|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3674505|NCT02314247|3518418|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3674506|NCT02314247|3518419|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3674507|NCT02314247|3518417|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3674508|NCT02314247|3518418|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3674509|NCT02314247|3518419|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3674510|NCT02314247|3518417|B3|||Age||years|Median|69|69.0|Full Range|||51.0|84.0|
3674511|NCT02314247|3518418|B2|||Age||years|Median|74|74.0|Full Range|||59.0|84.0|
3674512|NCT02314247|3518419|B1|||Age||years|Median|65|65.0|Full Range|||51.0|83.0|
3674513|NCT02314117|3518443|B3|Germany||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3674514|NCT02314117|3518444|B2|Germany||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3674515|NCT02314117|3518445|B1|Germany||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3674516|NCT02314117|3518443|B3|France||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3674517|NCT02314117|3518444|B2|France||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3674518|NCT02314117|3518445|B1|France||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3674519|NCT02314117|3518443|B3|Israel||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3674520|NCT02314117|3518444|B2|Israel||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3674521|NCT02314117|3518445|B1|Israel||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3674522|NCT02314117|3518443|B3|Mexico||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
3674523|NCT02314117|3518444|B2|Mexico||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3674524|NCT02314117|3518445|B1|Mexico||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3674525|NCT02314117|3518443|B3|Italy||Region of Enrollment||Participants|Count of Participants|73|73.0||||||
3674526|NCT02314117|3518444|B2|Italy||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3674527|NCT02314117|3518445|B1|Italy||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3674528|NCT02314117|3518443|B3|Poland||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3674529|NCT02314117|3518444|B2|Poland||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3674530|NCT02314117|3518445|B1|Poland||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3674531|NCT02314117|3518443|B3|Denmark||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3674532|NCT02314117|3518444|B2|Denmark||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3674533|NCT02314117|3518445|B1|Denmark||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3674534|NCT02314117|3518443|B3|Finland||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3674535|NCT02314117|3518444|B2|Finland||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3674536|NCT02314117|3518445|B1|Finland||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3674537|NCT02314117|3518443|B3|Belgium||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3674538|NCT02314117|3518444|B2|Belgium||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3674539|NCT02314117|3518445|B1|Belgium||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3674540|NCT02314117|3518443|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3674541|NCT02314117|3518444|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3674542|NCT02314117|3518445|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3674543|NCT02314117|3518443|B3|Canada||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3674544|NCT02314117|3518444|B2|Canada||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3674545|NCT02314117|3518445|B1|Canada||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3674546|NCT02314117|3518443|B3|Spain||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3674547|NCT02314117|3518444|B2|Spain||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3674548|NCT02314117|3518445|B1|Spain||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3674549|NCT02314117|3518443|B3|Russia||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3674550|NCT02314117|3518444|B2|Russia||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3674551|NCT02314117|3518445|B1|Russia||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3674552|NCT02314117|3518443|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3674553|NCT02314117|3518444|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3674554|NCT02314117|3518445|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3674555|NCT02314117|3518443|B3|Japan||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3674556|NCT02314117|3518444|B2|Japan||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3674557|NCT02314117|3518445|B1|Japan||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3674558|NCT02314117|3518443|B3|Czechia||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3674559|NCT02314117|3518444|B2|Czechia||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3674560|NCT02314117|3518445|B1|Czechia||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3674561|NCT02314117|3518443|B3|United States||Region of Enrollment||Participants|Count of Participants|73|73.0||||||
3674562|NCT02314117|3518444|B2|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3674563|NCT02314117|3518445|B1|United States||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3674564|NCT02314117|3518443|B3|Hungary||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3674565|NCT02314117|3518444|B2|Hungary||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3674566|NCT02314117|3518445|B1|Hungary||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3674567|NCT02314117|3518443|B3|Argentina||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
3674568|NCT02314117|3518444|B2|Argentina||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3674569|NCT02314117|3518445|B1|Argentina||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3674570|NCT02314117|3518443|B3|Puerto Rico||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3674571|NCT02314117|3518444|B2|Puerto Rico||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3674572|NCT02314117|3518445|B1|Puerto Rico||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3674573|NCT02314117|3518443|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3674574|NCT02314117|3518444|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3674575|NCT02314117|3518445|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3674576|NCT02314117|3518443|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674577|NCT02314117|3518444|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674578|NCT02314117|3518445|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674579|NCT02314117|3518443|B3||White|Race (NIH/OMB)||Participants|Count of Participants|520|520.0||||||
3674580|NCT02314117|3518444|B2||White|Race (NIH/OMB)||Participants|Count of Participants|264|264.0||||||
3674581|NCT02314117|3518445|B1||White|Race (NIH/OMB)||Participants|Count of Participants|256|256.0||||||
3674582|NCT02314117|3518443|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3674583|NCT02314117|3518444|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3674584|NCT02314117|3518445|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3674585|NCT02314117|3518443|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3674586|NCT02314117|3518444|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674587|NCT02314117|3518445|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3674588|NCT02314117|3518443|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3674589|NCT02314117|3518444|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3674590|NCT02314117|3518445|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3674591|NCT02314117|3518443|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3674592|NCT02314117|3518444|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3674593|NCT02314117|3518445|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3674594|NCT02314117|3518443|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3674595|NCT02314117|3518444|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3674596|NCT02314117|3518445|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3674597|NCT02314117|3518443|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|472|472.0||||||
3674598|NCT02314117|3518444|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|245|245.0||||||
3674599|NCT02314117|3518445|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|227|227.0||||||
3674600|NCT02314117|3518443|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
3674601|NCT02314117|3518444|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3674602|NCT02314117|3518445|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3674603|NCT02314117|3518443|B3||Male|Sex: Female, Male||Participants|Count of Participants|429|429.0||||||
3674604|NCT02314117|3518444|B2||Male|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
3674605|NCT02314117|3518445|B1||Male|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
3674606|NCT02314117|3518443|B3||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
3674607|NCT02314117|3518444|B2||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3674608|NCT02314117|3518445|B1||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3674609|NCT02314117|3518443|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|11.7|11.7|||
3674610|NCT02314117|3518444|B2|||Age||years|Mean|60.1|60.1|Standard Deviation|11.8|11.8|||
3674611|NCT02314117|3518445|B1|||Age||years|Mean|58.9|58.9|Standard Deviation|11.6|11.6|||
3674612|NCT02314104|3518474|B4|||Height (inches)||inches|Mean|64.3|64.3|Standard Deviation|2.5|2.5|||
3674613|NCT02314104|3518475|B3|||Height (inches)||inches|Mean|64.1|64.1|Standard Deviation|2.5|2.5|||
3674614|NCT02314104|3518476|B2|||Height (inches)||inches|Mean|64.7|64.7|Standard Deviation|2.5|2.5|||
3674615|NCT02314104|3518477|B1|||Height (inches)||inches|Mean|64|64.0|Standard Deviation|2.6|2.6|||
3674616|NCT02314104|3518474|B4|||Weight (kg)||kg|Mean|82.0|82.0|Standard Deviation|19.6|19.6|||
3674617|NCT02314104|3518475|B3|||Weight (kg)||kg|Mean|79.2|79.2|Standard Deviation|20.0|20.0|||
3674618|NCT02314104|3518476|B2|||Weight (kg)||kg|Mean|85.9|85.9|Standard Deviation|18.4|18.4|||
3674619|NCT02314104|3518477|B1|||Weight (kg)||kg|Mean|80.8|80.8|Standard Deviation|20.5|20.5|||
3674620|NCT02314104|3518474|B4|||BMI (m/kg2)||kg/m^2|Mean|30.8|30.8|Standard Deviation|7.3|7.3|||
3674621|NCT02314104|3518475|B3|||BMI (m/kg2)||kg/m^2|Mean|29.9|29.9|Standard Deviation|7.5|7.5|||
3674622|NCT02314104|3518476|B2|||BMI (m/kg2)||kg/m^2|Mean|31.9|31.9|Standard Deviation|7.0|7.0|||
3674623|NCT02314104|3518477|B1|||BMI (m/kg2)||kg/m^2|Mean|30.5|30.5|Standard Deviation|7.4|7.4|||
3674624|NCT02314104|3518474|B4|United States||Region of Enrollment||participants|Number|183|183.0||||||
3674625|NCT02314104|3518475|B3|United States||Region of Enrollment||participants|Number|59|59.0||||||
3674626|NCT02314104|3518476|B2|United States||Region of Enrollment||participants|Number|63|63.0||||||
3674627|NCT02314104|3518477|B1|United States||Region of Enrollment||participants|Number|61|61.0||||||
3674628|NCT02314104|3518474|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3674629|NCT02314104|3518475|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3674630|NCT02314104|3518476|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3674631|NCT02314104|3518477|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3674632|NCT02314104|3518474|B4||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3674633|NCT02314104|3518475|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3674634|NCT02314104|3518476|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3674635|NCT02314104|3518477|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3674636|NCT02314104|3518474|B4|||Age||years|Mean|54.0|54.0|Standard Deviation|10.7|10.7|||
3674637|NCT02314104|3518475|B3|||Age||years|Mean|56.1|56.1|Standard Deviation|11.0|11.0|||
3674638|NCT02314104|3518476|B2|||Age||years|Mean|52.0|52.0|Standard Deviation|9.9|9.9|||
3674639|NCT02314104|3518477|B1|||Age||years|Mean|53.8|53.8|Standard Deviation|11.3|11.3|||
3674640|NCT02314052|3518499|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3674641|NCT02314052|3518499|B1|Singapore||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3674642|NCT02314052|3518499|B1|South Korea||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3674643|NCT02314052|3518499|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3674644|NCT02314052|3518499|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674645|NCT02314052|3518499|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3674646|NCT02314052|3518499|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674647|NCT02314052|3518499|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674648|NCT02314052|3518499|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3674649|NCT02314052|3518499|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674650|NCT02314052|3518499|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3674651|NCT02314052|3518499|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3674652|NCT02314052|3518499|B1|||Age||years|Mean|64.1|64.1|Standard Deviation|7.24|7.24|||
3674653|NCT02314052|3518499|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3674654|NCT02314052|3518499|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3674655|NCT02314052|3518499|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3674656|NCT02313766|3518572|B4|France||Region of Enrollment||participants|Number|146|146.0||||||
3674657|NCT02313766|3518573|B3|France||Region of Enrollment||participants|Number|50|50.0||||||
3674658|NCT02313766|3518574|B2|France||Region of Enrollment||participants|Number|47|47.0||||||
3674659|NCT02313766|3518575|B1|France||Region of Enrollment||participants|Number|49|49.0||||||
3674660|NCT02313766|3518572|B4||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3674661|NCT02313766|3518573|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3674662|NCT02313766|3518574|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3674663|NCT02313766|3518575|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3674664|NCT02313766|3518572|B4||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3674665|NCT02313766|3518573|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3674666|NCT02313766|3518574|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3674667|NCT02313766|3518575|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3674668|NCT02313766|3518572|B4|||Age||years|Mean|44|44.0|Standard Deviation|19|19.0|||
3674669|NCT02313766|3518573|B3|||Age||years|Mean|45|45.0|Standard Deviation|20|20.0|||
3674670|NCT02313766|3518574|B2|||Age||years|Mean|40|40.0|Standard Deviation|17|17.0|||
3674671|NCT02313766|3518575|B1|||Age||years|Mean|45|45.0|Standard Deviation|18|18.0|||
3674672|NCT02313766|3518572|B4||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3674673|NCT02313766|3518573|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3674674|NCT02313766|3518574|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3674675|NCT02313766|3518575|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3674676|NCT02313766|3518572|B4||Between 18 and 65 years|Age||Participants|Count of Participants|125|125.0||||||
3674677|NCT02313766|3518573|B3||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3674678|NCT02313766|3518574|B2||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3674679|NCT02313766|3518575|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3674680|NCT02313766|3518572|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3674681|NCT02313766|3518573|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3674682|NCT02313766|3518574|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3674683|NCT02313766|3518575|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3674684|NCT02313675|3518591|B5|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3674685|NCT02313675|3518591|B5||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3674686|NCT02313675|3518592|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3674687|NCT02313675|3518593|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3674688|NCT02313675|3518594|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3674689|NCT02313675|3518595|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3674690|NCT02313675|3518591|B5||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3674691|NCT02313675|3518592|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3674692|NCT02313675|3518593|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3674693|NCT02313675|3518594|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3674694|NCT02313675|3518595|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3674695|NCT02313675|3518591|B5|||Age||years|Mean|51|51.0|Full Range|||43.0|63.0|
3674696|NCT02313675|3518592|B4|||Age||years|Mean|55|55.0|Full Range|||45.0|65.0|
3674697|NCT02313675|3518593|B3|||Age||years|Mean|43|43.0|Full Range|||32.0|53.0|
3674698|NCT02313675|3518594|B2|||Age||years|Mean|48|48.0|Full Range|||37.0|58.0|
3674699|NCT02313675|3518595|B1|||Age||years|Mean|57|57.0|Full Range|||48.0|67.0|
3674700|NCT02313558|3518612|B3|||baseline gingivitis score|"The degree of gingivitis was scored at 6 sites (disto-, mid-, mesio-buccal and disto-, mid-, mesio-lingual) of each tooth according to the criteria of the Löe-Silness Gingival Index: 0= Absence of inflammation; 1 =Mild inflammation-slight change in color and little change in texture; 2=Moderate inflammation-moderate glazing, redness, edema and hypertrophy; 3=Severe inflammation-marked redness and hypertrophy. Tendency for spontaneous bleeding.~Whole-mouth mean plaque scores were calculated by summing all scores for all sites and dividing by the total number of sites scored."|units on a scale|Mean|1.34|1.34|Standard Deviation|0.24|0.24|||
3674701|NCT02313558|3518613|B2|||baseline gingivitis score|"The degree of gingivitis was scored at 6 sites (disto-, mid-, mesio-buccal and disto-, mid-, mesio-lingual) of each tooth according to the criteria of the Löe-Silness Gingival Index: 0= Absence of inflammation; 1 =Mild inflammation-slight change in color and little change in texture; 2=Moderate inflammation-moderate glazing, redness, edema and hypertrophy; 3=Severe inflammation-marked redness and hypertrophy. Tendency for spontaneous bleeding.~Whole-mouth mean plaque scores were calculated by summing all scores for all sites and dividing by the total number of sites scored."|units on a scale|Mean|1.35|1.35|Standard Deviation|0.24|0.24|||
3674729|NCT02313233|3518629|B1|Harnalidge® 0.2 mg QD treatment||Different original medications and dosages|The study product (Umooze or placebo) is given as add-on therapy in BPH, therefore the evaluation of benefit may be affected by the original medication.|participants|Number|2|2.0||||||
3674753|NCT02313233|3518629|B1|Taiwan||Region of Enrollment||participants|Number|18|18.0||||||
3674754|NCT02313233|3518627|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674702|NCT02313558|3518614|B1|||baseline gingivitis score|"The degree of gingivitis was scored at 6 sites (disto-, mid-, mesio-buccal and disto-, mid-, mesio-lingual) of each tooth according to the criteria of the Löe-Silness Gingival Index: 0= Absence of inflammation; 1 =Mild inflammation-slight change in color and little change in texture; 2=Moderate inflammation-moderate glazing, redness, edema and hypertrophy; 3=Severe inflammation-marked redness and hypertrophy. Tendency for spontaneous bleeding.~Whole-mouth mean plaque scores were calculated by summing all scores for all sites and dividing by the total number of sites scored."|units on a scale|Mean|1.32|1.32|Standard Deviation|0.25|0.25|||
3674703|NCT02313558|3518612|B3|||baseline dental plaque score|Plaque were scored at the disto-, mid-, mesio-buccal and disto-, mid-, mesio-lingual surfaces of each tooth according to the criteria of the Turesky modification of the Quigley-Hein Plaque Index: 0 =No plaque; 1 =Separate flecks of plaque at the cervical margin; 2 =A thin, continuous band of plaque (up to 1 mm) at the cervical margin; 3 =A band of plaque wider than 1 mm, but covering less than 1/3 of the side of the crown of the tooth; 4= Plaque covering at least 1/3, but less than 2/3 of the side of the crown of the tooth;5 =Plaque covering 2/3 or more of the side of the crown of the tooth.|units on a scale|Mean|3.07|3.07|Standard Deviation|0.53|0.53|||
3674704|NCT02313558|3518613|B2|||baseline dental plaque score|Plaque were scored at the disto-, mid-, mesio-buccal and disto-, mid-, mesio-lingual surfaces of each tooth according to the criteria of the Turesky modification of the Quigley-Hein Plaque Index: 0 =No plaque; 1 =Separate flecks of plaque at the cervical margin; 2 =A thin, continuous band of plaque (up to 1 mm) at the cervical margin; 3 =A band of plaque wider than 1 mm, but covering less than 1/3 of the side of the crown of the tooth; 4= Plaque covering at least 1/3, but less than 2/3 of the side of the crown of the tooth;5 =Plaque covering 2/3 or more of the side of the crown of the tooth.|units on a scale|Mean|3.05|3.05|Standard Deviation|0.46|0.46|||
3674705|NCT02313558|3518614|B1|||baseline dental plaque score|Plaque were scored at the disto-, mid-, mesio-buccal and disto-, mid-, mesio-lingual surfaces of each tooth according to the criteria of the Turesky modification of the Quigley-Hein Plaque Index: 0 =No plaque; 1 =Separate flecks of plaque at the cervical margin; 2 =A thin, continuous band of plaque (up to 1 mm) at the cervical margin; 3 =A band of plaque wider than 1 mm, but covering less than 1/3 of the side of the crown of the tooth; 4= Plaque covering at least 1/3, but less than 2/3 of the side of the crown of the tooth;5 =Plaque covering 2/3 or more of the side of the crown of the tooth.|units on a scale|Mean|3.08|3.08|Standard Deviation|0.59|0.59|||
3674706|NCT02313558|3518612|B3|China||Region of Enrollment||participants|Number|90|90.0||||||
3674707|NCT02313558|3518613|B2|China||Region of Enrollment||participants|Number|46|46.0||||||
3674708|NCT02313558|3518614|B1|China||Region of Enrollment||participants|Number|44|44.0||||||
3674709|NCT02313558|3518612|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3674710|NCT02313558|3518613|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3674711|NCT02313558|3518614|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3674712|NCT02313558|3518612|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3674713|NCT02313558|3518613|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3674714|NCT02313558|3518614|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3674715|NCT02313558|3518612|B3|||Age||years|Mean|30.72|30.72|Standard Deviation|7.86|7.86|||
3674716|NCT02313558|3518613|B2|||Age||years|Mean|31.26|31.26|Standard Deviation|7.86|7.86|||
3674717|NCT02313558|3518614|B1|||Age||years|Mean|30.16|30.16|Standard Deviation|7.9|7.9|||
3674718|NCT02313233|3518627|B3|Doxaben® XL 4 mg QD treatment||Different original medications and dosages|The study product (Umooze or placebo) is given as add-on therapy in BPH, therefore the evaluation of benefit may be affected by the original medication.|participants|Number|4|4.0||||||
3674719|NCT02313233|3518628|B2|Doxaben® XL 4 mg QD treatment||Different original medications and dosages|The study product (Umooze or placebo) is given as add-on therapy in BPH, therefore the evaluation of benefit may be affected by the original medication.|participants|Number|2|2.0||||||
3674720|NCT02313233|3518629|B1|Doxaben® XL 4 mg QD treatment||Different original medications and dosages|The study product (Umooze or placebo) is given as add-on therapy in BPH, therefore the evaluation of benefit may be affected by the original medication.|participants|Number|2|2.0||||||
3674721|NCT02313233|3518627|B3|Doxaben® 4 mg QD treatment||Different original medications and dosages|The study product (Umooze or placebo) is given as add-on therapy in BPH, therefore the evaluation of benefit may be affected by the original medication.|participants|Number|4|4.0||||||
3674722|NCT02313233|3518628|B2|Doxaben® 4 mg QD treatment||Different original medications and dosages|The study product (Umooze or placebo) is given as add-on therapy in BPH, therefore the evaluation of benefit may be affected by the original medication.|participants|Number|2|2.0||||||
3674723|NCT02313233|3518629|B1|Doxaben® 4 mg QD treatment||Different original medications and dosages|The study product (Umooze or placebo) is given as add-on therapy in BPH, therefore the evaluation of benefit may be affected by the original medication.|participants|Number|2|2.0||||||
3674724|NCT02313233|3518627|B3|Harnalidge® 0.1 mg QD treatment||Different original medications and dosages|The study product (Umooze or placebo) is given as add-on therapy in BPH, therefore the evaluation of benefit may be affected by the original medication.|participants|Number|1|1.0||||||
3674725|NCT02313233|3518628|B2|Harnalidge® 0.1 mg QD treatment||Different original medications and dosages|The study product (Umooze or placebo) is given as add-on therapy in BPH, therefore the evaluation of benefit may be affected by the original medication.|participants|Number|0|0.0||||||
3674726|NCT02313233|3518629|B1|Harnalidge® 0.1 mg QD treatment||Different original medications and dosages|The study product (Umooze or placebo) is given as add-on therapy in BPH, therefore the evaluation of benefit may be affected by the original medication.|participants|Number|1|1.0||||||
3674727|NCT02313233|3518627|B3|Harnalidge® 0.2 mg QD treatment||Different original medications and dosages|The study product (Umooze or placebo) is given as add-on therapy in BPH, therefore the evaluation of benefit may be affected by the original medication.|participants|Number|5|5.0||||||
3674728|NCT02313233|3518628|B2|Harnalidge® 0.2 mg QD treatment||Different original medications and dosages|The study product (Umooze or placebo) is given as add-on therapy in BPH, therefore the evaluation of benefit may be affected by the original medication.|participants|Number|3|3.0||||||
3674730|NCT02313233|3518627|B3|Harnalidge® 0.4 mg QD treatment||Different original medications and dosages|The study product (Umooze or placebo) is given as add-on therapy in BPH, therefore the evaluation of benefit may be affected by the original medication.|participants|Number|22|22.0||||||
3674731|NCT02313233|3518628|B2|Harnalidge® 0.4 mg QD treatment||Different original medications and dosages|The study product (Umooze or placebo) is given as add-on therapy in BPH, therefore the evaluation of benefit may be affected by the original medication.|participants|Number|11|11.0||||||
3674732|NCT02313233|3518629|B1|Harnalidge® 0.4 mg QD treatment||Different original medications and dosages|The study product (Umooze or placebo) is given as add-on therapy in BPH, therefore the evaluation of benefit may be affected by the original medication.|participants|Number|11|11.0||||||
3674733|NCT02313233|3518627|B3|||Serum Total Prostate-Specific Antigen level (PSA)|The prostate- specific antigen (PSA) is a protein produced by the prostate gland. This test is utilized to evaluate the presence of prostate hyperplasia if a rise of PSA level detected in a man's blood.|nanograms/ ml|Mean|1.74|1.74|Standard Deviation|1.31|1.31|||
3674734|NCT02313233|3518628|B2|||Serum Total Prostate-Specific Antigen level (PSA)|The prostate- specific antigen (PSA) is a protein produced by the prostate gland. This test is utilized to evaluate the presence of prostate hyperplasia if a rise of PSA level detected in a man's blood.|nanograms/ ml|Mean|1.95|1.95|Standard Deviation|1.31|1.31|||
3674735|NCT02313233|3518629|B1|||Serum Total Prostate-Specific Antigen level (PSA)|The prostate- specific antigen (PSA) is a protein produced by the prostate gland. This test is utilized to evaluate the presence of prostate hyperplasia if a rise of PSA level detected in a man's blood.|nanograms/ ml|Mean|1.54|1.54|Standard Deviation|1.34|1.34|||
3674736|NCT02313233|3518627|B3|||Prostate volume|The measurement of prostate volume is used to diagnose an abnormal enlargement of the prostate. Abnormally enlarged prostate may be caused by inflammation or viral infection.|cm^3|Mean|39.10|39.1|Standard Deviation|18.51|18.51|||
3674737|NCT02313233|3518628|B2|||Prostate volume|The measurement of prostate volume is used to diagnose an abnormal enlargement of the prostate. Abnormally enlarged prostate may be caused by inflammation or viral infection.|cm^3|Mean|39.5|39.5|Standard Deviation|16.9|16.9|||
3674738|NCT02313233|3518629|B1|||Prostate volume|The measurement of prostate volume is used to diagnose an abnormal enlargement of the prostate. Abnormally enlarged prostate may be caused by inflammation or viral infection.|cm^3|Mean|37.2|37.2|Standard Deviation|20.1|20.1|||
3674739|NCT02313233|3518627|B3|||Postvoid Residual Volume (PVR)|This PVR test measures the quantity of urine remained in the bladder after urination. This test is helpful to evaluate the existence of urination problems including an enlarged prostate (BPH).|ml|Mean|48.06|48.06|Standard Deviation|50.00|50.0|||
3674740|NCT02313233|3518628|B2|||Postvoid Residual Volume (PVR)|This PVR test measures the quantity of urine remained in the bladder after urination. This test is helpful to evaluate the existence of urination problems including an enlarged prostate (BPH).|ml|Mean|52.4|52.4|Standard Deviation|67.0|67.0|||
3674741|NCT02313233|3518629|B1|||Postvoid Residual Volume (PVR)|This PVR test measures the quantity of urine remained in the bladder after urination. This test is helpful to evaluate the existence of urination problems including an enlarged prostate (BPH).|ml|Mean|43.7|43.7|Standard Deviation|27.6|27.6|||
3674742|NCT02313233|3518627|B3|||Uroflowmetry (UFR) measure of maximum flow rate (Qmax)|Urine flow rate is a measure of the quantity of urine excreted. Qmax is an indicator to diagnose the enlarged prostate. A lower Qmax may relate to the pressure on the urethra by the enlarged prostate.|ml/ sec|Mean|10.85|10.85|Standard Deviation|3.29|3.29|||
3674743|NCT02313233|3518628|B2|||Uroflowmetry (UFR) measure of maximum flow rate (Qmax)|Urine flow rate is a measure of the quantity of urine excreted. Qmax is an indicator to diagnose the enlarged prostate. A lower Qmax may relate to the pressure on the urethra by the enlarged prostate.|ml/ sec|Mean|10.23|10.23|Standard Deviation|3.71|3.71|||
3674744|NCT02313233|3518629|B1|||Uroflowmetry (UFR) measure of maximum flow rate (Qmax)|Urine flow rate is a measure of the quantity of urine excreted. Qmax is an indicator to diagnose the enlarged prostate. A lower Qmax may relate to the pressure on the urethra by the enlarged prostate.|ml/ sec|Mean|11.5|11.5|Standard Deviation|2.88|2.88|||
3674745|NCT02313233|3518627|B3|||Quality-of-Life|The QoL index is a single question with scores of 0-6 point and corresponding to the assessment index ranging from delighted to terrible.|units on a scale|Mean|3.56|3.56|Standard Deviation|1.34|1.34|||
3674746|NCT02313233|3518628|B2|||Quality-of-Life|The QoL index is a single question with scores of 0-6 point and corresponding to the assessment index ranging from delighted to terrible.|units on a scale|Mean|3.78|3.78|Standard Deviation|1.22|1.22|||
3674747|NCT02313233|3518629|B1|||Quality-of-Life|The QoL index is a single question with scores of 0-6 point and corresponding to the assessment index ranging from delighted to terrible.|units on a scale|Mean|3.33|3.33|Standard Deviation|1.50|1.5|||
3674748|NCT02313233|3518627|B3|||Internation Prostate Symptom Score (IPSS)|The international prostate symptom score (IPSS) is a validated 7- item urinary symptom severity scale. The answers are assigned from 0 to 5, indicating increasing severity. The total score therefore ranges from 0 to 35 points (asymptomatic to symptomatic). Patients can be classified as follows: <=7 is mildly symptomatic; 8~ 19 is moderately symptomatic; 20~ 35 is severely symptomatic.|units on a scale|Mean|16.36|16.36|Standard Deviation|7.67|7.67|||
3674749|NCT02313233|3518628|B2|||Internation Prostate Symptom Score (IPSS)|The international prostate symptom score (IPSS) is a validated 7- item urinary symptom severity scale. The answers are assigned from 0 to 5, indicating increasing severity. The total score therefore ranges from 0 to 35 points (asymptomatic to symptomatic). Patients can be classified as follows: <=7 is mildly symptomatic; 8~ 19 is moderately symptomatic; 20~ 35 is severely symptomatic.|units on a scale|Mean|19.5|19.5|Standard Deviation|8.03|8.03|||
3674750|NCT02313233|3518629|B1|||Internation Prostate Symptom Score (IPSS)|The international prostate symptom score (IPSS) is a validated 7- item urinary symptom severity scale. The answers are assigned from 0 to 5, indicating increasing severity. The total score therefore ranges from 0 to 35 points (asymptomatic to symptomatic). Patients can be classified as follows: <=7 is mildly symptomatic; 8~ 19 is moderately symptomatic; 20~ 35 is severely symptomatic.|units on a scale|Mean|13.22|13.22|Standard Deviation|6.26|6.26|||
3674751|NCT02313233|3518627|B3|Taiwan||Region of Enrollment||participants|Number|36|36.0||||||
3674752|NCT02313233|3518628|B2|Taiwan||Region of Enrollment||participants|Number|18|18.0||||||
3674755|NCT02313233|3518628|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674756|NCT02313233|3518629|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674757|NCT02313233|3518627|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674758|NCT02313233|3518628|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674759|NCT02313233|3518629|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674760|NCT02313233|3518627|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674761|NCT02313233|3518628|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674762|NCT02313233|3518629|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674763|NCT02313233|3518627|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674764|NCT02313233|3518628|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674765|NCT02313233|3518629|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674766|NCT02313233|3518627|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674767|NCT02313233|3518628|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674768|NCT02313233|3518629|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674769|NCT02313233|3518627|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3674770|NCT02313233|3518628|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3674771|NCT02313233|3518629|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3674772|NCT02313233|3518627|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674773|NCT02313233|3518628|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674774|NCT02313233|3518629|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674775|NCT02313233|3518627|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3674776|NCT02313233|3518628|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3674777|NCT02313233|3518629|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3674778|NCT02313233|3518627|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3674779|NCT02313233|3518628|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3674780|NCT02313233|3518629|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3674781|NCT02313233|3518627|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3674782|NCT02313233|3518628|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3674783|NCT02313233|3518629|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3674784|NCT02313233|3518627|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3674785|NCT02313233|3518628|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3674786|NCT02313233|3518629|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3674787|NCT02313233|3518627|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3674788|NCT02313233|3518628|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3674789|NCT02313233|3518629|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3674790|NCT02313155|3518650|B3|>=40 to <=Max titer||HI(Egg-derived) - Influenza B(B) at Day1(Predose) Titer|Number of participants with values of HI antibody titer for B strain pre-dose at Day 1 were reported.|participants|Number|60|60.0||||||
3674791|NCT02313155|3518651|B2|>=40 to <=Max titer||HI(Egg-derived) - Influenza B(B) at Day1(Predose) Titer|Number of participants with values of HI antibody titer for B strain pre-dose at Day 1 were reported.|participants|Number|30|30.0||||||
3674792|NCT02313155|3518652|B1|>=40 to <=Max titer||HI(Egg-derived) - Influenza B(B) at Day1(Predose) Titer|Number of participants with values of HI antibody titer for B strain pre-dose at Day 1 were reported.|participants|Number|30|30.0||||||
3674793|NCT02313155|3518650|B3|>=Min to < 40 titer||HI(Egg-derived) - Influenza B(B) at Day1(Predose) Titer|Number of participants with values of HI antibody titer for B strain pre-dose at Day 1 were reported.|participants|Number|50|50.0||||||
3674794|NCT02313155|3518651|B2|>=Min to < 40 titer||HI(Egg-derived) - Influenza B(B) at Day1(Predose) Titer|Number of participants with values of HI antibody titer for B strain pre-dose at Day 1 were reported.|participants|Number|25|25.0||||||
3674795|NCT02313155|3518652|B1|>=Min to < 40 titer||HI(Egg-derived) - Influenza B(B) at Day1(Predose) Titer|Number of participants with values of HI antibody titer for B strain pre-dose at Day 1 were reported.|participants|Number|25|25.0||||||
3674796|NCT02313155|3518650|B3|>=40 to <=Max titer||HI(Egg-derived) - A/H3N2 at Day1(Predose) Titer|Number of participants with values of HI antibody titer for A/H3N2 strain pre-dose at Day 1 were reported.|participants|Number|21|21.0||||||
3674797|NCT02313155|3518651|B2|>=40 to <=Max titer||HI(Egg-derived) - A/H3N2 at Day1(Predose) Titer|Number of participants with values of HI antibody titer for A/H3N2 strain pre-dose at Day 1 were reported.|participants|Number|14|14.0||||||
3674798|NCT02313155|3518652|B1|>=40 to <=Max titer||HI(Egg-derived) - A/H3N2 at Day1(Predose) Titer|Number of participants with values of HI antibody titer for A/H3N2 strain pre-dose at Day 1 were reported.|participants|Number|7|7.0||||||
3674799|NCT02313155|3518650|B3|>=Min to less than (<) 40 titer||HI(Egg-derived) - A/H3N2 at Day1(Predose) Titer|Number of participants with values of HI antibody titer for A/H3N2 strain pre-dose at Day 1 were reported.|participants|Number|89|89.0||||||
3674800|NCT02313155|3518651|B2|>=Min to less than (<) 40 titer||HI(Egg-derived) - A/H3N2 at Day1(Predose) Titer|Number of participants with values of HI antibody titer for A/H3N2 strain pre-dose at Day 1 were reported.|participants|Number|41|41.0||||||
3674801|NCT02313155|3518652|B1|>=Min to less than (<) 40 titer||HI(Egg-derived) - A/H3N2 at Day1(Predose) Titer|Number of participants with values of HI antibody titer for A/H3N2 strain pre-dose at Day 1 were reported.|participants|Number|48|48.0||||||
3674802|NCT02313155|3518650|B3|>=40 to <=Maximum (Max) titer||Hemagglutination Inhibition (HI) (Egg-derived) - A/H1N1 at Day1 (Predose) Titer|Number of participants with values of HI antibody titer for A/H1N1 strain pre-dose at Day 1 were reported. Influenza A/Hemagglutinin Type 1 and Neuraminidase Type 1 (A/H1N1). Greater than or equal to (>=). Less than or equal to (<=).|participants|Number|33|33.0||||||
3674803|NCT02313155|3518651|B2|>=40 to <=Maximum (Max) titer||Hemagglutination Inhibition (HI) (Egg-derived) - A/H1N1 at Day1 (Predose) Titer|Number of participants with values of HI antibody titer for A/H1N1 strain pre-dose at Day 1 were reported. Influenza A/Hemagglutinin Type 1 and Neuraminidase Type 1 (A/H1N1). Greater than or equal to (>=). Less than or equal to (<=).|participants|Number|18|18.0||||||
3674804|NCT02313155|3518652|B1|>=40 to <=Maximum (Max) titer||Hemagglutination Inhibition (HI) (Egg-derived) - A/H1N1 at Day1 (Predose) Titer|Number of participants with values of HI antibody titer for A/H1N1 strain pre-dose at Day 1 were reported. Influenza A/Hemagglutinin Type 1 and Neuraminidase Type 1 (A/H1N1). Greater than or equal to (>=). Less than or equal to (<=).|participants|Number|15|15.0||||||
3674805|NCT02313155|3518650|B3|>=Minimum (Min) to <40 titer||Hemagglutination Inhibition (HI) (Egg-derived) - A/H1N1 at Day1 (Predose) Titer|Number of participants with values of HI antibody titer for A/H1N1 strain pre-dose at Day 1 were reported. Influenza A/Hemagglutinin Type 1 and Neuraminidase Type 1 (A/H1N1). Greater than or equal to (>=). Less than or equal to (<=).|participants|Number|77|77.0||||||
3674806|NCT02313155|3518651|B2|>=Minimum (Min) to <40 titer||Hemagglutination Inhibition (HI) (Egg-derived) - A/H1N1 at Day1 (Predose) Titer|Number of participants with values of HI antibody titer for A/H1N1 strain pre-dose at Day 1 were reported. Influenza A/Hemagglutinin Type 1 and Neuraminidase Type 1 (A/H1N1). Greater than or equal to (>=). Less than or equal to (<=).|participants|Number|37|37.0||||||
3674807|NCT02313155|3518652|B1|>=Minimum (Min) to <40 titer||Hemagglutination Inhibition (HI) (Egg-derived) - A/H1N1 at Day1 (Predose) Titer|Number of participants with values of HI antibody titer for A/H1N1 strain pre-dose at Day 1 were reported. Influenza A/Hemagglutinin Type 1 and Neuraminidase Type 1 (A/H1N1). Greater than or equal to (>=). Less than or equal to (<=).|participants|Number|40|40.0||||||
3674808|NCT02313155|3518650|B3|Participant didnot have influenza infection in 1yr||Influenza Infection Within 1 Year||participants|Number|109|109.0||||||
3674809|NCT02313155|3518651|B2|Participant didnot have influenza infection in 1yr||Influenza Infection Within 1 Year||participants|Number|54|54.0||||||
3674810|NCT02313155|3518652|B1|Participant didnot have influenza infection in 1yr||Influenza Infection Within 1 Year||participants|Number|55|55.0||||||
3674811|NCT02313155|3518650|B3|Participant had influenza infection in 1 year (yr)||Influenza Infection Within 1 Year||participants|Number|1|1.0||||||
3674812|NCT02313155|3518651|B2|Participant had influenza infection in 1 year (yr)||Influenza Infection Within 1 Year||participants|Number|1|1.0||||||
3674813|NCT02313155|3518652|B1|Participant had influenza infection in 1 year (yr)||Influenza Infection Within 1 Year||participants|Number|0|0.0||||||
3674814|NCT02313155|3518650|B3|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|20.79|20.79|Standard Deviation|1.552|1.552|||
3674815|NCT02313155|3518651|B2|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|21.18|21.18|Standard Deviation|1.561|1.561|||
3674816|NCT02313155|3518652|B1|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|20.41|20.41|Standard Deviation|1.457|1.457|||
3674817|NCT02313155|3518650|B3|||Weight||kilogram (kg)|Mean|57.27|57.27|Standard Deviation|7.492|7.492|||
3674818|NCT02313155|3518651|B2|||Weight||kilogram (kg)|Mean|58.19|58.19|Standard Deviation|7.610|7.61|||
3674819|NCT02313155|3518652|B1|||Weight||kilogram (kg)|Mean|56.35|56.35|Standard Deviation|7.325|7.325|||
3674820|NCT02313155|3518650|B3|||Height||centimeter (cm)|Mean|165.7|165.7|Standard Deviation|8.71|8.71|||
3674821|NCT02313155|3518651|B2|||Height||centimeter (cm)|Mean|165.5|165.5|Standard Deviation|8.67|8.67|||
3674822|NCT02313155|3518652|B1|||Height||centimeter (cm)|Mean|165.9|165.9|Standard Deviation|8.83|8.83|||
3674823|NCT02313155|3518650|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3674824|NCT02313155|3518651|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3674825|NCT02313155|3518652|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3674826|NCT02313155|3518650|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3674827|NCT02313155|3518651|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3674828|NCT02313155|3518652|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3674829|NCT02313155|3518650|B3|||Age||years|Mean|24.6|24.6|Standard Deviation|3.82|3.82|||
3674830|NCT02313155|3518651|B2|||Age||years|Mean|25.1|25.1|Standard Deviation|4.08|4.08|||
3674831|NCT02313155|3518652|B1|||Age||years|Mean|24.1|24.1|Standard Deviation|3.50|3.5|||
3674832|NCT02312882|3518701|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3674833|NCT02312882|3518701|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3674834|NCT02312882|3518701|B1|||Age||years|Median|37|37.0|Full Range|||19.0|65.0|
3674835|NCT02312739|3518705|B3|United States||Region of Enrollment||participants|Number|64|64.0||||||
3674836|NCT02312739|3518706|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
3674837|NCT02312739|3518707|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3674838|NCT02312739|3518705|B3|Unknown||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3674839|NCT02312739|3518706|B2|Unknown||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3674840|NCT02312739|3518707|B1|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3674841|NCT02312739|3518705|B3|More than one||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3674842|NCT02312739|3518706|B2|More than one||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3674843|NCT02312739|3518707|B1|More than one||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3674844|NCT02312739|3518705|B3|Native American/Alaska native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3674845|NCT02312739|3518706|B2|Native American/Alaska native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3674846|NCT02312739|3518707|B1|Native American/Alaska native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3674847|NCT02312739|3518705|B3|Hispanic/Mexican/Spanish||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3674848|NCT02312739|3518706|B2|Hispanic/Mexican/Spanish||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3674849|NCT02312739|3518707|B1|Hispanic/Mexican/Spanish||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3674850|NCT02312739|3518705|B3|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3674851|NCT02312739|3518706|B2|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3674852|NCT02312739|3518707|B1|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3674853|NCT02312739|3518705|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674854|NCT02312739|3518706|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674855|NCT02312739|3518707|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674856|NCT02312739|3518705|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3674857|NCT02312739|3518706|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3674858|NCT02312739|3518707|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3674859|NCT02312739|3518705|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3674860|NCT02312739|3518706|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3674861|NCT02312739|3518707|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3674862|NCT02312739|3518705|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3674863|NCT02312739|3518706|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3674864|NCT02312739|3518707|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3674865|NCT02312739|3518705|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3674866|NCT02312739|3518706|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3674867|NCT02312739|3518707|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3674868|NCT02312739|3518705|B3|||Age||years|Mean|34.1|34.1|Standard Deviation|5.7|5.7|||
3674869|NCT02312739|3518706|B2|||Age||years|Mean|33.6|33.6|Standard Deviation|4.9|4.9|||
3674870|NCT02312739|3518707|B1|||Age||years|Mean|34.6|34.6|Standard Deviation|6.6|6.6|||
3674871|NCT02312726|3518722|B1|Commercial||Insurance||participants|Number|3|3.0||||||
3674872|NCT02312726|3518722|B1|Medicaid||Insurance||participants|Number|26|26.0||||||
3674873|NCT02312726|3518722|B1|None||Insurance||participants|Number|39|39.0||||||
3674874|NCT02312726|3518722|B1|Spanish||Language of Preference||participants|Number|30|30.0||||||
3674875|NCT02312726|3518722|B1|English||Language of Preference||participants|Number|38|38.0||||||
3674876|NCT02312726|3518722|B1|Declined to answer||Income||participants|Number|2|2.0||||||
3674877|NCT02312726|3518722|B1|$60,000 - $80,000||Income||participants|Number|1|1.0||||||
3674878|NCT02312726|3518722|B1|$40,000 - $60,000||Income||participants|Number|3|3.0||||||
3674879|NCT02312726|3518722|B1|$20,000 - $40,000||Income||participants|Number|23|23.0||||||
3674880|NCT02312726|3518722|B1|Less than $20,000||Income||participants|Number|39|39.0||||||
3674881|NCT02312726|3518722|B1|Unemployed||Employment||participants|Number|12|12.0||||||
3674882|NCT02312726|3518722|B1|Temporary work leave||Employment||participants|Number|2|2.0||||||
3674883|NCT02312726|3518722|B1|Homemaker||Employment||participants|Number|31|31.0||||||
3674884|NCT02312726|3518722|B1|Student||Employment||participants|Number|7|7.0||||||
3674885|NCT02312726|3518722|B1|Employed full time||Employment||participants|Number|8|8.0||||||
3674886|NCT02312726|3518722|B1|Employed part time||Employment||participants|Number|8|8.0||||||
3674887|NCT02312726|3518722|B1|Completed college||Education||participants|Number|3|3.0||||||
3674888|NCT02312726|3518722|B1|In college/completed some college||Education||participants|Number|16|16.0||||||
3674889|NCT02312726|3518722|B1|Completed high school/ GED||Education||participants|Number|28|28.0||||||
3674890|NCT02312726|3518722|B1|Did not complete high school||Education||participants|Number|21|21.0||||||
3674891|NCT02312726|3518722|B1|United States||Region of Enrollment||participants|Number|68|68.0||||||
3674892|NCT02312726|3518722|B1|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3674893|NCT02312726|3518722|B1|Asian American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3674894|NCT02312726|3518722|B1|American Indian/Alaskan||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3674895|NCT02312726|3518722|B1|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3674896|NCT02312726|3518722|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
3674897|NCT02312726|3518722|B1|Female||Sex/Gender, Customized||participants|Number|68|68.0||||||
3674898|NCT02312726|3518722|B1|Median Age||Age, Customized||years|Median|27|27.0|Full Range|||18.0|43.0|
3674899|NCT02312713|3518736|B4|||Self-reported Years with Arthritis Symptoms||years|Mean|13.1|13.1|Standard Deviation|11.7|11.7|||
3674900|NCT02312713|3518737|B3|||Self-reported Years with Arthritis Symptoms||years|Mean|14.2|14.2|Standard Deviation|13.0|13.0|||
3674901|NCT02312713|3518738|B2|||Self-reported Years with Arthritis Symptoms||years|Mean|11.6|11.6|Standard Deviation|11.0|11.0|||
3674902|NCT02312713|3518739|B1|||Self-reported Years with Arthritis Symptoms||years|Mean|14.1|14.1|Standard Deviation|11.6|11.6|||
3674903|NCT02312713|3518736|B4|||Number of Joints with Arthritis Symptoms||joints|Mean|5.4|5.4|Standard Deviation|3.2|3.2|||
3674904|NCT02312713|3518737|B3|||Number of Joints with Arthritis Symptoms||joints|Mean|5.5|5.5|Standard Deviation|3.9|3.9|||
3674905|NCT02312713|3518738|B2|||Number of Joints with Arthritis Symptoms||joints|Mean|5.2|5.2|Standard Deviation|3.1|3.1|||
3674906|NCT02312713|3518739|B1|||Number of Joints with Arthritis Symptoms||joints|Mean|5.5|5.5|Standard Deviation|3.0|3.0|||
3674907|NCT02312713|3518736|B4|||Fair or Poor Self-Reported Health|"Participants were asked, How would you rate your current health? Options were: excellent, very good, good, fair and poor.~For this metric we grouped those reporting fair or poor."|Participants|Count of Participants|48|48.0||||||
3674908|NCT02312713|3518737|B3|||Fair or Poor Self-Reported Health|"Participants were asked, How would you rate your current health? Options were: excellent, very good, good, fair and poor.~For this metric we grouped those reporting fair or poor."|Participants|Count of Participants|12|12.0||||||
3674909|NCT02312713|3518738|B2|||Fair or Poor Self-Reported Health|"Participants were asked, How would you rate your current health? Options were: excellent, very good, good, fair and poor.~For this metric we grouped those reporting fair or poor."|Participants|Count of Participants|22|22.0||||||
3674910|NCT02312713|3518739|B1|||Fair or Poor Self-Reported Health|"Participants were asked, How would you rate your current health? Options were: excellent, very good, good, fair and poor.~For this metric we grouped those reporting fair or poor."|Participants|Count of Participants|14|14.0||||||
3674911|NCT02312713|3518736|B4|||Low Income Financial Status|"Low income defined as self report of “just meeting basic expenses” or “don’t even have enough to meet basic expenses vs. responses of live comfortably or meet your basic expenses with a little left over for extras in response to a question asking participants to describe your household’s financial situation."|Participants|Count of Participants|62|62.0||||||
3674912|NCT02312713|3518737|B3|||Low Income Financial Status|"Low income defined as self report of “just meeting basic expenses” or “don’t even have enough to meet basic expenses vs. responses of live comfortably or meet your basic expenses with a little left over for extras in response to a question asking participants to describe your household’s financial situation."|Participants|Count of Participants|13|13.0||||||
3674913|NCT02312713|3518738|B2|||Low Income Financial Status|"Low income defined as self report of “just meeting basic expenses” or “don’t even have enough to meet basic expenses vs. responses of live comfortably or meet your basic expenses with a little left over for extras in response to a question asking participants to describe your household’s financial situation."|Participants|Count of Participants|29|29.0||||||
3674914|NCT02312713|3518739|B1|||Low Income Financial Status|"Low income defined as self report of “just meeting basic expenses” or “don’t even have enough to meet basic expenses vs. responses of live comfortably or meet your basic expenses with a little left over for extras in response to a question asking participants to describe your household’s financial situation."|Participants|Count of Participants|20|20.0||||||
3674915|NCT02312713|3518736|B4|||Employed||Participants|Count of Participants|141|141.0||||||
3674916|NCT02312713|3518737|B3|||Employed||Participants|Count of Participants|31|31.0||||||
3674917|NCT02312713|3518738|B2|||Employed||Participants|Count of Participants|51|51.0||||||
3674918|NCT02312713|3518739|B1|||Employed||Participants|Count of Participants|59|59.0||||||
3674919|NCT02312713|3518736|B4|||Bachelors Degree or More Education||Participants|Count of Participants|208|208.0||||||
3674920|NCT02312713|3518737|B3|||Bachelors Degree or More Education||Participants|Count of Participants|42|42.0||||||
3674921|NCT02312713|3518738|B2|||Bachelors Degree or More Education||Participants|Count of Participants|80|80.0||||||
3674922|NCT02312713|3518739|B1|||Bachelors Degree or More Education||Participants|Count of Participants|86|86.0||||||
3674923|NCT02312713|3518736|B4|||Married or Living with Partner||Participants|Count of Participants|215|215.0||||||
3674924|NCT02312713|3518737|B3|||Married or Living with Partner||Participants|Count of Participants|42|42.0||||||
3674925|NCT02312713|3518738|B2|||Married or Living with Partner||Participants|Count of Participants|93|93.0||||||
3674926|NCT02312713|3518739|B1|||Married or Living with Partner||Participants|Count of Participants|80|80.0||||||
3674927|NCT02312713|3518736|B4|||Body Mass Index||kg/m2|Mean|31.4|31.4|Standard Deviation|8.0|8.0|||
3674928|NCT02312713|3518737|B3|||Body Mass Index||kg/m2|Mean|30.1|30.1|Standard Deviation|7.3|7.3|||
3674929|NCT02312713|3518738|B2|||Body Mass Index||kg/m2|Mean|31.5|31.5|Standard Deviation|7.8|7.8|||
3674930|NCT02312713|3518739|B1|||Body Mass Index||kg/m2|Mean|31.9|31.9|Standard Deviation|8.6|8.6|||
3674931|NCT02312713|3518736|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3674932|NCT02312713|3518737|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3674933|NCT02312713|3518738|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3674934|NCT02312713|3518739|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3674935|NCT02312713|3518736|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3674936|NCT02312713|3518737|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3674937|NCT02312713|3518738|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3674938|NCT02312713|3518739|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3674939|NCT02312713|3518736|B4||White|Race (NIH/OMB)||Participants|Count of Participants|252|252.0||||||
3674940|NCT02312713|3518737|B3||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3674941|NCT02312713|3518738|B2||White|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3674942|NCT02312713|3518739|B1||White|Race (NIH/OMB)||Participants|Count of Participants|109|109.0||||||
3674943|NCT02312713|3518736|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3674944|NCT02312713|3518737|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3674945|NCT02312713|3518738|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3674946|NCT02312713|3518739|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3674947|NCT02312713|3518736|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3674948|NCT02312713|3518737|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3674949|NCT02312713|3518738|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3674950|NCT02312713|3518739|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674951|NCT02312713|3518736|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3674952|NCT02312713|3518737|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3674953|NCT02312713|3518738|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3674954|NCT02312713|3518739|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3674955|NCT02312713|3518736|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3674956|NCT02312713|3518737|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3674957|NCT02312713|3518738|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3674958|NCT02312713|3518739|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3674959|NCT02312713|3518736|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3674960|NCT02312713|3518737|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674961|NCT02312713|3518738|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3674962|NCT02312713|3518739|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3674963|NCT02312713|3518736|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|339|339.0||||||
3674964|NCT02312713|3518737|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3674965|NCT02312713|3518738|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
3674966|NCT02312713|3518739|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
3674967|NCT02312713|3518736|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3674968|NCT02312713|3518737|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3674969|NCT02312713|3518738|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3674970|NCT02312713|3518739|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3674971|NCT02312713|3518736|B4||Male|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
3674972|NCT02312713|3518737|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3674973|NCT02312713|3518738|B2||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3674974|NCT02312713|3518739|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3674975|NCT02312713|3518736|B4||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3674976|NCT02312713|3518737|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3674977|NCT02312713|3518738|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3674978|NCT02312713|3518739|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3674979|NCT02312713|3518736|B4|||Age||years|Mean|65.3|65.3|Standard Deviation|11.1|11.1|||
3674980|NCT02312713|3518737|B3|||Age||years|Mean|64.3|64.3|Standard Deviation|12.2|12.2|||
3674981|NCT02312713|3518738|B2|||Age||years|Mean|65.3|65.3|Standard Deviation|11.5|11.5|||
3674982|NCT02312713|3518739|B1|||Age||years|Mean|65.7|65.7|Standard Deviation|10.3|10.3|||
3674983|NCT02312154|3518785|B1|untreated side||erythema index|"We measured a erythema index by a combination corneometer/mexameter/reviscometer device (Courage & Khazaka, Cologne, Germany).~The range of erythema index is 0~999 AU(Arbitrary Unit). The lower erythema indices than baseline reflect improvement of erythema."|AU(arbitrary unit)|Mean|290.50|290.5|Standard Deviation|59.35|59.35|||
3674984|NCT02312154|3518785|B1|treated side||erythema index|"We measured a erythema index by a combination corneometer/mexameter/reviscometer device (Courage & Khazaka, Cologne, Germany).~The range of erythema index is 0~999 AU(Arbitrary Unit). The lower erythema indices than baseline reflect improvement of erythema."|AU(arbitrary unit)|Mean|292.74|292.74|Standard Deviation|71.64|71.64|||
3674985|NCT02312154|3518785|B1|untreated side||melanin index|"We measured a melanin index by a combination corneometer/mexameter/reviscometer device (Courage & Khazaka, Cologne, Germany).~The range of melamin index is 0~999 AU(Arbitrary Unit).~0~49: Phototype I (celtic type), 50~99 : Phototype II (Caucasian type), 100~149 : Phototype III (European mixed type), 150~199 : Phototype IV (Mediterranean type), 200~299 : Phototype V (Asian/Indian type), 300~999 : Phototype VI (Black skin type) (This is only an approach. It is recommend that each user should develop an own interpretation scale.)"|AU(arbitrary unit)|Mean|133.66|133.66|Standard Deviation|27.68|27.68|||
3674986|NCT02312154|3518785|B1|treated side||melanin index|"We measured a melanin index by a combination corneometer/mexameter/reviscometer device (Courage & Khazaka, Cologne, Germany).~The range of melamin index is 0~999 AU(Arbitrary Unit).~0~49: Phototype I (celtic type), 50~99 : Phototype II (Caucasian type), 100~149 : Phototype III (European mixed type), 150~199 : Phototype IV (Mediterranean type), 200~299 : Phototype V (Asian/Indian type), 300~999 : Phototype VI (Black skin type) (This is only an approach. It is recommend that each user should develop an own interpretation scale.)"|AU(arbitrary unit)|Mean|133.97|133.97|Standard Deviation|25.56|25.56|||
3674987|NCT02312154|3518785|B1|untreated side||elasticity|"We measured a elasticity by a combination corneometer/mexameter/reviscometer device (Courage & Khazaka, Cologne, Germany).~The range of elasticity is 0~400 AU(Arbitrary Unit). The lower revisometer values reflect higher elasticity."|AU (arbitrary unit)|Mean|272.70|272.7|Standard Deviation|96.89|96.89|||
3674988|NCT02312154|3518785|B1|treated side||elasticity|"We measured a elasticity by a combination corneometer/mexameter/reviscometer device (Courage & Khazaka, Cologne, Germany).~The range of elasticity is 0~400 AU(Arbitrary Unit). The lower revisometer values reflect higher elasticity."|AU (arbitrary unit)|Mean|294.32|294.32|Standard Deviation|90.25|90.25|||
3675046|NCT02311894|3518845|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3674989|NCT02312154|3518785|B1|untreated side||hydration|"We measured a hydration level by a combination corneometer/mexameter/reviscometer device (Courage & Khazaka, Cologne, Germany).~The range of hydration level was 0~120 AU(Arbitrary Unit).~< 30 : Very dry, 30~49 : Dry, 50~59: Moisturized, >60 : Sufficiently Moisturized"|AU (Arbitrary Unit)|Mean|46.21|46.21|Standard Deviation|11.35|11.35|||
3674990|NCT02312154|3518785|B1|treated side||hydration|"We measured a hydration level by a combination corneometer/mexameter/reviscometer device (Courage & Khazaka, Cologne, Germany).~The range of hydration level was 0~120 AU(Arbitrary Unit).~< 30 : Very dry, 30~49 : Dry, 50~59: Moisturized, >60 : Sufficiently Moisturized"|AU (Arbitrary Unit)|Mean|45.47|45.47|Standard Deviation|10.53|10.53|||
3674991|NCT02312154|3518785|B1|Korea, Republic of||Region of Enrollment||participants|Number|25|25.0||||||
3674992|NCT02312154|3518785|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3674993|NCT02312154|3518785|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3674994|NCT02312154|3518785|B1|50-59 years||Age, Customized||participants|Number|2|2.0||||||
3674995|NCT02312154|3518785|B1|40-49 years||Age, Customized||participants|Number|5|5.0||||||
3674996|NCT02312154|3518785|B1|30-39 years||Age, Customized||participants|Number|14|14.0||||||
3674997|NCT02312154|3518785|B1|20-29 years||Age, Customized||participants|Number|4|4.0||||||
3674998|NCT02312154|3518785|B1|||Age||years|Mean|37|37.0|Standard Deviation|8|8.0|||
3674999|NCT02311972|3518800|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3675000|NCT02311972|3518801|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3675001|NCT02311972|3518802|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3675002|NCT02311972|3518800|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675003|NCT02311972|3518801|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675004|NCT02311972|3518802|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675005|NCT02311972|3518800|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3675006|NCT02311972|3518801|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3675007|NCT02311972|3518802|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3675008|NCT02311972|3518800|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3675009|NCT02311972|3518801|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3675010|NCT02311972|3518802|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675011|NCT02311972|3518800|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3675012|NCT02311972|3518801|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3675013|NCT02311972|3518802|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3675014|NCT02311972|3518800|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3675015|NCT02311972|3518801|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3675016|NCT02311972|3518802|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3675017|NCT02311972|3518800|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3675018|NCT02311972|3518801|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3675019|NCT02311972|3518802|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3675020|NCT02311972|3518800|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3675021|NCT02311972|3518801|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3675022|NCT02311972|3518802|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3675023|NCT02311972|3518800|B3||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
3675024|NCT02311972|3518801|B2||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
3675025|NCT02311972|3518802|B1||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
3675026|NCT02311907|3518820|B3|United States||Region of Enrollment||participants|Number|185|185.0||||||
3675027|NCT02311907|3518821|B2|United States||Region of Enrollment||participants|Number|91|91.0||||||
3675028|NCT02311907|3518822|B1|United States||Region of Enrollment||participants|Number|94|94.0||||||
3675029|NCT02311907|3518820|B3||Male|Gender||Participants|Count of Participants|35|35.0||||||
3675030|NCT02311907|3518821|B2||Male|Gender||Participants|Count of Participants|15|15.0||||||
3675031|NCT02311907|3518822|B1||Male|Gender||Participants|Count of Participants|20|20.0||||||
3675032|NCT02311907|3518820|B3||Female|Gender||Participants|Count of Participants|150|150.0||||||
3675033|NCT02311907|3518821|B2||Female|Gender||Participants|Count of Participants|76|76.0||||||
3675034|NCT02311907|3518822|B1||Female|Gender||Participants|Count of Participants|74|74.0||||||
3675035|NCT02311907|3518820|B3|||Age||years|Median|63|63.0|Full Range|||28.0|85.0|
3675036|NCT02311907|3518821|B2|||Age||years|Median|63|63.0|Full Range|||28.0|84.0|
3675037|NCT02311907|3518822|B1|||Age||years|Median|63|63.0|Full Range|||37.0|85.0|
3675038|NCT02311894|3518845|B1|White||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
3675039|NCT02311894|3518845|B1|Unknown||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3675040|NCT02311894|3518845|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3675041|NCT02311894|3518845|B1|Multiple||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3675042|NCT02311894|3518845|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3675043|NCT02311894|3518845|B1|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3675044|NCT02311894|3518845|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3675045|NCT02311894|3518845|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3675047|NCT02311894|3518845|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3675048|NCT02311894|3518845|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3675049|NCT02311894|3518845|B1|||Age||years|Mean|9.0|9.0|Standard Deviation|1.91|1.91|||
3675050|NCT02311881|3518854|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||number of participants|Number|454|454.0||||||
3675051|NCT02311881|3518855|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||number of participants|Number|142|142.0||||||
3675052|NCT02311881|3518856|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||number of participants|Number|155|155.0||||||
3675053|NCT02311881|3518857|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||number of participants|Number|157|157.0||||||
3675054|NCT02311881|3518854|B4|Hispanic or Latino||Race/Ethnicity, Customized||number of participants|Number|253|253.0||||||
3675055|NCT02311881|3518855|B3|Hispanic or Latino||Race/Ethnicity, Customized||number of participants|Number|95|95.0||||||
3675056|NCT02311881|3518856|B2|Hispanic or Latino||Race/Ethnicity, Customized||number of participants|Number|81|81.0||||||
3675057|NCT02311881|3518857|B1|Hispanic or Latino||Race/Ethnicity, Customized||number of participants|Number|77|77.0||||||
3675058|NCT02311881|3518854|B4||Male|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
3675059|NCT02311881|3518855|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3675060|NCT02311881|3518856|B2||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3675061|NCT02311881|3518857|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3675062|NCT02311881|3518854|B4||Female|Sex: Female, Male||Participants|Count of Participants|443|443.0||||||
3675063|NCT02311881|3518855|B3||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3675064|NCT02311881|3518856|B2||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3675065|NCT02311881|3518857|B1||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3675066|NCT02311881|3518854|B4|||Age||Years|Mean|60.73|60.73|Standard Deviation|8.385|8.385|||
3675067|NCT02311881|3518855|B3|||Age||Years|Mean|61.46|61.46|Standard Deviation|8.187|8.187|||
3675068|NCT02311881|3518856|B2|||Age||Years|Mean|60.47|60.47|Standard Deviation|8.410|8.41|||
3675069|NCT02311881|3518857|B1|||Age||Years|Mean|60.27|60.27|Standard Deviation|8.544|8.544|||
3675070|NCT02311309|3518894|B4|||Units of packed red blood cell pre planned (number)||units of packed red blood cell|Median|3|3.0|Inter-Quartile Range|||2.0|3.0|
3675071|NCT02311309|3518895|B3|||Units of packed red blood cell pre planned (number)||units of packed red blood cell|Median|2|2.0|Inter-Quartile Range|||2.0|3.0|
3675072|NCT02311309|3518896|B2|||Units of packed red blood cell pre planned (number)||units of packed red blood cell|Median|3|3.0|Inter-Quartile Range|||3.0|4.0|
3675073|NCT02311309|3518897|B1|||Units of packed red blood cell pre planned (number)||units of packed red blood cell|Median|3|3.0|Inter-Quartile Range|||2.0|3.0|
3675074|NCT02311309|3518894|B4|No||red blood cell pre-planned (yes/no)||participants|Number|1221|1221.0||||||
3675075|NCT02311309|3518895|B3|No||red blood cell pre-planned (yes/no)||participants|Number|835|835.0||||||
3675076|NCT02311309|3518896|B2|No||red blood cell pre-planned (yes/no)||participants|Number|18|18.0||||||
3675077|NCT02311309|3518897|B1|No||red blood cell pre-planned (yes/no)||participants|Number|368|368.0||||||
3675078|NCT02311309|3518894|B4|Yes||red blood cell pre-planned (yes/no)||participants|Number|218|218.0||||||
3675079|NCT02311309|3518895|B3|Yes||red blood cell pre-planned (yes/no)||participants|Number|28|28.0||||||
3675080|NCT02311309|3518896|B2|Yes||red blood cell pre-planned (yes/no)||participants|Number|17|17.0||||||
3675081|NCT02311309|3518897|B1|Yes||red blood cell pre-planned (yes/no)||participants|Number|173|173.0||||||
3675082|NCT02311309|3518894|B4|||body mass index||kg/m^2|Mean|27|27.0|Standard Deviation|6|6.0|||
3675083|NCT02311309|3518895|B3|||body mass index||kg/m^2|Mean|26|26.0|Standard Deviation|6|6.0|||
3675084|NCT02311309|3518896|B2|||body mass index||kg/m^2|Mean|27|27.0|Standard Deviation|6|6.0|||
3675085|NCT02311309|3518897|B1|||body mass index||kg/m^2|Mean|28|28.0|Standard Deviation|6|6.0|||
3675086|NCT02311309|3518894|B4|ASA Class 4||ASA class|ASA class reported in number of patients in a 4 class scale as defined by the American Society of anesthesiologists ASA 1 : otherwise healthy patient ASA 2 : A patient with mild systemic disease ASA 3 : A patient with severe systemic disease ASA 4 : A patient with severe systemic disease that is a constant threat to life|participants|Number|6|6.0||||||
3675087|NCT02311309|3518895|B3|ASA Class 4||ASA class|ASA class reported in number of patients in a 4 class scale as defined by the American Society of anesthesiologists ASA 1 : otherwise healthy patient ASA 2 : A patient with mild systemic disease ASA 3 : A patient with severe systemic disease ASA 4 : A patient with severe systemic disease that is a constant threat to life|participants|Number|4|4.0||||||
3675088|NCT02311309|3518896|B2|ASA Class 4||ASA class|ASA class reported in number of patients in a 4 class scale as defined by the American Society of anesthesiologists ASA 1 : otherwise healthy patient ASA 2 : A patient with mild systemic disease ASA 3 : A patient with severe systemic disease ASA 4 : A patient with severe systemic disease that is a constant threat to life|participants|Number|1|1.0||||||
3675089|NCT02311309|3518897|B1|ASA Class 4||ASA class|ASA class reported in number of patients in a 4 class scale as defined by the American Society of anesthesiologists ASA 1 : otherwise healthy patient ASA 2 : A patient with mild systemic disease ASA 3 : A patient with severe systemic disease ASA 4 : A patient with severe systemic disease that is a constant threat to life|participants|Number|1|1.0||||||
3675090|NCT02311309|3518894|B4|ASA Class 3||ASA class|ASA class reported in number of patients in a 4 class scale as defined by the American Society of anesthesiologists ASA 1 : otherwise healthy patient ASA 2 : A patient with mild systemic disease ASA 3 : A patient with severe systemic disease ASA 4 : A patient with severe systemic disease that is a constant threat to life|participants|Number|314|314.0||||||
3675123|NCT02311153|3518910|B3||>=65 years|Age|Date of birth was collected from the medical record and confirmed at date of surgery.|Participants|Count of Participants|22|22.0||||||
3675124|NCT02311153|3518911|B2||>=65 years|Age|Date of birth was collected from the medical record and confirmed at date of surgery.|Participants|Count of Participants|4|4.0||||||
3675091|NCT02311309|3518895|B3|ASA Class 3||ASA class|ASA class reported in number of patients in a 4 class scale as defined by the American Society of anesthesiologists ASA 1 : otherwise healthy patient ASA 2 : A patient with mild systemic disease ASA 3 : A patient with severe systemic disease ASA 4 : A patient with severe systemic disease that is a constant threat to life|participants|Number|150|150.0||||||
3675092|NCT02311309|3518896|B2|ASA Class 3||ASA class|ASA class reported in number of patients in a 4 class scale as defined by the American Society of anesthesiologists ASA 1 : otherwise healthy patient ASA 2 : A patient with mild systemic disease ASA 3 : A patient with severe systemic disease ASA 4 : A patient with severe systemic disease that is a constant threat to life|participants|Number|14|14.0||||||
3675093|NCT02311309|3518897|B1|ASA Class 3||ASA class|ASA class reported in number of patients in a 4 class scale as defined by the American Society of anesthesiologists ASA 1 : otherwise healthy patient ASA 2 : A patient with mild systemic disease ASA 3 : A patient with severe systemic disease ASA 4 : A patient with severe systemic disease that is a constant threat to life|participants|Number|150|150.0||||||
3675094|NCT02311309|3518894|B4|ASA Class 2||ASA class|ASA class reported in number of patients in a 4 class scale as defined by the American Society of anesthesiologists ASA 1 : otherwise healthy patient ASA 2 : A patient with mild systemic disease ASA 3 : A patient with severe systemic disease ASA 4 : A patient with severe systemic disease that is a constant threat to life|participants|Number|749|749.0||||||
3675095|NCT02311309|3518895|B3|ASA Class 2||ASA class|ASA class reported in number of patients in a 4 class scale as defined by the American Society of anesthesiologists ASA 1 : otherwise healthy patient ASA 2 : A patient with mild systemic disease ASA 3 : A patient with severe systemic disease ASA 4 : A patient with severe systemic disease that is a constant threat to life|participants|Number|448|448.0||||||
3675096|NCT02311309|3518896|B2|ASA Class 2||ASA class|ASA class reported in number of patients in a 4 class scale as defined by the American Society of anesthesiologists ASA 1 : otherwise healthy patient ASA 2 : A patient with mild systemic disease ASA 3 : A patient with severe systemic disease ASA 4 : A patient with severe systemic disease that is a constant threat to life|participants|Number|18|18.0||||||
3675097|NCT02311309|3518897|B1|ASA Class 2||ASA class|ASA class reported in number of patients in a 4 class scale as defined by the American Society of anesthesiologists ASA 1 : otherwise healthy patient ASA 2 : A patient with mild systemic disease ASA 3 : A patient with severe systemic disease ASA 4 : A patient with severe systemic disease that is a constant threat to life|participants|Number|283|283.0||||||
3675098|NCT02311309|3518894|B4|ASA Class 1||ASA class|ASA class reported in number of patients in a 4 class scale as defined by the American Society of anesthesiologists ASA 1 : otherwise healthy patient ASA 2 : A patient with mild systemic disease ASA 3 : A patient with severe systemic disease ASA 4 : A patient with severe systemic disease that is a constant threat to life|participants|Number|370|370.0||||||
3675099|NCT02311309|3518895|B3|ASA Class 1||ASA class|ASA class reported in number of patients in a 4 class scale as defined by the American Society of anesthesiologists ASA 1 : otherwise healthy patient ASA 2 : A patient with mild systemic disease ASA 3 : A patient with severe systemic disease ASA 4 : A patient with severe systemic disease that is a constant threat to life|participants|Number|261|261.0||||||
3675100|NCT02311309|3518896|B2|ASA Class 1||ASA class|ASA class reported in number of patients in a 4 class scale as defined by the American Society of anesthesiologists ASA 1 : otherwise healthy patient ASA 2 : A patient with mild systemic disease ASA 3 : A patient with severe systemic disease ASA 4 : A patient with severe systemic disease that is a constant threat to life|participants|Number|2|2.0||||||
3675101|NCT02311309|3518897|B1|ASA Class 1||ASA class|ASA class reported in number of patients in a 4 class scale as defined by the American Society of anesthesiologists ASA 1 : otherwise healthy patient ASA 2 : A patient with mild systemic disease ASA 3 : A patient with severe systemic disease ASA 4 : A patient with severe systemic disease that is a constant threat to life|participants|Number|107|107.0||||||
3675102|NCT02311309|3518894|B4||Male|Sex: Female, Male||Participants|Count of Participants|761|761.0||||||
3675103|NCT02311309|3518895|B3||Male|Sex: Female, Male||Participants|Count of Participants|458|458.0||||||
3675104|NCT02311309|3518896|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3675105|NCT02311309|3518897|B1||Male|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
3675106|NCT02311309|3518894|B4||Female|Sex: Female, Male||Participants|Count of Participants|678|678.0||||||
3675107|NCT02311309|3518895|B3||Female|Sex: Female, Male||Participants|Count of Participants|405|405.0||||||
3675108|NCT02311309|3518896|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3675109|NCT02311309|3518897|B1||Female|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
3675110|NCT02311309|3518894|B4|||Age||years|Mean|56|56.0|Standard Deviation|18|18.0|||
3675111|NCT02311309|3518895|B3|||Age||years|Mean|53|53.0|Standard Deviation|19|19.0|||
3675112|NCT02311309|3518896|B2|||Age||years|Mean|66|66.0|Standard Deviation|16|16.0|||
3675113|NCT02311309|3518897|B1|||Age||years|Mean|59|59.0|Standard Deviation|17|17.0|||
3675114|NCT02311153|3518910|B3|United States||Region of Enrollment||participants|Number|102|102.0||||||
3675115|NCT02311153|3518911|B2|United States||Region of Enrollment||participants|Number|49|49.0||||||
3675116|NCT02311153|3518912|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
3675117|NCT02311153|3518910|B3||Male|Sex: Female, Male|Sex was recorded from the medical record, with in-person confirmation at clinic visit(s).|Participants|Count of Participants|48|48.0||||||
3675118|NCT02311153|3518911|B2||Male|Sex: Female, Male|Sex was recorded from the medical record, with in-person confirmation at clinic visit(s).|Participants|Count of Participants|20|20.0||||||
3675119|NCT02311153|3518912|B1||Male|Sex: Female, Male|Sex was recorded from the medical record, with in-person confirmation at clinic visit(s).|Participants|Count of Participants|28|28.0||||||
3675120|NCT02311153|3518910|B3||Female|Sex: Female, Male|Sex was recorded from the medical record, with in-person confirmation at clinic visit(s).|Participants|Count of Participants|54|54.0||||||
3675121|NCT02311153|3518911|B2||Female|Sex: Female, Male|Sex was recorded from the medical record, with in-person confirmation at clinic visit(s).|Participants|Count of Participants|29|29.0||||||
3675122|NCT02311153|3518912|B1||Female|Sex: Female, Male|Sex was recorded from the medical record, with in-person confirmation at clinic visit(s).|Participants|Count of Participants|25|25.0||||||
3675125|NCT02311153|3518912|B1||>=65 years|Age|Date of birth was collected from the medical record and confirmed at date of surgery.|Participants|Count of Participants|18|18.0||||||
3675126|NCT02311153|3518910|B3||Between 18 and 65 years|Age|Date of birth was collected from the medical record and confirmed at date of surgery.|Participants|Count of Participants|80|80.0||||||
3675127|NCT02311153|3518911|B2||Between 18 and 65 years|Age|Date of birth was collected from the medical record and confirmed at date of surgery.|Participants|Count of Participants|45|45.0||||||
3675128|NCT02311153|3518912|B1||Between 18 and 65 years|Age|Date of birth was collected from the medical record and confirmed at date of surgery.|Participants|Count of Participants|35|35.0||||||
3675129|NCT02311153|3518910|B3||<=18 years|Age|Date of birth was collected from the medical record and confirmed at date of surgery.|Participants|Count of Participants|0|0.0||||||
3675130|NCT02311153|3518911|B2||<=18 years|Age|Date of birth was collected from the medical record and confirmed at date of surgery.|Participants|Count of Participants|0|0.0||||||
3675131|NCT02311153|3518912|B1||<=18 years|Age|Date of birth was collected from the medical record and confirmed at date of surgery.|Participants|Count of Participants|0|0.0||||||
3675132|NCT02310789|3518929|B1|||Healthy Volunteers||Participants|Count of Participants|8|8.0||||||
3675133|NCT02310789|3518929|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3675134|NCT02310789|3518929|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675135|NCT02310789|3518929|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675136|NCT02310789|3518929|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3675137|NCT02310789|3518929|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675138|NCT02310789|3518929|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675139|NCT02310789|3518929|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675140|NCT02310789|3518929|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675141|NCT02310789|3518929|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675142|NCT02310789|3518929|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3675143|NCT02310789|3518929|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3675144|NCT02310789|3518929|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3675145|NCT02310789|3518929|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3675146|NCT02310789|3518929|B1|||Age||years|Median|46.5|46.5|Full Range|||20.0|75.0|
3675147|NCT02310789|3518929|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3675148|NCT02310789|3518929|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3675149|NCT02310789|3518929|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3675150|NCT02310776|3518934|B1|United States||Region of Enrollment||participants|Number|501|501.0||||||
3675151|NCT02310776|3518934|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3675152|NCT02310776|3518934|B1||Female|Sex: Female, Male||Participants|Count of Participants|501|501.0||||||
3675153|NCT02310776|3518934|B1||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
3675154|NCT02310776|3518934|B1||Between 18 and 65 years|Age||Participants|Count of Participants|461|461.0||||||
3675155|NCT02310776|3518934|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3675156|NCT02310750|3518938|B12||Male|Gender||Participants|Count of Participants|90|90.0||||||
3675157|NCT02310750|3518939|B11||Male|Gender||Participants|Count of Participants|11|11.0||||||
3675158|NCT02310750|3518940|B10||Male|Gender||Participants|Count of Participants|7|7.0||||||
3675159|NCT02310750|3518941|B9||Male|Gender||Participants|Count of Participants|12|12.0||||||
3675160|NCT02310750|3518942|B8||Male|Gender||Participants|Count of Participants|8|8.0||||||
3675161|NCT02310750|3518943|B7||Male|Gender||Participants|Count of Participants|12|12.0||||||
3675162|NCT02310750|3518944|B6||Male|Gender||Participants|Count of Participants|7|7.0||||||
3675163|NCT02310750|3518945|B5||Male|Gender||Participants|Count of Participants|8|8.0||||||
3675164|NCT02310750|3518946|B4||Male|Gender||Participants|Count of Participants|6|6.0||||||
3675165|NCT02310750|3518947|B3||Male|Gender||Participants|Count of Participants|6|6.0||||||
3675166|NCT02310750|3518948|B2||Male|Gender||Participants|Count of Participants|6|6.0||||||
3675167|NCT02310750|3518949|B1||Male|Gender||Participants|Count of Participants|7|7.0||||||
3675168|NCT02310750|3518938|B12||Female|Gender||Participants|Count of Participants|6|6.0||||||
3675169|NCT02310750|3518939|B11||Female|Gender||Participants|Count of Participants|1|1.0||||||
3675170|NCT02310750|3518940|B10||Female|Gender||Participants|Count of Participants|0|0.0||||||
3675171|NCT02310750|3518941|B9||Female|Gender||Participants|Count of Participants|2|2.0||||||
3675172|NCT02310750|3518942|B8||Female|Gender||Participants|Count of Participants|1|1.0||||||
3675173|NCT02310750|3518943|B7||Female|Gender||Participants|Count of Participants|1|1.0||||||
3675174|NCT02310750|3518944|B6||Female|Gender||Participants|Count of Participants|1|1.0||||||
3675175|NCT02310750|3518945|B5||Female|Gender||Participants|Count of Participants|0|0.0||||||
3675176|NCT02310750|3518946|B4||Female|Gender||Participants|Count of Participants|0|0.0||||||
3675177|NCT02310750|3518947|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
3675178|NCT02310750|3518948|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
3675179|NCT02310750|3518949|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3675180|NCT02310750|3518938|B12|45-64 Years||Age, Customized||participants|Number|41|41.0||||||
3675181|NCT02310750|3518939|B11|45-64 Years||Age, Customized||participants|Number|7|7.0||||||
3675182|NCT02310750|3518940|B10|45-64 Years||Age, Customized||participants|Number|2|2.0||||||
3675183|NCT02310750|3518941|B9|45-64 Years||Age, Customized||participants|Number|8|8.0||||||
3675184|NCT02310750|3518942|B8|45-64 Years||Age, Customized||participants|Number|3|3.0||||||
3675185|NCT02310750|3518943|B7|45-64 Years||Age, Customized||participants|Number|2|2.0||||||
3675186|NCT02310750|3518944|B6|45-64 Years||Age, Customized||participants|Number|2|2.0||||||
3675187|NCT02310750|3518945|B5|45-64 Years||Age, Customized||participants|Number|3|3.0||||||
3675188|NCT02310750|3518946|B4|45-64 Years||Age, Customized||participants|Number|2|2.0||||||
3675189|NCT02310750|3518947|B3|45-64 Years||Age, Customized||participants|Number|5|5.0||||||
3675190|NCT02310750|3518948|B2|45-64 Years||Age, Customized||participants|Number|4|4.0||||||
3675191|NCT02310750|3518949|B1|45-64 Years||Age, Customized||participants|Number|3|3.0||||||
3675192|NCT02310750|3518938|B12|18-44 Years||Age, Customized||participants|Number|55|55.0||||||
3675193|NCT02310750|3518939|B11|18-44 Years||Age, Customized||participants|Number|5|5.0||||||
3675194|NCT02310750|3518940|B10|18-44 Years||Age, Customized||participants|Number|5|5.0||||||
3675195|NCT02310750|3518941|B9|18-44 Years||Age, Customized||participants|Number|6|6.0||||||
3675196|NCT02310750|3518942|B8|18-44 Years||Age, Customized||participants|Number|6|6.0||||||
3675197|NCT02310750|3518943|B7|18-44 Years||Age, Customized||participants|Number|11|11.0||||||
3675198|NCT02310750|3518944|B6|18-44 Years||Age, Customized||participants|Number|6|6.0||||||
3675199|NCT02310750|3518945|B5|18-44 Years||Age, Customized||participants|Number|5|5.0||||||
3675200|NCT02310750|3518946|B4|18-44 Years||Age, Customized||participants|Number|4|4.0||||||
3675201|NCT02310750|3518947|B3|18-44 Years||Age, Customized||participants|Number|1|1.0||||||
3675202|NCT02310750|3518948|B2|18-44 Years||Age, Customized||participants|Number|2|2.0||||||
3675203|NCT02310750|3518949|B1|18-44 Years||Age, Customized||participants|Number|4|4.0||||||
3675204|NCT02310646|3519403|B3||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3675205|NCT02310646|3519404|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3675206|NCT02310646|3519405|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3675207|NCT02310646|3519403|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3675208|NCT02310646|3519404|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3675209|NCT02310646|3519405|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3675210|NCT02310646|3519403|B3|||Age||years|Mean|51.9|51.9|Standard Deviation|14.1|14.1|||
3675211|NCT02310646|3519404|B2|||Age||years|Mean|51.6|51.6|Standard Deviation|14.2|14.2|||
3675212|NCT02310646|3519405|B1|||Age||years|Mean|52.1|52.1|Standard Deviation|14.0|14.0|||
3675213|NCT02310646|3519403|B3||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
3675214|NCT02310646|3519404|B2||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3675215|NCT02310646|3519405|B1||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
3675216|NCT02310646|3519403|B3||Between 18 and 65 years|Age||Participants|Count of Participants|162|162.0||||||
3675217|NCT02310646|3519404|B2||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
3675218|NCT02310646|3519405|B1||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
3675219|NCT02310646|3519403|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3675220|NCT02310646|3519404|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3675221|NCT02310646|3519405|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3675222|NCT02310581|3519430|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3675223|NCT02310581|3519431|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3675224|NCT02310581|3519432|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3675225|NCT02310581|3519433|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3675226|NCT02310581|3519434|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3675227|NCT02310581|3519430|B5||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3675228|NCT02310581|3519431|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3675229|NCT02310581|3519432|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3675230|NCT02310581|3519433|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3675231|NCT02310581|3519434|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3675232|NCT02310581|3519430|B5|||Age||years|Mean|43.2|43.2|Full Range|||19.0|65.0|
3675233|NCT02310581|3519431|B4|||Age||years|Mean|40.5|40.5|Full Range|||19.0|61.0|
3675234|NCT02310581|3519432|B3|||Age||years|Mean|40.8|40.8|Full Range|||28.0|61.0|
3675235|NCT02310581|3519433|B2|||Age||years|Mean|43.5|43.5|Full Range|||26.0|65.0|
3675236|NCT02310581|3519434|B1|||Age||years|Mean|48.0|48.0|Full Range|||31.0|65.0|
3675237|NCT02310568|3519471|B6||Male|Gender||Participants|Count of Participants|23|23.0||||||
3675238|NCT02310568|3519472|B5||Male|Gender||Participants|Count of Participants|3|3.0||||||
3675239|NCT02310568|3519473|B4||Male|Gender||Participants|Count of Participants|5|5.0||||||
3675240|NCT02310568|3519474|B3||Male|Gender||Participants|Count of Participants|5|5.0||||||
3675241|NCT02310568|3519475|B2||Male|Gender||Participants|Count of Participants|6|6.0||||||
3675242|NCT02310568|3519476|B1||Male|Gender||Participants|Count of Participants|4|4.0||||||
3675243|NCT02310568|3519471|B6||Female|Gender||Participants|Count of Participants|67|67.0||||||
3675244|NCT02310568|3519472|B5||Female|Gender||Participants|Count of Participants|18|18.0||||||
3675245|NCT02310568|3519473|B4||Female|Gender||Participants|Count of Participants|19|19.0||||||
3675246|NCT02310568|3519474|B3||Female|Gender||Participants|Count of Participants|10|10.0||||||
3675247|NCT02310568|3519475|B2||Female|Gender||Participants|Count of Participants|9|9.0||||||
3675248|NCT02310568|3519476|B1||Female|Gender||Participants|Count of Participants|11|11.0||||||
3675249|NCT02310568|3519471|B6|||Age||years|Mean|41.2|41.2|Standard Deviation|13.7|13.7|||
3675250|NCT02310568|3519472|B5|||Age||years|Mean|42|42.0|Standard Deviation|12|12.0|||
3675251|NCT02310568|3519473|B4|||Age||years|Mean|38.8|38.8|Standard Deviation|14|14.0|||
3675252|NCT02310568|3519474|B3|||Age||years|Mean|42.7|42.7|Standard Deviation|13.8|13.8|||
3675253|NCT02310568|3519475|B2|||Age||years|Mean|47.1|47.1|Standard Deviation|15.6|15.6|||
3675254|NCT02310568|3519476|B1|||Age||years|Mean|36.5|36.5|Standard Deviation|12.4|12.4|||
3675255|NCT02310126|3519558|B3|United States||Region of Enrollment||participants|Number|191|191.0||||||
3675256|NCT02310126|3519559|B2|United States||Region of Enrollment||participants|Number|97|97.0||||||
3675257|NCT02310126|3519560|B1|United States||Region of Enrollment||participants|Number|94|94.0||||||
3675258|NCT02310126|3519558|B3|White||Race/Ethnicity, Customized||participants|Number|176|176.0||||||
3675259|NCT02310126|3519559|B2|White||Race/Ethnicity, Customized||participants|Number|87|87.0||||||
3675260|NCT02310126|3519560|B1|White||Race/Ethnicity, Customized||participants|Number|89|89.0||||||
3675261|NCT02310126|3519558|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3675262|NCT02310126|3519559|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3675263|NCT02310126|3519560|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3675264|NCT02310126|3519558|B3|Black of African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3675265|NCT02310126|3519559|B2|Black of African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3675266|NCT02310126|3519560|B1|Black of African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3675267|NCT02310126|3519558|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3675268|NCT02310126|3519559|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3675269|NCT02310126|3519560|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3675270|NCT02310126|3519558|B3|American Indian Or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3675271|NCT02310126|3519559|B2|American Indian Or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3675272|NCT02310126|3519560|B1|American Indian Or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3675273|NCT02310126|3519558|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3675274|NCT02310126|3519559|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3675275|NCT02310126|3519560|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3675276|NCT02310126|3519558|B3||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3675277|NCT02310126|3519559|B2||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3675278|NCT02310126|3519560|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3675279|NCT02310126|3519558|B3|Myopes, N=56, N=64, N=120||Age||years|Mean|51.0|51.0|Standard Deviation|7.12|7.12|||
3675280|NCT02310126|3519559|B2|Myopes, N=56, N=64, N=120||Age||years|Mean|51.1|51.1|Standard Deviation|7.24|7.24|||
3675281|NCT02310126|3519560|B1|Myopes, N=56, N=64, N=120||Age||years|Mean|50.8|50.8|Standard Deviation|7.03|7.03|||
3675282|NCT02310126|3519558|B3|Hyperopes, N=38, N=33, N=71||Age||years|Mean|56.2|56.2|Standard Deviation|7.06|7.06|||
3675283|NCT02310126|3519559|B2|Hyperopes, N=38, N=33, N=71||Age||years|Mean|57.3|57.3|Standard Deviation|6.45|6.45|||
3675284|NCT02310126|3519560|B1|Hyperopes, N=38, N=33, N=71||Age||years|Mean|55.2|55.2|Standard Deviation|7.49|7.49|||
3675285|NCT02309723|3519567|B4|||Beta Amyloid imaging findings||participants|Number|315|315.0||||||
3675286|NCT02309723|3519568|B3|||Beta Amyloid imaging findings||participants|Number|104|104.0||||||
3675287|NCT02309723|3519569|B2|||Beta Amyloid imaging findings||participants|Number|105|105.0||||||
3675288|NCT02309723|3519570|B1|||Beta Amyloid imaging findings||participants|Number|106|106.0||||||
3675289|NCT02309723|3519567|B4||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
3675290|NCT02309723|3519568|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3675291|NCT02309723|3519569|B2||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3675292|NCT02309723|3519570|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3675293|NCT02309723|3519567|B4||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3675294|NCT02309723|3519568|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3675295|NCT02309723|3519569|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3675296|NCT02309723|3519570|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3675297|NCT02309723|3519567|B4|||Age|Baseline characteristics are reported by subject.|years|Mean|51.8|51.8|Standard Deviation|8.2|8.2|||
3675298|NCT02309723|3519568|B3|||Age|Baseline characteristics are reported by subject.|years|Mean|52.7|52.7|Standard Deviation|8.0|8.0|||
3675299|NCT02309723|3519569|B2|||Age|Baseline characteristics are reported by subject.|years|Mean|51.5|51.5|Standard Deviation|7.8|7.8|||
3675300|NCT02309723|3519570|B1|||Age|Baseline characteristics are reported by subject.|years|Mean|51.3|51.3|Standard Deviation|8.8|8.8|||
3675301|NCT02309411|3519586|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3675302|NCT02309411|3519587|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675303|NCT02309411|3519588|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3675304|NCT02309411|3519589|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3675305|NCT02309411|3519586|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3675306|NCT02309411|3519587|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675307|NCT02309411|3519588|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3675308|NCT02309411|3519589|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675309|NCT02309411|3519586|B4||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3675310|NCT02309411|3519587|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3675311|NCT02309411|3519588|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3675312|NCT02309411|3519589|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3675313|NCT02309411|3519586|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3675314|NCT02309411|3519587|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675315|NCT02309411|3519588|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3675316|NCT02309411|3519589|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3675317|NCT02309411|3519586|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675318|NCT02309411|3519587|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675319|NCT02309411|3519588|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675320|NCT02309411|3519589|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675321|NCT02309411|3519586|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3675322|NCT02309411|3519587|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675323|NCT02309411|3519588|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3675324|NCT02309411|3519589|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675325|NCT02309411|3519586|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675326|NCT02309411|3519587|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675327|NCT02309411|3519588|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675328|NCT02309411|3519589|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675329|NCT02309411|3519586|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3675330|NCT02309411|3519587|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3675331|NCT02309411|3519588|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3675332|NCT02309411|3519589|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3675333|NCT02309411|3519586|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3675334|NCT02309411|3519587|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3675335|NCT02309411|3519588|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3675336|NCT02309411|3519589|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3675337|NCT02309411|3519586|B4|||Age||years|Mean|2.94|2.94|Standard Deviation|1.45|1.45|||
3675338|NCT02309411|3519587|B3|||Age||years|Mean|3.67|3.67|Standard Deviation|0.82|0.82|||
3675339|NCT02309411|3519588|B2|||Age||years|Mean|1.26|1.26|Standard Deviation|0.45|0.45|||
3675340|NCT02309411|3519589|B1|||Age||years|Mean|3.77|3.77|Standard Deviation|1.03|1.03|||
3675341|NCT02309294|3519610|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3675342|NCT02309294|3519610|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3675343|NCT02309294|3519610|B1|20-72||Age, Customized||participants|Number|41|41.0||||||
3675344|NCT02309112|3519614|B4|Post-surgical Intervention||Types of Conventional Treatment|Participants were asked to self-report any and all aspects of current conventional treatments for their cancer diagnosis; multiple treatments were recorded (i.e. radiotherapy, chemotherapy, hormone therapy or active surveillance)|participants|Number|3|3.0||||||
3675345|NCT02309112|3519615|B3|Post-surgical Intervention||Types of Conventional Treatment|Participants were asked to self-report any and all aspects of current conventional treatments for their cancer diagnosis; multiple treatments were recorded (i.e. radiotherapy, chemotherapy, hormone therapy or active surveillance)|participants|Number|2|2.0||||||
3675346|NCT02309112|3519616|B2|Post-surgical Intervention||Types of Conventional Treatment|Participants were asked to self-report any and all aspects of current conventional treatments for their cancer diagnosis; multiple treatments were recorded (i.e. radiotherapy, chemotherapy, hormone therapy or active surveillance)|participants|Number|1|1.0||||||
3675347|NCT02309112|3519617|B1|Post-surgical Intervention||Types of Conventional Treatment|Participants were asked to self-report any and all aspects of current conventional treatments for their cancer diagnosis; multiple treatments were recorded (i.e. radiotherapy, chemotherapy, hormone therapy or active surveillance)|participants|Number|0|0.0||||||
3675348|NCT02309112|3519614|B4|Active Surveillance||Types of Conventional Treatment|Participants were asked to self-report any and all aspects of current conventional treatments for their cancer diagnosis; multiple treatments were recorded (i.e. radiotherapy, chemotherapy, hormone therapy or active surveillance)|participants|Number|5|5.0||||||
3675349|NCT02309112|3519615|B3|Active Surveillance||Types of Conventional Treatment|Participants were asked to self-report any and all aspects of current conventional treatments for their cancer diagnosis; multiple treatments were recorded (i.e. radiotherapy, chemotherapy, hormone therapy or active surveillance)|participants|Number|2|2.0||||||
3675350|NCT02309112|3519616|B2|Active Surveillance||Types of Conventional Treatment|Participants were asked to self-report any and all aspects of current conventional treatments for their cancer diagnosis; multiple treatments were recorded (i.e. radiotherapy, chemotherapy, hormone therapy or active surveillance)|participants|Number|2|2.0||||||
3675351|NCT02309112|3519617|B1|Active Surveillance||Types of Conventional Treatment|Participants were asked to self-report any and all aspects of current conventional treatments for their cancer diagnosis; multiple treatments were recorded (i.e. radiotherapy, chemotherapy, hormone therapy or active surveillance)|participants|Number|1|1.0||||||
3675352|NCT02309112|3519614|B4|Hormone Therapy||Types of Conventional Treatment|Participants were asked to self-report any and all aspects of current conventional treatments for their cancer diagnosis; multiple treatments were recorded (i.e. radiotherapy, chemotherapy, hormone therapy or active surveillance)|participants|Number|5|5.0||||||
3675353|NCT02309112|3519615|B3|Hormone Therapy||Types of Conventional Treatment|Participants were asked to self-report any and all aspects of current conventional treatments for their cancer diagnosis; multiple treatments were recorded (i.e. radiotherapy, chemotherapy, hormone therapy or active surveillance)|participants|Number|1|1.0||||||
3675354|NCT02309112|3519616|B2|Hormone Therapy||Types of Conventional Treatment|Participants were asked to self-report any and all aspects of current conventional treatments for their cancer diagnosis; multiple treatments were recorded (i.e. radiotherapy, chemotherapy, hormone therapy or active surveillance)|participants|Number|2|2.0||||||
3675355|NCT02309112|3519617|B1|Hormone Therapy||Types of Conventional Treatment|Participants were asked to self-report any and all aspects of current conventional treatments for their cancer diagnosis; multiple treatments were recorded (i.e. radiotherapy, chemotherapy, hormone therapy or active surveillance)|participants|Number|2|2.0||||||
3675356|NCT02309112|3519614|B4|Radiotherapy||Types of Conventional Treatment|Participants were asked to self-report any and all aspects of current conventional treatments for their cancer diagnosis; multiple treatments were recorded (i.e. radiotherapy, chemotherapy, hormone therapy or active surveillance)|participants|Number|8|8.0||||||
3675357|NCT02309112|3519615|B3|Radiotherapy||Types of Conventional Treatment|Participants were asked to self-report any and all aspects of current conventional treatments for their cancer diagnosis; multiple treatments were recorded (i.e. radiotherapy, chemotherapy, hormone therapy or active surveillance)|participants|Number|2|2.0||||||
3675358|NCT02309112|3519616|B2|Radiotherapy||Types of Conventional Treatment|Participants were asked to self-report any and all aspects of current conventional treatments for their cancer diagnosis; multiple treatments were recorded (i.e. radiotherapy, chemotherapy, hormone therapy or active surveillance)|participants|Number|3|3.0||||||
3675359|NCT02309112|3519617|B1|Radiotherapy||Types of Conventional Treatment|Participants were asked to self-report any and all aspects of current conventional treatments for their cancer diagnosis; multiple treatments were recorded (i.e. radiotherapy, chemotherapy, hormone therapy or active surveillance)|participants|Number|3|3.0||||||
3675360|NCT02309112|3519614|B4|Chemotherapy||Types of Conventional Treatment|Participants were asked to self-report any and all aspects of current conventional treatments for their cancer diagnosis; multiple treatments were recorded (i.e. radiotherapy, chemotherapy, hormone therapy or active surveillance)|participants|Number|7|7.0||||||
3675361|NCT02309112|3519615|B3|Chemotherapy||Types of Conventional Treatment|Participants were asked to self-report any and all aspects of current conventional treatments for their cancer diagnosis; multiple treatments were recorded (i.e. radiotherapy, chemotherapy, hormone therapy or active surveillance)|participants|Number|2|2.0||||||
3675362|NCT02309112|3519616|B2|Chemotherapy||Types of Conventional Treatment|Participants were asked to self-report any and all aspects of current conventional treatments for their cancer diagnosis; multiple treatments were recorded (i.e. radiotherapy, chemotherapy, hormone therapy or active surveillance)|participants|Number|2|2.0||||||
3675363|NCT02309112|3519617|B1|Chemotherapy||Types of Conventional Treatment|Participants were asked to self-report any and all aspects of current conventional treatments for their cancer diagnosis; multiple treatments were recorded (i.e. radiotherapy, chemotherapy, hormone therapy or active surveillance)|participants|Number|3|3.0||||||
3675364|NCT02309112|3519614|B4|not reported||Stage of Cancer Diagnosis||participants|Number|2|2.0||||||
3675365|NCT02309112|3519615|B3|not reported||Stage of Cancer Diagnosis||participants|Number|1|1.0||||||
3675366|NCT02309112|3519616|B2|not reported||Stage of Cancer Diagnosis||participants|Number|1|1.0||||||
3675367|NCT02309112|3519617|B1|not reported||Stage of Cancer Diagnosis||participants|Number|0|0.0||||||
3675368|NCT02309112|3519614|B4|Stage IV||Stage of Cancer Diagnosis||participants|Number|1|1.0||||||
3675369|NCT02309112|3519615|B3|Stage IV||Stage of Cancer Diagnosis||participants|Number|0|0.0||||||
3675370|NCT02309112|3519616|B2|Stage IV||Stage of Cancer Diagnosis||participants|Number|1|1.0||||||
3675371|NCT02309112|3519617|B1|Stage IV||Stage of Cancer Diagnosis||participants|Number|0|0.0||||||
3675372|NCT02309112|3519614|B4|Stage III||Stage of Cancer Diagnosis||participants|Number|5|5.0||||||
3675373|NCT02309112|3519615|B3|Stage III||Stage of Cancer Diagnosis||participants|Number|2|2.0||||||
3675374|NCT02309112|3519616|B2|Stage III||Stage of Cancer Diagnosis||participants|Number|2|2.0||||||
3675375|NCT02309112|3519617|B1|Stage III||Stage of Cancer Diagnosis||participants|Number|1|1.0||||||
3675376|NCT02309112|3519614|B4|Stage II||Stage of Cancer Diagnosis||participants|Number|3|3.0||||||
3675377|NCT02309112|3519615|B3|Stage II||Stage of Cancer Diagnosis||participants|Number|1|1.0||||||
3675378|NCT02309112|3519616|B2|Stage II||Stage of Cancer Diagnosis||participants|Number|0|0.0||||||
3675379|NCT02309112|3519617|B1|Stage II||Stage of Cancer Diagnosis||participants|Number|2|2.0||||||
3675380|NCT02309112|3519614|B4|Stage I||Stage of Cancer Diagnosis||participants|Number|4|4.0||||||
3675381|NCT02309112|3519615|B3|Stage I||Stage of Cancer Diagnosis||participants|Number|1|1.0||||||
3675382|NCT02309112|3519616|B2|Stage I||Stage of Cancer Diagnosis||participants|Number|1|1.0||||||
3675383|NCT02309112|3519617|B1|Stage I||Stage of Cancer Diagnosis||participants|Number|2|2.0||||||
3675384|NCT02309112|3519614|B4|Brain||Tumour Location||participants|Number|1|1.0||||||
3675385|NCT02309112|3519615|B3|Brain||Tumour Location||participants|Number|1|1.0||||||
3675386|NCT02309112|3519616|B2|Brain||Tumour Location||participants|Number|0|0.0||||||
3675387|NCT02309112|3519617|B1|Brain||Tumour Location||participants|Number|0|0.0||||||
3675388|NCT02309112|3519614|B4|Tongue||Tumour Location||participants|Number|1|1.0||||||
3675389|NCT02309112|3519615|B3|Tongue||Tumour Location||participants|Number|0|0.0||||||
3675390|NCT02309112|3519616|B2|Tongue||Tumour Location||participants|Number|0|0.0||||||
3675391|NCT02309112|3519617|B1|Tongue||Tumour Location||participants|Number|1|1.0||||||
3675392|NCT02309112|3519614|B4|Abdomen||Tumour Location||participants|Number|1|1.0||||||
3675393|NCT02309112|3519615|B3|Abdomen||Tumour Location||participants|Number|0|0.0||||||
3675394|NCT02309112|3519616|B2|Abdomen||Tumour Location||participants|Number|1|1.0||||||
3675395|NCT02309112|3519617|B1|Abdomen||Tumour Location||participants|Number|0|0.0||||||
3675396|NCT02309112|3519614|B4|Skin||Tumour Location||participants|Number|1|1.0||||||
3675397|NCT02309112|3519615|B3|Skin||Tumour Location||participants|Number|0|0.0||||||
3675398|NCT02309112|3519616|B2|Skin||Tumour Location||participants|Number|1|1.0||||||
3675399|NCT02309112|3519617|B1|Skin||Tumour Location||participants|Number|0|0.0||||||
3675400|NCT02309112|3519614|B4|Blood||Tumour Location||participants|Number|1|1.0||||||
3675401|NCT02309112|3519615|B3|Blood||Tumour Location||participants|Number|1|1.0||||||
3675402|NCT02309112|3519616|B2|Blood||Tumour Location||participants|Number|0|0.0||||||
3675403|NCT02309112|3519617|B1|Blood||Tumour Location||participants|Number|0|0.0||||||
3675404|NCT02309112|3519614|B4|Colorectal||Tumour Location||participants|Number|2|2.0||||||
3675405|NCT02309112|3519615|B3|Colorectal||Tumour Location||participants|Number|0|0.0||||||
3675406|NCT02309112|3519616|B2|Colorectal||Tumour Location||participants|Number|1|1.0||||||
3675407|NCT02309112|3519617|B1|Colorectal||Tumour Location||participants|Number|1|1.0||||||
3675408|NCT02309112|3519614|B4|Prostate||Tumour Location||participants|Number|2|2.0||||||
3675409|NCT02309112|3519615|B3|Prostate||Tumour Location||participants|Number|1|1.0||||||
3675410|NCT02309112|3519616|B2|Prostate||Tumour Location||participants|Number|1|1.0||||||
3675411|NCT02309112|3519617|B1|Prostate||Tumour Location||participants|Number|0|0.0||||||
3675412|NCT02309112|3519614|B4|Breast||Tumour Location||participants|Number|6|6.0||||||
3675413|NCT02309112|3519615|B3|Breast||Tumour Location||participants|Number|2|2.0||||||
3675414|NCT02309112|3519616|B2|Breast||Tumour Location||participants|Number|1|1.0||||||
3675415|NCT02309112|3519617|B1|Breast||Tumour Location||participants|Number|3|3.0||||||
3675416|NCT02309112|3519614|B4|Canada||Region of Enrollment||participants|Number|15|15.0||||||
3675417|NCT02309112|3519615|B3|Canada||Region of Enrollment||participants|Number|5|5.0||||||
3675418|NCT02309112|3519616|B2|Canada||Region of Enrollment||participants|Number|5|5.0||||||
3675419|NCT02309112|3519617|B1|Canada||Region of Enrollment||participants|Number|5|5.0||||||
3675420|NCT02309112|3519614|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3675421|NCT02309112|3519615|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3675422|NCT02309112|3519616|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3675423|NCT02309112|3519617|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3675424|NCT02309112|3519614|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3675425|NCT02309112|3519615|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3675426|NCT02309112|3519616|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3675427|NCT02309112|3519617|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3675428|NCT02309112|3519614|B4|||Age||years|Mean|51.3|51.3|Full Range|||33.0|72.0|
3675429|NCT02309112|3519615|B3|||Age||years|Mean|45|45.0|Full Range|||33.0|57.0|
3675430|NCT02309112|3519616|B2|||Age||years|Mean|57.2|57.2|Full Range|||43.0|72.0|
3675431|NCT02309112|3519617|B1|||Age||years|Mean|51.6|51.6|Full Range|||41.0|66.0|
3675432|NCT02309099|3519640|B3|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3675433|NCT02309099|3519641|B2|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3675434|NCT02309099|3519642|B1|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3675435|NCT02309099|3519640|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3675436|NCT02309099|3519640|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3675437|NCT02309099|3519641|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3675438|NCT02309099|3519642|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3675439|NCT02309099|3519640|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3675440|NCT02309099|3519641|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3675441|NCT02309099|3519642|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3675442|NCT02309099|3519640|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3675443|NCT02309099|3519641|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3675444|NCT02309099|3519642|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3675445|NCT02309099|3519640|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3675446|NCT02309099|3519641|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3675447|NCT02309099|3519642|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3675448|NCT02309099|3519640|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3675449|NCT02309099|3519641|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3675450|NCT02309099|3519642|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3675451|NCT02308787|3519689|B1|Polycythaemia vera||Diagnosis||pariticpants|Number|1|1.0||||||
3675452|NCT02308787|3519689|B1|Myelodysplastic/myeloproliferative neoplasm||Diagnosis||pariticpants|Number|1|1.0||||||
3675453|NCT02308787|3519689|B1|Chronic myeloid leukaemia||Diagnosis||pariticpants|Number|1|1.0||||||
3675454|NCT02308787|3519689|B1|Essential thrombocythaemia||Diagnosis||pariticpants|Number|9|9.0||||||
3675455|NCT02308787|3519689|B1|||Total Blood Volume|Estimated by Nadler’s formula for total blood volume of a human based on gender, height, and weight.|Liters|Mean|4.0|4.0|Standard Deviation|0.7|0.7|||
3675456|NCT02308787|3519689|B1|||Height||cm|Mean|163.9|163.9|Standard Deviation|9.2|9.2|||
3675457|NCT02308787|3519689|B1|||Weight||kg|Mean|63.6|63.6|Standard Deviation|13.4|13.4|||
3675458|NCT02308787|3519689|B1|Hungary||Region of Enrollment||participants|Number|9|9.0||||||
3675459|NCT02308787|3519689|B1|Denmark||Region of Enrollment||participants|Number|3|3.0||||||
3675460|NCT02308787|3519689|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3675461|NCT02308787|3519689|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3675462|NCT02308787|3519689|B1|Age (years)||Age, Customized||years|Mean|64.3|64.3|Standard Deviation|13|13.0|||
3675463|NCT02308748|3519704|B1|||QTc (Fridericia's heart rate corrected QT interval)||ms|Mean|397.8|397.8|Standard Deviation|14.2|14.2|||
3675464|NCT02308748|3519704|B1|||Tpeak-Tend interval||ms|Mean|81.9|81.9|Standard Deviation|6.4|6.4|||
3675465|NCT02308748|3519704|B1|||J-Tpeakc (heart rate corrected J-Tpeak interval)||ms|Mean|229.5|229.5|Standard Deviation|19.0|19.0|||
3675466|NCT02308748|3519704|B1|||QRS duration||ms|Mean|86.7|86.7|Standard Deviation|8.5|8.5|||
3675467|NCT02308748|3519704|B1|||PR interval||ms|Mean|160.8|160.8|Standard Deviation|19.1|19.1|||
3675468|NCT02308748|3519704|B1|||Heart rate||beats per minute (bpm)|Mean|61.3|61.3|Standard Deviation|6.7|6.7|||
3675469|NCT02308748|3519704|B1|||Diastolic blood pressure||mm Hg|Mean|60.2|60.2|Standard Deviation|3.5|3.5|||
3675470|NCT02308748|3519704|B1|||Systolic blood pressure||mm Hg|Mean|109.5|109.5|Standard Deviation|5.5|5.5|||
3675471|NCT02308748|3519704|B1|||Weight||kg|Mean|69.9|69.9|Standard Deviation|9.0|9.0|||
3675472|NCT02308748|3519704|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3675473|NCT02308748|3519704|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675474|NCT02308748|3519704|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675475|NCT02308748|3519704|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3675476|NCT02308748|3519704|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3675477|NCT02308748|3519704|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675478|NCT02308748|3519704|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3675479|NCT02308748|3519704|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3675480|NCT02308748|3519704|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675481|NCT02308748|3519704|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3675482|NCT02308748|3519704|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3675483|NCT02308748|3519704|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3675484|NCT02308748|3519704|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3675485|NCT02308748|3519704|B1|||Age||years|Mean|26.1|26.1|Standard Deviation|4.9|4.9|||
3675486|NCT02308475|3519725|B1|||Weight||lbs|Mean|248.5|248.5|Full Range|||241.0|256.0|
3675487|NCT02308475|3519725|B1|||Height||inches|Mean|67|67.0|Full Range|||65.0|69.0|
3675488|NCT02308475|3519725|B1|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3675489|NCT02308475|3519725|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675490|NCT02308475|3519725|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675491|NCT02308475|3519725|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675492|NCT02308475|3519725|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3675493|NCT02308475|3519725|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675494|NCT02308475|3519725|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675495|NCT02308475|3519725|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675496|NCT02308475|3519725|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3675497|NCT02308475|3519725|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3675498|NCT02308475|3519725|B1|||Age||years|Mean|34.5|34.5|Full Range|||33.0|36.0|
3675499|NCT02308371|3519731|B3|Cerebral Edema||Diagnosis||participants|Number|4|4.0||||||
3675500|NCT02308371|3519732|B2|Cerebral Edema||Diagnosis||participants|Number|2|2.0||||||
3675501|NCT02308371|3519733|B1|Cerebral Edema||Diagnosis||participants|Number|2|2.0||||||
3675502|NCT02308371|3519731|B3|Congenital Cardiac Disease||Diagnosis||participants|Number|48|48.0||||||
3675503|NCT02308371|3519732|B2|Congenital Cardiac Disease||Diagnosis||participants|Number|24|24.0||||||
3675504|NCT02308371|3519733|B1|Congenital Cardiac Disease||Diagnosis||participants|Number|24|24.0||||||
3675505|NCT02308371|3519731|B3|Congenital Diaphragmatic Hernia||Diagnosis||participants|Number|4|4.0||||||
3675506|NCT02308371|3519732|B2|Congenital Diaphragmatic Hernia||Diagnosis||participants|Number|2|2.0||||||
3675507|NCT02308371|3519733|B1|Congenital Diaphragmatic Hernia||Diagnosis||participants|Number|2|2.0||||||
3675508|NCT02308371|3519731|B3|Craniotomy||Diagnosis||participants|Number|2|2.0||||||
3675509|NCT02308371|3519732|B2|Craniotomy||Diagnosis||participants|Number|1|1.0||||||
3675510|NCT02308371|3519733|B1|Craniotomy||Diagnosis||participants|Number|1|1.0||||||
3675511|NCT02308371|3519731|B3|Spinal Fusion||Diagnosis||participants|Number|8|8.0||||||
3675512|NCT02308371|3519732|B2|Spinal Fusion||Diagnosis||participants|Number|4|4.0||||||
3675513|NCT02308371|3519733|B1|Spinal Fusion||Diagnosis||participants|Number|4|4.0||||||
3675514|NCT02308371|3519731|B3|Neuroblastoma||Diagnosis||participants|Number|2|2.0||||||
3675515|NCT02308371|3519732|B2|Neuroblastoma||Diagnosis||participants|Number|1|1.0||||||
3675516|NCT02308371|3519733|B1|Neuroblastoma||Diagnosis||participants|Number|1|1.0||||||
3675517|NCT02308371|3519731|B3|Persistent Pulmonary Hypertension of the Newborn||Diagnosis||participants|Number|2|2.0||||||
3675518|NCT02308371|3519732|B2|Persistent Pulmonary Hypertension of the Newborn||Diagnosis||participants|Number|1|1.0||||||
3675519|NCT02308371|3519733|B1|Persistent Pulmonary Hypertension of the Newborn||Diagnosis||participants|Number|1|1.0||||||
3675520|NCT02308371|3519731|B3|Diabetic Ketoacidosis||Diagnosis||participants|Number|2|2.0||||||
3675521|NCT02308371|3519732|B2|Diabetic Ketoacidosis||Diagnosis||participants|Number|1|1.0||||||
3675522|NCT02308371|3519733|B1|Diabetic Ketoacidosis||Diagnosis||participants|Number|1|1.0||||||
3675523|NCT02308371|3519731|B3|Sepsis||Diagnosis||participants|Number|14|14.0||||||
3675524|NCT02308371|3519732|B2|Sepsis||Diagnosis||participants|Number|7|7.0||||||
3675525|NCT02308371|3519733|B1|Sepsis||Diagnosis||participants|Number|7|7.0||||||
3675526|NCT02308371|3519731|B3|Primary Respiratory Failure||Diagnosis||participants|Number|14|14.0||||||
3675527|NCT02308371|3519732|B2|Primary Respiratory Failure||Diagnosis||participants|Number|7|7.0||||||
3675528|NCT02308371|3519733|B1|Primary Respiratory Failure||Diagnosis||participants|Number|7|7.0||||||
3675529|NCT02308371|3519731|B3||Male|Gender||Participants|Count of Participants|54|54.0||||||
3675530|NCT02308371|3519732|B2||Male|Gender||Participants|Count of Participants|23|23.0||||||
3675531|NCT02308371|3519733|B1||Male|Gender||Participants|Count of Participants|31|31.0||||||
3675532|NCT02308371|3519731|B3||Female|Gender||Participants|Count of Participants|46|46.0||||||
3675533|NCT02308371|3519732|B2||Female|Gender||Participants|Count of Participants|27|27.0||||||
3675534|NCT02308371|3519733|B1||Female|Gender||Participants|Count of Participants|19|19.0||||||
3675535|NCT02308371|3519731|B3|||Age||years|Mean|4.121|4.121|Standard Deviation|5.738|5.738|||
3675536|NCT02308371|3519732|B2|||Age||years|Mean|4.144|4.144|Standard Deviation|5.828|5.828|||
3675537|NCT02308371|3519733|B1|||Age||years|Mean|4.099|4.099|Standard Deviation|5.765|5.765|||
3675538|NCT02308189|3519748|B3|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3675539|NCT02308189|3519749|B2|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3675540|NCT02308189|3519750|B1|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3675541|NCT02308189|3519748|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3675542|NCT02308189|3519749|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3675543|NCT02308189|3519750|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3675544|NCT02308189|3519748|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3675545|NCT02308189|3519749|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3675546|NCT02308189|3519750|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3675547|NCT02308189|3519748|B3|||Age||years|Mean|29.2|29.2|Standard Deviation|9.5|9.5|||
3675548|NCT02308189|3519749|B2|||Age||years|Mean|28.4|28.4|Standard Deviation|9.2|9.2|||
3675549|NCT02308189|3519750|B1|||Age||years|Mean|29.9|29.9|Standard Deviation|10.3|10.3|||
3675550|NCT02308189|3519748|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3675551|NCT02308189|3519749|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3675552|NCT02308189|3519750|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3675553|NCT02308189|3519748|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3675554|NCT02308189|3519749|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3675555|NCT02308189|3519750|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3675556|NCT02308189|3519748|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3675557|NCT02308189|3519749|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3675558|NCT02308189|3519750|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3675559|NCT02308124|3519761|B4|||Orthostatic diastolic blood pressure change|Maximum decrements in DBP within 3 minutes of standing were recorded.|mmHg|Mean|-14.1|-14.1|Standard Deviation|9.0|9.0|||
3675560|NCT02308124|3519762|B3|||Orthostatic diastolic blood pressure change|Maximum decrements in DBP within 3 minutes of standing were recorded.|mmHg|Mean|-13.4|-13.4|Standard Deviation|8.2|8.2|||
3675561|NCT02308124|3519763|B2|||Orthostatic diastolic blood pressure change|Maximum decrements in DBP within 3 minutes of standing were recorded.|mmHg|Mean|-15.5|-15.5|Standard Deviation|9.9|9.9|||
3675562|NCT02308124|3519764|B1|||Orthostatic diastolic blood pressure change|Maximum decrements in DBP within 3 minutes of standing were recorded.|mmHg|Mean|-13.4|-13.4|Standard Deviation|9.0|9.0|||
3675563|NCT02308124|3519761|B4|||Orthostatic systolic blood pressure change|Maximum decrements in SBP within 3 minutes of standing were recorded.|mmHg|Mean|-23.5|-23.5|Standard Deviation|10.8|10.8|||
3675564|NCT02308124|3519762|B3|||Orthostatic systolic blood pressure change|Maximum decrements in SBP within 3 minutes of standing were recorded.|mmHg|Mean|-22.5|-22.5|Standard Deviation|10.1|10.1|||
3675565|NCT02308124|3519763|B2|||Orthostatic systolic blood pressure change|Maximum decrements in SBP within 3 minutes of standing were recorded.|mmHg|Mean|-23.3|-23.3|Standard Deviation|12.5|12.5|||
3675566|NCT02308124|3519764|B1|||Orthostatic systolic blood pressure change|Maximum decrements in SBP within 3 minutes of standing were recorded.|mmHg|Mean|-24.7|-24.7|Standard Deviation|9.9|9.9|||
3675567|NCT02308124|3519761|B4|||Supine heart rate||Beats per Minute|Mean|67.2|67.2|Standard Deviation|11.8|11.8|||
3675568|NCT02308124|3519762|B3|||Supine heart rate||Beats per Minute|Mean|67.0|67.0|Standard Deviation|10.7|10.7|||
3675569|NCT02308124|3519763|B2|||Supine heart rate||Beats per Minute|Mean|66.7|66.7|Standard Deviation|13.5|13.5|||
3675570|NCT02308124|3519764|B1|||Supine heart rate||Beats per Minute|Mean|68.0|68.0|Standard Deviation|11.3|11.3|||
3675571|NCT02308124|3519761|B4|||Supine diastolic blood pressure||mmHg|Mean|78.9|78.9|Standard Deviation|11.4|11.4|||
3675572|NCT02308124|3519762|B3|||Supine diastolic blood pressure||mmHg|Mean|76.9|76.9|Standard Deviation|10.4|10.4|||
3675573|NCT02308124|3519763|B2|||Supine diastolic blood pressure||mmHg|Mean|76.5|76.5|Standard Deviation|9.8|9.8|||
3675574|NCT02308124|3519764|B1|||Supine diastolic blood pressure||mmHg|Mean|83.2|83.2|Standard Deviation|12.8|12.8|||
3675575|NCT02308124|3519761|B4|||Supine systolic blood pressure||mmHg|Mean|127.9|127.9|Standard Deviation|19.4|19.4|||
3675576|NCT02308124|3519762|B3|||Supine systolic blood pressure||mmHg|Mean|122.0|122.0|Standard Deviation|15.6|15.6|||
3675577|NCT02308124|3519763|B2|||Supine systolic blood pressure||mmHg|Mean|124.5|124.5|Standard Deviation|18.5|18.5|||
3675578|NCT02308124|3519764|B1|||Supine systolic blood pressure||mmHg|Mean|137.3|137.3|Standard Deviation|20.9|20.9|||
3675579|NCT02308124|3519761|B4|Korea, Republic of||Region of Enrollment||participants|Number|87|87.0||||||
3675580|NCT02308124|3519762|B3|Korea, Republic of||Region of Enrollment||participants|Number|29|29.0||||||
3675581|NCT02308124|3519763|B2|Korea, Republic of||Region of Enrollment||participants|Number|29|29.0||||||
3675582|NCT02308124|3519764|B1|Korea, Republic of||Region of Enrollment||participants|Number|29|29.0||||||
3675583|NCT02308124|3519761|B4||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3675584|NCT02308124|3519762|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3675585|NCT02308124|3519763|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3675586|NCT02308124|3519764|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3675587|NCT02308124|3519761|B4||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3675588|NCT02308124|3519762|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3675589|NCT02308124|3519763|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3675590|NCT02308124|3519764|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3675591|NCT02308124|3519761|B4|||Age||years|Mean|57.2|57.2|Standard Deviation|16.0|16.0|||
3675592|NCT02308124|3519762|B3|||Age||years|Mean|52.7|52.7|Standard Deviation|16.2|16.2|||
3675593|NCT02308124|3519763|B2|||Age||years|Mean|59.7|59.7|Standard Deviation|13.4|13.4|||
3675594|NCT02308124|3519764|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|17.7|17.7|||
3675595|NCT02307838|3519786|B4||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3675596|NCT02307838|3519787|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3675597|NCT02307838|3519788|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3675598|NCT02307838|3519789|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3675599|NCT02307838|3519786|B4||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3675600|NCT02307838|3519787|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3675601|NCT02307838|3519788|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3675602|NCT02307838|3519789|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3675603|NCT02307838|3519786|B4|||Age||Years|Mean|37.4|37.4|Standard Deviation|9.34|9.34|||
3675604|NCT02307838|3519787|B3|||Age||Years|Mean|38.9|38.9|Standard Deviation|10.49|10.49|||
3675605|NCT02307838|3519788|B2|||Age||Years|Mean|31.9|31.9|Standard Deviation|9.05|9.05|||
3675606|NCT02307838|3519789|B1|||Age||Years|Mean|37.4|37.4|Standard Deviation|8.47|8.47|||
3675607|NCT02307552|3519834|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3675608|NCT02307552|3519834|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3675609|NCT02307552|3519834|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3675610|NCT02307552|3519834|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3675611|NCT02307552|3519834|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3675612|NCT02307552|3519834|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3675613|NCT02307526|3519838|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3675614|NCT02307526|3519838|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3675615|NCT02307526|3519838|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3675616|NCT02307526|3519838|B1|||Age||years|Mean|38|38.0|Standard Deviation|10|10.0|||
3675617|NCT02307526|3519838|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3675618|NCT02307526|3519838|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3675619|NCT02307526|3519838|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3675620|NCT02307318|3519848|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
3675621|NCT02307318|3519848|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675622|NCT02307318|3519848|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675623|NCT02307318|3519848|B1||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3675624|NCT02307318|3519848|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3675625|NCT02307318|3519848|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675626|NCT02307318|3519848|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3675627|NCT02307318|3519848|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3675628|NCT02307318|3519848|B1||Male|Gender||Participants|Count of Participants|29|29.0||||||
3675629|NCT02307318|3519848|B1||Female|Gender||Participants|Count of Participants|22|22.0||||||
3675630|NCT02307318|3519848|B1|||Age||years|Mean|61.1|61.1|Standard Deviation|8.7|8.7|||
3675631|NCT02307266|3519855|B4|More than 5 years||Acne History|Duration in years|participants|Number|29|29.0||||||
3675632|NCT02307266|3519856|B3|More than 5 years||Acne History|Duration in years|participants|Number|7|7.0||||||
3675633|NCT02307266|3519857|B2|More than 5 years||Acne History|Duration in years|participants|Number|12|12.0||||||
3675634|NCT02307266|3519858|B1|More than 5 years||Acne History|Duration in years|participants|Number|10|10.0||||||
3675635|NCT02307266|3519855|B4|Between 1 and 5 years||Acne History|Duration in years|participants|Number|40|40.0||||||
3675636|NCT02307266|3519856|B3|Between 1 and 5 years||Acne History|Duration in years|participants|Number|17|17.0||||||
3675637|NCT02307266|3519857|B2|Between 1 and 5 years||Acne History|Duration in years|participants|Number|12|12.0||||||
3675638|NCT02307266|3519858|B1|Between 1 and 5 years||Acne History|Duration in years|participants|Number|11|11.0||||||
3675639|NCT02307266|3519855|B4|Less than 1 year||Acne History|Duration in years|participants|Number|28|28.0||||||
3675640|NCT02307266|3519856|B3|Less than 1 year||Acne History|Duration in years|participants|Number|7|7.0||||||
3675641|NCT02307266|3519857|B2|Less than 1 year||Acne History|Duration in years|participants|Number|9|9.0||||||
3675642|NCT02307266|3519858|B1|Less than 1 year||Acne History|Duration in years|participants|Number|12|12.0||||||
3675643|NCT02307266|3519855|B4|Moderate||Investigator Global Assessment of Acne|"Clear: Residual hyperpigmentation and erythema may be present Almost clear: a few scattered comedones and a few small papules Mild: Some comedones and some papules and pustules. No nodules present. Moderate: Many comedones, papules and pustules. One nodule may be present. Severe: Covered with comedones, numerous papules and pustules and few nodules may be present.~Very severe: Highly inflammatory acne covering the face, with nodules present."|participants|Number|26|26.0||||||
3675644|NCT02307266|3519856|B3|Moderate||Investigator Global Assessment of Acne|"Clear: Residual hyperpigmentation and erythema may be present Almost clear: a few scattered comedones and a few small papules Mild: Some comedones and some papules and pustules. No nodules present. Moderate: Many comedones, papules and pustules. One nodule may be present. Severe: Covered with comedones, numerous papules and pustules and few nodules may be present.~Very severe: Highly inflammatory acne covering the face, with nodules present."|participants|Number|8|8.0||||||
3675645|NCT02307266|3519857|B2|Moderate||Investigator Global Assessment of Acne|"Clear: Residual hyperpigmentation and erythema may be present Almost clear: a few scattered comedones and a few small papules Mild: Some comedones and some papules and pustules. No nodules present. Moderate: Many comedones, papules and pustules. One nodule may be present. Severe: Covered with comedones, numerous papules and pustules and few nodules may be present.~Very severe: Highly inflammatory acne covering the face, with nodules present."|participants|Number|10|10.0||||||
3675646|NCT02307266|3519858|B1|Moderate||Investigator Global Assessment of Acne|"Clear: Residual hyperpigmentation and erythema may be present Almost clear: a few scattered comedones and a few small papules Mild: Some comedones and some papules and pustules. No nodules present. Moderate: Many comedones, papules and pustules. One nodule may be present. Severe: Covered with comedones, numerous papules and pustules and few nodules may be present.~Very severe: Highly inflammatory acne covering the face, with nodules present."|participants|Number|8|8.0||||||
3675647|NCT02307266|3519855|B4|Mild||Investigator Global Assessment of Acne|"Clear: Residual hyperpigmentation and erythema may be present Almost clear: a few scattered comedones and a few small papules Mild: Some comedones and some papules and pustules. No nodules present. Moderate: Many comedones, papules and pustules. One nodule may be present. Severe: Covered with comedones, numerous papules and pustules and few nodules may be present.~Very severe: Highly inflammatory acne covering the face, with nodules present."|participants|Number|59|59.0||||||
3675648|NCT02307266|3519856|B3|Mild||Investigator Global Assessment of Acne|"Clear: Residual hyperpigmentation and erythema may be present Almost clear: a few scattered comedones and a few small papules Mild: Some comedones and some papules and pustules. No nodules present. Moderate: Many comedones, papules and pustules. One nodule may be present. Severe: Covered with comedones, numerous papules and pustules and few nodules may be present.~Very severe: Highly inflammatory acne covering the face, with nodules present."|participants|Number|20|20.0||||||
3675649|NCT02307266|3519857|B2|Mild||Investigator Global Assessment of Acne|"Clear: Residual hyperpigmentation and erythema may be present Almost clear: a few scattered comedones and a few small papules Mild: Some comedones and some papules and pustules. No nodules present. Moderate: Many comedones, papules and pustules. One nodule may be present. Severe: Covered with comedones, numerous papules and pustules and few nodules may be present.~Very severe: Highly inflammatory acne covering the face, with nodules present."|participants|Number|22|22.0||||||
3675650|NCT02307266|3519858|B1|Mild||Investigator Global Assessment of Acne|"Clear: Residual hyperpigmentation and erythema may be present Almost clear: a few scattered comedones and a few small papules Mild: Some comedones and some papules and pustules. No nodules present. Moderate: Many comedones, papules and pustules. One nodule may be present. Severe: Covered with comedones, numerous papules and pustules and few nodules may be present.~Very severe: Highly inflammatory acne covering the face, with nodules present."|participants|Number|17|17.0||||||
3675651|NCT02307266|3519855|B4|Almost clear||Investigator Global Assessment of Acne|"Clear: Residual hyperpigmentation and erythema may be present Almost clear: a few scattered comedones and a few small papules Mild: Some comedones and some papules and pustules. No nodules present. Moderate: Many comedones, papules and pustules. One nodule may be present. Severe: Covered with comedones, numerous papules and pustules and few nodules may be present.~Very severe: Highly inflammatory acne covering the face, with nodules present."|participants|Number|12|12.0||||||
3675652|NCT02307266|3519856|B3|Almost clear||Investigator Global Assessment of Acne|"Clear: Residual hyperpigmentation and erythema may be present Almost clear: a few scattered comedones and a few small papules Mild: Some comedones and some papules and pustules. No nodules present. Moderate: Many comedones, papules and pustules. One nodule may be present. Severe: Covered with comedones, numerous papules and pustules and few nodules may be present.~Very severe: Highly inflammatory acne covering the face, with nodules present."|participants|Number|3|3.0||||||
3675653|NCT02307266|3519857|B2|Almost clear||Investigator Global Assessment of Acne|"Clear: Residual hyperpigmentation and erythema may be present Almost clear: a few scattered comedones and a few small papules Mild: Some comedones and some papules and pustules. No nodules present. Moderate: Many comedones, papules and pustules. One nodule may be present. Severe: Covered with comedones, numerous papules and pustules and few nodules may be present.~Very severe: Highly inflammatory acne covering the face, with nodules present."|participants|Number|1|1.0||||||
3675654|NCT02307266|3519858|B1|Almost clear||Investigator Global Assessment of Acne|"Clear: Residual hyperpigmentation and erythema may be present Almost clear: a few scattered comedones and a few small papules Mild: Some comedones and some papules and pustules. No nodules present. Moderate: Many comedones, papules and pustules. One nodule may be present. Severe: Covered with comedones, numerous papules and pustules and few nodules may be present.~Very severe: Highly inflammatory acne covering the face, with nodules present."|participants|Number|8|8.0||||||
3675655|NCT02307266|3519855|B4|V||Skin Phototype|"Type I: never tan; always sunburn if exposed to sunlight, primarily read headed and lighty complected blondes Type II: frequently burn but are able to tan to a small degree after extended exposure Type III: burn infrequently; tan readily Type IV: rarely burn, tan heavily with moderate sun exposure; esp. Asian, American Indian, Mediterranean and Latin American.~Type V: have dark constitutive pigmentation, become darker with sun exposure, esp. light complected black individuals, Indian descent.~Type VI: have the heaviest constitutive pigmentation, esp. dark skinned black individuals."|participants|Number|5|5.0||||||
3675656|NCT02307266|3519856|B3|V||Skin Phototype|"Type I: never tan; always sunburn if exposed to sunlight, primarily read headed and lighty complected blondes Type II: frequently burn but are able to tan to a small degree after extended exposure Type III: burn infrequently; tan readily Type IV: rarely burn, tan heavily with moderate sun exposure; esp. Asian, American Indian, Mediterranean and Latin American.~Type V: have dark constitutive pigmentation, become darker with sun exposure, esp. light complected black individuals, Indian descent.~Type VI: have the heaviest constitutive pigmentation, esp. dark skinned black individuals."|participants|Number|2|2.0||||||
3675657|NCT02307266|3519857|B2|V||Skin Phototype|"Type I: never tan; always sunburn if exposed to sunlight, primarily read headed and lighty complected blondes Type II: frequently burn but are able to tan to a small degree after extended exposure Type III: burn infrequently; tan readily Type IV: rarely burn, tan heavily with moderate sun exposure; esp. Asian, American Indian, Mediterranean and Latin American.~Type V: have dark constitutive pigmentation, become darker with sun exposure, esp. light complected black individuals, Indian descent.~Type VI: have the heaviest constitutive pigmentation, esp. dark skinned black individuals."|participants|Number|2|2.0||||||
3675658|NCT02307266|3519858|B1|V||Skin Phototype|"Type I: never tan; always sunburn if exposed to sunlight, primarily read headed and lighty complected blondes Type II: frequently burn but are able to tan to a small degree after extended exposure Type III: burn infrequently; tan readily Type IV: rarely burn, tan heavily with moderate sun exposure; esp. Asian, American Indian, Mediterranean and Latin American.~Type V: have dark constitutive pigmentation, become darker with sun exposure, esp. light complected black individuals, Indian descent.~Type VI: have the heaviest constitutive pigmentation, esp. dark skinned black individuals."|participants|Number|1|1.0||||||
3675659|NCT02307266|3519855|B4|IV||Skin Phototype|"Type I: never tan; always sunburn if exposed to sunlight, primarily read headed and lighty complected blondes Type II: frequently burn but are able to tan to a small degree after extended exposure Type III: burn infrequently; tan readily Type IV: rarely burn, tan heavily with moderate sun exposure; esp. Asian, American Indian, Mediterranean and Latin American.~Type V: have dark constitutive pigmentation, become darker with sun exposure, esp. light complected black individuals, Indian descent.~Type VI: have the heaviest constitutive pigmentation, esp. dark skinned black individuals."|participants|Number|15|15.0||||||
3675660|NCT02307266|3519856|B3|IV||Skin Phototype|"Type I: never tan; always sunburn if exposed to sunlight, primarily read headed and lighty complected blondes Type II: frequently burn but are able to tan to a small degree after extended exposure Type III: burn infrequently; tan readily Type IV: rarely burn, tan heavily with moderate sun exposure; esp. Asian, American Indian, Mediterranean and Latin American.~Type V: have dark constitutive pigmentation, become darker with sun exposure, esp. light complected black individuals, Indian descent.~Type VI: have the heaviest constitutive pigmentation, esp. dark skinned black individuals."|participants|Number|4|4.0||||||
3675661|NCT02307266|3519857|B2|IV||Skin Phototype|"Type I: never tan; always sunburn if exposed to sunlight, primarily read headed and lighty complected blondes Type II: frequently burn but are able to tan to a small degree after extended exposure Type III: burn infrequently; tan readily Type IV: rarely burn, tan heavily with moderate sun exposure; esp. Asian, American Indian, Mediterranean and Latin American.~Type V: have dark constitutive pigmentation, become darker with sun exposure, esp. light complected black individuals, Indian descent.~Type VI: have the heaviest constitutive pigmentation, esp. dark skinned black individuals."|participants|Number|6|6.0||||||
3675662|NCT02307266|3519858|B1|IV||Skin Phototype|"Type I: never tan; always sunburn if exposed to sunlight, primarily read headed and lighty complected blondes Type II: frequently burn but are able to tan to a small degree after extended exposure Type III: burn infrequently; tan readily Type IV: rarely burn, tan heavily with moderate sun exposure; esp. Asian, American Indian, Mediterranean and Latin American.~Type V: have dark constitutive pigmentation, become darker with sun exposure, esp. light complected black individuals, Indian descent.~Type VI: have the heaviest constitutive pigmentation, esp. dark skinned black individuals."|participants|Number|5|5.0||||||
3675663|NCT02307266|3519855|B4|III||Skin Phototype|"Type I: never tan; always sunburn if exposed to sunlight, primarily read headed and lighty complected blondes Type II: frequently burn but are able to tan to a small degree after extended exposure Type III: burn infrequently; tan readily Type IV: rarely burn, tan heavily with moderate sun exposure; esp. Asian, American Indian, Mediterranean and Latin American.~Type V: have dark constitutive pigmentation, become darker with sun exposure, esp. light complected black individuals, Indian descent.~Type VI: have the heaviest constitutive pigmentation, esp. dark skinned black individuals."|participants|Number|39|39.0||||||
3675664|NCT02307266|3519856|B3|III||Skin Phototype|"Type I: never tan; always sunburn if exposed to sunlight, primarily read headed and lighty complected blondes Type II: frequently burn but are able to tan to a small degree after extended exposure Type III: burn infrequently; tan readily Type IV: rarely burn, tan heavily with moderate sun exposure; esp. Asian, American Indian, Mediterranean and Latin American.~Type V: have dark constitutive pigmentation, become darker with sun exposure, esp. light complected black individuals, Indian descent.~Type VI: have the heaviest constitutive pigmentation, esp. dark skinned black individuals."|participants|Number|12|12.0||||||
3675682|NCT02307266|3519858|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675683|NCT02307266|3519855|B4||White|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3675684|NCT02307266|3519856|B3||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3675665|NCT02307266|3519857|B2|III||Skin Phototype|"Type I: never tan; always sunburn if exposed to sunlight, primarily read headed and lighty complected blondes Type II: frequently burn but are able to tan to a small degree after extended exposure Type III: burn infrequently; tan readily Type IV: rarely burn, tan heavily with moderate sun exposure; esp. Asian, American Indian, Mediterranean and Latin American.~Type V: have dark constitutive pigmentation, become darker with sun exposure, esp. light complected black individuals, Indian descent.~Type VI: have the heaviest constitutive pigmentation, esp. dark skinned black individuals."|participants|Number|13|13.0||||||
3675666|NCT02307266|3519858|B1|III||Skin Phototype|"Type I: never tan; always sunburn if exposed to sunlight, primarily read headed and lighty complected blondes Type II: frequently burn but are able to tan to a small degree after extended exposure Type III: burn infrequently; tan readily Type IV: rarely burn, tan heavily with moderate sun exposure; esp. Asian, American Indian, Mediterranean and Latin American.~Type V: have dark constitutive pigmentation, become darker with sun exposure, esp. light complected black individuals, Indian descent.~Type VI: have the heaviest constitutive pigmentation, esp. dark skinned black individuals."|participants|Number|14|14.0||||||
3675667|NCT02307266|3519855|B4|II||Skin Phototype|"Type I: never tan; always sunburn if exposed to sunlight, primarily read headed and lighty complected blondes Type II: frequently burn but are able to tan to a small degree after extended exposure Type III: burn infrequently; tan readily Type IV: rarely burn, tan heavily with moderate sun exposure; esp. Asian, American Indian, Mediterranean and Latin American.~Type V: have dark constitutive pigmentation, become darker with sun exposure, esp. light complected black individuals, Indian descent.~Type VI: have the heaviest constitutive pigmentation, esp. dark skinned black individuals."|participants|Number|31|31.0||||||
3675668|NCT02307266|3519856|B3|II||Skin Phototype|"Type I: never tan; always sunburn if exposed to sunlight, primarily read headed and lighty complected blondes Type II: frequently burn but are able to tan to a small degree after extended exposure Type III: burn infrequently; tan readily Type IV: rarely burn, tan heavily with moderate sun exposure; esp. Asian, American Indian, Mediterranean and Latin American.~Type V: have dark constitutive pigmentation, become darker with sun exposure, esp. light complected black individuals, Indian descent.~Type VI: have the heaviest constitutive pigmentation, esp. dark skinned black individuals."|participants|Number|11|11.0||||||
3675669|NCT02307266|3519857|B2|II||Skin Phototype|"Type I: never tan; always sunburn if exposed to sunlight, primarily read headed and lighty complected blondes Type II: frequently burn but are able to tan to a small degree after extended exposure Type III: burn infrequently; tan readily Type IV: rarely burn, tan heavily with moderate sun exposure; esp. Asian, American Indian, Mediterranean and Latin American.~Type V: have dark constitutive pigmentation, become darker with sun exposure, esp. light complected black individuals, Indian descent.~Type VI: have the heaviest constitutive pigmentation, esp. dark skinned black individuals."|participants|Number|9|9.0||||||
3675670|NCT02307266|3519858|B1|II||Skin Phototype|"Type I: never tan; always sunburn if exposed to sunlight, primarily read headed and lighty complected blondes Type II: frequently burn but are able to tan to a small degree after extended exposure Type III: burn infrequently; tan readily Type IV: rarely burn, tan heavily with moderate sun exposure; esp. Asian, American Indian, Mediterranean and Latin American.~Type V: have dark constitutive pigmentation, become darker with sun exposure, esp. light complected black individuals, Indian descent.~Type VI: have the heaviest constitutive pigmentation, esp. dark skinned black individuals."|participants|Number|11|11.0||||||
3675671|NCT02307266|3519855|B4|I||Skin Phototype|"Type I: never tan; always sunburn if exposed to sunlight, primarily read headed and lighty complected blondes Type II: frequently burn but are able to tan to a small degree after extended exposure Type III: burn infrequently; tan readily Type IV: rarely burn, tan heavily with moderate sun exposure; esp. Asian, American Indian, Mediterranean and Latin American.~Type V: have dark constitutive pigmentation, become darker with sun exposure, esp. light complected black individuals, Indian descent.~Type VI: have the heaviest constitutive pigmentation, esp. dark skinned black individuals."|participants|Number|7|7.0||||||
3675672|NCT02307266|3519856|B3|I||Skin Phototype|"Type I: never tan; always sunburn if exposed to sunlight, primarily read headed and lighty complected blondes Type II: frequently burn but are able to tan to a small degree after extended exposure Type III: burn infrequently; tan readily Type IV: rarely burn, tan heavily with moderate sun exposure; esp. Asian, American Indian, Mediterranean and Latin American.~Type V: have dark constitutive pigmentation, become darker with sun exposure, esp. light complected black individuals, Indian descent.~Type VI: have the heaviest constitutive pigmentation, esp. dark skinned black individuals."|participants|Number|2|2.0||||||
3675673|NCT02307266|3519857|B2|I||Skin Phototype|"Type I: never tan; always sunburn if exposed to sunlight, primarily read headed and lighty complected blondes Type II: frequently burn but are able to tan to a small degree after extended exposure Type III: burn infrequently; tan readily Type IV: rarely burn, tan heavily with moderate sun exposure; esp. Asian, American Indian, Mediterranean and Latin American.~Type V: have dark constitutive pigmentation, become darker with sun exposure, esp. light complected black individuals, Indian descent.~Type VI: have the heaviest constitutive pigmentation, esp. dark skinned black individuals."|participants|Number|3|3.0||||||
3675674|NCT02307266|3519858|B1|I||Skin Phototype|"Type I: never tan; always sunburn if exposed to sunlight, primarily read headed and lighty complected blondes Type II: frequently burn but are able to tan to a small degree after extended exposure Type III: burn infrequently; tan readily Type IV: rarely burn, tan heavily with moderate sun exposure; esp. Asian, American Indian, Mediterranean and Latin American.~Type V: have dark constitutive pigmentation, become darker with sun exposure, esp. light complected black individuals, Indian descent.~Type VI: have the heaviest constitutive pigmentation, esp. dark skinned black individuals."|participants|Number|2|2.0||||||
3675675|NCT02307266|3519855|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3675676|NCT02307266|3519856|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675677|NCT02307266|3519857|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3675678|NCT02307266|3519858|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3675679|NCT02307266|3519855|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675680|NCT02307266|3519856|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675681|NCT02307266|3519857|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675685|NCT02307266|3519857|B2||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3675686|NCT02307266|3519858|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3675687|NCT02307266|3519855|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675688|NCT02307266|3519856|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675689|NCT02307266|3519857|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675690|NCT02307266|3519858|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675691|NCT02307266|3519855|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675692|NCT02307266|3519856|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675693|NCT02307266|3519857|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675694|NCT02307266|3519858|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675695|NCT02307266|3519855|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3675696|NCT02307266|3519856|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3675697|NCT02307266|3519857|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3675698|NCT02307266|3519858|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3675699|NCT02307266|3519855|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675700|NCT02307266|3519856|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675701|NCT02307266|3519857|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675702|NCT02307266|3519858|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675703|NCT02307266|3519855|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3675704|NCT02307266|3519856|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3675705|NCT02307266|3519857|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3675706|NCT02307266|3519858|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3675707|NCT02307266|3519855|B4||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3675708|NCT02307266|3519856|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3675709|NCT02307266|3519857|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3675710|NCT02307266|3519858|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3675711|NCT02307266|3519855|B4|||Age||years|Mean|22.5|22.5|Standard Deviation|9.6|9.6|||
3675712|NCT02307266|3519856|B3|||Age||years|Mean|22.5|22.5|Standard Deviation|11.1|11.1|||
3675713|NCT02307266|3519857|B2|||Age||years|Mean|21.0|21.0|Standard Deviation|7.9|7.9|||
3675714|NCT02307266|3519858|B1|||Age||years|Mean|24.1|24.1|Standard Deviation|9.6|9.6|||
3675715|NCT02307188|3519868|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3675716|NCT02307188|3519868|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3675717|NCT02307188|3519868|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3675718|NCT02307188|3519868|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3675719|NCT02307188|3519868|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3675720|NCT02307188|3519868|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3675721|NCT02307123|3519872|B1||Male|Gender||Participants|Count of Participants|319|319.0||||||
3675722|NCT02307123|3519872|B1||Female|Gender||Participants|Count of Participants|164|164.0||||||
3675723|NCT02307123|3519872|B1|||Age||years|Median|47.8|47.8|Full Range|||0.0|91.0|
3675724|NCT02306928|3519877|B1|||Body weight||kg|Median|80|80.0|Inter-Quartile Range|||70.2|95.0|
3675725|NCT02306928|3519877|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3675726|NCT02306928|3519877|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3675727|NCT02306928|3519877|B1|||Age||years|Median|66|66.0|Inter-Quartile Range|||59.0|79.0|
3675728|NCT02306759|3519885|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
3675729|NCT02306759|3519886|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3675730|NCT02306759|3519887|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3675731|NCT02306759|3519885|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675732|NCT02306759|3519886|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675733|NCT02306759|3519887|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675734|NCT02306759|3519885|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3675735|NCT02306759|3519886|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3675736|NCT02306759|3519887|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3675737|NCT02306759|3519885|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3675738|NCT02306759|3519886|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3675739|NCT02306759|3519887|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3675740|NCT02306759|3519885|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3675741|NCT02306759|3519886|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3675742|NCT02306759|3519887|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3675743|NCT02306759|3519885|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3675744|NCT02306759|3519886|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3675745|NCT02306759|3519887|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3675746|NCT02306759|3519885|B3|||Age||years|Mean|44|44.0|Standard Deviation|16|16.0|||
3675747|NCT02306759|3519886|B2|||Age||years|Mean|48|48.0|Standard Deviation|17|17.0|||
3675748|NCT02306759|3519887|B1|||Age||years|Mean|41|41.0|Standard Deviation|16|16.0|||
3675749|NCT02305797|3519902|B3|United States||Region of Enrollment||participants|Number|479|479.0||||||
3675750|NCT02305797|3519903|B2|United States||Region of Enrollment||participants|Number|240|240.0||||||
3675751|NCT02305797|3519904|B1|United States||Region of Enrollment||participants|Number|239|239.0||||||
3675752|NCT02305797|3519902|B3||Male|Sex: Female, Male||Participants|Count of Participants|341|341.0||||||
3675753|NCT02305797|3519903|B2||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
3675754|NCT02305797|3519904|B1||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3675755|NCT02305797|3519902|B3||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3675756|NCT02305797|3519903|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3675757|NCT02305797|3519904|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3675758|NCT02305797|3519902|B3|||Age||years|Mean|36.2|36.2|Standard Deviation|12.15|12.15|||
3675759|NCT02305797|3519903|B2|||Age||years|Mean|35.9|35.9|Standard Deviation|11.96|11.96|||
3675760|NCT02305797|3519904|B1|||Age||years|Mean|36.4|36.4|Standard Deviation|12.36|12.36|||
3675761|NCT02305758|3519913|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675762|NCT02305758|3519914|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675763|NCT02305758|3519915|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675764|NCT02305758|3519913|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675765|NCT02305758|3519914|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675766|NCT02305758|3519915|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675767|NCT02305758|3519913|B3||White|Race (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
3675768|NCT02305758|3519914|B2||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3675769|NCT02305758|3519915|B1||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3675770|NCT02305758|3519913|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3675771|NCT02305758|3519914|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3675772|NCT02305758|3519915|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3675773|NCT02305758|3519913|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675774|NCT02305758|3519914|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675775|NCT02305758|3519915|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675776|NCT02305758|3519913|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675777|NCT02305758|3519914|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675778|NCT02305758|3519915|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675779|NCT02305758|3519913|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675780|NCT02305758|3519914|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675781|NCT02305758|3519915|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3675782|NCT02305758|3519913|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3675783|NCT02305758|3519914|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3675784|NCT02305758|3519915|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3675785|NCT02305758|3519913|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3675786|NCT02305758|3519914|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3675787|NCT02305758|3519915|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3675788|NCT02305758|3519913|B3|||Age||years|Mean|61.3|61.3|Standard Deviation|11.4|11.4|||
3675789|NCT02305758|3519914|B2|||Age||years|Mean|63.8|63.8|Standard Deviation|9.04|9.04|||
3675790|NCT02305758|3519915|B1|||Age||years|Mean|58.9|58.9|Standard Deviation|13.06|13.06|||
3675791|NCT02305732|3519926|B1|Puerto Rico||Region of Enrollment||participants|Number|90|90.0||||||
3675792|NCT02305732|3519926|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3675793|NCT02305732|3519926|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3675794|NCT02305732|3519926|B1|||Age||Years|Mean|67.2|67.2|Standard Deviation|15.8|15.8|||
3675795|NCT02305732|3519926|B1||>=65 years|Age||Participants|Count of Participants|59|59.0||||||
3675796|NCT02305732|3519926|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3675797|NCT02305732|3519926|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3675798|NCT02305446|3519934|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3675799|NCT02305446|3519934|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3675800|NCT02305446|3519934|B1|||Age||YEARS|Mean|27.2|27.2|Standard Deviation|6.932|6.932|||
3675841|NCT02305381|3519939|B4|From 65-84 years||Age, Customized||participants|Number|114|114.0||||||
3675842|NCT02305381|3519940|B3|From 65-84 years||Age, Customized||participants|Number|46|46.0||||||
3675843|NCT02305381|3519941|B2|From 65-84 years||Age, Customized||participants|Number|29|29.0||||||
3675844|NCT02305381|3519942|B1|From 65-84 years||Age, Customized||participants|Number|39|39.0||||||
3675801|NCT02305381|3519939|B4|||Diabetes Treatment Satisfaction Questionnaire|The DTSQs questionnaire was used to assess subjects’ treatment satisfaction and contained 8 components and evaluates the diabetes treatment (including insulin, tablets and/or diet) in terms of convenience, flexibility and general feelings towards the treatment. The result presented is the 'Treatment Satisfaction' summary score, which is the sum of 6 of the 8 items of the DTSQs questionnaire. Response options range from 6 (best case) to 0 (worst case). Total scores for treatment satisfaction range from 0-36. Higher scores indicate higher satisfaction.|scores on scale|Mean|28.34|28.34|Standard Deviation|6.46|6.46|||
3675802|NCT02305381|3519940|B3|||Diabetes Treatment Satisfaction Questionnaire|The DTSQs questionnaire was used to assess subjects’ treatment satisfaction and contained 8 components and evaluates the diabetes treatment (including insulin, tablets and/or diet) in terms of convenience, flexibility and general feelings towards the treatment. The result presented is the 'Treatment Satisfaction' summary score, which is the sum of 6 of the 8 items of the DTSQs questionnaire. Response options range from 6 (best case) to 0 (worst case). Total scores for treatment satisfaction range from 0-36. Higher scores indicate higher satisfaction.|scores on scale|Mean|27.54|27.54|Standard Deviation|6.55|6.55|||
3675803|NCT02305381|3519941|B2|||Diabetes Treatment Satisfaction Questionnaire|The DTSQs questionnaire was used to assess subjects’ treatment satisfaction and contained 8 components and evaluates the diabetes treatment (including insulin, tablets and/or diet) in terms of convenience, flexibility and general feelings towards the treatment. The result presented is the 'Treatment Satisfaction' summary score, which is the sum of 6 of the 8 items of the DTSQs questionnaire. Response options range from 6 (best case) to 0 (worst case). Total scores for treatment satisfaction range from 0-36. Higher scores indicate higher satisfaction.|scores on scale|Mean|28.62|28.62|Standard Deviation|6.45|6.45|||
3675804|NCT02305381|3519942|B1|||Diabetes Treatment Satisfaction Questionnaire|The DTSQs questionnaire was used to assess subjects’ treatment satisfaction and contained 8 components and evaluates the diabetes treatment (including insulin, tablets and/or diet) in terms of convenience, flexibility and general feelings towards the treatment. The result presented is the 'Treatment Satisfaction' summary score, which is the sum of 6 of the 8 items of the DTSQs questionnaire. Response options range from 6 (best case) to 0 (worst case). Total scores for treatment satisfaction range from 0-36. Higher scores indicate higher satisfaction.|scores on scale|Mean|28.86|28.86|Standard Deviation|6.35|6.35|||
3675805|NCT02305381|3519939|B4|||Systolic Blood Pressure||mm Hg|Mean|134.76|134.76|Standard Deviation|15.98|15.98|||
3675806|NCT02305381|3519940|B3|||Systolic Blood Pressure||mm Hg|Mean|134.99|134.99|Standard Deviation|16.68|16.68|||
3675807|NCT02305381|3519941|B2|||Systolic Blood Pressure||mm Hg|Mean|134.40|134.4|Standard Deviation|16.32|16.32|||
3675808|NCT02305381|3519942|B1|||Systolic Blood Pressure||mm Hg|Mean|134.87|134.87|Standard Deviation|15.00|15.0|||
3675809|NCT02305381|3519939|B4|||Diastolic Blood Pressure||mm Hg|Mean|78.99|78.99|Standard Deviation|9.79|9.79|||
3675810|NCT02305381|3519940|B3|||Diastolic Blood Pressure||mm Hg|Mean|79.35|79.35|Standard Deviation|9.71|9.71|||
3675811|NCT02305381|3519941|B2|||Diastolic Blood Pressure||mm Hg|Mean|78.73|78.73|Standard Deviation|9.98|9.98|||
3675812|NCT02305381|3519942|B1|||Diastolic Blood Pressure||mm Hg|Mean|78.89|78.89|Standard Deviation|9.72|9.72|||
3675813|NCT02305381|3519939|B4|||Insulin dose||international unit|Median|36.00|36.0|Full Range|||12.0|320.0|
3675814|NCT02305381|3519940|B3|||Insulin dose||international unit|Median|36.00|36.0|Full Range|||12.0|124.0|
3675815|NCT02305381|3519941|B2|||Insulin dose||international unit|Median|36.00|36.0|Full Range|||14.0|320.0|
3675816|NCT02305381|3519942|B1|||Insulin dose||international unit|Median|35.00|35.0|Full Range|||15.0|300.0|
3675817|NCT02305381|3519939|B4|||Fasting plasma glucose||mg/dL|Mean|155.9|155.9|Standard Deviation|53.68|53.68|||
3675818|NCT02305381|3519940|B3|||Fasting plasma glucose||mg/dL|Mean|154.1|154.1|Standard Deviation|46.66|46.66|||
3675819|NCT02305381|3519941|B2|||Fasting plasma glucose||mg/dL|Mean|152.5|152.5|Standard Deviation|50.91|50.91|||
3675820|NCT02305381|3519942|B1|||Fasting plasma glucose||mg/dL|Mean|161.0|161.0|Standard Deviation|62.38|62.38|||
3675821|NCT02305381|3519939|B4|||Body weight||kg|Mean|91.70|91.7|Standard Deviation|20.97|20.97|||
3675822|NCT02305381|3519940|B3|||Body weight||kg|Mean|89.88|89.88|Standard Deviation|21.06|21.06|||
3675823|NCT02305381|3519941|B2|||Body weight||kg|Mean|92.49|92.49|Standard Deviation|22.23|22.23|||
3675824|NCT02305381|3519942|B1|||Body weight||kg|Mean|92.74|92.74|Standard Deviation|19.57|19.57|||
3675825|NCT02305381|3519939|B4|||Glycosylated haemoglobin||percentage of glycosylated haemoglobin|Mean|8.37|8.37|Standard Deviation|0.84|0.84|||
3675826|NCT02305381|3519940|B3|||Glycosylated haemoglobin||percentage of glycosylated haemoglobin|Mean|8.42|8.42|Standard Deviation|0.88|0.88|||
3675827|NCT02305381|3519941|B2|||Glycosylated haemoglobin||percentage of glycosylated haemoglobin|Mean|8.31|8.31|Standard Deviation|0.82|0.82|||
3675828|NCT02305381|3519942|B1|||Glycosylated haemoglobin||percentage of glycosylated haemoglobin|Mean|8.36|8.36|Standard Deviation|0.83|0.83|||
3675829|NCT02305381|3519939|B4||Male|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
3675830|NCT02305381|3519940|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3675831|NCT02305381|3519941|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3675832|NCT02305381|3519942|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3675833|NCT02305381|3519939|B4||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3675834|NCT02305381|3519940|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3675835|NCT02305381|3519941|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3675836|NCT02305381|3519942|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3675837|NCT02305381|3519939|B4|85 years and over||Age, Customized||participants|Number|1|1.0||||||
3675838|NCT02305381|3519940|B3|85 years and over||Age, Customized||participants|Number|1|1.0||||||
3675839|NCT02305381|3519941|B2|85 years and over||Age, Customized||participants|Number|0|0.0||||||
3675840|NCT02305381|3519942|B1|85 years and over||Age, Customized||participants|Number|0|0.0||||||
3675845|NCT02305381|3519939|B4|Adults (18-64 years)||Age, Customized||participants|Number|281|281.0||||||
3675846|NCT02305381|3519940|B3|Adults (18-64 years)||Age, Customized||participants|Number|86|86.0||||||
3675847|NCT02305381|3519941|B2|Adults (18-64 years)||Age, Customized||participants|Number|102|102.0||||||
3675848|NCT02305381|3519942|B1|Adults (18-64 years)||Age, Customized||participants|Number|93|93.0||||||
3675849|NCT02305381|3519939|B4|||Age||years|Mean|58.8|58.8|Standard Deviation|10.1|10.1|||
3675850|NCT02305381|3519940|B3|||Age||years|Mean|58.8|58.8|Standard Deviation|10.9|10.9|||
3675851|NCT02305381|3519941|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|9.0|9.0|||
3675852|NCT02305381|3519942|B1|||Age||years|Mean|59.1|59.1|Standard Deviation|10.3|10.3|||
3675853|NCT02305329|3519973|B5||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3675854|NCT02305329|3519974|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3675855|NCT02305329|3519975|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3675856|NCT02305329|3519976|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3675857|NCT02305329|3519977|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3675858|NCT02305329|3519973|B5||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3675859|NCT02305329|3519974|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3675860|NCT02305329|3519975|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3675861|NCT02305329|3519976|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3675862|NCT02305329|3519977|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3675863|NCT02305329|3519973|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3675864|NCT02305329|3519974|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3675865|NCT02305329|3519975|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3675866|NCT02305329|3519976|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3675867|NCT02305329|3519977|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3675868|NCT02305329|3519973|B5||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
3675869|NCT02305329|3519974|B4||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3675870|NCT02305329|3519975|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3675871|NCT02305329|3519976|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3675872|NCT02305329|3519977|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3675873|NCT02305329|3519973|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3675874|NCT02305329|3519974|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3675875|NCT02305329|3519975|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3675876|NCT02305329|3519976|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3675877|NCT02305329|3519977|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3675878|NCT02305316|3520002|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3675879|NCT02305316|3520003|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3675880|NCT02305316|3520004|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3675881|NCT02305316|3520002|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3675882|NCT02305316|3520003|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3675883|NCT02305316|3520004|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3675884|NCT02305316|3520002|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3675885|NCT02305316|3520003|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3675886|NCT02305316|3520004|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3675887|NCT02305316|3520002|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3675888|NCT02305316|3520003|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3675889|NCT02305316|3520004|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3675890|NCT02305316|3520002|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3675891|NCT02305316|3520003|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3675892|NCT02305316|3520004|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3675893|NCT02305277|3520017|B7||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3675894|NCT02305277|3520018|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3675895|NCT02305277|3520019|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3675896|NCT02305277|3520020|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3675897|NCT02305277|3520021|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3675898|NCT02305277|3520022|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3675899|NCT02305277|3520023|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3675900|NCT02305277|3520017|B7||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3675901|NCT02305277|3520018|B6||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3675902|NCT02305277|3520019|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3675903|NCT02305277|3520020|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3675904|NCT02305277|3520021|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3675905|NCT02305277|3520022|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3675906|NCT02305277|3520023|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3675907|NCT02305277|3520017|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3675908|NCT02305277|3520018|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3675909|NCT02305277|3520019|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3675910|NCT02305277|3520020|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3675911|NCT02305277|3520021|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3675912|NCT02305277|3520022|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3675913|NCT02305277|3520023|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3675914|NCT02305277|3520017|B7||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
3675915|NCT02305277|3520018|B6||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3675916|NCT02305277|3520019|B5||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3675917|NCT02305277|3520020|B4||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3675918|NCT02305277|3520021|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3675919|NCT02305277|3520022|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3675920|NCT02305277|3520023|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3675921|NCT02305277|3520017|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3675922|NCT02305277|3520018|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3675923|NCT02305277|3520019|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3675924|NCT02305277|3520020|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3675925|NCT02305277|3520021|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3675926|NCT02305277|3520022|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3675927|NCT02305277|3520023|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3675928|NCT02305238|3520054|B4||Yes|Retinal Angiomatous Proliferation||Participants|Count of Participants|14|14.0||||||
3675929|NCT02305238|3520055|B3||Yes|Retinal Angiomatous Proliferation||Participants|Count of Participants|1|1.0||||||
3675930|NCT02305238|3520056|B2||Yes|Retinal Angiomatous Proliferation||Participants|Count of Participants|9|9.0||||||
3675931|NCT02305238|3520057|B1||Yes|Retinal Angiomatous Proliferation||Participants|Count of Participants|4|4.0||||||
3675932|NCT02305238|3520054|B4||No|Retinal Angiomatous Proliferation||Participants|Count of Participants|238|238.0||||||
3675933|NCT02305238|3520055|B3||No|Retinal Angiomatous Proliferation||Participants|Count of Participants|6|6.0||||||
3675934|NCT02305238|3520056|B2||No|Retinal Angiomatous Proliferation||Participants|Count of Participants|114|114.0||||||
3675935|NCT02305238|3520057|B1||No|Retinal Angiomatous Proliferation||Participants|Count of Participants|118|118.0||||||
3675936|NCT02305238|3520054|B4||missing|Retinal Angiomatous Proliferation||Participants|Count of Participants|2|2.0||||||
3675937|NCT02305238|3520055|B3||missing|Retinal Angiomatous Proliferation||Participants|Count of Participants|0|0.0||||||
3675938|NCT02305238|3520056|B2||missing|Retinal Angiomatous Proliferation||Participants|Count of Participants|0|0.0||||||
3675939|NCT02305238|3520057|B1||missing|Retinal Angiomatous Proliferation||Participants|Count of Participants|2|2.0||||||
3675940|NCT02305238|3520054|B4||Yes|Polypoidal Choroidal Vasculopathy||Participants|Count of Participants|92|92.0||||||
3675941|NCT02305238|3520055|B3||Yes|Polypoidal Choroidal Vasculopathy||Participants|Count of Participants|2|2.0||||||
3675942|NCT02305238|3520056|B2||Yes|Polypoidal Choroidal Vasculopathy||Participants|Count of Participants|44|44.0||||||
3675943|NCT02305238|3520057|B1||Yes|Polypoidal Choroidal Vasculopathy||Participants|Count of Participants|46|46.0||||||
3675944|NCT02305238|3520054|B4||No|Polypoidal Choroidal Vasculopathy||Participants|Count of Participants|160|160.0||||||
3675945|NCT02305238|3520055|B3||No|Polypoidal Choroidal Vasculopathy||Participants|Count of Participants|5|5.0||||||
3675946|NCT02305238|3520056|B2||No|Polypoidal Choroidal Vasculopathy||Participants|Count of Participants|79|79.0||||||
3675947|NCT02305238|3520057|B1||No|Polypoidal Choroidal Vasculopathy||Participants|Count of Participants|76|76.0||||||
3675948|NCT02305238|3520054|B4||missing|Polypoidal Choroidal Vasculopathy||Participants|Count of Participants|2|2.0||||||
3675949|NCT02305238|3520055|B3||missing|Polypoidal Choroidal Vasculopathy||Participants|Count of Participants|0|0.0||||||
3675950|NCT02305238|3520056|B2||missing|Polypoidal Choroidal Vasculopathy||Participants|Count of Participants|0|0.0||||||
3675951|NCT02305238|3520057|B1||missing|Polypoidal Choroidal Vasculopathy||Participants|Count of Participants|2|2.0||||||
3675952|NCT02305238|3520054|B4||Yes|Typical age-related macular degeneration||Participants|Count of Participants|156|156.0||||||
3675953|NCT02305238|3520055|B3||Yes|Typical age-related macular degeneration||Participants|Count of Participants|5|5.0||||||
3675954|NCT02305238|3520056|B2||Yes|Typical age-related macular degeneration||Participants|Count of Participants|75|75.0||||||
3675955|NCT02305238|3520057|B1||Yes|Typical age-related macular degeneration||Participants|Count of Participants|76|76.0||||||
3675956|NCT02305238|3520054|B4||No|Typical age-related macular degeneration||Participants|Count of Participants|96|96.0||||||
3675957|NCT02305238|3520055|B3||No|Typical age-related macular degeneration||Participants|Count of Participants|2|2.0||||||
3675958|NCT02305238|3520056|B2||No|Typical age-related macular degeneration||Participants|Count of Participants|48|48.0||||||
3675959|NCT02305238|3520057|B1||No|Typical age-related macular degeneration||Participants|Count of Participants|46|46.0||||||
3675960|NCT02305238|3520054|B4||Missing|Typical age-related macular degeneration||Participants|Count of Participants|2|2.0||||||
3675961|NCT02305238|3520055|B3||Missing|Typical age-related macular degeneration||Participants|Count of Participants|0|0.0||||||
3675962|NCT02305238|3520056|B2||Missing|Typical age-related macular degeneration||Participants|Count of Participants|0|0.0||||||
3675963|NCT02305238|3520057|B1||Missing|Typical age-related macular degeneration||Participants|Count of Participants|2|2.0||||||
3675964|NCT02305238|3520054|B4||Unknown|Choroidal neovascularization||Participants|Count of Participants|3|3.0||||||
3675965|NCT02305238|3520055|B3||Unknown|Choroidal neovascularization||Participants|Count of Participants|0|0.0||||||
3675966|NCT02305238|3520056|B2||Unknown|Choroidal neovascularization||Participants|Count of Participants|1|1.0||||||
3675967|NCT02305238|3520057|B1||Unknown|Choroidal neovascularization||Participants|Count of Participants|2|2.0||||||
3675968|NCT02305238|3520054|B4||Occult|Choroidal neovascularization||Participants|Count of Participants|138|138.0||||||
3675969|NCT02305238|3520055|B3||Occult|Choroidal neovascularization||Participants|Count of Participants|4|4.0||||||
3675970|NCT02305238|3520056|B2||Occult|Choroidal neovascularization||Participants|Count of Participants|62|62.0||||||
3675971|NCT02305238|3520057|B1||Occult|Choroidal neovascularization||Participants|Count of Participants|72|72.0||||||
3675972|NCT02305238|3520054|B4||Classic & occult|Choroidal neovascularization||Participants|Count of Participants|34|34.0||||||
3675973|NCT02305238|3520055|B3||Classic & occult|Choroidal neovascularization||Participants|Count of Participants|2|2.0||||||
3675974|NCT02305238|3520056|B2||Classic & occult|Choroidal neovascularization||Participants|Count of Participants|17|17.0||||||
3675975|NCT02305238|3520057|B1||Classic & occult|Choroidal neovascularization||Participants|Count of Participants|15|15.0||||||
3675976|NCT02305238|3520054|B4||Classic CNV|Choroidal neovascularization||Participants|Count of Participants|78|78.0||||||
3675977|NCT02305238|3520055|B3||Classic CNV|Choroidal neovascularization||Participants|Count of Participants|1|1.0||||||
3675978|NCT02305238|3520056|B2||Classic CNV|Choroidal neovascularization||Participants|Count of Participants|42|42.0||||||
3675979|NCT02305238|3520057|B1||Classic CNV|Choroidal neovascularization||Participants|Count of Participants|35|35.0||||||
3675980|NCT02305238|3520054|B4||No choroidal neovascularization (CNV)|Choroidal neovascularization||Participants|Count of Participants|1|1.0||||||
3675981|NCT02305238|3520055|B3||No choroidal neovascularization (CNV)|Choroidal neovascularization||Participants|Count of Participants|0|0.0||||||
3675982|NCT02305238|3520056|B2||No choroidal neovascularization (CNV)|Choroidal neovascularization||Participants|Count of Participants|1|1.0||||||
3675983|NCT02305238|3520057|B1||No choroidal neovascularization (CNV)|Choroidal neovascularization||Participants|Count of Participants|0|0.0||||||
3675984|NCT02305238|3520054|B4|||Central Retinal Thickness||um|Mean|378.3|378.3|Standard Deviation|139.4|139.4|||
3675985|NCT02305238|3520055|B3|||Central Retinal Thickness||um|Mean|371.6|371.6|Standard Deviation|88.5|88.5|||
3675986|NCT02305238|3520056|B2|||Central Retinal Thickness||um|Mean|370.3|370.3|Standard Deviation|120.0|120.0|||
3675987|NCT02305238|3520057|B1|||Central Retinal Thickness||um|Mean|386.5|386.5|Standard Deviation|158.6|158.6|||
3675988|NCT02305238|3520054|B4|||Best-corrected visual acuity (BCVA)|Visual functions of the study eye at Screening visit were assessed, according to the Early Treatment Diabetic Retinopathy Study (ETDRS) protocol as described in detail in the operation manual.|letters|Mean|55.0|55.0|Standard Deviation|12.7|12.7|||
3675989|NCT02305238|3520055|B3|||Best-corrected visual acuity (BCVA)|Visual functions of the study eye at Screening visit were assessed, according to the Early Treatment Diabetic Retinopathy Study (ETDRS) protocol as described in detail in the operation manual.|letters|Mean|54.9|54.9|Standard Deviation|17.9|17.9|||
3675990|NCT02305238|3520056|B2|||Best-corrected visual acuity (BCVA)|Visual functions of the study eye at Screening visit were assessed, according to the Early Treatment Diabetic Retinopathy Study (ETDRS) protocol as described in detail in the operation manual.|letters|Mean|55.3|55.3|Standard Deviation|12.0|12.0|||
3675991|NCT02305238|3520057|B1|||Best-corrected visual acuity (BCVA)|Visual functions of the study eye at Screening visit were assessed, according to the Early Treatment Diabetic Retinopathy Study (ETDRS) protocol as described in detail in the operation manual.|letters|Mean|54.6|54.6|Standard Deviation|13.1|13.1|||
3675992|NCT02305238|3520054|B4||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
3675993|NCT02305238|3520055|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3675994|NCT02305238|3520056|B2||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3675995|NCT02305238|3520057|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3675996|NCT02305238|3520054|B4||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3675997|NCT02305238|3520055|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3675998|NCT02305238|3520056|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3675999|NCT02305238|3520057|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3676000|NCT02305238|3520054|B4|||Age||years|Mean|74.2|74.2|Standard Deviation|8.1|8.1|||
3676001|NCT02305238|3520055|B3|||Age||years|Mean|80.3|80.3|Standard Deviation|7.8|7.8|||
3676002|NCT02305238|3520056|B2|||Age||years|Mean|75.0|75.0|Standard Deviation|8.1|8.1|||
3676003|NCT02305238|3520057|B1|||Age||years|Mean|73.0|73.0|Standard Deviation|7.9|7.9|||
3676004|NCT02305017|3520074|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3676005|NCT02305017|3520075|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3676006|NCT02305017|3520076|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3676007|NCT02305017|3520074|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3676008|NCT02305017|3520075|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3676009|NCT02305017|3520076|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3676010|NCT02305017|3520074|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3676011|NCT02305017|3520075|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3676012|NCT02305017|3520076|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3676013|NCT02305017|3520074|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3676014|NCT02305017|3520075|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3676015|NCT02305017|3520076|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3676016|NCT02305017|3520074|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3676017|NCT02305017|3520075|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3676018|NCT02305017|3520076|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3676019|NCT02304926|3520089|B3|||Diastolic blood pressure (mm Hg)||mm Hg|Mean|80|80.0|Standard Deviation|8|8.0|||
3676020|NCT02304926|3520090|B2|||Diastolic blood pressure (mm Hg)||mm Hg|Mean|80|80.0|Standard Deviation|7|7.0|||
3676021|NCT02304926|3520091|B1|||Diastolic blood pressure (mm Hg)||mm Hg|Mean|79|79.0|Standard Deviation|10|10.0|||
3676022|NCT02304926|3520089|B3|||Systolic blood pressure||mm Hg|Mean|134|134.0|Standard Deviation|15|15.0|||
3676023|NCT02304926|3520090|B2|||Systolic blood pressure||mm Hg|Mean|137|137.0|Standard Deviation|14|14.0|||
3676024|NCT02304926|3520091|B1|||Systolic blood pressure||mm Hg|Mean|133|133.0|Standard Deviation|17|17.0|||
3676025|NCT02304926|3520089|B3|||Body mass index||Kg/m2|Mean|29.8|29.8|Standard Deviation|5.6|5.6|||
3676026|NCT02304926|3520090|B2|||Body mass index||Kg/m2|Mean|31.2|31.2|Standard Deviation|7.3|7.3|||
3676027|NCT02304926|3520091|B1|||Body mass index||Kg/m2|Mean|28.6|28.6|Standard Deviation|3.9|3.9|||
3676028|NCT02304926|3520089|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3676029|NCT02304926|3520090|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3676030|NCT02304926|3520091|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3676031|NCT02304926|3520089|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3676032|NCT02304926|3520090|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3676033|NCT02304926|3520091|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3676034|NCT02304926|3520089|B3|||Age||years|Mean|57.7|57.7|Standard Deviation|11.5|11.5|||
3676035|NCT02304926|3520090|B2|||Age||years|Mean|57.6|57.6|Standard Deviation|10.2|10.2|||
3676036|NCT02304926|3520091|B1|||Age||years|Mean|57.7|57.7|Standard Deviation|12.7|12.7|||
3676037|NCT02304432|3520136|B1|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3676038|NCT02304432|3520136|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676039|NCT02304432|3520136|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676040|NCT02304432|3520136|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3676041|NCT02304432|3520136|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676042|NCT02304432|3520136|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676043|NCT02304432|3520136|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676044|NCT02304432|3520136|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676045|NCT02304432|3520136|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3676046|NCT02304432|3520136|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3676047|NCT02304432|3520136|B1|||Age|age at beginning of study|years|Mean|42|42.0|Full Range|||34.0|62.0|
3676048|NCT02303743|3520171|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3676049|NCT02303743|3520172|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3676050|NCT02303743|3520173|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3676051|NCT02303743|3520171|B3||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3676052|NCT02303743|3520172|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3676053|NCT02303743|3520173|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3676054|NCT02303743|3520171|B3|||Age||years|Mean|50|50.0|Full Range|||21.0|85.0|
3676055|NCT02303743|3520172|B2|||Age||years|Mean|52|52.0|Full Range|||21.0|85.0|
3676056|NCT02303743|3520173|B1|||Age||years|Mean|48|48.0|Full Range|||30.0|66.0|
3676057|NCT02303704|3520182|B3||Male|Sex: Female, Male||Participants|Count of Participants|378|378.0||||||
3676058|NCT02303704|3520183|B2||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
3676059|NCT02303704|3520184|B1||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
3676060|NCT02303704|3520182|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3676061|NCT02303704|3520183|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3676062|NCT02303704|3520184|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3676063|NCT02303704|3520182|B3|||Age||years|Mean|54.29|54.29|Standard Deviation|9.06|9.06|||
3676064|NCT02303704|3520183|B2|||Age||years|Mean|53.62|53.62|Standard Deviation|9.60|9.6|||
3676065|NCT02303704|3520184|B1|||Age||years|Mean|54.97|54.97|Standard Deviation|8.44|8.44|||
3676066|NCT02303574|3520201|B13|Part 2|Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3676067|NCT02303574|3520202|B12|Part 2|Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3676068|NCT02303574|3520203|B11|Part 2|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676069|NCT02303574|3520204|B10|Part 2|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676070|NCT02303574|3520205|B9|Part 2|Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3676071|NCT02303574|3520206|B8|Part 2|Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3676072|NCT02303574|3520207|B7|Part 2|Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3676073|NCT02303574|3520208|B6|Part 2|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676074|NCT02303574|3520209|B5|Part 2|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676075|NCT02303574|3520210|B4|Part 2|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676076|NCT02303574|3520211|B3|Part 2|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676077|NCT02303574|3520212|B2|Part 2|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676078|NCT02303574|3520213|B1|Part 2|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676079|NCT02303574|3520201|B13|Part 2|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676080|NCT02303574|3520202|B12|Part 2|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676081|NCT02303574|3520203|B11|Part 2|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676082|NCT02303574|3520204|B10|Part 2|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676083|NCT02303574|3520205|B9|Part 2|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676084|NCT02303574|3520206|B8|Part 2|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676085|NCT02303574|3520207|B7|Part 2|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676086|NCT02303574|3520208|B6|Part 2|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676087|NCT02303574|3520209|B5|Part 2|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676088|NCT02303574|3520210|B4|Part 2|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676089|NCT02303574|3520211|B3|Part 2|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676090|NCT02303574|3520212|B2|Part 2|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676091|NCT02303574|3520213|B1|Part 2|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676092|NCT02303574|3520201|B13|Part 1b|Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3676093|NCT02303574|3520202|B12|Part 1b|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676094|NCT02303574|3520203|B11|Part 1b|Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3676095|NCT02303574|3520204|B10|Part 1b|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676096|NCT02303574|3520205|B9|Part 1b|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676097|NCT02303574|3520206|B8|Part 1b|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676098|NCT02303574|3520207|B7|Part 1b|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676099|NCT02303574|3520208|B6|Part 1b|Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3676100|NCT02303574|3520209|B5|Part 1b|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676101|NCT02303574|3520210|B4|Part 1b|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676102|NCT02303574|3520211|B3|Part 1b|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676103|NCT02303574|3520212|B2|Part 1b|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676104|NCT02303574|3520213|B1|Part 1b|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676105|NCT02303574|3520201|B13|Part 1b|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676106|NCT02303574|3520202|B12|Part 1b|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676107|NCT02303574|3520203|B11|Part 1b|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676108|NCT02303574|3520204|B10|Part 1b|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676109|NCT02303574|3520205|B9|Part 1b|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676110|NCT02303574|3520206|B8|Part 1b|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676111|NCT02303574|3520207|B7|Part 1b|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676112|NCT02303574|3520208|B6|Part 1b|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676113|NCT02303574|3520209|B5|Part 1b|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676114|NCT02303574|3520210|B4|Part 1b|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676115|NCT02303574|3520211|B3|Part 1b|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676116|NCT02303574|3520212|B2|Part 1b|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676117|NCT02303574|3520213|B1|Part 1b|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676118|NCT02303574|3520201|B13|Part 1a|Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3676119|NCT02303574|3520202|B12|Part 1a|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676120|NCT02303574|3520203|B11|Part 1a|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676121|NCT02303574|3520204|B10|Part 1a|Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3676122|NCT02303574|3520205|B9|Part 1a|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676123|NCT02303574|3520206|B8|Part 1a|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676124|NCT02303574|3520207|B7|Part 1a|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676125|NCT02303574|3520208|B6|Part 1a|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676126|NCT02303574|3520209|B5|Part 1a|Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3676127|NCT02303574|3520210|B4|Part 1a|Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3676128|NCT02303574|3520211|B3|Part 1a|Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3676129|NCT02303574|3520212|B2|Part 1a|Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3676130|NCT02303574|3520213|B1|Part 1a|Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3676131|NCT02303574|3520201|B13|Part 1a|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676132|NCT02303574|3520202|B12|Part 1a|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676133|NCT02303574|3520203|B11|Part 1a|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676134|NCT02303574|3520204|B10|Part 1a|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676135|NCT02303574|3520205|B9|Part 1a|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676136|NCT02303574|3520206|B8|Part 1a|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676137|NCT02303574|3520207|B7|Part 1a|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676138|NCT02303574|3520208|B6|Part 1a|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676139|NCT02303574|3520209|B5|Part 1a|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676140|NCT02303574|3520210|B4|Part 1a|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676141|NCT02303574|3520211|B3|Part 1a|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676142|NCT02303574|3520212|B2|Part 1a|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676143|NCT02303574|3520213|B1|Part 1a|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676144|NCT02303574|3520201|B13|Part 2 Placebo||Age||Years|Mean|36.2|36.2|Standard Deviation|7.2|7.2|||
3676145|NCT02303574|3520202|B12|Part 2 Placebo||Age||Years|Mean|36.2|36.2|Standard Deviation|7.2|7.2|||
3676146|NCT02303574|3520201|B13|Part 1b Placebo||Age||Years|Mean|28.7|28.7|Standard Deviation|8.5|8.5|||
3676147|NCT02303574|3520203|B11|Part 1b Placebo||Age||Years|Mean|28.7|28.7|Standard Deviation|8.5|8.5|||
3676148|NCT02303574|3520201|B13|Part 1a Placebo||Age||Years|Mean|29.9|29.9|Standard Deviation|7.24|7.24|||
3676149|NCT02303574|3520204|B10|Part 1a Placebo||Age||Years|Mean|29.9|29.9|Standard Deviation|7.24|7.24|||
3676150|NCT02303574|3520201|B13|Part 2||Age||Years|Mean|34.8|34.8|Standard Deviation|8.05|8.05|||
3676151|NCT02303574|3520205|B9|Part 2||Age||Years|Mean|34.4|34.4|Standard Deviation|9.17|9.17|||
3676152|NCT02303574|3520206|B8|Part 2||Age||Years|Mean|38.4|38.4|Standard Deviation|7.25|7.25|||
3676153|NCT02303574|3520207|B7|Part 2||Age||Years|Mean|30.7|30.7|Standard Deviation|5.65|5.65|||
3676154|NCT02303574|3520201|B13|Part 1b||Age||Years|Mean|26.6|26.6|Standard Deviation|3.91|3.91|||
3676155|NCT02303574|3520208|B6|Part 1b||Age||Years|Mean|26.6|26.6|Standard Deviation|3.91|3.91|||
3676156|NCT02303574|3520201|B13|Part 1a||Age||Years|Mean|29.2|29.2|Standard Deviation|7.14|7.14|||
3676157|NCT02303574|3520209|B5|Part 1a||Age||Years|Mean|29.7|29.7|Standard Deviation|6.65|6.65|||
3676158|NCT02303574|3520210|B4|Part 1a||Age||Years|Mean|32.2|32.2|Standard Deviation|10.5|10.5|||
3676159|NCT02303574|3520211|B3|Part 1a||Age||Years|Mean|26.2|26.2|Standard Deviation|3.66|3.66|||
3676160|NCT02303574|3520212|B2|Part 1a||Age||Years|Mean|29.7|29.7|Standard Deviation|8.78|8.78|||
3676161|NCT02303574|3520213|B1|Part 1a||Age||Years|Mean|28.5|28.5|Standard Deviation|5.39|5.39|||
3676162|NCT02302846|3520434|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3676163|NCT02302846|3520434|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676164|NCT02302846|3520434|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3676165|NCT02302846|3520434|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3676166|NCT02302846|3520434|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3676167|NCT02302846|3520434|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3676168|NCT02302846|3520434|B1|||Age||years|Median|60|60.0|Full Range|||20.0|80.0|
3676169|NCT02302846|3520434|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3676170|NCT02302846|3520434|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3676171|NCT02302846|3520434|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3676172|NCT02302807|3520438|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
3676173|NCT02302807|3520439|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3676174|NCT02302807|3520440|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3676175|NCT02302807|3520438|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3676176|NCT02302807|3520439|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676177|NCT02302807|3520440|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3676178|NCT02302807|3520438|B3||White|Race (NIH/OMB)||Participants|Count of Participants|671|671.0||||||
3676179|NCT02302807|3520439|B2||White|Race (NIH/OMB)||Participants|Count of Participants|335|335.0||||||
3676180|NCT02302807|3520440|B1||White|Race (NIH/OMB)||Participants|Count of Participants|336|336.0||||||
3676181|NCT02302807|3520438|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3676182|NCT02302807|3520439|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3676183|NCT02302807|3520440|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3676184|NCT02302807|3520438|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676185|NCT02302807|3520439|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676186|NCT02302807|3520440|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676187|NCT02302807|3520438|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|118|118.0||||||
3676188|NCT02302807|3520439|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3676189|NCT02302807|3520440|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3676190|NCT02302807|3520438|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676191|NCT02302807|3520439|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676192|NCT02302807|3520440|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676193|NCT02302807|3520438|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|171|171.0||||||
3676194|NCT02302807|3520439|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3676195|NCT02302807|3520440|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3676196|NCT02302807|3520438|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|731|731.0||||||
3676197|NCT02302807|3520439|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|363|363.0||||||
3676198|NCT02302807|3520440|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|368|368.0||||||
3676199|NCT02302807|3520438|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3676200|NCT02302807|3520439|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3676201|NCT02302807|3520440|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3676202|NCT02302807|3520438|B3||Male|Sex: Female, Male||Participants|Count of Participants|718|718.0||||||
3676203|NCT02302807|3520439|B2||Male|Sex: Female, Male||Participants|Count of Participants|357|357.0||||||
3676204|NCT02302807|3520440|B1||Male|Sex: Female, Male||Participants|Count of Participants|361|361.0||||||
3676205|NCT02302807|3520438|B3||Female|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
3676206|NCT02302807|3520439|B2||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3676207|NCT02302807|3520440|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3676208|NCT02302807|3520438|B3|||Age||Years|Mean|66.0|66.0|Standard Deviation|9.4|9.4|||
3676209|NCT02302807|3520439|B2|||Age||Years|Mean|65.9|65.9|Standard Deviation|9.6|9.6|||
3676210|NCT02302807|3520440|B1|||Age||Years|Mean|66.1|66.1|Standard Deviation|9.3|9.3|||
3676211|NCT02302716|3520486|B3||Evening/Bedtime|Time of basal insulin injection|Number of participants who administered a basal insulin injection during the Daytime and Evening/Bedtime.|Participants|Count of Participants|298|298.0||||||
3676212|NCT02302716|3520487|B2||Evening/Bedtime|Time of basal insulin injection|Number of participants who administered a basal insulin injection during the Daytime and Evening/Bedtime.|Participants|Count of Participants|148|148.0||||||
3676213|NCT02302716|3520488|B1||Evening/Bedtime|Time of basal insulin injection|Number of participants who administered a basal insulin injection during the Daytime and Evening/Bedtime.|Participants|Count of Participants|150|150.0||||||
3676214|NCT02302716|3520486|B3||Daytime|Time of basal insulin injection|Number of participants who administered a basal insulin injection during the Daytime and Evening/Bedtime.|Participants|Count of Participants|195|195.0||||||
3676215|NCT02302716|3520487|B2||Daytime|Time of basal insulin injection|Number of participants who administered a basal insulin injection during the Daytime and Evening/Bedtime.|Participants|Count of Participants|96|96.0||||||
3676216|NCT02302716|3520488|B1||Daytime|Time of basal insulin injection|Number of participants who administered a basal insulin injection during the Daytime and Evening/Bedtime.|Participants|Count of Participants|99|99.0||||||
3676217|NCT02302716|3520486|B3|||Duration of Diabetes||years|Mean|11.92|11.92|Standard Deviation|6.40|6.4|||
3676218|NCT02302716|3520487|B2|||Duration of Diabetes||years|Mean|12.26|12.26|Standard Deviation|6.45|6.45|||
3676219|NCT02302716|3520488|B1|||Duration of Diabetes||years|Mean|11.59|11.59|Standard Deviation|6.34|6.34|||
3676220|NCT02302716|3520486|B3|No, did not use sulfonylurea||Sulfonylurea Group||Participants|Count of Participants|79|79.0||||||
3676221|NCT02302716|3520487|B2|No, did not use sulfonylurea||Sulfonylurea Group||Participants|Count of Participants|37|37.0||||||
3676222|NCT02302716|3520488|B1|No, did not use sulfonylurea||Sulfonylurea Group||Participants|Count of Participants|42|42.0||||||
3676223|NCT02302716|3520486|B3|Yes, did use sulfonylurea||Sulfonylurea Group||Participants|Count of Participants|414|414.0||||||
3676224|NCT02302716|3520487|B2|Yes, did use sulfonylurea||Sulfonylurea Group||Participants|Count of Participants|207|207.0||||||
3676225|NCT02302716|3520488|B1|Yes, did use sulfonylurea||Sulfonylurea Group||Participants|Count of Participants|207|207.0||||||
3676226|NCT02302716|3520486|B3|||Baseline Hemoglobin A1c (HbA1c)|HbA1c is the glycosylated fraction of hemoglobin A. HbA1c is measured primarily to identify average plasma glucose concentration over prolonged periods of time.|Percentage of glycosylated hemoglobin|Mean|8.61|8.61|Standard Deviation|1.06|1.06|||
3676227|NCT02302716|3520487|B2|||Baseline Hemoglobin A1c (HbA1c)|HbA1c is the glycosylated fraction of hemoglobin A. HbA1c is measured primarily to identify average plasma glucose concentration over prolonged periods of time.|Percentage of glycosylated hemoglobin|Mean|8.56|8.56|Standard Deviation|1.02|1.02|||
3676228|NCT02302716|3520488|B1|||Baseline Hemoglobin A1c (HbA1c)|HbA1c is the glycosylated fraction of hemoglobin A. HbA1c is measured primarily to identify average plasma glucose concentration over prolonged periods of time.|Percentage of glycosylated hemoglobin|Mean|8.66|8.66|Standard Deviation|1.09|1.09|||
3676229|NCT02302716|3520486|B3|Russia||Region of Enrollment||Participants|Count of Participants|55|55.0||||||
3676230|NCT02302716|3520487|B2|Russia||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3676231|NCT02302716|3520488|B1|Russia||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3676232|NCT02302716|3520486|B3|India||Region of Enrollment||Participants|Count of Participants|100|100.0||||||
3676233|NCT02302716|3520487|B2|India||Region of Enrollment||Participants|Count of Participants|51|51.0||||||
3676234|NCT02302716|3520488|B1|India||Region of Enrollment||Participants|Count of Participants|49|49.0||||||
3676235|NCT02302716|3520486|B3|Taiwan||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3676236|NCT02302716|3520487|B2|Taiwan||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3676237|NCT02302716|3520488|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3676238|NCT02302716|3520486|B3|United States||Region of Enrollment||Participants|Count of Participants|117|117.0||||||
3676239|NCT02302716|3520487|B2|United States||Region of Enrollment||Participants|Count of Participants|57|57.0||||||
3676240|NCT02302716|3520488|B1|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3676241|NCT02302716|3520486|B3|Turkey||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3676242|NCT02302716|3520487|B2|Turkey||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3676243|NCT02302716|3520488|B1|Turkey||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3676244|NCT02302716|3520486|B3|Puerto Rico||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
3676245|NCT02302716|3520487|B2|Puerto Rico||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3676246|NCT02302716|3520488|B1|Puerto Rico||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3676247|NCT02302716|3520486|B3|South Korea||Region of Enrollment||Participants|Count of Participants|92|92.0||||||
3676248|NCT02302716|3520487|B2|South Korea||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3676249|NCT02302716|3520488|B1|South Korea||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
3676250|NCT02302716|3520486|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676251|NCT02302716|3520487|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676252|NCT02302716|3520488|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676253|NCT02302716|3520486|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3676254|NCT02302716|3520487|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3676255|NCT02302716|3520488|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3676256|NCT02302716|3520486|B3||White|Race (NIH/OMB)||Participants|Count of Participants|225|225.0||||||
3676257|NCT02302716|3520487|B2||White|Race (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
3676258|NCT02302716|3520488|B1||White|Race (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
3676259|NCT02302716|3520486|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3676260|NCT02302716|3520487|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3676261|NCT02302716|3520488|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3676262|NCT02302716|3520486|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676263|NCT02302716|3520487|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676264|NCT02302716|3520488|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676265|NCT02302716|3520486|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|234|234.0||||||
3676266|NCT02302716|3520487|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|118|118.0||||||
3676267|NCT02302716|3520488|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|116|116.0||||||
3676268|NCT02302716|3520486|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3676269|NCT02302716|3520487|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676270|NCT02302716|3520488|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3676271|NCT02302716|3520486|B3||Male|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
3676272|NCT02302716|3520487|B2||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3676273|NCT02302716|3520488|B1||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3676274|NCT02302716|3520486|B3||Female|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
3676275|NCT02302716|3520487|B2||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3676276|NCT02302716|3520488|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3676277|NCT02302716|3520486|B3|||Age||years|Mean|57.40|57.4|Standard Deviation|9.35|9.35|||
3676278|NCT02302716|3520487|B2|||Age||years|Mean|56.98|56.98|Standard Deviation|9.86|9.86|||
3676279|NCT02302716|3520488|B1|||Age||years|Mean|57.82|57.82|Standard Deviation|8.83|8.83|||
3676280|NCT02302365|3520515|B1|||Total Blood Volume||Liters|Mean|4.7|4.7|Standard Deviation|0.8|0.8|||
3676281|NCT02302365|3520515|B1|||Height||cm|Mean|170.9|170.9|Standard Deviation|10.3|10.3|||
3676282|NCT02302365|3520515|B1|||Weight||kg|Mean|73.2|73.2|Standard Deviation|16.7|16.7|||
3676283|NCT02302365|3520515|B1|Hungary||Region of Enrollment||participants|Number|23|23.0||||||
3676284|NCT02302365|3520515|B1|Germany||Region of Enrollment||participants|Number|11|11.0||||||
3676285|NCT02302365|3520515|B1|Belgium||Region of Enrollment||participants|Number|9|9.0||||||
3676286|NCT02302365|3520515|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3676287|NCT02302365|3520515|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3676288|NCT02302365|3520515|B1|||Age||years|Mean|51.9|51.9|Standard Deviation|17.1|17.1|||
3676289|NCT02302222|3520533|B3|United States||Region of Enrollment||participants|Number|70|70.0||||||
3676290|NCT02302222|3520534|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
3676291|NCT02302222|3520535|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
3676292|NCT02302222|3520533|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676293|NCT02302222|3520534|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676294|NCT02302222|3520535|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676295|NCT02302222|3520533|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676296|NCT02302222|3520534|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676297|NCT02302222|3520535|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676298|NCT02302222|3520533|B3||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3676299|NCT02302222|3520534|B2||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3676300|NCT02302222|3520535|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3676301|NCT02302222|3520533|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3676302|NCT02302222|3520534|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3676303|NCT02302222|3520535|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3676304|NCT02302222|3520533|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676305|NCT02302222|3520534|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676306|NCT02302222|3520535|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676307|NCT02302222|3520533|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676308|NCT02302222|3520534|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676309|NCT02302222|3520535|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676310|NCT02302222|3520533|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3676311|NCT02302222|3520534|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3676312|NCT02302222|3520535|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676313|NCT02302222|3520533|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676314|NCT02302222|3520534|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676315|NCT02302222|3520535|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676316|NCT02302222|3520533|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3676317|NCT02302222|3520534|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3676318|NCT02302222|3520535|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3676319|NCT02302222|3520533|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3676320|NCT02302222|3520534|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3676321|NCT02302222|3520535|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3676322|NCT02302222|3520533|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3676323|NCT02302222|3520534|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3676324|NCT02302222|3520535|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676325|NCT02302222|3520533|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3676326|NCT02302222|3520534|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3676327|NCT02302222|3520535|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3676328|NCT02302222|3520533|B3|||Age||years|Mean|42.5|42.5|Standard Deviation|7.78|7.78|||
3676329|NCT02302222|3520534|B2|||Age||years|Mean|41.8|41.8|Standard Deviation|7.83|7.83|||
3676330|NCT02302222|3520535|B1|||Age||years|Mean|43.2|43.2|Standard Deviation|7.79|7.79|||
3676331|NCT02302092|3520542|B3|Tobacco user||Smoking status||participants|Number|3|3.0||||||
3676332|NCT02302092|3520543|B2|Tobacco user||Smoking status||participants|Number|1|1.0||||||
3676333|NCT02302092|3520544|B1|Tobacco user||Smoking status||participants|Number|2|2.0||||||
3676334|NCT02302092|3520542|B3|Non-tobacco user||Smoking status||participants|Number|10|10.0||||||
3676335|NCT02302092|3520543|B2|Non-tobacco user||Smoking status||participants|Number|6|6.0||||||
3676336|NCT02302092|3520544|B1|Non-tobacco user||Smoking status||participants|Number|4|4.0||||||
3676337|NCT02302092|3520542|B3|||Body mass index|Body Mass Index = weight (kg)/[height (m)^2].|kg/m^2|Mean|28.458|28.458|Standard Deviation|7.262|7.262|||
3676338|NCT02302092|3520543|B2|||Body mass index|Body Mass Index = weight (kg)/[height (m)^2].|kg/m^2|Mean|31.041|31.041|Standard Deviation|8.321|8.321|||
3676339|NCT02302092|3520544|B1|||Body mass index|Body Mass Index = weight (kg)/[height (m)^2].|kg/m^2|Mean|25.443|25.443|Standard Deviation|4.821|4.821|||
3676340|NCT02302092|3520542|B3|Russia||Region of Enrollment||participants|Number|13|13.0||||||
3676341|NCT02302092|3520543|B2|Russia||Region of Enrollment||participants|Number|7|7.0||||||
3676342|NCT02302092|3520544|B1|Russia||Region of Enrollment||participants|Number|6|6.0||||||
3676343|NCT02302092|3520542|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3676344|NCT02302092|3520543|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3676345|NCT02302092|3520544|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3676346|NCT02302092|3520542|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3676347|NCT02302092|3520543|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3676348|NCT02302092|3520544|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3676349|NCT02302092|3520542|B3|||Age||years|Mean|54.1|54.1|Standard Deviation|14.3|14.3|||
3676350|NCT02302092|3520543|B2|||Age||years|Mean|53.3|53.3|Standard Deviation|12.9|12.9|||
3676351|NCT02302092|3520544|B1|||Age||years|Mean|55.0|55.0|Standard Deviation|17.1|17.1|||
3676352|NCT02301988|3520571|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3676353|NCT02301988|3520572|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3676354|NCT02301988|3520573|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3676355|NCT02301988|3520571|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676356|NCT02301988|3520572|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676357|NCT02301988|3520573|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676358|NCT02301988|3520571|B3||White|Race (NIH/OMB)||Participants|Count of Participants|141|141.0||||||
3676359|NCT02301988|3520572|B2||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3676360|NCT02301988|3520573|B1||White|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3676361|NCT02301988|3520571|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3676362|NCT02301988|3520572|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3676363|NCT02301988|3520573|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3676364|NCT02301988|3520571|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3676365|NCT02301988|3520572|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676366|NCT02301988|3520573|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3676367|NCT02301988|3520571|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3676368|NCT02301988|3520572|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3676369|NCT02301988|3520573|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676370|NCT02301988|3520571|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676371|NCT02301988|3520572|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676372|NCT02301988|3520573|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676373|NCT02301988|3520571|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676374|NCT02301988|3520572|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676375|NCT02301988|3520573|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676376|NCT02301988|3520571|B3||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3676377|NCT02301988|3520572|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3676378|NCT02301988|3520573|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3676379|NCT02301988|3520571|B3|||Age||years|Mean|53.8|53.8|Standard Deviation|11.5|11.5|||
3676380|NCT02301988|3520572|B2|||Age||years|Mean|53.8|53.8|Standard Deviation|12.0|12.0|||
3676381|NCT02301988|3520573|B1|||Age||years|Mean|53.8|53.8|Standard Deviation|10.9|10.9|||
3676382|NCT02301975|3520604|B4|Asian - East Asian and White Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3676383|NCT02301975|3520605|B3|Asian - East Asian and White Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3676384|NCT02301975|3520606|B2|Asian - East Asian and White Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3676385|NCT02301975|3520607|B1|Asian - East Asian and White Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3676386|NCT02301975|3520604|B4|American Indian/Alaskan Native and White Heritage||Race/Ethnicity, Customized||Participants|Number|192|192.0||||||
3676387|NCT02301975|3520605|B3|American Indian/Alaskan Native and White Heritage||Race/Ethnicity, Customized||Participants|Number|64|64.0||||||
3676388|NCT02301975|3520606|B2|American Indian/Alaskan Native and White Heritage||Race/Ethnicity, Customized||Participants|Number|62|62.0||||||
3676389|NCT02301975|3520607|B1|American Indian/Alaskan Native and White Heritage||Race/Ethnicity, Customized||Participants|Number|66|66.0||||||
3676390|NCT02301975|3520604|B4|African American/ African and White Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3676391|NCT02301975|3520605|B3|African American/ African and White Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3676392|NCT02301975|3520606|B2|African American/ African and White Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3676393|NCT02301975|3520607|B1|African American/ African and White Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3676394|NCT02301975|3520604|B4|White- Mixed White Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3676395|NCT02301975|3520605|B3|White- Mixed White Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3676396|NCT02301975|3520606|B2|White- Mixed White Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3676397|NCT02301975|3520607|B1|White- Mixed White Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3676398|NCT02301975|3520604|B4|White- White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|1232|1232.0||||||
3676399|NCT02301975|3520605|B3|White- White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|410|410.0||||||
3676400|NCT02301975|3520606|B2|White- White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|407|407.0||||||
3676401|NCT02301975|3520607|B1|White- White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|415|415.0||||||
3676402|NCT02301975|3520604|B4|White- Arabic/ North African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3676403|NCT02301975|3520605|B3|White- Arabic/ North African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3676404|NCT02301975|3520606|B2|White- Arabic/ North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3676405|NCT02301975|3520607|B1|White- Arabic/ North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3676406|NCT02301975|3520604|B4|Black/African American Heritage||Race/Ethnicity, Customized||Participants|Number|43|43.0||||||
3676407|NCT02301975|3520605|B3|Black/African American Heritage||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
3676408|NCT02301975|3520606|B2|Black/African American Heritage||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3676409|NCT02301975|3520607|B1|Black/African American Heritage||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3676410|NCT02301975|3520604|B4|Asian- South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3676411|NCT02301975|3520605|B3|Asian- South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3676412|NCT02301975|3520606|B2|Asian- South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3676413|NCT02301975|3520607|B1|Asian- South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3676414|NCT02301975|3520604|B4|Asian- Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3676415|NCT02301975|3520605|B3|Asian- Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3676416|NCT02301975|3520606|B2|Asian- Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3676417|NCT02301975|3520607|B1|Asian- Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3676418|NCT02301975|3520604|B4|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
3676419|NCT02301975|3520605|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3676420|NCT02301975|3520606|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3676421|NCT02301975|3520607|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3676422|NCT02301975|3520604|B4|American Indian or Alaska native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3676423|NCT02301975|3520605|B3|American Indian or Alaska native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3676424|NCT02301975|3520606|B2|American Indian or Alaska native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3676425|NCT02301975|3520607|B1|American Indian or Alaska native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3676426|NCT02301975|3520604|B4||Male|Sex: Female, Male||Participants|Count of Participants|540|540.0||||||
3676427|NCT02301975|3520605|B3||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
3676428|NCT02301975|3520606|B2||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3676429|NCT02301975|3520607|B1||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
3676430|NCT02301975|3520604|B4||Female|Sex: Female, Male||Participants|Count of Participants|964|964.0||||||
3676431|NCT02301975|3520605|B3||Female|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
3676432|NCT02301975|3520606|B2||Female|Sex: Female, Male||Participants|Count of Participants|336|336.0||||||
3676433|NCT02301975|3520607|B1||Female|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
3676434|NCT02301975|3520604|B4|||Age||Participants|Mean|43.5|43.5|Standard Deviation|16.04|16.04|||
3676435|NCT02301975|3520605|B3|||Age||Participants|Mean|43.0|43.0|Standard Deviation|16.58|16.58|||
3676436|NCT02301975|3520606|B2|||Age||Participants|Mean|43.0|43.0|Standard Deviation|15.20|15.2|||
3676437|NCT02301975|3520607|B1|||Age||Participants|Mean|44.4|44.4|Standard Deviation|16.30|16.3|||
3676438|NCT02301936|3520635|B3|Treatment-Experienced (Cirrhosis)||Prior HCV Treatment Experience With Cirrhosis||Participants|Count of Participants|1|1.0||||||
3676439|NCT02301936|3520636|B2|Treatment-Experienced (Cirrhosis)||Prior HCV Treatment Experience With Cirrhosis||Participants|Count of Participants|1|1.0||||||
3676440|NCT02301936|3520637|B1|Treatment-Experienced (Cirrhosis)||Prior HCV Treatment Experience With Cirrhosis||Participants|Count of Participants|0|0.0||||||
3676441|NCT02301936|3520635|B3|Treatment-Experienced (Non-cirrhosis)||Prior HCV Treatment Experience With Cirrhosis||Participants|Count of Participants|2|2.0||||||
3676442|NCT02301936|3520636|B2|Treatment-Experienced (Non-cirrhosis)||Prior HCV Treatment Experience With Cirrhosis||Participants|Count of Participants|0|0.0||||||
3676443|NCT02301936|3520637|B1|Treatment-Experienced (Non-cirrhosis)||Prior HCV Treatment Experience With Cirrhosis||Participants|Count of Participants|2|2.0||||||
3676444|NCT02301936|3520635|B3|Treatment-Naive (Non-cirrhosis)||Prior HCV Treatment Experience With Cirrhosis||Participants|Count of Participants|7|7.0||||||
3676445|NCT02301936|3520636|B2|Treatment-Naive (Non-cirrhosis)||Prior HCV Treatment Experience With Cirrhosis||Participants|Count of Participants|0|0.0||||||
3676446|NCT02301936|3520637|B1|Treatment-Naive (Non-cirrhosis)||Prior HCV Treatment Experience With Cirrhosis||Participants|Count of Participants|7|7.0||||||
3676447|NCT02301936|3520635|B3|Presence||Cirrhosis status||Participants|Count of Participants|1|1.0||||||
3676448|NCT02301936|3520636|B2|Presence||Cirrhosis status||Participants|Count of Participants|1|1.0||||||
3676449|NCT02301936|3520637|B1|Presence||Cirrhosis status||Participants|Count of Participants|0|0.0||||||
3676450|NCT02301936|3520635|B3|Absence||Cirrhosis status||Participants|Count of Participants|9|9.0||||||
3676451|NCT02301936|3520636|B2|Absence||Cirrhosis status||Participants|Count of Participants|0|0.0||||||
3676452|NCT02301936|3520637|B1|Absence||Cirrhosis status||Participants|Count of Participants|9|9.0||||||
3676453|NCT02301936|3520635|B3|Genotype 4h||HCV genotype||Participants|Count of Participants|1|1.0||||||
3676454|NCT02301936|3520636|B2|Genotype 4h||HCV genotype||Participants|Count of Participants|0|0.0||||||
3676455|NCT02301936|3520637|B1|Genotype 4h||HCV genotype||Participants|Count of Participants|1|1.0||||||
3676456|NCT02301936|3520635|B3|Genotype 4f||HCV genotype||Participants|Count of Participants|1|1.0||||||
3676457|NCT02301936|3520636|B2|Genotype 4f||HCV genotype||Participants|Count of Participants|0|0.0||||||
3676458|NCT02301936|3520637|B1|Genotype 4f||HCV genotype||Participants|Count of Participants|1|1.0||||||
3676459|NCT02301936|3520635|B3|Genotype 4a/4c/4d||HCV genotype||Participants|Count of Participants|1|1.0||||||
3676460|NCT02301936|3520636|B2|Genotype 4a/4c/4d||HCV genotype||Participants|Count of Participants|0|0.0||||||
3676461|NCT02301936|3520637|B1|Genotype 4a/4c/4d||HCV genotype||Participants|Count of Participants|1|1.0||||||
3676462|NCT02301936|3520635|B3|Genotype 1b||HCV genotype||Participants|Count of Participants|1|1.0||||||
3676463|NCT02301936|3520636|B2|Genotype 1b||HCV genotype||Participants|Count of Participants|0|0.0||||||
3676464|NCT02301936|3520637|B1|Genotype 1b||HCV genotype||Participants|Count of Participants|1|1.0||||||
3676465|NCT02301936|3520635|B3|Genotype 1a||HCV genotype||Participants|Count of Participants|6|6.0||||||
3676466|NCT02301936|3520636|B2|Genotype 1a||HCV genotype||Participants|Count of Participants|1|1.0||||||
3676467|NCT02301936|3520637|B1|Genotype 1a||HCV genotype||Participants|Count of Participants|5|5.0||||||
3676468|NCT02301936|3520635|B3|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|4|4.0||||||
3676469|NCT02301936|3520636|B2|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|1|1.0||||||
3676470|NCT02301936|3520637|B1|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|3|3.0||||||
3676471|NCT02301936|3520635|B3|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|6|6.0||||||
3676472|NCT02301936|3520636|B2|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|0|0.0||||||
3676473|NCT02301936|3520637|B1|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|6|6.0||||||
3676474|NCT02301936|3520635|B3|||HCV RNA||log10 IU/mL|Mean|5.8|5.8|Standard Deviation|0.71|0.71|||
3676475|NCT02301936|3520636|B2|||HCV RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|NA||||This treatment group had 1 participant only so SD is not applicable.
3676476|NCT02301936|3520637|B1|||HCV RNA||log10 IU/mL|Mean|5.8|5.8|Standard Deviation|0.74|0.74|||
3676477|NCT02301936|3520635|B3|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|6|6.0||||||
3676478|NCT02301936|3520636|B2|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|0|0.0||||||
3676479|NCT02301936|3520637|B1|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|6|6.0||||||
3676480|NCT02301936|3520635|B3|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|3|3.0||||||
3676481|NCT02301936|3520636|B2|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|1|1.0||||||
3676482|NCT02301936|3520637|B1|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|2|2.0||||||
3676483|NCT02301936|3520635|B3|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|1|1.0||||||
3676484|NCT02301936|3520636|B2|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|0|0.0||||||
3676485|NCT02301936|3520637|B1|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|1|1.0||||||
3676486|NCT02301936|3520635|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3676487|NCT02301936|3520636|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3676488|NCT02301936|3520637|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3676489|NCT02301936|3520635|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3676490|NCT02301936|3520636|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3676491|NCT02301936|3520637|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3676492|NCT02301936|3520635|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3676493|NCT02301936|3520636|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676494|NCT02301936|3520637|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3676495|NCT02301936|3520635|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3676496|NCT02301936|3520636|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3676497|NCT02301936|3520637|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3676498|NCT02301936|3520635|B3|||Age||Years|Mean|43|43.0|Standard Deviation|14.1|14.1|||
3676499|NCT02301936|3520636|B2|||Age||Years|Mean|44|44.0|Standard Deviation|NA||||This treatment group had 1 participant only so standard deviation (SD) is not applicable.
3676500|NCT02301936|3520637|B1|||Age||Years|Mean|43|43.0|Standard Deviation|14.9|14.9|||
3676501|NCT02301429|3520660|B1|||QRS duration||msec|Mean|108.7|108.7|Standard Deviation|17.6|17.6|||
3676502|NCT02301429|3520660|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3676503|NCT02301429|3520660|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3676504|NCT02301429|3520660|B1|||Age||years|Mean|73.2|73.2|Standard Deviation|11.2|11.2|||
3676505|NCT02301377|3520664|B3|||Cystic Fibrosis Questionnaire-Revised (CFQ-R) Treatment Burden Domain (Parent)|This is a well-validated measure of health-related quality of life among children with CF. It assesses functionality in several disease-specific domains including treatment burden. A total score is calculated for each domain, which varies based on the number of questions in that domain. This is then converted to a scaled score between 0-100 for better comparison between the domains. Higher scores reflect better quality of life.|units on a scale|Mean|60|60.0|Standard Deviation|17.14|17.14|||
3676506|NCT02301377|3520665|B2|||Cystic Fibrosis Questionnaire-Revised (CFQ-R) Treatment Burden Domain (Parent)|This is a well-validated measure of health-related quality of life among children with CF. It assesses functionality in several disease-specific domains including treatment burden. A total score is calculated for each domain, which varies based on the number of questions in that domain. This is then converted to a scaled score between 0-100 for better comparison between the domains. Higher scores reflect better quality of life.|units on a scale|Mean|61|61.0|Standard Deviation|24.04|24.04|||
3676549|NCT02300558|3520701|B1|||Mean Nocturnal QTcF in Lead V5 (Holter)|"AUC(0-6) for QTcF was calculated using the trapezoidal rule, mean of triplicate values, and nominal time.~Mean nocturnal QTcF (AUC 0-6/6) was computed by dividing AUC(0-6) by the time from the first nonmissing nominal time point to the last nonmissing nominal time point, from midnight to 6:00 AM."|msec|Mean|530.6|530.6|Standard Deviation|52.25|52.25|||
3676603|NCT02300103|3520751|B1|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|15|15.0||||||
3676507|NCT02301377|3520666|B1|||Cystic Fibrosis Questionnaire-Revised (CFQ-R) Treatment Burden Domain (Parent)|This is a well-validated measure of health-related quality of life among children with CF. It assesses functionality in several disease-specific domains including treatment burden. A total score is calculated for each domain, which varies based on the number of questions in that domain. This is then converted to a scaled score between 0-100 for better comparison between the domains. Higher scores reflect better quality of life.|units on a scale|Mean|59.33|59.33|Standard Deviation|17.24|17.24|||
3676508|NCT02301377|3520664|B3|||Cystic Fibrosis Questionnaire-Revised (CFQ-R) Treatment Burden Domain Score (Child)|This is a well-validated measure of health-related quality of life among children with CF. It assesses functionality in several disease-specific domains including treatment burden. A total score is calculated for each domain, which varies based on the number of questions in that domain. This is then converted to a scaled score between 0-100 for better comparison between the domains. Higher scores reflect better quality of life.|units on a scale|Mean|75.8|75.8|Standard Deviation|16.31|16.31|||
3676509|NCT02301377|3520665|B2|||Cystic Fibrosis Questionnaire-Revised (CFQ-R) Treatment Burden Domain Score (Child)|This is a well-validated measure of health-related quality of life among children with CF. It assesses functionality in several disease-specific domains including treatment burden. A total score is calculated for each domain, which varies based on the number of questions in that domain. This is then converted to a scaled score between 0-100 for better comparison between the domains. Higher scores reflect better quality of life.|units on a scale|Mean|78|78.0|Standard Deviation|31.11|31.11|||
3676510|NCT02301377|3520666|B1|||Cystic Fibrosis Questionnaire-Revised (CFQ-R) Treatment Burden Domain Score (Child)|This is a well-validated measure of health-related quality of life among children with CF. It assesses functionality in several disease-specific domains including treatment burden. A total score is calculated for each domain, which varies based on the number of questions in that domain. This is then converted to a scaled score between 0-100 for better comparison between the domains. Higher scores reflect better quality of life.|units on a scale|Mean|74.33|74.33|Standard Deviation|6.35|6.35|||
3676511|NCT02301377|3520664|B3|||Body Mass Index (BMI) Percentile||Percentile|Mean|55.2|55.2|Standard Deviation|20.14|20.14|||
3676512|NCT02301377|3520665|B2|||Body Mass Index (BMI) Percentile||Percentile|Mean|41.5|41.5|Standard Deviation|16.26|16.26|||
3676513|NCT02301377|3520666|B1|||Body Mass Index (BMI) Percentile||Percentile|Mean|64.33|64.33|Standard Deviation|19.14|19.14|||
3676514|NCT02301377|3520664|B3|||Forced expiratory volume in 1 second (FEV1)||%predicted|Mean|81.8|81.8|Standard Deviation|15.61|15.61|||
3676515|NCT02301377|3520665|B2|||Forced expiratory volume in 1 second (FEV1)||%predicted|Mean|93|93.0|Standard Deviation|1.41|1.41|||
3676516|NCT02301377|3520666|B1|||Forced expiratory volume in 1 second (FEV1)||%predicted|Mean|74.33|74.33|Standard Deviation|16.65|16.65|||
3676517|NCT02301377|3520664|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3676518|NCT02301377|3520665|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3676519|NCT02301377|3520666|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676520|NCT02301377|3520664|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3676521|NCT02301377|3520665|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3676522|NCT02301377|3520666|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3676523|NCT02301377|3520664|B3|||Age||years|Mean|11.67|11.67|Standard Deviation|0.82|0.82|||
3676524|NCT02301377|3520665|B2|||Age||years|Mean|11.93|11.93|Standard Deviation|1.29|1.29|||
3676525|NCT02301377|3520666|B1|||Age||years|Mean|11.51|11.51|Standard Deviation|0.64|0.64|||
3676526|NCT02301364|3520677|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3676527|NCT02301364|3520677|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676528|NCT02301364|3520677|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676529|NCT02301364|3520677|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3676530|NCT02301364|3520677|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676531|NCT02301364|3520677|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676532|NCT02301364|3520677|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676533|NCT02301364|3520677|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676534|NCT02301364|3520677|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676535|NCT02301364|3520677|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3676536|NCT02301364|3520677|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676537|NCT02301364|3520677|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3676538|NCT02301364|3520677|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3676539|NCT02301364|3520677|B1|||Age||years|Median|64|64.0|Full Range|||55.0|79.0|
3676540|NCT02301169|3520684|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3676541|NCT02301169|3520685|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3676542|NCT02301169|3520686|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3676543|NCT02301169|3520684|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3676544|NCT02301169|3520685|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3676545|NCT02301169|3520686|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3676546|NCT02301169|3520684|B3|||Age||years|Mean|56.8|56.8|Standard Deviation|11.5|11.5|||
3676547|NCT02301169|3520685|B2|||Age||years|Mean|55.5|55.5|Standard Deviation|12.7|12.7|||
3676548|NCT02301169|3520686|B1|||Age||years|Mean|58|58.0|Standard Deviation|10.3|10.3|||
3676601|NCT02300129|3520738|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3676602|NCT02300103|3520751|B1|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|54|54.0||||||
3676550|NCT02300558|3520701|B1|||Mean Daily QTcF in Lead V5 (Holter)|"AUC (0-6) was calculated using the trapezoidal rule, mean of triplicate vales, and nominal time.~Mean daytime QTcF (AUC 0-6/6) was computed by dividing AUC(0-6) by the time from the first nonmissing time^ to the last nonmissing time^, from predose to 6 hours postdose.~Mean nocturnal QTcF (AUC 0-6/6) was computed by dividing AUC(0-6) by the time from the first nonmissing time^ to the last nonmissing time^, from midnight to 6:00 AM.~Daily was computed as the average of daytime AUC(0-6/6) and nocturnal AUC (0-6/6), when both values are not missing.~^ = nominal time point"|msec|Mean|514.7|514.7|Standard Deviation|45.76|45.76|||
3676551|NCT02300558|3520701|B1|||Mean Daytime QTcF Lead V5 (Standard 12-lead ECG)|"QTcF refers to QT interval corrected for heart rate using the Fridericia formula. QTcF = QT/cube root (RR), where RR is in seconds.~AUC0-6 for QTcF was calculated using the trapezoidal rule, mean of triplicate values, and actual time (latest of triplicate times).~Mean daytime QTcF (AUC0-6/6) was computed by dividing AUC0-6 by the time from dosing to the 6 hour postdose time point."|msec|Mean|507.5|507.5|Standard Deviation|38.11|38.11|||
3676552|NCT02300558|3520701|B1|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3676553|NCT02300558|3520701|B1|France||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3676554|NCT02300558|3520701|B1|Israel||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3676555|NCT02300558|3520701|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3676556|NCT02300558|3520701|B1|Italy||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3676557|NCT02300558|3520701|B1|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3676558|NCT02300558|3520701|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3676559|NCT02300558|3520701|B1|Canada||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3676560|NCT02300558|3520701|B1||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3676561|NCT02300558|3520701|B1||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3676562|NCT02300558|3520701|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3676563|NCT02300558|3520701|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3676564|NCT02300558|3520701|B1||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3676565|NCT02300558|3520701|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3676566|NCT02300558|3520701|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3676567|NCT02300558|3520701|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3676568|NCT02300558|3520701|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3676569|NCT02300558|3520701|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3676570|NCT02300558|3520701|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3676571|NCT02300558|3520701|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3676572|NCT02300558|3520701|B1|||Age||Years|Mean|46|46.0|Standard Deviation|12.5|12.5|||
3676573|NCT02300311|3520712|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3676574|NCT02300311|3520713|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3676575|NCT02300311|3520714|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3676576|NCT02300311|3520712|B3||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3676577|NCT02300311|3520713|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3676578|NCT02300311|3520714|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3676579|NCT02300311|3520712|B3|||Age||years|Mean|43.38|43.38|Standard Deviation|12.02|12.02|||
3676580|NCT02300311|3520713|B2|||Age||years|Mean|44.25|44.25|Standard Deviation|12.68|12.68|||
3676581|NCT02300311|3520714|B1|||Age||years|Mean|42.52|42.52|Standard Deviation|11.34|11.34|||
3676582|NCT02300298|3520727|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676583|NCT02300298|3520727|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676584|NCT02300298|3520727|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676585|NCT02300298|3520727|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676586|NCT02300298|3520727|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676587|NCT02300298|3520727|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3676588|NCT02300298|3520727|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676589|NCT02300298|3520727|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676590|NCT02300298|3520727|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3676591|NCT02300298|3520727|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676592|NCT02300298|3520727|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3676593|NCT02300298|3520727|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3676594|NCT02300298|3520727|B1|||Age||Years|Mean|67.30|67.3|Standard Deviation|6.98|6.98|||
3676595|NCT02300129|3520738|B1|Germany||Region of Enrollment||participants|Number|33|33.0||||||
3676596|NCT02300129|3520738|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3676597|NCT02300129|3520738|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3676598|NCT02300129|3520738|B1|||Age||years|Mean|50.2|50.2|Standard Deviation|10.4|10.4|||
3676599|NCT02300129|3520738|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3676600|NCT02300129|3520738|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3676604|NCT02300103|3520751|B1|||HCV RNA||log10 IU/mL|Mean|6.4|6.4|Standard Deviation|0.67|0.67|||
3676605|NCT02300103|3520751|B1|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|14|14.0||||||
3676606|NCT02300103|3520751|B1|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|32|32.0||||||
3676607|NCT02300103|3520751|B1|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|23|23.0||||||
3676608|NCT02300103|3520751|B1|Australia||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3676609|NCT02300103|3520751|B1|New Zealand||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3676610|NCT02300103|3520751|B1|United States||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3676611|NCT02300103|3520751|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|64|64.0||||||
3676612|NCT02300103|3520751|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3676613|NCT02300103|3520751|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3676614|NCT02300103|3520751|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3676615|NCT02300103|3520751|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|61|61.0||||||
3676616|NCT02300103|3520751|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3676617|NCT02300103|3520751|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3676618|NCT02300103|3520751|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3676619|NCT02300103|3520751|B1|||Age||years|Mean|57|57.0|Standard Deviation|7.7|7.7|||
3676620|NCT02300025|3520760|B5||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3676621|NCT02300025|3520761|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3676622|NCT02300025|3520762|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3676623|NCT02300025|3520763|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3676624|NCT02300025|3520764|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3676625|NCT02300025|3520760|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3676626|NCT02300025|3520761|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3676627|NCT02300025|3520762|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3676628|NCT02300025|3520763|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3676629|NCT02300025|3520764|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3676630|NCT02300025|3520760|B5|||Age||Years|Mean|57|57.0|Standard Deviation|5.6|5.6|||
3676631|NCT02300025|3520761|B4|||Age||Years|Mean|53|53.0|Standard Deviation|5.3|5.3|||
3676632|NCT02300025|3520762|B3|||Age||Years|Mean|61|61.0|Standard Deviation|2.9|2.9|||
3676633|NCT02300025|3520763|B2|||Age||Years|Mean|59|59.0|Standard Deviation|2.8|2.8|||
3676634|NCT02300025|3520764|B1|||Age||Years|Mean|56|56.0|Standard Deviation|6.8|6.8|||
3676635|NCT02299869|3520809|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3676636|NCT02299869|3520810|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3676637|NCT02299869|3520811|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676638|NCT02299869|3520812|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3676639|NCT02299869|3520813|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3676640|NCT02299869|3520809|B5||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3676641|NCT02299869|3520810|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3676642|NCT02299869|3520811|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3676643|NCT02299869|3520812|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3676644|NCT02299869|3520813|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3676645|NCT02299869|3520809|B5|||Age||years|Mean|21.2|21.2|Standard Deviation|2.1|2.1|||
3676646|NCT02299869|3520810|B4|||Age||years|Mean|20.9|20.9|Standard Deviation|1.9|1.9|||
3676647|NCT02299869|3520811|B3|||Age||years|Mean|20.7|20.7|Standard Deviation|2.4|2.4|||
3676648|NCT02299869|3520812|B2|||Age||years|Mean|21.8|21.8|Standard Deviation|2.3|2.3|||
3676649|NCT02299869|3520813|B1|||Age||years|Mean|21.5|21.5|Standard Deviation|2.3|2.3|||
3676650|NCT02299791|3520839|B3|United States||Region of Enrollment||Participants|Count of Participants|4856|4856.0||||||
3676651|NCT02299791|3520840|B2|United States||Region of Enrollment||Participants|Count of Participants|2803|2803.0||||||
3676652|NCT02299791|3520841|B1|United States||Region of Enrollment||Participants|Count of Participants|2053|2053.0||||||
3676653|NCT02299791|3520839|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1148|1148.0||||||
3676654|NCT02299791|3520840|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|663|663.0||||||
3676655|NCT02299791|3520841|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|485|485.0||||||
3676656|NCT02299791|3520839|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676657|NCT02299791|3520840|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676658|NCT02299791|3520841|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676659|NCT02299791|3520839|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2975|2975.0||||||
3676660|NCT02299791|3520840|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1717|1717.0||||||
3676661|NCT02299791|3520841|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1258|1258.0||||||
3676662|NCT02299791|3520839|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|423|423.0||||||
3676663|NCT02299791|3520840|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|244|244.0||||||
3676664|NCT02299791|3520841|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|179|179.0||||||
3676665|NCT02299791|3520839|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3676666|NCT02299791|3520840|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3676667|NCT02299791|3520841|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3676668|NCT02299791|3520839|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|239|239.0||||||
3676669|NCT02299791|3520840|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
3676670|NCT02299791|3520841|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
3676671|NCT02299791|3520839|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3676672|NCT02299791|3520840|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3676673|NCT02299791|3520841|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3676674|NCT02299791|3520839|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3676675|NCT02299791|3520840|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3676676|NCT02299791|3520841|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3676677|NCT02299791|3520839|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3251|3251.0||||||
3676678|NCT02299791|3520840|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1877|1877.0||||||
3676679|NCT02299791|3520841|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1374|1374.0||||||
3676680|NCT02299791|3520839|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1559|1559.0||||||
3676681|NCT02299791|3520840|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|900|900.0||||||
3676682|NCT02299791|3520841|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|659|659.0||||||
3676683|NCT02299791|3520839|B3||Male|Sex: Female, Male||Participants|Count of Participants|1982|1982.0||||||
3676684|NCT02299791|3520840|B2||Male|Sex: Female, Male||Participants|Count of Participants|1169|1169.0||||||
3676685|NCT02299791|3520841|B1||Male|Sex: Female, Male||Participants|Count of Participants|813|813.0||||||
3676686|NCT02299791|3520839|B3||Female|Sex: Female, Male||Participants|Count of Participants|2874|2874.0||||||
3676687|NCT02299791|3520840|B2||Female|Sex: Female, Male||Participants|Count of Participants|1634|1634.0||||||
3676688|NCT02299791|3520841|B1||Female|Sex: Female, Male||Participants|Count of Participants|1240|1240.0||||||
3676689|NCT02299791|3520839|B3|||Age||Years|Mean|63|63.0|Full Range|||18.0|75.0|
3676690|NCT02299791|3520840|B2|||Age||Years|Mean|63|63.0|Full Range|||18.0|75.0|
3676691|NCT02299791|3520841|B1|||Age||Years|Mean|62|62.0|Full Range|||18.0|75.0|
3676692|NCT02299791|3520839|B3||>=65 years|Age||Participants|Count of Participants|1094|1094.0||||||
3676693|NCT02299791|3520840|B2||>=65 years|Age||Participants|Count of Participants|559|559.0||||||
3676694|NCT02299791|3520841|B1||>=65 years|Age||Participants|Count of Participants|535|535.0||||||
3676695|NCT02299791|3520839|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3762|3762.0||||||
3676696|NCT02299791|3520840|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2244|2244.0||||||
3676697|NCT02299791|3520841|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1518|1518.0||||||
3676698|NCT02299791|3520839|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3676699|NCT02299791|3520840|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3676700|NCT02299791|3520841|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3676701|NCT02299635|3520848|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3676702|NCT02299635|3520848|B1||Female|Gender||Participants|Count of Participants|19|19.0||||||
3676703|NCT02299635|3520848|B1|||Age||years|Mean|57.4|57.4|Standard Deviation|12.1|12.1|||
3676704|NCT02299570|3520867|B4|United States||Region of Enrollment||participants|Number|105|105.0||||||
3676705|NCT02299570|3520868|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
3676706|NCT02299570|3520869|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
3676707|NCT02299570|3520870|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
3676708|NCT02299570|3520867|B4|Canada||Region of Enrollment||participants|Number|28|28.0||||||
3676709|NCT02299570|3520868|B3|Canada||Region of Enrollment||participants|Number|8|8.0||||||
3676710|NCT02299570|3520869|B2|Canada||Region of Enrollment||participants|Number|8|8.0||||||
3676711|NCT02299570|3520870|B1|Canada||Region of Enrollment||participants|Number|12|12.0||||||
3676712|NCT02299570|3520867|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676713|NCT02299570|3520868|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676714|NCT02299570|3520869|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676715|NCT02299570|3520870|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676716|NCT02299570|3520867|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3676717|NCT02299570|3520868|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676718|NCT02299570|3520869|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676719|NCT02299570|3520870|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3676720|NCT02299570|3520867|B4||White|Race (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
3676721|NCT02299570|3520868|B3||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3676722|NCT02299570|3520869|B2||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3676723|NCT02299570|3520870|B1||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3676724|NCT02299570|3520867|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676725|NCT02299570|3520868|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676726|NCT02299570|3520869|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676727|NCT02299570|3520870|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676728|NCT02299570|3520867|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3676729|NCT02299570|3520868|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3676730|NCT02299570|3520869|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3676731|NCT02299570|3520870|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676732|NCT02299570|3520867|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676733|NCT02299570|3520868|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676734|NCT02299570|3520869|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676735|NCT02299570|3520870|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676736|NCT02299570|3520867|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676737|NCT02299570|3520868|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676738|NCT02299570|3520869|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676739|NCT02299570|3520870|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676740|NCT02299570|3520867|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3676741|NCT02299570|3520868|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3676742|NCT02299570|3520869|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676743|NCT02299570|3520870|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3676744|NCT02299570|3520867|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|127|127.0||||||
3676745|NCT02299570|3520868|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3676746|NCT02299570|3520869|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3676747|NCT02299570|3520870|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3676748|NCT02299570|3520867|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3676749|NCT02299570|3520868|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3676750|NCT02299570|3520869|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3676751|NCT02299570|3520870|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3676752|NCT02299570|3520867|B4||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3676753|NCT02299570|3520868|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3676754|NCT02299570|3520869|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3676755|NCT02299570|3520870|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3676756|NCT02299570|3520867|B4||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3676757|NCT02299570|3520868|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3676758|NCT02299570|3520869|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3676759|NCT02299570|3520870|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3676760|NCT02299570|3520867|B4|||Age||years|Mean|61.1|61.1|Standard Deviation|19.31|19.31|||
3676761|NCT02299570|3520868|B3|||Age||years|Mean|61.0|61.0|Standard Deviation|19.69|19.69|||
3676762|NCT02299570|3520869|B2|||Age||years|Mean|58.8|58.8|Standard Deviation|19.24|19.24|||
3676763|NCT02299570|3520870|B1|||Age||years|Mean|63.6|63.6|Standard Deviation|19.15|19.15|||
3676764|NCT02299570|3520867|B4||>=65 years|Age||Participants|Count of Participants|63|63.0||||||
3676765|NCT02299570|3520868|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3676766|NCT02299570|3520869|B2||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3676767|NCT02299570|3520870|B1||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
3676768|NCT02299570|3520867|B4||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
3676769|NCT02299570|3520868|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3676770|NCT02299570|3520869|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3676771|NCT02299570|3520870|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3676772|NCT02299570|3520867|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3676773|NCT02299570|3520868|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3676774|NCT02299570|3520869|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3676775|NCT02299570|3520870|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3676776|NCT02299479|3520880|B1|||Total Daily Insulin Use||units of insulin/kg/day|Median|0.8|0.8|Full Range|||0.55|1.12|
3676777|NCT02299479|3520880|B1|||Body Mass Index||kg/m^2|Mean|18.7|18.7|Standard Deviation|0.6|0.6|||
3676778|NCT02299479|3520880|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676779|NCT02299479|3520880|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3676780|NCT02299479|3520880|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3676781|NCT02299479|3520880|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3676782|NCT02299479|3520880|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3676783|NCT02299479|3520880|B1|||Age||Years|Median|12|12.0|Full Range|||7.0|17.0|
3676784|NCT02299427|3520886|B3|United States||Region of Enrollment||participants|Number|69|69.0||||||
3676785|NCT02299427|3520887|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
3676786|NCT02299427|3520888|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3676787|NCT02299427|3520886|B3|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3676788|NCT02299427|3520887|B2|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3676789|NCT02299427|3520888|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3676790|NCT02299427|3520886|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
3676791|NCT02299427|3520887|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3676792|NCT02299427|3520888|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
3676793|NCT02299427|3520886|B3|African American||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3676794|NCT02299427|3520887|B2|African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3676795|NCT02299427|3520888|B1|African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3676796|NCT02299427|3520886|B3||Male|Gender||Participants|Count of Participants|33|33.0||||||
3676797|NCT02299427|3520887|B2||Male|Gender||Participants|Count of Participants|12|12.0||||||
3676798|NCT02299427|3520888|B1||Male|Gender||Participants|Count of Participants|21|21.0||||||
3676799|NCT02299427|3520886|B3||Female|Gender||Participants|Count of Participants|36|36.0||||||
3676800|NCT02299427|3520887|B2||Female|Gender||Participants|Count of Participants|22|22.0||||||
3676801|NCT02299427|3520888|B1||Female|Gender||Participants|Count of Participants|14|14.0||||||
3676802|NCT02299427|3520886|B3|||Age||years|Mean|5.1|5.1|Standard Deviation|.6|0.6|||
3676803|NCT02299427|3520887|B2|||Age||years|Mean|5.1|5.1|Standard Deviation|0.6|0.6|||
3676804|NCT02299427|3520888|B1|||Age||years|Mean|5.0|5.0|Standard Deviation|0.6|0.6|||
3676805|NCT02299375|3520897|B3|Race/ Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|165|165.0||||||
3676806|NCT02299375|3520898|B2|Race/ Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|81|81.0||||||
3676807|NCT02299375|3520899|B1|Race/ Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|84|84.0||||||
3676808|NCT02299375|3520897|B3|Race/ Ethnicity|Japanese/East Asian /South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3676809|NCT02299375|3520898|B2|Race/ Ethnicity|Japanese/East Asian /South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3676810|NCT02299375|3520899|B1|Race/ Ethnicity|Japanese/East Asian /South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3676811|NCT02299375|3520897|B3||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3676812|NCT02299375|3520898|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3676813|NCT02299375|3520899|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3676814|NCT02299375|3520897|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3676815|NCT02299375|3520898|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3676816|NCT02299375|3520899|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3676817|NCT02299375|3520897|B3|||Age||Years|Mean|65.5|65.5|Standard Deviation|7.55|7.55|||
3676818|NCT02299375|3520898|B2|||Age||Years|Mean|66.4|66.4|Standard Deviation|6.66|6.66|||
3676819|NCT02299375|3520899|B1|||Age||Years|Mean|64.6|64.6|Standard Deviation|8.27|8.27|||
3676820|NCT02299349|3520948|B3|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3676821|NCT02299349|3520949|B2|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3676822|NCT02299349|3520950|B1|African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3676823|NCT02299349|3520948|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
3676824|NCT02299349|3520949|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
3676825|NCT02299349|3520950|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3676826|NCT02299349|3520948|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3676827|NCT02299349|3520949|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3676828|NCT02299349|3520950|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3676829|NCT02299349|3520948|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3676830|NCT02299349|3520949|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3676831|NCT02299349|3520950|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3676832|NCT02299349|3520948|B3|||Age||years|Mean|66.4|66.4|Standard Deviation|9.1|9.1|||
3676833|NCT02299349|3520949|B2|||Age||years|Mean|65.6|65.6|Standard Deviation|7.9|7.9|||
3676834|NCT02299349|3520950|B1|||Age||years|Mean|67.3|67.3|Standard Deviation|10.3|10.3|||
3676835|NCT02299336|3520959|B1|||Central Retinal Thickness||Microns|Mean|290|290.0|Standard Deviation|88.8|88.8|||
3676836|NCT02299336|3520959|B1|||Early Treatment Diabetic Retinopathy Study Best-Corrected Visual Acuity|Participants were challenged with reading letters on lines of an eye chart (5 letters per line) in standardized lighting conditions. Lines became smaller as participants progressed from the top to the bottom of the chart. Participants read down the chart until they reached a row where a minimum of three letters on a line could be read, and were scored by how many letters could be correctly identified.|letters|Mean|69.6|69.6|Standard Deviation|13.4|13.4|||
3676837|NCT02299336|3520959|B1|||Duration of Diabetes||years|Mean|18.6|18.6|Standard Deviation|10.6|10.6|||
3676838|NCT02299336|3520959|B1|||Glycated Hemoglobin||Percent|Mean|7.5|7.5|Standard Deviation|1.1|1.1|||
3676839|NCT02299336|3520959|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
3676840|NCT02299336|3520959|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676841|NCT02299336|3520959|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676842|NCT02299336|3520959|B1||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3676843|NCT02299336|3520959|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3676844|NCT02299336|3520959|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676845|NCT02299336|3520959|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3676846|NCT02299336|3520959|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676847|NCT02299336|3520959|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3676848|NCT02299336|3520959|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3676849|NCT02299336|3520959|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|9.2|9.2|||
3676850|NCT02299258|3520972|B3|||Gastric outlet obstruction score|Gastric outlet obstruction score ranges from 2(best possible outcome) to 4(worst possible outcome)|units on a scale|Mean|3.2|3.2|Full Range|||2.7|3.7|
3676851|NCT02299258|3520973|B2|||Gastric outlet obstruction score|Gastric outlet obstruction score ranges from 2(best possible outcome) to 4(worst possible outcome)|units on a scale|Mean|3.1|3.1|Full Range|||2.7|3.5|
3676852|NCT02299258|3520974|B1|||Gastric outlet obstruction score|Gastric outlet obstruction score ranges from 2(best possible outcome) to 4(worst possible outcome)|units on a scale|Mean|3.2|3.2|Full Range|||2.7|3.7|
3676853|NCT02299258|3520972|B3|China||Region of Enrollment||participants|Number|63|63.0||||||
3676854|NCT02299258|3520973|B2|China||Region of Enrollment||participants|Number|31|31.0||||||
3676855|NCT02299258|3520974|B1|China||Region of Enrollment||participants|Number|32|32.0||||||
3676856|NCT02299258|3520972|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3676857|NCT02299258|3520973|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3676858|NCT02299258|3520974|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3676859|NCT02299258|3520972|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3676860|NCT02299258|3520973|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3676861|NCT02299258|3520974|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3676862|NCT02299258|3520972|B3||>=65 years|Age||Participants|Count of Participants|63|63.0||||||
3676863|NCT02299258|3520973|B2||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
3676864|NCT02299258|3520974|B1||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
3676865|NCT02299258|3520972|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3676866|NCT02299258|3520973|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3676867|NCT02299258|3520974|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3676868|NCT02299258|3520972|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3676869|NCT02299258|3520973|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3676870|NCT02299258|3520974|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3676871|NCT02299258|3520972|B3|||Age||years|Mean|76.1|76.1|Standard Deviation|7.7|7.7|||
3676872|NCT02299258|3520973|B2|||Age||years|Mean|75.8|75.8|Standard Deviation|7.6|7.6|||
3676873|NCT02299258|3520974|B1|||Age||years|Mean|76.4|76.4|Standard Deviation|7.7|7.7|||
3676874|NCT02299206|3520983|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3676875|NCT02299206|3520983|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3676876|NCT02299206|3520983|B1|||Age||months|Mean|11.5|11.5|Standard Deviation|1.73|1.73|||
3676877|NCT02299089|3520991|B5|Germany||Region of Enrollment||participants|Number|4|4.0||||||
3676878|NCT02299089|3520992|B4|Germany||Region of Enrollment||participants|Number|3|3.0||||||
3676879|NCT02299089|3520993|B3|Germany||Region of Enrollment||participants|Number|1|1.0||||||
3676880|NCT02299089|3520994|B2|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3676881|NCT02299089|3520995|B1|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3676882|NCT02299089|3520991|B5|France||Region of Enrollment||participants|Number|5|5.0||||||
3676883|NCT02299089|3520992|B4|France||Region of Enrollment||participants|Number|1|1.0||||||
3676884|NCT02299089|3520993|B3|France||Region of Enrollment||participants|Number|0|0.0||||||
3676885|NCT02299089|3520994|B2|France||Region of Enrollment||participants|Number|3|3.0||||||
3676886|NCT02299089|3520995|B1|France||Region of Enrollment||participants|Number|1|1.0||||||
3676887|NCT02299089|3520991|B5|Italy||Region of Enrollment||participants|Number|3|3.0||||||
3676888|NCT02299089|3520992|B4|Italy||Region of Enrollment||participants|Number|0|0.0||||||
3676889|NCT02299089|3520993|B3|Italy||Region of Enrollment||participants|Number|0|0.0||||||
3676890|NCT02299089|3520994|B2|Italy||Region of Enrollment||participants|Number|1|1.0||||||
3676891|NCT02299089|3520995|B1|Italy||Region of Enrollment||participants|Number|2|2.0||||||
3676892|NCT02299089|3520991|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3676893|NCT02299089|3520992|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3676894|NCT02299089|3520993|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3676895|NCT02299089|3520994|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3676896|NCT02299089|3520995|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3676897|NCT02299089|3520991|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3676898|NCT02299089|3520992|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676899|NCT02299089|3520993|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3676900|NCT02299089|3520994|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3676901|NCT02299089|3520995|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3676902|NCT02299089|3520991|B5|||Age||years|Mean|62.1|62.1|Standard Deviation|7.59|7.59|||
3676903|NCT02299089|3520992|B4|||Age||years|Mean|64.8|64.8|Standard Deviation|4.11|4.11|||
3676904|NCT02299089|3520993|B3|||Age||years|Mean|59|59.0|Standard Deviation|0|0.0|||
3676905|NCT02299089|3520994|B2|||Age||years|Mean|62.5|62.5|Standard Deviation|4.80|4.8|||
3676906|NCT02299089|3520995|B1|||Age||years|Mean|59|59.0|Standard Deviation|14.93|14.93|||
3676907|NCT02299089|3520991|B5||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3676908|NCT02299089|3520992|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3676909|NCT02299089|3520993|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3676910|NCT02299089|3520994|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3676911|NCT02299089|3520995|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3676912|NCT02299089|3520991|B5||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3676913|NCT02299089|3520992|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3676914|NCT02299089|3520993|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3676915|NCT02299089|3520994|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3676916|NCT02299089|3520995|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3676917|NCT02299089|3520991|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3676918|NCT02299089|3520992|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3676919|NCT02299089|3520993|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3676920|NCT02299089|3520994|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3676921|NCT02299089|3520995|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3676922|NCT02299076|3521042|B3|United States||Region of Enrollment||Participants|Count of Participants|422|422.0||||||
3676923|NCT02299076|3521043|B2|United States||Region of Enrollment||Participants|Count of Participants|212|212.0||||||
3676924|NCT02299076|3521044|B1|United States||Region of Enrollment||Participants|Count of Participants|210|210.0||||||
3676925|NCT02299076|3521042|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3676926|NCT02299076|3521043|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3676927|NCT02299076|3521044|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3676928|NCT02299076|3521042|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|384|384.0||||||
3676929|NCT02299076|3521043|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|188|188.0||||||
3676930|NCT02299076|3521044|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|196|196.0||||||
3676931|NCT02299076|3521042|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3676932|NCT02299076|3521043|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3676933|NCT02299076|3521044|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3676934|NCT02299076|3521042|B3||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3676935|NCT02299076|3521043|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3676936|NCT02299076|3521044|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3676937|NCT02299076|3521042|B3||Female|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
3676938|NCT02299076|3521043|B2||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3676939|NCT02299076|3521044|B1||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3676940|NCT02299076|3521042|B3|||Age||years|Mean|44|44.0|Full Range|||20.0|79.0|
3676941|NCT02299076|3521043|B2|||Age||years|Mean|44|44.0|Full Range|||20.0|74.0|
3676942|NCT02299076|3521044|B1|||Age||years|Mean|44|44.0|Full Range|||20.0|79.0|
3676943|NCT02298868|3521053|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3676944|NCT02298868|3521053|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3676945|NCT02298868|3521053|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3676946|NCT02298868|3521053|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3676947|NCT02298868|3521053|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3676948|NCT02298868|3521053|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3676949|NCT02298842|3521065|B3|||Total Blood Volume (TBV)||mL|Mean|5280.0|5280.0|Standard Deviation|767.04|767.04|||
3676950|NCT02298842|3521066|B2|||Total Blood Volume (TBV)||mL|Mean|5172.5|5172.5|Standard Deviation|757.45|757.45|||
3676951|NCT02298842|3521067|B1|||Total Blood Volume (TBV)||mL|Mean|5380.1|5380.1|Standard Deviation|770.93|770.93|||
3676952|NCT02298842|3521065|B3|||Weight||lbs|Mean|193.4|193.4|Standard Deviation|32.87|32.87|||
3676953|NCT02298842|3521066|B2|||Weight||lbs|Mean|188.7|188.7|Standard Deviation|30.87|30.87|||
3676954|NCT02298842|3521067|B1|||Weight||lbs|Mean|197.9|197.9|Standard Deviation|34.38|34.38|||
3676955|NCT02298842|3521065|B3|||Height||inches|Mean|69.0|69.0|Standard Deviation|3.30|3.3|||
3676956|NCT02298842|3521066|B2|||Height||inches|Mean|68.5|68.5|Standard Deviation|3.43|3.43|||
3676957|NCT02298842|3521067|B1|||Height||inches|Mean|69.5|69.5|Standard Deviation|3.12|3.12|||
3676958|NCT02298842|3521065|B3|United States||Region of Enrollment||participants|Number|85|85.0||||||
3676959|NCT02298842|3521066|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
3676960|NCT02298842|3521067|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
3676961|NCT02298842|3521065|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676962|NCT02298842|3521066|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676963|NCT02298842|3521067|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3676964|NCT02298842|3521065|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3676965|NCT02298842|3521066|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3676966|NCT02298842|3521067|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3676967|NCT02298842|3521065|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3676968|NCT02298842|3521066|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3676969|NCT02298842|3521067|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3676970|NCT02298842|3521065|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3676971|NCT02298842|3521066|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3676972|NCT02298842|3521067|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3676973|NCT02298842|3521065|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3676974|NCT02298842|3521066|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3676975|NCT02298842|3521067|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3676976|NCT02298842|3521065|B3|||Age||years|Mean|42.1|42.1|Standard Deviation|14.49|14.49|||
3676977|NCT02298842|3521066|B2|||Age||years|Mean|43.3|43.3|Standard Deviation|14.98|14.98|||
3676978|NCT02298842|3521067|B1|||Age||years|Mean|40.9|40.9|Standard Deviation|14.10|14.1|||
3676979|NCT02298842|3521065|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3676980|NCT02298842|3521066|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3676981|NCT02298842|3521067|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3676982|NCT02298842|3521065|B3||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
3676983|NCT02298842|3521066|B2||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3676984|NCT02298842|3521067|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3676985|NCT02298842|3521065|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3676986|NCT02298842|3521066|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3676987|NCT02298842|3521067|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3676988|NCT02298803|3521092|B3||Absent|Microvascular Complication Status: Present, Absent|"Those participants with microvascular complications appear in the Present subgroup.~Those participants without microvascular complications appear in the Absent subgroup."|Participants|Count of Participants|21|21.0||||||
3676989|NCT02298803|3521093|B2||Absent|Microvascular Complication Status: Present, Absent|"Those participants with microvascular complications appear in the Present subgroup.~Those participants without microvascular complications appear in the Absent subgroup."|Participants|Count of Participants|13|13.0||||||
3676990|NCT02298803|3521094|B1||Absent|Microvascular Complication Status: Present, Absent|"Those participants with microvascular complications appear in the Present subgroup.~Those participants without microvascular complications appear in the Absent subgroup."|Participants|Count of Participants|8|8.0||||||
3676991|NCT02298803|3521092|B3||Present|Microvascular Complication Status: Present, Absent|"Those participants with microvascular complications appear in the Present subgroup.~Those participants without microvascular complications appear in the Absent subgroup."|Participants|Count of Participants|9|9.0||||||
3676992|NCT02298803|3521093|B2||Present|Microvascular Complication Status: Present, Absent|"Those participants with microvascular complications appear in the Present subgroup.~Those participants without microvascular complications appear in the Absent subgroup."|Participants|Count of Participants|8|8.0||||||
3676993|NCT02298803|3521094|B1||Present|Microvascular Complication Status: Present, Absent|"Those participants with microvascular complications appear in the Present subgroup.~Those participants without microvascular complications appear in the Absent subgroup."|Participants|Count of Participants|1|1.0||||||
3676994|NCT02298803|3521092|B3||Abstainer|Alcohol consumption status: Consumer, Abstainer|Participants who reported consuming alcohol are classified as consumers. Participants who reported no alcohol consumption are classified as abstainers.|Participants|Count of Participants|8|8.0||||||
3676995|NCT02298803|3521093|B2||Abstainer|Alcohol consumption status: Consumer, Abstainer|Participants who reported consuming alcohol are classified as consumers. Participants who reported no alcohol consumption are classified as abstainers.|Participants|Count of Participants|4|4.0||||||
3676996|NCT02298803|3521094|B1||Abstainer|Alcohol consumption status: Consumer, Abstainer|Participants who reported consuming alcohol are classified as consumers. Participants who reported no alcohol consumption are classified as abstainers.|Participants|Count of Participants|4|4.0||||||
3676997|NCT02298803|3521092|B3||Consumer|Alcohol consumption status: Consumer, Abstainer|Participants who reported consuming alcohol are classified as consumers. Participants who reported no alcohol consumption are classified as abstainers.|Participants|Count of Participants|22|22.0||||||
3676998|NCT02298803|3521093|B2||Consumer|Alcohol consumption status: Consumer, Abstainer|Participants who reported consuming alcohol are classified as consumers. Participants who reported no alcohol consumption are classified as abstainers.|Participants|Count of Participants|17|17.0||||||
3676999|NCT02298803|3521094|B1||Consumer|Alcohol consumption status: Consumer, Abstainer|Participants who reported consuming alcohol are classified as consumers. Participants who reported no alcohol consumption are classified as abstainers.|Participants|Count of Participants|5|5.0||||||
3677000|NCT02298803|3521092|B3||Lifelong non-smoker|Smoking Status: Current, Former, Lifelong non-smoker|"Smoking Status: Current refers to those participants currently smoking tobacco products.~Smoking Status: Former refers to those participants who are not currently smoking but have smoked tobacco products in the past.~Smoking Status: Lifelong non-smoker refers to those participants who have never smoked tobacco products."|Participants|Count of Participants|18|18.0||||||
3677001|NCT02298803|3521093|B2||Lifelong non-smoker|Smoking Status: Current, Former, Lifelong non-smoker|"Smoking Status: Current refers to those participants currently smoking tobacco products.~Smoking Status: Former refers to those participants who are not currently smoking but have smoked tobacco products in the past.~Smoking Status: Lifelong non-smoker refers to those participants who have never smoked tobacco products."|Participants|Count of Participants|15|15.0||||||
3677002|NCT02298803|3521094|B1||Lifelong non-smoker|Smoking Status: Current, Former, Lifelong non-smoker|"Smoking Status: Current refers to those participants currently smoking tobacco products.~Smoking Status: Former refers to those participants who are not currently smoking but have smoked tobacco products in the past.~Smoking Status: Lifelong non-smoker refers to those participants who have never smoked tobacco products."|Participants|Count of Participants|3|3.0||||||
3677003|NCT02298803|3521092|B3||Former|Smoking Status: Current, Former, Lifelong non-smoker|"Smoking Status: Current refers to those participants currently smoking tobacco products.~Smoking Status: Former refers to those participants who are not currently smoking but have smoked tobacco products in the past.~Smoking Status: Lifelong non-smoker refers to those participants who have never smoked tobacco products."|Participants|Count of Participants|10|10.0||||||
3677004|NCT02298803|3521093|B2||Former|Smoking Status: Current, Former, Lifelong non-smoker|"Smoking Status: Current refers to those participants currently smoking tobacco products.~Smoking Status: Former refers to those participants who are not currently smoking but have smoked tobacco products in the past.~Smoking Status: Lifelong non-smoker refers to those participants who have never smoked tobacco products."|Participants|Count of Participants|6|6.0||||||
3677005|NCT02298803|3521094|B1||Former|Smoking Status: Current, Former, Lifelong non-smoker|"Smoking Status: Current refers to those participants currently smoking tobacco products.~Smoking Status: Former refers to those participants who are not currently smoking but have smoked tobacco products in the past.~Smoking Status: Lifelong non-smoker refers to those participants who have never smoked tobacco products."|Participants|Count of Participants|4|4.0||||||
3677006|NCT02298803|3521092|B3||Current|Smoking Status: Current, Former, Lifelong non-smoker|"Smoking Status: Current refers to those participants currently smoking tobacco products.~Smoking Status: Former refers to those participants who are not currently smoking but have smoked tobacco products in the past.~Smoking Status: Lifelong non-smoker refers to those participants who have never smoked tobacco products."|Participants|Count of Participants|2|2.0||||||
3677007|NCT02298803|3521093|B2||Current|Smoking Status: Current, Former, Lifelong non-smoker|"Smoking Status: Current refers to those participants currently smoking tobacco products.~Smoking Status: Former refers to those participants who are not currently smoking but have smoked tobacco products in the past.~Smoking Status: Lifelong non-smoker refers to those participants who have never smoked tobacco products."|Participants|Count of Participants|0|0.0||||||
3677008|NCT02298803|3521094|B1||Current|Smoking Status: Current, Former, Lifelong non-smoker|"Smoking Status: Current refers to those participants currently smoking tobacco products.~Smoking Status: Former refers to those participants who are not currently smoking but have smoked tobacco products in the past.~Smoking Status: Lifelong non-smoker refers to those participants who have never smoked tobacco products."|Participants|Count of Participants|2|2.0||||||
3677009|NCT02298803|3521092|B3|||Systolic Blood Pressure||mmHg|Mean|128|128.0|Standard Deviation|11|11.0|||
3677010|NCT02298803|3521093|B2|||Systolic Blood Pressure||mmHg|Mean|131|131.0|Standard Deviation|10|10.0|||
3677011|NCT02298803|3521094|B1|||Systolic Blood Pressure||mmHg|Mean|122|122.0|Standard Deviation|10|10.0|||
3677012|NCT02298803|3521092|B3|Female||Waist circumference||cm|Mean|108|108.0|Standard Deviation|10|10.0|||
3677013|NCT02298803|3521093|B2|Female||Waist circumference||cm|Mean|108|108.0|Standard Deviation|11|11.0|||
3677014|NCT02298803|3521094|B1|Female||Waist circumference||cm|Mean|108|108.0|Standard Deviation|10|10.0|||
3677015|NCT02298803|3521092|B3|Male||Waist circumference||cm|Mean|109|109.0|Standard Deviation|13|13.0|||
3677016|NCT02298803|3521093|B2|Male||Waist circumference||cm|Mean|107|107.0|Standard Deviation|11|11.0|||
3677017|NCT02298803|3521094|B1|Male||Waist circumference||cm|Mean|113|113.0|Standard Deviation|13|13.0|||
3677018|NCT02298803|3521092|B3|||Body Mass Index||kg/m2|Mean|31.3|31.3|Standard Deviation|5.4|5.4|||
3677019|NCT02298803|3521093|B2|||Body Mass Index||kg/m2|Mean|31.2|31.2|Standard Deviation|5.0|5.0|||
3677020|NCT02298803|3521094|B1|||Body Mass Index||kg/m2|Mean|31.8|31.8|Standard Deviation|6.3|6.3|||
3677021|NCT02298803|3521092|B3|||HbA1c||%|Mean|6.9|6.9|Standard Deviation|0.9|0.9|||
3677022|NCT02298803|3521093|B2|||HbA1c||%|Mean|7.0|7.0|Standard Deviation|0.9|0.9|||
3677023|NCT02298803|3521094|B1|||HbA1c||%|Mean|6.6|6.6|Standard Deviation|0.8|0.8|||
3677024|NCT02298803|3521092|B3||Triple or quadruple therapy|Diabetes Treatment: Mono or dual therapy, Triple or quadruple therapy|"Mono or dual therapy refers to treatment with one or two oral hypoglycemic agents.~Triple or quadruple therapy refers to treatment with three or four oral hypoglycemic agents."|Participants|Count of Participants|16|16.0||||||
3677025|NCT02298803|3521093|B2||Triple or quadruple therapy|Diabetes Treatment: Mono or dual therapy, Triple or quadruple therapy|"Mono or dual therapy refers to treatment with one or two oral hypoglycemic agents.~Triple or quadruple therapy refers to treatment with three or four oral hypoglycemic agents."|Participants|Count of Participants|12|12.0||||||
3677026|NCT02298803|3521094|B1||Triple or quadruple therapy|Diabetes Treatment: Mono or dual therapy, Triple or quadruple therapy|"Mono or dual therapy refers to treatment with one or two oral hypoglycemic agents.~Triple or quadruple therapy refers to treatment with three or four oral hypoglycemic agents."|Participants|Count of Participants|4|4.0||||||
3677027|NCT02298803|3521092|B3||Mono or dual therapy|Diabetes Treatment: Mono or dual therapy, Triple or quadruple therapy|"Mono or dual therapy refers to treatment with one or two oral hypoglycemic agents.~Triple or quadruple therapy refers to treatment with three or four oral hypoglycemic agents."|Participants|Count of Participants|14|14.0||||||
3677308|NCT02297230|3521443|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3677028|NCT02298803|3521093|B2||Mono or dual therapy|Diabetes Treatment: Mono or dual therapy, Triple or quadruple therapy|"Mono or dual therapy refers to treatment with one or two oral hypoglycemic agents.~Triple or quadruple therapy refers to treatment with three or four oral hypoglycemic agents."|Participants|Count of Participants|9|9.0||||||
3677029|NCT02298803|3521094|B1||Mono or dual therapy|Diabetes Treatment: Mono or dual therapy, Triple or quadruple therapy|"Mono or dual therapy refers to treatment with one or two oral hypoglycemic agents.~Triple or quadruple therapy refers to treatment with three or four oral hypoglycemic agents."|Participants|Count of Participants|5|5.0||||||
3677030|NCT02298803|3521092|B3|||Diabetes duration||years|Median|14.5|14.5|Inter-Quartile Range|||10.0|16.8|
3677031|NCT02298803|3521093|B2|||Diabetes duration||years|Median|14.0|14.0|Inter-Quartile Range|||11.0|18.0|
3677032|NCT02298803|3521094|B1|||Diabetes duration||years|Median|15.0|15.0|Inter-Quartile Range|||4.0|16.0|
3677033|NCT02298803|3521092|B3||Non-Caucasian|Ethnicity: Caucasian, Non-Caucasian||Participants|Count of Participants|6|6.0||||||
3677034|NCT02298803|3521093|B2||Non-Caucasian|Ethnicity: Caucasian, Non-Caucasian||Participants|Count of Participants|4|4.0||||||
3677035|NCT02298803|3521094|B1||Non-Caucasian|Ethnicity: Caucasian, Non-Caucasian||Participants|Count of Participants|2|2.0||||||
3677036|NCT02298803|3521092|B3||Caucasian|Ethnicity: Caucasian, Non-Caucasian||Participants|Count of Participants|24|24.0||||||
3677037|NCT02298803|3521093|B2||Caucasian|Ethnicity: Caucasian, Non-Caucasian||Participants|Count of Participants|17|17.0||||||
3677038|NCT02298803|3521094|B1||Caucasian|Ethnicity: Caucasian, Non-Caucasian||Participants|Count of Participants|7|7.0||||||
3677039|NCT02298803|3521092|B3|Australia||Region of Enrollment||participants|Number|30|30.0||||||
3677040|NCT02298803|3521093|B2|Australia||Region of Enrollment||participants|Number|21|21.0||||||
3677041|NCT02298803|3521094|B1|Australia||Region of Enrollment||participants|Number|9|9.0||||||
3677042|NCT02298803|3521092|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3677043|NCT02298803|3521093|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3677044|NCT02298803|3521094|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3677045|NCT02298803|3521092|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3677046|NCT02298803|3521093|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3677047|NCT02298803|3521094|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3677048|NCT02298803|3521092|B3|||Age||years|Mean|66.7|66.7|Standard Deviation|8.6|8.6|||
3677049|NCT02298803|3521093|B2|||Age||years|Mean|68.3|68.3|Standard Deviation|7.4|7.4|||
3677050|NCT02298803|3521094|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|10.2|10.2|||
3677051|NCT02298361|3521103|B4|Unknown||Household income as percent of Federal Poverty Level||participants|Number|635|635.0||||||
3677052|NCT02298361|3521104|B3|Unknown||Household income as percent of Federal Poverty Level||participants|Number|107|107.0||||||
3677053|NCT02298361|3521105|B2|Unknown||Household income as percent of Federal Poverty Level||participants|Number|514|514.0||||||
3677054|NCT02298361|3521106|B1|Unknown||Household income as percent of Federal Poverty Level||participants|Number|14|14.0||||||
3677055|NCT02298361|3521103|B4|>=200% FPL||Household income as percent of Federal Poverty Level||participants|Number|1516|1516.0||||||
3677056|NCT02298361|3521104|B3|>=200% FPL||Household income as percent of Federal Poverty Level||participants|Number|1204|1204.0||||||
3677057|NCT02298361|3521105|B2|>=200% FPL||Household income as percent of Federal Poverty Level||participants|Number|283|283.0||||||
3677058|NCT02298361|3521106|B1|>=200% FPL||Household income as percent of Federal Poverty Level||participants|Number|29|29.0||||||
3677059|NCT02298361|3521103|B4|139-199% FPL||Household income as percent of Federal Poverty Level||participants|Number|1766|1766.0||||||
3677060|NCT02298361|3521104|B3|139-199% FPL||Household income as percent of Federal Poverty Level||participants|Number|918|918.0||||||
3677061|NCT02298361|3521105|B2|139-199% FPL||Household income as percent of Federal Poverty Level||participants|Number|734|734.0||||||
3677062|NCT02298361|3521106|B1|139-199% FPL||Household income as percent of Federal Poverty Level||participants|Number|114|114.0||||||
3677063|NCT02298361|3521103|B4|<=138% FPL||Household income as percent of Federal Poverty Level||participants|Number|23334|23334.0||||||
3677064|NCT02298361|3521104|B3|<=138% FPL||Household income as percent of Federal Poverty Level||participants|Number|9998|9998.0||||||
3677065|NCT02298361|3521105|B2|<=138% FPL||Household income as percent of Federal Poverty Level||participants|Number|11253|11253.0||||||
3677066|NCT02298361|3521106|B1|<=138% FPL||Household income as percent of Federal Poverty Level||participants|Number|2083|2083.0||||||
3677067|NCT02298361|3521103|B4|Unknown||Primary language||participants|Number|240|240.0||||||
3677068|NCT02298361|3521104|B3|Unknown||Primary language||participants|Number|196|196.0||||||
3677069|NCT02298361|3521105|B2|Unknown||Primary language||participants|Number|43|43.0||||||
3677070|NCT02298361|3521106|B1|Unknown||Primary language||participants|Number|1|1.0||||||
3677071|NCT02298361|3521103|B4|Other||Primary language||participants|Number|1769|1769.0||||||
3677072|NCT02298361|3521104|B3|Other||Primary language||participants|Number|1125|1125.0||||||
3677073|NCT02298361|3521105|B2|Other||Primary language||participants|Number|622|622.0||||||
3677074|NCT02298361|3521106|B1|Other||Primary language||participants|Number|22|22.0||||||
3677075|NCT02298361|3521103|B4|English||Primary language||participants|Number|10973|10973.0||||||
3677076|NCT02298361|3521104|B3|English||Primary language||participants|Number|5103|5103.0||||||
3677077|NCT02298361|3521105|B2|English||Primary language||participants|Number|5629|5629.0||||||
3677078|NCT02298361|3521106|B1|English||Primary language||participants|Number|241|241.0||||||
3677079|NCT02298361|3521103|B4|Spanish||Primary language||participants|Number|14269|14269.0||||||
3677080|NCT02298361|3521104|B3|Spanish||Primary language||participants|Number|5803|5803.0||||||
3677081|NCT02298361|3521105|B2|Spanish||Primary language||participants|Number|6490|6490.0||||||
3677082|NCT02298361|3521106|B1|Spanish||Primary language||participants|Number|1976|1976.0||||||
3677083|NCT02298361|3521103|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3121|3121.0||||||
3677084|NCT02298361|3521104|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1569|1569.0||||||
3677085|NCT02298361|3521105|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1339|1339.0||||||
3677086|NCT02298361|3521106|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|213|213.0||||||
3677087|NCT02298361|3521103|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|287|287.0||||||
3677088|NCT02298361|3521104|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|260|260.0||||||
3677089|NCT02298361|3521105|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3677090|NCT02298361|3521106|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3677091|NCT02298361|3521103|B4||White|Race (NIH/OMB)||Participants|Count of Participants|21216|21216.0||||||
3677092|NCT02298361|3521104|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8462|8462.0||||||
3677093|NCT02298361|3521105|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10758|10758.0||||||
3677094|NCT02298361|3521106|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1996|1996.0||||||
3677095|NCT02298361|3521103|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1769|1769.0||||||
3677096|NCT02298361|3521104|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1345|1345.0||||||
3677097|NCT02298361|3521105|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|407|407.0||||||
3677098|NCT02298361|3521106|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3677099|NCT02298361|3521103|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|161|161.0||||||
3677100|NCT02298361|3521104|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
3677101|NCT02298361|3521105|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3677102|NCT02298361|3521106|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3677103|NCT02298361|3521103|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|503|503.0||||||
3677104|NCT02298361|3521104|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|297|297.0||||||
3677105|NCT02298361|3521105|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|198|198.0||||||
3677106|NCT02298361|3521106|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3677107|NCT02298361|3521103|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|194|194.0||||||
3677108|NCT02298361|3521104|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|166|166.0||||||
3677109|NCT02298361|3521105|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3677110|NCT02298361|3521106|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3677111|NCT02298361|3521103|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|622|622.0||||||
3677112|NCT02298361|3521104|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
3677113|NCT02298361|3521105|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|483|483.0||||||
3677114|NCT02298361|3521106|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3677115|NCT02298361|3521103|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8965|8965.0||||||
3677116|NCT02298361|3521104|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4831|4831.0||||||
3677117|NCT02298361|3521105|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4031|4031.0||||||
3677118|NCT02298361|3521106|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
3677119|NCT02298361|3521103|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17664|17664.0||||||
3677120|NCT02298361|3521104|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7266|7266.0||||||
3677121|NCT02298361|3521105|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8270|8270.0||||||
3677122|NCT02298361|3521106|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2128|2128.0||||||
3677123|NCT02298361|3521103|B4||Male|Sex: Female, Male||Participants|Count of Participants|13480|13480.0||||||
3677124|NCT02298361|3521104|B3||Male|Sex: Female, Male||Participants|Count of Participants|6099|6099.0||||||
3677125|NCT02298361|3521105|B2||Male|Sex: Female, Male||Participants|Count of Participants|6260|6260.0||||||
3677126|NCT02298361|3521106|B1||Male|Sex: Female, Male||Participants|Count of Participants|1121|1121.0||||||
3677127|NCT02298361|3521103|B4||Female|Sex: Female, Male||Participants|Count of Participants|13771|13771.0||||||
3677128|NCT02298361|3521104|B3||Female|Sex: Female, Male||Participants|Count of Participants|6128|6128.0||||||
3677129|NCT02298361|3521105|B2||Female|Sex: Female, Male||Participants|Count of Participants|6524|6524.0||||||
3677130|NCT02298361|3521106|B1||Female|Sex: Female, Male||Participants|Count of Participants|1119|1119.0||||||
3677131|NCT02298361|3521103|B4|||Age||years|Mean|8.5|8.5|Standard Deviation|5.8|5.8|||
3677132|NCT02298361|3521104|B3|||Age||years|Mean|8.2|8.2|Standard Deviation|5.9|5.9|||
3677133|NCT02298361|3521105|B2|||Age||years|Mean|8.6|8.6|Standard Deviation|5.9|5.9|||
3677134|NCT02298361|3521106|B1|||Age||years|Mean|9.3|9.3|Standard Deviation|5.4|5.4|||
3677135|NCT02298361|3521103|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3677136|NCT02298361|3521104|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3677137|NCT02298361|3521105|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3677138|NCT02298361|3521106|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3677139|NCT02298361|3521103|B4||Between 18 and 65 years|Age||Participants|Count of Participants|992|992.0||||||
3677140|NCT02298361|3521104|B3||Between 18 and 65 years|Age||Participants|Count of Participants|444|444.0||||||
3677141|NCT02298361|3521105|B2||Between 18 and 65 years|Age||Participants|Count of Participants|478|478.0||||||
3677142|NCT02298361|3521106|B1||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
3677143|NCT02298361|3521103|B4||<=18 years|Age||Participants|Count of Participants|26259|26259.0||||||
3677144|NCT02298361|3521104|B3||<=18 years|Age||Participants|Count of Participants|11783|11783.0||||||
3677145|NCT02298361|3521105|B2||<=18 years|Age||Participants|Count of Participants|12306|12306.0||||||
3677146|NCT02298361|3521106|B1||<=18 years|Age||Participants|Count of Participants|2170|2170.0||||||
3677147|NCT02298192|3521122|B3|||HbA1c||percentage|Mean|8.1|8.1|Standard Deviation|0.9|0.9|||
3677148|NCT02298192|3521123|B2|||HbA1c||percentage|Mean|8.1|8.1|Standard Deviation|0.9|0.9|||
3677149|NCT02298192|3521124|B1|||HbA1c||percentage|Mean|8.2|8.2|Standard Deviation|0.9|0.9|||
3677150|NCT02298192|3521122|B3||Male|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
3677151|NCT02298192|3521123|B2||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3677152|NCT02298192|3521124|B1||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3677153|NCT02298192|3521122|B3||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
3677154|NCT02298192|3521123|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3677155|NCT02298192|3521124|B1||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3677156|NCT02298192|3521122|B3|||Age||years|Mean|56.8|56.8|Standard Deviation|9.9|9.9|||
3677157|NCT02298192|3521123|B2|||Age||years|Mean|57.0|57.0|Standard Deviation|9.6|9.6|||
3677158|NCT02298192|3521124|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|10.3|10.3|||
3677159|NCT02298179|3521137|B13|NOT SPECIFIED||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3677160|NCT02298179|3521138|B12|NOT SPECIFIED||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3677161|NCT02298179|3521139|B11|NOT SPECIFIED||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3677162|NCT02298179|3521140|B10|NOT SPECIFIED||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3677163|NCT02298179|3521141|B9|NOT SPECIFIED||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3677164|NCT02298179|3521142|B8|NOT SPECIFIED||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3677165|NCT02298179|3521143|B7|NOT SPECIFIED||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3677166|NCT02298179|3521144|B6|NOT SPECIFIED||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3677167|NCT02298179|3521145|B5|NOT SPECIFIED||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3677168|NCT02298179|3521146|B4|NOT SPECIFIED||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3677169|NCT02298179|3521147|B3|NOT SPECIFIED||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3677170|NCT02298179|3521148|B2|NOT SPECIFIED||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3677171|NCT02298179|3521149|B1|NOT SPECIFIED||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3677172|NCT02298179|3521137|B13|WHITE||Race/Ethnicity, Customized||Participants|Count of Participants|284|284.0||||||
3677173|NCT02298179|3521138|B12|WHITE||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3677174|NCT02298179|3521139|B11|WHITE||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3677175|NCT02298179|3521140|B10|WHITE||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3677176|NCT02298179|3521141|B9|WHITE||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3677177|NCT02298179|3521142|B8|WHITE||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3677178|NCT02298179|3521143|B7|WHITE||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3677179|NCT02298179|3521144|B6|WHITE||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3677180|NCT02298179|3521145|B5|WHITE||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3677181|NCT02298179|3521146|B4|WHITE||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3677182|NCT02298179|3521147|B3|WHITE||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3677183|NCT02298179|3521148|B2|WHITE||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3677184|NCT02298179|3521149|B1|WHITE||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3677185|NCT02298179|3521137|B13|NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3677186|NCT02298179|3521138|B12|NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3677187|NCT02298179|3521139|B11|NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3677188|NCT02298179|3521140|B10|NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3677189|NCT02298179|3521141|B9|NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3677190|NCT02298179|3521142|B8|NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3677191|NCT02298179|3521143|B7|NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3677192|NCT02298179|3521144|B6|NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3677193|NCT02298179|3521145|B5|NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3677194|NCT02298179|3521146|B4|NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3677195|NCT02298179|3521147|B3|NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3677196|NCT02298179|3521148|B2|NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3677197|NCT02298179|3521149|B1|NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3677198|NCT02298179|3521137|B13|BLACK OR AFRICAN AMERICAN||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3677199|NCT02298179|3521138|B12|BLACK OR AFRICAN AMERICAN||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3677200|NCT02298179|3521139|B11|BLACK OR AFRICAN AMERICAN||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3677201|NCT02298179|3521140|B10|BLACK OR AFRICAN AMERICAN||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3677202|NCT02298179|3521141|B9|BLACK OR AFRICAN AMERICAN||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3677203|NCT02298179|3521142|B8|BLACK OR AFRICAN AMERICAN||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3677204|NCT02298179|3521143|B7|BLACK OR AFRICAN AMERICAN||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3677205|NCT02298179|3521144|B6|BLACK OR AFRICAN AMERICAN||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3677206|NCT02298179|3521145|B5|BLACK OR AFRICAN AMERICAN||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3677207|NCT02298179|3521146|B4|BLACK OR AFRICAN AMERICAN||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3677208|NCT02298179|3521147|B3|BLACK OR AFRICAN AMERICAN||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3677209|NCT02298179|3521148|B2|BLACK OR AFRICAN AMERICAN||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3677210|NCT02298179|3521149|B1|BLACK OR AFRICAN AMERICAN||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3677211|NCT02298179|3521137|B13||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3677212|NCT02298179|3521138|B12||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3677213|NCT02298179|3521139|B11||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3677214|NCT02298179|3521140|B10||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3677215|NCT02298179|3521141|B9||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3677216|NCT02298179|3521142|B8||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3677217|NCT02298179|3521143|B7||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3677218|NCT02298179|3521144|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3677219|NCT02298179|3521145|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3677220|NCT02298179|3521146|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3677221|NCT02298179|3521147|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3677222|NCT02298179|3521148|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3677223|NCT02298179|3521149|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3677224|NCT02298179|3521137|B13||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
3677225|NCT02298179|3521138|B12||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3677226|NCT02298179|3521139|B11||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3677227|NCT02298179|3521140|B10||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3677228|NCT02298179|3521141|B9||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3677229|NCT02298179|3521142|B8||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3677230|NCT02298179|3521143|B7||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3677231|NCT02298179|3521144|B6||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3677232|NCT02298179|3521145|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3677233|NCT02298179|3521146|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3677234|NCT02298179|3521147|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3677235|NCT02298179|3521148|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3677236|NCT02298179|3521149|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3677237|NCT02298179|3521137|B13|||Age||Years|Mean|29.13|29.13|Standard Deviation|7.24|7.24|||
3677238|NCT02298179|3521138|B12|||Age||Years|Mean|27.9|27.9|Standard Deviation|5.86|5.86|||
3677239|NCT02298179|3521139|B11|||Age||Years|Mean|32.9|32.9|Standard Deviation|8.46|8.46|||
3677240|NCT02298179|3521140|B10|||Age||Years|Mean|29.5|29.5|Standard Deviation|6.98|6.98|||
3677241|NCT02298179|3521141|B9|||Age||Years|Mean|28.3|28.3|Standard Deviation|6.8|6.8|||
3677242|NCT02298179|3521142|B8|||Age||Years|Mean|28|28.0|Standard Deviation|7.3|7.3|||
3677243|NCT02298179|3521143|B7|||Age||Years|Mean|27.6|27.6|Standard Deviation|6.84|6.84|||
3677244|NCT02298179|3521144|B6|||Age||Years|Mean|31.2|31.2|Standard Deviation|7.47|7.47|||
3677245|NCT02298179|3521145|B5|||Age||Years|Mean|30.4|30.4|Standard Deviation|8.31|8.31|||
3677246|NCT02298179|3521146|B4|||Age||Years|Mean|30.3|30.3|Standard Deviation|7.62|7.62|||
3677247|NCT02298179|3521147|B3|||Age||Years|Mean|30.2|30.2|Standard Deviation|7.9|7.9|||
3677248|NCT02298179|3521148|B2|||Age||Years|Mean|27.7|27.7|Standard Deviation|6.55|6.55|||
3677249|NCT02298179|3521149|B1|||Age||Years|Mean|28.6|28.6|Standard Deviation|6.8|6.8|||
3677250|NCT02297841|3521402|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3677251|NCT02297841|3521402|B1||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3677252|NCT02297841|3521402|B1|18-70||Age, Customized||participants|Number|201|201.0||||||
3677309|NCT02297230|3521444|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3677253|NCT02297815|3521406|B3|United States||Region of Enrollment||Participants|Count of Participants|2472|2472.0||||||
3677254|NCT02297815|3521407|B2|United States||Region of Enrollment||Participants|Count of Participants|868|868.0||||||
3677255|NCT02297815|3521408|B1|United States||Region of Enrollment||Participants|Count of Participants|1604|1604.0||||||
3677256|NCT02297815|3521406|B3|Race/Ethnicity|Unknown race and unknown ethnicity|Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
3677257|NCT02297815|3521407|B2|Race/Ethnicity|Unknown race and unknown ethnicity|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3677258|NCT02297815|3521408|B1|Race/Ethnicity|Unknown race and unknown ethnicity|Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3677259|NCT02297815|3521406|B3|Race/Ethnicity|Other (non-latino/unknown ethnicity)|Race/Ethnicity, Customized||Participants|Count of Participants|188|188.0||||||
3677260|NCT02297815|3521407|B2|Race/Ethnicity|Other (non-latino/unknown ethnicity)|Race/Ethnicity, Customized||Participants|Count of Participants|59|59.0||||||
3677261|NCT02297815|3521408|B1|Race/Ethnicity|Other (non-latino/unknown ethnicity)|Race/Ethnicity, Customized||Participants|Count of Participants|129|129.0||||||
3677262|NCT02297815|3521406|B3|Race/Ethnicity|Black (non-latino or unknown ethnicity)|Race/Ethnicity, Customized||Participants|Count of Participants|580|580.0||||||
3677263|NCT02297815|3521407|B2|Race/Ethnicity|Black (non-latino or unknown ethnicity)|Race/Ethnicity, Customized||Participants|Count of Participants|106|106.0||||||
3677264|NCT02297815|3521408|B1|Race/Ethnicity|Black (non-latino or unknown ethnicity)|Race/Ethnicity, Customized||Participants|Count of Participants|474|474.0||||||
3677265|NCT02297815|3521406|B3|Race/Ethnicity|White (non-latino or unknown ethnicity)|Race/Ethnicity, Customized||Participants|Count of Participants|1451|1451.0||||||
3677266|NCT02297815|3521407|B2|Race/Ethnicity|White (non-latino or unknown ethnicity)|Race/Ethnicity, Customized||Participants|Count of Participants|630|630.0||||||
3677267|NCT02297815|3521408|B1|Race/Ethnicity|White (non-latino or unknown ethnicity)|Race/Ethnicity, Customized||Participants|Count of Participants|821|821.0||||||
3677268|NCT02297815|3521406|B3|Race/Ethnicity|Latino/hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|212|212.0||||||
3677269|NCT02297815|3521407|B2|Race/Ethnicity|Latino/hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|65|65.0||||||
3677270|NCT02297815|3521408|B1|Race/Ethnicity|Latino/hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|147|147.0||||||
3677271|NCT02297815|3521406|B3||Male|Sex: Female, Male||Participants|Count of Participants|1275|1275.0||||||
3677272|NCT02297815|3521407|B2||Male|Sex: Female, Male||Participants|Count of Participants|445|445.0||||||
3677273|NCT02297815|3521408|B1||Male|Sex: Female, Male||Participants|Count of Participants|830|830.0||||||
3677274|NCT02297815|3521406|B3||Female|Sex: Female, Male||Participants|Count of Participants|1197|1197.0||||||
3677275|NCT02297815|3521407|B2||Female|Sex: Female, Male||Participants|Count of Participants|423|423.0||||||
3677276|NCT02297815|3521408|B1||Female|Sex: Female, Male||Participants|Count of Participants|774|774.0||||||
3677277|NCT02297815|3521406|B3|||Age||Years|Mean|4.96|4.96|Standard Deviation|3.53|3.53|||
3677278|NCT02297815|3521407|B2|||Age||Years|Mean|5.19|5.19|Standard Deviation|3.56|3.56|||
3677279|NCT02297815|3521408|B1|||Age||Years|Mean|4.83|4.83|Standard Deviation|3.51|3.51|||
3677280|NCT02297412|3521423|B3|United States||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3677281|NCT02297412|3521424|B2|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3677282|NCT02297412|3521425|B1|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3677283|NCT02297412|3521423|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3677284|NCT02297412|3521424|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3677285|NCT02297412|3521425|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3677286|NCT02297412|3521423|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3677287|NCT02297412|3521424|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3677288|NCT02297412|3521425|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3677289|NCT02297412|3521423|B3|||Age||years|Mean|54.9|54.9|Standard Deviation|10.9|10.9|||
3677290|NCT02297412|3521424|B2|||Age||years|Mean|55.0|55.0|Standard Deviation|11.8|11.8|||
3677291|NCT02297412|3521425|B1|||Age||years|Mean|54.8|54.8|Standard Deviation|10.1|10.1|||
3677292|NCT02297308|3521436|B1|Canada||Region of Enrollment||participants|Number|90|90.0||||||
3677293|NCT02297308|3521436|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3677294|NCT02297308|3521436|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3677295|NCT02297308|3521436|B1|||Age||years|Mean|83.3|83.3|Standard Deviation|6.9|6.9|||
3677296|NCT02297230|3521441|B5|United States||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3677297|NCT02297230|3521442|B4|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3677298|NCT02297230|3521443|B3|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3677299|NCT02297230|3521444|B2|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3677300|NCT02297230|3521445|B1|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3677301|NCT02297230|3521441|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3677302|NCT02297230|3521442|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3677303|NCT02297230|3521443|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3677304|NCT02297230|3521444|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3677305|NCT02297230|3521445|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3677306|NCT02297230|3521441|B5||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3677307|NCT02297230|3521442|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3677310|NCT02297230|3521445|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3677311|NCT02297230|3521441|B5||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3677312|NCT02297230|3521442|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3677313|NCT02297230|3521443|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3677314|NCT02297230|3521444|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3677315|NCT02297230|3521445|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3677316|NCT02297230|3521441|B5||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3677317|NCT02297230|3521442|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3677318|NCT02297230|3521443|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3677319|NCT02297230|3521444|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3677320|NCT02297230|3521445|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3677321|NCT02297230|3521441|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3677322|NCT02297230|3521442|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3677323|NCT02297230|3521443|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3677324|NCT02297230|3521444|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3677325|NCT02297230|3521445|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3677326|NCT02297100|3521470|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677327|NCT02297100|3521471|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677328|NCT02297100|3521472|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677329|NCT02297100|3521470|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677330|NCT02297100|3521471|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677331|NCT02297100|3521472|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677332|NCT02297100|3521470|B3||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3677333|NCT02297100|3521471|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3677334|NCT02297100|3521472|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3677335|NCT02297100|3521470|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3677336|NCT02297100|3521471|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677337|NCT02297100|3521472|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3677338|NCT02297100|3521470|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677339|NCT02297100|3521471|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677340|NCT02297100|3521472|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677341|NCT02297100|3521470|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3677342|NCT02297100|3521471|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3677343|NCT02297100|3521472|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677344|NCT02297100|3521470|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677345|NCT02297100|3521471|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677346|NCT02297100|3521472|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677347|NCT02297100|3521470|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677348|NCT02297100|3521471|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677349|NCT02297100|3521472|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677350|NCT02297100|3521470|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3677351|NCT02297100|3521471|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3677352|NCT02297100|3521472|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3677353|NCT02297100|3521470|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3677354|NCT02297100|3521471|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3677355|NCT02297100|3521472|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677356|NCT02297100|3521470|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3677357|NCT02297100|3521471|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3677358|NCT02297100|3521472|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3677359|NCT02297100|3521470|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3677360|NCT02297100|3521471|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3677361|NCT02297100|3521472|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3677362|NCT02297100|3521470|B3|||Age||years|Mean|47.41|47.41|Standard Deviation|12.76|12.76|||
3677363|NCT02297100|3521471|B2|||Age||years|Mean|46.5|46.5|Standard Deviation|12.32|12.32|||
3677364|NCT02297100|3521472|B1|||Age||years|Mean|48.38|48.38|Standard Deviation|13.64|13.64|||
3677365|NCT02296931|3521485|B3|Malawi||Region of Enrollment||participants|Number|32|32.0||||||
3677366|NCT02296931|3521486|B2|Malawi||Region of Enrollment||participants|Number|22|22.0||||||
3677367|NCT02296931|3521487|B1|Malawi||Region of Enrollment||participants|Number|10|10.0||||||
3677368|NCT02296931|3521485|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3677369|NCT02296931|3521486|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3677370|NCT02296931|3521487|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3677371|NCT02296931|3521485|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3677372|NCT02296931|3521486|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3677373|NCT02296931|3521487|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3677374|NCT02296931|3521485|B3|||Age||years|Median|27|27.0|Full Range|||19.0|50.0|
3677375|NCT02296931|3521486|B2|||Age||years|Median|26|26.0|Full Range|||19.0|37.0|
3677376|NCT02296931|3521487|B1|||Age||years|Median|28|28.0|Full Range|||23.0|50.0|
3677377|NCT02296840|3521494|B3|United States||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3677378|NCT02296840|3521495|B2|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3677379|NCT02296840|3521496|B1|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3677380|NCT02296840|3521494|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3677381|NCT02296840|3521495|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3677382|NCT02296840|3521496|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3677383|NCT02296840|3521494|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3677384|NCT02296840|3521495|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3677385|NCT02296840|3521496|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3677386|NCT02296840|3521494|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3677387|NCT02296840|3521495|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3677388|NCT02296840|3521496|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3677389|NCT02296840|3521494|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3677390|NCT02296840|3521495|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3677391|NCT02296840|3521496|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3677392|NCT02296840|3521494|B3||<=18 years|Age||Participants|Count of Participants|45|45.0||||||
3677393|NCT02296840|3521495|B2||<=18 years|Age||Participants|Count of Participants|27|27.0||||||
3677394|NCT02296840|3521496|B1||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
3677395|NCT02296606|3521505|B1|United States||Region of Enrollment||participants|Number|127|127.0||||||
3677396|NCT02296606|3521505|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3677397|NCT02296606|3521505|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677398|NCT02296606|3521505|B1||White|Race (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
3677399|NCT02296606|3521505|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3677400|NCT02296606|3521505|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677401|NCT02296606|3521505|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677402|NCT02296606|3521505|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677403|NCT02296606|3521505|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677404|NCT02296606|3521505|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
3677405|NCT02296606|3521505|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3677406|NCT02296606|3521505|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3677407|NCT02296606|3521505|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3677408|NCT02296606|3521505|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|15.6|15.6|||
3677409|NCT02296476|3521509|B4|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3677410|NCT02296476|3521509|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3677411|NCT02296476|3521510|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3677412|NCT02296476|3521511|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3677413|NCT02296476|3521512|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3677414|NCT02296476|3521509|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3677415|NCT02296476|3521510|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3677416|NCT02296476|3521511|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3677417|NCT02296476|3521512|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3677418|NCT02296476|3521509|B4|||Age||Years|Mean|52.5|52.5|Standard Deviation|13.3|13.3|||
3677419|NCT02296476|3521510|B3|||Age||Years|Mean|54.5|54.5|Standard Deviation|21.9|21.9|||
3677420|NCT02296476|3521511|B2|||Age||Years|Mean|55.8|55.8|Standard Deviation|11.2|11.2|||
3677421|NCT02296476|3521512|B1|||Age||Years|Mean|49.7|49.7|Standard Deviation|14.2|14.2|||
3677422|NCT02296242|3521567|B6|United States||Region of Enrollment||participants|Number|53|53.0||||||
3677423|NCT02296242|3521568|B5|United States||Region of Enrollment||participants|Number|21|21.0||||||
3677424|NCT02296242|3521569|B4|United States||Region of Enrollment||participants|Number|14|14.0||||||
3677425|NCT02296242|3521570|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
3677426|NCT02296242|3521571|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3677427|NCT02296242|3521572|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3677428|NCT02296242|3521567|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3677429|NCT02296242|3521568|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3677430|NCT02296242|3521569|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3677431|NCT02296242|3521570|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677432|NCT02296242|3521571|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677433|NCT02296242|3521572|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677434|NCT02296242|3521567|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3677435|NCT02296242|3521568|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677436|NCT02296242|3521569|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677437|NCT02296242|3521570|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3677438|NCT02296242|3521571|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3677439|NCT02296242|3521572|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677440|NCT02296242|3521567|B6||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3677441|NCT02296242|3521568|B5||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3677442|NCT02296242|3521569|B4||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3677443|NCT02296242|3521570|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3677444|NCT02296242|3521571|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3677445|NCT02296242|3521572|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3677446|NCT02296242|3521567|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3677447|NCT02296242|3521568|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3677448|NCT02296242|3521569|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3677449|NCT02296242|3521570|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677450|NCT02296242|3521571|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677451|NCT02296242|3521572|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677452|NCT02296242|3521567|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677453|NCT02296242|3521568|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677454|NCT02296242|3521569|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677455|NCT02296242|3521570|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677456|NCT02296242|3521571|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677457|NCT02296242|3521572|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677458|NCT02296242|3521567|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3677459|NCT02296242|3521568|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3677460|NCT02296242|3521569|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677461|NCT02296242|3521570|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3677462|NCT02296242|3521571|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3677463|NCT02296242|3521572|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677464|NCT02296242|3521567|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677465|NCT02296242|3521568|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677466|NCT02296242|3521569|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677467|NCT02296242|3521570|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677468|NCT02296242|3521571|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677469|NCT02296242|3521572|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677470|NCT02296242|3521567|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677471|NCT02296242|3521568|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677472|NCT02296242|3521569|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677473|NCT02296242|3521570|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677474|NCT02296242|3521571|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677475|NCT02296242|3521572|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677476|NCT02296242|3521567|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3677477|NCT02296242|3521568|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3677478|NCT02296242|3521569|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3677479|NCT02296242|3521570|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3677480|NCT02296242|3521571|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3677481|NCT02296242|3521572|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3677482|NCT02296242|3521567|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3677483|NCT02296242|3521568|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3677484|NCT02296242|3521569|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3677485|NCT02296242|3521570|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3677486|NCT02296242|3521571|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677487|NCT02296242|3521572|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677488|NCT02296242|3521567|B6||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3677489|NCT02296242|3521568|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3677490|NCT02296242|3521569|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3677491|NCT02296242|3521570|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3677492|NCT02296242|3521571|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3677493|NCT02296242|3521572|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3677494|NCT02296242|3521567|B6||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3677495|NCT02296242|3521568|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3677496|NCT02296242|3521569|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3677497|NCT02296242|3521570|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3677498|NCT02296242|3521571|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3677499|NCT02296242|3521572|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3677500|NCT02296242|3521567|B6|||Age||years|Mean|66.8|66.8|Standard Deviation|14.62|14.62|||
3677501|NCT02296242|3521568|B5|||Age||years|Mean|66.0|66.0|Standard Deviation|15.66|15.66|||
3677502|NCT02296242|3521569|B4|||Age||years|Mean|70.6|70.6|Standard Deviation|10.08|10.08|||
3677503|NCT02296242|3521570|B3|||Age||years|Mean|65.6|65.6|Standard Deviation|18.11|18.11|||
3677504|NCT02296242|3521571|B2|||Age||years|Mean|58.7|58.7|Standard Deviation|19.18|19.18|||
3677505|NCT02296242|3521572|B1|||Age||years|Mean|71.6|71.6|Standard Deviation|9.21|9.21|||
3677506|NCT02296138|3521598|B3||Unknown or Not Reported|Race (NIH/OMB)|Ethnicity was not captured in this trial|Participants|Count of Participants|168|168.0||||||
3677507|NCT02296138|3521599|B2||Unknown or Not Reported|Race (NIH/OMB)|Ethnicity was not captured in this trial|Participants|Count of Participants|88|88.0||||||
3677508|NCT02296138|3521600|B1||Unknown or Not Reported|Race (NIH/OMB)|Ethnicity was not captured in this trial|Participants|Count of Participants|80|80.0||||||
3677509|NCT02296138|3521598|B3||More than one race|Race (NIH/OMB)|Ethnicity was not captured in this trial|Participants|Count of Participants|42|42.0||||||
3677510|NCT02296138|3521599|B2||More than one race|Race (NIH/OMB)|Ethnicity was not captured in this trial|Participants|Count of Participants|22|22.0||||||
3677511|NCT02296138|3521600|B1||More than one race|Race (NIH/OMB)|Ethnicity was not captured in this trial|Participants|Count of Participants|20|20.0||||||
3677512|NCT02296138|3521598|B3||White|Race (NIH/OMB)|Ethnicity was not captured in this trial|Participants|Count of Participants|6247|6247.0||||||
3677513|NCT02296138|3521599|B2||White|Race (NIH/OMB)|Ethnicity was not captured in this trial|Participants|Count of Participants|3134|3134.0||||||
3677514|NCT02296138|3521600|B1||White|Race (NIH/OMB)|Ethnicity was not captured in this trial|Participants|Count of Participants|3113|3113.0||||||
3677515|NCT02296138|3521598|B3||Black or African American|Race (NIH/OMB)|Ethnicity was not captured in this trial|Participants|Count of Participants|110|110.0||||||
3677516|NCT02296138|3521599|B2||Black or African American|Race (NIH/OMB)|Ethnicity was not captured in this trial|Participants|Count of Participants|58|58.0||||||
3677517|NCT02296138|3521600|B1||Black or African American|Race (NIH/OMB)|Ethnicity was not captured in this trial|Participants|Count of Participants|52|52.0||||||
3677518|NCT02296138|3521598|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Ethnicity was not captured in this trial|Participants|Count of Participants|8|8.0||||||
3677519|NCT02296138|3521599|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Ethnicity was not captured in this trial|Participants|Count of Participants|3|3.0||||||
3677520|NCT02296138|3521600|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Ethnicity was not captured in this trial|Participants|Count of Participants|5|5.0||||||
3677521|NCT02296138|3521598|B3||Asian|Race (NIH/OMB)|Ethnicity was not captured in this trial|Participants|Count of Participants|1164|1164.0||||||
3677522|NCT02296138|3521599|B2||Asian|Race (NIH/OMB)|Ethnicity was not captured in this trial|Participants|Count of Participants|557|557.0||||||
3677523|NCT02296138|3521600|B1||Asian|Race (NIH/OMB)|Ethnicity was not captured in this trial|Participants|Count of Participants|607|607.0||||||
3677524|NCT02296138|3521598|B3||American Indian or Alaska Native|Race (NIH/OMB)|Ethnicity was not captured in this trial|Participants|Count of Participants|141|141.0||||||
3677525|NCT02296138|3521599|B2||American Indian or Alaska Native|Race (NIH/OMB)|Ethnicity was not captured in this trial|Participants|Count of Participants|77|77.0||||||
3677526|NCT02296138|3521600|B1||American Indian or Alaska Native|Race (NIH/OMB)|Ethnicity was not captured in this trial|Participants|Count of Participants|64|64.0||||||
3677527|NCT02296138|3521598|B3||Male|Sex: Female, Male|Number of subjects is categorized as Male or Female.|Participants|Count of Participants|5626|5626.0||||||
3677528|NCT02296138|3521599|B2||Male|Sex: Female, Male|Number of subjects is categorized as Male or Female.|Participants|Count of Participants|2785|2785.0||||||
3677529|NCT02296138|3521600|B1||Male|Sex: Female, Male|Number of subjects is categorized as Male or Female.|Participants|Count of Participants|2841|2841.0||||||
3677530|NCT02296138|3521598|B3||Female|Sex: Female, Male|Number of subjects is categorized as Male or Female.|Participants|Count of Participants|2254|2254.0||||||
3677531|NCT02296138|3521599|B2||Female|Sex: Female, Male|Number of subjects is categorized as Male or Female.|Participants|Count of Participants|1154|1154.0||||||
3677532|NCT02296138|3521600|B1||Female|Sex: Female, Male|Number of subjects is categorized as Male or Female.|Participants|Count of Participants|1100|1100.0||||||
3677533|NCT02296138|3521598|B3|||Age|Age at the time of signing informed consent form is presented.|Years|Mean|66.4|66.4|Standard Deviation|8.5|8.5|||
3677591|NCT02296125|3521616|B2|||Age||Years|Mean|63.3|63.3|Standard Deviation|10.90|10.9|||
3677534|NCT02296138|3521599|B2|||Age|Age at the time of signing informed consent form is presented.|Years|Mean|66.5|66.5|Standard Deviation|8.4|8.4|||
3677535|NCT02296138|3521600|B1|||Age|Age at the time of signing informed consent form is presented.|Years|Mean|66.3|66.3|Standard Deviation|8.5|8.5|||
3677536|NCT02296125|3521615|B3|Former smokers||Smoking status||Participants|Count of Participants|182|182.0||||||
3677537|NCT02296125|3521616|B2|Former smokers||Smoking status||Participants|Count of Participants|93|93.0||||||
3677538|NCT02296125|3521617|B1|Former smokers||Smoking status||Participants|Count of Participants|89|89.0||||||
3677539|NCT02296125|3521615|B3|Current smokers||Smoking status||Participants|Count of Participants|17|17.0||||||
3677540|NCT02296125|3521616|B2|Current smokers||Smoking status||Participants|Count of Participants|9|9.0||||||
3677541|NCT02296125|3521617|B1|Current smokers||Smoking status||Participants|Count of Participants|8|8.0||||||
3677542|NCT02296125|3521615|B3|Never smoked||Smoking status||Participants|Count of Participants|357|357.0||||||
3677543|NCT02296125|3521616|B2|Never smoked||Smoking status||Participants|Count of Participants|175|175.0||||||
3677544|NCT02296125|3521617|B1|Never smoked||Smoking status||Participants|Count of Participants|182|182.0||||||
3677545|NCT02296125|3521615|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3677546|NCT02296125|3521616|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3677547|NCT02296125|3521617|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3677548|NCT02296125|3521615|B3|Missing||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3677549|NCT02296125|3521616|B2|Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3677550|NCT02296125|3521617|B1|Missing||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3677551|NCT02296125|3521615|B3|Other||Race/Ethnicity, Customized||Participants|Number|207|207.0||||||
3677552|NCT02296125|3521616|B2|Other||Race/Ethnicity, Customized||Participants|Number|104|104.0||||||
3677553|NCT02296125|3521617|B1|Other||Race/Ethnicity, Customized||Participants|Number|103|103.0||||||
3677554|NCT02296125|3521615|B3|Japanese||Race/Ethnicity, Customized||Participants|Number|120|120.0||||||
3677555|NCT02296125|3521616|B2|Japanese||Race/Ethnicity, Customized||Participants|Number|55|55.0||||||
3677556|NCT02296125|3521617|B1|Japanese||Race/Ethnicity, Customized||Participants|Number|65|65.0||||||
3677557|NCT02296125|3521615|B3|Chinese||Race/Ethnicity, Customized||Participants|Number|56|56.0||||||
3677558|NCT02296125|3521616|B2|Chinese||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
3677559|NCT02296125|3521617|B1|Chinese||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
3677560|NCT02296125|3521615|B3|Asian (other than Chinese and Japanese)||Race/Ethnicity, Customized||Participants|Number|171|171.0||||||
3677561|NCT02296125|3521616|B2|Asian (other than Chinese and Japanese)||Race/Ethnicity, Customized||Participants|Number|94|94.0||||||
3677562|NCT02296125|3521617|B1|Asian (other than Chinese and Japanese)||Race/Ethnicity, Customized||Participants|Number|77|77.0||||||
3677563|NCT02296125|3521615|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3677564|NCT02296125|3521616|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3677565|NCT02296125|3521617|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3677566|NCT02296125|3521615|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677567|NCT02296125|3521616|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677568|NCT02296125|3521617|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677569|NCT02296125|3521615|B3||White|Race (NIH/OMB)||Participants|Count of Participants|201|201.0||||||
3677570|NCT02296125|3521616|B2||White|Race (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3677571|NCT02296125|3521617|B1||White|Race (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
3677572|NCT02296125|3521615|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3677573|NCT02296125|3521616|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3677574|NCT02296125|3521617|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3677575|NCT02296125|3521615|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677576|NCT02296125|3521616|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677577|NCT02296125|3521617|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677578|NCT02296125|3521615|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|347|347.0||||||
3677579|NCT02296125|3521616|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|173|173.0||||||
3677580|NCT02296125|3521617|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|174|174.0||||||
3677581|NCT02296125|3521615|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3677582|NCT02296125|3521616|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3677583|NCT02296125|3521617|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3677584|NCT02296125|3521615|B3||Male|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
3677585|NCT02296125|3521616|B2||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3677586|NCT02296125|3521617|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3677587|NCT02296125|3521615|B3||Female|Sex: Female, Male||Participants|Count of Participants|350|350.0||||||
3677588|NCT02296125|3521616|B2||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3677589|NCT02296125|3521617|B1||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
3677590|NCT02296125|3521615|B3|||Age||Years|Mean|63.0|63.0|Standard Deviation|10.79|10.79|||
3677592|NCT02296125|3521617|B1|||Age||Years|Mean|62.7|62.7|Standard Deviation|10.70|10.7|||
3677593|NCT02296099|3521645|B3|United States||Region of Enrollment||Participants|Count of Participants|109|109.0||||||
3677594|NCT02296099|3521646|B2|United States||Region of Enrollment||Participants|Count of Participants|55|55.0||||||
3677595|NCT02296099|3521647|B1|United States||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
3677596|NCT02296099|3521645|B3|Race|Latina|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3677597|NCT02296099|3521646|B2|Race|Latina|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3677598|NCT02296099|3521647|B1|Race|Latina|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3677599|NCT02296099|3521645|B3|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3677600|NCT02296099|3521646|B2|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3677601|NCT02296099|3521647|B1|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3677602|NCT02296099|3521645|B3|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3677603|NCT02296099|3521646|B2|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3677604|NCT02296099|3521647|B1|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3677605|NCT02296099|3521645|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|103|103.0||||||
3677606|NCT02296099|3521646|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|53|53.0||||||
3677607|NCT02296099|3521647|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
3677608|NCT02296099|3521645|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3677609|NCT02296099|3521646|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3677610|NCT02296099|3521647|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3677611|NCT02296099|3521645|B3||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3677612|NCT02296099|3521646|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3677613|NCT02296099|3521647|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3677614|NCT02296099|3521645|B3|||Age||years|Mean|52|52.0|Standard Deviation|10|10.0|||
3677615|NCT02296099|3521646|B2|||Age||years|Mean|53|53.0|Standard Deviation|10|10.0|||
3677616|NCT02296099|3521647|B1|||Age||years|Mean|51|51.0|Standard Deviation|11|11.0|||
3677617|NCT02295774|3521672|B1|||Height||cm|Mean|168.2|168.2|Standard Deviation|11.2|11.2|||
3677618|NCT02295774|3521672|B1|||Body weight||kg|Mean|74.40|74.4|Standard Deviation|15.48|15.48|||
3677619|NCT02295774|3521672|B1|Italy||Region of Enrollment||participants|Number|10|10.0||||||
3677620|NCT02295774|3521672|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3677621|NCT02295774|3521672|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3677622|NCT02295774|3521672|B1|||Age||Years|Mean|63.1|63.1|Standard Deviation|9.2|9.2|||
3677623|NCT02295644|3521677|B5|United States||Region of Enrollment||participants|Number|25|25.0||||||
3677624|NCT02295644|3521678|B4|United States||Region of Enrollment||participants|Number|5|5.0||||||
3677625|NCT02295644|3521679|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3677626|NCT02295644|3521680|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3677627|NCT02295644|3521681|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3677628|NCT02295644|3521677|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3677629|NCT02295644|3521678|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3677630|NCT02295644|3521679|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3677631|NCT02295644|3521680|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3677632|NCT02295644|3521681|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3677633|NCT02295644|3521677|B5||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3677634|NCT02295644|3521678|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3677635|NCT02295644|3521679|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3677636|NCT02295644|3521680|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3677637|NCT02295644|3521681|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3677638|NCT02295644|3521677|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3677639|NCT02295644|3521678|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3677640|NCT02295644|3521679|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3677641|NCT02295644|3521680|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3677642|NCT02295644|3521681|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3677643|NCT02295644|3521677|B5||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3677644|NCT02295644|3521678|B4||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3677645|NCT02295644|3521679|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3677646|NCT02295644|3521680|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3677647|NCT02295644|3521681|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3677648|NCT02295644|3521677|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3677649|NCT02295644|3521678|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3677650|NCT02295644|3521679|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3677651|NCT02295644|3521680|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3677652|NCT02295644|3521681|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3677653|NCT02295280|3521702|B3|United States||Region of Enrollment||participants|Number|69|69.0||||||
3677654|NCT02295280|3521703|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
3677655|NCT02295280|3521704|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3677656|NCT02295280|3521702|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3677657|NCT02295280|3521703|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3677658|NCT02295280|3521704|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3677659|NCT02295280|3521702|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3677660|NCT02295280|3521703|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3677661|NCT02295280|3521704|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3677662|NCT02295280|3521702|B3|||Age||years|Median|23|23.0|Full Range|||21.0|27.0|
3677663|NCT02295280|3521703|B2|||Age||years|Median|23.5|23.5|Full Range|||21.0|27.0|
3677664|NCT02295280|3521704|B1|||Age||years|Median|23|23.0|Full Range|||21.0|25.0|
3677665|NCT02295280|3521702|B3|>=65 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3677666|NCT02295280|3521703|B2|>=65 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3677667|NCT02295280|3521704|B1|>=65 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3677668|NCT02295280|3521702|B3|Between 18 and 65 years||Age, Customized||Participants|Count of Participants|69|69.0||||||
3677669|NCT02295280|3521703|B2|Between 18 and 65 years||Age, Customized||Participants|Count of Participants|34|34.0||||||
3677670|NCT02295280|3521704|B1|Between 18 and 65 years||Age, Customized||Participants|Count of Participants|35|35.0||||||
3677671|NCT02295280|3521702|B3|<=18 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3677672|NCT02295280|3521703|B2|<=18 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3677673|NCT02295280|3521704|B1|<=18 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3677674|NCT02295020|3521711|B3|||MCP-1||pg/mL|Median|10188|10188.0|Full Range|||876.7|24831.0|
3677675|NCT02295020|3521712|B2|||MCP-1||pg/mL|Median|10944|10944.0|Full Range|||876.7|21443.0|
3677676|NCT02295020|3521713|B1|||MCP-1||pg/mL|Median|8664|8664.0|Full Range|||1233.0|24831.0|
3677677|NCT02295020|3521711|B3|||MIP-1alpha||pg/mL|Median|250.8|250.8|Full Range|||1.2|24590.0|
3677678|NCT02295020|3521712|B2|||MIP-1alpha||pg/mL|Median|162.2|162.2|Full Range|||4.2|2069.0|
3677679|NCT02295020|3521713|B1|||MIP-1alpha||pg/mL|Median|255.5|255.5|Full Range|||1.2|24590.0|
3677680|NCT02295020|3521711|B3|||TNF-alpha||pg/mL|Median|108.1|108.1|Full Range|||2.1|1079.0|
3677681|NCT02295020|3521712|B2|||TNF-alpha||pg/mL|Median|104.8|104.8|Full Range|||2.1|436.8|
3677682|NCT02295020|3521713|B1|||TNF-alpha||pg/mL|Median|108.1|108.1|Full Range|||7.7|1079.0|
3677683|NCT02295020|3521711|B3|||IL-8||pg/mL|Median|643.0|643.0|Full Range|||8.9|7802.0|
3677684|NCT02295020|3521712|B2|||IL-8||pg/mL|Median|486.5|486.5|Full Range|||8.9|7802.0|
3677685|NCT02295020|3521713|B1|||IL-8||pg/mL|Median|653.3|653.3|Full Range|||19.2|4043.0|
3677686|NCT02295020|3521711|B3|||IL-6||pg/mL|Median|1467.1|1467.1|Full Range|||9.2|25426.0|
3677687|NCT02295020|3521712|B2|||IL-6||pg/mL|Median|1309|1309.0|Full Range|||9.2|7905.0|
3677688|NCT02295020|3521713|B1|||IL-6||pg/mL|Median|1639|1639.0|Full Range|||49.9|25426.0|
3677689|NCT02295020|3521711|B3|||KOOS - QOL|KOOS = Knee injury and Osteoarthritis Outcome Score. QOL refers to the quality of life sub-score. The scale is 0 to 100 where 100 indicates no problems and 0 indicates extreme problems.|units on a scale|Mean|20.9|20.9|Standard Deviation|18.0|18.0|||
3677690|NCT02295020|3521712|B2|||KOOS - QOL|KOOS = Knee injury and Osteoarthritis Outcome Score. QOL refers to the quality of life sub-score. The scale is 0 to 100 where 100 indicates no problems and 0 indicates extreme problems.|units on a scale|Mean|14.4|14.4|Standard Deviation|13.8|13.8|||
3677691|NCT02295020|3521713|B1|||KOOS - QOL|KOOS = Knee injury and Osteoarthritis Outcome Score. QOL refers to the quality of life sub-score. The scale is 0 to 100 where 100 indicates no problems and 0 indicates extreme problems.|units on a scale|Mean|28.7|28.7|Standard Deviation|19.6|19.6|||
3677692|NCT02295020|3521711|B3|||KOOS - Sport/Rec|KOOS = Knee injury and Osteoarthritis Outcome Score. Sport/Rec refers to the sport and recreational activities sub-score. The scale is 0 to 100 where 100 indicates no problems and 0 indicates extreme problems.|units on a scale|Mean|19.8|19.8|Standard Deviation|22.9|22.9|||
3677693|NCT02295020|3521712|B2|||KOOS - Sport/Rec|KOOS = Knee injury and Osteoarthritis Outcome Score. Sport/Rec refers to the sport and recreational activities sub-score. The scale is 0 to 100 where 100 indicates no problems and 0 indicates extreme problems.|units on a scale|Mean|12.1|12.1|Standard Deviation|17.1|17.1|||
3677694|NCT02295020|3521713|B1|||KOOS - Sport/Rec|KOOS = Knee injury and Osteoarthritis Outcome Score. Sport/Rec refers to the sport and recreational activities sub-score. The scale is 0 to 100 where 100 indicates no problems and 0 indicates extreme problems.|units on a scale|Mean|29.3|29.3|Standard Deviation|25.9|25.9|||
3677695|NCT02295020|3521711|B3|||KOOS - ADL|KOOS = Knee injury and Osteoarthritis Outcome Score. ADL refers to the activities of daily living sub-score. The scale is 0 to 100 where 100 indicates no problems and 0 indicates extreme problems.|units on a scale|Mean|39.0|39.0|Standard Deviation|19.1|19.1|||
3677696|NCT02295020|3521712|B2|||KOOS - ADL|KOOS = Knee injury and Osteoarthritis Outcome Score. ADL refers to the activities of daily living sub-score. The scale is 0 to 100 where 100 indicates no problems and 0 indicates extreme problems.|units on a scale|Mean|37.2|37.2|Standard Deviation|22.2|22.2|||
3677697|NCT02295020|3521713|B1|||KOOS - ADL|KOOS = Knee injury and Osteoarthritis Outcome Score. ADL refers to the activities of daily living sub-score. The scale is 0 to 100 where 100 indicates no problems and 0 indicates extreme problems.|units on a scale|Mean|40.8|40.8|Standard Deviation|15.6|15.6|||
3677750|NCT02294773|3521745|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3677751|NCT02294773|3521746|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3677698|NCT02295020|3521711|B3|||KOOS - Symptoms|KOOS = Knee injury and Osteoarthritis Outcome Score. Symptoms refers to the Symptoms sub-score.The scale is 0 to 100 where 100 indicates no problems and 0 indicates extreme problems.|units on a scale|Mean|40.4|40.4|Standard Deviation|20.1|20.1|||
3677699|NCT02295020|3521712|B2|||KOOS - Symptoms|KOOS = Knee injury and Osteoarthritis Outcome Score. Symptoms refers to the Symptoms sub-score.The scale is 0 to 100 where 100 indicates no problems and 0 indicates extreme problems.|units on a scale|Mean|35.6|35.6|Standard Deviation|16.7|16.7|||
3677700|NCT02295020|3521713|B1|||KOOS - Symptoms|KOOS = Knee injury and Osteoarthritis Outcome Score. Symptoms refers to the Symptoms sub-score.The scale is 0 to 100 where 100 indicates no problems and 0 indicates extreme problems.|units on a scale|Mean|45.5|45.5|Standard Deviation|22.4|22.4|||
3677701|NCT02295020|3521711|B3|||KOOS - Pain|KOOS = Knee injury and Osteoarthritis Outcome Score. Pain refers to the pain sub-score.The scale is 0 to 100 where 100 indicates no problems and 0 indicates extreme problems.|units on a scale|Mean|35.6|35.6|Standard Deviation|19.4|19.4|||
3677702|NCT02295020|3521712|B2|||KOOS - Pain|KOOS = Knee injury and Osteoarthritis Outcome Score. Pain refers to the pain sub-score.The scale is 0 to 100 where 100 indicates no problems and 0 indicates extreme problems.|units on a scale|Mean|33.5|33.5|Standard Deviation|20.3|20.3|||
3677703|NCT02295020|3521713|B1|||KOOS - Pain|KOOS = Knee injury and Osteoarthritis Outcome Score. Pain refers to the pain sub-score.The scale is 0 to 100 where 100 indicates no problems and 0 indicates extreme problems.|units on a scale|Mean|37.8|37.8|Standard Deviation|18.7|18.7|||
3677704|NCT02295020|3521711|B3|||Body Mass Index||kg/m^2|Mean|32.4|32.4|Standard Deviation|5.4|5.4|||
3677705|NCT02295020|3521712|B2|||Body Mass Index||kg/m^2|Mean|30.4|30.4|Standard Deviation|4.3|4.3|||
3677706|NCT02295020|3521713|B1|||Body Mass Index||kg/m^2|Mean|34.2|34.2|Standard Deviation|5.8|5.8|||
3677707|NCT02295020|3521711|B3|Medications||Standard of care||participants|Number|20|20.0||||||
3677708|NCT02295020|3521712|B2|Medications||Standard of care||participants|Number|16|16.0||||||
3677709|NCT02295020|3521713|B1|Medications||Standard of care||participants|Number|4|4.0||||||
3677710|NCT02295020|3521711|B3|NSAID||Standard of care||participants|Number|18|18.0||||||
3677711|NCT02295020|3521712|B2|NSAID||Standard of care||participants|Number|4|4.0||||||
3677712|NCT02295020|3521713|B1|NSAID||Standard of care||participants|Number|14|14.0||||||
3677713|NCT02295020|3521711|B3|Surpatz||Standard of care||participants|Number|2|2.0||||||
3677714|NCT02295020|3521712|B2|Surpatz||Standard of care||participants|Number|0|0.0||||||
3677715|NCT02295020|3521713|B1|Surpatz||Standard of care||participants|Number|2|2.0||||||
3677716|NCT02295020|3521711|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3677717|NCT02295020|3521712|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3677718|NCT02295020|3521713|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3677719|NCT02295020|3521711|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3677720|NCT02295020|3521712|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3677721|NCT02295020|3521713|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3677722|NCT02295020|3521711|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3677723|NCT02295020|3521712|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3677724|NCT02295020|3521713|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3677725|NCT02295020|3521711|B3|||Age||years|Mean|59.4|59.4|Standard Deviation|10.2|10.2|||
3677726|NCT02295020|3521712|B2|||Age||years|Mean|61.5|61.5|Standard Deviation|8.8|8.8|||
3677727|NCT02295020|3521713|B1|||Age||years|Mean|57.4|57.4|Standard Deviation|11.3|11.3|||
3677728|NCT02294773|3521744|B3|||Mid-luteal progesterone||ng/ml|Mean|18.6|18.6|Standard Deviation|13.7|13.7|||
3677729|NCT02294773|3521745|B2|||Mid-luteal progesterone||ng/ml|Mean|12.1|12.1|Standard Deviation|4.3|4.3|||
3677730|NCT02294773|3521746|B1|||Mid-luteal progesterone||ng/ml|Mean|21.1|21.1|Standard Deviation|16.4|16.4|||
3677731|NCT02294773|3521744|B3|||Sperm morphology||Percent normal|Mean|6.2|6.2|Standard Deviation|2.6|2.6|||
3677732|NCT02294773|3521745|B2|||Sperm morphology||Percent normal|Mean|8.5|8.5|Standard Deviation|2.4|2.4|||
3677733|NCT02294773|3521746|B1|||Sperm morphology||Percent normal|Mean|5.6|5.6|Standard Deviation|2.3|2.3|||
3677734|NCT02294773|3521744|B3|||Sperm Concentration||million sperm/ml|Mean|39.4|39.4|Standard Deviation|30.9|30.9|||
3677735|NCT02294773|3521745|B2|||Sperm Concentration||million sperm/ml|Mean|71.2|71.2|Standard Deviation|39.2|39.2|||
3677736|NCT02294773|3521746|B1|||Sperm Concentration||million sperm/ml|Mean|32.6|32.6|Standard Deviation|13.9|13.9|||
3677737|NCT02294773|3521744|B3|||Anti-mullerian Hormone||ng/ml|Mean|5.2|5.2|Standard Deviation|2.3|2.3|||
3677738|NCT02294773|3521745|B2|||Anti-mullerian Hormone||ng/ml|Mean|5.8|5.8|Standard Deviation|0|0.0|||
3677739|NCT02294773|3521746|B1|||Anti-mullerian Hormone||ng/ml|Mean|3.1|3.1|Standard Deviation|2.2|2.2|||
3677740|NCT02294773|3521744|B3|||Day 3 Follicle Stimulating Hormone||mIU/ml|Mean|6.9|6.9|Standard Deviation|1.8|1.8|||
3677741|NCT02294773|3521745|B2|||Day 3 Follicle Stimulating Hormone||mIU/ml|Mean|6.2|6.2|Standard Deviation|1.9|1.9|||
3677742|NCT02294773|3521746|B1|||Day 3 Follicle Stimulating Hormone||mIU/ml|Mean|7.6|7.6|Standard Deviation|1.7|1.7|||
3677743|NCT02294773|3521744|B3|||Body Mass Index||kg/m^2|Mean|27.9|27.9|Standard Deviation|7.5|7.5|||
3677744|NCT02294773|3521745|B2|||Body Mass Index||kg/m^2|Mean|25|25.0|Standard Deviation|4|4.0|||
3677745|NCT02294773|3521746|B1|||Body Mass Index||kg/m^2|Mean|30|30.0|Standard Deviation|8.9|8.9|||
3677746|NCT02294773|3521744|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
3677747|NCT02294773|3521745|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3677748|NCT02294773|3521746|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3677749|NCT02294773|3521744|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3677752|NCT02294773|3521744|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3677753|NCT02294773|3521745|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3677754|NCT02294773|3521746|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3677755|NCT02294773|3521744|B3|||Age||years|Mean|30.1|30.1|Standard Deviation|4.8|4.8|||
3677756|NCT02294773|3521745|B2|||Age||years|Mean|29.6|29.6|Standard Deviation|3.05|3.05|||
3677757|NCT02294773|3521746|B1|||Age||years|Mean|30.4|30.4|Standard Deviation|5.9|5.9|||
3677758|NCT02294734|3521761|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|125|125.0||||||
3677759|NCT02294734|3521762|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|62|62.0||||||
3677760|NCT02294734|3521763|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|63|63.0||||||
3677761|NCT02294734|3521761|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3677762|NCT02294734|3521762|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3677763|NCT02294734|3521763|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3677764|NCT02294734|3521761|B3||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3677765|NCT02294734|3521762|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3677766|NCT02294734|3521763|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3677767|NCT02294734|3521761|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3677768|NCT02294734|3521762|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3677769|NCT02294734|3521763|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3677770|NCT02294734|3521761|B3|||Age||Years|Mean|65.2|65.2|Standard Deviation|7.50|7.5|||
3677771|NCT02294734|3521762|B2|||Age||Years|Mean|65.6|65.6|Standard Deviation|7.14|7.14|||
3677772|NCT02294734|3521763|B1|||Age||Years|Mean|64.9|64.9|Standard Deviation|7.88|7.88|||
3677773|NCT02294682|3521814|B3|Unknown||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3677774|NCT02294682|3521815|B2|Unknown||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3677775|NCT02294682|3521816|B1|Unknown||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3677776|NCT02294682|3521814|B3|White & African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3677777|NCT02294682|3521815|B2|White & African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3677778|NCT02294682|3521816|B1|White & African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3677779|NCT02294682|3521814|B3|White||Race/Ethnicity, Customized||Participants|Number|45|45.0||||||
3677780|NCT02294682|3521815|B2|White||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
3677781|NCT02294682|3521816|B1|White||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
3677782|NCT02294682|3521814|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3677783|NCT02294682|3521815|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3677784|NCT02294682|3521816|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3677785|NCT02294682|3521814|B3|Japanese/East Asian Heri. /South East Asian Heri.||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3677786|NCT02294682|3521815|B2|Japanese/East Asian Heri. /South East Asian Heri.||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3677787|NCT02294682|3521816|B1|Japanese/East Asian Heri. /South East Asian Heri.||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3677788|NCT02294682|3521814|B3|Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3677789|NCT02294682|3521815|B2|Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3677790|NCT02294682|3521816|B1|Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3677791|NCT02294682|3521814|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3677792|NCT02294682|3521815|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3677793|NCT02294682|3521816|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3677794|NCT02294682|3521814|B3|African American/African Heritage (Heri.)||Race/Ethnicity, Customized||Participants|Number|47|47.0||||||
3677795|NCT02294682|3521815|B2|African American/African Heritage (Heri.)||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
3677796|NCT02294682|3521816|B1|African American/African Heritage (Heri.)||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
3677797|NCT02294682|3521814|B3||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3677798|NCT02294682|3521815|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3677799|NCT02294682|3521816|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3677800|NCT02294682|3521814|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3677801|NCT02294682|3521815|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3677802|NCT02294682|3521816|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3677803|NCT02294682|3521814|B3|||Age||Years|Mean|33.3|33.3|Standard Deviation|11.37|11.37|||
3677804|NCT02294682|3521815|B2|||Age||Years|Mean|32.4|32.4|Standard Deviation|11.33|11.33|||
3677805|NCT02294682|3521816|B1|||Age||Years|Mean|34.1|34.1|Standard Deviation|11.45|11.45|||
3677806|NCT02294604|3521857|B4|Taiwan||Region of Enrollment||participants|Number|240|240.0||||||
3677807|NCT02294604|3521858|B3|Taiwan||Region of Enrollment||participants|Number|80|80.0||||||
3677808|NCT02294604|3521859|B2|Taiwan||Region of Enrollment||participants|Number|80|80.0||||||
3677809|NCT02294604|3521860|B1|Taiwan||Region of Enrollment||participants|Number|80|80.0||||||
3677810|NCT02294604|3521857|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677811|NCT02294604|3521858|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677812|NCT02294604|3521859|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677813|NCT02294604|3521860|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677814|NCT02294604|3521857|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677815|NCT02294604|3521858|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677816|NCT02294604|3521859|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677817|NCT02294604|3521860|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677818|NCT02294604|3521857|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677819|NCT02294604|3521858|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677820|NCT02294604|3521859|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677821|NCT02294604|3521860|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677822|NCT02294604|3521857|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677823|NCT02294604|3521858|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677824|NCT02294604|3521859|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677825|NCT02294604|3521860|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677826|NCT02294604|3521857|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677827|NCT02294604|3521858|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677828|NCT02294604|3521859|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677829|NCT02294604|3521860|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677830|NCT02294604|3521857|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|240|240.0||||||
3677831|NCT02294604|3521858|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3677832|NCT02294604|3521859|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3677833|NCT02294604|3521860|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3677834|NCT02294604|3521857|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677835|NCT02294604|3521858|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677836|NCT02294604|3521859|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677837|NCT02294604|3521860|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3677838|NCT02294604|3521857|B4|Unknown||Sex/Gender, Customized|Gender was not assessed|participants|Number|240|240.0||||||
3677839|NCT02294604|3521858|B3|Unknown||Sex/Gender, Customized|Gender was not assessed|participants|Number|80|80.0||||||
3677840|NCT02294604|3521859|B2|Unknown||Sex/Gender, Customized|Gender was not assessed|participants|Number|80|80.0||||||
3677841|NCT02294604|3521860|B1|Unknown||Sex/Gender, Customized|Gender was not assessed|participants|Number|80|80.0||||||
3677842|NCT02294604|3521857|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3677843|NCT02294604|3521858|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3677844|NCT02294604|3521859|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3677845|NCT02294604|3521860|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3677846|NCT02294604|3521857|B4||Between 18 and 65 years|Age||Participants|Count of Participants|240|240.0||||||
3677847|NCT02294604|3521858|B3||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
3677848|NCT02294604|3521859|B2||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
3677849|NCT02294604|3521860|B1||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
3677850|NCT02294604|3521857|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3677851|NCT02294604|3521858|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3677852|NCT02294604|3521859|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3677853|NCT02294604|3521860|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3677854|NCT02294474|3521879|B3|||Average Daily Total Insulin Dose||U/kg|Mean|0.907|0.907|Standard Deviation|0.459|0.459|||
3677855|NCT02294474|3521880|B2|||Average Daily Total Insulin Dose||U/kg|Mean|0.888|0.888|Standard Deviation|0.449|0.449|||
3677856|NCT02294474|3521881|B1|||Average Daily Total Insulin Dose||U/kg|Mean|0.927|0.927|Standard Deviation|0.47|0.47|||
3677857|NCT02294474|3521879|B3|||Average Daily Mealtime Insulin Dose||U/kg|Mean|0.441|0.441|Standard Deviation|0.305|0.305|||
3677858|NCT02294474|3521880|B2|||Average Daily Mealtime Insulin Dose||U/kg|Mean|0.433|0.433|Standard Deviation|0.315|0.315|||
3677859|NCT02294474|3521881|B1|||Average Daily Mealtime Insulin Dose||U/kg|Mean|0.449|0.449|Standard Deviation|0.294|0.294|||
3677860|NCT02294474|3521879|B3|||Average Daily Basal Insulin Dose||U/kg|Mean|0.467|0.467|Standard Deviation|0.252|0.252|||
3677861|NCT02294474|3521880|B2|||Average Daily Basal Insulin Dose||U/kg|Mean|0.458|0.458|Standard Deviation|0.239|0.239|||
3677862|NCT02294474|3521881|B1|||Average Daily Basal Insulin Dose||U/kg|Mean|0.477|0.477|Standard Deviation|0.265|0.265|||
3677863|NCT02294474|3521879|B3|||HbA1c %||percentage of hemoglobin|Mean|8.01|8.01|Standard Deviation|0.89|0.89|||
3677864|NCT02294474|3521880|B2|||HbA1c %||percentage of hemoglobin|Mean|8.03|8.03|Standard Deviation|0.91|0.91|||
3677865|NCT02294474|3521881|B1|||HbA1c %||percentage of hemoglobin|Mean|8|8.0|Standard Deviation|0.86|0.86|||
3677866|NCT02294474|3521879|B3|||Duration of type 2 diabetes mellitus (T2DM)||years|Mean|17.06|17.06|Standard Deviation|8.31|8.31|||
3677867|NCT02294474|3521880|B2|||Duration of type 2 diabetes mellitus (T2DM)||years|Mean|17.52|17.52|Standard Deviation|8.67|8.67|||
3677868|NCT02294474|3521881|B1|||Duration of type 2 diabetes mellitus (T2DM)||years|Mean|16.6|16.6|Standard Deviation|7.93|7.93|||
3677869|NCT02294474|3521879|B3|||Body mass index (BMI)||kg/m^2|Mean|32.2|32.2|Standard Deviation|4.8|4.8|||
3677870|NCT02294474|3521880|B2|||Body mass index (BMI)||kg/m^2|Mean|32.1|32.1|Standard Deviation|4.8|4.8|||
3677871|NCT02294474|3521881|B1|||Body mass index (BMI)||kg/m^2|Mean|32.3|32.3|Standard Deviation|4.8|4.8|||
3677872|NCT02294474|3521879|B3|>=8 %||Randomization Strata of Screening HbA1c||Participants|Count of Participants|296|296.0||||||
3677873|NCT02294474|3521880|B2|>=8 %||Randomization Strata of Screening HbA1c||Participants|Count of Participants|148|148.0||||||
3677874|NCT02294474|3521881|B1|>=8 %||Randomization Strata of Screening HbA1c||Participants|Count of Participants|148|148.0||||||
3677875|NCT02294474|3521879|B3|<8 %||Randomization Strata of Screening HbA1c||Participants|Count of Participants|209|209.0||||||
3677876|NCT02294474|3521880|B2|<8 %||Randomization Strata of Screening HbA1c||Participants|Count of Participants|104|104.0||||||
3677877|NCT02294474|3521881|B1|<8 %||Randomization Strata of Screening HbA1c||Participants|Count of Participants|105|105.0||||||
3677878|NCT02294474|3521879|B3|None of the above||Previous meal time insulin||Participants|Count of Participants|1|1.0||||||
3677879|NCT02294474|3521880|B2|None of the above||Previous meal time insulin||Participants|Count of Participants|1|1.0||||||
3677880|NCT02294474|3521881|B1|None of the above||Previous meal time insulin||Participants|Count of Participants|0|0.0||||||
3677881|NCT02294474|3521879|B3|Both Humalog/Liprolog and NovoLog/NovoRapid||Previous meal time insulin||Participants|Count of Participants|2|2.0||||||
3677882|NCT02294474|3521880|B2|Both Humalog/Liprolog and NovoLog/NovoRapid||Previous meal time insulin||Participants|Count of Participants|1|1.0||||||
3677883|NCT02294474|3521881|B1|Both Humalog/Liprolog and NovoLog/NovoRapid||Previous meal time insulin||Participants|Count of Participants|1|1.0||||||
3677884|NCT02294474|3521879|B3|NovoLog/NovoRapid||Previous meal time insulin||Participants|Count of Participants|243|243.0||||||
3677885|NCT02294474|3521880|B2|NovoLog/NovoRapid||Previous meal time insulin||Participants|Count of Participants|124|124.0||||||
3677886|NCT02294474|3521881|B1|NovoLog/NovoRapid||Previous meal time insulin||Participants|Count of Participants|119|119.0||||||
3677887|NCT02294474|3521879|B3|Humalog/Liprolog||Previous meal time insulin||Participants|Count of Participants|259|259.0||||||
3677888|NCT02294474|3521880|B2|Humalog/Liprolog||Previous meal time insulin||Participants|Count of Participants|126|126.0||||||
3677889|NCT02294474|3521881|B1|Humalog/Liprolog||Previous meal time insulin||Participants|Count of Participants|133|133.0||||||
3677890|NCT02294474|3521879|B3||Male|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
3677891|NCT02294474|3521880|B2||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3677892|NCT02294474|3521881|B1||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3677893|NCT02294474|3521879|B3||Female|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
3677894|NCT02294474|3521880|B2||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3677895|NCT02294474|3521881|B1||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3677896|NCT02294474|3521879|B3|||Age||years|Mean|62.5|62.5|Standard Deviation|9.1|9.1|||
3677897|NCT02294474|3521880|B2|||Age||years|Mean|62.8|62.8|Standard Deviation|8.9|8.9|||
3677898|NCT02294474|3521881|B1|||Age||years|Mean|62.1|62.1|Standard Deviation|9.4|9.4|||
3677899|NCT02294461|3521904|B3||Male|Sex: Female, Male||Participants|Count of Participants|388|388.0||||||
3677900|NCT02294461|3521905|B2||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
3677901|NCT02294461|3521906|B1||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
3677902|NCT02294461|3521904|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3677903|NCT02294461|3521905|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3677904|NCT02294461|3521906|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3677905|NCT02294461|3521904|B3|||Age||Years|Mean|71.2|71.2|Standard Deviation|8.4|8.4|||
3677906|NCT02294461|3521905|B2|||Age||Years|Mean|71.0|71.0|Standard Deviation|8.7|8.7|||
3677907|NCT02294461|3521906|B1|||Age||Years|Mean|71.4|71.4|Standard Deviation|8.2|8.2|||
3677908|NCT02294396|3521959|B5|||Postvoid Residual (PVR) Volume|Measurement of PVR volume was made using either ultrasonography or urethral catheterization, provided that the same method was used for the same participant throughout the study.|mL|Mean|10.08|10.08|Standard Deviation|15.34|15.34|||
3677909|NCT02294396|3521960|B4|||Postvoid Residual (PVR) Volume|Measurement of PVR volume was made using either ultrasonography or urethral catheterization, provided that the same method was used for the same participant throughout the study.|mL|Mean|9.10|9.1|Standard Deviation|14.41|14.41|||
3677910|NCT02294396|3521961|B3|||Postvoid Residual (PVR) Volume|Measurement of PVR volume was made using either ultrasonography or urethral catheterization, provided that the same method was used for the same participant throughout the study.|mL|Mean|9.74|9.74|Standard Deviation|14.35|14.35|||
3677911|NCT02294396|3521962|B2|||Postvoid Residual (PVR) Volume|Measurement of PVR volume was made using either ultrasonography or urethral catheterization, provided that the same method was used for the same participant throughout the study.|mL|Mean|10.43|10.43|Standard Deviation|17.07|17.07|||
3677912|NCT02294396|3521963|B1|||Postvoid Residual (PVR) Volume|Measurement of PVR volume was made using either ultrasonography or urethral catheterization, provided that the same method was used for the same participant throughout the study.|mL|Mean|11.02|11.02|Standard Deviation|15.43|15.43|||
3677989|NCT02293863|3522108|B3||Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3677990|NCT02293863|3522109|B2||Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3677913|NCT02294396|3521959|B5|||Mean Number of Nocturia Episodes per Night|"A nocturia episode was defined as waking at night 1 or more times to void. Night time was defined as the period between bedtime and the wake-up time the following day (micturitions at the same time as the wake-up time were excluded). The mean number of nocturia episodes per night was calculated by taking the sum of nocturia episodes in the patient diary where the variable urinated was indicated during the night time, divided by the number of nights. Only participants who had a nocturia episode at baseline was included in the analysis."|nocturia episodes|Mean|1.61|1.61|Standard Deviation|1.10|1.1|||
3677914|NCT02294396|3521960|B4|||Mean Number of Nocturia Episodes per Night|"A nocturia episode was defined as waking at night 1 or more times to void. Night time was defined as the period between bedtime and the wake-up time the following day (micturitions at the same time as the wake-up time were excluded). The mean number of nocturia episodes per night was calculated by taking the sum of nocturia episodes in the patient diary where the variable urinated was indicated during the night time, divided by the number of nights. Only participants who had a nocturia episode at baseline was included in the analysis."|nocturia episodes|Mean|1.67|1.67|Standard Deviation|1.04|1.04|||
3677915|NCT02294396|3521961|B3|||Mean Number of Nocturia Episodes per Night|"A nocturia episode was defined as waking at night 1 or more times to void. Night time was defined as the period between bedtime and the wake-up time the following day (micturitions at the same time as the wake-up time were excluded). The mean number of nocturia episodes per night was calculated by taking the sum of nocturia episodes in the patient diary where the variable urinated was indicated during the night time, divided by the number of nights. Only participants who had a nocturia episode at baseline was included in the analysis."|nocturia episodes|Mean|1.61|1.61|Standard Deviation|1.29|1.29|||
3677916|NCT02294396|3521962|B2|||Mean Number of Nocturia Episodes per Night|"A nocturia episode was defined as waking at night 1 or more times to void. Night time was defined as the period between bedtime and the wake-up time the following day (micturitions at the same time as the wake-up time were excluded). The mean number of nocturia episodes per night was calculated by taking the sum of nocturia episodes in the patient diary where the variable urinated was indicated during the night time, divided by the number of nights. Only participants who had a nocturia episode at baseline was included in the analysis."|nocturia episodes|Mean|1.68|1.68|Standard Deviation|1.08|1.08|||
3677917|NCT02294396|3521963|B1|||Mean Number of Nocturia Episodes per Night|"A nocturia episode was defined as waking at night 1 or more times to void. Night time was defined as the period between bedtime and the wake-up time the following day (micturitions at the same time as the wake-up time were excluded). The mean number of nocturia episodes per night was calculated by taking the sum of nocturia episodes in the patient diary where the variable urinated was indicated during the night time, divided by the number of nights. Only participants who had a nocturia episode at baseline was included in the analysis."|nocturia episodes|Mean|1.50|1.5|Standard Deviation|0.96|0.96|||
3677918|NCT02294396|3521959|B5|||Mean Volume Voided per Micturition|"The mean volume per micturition was calculated by taking the sum of the urinary volumes where the volume voided was > 0 and where urinary incontinence was not indicated in the patient diary, divided by the number of micturitions where the volume voided was > 0 and where urinary incontinence was not indicated. Only participants who had volume voided was > 0 at baseline was included in the analysis."|mL|Mean|168.368|168.368|Standard Deviation|54.839|54.839|||
3677919|NCT02294396|3521960|B4|||Mean Volume Voided per Micturition|"The mean volume per micturition was calculated by taking the sum of the urinary volumes where the volume voided was > 0 and where urinary incontinence was not indicated in the patient diary, divided by the number of micturitions where the volume voided was > 0 and where urinary incontinence was not indicated. Only participants who had volume voided was > 0 at baseline was included in the analysis."|mL|Mean|167.542|167.542|Standard Deviation|54.320|54.32|||
3677920|NCT02294396|3521961|B3|||Mean Volume Voided per Micturition|"The mean volume per micturition was calculated by taking the sum of the urinary volumes where the volume voided was > 0 and where urinary incontinence was not indicated in the patient diary, divided by the number of micturitions where the volume voided was > 0 and where urinary incontinence was not indicated. Only participants who had volume voided was > 0 at baseline was included in the analysis."|mL|Mean|169.309|169.309|Standard Deviation|50.324|50.324|||
3677921|NCT02294396|3521962|B2|||Mean Volume Voided per Micturition|"The mean volume per micturition was calculated by taking the sum of the urinary volumes where the volume voided was > 0 and where urinary incontinence was not indicated in the patient diary, divided by the number of micturitions where the volume voided was > 0 and where urinary incontinence was not indicated. Only participants who had volume voided was > 0 at baseline was included in the analysis."|mL|Mean|170.064|170.064|Standard Deviation|63.781|63.781|||
3677922|NCT02294396|3521963|B1|||Mean Volume Voided per Micturition|"The mean volume per micturition was calculated by taking the sum of the urinary volumes where the volume voided was > 0 and where urinary incontinence was not indicated in the patient diary, divided by the number of micturitions where the volume voided was > 0 and where urinary incontinence was not indicated. Only participants who had volume voided was > 0 at baseline was included in the analysis."|mL|Mean|166.600|166.6|Standard Deviation|50.404|50.404|||
3677923|NCT02294396|3521959|B5|||Mean Number of Urge Incontinence Episodes per 24 Hours|"An urge incontinence episode was defined as any episode when both urgency and incontinence occurred concurrently. The mean number of incontinence episodes per 24 hours was calculated by taking the sum of all marked episodes in the patient diary where the variable urgency and urinary incontinence’ were indicated, divided by the number of days on which episodes were recorded. Only participants who had an urge incontinence episode at baseline was included in the analysis."|urge incontinence episodes|Mean|1.38|1.38|Standard Deviation|1.43|1.43|||
3677924|NCT02294396|3521960|B4|||Mean Number of Urge Incontinence Episodes per 24 Hours|"An urge incontinence episode was defined as any episode when both urgency and incontinence occurred concurrently. The mean number of incontinence episodes per 24 hours was calculated by taking the sum of all marked episodes in the patient diary where the variable urgency and urinary incontinence’ were indicated, divided by the number of days on which episodes were recorded. Only participants who had an urge incontinence episode at baseline was included in the analysis."|urge incontinence episodes|Mean|1.31|1.31|Standard Deviation|1.62|1.62|||
3677991|NCT02293863|3522110|B1||Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3677992|NCT02293863|3522107|B4||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3677925|NCT02294396|3521961|B3|||Mean Number of Urge Incontinence Episodes per 24 Hours|"An urge incontinence episode was defined as any episode when both urgency and incontinence occurred concurrently. The mean number of incontinence episodes per 24 hours was calculated by taking the sum of all marked episodes in the patient diary where the variable urgency and urinary incontinence’ were indicated, divided by the number of days on which episodes were recorded. Only participants who had an urge incontinence episode at baseline was included in the analysis."|urge incontinence episodes|Mean|1.30|1.3|Standard Deviation|1.16|1.16|||
3677926|NCT02294396|3521962|B2|||Mean Number of Urge Incontinence Episodes per 24 Hours|"An urge incontinence episode was defined as any episode when both urgency and incontinence occurred concurrently. The mean number of incontinence episodes per 24 hours was calculated by taking the sum of all marked episodes in the patient diary where the variable urgency and urinary incontinence’ were indicated, divided by the number of days on which episodes were recorded. Only participants who had an urge incontinence episode at baseline was included in the analysis."|urge incontinence episodes|Mean|1.39|1.39|Standard Deviation|1.45|1.45|||
3677927|NCT02294396|3521963|B1|||Mean Number of Urge Incontinence Episodes per 24 Hours|"An urge incontinence episode was defined as any episode when both urgency and incontinence occurred concurrently. The mean number of incontinence episodes per 24 hours was calculated by taking the sum of all marked episodes in the patient diary where the variable urgency and urinary incontinence’ were indicated, divided by the number of days on which episodes were recorded. Only participants who had an urge incontinence episode at baseline was included in the analysis."|urge incontinence episodes|Mean|1.55|1.55|Standard Deviation|1.47|1.47|||
3677928|NCT02294396|3521959|B5|||Mean Number of Incontinence Episodes per 24 Hours|"An incontinence episode was defined as the complaint of any involuntary leakage of urine. The mean number of incontinence episodes per 24 hours was calculated by taking the sum of all marked episodes in the patient diary where the variable urinary incontinence’ was indicated, divided by the number of days on which episodes were recorded. Only participants who had an incontinence episode at baseline was included in the analysis."|incontinence episodes|Mean|1.56|1.56|Standard Deviation|1.64|1.64|||
3677929|NCT02294396|3521960|B4|||Mean Number of Incontinence Episodes per 24 Hours|"An incontinence episode was defined as the complaint of any involuntary leakage of urine. The mean number of incontinence episodes per 24 hours was calculated by taking the sum of all marked episodes in the patient diary where the variable urinary incontinence’ was indicated, divided by the number of days on which episodes were recorded. Only participants who had an incontinence episode at baseline was included in the analysis."|incontinence episodes|Mean|1.55|1.55|Standard Deviation|1.76|1.76|||
3677930|NCT02294396|3521961|B3|||Mean Number of Incontinence Episodes per 24 Hours|"An incontinence episode was defined as the complaint of any involuntary leakage of urine. The mean number of incontinence episodes per 24 hours was calculated by taking the sum of all marked episodes in the patient diary where the variable urinary incontinence’ was indicated, divided by the number of days on which episodes were recorded. Only participants who had an incontinence episode at baseline was included in the analysis."|incontinence episodes|Mean|1.47|1.47|Standard Deviation|1.35|1.35|||
3677931|NCT02294396|3521962|B2|||Mean Number of Incontinence Episodes per 24 Hours|"An incontinence episode was defined as the complaint of any involuntary leakage of urine. The mean number of incontinence episodes per 24 hours was calculated by taking the sum of all marked episodes in the patient diary where the variable urinary incontinence’ was indicated, divided by the number of days on which episodes were recorded. Only participants who had an incontinence episode at baseline was included in the analysis."|incontinence episodes|Mean|1.59|1.59|Standard Deviation|1.83|1.83|||
3677932|NCT02294396|3521963|B1|||Mean Number of Incontinence Episodes per 24 Hours|"An incontinence episode was defined as the complaint of any involuntary leakage of urine. The mean number of incontinence episodes per 24 hours was calculated by taking the sum of all marked episodes in the patient diary where the variable urinary incontinence’ was indicated, divided by the number of days on which episodes were recorded. Only participants who had an incontinence episode at baseline was included in the analysis."|incontinence episodes|Mean|1.62|1.62|Standard Deviation|1.62|1.62|||
3677933|NCT02294396|3521959|B5|||Mean Number of Urgency Episodes per 24 Hours|"An urgency episode was defined as a complaint of a sudden, compelling desire to pass urine, which is difficult to defer. The mean number of urgency episodes per 24 hours was calculated by taking the sum of all marked episodes in the patient diary where the variable urgency was indicated, divided by the number of days on which episodes were recorded. Only participants who had an urgency episode at baseline was included in the analysis."|urgency episodes|Mean|3.20|3.2|Standard Deviation|2.47|2.47|||
3677934|NCT02294396|3521960|B4|||Mean Number of Urgency Episodes per 24 Hours|"An urgency episode was defined as a complaint of a sudden, compelling desire to pass urine, which is difficult to defer. The mean number of urgency episodes per 24 hours was calculated by taking the sum of all marked episodes in the patient diary where the variable urgency was indicated, divided by the number of days on which episodes were recorded. Only participants who had an urgency episode at baseline was included in the analysis."|urgency episodes|Mean|3.15|3.15|Standard Deviation|2.54|2.54|||
3677935|NCT02294396|3521961|B3|||Mean Number of Urgency Episodes per 24 Hours|"An urgency episode was defined as a complaint of a sudden, compelling desire to pass urine, which is difficult to defer. The mean number of urgency episodes per 24 hours was calculated by taking the sum of all marked episodes in the patient diary where the variable urgency was indicated, divided by the number of days on which episodes were recorded. Only participants who had an urgency episode at baseline was included in the analysis."|urgency episodes|Mean|3.27|3.27|Standard Deviation|2.20|2.2|||
3677936|NCT02294396|3521962|B2|||Mean Number of Urgency Episodes per 24 Hours|"An urgency episode was defined as a complaint of a sudden, compelling desire to pass urine, which is difficult to defer. The mean number of urgency episodes per 24 hours was calculated by taking the sum of all marked episodes in the patient diary where the variable urgency was indicated, divided by the number of days on which episodes were recorded. Only participants who had an urgency episode at baseline was included in the analysis."|urgency episodes|Mean|3.12|3.12|Standard Deviation|2.67|2.67|||
3677993|NCT02293863|3522108|B3||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3677994|NCT02293863|3522109|B2||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3677995|NCT02293863|3522110|B1||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3677937|NCT02294396|3521963|B1|||Mean Number of Urgency Episodes per 24 Hours|"An urgency episode was defined as a complaint of a sudden, compelling desire to pass urine, which is difficult to defer. The mean number of urgency episodes per 24 hours was calculated by taking the sum of all marked episodes in the patient diary where the variable urgency was indicated, divided by the number of days on which episodes were recorded. Only participants who had an urgency episode at baseline was included in the analysis."|urgency episodes|Mean|3.26|3.26|Standard Deviation|2.46|2.46|||
3677938|NCT02294396|3521959|B5|||Mean Number of Micturitions per 24 Hours|"The mean number of micturitions per 24 hours was calculated by taking the sum of all marked episodes in the patient diary where the variable urinated was indicated, divided by the number of days on which episodes were recorded."|micturitions|Mean|10.19|10.19|Standard Deviation|2.69|2.69|||
3677939|NCT02294396|3521960|B4|||Mean Number of Micturitions per 24 Hours|"The mean number of micturitions per 24 hours was calculated by taking the sum of all marked episodes in the patient diary where the variable urinated was indicated, divided by the number of days on which episodes were recorded."|micturitions|Mean|10.20|10.2|Standard Deviation|2.62|2.62|||
3677940|NCT02294396|3521961|B3|||Mean Number of Micturitions per 24 Hours|"The mean number of micturitions per 24 hours was calculated by taking the sum of all marked episodes in the patient diary where the variable urinated was indicated, divided by the number of days on which episodes were recorded."|micturitions|Mean|10.13|10.13|Standard Deviation|2.92|2.92|||
3677941|NCT02294396|3521962|B2|||Mean Number of Micturitions per 24 Hours|"The mean number of micturitions per 24 hours was calculated by taking the sum of all marked episodes in the patient diary where the variable urinated was indicated, divided by the number of days on which episodes were recorded."|micturitions|Mean|10.37|10.37|Standard Deviation|2.65|2.65|||
3677942|NCT02294396|3521963|B1|||Mean Number of Micturitions per 24 Hours|"The mean number of micturitions per 24 hours was calculated by taking the sum of all marked episodes in the patient diary where the variable urinated was indicated, divided by the number of days on which episodes were recorded."|micturitions|Mean|10.06|10.06|Standard Deviation|2.59|2.59|||
3677943|NCT02294396|3521959|B5|||OAB-q SF Score: Total Health-Related Quality of Life (HRQOL)|The OAB-q SF questionnaire was a questionnaire completed by participants composed of 2 sections: Severity Symptom and the HRQL. The HRQL section included 13 questions. For each participant, the total HRQL score was derived as a sum of scores for Questions 7 to 19. The total score ranges from 13 to 78 with higher total HRQL score indicating greater HRQL. OAB-q SF data obtained at week 0 visit were used as baseline.|Units on a Scale|Mean|75.68|75.68|Standard Deviation|17.91|17.91|||
3677944|NCT02294396|3521960|B4|||OAB-q SF Score: Total Health-Related Quality of Life (HRQOL)|The OAB-q SF questionnaire was a questionnaire completed by participants composed of 2 sections: Severity Symptom and the HRQL. The HRQL section included 13 questions. For each participant, the total HRQL score was derived as a sum of scores for Questions 7 to 19. The total score ranges from 13 to 78 with higher total HRQL score indicating greater HRQL. OAB-q SF data obtained at week 0 visit were used as baseline.|Units on a Scale|Mean|75.37|75.37|Standard Deviation|19.33|19.33|||
3677945|NCT02294396|3521961|B3|||OAB-q SF Score: Total Health-Related Quality of Life (HRQOL)|The OAB-q SF questionnaire was a questionnaire completed by participants composed of 2 sections: Severity Symptom and the HRQL. The HRQL section included 13 questions. For each participant, the total HRQL score was derived as a sum of scores for Questions 7 to 19. The total score ranges from 13 to 78 with higher total HRQL score indicating greater HRQL. OAB-q SF data obtained at week 0 visit were used as baseline.|Units on a Scale|Mean|74.85|74.85|Standard Deviation|18.50|18.5|||
3677946|NCT02294396|3521962|B2|||OAB-q SF Score: Total Health-Related Quality of Life (HRQOL)|The OAB-q SF questionnaire was a questionnaire completed by participants composed of 2 sections: Severity Symptom and the HRQL. The HRQL section included 13 questions. For each participant, the total HRQL score was derived as a sum of scores for Questions 7 to 19. The total score ranges from 13 to 78 with higher total HRQL score indicating greater HRQL. OAB-q SF data obtained at week 0 visit were used as baseline.|Units on a Scale|Mean|77.36|77.36|Standard Deviation|16.11|16.11|||
3677947|NCT02294396|3521963|B1|||OAB-q SF Score: Total Health-Related Quality of Life (HRQOL)|The OAB-q SF questionnaire was a questionnaire completed by participants composed of 2 sections: Severity Symptom and the HRQL. The HRQL section included 13 questions. For each participant, the total HRQL score was derived as a sum of scores for Questions 7 to 19. The total score ranges from 13 to 78 with higher total HRQL score indicating greater HRQL. OAB-q SF data obtained at week 0 visit were used as baseline.|Units on a Scale|Mean|75.16|75.16|Standard Deviation|17.65|17.65|||
3677948|NCT02294396|3521959|B5|||Overactive Bladder questionnaire Short Form (OAB-q SF) Score: Symptom Severity|The OAB-q SF questionnaire was a questionnaire completed by participants composed of 2 sections: Severity Symptom and the Health-related Quality of Life (HRQL). The Severity Symptom section included 6 questions. For each participant, the symptom severity score was derived as a sum of scores for Questions 1 to 6. The total score ranges from 6 to 36 with higher symptom severity score indicating greater symptom bother. OAB-q SF data obtained at week 0 visit were used as baseline.|Units on a Scale|Mean|33.08|33.08|Standard Deviation|21.00|21.0|||
3677949|NCT02294396|3521960|B4|||Overactive Bladder questionnaire Short Form (OAB-q SF) Score: Symptom Severity|The OAB-q SF questionnaire was a questionnaire completed by participants composed of 2 sections: Severity Symptom and the Health-related Quality of Life (HRQL). The Severity Symptom section included 6 questions. For each participant, the symptom severity score was derived as a sum of scores for Questions 1 to 6. The total score ranges from 6 to 36 with higher symptom severity score indicating greater symptom bother. OAB-q SF data obtained at week 0 visit were used as baseline.|Units on a Scale|Mean|34.23|34.23|Standard Deviation|22.60|22.6|||
3677950|NCT02294396|3521961|B3|||Overactive Bladder questionnaire Short Form (OAB-q SF) Score: Symptom Severity|The OAB-q SF questionnaire was a questionnaire completed by participants composed of 2 sections: Severity Symptom and the Health-related Quality of Life (HRQL). The Severity Symptom section included 6 questions. For each participant, the symptom severity score was derived as a sum of scores for Questions 1 to 6. The total score ranges from 6 to 36 with higher symptom severity score indicating greater symptom bother. OAB-q SF data obtained at week 0 visit were used as baseline.|Units on a Scale|Mean|32.92|32.92|Standard Deviation|19.45|19.45|||
3677996|NCT02293863|3522107|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|128|128.0||||||
3677997|NCT02293863|3522108|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
3677951|NCT02294396|3521962|B2|||Overactive Bladder questionnaire Short Form (OAB-q SF) Score: Symptom Severity|The OAB-q SF questionnaire was a questionnaire completed by participants composed of 2 sections: Severity Symptom and the Health-related Quality of Life (HRQL). The Severity Symptom section included 6 questions. For each participant, the symptom severity score was derived as a sum of scores for Questions 1 to 6. The total score ranges from 6 to 36 with higher symptom severity score indicating greater symptom bother. OAB-q SF data obtained at week 0 visit were used as baseline.|Units on a Scale|Mean|32.36|32.36|Standard Deviation|21.23|21.23|||
3677952|NCT02294396|3521963|B1|||Overactive Bladder questionnaire Short Form (OAB-q SF) Score: Symptom Severity|The OAB-q SF questionnaire was a questionnaire completed by participants composed of 2 sections: Severity Symptom and the Health-related Quality of Life (HRQL). The Severity Symptom section included 6 questions. For each participant, the symptom severity score was derived as a sum of scores for Questions 1 to 6. The total score ranges from 6 to 36 with higher symptom severity score indicating greater symptom bother. OAB-q SF data obtained at week 0 visit were used as baseline.|Units on a Scale|Mean|32.81|32.81|Standard Deviation|20.78|20.78|||
3677953|NCT02294396|3521959|B5|||Overactive Bladder Symptom Score (OABSS)|The OABSS questionnaire was a questionnaire completed by participants with 4 questions regarding their OAB symptoms. For each participant, the OABSS total score was calculated from the sum total of the score of each question. The total score ranges from 0 to 15 with higher score indicating more symptoms. The OABSS data obtained at week 0 were used as baseline.|Units on a Scale|Mean|7.6|7.6|Standard Deviation|2.4|2.4|||
3677954|NCT02294396|3521960|B4|||Overactive Bladder Symptom Score (OABSS)|The OABSS questionnaire was a questionnaire completed by participants with 4 questions regarding their OAB symptoms. For each participant, the OABSS total score was calculated from the sum total of the score of each question. The total score ranges from 0 to 15 with higher score indicating more symptoms. The OABSS data obtained at week 0 were used as baseline.|Units on a Scale|Mean|7.7|7.7|Standard Deviation|2.3|2.3|||
3677955|NCT02294396|3521961|B3|||Overactive Bladder Symptom Score (OABSS)|The OABSS questionnaire was a questionnaire completed by participants with 4 questions regarding their OAB symptoms. For each participant, the OABSS total score was calculated from the sum total of the score of each question. The total score ranges from 0 to 15 with higher score indicating more symptoms. The OABSS data obtained at week 0 were used as baseline.|Units on a Scale|Mean|7.8|7.8|Standard Deviation|2.3|2.3|||
3677956|NCT02294396|3521962|B2|||Overactive Bladder Symptom Score (OABSS)|The OABSS questionnaire was a questionnaire completed by participants with 4 questions regarding their OAB symptoms. For each participant, the OABSS total score was calculated from the sum total of the score of each question. The total score ranges from 0 to 15 with higher score indicating more symptoms. The OABSS data obtained at week 0 were used as baseline.|Units on a Scale|Mean|7.7|7.7|Standard Deviation|2.5|2.5|||
3677957|NCT02294396|3521963|B1|||Overactive Bladder Symptom Score (OABSS)|The OABSS questionnaire was a questionnaire completed by participants with 4 questions regarding their OAB symptoms. For each participant, the OABSS total score was calculated from the sum total of the score of each question. The total score ranges from 0 to 15 with higher score indicating more symptoms. The OABSS data obtained at week 0 were used as baseline.|Units on a Scale|Mean|7.4|7.4|Standard Deviation|2.6|2.6|||
3677958|NCT02294396|3521959|B5||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3677959|NCT02294396|3521960|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3677960|NCT02294396|3521961|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3677961|NCT02294396|3521962|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3677962|NCT02294396|3521963|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3677963|NCT02294396|3521959|B5||Female|Sex: Female, Male||Participants|Count of Participants|570|570.0||||||
3677964|NCT02294396|3521960|B4||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3677965|NCT02294396|3521961|B3||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3677966|NCT02294396|3521962|B2||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3677967|NCT02294396|3521963|B1||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3677968|NCT02294396|3521959|B5|||Age||years|Mean|65.0|65.0|Standard Deviation|9.4|9.4|||
3677969|NCT02294396|3521960|B4|||Age||years|Mean|65.7|65.7|Standard Deviation|10.0|10.0|||
3677970|NCT02294396|3521961|B3|||Age||years|Mean|65.7|65.7|Standard Deviation|8.7|8.7|||
3677971|NCT02294396|3521962|B2|||Age||years|Mean|64.0|64.0|Standard Deviation|9.3|9.3|||
3677972|NCT02294396|3521963|B1|||Age||years|Mean|64.6|64.6|Standard Deviation|9.4|9.4|||
3677973|NCT02294019|3522036|B1||Male|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
3677974|NCT02294019|3522036|B1||Female|Sex: Female, Male||Participants|Count of Participants|412|412.0||||||
3677975|NCT02294019|3522036|B1|||Age||Years|Mean|53.5|53.5|Standard Deviation|13.7|13.7|||
3677976|NCT02293902|3522041|B4||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3677977|NCT02293902|3522042|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3677978|NCT02293902|3522043|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3677979|NCT02293902|3522044|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3677980|NCT02293902|3522041|B4||Female|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
3677981|NCT02293902|3522042|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3677982|NCT02293902|3522043|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3677983|NCT02293902|3522044|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3677984|NCT02293902|3522041|B4|||Age||years|Mean|54.9|54.9|Standard Deviation|10.7|10.7|||
3677985|NCT02293902|3522042|B3|||Age||years|Mean|55.3|55.3|Standard Deviation|11.0|11.0|||
3677986|NCT02293902|3522043|B2|||Age||years|Mean|56.1|56.1|Standard Deviation|9.5|9.5|||
3677987|NCT02293902|3522044|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|11.5|11.5|||
3677988|NCT02293863|3522107|B4||Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3677998|NCT02293863|3522109|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
3677999|NCT02293863|3522110|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|45|45.0||||||
3678000|NCT02293863|3522107|B4||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3678001|NCT02293863|3522108|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678002|NCT02293863|3522109|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3678003|NCT02293863|3522110|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3678004|NCT02293863|3522107|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3678005|NCT02293863|3522108|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3678006|NCT02293863|3522109|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678007|NCT02293863|3522110|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3678008|NCT02293863|3522107|B4||American Indian or Alaska native|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3678009|NCT02293863|3522108|B3||American Indian or Alaska native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3678010|NCT02293863|3522109|B2||American Indian or Alaska native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678011|NCT02293863|3522110|B1||American Indian or Alaska native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3678012|NCT02293863|3522107|B4||Not Stated|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3678013|NCT02293863|3522108|B3||Not Stated|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3678014|NCT02293863|3522109|B2||Not Stated|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3678015|NCT02293863|3522110|B1||Not Stated|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3678016|NCT02293863|3522107|B4||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|99|99.0||||||
3678017|NCT02293863|3522108|B3||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3678018|NCT02293863|3522109|B2||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3678019|NCT02293863|3522110|B1||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
3678020|NCT02293863|3522107|B4||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
3678021|NCT02293863|3522108|B3||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3678022|NCT02293863|3522109|B2||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3678023|NCT02293863|3522110|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3678024|NCT02293863|3522107|B4||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3678025|NCT02293863|3522108|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3678026|NCT02293863|3522109|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3678027|NCT02293863|3522110|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3678028|NCT02293863|3522107|B4||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3678029|NCT02293863|3522108|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3678030|NCT02293863|3522109|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3678031|NCT02293863|3522110|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3678032|NCT02293863|3522107|B4|||Age||years|Mean|60.7|60.7|Standard Deviation|18.2|18.2|||
3678033|NCT02293863|3522108|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|17.9|17.9|||
3678034|NCT02293863|3522109|B2|||Age||years|Mean|56.5|56.5|Standard Deviation|18.2|18.2|||
3678035|NCT02293863|3522110|B1|||Age||years|Mean|65.7|65.7|Standard Deviation|17.5|17.5|||
3678036|NCT02293538|3522175|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3678037|NCT02293538|3522176|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3678038|NCT02293538|3522177|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3678039|NCT02293538|3522175|B3||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3678040|NCT02293538|3522176|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3678041|NCT02293538|3522177|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3678042|NCT02293538|3522175|B3|≥ 65 years||Age, Customized||participants|Number|2|2.0||||||
3678043|NCT02293538|3522176|B2|≥ 65 years||Age, Customized||participants|Number|1|1.0||||||
3678044|NCT02293538|3522177|B1|≥ 65 years||Age, Customized||participants|Number|1|1.0||||||
3678045|NCT02293538|3522175|B3|18-64 years||Age, Customized||participants|Number|144|144.0||||||
3678046|NCT02293538|3522176|B2|18-64 years||Age, Customized||participants|Number|71|71.0||||||
3678047|NCT02293538|3522177|B1|18-64 years||Age, Customized||participants|Number|73|73.0||||||
3678048|NCT02293538|3522175|B3|||Age||years|Mean|36.2|36.2|Standard Deviation|12.43|12.43|||
3678049|NCT02293538|3522176|B2|||Age||years|Mean|38.3|38.3|Standard Deviation|12.36|12.36|||
3678050|NCT02293538|3522177|B1|||Age||years|Mean|34.3|34.3|Standard Deviation|12.25|12.25|||
3678051|NCT02293512|3522191|B5|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3678052|NCT02293512|3522192|B4|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3678053|NCT02293512|3522193|B3|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3678054|NCT02293512|3522194|B2|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3678055|NCT02293512|3522195|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3678056|NCT02293512|3522191|B5||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3678057|NCT02293512|3522192|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3678058|NCT02293512|3522193|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3678059|NCT02293512|3522194|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3678060|NCT02293512|3522195|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3678061|NCT02293512|3522191|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3678062|NCT02293512|3522192|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3678063|NCT02293512|3522193|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3678064|NCT02293512|3522194|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3678065|NCT02293512|3522195|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3678066|NCT02293512|3522191|B5|||Age||years|Mean|57.8|57.8|Standard Deviation|16.4|16.4|||
3678067|NCT02293512|3522192|B4|||Age||years|Mean|60.7|60.7|Standard Deviation|14.3|14.3|||
3678068|NCT02293512|3522193|B3|||Age||years|Mean|61.6|61.6|Standard Deviation|17.6|17.6|||
3678069|NCT02293512|3522194|B2|||Age||years|Mean|56.9|56.9|Standard Deviation|15.2|15.2|||
3678070|NCT02293512|3522195|B1|||Age||years|Mean|52.1|52.1|Standard Deviation|18.9|18.9|||
3678071|NCT02293395|3522208|B3|Korea, Republic Of||Region of Enrollment||participants|Number|54|54.0||||||
3678072|NCT02293395|3522209|B2|Korea, Republic Of||Region of Enrollment||participants|Number|30|30.0||||||
3678073|NCT02293395|3522210|B1|Korea, Republic Of||Region of Enrollment||participants|Number|24|24.0||||||
3678074|NCT02293395|3522208|B3|UNITED STATES||Region of Enrollment||participants|Number|181|181.0||||||
3678075|NCT02293395|3522209|B2|UNITED STATES||Region of Enrollment||participants|Number|88|88.0||||||
3678076|NCT02293395|3522210|B1|UNITED STATES||Region of Enrollment||participants|Number|93|93.0||||||
3678077|NCT02293395|3522208|B3|UKRAINE||Region of Enrollment||participants|Number|266|266.0||||||
3678078|NCT02293395|3522209|B2|UKRAINE||Region of Enrollment||participants|Number|129|129.0||||||
3678079|NCT02293395|3522210|B1|UKRAINE||Region of Enrollment||participants|Number|137|137.0||||||
3678080|NCT02293395|3522208|B3|TURKEY||Region of Enrollment||participants|Number|200|200.0||||||
3678081|NCT02293395|3522209|B2|TURKEY||Region of Enrollment||participants|Number|98|98.0||||||
3678082|NCT02293395|3522210|B1|TURKEY||Region of Enrollment||participants|Number|102|102.0||||||
3678083|NCT02293395|3522208|B3|SWEDEN||Region of Enrollment||participants|Number|79|79.0||||||
3678084|NCT02293395|3522209|B2|SWEDEN||Region of Enrollment||participants|Number|37|37.0||||||
3678085|NCT02293395|3522210|B1|SWEDEN||Region of Enrollment||participants|Number|42|42.0||||||
3678086|NCT02293395|3522208|B3|SPAIN||Region of Enrollment||participants|Number|122|122.0||||||
3678087|NCT02293395|3522209|B2|SPAIN||Region of Enrollment||participants|Number|60|60.0||||||
3678088|NCT02293395|3522210|B1|SPAIN||Region of Enrollment||participants|Number|62|62.0||||||
3678089|NCT02293395|3522208|B3|RUSSIA||Region of Enrollment||participants|Number|481|481.0||||||
3678090|NCT02293395|3522209|B2|RUSSIA||Region of Enrollment||participants|Number|244|244.0||||||
3678091|NCT02293395|3522210|B1|RUSSIA||Region of Enrollment||participants|Number|237|237.0||||||
3678092|NCT02293395|3522208|B3|POLAND||Region of Enrollment||participants|Number|333|333.0||||||
3678093|NCT02293395|3522209|B2|POLAND||Region of Enrollment||participants|Number|175|175.0||||||
3678094|NCT02293395|3522210|B1|POLAND||Region of Enrollment||participants|Number|158|158.0||||||
3678095|NCT02293395|3522208|B3|NETHERLANDS||Region of Enrollment||participants|Number|134|134.0||||||
3678096|NCT02293395|3522209|B2|NETHERLANDS||Region of Enrollment||participants|Number|65|65.0||||||
3678097|NCT02293395|3522210|B1|NETHERLANDS||Region of Enrollment||participants|Number|69|69.0||||||
3678098|NCT02293395|3522208|B3|JAPAN||Region of Enrollment||participants|Number|59|59.0||||||
3678099|NCT02293395|3522209|B2|JAPAN||Region of Enrollment||participants|Number|33|33.0||||||
3678100|NCT02293395|3522210|B1|JAPAN||Region of Enrollment||participants|Number|26|26.0||||||
3678101|NCT02293395|3522208|B3|ITALY||Region of Enrollment||participants|Number|134|134.0||||||
3678102|NCT02293395|3522209|B2|ITALY||Region of Enrollment||participants|Number|59|59.0||||||
3678103|NCT02293395|3522210|B1|ITALY||Region of Enrollment||participants|Number|75|75.0||||||
3678104|NCT02293395|3522208|B3|HUNGARY||Region of Enrollment||participants|Number|201|201.0||||||
3678105|NCT02293395|3522209|B2|HUNGARY||Region of Enrollment||participants|Number|100|100.0||||||
3678106|NCT02293395|3522210|B1|HUNGARY||Region of Enrollment||participants|Number|101|101.0||||||
3678107|NCT02293395|3522208|B3|FRANCE||Region of Enrollment||participants|Number|57|57.0||||||
3678108|NCT02293395|3522209|B2|FRANCE||Region of Enrollment||participants|Number|29|29.0||||||
3678109|NCT02293395|3522210|B1|FRANCE||Region of Enrollment||participants|Number|28|28.0||||||
3678110|NCT02293395|3522208|B3|DENMARK||Region of Enrollment||participants|Number|3|3.0||||||
3678111|NCT02293395|3522209|B2|DENMARK||Region of Enrollment||participants|Number|2|2.0||||||
3678112|NCT02293395|3522210|B1|DENMARK||Region of Enrollment||participants|Number|1|1.0||||||
3678113|NCT02293395|3522208|B3|CZECH REPUBLIC||Region of Enrollment||participants|Number|71|71.0||||||
3678114|NCT02293395|3522209|B2|CZECH REPUBLIC||Region of Enrollment||participants|Number|37|37.0||||||
3678115|NCT02293395|3522210|B1|CZECH REPUBLIC||Region of Enrollment||participants|Number|34|34.0||||||
3678116|NCT02293395|3522208|B3|CANADA||Region of Enrollment||participants|Number|84|84.0||||||
3678117|NCT02293395|3522209|B2|CANADA||Region of Enrollment||participants|Number|47|47.0||||||
3678118|NCT02293395|3522210|B1|CANADA||Region of Enrollment||participants|Number|37|37.0||||||
3678119|NCT02293395|3522208|B3|BULGARIA||Region of Enrollment||participants|Number|161|161.0||||||
3678120|NCT02293395|3522209|B2|BULGARIA||Region of Enrollment||participants|Number|78|78.0||||||
3678121|NCT02293395|3522210|B1|BULGARIA||Region of Enrollment||participants|Number|83|83.0||||||
3678122|NCT02293395|3522208|B3|BRAZIL||Region of Enrollment||participants|Number|162|162.0||||||
3678123|NCT02293395|3522209|B2|BRAZIL||Region of Enrollment||participants|Number|85|85.0||||||
3678124|NCT02293395|3522210|B1|BRAZIL||Region of Enrollment||participants|Number|77|77.0||||||
3678125|NCT02293395|3522208|B3|BELGIUM||Region of Enrollment||participants|Number|89|89.0||||||
3678126|NCT02293395|3522209|B2|BELGIUM||Region of Enrollment||participants|Number|40|40.0||||||
3678127|NCT02293395|3522210|B1|BELGIUM||Region of Enrollment||participants|Number|49|49.0||||||
3678128|NCT02293395|3522208|B3|AUSTRALIA||Region of Enrollment||participants|Number|35|35.0||||||
3678129|NCT02293395|3522209|B2|AUSTRALIA||Region of Enrollment||participants|Number|17|17.0||||||
3678130|NCT02293395|3522210|B1|AUSTRALIA||Region of Enrollment||participants|Number|18|18.0||||||
3678131|NCT02293395|3522208|B3|ARGENTINA||Region of Enrollment||participants|Number|131|131.0||||||
3678132|NCT02293395|3522209|B2|ARGENTINA||Region of Enrollment||participants|Number|65|65.0||||||
3678133|NCT02293395|3522210|B1|ARGENTINA||Region of Enrollment||participants|Number|66|66.0||||||
3678134|NCT02293395|3522208|B3||Others|Race/Ethnicity, Customized||Participants|Count of Participants|56|56.0||||||
3678135|NCT02293395|3522209|B2||Others|Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3678136|NCT02293395|3522210|B1||Others|Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3678137|NCT02293395|3522208|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|117|117.0||||||
3678138|NCT02293395|3522209|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|63|63.0||||||
3678139|NCT02293395|3522210|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|54|54.0||||||
3678140|NCT02293395|3522208|B3||Black|Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3678141|NCT02293395|3522209|B2||Black|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3678142|NCT02293395|3522210|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3678143|NCT02293395|3522208|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|2824|2824.0||||||
3678144|NCT02293395|3522209|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|1407|1407.0||||||
3678145|NCT02293395|3522210|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|1417|1417.0||||||
3678146|NCT02293395|3522208|B3||Male|Sex: Female, Male||Participants|Count of Participants|2275|2275.0||||||
3678147|NCT02293395|3522209|B2||Male|Sex: Female, Male||Participants|Count of Participants|1141|1141.0||||||
3678148|NCT02293395|3522210|B1||Male|Sex: Female, Male||Participants|Count of Participants|1134|1134.0||||||
3678149|NCT02293395|3522208|B3||Female|Sex: Female, Male||Participants|Count of Participants|762|762.0||||||
3678150|NCT02293395|3522209|B2||Female|Sex: Female, Male||Participants|Count of Participants|377|377.0||||||
3678151|NCT02293395|3522210|B1||Female|Sex: Female, Male||Participants|Count of Participants|385|385.0||||||
3678152|NCT02293395|3522208|B3|||Age||years|Mean|62.8|62.8|Standard Deviation|8.98|8.98|||
3678153|NCT02293395|3522209|B2|||Age||years|Mean|62.9|62.9|Standard Deviation|8.82|8.82|||
3678154|NCT02293395|3522210|B1|||Age||years|Mean|62.7|62.7|Standard Deviation|9.14|9.14|||
3678155|NCT02292849|3522217|B4|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3678156|NCT02292849|3522218|B3|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3678157|NCT02292849|3522219|B2|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3678158|NCT02292849|3522220|B1|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3678159|NCT02292849|3522217|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678160|NCT02292849|3522218|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678161|NCT02292849|3522219|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678162|NCT02292849|3522220|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678163|NCT02292849|3522217|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3678164|NCT02292849|3522218|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678165|NCT02292849|3522219|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678166|NCT02292849|3522220|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3678167|NCT02292849|3522217|B4||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3678168|NCT02292849|3522218|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3678169|NCT02292849|3522219|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3678170|NCT02292849|3522220|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3678171|NCT02292849|3522217|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3678172|NCT02292849|3522218|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3678173|NCT02292849|3522219|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3678174|NCT02292849|3522220|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3678175|NCT02292849|3522217|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678176|NCT02292849|3522218|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678177|NCT02292849|3522219|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678178|NCT02292849|3522220|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678179|NCT02292849|3522217|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678180|NCT02292849|3522218|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678181|NCT02292849|3522219|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678182|NCT02292849|3522220|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678183|NCT02292849|3522217|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678184|NCT02292849|3522218|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678185|NCT02292849|3522219|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678186|NCT02292849|3522220|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678187|NCT02292849|3522217|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678188|NCT02292849|3522218|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678189|NCT02292849|3522219|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678190|NCT02292849|3522220|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678191|NCT02292849|3522217|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3678192|NCT02292849|3522218|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3678193|NCT02292849|3522219|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3678194|NCT02292849|3522220|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3678195|NCT02292849|3522217|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3678196|NCT02292849|3522218|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3678197|NCT02292849|3522219|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678198|NCT02292849|3522220|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678199|NCT02292849|3522217|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3678200|NCT02292849|3522218|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3678201|NCT02292849|3522219|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3678202|NCT02292849|3522220|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3678203|NCT02292849|3522217|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3678204|NCT02292849|3522218|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3678205|NCT02292849|3522219|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3678206|NCT02292849|3522220|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3678207|NCT02292849|3522217|B4||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
3678208|NCT02292849|3522218|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3678209|NCT02292849|3522219|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3678210|NCT02292849|3522220|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3678211|NCT02292849|3522217|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3678212|NCT02292849|3522218|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3678213|NCT02292849|3522219|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3678214|NCT02292849|3522220|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3678215|NCT02292849|3522217|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3678216|NCT02292849|3522218|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3678217|NCT02292849|3522219|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3678218|NCT02292849|3522220|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3678219|NCT02292771|3522230|B3|African American/African Heritage||Race/Ethnicity, Customized||Count of Participants|Number|3|3.0||||||
3678220|NCT02292771|3522231|B2|African American/African Heritage||Race/Ethnicity, Customized||Count of Participants|Number|3|3.0||||||
3678221|NCT02292771|3522232|B1|African American/African Heritage||Race/Ethnicity, Customized||Count of Participants|Number|0|0.0||||||
3678222|NCT02292771|3522230|B3|Arabic/North African Heritage||Race/Ethnicity, Customized||Count of Participants|Number|21|21.0||||||
3678223|NCT02292771|3522231|B2|Arabic/North African Heritage||Race/Ethnicity, Customized||Count of Participants|Number|10|10.0||||||
3678224|NCT02292771|3522232|B1|Arabic/North African Heritage||Race/Ethnicity, Customized||Count of Participants|Number|11|11.0||||||
3678225|NCT02292771|3522230|B3|East Asian Heritage||Race/Ethnicity, Customized||Count of Participants|Number|13|13.0||||||
3678226|NCT02292771|3522231|B2|East Asian Heritage||Race/Ethnicity, Customized||Count of Participants|Number|4|4.0||||||
3678227|NCT02292771|3522232|B1|East Asian Heritage||Race/Ethnicity, Customized||Count of Participants|Number|9|9.0||||||
3678228|NCT02292771|3522230|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Count of Participants|Number|11|11.0||||||
3678229|NCT02292771|3522231|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Count of Participants|Number|4|4.0||||||
3678230|NCT02292771|3522232|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Count of Participants|Number|7|7.0||||||
3678231|NCT02292771|3522230|B3|White/Caucasian/European Heritage||Race/Ethnicity, Customized||Count of Participants|Number|52|52.0||||||
3678232|NCT02292771|3522231|B2|White/Caucasian/European Heritage||Race/Ethnicity, Customized||Count of Participants|Number|31|31.0||||||
3678233|NCT02292771|3522232|B1|White/Caucasian/European Heritage||Race/Ethnicity, Customized||Count of Participants|Number|21|21.0||||||
3678234|NCT02292771|3522230|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3678235|NCT02292771|3522231|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3678236|NCT02292771|3522232|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3678237|NCT02292771|3522230|B3||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3678238|NCT02292771|3522231|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3678239|NCT02292771|3522232|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3678240|NCT02292771|3522230|B3|||Age||Years|Mean|27.4|27.4|Standard Deviation|5.88|5.88|||
3678241|NCT02292771|3522231|B2|||Age||Years|Mean|27.1|27.1|Standard Deviation|5.66|5.66|||
3678242|NCT02292771|3522232|B1|||Age||Years|Mean|27.7|27.7|Standard Deviation|6.15|6.15|||
3678243|NCT02292719|3522323|B7|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3678244|NCT02292719|3522324|B6|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678245|NCT02292719|3522325|B5|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678246|NCT02292719|3522326|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678247|NCT02292719|3522327|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678248|NCT02292719|3522328|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678249|NCT02292719|3522329|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3678250|NCT02292719|3522323|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3678251|NCT02292719|3522324|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678252|NCT02292719|3522325|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3678253|NCT02292719|3522326|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678254|NCT02292719|3522327|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678255|NCT02292719|3522328|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678256|NCT02292719|3522329|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678257|NCT02292719|3522323|B7|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3678258|NCT02292719|3522324|B6|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3678259|NCT02292719|3522325|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3678260|NCT02292719|3522326|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3678261|NCT02292719|3522327|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678262|NCT02292719|3522328|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678263|NCT02292719|3522329|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3678264|NCT02292719|3522323|B7|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3678265|NCT02292719|3522324|B6|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678266|NCT02292719|3522325|B5|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3678267|NCT02292719|3522326|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678268|NCT02292719|3522327|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678269|NCT02292719|3522328|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678270|NCT02292719|3522329|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678271|NCT02292719|3522323|B7|White||Race/Ethnicity, Customized||Participants|Count of Participants|61|61.0||||||
3678272|NCT02292719|3522324|B6|White||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3678273|NCT02292719|3522325|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3678274|NCT02292719|3522326|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3678275|NCT02292719|3522327|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3678276|NCT02292719|3522328|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3678277|NCT02292719|3522329|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3678278|NCT02292719|3522323|B7||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3678279|NCT02292719|3522324|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3678280|NCT02292719|3522325|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3678281|NCT02292719|3522326|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3678282|NCT02292719|3522327|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3678283|NCT02292719|3522328|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3678284|NCT02292719|3522329|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3678285|NCT02292719|3522323|B7||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3678286|NCT02292719|3522324|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3678287|NCT02292719|3522325|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3678288|NCT02292719|3522326|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3678289|NCT02292719|3522327|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3678290|NCT02292719|3522328|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3678291|NCT02292719|3522329|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3678292|NCT02292719|3522323|B7|||Age||years|Mean|54.2|54.2|Standard Deviation|7.88|7.88|||
3678293|NCT02292719|3522324|B6|||Age||years|Mean|48.9|48.9|Standard Deviation|7.52|7.52|||
3678294|NCT02292719|3522325|B5|||Age||years|Mean|53.8|53.8|Standard Deviation|6.56|6.56|||
3678295|NCT02292719|3522326|B4|||Age||years|Mean|61.6|61.6|Standard Deviation|5.90|5.9|||
3678296|NCT02292719|3522327|B3|||Age||years|Mean|56.6|56.6|Standard Deviation|6.70|6.7|||
3678297|NCT02292719|3522328|B2|||Age||years|Mean|53.5|53.5|Standard Deviation|8.26|8.26|||
3678298|NCT02292719|3522329|B1|||Age||years|Mean|52.1|52.1|Standard Deviation|9.17|9.17|||
3678299|NCT02292537|3522360|B3|||Hammersmith Functional Motor Scale - Expanded (HFMSE) Score|The HFMSE consists of 33 scored activities used to assess motor function in children with SMA. Participants were asked to do a specific activity (such as rolling) and they were then graded on the quality and execution of that movement on a scale of 0=being unable, 1=performed with some compensation, and 2=unaided. The overall score is the sum of the scores for all activities with a maximum achievable score of 66. Higher scores indicate increased motor function.|scores on a scale|Mean|21.6|21.6|Standard Deviation|8.03|8.03|||
3678300|NCT02292537|3522361|B2|||Hammersmith Functional Motor Scale - Expanded (HFMSE) Score|The HFMSE consists of 33 scored activities used to assess motor function in children with SMA. Participants were asked to do a specific activity (such as rolling) and they were then graded on the quality and execution of that movement on a scale of 0=being unable, 1=performed with some compensation, and 2=unaided. The overall score is the sum of the scores for all activities with a maximum achievable score of 66. Higher scores indicate increased motor function.|scores on a scale|Mean|22.4|22.4|Standard Deviation|8.33|8.33|||
3678301|NCT02292537|3522362|B1|||Hammersmith Functional Motor Scale - Expanded (HFMSE) Score|The HFMSE consists of 33 scored activities used to assess motor function in children with SMA. Participants were asked to do a specific activity (such as rolling) and they were then graded on the quality and execution of that movement on a scale of 0=being unable, 1=performed with some compensation, and 2=unaided. The overall score is the sum of the scores for all activities with a maximum achievable score of 66. Higher scores indicate increased motor function.|scores on a scale|Mean|19.9|19.9|Standard Deviation|7.23|7.23|||
3678302|NCT02292537|3522360|B3|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3678303|NCT02292537|3522361|B2|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3678304|NCT02292537|3522362|B1|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3678305|NCT02292537|3522360|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|94|94.0||||||
3678306|NCT02292537|3522361|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|64|64.0||||||
3678307|NCT02292537|3522362|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3678308|NCT02292537|3522360|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3678309|NCT02292537|3522361|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3678310|NCT02292537|3522362|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3678311|NCT02292537|3522360|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3678312|NCT02292537|3522361|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3678313|NCT02292537|3522362|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3678314|NCT02292537|3522360|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|122|122.0||||||
3678315|NCT02292537|3522361|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|80|80.0||||||
3678316|NCT02292537|3522362|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3678317|NCT02292537|3522360|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3678318|NCT02292537|3522361|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3678319|NCT02292537|3522362|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678320|NCT02292537|3522360|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3678321|NCT02292537|3522361|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3678322|NCT02292537|3522362|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3678323|NCT02292537|3522360|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3678324|NCT02292537|3522361|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3678325|NCT02292537|3522362|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3678326|NCT02292537|3522360|B3|||Age||years|Mean|3.6|3.6|Standard Deviation|1.63|1.63|||
3678327|NCT02292537|3522361|B2|||Age||years|Mean|3.8|3.8|Standard Deviation|1.63|1.63|||
3678328|NCT02292537|3522362|B1|||Age||years|Mean|3.4|3.4|Standard Deviation|1.61|1.61|||
3678329|NCT02292433|3522397|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3678330|NCT02292433|3522398|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3678331|NCT02292433|3522399|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3678332|NCT02292433|3522400|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3678333|NCT02292433|3522397|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3678334|NCT02292433|3522398|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3678335|NCT02292433|3522399|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3678336|NCT02292433|3522400|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3678337|NCT02292433|3522397|B4|||Age||years|Mean|51.8|51.8|Standard Deviation|7.5|7.5|||
3678338|NCT02292433|3522398|B3|||Age||years|Mean|53.8|53.8|Standard Deviation|6.2|6.2|||
3678339|NCT02292433|3522399|B2|||Age||years|Mean|52.5|52.5|Standard Deviation|10.5|10.5|||
3678340|NCT02292433|3522400|B1|||Age||years|Mean|49.3|49.3|Standard Deviation|6.6|6.6|||
3678341|NCT02292212|3522473|B1|Native Canadian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3678342|NCT02292212|3522473|B1|Asian Sri Lankan||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3678343|NCT02292212|3522473|B1|Asian Indian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3678344|NCT02292212|3522473|B1|Asian Filipino||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3678345|NCT02292212|3522473|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678346|NCT02292212|3522473|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678347|NCT02292212|3522473|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678348|NCT02292212|3522473|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3678349|NCT02292212|3522473|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678350|NCT02292212|3522473|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3678351|NCT02292212|3522473|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3678352|NCT02292212|3522473|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3678353|NCT02292212|3522473|B1|||Age||years|Mean|69.4|69.4|Standard Deviation|10.0|10.0|||
3678354|NCT02292186|3522505|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678355|NCT02292186|3522505|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678356|NCT02292186|3522505|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3678357|NCT02292186|3522505|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3678358|NCT02292186|3522505|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678359|NCT02292186|3522505|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678360|NCT02292186|3522505|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678361|NCT02292186|3522505|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3678362|NCT02292186|3522505|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3678363|NCT02292186|3522505|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678364|NCT02292186|3522505|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3678365|NCT02292186|3522505|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3678366|NCT02292186|3522505|B1|||Age||years|Mean|68.8|68.8|Standard Deviation|6.47|6.47|||
3678367|NCT02291861|3522513|B5||No|Baseline Use of a Dopamine Receptor Antagonist (DRA)|The randomization was stratified by baseline use of DRA (currently taking versus not currently taking a DRA).|Participants|Count of Participants|71|71.0||||||
3678368|NCT02291861|3522514|B4||No|Baseline Use of a Dopamine Receptor Antagonist (DRA)|The randomization was stratified by baseline use of DRA (currently taking versus not currently taking a DRA).|Participants|Count of Participants|21|21.0||||||
3678369|NCT02291861|3522515|B3||No|Baseline Use of a Dopamine Receptor Antagonist (DRA)|The randomization was stratified by baseline use of DRA (currently taking versus not currently taking a DRA).|Participants|Count of Participants|16|16.0||||||
3678370|NCT02291861|3522516|B2||No|Baseline Use of a Dopamine Receptor Antagonist (DRA)|The randomization was stratified by baseline use of DRA (currently taking versus not currently taking a DRA).|Participants|Count of Participants|18|18.0||||||
3678371|NCT02291861|3522517|B1||No|Baseline Use of a Dopamine Receptor Antagonist (DRA)|The randomization was stratified by baseline use of DRA (currently taking versus not currently taking a DRA).|Participants|Count of Participants|16|16.0||||||
3678372|NCT02291861|3522513|B5||Yes|Baseline Use of a Dopamine Receptor Antagonist (DRA)|The randomization was stratified by baseline use of DRA (currently taking versus not currently taking a DRA).|Participants|Count of Participants|222|222.0||||||
3678373|NCT02291861|3522514|B4||Yes|Baseline Use of a Dopamine Receptor Antagonist (DRA)|The randomization was stratified by baseline use of DRA (currently taking versus not currently taking a DRA).|Participants|Count of Participants|53|53.0||||||
3678374|NCT02291861|3522515|B3||Yes|Baseline Use of a Dopamine Receptor Antagonist (DRA)|The randomization was stratified by baseline use of DRA (currently taking versus not currently taking a DRA).|Participants|Count of Participants|57|57.0||||||
3678375|NCT02291861|3522516|B2||Yes|Baseline Use of a Dopamine Receptor Antagonist (DRA)|The randomization was stratified by baseline use of DRA (currently taking versus not currently taking a DRA).|Participants|Count of Participants|56|56.0||||||
3678376|NCT02291861|3522517|B1||Yes|Baseline Use of a Dopamine Receptor Antagonist (DRA)|The randomization was stratified by baseline use of DRA (currently taking versus not currently taking a DRA).|Participants|Count of Participants|56|56.0||||||
3678377|NCT02291861|3522513|B5|||Modified Craniocervical Dystonia Questionnaire (mCDQ-24)|The CDQ-24 is a disease-specific quality of life questionnaire developed for use in patients with craniocervical dystonia, including both cervical dystonia (CD) and blepharospasm (BPS). The CDQ 24 was modified such that the questions focus more directly on the impact of TD (as opposed to CD/BPS) on quality of life. Each of the 24 questions was rated by patients on a scale of 0=no impairment to 4=severest impairment for a total scale of 0 – 96.|units on a scale|Mean|36.7|36.7|Standard Deviation|19.55|19.55|||
3678403|NCT02291861|3522514|B4|||Body Mass Index||kg/m^2|Mean|27.99|27.99|Standard Deviation|6.178|6.178|||
3678404|NCT02291861|3522515|B3|||Body Mass Index||kg/m^2|Mean|30.64|30.64|Standard Deviation|7.021|7.021|||
3678405|NCT02291861|3522516|B2|||Body Mass Index||kg/m^2|Mean|28.69|28.69|Standard Deviation|6.814|6.814|||
3678378|NCT02291861|3522514|B4|||Modified Craniocervical Dystonia Questionnaire (mCDQ-24)|The CDQ-24 is a disease-specific quality of life questionnaire developed for use in patients with craniocervical dystonia, including both cervical dystonia (CD) and blepharospasm (BPS). The CDQ 24 was modified such that the questions focus more directly on the impact of TD (as opposed to CD/BPS) on quality of life. Each of the 24 questions was rated by patients on a scale of 0=no impairment to 4=severest impairment for a total scale of 0 – 96.|units on a scale|Mean|34.9|34.9|Standard Deviation|18.34|18.34|||
3678379|NCT02291861|3522515|B3|||Modified Craniocervical Dystonia Questionnaire (mCDQ-24)|The CDQ-24 is a disease-specific quality of life questionnaire developed for use in patients with craniocervical dystonia, including both cervical dystonia (CD) and blepharospasm (BPS). The CDQ 24 was modified such that the questions focus more directly on the impact of TD (as opposed to CD/BPS) on quality of life. Each of the 24 questions was rated by patients on a scale of 0=no impairment to 4=severest impairment for a total scale of 0 – 96.|units on a scale|Mean|34.4|34.4|Standard Deviation|19.59|19.59|||
3678380|NCT02291861|3522516|B2|||Modified Craniocervical Dystonia Questionnaire (mCDQ-24)|The CDQ-24 is a disease-specific quality of life questionnaire developed for use in patients with craniocervical dystonia, including both cervical dystonia (CD) and blepharospasm (BPS). The CDQ 24 was modified such that the questions focus more directly on the impact of TD (as opposed to CD/BPS) on quality of life. Each of the 24 questions was rated by patients on a scale of 0=no impairment to 4=severest impairment for a total scale of 0 – 96.|units on a scale|Mean|37.2|37.2|Standard Deviation|20.15|20.15|||
3678381|NCT02291861|3522517|B1|||Modified Craniocervical Dystonia Questionnaire (mCDQ-24)|The CDQ-24 is a disease-specific quality of life questionnaire developed for use in patients with craniocervical dystonia, including both cervical dystonia (CD) and blepharospasm (BPS). The CDQ 24 was modified such that the questions focus more directly on the impact of TD (as opposed to CD/BPS) on quality of life. Each of the 24 questions was rated by patients on a scale of 0=no impairment to 4=severest impairment for a total scale of 0 – 96.|units on a scale|Mean|40.5|40.5|Standard Deviation|19.88|19.88|||
3678382|NCT02291861|3522513|B5|||Total Motor Abnormal Involuntary Movement Scale (AIMS) Score|"The AIMS is an assessment tool used to detect and follow the severity of TD over time. The AIMS is composed of 12 clinician-administered and scored items.~Total Motor assessment sums items 1 through 7 which cover orofacial movements, as well as extremity and truncal dyskinesia. Ratings were based on a 5-point scale of severity from 0 (none), 1 (minimal), 2 (mild), 3 (moderate), to 4 (severe) for a total scale of 0-28."|units on a scale|Mean|8.4|8.4|Standard Deviation|3.46|3.46|||
3678383|NCT02291861|3522514|B4|||Total Motor Abnormal Involuntary Movement Scale (AIMS) Score|"The AIMS is an assessment tool used to detect and follow the severity of TD over time. The AIMS is composed of 12 clinician-administered and scored items.~Total Motor assessment sums items 1 through 7 which cover orofacial movements, as well as extremity and truncal dyskinesia. Ratings were based on a 5-point scale of severity from 0 (none), 1 (minimal), 2 (mild), 3 (moderate), to 4 (severe) for a total scale of 0-28."|units on a scale|Mean|8.6|8.6|Standard Deviation|3.84|3.84|||
3678384|NCT02291861|3522515|B3|||Total Motor Abnormal Involuntary Movement Scale (AIMS) Score|"The AIMS is an assessment tool used to detect and follow the severity of TD over time. The AIMS is composed of 12 clinician-administered and scored items.~Total Motor assessment sums items 1 through 7 which cover orofacial movements, as well as extremity and truncal dyskinesia. Ratings were based on a 5-point scale of severity from 0 (none), 1 (minimal), 2 (mild), 3 (moderate), to 4 (severe) for a total scale of 0-28."|units on a scale|Mean|7.7|7.7|Standard Deviation|3.51|3.51|||
3678385|NCT02291861|3522516|B2|||Total Motor Abnormal Involuntary Movement Scale (AIMS) Score|"The AIMS is an assessment tool used to detect and follow the severity of TD over time. The AIMS is composed of 12 clinician-administered and scored items.~Total Motor assessment sums items 1 through 7 which cover orofacial movements, as well as extremity and truncal dyskinesia. Ratings were based on a 5-point scale of severity from 0 (none), 1 (minimal), 2 (mild), 3 (moderate), to 4 (severe) for a total scale of 0-28."|units on a scale|Mean|8.6|8.6|Standard Deviation|3.13|3.13|||
3678386|NCT02291861|3522517|B1|||Total Motor Abnormal Involuntary Movement Scale (AIMS) Score|"The AIMS is an assessment tool used to detect and follow the severity of TD over time. The AIMS is composed of 12 clinician-administered and scored items.~Total Motor assessment sums items 1 through 7 which cover orofacial movements, as well as extremity and truncal dyskinesia. Ratings were based on a 5-point scale of severity from 0 (none), 1 (minimal), 2 (mild), 3 (moderate), to 4 (severe) for a total scale of 0-28."|units on a scale|Mean|8.5|8.5|Standard Deviation|3.28|3.28|||
3678387|NCT02291861|3522513|B5|||Time Since Tardive Dyskinesia (TD) Diagnosis||years|Mean|5.60|5.6|Standard Deviation|5.532|5.532|||
3678388|NCT02291861|3522514|B4|||Time Since Tardive Dyskinesia (TD) Diagnosis||years|Mean|5.89|5.89|Standard Deviation|5.342|5.342|||
3678389|NCT02291861|3522515|B3|||Time Since Tardive Dyskinesia (TD) Diagnosis||years|Mean|4.98|4.98|Standard Deviation|6.034|6.034|||
3678390|NCT02291861|3522516|B2|||Time Since Tardive Dyskinesia (TD) Diagnosis||years|Mean|5.49|5.49|Standard Deviation|5.426|5.426|||
3678391|NCT02291861|3522517|B1|||Time Since Tardive Dyskinesia (TD) Diagnosis||years|Mean|6.03|6.03|Standard Deviation|5.353|5.353|||
3678392|NCT02291861|3522513|B5||> 12 years|Education Level||Participants|Count of Participants|126|126.0||||||
3678393|NCT02291861|3522514|B4||> 12 years|Education Level||Participants|Count of Participants|35|35.0||||||
3678394|NCT02291861|3522515|B3||> 12 years|Education Level||Participants|Count of Participants|29|29.0||||||
3678395|NCT02291861|3522516|B2||> 12 years|Education Level||Participants|Count of Participants|30|30.0||||||
3678396|NCT02291861|3522517|B1||> 12 years|Education Level||Participants|Count of Participants|32|32.0||||||
3678397|NCT02291861|3522513|B5||<= 12 years|Education Level||Participants|Count of Participants|167|167.0||||||
3678398|NCT02291861|3522514|B4||<= 12 years|Education Level||Participants|Count of Participants|39|39.0||||||
3678399|NCT02291861|3522515|B3||<= 12 years|Education Level||Participants|Count of Participants|44|44.0||||||
3678400|NCT02291861|3522516|B2||<= 12 years|Education Level||Participants|Count of Participants|44|44.0||||||
3678401|NCT02291861|3522517|B1||<= 12 years|Education Level||Participants|Count of Participants|40|40.0||||||
3678402|NCT02291861|3522513|B5|||Body Mass Index||kg/m^2|Mean|29.12|29.12|Standard Deviation|6.587|6.587|||
3678678|NCT02291237|3522676|B2|United States||Region of Enrollment||participants|Number|54|54.0||||||
3678406|NCT02291861|3522517|B1|||Body Mass Index||kg/m^2|Mean|29.18|29.18|Standard Deviation|6.128|6.128|||
3678407|NCT02291861|3522513|B5|||Height||cm|Mean|168.1|168.1|Standard Deviation|9.96|9.96|||
3678408|NCT02291861|3522514|B4|||Height||cm|Mean|167.6|167.6|Standard Deviation|10.55|10.55|||
3678409|NCT02291861|3522515|B3|||Height||cm|Mean|168.7|168.7|Standard Deviation|9.39|9.39|||
3678410|NCT02291861|3522516|B2|||Height||cm|Mean|167.7|167.7|Standard Deviation|10.68|10.68|||
3678411|NCT02291861|3522517|B1|||Height||cm|Mean|168.3|168.3|Standard Deviation|9.25|9.25|||
3678412|NCT02291861|3522513|B5|||Weight||kg|Mean|82.2|82.2|Standard Deviation|19.16|19.16|||
3678413|NCT02291861|3522514|B4|||Weight||kg|Mean|78.5|78.5|Standard Deviation|17.56|17.56|||
3678414|NCT02291861|3522515|B3|||Weight||kg|Mean|86.8|86.8|Standard Deviation|18.79|18.79|||
3678415|NCT02291861|3522516|B2|||Weight||kg|Mean|80.8|80.8|Standard Deviation|21.00|21.0|||
3678416|NCT02291861|3522517|B1|||Weight||kg|Mean|82.8|82.8|Standard Deviation|18.51|18.51|||
3678417|NCT02291861|3522513|B5||Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3678418|NCT02291861|3522514|B4||Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3678419|NCT02291861|3522515|B3||Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678420|NCT02291861|3522516|B2||Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3678421|NCT02291861|3522517|B1||Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3678422|NCT02291861|3522513|B5||Not reported|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3678423|NCT02291861|3522514|B4||Not reported|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3678424|NCT02291861|3522515|B3||Not reported|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3678425|NCT02291861|3522516|B2||Not reported|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3678426|NCT02291861|3522517|B1||Not reported|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678427|NCT02291861|3522513|B5||Not hispanic or latino|Race/Ethnicity, Customized||Participants|Count of Participants|262|262.0||||||
3678428|NCT02291861|3522514|B4||Not hispanic or latino|Race/Ethnicity, Customized||Participants|Count of Participants|65|65.0||||||
3678429|NCT02291861|3522515|B3||Not hispanic or latino|Race/Ethnicity, Customized||Participants|Count of Participants|69|69.0||||||
3678430|NCT02291861|3522516|B2||Not hispanic or latino|Race/Ethnicity, Customized||Participants|Count of Participants|64|64.0||||||
3678431|NCT02291861|3522517|B1||Not hispanic or latino|Race/Ethnicity, Customized||Participants|Count of Participants|64|64.0||||||
3678432|NCT02291861|3522513|B5||Hispanic or latino|Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3678433|NCT02291861|3522514|B4||Hispanic or latino|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3678434|NCT02291861|3522515|B3||Hispanic or latino|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3678435|NCT02291861|3522516|B2||Hispanic or latino|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3678436|NCT02291861|3522517|B1||Hispanic or latino|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3678437|NCT02291861|3522513|B5||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3678438|NCT02291861|3522514|B4||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3678439|NCT02291861|3522515|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678440|NCT02291861|3522516|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678441|NCT02291861|3522517|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678442|NCT02291861|3522513|B5||White|Race/Ethnicity, Customized||Participants|Count of Participants|232|232.0||||||
3678443|NCT02291861|3522514|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|61|61.0||||||
3678444|NCT02291861|3522515|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|54|54.0||||||
3678445|NCT02291861|3522516|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|58|58.0||||||
3678446|NCT02291861|3522517|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|59|59.0||||||
3678447|NCT02291861|3522513|B5||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678448|NCT02291861|3522514|B4||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678449|NCT02291861|3522515|B3||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678450|NCT02291861|3522516|B2||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678451|NCT02291861|3522517|B1||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678452|NCT02291861|3522513|B5||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|56|56.0||||||
3678453|NCT02291861|3522514|B4||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3678454|NCT02291861|3522515|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3678455|NCT02291861|3522516|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3678456|NCT02291861|3522517|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3678457|NCT02291861|3522513|B5||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678458|NCT02291861|3522514|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678459|NCT02291861|3522515|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678460|NCT02291861|3522516|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678461|NCT02291861|3522517|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678462|NCT02291861|3522513|B5||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3678463|NCT02291861|3522514|B4||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3678464|NCT02291861|3522515|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678465|NCT02291861|3522516|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3678466|NCT02291861|3522517|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3678467|NCT02291861|3522513|B5||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3678468|NCT02291861|3522514|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3678469|NCT02291861|3522515|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3678470|NCT02291861|3522516|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3678471|NCT02291861|3522517|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3678472|NCT02291861|3522513|B5||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3678473|NCT02291861|3522514|B4||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3678474|NCT02291861|3522515|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3678475|NCT02291861|3522516|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3678476|NCT02291861|3522517|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3678477|NCT02291861|3522513|B5|||Age||years|Mean|56.4|56.4|Standard Deviation|11.27|11.27|||
3678478|NCT02291861|3522514|B4|||Age||years|Mean|58.3|58.3|Standard Deviation|11.55|11.55|||
3678479|NCT02291861|3522515|B3|||Age||years|Mean|55.6|55.6|Standard Deviation|11.34|11.34|||
3678480|NCT02291861|3522516|B2|||Age||years|Mean|57.0|57.0|Standard Deviation|9.95|9.95|||
3678481|NCT02291861|3522517|B1|||Age||years|Mean|54.6|54.6|Standard Deviation|12.06|12.06|||
3678482|NCT02291718|3522558|B4||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3678483|NCT02291718|3522559|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3678484|NCT02291718|3522560|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3678485|NCT02291718|3522561|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3678486|NCT02291718|3522558|B4||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3678487|NCT02291718|3522559|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3678488|NCT02291718|3522560|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3678489|NCT02291718|3522561|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3678490|NCT02291718|3522558|B4||>=65 years|Age||Participants|Count of Participants|100|100.0||||||
3678491|NCT02291718|3522559|B3||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
3678492|NCT02291718|3522560|B2||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
3678493|NCT02291718|3522561|B1||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
3678494|NCT02291718|3522558|B4||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3678495|NCT02291718|3522559|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3678496|NCT02291718|3522560|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3678497|NCT02291718|3522561|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3678498|NCT02291718|3522558|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3678499|NCT02291718|3522559|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3678500|NCT02291718|3522560|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3678501|NCT02291718|3522561|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3678502|NCT02291679|3522580|B4|||Abdominal Bloating|Abdominal bloating was measured daily using an 11-point NRS (0 = none; 10 = very severe). Baseline efficacy values are derived from the IVRS daily diary data collected in the Pretreatment Period, specifically the period of time from 14 days before randomization up to the time of randomization.|units on a scale|Mean|5.27|5.27|Standard Deviation|2.52|2.52|||
3678503|NCT02291679|3522581|B3|||Abdominal Bloating|Abdominal bloating was measured daily using an 11-point NRS (0 = none; 10 = very severe). Baseline efficacy values are derived from the IVRS daily diary data collected in the Pretreatment Period, specifically the period of time from 14 days before randomization up to the time of randomization.|units on a scale|Mean|5.30|5.3|Standard Deviation|2.57|2.57|||
3678504|NCT02291679|3522582|B2|||Abdominal Bloating|Abdominal bloating was measured daily using an 11-point NRS (0 = none; 10 = very severe). Baseline efficacy values are derived from the IVRS daily diary data collected in the Pretreatment Period, specifically the period of time from 14 days before randomization up to the time of randomization.|units on a scale|Mean|5.24|5.24|Standard Deviation|2.61|2.61|||
3678505|NCT02291679|3522583|B1|||Abdominal Bloating|Abdominal bloating was measured daily using an 11-point NRS (0 = none; 10 = very severe). Baseline efficacy values are derived from the IVRS daily diary data collected in the Pretreatment Period, specifically the period of time from 14 days before randomization up to the time of randomization.|units on a scale|Mean|5.29|5.29|Standard Deviation|2.39|2.39|||
3678506|NCT02291679|3522580|B4|||Abdominal Discomfort|Abdominal discomfort was measured daily using an 11-point numerical rating scale (NRS; 0 = none; 10 = very severe). Baseline efficacy values are derived from the IVRS daily diary data collected in the Pretreatment Period, specifically the period of time from 14 days before randomization up to the time of randomization.|units on a scale|Mean|4.70|4.7|Standard Deviation|2.65|2.65|||
3678507|NCT02291679|3522581|B3|||Abdominal Discomfort|Abdominal discomfort was measured daily using an 11-point numerical rating scale (NRS; 0 = none; 10 = very severe). Baseline efficacy values are derived from the IVRS daily diary data collected in the Pretreatment Period, specifically the period of time from 14 days before randomization up to the time of randomization.|units on a scale|Mean|4.71|4.71|Standard Deviation|2.66|2.66|||
3678508|NCT02291679|3522582|B2|||Abdominal Discomfort|Abdominal discomfort was measured daily using an 11-point numerical rating scale (NRS; 0 = none; 10 = very severe). Baseline efficacy values are derived from the IVRS daily diary data collected in the Pretreatment Period, specifically the period of time from 14 days before randomization up to the time of randomization.|units on a scale|Mean|4.64|4.64|Standard Deviation|2.74|2.74|||
3678509|NCT02291679|3522583|B1|||Abdominal Discomfort|Abdominal discomfort was measured daily using an 11-point numerical rating scale (NRS; 0 = none; 10 = very severe). Baseline efficacy values are derived from the IVRS daily diary data collected in the Pretreatment Period, specifically the period of time from 14 days before randomization up to the time of randomization.|units on a scale|Mean|4.76|4.76|Standard Deviation|2.56|2.56|||
3678510|NCT02291679|3522580|B4|||Straining Score|Straining was measured daily using a 5-point ordinal scale (1 = not at all; 2 = a little bit; 3 = a moderate amount; 4 = a great deal; 5 = an extreme amount). Baseline efficacy values are derived from the IVRS daily diary data collected in the Pretreatment Period, specifically the period of time from 14 days before randomization up to the time of randomization.|units on a scale|Mean|3.55|3.55|Standard Deviation|0.85|0.85|||
3678511|NCT02291679|3522581|B3|||Straining Score|Straining was measured daily using a 5-point ordinal scale (1 = not at all; 2 = a little bit; 3 = a moderate amount; 4 = a great deal; 5 = an extreme amount). Baseline efficacy values are derived from the IVRS daily diary data collected in the Pretreatment Period, specifically the period of time from 14 days before randomization up to the time of randomization.|units on a scale|Mean|3.52|3.52|Standard Deviation|0.82|0.82|||
3678512|NCT02291679|3522582|B2|||Straining Score|Straining was measured daily using a 5-point ordinal scale (1 = not at all; 2 = a little bit; 3 = a moderate amount; 4 = a great deal; 5 = an extreme amount). Baseline efficacy values are derived from the IVRS daily diary data collected in the Pretreatment Period, specifically the period of time from 14 days before randomization up to the time of randomization.|units on a scale|Mean|3.62|3.62|Standard Deviation|0.86|0.86|||
3678513|NCT02291679|3522583|B1|||Straining Score|Straining was measured daily using a 5-point ordinal scale (1 = not at all; 2 = a little bit; 3 = a moderate amount; 4 = a great deal; 5 = an extreme amount). Baseline efficacy values are derived from the IVRS daily diary data collected in the Pretreatment Period, specifically the period of time from 14 days before randomization up to the time of randomization.|units on a scale|Mean|3.51|3.51|Standard Deviation|0.88|0.88|||
3678514|NCT02291679|3522580|B4|||Stool Consistency Score|Measured daily using the 7-point ordinal Bristol Stool Form Scale (BSFS; 1=separate hard lumps like nuts [difficult to pass]; 2=sausage shaped but lumpy; 3=like a sausage but with cracks on surface; 4=like a sausage or snake, smooth and soft; 5=soft blobs with clear-cut edges [passed easily]; 6=fluffy pieces with ragged edges, a mushy stool; 7=watery, no solid pieces [entirely liquid]). Baseline efficacy values are derived from the IVRS daily diary data collected in the Pretreatment Period, specifically the period of time from 14 days before randomization up to the time of randomization.|units on a scale|Mean|1.98|1.98|Standard Deviation|0.96|0.96|||
3678515|NCT02291679|3522581|B3|||Stool Consistency Score|Measured daily using the 7-point ordinal Bristol Stool Form Scale (BSFS; 1=separate hard lumps like nuts [difficult to pass]; 2=sausage shaped but lumpy; 3=like a sausage but with cracks on surface; 4=like a sausage or snake, smooth and soft; 5=soft blobs with clear-cut edges [passed easily]; 6=fluffy pieces with ragged edges, a mushy stool; 7=watery, no solid pieces [entirely liquid]). Baseline efficacy values are derived from the IVRS daily diary data collected in the Pretreatment Period, specifically the period of time from 14 days before randomization up to the time of randomization.|units on a scale|Mean|1.96|1.96|Standard Deviation|0.94|0.94|||
3678516|NCT02291679|3522582|B2|||Stool Consistency Score|Measured daily using the 7-point ordinal Bristol Stool Form Scale (BSFS; 1=separate hard lumps like nuts [difficult to pass]; 2=sausage shaped but lumpy; 3=like a sausage but with cracks on surface; 4=like a sausage or snake, smooth and soft; 5=soft blobs with clear-cut edges [passed easily]; 6=fluffy pieces with ragged edges, a mushy stool; 7=watery, no solid pieces [entirely liquid]). Baseline efficacy values are derived from the IVRS daily diary data collected in the Pretreatment Period, specifically the period of time from 14 days before randomization up to the time of randomization.|units on a scale|Mean|1.94|1.94|Standard Deviation|0.93|0.93|||
3678517|NCT02291679|3522583|B1|||Stool Consistency Score|Measured daily using the 7-point ordinal Bristol Stool Form Scale (BSFS; 1=separate hard lumps like nuts [difficult to pass]; 2=sausage shaped but lumpy; 3=like a sausage but with cracks on surface; 4=like a sausage or snake, smooth and soft; 5=soft blobs with clear-cut edges [passed easily]; 6=fluffy pieces with ragged edges, a mushy stool; 7=watery, no solid pieces [entirely liquid]). Baseline efficacy values are derived from the IVRS daily diary data collected in the Pretreatment Period, specifically the period of time from 14 days before randomization up to the time of randomization.|units on a scale|Mean|2.04|2.04|Standard Deviation|1.02|1.02|||
3678518|NCT02291679|3522580|B4|||Spontaneous Bowel Movement Weekly Rate|Number of spontaneous bowel movements (SBMs) per week. An SBM is defined as a BM that occurred in the absence of laxative, enema, or suppository use on either the calendar day of the BM or the calendar day before the BM. Baseline efficacy values are derived from the IVRS daily diary data collected in the Pretreatment Period, specifically the period of time from 14 days before randomization up to the time of randomization.|SBMs/week|Mean|1.66|1.66|Standard Deviation|1.33|1.33|||
3678519|NCT02291679|3522581|B3|||Spontaneous Bowel Movement Weekly Rate|Number of spontaneous bowel movements (SBMs) per week. An SBM is defined as a BM that occurred in the absence of laxative, enema, or suppository use on either the calendar day of the BM or the calendar day before the BM. Baseline efficacy values are derived from the IVRS daily diary data collected in the Pretreatment Period, specifically the period of time from 14 days before randomization up to the time of randomization.|SBMs/week|Mean|1.67|1.67|Standard Deviation|1.38|1.38|||
3678520|NCT02291679|3522582|B2|||Spontaneous Bowel Movement Weekly Rate|Number of spontaneous bowel movements (SBMs) per week. An SBM is defined as a BM that occurred in the absence of laxative, enema, or suppository use on either the calendar day of the BM or the calendar day before the BM. Baseline efficacy values are derived from the IVRS daily diary data collected in the Pretreatment Period, specifically the period of time from 14 days before randomization up to the time of randomization.|SBMs/week|Mean|1.74|1.74|Standard Deviation|1.42|1.42|||
3678558|NCT02291549|3522616|B1|Race/Ethnicity|Black|Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3678559|NCT02291549|3522614|B3|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|244|244.0||||||
3678521|NCT02291679|3522583|B1|||Spontaneous Bowel Movement Weekly Rate|Number of spontaneous bowel movements (SBMs) per week. An SBM is defined as a BM that occurred in the absence of laxative, enema, or suppository use on either the calendar day of the BM or the calendar day before the BM. Baseline efficacy values are derived from the IVRS daily diary data collected in the Pretreatment Period, specifically the period of time from 14 days before randomization up to the time of randomization.|SBMs/week|Mean|1.56|1.56|Standard Deviation|1.15|1.15|||
3678522|NCT02291679|3522580|B4|||Complete Spontaneous Bowel Movement Weekly Rate|Number of complete spontaneous bowel movements (CSBMs) per week. A CSBM is defined as a spontaneous bowel movement (SBM) that is associated with a sense of complete evacuation. An SBM is defined as a bowel movement (BM) that occurred in the absence of laxative, enema, or suppository use on either the calendar day of the BM or the calendar day before the BM. Baseline efficacy values are derived from the interactive voice response system (IVRS) daily diary data collected in the Pretreatment Period, specifically the period of time from 14 days before randomization up to the time of randomization.|CSBMs/week|Mean|0.22|0.22|Standard Deviation|0.48|0.48|||
3678523|NCT02291679|3522581|B3|||Complete Spontaneous Bowel Movement Weekly Rate|Number of complete spontaneous bowel movements (CSBMs) per week. A CSBM is defined as a spontaneous bowel movement (SBM) that is associated with a sense of complete evacuation. An SBM is defined as a bowel movement (BM) that occurred in the absence of laxative, enema, or suppository use on either the calendar day of the BM or the calendar day before the BM. Baseline efficacy values are derived from the interactive voice response system (IVRS) daily diary data collected in the Pretreatment Period, specifically the period of time from 14 days before randomization up to the time of randomization.|CSBMs/week|Mean|0.20|0.2|Standard Deviation|0.44|0.44|||
3678524|NCT02291679|3522582|B2|||Complete Spontaneous Bowel Movement Weekly Rate|Number of complete spontaneous bowel movements (CSBMs) per week. A CSBM is defined as a spontaneous bowel movement (SBM) that is associated with a sense of complete evacuation. An SBM is defined as a bowel movement (BM) that occurred in the absence of laxative, enema, or suppository use on either the calendar day of the BM or the calendar day before the BM. Baseline efficacy values are derived from the interactive voice response system (IVRS) daily diary data collected in the Pretreatment Period, specifically the period of time from 14 days before randomization up to the time of randomization.|CSBMs/week|Mean|0.22|0.22|Standard Deviation|0.52|0.52|||
3678525|NCT02291679|3522583|B1|||Complete Spontaneous Bowel Movement Weekly Rate|Number of complete spontaneous bowel movements (CSBMs) per week. A CSBM is defined as a spontaneous bowel movement (SBM) that is associated with a sense of complete evacuation. An SBM is defined as a bowel movement (BM) that occurred in the absence of laxative, enema, or suppository use on either the calendar day of the BM or the calendar day before the BM. Baseline efficacy values are derived from the interactive voice response system (IVRS) daily diary data collected in the Pretreatment Period, specifically the period of time from 14 days before randomization up to the time of randomization.|CSBMs/week|Mean|0.25|0.25|Standard Deviation|0.48|0.48|||
3678526|NCT02291679|3522580|B4||Male|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
3678527|NCT02291679|3522581|B3||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3678528|NCT02291679|3522582|B2||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3678529|NCT02291679|3522583|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3678530|NCT02291679|3522580|B4||Female|Sex: Female, Male||Participants|Count of Participants|942|942.0||||||
3678531|NCT02291679|3522581|B3||Female|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
3678532|NCT02291679|3522582|B2||Female|Sex: Female, Male||Participants|Count of Participants|312|312.0||||||
3678533|NCT02291679|3522583|B1||Female|Sex: Female, Male||Participants|Count of Participants|316|316.0||||||
3678534|NCT02291679|3522580|B4|≥ 65 years||Age, Customized||Participants|Count of Participants|118|118.0||||||
3678535|NCT02291679|3522581|B3|≥ 65 years||Age, Customized||Participants|Count of Participants|43|43.0||||||
3678536|NCT02291679|3522582|B2|≥ 65 years||Age, Customized||Participants|Count of Participants|36|36.0||||||
3678537|NCT02291679|3522583|B1|≥ 65 years||Age, Customized||Participants|Count of Participants|39|39.0||||||
3678538|NCT02291679|3522580|B4|40 to < 65 years||Age, Customized||Participants|Count of Participants|695|695.0||||||
3678539|NCT02291679|3522581|B3|40 to < 65 years||Age, Customized||Participants|Count of Participants|240|240.0||||||
3678540|NCT02291679|3522582|B2|40 to < 65 years||Age, Customized||Participants|Count of Participants|235|235.0||||||
3678541|NCT02291679|3522583|B1|40 to < 65 years||Age, Customized||Participants|Count of Participants|220|220.0||||||
3678542|NCT02291679|3522580|B4|18 to < 40 years||Age, Customized||Participants|Count of Participants|410|410.0||||||
3678543|NCT02291679|3522581|B3|18 to < 40 years||Age, Customized||Participants|Count of Participants|128|128.0||||||
3678544|NCT02291679|3522582|B2|18 to < 40 years||Age, Customized||Participants|Count of Participants|140|140.0||||||
3678545|NCT02291679|3522583|B1|18 to < 40 years||Age, Customized||Participants|Count of Participants|142|142.0||||||
3678546|NCT02291679|3522580|B4|||Age||years|Mean|46.0|46.0|Standard Deviation|14.3|14.3|||
3678547|NCT02291679|3522581|B3|||Age||years|Mean|46.8|46.8|Standard Deviation|14.0|14.0|||
3678548|NCT02291679|3522582|B2|||Age||years|Mean|45.8|45.8|Standard Deviation|14.3|14.3|||
3678549|NCT02291679|3522583|B1|||Age||years|Mean|45.2|45.2|Standard Deviation|14.7|14.7|||
3678550|NCT02291549|3522614|B3|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3678551|NCT02291549|3522615|B2|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3678552|NCT02291549|3522616|B1|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3678553|NCT02291549|3522614|B3|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3678554|NCT02291549|3522615|B2|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3678555|NCT02291549|3522616|B1|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3678556|NCT02291549|3522614|B3|Race/Ethnicity|Black|Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3678557|NCT02291549|3522615|B2|Race/Ethnicity|Black|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3678560|NCT02291549|3522615|B2|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|80|80.0||||||
3678561|NCT02291549|3522616|B1|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|164|164.0||||||
3678562|NCT02291549|3522614|B3||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3678563|NCT02291549|3522615|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3678564|NCT02291549|3522616|B1||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3678565|NCT02291549|3522614|B3||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3678566|NCT02291549|3522615|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3678567|NCT02291549|3522616|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3678568|NCT02291549|3522614|B3|||Age||years|Mean|49.6|49.6|Standard Deviation|12.74|12.74|||
3678569|NCT02291549|3522615|B2|||Age||years|Mean|47.9|47.9|Standard Deviation|12.4|12.4|||
3678570|NCT02291549|3522616|B1|||Age||years|Mean|50.5|50.5|Standard Deviation|12.9|12.9|||
3678571|NCT02291510|3522635|B5|||Body Mass Index (BMI)||kg/m^2|Mean|29.6|29.6|Standard Deviation|2.8|2.8|||
3678572|NCT02291510|3522636|B4|||Body Mass Index (BMI)||kg/m^2|Mean|30.0|30.0|Standard Deviation|1.8|1.8|||
3678573|NCT02291510|3522637|B3|||Body Mass Index (BMI)||kg/m^2|Mean|28.7|28.7|Standard Deviation|2.8|2.8|||
3678574|NCT02291510|3522638|B2|||Body Mass Index (BMI)||kg/m^2|Mean|29.5|29.5|Standard Deviation|2.8|2.8|||
3678575|NCT02291510|3522639|B1|||Body Mass Index (BMI)||kg/m^2|Mean|30.1|30.1|Standard Deviation|4.0|4.0|||
3678576|NCT02291510|3522635|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678577|NCT02291510|3522636|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678578|NCT02291510|3522637|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678579|NCT02291510|3522638|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678580|NCT02291510|3522639|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678581|NCT02291510|3522635|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3678582|NCT02291510|3522636|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678583|NCT02291510|3522637|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678584|NCT02291510|3522638|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3678585|NCT02291510|3522639|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678586|NCT02291510|3522635|B5||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3678587|NCT02291510|3522636|B4||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3678588|NCT02291510|3522637|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3678589|NCT02291510|3522638|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3678590|NCT02291510|3522639|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3678591|NCT02291510|3522635|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3678592|NCT02291510|3522636|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3678593|NCT02291510|3522637|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678594|NCT02291510|3522638|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3678595|NCT02291510|3522639|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3678596|NCT02291510|3522635|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678597|NCT02291510|3522636|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678598|NCT02291510|3522637|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678599|NCT02291510|3522638|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678600|NCT02291510|3522639|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678601|NCT02291510|3522635|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678602|NCT02291510|3522636|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678603|NCT02291510|3522637|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678604|NCT02291510|3522638|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678605|NCT02291510|3522639|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678606|NCT02291510|3522635|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3678607|NCT02291510|3522636|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3678608|NCT02291510|3522637|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3678609|NCT02291510|3522638|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678610|NCT02291510|3522639|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678611|NCT02291510|3522635|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678612|NCT02291510|3522636|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678613|NCT02291510|3522637|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678614|NCT02291510|3522638|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678615|NCT02291510|3522639|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678616|NCT02291510|3522635|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3678617|NCT02291510|3522636|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3678618|NCT02291510|3522637|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3678619|NCT02291510|3522638|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3678620|NCT02291510|3522639|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3678621|NCT02291510|3522635|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3678622|NCT02291510|3522636|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3678623|NCT02291510|3522637|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678624|NCT02291510|3522638|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678625|NCT02291510|3522639|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3678626|NCT02291510|3522635|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3678627|NCT02291510|3522636|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3678628|NCT02291510|3522637|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3678629|NCT02291510|3522638|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3678630|NCT02291510|3522639|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3678631|NCT02291510|3522635|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3678632|NCT02291510|3522636|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3678633|NCT02291510|3522637|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3678634|NCT02291510|3522638|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3678635|NCT02291510|3522639|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3678636|NCT02291510|3522635|B5|||Age||years|Mean|32.2|32.2|Standard Deviation|10.6|10.6|||
3678637|NCT02291510|3522636|B4|||Age||years|Mean|25.8|25.8|Standard Deviation|5.0|5.0|||
3678638|NCT02291510|3522637|B3|||Age||years|Mean|33.8|33.8|Standard Deviation|9.2|9.2|||
3678639|NCT02291510|3522638|B2|||Age||years|Mean|34.8|34.8|Standard Deviation|13.1|13.1|||
3678640|NCT02291510|3522639|B1|||Age||years|Mean|34.2|34.2|Standard Deviation|13.6|13.6|||
3678641|NCT02291419|3522656|B3|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3678642|NCT02291419|3522657|B2|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3678643|NCT02291419|3522658|B1|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3678644|NCT02291419|3522656|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3678645|NCT02291419|3522657|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3678646|NCT02291419|3522658|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3678647|NCT02291419|3522656|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3678648|NCT02291419|3522657|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3678649|NCT02291419|3522658|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3678650|NCT02291419|3522656|B3|> or = to 40 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
3678651|NCT02291419|3522657|B2|> or = to 40 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
3678652|NCT02291419|3522658|B1|> or = to 40 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3678653|NCT02291237|3522675|B3|||Peak Oxygen Intake (VO2)||mL/kg/min|Mean|19.47|19.47|Standard Deviation|4.755|4.755|||
3678654|NCT02291237|3522676|B2|||Peak Oxygen Intake (VO2)||mL/kg/min|Mean|19.88|19.88|Standard Deviation|4.645|4.645|||
3678655|NCT02291237|3522677|B1|||Peak Oxygen Intake (VO2)||mL/kg/min|Mean|19.06|19.06|Standard Deviation|4.853|4.853|||
3678656|NCT02291237|3522675|B3|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3678657|NCT02291237|3522676|B2|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3678658|NCT02291237|3522677|B1|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3678659|NCT02291237|3522675|B3|Netherlands||Region of Enrollment||participants|Number|7|7.0||||||
3678660|NCT02291237|3522676|B2|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
3678661|NCT02291237|3522677|B1|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
3678662|NCT02291237|3522675|B3|Italy||Region of Enrollment||participants|Number|25|25.0||||||
3678663|NCT02291237|3522676|B2|Italy||Region of Enrollment||participants|Number|13|13.0||||||
3678664|NCT02291237|3522677|B1|Italy||Region of Enrollment||participants|Number|12|12.0||||||
3678665|NCT02291237|3522675|B3|Israel||Region of Enrollment||participants|Number|14|14.0||||||
3678666|NCT02291237|3522676|B2|Israel||Region of Enrollment||participants|Number|6|6.0||||||
3678667|NCT02291237|3522677|B1|Israel||Region of Enrollment||participants|Number|8|8.0||||||
3678668|NCT02291237|3522675|B3|Germany||Region of Enrollment||participants|Number|4|4.0||||||
3678669|NCT02291237|3522676|B2|Germany||Region of Enrollment||participants|Number|2|2.0||||||
3678670|NCT02291237|3522677|B1|Germany||Region of Enrollment||participants|Number|2|2.0||||||
3678671|NCT02291237|3522675|B3|France||Region of Enrollment||participants|Number|8|8.0||||||
3678672|NCT02291237|3522676|B2|France||Region of Enrollment||participants|Number|5|5.0||||||
3678673|NCT02291237|3522677|B1|France||Region of Enrollment||participants|Number|3|3.0||||||
3678674|NCT02291237|3522675|B3|Australia||Region of Enrollment||participants|Number|2|2.0||||||
3678675|NCT02291237|3522676|B2|Australia||Region of Enrollment||participants|Number|1|1.0||||||
3678676|NCT02291237|3522677|B1|Australia||Region of Enrollment||participants|Number|1|1.0||||||
3678677|NCT02291237|3522675|B3|United States||Region of Enrollment||participants|Number|109|109.0||||||
3678679|NCT02291237|3522677|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
3678680|NCT02291237|3522675|B3||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3678681|NCT02291237|3522676|B2||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3678682|NCT02291237|3522677|B1||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678683|NCT02291237|3522675|B3||Not Hispanic Or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|150|150.0||||||
3678684|NCT02291237|3522676|B2||Not Hispanic Or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|75|75.0||||||
3678685|NCT02291237|3522677|B1||Not Hispanic Or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|75|75.0||||||
3678686|NCT02291237|3522675|B3||Hispanic Or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3678687|NCT02291237|3522676|B2||Hispanic Or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3678688|NCT02291237|3522677|B1||Hispanic Or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3678689|NCT02291237|3522675|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3678690|NCT02291237|3522676|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678691|NCT02291237|3522677|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3678692|NCT02291237|3522675|B3||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3678693|NCT02291237|3522676|B2||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3678694|NCT02291237|3522677|B1||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3678695|NCT02291237|3522675|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3678696|NCT02291237|3522676|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3678697|NCT02291237|3522677|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3678698|NCT02291237|3522675|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3678699|NCT02291237|3522676|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3678700|NCT02291237|3522677|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3678701|NCT02291237|3522675|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3678702|NCT02291237|3522676|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3678703|NCT02291237|3522677|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3678704|NCT02291237|3522675|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|147|147.0||||||
3678705|NCT02291237|3522676|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|73|73.0||||||
3678706|NCT02291237|3522677|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|74|74.0||||||
3678707|NCT02291237|3522675|B3||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3678708|NCT02291237|3522676|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3678709|NCT02291237|3522677|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3678710|NCT02291237|3522675|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3678711|NCT02291237|3522676|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3678712|NCT02291237|3522677|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3678713|NCT02291237|3522675|B3|||Age||years|Mean|47|47.0|Standard Deviation|11.1|11.1|||
3678714|NCT02291237|3522676|B2|||Age||years|Mean|48|48.0|Standard Deviation|10.3|10.3|||
3678715|NCT02291237|3522677|B1|||Age||years|Mean|46|46.0|Standard Deviation|11.7|11.7|||
3678716|NCT02290873|3522694|B4|||Body Max Index (BMI)||kg/m2|Mean|29|29.0|Standard Deviation|4.81|4.81|||
3678717|NCT02290873|3522695|B3|||Body Max Index (BMI)||kg/m2|Mean|28.8|28.8|Standard Deviation|4.75|4.75|||
3678718|NCT02290873|3522696|B2|||Body Max Index (BMI)||kg/m2|Mean|30|30.0|Standard Deviation|5.31|5.31|||
3678719|NCT02290873|3522697|B1|||Body Max Index (BMI)||kg/m2|Mean|28.9|28.9|Standard Deviation|4.72|4.72|||
3678720|NCT02290873|3522694|B4|||Height||cm|Mean|169.6|169.6|Standard Deviation|10.53|10.53|||
3678721|NCT02290873|3522695|B3|||Height||cm|Mean|169.5|169.5|Standard Deviation|11.15|11.15|||
3678722|NCT02290873|3522696|B2|||Height||cm|Mean|167.8|167.8|Standard Deviation|10.24|10.24|||
3678723|NCT02290873|3522697|B1|||Height||cm|Mean|170.1|170.1|Standard Deviation|10.36|10.36|||
3678724|NCT02290873|3522694|B4|||Weight||Kg|Mean|83.1|83.1|Standard Deviation|17.47|17.47|||
3678725|NCT02290873|3522695|B3|||Weight||Kg|Mean|81.9|81.9|Standard Deviation|16.24|16.24|||
3678726|NCT02290873|3522696|B2|||Weight||Kg|Mean|84.6|84.6|Standard Deviation|19.9|19.9|||
3678727|NCT02290873|3522697|B1|||Weight||Kg|Mean|83.2|83.2|Standard Deviation|17.39|17.39|||
3678728|NCT02290873|3522694|B4|United States||Region of Enrollment||participants|Number|458|458.0||||||
3678729|NCT02290873|3522695|B3|United States||Region of Enrollment||participants|Number|102|102.0||||||
3678730|NCT02290873|3522696|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
3678731|NCT02290873|3522697|B1|United States||Region of Enrollment||participants|Number|296|296.0||||||
3678732|NCT02290873|3522694|B4||Male|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
3678733|NCT02290873|3522695|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3678734|NCT02290873|3522696|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3678735|NCT02290873|3522697|B1||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3678736|NCT02290873|3522694|B4||Female|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
3678737|NCT02290873|3522695|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3678738|NCT02290873|3522696|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3678739|NCT02290873|3522697|B1||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3678740|NCT02290873|3522694|B4|≥65||Age, Customized||Participants|Count of Participants|63|63.0||||||
3678741|NCT02290873|3522695|B3|≥65||Age, Customized||Participants|Count of Participants|14|14.0||||||
3678742|NCT02290873|3522696|B2|≥65||Age, Customized||Participants|Count of Participants|7|7.0||||||
3678743|NCT02290873|3522697|B1|≥65||Age, Customized||Participants|Count of Participants|42|42.0||||||
3678744|NCT02290873|3522694|B4|<65||Age, Customized||Participants|Count of Participants|395|395.0||||||
3678745|NCT02290873|3522695|B3|<65||Age, Customized||Participants|Count of Participants|88|88.0||||||
3678746|NCT02290873|3522696|B2|<65||Age, Customized||Participants|Count of Participants|53|53.0||||||
3678747|NCT02290873|3522697|B1|<65||Age, Customized||Participants|Count of Participants|254|254.0||||||
3678748|NCT02290873|3522694|B4|||Age||years|Mean|54.9|54.9|Standard Deviation|10.05|10.05|||
3678749|NCT02290873|3522695|B3|||Age||years|Mean|55.6|55.6|Standard Deviation|10.15|10.15|||
3678750|NCT02290873|3522696|B2|||Age||years|Mean|56|56.0|Standard Deviation|9.51|9.51|||
3678751|NCT02290873|3522697|B1|||Age||years|Mean|54.4|54.4|Standard Deviation|10.12|10.12|||
3678752|NCT02290821|3522716|B3|United States||Region of Enrollment||participants|Number|215|215.0||||||
3678753|NCT02290821|3522717|B2|United States||Region of Enrollment||participants|Number|106|106.0||||||
3678754|NCT02290821|3522718|B1|United States||Region of Enrollment||participants|Number|109|109.0||||||
3678755|NCT02290821|3522716|B3||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3678756|NCT02290821|3522717|B2||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3678757|NCT02290821|3522718|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3678758|NCT02290821|3522716|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3678759|NCT02290821|3522717|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3678760|NCT02290821|3522718|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3678761|NCT02290821|3522716|B3|||Age||years|Mean|26.8|26.8|Standard Deviation|9.7|9.7|||
3678762|NCT02290821|3522717|B2|||Age||years|Mean|26.3|26.3|Standard Deviation|8.5|8.5|||
3678763|NCT02290821|3522718|B1|||Age||years|Mean|27.3|27.3|Standard Deviation|10.7|10.7|||
3678764|NCT02290691|3522725|B3||Male|Sex: Female, Male||Participants|Count of Participants|488|488.0||||||
3678765|NCT02290691|3522726|B2||Male|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
3678766|NCT02290691|3522727|B1||Male|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
3678767|NCT02290691|3522725|B3||Female|Sex: Female, Male||Participants|Count of Participants|496|496.0||||||
3678768|NCT02290691|3522726|B2||Female|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
3678769|NCT02290691|3522727|B1||Female|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
3678770|NCT02290691|3522725|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3678771|NCT02290691|3522726|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3678772|NCT02290691|3522727|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3678773|NCT02290691|3522725|B3||Between 18 and 65 years|Age||Participants|Count of Participants|984|984.0||||||
3678774|NCT02290691|3522726|B2||Between 18 and 65 years|Age||Participants|Count of Participants|488|488.0||||||
3678775|NCT02290691|3522727|B1||Between 18 and 65 years|Age||Participants|Count of Participants|496|496.0||||||
3678776|NCT02290691|3522725|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3678777|NCT02290691|3522726|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3678778|NCT02290691|3522727|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3678779|NCT02290509|3522742|B3|United States||Region of Enrollment||participants|Number|1330|1330.0||||||
3678780|NCT02290509|3522743|B2|United States||Region of Enrollment||participants|Number|332|332.0||||||
3678781|NCT02290509|3522744|B1|United States||Region of Enrollment||participants|Number|998|998.0||||||
3678782|NCT02290509|3522742|B3||Male|Sex: Female, Male||Participants|Count of Participants|469|469.0||||||
3678783|NCT02290509|3522743|B2||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3678784|NCT02290509|3522744|B1||Male|Sex: Female, Male||Participants|Count of Participants|359|359.0||||||
3678785|NCT02290509|3522742|B3||Female|Sex: Female, Male||Participants|Count of Participants|861|861.0||||||
3678786|NCT02290509|3522743|B2||Female|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
3678787|NCT02290509|3522744|B1||Female|Sex: Female, Male||Participants|Count of Participants|639|639.0||||||
3678788|NCT02290509|3522742|B3|18-49 years||Age, Customized||participants|Number|1330|1330.0||||||
3678789|NCT02290509|3522743|B2|18-49 years||Age, Customized||participants|Number|332|332.0||||||
3678790|NCT02290509|3522744|B1|18-49 years||Age, Customized||participants|Number|998|998.0||||||
3678791|NCT02290340|3522757|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3678792|NCT02290340|3522758|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3678793|NCT02290340|3522759|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3678794|NCT02290340|3522760|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678795|NCT02290340|3522761|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3678796|NCT02290340|3522757|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3678797|NCT02290340|3522758|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3678798|NCT02290340|3522759|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678799|NCT02290340|3522760|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3678800|NCT02290340|3522761|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678801|NCT02290340|3522757|B5||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3678802|NCT02290340|3522758|B4||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3678803|NCT02290340|3522759|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678804|NCT02290340|3522760|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3678805|NCT02290340|3522761|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3678806|NCT02290340|3522757|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3678807|NCT02290340|3522758|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3678808|NCT02290340|3522759|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3678809|NCT02290340|3522760|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3678810|NCT02290340|3522761|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3678811|NCT02290340|3522757|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678812|NCT02290340|3522758|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678813|NCT02290340|3522759|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678814|NCT02290340|3522760|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678815|NCT02290340|3522761|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678816|NCT02290340|3522757|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3678817|NCT02290340|3522758|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678818|NCT02290340|3522759|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3678819|NCT02290340|3522760|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678820|NCT02290340|3522761|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678821|NCT02290340|3522757|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3678822|NCT02290340|3522758|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3678823|NCT02290340|3522759|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678824|NCT02290340|3522760|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678825|NCT02290340|3522761|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678826|NCT02290340|3522757|B5||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3678827|NCT02290340|3522758|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3678828|NCT02290340|3522759|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3678829|NCT02290340|3522760|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3678830|NCT02290340|3522761|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3678831|NCT02290340|3522757|B5||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3678832|NCT02290340|3522758|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3678833|NCT02290340|3522759|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3678834|NCT02290340|3522760|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3678835|NCT02290340|3522761|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3678836|NCT02290340|3522757|B5|||Age||Months|Mean|6.6|6.6|Standard Deviation|2.6|2.6|||
3678837|NCT02290340|3522758|B4|||Age||Months|Mean|6.9|6.9|Standard Deviation|2.5|2.5|||
3678838|NCT02290340|3522759|B3|||Age||Months|Mean|6.7|6.7|Standard Deviation|2.7|2.7|||
3678839|NCT02290340|3522760|B2|||Age||Months|Mean|4.2|4.2|Standard Deviation|2.1|2.1|||
3678840|NCT02290340|3522761|B1|||Age||Months|Mean|7.0|7.0|Standard Deviation|2.6|2.6|||
3678841|NCT02289989|3522807|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678842|NCT02289989|3522808|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678843|NCT02289989|3522807|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678844|NCT02289989|3522808|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678845|NCT02289989|3522807|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3678846|NCT02289989|3522808|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3678847|NCT02289989|3522807|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678848|NCT02289989|3522808|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678849|NCT02289989|3522807|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678850|NCT02289989|3522808|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678851|NCT02289989|3522807|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678852|NCT02289989|3522808|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678853|NCT02289989|3522807|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678854|NCT02289989|3522808|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678855|NCT02289989|3522807|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3678856|NCT02289989|3522808|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3678857|NCT02289989|3522807|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3678858|NCT02289989|3522808|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3678859|NCT02289989|3522807|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3678860|NCT02289989|3522808|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3678861|NCT02289989|3522807|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3678862|NCT02289989|3522808|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3678863|NCT02289989|3522807|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3678864|NCT02289989|3522808|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3678865|NCT02289963|3522826|B3|||Calculated LDL-C in mmol/L|Calculated LDL-C in mmol/L from Friedewald formula (LDL-C = Total cholesterol - High-density lipoprotein cholesterol [HDL-C] - [Triglyceride/2.2]).|mmol/L|Mean|2.543|2.543|Standard Deviation|0.686|0.686|||
3678866|NCT02289963|3522827|B2|||Calculated LDL-C in mmol/L|Calculated LDL-C in mmol/L from Friedewald formula (LDL-C = Total cholesterol - High-density lipoprotein cholesterol [HDL-C] - [Triglyceride/2.2]).|mmol/L|Mean|2.513|2.513|Standard Deviation|0.721|0.721|||
3678867|NCT02289963|3522828|B1|||Calculated LDL-C in mmol/L|Calculated LDL-C in mmol/L from Friedewald formula (LDL-C = Total cholesterol - High-density lipoprotein cholesterol [HDL-C] - [Triglyceride/2.2]).|mmol/L|Mean|2.572|2.572|Standard Deviation|0.653|0.653|||
3678868|NCT02289963|3522826|B3||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3678869|NCT02289963|3522827|B2||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3678870|NCT02289963|3522828|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3678871|NCT02289963|3522826|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3678872|NCT02289963|3522827|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3678873|NCT02289963|3522828|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3678874|NCT02289963|3522826|B3|||Age||years|Mean|60.6|60.6|Standard Deviation|9.7|9.7|||
3678875|NCT02289963|3522827|B2|||Age||years|Mean|61.2|61.2|Standard Deviation|10.4|10.4|||
3678876|NCT02289963|3522828|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|9.1|9.1|||
3678877|NCT02289898|3522877|B4|Spain||Region of Enrollment||Participants|Count of Participants|71|71.0||||||
3678878|NCT02289898|3522878|B3|Spain||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3678879|NCT02289898|3522879|B2|Spain||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3678880|NCT02289898|3522880|B1|Spain||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3678881|NCT02289898|3522877|B4|Australia||Region of Enrollment||Participants|Count of Participants|56|56.0||||||
3678882|NCT02289898|3522878|B3|Australia||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3678883|NCT02289898|3522879|B2|Australia||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3678884|NCT02289898|3522880|B1|Australia||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3678885|NCT02289898|3522877|B4|United Kingdom||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3678886|NCT02289898|3522878|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3678887|NCT02289898|3522879|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3678888|NCT02289898|3522880|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3678889|NCT02289898|3522877|B4|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3678890|NCT02289898|3522878|B3|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3678891|NCT02289898|3522879|B2|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3678892|NCT02289898|3522880|B1|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3678893|NCT02289898|3522877|B4|Belgium||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3678894|NCT02289898|3522878|B3|Belgium||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3678895|NCT02289898|3522879|B2|Belgium||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3678896|NCT02289898|3522880|B1|Belgium||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3678897|NCT02289898|3522877|B4|Canada||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3678898|NCT02289898|3522878|B3|Canada||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3678899|NCT02289898|3522879|B2|Canada||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3678900|NCT02289898|3522880|B1|Canada||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3678901|NCT02289898|3522877|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3678902|NCT02289898|3522878|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3678903|NCT02289898|3522879|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678904|NCT02289898|3522880|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3678905|NCT02289898|3522877|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678906|NCT02289898|3522878|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678907|NCT02289898|3522879|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678908|NCT02289898|3522880|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678909|NCT02289898|3522877|B4||White|Race (NIH/OMB)||Participants|Count of Participants|192|192.0||||||
3678910|NCT02289898|3522878|B3||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3678911|NCT02289898|3522879|B2||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3678912|NCT02289898|3522880|B1||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3678913|NCT02289898|3522877|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3678914|NCT02289898|3522878|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678915|NCT02289898|3522879|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678916|NCT02289898|3522880|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3678917|NCT02289898|3522877|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3678918|NCT02289898|3522878|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678919|NCT02289898|3522879|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3678920|NCT02289898|3522880|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678921|NCT02289898|3522877|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3678922|NCT02289898|3522878|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3678923|NCT02289898|3522879|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678924|NCT02289898|3522880|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3678925|NCT02289898|3522877|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3678926|NCT02289898|3522878|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3678927|NCT02289898|3522879|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678928|NCT02289898|3522880|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678929|NCT02289898|3522877|B4||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3678930|NCT02289898|3522878|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3678931|NCT02289898|3522879|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3678932|NCT02289898|3522880|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3678933|NCT02289898|3522877|B4||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3678934|NCT02289898|3522878|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3678935|NCT02289898|3522879|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3678936|NCT02289898|3522880|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3678937|NCT02289898|3522877|B4|||Age||years|Median|63|63.0|Full Range|||30.0|85.0|
3678938|NCT02289898|3522878|B3|||Age||years|Median|66|66.0|Full Range|||30.0|78.0|
3678939|NCT02289898|3522879|B2|||Age||years|Median|63|63.0|Full Range|||38.0|85.0|
3678940|NCT02289898|3522880|B1|||Age||years|Median|62|62.0|Full Range|||41.0|82.0|
3678941|NCT02289898|3522877|B4||>=65 years|Age||Participants|Count of Participants|103|103.0||||||
3678942|NCT02289898|3522878|B3||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
3678943|NCT02289898|3522879|B2||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
3678944|NCT02289898|3522880|B1||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
3678945|NCT02289898|3522877|B4||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
3678946|NCT02289898|3522878|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3678947|NCT02289898|3522879|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3678948|NCT02289898|3522880|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3678949|NCT02289898|3522877|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3678950|NCT02289898|3522878|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3678951|NCT02289898|3522879|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3678952|NCT02289898|3522880|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3678953|NCT02289833|3522889|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3678954|NCT02289833|3522890|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3678955|NCT02289833|3522891|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3678956|NCT02289833|3522889|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3678957|NCT02289833|3522890|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3678958|NCT02289833|3522891|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3678959|NCT02289833|3522889|B3|||Age||years|Mean|62.3|62.3|Standard Deviation|9.6|9.6|||
3678960|NCT02289833|3522890|B2|||Age||years|Mean|61.3|61.3|Standard Deviation|8.5|8.5|||
3678961|NCT02289833|3522891|B1|||Age||years|Mean|63.0|63.0|Standard Deviation|10.3|10.3|||
3678962|NCT02289820|3522923|B8||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3678963|NCT02289820|3522924|B7||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3678964|NCT02289820|3522925|B6||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3678965|NCT02289820|3522926|B5||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3678966|NCT02289820|3522927|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3678967|NCT02289820|3522928|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3678968|NCT02289820|3522929|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3678969|NCT02289820|3522930|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3678970|NCT02289820|3522923|B8||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3678971|NCT02289820|3522924|B7||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3678972|NCT02289820|3522925|B6||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3678973|NCT02289820|3522926|B5||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3678974|NCT02289820|3522927|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3678975|NCT02289820|3522928|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3678976|NCT02289820|3522929|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3678977|NCT02289820|3522930|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3678978|NCT02289820|3522923|B8|||Age||Years|Mean|69.5|69.5|Standard Deviation|6.3|6.3|||
3678979|NCT02289820|3522924|B7|||Age||Years|Mean|68.9|68.9|Standard Deviation|6.5|6.5|||
3678980|NCT02289820|3522925|B6|||Age||Years|Mean|70.2|70.2|Standard Deviation|6.8|6.8|||
3678981|NCT02289820|3522926|B5|||Age||Years|Mean|70.1|70.1|Standard Deviation|5.9|5.9|||
3678982|NCT02289820|3522927|B4|||Age||Years|Mean|67.9|67.9|Standard Deviation|5.8|5.8|||
3678983|NCT02289820|3522928|B3|||Age||Years|Mean|69.3|69.3|Standard Deviation|5.2|5.2|||
3678984|NCT02289820|3522929|B2|||Age||Years|Mean|69.6|69.6|Standard Deviation|7.0|7.0|||
3678985|NCT02289820|3522930|B1|||Age||Years|Mean|70.5|70.5|Standard Deviation|6.9|6.9|||
3678986|NCT02289755|3523047|B1|||24-hour Urinary Oxalate||mg/day|Mean|77.65|77.65|Standard Deviation|55.87|55.87|||
3678987|NCT02289755|3523047|B1|Calcium||Concomitant medications|Usual methods for treatment of kidney stones/nephrolithiasis were continued throughout the study. Participants could have been prescribed more than one medication, so the sum of participants would be greater than the population.|participants|Number|5|5.0||||||
3678988|NCT02289755|3523047|B1|Hydrochlorothiazide||Concomitant medications|Usual methods for treatment of kidney stones/nephrolithiasis were continued throughout the study. Participants could have been prescribed more than one medication, so the sum of participants would be greater than the population.|participants|Number|1|1.0||||||
3678989|NCT02289755|3523047|B1|Chlorthalidone||Concomitant medications|Usual methods for treatment of kidney stones/nephrolithiasis were continued throughout the study. Participants could have been prescribed more than one medication, so the sum of participants would be greater than the population.|participants|Number|2|2.0||||||
3678990|NCT02289755|3523047|B1|Potassium citrate||Concomitant medications|Usual methods for treatment of kidney stones/nephrolithiasis were continued throughout the study. Participants could have been prescribed more than one medication, so the sum of participants would be greater than the population.|participants|Number|5|5.0||||||
3678991|NCT02289755|3523047|B1|||Glomerular Filtration Rate (GFR)||ml/min/1.73 m^2|Mean|85.1|85.1|Full Range|||39.0|118.0|
3678992|NCT02289755|3523047|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3678993|NCT02289755|3523047|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678994|NCT02289755|3523047|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678995|NCT02289755|3523047|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3678996|NCT02289755|3523047|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3678997|NCT02289755|3523047|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678998|NCT02289755|3523047|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3678999|NCT02289755|3523047|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3679000|NCT02289755|3523047|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3679001|NCT02289755|3523047|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3679002|NCT02289755|3523047|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3679003|NCT02289755|3523047|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3679004|NCT02289755|3523047|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3679005|NCT02289755|3523047|B1|||Age||years|Median|58.0|58.0|Full Range|||24.0|72.0|
3679006|NCT02289755|3523047|B1|||Age||years|Mean|54.1|54.1|Standard Deviation|14.5|14.5|||
3679007|NCT02289755|3523047|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3679008|NCT02289755|3523047|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3679009|NCT02289755|3523047|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3679010|NCT02289742|3523052|B3|Germany||Region of Enrollment||participants|Number|43|43.0||||||
3679011|NCT02289742|3523053|B2|Germany||Region of Enrollment||participants|Number|21|21.0||||||
3679012|NCT02289742|3523054|B1|Germany||Region of Enrollment||participants|Number|22|22.0||||||
3679013|NCT02289742|3523052|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3679014|NCT02289742|3523053|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3679015|NCT02289742|3523054|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3679016|NCT02289742|3523052|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3679017|NCT02289742|3523053|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3679018|NCT02289742|3523054|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3679019|NCT02289742|3523052|B3|||Age||years|Mean|39.0|39.0|Standard Deviation|14.6|14.6|||
3679020|NCT02289742|3523053|B2|||Age||years|Mean|25.8|25.8|Standard Deviation|4.5|4.5|||
3679021|NCT02289742|3523054|B1|||Age||years|Mean|51.7|51.7|Standard Deviation|8.1|8.1|||
3679037|NCT02289469|3523074|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3679038|NCT02289469|3523075|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3679022|NCT02289469|3523074|B3|5||ESI acuity level|The Emergency Severity Index (ESI) is a widely-used triage tool, which Emergency Department nurses use to rate patient acuity and resource needs (range 1-5). Briefly, level 1 patients require immediate life-saving intervention. Level 2 are high-risk, have altered mental status, are in severe pain/distress, or may have certain vital sign abnormalities. Level 3 require many resources. Level 4 require one resource. Level 5 require no additional resources. (See www.esitriage.org for more information.)|Participants|Count of Participants|27|27.0||||||
3679023|NCT02289469|3523075|B2|5||ESI acuity level|The Emergency Severity Index (ESI) is a widely-used triage tool, which Emergency Department nurses use to rate patient acuity and resource needs (range 1-5). Briefly, level 1 patients require immediate life-saving intervention. Level 2 are high-risk, have altered mental status, are in severe pain/distress, or may have certain vital sign abnormalities. Level 3 require many resources. Level 4 require one resource. Level 5 require no additional resources. (See www.esitriage.org for more information.)|Participants|Count of Participants|13|13.0||||||
3679024|NCT02289469|3523076|B1|5||ESI acuity level|The Emergency Severity Index (ESI) is a widely-used triage tool, which Emergency Department nurses use to rate patient acuity and resource needs (range 1-5). Briefly, level 1 patients require immediate life-saving intervention. Level 2 are high-risk, have altered mental status, are in severe pain/distress, or may have certain vital sign abnormalities. Level 3 require many resources. Level 4 require one resource. Level 5 require no additional resources. (See www.esitriage.org for more information.)|Participants|Count of Participants|14|14.0||||||
3679025|NCT02289469|3523074|B3|4||ESI acuity level|The Emergency Severity Index (ESI) is a widely-used triage tool, which Emergency Department nurses use to rate patient acuity and resource needs (range 1-5). Briefly, level 1 patients require immediate life-saving intervention. Level 2 are high-risk, have altered mental status, are in severe pain/distress, or may have certain vital sign abnormalities. Level 3 require many resources. Level 4 require one resource. Level 5 require no additional resources. (See www.esitriage.org for more information.)|Participants|Count of Participants|193|193.0||||||
3679026|NCT02289469|3523075|B2|4||ESI acuity level|The Emergency Severity Index (ESI) is a widely-used triage tool, which Emergency Department nurses use to rate patient acuity and resource needs (range 1-5). Briefly, level 1 patients require immediate life-saving intervention. Level 2 are high-risk, have altered mental status, are in severe pain/distress, or may have certain vital sign abnormalities. Level 3 require many resources. Level 4 require one resource. Level 5 require no additional resources. (See www.esitriage.org for more information.)|Participants|Count of Participants|97|97.0||||||
3679027|NCT02289469|3523076|B1|4||ESI acuity level|The Emergency Severity Index (ESI) is a widely-used triage tool, which Emergency Department nurses use to rate patient acuity and resource needs (range 1-5). Briefly, level 1 patients require immediate life-saving intervention. Level 2 are high-risk, have altered mental status, are in severe pain/distress, or may have certain vital sign abnormalities. Level 3 require many resources. Level 4 require one resource. Level 5 require no additional resources. (See www.esitriage.org for more information.)|Participants|Count of Participants|96|96.0||||||
3679028|NCT02289469|3523074|B3|3||ESI acuity level|The Emergency Severity Index (ESI) is a widely-used triage tool, which Emergency Department nurses use to rate patient acuity and resource needs (range 1-5). Briefly, level 1 patients require immediate life-saving intervention. Level 2 are high-risk, have altered mental status, are in severe pain/distress, or may have certain vital sign abnormalities. Level 3 require many resources. Level 4 require one resource. Level 5 require no additional resources. (See www.esitriage.org for more information.)|Participants|Count of Participants|204|204.0||||||
3679029|NCT02289469|3523075|B2|3||ESI acuity level|The Emergency Severity Index (ESI) is a widely-used triage tool, which Emergency Department nurses use to rate patient acuity and resource needs (range 1-5). Briefly, level 1 patients require immediate life-saving intervention. Level 2 are high-risk, have altered mental status, are in severe pain/distress, or may have certain vital sign abnormalities. Level 3 require many resources. Level 4 require one resource. Level 5 require no additional resources. (See www.esitriage.org for more information.)|Participants|Count of Participants|102|102.0||||||
3679030|NCT02289469|3523076|B1|3||ESI acuity level|The Emergency Severity Index (ESI) is a widely-used triage tool, which Emergency Department nurses use to rate patient acuity and resource needs (range 1-5). Briefly, level 1 patients require immediate life-saving intervention. Level 2 are high-risk, have altered mental status, are in severe pain/distress, or may have certain vital sign abnormalities. Level 3 require many resources. Level 4 require one resource. Level 5 require no additional resources. (See www.esitriage.org for more information.)|Participants|Count of Participants|102|102.0||||||
3679031|NCT02289469|3523074|B3|2||ESI acuity level|The Emergency Severity Index (ESI) is a widely-used triage tool, which Emergency Department nurses use to rate patient acuity and resource needs (range 1-5). Briefly, level 1 patients require immediate life-saving intervention. Level 2 are high-risk, have altered mental status, are in severe pain/distress, or may have certain vital sign abnormalities. Level 3 require many resources. Level 4 require one resource. Level 5 require no additional resources. (See www.esitriage.org for more information.)|Participants|Count of Participants|64|64.0||||||
3679032|NCT02289469|3523075|B2|2||ESI acuity level|The Emergency Severity Index (ESI) is a widely-used triage tool, which Emergency Department nurses use to rate patient acuity and resource needs (range 1-5). Briefly, level 1 patients require immediate life-saving intervention. Level 2 are high-risk, have altered mental status, are in severe pain/distress, or may have certain vital sign abnormalities. Level 3 require many resources. Level 4 require one resource. Level 5 require no additional resources. (See www.esitriage.org for more information.)|Participants|Count of Participants|32|32.0||||||
3679033|NCT02289469|3523076|B1|2||ESI acuity level|The Emergency Severity Index (ESI) is a widely-used triage tool, which Emergency Department nurses use to rate patient acuity and resource needs (range 1-5). Briefly, level 1 patients require immediate life-saving intervention. Level 2 are high-risk, have altered mental status, are in severe pain/distress, or may have certain vital sign abnormalities. Level 3 require many resources. Level 4 require one resource. Level 5 require no additional resources. (See www.esitriage.org for more information.)|Participants|Count of Participants|32|32.0||||||
3679034|NCT02289469|3523074|B3|United States||Region of Enrollment||Participants|Count of Participants|488|488.0||||||
3679035|NCT02289469|3523075|B2|United States||Region of Enrollment||Participants|Count of Participants|244|244.0||||||
3679036|NCT02289469|3523076|B1|United States||Region of Enrollment||Participants|Count of Participants|244|244.0||||||
3679039|NCT02289469|3523076|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3679040|NCT02289469|3523074|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3679041|NCT02289469|3523075|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3679042|NCT02289469|3523076|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3679043|NCT02289469|3523074|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3679044|NCT02289469|3523075|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3679045|NCT02289469|3523076|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3679046|NCT02289469|3523074|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|165|165.0||||||
3679047|NCT02289469|3523075|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|71|71.0||||||
3679048|NCT02289469|3523076|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|94|94.0||||||
3679049|NCT02289469|3523074|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|295|295.0||||||
3679050|NCT02289469|3523075|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|151|151.0||||||
3679051|NCT02289469|3523076|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|144|144.0||||||
3679052|NCT02289469|3523074|B3||Male|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
3679053|NCT02289469|3523075|B2||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3679054|NCT02289469|3523076|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3679055|NCT02289469|3523074|B3||Female|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
3679056|NCT02289469|3523075|B2||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3679057|NCT02289469|3523076|B1||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3679058|NCT02289469|3523074|B3|||Age||years|Mean|41|41.0|Standard Deviation|15|15.0|||
3679059|NCT02289469|3523075|B2|||Age||years|Mean|41|41.0|Standard Deviation|16|16.0|||
3679060|NCT02289469|3523076|B1|||Age||years|Mean|41|41.0|Standard Deviation|13|13.0|||
3679061|NCT02289456|3523085|B1|||Number of Participants with Prior Systemic Anticancer Therapies||Participants|Number|3|3.0||||||
3679062|NCT02289456|3523085|B1|Stage IV||Stage of Disease at Enrollment|Disease stage means how big the tumor is and how far it has spread. Disease stages range from 0 (not spread) to IV (spread throughout the body). Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|Participants|Count of Participants|39|39.0||||||
3679063|NCT02289456|3523085|B1|Stage IIIb||Stage of Disease at Enrollment|Disease stage means how big the tumor is and how far it has spread. Disease stages range from 0 (not spread) to IV (spread throughout the body). Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|Participants|Count of Participants|1|1.0||||||
3679064|NCT02289456|3523085|B1|Stage II||Stage of Disease at Enrollment|Disease stage means how big the tumor is and how far it has spread. Disease stages range from 0 (not spread) to IV (spread throughout the body). Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|Participants|Count of Participants|0|0.0||||||
3679065|NCT02289456|3523085|B1|Stage I||Stage of Disease at Enrollment|Disease stage means how big the tumor is and how far it has spread. Disease stages range from 0 (not spread) to IV (spread throughout the body). Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|Participants|Count of Participants|0|0.0||||||
3679066|NCT02289456|3523085|B1|Stage 0||Stage of Disease at Enrollment|Disease stage means how big the tumor is and how far it has spread. Disease stages range from 0 (not spread) to IV (spread throughout the body). Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|Participants|Count of Participants|0|0.0||||||
3679067|NCT02289456|3523085|B1|Non-squamous||Histology||Participants|Count of Participants|25|25.0||||||
3679068|NCT02289456|3523085|B1|Squamous||Histology||Participants|Count of Participants|15|15.0||||||
3679069|NCT02289456|3523085|B1|5 = Dead||Physician Reported Eastern Cooperative Oncology Group (ECOG) Performance Status at Screening|ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|0|0.0||||||
3679126|NCT02289417|3523105|B4|||Age||Years|Mean|42.1|42.1|Standard Deviation|14.15|14.15|||
3679127|NCT02289417|3523106|B3|||Age||Years|Mean|43.4|43.4|Standard Deviation|14.92|14.92|||
3679128|NCT02289417|3523107|B2|||Age||Years|Mean|40.1|40.1|Standard Deviation|13.50|13.5|||
3679070|NCT02289456|3523085|B1|4 = Completely Disabled.||Physician Reported Eastern Cooperative Oncology Group (ECOG) Performance Status at Screening|ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|0|0.0||||||
3679071|NCT02289456|3523085|B1|3 = Capable of Only Limited Self-care||Physician Reported Eastern Cooperative Oncology Group (ECOG) Performance Status at Screening|ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|0|0.0||||||
3679072|NCT02289456|3523085|B1|2 = Ambulatory and Capable of All Self-care||Physician Reported Eastern Cooperative Oncology Group (ECOG) Performance Status at Screening|ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|40|40.0||||||
3679073|NCT02289456|3523085|B1|1 = Restricted in Physical Activity; Ambulatory||Physician Reported Eastern Cooperative Oncology Group (ECOG) Performance Status at Screening|ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|0|0.0||||||
3679074|NCT02289456|3523085|B1|0 = Fully Active||Physician Reported Eastern Cooperative Oncology Group (ECOG) Performance Status at Screening|ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|0|0.0||||||
3679075|NCT02289456|3523085|B1|Black||Race||Participants|Count of Participants|3|3.0||||||
3679076|NCT02289456|3523085|B1|White||Race||Participants|Count of Participants|37|37.0||||||
3679077|NCT02289456|3523085|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
3679078|NCT02289456|3523085|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3679079|NCT02289456|3523085|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3679080|NCT02289456|3523085|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3679081|NCT02289456|3523085|B1|||Age||Years|Mean|67.4|67.4|Standard Deviation|9.80|9.8|||
3679082|NCT02289417|3523105|B4|||Mayo Endoscopic Subscore (MES)|"The Mayo endoscopy subscore findings are defined as:~0 = Normal or inactive disease~= Mild Disease (erythema, decreased vascular pattern, mild friability)~= Moderate Disease (marked erythema, lack of vascular pattern, friability erosions) 3 = Severe Disease (spontaneous bleeding, ulceration)."|units on a scale|Mean|2.6|2.6|Standard Deviation|0.48|0.48|||
3679083|NCT02289417|3523106|B3|||Mayo Endoscopic Subscore (MES)|"The Mayo endoscopy subscore findings are defined as:~0 = Normal or inactive disease~= Mild Disease (erythema, decreased vascular pattern, mild friability)~= Moderate Disease (marked erythema, lack of vascular pattern, friability erosions) 3 = Severe Disease (spontaneous bleeding, ulceration)."|units on a scale|Mean|2.6|2.6|Standard Deviation|0.49|0.49|||
3679084|NCT02289417|3523107|B2|||Mayo Endoscopic Subscore (MES)|"The Mayo endoscopy subscore findings are defined as:~0 = Normal or inactive disease~= Mild Disease (erythema, decreased vascular pattern, mild friability)~= Moderate Disease (marked erythema, lack of vascular pattern, friability erosions) 3 = Severe Disease (spontaneous bleeding, ulceration)."|units on a scale|Mean|2.7|2.7|Standard Deviation|0.45|0.45|||
3679085|NCT02289417|3523108|B1|||Mayo Endoscopic Subscore (MES)|"The Mayo endoscopy subscore findings are defined as:~0 = Normal or inactive disease~= Mild Disease (erythema, decreased vascular pattern, mild friability)~= Moderate Disease (marked erythema, lack of vascular pattern, friability erosions) 3 = Severe Disease (spontaneous bleeding, ulceration)."|units on a scale|Mean|2.6|2.6|Standard Deviation|0.49|0.49|||
3679086|NCT02289417|3523105|B4|||Partial Mayo Score (PMS)|The partial Mayo score is the sum of the rectal bleeding score, the stool frequency score and the physician's global assessment. The partial Mayo score range is from 0 to 9 points with zero indicating no symptoms of active ulcerative colitis and 9 indicating the most severe symptoms and assessment.|units on a scale|Mean|5.6|5.6|Standard Deviation|1.49|1.49|||
3679087|NCT02289417|3523106|B3|||Partial Mayo Score (PMS)|The partial Mayo score is the sum of the rectal bleeding score, the stool frequency score and the physician's global assessment. The partial Mayo score range is from 0 to 9 points with zero indicating no symptoms of active ulcerative colitis and 9 indicating the most severe symptoms and assessment.|units on a scale|Mean|5.5|5.5|Standard Deviation|1.57|1.57|||
3679088|NCT02289417|3523107|B2|||Partial Mayo Score (PMS)|The partial Mayo score is the sum of the rectal bleeding score, the stool frequency score and the physician's global assessment. The partial Mayo score range is from 0 to 9 points with zero indicating no symptoms of active ulcerative colitis and 9 indicating the most severe symptoms and assessment.|units on a scale|Mean|5.8|5.8|Standard Deviation|1.44|1.44|||
3679089|NCT02289417|3523108|B1|||Partial Mayo Score (PMS)|The partial Mayo score is the sum of the rectal bleeding score, the stool frequency score and the physician's global assessment. The partial Mayo score range is from 0 to 9 points with zero indicating no symptoms of active ulcerative colitis and 9 indicating the most severe symptoms and assessment.|units on a scale|Mean|5.6|5.6|Standard Deviation|1.46|1.46|||
3679090|NCT02289417|3523105|B4|||Modified Mayo Score (MMS)|The MMS was based on the stool frequency, rectal bleeding and endoscopy subscores of the total Mayo score, and excluded the Physician's Global subscore, since this was a global measure that is subjective in nature. The MMS range from 0 to 9 points with zero indicating no symptoms of active ulcerative colitis and 9 indicating the most severe symptoms.|units on a scale|Mean|6.2|6.2|Standard Deviation|1.49|1.49|||
3679091|NCT02289417|3523106|B3|||Modified Mayo Score (MMS)|The MMS was based on the stool frequency, rectal bleeding and endoscopy subscores of the total Mayo score, and excluded the Physician's Global subscore, since this was a global measure that is subjective in nature. The MMS range from 0 to 9 points with zero indicating no symptoms of active ulcerative colitis and 9 indicating the most severe symptoms.|units on a scale|Mean|6.0|6.0|Standard Deviation|1.47|1.47|||
3679092|NCT02289417|3523107|B2|||Modified Mayo Score (MMS)|The MMS was based on the stool frequency, rectal bleeding and endoscopy subscores of the total Mayo score, and excluded the Physician's Global subscore, since this was a global measure that is subjective in nature. The MMS range from 0 to 9 points with zero indicating no symptoms of active ulcerative colitis and 9 indicating the most severe symptoms.|units on a scale|Mean|6.4|6.4|Standard Deviation|1.48|1.48|||
3679093|NCT02289417|3523108|B1|||Modified Mayo Score (MMS)|The MMS was based on the stool frequency, rectal bleeding and endoscopy subscores of the total Mayo score, and excluded the Physician's Global subscore, since this was a global measure that is subjective in nature. The MMS range from 0 to 9 points with zero indicating no symptoms of active ulcerative colitis and 9 indicating the most severe symptoms.|units on a scale|Mean|6.1|6.1|Standard Deviation|1.51|1.51|||
3679094|NCT02289417|3523105|B4|||Baseline Total Mayo Score (TMS)|"The TMS is an instrument designed to measure disease activity of Ulcerative Colitis (UC). The Mayo score ranges from 0 to 12 points. It consists of 4 subscores, each graded from 0 to 3 with higher scores indicating more severe disease:~Stool Frequency Subscore (SFS)~Rectal Bleeding Subscore (RBS)~Endoscopy Subscore~Physician’s Global Assessment (PGA)"|units on a scale|Mean|8.3|8.3|Standard Deviation|1.65|1.65|||
3679095|NCT02289417|3523106|B3|||Baseline Total Mayo Score (TMS)|"The TMS is an instrument designed to measure disease activity of Ulcerative Colitis (UC). The Mayo score ranges from 0 to 12 points. It consists of 4 subscores, each graded from 0 to 3 with higher scores indicating more severe disease:~Stool Frequency Subscore (SFS)~Rectal Bleeding Subscore (RBS)~Endoscopy Subscore~Physician’s Global Assessment (PGA)"|units on a scale|Mean|8.1|8.1|Standard Deviation|1.67|1.67|||
3679096|NCT02289417|3523107|B2|||Baseline Total Mayo Score (TMS)|"The TMS is an instrument designed to measure disease activity of Ulcerative Colitis (UC). The Mayo score ranges from 0 to 12 points. It consists of 4 subscores, each graded from 0 to 3 with higher scores indicating more severe disease:~Stool Frequency Subscore (SFS)~Rectal Bleeding Subscore (RBS)~Endoscopy Subscore~Physician’s Global Assessment (PGA)"|units on a scale|Mean|8.5|8.5|Standard Deviation|1.62|1.62|||
3679097|NCT02289417|3523108|B1|||Baseline Total Mayo Score (TMS)|"The TMS is an instrument designed to measure disease activity of Ulcerative Colitis (UC). The Mayo score ranges from 0 to 12 points. It consists of 4 subscores, each graded from 0 to 3 with higher scores indicating more severe disease:~Stool Frequency Subscore (SFS)~Rectal Bleeding Subscore (RBS)~Endoscopy Subscore~Physician’s Global Assessment (PGA)"|units on a scale|Mean|8.2|8.2|Standard Deviation|1.68|1.68|||
3679098|NCT02289417|3523105|B4|||Duration of Ulcerative Colitis||Years|Mean|7.19|7.19|Standard Deviation|7.832|7.832|||
3679099|NCT02289417|3523106|B3|||Duration of Ulcerative Colitis||Years|Mean|8.63|8.63|Standard Deviation|10.278|10.278|||
3679100|NCT02289417|3523107|B2|||Duration of Ulcerative Colitis||Years|Mean|6.15|6.15|Standard Deviation|5.432|5.432|||
3679101|NCT02289417|3523108|B1|||Duration of Ulcerative Colitis||Years|Mean|6.85|6.85|Standard Deviation|7.043|7.043|||
3679102|NCT02289417|3523105|B4||Not Reported or Collected|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3679103|NCT02289417|3523106|B3||Not Reported or Collected|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3679104|NCT02289417|3523107|B2||Not Reported or Collected|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3679105|NCT02289417|3523108|B1||Not Reported or Collected|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3679106|NCT02289417|3523105|B4||Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3679107|NCT02289417|3523106|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3679108|NCT02289417|3523107|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3679109|NCT02289417|3523108|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3679110|NCT02289417|3523105|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|151|151.0||||||
3679111|NCT02289417|3523106|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|45|45.0||||||
3679112|NCT02289417|3523107|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|52|52.0||||||
3679113|NCT02289417|3523108|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|54|54.0||||||
3679114|NCT02289417|3523105|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3679115|NCT02289417|3523106|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3679116|NCT02289417|3523107|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3679117|NCT02289417|3523108|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3679118|NCT02289417|3523105|B4||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3679119|NCT02289417|3523106|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3679120|NCT02289417|3523107|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3679121|NCT02289417|3523108|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3679122|NCT02289417|3523105|B4||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3679123|NCT02289417|3523106|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3679124|NCT02289417|3523107|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3679125|NCT02289417|3523108|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3679129|NCT02289417|3523108|B1|||Age||Years|Mean|42.9|42.9|Standard Deviation|14.04|14.04|||
3679130|NCT02289222|3523148|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3679131|NCT02289222|3523148|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3679132|NCT02289222|3523148|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3679133|NCT02289222|3523148|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3679134|NCT02289222|3523148|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3679135|NCT02289222|3523148|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3679136|NCT02289222|3523148|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3679137|NCT02289222|3523148|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3679138|NCT02289222|3523148|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3679139|NCT02289222|3523148|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3679140|NCT02289222|3523148|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3679141|NCT02289222|3523148|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3679142|NCT02289222|3523148|B1|||Age||years|Median|64|64.0|Full Range|||35.0|82.0|
3679143|NCT02289157|3523154|B3|||Chorioamnionitis||Participants|Count of Participants|27|27.0||||||
3679144|NCT02289157|3523155|B2|||Chorioamnionitis||Participants|Count of Participants|12|12.0||||||
3679145|NCT02289157|3523156|B1|||Chorioamnionitis||Participants|Count of Participants|15|15.0||||||
3679146|NCT02289157|3523154|B3|||Ruptured Membranes||Participants|Count of Participants|136|136.0||||||
3679147|NCT02289157|3523155|B2|||Ruptured Membranes||Participants|Count of Participants|59|59.0||||||
3679148|NCT02289157|3523156|B1|||Ruptured Membranes||Participants|Count of Participants|77|77.0||||||
3679149|NCT02289157|3523154|B3|||Induction Labor||Participants|Count of Participants|90|90.0||||||
3679150|NCT02289157|3523155|B2|||Induction Labor||Participants|Count of Participants|43|43.0||||||
3679151|NCT02289157|3523156|B1|||Induction Labor||Participants|Count of Participants|47|47.0||||||
3679152|NCT02289157|3523154|B3|||Patients in labor prior cesarean||Participants|Count of Participants|76|76.0||||||
3679153|NCT02289157|3523155|B2|||Patients in labor prior cesarean||Participants|Count of Participants|32|32.0||||||
3679154|NCT02289157|3523156|B1|||Patients in labor prior cesarean||Participants|Count of Participants|44|44.0||||||
3679155|NCT02289157|3523154|B3|||Incision length in cm||cm|Mean|14.6|14.6|Standard Deviation|2.7|2.7|||
3679156|NCT02289157|3523155|B2|||Incision length in cm||cm|Mean|14.6|14.6|Standard Deviation|2.9|2.9|||
3679157|NCT02289157|3523156|B1|||Incision length in cm||cm|Mean|14.5|14.5|Standard Deviation|2.5|2.5|||
3679158|NCT02289157|3523154|B3|||Number subcutaneous layers closed||layers|Median|3|3.0|Inter-Quartile Range|||2.0|4.0|
3679159|NCT02289157|3523155|B2|||Number subcutaneous layers closed||layers|Median|3|3.0|Inter-Quartile Range|||2.0|4.0|
3679160|NCT02289157|3523156|B1|||Number subcutaneous layers closed||layers|Median|3|3.0|Inter-Quartile Range|||2.0|4.0|
3679161|NCT02289157|3523154|B3|||Subcutaneous skin depth in cm||cm|Mean|5.4|5.4|Standard Deviation|1.7|1.7|||
3679162|NCT02289157|3523155|B2|||Subcutaneous skin depth in cm||cm|Mean|5.3|5.3|Standard Deviation|1.8|1.8|||
3679163|NCT02289157|3523156|B1|||Subcutaneous skin depth in cm||cm|Mean|5.5|5.5|Standard Deviation|1.3|1.3|||
3679164|NCT02289157|3523154|B3|||Suture skin closure||Participants|Count of Participants|421|421.0||||||
3679165|NCT02289157|3523155|B2|||Suture skin closure||Participants|Count of Participants|211|211.0||||||
3679166|NCT02289157|3523156|B1|||Suture skin closure||Participants|Count of Participants|210|210.0||||||
3679167|NCT02289157|3523154|B3|||Midline skin incision||participants|Number|328|328.0||||||
3679168|NCT02289157|3523155|B2|||Midline skin incision||participants|Number|158|158.0||||||
3679169|NCT02289157|3523156|B1|||Midline skin incision||participants|Number|170|170.0||||||
3679170|NCT02289157|3523154|B3|||Estimated blood loss||ml|Mean|1159|1159.0|Standard Deviation|291|291.0|||
3679171|NCT02289157|3523155|B2|||Estimated blood loss||ml|Mean|1136|1136.0|Standard Deviation|285|285.0|||
3679172|NCT02289157|3523156|B1|||Estimated blood loss||ml|Mean|1181|1181.0|Standard Deviation|294|294.0|||
3679173|NCT02289157|3523154|B3|||Length of Surgery||minutes|Median|82|82.0|Inter-Quartile Range|||67.0|101.0|
3679174|NCT02289157|3523155|B2|||Length of Surgery||minutes|Median|80|80.0|Inter-Quartile Range|||64.0|99.0|
3679175|NCT02289157|3523156|B1|||Length of Surgery||minutes|Median|84|84.0|Inter-Quartile Range|||70.0|103.0|
3679176|NCT02289157|3523154|B3|Emergent||Cesarean Priority||participants|Number|18|18.0||||||
3679177|NCT02289157|3523155|B2|Emergent||Cesarean Priority||participants|Number|9|9.0||||||
3679178|NCT02289157|3523156|B1|Emergent||Cesarean Priority||participants|Number|9|9.0||||||
3679179|NCT02289157|3523154|B3|ASAP||Cesarean Priority||participants|Number|279|279.0||||||
3679180|NCT02289157|3523155|B2|ASAP||Cesarean Priority||participants|Number|138|138.0||||||
3679181|NCT02289157|3523156|B1|ASAP||Cesarean Priority||participants|Number|141|141.0||||||
3679182|NCT02289157|3523154|B3|Scheduled||Cesarean Priority||participants|Number|144|144.0||||||
3679183|NCT02289157|3523155|B2|Scheduled||Cesarean Priority||participants|Number|72|72.0||||||
3679184|NCT02289157|3523156|B1|Scheduled||Cesarean Priority||participants|Number|72|72.0||||||
3679185|NCT02289157|3523154|B3|||Primary Cesarean||participants|Number|175|175.0||||||
3679186|NCT02289157|3523155|B2|||Primary Cesarean||participants|Number|80|80.0||||||
3679187|NCT02289157|3523156|B1|||Primary Cesarean||participants|Number|95|95.0||||||
3679188|NCT02289157|3523154|B3|||Insulin Requiring Diabetes||participants|Number|60|60.0||||||
3679189|NCT02289157|3523155|B2|||Insulin Requiring Diabetes||participants|Number|24|24.0||||||
3679190|NCT02289157|3523156|B1|||Insulin Requiring Diabetes||participants|Number|36|36.0||||||
3679191|NCT02289157|3523154|B3|||Chronic hypertension||participants|Number|76|76.0||||||
3679192|NCT02289157|3523155|B2|||Chronic hypertension||participants|Number|36|36.0||||||
3679193|NCT02289157|3523156|B1|||Chronic hypertension||participants|Number|40|40.0||||||
3679194|NCT02289157|3523154|B3|||Tobacco use|Number of smokers in each arm numbers|participants|Number|33|33.0||||||
3679195|NCT02289157|3523155|B2|||Tobacco use|Number of smokers in each arm numbers|participants|Number|15|15.0||||||
3679196|NCT02289157|3523156|B1|||Tobacco use|Number of smokers in each arm numbers|participants|Number|18|18.0||||||
3679197|NCT02289157|3523154|B3|||BMI at Delivery||BMI = kg/meter^2|Mean|46.3|46.3|Standard Deviation|6.2|6.2|||
3679198|NCT02289157|3523155|B2|||BMI at Delivery||BMI = kg/meter^2|Mean|45.8|45.8|Standard Deviation|5.8|5.8|||
3679199|NCT02289157|3523156|B1|||BMI at Delivery||BMI = kg/meter^2|Mean|46.6|46.6|Standard Deviation|6.0|6.0|||
3679200|NCT02289157|3523154|B3|Parity > 2||Parity|Number of deliveries after 20 weeks prior to the present delivery|participants|Number|93|93.0||||||
3679201|NCT02289157|3523155|B2|Parity > 2||Parity|Number of deliveries after 20 weeks prior to the present delivery|participants|Number|52|52.0||||||
3679202|NCT02289157|3523156|B1|Parity > 2||Parity|Number of deliveries after 20 weeks prior to the present delivery|participants|Number|41|41.0||||||
3679203|NCT02289157|3523154|B3|Parity 2||Parity|Number of deliveries after 20 weeks prior to the present delivery|participants|Number|119|119.0||||||
3679204|NCT02289157|3523155|B2|Parity 2||Parity|Number of deliveries after 20 weeks prior to the present delivery|participants|Number|57|57.0||||||
3679205|NCT02289157|3523156|B1|Parity 2||Parity|Number of deliveries after 20 weeks prior to the present delivery|participants|Number|62|62.0||||||
3679206|NCT02289157|3523154|B3|Parity 1||Parity|Number of deliveries after 20 weeks prior to the present delivery|participants|Number|132|132.0||||||
3679207|NCT02289157|3523155|B2|Parity 1||Parity|Number of deliveries after 20 weeks prior to the present delivery|participants|Number|68|68.0||||||
3679208|NCT02289157|3523156|B1|Parity 1||Parity|Number of deliveries after 20 weeks prior to the present delivery|participants|Number|64|64.0||||||
3679209|NCT02289157|3523154|B3|Parity 0||Parity|Number of deliveries after 20 weeks prior to the present delivery|participants|Number|97|97.0||||||
3679210|NCT02289157|3523155|B2|Parity 0||Parity|Number of deliveries after 20 weeks prior to the present delivery|participants|Number|42|42.0||||||
3679211|NCT02289157|3523156|B1|Parity 0||Parity|Number of deliveries after 20 weeks prior to the present delivery|participants|Number|55|55.0||||||
3679212|NCT02289157|3523154|B3|||Gestational age at delivery||weeks|Mean|38.6|38.6|Standard Deviation|3.5|3.5|||
3679213|NCT02289157|3523155|B2|||Gestational age at delivery||weeks|Mean|38.7|38.7|Standard Deviation|4.5|4.5|||
3679214|NCT02289157|3523156|B1|||Gestational age at delivery||weeks|Mean|38.6|38.6|Standard Deviation|1.9|1.9|||
3679215|NCT02289157|3523154|B3|Race White||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3679216|NCT02289157|3523155|B2|Race White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3679217|NCT02289157|3523156|B1|Race White||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3679218|NCT02289157|3523154|B3|Race Hispanic||Race/Ethnicity, Customized||participants|Number|297|297.0||||||
3679219|NCT02289157|3523155|B2|Race Hispanic||Race/Ethnicity, Customized||participants|Number|146|146.0||||||
3679220|NCT02289157|3523156|B1|Race Hispanic||Race/Ethnicity, Customized||participants|Number|151|151.0||||||
3679221|NCT02289157|3523154|B3|Race Black||Race/Ethnicity, Customized||participants|Number|116|116.0||||||
3679222|NCT02289157|3523155|B2|Race Black||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
3679223|NCT02289157|3523156|B1|Race Black||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
3679224|NCT02289157|3523154|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3679225|NCT02289157|3523155|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3679226|NCT02289157|3523156|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3679227|NCT02289157|3523154|B3||Female|Sex: Female, Male||Participants|Count of Participants|441|441.0||||||
3679228|NCT02289157|3523155|B2||Female|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
3679229|NCT02289157|3523156|B1||Female|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
3679230|NCT02289157|3523154|B3|||Age||years|Mean|29.7|29.7|Standard Deviation|6.1|6.1|||
3679231|NCT02289157|3523155|B2|||Age||years|Mean|30.3|30.3|Standard Deviation|6.1|6.1|||
3679232|NCT02289157|3523156|B1|||Age||years|Mean|29.1|29.1|Standard Deviation|6.1|6.1|||
3679233|NCT02289105|3523189|B3|Yes||Clinical Degree||participants|Number|269|269.0||||||
3679234|NCT02289105|3523190|B2|Yes||Clinical Degree||participants|Number|127|127.0||||||
3679235|NCT02289105|3523191|B1|Yes||Clinical Degree||participants|Number|142|142.0||||||
3679236|NCT02289105|3523189|B3|No||Clinical Degree||participants|Number|1010|1010.0||||||
3679237|NCT02289105|3523190|B2|No||Clinical Degree||participants|Number|510|510.0||||||
3679238|NCT02289105|3523191|B1|No||Clinical Degree||participants|Number|500|500.0||||||
3679239|NCT02289105|3523189|B3|Missing||Highest level of education||participants|Number|76|76.0||||||
3679240|NCT02289105|3523190|B2|Missing||Highest level of education||participants|Number|46|46.0||||||
3679241|NCT02289105|3523191|B1|Missing||Highest level of education||participants|Number|30|30.0||||||
3679242|NCT02289105|3523189|B3|High School or Less||Highest level of education||participants|Number|108|108.0||||||
3679243|NCT02289105|3523190|B2|High School or Less||Highest level of education||participants|Number|51|51.0||||||
3679244|NCT02289105|3523191|B1|High School or Less||Highest level of education||participants|Number|57|57.0||||||
3679245|NCT02289105|3523189|B3|Some College||Highest level of education||participants|Number|269|269.0||||||
3679246|NCT02289105|3523190|B2|Some College||Highest level of education||participants|Number|133|133.0||||||
3679247|NCT02289105|3523191|B1|Some College||Highest level of education||participants|Number|136|136.0||||||
3679248|NCT02289105|3523189|B3|College Degree||Highest level of education||participants|Number|602|602.0||||||
3679249|NCT02289105|3523190|B2|College Degree||Highest level of education||participants|Number|298|298.0||||||
3679250|NCT02289105|3523191|B1|College Degree||Highest level of education||participants|Number|304|304.0||||||
3679251|NCT02289105|3523189|B3|Graduate Degree||Highest level of education||participants|Number|224|224.0||||||
3679252|NCT02289105|3523190|B2|Graduate Degree||Highest level of education||participants|Number|109|109.0||||||
3679253|NCT02289105|3523191|B1|Graduate Degree||Highest level of education||participants|Number|115|115.0||||||
3679254|NCT02289105|3523189|B3|Part-time||Employment Status||participants|Number|346|346.0||||||
3679255|NCT02289105|3523190|B2|Part-time||Employment Status||participants|Number|168|168.0||||||
3679256|NCT02289105|3523191|B1|Part-time||Employment Status||participants|Number|178|178.0||||||
3679257|NCT02289105|3523189|B3|Full-time||Employment Status||participants|Number|933|933.0||||||
3679258|NCT02289105|3523190|B2|Full-time||Employment Status||participants|Number|469|469.0||||||
3679259|NCT02289105|3523191|B1|Full-time||Employment Status||participants|Number|464|464.0||||||
3679260|NCT02289105|3523189|B3|United States||Region of Enrollment||participants|Number|1279|1279.0||||||
3679261|NCT02289105|3523190|B2|United States||Region of Enrollment||participants|Number|637|637.0||||||
3679262|NCT02289105|3523191|B1|United States||Region of Enrollment||participants|Number|642|642.0||||||
3679263|NCT02289105|3523189|B3|Prefer not to answer or missing||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
3679264|NCT02289105|3523190|B2|Prefer not to answer or missing||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
3679265|NCT02289105|3523191|B1|Prefer not to answer or missing||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3679266|NCT02289105|3523189|B3|Mixed or Other||Race/Ethnicity, Customized||participants|Number|105|105.0||||||
3679267|NCT02289105|3523190|B2|Mixed or Other||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
3679268|NCT02289105|3523191|B1|Mixed or Other||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
3679269|NCT02289105|3523189|B3|Asian||Race/Ethnicity, Customized||participants|Number|92|92.0||||||
3679270|NCT02289105|3523190|B2|Asian||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
3679271|NCT02289105|3523191|B1|Asian||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
3679272|NCT02289105|3523189|B3|Black||Race/Ethnicity, Customized||participants|Number|344|344.0||||||
3679273|NCT02289105|3523190|B2|Black||Race/Ethnicity, Customized||participants|Number|167|167.0||||||
3679274|NCT02289105|3523191|B1|Black||Race/Ethnicity, Customized||participants|Number|177|177.0||||||
3679275|NCT02289105|3523189|B3|White||Race/Ethnicity, Customized||participants|Number|678|678.0||||||
3679276|NCT02289105|3523190|B2|White||Race/Ethnicity, Customized||participants|Number|345|345.0||||||
3679277|NCT02289105|3523191|B1|White||Race/Ethnicity, Customized||participants|Number|333|333.0||||||
3679278|NCT02289105|3523189|B3|Prefer not to answer or missing||Sex/Gender, Customized||participants|Number|28|28.0||||||
3679279|NCT02289105|3523190|B2|Prefer not to answer or missing||Sex/Gender, Customized||participants|Number|18|18.0||||||
3679280|NCT02289105|3523191|B1|Prefer not to answer or missing||Sex/Gender, Customized||participants|Number|10|10.0||||||
3679281|NCT02289105|3523189|B3|Female||Sex/Gender, Customized||participants|Number|333|333.0||||||
3679282|NCT02289105|3523190|B2|Female||Sex/Gender, Customized||participants|Number|147|147.0||||||
3679283|NCT02289105|3523191|B1|Female||Sex/Gender, Customized||participants|Number|186|186.0||||||
3679284|NCT02289105|3523189|B3|Male||Sex/Gender, Customized||participants|Number|918|918.0||||||
3679285|NCT02289105|3523190|B2|Male||Sex/Gender, Customized||participants|Number|472|472.0||||||
3679286|NCT02289105|3523191|B1|Male||Sex/Gender, Customized||participants|Number|446|446.0||||||
3679287|NCT02289105|3523189|B3|||Age||years|Median|29|29.0|Inter-Quartile Range|||25.0|38.0|
3679288|NCT02289105|3523190|B2|||Age||years|Median|29|29.0|Inter-Quartile Range|||25.0|37.0|
3679289|NCT02289105|3523191|B1|||Age||years|Median|29|29.0|Inter-Quartile Range|||25.0|39.0|
3679290|NCT02289079|3523202|B3|||weight||kilograms|Mean|93.5|93.5|Standard Deviation|30.2|30.2|||
3679291|NCT02289079|3523203|B2|||weight||kilograms|Mean|98.5|98.5|Standard Deviation|34.2|34.2|||
3679292|NCT02289079|3523204|B1|||weight||kilograms|Mean|89.3|89.3|Standard Deviation|25.1|25.1|||
3679293|NCT02289079|3523202|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
3679294|NCT02289079|3523203|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3679295|NCT02289079|3523204|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
3679296|NCT02289079|3523202|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3679297|NCT02289079|3523203|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3679298|NCT02289079|3523204|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3679299|NCT02289079|3523202|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3679300|NCT02289079|3523203|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3679301|NCT02289079|3523204|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3679302|NCT02289079|3523202|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3679303|NCT02289079|3523203|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3679304|NCT02289079|3523204|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3679305|NCT02289079|3523202|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3679306|NCT02289079|3523203|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3679307|NCT02289079|3523204|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3679308|NCT02289079|3523202|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3679309|NCT02289079|3523203|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3679310|NCT02289079|3523204|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3679311|NCT02288364|3523217|B3|United States||Region of Enrollment||participants|Number|86|86.0||||||
3679312|NCT02288364|3523218|B2|United States||Region of Enrollment||participants|Number|44|44.0||||||
3679313|NCT02288364|3523219|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
3679314|NCT02288364|3523217|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3679315|NCT02288364|3523218|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3679316|NCT02288364|3523219|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3679317|NCT02288364|3523217|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3679318|NCT02288364|3523218|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3679319|NCT02288364|3523219|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3679320|NCT02288364|3523217|B3|Black||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3679321|NCT02288364|3523218|B2|Black||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3679322|NCT02288364|3523219|B1|Black||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3679323|NCT02288364|3523217|B3|White||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
3679324|NCT02288364|3523218|B2|White||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3679325|NCT02288364|3523219|B1|White||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3679326|NCT02288364|3523217|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3679327|NCT02288364|3523218|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3679328|NCT02288364|3523219|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3679329|NCT02288364|3523217|B3||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3679330|NCT02288364|3523218|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3679331|NCT02288364|3523219|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3679332|NCT02288364|3523217|B3|||Age||years|Mean|53.53|53.53|Standard Deviation|13.38|13.38|||
3679333|NCT02288364|3523218|B2|||Age||years|Mean|53.80|53.8|Standard Deviation|13.22|13.22|||
3679334|NCT02288364|3523219|B1|||Age||years|Mean|53.26|53.26|Standard Deviation|13.70|13.7|||
3679335|NCT02288325|3523244|B1||Male|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
3679336|NCT02288325|3523244|B1||Female|Sex: Female, Male||Participants|Count of Participants|404|404.0||||||
3679337|NCT02288325|3523244|B1|||Age||years|Mean|43.1|43.1|Standard Deviation|13.9|13.9|||
3679338|NCT02288312|3523253|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3679339|NCT02288312|3523254|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3679340|NCT02288312|3523255|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3679341|NCT02288312|3523256|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3679342|NCT02288312|3523253|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3679343|NCT02288312|3523254|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3679344|NCT02288312|3523255|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3679345|NCT02288312|3523256|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3679346|NCT02288312|3523253|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3679347|NCT02288312|3523254|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3679348|NCT02288312|3523255|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3679349|NCT02288312|3523256|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3679350|NCT02288312|3523253|B4||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3679351|NCT02288312|3523254|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3679352|NCT02288312|3523255|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3679353|NCT02288312|3523256|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3679354|NCT02288312|3523253|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3679355|NCT02288312|3523254|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3679356|NCT02288312|3523255|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3679357|NCT02288312|3523256|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3679358|NCT02288273|3523275|B3||Male|Gender||Participants|Count of Participants|65|65.0||||||
3679359|NCT02288273|3523276|B2||Male|Gender||Participants|Count of Participants|32|32.0||||||
3679360|NCT02288273|3523277|B1||Male|Gender||Participants|Count of Participants|33|33.0||||||
3679361|NCT02288273|3523275|B3||Female|Gender||Participants|Count of Participants|51|51.0||||||
3679362|NCT02288273|3523276|B2||Female|Gender||Participants|Count of Participants|24|24.0||||||
3679363|NCT02288273|3523277|B1||Female|Gender||Participants|Count of Participants|27|27.0||||||
3679364|NCT02288273|3523275|B3|||Age||Years|Mean|55.6|55.6|Standard Deviation|10.21|10.21|||
3679365|NCT02288273|3523276|B2|||Age||Years|Mean|56|56.0|Standard Deviation|9.80|9.8|||
3679366|NCT02288273|3523277|B1|||Age||Years|Mean|55|55.0|Standard Deviation|10.63|10.63|||
3679367|NCT02288091|3523296|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3679368|NCT02288091|3523296|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3679369|NCT02288091|3523296|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3679370|NCT02288091|3523296|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3679371|NCT02288091|3523296|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3679372|NCT02288091|3523296|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3679373|NCT02288091|3523296|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3679374|NCT02288091|3523296|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3679375|NCT02288091|3523296|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3679376|NCT02288091|3523296|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3679377|NCT02288091|3523296|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3679378|NCT02288091|3523296|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3679379|NCT02288091|3523296|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3679380|NCT02288091|3523296|B1|||Age||years|Mean|61.2|61.2|Standard Deviation|8.4|8.4|||
3679381|NCT02287883|3523304|B3|||Hemoglobin A1c (HbA1c)||percentage|Mean|7.27|7.27|Standard Deviation|1.57|1.57|||
3679382|NCT02287883|3523305|B2|||Hemoglobin A1c (HbA1c)||percentage|Mean|7.20|7.2|Standard Deviation|1.49|1.49|||
3679383|NCT02287883|3523306|B1|||Hemoglobin A1c (HbA1c)||percentage|Mean|7.33|7.33|Standard Deviation|1.63|1.63|||
3679384|NCT02287883|3523304|B3|||Low density lipoprotein cholesterol (LDL-C)||mg/dL|Mean|91.22|91.22|Standard Deviation|31.89|31.89|||
3679385|NCT02287883|3523305|B2|||Low density lipoprotein cholesterol (LDL-C)||mg/dL|Mean|90.58|90.58|Standard Deviation|31.50|31.5|||
3679386|NCT02287883|3523306|B1|||Low density lipoprotein cholesterol (LDL-C)||mg/dL|Mean|91.82|91.82|Standard Deviation|32.27|32.27|||
3679387|NCT02287883|3523304|B3|||Diastolic Blood Pressure||mmHg|Mean|75.80|75.8|Standard Deviation|8.39|8.39|||
3679388|NCT02287883|3523305|B2|||Diastolic Blood Pressure||mmHg|Mean|75.47|75.47|Standard Deviation|8.10|8.1|||
3679389|NCT02287883|3523306|B1|||Diastolic Blood Pressure||mmHg|Mean|76.14|76.14|Standard Deviation|8.65|8.65|||
3679390|NCT02287883|3523304|B3|||Systolic Blood Pressure||mmHg|Mean|131.70|131.7|Standard Deviation|14.18|14.18|||
3679391|NCT02287883|3523305|B2|||Systolic Blood Pressure||mmHg|Mean|130.31|130.31|Standard Deviation|13.19|13.19|||
3679392|NCT02287883|3523306|B1|||Systolic Blood Pressure||mmHg|Mean|133.11|133.11|Standard Deviation|14.99|14.99|||
3679393|NCT02287883|3523304|B3|||Patient Health Questionnaire 4 (PHQ-4)|Patient Reported Emotional Functioning, scale 1 (not at all anxious or depressed) -5 (anxious or depressed nearly every day)|units on a scale|Mean|1.53|1.53|Standard Deviation|0.74|0.74|||
3679394|NCT02287883|3523305|B2|||Patient Health Questionnaire 4 (PHQ-4)|Patient Reported Emotional Functioning, scale 1 (not at all anxious or depressed) -5 (anxious or depressed nearly every day)|units on a scale|Mean|1.51|1.51|Standard Deviation|0.72|0.72|||
3679395|NCT02287883|3523306|B1|||Patient Health Questionnaire 4 (PHQ-4)|Patient Reported Emotional Functioning, scale 1 (not at all anxious or depressed) -5 (anxious or depressed nearly every day)|units on a scale|Mean|1.55|1.55|Standard Deviation|0.75|0.75|||
3679396|NCT02287883|3523304|B3|||Patient Reported Outcomes Measurement Information System (PROMIS) Short Form 12a|Patient-Reported Physical Functioning, scale 1 (no difficulty) -5 (unable to do activity)|units on a scale|Mean|2.00|2.0|Standard Deviation|0.88|0.88|||
3679397|NCT02287883|3523305|B2|||Patient Reported Outcomes Measurement Information System (PROMIS) Short Form 12a|Patient-Reported Physical Functioning, scale 1 (no difficulty) -5 (unable to do activity)|units on a scale|Mean|1.99|1.99|Standard Deviation|0.88|0.88|||
3679398|NCT02287883|3523306|B1|||Patient Reported Outcomes Measurement Information System (PROMIS) Short Form 12a|Patient-Reported Physical Functioning, scale 1 (no difficulty) -5 (unable to do activity)|units on a scale|Mean|2.01|2.01|Standard Deviation|0.89|0.89|||
3679399|NCT02287883|3523304|B3|||Patient Reported Outcomes Measurement Information System (PROMIS) Short Form 8a|Patient Reported Social Functioning, scale 1 (never trouble or limited)-5 (always trouble or limited)|units on a scale|Mean|2.35|2.35|Standard Deviation|1.05|1.05|||
3679400|NCT02287883|3523305|B2|||Patient Reported Outcomes Measurement Information System (PROMIS) Short Form 8a|Patient Reported Social Functioning, scale 1 (never trouble or limited)-5 (always trouble or limited)|units on a scale|Mean|2.34|2.34|Standard Deviation|1.06|1.06|||
3679401|NCT02287883|3523306|B1|||Patient Reported Outcomes Measurement Information System (PROMIS) Short Form 8a|Patient Reported Social Functioning, scale 1 (never trouble or limited)-5 (always trouble or limited)|units on a scale|Mean|2.37|2.37|Standard Deviation|1.03|1.03|||
3679402|NCT02287883|3523304|B3|||Patient Assessment of Chronic Illness Care (PACIC)|Unweighted average of responses to 11-item Patient Assessment of Chronic Illness Care (PACIC). PACIC measures patients' experience with care they received from their health care providers with for their chronic condition. The response scale for all items ranges from 1 (never experienced care management process) -4 (always experienced care management process).|units on a scale|Mean|2.68|2.68|Standard Deviation|0.83|0.83|||
3679403|NCT02287883|3523305|B2|||Patient Assessment of Chronic Illness Care (PACIC)|Unweighted average of responses to 11-item Patient Assessment of Chronic Illness Care (PACIC). PACIC measures patients' experience with care they received from their health care providers with for their chronic condition. The response scale for all items ranges from 1 (never experienced care management process) -4 (always experienced care management process).|units on a scale|Mean|2.65|2.65|Standard Deviation|0.84|0.84|||
3679404|NCT02287883|3523306|B1|||Patient Assessment of Chronic Illness Care (PACIC)|Unweighted average of responses to 11-item Patient Assessment of Chronic Illness Care (PACIC). PACIC measures patients' experience with care they received from their health care providers with for their chronic condition. The response scale for all items ranges from 1 (never experienced care management process) -4 (always experienced care management process).|units on a scale|Mean|2.72|2.72|Standard Deviation|0.83|0.83|||
3679405|NCT02287883|3523304|B3|||Patient Activation Measure (PAM-13)|Unweighted average of responses to 13-item Patient Activation Measure (PAM-13) which assesses patient knowledge, skill, and confidence for self-management. Response categories for all items range from 1 (disagree strongly with statements of activation) -4 (agree strongly with statements of activation).|units on a scale|Mean|3.27|3.27|Standard Deviation|0.45|0.45|||
3679406|NCT02287883|3523305|B2|||Patient Activation Measure (PAM-13)|Unweighted average of responses to 13-item Patient Activation Measure (PAM-13) which assesses patient knowledge, skill, and confidence for self-management. Response categories for all items range from 1 (disagree strongly with statements of activation) -4 (agree strongly with statements of activation).|units on a scale|Mean|3.27|3.27|Standard Deviation|0.44|0.44|||
3679407|NCT02287883|3523306|B1|||Patient Activation Measure (PAM-13)|Unweighted average of responses to 13-item Patient Activation Measure (PAM-13) which assesses patient knowledge, skill, and confidence for self-management. Response categories for all items range from 1 (disagree strongly with statements of activation) -4 (agree strongly with statements of activation).|units on a scale|Mean|3.27|3.27|Standard Deviation|0.45|0.45|||
3679408|NCT02287883|3523304|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|631|631.0||||||
3679409|NCT02287883|3523305|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|315|315.0||||||
3679410|NCT02287883|3523306|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|316|316.0||||||
3679411|NCT02287883|3523304|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3679412|NCT02287883|3523305|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3679413|NCT02287883|3523306|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3679414|NCT02287883|3523304|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1013|1013.0||||||
3679415|NCT02287883|3523305|B2||White|Race (NIH/OMB)||Participants|Count of Participants|601|601.0||||||
3679416|NCT02287883|3523306|B1||White|Race (NIH/OMB)||Participants|Count of Participants|412|412.0||||||
3679417|NCT02287883|3523304|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|265|265.0||||||
3679418|NCT02287883|3523305|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3679419|NCT02287883|3523306|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|230|230.0||||||
3679420|NCT02287883|3523304|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3679421|NCT02287883|3523305|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3679422|NCT02287883|3523306|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3679423|NCT02287883|3523304|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|196|196.0||||||
3679424|NCT02287883|3523305|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
3679425|NCT02287883|3523306|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
3679426|NCT02287883|3523304|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3679427|NCT02287883|3523305|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3679428|NCT02287883|3523306|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3679429|NCT02287883|3523304|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3679430|NCT02287883|3523305|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3679431|NCT02287883|3523306|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3679432|NCT02287883|3523304|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1367|1367.0||||||
3679433|NCT02287883|3523305|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|699|699.0||||||
3679434|NCT02287883|3523306|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|668|668.0||||||
3679435|NCT02287883|3523304|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|729|729.0||||||
3679436|NCT02287883|3523305|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|358|358.0||||||
3679437|NCT02287883|3523306|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|371|371.0||||||
3679438|NCT02287883|3523304|B3||Male|Sex: Female, Male||Participants|Count of Participants|985|985.0||||||
3679439|NCT02287883|3523305|B2||Male|Sex: Female, Male||Participants|Count of Participants|503|503.0||||||
3679440|NCT02287883|3523306|B1||Male|Sex: Female, Male||Participants|Count of Participants|482|482.0||||||
3679441|NCT02287883|3523304|B3||Female|Sex: Female, Male||Participants|Count of Participants|1191|1191.0||||||
3679442|NCT02287883|3523305|B2||Female|Sex: Female, Male||Participants|Count of Participants|592|592.0||||||
3679443|NCT02287883|3523306|B1||Female|Sex: Female, Male||Participants|Count of Participants|599|599.0||||||
3679444|NCT02287883|3523304|B3||>=65 years|Age||Participants|Count of Participants|1172|1172.0||||||
3679445|NCT02287883|3523305|B2||>=65 years|Age||Participants|Count of Participants|582|582.0||||||
3679446|NCT02287883|3523306|B1||>=65 years|Age||Participants|Count of Participants|590|590.0||||||
3679447|NCT02287883|3523304|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1004|1004.0||||||
3679448|NCT02287883|3523305|B2||Between 18 and 65 years|Age||Participants|Count of Participants|513|513.0||||||
3679449|NCT02287883|3523306|B1||Between 18 and 65 years|Age||Participants|Count of Participants|491|491.0||||||
3679450|NCT02287883|3523304|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3679451|NCT02287883|3523305|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3679452|NCT02287883|3523306|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3679453|NCT02287779|3523317|B9||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3679454|NCT02287779|3523318|B8||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3679455|NCT02287779|3523319|B7||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3679456|NCT02287779|3523320|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3679457|NCT02287779|3523321|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3679458|NCT02287779|3523322|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3679459|NCT02287779|3523323|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3679460|NCT02287779|3523324|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3679461|NCT02287779|3523325|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3679462|NCT02287779|3523317|B9||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3679463|NCT02287779|3523318|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3679464|NCT02287779|3523319|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3679465|NCT02287779|3523320|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3679466|NCT02287779|3523321|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3679467|NCT02287779|3523322|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3679468|NCT02287779|3523323|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3679469|NCT02287779|3523324|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3679470|NCT02287779|3523325|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3679471|NCT02287779|3523317|B9|Age||Age||years|Mean|40.1|40.1|Standard Deviation|10.93|10.93|||
3679472|NCT02287779|3523318|B8|Age||Age||years|Mean|33.2|33.2|Standard Deviation|11.34|11.34|||
3679473|NCT02287779|3523319|B7|Age||Age||years|Mean|36.6|36.6|Standard Deviation|8.92|8.92|||
3679474|NCT02287779|3523320|B6|Age||Age||years|Mean|44.6|44.6|Standard Deviation|10.70|10.7|||
3679475|NCT02287779|3523321|B5|Age||Age||years|Mean|46.2|46.2|Standard Deviation|7.82|7.82|||
3679476|NCT02287779|3523322|B4|Age||Age||years|Mean|33.3|33.3|Standard Deviation|9.82|9.82|||
3679477|NCT02287779|3523323|B3|Age||Age||years|Mean|46.2|46.2|Standard Deviation|7.61|7.61|||
3679478|NCT02287779|3523324|B2|Age||Age||years|Mean|37.1|37.1|Standard Deviation|15.40|15.4|||
3679479|NCT02287779|3523325|B1|Age||Age||years|Mean|41.5|41.5|Standard Deviation|9.47|9.47|||
3679480|NCT02287623|3523470|B3|||weight||kilograms|Mean|77.1|77.1|Standard Deviation|13.9|13.9|||
3679481|NCT02287623|3523471|B2|||weight||kilograms|Mean|75.5|75.5|Standard Deviation|15.5|15.5|||
3679482|NCT02287623|3523472|B1|||weight||kilograms|Mean|78.7|78.7|Standard Deviation|12.3|12.3|||
3679483|NCT02287623|3523470|B3|United States||Region of Enrollment||participants|Number|59|59.0||||||
3679484|NCT02287623|3523471|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
3679485|NCT02287623|3523472|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3679486|NCT02287623|3523470|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3679487|NCT02287623|3523471|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3679488|NCT02287623|3523472|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3679489|NCT02287623|3523470|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3679490|NCT02287623|3523471|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3679491|NCT02287623|3523472|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3679492|NCT02287623|3523470|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3679493|NCT02287623|3523471|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3679494|NCT02287623|3523472|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3679495|NCT02287623|3523470|B3||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
3679496|NCT02287623|3523471|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3679497|NCT02287623|3523472|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3679498|NCT02287623|3523470|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3679499|NCT02287623|3523471|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3679500|NCT02287623|3523472|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3679501|NCT02287610|3523489|B1|||Age at Rheumatoid Arthritis Diagnosis||years|Mean|56.49|56.49|Standard Deviation|14.69|14.69|||
3679502|NCT02287610|3523489|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3679503|NCT02287610|3523489|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3679504|NCT02287610|3523489|B1|||Age||years|Mean|63.05|63.05|Standard Deviation|12.72|12.72|||
3679505|NCT02287415|3523522|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3679506|NCT02287415|3523522|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3679507|NCT02287415|3523522|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3679508|NCT02287415|3523522|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3679509|NCT02287415|3523522|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3679510|NCT02287402|3523528|B1|Japan||Region of Enrollment||participants|Number|197|197.0||||||
3679511|NCT02287402|3523528|B1||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3679512|NCT02287402|3523528|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3679513|NCT02287402|3523528|B1|≥65 years||Age, Customized||participants|Number|60|60.0||||||
3679514|NCT02287402|3523528|B1|<65 years||Age, Customized||participants|Number|137|137.0||||||
3679515|NCT02287402|3523528|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|9.35|9.35|||
3679516|NCT02287376|3523543|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3679517|NCT02287376|3523543|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3679518|NCT02287376|3523543|B1|||Age||years|Mean|15.5|15.5|Standard Deviation|1.66|1.66|||
3679519|NCT02287350|3523586|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3679520|NCT02287350|3523586|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3679521|NCT02287350|3523586|B1|||Age||years|Mean|6.4|6.4|Standard Deviation|3.10|3.1|||
3679522|NCT02287025|3523631|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3679523|NCT02287025|3523632|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3679524|NCT02287025|3523633|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3679525|NCT02287025|3523631|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3679526|NCT02287025|3523632|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3679527|NCT02287025|3523633|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3679528|NCT02287025|3523631|B3|||Age||Years|Mean|60.52|60.52|Standard Deviation|11.70|11.7|||
3679529|NCT02287025|3523632|B2|||Age||Years|Mean|59.91|59.91|Standard Deviation|4.29|4.29|||
3679530|NCT02287025|3523633|B1|||Age||Years|Mean|61.08|61.08|Standard Deviation|15.28|15.28|||
3679531|NCT02286895|3523643|B3||Other|Ethnicity||Participants|Count of Participants|146|146.0||||||
3679532|NCT02286895|3523644|B2||Other|Ethnicity||Participants|Count of Participants|72|72.0||||||
3679533|NCT02286895|3523645|B1||Other|Ethnicity||Participants|Count of Participants|74|74.0||||||
3679534|NCT02286895|3523643|B3||Sarahule/Sarakole|Ethnicity||Participants|Count of Participants|72|72.0||||||
3679535|NCT02286895|3523644|B2||Sarahule/Sarakole|Ethnicity||Participants|Count of Participants|37|37.0||||||
3679536|NCT02286895|3523645|B1||Sarahule/Sarakole|Ethnicity||Participants|Count of Participants|35|35.0||||||
3679537|NCT02286895|3523643|B3||Fula/Peulh|Ethnicity||Participants|Count of Participants|83|83.0||||||
3679538|NCT02286895|3523644|B2||Fula/Peulh|Ethnicity||Participants|Count of Participants|34|34.0||||||
3679539|NCT02286895|3523645|B1||Fula/Peulh|Ethnicity||Participants|Count of Participants|49|49.0||||||
3679540|NCT02286895|3523643|B3||Mandika/Malinke|Ethnicity||Participants|Count of Participants|78|78.0||||||
3679541|NCT02286895|3523644|B2||Mandika/Malinke|Ethnicity||Participants|Count of Participants|37|37.0||||||
3679542|NCT02286895|3523645|B1||Mandika/Malinke|Ethnicity||Participants|Count of Participants|41|41.0||||||
3679543|NCT02286895|3523643|B3||Bambara|Ethnicity||Participants|Count of Participants|221|221.0||||||
3679544|NCT02286895|3523644|B2||Bambara|Ethnicity||Participants|Count of Participants|120|120.0||||||
3679545|NCT02286895|3523645|B1||Bambara|Ethnicity||Participants|Count of Participants|101|101.0||||||
3679546|NCT02286895|3523643|B3|Mali||Region of Enrollment||participants|Number|600|600.0||||||
3679547|NCT02286895|3523644|B2|Mali||Region of Enrollment||participants|Number|300|300.0||||||
3679548|NCT02286895|3523645|B1|Mali||Region of Enrollment||participants|Number|300|300.0||||||
3679549|NCT02286895|3523643|B3||Male|Sex: Female, Male||Participants|Count of Participants|316|316.0||||||
3679550|NCT02286895|3523644|B2||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3679551|NCT02286895|3523645|B1||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3679552|NCT02286895|3523643|B3||Female|Sex: Female, Male||Participants|Count of Participants|284|284.0||||||
3679553|NCT02286895|3523644|B2||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3679554|NCT02286895|3523645|B1||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3679555|NCT02286895|3523643|B3|11 months||Age, Customized||Participants|Count of Participants|49|49.0||||||
3679556|NCT02286895|3523644|B2|11 months||Age, Customized||Participants|Count of Participants|25|25.0||||||
3679557|NCT02286895|3523645|B1|11 months||Age, Customized||Participants|Count of Participants|24|24.0||||||
3679558|NCT02286895|3523643|B3|10 months||Age, Customized||Participants|Count of Participants|104|104.0||||||
3679559|NCT02286895|3523644|B2|10 months||Age, Customized||Participants|Count of Participants|51|51.0||||||
3679560|NCT02286895|3523645|B1|10 months||Age, Customized||Participants|Count of Participants|53|53.0||||||
3679561|NCT02286895|3523643|B3|9 months||Age, Customized||Participants|Count of Participants|447|447.0||||||
3679562|NCT02286895|3523644|B2|9 months||Age, Customized||Participants|Count of Participants|224|224.0||||||
3679563|NCT02286895|3523645|B1|9 months||Age, Customized||Participants|Count of Participants|223|223.0||||||
3679564|NCT02286895|3523643|B3|||Age||months|Mean|9.7|9.7|Standard Deviation|.7|0.7|||
3679565|NCT02286895|3523644|B2|||Age||months|Mean|9.7|9.7|Standard Deviation|.7|0.7|||
3679566|NCT02286895|3523645|B1|||Age||months|Mean|9.7|9.7|Standard Deviation|.7|0.7|||
3679567|NCT02286518|3523688|B15|Ex-smoker||Smoking Classification||Participants|Number|30|30.0||||||
3679568|NCT02286518|3523689|B14|Ex-smoker||Smoking Classification||Participants|Number|2|2.0||||||
3679569|NCT02286518|3523690|B13|Ex-smoker||Smoking Classification||Participants|Number|2|2.0||||||
3679570|NCT02286518|3523691|B12|Ex-smoker||Smoking Classification||Participants|Number|1|1.0||||||
3679571|NCT02286518|3523692|B11|Ex-smoker||Smoking Classification||Participants|Number|3|3.0||||||
3679572|NCT02286518|3523693|B10|Ex-smoker||Smoking Classification||Participants|Number|3|3.0||||||
3679573|NCT02286518|3523694|B9|Ex-smoker||Smoking Classification||Participants|Number|2|2.0||||||
3679574|NCT02286518|3523695|B8|Ex-smoker||Smoking Classification||Participants|Number|3|3.0||||||
3679575|NCT02286518|3523696|B7|Ex-smoker||Smoking Classification||Participants|Number|3|3.0||||||
3679576|NCT02286518|3523697|B6|Ex-smoker||Smoking Classification||Participants|Number|1|1.0||||||
3679577|NCT02286518|3523698|B5|Ex-smoker||Smoking Classification||Participants|Number|1|1.0||||||
3679578|NCT02286518|3523699|B4|Ex-smoker||Smoking Classification||Participants|Number|3|3.0||||||
3679579|NCT02286518|3523700|B3|Ex-smoker||Smoking Classification||Participants|Number|3|3.0||||||
3679580|NCT02286518|3523701|B2|Ex-smoker||Smoking Classification||Participants|Number|1|1.0||||||
3679581|NCT02286518|3523702|B1|Ex-smoker||Smoking Classification||Participants|Number|2|2.0||||||
3679582|NCT02286518|3523688|B15|Never smoked||Smoking Classification||Participants|Number|52|52.0||||||
3679583|NCT02286518|3523689|B14|Never smoked||Smoking Classification||Participants|Number|4|4.0||||||
3679584|NCT02286518|3523690|B13|Never smoked||Smoking Classification||Participants|Number|4|4.0||||||
3679585|NCT02286518|3523691|B12|Never smoked||Smoking Classification||Participants|Number|5|5.0||||||
3679586|NCT02286518|3523692|B11|Never smoked||Smoking Classification||Participants|Number|3|3.0||||||
3679587|NCT02286518|3523693|B10|Never smoked||Smoking Classification||Participants|Number|1|1.0||||||
3679588|NCT02286518|3523694|B9|Never smoked||Smoking Classification||Participants|Number|4|4.0||||||
3679589|NCT02286518|3523695|B8|Never smoked||Smoking Classification||Participants|Number|3|3.0||||||
3679590|NCT02286518|3523696|B7|Never smoked||Smoking Classification||Participants|Number|3|3.0||||||
3679591|NCT02286518|3523697|B6|Never smoked||Smoking Classification||Participants|Number|5|5.0||||||
3679592|NCT02286518|3523698|B5|Never smoked||Smoking Classification||Participants|Number|5|5.0||||||
3679593|NCT02286518|3523699|B4|Never smoked||Smoking Classification||Participants|Number|3|3.0||||||
3679594|NCT02286518|3523700|B3|Never smoked||Smoking Classification||Participants|Number|3|3.0||||||
3679595|NCT02286518|3523701|B2|Never smoked||Smoking Classification||Participants|Number|5|5.0||||||
3679596|NCT02286518|3523702|B1|Never smoked||Smoking Classification||Participants|Number|4|4.0||||||
3679597|NCT02286518|3523688|B15|No Caffeine Consumption||Caffeine Classification||Participants|Number|18|18.0||||||
3679598|NCT02286518|3523689|B14|No Caffeine Consumption||Caffeine Classification||Participants|Number|0|0.0||||||
3679599|NCT02286518|3523690|B13|No Caffeine Consumption||Caffeine Classification||Participants|Number|1|1.0||||||
3679600|NCT02286518|3523691|B12|No Caffeine Consumption||Caffeine Classification||Participants|Number|2|2.0||||||
3679601|NCT02286518|3523692|B11|No Caffeine Consumption||Caffeine Classification||Participants|Number|2|2.0||||||
3679602|NCT02286518|3523693|B10|No Caffeine Consumption||Caffeine Classification||Participants|Number|2|2.0||||||
3679603|NCT02286518|3523694|B9|No Caffeine Consumption||Caffeine Classification||Participants|Number|1|1.0||||||
3679604|NCT02286518|3523695|B8|No Caffeine Consumption||Caffeine Classification||Participants|Number|1|1.0||||||
3679605|NCT02286518|3523696|B7|No Caffeine Consumption||Caffeine Classification||Participants|Number|2|2.0||||||
3679606|NCT02286518|3523697|B6|No Caffeine Consumption||Caffeine Classification||Participants|Number|0|0.0||||||
3679607|NCT02286518|3523698|B5|No Caffeine Consumption||Caffeine Classification||Participants|Number|2|2.0||||||
3679608|NCT02286518|3523699|B4|No Caffeine Consumption||Caffeine Classification||Participants|Number|0|0.0||||||
3679609|NCT02286518|3523700|B3|No Caffeine Consumption||Caffeine Classification||Participants|Number|3|3.0||||||
3679610|NCT02286518|3523701|B2|No Caffeine Consumption||Caffeine Classification||Participants|Number|0|0.0||||||
3679611|NCT02286518|3523702|B1|No Caffeine Consumption||Caffeine Classification||Participants|Number|2|2.0||||||
3679612|NCT02286518|3523688|B15|Caffeine Consumption||Caffeine Classification||Participants|Number|64|64.0||||||
3679613|NCT02286518|3523689|B14|Caffeine Consumption||Caffeine Classification||Participants|Number|6|6.0||||||
3679614|NCT02286518|3523690|B13|Caffeine Consumption||Caffeine Classification||Participants|Number|5|5.0||||||
3679615|NCT02286518|3523691|B12|Caffeine Consumption||Caffeine Classification||Participants|Number|4|4.0||||||
3679616|NCT02286518|3523692|B11|Caffeine Consumption||Caffeine Classification||Participants|Number|4|4.0||||||
3679617|NCT02286518|3523693|B10|Caffeine Consumption||Caffeine Classification||Participants|Number|2|2.0||||||
3679618|NCT02286518|3523694|B9|Caffeine Consumption||Caffeine Classification||Participants|Number|5|5.0||||||
3679619|NCT02286518|3523695|B8|Caffeine Consumption||Caffeine Classification||Participants|Number|5|5.0||||||
3679620|NCT02286518|3523696|B7|Caffeine Consumption||Caffeine Classification||Participants|Number|4|4.0||||||
3679621|NCT02286518|3523697|B6|Caffeine Consumption||Caffeine Classification||Participants|Number|6|6.0||||||
3679622|NCT02286518|3523698|B5|Caffeine Consumption||Caffeine Classification||Participants|Number|4|4.0||||||
3679623|NCT02286518|3523699|B4|Caffeine Consumption||Caffeine Classification||Participants|Number|6|6.0||||||
3679624|NCT02286518|3523700|B3|Caffeine Consumption||Caffeine Classification||Participants|Number|3|3.0||||||
3679625|NCT02286518|3523701|B2|Caffeine Consumption||Caffeine Classification||Participants|Number|6|6.0||||||
3679626|NCT02286518|3523702|B1|Caffeine Consumption||Caffeine Classification||Participants|Number|4|4.0||||||
3679627|NCT02286518|3523688|B15|Does not drink||Alcohol Classification||Participants|Number|19|19.0||||||
3679628|NCT02286518|3523689|B14|Does not drink||Alcohol Classification||Participants|Number|1|1.0||||||
3679629|NCT02286518|3523690|B13|Does not drink||Alcohol Classification||Participants|Number|0|0.0||||||
3679630|NCT02286518|3523691|B12|Does not drink||Alcohol Classification||Participants|Number|2|2.0||||||
3679631|NCT02286518|3523692|B11|Does not drink||Alcohol Classification||Participants|Number|3|3.0||||||
3679632|NCT02286518|3523693|B10|Does not drink||Alcohol Classification||Participants|Number|3|3.0||||||
3679633|NCT02286518|3523694|B9|Does not drink||Alcohol Classification||Participants|Number|0|0.0||||||
3679634|NCT02286518|3523695|B8|Does not drink||Alcohol Classification||Participants|Number|2|2.0||||||
3679635|NCT02286518|3523696|B7|Does not drink||Alcohol Classification||Participants|Number|2|2.0||||||
3679636|NCT02286518|3523697|B6|Does not drink||Alcohol Classification||Participants|Number|0|0.0||||||
3679637|NCT02286518|3523698|B5|Does not drink||Alcohol Classification||Participants|Number|0|0.0||||||
3679638|NCT02286518|3523699|B4|Does not drink||Alcohol Classification||Participants|Number|2|2.0||||||
3679639|NCT02286518|3523700|B3|Does not drink||Alcohol Classification||Participants|Number|1|1.0||||||
3679640|NCT02286518|3523701|B2|Does not drink||Alcohol Classification||Participants|Number|2|2.0||||||
3679641|NCT02286518|3523702|B1|Does not drink||Alcohol Classification||Participants|Number|1|1.0||||||
3679642|NCT02286518|3523688|B15|Drinks a Few Days per Month||Alcohol Classification||Participants|Number|12|12.0||||||
3679643|NCT02286518|3523689|B14|Drinks a Few Days per Month||Alcohol Classification||Participants|Number|1|1.0||||||
3679644|NCT02286518|3523690|B13|Drinks a Few Days per Month||Alcohol Classification||Participants|Number|0|0.0||||||
3679645|NCT02286518|3523691|B12|Drinks a Few Days per Month||Alcohol Classification||Participants|Number|1|1.0||||||
3679646|NCT02286518|3523692|B11|Drinks a Few Days per Month||Alcohol Classification||Participants|Number|0|0.0||||||
3679647|NCT02286518|3523693|B10|Drinks a Few Days per Month||Alcohol Classification||Participants|Number|0|0.0||||||
3679648|NCT02286518|3523694|B9|Drinks a Few Days per Month||Alcohol Classification||Participants|Number|1|1.0||||||
3679649|NCT02286518|3523695|B8|Drinks a Few Days per Month||Alcohol Classification||Participants|Number|3|3.0||||||
3679650|NCT02286518|3523696|B7|Drinks a Few Days per Month||Alcohol Classification||Participants|Number|0|0.0||||||
3679651|NCT02286518|3523697|B6|Drinks a Few Days per Month||Alcohol Classification||Participants|Number|1|1.0||||||
3679652|NCT02286518|3523698|B5|Drinks a Few Days per Month||Alcohol Classification||Participants|Number|0|0.0||||||
3679653|NCT02286518|3523699|B4|Drinks a Few Days per Month||Alcohol Classification||Participants|Number|1|1.0||||||
3679654|NCT02286518|3523700|B3|Drinks a Few Days per Month||Alcohol Classification||Participants|Number|0|0.0||||||
3679655|NCT02286518|3523701|B2|Drinks a Few Days per Month||Alcohol Classification||Participants|Number|2|2.0||||||
3679656|NCT02286518|3523702|B1|Drinks a Few Days per Month||Alcohol Classification||Participants|Number|2|2.0||||||
3679657|NCT02286518|3523688|B15|Drinks a Few Days per Week||Alcohol Classification||Participants|Number|44|44.0||||||
3679658|NCT02286518|3523689|B14|Drinks a Few Days per Week||Alcohol Classification||Participants|Number|4|4.0||||||
3679659|NCT02286518|3523690|B13|Drinks a Few Days per Week||Alcohol Classification||Participants|Number|5|5.0||||||
3679660|NCT02286518|3523691|B12|Drinks a Few Days per Week||Alcohol Classification||Participants|Number|3|3.0||||||
3679661|NCT02286518|3523692|B11|Drinks a Few Days per Week||Alcohol Classification||Participants|Number|2|2.0||||||
3679662|NCT02286518|3523693|B10|Drinks a Few Days per Week||Alcohol Classification||Participants|Number|1|1.0||||||
3679663|NCT02286518|3523694|B9|Drinks a Few Days per Week||Alcohol Classification||Participants|Number|5|5.0||||||
3679664|NCT02286518|3523695|B8|Drinks a Few Days per Week||Alcohol Classification||Participants|Number|1|1.0||||||
3679665|NCT02286518|3523696|B7|Drinks a Few Days per Week||Alcohol Classification||Participants|Number|4|4.0||||||
3679666|NCT02286518|3523697|B6|Drinks a Few Days per Week||Alcohol Classification||Participants|Number|5|5.0||||||
3679667|NCT02286518|3523698|B5|Drinks a Few Days per Week||Alcohol Classification||Participants|Number|3|3.0||||||
3679668|NCT02286518|3523699|B4|Drinks a Few Days per Week||Alcohol Classification||Participants|Number|3|3.0||||||
3679669|NCT02286518|3523700|B3|Drinks a Few Days per Week||Alcohol Classification||Participants|Number|5|5.0||||||
3679670|NCT02286518|3523701|B2|Drinks a Few Days per Week||Alcohol Classification||Participants|Number|1|1.0||||||
3679671|NCT02286518|3523702|B1|Drinks a Few Days per Week||Alcohol Classification||Participants|Number|2|2.0||||||
3679672|NCT02286518|3523688|B15|Drinks Every Day||Alcohol Classification||Participants|Number|7|7.0||||||
3679673|NCT02286518|3523689|B14|Drinks Every Day||Alcohol Classification||Participants|Number|0|0.0||||||
3679674|NCT02286518|3523690|B13|Drinks Every Day||Alcohol Classification||Participants|Number|1|1.0||||||
3679675|NCT02286518|3523691|B12|Drinks Every Day||Alcohol Classification||Participants|Number|0|0.0||||||
3679676|NCT02286518|3523692|B11|Drinks Every Day||Alcohol Classification||Participants|Number|1|1.0||||||
3679677|NCT02286518|3523693|B10|Drinks Every Day||Alcohol Classification||Participants|Number|0|0.0||||||
3679678|NCT02286518|3523694|B9|Drinks Every Day||Alcohol Classification||Participants|Number|0|0.0||||||
3679679|NCT02286518|3523695|B8|Drinks Every Day||Alcohol Classification||Participants|Number|0|0.0||||||
3679680|NCT02286518|3523696|B7|Drinks Every Day||Alcohol Classification||Participants|Number|0|0.0||||||
3679681|NCT02286518|3523697|B6|Drinks Every Day||Alcohol Classification||Participants|Number|0|0.0||||||
3679682|NCT02286518|3523698|B5|Drinks Every Day||Alcohol Classification||Participants|Number|3|3.0||||||
3679683|NCT02286518|3523699|B4|Drinks Every Day||Alcohol Classification||Participants|Number|0|0.0||||||
3679684|NCT02286518|3523700|B3|Drinks Every Day||Alcohol Classification||Participants|Number|0|0.0||||||
3679685|NCT02286518|3523701|B2|Drinks Every Day||Alcohol Classification||Participants|Number|1|1.0||||||
3679686|NCT02286518|3523702|B1|Drinks Every Day||Alcohol Classification||Participants|Number|1|1.0||||||
3679687|NCT02286518|3523688|B15|Male||Sex/Gender, Customized|All participants enrolled in the study were male.|Participants|Number|82|82.0||||||
3679688|NCT02286518|3523689|B14|Male||Sex/Gender, Customized|All participants enrolled in the study were male.|Participants|Number|6|6.0||||||
3679689|NCT02286518|3523690|B13|Male||Sex/Gender, Customized|All participants enrolled in the study were male.|Participants|Number|6|6.0||||||
3679690|NCT02286518|3523691|B12|Male||Sex/Gender, Customized|All participants enrolled in the study were male.|Participants|Number|6|6.0||||||
3679691|NCT02286518|3523692|B11|Male||Sex/Gender, Customized|All participants enrolled in the study were male.|Participants|Number|6|6.0||||||
3679692|NCT02286518|3523693|B10|Male||Sex/Gender, Customized|All participants enrolled in the study were male.|Participants|Number|4|4.0||||||
3679693|NCT02286518|3523694|B9|Male||Sex/Gender, Customized|All participants enrolled in the study were male.|Participants|Number|6|6.0||||||
3679694|NCT02286518|3523695|B8|Male||Sex/Gender, Customized|All participants enrolled in the study were male.|Participants|Number|6|6.0||||||
3679695|NCT02286518|3523696|B7|Male||Sex/Gender, Customized|All participants enrolled in the study were male.|Participants|Number|6|6.0||||||
3679696|NCT02286518|3523697|B6|Male||Sex/Gender, Customized|All participants enrolled in the study were male.|Participants|Number|6|6.0||||||
3679697|NCT02286518|3523698|B5|Male||Sex/Gender, Customized|All participants enrolled in the study were male.|Participants|Number|6|6.0||||||
3679698|NCT02286518|3523699|B4|Male||Sex/Gender, Customized|All participants enrolled in the study were male.|Participants|Number|6|6.0||||||
3679699|NCT02286518|3523700|B3|Male||Sex/Gender, Customized|All participants enrolled in the study were male.|Participants|Number|6|6.0||||||
3679700|NCT02286518|3523701|B2|Male||Sex/Gender, Customized|All participants enrolled in the study were male.|Participants|Number|6|6.0||||||
3679701|NCT02286518|3523702|B1|Male||Sex/Gender, Customized|All participants enrolled in the study were male.|Participants|Number|6|6.0||||||
3679702|NCT02286518|3523688|B15|Age||Age||Years|Mean|31.3|31.3|Standard Deviation|7.87|7.87|||
3679703|NCT02286518|3523689|B14|Age||Age||Years|Mean|33.2|33.2|Standard Deviation|5.74|5.74|||
3679704|NCT02286518|3523690|B13|Age||Age||Years|Mean|29.3|29.3|Standard Deviation|5.54|5.54|||
3679705|NCT02286518|3523691|B12|Age||Age||Years|Mean|33.7|33.7|Standard Deviation|10.73|10.73|||
3679706|NCT02286518|3523692|B11|Age||Age||Years|Mean|30.3|30.3|Standard Deviation|9.22|9.22|||
3679707|NCT02286518|3523693|B10|Age||Age||Years|Mean|41.0|41.0|Standard Deviation|4.08|4.08|||
3679708|NCT02286518|3523694|B9|Age||Age||Years|Mean|35.3|35.3|Standard Deviation|8.12|8.12|||
3679709|NCT02286518|3523695|B8|Age||Age||Years|Mean|25.5|25.5|Standard Deviation|3.51|3.51|||
3679710|NCT02286518|3523696|B7|Age||Age||Years|Mean|26.3|26.3|Standard Deviation|4.97|4.97|||
3679711|NCT02286518|3523697|B6|Age||Age||Years|Mean|30.3|30.3|Standard Deviation|5.65|5.65|||
3679712|NCT02286518|3523698|B5|Age||Age||Years|Mean|32.0|32.0|Standard Deviation|7.24|7.24|||
3679713|NCT02286518|3523699|B4|Age||Age||Years|Mean|34.2|34.2|Standard Deviation|10.26|10.26|||
3679714|NCT02286518|3523700|B3|Age||Age||Years|Mean|28.3|28.3|Standard Deviation|10.27|10.27|||
3679715|NCT02286518|3523701|B2|Age||Age||Years|Mean|29.8|29.8|Standard Deviation|7.25|7.25|||
3679716|NCT02286518|3523702|B1|Age||Age||Years|Mean|31.5|31.5|Standard Deviation|8.48|8.48|||
3679717|NCT02286466|3523855|B3||Thyroid|Cancer type||Participants|Count of Participants|1|1.0||||||
3679718|NCT02286466|3523856|B2||Thyroid|Cancer type||Participants|Count of Participants|1|1.0||||||
3679719|NCT02286466|3523857|B1||Thyroid|Cancer type||Participants|Count of Participants|0|0.0||||||
3679720|NCT02286466|3523855|B3||Peritoneal|Cancer type||Participants|Count of Participants|3|3.0||||||
3679721|NCT02286466|3523856|B2||Peritoneal|Cancer type||Participants|Count of Participants|0|0.0||||||
3679722|NCT02286466|3523857|B1||Peritoneal|Cancer type||Participants|Count of Participants|3|3.0||||||
3679723|NCT02286466|3523855|B3||Genitourinary|Cancer type||Participants|Count of Participants|7|7.0||||||
3679724|NCT02286466|3523856|B2||Genitourinary|Cancer type||Participants|Count of Participants|5|5.0||||||
3679725|NCT02286466|3523857|B1||Genitourinary|Cancer type||Participants|Count of Participants|2|2.0||||||
3679726|NCT02286466|3523855|B3||Sarcoma|Cancer type||Participants|Count of Participants|14|14.0||||||
3679727|NCT02286466|3523856|B2||Sarcoma|Cancer type||Participants|Count of Participants|7|7.0||||||
3679728|NCT02286466|3523857|B1||Sarcoma|Cancer type||Participants|Count of Participants|7|7.0||||||
3679729|NCT02286466|3523855|B3||Melanoma|Cancer type||Participants|Count of Participants|15|15.0||||||
3679730|NCT02286466|3523856|B2||Melanoma|Cancer type||Participants|Count of Participants|5|5.0||||||
3679731|NCT02286466|3523857|B1||Melanoma|Cancer type||Participants|Count of Participants|10|10.0||||||
3679732|NCT02286466|3523855|B3||Breast|Cancer type||Participants|Count of Participants|16|16.0||||||
3679733|NCT02286466|3523856|B2||Breast|Cancer type||Participants|Count of Participants|8|8.0||||||
3679734|NCT02286466|3523857|B1||Breast|Cancer type||Participants|Count of Participants|8|8.0||||||
3679735|NCT02286466|3523855|B3||Lung|Cancer type||Participants|Count of Participants|24|24.0||||||
3679736|NCT02286466|3523856|B2||Lung|Cancer type||Participants|Count of Participants|15|15.0||||||
3679737|NCT02286466|3523857|B1||Lung|Cancer type||Participants|Count of Participants|9|9.0||||||
3679738|NCT02286466|3523855|B3||Gynecologic|Cancer type||Participants|Count of Participants|24|24.0||||||
3679739|NCT02286466|3523856|B2||Gynecologic|Cancer type||Participants|Count of Participants|14|14.0||||||
3679740|NCT02286466|3523857|B1||Gynecologic|Cancer type||Participants|Count of Participants|10|10.0||||||
3679741|NCT02286466|3523855|B3||Gastrointestinal|Cancer type||Participants|Count of Participants|41|41.0||||||
3679742|NCT02286466|3523856|B2||Gastrointestinal|Cancer type||Participants|Count of Participants|18|18.0||||||
3679743|NCT02286466|3523857|B1||Gastrointestinal|Cancer type||Participants|Count of Participants|23|23.0||||||
3679744|NCT02286466|3523855|B3||ECOG = 2|Eastern Cooperative Oncology Group (ECOG) Performance Status|"Grade 0 -- Asymptomatic (Fully active, able to carry on all pre-disease performance without restriction)~Grade 1 -- Symptomatic but completely ambulatory (Restricted in psychically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g. light house work, office work)~Grade 2 -- Symptomatic, <50% in bed during the day (Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours)~Higher score indicates worse performance status."|Participants|Count of Participants|9|9.0||||||
3679745|NCT02286466|3523856|B2||ECOG = 2|Eastern Cooperative Oncology Group (ECOG) Performance Status|"Grade 0 -- Asymptomatic (Fully active, able to carry on all pre-disease performance without restriction)~Grade 1 -- Symptomatic but completely ambulatory (Restricted in psychically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g. light house work, office work)~Grade 2 -- Symptomatic, <50% in bed during the day (Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours)~Higher score indicates worse performance status."|Participants|Count of Participants|2|2.0||||||
3679773|NCT02286466|3523857|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3679774|NCT02286466|3523855|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3679775|NCT02286466|3523856|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3679746|NCT02286466|3523857|B1||ECOG = 2|Eastern Cooperative Oncology Group (ECOG) Performance Status|"Grade 0 -- Asymptomatic (Fully active, able to carry on all pre-disease performance without restriction)~Grade 1 -- Symptomatic but completely ambulatory (Restricted in psychically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g. light house work, office work)~Grade 2 -- Symptomatic, <50% in bed during the day (Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours)~Higher score indicates worse performance status."|Participants|Count of Participants|7|7.0||||||
3679747|NCT02286466|3523855|B3||ECOG = 1|Eastern Cooperative Oncology Group (ECOG) Performance Status|"Grade 0 -- Asymptomatic (Fully active, able to carry on all pre-disease performance without restriction)~Grade 1 -- Symptomatic but completely ambulatory (Restricted in psychically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g. light house work, office work)~Grade 2 -- Symptomatic, <50% in bed during the day (Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours)~Higher score indicates worse performance status."|Participants|Count of Participants|83|83.0||||||
3679748|NCT02286466|3523856|B2||ECOG = 1|Eastern Cooperative Oncology Group (ECOG) Performance Status|"Grade 0 -- Asymptomatic (Fully active, able to carry on all pre-disease performance without restriction)~Grade 1 -- Symptomatic but completely ambulatory (Restricted in psychically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g. light house work, office work)~Grade 2 -- Symptomatic, <50% in bed during the day (Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours)~Higher score indicates worse performance status."|Participants|Count of Participants|44|44.0||||||
3679749|NCT02286466|3523857|B1||ECOG = 1|Eastern Cooperative Oncology Group (ECOG) Performance Status|"Grade 0 -- Asymptomatic (Fully active, able to carry on all pre-disease performance without restriction)~Grade 1 -- Symptomatic but completely ambulatory (Restricted in psychically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g. light house work, office work)~Grade 2 -- Symptomatic, <50% in bed during the day (Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours)~Higher score indicates worse performance status."|Participants|Count of Participants|39|39.0||||||
3679750|NCT02286466|3523855|B3||ECOG = 0|Eastern Cooperative Oncology Group (ECOG) Performance Status|"Grade 0 -- Asymptomatic (Fully active, able to carry on all pre-disease performance without restriction)~Grade 1 -- Symptomatic but completely ambulatory (Restricted in psychically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g. light house work, office work)~Grade 2 -- Symptomatic, <50% in bed during the day (Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours)~Higher score indicates worse performance status."|Participants|Count of Participants|53|53.0||||||
3679751|NCT02286466|3523856|B2||ECOG = 0|Eastern Cooperative Oncology Group (ECOG) Performance Status|"Grade 0 -- Asymptomatic (Fully active, able to carry on all pre-disease performance without restriction)~Grade 1 -- Symptomatic but completely ambulatory (Restricted in psychically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g. light house work, office work)~Grade 2 -- Symptomatic, <50% in bed during the day (Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours)~Higher score indicates worse performance status."|Participants|Count of Participants|27|27.0||||||
3679752|NCT02286466|3523857|B1||ECOG = 0|Eastern Cooperative Oncology Group (ECOG) Performance Status|"Grade 0 -- Asymptomatic (Fully active, able to carry on all pre-disease performance without restriction)~Grade 1 -- Symptomatic but completely ambulatory (Restricted in psychically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g. light house work, office work)~Grade 2 -- Symptomatic, <50% in bed during the day (Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours)~Higher score indicates worse performance status."|Participants|Count of Participants|26|26.0||||||
3679753|NCT02286466|3523855|B3|Race|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3679754|NCT02286466|3523856|B2|Race|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3679755|NCT02286466|3523857|B1|Race|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3679756|NCT02286466|3523855|B3|Race|Multiracial|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3679757|NCT02286466|3523856|B2|Race|Multiracial|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3679758|NCT02286466|3523857|B1|Race|Multiracial|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3679759|NCT02286466|3523855|B3|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3679760|NCT02286466|3523856|B2|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3679761|NCT02286466|3523857|B1|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3679762|NCT02286466|3523855|B3|Race|African American or Black|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3679763|NCT02286466|3523856|B2|Race|African American or Black|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3679764|NCT02286466|3523857|B1|Race|African American or Black|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3679765|NCT02286466|3523855|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|132|132.0||||||
3679766|NCT02286466|3523856|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|65|65.0||||||
3679767|NCT02286466|3523857|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|67|67.0||||||
3679768|NCT02286466|3523855|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3679769|NCT02286466|3523856|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3679770|NCT02286466|3523857|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3679771|NCT02286466|3523855|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|133|133.0||||||
3679772|NCT02286466|3523856|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3679776|NCT02286466|3523857|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3679777|NCT02286466|3523855|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3679778|NCT02286466|3523856|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3679779|NCT02286466|3523857|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3679780|NCT02286466|3523855|B3||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3679781|NCT02286466|3523856|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3679782|NCT02286466|3523857|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3679783|NCT02286466|3523855|B3|||Age||years|Mean|56.45|56.45|Standard Deviation|11.30|11.3|||
3679784|NCT02286466|3523856|B2|||Age||years|Mean|57.03|57.03|Standard Deviation|12.42|12.42|||
3679785|NCT02286466|3523857|B1|||Age||years|Mean|55.86|55.86|Standard Deviation|10.08|10.08|||
3679786|NCT02286193|3523870|B1|Unknown||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3679787|NCT02286193|3523870|B1|Other||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3679788|NCT02286193|3523870|B1|White||Race/Ethnicity, Customized||participants|Number|228|228.0||||||
3679789|NCT02286193|3523870|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3679790|NCT02286193|3523870|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
3679791|NCT02286193|3523870|B1|Asian||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
3679792|NCT02286193|3523870|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3679793|NCT02286193|3523870|B1||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3679794|NCT02286193|3523870|B1||Female|Sex: Female, Male||Participants|Count of Participants|305|305.0||||||
3679795|NCT02286193|3523870|B1|65 or older||Age, Customized||participants|Number|145|145.0||||||
3679796|NCT02286193|3523870|B1|35 - 64||Age, Customized||participants|Number|165|165.0||||||
3679797|NCT02286193|3523870|B1|19 - 34||Age, Customized||participants|Number|38|38.0||||||
3679798|NCT02286193|3523870|B1|Less than or equal to 18||Age, Customized||participants|Number|70|70.0||||||
3679799|NCT02286102|3523875|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3679800|NCT02286102|3523876|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3679801|NCT02286102|3523877|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3679802|NCT02286102|3523875|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3679803|NCT02286102|3523876|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3679804|NCT02286102|3523877|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3679805|NCT02286102|3523875|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3679806|NCT02286102|3523876|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3679807|NCT02286102|3523877|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3679808|NCT02286102|3523875|B3||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
3679809|NCT02286102|3523876|B2||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3679810|NCT02286102|3523877|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3679811|NCT02286102|3523875|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3679812|NCT02286102|3523876|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3679813|NCT02286102|3523877|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3679814|NCT02285998|3523888|B3||Male|Sex: Female, Male||Participants|Count of Participants|3603|3603.0||||||
3679815|NCT02285998|3523889|B2||Male|Sex: Female, Male||Participants|Count of Participants|1807|1807.0||||||
3679816|NCT02285998|3523890|B1||Male|Sex: Female, Male||Participants|Count of Participants|1796|1796.0||||||
3679817|NCT02285998|3523888|B3||Female|Sex: Female, Male||Participants|Count of Participants|5069|5069.0||||||
3679818|NCT02285998|3523889|B2||Female|Sex: Female, Male||Participants|Count of Participants|2537|2537.0||||||
3679819|NCT02285998|3523890|B1||Female|Sex: Female, Male||Participants|Count of Participants|2532|2532.0||||||
3679820|NCT02285998|3523888|B3|75 years and older||Age, Customized||participants|Number|998|998.0||||||
3679821|NCT02285998|3523889|B2|75 years and older||Age, Customized||participants|Number|473|473.0||||||
3679822|NCT02285998|3523890|B1|75 years and older||Age, Customized||participants|Number|525|525.0||||||
3679823|NCT02285998|3523888|B3|65-74 years||Age, Customized||participants|Number|2488|2488.0||||||
3679824|NCT02285998|3523889|B2|65-74 years||Age, Customized||participants|Number|1254|1254.0||||||
3679825|NCT02285998|3523890|B1|65-74 years||Age, Customized||participants|Number|1234|1234.0||||||
3679826|NCT02285998|3523888|B3|50-64 years||Age, Customized||participants|Number|5186|5186.0||||||
3679827|NCT02285998|3523889|B2|50-64 years||Age, Customized||participants|Number|2617|2617.0||||||
3679828|NCT02285998|3523890|B1|50-64 years||Age, Customized||participants|Number|2569|2569.0||||||
3679829|NCT02285907|3523915|B1|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3679830|NCT02285907|3523915|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3679831|NCT02285907|3523915|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3679832|NCT02285907|3523915|B1|||Age||years|Mean|23|23.0|Standard Deviation|1|1.0|||
3679833|NCT02285907|3523915|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3679834|NCT02285907|3523915|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3679835|NCT02285907|3523915|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3679836|NCT02285777|3523941|B3|OTHER||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3679837|NCT02285777|3523942|B2|OTHER||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3679838|NCT02285777|3523943|B1|OTHER||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3679839|NCT02285777|3523941|B3|WHITE||Race/Ethnicity, Customized||Participants|Count of Participants|140|140.0||||||
3679840|NCT02285777|3523942|B2|WHITE||Race/Ethnicity, Customized||Participants|Count of Participants|66|66.0||||||
3679841|NCT02285777|3523943|B1|WHITE||Race/Ethnicity, Customized||Participants|Count of Participants|74|74.0||||||
3679842|NCT02285777|3523941|B3|NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3679843|NCT02285777|3523942|B2|NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3679844|NCT02285777|3523943|B1|NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3679845|NCT02285777|3523941|B3|BLACK OR AFRICAN AMERICAN||Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
3679846|NCT02285777|3523942|B2|BLACK OR AFRICAN AMERICAN||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3679847|NCT02285777|3523943|B1|BLACK OR AFRICAN AMERICAN||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3679848|NCT02285777|3523941|B3|ASIAN||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3679849|NCT02285777|3523942|B2|ASIAN||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3679850|NCT02285777|3523943|B1|ASIAN||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3679851|NCT02285777|3523941|B3|AMERICAN INDIAN OR ALASKA NATIVE||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3679852|NCT02285777|3523942|B2|AMERICAN INDIAN OR ALASKA NATIVE||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3679853|NCT02285777|3523943|B1|AMERICAN INDIAN OR ALASKA NATIVE||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3679854|NCT02285777|3523941|B3||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3679855|NCT02285777|3523942|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3679856|NCT02285777|3523943|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3679857|NCT02285777|3523941|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3679858|NCT02285777|3523942|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3679859|NCT02285777|3523943|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3679860|NCT02285777|3523941|B3|||Age||Years|Mean|12.6|12.6|Standard Deviation|2.38|2.38|||
3679861|NCT02285777|3523942|B2|||Age||Years|Mean|12.4|12.4|Standard Deviation|2.4|2.4|||
3679862|NCT02285777|3523943|B1|||Age||Years|Mean|12.8|12.8|Standard Deviation|2.36|2.36|||
3679863|NCT02285634|3523996|B5|United States||Region of Enrollment||participants|Number|63|63.0||||||
3679864|NCT02285634|3523997|B4|United States||Region of Enrollment||participants|Number|17|17.0||||||
3679865|NCT02285634|3523998|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3679866|NCT02285634|3523999|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3679867|NCT02285634|3524000|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3679868|NCT02285634|3523996|B5|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3679869|NCT02285634|3523996|B5||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3679870|NCT02285634|3523997|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3679871|NCT02285634|3523998|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3679872|NCT02285634|3523999|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3679873|NCT02285634|3524000|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3679874|NCT02285634|3523996|B5||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3679875|NCT02285634|3523997|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3679876|NCT02285634|3523998|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3679877|NCT02285634|3523999|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3679878|NCT02285634|3524000|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3679879|NCT02285634|3523996|B5|||Age||years|Mean|36.0|36.0|Standard Deviation|14.4|14.4|||
3679880|NCT02285634|3523997|B4|||Age||years|Mean|31.2|31.2|Standard Deviation|10.1|10.1|||
3679881|NCT02285634|3523998|B3|||Age||years|Mean|38.6|38.6|Standard Deviation|15.7|15.7|||
3679882|NCT02285634|3523999|B2|||Age||years|Mean|40.0|40.0|Standard Deviation|16.8|16.8|||
3679883|NCT02285634|3524000|B1|||Age||years|Mean|34.5|34.5|Standard Deviation|15.0|15.0|||
3679884|NCT02285270|3524025|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3679885|NCT02285270|3524025|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3679886|NCT02285270|3524025|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3679887|NCT02285270|3524025|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3679888|NCT02285270|3524025|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3679889|NCT02285270|3524025|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3679890|NCT02285270|3524025|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3679891|NCT02285270|3524025|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3679892|NCT02285270|3524025|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3679893|NCT02285270|3524025|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3679894|NCT02285270|3524025|B1||Male|Gender||Participants|Count of Participants|10|10.0||||||
3679895|NCT02285270|3524025|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3679896|NCT02285270|3524025|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3679897|NCT02285270|3524025|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3679898|NCT02285270|3524025|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3679899|NCT02284893|3524031|B3|Central America||Region of Enrollment||participants|Number|88|88.0||||||
3679900|NCT02284893|3524032|B2|Central America||Region of Enrollment||participants|Number|42|42.0||||||
3679901|NCT02284893|3524033|B1|Central America||Region of Enrollment||participants|Number|46|46.0||||||
3679902|NCT02284893|3524031|B3|North America||Region of Enrollment||participants|Number|227|227.0||||||
3679903|NCT02284893|3524032|B2|North America||Region of Enrollment||participants|Number|113|113.0||||||
3679904|NCT02284893|3524033|B1|North America||Region of Enrollment||participants|Number|114|114.0||||||
3679905|NCT02284893|3524031|B3|Europe||Region of Enrollment||participants|Number|146|146.0||||||
3679906|NCT02284893|3524032|B2|Europe||Region of Enrollment||participants|Number|74|74.0||||||
3679907|NCT02284893|3524033|B1|Europe||Region of Enrollment||participants|Number|72|72.0||||||
3679908|NCT02284893|3524031|B3||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
3679909|NCT02284893|3524032|B2||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3679910|NCT02284893|3524033|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3679911|NCT02284893|3524031|B3||Female|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
3679912|NCT02284893|3524032|B2||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3679913|NCT02284893|3524033|B1||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3679914|NCT02284893|3524031|B3|||Age||years|Mean|55.9|55.9|Standard Deviation|9.21|9.21|||
3679915|NCT02284893|3524032|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|9.55|9.55|||
3679916|NCT02284893|3524033|B1|||Age||years|Mean|55.9|55.9|Standard Deviation|8.87|8.87|||
3679917|NCT02284880|3524046|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3679918|NCT02284880|3524047|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3679919|NCT02284880|3524048|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3679920|NCT02284880|3524046|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3679921|NCT02284880|3524047|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3679922|NCT02284880|3524048|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3679923|NCT02284880|3524046|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3679924|NCT02284880|3524047|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3679925|NCT02284880|3524048|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3679926|NCT02284880|3524046|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3679927|NCT02284880|3524047|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3679928|NCT02284880|3524048|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3679929|NCT02284880|3524046|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3679930|NCT02284880|3524047|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3679931|NCT02284880|3524048|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3679932|NCT02284867|3524065|B3|||Body Mass Index||Kg/M^2|Mean|21.7|21.7|Standard Deviation|2.4|2.4|||
3679933|NCT02284867|3524066|B2|||Body Mass Index||Kg/M^2|Mean|21.8|21.8|Standard Deviation|2.3|2.3|||
3679934|NCT02284867|3524067|B1|||Body Mass Index||Kg/M^2|Mean|21.7|21.7|Standard Deviation|2.3|2.3|||
3679935|NCT02284867|3524065|B3|||Parity||live birth|Median|1|1.0|Inter-Quartile Range|||0.0|2.0|
3679936|NCT02284867|3524066|B2|||Parity||live birth|Median|2|2.0|Inter-Quartile Range|||1.0|2.0|
3679937|NCT02284867|3524067|B1|||Parity||live birth|Median|1|1.0|Inter-Quartile Range|||0.0|1.0|
3679938|NCT02284867|3524065|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3679939|NCT02284867|3524066|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3679940|NCT02284867|3524067|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3679941|NCT02284867|3524065|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3679942|NCT02284867|3524066|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3679943|NCT02284867|3524067|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3679944|NCT02284867|3524065|B3|||Age||years|Mean|26.1|26.1|Standard Deviation|4|4.0|||
3679945|NCT02284867|3524066|B2|||Age||years|Mean|26.4|26.4|Standard Deviation|3.9|3.9|||
3679946|NCT02284867|3524067|B1|||Age||years|Mean|25.8|25.8|Standard Deviation|4|4.0|||
3679947|NCT02284854|3524076|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3679948|NCT02284854|3524077|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3679949|NCT02284854|3524078|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3679950|NCT02284854|3524076|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3679951|NCT02284854|3524077|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3679952|NCT02284854|3524078|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3679953|NCT02284854|3524076|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3679954|NCT02284854|3524077|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3679955|NCT02284854|3524078|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3679956|NCT02284854|3524076|B3||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
3679957|NCT02284854|3524077|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3679958|NCT02284854|3524078|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3679959|NCT02284854|3524076|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3679960|NCT02284854|3524077|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3679961|NCT02284854|3524078|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3679962|NCT02284828|3524096|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3679963|NCT02284828|3524096|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3679964|NCT02284828|3524096|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3679965|NCT02284828|3524096|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3679966|NCT02284828|3524096|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3679967|NCT02284568|3524108|B4||EDSS score 6.5|Expanded Disability Status Scale (EDSS)|EDSS is a method of quantifying disability in multiple sclerosis and monitoring changes in the level of disability over time. The EDSS scale ranges from 0 to 10 in 0.5 unit increments with 0=no disability and 10=death due to MS. Only an Examining Neurologist administered the EDSS. The Examining Neurologist did not have access to the patient’s medical records or source documents, including previous EDSS forms or adverse events.|Participants|Count of Participants|10|10.0||||||
3679968|NCT02284568|3524109|B3||EDSS score 6.5|Expanded Disability Status Scale (EDSS)|EDSS is a method of quantifying disability in multiple sclerosis and monitoring changes in the level of disability over time. The EDSS scale ranges from 0 to 10 in 0.5 unit increments with 0=no disability and 10=death due to MS. Only an Examining Neurologist administered the EDSS. The Examining Neurologist did not have access to the patient’s medical records or source documents, including previous EDSS forms or adverse events.|Participants|Count of Participants|4|4.0||||||
3679969|NCT02284568|3524110|B2||EDSS score 6.5|Expanded Disability Status Scale (EDSS)|EDSS is a method of quantifying disability in multiple sclerosis and monitoring changes in the level of disability over time. The EDSS scale ranges from 0 to 10 in 0.5 unit increments with 0=no disability and 10=death due to MS. Only an Examining Neurologist administered the EDSS. The Examining Neurologist did not have access to the patient’s medical records or source documents, including previous EDSS forms or adverse events.|Participants|Count of Participants|3|3.0||||||
3679970|NCT02284568|3524111|B1||EDSS score 6.5|Expanded Disability Status Scale (EDSS)|EDSS is a method of quantifying disability in multiple sclerosis and monitoring changes in the level of disability over time. The EDSS scale ranges from 0 to 10 in 0.5 unit increments with 0=no disability and 10=death due to MS. Only an Examining Neurologist administered the EDSS. The Examining Neurologist did not have access to the patient’s medical records or source documents, including previous EDSS forms or adverse events.|Participants|Count of Participants|3|3.0||||||
3679971|NCT02284568|3524108|B4||EDSS score 6|Expanded Disability Status Scale (EDSS)|EDSS is a method of quantifying disability in multiple sclerosis and monitoring changes in the level of disability over time. The EDSS scale ranges from 0 to 10 in 0.5 unit increments with 0=no disability and 10=death due to MS. Only an Examining Neurologist administered the EDSS. The Examining Neurologist did not have access to the patient’s medical records or source documents, including previous EDSS forms or adverse events.|Participants|Count of Participants|25|25.0||||||
3679972|NCT02284568|3524109|B3||EDSS score 6|Expanded Disability Status Scale (EDSS)|EDSS is a method of quantifying disability in multiple sclerosis and monitoring changes in the level of disability over time. The EDSS scale ranges from 0 to 10 in 0.5 unit increments with 0=no disability and 10=death due to MS. Only an Examining Neurologist administered the EDSS. The Examining Neurologist did not have access to the patient’s medical records or source documents, including previous EDSS forms or adverse events.|Participants|Count of Participants|4|4.0||||||
3679973|NCT02284568|3524110|B2||EDSS score 6|Expanded Disability Status Scale (EDSS)|EDSS is a method of quantifying disability in multiple sclerosis and monitoring changes in the level of disability over time. The EDSS scale ranges from 0 to 10 in 0.5 unit increments with 0=no disability and 10=death due to MS. Only an Examining Neurologist administered the EDSS. The Examining Neurologist did not have access to the patient’s medical records or source documents, including previous EDSS forms or adverse events.|Participants|Count of Participants|12|12.0||||||
3679974|NCT02284568|3524111|B1||EDSS score 6|Expanded Disability Status Scale (EDSS)|EDSS is a method of quantifying disability in multiple sclerosis and monitoring changes in the level of disability over time. The EDSS scale ranges from 0 to 10 in 0.5 unit increments with 0=no disability and 10=death due to MS. Only an Examining Neurologist administered the EDSS. The Examining Neurologist did not have access to the patient’s medical records or source documents, including previous EDSS forms or adverse events.|Participants|Count of Participants|9|9.0||||||
3679975|NCT02284568|3524108|B4||EDSS score 5.5|Expanded Disability Status Scale (EDSS)|EDSS is a method of quantifying disability in multiple sclerosis and monitoring changes in the level of disability over time. The EDSS scale ranges from 0 to 10 in 0.5 unit increments with 0=no disability and 10=death due to MS. Only an Examining Neurologist administered the EDSS. The Examining Neurologist did not have access to the patient’s medical records or source documents, including previous EDSS forms or adverse events.|Participants|Count of Participants|63|63.0||||||
3679976|NCT02284568|3524109|B3||EDSS score 5.5|Expanded Disability Status Scale (EDSS)|EDSS is a method of quantifying disability in multiple sclerosis and monitoring changes in the level of disability over time. The EDSS scale ranges from 0 to 10 in 0.5 unit increments with 0=no disability and 10=death due to MS. Only an Examining Neurologist administered the EDSS. The Examining Neurologist did not have access to the patient’s medical records or source documents, including previous EDSS forms or adverse events.|Participants|Count of Participants|16|16.0||||||
3679977|NCT02284568|3524110|B2||EDSS score 5.5|Expanded Disability Status Scale (EDSS)|EDSS is a method of quantifying disability in multiple sclerosis and monitoring changes in the level of disability over time. The EDSS scale ranges from 0 to 10 in 0.5 unit increments with 0=no disability and 10=death due to MS. Only an Examining Neurologist administered the EDSS. The Examining Neurologist did not have access to the patient’s medical records or source documents, including previous EDSS forms or adverse events.|Participants|Count of Participants|23|23.0||||||
3680019|NCT02284568|3524108|B4|||Weight||kg|Mean|74.57|74.57|Standard Deviation|16.275|16.275|||
3680020|NCT02284568|3524109|B3|||Weight||kg|Mean|73.47|73.47|Standard Deviation|14.831|14.831|||
3680021|NCT02284568|3524110|B2|||Weight||kg|Mean|75.91|75.91|Standard Deviation|16.668|16.668|||
3679978|NCT02284568|3524111|B1||EDSS score 5.5|Expanded Disability Status Scale (EDSS)|EDSS is a method of quantifying disability in multiple sclerosis and monitoring changes in the level of disability over time. The EDSS scale ranges from 0 to 10 in 0.5 unit increments with 0=no disability and 10=death due to MS. Only an Examining Neurologist administered the EDSS. The Examining Neurologist did not have access to the patient’s medical records or source documents, including previous EDSS forms or adverse events.|Participants|Count of Participants|24|24.0||||||
3679979|NCT02284568|3524108|B4||EDSS score 5|Expanded Disability Status Scale (EDSS)|EDSS is a method of quantifying disability in multiple sclerosis and monitoring changes in the level of disability over time. The EDSS scale ranges from 0 to 10 in 0.5 unit increments with 0=no disability and 10=death due to MS. Only an Examining Neurologist administered the EDSS. The Examining Neurologist did not have access to the patient’s medical records or source documents, including previous EDSS forms or adverse events.|Participants|Count of Participants|38|38.0||||||
3679980|NCT02284568|3524109|B3||EDSS score 5|Expanded Disability Status Scale (EDSS)|EDSS is a method of quantifying disability in multiple sclerosis and monitoring changes in the level of disability over time. The EDSS scale ranges from 0 to 10 in 0.5 unit increments with 0=no disability and 10=death due to MS. Only an Examining Neurologist administered the EDSS. The Examining Neurologist did not have access to the patient’s medical records or source documents, including previous EDSS forms or adverse events.|Participants|Count of Participants|6|6.0||||||
3679981|NCT02284568|3524110|B2||EDSS score 5|Expanded Disability Status Scale (EDSS)|EDSS is a method of quantifying disability in multiple sclerosis and monitoring changes in the level of disability over time. The EDSS scale ranges from 0 to 10 in 0.5 unit increments with 0=no disability and 10=death due to MS. Only an Examining Neurologist administered the EDSS. The Examining Neurologist did not have access to the patient’s medical records or source documents, including previous EDSS forms or adverse events.|Participants|Count of Participants|15|15.0||||||
3679982|NCT02284568|3524111|B1||EDSS score 5|Expanded Disability Status Scale (EDSS)|EDSS is a method of quantifying disability in multiple sclerosis and monitoring changes in the level of disability over time. The EDSS scale ranges from 0 to 10 in 0.5 unit increments with 0=no disability and 10=death due to MS. Only an Examining Neurologist administered the EDSS. The Examining Neurologist did not have access to the patient’s medical records or source documents, including previous EDSS forms or adverse events.|Participants|Count of Participants|17|17.0||||||
3679983|NCT02284568|3524108|B4||EDSS score 4.5|Expanded Disability Status Scale (EDSS)|EDSS is a method of quantifying disability in multiple sclerosis and monitoring changes in the level of disability over time. The EDSS scale ranges from 0 to 10 in 0.5 unit increments with 0=no disability and 10=death due to MS. Only an Examining Neurologist administered the EDSS. The Examining Neurologist did not have access to the patient’s medical records or source documents, including previous EDSS forms or adverse events.|Participants|Count of Participants|62|62.0||||||
3679984|NCT02284568|3524109|B3||EDSS score 4.5|Expanded Disability Status Scale (EDSS)|EDSS is a method of quantifying disability in multiple sclerosis and monitoring changes in the level of disability over time. The EDSS scale ranges from 0 to 10 in 0.5 unit increments with 0=no disability and 10=death due to MS. Only an Examining Neurologist administered the EDSS. The Examining Neurologist did not have access to the patient’s medical records or source documents, including previous EDSS forms or adverse events.|Participants|Count of Participants|17|17.0||||||
3679985|NCT02284568|3524110|B2||EDSS score 4.5|Expanded Disability Status Scale (EDSS)|EDSS is a method of quantifying disability in multiple sclerosis and monitoring changes in the level of disability over time. The EDSS scale ranges from 0 to 10 in 0.5 unit increments with 0=no disability and 10=death due to MS. Only an Examining Neurologist administered the EDSS. The Examining Neurologist did not have access to the patient’s medical records or source documents, including previous EDSS forms or adverse events.|Participants|Count of Participants|19|19.0||||||
3679986|NCT02284568|3524111|B1||EDSS score 4.5|Expanded Disability Status Scale (EDSS)|EDSS is a method of quantifying disability in multiple sclerosis and monitoring changes in the level of disability over time. The EDSS scale ranges from 0 to 10 in 0.5 unit increments with 0=no disability and 10=death due to MS. Only an Examining Neurologist administered the EDSS. The Examining Neurologist did not have access to the patient’s medical records or source documents, including previous EDSS forms or adverse events.|Participants|Count of Participants|26|26.0||||||
3679987|NCT02284568|3524108|B4||EDSS score 4|Expanded Disability Status Scale (EDSS)|EDSS is a method of quantifying disability in multiple sclerosis and monitoring changes in the level of disability over time. The EDSS scale ranges from 0 to 10 in 0.5 unit increments with 0=no disability and 10=death due to MS. Only an Examining Neurologist administered the EDSS. The Examining Neurologist did not have access to the patient’s medical records or source documents, including previous EDSS forms or adverse events.|Participants|Count of Participants|72|72.0||||||
3679988|NCT02284568|3524109|B3||EDSS score 4|Expanded Disability Status Scale (EDSS)|EDSS is a method of quantifying disability in multiple sclerosis and monitoring changes in the level of disability over time. The EDSS scale ranges from 0 to 10 in 0.5 unit increments with 0=no disability and 10=death due to MS. Only an Examining Neurologist administered the EDSS. The Examining Neurologist did not have access to the patient’s medical records or source documents, including previous EDSS forms or adverse events.|Participants|Count of Participants|18|18.0||||||
3679989|NCT02284568|3524110|B2||EDSS score 4|Expanded Disability Status Scale (EDSS)|EDSS is a method of quantifying disability in multiple sclerosis and monitoring changes in the level of disability over time. The EDSS scale ranges from 0 to 10 in 0.5 unit increments with 0=no disability and 10=death due to MS. Only an Examining Neurologist administered the EDSS. The Examining Neurologist did not have access to the patient’s medical records or source documents, including previous EDSS forms or adverse events.|Participants|Count of Participants|30|30.0||||||
3679990|NCT02284568|3524111|B1||EDSS score 4|Expanded Disability Status Scale (EDSS)|EDSS is a method of quantifying disability in multiple sclerosis and monitoring changes in the level of disability over time. The EDSS scale ranges from 0 to 10 in 0.5 unit increments with 0=no disability and 10=death due to MS. Only an Examining Neurologist administered the EDSS. The Examining Neurologist did not have access to the patient’s medical records or source documents, including previous EDSS forms or adverse events.|Participants|Count of Participants|24|24.0||||||
3680022|NCT02284568|3524111|B1|||Weight||kg|Mean|73.97|73.97|Standard Deviation|16.809|16.809|||
3680023|NCT02284568|3524108|B4||Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3679991|NCT02284568|3524108|B4||EDSS score 3.5|Expanded Disability Status Scale (EDSS)|EDSS is a method of quantifying disability in multiple sclerosis and monitoring changes in the level of disability over time. The EDSS scale ranges from 0 to 10 in 0.5 unit increments with 0=no disability and 10=death due to MS. Only an Examining Neurologist administered the EDSS. The Examining Neurologist did not have access to the patient’s medical records or source documents, including previous EDSS forms or adverse events.|Participants|Count of Participants|72|72.0||||||
3679992|NCT02284568|3524109|B3||EDSS score 3.5|Expanded Disability Status Scale (EDSS)|EDSS is a method of quantifying disability in multiple sclerosis and monitoring changes in the level of disability over time. The EDSS scale ranges from 0 to 10 in 0.5 unit increments with 0=no disability and 10=death due to MS. Only an Examining Neurologist administered the EDSS. The Examining Neurologist did not have access to the patient’s medical records or source documents, including previous EDSS forms or adverse events.|Participants|Count of Participants|20|20.0||||||
3679993|NCT02284568|3524110|B2||EDSS score 3.5|Expanded Disability Status Scale (EDSS)|EDSS is a method of quantifying disability in multiple sclerosis and monitoring changes in the level of disability over time. The EDSS scale ranges from 0 to 10 in 0.5 unit increments with 0=no disability and 10=death due to MS. Only an Examining Neurologist administered the EDSS. The Examining Neurologist did not have access to the patient’s medical records or source documents, including previous EDSS forms or adverse events.|Participants|Count of Participants|25|25.0||||||
3679994|NCT02284568|3524111|B1||EDSS score 3.5|Expanded Disability Status Scale (EDSS)|EDSS is a method of quantifying disability in multiple sclerosis and monitoring changes in the level of disability over time. The EDSS scale ranges from 0 to 10 in 0.5 unit increments with 0=no disability and 10=death due to MS. Only an Examining Neurologist administered the EDSS. The Examining Neurologist did not have access to the patient’s medical records or source documents, including previous EDSS forms or adverse events.|Participants|Count of Participants|27|27.0||||||
3679995|NCT02284568|3524108|B4||EDSS score 3|Expanded Disability Status Scale (EDSS)|EDSS is a method of quantifying disability in multiple sclerosis and monitoring changes in the level of disability over time. The EDSS scale ranges from 0 to 10 in 0.5 unit increments with 0=no disability and 10=death due to MS. Only an Examining Neurologist administered the EDSS. The Examining Neurologist did not have access to the patient’s medical records or source documents, including previous EDSS forms or adverse events.|Participants|Count of Participants|32|32.0||||||
3679996|NCT02284568|3524109|B3||EDSS score 3|Expanded Disability Status Scale (EDSS)|EDSS is a method of quantifying disability in multiple sclerosis and monitoring changes in the level of disability over time. The EDSS scale ranges from 0 to 10 in 0.5 unit increments with 0=no disability and 10=death due to MS. Only an Examining Neurologist administered the EDSS. The Examining Neurologist did not have access to the patient’s medical records or source documents, including previous EDSS forms or adverse events.|Participants|Count of Participants|10|10.0||||||
3679997|NCT02284568|3524110|B2||EDSS score 3|Expanded Disability Status Scale (EDSS)|EDSS is a method of quantifying disability in multiple sclerosis and monitoring changes in the level of disability over time. The EDSS scale ranges from 0 to 10 in 0.5 unit increments with 0=no disability and 10=death due to MS. Only an Examining Neurologist administered the EDSS. The Examining Neurologist did not have access to the patient’s medical records or source documents, including previous EDSS forms or adverse events.|Participants|Count of Participants|12|12.0||||||
3679998|NCT02284568|3524111|B1||EDSS score 3|Expanded Disability Status Scale (EDSS)|EDSS is a method of quantifying disability in multiple sclerosis and monitoring changes in the level of disability over time. The EDSS scale ranges from 0 to 10 in 0.5 unit increments with 0=no disability and 10=death due to MS. Only an Examining Neurologist administered the EDSS. The Examining Neurologist did not have access to the patient’s medical records or source documents, including previous EDSS forms or adverse events.|Participants|Count of Participants|10|10.0||||||
3679999|NCT02284568|3524108|B4|||Normalized Brain Volume|Obtained from magnetic resonance imaging (MRI) scans|mL|Mean|1458.5|1458.5|Standard Deviation|102.69|102.69|||
3680000|NCT02284568|3524109|B3|||Normalized Brain Volume|Obtained from magnetic resonance imaging (MRI) scans|mL|Mean|1455.2|1455.2|Standard Deviation|101.44|101.44|||
3680001|NCT02284568|3524110|B2|||Normalized Brain Volume|Obtained from magnetic resonance imaging (MRI) scans|mL|Mean|1461.3|1461.3|Standard Deviation|96.63|96.63|||
3680002|NCT02284568|3524111|B1|||Normalized Brain Volume|Obtained from magnetic resonance imaging (MRI) scans|mL|Mean|1457.9|1457.9|Standard Deviation|109.78|109.78|||
3680003|NCT02284568|3524108|B4|||Time Since First PPMS Diagnosis|Primary progressive multiple sclerosis (PPMS)|years|Mean|3.7|3.7|Standard Deviation|3.70|3.7|||
3680004|NCT02284568|3524109|B3|||Time Since First PPMS Diagnosis|Primary progressive multiple sclerosis (PPMS)|years|Mean|4.1|4.1|Standard Deviation|4.04|4.04|||
3680005|NCT02284568|3524110|B2|||Time Since First PPMS Diagnosis|Primary progressive multiple sclerosis (PPMS)|years|Mean|4.0|4.0|Standard Deviation|4.05|4.05|||
3680006|NCT02284568|3524111|B1|||Time Since First PPMS Diagnosis|Primary progressive multiple sclerosis (PPMS)|years|Mean|3.1|3.1|Standard Deviation|2.98|2.98|||
3680007|NCT02284568|3524108|B4|||Time Since First MS Symptom|Multiple sclerosis (MS)|years|Mean|8.0|8.0|Standard Deviation|5.76|5.76|||
3680008|NCT02284568|3524109|B3|||Time Since First MS Symptom|Multiple sclerosis (MS)|years|Mean|8.5|8.5|Standard Deviation|5.61|5.61|||
3680009|NCT02284568|3524110|B2|||Time Since First MS Symptom|Multiple sclerosis (MS)|years|Mean|8.3|8.3|Standard Deviation|6.33|6.33|||
3680010|NCT02284568|3524111|B1|||Time Since First MS Symptom|Multiple sclerosis (MS)|years|Mean|7.4|7.4|Standard Deviation|5.22|5.22|||
3680011|NCT02284568|3524108|B4|||Body Mass Index||kg/m^2|Mean|25.196|25.196|Standard Deviation|4.6208|4.6208|||
3680012|NCT02284568|3524109|B3|||Body Mass Index||kg/m^2|Mean|25.026|25.026|Standard Deviation|4.1002|4.1002|||
3680013|NCT02284568|3524110|B2|||Body Mass Index||kg/m^2|Mean|25.373|25.373|Standard Deviation|4.5539|4.5539|||
3680014|NCT02284568|3524111|B1|||Body Mass Index||kg/m^2|Mean|25.136|25.136|Standard Deviation|5.0283|5.0283|||
3680015|NCT02284568|3524108|B4|||Height||cm|Mean|171.70|171.7|Standard Deviation|9.573|9.573|||
3680016|NCT02284568|3524109|B3|||Height||cm|Mean|171.03|171.03|Standard Deviation|9.677|9.677|||
3680017|NCT02284568|3524110|B2|||Height||cm|Mean|172.61|172.61|Standard Deviation|9.246|9.246|||
3680018|NCT02284568|3524111|B1|||Height||cm|Mean|171.25|171.25|Standard Deviation|9.818|9.818|||
3680024|NCT02284568|3524109|B3||Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3680025|NCT02284568|3524110|B2||Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3680026|NCT02284568|3524111|B1||Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3680027|NCT02284568|3524108|B4||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3680028|NCT02284568|3524109|B3||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3680029|NCT02284568|3524110|B2||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3680030|NCT02284568|3524111|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3680031|NCT02284568|3524108|B4||Not HIspanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|360|360.0||||||
3680032|NCT02284568|3524109|B3||Not HIspanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|91|91.0||||||
3680033|NCT02284568|3524110|B2||Not HIspanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|134|134.0||||||
3680034|NCT02284568|3524111|B1||Not HIspanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|135|135.0||||||
3680035|NCT02284568|3524108|B4||Other|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3680036|NCT02284568|3524109|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3680037|NCT02284568|3524110|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3680038|NCT02284568|3524111|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3680039|NCT02284568|3524108|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3680040|NCT02284568|3524109|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3680041|NCT02284568|3524110|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3680042|NCT02284568|3524111|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3680043|NCT02284568|3524108|B4||Black|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3680044|NCT02284568|3524109|B3||Black|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3680045|NCT02284568|3524110|B2||Black|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3680046|NCT02284568|3524111|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3680047|NCT02284568|3524108|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|362|362.0||||||
3680048|NCT02284568|3524109|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|92|92.0||||||
3680049|NCT02284568|3524110|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|132|132.0||||||
3680050|NCT02284568|3524111|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|138|138.0||||||
3680051|NCT02284568|3524108|B4||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
3680052|NCT02284568|3524109|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3680053|NCT02284568|3524110|B2||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3680054|NCT02284568|3524111|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3680055|NCT02284568|3524108|B4||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3680056|NCT02284568|3524109|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3680057|NCT02284568|3524110|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3680058|NCT02284568|3524111|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3680059|NCT02284568|3524108|B4|||Age||years|Mean|46.3|46.3|Standard Deviation|6.99|6.99|||
3680060|NCT02284568|3524109|B3|||Age||years|Mean|46.1|46.1|Standard Deviation|7.21|7.21|||
3680061|NCT02284568|3524110|B2|||Age||years|Mean|46.1|46.1|Standard Deviation|6.68|6.68|||
3680062|NCT02284568|3524111|B1|||Age||years|Mean|46.6|46.6|Standard Deviation|7.18|7.18|||
3680063|NCT02284555|3524139|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680064|NCT02284555|3524139|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680065|NCT02284555|3524139|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3680066|NCT02284555|3524139|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680067|NCT02284555|3524139|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680068|NCT02284555|3524139|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680069|NCT02284555|3524139|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680070|NCT02284555|3524139|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3680071|NCT02284555|3524139|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3680072|NCT02284555|3524139|B1|||Age||years|Mean|40.8|40.8|Standard Deviation|14.21|14.21|||
3680073|NCT02284516|3524144|B3||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3680074|NCT02284516|3524145|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3680075|NCT02284516|3524146|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3680076|NCT02284516|3524144|B3||Female|Sex: Female, Male||Participants|Count of Participants|537|537.0||||||
3680077|NCT02284516|3524145|B2||Female|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
3680078|NCT02284516|3524146|B1||Female|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
3680079|NCT02284516|3524144|B3|||Age||years|Mean|58.7|58.7|Standard Deviation|14.47|14.47|||
3680080|NCT02284516|3524145|B2|||Age||years|Mean|58.8|58.8|Standard Deviation|14.10|14.1|||
3680081|NCT02284516|3524146|B1|||Age||years|Mean|58.6|58.6|Standard Deviation|14.84|14.84|||
3680082|NCT02284386|3524155|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3680083|NCT02284386|3524155|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680084|NCT02284386|3524155|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680085|NCT02284386|3524155|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3680086|NCT02284386|3524155|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680087|NCT02284386|3524155|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680088|NCT02284386|3524155|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680089|NCT02284386|3524155|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680090|NCT02284386|3524155|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680091|NCT02284386|3524155|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3680092|NCT02284386|3524155|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3680093|NCT02284386|3524155|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3680094|NCT02284386|3524155|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3680095|NCT02284386|3524155|B1|||Age||years|Mean|67.8|67.8|Full Range|||52.0|81.0|
3680096|NCT02284347|3524164|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
3680097|NCT02284347|3524164|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3680098|NCT02284347|3524164|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680099|NCT02284347|3524164|B1||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3680100|NCT02284347|3524164|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3680101|NCT02284347|3524164|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680102|NCT02284347|3524164|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3680103|NCT02284347|3524164|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680104|NCT02284347|3524164|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3680105|NCT02284347|3524164|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3680106|NCT02284347|3524164|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680107|NCT02284347|3524164|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3680108|NCT02284347|3524164|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3680109|NCT02284347|3524164|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|14.02|14.02|||
3680110|NCT02284243|3524170|B3|||Baseline pain intensity score (NPRS)|Pain intensity was recorded using a Numeric Rating Scale (Range 0-10) where 0 equates to no pain, and 10 equates to the worst pain imaginable.|units on a scale|Mean|6.5|6.5|Standard Deviation|1.68|1.68|||
3680111|NCT02284243|3524171|B2|||Baseline pain intensity score (NPRS)|Pain intensity was recorded using a Numeric Rating Scale (Range 0-10) where 0 equates to no pain, and 10 equates to the worst pain imaginable.|units on a scale|Mean|6.7|6.7|Standard Deviation|1.90|1.9|||
3680112|NCT02284243|3524172|B1|||Baseline pain intensity score (NPRS)|Pain intensity was recorded using a Numeric Rating Scale (Range 0-10) where 0 equates to no pain, and 10 equates to the worst pain imaginable.|units on a scale|Mean|6.4|6.4|Standard Deviation|1.42|1.42|||
3680113|NCT02284243|3524170|B3|||Body Mass Index (BMI)||kg/m^2|Mean|27.0|27.0|Standard Deviation|4.20|4.2|||
3680114|NCT02284243|3524171|B2|||Body Mass Index (BMI)||kg/m^2|Mean|27.4|27.4|Standard Deviation|4.08|4.08|||
3680115|NCT02284243|3524172|B1|||Body Mass Index (BMI)||kg/m^2|Mean|26.6|26.6|Standard Deviation|4.31|4.31|||
3680116|NCT02284243|3524170|B3|United States||Region of Enrollment||participants|Number|168|168.0||||||
3680117|NCT02284243|3524171|B2|United States||Region of Enrollment||participants|Number|84|84.0||||||
3680118|NCT02284243|3524172|B1|United States||Region of Enrollment||participants|Number|84|84.0||||||
3680119|NCT02284243|3524170|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3680120|NCT02284243|3524171|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680121|NCT02284243|3524172|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3680122|NCT02284243|3524170|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680123|NCT02284243|3524171|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680124|NCT02284243|3524172|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680125|NCT02284243|3524170|B3||White|Race (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
3680126|NCT02284243|3524171|B2||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3680127|NCT02284243|3524172|B1||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3680128|NCT02284243|3524170|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3680129|NCT02284243|3524171|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3680130|NCT02284243|3524172|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3680131|NCT02284243|3524170|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680132|NCT02284243|3524171|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680133|NCT02284243|3524172|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680134|NCT02284243|3524170|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3680135|NCT02284243|3524171|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3680136|NCT02284243|3524172|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3680137|NCT02284243|3524170|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3680138|NCT02284243|3524171|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3680139|NCT02284243|3524172|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680140|NCT02284243|3524170|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680141|NCT02284243|3524171|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680142|NCT02284243|3524172|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680143|NCT02284243|3524170|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3680144|NCT02284243|3524171|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3680145|NCT02284243|3524172|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3680146|NCT02284243|3524170|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3680147|NCT02284243|3524171|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3680148|NCT02284243|3524172|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3680149|NCT02284243|3524170|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3680150|NCT02284243|3524171|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3680151|NCT02284243|3524172|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3680152|NCT02284243|3524170|B3||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3680153|NCT02284243|3524171|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3680154|NCT02284243|3524172|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3680155|NCT02284243|3524170|B3|||Age||years|Mean|44.0|44.0|Standard Deviation|12.69|12.69|||
3680156|NCT02284243|3524171|B2|||Age||years|Mean|44.0|44.0|Standard Deviation|13.08|13.08|||
3680157|NCT02284243|3524172|B1|||Age||years|Mean|43.9|43.9|Standard Deviation|12.37|12.37|||
3680158|NCT02284243|3524170|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3680159|NCT02284243|3524171|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3680160|NCT02284243|3524172|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3680161|NCT02284243|3524170|B3||Between 18 and 65 years|Age||Participants|Count of Participants|163|163.0||||||
3680162|NCT02284243|3524171|B2||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
3680163|NCT02284243|3524172|B1||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
3680164|NCT02284243|3524170|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680165|NCT02284243|3524171|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680166|NCT02284243|3524172|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680167|NCT02284165|3524191|B4|United States||Region of Enrollment||participants|Number|147716|147716.0||||||
3680168|NCT02284165|3524192|B3|United States||Region of Enrollment||participants|Number|70996|70996.0||||||
3680169|NCT02284165|3524193|B2|United States||Region of Enrollment||participants|Number|40272|40272.0||||||
3680170|NCT02284165|3524194|B1|United States||Region of Enrollment||participants|Number|36448|36448.0||||||
3680171|NCT02284165|3524191|B4|Unknown or Not Reported||Race/Ethnicity, Customized|All analyses calculated by comparing only non-missing values. Hispanic ethnicity collected as a category under Race, prior to revision of collection standards to match NIH/OMB.|participants|Number|18790|18790.0||||||
3680172|NCT02284165|3524192|B3|Unknown or Not Reported||Race/Ethnicity, Customized|All analyses calculated by comparing only non-missing values. Hispanic ethnicity collected as a category under Race, prior to revision of collection standards to match NIH/OMB.|participants|Number|8794|8794.0||||||
3680173|NCT02284165|3524193|B2|Unknown or Not Reported||Race/Ethnicity, Customized|All analyses calculated by comparing only non-missing values. Hispanic ethnicity collected as a category under Race, prior to revision of collection standards to match NIH/OMB.|participants|Number|5275|5275.0||||||
3680174|NCT02284165|3524194|B1|Unknown or Not Reported||Race/Ethnicity, Customized|All analyses calculated by comparing only non-missing values. Hispanic ethnicity collected as a category under Race, prior to revision of collection standards to match NIH/OMB.|participants|Number|4721|4721.0||||||
3680175|NCT02284165|3524191|B4|More than one race||Race/Ethnicity, Customized|All analyses calculated by comparing only non-missing values. Hispanic ethnicity collected as a category under Race, prior to revision of collection standards to match NIH/OMB.|participants|Number|0|0.0||||||
3680176|NCT02284165|3524192|B3|More than one race||Race/Ethnicity, Customized|All analyses calculated by comparing only non-missing values. Hispanic ethnicity collected as a category under Race, prior to revision of collection standards to match NIH/OMB.|participants|Number|0|0.0||||||
3680177|NCT02284165|3524193|B2|More than one race||Race/Ethnicity, Customized|All analyses calculated by comparing only non-missing values. Hispanic ethnicity collected as a category under Race, prior to revision of collection standards to match NIH/OMB.|participants|Number|0|0.0||||||
3680178|NCT02284165|3524194|B1|More than one race||Race/Ethnicity, Customized|All analyses calculated by comparing only non-missing values. Hispanic ethnicity collected as a category under Race, prior to revision of collection standards to match NIH/OMB.|participants|Number|0|0.0||||||
3680179|NCT02284165|3524191|B4|White||Race/Ethnicity, Customized|All analyses calculated by comparing only non-missing values. Hispanic ethnicity collected as a category under Race, prior to revision of collection standards to match NIH/OMB.|participants|Number|121097|121097.0||||||
3680180|NCT02284165|3524192|B3|White||Race/Ethnicity, Customized|All analyses calculated by comparing only non-missing values. Hispanic ethnicity collected as a category under Race, prior to revision of collection standards to match NIH/OMB.|participants|Number|58290|58290.0||||||
3680181|NCT02284165|3524193|B2|White||Race/Ethnicity, Customized|All analyses calculated by comparing only non-missing values. Hispanic ethnicity collected as a category under Race, prior to revision of collection standards to match NIH/OMB.|participants|Number|33087|33087.0||||||
3680182|NCT02284165|3524194|B1|White||Race/Ethnicity, Customized|All analyses calculated by comparing only non-missing values. Hispanic ethnicity collected as a category under Race, prior to revision of collection standards to match NIH/OMB.|participants|Number|29720|29720.0||||||
3680183|NCT02284165|3524191|B4|Black or African American||Race/Ethnicity, Customized|All analyses calculated by comparing only non-missing values. Hispanic ethnicity collected as a category under Race, prior to revision of collection standards to match NIH/OMB.|participants|Number|5165|5165.0||||||
3680184|NCT02284165|3524192|B3|Black or African American||Race/Ethnicity, Customized|All analyses calculated by comparing only non-missing values. Hispanic ethnicity collected as a category under Race, prior to revision of collection standards to match NIH/OMB.|participants|Number|2576|2576.0||||||
3680185|NCT02284165|3524193|B2|Black or African American||Race/Ethnicity, Customized|All analyses calculated by comparing only non-missing values. Hispanic ethnicity collected as a category under Race, prior to revision of collection standards to match NIH/OMB.|participants|Number|1231|1231.0||||||
3680186|NCT02284165|3524194|B1|Black or African American||Race/Ethnicity, Customized|All analyses calculated by comparing only non-missing values. Hispanic ethnicity collected as a category under Race, prior to revision of collection standards to match NIH/OMB.|participants|Number|1358|1358.0||||||
3680187|NCT02284165|3524191|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|All analyses calculated by comparing only non-missing values. Hispanic ethnicity collected as a category under Race, prior to revision of collection standards to match NIH/OMB.|participants|Number|258|258.0||||||
3680188|NCT02284165|3524192|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|All analyses calculated by comparing only non-missing values. Hispanic ethnicity collected as a category under Race, prior to revision of collection standards to match NIH/OMB.|participants|Number|135|135.0||||||
3680189|NCT02284165|3524193|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|All analyses calculated by comparing only non-missing values. Hispanic ethnicity collected as a category under Race, prior to revision of collection standards to match NIH/OMB.|participants|Number|56|56.0||||||
3680190|NCT02284165|3524194|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|All analyses calculated by comparing only non-missing values. Hispanic ethnicity collected as a category under Race, prior to revision of collection standards to match NIH/OMB.|participants|Number|67|67.0||||||
3680191|NCT02284165|3524191|B4|Asian||Race/Ethnicity, Customized|All analyses calculated by comparing only non-missing values. Hispanic ethnicity collected as a category under Race, prior to revision of collection standards to match NIH/OMB.|participants|Number|2179|2179.0||||||
3680192|NCT02284165|3524192|B3|Asian||Race/Ethnicity, Customized|All analyses calculated by comparing only non-missing values. Hispanic ethnicity collected as a category under Race, prior to revision of collection standards to match NIH/OMB.|participants|Number|1091|1091.0||||||
3680193|NCT02284165|3524193|B2|Asian||Race/Ethnicity, Customized|All analyses calculated by comparing only non-missing values. Hispanic ethnicity collected as a category under Race, prior to revision of collection standards to match NIH/OMB.|participants|Number|580|580.0||||||
3680194|NCT02284165|3524194|B1|Asian||Race/Ethnicity, Customized|All analyses calculated by comparing only non-missing values. Hispanic ethnicity collected as a category under Race, prior to revision of collection standards to match NIH/OMB.|participants|Number|508|508.0||||||
3680195|NCT02284165|3524191|B4|American Indian or Alaska Native||Race/Ethnicity, Customized|All analyses calculated by comparing only non-missing values. Hispanic ethnicity collected as a category under Race, prior to revision of collection standards to match NIH/OMB.|participants|Number|227|227.0||||||
3680196|NCT02284165|3524192|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|All analyses calculated by comparing only non-missing values. Hispanic ethnicity collected as a category under Race, prior to revision of collection standards to match NIH/OMB.|participants|Number|110|110.0||||||
3680197|NCT02284165|3524193|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|All analyses calculated by comparing only non-missing values. Hispanic ethnicity collected as a category under Race, prior to revision of collection standards to match NIH/OMB.|participants|Number|43|43.0||||||
3680198|NCT02284165|3524194|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|All analyses calculated by comparing only non-missing values. Hispanic ethnicity collected as a category under Race, prior to revision of collection standards to match NIH/OMB.|participants|Number|74|74.0||||||
3680199|NCT02284165|3524191|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)|All analyses calculated by comparing only non-missing values.|Participants|Count of Participants|0|0.0||||||
3680200|NCT02284165|3524192|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)|All analyses calculated by comparing only non-missing values.|Participants|Count of Participants|0|0.0||||||
3680201|NCT02284165|3524193|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)|All analyses calculated by comparing only non-missing values.|Participants|Count of Participants|0|0.0||||||
3680202|NCT02284165|3524194|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|All analyses calculated by comparing only non-missing values.|Participants|Count of Participants|0|0.0||||||
3680203|NCT02284165|3524191|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)|All analyses calculated by comparing only non-missing values.|Participants|Count of Participants|142551|142551.0||||||
3680204|NCT02284165|3524192|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)|All analyses calculated by comparing only non-missing values.|Participants|Count of Participants|68420|68420.0||||||
3680205|NCT02284165|3524193|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)|All analyses calculated by comparing only non-missing values.|Participants|Count of Participants|39041|39041.0||||||
3680206|NCT02284165|3524194|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|All analyses calculated by comparing only non-missing values.|Participants|Count of Participants|35090|35090.0||||||
3680207|NCT02284165|3524191|B4||Hispanic or Latino|Ethnicity (NIH/OMB)|All analyses calculated by comparing only non-missing values.|Participants|Count of Participants|5165|5165.0||||||
3680208|NCT02284165|3524192|B3||Hispanic or Latino|Ethnicity (NIH/OMB)|All analyses calculated by comparing only non-missing values.|Participants|Count of Participants|2576|2576.0||||||
3680209|NCT02284165|3524193|B2||Hispanic or Latino|Ethnicity (NIH/OMB)|All analyses calculated by comparing only non-missing values.|Participants|Count of Participants|1231|1231.0||||||
3680210|NCT02284165|3524194|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|All analyses calculated by comparing only non-missing values.|Participants|Count of Participants|1358|1358.0||||||
3680211|NCT02284165|3524191|B4|Missing||Sex/Gender, Customized|All analyses calculated by comparing only non-missing values. Gender missing among 5 patients discharged to IRF, and 2 patients discharged to SNF.|participants|Number|7|7.0||||||
3680212|NCT02284165|3524192|B3|Missing||Sex/Gender, Customized|All analyses calculated by comparing only non-missing values. Gender missing among 5 patients discharged to IRF, and 2 patients discharged to SNF.|participants|Number|0|0.0||||||
3680213|NCT02284165|3524193|B2|Missing||Sex/Gender, Customized|All analyses calculated by comparing only non-missing values. Gender missing among 5 patients discharged to IRF, and 2 patients discharged to SNF.|participants|Number|2|2.0||||||
3680214|NCT02284165|3524194|B1|Missing||Sex/Gender, Customized|All analyses calculated by comparing only non-missing values. Gender missing among 5 patients discharged to IRF, and 2 patients discharged to SNF.|participants|Number|5|5.0||||||
3680215|NCT02284165|3524191|B4|Male||Sex/Gender, Customized|All analyses calculated by comparing only non-missing values. Gender missing among 5 patients discharged to IRF, and 2 patients discharged to SNF.|participants|Number|61612|61612.0||||||
3680216|NCT02284165|3524192|B3|Male||Sex/Gender, Customized|All analyses calculated by comparing only non-missing values. Gender missing among 5 patients discharged to IRF, and 2 patients discharged to SNF.|participants|Number|32270|32270.0||||||
3680217|NCT02284165|3524193|B2|Male||Sex/Gender, Customized|All analyses calculated by comparing only non-missing values. Gender missing among 5 patients discharged to IRF, and 2 patients discharged to SNF.|participants|Number|13469|13469.0||||||
3680218|NCT02284165|3524194|B1|Male||Sex/Gender, Customized|All analyses calculated by comparing only non-missing values. Gender missing among 5 patients discharged to IRF, and 2 patients discharged to SNF.|participants|Number|15873|15873.0||||||
3680219|NCT02284165|3524191|B4|Female||Sex/Gender, Customized|All analyses calculated by comparing only non-missing values. Gender missing among 5 patients discharged to IRF, and 2 patients discharged to SNF.|participants|Number|86097|86097.0||||||
3680220|NCT02284165|3524192|B3|Female||Sex/Gender, Customized|All analyses calculated by comparing only non-missing values. Gender missing among 5 patients discharged to IRF, and 2 patients discharged to SNF.|participants|Number|38726|38726.0||||||
3680221|NCT02284165|3524193|B2|Female||Sex/Gender, Customized|All analyses calculated by comparing only non-missing values. Gender missing among 5 patients discharged to IRF, and 2 patients discharged to SNF.|participants|Number|26801|26801.0||||||
3680222|NCT02284165|3524194|B1|Female||Sex/Gender, Customized|All analyses calculated by comparing only non-missing values. Gender missing among 5 patients discharged to IRF, and 2 patients discharged to SNF.|participants|Number|20570|20570.0||||||
3680223|NCT02284165|3524191|B4|||Age|All analyses calculated by comparing only non-missing values.|years|Median|80|80.0|Inter-Quartile Range|||74.0|86.0|
3680224|NCT02284165|3524192|B3|||Age|All analyses calculated by comparing only non-missing values.|years|Median|78|78.0|Inter-Quartile Range|||71.0|84.0|
3680225|NCT02284165|3524193|B2|||Age|All analyses calculated by comparing only non-missing values.|years|Median|83|83.0|Inter-Quartile Range|||73.0|88.0|
3680226|NCT02284165|3524194|B1|||Age|All analyses calculated by comparing only non-missing values.|years|Median|79|79.0|Inter-Quartile Range|||73.0|84.0|
3680227|NCT02283840|3524212|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3680228|NCT02283840|3524213|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3680229|NCT02283840|3524214|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3680230|NCT02283840|3524215|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3680231|NCT02283840|3524212|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3680232|NCT02283840|3524213|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3680233|NCT02283840|3524214|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3680234|NCT02283840|3524215|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3680235|NCT02283840|3524212|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3680236|NCT02283840|3524213|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3680237|NCT02283840|3524214|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3680238|NCT02283840|3524215|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3680239|NCT02283840|3524212|B4||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3680240|NCT02283840|3524213|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3680241|NCT02283840|3524214|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3680242|NCT02283840|3524215|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3680243|NCT02283840|3524212|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680244|NCT02283840|3524213|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680245|NCT02283840|3524214|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680246|NCT02283840|3524215|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680247|NCT02283827|3524234|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3680248|NCT02283827|3524235|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3680249|NCT02283827|3524236|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3680250|NCT02283827|3524234|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3680251|NCT02283827|3524235|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3680252|NCT02283827|3524236|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3680253|NCT02283827|3524234|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3680254|NCT02283827|3524235|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3680255|NCT02283827|3524236|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3680256|NCT02283827|3524234|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3680257|NCT02283827|3524235|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3680258|NCT02283827|3524236|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3680259|NCT02283827|3524234|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680260|NCT02283827|3524235|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680261|NCT02283827|3524236|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680262|NCT02283814|3524252|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3680263|NCT02283814|3524253|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3680264|NCT02283814|3524254|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3680265|NCT02283814|3524252|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3680266|NCT02283814|3524253|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3680267|NCT02283814|3524254|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3680268|NCT02283814|3524252|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3680269|NCT02283814|3524253|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3680270|NCT02283814|3524254|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3680271|NCT02283814|3524252|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3680272|NCT02283814|3524253|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3680273|NCT02283814|3524254|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3680274|NCT02283814|3524252|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680275|NCT02283814|3524253|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680276|NCT02283814|3524254|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680277|NCT02283788|3524265|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680278|NCT02283788|3524266|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680279|NCT02283788|3524267|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680280|NCT02283788|3524268|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680281|NCT02283788|3524269|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680282|NCT02283788|3524265|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680283|NCT02283788|3524266|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680284|NCT02283788|3524267|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680285|NCT02283788|3524268|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680286|NCT02283788|3524269|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680287|NCT02283788|3524265|B5||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3680288|NCT02283788|3524266|B4||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3680289|NCT02283788|3524267|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3680290|NCT02283788|3524268|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3680291|NCT02283788|3524269|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3680292|NCT02283788|3524265|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3680293|NCT02283788|3524266|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3680294|NCT02283788|3524267|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3680295|NCT02283788|3524268|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680296|NCT02283788|3524269|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3680297|NCT02283788|3524265|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680298|NCT02283788|3524266|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680299|NCT02283788|3524267|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680300|NCT02283788|3524268|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680301|NCT02283788|3524269|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680302|NCT02283788|3524265|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680303|NCT02283788|3524266|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680304|NCT02283788|3524267|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680305|NCT02283788|3524268|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680306|NCT02283788|3524269|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680307|NCT02283788|3524265|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3680308|NCT02283788|3524266|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680309|NCT02283788|3524267|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680310|NCT02283788|3524268|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3680311|NCT02283788|3524269|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680312|NCT02283788|3524265|B5||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3680313|NCT02283788|3524266|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3680314|NCT02283788|3524267|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3680315|NCT02283788|3524268|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3680316|NCT02283788|3524269|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3680317|NCT02283788|3524265|B5||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3680318|NCT02283788|3524266|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3680319|NCT02283788|3524267|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3680320|NCT02283788|3524268|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3680321|NCT02283788|3524269|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3680322|NCT02283788|3524265|B5|||Age||years|Mean|34.5|34.5|Standard Deviation|7.31|7.31|||
3680323|NCT02283788|3524266|B4|||Age||years|Mean|35.8|35.8|Standard Deviation|7.35|7.35|||
3680324|NCT02283788|3524267|B3|||Age||years|Mean|32.6|32.6|Standard Deviation|7.88|7.88|||
3680325|NCT02283788|3524268|B2|||Age||years|Mean|33.6|33.6|Standard Deviation|6.41|6.41|||
3680326|NCT02283788|3524269|B1|||Age||years|Mean|36.2|36.2|Standard Deviation|7.55|7.55|||
3680327|NCT02283749|3524282|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3680328|NCT02283749|3524282|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680329|NCT02283749|3524282|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680330|NCT02283749|3524282|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3680331|NCT02283749|3524282|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680332|NCT02283749|3524282|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680333|NCT02283749|3524282|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3680334|NCT02283749|3524282|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680335|NCT02283749|3524282|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3680336|NCT02283749|3524282|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3680337|NCT02283749|3524282|B1|||Age||years|Median|58|58.0|Full Range|||44.0|67.0|
3680338|NCT02283749|3524282|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3680339|NCT02283749|3524282|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3680340|NCT02283749|3524282|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680341|NCT02283411|3524288|B1|United States||Region of Enrollment||Participants|Count of Participants|125|125.0||||||
3680342|NCT02283411|3524288|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3680343|NCT02283411|3524288|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3680344|NCT02283411|3524288|B1|||Age||years|Mean|46.7|46.7|Standard Deviation|14.4|14.4|||
3680345|NCT02283268|3524296|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3680346|NCT02283268|3524296|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3680347|NCT02283268|3524296|B1|||Age||Years|Median|40.0|40.0|Full Range|||20.0|70.0|
3680348|NCT02282982|3524357|B1||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3680349|NCT02282982|3524357|B1||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
3680350|NCT02282982|3524357|B1|||Age||months|Mean|3.4|3.4|Standard Deviation|3.6|3.6|||
3680351|NCT02282813|3524372|B4|United States||Region of Enrollment||participants|Number|298|298.0||||||
3680352|NCT02282813|3524373|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
3680353|NCT02282813|3524374|B2|United States||Region of Enrollment||participants|Number|153|153.0||||||
3680354|NCT02282813|3524375|B1|United States||Region of Enrollment||participants|Number|103|103.0||||||
3680355|NCT02282813|3524372|B4||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3680356|NCT02282813|3524373|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3680357|NCT02282813|3524374|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3680358|NCT02282813|3524375|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3680359|NCT02282813|3524372|B4||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3680360|NCT02282813|3524373|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3680361|NCT02282813|3524374|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3680362|NCT02282813|3524375|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3680363|NCT02282813|3524372|B4|||Age||years|Mean|65.9|65.9|Standard Deviation|10.56|10.56|||
3680364|NCT02282813|3524373|B3|||Age||years|Mean|65.0|65.0|Standard Deviation|12.34|12.34|||
3680365|NCT02282813|3524374|B2|||Age||years|Mean|66.9|66.9|Standard Deviation|9.83|9.83|||
3680366|NCT02282813|3524375|B1|||Age||years|Mean|64.7|64.7|Standard Deviation|10.78|10.78|||
3680367|NCT02282722|3524394|B3||Unknown/Missing|ECOG Performance Status||Participants|Count of Participants|32|32.0||||||
3680368|NCT02282722|3524395|B2||Unknown/Missing|ECOG Performance Status||Participants|Count of Participants|16|16.0||||||
3680369|NCT02282722|3524396|B1||Unknown/Missing|ECOG Performance Status||Participants|Count of Participants|16|16.0||||||
3680370|NCT02282722|3524394|B3||4 - Completely disabled|ECOG Performance Status||Participants|Count of Participants|0|0.0||||||
3680371|NCT02282722|3524395|B2||4 - Completely disabled|ECOG Performance Status||Participants|Count of Participants|0|0.0||||||
3680372|NCT02282722|3524396|B1||4 - Completely disabled|ECOG Performance Status||Participants|Count of Participants|0|0.0||||||
3680429|NCT02282722|3524396|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3680373|NCT02282722|3524394|B3||3 - Capable of limited self-care|ECOG Performance Status||Participants|Count of Participants|0|0.0||||||
3680374|NCT02282722|3524395|B2||3 - Capable of limited self-care|ECOG Performance Status||Participants|Count of Participants|0|0.0||||||
3680375|NCT02282722|3524396|B1||3 - Capable of limited self-care|ECOG Performance Status||Participants|Count of Participants|0|0.0||||||
3680376|NCT02282722|3524394|B3||2 - Ambulatory but unable to work|ECOG Performance Status||Participants|Count of Participants|11|11.0||||||
3680377|NCT02282722|3524395|B2||2 - Ambulatory but unable to work|ECOG Performance Status||Participants|Count of Participants|6|6.0||||||
3680378|NCT02282722|3524396|B1||2 - Ambulatory but unable to work|ECOG Performance Status||Participants|Count of Participants|5|5.0||||||
3680379|NCT02282722|3524394|B3||1 - Restricted in physically strenuous activity|ECOG Performance Status||Participants|Count of Participants|68|68.0||||||
3680380|NCT02282722|3524395|B2||1 - Restricted in physically strenuous activity|ECOG Performance Status||Participants|Count of Participants|26|26.0||||||
3680381|NCT02282722|3524396|B1||1 - Restricted in physically strenuous activity|ECOG Performance Status||Participants|Count of Participants|42|42.0||||||
3680382|NCT02282722|3524394|B3||0 - Fully Active|ECOG Performance Status||Participants|Count of Participants|75|75.0||||||
3680383|NCT02282722|3524395|B2||0 - Fully Active|ECOG Performance Status||Participants|Count of Participants|44|44.0||||||
3680384|NCT02282722|3524396|B1||0 - Fully Active|ECOG Performance Status||Participants|Count of Participants|31|31.0||||||
3680385|NCT02282722|3524394|B3||Advanced pancreatic cancer|Diagnosis||Participants|Count of Participants|68|68.0||||||
3680386|NCT02282722|3524395|B2||Advanced pancreatic cancer|Diagnosis||Participants|Count of Participants|33|33.0||||||
3680387|NCT02282722|3524396|B1||Advanced pancreatic cancer|Diagnosis||Participants|Count of Participants|35|35.0||||||
3680388|NCT02282722|3524394|B3||Metastatic colorectal cancer|Diagnosis||Participants|Count of Participants|118|118.0||||||
3680389|NCT02282722|3524395|B2||Metastatic colorectal cancer|Diagnosis||Participants|Count of Participants|59|59.0||||||
3680390|NCT02282722|3524396|B1||Metastatic colorectal cancer|Diagnosis||Participants|Count of Participants|59|59.0||||||
3680391|NCT02282722|3524394|B3||Unknown/missing|Education||Participants|Count of Participants|2|2.0||||||
3680392|NCT02282722|3524395|B2||Unknown/missing|Education||Participants|Count of Participants|1|1.0||||||
3680393|NCT02282722|3524396|B1||Unknown/missing|Education||Participants|Count of Participants|1|1.0||||||
3680394|NCT02282722|3524394|B3||College degree or higher|Education||Participants|Count of Participants|106|106.0||||||
3680395|NCT02282722|3524395|B2||College degree or higher|Education||Participants|Count of Participants|57|57.0||||||
3680396|NCT02282722|3524396|B1||College degree or higher|Education||Participants|Count of Participants|49|49.0||||||
3680397|NCT02282722|3524394|B3||High school graduate, or some college|Education||Participants|Count of Participants|65|65.0||||||
3680398|NCT02282722|3524395|B2||High school graduate, or some college|Education||Participants|Count of Participants|29|29.0||||||
3680399|NCT02282722|3524396|B1||High school graduate, or some college|Education||Participants|Count of Participants|36|36.0||||||
3680400|NCT02282722|3524394|B3||Grade school or less|Education||Participants|Count of Participants|13|13.0||||||
3680401|NCT02282722|3524395|B2||Grade school or less|Education||Participants|Count of Participants|5|5.0||||||
3680402|NCT02282722|3524396|B1||Grade school or less|Education||Participants|Count of Participants|8|8.0||||||
3680403|NCT02282722|3524394|B3||Unknown|Live alone||Participants|Count of Participants|3|3.0||||||
3680404|NCT02282722|3524395|B2||Unknown|Live alone||Participants|Count of Participants|1|1.0||||||
3680405|NCT02282722|3524396|B1||Unknown|Live alone||Participants|Count of Participants|2|2.0||||||
3680406|NCT02282722|3524394|B3||No|Live alone||Participants|Count of Participants|155|155.0||||||
3680407|NCT02282722|3524395|B2||No|Live alone||Participants|Count of Participants|79|79.0||||||
3680408|NCT02282722|3524396|B1||No|Live alone||Participants|Count of Participants|76|76.0||||||
3680409|NCT02282722|3524394|B3||Yes|Live alone||Participants|Count of Participants|28|28.0||||||
3680410|NCT02282722|3524395|B2||Yes|Live alone||Participants|Count of Participants|12|12.0||||||
3680411|NCT02282722|3524396|B1||Yes|Live alone||Participants|Count of Participants|16|16.0||||||
3680412|NCT02282722|3524394|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3680413|NCT02282722|3524395|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680414|NCT02282722|3524396|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3680415|NCT02282722|3524394|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680416|NCT02282722|3524395|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680417|NCT02282722|3524396|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680418|NCT02282722|3524394|B3||White|Race (NIH/OMB)||Participants|Count of Participants|160|160.0||||||
3680419|NCT02282722|3524395|B2||White|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3680420|NCT02282722|3524396|B1||White|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
3680421|NCT02282722|3524394|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3680422|NCT02282722|3524395|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3680423|NCT02282722|3524396|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3680424|NCT02282722|3524394|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680425|NCT02282722|3524395|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680426|NCT02282722|3524396|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680427|NCT02282722|3524394|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3680428|NCT02282722|3524395|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3680430|NCT02282722|3524394|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680431|NCT02282722|3524395|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680432|NCT02282722|3524396|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680433|NCT02282722|3524394|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3680434|NCT02282722|3524395|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3680435|NCT02282722|3524396|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3680436|NCT02282722|3524394|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3680437|NCT02282722|3524395|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3680438|NCT02282722|3524396|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3680439|NCT02282722|3524394|B3|||Age||Years|Mean|59.3|59.3|Full Range|||28.0|86.0|
3680440|NCT02282722|3524395|B2|||Age||Years|Mean|59.4|59.4|Full Range|||28.0|86.0|
3680441|NCT02282722|3524396|B1|||Age||Years|Mean|59.2|59.2|Full Range|||30.0|85.0|
3680442|NCT02282722|3524394|B3||>=65 years|Age||Participants|Count of Participants|73|73.0||||||
3680443|NCT02282722|3524395|B2||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
3680444|NCT02282722|3524396|B1||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
3680445|NCT02282722|3524394|B3||Between 18 and 65 years|Age||Participants|Count of Participants|113|113.0||||||
3680446|NCT02282722|3524395|B2||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
3680447|NCT02282722|3524396|B1||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
3680448|NCT02282722|3524394|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680449|NCT02282722|3524395|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680450|NCT02282722|3524396|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680451|NCT02282631|3524421|B3|||Parent completing questionnaire has degree or higher degree||Participants|Count of Participants|8|8.0||||||
3680452|NCT02282631|3524422|B2|||Parent completing questionnaire has degree or higher degree||Participants|Count of Participants|6|6.0||||||
3680453|NCT02282631|3524423|B1|||Parent completing questionnaire has degree or higher degree||Participants|Count of Participants|2|2.0||||||
3680454|NCT02282631|3524421|B3|||Car available to drive child to school||Participants|Count of Participants|21|21.0||||||
3680455|NCT02282631|3524422|B2|||Car available to drive child to school||Participants|Count of Participants|12|12.0||||||
3680456|NCT02282631|3524423|B1|||Car available to drive child to school||Participants|Count of Participants|9|9.0||||||
3680457|NCT02282631|3524421|B3|Other Ethnic Group||Ethnic group||participants|Number|2|2.0||||||
3680458|NCT02282631|3524422|B2|Other Ethnic Group||Ethnic group||participants|Number|1|1.0||||||
3680459|NCT02282631|3524423|B1|Other Ethnic Group||Ethnic group||participants|Number|1|1.0||||||
3680460|NCT02282631|3524421|B3|White British||Ethnic group||participants|Number|27|27.0||||||
3680461|NCT02282631|3524422|B2|White British||Ethnic group||participants|Number|14|14.0||||||
3680462|NCT02282631|3524423|B1|White British||Ethnic group||participants|Number|13|13.0||||||
3680463|NCT02282631|3524421|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3680464|NCT02282631|3524422|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3680465|NCT02282631|3524423|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3680466|NCT02282631|3524421|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3680467|NCT02282631|3524422|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3680468|NCT02282631|3524423|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3680469|NCT02282631|3524421|B3|||Age||years of age|Median|9|9.0|Inter-Quartile Range|||9.0|9.0|
3680470|NCT02282631|3524422|B2|||Age||years of age|Median|9|9.0|Inter-Quartile Range|||9.0|9.0|
3680471|NCT02282631|3524423|B1|||Age||years of age|Median|9|9.0|Inter-Quartile Range|||9.0|9.0|
3680472|NCT02282605|3524462|B4|United Kingdom||Region of Enrollment||participants|Number|63|63.0||||||
3680473|NCT02282605|3524463|B3|United Kingdom||Region of Enrollment||participants|Number|24|24.0||||||
3680474|NCT02282605|3524464|B2|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
3680475|NCT02282605|3524465|B1|United Kingdom||Region of Enrollment||participants|Number|27|27.0||||||
3680476|NCT02282605|3524462|B4||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3680477|NCT02282605|3524463|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3680478|NCT02282605|3524464|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3680479|NCT02282605|3524465|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3680480|NCT02282605|3524462|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3680481|NCT02282605|3524463|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3680482|NCT02282605|3524464|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3680483|NCT02282605|3524465|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3680484|NCT02282605|3524462|B4|||Age||years|Mean|37.0|37.0|Standard Deviation|11.5|11.5|||
3680485|NCT02282605|3524463|B3|||Age||years|Mean|39.0|39.0|Standard Deviation|12.5|12.5|||
3680486|NCT02282605|3524464|B2|||Age||years|Mean|38.0|38.0|Standard Deviation|12.8|12.8|||
3680487|NCT02282605|3524465|B1|||Age||years|Mean|34.7|34.7|Standard Deviation|12.4|12.4|||
3680488|NCT02282527|3524487|B3|Non-naive||Alpha1-PI concentration||mg/mL|Mean|0.70|0.7|Standard Deviation|0.248|0.248|||
3680489|NCT02282527|3524488|B2|Non-naive||Alpha1-PI concentration||mg/mL|Mean|0.69|0.69|Standard Deviation|0.215|0.215|||
3680490|NCT02282527|3524489|B1|Non-naive||Alpha1-PI concentration||mg/mL|Mean|0.72|0.72|Standard Deviation|0.283|0.283|||
3680491|NCT02282527|3524487|B3|Naive||Alpha1-PI concentration||mg/mL|Mean|0.24|0.24|Standard Deviation|0.059|0.059|||
3680492|NCT02282527|3524488|B2|Naive||Alpha1-PI concentration||mg/mL|Mean|0.21|0.21|Standard Deviation|0.040|0.04|||
3680493|NCT02282527|3524489|B1|Naive||Alpha1-PI concentration||mg/mL|Mean|0.31|0.31|Standard Deviation|NA||||The standard deviation was not calculated as only 1 subject was assessed.
3680494|NCT02282527|3524487|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
3680495|NCT02282527|3524488|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3680496|NCT02282527|3524489|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3680497|NCT02282527|3524487|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680498|NCT02282527|3524488|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680499|NCT02282527|3524489|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680500|NCT02282527|3524487|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3680501|NCT02282527|3524488|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3680502|NCT02282527|3524489|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3680503|NCT02282527|3524487|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3680504|NCT02282527|3524488|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3680505|NCT02282527|3524489|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680506|NCT02282527|3524487|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3680507|NCT02282527|3524488|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3680508|NCT02282527|3524489|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3680509|NCT02282527|3524487|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3680510|NCT02282527|3524488|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3680511|NCT02282527|3524489|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3680512|NCT02282527|3524487|B3|||Age||years|Mean|61.9|61.9|Standard Deviation|7.00|7.0|||
3680513|NCT02282527|3524488|B2|||Age||years|Mean|63.1|63.1|Standard Deviation|5.93|5.93|||
3680514|NCT02282527|3524489|B1|||Age||years|Mean|60.7|60.7|Standard Deviation|7.94|7.94|||
3680515|NCT02282111|3524500|B3|||Greatest diameter of the lesion||millimeters|Median|24.5|24.5|Inter-Quartile Range|||20.0|33.0|
3680516|NCT02282111|3524501|B2|||Greatest diameter of the lesion||millimeters|Median|25|25.0|Inter-Quartile Range|||20.0|30.0|
3680517|NCT02282111|3524502|B1|||Greatest diameter of the lesion||millimeters|Median|23.5|23.5|Inter-Quartile Range|||20.0|39.0|
3680518|NCT02282111|3524500|B3|No||Calcification||participants|Number|52|52.0||||||
3680519|NCT02282111|3524501|B2|No||Calcification||participants|Number|26|26.0||||||
3680520|NCT02282111|3524502|B1|No||Calcification||participants|Number|26|26.0||||||
3680521|NCT02282111|3524500|B3|Yes||Calcification||participants|Number|4|4.0||||||
3680522|NCT02282111|3524501|B2|Yes||Calcification||participants|Number|4|4.0||||||
3680523|NCT02282111|3524502|B1|Yes||Calcification||participants|Number|0|0.0||||||
3680524|NCT02282111|3524500|B3|Doudenum||Location of the lesion||participants|Number|3|3.0||||||
3680525|NCT02282111|3524501|B2|Doudenum||Location of the lesion||participants|Number|1|1.0||||||
3680526|NCT02282111|3524502|B1|Doudenum||Location of the lesion||participants|Number|2|2.0||||||
3680527|NCT02282111|3524500|B3|Antrum||Location of the lesion||participants|Number|11|11.0||||||
3680528|NCT02282111|3524501|B2|Antrum||Location of the lesion||participants|Number|7|7.0||||||
3680529|NCT02282111|3524502|B1|Antrum||Location of the lesion||participants|Number|4|4.0||||||
3680530|NCT02282111|3524500|B3|Gastric body||Location of the lesion||participants|Number|24|24.0||||||
3680531|NCT02282111|3524501|B2|Gastric body||Location of the lesion||participants|Number|12|12.0||||||
3680532|NCT02282111|3524502|B1|Gastric body||Location of the lesion||participants|Number|12|12.0||||||
3680533|NCT02282111|3524500|B3|Gastric fundus||Location of the lesion||participants|Number|16|16.0||||||
3680534|NCT02282111|3524501|B2|Gastric fundus||Location of the lesion||participants|Number|9|9.0||||||
3680535|NCT02282111|3524502|B1|Gastric fundus||Location of the lesion||participants|Number|7|7.0||||||
3680536|NCT02282111|3524500|B3|Esophagus||Location of the lesion||participants|Number|2|2.0||||||
3680537|NCT02282111|3524501|B2|Esophagus||Location of the lesion||participants|Number|1|1.0||||||
3680538|NCT02282111|3524502|B1|Esophagus||Location of the lesion||participants|Number|1|1.0||||||
3680539|NCT02282111|3524500|B3|Mixed echogenicity||Echogenicity|Tissue echogenicity is the ability of a tissue in reflection or transmission of the ultrasound waves as compared to its surrounding tissues. The higher the echogenicity of the tissue is, the whiter it will appear on the ultrasound screen as compared to its surrounding tissues. On the contrary, the lower the echogenicity of the tissue is, the blacker it will appear on the screen.|participants|Number|1|1.0||||||
3680540|NCT02282111|3524501|B2|Mixed echogenicity||Echogenicity|Tissue echogenicity is the ability of a tissue in reflection or transmission of the ultrasound waves as compared to its surrounding tissues. The higher the echogenicity of the tissue is, the whiter it will appear on the ultrasound screen as compared to its surrounding tissues. On the contrary, the lower the echogenicity of the tissue is, the blacker it will appear on the screen.|participants|Number|0|0.0||||||
3680541|NCT02282111|3524502|B1|Mixed echogenicity||Echogenicity|Tissue echogenicity is the ability of a tissue in reflection or transmission of the ultrasound waves as compared to its surrounding tissues. The higher the echogenicity of the tissue is, the whiter it will appear on the ultrasound screen as compared to its surrounding tissues. On the contrary, the lower the echogenicity of the tissue is, the blacker it will appear on the screen.|participants|Number|1|1.0||||||
3680542|NCT02282111|3524500|B3|Hyperechoic||Echogenicity|Tissue echogenicity is the ability of a tissue in reflection or transmission of the ultrasound waves as compared to its surrounding tissues. The higher the echogenicity of the tissue is, the whiter it will appear on the ultrasound screen as compared to its surrounding tissues. On the contrary, the lower the echogenicity of the tissue is, the blacker it will appear on the screen.|participants|Number|2|2.0||||||
3680543|NCT02282111|3524501|B2|Hyperechoic||Echogenicity|Tissue echogenicity is the ability of a tissue in reflection or transmission of the ultrasound waves as compared to its surrounding tissues. The higher the echogenicity of the tissue is, the whiter it will appear on the ultrasound screen as compared to its surrounding tissues. On the contrary, the lower the echogenicity of the tissue is, the blacker it will appear on the screen.|participants|Number|1|1.0||||||
3680544|NCT02282111|3524502|B1|Hyperechoic||Echogenicity|Tissue echogenicity is the ability of a tissue in reflection or transmission of the ultrasound waves as compared to its surrounding tissues. The higher the echogenicity of the tissue is, the whiter it will appear on the ultrasound screen as compared to its surrounding tissues. On the contrary, the lower the echogenicity of the tissue is, the blacker it will appear on the screen.|participants|Number|1|1.0||||||
3680545|NCT02282111|3524500|B3|Isoechoic||Echogenicity|Tissue echogenicity is the ability of a tissue in reflection or transmission of the ultrasound waves as compared to its surrounding tissues. The higher the echogenicity of the tissue is, the whiter it will appear on the ultrasound screen as compared to its surrounding tissues. On the contrary, the lower the echogenicity of the tissue is, the blacker it will appear on the screen.|participants|Number|12|12.0||||||
3680546|NCT02282111|3524501|B2|Isoechoic||Echogenicity|Tissue echogenicity is the ability of a tissue in reflection or transmission of the ultrasound waves as compared to its surrounding tissues. The higher the echogenicity of the tissue is, the whiter it will appear on the ultrasound screen as compared to its surrounding tissues. On the contrary, the lower the echogenicity of the tissue is, the blacker it will appear on the screen.|participants|Number|7|7.0||||||
3680547|NCT02282111|3524502|B1|Isoechoic||Echogenicity|Tissue echogenicity is the ability of a tissue in reflection or transmission of the ultrasound waves as compared to its surrounding tissues. The higher the echogenicity of the tissue is, the whiter it will appear on the ultrasound screen as compared to its surrounding tissues. On the contrary, the lower the echogenicity of the tissue is, the blacker it will appear on the screen.|participants|Number|5|5.0||||||
3680548|NCT02282111|3524500|B3|Hypoechoic||Echogenicity|Tissue echogenicity is the ability of a tissue in reflection or transmission of the ultrasound waves as compared to its surrounding tissues. The higher the echogenicity of the tissue is, the whiter it will appear on the ultrasound screen as compared to its surrounding tissues. On the contrary, the lower the echogenicity of the tissue is, the blacker it will appear on the screen.|participants|Number|41|41.0||||||
3680549|NCT02282111|3524501|B2|Hypoechoic||Echogenicity|Tissue echogenicity is the ability of a tissue in reflection or transmission of the ultrasound waves as compared to its surrounding tissues. The higher the echogenicity of the tissue is, the whiter it will appear on the ultrasound screen as compared to its surrounding tissues. On the contrary, the lower the echogenicity of the tissue is, the blacker it will appear on the screen.|participants|Number|22|22.0||||||
3680550|NCT02282111|3524502|B1|Hypoechoic||Echogenicity|Tissue echogenicity is the ability of a tissue in reflection or transmission of the ultrasound waves as compared to its surrounding tissues. The higher the echogenicity of the tissue is, the whiter it will appear on the ultrasound screen as compared to its surrounding tissues. On the contrary, the lower the echogenicity of the tissue is, the blacker it will appear on the screen.|participants|Number|19|19.0||||||
3680551|NCT02282111|3524500|B3|Indeterminate||Layer of origin||participants|Number|6|6.0||||||
3680552|NCT02282111|3524501|B2|Indeterminate||Layer of origin||participants|Number|4|4.0||||||
3680553|NCT02282111|3524502|B1|Indeterminate||Layer of origin||participants|Number|2|2.0||||||
3680554|NCT02282111|3524500|B3|Muscularis propria||Layer of origin||participants|Number|34|34.0||||||
3680555|NCT02282111|3524501|B2|Muscularis propria||Layer of origin||participants|Number|17|17.0||||||
3680556|NCT02282111|3524502|B1|Muscularis propria||Layer of origin||participants|Number|17|17.0||||||
3680557|NCT02282111|3524500|B3|Submucosa||Layer of origin||participants|Number|16|16.0||||||
3680558|NCT02282111|3524501|B2|Submucosa||Layer of origin||participants|Number|9|9.0||||||
3680559|NCT02282111|3524502|B1|Submucosa||Layer of origin||participants|Number|7|7.0||||||
3680560|NCT02282111|3524500|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3680561|NCT02282111|3524500|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3680562|NCT02282111|3524501|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3680563|NCT02282111|3524502|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3680564|NCT02282111|3524500|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3680565|NCT02282111|3524501|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3680566|NCT02282111|3524502|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3680567|NCT02282111|3524500|B3|||Age||years|Mean|67.4|67.4|Standard Deviation|12.7|12.7|||
3680568|NCT02282111|3524501|B2|||Age||years|Mean|66.2|66.2|Standard Deviation|13.4|13.4|||
3680569|NCT02282111|3524502|B1|||Age||years|Mean|68.7|68.7|Standard Deviation|11.9|11.9|||
3680570|NCT02281773|3524517|B6||Male|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
3680571|NCT02281773|3524518|B5||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3680572|NCT02281773|3524519|B4||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3680573|NCT02281773|3524520|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3680574|NCT02281773|3524521|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3680575|NCT02281773|3524522|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3680576|NCT02281773|3524517|B6||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3680577|NCT02281773|3524518|B5||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3680578|NCT02281773|3524519|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3680579|NCT02281773|3524520|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3680580|NCT02281773|3524521|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3680581|NCT02281773|3524522|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3680582|NCT02281773|3524517|B6|||Age||Years|Mean|42.3|42.3|Standard Deviation|9.5|9.5|||
3680583|NCT02281773|3524518|B5|||Age||Years|Mean|41.5|41.5|Standard Deviation|9.7|9.7|||
3680584|NCT02281773|3524519|B4|||Age||Years|Mean|42.3|42.3|Standard Deviation|9.5|9.5|||
3680585|NCT02281773|3524520|B3|||Age||Years|Mean|41.4|41.4|Standard Deviation|9.5|9.5|||
3680586|NCT02281773|3524521|B2|||Age||Years|Mean|43.2|43.2|Standard Deviation|9.4|9.4|||
3680587|NCT02281773|3524522|B1|||Age||Years|Mean|44.1|44.1|Standard Deviation|8.9|8.9|||
3680588|NCT02281591|3524583|B5||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3680589|NCT02281591|3524584|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3680590|NCT02281591|3524585|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3680591|NCT02281591|3524586|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3680592|NCT02281591|3524587|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3680593|NCT02281591|3524583|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3680594|NCT02281591|3524584|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3680595|NCT02281591|3524585|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3680596|NCT02281591|3524586|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3680597|NCT02281591|3524587|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3680598|NCT02281591|3524583|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3680599|NCT02281591|3524584|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3680600|NCT02281591|3524585|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3680601|NCT02281591|3524586|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3680602|NCT02281591|3524587|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3680603|NCT02281591|3524583|B5||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3680604|NCT02281591|3524584|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3680605|NCT02281591|3524585|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3680606|NCT02281591|3524586|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3680607|NCT02281591|3524587|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3680608|NCT02281591|3524583|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680609|NCT02281591|3524584|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680610|NCT02281591|3524585|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680611|NCT02281591|3524586|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680612|NCT02281591|3524587|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680613|NCT02281552|3524612|B3||Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3680614|NCT02281552|3524613|B2||Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3680615|NCT02281552|3524614|B1||Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3680616|NCT02281552|3524612|B3||More than one race|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3680617|NCT02281552|3524613|B2||More than one race|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3680618|NCT02281552|3524614|B1||More than one race|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3680619|NCT02281552|3524612|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3680620|NCT02281552|3524613|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3680621|NCT02281552|3524614|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3680622|NCT02281552|3524612|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3680623|NCT02281552|3524613|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3680624|NCT02281552|3524614|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3680625|NCT02281552|3524612|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3680626|NCT02281552|3524613|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3680627|NCT02281552|3524614|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3680628|NCT02281552|3524612|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3680629|NCT02281552|3524613|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3680630|NCT02281552|3524614|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3680631|NCT02281552|3524612|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|209|209.0||||||
3680632|NCT02281552|3524613|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|105|105.0||||||
3680633|NCT02281552|3524614|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|104|104.0||||||
3680634|NCT02281552|3524612|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3680635|NCT02281552|3524613|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3680636|NCT02281552|3524614|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3680637|NCT02281552|3524612|B3||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3680638|NCT02281552|3524613|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3680639|NCT02281552|3524614|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3680640|NCT02281552|3524612|B3|||Age||years|Mean|58|58.0|Standard Deviation|10.8|10.8|||
3680641|NCT02281552|3524613|B2|||Age||years|Mean|58.9|58.9|Standard Deviation|10.2|10.2|||
3680642|NCT02281552|3524614|B1|||Age||years|Mean|57.1|57.1|Standard Deviation|11.4|11.4|||
3680643|NCT02281526|3524653|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3680644|NCT02281526|3524654|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3680645|NCT02281526|3524655|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3680646|NCT02281526|3524653|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3680647|NCT02281526|3524654|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3680648|NCT02281526|3524655|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3680649|NCT02281526|3524653|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3680650|NCT02281526|3524654|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3680651|NCT02281526|3524655|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3680652|NCT02281526|3524653|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3680653|NCT02281526|3524654|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3680654|NCT02281526|3524655|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3680655|NCT02281526|3524653|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680656|NCT02281526|3524654|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680657|NCT02281526|3524655|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680658|NCT02281448|3524664|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3680659|NCT02281448|3524665|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3680660|NCT02281448|3524666|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3680661|NCT02281448|3524664|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3680662|NCT02281448|3524665|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3680663|NCT02281448|3524666|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3680664|NCT02281448|3524664|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3680665|NCT02281448|3524665|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3680666|NCT02281448|3524666|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3680667|NCT02281448|3524664|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3680668|NCT02281448|3524665|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3680669|NCT02281448|3524666|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3680670|NCT02281448|3524664|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680671|NCT02281448|3524665|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680672|NCT02281448|3524666|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680673|NCT02281422|3524675|B6||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3680674|NCT02281422|3524676|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3680675|NCT02281422|3524677|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3680676|NCT02281422|3524678|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3680677|NCT02281422|3524679|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3680678|NCT02281422|3524680|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3680679|NCT02281422|3524675|B6||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3680680|NCT02281422|3524676|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3680681|NCT02281422|3524677|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3680682|NCT02281422|3524678|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3680683|NCT02281422|3524679|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3680684|NCT02281422|3524680|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3680685|NCT02281422|3524675|B6||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3680686|NCT02281422|3524676|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3680687|NCT02281422|3524677|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3680688|NCT02281422|3524678|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3680689|NCT02281422|3524679|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3680690|NCT02281422|3524680|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3680691|NCT02281422|3524675|B6||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3680692|NCT02281422|3524676|B5||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3680693|NCT02281422|3524677|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3680694|NCT02281422|3524678|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3680695|NCT02281422|3524679|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3680696|NCT02281422|3524680|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3680697|NCT02281422|3524675|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680698|NCT02281422|3524676|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680699|NCT02281422|3524677|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680700|NCT02281422|3524678|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680701|NCT02281422|3524679|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680702|NCT02281422|3524680|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680703|NCT02281357|3524706|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3680704|NCT02281357|3524707|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3680705|NCT02281357|3524708|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3680706|NCT02281357|3524706|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680707|NCT02281357|3524707|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680708|NCT02281357|3524708|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680709|NCT02281357|3524706|B3||White|Race (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
3680710|NCT02281357|3524707|B2||White|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3680711|NCT02281357|3524708|B1||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3680712|NCT02281357|3524706|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3680713|NCT02281357|3524707|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3680714|NCT02281357|3524708|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3680715|NCT02281357|3524706|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680716|NCT02281357|3524707|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680717|NCT02281357|3524708|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680718|NCT02281357|3524706|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3680719|NCT02281357|3524707|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680720|NCT02281357|3524708|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3680721|NCT02281357|3524706|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680722|NCT02281357|3524707|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680723|NCT02281357|3524708|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680724|NCT02281357|3524706|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3680725|NCT02281357|3524707|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3680726|NCT02281357|3524708|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3680727|NCT02281357|3524706|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3680728|NCT02281357|3524707|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3680729|NCT02281357|3524708|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3680730|NCT02281357|3524706|B3|||Age||years|Mean|54.7|54.7|Standard Deviation|10.65|10.65|||
3680731|NCT02281357|3524707|B2|||Age||years|Mean|55.4|55.4|Standard Deviation|10.26|10.26|||
3680732|NCT02281357|3524708|B1|||Age||years|Mean|54.0|54.0|Standard Deviation|11.05|11.05|||
3680733|NCT02281357|3524706|B3||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
3680734|NCT02281357|3524707|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3680735|NCT02281357|3524708|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3680736|NCT02281357|3524706|B3||Between 18 and 65 years|Age||Participants|Count of Participants|113|113.0||||||
3680737|NCT02281357|3524707|B2||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
3680738|NCT02281357|3524708|B1||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3680739|NCT02281357|3524706|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3680740|NCT02281357|3524707|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680741|NCT02281357|3524708|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3680742|NCT02281318|3524721|B3|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|502|502.0||||||
3680743|NCT02281318|3524722|B2|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|251|251.0||||||
3680744|NCT02281318|3524723|B1|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|251|251.0||||||
3680745|NCT02281318|3524721|B3|White-Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3680746|NCT02281318|3524722|B2|White-Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3680747|NCT02281318|3524723|B1|White-Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3680748|NCT02281318|3524721|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3680749|NCT02281318|3524722|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3680750|NCT02281318|3524723|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3680751|NCT02281318|3524721|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
3680752|NCT02281318|3524722|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3680753|NCT02281318|3524723|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3680754|NCT02281318|3524721|B3|Asian-South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3680755|NCT02281318|3524722|B2|Asian-South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3680756|NCT02281318|3524723|B1|Asian-South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3680757|NCT02281318|3524721|B3|Asian-East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3680758|NCT02281318|3524722|B2|Asian-East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3680759|NCT02281318|3524723|B1|Asian-East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3680760|NCT02281318|3524721|B3|Asian-Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3680761|NCT02281318|3524722|B2|Asian-Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3680762|NCT02281318|3524723|B1|Asian-Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3680763|NCT02281318|3524721|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
3680764|NCT02281318|3524722|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3680765|NCT02281318|3524723|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
3680766|NCT02281318|3524721|B3||Male|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
3680767|NCT02281318|3524722|B2||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3680768|NCT02281318|3524723|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3680769|NCT02281318|3524721|B3||Female|Sex: Female, Male||Participants|Count of Participants|325|325.0||||||
3680770|NCT02281318|3524722|B2||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3680771|NCT02281318|3524723|B1||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
3680772|NCT02281318|3524721|B3|||Age||Years|Mean|51.0|51.0|Standard Deviation|13.52|13.52|||
3680773|NCT02281318|3524722|B2|||Age||Years|Mean|49.8|49.8|Standard Deviation|14.01|14.01|||
3680774|NCT02281318|3524723|B1|||Age||Years|Mean|52.1|52.1|Standard Deviation|12.94|12.94|||
3680775|NCT02281136|3524736|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3680776|NCT02281136|3524736|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680777|NCT02281136|3524736|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680778|NCT02281136|3524736|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3680779|NCT02281136|3524736|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680780|NCT02281136|3524736|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680781|NCT02281136|3524736|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680782|NCT02281136|3524736|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680783|NCT02281136|3524736|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680784|NCT02281136|3524736|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3680785|NCT02281136|3524736|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680786|NCT02281136|3524736|B1||Male|Gender||Participants|Count of Participants|23|23.0||||||
3680787|NCT02281136|3524736|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
3680788|NCT02281136|3524736|B1|||Age||years|Mean|67.7|67.7|Standard Deviation|8.8|8.8|||
3680789|NCT02280863|3524768|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3680790|NCT02280863|3524769|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3680791|NCT02280863|3524770|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3680792|NCT02280863|3524768|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3680793|NCT02280863|3524769|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3680794|NCT02280863|3524770|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3680795|NCT02280863|3524768|B3|65 year and older||Age, Customized||Participants|Count of Participants|0|0.0||||||
3680796|NCT02280863|3524769|B2|65 year and older||Age, Customized||Participants|Count of Participants|0|0.0||||||
3680797|NCT02280863|3524770|B1|65 year and older||Age, Customized||Participants|Count of Participants|0|0.0||||||
3680798|NCT02280863|3524768|B3|18-64 years||Age, Customized||Participants|Count of Participants|9|9.0||||||
3680799|NCT02280863|3524769|B2|18-64 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3680800|NCT02280863|3524770|B1|18-64 years||Age, Customized||Participants|Count of Participants|9|9.0||||||
3680801|NCT02280863|3524768|B3|13-17 years||Age, Customized||Participants|Count of Participants|15|15.0||||||
3680802|NCT02280863|3524769|B2|13-17 years||Age, Customized||Participants|Count of Participants|15|15.0||||||
3680803|NCT02280863|3524770|B1|13-17 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3680804|NCT02280863|3524768|B3|0-12 year||Age, Customized||Participants|Count of Participants|0|0.0||||||
3680805|NCT02280863|3524769|B2|0-12 year||Age, Customized||Participants|Count of Participants|0|0.0||||||
3680806|NCT02280863|3524770|B1|0-12 year||Age, Customized||Participants|Count of Participants|0|0.0||||||
3680807|NCT02280811|3524796|B6||Vaginal|Baseline Cancer Types||Participants|Count of Participants|1|1.0||||||
3680808|NCT02280811|3524797|B5||Vaginal|Baseline Cancer Types||Participants|Count of Participants|0|0.0||||||
3680809|NCT02280811|3524798|B4||Vaginal|Baseline Cancer Types||Participants|Count of Participants|0|0.0||||||
3680810|NCT02280811|3524799|B3||Vaginal|Baseline Cancer Types||Participants|Count of Participants|0|0.0||||||
3680811|NCT02280811|3524800|B2||Vaginal|Baseline Cancer Types||Participants|Count of Participants|0|0.0||||||
3680812|NCT02280811|3524801|B1||Vaginal|Baseline Cancer Types||Participants|Count of Participants|1|1.0||||||
3680813|NCT02280811|3524796|B6||Oropharyngeal|Baseline Cancer Types||Participants|Count of Participants|1|1.0||||||
3680814|NCT02280811|3524797|B5||Oropharyngeal|Baseline Cancer Types||Participants|Count of Participants|0|0.0||||||
3680815|NCT02280811|3524798|B4||Oropharyngeal|Baseline Cancer Types||Participants|Count of Participants|1|1.0||||||
3680816|NCT02280811|3524799|B3||Oropharyngeal|Baseline Cancer Types||Participants|Count of Participants|0|0.0||||||
3680817|NCT02280811|3524800|B2||Oropharyngeal|Baseline Cancer Types||Participants|Count of Participants|0|0.0||||||
3680818|NCT02280811|3524801|B1||Oropharyngeal|Baseline Cancer Types||Participants|Count of Participants|0|0.0||||||
3680819|NCT02280811|3524796|B6||Anal|Baseline Cancer Types||Participants|Count of Participants|4|4.0||||||
3680820|NCT02280811|3524797|B5||Anal|Baseline Cancer Types||Participants|Count of Participants|2|2.0||||||
3680821|NCT02280811|3524798|B4||Anal|Baseline Cancer Types||Participants|Count of Participants|2|2.0||||||
3680822|NCT02280811|3524799|B3||Anal|Baseline Cancer Types||Participants|Count of Participants|0|0.0||||||
3680823|NCT02280811|3524800|B2||Anal|Baseline Cancer Types||Participants|Count of Participants|0|0.0||||||
3680824|NCT02280811|3524801|B1||Anal|Baseline Cancer Types||Participants|Count of Participants|0|0.0||||||
3680825|NCT02280811|3524796|B6||Cervical|Baseline Cancer Types||Participants|Count of Participants|6|6.0||||||
3680826|NCT02280811|3524797|B5||Cervical|Baseline Cancer Types||Participants|Count of Participants|0|0.0||||||
3680827|NCT02280811|3524798|B4||Cervical|Baseline Cancer Types||Participants|Count of Participants|3|3.0||||||
3680828|NCT02280811|3524799|B3||Cervical|Baseline Cancer Types||Participants|Count of Participants|1|1.0||||||
3680829|NCT02280811|3524800|B2||Cervical|Baseline Cancer Types||Participants|Count of Participants|2|2.0||||||
3680830|NCT02280811|3524801|B1||Cervical|Baseline Cancer Types||Participants|Count of Participants|0|0.0||||||
3680831|NCT02280811|3524796|B6|United States||Region of Enrollment||participants|Number|12|12.0||||||
3680832|NCT02280811|3524797|B5|United States||Region of Enrollment||participants|Number|2|2.0||||||
3680833|NCT02280811|3524798|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
3680834|NCT02280811|3524799|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3680835|NCT02280811|3524800|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3680836|NCT02280811|3524801|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3680837|NCT02280811|3524796|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3680838|NCT02280811|3524797|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680839|NCT02280811|3524798|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680840|NCT02280811|3524799|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680841|NCT02280811|3524800|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3680842|NCT02280811|3524801|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680843|NCT02280811|3524796|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680844|NCT02280811|3524797|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680845|NCT02280811|3524798|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680846|NCT02280811|3524799|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680847|NCT02280811|3524800|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680848|NCT02280811|3524801|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680849|NCT02280811|3524796|B6||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3680850|NCT02280811|3524797|B5||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3680851|NCT02280811|3524798|B4||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3680852|NCT02280811|3524799|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3680853|NCT02280811|3524800|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3680854|NCT02280811|3524801|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3680855|NCT02280811|3524796|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680856|NCT02280811|3524797|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680857|NCT02280811|3524798|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680858|NCT02280811|3524799|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680859|NCT02280811|3524800|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680860|NCT02280811|3524801|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680861|NCT02280811|3524796|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680862|NCT02280811|3524797|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680863|NCT02280811|3524798|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680864|NCT02280811|3524799|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680865|NCT02280811|3524800|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680866|NCT02280811|3524801|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680867|NCT02280811|3524796|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680868|NCT02280811|3524797|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680869|NCT02280811|3524798|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680870|NCT02280811|3524799|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680871|NCT02280811|3524800|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680872|NCT02280811|3524801|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680873|NCT02280811|3524796|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680874|NCT02280811|3524797|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680875|NCT02280811|3524798|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680876|NCT02280811|3524799|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680877|NCT02280811|3524800|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680878|NCT02280811|3524801|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680879|NCT02280811|3524796|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680880|NCT02280811|3524797|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680881|NCT02280811|3524798|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680882|NCT02280811|3524799|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680883|NCT02280811|3524800|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680884|NCT02280811|3524801|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680885|NCT02280811|3524796|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3680886|NCT02280811|3524797|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3680887|NCT02280811|3524798|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3680888|NCT02280811|3524799|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3680889|NCT02280811|3524800|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3680890|NCT02280811|3524801|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3680891|NCT02280811|3524796|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3680892|NCT02280811|3524797|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680893|NCT02280811|3524798|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680894|NCT02280811|3524799|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680895|NCT02280811|3524800|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3680896|NCT02280811|3524801|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680897|NCT02280811|3524796|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3680898|NCT02280811|3524797|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3680899|NCT02280811|3524798|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3680900|NCT02280811|3524799|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3680901|NCT02280811|3524800|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3680902|NCT02280811|3524801|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3680903|NCT02280811|3524796|B6||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3680904|NCT02280811|3524797|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3680905|NCT02280811|3524798|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3680906|NCT02280811|3524799|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3680907|NCT02280811|3524800|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3680908|NCT02280811|3524801|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3680909|NCT02280811|3524796|B6|||Age||years|Mean|50.5|50.5|Standard Deviation|12.7|12.7|||
3680910|NCT02280811|3524797|B5|||Age||years|Mean|60.0|60.0|Standard Deviation|14.1|14.1|||
3680911|NCT02280811|3524798|B4|||Age||years|Mean|53.5|53.5|Standard Deviation|12.5|12.5|||
3680912|NCT02280811|3524799|B3|||Age||years|Mean|46.0|46.0|Standard Deviation|0|0.0|||
3680913|NCT02280811|3524800|B2|||Age||years|Mean|34.5|34.5|Standard Deviation|3.5|3.5|||
3680914|NCT02280811|3524801|B1|||Age||years|Mean|50.0|50.0|Standard Deviation|0|0.0|||
3680915|NCT02280811|3524796|B6||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3680916|NCT02280811|3524797|B5||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3680917|NCT02280811|3524798|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3680918|NCT02280811|3524799|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3680919|NCT02280811|3524800|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3680920|NCT02280811|3524801|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3680921|NCT02280811|3524796|B6||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3680922|NCT02280811|3524797|B5||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3680923|NCT02280811|3524798|B4||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3680924|NCT02280811|3524799|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3680925|NCT02280811|3524800|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3680926|NCT02280811|3524801|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3680927|NCT02280811|3524796|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680928|NCT02280811|3524797|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680929|NCT02280811|3524798|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680930|NCT02280811|3524799|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680931|NCT02280811|3524800|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680932|NCT02280811|3524801|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3680933|NCT02280655|3524844|B3|United States||Region of Enrollment||participants|Number|43|43.0||||||
3680934|NCT02280655|3524845|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
3680935|NCT02280655|3524846|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3680936|NCT02280655|3524844|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3680937|NCT02280655|3524845|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3680938|NCT02280655|3524846|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3680939|NCT02280655|3524844|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3680940|NCT02280655|3524845|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3680941|NCT02280655|3524846|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3680942|NCT02280655|3524844|B3|||Age||years|Mean|59|59.0|Standard Deviation|13|13.0|||
3680943|NCT02280655|3524845|B2|||Age||years|Mean|60|60.0|Standard Deviation|15|15.0|||
3680944|NCT02280655|3524846|B1|||Age||years|Mean|58|58.0|Standard Deviation|12|12.0|||
3680945|NCT02280499|3524855|B1|||Body Mass Index||kg/m2|Mean|26.81|26.81|Standard Deviation|4.45|4.45|||
3680946|NCT02280499|3524855|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3680947|NCT02280499|3524855|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3680948|NCT02280499|3524855|B1|||Age||years|Mean|67.8|67.8|Standard Deviation|11.4|11.4|||
3680949|NCT02280473|3524861|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3680950|NCT02280473|3524862|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3680951|NCT02280473|3524863|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3680952|NCT02280473|3524861|B3||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3680953|NCT02280473|3524862|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3680954|NCT02280473|3524863|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3680955|NCT02280473|3524861|B3|More than 40 years||Age, Customized||Participants|Number|139|139.0||||||
3680956|NCT02280473|3524862|B2|More than 40 years||Age, Customized||Participants|Number|67|67.0||||||
3680957|NCT02280473|3524863|B1|More than 40 years||Age, Customized||Participants|Number|72|72.0||||||
3680958|NCT02280473|3524861|B3|30 to 40 years||Age, Customized||Participants|Number|25|25.0||||||
3680959|NCT02280473|3524862|B2|30 to 40 years||Age, Customized||Participants|Number|14|14.0||||||
3680960|NCT02280473|3524863|B1|30 to 40 years||Age, Customized||Participants|Number|11|11.0||||||
3680961|NCT02280473|3524861|B3|18 to less than 30 years||Age, Customized||Participants|Number|24|24.0||||||
3680962|NCT02280473|3524862|B2|18 to less than 30 years||Age, Customized||Participants|Number|13|13.0||||||
3680963|NCT02280473|3524863|B1|18 to less than 30 years||Age, Customized||Participants|Number|11|11.0||||||
3680964|NCT02280226|3524878|B1|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
3680965|NCT02280226|3524878|B1|Germany||Region of Enrollment||participants|Number|16|16.0||||||
3680966|NCT02280226|3524878|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3680967|NCT02280226|3524878|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3680968|NCT02280226|3524878|B1|||Age||years|Mean|40|40.0|Standard Deviation|11|11.0|||
3680969|NCT02280187|3524883|B1|Non-diabetics||Medical history with or without Diabetes||participants|Number|371|371.0||||||
3680970|NCT02280187|3524883|B1|Diabetics||Medical history with or without Diabetes||participants|Number|29|29.0||||||
3680971|NCT02280187|3524883|B1|Not available||Smoking Status||participants|Number|23|23.0||||||
3680972|NCT02280187|3524883|B1|Not currently smoking||Smoking Status||participants|Number|267|267.0||||||
3680973|NCT02280187|3524883|B1|Current smoker||Smoking Status||participants|Number|110|110.0||||||
3680974|NCT02280187|3524883|B1||Male|Gender||Participants|Count of Participants|163|163.0||||||
3680975|NCT02280187|3524883|B1||Female|Gender||Participants|Count of Participants|237|237.0||||||
3680976|NCT02280187|3524883|B1|||Age||years|Mean|54.5|54.5|Standard Deviation|14.8|14.8|||
3680977|NCT02280122|3524899|B3|Germany||Region of Enrollment||participants|Number|60|60.0||||||
3680978|NCT02280122|3524900|B2|Germany||Region of Enrollment||participants|Number|30|30.0||||||
3680979|NCT02280122|3524901|B1|Germany||Region of Enrollment||participants|Number|30|30.0||||||
3680980|NCT02280122|3524899|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3680981|NCT02280122|3524900|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3680982|NCT02280122|3524901|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3680983|NCT02280122|3524899|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3680984|NCT02280122|3524900|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3680985|NCT02280122|3524901|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3680986|NCT02280122|3524899|B3|||Age||years|Mean|41.2|41.2|Standard Deviation|15.9|15.9|||
3680987|NCT02280122|3524900|B2|||Age||years|Mean|28.4|28.4|Standard Deviation|7.9|7.9|||
3680988|NCT02280122|3524901|B1|||Age||years|Mean|53.9|53.9|Standard Deviation|10.7|10.7|||
3680989|NCT02280044|3524909|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3680990|NCT02280044|3524910|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3680991|NCT02280044|3524911|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3680992|NCT02280044|3524909|B3|Race|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681050|NCT02279862|3524921|B2|||Age||years|Median|66.50|66.5|Full Range|9.98|9.98|49.0|87.0|
3680993|NCT02280044|3524910|B2|Race|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680994|NCT02280044|3524911|B1|Race|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680995|NCT02280044|3524909|B3|Race|More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3680996|NCT02280044|3524910|B2|Race|More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3680997|NCT02280044|3524911|B1|Race|More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3680998|NCT02280044|3524909|B3|Race|White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3680999|NCT02280044|3524910|B2|Race|White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3681000|NCT02280044|3524911|B1|Race|White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3681001|NCT02280044|3524909|B3|Race|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3681002|NCT02280044|3524910|B2|Race|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3681003|NCT02280044|3524911|B1|Race|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3681004|NCT02280044|3524909|B3|Race|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681005|NCT02280044|3524910|B2|Race|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681006|NCT02280044|3524911|B1|Race|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681007|NCT02280044|3524909|B3|Race|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681008|NCT02280044|3524910|B2|Race|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681009|NCT02280044|3524911|B1|Race|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681010|NCT02280044|3524909|B3|Race|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681011|NCT02280044|3524910|B2|Race|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681012|NCT02280044|3524911|B1|Race|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681013|NCT02280044|3524909|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3681014|NCT02280044|3524910|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3681015|NCT02280044|3524911|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3681016|NCT02280044|3524909|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3681017|NCT02280044|3524910|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3681018|NCT02280044|3524911|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3681019|NCT02280044|3524909|B3|||Age||years|Median|31|31.0|Inter-Quartile Range|||29.0|38.0|
3681020|NCT02280044|3524910|B2|||Age||years|Median|31|31.0|Inter-Quartile Range|||26.0|41.0|
3681021|NCT02280044|3524911|B1|||Age||years|Median|30|30.0|Inter-Quartile Range|||29.0|37.0|
3681022|NCT02279862|3524920|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3681023|NCT02279862|3524921|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3681024|NCT02279862|3524922|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681025|NCT02279862|3524920|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681026|NCT02279862|3524921|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681027|NCT02279862|3524922|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681028|NCT02279862|3524920|B3||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3681029|NCT02279862|3524921|B2||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3681030|NCT02279862|3524922|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3681031|NCT02279862|3524920|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3681032|NCT02279862|3524921|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3681033|NCT02279862|3524922|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681034|NCT02279862|3524920|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681035|NCT02279862|3524921|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681036|NCT02279862|3524922|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681037|NCT02279862|3524920|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681038|NCT02279862|3524921|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681039|NCT02279862|3524922|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681040|NCT02279862|3524920|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681041|NCT02279862|3524921|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681042|NCT02279862|3524922|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681043|NCT02279862|3524920|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3681044|NCT02279862|3524921|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3681045|NCT02279862|3524922|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3681046|NCT02279862|3524920|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3681047|NCT02279862|3524921|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3681048|NCT02279862|3524922|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3681049|NCT02279862|3524920|B3|||Age||years|Median|66.00|66.0|Full Range|9.08|9.08|49.0|87.0|
3681051|NCT02279862|3524922|B1|||Age||years|Median|66.00|66.0|Full Range|8.23|8.23|50.0|85.0|
3681052|NCT02279667|3524939|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3681053|NCT02279667|3524940|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3681054|NCT02279667|3524941|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3681055|NCT02279667|3524942|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3681056|NCT02279667|3524939|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3681057|NCT02279667|3524940|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3681058|NCT02279667|3524941|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3681059|NCT02279667|3524942|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3681060|NCT02279667|3524939|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3681061|NCT02279667|3524940|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3681062|NCT02279667|3524941|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3681063|NCT02279667|3524942|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3681064|NCT02279667|3524939|B4||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3681065|NCT02279667|3524940|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3681066|NCT02279667|3524941|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3681067|NCT02279667|3524942|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3681068|NCT02279667|3524939|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3681069|NCT02279667|3524940|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3681070|NCT02279667|3524941|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3681071|NCT02279667|3524942|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3681072|NCT02279641|3524962|B3|United States||Region of Enrollment||Participants|Number|12|12.0||||||
3681073|NCT02279641|3524963|B2|United States||Region of Enrollment||Participants|Number|6|6.0||||||
3681074|NCT02279641|3524964|B1|United States||Region of Enrollment||Participants|Number|6|6.0||||||
3681075|NCT02279641|3524962|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3681076|NCT02279641|3524963|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3681077|NCT02279641|3524964|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3681078|NCT02279641|3524962|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3681079|NCT02279641|3524963|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3681080|NCT02279641|3524964|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3681081|NCT02279641|3524962|B3|>=65||Age, Customized||Participants|Number|0|0.0||||||
3681082|NCT02279641|3524963|B2|>=65||Age, Customized||Participants|Number|0|0.0||||||
3681083|NCT02279641|3524964|B1|>=65||Age, Customized||Participants|Number|0|0.0||||||
3681084|NCT02279641|3524962|B3|<65||Age, Customized||Participants|Number|12|12.0||||||
3681085|NCT02279641|3524963|B2|<65||Age, Customized||Participants|Number|6|6.0||||||
3681086|NCT02279641|3524964|B1|<65||Age, Customized||Participants|Number|6|6.0||||||
3681087|NCT02279641|3524962|B3|||Age||Years|Mean|51|51.0|Standard Deviation|10.0|10.0|||
3681088|NCT02279641|3524963|B2|||Age||Years|Mean|49|49.0|Standard Deviation|10.4|10.4|||
3681089|NCT02279641|3524964|B1|||Age||Years|Mean|53|53.0|Standard Deviation|10.1|10.1|||
3681090|NCT02279498|3525019|B3|||pre-randomization enzyme dose||lipase units/kg/day|Mean|6282|6282.0|Full Range|||1190.0|9981.0|
3681091|NCT02279498|3525020|B2|||pre-randomization enzyme dose||lipase units/kg/day|Mean|6264|6264.0|Full Range|||1692.0|9962.0|
3681092|NCT02279498|3525021|B1|||pre-randomization enzyme dose||lipase units/kg/day|Mean|6299|6299.0|Full Range|||1190.0|9981.0|
3681093|NCT02279498|3525019|B3|||Coefficient of nitrogen absorption (CNA)||% of nitrogen ingested|Mean|97.1|97.1|Full Range|||92.0|99.0|
3681094|NCT02279498|3525020|B2|||Coefficient of nitrogen absorption (CNA)||% of nitrogen ingested|Mean|97.3|97.3|Full Range|||94.0|99.0|
3681095|NCT02279498|3525021|B1|||Coefficient of nitrogen absorption (CNA)||% of nitrogen ingested|Mean|96.9|96.9|Full Range|||92.0|99.0|
3681096|NCT02279498|3525019|B3|||Coefficient of fat absorption (CFA)||fat absorbed as percent of fat ingested|Mean|89.1|89.1|Full Range|||79.0|98.0|
3681097|NCT02279498|3525020|B2|||Coefficient of fat absorption (CFA)||fat absorbed as percent of fat ingested|Mean|89.4|89.4|Full Range|||79.0|97.0|
3681098|NCT02279498|3525021|B1|||Coefficient of fat absorption (CFA)||fat absorbed as percent of fat ingested|Mean|88.7|88.7|Full Range|||80.0|98.0|
3681099|NCT02279498|3525019|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3681100|NCT02279498|3525020|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3681101|NCT02279498|3525021|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3681102|NCT02279498|3525019|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681103|NCT02279498|3525020|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681104|NCT02279498|3525021|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681105|NCT02279498|3525019|B3||White|Race (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
3681106|NCT02279498|3525020|B2||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3681107|NCT02279498|3525021|B1||White|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3681108|NCT02279498|3525019|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681109|NCT02279498|3525020|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681110|NCT02279498|3525021|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681111|NCT02279498|3525019|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3681112|NCT02279498|3525020|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681113|NCT02279498|3525021|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3681114|NCT02279498|3525019|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681115|NCT02279498|3525020|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681116|NCT02279498|3525021|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681117|NCT02279498|3525019|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681118|NCT02279498|3525020|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681119|NCT02279498|3525021|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681120|NCT02279498|3525019|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3681121|NCT02279498|3525020|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3681122|NCT02279498|3525021|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3681123|NCT02279498|3525019|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3681124|NCT02279498|3525020|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3681125|NCT02279498|3525021|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3681126|NCT02279498|3525019|B3|||Age||years|Mean|21.8|21.8|Standard Deviation|8.74|8.74|||
3681127|NCT02279498|3525020|B2|||Age||years|Mean|21.0|21.0|Standard Deviation|8.95|8.95|||
3681128|NCT02279498|3525021|B1|||Age||years|Mean|22.5|22.5|Standard Deviation|8.54|8.54|||
3681129|NCT02279420|3525031|B1|United States||Region of Enrollment||Participants|Count of Participants|73|73.0||||||
3681130|NCT02279420|3525031|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3681131|NCT02279420|3525031|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3681132|NCT02279420|3525031|B1|||Age||years|Mean|45.2|45.2|Standard Deviation|9.1|9.1|||
3681133|NCT02279407|3525035|B5|White||Race/Ethnicity, Customized||Participants|Number|82|82.0||||||
3681134|NCT02279407|3525036|B4|White||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
3681135|NCT02279407|3525037|B3|White||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
3681136|NCT02279407|3525038|B2|White||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
3681137|NCT02279407|3525039|B1|White||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
3681138|NCT02279407|3525035|B5|Black Or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3681139|NCT02279407|3525036|B4|Black Or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3681140|NCT02279407|3525037|B3|Black Or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3681141|NCT02279407|3525038|B2|Black Or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3681142|NCT02279407|3525039|B1|Black Or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3681143|NCT02279407|3525035|B5||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3681144|NCT02279407|3525036|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3681145|NCT02279407|3525037|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3681146|NCT02279407|3525038|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3681147|NCT02279407|3525039|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3681148|NCT02279407|3525035|B5||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3681149|NCT02279407|3525036|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3681150|NCT02279407|3525037|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3681151|NCT02279407|3525038|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3681152|NCT02279407|3525039|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3681153|NCT02279407|3525035|B5|>=65||Age, Customized||Participants|Number|56|56.0||||||
3681154|NCT02279407|3525036|B4|>=65||Age, Customized||Participants|Number|15|15.0||||||
3681155|NCT02279407|3525037|B3|>=65||Age, Customized||Participants|Number|14|14.0||||||
3681156|NCT02279407|3525038|B2|>=65||Age, Customized||Participants|Number|14|14.0||||||
3681157|NCT02279407|3525039|B1|>=65||Age, Customized||Participants|Number|13|13.0||||||
3681158|NCT02279407|3525035|B5|>=50 - <65||Age, Customized||Participants|Number|27|27.0||||||
3681159|NCT02279407|3525036|B4|>=50 - <65||Age, Customized||Participants|Number|6|6.0||||||
3681160|NCT02279407|3525037|B3|>=50 - <65||Age, Customized||Participants|Number|6|6.0||||||
3681161|NCT02279407|3525038|B2|>=50 - <65||Age, Customized||Participants|Number|6|6.0||||||
3681162|NCT02279407|3525039|B1|>=50 - <65||Age, Customized||Participants|Number|9|9.0||||||
3681163|NCT02279407|3525035|B5|<50||Age, Customized||Participants|Number|1|1.0||||||
3681164|NCT02279407|3525036|B4|<50||Age, Customized||Participants|Number|0|0.0||||||
3681165|NCT02279407|3525037|B3|<50||Age, Customized||Participants|Number|1|1.0||||||
3681166|NCT02279407|3525038|B2|<50||Age, Customized||Participants|Number|0|0.0||||||
3681167|NCT02279407|3525039|B1|<50||Age, Customized||Participants|Number|0|0.0||||||
3681168|NCT02279407|3525035|B5|||Age||Years|Mean|65.5|65.5|Standard Deviation|5.92|5.92|48.0|74.0|
3681169|NCT02279407|3525036|B4|||Age||Years|Mean|65.6|65.6|Standard Deviation|6.10|6.1|52.0|74.0|
3681170|NCT02279407|3525037|B3|||Age||Years|Mean|65.0|65.0|Standard Deviation|6.54|6.54|48.0|74.0|
3681171|NCT02279407|3525038|B2|||Age||Years|Mean|66.2|66.2|Standard Deviation|5.94|5.94|50.0|73.0|
3681172|NCT02279407|3525039|B1|||Age||Years|Mean|65.0|65.0|Standard Deviation|5.42|5.42|54.0|74.0|
3681173|NCT02279108|3525053|B3|||tumor size||mm|Median|15|15.0|Inter-Quartile Range|||10.0|23.0|
3681174|NCT02279108|3525054|B2|||tumor size||mm|Median|15|15.0|Inter-Quartile Range|||11.0|22.5|
3681175|NCT02279108|3525055|B1|||tumor size||mm|Median|15|15.0|Inter-Quartile Range|||10.0|25.0|
3681176|NCT02279108|3525053|B3|||menopause||Participants|Count of Participants|64|64.0||||||
3681177|NCT02279108|3525054|B2|||menopause||Participants|Count of Participants|30|30.0||||||
3681178|NCT02279108|3525055|B1|||menopause||Participants|Count of Participants|34|34.0||||||
3681179|NCT02279108|3525053|B3|||age of first menstruation, continuous||years|Mean|12.8|12.8|Standard Deviation|1.5|1.5|||
3681180|NCT02279108|3525054|B2|||age of first menstruation, continuous||years|Mean|12.8|12.8|Standard Deviation|1.4|1.4|||
3681181|NCT02279108|3525055|B1|||age of first menstruation, continuous||years|Mean|12.8|12.8|Standard Deviation|1.5|1.5|||
3681182|NCT02279108|3525053|B3|||weight, continuous||kg|Mean|67.3|67.3|Standard Deviation|12.3|12.3|||
3681183|NCT02279108|3525054|B2|||weight, continuous||kg|Mean|65.0|65.0|Standard Deviation|11.1|11.1|||
3681184|NCT02279108|3525055|B1|||weight, continuous||kg|Mean|69.6|69.6|Standard Deviation|13|13.0|||
3681185|NCT02279108|3525053|B3|||height, continuous||cm|Mean|160.8|160.8|Standard Deviation|5.7|5.7|||
3681186|NCT02279108|3525054|B2|||height, continuous||cm|Mean|160.4|160.4|Standard Deviation|6.1|6.1|||
3681187|NCT02279108|3525055|B1|||height, continuous||cm|Mean|161.1|161.1|Standard Deviation|5.4|5.4|||
3681188|NCT02279108|3525053|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3681189|NCT02279108|3525053|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3681190|NCT02279108|3525054|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3681191|NCT02279108|3525055|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3681192|NCT02279108|3525053|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3681193|NCT02279108|3525054|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3681194|NCT02279108|3525055|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3681195|NCT02279108|3525053|B3|||Age||years|Mean|61.3|61.3|Standard Deviation|12.2|12.2|||
3681196|NCT02279108|3525054|B2|||Age||years|Mean|60.2|60.2|Standard Deviation|12.5|12.5|||
3681197|NCT02279108|3525055|B1|||Age||years|Mean|62.2|62.2|Standard Deviation|12.0|12.0|||
3681198|NCT02279082|3525078|B1|United States||Region of Enrollment||participants|Number|167|167.0||||||
3681199|NCT02279082|3525078|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681200|NCT02279082|3525078|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3681201|NCT02279082|3525078|B1||White|Race (NIH/OMB)||Participants|Count of Participants|136|136.0||||||
3681202|NCT02279082|3525078|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3681203|NCT02279082|3525078|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3681204|NCT02279082|3525078|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3681205|NCT02279082|3525078|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681206|NCT02279082|3525078|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3681207|NCT02279082|3525078|B1||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3681208|NCT02279082|3525078|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3681209|NCT02279082|3525078|B1||Between 18 and 65 years|Age||Participants|Count of Participants|167|167.0||||||
3681210|NCT02279082|3525078|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3681211|NCT02278939|3525082|B3|United States||Region of Enrollment||participants|Number|67|67.0||||||
3681212|NCT02278939|3525083|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
3681213|NCT02278939|3525084|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
3681214|NCT02278939|3525082|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681215|NCT02278939|3525083|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681216|NCT02278939|3525084|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|00|0.0||||||
3681217|NCT02278939|3525082|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681218|NCT02278939|3525083|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681219|NCT02278939|3525084|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681220|NCT02278939|3525082|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681221|NCT02278939|3525083|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681222|NCT02278939|3525084|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681223|NCT02278939|3525082|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681224|NCT02278939|3525083|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681225|NCT02278939|3525084|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681226|NCT02278939|3525082|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681227|NCT02278939|3525083|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681228|NCT02278939|3525084|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681229|NCT02278939|3525082|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3681230|NCT02278939|3525083|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3681231|NCT02278939|3525084|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3681232|NCT02278939|3525082|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681233|NCT02278939|3525083|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681234|NCT02278939|3525084|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681235|NCT02278939|3525082|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681236|NCT02278939|3525083|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681237|NCT02278939|3525084|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681238|NCT02278939|3525082|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3681239|NCT02278939|3525083|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3681240|NCT02278939|3525084|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3681241|NCT02278939|3525082|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681242|NCT02278939|3525083|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681243|NCT02278939|3525084|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681244|NCT02278939|3525082|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3681245|NCT02278939|3525083|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3681246|NCT02278939|3525084|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3681247|NCT02278939|3525082|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3681248|NCT02278939|3525083|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3681249|NCT02278939|3525084|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3681250|NCT02278939|3525082|B3|||Age||years|Mean|41.8|41.8|Standard Deviation|11.8|11.8|||
3681251|NCT02278939|3525083|B2|||Age||years|Mean|42.1|42.1|Standard Deviation|12.1|12.1|||
3681252|NCT02278939|3525084|B1|||Age||years|Mean|41.3|41.3|Standard Deviation|12.1|12.1|||
3681253|NCT02278939|3525082|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3681254|NCT02278939|3525083|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3681255|NCT02278939|3525084|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3681256|NCT02278939|3525082|B3||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
3681257|NCT02278939|3525083|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3681258|NCT02278939|3525084|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3681259|NCT02278939|3525082|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3681260|NCT02278939|3525083|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3681261|NCT02278939|3525084|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3681262|NCT02278783|3525097|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3681263|NCT02278783|3525097|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3681264|NCT02278783|3525097|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3681265|NCT02278783|3525097|B1|||Age||years|Median|71|71.0|Full Range|||71.0|71.0|
3681266|NCT02278783|3525097|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3681267|NCT02278783|3525097|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3681268|NCT02278783|3525097|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3681269|NCT02278640|3525104|B1|United Kingdom||Region of Enrollment||participants|Number|20|20.0||||||
3681270|NCT02278640|3525104|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3681271|NCT02278640|3525104|B1|Netherlands||Region of Enrollment||participants|Number|15|15.0||||||
3681272|NCT02278640|3525104|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681273|NCT02278640|3525104|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681274|NCT02278640|3525104|B1||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3681275|NCT02278640|3525104|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3681276|NCT02278640|3525104|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681277|NCT02278640|3525104|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681278|NCT02278640|3525104|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681279|NCT02278640|3525104|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3681280|NCT02278640|3525104|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3681281|NCT02278640|3525104|B1|||Age||years|Mean|48.5|48.5|Standard Deviation|6.9|6.9|||
3681282|NCT02278614|3525111|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3681283|NCT02278614|3525112|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3681284|NCT02278614|3525113|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3681285|NCT02278614|3525111|B3||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3681286|NCT02278614|3525112|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3681287|NCT02278614|3525113|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3681288|NCT02278614|3525111|B3|||Age||years|Mean|66.3|66.3|Standard Deviation|10.8|10.8|||
3681289|NCT02278614|3525112|B2|||Age||years|Mean|67.2|67.2|Standard Deviation|10.6|10.6|||
3681290|NCT02278614|3525113|B1|||Age||years|Mean|65.8|65.8|Standard Deviation|10.8|10.8|||
3681291|NCT02278614|3525111|B3||>=65 years|Age||Participants|Count of Participants|146|146.0||||||
3681292|NCT02278614|3525112|B2||>=65 years|Age||Participants|Count of Participants|72|72.0||||||
3681293|NCT02278614|3525113|B1||>=65 years|Age||Participants|Count of Participants|74|74.0||||||
3681294|NCT02278614|3525111|B3||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
3681295|NCT02278614|3525112|B2||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
3681296|NCT02278614|3525113|B1||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
3681297|NCT02278614|3525111|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3681298|NCT02278614|3525112|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3681299|NCT02278614|3525113|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3681300|NCT02278562|3525120|B4|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3681301|NCT02278562|3525121|B3|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3681302|NCT02278562|3525122|B2|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3681303|NCT02278562|3525123|B1|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3681304|NCT02278562|3525120|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681305|NCT02278562|3525121|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681306|NCT02278562|3525122|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681307|NCT02278562|3525123|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681308|NCT02278562|3525120|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681309|NCT02278562|3525121|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681310|NCT02278562|3525122|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681311|NCT02278562|3525123|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681312|NCT02278562|3525120|B4||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3681313|NCT02278562|3525121|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3681314|NCT02278562|3525122|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3681315|NCT02278562|3525123|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3681316|NCT02278562|3525120|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3681317|NCT02278562|3525121|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3681318|NCT02278562|3525122|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3681319|NCT02278562|3525123|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3681320|NCT02278562|3525120|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681321|NCT02278562|3525121|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681322|NCT02278562|3525122|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681323|NCT02278562|3525123|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681324|NCT02278562|3525120|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681325|NCT02278562|3525121|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681326|NCT02278562|3525122|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681327|NCT02278562|3525123|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681328|NCT02278562|3525120|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681329|NCT02278562|3525121|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681330|NCT02278562|3525122|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681331|NCT02278562|3525123|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681332|NCT02278562|3525120|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681333|NCT02278562|3525121|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681334|NCT02278562|3525122|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681335|NCT02278562|3525123|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681336|NCT02278562|3525120|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3681337|NCT02278562|3525121|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3681338|NCT02278562|3525122|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3681339|NCT02278562|3525123|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3681340|NCT02278562|3525120|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3681341|NCT02278562|3525121|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3681342|NCT02278562|3525122|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681343|NCT02278562|3525123|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681344|NCT02278562|3525120|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3681345|NCT02278562|3525121|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3681346|NCT02278562|3525122|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3681347|NCT02278562|3525123|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3681348|NCT02278562|3525120|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3681349|NCT02278562|3525121|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3681350|NCT02278562|3525122|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3681351|NCT02278562|3525123|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3681352|NCT02278562|3525120|B4|||Age||years|Mean|49|49.0|Standard Deviation|15|15.0|||
3681353|NCT02278562|3525121|B3|||Age||years|Mean|56|56.0|Standard Deviation|12|12.0|||
3681354|NCT02278562|3525122|B2|||Age||years|Mean|46|46.0|Standard Deviation|15|15.0|||
3681355|NCT02278562|3525123|B1|||Age||years|Mean|45|45.0|Standard Deviation|17|17.0|||
3681356|NCT02278484|3525139|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3681357|NCT02278484|3525139|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3681358|NCT02278484|3525139|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3681359|NCT02278484|3525139|B1|||Age||years|Mean|9.7|9.7|Standard Deviation|4.9|4.9|||
3681360|NCT02278146|3525146|B3|Female||Sex/Gender, Customized||participants|Number|16|16.0||||||
3681361|NCT02278146|3525147|B2|Female||Sex/Gender, Customized||participants|Number|10|10.0||||||
3681362|NCT02278146|3525148|B1|Female||Sex/Gender, Customized||participants|Number|6|6.0||||||
3681363|NCT02278146|3525146|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3681364|NCT02278146|3525147|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3681365|NCT02278146|3525148|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3681366|NCT02278146|3525146|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3681367|NCT02278146|3525147|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3681368|NCT02278146|3525148|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3681369|NCT02278146|3525146|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3681370|NCT02278146|3525147|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3681371|NCT02278146|3525148|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3681372|NCT02278003|3525159|B3|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3681373|NCT02278003|3525160|B2|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3681374|NCT02278003|3525161|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3681375|NCT02278003|3525159|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3681376|NCT02278003|3525160|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681377|NCT02278003|3525161|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3681378|NCT02278003|3525159|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681379|NCT02278003|3525160|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681380|NCT02278003|3525161|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681381|NCT02278003|3525159|B3||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3681382|NCT02278003|3525160|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3681383|NCT02278003|3525161|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3681384|NCT02278003|3525159|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3681385|NCT02278003|3525160|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3681386|NCT02278003|3525161|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3681387|NCT02278003|3525159|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681388|NCT02278003|3525160|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681389|NCT02278003|3525161|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681390|NCT02278003|3525159|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681391|NCT02278003|3525160|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681392|NCT02278003|3525161|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681393|NCT02278003|3525159|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681394|NCT02278003|3525160|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681395|NCT02278003|3525161|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681396|NCT02278003|3525159|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681397|NCT02278003|3525160|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681398|NCT02278003|3525161|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681399|NCT02278003|3525159|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3681400|NCT02278003|3525160|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3681401|NCT02278003|3525161|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3681402|NCT02278003|3525159|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3681403|NCT02278003|3525160|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3681404|NCT02278003|3525161|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3681405|NCT02278003|3525159|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3681406|NCT02278003|3525160|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3681407|NCT02278003|3525161|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3681408|NCT02278003|3525159|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3681409|NCT02278003|3525160|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3681410|NCT02278003|3525161|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3681411|NCT02278003|3525159|B3|||Age||years|Mean|7.2|7.2|Full Range|||4.2|12.6|
3681412|NCT02278003|3525160|B2|||Age||years|Mean|8.8|8.8|Full Range|||4.4|12.6|
3681413|NCT02278003|3525161|B1|||Age||years|Mean|6.2|6.2|Full Range|||4.2|11.0|
3681414|NCT02277769|3525170|B4|||Total Hospital Anxiety Depression Scale (HADS)|The HADS is a fourteen item scale. Seven of the items relate to anxiety and seven relate to depression. Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 (no symptoms) and 21 (severe symptoms) for either anxiety or depression. Cut-offs for identifying psychiatric distress has been reported as 7 to 8 for possible presence, 10 to 11 for probable presence, and 14 to 15 for severe anxiety or depression.|units on a scale|Mean|14.0|14.0|Standard Deviation|8.04|8.04|||
3681415|NCT02277769|3525171|B3|||Total Hospital Anxiety Depression Scale (HADS)|The HADS is a fourteen item scale. Seven of the items relate to anxiety and seven relate to depression. Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 (no symptoms) and 21 (severe symptoms) for either anxiety or depression. Cut-offs for identifying psychiatric distress has been reported as 7 to 8 for possible presence, 10 to 11 for probable presence, and 14 to 15 for severe anxiety or depression.|units on a scale|Mean|14.6|14.6|Standard Deviation|8.24|8.24|||
3681416|NCT02277769|3525172|B2|||Total Hospital Anxiety Depression Scale (HADS)|The HADS is a fourteen item scale. Seven of the items relate to anxiety and seven relate to depression. Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 (no symptoms) and 21 (severe symptoms) for either anxiety or depression. Cut-offs for identifying psychiatric distress has been reported as 7 to 8 for possible presence, 10 to 11 for probable presence, and 14 to 15 for severe anxiety or depression.|units on a scale|Mean|13.7|13.7|Standard Deviation|7.52|7.52|||
3681417|NCT02277769|3525173|B1|||Total Hospital Anxiety Depression Scale (HADS)|The HADS is a fourteen item scale. Seven of the items relate to anxiety and seven relate to depression. Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 (no symptoms) and 21 (severe symptoms) for either anxiety or depression. Cut-offs for identifying psychiatric distress has been reported as 7 to 8 for possible presence, 10 to 11 for probable presence, and 14 to 15 for severe anxiety or depression.|units on a scale|Mean|13.7|13.7|Standard Deviation|8.32|8.32|||
3681418|NCT02277769|3525170|B4|||Global Individual Signs Score (GISS)|Individual components of the AD lesions (erythema, infiltration/ papulation, excoriations, and lichenification) were rated globally (each assessed for the whole body, not by anatomical region) on a 4-point scale (0= none, 1= mild, 2= moderate and 3= severe) using the EASI severity grading criteria. Total score ranges from 0 (absent disease) to 12 (severe disease).|units on a scale|Mean|9.1|9.1|Standard Deviation|1.77|1.77|||
3681419|NCT02277769|3525171|B3|||Global Individual Signs Score (GISS)|Individual components of the AD lesions (erythema, infiltration/ papulation, excoriations, and lichenification) were rated globally (each assessed for the whole body, not by anatomical region) on a 4-point scale (0= none, 1= mild, 2= moderate and 3= severe) using the EASI severity grading criteria. Total score ranges from 0 (absent disease) to 12 (severe disease).|units on a scale|Mean|9.0|9.0|Standard Deviation|1.75|1.75|||
3681420|NCT02277769|3525172|B2|||Global Individual Signs Score (GISS)|Individual components of the AD lesions (erythema, infiltration/ papulation, excoriations, and lichenification) were rated globally (each assessed for the whole body, not by anatomical region) on a 4-point scale (0= none, 1= mild, 2= moderate and 3= severe) using the EASI severity grading criteria. Total score ranges from 0 (absent disease) to 12 (severe disease).|units on a scale|Mean|9.0|9.0|Standard Deviation|1.80|1.8|||
3681421|NCT02277769|3525173|B1|||Global Individual Signs Score (GISS)|Individual components of the AD lesions (erythema, infiltration/ papulation, excoriations, and lichenification) were rated globally (each assessed for the whole body, not by anatomical region) on a 4-point scale (0= none, 1= mild, 2= moderate and 3= severe) using the EASI severity grading criteria. Total score ranges from 0 (absent disease) to 12 (severe disease).|units on a scale|Mean|9.2|9.2|Standard Deviation|1.78|1.78|||
3681422|NCT02277769|3525170|B4|||Patient Oriented Eczema Measure (POEM)|The POEM was a 7-item questionnaire that assessed disease symptoms (dryness, itching, flaking, cracking, sleep loss, bleeding and weeping) with a scoring system of 0 (absent disease) to 28 (severe disease) (high score indicative of poor quality of life [QOL]).|units on a scale|Mean|20.9|20.9|Standard Deviation|5.67|5.67|||
3681423|NCT02277769|3525171|B3|||Patient Oriented Eczema Measure (POEM)|The POEM was a 7-item questionnaire that assessed disease symptoms (dryness, itching, flaking, cracking, sleep loss, bleeding and weeping) with a scoring system of 0 (absent disease) to 28 (severe disease) (high score indicative of poor quality of life [QOL]).|units on a scale|Mean|20.9|20.9|Standard Deviation|5.59|5.59|||
3681424|NCT02277769|3525172|B2|||Patient Oriented Eczema Measure (POEM)|The POEM was a 7-item questionnaire that assessed disease symptoms (dryness, itching, flaking, cracking, sleep loss, bleeding and weeping) with a scoring system of 0 (absent disease) to 28 (severe disease) (high score indicative of poor quality of life [QOL]).|units on a scale|Mean|20.8|20.8|Standard Deviation|5.49|5.49|||
3681425|NCT02277769|3525173|B1|||Patient Oriented Eczema Measure (POEM)|The POEM was a 7-item questionnaire that assessed disease symptoms (dryness, itching, flaking, cracking, sleep loss, bleeding and weeping) with a scoring system of 0 (absent disease) to 28 (severe disease) (high score indicative of poor quality of life [QOL]).|units on a scale|Mean|21.0|21.0|Standard Deviation|5.94|5.94|||
3681426|NCT02277769|3525170|B4|||Dermatology Life Quality Index (DLQI) Score|The DLQI is a 10-item, validated questionnaire used in clinical practice and clinical trials to assess the impact of AD disease symptoms and treatment on quality of life (QOL). The 10 questions assessed QOL over the past week, with an overall scoring of 0 (absent disease) to 30 (severe disease); a high score indicative of a poor QOL.|units on a scale|Mean|15.6|15.6|Standard Deviation|7.37|7.37|||
3681473|NCT02277769|3525173|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3681474|NCT02277769|3525170|B4||White|Race (NIH/OMB)||Participants|Count of Participants|489|489.0||||||
3681427|NCT02277769|3525171|B3|||Dermatology Life Quality Index (DLQI) Score|The DLQI is a 10-item, validated questionnaire used in clinical practice and clinical trials to assess the impact of AD disease symptoms and treatment on quality of life (QOL). The 10 questions assessed QOL over the past week, with an overall scoring of 0 (absent disease) to 30 (severe disease); a high score indicative of a poor QOL.|units on a scale|Mean|16.0|16.0|Standard Deviation|7.33|7.33|||
3681428|NCT02277769|3525172|B2|||Dermatology Life Quality Index (DLQI) Score|The DLQI is a 10-item, validated questionnaire used in clinical practice and clinical trials to assess the impact of AD disease symptoms and treatment on quality of life (QOL). The 10 questions assessed QOL over the past week, with an overall scoring of 0 (absent disease) to 30 (severe disease); a high score indicative of a poor QOL.|units on a scale|Mean|15.4|15.4|Standard Deviation|7.07|7.07|||
3681429|NCT02277769|3525173|B1|||Dermatology Life Quality Index (DLQI) Score|The DLQI is a 10-item, validated questionnaire used in clinical practice and clinical trials to assess the impact of AD disease symptoms and treatment on quality of life (QOL). The 10 questions assessed QOL over the past week, with an overall scoring of 0 (absent disease) to 30 (severe disease); a high score indicative of a poor QOL.|units on a scale|Mean|15.4|15.4|Standard Deviation|7.69|7.69|||
3681430|NCT02277769|3525170|B4|||SCORing Atopic Dermatitis (SCORAD) Score|SCORAD was a clinical tool for assessing the severity of AD developed by the European Task Force on Atopic Dermatitis (Severity scoring of atopic dermatitis: the SCORAD index). Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology (Basel) 186 (1): 23–31. 1993. Extent and intensity of eczema as well as subjective signs (insomnia, etc.) were assessed and scored. Total score ranges from 0 (absent disease) to 103 (severe disease).|units on a scale|Mean|68.0|68.0|Standard Deviation|13.86|13.86|||
3681431|NCT02277769|3525171|B3|||SCORing Atopic Dermatitis (SCORAD) Score|SCORAD was a clinical tool for assessing the severity of AD developed by the European Task Force on Atopic Dermatitis (Severity scoring of atopic dermatitis: the SCORAD index). Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology (Basel) 186 (1): 23–31. 1993. Extent and intensity of eczema as well as subjective signs (insomnia, etc.) were assessed and scored. Total score ranges from 0 (absent disease) to 103 (severe disease).|units on a scale|Mean|67.5|67.5|Standard Deviation|13.10|13.1|||
3681432|NCT02277769|3525172|B2|||SCORing Atopic Dermatitis (SCORAD) Score|SCORAD was a clinical tool for assessing the severity of AD developed by the European Task Force on Atopic Dermatitis (Severity scoring of atopic dermatitis: the SCORAD index). Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology (Basel) 186 (1): 23–31. 1993. Extent and intensity of eczema as well as subjective signs (insomnia, etc.) were assessed and scored. Total score ranges from 0 (absent disease) to 103 (severe disease).|units on a scale|Mean|67.2|67.2|Standard Deviation|13.48|13.48|||
3681433|NCT02277769|3525173|B1|||SCORing Atopic Dermatitis (SCORAD) Score|SCORAD was a clinical tool for assessing the severity of AD developed by the European Task Force on Atopic Dermatitis (Severity scoring of atopic dermatitis: the SCORAD index). Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology (Basel) 186 (1): 23–31. 1993. Extent and intensity of eczema as well as subjective signs (insomnia, etc.) were assessed and scored. Total score ranges from 0 (absent disease) to 103 (severe disease).|units on a scale|Mean|69.2|69.2|Standard Deviation|14.91|14.91|||
3681434|NCT02277769|3525170|B4|||Body Surface Area (BSA) Involvement with AD|Body surface area affected by AD was assessed for each section of the body (the possible highest score for each region was: head and neck [9%], anterior trunk [18%], back [18%], upper limbs [18%], lower limbs [36%], and genitals [1%]). It was reported as a percentage of all major body sections combined.|percentage of body surface area|Mean|53.1|53.1|Standard Deviation|21.94|21.94|||
3681435|NCT02277769|3525171|B3|||Body Surface Area (BSA) Involvement with AD|Body surface area affected by AD was assessed for each section of the body (the possible highest score for each region was: head and neck [9%], anterior trunk [18%], back [18%], upper limbs [18%], lower limbs [36%], and genitals [1%]). It was reported as a percentage of all major body sections combined.|percentage of body surface area|Mean|52.2|52.2|Standard Deviation|21.51|21.51|||
3681436|NCT02277769|3525172|B2|||Body Surface Area (BSA) Involvement with AD|Body surface area affected by AD was assessed for each section of the body (the possible highest score for each region was: head and neck [9%], anterior trunk [18%], back [18%], upper limbs [18%], lower limbs [36%], and genitals [1%]). It was reported as a percentage of all major body sections combined.|percentage of body surface area|Mean|52.7|52.7|Standard Deviation|21.23|21.23|||
3681437|NCT02277769|3525173|B1|||Body Surface Area (BSA) Involvement with AD|Body surface area affected by AD was assessed for each section of the body (the possible highest score for each region was: head and neck [9%], anterior trunk [18%], back [18%], upper limbs [18%], lower limbs [36%], and genitals [1%]). It was reported as a percentage of all major body sections combined.|percentage of body surface area|Mean|54.3|54.3|Standard Deviation|23.06|23.06|||
3681438|NCT02277769|3525170|B4|||Weekly Average of Peak Daily Pruritus Numerical Rating Scale (NRS)|Pruritus NRS scale is an assessment tool that is used to report the intensity of participant’s pruritus (itch), both maximum and average intensity, during a 24-hour recall period. Participants were asked the following question: how would a participant rate his itch at the worst moment during the previous 24 hours (for maximum itch intensity on a scale of 0 – 10 [0= no itch; 10= worst itch imaginable]).|units on a scale|Mean|7.5|7.5|Standard Deviation|1.76|1.76|||
3681439|NCT02277769|3525171|B3|||Weekly Average of Peak Daily Pruritus Numerical Rating Scale (NRS)|Pruritus NRS scale is an assessment tool that is used to report the intensity of participant’s pruritus (itch), both maximum and average intensity, during a 24-hour recall period. Participants were asked the following question: how would a participant rate his itch at the worst moment during the previous 24 hours (for maximum itch intensity on a scale of 0 – 10 [0= no itch; 10= worst itch imaginable]).|units on a scale|Mean|7.5|7.5|Standard Deviation|1.81|1.81|||
3681440|NCT02277769|3525172|B2|||Weekly Average of Peak Daily Pruritus Numerical Rating Scale (NRS)|Pruritus NRS scale is an assessment tool that is used to report the intensity of participant’s pruritus (itch), both maximum and average intensity, during a 24-hour recall period. Participants were asked the following question: how would a participant rate his itch at the worst moment during the previous 24 hours (for maximum itch intensity on a scale of 0 – 10 [0= no itch; 10= worst itch imaginable]).|units on a scale|Mean|7.6|7.6|Standard Deviation|1.60|1.6|||
3681475|NCT02277769|3525171|B3||White|Race (NIH/OMB)||Participants|Count of Participants|168|168.0||||||
3681441|NCT02277769|3525173|B1|||Weekly Average of Peak Daily Pruritus Numerical Rating Scale (NRS)|Pruritus NRS scale is an assessment tool that is used to report the intensity of participant’s pruritus (itch), both maximum and average intensity, during a 24-hour recall period. Participants were asked the following question: how would a participant rate his itch at the worst moment during the previous 24 hours (for maximum itch intensity on a scale of 0 – 10 [0= no itch; 10= worst itch imaginable]).|units on a scale|Mean|7.5|7.5|Standard Deviation|1.85|1.85|||
3681442|NCT02277769|3525170|B4|||Investigator’s Global Assessment (IGA) Score|IGA was an assessment scale used to determine severity of AD and clinical response to treatment on a 5-point scale (0= clear; 1= almost clear; 2= mild; 3= moderate; 4= severe) based on erythema and papulation/infiltration. Therapeutic response was an IGA score of 0 (clear) or 1 (almost clear).|units on a scale|Mean|3.5|3.5|Standard Deviation|0.50|0.5|||
3681443|NCT02277769|3525171|B3|||Investigator’s Global Assessment (IGA) Score|IGA was an assessment scale used to determine severity of AD and clinical response to treatment on a 5-point scale (0= clear; 1= almost clear; 2= mild; 3= moderate; 4= severe) based on erythema and papulation/infiltration. Therapeutic response was an IGA score of 0 (clear) or 1 (almost clear).|units on a scale|Mean|3.5|3.5|Standard Deviation|0.50|0.5|||
3681444|NCT02277769|3525172|B2|||Investigator’s Global Assessment (IGA) Score|IGA was an assessment scale used to determine severity of AD and clinical response to treatment on a 5-point scale (0= clear; 1= almost clear; 2= mild; 3= moderate; 4= severe) based on erythema and papulation/infiltration. Therapeutic response was an IGA score of 0 (clear) or 1 (almost clear).|units on a scale|Mean|3.5|3.5|Standard Deviation|0.50|0.5|||
3681445|NCT02277769|3525173|B1|||Investigator’s Global Assessment (IGA) Score|IGA was an assessment scale used to determine severity of AD and clinical response to treatment on a 5-point scale (0= clear; 1= almost clear; 2= mild; 3= moderate; 4= severe) based on erythema and papulation/infiltration. Therapeutic response was an IGA score of 0 (clear) or 1 (almost clear).|units on a scale|Mean|3.5|3.5|Standard Deviation|0.50|0.5|||
3681446|NCT02277769|3525170|B4|||Eczema Area and Severity Index (EASI) Score|The EASI score was used to measure the severity and extent of atopic dermatitis (AD) and measured erythema, infiltration, excoriation and lichenification on 4 anatomic regions of the body: head, trunk, upper and lower extremities. The total EASI score range from 0 (minimum) to 72 (maximum) points, with the higher scores reflecting the worse severity of AD.|units on a scale|Mean|32.4|32.4|Standard Deviation|13.39|13.39|||
3681447|NCT02277769|3525171|B3|||Eczema Area and Severity Index (EASI) Score|The EASI score was used to measure the severity and extent of atopic dermatitis (AD) and measured erythema, infiltration, excoriation and lichenification on 4 anatomic regions of the body: head, trunk, upper and lower extremities. The total EASI score range from 0 (minimum) to 72 (maximum) points, with the higher scores reflecting the worse severity of AD.|units on a scale|Mean|31.9|31.9|Standard Deviation|12.70|12.7|||
3681448|NCT02277769|3525172|B2|||Eczema Area and Severity Index (EASI) Score|The EASI score was used to measure the severity and extent of atopic dermatitis (AD) and measured erythema, infiltration, excoriation and lichenification on 4 anatomic regions of the body: head, trunk, upper and lower extremities. The total EASI score range from 0 (minimum) to 72 (maximum) points, with the higher scores reflecting the worse severity of AD.|units on a scale|Mean|31.8|31.8|Standard Deviation|13.08|13.08|||
3681449|NCT02277769|3525173|B1|||Eczema Area and Severity Index (EASI) Score|The EASI score was used to measure the severity and extent of atopic dermatitis (AD) and measured erythema, infiltration, excoriation and lichenification on 4 anatomic regions of the body: head, trunk, upper and lower extremities. The total EASI score range from 0 (minimum) to 72 (maximum) points, with the higher scores reflecting the worse severity of AD.|units on a scale|Mean|33.6|33.6|Standard Deviation|14.31|14.31|||
3681450|NCT02277769|3525170|B4||Asia Pacific|Region of Enrollment||Participants|Count of Participants|85|85.0||||||
3681451|NCT02277769|3525171|B3||Asia Pacific|Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3681452|NCT02277769|3525172|B2||Asia Pacific|Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3681453|NCT02277769|3525173|B1||Asia Pacific|Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3681454|NCT02277769|3525170|B4||Eastern Europe|Region of Enrollment||Participants|Count of Participants|114|114.0||||||
3681455|NCT02277769|3525171|B3||Eastern Europe|Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3681456|NCT02277769|3525172|B2||Eastern Europe|Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3681457|NCT02277769|3525173|B1||Eastern Europe|Region of Enrollment||Participants|Count of Participants|38|38.0||||||
3681458|NCT02277769|3525170|B4||Western Europe|Region of Enrollment||Participants|Count of Participants|163|163.0||||||
3681459|NCT02277769|3525171|B3||Western Europe|Region of Enrollment||Participants|Count of Participants|55|55.0||||||
3681460|NCT02277769|3525172|B2||Western Europe|Region of Enrollment||Participants|Count of Participants|54|54.0||||||
3681461|NCT02277769|3525173|B1||Western Europe|Region of Enrollment||Participants|Count of Participants|54|54.0||||||
3681462|NCT02277769|3525170|B4||North and South America|Region of Enrollment||Participants|Count of Participants|346|346.0||||||
3681463|NCT02277769|3525171|B3||North and South America|Region of Enrollment||Participants|Count of Participants|116|116.0||||||
3681464|NCT02277769|3525172|B2||North and South America|Region of Enrollment||Participants|Count of Participants|114|114.0||||||
3681465|NCT02277769|3525173|B1||North and South America|Region of Enrollment||Participants|Count of Participants|116|116.0||||||
3681466|NCT02277769|3525170|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3681467|NCT02277769|3525171|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3681468|NCT02277769|3525172|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3681469|NCT02277769|3525173|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3681470|NCT02277769|3525170|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3681471|NCT02277769|3525171|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3681472|NCT02277769|3525172|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3681476|NCT02277769|3525172|B2||White|Race (NIH/OMB)||Participants|Count of Participants|165|165.0||||||
3681477|NCT02277769|3525173|B1||White|Race (NIH/OMB)||Participants|Count of Participants|156|156.0||||||
3681478|NCT02277769|3525170|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3681479|NCT02277769|3525171|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3681480|NCT02277769|3525172|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3681481|NCT02277769|3525173|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3681482|NCT02277769|3525170|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681483|NCT02277769|3525171|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681484|NCT02277769|3525172|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681485|NCT02277769|3525173|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681486|NCT02277769|3525170|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|139|139.0||||||
3681487|NCT02277769|3525171|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3681488|NCT02277769|3525172|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3681489|NCT02277769|3525173|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3681490|NCT02277769|3525170|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681491|NCT02277769|3525171|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681492|NCT02277769|3525172|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681493|NCT02277769|3525173|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681494|NCT02277769|3525170|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3681495|NCT02277769|3525171|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3681496|NCT02277769|3525172|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3681497|NCT02277769|3525173|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3681498|NCT02277769|3525170|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|657|657.0||||||
3681499|NCT02277769|3525171|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|220|220.0||||||
3681500|NCT02277769|3525172|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|218|218.0||||||
3681501|NCT02277769|3525173|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|219|219.0||||||
3681502|NCT02277769|3525170|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3681503|NCT02277769|3525171|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3681504|NCT02277769|3525172|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3681505|NCT02277769|3525173|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3681506|NCT02277769|3525170|B4||Male|Sex: Female, Male||Participants|Count of Participants|408|408.0||||||
3681507|NCT02277769|3525171|B3||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3681508|NCT02277769|3525172|B2||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3681509|NCT02277769|3525173|B1||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3681510|NCT02277769|3525170|B4||Female|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
3681511|NCT02277769|3525171|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3681512|NCT02277769|3525172|B2||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3681513|NCT02277769|3525173|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3681514|NCT02277769|3525170|B4|||Age||years|Mean|37.1|37.1|Standard Deviation|14.17|14.17|||
3681515|NCT02277769|3525171|B3|||Age||years|Mean|37.1|37.1|Standard Deviation|14.51|14.51|||
3681516|NCT02277769|3525172|B2|||Age||years|Mean|36.9|36.9|Standard Deviation|13.96|13.96|||
3681517|NCT02277769|3525173|B1|||Age||years|Mean|37.4|37.4|Standard Deviation|14.09|14.09|||
3681518|NCT02277743|3525243|B4|||Total Hospital Anxiety Depression Scale (HADS)|The HADS is a fourteen item scale. Seven of the items relate to anxiety and seven relate to depression. Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 (no symptoms) and 21 (severe symptoms) for either anxiety or depression. Cut-offs for identifying psychiatric distress has been reported as 7 to 8 for possible presence, 10 to 11 for probable presence, and 14 to 15 for severe anxiety or depression.|units on a scale|Mean|12.5|12.5|Standard Deviation|7.85|7.85|||
3681519|NCT02277743|3525244|B3|||Total Hospital Anxiety Depression Scale (HADS)|The HADS is a fourteen item scale. Seven of the items relate to anxiety and seven relate to depression. Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 (no symptoms) and 21 (severe symptoms) for either anxiety or depression. Cut-offs for identifying psychiatric distress has been reported as 7 to 8 for possible presence, 10 to 11 for probable presence, and 14 to 15 for severe anxiety or depression.|units on a scale|Mean|12.6|12.6|Standard Deviation|7.95|7.95|||
3681520|NCT02277743|3525245|B2|||Total Hospital Anxiety Depression Scale (HADS)|The HADS is a fourteen item scale. Seven of the items relate to anxiety and seven relate to depression. Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 (no symptoms) and 21 (severe symptoms) for either anxiety or depression. Cut-offs for identifying psychiatric distress has been reported as 7 to 8 for possible presence, 10 to 11 for probable presence, and 14 to 15 for severe anxiety or depression.|units on a scale|Mean|12.2|12.2|Standard Deviation|7.26|7.26|||
3681598|NCT02277743|3525243|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3681521|NCT02277743|3525246|B1|||Total Hospital Anxiety Depression Scale (HADS)|The HADS is a fourteen item scale. Seven of the items relate to anxiety and seven relate to depression. Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 (no symptoms) and 21 (severe symptoms) for either anxiety or depression. Cut-offs for identifying psychiatric distress has been reported as 7 to 8 for possible presence, 10 to 11 for probable presence, and 14 to 15 for severe anxiety or depression.|units on a scale|Mean|12.6|12.6|Standard Deviation|8.33|8.33|||
3681522|NCT02277743|3525243|B4|||Global Individual Signs Score (GISS)|Individual components of the AD lesions (erythema, infiltration/ papulation, excoriations, and lichenification) were rated globally (each assessed for the whole body, not by anatomical region) on a 4-point scale (0= none, 1= mild, 2= moderate and 3= severe) using the EASI severity grading criteria. Total score ranges from 0 (absent disease) to 12 (severe disease).|units on a scale|Mean|9.0|9.0|Standard Deviation|1.80|1.8|||
3681523|NCT02277743|3525244|B3|||Global Individual Signs Score (GISS)|Individual components of the AD lesions (erythema, infiltration/ papulation, excoriations, and lichenification) were rated globally (each assessed for the whole body, not by anatomical region) on a 4-point scale (0= none, 1= mild, 2= moderate and 3= severe) using the EASI severity grading criteria. Total score ranges from 0 (absent disease) to 12 (severe disease).|units on a scale|Mean|8.9|8.9|Standard Deviation|1.74|1.74|||
3681524|NCT02277743|3525245|B2|||Global Individual Signs Score (GISS)|Individual components of the AD lesions (erythema, infiltration/ papulation, excoriations, and lichenification) were rated globally (each assessed for the whole body, not by anatomical region) on a 4-point scale (0= none, 1= mild, 2= moderate and 3= severe) using the EASI severity grading criteria. Total score ranges from 0 (absent disease) to 12 (severe disease).|units on a scale|Mean|8.9|8.9|Standard Deviation|1.81|1.81|||
3681525|NCT02277743|3525246|B1|||Global Individual Signs Score (GISS)|Individual components of the AD lesions (erythema, infiltration/ papulation, excoriations, and lichenification) were rated globally (each assessed for the whole body, not by anatomical region) on a 4-point scale (0= none, 1= mild, 2= moderate and 3= severe) using the EASI severity grading criteria. Total score ranges from 0 (absent disease) to 12 (severe disease).|units on a scale|Mean|9.0|9.0|Standard Deviation|1.85|1.85|||
3681526|NCT02277743|3525243|B4|||Patient Oriented Eczema Measure (POEM)|The POEM was a 7-item questionnaire that assessed disease symptoms (dryness, itching, flaking, cracking, sleep loss, bleeding and weeping) with a scoring system of 0 (absent disease) to 28 (severe disease) (high score indicative of poor quality of life [QOL]).|units on a scale|Mean|20.1|20.1|Standard Deviation|6.17|6.17|||
3681527|NCT02277743|3525244|B3|||Patient Oriented Eczema Measure (POEM)|The POEM was a 7-item questionnaire that assessed disease symptoms (dryness, itching, flaking, cracking, sleep loss, bleeding and weeping) with a scoring system of 0 (absent disease) to 28 (severe disease) (high score indicative of poor quality of life [QOL]).|units on a scale|Mean|20.4|20.4|Standard Deviation|6.25|6.25|||
3681528|NCT02277743|3525245|B2|||Patient Oriented Eczema Measure (POEM)|The POEM was a 7-item questionnaire that assessed disease symptoms (dryness, itching, flaking, cracking, sleep loss, bleeding and weeping) with a scoring system of 0 (absent disease) to 28 (severe disease) (high score indicative of poor quality of life [QOL]).|units on a scale|Mean|19.8|19.8|Standard Deviation|6.37|6.37|||
3681529|NCT02277743|3525246|B1|||Patient Oriented Eczema Measure (POEM)|The POEM was a 7-item questionnaire that assessed disease symptoms (dryness, itching, flaking, cracking, sleep loss, bleeding and weeping) with a scoring system of 0 (absent disease) to 28 (severe disease) (high score indicative of poor quality of life [QOL]).|units on a scale|Mean|20.3|20.3|Standard Deviation|5.90|5.9|||
3681530|NCT02277743|3525243|B4|||Dermatology Life Quality Index (DLQI) Score|The DLQI is a 10-item, validated questionnaire used in clinical practice and clinical trials to assess the impact of AD disease symptoms and treatment on quality of life (QOL). The 10 questions assessed QOL over the past week, with an overall scoring of 0 (absent disease) to 30 (severe disease); a high score indicative of a poor QOL.|units on a scale|Mean|14.2|14.2|Standard Deviation|7.37|7.37|||
3681531|NCT02277743|3525244|B3|||Dermatology Life Quality Index (DLQI) Score|The DLQI is a 10-item, validated questionnaire used in clinical practice and clinical trials to assess the impact of AD disease symptoms and treatment on quality of life (QOL). The 10 questions assessed QOL over the past week, with an overall scoring of 0 (absent disease) to 30 (severe disease); a high score indicative of a poor QOL.|units on a scale|Mean|14.1|14.1|Standard Deviation|7.51|7.51|||
3681532|NCT02277743|3525245|B2|||Dermatology Life Quality Index (DLQI) Score|The DLQI is a 10-item, validated questionnaire used in clinical practice and clinical trials to assess the impact of AD disease symptoms and treatment on quality of life (QOL). The 10 questions assessed QOL over the past week, with an overall scoring of 0 (absent disease) to 30 (severe disease); a high score indicative of a poor QOL.|units on a scale|Mean|13.9|13.9|Standard Deviation|7.37|7.37|||
3681533|NCT02277743|3525246|B1|||Dermatology Life Quality Index (DLQI) Score|The DLQI is a 10-item, validated questionnaire used in clinical practice and clinical trials to assess the impact of AD disease symptoms and treatment on quality of life (QOL). The 10 questions assessed QOL over the past week, with an overall scoring of 0 (absent disease) to 30 (severe disease); a high score indicative of a poor QOL.|units on a scale|Mean|14.8|14.8|Standard Deviation|7.23|7.23|||
3681534|NCT02277743|3525243|B4|||SCORing Atopic Dermatitis (SCORAD) Score|SCORAD was a clinical tool for assessing the severity of AD developed by the European Task Force on Atopic Dermatitis (Severity scoring of atopic dermatitis: the SCORAD index). Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology (Basel) 186 (1): 23–31. 1993. Extent and intensity of eczema as well as subjective signs (insomnia, etc.) were assessed and scored. Total score ranges from 0 (absent disease) to 103 (severe disease).|units on a scale|Mean|67.6|67.6|Standard Deviation|13.84|13.84|||
3681535|NCT02277743|3525244|B3|||SCORing Atopic Dermatitis (SCORAD) Score|SCORAD was a clinical tool for assessing the severity of AD developed by the European Task Force on Atopic Dermatitis (Severity scoring of atopic dermatitis: the SCORAD index). Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology (Basel) 186 (1): 23–31. 1993. Extent and intensity of eczema as well as subjective signs (insomnia, etc.) were assessed and scored. Total score ranges from 0 (absent disease) to 103 (severe disease).|units on a scale|Mean|67.5|67.5|Standard Deviation|13.61|13.61|||
3681599|NCT02277743|3525244|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3681692|NCT02277119|3525359|B4||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3681536|NCT02277743|3525245|B2|||SCORing Atopic Dermatitis (SCORAD) Score|SCORAD was a clinical tool for assessing the severity of AD developed by the European Task Force on Atopic Dermatitis (Severity scoring of atopic dermatitis: the SCORAD index). Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology (Basel) 186 (1): 23–31. 1993. Extent and intensity of eczema as well as subjective signs (insomnia, etc.) were assessed and scored. Total score ranges from 0 (absent disease) to 103 (severe disease).|units on a scale|Mean|66.9|66.9|Standard Deviation|13.97|13.97|||
3681537|NCT02277743|3525246|B1|||SCORing Atopic Dermatitis (SCORAD) Score|SCORAD was a clinical tool for assessing the severity of AD developed by the European Task Force on Atopic Dermatitis (Severity scoring of atopic dermatitis: the SCORAD index). Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology (Basel) 186 (1): 23–31. 1993. Extent and intensity of eczema as well as subjective signs (insomnia, etc.) were assessed and scored. Total score ranges from 0 (absent disease) to 103 (severe disease).|units on a scale|Mean|68.3|68.3|Standard Deviation|13.96|13.96|||
3681538|NCT02277743|3525243|B4|||Body Surface Area (BSA) Involvement with AD|Body surface area affected by AD was assessed for each section of the body (the possible highest score for each region was: head and neck [9%], anterior trunk [18%], back [18%], upper limbs [18%], lower limbs [36%], and genitals [1%]). It was reported as a percentage of all major body sections combined.|percentage of body surface area|Mean|56.1|56.1|Standard Deviation|23.17|23.17|||
3681539|NCT02277743|3525244|B3|||Body Surface Area (BSA) Involvement with AD|Body surface area affected by AD was assessed for each section of the body (the possible highest score for each region was: head and neck [9%], anterior trunk [18%], back [18%], upper limbs [18%], lower limbs [36%], and genitals [1%]). It was reported as a percentage of all major body sections combined.|percentage of body surface area|Mean|56.1|56.1|Standard Deviation|22.96|22.96|||
3681540|NCT02277743|3525245|B2|||Body Surface Area (BSA) Involvement with AD|Body surface area affected by AD was assessed for each section of the body (the possible highest score for each region was: head and neck [9%], anterior trunk [18%], back [18%], upper limbs [18%], lower limbs [36%], and genitals [1%]). It was reported as a percentage of all major body sections combined.|percentage of body surface area|Mean|54.7|54.7|Standard Deviation|23.19|23.19|||
3681541|NCT02277743|3525246|B1|||Body Surface Area (BSA) Involvement with AD|Body surface area affected by AD was assessed for each section of the body (the possible highest score for each region was: head and neck [9%], anterior trunk [18%], back [18%], upper limbs [18%], lower limbs [36%], and genitals [1%]). It was reported as a percentage of all major body sections combined.|percentage of body surface area|Mean|57.5|57.5|Standard Deviation|23.38|23.38|||
3681542|NCT02277743|3525243|B4|||Weekly Average of Peak Daily Pruritus Numerical Rating Scale (NRS)|Pruritus NRS scale is an assessment tool that is used to report the intensity of participant’s pruritus (itch), both maximum and average intensity, during a 24-hour recall period. Participants were asked the following question: how would a participant rate his itch at the worst moment during the previous 24 hours (for maximum itch intensity on a scale of 0 – 10 [0= no itch; 10= worst itch imaginable]).|units on a scale|Mean|7.3|7.3|Standard Deviation|1.91|1.91|||
3681543|NCT02277743|3525244|B3|||Weekly Average of Peak Daily Pruritus Numerical Rating Scale (NRS)|Pruritus NRS scale is an assessment tool that is used to report the intensity of participant’s pruritus (itch), both maximum and average intensity, during a 24-hour recall period. Participants were asked the following question: how would a participant rate his itch at the worst moment during the previous 24 hours (for maximum itch intensity on a scale of 0 – 10 [0= no itch; 10= worst itch imaginable]).|units on a scale|Mean|7.2|7.2|Standard Deviation|2.06|2.06|||
3681544|NCT02277743|3525245|B2|||Weekly Average of Peak Daily Pruritus Numerical Rating Scale (NRS)|Pruritus NRS scale is an assessment tool that is used to report the intensity of participant’s pruritus (itch), both maximum and average intensity, during a 24-hour recall period. Participants were asked the following question: how would a participant rate his itch at the worst moment during the previous 24 hours (for maximum itch intensity on a scale of 0 – 10 [0= no itch; 10= worst itch imaginable]).|units on a scale|Mean|7.2|7.2|Standard Deviation|1.89|1.89|||
3681545|NCT02277743|3525246|B1|||Weekly Average of Peak Daily Pruritus Numerical Rating Scale (NRS)|Pruritus NRS scale is an assessment tool that is used to report the intensity of participant’s pruritus (itch), both maximum and average intensity, during a 24-hour recall period. Participants were asked the following question: how would a participant rate his itch at the worst moment during the previous 24 hours (for maximum itch intensity on a scale of 0 – 10 [0= no itch; 10= worst itch imaginable]).|units on a scale|Mean|7.4|7.4|Standard Deviation|1.77|1.77|||
3681546|NCT02277743|3525243|B4|||Investigator’s Global Assessment (IGA) Score|IGA was an assessment scale used to determine severity of AD and clinical response to treatment on a 5-point scale (0= clear; 1= almost clear; 2= mild; 3= moderate; 4= severe) based on erythema and papulation/infiltration. Therapeutic response was an IGA score of 0 (clear) or 1 (almost clear).|units on a scale|Mean|3.5|3.5|Standard Deviation|0.5|0.5|||
3681547|NCT02277743|3525244|B3|||Investigator’s Global Assessment (IGA) Score|IGA was an assessment scale used to determine severity of AD and clinical response to treatment on a 5-point scale (0= clear; 1= almost clear; 2= mild; 3= moderate; 4= severe) based on erythema and papulation/infiltration. Therapeutic response was an IGA score of 0 (clear) or 1 (almost clear).|units on a scale|Mean|3.5|3.5|Standard Deviation|0.5|0.5|||
3681548|NCT02277743|3525245|B2|||Investigator’s Global Assessment (IGA) Score|IGA was an assessment scale used to determine severity of AD and clinical response to treatment on a 5-point scale (0= clear; 1= almost clear; 2= mild; 3= moderate; 4= severe) based on erythema and papulation/infiltration. Therapeutic response was an IGA score of 0 (clear) or 1 (almost clear).|units on a scale|Mean|3.5|3.5|Standard Deviation|0.5|0.5|||
3681549|NCT02277743|3525246|B1|||Investigator’s Global Assessment (IGA) Score|IGA was an assessment scale used to determine severity of AD and clinical response to treatment on a 5-point scale (0= clear; 1= almost clear; 2= mild; 3= moderate; 4= severe) based on erythema and papulation/infiltration. Therapeutic response was an IGA score of 0 (clear) or 1 (almost clear).|units on a scale|Mean|3.5|3.5|Standard Deviation|0.5|0.5|||
3681550|NCT02277743|3525243|B4|||Eczema Area and Severity Index (EASI) Score|The EASI score was used to measure the severity and extent of atopic dermatitis (AD) and measured erythema, infiltration, excoriation and lichenification on 4 anatomic regions of the body: head, trunk, upper and lower extremities. The total EASI score range from 0 (minimum) to 72 (maximum) points, with the higher scores reflecting the worse severity of AD.|units on scale|Mean|33.6|33.6|Standard Deviation|14.00|14.0|||
3681551|NCT02277743|3525244|B3|||Eczema Area and Severity Index (EASI) Score|The EASI score was used to measure the severity and extent of atopic dermatitis (AD) and measured erythema, infiltration, excoriation and lichenification on 4 anatomic regions of the body: head, trunk, upper and lower extremities. The total EASI score range from 0 (minimum) to 72 (maximum) points, with the higher scores reflecting the worse severity of AD.|units on scale|Mean|33.2|33.2|Standard Deviation|13.98|13.98|||
3681552|NCT02277743|3525245|B2|||Eczema Area and Severity Index (EASI) Score|The EASI score was used to measure the severity and extent of atopic dermatitis (AD) and measured erythema, infiltration, excoriation and lichenification on 4 anatomic regions of the body: head, trunk, upper and lower extremities. The total EASI score range from 0 (minimum) to 72 (maximum) points, with the higher scores reflecting the worse severity of AD.|units on scale|Mean|33|33.0|Standard Deviation|13.57|13.57|||
3681553|NCT02277743|3525246|B1|||Eczema Area and Severity Index (EASI) Score|The EASI score was used to measure the severity and extent of atopic dermatitis (AD) and measured erythema, infiltration, excoriation and lichenification on 4 anatomic regions of the body: head, trunk, upper and lower extremities. The total EASI score range from 0 (minimum) to 72 (maximum) points, with the higher scores reflecting the worse severity of AD.|units on scale|Mean|34.5|34.5|Standard Deviation|14.47|14.47|||
3681554|NCT02277743|3525243|B4||Western Europe|Region of Enrollment||Participants|Count of Participants|196|196.0||||||
3681555|NCT02277743|3525244|B3||Western Europe|Region of Enrollment||Participants|Count of Participants|65|65.0||||||
3681556|NCT02277743|3525245|B2||Western Europe|Region of Enrollment||Participants|Count of Participants|65|65.0||||||
3681557|NCT02277743|3525246|B1||Western Europe|Region of Enrollment||Participants|Count of Participants|66|66.0||||||
3681558|NCT02277743|3525243|B4||Eastern Europe|Region of Enrollment||Participants|Count of Participants|69|69.0||||||
3681559|NCT02277743|3525244|B3||Eastern Europe|Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3681560|NCT02277743|3525245|B2||Eastern Europe|Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3681561|NCT02277743|3525246|B1||Eastern Europe|Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3681562|NCT02277743|3525243|B4||Asia Pacific|Region of Enrollment||Participants|Count of Participants|120|120.0||||||
3681563|NCT02277743|3525244|B3||Asia Pacific|Region of Enrollment||Participants|Count of Participants|38|38.0||||||
3681564|NCT02277743|3525245|B2||Asia Pacific|Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3681565|NCT02277743|3525246|B1||Asia Pacific|Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3681566|NCT02277743|3525243|B4||North and South America|Region of Enrollment||Participants|Count of Participants|286|286.0||||||
3681567|NCT02277743|3525244|B3||North and South America|Region of Enrollment||Participants|Count of Participants|96|96.0||||||
3681568|NCT02277743|3525245|B2||North and South America|Region of Enrollment||Participants|Count of Participants|95|95.0||||||
3681569|NCT02277743|3525246|B1||North and South America|Region of Enrollment||Participants|Count of Participants|95|95.0||||||
3681570|NCT02277743|3525243|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3681571|NCT02277743|3525244|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3681572|NCT02277743|3525245|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3681573|NCT02277743|3525246|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3681574|NCT02277743|3525243|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681575|NCT02277743|3525244|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681576|NCT02277743|3525245|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681577|NCT02277743|3525246|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681578|NCT02277743|3525243|B4||White|Race (NIH/OMB)||Participants|Count of Participants|450|450.0||||||
3681579|NCT02277743|3525244|B3||White|Race (NIH/OMB)||Participants|Count of Participants|149|149.0||||||
3681580|NCT02277743|3525245|B2||White|Race (NIH/OMB)||Participants|Count of Participants|155|155.0||||||
3681581|NCT02277743|3525246|B1||White|Race (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
3681582|NCT02277743|3525243|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3681583|NCT02277743|3525244|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3681584|NCT02277743|3525245|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3681585|NCT02277743|3525246|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3681586|NCT02277743|3525243|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681587|NCT02277743|3525244|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681588|NCT02277743|3525245|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681589|NCT02277743|3525246|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681590|NCT02277743|3525243|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|161|161.0||||||
3681591|NCT02277743|3525244|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3681592|NCT02277743|3525245|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3681593|NCT02277743|3525246|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3681594|NCT02277743|3525243|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681595|NCT02277743|3525244|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681596|NCT02277743|3525245|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681597|NCT02277743|3525246|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681600|NCT02277743|3525245|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3681601|NCT02277743|3525246|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3681602|NCT02277743|3525243|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|639|639.0||||||
3681603|NCT02277743|3525244|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|212|212.0||||||
3681604|NCT02277743|3525245|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|215|215.0||||||
3681605|NCT02277743|3525246|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|212|212.0||||||
3681606|NCT02277743|3525243|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3681607|NCT02277743|3525244|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3681608|NCT02277743|3525245|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3681609|NCT02277743|3525246|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3681610|NCT02277743|3525243|B4||Male|Sex: Female, Male||Participants|Count of Participants|390|390.0||||||
3681611|NCT02277743|3525244|B3||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3681612|NCT02277743|3525245|B2||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3681613|NCT02277743|3525246|B1||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3681614|NCT02277743|3525243|B4||Female|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
3681615|NCT02277743|3525244|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3681616|NCT02277743|3525245|B2||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3681617|NCT02277743|3525246|B1||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3681618|NCT02277743|3525243|B4|||Age||years|Mean|39.5|39.5|Standard Deviation|14.31|14.31|||
3681619|NCT02277743|3525244|B3|||Age||years|Mean|39.3|39.3|Standard Deviation|14.39|14.39|||
3681620|NCT02277743|3525245|B2|||Age||years|Mean|39.8|39.8|Standard Deviation|14.68|14.68|||
3681621|NCT02277743|3525246|B1|||Age||years|Mean|39.5|39.5|Standard Deviation|13.91|13.91|||
3681622|NCT02277691|3525316|B1|Other Antihypertensives||Medication History (Antihypertensives)|Only participants with medication history are reported. Participants may be counted in more than 1 category. ARB=angiotensin II receptor blocker, ACE=angiotensin converting enzyme, CCB=calcium channel blocker, β-blockers=beta blockers.|Participants|Count of Participants|14|14.0||||||
3681623|NCT02277691|3525316|B1|β-blockers||Medication History (Antihypertensives)|Only participants with medication history are reported. Participants may be counted in more than 1 category. ARB=angiotensin II receptor blocker, ACE=angiotensin converting enzyme, CCB=calcium channel blocker, β-blockers=beta blockers.|Participants|Count of Participants|19|19.0||||||
3681624|NCT02277691|3525316|B1|Diuretics||Medication History (Antihypertensives)|Only participants with medication history are reported. Participants may be counted in more than 1 category. ARB=angiotensin II receptor blocker, ACE=angiotensin converting enzyme, CCB=calcium channel blocker, β-blockers=beta blockers.|Participants|Count of Participants|66|66.0||||||
3681625|NCT02277691|3525316|B1|CCBs||Medication History (Antihypertensives)|Only participants with medication history are reported. Participants may be counted in more than 1 category. ARB=angiotensin II receptor blocker, ACE=angiotensin converting enzyme, CCB=calcium channel blocker, β-blockers=beta blockers.|Participants|Count of Participants|313|313.0||||||
3681626|NCT02277691|3525316|B1|ACE Inhibitors||Medication History (Antihypertensives)|Only participants with medication history are reported. Participants may be counted in more than 1 category. ARB=angiotensin II receptor blocker, ACE=angiotensin converting enzyme, CCB=calcium channel blocker, β-blockers=beta blockers.|Participants|Count of Participants|9|9.0||||||
3681627|NCT02277691|3525316|B1|ARBs||Medication History (Antihypertensives)|Only participants with medication history are reported. Participants may be counted in more than 1 category. ARB=angiotensin II receptor blocker, ACE=angiotensin converting enzyme, CCB=calcium channel blocker, β-blockers=beta blockers.|Participants|Count of Participants|310|310.0||||||
3681628|NCT02277691|3525316|B1|Other Concurrent Medical Conditions||Concurrent Medical Conditions|Only participants with medical conditions are reported. Participants may be counted in more than 1 category.|Participants|Count of Participants|292|292.0||||||
3681629|NCT02277691|3525316|B1|Dyslipidemia||Concurrent Medical Conditions|Only participants with medical conditions are reported. Participants may be counted in more than 1 category.|Participants|Count of Participants|174|174.0||||||
3681630|NCT02277691|3525316|B1|Hepatic Disorder||Concurrent Medical Conditions|Only participants with medical conditions are reported. Participants may be counted in more than 1 category.|Participants|Count of Participants|43|43.0||||||
3681631|NCT02277691|3525316|B1|Vascular Disorder||Concurrent Medical Conditions|Only participants with medical conditions are reported. Participants may be counted in more than 1 category.|Participants|Count of Participants|21|21.0||||||
3681632|NCT02277691|3525316|B1|Cardiac Disease||Concurrent Medical Conditions|Only participants with medical conditions are reported. Participants may be counted in more than 1 category.|Participants|Count of Participants|11|11.0||||||
3681633|NCT02277691|3525316|B1|Cerebrovascular Disorder||Concurrent Medical Conditions|Only participants with medical conditions are reported. Participants may be counted in more than 1 category.|Participants|Count of Participants|2|2.0||||||
3681634|NCT02277691|3525316|B1|Other Medical History||Medical History|Only participants with medical history are reported. Participants may also be counted in more than 1 category.|Participants|Count of Participants|52|52.0||||||
3681635|NCT02277691|3525316|B1|Dyslipidemia||Medical History|Only participants with medical history are reported. Participants may also be counted in more than 1 category.|Participants|Count of Participants|1|1.0||||||
3681636|NCT02277691|3525316|B1|Hepatic Disorder||Medical History|Only participants with medical history are reported. Participants may also be counted in more than 1 category.|Participants|Count of Participants|2|2.0||||||
3681637|NCT02277691|3525316|B1|Vascular Disorder||Medical History|Only participants with medical history are reported. Participants may also be counted in more than 1 category.|Participants|Count of Participants|1|1.0||||||
3681638|NCT02277691|3525316|B1|Cardiac Disease||Medical History|Only participants with medical history are reported. Participants may also be counted in more than 1 category.|Participants|Count of Participants|9|9.0||||||
3681639|NCT02277691|3525316|B1|Cerebrovascular Disorder||Medical History|Only participants with medical history are reported. Participants may also be counted in more than 1 category.|Participants|Count of Participants|13|13.0||||||
3681640|NCT02277691|3525316|B1|||Estimated Glomerular Filtration Rate According To Creatinine (eGFRcreat)|Male: eGFRcreat (mL/min/1.73 m^2)=194×Cr (mg/dL)-1.094×age (years)-0.287 Female: eGFRcreat (mL/min/1.73 m^2)=194×Cr (mg/dL)-1.094×age (years)-0.287×0.739 Cr: serum creatinine|mL/min/1.73 m^2|Mean|78.1|78.1|Standard Deviation|16.73|16.73|||
3681641|NCT02277691|3525316|B1|||Office Sitting Diastolic Blood Pressure (DBP)||mmHg|Mean|86.2|86.2|Standard Deviation|9.28|9.28|||
3681642|NCT02277691|3525316|B1|||Office Sitting Systolic Blood Pressure (SBP)||mmHg|Mean|143.7|143.7|Standard Deviation|8.23|8.23|||
3681643|NCT02277691|3525316|B1|||Concurrent Chronic Kidney Disease|Only participants with chronic kidney disease as complication are reported.|Participants|Count of Participants|65|65.0||||||
3681644|NCT02277691|3525316|B1|||Concurrent Diabetes Mellitus|Only participants with diabetes mellitus as complication are reported.|Participants|Count of Participants|90|90.0||||||
3681645|NCT02277691|3525316|B1|||Duration of Hypertension||years|Mean|9.42|9.42|Standard Deviation|7.728|7.728|||
3681646|NCT02277691|3525316|B1|||History of Alcohol Consumption|Only participants with history of any alcohol consumption are reported.|Participants|Count of Participants|120|120.0||||||
3681647|NCT02277691|3525316|B1|Ex-Smoker||Smoking Classification||Participants|Count of Participants|141|141.0||||||
3681648|NCT02277691|3525316|B1|Current Smoker||Smoking Classification||Participants|Count of Participants|84|84.0||||||
3681649|NCT02277691|3525316|B1|Never Smoked||Smoking Classification||Participants|Count of Participants|116|116.0||||||
3681650|NCT02277691|3525316|B1|||BMI|Body Mass Index = weight (kg)/[height (m)^2]|kg/m^2|Mean|26.20|26.2|Standard Deviation|3.883|3.883|||
3681651|NCT02277691|3525316|B1|||Weight||kg|Mean|70.80|70.8|Standard Deviation|12.943|12.943|||
3681652|NCT02277691|3525316|B1|||Height||cm|Mean|164.1|164.1|Standard Deviation|8.51|8.51|||
3681653|NCT02277691|3525316|B1|Japan||Region of Enrollment|All participants were enrolled in Japan.|Participants|Count of Participants|341|341.0||||||
3681654|NCT02277691|3525316|B1||Male|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
3681655|NCT02277691|3525316|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3681656|NCT02277691|3525316|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|11.44|11.44|||
3681657|NCT02277639|3525326|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3681658|NCT02277639|3525327|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3681659|NCT02277639|3525326|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3681660|NCT02277639|3525327|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3681661|NCT02277639|3525326|B3|||Age||years|Median|9.5|9.5|Full Range|||4.0|15.0|
3681662|NCT02277639|3525327|B2|||Age||years|Median|9.5|9.5|Full Range|||4.0|15.0|
3681663|NCT02277626|3525335|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3681664|NCT02277626|3525335|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3681665|NCT02277626|3525335|B1|||Age||years|Mean|33.33|33.33|Full Range|||12.78|53.88|
3681666|NCT02277249|3525350|B3|||Body Mass Index||Kilograms/meters squared|Mean|27.1|27.1|Standard Deviation|4.8|4.8|||
3681667|NCT02277249|3525351|B2|||Body Mass Index||Kilograms/meters squared|Mean|26.7|26.7|Standard Deviation|4.8|4.8|||
3681668|NCT02277249|3525352|B1|||Body Mass Index||Kilograms/meters squared|Mean|27.4|27.4|Standard Deviation|5.0|5.0|||
3681669|NCT02277249|3525350|B3|||Parity||Births|Mean|0.83|0.83|Standard Deviation|1.0|1.0|||
3681670|NCT02277249|3525351|B2|||Parity||Births|Mean|0.87|0.87|Standard Deviation|1.2|1.2|||
3681671|NCT02277249|3525352|B1|||Parity||Births|Mean|0.8|0.8|Standard Deviation|0.8|0.8|||
3681672|NCT02277249|3525350|B3|||Gestational Age||Weeks|Mean|21.4|21.4|Standard Deviation|1.4|1.4|||
3681673|NCT02277249|3525351|B2|||Gestational Age||Weeks|Mean|21.4|21.4|Standard Deviation|1.6|1.6|||
3681674|NCT02277249|3525352|B1|||Gestational Age||Weeks|Mean|21.5|21.5|Standard Deviation|1.2|1.2|||
3681675|NCT02277249|3525350|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3681676|NCT02277249|3525351|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3681677|NCT02277249|3525352|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3681678|NCT02277249|3525350|B3||Female|Gender||Participants|Count of Participants|60|60.0||||||
3681679|NCT02277249|3525351|B2||Female|Gender||Participants|Count of Participants|30|30.0||||||
3681680|NCT02277249|3525352|B1||Female|Gender||Participants|Count of Participants|30|30.0||||||
3681681|NCT02277249|3525350|B3|||Age||Years|Mean|26.7|26.7|Standard Deviation|6.4|6.4|||
3681682|NCT02277249|3525351|B2|||Age||Years|Mean|26.6|26.6|Standard Deviation|6.1|6.1|||
3681683|NCT02277249|3525352|B1|||Age||Years|Mean|26.8|26.8|Standard Deviation|6.7|6.7|||
3681684|NCT02277119|3525359|B4|||Optic Disc Area Difference||Microns Squared|Mean|0.165|0.165|Standard Deviation|0.235|0.235|||
3681685|NCT02277119|3525360|B3|||Optic Disc Area Difference||Microns Squared|Mean|0.097|0.097|Standard Deviation|0.216|0.216|||
3681686|NCT02277119|3525361|B2|||Optic Disc Area Difference||Microns Squared|Mean|0.201|0.201|Standard Deviation|0.262|0.262|||
3681687|NCT02277119|3525362|B1|||Optic Disc Area Difference||Microns Squared|Mean|0.197|0.197|Standard Deviation|0.228|0.228|||
3681688|NCT02277119|3525359|B4|United States||Region of Enrollment||participants|Number|109|109.0||||||
3681689|NCT02277119|3525360|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
3681690|NCT02277119|3525361|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
3681691|NCT02277119|3525362|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
3681693|NCT02277119|3525360|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3681694|NCT02277119|3525361|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3681695|NCT02277119|3525362|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3681696|NCT02277119|3525359|B4||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3681697|NCT02277119|3525360|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3681698|NCT02277119|3525361|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3681699|NCT02277119|3525362|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3681700|NCT02277119|3525359|B4|||Age||years|Mean|48.7|48.7|Standard Deviation|18.1|18.1|||
3681701|NCT02277119|3525360|B3|||Age||years|Mean|60.5|60.5|Standard Deviation|13.4|13.4|||
3681702|NCT02277119|3525361|B2|||Age||years|Mean|57.8|57.8|Standard Deviation|20.2|20.2|||
3681703|NCT02277119|3525362|B1|||Age||years|Mean|39.2|39.2|Standard Deviation|13.3|13.3|||
3681704|NCT02277119|3525359|B4||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3681705|NCT02277119|3525360|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3681706|NCT02277119|3525361|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3681707|NCT02277119|3525362|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3681708|NCT02277119|3525359|B4||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
3681709|NCT02277119|3525360|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3681710|NCT02277119|3525361|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3681711|NCT02277119|3525362|B1||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
3681712|NCT02277119|3525359|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3681713|NCT02277119|3525360|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3681714|NCT02277119|3525361|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3681715|NCT02277119|3525362|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3681716|NCT02277093|3525381|B1|||Prior lines of therapy for metastatic disease||prior lines of therapy|Median|4|4.0|Full Range|||2.0|6.0|
3681717|NCT02277093|3525381|B1|||Baseline c-reactive protein (CRP)||mg/L|Median|12.1|12.1|Full Range|||2.1|147.0|
3681718|NCT02277093|3525381|B1|Rectal||Primary Site of Cancer||Participants|Count of Participants|2|2.0||||||
3681719|NCT02277093|3525381|B1|Left colon||Primary Site of Cancer||Participants|Count of Participants|2|2.0||||||
3681720|NCT02277093|3525381|B1|Right colon||Primary Site of Cancer||Participants|Count of Participants|7|7.0||||||
3681721|NCT02277093|3525381|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3681722|NCT02277093|3525381|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3681723|NCT02277093|3525381|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3681724|NCT02277093|3525381|B1|||Age||years|Median|63|63.0|Full Range|||43.0|80.0|
3681725|NCT02277054|3525389|B1|Ukraine||Region of Enrollment||participants|Number|5|5.0||||||
3681726|NCT02277054|3525389|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681727|NCT02277054|3525389|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681728|NCT02277054|3525389|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3681729|NCT02277054|3525389|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681730|NCT02277054|3525389|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681731|NCT02277054|3525389|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681732|NCT02277054|3525389|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681733|NCT02277054|3525389|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3681734|NCT02277054|3525389|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3681735|NCT02277054|3525389|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3681736|NCT02277054|3525389|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3681737|NCT02277054|3525389|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3681738|NCT02276612|3525395|B3|||CD4 Percentage||percentage|Mean|34.6|34.6|Standard Deviation|6.66|6.66|||
3681739|NCT02276612|3525396|B2|||CD4 Percentage||percentage|Mean|35.9|35.9|Standard Deviation|6.53|6.53|||
3681740|NCT02276612|3525397|B1|||CD4 Percentage||percentage|Mean|34.3|34.3|Standard Deviation|6.72|6.72|||
3681741|NCT02276612|3525395|B3|||CD4 Cell Count||cells/µL|Mean|757|757.0|Standard Deviation|214.8|214.8|||
3681742|NCT02276612|3525396|B2|||CD4 Cell Count||cells/µL|Mean|776|776.0|Standard Deviation|179.9|179.9|||
3681743|NCT02276612|3525397|B1|||CD4 Cell Count||cells/µL|Mean|753|753.0|Standard Deviation|222.5|222.5|||
3681744|NCT02276612|3525395|B3||≥ 50 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|2|2.0||||||
3681745|NCT02276612|3525396|B2||≥ 50 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|1|1.0||||||
3681746|NCT02276612|3525397|B1||≥ 50 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|1|1.0||||||
3681747|NCT02276612|3525395|B3||< 50 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|58|58.0||||||
3681748|NCT02276612|3525396|B2||< 50 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|9|9.0||||||
3681749|NCT02276612|3525397|B1||< 50 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|49|49.0||||||
3681750|NCT02276612|3525395|B3|South Africa||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
3681751|NCT02276612|3525396|B2|South Africa||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3681752|NCT02276612|3525397|B1|South Africa||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3681753|NCT02276612|3525395|B3|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3681754|NCT02276612|3525396|B2|United States||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3681755|NCT02276612|3525397|B1|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3681756|NCT02276612|3525395|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3681757|NCT02276612|3525396|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3681758|NCT02276612|3525397|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3681759|NCT02276612|3525395|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3681760|NCT02276612|3525396|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3681761|NCT02276612|3525397|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3681762|NCT02276612|3525395|B3||Black|Race/Ethnicity, Customized||Participants|Count of Participants|58|58.0||||||
3681763|NCT02276612|3525396|B2||Black|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3681764|NCT02276612|3525397|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|49|49.0||||||
3681765|NCT02276612|3525395|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681766|NCT02276612|3525396|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681767|NCT02276612|3525397|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681768|NCT02276612|3525395|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3681769|NCT02276612|3525396|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3681770|NCT02276612|3525397|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3681771|NCT02276612|3525395|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3681772|NCT02276612|3525396|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681773|NCT02276612|3525397|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3681774|NCT02276612|3525395|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3681775|NCT02276612|3525396|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3681776|NCT02276612|3525397|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3681777|NCT02276612|3525395|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3681778|NCT02276612|3525396|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3681779|NCT02276612|3525397|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3681780|NCT02276612|3525395|B3|||Age||years|Mean|16|16.0|Standard Deviation|2.2|2.2|||
3681781|NCT02276612|3525396|B2|||Age||years|Mean|19|19.0|Standard Deviation|1.2|1.2|||
3681782|NCT02276612|3525397|B1|||Age||years|Mean|15|15.0|Standard Deviation|1.6|1.6|||
3681783|NCT02276560|3525418|B4|United States||Region of Enrollment||participants|Number|1|1.0||||||
3681784|NCT02276560|3525421|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3681785|NCT02276560|3525418|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3681786|NCT02276560|3525419|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681787|NCT02276560|3525420|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681788|NCT02276560|3525421|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3681789|NCT02276560|3525418|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681790|NCT02276560|3525419|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681791|NCT02276560|3525420|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681792|NCT02276560|3525421|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681793|NCT02276560|3525418|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681794|NCT02276560|3525419|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681795|NCT02276560|3525420|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681796|NCT02276560|3525421|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681797|NCT02276560|3525418|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681798|NCT02276560|3525419|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681799|NCT02276560|3525420|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681800|NCT02276560|3525421|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681801|NCT02276560|3525418|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681802|NCT02276560|3525419|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681803|NCT02276560|3525420|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681804|NCT02276560|3525421|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681805|NCT02276560|3525418|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681806|NCT02276560|3525419|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681807|NCT02276560|3525420|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681808|NCT02276560|3525421|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681809|NCT02276560|3525418|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681810|NCT02276560|3525419|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681811|NCT02276560|3525420|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681812|NCT02276560|3525421|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681813|NCT02276560|3525418|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681814|NCT02276560|3525419|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681815|NCT02276560|3525420|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681816|NCT02276560|3525421|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681817|NCT02276560|3525418|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3681818|NCT02276560|3525419|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681819|NCT02276560|3525420|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681820|NCT02276560|3525421|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3681821|NCT02276560|3525418|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681822|NCT02276560|3525419|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681823|NCT02276560|3525420|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681824|NCT02276560|3525421|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681825|NCT02276560|3525418|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3681826|NCT02276560|3525419|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3681827|NCT02276560|3525420|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3681828|NCT02276560|3525421|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3681829|NCT02276560|3525418|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3681830|NCT02276560|3525419|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3681831|NCT02276560|3525420|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3681832|NCT02276560|3525421|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3681833|NCT02276560|3525418|B4|||Age||years|Mean|67|67.0|Full Range|||67.0|67.0|
3681834|NCT02276560|3525421|B1|||Age||years|Mean|67|67.0|Full Range|||67.0|67.0|
3681835|NCT02276274|3525431|B3|Did not take Caffeine||Caffeine Classification||participants|Number|9|9.0||||||
3681836|NCT02276274|3525432|B2|Did not take Caffeine||Caffeine Classification||participants|Number|5|5.0||||||
3681837|NCT02276274|3525433|B1|Did not take Caffeine||Caffeine Classification||participants|Number|4|4.0||||||
3681838|NCT02276274|3525431|B3|Took Caffeine||Caffeine Classification||participants|Number|3|3.0||||||
3681839|NCT02276274|3525432|B2|Took Caffeine||Caffeine Classification||participants|Number|1|1.0||||||
3681840|NCT02276274|3525433|B1|Took Caffeine||Caffeine Classification||participants|Number|2|2.0||||||
3681841|NCT02276274|3525431|B3|No||Alcohol Classification||participants|Number|5|5.0||||||
3681842|NCT02276274|3525432|B2|No||Alcohol Classification||participants|Number|3|3.0||||||
3681843|NCT02276274|3525433|B1|No||Alcohol Classification||participants|Number|2|2.0||||||
3681844|NCT02276274|3525431|B3|Drank a Few Days per Month||Alcohol Classification||participants|Number|7|7.0||||||
3681845|NCT02276274|3525432|B2|Drank a Few Days per Month||Alcohol Classification||participants|Number|3|3.0||||||
3681846|NCT02276274|3525433|B1|Drank a Few Days per Month||Alcohol Classification||participants|Number|4|4.0||||||
3681847|NCT02276274|3525431|B3|Drank a Few Days per Week||Alcohol Classification||participants|Number|0|0.0||||||
3681848|NCT02276274|3525432|B2|Drank a Few Days per Week||Alcohol Classification||participants|Number|0|0.0||||||
3681849|NCT02276274|3525433|B1|Drank a Few Days per Week||Alcohol Classification||participants|Number|0|0.0||||||
3681850|NCT02276274|3525431|B3|Drank Every Day||Alcohol Classification||participants|Number|0|0.0||||||
3681851|NCT02276274|3525432|B2|Drank Every Day||Alcohol Classification||participants|Number|0|0.0||||||
3681852|NCT02276274|3525433|B1|Drank Every Day||Alcohol Classification||participants|Number|0|0.0||||||
3681853|NCT02276274|3525431|B3|Ex-Smoker||Smoking Classification||participants|Number|3|3.0||||||
3681854|NCT02276274|3525432|B2|Ex-Smoker||Smoking Classification||participants|Number|2|2.0||||||
3681855|NCT02276274|3525433|B1|Ex-Smoker||Smoking Classification||participants|Number|1|1.0||||||
3681856|NCT02276274|3525431|B3|Current Smoker||Smoking Classification||participants|Number|6|6.0||||||
3681857|NCT02276274|3525432|B2|Current Smoker||Smoking Classification||participants|Number|3|3.0||||||
3681858|NCT02276274|3525433|B1|Current Smoker||Smoking Classification||participants|Number|3|3.0||||||
3681859|NCT02276274|3525431|B3|Never Smoked||Smoking Classification||participants|Number|3|3.0||||||
3681860|NCT02276274|3525432|B2|Never Smoked||Smoking Classification||participants|Number|1|1.0||||||
3681861|NCT02276274|3525433|B1|Never Smoked||Smoking Classification||participants|Number|2|2.0||||||
3681862|NCT02276274|3525431|B3|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|21.32|21.32|Standard Deviation|1.406|1.406|||
3681863|NCT02276274|3525432|B2|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|21.15|21.15|Standard Deviation|0.869|0.869|||
3681864|NCT02276274|3525433|B1|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|21.48|21.48|Standard Deviation|1.878|1.878|||
3681865|NCT02276274|3525431|B3|||Weight||kilogram (kg)|Mean|63.28|63.28|Standard Deviation|7.451|7.451|||
3681866|NCT02276274|3525432|B2|||Weight||kilogram (kg)|Mean|65.40|65.4|Standard Deviation|6.425|6.425|||
3681867|NCT02276274|3525433|B1|||Weight||kilogram (kg)|Mean|61.17|61.17|Standard Deviation|8.373|8.373|||
3681868|NCT02276274|3525431|B3|||height||centimeters (cm)|Mean|172.1|172.1|Standard Deviation|7.51|7.51|||
3681869|NCT02276274|3525432|B2|||height||centimeters (cm)|Mean|175.7|175.7|Standard Deviation|6.68|6.68|||
3681870|NCT02276274|3525433|B1|||height||centimeters (cm)|Mean|168.5|168.5|Standard Deviation|6.98|6.98|||
3681871|NCT02276274|3525431|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3681872|NCT02276274|3525432|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3681873|NCT02276274|3525433|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3681874|NCT02276274|3525431|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3681875|NCT02276274|3525432|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3681876|NCT02276274|3525433|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3681877|NCT02276274|3525431|B3|||Age||years|Mean|25.2|25.2|Standard Deviation|4.99|4.99|||
3681878|NCT02276274|3525432|B2|||Age||years|Mean|27.2|27.2|Standard Deviation|6.43|6.43|||
3681879|NCT02276274|3525433|B1|||Age||years|Mean|23.2|23.2|Standard Deviation|1.94|1.94|||
3681880|NCT02276222|3525542|B3|||Forced expiratory volume in one second (FEV1)||liters|Mean|1.3365|1.3365|Standard Deviation|0.51414|0.51414|||
3681881|NCT02276222|3525543|B2|||Forced expiratory volume in one second (FEV1)||liters|Mean|1.3257|1.3257|Standard Deviation|0.50186|0.50186|||
3681882|NCT02276222|3525544|B1|||Forced expiratory volume in one second (FEV1)||liters|Mean|1.3399|1.3399|Standard Deviation|0.49604|0.49604|||
3681883|NCT02276222|3525542|B3|background LABA use -no||background long-acting beta (2) agonist (LABA) use||Participants|Count of Participants|627|627.0||||||
3681884|NCT02276222|3525543|B2|background LABA use -no||background long-acting beta (2) agonist (LABA) use||Participants|Count of Participants|274|274.0||||||
3681885|NCT02276222|3525544|B1|background LABA use -no||background long-acting beta (2) agonist (LABA) use||Participants|Count of Participants|353|353.0||||||
3681886|NCT02276222|3525542|B3|background LABA use -yes||background long-acting beta (2) agonist (LABA) use||Participants|Count of Participants|459|459.0||||||
3681887|NCT02276222|3525543|B2|background LABA use -yes||background long-acting beta (2) agonist (LABA) use||Participants|Count of Participants|192|192.0||||||
3681888|NCT02276222|3525544|B1|background LABA use -yes||background long-acting beta (2) agonist (LABA) use||Participants|Count of Participants|267|267.0||||||
3681889|NCT02276222|3525542|B3|hyertension||cardiovascular risk (low/high) and categories for high cardiovascular risk||Participants|Count of Participants|637|637.0||||||
3681890|NCT02276222|3525543|B2|hyertension||cardiovascular risk (low/high) and categories for high cardiovascular risk||Participants|Count of Participants|275|275.0||||||
3681891|NCT02276222|3525544|B1|hyertension||cardiovascular risk (low/high) and categories for high cardiovascular risk||Participants|Count of Participants|362|362.0||||||
3681892|NCT02276222|3525542|B3|heart failure||cardiovascular risk (low/high) and categories for high cardiovascular risk||Participants|Count of Participants|32|32.0||||||
3681893|NCT02276222|3525543|B2|heart failure||cardiovascular risk (low/high) and categories for high cardiovascular risk||Participants|Count of Participants|9|9.0||||||
3681894|NCT02276222|3525544|B1|heart failure||cardiovascular risk (low/high) and categories for high cardiovascular risk||Participants|Count of Participants|23|23.0||||||
3681895|NCT02276222|3525542|B3|clinically significant arrhythmia||cardiovascular risk (low/high) and categories for high cardiovascular risk||Participants|Count of Participants|36|36.0||||||
3681896|NCT02276222|3525543|B2|clinically significant arrhythmia||cardiovascular risk (low/high) and categories for high cardiovascular risk||Participants|Count of Participants|14|14.0||||||
3681897|NCT02276222|3525544|B1|clinically significant arrhythmia||cardiovascular risk (low/high) and categories for high cardiovascular risk||Participants|Count of Participants|22|22.0||||||
3681898|NCT02276222|3525542|B3|periheral arterial disease||cardiovascular risk (low/high) and categories for high cardiovascular risk||Participants|Count of Participants|63|63.0||||||
3681899|NCT02276222|3525543|B2|periheral arterial disease||cardiovascular risk (low/high) and categories for high cardiovascular risk||Participants|Count of Participants|24|24.0||||||
3681900|NCT02276222|3525544|B1|periheral arterial disease||cardiovascular risk (low/high) and categories for high cardiovascular risk||Participants|Count of Participants|39|39.0||||||
3681901|NCT02276222|3525542|B3|cerebrovascular disease||cardiovascular risk (low/high) and categories for high cardiovascular risk||Participants|Count of Participants|46|46.0||||||
3681902|NCT02276222|3525543|B2|cerebrovascular disease||cardiovascular risk (low/high) and categories for high cardiovascular risk||Participants|Count of Participants|18|18.0||||||
3681903|NCT02276222|3525544|B1|cerebrovascular disease||cardiovascular risk (low/high) and categories for high cardiovascular risk||Participants|Count of Participants|28|28.0||||||
3681904|NCT02276222|3525542|B3|ischemic heart disease||cardiovascular risk (low/high) and categories for high cardiovascular risk||Participants|Count of Participants|105|105.0||||||
3681905|NCT02276222|3525543|B2|ischemic heart disease||cardiovascular risk (low/high) and categories for high cardiovascular risk||Participants|Count of Participants|44|44.0||||||
3681906|NCT02276222|3525544|B1|ischemic heart disease||cardiovascular risk (low/high) and categories for high cardiovascular risk||Participants|Count of Participants|61|61.0||||||
3681907|NCT02276222|3525542|B3|high cardiovascular risk||cardiovascular risk (low/high) and categories for high cardiovascular risk||Participants|Count of Participants|698|698.0||||||
3681908|NCT02276222|3525543|B2|high cardiovascular risk||cardiovascular risk (low/high) and categories for high cardiovascular risk||Participants|Count of Participants|297|297.0||||||
3681909|NCT02276222|3525544|B1|high cardiovascular risk||cardiovascular risk (low/high) and categories for high cardiovascular risk||Participants|Count of Participants|401|401.0||||||
3681910|NCT02276222|3525542|B3|low cardiovascular risk||cardiovascular risk (low/high) and categories for high cardiovascular risk||Participants|Count of Participants|388|388.0||||||
3681911|NCT02276222|3525543|B2|low cardiovascular risk||cardiovascular risk (low/high) and categories for high cardiovascular risk||Participants|Count of Participants|169|169.0||||||
3681912|NCT02276222|3525544|B1|low cardiovascular risk||cardiovascular risk (low/high) and categories for high cardiovascular risk||Participants|Count of Participants|219|219.0||||||
3681913|NCT02276222|3525542|B3|United States||Region of Enrollment||Participants|Count of Participants|977|977.0||||||
3681914|NCT02276222|3525543|B2|United States||Region of Enrollment||Participants|Count of Participants|421|421.0||||||
3681915|NCT02276222|3525544|B1|United States||Region of Enrollment||Participants|Count of Participants|556|556.0||||||
3681916|NCT02276222|3525542|B3|Hungary||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
3681917|NCT02276222|3525543|B2|Hungary||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3681918|NCT02276222|3525544|B1|Hungary||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3681919|NCT02276222|3525542|B3|Czechia||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3681920|NCT02276222|3525543|B2|Czechia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3681921|NCT02276222|3525544|B1|Czechia||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3681922|NCT02276222|3525542|B3|Russia||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
3681923|NCT02276222|3525543|B2|Russia||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3681924|NCT02276222|3525544|B1|Russia||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3681925|NCT02276222|3525542|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681926|NCT02276222|3525543|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681927|NCT02276222|3525544|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681928|NCT02276222|3525542|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681929|NCT02276222|3525543|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681930|NCT02276222|3525544|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681931|NCT02276222|3525542|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1018|1018.0||||||
3681932|NCT02276222|3525543|B2||White|Race (NIH/OMB)||Participants|Count of Participants|436|436.0||||||
3681933|NCT02276222|3525544|B1||White|Race (NIH/OMB)||Participants|Count of Participants|582|582.0||||||
3681934|NCT02276222|3525542|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3681935|NCT02276222|3525543|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3681936|NCT02276222|3525544|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3681937|NCT02276222|3525542|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681938|NCT02276222|3525543|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681939|NCT02276222|3525544|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681940|NCT02276222|3525542|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3681941|NCT02276222|3525543|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3681942|NCT02276222|3525544|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3681943|NCT02276222|3525542|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3681944|NCT02276222|3525543|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3681945|NCT02276222|3525544|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3681946|NCT02276222|3525542|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681947|NCT02276222|3525543|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681948|NCT02276222|3525544|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3681949|NCT02276222|3525542|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1068|1068.0||||||
3681950|NCT02276222|3525543|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|457|457.0||||||
3681951|NCT02276222|3525544|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|611|611.0||||||
3681952|NCT02276222|3525542|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3681953|NCT02276222|3525543|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3681954|NCT02276222|3525544|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3681955|NCT02276222|3525542|B3||Male|Sex: Female, Male||Participants|Count of Participants|610|610.0||||||
3681956|NCT02276222|3525543|B2||Male|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
3681957|NCT02276222|3525544|B1||Male|Sex: Female, Male||Participants|Count of Participants|350|350.0||||||
3681958|NCT02276222|3525542|B3||Female|Sex: Female, Male||Participants|Count of Participants|476|476.0||||||
3681959|NCT02276222|3525543|B2||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
3681960|NCT02276222|3525544|B1||Female|Sex: Female, Male||Participants|Count of Participants|270|270.0||||||
3681961|NCT02276222|3525542|B3|||Age||years|Mean|63.3|63.3|Standard Deviation|8.68|8.68|||
3681962|NCT02276222|3525543|B2|||Age||years|Mean|63.3|63.3|Standard Deviation|8.97|8.97|||
3681963|NCT02276222|3525544|B1|||Age||years|Mean|63.3|63.3|Standard Deviation|8.46|8.46|||
3681964|NCT02276222|3525542|B3||>=65 years|Age||Participants|Count of Participants|500|500.0||||||
3681965|NCT02276222|3525543|B2||>=65 years|Age||Participants|Count of Participants|210|210.0||||||
3681966|NCT02276222|3525544|B1||>=65 years|Age||Participants|Count of Participants|290|290.0||||||
3681967|NCT02276222|3525542|B3||Between 18 and 65 years|Age||Participants|Count of Participants|586|586.0||||||
3681968|NCT02276222|3525543|B2||Between 18 and 65 years|Age||Participants|Count of Participants|256|256.0||||||
3681969|NCT02276222|3525544|B1||Between 18 and 65 years|Age||Participants|Count of Participants|330|330.0||||||
3681970|NCT02276222|3525542|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3681971|NCT02276222|3525543|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3681972|NCT02276222|3525544|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3681973|NCT02276040|3525569|B1||Total Knee Arthroplasty|Surgery Performed||Participants|Count of Participants|6|6.0||||||
3681974|NCT02276040|3525569|B1||Total Hip Arthroplasty|Surgery Performed||Participants|Count of Participants|5|5.0||||||
3681975|NCT02276040|3525569|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3681976|NCT02276040|3525569|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3681977|NCT02276040|3525569|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3681978|NCT02276040|3525569|B1|||Age||years|Median|63|63.0|Inter-Quartile Range|||60.0|70.0|
3681979|NCT02275780|3525573|B3|||Plasma HIV-1 RNA|Plasma HIV-1 RNA levels were quantified with the Abbott RealTime HIV-1 Assay|Copies/mL|Median|27073.0|27073.0|Full Range|||105.0|3272236.0|
3681980|NCT02275780|3525574|B2|||Plasma HIV-1 RNA|Plasma HIV-1 RNA levels were quantified with the Abbott RealTime HIV-1 Assay|Copies/mL|Median|27357.0|27357.0|Full Range|||235.0|3272236.0|
3681981|NCT02275780|3525575|B1|||Plasma HIV-1 RNA|Plasma HIV-1 RNA levels were quantified with the Abbott RealTime HIV-1 Assay|Copies/mL|Median|27073.0|27073.0|Full Range|||105.0|2776658.0|
3681982|NCT02275780|3525573|B3|||Mean Cluster of Differentiation 4 (CD4+) T-cell Count|CD4+ T-cell count was quantified by a central laboratory using a commercially available assay|Cells/mm^3|Mean|422.2|422.2|Standard Deviation|219.4|219.4|||
3681983|NCT02275780|3525574|B2|||Mean Cluster of Differentiation 4 (CD4+) T-cell Count|CD4+ T-cell count was quantified by a central laboratory using a commercially available assay|Cells/mm^3|Mean|411.9|411.9|Standard Deviation|229.6|229.6|||
3681984|NCT02275780|3525575|B1|||Mean Cluster of Differentiation 4 (CD4+) T-cell Count|CD4+ T-cell count was quantified by a central laboratory using a commercially available assay|Cells/mm^3|Mean|432.6|432.6|Standard Deviation|208.4|208.4|||
3681985|NCT02275780|3525573|B3||Male|Sex: Female, Male||Participants|Count of Participants|645|645.0||||||
3681986|NCT02275780|3525574|B2||Male|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
3681987|NCT02275780|3525575|B1||Male|Sex: Female, Male||Participants|Count of Participants|319|319.0||||||
3681988|NCT02275780|3525573|B3||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3681989|NCT02275780|3525574|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3681990|NCT02275780|3525575|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3681991|NCT02275780|3525573|B3|||Age||Years|Mean|35.2|35.2|Standard Deviation|10.6|10.6|||
3681992|NCT02275780|3525574|B2|||Age||Years|Mean|35.7|35.7|Standard Deviation|10.7|10.7|||
3681993|NCT02275780|3525575|B1|||Age||Years|Mean|34.8|34.8|Standard Deviation|10.5|10.5|||
3681994|NCT02275767|3525612|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3681995|NCT02275767|3525613|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3681996|NCT02275767|3525614|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3681997|NCT02275767|3525615|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3681998|NCT02275767|3525612|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3681999|NCT02275767|3525613|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3682000|NCT02275767|3525614|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3682001|NCT02275767|3525615|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3682002|NCT02275767|3525612|B4|||Age||years|Mean|53.2|53.2|Full Range|||27.0|74.0|
3682003|NCT02275767|3525613|B3|||Age||years|Mean|53.7|53.7|Full Range|||27.0|74.0|
3682004|NCT02275767|3525614|B2|||Age||years|Mean|52.6|52.6|Full Range|||30.0|69.0|
3682005|NCT02275767|3525615|B1|||Age||years|Mean|54.4|54.4|Full Range|||29.0|72.0|
3682006|NCT02275611|3525628|B5|||Clinical Institute Withdrawal Assessment for Alcohol (CIWA)|The Clinical Institute Withdrawal Assessment for Alcohol (CIWA) measure is a ten item measure of alcohol withdrawal symptoms. The CIWA total score is the summation of 10 questions, with a range from 0 (little to no withdrawal) to 67 (worse alcohol withdrawal).|scores on a scale|Mean|5.99|5.99|Standard Deviation|1.60|1.6|||
3682007|NCT02275611|3525631|B2|||Clinical Institute Withdrawal Assessment for Alcohol (CIWA)|The Clinical Institute Withdrawal Assessment for Alcohol (CIWA) measure is a ten item measure of alcohol withdrawal symptoms. The CIWA total score is the summation of 10 questions, with a range from 0 (little to no withdrawal) to 67 (worse alcohol withdrawal).|scores on a scale|Mean|5.57|5.57|Standard Deviation|1.85|1.85|||
3682008|NCT02275611|3525632|B1|||Clinical Institute Withdrawal Assessment for Alcohol (CIWA)|The Clinical Institute Withdrawal Assessment for Alcohol (CIWA) measure is a ten item measure of alcohol withdrawal symptoms. The CIWA total score is the summation of 10 questions, with a range from 0 (little to no withdrawal) to 67 (worse alcohol withdrawal).|scores on a scale|Mean|6.41|6.41|Standard Deviation|1.45|1.45|||
3682009|NCT02275611|3525628|B5|United States||Region of Enrollment||participants|Number|9|9.0||||||
3682010|NCT02275611|3525629|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
3682011|NCT02275611|3525630|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3682012|NCT02275611|3525631|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3682013|NCT02275611|3525632|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3682014|NCT02275611|3525628|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682015|NCT02275611|3525629|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682016|NCT02275611|3525630|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682017|NCT02275611|3525631|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682018|NCT02275611|3525632|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682019|NCT02275611|3525628|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682020|NCT02275611|3525629|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682021|NCT02275611|3525630|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682022|NCT02275611|3525631|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682023|NCT02275611|3525632|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682024|NCT02275611|3525628|B5||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3682025|NCT02275611|3525629|B4||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3682026|NCT02275611|3525630|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3682027|NCT02275611|3525631|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3682028|NCT02275611|3525632|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3682029|NCT02275611|3525628|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3682030|NCT02275611|3525629|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3682031|NCT02275611|3525630|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3682032|NCT02275611|3525631|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3682033|NCT02275611|3525632|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3682034|NCT02275611|3525628|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682035|NCT02275611|3525629|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682036|NCT02275611|3525630|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682037|NCT02275611|3525631|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682038|NCT02275611|3525632|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682039|NCT02275611|3525628|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682040|NCT02275611|3525629|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682041|NCT02275611|3525630|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682042|NCT02275611|3525631|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682043|NCT02275611|3525632|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682044|NCT02275611|3525628|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682045|NCT02275611|3525629|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682046|NCT02275611|3525630|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682047|NCT02275611|3525631|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682048|NCT02275611|3525632|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682049|NCT02275611|3525628|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682050|NCT02275611|3525629|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682051|NCT02275611|3525630|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682052|NCT02275611|3525631|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682053|NCT02275611|3525632|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682054|NCT02275611|3525628|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3682055|NCT02275611|3525629|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3682056|NCT02275611|3525630|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3682057|NCT02275611|3525631|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3682058|NCT02275611|3525632|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3682059|NCT02275611|3525628|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682060|NCT02275611|3525629|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682061|NCT02275611|3525630|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682062|NCT02275611|3525631|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682063|NCT02275611|3525632|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682064|NCT02275611|3525628|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3682065|NCT02275611|3525629|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3682066|NCT02275611|3525630|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3682067|NCT02275611|3525631|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3682068|NCT02275611|3525632|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3682069|NCT02275611|3525628|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3682070|NCT02275611|3525629|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3682071|NCT02275611|3525630|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3682072|NCT02275611|3525631|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3682073|NCT02275611|3525632|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3682074|NCT02275611|3525628|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3682075|NCT02275611|3525629|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3682076|NCT02275611|3525630|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3682077|NCT02275611|3525631|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3682078|NCT02275611|3525632|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3682079|NCT02275611|3525628|B5||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3682080|NCT02275611|3525629|B4||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3682081|NCT02275611|3525630|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3682082|NCT02275611|3525631|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3682083|NCT02275611|3525632|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3682084|NCT02275611|3525628|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3682085|NCT02275611|3525629|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3682086|NCT02275611|3525630|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3682087|NCT02275611|3525631|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3682088|NCT02275611|3525632|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3682089|NCT02275546|3525647|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3682090|NCT02275546|3525647|B1||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3682091|NCT02275546|3525647|B1|||Age||Years|Mean|30.2|30.2|Standard Deviation|6.8|6.8|||
3682092|NCT02275481|3525656|B3|United States||Region of Enrollment||Participants|Count of Participants|66|66.0||||||
3682093|NCT02275481|3525657|B2|United States||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3682094|NCT02275481|3525658|B1|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3682095|NCT02275481|3525656|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682096|NCT02275481|3525657|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682097|NCT02275481|3525658|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682098|NCT02275481|3525656|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682099|NCT02275481|3525657|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682100|NCT02275481|3525658|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682101|NCT02275481|3525656|B3||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3682102|NCT02275481|3525657|B2||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3682103|NCT02275481|3525658|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3682104|NCT02275481|3525656|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3682105|NCT02275481|3525657|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3682106|NCT02275481|3525658|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3682107|NCT02275481|3525656|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682108|NCT02275481|3525657|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682109|NCT02275481|3525658|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682110|NCT02275481|3525656|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682111|NCT02275481|3525657|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682112|NCT02275481|3525658|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682113|NCT02275481|3525656|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682114|NCT02275481|3525657|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682115|NCT02275481|3525658|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682116|NCT02275481|3525656|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682117|NCT02275481|3525657|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682118|NCT02275481|3525658|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682119|NCT02275481|3525656|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3682120|NCT02275481|3525657|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3682121|NCT02275481|3525658|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3682122|NCT02275481|3525656|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682123|NCT02275481|3525657|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682124|NCT02275481|3525658|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682125|NCT02275481|3525656|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3682126|NCT02275481|3525657|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3682127|NCT02275481|3525658|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3682128|NCT02275481|3525656|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3682129|NCT02275481|3525657|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3682130|NCT02275481|3525658|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3682131|NCT02275481|3525656|B3|||Age||years|Mean|72.0|72.0|Standard Deviation|6.70|6.7|||
3682132|NCT02275481|3525657|B2|||Age||years|Mean|72.1|72.1|Standard Deviation|6.65|6.65|||
3682133|NCT02275481|3525658|B1|||Age||years|Mean|71.9|71.9|Standard Deviation|6.86|6.86|||
3682134|NCT02275481|3525656|B3||>=65 years|Age||Participants|Count of Participants|59|59.0||||||
3682135|NCT02275481|3525657|B2||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
3682136|NCT02275481|3525658|B1||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
3682137|NCT02275481|3525656|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3682138|NCT02275481|3525657|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3682139|NCT02275481|3525658|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3682140|NCT02275481|3525656|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3682141|NCT02275481|3525657|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3682142|NCT02275481|3525658|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3682143|NCT02275364|3525665|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3682144|NCT02275364|3525665|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3682145|NCT02275364|3525665|B1|||Age||Years|Mean|33.0|33.0|Standard Deviation|10.98|10.98|||
3682146|NCT02275156|3525695|B4|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3682147|NCT02275156|3525696|B3|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3682148|NCT02275156|3525697|B2|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3682149|NCT02275156|3525698|B1|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3682150|NCT02275156|3525695|B4|Black (or African American)||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3682151|NCT02275156|3525696|B3|Black (or African American)||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3682152|NCT02275156|3525697|B2|Black (or African American)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3682153|NCT02275156|3525698|B1|Black (or African American)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3682154|NCT02275156|3525695|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3682155|NCT02275156|3525696|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3682156|NCT02275156|3525697|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3682157|NCT02275156|3525698|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3682158|NCT02275156|3525695|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3682159|NCT02275156|3525696|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3682160|NCT02275156|3525697|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3682161|NCT02275156|3525698|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3682162|NCT02275156|3525695|B4|||Age||years|Mean|57.2|57.2|Standard Deviation|9.6|9.6|||
3682163|NCT02275156|3525696|B3|||Age||years|Mean|57.0|57.0|Standard Deviation|8.1|8.1|||
3682164|NCT02275156|3525697|B2|||Age||years|Mean|63.3|63.3|Standard Deviation|7.8|7.8|||
3682165|NCT02275156|3525698|B1|||Age||years|Mean|51.2|51.2|Standard Deviation|9.9|9.9|||
3682166|NCT02275052|3525727|B1|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|179|179.0||||||
3682167|NCT02275052|3525727|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
3682168|NCT02275052|3525727|B1||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3682169|NCT02275052|3525727|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3682170|NCT02275052|3525727|B1|||Age||Years|Mean|60.7|60.7|Standard Deviation|9.47|9.47|||
3682171|NCT02274948|3525742|B3|||Percentage Fat Mass Standard Deviation Score|"The Percent Fat Mass SDS is calculated by; (Percent FM of the subject - median value of the population)/Standard deviation of the population.~This will provide how far the measured individuals Percent FM is deviated from the median in multiples of the SD value of the population. Value could be either positive (if measured value is greater than the median) or a negative value (if measured value is less than the median)."|units on a scale|Mean|2.82|2.82|Standard Deviation|0.43|0.43|||
3682172|NCT02274948|3525743|B2|||Percentage Fat Mass Standard Deviation Score|"The Percent Fat Mass SDS is calculated by; (Percent FM of the subject - median value of the population)/Standard deviation of the population.~This will provide how far the measured individuals Percent FM is deviated from the median in multiples of the SD value of the population. Value could be either positive (if measured value is greater than the median) or a negative value (if measured value is less than the median)."|units on a scale|Mean|2.81|2.81|Standard Deviation|0.44|0.44|||
3682173|NCT02274948|3525744|B1|||Percentage Fat Mass Standard Deviation Score|"The Percent Fat Mass SDS is calculated by; (Percent FM of the subject - median value of the population)/Standard deviation of the population.~This will provide how far the measured individuals Percent FM is deviated from the median in multiples of the SD value of the population. Value could be either positive (if measured value is greater than the median) or a negative value (if measured value is less than the median)."|units on a scale|Mean|2.82|2.82|Standard Deviation|0.42|0.42|||
3682174|NCT02274948|3525742|B3|||Percentage fat mass||Percent|Mean|42.95|42.95|Standard Deviation|5.08|5.08|||
3682175|NCT02274948|3525743|B2|||Percentage fat mass||Percent|Mean|42.88|42.88|Standard Deviation|5.03|5.03|||
3682176|NCT02274948|3525744|B1|||Percentage fat mass||Percent|Mean|43.02|43.02|Standard Deviation|5.14|5.14|||
3682177|NCT02274948|3525742|B3|||BMI Standard Deviation Score|"The BMI SDS is calculated by; (BMI value of the subject - median value of the population)/Standard deviation of the population.~This will provide how far the measured individuals BMI is deviated from the median in multiples of the SD value of the population. Value could be either positive (if measured value is greater than the median) or a negative value (if measured value is less than the median)."|units on a scale|Median|2.56|2.56|Standard Deviation|0.42|0.42|||
3682178|NCT02274948|3525743|B2|||BMI Standard Deviation Score|"The BMI SDS is calculated by; (BMI value of the subject - median value of the population)/Standard deviation of the population.~This will provide how far the measured individuals BMI is deviated from the median in multiples of the SD value of the population. Value could be either positive (if measured value is greater than the median) or a negative value (if measured value is less than the median)."|units on a scale|Median|2.54|2.54|Standard Deviation|0.42|0.42|||
3682179|NCT02274948|3525744|B1|||BMI Standard Deviation Score|"The BMI SDS is calculated by; (BMI value of the subject - median value of the population)/Standard deviation of the population.~This will provide how far the measured individuals BMI is deviated from the median in multiples of the SD value of the population. Value could be either positive (if measured value is greater than the median) or a negative value (if measured value is less than the median)."|units on a scale|Median|2.58|2.58|Standard Deviation|0.42|0.42|||
3682180|NCT02274948|3525742|B3|||BMI||kg/m^2|Mean|27.73|27.73|Standard Deviation|3.42|3.42|||
3682181|NCT02274948|3525743|B2|||BMI||kg/m^2|Mean|27.57|27.57|Standard Deviation|3.32|3.32|||
3682182|NCT02274948|3525744|B1|||BMI||kg/m^2|Mean|27.89|27.89|Standard Deviation|3.53|3.53|||
3682183|NCT02274948|3525742|B3||Male|Gender||Participants|Count of Participants|177|177.0||||||
3682184|NCT02274948|3525743|B2||Male|Gender||Participants|Count of Participants|89|89.0||||||
3682185|NCT02274948|3525744|B1||Male|Gender||Participants|Count of Participants|88|88.0||||||
3682186|NCT02274948|3525742|B3||Female|Gender||Participants|Count of Participants|162|162.0||||||
3682187|NCT02274948|3525743|B2||Female|Gender||Participants|Count of Participants|84|84.0||||||
3682188|NCT02274948|3525744|B1||Female|Gender||Participants|Count of Participants|78|78.0||||||
3682189|NCT02274948|3525742|B3|||Age||years|Mean|11.94|11.94|Standard Deviation|2.31|2.31|||
3682190|NCT02274948|3525743|B2|||Age||years|Mean|11.95|11.95|Standard Deviation|2.34|2.34|||
3682191|NCT02274948|3525744|B1|||Age||years|Mean|11.92|11.92|Standard Deviation|2.3|2.3|||
3682192|NCT02274870|3525759|B3|||BMI, Continuous||kg/m^2|Mean|32.84|32.84|Standard Deviation|4.52|4.52|||
3682193|NCT02274870|3525760|B2|||BMI, Continuous||kg/m^2|Mean|32.57|32.57|Standard Deviation|4.55|4.55|||
3682194|NCT02274870|3525761|B1|||BMI, Continuous||kg/m^2|Mean|33.13|33.13|Standard Deviation|4.53|4.53|||
3682195|NCT02274870|3525759|B3|United States||Region of Enrollment||Count of Participants|Number|65|65.0||||||
3682196|NCT02274870|3525760|B2|United States||Region of Enrollment||Count of Participants|Number|33|33.0||||||
3682197|NCT02274870|3525761|B1|United States||Region of Enrollment||Count of Participants|Number|32|32.0||||||
3682198|NCT02274870|3525759|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3682199|NCT02274870|3525760|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3682200|NCT02274870|3525761|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3682201|NCT02274870|3525759|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3682202|NCT02274870|3525760|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3682203|NCT02274870|3525761|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3682204|NCT02274870|3525759|B3|||Age||years|Mean|63.22|63.22|Standard Deviation|7.86|7.86|||
3682205|NCT02274870|3525760|B2|||Age||years|Mean|62.29|62.29|Standard Deviation|8.11|8.11|||
3682206|NCT02274870|3525761|B1|||Age||years|Mean|64.19|64.19|Standard Deviation|7.59|7.59|||
3682207|NCT02274792|3525786|B1|||Duration of Psoriasis||years|Mean|18.1|18.1|Standard Deviation|12.6|12.6|||
3682208|NCT02274792|3525786|B1|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|111|111.0||||||
3682209|NCT02274792|3525786|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3682210|NCT02274792|3525786|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3682211|NCT02274792|3525786|B1|White||Race/Ethnicity, Customized||participants|Number|112|112.0||||||
3682212|NCT02274792|3525786|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3682213|NCT02274792|3525786|B1|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3682214|NCT02274792|3525786|B1|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3682215|NCT02274792|3525786|B1||Male|Gender||Participants|Count of Participants|89|89.0||||||
3682216|NCT02274792|3525786|B1||Female|Gender||Participants|Count of Participants|42|42.0||||||
3682217|NCT02274792|3525786|B1|≥ 65 years||Age, Customized||participants|Number|17|17.0||||||
3682218|NCT02274792|3525786|B1|< 65 years||Age, Customized||participants|Number|114|114.0||||||
3682219|NCT02274792|3525786|B1|||Age||years|Mean|46.3|46.3|Standard Deviation|13.2|13.2|||
3682220|NCT02274766|3525794|B3|Anticholinergics||Subjects taking Antiparkinson Medication|Subjects may have been taking more than 1 antiparkinson medication at Baseline.|Participants|Count of Participants|2|2.0||||||
3682221|NCT02274766|3525795|B2|Anticholinergics||Subjects taking Antiparkinson Medication|Subjects may have been taking more than 1 antiparkinson medication at Baseline.|Participants|Count of Participants|0|0.0||||||
3682222|NCT02274766|3525796|B1|Anticholinergics||Subjects taking Antiparkinson Medication|Subjects may have been taking more than 1 antiparkinson medication at Baseline.|Participants|Count of Participants|2|2.0||||||
3682223|NCT02274766|3525794|B3|COMT Inhibitors||Subjects taking Antiparkinson Medication|Subjects may have been taking more than 1 antiparkinson medication at Baseline.|Participants|Count of Participants|4|4.0||||||
3682224|NCT02274766|3525795|B2|COMT Inhibitors||Subjects taking Antiparkinson Medication|Subjects may have been taking more than 1 antiparkinson medication at Baseline.|Participants|Count of Participants|3|3.0||||||
3682225|NCT02274766|3525796|B1|COMT Inhibitors||Subjects taking Antiparkinson Medication|Subjects may have been taking more than 1 antiparkinson medication at Baseline.|Participants|Count of Participants|1|1.0||||||
3682226|NCT02274766|3525794|B3|MAO Inhibitors||Subjects taking Antiparkinson Medication|Subjects may have been taking more than 1 antiparkinson medication at Baseline.|Participants|Count of Participants|37|37.0||||||
3682227|NCT02274766|3525795|B2|MAO Inhibitors||Subjects taking Antiparkinson Medication|Subjects may have been taking more than 1 antiparkinson medication at Baseline.|Participants|Count of Participants|17|17.0||||||
3682228|NCT02274766|3525796|B1|MAO Inhibitors||Subjects taking Antiparkinson Medication|Subjects may have been taking more than 1 antiparkinson medication at Baseline.|Participants|Count of Participants|20|20.0||||||
3682293|NCT02274766|3525795|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3682229|NCT02274766|3525794|B3|Dopamine Agonists||Subjects taking Antiparkinson Medication|Subjects may have been taking more than 1 antiparkinson medication at Baseline.|Participants|Count of Participants|46|46.0||||||
3682230|NCT02274766|3525795|B2|Dopamine Agonists||Subjects taking Antiparkinson Medication|Subjects may have been taking more than 1 antiparkinson medication at Baseline.|Participants|Count of Participants|21|21.0||||||
3682231|NCT02274766|3525796|B1|Dopamine Agonists||Subjects taking Antiparkinson Medication|Subjects may have been taking more than 1 antiparkinson medication at Baseline.|Participants|Count of Participants|25|25.0||||||
3682232|NCT02274766|3525794|B3|Levodopa||Subjects taking Antiparkinson Medication|Subjects may have been taking more than 1 antiparkinson medication at Baseline.|Participants|Count of Participants|75|75.0||||||
3682233|NCT02274766|3525795|B2|Levodopa||Subjects taking Antiparkinson Medication|Subjects may have been taking more than 1 antiparkinson medication at Baseline.|Participants|Count of Participants|37|37.0||||||
3682234|NCT02274766|3525796|B1|Levodopa||Subjects taking Antiparkinson Medication|Subjects may have been taking more than 1 antiparkinson medication at Baseline.|Participants|Count of Participants|38|38.0||||||
3682235|NCT02274766|3525794|B3|||Hoehn and Yahr Stage|The Hoehn and Yahr scale, from 1-5, describes the subject's PD progression. The higher the score the more severe the symptoms of PD.|units on a scale|Mean|2.2|2.2|Standard Deviation|0.59|0.59|||
3682236|NCT02274766|3525795|B2|||Hoehn and Yahr Stage|The Hoehn and Yahr scale, from 1-5, describes the subject's PD progression. The higher the score the more severe the symptoms of PD.|units on a scale|Mean|2.1|2.1|Standard Deviation|0.60|0.6|||
3682237|NCT02274766|3525796|B1|||Hoehn and Yahr Stage|The Hoehn and Yahr scale, from 1-5, describes the subject's PD progression. The higher the score the more severe the symptoms of PD.|units on a scale|Mean|2.4|2.4|Standard Deviation|0.55|0.55|||
3682238|NCT02274766|3525794|B3|||Duration of LID||years|Mean|3.88|3.88|Standard Deviation|2.857|2.857|||
3682239|NCT02274766|3525795|B2|||Duration of LID||years|Mean|3.78|3.78|Standard Deviation|3.160|3.16|||
3682240|NCT02274766|3525796|B1|||Duration of LID||years|Mean|3.98|3.98|Standard Deviation|2.566|2.566|||
3682241|NCT02274766|3525794|B3|||Duration of Levodopa Treatment||years|Mean|8.12|8.12|Standard Deviation|4.493|4.493|||
3682242|NCT02274766|3525795|B2|||Duration of Levodopa Treatment||years|Mean|7.69|7.69|Standard Deviation|4.121|4.121|||
3682243|NCT02274766|3525796|B1|||Duration of Levodopa Treatment||years|Mean|8.54|8.54|Standard Deviation|4.845|4.845|||
3682244|NCT02274766|3525794|B3|||Time Since PD Diagnosis||years|Mean|10.55|10.55|Standard Deviation|4.669|4.669|||
3682245|NCT02274766|3525795|B2|||Time Since PD Diagnosis||years|Mean|10.40|10.4|Standard Deviation|5.105|5.105|||
3682246|NCT02274766|3525796|B1|||Time Since PD Diagnosis||years|Mean|10.71|10.71|Standard Deviation|4.265|4.265|||
3682247|NCT02274766|3525794|B3|Part IV, Item 4.2||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|2.5|2.5|Standard Deviation|0.55|0.55|||
3682248|NCT02274766|3525795|B2|Part IV, Item 4.2||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|2.5|2.5|Standard Deviation|0.61|0.61|||
3682249|NCT02274766|3525796|B1|Part IV, Item 4.2||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|2.5|2.5|Standard Deviation|0.51|0.51|||
3682250|NCT02274766|3525794|B3|Part IV, Item 4.1||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|2.5|2.5|Standard Deviation|0.92|0.92|||
3682251|NCT02274766|3525795|B2|Part IV, Item 4.1||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|2.2|2.2|Standard Deviation|0.81|0.81|||
3682294|NCT02274766|3525796|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682295|NCT02274766|3525794|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682296|NCT02274766|3525795|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682252|NCT02274766|3525796|B1|Part IV, Item 4.1||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|2.8|2.8|Standard Deviation|0.94|0.94|||
3682253|NCT02274766|3525794|B3|Part IV||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|10.5|10.5|Standard Deviation|2.66|2.66|||
3682254|NCT02274766|3525795|B2|Part IV||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|9.8|9.8|Standard Deviation|2.78|2.78|||
3682255|NCT02274766|3525796|B1|Part IV||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|11.1|11.1|Standard Deviation|2.40|2.4|||
3682256|NCT02274766|3525794|B3|Combined Parts I, II, and III||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|46.3|46.3|Standard Deviation|15.83|15.83|||
3682257|NCT02274766|3525795|B2|Combined Parts I, II, and III||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|46.6|46.6|Standard Deviation|14.76|14.76|||
3682258|NCT02274766|3525796|B1|Combined Parts I, II, and III||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|46.1|46.1|Standard Deviation|17.00|17.0|||
3682259|NCT02274766|3525794|B3|Part III||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|21.3|21.3|Standard Deviation|9.68|9.68|||
3682260|NCT02274766|3525795|B2|Part III||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|21.2|21.2|Standard Deviation|9.24|9.24|||
3682261|NCT02274766|3525796|B1|Part III||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|21.4|21.4|Standard Deviation|10.22|10.22|||
3682262|NCT02274766|3525794|B3|Part II||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|14.4|14.4|Standard Deviation|6.07|6.07|||
3682263|NCT02274766|3525795|B2|Part II||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|14.1|14.1|Standard Deviation|6.15|6.15|||
3682264|NCT02274766|3525796|B1|Part II||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|14.8|14.8|Standard Deviation|6.06|6.06|||
3682265|NCT02274766|3525794|B3|Part I||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|10.6|10.6|Standard Deviation|5.39|5.39|||
3682266|NCT02274766|3525795|B2|Part I||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|11.3|11.3|Standard Deviation|5.87|5.87|||
3682267|NCT02274766|3525796|B1|Part I||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|9.9|9.9|Standard Deviation|4.86|4.86|||
3682268|NCT02274766|3525794|B3|Asleep time||PD Home Diary|"A PD home diary was used to score 5 different conditions in 30-minute intervals: ASLEEP, OFF, ON (ie, had adequate control of PD symptoms) without dyskinesia, ON with non-troublesome dyskinesia, and ON with troublesome dyskinesia.~Total time with dyskinesia includes ON time with non-troublesome and troublesome dyskinesia."|hours|Mean|8.06|8.06|Standard Deviation|1.572|1.572|||
3682269|NCT02274766|3525795|B2|Asleep time||PD Home Diary|"A PD home diary was used to score 5 different conditions in 30-minute intervals: ASLEEP, OFF, ON (ie, had adequate control of PD symptoms) without dyskinesia, ON with non-troublesome dyskinesia, and ON with troublesome dyskinesia.~Total time with dyskinesia includes ON time with non-troublesome and troublesome dyskinesia."|hours|Mean|7.91|7.91|Standard Deviation|1.502|1.502|||
3682270|NCT02274766|3525796|B1|Asleep time||PD Home Diary|"A PD home diary was used to score 5 different conditions in 30-minute intervals: ASLEEP, OFF, ON (ie, had adequate control of PD symptoms) without dyskinesia, ON with non-troublesome dyskinesia, and ON with troublesome dyskinesia.~Total time with dyskinesia includes ON time with non-troublesome and troublesome dyskinesia."|hours|Mean|8.21|8.21|Standard Deviation|1.643|1.643|||
3682271|NCT02274766|3525794|B3|OFF time||PD Home Diary|"A PD home diary was used to score 5 different conditions in 30-minute intervals: ASLEEP, OFF, ON (ie, had adequate control of PD symptoms) without dyskinesia, ON with non-troublesome dyskinesia, and ON with troublesome dyskinesia.~Total time with dyskinesia includes ON time with non-troublesome and troublesome dyskinesia."|hours|Mean|2.30|2.3|Standard Deviation|1.871|1.871|||
3682272|NCT02274766|3525795|B2|OFF time||PD Home Diary|"A PD home diary was used to score 5 different conditions in 30-minute intervals: ASLEEP, OFF, ON (ie, had adequate control of PD symptoms) without dyskinesia, ON with non-troublesome dyskinesia, and ON with troublesome dyskinesia.~Total time with dyskinesia includes ON time with non-troublesome and troublesome dyskinesia."|hours|Mean|2.62|2.62|Standard Deviation|2.015|2.015|||
3682273|NCT02274766|3525796|B1|OFF time||PD Home Diary|"A PD home diary was used to score 5 different conditions in 30-minute intervals: ASLEEP, OFF, ON (ie, had adequate control of PD symptoms) without dyskinesia, ON with non-troublesome dyskinesia, and ON with troublesome dyskinesia.~Total time with dyskinesia includes ON time with non-troublesome and troublesome dyskinesia."|hours|Mean|1.98|1.98|Standard Deviation|1.687|1.687|||
3682274|NCT02274766|3525794|B3|ON time with troublesome dyskinesia||PD Home Diary|"A PD home diary was used to score 5 different conditions in 30-minute intervals: ASLEEP, OFF, ON (ie, had adequate control of PD symptoms) without dyskinesia, ON with non-troublesome dyskinesia, and ON with troublesome dyskinesia.~Total time with dyskinesia includes ON time with non-troublesome and troublesome dyskinesia."|hours|Mean|5.37|5.37|Standard Deviation|3.020|3.02|||
3682275|NCT02274766|3525795|B2|ON time with troublesome dyskinesia||PD Home Diary|"A PD home diary was used to score 5 different conditions in 30-minute intervals: ASLEEP, OFF, ON (ie, had adequate control of PD symptoms) without dyskinesia, ON with non-troublesome dyskinesia, and ON with troublesome dyskinesia.~Total time with dyskinesia includes ON time with non-troublesome and troublesome dyskinesia."|hours|Mean|4.71|4.71|Standard Deviation|2.509|2.509|||
3682276|NCT02274766|3525796|B1|ON time with troublesome dyskinesia||PD Home Diary|"A PD home diary was used to score 5 different conditions in 30-minute intervals: ASLEEP, OFF, ON (ie, had adequate control of PD symptoms) without dyskinesia, ON with non-troublesome dyskinesia, and ON with troublesome dyskinesia.~Total time with dyskinesia includes ON time with non-troublesome and troublesome dyskinesia."|hours|Mean|6.02|6.02|Standard Deviation|3.353|3.353|||
3682277|NCT02274766|3525794|B3|ON time without troublesome dyskinesia||PD Home Diary|"A PD home diary was used to score 5 different conditions in 30-minute intervals: ASLEEP, OFF, ON (ie, had adequate control of PD symptoms) without dyskinesia, ON with non-troublesome dyskinesia, and ON with troublesome dyskinesia.~Total time with dyskinesia includes ON time with non-troublesome and troublesome dyskinesia."|hours|Mean|8.27|8.27|Standard Deviation|2.909|2.909|||
3682278|NCT02274766|3525795|B2|ON time without troublesome dyskinesia||PD Home Diary|"A PD home diary was used to score 5 different conditions in 30-minute intervals: ASLEEP, OFF, ON (ie, had adequate control of PD symptoms) without dyskinesia, ON with non-troublesome dyskinesia, and ON with troublesome dyskinesia.~Total time with dyskinesia includes ON time with non-troublesome and troublesome dyskinesia."|hours|Mean|8.77|8.77|Standard Deviation|2.457|2.457|||
3682279|NCT02274766|3525796|B1|ON time without troublesome dyskinesia||PD Home Diary|"A PD home diary was used to score 5 different conditions in 30-minute intervals: ASLEEP, OFF, ON (ie, had adequate control of PD symptoms) without dyskinesia, ON with non-troublesome dyskinesia, and ON with troublesome dyskinesia.~Total time with dyskinesia includes ON time with non-troublesome and troublesome dyskinesia."|hours|Mean|7.79|7.79|Standard Deviation|3.249|3.249|||
3682280|NCT02274766|3525794|B3|Total Objective Score (Parts III, IV)||Unified Dyskinesia Rating Scale (UDysRS)|The UDysRS is a dyskinesia rating scale that evaluates involuntary movements associated with PD; the UDysRS consists of the following sub-parts: IA, IB, IIA, IIB, III, and IV. The total score is the sum of all individual sub-parts, and scores for this measure can range from 0-104. The total objective score is the sum of Part III (which measures objective impairment) and Part IV (which measures objective disability), and scores for this measure can range from 0-44. For both the total score and total objective score, a higher score indicates more severe PD.|units on a scale|Mean|17.0|17.0|Standard Deviation|7.53|7.53|||
3682281|NCT02274766|3525795|B2|Total Objective Score (Parts III, IV)||Unified Dyskinesia Rating Scale (UDysRS)|The UDysRS is a dyskinesia rating scale that evaluates involuntary movements associated with PD; the UDysRS consists of the following sub-parts: IA, IB, IIA, IIB, III, and IV. The total score is the sum of all individual sub-parts, and scores for this measure can range from 0-104. The total objective score is the sum of Part III (which measures objective impairment) and Part IV (which measures objective disability), and scores for this measure can range from 0-44. For both the total score and total objective score, a higher score indicates more severe PD.|units on a scale|Mean|18.1|18.1|Standard Deviation|7.99|7.99|||
3682282|NCT02274766|3525796|B1|Total Objective Score (Parts III, IV)||Unified Dyskinesia Rating Scale (UDysRS)|The UDysRS is a dyskinesia rating scale that evaluates involuntary movements associated with PD; the UDysRS consists of the following sub-parts: IA, IB, IIA, IIB, III, and IV. The total score is the sum of all individual sub-parts, and scores for this measure can range from 0-104. The total objective score is the sum of Part III (which measures objective impairment) and Part IV (which measures objective disability), and scores for this measure can range from 0-44. For both the total score and total objective score, a higher score indicates more severe PD.|units on a scale|Mean|15.9|15.9|Standard Deviation|7.00|7.0|||
3682283|NCT02274766|3525794|B3|Total Score||Unified Dyskinesia Rating Scale (UDysRS)|The UDysRS is a dyskinesia rating scale that evaluates involuntary movements associated with PD; the UDysRS consists of the following sub-parts: IA, IB, IIA, IIB, III, and IV. The total score is the sum of all individual sub-parts, and scores for this measure can range from 0-104. The total objective score is the sum of Part III (which measures objective impairment) and Part IV (which measures objective disability), and scores for this measure can range from 0-44. For both the total score and total objective score, a higher score indicates more severe PD.|units on a scale|Mean|40.7|40.7|Standard Deviation|11.68|11.68|||
3682284|NCT02274766|3525795|B2|Total Score||Unified Dyskinesia Rating Scale (UDysRS)|The UDysRS is a dyskinesia rating scale that evaluates involuntary movements associated with PD; the UDysRS consists of the following sub-parts: IA, IB, IIA, IIB, III, and IV. The total score is the sum of all individual sub-parts, and scores for this measure can range from 0-104. The total objective score is the sum of Part III (which measures objective impairment) and Part IV (which measures objective disability), and scores for this measure can range from 0-44. For both the total score and total objective score, a higher score indicates more severe PD.|units on a scale|Mean|40.2|40.2|Standard Deviation|13.06|13.06|||
3682285|NCT02274766|3525796|B1|Total Score||Unified Dyskinesia Rating Scale (UDysRS)|The UDysRS is a dyskinesia rating scale that evaluates involuntary movements associated with PD; the UDysRS consists of the following sub-parts: IA, IB, IIA, IIB, III, and IV. The total score is the sum of all individual sub-parts, and scores for this measure can range from 0-104. The total objective score is the sum of Part III (which measures objective impairment) and Part IV (which measures objective disability), and scores for this measure can range from 0-44. For both the total score and total objective score, a higher score indicates more severe PD.|units on a scale|Mean|41.2|41.2|Standard Deviation|10.32|10.32|||
3682286|NCT02274766|3525794|B3|Europe||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
3682287|NCT02274766|3525795|B2|Europe||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3682288|NCT02274766|3525796|B1|Europe||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3682289|NCT02274766|3525794|B3|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3682290|NCT02274766|3525795|B2|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3682291|NCT02274766|3525796|B1|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3682292|NCT02274766|3525794|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3682297|NCT02274766|3525796|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682298|NCT02274766|3525794|B3||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3682299|NCT02274766|3525795|B2||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3682300|NCT02274766|3525796|B1||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3682301|NCT02274766|3525794|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682302|NCT02274766|3525795|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682303|NCT02274766|3525796|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682304|NCT02274766|3525794|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682305|NCT02274766|3525795|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682306|NCT02274766|3525796|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682307|NCT02274766|3525794|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682308|NCT02274766|3525795|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682309|NCT02274766|3525796|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682310|NCT02274766|3525794|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682311|NCT02274766|3525795|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682312|NCT02274766|3525796|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682313|NCT02274766|3525794|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682314|NCT02274766|3525795|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682315|NCT02274766|3525796|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682316|NCT02274766|3525794|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3682317|NCT02274766|3525795|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3682318|NCT02274766|3525796|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3682319|NCT02274766|3525794|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3682320|NCT02274766|3525795|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3682321|NCT02274766|3525796|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682322|NCT02274766|3525794|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3682323|NCT02274766|3525795|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3682324|NCT02274766|3525796|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3682325|NCT02274766|3525794|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3682326|NCT02274766|3525795|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3682327|NCT02274766|3525796|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3682328|NCT02274766|3525794|B3|||Age||years|Mean|64.8|64.8|Standard Deviation|9.31|9.31|||
3682329|NCT02274766|3525795|B2|||Age||years|Mean|64.7|64.7|Standard Deviation|9.66|9.66|||
3682330|NCT02274766|3525796|B1|||Age||years|Mean|64.9|64.9|Standard Deviation|9.08|9.08|||
3682331|NCT02274766|3525794|B3||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
3682332|NCT02274766|3525795|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3682333|NCT02274766|3525796|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3682334|NCT02274766|3525794|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3682335|NCT02274766|3525795|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3682336|NCT02274766|3525796|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3682337|NCT02274766|3525794|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3682338|NCT02274766|3525795|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3682339|NCT02274766|3525796|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3682340|NCT02274688|3525805|B3|United States||Region of Enrollment||participants|Number|171|171.0||||||
3682341|NCT02274688|3525806|B2|United States||Region of Enrollment||participants|Number|85|85.0||||||
3682342|NCT02274688|3525807|B1|United States||Region of Enrollment||participants|Number|86|86.0||||||
3682343|NCT02274688|3525805|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3682344|NCT02274688|3525806|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3682345|NCT02274688|3525807|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3682346|NCT02274688|3525805|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3682347|NCT02274688|3525806|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3682348|NCT02274688|3525807|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3682349|NCT02274688|3525805|B3||White|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3682350|NCT02274688|3525806|B2||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3682351|NCT02274688|3525807|B1||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3682352|NCT02274688|3525805|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3682353|NCT02274688|3525806|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3682354|NCT02274688|3525807|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3682355|NCT02274688|3525805|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3682356|NCT02274688|3525806|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3682357|NCT02274688|3525807|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3682358|NCT02274688|3525805|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3682359|NCT02274688|3525806|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3682360|NCT02274688|3525807|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3682361|NCT02274688|3525805|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3682362|NCT02274688|3525806|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3682363|NCT02274688|3525807|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3682364|NCT02274688|3525805|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682365|NCT02274688|3525806|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682366|NCT02274688|3525807|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682367|NCT02274688|3525805|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|156|156.0||||||
3682368|NCT02274688|3525806|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
3682369|NCT02274688|3525807|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3682370|NCT02274688|3525805|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3682371|NCT02274688|3525806|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3682372|NCT02274688|3525807|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3682373|NCT02274688|3525805|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3682374|NCT02274688|3525806|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3682375|NCT02274688|3525807|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3682376|NCT02274688|3525805|B3||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3682377|NCT02274688|3525806|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3682378|NCT02274688|3525807|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3682379|NCT02274688|3525805|B3|||Age||years|Mean|42.4|42.4|Standard Deviation|16.0|16.0|||
3682380|NCT02274688|3525806|B2|||Age||years|Mean|41.2|41.2|Standard Deviation|16.1|16.1|||
3682381|NCT02274688|3525807|B1|||Age||years|Mean|43.6|43.6|Standard Deviation|16|16.0|||
3682382|NCT02274688|3525805|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3682383|NCT02274688|3525806|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3682384|NCT02274688|3525807|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3682385|NCT02274688|3525805|B3||Between 18 and 65 years|Age||Participants|Count of Participants|151|151.0||||||
3682386|NCT02274688|3525806|B2||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
3682387|NCT02274688|3525807|B1||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
3682388|NCT02274688|3525805|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3682389|NCT02274688|3525806|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3682390|NCT02274688|3525807|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3682391|NCT02274675|3525830|B1|||Wrist's Active Range of Motion|Wrist's active range of motion (AROM) is a measurement to identify how far the person's joints range can move in by moving with their own effort.|Angular degree|Mean|64.14|64.14|Standard Deviation|45.86|45.86|||
3682392|NCT02274675|3525830|B1|||Wrist's Passive Range of Motion|Wrist's passive range of motion (PROM) is a measurement to identify how far the person's joints range can move in flexion-extension directed by a person manually.|Angular degree|Mean|121.57|121.57|Standard Deviation|14.55|14.55|||
3682393|NCT02274675|3525830|B1|||Forearm's Passive Range of Motion|Forearm's passive range of motion (PROM) is a measurement to identify how far the person's joints range can move in pronation-supination directed by a person manually.|Angular degree|Mean|168.57|168.57|Standard Deviation|12.19|12.19|||
3682394|NCT02274675|3525830|B1|||Forearm's Active Range of Movement|Forearm's active range of motion (AROM) is a measurement to identify how far the person's joints range can move in pronation-supination by moving with their own effort.|Angular degree|Mean|76.29|76.29|Standard Deviation|52.37|52.37|||
3682395|NCT02274675|3525830|B1|||Spasticity Level of Wrist|The spasticity level of wrist is measured by using Modified Ashworth Scale. It measures resistance during passive soft-tissue stretching. This measure will only measure the wrist component, as forearm component is not included in this scale. The score range = 4 and the best/worst score = 0/4 scores.|Scores|Mean|1|1.0|Standard Deviation|0.82|0.82|||
3682396|NCT02274675|3525830|B1|||Motor Function Assessment of Hand Movement|Motor function that are related to wrist and forearm are measured using the Motor Assessment Scale. The Motor Assessment Scale (MAS) is a performance-based scale that was developed as a means of assessing everyday motor function in patients with stroke. In MAS, task 1 and 3 in the hand movement sub-component assessment were accessed (MAS-Hand), as the two task is the most related component to the tested movement. The score range = 2 and the best/worst score = 2/0 scores.|Scores|Mean|0.29|0.29|Standard Deviation|0.76|0.76|||
3682397|NCT02274675|3525830|B1|||Motor Impairment of Wrist and Forearm|Motor impairment of the upper limb is measured by the means of the Fugl-Meyer Assessment Scale that are related to wrist and forearm component. The Fugl-Meyer Assessment (FMA) is a stroke-specific, performance-based impairment index.|Scores|Mean|20.29|20.29|Standard Deviation|4.86|4.86|||
3682398|NCT02274675|3525830|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3682399|NCT02274675|3525830|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3682400|NCT02274675|3525830|B1|||Age||years|Mean|59.4|59.4|Standard Deviation|10.3|10.3|||
3682401|NCT02274675|3525830|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3682402|NCT02274675|3525830|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3682403|NCT02274675|3525830|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3682404|NCT02274558|3525840|B4|||Baseline AIMS Total Dyskinesia Score|The AIMS Total Dyskinesia Score rates a total of 7 items, rating involuntary movement from 0 (no dyskinesia) to 4 (severe dyskinesia). Items 1 through 7 include facial and oral movements (Items 1-4), extremity movements (Items 5-6), and trunk movements (Item 7). The AIMS dyskinesia total score for Items 1-7 ranges from 0 to 28; a higher score reflects increased severity.|units on a scale|Mean|10.0|10.0|Standard Deviation|4.0|4.0|||
3682405|NCT02274558|3525841|B3|||Baseline AIMS Total Dyskinesia Score|The AIMS Total Dyskinesia Score rates a total of 7 items, rating involuntary movement from 0 (no dyskinesia) to 4 (severe dyskinesia). Items 1 through 7 include facial and oral movements (Items 1-4), extremity movements (Items 5-6), and trunk movements (Item 7). The AIMS dyskinesia total score for Items 1-7 ranges from 0 to 28; a higher score reflects increased severity.|units on a scale|Mean|10.4|10.4|Standard Deviation|3.6|3.6|||
3682406|NCT02274558|3525842|B2|||Baseline AIMS Total Dyskinesia Score|The AIMS Total Dyskinesia Score rates a total of 7 items, rating involuntary movement from 0 (no dyskinesia) to 4 (severe dyskinesia). Items 1 through 7 include facial and oral movements (Items 1-4), extremity movements (Items 5-6), and trunk movements (Item 7). The AIMS dyskinesia total score for Items 1-7 ranges from 0 to 28; a higher score reflects increased severity.|units on a scale|Mean|9.7|9.7|Standard Deviation|4.1|4.1|||
3682407|NCT02274558|3525843|B1|||Baseline AIMS Total Dyskinesia Score|The AIMS Total Dyskinesia Score rates a total of 7 items, rating involuntary movement from 0 (no dyskinesia) to 4 (severe dyskinesia). Items 1 through 7 include facial and oral movements (Items 1-4), extremity movements (Items 5-6), and trunk movements (Item 7). The AIMS dyskinesia total score for Items 1-7 ranges from 0 to 28; a higher score reflects increased severity.|units on a scale|Mean|9.9|9.9|Standard Deviation|4.3|4.3|||
3682408|NCT02274558|3525840|B4|||BPRS Total Score|The Brief Psychiatric Rating Scale (BPRS) is a clinician-rated tool designed to assess change in the severity of psychopathology in patients with schizophrenia and other psychotic disorders (Overall and Gorham, 1962, 1988). The severity of each of the 18 items of the BPRS is rated on a scale of 1 (not present) to 7 (extremely severe) (total score range: 18 to 126). Higher scores represent greater symptom severity.|units on a scale|Mean|29.7|29.7|Full Range|||18.0|48.0|
3682409|NCT02274558|3525841|B3|||BPRS Total Score|The Brief Psychiatric Rating Scale (BPRS) is a clinician-rated tool designed to assess change in the severity of psychopathology in patients with schizophrenia and other psychotic disorders (Overall and Gorham, 1962, 1988). The severity of each of the 18 items of the BPRS is rated on a scale of 1 (not present) to 7 (extremely severe) (total score range: 18 to 126). Higher scores represent greater symptom severity.|units on a scale|Mean|29.1|29.1|Full Range|||18.0|48.0|
3682410|NCT02274558|3525842|B2|||BPRS Total Score|The Brief Psychiatric Rating Scale (BPRS) is a clinician-rated tool designed to assess change in the severity of psychopathology in patients with schizophrenia and other psychotic disorders (Overall and Gorham, 1962, 1988). The severity of each of the 18 items of the BPRS is rated on a scale of 1 (not present) to 7 (extremely severe) (total score range: 18 to 126). Higher scores represent greater symptom severity.|units on a scale|Mean|30.6|30.6|Full Range|||20.0|48.0|
3682411|NCT02274558|3525843|B1|||BPRS Total Score|The Brief Psychiatric Rating Scale (BPRS) is a clinician-rated tool designed to assess change in the severity of psychopathology in patients with schizophrenia and other psychotic disorders (Overall and Gorham, 1962, 1988). The severity of each of the 18 items of the BPRS is rated on a scale of 1 (not present) to 7 (extremely severe) (total score range: 18 to 126). Higher scores represent greater symptom severity.|units on a scale|Mean|29.3|29.3|Full Range|||18.0|46.0|
3682412|NCT02274558|3525840|B4|||Age at TD Diagnosis||years|Mean|48.2|48.2|Full Range|||17.0|81.0|
3682413|NCT02274558|3525841|B3|||Age at TD Diagnosis||years|Mean|47.6|47.6|Full Range|||17.0|72.0|
3682414|NCT02274558|3525842|B2|||Age at TD Diagnosis||years|Mean|47.8|47.8|Full Range|||22.0|67.0|
3682415|NCT02274558|3525843|B1|||Age at TD Diagnosis||years|Mean|49.4|49.4|Full Range|||29.0|81.0|
3682416|NCT02274558|3525840|B4||Mood disorder|Psychiatric Diagnosis Category||Participants|Count of Participants|77|77.0||||||
3682417|NCT02274558|3525841|B3||Mood disorder|Psychiatric Diagnosis Category||Participants|Count of Participants|27|27.0||||||
3682418|NCT02274558|3525842|B2||Mood disorder|Psychiatric Diagnosis Category||Participants|Count of Participants|24|24.0||||||
3682419|NCT02274558|3525843|B1||Mood disorder|Psychiatric Diagnosis Category||Participants|Count of Participants|26|26.0||||||
3682420|NCT02274558|3525840|B4||Schizophrenia/Schizoaffective disorder|Psychiatric Diagnosis Category||Participants|Count of Participants|150|150.0||||||
3682421|NCT02274558|3525841|B3||Schizophrenia/Schizoaffective disorder|Psychiatric Diagnosis Category||Participants|Count of Participants|52|52.0||||||
3682422|NCT02274558|3525842|B2||Schizophrenia/Schizoaffective disorder|Psychiatric Diagnosis Category||Participants|Count of Participants|48|48.0||||||
3682423|NCT02274558|3525843|B1||Schizophrenia/Schizoaffective disorder|Psychiatric Diagnosis Category||Participants|Count of Participants|50|50.0||||||
3682424|NCT02274558|3525840|B4|||Body Mass Index||kg/m^2|Mean|28.13|28.13|Full Range|||18.1|46.9|
3682425|NCT02274558|3525841|B3|||Body Mass Index||kg/m^2|Mean|27.78|27.78|Full Range|||18.2|46.9|
3682426|NCT02274558|3525842|B2|||Body Mass Index||kg/m^2|Mean|28.64|28.64|Full Range|||19.4|40.6|
3682427|NCT02274558|3525843|B1|||Body Mass Index||kg/m^2|Mean|28.03|28.03|Full Range|||18.1|42.2|
3682428|NCT02274558|3525840|B4|Other: Mixed||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3682429|NCT02274558|3525841|B3|Other: Mixed||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3682430|NCT02274558|3525842|B2|Other: Mixed||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3682431|NCT02274558|3525843|B1|Other: Mixed||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3682432|NCT02274558|3525840|B4|Other: Mexican||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3682433|NCT02274558|3525841|B3|Other: Mexican||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3682434|NCT02274558|3525842|B2|Other: Mexican||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3682435|NCT02274558|3525843|B1|Other: Mexican||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3682436|NCT02274558|3525840|B4|Other: Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3682437|NCT02274558|3525841|B3|Other: Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3682438|NCT02274558|3525842|B2|Other: Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3682439|NCT02274558|3525843|B1|Other: Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3682440|NCT02274558|3525840|B4|Other: Arabic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3682441|NCT02274558|3525841|B3|Other: Arabic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3682442|NCT02274558|3525842|B2|Other: Arabic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3682443|NCT02274558|3525843|B1|Other: Arabic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3682444|NCT02274558|3525840|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3682445|NCT02274558|3525841|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3682446|NCT02274558|3525842|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3682447|NCT02274558|3525843|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3682448|NCT02274558|3525840|B4|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|128|128.0||||||
3682449|NCT02274558|3525841|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
3682450|NCT02274558|3525842|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
3682451|NCT02274558|3525843|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
3682452|NCT02274558|3525840|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|87|87.0||||||
3682453|NCT02274558|3525841|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3682454|NCT02274558|3525842|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3682455|NCT02274558|3525843|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3682456|NCT02274558|3525840|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3682457|NCT02274558|3525841|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3682458|NCT02274558|3525842|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3682459|NCT02274558|3525843|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3682460|NCT02274558|3525840|B4|American Indian or Alaska Native, Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3682461|NCT02274558|3525841|B3|American Indian or Alaska Native, Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3682462|NCT02274558|3525842|B2|American Indian or Alaska Native, Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3682463|NCT02274558|3525843|B1|American Indian or Alaska Native, Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3682464|NCT02274558|3525840|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3682465|NCT02274558|3525841|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3682466|NCT02274558|3525842|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3682467|NCT02274558|3525843|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3682468|NCT02274558|3525840|B4||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3682469|NCT02274558|3525841|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3682470|NCT02274558|3525842|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3682471|NCT02274558|3525843|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3682472|NCT02274558|3525840|B4||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3682473|NCT02274558|3525841|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3682474|NCT02274558|3525842|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3682475|NCT02274558|3525843|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3682476|NCT02274558|3525840|B4|||Age||years|Mean|56.1|56.1|Full Range|||26.0|84.0|
3682477|NCT02274558|3525841|B3|||Age||years|Mean|56.0|56.0|Full Range|||32.0|83.0|
3682478|NCT02274558|3525842|B2|||Age||years|Mean|55.3|55.3|Full Range|||26.0|74.0|
3682479|NCT02274558|3525843|B1|||Age||years|Mean|57.0|57.0|Full Range|||30.0|84.0|
3682480|NCT02273973|3525859|B3|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3682481|NCT02273973|3525860|B2|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3682482|NCT02273973|3525861|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3682483|NCT02273973|3525859|B3|Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3682484|NCT02273973|3525860|B2|Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3682485|NCT02273973|3525861|B1|Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3682486|NCT02273973|3525859|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|223|223.0||||||
3682487|NCT02273973|3525860|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|109|109.0||||||
3682488|NCT02273973|3525861|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|114|114.0||||||
3682489|NCT02273973|3525859|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|84|84.0||||||
3682490|NCT02273973|3525860|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
3682491|NCT02273973|3525861|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3682492|NCT02273973|3525859|B3|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3682493|NCT02273973|3525860|B2|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3682494|NCT02273973|3525861|B1|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3682495|NCT02273973|3525859|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3682496|NCT02273973|3525860|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3682497|NCT02273973|3525861|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3682498|NCT02273973|3525859|B3|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3682499|NCT02273973|3525860|B2|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3682500|NCT02273973|3525861|B1|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3682501|NCT02273973|3525859|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3682502|NCT02273973|3525860|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3682503|NCT02273973|3525861|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3682504|NCT02273973|3525859|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3682505|NCT02273973|3525860|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3682506|NCT02273973|3525861|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3682507|NCT02273973|3525859|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3682508|NCT02273973|3525860|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3682509|NCT02273973|3525861|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3682510|NCT02273973|3525859|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|283|283.0||||||
3682511|NCT02273973|3525860|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|140|140.0||||||
3682512|NCT02273973|3525861|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|143|143.0||||||
3682513|NCT02273973|3525859|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3682514|NCT02273973|3525860|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3682515|NCT02273973|3525861|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3682516|NCT02273973|3525859|B3||Female|Sex: Female, Male||Participants|Count of Participants|334|334.0||||||
3682517|NCT02273973|3525860|B2||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3682518|NCT02273973|3525861|B1||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3682519|NCT02273973|3525859|B3|||Age||years|Mean|64.6|64.6|Standard Deviation|8.6|8.6|||
3682520|NCT02273973|3525860|B2|||Age||years|Mean|64.7|64.7|Standard Deviation|8.7|8.7|||
3682521|NCT02273973|3525861|B1|||Age||years|Mean|64.6|64.6|Standard Deviation|8.5|8.5|||
3682522|NCT02273908|3525902|B3|Japan||Region of Enrollment||participants|Number|331|331.0||||||
3682523|NCT02273908|3525903|B2|Japan||Region of Enrollment||participants|Number|174|174.0||||||
3682524|NCT02273908|3525904|B1|Japan||Region of Enrollment||participants|Number|157|157.0||||||
3682525|NCT02273908|3525902|B3||Male|Gender||Participants|Count of Participants|133|133.0||||||
3682526|NCT02273908|3525903|B2||Male|Gender||Participants|Count of Participants|68|68.0||||||
3682527|NCT02273908|3525904|B1||Male|Gender||Participants|Count of Participants|65|65.0||||||
3682528|NCT02273908|3525902|B3||Female|Gender||Participants|Count of Participants|198|198.0||||||
3682529|NCT02273908|3525903|B2||Female|Gender||Participants|Count of Participants|106|106.0||||||
3682530|NCT02273908|3525904|B1||Female|Gender||Participants|Count of Participants|92|92.0||||||
3682531|NCT02273908|3525902|B3|||Age||years|Mean|70.0|70.0|Standard Deviation|13.13|13.13|||
3682532|NCT02273908|3525903|B2|||Age||years|Mean|70.7|70.7|Standard Deviation|12.17|12.17|||
3682533|NCT02273908|3525904|B1|||Age||years|Mean|69.1|69.1|Standard Deviation|14.12|14.12|||
3682534|NCT02273908|3525902|B3||>=65 years|Age||Participants|Count of Participants|244|244.0||||||
3682535|NCT02273908|3525903|B2||>=65 years|Age||Participants|Count of Participants|130|130.0||||||
3682536|NCT02273908|3525904|B1||>=65 years|Age||Participants|Count of Participants|114|114.0||||||
3682537|NCT02273908|3525902|B3||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
3682538|NCT02273908|3525903|B2||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3682539|NCT02273908|3525904|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
3682540|NCT02273908|3525902|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3682541|NCT02273908|3525903|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3682542|NCT02273908|3525904|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3682543|NCT02273752|3525927|B1|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3682544|NCT02273752|3525927|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682545|NCT02273752|3525927|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682546|NCT02273752|3525927|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3682547|NCT02273752|3525927|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682548|NCT02273752|3525927|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682549|NCT02273752|3525927|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682550|NCT02273752|3525927|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682551|NCT02273752|3525927|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682552|NCT02273752|3525927|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3682553|NCT02273752|3525927|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682554|NCT02273752|3525927|B1||Male|Gender||Participants|Count of Participants|1|1.0||||||
3682555|NCT02273752|3525927|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
3682556|NCT02273752|3525927|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3682557|NCT02273752|3525927|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3682558|NCT02273752|3525927|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3682559|NCT02273323|3525938|B1|||Diastolic blood pressure||mmHg|Median|92|92.0|Full Range|||67.0|102.0|
3682560|NCT02273323|3525938|B1|||Systolic blood pressure||mmHg|Median|145|145.0|Full Range|||119.0|160.0|
3682561|NCT02273323|3525938|B1|||Body Mass Index||kg/m^2|Median|26.3|26.3|Full Range|||19.8|34.7|
3682562|NCT02273323|3525938|B1||Male|Gender||Participants|Count of Participants|23|23.0||||||
3682563|NCT02273323|3525938|B1||Female|Gender||Participants|Count of Participants|7|7.0||||||
3682564|NCT02273323|3525938|B1|||Age||years|Median|53|53.0|Full Range|||23.0|65.0|
3682565|NCT02273310|3525955|B3|United States||Region of Enrollment||participants|Number|83|83.0||||||
3682566|NCT02273310|3525956|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
3682567|NCT02273310|3525957|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
3682568|NCT02273310|3525955|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3682569|NCT02273310|3525956|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3682570|NCT02273310|3525957|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3682571|NCT02273310|3525955|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3682572|NCT02273310|3525956|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3682573|NCT02273310|3525957|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3682574|NCT02273310|3525955|B3|||Age||years|Mean|8.47|8.47|Standard Deviation|2.11|2.11|||
3682575|NCT02273310|3525956|B2|||Age||years|Mean|8.66|8.66|Standard Deviation|2.10|2.1|||
3682576|NCT02273310|3525957|B1|||Age||years|Mean|8.29|8.29|Standard Deviation|2.12|2.12|||
3682577|NCT02273180|3525969|B3|||Glycated Haemoglobin (HbA1c %)||percentage of hemoglobin|Mean|8.03|8.03|Standard Deviation|0.72|0.72|||
3682578|NCT02273180|3525970|B2|||Glycated Haemoglobin (HbA1c %)||percentage of hemoglobin|Mean|7.99|7.99|Standard Deviation|0.64|0.64|||
3682579|NCT02273180|3525971|B1|||Glycated Haemoglobin (HbA1c %)||percentage of hemoglobin|Mean|8.07|8.07|Standard Deviation|0.79|0.79|||
3682580|NCT02273180|3525969|B3|||Average Daily Total Insulin Dose||U/kg|Mean|0.695|0.695|Standard Deviation|0.278|0.278|||
3682581|NCT02273180|3525970|B2|||Average Daily Total Insulin Dose||U/kg|Mean|0.685|0.685|Standard Deviation|0.242|0.242|||
3682582|NCT02273180|3525971|B1|||Average Daily Total Insulin Dose||U/kg|Mean|0.704|0.704|Standard Deviation|0.309|0.309|||
3682583|NCT02273180|3525969|B3|||Average Daily Mealtime Insulin Dose||U/kg|Mean|0.360|0.36|Standard Deviation|0.172|0.172|||
3682584|NCT02273180|3525970|B2|||Average Daily Mealtime Insulin Dose||U/kg|Mean|0.355|0.355|Standard Deviation|0.168|0.168|||
3682585|NCT02273180|3525971|B1|||Average Daily Mealtime Insulin Dose||U/kg|Mean|0.364|0.364|Standard Deviation|0.175|0.175|||
3682586|NCT02273180|3525969|B3|||Average Daily Basal Insulin Dose||Units (U)/kg|Mean|0.335|0.335|Standard Deviation|0.170|0.17|||
3682587|NCT02273180|3525970|B2|||Average Daily Basal Insulin Dose||Units (U)/kg|Mean|0.33|0.33|Standard Deviation|0.141|0.141|||
3682588|NCT02273180|3525971|B1|||Average Daily Basal Insulin Dose||Units (U)/kg|Mean|0.339|0.339|Standard Deviation|0.195|0.195|||
3682589|NCT02273180|3525969|B3|||Duration of Diabetes Type 1(T1DM)||years|Mean|19.05|19.05|Standard Deviation|12.31|12.31|||
3682590|NCT02273180|3525970|B2|||Duration of Diabetes Type 1(T1DM)||years|Mean|18.57|18.57|Standard Deviation|11.99|11.99|||
3682591|NCT02273180|3525971|B1|||Duration of Diabetes Type 1(T1DM)||years|Mean|19.53|19.53|Standard Deviation|12.63|12.63|||
3682592|NCT02273180|3525969|B3|||Body mass index (BMI)||kg/m^2|Mean|26.0|26.0|Standard Deviation|4.1|4.1|||
3682593|NCT02273180|3525970|B2|||Body mass index (BMI)||kg/m^2|Mean|25.8|25.8|Standard Deviation|4.1|4.1|||
3682594|NCT02273180|3525971|B1|||Body mass index (BMI)||kg/m^2|Mean|26.2|26.2|Standard Deviation|4|4.0|||
3682595|NCT02273180|3525969|B3|Non-Japan||Randomization strata of geographical region||Participants|Count of Participants|446|446.0||||||
3682596|NCT02273180|3525970|B2|Non-Japan||Randomization strata of geographical region||Participants|Count of Participants|224|224.0||||||
3682597|NCT02273180|3525971|B1|Non-Japan||Randomization strata of geographical region||Participants|Count of Participants|222|222.0||||||
3682598|NCT02273180|3525969|B3|Japan||Randomization strata of geographical region||Participants|Count of Participants|61|61.0||||||
3682599|NCT02273180|3525970|B2|Japan||Randomization strata of geographical region||Participants|Count of Participants|30|30.0||||||
3682600|NCT02273180|3525971|B1|Japan||Randomization strata of geographical region||Participants|Count of Participants|31|31.0||||||
3682601|NCT02273180|3525969|B3|>=8%||Randomization Strata of Screening HbA1c||Participants|Count of Participants|309|309.0||||||
3682717|NCT02273050|3526098|B1|Asian||Race/Ethnicity, Customized||Participants|Number|210|210.0||||||
3682602|NCT02273180|3525970|B2|>=8%||Randomization Strata of Screening HbA1c||Participants|Count of Participants|155|155.0||||||
3682603|NCT02273180|3525971|B1|>=8%||Randomization Strata of Screening HbA1c||Participants|Count of Participants|154|154.0||||||
3682604|NCT02273180|3525969|B3|<8 %||Randomization Strata of Screening HbA1c||Participants|Count of Participants|198|198.0||||||
3682605|NCT02273180|3525970|B2|<8 %||Randomization Strata of Screening HbA1c||Participants|Count of Participants|99|99.0||||||
3682606|NCT02273180|3525971|B1|<8 %||Randomization Strata of Screening HbA1c||Participants|Count of Participants|99|99.0||||||
3682607|NCT02273180|3525969|B3|Both Humalog/Liprolog and NovoLog/NovoRapid||Previous mealtime insulin type||Participants|Count of Participants|10|10.0||||||
3682608|NCT02273180|3525970|B2|Both Humalog/Liprolog and NovoLog/NovoRapid||Previous mealtime insulin type||Participants|Count of Participants|7|7.0||||||
3682609|NCT02273180|3525971|B1|Both Humalog/Liprolog and NovoLog/NovoRapid||Previous mealtime insulin type||Participants|Count of Participants|3|3.0||||||
3682610|NCT02273180|3525969|B3|NovoLog/NovoRapid||Previous mealtime insulin type||Participants|Count of Participants|190|190.0||||||
3682611|NCT02273180|3525970|B2|NovoLog/NovoRapid||Previous mealtime insulin type||Participants|Count of Participants|95|95.0||||||
3682612|NCT02273180|3525971|B1|NovoLog/NovoRapid||Previous mealtime insulin type||Participants|Count of Participants|95|95.0||||||
3682613|NCT02273180|3525969|B3|Humalog/Liprolog||Previous mealtime insulin type||Participants|Count of Participants|307|307.0||||||
3682614|NCT02273180|3525970|B2|Humalog/Liprolog||Previous mealtime insulin type||Participants|Count of Participants|152|152.0||||||
3682615|NCT02273180|3525971|B1|Humalog/Liprolog||Previous mealtime insulin type||Participants|Count of Participants|155|155.0||||||
3682616|NCT02273180|3525969|B3||Male|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
3682617|NCT02273180|3525970|B2||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3682618|NCT02273180|3525971|B1||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3682619|NCT02273180|3525969|B3||Female|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
3682620|NCT02273180|3525970|B2||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3682621|NCT02273180|3525971|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3682622|NCT02273180|3525969|B3|||Age||years|Mean|43.0|43.0|Standard Deviation|14.2|14.2|||
3682623|NCT02273180|3525970|B2|||Age||years|Mean|42.6|42.6|Standard Deviation|13.9|13.9|||
3682624|NCT02273180|3525971|B1|||Age||years|Mean|43.3|43.3|Standard Deviation|14.5|14.5|||
3682625|NCT02273167|3525994|B4||Male|Sex: Female, Male||Participants|Count of Participants|395|395.0||||||
3682626|NCT02273167|3525995|B3||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3682627|NCT02273167|3525996|B2||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3682628|NCT02273167|3525997|B1||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3682629|NCT02273167|3525994|B4||Female|Sex: Female, Male||Participants|Count of Participants|454|454.0||||||
3682630|NCT02273167|3525995|B3||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3682631|NCT02273167|3525996|B2||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3682632|NCT02273167|3525997|B1||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3682633|NCT02273167|3525994|B4|||Age||years|Mean|55.2|55.2|Standard Deviation|12.57|12.57|||
3682634|NCT02273167|3525995|B3|||Age||years|Mean|54.9|54.9|Standard Deviation|13.21|13.21|||
3682635|NCT02273167|3525996|B2|||Age||years|Mean|56.3|56.3|Standard Deviation|12.03|12.03|||
3682636|NCT02273167|3525997|B1|||Age||years|Mean|54.3|54.3|Standard Deviation|12.48|12.48|||
3682637|NCT02273167|3525994|B4||>=65 years|Age||Participants|Count of Participants|209|209.0||||||
3682638|NCT02273167|3525995|B3||>=65 years|Age||Participants|Count of Participants|74|74.0||||||
3682639|NCT02273167|3525996|B2||>=65 years|Age||Participants|Count of Participants|80|80.0||||||
3682640|NCT02273167|3525997|B1||>=65 years|Age||Participants|Count of Participants|55|55.0||||||
3682641|NCT02273167|3525994|B4||Between 18 and 65 years|Age||Participants|Count of Participants|639|639.0||||||
3682642|NCT02273167|3525995|B3||Between 18 and 65 years|Age||Participants|Count of Participants|209|209.0||||||
3682643|NCT02273167|3525996|B2||Between 18 and 65 years|Age||Participants|Count of Participants|202|202.0||||||
3682644|NCT02273167|3525997|B1||Between 18 and 65 years|Age||Participants|Count of Participants|228|228.0||||||
3682645|NCT02273167|3525994|B4||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3682646|NCT02273167|3525995|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3682647|NCT02273167|3525996|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3682648|NCT02273167|3525997|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3682649|NCT02273141|3526022|B3||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
3682650|NCT02273141|3526023|B2||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3682651|NCT02273141|3526024|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3682652|NCT02273141|3526022|B3||Female|Sex: Female, Male||Participants|Count of Participants|342|342.0||||||
3682653|NCT02273141|3526023|B2||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3682654|NCT02273141|3526024|B1||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3682655|NCT02273141|3526022|B3|||Age||years|Mean|53.8|53.8|Standard Deviation|12.50|12.5|||
3682656|NCT02273141|3526023|B2|||Age||years|Mean|54.6|54.6|Standard Deviation|11.64|11.64|||
3682657|NCT02273141|3526024|B1|||Age||years|Mean|52.9|52.9|Standard Deviation|13.35|13.35|||
3682658|NCT02273141|3526022|B3||>=65 years|Age||Participants|Count of Participants|104|104.0||||||
3682659|NCT02273141|3526023|B2||>=65 years|Age||Participants|Count of Participants|54|54.0||||||
3682660|NCT02273141|3526024|B1||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
3682661|NCT02273141|3526022|B3||Between 18 and 65 years|Age||Participants|Count of Participants|410|410.0||||||
3682662|NCT02273141|3526023|B2||Between 18 and 65 years|Age||Participants|Count of Participants|203|203.0||||||
3682663|NCT02273141|3526024|B1||Between 18 and 65 years|Age||Participants|Count of Participants|207|207.0||||||
3682664|NCT02273141|3526022|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3682665|NCT02273141|3526023|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3682666|NCT02273141|3526024|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3682667|NCT02273115|3526041|B5|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3682668|NCT02273115|3526042|B4|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3682669|NCT02273115|3526043|B3|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3682670|NCT02273115|3526044|B2|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3682671|NCT02273115|3526045|B1|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3682672|NCT02273115|3526041|B5|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3682673|NCT02273115|3526042|B4|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3682674|NCT02273115|3526043|B3|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3682675|NCT02273115|3526044|B2|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3682676|NCT02273115|3526045|B1|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3682677|NCT02273115|3526041|B5|Race/Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|132|132.0||||||
3682678|NCT02273115|3526042|B4|Race/Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3682679|NCT02273115|3526043|B3|Race/Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3682680|NCT02273115|3526044|B2|Race/Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|49|49.0||||||
3682681|NCT02273115|3526045|B1|Race/Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
3682682|NCT02273115|3526041|B5|Race/Ethnicity|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|145|145.0||||||
3682683|NCT02273115|3526042|B4|Race/Ethnicity|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
3682684|NCT02273115|3526043|B3|Race/Ethnicity|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
3682685|NCT02273115|3526044|B2|Race/Ethnicity|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3682686|NCT02273115|3526045|B1|Race/Ethnicity|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
3682687|NCT02273115|3526041|B5|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3682688|NCT02273115|3526042|B4|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3682689|NCT02273115|3526043|B3|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3682690|NCT02273115|3526044|B2|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3682691|NCT02273115|3526045|B1|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3682692|NCT02273115|3526041|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3682693|NCT02273115|3526042|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3682694|NCT02273115|3526043|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3682695|NCT02273115|3526044|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3682696|NCT02273115|3526045|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3682697|NCT02273115|3526041|B5||Female|Sex: Female, Male||Participants|Count of Participants|322|322.0||||||
3682698|NCT02273115|3526042|B4||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3682699|NCT02273115|3526043|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3682700|NCT02273115|3526044|B2||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3682701|NCT02273115|3526045|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3682702|NCT02273115|3526041|B5|||Age||years|Mean|29|29.0|Standard Deviation|1|1.0|||
3682703|NCT02273115|3526042|B4|||Age||years|Mean|31|31.0|Standard Deviation|5|5.0|||
3682704|NCT02273115|3526043|B3|||Age||years|Mean|31|31.0|Standard Deviation|5|5.0|||
3682705|NCT02273115|3526044|B2|||Age||years|Mean|27|27.0|Standard Deviation|6|6.0|||
3682706|NCT02273115|3526045|B1|||Age||years|Mean|27|27.0|Standard Deviation|5|5.0|||
3682707|NCT02273063|3526090|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3682708|NCT02273063|3526090|B1|Multiracial||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3682709|NCT02273063|3526090|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3682710|NCT02273063|3526090|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3682711|NCT02273063|3526090|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3682712|NCT02273063|3526090|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3682713|NCT02273063|3526090|B1|||Age||years|Mean|51.6|51.6|Standard Deviation|10.3|10.3|||
3682714|NCT02273050|3526095|B4|Asian||Race/Ethnicity, Customized||Participants|Number|640|640.0||||||
3682715|NCT02273050|3526096|B3|Asian||Race/Ethnicity, Customized||Participants|Number|214|214.0||||||
3682716|NCT02273050|3526097|B2|Asian||Race/Ethnicity, Customized||Participants|Number|216|216.0||||||
3682718|NCT02273050|3526095|B4||Male|Sex: Female, Male||Participants|Count of Participants|426|426.0||||||
3682719|NCT02273050|3526096|B3||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3682720|NCT02273050|3526097|B2||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3682721|NCT02273050|3526098|B1||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3682722|NCT02273050|3526095|B4||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
3682723|NCT02273050|3526096|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3682724|NCT02273050|3526097|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3682725|NCT02273050|3526098|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3682726|NCT02273050|3526095|B4|||Age||Years|Mean|50.0|50.0|Standard Deviation|10.92|10.92|20.0|75.0|
3682727|NCT02273050|3526096|B3|||Age||Years|Mean|49.5|49.5|Standard Deviation|10.93|10.93|24.0|74.0|
3682728|NCT02273050|3526097|B2|||Age||Years|Mean|50.4|50.4|Standard Deviation|10.78|10.78|23.0|74.0|
3682729|NCT02273050|3526098|B1|||Age||Years|Mean|50.1|50.1|Standard Deviation|11.08|11.08|20.0|75.0|
3682730|NCT02273037|3526126|B3|Uganda||Region of Enrollment||participants|Number|1971|1971.0||||||
3682731|NCT02273037|3526127|B2|Uganda||Region of Enrollment||participants|Number|992|992.0||||||
3682732|NCT02273037|3526128|B1|Uganda||Region of Enrollment||participants|Number|979|979.0||||||
3682733|NCT02273037|3526126|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3682734|NCT02273037|3526126|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3682735|NCT02273037|3526127|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3682736|NCT02273037|3526128|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3682737|NCT02273037|3526126|B3||Female|Sex: Female, Male||Participants|Count of Participants|1971|1971.0||||||
3682738|NCT02273037|3526127|B2||Female|Sex: Female, Male||Participants|Count of Participants|992|992.0||||||
3682739|NCT02273037|3526128|B1||Female|Sex: Female, Male||Participants|Count of Participants|979|979.0||||||
3682740|NCT02273037|3526126|B3|||Age||years|Median|27|27.0|Inter-Quartile Range|||23.0|30.0|
3682741|NCT02273037|3526127|B2|||Age||years|Median|27|27.0|Inter-Quartile Range|||24.0|30.0|
3682742|NCT02273037|3526128|B1|||Age||years|Median|26|26.0|Inter-Quartile Range|||23.0|30.0|
3682743|NCT02272803|3526139|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682744|NCT02272803|3526140|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682745|NCT02272803|3526141|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682746|NCT02272803|3526139|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682747|NCT02272803|3526140|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682748|NCT02272803|3526141|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682749|NCT02272803|3526139|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682750|NCT02272803|3526140|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682751|NCT02272803|3526141|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682752|NCT02272803|3526139|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682753|NCT02272803|3526140|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682754|NCT02272803|3526141|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682755|NCT02272803|3526139|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682756|NCT02272803|3526140|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682757|NCT02272803|3526141|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682758|NCT02272803|3526139|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3682759|NCT02272803|3526140|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3682760|NCT02272803|3526141|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3682761|NCT02272803|3526139|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682762|NCT02272803|3526140|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682763|NCT02272803|3526141|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682764|NCT02272803|3526139|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3682765|NCT02272803|3526140|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3682766|NCT02272803|3526141|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3682767|NCT02272803|3526139|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682768|NCT02272803|3526140|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682769|NCT02272803|3526141|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682770|NCT02272803|3526139|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682771|NCT02272803|3526140|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682772|NCT02272803|3526141|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682773|NCT02272803|3526139|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3682774|NCT02272803|3526140|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3682775|NCT02272803|3526141|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3682776|NCT02272803|3526139|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3682777|NCT02272803|3526140|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3682778|NCT02272803|3526141|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3682779|NCT02272803|3526139|B3|||Age||years|Mean|73.3|73.3|Standard Deviation|5.69|5.69|||
3682780|NCT02272803|3526140|B2|||Age||years|Mean|74.0|74.0|Standard Deviation|6.32|6.32|||
3682781|NCT02272803|3526141|B1|||Age||years|Mean|72.6|72.6|Standard Deviation|4.91|4.91|||
3682782|NCT02272725|3526153|B3|||Creatinine|Baseline creatinine estimated on baseline age and weight|mg/dL|Mean|0.83|0.83|Standard Deviation|0.1|0.1|||
3682783|NCT02272725|3526154|B2|||Creatinine|Baseline creatinine estimated on baseline age and weight|mg/dL|Mean|0.83|0.83|Standard Deviation|0.1|0.1|||
3682784|NCT02272725|3526155|B1|||Creatinine|Baseline creatinine estimated on baseline age and weight|mg/dL|Mean|0.83|0.83|Standard Deviation|0.1|0.1|||
3682785|NCT02272725|3526153|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3682786|NCT02272725|3526154|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3682787|NCT02272725|3526155|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3682788|NCT02272725|3526153|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3682789|NCT02272725|3526154|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3682790|NCT02272725|3526155|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3682791|NCT02272725|3526153|B3|||Age||years|Mean|41|41.0|Standard Deviation|8.8|8.8|||
3682792|NCT02272725|3526154|B2|||Age||years|Mean|40|40.0|Standard Deviation|7.1|7.1|||
3682793|NCT02272725|3526155|B1|||Age||years|Mean|42|42.0|Standard Deviation|10.5|10.5|||
3682794|NCT02272725|3526153|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3682795|NCT02272725|3526154|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3682796|NCT02272725|3526155|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3682797|NCT02272725|3526153|B3||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
3682798|NCT02272725|3526154|B2||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3682799|NCT02272725|3526155|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3682800|NCT02272725|3526153|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3682801|NCT02272725|3526154|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3682802|NCT02272725|3526155|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3682803|NCT02272686|3526166|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682804|NCT02272686|3526166|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682805|NCT02272686|3526166|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3682806|NCT02272686|3526166|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3682807|NCT02272686|3526166|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3682808|NCT02272686|3526166|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3682809|NCT02272686|3526166|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3682810|NCT02272686|3526166|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3682811|NCT02271984|3526171|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3682812|NCT02271984|3526171|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3682813|NCT02271984|3526171|B1|||Age||Years|Mean|26.3|26.3|Standard Deviation|6.99|6.99|||
3682814|NCT02271945|3526269|B3||Unknown or Not Reported|Race (NIH/OMB)|"Data for the participants in the category for Other is included under unknown or not reported category."|Participants|Count of Participants|1|1.0||||||
3682815|NCT02271945|3526270|B2||Unknown or Not Reported|Race (NIH/OMB)|"Data for the participants in the category for Other is included under unknown or not reported category."|Participants|Count of Participants|0|0.0||||||
3682816|NCT02271945|3526271|B1||Unknown or Not Reported|Race (NIH/OMB)|"Data for the participants in the category for Other is included under unknown or not reported category."|Participants|Count of Participants|1|1.0||||||
3682817|NCT02271945|3526269|B3||More than one race|Race (NIH/OMB)|"Data for the participants in the category for Other is included under unknown or not reported category."|Participants|Count of Participants|0|0.0||||||
3682818|NCT02271945|3526270|B2||More than one race|Race (NIH/OMB)|"Data for the participants in the category for Other is included under unknown or not reported category."|Participants|Count of Participants|0|0.0||||||
3682819|NCT02271945|3526271|B1||More than one race|Race (NIH/OMB)|"Data for the participants in the category for Other is included under unknown or not reported category."|Participants|Count of Participants|0|0.0||||||
3682820|NCT02271945|3526269|B3||White|Race (NIH/OMB)|"Data for the participants in the category for Other is included under unknown or not reported category."|Participants|Count of Participants|8|8.0||||||
3682821|NCT02271945|3526270|B2||White|Race (NIH/OMB)|"Data for the participants in the category for Other is included under unknown or not reported category."|Participants|Count of Participants|4|4.0||||||
3682822|NCT02271945|3526271|B1||White|Race (NIH/OMB)|"Data for the participants in the category for Other is included under unknown or not reported category."|Participants|Count of Participants|4|4.0||||||
3682823|NCT02271945|3526269|B3||Black or African American|Race (NIH/OMB)|"Data for the participants in the category for Other is included under unknown or not reported category."|Participants|Count of Participants|0|0.0||||||
3682824|NCT02271945|3526270|B2||Black or African American|Race (NIH/OMB)|"Data for the participants in the category for Other is included under unknown or not reported category."|Participants|Count of Participants|0|0.0||||||
3682825|NCT02271945|3526271|B1||Black or African American|Race (NIH/OMB)|"Data for the participants in the category for Other is included under unknown or not reported category."|Participants|Count of Participants|0|0.0||||||
3682876|NCT02271880|3526310|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682826|NCT02271945|3526269|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|"Data for the participants in the category for Other is included under unknown or not reported category."|Participants|Count of Participants|0|0.0||||||
3682827|NCT02271945|3526270|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|"Data for the participants in the category for Other is included under unknown or not reported category."|Participants|Count of Participants|0|0.0||||||
3682828|NCT02271945|3526271|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|"Data for the participants in the category for Other is included under unknown or not reported category."|Participants|Count of Participants|0|0.0||||||
3682829|NCT02271945|3526269|B3||Asian|Race (NIH/OMB)|"Data for the participants in the category for Other is included under unknown or not reported category."|Participants|Count of Participants|1|1.0||||||
3682830|NCT02271945|3526270|B2||Asian|Race (NIH/OMB)|"Data for the participants in the category for Other is included under unknown or not reported category."|Participants|Count of Participants|1|1.0||||||
3682831|NCT02271945|3526271|B1||Asian|Race (NIH/OMB)|"Data for the participants in the category for Other is included under unknown or not reported category."|Participants|Count of Participants|0|0.0||||||
3682832|NCT02271945|3526269|B3||American Indian or Alaska Native|Race (NIH/OMB)|"Data for the participants in the category for Other is included under unknown or not reported category."|Participants|Count of Participants|0|0.0||||||
3682833|NCT02271945|3526270|B2||American Indian or Alaska Native|Race (NIH/OMB)|"Data for the participants in the category for Other is included under unknown or not reported category."|Participants|Count of Participants|0|0.0||||||
3682834|NCT02271945|3526271|B1||American Indian or Alaska Native|Race (NIH/OMB)|"Data for the participants in the category for Other is included under unknown or not reported category."|Participants|Count of Participants|0|0.0||||||
3682835|NCT02271945|3526269|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3682836|NCT02271945|3526270|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3682837|NCT02271945|3526271|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682838|NCT02271945|3526269|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3682839|NCT02271945|3526270|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3682840|NCT02271945|3526271|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3682841|NCT02271945|3526269|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3682842|NCT02271945|3526270|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682843|NCT02271945|3526271|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3682844|NCT02271945|3526269|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3682845|NCT02271945|3526270|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3682846|NCT02271945|3526271|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3682847|NCT02271945|3526269|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3682848|NCT02271945|3526270|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3682849|NCT02271945|3526271|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3682850|NCT02271945|3526269|B3|>= 65 YEARS||Age, Customized||Participants|Count of Participants|4|4.0||||||
3682851|NCT02271945|3526270|B2|>= 65 YEARS||Age, Customized||Participants|Count of Participants|2|2.0||||||
3682852|NCT02271945|3526271|B1|>= 65 YEARS||Age, Customized||Participants|Count of Participants|2|2.0||||||
3682853|NCT02271945|3526269|B3|< 65 YEARS||Age, Customized||Participants|Count of Participants|6|6.0||||||
3682854|NCT02271945|3526270|B2|< 65 YEARS||Age, Customized||Participants|Count of Participants|3|3.0||||||
3682855|NCT02271945|3526271|B1|< 65 YEARS||Age, Customized||Participants|Count of Participants|3|3.0||||||
3682856|NCT02271945|3526269|B3|||Age||YEARS|Mean|63.5|63.5|Standard Deviation|11.0|11.0|||
3682857|NCT02271945|3526270|B2|||Age||YEARS|Mean|63.8|63.8|Standard Deviation|14.8|14.8|||
3682858|NCT02271945|3526271|B1|||Age||YEARS|Mean|63.2|63.2|Standard Deviation|7.1|7.1|||
3682859|NCT02271880|3526308|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
3682860|NCT02271880|3526309|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3682861|NCT02271880|3526310|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3682862|NCT02271880|3526308|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3682863|NCT02271880|3526309|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3682864|NCT02271880|3526310|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682865|NCT02271880|3526308|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682866|NCT02271880|3526309|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682867|NCT02271880|3526310|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682868|NCT02271880|3526308|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3682869|NCT02271880|3526309|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3682870|NCT02271880|3526310|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3682871|NCT02271880|3526308|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3682872|NCT02271880|3526309|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3682873|NCT02271880|3526310|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3682874|NCT02271880|3526308|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682875|NCT02271880|3526309|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682877|NCT02271880|3526308|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682878|NCT02271880|3526309|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682879|NCT02271880|3526310|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682880|NCT02271880|3526308|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682881|NCT02271880|3526309|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682882|NCT02271880|3526310|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682883|NCT02271880|3526308|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3682884|NCT02271880|3526309|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682885|NCT02271880|3526310|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3682886|NCT02271880|3526308|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3682887|NCT02271880|3526309|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3682888|NCT02271880|3526310|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3682889|NCT02271880|3526308|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3682890|NCT02271880|3526309|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3682891|NCT02271880|3526310|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682892|NCT02271880|3526308|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3682893|NCT02271880|3526309|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3682894|NCT02271880|3526310|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3682895|NCT02271880|3526308|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3682896|NCT02271880|3526309|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3682897|NCT02271880|3526310|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3682898|NCT02271880|3526308|B3|||Age||years|Mean|14.33|14.33|Standard Deviation|1.41|1.41|||
3682899|NCT02271880|3526309|B2|||Age||years|Mean|15.75|15.75|Standard Deviation|0.50|0.5|||
3682900|NCT02271880|3526310|B1|||Age||years|Mean|13.00|13.0|Standard Deviation|0.00|0.0|||
3682901|NCT02271854|3526317|B1|United States||Region of Enrollment||participants|Number|86|86.0||||||
3682902|NCT02271854|3526317|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3682903|NCT02271854|3526317|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3682904|NCT02271854|3526317|B1|||Age||years|Mean|27.5|27.5|Standard Deviation|4.5|4.5|||
3682905|NCT02271698|3526324|B5||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3682906|NCT02271698|3526325|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3682907|NCT02271698|3526326|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3682908|NCT02271698|3526327|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3682909|NCT02271698|3526328|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3682910|NCT02271698|3526324|B5||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3682911|NCT02271698|3526325|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3682912|NCT02271698|3526326|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3682913|NCT02271698|3526327|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3682914|NCT02271698|3526328|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3682915|NCT02271698|3526324|B5|||Age||years|Mean|67.13|67.13|Standard Deviation|7.35|7.35|||
3682916|NCT02271698|3526325|B4|||Age||years|Mean|69.45|69.45|Standard Deviation|5.45|5.45|||
3682917|NCT02271698|3526326|B3|||Age||years|Mean|64.14|64.14|Standard Deviation|6.43|6.43|||
3682918|NCT02271698|3526327|B2|||Age||years|Mean|66.56|66.56|Standard Deviation|8.32|8.32|||
3682919|NCT02271698|3526328|B1|||Age||years|Mean|68.06|68.06|Standard Deviation|8.74|8.74|||
3682920|NCT02271529|3526357|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3682921|NCT02271529|3526357|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3682922|NCT02271529|3526357|B1|||Age||years|Mean|67|67.0|Standard Deviation|10|10.0|||
3682923|NCT02271477|3526361|B3|NaCl 0.9%||Type of crystalloid therapy|Type of crystalloid used during the procedure|participants|Number|0|0.0||||||
3682924|NCT02271477|3526362|B2|NaCl 0.9%||Type of crystalloid therapy|Type of crystalloid used during the procedure|participants|Number|0|0.0||||||
3682925|NCT02271477|3526363|B1|NaCl 0.9%||Type of crystalloid therapy|Type of crystalloid used during the procedure|participants|Number|0|0.0||||||
3682926|NCT02271477|3526361|B3|Ringer||Type of crystalloid therapy|Type of crystalloid used during the procedure|participants|Number|160|160.0||||||
3682927|NCT02271477|3526362|B2|Ringer||Type of crystalloid therapy|Type of crystalloid used during the procedure|participants|Number|80|80.0||||||
3682928|NCT02271477|3526363|B1|Ringer||Type of crystalloid therapy|Type of crystalloid used during the procedure|participants|Number|80|80.0||||||
3682929|NCT02271477|3526361|B3|||Crystalloid therapy|Use of crystalloid therapy during the procedure|participants|Number|160|160.0||||||
3682930|NCT02271477|3526362|B2|||Crystalloid therapy|Use of crystalloid therapy during the procedure|participants|Number|80|80.0||||||
3682931|NCT02271477|3526363|B1|||Crystalloid therapy|Use of crystalloid therapy during the procedure|participants|Number|80|80.0||||||
3682932|NCT02271477|3526361|B3|No therapy||ACE-inhibitors therapy|Chronic assumption of ACE-inhibitors therapy prior to intervention|participants|Number|146|146.0||||||
3682933|NCT02271477|3526362|B2|No therapy||ACE-inhibitors therapy|Chronic assumption of ACE-inhibitors therapy prior to intervention|participants|Number|75|75.0||||||
3682934|NCT02271477|3526363|B1|No therapy||ACE-inhibitors therapy|Chronic assumption of ACE-inhibitors therapy prior to intervention|participants|Number|71|71.0||||||
3682935|NCT02271477|3526361|B3|ACE-inhibitors||ACE-inhibitors therapy|Chronic assumption of ACE-inhibitors therapy prior to intervention|participants|Number|14|14.0||||||
3682936|NCT02271477|3526362|B2|ACE-inhibitors||ACE-inhibitors therapy|Chronic assumption of ACE-inhibitors therapy prior to intervention|participants|Number|5|5.0||||||
3682937|NCT02271477|3526363|B1|ACE-inhibitors||ACE-inhibitors therapy|Chronic assumption of ACE-inhibitors therapy prior to intervention|participants|Number|9|9.0||||||
3682938|NCT02271477|3526361|B3|No therapy||B-blockers therapy|Chronic assumption of B-blockers therapy prior to the procedure|participants|Number|152|152.0||||||
3682939|NCT02271477|3526362|B2|No therapy||B-blockers therapy|Chronic assumption of B-blockers therapy prior to the procedure|participants|Number|79|79.0||||||
3682940|NCT02271477|3526363|B1|No therapy||B-blockers therapy|Chronic assumption of B-blockers therapy prior to the procedure|participants|Number|73|73.0||||||
3682941|NCT02271477|3526361|B3|B-blockers||B-blockers therapy|Chronic assumption of B-blockers therapy prior to the procedure|participants|Number|8|8.0||||||
3682942|NCT02271477|3526362|B2|B-blockers||B-blockers therapy|Chronic assumption of B-blockers therapy prior to the procedure|participants|Number|1|1.0||||||
3682943|NCT02271477|3526363|B1|B-blockers||B-blockers therapy|Chronic assumption of B-blockers therapy prior to the procedure|participants|Number|7|7.0||||||
3682944|NCT02271477|3526361|B3|||Heart Rate (HR) pre-induction||bpm|Mean|71.88|71.88|Standard Deviation|12.27|12.27|||
3682945|NCT02271477|3526362|B2|||Heart Rate (HR) pre-induction||bpm|Mean|72|72.0|Standard Deviation|12|12.0|||
3682946|NCT02271477|3526363|B1|||Heart Rate (HR) pre-induction||bpm|Mean|70|70.0|Standard Deviation|16|16.0|||
3682947|NCT02271477|3526361|B3|||Mean blood pressure (MBP) pre-induction|This is the mean blood pressure recorder at the entrance in the operative block. The measure is the international unit of measure: mmHg|mmHg|Mean|93|93.0|Standard Deviation|13.21|13.21|||
3682948|NCT02271477|3526362|B2|||Mean blood pressure (MBP) pre-induction|This is the mean blood pressure recorder at the entrance in the operative block. The measure is the international unit of measure: mmHg|mmHg|Mean|91.5|91.5|Standard Deviation|13|13.0|||
3682949|NCT02271477|3526363|B1|||Mean blood pressure (MBP) pre-induction|This is the mean blood pressure recorder at the entrance in the operative block. The measure is the international unit of measure: mmHg|mmHg|Mean|94.5|94.5|Standard Deviation|13.99|13.99|||
3682950|NCT02271477|3526361|B3|||Systolic blood pressure (SBP) pre-induction|This is the blood pressure recorder at the entrance in the operative block. The measure is the international unit of measure: mmHg|mmHg|Mean|134.05|134.05|Standard Deviation|21.95|21.95|||
3682951|NCT02271477|3526362|B2|||Systolic blood pressure (SBP) pre-induction|This is the blood pressure recorder at the entrance in the operative block. The measure is the international unit of measure: mmHg|mmHg|Mean|132|132.0|Standard Deviation|21|21.0|||
3682952|NCT02271477|3526363|B1|||Systolic blood pressure (SBP) pre-induction|This is the blood pressure recorder at the entrance in the operative block. The measure is the international unit of measure: mmHg|mmHg|Mean|136|136.0|Standard Deviation|22|22.0|||
3682953|NCT02271477|3526361|B3|||Weight||Kg|Mean|76.52|76.52|Standard Deviation|25|25.0|||
3682954|NCT02271477|3526362|B2|||Weight||Kg|Mean|76.07|76.07|Standard Deviation|17.59|17.59|||
3682955|NCT02271477|3526363|B1|||Weight||Kg|Mean|78.01|78.01|Standard Deviation|18.40|18.4|||
3682956|NCT02271477|3526361|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3682957|NCT02271477|3526362|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3682958|NCT02271477|3526363|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3682959|NCT02271477|3526361|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3682960|NCT02271477|3526362|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3682961|NCT02271477|3526363|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3682962|NCT02271477|3526361|B3|||Age||years|Mean|57.74|57.74|Standard Deviation|18.18|18.18|||
3682963|NCT02271477|3526362|B2|||Age||years|Mean|56.6|56.6|Standard Deviation|18.8|18.8|||
3682964|NCT02271477|3526363|B1|||Age||years|Mean|59.7|59.7|Standard Deviation|16.7|16.7|||
3682965|NCT02271217|3526376|B4|||Weight at Screening||kg|Mean|83.63|83.63|Standard Deviation|14.72|14.72|||
3682966|NCT02271217|3526377|B3|||Weight at Screening||kg|Mean|84.49|84.49|Standard Deviation|14.771|14.771|||
3682967|NCT02271217|3526378|B2|||Weight at Screening||kg|Mean|82.43|82.43|Standard Deviation|14.514|14.514|||
3682968|NCT02271217|3526379|B1|||Weight at Screening||kg|Mean|83.98|83.98|Standard Deviation|14.914|14.914|||
3682969|NCT02271217|3526376|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682970|NCT02271217|3526377|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682971|NCT02271217|3526378|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682972|NCT02271217|3526379|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682973|NCT02271217|3526376|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3682974|NCT02271217|3526377|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3682975|NCT02271217|3526378|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3682976|NCT02271217|3526379|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3682977|NCT02271217|3526376|B4||White|Race (NIH/OMB)||Participants|Count of Participants|299|299.0||||||
3682978|NCT02271217|3526377|B3||White|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3682979|NCT02271217|3526378|B2||White|Race (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
3682980|NCT02271217|3526379|B1||White|Race (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3682981|NCT02271217|3526376|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3682982|NCT02271217|3526377|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3682983|NCT02271217|3526378|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3682984|NCT02271217|3526379|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3682985|NCT02271217|3526376|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3682986|NCT02271217|3526377|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3682987|NCT02271217|3526378|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682988|NCT02271217|3526379|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682989|NCT02271217|3526376|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3682990|NCT02271217|3526377|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3682991|NCT02271217|3526378|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3682992|NCT02271217|3526379|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3682993|NCT02271217|3526376|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3682994|NCT02271217|3526377|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3682995|NCT02271217|3526378|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3682996|NCT02271217|3526379|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3682997|NCT02271217|3526376|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682998|NCT02271217|3526377|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3682999|NCT02271217|3526378|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683000|NCT02271217|3526379|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683001|NCT02271217|3526376|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|318|318.0||||||
3683002|NCT02271217|3526377|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
3683003|NCT02271217|3526378|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
3683004|NCT02271217|3526379|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
3683005|NCT02271217|3526376|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3683006|NCT02271217|3526377|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3683007|NCT02271217|3526378|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3683008|NCT02271217|3526379|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3683009|NCT02271217|3526376|B4||Male|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
3683010|NCT02271217|3526377|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3683011|NCT02271217|3526378|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3683012|NCT02271217|3526379|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3683013|NCT02271217|3526376|B4||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3683014|NCT02271217|3526377|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3683015|NCT02271217|3526378|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3683016|NCT02271217|3526379|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3683017|NCT02271217|3526376|B4|||Age||years|Mean|62.9|62.9|Standard Deviation|10.77|10.77|||
3683018|NCT02271217|3526377|B3|||Age||years|Mean|64.3|64.3|Standard Deviation|10.01|10.01|||
3683019|NCT02271217|3526378|B2|||Age||years|Mean|61.7|61.7|Standard Deviation|10.48|10.48|||
3683020|NCT02271217|3526379|B1|||Age||years|Mean|62.9|62.9|Standard Deviation|11.68|11.68|||
3683021|NCT02270944|3526392|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3683022|NCT02270944|3526393|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3683023|NCT02270944|3526394|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3683024|NCT02270944|3526392|B3||Female|Sex: Female, Male||Participants|Count of Participants|1050|1050.0||||||
3683025|NCT02270944|3526393|B2||Female|Sex: Female, Male||Participants|Count of Participants|521|521.0||||||
3683026|NCT02270944|3526394|B1||Female|Sex: Female, Male||Participants|Count of Participants|529|529.0||||||
3683027|NCT02270944|3526392|B3|||Age||Years|Mean|27.2|27.2|Standard Deviation|6.15|6.15|||
3683028|NCT02270944|3526393|B2|||Age||Years|Mean|27.4|27.4|Standard Deviation|6.05|6.05|||
3683029|NCT02270944|3526394|B1|||Age||Years|Mean|27.1|27.1|Standard Deviation|6.24|6.24|||
3683030|NCT02270684|3526409|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3683031|NCT02270684|3526410|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3683032|NCT02270684|3526411|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3683033|NCT02270684|3526409|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3683034|NCT02270684|3526410|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3683035|NCT02270684|3526411|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3683036|NCT02270684|3526409|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3683037|NCT02270684|3526410|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3683038|NCT02270684|3526411|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3683039|NCT02270684|3526409|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3683040|NCT02270684|3526410|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3683041|NCT02270684|3526411|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3683042|NCT02270684|3526409|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3683043|NCT02270684|3526410|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3683044|NCT02270684|3526411|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3683045|NCT02270684|3526409|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3683046|NCT02270684|3526410|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3683047|NCT02270684|3526411|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3683048|NCT02270671|3526418|B3|||Depression Symptoms|The Revised Child Anxiety and Depression Scale – Major Depressive Disorder (RCADS-MDD). The major depressive disorder subscale of the RCADS (Chorpita, Yim, Moffitt, Umemoto, & Francis, 2000) is a 10-item subscale exploring symptoms of MDD as characterised by the DSM-IV, with on a 4-point Likert scale ranging from 0 = never to 3 = always. Scores range from 0 to 30. A score of 11 or higher has been shown to optimise sensitivity and specificity for the prediction of MDD (Ebesutani et al., 2012).|units on a scale|Mean|12.25|12.25|Standard Deviation|6.69|6.69|||
3683049|NCT02270671|3526419|B2|||Depression Symptoms|The Revised Child Anxiety and Depression Scale – Major Depressive Disorder (RCADS-MDD). The major depressive disorder subscale of the RCADS (Chorpita, Yim, Moffitt, Umemoto, & Francis, 2000) is a 10-item subscale exploring symptoms of MDD as characterised by the DSM-IV, with on a 4-point Likert scale ranging from 0 = never to 3 = always. Scores range from 0 to 30. A score of 11 or higher has been shown to optimise sensitivity and specificity for the prediction of MDD (Ebesutani et al., 2012).|units on a scale|Mean|12.84|12.84|Standard Deviation|7.31|7.31|||
3683050|NCT02270671|3526420|B1|||Depression Symptoms|The Revised Child Anxiety and Depression Scale – Major Depressive Disorder (RCADS-MDD). The major depressive disorder subscale of the RCADS (Chorpita, Yim, Moffitt, Umemoto, & Francis, 2000) is a 10-item subscale exploring symptoms of MDD as characterised by the DSM-IV, with on a 4-point Likert scale ranging from 0 = never to 3 = always. Scores range from 0 to 30. A score of 11 or higher has been shown to optimise sensitivity and specificity for the prediction of MDD (Ebesutani et al., 2012).|units on a scale|Mean|11.64|11.64|Standard Deviation|5.99|5.99|||
3683051|NCT02270671|3526418|B3|||Anxiety Related Disorders|The Screen for Child Anxiety Related Emotional Disorders (SCARED)(Birmaher et al., 1997) is a 41-item measure which has five subscales. Responses use a 3-point Likert scale, 0 = not true, or hardly ever true to 2 = very true or often true. The subscales are: Generalized Anxiety Disorder (GAD) (9 items, range 0-18); Panic Disorder (13 items, 0-26); Separation Anxiety Disorder (8 items, 0-16); and Social Phobia (7 items, 0-14), and School Avoidance (4 items, 0-8). Subscales are summed to provide a total score (range 0-82; while scores over 25 may be indicative of an anxiety disorder).|units on a scale|Mean|37.78|37.78|Standard Deviation|13.15|13.15|||
3683052|NCT02270671|3526419|B2|||Anxiety Related Disorders|The Screen for Child Anxiety Related Emotional Disorders (SCARED)(Birmaher et al., 1997) is a 41-item measure which has five subscales. Responses use a 3-point Likert scale, 0 = not true, or hardly ever true to 2 = very true or often true. The subscales are: Generalized Anxiety Disorder (GAD) (9 items, range 0-18); Panic Disorder (13 items, 0-26); Separation Anxiety Disorder (8 items, 0-16); and Social Phobia (7 items, 0-14), and School Avoidance (4 items, 0-8). Subscales are summed to provide a total score (range 0-82; while scores over 25 may be indicative of an anxiety disorder).|units on a scale|Mean|39.46|39.46|Standard Deviation|13.81|13.81|||
3683053|NCT02270671|3526420|B1|||Anxiety Related Disorders|The Screen for Child Anxiety Related Emotional Disorders (SCARED)(Birmaher et al., 1997) is a 41-item measure which has five subscales. Responses use a 3-point Likert scale, 0 = not true, or hardly ever true to 2 = very true or often true. The subscales are: Generalized Anxiety Disorder (GAD) (9 items, range 0-18); Panic Disorder (13 items, 0-26); Separation Anxiety Disorder (8 items, 0-16); and Social Phobia (7 items, 0-14), and School Avoidance (4 items, 0-8). Subscales are summed to provide a total score (range 0-82; while scores over 25 may be indicative of an anxiety disorder).|units on a scale|Mean|36.05|36.05|Standard Deviation|12.31|12.31|||
3683054|NCT02270671|3526418|B3|||Fear of Negative Evaluation|"Measured using the Brief Fear of Negative Evaluation-Revised (BFNE-R; Carleton et al., 2006).~The BFNE-R (Carleton, McCreary, Norton, & Asmundson, 2006) is a 12-item, revised version of the BFNE (Leary, 1983) used to elicit respondents’ fear of negative evaluation. Responses are indicated using a 5-point Likert scale response format from 0 = not at all characteristics of me to 4 = entirely characteristic of me. Scores range from 0 to 48. Higher scores indicate higher fear of negative evaluation."|units on a scale|Mean|31.55|31.55|Standard Deviation|9.99|9.99|||
3683055|NCT02270671|3526419|B2|||Fear of Negative Evaluation|"Measured using the Brief Fear of Negative Evaluation-Revised (BFNE-R; Carleton et al., 2006).~The BFNE-R (Carleton, McCreary, Norton, & Asmundson, 2006) is a 12-item, revised version of the BFNE (Leary, 1983) used to elicit respondents’ fear of negative evaluation. Responses are indicated using a 5-point Likert scale response format from 0 = not at all characteristics of me to 4 = entirely characteristic of me. Scores range from 0 to 48. Higher scores indicate higher fear of negative evaluation."|units on a scale|Mean|31.80|31.8|Standard Deviation|9.67|9.67|||
3683056|NCT02270671|3526420|B1|||Fear of Negative Evaluation|"Measured using the Brief Fear of Negative Evaluation-Revised (BFNE-R; Carleton et al., 2006).~The BFNE-R (Carleton, McCreary, Norton, & Asmundson, 2006) is a 12-item, revised version of the BFNE (Leary, 1983) used to elicit respondents’ fear of negative evaluation. Responses are indicated using a 5-point Likert scale response format from 0 = not at all characteristics of me to 4 = entirely characteristic of me. Scores range from 0 to 48. Higher scores indicate higher fear of negative evaluation."|units on a scale|Mean|31.29|31.29|Standard Deviation|10.38|10.38|||
3683057|NCT02270671|3526418|B3|||Social Phobia and Anxiety|"Measured using the Social Phobia and Anxiety Inventory for Children (SPAI-C; Beidel et al., 1998, 2000).~The Social Phobia and Anxiety Inventory for Children (SPAI-C). The SPAI-C (Beidel et al., 1998, 2000) is a 26-item, self-report measure exploring anxiety in social situations. Responses are indicated using a 3-point Likert scale from 0 = never or hardly ever to 2 = most of the time or always with scores ranging from 0-52. Higher scores on the SPAI-C represent higher levels of social anxiety."|units on a scale|Mean|30.34|30.34|Standard Deviation|7.56|7.56|||
3683089|NCT02270671|3526420|B1||<=18 years|Age||Participants|Count of Participants|59|59.0||||||
3683058|NCT02270671|3526419|B2|||Social Phobia and Anxiety|"Measured using the Social Phobia and Anxiety Inventory for Children (SPAI-C; Beidel et al., 1998, 2000).~The Social Phobia and Anxiety Inventory for Children (SPAI-C). The SPAI-C (Beidel et al., 1998, 2000) is a 26-item, self-report measure exploring anxiety in social situations. Responses are indicated using a 3-point Likert scale from 0 = never or hardly ever to 2 = most of the time or always with scores ranging from 0-52. Higher scores on the SPAI-C represent higher levels of social anxiety."|units on a scale|Mean|31.49|31.49|Standard Deviation|7.53|7.53|||
3683059|NCT02270671|3526420|B1|||Social Phobia and Anxiety|"Measured using the Social Phobia and Anxiety Inventory for Children (SPAI-C; Beidel et al., 1998, 2000).~The Social Phobia and Anxiety Inventory for Children (SPAI-C). The SPAI-C (Beidel et al., 1998, 2000) is a 26-item, self-report measure exploring anxiety in social situations. Responses are indicated using a 3-point Likert scale from 0 = never or hardly ever to 2 = most of the time or always with scores ranging from 0-52. Higher scores on the SPAI-C represent higher levels of social anxiety."|units on a scale|Mean|29.15|29.15|Standard Deviation|7.47|7.47|||
3683060|NCT02270671|3526418|B3|||Threat Bias Measurement|The threat bias measurement consisted of 120 trials of the dot-probe task, 80 of which contained angry-neutral face pairs and 40 of which contained neutral-neutral face pairs. The threat bias score equal the mean of neutral NT trials minus mean of threat NT trials. A threat bias scores >0 indicate a bias towards threat, whereas scores <0 mean that the participant is slower to respond to threatening stimuli than neutral stimuli. Reaction times were measured in milliseconds.|milliseconds|Mean|1.94|1.94|Standard Deviation|24.05|24.05|||
3683061|NCT02270671|3526419|B2|||Threat Bias Measurement|The threat bias measurement consisted of 120 trials of the dot-probe task, 80 of which contained angry-neutral face pairs and 40 of which contained neutral-neutral face pairs. The threat bias score equal the mean of neutral NT trials minus mean of threat NT trials. A threat bias scores >0 indicate a bias towards threat, whereas scores <0 mean that the participant is slower to respond to threatening stimuli than neutral stimuli. Reaction times were measured in milliseconds.|milliseconds|Mean|-.06|-0.06|Standard Deviation|19.03|19.03|||
3683062|NCT02270671|3526420|B1|||Threat Bias Measurement|The threat bias measurement consisted of 120 trials of the dot-probe task, 80 of which contained angry-neutral face pairs and 40 of which contained neutral-neutral face pairs. The threat bias score equal the mean of neutral NT trials minus mean of threat NT trials. A threat bias scores >0 indicate a bias towards threat, whereas scores <0 mean that the participant is slower to respond to threatening stimuli than neutral stimuli. Reaction times were measured in milliseconds.|milliseconds|Mean|4.01|4.01|Standard Deviation|28.35|28.35|||
3683063|NCT02270671|3526418|B3|No||Previously Used Mental Health Services|"Participants answered the following question:~Have you used any of the following services? Mental health drop in services, Mental health apps (applications), Online support groups (One-on-one support or Support forum), E-mail support services, Helplines"|participants|Number|99|99.0||||||
3683064|NCT02270671|3526419|B2|No||Previously Used Mental Health Services|"Participants answered the following question:~Have you used any of the following services? Mental health drop in services, Mental health apps (applications), Online support groups (One-on-one support or Support forum), E-mail support services, Helplines"|participants|Number|53|53.0||||||
3683065|NCT02270671|3526420|B1|No||Previously Used Mental Health Services|"Participants answered the following question:~Have you used any of the following services? Mental health drop in services, Mental health apps (applications), Online support groups (One-on-one support or Support forum), E-mail support services, Helplines"|participants|Number|46|46.0||||||
3683066|NCT02270671|3526418|B3|Yes||Previously Used Mental Health Services|"Participants answered the following question:~Have you used any of the following services? Mental health drop in services, Mental health apps (applications), Online support groups (One-on-one support or Support forum), E-mail support services, Helplines"|participants|Number|21|21.0||||||
3683067|NCT02270671|3526419|B2|Yes||Previously Used Mental Health Services|"Participants answered the following question:~Have you used any of the following services? Mental health drop in services, Mental health apps (applications), Online support groups (One-on-one support or Support forum), E-mail support services, Helplines"|participants|Number|8|8.0||||||
3683068|NCT02270671|3526420|B1|Yes||Previously Used Mental Health Services|"Participants answered the following question:~Have you used any of the following services? Mental health drop in services, Mental health apps (applications), Online support groups (One-on-one support or Support forum), E-mail support services, Helplines"|participants|Number|13|13.0||||||
3683069|NCT02270671|3526418|B3|Ireland||Region of Enrollment||participants|Number|120|120.0||||||
3683070|NCT02270671|3526419|B2|Ireland||Region of Enrollment||participants|Number|61|61.0||||||
3683071|NCT02270671|3526420|B1|Ireland||Region of Enrollment||participants|Number|59|59.0||||||
3683072|NCT02270671|3526418|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3683073|NCT02270671|3526419|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3683074|NCT02270671|3526420|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3683075|NCT02270671|3526418|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3683076|NCT02270671|3526419|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3683077|NCT02270671|3526420|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3683078|NCT02270671|3526418|B3|||Age||years|Mean|15.95|15.95|Standard Deviation|.71|0.71|||
3683079|NCT02270671|3526419|B2|||Age||years|Mean|15.93|15.93|Standard Deviation|.68|0.68|||
3683080|NCT02270671|3526420|B1|||Age||years|Mean|15.97|15.97|Standard Deviation|.74|0.74|||
3683081|NCT02270671|3526418|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3683082|NCT02270671|3526419|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3683083|NCT02270671|3526420|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3683084|NCT02270671|3526418|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3683085|NCT02270671|3526419|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3683086|NCT02270671|3526420|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3683087|NCT02270671|3526418|B3||<=18 years|Age||Participants|Count of Participants|120|120.0||||||
3683088|NCT02270671|3526419|B2||<=18 years|Age||Participants|Count of Participants|61|61.0||||||
3683090|NCT02270645|3526435|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683091|NCT02270645|3526436|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683092|NCT02270645|3526437|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683093|NCT02270645|3526435|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683094|NCT02270645|3526436|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683095|NCT02270645|3526437|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683096|NCT02270645|3526435|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3683097|NCT02270645|3526436|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3683098|NCT02270645|3526437|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3683099|NCT02270645|3526435|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683100|NCT02270645|3526436|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683101|NCT02270645|3526437|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683102|NCT02270645|3526435|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683103|NCT02270645|3526436|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683104|NCT02270645|3526437|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683105|NCT02270645|3526435|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683106|NCT02270645|3526436|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683107|NCT02270645|3526437|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683108|NCT02270645|3526435|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683109|NCT02270645|3526436|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683110|NCT02270645|3526437|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683111|NCT02270645|3526435|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683112|NCT02270645|3526436|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683113|NCT02270645|3526437|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683114|NCT02270645|3526435|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3683115|NCT02270645|3526436|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3683116|NCT02270645|3526437|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3683117|NCT02270645|3526435|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3683118|NCT02270645|3526436|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3683119|NCT02270645|3526437|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3683120|NCT02270645|3526435|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3683121|NCT02270645|3526436|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3683122|NCT02270645|3526437|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3683123|NCT02270645|3526435|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3683124|NCT02270645|3526436|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3683125|NCT02270645|3526437|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3683126|NCT02270645|3526435|B3|||Age||years|Mean|59.6|59.6|Full Range|||32.0|76.0|
3683127|NCT02270645|3526436|B2|||Age||years|Mean|63.5|63.5|Full Range|||60.0|69.0|
3683128|NCT02270645|3526437|B1|||Age||years|Mean|57.7|57.7|Full Range|||32.0|76.0|
3683129|NCT02270645|3526435|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3683130|NCT02270645|3526436|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3683131|NCT02270645|3526437|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3683132|NCT02270645|3526435|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3683133|NCT02270645|3526436|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3683134|NCT02270645|3526437|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3683135|NCT02270645|3526435|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3683136|NCT02270645|3526436|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3683137|NCT02270645|3526437|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3683138|NCT02270515|3526446|B1||Inadequate/marginal (9-15)|Health Literacy|Health literacy score ranges from 3 to 15 with lower score meaning higher health literacy.|Participants|Count of Participants|69|69.0||||||
3683139|NCT02270515|3526446|B1||Adequate (3-8)|Health Literacy|Health literacy score ranges from 3 to 15 with lower score meaning higher health literacy.|Participants|Count of Participants|106|106.0||||||
3683140|NCT02270515|3526446|B1|||Chronic Hemodialysis Knowledge Survey (CHeKS)|Chronic Hemodialysis Knowledge Survey (CHeKS) measures patient's hemodialysis knowledge. Score ranges from 0 to 100. Mean score closer to 100 means better outcome/score.|units on scale|Mean|51.8|51.8|Standard Deviation|15.7|15.7|||
3683141|NCT02270515|3526446|B1|||Self-Efficacy for Managing Chronic Disease (SEMCD)|This 6-item scale measures confidence in common activities needed to managechronic conditions. Scores range from 1 to 10. Higher scores indicate higher self-efficacy.|units on scale|Mean|7.2|7.2|Standard Deviation|2.0|2.0|||
3683184|NCT02270515|3526446|B1||Hispanic, Spanish interview|Race/ethnicity*language||Participants|Count of Participants|58|58.0||||||
3683185|NCT02270515|3526446|B1||Hispanic/other, English interview|Race/ethnicity*language||Participants|Count of Participants|31|31.0||||||
3683142|NCT02270515|3526446|B1|Integration of Care||Primary Care Assessment Survey (PCAS)|Primary Care Assessment Survey (PCAS) assesses patient satisfaction for five (5) primary care characteristics Longitudinal Continuity, Comprehensive Knowledge, Communication, Interpersonal Treatment, and Integration of Care. PCAS scale scores ranges from 0 to 100. Higher scores are more positive (better outcome).|units on a scale|Mean|67.8|67.8|Standard Deviation|22.2|22.2|||
3683143|NCT02270515|3526446|B1|Interpersonal Treatment||Primary Care Assessment Survey (PCAS)|Primary Care Assessment Survey (PCAS) assesses patient satisfaction for five (5) primary care characteristics Longitudinal Continuity, Comprehensive Knowledge, Communication, Interpersonal Treatment, and Integration of Care. PCAS scale scores ranges from 0 to 100. Higher scores are more positive (better outcome).|units on a scale|Mean|75.2|75.2|Standard Deviation|17.3|17.3|||
3683144|NCT02270515|3526446|B1|Communication||Primary Care Assessment Survey (PCAS)|Primary Care Assessment Survey (PCAS) assesses patient satisfaction for five (5) primary care characteristics Longitudinal Continuity, Comprehensive Knowledge, Communication, Interpersonal Treatment, and Integration of Care. PCAS scale scores ranges from 0 to 100. Higher scores are more positive (better outcome).|units on a scale|Mean|74.3|74.3|Standard Deviation|18.8|18.8|||
3683145|NCT02270515|3526446|B1|Comprehensive Knowledge||Primary Care Assessment Survey (PCAS)|Primary Care Assessment Survey (PCAS) assesses patient satisfaction for five (5) primary care characteristics Longitudinal Continuity, Comprehensive Knowledge, Communication, Interpersonal Treatment, and Integration of Care. PCAS scale scores ranges from 0 to 100. Higher scores are more positive (better outcome).|units on a scale|Mean|65.4|65.4|Standard Deviation|21.3|21.3|||
3683146|NCT02270515|3526446|B1|Longitudinal Continuity||Primary Care Assessment Survey (PCAS)|Primary Care Assessment Survey (PCAS) assesses patient satisfaction for five (5) primary care characteristics Longitudinal Continuity, Comprehensive Knowledge, Communication, Interpersonal Treatment, and Integration of Care. PCAS scale scores ranges from 0 to 100. Higher scores are more positive (better outcome).|units on a scale|Mean|52.9|52.9|Standard Deviation|37.2|37.2|||
3683147|NCT02270515|3526446|B1||No regular personal doctor|Regular doctor (Primary Care Physician)||Participants|Count of Participants|71|71.0||||||
3683148|NCT02270515|3526446|B1||Has regular personal doctor|Regular doctor (Primary Care Physician)||Participants|Count of Participants|104|104.0||||||
3683149|NCT02270515|3526446|B1||No|Stressful life events (e.g. hospitalization, loss of employment or family member) in past 6 months||Participants|Count of Participants|96|96.0||||||
3683150|NCT02270515|3526446|B1||Yes|Stressful life events (e.g. hospitalization, loss of employment or family member) in past 6 months||Participants|Count of Participants|79|79.0||||||
3683151|NCT02270515|3526446|B1||4 to 7|Comorbidities||Participants|Count of Participants|14|14.0||||||
3683152|NCT02270515|3526446|B1||2 to 3|Comorbidities||Participants|Count of Participants|91|91.0||||||
3683153|NCT02270515|3526446|B1||1|Comorbidities||Participants|Count of Participants|55|55.0||||||
3683154|NCT02270515|3526446|B1||None|Comorbidities||Participants|Count of Participants|15|15.0||||||
3683155|NCT02270515|3526446|B1||No|Insurance (any type)||Participants|Count of Participants|17|17.0||||||
3683156|NCT02270515|3526446|B1||Yes|Insurance (any type)||Participants|Count of Participants|158|158.0||||||
3683157|NCT02270515|3526446|B1||Other|Primary transportation to clinic||Participants|Count of Participants|15|15.0||||||
3683158|NCT02270515|3526446|B1||PACE paratransit/door to door|Primary transportation to clinic||Participants|Count of Participants|17|17.0||||||
3683159|NCT02270515|3526446|B1||Medicar (Medicaid)|Primary transportation to clinic||Participants|Count of Participants|42|42.0||||||
3683160|NCT02270515|3526446|B1||Transit (L train or bus)|Primary transportation to clinic||Participants|Count of Participants|14|14.0||||||
3683161|NCT02270515|3526446|B1||Car (drive or ride)|Primary transportation to clinic||Participants|Count of Participants|87|87.0||||||
3683162|NCT02270515|3526446|B1|Years at current center||Dialysis History||years|Mean|3.3|3.3|Standard Deviation|4.4|4.4|||
3683163|NCT02270515|3526446|B1|Years on dialysis||Dialysis History||years|Mean|4.4|4.4|Standard Deviation|5.2|5.2|||
3683164|NCT02270515|3526446|B1||Refused|Income||Participants|Count of Participants|15|15.0||||||
3683165|NCT02270515|3526446|B1||≥ $40,000|Income||Participants|Count of Participants|22|22.0||||||
3683166|NCT02270515|3526446|B1||$20,000-$39,999|Income||Participants|Count of Participants|30|30.0||||||
3683167|NCT02270515|3526446|B1||Less than $20,000|Income||Participants|Count of Participants|108|108.0||||||
3683168|NCT02270515|3526446|B1||Not employed|Employment||Participants|Count of Participants|143|143.0||||||
3683169|NCT02270515|3526446|B1||Part-time|Employment||Participants|Count of Participants|15|15.0||||||
3683170|NCT02270515|3526446|B1||Full-time/Self-employed|Employment||Participants|Count of Participants|16|16.0||||||
3683171|NCT02270515|3526446|B1||Bachelor's degree|Education||Participants|Count of Participants|13|13.0||||||
3683172|NCT02270515|3526446|B1||HS graduate/GED|Education||Participants|Count of Participants|100|100.0||||||
3683173|NCT02270515|3526446|B1||Not HS graduate|Education||Participants|Count of Participants|62|62.0||||||
3683174|NCT02270515|3526446|B1||≥ 2 children under 18 yr in household|Children under 18 yr in household||Participants|Count of Participants|21|21.0||||||
3683175|NCT02270515|3526446|B1||1 child under 18 yr in household|Children under 18 yr in household||Participants|Count of Participants|22|22.0||||||
3683176|NCT02270515|3526446|B1||No children under 18 yr in household|Children under 18 yr in household||Participants|Count of Participants|132|132.0||||||
3683177|NCT02270515|3526446|B1||Separated, divorced|Marital status||Participants|Count of Participants|21|21.0||||||
3683178|NCT02270515|3526446|B1||Widowed|Marital status||Participants|Count of Participants|22|22.0||||||
3683179|NCT02270515|3526446|B1||Married/Living with a partner|Marital status||Participants|Count of Participants|62|62.0||||||
3683180|NCT02270515|3526446|B1||Single, never married|Marital status||Participants|Count of Participants|70|70.0||||||
3683181|NCT02270515|3526446|B1||Both equally|Primary language||Participants|Count of Participants|14|14.0||||||
3683182|NCT02270515|3526446|B1||Spanish/other|Primary language||Participants|Count of Participants|54|54.0||||||
3683183|NCT02270515|3526446|B1||English|Primary language||Participants|Count of Participants|107|107.0||||||
3683186|NCT02270515|3526446|B1||African-American|Race/ethnicity*language||Participants|Count of Participants|86|86.0||||||
3683187|NCT02270515|3526446|B1||Spanish|Interview language||Participants|Count of Participants|58|58.0||||||
3683188|NCT02270515|3526446|B1||English|Interview language||Participants|Count of Participants|117|117.0||||||
3683189|NCT02270515|3526446|B1|United States||Region of Enrollment||participants|Number|175|175.0||||||
3683190|NCT02270515|3526446|B1|Race/Ethnicity|Hispanic/other|Race/Ethnicity, Customized|Hispanic/other category consist of Hispanic and participants of unidentified race|Participants|Count of Participants|89|89.0||||||
3683191|NCT02270515|3526446|B1|Race/Ethnicity|African-American|Race/Ethnicity, Customized|Hispanic/other category consist of Hispanic and participants of unidentified race|Participants|Count of Participants|86|86.0||||||
3683192|NCT02270515|3526446|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3683193|NCT02270515|3526446|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3683194|NCT02270515|3526446|B1|||Age||years|Mean|54.4|54.4|Standard Deviation|15|15.0|||
3683195|NCT02269943|3526461|B3|||Participants with Prior Anti-Cancer Therapies||Participants|Count of Participants|35|35.0||||||
3683196|NCT02269943|3526462|B2|||Participants with Prior Anti-Cancer Therapies||Participants|Count of Participants|29|29.0||||||
3683197|NCT02269943|3526463|B1|||Participants with Prior Anti-Cancer Therapies||Participants|Count of Participants|6|6.0||||||
3683198|NCT02269943|3526461|B3|Other||Nasopharyngeal Cancer (NPC) Diagnosis Types|"The 3 types of NPC, based on how the cancer cells look under the microscope include:~Undifferentiated Nasopharyngeal Carcinoma~Poorly Differentiated Nasopharyngeal Carcinoma~Other"|Participants|Count of Participants|2|2.0||||||
3683199|NCT02269943|3526462|B2|Other||Nasopharyngeal Cancer (NPC) Diagnosis Types|"The 3 types of NPC, based on how the cancer cells look under the microscope include:~Undifferentiated Nasopharyngeal Carcinoma~Poorly Differentiated Nasopharyngeal Carcinoma~Other"|Participants|Count of Participants|0|0.0||||||
3683200|NCT02269943|3526463|B1|Other||Nasopharyngeal Cancer (NPC) Diagnosis Types|"The 3 types of NPC, based on how the cancer cells look under the microscope include:~Undifferentiated Nasopharyngeal Carcinoma~Poorly Differentiated Nasopharyngeal Carcinoma~Other"|Participants|Count of Participants|2|2.0||||||
3683201|NCT02269943|3526461|B3|Poorly Differentiated Nasopharyngeal Carcinoma||Nasopharyngeal Cancer (NPC) Diagnosis Types|"The 3 types of NPC, based on how the cancer cells look under the microscope include:~Undifferentiated Nasopharyngeal Carcinoma~Poorly Differentiated Nasopharyngeal Carcinoma~Other"|Participants|Count of Participants|11|11.0||||||
3683202|NCT02269943|3526462|B2|Poorly Differentiated Nasopharyngeal Carcinoma||Nasopharyngeal Cancer (NPC) Diagnosis Types|"The 3 types of NPC, based on how the cancer cells look under the microscope include:~Undifferentiated Nasopharyngeal Carcinoma~Poorly Differentiated Nasopharyngeal Carcinoma~Other"|Participants|Count of Participants|9|9.0||||||
3683203|NCT02269943|3526463|B1|Poorly Differentiated Nasopharyngeal Carcinoma||Nasopharyngeal Cancer (NPC) Diagnosis Types|"The 3 types of NPC, based on how the cancer cells look under the microscope include:~Undifferentiated Nasopharyngeal Carcinoma~Poorly Differentiated Nasopharyngeal Carcinoma~Other"|Participants|Count of Participants|2|2.0||||||
3683204|NCT02269943|3526461|B3|Undifferentiated Nasopharyngeal Carcinoma||Nasopharyngeal Cancer (NPC) Diagnosis Types|"The 3 types of NPC, based on how the cancer cells look under the microscope include:~Undifferentiated Nasopharyngeal Carcinoma~Poorly Differentiated Nasopharyngeal Carcinoma~Other"|Participants|Count of Participants|23|23.0||||||
3683205|NCT02269943|3526462|B2|Undifferentiated Nasopharyngeal Carcinoma||Nasopharyngeal Cancer (NPC) Diagnosis Types|"The 3 types of NPC, based on how the cancer cells look under the microscope include:~Undifferentiated Nasopharyngeal Carcinoma~Poorly Differentiated Nasopharyngeal Carcinoma~Other"|Participants|Count of Participants|21|21.0||||||
3683206|NCT02269943|3526463|B1|Undifferentiated Nasopharyngeal Carcinoma||Nasopharyngeal Cancer (NPC) Diagnosis Types|"The 3 types of NPC, based on how the cancer cells look under the microscope include:~Undifferentiated Nasopharyngeal Carcinoma~Poorly Differentiated Nasopharyngeal Carcinoma~Other"|Participants|Count of Participants|2|2.0||||||
3683207|NCT02269943|3526461|B3|||Time From Initial Diagnosis to First Dose||years|Mean|3.81|3.81|Standard Deviation|3.287|3.287|||
3683208|NCT02269943|3526462|B2|||Time From Initial Diagnosis to First Dose||years|Mean|3.86|3.86|Standard Deviation|3.358|3.358|||
3683209|NCT02269943|3526463|B1|||Time From Initial Diagnosis to First Dose||years|Mean|3.60|3.6|Standard Deviation|3.204|3.204|||
3683210|NCT02269943|3526461|B3|3 = Limited Self-Care||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|0|0.0||||||
3683211|NCT02269943|3526462|B2|3 = Limited Self-Care||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|0|0.0||||||
3683212|NCT02269943|3526463|B1|3 = Limited Self-Care||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|0|0.0||||||
3683237|NCT02269943|3526461|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3683238|NCT02269943|3526462|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3683239|NCT02269943|3526463|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3683213|NCT02269943|3526461|B3|2 = Ambulatory but unable to work||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|1|1.0||||||
3683214|NCT02269943|3526462|B2|2 = Ambulatory but unable to work||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|1|1.0||||||
3683215|NCT02269943|3526463|B1|2 = Ambulatory but unable to work||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|0|0.0||||||
3683216|NCT02269943|3526461|B3|1 = Restrictive but ambulatory||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|20|20.0||||||
3683217|NCT02269943|3526462|B2|1 = Restrictive but ambulatory||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|18|18.0||||||
3683218|NCT02269943|3526463|B1|1 = Restrictive but ambulatory||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|2|2.0||||||
3683219|NCT02269943|3526461|B3|0 = Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|15|15.0||||||
3683220|NCT02269943|3526462|B2|0 = Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|11|11.0||||||
3683221|NCT02269943|3526463|B1|0 = Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|4|4.0||||||
3683222|NCT02269943|3526461|B3|Non-Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3683223|NCT02269943|3526462|B2|Non-Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3683224|NCT02269943|3526463|B1|Non-Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3683225|NCT02269943|3526461|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3683226|NCT02269943|3526462|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3683227|NCT02269943|3526463|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3683228|NCT02269943|3526461|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3683229|NCT02269943|3526462|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3683230|NCT02269943|3526463|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3683231|NCT02269943|3526461|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3683232|NCT02269943|3526462|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3683233|NCT02269943|3526463|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3683234|NCT02269943|3526461|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3683235|NCT02269943|3526462|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3683236|NCT02269943|3526463|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3683240|NCT02269943|3526461|B3|||Age||Years|Mean|52.4|52.4|Standard Deviation|11.46|11.46|||
3683241|NCT02269943|3526462|B2|||Age||Years|Mean|52.2|52.2|Standard Deviation|11.60|11.6|||
3683242|NCT02269943|3526463|B1|||Age||Years|Mean|53.2|53.2|Standard Deviation|11.70|11.7|||
3683243|NCT02269917|3526492|B3|United States||Region of Enrollment||Participants|Count of Participants|494|494.0||||||
3683244|NCT02269917|3526493|B2|United States||Region of Enrollment||Participants|Count of Participants|181|181.0||||||
3683245|NCT02269917|3526494|B1|United States||Region of Enrollment||Participants|Count of Participants|313|313.0||||||
3683246|NCT02269917|3526492|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|70|70.0||||||
3683247|NCT02269917|3526493|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3683248|NCT02269917|3526494|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
3683249|NCT02269917|3526492|B3|Switzerland||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3683250|NCT02269917|3526493|B2|Switzerland||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3683251|NCT02269917|3526494|B1|Switzerland||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3683252|NCT02269917|3526492|B3|Sweden||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3683253|NCT02269917|3526493|B2|Sweden||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3683254|NCT02269917|3526494|B1|Sweden||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3683255|NCT02269917|3526492|B3|Spain||Region of Enrollment||Participants|Count of Participants|169|169.0||||||
3683256|NCT02269917|3526493|B2|Spain||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
3683257|NCT02269917|3526494|B1|Spain||Region of Enrollment||Participants|Count of Participants|117|117.0||||||
3683258|NCT02269917|3526492|B3|Poland||Region of Enrollment||Participants|Count of Participants|126|126.0||||||
3683259|NCT02269917|3526493|B2|Poland||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3683260|NCT02269917|3526494|B1|Poland||Region of Enrollment||Participants|Count of Participants|91|91.0||||||
3683261|NCT02269917|3526492|B3|France||Region of Enrollment||Participants|Count of Participants|97|97.0||||||
3683262|NCT02269917|3526493|B2|France||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3683263|NCT02269917|3526494|B1|France||Region of Enrollment||Participants|Count of Participants|69|69.0||||||
3683264|NCT02269917|3526492|B3|Canada||Region of Enrollment||Participants|Count of Participants|66|66.0||||||
3683265|NCT02269917|3526493|B2|Canada||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3683266|NCT02269917|3526494|B1|Canada||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3683267|NCT02269917|3526492|B3|Belgium||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
3683268|NCT02269917|3526493|B2|Belgium||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3683269|NCT02269917|3526494|B1|Belgium||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3683270|NCT02269917|3526492|B3|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|701|701.0||||||
3683271|NCT02269917|3526493|B2|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|225|225.0||||||
3683272|NCT02269917|3526494|B1|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|476|476.0||||||
3683273|NCT02269917|3526492|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3683274|NCT02269917|3526493|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3683275|NCT02269917|3526494|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3683276|NCT02269917|3526492|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|151|151.0||||||
3683277|NCT02269917|3526493|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|56|56.0||||||
3683278|NCT02269917|3526494|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|95|95.0||||||
3683279|NCT02269917|3526492|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|237|237.0||||||
3683280|NCT02269917|3526493|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|82|82.0||||||
3683281|NCT02269917|3526494|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|155|155.0||||||
3683282|NCT02269917|3526492|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3683283|NCT02269917|3526493|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3683284|NCT02269917|3526494|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3683285|NCT02269917|3526492|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3683286|NCT02269917|3526493|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3683287|NCT02269917|3526494|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3683288|NCT02269917|3526492|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3683289|NCT02269917|3526493|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3683290|NCT02269917|3526494|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3683291|NCT02269917|3526492|B3||White|Race (NIH/OMB)||Participants|Count of Participants|855|855.0||||||
3683292|NCT02269917|3526493|B2||White|Race (NIH/OMB)||Participants|Count of Participants|282|282.0||||||
3683293|NCT02269917|3526494|B1||White|Race (NIH/OMB)||Participants|Count of Participants|573|573.0||||||
3683294|NCT02269917|3526492|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|237|237.0||||||
3683295|NCT02269917|3526493|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3683598|NCT02267850|3526789|B3|||Age||years|Mean|13.3|13.3|Standard Deviation|1.0|1.0|||
3683296|NCT02269917|3526494|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|155|155.0||||||
3683297|NCT02269917|3526492|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3683298|NCT02269917|3526493|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683299|NCT02269917|3526494|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3683300|NCT02269917|3526492|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3683301|NCT02269917|3526493|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3683302|NCT02269917|3526494|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3683303|NCT02269917|3526492|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3683304|NCT02269917|3526493|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3683305|NCT02269917|3526494|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3683306|NCT02269917|3526492|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3683307|NCT02269917|3526493|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3683308|NCT02269917|3526494|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3683309|NCT02269917|3526492|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|966|966.0||||||
3683310|NCT02269917|3526493|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|317|317.0||||||
3683311|NCT02269917|3526494|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|649|649.0||||||
3683312|NCT02269917|3526492|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|170|170.0||||||
3683313|NCT02269917|3526493|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3683314|NCT02269917|3526494|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
3683315|NCT02269917|3526492|B3||Male|Sex: Female, Male||Participants|Count of Participants|936|936.0||||||
3683316|NCT02269917|3526493|B2||Male|Sex: Female, Male||Participants|Count of Participants|313|313.0||||||
3683317|NCT02269917|3526494|B1||Male|Sex: Female, Male||Participants|Count of Participants|623|623.0||||||
3683318|NCT02269917|3526492|B3||Female|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
3683319|NCT02269917|3526493|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3683320|NCT02269917|3526494|B1||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3683321|NCT02269917|3526492|B3|||Age||years|Mean|45.1|45.1|Standard Deviation|10.83|10.83|||
3683322|NCT02269917|3526493|B2|||Age||years|Mean|44.8|44.8|Standard Deviation|10.77|10.77|||
3683323|NCT02269917|3526494|B1|||Age||years|Mean|45.3|45.3|Standard Deviation|10.86|10.86|||
3683324|NCT02269709|3526546|B1|Age of Female Subjects||Age by Sex||Months|Mean|33|33.0|Full Range|||24.0|47.0|
3683325|NCT02269709|3526546|B1|Age of Male Subjects||Age by Sex||Months|Mean|34|34.0|Full Range|||18.0|52.0|
3683326|NCT02269709|3526546|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3683327|NCT02269709|3526546|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3683328|NCT02269709|3526546|B1|||Age||Months|Mean|33.5|33.5|Standard Deviation|10.5|10.5|||
3683329|NCT02269657|3526551|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
3683330|NCT02269657|3526551|B1||Male|Gender||Participants|Count of Participants|7|7.0||||||
3683331|NCT02269657|3526551|B1||Female|Gender||Participants|Count of Participants|30|30.0||||||
3683332|NCT02269657|3526551|B1|||Age||years|Mean|14.7|14.7|Standard Deviation|1.7|1.7|||
3683333|NCT02269488|3526565|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683334|NCT02269488|3526565|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683335|NCT02269488|3526565|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683336|NCT02269488|3526565|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683337|NCT02269488|3526565|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683338|NCT02269488|3526565|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3683339|NCT02269488|3526565|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683340|NCT02269488|3526565|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683341|NCT02269488|3526565|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3683342|NCT02269488|3526565|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683343|NCT02269488|3526565|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3683344|NCT02269488|3526565|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3683345|NCT02269488|3526565|B1|||Age||Years|Mean|4.2|4.2|Standard Deviation|1.4|1.4|||
3683346|NCT02269475|3526569|B3|No||Prior Influenza Vaccination||Participants|Number|127|127.0||||||
3683347|NCT02269475|3526570|B2|No||Prior Influenza Vaccination||Participants|Number|47|47.0||||||
3683348|NCT02269475|3526571|B1|No||Prior Influenza Vaccination||Participants|Number|80|80.0||||||
3683349|NCT02269475|3526569|B3|Yes||Prior Influenza Vaccination||Participants|Number|1174|1174.0||||||
3683350|NCT02269475|3526570|B2|Yes||Prior Influenza Vaccination||Participants|Number|386|386.0||||||
3683351|NCT02269475|3526571|B1|Yes||Prior Influenza Vaccination||Participants|Number|788|788.0||||||
3683352|NCT02269475|3526569|B3|2||Number of Doses of Study Vaccine to be Received||Participants|Number|39|39.0||||||
3683353|NCT02269475|3526570|B2|2||Number of Doses of Study Vaccine to be Received||Participants|Number|12|12.0||||||
3683354|NCT02269475|3526571|B1|2||Number of Doses of Study Vaccine to be Received||Participants|Number|27|27.0||||||
3683355|NCT02269475|3526569|B3|1||Number of Doses of Study Vaccine to be Received||Participants|Number|1262|1262.0||||||
3683356|NCT02269475|3526570|B2|1||Number of Doses of Study Vaccine to be Received||Participants|Number|421|421.0||||||
3683357|NCT02269475|3526571|B1|1||Number of Doses of Study Vaccine to be Received||Participants|Number|841|841.0||||||
3683358|NCT02269475|3526569|B3||Male|Sex: Female, Male||Participants|Count of Participants|667|667.0||||||
3683359|NCT02269475|3526570|B2||Male|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
3683360|NCT02269475|3526571|B1||Male|Sex: Female, Male||Participants|Count of Participants|460|460.0||||||
3683361|NCT02269475|3526569|B3||Female|Sex: Female, Male||Participants|Count of Participants|634|634.0||||||
3683362|NCT02269475|3526570|B2||Female|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
3683363|NCT02269475|3526571|B1||Female|Sex: Female, Male||Participants|Count of Participants|408|408.0||||||
3683364|NCT02269475|3526569|B3|||Age||years|Mean|10.9|10.9|Standard Deviation|2.9|2.9|||
3683365|NCT02269475|3526570|B2|||Age||years|Mean|10.8|10.8|Standard Deviation|2.8|2.8|||
3683366|NCT02269475|3526571|B1|||Age||years|Mean|11.0|11.0|Standard Deviation|3.0|3.0|||
3683367|NCT02269098|3526583|B3|United States||Region of Enrollment||participants|Number|101|101.0||||||
3683368|NCT02269098|3526584|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
3683369|NCT02269098|3526585|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
3683370|NCT02269098|3526583|B3||Male|Gender||Participants|Count of Participants|46|46.0||||||
3683371|NCT02269098|3526584|B2||Male|Gender||Participants|Count of Participants|26|26.0||||||
3683372|NCT02269098|3526585|B1||Male|Gender||Participants|Count of Participants|20|20.0||||||
3683373|NCT02269098|3526583|B3||Female|Gender||Participants|Count of Participants|55|55.0||||||
3683374|NCT02269098|3526584|B2||Female|Gender||Participants|Count of Participants|24|24.0||||||
3683375|NCT02269098|3526585|B1||Female|Gender||Participants|Count of Participants|31|31.0||||||
3683376|NCT02269098|3526583|B3|||Age||years|Mean|50|50.0|Standard Deviation|13|13.0|||
3683377|NCT02269098|3526584|B2|||Age||years|Mean|50|50.0|Standard Deviation|12|12.0|||
3683378|NCT02269098|3526585|B1|||Age||years|Mean|50|50.0|Standard Deviation|14|14.0|||
3683379|NCT02269098|3526583|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3683380|NCT02269098|3526584|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3683381|NCT02269098|3526585|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3683382|NCT02269098|3526583|B3||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
3683383|NCT02269098|3526584|B2||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3683384|NCT02269098|3526585|B1||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
3683385|NCT02269098|3526583|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3683386|NCT02269098|3526584|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3683387|NCT02269098|3526585|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3683388|NCT02268994|3526600|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683389|NCT02268994|3526601|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683390|NCT02268994|3526602|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683391|NCT02268994|3526600|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683392|NCT02268994|3526601|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683393|NCT02268994|3526602|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683394|NCT02268994|3526600|B3||White|Race (NIH/OMB)||Participants|Count of Participants|160|160.0||||||
3683395|NCT02268994|3526601|B2||White|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3683396|NCT02268994|3526602|B1||White|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3683397|NCT02268994|3526600|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3683398|NCT02268994|3526601|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3683399|NCT02268994|3526602|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3683400|NCT02268994|3526600|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683401|NCT02268994|3526601|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683402|NCT02268994|3526602|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683403|NCT02268994|3526600|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3683404|NCT02268994|3526601|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3683405|NCT02268994|3526602|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3683406|NCT02268994|3526600|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3683407|NCT02268994|3526601|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3683408|NCT02268994|3526602|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683409|NCT02268994|3526600|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683410|NCT02268994|3526601|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683411|NCT02268994|3526602|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683412|NCT02268994|3526600|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|180|180.0||||||
3683413|NCT02268994|3526601|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
3683414|NCT02268994|3526602|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3683415|NCT02268994|3526600|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3683416|NCT02268994|3526601|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3683417|NCT02268994|3526602|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3683418|NCT02268994|3526600|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3683419|NCT02268994|3526601|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3683420|NCT02268994|3526602|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3683421|NCT02268994|3526600|B3||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3683422|NCT02268994|3526601|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3683423|NCT02268994|3526602|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3683424|NCT02268994|3526600|B3|||Age||years|Mean|65.4|65.4|Standard Deviation|12.12|12.12|||
3683425|NCT02268994|3526601|B2|||Age||years|Mean|65.2|65.2|Standard Deviation|13.08|13.08|||
3683426|NCT02268994|3526602|B1|||Age||years|Mean|65.6|65.6|Standard Deviation|11.15|11.15|||
3683427|NCT02268994|3526600|B3||>=65 years|Age||Participants|Count of Participants|137|137.0||||||
3683428|NCT02268994|3526601|B2||>=65 years|Age||Participants|Count of Participants|68|68.0||||||
3683429|NCT02268994|3526602|B1||>=65 years|Age||Participants|Count of Participants|69|69.0||||||
3683430|NCT02268994|3526600|B3||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
3683431|NCT02268994|3526601|B2||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
3683432|NCT02268994|3526602|B1||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
3683433|NCT02268994|3526600|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3683434|NCT02268994|3526601|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3683435|NCT02268994|3526602|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3683436|NCT02268877|3526619|B3|United States||Region of Enrollment||participants|Number|224|224.0||||||
3683437|NCT02268877|3526620|B2|United States||Region of Enrollment||participants|Number|106|106.0||||||
3683438|NCT02268877|3526621|B1|United States||Region of Enrollment||participants|Number|118|118.0||||||
3683439|NCT02268877|3526619|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3683440|NCT02268877|3526619|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3683441|NCT02268877|3526620|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3683442|NCT02268877|3526621|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3683443|NCT02268877|3526619|B3||Female|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
3683444|NCT02268877|3526620|B2||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3683445|NCT02268877|3526621|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3683446|NCT02268877|3526619|B3|||Age||years|Median|26|26.0|Inter-Quartile Range|||22.0|31.0|
3683447|NCT02268877|3526620|B2|||Age||years|Median|26|26.0|Inter-Quartile Range|||22.0|31.0|
3683448|NCT02268877|3526621|B1|||Age||years|Median|26|26.0|Inter-Quartile Range|||22.0|31.0|
3683449|NCT02268864|3526630|B4|United Kingdom||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3683450|NCT02268864|3526631|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3683451|NCT02268864|3526632|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3683452|NCT02268864|3526633|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3683453|NCT02268864|3526630|B4|Spain||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3683454|NCT02268864|3526631|B3|Spain||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3683455|NCT02268864|3526632|B2|Spain||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3683456|NCT02268864|3526633|B1|Spain||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3683457|NCT02268864|3526630|B4|Italy||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3683458|NCT02268864|3526631|B3|Italy||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3683459|NCT02268864|3526632|B2|Italy||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3683460|NCT02268864|3526633|B1|Italy||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3683461|NCT02268864|3526630|B4|Hungary||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3683462|NCT02268864|3526631|B3|Hungary||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3683463|NCT02268864|3526632|B2|Hungary||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3683464|NCT02268864|3526633|B1|Hungary||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3683465|NCT02268864|3526630|B4|Germany||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3683466|NCT02268864|3526631|B3|Germany||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3683467|NCT02268864|3526632|B2|Germany||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3683468|NCT02268864|3526633|B1|Germany||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3683469|NCT02268864|3526630|B4|France||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3683470|NCT02268864|3526631|B3|France||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3683471|NCT02268864|3526632|B2|France||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3683472|NCT02268864|3526633|B1|France||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3683473|NCT02268864|3526630|B4|Belgium||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3683474|NCT02268864|3526631|B3|Belgium||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3683475|NCT02268864|3526632|B2|Belgium||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3683476|NCT02268864|3526633|B1|Belgium||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3683477|NCT02268864|3526630|B4||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3683478|NCT02268864|3526631|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3683479|NCT02268864|3526632|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3683480|NCT02268864|3526633|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3683481|NCT02268864|3526630|B4||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3683482|NCT02268864|3526631|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3683483|NCT02268864|3526632|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3683484|NCT02268864|3526633|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3683485|NCT02268864|3526630|B4|||Age||years|Median|59.0|59.0|Full Range|13.53|13.53|21.0|83.0|
3683486|NCT02268864|3526631|B3|||Age||years|Median|59.0|59.0|Full Range|12.6|12.6|26.0|83.0|
3683487|NCT02268864|3526632|B2|||Age||years|Median|64.0|64.0|Full Range|14.77|14.77|25.0|83.0|
3683488|NCT02268864|3526633|B1|||Age||years|Median|53.0|53.0|Full Range|15.34|15.34|21.0|82.0|
3683489|NCT02268812|3526657|B5||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3683490|NCT02268812|3526658|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3683491|NCT02268812|3526659|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3683492|NCT02268812|3526660|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3683493|NCT02268812|3526661|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3683494|NCT02268812|3526657|B5||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3683495|NCT02268812|3526658|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3683496|NCT02268812|3526659|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3683497|NCT02268812|3526660|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3683498|NCT02268812|3526661|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3683499|NCT02268812|3526657|B5|||Age||Years|Mean|54.8|54.8|Standard Deviation|12.39|12.39|||
3683500|NCT02268812|3526658|B4|||Age||Years|Mean|54.4|54.4|Standard Deviation|11.69|11.69|||
3683501|NCT02268812|3526659|B3|||Age||Years|Mean|56.7|56.7|Standard Deviation|12.78|12.78|||
3683502|NCT02268812|3526660|B2|||Age||Years|Mean|55.9|55.9|Standard Deviation|13.46|13.46|||
3683503|NCT02268812|3526661|B1|||Age||Years|Mean|53.2|53.2|Standard Deviation|11.56|11.56|||
3683504|NCT02268526|3526694|B4||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3683505|NCT02268526|3526695|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3683506|NCT02268526|3526696|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3683507|NCT02268526|3526697|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3683508|NCT02268526|3526694|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3683509|NCT02268526|3526695|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3683510|NCT02268526|3526696|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3683511|NCT02268526|3526697|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3683512|NCT02268526|3526694|B4|||Age||years|Mean|52.5|52.5|Standard Deviation|13.04|13.04|||
3683513|NCT02268526|3526695|B3|||Age||years|Mean|46.0|46.0|Standard Deviation|14.33|14.33|||
3683514|NCT02268526|3526696|B2|||Age||years|Mean|54.7|54.7|Standard Deviation|12.33|12.33|||
3683515|NCT02268526|3526697|B1|||Age||years|Mean|52.8|52.8|Standard Deviation|8.70|8.7|||
3683516|NCT02268396|3526720|B1||Male|Gender||Participants|Count of Participants|70|70.0||||||
3683517|NCT02268396|3526720|B1||Female|Gender||Participants|Count of Participants|68|68.0||||||
3683518|NCT02268396|3526720|B1|||Age||Years|Mean|62.1|62.1|Standard Deviation|8.3|8.3|||
3683519|NCT02268214|3526729|B4||Male|Sex: Female, Male||Participants|Count of Participants|403|403.0||||||
3683520|NCT02268214|3526730|B3||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3683521|NCT02268214|3526731|B2||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3683522|NCT02268214|3526732|B1||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3683523|NCT02268214|3526729|B4||Female|Sex: Female, Male||Participants|Count of Participants|430|430.0||||||
3683524|NCT02268214|3526730|B3||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3683525|NCT02268214|3526731|B2||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3683526|NCT02268214|3526732|B1||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3683527|NCT02268214|3526729|B4||>= 75 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
3683528|NCT02268214|3526730|B3||>= 75 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3683529|NCT02268214|3526731|B2||>= 75 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
3683530|NCT02268214|3526732|B1||>= 75 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3683531|NCT02268214|3526729|B4||Between 65 and 75 years|Age, Customized||Participants|Count of Participants|45|45.0||||||
3683532|NCT02268214|3526730|B3||Between 65 and 75 years|Age, Customized||Participants|Count of Participants|14|14.0||||||
3683533|NCT02268214|3526731|B2||Between 65 and 75 years|Age, Customized||Participants|Count of Participants|16|16.0||||||
3683534|NCT02268214|3526732|B1||Between 65 and 75 years|Age, Customized||Participants|Count of Participants|15|15.0||||||
3683535|NCT02268214|3526729|B4||< 65 years|Age, Customized||Participants|Count of Participants|787|787.0||||||
3683536|NCT02268214|3526730|B3||< 65 years|Age, Customized||Participants|Count of Participants|246|246.0||||||
3683537|NCT02268214|3526731|B2||< 65 years|Age, Customized||Participants|Count of Participants|279|279.0||||||
3683538|NCT02268214|3526732|B1||< 65 years|Age, Customized||Participants|Count of Participants|262|262.0||||||
3683539|NCT02268214|3526729|B4|||Age||Years|Mean|42.7|42.7|Standard Deviation|13.80|13.8|||
3683540|NCT02268214|3526730|B3|||Age||Years|Mean|42.7|42.7|Standard Deviation|13.57|13.57|||
3683541|NCT02268214|3526731|B2|||Age||Years|Mean|43.4|43.4|Standard Deviation|13.89|13.89|||
3683542|NCT02268214|3526732|B1|||Age||Years|Mean|42.1|42.1|Standard Deviation|13.94|13.94|||
3683543|NCT02268058|3526760|B5|other||mechanism of injury||participants|Number|7|7.0||||||
3683544|NCT02268058|3526761|B4|other||mechanism of injury||participants|Number|2|2.0||||||
3683545|NCT02268058|3526762|B3|other||mechanism of injury||participants|Number|3|3.0||||||
3683546|NCT02268058|3526763|B2|other||mechanism of injury||participants|Number|0|0.0||||||
3683547|NCT02268058|3526764|B1|other||mechanism of injury||participants|Number|2|2.0||||||
3683548|NCT02268058|3526760|B5|assault||mechanism of injury||participants|Number|3|3.0||||||
3683549|NCT02268058|3526761|B4|assault||mechanism of injury||participants|Number|0|0.0||||||
3683550|NCT02268058|3526762|B3|assault||mechanism of injury||participants|Number|0|0.0||||||
3683551|NCT02268058|3526763|B2|assault||mechanism of injury||participants|Number|2|2.0||||||
3683552|NCT02268058|3526764|B1|assault||mechanism of injury||participants|Number|1|1.0||||||
3683553|NCT02268058|3526760|B5|motor vehicle accident||mechanism of injury||participants|Number|3|3.0||||||
3683554|NCT02268058|3526761|B4|motor vehicle accident||mechanism of injury||participants|Number|1|1.0||||||
3683555|NCT02268058|3526762|B3|motor vehicle accident||mechanism of injury||participants|Number|0|0.0||||||
3683556|NCT02268058|3526763|B2|motor vehicle accident||mechanism of injury||participants|Number|0|0.0||||||
3683557|NCT02268058|3526764|B1|motor vehicle accident||mechanism of injury||participants|Number|2|2.0||||||
3683558|NCT02268058|3526760|B5|sports||mechanism of injury||participants|Number|49|49.0||||||
3683559|NCT02268058|3526761|B4|sports||mechanism of injury||participants|Number|12|12.0||||||
3683560|NCT02268058|3526762|B3|sports||mechanism of injury||participants|Number|13|13.0||||||
3683561|NCT02268058|3526763|B2|sports||mechanism of injury||participants|Number|12|12.0||||||
3683562|NCT02268058|3526764|B1|sports||mechanism of injury||participants|Number|12|12.0||||||
3683563|NCT02268058|3526760|B5|fall||mechanism of injury||participants|Number|18|18.0||||||
3683564|NCT02268058|3526761|B4|fall||mechanism of injury||participants|Number|5|5.0||||||
3683565|NCT02268058|3526762|B3|fall||mechanism of injury||participants|Number|4|4.0||||||
3683566|NCT02268058|3526763|B2|fall||mechanism of injury||participants|Number|6|6.0||||||
3683567|NCT02268058|3526764|B1|fall||mechanism of injury||participants|Number|3|3.0||||||
3683568|NCT02268058|3526760|B5|Canada||Region of Enrollment||participants|Number|80|80.0||||||
3683569|NCT02268058|3526761|B4|Canada||Region of Enrollment||participants|Number|20|20.0||||||
3683570|NCT02268058|3526762|B3|Canada||Region of Enrollment||participants|Number|20|20.0||||||
3683571|NCT02268058|3526763|B2|Canada||Region of Enrollment||participants|Number|20|20.0||||||
3683572|NCT02268058|3526764|B1|Canada||Region of Enrollment||participants|Number|20|20.0||||||
3683573|NCT02268058|3526760|B5||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3683574|NCT02268058|3526761|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3683575|NCT02268058|3526762|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3683576|NCT02268058|3526763|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3683577|NCT02268058|3526764|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3683578|NCT02268058|3526760|B5||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3683579|NCT02268058|3526761|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3683580|NCT02268058|3526762|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3683581|NCT02268058|3526763|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3683582|NCT02268058|3526764|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3683583|NCT02268058|3526760|B5|||Age||years|Mean|13.1|13.1|Standard Deviation|2.6|2.6|||
3683584|NCT02268058|3526761|B4|||Age||years|Mean|12.3|12.3|Standard Deviation|2.4|2.4|||
3683585|NCT02268058|3526762|B3|||Age||years|Mean|12.3|12.3|Standard Deviation|3.0|3.0|||
3683586|NCT02268058|3526763|B2|||Age||years|Mean|13.0|13.0|Standard Deviation|2.6|2.6|||
3683587|NCT02268058|3526764|B1|||Age||years|Mean|14.1|14.1|Standard Deviation|2.2|2.2|||
3683588|NCT02267850|3526789|B3|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3683589|NCT02267850|3526790|B2|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3683590|NCT02267850|3526791|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3683591|NCT02267850|3526789|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3683592|NCT02267850|3526789|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3683593|NCT02267850|3526790|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3683594|NCT02267850|3526791|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3683595|NCT02267850|3526789|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3683596|NCT02267850|3526790|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3683597|NCT02267850|3526791|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3683599|NCT02267850|3526790|B2|||Age||years|Mean|13.3|13.3|Standard Deviation|1.0|1.0|||
3683600|NCT02267850|3526791|B1|||Age||years|Mean|13.4|13.4|Standard Deviation|1.5|1.5|||
3683601|NCT02267837|3526798|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3683602|NCT02267837|3526799|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3683603|NCT02267837|3526800|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3683604|NCT02267837|3526798|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3683605|NCT02267837|3526799|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3683606|NCT02267837|3526800|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3683607|NCT02267837|3526798|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3683608|NCT02267837|3526799|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3683609|NCT02267837|3526800|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3683610|NCT02267837|3526798|B3|Age||Age, Customized||years|Mean|14.5|14.5|Standard Deviation|3.4|3.4|||
3683611|NCT02267837|3526799|B2|Age||Age, Customized||years|Mean|15.0|15.0|Standard Deviation|4.8|4.8|||
3683612|NCT02267837|3526800|B1|Age||Age, Customized||years|Mean|14.0|14.0|Standard Deviation|1.7|1.7|||
3683613|NCT02267824|3526807|B3|Thailand||Region of Enrollment||participants|Number|30|30.0||||||
3683614|NCT02267824|3526808|B2|Thailand||Region of Enrollment||participants|Number|9|9.0||||||
3683615|NCT02267824|3526809|B1|Thailand||Region of Enrollment||participants|Number|21|21.0||||||
3683616|NCT02267824|3526807|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
3683617|NCT02267824|3526808|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3683618|NCT02267824|3526809|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
3683619|NCT02267824|3526807|B3|Canada||Region of Enrollment||participants|Number|13|13.0||||||
3683620|NCT02267824|3526808|B2|Canada||Region of Enrollment||participants|Number|0|0.0||||||
3683621|NCT02267824|3526809|B1|Canada||Region of Enrollment||participants|Number|13|13.0||||||
3683622|NCT02267824|3526807|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3683623|NCT02267824|3526808|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3683624|NCT02267824|3526809|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3683625|NCT02267824|3526807|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3683626|NCT02267824|3526808|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3683627|NCT02267824|3526809|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3683628|NCT02267824|3526807|B3|Age||Age, Customized||years|Mean|18.3|18.3|Standard Deviation|7.1|7.1|||
3683629|NCT02267824|3526808|B2|Age||Age, Customized||years|Mean|19.5|19.5|Standard Deviation|7.4|7.4|||
3683630|NCT02267824|3526809|B1|Age||Age, Customized||years|Mean|18.0|18.0|Standard Deviation|7.0|7.0|||
3683631|NCT02267629|3526816|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683632|NCT02267629|3526816|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683633|NCT02267629|3526816|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3683634|NCT02267629|3526816|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683635|NCT02267629|3526816|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683636|NCT02267629|3526816|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683637|NCT02267629|3526816|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683638|NCT02267629|3526816|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683639|NCT02267629|3526816|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3683640|NCT02267629|3526816|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3683641|NCT02267629|3526816|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3683642|NCT02267629|3526816|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3683643|NCT02267629|3526816|B1|||Age||years|Mean|36|36.0|Standard Deviation|11|11.0|||
3683644|NCT02267538|3526821|B3|||Delirium||Participants|Count of Participants|0|0.0||||||
3683645|NCT02267538|3526822|B2|||Delirium||Participants|Count of Participants|0|0.0||||||
3683646|NCT02267538|3526823|B1|||Delirium||Participants|Count of Participants|0|0.0||||||
3683647|NCT02267538|3526821|B3|||Barthe Index(BI)score|The Barthel scale is an ordinal scale used to measure performance in activities of daily living (ADL). It uses ten variables describing ADL and mobility, which index range from 0 to 100, with higher score indicating better daily life activity and a greater likelihood of being able to live at home with a degree of independence following discharge from hospital.|units on a scale|Median|100|100.0|Inter-Quartile Range|||95.0|100.0|
3683648|NCT02267538|3526822|B2|||Barthe Index(BI)score|The Barthel scale is an ordinal scale used to measure performance in activities of daily living (ADL). It uses ten variables describing ADL and mobility, which index range from 0 to 100, with higher score indicating better daily life activity and a greater likelihood of being able to live at home with a degree of independence following discharge from hospital.|units on a scale|Median|100|100.0|Inter-Quartile Range|||95.0|100.0|
3683649|NCT02267538|3526823|B1|||Barthe Index(BI)score|The Barthel scale is an ordinal scale used to measure performance in activities of daily living (ADL). It uses ten variables describing ADL and mobility, which index range from 0 to 100, with higher score indicating better daily life activity and a greater likelihood of being able to live at home with a degree of independence following discharge from hospital.|units on a scale|Median|100|100.0|Inter-Quartile Range|||95.0|100.0|
3683695|NCT02267538|3526821|B3|||β-blocker||Participants|Count of Participants|129|129.0||||||
3683650|NCT02267538|3526821|B3|||Hospital Anxiety and Depression Scale score|"Hospital Anxiety and Depression Scale (HADS) is commonly used to determine the levels of anxiety and depression of the patient. The HADS is a fourteen item scale that generates ordinal data. Seven of the items relate to anxiety and seven relate to depression.~Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 and 21 for either anxiety or depression.~The HADS scores range from 0 to 42, with higher scores indicating more severe anxiety anddepression."|units on a scale|Median|8|8.0|Inter-Quartile Range|||4.0|12.0|
3683651|NCT02267538|3526822|B2|||Hospital Anxiety and Depression Scale score|"Hospital Anxiety and Depression Scale (HADS) is commonly used to determine the levels of anxiety and depression of the patient. The HADS is a fourteen item scale that generates ordinal data. Seven of the items relate to anxiety and seven relate to depression.~Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 and 21 for either anxiety or depression.~The HADS scores range from 0 to 42, with higher scores indicating more severe anxiety anddepression."|units on a scale|Median|8|8.0|Inter-Quartile Range|||4.0|12.0|
3683652|NCT02267538|3526823|B1|||Hospital Anxiety and Depression Scale score|"Hospital Anxiety and Depression Scale (HADS) is commonly used to determine the levels of anxiety and depression of the patient. The HADS is a fourteen item scale that generates ordinal data. Seven of the items relate to anxiety and seven relate to depression.~Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 and 21 for either anxiety or depression.~The HADS scores range from 0 to 42, with higher scores indicating more severe anxiety anddepression."|units on a scale|Median|8|8.0|Inter-Quartile Range|||4.0|12.0|
3683653|NCT02267538|3526821|B3|||Mini-Mental State Examination（MMSE）score|"The Mini–Mental State Examination (MMSE) is a questionnaire that is used extensively in clinical and research settings to measure cognitive impairment. It is used to estimate the severity and progression of cognitive impairment and to follow the course of cognitive changes in an individual over time.~Administration of the test takes between 5 and 10 minutes and examines functions including registration, attention and calculation, recall, language, ability to follow simple commands and orientation.~The MMSE scores range from 0 to 30, with higher scores indicating better cognitive function"|units on a scale|Median|29|29.0|Inter-Quartile Range|||28.0|30.0|
3683654|NCT02267538|3526822|B2|||Mini-Mental State Examination（MMSE）score|"The Mini–Mental State Examination (MMSE) is a questionnaire that is used extensively in clinical and research settings to measure cognitive impairment. It is used to estimate the severity and progression of cognitive impairment and to follow the course of cognitive changes in an individual over time.~Administration of the test takes between 5 and 10 minutes and examines functions including registration, attention and calculation, recall, language, ability to follow simple commands and orientation.~The MMSE scores range from 0 to 30, with higher scores indicating better cognitive function"|units on a scale|Median|29|29.0|Inter-Quartile Range|||28.0|30.0|
3683655|NCT02267538|3526823|B1|||Mini-Mental State Examination（MMSE）score|"The Mini–Mental State Examination (MMSE) is a questionnaire that is used extensively in clinical and research settings to measure cognitive impairment. It is used to estimate the severity and progression of cognitive impairment and to follow the course of cognitive changes in an individual over time.~Administration of the test takes between 5 and 10 minutes and examines functions including registration, attention and calculation, recall, language, ability to follow simple commands and orientation.~The MMSE scores range from 0 to 30, with higher scores indicating better cognitive function"|units on a scale|Median|29|29.0|Inter-Quartile Range|||28.0|30.0|
3683656|NCT02267538|3526821|B3||IV|the American Society of Anesthesiologists (ASA) Classification|"The ASA physical status classification system is a system for assessing the fitness of patients before surgery raised by the American Society of Anesthesiologists (ASA).~The ASA class has 6 levels. From Class 1 to Class 5, the comorbidity of the patient and the risk to surgery operation are both increased. Class 6 is specially scene indicating a brain-dead patient whose organs are being removed for donor purposes."|Participants|Count of Participants|25|25.0||||||
3683657|NCT02267538|3526822|B2||IV|the American Society of Anesthesiologists (ASA) Classification|"The ASA physical status classification system is a system for assessing the fitness of patients before surgery raised by the American Society of Anesthesiologists (ASA).~The ASA class has 6 levels. From Class 1 to Class 5, the comorbidity of the patient and the risk to surgery operation are both increased. Class 6 is specially scene indicating a brain-dead patient whose organs are being removed for donor purposes."|Participants|Count of Participants|12|12.0||||||
3683658|NCT02267538|3526823|B1||IV|the American Society of Anesthesiologists (ASA) Classification|"The ASA physical status classification system is a system for assessing the fitness of patients before surgery raised by the American Society of Anesthesiologists (ASA).~The ASA class has 6 levels. From Class 1 to Class 5, the comorbidity of the patient and the risk to surgery operation are both increased. Class 6 is specially scene indicating a brain-dead patient whose organs are being removed for donor purposes."|Participants|Count of Participants|13|13.0||||||
3683659|NCT02267538|3526821|B3||III|the American Society of Anesthesiologists (ASA) Classification|"The ASA physical status classification system is a system for assessing the fitness of patients before surgery raised by the American Society of Anesthesiologists (ASA).~The ASA class has 6 levels. From Class 1 to Class 5, the comorbidity of the patient and the risk to surgery operation are both increased. Class 6 is specially scene indicating a brain-dead patient whose organs are being removed for donor purposes."|Participants|Count of Participants|257|257.0||||||
3683660|NCT02267538|3526822|B2||III|the American Society of Anesthesiologists (ASA) Classification|"The ASA physical status classification system is a system for assessing the fitness of patients before surgery raised by the American Society of Anesthesiologists (ASA).~The ASA class has 6 levels. From Class 1 to Class 5, the comorbidity of the patient and the risk to surgery operation are both increased. Class 6 is specially scene indicating a brain-dead patient whose organs are being removed for donor purposes."|Participants|Count of Participants|129|129.0||||||
3683661|NCT02267538|3526823|B1||III|the American Society of Anesthesiologists (ASA) Classification|"The ASA physical status classification system is a system for assessing the fitness of patients before surgery raised by the American Society of Anesthesiologists (ASA).~The ASA class has 6 levels. From Class 1 to Class 5, the comorbidity of the patient and the risk to surgery operation are both increased. Class 6 is specially scene indicating a brain-dead patient whose organs are being removed for donor purposes."|Participants|Count of Participants|128|128.0||||||
3683696|NCT02267538|3526822|B2|||β-blocker||Participants|Count of Participants|66|66.0||||||
3683697|NCT02267538|3526823|B1|||β-blocker||Participants|Count of Participants|63|63.0||||||
3683662|NCT02267538|3526821|B3||II|the American Society of Anesthesiologists (ASA) Classification|"The ASA physical status classification system is a system for assessing the fitness of patients before surgery raised by the American Society of Anesthesiologists (ASA).~The ASA class has 6 levels. From Class 1 to Class 5, the comorbidity of the patient and the risk to surgery operation are both increased. Class 6 is specially scene indicating a brain-dead patient whose organs are being removed for donor purposes."|Participants|Count of Participants|3|3.0||||||
3683663|NCT02267538|3526822|B2||II|the American Society of Anesthesiologists (ASA) Classification|"The ASA physical status classification system is a system for assessing the fitness of patients before surgery raised by the American Society of Anesthesiologists (ASA).~The ASA class has 6 levels. From Class 1 to Class 5, the comorbidity of the patient and the risk to surgery operation are both increased. Class 6 is specially scene indicating a brain-dead patient whose organs are being removed for donor purposes."|Participants|Count of Participants|2|2.0||||||
3683664|NCT02267538|3526823|B1||II|the American Society of Anesthesiologists (ASA) Classification|"The ASA physical status classification system is a system for assessing the fitness of patients before surgery raised by the American Society of Anesthesiologists (ASA).~The ASA class has 6 levels. From Class 1 to Class 5, the comorbidity of the patient and the risk to surgery operation are both increased. Class 6 is specially scene indicating a brain-dead patient whose organs are being removed for donor purposes."|Participants|Count of Participants|1|1.0||||||
3683665|NCT02267538|3526821|B3|||left ventricular ejection fraction (LVEF)%|Left ventricular ejection fraction (LVEF) is the fraction of blood ejected from Left ventricle with each heart beat,which is calculated by dividing the stroke volume by the end-diastolic volume. In clinical practice, LVEF is most commonly measured by an echocardiogram and serves as a general measure of a person's cardiac function.|percentage|Median|64.7|64.7|Inter-Quartile Range|||57.0|70.6|
3683666|NCT02267538|3526822|B2|||left ventricular ejection fraction (LVEF)%|Left ventricular ejection fraction (LVEF) is the fraction of blood ejected from Left ventricle with each heart beat,which is calculated by dividing the stroke volume by the end-diastolic volume. In clinical practice, LVEF is most commonly measured by an echocardiogram and serves as a general measure of a person's cardiac function.|percentage|Median|64.8|64.8|Inter-Quartile Range|||58.2|70.6|
3683667|NCT02267538|3526823|B1|||left ventricular ejection fraction (LVEF)%|Left ventricular ejection fraction (LVEF) is the fraction of blood ejected from Left ventricle with each heart beat,which is calculated by dividing the stroke volume by the end-diastolic volume. In clinical practice, LVEF is most commonly measured by an echocardiogram and serves as a general measure of a person's cardiac function.|percentage|Median|64.4|64.4|Inter-Quartile Range|||56.2|70.4|
3683668|NCT02267538|3526821|B3||IV|New York Heart Association (NYHA) Functional Classification|"New York Heart Association (NYHA) Functional Classification provides a simple way of classifying the extent of heart failure. It has four categories based on the degree of limitation during physical activity,the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina.~From Class I to Class IV, the degree of heart failure is increased with more severe symptoms, for example, no shortness of breath when walking, climbing stairs occurs in patient of Class I while symptoms even exist while at rest in patient of Class IV."|Participants|Count of Participants|5|5.0||||||
3683669|NCT02267538|3526822|B2||IV|New York Heart Association (NYHA) Functional Classification|"New York Heart Association (NYHA) Functional Classification provides a simple way of classifying the extent of heart failure. It has four categories based on the degree of limitation during physical activity,the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina.~From Class I to Class IV, the degree of heart failure is increased with more severe symptoms, for example, no shortness of breath when walking, climbing stairs occurs in patient of Class I while symptoms even exist while at rest in patient of Class IV."|Participants|Count of Participants|2|2.0||||||
3683670|NCT02267538|3526823|B1||IV|New York Heart Association (NYHA) Functional Classification|"New York Heart Association (NYHA) Functional Classification provides a simple way of classifying the extent of heart failure. It has four categories based on the degree of limitation during physical activity,the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina.~From Class I to Class IV, the degree of heart failure is increased with more severe symptoms, for example, no shortness of breath when walking, climbing stairs occurs in patient of Class I while symptoms even exist while at rest in patient of Class IV."|Participants|Count of Participants|3|3.0||||||
3683671|NCT02267538|3526821|B3||III|New York Heart Association (NYHA) Functional Classification|"New York Heart Association (NYHA) Functional Classification provides a simple way of classifying the extent of heart failure. It has four categories based on the degree of limitation during physical activity,the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina.~From Class I to Class IV, the degree of heart failure is increased with more severe symptoms, for example, no shortness of breath when walking, climbing stairs occurs in patient of Class I while symptoms even exist while at rest in patient of Class IV."|Participants|Count of Participants|69|69.0||||||
3683672|NCT02267538|3526822|B2||III|New York Heart Association (NYHA) Functional Classification|"New York Heart Association (NYHA) Functional Classification provides a simple way of classifying the extent of heart failure. It has four categories based on the degree of limitation during physical activity,the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina.~From Class I to Class IV, the degree of heart failure is increased with more severe symptoms, for example, no shortness of breath when walking, climbing stairs occurs in patient of Class I while symptoms even exist while at rest in patient of Class IV."|Participants|Count of Participants|36|36.0||||||
3683673|NCT02267538|3526823|B1||III|New York Heart Association (NYHA) Functional Classification|"New York Heart Association (NYHA) Functional Classification provides a simple way of classifying the extent of heart failure. It has four categories based on the degree of limitation during physical activity,the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina.~From Class I to Class IV, the degree of heart failure is increased with more severe symptoms, for example, no shortness of breath when walking, climbing stairs occurs in patient of Class I while symptoms even exist while at rest in patient of Class IV."|Participants|Count of Participants|33|33.0||||||
3683698|NCT02267538|3526821|B3|||Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers||Participants|Count of Participants|96|96.0||||||
3683760|NCT02267447|3526844|B1|Male||Age||years|Median|46.0|46.0|Inter-Quartile Range|||35.0|59.0|
3683674|NCT02267538|3526821|B3||II|New York Heart Association (NYHA) Functional Classification|"New York Heart Association (NYHA) Functional Classification provides a simple way of classifying the extent of heart failure. It has four categories based on the degree of limitation during physical activity,the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina.~From Class I to Class IV, the degree of heart failure is increased with more severe symptoms, for example, no shortness of breath when walking, climbing stairs occurs in patient of Class I while symptoms even exist while at rest in patient of Class IV."|Participants|Count of Participants|179|179.0||||||
3683675|NCT02267538|3526822|B2||II|New York Heart Association (NYHA) Functional Classification|"New York Heart Association (NYHA) Functional Classification provides a simple way of classifying the extent of heart failure. It has four categories based on the degree of limitation during physical activity,the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina.~From Class I to Class IV, the degree of heart failure is increased with more severe symptoms, for example, no shortness of breath when walking, climbing stairs occurs in patient of Class I while symptoms even exist while at rest in patient of Class IV."|Participants|Count of Participants|92|92.0||||||
3683676|NCT02267538|3526823|B1||II|New York Heart Association (NYHA) Functional Classification|"New York Heart Association (NYHA) Functional Classification provides a simple way of classifying the extent of heart failure. It has four categories based on the degree of limitation during physical activity,the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina.~From Class I to Class IV, the degree of heart failure is increased with more severe symptoms, for example, no shortness of breath when walking, climbing stairs occurs in patient of Class I while symptoms even exist while at rest in patient of Class IV."|Participants|Count of Participants|87|87.0||||||
3683677|NCT02267538|3526821|B3||I|New York Heart Association (NYHA) Functional Classification|"New York Heart Association (NYHA) Functional Classification provides a simple way of classifying the extent of heart failure. It has four categories based on the degree of limitation during physical activity,the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina.~From Class I to Class IV, the degree of heart failure is increased with more severe symptoms, for example, no shortness of breath when walking, climbing stairs occurs in patient of Class I while symptoms even exist while at rest in patient of Class IV."|Participants|Count of Participants|4|4.0||||||
3683678|NCT02267538|3526822|B2||I|New York Heart Association (NYHA) Functional Classification|"New York Heart Association (NYHA) Functional Classification provides a simple way of classifying the extent of heart failure. It has four categories based on the degree of limitation during physical activity,the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina.~From Class I to Class IV, the degree of heart failure is increased with more severe symptoms, for example, no shortness of breath when walking, climbing stairs occurs in patient of Class I while symptoms even exist while at rest in patient of Class IV."|Participants|Count of Participants|2|2.0||||||
3683679|NCT02267538|3526823|B1||I|New York Heart Association (NYHA) Functional Classification|"New York Heart Association (NYHA) Functional Classification provides a simple way of classifying the extent of heart failure. It has four categories based on the degree of limitation during physical activity,the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina.~From Class I to Class IV, the degree of heart failure is increased with more severe symptoms, for example, no shortness of breath when walking, climbing stairs occurs in patient of Class I while symptoms even exist while at rest in patient of Class IV."|Participants|Count of Participants|2|2.0||||||
3683680|NCT02267538|3526821|B3|||History of general anesthesia||Participants|Count of Participants|48|48.0||||||
3683681|NCT02267538|3526822|B2|||History of general anesthesia||Participants|Count of Participants|24|24.0||||||
3683682|NCT02267538|3526823|B1|||History of general anesthesia||Participants|Count of Participants|24|24.0||||||
3683683|NCT02267538|3526821|B3|||History of surgery||Participants|Count of Participants|107|107.0||||||
3683684|NCT02267538|3526822|B2|||History of surgery||Participants|Count of Participants|52|52.0||||||
3683685|NCT02267538|3526823|B1|||History of surgery||Participants|Count of Participants|55|55.0||||||
3683686|NCT02267538|3526821|B3|||European System for Cardiac Operative Risk Evaluation|"European System for Cardiac Operative Risk Evaluation is a risk model which allows the calculation of the risk of death after a heart operation.~The model asks for 17 items of information about the patient, the state of the heart and the proposed operation,and uses logistic regression to calculate the risk of death.~The minimum score is 0 indicating the lowest risk of death after sugery while the maximum score is 35 indicating the highest risk of death after the heart operation"|units on a scale|Median|3|3.0|Inter-Quartile Range|||2.0|5.0|
3683687|NCT02267538|3526822|B2|||European System for Cardiac Operative Risk Evaluation|"European System for Cardiac Operative Risk Evaluation is a risk model which allows the calculation of the risk of death after a heart operation.~The model asks for 17 items of information about the patient, the state of the heart and the proposed operation,and uses logistic regression to calculate the risk of death.~The minimum score is 0 indicating the lowest risk of death after sugery while the maximum score is 35 indicating the highest risk of death after the heart operation"|units on a scale|Median|3|3.0|Inter-Quartile Range|||2.0|5.0|
3683688|NCT02267538|3526823|B1|||European System for Cardiac Operative Risk Evaluation|"European System for Cardiac Operative Risk Evaluation is a risk model which allows the calculation of the risk of death after a heart operation.~The model asks for 17 items of information about the patient, the state of the heart and the proposed operation,and uses logistic regression to calculate the risk of death.~The minimum score is 0 indicating the lowest risk of death after sugery while the maximum score is 35 indicating the highest risk of death after the heart operation"|units on a scale|Median|3|3.0|Inter-Quartile Range|||2.0|5.0|
3683689|NCT02267538|3526821|B3|||Antiplatelet drugs||Participants|Count of Participants|167|167.0||||||
3683690|NCT02267538|3526822|B2|||Antiplatelet drugs||Participants|Count of Participants|82|82.0||||||
3683691|NCT02267538|3526823|B1|||Antiplatelet drugs||Participants|Count of Participants|85|85.0||||||
3683692|NCT02267538|3526821|B3|||Statins||Participants|Count of Participants|138|138.0||||||
3683693|NCT02267538|3526822|B2|||Statins||Participants|Count of Participants|75|75.0||||||
3683694|NCT02267538|3526823|B1|||Statins||Participants|Count of Participants|63|63.0||||||
3683699|NCT02267538|3526822|B2|||Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers||Participants|Count of Participants|46|46.0||||||
3683700|NCT02267538|3526823|B1|||Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers||Participants|Count of Participants|50|50.0||||||
3683701|NCT02267538|3526821|B3|||Calcium Channel Blocker||Participants|Count of Participants|78|78.0||||||
3683702|NCT02267538|3526822|B2|||Calcium Channel Blocker||Participants|Count of Participants|45|45.0||||||
3683703|NCT02267538|3526823|B1|||Calcium Channel Blocker||Participants|Count of Participants|33|33.0||||||
3683704|NCT02267538|3526821|B3|||Acute myocardial infarction||Participants|Count of Participants|28|28.0||||||
3683705|NCT02267538|3526822|B2|||Acute myocardial infarction||Participants|Count of Participants|11|11.0||||||
3683706|NCT02267538|3526823|B1|||Acute myocardial infarction||Participants|Count of Participants|17|17.0||||||
3683707|NCT02267538|3526821|B3|||Smoking||Participants|Count of Participants|117|117.0||||||
3683708|NCT02267538|3526822|B2|||Smoking||Participants|Count of Participants|66|66.0||||||
3683709|NCT02267538|3526823|B1|||Smoking||Participants|Count of Participants|51|51.0||||||
3683710|NCT02267538|3526821|B3|||Thyroid disease||Participants|Count of Participants|7|7.0||||||
3683711|NCT02267538|3526822|B2|||Thyroid disease||Participants|Count of Participants|3|3.0||||||
3683712|NCT02267538|3526823|B1|||Thyroid disease||Participants|Count of Participants|4|4.0||||||
3683713|NCT02267538|3526821|B3|||Tumor||Participants|Count of Participants|10|10.0||||||
3683714|NCT02267538|3526822|B2|||Tumor||Participants|Count of Participants|3|3.0||||||
3683715|NCT02267538|3526823|B1|||Tumor||Participants|Count of Participants|7|7.0||||||
3683716|NCT02267538|3526821|B3|||Chronic kidney disease||Participants|Count of Participants|8|8.0||||||
3683717|NCT02267538|3526822|B2|||Chronic kidney disease||Participants|Count of Participants|7|7.0||||||
3683718|NCT02267538|3526823|B1|||Chronic kidney disease||Participants|Count of Participants|1|1.0||||||
3683719|NCT02267538|3526821|B3|||Hyperlipidemia||Participants|Count of Participants|99|99.0||||||
3683720|NCT02267538|3526822|B2|||Hyperlipidemia||Participants|Count of Participants|61|61.0||||||
3683721|NCT02267538|3526823|B1|||Hyperlipidemia||Participants|Count of Participants|38|38.0||||||
3683722|NCT02267538|3526821|B3|||Diabetes Mellitus||Participants|Count of Participants|92|92.0||||||
3683723|NCT02267538|3526822|B2|||Diabetes Mellitus||Participants|Count of Participants|49|49.0||||||
3683724|NCT02267538|3526823|B1|||Diabetes Mellitus||Participants|Count of Participants|43|43.0||||||
3683725|NCT02267538|3526821|B3|||Chronic Obstructive Ppulmonary Disease||Participants|Count of Participants|11|11.0||||||
3683726|NCT02267538|3526822|B2|||Chronic Obstructive Ppulmonary Disease||Participants|Count of Participants|4|4.0||||||
3683727|NCT02267538|3526823|B1|||Chronic Obstructive Ppulmonary Disease||Participants|Count of Participants|7|7.0||||||
3683728|NCT02267538|3526821|B3|||Stroke||Participants|Count of Participants|59|59.0||||||
3683729|NCT02267538|3526822|B2|||Stroke||Participants|Count of Participants|33|33.0||||||
3683730|NCT02267538|3526823|B1|||Stroke||Participants|Count of Participants|26|26.0||||||
3683731|NCT02267538|3526821|B3|||Arrhythmia||Participants|Count of Participants|61|61.0||||||
3683732|NCT02267538|3526822|B2|||Arrhythmia||Participants|Count of Participants|29|29.0||||||
3683733|NCT02267538|3526823|B1|||Arrhythmia||Participants|Count of Participants|32|32.0||||||
3683734|NCT02267538|3526821|B3|||Hypertension||Participants|Count of Participants|180|180.0||||||
3683735|NCT02267538|3526822|B2|||Hypertension||Participants|Count of Participants|91|91.0||||||
3683736|NCT02267538|3526823|B1|||Hypertension||Participants|Count of Participants|89|89.0||||||
3683737|NCT02267538|3526821|B3|||Education (year)||years|Median|9|9.0|Inter-Quartile Range|||5.0|12.0|
3683738|NCT02267538|3526822|B2|||Education (year)||years|Median|9|9.0|Inter-Quartile Range|||5.0|10.0|
3683739|NCT02267538|3526823|B1|||Education (year)||years|Median|9|9.0|Inter-Quartile Range|||5.0|12.0|
3683740|NCT02267538|3526821|B3|||"Body Mass Index kg/m^2"||kg/m^2|Mean|25.1|25.1|Standard Deviation|3.1|3.1|||
3683741|NCT02267538|3526822|B2|||"Body Mass Index kg/m^2"||kg/m^2|Mean|24.9|24.9|Standard Deviation|2.8|2.8|||
3683742|NCT02267538|3526823|B1|||"Body Mass Index kg/m^2"||kg/m^2|Mean|25.3|25.3|Standard Deviation|3.4|3.4|||
3683743|NCT02267538|3526821|B3||Male|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
3683744|NCT02267538|3526822|B2||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3683745|NCT02267538|3526823|B1||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3683746|NCT02267538|3526821|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3683747|NCT02267538|3526822|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3683748|NCT02267538|3526823|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3683749|NCT02267538|3526821|B3|||Age||years|Mean|66.9|66.9|Standard Deviation|5.4|5.4|||
3683750|NCT02267538|3526822|B2|||Age||years|Mean|67.5|67.5|Standard Deviation|5.3|5.3|||
3683751|NCT02267538|3526823|B1|||Age||years|Mean|66.4|66.4|Standard Deviation|5.4|5.4|||
3683752|NCT02267447|3526842|B3||Male|Sex: Female, Male||Participants|Count of Participants|47233|47233.0||||||
3683753|NCT02267447|3526843|B2||Male|Sex: Female, Male||Participants|Count of Participants|12167|12167.0||||||
3683754|NCT02267447|3526844|B1||Male|Sex: Female, Male||Participants|Count of Participants|35066|35066.0||||||
3683755|NCT02267447|3526842|B3||Female|Sex: Female, Male||Participants|Count of Participants|56986|56986.0||||||
3683756|NCT02267447|3526843|B2||Female|Sex: Female, Male||Participants|Count of Participants|14801|14801.0||||||
3683757|NCT02267447|3526844|B1||Female|Sex: Female, Male||Participants|Count of Participants|42185|42185.0||||||
3683758|NCT02267447|3526842|B3|Male||Age||years|Median|47.0|47.0|Inter-Quartile Range|||35.0|61.0|
3683759|NCT02267447|3526843|B2|Male||Age||years|Median|48.0|48.0|Inter-Quartile Range|||35.0|63.0|
3683761|NCT02267447|3526842|B3|Female||Age||years|Median|49.5|49.5|Inter-Quartile Range|||36.0|63.5|
3683762|NCT02267447|3526843|B2|Female||Age||years|Median|51.0|51.0|Inter-Quartile Range|||37.0|64.0|
3683763|NCT02267447|3526844|B1|Female||Age||years|Median|48.0|48.0|Inter-Quartile Range|||35.0|63.0|
3683764|NCT02267187|3526853|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3683765|NCT02267187|3526853|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683766|NCT02267187|3526853|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683767|NCT02267187|3526853|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3683768|NCT02267187|3526853|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683769|NCT02267187|3526853|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683770|NCT02267187|3526853|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683771|NCT02267187|3526853|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683772|NCT02267187|3526853|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3683773|NCT02267187|3526853|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3683774|NCT02267187|3526853|B1|||Age||years|Mean|46.2|46.2|Standard Deviation|13.3|13.3|||
3683775|NCT02267135|3526859|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3683776|NCT02267135|3526860|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3683777|NCT02267135|3526861|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3683778|NCT02267135|3526859|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3683779|NCT02267135|3526860|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3683780|NCT02267135|3526861|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3683781|NCT02267135|3526859|B3|Mean||Age, Customized||Age (years)|Mean|41.9|41.9|Standard Deviation|13.74|13.74|18.0|69.0|
3683782|NCT02267135|3526860|B2|Mean||Age, Customized||Age (years)|Mean|41.1|41.1|Standard Deviation|14.17|14.17|18.0|69.0|
3683783|NCT02267135|3526861|B1|Mean||Age, Customized||Age (years)|Mean|42.7|42.7|Standard Deviation|13.39|13.39|19.0|68.0|
3683784|NCT02267083|3526893|B1|United States||Region of Enrollment|Subjects diagnosed with advanced and/or metastatic soft tissue sarcoma of intermediate or high histologic grade.|participants|Number|22|22.0||||||
3683785|NCT02267083|3526893|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3683786|NCT02267083|3526893|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3683787|NCT02267083|3526893|B1|||Age||years|Mean|59.4|59.4|Standard Deviation|13.6|13.6|||
3683788|NCT02266875|3526900|B3|||Pre-treatment Score: Modified Borg Dyspnea Scale|"This is a patient-reported scale to rate the difficulty of breathing. The scale ranges from 0 to 10, wherein 0 indicates no difficulty breathing, and 10 indicates a maximal difficulty in breathing.~Patients may report in whole numbers, from 0 to 10, in addition to reporting 0.5, which indicates very, very slight (just noticeable) difficulty in breathing."|units on a scale|Mean|4.8|4.8|Standard Deviation|2.0|2.0|||
3683789|NCT02266875|3526901|B2|||Pre-treatment Score: Modified Borg Dyspnea Scale|"This is a patient-reported scale to rate the difficulty of breathing. The scale ranges from 0 to 10, wherein 0 indicates no difficulty breathing, and 10 indicates a maximal difficulty in breathing.~Patients may report in whole numbers, from 0 to 10, in addition to reporting 0.5, which indicates very, very slight (just noticeable) difficulty in breathing."|units on a scale|Mean|4.4|4.4|Standard Deviation|2.2|2.2|||
3683790|NCT02266875|3526902|B1|||Pre-treatment Score: Modified Borg Dyspnea Scale|"This is a patient-reported scale to rate the difficulty of breathing. The scale ranges from 0 to 10, wherein 0 indicates no difficulty breathing, and 10 indicates a maximal difficulty in breathing.~Patients may report in whole numbers, from 0 to 10, in addition to reporting 0.5, which indicates very, very slight (just noticeable) difficulty in breathing."|units on a scale|Mean|5.1|5.1|Standard Deviation|1.6|1.6|||
3683791|NCT02266875|3526900|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3683792|NCT02266875|3526900|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3683793|NCT02266875|3526901|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3683794|NCT02266875|3526902|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3683795|NCT02266875|3526900|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3683796|NCT02266875|3526901|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3683797|NCT02266875|3526902|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3683798|NCT02266875|3526900|B3|||Age||years|Mean|61.2|61.2|Standard Deviation|9.3|9.3|||
3683799|NCT02266875|3526901|B2|||Age||years|Mean|63.3|63.3|Standard Deviation|9.8|9.8|||
3683800|NCT02266875|3526902|B1|||Age||years|Mean|58.9|58.9|Standard Deviation|8.4|8.4|||
3683801|NCT02266810|3526913|B3|United States||Region of Enrollment||participants|Number|160|160.0||||||
3683802|NCT02266810|3526914|B2|United States||Region of Enrollment||participants|Number|80|80.0||||||
3683803|NCT02266810|3526915|B1|United States||Region of Enrollment||participants|Number|80|80.0||||||
3683804|NCT02266810|3526913|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3683805|NCT02266810|3526914|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3683806|NCT02266810|3526915|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683807|NCT02266810|3526913|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683808|NCT02266810|3526914|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683809|NCT02266810|3526915|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683810|NCT02266810|3526913|B3||White|Race (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
3683811|NCT02266810|3526914|B2||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3683812|NCT02266810|3526915|B1||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3683813|NCT02266810|3526913|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3683814|NCT02266810|3526914|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3683815|NCT02266810|3526915|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3683816|NCT02266810|3526913|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683817|NCT02266810|3526914|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683818|NCT02266810|3526915|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683819|NCT02266810|3526913|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3683820|NCT02266810|3526914|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3683821|NCT02266810|3526915|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3683822|NCT02266810|3526913|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683823|NCT02266810|3526914|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683824|NCT02266810|3526915|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683825|NCT02266810|3526913|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683826|NCT02266810|3526914|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683827|NCT02266810|3526915|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683828|NCT02266810|3526913|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|157|157.0||||||
3683829|NCT02266810|3526914|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3683830|NCT02266810|3526915|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3683831|NCT02266810|3526913|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3683832|NCT02266810|3526914|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3683833|NCT02266810|3526915|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683834|NCT02266810|3526913|B3||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3683835|NCT02266810|3526914|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3683836|NCT02266810|3526915|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3683837|NCT02266810|3526913|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3683838|NCT02266810|3526914|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3683839|NCT02266810|3526915|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3683840|NCT02266810|3526913|B3|||Age||years|Mean|49.7|49.7|Standard Deviation|13.6|13.6|||
3683841|NCT02266810|3526914|B2|||Age||years|Mean|49.5|49.5|Standard Deviation|13.36|13.36|||
3683842|NCT02266810|3526915|B1|||Age||years|Mean|49.9|49.9|Standard Deviation|13.91|13.91|||
3683843|NCT02266797|3526940|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3683844|NCT02266797|3526941|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3683845|NCT02266797|3526942|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3683846|NCT02266797|3526940|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3683847|NCT02266797|3526941|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3683848|NCT02266797|3526942|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3683849|NCT02266797|3526940|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3683850|NCT02266797|3526941|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3683851|NCT02266797|3526942|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3683852|NCT02266797|3526940|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3683853|NCT02266797|3526941|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3683854|NCT02266797|3526942|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3683855|NCT02266797|3526940|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3683856|NCT02266797|3526941|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3683857|NCT02266797|3526942|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3683858|NCT02266797|3526940|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3683859|NCT02266797|3526941|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3683860|NCT02266797|3526942|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3683861|NCT02266472|3526959|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3683862|NCT02266472|3526960|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3683863|NCT02266472|3526961|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3683864|NCT02266472|3526959|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3683865|NCT02266472|3526960|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3683866|NCT02266472|3526961|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3683867|NCT02266472|3526959|B3|||Age||years|Mean|33.6|33.6|Standard Deviation|9.0|9.0|||
3683868|NCT02266472|3526960|B2|||Age||years|Mean|33.7|33.7|Standard Deviation|10.1|10.1|||
3683869|NCT02266472|3526961|B1|||Age||years|Mean|33.5|33.5|Standard Deviation|8.1|8.1|||
3683870|NCT02266381|3526978|B4|China||Region of Enrollment||participants|Number|438|438.0||||||
3683871|NCT02266381|3526979|B3|China||Region of Enrollment||participants|Number|146|146.0||||||
3683872|NCT02266381|3526980|B2|China||Region of Enrollment||participants|Number|145|145.0||||||
3683873|NCT02266381|3526981|B1|China||Region of Enrollment||participants|Number|147|147.0||||||
3683874|NCT02266381|3526978|B4||Male|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
3683875|NCT02266381|3526979|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3683876|NCT02266381|3526980|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3683877|NCT02266381|3526981|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3683878|NCT02266381|3526978|B4||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
3683879|NCT02266381|3526979|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3683880|NCT02266381|3526980|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3683881|NCT02266381|3526981|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3683882|NCT02266381|3526978|B4|||Age||years|Mean|49.4|49.4|Standard Deviation|11.1|11.1|||
3683883|NCT02266381|3526979|B3|||Age||years|Mean|48.8|48.8|Standard Deviation|11.3|11.3|||
3683884|NCT02266381|3526980|B2|||Age||years|Mean|49.6|49.6|Standard Deviation|11.3|11.3|||
3683885|NCT02266381|3526981|B1|||Age||years|Mean|49.9|49.9|Standard Deviation|10.9|10.9|||
3683886|NCT02266277|3527000|B7|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|3685|3685.0||||||
3683887|NCT02266277|3527001|B6|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|855|855.0||||||
3683888|NCT02266277|3527002|B5|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|920|920.0||||||
3683889|NCT02266277|3527003|B4|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|467|467.0||||||
3683890|NCT02266277|3527004|B3|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|496|496.0||||||
3683891|NCT02266277|3527005|B2|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|466|466.0||||||
3683892|NCT02266277|3527006|B1|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|481|481.0||||||
3683893|NCT02266277|3527000|B7|Other||Race/Ethnicity, Customized||Participants|Count of Participants|622|622.0||||||
3683894|NCT02266277|3527001|B6|Other||Race/Ethnicity, Customized||Participants|Count of Participants|161|161.0||||||
3683895|NCT02266277|3527002|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|138|138.0||||||
3683896|NCT02266277|3527003|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|84|84.0||||||
3683897|NCT02266277|3527004|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|81|81.0||||||
3683898|NCT02266277|3527005|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|72|72.0||||||
3683899|NCT02266277|3527006|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|86|86.0||||||
3683900|NCT02266277|3527000|B7|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1312|1312.0||||||
3683901|NCT02266277|3527001|B6|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|200|200.0||||||
3683902|NCT02266277|3527002|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|189|189.0||||||
3683903|NCT02266277|3527003|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|211|211.0||||||
3683904|NCT02266277|3527004|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|248|248.0||||||
3683905|NCT02266277|3527005|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|212|212.0||||||
3683906|NCT02266277|3527006|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|252|252.0||||||
3683907|NCT02266277|3527000|B7|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1025|1025.0||||||
3683908|NCT02266277|3527001|B6|Black||Race/Ethnicity, Customized||Participants|Count of Participants|230|230.0||||||
3683909|NCT02266277|3527002|B5|Black||Race/Ethnicity, Customized||Participants|Count of Participants|234|234.0||||||
3683910|NCT02266277|3527003|B4|Black||Race/Ethnicity, Customized||Participants|Count of Participants|113|113.0||||||
3683911|NCT02266277|3527004|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|153|153.0||||||
3683912|NCT02266277|3527005|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|145|145.0||||||
3683913|NCT02266277|3527006|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|150|150.0||||||
3683914|NCT02266277|3527000|B7|White||Race/Ethnicity, Customized||Participants|Count of Participants|23356|23356.0||||||
3683915|NCT02266277|3527001|B6|White||Race/Ethnicity, Customized||Participants|Count of Participants|3554|3554.0||||||
3683916|NCT02266277|3527002|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|3519|3519.0||||||
3683917|NCT02266277|3527003|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|4125|4125.0||||||
3683918|NCT02266277|3527004|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|4022|4022.0||||||
3683919|NCT02266277|3527005|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|4105|4105.0||||||
3683920|NCT02266277|3527006|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|4031|4031.0||||||
3683921|NCT02266277|3527000|B7||Male|Sex: Female, Male||Participants|Count of Participants|12384|12384.0||||||
3683922|NCT02266277|3527001|B6||Male|Sex: Female, Male||Participants|Count of Participants|2469|2469.0||||||
3683923|NCT02266277|3527002|B5||Male|Sex: Female, Male||Participants|Count of Participants|2503|2503.0||||||
3683924|NCT02266277|3527003|B4||Male|Sex: Female, Male||Participants|Count of Participants|1868|1868.0||||||
3683925|NCT02266277|3527004|B3||Male|Sex: Female, Male||Participants|Count of Participants|1834|1834.0||||||
3683926|NCT02266277|3527005|B2||Male|Sex: Female, Male||Participants|Count of Participants|1821|1821.0||||||
3683927|NCT02266277|3527006|B1||Male|Sex: Female, Male||Participants|Count of Participants|1889|1889.0||||||
3683928|NCT02266277|3527000|B7||Female|Sex: Female, Male||Participants|Count of Participants|17616|17616.0||||||
3683929|NCT02266277|3527001|B6||Female|Sex: Female, Male||Participants|Count of Participants|2531|2531.0||||||
3683930|NCT02266277|3527002|B5||Female|Sex: Female, Male||Participants|Count of Participants|2497|2497.0||||||
3683931|NCT02266277|3527003|B4||Female|Sex: Female, Male||Participants|Count of Participants|3132|3132.0||||||
3683932|NCT02266277|3527004|B3||Female|Sex: Female, Male||Participants|Count of Participants|3166|3166.0||||||
3683933|NCT02266277|3527005|B2||Female|Sex: Female, Male||Participants|Count of Participants|3179|3179.0||||||
3683934|NCT02266277|3527006|B1||Female|Sex: Female, Male||Participants|Count of Participants|3111|3111.0||||||
3683935|NCT02266277|3527000|B7||>=65 years|Age||Participants|Count of Participants|3754|3754.0||||||
3683936|NCT02266277|3527001|B6||>=65 years|Age||Participants|Count of Participants|697|697.0||||||
3683937|NCT02266277|3527002|B5||>=65 years|Age||Participants|Count of Participants|680|680.0||||||
3683938|NCT02266277|3527003|B4||>=65 years|Age||Participants|Count of Participants|640|640.0||||||
3683939|NCT02266277|3527004|B3||>=65 years|Age||Participants|Count of Participants|597|597.0||||||
3683940|NCT02266277|3527005|B2||>=65 years|Age||Participants|Count of Participants|584|584.0||||||
3683941|NCT02266277|3527006|B1||>=65 years|Age||Participants|Count of Participants|556|556.0||||||
3683942|NCT02266277|3527000|B7||Between 18 and 65 years|Age||Participants|Count of Participants|26246|26246.0||||||
3683943|NCT02266277|3527001|B6||Between 18 and 65 years|Age||Participants|Count of Participants|4303|4303.0||||||
3683944|NCT02266277|3527002|B5||Between 18 and 65 years|Age||Participants|Count of Participants|4320|4320.0||||||
3683945|NCT02266277|3527003|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4360|4360.0||||||
3683946|NCT02266277|3527004|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4403|4403.0||||||
3683947|NCT02266277|3527005|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4416|4416.0||||||
3683948|NCT02266277|3527006|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4444|4444.0||||||
3683949|NCT02266277|3527000|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3683950|NCT02266277|3527001|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3683951|NCT02266277|3527002|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3683952|NCT02266277|3527003|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3683953|NCT02266277|3527004|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3683954|NCT02266277|3527005|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3683955|NCT02266277|3527006|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3683956|NCT02265848|3527033|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
3683957|NCT02265848|3527034|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3683958|NCT02265848|3527035|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3683959|NCT02265848|3527033|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683960|NCT02265848|3527034|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683961|NCT02265848|3527035|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683962|NCT02265848|3527033|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683963|NCT02265848|3527034|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683964|NCT02265848|3527035|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683965|NCT02265848|3527033|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3683966|NCT02265848|3527034|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3683967|NCT02265848|3527035|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3683968|NCT02265848|3527033|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3683969|NCT02265848|3527034|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3683970|NCT02265848|3527035|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3683971|NCT02265848|3527033|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683972|NCT02265848|3527034|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683973|NCT02265848|3527035|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683974|NCT02265848|3527033|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683975|NCT02265848|3527034|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683976|NCT02265848|3527035|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683977|NCT02265848|3527033|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683978|NCT02265848|3527034|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683979|NCT02265848|3527035|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683980|NCT02265848|3527033|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683981|NCT02265848|3527034|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683982|NCT02265848|3527035|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683983|NCT02265848|3527033|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3683984|NCT02265848|3527034|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3683985|NCT02265848|3527035|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3683986|NCT02265848|3527033|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683987|NCT02265848|3527034|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683988|NCT02265848|3527035|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3683989|NCT02265848|3527033|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3683990|NCT02265848|3527034|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3683991|NCT02265848|3527035|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3683992|NCT02265848|3527033|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3683993|NCT02265848|3527034|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3683994|NCT02265848|3527035|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3683995|NCT02265848|3527033|B3|||Age||years|Mean|57|57.0|Full Range|||36.0|75.0|
3683996|NCT02265848|3527034|B2|||Age||years|Mean|56|56.0|Full Range|||36.0|72.0|
3683997|NCT02265848|3527035|B1|||Age||years|Mean|59|59.0|Full Range|||45.0|75.0|
3683998|NCT02265848|3527033|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3683999|NCT02265848|3527034|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3684000|NCT02265848|3527035|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3684001|NCT02265848|3527033|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3684002|NCT02265848|3527034|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3684003|NCT02265848|3527035|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3684004|NCT02265848|3527033|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3684005|NCT02265848|3527034|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3684006|NCT02265848|3527035|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3684007|NCT02265796|3527048|B3|||history of Coronary Artery Bypass Graft surgery||Participants|Count of Participants|14|14.0||||||
3684008|NCT02265796|3527049|B2|||history of Coronary Artery Bypass Graft surgery||Participants|Count of Participants|6|6.0||||||
3684009|NCT02265796|3527050|B1|||history of Coronary Artery Bypass Graft surgery||Participants|Count of Participants|8|8.0||||||
3684010|NCT02265796|3527048|B3|||history of Percutaneous Coronary Intervention||Participants|Count of Participants|33|33.0||||||
3684011|NCT02265796|3527049|B2|||history of Percutaneous Coronary Intervention||Participants|Count of Participants|14|14.0||||||
3684012|NCT02265796|3527050|B1|||history of Percutaneous Coronary Intervention||Participants|Count of Participants|19|19.0||||||
3684013|NCT02265796|3527048|B3|||on Insulin||Participants|Count of Participants|12|12.0||||||
3684014|NCT02265796|3527049|B2|||on Insulin||Participants|Count of Participants|7|7.0||||||
3684015|NCT02265796|3527050|B1|||on Insulin||Participants|Count of Participants|5|5.0||||||
3684016|NCT02265796|3527048|B3|||Diabetes mellitus||Participants|Count of Participants|30|30.0||||||
3684017|NCT02265796|3527049|B2|||Diabetes mellitus||Participants|Count of Participants|16|16.0||||||
3684018|NCT02265796|3527050|B1|||Diabetes mellitus||Participants|Count of Participants|14|14.0||||||
3684019|NCT02265796|3527048|B3|||Hyperlipidemia||Participants|Count of Participants|33|33.0||||||
3684020|NCT02265796|3527049|B2|||Hyperlipidemia||Participants|Count of Participants|17|17.0||||||
3684021|NCT02265796|3527050|B1|||Hyperlipidemia||Participants|Count of Participants|16|16.0||||||
3684022|NCT02265796|3527048|B3|||Hypertension||Participants|Count of Participants|50|50.0||||||
3684023|NCT02265796|3527049|B2|||Hypertension||Participants|Count of Participants|25|25.0||||||
3684024|NCT02265796|3527050|B1|||Hypertension||Participants|Count of Participants|25|25.0||||||
3684025|NCT02265796|3527048|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3684026|NCT02265796|3527049|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3684027|NCT02265796|3527050|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3684028|NCT02265796|3527048|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3684029|NCT02265796|3527049|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3684030|NCT02265796|3527050|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3684031|NCT02265796|3527048|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3684032|NCT02265796|3527049|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3684033|NCT02265796|3527050|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3684034|NCT02265796|3527048|B3||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
3684035|NCT02265796|3527049|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3684036|NCT02265796|3527050|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3684037|NCT02265796|3527048|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3684038|NCT02265796|3527049|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3684039|NCT02265796|3527050|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3684040|NCT02265796|3527048|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3684041|NCT02265796|3527049|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3684042|NCT02265796|3527050|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3684043|NCT02265783|3527061|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3684044|NCT02265783|3527061|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684045|NCT02265783|3527061|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684046|NCT02265783|3527061|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3684047|NCT02265783|3527061|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3684048|NCT02265783|3527061|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684049|NCT02265783|3527061|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3684050|NCT02265783|3527061|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684051|NCT02265783|3527061|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3684052|NCT02265783|3527061|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3684053|NCT02265783|3527061|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3684054|NCT02265783|3527061|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3684055|NCT02265783|3527061|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3684056|NCT02265237|3527065|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684057|NCT02265237|3527066|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684058|NCT02265237|3527067|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684059|NCT02265237|3527068|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684060|NCT02265237|3527069|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684061|NCT02265237|3527065|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|175|175.0||||||
3684062|NCT02265237|3527066|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3684063|NCT02265237|3527067|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3684064|NCT02265237|3527068|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3684065|NCT02265237|3527069|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3684066|NCT02265237|3527065|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3684067|NCT02265237|3527066|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684068|NCT02265237|3527067|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3684069|NCT02265237|3527068|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3684070|NCT02265237|3527069|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3684071|NCT02265237|3527065|B5||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3684072|NCT02265237|3527066|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3684073|NCT02265237|3527067|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3684074|NCT02265237|3527068|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3684075|NCT02265237|3527069|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3684076|NCT02265237|3527065|B5||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3684077|NCT02265237|3527066|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3684078|NCT02265237|3527067|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3684079|NCT02265237|3527068|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3684080|NCT02265237|3527069|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3684081|NCT02265237|3527065|B5|||Age||years|Mean|56.6|56.6|Standard Deviation|8.80|8.8|||
3684082|NCT02265237|3527066|B4|||Age||years|Mean|62.3|62.3|Standard Deviation|8.08|8.08|||
3684083|NCT02265237|3527067|B3|||Age||years|Mean|54.6|54.6|Standard Deviation|9.02|9.02|||
3684084|NCT02265237|3527068|B2|||Age||years|Mean|57.1|57.1|Standard Deviation|9.08|9.08|||
3684085|NCT02265237|3527069|B1|||Age||years|Mean|57.7|57.7|Standard Deviation|8.08|8.08|||
3684086|NCT02264977|3527091|B1|||BMI, Continuous||kg/(m^2)|Mean|26.2|26.2|Standard Deviation|5.5|5.5|||
3684087|NCT02264977|3527091|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3684088|NCT02264977|3527091|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684089|NCT02264977|3527091|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3684090|NCT02264977|3527091|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3684091|NCT02264977|3527091|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684092|NCT02264977|3527091|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684093|NCT02264977|3527091|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684094|NCT02264977|3527091|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3684095|NCT02264977|3527091|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3684096|NCT02264977|3527091|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684097|NCT02264977|3527091|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3684098|NCT02264977|3527091|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3684099|NCT02264977|3527091|B1|||Age||years|Mean|72.8|72.8|Standard Deviation|8.0|8.0|||
3684100|NCT02264821|3527099|B4|Belgium||Region of Enrollment||participants|Number|182|182.0||||||
3684101|NCT02264821|3527100|B3|Belgium||Region of Enrollment||participants|Number|58|58.0||||||
3684102|NCT02264821|3527101|B2|Belgium||Region of Enrollment||participants|Number|61|61.0||||||
3684103|NCT02264821|3527102|B1|Belgium||Region of Enrollment||participants|Number|63|63.0||||||
3684104|NCT02264821|3527099|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3684105|NCT02264821|3527100|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3684106|NCT02264821|3527101|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3684107|NCT02264821|3527102|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3684108|NCT02264821|3527099|B4||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3684109|NCT02264821|3527100|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3684110|NCT02264821|3527101|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3684111|NCT02264821|3527102|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3684112|NCT02264821|3527099|B4|||Age||years|Median|32|32.0|Inter-Quartile Range|||27.0|37.0|
3684113|NCT02264821|3527100|B3|||Age||years|Median|32|32.0|Inter-Quartile Range|||28.0|37.0|
3684114|NCT02264821|3527101|B2|||Age||years|Median|32|32.0|Inter-Quartile Range|||28.0|34.0|
3684115|NCT02264821|3527102|B1|||Age||years|Median|30|30.0|Inter-Quartile Range|||27.0|34.0|
3684116|NCT02264249|3527115|B4|||Last ingestion of clear liquids (hours)||hours|Mean|7.7|7.7|Standard Deviation|4.1|4.1|||
3684117|NCT02264249|3527116|B3|||Last ingestion of clear liquids (hours)||hours|Mean|5.8|5.8|Standard Deviation|2.4|2.4|||
3684118|NCT02264249|3527117|B2|||Last ingestion of clear liquids (hours)||hours|Mean|10.3|10.3|Standard Deviation|4.6|4.6|||
3684119|NCT02264249|3527118|B1|||Last ingestion of clear liquids (hours)||hours|Mean|5.4|5.4|Standard Deviation|1.9|1.9|||
3684120|NCT02264249|3527115|B4|||Last ingestion of solids (hours)||hours|Mean|38.4|38.4|Standard Deviation|9.7|9.7|||
3684121|NCT02264249|3527116|B3|||Last ingestion of solids (hours)||hours|Mean|39.4|39.4|Standard Deviation|9.6|9.6|||
3684122|NCT02264249|3527117|B2|||Last ingestion of solids (hours)||hours|Mean|37.3|37.3|Standard Deviation|9.8|9.8|||
3684123|NCT02264249|3527118|B1|||Last ingestion of solids (hours)||hours|Mean|35.5|35.5|Standard Deviation|8.7|8.7|||
3684124|NCT02264249|3527115|B4|||Volume of preparation: 4L||participants|Number|277|277.0||||||
3684125|NCT02264249|3527116|B3|||Volume of preparation: 4L||participants|Number|155|155.0||||||
3684126|NCT02264249|3527117|B2|||Volume of preparation: 4L||participants|Number|101|101.0||||||
3684127|NCT02264249|3527118|B1|||Volume of preparation: 4L||participants|Number|21|21.0||||||
3684128|NCT02264249|3527115|B4|||Drugs affecting GI motility||participants|Number|202|202.0||||||
3684129|NCT02264249|3527116|B3|||Drugs affecting GI motility||participants|Number|98|98.0||||||
3684130|NCT02264249|3527117|B2|||Drugs affecting GI motility||participants|Number|94|94.0||||||
3684131|NCT02264249|3527118|B1|||Drugs affecting GI motility||participants|Number|10|10.0||||||
3684132|NCT02264249|3527115|B4|||PPI/H2 Blocker||participants|Number|224|224.0||||||
3684133|NCT02264249|3527116|B3|||PPI/H2 Blocker||participants|Number|117|117.0||||||
3684134|NCT02264249|3527117|B2|||PPI/H2 Blocker||participants|Number|98|98.0||||||
3684135|NCT02264249|3527118|B1|||PPI/H2 Blocker||participants|Number|9|9.0||||||
3684136|NCT02264249|3527115|B4|||Constipation||participants|Number|34|34.0||||||
3684137|NCT02264249|3527116|B3|||Constipation||participants|Number|12|12.0||||||
3684138|NCT02264249|3527117|B2|||Constipation||participants|Number|19|19.0||||||
3684139|NCT02264249|3527118|B1|||Constipation||participants|Number|3|3.0||||||
3684140|NCT02264249|3527115|B4|||Diabetes Mellitus||participants|Number|41|41.0||||||
3684141|NCT02264249|3527116|B3|||Diabetes Mellitus||participants|Number|19|19.0||||||
3684142|NCT02264249|3527117|B2|||Diabetes Mellitus||participants|Number|17|17.0||||||
3684143|NCT02264249|3527118|B1|||Diabetes Mellitus||participants|Number|5|5.0||||||
3684144|NCT02264249|3527115|B4|United States||Region of Enrollment||participants|Number|449|449.0||||||
3684145|NCT02264249|3527116|B3|United States||Region of Enrollment||participants|Number|241|241.0||||||
3684146|NCT02264249|3527117|B2|United States||Region of Enrollment||participants|Number|187|187.0||||||
3684147|NCT02264249|3527118|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3684148|NCT02264249|3527115|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3684149|NCT02264249|3527116|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3684150|NCT02264249|3527117|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3684151|NCT02264249|3527118|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684152|NCT02264249|3527115|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|297|297.0||||||
3684153|NCT02264249|3527116|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|160|160.0||||||
3684154|NCT02264249|3527117|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|121|121.0||||||
3684155|NCT02264249|3527118|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3684156|NCT02264249|3527115|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
3684157|NCT02264249|3527116|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3684158|NCT02264249|3527117|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3684159|NCT02264249|3527118|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3684160|NCT02264249|3527115|B4||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
3684161|NCT02264249|3527116|B3||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3684162|NCT02264249|3527117|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3684163|NCT02264249|3527118|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3684164|NCT02264249|3527115|B4||Female|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
3684165|NCT02264249|3527116|B3||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3684166|NCT02264249|3527117|B2||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3684167|NCT02264249|3527118|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3684168|NCT02264249|3527115|B4|||Age||years|Mean|56|56.0|Standard Deviation|11.5|11.5|||
3684169|NCT02264249|3527116|B3|||Age||years|Mean|56|56.0|Standard Deviation|12|12.0|||
3684170|NCT02264249|3527117|B2|||Age||years|Mean|56|56.0|Standard Deviation|11|11.0|||
3684171|NCT02264249|3527118|B1|||Age||years|Mean|53|53.0|Standard Deviation|13|13.0|||
3684172|NCT02263911|3527134|B1|Japan||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3684173|NCT02263911|3527134|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684174|NCT02263911|3527134|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684175|NCT02263911|3527134|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684176|NCT02263911|3527134|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684177|NCT02263911|3527134|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684178|NCT02263911|3527134|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3684179|NCT02263911|3527134|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684180|NCT02263911|3527134|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684181|NCT02263911|3527134|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3684182|NCT02263911|3527134|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684183|NCT02263911|3527134|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3684184|NCT02263911|3527134|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3684185|NCT02263911|3527134|B1|||Age||Years|Mean|36.8|36.8|Standard Deviation|7.8|7.8|||
3684186|NCT02263833|3527159|B1||Male|Sex: Female, Male||Participants|Count of Participants|366|366.0||||||
3684187|NCT02263833|3527159|B1||Female|Sex: Female, Male||Participants|Count of Participants|376|376.0||||||
3684188|NCT02263833|3527159|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|14.2|14.2|||
3684189|NCT02263326|3527179|B3||Nonnucleoside reverse transcriptase inhibitor|Current ART Regimen||Participants|Count of Participants|27|27.0||||||
3684190|NCT02263326|3527180|B2||Nonnucleoside reverse transcriptase inhibitor|Current ART Regimen||Participants|Count of Participants|15|15.0||||||
3684191|NCT02263326|3527181|B1||Nonnucleoside reverse transcriptase inhibitor|Current ART Regimen||Participants|Count of Participants|12|12.0||||||
3684192|NCT02263326|3527179|B3||Protease Inhibitor|Current ART Regimen||Participants|Count of Participants|29|29.0||||||
3684193|NCT02263326|3527180|B2||Protease Inhibitor|Current ART Regimen||Participants|Count of Participants|15|15.0||||||
3684194|NCT02263326|3527181|B1||Protease Inhibitor|Current ART Regimen||Participants|Count of Participants|14|14.0||||||
3684195|NCT02263326|3527179|B3||Integrase Inhibitor|Current ART Regimen||Participants|Count of Participants|33|33.0||||||
3684196|NCT02263326|3527180|B2||Integrase Inhibitor|Current ART Regimen||Participants|Count of Participants|15|15.0||||||
3684197|NCT02263326|3527181|B1||Integrase Inhibitor|Current ART Regimen||Participants|Count of Participants|18|18.0||||||
3684198|NCT02263326|3527179|B3|||Time on Antiretroviral Therapy||years|Median|5.7|5.7|Inter-Quartile Range|||3.72|7.48|
3684199|NCT02263326|3527180|B2|||Time on Antiretroviral Therapy||years|Median|6.03|6.03|Inter-Quartile Range|||3.72|7.44|
3684200|NCT02263326|3527181|B1|||Time on Antiretroviral Therapy||years|Median|5.28|5.28|Inter-Quartile Range|||3.81|7.49|
3684201|NCT02263326|3527179|B3|||CD4 Cell Count||cells/mm3|Median|680|680.0|Inter-Quartile Range|||498.0|927.0|
3684202|NCT02263326|3527180|B2|||CD4 Cell Count||cells/mm3|Median|646|646.0|Inter-Quartile Range|||380.0|819.0|
3684203|NCT02263326|3527181|B1|||CD4 Cell Count||cells/mm3|Median|694|694.0|Inter-Quartile Range|||533.0|1034.0|
3684204|NCT02263326|3527179|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684205|NCT02263326|3527180|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684206|NCT02263326|3527181|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684207|NCT02263326|3527179|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684208|NCT02263326|3527180|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684209|NCT02263326|3527181|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684210|NCT02263326|3527179|B3||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3684211|NCT02263326|3527180|B2||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3684212|NCT02263326|3527181|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3684213|NCT02263326|3527179|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3684214|NCT02263326|3527180|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3684215|NCT02263326|3527181|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3684216|NCT02263326|3527179|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684217|NCT02263326|3527180|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684218|NCT02263326|3527181|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684219|NCT02263326|3527179|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3684220|NCT02263326|3527180|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3684221|NCT02263326|3527181|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3684222|NCT02263326|3527179|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684334|NCT02262728|3527320|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3684223|NCT02263326|3527180|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684224|NCT02263326|3527181|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684225|NCT02263326|3527179|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3684226|NCT02263326|3527180|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684227|NCT02263326|3527181|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3684228|NCT02263326|3527179|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3684229|NCT02263326|3527180|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3684230|NCT02263326|3527181|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3684231|NCT02263326|3527179|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3684232|NCT02263326|3527180|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3684233|NCT02263326|3527181|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3684234|NCT02263326|3527179|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3684235|NCT02263326|3527180|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3684236|NCT02263326|3527181|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3684237|NCT02263326|3527179|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3684238|NCT02263326|3527180|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3684239|NCT02263326|3527181|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3684240|NCT02263326|3527179|B3|||Age||years|Median|47|47.0|Inter-Quartile Range|||38.0|54.0|
3684241|NCT02263326|3527180|B2|||Age||years|Median|50|50.0|Inter-Quartile Range|||41.0|53.0|
3684242|NCT02263326|3527181|B1|||Age||years|Median|46|46.0|Inter-Quartile Range|||37.0|56.0|
3684243|NCT02263131|3527200|B3||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
3684244|NCT02263131|3527201|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3684245|NCT02263131|3527202|B1||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3684246|NCT02263131|3527200|B3||Female|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
3684247|NCT02263131|3527201|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3684248|NCT02263131|3527202|B1||Female|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
3684249|NCT02263131|3527200|B3|||Age||years|Mean|7.77|7.77|Standard Deviation|4.89|4.89|||
3684250|NCT02263131|3527201|B2|||Age||years|Mean|7.45|7.45|Standard Deviation|5.01|5.01|||
3684251|NCT02263131|3527202|B1|||Age||years|Mean|7.83|7.83|Standard Deviation|4.87|4.87|||
3684252|NCT02263118|3527211|B5|Not Aware||Aware of exclusive breastfeeding message|Was the participant aware of exclusive breastfeeding practice at enrollment?|participants|Number|33|33.0||||||
3684253|NCT02263118|3527212|B4|Not Aware||Aware of exclusive breastfeeding message|Was the participant aware of exclusive breastfeeding practice at enrollment?|participants|Number|3|3.0||||||
3684254|NCT02263118|3527213|B3|Not Aware||Aware of exclusive breastfeeding message|Was the participant aware of exclusive breastfeeding practice at enrollment?|participants|Number|12|12.0||||||
3684255|NCT02263118|3527214|B2|Not Aware||Aware of exclusive breastfeeding message|Was the participant aware of exclusive breastfeeding practice at enrollment?|participants|Number|6|6.0||||||
3684256|NCT02263118|3527215|B1|Not Aware||Aware of exclusive breastfeeding message|Was the participant aware of exclusive breastfeeding practice at enrollment?|participants|Number|12|12.0||||||
3684257|NCT02263118|3527211|B5|Aware||Aware of exclusive breastfeeding message|Was the participant aware of exclusive breastfeeding practice at enrollment?|participants|Number|45|45.0||||||
3684258|NCT02263118|3527212|B4|Aware||Aware of exclusive breastfeeding message|Was the participant aware of exclusive breastfeeding practice at enrollment?|participants|Number|9|9.0||||||
3684259|NCT02263118|3527213|B3|Aware||Aware of exclusive breastfeeding message|Was the participant aware of exclusive breastfeeding practice at enrollment?|participants|Number|10|10.0||||||
3684260|NCT02263118|3527214|B2|Aware||Aware of exclusive breastfeeding message|Was the participant aware of exclusive breastfeeding practice at enrollment?|participants|Number|18|18.0||||||
3684261|NCT02263118|3527215|B1|Aware||Aware of exclusive breastfeeding message|Was the participant aware of exclusive breastfeeding practice at enrollment?|participants|Number|8|8.0||||||
3684262|NCT02263118|3527211|B5|> High school||Education|Women's education|participants|Number|1|1.0||||||
3684263|NCT02263118|3527212|B4|> High school||Education|Women's education|participants|Number|1|1.0||||||
3684264|NCT02263118|3527213|B3|> High school||Education|Women's education|participants|Number|0|0.0||||||
3684265|NCT02263118|3527214|B2|> High school||Education|Women's education|participants|Number|0|0.0||||||
3684266|NCT02263118|3527215|B1|> High school||Education|Women's education|participants|Number|0|0.0||||||
3684267|NCT02263118|3527211|B5|Some high school education||Education|Women's education|participants|Number|11|11.0||||||
3684268|NCT02263118|3527212|B4|Some high school education||Education|Women's education|participants|Number|3|3.0||||||
3684269|NCT02263118|3527213|B3|Some high school education||Education|Women's education|participants|Number|3|3.0||||||
3684270|NCT02263118|3527214|B2|Some high school education||Education|Women's education|participants|Number|3|3.0||||||
3684271|NCT02263118|3527215|B1|Some high school education||Education|Women's education|participants|Number|2|2.0||||||
3684272|NCT02263118|3527211|B5|Some primary school education||Education|Women's education|participants|Number|59|59.0||||||
3684273|NCT02263118|3527212|B4|Some primary school education||Education|Women's education|participants|Number|7|7.0||||||
3684274|NCT02263118|3527213|B3|Some primary school education||Education|Women's education|participants|Number|18|18.0||||||
3684275|NCT02263118|3527214|B2|Some primary school education||Education|Women's education|participants|Number|18|18.0||||||
3684276|NCT02263118|3527215|B1|Some primary school education||Education|Women's education|participants|Number|16|16.0||||||
3684277|NCT02263118|3527211|B5|None||Education|Women's education|participants|Number|7|7.0||||||
3684278|NCT02263118|3527212|B4|None||Education|Women's education|participants|Number|1|1.0||||||
3684279|NCT02263118|3527213|B3|None||Education|Women's education|participants|Number|1|1.0||||||
3684280|NCT02263118|3527214|B2|None||Education|Women's education|participants|Number|3|3.0||||||
3684281|NCT02263118|3527215|B1|None||Education|Women's education|participants|Number|2|2.0||||||
3684282|NCT02263118|3527211|B5|No||Maternal experience|Does the participant have other children?|participants|Number|34|34.0||||||
3684283|NCT02263118|3527212|B4|No||Maternal experience|Does the participant have other children?|participants|Number|4|4.0||||||
3684284|NCT02263118|3527213|B3|No||Maternal experience|Does the participant have other children?|participants|Number|9|9.0||||||
3684285|NCT02263118|3527214|B2|No||Maternal experience|Does the participant have other children?|participants|Number|12|12.0||||||
3684286|NCT02263118|3527215|B1|No||Maternal experience|Does the participant have other children?|participants|Number|9|9.0||||||
3684287|NCT02263118|3527211|B5|Yes||Maternal experience|Does the participant have other children?|participants|Number|44|44.0||||||
3684288|NCT02263118|3527212|B4|Yes||Maternal experience|Does the participant have other children?|participants|Number|8|8.0||||||
3684289|NCT02263118|3527213|B3|Yes||Maternal experience|Does the participant have other children?|participants|Number|13|13.0||||||
3684290|NCT02263118|3527214|B2|Yes||Maternal experience|Does the participant have other children?|participants|Number|12|12.0||||||
3684291|NCT02263118|3527215|B1|Yes||Maternal experience|Does the participant have other children?|participants|Number|11|11.0||||||
3684292|NCT02263118|3527211|B5||Male|Sex: Female, Male|Gender of participant's baby|Participants|Count of Participants|41|41.0||||||
3684293|NCT02263118|3527212|B4||Male|Sex: Female, Male|Gender of participant's baby|Participants|Count of Participants|6|6.0||||||
3684294|NCT02263118|3527213|B3||Male|Sex: Female, Male|Gender of participant's baby|Participants|Count of Participants|17|17.0||||||
3684295|NCT02263118|3527214|B2||Male|Sex: Female, Male|Gender of participant's baby|Participants|Count of Participants|10|10.0||||||
3684296|NCT02263118|3527215|B1||Male|Sex: Female, Male|Gender of participant's baby|Participants|Count of Participants|8|8.0||||||
3684297|NCT02263118|3527211|B5||Female|Sex: Female, Male|Gender of participant's baby|Participants|Count of Participants|37|37.0||||||
3684298|NCT02263118|3527212|B4||Female|Sex: Female, Male|Gender of participant's baby|Participants|Count of Participants|6|6.0||||||
3684299|NCT02263118|3527213|B3||Female|Sex: Female, Male|Gender of participant's baby|Participants|Count of Participants|5|5.0||||||
3684300|NCT02263118|3527214|B2||Female|Sex: Female, Male|Gender of participant's baby|Participants|Count of Participants|14|14.0||||||
3684301|NCT02263118|3527215|B1||Female|Sex: Female, Male|Gender of participant's baby|Participants|Count of Participants|12|12.0||||||
3684302|NCT02263118|3527211|B5|>30 years||Age, Customized||participants|Number|11|11.0||||||
3684303|NCT02263118|3527212|B4|>30 years||Age, Customized||participants|Number|3|3.0||||||
3684304|NCT02263118|3527213|B3|>30 years||Age, Customized||participants|Number|3|3.0||||||
3684305|NCT02263118|3527214|B2|>30 years||Age, Customized||participants|Number|3|3.0||||||
3684306|NCT02263118|3527215|B1|>30 years||Age, Customized||participants|Number|2|2.0||||||
3684307|NCT02263118|3527211|B5|23-30 years||Age, Customized||participants|Number|35|35.0||||||
3684308|NCT02263118|3527212|B4|23-30 years||Age, Customized||participants|Number|7|7.0||||||
3684309|NCT02263118|3527213|B3|23-30 years||Age, Customized||participants|Number|9|9.0||||||
3684310|NCT02263118|3527214|B2|23-30 years||Age, Customized||participants|Number|10|10.0||||||
3684311|NCT02263118|3527215|B1|23-30 years||Age, Customized||participants|Number|9|9.0||||||
3684312|NCT02263118|3527211|B5|16-22 years||Age, Customized||participants|Number|32|32.0||||||
3684313|NCT02263118|3527212|B4|16-22 years||Age, Customized||participants|Number|2|2.0||||||
3684314|NCT02263118|3527213|B3|16-22 years||Age, Customized||participants|Number|10|10.0||||||
3684315|NCT02263118|3527214|B2|16-22 years||Age, Customized||participants|Number|11|11.0||||||
3684316|NCT02263118|3527215|B1|16-22 years||Age, Customized||participants|Number|9|9.0||||||
3684317|NCT02262754|3527240|B4||MALE|Gender||Participants|Count of Participants|108|108.0||||||
3684318|NCT02262754|3527241|B3||MALE|Gender||Participants|Count of Participants|37|37.0||||||
3684319|NCT02262754|3527242|B2||MALE|Gender||Participants|Count of Participants|35|35.0||||||
3684320|NCT02262754|3527243|B1||MALE|Gender||Participants|Count of Participants|36|36.0||||||
3684321|NCT02262754|3527240|B4||FEMALE|Gender||Participants|Count of Participants|114|114.0||||||
3684322|NCT02262754|3527241|B3||FEMALE|Gender||Participants|Count of Participants|37|37.0||||||
3684323|NCT02262754|3527242|B2||FEMALE|Gender||Participants|Count of Participants|39|39.0||||||
3684324|NCT02262754|3527243|B1||FEMALE|Gender||Participants|Count of Participants|38|38.0||||||
3684325|NCT02262754|3527240|B4|||Age||years|Mean|50.8|50.8|Standard Deviation|12.9|12.9|||
3684326|NCT02262754|3527241|B3|||Age||years|Mean|51.6|51.6|Standard Deviation|13.1|13.1|||
3684327|NCT02262754|3527242|B2|||Age||years|Mean|49.7|49.7|Standard Deviation|13.8|13.8|||
3684328|NCT02262754|3527243|B1|||Age||years|Mean|51.1|51.1|Standard Deviation|12.1|12.1|||
3684329|NCT02262728|3527318|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3684330|NCT02262728|3527319|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3684331|NCT02262728|3527320|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3684332|NCT02262728|3527318|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3684333|NCT02262728|3527319|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3684335|NCT02262728|3527318|B3|||Age||years|Median|58.5|58.5|Full Range|||30.0|75.0|
3684336|NCT02262728|3527319|B2|||Age||years|Median|61|61.0|Full Range|||50.0|75.0|
3684337|NCT02262728|3527320|B1|||Age||years|Median|56|56.0|Full Range|||30.0|64.0|
3684338|NCT02262130|3527349|B1|France||Region of Enrollment||participants|Number|10|10.0||||||
3684339|NCT02262130|3527349|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3684340|NCT02262130|3527349|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3684341|NCT02262130|3527349|B1|||Age||years|Mean|42.9|42.9|Standard Deviation|10.52|10.52|||
3684342|NCT02262078|3527357|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
3684343|NCT02262078|3527358|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3684344|NCT02262078|3527359|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3684345|NCT02262078|3527357|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684346|NCT02262078|3527358|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684347|NCT02262078|3527359|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684348|NCT02262078|3527357|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684349|NCT02262078|3527358|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684350|NCT02262078|3527359|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684351|NCT02262078|3527357|B3||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3684352|NCT02262078|3527358|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3684353|NCT02262078|3527359|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3684354|NCT02262078|3527357|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684355|NCT02262078|3527358|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684356|NCT02262078|3527359|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684357|NCT02262078|3527357|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684358|NCT02262078|3527358|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684359|NCT02262078|3527359|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684360|NCT02262078|3527357|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684361|NCT02262078|3527358|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684362|NCT02262078|3527359|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684363|NCT02262078|3527357|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684364|NCT02262078|3527358|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684365|NCT02262078|3527359|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684366|NCT02262078|3527357|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3684367|NCT02262078|3527358|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3684368|NCT02262078|3527359|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3684369|NCT02262078|3527357|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3684370|NCT02262078|3527358|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3684371|NCT02262078|3527359|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3684372|NCT02262078|3527357|B3|||Age||years|Mean|70|70.0|Standard Deviation|10|10.0|||
3684373|NCT02262078|3527358|B2|||Age||years|Mean|67|67.0|Standard Deviation|9|9.0|||
3684374|NCT02262078|3527359|B1|||Age||years|Mean|72|72.0|Standard Deviation|10|10.0|||
3684375|NCT02262039|3527366|B3|2||ASA Class|"American Society of Anesthesiologists: ASA physical status classification system to assess fitness of patients before surgery.~Classifications range from 1 (Healthy Person) to 6 (Declared brain-dead)~Only participants in groups 1 and 2 (Healthy or mild systemic disease) are eligible to become living kidney donors."|participants|Number|15|15.0||||||
3684376|NCT02262039|3527367|B2|2||ASA Class|"American Society of Anesthesiologists: ASA physical status classification system to assess fitness of patients before surgery.~Classifications range from 1 (Healthy Person) to 6 (Declared brain-dead)~Only participants in groups 1 and 2 (Healthy or mild systemic disease) are eligible to become living kidney donors."|participants|Number|10|10.0||||||
3684377|NCT02262039|3527368|B1|2||ASA Class|"American Society of Anesthesiologists: ASA physical status classification system to assess fitness of patients before surgery.~Classifications range from 1 (Healthy Person) to 6 (Declared brain-dead)~Only participants in groups 1 and 2 (Healthy or mild systemic disease) are eligible to become living kidney donors."|participants|Number|5|5.0||||||
3684378|NCT02262039|3527366|B3|1||ASA Class|"American Society of Anesthesiologists: ASA physical status classification system to assess fitness of patients before surgery.~Classifications range from 1 (Healthy Person) to 6 (Declared brain-dead)~Only participants in groups 1 and 2 (Healthy or mild systemic disease) are eligible to become living kidney donors."|participants|Number|26|26.0||||||
3684379|NCT02262039|3527367|B2|1||ASA Class|"American Society of Anesthesiologists: ASA physical status classification system to assess fitness of patients before surgery.~Classifications range from 1 (Healthy Person) to 6 (Declared brain-dead)~Only participants in groups 1 and 2 (Healthy or mild systemic disease) are eligible to become living kidney donors."|participants|Number|17|17.0||||||
3684380|NCT02262039|3527368|B1|1||ASA Class|"American Society of Anesthesiologists: ASA physical status classification system to assess fitness of patients before surgery.~Classifications range from 1 (Healthy Person) to 6 (Declared brain-dead)~Only participants in groups 1 and 2 (Healthy or mild systemic disease) are eligible to become living kidney donors."|participants|Number|9|9.0||||||
3684433|NCT02261974|3527388|B2|Psychiatric condition||Comorbidities||Participants|Count of Participants|3|3.0||||||
3684381|NCT02262039|3527366|B3|Right||Nephrectomy Laterality|This refers to the location (left side vs. right side) of the kidney removed during the donor surgery|participants|Number|6|6.0||||||
3684382|NCT02262039|3527367|B2|Right||Nephrectomy Laterality|This refers to the location (left side vs. right side) of the kidney removed during the donor surgery|participants|Number|3|3.0||||||
3684383|NCT02262039|3527368|B1|Right||Nephrectomy Laterality|This refers to the location (left side vs. right side) of the kidney removed during the donor surgery|participants|Number|3|3.0||||||
3684384|NCT02262039|3527366|B3|Left||Nephrectomy Laterality|This refers to the location (left side vs. right side) of the kidney removed during the donor surgery|participants|Number|35|35.0||||||
3684385|NCT02262039|3527367|B2|Left||Nephrectomy Laterality|This refers to the location (left side vs. right side) of the kidney removed during the donor surgery|participants|Number|24|24.0||||||
3684386|NCT02262039|3527368|B1|Left||Nephrectomy Laterality|This refers to the location (left side vs. right side) of the kidney removed during the donor surgery|participants|Number|11|11.0||||||
3684387|NCT02262039|3527366|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3684388|NCT02262039|3527367|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3684389|NCT02262039|3527368|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3684390|NCT02262039|3527366|B3|African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3684391|NCT02262039|3527367|B2|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3684392|NCT02262039|3527368|B1|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3684393|NCT02262039|3527366|B3|White||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
3684394|NCT02262039|3527367|B2|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3684395|NCT02262039|3527368|B1|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3684396|NCT02262039|3527366|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3684397|NCT02262039|3527367|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3684398|NCT02262039|3527368|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3684399|NCT02262039|3527366|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3684400|NCT02262039|3527367|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3684401|NCT02262039|3527368|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3684402|NCT02262039|3527366|B3|||Age||years|Mean|47.6|47.6|Standard Deviation|13.2|13.2|||
3684403|NCT02262039|3527367|B2|||Age||years|Mean|51.6|51.6|Standard Deviation|14.5|14.5|||
3684404|NCT02262039|3527368|B1|||Age||years|Mean|45.6|45.6|Standard Deviation|12.3|12.3|||
3684405|NCT02261974|3527387|B3|||Number of Vaginal Deliveries per Subject||Number of Reported Vaginal Deliveries|Mean|2.1|2.1|Standard Deviation|.9|0.9|||
3684406|NCT02261974|3527388|B2|||Number of Vaginal Deliveries per Subject||Number of Reported Vaginal Deliveries|Mean|2|2.0|Standard Deviation|.9|0.9|||
3684407|NCT02261974|3527389|B1|||Number of Vaginal Deliveries per Subject||Number of Reported Vaginal Deliveries|Mean|2.1|2.1|Standard Deviation|1|1.0|||
3684408|NCT02261974|3527387|B3|||Median Birth weight|Maternal History: Average of median birth weights.|kg|Mean|3.3|3.3|Standard Deviation|.6|0.6|||
3684409|NCT02261974|3527388|B2|||Median Birth weight|Maternal History: Average of median birth weights.|kg|Mean|3.4|3.4|Standard Deviation|.5|0.5|||
3684410|NCT02261974|3527389|B1|||Median Birth weight|Maternal History: Average of median birth weights.|kg|Mean|3.3|3.3|Standard Deviation|.7|0.7|||
3684411|NCT02261974|3527387|B3|||Time Since Last Delivery||years|Mean|8|8.0|Standard Deviation|6|6.0|||
3684412|NCT02261974|3527388|B2|||Time Since Last Delivery||years|Mean|8|8.0|Standard Deviation|5.5|5.5|||
3684413|NCT02261974|3527389|B1|||Time Since Last Delivery||years|Mean|8.0|8.0|Standard Deviation|6.3|6.3|||
3684414|NCT02261974|3527387|B3|||Gravidity Per Subject|Average number of reported pregnancies per subject|Pregnancies|Mean|2.7|2.7|Standard Deviation|1.4|1.4|||
3684415|NCT02261974|3527388|B2|||Gravidity Per Subject|Average number of reported pregnancies per subject|Pregnancies|Mean|2.7|2.7|Standard Deviation|1.3|1.3|||
3684416|NCT02261974|3527389|B1|||Gravidity Per Subject|Average number of reported pregnancies per subject|Pregnancies|Mean|2.7|2.7|Standard Deviation|1.4|1.4|||
3684417|NCT02261974|3527387|B3|Prior STD||Comorbidities||Participants|Count of Participants|9|9.0||||||
3684418|NCT02261974|3527388|B2|Prior STD||Comorbidities||Participants|Count of Participants|2|2.0||||||
3684419|NCT02261974|3527389|B1|Prior STD||Comorbidities||Participants|Count of Participants|7|7.0||||||
3684420|NCT02261974|3527387|B3|Prior Surgeries||Comorbidities||Participants|Count of Participants|123|123.0||||||
3684421|NCT02261974|3527388|B2|Prior Surgeries||Comorbidities||Participants|Count of Participants|41|41.0||||||
3684422|NCT02261974|3527389|B1|Prior Surgeries||Comorbidities||Participants|Count of Participants|82|82.0||||||
3684423|NCT02261974|3527387|B3|Gynecologic condition||Comorbidities||Participants|Count of Participants|26|26.0||||||
3684424|NCT02261974|3527388|B2|Gynecologic condition||Comorbidities||Participants|Count of Participants|7|7.0||||||
3684425|NCT02261974|3527389|B1|Gynecologic condition||Comorbidities||Participants|Count of Participants|19|19.0||||||
3684426|NCT02261974|3527387|B3|Allergies||Comorbidities||Participants|Count of Participants|33|33.0||||||
3684427|NCT02261974|3527388|B2|Allergies||Comorbidities||Participants|Count of Participants|13|13.0||||||
3684428|NCT02261974|3527389|B1|Allergies||Comorbidities||Participants|Count of Participants|20|20.0||||||
3684429|NCT02261974|3527387|B3|Hematologic condition||Comorbidities||Participants|Count of Participants|13|13.0||||||
3684430|NCT02261974|3527388|B2|Hematologic condition||Comorbidities||Participants|Count of Participants|5|5.0||||||
3684431|NCT02261974|3527389|B1|Hematologic condition||Comorbidities||Participants|Count of Participants|8|8.0||||||
3684432|NCT02261974|3527387|B3|Psychiatric condition||Comorbidities||Participants|Count of Participants|6|6.0||||||
3684490|NCT02261948|3527404|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3684434|NCT02261974|3527389|B1|Psychiatric condition||Comorbidities||Participants|Count of Participants|3|3.0||||||
3684435|NCT02261974|3527387|B3|Neurologic condition||Comorbidities||Participants|Count of Participants|13|13.0||||||
3684436|NCT02261974|3527388|B2|Neurologic condition||Comorbidities||Participants|Count of Participants|3|3.0||||||
3684437|NCT02261974|3527389|B1|Neurologic condition||Comorbidities||Participants|Count of Participants|10|10.0||||||
3684438|NCT02261974|3527387|B3|Endocrine condition||Comorbidities||Participants|Count of Participants|17|17.0||||||
3684439|NCT02261974|3527388|B2|Endocrine condition||Comorbidities||Participants|Count of Participants|5|5.0||||||
3684440|NCT02261974|3527389|B1|Endocrine condition||Comorbidities||Participants|Count of Participants|12|12.0||||||
3684441|NCT02261974|3527387|B3|Hepatic or biliary condition||Comorbidities||Participants|Count of Participants|7|7.0||||||
3684442|NCT02261974|3527388|B2|Hepatic or biliary condition||Comorbidities||Participants|Count of Participants|4|4.0||||||
3684443|NCT02261974|3527389|B1|Hepatic or biliary condition||Comorbidities||Participants|Count of Participants|3|3.0||||||
3684444|NCT02261974|3527387|B3|Pulmonary condition||Comorbidities||Participants|Count of Participants|6|6.0||||||
3684445|NCT02261974|3527388|B2|Pulmonary condition||Comorbidities||Participants|Count of Participants|4|4.0||||||
3684446|NCT02261974|3527389|B1|Pulmonary condition||Comorbidities||Participants|Count of Participants|2|2.0||||||
3684447|NCT02261974|3527387|B3|Dermatologic condition||Comorbidities||Participants|Count of Participants|13|13.0||||||
3684448|NCT02261974|3527388|B2|Dermatologic condition||Comorbidities||Participants|Count of Participants|4|4.0||||||
3684449|NCT02261974|3527389|B1|Dermatologic condition||Comorbidities||Participants|Count of Participants|9|9.0||||||
3684450|NCT02261974|3527387|B3|Ear, nose, or throat condition||Comorbidities||Participants|Count of Participants|13|13.0||||||
3684451|NCT02261974|3527388|B2|Ear, nose, or throat condition||Comorbidities||Participants|Count of Participants|7|7.0||||||
3684452|NCT02261974|3527389|B1|Ear, nose, or throat condition||Comorbidities||Participants|Count of Participants|6|6.0||||||
3684453|NCT02261974|3527387|B3|Hypertension||Comorbidities||Participants|Count of Participants|9|9.0||||||
3684454|NCT02261974|3527388|B2|Hypertension||Comorbidities||Participants|Count of Participants|2|2.0||||||
3684455|NCT02261974|3527389|B1|Hypertension||Comorbidities||Participants|Count of Participants|7|7.0||||||
3684456|NCT02261974|3527387|B3|||BMI||kg/m^2|Mean|24.5|24.5|Standard Deviation|4.8|4.8|||
3684457|NCT02261974|3527388|B2|||BMI||kg/m^2|Mean|24.4|24.4|Standard Deviation|5.4|5.4|||
3684458|NCT02261974|3527389|B1|||BMI||kg/m^2|Mean|24.6|24.6|Standard Deviation|4.6|4.6|||
3684459|NCT02261974|3527387|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3684460|NCT02261974|3527387|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3684461|NCT02261974|3527388|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3684462|NCT02261974|3527389|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3684463|NCT02261974|3527387|B3||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
3684464|NCT02261974|3527388|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3684465|NCT02261974|3527389|B1||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3684466|NCT02261974|3527387|B3|||Age||years|Mean|40.8|40.8|Standard Deviation|5.9|5.9|||
3684467|NCT02261974|3527388|B2|||Age||years|Mean|41.1|41.1|Standard Deviation|5.6|5.6|||
3684468|NCT02261974|3527389|B1|||Age||years|Mean|40.6|40.6|Standard Deviation|6.0|6.0|||
3684469|NCT02261948|3527404|B3|||NYHA class|New York Heart Association Class is the index used to classify the severity of symptoms referred by patients with heart failure. Lower index (1-2) is considered to have better outcome.|units on a scale|Mean|3.3|3.3|Standard Deviation|0.47|0.47|||
3684470|NCT02261948|3527405|B2|||NYHA class|New York Heart Association Class is the index used to classify the severity of symptoms referred by patients with heart failure. Lower index (1-2) is considered to have better outcome.|units on a scale|Mean|3.2|3.2|Standard Deviation|0.4|0.4|||
3684471|NCT02261948|3527406|B1|||NYHA class|New York Heart Association Class is the index used to classify the severity of symptoms referred by patients with heart failure. Lower index (1-2) is considered to have better outcome.|units on a scale|Mean|3.3|3.3|Standard Deviation|0.4|0.4|||
3684472|NCT02261948|3527404|B3|Italy||Region of Enrollment||participants|Number|42|42.0||||||
3684473|NCT02261948|3527405|B2|Italy||Region of Enrollment||participants|Number|19|19.0||||||
3684474|NCT02261948|3527406|B1|Italy||Region of Enrollment||participants|Number|23|23.0||||||
3684475|NCT02261948|3527404|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3684476|NCT02261948|3527405|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3684477|NCT02261948|3527406|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3684478|NCT02261948|3527404|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3684479|NCT02261948|3527405|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3684480|NCT02261948|3527406|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3684481|NCT02261948|3527404|B3|||Age||years|Mean|69|69.0|Standard Deviation|8.7|8.7|||
3684482|NCT02261948|3527405|B2|||Age||years|Mean|68.2|68.2|Standard Deviation|8.3|8.3|||
3684483|NCT02261948|3527406|B1|||Age||years|Mean|70.39|70.39|Standard Deviation|9.4|9.4|||
3684484|NCT02261948|3527404|B3||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
3684485|NCT02261948|3527405|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3684486|NCT02261948|3527406|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3684487|NCT02261948|3527404|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3684488|NCT02261948|3527405|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3684489|NCT02261948|3527406|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3684491|NCT02261948|3527405|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3684492|NCT02261948|3527406|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3684493|NCT02261818|3527417|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3684494|NCT02261818|3527417|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3684495|NCT02261818|3527417|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3684496|NCT02261818|3527417|B1|||Age||years|Mean|68.9|68.9|Standard Deviation|6.6|6.6|||
3684497|NCT02261818|3527417|B1||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
3684498|NCT02261818|3527417|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3684499|NCT02261818|3527417|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3684500|NCT02261805|3527421|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3684501|NCT02261805|3527421|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3684502|NCT02261805|3527421|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3684503|NCT02261805|3527421|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3684504|NCT02261805|3527421|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3684505|NCT02261493|3527431|B4||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3684506|NCT02261493|3527432|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3684507|NCT02261493|3527433|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3684508|NCT02261493|3527434|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3684509|NCT02261493|3527431|B4||Female|Sex: Female, Male||Participants|Count of Participants|702|702.0||||||
3684510|NCT02261493|3527432|B3||Female|Sex: Female, Male||Participants|Count of Participants|284|284.0||||||
3684511|NCT02261493|3527433|B2||Female|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
3684512|NCT02261493|3527434|B1||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3684513|NCT02261493|3527431|B4|>=65 years||Age, Customized||Participants|Number|38|38.0||||||
3684514|NCT02261493|3527432|B3|>=65 years||Age, Customized||Participants|Number|11|11.0||||||
3684515|NCT02261493|3527433|B2|>=65 years||Age, Customized||Participants|Number|18|18.0||||||
3684516|NCT02261493|3527434|B1|>=65 years||Age, Customized||Participants|Number|9|9.0||||||
3684517|NCT02261493|3527431|B4|<65 years||Age, Customized||Participants|Number|749|749.0||||||
3684518|NCT02261493|3527432|B3|<65 years||Age, Customized||Participants|Number|302|302.0||||||
3684519|NCT02261493|3527433|B2|<65 years||Age, Customized||Participants|Number|300|300.0||||||
3684520|NCT02261493|3527434|B1|<65 years||Age, Customized||Participants|Number|147|147.0||||||
3684521|NCT02261467|3527462|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3684522|NCT02261467|3527463|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3684523|NCT02261467|3527464|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3684524|NCT02261467|3527462|B3||Female|Sex: Female, Male||Participants|Count of Participants|336|336.0||||||
3684525|NCT02261467|3527463|B2||Female|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
3684526|NCT02261467|3527464|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3684527|NCT02261467|3527462|B3|>=65 years||Age, Customized||Participants|Number|9|9.0||||||
3684528|NCT02261467|3527463|B2|>=65 years||Age, Customized||Participants|Number|9|9.0||||||
3684529|NCT02261467|3527464|B1|>=65 years||Age, Customized||Participants|Number|0|0.0||||||
3684530|NCT02261467|3527462|B3|<65 years||Age, Customized||Participants|Number|382|382.0||||||
3684531|NCT02261467|3527463|B2|<65 years||Age, Customized||Participants|Number|281|281.0||||||
3684532|NCT02261467|3527464|B1|<65 years||Age, Customized||Participants|Number|101|101.0||||||
3684533|NCT02261428|3527483|B3|≥ 10 days||Hospitalisation day|Specifies the degree of ICU neuromyopathy associated with weakness cough.|participants|Number|10|10.0||||||
3684534|NCT02261428|3527484|B2|≥ 10 days||Hospitalisation day|Specifies the degree of ICU neuromyopathy associated with weakness cough.|participants|Number|5|5.0||||||
3684535|NCT02261428|3527485|B1|≥ 10 days||Hospitalisation day|Specifies the degree of ICU neuromyopathy associated with weakness cough.|participants|Number|5|5.0||||||
3684536|NCT02261428|3527483|B3|≥ 5 days, < 10 days||Hospitalisation day|Specifies the degree of ICU neuromyopathy associated with weakness cough.|participants|Number|6|6.0||||||
3684537|NCT02261428|3527484|B2|≥ 5 days, < 10 days||Hospitalisation day|Specifies the degree of ICU neuromyopathy associated with weakness cough.|participants|Number|3|3.0||||||
3684538|NCT02261428|3527485|B1|≥ 5 days, < 10 days||Hospitalisation day|Specifies the degree of ICU neuromyopathy associated with weakness cough.|participants|Number|3|3.0||||||
3684539|NCT02261428|3527483|B3|< 5 days||Hospitalisation day|Specifies the degree of ICU neuromyopathy associated with weakness cough.|participants|Number|4|4.0||||||
3684540|NCT02261428|3527484|B2|< 5 days||Hospitalisation day|Specifies the degree of ICU neuromyopathy associated with weakness cough.|participants|Number|2|2.0||||||
3684541|NCT02261428|3527485|B1|< 5 days||Hospitalisation day|Specifies the degree of ICU neuromyopathy associated with weakness cough.|participants|Number|2|2.0||||||
3684542|NCT02261428|3527483|B3|9||SOFA|"Used to monitor the patient's condition during the stay in the intensive care unit (ICU).~Both the mean and highest SOFA scores are predictors of outcome. An increase in SOFA score during the first 24 to 48 hours in the ICU provided a mortality rate of at least 50% to 95%. Scores less than 9 give prediction of mortality by 33%, while over 11 may be near or above 95%"|participants|Number|2|2.0||||||
3684543|NCT02261428|3527484|B2|9||SOFA|"Used to monitor the patient's condition during the stay in the intensive care unit (ICU).~Both the mean and highest SOFA scores are predictors of outcome. An increase in SOFA score during the first 24 to 48 hours in the ICU provided a mortality rate of at least 50% to 95%. Scores less than 9 give prediction of mortality by 33%, while over 11 may be near or above 95%"|participants|Number|1|1.0||||||
3684544|NCT02261428|3527485|B1|9||SOFA|"Used to monitor the patient's condition during the stay in the intensive care unit (ICU).~Both the mean and highest SOFA scores are predictors of outcome. An increase in SOFA score during the first 24 to 48 hours in the ICU provided a mortality rate of at least 50% to 95%. Scores less than 9 give prediction of mortality by 33%, while over 11 may be near or above 95%"|participants|Number|1|1.0||||||
3684545|NCT02261428|3527483|B3|6||SOFA|"Used to monitor the patient's condition during the stay in the intensive care unit (ICU).~Both the mean and highest SOFA scores are predictors of outcome. An increase in SOFA score during the first 24 to 48 hours in the ICU provided a mortality rate of at least 50% to 95%. Scores less than 9 give prediction of mortality by 33%, while over 11 may be near or above 95%"|participants|Number|4|4.0||||||
3684546|NCT02261428|3527484|B2|6||SOFA|"Used to monitor the patient's condition during the stay in the intensive care unit (ICU).~Both the mean and highest SOFA scores are predictors of outcome. An increase in SOFA score during the first 24 to 48 hours in the ICU provided a mortality rate of at least 50% to 95%. Scores less than 9 give prediction of mortality by 33%, while over 11 may be near or above 95%"|participants|Number|2|2.0||||||
3684547|NCT02261428|3527485|B1|6||SOFA|"Used to monitor the patient's condition during the stay in the intensive care unit (ICU).~Both the mean and highest SOFA scores are predictors of outcome. An increase in SOFA score during the first 24 to 48 hours in the ICU provided a mortality rate of at least 50% to 95%. Scores less than 9 give prediction of mortality by 33%, while over 11 may be near or above 95%"|participants|Number|2|2.0||||||
3684548|NCT02261428|3527483|B3|<4||SOFA|"Used to monitor the patient's condition during the stay in the intensive care unit (ICU).~Both the mean and highest SOFA scores are predictors of outcome. An increase in SOFA score during the first 24 to 48 hours in the ICU provided a mortality rate of at least 50% to 95%. Scores less than 9 give prediction of mortality by 33%, while over 11 may be near or above 95%"|participants|Number|14|14.0||||||
3684549|NCT02261428|3527484|B2|<4||SOFA|"Used to monitor the patient's condition during the stay in the intensive care unit (ICU).~Both the mean and highest SOFA scores are predictors of outcome. An increase in SOFA score during the first 24 to 48 hours in the ICU provided a mortality rate of at least 50% to 95%. Scores less than 9 give prediction of mortality by 33%, while over 11 may be near or above 95%"|participants|Number|7|7.0||||||
3684550|NCT02261428|3527485|B1|<4||SOFA|"Used to monitor the patient's condition during the stay in the intensive care unit (ICU).~Both the mean and highest SOFA scores are predictors of outcome. An increase in SOFA score during the first 24 to 48 hours in the ICU provided a mortality rate of at least 50% to 95%. Scores less than 9 give prediction of mortality by 33%, while over 11 may be near or above 95%"|participants|Number|7|7.0||||||
3684551|NCT02261428|3527483|B3||Male|Sex: Female, Male|Gender determines the behavior of the autonomic nervous system|Participants|Count of Participants|10|10.0||||||
3684552|NCT02261428|3527484|B2||Male|Sex: Female, Male|Gender determines the behavior of the autonomic nervous system|Participants|Count of Participants|5|5.0||||||
3684553|NCT02261428|3527485|B1||Male|Sex: Female, Male|Gender determines the behavior of the autonomic nervous system|Participants|Count of Participants|5|5.0||||||
3684554|NCT02261428|3527483|B3||Female|Sex: Female, Male|Gender determines the behavior of the autonomic nervous system|Participants|Count of Participants|10|10.0||||||
3684555|NCT02261428|3527484|B2||Female|Sex: Female, Male|Gender determines the behavior of the autonomic nervous system|Participants|Count of Participants|5|5.0||||||
3684556|NCT02261428|3527485|B1||Female|Sex: Female, Male|Gender determines the behavior of the autonomic nervous system|Participants|Count of Participants|5|5.0||||||
3684557|NCT02261428|3527483|B3|>80 years||Age, Customized|Αge categories were defined in order to reflect the age in relation to the sensitivity of the population it invasive interventions|participants|Number|9|9.0||||||
3684558|NCT02261428|3527484|B2|>80 years||Age, Customized|Αge categories were defined in order to reflect the age in relation to the sensitivity of the population it invasive interventions|participants|Number|5|5.0||||||
3684559|NCT02261428|3527485|B1|>80 years||Age, Customized|Αge categories were defined in order to reflect the age in relation to the sensitivity of the population it invasive interventions|participants|Number|4|4.0||||||
3684560|NCT02261428|3527483|B3|70-79 years||Age, Customized|Αge categories were defined in order to reflect the age in relation to the sensitivity of the population it invasive interventions|participants|Number|6|6.0||||||
3684561|NCT02261428|3527484|B2|70-79 years||Age, Customized|Αge categories were defined in order to reflect the age in relation to the sensitivity of the population it invasive interventions|participants|Number|3|3.0||||||
3684562|NCT02261428|3527485|B1|70-79 years||Age, Customized|Αge categories were defined in order to reflect the age in relation to the sensitivity of the population it invasive interventions|participants|Number|3|3.0||||||
3684563|NCT02261428|3527483|B3|60-69 years||Age, Customized|Αge categories were defined in order to reflect the age in relation to the sensitivity of the population it invasive interventions|participants|Number|4|4.0||||||
3684564|NCT02261428|3527484|B2|60-69 years||Age, Customized|Αge categories were defined in order to reflect the age in relation to the sensitivity of the population it invasive interventions|participants|Number|2|2.0||||||
3684565|NCT02261428|3527485|B1|60-69 years||Age, Customized|Αge categories were defined in order to reflect the age in relation to the sensitivity of the population it invasive interventions|participants|Number|2|2.0||||||
3684566|NCT02261428|3527483|B3|<60 years||Age, Customized|Αge categories were defined in order to reflect the age in relation to the sensitivity of the population it invasive interventions|participants|Number|1|1.0||||||
3684567|NCT02261428|3527484|B2|<60 years||Age, Customized|Αge categories were defined in order to reflect the age in relation to the sensitivity of the population it invasive interventions|participants|Number|0|0.0||||||
3684568|NCT02261428|3527485|B1|<60 years||Age, Customized|Αge categories were defined in order to reflect the age in relation to the sensitivity of the population it invasive interventions|participants|Number|1|1.0||||||
3684569|NCT02260986|3527504|B4|||Total Hospital Anxiety Depression Scale (HADS)|The HADS is a fourteen item scale. Seven of the items relate to anxiety and seven relate to depression. Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 (no symptoms) and 21 (severe symptoms) for either anxiety or depression. Cut-offs for identifying psychiatric distress has been reported as 7 to 8 for possible presence, 10 to 11 for probable presence, and 14 to 15 for severe anxiety or depression.|units on a scale|Mean|12.7|12.7|Standard Deviation|7.98|7.98|||
3684570|NCT02260986|3527505|B3|||Total Hospital Anxiety Depression Scale (HADS)|The HADS is a fourteen item scale. Seven of the items relate to anxiety and seven relate to depression. Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 (no symptoms) and 21 (severe symptoms) for either anxiety or depression. Cut-offs for identifying psychiatric distress has been reported as 7 to 8 for possible presence, 10 to 11 for probable presence, and 14 to 15 for severe anxiety or depression.|units on a scale|Mean|12.8|12.8|Standard Deviation|8.01|8.01|||
3684571|NCT02260986|3527506|B2|||Total Hospital Anxiety Depression Scale (HADS)|The HADS is a fourteen item scale. Seven of the items relate to anxiety and seven relate to depression. Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 (no symptoms) and 21 (severe symptoms) for either anxiety or depression. Cut-offs for identifying psychiatric distress has been reported as 7 to 8 for possible presence, 10 to 11 for probable presence, and 14 to 15 for severe anxiety or depression.|units on a scale|Mean|12.9|12.9|Standard Deviation|7.73|7.73|||
3684572|NCT02260986|3527507|B1|||Total Hospital Anxiety Depression Scale (HADS)|The HADS is a fourteen item scale. Seven of the items relate to anxiety and seven relate to depression. Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 (no symptoms) and 21 (severe symptoms) for either anxiety or depression. Cut-offs for identifying psychiatric distress has been reported as 7 to 8 for possible presence, 10 to 11 for probable presence, and 14 to 15 for severe anxiety or depression.|units on a scale|Mean|12.6|12.6|Standard Deviation|8.06|8.06|||
3684573|NCT02260986|3527504|B4|||Global Individual Signs Score (GISS)|Individual components of the AD lesions (erythema, infiltration/ papulation, excoriations, and lichenification) were rated globally (each assessed for the whole body, not by anatomical region) on a 4-point scale (0 = none, 1 = mild, 2 = moderate and 3 = severe) using the EASI severity grading criteria. Total score ranges from 0 (absent disease) to 12 (severe disease).|units on a scale|Mean|8.8|8.8|Standard Deviation|1.85|1.85|||
3684574|NCT02260986|3527505|B3|||Global Individual Signs Score (GISS)|Individual components of the AD lesions (erythema, infiltration/ papulation, excoriations, and lichenification) were rated globally (each assessed for the whole body, not by anatomical region) on a 4-point scale (0 = none, 1 = mild, 2 = moderate and 3 = severe) using the EASI severity grading criteria. Total score ranges from 0 (absent disease) to 12 (severe disease).|units on a scale|Mean|8.9|8.9|Standard Deviation|1.80|1.8|||
3684575|NCT02260986|3527506|B2|||Global Individual Signs Score (GISS)|Individual components of the AD lesions (erythema, infiltration/ papulation, excoriations, and lichenification) were rated globally (each assessed for the whole body, not by anatomical region) on a 4-point scale (0 = none, 1 = mild, 2 = moderate and 3 = severe) using the EASI severity grading criteria. Total score ranges from 0 (absent disease) to 12 (severe disease).|units on a scale|Mean|8.9|8.9|Standard Deviation|2.04|2.04|||
3684576|NCT02260986|3527507|B1|||Global Individual Signs Score (GISS)|Individual components of the AD lesions (erythema, infiltration/ papulation, excoriations, and lichenification) were rated globally (each assessed for the whole body, not by anatomical region) on a 4-point scale (0 = none, 1 = mild, 2 = moderate and 3 = severe) using the EASI severity grading criteria. Total score ranges from 0 (absent disease) to 12 (severe disease).|units on a scale|Mean|8.7|8.7|Standard Deviation|1.84|1.84|||
3684577|NCT02260986|3527504|B4|||Patient Oriented Eczema Measure (POEM)|The POEM was a 7-item questionnaire that assessed disease symptoms (dryness, itching, flaking, cracking, sleep loss, bleeding and weeping) with a scoring system of 0 (absent disease) to 28 (severe disease) (high score indicative of poor quality of life [QOL]).|units on a scale|Mean|20.1|20.1|Standard Deviation|5.95|5.95|||
3684578|NCT02260986|3527505|B3|||Patient Oriented Eczema Measure (POEM)|The POEM was a 7-item questionnaire that assessed disease symptoms (dryness, itching, flaking, cracking, sleep loss, bleeding and weeping) with a scoring system of 0 (absent disease) to 28 (severe disease) (high score indicative of poor quality of life [QOL]).|units on a scale|Mean|20.1|20.1|Standard Deviation|6.05|6.05|||
3684579|NCT02260986|3527506|B2|||Patient Oriented Eczema Measure (POEM)|The POEM was a 7-item questionnaire that assessed disease symptoms (dryness, itching, flaking, cracking, sleep loss, bleeding and weeping) with a scoring system of 0 (absent disease) to 28 (severe disease) (high score indicative of poor quality of life [QOL]).|units on a scale|Mean|20.3|20.3|Standard Deviation|5.68|5.68|||
3684580|NCT02260986|3527507|B1|||Patient Oriented Eczema Measure (POEM)|The POEM was a 7-item questionnaire that assessed disease symptoms (dryness, itching, flaking, cracking, sleep loss, bleeding and weeping) with a scoring system of 0 (absent disease) to 28 (severe disease) (high score indicative of poor quality of life [QOL]).|units on a scale|Mean|20.0|20.0|Standard Deviation|5.99|5.99|||
3684581|NCT02260986|3527504|B4|||Dermatology Life Quality Index (DLQI) Total Score|DLQI is a 10-item, validated questionnaire used in clinical practice and clinical trials to assess the impact of AD disease symptoms and treatment on quality of life (QOL). The 10 questions assessed QOL over the past week, with an overall scoring of 0 (absent disease) to 30 (severe disease); a high score was indicative of a poor QOL.|units on a scale|Mean|14.5|14.5|Standard Deviation|7.27|7.27|||
3684582|NCT02260986|3527505|B3|||Dermatology Life Quality Index (DLQI) Total Score|DLQI is a 10-item, validated questionnaire used in clinical practice and clinical trials to assess the impact of AD disease symptoms and treatment on quality of life (QOL). The 10 questions assessed QOL over the past week, with an overall scoring of 0 (absent disease) to 30 (severe disease); a high score was indicative of a poor QOL.|units on a scale|Mean|14.4|14.4|Standard Deviation|7.17|7.17|||
3684583|NCT02260986|3527506|B2|||Dermatology Life Quality Index (DLQI) Total Score|DLQI is a 10-item, validated questionnaire used in clinical practice and clinical trials to assess the impact of AD disease symptoms and treatment on quality of life (QOL). The 10 questions assessed QOL over the past week, with an overall scoring of 0 (absent disease) to 30 (severe disease); a high score was indicative of a poor QOL.|units on a scale|Mean|14.5|14.5|Standard Deviation|7.31|7.31|||
3684584|NCT02260986|3527507|B1|||Dermatology Life Quality Index (DLQI) Total Score|DLQI is a 10-item, validated questionnaire used in clinical practice and clinical trials to assess the impact of AD disease symptoms and treatment on quality of life (QOL). The 10 questions assessed QOL over the past week, with an overall scoring of 0 (absent disease) to 30 (severe disease); a high score was indicative of a poor QOL.|units on a scale|Mean|14.7|14.7|Standard Deviation|7.37|7.37|||
3684645|NCT02260986|3527504|B4|Japan||Region of Enrollment||participants|Number|117|117.0||||||
3684646|NCT02260986|3527505|B3|Japan||Region of Enrollment||participants|Number|47|47.0||||||
3684585|NCT02260986|3527504|B4|||SCORing Atopic Dermatitis (SCORAD) Score|SCORAD is a clinical tool for assessing the severity of atopic dermatitis developed by the European Task Force on Atopic Dermatitis (Severity scoring of atopic dermatitis: the SCORAD index). Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology (Basel) 186 (1): 23–31. 1993. Extent and intensity of eczema as well as subjective signs (insomnia, etc.) are assessed and scored. Total score ranges from 0 (absent disease) to 103 (severe disease).|units on a scale|Mean|66.4|66.4|Standard Deviation|13.86|13.86|||
3684586|NCT02260986|3527505|B3|||SCORing Atopic Dermatitis (SCORAD) Score|SCORAD is a clinical tool for assessing the severity of atopic dermatitis developed by the European Task Force on Atopic Dermatitis (Severity scoring of atopic dermatitis: the SCORAD index). Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology (Basel) 186 (1): 23–31. 1993. Extent and intensity of eczema as well as subjective signs (insomnia, etc.) are assessed and scored. Total score ranges from 0 (absent disease) to 103 (severe disease).|units on a scale|Mean|65.9|65.9|Standard Deviation|13.63|13.63|||
3684587|NCT02260986|3527506|B2|||SCORing Atopic Dermatitis (SCORAD) Score|SCORAD is a clinical tool for assessing the severity of atopic dermatitis developed by the European Task Force on Atopic Dermatitis (Severity scoring of atopic dermatitis: the SCORAD index). Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology (Basel) 186 (1): 23–31. 1993. Extent and intensity of eczema as well as subjective signs (insomnia, etc.) are assessed and scored. Total score ranges from 0 (absent disease) to 103 (severe disease).|units on a scale|Mean|69.3|69.3|Standard Deviation|15.24|15.24|||
3684588|NCT02260986|3527507|B1|||SCORing Atopic Dermatitis (SCORAD) Score|SCORAD is a clinical tool for assessing the severity of atopic dermatitis developed by the European Task Force on Atopic Dermatitis (Severity scoring of atopic dermatitis: the SCORAD index). Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology (Basel) 186 (1): 23–31. 1993. Extent and intensity of eczema as well as subjective signs (insomnia, etc.) are assessed and scored. Total score ranges from 0 (absent disease) to 103 (severe disease).|units on a scale|Mean|66.0|66.0|Standard Deviation|13.53|13.53|||
3684589|NCT02260986|3527504|B4|||Body Surface Area (BSA) Involvement with Atopic Dermatitis|Body surface area affected by AD was assessed for each section of the body (the possible highest score for each region was: head and neck [9%], anterior trunk [18%], back [18%], upper limbs [18%], lower limbs [36%], and genitals [1%]). It was reported as a percentage of all major body sections combined.|Percentage of body surface area|Mean|56.1|56.1|Standard Deviation|21.66|21.66|||
3684590|NCT02260986|3527505|B3|||Body Surface Area (BSA) Involvement with Atopic Dermatitis|Body surface area affected by AD was assessed for each section of the body (the possible highest score for each region was: head and neck [9%], anterior trunk [18%], back [18%], upper limbs [18%], lower limbs [36%], and genitals [1%]). It was reported as a percentage of all major body sections combined.|Percentage of body surface area|Mean|54.1|54.1|Standard Deviation|21.76|21.76|||
3684591|NCT02260986|3527506|B2|||Body Surface Area (BSA) Involvement with Atopic Dermatitis|Body surface area affected by AD was assessed for each section of the body (the possible highest score for each region was: head and neck [9%], anterior trunk [18%], back [18%], upper limbs [18%], lower limbs [36%], and genitals [1%]). It was reported as a percentage of all major body sections combined.|Percentage of body surface area|Mean|59.5|59.5|Standard Deviation|20.84|20.84|||
3684592|NCT02260986|3527507|B1|||Body Surface Area (BSA) Involvement with Atopic Dermatitis|Body surface area affected by AD was assessed for each section of the body (the possible highest score for each region was: head and neck [9%], anterior trunk [18%], back [18%], upper limbs [18%], lower limbs [36%], and genitals [1%]). It was reported as a percentage of all major body sections combined.|Percentage of body surface area|Mean|56.9|56.9|Standard Deviation|21.69|21.69|||
3684593|NCT02260986|3527504|B4|||Weekly Peak Averaged Pruritus Numeric Rating Scale (NRS)|Pruritus NRS was an assessment tool that was used to report the intensity of participant’s pruritus (itch), both maximum and average intensity, during a 24-hour recall period. Participants were asked the following question: how would a participant rate his itch at worst moment during previous 24 hours (for maximum itch intensity on a scale of 0–10 [0=no itch;10=worst itch imaginable]).|units on a scale|Mean|7.3|7.3|Standard Deviation|1.84|1.84|||
3684594|NCT02260986|3527505|B3|||Weekly Peak Averaged Pruritus Numeric Rating Scale (NRS)|Pruritus NRS was an assessment tool that was used to report the intensity of participant’s pruritus (itch), both maximum and average intensity, during a 24-hour recall period. Participants were asked the following question: how would a participant rate his itch at worst moment during previous 24 hours (for maximum itch intensity on a scale of 0–10 [0=no itch;10=worst itch imaginable]).|units on a scale|Mean|7.1|7.1|Standard Deviation|1.90|1.9|||
3684595|NCT02260986|3527506|B2|||Weekly Peak Averaged Pruritus Numeric Rating Scale (NRS)|Pruritus NRS was an assessment tool that was used to report the intensity of participant’s pruritus (itch), both maximum and average intensity, during a 24-hour recall period. Participants were asked the following question: how would a participant rate his itch at worst moment during previous 24 hours (for maximum itch intensity on a scale of 0–10 [0=no itch;10=worst itch imaginable]).|units on a scale|Mean|7.4|7.4|Standard Deviation|1.66|1.66|||
3684596|NCT02260986|3527507|B1|||Weekly Peak Averaged Pruritus Numeric Rating Scale (NRS)|Pruritus NRS was an assessment tool that was used to report the intensity of participant’s pruritus (itch), both maximum and average intensity, during a 24-hour recall period. Participants were asked the following question: how would a participant rate his itch at worst moment during previous 24 hours (for maximum itch intensity on a scale of 0–10 [0=no itch;10=worst itch imaginable]).|units on a scale|Mean|7.3|7.3|Standard Deviation|1.84|1.84|||
3684597|NCT02260986|3527504|B4|||Investigator Global Assessment (IGA) Score|IGA was an assessment scale used to determine severity of AD and clinical response to treatment on a 5-point scale (0 = clear; 1 = almost clear; 2 = mild; 3 = moderate; 4 = severe) based on erythema and papulation/infiltration. Therapeutic response was an IGA score of 0 (clear) or 1 (almost clear).|units on a scale|Mean|3.5|3.5|Standard Deviation|0.50|0.5|||
3684598|NCT02260986|3527505|B3|||Investigator Global Assessment (IGA) Score|IGA was an assessment scale used to determine severity of AD and clinical response to treatment on a 5-point scale (0 = clear; 1 = almost clear; 2 = mild; 3 = moderate; 4 = severe) based on erythema and papulation/infiltration. Therapeutic response was an IGA score of 0 (clear) or 1 (almost clear).|units on a scale|Mean|3.5|3.5|Standard Deviation|0.50|0.5|||
3684647|NCT02260986|3527506|B2|Japan||Region of Enrollment||participants|Number|16|16.0||||||
3684599|NCT02260986|3527506|B2|||Investigator Global Assessment (IGA) Score|IGA was an assessment scale used to determine severity of AD and clinical response to treatment on a 5-point scale (0 = clear; 1 = almost clear; 2 = mild; 3 = moderate; 4 = severe) based on erythema and papulation/infiltration. Therapeutic response was an IGA score of 0 (clear) or 1 (almost clear).|units on a scale|Mean|3.5|3.5|Standard Deviation|0.50|0.5|||
3684600|NCT02260986|3527507|B1|||Investigator Global Assessment (IGA) Score|IGA was an assessment scale used to determine severity of AD and clinical response to treatment on a 5-point scale (0 = clear; 1 = almost clear; 2 = mild; 3 = moderate; 4 = severe) based on erythema and papulation/infiltration. Therapeutic response was an IGA score of 0 (clear) or 1 (almost clear).|units on a scale|Mean|3.5|3.5|Standard Deviation|0.50|0.5|||
3684601|NCT02260986|3527504|B4|||Eczema Area and Severity Index (EASI) Score|The EASI score was used to measure the severity and extent of atopic dermatitis (AD) and measures erythema, infiltration, excoriation and lichenification on 4 anatomic regions of the body: head, trunk, upper and lower extremities. The total EASI score ranges from 0 (minimum) to 72 (maximum) points, with the higher scores reflecting the worse severity of AD.|units on a scale|Mean|32.5|32.5|Standard Deviation|12.90|12.9|||
3684602|NCT02260986|3527505|B3|||Eczema Area and Severity Index (EASI) Score|The EASI score was used to measure the severity and extent of atopic dermatitis (AD) and measures erythema, infiltration, excoriation and lichenification on 4 anatomic regions of the body: head, trunk, upper and lower extremities. The total EASI score ranges from 0 (minimum) to 72 (maximum) points, with the higher scores reflecting the worse severity of AD.|units on a scale|Mean|32.1|32.1|Standard Deviation|12.76|12.76|||
3684603|NCT02260986|3527506|B2|||Eczema Area and Severity Index (EASI) Score|The EASI score was used to measure the severity and extent of atopic dermatitis (AD) and measures erythema, infiltration, excoriation and lichenification on 4 anatomic regions of the body: head, trunk, upper and lower extremities. The total EASI score ranges from 0 (minimum) to 72 (maximum) points, with the higher scores reflecting the worse severity of AD.|units on a scale|Mean|33.6|33.6|Standard Deviation|13.30|13.3|||
3684604|NCT02260986|3527507|B1|||Eczema Area and Severity Index (EASI) Score|The EASI score was used to measure the severity and extent of atopic dermatitis (AD) and measures erythema, infiltration, excoriation and lichenification on 4 anatomic regions of the body: head, trunk, upper and lower extremities. The total EASI score ranges from 0 (minimum) to 72 (maximum) points, with the higher scores reflecting the worse severity of AD.|units on a scale|Mean|32.6|32.6|Standard Deviation|12.93|12.93|||
3684605|NCT02260986|3527504|B4|Australia||Region of Enrollment||participants|Number|41|41.0||||||
3684606|NCT02260986|3527505|B3|Australia||Region of Enrollment||participants|Number|17|17.0||||||
3684607|NCT02260986|3527506|B2|Australia||Region of Enrollment||participants|Number|6|6.0||||||
3684608|NCT02260986|3527507|B1|Australia||Region of Enrollment||participants|Number|18|18.0||||||
3684609|NCT02260986|3527504|B4|Italy||Region of Enrollment||participants|Number|13|13.0||||||
3684610|NCT02260986|3527505|B3|Italy||Region of Enrollment||participants|Number|7|7.0||||||
3684611|NCT02260986|3527506|B2|Italy||Region of Enrollment||participants|Number|1|1.0||||||
3684612|NCT02260986|3527507|B1|Italy||Region of Enrollment||participants|Number|5|5.0||||||
3684613|NCT02260986|3527504|B4|Poland||Region of Enrollment||participants|Number|144|144.0||||||
3684614|NCT02260986|3527505|B3|Poland||Region of Enrollment||participants|Number|64|64.0||||||
3684615|NCT02260986|3527506|B2|Poland||Region of Enrollment||participants|Number|17|17.0||||||
3684616|NCT02260986|3527507|B1|Poland||Region of Enrollment||participants|Number|63|63.0||||||
3684617|NCT02260986|3527504|B4|Korea, Republic of||Region of Enrollment||participants|Number|26|26.0||||||
3684618|NCT02260986|3527505|B3|Korea, Republic of||Region of Enrollment||participants|Number|14|14.0||||||
3684619|NCT02260986|3527506|B2|Korea, Republic of||Region of Enrollment||participants|Number|4|4.0||||||
3684620|NCT02260986|3527507|B1|Korea, Republic of||Region of Enrollment||participants|Number|8|8.0||||||
3684621|NCT02260986|3527504|B4|Netherlands||Region of Enrollment||participants|Number|43|43.0||||||
3684622|NCT02260986|3527505|B3|Netherlands||Region of Enrollment||participants|Number|19|19.0||||||
3684623|NCT02260986|3527506|B2|Netherlands||Region of Enrollment||participants|Number|7|7.0||||||
3684624|NCT02260986|3527507|B1|Netherlands||Region of Enrollment||participants|Number|17|17.0||||||
3684625|NCT02260986|3527504|B4|Czech Republic||Region of Enrollment||participants|Number|20|20.0||||||
3684626|NCT02260986|3527505|B3|Czech Republic||Region of Enrollment||participants|Number|6|6.0||||||
3684627|NCT02260986|3527506|B2|Czech Republic||Region of Enrollment||participants|Number|7|7.0||||||
3684628|NCT02260986|3527507|B1|Czech Republic||Region of Enrollment||participants|Number|7|7.0||||||
3684629|NCT02260986|3527504|B4|Canada||Region of Enrollment||participants|Number|115|115.0||||||
3684630|NCT02260986|3527505|B3|Canada||Region of Enrollment||participants|Number|51|51.0||||||
3684631|NCT02260986|3527506|B2|Canada||Region of Enrollment||participants|Number|17|17.0||||||
3684632|NCT02260986|3527507|B1|Canada||Region of Enrollment||participants|Number|47|47.0||||||
3684633|NCT02260986|3527504|B4|New Zealand||Region of Enrollment||participants|Number|5|5.0||||||
3684634|NCT02260986|3527505|B3|New Zealand||Region of Enrollment||participants|Number|3|3.0||||||
3684635|NCT02260986|3527506|B2|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
3684636|NCT02260986|3527507|B1|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
3684637|NCT02260986|3527504|B4|Spain||Region of Enrollment||participants|Number|10|10.0||||||
3684638|NCT02260986|3527505|B3|Spain||Region of Enrollment||participants|Number|4|4.0||||||
3684639|NCT02260986|3527506|B2|Spain||Region of Enrollment||participants|Number|2|2.0||||||
3684640|NCT02260986|3527507|B1|Spain||Region of Enrollment||participants|Number|4|4.0||||||
3684641|NCT02260986|3527504|B4|United Kingdom||Region of Enrollment||participants|Number|36|36.0||||||
3684642|NCT02260986|3527505|B3|United Kingdom||Region of Enrollment||participants|Number|15|15.0||||||
3684643|NCT02260986|3527506|B2|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3684644|NCT02260986|3527507|B1|United Kingdom||Region of Enrollment||participants|Number|17|17.0||||||
3684648|NCT02260986|3527507|B1|Japan||Region of Enrollment||participants|Number|54|54.0||||||
3684649|NCT02260986|3527504|B4|United States||Region of Enrollment||participants|Number|139|139.0||||||
3684650|NCT02260986|3527505|B3|United States||Region of Enrollment||participants|Number|59|59.0||||||
3684651|NCT02260986|3527506|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3684652|NCT02260986|3527507|B1|United States||Region of Enrollment||participants|Number|61|61.0||||||
3684653|NCT02260986|3527504|B4|Hungary||Region of Enrollment||participants|Number|27|27.0||||||
3684654|NCT02260986|3527505|B3|Hungary||Region of Enrollment||participants|Number|11|11.0||||||
3684655|NCT02260986|3527506|B2|Hungary||Region of Enrollment||participants|Number|5|5.0||||||
3684656|NCT02260986|3527507|B1|Hungary||Region of Enrollment||participants|Number|11|11.0||||||
3684657|NCT02260986|3527504|B4|Romania||Region of Enrollment||participants|Number|4|4.0||||||
3684658|NCT02260986|3527505|B3|Romania||Region of Enrollment||participants|Number|2|2.0||||||
3684659|NCT02260986|3527506|B2|Romania||Region of Enrollment||participants|Number|0|0.0||||||
3684660|NCT02260986|3527507|B1|Romania||Region of Enrollment||participants|Number|2|2.0||||||
3684661|NCT02260986|3527504|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3684662|NCT02260986|3527505|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3684663|NCT02260986|3527506|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3684664|NCT02260986|3527507|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3684665|NCT02260986|3527504|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684666|NCT02260986|3527505|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684667|NCT02260986|3527506|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684668|NCT02260986|3527507|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684669|NCT02260986|3527504|B4||White|Race (NIH/OMB)||Participants|Count of Participants|490|490.0||||||
3684670|NCT02260986|3527505|B3||White|Race (NIH/OMB)||Participants|Count of Participants|208|208.0||||||
3684671|NCT02260986|3527506|B2||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3684672|NCT02260986|3527507|B1||White|Race (NIH/OMB)||Participants|Count of Participants|208|208.0||||||
3684673|NCT02260986|3527504|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3684674|NCT02260986|3527505|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3684675|NCT02260986|3527506|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3684676|NCT02260986|3527507|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3684677|NCT02260986|3527504|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684678|NCT02260986|3527505|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684679|NCT02260986|3527506|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684680|NCT02260986|3527507|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684681|NCT02260986|3527504|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|201|201.0||||||
3684682|NCT02260986|3527505|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
3684683|NCT02260986|3527506|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3684684|NCT02260986|3527507|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3684685|NCT02260986|3527504|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684686|NCT02260986|3527505|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684687|NCT02260986|3527506|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684688|NCT02260986|3527507|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684689|NCT02260986|3527504|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3684690|NCT02260986|3527505|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3684691|NCT02260986|3527506|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3684692|NCT02260986|3527507|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3684693|NCT02260986|3527504|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|711|711.0||||||
3684694|NCT02260986|3527505|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|309|309.0||||||
3684695|NCT02260986|3527506|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
3684696|NCT02260986|3527507|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|299|299.0||||||
3684697|NCT02260986|3527504|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3684698|NCT02260986|3527505|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3684699|NCT02260986|3527506|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3684700|NCT02260986|3527507|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3684701|NCT02260986|3527504|B4||Male|Sex: Female, Male||Participants|Count of Participants|446|446.0||||||
3684702|NCT02260986|3527505|B3||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
3684703|NCT02260986|3527506|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3684704|NCT02260986|3527507|B1||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
3684705|NCT02260986|3527504|B4||Female|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
3684706|NCT02260986|3527505|B3||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3684707|NCT02260986|3527506|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3684708|NCT02260986|3527507|B1||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3684709|NCT02260986|3527504|B4|||Age||years|Mean|37.1|37.1|Standard Deviation|13.46|13.46|||
3684710|NCT02260986|3527505|B3|||Age||years|Mean|36.9|36.9|Standard Deviation|13.67|13.67|||
3684711|NCT02260986|3527506|B2|||Age||years|Mean|39.6|39.6|Standard Deviation|13.98|13.98|||
3684712|NCT02260986|3527507|B1|||Age||years|Mean|36.6|36.6|Standard Deviation|13.01|13.01|||
3684713|NCT02260882|3527625|B3||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3684714|NCT02260882|3527626|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3684715|NCT02260882|3527627|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3684716|NCT02260882|3527625|B3||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3684717|NCT02260882|3527626|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3684718|NCT02260882|3527627|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3684719|NCT02260882|3527625|B3|||Age||Years|Mean|78.6|78.6|Standard Deviation|4.8|4.8|||
3684720|NCT02260882|3527626|B2|||Age||Years|Mean|78.2|78.2|Standard Deviation|5.0|5.0|||
3684721|NCT02260882|3527627|B1|||Age||Years|Mean|78.8|78.8|Standard Deviation|4.8|4.8|||
3684722|NCT02260791|3527650|B3|Russia||Region of Enrollment||participants|Number|109|109.0||||||
3684723|NCT02260791|3527651|B2|Russia||Region of Enrollment||participants|Number|52|52.0||||||
3684724|NCT02260791|3527652|B1|Russia||Region of Enrollment||participants|Number|57|57.0||||||
3684725|NCT02260791|3527650|B3|Spain||Region of Enrollment||participants|Number|10|10.0||||||
3684726|NCT02260791|3527651|B2|Spain||Region of Enrollment||participants|Number|6|6.0||||||
3684727|NCT02260791|3527652|B1|Spain||Region of Enrollment||participants|Number|4|4.0||||||
3684728|NCT02260791|3527650|B3|Germany||Region of Enrollment||participants|Number|26|26.0||||||
3684729|NCT02260791|3527651|B2|Germany||Region of Enrollment||participants|Number|12|12.0||||||
3684730|NCT02260791|3527652|B1|Germany||Region of Enrollment||participants|Number|14|14.0||||||
3684731|NCT02260791|3527650|B3|Peru||Region of Enrollment||participants|Number|100|100.0||||||
3684732|NCT02260791|3527651|B2|Peru||Region of Enrollment||participants|Number|49|49.0||||||
3684733|NCT02260791|3527652|B1|Peru||Region of Enrollment||participants|Number|51|51.0||||||
3684734|NCT02260791|3527650|B3|Chile||Region of Enrollment||participants|Number|41|41.0||||||
3684735|NCT02260791|3527651|B2|Chile||Region of Enrollment||participants|Number|21|21.0||||||
3684736|NCT02260791|3527652|B1|Chile||Region of Enrollment||participants|Number|20|20.0||||||
3684737|NCT02260791|3527650|B3|Bulgaria||Region of Enrollment||participants|Number|14|14.0||||||
3684738|NCT02260791|3527651|B2|Bulgaria||Region of Enrollment||participants|Number|7|7.0||||||
3684739|NCT02260791|3527652|B1|Bulgaria||Region of Enrollment||participants|Number|7|7.0||||||
3684740|NCT02260791|3527650|B3|Poland||Region of Enrollment||participants|Number|134|134.0||||||
3684741|NCT02260791|3527651|B2|Poland||Region of Enrollment||participants|Number|67|67.0||||||
3684742|NCT02260791|3527652|B1|Poland||Region of Enrollment||participants|Number|67|67.0||||||
3684743|NCT02260791|3527650|B3|Ukraine||Region of Enrollment||participants|Number|114|114.0||||||
3684744|NCT02260791|3527651|B2|Ukraine||Region of Enrollment||participants|Number|58|58.0||||||
3684745|NCT02260791|3527652|B1|Ukraine||Region of Enrollment||participants|Number|56|56.0||||||
3684746|NCT02260791|3527650|B3|Czech Republic||Region of Enrollment||participants|Number|67|67.0||||||
3684747|NCT02260791|3527651|B2|Czech Republic||Region of Enrollment||participants|Number|34|34.0||||||
3684748|NCT02260791|3527652|B1|Czech Republic||Region of Enrollment||participants|Number|33|33.0||||||
3684749|NCT02260791|3527650|B3|United States||Region of Enrollment||participants|Number|78|78.0||||||
3684750|NCT02260791|3527651|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
3684751|NCT02260791|3527652|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
3684752|NCT02260791|3527650|B3|Romania||Region of Enrollment||participants|Number|28|28.0||||||
3684753|NCT02260791|3527651|B2|Romania||Region of Enrollment||participants|Number|13|13.0||||||
3684754|NCT02260791|3527652|B1|Romania||Region of Enrollment||participants|Number|15|15.0||||||
3684755|NCT02260791|3527650|B3|Canada||Region of Enrollment||participants|Number|7|7.0||||||
3684756|NCT02260791|3527651|B2|Canada||Region of Enrollment||participants|Number|4|4.0||||||
3684757|NCT02260791|3527652|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
3684758|NCT02260791|3527650|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3684759|NCT02260791|3527651|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3684760|NCT02260791|3527652|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3684761|NCT02260791|3527650|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684762|NCT02260791|3527651|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684763|NCT02260791|3527652|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684764|NCT02260791|3527650|B3||White|Race (NIH/OMB)||Participants|Count of Participants|619|619.0||||||
3684765|NCT02260791|3527651|B2||White|Race (NIH/OMB)||Participants|Count of Participants|308|308.0||||||
3684766|NCT02260791|3527652|B1||White|Race (NIH/OMB)||Participants|Count of Participants|311|311.0||||||
3684767|NCT02260791|3527650|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3684768|NCT02260791|3527651|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3684769|NCT02260791|3527652|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3684770|NCT02260791|3527650|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684771|NCT02260791|3527651|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684772|NCT02260791|3527652|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684773|NCT02260791|3527650|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3684774|NCT02260791|3527651|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3684775|NCT02260791|3527652|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3684776|NCT02260791|3527650|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3684777|NCT02260791|3527651|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3684778|NCT02260791|3527652|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3684779|NCT02260791|3527650|B3||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3684780|NCT02260791|3527651|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3684781|NCT02260791|3527652|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3684782|NCT02260791|3527650|B3||Female|Sex: Female, Male||Participants|Count of Participants|565|565.0||||||
3684783|NCT02260791|3527651|B2||Female|Sex: Female, Male||Participants|Count of Participants|284|284.0||||||
3684784|NCT02260791|3527652|B1||Female|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
3684785|NCT02260791|3527650|B3|>65 years||Age, Customized||Participants|Count of Participants|127|127.0||||||
3684786|NCT02260791|3527651|B2|>65 years||Age, Customized||Participants|Count of Participants|63|63.0||||||
3684787|NCT02260791|3527652|B1|>65 years||Age, Customized||Participants|Count of Participants|64|64.0||||||
3684788|NCT02260791|3527650|B3|Between 18 and 65 years||Age, Customized||Participants|Count of Participants|601|601.0||||||
3684789|NCT02260791|3527651|B2|Between 18 and 65 years||Age, Customized||Participants|Count of Participants|299|299.0||||||
3684790|NCT02260791|3527652|B1|Between 18 and 65 years||Age, Customized||Participants|Count of Participants|302|302.0||||||
3684791|NCT02260791|3527650|B3|<18 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3684792|NCT02260791|3527651|B2|<18 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3684793|NCT02260791|3527652|B1|<18 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3684794|NCT02260791|3527650|B3|||Age||years|Mean|53.3|53.3|Full Range|||18.0|93.0|
3684795|NCT02260791|3527651|B2|||Age||years|Mean|53.6|53.6|Full Range|||21.0|93.0|
3684796|NCT02260791|3527652|B1|||Age||years|Mean|53|53.0|Full Range|||18.0|85.0|
3684797|NCT02260648|3527689|B4|Japan||Region of Enrollment||Participants|Count of Participants|149|149.0||||||
3684798|NCT02260648|3527690|B3|Japan||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3684799|NCT02260648|3527691|B2|Japan||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
3684800|NCT02260648|3527692|B1|Japan||Region of Enrollment||Participants|Count of Participants|53|53.0||||||
3684801|NCT02260648|3527689|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684802|NCT02260648|3527690|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684803|NCT02260648|3527691|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684804|NCT02260648|3527692|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684805|NCT02260648|3527689|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684806|NCT02260648|3527690|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684807|NCT02260648|3527691|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684808|NCT02260648|3527692|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684809|NCT02260648|3527689|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684810|NCT02260648|3527690|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684811|NCT02260648|3527691|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684812|NCT02260648|3527692|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684813|NCT02260648|3527689|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684814|NCT02260648|3527690|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684815|NCT02260648|3527691|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684816|NCT02260648|3527692|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684817|NCT02260648|3527689|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684818|NCT02260648|3527690|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684819|NCT02260648|3527691|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684820|NCT02260648|3527692|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684821|NCT02260648|3527689|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|149|149.0||||||
3684822|NCT02260648|3527690|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3684823|NCT02260648|3527691|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3684824|NCT02260648|3527692|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3684825|NCT02260648|3527689|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684826|NCT02260648|3527690|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684827|NCT02260648|3527691|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684828|NCT02260648|3527692|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684829|NCT02260648|3527689|B4||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3684830|NCT02260648|3527690|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3684831|NCT02260648|3527691|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3684832|NCT02260648|3527692|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3684833|NCT02260648|3527689|B4||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3684834|NCT02260648|3527690|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3684835|NCT02260648|3527691|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3684836|NCT02260648|3527692|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3684837|NCT02260648|3527689|B4|||Age||years|Mean|58.2|58.2|Standard Deviation|10.87|10.87|||
3684838|NCT02260648|3527690|B3|||Age||years|Mean|58.0|58.0|Standard Deviation|10.40|10.4|||
3684839|NCT02260648|3527691|B2|||Age||years|Mean|57.9|57.9|Standard Deviation|10.81|10.81|||
3684840|NCT02260648|3527692|B1|||Age||years|Mean|58.5|58.5|Standard Deviation|11.53|11.53|||
3684841|NCT02260635|3527720|B3|Japan||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
3684842|NCT02260635|3527721|B2|Japan||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3684843|NCT02260635|3527722|B1|Japan||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3684844|NCT02260635|3527720|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684845|NCT02260635|3527721|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684846|NCT02260635|3527722|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684847|NCT02260635|3527720|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684848|NCT02260635|3527721|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684849|NCT02260635|3527722|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684850|NCT02260635|3527720|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684851|NCT02260635|3527721|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684852|NCT02260635|3527722|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684853|NCT02260635|3527720|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684854|NCT02260635|3527721|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684855|NCT02260635|3527722|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684856|NCT02260635|3527720|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684857|NCT02260635|3527721|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684858|NCT02260635|3527722|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684859|NCT02260635|3527720|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3684860|NCT02260635|3527721|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3684861|NCT02260635|3527722|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3684862|NCT02260635|3527720|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684863|NCT02260635|3527721|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684864|NCT02260635|3527722|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684865|NCT02260635|3527720|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3684866|NCT02260635|3527721|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3684867|NCT02260635|3527722|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3684868|NCT02260635|3527720|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3684869|NCT02260635|3527721|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3684870|NCT02260635|3527722|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3684871|NCT02260635|3527720|B3|||Age||years|Mean|52.8|52.8|Standard Deviation|10.08|10.08|||
3684872|NCT02260635|3527721|B2|||Age||years|Mean|53.3|53.3|Standard Deviation|10.13|10.13|||
3684873|NCT02260635|3527722|B1|||Age||years|Mean|52.2|52.2|Standard Deviation|10.19|10.19|||
3684874|NCT02260492|3527743|B4|||Airways Reversibility with Albuterol|Patients were screened for their airways reversibility following albuterol. Baseline FEV1 was measured then the patient received 360 mcg of albuterol (pMDI), a short-acting adrenergic agonist. Within 30 min of albuterol administration, lung function was measured again. Inclusion Criteria #5 required at least 15% reversibility or improvement in FEV1.|% change from pre-albuterol lung functio|Mean|29.9|29.9|Standard Deviation|18.3|18.3|||
3684875|NCT02260492|3527744|B3|||Airways Reversibility with Albuterol|Patients were screened for their airways reversibility following albuterol. Baseline FEV1 was measured then the patient received 360 mcg of albuterol (pMDI), a short-acting adrenergic agonist. Within 30 min of albuterol administration, lung function was measured again. Inclusion Criteria #5 required at least 15% reversibility or improvement in FEV1.|% change from pre-albuterol lung functio|Mean|25.9|25.9|Standard Deviation|13.3|13.3|||
3684927|NCT02260492|3527744|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3684928|NCT02260492|3527745|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|301|301.0||||||
3684876|NCT02260492|3527745|B2|||Airways Reversibility with Albuterol|Patients were screened for their airways reversibility following albuterol. Baseline FEV1 was measured then the patient received 360 mcg of albuterol (pMDI), a short-acting adrenergic agonist. Within 30 min of albuterol administration, lung function was measured again. Inclusion Criteria #5 required at least 15% reversibility or improvement in FEV1.|% change from pre-albuterol lung functio|Mean|29.7|29.7|Standard Deviation|17.5|17.5|||
3684877|NCT02260492|3527746|B1|||Airways Reversibility with Albuterol|Patients were screened for their airways reversibility following albuterol. Baseline FEV1 was measured then the patient received 360 mcg of albuterol (pMDI), a short-acting adrenergic agonist. Within 30 min of albuterol administration, lung function was measured again. Inclusion Criteria #5 required at least 15% reversibility or improvement in FEV1.|% change from pre-albuterol lung functio|Mean|30.5|30.5|Standard Deviation|19.3|19.3|||
3684878|NCT02260492|3527743|B4|||Body Mass Index||Kg/m^2|Mean|30.63|30.63|Standard Deviation|7.40|7.4|||
3684879|NCT02260492|3527744|B3|||Body Mass Index||Kg/m^2|Mean|29.32|29.32|Standard Deviation|6.30|6.3|||
3684880|NCT02260492|3527745|B2|||Body Mass Index||Kg/m^2|Mean|29.91|29.91|Standard Deviation|7.20|7.2|||
3684881|NCT02260492|3527746|B1|||Body Mass Index||Kg/m^2|Mean|31.49|31.49|Standard Deviation|7.61|7.61|||
3684882|NCT02260492|3527743|B4|||Height (cm)||cm|Mean|168.2|168.2|Standard Deviation|10.2|10.2|||
3684883|NCT02260492|3527744|B3|||Height (cm)||cm|Mean|166.3|166.3|Standard Deviation|8.3|8.3|||
3684884|NCT02260492|3527745|B2|||Height (cm)||cm|Mean|169.2|169.2|Standard Deviation|10.7|10.7|||
3684885|NCT02260492|3527746|B1|||Height (cm)||cm|Mean|167.5|167.5|Standard Deviation|9.9|9.9|||
3684886|NCT02260492|3527743|B4|||Weight (kg)||Kg|Mean|86.9|86.9|Standard Deviation|22.8|22.8|||
3684887|NCT02260492|3527744|B3|||Weight (kg)||Kg|Mean|81.0|81.0|Standard Deviation|17.2|17.2|||
3684888|NCT02260492|3527745|B2|||Weight (kg)||Kg|Mean|85.9|85.9|Standard Deviation|23.1|23.1|||
3684889|NCT02260492|3527746|B1|||Weight (kg)||Kg|Mean|88.5|88.5|Standard Deviation|22.9|22.9|||
3684890|NCT02260492|3527743|B4|United States||Region of Enrollment||participants|Number|879|879.0||||||
3684891|NCT02260492|3527744|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
3684892|NCT02260492|3527745|B2|United States||Region of Enrollment||participants|Number|419|419.0||||||
3684893|NCT02260492|3527746|B1|United States||Region of Enrollment||participants|Number|418|418.0||||||
3684894|NCT02260492|3527743|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684895|NCT02260492|3527744|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684896|NCT02260492|3527745|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684897|NCT02260492|3527746|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684898|NCT02260492|3527743|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3684899|NCT02260492|3527744|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3684900|NCT02260492|3527745|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3684901|NCT02260492|3527746|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3684902|NCT02260492|3527743|B4||White|Race (NIH/OMB)||Participants|Count of Participants|669|669.0||||||
3684903|NCT02260492|3527744|B3||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3684904|NCT02260492|3527745|B2||White|Race (NIH/OMB)||Participants|Count of Participants|308|308.0||||||
3684905|NCT02260492|3527746|B1||White|Race (NIH/OMB)||Participants|Count of Participants|332|332.0||||||
3684906|NCT02260492|3527743|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|173|173.0||||||
3684907|NCT02260492|3527744|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3684908|NCT02260492|3527745|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
3684909|NCT02260492|3527746|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3684910|NCT02260492|3527743|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3684911|NCT02260492|3527744|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684912|NCT02260492|3527745|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3684913|NCT02260492|3527746|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684914|NCT02260492|3527743|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3684915|NCT02260492|3527744|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3684916|NCT02260492|3527745|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3684917|NCT02260492|3527746|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3684918|NCT02260492|3527743|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3684919|NCT02260492|3527744|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684920|NCT02260492|3527745|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3684921|NCT02260492|3527746|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3684922|NCT02260492|3527743|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684923|NCT02260492|3527744|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684924|NCT02260492|3527745|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684925|NCT02260492|3527746|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684926|NCT02260492|3527743|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|630|630.0||||||
3684929|NCT02260492|3527746|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|296|296.0||||||
3684930|NCT02260492|3527743|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|249|249.0||||||
3684931|NCT02260492|3527744|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3684932|NCT02260492|3527745|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|118|118.0||||||
3684933|NCT02260492|3527746|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
3684934|NCT02260492|3527743|B4||Male|Sex: Female, Male||Participants|Count of Participants|324|324.0||||||
3684935|NCT02260492|3527744|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3684936|NCT02260492|3527745|B2||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3684937|NCT02260492|3527746|B1||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3684938|NCT02260492|3527743|B4||Female|Sex: Female, Male||Participants|Count of Participants|555|555.0||||||
3684939|NCT02260492|3527744|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3684940|NCT02260492|3527745|B2||Female|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
3684941|NCT02260492|3527746|B1||Female|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
3684942|NCT02260492|3527743|B4|||Age||years|Mean|43.6|43.6|Standard Deviation|14.42|14.42|||
3684943|NCT02260492|3527744|B3|||Age||years|Mean|43.2|43.2|Standard Deviation|15.25|15.25|||
3684944|NCT02260492|3527745|B2|||Age||years|Mean|43.3|43.3|Standard Deviation|14.26|14.26|||
3684945|NCT02260492|3527746|B1|||Age||years|Mean|43.9|43.9|Standard Deviation|14.52|14.52|||
3684946|NCT02260440|3527762|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3684947|NCT02260440|3527762|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3684948|NCT02260440|3527762|B1|||Age||years|Median|61|61.0|Full Range|||30.0|79.0|
3684949|NCT02260401|3527768|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3684950|NCT02260401|3527769|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3684951|NCT02260401|3527770|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3684952|NCT02260401|3527768|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|156|156.0||||||
3684953|NCT02260401|3527769|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
3684954|NCT02260401|3527770|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3684955|NCT02260401|3527768|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3684956|NCT02260401|3527769|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3684957|NCT02260401|3527770|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3684958|NCT02260401|3527768|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3684959|NCT02260401|3527769|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3684960|NCT02260401|3527770|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3684961|NCT02260401|3527768|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3684962|NCT02260401|3527769|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3684963|NCT02260401|3527770|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3684964|NCT02260401|3527768|B3|||Age||years|Mean|67.8|67.8|Standard Deviation|9.7|9.7|||
3684965|NCT02260401|3527769|B2|||Age||years|Mean|69.1|69.1|Standard Deviation|9.4|9.4|||
3684966|NCT02260401|3527770|B1|||Age||years|Mean|66.4|66.4|Standard Deviation|10|10.0|||
3684967|NCT02260388|3527777|B5|||Likert Pain Scale|Likert Pain Scale - Incremental Scale 0 to 10 with 10 indicating most pain.|units on a scale|Mean|6.7|6.7|Standard Deviation|1.6|1.6|||
3684968|NCT02260388|3527778|B4|||Likert Pain Scale|Likert Pain Scale - Incremental Scale 0 to 10 with 10 indicating most pain.|units on a scale|Mean|6.5|6.5|Standard Deviation|1.7|1.7|||
3684969|NCT02260388|3527779|B3|||Likert Pain Scale|Likert Pain Scale - Incremental Scale 0 to 10 with 10 indicating most pain.|units on a scale|Mean|6.4|6.4|Standard Deviation|1.6|1.6|||
3684970|NCT02260388|3527780|B2|||Likert Pain Scale|Likert Pain Scale - Incremental Scale 0 to 10 with 10 indicating most pain.|units on a scale|Mean|6.7|6.7|Standard Deviation|1.6|1.6|||
3684971|NCT02260388|3527781|B1|||Likert Pain Scale|Likert Pain Scale - Incremental Scale 0 to 10 with 10 indicating most pain.|units on a scale|Mean|6.9|6.9|Standard Deviation|1.5|1.5|||
3684972|NCT02260388|3527777|B5|Mental Component Score||SF12 Health Component Scores|"SF-12v2® Health Survey Standard The Optum™ SF-12v2® Health Survey is a shorter version of the SF-36v2® Health Survey that uses just 12 questions to measure functional health and well-being from the patient’s point of view.~Survey provides psychometrically-based physical component summary (PCS) and mental component summary (MCS) scores.~Scores are calibrated so that 50 is the average score or norm, standard deviation = 10.~Higher scores indicate better health for both mental and physical component summary scores."|Norm-Based Standardization Score|Mean|47.2|47.2|Standard Deviation|10.6|10.6|||
3684973|NCT02260388|3527778|B4|Mental Component Score||SF12 Health Component Scores|"SF-12v2® Health Survey Standard The Optum™ SF-12v2® Health Survey is a shorter version of the SF-36v2® Health Survey that uses just 12 questions to measure functional health and well-being from the patient’s point of view.~Survey provides psychometrically-based physical component summary (PCS) and mental component summary (MCS) scores.~Scores are calibrated so that 50 is the average score or norm, standard deviation = 10.~Higher scores indicate better health for both mental and physical component summary scores."|Norm-Based Standardization Score|Mean|47.2|47.2|Standard Deviation|11.1|11.1|||
3685036|NCT02260388|3527781|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3685037|NCT02260388|3527777|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3684974|NCT02260388|3527779|B3|Mental Component Score||SF12 Health Component Scores|"SF-12v2® Health Survey Standard The Optum™ SF-12v2® Health Survey is a shorter version of the SF-36v2® Health Survey that uses just 12 questions to measure functional health and well-being from the patient’s point of view.~Survey provides psychometrically-based physical component summary (PCS) and mental component summary (MCS) scores.~Scores are calibrated so that 50 is the average score or norm, standard deviation = 10.~Higher scores indicate better health for both mental and physical component summary scores."|Norm-Based Standardization Score|Mean|46.8|46.8|Standard Deviation|11.3|11.3|||
3684975|NCT02260388|3527780|B2|Mental Component Score||SF12 Health Component Scores|"SF-12v2® Health Survey Standard The Optum™ SF-12v2® Health Survey is a shorter version of the SF-36v2® Health Survey that uses just 12 questions to measure functional health and well-being from the patient’s point of view.~Survey provides psychometrically-based physical component summary (PCS) and mental component summary (MCS) scores.~Scores are calibrated so that 50 is the average score or norm, standard deviation = 10.~Higher scores indicate better health for both mental and physical component summary scores."|Norm-Based Standardization Score|Mean|46.7|46.7|Standard Deviation|10.1|10.1|||
3684976|NCT02260388|3527781|B1|Mental Component Score||SF12 Health Component Scores|"SF-12v2® Health Survey Standard The Optum™ SF-12v2® Health Survey is a shorter version of the SF-36v2® Health Survey that uses just 12 questions to measure functional health and well-being from the patient’s point of view.~Survey provides psychometrically-based physical component summary (PCS) and mental component summary (MCS) scores.~Scores are calibrated so that 50 is the average score or norm, standard deviation = 10.~Higher scores indicate better health for both mental and physical component summary scores."|Norm-Based Standardization Score|Mean|48.0|48.0|Standard Deviation|10.4|10.4|||
3684977|NCT02260388|3527777|B5|Physical Component Score||SF12 Health Component Scores|"SF-12v2® Health Survey Standard The Optum™ SF-12v2® Health Survey is a shorter version of the SF-36v2® Health Survey that uses just 12 questions to measure functional health and well-being from the patient’s point of view.~Survey provides psychometrically-based physical component summary (PCS) and mental component summary (MCS) scores.~Scores are calibrated so that 50 is the average score or norm, standard deviation = 10.~Higher scores indicate better health for both mental and physical component summary scores."|Norm-Based Standardization Score|Mean|38.7|38.7|Standard Deviation|9.4|9.4|||
3684978|NCT02260388|3527778|B4|Physical Component Score||SF12 Health Component Scores|"SF-12v2® Health Survey Standard The Optum™ SF-12v2® Health Survey is a shorter version of the SF-36v2® Health Survey that uses just 12 questions to measure functional health and well-being from the patient’s point of view.~Survey provides psychometrically-based physical component summary (PCS) and mental component summary (MCS) scores.~Scores are calibrated so that 50 is the average score or norm, standard deviation = 10.~Higher scores indicate better health for both mental and physical component summary scores."|Norm-Based Standardization Score|Mean|41.1|41.1|Standard Deviation|10.1|10.1|||
3684979|NCT02260388|3527779|B3|Physical Component Score||SF12 Health Component Scores|"SF-12v2® Health Survey Standard The Optum™ SF-12v2® Health Survey is a shorter version of the SF-36v2® Health Survey that uses just 12 questions to measure functional health and well-being from the patient’s point of view.~Survey provides psychometrically-based physical component summary (PCS) and mental component summary (MCS) scores.~Scores are calibrated so that 50 is the average score or norm, standard deviation = 10.~Higher scores indicate better health for both mental and physical component summary scores."|Norm-Based Standardization Score|Mean|37.9|37.9|Standard Deviation|9.1|9.1|||
3684980|NCT02260388|3527780|B2|Physical Component Score||SF12 Health Component Scores|"SF-12v2® Health Survey Standard The Optum™ SF-12v2® Health Survey is a shorter version of the SF-36v2® Health Survey that uses just 12 questions to measure functional health and well-being from the patient’s point of view.~Survey provides psychometrically-based physical component summary (PCS) and mental component summary (MCS) scores.~Scores are calibrated so that 50 is the average score or norm, standard deviation = 10.~Higher scores indicate better health for both mental and physical component summary scores."|Norm-Based Standardization Score|Mean|38.5|38.5|Standard Deviation|9.3|9.3|||
3684981|NCT02260388|3527781|B1|Physical Component Score||SF12 Health Component Scores|"SF-12v2® Health Survey Standard The Optum™ SF-12v2® Health Survey is a shorter version of the SF-36v2® Health Survey that uses just 12 questions to measure functional health and well-being from the patient’s point of view.~Survey provides psychometrically-based physical component summary (PCS) and mental component summary (MCS) scores.~Scores are calibrated so that 50 is the average score or norm, standard deviation = 10.~Higher scores indicate better health for both mental and physical component summary scores."|Norm-Based Standardization Score|Mean|38.0|38.0|Standard Deviation|9.3|9.3|||
3684982|NCT02260388|3527777|B5|PROMIS Sleep Disturbance T-Score||Patient-Reported Outcomes Measurement Information System (PROMIS) Scale T-Scores|"T-score metric: 50 is the mean of a relevant reference population and 10 is the standard deviation (SD). A score of 40 is one SD lower than the mean of the reference population; A score of 60 is one SD higher than the mean of the reference population~PROMIS Pain Interference Short Form v1.0 8a: Higher scores for pain interference represents worse outcome (more pain interference) PROMIS Fatigue Short Form v1.0 8a Higher scores indicate more fatigue (worse outcome).~PROMIS Sleep Disturbance Short Form v1.0 8a Higher scores indicate more sleep disturbance (worse outcome)."|T-Score|Mean|59.3|59.3|Standard Deviation|9.5|9.5|||
3684983|NCT02260388|3527778|B4|PROMIS Sleep Disturbance T-Score||Patient-Reported Outcomes Measurement Information System (PROMIS) Scale T-Scores|"T-score metric: 50 is the mean of a relevant reference population and 10 is the standard deviation (SD). A score of 40 is one SD lower than the mean of the reference population; A score of 60 is one SD higher than the mean of the reference population~PROMIS Pain Interference Short Form v1.0 8a: Higher scores for pain interference represents worse outcome (more pain interference) PROMIS Fatigue Short Form v1.0 8a Higher scores indicate more fatigue (worse outcome).~PROMIS Sleep Disturbance Short Form v1.0 8a Higher scores indicate more sleep disturbance (worse outcome)."|T-Score|Mean|57.0|57.0|Standard Deviation|11.4|11.4|||
3685038|NCT02260388|3527778|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685039|NCT02260388|3527779|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3685040|NCT02260388|3527780|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3685041|NCT02260388|3527781|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3684984|NCT02260388|3527779|B3|PROMIS Sleep Disturbance T-Score||Patient-Reported Outcomes Measurement Information System (PROMIS) Scale T-Scores|"T-score metric: 50 is the mean of a relevant reference population and 10 is the standard deviation (SD). A score of 40 is one SD lower than the mean of the reference population; A score of 60 is one SD higher than the mean of the reference population~PROMIS Pain Interference Short Form v1.0 8a: Higher scores for pain interference represents worse outcome (more pain interference) PROMIS Fatigue Short Form v1.0 8a Higher scores indicate more fatigue (worse outcome).~PROMIS Sleep Disturbance Short Form v1.0 8a Higher scores indicate more sleep disturbance (worse outcome)."|T-Score|Mean|59.8|59.8|Standard Deviation|8.7|8.7|||
3684985|NCT02260388|3527780|B2|PROMIS Sleep Disturbance T-Score||Patient-Reported Outcomes Measurement Information System (PROMIS) Scale T-Scores|"T-score metric: 50 is the mean of a relevant reference population and 10 is the standard deviation (SD). A score of 40 is one SD lower than the mean of the reference population; A score of 60 is one SD higher than the mean of the reference population~PROMIS Pain Interference Short Form v1.0 8a: Higher scores for pain interference represents worse outcome (more pain interference) PROMIS Fatigue Short Form v1.0 8a Higher scores indicate more fatigue (worse outcome).~PROMIS Sleep Disturbance Short Form v1.0 8a Higher scores indicate more sleep disturbance (worse outcome)."|T-Score|Mean|60.6|60.6|Standard Deviation|8.3|8.3|||
3684986|NCT02260388|3527781|B1|PROMIS Sleep Disturbance T-Score||Patient-Reported Outcomes Measurement Information System (PROMIS) Scale T-Scores|"T-score metric: 50 is the mean of a relevant reference population and 10 is the standard deviation (SD). A score of 40 is one SD lower than the mean of the reference population; A score of 60 is one SD higher than the mean of the reference population~PROMIS Pain Interference Short Form v1.0 8a: Higher scores for pain interference represents worse outcome (more pain interference) PROMIS Fatigue Short Form v1.0 8a Higher scores indicate more fatigue (worse outcome).~PROMIS Sleep Disturbance Short Form v1.0 8a Higher scores indicate more sleep disturbance (worse outcome)."|T-Score|Mean|59.1|59.1|Standard Deviation|9.8|9.8|||
3684987|NCT02260388|3527777|B5|PROMIS Fatigue T-Score||Patient-Reported Outcomes Measurement Information System (PROMIS) Scale T-Scores|"T-score metric: 50 is the mean of a relevant reference population and 10 is the standard deviation (SD). A score of 40 is one SD lower than the mean of the reference population; A score of 60 is one SD higher than the mean of the reference population~PROMIS Pain Interference Short Form v1.0 8a: Higher scores for pain interference represents worse outcome (more pain interference) PROMIS Fatigue Short Form v1.0 8a Higher scores indicate more fatigue (worse outcome).~PROMIS Sleep Disturbance Short Form v1.0 8a Higher scores indicate more sleep disturbance (worse outcome)."|T-Score|Mean|59.6|59.6|Standard Deviation|3.4|3.4|||
3684988|NCT02260388|3527778|B4|PROMIS Fatigue T-Score||Patient-Reported Outcomes Measurement Information System (PROMIS) Scale T-Scores|"T-score metric: 50 is the mean of a relevant reference population and 10 is the standard deviation (SD). A score of 40 is one SD lower than the mean of the reference population; A score of 60 is one SD higher than the mean of the reference population~PROMIS Pain Interference Short Form v1.0 8a: Higher scores for pain interference represents worse outcome (more pain interference) PROMIS Fatigue Short Form v1.0 8a Higher scores indicate more fatigue (worse outcome).~PROMIS Sleep Disturbance Short Form v1.0 8a Higher scores indicate more sleep disturbance (worse outcome)."|T-Score|Mean|59.7|59.7|Standard Deviation|3.2|3.2|||
3684989|NCT02260388|3527779|B3|PROMIS Fatigue T-Score||Patient-Reported Outcomes Measurement Information System (PROMIS) Scale T-Scores|"T-score metric: 50 is the mean of a relevant reference population and 10 is the standard deviation (SD). A score of 40 is one SD lower than the mean of the reference population; A score of 60 is one SD higher than the mean of the reference population~PROMIS Pain Interference Short Form v1.0 8a: Higher scores for pain interference represents worse outcome (more pain interference) PROMIS Fatigue Short Form v1.0 8a Higher scores indicate more fatigue (worse outcome).~PROMIS Sleep Disturbance Short Form v1.0 8a Higher scores indicate more sleep disturbance (worse outcome)."|T-Score|Mean|59.1|59.1|Standard Deviation|3.7|3.7|||
3684990|NCT02260388|3527780|B2|PROMIS Fatigue T-Score||Patient-Reported Outcomes Measurement Information System (PROMIS) Scale T-Scores|"T-score metric: 50 is the mean of a relevant reference population and 10 is the standard deviation (SD). A score of 40 is one SD lower than the mean of the reference population; A score of 60 is one SD higher than the mean of the reference population~PROMIS Pain Interference Short Form v1.0 8a: Higher scores for pain interference represents worse outcome (more pain interference) PROMIS Fatigue Short Form v1.0 8a Higher scores indicate more fatigue (worse outcome).~PROMIS Sleep Disturbance Short Form v1.0 8a Higher scores indicate more sleep disturbance (worse outcome)."|T-Score|Mean|59.7|59.7|Standard Deviation|3.3|3.3|||
3684991|NCT02260388|3527781|B1|PROMIS Fatigue T-Score||Patient-Reported Outcomes Measurement Information System (PROMIS) Scale T-Scores|"T-score metric: 50 is the mean of a relevant reference population and 10 is the standard deviation (SD). A score of 40 is one SD lower than the mean of the reference population; A score of 60 is one SD higher than the mean of the reference population~PROMIS Pain Interference Short Form v1.0 8a: Higher scores for pain interference represents worse outcome (more pain interference) PROMIS Fatigue Short Form v1.0 8a Higher scores indicate more fatigue (worse outcome).~PROMIS Sleep Disturbance Short Form v1.0 8a Higher scores indicate more sleep disturbance (worse outcome)."|T-Score|Mean|59.6|59.6|Standard Deviation|3.4|3.4|||
3684992|NCT02260388|3527777|B5|PROMIS Pain Interference T-Score||Patient-Reported Outcomes Measurement Information System (PROMIS) Scale T-Scores|"T-score metric: 50 is the mean of a relevant reference population and 10 is the standard deviation (SD). A score of 40 is one SD lower than the mean of the reference population; A score of 60 is one SD higher than the mean of the reference population~PROMIS Pain Interference Short Form v1.0 8a: Higher scores for pain interference represents worse outcome (more pain interference) PROMIS Fatigue Short Form v1.0 8a Higher scores indicate more fatigue (worse outcome).~PROMIS Sleep Disturbance Short Form v1.0 8a Higher scores indicate more sleep disturbance (worse outcome)."|T-Score|Mean|62.5|62.5|Standard Deviation|6.9|6.9|||
3684993|NCT02260388|3527778|B4|PROMIS Pain Interference T-Score||Patient-Reported Outcomes Measurement Information System (PROMIS) Scale T-Scores|"T-score metric: 50 is the mean of a relevant reference population and 10 is the standard deviation (SD). A score of 40 is one SD lower than the mean of the reference population; A score of 60 is one SD higher than the mean of the reference population~PROMIS Pain Interference Short Form v1.0 8a: Higher scores for pain interference represents worse outcome (more pain interference) PROMIS Fatigue Short Form v1.0 8a Higher scores indicate more fatigue (worse outcome).~PROMIS Sleep Disturbance Short Form v1.0 8a Higher scores indicate more sleep disturbance (worse outcome)."|T-Score|Mean|60.9|60.9|Standard Deviation|7.9|7.9|||
3684994|NCT02260388|3527779|B3|PROMIS Pain Interference T-Score||Patient-Reported Outcomes Measurement Information System (PROMIS) Scale T-Scores|"T-score metric: 50 is the mean of a relevant reference population and 10 is the standard deviation (SD). A score of 40 is one SD lower than the mean of the reference population; A score of 60 is one SD higher than the mean of the reference population~PROMIS Pain Interference Short Form v1.0 8a: Higher scores for pain interference represents worse outcome (more pain interference) PROMIS Fatigue Short Form v1.0 8a Higher scores indicate more fatigue (worse outcome).~PROMIS Sleep Disturbance Short Form v1.0 8a Higher scores indicate more sleep disturbance (worse outcome)."|T-Score|Mean|63.3|63.3|Standard Deviation|5.5|5.5|||
3684995|NCT02260388|3527780|B2|PROMIS Pain Interference T-Score||Patient-Reported Outcomes Measurement Information System (PROMIS) Scale T-Scores|"T-score metric: 50 is the mean of a relevant reference population and 10 is the standard deviation (SD). A score of 40 is one SD lower than the mean of the reference population; A score of 60 is one SD higher than the mean of the reference population~PROMIS Pain Interference Short Form v1.0 8a: Higher scores for pain interference represents worse outcome (more pain interference) PROMIS Fatigue Short Form v1.0 8a Higher scores indicate more fatigue (worse outcome).~PROMIS Sleep Disturbance Short Form v1.0 8a Higher scores indicate more sleep disturbance (worse outcome)."|T-Score|Mean|62.4|62.4|Standard Deviation|6.8|6.8|||
3684996|NCT02260388|3527781|B1|PROMIS Pain Interference T-Score||Patient-Reported Outcomes Measurement Information System (PROMIS) Scale T-Scores|"T-score metric: 50 is the mean of a relevant reference population and 10 is the standard deviation (SD). A score of 40 is one SD lower than the mean of the reference population; A score of 60 is one SD higher than the mean of the reference population~PROMIS Pain Interference Short Form v1.0 8a: Higher scores for pain interference represents worse outcome (more pain interference) PROMIS Fatigue Short Form v1.0 8a Higher scores indicate more fatigue (worse outcome).~PROMIS Sleep Disturbance Short Form v1.0 8a Higher scores indicate more sleep disturbance (worse outcome)."|T-Score|Mean|63.1|63.1|Standard Deviation|7.0|7.0|||
3684997|NCT02260388|3527777|B5|United States||Region of Enrollment||Participants|Count of Participants|402|402.0||||||
3684998|NCT02260388|3527778|B4|United States||Region of Enrollment||Participants|Count of Participants|69|69.0||||||
3684999|NCT02260388|3527779|B3|United States||Region of Enrollment||Participants|Count of Participants|73|73.0||||||
3685000|NCT02260388|3527780|B2|United States||Region of Enrollment||Participants|Count of Participants|126|126.0||||||
3685001|NCT02260388|3527781|B1|United States||Region of Enrollment||Participants|Count of Participants|134|134.0||||||
3685002|NCT02260388|3527777|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3685003|NCT02260388|3527778|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3685004|NCT02260388|3527779|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3685005|NCT02260388|3527780|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3685006|NCT02260388|3527781|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3685007|NCT02260388|3527777|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685008|NCT02260388|3527778|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685009|NCT02260388|3527779|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685010|NCT02260388|3527780|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685011|NCT02260388|3527781|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685012|NCT02260388|3527777|B5||White|Race (NIH/OMB)||Participants|Count of Participants|343|343.0||||||
3685013|NCT02260388|3527778|B4||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3685014|NCT02260388|3527779|B3||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3685015|NCT02260388|3527780|B2||White|Race (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
3685016|NCT02260388|3527781|B1||White|Race (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
3685017|NCT02260388|3527777|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3685018|NCT02260388|3527778|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3685019|NCT02260388|3527779|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3685020|NCT02260388|3527780|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3685021|NCT02260388|3527781|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3685022|NCT02260388|3527777|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685023|NCT02260388|3527778|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685024|NCT02260388|3527779|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685025|NCT02260388|3527780|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685026|NCT02260388|3527781|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685027|NCT02260388|3527777|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3685028|NCT02260388|3527778|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3685029|NCT02260388|3527779|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3685030|NCT02260388|3527780|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3685031|NCT02260388|3527781|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3685032|NCT02260388|3527777|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3685033|NCT02260388|3527778|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685034|NCT02260388|3527779|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685035|NCT02260388|3527780|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685042|NCT02260388|3527777|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|379|379.0||||||
3685043|NCT02260388|3527778|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3685044|NCT02260388|3527779|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3685045|NCT02260388|3527780|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
3685046|NCT02260388|3527781|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
3685047|NCT02260388|3527777|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3685048|NCT02260388|3527778|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3685049|NCT02260388|3527779|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3685050|NCT02260388|3527780|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3685051|NCT02260388|3527781|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3685052|NCT02260388|3527777|B5||Male|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
3685053|NCT02260388|3527778|B4||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3685054|NCT02260388|3527779|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3685055|NCT02260388|3527780|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3685056|NCT02260388|3527781|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3685057|NCT02260388|3527777|B5||Female|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
3685058|NCT02260388|3527778|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3685059|NCT02260388|3527779|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3685060|NCT02260388|3527780|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3685061|NCT02260388|3527781|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3685062|NCT02260388|3527777|B5|||Age||years|Mean|60.1|60.1|Standard Deviation|13.4|13.4|||
3685063|NCT02260388|3527778|B4|||Age||years|Mean|60.7|60.7|Standard Deviation|13.7|13.7|||
3685064|NCT02260388|3527779|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|13.6|13.6|||
3685065|NCT02260388|3527780|B2|||Age||years|Mean|59.9|59.9|Standard Deviation|14.0|14.0|||
3685066|NCT02260388|3527781|B1|||Age||years|Mean|60.3|60.3|Standard Deviation|12.7|12.7|||
3685067|NCT02260388|3527777|B5||>=65 years|Age||Participants|Count of Participants|134|134.0||||||
3685068|NCT02260388|3527778|B4||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
3685069|NCT02260388|3527779|B3||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3685070|NCT02260388|3527780|B2||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
3685071|NCT02260388|3527781|B1||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
3685072|NCT02260388|3527777|B5||Between 18 and 65 years|Age||Participants|Count of Participants|268|268.0||||||
3685073|NCT02260388|3527778|B4||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3685074|NCT02260388|3527779|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3685075|NCT02260388|3527780|B2||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
3685076|NCT02260388|3527781|B1||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
3685077|NCT02260388|3527777|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3685078|NCT02260388|3527778|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3685079|NCT02260388|3527779|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3685080|NCT02260388|3527780|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3685081|NCT02260388|3527781|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3685082|NCT02260180|3527810|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685083|NCT02260180|3527811|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685084|NCT02260180|3527812|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685085|NCT02260180|3527813|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685086|NCT02260180|3527810|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685087|NCT02260180|3527811|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685088|NCT02260180|3527812|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685089|NCT02260180|3527813|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685090|NCT02260180|3527810|B4||White|Race (NIH/OMB)||Participants|Count of Participants|118|118.0||||||
3685091|NCT02260180|3527811|B3||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3685092|NCT02260180|3527812|B2||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3685093|NCT02260180|3527813|B1||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3685094|NCT02260180|3527810|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685095|NCT02260180|3527811|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685096|NCT02260180|3527812|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685097|NCT02260180|3527813|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685098|NCT02260180|3527810|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685099|NCT02260180|3527811|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685100|NCT02260180|3527812|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685101|NCT02260180|3527813|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685102|NCT02260180|3527810|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3685103|NCT02260180|3527811|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685104|NCT02260180|3527812|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685105|NCT02260180|3527813|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3685106|NCT02260180|3527810|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685107|NCT02260180|3527811|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685108|NCT02260180|3527812|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685109|NCT02260180|3527813|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685110|NCT02260180|3527810|B4||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3685111|NCT02260180|3527811|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3685112|NCT02260180|3527812|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3685113|NCT02260180|3527813|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3685114|NCT02260180|3527810|B4||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3685115|NCT02260180|3527811|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3685116|NCT02260180|3527812|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3685117|NCT02260180|3527813|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3685118|NCT02260180|3527810|B4|Age||Age, Customized||years|Mean|70|70.0|Full Range|||33.0|93.0|
3685119|NCT02260180|3527811|B3|Age||Age, Customized||years|Mean|67|67.0|Full Range|||47.0|87.0|
3685120|NCT02260180|3527812|B2|Age||Age, Customized||years|Mean|71|71.0|Full Range|||33.0|88.0|
3685121|NCT02260180|3527813|B1|Age||Age, Customized||years|Mean|71|71.0|Full Range|||53.0|93.0|
3685122|NCT02259608|3527826|B1|||Healthy||participants|Number|15|15.0||||||
3685123|NCT02259608|3527826|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3685124|NCT02259608|3527826|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3685125|NCT02259608|3527826|B1|||Age||years|Mean|23|23.0|Full Range|||20.0|34.0|
3685126|NCT02259608|3527826|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3685127|NCT02259608|3527826|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3685128|NCT02259608|3527826|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3685129|NCT02259582|3527831|B4|Spain||Region of Enrollment||participants|Number|19|19.0||||||
3685130|NCT02259582|3527832|B3|Spain||Region of Enrollment||participants|Number|8|8.0||||||
3685131|NCT02259582|3527833|B2|Spain||Region of Enrollment||participants|Number|7|7.0||||||
3685132|NCT02259582|3527834|B1|Spain||Region of Enrollment||participants|Number|4|4.0||||||
3685133|NCT02259582|3527831|B4|Australia||Region of Enrollment||participants|Number|34|34.0||||||
3685134|NCT02259582|3527832|B3|Australia||Region of Enrollment||participants|Number|10|10.0||||||
3685135|NCT02259582|3527833|B2|Australia||Region of Enrollment||participants|Number|10|10.0||||||
3685136|NCT02259582|3527834|B1|Australia||Region of Enrollment||participants|Number|14|14.0||||||
3685137|NCT02259582|3527831|B4|Italy||Region of Enrollment||participants|Number|7|7.0||||||
3685138|NCT02259582|3527832|B3|Italy||Region of Enrollment||participants|Number|3|3.0||||||
3685139|NCT02259582|3527833|B2|Italy||Region of Enrollment||participants|Number|2|2.0||||||
3685140|NCT02259582|3527834|B1|Italy||Region of Enrollment||participants|Number|2|2.0||||||
3685141|NCT02259582|3527831|B4|United States||Region of Enrollment||participants|Number|20|20.0||||||
3685142|NCT02259582|3527832|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
3685143|NCT02259582|3527833|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3685144|NCT02259582|3527834|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3685145|NCT02259582|3527831|B4|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
3685146|NCT02259582|3527832|B3|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
3685147|NCT02259582|3527833|B2|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
3685148|NCT02259582|3527834|B1|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
3685149|NCT02259582|3527831|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685150|NCT02259582|3527832|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685151|NCT02259582|3527833|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685152|NCT02259582|3527834|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685153|NCT02259582|3527831|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3685154|NCT02259582|3527832|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685155|NCT02259582|3527833|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3685156|NCT02259582|3527834|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685157|NCT02259582|3527831|B4||White|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3685158|NCT02259582|3527832|B3||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3685159|NCT02259582|3527833|B2||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3685160|NCT02259582|3527834|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3685161|NCT02259582|3527831|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685162|NCT02259582|3527832|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685163|NCT02259582|3527833|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685164|NCT02259582|3527834|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685165|NCT02259582|3527831|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3685166|NCT02259582|3527832|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3685167|NCT02259582|3527833|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685168|NCT02259582|3527834|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685169|NCT02259582|3527831|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3685170|NCT02259582|3527832|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685171|NCT02259582|3527833|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3685172|NCT02259582|3527834|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3685173|NCT02259582|3527831|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685174|NCT02259582|3527832|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685175|NCT02259582|3527833|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685176|NCT02259582|3527834|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685177|NCT02259582|3527831|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3685178|NCT02259582|3527832|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3685179|NCT02259582|3527833|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3685180|NCT02259582|3527834|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3685181|NCT02259582|3527831|B4||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3685182|NCT02259582|3527832|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3685183|NCT02259582|3527833|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3685184|NCT02259582|3527834|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3685185|NCT02259582|3527831|B4|||Age||years|Median|62|62.0|Full Range|||31.0|77.0|
3685186|NCT02259582|3527832|B3|||Age||years|Median|61|61.0|Full Range|||39.0|76.0|
3685187|NCT02259582|3527833|B2|||Age||years|Median|66|66.0|Full Range|||31.0|76.0|
3685188|NCT02259582|3527834|B1|||Age||years|Median|60|60.0|Full Range|||40.0|77.0|
3685189|NCT02259400|3527844|B3|||BIRTH-WEIGHT||GRAMS|Mean|1135|1135.0|Standard Deviation|289|289.0|||
3685190|NCT02259400|3527845|B2|||BIRTH-WEIGHT||GRAMS|Mean|1165|1165.0|Standard Deviation|275|275.0|||
3685191|NCT02259400|3527846|B1|||BIRTH-WEIGHT||GRAMS|Mean|1106|1106.0|Standard Deviation|276|276.0|||
3685192|NCT02259400|3527844|B3|||SMALL FOR GESTATIONAL AGE|newborn with a birth weight below the 10th percentile for gestational age|participants|Number|26|26.0||||||
3685193|NCT02259400|3527845|B2|||SMALL FOR GESTATIONAL AGE|newborn with a birth weight below the 10th percentile for gestational age|participants|Number|12|12.0||||||
3685194|NCT02259400|3527846|B1|||SMALL FOR GESTATIONAL AGE|newborn with a birth weight below the 10th percentile for gestational age|participants|Number|14|14.0||||||
3685195|NCT02259400|3527844|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3685196|NCT02259400|3527845|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3685197|NCT02259400|3527846|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3685198|NCT02259400|3527844|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3685199|NCT02259400|3527845|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3685200|NCT02259400|3527846|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3685201|NCT02259400|3527844|B3|> 29 wGA||Age, Customized|GESTATIONAL AGE SUBGROUPS|participants|Number|41|41.0||||||
3685202|NCT02259400|3527845|B2|> 29 wGA||Age, Customized|GESTATIONAL AGE SUBGROUPS|participants|Number|21|21.0||||||
3685203|NCT02259400|3527846|B1|> 29 wGA||Age, Customized|GESTATIONAL AGE SUBGROUPS|participants|Number|20|20.0||||||
3685204|NCT02259400|3527844|B3|> 26 and ≤29 wGA||Age, Customized|GESTATIONAL AGE SUBGROUPS|participants|Number|65|65.0||||||
3685205|NCT02259400|3527845|B2|> 26 and ≤29 wGA||Age, Customized|GESTATIONAL AGE SUBGROUPS|participants|Number|32|32.0||||||
3685206|NCT02259400|3527846|B1|> 26 and ≤29 wGA||Age, Customized|GESTATIONAL AGE SUBGROUPS|participants|Number|33|33.0||||||
3685207|NCT02259400|3527844|B3|≤ 26 wGA||Age, Customized|GESTATIONAL AGE SUBGROUPS|participants|Number|18|18.0||||||
3685208|NCT02259400|3527845|B2|≤ 26 wGA||Age, Customized|GESTATIONAL AGE SUBGROUPS|participants|Number|9|9.0||||||
3685209|NCT02259400|3527846|B1|≤ 26 wGA||Age, Customized|GESTATIONAL AGE SUBGROUPS|participants|Number|9|9.0||||||
3685210|NCT02259400|3527844|B3|||Age|GESTATIONAL AGE|WEEKS|Mean|28.7|28.7|Standard Deviation|2.3|2.3|||
3685211|NCT02259400|3527845|B2|||Age|GESTATIONAL AGE|WEEKS|Mean|28.8|28.8|Standard Deviation|2.2|2.2|||
3685212|NCT02259400|3527846|B1|||Age|GESTATIONAL AGE|WEEKS|Mean|28.6|28.6|Standard Deviation|2.1|2.1|||
3685213|NCT02259348|3527879|B1|AML, without maturation||Primary Diagnosis|AML = acute myeloid leukemia; MLL = myeloid-lymphoid leukemia; MDS = myelodysplastic syndrome|participants|Number|1|1.0||||||
3685214|NCT02259348|3527879|B1|AML, not otherwise specified||Primary Diagnosis|AML = acute myeloid leukemia; MLL = myeloid-lymphoid leukemia; MDS = myelodysplastic syndrome|participants|Number|2|2.0||||||
3685215|NCT02259348|3527879|B1|AML, multilineage dysplasia with prior MDS||Primary Diagnosis|AML = acute myeloid leukemia; MLL = myeloid-lymphoid leukemia; MDS = myelodysplastic syndrome|participants|Number|1|1.0||||||
3685397|NCT02258334|3528046|B1|United States||Region of Enrollment||Participants|Number|50|50.0||||||
3685216|NCT02259348|3527879|B1|AML with 11q23/MLL abnormalities||Primary Diagnosis|AML = acute myeloid leukemia; MLL = myeloid-lymphoid leukemia; MDS = myelodysplastic syndrome|participants|Number|2|2.0||||||
3685217|NCT02259348|3527879|B1|Non Spanish speaking, Non Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3685218|NCT02259348|3527879|B1|Not otherwise specified Spanish, Hispanic, Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3685219|NCT02259348|3527879|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3685220|NCT02259348|3527879|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3685221|NCT02259348|3527879|B1|Age, Median||Age, Customized||years|Median|12.2|12.2|Full Range|||6.7|19.5|
3685222|NCT02259348|3527879|B1|||Age||years|Mean|12.6|12.6|Standard Deviation|5.5|5.5|||
3685223|NCT02259114|3527891|B6|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3685224|NCT02259114|3527891|B6||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3685225|NCT02259114|3527892|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3685226|NCT02259114|3527893|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3685227|NCT02259114|3527894|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3685228|NCT02259114|3527895|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3685229|NCT02259114|3527896|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3685230|NCT02259114|3527891|B6||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3685231|NCT02259114|3527892|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3685232|NCT02259114|3527893|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3685233|NCT02259114|3527894|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3685234|NCT02259114|3527895|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3685235|NCT02259114|3527896|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3685236|NCT02259114|3527891|B6|||Age||Years|Mean|57.2|57.2|Standard Deviation|15.3|15.3|||
3685237|NCT02259114|3527892|B5|||Age||Years|Mean|58.5|58.5|Standard Deviation|5.3|5.3|||
3685238|NCT02259114|3527893|B4|||Age||Years|Mean|63.3|63.3|Standard Deviation|9.3|9.3|||
3685239|NCT02259114|3527894|B3|||Age||Years|Mean|64.3|64.3|Standard Deviation|9.5|9.5|||
3685240|NCT02259114|3527895|B2|||Age||Years|Mean|62.5|62.5|Standard Deviation|13.5|13.5|||
3685241|NCT02259114|3527896|B1|||Age||Years|Mean|50.2|50.2|Standard Deviation|18.8|18.8|||
3685242|NCT02258529|3527957|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685243|NCT02258529|3527957|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685244|NCT02258529|3527957|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3685245|NCT02258529|3527957|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685246|NCT02258529|3527957|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685247|NCT02258529|3527957|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685248|NCT02258529|3527957|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685249|NCT02258529|3527957|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685250|NCT02258529|3527957|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3685251|NCT02258529|3527957|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685252|NCT02258529|3527957|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3685253|NCT02258529|3527957|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3685254|NCT02258529|3527957|B1|||Age||years|Mean|69|69.0|Standard Deviation|11.7|11.7|||
3685255|NCT02258477|3527969|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
3685256|NCT02258477|3527969|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3685257|NCT02258477|3527969|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3685258|NCT02258477|3527969|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3685259|NCT02258477|3527969|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3685260|NCT02258477|3527969|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685261|NCT02258477|3527969|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685262|NCT02258477|3527969|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685263|NCT02258477|3527969|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685264|NCT02258477|3527969|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3685265|NCT02258477|3527969|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3685266|NCT02258477|3527969|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3685267|NCT02258477|3527969|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3685268|NCT02258477|3527969|B1|||Age, Customized||years|Mean|44.6|44.6|Standard Deviation|12.5|12.5|||
3685269|NCT02258412|3527987|B4|United States||Region of Enrollment||participants|Number|112|112.0||||||
3685270|NCT02258412|3527988|B3|United States||Region of Enrollment||participants|Number|61|61.0||||||
3685271|NCT02258412|3527989|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3685272|NCT02258412|3527990|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
3685273|NCT02258412|3527987|B4||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3685274|NCT02258412|3527988|B3||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Subject gender was not recorded as it is not relevant to the study outcome
3685275|NCT02258412|3527989|B2||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Subject gender was not recorded as it is not relevant to the study outcome
3685276|NCT02258412|3527990|B1||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Subject gender was not recorded as it is not relevant to the study outcome
3685277|NCT02258412|3527987|B4||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3685278|NCT02258412|3527988|B3||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Subject gender was not recorded as it is not relevant to the study outcome
3685279|NCT02258412|3527989|B2||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Subject gender was not recorded as it is not relevant to the study outcome
3685280|NCT02258412|3527990|B1||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Subject gender was not recorded as it is not relevant to the study outcome
3685281|NCT02258412|3527987|B4|||Age||years|Mean|NA||Standard Deviation|NA||||Subject age was not recorded as it is not relevant to the study outcome
3685282|NCT02258412|3527988|B3|||Age||years|Mean|NA||Standard Deviation|NA||||Subject age was not recorded as it is not relevant to the study outcome
3685283|NCT02258412|3527989|B2|||Age||years|Mean|NA||Standard Deviation|NA||||Subject age was not recorded as it is not relevant to the study outcome
3685284|NCT02258412|3527990|B1|||Age||years|Mean|NA||Standard Deviation|NA||||Subject age was not recorded as it is not relevant to the study outcome
3685285|NCT02258373|3527999|B3||7|Clarke Hypoglycemia Unawareness Survey Total Score|8 items related to hypoglycemia unawareness. Each item is scored differently. Range is 0 to 7. Total score ≥4 is reduced awareness, =3 is uncertain and ≤2 is aware.|Participants|Count of Participants|0|0.0||||||
3685286|NCT02258373|3528000|B2||7|Clarke Hypoglycemia Unawareness Survey Total Score|8 items related to hypoglycemia unawareness. Each item is scored differently. Range is 0 to 7. Total score ≥4 is reduced awareness, =3 is uncertain and ≤2 is aware.|Participants|Count of Participants|0|0.0||||||
3685287|NCT02258373|3528001|B1||7|Clarke Hypoglycemia Unawareness Survey Total Score|8 items related to hypoglycemia unawareness. Each item is scored differently. Range is 0 to 7. Total score ≥4 is reduced awareness, =3 is uncertain and ≤2 is aware.|Participants|Count of Participants|0|0.0||||||
3685288|NCT02258373|3527999|B3||6|Clarke Hypoglycemia Unawareness Survey Total Score|8 items related to hypoglycemia unawareness. Each item is scored differently. Range is 0 to 7. Total score ≥4 is reduced awareness, =3 is uncertain and ≤2 is aware.|Participants|Count of Participants|0|0.0||||||
3685289|NCT02258373|3528000|B2||6|Clarke Hypoglycemia Unawareness Survey Total Score|8 items related to hypoglycemia unawareness. Each item is scored differently. Range is 0 to 7. Total score ≥4 is reduced awareness, =3 is uncertain and ≤2 is aware.|Participants|Count of Participants|0|0.0||||||
3685290|NCT02258373|3528001|B1||6|Clarke Hypoglycemia Unawareness Survey Total Score|8 items related to hypoglycemia unawareness. Each item is scored differently. Range is 0 to 7. Total score ≥4 is reduced awareness, =3 is uncertain and ≤2 is aware.|Participants|Count of Participants|0|0.0||||||
3685291|NCT02258373|3527999|B3||5|Clarke Hypoglycemia Unawareness Survey Total Score|8 items related to hypoglycemia unawareness. Each item is scored differently. Range is 0 to 7. Total score ≥4 is reduced awareness, =3 is uncertain and ≤2 is aware.|Participants|Count of Participants|0|0.0||||||
3685292|NCT02258373|3528000|B2||5|Clarke Hypoglycemia Unawareness Survey Total Score|8 items related to hypoglycemia unawareness. Each item is scored differently. Range is 0 to 7. Total score ≥4 is reduced awareness, =3 is uncertain and ≤2 is aware.|Participants|Count of Participants|0|0.0||||||
3685293|NCT02258373|3528001|B1||5|Clarke Hypoglycemia Unawareness Survey Total Score|8 items related to hypoglycemia unawareness. Each item is scored differently. Range is 0 to 7. Total score ≥4 is reduced awareness, =3 is uncertain and ≤2 is aware.|Participants|Count of Participants|0|0.0||||||
3685294|NCT02258373|3527999|B3||4|Clarke Hypoglycemia Unawareness Survey Total Score|8 items related to hypoglycemia unawareness. Each item is scored differently. Range is 0 to 7. Total score ≥4 is reduced awareness, =3 is uncertain and ≤2 is aware.|Participants|Count of Participants|0|0.0||||||
3685295|NCT02258373|3528000|B2||4|Clarke Hypoglycemia Unawareness Survey Total Score|8 items related to hypoglycemia unawareness. Each item is scored differently. Range is 0 to 7. Total score ≥4 is reduced awareness, =3 is uncertain and ≤2 is aware.|Participants|Count of Participants|0|0.0||||||
3685296|NCT02258373|3528001|B1||4|Clarke Hypoglycemia Unawareness Survey Total Score|8 items related to hypoglycemia unawareness. Each item is scored differently. Range is 0 to 7. Total score ≥4 is reduced awareness, =3 is uncertain and ≤2 is aware.|Participants|Count of Participants|0|0.0||||||
3685297|NCT02258373|3527999|B3||3|Clarke Hypoglycemia Unawareness Survey Total Score|8 items related to hypoglycemia unawareness. Each item is scored differently. Range is 0 to 7. Total score ≥4 is reduced awareness, =3 is uncertain and ≤2 is aware.|Participants|Count of Participants|0|0.0||||||
3685298|NCT02258373|3528000|B2||3|Clarke Hypoglycemia Unawareness Survey Total Score|8 items related to hypoglycemia unawareness. Each item is scored differently. Range is 0 to 7. Total score ≥4 is reduced awareness, =3 is uncertain and ≤2 is aware.|Participants|Count of Participants|0|0.0||||||
3685299|NCT02258373|3528001|B1||3|Clarke Hypoglycemia Unawareness Survey Total Score|8 items related to hypoglycemia unawareness. Each item is scored differently. Range is 0 to 7. Total score ≥4 is reduced awareness, =3 is uncertain and ≤2 is aware.|Participants|Count of Participants|0|0.0||||||
3685300|NCT02258373|3527999|B3||2|Clarke Hypoglycemia Unawareness Survey Total Score|8 items related to hypoglycemia unawareness. Each item is scored differently. Range is 0 to 7. Total score ≥4 is reduced awareness, =3 is uncertain and ≤2 is aware.|Participants|Count of Participants|25|25.0||||||
3685301|NCT02258373|3528000|B2||2|Clarke Hypoglycemia Unawareness Survey Total Score|8 items related to hypoglycemia unawareness. Each item is scored differently. Range is 0 to 7. Total score ≥4 is reduced awareness, =3 is uncertain and ≤2 is aware.|Participants|Count of Participants|10|10.0||||||
3685302|NCT02258373|3528001|B1||2|Clarke Hypoglycemia Unawareness Survey Total Score|8 items related to hypoglycemia unawareness. Each item is scored differently. Range is 0 to 7. Total score ≥4 is reduced awareness, =3 is uncertain and ≤2 is aware.|Participants|Count of Participants|15|15.0||||||
3685303|NCT02258373|3527999|B3||1|Clarke Hypoglycemia Unawareness Survey Total Score|8 items related to hypoglycemia unawareness. Each item is scored differently. Range is 0 to 7. Total score ≥4 is reduced awareness, =3 is uncertain and ≤2 is aware.|Participants|Count of Participants|48|48.0||||||
3685304|NCT02258373|3528000|B2||1|Clarke Hypoglycemia Unawareness Survey Total Score|8 items related to hypoglycemia unawareness. Each item is scored differently. Range is 0 to 7. Total score ≥4 is reduced awareness, =3 is uncertain and ≤2 is aware.|Participants|Count of Participants|14|14.0||||||
3685305|NCT02258373|3528001|B1||1|Clarke Hypoglycemia Unawareness Survey Total Score|8 items related to hypoglycemia unawareness. Each item is scored differently. Range is 0 to 7. Total score ≥4 is reduced awareness, =3 is uncertain and ≤2 is aware.|Participants|Count of Participants|34|34.0||||||
3685306|NCT02258373|3527999|B3||0|Clarke Hypoglycemia Unawareness Survey Total Score|8 items related to hypoglycemia unawareness. Each item is scored differently. Range is 0 to 7. Total score ≥4 is reduced awareness, =3 is uncertain and ≤2 is aware.|Participants|Count of Participants|153|153.0||||||
3685307|NCT02258373|3528000|B2||0|Clarke Hypoglycemia Unawareness Survey Total Score|8 items related to hypoglycemia unawareness. Each item is scored differently. Range is 0 to 7. Total score ≥4 is reduced awareness, =3 is uncertain and ≤2 is aware.|Participants|Count of Participants|53|53.0||||||
3685308|NCT02258373|3528001|B1||0|Clarke Hypoglycemia Unawareness Survey Total Score|8 items related to hypoglycemia unawareness. Each item is scored differently. Range is 0 to 7. Total score ≥4 is reduced awareness, =3 is uncertain and ≤2 is aware.|Participants|Count of Participants|100|100.0||||||
3685309|NCT02258373|3527999|B3|||Self-reported BGM Testing||tests/day|Mean|5.1|5.1|Standard Deviation|2.0|2.0|||
3685310|NCT02258373|3528000|B2|||Self-reported BGM Testing||tests/day|Mean|4.9|4.9|Standard Deviation|1.9|1.9|||
3685311|NCT02258373|3528001|B1|||Self-reported BGM Testing||tests/day|Mean|5.2|5.2|Standard Deviation|2.1|2.1|||
3685312|NCT02258373|3527999|B3||>=8.0% (64 mmol/mol)|Central Laboratory HbA1c Value|The local laboratory HbA1c value was used for one participant in the CGM+BGM group whose central laboratory value was unavailable.|Participants|Count of Participants|18|18.0||||||
3685313|NCT02258373|3528000|B2||>=8.0% (64 mmol/mol)|Central Laboratory HbA1c Value|The local laboratory HbA1c value was used for one participant in the CGM+BGM group whose central laboratory value was unavailable.|Participants|Count of Participants|7|7.0||||||
3685314|NCT02258373|3528001|B1||>=8.0% (64 mmol/mol)|Central Laboratory HbA1c Value|The local laboratory HbA1c value was used for one participant in the CGM+BGM group whose central laboratory value was unavailable.|Participants|Count of Participants|11|11.0||||||
3685315|NCT02258373|3527999|B3||7.0%-<8.0% (53-<64 mmol/mol)|Central Laboratory HbA1c Value|The local laboratory HbA1c value was used for one participant in the CGM+BGM group whose central laboratory value was unavailable.|Participants|Count of Participants|110|110.0||||||
3685316|NCT02258373|3528000|B2||7.0%-<8.0% (53-<64 mmol/mol)|Central Laboratory HbA1c Value|The local laboratory HbA1c value was used for one participant in the CGM+BGM group whose central laboratory value was unavailable.|Participants|Count of Participants|31|31.0||||||
3685317|NCT02258373|3528001|B1||7.0%-<8.0% (53-<64 mmol/mol)|Central Laboratory HbA1c Value|The local laboratory HbA1c value was used for one participant in the CGM+BGM group whose central laboratory value was unavailable.|Participants|Count of Participants|79|79.0||||||
3685318|NCT02258373|3527999|B3||<7.0% (53 mmol/mol)|Central Laboratory HbA1c Value|The local laboratory HbA1c value was used for one participant in the CGM+BGM group whose central laboratory value was unavailable.|Participants|Count of Participants|98|98.0||||||
3685319|NCT02258373|3528000|B2||<7.0% (53 mmol/mol)|Central Laboratory HbA1c Value|The local laboratory HbA1c value was used for one participant in the CGM+BGM group whose central laboratory value was unavailable.|Participants|Count of Participants|39|39.0||||||
3685320|NCT02258373|3528001|B1||<7.0% (53 mmol/mol)|Central Laboratory HbA1c Value|The local laboratory HbA1c value was used for one participant in the CGM+BGM group whose central laboratory value was unavailable.|Participants|Count of Participants|59|59.0||||||
3685321|NCT02258373|3527999|B3||Current Medtronic CGM user|CGM Use Before Study||Participants|Count of Participants|30|30.0||||||
3685322|NCT02258373|3528000|B2||Current Medtronic CGM user|CGM Use Before Study||Participants|Count of Participants|10|10.0||||||
3685323|NCT02258373|3528001|B1||Current Medtronic CGM user|CGM Use Before Study||Participants|Count of Participants|20|20.0||||||
3685324|NCT02258373|3527999|B3||Current Dexcom CGM user|CGM Use Before Study||Participants|Count of Participants|77|77.0||||||
3685325|NCT02258373|3528000|B2||Current Dexcom CGM user|CGM Use Before Study||Participants|Count of Participants|28|28.0||||||
3685326|NCT02258373|3528001|B1||Current Dexcom CGM user|CGM Use Before Study||Participants|Count of Participants|49|49.0||||||
3685327|NCT02258373|3527999|B3||In past, but not current|CGM Use Before Study||Participants|Count of Participants|79|79.0||||||
3685328|NCT02258373|3528000|B2||In past, but not current|CGM Use Before Study||Participants|Count of Participants|25|25.0||||||
3685329|NCT02258373|3528001|B1||In past, but not current|CGM Use Before Study||Participants|Count of Participants|54|54.0||||||
3685330|NCT02258373|3527999|B3||Never used CGM|CGM Use Before Study||Participants|Count of Participants|40|40.0||||||
3685331|NCT02258373|3528000|B2||Never used CGM|CGM Use Before Study||Participants|Count of Participants|14|14.0||||||
3685332|NCT02258373|3528001|B1||Never used CGM|CGM Use Before Study||Participants|Count of Participants|26|26.0||||||
3685333|NCT02258373|3527999|B3||None|Insurance||Participants|Count of Participants|4|4.0||||||
3685334|NCT02258373|3528000|B2||None|Insurance||Participants|Count of Participants|2|2.0||||||
3685335|NCT02258373|3528001|B1||None|Insurance||Participants|Count of Participants|2|2.0||||||
3685336|NCT02258373|3527999|B3||Other|Insurance||Participants|Count of Participants|22|22.0||||||
3685337|NCT02258373|3528000|B2||Other|Insurance||Participants|Count of Participants|7|7.0||||||
3685338|NCT02258373|3528001|B1||Other|Insurance||Participants|Count of Participants|15|15.0||||||
3685339|NCT02258373|3527999|B3||Private|Insurance||Participants|Count of Participants|198|198.0||||||
3685340|NCT02258373|3528000|B2||Private|Insurance||Participants|Count of Participants|66|66.0||||||
3685341|NCT02258373|3528001|B1||Private|Insurance||Participants|Count of Participants|132|132.0||||||
3685342|NCT02258373|3527999|B3||Post-Bachelor's Degree|Highest Education||Participants|Count of Participants|64|64.0||||||
3685343|NCT02258373|3528000|B2||Post-Bachelor's Degree|Highest Education||Participants|Count of Participants|26|26.0||||||
3685344|NCT02258373|3528001|B1||Post-Bachelor's Degree|Highest Education||Participants|Count of Participants|38|38.0||||||
3685345|NCT02258373|3527999|B3||Bachelor's Degree|Highest Education||Participants|Count of Participants|110|110.0||||||
3685346|NCT02258373|3528000|B2||Bachelor's Degree|Highest Education||Participants|Count of Participants|35|35.0||||||
3685347|NCT02258373|3528001|B1||Bachelor's Degree|Highest Education||Participants|Count of Participants|75|75.0||||||
3685348|NCT02258373|3527999|B3||<Bachelor's Degree|Highest Education||Participants|Count of Participants|47|47.0||||||
3685349|NCT02258373|3528000|B2||<Bachelor's Degree|Highest Education||Participants|Count of Participants|12|12.0||||||
3685350|NCT02258373|3528001|B1||<Bachelor's Degree|Highest Education||Participants|Count of Participants|35|35.0||||||
3685351|NCT02258373|3527999|B3||>=100,000|Annual Household Income ($)||Participants|Count of Participants|87|87.0||||||
3685352|NCT02258373|3528000|B2||>=100,000|Annual Household Income ($)||Participants|Count of Participants|33|33.0||||||
3685353|NCT02258373|3528001|B1||>=100,000|Annual Household Income ($)||Participants|Count of Participants|54|54.0||||||
3685354|NCT02258373|3527999|B3||50,000-<100,000|Annual Household Income ($)||Participants|Count of Participants|56|56.0||||||
3685355|NCT02258373|3528000|B2||50,000-<100,000|Annual Household Income ($)||Participants|Count of Participants|17|17.0||||||
3685356|NCT02258373|3528001|B1||50,000-<100,000|Annual Household Income ($)||Participants|Count of Participants|39|39.0||||||
3685357|NCT02258373|3527999|B3||<50,000|Annual Household Income ($)||Participants|Count of Participants|25|25.0||||||
3685358|NCT02258373|3528000|B2||<50,000|Annual Household Income ($)||Participants|Count of Participants|7|7.0||||||
3685359|NCT02258373|3528001|B1||<50,000|Annual Household Income ($)||Participants|Count of Participants|18|18.0||||||
3685360|NCT02258373|3527999|B3|||Diabetes Duration||years|Mean|24|24.0|Standard Deviation|12|12.0|||
3685361|NCT02258373|3528000|B2|||Diabetes Duration||years|Mean|25|25.0|Standard Deviation|12|12.0|||
3685362|NCT02258373|3528001|B1|||Diabetes Duration||years|Mean|23|23.0|Standard Deviation|12|12.0|||
3685363|NCT02258373|3527999|B3|||BMI||kg/m2|Mean|27.3|27.3|Standard Deviation|4.4|4.4|||
3685364|NCT02258373|3528000|B2|||BMI||kg/m2|Mean|26.5|26.5|Standard Deviation|4.9|4.9|||
3685365|NCT02258373|3528001|B1|||BMI||kg/m2|Mean|27.7|27.7|Standard Deviation|4.1|4.1|||
3685366|NCT02258373|3527999|B3|United States||Region of Enrollment||Participants|Count of Participants|226|226.0||||||
3685367|NCT02258373|3528000|B2|United States||Region of Enrollment||Participants|Count of Participants|77|77.0||||||
3685368|NCT02258373|3528001|B1|United States||Region of Enrollment||Participants|Count of Participants|149|149.0||||||
3685369|NCT02258373|3527999|B3|Race/Ethnicity|Other/unknown|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3685370|NCT02258373|3528000|B2|Race/Ethnicity|Other/unknown|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3685371|NCT02258373|3528001|B1|Race/Ethnicity|Other/unknown|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3685372|NCT02258373|3527999|B3|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3685373|NCT02258373|3528000|B2|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3685374|NCT02258373|3528001|B1|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3685375|NCT02258373|3527999|B3|Race/Ethnicity|Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3685376|NCT02258373|3528000|B2|Race/Ethnicity|Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3685377|NCT02258373|3528001|B1|Race/Ethnicity|Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3685378|NCT02258373|3527999|B3|Race/Ethnicity|Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3685379|NCT02258373|3528000|B2|Race/Ethnicity|Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3685380|NCT02258373|3528001|B1|Race/Ethnicity|Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3685381|NCT02258373|3527999|B3|Race/Ethnicity|White non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|207|207.0||||||
3685382|NCT02258373|3528000|B2|Race/Ethnicity|White non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|68|68.0||||||
3685383|NCT02258373|3528001|B1|Race/Ethnicity|White non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|139|139.0||||||
3685384|NCT02258373|3527999|B3||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3685385|NCT02258373|3528000|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3685386|NCT02258373|3528001|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3685387|NCT02258373|3527999|B3||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3685388|NCT02258373|3528000|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3685389|NCT02258373|3528001|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3685390|NCT02258373|3527999|B3|||Age||years|Mean|44|44.0|Standard Deviation|14|14.0|||
3685391|NCT02258373|3528000|B2|||Age||years|Mean|45|45.0|Standard Deviation|13|13.0|||
3685392|NCT02258373|3528001|B1|||Age||years|Mean|44|44.0|Standard Deviation|14|14.0|||
3685393|NCT02258334|3528042|B5|United States||Region of Enrollment||Participants|Number|208|208.0||||||
3685394|NCT02258334|3528043|B4|United States||Region of Enrollment||Participants|Number|52|52.0||||||
3685395|NCT02258334|3528044|B3|United States||Region of Enrollment||Participants|Number|52|52.0||||||
3685396|NCT02258334|3528045|B2|United States||Region of Enrollment||Participants|Number|54|54.0||||||
3685398|NCT02258334|3528042|B5||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3685399|NCT02258334|3528043|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3685400|NCT02258334|3528044|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3685401|NCT02258334|3528045|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3685402|NCT02258334|3528046|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3685403|NCT02258334|3528042|B5||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3685404|NCT02258334|3528043|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3685405|NCT02258334|3528044|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3685406|NCT02258334|3528045|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3685407|NCT02258334|3528046|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3685408|NCT02258334|3528042|B5|Age Continuous||Age||Years|Mean|59.8|59.8|Standard Deviation|16.8|16.8|||
3685409|NCT02258334|3528043|B4|Age Continuous||Age||Years|Mean|72.2|72.2|Standard Deviation|5.4|5.4|||
3685410|NCT02258334|3528044|B3|Age Continuous||Age||Years|Mean|73.9|73.9|Standard Deviation|5.0|5.0|||
3685411|NCT02258334|3528045|B2|Age Continuous||Age||Years|Mean|48.0|48.0|Standard Deviation|12.1|12.1|||
3685412|NCT02258334|3528046|B1|Age Continuous||Age||Years|Mean|44.8|44.8|Standard Deviation|14.9|14.9|||
3685413|NCT02258334|3528042|B5||>=65 years|Age||Participants|Count of Participants|104|104.0||||||
3685414|NCT02258334|3528043|B4||>=65 years|Age||Participants|Count of Participants|52|52.0||||||
3685415|NCT02258334|3528044|B3||>=65 years|Age||Participants|Count of Participants|52|52.0||||||
3685416|NCT02258334|3528045|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3685417|NCT02258334|3528046|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3685418|NCT02258334|3528042|B5||Between 18 and 65 years|Age||Participants|Count of Participants|104|104.0||||||
3685419|NCT02258334|3528043|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3685420|NCT02258334|3528044|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3685421|NCT02258334|3528045|B2||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3685422|NCT02258334|3528046|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3685423|NCT02258334|3528042|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3685424|NCT02258334|3528043|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3685425|NCT02258334|3528044|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3685426|NCT02258334|3528045|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3685427|NCT02258334|3528046|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3685428|NCT02258256|3528075|B1|Malawi||Region of Enrollment||participants|Number|11|11.0||||||
3685429|NCT02258256|3528075|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685430|NCT02258256|3528075|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685431|NCT02258256|3528075|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685432|NCT02258256|3528075|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3685433|NCT02258256|3528075|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685434|NCT02258256|3528075|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685435|NCT02258256|3528075|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685436|NCT02258256|3528075|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3685437|NCT02258256|3528075|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3685438|NCT02258256|3528075|B1|||Age||years|Median|28|28.0|Full Range|||20.0|38.0|
3685439|NCT02257970|3528079|B5||Lower extremity|Lymphedema location||Participants|Count of Participants|67|67.0||||||
3685440|NCT02257970|3528080|B4||Lower extremity|Lymphedema location||Participants|Count of Participants|12|12.0||||||
3685441|NCT02257970|3528081|B3||Lower extremity|Lymphedema location||Participants|Count of Participants|11|11.0||||||
3685442|NCT02257970|3528082|B2||Lower extremity|Lymphedema location||Participants|Count of Participants|12|12.0||||||
3685443|NCT02257970|3528083|B1||Lower extremity|Lymphedema location||Participants|Count of Participants|32|32.0||||||
3685444|NCT02257970|3528079|B5||Upper extermity|Lymphedema location||Participants|Count of Participants|29|29.0||||||
3685445|NCT02257970|3528080|B4||Upper extermity|Lymphedema location||Participants|Count of Participants|2|2.0||||||
3685446|NCT02257970|3528081|B3||Upper extermity|Lymphedema location||Participants|Count of Participants|5|5.0||||||
3685447|NCT02257970|3528082|B2||Upper extermity|Lymphedema location||Participants|Count of Participants|4|4.0||||||
3685448|NCT02257970|3528083|B1||Upper extermity|Lymphedema location||Participants|Count of Participants|18|18.0||||||
3685449|NCT02257970|3528079|B5||Secondary|Lymphedema classification|"Primary lymphedema is defined as having been born with the condition, or developed the condition in the first year of life.~Secondary lymphedema is defined as a condition that results due to some other event (e.g., trauma, cancer treatment, May-Turner Syndrome (MTS))."|Participants|Count of Participants|81|81.0||||||
3685450|NCT02257970|3528080|B4||Secondary|Lymphedema classification|"Primary lymphedema is defined as having been born with the condition, or developed the condition in the first year of life.~Secondary lymphedema is defined as a condition that results due to some other event (e.g., trauma, cancer treatment, May-Turner Syndrome (MTS))."|Participants|Count of Participants|12|12.0||||||
3685495|NCT02257918|3528111|B2|United States||Region of Enrollment||participants|Number|67|67.0||||||
3685496|NCT02257918|3528112|B1|United States||Region of Enrollment||participants|Number|72|72.0||||||
3685611|NCT02257372|3528183|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3685451|NCT02257970|3528081|B3||Secondary|Lymphedema classification|"Primary lymphedema is defined as having been born with the condition, or developed the condition in the first year of life.~Secondary lymphedema is defined as a condition that results due to some other event (e.g., trauma, cancer treatment, May-Turner Syndrome (MTS))."|Participants|Count of Participants|12|12.0||||||
3685452|NCT02257970|3528082|B2||Secondary|Lymphedema classification|"Primary lymphedema is defined as having been born with the condition, or developed the condition in the first year of life.~Secondary lymphedema is defined as a condition that results due to some other event (e.g., trauma, cancer treatment, May-Turner Syndrome (MTS))."|Participants|Count of Participants|11|11.0||||||
3685453|NCT02257970|3528083|B1||Secondary|Lymphedema classification|"Primary lymphedema is defined as having been born with the condition, or developed the condition in the first year of life.~Secondary lymphedema is defined as a condition that results due to some other event (e.g., trauma, cancer treatment, May-Turner Syndrome (MTS))."|Participants|Count of Participants|46|46.0||||||
3685454|NCT02257970|3528079|B5||Primary|Lymphedema classification|"Primary lymphedema is defined as having been born with the condition, or developed the condition in the first year of life.~Secondary lymphedema is defined as a condition that results due to some other event (e.g., trauma, cancer treatment, May-Turner Syndrome (MTS))."|Participants|Count of Participants|15|15.0||||||
3685455|NCT02257970|3528080|B4||Primary|Lymphedema classification|"Primary lymphedema is defined as having been born with the condition, or developed the condition in the first year of life.~Secondary lymphedema is defined as a condition that results due to some other event (e.g., trauma, cancer treatment, May-Turner Syndrome (MTS))."|Participants|Count of Participants|2|2.0||||||
3685456|NCT02257970|3528081|B3||Primary|Lymphedema classification|"Primary lymphedema is defined as having been born with the condition, or developed the condition in the first year of life.~Secondary lymphedema is defined as a condition that results due to some other event (e.g., trauma, cancer treatment, May-Turner Syndrome (MTS))."|Participants|Count of Participants|4|4.0||||||
3685457|NCT02257970|3528082|B2||Primary|Lymphedema classification|"Primary lymphedema is defined as having been born with the condition, or developed the condition in the first year of life.~Secondary lymphedema is defined as a condition that results due to some other event (e.g., trauma, cancer treatment, May-Turner Syndrome (MTS))."|Participants|Count of Participants|5|5.0||||||
3685458|NCT02257970|3528083|B1||Primary|Lymphedema classification|"Primary lymphedema is defined as having been born with the condition, or developed the condition in the first year of life.~Secondary lymphedema is defined as a condition that results due to some other event (e.g., trauma, cancer treatment, May-Turner Syndrome (MTS))."|Participants|Count of Participants|4|4.0||||||
3685459|NCT02257970|3528079|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3685460|NCT02257970|3528080|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3685461|NCT02257970|3528081|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3685462|NCT02257970|3528082|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3685463|NCT02257970|3528083|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3685464|NCT02257970|3528079|B5||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3685465|NCT02257970|3528080|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3685466|NCT02257970|3528081|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3685467|NCT02257970|3528082|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3685468|NCT02257970|3528083|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3685469|NCT02257970|3528079|B5|||Age||years|Mean|54.92|54.92|Standard Deviation|13.07|13.07|||
3685470|NCT02257970|3528080|B4|||Age||years|Mean|53.92|53.92|Standard Deviation|13.14|13.14|||
3685471|NCT02257970|3528081|B3|||Age||years|Mean|50.25|50.25|Standard Deviation|15.12|15.12|||
3685472|NCT02257970|3528082|B2|||Age||years|Mean|56.43|56.43|Standard Deviation|11.15|11.15|||
3685473|NCT02257970|3528083|B1|||Age||years|Mean|56.72|56.72|Standard Deviation|13.46|13.46|||
3685474|NCT02257970|3528079|B5||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3685475|NCT02257970|3528080|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3685476|NCT02257970|3528081|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3685477|NCT02257970|3528082|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3685478|NCT02257970|3528083|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3685479|NCT02257970|3528079|B5||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
3685480|NCT02257970|3528080|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3685481|NCT02257970|3528081|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3685482|NCT02257970|3528082|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3685483|NCT02257970|3528083|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3685484|NCT02257970|3528079|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3685485|NCT02257970|3528080|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3685486|NCT02257970|3528081|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3685487|NCT02257970|3528082|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3685488|NCT02257970|3528083|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3685489|NCT02257918|3528109|B4|||Positive culture result for N. gonorrhoeae||Participants|Count of Participants|141|141.0||||||
3685490|NCT02257918|3528110|B3|||Positive culture result for N. gonorrhoeae||Participants|Count of Participants|28|28.0||||||
3685491|NCT02257918|3528111|B2|||Positive culture result for N. gonorrhoeae||Participants|Count of Participants|56|56.0||||||
3685492|NCT02257918|3528112|B1|||Positive culture result for N. gonorrhoeae||Participants|Count of Participants|57|57.0||||||
3685493|NCT02257918|3528109|B4|United States||Region of Enrollment||participants|Number|180|180.0||||||
3685494|NCT02257918|3528110|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
3685497|NCT02257918|3528109|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3685498|NCT02257918|3528110|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685499|NCT02257918|3528111|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3685500|NCT02257918|3528112|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685501|NCT02257918|3528109|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3685502|NCT02257918|3528110|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3685503|NCT02257918|3528111|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3685504|NCT02257918|3528112|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3685505|NCT02257918|3528109|B4||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3685506|NCT02257918|3528110|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3685507|NCT02257918|3528111|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3685508|NCT02257918|3528112|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3685509|NCT02257918|3528109|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
3685510|NCT02257918|3528110|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3685511|NCT02257918|3528111|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3685512|NCT02257918|3528112|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3685513|NCT02257918|3528109|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3685514|NCT02257918|3528110|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3685515|NCT02257918|3528111|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685516|NCT02257918|3528112|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685517|NCT02257918|3528109|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3685518|NCT02257918|3528110|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685519|NCT02257918|3528111|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3685520|NCT02257918|3528112|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3685521|NCT02257918|3528109|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3685522|NCT02257918|3528110|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685523|NCT02257918|3528111|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685524|NCT02257918|3528112|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3685525|NCT02257918|3528109|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685526|NCT02257918|3528110|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685527|NCT02257918|3528111|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685528|NCT02257918|3528112|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685529|NCT02257918|3528109|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
3685530|NCT02257918|3528110|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3685531|NCT02257918|3528111|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3685532|NCT02257918|3528112|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3685533|NCT02257918|3528109|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3685534|NCT02257918|3528110|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3685535|NCT02257918|3528111|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3685536|NCT02257918|3528112|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3685537|NCT02257918|3528109|B4||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3685538|NCT02257918|3528110|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3685539|NCT02257918|3528111|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3685540|NCT02257918|3528112|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3685541|NCT02257918|3528109|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3685542|NCT02257918|3528110|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3685543|NCT02257918|3528111|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3685544|NCT02257918|3528112|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3685545|NCT02257918|3528109|B4|||Age||years|Mean|28.8|28.8|Standard Deviation|8.2|8.2|||
3685546|NCT02257918|3528110|B3|||Age||years|Mean|29.1|29.1|Standard Deviation|8.2|8.2|||
3685547|NCT02257918|3528111|B2|||Age||years|Mean|28.3|28.3|Standard Deviation|7.6|7.6|||
3685548|NCT02257918|3528112|B1|||Age||years|Mean|29.2|29.2|Standard Deviation|8.9|8.9|||
3685549|NCT02257918|3528109|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3685550|NCT02257918|3528110|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3685551|NCT02257918|3528111|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3685552|NCT02257918|3528112|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3685553|NCT02257918|3528109|B4||Between 18 and 65 years|Age||Participants|Count of Participants|180|180.0||||||
3685554|NCT02257918|3528110|B3||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3685555|NCT02257918|3528111|B2||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
3685556|NCT02257918|3528112|B1||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
3685557|NCT02257918|3528109|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3685558|NCT02257918|3528110|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3685559|NCT02257918|3528111|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3685560|NCT02257918|3528112|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3685561|NCT02257684|3528164|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3685562|NCT02257684|3528164|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685563|NCT02257684|3528164|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685564|NCT02257684|3528164|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3685565|NCT02257684|3528164|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685566|NCT02257684|3528164|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685567|NCT02257684|3528164|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685568|NCT02257684|3528164|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685569|NCT02257684|3528164|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685570|NCT02257684|3528164|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3685571|NCT02257684|3528164|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3685572|NCT02257684|3528164|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3685573|NCT02257684|3528164|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3685574|NCT02257684|3528164|B1|||Age||years|Mean|12.95|12.95|Full Range|||7.8|20.3|
3685575|NCT02257385|3528172|B3|White -White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|902|902.0||||||
3685576|NCT02257385|3528173|B2|White -White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|449|449.0||||||
3685577|NCT02257385|3528174|B1|White -White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|453|453.0||||||
3685578|NCT02257385|3528172|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3685579|NCT02257385|3528173|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3685580|NCT02257385|3528174|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3685581|NCT02257385|3528172|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3685582|NCT02257385|3528173|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3685583|NCT02257385|3528174|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3685584|NCT02257385|3528172|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3685585|NCT02257385|3528173|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3685586|NCT02257385|3528174|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3685587|NCT02257385|3528172|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3685588|NCT02257385|3528173|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3685589|NCT02257385|3528174|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3685590|NCT02257385|3528172|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|51|51.0||||||
3685591|NCT02257385|3528173|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
3685592|NCT02257385|3528174|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
3685593|NCT02257385|3528172|B3||Male|Sex: Female, Male||Participants|Count of Participants|696|696.0||||||
3685594|NCT02257385|3528173|B2||Male|Sex: Female, Male||Participants|Count of Participants|341|341.0||||||
3685595|NCT02257385|3528174|B1||Male|Sex: Female, Male||Participants|Count of Participants|355|355.0||||||
3685596|NCT02257385|3528172|B3||Female|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
3685597|NCT02257385|3528173|B2||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3685598|NCT02257385|3528174|B1||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3685599|NCT02257385|3528172|B3|||Age||Years|Mean|64.2|64.2|Standard Deviation|8.10|8.1|||
3685600|NCT02257385|3528173|B2|||Age||Years|Mean|64.0|64.0|Standard Deviation|8.44|8.44|||
3685601|NCT02257385|3528174|B1|||Age||Years|Mean|64.4|64.4|Standard Deviation|7.75|7.75|||
3685602|NCT02257372|3528183|B3|White - White/Caucasian/European||Race/Ethnicity, Customized||Participants|Number|235|235.0||||||
3685603|NCT02257372|3528184|B2|White - White/Caucasian/European||Race/Ethnicity, Customized||Participants|Number|119|119.0||||||
3685604|NCT02257372|3528185|B1|White - White/Caucasian/European||Race/Ethnicity, Customized||Participants|Number|116|116.0||||||
3685605|NCT02257372|3528183|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3685606|NCT02257372|3528184|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3685607|NCT02257372|3528185|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3685608|NCT02257372|3528183|B3||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3685609|NCT02257372|3528184|B2||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3685610|NCT02257372|3528185|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3685612|NCT02257372|3528184|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3685613|NCT02257372|3528185|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3685614|NCT02257372|3528183|B3|||Age||Years|Mean|64.1|64.1|Standard Deviation|7.72|7.72|||
3685615|NCT02257372|3528184|B2|||Age||Years|Mean|65.2|65.2|Standard Deviation|7.46|7.46|||
3685616|NCT02257372|3528185|B1|||Age||Years|Mean|63.1|63.1|Standard Deviation|7.86|7.86|||
3685617|NCT02256982|3528194|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3685618|NCT02256982|3528195|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3685619|NCT02256982|3528196|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3685620|NCT02256982|3528194|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3685621|NCT02256982|3528195|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3685622|NCT02256982|3528196|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3685623|NCT02256982|3528194|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3685624|NCT02256982|3528195|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3685625|NCT02256982|3528196|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3685626|NCT02256982|3528194|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3685627|NCT02256982|3528195|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3685628|NCT02256982|3528196|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3685629|NCT02256982|3528194|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3685630|NCT02256982|3528195|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3685631|NCT02256982|3528196|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3685632|NCT02256969|3528203|B4|||Tear Film Break-Up Time (TBUT)|TBUT measures the amount of time, in seconds, a dry spot appears in the tear film after each blink. Values less than 10 seconds are considered abnormal.|Seconds|Mean|3.0|3.0|Standard Deviation|1.9|1.9|||
3685633|NCT02256969|3528204|B3|||Tear Film Break-Up Time (TBUT)|TBUT measures the amount of time, in seconds, a dry spot appears in the tear film after each blink. Values less than 10 seconds are considered abnormal.|Seconds|Mean|2.3|2.3|Standard Deviation|2.5|2.5|||
3685634|NCT02256969|3528205|B2|||Tear Film Break-Up Time (TBUT)|TBUT measures the amount of time, in seconds, a dry spot appears in the tear film after each blink. Values less than 10 seconds are considered abnormal.|Seconds|Mean|3.0|3.0|Standard Deviation|1.5|1.5|||
3685635|NCT02256969|3528206|B1|||Tear Film Break-Up Time (TBUT)|TBUT measures the amount of time, in seconds, a dry spot appears in the tear film after each blink. Values less than 10 seconds are considered abnormal.|Seconds|Mean|2.9|2.9|Standard Deviation|1.5|1.5|||
3685636|NCT02256969|3528203|B4|||Corneal Fluorescein Staining (CFS)|The Corneal Fluorescein Staining (CFS) scale ranges from 0 to 15 scale, with 0 representing the minimum level of corneal epitheliopathy and 15 representing the maximum level of epitheliopathy.|units on a scale|Mean|1.6|1.6|Standard Deviation|1.6|1.6|||
3685637|NCT02256969|3528204|B3|||Corneal Fluorescein Staining (CFS)|The Corneal Fluorescein Staining (CFS) scale ranges from 0 to 15 scale, with 0 representing the minimum level of corneal epitheliopathy and 15 representing the maximum level of epitheliopathy.|units on a scale|Mean|0.9|0.9|Standard Deviation|1.0|1.0|||
3685638|NCT02256969|3528205|B2|||Corneal Fluorescein Staining (CFS)|The Corneal Fluorescein Staining (CFS) scale ranges from 0 to 15 scale, with 0 representing the minimum level of corneal epitheliopathy and 15 representing the maximum level of epitheliopathy.|units on a scale|Mean|2.0|2.0|Standard Deviation|2.0|2.0|||
3685639|NCT02256969|3528206|B1|||Corneal Fluorescein Staining (CFS)|The Corneal Fluorescein Staining (CFS) scale ranges from 0 to 15 scale, with 0 representing the minimum level of corneal epitheliopathy and 15 representing the maximum level of epitheliopathy.|units on a scale|Mean|1.9|1.9|Standard Deviation|1.6|1.6|||
3685640|NCT02256969|3528203|B4|||Symptom Assessment in Dry Eye (SANDE)|A two-item survey used to assess the frequency and severity of dry eye disease. The SANDE score is calculated by taking the square root of the product of the frequency of symptoms score and the severity of symptoms score. The SANDE scale ranges from 0 to 100 with 100 being the maximal amount of dry eye symptoms and 0 being the minimal amount of dry eye symptoms.|units on a scale|Mean|67.5|67.5|Standard Deviation|17.8|17.8|||
3685641|NCT02256969|3528204|B3|||Symptom Assessment in Dry Eye (SANDE)|A two-item survey used to assess the frequency and severity of dry eye disease. The SANDE score is calculated by taking the square root of the product of the frequency of symptoms score and the severity of symptoms score. The SANDE scale ranges from 0 to 100 with 100 being the maximal amount of dry eye symptoms and 0 being the minimal amount of dry eye symptoms.|units on a scale|Mean|72.1|72.1|Standard Deviation|14.1|14.1|||
3685642|NCT02256969|3528205|B2|||Symptom Assessment in Dry Eye (SANDE)|A two-item survey used to assess the frequency and severity of dry eye disease. The SANDE score is calculated by taking the square root of the product of the frequency of symptoms score and the severity of symptoms score. The SANDE scale ranges from 0 to 100 with 100 being the maximal amount of dry eye symptoms and 0 being the minimal amount of dry eye symptoms.|units on a scale|Mean|61.8|61.8|Standard Deviation|22.5|22.5|||
3685643|NCT02256969|3528206|B1|||Symptom Assessment in Dry Eye (SANDE)|A two-item survey used to assess the frequency and severity of dry eye disease. The SANDE score is calculated by taking the square root of the product of the frequency of symptoms score and the severity of symptoms score. The SANDE scale ranges from 0 to 100 with 100 being the maximal amount of dry eye symptoms and 0 being the minimal amount of dry eye symptoms.|units on a scale|Mean|68.7|68.7|Standard Deviation|15.4|15.4|||
3685644|NCT02256969|3528203|B4|||Ocular Surface Disease Index (OSDI)|The overall ODSI score is calculated by adding all of the values from the 12 questions, multiplying that value by 25, and dividing the resulting value by the number of questions answered. This results in an overall scale that ranges from 0-100, with 100 being severe dry eye symptoms and 0 being no dry eye symptoms.|units on a scale|Mean|47.9|47.9|Standard Deviation|23.3|23.3|||
3685699|NCT02256358|3528321|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3685700|NCT02256358|3528322|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3685645|NCT02256969|3528204|B3|||Ocular Surface Disease Index (OSDI)|The overall ODSI score is calculated by adding all of the values from the 12 questions, multiplying that value by 25, and dividing the resulting value by the number of questions answered. This results in an overall scale that ranges from 0-100, with 100 being severe dry eye symptoms and 0 being no dry eye symptoms.|units on a scale|Mean|49.1|49.1|Standard Deviation|19.9|19.9|||
3685646|NCT02256969|3528205|B2|||Ocular Surface Disease Index (OSDI)|The overall ODSI score is calculated by adding all of the values from the 12 questions, multiplying that value by 25, and dividing the resulting value by the number of questions answered. This results in an overall scale that ranges from 0-100, with 100 being severe dry eye symptoms and 0 being no dry eye symptoms.|units on a scale|Mean|49.1|49.1|Standard Deviation|27.1|27.1|||
3685647|NCT02256969|3528206|B1|||Ocular Surface Disease Index (OSDI)|The overall ODSI score is calculated by adding all of the values from the 12 questions, multiplying that value by 25, and dividing the resulting value by the number of questions answered. This results in an overall scale that ranges from 0-100, with 100 being severe dry eye symptoms and 0 being no dry eye symptoms.|units on a scale|Mean|45.3|45.3|Standard Deviation|23.8|23.8|||
3685648|NCT02256969|3528203|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3685649|NCT02256969|3528204|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3685650|NCT02256969|3528205|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3685651|NCT02256969|3528206|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3685652|NCT02256969|3528203|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3685653|NCT02256969|3528204|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3685654|NCT02256969|3528205|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3685655|NCT02256969|3528206|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3685656|NCT02256969|3528203|B4|||Age||years|Mean|61.1|61.1|Standard Deviation|15.2|15.2|||
3685657|NCT02256969|3528204|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|17.4|17.4|||
3685658|NCT02256969|3528205|B2|||Age||years|Mean|63.9|63.9|Standard Deviation|13.8|13.8|||
3685659|NCT02256969|3528206|B1|||Age||years|Mean|59.6|59.6|Standard Deviation|13.7|13.7|||
3685660|NCT02256891|3528225|B3|United States||Region of Enrollment||participants|Number|97|97.0||||||
3685661|NCT02256891|3528226|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
3685662|NCT02256891|3528227|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
3685663|NCT02256891|3528225|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3685664|NCT02256891|3528226|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3685665|NCT02256891|3528227|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3685666|NCT02256891|3528225|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3685667|NCT02256891|3528226|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3685668|NCT02256891|3528227|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3685669|NCT02256891|3528225|B3|||Age||years|Mean|56.15|56.15|Full Range|||34.0|75.0|
3685670|NCT02256891|3528226|B2|||Age||years|Mean|58.64|58.64|Full Range|||42.0|75.0|
3685671|NCT02256891|3528227|B1|||Age||years|Mean|53.00|53.0|Full Range|||34.0|73.0|
3685672|NCT02256553|3528252|B1||Male|Gender||Participants|Count of Participants|49|49.0||||||
3685673|NCT02256553|3528252|B1||Female|Gender||Participants|Count of Participants|53|53.0||||||
3685674|NCT02256553|3528252|B1|||Age||Years|Mean|40.0|40.0|Standard Deviation|12.0|12.0|||
3685675|NCT02256488|3528261|B5||Male|Sex: Female, Male||Participants|Count of Participants|620|620.0||||||
3685676|NCT02256488|3528262|B4||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3685677|NCT02256488|3528263|B3||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3685678|NCT02256488|3528264|B2||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3685679|NCT02256488|3528265|B1||Male|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3685680|NCT02256488|3528261|B5||Female|Sex: Female, Male||Participants|Count of Participants|941|941.0||||||
3685681|NCT02256488|3528262|B4||Female|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
3685682|NCT02256488|3528263|B3||Female|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
3685683|NCT02256488|3528264|B2||Female|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
3685684|NCT02256488|3528265|B1||Female|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
3685685|NCT02256488|3528261|B5|||Age||years|Mean|33.1|33.1|Standard Deviation|8.9|8.9|||
3685686|NCT02256488|3528262|B4|||Age||years|Mean|33.2|33.2|Standard Deviation|9.0|9.0|||
3685687|NCT02256488|3528263|B3|||Age||years|Mean|33.8|33.8|Standard Deviation|8.8|8.8|||
3685688|NCT02256488|3528264|B2|||Age||years|Mean|33.1|33.1|Standard Deviation|8.8|8.8|||
3685689|NCT02256488|3528265|B1|||Age||years|Mean|32.4|32.4|Standard Deviation|9.1|9.1|||
3685690|NCT02256436|3528282|B3||Male|Sex: Female, Male||Participants|Count of Participants|402|402.0||||||
3685691|NCT02256436|3528283|B2||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3685692|NCT02256436|3528284|B1||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
3685693|NCT02256436|3528282|B3||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3685694|NCT02256436|3528283|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3685695|NCT02256436|3528284|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3685696|NCT02256436|3528282|B3|||Age||Years|Mean|65.5|65.5|Standard Deviation|9.7|9.7|||
3685697|NCT02256436|3528283|B2|||Age||Years|Mean|65.1|65.1|Standard Deviation|9.2|9.2|||
3685698|NCT02256436|3528284|B1|||Age||Years|Mean|66.0|66.0|Standard Deviation|10.2|10.2|||
3685701|NCT02256358|3528323|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3685702|NCT02256358|3528321|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3685703|NCT02256358|3528322|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3685704|NCT02256358|3528323|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3685705|NCT02256358|3528321|B3|||Age||year|Mean|4.18|4.18|Standard Deviation|1.35|1.35|||
3685706|NCT02256358|3528322|B2|||Age||year|Mean|4.21|4.21|Standard Deviation|1.32|1.32|||
3685707|NCT02256358|3528323|B1|||Age||year|Mean|4.15|4.15|Standard Deviation|1.40|1.4|||
3685708|NCT02256345|3528330|B3|||Left ventricular ejection fraction, %, mean (SD)||% (stroke volume/ end-diastolic vol)x100|Mean|64.23|64.23|Standard Deviation|9.27|9.27|||
3685709|NCT02256345|3528331|B2|||Left ventricular ejection fraction, %, mean (SD)||% (stroke volume/ end-diastolic vol)x100|Mean|59.41|59.41|Standard Deviation|13.66|13.66|||
3685710|NCT02256345|3528332|B1|||Left ventricular ejection fraction, %, mean (SD)||% (stroke volume/ end-diastolic vol)x100|Mean|65.84|65.84|Standard Deviation|7.74|7.74|||
3685711|NCT02256345|3528330|B3|||Left atrial volume index, mL/m^2, mean (SD)||mL/m^2|Mean|27.74|27.74|Standard Deviation|7.15|7.15|||
3685712|NCT02256345|3528331|B2|||Left atrial volume index, mL/m^2, mean (SD)||mL/m^2|Mean|29.38|29.38|Standard Deviation|5.33|5.33|||
3685713|NCT02256345|3528332|B1|||Left atrial volume index, mL/m^2, mean (SD)||mL/m^2|Mean|27.20|27.2|Standard Deviation|7.87|7.87|||
3685714|NCT02256345|3528330|B3|||Septal E/e' ratio, mean (SD)||ratio|Mean|10.42|10.42|Standard Deviation|3.40|3.4|||
3685715|NCT02256345|3528331|B2|||Septal E/e' ratio, mean (SD)||ratio|Mean|9.60|9.6|Standard Deviation|2.39|2.39|||
3685716|NCT02256345|3528332|B1|||Septal E/e' ratio, mean (SD)||ratio|Mean|10.70|10.7|Standard Deviation|3.76|3.76|||
3685717|NCT02256345|3528330|B3|||Septal tissue doppler early velocity (e'), mm/s, mean (SD)||mm/s|Mean|76.41|76.41|Standard Deviation|19.26|19.26|||
3685718|NCT02256345|3528331|B2|||Septal tissue doppler early velocity (e'), mm/s, mean (SD)||mm/s|Mean|93.71|93.71|Standard Deviation|28.65|28.65|||
3685719|NCT02256345|3528332|B1|||Septal tissue doppler early velocity (e'), mm/s, mean (SD)||mm/s|Mean|70.64|70.64|Standard Deviation|12.45|12.45|||
3685720|NCT02256345|3528330|B3|||Mitral atrial inflow velocity (E), cm/s, mean (SD)||cm/s|Mean|75.21|75.21|Standard Deviation|20.99|20.99|||
3685721|NCT02256345|3528331|B2|||Mitral atrial inflow velocity (E), cm/s, mean (SD)||cm/s|Mean|88.61|88.61|Standard Deviation|21.28|21.28|||
3685722|NCT02256345|3528332|B1|||Mitral atrial inflow velocity (E), cm/s, mean (SD)||cm/s|Mean|70.74|70.74|Standard Deviation|20.06|20.06|||
3685723|NCT02256345|3528330|B3|||Mitral early inflow velocity (E), cm/s, mean (SD)||cm/s|Mean|77.33|77.33|Standard Deviation|21.91|21.91|||
3685724|NCT02256345|3528331|B2|||Mitral early inflow velocity (E), cm/s, mean (SD)||cm/s|Mean|85.73|85.73|Standard Deviation|7.04|7.04|||
3685725|NCT02256345|3528332|B1|||Mitral early inflow velocity (E), cm/s, mean (SD)||cm/s|Mean|74.53|74.53|Standard Deviation|24.75|24.75|||
3685726|NCT02256345|3528330|B3|||Relative wall thickness, mean (SD)|The ratio of twice LV diastolic posterior wall thickness to left ventricular end-diastolic dimension|ratio|Mean|0.47|0.47|Standard Deviation|0.09|0.09|||
3685727|NCT02256345|3528331|B2|||Relative wall thickness, mean (SD)|The ratio of twice LV diastolic posterior wall thickness to left ventricular end-diastolic dimension|ratio|Mean|0.46|0.46|Standard Deviation|0.09|0.09|||
3685728|NCT02256345|3528332|B1|||Relative wall thickness, mean (SD)|The ratio of twice LV diastolic posterior wall thickness to left ventricular end-diastolic dimension|ratio|Mean|0.47|0.47|Standard Deviation|0.09|0.09|||
3685729|NCT02256345|3528330|B3|||Left Ventricular (LV) mass index, g/m^2, mean (SD)||g/m^2|Mean|78.88|78.88|Standard Deviation|22.46|22.46|||
3685730|NCT02256345|3528331|B2|||Left Ventricular (LV) mass index, g/m^2, mean (SD)||g/m^2|Mean|76.18|76.18|Standard Deviation|7.33|7.33|||
3685731|NCT02256345|3528332|B1|||Left Ventricular (LV) mass index, g/m^2, mean (SD)||g/m^2|Mean|79.78|79.78|Standard Deviation|26.01|26.01|||
3685732|NCT02256345|3528330|B3|||Left Ventricular (LV) mass,g, mean (SD)||g|Mean|172.32|172.32|Standard Deviation|66.36|66.36|||
3685733|NCT02256345|3528331|B2|||Left Ventricular (LV) mass,g, mean (SD)||g|Mean|165.98|165.98|Standard Deviation|19.27|19.27|||
3685734|NCT02256345|3528332|B1|||Left Ventricular (LV) mass,g, mean (SD)||g|Mean|174.43|174.43|Standard Deviation|77.09|77.09|||
3685735|NCT02256345|3528330|B3|||Methemoglobin, %, mean (SD)||percent of total hemoglobin|Mean|1.0|1.0|Standard Deviation|0.3|0.3|||
3685736|NCT02256345|3528331|B2|||Methemoglobin, %, mean (SD)||percent of total hemoglobin|Mean|1.0|1.0|Standard Deviation|0.5|0.5|||
3685737|NCT02256345|3528332|B1|||Methemoglobin, %, mean (SD)||percent of total hemoglobin|Mean|1.0|1.0|Standard Deviation|0.2|0.2|||
3685738|NCT02256345|3528330|B3|||Hemoglobin, g/dL, mean (SD)||g/dL|Mean|13.6|13.6|Standard Deviation|0.8|0.8|||
3685739|NCT02256345|3528331|B2|||Hemoglobin, g/dL, mean (SD)||g/dL|Mean|13.5|13.5|Standard Deviation|1.0|1.0|||
3685740|NCT02256345|3528332|B1|||Hemoglobin, g/dL, mean (SD)||g/dL|Mean|13.6|13.6|Standard Deviation|0.8|0.8|||
3685741|NCT02256345|3528330|B3|||Number of Participants with high N-terminal pro-brain natriuretic peptide (NT-proBNP), pg/ml, n (%)||Participants|Count of Participants|5|5.0||||||
3685742|NCT02256345|3528331|B2|||Number of Participants with high N-terminal pro-brain natriuretic peptide (NT-proBNP), pg/ml, n (%)||Participants|Count of Participants|2|2.0||||||
3685743|NCT02256345|3528332|B1|||Number of Participants with high N-terminal pro-brain natriuretic peptide (NT-proBNP), pg/ml, n (%)||Participants|Count of Participants|3|3.0||||||
3685744|NCT02256345|3528330|B3|||N-terminal pro-brain natriuretic peptide (NT-proBNP), pg/ml, mean (SD)||pg/ml|Mean|111|111.0|Standard Deviation|89.0|89.0|||
3685745|NCT02256345|3528331|B2|||N-terminal pro-brain natriuretic peptide (NT-proBNP), pg/ml, mean (SD)||pg/ml|Mean|119|119.0|Standard Deviation|87.0|87.0|||
3685746|NCT02256345|3528332|B1|||N-terminal pro-brain natriuretic peptide (NT-proBNP), pg/ml, mean (SD)||pg/ml|Mean|108.3|108.3|Standard Deviation|94.7|94.7|||
3685747|NCT02256345|3528330|B3|||Estimated Glomerular Filtration Rate (eGFR) <60 mL/min per 1.73m^2, n (%)||Participants|Count of Participants|4|4.0||||||
3685748|NCT02256345|3528331|B2|||Estimated Glomerular Filtration Rate (eGFR) <60 mL/min per 1.73m^2, n (%)||Participants|Count of Participants|1|1.0||||||
3685749|NCT02256345|3528332|B1|||Estimated Glomerular Filtration Rate (eGFR) <60 mL/min per 1.73m^2, n (%)||Participants|Count of Participants|3|3.0||||||
3685750|NCT02256345|3528330|B3|||Estimated Glomerular Filtration Rate (eGFR), mL/min per 1.73m^2, mean (SD)||mL/min per 1.73m^2|Mean|69.4|69.4|Standard Deviation|12.6|12.6|||
3685751|NCT02256345|3528331|B2|||Estimated Glomerular Filtration Rate (eGFR), mL/min per 1.73m^2, mean (SD)||mL/min per 1.73m^2|Mean|64.7|64.7|Standard Deviation|5.9|5.9|||
3685752|NCT02256345|3528332|B1|||Estimated Glomerular Filtration Rate (eGFR), mL/min per 1.73m^2, mean (SD)||mL/min per 1.73m^2|Mean|71.0|71.0|Standard Deviation|14.1|14.1|||
3685753|NCT02256345|3528330|B3|||Number of Participants on Statin, n (%)||Participants|Count of Participants|7|7.0||||||
3685754|NCT02256345|3528331|B2|||Number of Participants on Statin, n (%)||Participants|Count of Participants|2|2.0||||||
3685755|NCT02256345|3528332|B1|||Number of Participants on Statin, n (%)||Participants|Count of Participants|5|5.0||||||
3685756|NCT02256345|3528330|B3|||Number of Participants on Thiazide diuretic, n (%)||Participants|Count of Participants|4|4.0||||||
3685757|NCT02256345|3528331|B2|||Number of Participants on Thiazide diuretic, n (%)||Participants|Count of Participants|1|1.0||||||
3685758|NCT02256345|3528332|B1|||Number of Participants on Thiazide diuretic, n (%)||Participants|Count of Participants|3|3.0||||||
3685759|NCT02256345|3528330|B3|||Number of Participants on Loop diuretics, n (%)||Participants|Count of Participants|9|9.0||||||
3685760|NCT02256345|3528331|B2|||Number of Participants on Loop diuretics, n (%)||Participants|Count of Participants|2|2.0||||||
3685761|NCT02256345|3528332|B1|||Number of Participants on Loop diuretics, n (%)||Participants|Count of Participants|7|7.0||||||
3685762|NCT02256345|3528330|B3|||Number of Participants on Calcium-channel blockers, n (%)||Participants|Count of Participants|4|4.0||||||
3685763|NCT02256345|3528331|B2|||Number of Participants on Calcium-channel blockers, n (%)||Participants|Count of Participants|1|1.0||||||
3685764|NCT02256345|3528332|B1|||Number of Participants on Calcium-channel blockers, n (%)||Participants|Count of Participants|3|3.0||||||
3685765|NCT02256345|3528330|B3|||Number of Participants on Mineralocorticoid receptor antagonists, n (%)||Participants|Count of Participants|3|3.0||||||
3685766|NCT02256345|3528331|B2|||Number of Participants on Mineralocorticoid receptor antagonists, n (%)||Participants|Count of Participants|1|1.0||||||
3685767|NCT02256345|3528332|B1|||Number of Participants on Mineralocorticoid receptor antagonists, n (%)||Participants|Count of Participants|2|2.0||||||
3685768|NCT02256345|3528330|B3|||Number of Participants onACEI/ARB, n (%)||Participants|Count of Participants|9|9.0||||||
3685769|NCT02256345|3528331|B2|||Number of Participants onACEI/ARB, n (%)||Participants|Count of Participants|2|2.0||||||
3685770|NCT02256345|3528332|B1|||Number of Participants onACEI/ARB, n (%)||Participants|Count of Participants|7|7.0||||||
3685771|NCT02256345|3528330|B3|||Number of Participants on Beta-blockers, n (%)||Participants|Count of Participants|9|9.0||||||
3685772|NCT02256345|3528331|B2|||Number of Participants on Beta-blockers, n (%)||Participants|Count of Participants|2|2.0||||||
3685773|NCT02256345|3528332|B1|||Number of Participants on Beta-blockers, n (%)||Participants|Count of Participants|7|7.0||||||
3685774|NCT02256345|3528330|B3|||Number of Participants with Obstructive lung disease, n (%)||Participants|Count of Participants|3|3.0||||||
3685775|NCT02256345|3528331|B2|||Number of Participants with Obstructive lung disease, n (%)||Participants|Count of Participants|1|1.0||||||
3685776|NCT02256345|3528332|B1|||Number of Participants with Obstructive lung disease, n (%)||Participants|Count of Participants|2|2.0||||||
3685777|NCT02256345|3528330|B3|||Number of Participants with Current Continuous Positive Airway Pressure (CPAP) use, n (%)||Participants|Count of Participants|5|5.0||||||
3685778|NCT02256345|3528331|B2|||Number of Participants with Current Continuous Positive Airway Pressure (CPAP) use, n (%)||Participants|Count of Participants|3|3.0||||||
3685779|NCT02256345|3528332|B1|||Number of Participants with Current Continuous Positive Airway Pressure (CPAP) use, n (%)||Participants|Count of Participants|2|2.0||||||
3685780|NCT02256345|3528330|B3|||Number of Participants with Obstructive sleep apnea, n (%)||Participants|Count of Participants|6|6.0||||||
3685781|NCT02256345|3528331|B2|||Number of Participants with Obstructive sleep apnea, n (%)||Participants|Count of Participants|3|3.0||||||
3685782|NCT02256345|3528332|B1|||Number of Participants with Obstructive sleep apnea, n (%)||Participants|Count of Participants|3|3.0||||||
3685783|NCT02256345|3528330|B3|||Number of Participants with Diabetes Mellitus, n (%)||Participants|Count of Participants|7|7.0||||||
3685784|NCT02256345|3528331|B2|||Number of Participants with Diabetes Mellitus, n (%)||Participants|Count of Participants|2|2.0||||||
3685785|NCT02256345|3528332|B1|||Number of Participants with Diabetes Mellitus, n (%)||Participants|Count of Participants|5|5.0||||||
3685786|NCT02256345|3528330|B3|||Number of Participants with History of atrial fibrillation, n (%)||Participants|Count of Participants|1|1.0||||||
3685787|NCT02256345|3528331|B2|||Number of Participants with History of atrial fibrillation, n (%)||Participants|Count of Participants|1|1.0||||||
3685788|NCT02256345|3528332|B1|||Number of Participants with History of atrial fibrillation, n (%)||Participants|Count of Participants|0|0.0||||||
3685789|NCT02256345|3528330|B3|||Number of Participants with Coronary Artery Disease, n (%)||Participants|Count of Participants|4|4.0||||||
3685790|NCT02256345|3528331|B2|||Number of Participants with Coronary Artery Disease, n (%)||Participants|Count of Participants|1|1.0||||||
3685791|NCT02256345|3528332|B1|||Number of Participants with Coronary Artery Disease, n (%)||Participants|Count of Participants|3|3.0||||||
3685792|NCT02256345|3528330|B3|||Number of Participants with Hyperlipidemia, n (%)||Participants|Count of Participants|10|10.0||||||
3685793|NCT02256345|3528331|B2|||Number of Participants with Hyperlipidemia, n (%)||Participants|Count of Participants|3|3.0||||||
3685794|NCT02256345|3528332|B1|||Number of Participants with Hyperlipidemia, n (%)||Participants|Count of Participants|7|7.0||||||
3685795|NCT02256345|3528330|B3|||Number of Hypertensive Participants, n(%)||Participants|Count of Participants|12|12.0||||||
3685796|NCT02256345|3528331|B2|||Number of Hypertensive Participants, n(%)||Participants|Count of Participants|3|3.0||||||
3685797|NCT02256345|3528332|B1|||Number of Hypertensive Participants, n(%)||Participants|Count of Participants|9|9.0||||||
3685798|NCT02256345|3528330|B3|||Number of Obese Participants, n(%)||Participants|Count of Participants|8|8.0||||||
3685799|NCT02256345|3528331|B2|||Number of Obese Participants, n(%)||Participants|Count of Participants|3|3.0||||||
3685800|NCT02256345|3528332|B1|||Number of Obese Participants, n(%)||Participants|Count of Participants|5|5.0||||||
3685801|NCT02256345|3528330|B3|||Body Mass Index, kg/m^2, mean (SD)||kg/m^2|Mean|34.4|34.4|Standard Deviation|7.0|7.0|||
3685802|NCT02256345|3528331|B2|||Body Mass Index, kg/m^2, mean (SD)||kg/m^2|Mean|37.4|37.4|Standard Deviation|9.9|9.9|||
3685803|NCT02256345|3528332|B1|||Body Mass Index, kg/m^2, mean (SD)||kg/m^2|Mean|33.4|33.4|Standard Deviation|6.3|6.3|||
3685804|NCT02256345|3528330|B3||Class III|New York Heart Association Heart failure classification (NYHA Class) n (%)|"Class II- Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~Class III- Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea."|Participants|Count of Participants|2|2.0||||||
3685805|NCT02256345|3528331|B2||Class III|New York Heart Association Heart failure classification (NYHA Class) n (%)|"Class II- Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~Class III- Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea."|Participants|Count of Participants|1|1.0||||||
3685806|NCT02256345|3528332|B1||Class III|New York Heart Association Heart failure classification (NYHA Class) n (%)|"Class II- Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~Class III- Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea."|Participants|Count of Participants|1|1.0||||||
3685807|NCT02256345|3528330|B3||Class II|New York Heart Association Heart failure classification (NYHA Class) n (%)|"Class II- Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~Class III- Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea."|Participants|Count of Participants|10|10.0||||||
3685808|NCT02256345|3528331|B2||Class II|New York Heart Association Heart failure classification (NYHA Class) n (%)|"Class II- Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~Class III- Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea."|Participants|Count of Participants|2|2.0||||||
3685809|NCT02256345|3528332|B1||Class II|New York Heart Association Heart failure classification (NYHA Class) n (%)|"Class II- Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~Class III- Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea."|Participants|Count of Participants|8|8.0||||||
3685810|NCT02256345|3528330|B3|Race, n (%)|Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3685811|NCT02256345|3528331|B2|Race, n (%)|Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3685812|NCT02256345|3528332|B1|Race, n (%)|Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3685813|NCT02256345|3528330|B3|Race, n (%)|Black|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3685814|NCT02256345|3528331|B2|Race, n (%)|Black|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3685815|NCT02256345|3528332|B1|Race, n (%)|Black|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3685816|NCT02256345|3528330|B3|Race, n (%)|White|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3685817|NCT02256345|3528331|B2|Race, n (%)|White|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3685818|NCT02256345|3528332|B1|Race, n (%)|White|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3685819|NCT02256345|3528330|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3685820|NCT02256345|3528331|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3685821|NCT02256345|3528332|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3685822|NCT02256345|3528330|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3685823|NCT02256345|3528331|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3685824|NCT02256345|3528332|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3685825|NCT02256345|3528330|B3|||Age||years|Mean|62.5|62.5|Standard Deviation|5.8|5.8|||
3685826|NCT02256345|3528331|B2|||Age||years|Mean|62.7|62.7|Standard Deviation|8.0|8.0|||
3685827|NCT02256345|3528332|B1|||Age||years|Mean|62.4|62.4|Standard Deviation|5.5|5.5|||
3685828|NCT02256267|3528345|B1|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3685829|NCT02256267|3528345|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685830|NCT02256267|3528345|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3685831|NCT02256267|3528345|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3685832|NCT02256267|3528345|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3685833|NCT02256267|3528345|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685834|NCT02256267|3528345|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685835|NCT02256267|3528345|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3685836|NCT02256267|3528345|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3685837|NCT02256267|3528345|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3685838|NCT02256267|3528345|B1|||Age||years|Mean|58.8|58.8|Standard Deviation|7.4|7.4|||
3685839|NCT02256072|3528354|B3|Adequate Literacy||REALM-R|REALM-R score.|participants|Number|324|324.0||||||
3685840|NCT02256072|3528355|B2|Adequate Literacy||REALM-R|REALM-R score.|participants|Number|159|159.0||||||
3685841|NCT02256072|3528356|B1|Adequate Literacy||REALM-R|REALM-R score.|participants|Number|165|165.0||||||
3685842|NCT02256072|3528354|B3|Marginal Literacy||REALM-R|REALM-R score.|participants|Number|57|57.0||||||
3685843|NCT02256072|3528355|B2|Marginal Literacy||REALM-R|REALM-R score.|participants|Number|29|29.0||||||
3685844|NCT02256072|3528356|B1|Marginal Literacy||REALM-R|REALM-R score.|participants|Number|28|28.0||||||
3685845|NCT02256072|3528354|B3|Low Literacy||REALM-R|REALM-R score.|participants|Number|4|4.0||||||
3685846|NCT02256072|3528355|B2|Low Literacy||REALM-R|REALM-R score.|participants|Number|3|3.0||||||
3685847|NCT02256072|3528356|B1|Low Literacy||REALM-R|REALM-R score.|participants|Number|1|1.0||||||
3685848|NCT02256072|3528354|B3|Live with multiple people (more than one)||Living Arrangement|Self-reported current living arrangement.|participants|Number|22|22.0||||||
3685849|NCT02256072|3528355|B2|Live with multiple people (more than one)||Living Arrangement|Self-reported current living arrangement.|participants|Number|12|12.0||||||
3685850|NCT02256072|3528356|B1|Live with multiple people (more than one)||Living Arrangement|Self-reported current living arrangement.|participants|Number|10|10.0||||||
3685851|NCT02256072|3528354|B3|Live with one other person||Living Arrangement|Self-reported current living arrangement.|participants|Number|165|165.0||||||
3685852|NCT02256072|3528355|B2|Live with one other person||Living Arrangement|Self-reported current living arrangement.|participants|Number|75|75.0||||||
3685853|NCT02256072|3528356|B1|Live with one other person||Living Arrangement|Self-reported current living arrangement.|participants|Number|90|90.0||||||
3685854|NCT02256072|3528354|B3|Live alone||Living Arrangement|Self-reported current living arrangement.|participants|Number|198|198.0||||||
3685855|NCT02256072|3528355|B2|Live alone||Living Arrangement|Self-reported current living arrangement.|participants|Number|104|104.0||||||
3685856|NCT02256072|3528356|B1|Live alone||Living Arrangement|Self-reported current living arrangement.|participants|Number|94|94.0||||||
3685857|NCT02256072|3528354|B3|Excellent||Self-Reported Health Rating||participants|Number|48|48.0||||||
3685858|NCT02256072|3528355|B2|Excellent||Self-Reported Health Rating||participants|Number|27|27.0||||||
3685859|NCT02256072|3528356|B1|Excellent||Self-Reported Health Rating||participants|Number|21|21.0||||||
3685860|NCT02256072|3528354|B3|Very Good||Self-Reported Health Rating||participants|Number|132|132.0||||||
3685861|NCT02256072|3528355|B2|Very Good||Self-Reported Health Rating||participants|Number|62|62.0||||||
3685862|NCT02256072|3528356|B1|Very Good||Self-Reported Health Rating||participants|Number|70|70.0||||||
3685863|NCT02256072|3528354|B3|Good||Self-Reported Health Rating||participants|Number|157|157.0||||||
3685864|NCT02256072|3528355|B2|Good||Self-Reported Health Rating||participants|Number|76|76.0||||||
3685865|NCT02256072|3528356|B1|Good||Self-Reported Health Rating||participants|Number|81|81.0||||||
3685866|NCT02256072|3528354|B3|Fair||Self-Reported Health Rating||participants|Number|40|40.0||||||
3685867|NCT02256072|3528355|B2|Fair||Self-Reported Health Rating||participants|Number|22|22.0||||||
3685868|NCT02256072|3528356|B1|Fair||Self-Reported Health Rating||participants|Number|18|18.0||||||
3685869|NCT02256072|3528354|B3|Poor||Self-Reported Health Rating||participants|Number|8|8.0||||||
3685870|NCT02256072|3528355|B2|Poor||Self-Reported Health Rating||participants|Number|4|4.0||||||
3685871|NCT02256072|3528356|B1|Poor||Self-Reported Health Rating||participants|Number|4|4.0||||||
3685872|NCT02256072|3528354|B3|Prefer not to say||Household Income|Self-reported combined annual household income.|participants|Number|11|11.0||||||
3685873|NCT02256072|3528355|B2|Prefer not to say||Household Income|Self-reported combined annual household income.|participants|Number|4|4.0||||||
3685874|NCT02256072|3528356|B1|Prefer not to say||Household Income|Self-reported combined annual household income.|participants|Number|7|7.0||||||
3685875|NCT02256072|3528354|B3|Not Sure/Don't Know||Household Income|Self-reported combined annual household income.|participants|Number|6|6.0||||||
3685876|NCT02256072|3528355|B2|Not Sure/Don't Know||Household Income|Self-reported combined annual household income.|participants|Number|4|4.0||||||
3685877|NCT02256072|3528356|B1|Not Sure/Don't Know||Household Income|Self-reported combined annual household income.|participants|Number|2|2.0||||||
3685878|NCT02256072|3528354|B3|More than $100,000||Household Income|Self-reported combined annual household income.|participants|Number|31|31.0||||||
3685879|NCT02256072|3528355|B2|More than $100,000||Household Income|Self-reported combined annual household income.|participants|Number|13|13.0||||||
3685880|NCT02256072|3528356|B1|More than $100,000||Household Income|Self-reported combined annual household income.|participants|Number|18|18.0||||||
3685881|NCT02256072|3528354|B3|$80,001-$100,000||Household Income|Self-reported combined annual household income.|participants|Number|36|36.0||||||
3685882|NCT02256072|3528355|B2|$80,001-$100,000||Household Income|Self-reported combined annual household income.|participants|Number|19|19.0||||||
3685883|NCT02256072|3528356|B1|$80,001-$100,000||Household Income|Self-reported combined annual household income.|participants|Number|17|17.0||||||
3685884|NCT02256072|3528354|B3|$60,001-$80,000||Household Income|Self-reported combined annual household income.|participants|Number|51|51.0||||||
3685885|NCT02256072|3528355|B2|$60,001-$80,000||Household Income|Self-reported combined annual household income.|participants|Number|25|25.0||||||
3685886|NCT02256072|3528356|B1|$60,001-$80,000||Household Income|Self-reported combined annual household income.|participants|Number|26|26.0||||||
3685887|NCT02256072|3528354|B3|$40,001-$60,000||Household Income|Self-reported combined annual household income.|participants|Number|58|58.0||||||
3685888|NCT02256072|3528355|B2|$40,001-$60,000||Household Income|Self-reported combined annual household income.|participants|Number|31|31.0||||||
3685889|NCT02256072|3528356|B1|$40,001-$60,000||Household Income|Self-reported combined annual household income.|participants|Number|27|27.0||||||
3685890|NCT02256072|3528354|B3|$20,000-$40,000||Household Income|Self-reported combined annual household income.|participants|Number|104|104.0||||||
3685891|NCT02256072|3528355|B2|$20,000-$40,000||Household Income|Self-reported combined annual household income.|participants|Number|50|50.0||||||
3685892|NCT02256072|3528356|B1|$20,000-$40,000||Household Income|Self-reported combined annual household income.|participants|Number|54|54.0||||||
3685893|NCT02256072|3528354|B3|less than $20,000||Household Income|Self-reported combined annual household income.|participants|Number|88|88.0||||||
3685894|NCT02256072|3528355|B2|less than $20,000||Household Income|Self-reported combined annual household income.|participants|Number|45|45.0||||||
3685895|NCT02256072|3528356|B1|less than $20,000||Household Income|Self-reported combined annual household income.|participants|Number|43|43.0||||||
3685896|NCT02256072|3528354|B3|College graduate||Education|Reported education|participants|Number|198|198.0||||||
3685897|NCT02256072|3528355|B2|College graduate||Education|Reported education|participants|Number|103|103.0||||||
3685898|NCT02256072|3528356|B1|College graduate||Education|Reported education|participants|Number|95|95.0||||||
3685899|NCT02256072|3528354|B3|Some college||Education|Reported education|participants|Number|114|114.0||||||
3685900|NCT02256072|3528355|B2|Some college||Education|Reported education|participants|Number|55|55.0||||||
3685901|NCT02256072|3528356|B1|Some college||Education|Reported education|participants|Number|59|59.0||||||
3685902|NCT02256072|3528354|B3|High school or less||Education|Reported education|participants|Number|73|73.0||||||
3685903|NCT02256072|3528355|B2|High school or less||Education|Reported education|participants|Number|33|33.0||||||
3685904|NCT02256072|3528356|B1|High school or less||Education|Reported education|participants|Number|40|40.0||||||
3685905|NCT02256072|3528354|B3|Divorced/Separated||Marital Status||participants|Number|95|95.0||||||
3685906|NCT02256072|3528355|B2|Divorced/Separated||Marital Status||participants|Number|45|45.0||||||
3685907|NCT02256072|3528356|B1|Divorced/Separated||Marital Status||participants|Number|50|50.0||||||
3685908|NCT02256072|3528354|B3|Widowed||Marital Status||participants|Number|80|80.0||||||
3685909|NCT02256072|3528355|B2|Widowed||Marital Status||participants|Number|44|44.0||||||
3685910|NCT02256072|3528356|B1|Widowed||Marital Status||participants|Number|36|36.0||||||
3685911|NCT02256072|3528354|B3|Married||Marital Status||participants|Number|160|160.0||||||
3685912|NCT02256072|3528355|B2|Married||Marital Status||participants|Number|75|75.0||||||
3685913|NCT02256072|3528356|B1|Married||Marital Status||participants|Number|85|85.0||||||
3685914|NCT02256072|3528354|B3|Single, never married||Marital Status||participants|Number|50|50.0||||||
3685915|NCT02256072|3528355|B2|Single, never married||Marital Status||participants|Number|27|27.0||||||
3685916|NCT02256072|3528356|B1|Single, never married||Marital Status||participants|Number|23|23.0||||||
3685917|NCT02256072|3528354|B3|More than one race||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3685918|NCT02256072|3528355|B2|More than one race||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3685919|NCT02256072|3528356|B1|More than one race||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3685920|NCT02256072|3528354|B3|Other||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3685921|NCT02256072|3528355|B2|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3685922|NCT02256072|3528356|B1|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3685923|NCT02256072|3528354|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3685924|NCT02256072|3528355|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3685925|NCT02256072|3528356|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3685926|NCT02256072|3528354|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|93|93.0||||||
3685927|NCT02256072|3528355|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
3685928|NCT02256072|3528356|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
3685929|NCT02256072|3528354|B3|White or Caucasian||Race/Ethnicity, Customized||participants|Number|242|242.0||||||
3685930|NCT02256072|3528355|B2|White or Caucasian||Race/Ethnicity, Customized||participants|Number|125|125.0||||||
3685931|NCT02256072|3528356|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|117|117.0||||||
3685932|NCT02256072|3528354|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3685933|NCT02256072|3528355|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3685934|NCT02256072|3528356|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3685935|NCT02256072|3528354|B3||Female|Sex: Female, Male||Participants|Count of Participants|306|306.0||||||
3685936|NCT02256072|3528355|B2||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3685937|NCT02256072|3528356|B1||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3685938|NCT02256072|3528354|B3|||Age||years|Mean|71.86|71.86|Standard Deviation|5.56|5.56|||
3685939|NCT02256072|3528355|B2|||Age||years|Mean|72.05|72.05|Standard Deviation|5.57|5.57|||
3685940|NCT02256072|3528356|B1|||Age||years|Mean|71.67|71.67|Standard Deviation|5.56|5.56|||
3685941|NCT02255760|3528371|B6||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3685942|NCT02255760|3528372|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3685943|NCT02255760|3528373|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3685944|NCT02255760|3528374|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3685945|NCT02255760|3528375|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3685946|NCT02255760|3528376|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3685947|NCT02255760|3528371|B6||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3685948|NCT02255760|3528372|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3685949|NCT02255760|3528373|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3685950|NCT02255760|3528374|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3685951|NCT02255760|3528375|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3685952|NCT02255760|3528376|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3685953|NCT02255760|3528371|B6|||Age||Years|Mean|40.3|40.3|Standard Deviation|11.6|11.6|||
3685954|NCT02255760|3528372|B5|||Age||Years|Mean|39.8|39.8|Standard Deviation|13.1|13.1|||
3685955|NCT02255760|3528373|B4|||Age||Years|Mean|40.3|40.3|Standard Deviation|12.4|12.4|||
3685956|NCT02255760|3528374|B3|||Age||Years|Mean|40.9|40.9|Standard Deviation|11.8|11.8|||
3685957|NCT02255760|3528375|B2|||Age||Years|Mean|34.0|34.0|Standard Deviation|9.5|9.5|||
3685958|NCT02255760|3528376|B1|||Age||Years|Mean|41.2|41.2|Standard Deviation|10.9|10.9|||
3685959|NCT02255565|3528432|B4|United States||Region of Enrollment||participants|Number|26|26.0||||||
3685960|NCT02255565|3528433|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
3685961|NCT02255565|3528434|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3685962|NCT02255565|3528435|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3685963|NCT02255565|3528432|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3685964|NCT02255565|3528433|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3685965|NCT02255565|3528434|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3685966|NCT02255565|3528435|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3685967|NCT02255565|3528432|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3685968|NCT02255565|3528433|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3685969|NCT02255565|3528434|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3685970|NCT02255565|3528435|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3685971|NCT02255565|3528432|B4|||Age||years|Mean|9.19|9.19|Standard Deviation|3.00|3.0|||
3685972|NCT02255565|3528433|B3|||Age||years|Mean|10.22|10.22|Standard Deviation|3.03|3.03|||
3685973|NCT02255565|3528434|B2|||Age||years|Mean|8.00|8.0|Standard Deviation|2.96|2.96|||
3685974|NCT02255565|3528435|B1|||Age||years|Mean|9.33|9.33|Standard Deviation|2.92|2.92|||
3685975|NCT02255565|3528432|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3685976|NCT02255565|3528433|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3685977|NCT02255565|3528434|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3685978|NCT02255565|3528435|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3685979|NCT02255565|3528432|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3685980|NCT02255565|3528433|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3685981|NCT02255565|3528434|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3685982|NCT02255565|3528435|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3685983|NCT02255565|3528432|B4||<=18 years|Age||Participants|Count of Participants|27|27.0||||||
3685984|NCT02255565|3528433|B3||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
3685985|NCT02255565|3528434|B2||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
3685986|NCT02255565|3528435|B1||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
3685987|NCT02255279|3528496|B3||MALE|Gender||Participants|Count of Participants|147|147.0||||||
3685988|NCT02255279|3528497|B2||MALE|Gender||Participants|Count of Participants|71|71.0||||||
3685989|NCT02255279|3528498|B1||MALE|Gender||Participants|Count of Participants|76|76.0||||||
3685990|NCT02255279|3528496|B3||FEMALE|Gender||Participants|Count of Participants|140|140.0||||||
3685991|NCT02255279|3528497|B2||FEMALE|Gender||Participants|Count of Participants|72|72.0||||||
3685992|NCT02255279|3528498|B1||FEMALE|Gender||Participants|Count of Participants|68|68.0||||||
3685993|NCT02255279|3528496|B3|||Age||Months|Mean|29.8|29.8|Standard Deviation|18.6|18.6|||
3685994|NCT02255279|3528497|B2|||Age||Months|Mean|30.1|30.1|Standard Deviation|19.1|19.1|||
3685995|NCT02255279|3528498|B1|||Age||Months|Mean|29.5|29.5|Standard Deviation|18.2|18.2|||
3685996|NCT02255149|3528525|B1|||Bone height||millimeters|Mean|9.8|9.8|Full Range|||7.2|12.9|
3685997|NCT02255149|3528525|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3685998|NCT02255149|3528525|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3685999|NCT02255149|3528525|B1|>=18||Age, Customized||years|Number|9|9.0||||||
3686000|NCT02255110|3528529|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3686001|NCT02255110|3528529|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3686002|NCT02255110|3528529|B1|||Age||years|Mean|52.7|52.7|Standard Deviation|10.46|10.46|||
3686003|NCT02255097|3528541|B1||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3686004|NCT02255097|3528541|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3686005|NCT02255097|3528541|B1|||Age||Years|Mean|61.2|61.2|Standard Deviation|9.9|9.9|||
3686006|NCT02254772|3528562|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3686007|NCT02254772|3528562|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686008|NCT02254772|3528562|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686009|NCT02254772|3528562|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3686010|NCT02254772|3528562|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686011|NCT02254772|3528562|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3686012|NCT02254772|3528562|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686013|NCT02254772|3528562|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686014|NCT02254772|3528562|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3686015|NCT02254772|3528562|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3686016|NCT02254772|3528562|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3686017|NCT02254772|3528562|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3686018|NCT02254772|3528562|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3686019|NCT02254772|3528562|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3686020|NCT02254772|3528562|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3686021|NCT02254681|3528568|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3686022|NCT02254681|3528568|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686023|NCT02254681|3528568|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3686024|NCT02254681|3528568|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3686025|NCT02254681|3528568|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3686026|NCT02254681|3528568|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3686027|NCT02254681|3528568|B1|||Age||years|Mean|64|64.0|Standard Deviation|0|0.0|||
3686028|NCT02254551|3528578|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3686029|NCT02254551|3528578|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3686030|NCT02254551|3528578|B1|Black or African AMerican||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3686031|NCT02254551|3528578|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3686032|NCT02254551|3528578|B1||Male|Gender||Participants|Count of Participants|1|1.0||||||
3686033|NCT02254551|3528578|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
3686034|NCT02254551|3528578|B1|||Age||years|Median|79|79.0|Full Range|||52.0|84.0|
3686035|NCT02254486|3528586|B3||Male|Sex: Female, Male||Participants|Count of Participants|327|327.0||||||
3686036|NCT02254486|3528587|B2||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3686037|NCT02254486|3528588|B1||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3686038|NCT02254486|3528586|B3||Female|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
3686039|NCT02254486|3528587|B2||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3686040|NCT02254486|3528588|B1||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3686041|NCT02254486|3528586|B3|||Age||Years|Mean|57.5|57.5|Standard Deviation|10.44|10.44|||
3686042|NCT02254486|3528587|B2|||Age||Years|Mean|57.7|57.7|Standard Deviation|10.36|10.36|||
3686043|NCT02254486|3528588|B1|||Age||Years|Mean|57.3|57.3|Standard Deviation|10.56|10.56|||
3686044|NCT02254486|3528586|B3||>=65 years|Age||Participants|Count of Participants|139|139.0||||||
3686045|NCT02254486|3528587|B2||>=65 years|Age||Participants|Count of Participants|67|67.0||||||
3686046|NCT02254486|3528588|B1||>=65 years|Age||Participants|Count of Participants|72|72.0||||||
3686047|NCT02254486|3528586|B3||Between 18 and 65 years|Age||Participants|Count of Participants|481|481.0||||||
3686048|NCT02254486|3528587|B2||Between 18 and 65 years|Age||Participants|Count of Participants|243|243.0||||||
3686049|NCT02254486|3528588|B1||Between 18 and 65 years|Age||Participants|Count of Participants|238|238.0||||||
3686050|NCT02254486|3528586|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3686051|NCT02254486|3528587|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3686052|NCT02254486|3528588|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3686053|NCT02254460|3528605|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686054|NCT02254460|3528605|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686055|NCT02254460|3528605|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686056|NCT02254460|3528605|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686057|NCT02254460|3528605|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686058|NCT02254460|3528605|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3686059|NCT02254460|3528605|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686060|NCT02254460|3528605|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3686061|NCT02254460|3528605|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3686062|NCT02254460|3528605|B1|Years||Age||Years|Mean|8.60|8.6|Standard Deviation|1.000|1.0|||
3686063|NCT02254421|3528612|B3|||Oxygen Saturation|Oxygen saturation is a measure of how much oxygen the blood is carrying as a percentage of the maximum it could carry.|percent saturation|Mean|93|93.0|Standard Deviation|4.5|4.5|||
3686064|NCT02254421|3528613|B2|||Oxygen Saturation|Oxygen saturation is a measure of how much oxygen the blood is carrying as a percentage of the maximum it could carry.|percent saturation|Mean|93|93.0|Standard Deviation|5.1|5.1|||
3686065|NCT02254421|3528614|B1|||Oxygen Saturation|Oxygen saturation is a measure of how much oxygen the blood is carrying as a percentage of the maximum it could carry.|percent saturation|Mean|94|94.0|Standard Deviation|3.8|3.8|||
3686066|NCT02254421|3528612|B3|||Nasal Viral Load||log10 copies/mL|Mean|6.12|6.12|Standard Deviation|1.462|1.462|||
3686067|NCT02254421|3528613|B2|||Nasal Viral Load||log10 copies/mL|Mean|6.02|6.02|Standard Deviation|1.574|1.574|||
3686068|NCT02254421|3528614|B1|||Nasal Viral Load||log10 copies/mL|Mean|6.22|6.22|Standard Deviation|1.365|1.365|||
3686069|NCT02254421|3528612|B3||No|Stratification Factor: Treatment of Current RSV Infection with Ribavirin||Participants|Count of Participants|36|36.0||||||
3686070|NCT02254421|3528613|B2||No|Stratification Factor: Treatment of Current RSV Infection with Ribavirin||Participants|Count of Participants|18|18.0||||||
3686071|NCT02254421|3528614|B1||No|Stratification Factor: Treatment of Current RSV Infection with Ribavirin||Participants|Count of Participants|18|18.0||||||
3686072|NCT02254421|3528612|B3||Yes|Stratification Factor: Treatment of Current RSV Infection with Ribavirin||Participants|Count of Participants|23|23.0||||||
3686073|NCT02254421|3528613|B2||Yes|Stratification Factor: Treatment of Current RSV Infection with Ribavirin||Participants|Count of Participants|11|11.0||||||
3686074|NCT02254421|3528614|B1||Yes|Stratification Factor: Treatment of Current RSV Infection with Ribavirin||Participants|Count of Participants|12|12.0||||||
3686075|NCT02254421|3528612|B3||Supplemental O2 Requirement > 2 L/min|Stratification Factor: Supplemental O2 Requirement at Time of Randomization||Participants|Count of Participants|21|21.0||||||
3686076|NCT02254421|3528613|B2||Supplemental O2 Requirement > 2 L/min|Stratification Factor: Supplemental O2 Requirement at Time of Randomization||Participants|Count of Participants|10|10.0||||||
3686077|NCT02254421|3528614|B1||Supplemental O2 Requirement > 2 L/min|Stratification Factor: Supplemental O2 Requirement at Time of Randomization||Participants|Count of Participants|11|11.0||||||
3686078|NCT02254421|3528612|B3||Supplemental O2 Requirement ≤ 2 L/min|Stratification Factor: Supplemental O2 Requirement at Time of Randomization||Participants|Count of Participants|38|38.0||||||
3686079|NCT02254421|3528613|B2||Supplemental O2 Requirement ≤ 2 L/min|Stratification Factor: Supplemental O2 Requirement at Time of Randomization||Participants|Count of Participants|19|19.0||||||
3686080|NCT02254421|3528614|B1||Supplemental O2 Requirement ≤ 2 L/min|Stratification Factor: Supplemental O2 Requirement at Time of Randomization||Participants|Count of Participants|19|19.0||||||
3686081|NCT02254421|3528612|B3|Switzerland||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3686082|NCT02254421|3528613|B2|Switzerland||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3686083|NCT02254421|3528614|B1|Switzerland||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3686084|NCT02254421|3528612|B3|France||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3686085|NCT02254421|3528613|B2|France||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3686086|NCT02254421|3528614|B1|France||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3686087|NCT02254421|3528612|B3|United States||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
3686088|NCT02254421|3528613|B2|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3686089|NCT02254421|3528614|B1|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3686090|NCT02254421|3528612|B3|Sweden||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3686091|NCT02254421|3528613|B2|Sweden||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3686092|NCT02254421|3528614|B1|Sweden||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3686093|NCT02254421|3528612|B3|South Korea||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3686094|NCT02254421|3528613|B2|South Korea||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3686095|NCT02254421|3528614|B1|South Korea||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3686096|NCT02254421|3528612|B3||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3686097|NCT02254421|3528613|B2||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3686098|NCT02254421|3528614|B1||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3686099|NCT02254421|3528612|B3||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
3686100|NCT02254421|3528613|B2||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3686101|NCT02254421|3528614|B1||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3686102|NCT02254421|3528612|B3||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3686103|NCT02254421|3528613|B2||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3686104|NCT02254421|3528614|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3686105|NCT02254421|3528612|B3||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3686106|NCT02254421|3528613|B2||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3686107|NCT02254421|3528614|B1||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3686108|NCT02254421|3528612|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
3686109|NCT02254421|3528613|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3686110|NCT02254421|3528614|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3686111|NCT02254421|3528612|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3686112|NCT02254421|3528613|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3686113|NCT02254421|3528614|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3686114|NCT02254421|3528612|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3686115|NCT02254421|3528613|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3686116|NCT02254421|3528614|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3686117|NCT02254421|3528612|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3686118|NCT02254421|3528613|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3686119|NCT02254421|3528614|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3686120|NCT02254421|3528612|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3686121|NCT02254421|3528613|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3686122|NCT02254421|3528614|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3686123|NCT02254421|3528612|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3686124|NCT02254421|3528613|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3686125|NCT02254421|3528614|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3686126|NCT02254421|3528612|B3|||Age||years|Mean|52.4|52.4|Standard Deviation|14.58|14.58|||
3686127|NCT02254421|3528613|B2|||Age||years|Mean|54.4|54.4|Standard Deviation|12.59|12.59|||
3686128|NCT02254421|3528614|B1|||Age||years|Mean|50.5|50.5|Standard Deviation|16.27|16.27|||
3686129|NCT02254408|3528627|B3|||Nasal Viral Load||log10 copies/mL|Mean|6.41|6.41|Standard Deviation|1.691|1.691|||
3686130|NCT02254408|3528628|B2|||Nasal Viral Load||log10 copies/mL|Mean|6.51|6.51|Standard Deviation|1.437|1.437|||
3686131|NCT02254408|3528629|B1|||Nasal Viral Load||log10 copies/mL|Mean|6.31|6.31|Standard Deviation|1.899|1.899|||
3686132|NCT02254408|3528627|B3|France||Region of Enrollment|All Randomized Analysis Set: all participants randomized in the study.|participants|Number|18|18.0||||||
3686133|NCT02254408|3528628|B2|France||Region of Enrollment|All Randomized Analysis Set: all participants randomized in the study.|participants|Number|10|10.0||||||
3686134|NCT02254408|3528629|B1|France||Region of Enrollment|All Randomized Analysis Set: all participants randomized in the study.|participants|Number|7|7.0||||||
3686135|NCT02254408|3528627|B3|Australia||Region of Enrollment|All Randomized Analysis Set: all participants randomized in the study.|participants|Number|9|9.0||||||
3686136|NCT02254408|3528628|B2|Australia||Region of Enrollment|All Randomized Analysis Set: all participants randomized in the study.|participants|Number|3|3.0||||||
3686137|NCT02254408|3528629|B1|Australia||Region of Enrollment|All Randomized Analysis Set: all participants randomized in the study.|participants|Number|6|6.0||||||
3686138|NCT02254408|3528627|B3|Israel||Region of Enrollment|All Randomized Analysis Set: all participants randomized in the study.|participants|Number|21|21.0||||||
3686139|NCT02254408|3528628|B2|Israel||Region of Enrollment|All Randomized Analysis Set: all participants randomized in the study.|participants|Number|11|11.0||||||
3686140|NCT02254408|3528629|B1|Israel||Region of Enrollment|All Randomized Analysis Set: all participants randomized in the study.|participants|Number|10|10.0||||||
3686141|NCT02254408|3528627|B3|South Korea||Region of Enrollment|All Randomized Analysis Set: all participants randomized in the study.|participants|Number|6|6.0||||||
3686142|NCT02254408|3528628|B2|South Korea||Region of Enrollment|All Randomized Analysis Set: all participants randomized in the study.|participants|Number|1|1.0||||||
3686143|NCT02254408|3528629|B1|South Korea||Region of Enrollment|All Randomized Analysis Set: all participants randomized in the study.|participants|Number|5|5.0||||||
3686144|NCT02254408|3528627|B3|Canada||Region of Enrollment|All Randomized Analysis Set: all participants randomized in the study.|participants|Number|8|8.0||||||
3686145|NCT02254408|3528628|B2|Canada||Region of Enrollment|All Randomized Analysis Set: all participants randomized in the study.|participants|Number|5|5.0||||||
3686146|NCT02254408|3528629|B1|Canada||Region of Enrollment|All Randomized Analysis Set: all participants randomized in the study.|participants|Number|3|3.0||||||
3686147|NCT02254408|3528627|B3|Switzerland||Region of Enrollment|All Randomized Analysis Set: all participants randomized in the study.|participants|Number|1|1.0||||||
3686148|NCT02254408|3528628|B2|Switzerland||Region of Enrollment|All Randomized Analysis Set: all participants randomized in the study.|participants|Number|1|1.0||||||
3686149|NCT02254408|3528629|B1|Switzerland||Region of Enrollment|All Randomized Analysis Set: all participants randomized in the study.|participants|Number|0|0.0||||||
3686150|NCT02254408|3528627|B3|United Kingdom||Region of Enrollment|All Randomized Analysis Set: all participants randomized in the study.|participants|Number|5|5.0||||||
3686151|NCT02254408|3528628|B2|United Kingdom||Region of Enrollment|All Randomized Analysis Set: all participants randomized in the study.|participants|Number|2|2.0||||||
3686152|NCT02254408|3528629|B1|United Kingdom||Region of Enrollment|All Randomized Analysis Set: all participants randomized in the study.|participants|Number|3|3.0||||||
3686153|NCT02254408|3528627|B3|United States||Region of Enrollment|All Randomized Analysis Set: all participants randomized in the study.|participants|Number|116|116.0||||||
3686154|NCT02254408|3528628|B2|United States||Region of Enrollment|All Randomized Analysis Set: all participants randomized in the study.|participants|Number|55|55.0||||||
3686155|NCT02254408|3528629|B1|United States||Region of Enrollment|All Randomized Analysis Set: all participants randomized in the study.|participants|Number|58|58.0||||||
3686156|NCT02254408|3528627|B3|Singapore||Region of Enrollment|All Randomized Analysis Set: all participants randomized in the study.|participants|Number|5|5.0||||||
3686157|NCT02254408|3528628|B2|Singapore||Region of Enrollment|All Randomized Analysis Set: all participants randomized in the study.|participants|Number|2|2.0||||||
3686158|NCT02254408|3528629|B1|Singapore||Region of Enrollment|All Randomized Analysis Set: all participants randomized in the study.|participants|Number|3|3.0||||||
3686159|NCT02254408|3528627|B3||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3686160|NCT02254408|3528628|B2||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3686161|NCT02254408|3528629|B1||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3686162|NCT02254408|3528627|B3||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|156|156.0||||||
3686163|NCT02254408|3528628|B2||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|75|75.0||||||
3686164|NCT02254408|3528629|B1||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|81|81.0||||||
3686165|NCT02254408|3528627|B3||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3686166|NCT02254408|3528628|B2||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3686167|NCT02254408|3528629|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3686168|NCT02254408|3528627|B3||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3686169|NCT02254408|3528628|B2||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3686170|NCT02254408|3528629|B1||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3686171|NCT02254408|3528627|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3686172|NCT02254408|3528628|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3686173|NCT02254408|3528629|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3686174|NCT02254408|3528627|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|136|136.0||||||
3686175|NCT02254408|3528628|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|70|70.0||||||
3686176|NCT02254408|3528629|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|66|66.0||||||
3686177|NCT02254408|3528627|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3686178|NCT02254408|3528628|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3686179|NCT02254408|3528629|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3686180|NCT02254408|3528627|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3686181|NCT02254408|3528628|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3686182|NCT02254408|3528629|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3686183|NCT02254408|3528627|B3||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3686184|NCT02254408|3528628|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3686185|NCT02254408|3528629|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3686186|NCT02254408|3528627|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3686187|NCT02254408|3528628|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3686188|NCT02254408|3528629|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3686189|NCT02254408|3528627|B3|||Age||years|Mean|51.8|51.8|Standard Deviation|13.39|13.39|||
3686190|NCT02254408|3528628|B2|||Age||years|Mean|51.4|51.4|Standard Deviation|14.58|14.58|||
3686191|NCT02254408|3528629|B1|||Age||years|Mean|52.1|52.1|Standard Deviation|12.21|12.21|||
3686192|NCT02254304|3528640|B3|Subjects did not consume alcohol||Alcohol Consumption||subjects|Number|102|102.0||||||
3686193|NCT02254304|3528641|B2|Subjects did not consume alcohol||Alcohol Consumption||subjects|Number|16|16.0||||||
3686194|NCT02254304|3528642|B1|Subjects did not consume alcohol||Alcohol Consumption||subjects|Number|86|86.0||||||
3686195|NCT02254304|3528640|B3|Subjects consumed alcohol||Alcohol Consumption||subjects|Number|4|4.0||||||
3686196|NCT02254304|3528641|B2|Subjects consumed alcohol||Alcohol Consumption||subjects|Number|1|1.0||||||
3686197|NCT02254304|3528642|B1|Subjects consumed alcohol||Alcohol Consumption||subjects|Number|3|3.0||||||
3686198|NCT02254304|3528640|B3|Former user||Nicotine Used Status|Number of subjects with Nicotine used status was categorized under never used, regular user, occasional user and former user.|subjects|Number|11|11.0||||||
3686199|NCT02254304|3528641|B2|Former user||Nicotine Used Status|Number of subjects with Nicotine used status was categorized under never used, regular user, occasional user and former user.|subjects|Number|4|4.0||||||
3686200|NCT02254304|3528642|B1|Former user||Nicotine Used Status|Number of subjects with Nicotine used status was categorized under never used, regular user, occasional user and former user.|subjects|Number|7|7.0||||||
3686201|NCT02254304|3528640|B3|Occasional user||Nicotine Used Status|Number of subjects with Nicotine used status was categorized under never used, regular user, occasional user and former user.|subjects|Number|0|0.0||||||
3686202|NCT02254304|3528641|B2|Occasional user||Nicotine Used Status|Number of subjects with Nicotine used status was categorized under never used, regular user, occasional user and former user.|subjects|Number|0|0.0||||||
3686203|NCT02254304|3528642|B1|Occasional user||Nicotine Used Status|Number of subjects with Nicotine used status was categorized under never used, regular user, occasional user and former user.|subjects|Number|0|0.0||||||
3686204|NCT02254304|3528640|B3|Regular user||Nicotine Used Status|Number of subjects with Nicotine used status was categorized under never used, regular user, occasional user and former user.|subjects|Number|22|22.0||||||
3686205|NCT02254304|3528641|B2|Regular user||Nicotine Used Status|Number of subjects with Nicotine used status was categorized under never used, regular user, occasional user and former user.|subjects|Number|3|3.0||||||
3686206|NCT02254304|3528642|B1|Regular user||Nicotine Used Status|Number of subjects with Nicotine used status was categorized under never used, regular user, occasional user and former user.|subjects|Number|19|19.0||||||
3686207|NCT02254304|3528640|B3|Never used||Nicotine Used Status|Number of subjects with Nicotine used status was categorized under never used, regular user, occasional user and former user.|subjects|Number|73|73.0||||||
3686208|NCT02254304|3528641|B2|Never used||Nicotine Used Status|Number of subjects with Nicotine used status was categorized under never used, regular user, occasional user and former user.|subjects|Number|10|10.0||||||
3686209|NCT02254304|3528642|B1|Never used||Nicotine Used Status|Number of subjects with Nicotine used status was categorized under never used, regular user, occasional user and former user.|subjects|Number|63|63.0||||||
3686210|NCT02254304|3528640|B3|South western||Geographical Allocation|Number of subjects depending upon the geographical location were presented.|subjects|Number|4|4.0||||||
3686211|NCT02254304|3528641|B2|South western||Geographical Allocation|Number of subjects depending upon the geographical location were presented.|subjects|Number|1|1.0||||||
3686212|NCT02254304|3528642|B1|South western||Geographical Allocation|Number of subjects depending upon the geographical location were presented.|subjects|Number|3|3.0||||||
3686213|NCT02254304|3528640|B3|South eastern||Geographical Allocation|Number of subjects depending upon the geographical location were presented.|subjects|Number|55|55.0||||||
3686214|NCT02254304|3528641|B2|South eastern||Geographical Allocation|Number of subjects depending upon the geographical location were presented.|subjects|Number|10|10.0||||||
3686215|NCT02254304|3528642|B1|South eastern||Geographical Allocation|Number of subjects depending upon the geographical location were presented.|subjects|Number|45|45.0||||||
3686216|NCT02254304|3528640|B3|North western||Geographical Allocation|Number of subjects depending upon the geographical location were presented.|subjects|Number|26|26.0||||||
3686217|NCT02254304|3528641|B2|North western||Geographical Allocation|Number of subjects depending upon the geographical location were presented.|subjects|Number|3|3.0||||||
3686218|NCT02254304|3528642|B1|North western||Geographical Allocation|Number of subjects depending upon the geographical location were presented.|subjects|Number|23|23.0||||||
3686219|NCT02254304|3528640|B3|North eastern||Geographical Allocation|Number of subjects depending upon the geographical location were presented.|subjects|Number|21|21.0||||||
3686220|NCT02254304|3528641|B2|North eastern||Geographical Allocation|Number of subjects depending upon the geographical location were presented.|subjects|Number|3|3.0||||||
3686221|NCT02254304|3528642|B1|North eastern||Geographical Allocation|Number of subjects depending upon the geographical location were presented.|subjects|Number|18|18.0||||||
3686222|NCT02254304|3528640|B3|Rural||Number of Subjects Living in City or Rural Area|Number of subjects living in city or rural area were presented.|subjects|Number|22|22.0||||||
3686223|NCT02254304|3528641|B2|Rural||Number of Subjects Living in City or Rural Area|Number of subjects living in city or rural area were presented.|subjects|Number|4|4.0||||||
3686224|NCT02254304|3528642|B1|Rural||Number of Subjects Living in City or Rural Area|Number of subjects living in city or rural area were presented.|subjects|Number|18|18.0||||||
3686225|NCT02254304|3528640|B3|City||Number of Subjects Living in City or Rural Area|Number of subjects living in city or rural area were presented.|subjects|Number|84|84.0||||||
3686226|NCT02254304|3528641|B2|City||Number of Subjects Living in City or Rural Area|Number of subjects living in city or rural area were presented.|subjects|Number|13|13.0||||||
3686227|NCT02254304|3528642|B1|City||Number of Subjects Living in City or Rural Area|Number of subjects living in city or rural area were presented.|subjects|Number|71|71.0||||||
3686228|NCT02254304|3528640|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3686229|NCT02254304|3528641|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3686230|NCT02254304|3528642|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3686231|NCT02254304|3528640|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3686232|NCT02254304|3528641|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3686233|NCT02254304|3528642|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3686234|NCT02254304|3528640|B3|||Age||years|Mean|35.4|35.4|Standard Deviation|10.64|10.64|||
3686235|NCT02254304|3528641|B2|||Age||years|Mean|31.6|31.6|Standard Deviation|9.63|9.63|||
3686236|NCT02254304|3528642|B1|||Age||years|Mean|36.1|36.1|Standard Deviation|10.71|10.71|||
3686237|NCT02254291|3528700|B4|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.15|8.15|Standard Deviation|0.93|0.93|||
3686238|NCT02254291|3528701|B3|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.20|8.2|Standard Deviation|0.89|0.89|||
3686239|NCT02254291|3528702|B2|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.01|8.01|Standard Deviation|0.85|0.85|||
3686240|NCT02254291|3528703|B1|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.23|8.23|Standard Deviation|1.02|1.02|||
3686241|NCT02254291|3528700|B4||Male|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
3686242|NCT02254291|3528701|B3||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3686243|NCT02254291|3528702|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3686244|NCT02254291|3528703|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3686245|NCT02254291|3528700|B4||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3686246|NCT02254291|3528701|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3686247|NCT02254291|3528702|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3686248|NCT02254291|3528703|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3686249|NCT02254291|3528700|B4|||Age||years|Mean|58.3|58.3|Standard Deviation|10.7|10.7|||
3686250|NCT02254291|3528701|B3|||Age||years|Mean|57.9|57.9|Standard Deviation|10.1|10.1|||
3686251|NCT02254291|3528702|B2|||Age||years|Mean|58.1|58.1|Standard Deviation|11.6|11.6|||
3686252|NCT02254291|3528703|B1|||Age||years|Mean|58.8|58.8|Standard Deviation|10.4|10.4|||
3686253|NCT02254265|3528719|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686254|NCT02254265|3528720|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686255|NCT02254265|3528721|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686256|NCT02254265|3528722|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686257|NCT02254265|3528719|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3686258|NCT02254265|3528720|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3686259|NCT02254265|3528721|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3686260|NCT02254265|3528722|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3686261|NCT02254265|3528719|B4||White|Race (NIH/OMB)||Participants|Count of Participants|374|374.0||||||
3686262|NCT02254265|3528720|B3||White|Race (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
3686263|NCT02254265|3528721|B2||White|Race (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
3686264|NCT02254265|3528722|B1||White|Race (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
3686265|NCT02254265|3528719|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3686266|NCT02254265|3528720|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3686267|NCT02254265|3528721|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3686268|NCT02254265|3528722|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3686269|NCT02254265|3528719|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3686270|NCT02254265|3528720|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3686271|NCT02254265|3528721|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686272|NCT02254265|3528722|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686273|NCT02254265|3528719|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3686274|NCT02254265|3528720|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3686275|NCT02254265|3528721|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3686276|NCT02254265|3528722|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3686277|NCT02254265|3528719|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3686278|NCT02254265|3528720|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686279|NCT02254265|3528721|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686280|NCT02254265|3528722|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3686281|NCT02254265|3528719|B4||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3686282|NCT02254265|3528720|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3686283|NCT02254265|3528721|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3686284|NCT02254265|3528722|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3686285|NCT02254265|3528719|B4||Female|Sex: Female, Male||Participants|Count of Participants|361|361.0||||||
3686286|NCT02254265|3528720|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3686287|NCT02254265|3528721|B2||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3686288|NCT02254265|3528722|B1||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3686289|NCT02254265|3528719|B4|||Age||years|Mean|60.1|60.1|Standard Deviation|13.90|13.9|||
3686290|NCT02254265|3528720|B3|||Age||years|Mean|59.3|59.3|Standard Deviation|13.75|13.75|||
3686291|NCT02254265|3528721|B2|||Age||years|Mean|59.2|59.2|Standard Deviation|14.55|14.55|||
3686292|NCT02254265|3528722|B1|||Age||years|Mean|61.9|61.9|Standard Deviation|13.27|13.27|||
3686293|NCT02254252|3528747|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3686294|NCT02254252|3528748|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3686295|NCT02254252|3528749|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3686296|NCT02254252|3528747|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3686297|NCT02254252|3528748|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3686298|NCT02254252|3528749|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3686299|NCT02254252|3528747|B3|||Age||years|Mean|54.4|54.4|Standard Deviation|12.1|12.1|||
3686300|NCT02254252|3528748|B2|||Age||years|Mean|54.6|54.6|Standard Deviation|11.1|11.1|||
3686301|NCT02254252|3528749|B1|||Age||years|Mean|53.7|53.7|Standard Deviation|13.3|13.3|||
3686302|NCT02253654|3528760|B3|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|147|147.0||||||
3686303|NCT02253654|3528761|B2|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
3686304|NCT02253654|3528762|B1|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|78|78.0||||||
3686305|NCT02253654|3528760|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
3686306|NCT02253654|3528761|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
3686307|NCT02253654|3528762|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3686308|NCT02253654|3528760|B3|Other||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3686309|NCT02253654|3528761|B2|Other||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3686310|NCT02253654|3528762|B1|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3686311|NCT02253654|3528760|B3|White||Race/Ethnicity, Customized||participants|Number|80|80.0||||||
3686312|NCT02253654|3528761|B2|White||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
3686313|NCT02253654|3528762|B1|White||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
3686314|NCT02253654|3528760|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3686315|NCT02253654|3528761|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3686316|NCT02253654|3528762|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3686317|NCT02253654|3528760|B3|Black||Race/Ethnicity, Customized||participants|Number|103|103.0||||||
3686318|NCT02253654|3528761|B2|Black||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
3686319|NCT02253654|3528762|B1|Black||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
3686320|NCT02253654|3528760|B3|Asian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3686321|NCT02253654|3528761|B2|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3686322|NCT02253654|3528762|B1|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3686323|NCT02253654|3528760|B3||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3686324|NCT02253654|3528761|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3686325|NCT02253654|3528762|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3686326|NCT02253654|3528760|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3686327|NCT02253654|3528761|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3686328|NCT02253654|3528762|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3686329|NCT02253654|3528760|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|1.8|1.8|||
3686330|NCT02253654|3528761|B2|||Age||years|Mean|58.7|58.7|Standard Deviation|14.2|14.2|||
3686331|NCT02253654|3528762|B1|||Age||years|Mean|60.9|60.9|Standard Deviation|13.3|13.3|||
3686332|NCT02253433|3528783|B3|||Total Immunoglobulin E (Total IgE)|Total IgE is a measure of the immunoglobulin E antibody in the blood, and an estimate of allergic status. The laboratory lowest level of detection was 18 kU/L. Guidelines vary and must be assessed in conjunction with clinical presentation and allergen-specific testing, but for this population we consider a Total IgE > 100 kU/L to be of clinical relevance.|kU/L|Mean|597.6|597.6|Standard Deviation|1351.2|1351.2|||
3686333|NCT02253433|3528784|B2|||Total Immunoglobulin E (Total IgE)|Total IgE is a measure of the immunoglobulin E antibody in the blood, and an estimate of allergic status. The laboratory lowest level of detection was 18 kU/L. Guidelines vary and must be assessed in conjunction with clinical presentation and allergen-specific testing, but for this population we consider a Total IgE > 100 kU/L to be of clinical relevance.|kU/L|Mean|643.2|643.2|Standard Deviation|1217.6|1217.6|||
3686334|NCT02253433|3528785|B1|||Total Immunoglobulin E (Total IgE)|Total IgE is a measure of the immunoglobulin E antibody in the blood, and an estimate of allergic status. The laboratory lowest level of detection was 18 kU/L. Guidelines vary and must be assessed in conjunction with clinical presentation and allergen-specific testing, but for this population we consider a Total IgE > 100 kU/L to be of clinical relevance.|kU/L|Mean|550.5|550.5|Standard Deviation|1479.8|1479.8|||
3686335|NCT02253433|3528783|B3|||Body Mass Index (BMI)|Measured at clinic. BMI = weight (kilograms) divided by height (meters) squared. It is an estimate of body fat in adults. 30 and higher = obese.|kg/m^2|Mean|35.2|35.2|Standard Deviation|10.4|10.4|||
3686336|NCT02253433|3528784|B2|||Body Mass Index (BMI)|Measured at clinic. BMI = weight (kilograms) divided by height (meters) squared. It is an estimate of body fat in adults. 30 and higher = obese.|kg/m^2|Mean|34.4|34.4|Standard Deviation|10.1|10.1|||
3686337|NCT02253433|3528785|B1|||Body Mass Index (BMI)|Measured at clinic. BMI = weight (kilograms) divided by height (meters) squared. It is an estimate of body fat in adults. 30 and higher = obese.|kg/m^2|Mean|36.0|36.0|Standard Deviation|10.6|10.6|||
3686338|NCT02253433|3528783|B3|||Juniper Mini Asthma Quality of Life Questionnaire|Self report. A validated 15-item questionnaire, with each question having seven possible answers score from 1 (worst) to 7 (best). Minimum total score is 15 (worst asthma quality of life). Maximum total score is 105 (best asthma quality of life). By design, an individual's score is reported as the mean (total score/15). Thus the possible mean reported score ranges from 1 (worst asthma quality of life) to 7 (best asthma quality of life).|units on a scale|Mean|3.2|3.2|Standard Deviation|1.1|1.1|||
3686339|NCT02253433|3528784|B2|||Juniper Mini Asthma Quality of Life Questionnaire|Self report. A validated 15-item questionnaire, with each question having seven possible answers score from 1 (worst) to 7 (best). Minimum total score is 15 (worst asthma quality of life). Maximum total score is 105 (best asthma quality of life). By design, an individual's score is reported as the mean (total score/15). Thus the possible mean reported score ranges from 1 (worst asthma quality of life) to 7 (best asthma quality of life).|units on a scale|Mean|3.2|3.2|Standard Deviation|1.1|1.1|||
3686340|NCT02253433|3528785|B1|||Juniper Mini Asthma Quality of Life Questionnaire|Self report. A validated 15-item questionnaire, with each question having seven possible answers score from 1 (worst) to 7 (best). Minimum total score is 15 (worst asthma quality of life). Maximum total score is 105 (best asthma quality of life). By design, an individual's score is reported as the mean (total score/15). Thus the possible mean reported score ranges from 1 (worst asthma quality of life) to 7 (best asthma quality of life).|units on a scale|Mean|3.3|3.3|Standard Deviation|1.2|1.2|||
3686341|NCT02253433|3528783|B3|||Asthma Control Test (ACT)|The ACT is a validated 5-question scale assessing asthma control over the previous four weeks. Each question has five possible responses, from 1 (worst) to 5 (best). The total score ranges from 5 (worst control) to 25 (best control). In general, a total score of 19 or less suggests poor control.|units on a scale|Mean|12.5|12.5|Standard Deviation|4.3|4.3|||
3686342|NCT02253433|3528784|B2|||Asthma Control Test (ACT)|The ACT is a validated 5-question scale assessing asthma control over the previous four weeks. Each question has five possible responses, from 1 (worst) to 5 (best). The total score ranges from 5 (worst control) to 25 (best control). In general, a total score of 19 or less suggests poor control.|units on a scale|Mean|12.5|12.5|Standard Deviation|4.2|4.2|||
3686343|NCT02253433|3528785|B1|||Asthma Control Test (ACT)|The ACT is a validated 5-question scale assessing asthma control over the previous four weeks. Each question has five possible responses, from 1 (worst) to 5 (best). The total score ranges from 5 (worst control) to 25 (best control). In general, a total score of 19 or less suggests poor control.|units on a scale|Mean|12.5|12.5|Standard Deviation|4.3|4.3|||
3686344|NCT02253433|3528783|B3|United States||Region of Enrollment||participants|Number|264|264.0||||||
3686345|NCT02253433|3528784|B2|United States||Region of Enrollment||participants|Number|134|134.0||||||
3686346|NCT02253433|3528785|B1|United States||Region of Enrollment||participants|Number|130|130.0||||||
3686347|NCT02253433|3528783|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686348|NCT02253433|3528784|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686349|NCT02253433|3528785|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686350|NCT02253433|3528783|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686351|NCT02253433|3528784|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686352|NCT02253433|3528785|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686353|NCT02253433|3528783|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686354|NCT02253433|3528784|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686355|NCT02253433|3528785|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686356|NCT02253433|3528783|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|264|264.0||||||
3686357|NCT02253433|3528784|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
3686358|NCT02253433|3528785|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
3686359|NCT02253433|3528783|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686360|NCT02253433|3528784|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686361|NCT02253433|3528785|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686362|NCT02253433|3528783|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686363|NCT02253433|3528784|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686364|NCT02253433|3528785|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686365|NCT02253433|3528783|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686366|NCT02253433|3528784|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686367|NCT02253433|3528785|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686368|NCT02253433|3528783|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3686369|NCT02253433|3528784|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3686370|NCT02253433|3528785|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3686371|NCT02253433|3528783|B3||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
3686372|NCT02253433|3528784|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3686373|NCT02253433|3528785|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3686374|NCT02253433|3528783|B3|||Age||years|Mean|50.2|50.2|Standard Deviation|13.0|13.0|||
3686375|NCT02253433|3528784|B2|||Age||years|Mean|51.0|51.0|Standard Deviation|13.3|13.3|||
3686376|NCT02253433|3528785|B1|||Age||years|Mean|49.4|49.4|Standard Deviation|12.7|12.7|||
3686377|NCT02253433|3528783|B3||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
3686378|NCT02253433|3528784|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3686379|NCT02253433|3528785|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3686380|NCT02253433|3528783|B3||Between 18 and 65 years|Age||Participants|Count of Participants|235|235.0||||||
3686381|NCT02253433|3528784|B2||Between 18 and 65 years|Age||Participants|Count of Participants|118|118.0||||||
3686382|NCT02253433|3528785|B1||Between 18 and 65 years|Age||Participants|Count of Participants|117|117.0||||||
3686383|NCT02253433|3528783|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3686384|NCT02253433|3528784|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3686385|NCT02253433|3528785|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3686386|NCT02253173|3528796|B5|||BMI||kg/m^2|Mean|26.7|26.7|Standard Deviation|4.73|4.73|||
3686387|NCT02253173|3528797|B4|||BMI||kg/m^2|Mean|26.7|26.7|Standard Deviation|4.59|4.59|||
3686388|NCT02253173|3528798|B3|||BMI||kg/m^2|Mean|26.7|26.7|Standard Deviation|4.79|4.79|||
3686389|NCT02253173|3528799|B2|||BMI||kg/m^2|Mean|26.8|26.8|Standard Deviation|4.68|4.68|||
3686390|NCT02253173|3528800|B1|||BMI||kg/m^2|Mean|26.5|26.5|Standard Deviation|4.87|4.87|||
3686391|NCT02253173|3528796|B5|||Weight||kilograms|Mean|70.6|70.6|Standard Deviation|13.74|13.74|||
3686392|NCT02253173|3528797|B4|||Weight||kilograms|Mean|70.4|70.4|Standard Deviation|13.6|13.6|||
3686393|NCT02253173|3528798|B3|||Weight||kilograms|Mean|70.6|70.6|Standard Deviation|13.7|13.7|||
3686394|NCT02253173|3528799|B2|||Weight||kilograms|Mean|71.1|71.1|Standard Deviation|13.49|13.49|||
3686395|NCT02253173|3528800|B1|||Weight||kilograms|Mean|70.4|70.4|Standard Deviation|14.26|14.26|||
3686396|NCT02253173|3528796|B5|||Height||centimeters|Mean|162.5|162.5|Standard Deviation|6.62|6.62|||
3686397|NCT02253173|3528797|B4|||Height||centimeters|Mean|162.2|162.2|Standard Deviation|6.30|6.3|||
3686398|NCT02253173|3528798|B3|||Height||centimeters|Mean|162.3|162.3|Standard Deviation|6.37|6.37|||
3686399|NCT02253173|3528799|B2|||Height||centimeters|Mean|162.9|162.9|Standard Deviation|6.93|6.93|||
3686400|NCT02253173|3528800|B1|||Height||centimeters|Mean|162.7|162.7|Standard Deviation|6.86|6.86|||
3686401|NCT02253173|3528796|B5|United States||Region of Enrollment||participants|Number|714|714.0||||||
3686402|NCT02253173|3528797|B4|United States||Region of Enrollment||participants|Number|180|180.0||||||
3686403|NCT02253173|3528798|B3|United States||Region of Enrollment||participants|Number|175|175.0||||||
3686404|NCT02253173|3528799|B2|United States||Region of Enrollment||participants|Number|181|181.0||||||
3686405|NCT02253173|3528800|B1|United States||Region of Enrollment||participants|Number|178|178.0||||||
3686406|NCT02253173|3528796|B5|Canada||Region of Enrollment||participants|Number|50|50.0||||||
3686407|NCT02253173|3528797|B4|Canada||Region of Enrollment||participants|Number|12|12.0||||||
3686408|NCT02253173|3528798|B3|Canada||Region of Enrollment||participants|Number|15|15.0||||||
3686409|NCT02253173|3528799|B2|Canada||Region of Enrollment||participants|Number|10|10.0||||||
3686410|NCT02253173|3528800|B1|Canada||Region of Enrollment||participants|Number|13|13.0||||||
3686411|NCT02253173|3528796|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3686412|NCT02253173|3528797|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3686413|NCT02253173|3528798|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3686414|NCT02253173|3528799|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3686415|NCT02253173|3528800|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3686416|NCT02253173|3528796|B5||Female|Sex: Female, Male||Participants|Count of Participants|764|764.0||||||
3686417|NCT02253173|3528797|B4||Female|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
3686418|NCT02253173|3528798|B3||Female|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
3686419|NCT02253173|3528799|B2||Female|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
3686420|NCT02253173|3528800|B1||Female|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
3686421|NCT02253173|3528796|B5|||Age||years|Mean|59.1|59.1|Standard Deviation|6.14|6.14|||
3686422|NCT02253173|3528797|B4|||Age||years|Mean|59.3|59.3|Standard Deviation|6.07|6.07|||
3686423|NCT02253173|3528798|B3|||Age||years|Mean|58.9|58.9|Standard Deviation|6.26|6.26|||
3686424|NCT02253173|3528799|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|6.29|6.29|||
3686425|NCT02253173|3528800|B1|||Age||years|Mean|59.8|59.8|Standard Deviation|5.90|5.9|||
3686426|NCT02253173|3528796|B5||>=65 years|Age||Participants|Count of Participants|147|147.0||||||
3686427|NCT02253173|3528797|B4||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
3686428|NCT02253173|3528798|B3||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
3686429|NCT02253173|3528799|B2||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
3686430|NCT02253173|3528800|B1||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
3686431|NCT02253173|3528796|B5||Between 18 and 65 years|Age||Participants|Count of Participants|617|617.0||||||
3686432|NCT02253173|3528797|B4||Between 18 and 65 years|Age||Participants|Count of Participants|151|151.0||||||
3686433|NCT02253173|3528798|B3||Between 18 and 65 years|Age||Participants|Count of Participants|156|156.0||||||
3686434|NCT02253173|3528799|B2||Between 18 and 65 years|Age||Participants|Count of Participants|162|162.0||||||
3686435|NCT02253173|3528800|B1||Between 18 and 65 years|Age||Participants|Count of Participants|148|148.0||||||
3686436|NCT02253173|3528796|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3686437|NCT02253173|3528797|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3686438|NCT02253173|3528798|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3686439|NCT02253173|3528799|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3686440|NCT02253173|3528800|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3686441|NCT02253160|3528997|B4|||BMI||kg/m^2|Mean|34.17|34.17|Standard Deviation|8.579|8.579|||
3686442|NCT02253160|3528998|B3|||BMI||kg/m^2|Mean|30.88|30.88|Standard Deviation|6.050|6.05|||
3686443|NCT02253160|3528999|B2|||BMI||kg/m^2|Mean|35.82|35.82|Standard Deviation|9.413|9.413|||
3686444|NCT02253160|3529000|B1|||BMI||kg/m^2|Mean|47.36|47.36|Standard Deviation|NA||||no s.d. available when n=1
3686445|NCT02253160|3528997|B4|||Height||inches|Mean|69.7|69.7|Standard Deviation|3.83|3.83|||
3686446|NCT02253160|3528998|B3|||Height||inches|Mean|69.4|69.4|Standard Deviation|4.06|4.06|||
3686447|NCT02253160|3528999|B2|||Height||inches|Mean|70.8|70.8|Standard Deviation|2.45|2.45|||
3686448|NCT02253160|3529000|B1|||Height||inches|Mean|60|60.0|Standard Deviation|NA||||no s.d. available when n=1
3686449|NCT02253160|3528997|B4|||Weight||kilograms|Mean|107.11|107.11|Standard Deviation|28.124|28.124|||
3686450|NCT02253160|3528998|B3|||Weight||kilograms|Mean|97.08|97.08|Standard Deviation|26.654|26.654|||
3686451|NCT02253160|3528999|B2|||Weight||kilograms|Mean|115.23|115.23|Standard Deviation|28.921|28.921|||
3686452|NCT02253160|3529000|B1|||Weight||kilograms|Mean|110|110.0|Standard Deviation|NA||||no s.d. available when n=1
3686453|NCT02253160|3528997|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3686454|NCT02253160|3528998|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686455|NCT02253160|3528999|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3686456|NCT02253160|3529000|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686457|NCT02253160|3528997|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686458|NCT02253160|3528998|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686459|NCT02253160|3528999|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686460|NCT02253160|3529000|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686461|NCT02253160|3528997|B4||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3686462|NCT02253160|3528998|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3686463|NCT02253160|3528999|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3686464|NCT02253160|3529000|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686465|NCT02253160|3528997|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3686466|NCT02253160|3528998|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3686467|NCT02253160|3528999|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3686468|NCT02253160|3529000|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3686469|NCT02253160|3528997|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686470|NCT02253160|3528998|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686471|NCT02253160|3528999|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686472|NCT02253160|3529000|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686473|NCT02253160|3528997|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686474|NCT02253160|3528998|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686475|NCT02253160|3528999|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686476|NCT02253160|3529000|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686477|NCT02253160|3528997|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686478|NCT02253160|3528998|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686479|NCT02253160|3528999|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686480|NCT02253160|3529000|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686481|NCT02253160|3528997|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686482|NCT02253160|3528998|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686483|NCT02253160|3528999|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686484|NCT02253160|3529000|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686485|NCT02253160|3528997|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686486|NCT02253160|3528998|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686487|NCT02253160|3528999|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686488|NCT02253160|3529000|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686489|NCT02253160|3528997|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3686490|NCT02253160|3528998|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3686491|NCT02253160|3528999|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3686492|NCT02253160|3529000|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3686493|NCT02253160|3528997|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3686494|NCT02253160|3528998|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3686495|NCT02253160|3528999|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3686496|NCT02253160|3529000|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3686497|NCT02253160|3528997|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3686498|NCT02253160|3528998|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3686499|NCT02253160|3528999|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3686500|NCT02253160|3529000|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3686501|NCT02253160|3528997|B4|||Age||years|Mean|35.0|35.0|Standard Deviation|7.51|7.51|||
3686502|NCT02253160|3528998|B3|||Age||years|Mean|34.8|34.8|Standard Deviation|8.44|8.44|||
3686503|NCT02253160|3528999|B2|||Age||years|Mean|35.4|35.4|Standard Deviation|7.32|7.32|||
3686504|NCT02253160|3529000|B1|||Age||years|Mean|32|32.0|Standard Deviation|NA||||no s.d. available when n=1
3686505|NCT02253147|3529038|B1|Types IV to VI||Fitzpatrick Skin Type|"The Fitzpatrick scale is a numerical classification schema for human skin color.~Type I - always burns, never tans (pale white; blond or red hair; blue eyes; freckles).~Type II - usually burns, tans minimally (white; fair; blond or red hair; blue, green, or hazel eyes) Type III - sometimes mild burn, tans uniformly (cream white; fair with any hair or eye color) Type IV - burns minimally, always tans well (moderate brown) Type V - very rarely burns, tans very easily (dark brown) Type VI - Never burns, never tans (deeply pigmented dark brown to darkest brown)"|Participants|Count of Participants|53|53.0||||||
3686506|NCT02253147|3529038|B1|Types I to III||Fitzpatrick Skin Type|"The Fitzpatrick scale is a numerical classification schema for human skin color.~Type I - always burns, never tans (pale white; blond or red hair; blue eyes; freckles).~Type II - usually burns, tans minimally (white; fair; blond or red hair; blue, green, or hazel eyes) Type III - sometimes mild burn, tans uniformly (cream white; fair with any hair or eye color) Type IV - burns minimally, always tans well (moderate brown) Type V - very rarely burns, tans very easily (dark brown) Type VI - Never burns, never tans (deeply pigmented dark brown to darkest brown)"|Participants|Count of Participants|65|65.0||||||
3686507|NCT02253147|3529038|B1|United States||Region of Enrollment||Participants|Count of Participants|118|118.0||||||
3686508|NCT02253147|3529038|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686509|NCT02253147|3529038|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686510|NCT02253147|3529038|B1||White|Race (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
3686511|NCT02253147|3529038|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3686512|NCT02253147|3529038|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686513|NCT02253147|3529038|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3686514|NCT02253147|3529038|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3686515|NCT02253147|3529038|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686516|NCT02253147|3529038|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3686517|NCT02253147|3529038|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3686518|NCT02253147|3529038|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3686519|NCT02253147|3529038|B1||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3686520|NCT02253147|3529038|B1|||Age||years|Mean|57.4|57.4|Standard Deviation|10.0|10.0|||
3686521|NCT02252965|3529070|B3||Male|Gender||Participants|Count of Participants|312|312.0||||||
3686522|NCT02252965|3529071|B2||Male|Gender||Participants|Count of Participants|157|157.0||||||
3686523|NCT02252965|3529072|B1||Male|Gender||Participants|Count of Participants|155|155.0||||||
3686524|NCT02252965|3529070|B3||Female|Gender||Participants|Count of Participants|220|220.0||||||
3686525|NCT02252965|3529071|B2||Female|Gender||Participants|Count of Participants|108|108.0||||||
3686526|NCT02252965|3529072|B1||Female|Gender||Participants|Count of Participants|112|112.0||||||
3686527|NCT02252965|3529070|B3|||Age||years|Mean|53.8|53.8|Standard Deviation|9.98|9.98|||
3686528|NCT02252965|3529071|B2|||Age||years|Mean|53.1|53.1|Standard Deviation|9.72|9.72|||
3686529|NCT02252965|3529072|B1|||Age||years|Mean|54.4|54.4|Standard Deviation|10.21|10.21|||
3686530|NCT02252939|3529100|B1|United States||Region of Enrollment||Participants|Count of Participants|59|59.0||||||
3686531|NCT02252939|3529100|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3686532|NCT02252939|3529100|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686533|NCT02252939|3529100|B1||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3686534|NCT02252939|3529100|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686535|NCT02252939|3529100|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686536|NCT02252939|3529100|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3686537|NCT02252939|3529100|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686538|NCT02252939|3529100|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3686539|NCT02252939|3529100|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3686540|NCT02252939|3529100|B1|||Age||Years|Median|67|67.0|Inter-Quartile Range|||61.0|76.0|
3686541|NCT02252744|3529109|B1|United States||Region of Enrollment||participants|Number|286|286.0||||||
3686542|NCT02252744|3529109|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3686543|NCT02252744|3529109|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686544|NCT02252744|3529109|B1||White|Race (NIH/OMB)||Participants|Count of Participants|216|216.0||||||
3686545|NCT02252744|3529109|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3686546|NCT02252744|3529109|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3686547|NCT02252744|3529109|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3686548|NCT02252744|3529109|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3686549|NCT02252744|3529109|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3686550|NCT02252744|3529109|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|141|141.0||||||
3686551|NCT02252744|3529109|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|141|141.0||||||
3686552|NCT02252744|3529109|B1|Male||Gender|Gender data unavailable for 2 participants|participants|Number|41|41.0||||||
3686553|NCT02252744|3529109|B1|Female||Gender|Gender data unavailable for 2 participants|participants|Number|243|243.0||||||
3686554|NCT02252744|3529109|B1|||Age||years|Mean|57.46821|57.46821|Standard Deviation|13.46821|13.46821|||
3686555|NCT02252718|3529113|B1||Male|Gender||Participants|Count of Participants|58|58.0||||||
3686556|NCT02252718|3529113|B1||Female|Gender||Participants|Count of Participants|42|42.0||||||
3686557|NCT02252718|3529113|B1|||Age||month|Mean|5.02|5.02|Standard Deviation|4.4|4.4|||
3686558|NCT02252536|3529117|B3|United States||Region of Enrollment||Participants|Count of Participants|338|338.0||||||
3686559|NCT02252536|3529118|B2|United States||Region of Enrollment||Participants|Count of Participants|170|170.0||||||
3686560|NCT02252536|3529119|B1|United States||Region of Enrollment||Participants|Count of Participants|168|168.0||||||
3686561|NCT02252536|3529117|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3686562|NCT02252536|3529118|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3686563|NCT02252536|3529119|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3686564|NCT02252536|3529117|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3686565|NCT02252536|3529118|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3686566|NCT02252536|3529119|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3686567|NCT02252536|3529117|B3||White|Race (NIH/OMB)||Participants|Count of Participants|243|243.0||||||
3686568|NCT02252536|3529118|B2||White|Race (NIH/OMB)||Participants|Count of Participants|117|117.0||||||
3686569|NCT02252536|3529119|B1||White|Race (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
3686570|NCT02252536|3529117|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3686571|NCT02252536|3529118|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3686572|NCT02252536|3529119|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3686573|NCT02252536|3529117|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686574|NCT02252536|3529118|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686575|NCT02252536|3529119|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686576|NCT02252536|3529117|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3686577|NCT02252536|3529118|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3686578|NCT02252536|3529119|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686579|NCT02252536|3529117|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3686580|NCT02252536|3529118|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3686581|NCT02252536|3529119|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3686582|NCT02252536|3529117|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3686583|NCT02252536|3529118|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3686584|NCT02252536|3529119|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3686585|NCT02252536|3529117|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|296|296.0||||||
3686586|NCT02252536|3529118|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|150|150.0||||||
3686587|NCT02252536|3529119|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
3686588|NCT02252536|3529117|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3686589|NCT02252536|3529118|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3686590|NCT02252536|3529119|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3686591|NCT02252536|3529117|B3||Male|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
3686592|NCT02252536|3529118|B2||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3686593|NCT02252536|3529119|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3686594|NCT02252536|3529117|B3||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3686595|NCT02252536|3529118|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3686596|NCT02252536|3529119|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3686597|NCT02252536|3529117|B3|||Age||years|Mean|50.1|50.1|Standard Deviation|10.8|10.8|||
3686598|NCT02252536|3529118|B2|||Age||years|Mean|50.7|50.7|Standard Deviation|10.3|10.3|||
3686599|NCT02252536|3529119|B1|||Age||years|Mean|49.4|49.4|Standard Deviation|11.4|11.4|||
3686600|NCT02252445|3529152|B3|Korea, Republic of||Region of Enrollment||participants|Number|82|82.0||||||
3686601|NCT02252445|3529153|B2|Korea, Republic of||Region of Enrollment||participants|Number|41|41.0||||||
3686602|NCT02252445|3529154|B1|Korea, Republic of||Region of Enrollment||participants|Number|41|41.0||||||
3686603|NCT02252445|3529152|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3686604|NCT02252445|3529153|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3686605|NCT02252445|3529154|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3686606|NCT02252445|3529152|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3686607|NCT02252445|3529153|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3686608|NCT02252445|3529154|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3686609|NCT02252445|3529152|B3||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
3686610|NCT02252445|3529153|B2||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3686611|NCT02252445|3529154|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3686612|NCT02252445|3529152|B3||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3686613|NCT02252445|3529153|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3686614|NCT02252445|3529154|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3686615|NCT02252445|3529152|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3686616|NCT02252445|3529153|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3686617|NCT02252445|3529154|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3686618|NCT02252354|3529179|B3|The participant is an ex-drinker||Alcohol Classification||Participants|Number|0|0.0||||||
3686619|NCT02252354|3529180|B2|The participant is an ex-drinker||Alcohol Classification||Participants|Number|0|0.0||||||
3686620|NCT02252354|3529181|B1|The participant is an ex-drinker||Alcohol Classification||Participants|Number|0|0.0||||||
3686621|NCT02252354|3529179|B3|The participant is a current drinker||Alcohol Classification||Participants|Number|11|11.0||||||
3686622|NCT02252354|3529180|B2|The participant is a current drinker||Alcohol Classification||Participants|Number|6|6.0||||||
3686623|NCT02252354|3529181|B1|The participant is a current drinker||Alcohol Classification||Participants|Number|5|5.0||||||
3686624|NCT02252354|3529179|B3|The participant has never drunk||Alcohol Classification||Participants|Number|1|1.0||||||
3686625|NCT02252354|3529180|B2|The participant has never drunk||Alcohol Classification||Participants|Number|0|0.0||||||
3686626|NCT02252354|3529181|B1|The participant has never drunk||Alcohol Classification||Participants|Number|1|1.0||||||
3686627|NCT02252354|3529179|B3|Ex-smoker||Smoking Classification||Participants|Number|4|4.0||||||
3686628|NCT02252354|3529180|B2|Ex-smoker||Smoking Classification||Participants|Number|3|3.0||||||
3686629|NCT02252354|3529181|B1|Ex-smoker||Smoking Classification||Participants|Number|1|1.0||||||
3686630|NCT02252354|3529179|B3|Current smoker||Smoking Classification||Participants|Number|0|0.0||||||
3686631|NCT02252354|3529180|B2|Current smoker||Smoking Classification||Participants|Number|0|0.0||||||
3686632|NCT02252354|3529181|B1|Current smoker||Smoking Classification||Participants|Number|0|0.0||||||
3686633|NCT02252354|3529179|B3|Never smoked||Smoking Classification||Participants|Number|8|8.0||||||
3686634|NCT02252354|3529180|B2|Never smoked||Smoking Classification||Participants|Number|3|3.0||||||
3686635|NCT02252354|3529181|B1|Never smoked||Smoking Classification||Participants|Number|5|5.0||||||
3686636|NCT02252354|3529179|B3|No||Xanthine Consumption||Participants|Number|9|9.0||||||
3686637|NCT02252354|3529180|B2|No||Xanthine Consumption||Participants|Number|5|5.0||||||
3686638|NCT02252354|3529181|B1|No||Xanthine Consumption||Participants|Number|4|4.0||||||
3686639|NCT02252354|3529179|B3|Yes||Xanthine Consumption||Participants|Number|3|3.0||||||
3686640|NCT02252354|3529180|B2|Yes||Xanthine Consumption||Participants|Number|1|1.0||||||
3686641|NCT02252354|3529181|B1|Yes||Xanthine Consumption||Participants|Number|2|2.0||||||
3686642|NCT02252354|3529179|B3|No||Caffeine Consumption||Participants|Number|2|2.0||||||
3686643|NCT02252354|3529180|B2|No||Caffeine Consumption||Participants|Number|1|1.0||||||
3686644|NCT02252354|3529181|B1|No||Caffeine Consumption||Participants|Number|1|1.0||||||
3686645|NCT02252354|3529179|B3|Yes||Caffeine Consumption||Participants|Number|10|10.0||||||
3686646|NCT02252354|3529180|B2|Yes||Caffeine Consumption||Participants|Number|5|5.0||||||
3686647|NCT02252354|3529181|B1|Yes||Caffeine Consumption||Participants|Number|5|5.0||||||
3686648|NCT02252354|3529179|B3|More than one race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3686649|NCT02252354|3529180|B2|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3686650|NCT02252354|3529181|B1|More than one race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3686651|NCT02252354|3529179|B3|White||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3686652|NCT02252354|3529180|B2|White||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3686653|NCT02252354|3529181|B1|White||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3686654|NCT02252354|3529179|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3686655|NCT02252354|3529180|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3686656|NCT02252354|3529181|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3686657|NCT02252354|3529179|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3686658|NCT02252354|3529180|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3686659|NCT02252354|3529181|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3686660|NCT02252354|3529179|B3|Greater than(>)17 to less than equal to(<=)64||Age, Customized||Participants|Number|12|12.0||||||
3686661|NCT02252354|3529180|B2|Greater than(>)17 to less than equal to(<=)64||Age, Customized||Participants|Number|6|6.0||||||
3686662|NCT02252354|3529181|B1|Greater than(>)17 to less than equal to(<=)64||Age, Customized||Participants|Number|6|6.0||||||
3686663|NCT02252146|3529227|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3686664|NCT02252146|3529227|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686665|NCT02252146|3529227|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686666|NCT02252146|3529227|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3686667|NCT02252146|3529227|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686668|NCT02252146|3529227|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686669|NCT02252146|3529227|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3686670|NCT02252146|3529227|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686671|NCT02252146|3529227|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3686672|NCT02252146|3529227|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3686673|NCT02252146|3529227|B1|||Age||years|Median|67|67.0|Full Range|||61.0|81.0|
3686674|NCT02252133|3529231|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3686675|NCT02252133|3529231|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3686676|NCT02252133|3529231|B1|||Age||years|Mean|37.0|37.0|Standard Deviation|9.6|9.6|||
3686677|NCT02252042|3529238|B3||Missing|PD-L1 Combined Positive Score (CPS) Status|Participants were assessed for their PD-L1 tumor expression level by immunohistochemistry assay using tumor tissue from a newly obtained biopsy. Participants with a CPS ≥1 were classified as PD-L1 positive and participants with a CPS <1 were classified as PD-L1 negative.|Participants|Count of Participants|4|4.0||||||
3686678|NCT02252042|3529239|B2||Missing|PD-L1 Combined Positive Score (CPS) Status|Participants were assessed for their PD-L1 tumor expression level by immunohistochemistry assay using tumor tissue from a newly obtained biopsy. Participants with a CPS ≥1 were classified as PD-L1 positive and participants with a CPS <1 were classified as PD-L1 negative.|Participants|Count of Participants|3|3.0||||||
3686679|NCT02252042|3529240|B1||Missing|PD-L1 Combined Positive Score (CPS) Status|Participants were assessed for their PD-L1 tumor expression level by immunohistochemistry assay using tumor tissue from a newly obtained biopsy. Participants with a CPS ≥1 were classified as PD-L1 positive and participants with a CPS <1 were classified as PD-L1 negative.|Participants|Count of Participants|1|1.0||||||
3686680|NCT02252042|3529238|B3||PD-L1 CPS ≥1|PD-L1 Combined Positive Score (CPS) Status|Participants were assessed for their PD-L1 tumor expression level by immunohistochemistry assay using tumor tissue from a newly obtained biopsy. Participants with a CPS ≥1 were classified as PD-L1 positive and participants with a CPS <1 were classified as PD-L1 negative.|Participants|Count of Participants|387|387.0||||||
3686681|NCT02252042|3529239|B2||PD-L1 CPS ≥1|PD-L1 Combined Positive Score (CPS) Status|Participants were assessed for their PD-L1 tumor expression level by immunohistochemistry assay using tumor tissue from a newly obtained biopsy. Participants with a CPS ≥1 were classified as PD-L1 positive and participants with a CPS <1 were classified as PD-L1 negative.|Participants|Count of Participants|191|191.0||||||
3686682|NCT02252042|3529240|B1||PD-L1 CPS ≥1|PD-L1 Combined Positive Score (CPS) Status|Participants were assessed for their PD-L1 tumor expression level by immunohistochemistry assay using tumor tissue from a newly obtained biopsy. Participants with a CPS ≥1 were classified as PD-L1 positive and participants with a CPS <1 were classified as PD-L1 negative.|Participants|Count of Participants|196|196.0||||||
3686683|NCT02252042|3529238|B3||PD-L1 CPS <1|PD-L1 Combined Positive Score (CPS) Status|Participants were assessed for their PD-L1 tumor expression level by immunohistochemistry assay using tumor tissue from a newly obtained biopsy. Participants with a CPS ≥1 were classified as PD-L1 positive and participants with a CPS <1 were classified as PD-L1 negative.|Participants|Count of Participants|104|104.0||||||
3686716|NCT02252042|3529238|B3||More than one race|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|7|7.0||||||
3686684|NCT02252042|3529239|B2||PD-L1 CPS <1|PD-L1 Combined Positive Score (CPS) Status|Participants were assessed for their PD-L1 tumor expression level by immunohistochemistry assay using tumor tissue from a newly obtained biopsy. Participants with a CPS ≥1 were classified as PD-L1 positive and participants with a CPS <1 were classified as PD-L1 negative.|Participants|Count of Participants|54|54.0||||||
3686685|NCT02252042|3529240|B1||PD-L1 CPS <1|PD-L1 Combined Positive Score (CPS) Status|Participants were assessed for their PD-L1 tumor expression level by immunohistochemistry assay using tumor tissue from a newly obtained biopsy. Participants with a CPS ≥1 were classified as PD-L1 positive and participants with a CPS <1 were classified as PD-L1 negative.|Participants|Count of Participants|50|50.0||||||
3686686|NCT02252042|3529238|B3||Negative HPV Status|Human Papillomavirus (HPV) Tumor Status|Participants were assessed for the presence or absence of HPV in their tumors.|Participants|Count of Participants|376|376.0||||||
3686687|NCT02252042|3529239|B2||Negative HPV Status|Human Papillomavirus (HPV) Tumor Status|Participants were assessed for the presence or absence of HPV in their tumors.|Participants|Count of Participants|190|190.0||||||
3686688|NCT02252042|3529240|B1||Negative HPV Status|Human Papillomavirus (HPV) Tumor Status|Participants were assessed for the presence or absence of HPV in their tumors.|Participants|Count of Participants|186|186.0||||||
3686689|NCT02252042|3529238|B3||Positive HPV Status|Human Papillomavirus (HPV) Tumor Status|Participants were assessed for the presence or absence of HPV in their tumors.|Participants|Count of Participants|119|119.0||||||
3686690|NCT02252042|3529239|B2||Positive HPV Status|Human Papillomavirus (HPV) Tumor Status|Participants were assessed for the presence or absence of HPV in their tumors.|Participants|Count of Participants|58|58.0||||||
3686691|NCT02252042|3529240|B1||Positive HPV Status|Human Papillomavirus (HPV) Tumor Status|Participants were assessed for the presence or absence of HPV in their tumors.|Participants|Count of Participants|61|61.0||||||
3686692|NCT02252042|3529238|B3||ECOG PS=2|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Participants were assessed for ECOG PS: Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory & able to carry out work of a light or sedentary nature; Grade 2: Ambulatory & capable of all selfcare but unable to carry out any work activities, up & about more than 50% of waking hours; Grade 3: Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled, cannot carry on any selfcare, totally confined to bed or chair or Grade 5: Dead.|Participants|Count of Participants|1|1.0||||||
3686693|NCT02252042|3529239|B2||ECOG PS=2|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Participants were assessed for ECOG PS: Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory & able to carry out work of a light or sedentary nature; Grade 2: Ambulatory & capable of all selfcare but unable to carry out any work activities, up & about more than 50% of waking hours; Grade 3: Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled, cannot carry on any selfcare, totally confined to bed or chair or Grade 5: Dead.|Participants|Count of Participants|1|1.0||||||
3686694|NCT02252042|3529240|B1||ECOG PS=2|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Participants were assessed for ECOG PS: Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory & able to carry out work of a light or sedentary nature; Grade 2: Ambulatory & capable of all selfcare but unable to carry out any work activities, up & about more than 50% of waking hours; Grade 3: Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled, cannot carry on any selfcare, totally confined to bed or chair or Grade 5: Dead.|Participants|Count of Participants|0|0.0||||||
3686695|NCT02252042|3529238|B3||ECOG PS=1|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Participants were assessed for ECOG PS: Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory & able to carry out work of a light or sedentary nature; Grade 2: Ambulatory & capable of all selfcare but unable to carry out any work activities, up & about more than 50% of waking hours; Grade 3: Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled, cannot carry on any selfcare, totally confined to bed or chair or Grade 5: Dead.|Participants|Count of Participants|356|356.0||||||
3686696|NCT02252042|3529239|B2||ECOG PS=1|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Participants were assessed for ECOG PS: Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory & able to carry out work of a light or sedentary nature; Grade 2: Ambulatory & capable of all selfcare but unable to carry out any work activities, up & about more than 50% of waking hours; Grade 3: Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled, cannot carry on any selfcare, totally confined to bed or chair or Grade 5: Dead.|Participants|Count of Participants|180|180.0||||||
3686697|NCT02252042|3529240|B1||ECOG PS=1|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Participants were assessed for ECOG PS: Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory & able to carry out work of a light or sedentary nature; Grade 2: Ambulatory & capable of all selfcare but unable to carry out any work activities, up & about more than 50% of waking hours; Grade 3: Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled, cannot carry on any selfcare, totally confined to bed or chair or Grade 5: Dead.|Participants|Count of Participants|176|176.0||||||
3686698|NCT02252042|3529238|B3||EGOG PS=0|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Participants were assessed for ECOG PS: Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory & able to carry out work of a light or sedentary nature; Grade 2: Ambulatory & capable of all selfcare but unable to carry out any work activities, up & about more than 50% of waking hours; Grade 3: Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled, cannot carry on any selfcare, totally confined to bed or chair or Grade 5: Dead.|Participants|Count of Participants|138|138.0||||||
3686717|NCT02252042|3529239|B2||More than one race|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|3|3.0||||||
3686699|NCT02252042|3529239|B2||EGOG PS=0|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Participants were assessed for ECOG PS: Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory & able to carry out work of a light or sedentary nature; Grade 2: Ambulatory & capable of all selfcare but unable to carry out any work activities, up & about more than 50% of waking hours; Grade 3: Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled, cannot carry on any selfcare, totally confined to bed or chair or Grade 5: Dead.|Participants|Count of Participants|67|67.0||||||
3686700|NCT02252042|3529240|B1||EGOG PS=0|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Participants were assessed for ECOG PS: Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory & able to carry out work of a light or sedentary nature; Grade 2: Ambulatory & capable of all selfcare but unable to carry out any work activities, up & about more than 50% of waking hours; Grade 3: Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled, cannot carry on any selfcare, totally confined to bed or chair or Grade 5: Dead.|Participants|Count of Participants|71|71.0||||||
3686701|NCT02252042|3529238|B3||Missing|Programmed Cell Death-Ligand 1 (PD-L1) Expression Level: Tumor Proportion Score (TPS)|Participants were assessed for their PD-L1 tumor expression level by immunohistochemistry assay using tumor tissue from a newly obtained biopsy. Participants with a TPS ≥50% were classified as PD-L1 strongly positive and participants with a TPS <50% were classified as not strongly positive.|Participants|Count of Participants|4|4.0||||||
3686702|NCT02252042|3529239|B2||Missing|Programmed Cell Death-Ligand 1 (PD-L1) Expression Level: Tumor Proportion Score (TPS)|Participants were assessed for their PD-L1 tumor expression level by immunohistochemistry assay using tumor tissue from a newly obtained biopsy. Participants with a TPS ≥50% were classified as PD-L1 strongly positive and participants with a TPS <50% were classified as not strongly positive.|Participants|Count of Participants|3|3.0||||||
3686703|NCT02252042|3529240|B1||Missing|Programmed Cell Death-Ligand 1 (PD-L1) Expression Level: Tumor Proportion Score (TPS)|Participants were assessed for their PD-L1 tumor expression level by immunohistochemistry assay using tumor tissue from a newly obtained biopsy. Participants with a TPS ≥50% were classified as PD-L1 strongly positive and participants with a TPS <50% were classified as not strongly positive.|Participants|Count of Participants|1|1.0||||||
3686704|NCT02252042|3529238|B3||TPS >=50%|Programmed Cell Death-Ligand 1 (PD-L1) Expression Level: Tumor Proportion Score (TPS)|Participants were assessed for their PD-L1 tumor expression level by immunohistochemistry assay using tumor tissue from a newly obtained biopsy. Participants with a TPS ≥50% were classified as PD-L1 strongly positive and participants with a TPS <50% were classified as not strongly positive.|Participants|Count of Participants|129|129.0||||||
3686705|NCT02252042|3529239|B2||TPS >=50%|Programmed Cell Death-Ligand 1 (PD-L1) Expression Level: Tumor Proportion Score (TPS)|Participants were assessed for their PD-L1 tumor expression level by immunohistochemistry assay using tumor tissue from a newly obtained biopsy. Participants with a TPS ≥50% were classified as PD-L1 strongly positive and participants with a TPS <50% were classified as not strongly positive.|Participants|Count of Participants|65|65.0||||||
3686706|NCT02252042|3529240|B1||TPS >=50%|Programmed Cell Death-Ligand 1 (PD-L1) Expression Level: Tumor Proportion Score (TPS)|Participants were assessed for their PD-L1 tumor expression level by immunohistochemistry assay using tumor tissue from a newly obtained biopsy. Participants with a TPS ≥50% were classified as PD-L1 strongly positive and participants with a TPS <50% were classified as not strongly positive.|Participants|Count of Participants|64|64.0||||||
3686707|NCT02252042|3529238|B3||1%<=TPS<50%|Programmed Cell Death-Ligand 1 (PD-L1) Expression Level: Tumor Proportion Score (TPS)|Participants were assessed for their PD-L1 tumor expression level by immunohistochemistry assay using tumor tissue from a newly obtained biopsy. Participants with a TPS ≥50% were classified as PD-L1 strongly positive and participants with a TPS <50% were classified as not strongly positive.|Participants|Count of Participants|166|166.0||||||
3686708|NCT02252042|3529239|B2||1%<=TPS<50%|Programmed Cell Death-Ligand 1 (PD-L1) Expression Level: Tumor Proportion Score (TPS)|Participants were assessed for their PD-L1 tumor expression level by immunohistochemistry assay using tumor tissue from a newly obtained biopsy. Participants with a TPS ≥50% were classified as PD-L1 strongly positive and participants with a TPS <50% were classified as not strongly positive.|Participants|Count of Participants|87|87.0||||||
3686709|NCT02252042|3529240|B1||1%<=TPS<50%|Programmed Cell Death-Ligand 1 (PD-L1) Expression Level: Tumor Proportion Score (TPS)|Participants were assessed for their PD-L1 tumor expression level by immunohistochemistry assay using tumor tissue from a newly obtained biopsy. Participants with a TPS ≥50% were classified as PD-L1 strongly positive and participants with a TPS <50% were classified as not strongly positive.|Participants|Count of Participants|79|79.0||||||
3686710|NCT02252042|3529238|B3||TPS=0%|Programmed Cell Death-Ligand 1 (PD-L1) Expression Level: Tumor Proportion Score (TPS)|Participants were assessed for their PD-L1 tumor expression level by immunohistochemistry assay using tumor tissue from a newly obtained biopsy. Participants with a TPS ≥50% were classified as PD-L1 strongly positive and participants with a TPS <50% were classified as not strongly positive.|Participants|Count of Participants|196|196.0||||||
3686711|NCT02252042|3529239|B2||TPS=0%|Programmed Cell Death-Ligand 1 (PD-L1) Expression Level: Tumor Proportion Score (TPS)|Participants were assessed for their PD-L1 tumor expression level by immunohistochemistry assay using tumor tissue from a newly obtained biopsy. Participants with a TPS ≥50% were classified as PD-L1 strongly positive and participants with a TPS <50% were classified as not strongly positive.|Participants|Count of Participants|93|93.0||||||
3686712|NCT02252042|3529240|B1||TPS=0%|Programmed Cell Death-Ligand 1 (PD-L1) Expression Level: Tumor Proportion Score (TPS)|Participants were assessed for their PD-L1 tumor expression level by immunohistochemistry assay using tumor tissue from a newly obtained biopsy. Participants with a TPS ≥50% were classified as PD-L1 strongly positive and participants with a TPS <50% were classified as not strongly positive.|Participants|Count of Participants|103|103.0||||||
3686713|NCT02252042|3529238|B3||Unknown or Not Reported|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|31|31.0||||||
3686714|NCT02252042|3529239|B2||Unknown or Not Reported|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|15|15.0||||||
3686715|NCT02252042|3529240|B1||Unknown or Not Reported|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|16|16.0||||||
3686718|NCT02252042|3529240|B1||More than one race|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|4|4.0||||||
3686719|NCT02252042|3529238|B3||White|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|414|414.0||||||
3686720|NCT02252042|3529239|B2||White|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|207|207.0||||||
3686721|NCT02252042|3529240|B1||White|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|207|207.0||||||
3686722|NCT02252042|3529238|B3||Black or African American|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|10|10.0||||||
3686723|NCT02252042|3529239|B2||Black or African American|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|7|7.0||||||
3686724|NCT02252042|3529240|B1||Black or African American|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|3|3.0||||||
3686725|NCT02252042|3529238|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|0|0.0||||||
3686726|NCT02252042|3529239|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|0|0.0||||||
3686727|NCT02252042|3529240|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|0|0.0||||||
3686728|NCT02252042|3529238|B3||Asian|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|31|31.0||||||
3686729|NCT02252042|3529239|B2||Asian|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|16|16.0||||||
3686730|NCT02252042|3529240|B1||Asian|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|15|15.0||||||
3686731|NCT02252042|3529238|B3||American Indian or Alaska Native|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|2|2.0||||||
3686732|NCT02252042|3529239|B2||American Indian or Alaska Native|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|0|0.0||||||
3686733|NCT02252042|3529240|B1||American Indian or Alaska Native|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|2|2.0||||||
3686734|NCT02252042|3529238|B3||Male|Sex: Female, Male||Participants|Count of Participants|412|412.0||||||
3686735|NCT02252042|3529239|B2||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
3686736|NCT02252042|3529240|B1||Male|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
3686737|NCT02252042|3529238|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3686738|NCT02252042|3529239|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3686739|NCT02252042|3529240|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3686740|NCT02252042|3529238|B3|||Age||Years|Mean|60.2|60.2|Standard Deviation|9.2|9.2|||
3686741|NCT02252042|3529239|B2|||Age||Years|Mean|60.2|60.2|Standard Deviation|8.6|8.6|||
3686742|NCT02252042|3529240|B1|||Age||Years|Mean|60.3|60.3|Standard Deviation|9.8|9.8|||
3686743|NCT02252016|3529279|B3||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3686744|NCT02252016|3529280|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3686745|NCT02252016|3529281|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3686746|NCT02252016|3529279|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3686747|NCT02252016|3529280|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3686748|NCT02252016|3529281|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3686749|NCT02252016|3529279|B3|||Age||Years|Mean|43.6|43.6|Standard Deviation|10.7|10.7|||
3686750|NCT02252016|3529280|B2|||Age||Years|Mean|42.5|42.5|Standard Deviation|9.8|9.8|||
3686751|NCT02252016|3529281|B1|||Age||Years|Mean|44.2|44.2|Standard Deviation|11.2|11.2|||
3686752|NCT02251990|3529294|B3||Male|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
3686753|NCT02251990|3529295|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3686754|NCT02251990|3529296|B1||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3686755|NCT02251990|3529294|B3||Female|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
3686756|NCT02251990|3529295|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3686757|NCT02251990|3529296|B1||Female|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
3686758|NCT02251990|3529294|B3|||Age||years|Mean|48.3|48.3|Standard Deviation|12.9|12.9|||
3686759|NCT02251990|3529295|B2|||Age||years|Mean|48.6|48.6|Standard Deviation|12.9|12.9|||
3686760|NCT02251990|3529296|B1|||Age||years|Mean|48.1|48.1|Standard Deviation|12.9|12.9|||
3686761|NCT02251912|3529312|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
3686762|NCT02251912|3529313|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3686763|NCT02251912|3529314|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3686764|NCT02251912|3529312|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686765|NCT02251912|3529313|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686766|NCT02251912|3529314|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686767|NCT02251912|3529312|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686768|NCT02251912|3529313|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686769|NCT02251912|3529314|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686770|NCT02251912|3529312|B3||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3686771|NCT02251912|3529313|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3686772|NCT02251912|3529314|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3686773|NCT02251912|3529312|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3686774|NCT02251912|3529313|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3686775|NCT02251912|3529314|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3686776|NCT02251912|3529312|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686777|NCT02251912|3529313|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686778|NCT02251912|3529314|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686779|NCT02251912|3529312|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686780|NCT02251912|3529313|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686781|NCT02251912|3529314|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686782|NCT02251912|3529312|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686783|NCT02251912|3529313|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686784|NCT02251912|3529314|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686785|NCT02251912|3529312|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3686786|NCT02251912|3529313|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3686787|NCT02251912|3529314|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3686788|NCT02251912|3529312|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3686789|NCT02251912|3529313|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3686790|NCT02251912|3529314|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3686791|NCT02251912|3529312|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3686792|NCT02251912|3529313|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3686793|NCT02251912|3529314|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3686794|NCT02251912|3529312|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3686795|NCT02251912|3529313|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3686796|NCT02251912|3529314|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3686797|NCT02251912|3529312|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3686798|NCT02251912|3529313|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3686799|NCT02251912|3529314|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3686800|NCT02251886|3529325|B5|||Gestational age||days|Mean|230|230.0|Standard Deviation|6|6.0|||
3686801|NCT02251886|3529326|B4|||Gestational age||days|Mean|231|231.0|Standard Deviation|7|7.0|||
3686802|NCT02251886|3529327|B3|||Gestational age||days|Mean|230|230.0|Standard Deviation|7|7.0|||
3686803|NCT02251886|3529328|B2|||Gestational age||days|Mean|230|230.0|Standard Deviation|6|6.0|||
3686804|NCT02251886|3529329|B1|||Gestational age||days|Mean|229|229.0|Standard Deviation|6|6.0|||
3686805|NCT02251886|3529325|B5|||Weight||kg|Mean|76|76.0|Standard Deviation|14|14.0|||
3686806|NCT02251886|3529326|B4|||Weight||kg|Mean|74|74.0|Standard Deviation|15|15.0|||
3686807|NCT02251886|3529327|B3|||Weight||kg|Mean|75|75.0|Standard Deviation|12|12.0|||
3686808|NCT02251886|3529328|B2|||Weight||kg|Mean|78|78.0|Standard Deviation|14|14.0|||
3686809|NCT02251886|3529329|B1|||Weight||kg|Mean|76|76.0|Standard Deviation|14|14.0|||
3686810|NCT02251886|3529325|B5|Denmark||Region of Enrollment||participants|Number|200|200.0||||||
3686811|NCT02251886|3529326|B4|Denmark||Region of Enrollment||participants|Number|54|54.0||||||
3686812|NCT02251886|3529327|B3|Denmark||Region of Enrollment||participants|Number|44|44.0||||||
3686813|NCT02251886|3529328|B2|Denmark||Region of Enrollment||participants|Number|54|54.0||||||
3686814|NCT02251886|3529329|B1|Denmark||Region of Enrollment||participants|Number|48|48.0||||||
3686815|NCT02251886|3529325|B5||Male|Gender||Participants|Count of Participants|0|0.0||||||
3686816|NCT02251886|3529326|B4||Male|Gender||Participants|Count of Participants|0|0.0||||||
3686817|NCT02251886|3529327|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3686818|NCT02251886|3529328|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3686819|NCT02251886|3529329|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3686820|NCT02251886|3529325|B5||Female|Gender||Participants|Count of Participants|200|200.0||||||
3686821|NCT02251886|3529326|B4||Female|Gender||Participants|Count of Participants|54|54.0||||||
3686822|NCT02251886|3529327|B3||Female|Gender||Participants|Count of Participants|44|44.0||||||
3686823|NCT02251886|3529328|B2||Female|Gender||Participants|Count of Participants|54|54.0||||||
3686824|NCT02251886|3529329|B1||Female|Gender||Participants|Count of Participants|48|48.0||||||
3686825|NCT02251886|3529325|B5|||Age||years|Mean|30|30.0|Standard Deviation|4|4.0|||
3686826|NCT02251886|3529326|B4|||Age||years|Mean|31|31.0|Standard Deviation|3|3.0|||
3686827|NCT02251886|3529327|B3|||Age||years|Mean|29|29.0|Standard Deviation|4|4.0|||
3686828|NCT02251886|3529328|B2|||Age||years|Mean|31|31.0|Standard Deviation|3|3.0|||
3686829|NCT02251886|3529329|B1|||Age||years|Mean|28|28.0|Standard Deviation|4|4.0|||
3686830|NCT02251886|3529325|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3686831|NCT02251886|3529326|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3686832|NCT02251886|3529327|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3686833|NCT02251886|3529328|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3686834|NCT02251886|3529329|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3686835|NCT02251886|3529325|B5||Between 18 and 65 years|Age||Participants|Count of Participants|200|200.0||||||
3686836|NCT02251886|3529326|B4||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3686837|NCT02251886|3529327|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3686838|NCT02251886|3529328|B2||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3686839|NCT02251886|3529329|B1||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
3686840|NCT02251886|3529325|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3686841|NCT02251886|3529326|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3686842|NCT02251886|3529327|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3686843|NCT02251886|3529328|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3686844|NCT02251886|3529329|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3686845|NCT02251717|3529342|B3|Treatment-Experienced||Prior HCV Treatment Status||Participants|Count of Participants|35|35.0||||||
3686846|NCT02251717|3529343|B2|Treatment-Experienced||Prior HCV Treatment Status||Participants|Count of Participants|18|18.0||||||
3686847|NCT02251717|3529344|B1|Treatment-Experienced||Prior HCV Treatment Status||Participants|Count of Participants|17|17.0||||||
3686848|NCT02251717|3529342|B3|Treatment-Naive||Prior HCV Treatment Status||Participants|Count of Participants|79|79.0||||||
3686849|NCT02251717|3529343|B2|Treatment-Naive||Prior HCV Treatment Status||Participants|Count of Participants|39|39.0||||||
3686850|NCT02251717|3529344|B1|Treatment-Naive||Prior HCV Treatment Status||Participants|Count of Participants|40|40.0||||||
3686851|NCT02251717|3529342|B3|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|87|87.0||||||
3686852|NCT02251717|3529343|B2|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|41|41.0||||||
3686853|NCT02251717|3529344|B1|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|46|46.0||||||
3686854|NCT02251717|3529342|B3|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|27|27.0||||||
3686855|NCT02251717|3529343|B2|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|16|16.0||||||
3686856|NCT02251717|3529344|B1|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|11|11.0||||||
3686857|NCT02251717|3529342|B3|||HCV RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.58|0.58|||
3686858|NCT02251717|3529343|B2|||HCV RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.53|0.53|||
3686859|NCT02251717|3529344|B1|||HCV RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.63|0.63|||
3686860|NCT02251717|3529342|B3|||Years From Most Recent Kidney Transplant||years|Mean|13.2|13.2|Standard Deviation|9.61|9.61|||
3686861|NCT02251717|3529343|B2|||Years From Most Recent Kidney Transplant||years|Mean|14.4|14.4|Standard Deviation|9.66|9.66|||
3686862|NCT02251717|3529344|B1|||Years From Most Recent Kidney Transplant||years|Mean|12.1|12.1|Standard Deviation|9.51|9.51|||
3686863|NCT02251717|3529342|B3|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|14|14.0||||||
3686864|NCT02251717|3529343|B2|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|5|5.0||||||
3686865|NCT02251717|3529344|B1|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|9|9.0||||||
3686866|NCT02251717|3529342|B3|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|68|68.0||||||
3686867|NCT02251717|3529343|B2|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|34|34.0||||||
3686868|NCT02251717|3529344|B1|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|34|34.0||||||
3686869|NCT02251717|3529342|B3|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|32|32.0||||||
3686870|NCT02251717|3529343|B2|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|18|18.0||||||
3686871|NCT02251717|3529344|B1|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|14|14.0||||||
3686872|NCT02251717|3529342|B3|Yes||Cirrhosis Status||Participants|Count of Participants|17|17.0||||||
3686873|NCT02251717|3529343|B2|Yes||Cirrhosis Status||Participants|Count of Participants|9|9.0||||||
3686874|NCT02251717|3529344|B1|Yes||Cirrhosis Status||Participants|Count of Participants|8|8.0||||||
3686875|NCT02251717|3529342|B3|No||Cirrhosis Status||Participants|Count of Participants|97|97.0||||||
3686876|NCT02251717|3529343|B2|No||Cirrhosis Status||Participants|Count of Participants|48|48.0||||||
3686877|NCT02251717|3529344|B1|No||Cirrhosis Status||Participants|Count of Participants|49|49.0||||||
3686878|NCT02251717|3529342|B3|Genotype 4||HCV genotype||Participants|Count of Participants|10|10.0||||||
3686879|NCT02251717|3529343|B2|Genotype 4||HCV genotype||Participants|Count of Participants|4|4.0||||||
3686880|NCT02251717|3529344|B1|Genotype 4||HCV genotype||Participants|Count of Participants|6|6.0||||||
3686881|NCT02251717|3529342|B3|Genotype 1||HCV genotype||Participants|Count of Participants|104|104.0||||||
3686882|NCT02251717|3529343|B2|Genotype 1||HCV genotype||Participants|Count of Participants|53|53.0||||||
3686883|NCT02251717|3529344|B1|Genotype 1||HCV genotype||Participants|Count of Participants|51|51.0||||||
3686884|NCT02251717|3529342|B3|Germany||Region of Enrollment||participants|Number|5|5.0||||||
3686885|NCT02251717|3529343|B2|Germany||Region of Enrollment||participants|Number|4|4.0||||||
3686886|NCT02251717|3529344|B1|Germany||Region of Enrollment||participants|Number|1|1.0||||||
3686887|NCT02251717|3529342|B3|France||Region of Enrollment||participants|Number|36|36.0||||||
3686888|NCT02251717|3529343|B2|France||Region of Enrollment||participants|Number|21|21.0||||||
3686889|NCT02251717|3529344|B1|France||Region of Enrollment||participants|Number|15|15.0||||||
3686890|NCT02251717|3529342|B3|Italy||Region of Enrollment||participants|Number|49|49.0||||||
3686891|NCT02251717|3529343|B2|Italy||Region of Enrollment||participants|Number|17|17.0||||||
3686892|NCT02251717|3529344|B1|Italy||Region of Enrollment||participants|Number|32|32.0||||||
3686893|NCT02251717|3529342|B3|Austria||Region of Enrollment||participants|Number|24|24.0||||||
3686894|NCT02251717|3529343|B2|Austria||Region of Enrollment||participants|Number|15|15.0||||||
3686895|NCT02251717|3529344|B1|Austria||Region of Enrollment||participants|Number|9|9.0||||||
3686896|NCT02251717|3529342|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3686897|NCT02251717|3529343|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3686898|NCT02251717|3529344|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3686899|NCT02251717|3529342|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3686900|NCT02251717|3529343|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3686901|NCT02251717|3529344|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3686902|NCT02251717|3529342|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|107|107.0||||||
3686903|NCT02251717|3529343|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|53|53.0||||||
3686904|NCT02251717|3529344|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|54|54.0||||||
3686905|NCT02251717|3529342|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3686906|NCT02251717|3529343|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3686907|NCT02251717|3529344|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3686908|NCT02251717|3529342|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686909|NCT02251717|3529343|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686910|NCT02251717|3529344|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3686911|NCT02251717|3529342|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|109|109.0||||||
3686912|NCT02251717|3529343|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3686913|NCT02251717|3529344|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3686914|NCT02251717|3529342|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3686915|NCT02251717|3529343|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3686916|NCT02251717|3529344|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3686917|NCT02251717|3529342|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3686918|NCT02251717|3529343|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3686919|NCT02251717|3529344|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3686920|NCT02251717|3529342|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3686921|NCT02251717|3529343|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3686922|NCT02251717|3529344|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3686923|NCT02251717|3529342|B3|||Age||years|Mean|53|53.0|Standard Deviation|9.2|9.2|||
3686924|NCT02251717|3529343|B2|||Age||years|Mean|53|53.0|Standard Deviation|10.0|10.0|||
3686925|NCT02251717|3529344|B1|||Age||years|Mean|54|54.0|Standard Deviation|8.3|8.3|||
3686926|NCT02251652|3529357|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3686927|NCT02251652|3529357|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3686928|NCT02251652|3529357|B1|||Age||years|Mean|67.06|67.06|Standard Deviation|9.82|9.82|||
3686929|NCT02251613|3529367|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3686930|NCT02251613|3529367|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3686931|NCT02251613|3529367|B1|≥50 years||Age, Customized||participants|Number|1|1.0||||||
3686932|NCT02251613|3529367|B1|40-49 years||Age, Customized||participants|Number|14|14.0||||||
3686933|NCT02251613|3529367|B1|30-39 years||Age, Customized||participants|Number|13|13.0||||||
3686934|NCT02251613|3529367|B1|20-29 years||Age, Customized||participants|Number|22|22.0||||||
3686935|NCT02251561|3529375|B1|Japan||Region of Enrollment||participants|Number|28|28.0||||||
3686936|NCT02251561|3529375|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3686937|NCT02251561|3529375|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3686938|NCT02251561|3529375|B1|||Age||years|Mean|28.0|28.0|Standard Deviation|7.5|7.5|||
3686939|NCT02250807|3529383|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3686940|NCT02250807|3529383|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3686941|NCT02250807|3529383|B1|||Age||years|Median|51|51.0|Full Range|||29.0|69.0|
3686942|NCT02250703|3529393|B3|United States||Region of Enrollment||Participants|Count of Participants|73|73.0||||||
3686943|NCT02250703|3529394|B2|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3686944|NCT02250703|3529395|B1|United States||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3686945|NCT02250703|3529393|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3686946|NCT02250703|3529394|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3686947|NCT02250703|3529395|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3686948|NCT02250703|3529393|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3686949|NCT02250703|3529394|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3686950|NCT02250703|3529395|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3686951|NCT02250703|3529393|B3|||Age||years|Mean|7.9|7.9|Standard Deviation|3.1|3.1|||
3686952|NCT02250703|3529394|B2|||Age||years|Mean|8.0|8.0|Standard Deviation|3.37|3.37|||
3686953|NCT02250703|3529395|B1|||Age||years|Mean|7.62|7.62|Standard Deviation|2.3|2.3|||
3686954|NCT02250703|3529393|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3686955|NCT02250703|3529394|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3686956|NCT02250703|3529395|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3686957|NCT02250703|3529393|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3686958|NCT02250703|3529394|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3686959|NCT02250703|3529395|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3686960|NCT02250703|3529393|B3||<=18 years|Age||Participants|Count of Participants|73|73.0||||||
3686961|NCT02250703|3529394|B2||<=18 years|Age||Participants|Count of Participants|36|36.0||||||
3686962|NCT02250703|3529395|B1||<=18 years|Age||Participants|Count of Participants|37|37.0||||||
3686963|NCT02250521|3529408|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3686964|NCT02250521|3529408|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3686965|NCT02250521|3529408|B1|||Age|Age is reported not for 100 subjects, but only for the 94 who were analyzed. Of the 100 patients recruited, 6 patients were excluded from data analysis. 4 patients were found to not meet inclusion criteria. One patient with glottic view grade 3 was erroneously intubated via the indirect method. For another patient, the anesthesiologist aborted the protocol due to encountered difficulties.|years|Mean|53.17|53.17|Standard Deviation|14.70|14.7|||
3686966|NCT02250443|3529422|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3686967|NCT02250443|3529422|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3686968|NCT02250443|3529422|B1|||Age||Years|Mean|70.1|70.1|Standard Deviation|10.39|10.39|||
3686969|NCT02250417|3529435|B1|||Stage R Duration|Stage R is the last sleep stage-rapid eye movement (REM)|minutes|Mean|50.8|50.8|Standard Deviation|30.1|30.1|||
3686970|NCT02250417|3529435|B1|||Stage N3 Duration|"Stage N3 is the referred to as deep sleep or slow wave sleep."|minutes|Mean|21.1|21.1|Standard Deviation|23.0|23.0|||
3686971|NCT02250417|3529435|B1|||Stage N2 Duration|Stage N2 Duration is referred to as the longest sleep stage/largest percentage of sleep time|minutes|Mean|255.8|255.8|Standard Deviation|48.8|48.8|||
3686972|NCT02250417|3529435|B1|||Stage N1 Duration|Stage N1 is the lightest sleep stage|minutes|Mean|33.3|33.3|Standard Deviation|17.0|17.0|||
3686973|NCT02250417|3529435|B1|||Non-supine Sleep Time||mins|Mean|210.7|210.7|Standard Deviation|79.7|79.7|||
3686974|NCT02250417|3529435|B1|||Supine Sleep Time||mins|Mean|153.8|153.8|Standard Deviation|84.7|84.7|||
3686975|NCT02250417|3529435|B1|||Sleep Efficiency|Sleep Efficiency=total sleep time divided by total recording time x100|%|Mean|87.6|87.6|Standard Deviation|7.2|7.2|||
3686976|NCT02250417|3529435|B1|||Total Recording Time||mins|Mean|415.7|415.7|Standard Deviation|32.0|32.0|||
3686977|NCT02250417|3529435|B1|||Total Sleep Time||mins|Mean|364.5|364.5|Standard Deviation|43.8|43.8|||
3686978|NCT02250417|3529435|B1|||non-supine AHI||events/hr|Mean|1.6|1.6|Standard Deviation|1.1|1.1|||
3686979|NCT02250417|3529435|B1|||supine AHI||events/hr|Mean|38.1|38.1|Standard Deviation|24.6|24.6|||
3686980|NCT02250417|3529435|B1|||Total AHI||events/hr|Mean|14.4|14.4|Standard Deviation|5.8|5.8|||
3686981|NCT02250417|3529435|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3686982|NCT02250417|3529435|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3686983|NCT02250417|3529435|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3686984|NCT02250417|3529435|B1|||Age||years|Mean|48.4|48.4|Standard Deviation|8.7|8.7|||
3686985|NCT02250326|3529448|B4|Not Reported||Disease Stage at Enrollment|Disease stage means how big the tumor is and how far it has spread. Disease stages range from 0 (no spread) to IV (spread throughout the body). Stage 1 - the cancer is small and hasn't spread to the lymph nodes; Stage II - the cancer has spread to some lymph nodes near the tumor; Stage IIIA the cancer has spread to lymph nodes on the same side of the tumor; Stage IIIB - the the cancer has spread to the lymph nodes above the collarbone or in the opposite side of the chest tumor; Stage IV - the cancer has spread to other organs such as the other lung, brain or liver.|Participants|Count of Participants|1|1.0||||||
3686986|NCT02250326|3529449|B3|Not Reported||Disease Stage at Enrollment|Disease stage means how big the tumor is and how far it has spread. Disease stages range from 0 (no spread) to IV (spread throughout the body). Stage 1 - the cancer is small and hasn't spread to the lymph nodes; Stage II - the cancer has spread to some lymph nodes near the tumor; Stage IIIA the cancer has spread to lymph nodes on the same side of the tumor; Stage IIIB - the the cancer has spread to the lymph nodes above the collarbone or in the opposite side of the chest tumor; Stage IV - the cancer has spread to other organs such as the other lung, brain or liver.|Participants|Count of Participants|0|0.0||||||
3686987|NCT02250326|3529450|B2|Not Reported||Disease Stage at Enrollment|Disease stage means how big the tumor is and how far it has spread. Disease stages range from 0 (no spread) to IV (spread throughout the body). Stage 1 - the cancer is small and hasn't spread to the lymph nodes; Stage II - the cancer has spread to some lymph nodes near the tumor; Stage IIIA the cancer has spread to lymph nodes on the same side of the tumor; Stage IIIB - the the cancer has spread to the lymph nodes above the collarbone or in the opposite side of the chest tumor; Stage IV - the cancer has spread to other organs such as the other lung, brain or liver.|Participants|Count of Participants|1|1.0||||||
3686988|NCT02250326|3529451|B1|Not Reported||Disease Stage at Enrollment|Disease stage means how big the tumor is and how far it has spread. Disease stages range from 0 (no spread) to IV (spread throughout the body). Stage 1 - the cancer is small and hasn't spread to the lymph nodes; Stage II - the cancer has spread to some lymph nodes near the tumor; Stage IIIA the cancer has spread to lymph nodes on the same side of the tumor; Stage IIIB - the the cancer has spread to the lymph nodes above the collarbone or in the opposite side of the chest tumor; Stage IV - the cancer has spread to other organs such as the other lung, brain or liver.|Participants|Count of Participants|0|0.0||||||
3687106|NCT02249819|3529503|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3686989|NCT02250326|3529448|B4|Stage IV||Disease Stage at Enrollment|Disease stage means how big the tumor is and how far it has spread. Disease stages range from 0 (no spread) to IV (spread throughout the body). Stage 1 - the cancer is small and hasn't spread to the lymph nodes; Stage II - the cancer has spread to some lymph nodes near the tumor; Stage IIIA the cancer has spread to lymph nodes on the same side of the tumor; Stage IIIB - the the cancer has spread to the lymph nodes above the collarbone or in the opposite side of the chest tumor; Stage IV - the cancer has spread to other organs such as the other lung, brain or liver.|Participants|Count of Participants|231|231.0||||||
3686990|NCT02250326|3529449|B3|Stage IV||Disease Stage at Enrollment|Disease stage means how big the tumor is and how far it has spread. Disease stages range from 0 (no spread) to IV (spread throughout the body). Stage 1 - the cancer is small and hasn't spread to the lymph nodes; Stage II - the cancer has spread to some lymph nodes near the tumor; Stage IIIA the cancer has spread to lymph nodes on the same side of the tumor; Stage IIIB - the the cancer has spread to the lymph nodes above the collarbone or in the opposite side of the chest tumor; Stage IV - the cancer has spread to other organs such as the other lung, brain or liver.|Participants|Count of Participants|76|76.0||||||
3686991|NCT02250326|3529450|B2|Stage IV||Disease Stage at Enrollment|Disease stage means how big the tumor is and how far it has spread. Disease stages range from 0 (no spread) to IV (spread throughout the body). Stage 1 - the cancer is small and hasn't spread to the lymph nodes; Stage II - the cancer has spread to some lymph nodes near the tumor; Stage IIIA the cancer has spread to lymph nodes on the same side of the tumor; Stage IIIB - the the cancer has spread to the lymph nodes above the collarbone or in the opposite side of the chest tumor; Stage IV - the cancer has spread to other organs such as the other lung, brain or liver.|Participants|Count of Participants|75|75.0||||||
3686992|NCT02250326|3529451|B1|Stage IV||Disease Stage at Enrollment|Disease stage means how big the tumor is and how far it has spread. Disease stages range from 0 (no spread) to IV (spread throughout the body). Stage 1 - the cancer is small and hasn't spread to the lymph nodes; Stage II - the cancer has spread to some lymph nodes near the tumor; Stage IIIA the cancer has spread to lymph nodes on the same side of the tumor; Stage IIIB - the the cancer has spread to the lymph nodes above the collarbone or in the opposite side of the chest tumor; Stage IV - the cancer has spread to other organs such as the other lung, brain or liver.|Participants|Count of Participants|80|80.0||||||
3686993|NCT02250326|3529448|B4|Stage IIIb||Disease Stage at Enrollment|Disease stage means how big the tumor is and how far it has spread. Disease stages range from 0 (no spread) to IV (spread throughout the body). Stage 1 - the cancer is small and hasn't spread to the lymph nodes; Stage II - the cancer has spread to some lymph nodes near the tumor; Stage IIIA the cancer has spread to lymph nodes on the same side of the tumor; Stage IIIB - the the cancer has spread to the lymph nodes above the collarbone or in the opposite side of the chest tumor; Stage IV - the cancer has spread to other organs such as the other lung, brain or liver.|Participants|Count of Participants|6|6.0||||||
3686994|NCT02250326|3529449|B3|Stage IIIb||Disease Stage at Enrollment|Disease stage means how big the tumor is and how far it has spread. Disease stages range from 0 (no spread) to IV (spread throughout the body). Stage 1 - the cancer is small and hasn't spread to the lymph nodes; Stage II - the cancer has spread to some lymph nodes near the tumor; Stage IIIA the cancer has spread to lymph nodes on the same side of the tumor; Stage IIIB - the the cancer has spread to the lymph nodes above the collarbone or in the opposite side of the chest tumor; Stage IV - the cancer has spread to other organs such as the other lung, brain or liver.|Participants|Count of Participants|3|3.0||||||
3686995|NCT02250326|3529450|B2|Stage IIIb||Disease Stage at Enrollment|Disease stage means how big the tumor is and how far it has spread. Disease stages range from 0 (no spread) to IV (spread throughout the body). Stage 1 - the cancer is small and hasn't spread to the lymph nodes; Stage II - the cancer has spread to some lymph nodes near the tumor; Stage IIIA the cancer has spread to lymph nodes on the same side of the tumor; Stage IIIB - the the cancer has spread to the lymph nodes above the collarbone or in the opposite side of the chest tumor; Stage IV - the cancer has spread to other organs such as the other lung, brain or liver.|Participants|Count of Participants|3|3.0||||||
3686996|NCT02250326|3529451|B1|Stage IIIb||Disease Stage at Enrollment|Disease stage means how big the tumor is and how far it has spread. Disease stages range from 0 (no spread) to IV (spread throughout the body). Stage 1 - the cancer is small and hasn't spread to the lymph nodes; Stage II - the cancer has spread to some lymph nodes near the tumor; Stage IIIA the cancer has spread to lymph nodes on the same side of the tumor; Stage IIIB - the the cancer has spread to the lymph nodes above the collarbone or in the opposite side of the chest tumor; Stage IV - the cancer has spread to other organs such as the other lung, brain or liver.|Participants|Count of Participants|0|0.0||||||
3686997|NCT02250326|3529448|B4|Stage IIIa||Disease Stage at Enrollment|Disease stage means how big the tumor is and how far it has spread. Disease stages range from 0 (no spread) to IV (spread throughout the body). Stage 1 - the cancer is small and hasn't spread to the lymph nodes; Stage II - the cancer has spread to some lymph nodes near the tumor; Stage IIIA the cancer has spread to lymph nodes on the same side of the tumor; Stage IIIB - the the cancer has spread to the lymph nodes above the collarbone or in the opposite side of the chest tumor; Stage IV - the cancer has spread to other organs such as the other lung, brain or liver.|Participants|Count of Participants|2|2.0||||||
3686998|NCT02250326|3529449|B3|Stage IIIa||Disease Stage at Enrollment|Disease stage means how big the tumor is and how far it has spread. Disease stages range from 0 (no spread) to IV (spread throughout the body). Stage 1 - the cancer is small and hasn't spread to the lymph nodes; Stage II - the cancer has spread to some lymph nodes near the tumor; Stage IIIA the cancer has spread to lymph nodes on the same side of the tumor; Stage IIIB - the the cancer has spread to the lymph nodes above the collarbone or in the opposite side of the chest tumor; Stage IV - the cancer has spread to other organs such as the other lung, brain or liver.|Participants|Count of Participants|1|1.0||||||
3686999|NCT02250326|3529450|B2|Stage IIIa||Disease Stage at Enrollment|Disease stage means how big the tumor is and how far it has spread. Disease stages range from 0 (no spread) to IV (spread throughout the body). Stage 1 - the cancer is small and hasn't spread to the lymph nodes; Stage II - the cancer has spread to some lymph nodes near the tumor; Stage IIIA the cancer has spread to lymph nodes on the same side of the tumor; Stage IIIB - the the cancer has spread to the lymph nodes above the collarbone or in the opposite side of the chest tumor; Stage IV - the cancer has spread to other organs such as the other lung, brain or liver.|Participants|Count of Participants|0|0.0||||||
3687107|NCT02249819|3529503|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3687000|NCT02250326|3529451|B1|Stage IIIa||Disease Stage at Enrollment|Disease stage means how big the tumor is and how far it has spread. Disease stages range from 0 (no spread) to IV (spread throughout the body). Stage 1 - the cancer is small and hasn't spread to the lymph nodes; Stage II - the cancer has spread to some lymph nodes near the tumor; Stage IIIA the cancer has spread to lymph nodes on the same side of the tumor; Stage IIIB - the the cancer has spread to the lymph nodes above the collarbone or in the opposite side of the chest tumor; Stage IV - the cancer has spread to other organs such as the other lung, brain or liver.|Participants|Count of Participants|1|1.0||||||
3687001|NCT02250326|3529448|B4|Missing||Confirmed Histology||Participants|Count of Participants|1|1.0||||||
3687002|NCT02250326|3529449|B3|Missing||Confirmed Histology||Participants|Count of Participants|0|0.0||||||
3687003|NCT02250326|3529450|B2|Missing||Confirmed Histology||Participants|Count of Participants|1|1.0||||||
3687004|NCT02250326|3529451|B1|Missing||Confirmed Histology||Participants|Count of Participants|0|0.0||||||
3687005|NCT02250326|3529448|B4|Squamous Cell||Confirmed Histology||Participants|Count of Participants|23|23.0||||||
3687006|NCT02250326|3529449|B3|Squamous Cell||Confirmed Histology||Participants|Count of Participants|0|0.0||||||
3687007|NCT02250326|3529450|B2|Squamous Cell||Confirmed Histology||Participants|Count of Participants|23|23.0||||||
3687008|NCT02250326|3529451|B1|Squamous Cell||Confirmed Histology||Participants|Count of Participants|0|0.0||||||
3687009|NCT02250326|3529448|B4|Other||Confirmed Histology||Participants|Count of Participants|6|6.0||||||
3687010|NCT02250326|3529449|B3|Other||Confirmed Histology||Participants|Count of Participants|1|1.0||||||
3687011|NCT02250326|3529450|B2|Other||Confirmed Histology||Participants|Count of Participants|3|3.0||||||
3687012|NCT02250326|3529451|B1|Other||Confirmed Histology||Participants|Count of Participants|2|2.0||||||
3687013|NCT02250326|3529448|B4|Carcinoid Tumor||Confirmed Histology||Participants|Count of Participants|1|1.0||||||
3687014|NCT02250326|3529449|B3|Carcinoid Tumor||Confirmed Histology||Participants|Count of Participants|0|0.0||||||
3687015|NCT02250326|3529450|B2|Carcinoid Tumor||Confirmed Histology||Participants|Count of Participants|1|1.0||||||
3687016|NCT02250326|3529451|B1|Carcinoid Tumor||Confirmed Histology||Participants|Count of Participants|0|0.0||||||
3687017|NCT02250326|3529448|B4|Adenosquamous Carcinoma||Confirmed Histology||Participants|Count of Participants|0|0.0||||||
3687018|NCT02250326|3529449|B3|Adenosquamous Carcinoma||Confirmed Histology||Participants|Count of Participants|0|0.0||||||
3687019|NCT02250326|3529450|B2|Adenosquamous Carcinoma||Confirmed Histology||Participants|Count of Participants|0|0.0||||||
3687020|NCT02250326|3529451|B1|Adenosquamous Carcinoma||Confirmed Histology||Participants|Count of Participants|0|0.0||||||
3687021|NCT02250326|3529448|B4|Large Cell Carcinoma||Confirmed Histology||Participants|Count of Participants|8|8.0||||||
3687022|NCT02250326|3529449|B3|Large Cell Carcinoma||Confirmed Histology||Participants|Count of Participants|4|4.0||||||
3687023|NCT02250326|3529450|B2|Large Cell Carcinoma||Confirmed Histology||Participants|Count of Participants|3|3.0||||||
3687024|NCT02250326|3529451|B1|Large Cell Carcinoma||Confirmed Histology||Participants|Count of Participants|1|1.0||||||
3687025|NCT02250326|3529448|B4|Adenocarcinoma||Confirmed Histology||Participants|Count of Participants|201|201.0||||||
3687026|NCT02250326|3529449|B3|Adenocarcinoma||Confirmed Histology||Participants|Count of Participants|75|75.0||||||
3687027|NCT02250326|3529450|B2|Adenocarcinoma||Confirmed Histology||Participants|Count of Participants|48|48.0||||||
3687028|NCT02250326|3529451|B1|Adenocarcinoma||Confirmed Histology||Participants|Count of Participants|78|78.0||||||
3687029|NCT02250326|3529448|B4|Never Smoked||Smoking History||Participants|Count of Participants|22|22.0||||||
3687030|NCT02250326|3529449|B3|Never Smoked||Smoking History||Participants|Count of Participants|4|4.0||||||
3687031|NCT02250326|3529450|B2|Never Smoked||Smoking History||Participants|Count of Participants|9|9.0||||||
3687032|NCT02250326|3529451|B1|Never Smoked||Smoking History||Participants|Count of Participants|9|9.0||||||
3687033|NCT02250326|3529448|B4|Past Smoker||Smoking History||Participants|Count of Participants|174|174.0||||||
3687034|NCT02250326|3529449|B3|Past Smoker||Smoking History||Participants|Count of Participants|63|63.0||||||
3687035|NCT02250326|3529450|B2|Past Smoker||Smoking History||Participants|Count of Participants|57|57.0||||||
3687036|NCT02250326|3529451|B1|Past Smoker||Smoking History||Participants|Count of Participants|54|54.0||||||
3687037|NCT02250326|3529448|B4|Current Smoker||Smoking History||Participants|Count of Participants|44|44.0||||||
3687038|NCT02250326|3529449|B3|Current Smoker||Smoking History||Participants|Count of Participants|13|13.0||||||
3687039|NCT02250326|3529450|B2|Current Smoker||Smoking History||Participants|Count of Participants|13|13.0||||||
3687040|NCT02250326|3529451|B1|Current Smoker||Smoking History||Participants|Count of Participants|18|18.0||||||
3687041|NCT02250326|3529448|B4||Missing|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|0|0.0||||||
3687042|NCT02250326|3529449|B3||Missing|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|0|0.0||||||
3687108|NCT02249819|3529503|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3687109|NCT02249819|3529503|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3687110|NCT02249819|3529503|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3687043|NCT02250326|3529450|B2||Missing|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|0|0.0||||||
3687044|NCT02250326|3529451|B1||Missing|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|0|0.0||||||
3687045|NCT02250326|3529448|B4||2 = Ambulatory but unable to work|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|0|0.0||||||
3687046|NCT02250326|3529449|B3||2 = Ambulatory but unable to work|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|0|0.0||||||
3687047|NCT02250326|3529450|B2||2 = Ambulatory but unable to work|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|0|0.0||||||
3687048|NCT02250326|3529451|B1||2 = Ambulatory but unable to work|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|0|0.0||||||
3687049|NCT02250326|3529448|B4||1 = Restrictive but ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|171|171.0||||||
3687050|NCT02250326|3529449|B3||1 = Restrictive but ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|54|54.0||||||
3687051|NCT02250326|3529450|B2||1 = Restrictive but ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|61|61.0||||||
3687052|NCT02250326|3529451|B1||1 = Restrictive but ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|56|56.0||||||
3687053|NCT02250326|3529448|B4||0 = Fully Active|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|69|69.0||||||
3687054|NCT02250326|3529449|B3||0 = Fully Active|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|26|26.0||||||
3687111|NCT02249728|3529510|B1|||BMI||kg/m^2|Mean|27.55|27.55|Standard Deviation|4.72|4.72|||
3687055|NCT02250326|3529450|B2||0 = Fully Active|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|18|18.0||||||
3687056|NCT02250326|3529451|B1||0 = Fully Active|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|25|25.0||||||
3687057|NCT02250326|3529448|B4||Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3687058|NCT02250326|3529449|B3||Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3687059|NCT02250326|3529450|B2||Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3687060|NCT02250326|3529451|B1||Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3687061|NCT02250326|3529448|B4||Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3687062|NCT02250326|3529449|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3687063|NCT02250326|3529450|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3687064|NCT02250326|3529451|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3687065|NCT02250326|3529448|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|207|207.0||||||
3687066|NCT02250326|3529449|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|63|63.0||||||
3687067|NCT02250326|3529450|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|77|77.0||||||
3687068|NCT02250326|3529451|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|67|67.0||||||
3687069|NCT02250326|3529448|B4||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3687070|NCT02250326|3529449|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3687071|NCT02250326|3529450|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3687072|NCT02250326|3529451|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3687073|NCT02250326|3529448|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3687074|NCT02250326|3529449|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3687075|NCT02250326|3529450|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3687076|NCT02250326|3529451|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3687077|NCT02250326|3529448|B4||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3687078|NCT02250326|3529449|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3687079|NCT02250326|3529450|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3687080|NCT02250326|3529451|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3687081|NCT02250326|3529448|B4||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3687082|NCT02250326|3529449|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3687083|NCT02250326|3529450|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3687084|NCT02250326|3529451|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3687085|NCT02250326|3529448|B4|||Age||years|Mean|63.1|63.1|Standard Deviation|9.77|9.77|||
3687086|NCT02250326|3529449|B3|||Age||years|Mean|62.6|62.6|Standard Deviation|9.58|9.58|||
3687087|NCT02250326|3529450|B2|||Age||years|Mean|62.7|62.7|Standard Deviation|10.74|10.74|||
3687088|NCT02250326|3529451|B1|||Age||years|Mean|64.0|64.0|Standard Deviation|9.00|9.0|||
3687089|NCT02250274|3529484|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3687090|NCT02250274|3529485|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3687091|NCT02250274|3529486|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3687092|NCT02250274|3529484|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3687093|NCT02250274|3529485|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3687094|NCT02250274|3529486|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3687095|NCT02250274|3529484|B3|||Age||YEARS|Mean|11|11.0|Standard Deviation|3.2|3.2|||
3687096|NCT02250274|3529485|B2|||Age||YEARS|Mean|12|12.0|Standard Deviation|2.5|2.5|||
3687097|NCT02250274|3529486|B1|||Age||YEARS|Mean|10|10.0|Standard Deviation|3.2|3.2|||
3687098|NCT02249819|3529503|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3687099|NCT02249819|3529503|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687100|NCT02249819|3529503|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687101|NCT02249819|3529503|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3687102|NCT02249819|3529503|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3687103|NCT02249819|3529503|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687104|NCT02249819|3529503|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687105|NCT02249819|3529503|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687112|NCT02249728|3529510|B1|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3687113|NCT02249728|3529510|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687114|NCT02249728|3529510|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687115|NCT02249728|3529510|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3687116|NCT02249728|3529510|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687117|NCT02249728|3529510|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687118|NCT02249728|3529510|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687119|NCT02249728|3529510|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687120|NCT02249728|3529510|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3687121|NCT02249728|3529510|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3687122|NCT02249728|3529510|B1|||Age||years|Mean|51.8|51.8|Standard Deviation|5.9|5.9|||
3687123|NCT02249585|3529520|B4|South Korea||Region of Enrollment||Participants|Count of Participants|131|131.0||||||
3687124|NCT02249585|3529521|B3|South Korea||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3687125|NCT02249585|3529522|B2|South Korea||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3687126|NCT02249585|3529523|B1|South Korea||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
3687127|NCT02249585|3529520|B4||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3687128|NCT02249585|3529521|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3687129|NCT02249585|3529522|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3687130|NCT02249585|3529523|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3687131|NCT02249585|3529520|B4||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3687132|NCT02249585|3529521|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3687133|NCT02249585|3529522|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3687134|NCT02249585|3529523|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3687135|NCT02249585|3529520|B4|||Age||years|Mean|65|65.0|Standard Deviation|12|12.0|||
3687136|NCT02249585|3529521|B3|||Age||years|Mean|62|62.0|Standard Deviation|11|11.0|||
3687137|NCT02249585|3529522|B2|||Age||years|Mean|64|64.0|Standard Deviation|11|11.0|||
3687138|NCT02249585|3529523|B1|||Age||years|Mean|67|67.0|Standard Deviation|12|12.0|||
3687139|NCT02249143|3529548|B3|United States||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3687140|NCT02249143|3529549|B2|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3687141|NCT02249143|3529550|B1|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3687142|NCT02249143|3529548|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3687143|NCT02249143|3529549|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3687144|NCT02249143|3529550|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3687145|NCT02249143|3529548|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3687146|NCT02249143|3529549|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3687147|NCT02249143|3529550|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3687148|NCT02249143|3529548|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3687149|NCT02249143|3529549|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3687150|NCT02249143|3529550|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3687151|NCT02249143|3529548|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3687152|NCT02249143|3529549|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3687153|NCT02249143|3529550|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3687154|NCT02249143|3529548|B3||<=18 years|Age||Participants|Count of Participants|44|44.0||||||
3687155|NCT02249143|3529549|B2||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
3687156|NCT02249143|3529550|B1||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
3687157|NCT02249104|3529557|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
3687158|NCT02249104|3529557|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3687159|NCT02249104|3529557|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3687160|NCT02249104|3529557|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3687161|NCT02249104|3529557|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3687162|NCT02249104|3529557|B1||<=18 years|Age||Participants|Count of Participants|27|27.0||||||
3687163|NCT02249065|3529566|B1|United States||Region of Enrollment||Participants|Count of Participants|181|181.0||||||
3687164|NCT02249065|3529566|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3687165|NCT02249065|3529566|B1||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3687166|NCT02249065|3529566|B1|||Age||years|Mean|52.4|52.4|Full Range|||22.0|85.0|
3687167|NCT02249065|3529566|B1||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
3687168|NCT02249065|3529566|B1||Between 18 and 65 years|Age||Participants|Count of Participants|143|143.0||||||
3687169|NCT02249065|3529566|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3687170|NCT02249052|3529574|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687171|NCT02249052|3529574|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687172|NCT02249052|3529574|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3687173|NCT02249052|3529574|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3687174|NCT02249052|3529574|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687175|NCT02249052|3529574|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687176|NCT02249052|3529574|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687177|NCT02249052|3529574|B1||Male|Gender||Participants|Count of Participants|15|15.0||||||
3687178|NCT02249052|3529574|B1||Female|Gender||Participants|Count of Participants|4|4.0||||||
3687179|NCT02249052|3529574|B1|||Age||years|Mean|49.9|49.9|Standard Deviation|9.13|9.13|||
3687180|NCT02248922|3529590|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687181|NCT02248922|3529591|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687182|NCT02248922|3529592|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687183|NCT02248922|3529590|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687184|NCT02248922|3529591|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687185|NCT02248922|3529592|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687186|NCT02248922|3529590|B3||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3687187|NCT02248922|3529591|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3687188|NCT02248922|3529592|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3687189|NCT02248922|3529590|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687190|NCT02248922|3529591|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687191|NCT02248922|3529592|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687192|NCT02248922|3529590|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687193|NCT02248922|3529591|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687194|NCT02248922|3529592|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687195|NCT02248922|3529590|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687196|NCT02248922|3529591|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687197|NCT02248922|3529592|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687198|NCT02248922|3529590|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687199|NCT02248922|3529591|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687200|NCT02248922|3529592|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687201|NCT02248922|3529590|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3687202|NCT02248922|3529591|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3687203|NCT02248922|3529592|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3687204|NCT02248922|3529590|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3687205|NCT02248922|3529591|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3687206|NCT02248922|3529592|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3687207|NCT02248922|3529590|B3|||Age||years|Mean|26.4|26.4|Standard Deviation|9.99|9.99|||
3687208|NCT02248922|3529591|B2|||Age||years|Mean|28.9|28.9|Standard Deviation|9.79|9.79|||
3687209|NCT02248922|3529592|B1|||Age||years|Mean|20.2|20.2|Standard Deviation|8.26|8.26|||
3687210|NCT02248818|3529604|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687211|NCT02248818|3529605|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687212|NCT02248818|3529606|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687213|NCT02248818|3529607|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687214|NCT02248818|3529608|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687215|NCT02248818|3529609|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687216|NCT02248818|3529610|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687217|NCT02248818|3529611|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687218|NCT02248818|3529612|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687219|NCT02248818|3529604|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3687220|NCT02248818|3529605|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3687221|NCT02248818|3529606|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687222|NCT02248818|3529607|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3687223|NCT02248818|3529608|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3687224|NCT02248818|3529609|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3687225|NCT02248818|3529610|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3687226|NCT02248818|3529611|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687227|NCT02248818|3529612|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3687228|NCT02248818|3529604|B9||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3687229|NCT02248818|3529605|B8||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3687230|NCT02248818|3529606|B7||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3687231|NCT02248818|3529607|B6||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3687232|NCT02248818|3529608|B5||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3687233|NCT02248818|3529609|B4||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3687234|NCT02248818|3529610|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3687235|NCT02248818|3529611|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3687236|NCT02248818|3529612|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3687237|NCT02248818|3529604|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3687238|NCT02248818|3529605|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3687239|NCT02248818|3529606|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3687240|NCT02248818|3529607|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3687241|NCT02248818|3529608|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3687242|NCT02248818|3529609|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3687243|NCT02248818|3529610|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3687244|NCT02248818|3529611|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3687245|NCT02248818|3529612|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3687246|NCT02248818|3529604|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687247|NCT02248818|3529605|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687248|NCT02248818|3529606|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687249|NCT02248818|3529607|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687250|NCT02248818|3529608|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687251|NCT02248818|3529609|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687252|NCT02248818|3529610|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687253|NCT02248818|3529611|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687254|NCT02248818|3529612|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687255|NCT02248818|3529604|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3687256|NCT02248818|3529605|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687257|NCT02248818|3529606|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687258|NCT02248818|3529607|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3687259|NCT02248818|3529608|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3687260|NCT02248818|3529609|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687261|NCT02248818|3529610|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687262|NCT02248818|3529611|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687263|NCT02248818|3529612|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687264|NCT02248818|3529604|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687265|NCT02248818|3529605|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687266|NCT02248818|3529606|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687267|NCT02248818|3529607|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687268|NCT02248818|3529608|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687269|NCT02248818|3529609|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687270|NCT02248818|3529610|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687271|NCT02248818|3529611|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687272|NCT02248818|3529612|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687273|NCT02248818|3529604|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3687274|NCT02248818|3529605|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3687275|NCT02248818|3529606|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3687276|NCT02248818|3529607|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687277|NCT02248818|3529608|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687278|NCT02248818|3529609|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687279|NCT02248818|3529610|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687280|NCT02248818|3529611|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687281|NCT02248818|3529612|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687282|NCT02248818|3529604|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3687283|NCT02248818|3529605|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3687284|NCT02248818|3529606|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3687285|NCT02248818|3529607|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3687286|NCT02248818|3529608|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3687287|NCT02248818|3529609|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3687288|NCT02248818|3529610|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3687289|NCT02248818|3529611|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3687290|NCT02248818|3529612|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3687291|NCT02248818|3529604|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3687292|NCT02248818|3529605|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3687293|NCT02248818|3529606|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687294|NCT02248818|3529607|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3687295|NCT02248818|3529608|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3687296|NCT02248818|3529609|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3687297|NCT02248818|3529610|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3687298|NCT02248818|3529611|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687299|NCT02248818|3529612|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3687300|NCT02248818|3529604|B9||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3687301|NCT02248818|3529605|B8||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3687302|NCT02248818|3529606|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3687303|NCT02248818|3529607|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3687304|NCT02248818|3529608|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3687305|NCT02248818|3529609|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3687306|NCT02248818|3529610|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3687307|NCT02248818|3529611|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3687308|NCT02248818|3529612|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3687309|NCT02248818|3529604|B9||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3687310|NCT02248818|3529605|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3687311|NCT02248818|3529606|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3687312|NCT02248818|3529607|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3687313|NCT02248818|3529608|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3687314|NCT02248818|3529609|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3687315|NCT02248818|3529610|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3687316|NCT02248818|3529611|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3687317|NCT02248818|3529612|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3687318|NCT02248818|3529604|B9|||Age||Years|Mean|36.0|36.0|Standard Deviation|9.62|9.62|||
3687319|NCT02248818|3529605|B8|||Age||Years|Mean|39.3|39.3|Standard Deviation|9.22|9.22|||
3687320|NCT02248818|3529606|B7|||Age||Years|Mean|31.2|31.2|Standard Deviation|2.64|2.64|||
3687321|NCT02248818|3529607|B6|||Age||Years|Mean|35.4|35.4|Standard Deviation|10.31|10.31|||
3687322|NCT02248818|3529608|B5|||Age||Years|Mean|36.7|36.7|Standard Deviation|7.89|7.89|||
3687323|NCT02248818|3529609|B4|||Age||Years|Mean|38.0|38.0|Standard Deviation|10.53|10.53|||
3687324|NCT02248818|3529610|B3|||Age||Years|Mean|38.7|38.7|Standard Deviation|10.53|10.53|||
3687325|NCT02248818|3529611|B2|||Age||Years|Mean|36.3|36.3|Standard Deviation|12.55|12.55|||
3687326|NCT02248818|3529612|B1|||Age||Years|Mean|36.0|36.0|Standard Deviation|10.81|10.81|||
3687327|NCT02248766|3529758|B1|Spain||Region of Enrollment||participants|Number|30|30.0||||||
3687328|NCT02248766|3529758|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3687329|NCT02248766|3529758|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3687330|NCT02248766|3529758|B1|||Age||years|Mean|23.4|23.4|Standard Deviation|2.7|2.7|||
3687331|NCT02248727|3529770|B1|Spain||Region of Enrollment||participants|Number|30|30.0||||||
3687332|NCT02248727|3529770|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3687333|NCT02248727|3529770|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3687334|NCT02248727|3529770|B1|||Age||years|Mean|22.10|22.1|Standard Deviation|2.02|2.02|||
3687335|NCT02248675|3529781|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
3687336|NCT02248675|3529782|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
3687337|NCT02248675|3529783|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
3687338|NCT02248675|3529781|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3687339|NCT02248675|3529782|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3687340|NCT02248675|3529783|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687341|NCT02248675|3529781|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3687342|NCT02248675|3529782|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3687343|NCT02248675|3529783|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3687344|NCT02248675|3529781|B3||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3687345|NCT02248675|3529782|B2||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3687346|NCT02248675|3529783|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3687347|NCT02248675|3529781|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3687348|NCT02248675|3529782|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3687349|NCT02248675|3529783|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3687350|NCT02248675|3529781|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687351|NCT02248675|3529782|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687352|NCT02248675|3529783|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687353|NCT02248675|3529781|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687354|NCT02248675|3529782|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687355|NCT02248675|3529783|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687356|NCT02248675|3529781|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3687357|NCT02248675|3529782|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687358|NCT02248675|3529783|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3687359|NCT02248675|3529781|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687360|NCT02248675|3529782|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687361|NCT02248675|3529783|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687362|NCT02248675|3529781|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3687363|NCT02248675|3529782|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3687364|NCT02248675|3529783|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3687365|NCT02248675|3529781|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3687366|NCT02248675|3529782|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3687367|NCT02248675|3529783|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3687368|NCT02248675|3529781|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3687369|NCT02248675|3529782|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3687370|NCT02248675|3529783|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3687371|NCT02248675|3529781|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3687372|NCT02248675|3529782|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3687373|NCT02248675|3529783|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3687374|NCT02248675|3529781|B3|||Age||years|Mean|55.4|55.4|Standard Deviation|12.5|12.5|||
3687375|NCT02248675|3529782|B2|||Age||years|Mean|57.2|57.2|Standard Deviation|10.8|10.8|||
3687376|NCT02248675|3529783|B1|||Age||years|Mean|53.9|53.9|Standard Deviation|14.1|14.1|||
3687377|NCT02248558|3529796|B3|Anal sex with a condom||Recent Condomless anal sex||Participants|Count of Participants|115|115.0||||||
3687378|NCT02248558|3529797|B2|Anal sex with a condom||Recent Condomless anal sex||Participants|Count of Participants|58|58.0||||||
3687379|NCT02248558|3529798|B1|Anal sex with a condom||Recent Condomless anal sex||Participants|Count of Participants|57|57.0||||||
3687380|NCT02248558|3529796|B3|Condomless anal sex||Recent Condomless anal sex||Participants|Count of Participants|51|51.0||||||
3687381|NCT02248558|3529797|B2|Condomless anal sex||Recent Condomless anal sex||Participants|Count of Participants|28|28.0||||||
3687382|NCT02248558|3529798|B1|Condomless anal sex||Recent Condomless anal sex||Participants|Count of Participants|23|23.0||||||
3687383|NCT02248558|3529796|B3|No recent sex||Recent Condomless anal sex||Participants|Count of Participants|105|105.0||||||
3687384|NCT02248558|3529797|B2|No recent sex||Recent Condomless anal sex||Participants|Count of Participants|47|47.0||||||
3687385|NCT02248558|3529798|B1|No recent sex||Recent Condomless anal sex||Participants|Count of Participants|58|58.0||||||
3687386|NCT02248558|3529796|B3|No||Ever used gay mobile application||Participants|Count of Participants|168|168.0||||||
3687387|NCT02248558|3529797|B2|No||Ever used gay mobile application||Participants|Count of Participants|71|71.0||||||
3687388|NCT02248558|3529798|B1|No||Ever used gay mobile application||Participants|Count of Participants|97|97.0||||||
3687389|NCT02248558|3529796|B3|Yes||Ever used gay mobile application||Participants|Count of Participants|542|542.0||||||
3687390|NCT02248558|3529797|B2|Yes||Ever used gay mobile application||Participants|Count of Participants|275|275.0||||||
3687391|NCT02248558|3529798|B1|Yes||Ever used gay mobile application||Participants|Count of Participants|267|267.0||||||
3687392|NCT02248558|3529796|B3|No||Sexual orientation disclosure||Participants|Count of Participants|312|312.0||||||
3687393|NCT02248558|3529797|B2|No||Sexual orientation disclosure||Participants|Count of Participants|153|153.0||||||
3687394|NCT02248558|3529798|B1|No||Sexual orientation disclosure||Participants|Count of Participants|159|159.0||||||
3687395|NCT02248558|3529796|B3|Yes||Sexual orientation disclosure||Participants|Count of Participants|409|409.0||||||
3687396|NCT02248558|3529797|B2|Yes||Sexual orientation disclosure||Participants|Count of Participants|199|199.0||||||
3687397|NCT02248558|3529798|B1|Yes||Sexual orientation disclosure||Participants|Count of Participants|210|210.0||||||
3687398|NCT02248558|3529796|B3|Separated/divorced/Widowed||Marital status||Participants|Count of Participants|25|25.0||||||
3687399|NCT02248558|3529797|B2|Separated/divorced/Widowed||Marital status||Participants|Count of Participants|10|10.0||||||
3687400|NCT02248558|3529798|B1|Separated/divorced/Widowed||Marital status||Participants|Count of Participants|15|15.0||||||
3687401|NCT02248558|3529796|B3|Married/Engaged||Marital status||Participants|Count of Participants|89|89.0||||||
3687402|NCT02248558|3529797|B2|Married/Engaged||Marital status||Participants|Count of Participants|39|39.0||||||
3687403|NCT02248558|3529798|B1|Married/Engaged||Marital status||Participants|Count of Participants|50|50.0||||||
3687404|NCT02248558|3529796|B3|Never married||Marital status||Participants|Count of Participants|615|615.0||||||
3687405|NCT02248558|3529797|B2|Never married||Marital status||Participants|Count of Participants|311|311.0||||||
3687406|NCT02248558|3529798|B1|Never married||Marital status||Participants|Count of Participants|304|304.0||||||
3687407|NCT02248558|3529796|B3|>15000||Annual Income (SD)||Participants|Count of Participants|30|30.0||||||
3687408|NCT02248558|3529797|B2|>15000||Annual Income (SD)||Participants|Count of Participants|14|14.0||||||
3687409|NCT02248558|3529798|B1|>15000||Annual Income (SD)||Participants|Count of Participants|16|16.0||||||
3687410|NCT02248558|3529796|B3|9501-15000||Annual Income (SD)||Participants|Count of Participants|75|75.0||||||
3687411|NCT02248558|3529797|B2|9501-15000||Annual Income (SD)||Participants|Count of Participants|37|37.0||||||
3687412|NCT02248558|3529798|B1|9501-15000||Annual Income (SD)||Participants|Count of Participants|38|38.0||||||
3687413|NCT02248558|3529796|B3|6001-9500||Annual Income (SD)||Participants|Count of Participants|169|169.0||||||
3687414|NCT02248558|3529797|B2|6001-9500||Annual Income (SD)||Participants|Count of Participants|84|84.0||||||
3687415|NCT02248558|3529798|B1|6001-9500||Annual Income (SD)||Participants|Count of Participants|85|85.0||||||
3687416|NCT02248558|3529796|B3|3000-6000||Annual Income (SD)||Participants|Count of Participants|206|206.0||||||
3687417|NCT02248558|3529797|B2|3000-6000||Annual Income (SD)||Participants|Count of Participants|104|104.0||||||
3687418|NCT02248558|3529798|B1|3000-6000||Annual Income (SD)||Participants|Count of Participants|102|102.0||||||
3687419|NCT02248558|3529796|B3|<3000||Annual Income (SD)||Participants|Count of Participants|241|241.0||||||
3687420|NCT02248558|3529797|B2|<3000||Annual Income (SD)||Participants|Count of Participants|113|113.0||||||
3687421|NCT02248558|3529798|B1|<3000||Annual Income (SD)||Participants|Count of Participants|128|128.0||||||
3687422|NCT02248558|3529796|B3|Graduate Education||Education||Participants|Count of Participants|38|38.0||||||
3687423|NCT02248558|3529797|B2|Graduate Education||Education||Participants|Count of Participants|13|13.0||||||
3687424|NCT02248558|3529798|B1|Graduate Education||Education||Participants|Count of Participants|25|25.0||||||
3687425|NCT02248558|3529796|B3|College||Education||Participants|Count of Participants|470|470.0||||||
3687426|NCT02248558|3529797|B2|College||Education||Participants|Count of Participants|231|231.0||||||
3687427|NCT02248558|3529798|B1|College||Education||Participants|Count of Participants|239|239.0||||||
3687428|NCT02248558|3529796|B3|High School or below||Education||Participants|Count of Participants|213|213.0||||||
3687429|NCT02248558|3529797|B2|High School or below||Education||Participants|Count of Participants|108|108.0||||||
3687430|NCT02248558|3529798|B1|High School or below||Education||Participants|Count of Participants|105|105.0||||||
3687431|NCT02248558|3529796|B3|Transgender||Sex/Gender, Customized||Participants|Count of Participants|36|36.0||||||
3687432|NCT02248558|3529797|B2|Transgender||Sex/Gender, Customized||Participants|Count of Participants|18|18.0||||||
3687433|NCT02248558|3529798|B1|Transgender||Sex/Gender, Customized||Participants|Count of Participants|18|18.0||||||
3687434|NCT02248558|3529796|B3|Male||Sex/Gender, Customized||Participants|Count of Participants|685|685.0||||||
3687435|NCT02248558|3529797|B2|Male||Sex/Gender, Customized||Participants|Count of Participants|334|334.0||||||
3687436|NCT02248558|3529798|B1|Male||Sex/Gender, Customized||Participants|Count of Participants|351|351.0||||||
3687437|NCT02248558|3529796|B3|>35||Age, Customized||Participants|Count of Participants|45|45.0||||||
3687438|NCT02248558|3529797|B2|>35||Age, Customized||Participants|Count of Participants|18|18.0||||||
3687439|NCT02248558|3529798|B1|>35||Age, Customized||Participants|Count of Participants|27|27.0||||||
3687440|NCT02248558|3529796|B3|31-35||Age, Customized||Participants|Count of Participants|66|66.0||||||
3687441|NCT02248558|3529797|B2|31-35||Age, Customized||Participants|Count of Participants|28|28.0||||||
3687442|NCT02248558|3529798|B1|31-35||Age, Customized||Participants|Count of Participants|38|38.0||||||
3687443|NCT02248558|3529796|B3|26-30||Age, Customized||Participants|Count of Participants|112|112.0||||||
3687444|NCT02248558|3529797|B2|26-30||Age, Customized||Participants|Count of Participants|50|50.0||||||
3687445|NCT02248558|3529798|B1|26-30||Age, Customized||Participants|Count of Participants|62|62.0||||||
3687446|NCT02248558|3529796|B3|21-25||Age, Customized||Participants|Count of Participants|266|266.0||||||
3687447|NCT02248558|3529797|B2|21-25||Age, Customized||Participants|Count of Participants|136|136.0||||||
3687448|NCT02248558|3529798|B1|21-25||Age, Customized||Participants|Count of Participants|130|130.0||||||
3687449|NCT02248558|3529796|B3|16-20||Age, Customized||Participants|Count of Participants|234|234.0||||||
3687450|NCT02248558|3529797|B2|16-20||Age, Customized||Participants|Count of Participants|120|120.0||||||
3687451|NCT02248558|3529798|B1|16-20||Age, Customized||Participants|Count of Participants|114|114.0||||||
3687452|NCT02248480|3529809|B3|Japan||Region of Enrollment||participants|Number|353|353.0||||||
3687453|NCT02248480|3529810|B2|Japan||Region of Enrollment||participants|Number|176|176.0||||||
3687454|NCT02248480|3529811|B1|Japan||Region of Enrollment||participants|Number|177|177.0||||||
3687455|NCT02248480|3529809|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687456|NCT02248480|3529810|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687457|NCT02248480|3529811|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687458|NCT02248480|3529809|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687459|NCT02248480|3529810|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687460|NCT02248480|3529811|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687461|NCT02248480|3529809|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687462|NCT02248480|3529810|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687463|NCT02248480|3529811|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687464|NCT02248480|3529809|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687465|NCT02248480|3529810|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687466|NCT02248480|3529811|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687467|NCT02248480|3529809|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687468|NCT02248480|3529810|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687469|NCT02248480|3529811|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687470|NCT02248480|3529809|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|353|353.0||||||
3687471|NCT02248480|3529810|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|176|176.0||||||
3687472|NCT02248480|3529811|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|177|177.0||||||
3687473|NCT02248480|3529809|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687474|NCT02248480|3529810|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687475|NCT02248480|3529811|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687476|NCT02248480|3529809|B3||Male|Gender||Participants|Count of Participants|79|79.0||||||
3687477|NCT02248480|3529810|B2||Male|Gender||Participants|Count of Participants|44|44.0||||||
3687478|NCT02248480|3529811|B1||Male|Gender||Participants|Count of Participants|35|35.0||||||
3687479|NCT02248480|3529809|B3||Female|Gender||Participants|Count of Participants|274|274.0||||||
3687480|NCT02248480|3529810|B2||Female|Gender||Participants|Count of Participants|132|132.0||||||
3687481|NCT02248480|3529811|B1||Female|Gender||Participants|Count of Participants|142|142.0||||||
3687482|NCT02248480|3529809|B3|||Age||years|Mean|65.9|65.9|Standard Deviation|8.2|8.2|||
3687483|NCT02248480|3529810|B2|||Age||years|Mean|66.4|66.4|Standard Deviation|8.4|8.4|||
3687484|NCT02248480|3529811|B1|||Age||years|Mean|65.5|65.5|Standard Deviation|8.0|8.0|||
3687485|NCT02248285|3529850|B3|United States||Region of Enrollment||participants|Number|1157|1157.0||||||
3687486|NCT02248285|3529851|B2|United States||Region of Enrollment||participants|Number|571|571.0||||||
3687487|NCT02248285|3529852|B1|United States||Region of Enrollment||participants|Number|586|586.0||||||
3687488|NCT02248285|3529850|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3687489|NCT02248285|3529850|B3||Male|Sex: Female, Male||Participants|Count of Participants|585|585.0||||||
3687490|NCT02248285|3529851|B2||Male|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
3687491|NCT02248285|3529852|B1||Male|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
3687492|NCT02248285|3529850|B3||Female|Sex: Female, Male||Participants|Count of Participants|572|572.0||||||
3687493|NCT02248285|3529851|B2||Female|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
3687494|NCT02248285|3529852|B1||Female|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
3687495|NCT02248285|3529850|B3|||Age||years|Median|2.8|2.8|Inter-Quartile Range|||1.2|7.8|
3687496|NCT02248285|3529851|B2|||Age||years|Median|3|3.0|Inter-Quartile Range|||1.2|7.0|
3687497|NCT02248285|3529852|B1|||Age||years|Median|2.7|2.7|Inter-Quartile Range|||1.2|7.8|
3687498|NCT02248285|3529850|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3687499|NCT02248285|3529851|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3687500|NCT02248285|3529852|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3687501|NCT02248285|3529850|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3687502|NCT02248285|3529851|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3687503|NCT02248285|3529852|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3687504|NCT02248285|3529850|B3||<=18 years|Age||Participants|Count of Participants|1157|1157.0||||||
3687505|NCT02248285|3529851|B2||<=18 years|Age||Participants|Count of Participants|571|571.0||||||
3687506|NCT02248285|3529852|B1||<=18 years|Age||Participants|Count of Participants|586|586.0||||||
3687507|NCT02248246|3529859|B1|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
3687508|NCT02248246|3529859|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3687509|NCT02248246|3529859|B1|Belgium||Region of Enrollment||participants|Number|15|15.0||||||
3687510|NCT02248246|3529859|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687511|NCT02248246|3529859|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687512|NCT02248246|3529859|B1||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3687513|NCT02248246|3529859|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687514|NCT02248246|3529859|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687515|NCT02248246|3529859|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687516|NCT02248246|3529859|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687517|NCT02248246|3529859|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3687518|NCT02248246|3529859|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3687519|NCT02248246|3529859|B1|||Age||years|Mean|59.8|59.8|Standard Deviation|13.3|13.3|||
3687520|NCT02248103|3529864|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3687521|NCT02248103|3529865|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3687522|NCT02248103|3529866|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3687523|NCT02248103|3529864|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3687524|NCT02248103|3529865|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3687525|NCT02248103|3529866|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3687526|NCT02248103|3529864|B3|||Age||years|Mean|37.81|37.81|Standard Deviation|8.3|8.3|||
3687527|NCT02248103|3529865|B2|||Age||years|Mean|37.81|37.81|Standard Deviation|8.3|8.3|||
3687528|NCT02248103|3529866|B1|||Age||years|Mean|37.81|37.81|Standard Deviation|8.3|8.3|||
3687529|NCT02248103|3529864|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3687530|NCT02248103|3529865|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3687531|NCT02248103|3529866|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3687532|NCT02248103|3529864|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3687533|NCT02248103|3529865|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3687534|NCT02248103|3529866|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3687535|NCT02248103|3529864|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3687536|NCT02248103|3529865|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3687537|NCT02248103|3529866|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3687538|NCT02247960|3529877|B3|United States||Region of Enrollment||participants|Number|167|167.0||||||
3687539|NCT02247960|3529878|B2|United States||Region of Enrollment||participants|Number|84|84.0||||||
3687540|NCT02247960|3529879|B1|United States||Region of Enrollment||participants|Number|83|83.0||||||
3687541|NCT02247960|3529877|B3||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3687542|NCT02247960|3529878|B2||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3687543|NCT02247960|3529879|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3687544|NCT02247960|3529877|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3687545|NCT02247960|3529878|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3687546|NCT02247960|3529879|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3687547|NCT02247960|3529877|B3|||Age||years|Mean|62.8|62.8|Standard Deviation|6.8|6.8|||
3687548|NCT02247960|3529878|B2|||Age||years|Mean|62.98|62.98|Standard Deviation|6.82|6.82|||
3687549|NCT02247960|3529879|B1|||Age||years|Mean|62.49|62.49|Standard Deviation|6.86|6.86|||
3687550|NCT02247765|3529890|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3687551|NCT02247765|3529890|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3687552|NCT02247765|3529890|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687553|NCT02247765|3529890|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3687554|NCT02247765|3529890|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3687555|NCT02247765|3529890|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687556|NCT02247765|3529890|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3687557|NCT02247765|3529890|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687558|NCT02247765|3529890|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3687559|NCT02247765|3529890|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3687560|NCT02247765|3529890|B1|||Age||years|Mean|33.67|33.67|Standard Deviation|8.25|8.25|||
3687561|NCT02247739|3529895|B1|Israel||Region of Enrollment||participants|Number|4|4.0||||||
3687562|NCT02247739|3529895|B1|Serbia||Region of Enrollment||participants|Number|2|2.0||||||
3687563|NCT02247739|3529895|B1|Italy||Region of Enrollment||participants|Number|1|1.0||||||
3687564|NCT02247739|3529895|B1|Macedonia, The Former Yugoslav Republic of||Region of Enrollment||participants|Number|8|8.0||||||
3687565|NCT02247739|3529895|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3687566|NCT02247739|3529895|B1|Romania||Region of Enrollment||participants|Number|6|6.0||||||
3687567|NCT02247739|3529895|B1|Czech Republic||Region of Enrollment||participants|Number|2|2.0||||||
3687568|NCT02247739|3529895|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
3687569|NCT02247739|3529895|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3687570|NCT02247739|3529895|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3687571|NCT02247739|3529895|B1|||Age||years|Mean|46|46.0|Full Range|||17.0|74.0|
3687572|NCT02247739|3529895|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3687573|NCT02247739|3529895|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3687574|NCT02247739|3529895|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3687575|NCT02247401|3529916|B4||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3687576|NCT02247401|3529917|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3687577|NCT02247401|3529918|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3687578|NCT02247401|3529919|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3687579|NCT02247401|3529916|B4||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3687580|NCT02247401|3529917|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3687581|NCT02247401|3529918|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3687582|NCT02247401|3529919|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3687583|NCT02247401|3529916|B4|||Age||years|Mean|51.6|51.6|Standard Deviation|11.91|11.91|||
3687584|NCT02247401|3529917|B3|||Age||years|Mean|55.8|55.8|Standard Deviation|8.02|8.02|||
3687585|NCT02247401|3529918|B2|||Age||years|Mean|57.3|57.3|Standard Deviation|6.48|6.48|||
3687586|NCT02247401|3529919|B1|||Age||years|Mean|48.6|48.6|Standard Deviation|13.14|13.14|||
3687587|NCT02247063|3529938|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
3687588|NCT02247063|3529939|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3687589|NCT02247063|3529940|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3687590|NCT02247063|3529938|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3687591|NCT02247063|3529939|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3687592|NCT02247063|3529940|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3687593|NCT02247063|3529938|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3687594|NCT02247063|3529939|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3687595|NCT02247063|3529940|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3687596|NCT02247063|3529938|B3|||Age||years|Mean|35.2|35.2|Standard Deviation|15.0|15.0|||
3687597|NCT02247063|3529939|B2|||Age||years|Mean|34.8|34.8|Standard Deviation|13.7|13.7|||
3687598|NCT02247063|3529940|B1|||Age||years|Mean|35.6|35.6|Standard Deviation|16.7|16.7|||
3687599|NCT02247063|3529938|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3687600|NCT02247063|3529939|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3687601|NCT02247063|3529940|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3687602|NCT02247063|3529938|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3687603|NCT02247063|3529939|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3687604|NCT02247063|3529940|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3687605|NCT02247063|3529938|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3687606|NCT02247063|3529939|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3687607|NCT02247063|3529940|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3687608|NCT02247011|3529949|B3|||Body mass index||kg/m^2|Mean|25.46|25.46|Standard Deviation|4.82|4.82|||
3687609|NCT02247011|3529950|B2|||Body mass index||kg/m^2|Mean|25.47|25.47|Standard Deviation|4.85|4.85|||
3687610|NCT02247011|3529951|B1|||Body mass index||kg/m^2|Mean|25.21|25.21|Standard Deviation|5.04|5.04|||
3687611|NCT02247011|3529949|B3|No previous osteoporotic fracture||Previous osteoporotic fracture||participants|Number|615|615.0||||||
3687612|NCT02247011|3529950|B2|No previous osteoporotic fracture||Previous osteoporotic fracture||participants|Number|576|576.0||||||
3687613|NCT02247011|3529951|B1|No previous osteoporotic fracture||Previous osteoporotic fracture||participants|Number|39|39.0||||||
3687614|NCT02247011|3529949|B3|Previous osteoporotic fracture||Previous osteoporotic fracture||participants|Number|360|360.0||||||
3687615|NCT02247011|3529950|B2|Previous osteoporotic fracture||Previous osteoporotic fracture||participants|Number|288|288.0||||||
3687616|NCT02247011|3529951|B1|Previous osteoporotic fracture||Previous osteoporotic fracture||participants|Number|72|72.0||||||
3687617|NCT02247011|3529949|B3|||Years since menopause||years|Median|16.92|16.92|Inter-Quartile Range|||9.98|25.28|
3687618|NCT02247011|3529950|B2|||Years since menopause||years|Median|16.43|16.43|Inter-Quartile Range|||9.52|24.9|
3687619|NCT02247011|3529951|B1|||Years since menopause||years|Median|21.36|21.36|Inter-Quartile Range|||12.87|29.59|
3687620|NCT02247011|3529949|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3687621|NCT02247011|3529950|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3687622|NCT02247011|3529951|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3687623|NCT02247011|3529949|B3||Female|Sex: Female, Male||Participants|Count of Participants|975|975.0||||||
3687624|NCT02247011|3529950|B2||Female|Sex: Female, Male||Participants|Count of Participants|864|864.0||||||
3687625|NCT02247011|3529951|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3687626|NCT02247011|3529949|B3|||Age||years|Median|66.72|66.72|Inter-Quartile Range|||60.09|74.66|
3687627|NCT02247011|3529950|B2|||Age||years|Median|66.09|66.09|Inter-Quartile Range|||59.84|74.59|
3687628|NCT02247011|3529951|B1|||Age||years|Median|70.08|70.08|Inter-Quartile Range|||64.23|76.81|
3687629|NCT02246998|3529968|B5|||CD4 Cell Count||cells/uL|Mean|557|557.0|Standard Deviation|197.8|197.8|||
3687630|NCT02246998|3529969|B4|||CD4 Cell Count||cells/uL|Mean|524|524.0|Standard Deviation|190.0|190.0|||
3687631|NCT02246998|3529970|B3|||CD4 Cell Count||cells/uL|Mean|553|553.0|Standard Deviation|215.8|215.8|||
3687632|NCT02246998|3529971|B2|||CD4 Cell Count||cells/uL|Mean|600|600.0|Standard Deviation|217.9|217.9|||
3687633|NCT02246998|3529972|B1|||CD4 Cell Count||cells/uL|Mean|552|552.0|Standard Deviation|177.8|177.8|||
3687634|NCT02246998|3529968|B5|||Estimated Glomerular Filtration Rate by MDRD Formula||mL/min/1.73m2|Mean|107.0|107.0|Standard Deviation|16.71|16.71|||
3687635|NCT02246998|3529969|B4|||Estimated Glomerular Filtration Rate by MDRD Formula||mL/min/1.73m2|Mean|105.5|105.5|Standard Deviation|12.59|12.59|||
3687636|NCT02246998|3529970|B3|||Estimated Glomerular Filtration Rate by MDRD Formula||mL/min/1.73m2|Mean|108.4|108.4|Standard Deviation|21.42|21.42|||
3687637|NCT02246998|3529971|B2|||Estimated Glomerular Filtration Rate by MDRD Formula||mL/min/1.73m2|Mean|110.6|110.6|Standard Deviation|18.47|18.47|||
3687638|NCT02246998|3529972|B1|||Estimated Glomerular Filtration Rate by MDRD Formula||mL/min/1.73m2|Mean|103.8|103.8|Standard Deviation|14.06|14.06|||
3687639|NCT02246998|3529968|B5|||Estimated Glomerular Filtration Rate by Cockcroft-Gault||mL/min|Mean|121.0|121.0|Standard Deviation|19.55|19.55|||
3687695|NCT02246998|3529969|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3687640|NCT02246998|3529969|B4|||Estimated Glomerular Filtration Rate by Cockcroft-Gault||mL/min|Mean|122.6|122.6|Standard Deviation|20.25|20.25|||
3687641|NCT02246998|3529970|B3|||Estimated Glomerular Filtration Rate by Cockcroft-Gault||mL/min|Mean|119.5|119.5|Standard Deviation|20.36|20.36|||
3687642|NCT02246998|3529971|B2|||Estimated Glomerular Filtration Rate by Cockcroft-Gault||mL/min|Mean|121.2|121.2|Standard Deviation|24.34|24.34|||
3687643|NCT02246998|3529972|B1|||Estimated Glomerular Filtration Rate by Cockcroft-Gault||mL/min|Mean|120.8|120.8|Standard Deviation|13.94|13.94|||
3687644|NCT02246998|3529968|B5|||Actual Glomerular Filtration Rate||mL/min|Mean|106.4|106.4|Standard Deviation|31.52|31.52|||
3687645|NCT02246998|3529969|B4|||Actual Glomerular Filtration Rate||mL/min|Mean|96.6|96.6|Standard Deviation|34.52|34.52|||
3687646|NCT02246998|3529970|B3|||Actual Glomerular Filtration Rate||mL/min|Mean|105.4|105.4|Standard Deviation|38.22|38.22|||
3687647|NCT02246998|3529971|B2|||Actual Glomerular Filtration Rate||mL/min|Mean|112.0|112.0|Standard Deviation|19.17|19.17|||
3687648|NCT02246998|3529972|B1|||Actual Glomerular Filtration Rate||mL/min|Mean|111.8|111.8|Standard Deviation|31.07|31.07|||
3687649|NCT02246998|3529968|B5|Spain||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3687650|NCT02246998|3529969|B4|Spain||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3687651|NCT02246998|3529970|B3|Spain||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3687652|NCT02246998|3529971|B2|Spain||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3687653|NCT02246998|3529972|B1|Spain||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3687654|NCT02246998|3529968|B5|United Kingdom||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3687655|NCT02246998|3529969|B4|United Kingdom||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3687656|NCT02246998|3529970|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3687657|NCT02246998|3529971|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3687658|NCT02246998|3529972|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3687659|NCT02246998|3529968|B5|Ireland||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3687660|NCT02246998|3529969|B4|Ireland||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3687661|NCT02246998|3529970|B3|Ireland||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3687662|NCT02246998|3529971|B2|Ireland||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3687663|NCT02246998|3529972|B1|Ireland||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3687664|NCT02246998|3529968|B5|Belgium||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3687665|NCT02246998|3529969|B4|Belgium||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3687666|NCT02246998|3529970|B3|Belgium||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3687667|NCT02246998|3529971|B2|Belgium||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3687668|NCT02246998|3529972|B1|Belgium||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3687669|NCT02246998|3529968|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|59|59.0||||||
3687670|NCT02246998|3529969|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3687671|NCT02246998|3529970|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3687672|NCT02246998|3529971|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3687673|NCT02246998|3529972|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3687674|NCT02246998|3529968|B5|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3687675|NCT02246998|3529969|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3687676|NCT02246998|3529970|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3687677|NCT02246998|3529971|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3687678|NCT02246998|3529972|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3687679|NCT02246998|3529968|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3687680|NCT02246998|3529969|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3687681|NCT02246998|3529970|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3687682|NCT02246998|3529971|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3687683|NCT02246998|3529972|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3687684|NCT02246998|3529968|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|56|56.0||||||
3687685|NCT02246998|3529969|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3687686|NCT02246998|3529970|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3687687|NCT02246998|3529971|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3687688|NCT02246998|3529972|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3687689|NCT02246998|3529968|B5|Black||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3687690|NCT02246998|3529969|B4|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3687691|NCT02246998|3529970|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3687692|NCT02246998|3529971|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3687693|NCT02246998|3529972|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3687694|NCT02246998|3529968|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3687696|NCT02246998|3529970|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3687697|NCT02246998|3529971|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3687698|NCT02246998|3529972|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3687699|NCT02246998|3529968|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3687700|NCT02246998|3529969|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3687701|NCT02246998|3529970|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3687702|NCT02246998|3529971|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3687703|NCT02246998|3529972|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3687704|NCT02246998|3529968|B5||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3687705|NCT02246998|3529969|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3687706|NCT02246998|3529970|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3687707|NCT02246998|3529971|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3687708|NCT02246998|3529972|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3687709|NCT02246998|3529968|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3687710|NCT02246998|3529969|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3687711|NCT02246998|3529970|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3687712|NCT02246998|3529971|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3687713|NCT02246998|3529972|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3687714|NCT02246998|3529968|B5|||Age||years|Mean|35|35.0|Standard Deviation|8.3|8.3|||
3687715|NCT02246998|3529969|B4|||Age||years|Mean|34|34.0|Standard Deviation|7.5|7.5|||
3687716|NCT02246998|3529970|B3|||Age||years|Mean|34|34.0|Standard Deviation|9.6|9.6|||
3687717|NCT02246998|3529971|B2|||Age||years|Mean|34|34.0|Standard Deviation|8.4|8.4|||
3687718|NCT02246998|3529972|B1|||Age||years|Mean|36|36.0|Standard Deviation|8.1|8.1|||
3687719|NCT02246777|3530085|B1|||Intraocular Pressure (IOP)|IOP (fluid pressure inside the eye) was assessed using Goldmann applanation tonometry and reported in millimeters of mercury (mmHg). A higher IOP can be a greater risk factor for developing glaucoma or glaucoma progression (leading to optic nerve damage).|mmHG|Mean|14.8|14.8|Standard Deviation|2.3|2.3|||
3687720|NCT02246777|3530085|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3687721|NCT02246777|3530085|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3687722|NCT02246777|3530085|B1|||Age||years|Mean|61.2|61.2|Standard Deviation|10.8|10.8|||
3687723|NCT02246764|3530098|B4|Canada||Region of Enrollment||participants|Number|93|93.0||||||
3687724|NCT02246764|3530099|B3|Canada||Region of Enrollment||participants|Number|23|23.0||||||
3687725|NCT02246764|3530100|B2|Canada||Region of Enrollment||participants|Number|36|36.0||||||
3687726|NCT02246764|3530101|B1|Canada||Region of Enrollment||participants|Number|34|34.0||||||
3687727|NCT02246764|3530098|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3687728|NCT02246764|3530099|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687729|NCT02246764|3530100|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687730|NCT02246764|3530101|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3687731|NCT02246764|3530098|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687732|NCT02246764|3530099|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687733|NCT02246764|3530100|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687734|NCT02246764|3530101|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687735|NCT02246764|3530098|B4||White|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3687736|NCT02246764|3530099|B3||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3687737|NCT02246764|3530100|B2||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3687738|NCT02246764|3530101|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3687739|NCT02246764|3530098|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3687740|NCT02246764|3530099|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3687741|NCT02246764|3530100|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3687742|NCT02246764|3530101|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3687743|NCT02246764|3530098|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687744|NCT02246764|3530099|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687745|NCT02246764|3530100|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687746|NCT02246764|3530101|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687747|NCT02246764|3530098|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3687748|NCT02246764|3530099|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3687749|NCT02246764|3530100|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3687750|NCT02246764|3530101|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687751|NCT02246764|3530098|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687752|NCT02246764|3530099|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687753|NCT02246764|3530100|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687754|NCT02246764|3530101|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687755|NCT02246764|3530098|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687756|NCT02246764|3530099|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687757|NCT02246764|3530100|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687758|NCT02246764|3530101|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687759|NCT02246764|3530098|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3687760|NCT02246764|3530099|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3687761|NCT02246764|3530100|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3687762|NCT02246764|3530101|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3687763|NCT02246764|3530098|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3687764|NCT02246764|3530099|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687765|NCT02246764|3530100|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3687766|NCT02246764|3530101|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3687767|NCT02246764|3530098|B4||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3687768|NCT02246764|3530099|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3687769|NCT02246764|3530100|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3687770|NCT02246764|3530101|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3687771|NCT02246764|3530098|B4||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3687772|NCT02246764|3530099|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3687773|NCT02246764|3530100|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3687774|NCT02246764|3530101|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3687775|NCT02246764|3530098|B4|||Age||years|Mean|63.8|63.8|Standard Deviation|9.14|9.14|||
3687776|NCT02246764|3530099|B3|||Age||years|Mean|61.9|61.9|Standard Deviation|12.52|12.52|||
3687777|NCT02246764|3530100|B2|||Age||years|Mean|64.4|64.4|Standard Deviation|7.84|7.84|||
3687778|NCT02246764|3530101|B1|||Age||years|Mean|64.6|64.6|Standard Deviation|7.73|7.73|||
3687779|NCT02246673|3530111|B6||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3687780|NCT02246673|3530112|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3687781|NCT02246673|3530113|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3687782|NCT02246673|3530114|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3687783|NCT02246673|3530115|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3687784|NCT02246673|3530116|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3687785|NCT02246673|3530111|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3687786|NCT02246673|3530112|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3687787|NCT02246673|3530113|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3687788|NCT02246673|3530114|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3687789|NCT02246673|3530115|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3687790|NCT02246673|3530116|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3687791|NCT02246673|3530111|B6|||Age||Years|Mean|48|48.0|Standard Deviation|9.6|9.6|||
3687792|NCT02246673|3530112|B5|||Age||Years|Mean|49|49.0|Standard Deviation|10.9|10.9|||
3687793|NCT02246673|3530113|B4|||Age||Years|Mean|48|48.0|Standard Deviation|11.5|11.5|||
3687794|NCT02246673|3530114|B3|||Age||Years|Mean|50|50.0|Standard Deviation|8.5|8.5|||
3687795|NCT02246673|3530115|B2|||Age||Years|Mean|50|50.0|Standard Deviation|8.2|8.2|||
3687796|NCT02246673|3530116|B1|||Age||Years|Mean|45|45.0|Standard Deviation|8.9|8.9|||
3687797|NCT02246660|3530225|B4|||Reported walking for exercise 3 or more times/week||Participants|Count of Participants|19|19.0||||||
3687798|NCT02246660|3530226|B3|||Reported walking for exercise 3 or more times/week||Participants|Count of Participants|6|6.0||||||
3687799|NCT02246660|3530227|B2|||Reported walking for exercise 3 or more times/week||Participants|Count of Participants|4|4.0||||||
3687800|NCT02246660|3530228|B1|||Reported walking for exercise 3 or more times/week||Participants|Count of Participants|9|9.0||||||
3687801|NCT02246660|3530225|B4|||Statin use||Participants|Count of Participants|47|47.0||||||
3687802|NCT02246660|3530226|B3|||Statin use||Participants|Count of Participants|17|17.0||||||
3687803|NCT02246660|3530227|B2|||Statin use||Participants|Count of Participants|16|16.0||||||
3687804|NCT02246660|3530228|B1|||Statin use||Participants|Count of Participants|14|14.0||||||
3687805|NCT02246660|3530225|B4|||Antiplatelet therapy use||Participants|Count of Participants|52|52.0||||||
3687806|NCT02246660|3530226|B3|||Antiplatelet therapy use||Participants|Count of Participants|16|16.0||||||
3687807|NCT02246660|3530227|B2|||Antiplatelet therapy use||Participants|Count of Participants|19|19.0||||||
3687808|NCT02246660|3530228|B1|||Antiplatelet therapy use||Participants|Count of Participants|17|17.0||||||
3687809|NCT02246660|3530225|B4|||Pentoxifylline use||Participants|Count of Participants|3|3.0||||||
3687810|NCT02246660|3530226|B3|||Pentoxifylline use||Participants|Count of Participants|1|1.0||||||
3687811|NCT02246660|3530227|B2|||Pentoxifylline use||Participants|Count of Participants|2|2.0||||||
3687812|NCT02246660|3530228|B1|||Pentoxifylline use||Participants|Count of Participants|0|0.0||||||
3687813|NCT02246660|3530225|B4|||Cilostazol use||Participants|Count of Participants|4|4.0||||||
3687814|NCT02246660|3530226|B3|||Cilostazol use||Participants|Count of Participants|2|2.0||||||
3687815|NCT02246660|3530227|B2|||Cilostazol use||Participants|Count of Participants|1|1.0||||||
3687816|NCT02246660|3530228|B1|||Cilostazol use||Participants|Count of Participants|1|1.0||||||
3687817|NCT02246660|3530225|B4|||Treadmill distance at onset of leg symptom||meters|Mean|239.1|239.1|Standard Deviation|168.5|168.5|||
3687818|NCT02246660|3530226|B3|||Treadmill distance at onset of leg symptom||meters|Mean|218.0|218.0|Standard Deviation|147.3|147.3|||
3687819|NCT02246660|3530227|B2|||Treadmill distance at onset of leg symptom||meters|Mean|226.6|226.6|Standard Deviation|123.4|123.4|||
3687820|NCT02246660|3530228|B1|||Treadmill distance at onset of leg symptom||meters|Mean|271.1|271.1|Standard Deviation|217.7|217.7|||
3687821|NCT02246660|3530225|B4|||Total Treadmill Distance||meters|Mean|488.4|488.4|Standard Deviation|255.9|255.9|||
3687822|NCT02246660|3530226|B3|||Total Treadmill Distance||meters|Mean|443.3|443.3|Standard Deviation|242.4|242.4|||
3687823|NCT02246660|3530227|B2|||Total Treadmill Distance||meters|Mean|492.8|492.8|Standard Deviation|261.2|261.2|||
3687824|NCT02246660|3530228|B1|||Total Treadmill Distance||meters|Mean|529.4|529.4|Standard Deviation|268.6|268.6|||
3687825|NCT02246660|3530225|B4|||6-Minute Walk Distance||meters|Mean|360|360.0|Standard Deviation|63|63.0|||
3687826|NCT02246660|3530226|B3|||6-Minute Walk Distance||meters|Mean|354|354.0|Standard Deviation|70|70.0|||
3687827|NCT02246660|3530227|B2|||6-Minute Walk Distance||meters|Mean|370|370.0|Standard Deviation|65|65.0|||
3687828|NCT02246660|3530228|B1|||6-Minute Walk Distance||meters|Mean|357|357.0|Standard Deviation|58|58.0|||
3687829|NCT02246660|3530225|B4|||Asymptomatic||Participants|Count of Participants|12|12.0||||||
3687830|NCT02246660|3530226|B3|||Asymptomatic||Participants|Count of Participants|4|4.0||||||
3687831|NCT02246660|3530227|B2|||Asymptomatic||Participants|Count of Participants|3|3.0||||||
3687832|NCT02246660|3530228|B1|||Asymptomatic||Participants|Count of Participants|5|5.0||||||
3687833|NCT02246660|3530225|B4|||Exertional leg symptoms not consistent with classical intermittent claudication||Participants|Count of Participants|37|37.0||||||
3687834|NCT02246660|3530226|B3|||Exertional leg symptoms not consistent with classical intermittent claudication||Participants|Count of Participants|11|11.0||||||
3687835|NCT02246660|3530227|B2|||Exertional leg symptoms not consistent with classical intermittent claudication||Participants|Count of Participants|12|12.0||||||
3687836|NCT02246660|3530228|B1|||Exertional leg symptoms not consistent with classical intermittent claudication||Participants|Count of Participants|14|14.0||||||
3687837|NCT02246660|3530225|B4|||Intermittent Claudication|Intermittent claudication was defined as exertional calf pain that did not begin at rest, caused the participant to stop walking, and resolved within 10 minutes of rest. Participants without intermittent claudication were either asymptomatic (ie, reported no exertional leg symptoms) or had exertional leg symptoms that did not meet criteria for intermittent claudication.|Participants|Count of Participants|17|17.0||||||
3687838|NCT02246660|3530226|B3|||Intermittent Claudication|Intermittent claudication was defined as exertional calf pain that did not begin at rest, caused the participant to stop walking, and resolved within 10 minutes of rest. Participants without intermittent claudication were either asymptomatic (ie, reported no exertional leg symptoms) or had exertional leg symptoms that did not meet criteria for intermittent claudication.|Participants|Count of Participants|7|7.0||||||
3687839|NCT02246660|3530227|B2|||Intermittent Claudication|Intermittent claudication was defined as exertional calf pain that did not begin at rest, caused the participant to stop walking, and resolved within 10 minutes of rest. Participants without intermittent claudication were either asymptomatic (ie, reported no exertional leg symptoms) or had exertional leg symptoms that did not meet criteria for intermittent claudication.|Participants|Count of Participants|6|6.0||||||
3687840|NCT02246660|3530228|B1|||Intermittent Claudication|Intermittent claudication was defined as exertional calf pain that did not begin at rest, caused the participant to stop walking, and resolved within 10 minutes of rest. Participants without intermittent claudication were either asymptomatic (ie, reported no exertional leg symptoms) or had exertional leg symptoms that did not meet criteria for intermittent claudication.|Participants|Count of Participants|4|4.0||||||
3687841|NCT02246660|3530225|B4|||Diabetes||Participants|Count of Participants|26|26.0||||||
3687842|NCT02246660|3530226|B3|||Diabetes||Participants|Count of Participants|14|14.0||||||
3687843|NCT02246660|3530227|B2|||Diabetes||Participants|Count of Participants|5|5.0||||||
3687844|NCT02246660|3530228|B1|||Diabetes||Participants|Count of Participants|7|7.0||||||
3687845|NCT02246660|3530225|B4|||Cancer||Participants|Count of Participants|17|17.0||||||
3687846|NCT02246660|3530226|B3|||Cancer||Participants|Count of Participants|5|5.0||||||
3687847|NCT02246660|3530227|B2|||Cancer||Participants|Count of Participants|3|3.0||||||
3687848|NCT02246660|3530228|B1|||Cancer||Participants|Count of Participants|9|9.0||||||
3687849|NCT02246660|3530225|B4|||Pulmonary Disease||Participants|Count of Participants|10|10.0||||||
3687850|NCT02246660|3530226|B3|||Pulmonary Disease||Participants|Count of Participants|2|2.0||||||
3687851|NCT02246660|3530227|B2|||Pulmonary Disease||Participants|Count of Participants|3|3.0||||||
3687852|NCT02246660|3530228|B1|||Pulmonary Disease||Participants|Count of Participants|5|5.0||||||
3687853|NCT02246660|3530225|B4|||Angina||Participants|Count of Participants|7|7.0||||||
3687854|NCT02246660|3530226|B3|||Angina||Participants|Count of Participants|4|4.0||||||
3687855|NCT02246660|3530227|B2|||Angina||Participants|Count of Participants|1|1.0||||||
3687856|NCT02246660|3530228|B1|||Angina||Participants|Count of Participants|2|2.0||||||
3687857|NCT02246660|3530225|B4|||Stroke||Participants|Count of Participants|9|9.0||||||
3687858|NCT02246660|3530226|B3|||Stroke||Participants|Count of Participants|0|0.0||||||
3687859|NCT02246660|3530227|B2|||Stroke||Participants|Count of Participants|6|6.0||||||
3687860|NCT02246660|3530228|B1|||Stroke||Participants|Count of Participants|3|3.0||||||
3687861|NCT02246660|3530225|B4|||Heart Failure||Participants|Count of Participants|6|6.0||||||
3687862|NCT02246660|3530226|B3|||Heart Failure||Participants|Count of Participants|4|4.0||||||
3687863|NCT02246660|3530227|B2|||Heart Failure||Participants|Count of Participants|2|2.0||||||
3687864|NCT02246660|3530228|B1|||Heart Failure||Participants|Count of Participants|0|0.0||||||
3687865|NCT02246660|3530225|B4|||Myocardial Infarction||Participants|Count of Participants|2|2.0||||||
3687866|NCT02246660|3530226|B3|||Myocardial Infarction||Participants|Count of Participants|0|0.0||||||
3687867|NCT02246660|3530227|B2|||Myocardial Infarction||Participants|Count of Participants|1|1.0||||||
3687868|NCT02246660|3530228|B1|||Myocardial Infarction||Participants|Count of Participants|1|1.0||||||
3687869|NCT02246660|3530225|B4|||BMI||kg/m^2|Mean|29.9|29.9|Standard Deviation|5.3|5.3|||
3687870|NCT02246660|3530226|B3|||BMI||kg/m^2|Mean|31.2|31.2|Standard Deviation|4.8|4.8|||
3687871|NCT02246660|3530227|B2|||BMI||kg/m^2|Mean|28.9|28.9|Standard Deviation|5.4|5.4|||
3687872|NCT02246660|3530228|B1|||BMI||kg/m^2|Mean|29.6|29.6|Standard Deviation|5.5|5.5|||
3687873|NCT02246660|3530225|B4|||Former Smoker||Participants|Count of Participants|42|42.0||||||
3687874|NCT02246660|3530226|B3|||Former Smoker||Participants|Count of Participants|15|15.0||||||
3687875|NCT02246660|3530227|B2|||Former Smoker||Participants|Count of Participants|14|14.0||||||
3687876|NCT02246660|3530228|B1|||Former Smoker||Participants|Count of Participants|13|13.0||||||
3687877|NCT02246660|3530225|B4|||Current Smoker||Participants|Count of Participants|14|14.0||||||
3687878|NCT02246660|3530226|B3|||Current Smoker||Participants|Count of Participants|5|5.0||||||
3687879|NCT02246660|3530227|B2|||Current Smoker||Participants|Count of Participants|5|5.0||||||
3687880|NCT02246660|3530228|B1|||Current Smoker||Participants|Count of Participants|4|4.0||||||
3687881|NCT02246660|3530225|B4|||Ankle Brachial Index|A handheld Doppler probe was used to measure systolic blood pressures in the right brachial, dorsalis pedis, and posterior tibial arteries and left dorsalis pedis, posterior tibial, and brachial arteries. The ABI was calculated by dividing mean pressures in each leg by the mean of the 4 brachial pressures. A normal ABI is between 1.10- 1.30. A value of < 0.90 is about 70% sensitive and highly specific for the presence of peripheral artery disease. Lower ABI values indicate more severe PAD.|Ratio|Mean|0.67|0.67|Standard Deviation|0.18|0.18|||
3687882|NCT02246660|3530226|B3|||Ankle Brachial Index|A handheld Doppler probe was used to measure systolic blood pressures in the right brachial, dorsalis pedis, and posterior tibial arteries and left dorsalis pedis, posterior tibial, and brachial arteries. The ABI was calculated by dividing mean pressures in each leg by the mean of the 4 brachial pressures. A normal ABI is between 1.10- 1.30. A value of < 0.90 is about 70% sensitive and highly specific for the presence of peripheral artery disease. Lower ABI values indicate more severe PAD.|Ratio|Mean|0.63|0.63|Standard Deviation|0.13|0.13|||
3687883|NCT02246660|3530227|B2|||Ankle Brachial Index|A handheld Doppler probe was used to measure systolic blood pressures in the right brachial, dorsalis pedis, and posterior tibial arteries and left dorsalis pedis, posterior tibial, and brachial arteries. The ABI was calculated by dividing mean pressures in each leg by the mean of the 4 brachial pressures. A normal ABI is between 1.10- 1.30. A value of < 0.90 is about 70% sensitive and highly specific for the presence of peripheral artery disease. Lower ABI values indicate more severe PAD.|Ratio|Mean|0.68|0.68|Standard Deviation|0.15|0.15|||
3687884|NCT02246660|3530228|B1|||Ankle Brachial Index|A handheld Doppler probe was used to measure systolic blood pressures in the right brachial, dorsalis pedis, and posterior tibial arteries and left dorsalis pedis, posterior tibial, and brachial arteries. The ABI was calculated by dividing mean pressures in each leg by the mean of the 4 brachial pressures. A normal ABI is between 1.10- 1.30. A value of < 0.90 is about 70% sensitive and highly specific for the presence of peripheral artery disease. Lower ABI values indicate more severe PAD.|Ratio|Mean|0.69|0.69|Standard Deviation|0.23|0.23|||
3687885|NCT02246660|3530225|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687886|NCT02246660|3530226|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687887|NCT02246660|3530227|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687888|NCT02246660|3530228|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687889|NCT02246660|3530225|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687890|NCT02246660|3530226|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687891|NCT02246660|3530227|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687892|NCT02246660|3530228|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687893|NCT02246660|3530225|B4||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3687894|NCT02246660|3530226|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3687895|NCT02246660|3530227|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3687896|NCT02246660|3530228|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3687897|NCT02246660|3530225|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3687898|NCT02246660|3530226|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3687899|NCT02246660|3530227|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3687900|NCT02246660|3530228|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3687901|NCT02246660|3530225|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687902|NCT02246660|3530226|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687903|NCT02246660|3530227|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687904|NCT02246660|3530228|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687905|NCT02246660|3530225|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3687906|NCT02246660|3530226|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3687907|NCT02246660|3530227|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687908|NCT02246660|3530228|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3687909|NCT02246660|3530225|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687910|NCT02246660|3530226|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687911|NCT02246660|3530227|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687912|NCT02246660|3530228|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687913|NCT02246660|3530225|B4||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3687914|NCT02246660|3530226|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3687915|NCT02246660|3530227|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3687916|NCT02246660|3530228|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3687917|NCT02246660|3530225|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3687918|NCT02246660|3530226|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3687919|NCT02246660|3530227|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3687920|NCT02246660|3530228|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3687921|NCT02246660|3530225|B4|||Age||years|Mean|74.4|74.4|Standard Deviation|6.6|6.6|||
3687922|NCT02246660|3530226|B3|||Age||years|Mean|74.1|74.1|Standard Deviation|6.1|6.1|||
3687923|NCT02246660|3530227|B2|||Age||years|Mean|73.6|73.6|Standard Deviation|6.6|6.6|||
3687924|NCT02246660|3530228|B1|||Age||years|Mean|75.6|75.6|Standard Deviation|7.3|7.3|||
3687925|NCT02246621|3530238|B3|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3687926|NCT02246621|3530239|B2|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3687927|NCT02246621|3530240|B1|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3687928|NCT02246621|3530238|B3|Taiwan||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3687929|NCT02246621|3530239|B2|Taiwan||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3687930|NCT02246621|3530240|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3687931|NCT02246621|3530238|B3|Turkey||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3687932|NCT02246621|3530239|B2|Turkey||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3687933|NCT02246621|3530240|B1|Turkey||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3687934|NCT02246621|3530238|B3|Sweden||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3687935|NCT02246621|3530239|B2|Sweden||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3687936|NCT02246621|3530240|B1|Sweden||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3687937|NCT02246621|3530238|B3|Slovakia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3687938|NCT02246621|3530239|B2|Slovakia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3687939|NCT02246621|3530240|B1|Slovakia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3687940|NCT02246621|3530238|B3|Russia||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3687941|NCT02246621|3530239|B2|Russia||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3687942|NCT02246621|3530240|B1|Russia||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3687943|NCT02246621|3530238|B3|New Zealand||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3687944|NCT02246621|3530239|B2|New Zealand||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3687945|NCT02246621|3530240|B1|New Zealand||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3687946|NCT02246621|3530238|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3687947|NCT02246621|3530239|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3687948|NCT02246621|3530240|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3687949|NCT02246621|3530238|B3|Mexico||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3687950|NCT02246621|3530239|B2|Mexico||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3687951|NCT02246621|3530240|B1|Mexico||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3687952|NCT02246621|3530238|B3|South Korea||Region of Enrollment||Participants|Count of Participants|59|59.0||||||
3687953|NCT02246621|3530239|B2|South Korea||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3687954|NCT02246621|3530240|B1|South Korea||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3687955|NCT02246621|3530238|B3|Japan||Region of Enrollment||Participants|Count of Participants|53|53.0||||||
3687956|NCT02246621|3530239|B2|Japan||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3687957|NCT02246621|3530240|B1|Japan||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
3687958|NCT02246621|3530238|B3|Italy||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3687959|NCT02246621|3530239|B2|Italy||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3687960|NCT02246621|3530240|B1|Italy||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3687961|NCT02246621|3530238|B3|Israel||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
3687962|NCT02246621|3530239|B2|Israel||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3687963|NCT02246621|3530240|B1|Israel||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3687964|NCT02246621|3530238|B3|Greece||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3687965|NCT02246621|3530239|B2|Greece||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3687966|NCT02246621|3530240|B1|Greece||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3687967|NCT02246621|3530238|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3687968|NCT02246621|3530239|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3687969|NCT02246621|3530240|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3687970|NCT02246621|3530238|B3|France||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3687971|NCT02246621|3530239|B2|France||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3687972|NCT02246621|3530240|B1|France||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3687973|NCT02246621|3530238|B3|Spain||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3687974|NCT02246621|3530239|B2|Spain||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3687975|NCT02246621|3530240|B1|Spain||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3687976|NCT02246621|3530238|B3|Germany||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3687977|NCT02246621|3530239|B2|Germany||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3687978|NCT02246621|3530240|B1|Germany||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3687979|NCT02246621|3530238|B3|Canada||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3687980|NCT02246621|3530239|B2|Canada||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3687981|NCT02246621|3530240|B1|Canada||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3687982|NCT02246621|3530238|B3|Belgium||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3687983|NCT02246621|3530239|B2|Belgium||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3687984|NCT02246621|3530240|B1|Belgium||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3687985|NCT02246621|3530238|B3|Austria||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3687986|NCT02246621|3530239|B2|Austria||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3687987|NCT02246621|3530240|B1|Austria||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3687988|NCT02246621|3530238|B3|Australia||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3687989|NCT02246621|3530239|B2|Australia||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3687990|NCT02246621|3530240|B1|Australia||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3687991|NCT02246621|3530238|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3687992|NCT02246621|3530239|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3687993|NCT02246621|3530240|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3687994|NCT02246621|3530238|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3687995|NCT02246621|3530239|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3687996|NCT02246621|3530240|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3687997|NCT02246621|3530238|B3||White|Race (NIH/OMB)||Participants|Count of Participants|288|288.0||||||
3687998|NCT02246621|3530239|B2||White|Race (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
3687999|NCT02246621|3530240|B1||White|Race (NIH/OMB)||Participants|Count of Participants|186|186.0||||||
3688000|NCT02246621|3530238|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3688001|NCT02246621|3530239|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3688002|NCT02246621|3530240|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3688003|NCT02246621|3530238|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3688004|NCT02246621|3530239|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3688005|NCT02246621|3530240|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688006|NCT02246621|3530238|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|148|148.0||||||
3688007|NCT02246621|3530239|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3688008|NCT02246621|3530240|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
3688009|NCT02246621|3530238|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3688010|NCT02246621|3530239|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3688011|NCT02246621|3530240|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3688012|NCT02246621|3530238|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3688013|NCT02246621|3530239|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3688014|NCT02246621|3530240|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3688015|NCT02246621|3530238|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|355|355.0||||||
3688016|NCT02246621|3530239|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
3688017|NCT02246621|3530240|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|230|230.0||||||
3688018|NCT02246621|3530238|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3688019|NCT02246621|3530239|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3688020|NCT02246621|3530240|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3688021|NCT02246621|3530238|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3688022|NCT02246621|3530239|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3688023|NCT02246621|3530240|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3688024|NCT02246621|3530238|B3||Female|Sex: Female, Male||Participants|Count of Participants|493|493.0||||||
3688025|NCT02246621|3530239|B2||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3688026|NCT02246621|3530240|B1||Female|Sex: Female, Male||Participants|Count of Participants|328|328.0||||||
3688027|NCT02246621|3530238|B3|||Age||years|Mean|63.05|63.05|Standard Deviation|9.92|9.92|||
3688028|NCT02246621|3530239|B2|||Age||years|Mean|62.92|62.92|Standard Deviation|9.96|9.96|||
3688029|NCT02246621|3530240|B1|||Age||years|Mean|63.13|63.13|Standard Deviation|9.92|9.92|||
3688030|NCT02246608|3530267|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688031|NCT02246608|3530268|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688032|NCT02246608|3530269|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688033|NCT02246608|3530267|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688034|NCT02246608|3530268|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688035|NCT02246608|3530269|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688036|NCT02246608|3530267|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3688037|NCT02246608|3530268|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3688038|NCT02246608|3530269|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3688039|NCT02246608|3530267|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3688040|NCT02246608|3530268|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688041|NCT02246608|3530269|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3688042|NCT02246608|3530267|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688043|NCT02246608|3530268|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688044|NCT02246608|3530269|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688045|NCT02246608|3530267|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688046|NCT02246608|3530268|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688047|NCT02246608|3530269|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688048|NCT02246608|3530267|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688049|NCT02246608|3530268|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688050|NCT02246608|3530269|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688051|NCT02246608|3530267|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3688052|NCT02246608|3530268|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3688053|NCT02246608|3530269|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3688054|NCT02246608|3530267|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3688055|NCT02246608|3530268|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3688056|NCT02246608|3530269|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3688057|NCT02246608|3530267|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3688058|NCT02246608|3530268|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3688059|NCT02246608|3530269|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3688060|NCT02246608|3530267|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3688061|NCT02246608|3530268|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3688062|NCT02246608|3530269|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3688063|NCT02246608|3530267|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3688064|NCT02246608|3530268|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3688065|NCT02246608|3530269|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3688066|NCT02246582|3530278|B1|United States||Region of Enrollment||participants|Number|89|89.0||||||
3688067|NCT02246582|3530278|B1||Male|Gender||Participants|Count of Participants|46|46.0||||||
3688068|NCT02246582|3530278|B1||Female|Gender||Participants|Count of Participants|43|43.0||||||
3688069|NCT02246582|3530278|B1|||Age||years|Mean|41.7|41.7|Standard Deviation|19.14|19.14|||
3688070|NCT02246582|3530278|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3688071|NCT02246582|3530278|B1||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
3688072|NCT02246582|3530278|B1||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
3688073|NCT02246309|3530285|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3688074|NCT02246309|3530286|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3688075|NCT02246309|3530287|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3688076|NCT02246309|3530285|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3688077|NCT02246309|3530286|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3688078|NCT02246309|3530287|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3688079|NCT02246309|3530285|B3|||Age||years|Mean|39.5|39.5|Standard Deviation|4.8|4.8|||
3688080|NCT02246309|3530286|B2|||Age||years|Mean|40.4|40.4|Standard Deviation|6.97|6.97|||
3688081|NCT02246309|3530287|B1|||Age||years|Mean|38.8|38.8|Standard Deviation|4|4.0|||
3688082|NCT02246166|3530298|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3688083|NCT02246166|3530299|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3688084|NCT02246166|3530300|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3688085|NCT02246166|3530298|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3688086|NCT02246166|3530299|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3688087|NCT02246166|3530300|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3688088|NCT02246166|3530298|B3|||Age||Years|Mean|38.2|38.2|Standard Deviation|11.40|11.4|||
3688089|NCT02246166|3530299|B2|||Age||Years|Mean|38.5|38.5|Standard Deviation|11.06|11.06|||
3688090|NCT02246166|3530300|B1|||Age||Years|Mean|37.8|37.8|Standard Deviation|11.97|11.97|||
3688091|NCT02246114|3530335|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3688092|NCT02246114|3530337|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3688093|NCT02246114|3530335|B3||Female|Gender||Participants|Count of Participants|1|1.0||||||
3688094|NCT02246114|3530337|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
3688095|NCT02246114|3530335|B3|||Age||years|Mean|32|32.0|Full Range|||32.0|32.0|
3688096|NCT02246114|3530337|B1|||Age||years|Mean|32|32.0|Full Range|||32.0|32.0|
3688097|NCT02246062|3530344|B5||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3688098|NCT02246062|3530345|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3688099|NCT02246062|3530346|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3688100|NCT02246062|3530347|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3688101|NCT02246062|3530348|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3688102|NCT02246062|3530344|B5||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3688103|NCT02246062|3530345|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3688104|NCT02246062|3530346|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3688105|NCT02246062|3530347|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3688106|NCT02246062|3530348|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3688107|NCT02246062|3530344|B5|||Age||years|Mean|5.41|5.41|Standard Deviation|1.03|1.03|||
3688108|NCT02246062|3530345|B4|||Age||years|Mean|5.65|5.65|Standard Deviation|1.04|1.04|||
3688109|NCT02246062|3530346|B3|||Age||years|Mean|5.29|5.29|Standard Deviation|0.96|0.96|||
3688110|NCT02246062|3530347|B2|||Age||years|Mean|5.45|5.45|Standard Deviation|1.0|1.0|||
3688111|NCT02246062|3530348|B1|||Age||years|Mean|5.29|5.29|Standard Deviation|1.15|1.15|||
3688112|NCT02245412|3530369|B4|France||Region of Enrollment||participants|Number|1|1.0||||||
3688113|NCT02245412|3530370|B3|France||Region of Enrollment||participants|Number|0|0.0||||||
3688114|NCT02245412|3530371|B2|France||Region of Enrollment||participants|Number|0|0.0||||||
3688115|NCT02245412|3530372|B1|France||Region of Enrollment||participants|Number|1|1.0||||||
3688116|NCT02245412|3530369|B4|United States||Region of Enrollment||participants|Number|24|24.0||||||
3688117|NCT02245412|3530370|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3688118|NCT02245412|3530371|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3688119|NCT02245412|3530372|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3688120|NCT02245412|3530369|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3688121|NCT02245412|3530370|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688122|NCT02245412|3530371|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3688123|NCT02245412|3530372|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688124|NCT02245412|3530369|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688125|NCT02245412|3530370|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688126|NCT02245412|3530371|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688127|NCT02245412|3530372|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688128|NCT02245412|3530369|B4||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3688129|NCT02245412|3530370|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3688130|NCT02245412|3530371|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3688131|NCT02245412|3530372|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3688132|NCT02245412|3530369|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3688133|NCT02245412|3530370|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688134|NCT02245412|3530371|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688135|NCT02245412|3530372|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3688136|NCT02245412|3530369|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688137|NCT02245412|3530370|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688138|NCT02245412|3530371|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688139|NCT02245412|3530372|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688140|NCT02245412|3530369|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3688141|NCT02245412|3530370|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688142|NCT02245412|3530371|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3688143|NCT02245412|3530372|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688144|NCT02245412|3530369|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688145|NCT02245412|3530370|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688146|NCT02245412|3530371|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688147|NCT02245412|3530372|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688148|NCT02245412|3530369|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3688149|NCT02245412|3530370|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688150|NCT02245412|3530371|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688151|NCT02245412|3530372|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3688152|NCT02245412|3530369|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3688153|NCT02245412|3530370|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3688154|NCT02245412|3530371|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3688155|NCT02245412|3530372|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3688156|NCT02245412|3530369|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3688157|NCT02245412|3530370|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688158|NCT02245412|3530371|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3688159|NCT02245412|3530372|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3688160|NCT02245412|3530369|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3688161|NCT02245412|3530370|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3688162|NCT02245412|3530371|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3688163|NCT02245412|3530372|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3688164|NCT02245412|3530369|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3688165|NCT02245412|3530370|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3688166|NCT02245412|3530371|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3688167|NCT02245412|3530372|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3688168|NCT02245412|3530369|B4|||Age||years|Mean|54.2|54.2|Standard Deviation|14.32|14.32|||
3688169|NCT02245412|3530370|B3|||Age||years|Mean|70.5|70.5|Standard Deviation|2.12|2.12|||
3688170|NCT02245412|3530371|B2|||Age||years|Mean|47.7|47.7|Standard Deviation|13.14|13.14|||
3688171|NCT02245412|3530372|B1|||Age||years|Mean|54.6|54.6|Standard Deviation|14.27|14.27|||
3688172|NCT02245360|3530391|B3|Russian Federation||Region of Enrollment||participants|Number|107|107.0||||||
3688173|NCT02245360|3530392|B2|Russian Federation||Region of Enrollment||participants|Number|54|54.0||||||
3688174|NCT02245360|3530393|B1|Russian Federation||Region of Enrollment||participants|Number|53|53.0||||||
3688175|NCT02245360|3530391|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3688176|NCT02245360|3530392|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3688177|NCT02245360|3530393|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3688178|NCT02245360|3530391|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3688179|NCT02245360|3530392|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3688180|NCT02245360|3530393|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3688181|NCT02245360|3530391|B3|||Age||years|Mean|34.9|34.9|Standard Deviation|10.6|10.6|||
3688182|NCT02245360|3530392|B2|||Age||years|Mean|34.1|34.1|Standard Deviation|10.1|10.1|||
3688183|NCT02245360|3530393|B1|||Age||years|Mean|35.8|35.8|Standard Deviation|11.2|11.2|||
3688184|NCT02245360|3530391|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3688185|NCT02245360|3530392|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3688186|NCT02245360|3530393|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3688187|NCT02245360|3530391|B3||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
3688188|NCT02245360|3530392|B2||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3688189|NCT02245360|3530393|B1||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
3688190|NCT02245360|3530391|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3688191|NCT02245360|3530392|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3688192|NCT02245360|3530393|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3688193|NCT02245217|3530402|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3688194|NCT02245217|3530402|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3688195|NCT02245217|3530402|B1|||Age||years|Mean|67|67.0|Full Range|||54.0|78.0|
3688196|NCT02244944|3530408|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3688197|NCT02244944|3530408|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3688198|NCT02244944|3530408|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3688199|NCT02244944|3530408|B1|||Age||years|Mean|43.5|43.5|Full Range|||33.0|54.0|
3688200|NCT02244944|3530408|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3688201|NCT02244944|3530408|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3688202|NCT02244944|3530408|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3688203|NCT02244840|3530414|B1|Korea, Republic of||Region of Enrollment||participants|Number|40|40.0||||||
3688204|NCT02244840|3530414|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3688205|NCT02244840|3530414|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3688206|NCT02244840|3530414|B1|||Age||years|Mean|30.0|30.0|Full Range|||22.0|38.0|
3688207|NCT02244619|3530418|B3|||Intra-operative Bupivacaine Liposome Injectable Suspension||Participants|Count of Participants|325|325.0||||||
3688208|NCT02244619|3530419|B2|||Intra-operative Bupivacaine Liposome Injectable Suspension||Participants|Count of Participants|162|162.0||||||
3688209|NCT02244619|3530420|B1|||Intra-operative Bupivacaine Liposome Injectable Suspension||Participants|Count of Participants|163|163.0||||||
3688210|NCT02244619|3530418|B3|||Intra-operative Ketorolac||Participants|Count of Participants|71|71.0||||||
3688211|NCT02244619|3530419|B2|||Intra-operative Ketorolac||Participants|Count of Participants|36|36.0||||||
3688212|NCT02244619|3530420|B1|||Intra-operative Ketorolac||Participants|Count of Participants|35|35.0||||||
3688213|NCT02244619|3530418|B3|||Intra-operative total opioid||morphine milligram equivalents (MME)|Median|10.0|10.0|Inter-Quartile Range|||6.7|15.0|
3688214|NCT02244619|3530419|B2|||Intra-operative total opioid||morphine milligram equivalents (MME)|Median|10.0|10.0|Inter-Quartile Range|||6.7|15.0|
3688215|NCT02244619|3530420|B1|||Intra-operative total opioid||morphine milligram equivalents (MME)|Median|10.0|10.0|Inter-Quartile Range|||6.7|16.7|
3688216|NCT02244619|3530418|B3|||Pre-operative Pregabalin||Participants|Count of Participants|462|462.0||||||
3688217|NCT02244619|3530419|B2|||Pre-operative Pregabalin||Participants|Count of Participants|232|232.0||||||
3688218|NCT02244619|3530420|B1|||Pre-operative Pregabalin||Participants|Count of Participants|230|230.0||||||
3688219|NCT02244619|3530418|B3|||Pre-operative Celecoxib||Participants|Count of Participants|393|393.0||||||
3688220|NCT02244619|3530419|B2|||Pre-operative Celecoxib||Participants|Count of Participants|195|195.0||||||
3688221|NCT02244619|3530420|B1|||Pre-operative Celecoxib||Participants|Count of Participants|198|198.0||||||
3688222|NCT02244619|3530418|B3|||Pre-operative opioid||Participants|Count of Participants|107|107.0||||||
3688223|NCT02244619|3530419|B2|||Pre-operative opioid||Participants|Count of Participants|57|57.0||||||
3688224|NCT02244619|3530420|B1|||Pre-operative opioid||Participants|Count of Participants|50|50.0||||||
3688225|NCT02244619|3530418|B3||Hip|Type of surgery||Participants|Count of Participants|148|148.0||||||
3688226|NCT02244619|3530419|B2||Hip|Type of surgery||Participants|Count of Participants|75|75.0||||||
3688227|NCT02244619|3530420|B1||Hip|Type of surgery||Participants|Count of Participants|73|73.0||||||
3688228|NCT02244619|3530418|B3||Knee|Type of surgery||Participants|Count of Participants|338|338.0||||||
3688229|NCT02244619|3530419|B2||Knee|Type of surgery||Participants|Count of Participants|170|170.0||||||
3688230|NCT02244619|3530420|B1||Knee|Type of surgery||Participants|Count of Participants|168|168.0||||||
3688231|NCT02244619|3530418|B3|||Stroke||Participants|Count of Participants|9|9.0||||||
3688232|NCT02244619|3530419|B2|||Stroke||Participants|Count of Participants|4|4.0||||||
3688233|NCT02244619|3530420|B1|||Stroke||Participants|Count of Participants|5|5.0||||||
3688234|NCT02244619|3530418|B3|||Diabetes||Participants|Count of Participants|98|98.0||||||
3688235|NCT02244619|3530419|B2|||Diabetes||Participants|Count of Participants|50|50.0||||||
3688236|NCT02244619|3530420|B1|||Diabetes||Participants|Count of Participants|48|48.0||||||
3688237|NCT02244619|3530418|B3|||Body mass index|In the study data, BMI ranged from 19 (minimum) to 56 (maximum).|lb/in^2x703|Median|32.1|32.1|Inter-Quartile Range|||28.4|36.8|
3688238|NCT02244619|3530419|B2|||Body mass index|In the study data, BMI ranged from 19 (minimum) to 56 (maximum).|lb/in^2x703|Median|32.3|32.3|Inter-Quartile Range|||28.5|36.71|
3688239|NCT02244619|3530420|B1|||Body mass index|In the study data, BMI ranged from 19 (minimum) to 56 (maximum).|lb/in^2x703|Median|31.9|31.9|Inter-Quartile Range|||28.3|37.08|
3688240|NCT02244619|3530418|B3|||Oxford score (hip or knee as appropriate)|"12-item ordinal scales. Each item ranges from 0 (high impairment) to 4 (no impairment). Total score ranges from 0-48 with following interpretation:~0-19: May indicate severe arthritis.~20-29: May indicate moderate to severe arthritis.~30-39: May indicate mild to moderate arthritis.~40-48: May indicate satisfactory joint function."|units on a scale|Mean|20.47|20.47|Standard Deviation|7.6|7.6|||
3688241|NCT02244619|3530419|B2|||Oxford score (hip or knee as appropriate)|"12-item ordinal scales. Each item ranges from 0 (high impairment) to 4 (no impairment). Total score ranges from 0-48 with following interpretation:~0-19: May indicate severe arthritis.~20-29: May indicate moderate to severe arthritis.~30-39: May indicate mild to moderate arthritis.~40-48: May indicate satisfactory joint function."|units on a scale|Mean|20.19|20.19|Standard Deviation|7.8|7.8|||
3688242|NCT02244619|3530420|B1|||Oxford score (hip or knee as appropriate)|"12-item ordinal scales. Each item ranges from 0 (high impairment) to 4 (no impairment). Total score ranges from 0-48 with following interpretation:~0-19: May indicate severe arthritis.~20-29: May indicate moderate to severe arthritis.~30-39: May indicate mild to moderate arthritis.~40-48: May indicate satisfactory joint function."|units on a scale|Mean|20.76|20.76|Standard Deviation|7.5|7.5|||
3688243|NCT02244619|3530418|B3|||Taking medications for chronic pain||Participants|Count of Participants|426|426.0||||||
3688244|NCT02244619|3530419|B2|||Taking medications for chronic pain||Participants|Count of Participants|212|212.0||||||
3688245|NCT02244619|3530420|B1|||Taking medications for chronic pain||Participants|Count of Participants|214|214.0||||||
3688246|NCT02244619|3530418|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3688247|NCT02244619|3530419|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688248|NCT02244619|3530420|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3688249|NCT02244619|3530418|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3688250|NCT02244619|3530419|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3688251|NCT02244619|3530420|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688252|NCT02244619|3530418|B3||White|Race (NIH/OMB)||Participants|Count of Participants|464|464.0||||||
3688253|NCT02244619|3530419|B2||White|Race (NIH/OMB)||Participants|Count of Participants|230|230.0||||||
3688254|NCT02244619|3530420|B1||White|Race (NIH/OMB)||Participants|Count of Participants|234|234.0||||||
3688255|NCT02244619|3530418|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3688256|NCT02244619|3530419|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3688257|NCT02244619|3530420|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3688258|NCT02244619|3530418|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688259|NCT02244619|3530419|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688260|NCT02244619|3530420|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688261|NCT02244619|3530418|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3688262|NCT02244619|3530419|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3688263|NCT02244619|3530420|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688264|NCT02244619|3530418|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3688265|NCT02244619|3530419|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688266|NCT02244619|3530420|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3688267|NCT02244619|3530418|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3688268|NCT02244619|3530419|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688269|NCT02244619|3530420|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3688270|NCT02244619|3530418|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|477|477.0||||||
3688271|NCT02244619|3530419|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|240|240.0||||||
3688272|NCT02244619|3530420|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|237|237.0||||||
3688273|NCT02244619|3530418|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3688274|NCT02244619|3530419|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3688275|NCT02244619|3530420|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3688276|NCT02244619|3530418|B3||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
3688277|NCT02244619|3530419|B2||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3688278|NCT02244619|3530420|B1||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3688279|NCT02244619|3530418|B3||Female|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
3688280|NCT02244619|3530419|B2||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3688281|NCT02244619|3530420|B1||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3688282|NCT02244619|3530418|B3|||Age||years|Median|67.0|67.0|Inter-Quartile Range|||60.0|73.0|
3688283|NCT02244619|3530419|B2|||Age||years|Median|67.0|67.0|Inter-Quartile Range|||60.0|72.5|
3688284|NCT02244619|3530420|B1|||Age||years|Median|67.0|67.0|Inter-Quartile Range|||59.5|73.0|
3688285|NCT02244580|3530439|B1|Finland||Region of Enrollment||participants|Number|1010|1010.0||||||
3688286|NCT02244580|3530439|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3688287|NCT02244580|3530439|B1||Female|Sex: Female, Male||Participants|Count of Participants|1010|1010.0||||||
3688288|NCT02244580|3530439|B1|||Age||years|Median|50.9|50.9|Full Range|||25.5|65.8|
3688289|NCT02243943|3530447|B3||Male|Gender||Participants|Count of Participants|49|49.0||||||
3688290|NCT02243943|3530448|B2||Male|Gender||Participants|Count of Participants|26|26.0||||||
3688291|NCT02243943|3530449|B1||Male|Gender||Participants|Count of Participants|23|23.0||||||
3688292|NCT02243943|3530447|B3||Female|Gender||Participants|Count of Participants|51|51.0||||||
3688293|NCT02243943|3530448|B2||Female|Gender||Participants|Count of Participants|24|24.0||||||
3688294|NCT02243943|3530449|B1||Female|Gender||Participants|Count of Participants|27|27.0||||||
3688295|NCT02243943|3530447|B3|||Age||years of age|Median|55|55.0|Full Range|||19.0|94.0|
3688296|NCT02243943|3530448|B2|||Age||years of age|Median|55|55.0|Full Range|||19.0|94.0|
3688297|NCT02243943|3530449|B1|||Age||years of age|Median|55|55.0|Full Range|||27.0|72.0|
3688298|NCT02243293|3530460|B18||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688299|NCT02243293|3530461|B17||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688300|NCT02243293|3530462|B16||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688301|NCT02243293|3530463|B15||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688302|NCT02243293|3530464|B14||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688303|NCT02243293|3530465|B13||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688304|NCT02243293|3530466|B12||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688305|NCT02243293|3530467|B11||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688306|NCT02243293|3530468|B10||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688307|NCT02243293|3530469|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688308|NCT02243293|3530470|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688309|NCT02243293|3530471|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688310|NCT02243293|3530472|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688311|NCT02243293|3530473|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688312|NCT02243293|3530474|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688313|NCT02243293|3530475|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688314|NCT02243293|3530476|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688315|NCT02243293|3530477|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688316|NCT02243293|3530460|B18||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|626|626.0||||||
3688317|NCT02243293|3530461|B17||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3688318|NCT02243293|3530462|B16||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
3688319|NCT02243293|3530463|B15||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3688320|NCT02243293|3530464|B14||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3688321|NCT02243293|3530465|B13||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3688322|NCT02243293|3530466|B12||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3688323|NCT02243293|3530467|B11||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3688324|NCT02243293|3530468|B10||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3688325|NCT02243293|3530469|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3688326|NCT02243293|3530470|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3688327|NCT02243293|3530471|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3688328|NCT02243293|3530472|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3688329|NCT02243293|3530473|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3688330|NCT02243293|3530474|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3688331|NCT02243293|3530475|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3688332|NCT02243293|3530476|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3688333|NCT02243293|3530477|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3688334|NCT02243293|3530460|B18||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3688335|NCT02243293|3530461|B17||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3688336|NCT02243293|3530462|B16||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3688337|NCT02243293|3530463|B15||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3688338|NCT02243293|3530464|B14||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688339|NCT02243293|3530465|B13||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3688340|NCT02243293|3530466|B12||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3688341|NCT02243293|3530467|B11||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3688342|NCT02243293|3530468|B10||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3688343|NCT02243293|3530469|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3688344|NCT02243293|3530470|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3688345|NCT02243293|3530471|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3688346|NCT02243293|3530472|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3688347|NCT02243293|3530473|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3688348|NCT02243293|3530474|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3688349|NCT02243293|3530475|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3688350|NCT02243293|3530476|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3688351|NCT02243293|3530477|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3688352|NCT02243293|3530460|B18||Male|Sex: Female, Male||Participants|Count of Participants|398|398.0||||||
3688353|NCT02243293|3530461|B17||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3688354|NCT02243293|3530462|B16||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3688355|NCT02243293|3530463|B15||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3688356|NCT02243293|3530464|B14||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3688357|NCT02243293|3530465|B13||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3688358|NCT02243293|3530466|B12||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3688359|NCT02243293|3530467|B11||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3688360|NCT02243293|3530468|B10||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3688361|NCT02243293|3530469|B9||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3688362|NCT02243293|3530470|B8||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3688363|NCT02243293|3530471|B7||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3688364|NCT02243293|3530472|B6||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3688365|NCT02243293|3530473|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3688366|NCT02243293|3530474|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3688367|NCT02243293|3530475|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3688368|NCT02243293|3530476|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3688369|NCT02243293|3530477|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3688370|NCT02243293|3530460|B18||Female|Sex: Female, Male||Participants|Count of Participants|293|293.0||||||
3688371|NCT02243293|3530461|B17||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3688372|NCT02243293|3530462|B16||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3688373|NCT02243293|3530463|B15||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3688374|NCT02243293|3530464|B14||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3688375|NCT02243293|3530465|B13||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3688376|NCT02243293|3530466|B12||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3688377|NCT02243293|3530467|B11||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3688378|NCT02243293|3530468|B10||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3688379|NCT02243293|3530469|B9||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3688380|NCT02243293|3530470|B8||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3688381|NCT02243293|3530471|B7||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3688382|NCT02243293|3530472|B6||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3688383|NCT02243293|3530473|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3688384|NCT02243293|3530474|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3688385|NCT02243293|3530475|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3688386|NCT02243293|3530476|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3688387|NCT02243293|3530477|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3688388|NCT02243293|3530460|B18|>= 65 years||Age, Customized||participants|Number|75|75.0||||||
3688389|NCT02243293|3530461|B17|>= 65 years||Age, Customized||participants|Number|9|9.0||||||
3688390|NCT02243293|3530462|B16|>= 65 years||Age, Customized||participants|Number|17|17.0||||||
3688391|NCT02243293|3530463|B15|>= 65 years||Age, Customized||participants|Number|8|8.0||||||
3688392|NCT02243293|3530464|B14|>= 65 years||Age, Customized||participants|Number|3|3.0||||||
3688393|NCT02243293|3530465|B13|>= 65 years||Age, Customized||participants|Number|4|4.0||||||
3688394|NCT02243293|3530466|B12|>= 65 years||Age, Customized||participants|Number|2|2.0||||||
3688395|NCT02243293|3530467|B11|>= 65 years||Age, Customized||participants|Number|3|3.0||||||
3688396|NCT02243293|3530468|B10|>= 65 years||Age, Customized||participants|Number|2|2.0||||||
3688397|NCT02243293|3530469|B9|>= 65 years||Age, Customized||participants|Number|1|1.0||||||
3688398|NCT02243293|3530470|B8|>= 65 years||Age, Customized||participants|Number|10|10.0||||||
3688399|NCT02243293|3530471|B7|>= 65 years||Age, Customized||participants|Number|2|2.0||||||
3688400|NCT02243293|3530472|B6|>= 65 years||Age, Customized||participants|Number|1|1.0||||||
3688401|NCT02243293|3530473|B5|>= 65 years||Age, Customized||participants|Number|1|1.0||||||
3688402|NCT02243293|3530474|B4|>= 65 years||Age, Customized||participants|Number|2|2.0||||||
3688403|NCT02243293|3530475|B3|>= 65 years||Age, Customized||participants|Number|3|3.0||||||
3688404|NCT02243293|3530476|B2|>= 65 years||Age, Customized||participants|Number|3|3.0||||||
3688405|NCT02243293|3530477|B1|>= 65 years||Age, Customized||participants|Number|4|4.0||||||
3688406|NCT02243293|3530460|B18|< 65 years||Age, Customized||participants|Number|616|616.0||||||
3688407|NCT02243293|3530461|B17|< 65 years||Age, Customized||participants|Number|49|49.0||||||
3688408|NCT02243293|3530462|B16|< 65 years||Age, Customized||participants|Number|128|128.0||||||
3688409|NCT02243293|3530463|B15|< 65 years||Age, Customized||participants|Number|39|39.0||||||
3688410|NCT02243293|3530464|B14|< 65 years||Age, Customized||participants|Number|19|19.0||||||
3688411|NCT02243293|3530465|B13|< 65 years||Age, Customized||participants|Number|18|18.0||||||
3688412|NCT02243293|3530466|B12|< 65 years||Age, Customized||participants|Number|38|38.0||||||
3688413|NCT02243293|3530467|B11|< 65 years||Age, Customized||participants|Number|24|24.0||||||
3688414|NCT02243293|3530468|B10|< 65 years||Age, Customized||participants|Number|26|26.0||||||
3688415|NCT02243293|3530469|B9|< 65 years||Age, Customized||participants|Number|52|52.0||||||
3688416|NCT02243293|3530470|B8|< 65 years||Age, Customized||participants|Number|44|44.0||||||
3688417|NCT02243293|3530471|B7|< 65 years||Age, Customized||participants|Number|28|28.0||||||
3688418|NCT02243293|3530472|B6|< 65 years||Age, Customized||participants|Number|30|30.0||||||
3688419|NCT02243293|3530473|B5|< 65 years||Age, Customized||participants|Number|29|29.0||||||
3688420|NCT02243293|3530474|B4|< 65 years||Age, Customized||participants|Number|28|28.0||||||
3688421|NCT02243293|3530475|B3|< 65 years||Age, Customized||participants|Number|22|22.0||||||
3688422|NCT02243293|3530476|B2|< 65 years||Age, Customized||participants|Number|21|21.0||||||
3688423|NCT02243293|3530477|B1|< 65 years||Age, Customized||participants|Number|21|21.0||||||
3688424|NCT02243280|3530586|B12||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3688425|NCT02243280|3530587|B11||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3688426|NCT02243280|3530588|B10||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3688427|NCT02243280|3530589|B9||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3688428|NCT02243280|3530590|B8||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3688429|NCT02243280|3530591|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3688430|NCT02243280|3530592|B6||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3688431|NCT02243280|3530593|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3688432|NCT02243280|3530594|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3688433|NCT02243280|3530595|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3688434|NCT02243280|3530596|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3688435|NCT02243280|3530597|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3688436|NCT02243280|3530586|B12||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3688437|NCT02243280|3530587|B11||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3688438|NCT02243280|3530588|B10||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3688439|NCT02243280|3530589|B9||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3688440|NCT02243280|3530590|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3688441|NCT02243280|3530591|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3688442|NCT02243280|3530592|B6||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3688443|NCT02243280|3530593|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3688444|NCT02243280|3530594|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3688445|NCT02243280|3530595|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3688446|NCT02243280|3530596|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3688447|NCT02243280|3530597|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3688448|NCT02243280|3530586|B12|||Age||years|Mean|54.1|54.1|Standard Deviation|9.98|9.98|||
3688449|NCT02243280|3530587|B11|||Age||years|Mean|53.5|53.5|Standard Deviation|10.34|10.34|||
3688450|NCT02243280|3530589|B9|||Age||years|Mean|55.0|55.0|Standard Deviation|11.13|11.13|||
3688451|NCT02243280|3530592|B6|||Age||years|Mean|58.9|58.9|Standard Deviation|5.47|5.47|||
3688452|NCT02243280|3530596|B2|||Age||years|Mean|52.5|52.5|Standard Deviation|10.41|10.41|||
3688453|NCT02243280|3530597|B1|||Age||years|Mean|52.4|52.4|Standard Deviation|10.01|10.01|||
3688454|NCT02243202|3530658|B5|||Baseline Pulse Rate||(BEATS/MIN)|Mean|72.0|72.0|Standard Deviation|9.50|9.5|||
3688455|NCT02243202|3530659|B4|||Baseline Pulse Rate||(BEATS/MIN)|Mean|72.4|72.4|Standard Deviation|9.66|9.66|||
3688456|NCT02243202|3530660|B3|||Baseline Pulse Rate||(BEATS/MIN)|Mean|71.5|71.5|Standard Deviation|9.40|9.4|||
3688457|NCT02243202|3530661|B2|||Baseline Pulse Rate||(BEATS/MIN)|Mean|70.7|70.7|Standard Deviation|10.09|10.09|||
3688458|NCT02243202|3530662|B1|||Baseline Pulse Rate||(BEATS/MIN)|Mean|73.5|73.5|Standard Deviation|8.72|8.72|||
3688459|NCT02243202|3530658|B5|||Baseline Diastolic Blood Pressure||millimeters of mercury [mmHg]|Mean|79.1|79.1|Standard Deviation|8.39|8.39|||
3688460|NCT02243202|3530659|B4|||Baseline Diastolic Blood Pressure||millimeters of mercury [mmHg]|Mean|79.4|79.4|Standard Deviation|8.21|8.21|||
3688461|NCT02243202|3530660|B3|||Baseline Diastolic Blood Pressure||millimeters of mercury [mmHg]|Mean|80.2|80.2|Standard Deviation|7.88|7.88|||
3688462|NCT02243202|3530661|B2|||Baseline Diastolic Blood Pressure||millimeters of mercury [mmHg]|Mean|78.1|78.1|Standard Deviation|9.00|9.0|||
3688463|NCT02243202|3530662|B1|||Baseline Diastolic Blood Pressure||millimeters of mercury [mmHg]|Mean|78.8|78.8|Standard Deviation|8.43|8.43|||
3688464|NCT02243202|3530658|B5|||Baseline Systolic Blood Pressure||millimeters of mercury [mmHg]|Mean|123.7|123.7|Standard Deviation|12.87|12.87|||
3688465|NCT02243202|3530659|B4|||Baseline Systolic Blood Pressure||millimeters of mercury [mmHg]|Mean|124.8|124.8|Standard Deviation|12.83|12.83|||
3688466|NCT02243202|3530660|B3|||Baseline Systolic Blood Pressure||millimeters of mercury [mmHg]|Mean|124.5|124.5|Standard Deviation|13.01|13.01|||
3688467|NCT02243202|3530661|B2|||Baseline Systolic Blood Pressure||millimeters of mercury [mmHg]|Mean|123.0|123.0|Standard Deviation|11.83|11.83|||
3688468|NCT02243202|3530662|B1|||Baseline Systolic Blood Pressure||millimeters of mercury [mmHg]|Mean|122.5|122.5|Standard Deviation|13.86|13.86|||
3688469|NCT02243202|3530658|B5|||Baseline Body Mass Index (BMI)||kilogram per meter square [kg/m²]|Mean|37.3|37.3|Standard Deviation|5.16|5.16|||
3688470|NCT02243202|3530659|B4|||Baseline Body Mass Index (BMI)||kilogram per meter square [kg/m²]|Mean|36.8|36.8|Standard Deviation|5.36|5.36|||
3688471|NCT02243202|3530660|B3|||Baseline Body Mass Index (BMI)||kilogram per meter square [kg/m²]|Mean|37.3|37.3|Standard Deviation|4.68|4.68|||
3688472|NCT02243202|3530661|B2|||Baseline Body Mass Index (BMI)||kilogram per meter square [kg/m²]|Mean|37|37.0|Standard Deviation|5.4|5.4|||
3688473|NCT02243202|3530662|B1|||Baseline Body Mass Index (BMI)||kilogram per meter square [kg/m²]|Mean|38|38.0|Standard Deviation|5.2|5.2|||
3688474|NCT02243202|3530658|B5|||Baseline Weight||Kilogram [kg]|Mean|102.9|102.9|Standard Deviation|18.28|18.28|||
3688475|NCT02243202|3530659|B4|||Baseline Weight||Kilogram [kg]|Mean|101.1|101.1|Standard Deviation|18.07|18.07|||
3688476|NCT02243202|3530660|B3|||Baseline Weight||Kilogram [kg]|Mean|103.3|103.3|Standard Deviation|19.14|19.14|||
3688477|NCT02243202|3530661|B2|||Baseline Weight||Kilogram [kg]|Mean|102.8|102.8|Standard Deviation|17.89|17.89|||
3688478|NCT02243202|3530662|B1|||Baseline Weight||Kilogram [kg]|Mean|104.3|104.3|Standard Deviation|18.16|18.16|||
3688479|NCT02243202|3530658|B5|United States||Region of Enrollment||participants|Number|334|334.0||||||
3688480|NCT02243202|3530659|B4|United States||Region of Enrollment||participants|Number|83|83.0||||||
3688481|NCT02243202|3530660|B3|United States||Region of Enrollment||participants|Number|84|84.0||||||
3688482|NCT02243202|3530661|B2|United States||Region of Enrollment||participants|Number|85|85.0||||||
3688483|NCT02243202|3530662|B1|United States||Region of Enrollment||participants|Number|82|82.0||||||
3688484|NCT02243202|3530658|B5||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3688485|NCT02243202|3530659|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3688486|NCT02243202|3530660|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3688487|NCT02243202|3530661|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3688488|NCT02243202|3530662|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3688489|NCT02243202|3530658|B5||Female|Sex: Female, Male||Participants|Count of Participants|273|273.0||||||
3688490|NCT02243202|3530659|B4||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3688491|NCT02243202|3530660|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3688492|NCT02243202|3530661|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3688493|NCT02243202|3530662|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3688494|NCT02243202|3530658|B5|||Age||years|Mean|45.7|45.7|Standard Deviation|11.41|11.41|||
3688495|NCT02243202|3530659|B4|||Age||years|Mean|46.3|46.3|Standard Deviation|12.45|12.45|||
3688496|NCT02243202|3530660|B3|||Age||years|Mean|45.2|45.2|Standard Deviation|11.02|11.02|||
3688497|NCT02243202|3530661|B2|||Age||years|Mean|46.4|46.4|Standard Deviation|11.14|11.14|||
3688498|NCT02243202|3530662|B1|||Age||years|Mean|44.8|44.8|Standard Deviation|11.09|11.09|||
3688499|NCT02243176|3530699|B3|||HDL|High Density Lipoprotein-Cholesterol|mmol/l|Mean|1.18|1.18|Standard Deviation|0.3|0.3|||
3688500|NCT02243176|3530700|B2|||HDL|High Density Lipoprotein-Cholesterol|mmol/l|Mean|1.2|1.2|Standard Deviation|0.3|0.3|||
3688501|NCT02243176|3530701|B1|||HDL|High Density Lipoprotein-Cholesterol|mmol/l|Mean|1.16|1.16|Standard Deviation|0.29|0.29|||
3688502|NCT02243176|3530699|B3|||LDL|Low Density Lipoprotein-Cholesterol|mmol/l|Mean|2.75|2.75|Standard Deviation|0.84|0.84|||
3688503|NCT02243176|3530700|B2|||LDL|Low Density Lipoprotein-Cholesterol|mmol/l|Mean|2.77|2.77|Standard Deviation|0.79|0.79|||
3688504|NCT02243176|3530701|B1|||LDL|Low Density Lipoprotein-Cholesterol|mmol/l|Mean|2.73|2.73|Standard Deviation|0.89|0.89|||
3688505|NCT02243176|3530699|B3|||TC|Total Cholesterol|mmol/l|Mean|4.80|4.8|Standard Deviation|1.01|1.01|||
3688506|NCT02243176|3530700|B2|||TC|Total Cholesterol|mmol/l|Mean|4.82|4.82|Standard Deviation|0.94|0.94|||
3688507|NCT02243176|3530701|B1|||TC|Total Cholesterol|mmol/l|Mean|4.78|4.78|Standard Deviation|1.07|1.07|||
3688508|NCT02243176|3530699|B3|||Triglycerides||mmol/l|Mean|1.97|1.97|Standard Deviation|1.26|1.26|||
3688509|NCT02243176|3530700|B2|||Triglycerides||mmol/l|Mean|1.96|1.96|Standard Deviation|1.38|1.38|||
3688510|NCT02243176|3530701|B1|||Triglycerides||mmol/l|Mean|1.99|1.99|Standard Deviation|1.12|1.12|||
3688511|NCT02243176|3530699|B3|||2hPPG|2h Postprandial Plasma Glucose|mmol/l|Mean|10.7|10.7|Standard Deviation|2.89|2.89|||
3688512|NCT02243176|3530700|B2|||2hPPG|2h Postprandial Plasma Glucose|mmol/l|Mean|10.25|10.25|Standard Deviation|2.89|2.89|||
3688513|NCT02243176|3530701|B1|||2hPPG|2h Postprandial Plasma Glucose|mmol/l|Mean|11.17|11.17|Standard Deviation|2.82|2.82|||
3688514|NCT02243176|3530699|B3|||FPG|Fasting Plasma Glucose|mmol/l|Mean|8.90|8.9|Standard Deviation|2.04|2.04|||
3688515|NCT02243176|3530700|B2|||FPG|Fasting Plasma Glucose|mmol/l|Mean|8.81|8.81|Standard Deviation|1.95|1.95|||
3688516|NCT02243176|3530701|B1|||FPG|Fasting Plasma Glucose|mmol/l|Mean|9.01|9.01|Standard Deviation|2.14|2.14|||
3688517|NCT02243176|3530699|B3|||HbA1c (%)|Haemoglobin A1c|%|Mean|8.20|8.2|Standard Deviation|0.83|0.83|||
3688518|NCT02243176|3530700|B2|||HbA1c (%)|Haemoglobin A1c|%|Mean|8.16|8.16|Standard Deviation|0.81|0.81|||
3688519|NCT02243176|3530701|B1|||HbA1c (%)|Haemoglobin A1c|%|Mean|8.23|8.23|Standard Deviation|0.85|0.85|||
3688520|NCT02243176|3530699|B3|No||Any current medication，excluding antidiabetic drugs||Participants|Number|349|349.0||||||
3688521|NCT02243176|3530700|B2|No||Any current medication，excluding antidiabetic drugs||Participants|Number|170|170.0||||||
3688522|NCT02243176|3530701|B1|No||Any current medication，excluding antidiabetic drugs||Participants|Number|179|179.0||||||
3688523|NCT02243176|3530699|B3|Yes||Any current medication，excluding antidiabetic drugs||Participants|Number|132|132.0||||||
3688524|NCT02243176|3530700|B2|Yes||Any current medication，excluding antidiabetic drugs||Participants|Number|73|73.0||||||
3688525|NCT02243176|3530701|B1|Yes||Any current medication，excluding antidiabetic drugs||Participants|Number|59|59.0||||||
3688526|NCT02243176|3530699|B3|Missing||Any relevant medical conditions||Participants|Number|108|108.0||||||
3688527|NCT02243176|3530700|B2|Missing||Any relevant medical conditions||Participants|Number|54|54.0||||||
3688528|NCT02243176|3530701|B1|Missing||Any relevant medical conditions||Participants|Number|54|54.0||||||
3688529|NCT02243176|3530699|B3|No||Any relevant medical conditions||Participants|Number|129|129.0||||||
3688530|NCT02243176|3530700|B2|No||Any relevant medical conditions||Participants|Number|64|64.0||||||
3688531|NCT02243176|3530701|B1|No||Any relevant medical conditions||Participants|Number|65|65.0||||||
3688532|NCT02243176|3530699|B3|Yes||Any relevant medical conditions||Participants|Number|244|244.0||||||
3688533|NCT02243176|3530700|B2|Yes||Any relevant medical conditions||Participants|Number|125|125.0||||||
3688534|NCT02243176|3530701|B1|Yes||Any relevant medical conditions||Participants|Number|119|119.0||||||
3688535|NCT02243176|3530699|B3|Yes||Any diabetes mellitus complications||Participants|Number|46|46.0||||||
3688536|NCT02243176|3530700|B2|Yes||Any diabetes mellitus complications||Participants|Number|22|22.0||||||
3688537|NCT02243176|3530701|B1|Yes||Any diabetes mellitus complications||Participants|Number|24|24.0||||||
3688538|NCT02243176|3530699|B3|No||Any diabetes mellitus complications||Participants|Number|435|435.0||||||
3688539|NCT02243176|3530700|B2|No||Any diabetes mellitus complications||Participants|Number|221|221.0||||||
3688540|NCT02243176|3530701|B1|No||Any diabetes mellitus complications||Participants|Number|214|214.0||||||
3688541|NCT02243176|3530699|B3|||Currently taking antidiabetic medication||Participants|Number|481|481.0||||||
3688542|NCT02243176|3530700|B2|||Currently taking antidiabetic medication||Participants|Number|243|243.0||||||
3688543|NCT02243176|3530701|B1|||Currently taking antidiabetic medication||Participants|Number|238|238.0||||||
3688544|NCT02243176|3530699|B3|Other||Type of diabetes mellitus||Participants|Number|0|0.0||||||
3688545|NCT02243176|3530700|B2|Other||Type of diabetes mellitus||Participants|Number|0|0.0||||||
3688546|NCT02243176|3530701|B1|Other||Type of diabetes mellitus||Participants|Number|0|0.0||||||
3688547|NCT02243176|3530699|B3|Type 2||Type of diabetes mellitus||Participants|Number|481|481.0||||||
3688548|NCT02243176|3530700|B2|Type 2||Type of diabetes mellitus||Participants|Number|243|243.0||||||
3688549|NCT02243176|3530701|B1|Type 2||Type of diabetes mellitus||Participants|Number|238|238.0||||||
3688550|NCT02243176|3530699|B3|||Duration of diabetes mellitus (years)||Years|Mean|5.2|5.2|Standard Deviation|4.58|4.58|||
3688551|NCT02243176|3530700|B2|||Duration of diabetes mellitus (years)||Years|Mean|5.3|5.3|Standard Deviation|4.76|4.76|||
3688552|NCT02243176|3530701|B1|||Duration of diabetes mellitus (years)||Years|Mean|5.1|5.1|Standard Deviation|4.4|4.4|||
3688553|NCT02243176|3530699|B3|||BMI|Body Mass Index|kg/m^2|Mean|26.3|26.3|Standard Deviation|3.48|3.48|||
3688554|NCT02243176|3530700|B2|||BMI|Body Mass Index|kg/m^2|Mean|26.3|26.3|Standard Deviation|3.49|3.49|||
3688555|NCT02243176|3530701|B1|||BMI|Body Mass Index|kg/m^2|Mean|26.4|26.4|Standard Deviation|3.47|3.47|||
3688556|NCT02243176|3530699|B3|||Weight||kg|Mean|72.9|72.9|Standard Deviation|12.43|12.43|||
3688557|NCT02243176|3530700|B2|||Weight||kg|Mean|72.6|72.6|Standard Deviation|12.27|12.27|||
3688558|NCT02243176|3530701|B1|||Weight||kg|Mean|73.3|73.3|Standard Deviation|12.61|12.61|||
3688559|NCT02243176|3530699|B3|||Height||cm|Mean|166.1|166.1|Standard Deviation|7.87|7.87|||
3688560|NCT02243176|3530700|B2|||Height||cm|Mean|165.9|165.9|Standard Deviation|7.75|7.75|||
3688561|NCT02243176|3530701|B1|||Height||cm|Mean|166.3|166.3|Standard Deviation|8|8.0|||
3688562|NCT02243176|3530699|B3|Asian (China Mainland)||Race/Ethnicity, Customized||Participants|Number|481|481.0||||||
3688563|NCT02243176|3530700|B2|Asian (China Mainland)||Race/Ethnicity, Customized||Participants|Number|243|243.0||||||
3688564|NCT02243176|3530701|B1|Asian (China Mainland)||Race/Ethnicity, Customized||Participants|Number|238|238.0||||||
3688565|NCT02243176|3530699|B3||Male|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
3688566|NCT02243176|3530700|B2||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3688567|NCT02243176|3530701|B1||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3688568|NCT02243176|3530699|B3||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
3688569|NCT02243176|3530700|B2||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3688570|NCT02243176|3530701|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3688571|NCT02243176|3530699|B3|||Age||Years|Mean|55.6|55.6|Standard Deviation|10.69|10.69|||
3688572|NCT02243176|3530700|B2|||Age||Years|Mean|56.5|56.5|Standard Deviation|10.81|10.81|||
3688573|NCT02243176|3530701|B1|||Age||Years|Mean|54.7|54.7|Standard Deviation|10.51|10.51|||
3688574|NCT02243046|3530724|B4|Dominican Republic||Region of Enrollment||participants|Number|162|162.0||||||
3688575|NCT02243046|3530725|B3|Dominican Republic||Region of Enrollment||participants|Number|53|53.0||||||
3688576|NCT02243046|3530726|B2|Dominican Republic||Region of Enrollment||participants|Number|54|54.0||||||
3688577|NCT02243046|3530727|B1|Dominican Republic||Region of Enrollment||participants|Number|55|55.0||||||
3688578|NCT02243046|3530724|B4||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3688579|NCT02243046|3530725|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3688580|NCT02243046|3530726|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3688581|NCT02243046|3530727|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3688582|NCT02243046|3530724|B4||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3688583|NCT02243046|3530725|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3688584|NCT02243046|3530726|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3688585|NCT02243046|3530727|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3688586|NCT02243046|3530724|B4|||Age||years|Mean|30.62|30.62|Standard Deviation|11.39|11.39|||
3688587|NCT02243046|3530725|B3|||Age||years|Mean|30.39|30.39|Standard Deviation|13.47|13.47|||
3688588|NCT02243046|3530726|B2|||Age||years|Mean|30.92|30.92|Standard Deviation|9.82|9.82|||
3688589|NCT02243046|3530727|B1|||Age||years|Mean|30.52|30.52|Standard Deviation|10.99|10.99|||
3688590|NCT02243007|3530752|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
3688591|NCT02243007|3530753|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3688592|NCT02243007|3530754|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3688593|NCT02243007|3530752|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3688594|NCT02243007|3530753|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3688595|NCT02243007|3530754|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3688596|NCT02243007|3530752|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3688597|NCT02243007|3530753|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3688598|NCT02243007|3530754|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3688599|NCT02243007|3530752|B3|||Age||years|Median|65.6|65.6|Full Range|||49.4|74.1|
3688600|NCT02243007|3530753|B2|||Age||years|Median|71.9|71.9|Full Range|||59.9|74.1|
3688601|NCT02243007|3530754|B1|||Age||years|Median|63.4|63.4|Full Range|||49.4|68.3|
3688602|NCT02242994|3530777|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3688603|NCT02242994|3530777|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
3688604|NCT02242994|3530777|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
3688605|NCT02242994|3530777|B1|||Age||years|Mean|10.6|10.6|Standard Deviation|4.3|4.3|||
3688606|NCT02242903|3530782|B8|United States||Region of Enrollment||participants|Number|48|48.0||||||
3688607|NCT02242903|3530783|B7|United States||Region of Enrollment||participants|Number|6|6.0||||||
3688608|NCT02242903|3530784|B6|United States||Region of Enrollment||participants|Number|6|6.0||||||
3688609|NCT02242903|3530785|B5|United States||Region of Enrollment||participants|Number|6|6.0||||||
3688610|NCT02242903|3530786|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
3688611|NCT02242903|3530787|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3688612|NCT02242903|3530788|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3688613|NCT02242903|3530789|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3688614|NCT02242903|3530782|B8|Non-Japanese||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3688615|NCT02242903|3530783|B7|Non-Japanese||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3688616|NCT02242903|3530784|B6|Non-Japanese||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3688617|NCT02242903|3530785|B5|Non-Japanese||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3688618|NCT02242903|3530786|B4|Non-Japanese||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3688619|NCT02242903|3530787|B3|Non-Japanese||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3688620|NCT02242903|3530788|B2|Non-Japanese||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3688621|NCT02242903|3530789|B1|Non-Japanese||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3688622|NCT02242903|3530782|B8|Japanese||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3688623|NCT02242903|3530783|B7|Japanese||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3688624|NCT02242903|3530784|B6|Japanese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3688625|NCT02242903|3530785|B5|Japanese||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3688626|NCT02242903|3530786|B4|Japanese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3688627|NCT02242903|3530787|B3|Japanese||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3688628|NCT02242903|3530788|B2|Japanese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3688629|NCT02242903|3530789|B1|Japanese||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3688630|NCT02242903|3530782|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688631|NCT02242903|3530783|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688632|NCT02242903|3530784|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688633|NCT02242903|3530785|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688634|NCT02242903|3530786|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688635|NCT02242903|3530787|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688636|NCT02242903|3530788|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688637|NCT02242903|3530789|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688638|NCT02242903|3530782|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3688639|NCT02242903|3530783|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3688640|NCT02242903|3530784|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3688641|NCT02242903|3530785|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3688642|NCT02242903|3530786|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3688643|NCT02242903|3530787|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3688644|NCT02242903|3530788|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3688645|NCT02242903|3530789|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3688646|NCT02242903|3530782|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3688647|NCT02242903|3530783|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3688648|NCT02242903|3530784|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3688649|NCT02242903|3530785|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3688650|NCT02242903|3530786|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3688651|NCT02242903|3530787|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3688652|NCT02242903|3530788|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688653|NCT02242903|3530789|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3688654|NCT02242903|3530782|B8||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3688655|NCT02242903|3530783|B7||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3688656|NCT02242903|3530784|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3688657|NCT02242903|3530785|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3688658|NCT02242903|3530786|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3688659|NCT02242903|3530787|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3688660|NCT02242903|3530788|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3688661|NCT02242903|3530789|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3688662|NCT02242903|3530782|B8||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3688663|NCT02242903|3530783|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3688664|NCT02242903|3530784|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3688665|NCT02242903|3530785|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3688666|NCT02242903|3530786|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3688667|NCT02242903|3530787|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3688668|NCT02242903|3530788|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3688669|NCT02242903|3530789|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3688670|NCT02242903|3530782|B8|||Age||years|Mean|40.5|40.5|Standard Deviation|11.65|11.65|||
3688671|NCT02242903|3530783|B7|||Age||years|Mean|49.3|49.3|Standard Deviation|5.61|5.61|||
3688672|NCT02242903|3530784|B6|||Age||years|Mean|39.0|39.0|Standard Deviation|11.56|11.56|||
3688673|NCT02242903|3530785|B5|||Age||years|Mean|45.3|45.3|Standard Deviation|12.39|12.39|||
3688674|NCT02242903|3530786|B4|||Age||years|Mean|38.0|38.0|Standard Deviation|12.82|12.82|||
3688675|NCT02242903|3530787|B3|||Age||years|Mean|34.5|34.5|Standard Deviation|12.42|12.42|||
3688676|NCT02242903|3530788|B2|||Age||years|Mean|35.5|35.5|Standard Deviation|10.82|10.82|||
3688677|NCT02242903|3530789|B1|||Age||years|Mean|41.1|41.1|Standard Deviation|11.96|11.96|||
3688678|NCT02242643|3530823|B3||Male|Sex: Female, Male||Participants|Count of Participants|1295|1295.0||||||
3688679|NCT02242643|3530824|B2||Male|Sex: Female, Male||Participants|Count of Participants|635|635.0||||||
3688680|NCT02242643|3530825|B1||Male|Sex: Female, Male||Participants|Count of Participants|660|660.0||||||
3688681|NCT02242643|3530823|B3||Female|Sex: Female, Male||Participants|Count of Participants|1129|1129.0||||||
3688682|NCT02242643|3530824|B2||Female|Sex: Female, Male||Participants|Count of Participants|582|582.0||||||
3688683|NCT02242643|3530825|B1||Female|Sex: Female, Male||Participants|Count of Participants|547|547.0||||||
3688684|NCT02242643|3530823|B3|||Age||Months|Mean|19.45|19.45|Standard Deviation|8.80|8.8|||
3688685|NCT02242643|3530824|B2|||Age||Months|Mean|19.5|19.5|Standard Deviation|8.9|8.9|||
3688686|NCT02242643|3530825|B1|||Age||Months|Mean|19.4|19.4|Standard Deviation|8.7|8.7|||
3688687|NCT02242630|3530858|B5|United States||Region of Enrollment||participants|Number|61|61.0||||||
3688688|NCT02242630|3530859|B4|United States||Region of Enrollment||participants|Number|16|16.0||||||
3688689|NCT02242630|3530860|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
3688690|NCT02242630|3530861|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3688691|NCT02242630|3530862|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3688692|NCT02242630|3530858|B5||Male|Gender||Participants|Count of Participants|32|32.0||||||
3688693|NCT02242630|3530859|B4||Male|Gender||Participants|Count of Participants|9|9.0||||||
3688694|NCT02242630|3530860|B3||Male|Gender||Participants|Count of Participants|9|9.0||||||
3688695|NCT02242630|3530861|B2||Male|Gender||Participants|Count of Participants|9|9.0||||||
3688696|NCT02242630|3530862|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
3688697|NCT02242630|3530858|B5||Female|Gender||Participants|Count of Participants|29|29.0||||||
3688698|NCT02242630|3530859|B4||Female|Gender||Participants|Count of Participants|7|7.0||||||
3688699|NCT02242630|3530860|B3||Female|Gender||Participants|Count of Participants|6|6.0||||||
3688700|NCT02242630|3530861|B2||Female|Gender||Participants|Count of Participants|6|6.0||||||
3688701|NCT02242630|3530862|B1||Female|Gender||Participants|Count of Participants|10|10.0||||||
3688702|NCT02242630|3530858|B5|||Age||years|Mean|67.1|67.1|Standard Deviation|10.8|10.8|||
3688703|NCT02242630|3530859|B4|||Age||years|Mean|69.0|69.0|Standard Deviation|9.5|9.5|||
3688704|NCT02242630|3530860|B3|||Age||years|Mean|66.9|66.9|Standard Deviation|12.3|12.3|||
3688705|NCT02242630|3530861|B2|||Age||years|Mean|69.3|69.3|Standard Deviation|10.0|10.0|||
3688706|NCT02242630|3530862|B1|||Age||years|Mean|63.0|63.0|Standard Deviation|10.9|10.9|||
3688707|NCT02242630|3530858|B5||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
3688708|NCT02242630|3530859|B4||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3688709|NCT02242630|3530860|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3688710|NCT02242630|3530861|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3688711|NCT02242630|3530862|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3688712|NCT02242630|3530858|B5||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3688713|NCT02242630|3530859|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3688714|NCT02242630|3530860|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3688715|NCT02242630|3530861|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3688716|NCT02242630|3530862|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3688717|NCT02242630|3530858|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3688718|NCT02242630|3530859|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3688719|NCT02242630|3530860|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3688720|NCT02242630|3530861|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3688721|NCT02242630|3530862|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3688722|NCT02242305|3530879|B3||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3688723|NCT02242305|3530880|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3688724|NCT02242305|3530881|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3688725|NCT02242305|3530879|B3||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
3688726|NCT02242305|3530880|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3688727|NCT02242305|3530881|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3688728|NCT02242305|3530879|B3|||Age||Years|Mean|42.6|42.6|Standard Deviation|12.27|12.27|||
3688729|NCT02242305|3530880|B2|||Age||Years|Mean|41.9|41.9|Standard Deviation|12.05|12.05|||
3688730|NCT02242305|3530881|B1|||Age||Years|Mean|43.2|43.2|Standard Deviation|12.49|12.49|||
3688731|NCT02242201|3530900|B4|||BMI||kg/m2|Mean|30.1|30.1|Standard Deviation|5.8|5.8|||
3688732|NCT02242201|3530901|B3|||BMI||kg/m2|Mean|30.2|30.2|Standard Deviation|5.4|5.4|||
3688733|NCT02242201|3530902|B2|||BMI||kg/m2|Mean|30.1|30.1|Standard Deviation|6.0|6.0|||
3688734|NCT02242201|3530903|B1|||BMI||kg/m2|Mean|30.0|30.0|Standard Deviation|6.0|6.0|||
3688735|NCT02242201|3530900|B4||III|American Society of Anesthesiologists (ASA) Status|The ASA Physical Status Classification System assesses the fitness of patients prior to surgery. It defines an ASA I as a normal healthy patient, ASA II as a patient with mild systemic disease, and ASA III as a patient with severe systemic disease.|Participants|Count of Participants|29|29.0||||||
3688736|NCT02242201|3530901|B3||III|American Society of Anesthesiologists (ASA) Status|The ASA Physical Status Classification System assesses the fitness of patients prior to surgery. It defines an ASA I as a normal healthy patient, ASA II as a patient with mild systemic disease, and ASA III as a patient with severe systemic disease.|Participants|Count of Participants|9|9.0||||||
3688737|NCT02242201|3530902|B2||III|American Society of Anesthesiologists (ASA) Status|The ASA Physical Status Classification System assesses the fitness of patients prior to surgery. It defines an ASA I as a normal healthy patient, ASA II as a patient with mild systemic disease, and ASA III as a patient with severe systemic disease.|Participants|Count of Participants|13|13.0||||||
3688738|NCT02242201|3530903|B1||III|American Society of Anesthesiologists (ASA) Status|The ASA Physical Status Classification System assesses the fitness of patients prior to surgery. It defines an ASA I as a normal healthy patient, ASA II as a patient with mild systemic disease, and ASA III as a patient with severe systemic disease.|Participants|Count of Participants|7|7.0||||||
3688739|NCT02242201|3530900|B4||I or II|American Society of Anesthesiologists (ASA) Status|The ASA Physical Status Classification System assesses the fitness of patients prior to surgery. It defines an ASA I as a normal healthy patient, ASA II as a patient with mild systemic disease, and ASA III as a patient with severe systemic disease.|Participants|Count of Participants|130|130.0||||||
3688740|NCT02242201|3530901|B3||I or II|American Society of Anesthesiologists (ASA) Status|The ASA Physical Status Classification System assesses the fitness of patients prior to surgery. It defines an ASA I as a normal healthy patient, ASA II as a patient with mild systemic disease, and ASA III as a patient with severe systemic disease.|Participants|Count of Participants|45|45.0||||||
3688741|NCT02242201|3530902|B2||I or II|American Society of Anesthesiologists (ASA) Status|The ASA Physical Status Classification System assesses the fitness of patients prior to surgery. It defines an ASA I as a normal healthy patient, ASA II as a patient with mild systemic disease, and ASA III as a patient with severe systemic disease.|Participants|Count of Participants|41|41.0||||||
3688742|NCT02242201|3530903|B1||I or II|American Society of Anesthesiologists (ASA) Status|The ASA Physical Status Classification System assesses the fitness of patients prior to surgery. It defines an ASA I as a normal healthy patient, ASA II as a patient with mild systemic disease, and ASA III as a patient with severe systemic disease.|Participants|Count of Participants|44|44.0||||||
3688743|NCT02242201|3530900|B4||Spinal|Type of anesthetic||Participants|Count of Participants|123|123.0||||||
3688744|NCT02242201|3530901|B3||Spinal|Type of anesthetic||Participants|Count of Participants|41|41.0||||||
3688745|NCT02242201|3530902|B2||Spinal|Type of anesthetic||Participants|Count of Participants|44|44.0||||||
3688746|NCT02242201|3530903|B1||Spinal|Type of anesthetic||Participants|Count of Participants|38|38.0||||||
3688747|NCT02242201|3530900|B4||General|Type of anesthetic||Participants|Count of Participants|36|36.0||||||
3688748|NCT02242201|3530901|B3||General|Type of anesthetic||Participants|Count of Participants|13|13.0||||||
3688749|NCT02242201|3530902|B2||General|Type of anesthetic||Participants|Count of Participants|10|10.0||||||
3688750|NCT02242201|3530903|B1||General|Type of anesthetic||Participants|Count of Participants|13|13.0||||||
3688751|NCT02242201|3530900|B4|||Duration of surgery||minutes|Mean|89.2|89.2|Standard Deviation|25.2|25.2|||
3688752|NCT02242201|3530901|B3|||Duration of surgery||minutes|Mean|88.4|88.4|Standard Deviation|28.3|28.3|||
3688753|NCT02242201|3530902|B2|||Duration of surgery||minutes|Mean|88.1|88.1|Standard Deviation|23.2|23.2|||
3688754|NCT02242201|3530903|B1|||Duration of surgery||minutes|Mean|91.4|91.4|Standard Deviation|24.0|24.0|||
3688755|NCT02242201|3530900|B4|United States||Region of Enrollment||participants|Number|159|159.0||||||
3688756|NCT02242201|3530901|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
3688757|NCT02242201|3530902|B2|United States||Region of Enrollment||participants|Number|54|54.0||||||
3688758|NCT02242201|3530903|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
3688759|NCT02242201|3530900|B4|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3688760|NCT02242201|3530900|B4||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3688761|NCT02242201|3530901|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3688762|NCT02242201|3530902|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3688763|NCT02242201|3530903|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3688764|NCT02242201|3530900|B4||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3688765|NCT02242201|3530901|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3688766|NCT02242201|3530902|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3688767|NCT02242201|3530903|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3688768|NCT02242201|3530900|B4|||Age||years|Mean|61.0|61.0|Standard Deviation|12.9|12.9|||
3688769|NCT02242201|3530901|B3|||Age||years|Mean|61.7|61.7|Standard Deviation|11.7|11.7|||
3688770|NCT02242201|3530902|B2|||Age||years|Mean|59.4|59.4|Standard Deviation|15.3|15.3|||
3688771|NCT02242201|3530903|B1|||Age||years|Mean|62.1|62.1|Standard Deviation|11.5|11.5|||
3688772|NCT02242019|3530937|B1|||Millimeter (mm) of Clear Nail From the Lunula||millimeters (mm)|Mean|5.90|5.9|Standard Deviation|4.58|4.58|||
3688773|NCT02242019|3530937|B1|||Percent Toenail Onychomycosis Disease Involvement||percentage of toenail|Mean|63.21|63.21|Standard Deviation|23.88|23.88|||
3688774|NCT02242019|3530937|B1|||Duration of toenail onychomycosis Involvement||months|Mean|25.99|25.99|Standard Deviation|18.43|18.43|||
3688775|NCT02242019|3530937|B1|Ireland||Region of Enrollment||participants|Number|109|109.0||||||
3688776|NCT02242019|3530937|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688777|NCT02242019|3530937|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688778|NCT02242019|3530937|B1||White|Race (NIH/OMB)||Participants|Count of Participants|109|109.0||||||
3688779|NCT02242019|3530937|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688780|NCT02242019|3530937|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688781|NCT02242019|3530937|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688782|NCT02242019|3530937|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688783|NCT02242019|3530937|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3688784|NCT02242019|3530937|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3688785|NCT02242019|3530937|B1|||Age||years|Mean|43.89|43.89|Standard Deviation|10.74|10.74|||
3688786|NCT02241889|3530943|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
3688787|NCT02241889|3530943|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3688788|NCT02241889|3530943|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3688789|NCT02241889|3530943|B1|||Age||years|Mean|32|32.0|Standard Deviation|7|7.0|||
3688790|NCT02241889|3530943|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3688791|NCT02241889|3530943|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3688792|NCT02241889|3530943|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3688793|NCT02241785|3530983|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3688794|NCT02241785|3530983|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3688795|NCT02241785|3530983|B1|||Age||years|Mean|41.9|41.9|Standard Deviation|10.43|10.43|||
3688796|NCT02241720|3530991|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3688797|NCT02241720|3530991|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3688798|NCT02241720|3530991|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3688799|NCT02241720|3530991|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3688800|NCT02241720|3530991|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3688801|NCT02241720|3530991|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3688802|NCT02241551|3530995|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688803|NCT02241551|3530996|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688804|NCT02241551|3530997|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688805|NCT02241551|3530995|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688806|NCT02241551|3530996|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688807|NCT02241551|3530997|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688808|NCT02241551|3530995|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688809|NCT02241551|3530996|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688810|NCT02241551|3530997|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688811|NCT02241551|3530995|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3688812|NCT02241551|3530996|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688813|NCT02241551|3530997|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3688814|NCT02241551|3530995|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688815|NCT02241551|3530996|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688816|NCT02241551|3530997|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688817|NCT02241551|3530995|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688818|NCT02241551|3530996|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688819|NCT02241551|3530997|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688820|NCT02241551|3530995|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688821|NCT02241551|3530996|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688822|NCT02241551|3530997|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688823|NCT02241551|3530995|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3688824|NCT02241551|3530996|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3688825|NCT02241551|3530997|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3688826|NCT02241551|3530995|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3688827|NCT02241551|3530996|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3688828|NCT02241551|3530997|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3688829|NCT02241551|3530995|B3|||Age||years|Mean|54|54.0|Full Range|||54.0|54.0|
3688830|NCT02241551|3530997|B1|||Age||years|Mean|54|54.0|Full Range|||54.0|54.0|
3688831|NCT02241486|3531018|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3688832|NCT02241486|3531018|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3688833|NCT02241486|3531018|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3688834|NCT02241486|3531018|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3688835|NCT02241486|3531018|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3688836|NCT02241187|3531022|B1|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3688837|NCT02241187|3531022|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688838|NCT02241187|3531022|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688839|NCT02241187|3531022|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3688840|NCT02241187|3531022|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688841|NCT02241187|3531022|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688842|NCT02241187|3531022|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688843|NCT02241187|3531022|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688844|NCT02241187|3531022|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688845|NCT02241187|3531022|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3688846|NCT02241187|3531022|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3688847|NCT02241187|3531022|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3688848|NCT02241187|3531022|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3688849|NCT02241187|3531022|B1|||Age||years|Median|64|64.0|Full Range|||61.0|67.0|
3688850|NCT02240693|3531027|B6|||Neuropsychological Test Battery (NTB) Total|Baseline cognitive assessment data- NTB total z-score. The NTB consists of 9 validated components. Raw scores on each of the 9 NTB tests were converted to z-scores using the baseline means and standard deviations (SDs) for each test. The resultant z-scores were averaged to obtain a total z-score, incorporating all 9 NTB tests. The NTB Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean at baseline. Higher values indicate a better Outcome|z-score|Mean|-0.00|0.0|Standard Deviation|0.66|0.66|||
3688851|NCT02240693|3531028|B5|||Neuropsychological Test Battery (NTB) Total|Baseline cognitive assessment data- NTB total z-score. The NTB consists of 9 validated components. Raw scores on each of the 9 NTB tests were converted to z-scores using the baseline means and standard deviations (SDs) for each test. The resultant z-scores were averaged to obtain a total z-score, incorporating all 9 NTB tests. The NTB Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean at baseline. Higher values indicate a better Outcome|z-score|Mean|-0.03|-0.03|Standard Deviation|0.63|0.63|||
3688852|NCT02240693|3531029|B4|||Neuropsychological Test Battery (NTB) Total|Baseline cognitive assessment data- NTB total z-score. The NTB consists of 9 validated components. Raw scores on each of the 9 NTB tests were converted to z-scores using the baseline means and standard deviations (SDs) for each test. The resultant z-scores were averaged to obtain a total z-score, incorporating all 9 NTB tests. The NTB Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean at baseline. Higher values indicate a better Outcome|z-score|Mean|-0.02|-0.02|Standard Deviation|0.61|0.61|||
3688853|NCT02240693|3531030|B3|||Neuropsychological Test Battery (NTB) Total|Baseline cognitive assessment data- NTB total z-score. The NTB consists of 9 validated components. Raw scores on each of the 9 NTB tests were converted to z-scores using the baseline means and standard deviations (SDs) for each test. The resultant z-scores were averaged to obtain a total z-score, incorporating all 9 NTB tests. The NTB Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean at baseline. Higher values indicate a better Outcome|z-score|Mean|-0.02|-0.02|Standard Deviation|0.72|0.72|||
3688854|NCT02240693|3531031|B2|||Neuropsychological Test Battery (NTB) Total|Baseline cognitive assessment data- NTB total z-score. The NTB consists of 9 validated components. Raw scores on each of the 9 NTB tests were converted to z-scores using the baseline means and standard deviations (SDs) for each test. The resultant z-scores were averaged to obtain a total z-score, incorporating all 9 NTB tests. The NTB Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean at baseline. Higher values indicate a better Outcome|z-score|Mean|0.02|0.02|Standard Deviation|0.75|0.75|||
3688855|NCT02240693|3531032|B1|||Neuropsychological Test Battery (NTB) Total|Baseline cognitive assessment data- NTB total z-score. The NTB consists of 9 validated components. Raw scores on each of the 9 NTB tests were converted to z-scores using the baseline means and standard deviations (SDs) for each test. The resultant z-scores were averaged to obtain a total z-score, incorporating all 9 NTB tests. The NTB Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean at baseline. Higher values indicate a better Outcome|z-score|Mean|0.07|0.07|Standard Deviation|0.70|0.7|||
3688856|NCT02240693|3531027|B6||Unknown or Not Reported|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|0|0.0||||||
3688857|NCT02240693|3531028|B5||Unknown or Not Reported|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|0|0.0||||||
3688858|NCT02240693|3531029|B4||Unknown or Not Reported|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|0|0.0||||||
3688859|NCT02240693|3531030|B3||Unknown or Not Reported|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|0|0.0||||||
3688860|NCT02240693|3531031|B2||Unknown or Not Reported|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|0|0.0||||||
3688861|NCT02240693|3531032|B1||Unknown or Not Reported|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|0|0.0||||||
3688862|NCT02240693|3531027|B6||More than one race|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|0|0.0||||||
3688863|NCT02240693|3531028|B5||More than one race|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|0|0.0||||||
3688864|NCT02240693|3531029|B4||More than one race|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|0|0.0||||||
3688865|NCT02240693|3531030|B3||More than one race|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|0|0.0||||||
3688866|NCT02240693|3531031|B2||More than one race|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|0|0.0||||||
3688867|NCT02240693|3531032|B1||More than one race|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|0|0.0||||||
3688868|NCT02240693|3531027|B6||White|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|128|128.0||||||
3688869|NCT02240693|3531028|B5||White|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|43|43.0||||||
3688870|NCT02240693|3531029|B4||White|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|21|21.0||||||
3688871|NCT02240693|3531030|B3||White|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|21|21.0||||||
3688872|NCT02240693|3531031|B2||White|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|21|21.0||||||
3688873|NCT02240693|3531032|B1||White|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|22|22.0||||||
3688874|NCT02240693|3531027|B6||Black or African American|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|0|0.0||||||
3688875|NCT02240693|3531028|B5||Black or African American|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|0|0.0||||||
3688876|NCT02240693|3531029|B4||Black or African American|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|0|0.0||||||
3688877|NCT02240693|3531030|B3||Black or African American|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|0|0.0||||||
3688878|NCT02240693|3531031|B2||Black or African American|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|0|0.0||||||
3688879|NCT02240693|3531032|B1||Black or African American|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|0|0.0||||||
3688880|NCT02240693|3531027|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|0|0.0||||||
3688881|NCT02240693|3531028|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|0|0.0||||||
3688882|NCT02240693|3531029|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|0|0.0||||||
3688883|NCT02240693|3531030|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|0|0.0||||||
3688884|NCT02240693|3531031|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|0|0.0||||||
3688885|NCT02240693|3531032|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|0|0.0||||||
3688886|NCT02240693|3531027|B6||Asian|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|0|0.0||||||
3688887|NCT02240693|3531028|B5||Asian|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|0|0.0||||||
3688888|NCT02240693|3531029|B4||Asian|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|0|0.0||||||
3688889|NCT02240693|3531030|B3||Asian|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|0|0.0||||||
3688890|NCT02240693|3531031|B2||Asian|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|0|0.0||||||
3688891|NCT02240693|3531032|B1||Asian|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|0|0.0||||||
3688892|NCT02240693|3531027|B6||American Indian or Alaska Native|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|0|0.0||||||
3688893|NCT02240693|3531028|B5||American Indian or Alaska Native|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|0|0.0||||||
3688894|NCT02240693|3531029|B4||American Indian or Alaska Native|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|0|0.0||||||
3688895|NCT02240693|3531030|B3||American Indian or Alaska Native|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|0|0.0||||||
3688988|NCT02240589|3531125|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688896|NCT02240693|3531031|B2||American Indian or Alaska Native|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|0|0.0||||||
3688897|NCT02240693|3531032|B1||American Indian or Alaska Native|Race (NIH/OMB)|Race data is presented below; Ethnicity was not reported in this trial|Participants|Count of Participants|0|0.0||||||
3688898|NCT02240693|3531027|B6||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3688899|NCT02240693|3531028|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3688900|NCT02240693|3531029|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3688901|NCT02240693|3531030|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3688902|NCT02240693|3531031|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3688903|NCT02240693|3531032|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3688904|NCT02240693|3531027|B6||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3688905|NCT02240693|3531028|B5||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3688906|NCT02240693|3531029|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3688907|NCT02240693|3531030|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3688908|NCT02240693|3531031|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3688909|NCT02240693|3531032|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3688910|NCT02240693|3531027|B6|||Age||years|Mean|72.7|72.7|Standard Deviation|6.3|6.3|||
3688911|NCT02240693|3531028|B5|||Age||years|Mean|72.2|72.2|Standard Deviation|6.5|6.5|||
3688912|NCT02240693|3531029|B4|||Age||years|Mean|71.9|71.9|Standard Deviation|6.0|6.0|||
3688913|NCT02240693|3531030|B3|||Age||years|Mean|73.3|73.3|Standard Deviation|5.1|5.1|||
3688914|NCT02240693|3531031|B2|||Age||years|Mean|74.1|74.1|Standard Deviation|8.1|8.1|||
3688915|NCT02240693|3531032|B1|||Age||years|Mean|72.3|72.3|Standard Deviation|5.4|5.4|||
3688916|NCT02240680|3531070|B3|||Hemoglobin A1c (HbA1c) at baseline|HbA1c values measured at baseline in percent. HbA1c is a form of hemoglobin, a blood pigment that carries oxygen, which is bound to glucose. The term HbA1c also refers to glycated hemoglobin. High levels of HbA1c (Normal range is less than 6%) indicate poorer control of diabetes than level in normal range.|Percentage of HbA1c (%)|Mean|8.2|8.2|Standard Deviation|0.8|0.8|||
3688917|NCT02240680|3531071|B2|||Hemoglobin A1c (HbA1c) at baseline|HbA1c values measured at baseline in percent. HbA1c is a form of hemoglobin, a blood pigment that carries oxygen, which is bound to glucose. The term HbA1c also refers to glycated hemoglobin. High levels of HbA1c (Normal range is less than 6%) indicate poorer control of diabetes than level in normal range.|Percentage of HbA1c (%)|Mean|8.2|8.2|Standard Deviation|0.8|0.8|||
3688918|NCT02240680|3531072|B1|||Hemoglobin A1c (HbA1c) at baseline|HbA1c values measured at baseline in percent. HbA1c is a form of hemoglobin, a blood pigment that carries oxygen, which is bound to glucose. The term HbA1c also refers to glycated hemoglobin. High levels of HbA1c (Normal range is less than 6%) indicate poorer control of diabetes than level in normal range.|Percentage of HbA1c (%)|Mean|8.1|8.1|Standard Deviation|0.7|0.7|||
3688919|NCT02240680|3531070|B3||Unknown or Not Reported|Race (NIH/OMB)|Data for Race of patients collected under protocol for all included patients in the study.|Participants|Count of Participants|0|0.0||||||
3688920|NCT02240680|3531071|B2||Unknown or Not Reported|Race (NIH/OMB)|Data for Race of patients collected under protocol for all included patients in the study.|Participants|Count of Participants|0|0.0||||||
3688921|NCT02240680|3531072|B1||Unknown or Not Reported|Race (NIH/OMB)|Data for Race of patients collected under protocol for all included patients in the study.|Participants|Count of Participants|0|0.0||||||
3688922|NCT02240680|3531070|B3||More than one race|Race (NIH/OMB)|Data for Race of patients collected under protocol for all included patients in the study.|Participants|Count of Participants|3|3.0||||||
3688923|NCT02240680|3531071|B2||More than one race|Race (NIH/OMB)|Data for Race of patients collected under protocol for all included patients in the study.|Participants|Count of Participants|2|2.0||||||
3688924|NCT02240680|3531072|B1||More than one race|Race (NIH/OMB)|Data for Race of patients collected under protocol for all included patients in the study.|Participants|Count of Participants|1|1.0||||||
3688925|NCT02240680|3531070|B3||White|Race (NIH/OMB)|Data for Race of patients collected under protocol for all included patients in the study.|Participants|Count of Participants|165|165.0||||||
3688926|NCT02240680|3531071|B2||White|Race (NIH/OMB)|Data for Race of patients collected under protocol for all included patients in the study.|Participants|Count of Participants|84|84.0||||||
3688927|NCT02240680|3531072|B1||White|Race (NIH/OMB)|Data for Race of patients collected under protocol for all included patients in the study.|Participants|Count of Participants|81|81.0||||||
3688928|NCT02240680|3531070|B3||Black or African American|Race (NIH/OMB)|Data for Race of patients collected under protocol for all included patients in the study.|Participants|Count of Participants|18|18.0||||||
3688929|NCT02240680|3531071|B2||Black or African American|Race (NIH/OMB)|Data for Race of patients collected under protocol for all included patients in the study.|Participants|Count of Participants|8|8.0||||||
3688930|NCT02240680|3531072|B1||Black or African American|Race (NIH/OMB)|Data for Race of patients collected under protocol for all included patients in the study.|Participants|Count of Participants|10|10.0||||||
3688931|NCT02240680|3531070|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Data for Race of patients collected under protocol for all included patients in the study.|Participants|Count of Participants|1|1.0||||||
3688932|NCT02240680|3531071|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Data for Race of patients collected under protocol for all included patients in the study.|Participants|Count of Participants|1|1.0||||||
3688933|NCT02240680|3531072|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Data for Race of patients collected under protocol for all included patients in the study.|Participants|Count of Participants|0|0.0||||||
3688934|NCT02240680|3531070|B3||Asian|Race (NIH/OMB)|Data for Race of patients collected under protocol for all included patients in the study.|Participants|Count of Participants|104|104.0||||||
3688989|NCT02240589|3531126|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688935|NCT02240680|3531071|B2||Asian|Race (NIH/OMB)|Data for Race of patients collected under protocol for all included patients in the study.|Participants|Count of Participants|52|52.0||||||
3688936|NCT02240680|3531072|B1||Asian|Race (NIH/OMB)|Data for Race of patients collected under protocol for all included patients in the study.|Participants|Count of Participants|52|52.0||||||
3688937|NCT02240680|3531070|B3||American Indian or Alaska Native|Race (NIH/OMB)|Data for Race of patients collected under protocol for all included patients in the study.|Participants|Count of Participants|11|11.0||||||
3688938|NCT02240680|3531071|B2||American Indian or Alaska Native|Race (NIH/OMB)|Data for Race of patients collected under protocol for all included patients in the study.|Participants|Count of Participants|4|4.0||||||
3688939|NCT02240680|3531072|B1||American Indian or Alaska Native|Race (NIH/OMB)|Data for Race of patients collected under protocol for all included patients in the study.|Participants|Count of Participants|7|7.0||||||
3688940|NCT02240680|3531070|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)|Data for Ethnicity of patients collected under protocol for all included patients in the study.|Participants|Count of Participants|0|0.0||||||
3688941|NCT02240680|3531071|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)|Data for Ethnicity of patients collected under protocol for all included patients in the study.|Participants|Count of Participants|0|0.0||||||
3688942|NCT02240680|3531072|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|Data for Ethnicity of patients collected under protocol for all included patients in the study.|Participants|Count of Participants|0|0.0||||||
3688943|NCT02240680|3531070|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Data for Ethnicity of patients collected under protocol for all included patients in the study.|Participants|Count of Participants|268|268.0||||||
3688944|NCT02240680|3531071|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Data for Ethnicity of patients collected under protocol for all included patients in the study.|Participants|Count of Participants|136|136.0||||||
3688945|NCT02240680|3531072|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Data for Ethnicity of patients collected under protocol for all included patients in the study.|Participants|Count of Participants|132|132.0||||||
3688946|NCT02240680|3531070|B3||Hispanic or Latino|Ethnicity (NIH/OMB)|Data for Ethnicity of patients collected under protocol for all included patients in the study.|Participants|Count of Participants|34|34.0||||||
3688947|NCT02240680|3531071|B2||Hispanic or Latino|Ethnicity (NIH/OMB)|Data for Ethnicity of patients collected under protocol for all included patients in the study.|Participants|Count of Participants|15|15.0||||||
3688948|NCT02240680|3531072|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|Data for Ethnicity of patients collected under protocol for all included patients in the study.|Participants|Count of Participants|19|19.0||||||
3688949|NCT02240680|3531070|B3||Male|Sex: Female, Male|Data of Gender collected of all patients included in the study.|Participants|Count of Participants|183|183.0||||||
3688950|NCT02240680|3531071|B2||Male|Sex: Female, Male|Data of Gender collected of all patients included in the study.|Participants|Count of Participants|92|92.0||||||
3688951|NCT02240680|3531072|B1||Male|Sex: Female, Male|Data of Gender collected of all patients included in the study.|Participants|Count of Participants|91|91.0||||||
3688952|NCT02240680|3531070|B3||Female|Sex: Female, Male|Data of Gender collected of all patients included in the study.|Participants|Count of Participants|119|119.0||||||
3688953|NCT02240680|3531071|B2||Female|Sex: Female, Male|Data of Gender collected of all patients included in the study.|Participants|Count of Participants|59|59.0||||||
3688954|NCT02240680|3531072|B1||Female|Sex: Female, Male|Data of Gender collected of all patients included in the study.|Participants|Count of Participants|60|60.0||||||
3688955|NCT02240680|3531070|B3|||Age|Data of age collected for all included patients in the study.|Years|Mean|72.4|72.4|Standard Deviation|5.4|5.4|||
3688956|NCT02240680|3531071|B2|||Age|Data of age collected for all included patients in the study.|Years|Mean|72.3|72.3|Standard Deviation|5.1|5.1|||
3688957|NCT02240680|3531072|B1|||Age|Data of age collected for all included patients in the study.|Years|Mean|72.5|72.5|Standard Deviation|5.6|5.6|||
3688958|NCT02240654|3531093|B6||Male|Sex: Female, Male|"For 282 patients, information on gender was missing. Because it is not possible to rule out duplicate patients across the 2 French panels, all numbers were calculated stratified by data source, and for France further stratified by panel – i.e., not overall.~Total (men, women) may not be correct, as those assume that there were no duplicate patients in CSD-LPD."|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3688959|NCT02240654|3531094|B5||Male|Sex: Female, Male|"For 282 patients, information on gender was missing. Because it is not possible to rule out duplicate patients across the 2 French panels, all numbers were calculated stratified by data source, and for France further stratified by panel – i.e., not overall.~Total (men, women) may not be correct, as those assume that there were no duplicate patients in CSD-LPD."|Participants|Count of Participants|714|714.0||||||
3688960|NCT02240654|3531095|B4||Male|Sex: Female, Male|"For 282 patients, information on gender was missing. Because it is not possible to rule out duplicate patients across the 2 French panels, all numbers were calculated stratified by data source, and for France further stratified by panel – i.e., not overall.~Total (men, women) may not be correct, as those assume that there were no duplicate patients in CSD-LPD."|Participants|Count of Participants|1212|1212.0||||||
3688961|NCT02240654|3531096|B3||Male|Sex: Female, Male|"For 282 patients, information on gender was missing. Because it is not possible to rule out duplicate patients across the 2 French panels, all numbers were calculated stratified by data source, and for France further stratified by panel – i.e., not overall.~Total (men, women) may not be correct, as those assume that there were no duplicate patients in CSD-LPD."|Participants|Count of Participants|15052|15052.0||||||
3688962|NCT02240654|3531097|B2||Male|Sex: Female, Male|"For 282 patients, information on gender was missing. Because it is not possible to rule out duplicate patients across the 2 French panels, all numbers were calculated stratified by data source, and for France further stratified by panel – i.e., not overall.~Total (men, women) may not be correct, as those assume that there were no duplicate patients in CSD-LPD."|Participants|Count of Participants|1541|1541.0||||||
3688990|NCT02240589|3531127|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688991|NCT02240589|3531125|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688992|NCT02240589|3531126|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688963|NCT02240654|3531098|B1||Male|Sex: Female, Male|"For 282 patients, information on gender was missing. Because it is not possible to rule out duplicate patients across the 2 French panels, all numbers were calculated stratified by data source, and for France further stratified by panel – i.e., not overall.~Total (men, women) may not be correct, as those assume that there were no duplicate patients in CSD-LPD."|Participants|Count of Participants|NA|||||||825 patients and gender for 282 patients was missing
3688964|NCT02240654|3531093|B6||Female|Sex: Female, Male|"For 282 patients, information on gender was missing. Because it is not possible to rule out duplicate patients across the 2 French panels, all numbers were calculated stratified by data source, and for France further stratified by panel – i.e., not overall.~Total (men, women) may not be correct, as those assume that there were no duplicate patients in CSD-LPD."|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3688965|NCT02240654|3531094|B5||Female|Sex: Female, Male|"For 282 patients, information on gender was missing. Because it is not possible to rule out duplicate patients across the 2 French panels, all numbers were calculated stratified by data source, and for France further stratified by panel – i.e., not overall.~Total (men, women) may not be correct, as those assume that there were no duplicate patients in CSD-LPD."|Participants|Count of Participants|571|571.0||||||
3688966|NCT02240654|3531095|B4||Female|Sex: Female, Male|"For 282 patients, information on gender was missing. Because it is not possible to rule out duplicate patients across the 2 French panels, all numbers were calculated stratified by data source, and for France further stratified by panel – i.e., not overall.~Total (men, women) may not be correct, as those assume that there were no duplicate patients in CSD-LPD."|Participants|Count of Participants|938|938.0||||||
3688967|NCT02240654|3531096|B3||Female|Sex: Female, Male|"For 282 patients, information on gender was missing. Because it is not possible to rule out duplicate patients across the 2 French panels, all numbers were calculated stratified by data source, and for France further stratified by panel – i.e., not overall.~Total (men, women) may not be correct, as those assume that there were no duplicate patients in CSD-LPD."|Participants|Count of Participants|13567|13567.0||||||
3688968|NCT02240654|3531097|B2||Female|Sex: Female, Male|"For 282 patients, information on gender was missing. Because it is not possible to rule out duplicate patients across the 2 French panels, all numbers were calculated stratified by data source, and for France further stratified by panel – i.e., not overall.~Total (men, women) may not be correct, as those assume that there were no duplicate patients in CSD-LPD."|Participants|Count of Participants|1272|1272.0||||||
3688969|NCT02240654|3531098|B1||Female|Sex: Female, Male|"For 282 patients, information on gender was missing. Because it is not possible to rule out duplicate patients across the 2 French panels, all numbers were calculated stratified by data source, and for France further stratified by panel – i.e., not overall.~Total (men, women) may not be correct, as those assume that there were no duplicate patients in CSD-LPD."|Participants|Count of Participants|NA|||||||599 female patients and gender for 282 patients was missing
3688970|NCT02240654|3531093|B6|||Age|Because it is not possible to rule out duplicate patients across the 2 French panels, all numbers were calculated stratified by data source, and for France further stratified by panel – i.e., not overall. Totals computed here may not be correct, as those assume that there were no duplicate patients in CSD-LPD.|years|Mean|NA||Standard Deviation|NA||||Because it is not possible to rule out duplicate patients across the 2 French panels, all numbers were calculated stratified by data source, and for France further stratified by panel – i.e., not overall.
3688971|NCT02240654|3531094|B5|||Age|Because it is not possible to rule out duplicate patients across the 2 French panels, all numbers were calculated stratified by data source, and for France further stratified by panel – i.e., not overall. Totals computed here may not be correct, as those assume that there were no duplicate patients in CSD-LPD.|years|Mean|73.1|73.1|Standard Deviation|11.5|11.5|||
3688972|NCT02240654|3531095|B4|||Age|Because it is not possible to rule out duplicate patients across the 2 French panels, all numbers were calculated stratified by data source, and for France further stratified by panel – i.e., not overall. Totals computed here may not be correct, as those assume that there were no duplicate patients in CSD-LPD.|years|Mean|74.1|74.1|Standard Deviation|11.2|11.2|||
3688973|NCT02240654|3531096|B3|||Age|Because it is not possible to rule out duplicate patients across the 2 French panels, all numbers were calculated stratified by data source, and for France further stratified by panel – i.e., not overall. Totals computed here may not be correct, as those assume that there were no duplicate patients in CSD-LPD.|years|Mean|71.8|71.8|Standard Deviation|10.9|10.9|||
3688974|NCT02240654|3531097|B2|||Age|Because it is not possible to rule out duplicate patients across the 2 French panels, all numbers were calculated stratified by data source, and for France further stratified by panel – i.e., not overall. Totals computed here may not be correct, as those assume that there were no duplicate patients in CSD-LPD.|years|Mean|74.0|74.0|Standard Deviation|10.4|10.4|||
3688975|NCT02240654|3531098|B1|||Age|Because it is not possible to rule out duplicate patients across the 2 French panels, all numbers were calculated stratified by data source, and for France further stratified by panel – i.e., not overall. Totals computed here may not be correct, as those assume that there were no duplicate patients in CSD-LPD.|years|Mean|75.5|75.5|Standard Deviation|10.0|10.0|||
3688976|NCT02240628|3531114|B3|United States||Region of Enrollment||participants|Number|65|65.0||||||
3688977|NCT02240628|3531115|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
3688978|NCT02240628|3531116|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
3688979|NCT02240628|3531114|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3688980|NCT02240628|3531115|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3688981|NCT02240628|3531116|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3688982|NCT02240628|3531114|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3688983|NCT02240628|3531115|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3688984|NCT02240628|3531116|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3688985|NCT02240628|3531114|B3|||Age||years|Mean|14.46025|14.46025|Standard Deviation|2.18065|2.18065|||
3688986|NCT02240628|3531115|B2|||Age||years|Mean|14.5455|14.5455|Standard Deviation|2.0930|2.093|||
3688987|NCT02240628|3531116|B1|||Age||years|Mean|14.3750|14.375|Standard Deviation|2.2683|2.2683|||
3688993|NCT02240589|3531127|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688994|NCT02240589|3531125|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3688995|NCT02240589|3531126|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3688996|NCT02240589|3531127|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3688997|NCT02240589|3531125|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688998|NCT02240589|3531126|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3688999|NCT02240589|3531127|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689000|NCT02240589|3531125|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689001|NCT02240589|3531126|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689002|NCT02240589|3531127|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689003|NCT02240589|3531125|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689004|NCT02240589|3531126|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689005|NCT02240589|3531127|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689006|NCT02240589|3531125|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689007|NCT02240589|3531126|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689008|NCT02240589|3531127|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689009|NCT02240589|3531125|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689010|NCT02240589|3531126|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689011|NCT02240589|3531127|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689012|NCT02240589|3531125|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3689013|NCT02240589|3531126|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3689014|NCT02240589|3531127|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3689015|NCT02240589|3531125|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689016|NCT02240589|3531126|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689017|NCT02240589|3531127|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689018|NCT02240589|3531125|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3689019|NCT02240589|3531126|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3689020|NCT02240589|3531127|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3689021|NCT02240589|3531125|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3689022|NCT02240589|3531126|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3689023|NCT02240589|3531127|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3689024|NCT02240589|3531125|B3|||Age||years|Mean|33.82|33.82|Standard Deviation|14.29|14.29|||
3689025|NCT02240589|3531126|B2|||Age||years|Mean|40.83|40.83|Standard Deviation|6.52|6.52|||
3689026|NCT02240589|3531127|B1|||Age||years|Mean|25.4|25.4|Standard Deviation|2.3|2.3|||
3689027|NCT02240368|3531148|B4|Italy||Region of Enrollment||participants|Number|48|48.0||||||
3689028|NCT02240368|3531149|B3|Italy||Region of Enrollment||participants|Number|18|18.0||||||
3689029|NCT02240368|3531150|B2|Italy||Region of Enrollment||participants|Number|22|22.0||||||
3689030|NCT02240368|3531151|B1|Italy||Region of Enrollment||participants|Number|8|8.0||||||
3689031|NCT02240368|3531148|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3689032|NCT02240368|3531149|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3689033|NCT02240368|3531150|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3689034|NCT02240368|3531151|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3689035|NCT02240368|3531148|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3689036|NCT02240368|3531149|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3689037|NCT02240368|3531150|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3689038|NCT02240368|3531151|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3689039|NCT02240368|3531148|B4|||Age||months|Mean|43.38|43.38|Standard Deviation|37.56|37.56|||
3689040|NCT02240368|3531149|B3|||Age||months|Mean|82.22|82.22|Standard Deviation|33.8|33.8|||
3689041|NCT02240368|3531150|B2|||Age||months|Mean|24.95|24.95|Standard Deviation|8.0|8.0|||
3689042|NCT02240368|3531151|B1|||Age||months|Mean|6.63|6.63|Standard Deviation|3.7|3.7|||
3689043|NCT02240368|3531148|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3689044|NCT02240368|3531149|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3689045|NCT02240368|3531150|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3689046|NCT02240368|3531151|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3689047|NCT02240368|3531148|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3689048|NCT02240368|3531149|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3689049|NCT02240368|3531150|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3689050|NCT02240368|3531151|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3689051|NCT02240368|3531148|B4||<=18 years|Age||Participants|Count of Participants|48|48.0||||||
3689052|NCT02240368|3531149|B3||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
3689053|NCT02240368|3531150|B2||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
3689054|NCT02240368|3531151|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
3689055|NCT02240329|3531170|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3689056|NCT02240329|3531170|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3689057|NCT02240329|3531170|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3689058|NCT02240329|3531170|B1|||Age||years|Mean|28.38|28.38|Standard Deviation|13.97|13.97|||
3689059|NCT02240186|3531175|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3689060|NCT02240186|3531175|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3689061|NCT02240186|3531175|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3689062|NCT02240186|3531175|B1|||Age||years|Mean|69|69.0|Standard Deviation|9|9.0|||
3689063|NCT02240030|3531183|B4|Spain||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3689064|NCT02240030|3531184|B3|Spain||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3689065|NCT02240030|3531185|B2|Spain||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3689066|NCT02240030|3531186|B1|Spain||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3689067|NCT02240030|3531183|B4|Poland||Region of Enrollment||Participants|Count of Participants|66|66.0||||||
3689068|NCT02240030|3531184|B3|Poland||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3689069|NCT02240030|3531185|B2|Poland||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3689070|NCT02240030|3531186|B1|Poland||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3689071|NCT02240030|3531183|B4|United States||Region of Enrollment||Participants|Count of Participants|248|248.0||||||
3689072|NCT02240030|3531184|B3|United States||Region of Enrollment||Participants|Count of Participants|81|81.0||||||
3689073|NCT02240030|3531185|B2|United States||Region of Enrollment||Participants|Count of Participants|81|81.0||||||
3689074|NCT02240030|3531186|B1|United States||Region of Enrollment||Participants|Count of Participants|86|86.0||||||
3689075|NCT02240030|3531183|B4|Canada||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3689076|NCT02240030|3531184|B3|Canada||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3689077|NCT02240030|3531185|B2|Canada||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3689078|NCT02240030|3531186|B1|Canada||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3689079|NCT02240030|3531183|B4||Male|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
3689080|NCT02240030|3531184|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3689081|NCT02240030|3531185|B2||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3689082|NCT02240030|3531186|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3689083|NCT02240030|3531183|B4||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3689084|NCT02240030|3531184|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3689085|NCT02240030|3531185|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3689086|NCT02240030|3531186|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3689087|NCT02240030|3531183|B4|||Age||years|Mean|63.3|63.3|Standard Deviation|8.69|8.69|||
3689088|NCT02240030|3531184|B3|||Age||years|Mean|62.6|62.6|Standard Deviation|8.83|8.83|||
3689089|NCT02240030|3531185|B2|||Age||years|Mean|63.5|63.5|Standard Deviation|7.97|7.97|||
3689090|NCT02240030|3531186|B1|||Age||years|Mean|63.9|63.9|Standard Deviation|9.24|9.24|||
3689091|NCT02240030|3531183|B4||>=65 years|Age||Participants|Count of Participants|172|172.0||||||
3689092|NCT02240030|3531184|B3||>=65 years|Age||Participants|Count of Participants|57|57.0||||||
3689093|NCT02240030|3531185|B2||>=65 years|Age||Participants|Count of Participants|56|56.0||||||
3689094|NCT02240030|3531186|B1||>=65 years|Age||Participants|Count of Participants|59|59.0||||||
3689095|NCT02240030|3531183|B4||Between 18 and 65 years|Age||Participants|Count of Participants|167|167.0||||||
3689096|NCT02240030|3531184|B3||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
3689097|NCT02240030|3531185|B2||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3689098|NCT02240030|3531186|B1||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3689099|NCT02240030|3531183|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3689100|NCT02240030|3531184|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3689101|NCT02240030|3531185|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3689102|NCT02240030|3531186|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3689103|NCT02239978|3531210|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
3689104|NCT02239978|3531211|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3689105|NCT02239978|3531212|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3689106|NCT02239978|3531210|B3||Male|Gender||Participants|Count of Participants|26|26.0||||||
3689107|NCT02239978|3531211|B2||Male|Gender||Participants|Count of Participants|6|6.0||||||
3689108|NCT02239978|3531212|B1||Male|Gender||Participants|Count of Participants|20|20.0||||||
3689109|NCT02239978|3531210|B3||Female|Gender||Participants|Count of Participants|16|16.0||||||
3689110|NCT02239978|3531211|B2||Female|Gender||Participants|Count of Participants|6|6.0||||||
3689111|NCT02239978|3531212|B1||Female|Gender||Participants|Count of Participants|10|10.0||||||
3689112|NCT02239978|3531210|B3|||Age||years|Mean|67.16|67.16|Standard Deviation|7.10|7.1|||
3689113|NCT02239978|3531211|B2|||Age||years|Mean|68.04|68.04|Standard Deviation|6.62|6.62|||
3689114|NCT02239978|3531212|B1|||Age||years|Mean|66.05|66.05|Standard Deviation|9.67|9.67|||
3689115|NCT02239978|3531210|B3||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
3689116|NCT02239978|3531211|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3689117|NCT02239978|3531212|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3689118|NCT02239978|3531210|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3689119|NCT02239978|3531211|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3689120|NCT02239978|3531212|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3689121|NCT02239978|3531210|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3689122|NCT02239978|3531211|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3689123|NCT02239978|3531212|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3689124|NCT02239939|3531228|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
3689125|NCT02239939|3531229|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3689126|NCT02239939|3531230|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3689127|NCT02239939|3531228|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689128|NCT02239939|3531229|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689129|NCT02239939|3531230|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689130|NCT02239939|3531228|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689131|NCT02239939|3531229|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689132|NCT02239939|3531230|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689133|NCT02239939|3531228|B3||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3689134|NCT02239939|3531229|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3689135|NCT02239939|3531230|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3689136|NCT02239939|3531228|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3689137|NCT02239939|3531229|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3689138|NCT02239939|3531230|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3689139|NCT02239939|3531228|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689140|NCT02239939|3531229|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689141|NCT02239939|3531230|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689142|NCT02239939|3531228|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689143|NCT02239939|3531229|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689144|NCT02239939|3531230|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689145|NCT02239939|3531228|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689146|NCT02239939|3531229|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689147|NCT02239939|3531230|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689148|NCT02239939|3531228|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689149|NCT02239939|3531229|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689150|NCT02239939|3531230|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689151|NCT02239939|3531228|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3689152|NCT02239939|3531229|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3689153|NCT02239939|3531230|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3689154|NCT02239939|3531228|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689155|NCT02239939|3531229|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689156|NCT02239939|3531230|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689157|NCT02239939|3531228|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3689158|NCT02239939|3531229|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3689159|NCT02239939|3531230|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3689160|NCT02239939|3531228|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3689161|NCT02239939|3531229|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3689162|NCT02239939|3531230|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3689163|NCT02239939|3531228|B3|||Age||years|Mean|70.1|70.1|Standard Deviation|3.0|3.0|||
3689164|NCT02239939|3531229|B2|||Age||years|Mean|69.9|69.9|Standard Deviation|2.6|2.6|||
3689165|NCT02239939|3531230|B1|||Age||years|Mean|70.3|70.3|Standard Deviation|3.4|3.4|||
3689166|NCT02239926|3531245|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3689167|NCT02239926|3531246|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3689168|NCT02239926|3531245|B3|Male||Gender||participants|Number|0|0.0||||||
3689169|NCT02239926|3531246|B2|Male||Gender||participants|Number|0|0.0||||||
3689170|NCT02239926|3531245|B3|Female||Gender||participants|Number|2|2.0||||||
3689171|NCT02239926|3531246|B2|Female||Gender||participants|Number|2|2.0||||||
3689172|NCT02239926|3531245|B3|>=65 years||Age||participants|Number|0|0.0||||||
3689173|NCT02239926|3531246|B2|>=65 years||Age||participants|Number|0|0.0||||||
3689174|NCT02239926|3531245|B3|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
3689175|NCT02239926|3531246|B2|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
3689176|NCT02239926|3531245|B3|<=18 years||Age||participants|Number|0|0.0||||||
3689177|NCT02239926|3531246|B2|<=18 years||Age||participants|Number|0|0.0||||||
3689178|NCT02239770|3531256|B7|||Penn State Cigarette Dependence Index Total Score|"The total score of the Penn State Cigarette Dependence Index can range from 0 (no dependence/better outcome) to 20 (high dependence/worse outcome).~A score of 0 to 3 indicates no dependence on cigarettes. A score of 4 to 8 indicates low dependence on cigarettes. A score of 9 to 12 indicates medium dependence on cigarettes. A score of 13 or higher indicates a high dependence on cigarettes."|units on a scale|Mean|11.6|11.6|Standard Deviation|2.6|2.6|||
3689179|NCT02239770|3531257|B6|||Penn State Cigarette Dependence Index Total Score|"The total score of the Penn State Cigarette Dependence Index can range from 0 (no dependence/better outcome) to 20 (high dependence/worse outcome).~A score of 0 to 3 indicates no dependence on cigarettes. A score of 4 to 8 indicates low dependence on cigarettes. A score of 9 to 12 indicates medium dependence on cigarettes. A score of 13 or higher indicates a high dependence on cigarettes."|units on a scale|Mean|11.0|11.0|Standard Deviation|2.2|2.2|||
3689180|NCT02239770|3531258|B5|||Penn State Cigarette Dependence Index Total Score|"The total score of the Penn State Cigarette Dependence Index can range from 0 (no dependence/better outcome) to 20 (high dependence/worse outcome).~A score of 0 to 3 indicates no dependence on cigarettes. A score of 4 to 8 indicates low dependence on cigarettes. A score of 9 to 12 indicates medium dependence on cigarettes. A score of 13 or higher indicates a high dependence on cigarettes."|units on a scale|Mean|10.8|10.8|Standard Deviation|3.8|3.8|||
3689181|NCT02239770|3531259|B4|||Penn State Cigarette Dependence Index Total Score|"The total score of the Penn State Cigarette Dependence Index can range from 0 (no dependence/better outcome) to 20 (high dependence/worse outcome).~A score of 0 to 3 indicates no dependence on cigarettes. A score of 4 to 8 indicates low dependence on cigarettes. A score of 9 to 12 indicates medium dependence on cigarettes. A score of 13 or higher indicates a high dependence on cigarettes."|units on a scale|Mean|11.8|11.8|Standard Deviation|2.9|2.9|||
3689182|NCT02239770|3531260|B3|||Penn State Cigarette Dependence Index Total Score|"The total score of the Penn State Cigarette Dependence Index can range from 0 (no dependence/better outcome) to 20 (high dependence/worse outcome).~A score of 0 to 3 indicates no dependence on cigarettes. A score of 4 to 8 indicates low dependence on cigarettes. A score of 9 to 12 indicates medium dependence on cigarettes. A score of 13 or higher indicates a high dependence on cigarettes."|units on a scale|Mean|11|11.0|Standard Deviation|2.0|2.0|||
3689183|NCT02239770|3531261|B2|||Penn State Cigarette Dependence Index Total Score|"The total score of the Penn State Cigarette Dependence Index can range from 0 (no dependence/better outcome) to 20 (high dependence/worse outcome).~A score of 0 to 3 indicates no dependence on cigarettes. A score of 4 to 8 indicates low dependence on cigarettes. A score of 9 to 12 indicates medium dependence on cigarettes. A score of 13 or higher indicates a high dependence on cigarettes."|units on a scale|Mean|12|12.0|Standard Deviation|1.0|1.0|||
3689184|NCT02239770|3531262|B1|||Penn State Cigarette Dependence Index Total Score|"The total score of the Penn State Cigarette Dependence Index can range from 0 (no dependence/better outcome) to 20 (high dependence/worse outcome).~A score of 0 to 3 indicates no dependence on cigarettes. A score of 4 to 8 indicates low dependence on cigarettes. A score of 9 to 12 indicates medium dependence on cigarettes. A score of 13 or higher indicates a high dependence on cigarettes."|units on a scale|Mean|14|14.0|Standard Deviation|3.0|3.0|||
3689185|NCT02239770|3531256|B7|||Exhaled carbon monoxide||parts per million|Mean|5.6|5.6|Standard Deviation|2.8|2.8|||
3689186|NCT02239770|3531257|B6|||Exhaled carbon monoxide||parts per million|Mean|5.8|5.8|Standard Deviation|3.2|3.2|||
3689187|NCT02239770|3531258|B5|||Exhaled carbon monoxide||parts per million|Mean|6.3|6.3|Standard Deviation|3.3|3.3|||
3689188|NCT02239770|3531259|B4|||Exhaled carbon monoxide||parts per million|Mean|7.0|7.0|Standard Deviation|2.2|2.2|||
3689189|NCT02239770|3531260|B3|||Exhaled carbon monoxide||parts per million|Mean|4.0|4.0|Standard Deviation|3.0|3.0|||
3689190|NCT02239770|3531261|B2|||Exhaled carbon monoxide||parts per million|Mean|6.0|6.0|Standard Deviation|2.0|2.0|||
3689191|NCT02239770|3531262|B1|||Exhaled carbon monoxide||parts per million|Mean|5.0|5.0|Standard Deviation|3.0|3.0|||
3689192|NCT02239770|3531256|B7|||BMI||kg/m^2|Mean|28.2|28.2|Standard Deviation|5.3|5.3|||
3689193|NCT02239770|3531257|B6|||BMI||kg/m^2|Mean|27.4|27.4|Standard Deviation|5.3|5.3|||
3689194|NCT02239770|3531258|B5|||BMI||kg/m^2|Mean|26.9|26.9|Standard Deviation|4.2|4.2|||
3689195|NCT02239770|3531259|B4|||BMI||kg/m^2|Mean|28.7|28.7|Standard Deviation|3.5|3.5|||
3689196|NCT02239770|3531260|B3|||BMI||kg/m^2|Mean|27.2|27.2|Standard Deviation|2.1|2.1|||
3689197|NCT02239770|3531261|B2|||BMI||kg/m^2|Mean|30.1|30.1|Standard Deviation|10.0|10.0|||
3689198|NCT02239770|3531262|B1|||BMI||kg/m^2|Mean|28.7|28.7|Standard Deviation|6.4|6.4|||
3689199|NCT02239770|3531256|B7|||Cigarettes smoked per day||cigarettes per day|Mean|17.7|17.7|Standard Deviation|5.8|5.8|||
3689200|NCT02239770|3531257|B6|||Cigarettes smoked per day||cigarettes per day|Mean|14.8|14.8|Standard Deviation|6.3|6.3|||
3689201|NCT02239770|3531258|B5|||Cigarettes smoked per day||cigarettes per day|Mean|18.5|18.5|Standard Deviation|8.6|8.6|||
3689202|NCT02239770|3531259|B4|||Cigarettes smoked per day||cigarettes per day|Mean|18.8|18.8|Standard Deviation|5.1|5.1|||
3689203|NCT02239770|3531260|B3|||Cigarettes smoked per day||cigarettes per day|Mean|14|14.0|Standard Deviation|3.0|3.0|||
3689204|NCT02239770|3531261|B2|||Cigarettes smoked per day||cigarettes per day|Mean|20|20.0|Standard Deviation|0.0|0.0|||
3689205|NCT02239770|3531262|B1|||Cigarettes smoked per day||cigarettes per day|Mean|20|20.0|Standard Deviation|8.0|8.0|||
3689206|NCT02239770|3531256|B7|||Less than a college degree||Participants|Count of Participants|15|15.0||||||
3689207|NCT02239770|3531257|B6|||Less than a college degree||Participants|Count of Participants|3|3.0||||||
3689208|NCT02239770|3531258|B5|||Less than a college degree||Participants|Count of Participants|2|2.0||||||
3689209|NCT02239770|3531259|B4|||Less than a college degree||Participants|Count of Participants|2|2.0||||||
3689210|NCT02239770|3531260|B3|||Less than a college degree||Participants|Count of Participants|2|2.0||||||
3689211|NCT02239770|3531261|B2|||Less than a college degree||Participants|Count of Participants|3|3.0||||||
3689212|NCT02239770|3531262|B1|||Less than a college degree||Participants|Count of Participants|3|3.0||||||
3689213|NCT02239770|3531256|B7|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3689214|NCT02239770|3531257|B6|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3689215|NCT02239770|3531258|B5|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3689216|NCT02239770|3531259|B4|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3689217|NCT02239770|3531260|B3|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3689218|NCT02239770|3531261|B2|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3689219|NCT02239770|3531262|B1|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3689220|NCT02239770|3531256|B7|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3689221|NCT02239770|3531257|B6|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3689222|NCT02239770|3531258|B5|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3689223|NCT02239770|3531259|B4|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3689224|NCT02239770|3531260|B3|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3689225|NCT02239770|3531261|B2|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3689226|NCT02239770|3531262|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3689227|NCT02239770|3531256|B7|Race|African American/black|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3689228|NCT02239770|3531257|B6|Race|African American/black|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3689229|NCT02239770|3531258|B5|Race|African American/black|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3689230|NCT02239770|3531259|B4|Race|African American/black|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3689231|NCT02239770|3531260|B3|Race|African American/black|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3689232|NCT02239770|3531261|B2|Race|African American/black|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3689233|NCT02239770|3531262|B1|Race|African American/black|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3689234|NCT02239770|3531256|B7|Race|Caucasian/white|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3689235|NCT02239770|3531257|B6|Race|Caucasian/white|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3689236|NCT02239770|3531258|B5|Race|Caucasian/white|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3689237|NCT02239770|3531259|B4|Race|Caucasian/white|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3689238|NCT02239770|3531260|B3|Race|Caucasian/white|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3689239|NCT02239770|3531261|B2|Race|Caucasian/white|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3689240|NCT02239770|3531262|B1|Race|Caucasian/white|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3689241|NCT02239770|3531256|B7||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3689242|NCT02239770|3531257|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3689243|NCT02239770|3531258|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3689244|NCT02239770|3531259|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3689245|NCT02239770|3531260|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3689246|NCT02239770|3531261|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3689247|NCT02239770|3531262|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3689248|NCT02239770|3531256|B7||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3689249|NCT02239770|3531257|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3689250|NCT02239770|3531258|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3689251|NCT02239770|3531259|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3689252|NCT02239770|3531260|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3689253|NCT02239770|3531261|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3689254|NCT02239770|3531262|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3689255|NCT02239770|3531256|B7|||Age||years|Mean|38.0|38.0|Standard Deviation|11.3|11.3|||
3689256|NCT02239770|3531257|B6|||Age||years|Mean|37.5|37.5|Standard Deviation|14.7|14.7|||
3689257|NCT02239770|3531258|B5|||Age||years|Mean|36.0|36.0|Standard Deviation|12.3|12.3|||
3689258|NCT02239770|3531259|B4|||Age||years|Mean|44.8|44.8|Standard Deviation|6.5|6.5|||
3689259|NCT02239770|3531260|B3|||Age||years|Mean|31.8|31.8|Standard Deviation|11.0|11.0|||
3689260|NCT02239770|3531261|B2|||Age||years|Mean|40.8|40.8|Standard Deviation|13.6|13.6|||
3689261|NCT02239770|3531262|B1|||Age||years|Mean|37.3|37.3|Standard Deviation|11.8|11.8|||
3689262|NCT02239744|3531293|B3|||BMI||Kg/m^2|Mean|22|22.0|Standard Deviation|2.5|2.5|||
3689263|NCT02239744|3531294|B2|||BMI||Kg/m^2|Mean|22|22.0|Standard Deviation|2.5|2.5|||
3689264|NCT02239744|3531295|B1|||BMI||Kg/m^2|Mean|21|21.0|Standard Deviation|2.5|2.5|||
3689265|NCT02239744|3531293|B3|China||Region of Enrollment||participants|Number|35|35.0||||||
3689266|NCT02239744|3531294|B2|China||Region of Enrollment||participants|Number|18|18.0||||||
3689267|NCT02239744|3531295|B1|China||Region of Enrollment||participants|Number|17|17.0||||||
3689268|NCT02239744|3531293|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3689269|NCT02239744|3531294|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3689270|NCT02239744|3531295|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3689271|NCT02239744|3531293|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3689272|NCT02239744|3531294|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3689273|NCT02239744|3531295|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3689274|NCT02239744|3531293|B3|||Age|We recruited all participants from the Fenglin campus of Fudan University. Therefore, all these students are young adult whose age was nearly 23 years old.|years|Mean|23|23.0|Standard Deviation|2|2.0|||
3689275|NCT02239744|3531294|B2|||Age|We recruited all participants from the Fenglin campus of Fudan University. Therefore, all these students are young adult whose age was nearly 23 years old.|years|Mean|21|21.0|Standard Deviation|2|2.0|||
3689276|NCT02239744|3531295|B1|||Age|We recruited all participants from the Fenglin campus of Fudan University. Therefore, all these students are young adult whose age was nearly 23 years old.|years|Mean|24|24.0|Standard Deviation|2|2.0|||
3689277|NCT02239692|3531308|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689278|NCT02239692|3531309|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689279|NCT02239692|3531310|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689280|NCT02239692|3531308|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689281|NCT02239692|3531309|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689282|NCT02239692|3531310|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689283|NCT02239692|3531308|B3||White|Race (NIH/OMB)||Participants|Count of Participants|203|203.0||||||
3689284|NCT02239692|3531309|B2||White|Race (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
3689285|NCT02239692|3531310|B1||White|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3689286|NCT02239692|3531308|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689287|NCT02239692|3531309|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689288|NCT02239692|3531310|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689289|NCT02239692|3531308|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689290|NCT02239692|3531309|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689291|NCT02239692|3531310|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689292|NCT02239692|3531308|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3689293|NCT02239692|3531309|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3689294|NCT02239692|3531310|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689295|NCT02239692|3531308|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689296|NCT02239692|3531309|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689297|NCT02239692|3531310|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689298|NCT02239692|3531308|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689299|NCT02239692|3531309|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689300|NCT02239692|3531310|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689301|NCT02239692|3531308|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|199|199.0||||||
3689302|NCT02239692|3531309|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
3689303|NCT02239692|3531310|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3689304|NCT02239692|3531308|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3689305|NCT02239692|3531309|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3689306|NCT02239692|3531310|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3689307|NCT02239692|3531308|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3689308|NCT02239692|3531309|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3689309|NCT02239692|3531310|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3689310|NCT02239692|3531308|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3689311|NCT02239692|3531309|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3689312|NCT02239692|3531310|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3689313|NCT02239692|3531308|B3|||Age||years|Mean|57.8|57.8|Standard Deviation|13.9|13.9|||
3689314|NCT02239692|3531309|B2|||Age||years|Mean|58.4|58.4|Standard Deviation|13.3|13.3|||
3689315|NCT02239692|3531310|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|15.1|15.1|||
3689316|NCT02239692|3531308|B3||>=65 years|Age||Participants|Count of Participants|70|70.0||||||
3689317|NCT02239692|3531309|B2||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
3689318|NCT02239692|3531310|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3689319|NCT02239692|3531308|B3||Between 18 and 65 years|Age||Participants|Count of Participants|134|134.0||||||
3689320|NCT02239692|3531309|B2||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
3689321|NCT02239692|3531310|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3689322|NCT02239692|3531308|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3689323|NCT02239692|3531309|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3689324|NCT02239692|3531310|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3689325|NCT02239679|3531327|B4||Skin Type V - Rarely burns, tans profusely|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well Skin Type V - Rarely burns, tans profusely"|Participants|Count of Participants|1|1.0||||||
3689326|NCT02239679|3531328|B3||Skin Type V - Rarely burns, tans profusely|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well Skin Type V - Rarely burns, tans profusely"|Participants|Count of Participants|0|0.0||||||
3689327|NCT02239679|3531329|B2||Skin Type V - Rarely burns, tans profusely|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well Skin Type V - Rarely burns, tans profusely"|Participants|Count of Participants|1|1.0||||||
3689328|NCT02239679|3531330|B1||Skin Type V - Rarely burns, tans profusely|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well Skin Type V - Rarely burns, tans profusely"|Participants|Count of Participants|0|0.0||||||
3689329|NCT02239679|3531327|B4||Skin Type IV - Burns minimally, tans well|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well Skin Type V - Rarely burns, tans profusely"|Participants|Count of Participants|11|11.0||||||
3689330|NCT02239679|3531328|B3||Skin Type IV - Burns minimally, tans well|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well Skin Type V - Rarely burns, tans profusely"|Participants|Count of Participants|5|5.0||||||
3689331|NCT02239679|3531329|B2||Skin Type IV - Burns minimally, tans well|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well Skin Type V - Rarely burns, tans profusely"|Participants|Count of Participants|4|4.0||||||
3689332|NCT02239679|3531330|B1||Skin Type IV - Burns minimally, tans well|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well Skin Type V - Rarely burns, tans profusely"|Participants|Count of Participants|2|2.0||||||
3689333|NCT02239679|3531327|B4||Skin Type III - Burns moderately, tans gradually|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well Skin Type V - Rarely burns, tans profusely"|Participants|Count of Participants|40|40.0||||||
3689334|NCT02239679|3531328|B3||Skin Type III - Burns moderately, tans gradually|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well Skin Type V - Rarely burns, tans profusely"|Participants|Count of Participants|12|12.0||||||
3689335|NCT02239679|3531329|B2||Skin Type III - Burns moderately, tans gradually|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well Skin Type V - Rarely burns, tans profusely"|Participants|Count of Participants|12|12.0||||||
3689336|NCT02239679|3531330|B1||Skin Type III - Burns moderately, tans gradually|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well Skin Type V - Rarely burns, tans profusely"|Participants|Count of Participants|16|16.0||||||
3689337|NCT02239679|3531327|B4||Skin Type II - Burns easily, tans minimally|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well Skin Type V - Rarely burns, tans profusely"|Participants|Count of Participants|101|101.0||||||
3689338|NCT02239679|3531328|B3||Skin Type II - Burns easily, tans minimally|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well Skin Type V - Rarely burns, tans profusely"|Participants|Count of Participants|35|35.0||||||
3689339|NCT02239679|3531329|B2||Skin Type II - Burns easily, tans minimally|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well Skin Type V - Rarely burns, tans profusely"|Participants|Count of Participants|37|37.0||||||
3689340|NCT02239679|3531330|B1||Skin Type II - Burns easily, tans minimally|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well Skin Type V - Rarely burns, tans profusely"|Participants|Count of Participants|29|29.0||||||
3689341|NCT02239679|3531327|B4||Skin Type I - Burns easily, never tans|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well Skin Type V - Rarely burns, tans profusely"|Participants|Count of Participants|13|13.0||||||
3689342|NCT02239679|3531328|B3||Skin Type I - Burns easily, never tans|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well Skin Type V - Rarely burns, tans profusely"|Participants|Count of Participants|2|2.0||||||
3689343|NCT02239679|3531329|B2||Skin Type I - Burns easily, never tans|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well Skin Type V - Rarely burns, tans profusely"|Participants|Count of Participants|5|5.0||||||
3689399|NCT02239679|3531329|B2|||Age||years|Mean|66.7|66.7|Standard Deviation|9.35|9.35|||
3689344|NCT02239679|3531330|B1||Skin Type I - Burns easily, never tans|Skin Type|"Fitzpatrick Skin Type staging:~Skin Type I - Burns easily, never tans Skin Type II - Burns easily, tans minimally Skin Type III - Burns moderately, tans gradually Skin Type IV - Burns minimally, tans well Skin Type V - Rarely burns, tans profusely"|Participants|Count of Participants|6|6.0||||||
3689345|NCT02239679|3531327|B4|United States||Region of Enrollment||Participants|Count of Participants|166|166.0||||||
3689346|NCT02239679|3531328|B3|United States||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
3689347|NCT02239679|3531329|B2|United States||Region of Enrollment||Participants|Count of Participants|59|59.0||||||
3689348|NCT02239679|3531330|B1|United States||Region of Enrollment||Participants|Count of Participants|53|53.0||||||
3689349|NCT02239679|3531327|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689350|NCT02239679|3531328|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689351|NCT02239679|3531329|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689352|NCT02239679|3531330|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689353|NCT02239679|3531327|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689354|NCT02239679|3531328|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689355|NCT02239679|3531329|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689356|NCT02239679|3531330|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689357|NCT02239679|3531327|B4||White|Race (NIH/OMB)||Participants|Count of Participants|166|166.0||||||
3689358|NCT02239679|3531328|B3||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3689359|NCT02239679|3531329|B2||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3689360|NCT02239679|3531330|B1||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3689361|NCT02239679|3531327|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689362|NCT02239679|3531328|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689363|NCT02239679|3531329|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689364|NCT02239679|3531330|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689365|NCT02239679|3531327|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689366|NCT02239679|3531328|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689367|NCT02239679|3531329|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689368|NCT02239679|3531330|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689369|NCT02239679|3531327|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689370|NCT02239679|3531328|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689371|NCT02239679|3531329|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689372|NCT02239679|3531330|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689373|NCT02239679|3531327|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689374|NCT02239679|3531328|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689375|NCT02239679|3531329|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689376|NCT02239679|3531330|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689377|NCT02239679|3531327|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689378|NCT02239679|3531328|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689379|NCT02239679|3531329|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689380|NCT02239679|3531330|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689381|NCT02239679|3531327|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|164|164.0||||||
3689382|NCT02239679|3531328|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3689383|NCT02239679|3531329|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3689384|NCT02239679|3531330|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3689385|NCT02239679|3531327|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3689386|NCT02239679|3531328|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3689387|NCT02239679|3531329|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689388|NCT02239679|3531330|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3689389|NCT02239679|3531327|B4||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3689390|NCT02239679|3531328|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3689391|NCT02239679|3531329|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3689392|NCT02239679|3531330|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3689393|NCT02239679|3531327|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3689394|NCT02239679|3531328|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3689395|NCT02239679|3531329|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3689396|NCT02239679|3531330|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3689397|NCT02239679|3531327|B4|||Age||years|Mean|66.8|66.8|Standard Deviation|9.48|9.48|||
3689398|NCT02239679|3531328|B3|||Age||years|Mean|65.8|65.8|Standard Deviation|9.5|9.5|||
3689400|NCT02239679|3531330|B1|||Age||years|Mean|67.9|67.9|Standard Deviation|9.65|9.65|||
3689401|NCT02239328|3531544|B1|||Current smokers||Participants|Count of Participants|53|53.0||||||
3689402|NCT02239328|3531544|B1|United States||Region of Enrollment||Participants|Count of Participants|174|174.0||||||
3689403|NCT02239328|3531544|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689404|NCT02239328|3531544|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689405|NCT02239328|3531544|B1||White|Race (NIH/OMB)||Participants|Count of Participants|162|162.0||||||
3689406|NCT02239328|3531544|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3689407|NCT02239328|3531544|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689408|NCT02239328|3531544|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689409|NCT02239328|3531544|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689410|NCT02239328|3531544|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689411|NCT02239328|3531544|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|174|174.0||||||
3689412|NCT02239328|3531544|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689413|NCT02239328|3531544|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3689414|NCT02239328|3531544|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3689415|NCT02239328|3531544|B1|||Age||years|Mean|66.8|66.8|Standard Deviation|9.2|9.2|||
3689416|NCT02239289|3531548|B1|||Pain intensity in the past week|101-points numerical rating scale that ranges from 0 (no pain) to 100 (worst possible pain).|Units on a scale|Mean|24.62|24.62|Full Range|||0.0|60.0|
3689417|NCT02239289|3531548|B1|||Current pain intensity|101-points numerical rating scale that ranges from 0 (no pain) to 100 (worst possible pain).|Units on a scale|Mean|18.24|18.24|Full Range|||0.0|65.0|
3689418|NCT02239289|3531548|B1|||Disability level|Oswestry disability index ranges from 0 to 100. Higher score indicates a higher lumbar disability level.|units on a scale|Mean|12.95|12.95|Full Range|||0.0|28.0|
3689419|NCT02239289|3531548|B1|||Fear of movement level|Tampa scale for kinesiophobia ranges from 1 to 68. Higher score indicates a higher fear of movement level.|Units on a scale|Mean|32.76|32.76|Full Range|||22.0|48.0|
3689420|NCT02239289|3531548|B1|||Duration of low back pain in months, mean (SD)||months|Mean|88.36|88.36|Standard Deviation|65.26|65.26|||
3689421|NCT02239289|3531548|B1|||Body mass index, mean (SD)||kg/m^2|Mean|22.55|22.55|Standard Deviation|3.86|3.86|||
3689422|NCT02239289|3531548|B1|Canada||Region of Enrollment||participants|Number|21|21.0||||||
3689423|NCT02239289|3531548|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3689424|NCT02239289|3531548|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3689425|NCT02239289|3531548|B1|||Age||years|Mean|36.52|36.52|Standard Deviation|11.81|11.81|||
3689426|NCT02239094|3531567|B1|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3689427|NCT02239094|3531567|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3689428|NCT02239094|3531567|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3689429|NCT02239094|3531567|B1|||Age||years|Mean|33.4|33.4|Standard Deviation|9.8|9.8|||
3689430|NCT02239094|3531567|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3689431|NCT02239094|3531567|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3689432|NCT02239094|3531567|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3689433|NCT02238977|3531572|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689434|NCT02238977|3531573|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689435|NCT02238977|3531574|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689436|NCT02238977|3531572|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689437|NCT02238977|3531573|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689438|NCT02238977|3531574|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689439|NCT02238977|3531572|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689440|NCT02238977|3531573|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689441|NCT02238977|3531574|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689442|NCT02238977|3531572|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3689443|NCT02238977|3531573|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3689444|NCT02238977|3531574|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689445|NCT02238977|3531572|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689446|NCT02238977|3531573|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689447|NCT02238977|3531574|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689448|NCT02238977|3531572|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689449|NCT02238977|3531573|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689450|NCT02238977|3531574|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689451|NCT02238977|3531572|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689452|NCT02238977|3531573|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689453|NCT02238977|3531574|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689454|NCT02238977|3531572|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3689455|NCT02238977|3531573|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3689456|NCT02238977|3531572|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3689457|NCT02238977|3531573|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3689458|NCT02238977|3531572|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3689459|NCT02238977|3531573|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3689460|NCT02238977|3531572|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3689461|NCT02238977|3531573|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3689462|NCT02238977|3531572|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3689463|NCT02238977|3531573|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3689464|NCT02238925|3531581|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3689465|NCT02238925|3531581|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3689466|NCT02238925|3531581|B1|||Age||years|Mean|65.2|65.2|Standard Deviation|9.31|9.31|||
3689467|NCT02238782|3531589|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3689468|NCT02238782|3531589|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3689469|NCT02238782|3531589|B1|||Age||Years|Mean|42|42.0|Standard Deviation|11|11.0|||
3689470|NCT02238483|3531593|B3|Other||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
3689471|NCT02238483|3531594|B2|Other||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3689472|NCT02238483|3531595|B1|Other||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3689473|NCT02238483|3531593|B3|White||Race/Ethnicity, Customized||Participants|Number|173|173.0||||||
3689474|NCT02238483|3531594|B2|White||Race/Ethnicity, Customized||Participants|Number|88|88.0||||||
3689475|NCT02238483|3531595|B1|White||Race/Ethnicity, Customized||Participants|Number|85|85.0||||||
3689476|NCT02238483|3531593|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3689477|NCT02238483|3531594|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3689478|NCT02238483|3531595|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3689479|NCT02238483|3531593|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3689480|NCT02238483|3531594|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3689481|NCT02238483|3531595|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3689482|NCT02238483|3531593|B3|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3689483|NCT02238483|3531594|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3689484|NCT02238483|3531595|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3689485|NCT02238483|3531593|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3689486|NCT02238483|3531594|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3689487|NCT02238483|3531595|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3689488|NCT02238483|3531593|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689489|NCT02238483|3531594|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689490|NCT02238483|3531595|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689491|NCT02238483|3531593|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
3689492|NCT02238483|3531594|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3689493|NCT02238483|3531595|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3689494|NCT02238483|3531593|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
3689495|NCT02238483|3531594|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3689496|NCT02238483|3531595|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3689497|NCT02238483|3531593|B3||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3689498|NCT02238483|3531594|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3689499|NCT02238483|3531595|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3689500|NCT02238483|3531593|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3689501|NCT02238483|3531594|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3689502|NCT02238483|3531595|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3689503|NCT02238483|3531593|B3|||Age||Years|Mean|64.8|64.8|Standard Deviation|8.70|8.7|||
3689504|NCT02238483|3531594|B2|||Age||Years|Mean|64.2|64.2|Standard Deviation|8.67|8.67|||
3689505|NCT02238483|3531595|B1|||Age||Years|Mean|65.4|65.4|Standard Deviation|8.73|8.73|||
3689506|NCT02238483|3531593|B3||>=65 years|Age||Participants|Count of Participants|109|109.0||||||
3689507|NCT02238483|3531594|B2||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
3689508|NCT02238483|3531595|B1||>=65 years|Age||Participants|Count of Participants|58|58.0||||||
3689509|NCT02238483|3531593|B3||Between 18 and 65 years|Age||Participants|Count of Participants|103|103.0||||||
3689510|NCT02238483|3531594|B2||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3689511|NCT02238483|3531595|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3689512|NCT02238483|3531593|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3689513|NCT02238483|3531594|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3689514|NCT02238483|3531595|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3689515|NCT02238379|3531632|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
3689516|NCT02238379|3531633|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3689517|NCT02238379|3531634|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3689518|NCT02238379|3531632|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3689519|NCT02238379|3531633|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3689520|NCT02238379|3531634|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3689521|NCT02238379|3531632|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3689522|NCT02238379|3531633|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3689523|NCT02238379|3531634|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3689524|NCT02238379|3531632|B3|||Age||years|Mean|24|24.0|Standard Deviation|3|3.0|||
3689525|NCT02238379|3531633|B2|||Age||years|Mean|23|23.0|Standard Deviation|3|3.0|||
3689526|NCT02238379|3531634|B1|||Age||years|Mean|24|24.0|Standard Deviation|3|3.0|||
3689527|NCT02238379|3531632|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3689528|NCT02238379|3531633|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3689529|NCT02238379|3531634|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3689530|NCT02238379|3531632|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3689531|NCT02238379|3531633|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3689532|NCT02238379|3531634|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3689533|NCT02238379|3531632|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3689534|NCT02238379|3531633|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3689535|NCT02238379|3531634|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3689536|NCT02238080|3531661|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3689537|NCT02238080|3531661|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3689538|NCT02238080|3531661|B1|||Age||years|Mean|66.7|66.7|Standard Deviation|12.3|12.3|||
3689539|NCT02238067|3531675|B1||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3689540|NCT02238067|3531675|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3689541|NCT02238067|3531675|B1|||Age||years|Mean|74.6|74.6|Standard Deviation|10.6|10.6|||
3689542|NCT02238028|3531698|B1|||diastolic pressure||mmHg|Mean|70|70.0|Standard Deviation|5|5.0|||
3689543|NCT02238028|3531698|B1|||systolic pressure||mmHg|Mean|108|108.0|Standard Deviation|8|8.0|||
3689544|NCT02238028|3531698|B1|||BMI||kg/m^2|Mean|22|22.0|Standard Deviation|4|4.0|||
3689545|NCT02238028|3531698|B1|China||Region of Enrollment||participants|Number|24|24.0||||||
3689546|NCT02238028|3531698|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3689547|NCT02238028|3531698|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3689548|NCT02238028|3531698|B1|||Age||years|Mean|23|23.0|Standard Deviation|2|2.0|||
3689549|NCT02238028|3531698|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3689550|NCT02238028|3531698|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3689551|NCT02238028|3531698|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3689552|NCT02237118|3531718|B3|France||Region of Enrollment||participants|Number|123|123.0||||||
3689553|NCT02237118|3531719|B2|France||Region of Enrollment||participants|Number|63|63.0||||||
3689554|NCT02237118|3531720|B1|France||Region of Enrollment||participants|Number|60|60.0||||||
3689555|NCT02237118|3531718|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3689556|NCT02237118|3531719|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3689557|NCT02237118|3531720|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3689558|NCT02237118|3531718|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3689559|NCT02237118|3531719|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3689560|NCT02237118|3531720|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3689561|NCT02237118|3531718|B3|>=65 years||Age, Customized||participants|Number|61|61.0||||||
3689562|NCT02237118|3531719|B2|>=65 years||Age, Customized||participants|Number|32|32.0||||||
3689563|NCT02237118|3531720|B1|>=65 years||Age, Customized||participants|Number|29|29.0||||||
3689564|NCT02237118|3531718|B3|Between 18 and 65 years||Age, Customized||participants|Number|62|62.0||||||
3689565|NCT02237118|3531719|B2|Between 18 and 65 years||Age, Customized||participants|Number|31|31.0||||||
3689566|NCT02237118|3531720|B1|Between 18 and 65 years||Age, Customized||participants|Number|31|31.0||||||
3689567|NCT02237118|3531718|B3|||Age||years|Mean|62.3|62.3|Standard Deviation|22.2|22.2|||
3689568|NCT02237118|3531719|B2|||Age||years|Mean|59.8|59.8|Standard Deviation|23.0|23.0|||
3689569|NCT02237118|3531720|B1|||Age||years|Mean|64.8|64.8|Standard Deviation|21.2|21.2|||
3689570|NCT02237092|3531735|B1|||Abdominal circumference||cm|Median|105.1|105.1|Standard Deviation|10.2|10.2|||
3689571|NCT02237092|3531735|B1|||Body mass index||kg/m^2|Median|30.8|30.8|Standard Deviation|5.7|5.7|||
3689572|NCT02237092|3531735|B1|||Height||cm|Median|163.9|163.9|Standard Deviation|7.4|7.4|||
3689573|NCT02237092|3531735|B1|Male||Sex/Gender, Customized||Pregnant women|Number|0|0.0||||||
3689574|NCT02237092|3531735|B1|Female||Sex/Gender, Customized||Pregnant women|Number|196|196.0||||||
3689575|NCT02237092|3531735|B1|||Age||years|Median|29.5|29.5|Standard Deviation|5.7|5.7|||
3689576|NCT02236767|3531752|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3689577|NCT02236767|3531752|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3689578|NCT02236767|3531752|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3689579|NCT02236767|3531752|B1|||Age||years|Mean|58|58.0|Standard Deviation|0|0.0|||
3689580|NCT02236611|3531756|B3|White||Race/Ethnicity, Customized||Participants|Number|1030|1030.0||||||
3689581|NCT02236611|3531757|B2|White||Race/Ethnicity, Customized||Participants|Number|517|517.0||||||
3689582|NCT02236611|3531758|B1|White||Race/Ethnicity, Customized||Participants|Number|513|513.0||||||
3689583|NCT02236611|3531756|B3|Japanese/East Asian Heritage/South East Asian HRTG||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3689584|NCT02236611|3531757|B2|Japanese/East Asian Heritage/South East Asian HRTG||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3689585|NCT02236611|3531758|B1|Japanese/East Asian Heritage/South East Asian HRTG||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3689586|NCT02236611|3531756|B3|Central/South Asian Heritage (HRTG)||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3689587|NCT02236611|3531757|B2|Central/South Asian Heritage (HRTG)||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3689588|NCT02236611|3531758|B1|Central/South Asian Heritage (HRTG)||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3689589|NCT02236611|3531756|B3||Male|Sex: Female, Male||Participants|Count of Participants|705|705.0||||||
3689590|NCT02236611|3531757|B2||Male|Sex: Female, Male||Participants|Count of Participants|350|350.0||||||
3689591|NCT02236611|3531758|B1||Male|Sex: Female, Male||Participants|Count of Participants|355|355.0||||||
3689592|NCT02236611|3531756|B3||Female|Sex: Female, Male||Participants|Count of Participants|329|329.0||||||
3689593|NCT02236611|3531757|B2||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3689594|NCT02236611|3531758|B1||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3689595|NCT02236611|3531756|B3|||Age||Years|Mean|64.1|64.1|Standard Deviation|8.30|8.3|||
3689596|NCT02236611|3531757|B2|||Age||Years|Mean|64.0|64.0|Standard Deviation|8.26|8.26|||
3689597|NCT02236611|3531758|B1|||Age||Years|Mean|64.1|64.1|Standard Deviation|8.35|8.35|||
3689598|NCT02236598|3531765|B3|||BMI||kg/m2|Mean|34.8|34.8|Standard Deviation|5.3|5.3|||
3689599|NCT02236598|3531766|B2|||BMI||kg/m2|Mean|35.1|35.1|Standard Deviation|5.2|5.2|||
3689600|NCT02236598|3531767|B1|||BMI||kg/m2|Mean|34.3|34.3|Standard Deviation|5.4|5.4|||
3689601|NCT02236598|3531765|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
3689602|NCT02236598|3531766|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3689603|NCT02236598|3531767|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3689604|NCT02236598|3531765|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689605|NCT02236598|3531766|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689606|NCT02236598|3531767|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689607|NCT02236598|3531765|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689608|NCT02236598|3531766|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689609|NCT02236598|3531767|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689610|NCT02236598|3531765|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689611|NCT02236598|3531766|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689612|NCT02236598|3531767|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689613|NCT02236598|3531765|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3689614|NCT02236598|3531766|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3689615|NCT02236598|3531767|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3689616|NCT02236598|3531765|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689617|NCT02236598|3531766|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689618|NCT02236598|3531767|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689619|NCT02236598|3531765|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689620|NCT02236598|3531766|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689621|NCT02236598|3531767|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689622|NCT02236598|3531765|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689623|NCT02236598|3531766|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689624|NCT02236598|3531767|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689625|NCT02236598|3531765|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3689626|NCT02236598|3531766|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3689627|NCT02236598|3531767|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3689628|NCT02236598|3531765|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3689629|NCT02236598|3531766|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3689630|NCT02236598|3531767|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3689631|NCT02236598|3531765|B3|||Age||years|Mean|55.0|55.0|Standard Deviation|10.2|10.2|||
3689632|NCT02236598|3531766|B2|||Age||years|Mean|52.7|52.7|Standard Deviation|8.9|8.9|||
3689633|NCT02236598|3531767|B1|||Age||years|Mean|56.9|56.9|Standard Deviation|11.0|11.0|||
3689634|NCT02236546|3531780|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3689635|NCT02236546|3531780|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3689636|NCT02236546|3531780|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3689637|NCT02236546|3531780|B1|||Age||Years|Mean|57.66667|57.66667|Standard Deviation|19.85783|19.85783|||
3689638|NCT02236546|3531780|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3689639|NCT02236546|3531780|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3689640|NCT02236546|3531780|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3689641|NCT02236338|3531787|B3|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3689642|NCT02236338|3531788|B2|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3689643|NCT02236338|3531789|B1|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3689644|NCT02236338|3531787|B3|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3689645|NCT02236338|3531788|B2|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3689646|NCT02236338|3531789|B1|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3689647|NCT02236338|3531787|B3|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3689648|NCT02236338|3531788|B2|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3689649|NCT02236338|3531789|B1|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3689650|NCT02236338|3531787|B3|Race/Ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3689651|NCT02236338|3531788|B2|Race/Ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3689652|NCT02236338|3531789|B1|Race/Ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3689653|NCT02236338|3531787|B3|Race/Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|148|148.0||||||
3689654|NCT02236338|3531788|B2|Race/Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|70|70.0||||||
3689655|NCT02236338|3531789|B1|Race/Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|78|78.0||||||
3689656|NCT02236338|3531787|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3689657|NCT02236338|3531788|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3689658|NCT02236338|3531789|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3689659|NCT02236338|3531787|B3||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3689660|NCT02236338|3531788|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3689661|NCT02236338|3531789|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3689662|NCT02236338|3531787|B3|||Age||years|Median|48|48.0|Full Range|||19.0|86.0|
3689663|NCT02236338|3531788|B2|||Age||years|Median|48.5|48.5|Full Range|||23.0|86.0|
3689664|NCT02236338|3531789|B1|||Age||years|Median|47|47.0|Full Range|||19.0|86.0|
3689665|NCT02236130|3531802|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
3689666|NCT02236130|3531803|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
3689667|NCT02236130|3531804|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3689668|NCT02236130|3531802|B3||Male|Gender||Participants|Count of Participants|32|32.0||||||
3689669|NCT02236130|3531803|B2||Male|Gender||Participants|Count of Participants|16|16.0||||||
3689670|NCT02236130|3531804|B1||Male|Gender||Participants|Count of Participants|16|16.0||||||
3689671|NCT02236130|3531802|B3||Female|Gender||Participants|Count of Participants|17|17.0||||||
3689672|NCT02236130|3531803|B2||Female|Gender||Participants|Count of Participants|11|11.0||||||
3689673|NCT02236130|3531804|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
3689674|NCT02236130|3531802|B3|||Age||years|Mean|11.02|11.02|Full Range|||6.0|15.0|
3689675|NCT02236130|3531803|B2|||Age||years|Mean|11.41|11.41|Full Range|||6.0|15.0|
3689676|NCT02236130|3531804|B1|||Age||years|Mean|10.55|10.55|Full Range|||6.0|15.0|
3689677|NCT02236130|3531802|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3689678|NCT02236130|3531803|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3689679|NCT02236130|3531804|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3689680|NCT02236130|3531802|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3689681|NCT02236130|3531803|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3689682|NCT02236130|3531804|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3689683|NCT02236130|3531802|B3||<=18 years|Age||Participants|Count of Participants|49|49.0||||||
3689684|NCT02236130|3531803|B2||<=18 years|Age||Participants|Count of Participants|27|27.0||||||
3689685|NCT02236130|3531804|B1||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
3689686|NCT02235987|3531813|B1|Ukraine||Region of Enrollment||participants|Number|20|20.0||||||
3689687|NCT02235987|3531813|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3689688|NCT02235987|3531813|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3689689|NCT02235987|3531813|B1|||Age||years|Mean|47.8|47.8|Standard Deviation|11.5|11.5|||
3689690|NCT02235870|3531826|B3|||Body Mass Index (BMI)||kg/m^2|Mean|35.4|35.4|Standard Deviation|2.7|2.7|||
3689691|NCT02235870|3531827|B2|||Body Mass Index (BMI)||kg/m^2|Mean|35.5|35.5|Standard Deviation|2.7|2.7|||
3689692|NCT02235870|3531828|B1|||Body Mass Index (BMI)||kg/m^2|Mean|35.2|35.2|Standard Deviation|2.7|2.7|||
3689693|NCT02235870|3531826|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689694|NCT02235870|3531827|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689695|NCT02235870|3531828|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689696|NCT02235870|3531826|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3689697|NCT02235870|3531827|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3689698|NCT02235870|3531828|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3689699|NCT02235870|3531826|B3||White|Race (NIH/OMB)||Participants|Count of Participants|320|320.0||||||
3689700|NCT02235870|3531827|B2||White|Race (NIH/OMB)||Participants|Count of Participants|155|155.0||||||
3689701|NCT02235870|3531828|B1||White|Race (NIH/OMB)||Participants|Count of Participants|165|165.0||||||
3689702|NCT02235870|3531826|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3689703|NCT02235870|3531827|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3689704|NCT02235870|3531828|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3689705|NCT02235870|3531826|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689706|NCT02235870|3531827|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689707|NCT02235870|3531828|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689708|NCT02235870|3531826|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3689709|NCT02235870|3531827|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3689710|NCT02235870|3531828|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3689711|NCT02235870|3531826|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3689712|NCT02235870|3531827|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3689713|NCT02235870|3531828|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689714|NCT02235870|3531826|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689715|NCT02235870|3531827|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689716|NCT02235870|3531828|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689717|NCT02235870|3531826|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|348|348.0||||||
3689718|NCT02235870|3531827|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|165|165.0||||||
3689719|NCT02235870|3531828|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|183|183.0||||||
3689720|NCT02235870|3531826|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3689721|NCT02235870|3531827|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3689722|NCT02235870|3531828|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3689723|NCT02235870|3531826|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3689724|NCT02235870|3531827|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3689725|NCT02235870|3531828|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3689726|NCT02235870|3531826|B3||Female|Sex: Female, Male||Participants|Count of Participants|341|341.0||||||
3689727|NCT02235870|3531827|B2||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
3689728|NCT02235870|3531828|B1||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3689729|NCT02235870|3531826|B3|||Age||years|Mean|42.6|42.6|Standard Deviation|9.4|9.4|||
3689730|NCT02235870|3531827|B2|||Age||years|Mean|42.5|42.5|Standard Deviation|9.3|9.3|||
3689731|NCT02235870|3531828|B1|||Age||years|Mean|42.6|42.6|Standard Deviation|9.6|9.6|||
3689732|NCT02235831|3531838|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3689733|NCT02235831|3531838|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3689734|NCT02235831|3531838|B1|||Age||years|Mean|50.8|50.8|Standard Deviation|4.18|4.18|||
3689735|NCT02235493|3531850|B1|||Deceased/Alive Status - Alive||participants|Number|6|6.0||||||
3689736|NCT02235493|3531850|B1|||Deceased/Alive Status - Deceased||participants|Number|0|0.0||||||
3689737|NCT02235493|3531850|B1|||Modified Performance-Oriented Mobility Assessment - Gait subtest (MPOMA-G)|The MPOMA-G is a 5-component assessment that is used to evaluate gait performance. The first component has 4 sub-components. For 2 components and 2 sub-components, scores of 0 or 1 are assigned while scores of 0, 1 or 2 are assigned to the rest of the 2 components and 2 sub-components based on type of ambulation pattern observed. The maximum total score of 12 points = no impairment and 0 points = worst impairment.|units on a scale|Median|6.00|6.0|Inter-Quartile Range|||4.0|8.0|
3689738|NCT02235493|3531850|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3689739|NCT02235493|3531850|B1|White, Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3689740|NCT02235493|3531850|B1|White, Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3689741|NCT02235493|3531850|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3689742|NCT02235493|3531850|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3689743|NCT02235493|3531850|B1|||Age, Customized|Age at Diagnosis|months|Mean|28.2|28.2|Standard Deviation|10.6|10.6|||
3689744|NCT02235454|3531855|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
3689745|NCT02235454|3531855|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3689746|NCT02235454|3531855|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689747|NCT02235454|3531855|B1||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3689748|NCT02235454|3531855|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3689749|NCT02235454|3531855|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689750|NCT02235454|3531855|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3689751|NCT02235454|3531855|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689752|NCT02235454|3531855|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3689753|NCT02235454|3531855|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3689754|NCT02235454|3531855|B1|||Age||years|Mean|59.5|59.5|Standard Deviation|13.0|13.0|||
3689755|NCT02235311|3531859|B3|||Malignant cause identified||Participants|Count of Participants|0|0.0||||||
3689756|NCT02235311|3531861|B1|||Malignant cause identified||Participants|Count of Participants|0|0.0||||||
3689757|NCT02235311|3531859|B3|||transfusion required||Participants|Count of Participants|0|0.0||||||
3689758|NCT02235311|3531861|B1|||transfusion required||Participants|Count of Participants|0|0.0||||||
3689759|NCT02235311|3531859|B3|||endoscopic intervention required||Participants|Count of Participants|0|0.0||||||
3689760|NCT02235311|3531861|B1|||endoscopic intervention required||Participants|Count of Participants|0|0.0||||||
3689761|NCT02235311|3531859|B3|||history of bleed||Participants|Count of Participants|0|0.0||||||
3689762|NCT02235311|3531861|B1|||history of bleed||Participants|Count of Participants|0|0.0||||||
3689763|NCT02235311|3531859|B3|||history of ulcers||Participants|Count of Participants|0|0.0||||||
3689764|NCT02235311|3531861|B1|||history of ulcers||Participants|Count of Participants|0|0.0||||||
3689765|NCT02235311|3531859|B3|||alcoholism||Participants|Count of Participants|0|0.0||||||
3689766|NCT02235311|3531861|B1|||alcoholism||Participants|Count of Participants|0|0.0||||||
3689767|NCT02235311|3531859|B3|||smoker||Participants|Count of Participants|0|0.0||||||
3689768|NCT02235311|3531861|B1|||smoker||Participants|Count of Participants|0|0.0||||||
3689769|NCT02235311|3531859|B3|||Novel oral anticoagulant (NOAC) use||Participants|Count of Participants|0|0.0||||||
3689770|NCT02235311|3531861|B1|||Novel oral anticoagulant (NOAC) use||Participants|Count of Participants|0|0.0||||||
3689771|NCT02235311|3531859|B3|||Steroid use||Participants|Count of Participants|0|0.0||||||
3689772|NCT02235311|3531861|B1|||Steroid use||Participants|Count of Participants|0|0.0||||||
3689773|NCT02235311|3531859|B3|||Warfarin use||Participants|Count of Participants|0|0.0||||||
3689774|NCT02235311|3531861|B1|||Warfarin use||Participants|Count of Participants|0|0.0||||||
3689775|NCT02235311|3531859|B3|||NSAID use||Participants|Count of Participants|1|1.0||||||
3689776|NCT02235311|3531861|B1|||NSAID use||Participants|Count of Participants|1|1.0||||||
3689777|NCT02235311|3531859|B3|||Hepatic disease||Participants|Count of Participants|0|0.0||||||
3689778|NCT02235311|3531861|B1|||Hepatic disease||Participants|Count of Participants|0|0.0||||||
3689779|NCT02235311|3531859|B3|||Syncope||Participants|Count of Participants|0|0.0||||||
3689780|NCT02235311|3531861|B1|||Syncope||Participants|Count of Participants|0|0.0||||||
3689781|NCT02235311|3531859|B3|||Hematemesis present||Participants|Count of Participants|1|1.0||||||
3689782|NCT02235311|3531861|B1|||Hematemesis present||Participants|Count of Participants|1|1.0||||||
3689783|NCT02235311|3531859|B3|||Melena present||Participants|Count of Participants|1|1.0||||||
3689784|NCT02235311|3531861|B1|||Melena present||Participants|Count of Participants|1|1.0||||||
3689785|NCT02235311|3531859|B3|||Appearance of ulcer (oozing, bleeding)||Participants|Count of Participants|0|0.0||||||
3689786|NCT02235311|3531861|B1|||Appearance of ulcer (oozing, bleeding)||Participants|Count of Participants|0|0.0||||||
3689787|NCT02235311|3531859|B3|||Appearance of ulcer (clean-based)||Participants|Count of Participants|1|1.0||||||
3689788|NCT02235311|3531861|B1|||Appearance of ulcer (clean-based)||Participants|Count of Participants|1|1.0||||||
3689789|NCT02235311|3531859|B3|||H. pylori (serum) positive||Participants|Count of Participants|0|0.0||||||
3689790|NCT02235311|3531860|B2|||H. pylori (serum) positive||Participants|Count of Participants|0|0.0||||||
3689791|NCT02235311|3531861|B1|||H. pylori (serum) positive||Participants|Count of Participants|0|0.0||||||
3689792|NCT02235311|3531859|B3|||Positive fecal occult blood test (FOBT)||Participants|Count of Participants|0|0.0||||||
3689793|NCT02235311|3531861|B1|||Positive fecal occult blood test (FOBT)||Participants|Count of Participants|0|0.0||||||
3689794|NCT02235311|3531859|B3|||Serum creatinine (SCr)||mg/dL|Mean|0.7|0.7|Standard Deviation|NA||||Standard Deviation not calculable from one data value.
3689795|NCT02235311|3531861|B1|||Serum creatinine (SCr)||mg/dL|Mean|0.7|0.7|Standard Deviation|NA||||Standard Deviation not calculable from one data value.
3689796|NCT02235311|3531859|B3|||Blood urea nitrogen (BUN)||mg/dl|Mean|25|25.0|Standard Deviation|NA||||Standard Deviation not calculable from one data value.
3689797|NCT02235311|3531861|B1|||Blood urea nitrogen (BUN)||mg/dl|Mean|25|25.0|Standard Deviation|NA||||Standard Deviation not calculable from one data value.
3689798|NCT02235311|3531859|B3|||Platelets||Platelets/mm^3|Mean|299|299.0|Standard Deviation|NA||||Standard Deviation not calculable from one data value.
3689799|NCT02235311|3531861|B1|||Platelets||Platelets/mm^3|Mean|299|299.0|Standard Deviation|NA||||Standard Deviation not calculable from one data value.
3689800|NCT02235311|3531859|B3|||Mean arterial pressure (MAP)||mm Hg|Mean|76|76.0|Standard Deviation|NA||||Standard Deviation not calculable from one data value.
3689801|NCT02235311|3531861|B1|||Mean arterial pressure (MAP)||mm Hg|Mean|76|76.0|Standard Deviation|NA||||Standard Deviation not calculable from one data value.
3689802|NCT02235311|3531859|B3|||Participants with orthostasis|Orthostasis is a decrease in blood pressure that happens soon after standing. Measured by taking blood pressure while seated and then on standing.|participants|Number|0|0.0||||||
3689803|NCT02235311|3531861|B1|||Participants with orthostasis|Orthostasis is a decrease in blood pressure that happens soon after standing. Measured by taking blood pressure while seated and then on standing.|participants|Number|0|0.0||||||
3689804|NCT02235311|3531859|B3|||Heart rate||bpm|Mean|105|105.0|Standard Deviation|NA||||Standard Deviation not calculable form one data value.
3689805|NCT02235311|3531861|B1|||Heart rate||bpm|Mean|105|105.0|Standard Deviation|NA||||Standard Deviation not calculable form one data value.
3689806|NCT02235311|3531859|B3|||Glasgow-Blatchford Score|Summary score of presenting symptoms ranging from 0 - 29 to assess the likelihood that a patient with an acute upper gastrointestinal bleeding will need to have medical intervention. Score of >6 associated with higher risk of needing intervention.|summary score|Mean|17|17.0|Standard Deviation|NA||||Standard Deviation not calculable from one data value.
3689807|NCT02235311|3531861|B1|||Glasgow-Blatchford Score|Summary score of presenting symptoms ranging from 0 - 29 to assess the likelihood that a patient with an acute upper gastrointestinal bleeding will need to have medical intervention. Score of >6 associated with higher risk of needing intervention.|summary score|Mean|17|17.0|Standard Deviation|NA||||Standard Deviation not calculable from one data value.
3689808|NCT02235311|3531859|B3|||Weight||kg|Median|140|140.0|Inter-Quartile Range|||140.0|140.0|
3689809|NCT02235311|3531861|B1|||Weight||kg|Median|140|140.0|Inter-Quartile Range|||140.0|140.0|
3689810|NCT02235311|3531859|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3689811|NCT02235311|3531861|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3689812|NCT02235311|3531859|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3689813|NCT02235311|3531859|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3689814|NCT02235311|3531860|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3689815|NCT02235311|3531861|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3689816|NCT02235311|3531859|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3689817|NCT02235311|3531860|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3689818|NCT02235311|3531861|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3689819|NCT02235311|3531859|B3|Age >18 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3689820|NCT02235311|3531860|B2|Age >18 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3689821|NCT02235311|3531861|B1|Age >18 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3689822|NCT02235285|3531874|B1|Korea, Republic of||Region of Enrollment||participants|Number|162|162.0||||||
3689823|NCT02235285|3531874|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3689824|NCT02235285|3531874|B1||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3689825|NCT02235285|3531874|B1|||Age||years|Mean|33.98|33.98|Standard Deviation|8.7|8.7|||
3689826|NCT02235285|3531874|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3689827|NCT02235285|3531874|B1||Between 18 and 65 years|Age||Participants|Count of Participants|162|162.0||||||
3689828|NCT02235285|3531874|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3689829|NCT02235077|3531878|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689830|NCT02235077|3531879|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689831|NCT02235077|3531880|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689832|NCT02235077|3531878|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3689833|NCT02235077|3531879|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689834|NCT02235077|3531880|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3689835|NCT02235077|3531878|B3||White|Race (NIH/OMB)||Participants|Count of Participants|200|200.0||||||
3689836|NCT02235077|3531879|B2||White|Race (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3689837|NCT02235077|3531880|B1||White|Race (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
3689838|NCT02235077|3531878|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|151|151.0||||||
3689839|NCT02235077|3531879|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3689840|NCT02235077|3531880|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3689841|NCT02235077|3531878|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689842|NCT02235077|3531879|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689843|NCT02235077|3531880|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689844|NCT02235077|3531878|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3689845|NCT02235077|3531879|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3689846|NCT02235077|3531880|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3689847|NCT02235077|3531878|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3689848|NCT02235077|3531879|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3689849|NCT02235077|3531880|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3689850|NCT02235077|3531878|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689851|NCT02235077|3531879|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689852|NCT02235077|3531880|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689853|NCT02235077|3531878|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|352|352.0||||||
3689854|NCT02235077|3531879|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|172|172.0||||||
3689855|NCT02235077|3531880|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|180|180.0||||||
3689856|NCT02235077|3531878|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3689857|NCT02235077|3531879|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3689858|NCT02235077|3531880|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3689859|NCT02235077|3531878|B3||Male|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
3689860|NCT02235077|3531879|B2||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3689861|NCT02235077|3531880|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3689862|NCT02235077|3531878|B3||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3689863|NCT02235077|3531879|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3689864|NCT02235077|3531880|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3689865|NCT02235077|3531878|B3|||Age||years|Mean|64.7|64.7|Standard Deviation|14.1|14.1|||
3689866|NCT02235077|3531879|B2|||Age||years|Mean|63.5|63.5|Standard Deviation|14.4|14.4|||
3689867|NCT02235077|3531880|B1|||Age||years|Mean|65.9|65.9|Standard Deviation|13.7|13.7|||
3689868|NCT02235064|3531907|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3689869|NCT02235064|3531908|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3689870|NCT02235064|3531909|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3689871|NCT02235064|3531907|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3689872|NCT02235064|3531908|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3689873|NCT02235064|3531909|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3689874|NCT02235064|3531907|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3689875|NCT02235064|3531908|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3689876|NCT02235064|3531909|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3689877|NCT02235064|3531907|B3|||Age||years|Mean|31.5|31.5|Full Range|||30.0|33.0|
3689878|NCT02235064|3531908|B2|||Age||years|Mean|30|30.0|Full Range|||30.0|30.0|
3689879|NCT02235064|3531909|B1|||Age||years|Mean|33|33.0|Full Range|||33.0|33.0|
3689880|NCT02235064|3531907|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3689881|NCT02235064|3531908|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3689882|NCT02235064|3531909|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3689883|NCT02235064|3531907|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3689884|NCT02235064|3531908|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3689885|NCT02235064|3531909|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3689886|NCT02235064|3531907|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3689887|NCT02235064|3531908|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3689888|NCT02235064|3531909|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3689889|NCT02234752|3531936|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3689890|NCT02234752|3531936|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689891|NCT02234752|3531936|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689892|NCT02234752|3531936|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689893|NCT02234752|3531936|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3689894|NCT02234752|3531936|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689895|NCT02234752|3531936|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3689896|NCT02234752|3531936|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689897|NCT02234752|3531936|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3689898|NCT02234752|3531936|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3689899|NCT02234752|3531936|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3689900|NCT02234752|3531936|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3689901|NCT02234752|3531936|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3689902|NCT02234687|3531947|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3689903|NCT02234687|3531948|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3689904|NCT02234687|3531949|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3689905|NCT02234687|3531950|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3689906|NCT02234687|3531947|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3689907|NCT02234687|3531948|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3689908|NCT02234687|3531949|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3689909|NCT02234687|3531950|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3689910|NCT02234687|3531947|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3689911|NCT02234687|3531948|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3689912|NCT02234687|3531949|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3689913|NCT02234687|3531950|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3689914|NCT02234687|3531947|B4||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3689915|NCT02234687|3531948|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3689916|NCT02234687|3531949|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3689917|NCT02234687|3531950|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3689918|NCT02234687|3531947|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3689919|NCT02234687|3531948|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3689920|NCT02234687|3531949|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3689921|NCT02234687|3531950|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3689922|NCT02234479|3531960|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
3689923|NCT02234479|3531961|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
3689924|NCT02234479|3531962|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3689925|NCT02234479|3531960|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689926|NCT02234479|3531961|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689927|NCT02234479|3531962|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689928|NCT02234479|3531960|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689929|NCT02234479|3531961|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689930|NCT02234479|3531962|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689931|NCT02234479|3531960|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3689932|NCT02234479|3531961|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3689933|NCT02234479|3531962|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3689934|NCT02234479|3531960|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3689935|NCT02234479|3531961|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3689936|NCT02234479|3531962|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3689937|NCT02234479|3531960|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689938|NCT02234479|3531961|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689939|NCT02234479|3531962|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689940|NCT02234479|3531960|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689941|NCT02234479|3531961|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689942|NCT02234479|3531962|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689943|NCT02234479|3531960|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689944|NCT02234479|3531961|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689945|NCT02234479|3531962|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689946|NCT02234479|3531960|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3689947|NCT02234479|3531961|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3689948|NCT02234479|3531962|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3689949|NCT02234479|3531960|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3689950|NCT02234479|3531961|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3689951|NCT02234479|3531962|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3689952|NCT02234479|3531960|B3|||Age||years|Mean|40|40.0|Full Range|||18.0|75.0|
3689953|NCT02234479|3531961|B2|||Age||years|Mean|40|40.0|Full Range|||18.0|75.0|
3689954|NCT02234479|3531962|B1|||Age||years|Mean|40|40.0|Full Range|||18.0|75.0|
3689955|NCT02234479|3531960|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3689956|NCT02234479|3531961|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3689957|NCT02234479|3531962|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3689958|NCT02234479|3531960|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3689959|NCT02234479|3531961|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3689960|NCT02234479|3531962|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3689961|NCT02234479|3531960|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3689962|NCT02234479|3531961|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3689963|NCT02234479|3531962|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3689964|NCT02234427|3531969|B1|Caucasians||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3689965|NCT02234427|3531969|B1|African Americans||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3689966|NCT02234427|3531969|B1||Male|Gender||Participants|Count of Participants|17|17.0||||||
3689967|NCT02234427|3531969|B1||Female|Gender||Participants|Count of Participants|17|17.0||||||
3689968|NCT02234427|3531969|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|10.3|10.3|||
3689969|NCT02234362|3531973|B1||Never used hormone therapy in the past|Past hormone therapy use||Participants|Count of Participants|23|23.0||||||
3689970|NCT02234362|3531973|B1||Used hormone therapy in the past|Past hormone therapy use||Participants|Count of Participants|4|4.0||||||
3689971|NCT02234362|3531973|B1||Surgically postmenopausal|Menopausal Status||Participants|Count of Participants|2|2.0||||||
3689972|NCT02234362|3531973|B1||Naturally postmenopausal|Menopausal Status||Participants|Count of Participants|12|12.0||||||
3689973|NCT02234362|3531973|B1||Perimenopausal|Menopausal Status||Participants|Count of Participants|13|13.0||||||
3689974|NCT02234362|3531973|B1||Decline to answer|Marital Status||Participants|Count of Participants|0|0.0||||||
3689975|NCT02234362|3531973|B1||Never married/single|Marital Status||Participants|Count of Participants|13|13.0||||||
3689976|NCT02234362|3531973|B1||Separated/divorced/widowed|Marital Status||Participants|Count of Participants|8|8.0||||||
3689977|NCT02234362|3531973|B1||Married|Marital Status||Participants|Count of Participants|6|6.0||||||
3689978|NCT02234362|3531973|B1||Temporary work|Employment||Participants|Count of Participants|2|2.0||||||
3689979|NCT02234362|3531973|B1||Retired|Employment||Participants|Count of Participants|2|2.0||||||
3689980|NCT02234362|3531973|B1||Volunteer|Employment||Participants|Count of Participants|1|1.0||||||
3689981|NCT02234362|3531973|B1||Student|Employment||Participants|Count of Participants|0|0.0||||||
3689982|NCT02234362|3531973|B1||Not working, unemployed|Employment||Participants|Count of Participants|10|10.0||||||
3689983|NCT02234362|3531973|B1||Disabled|Employment||Participants|Count of Participants|3|3.0||||||
3689984|NCT02234362|3531973|B1||Homemaker|Employment||Participants|Count of Participants|2|2.0||||||
3689985|NCT02234362|3531973|B1||Full-or part-time work|Employment||Participants|Count of Participants|7|7.0||||||
3689986|NCT02234362|3531973|B1||Doctoral Degree (PhD, MD, etc.)|Highest Level of Education||Participants|Count of Participants|0|0.0||||||
3689987|NCT02234362|3531973|B1||Master's Degree|Highest Level of Education||Participants|Count of Participants|1|1.0||||||
3689988|NCT02234362|3531973|B1||Graduated college (BA, BS)|Highest Level of Education||Participants|Count of Participants|7|7.0||||||
3689989|NCT02234362|3531973|B1||Some college or Associate Degree|Highest Level of Education||Participants|Count of Participants|8|8.0||||||
3689990|NCT02234362|3531973|B1||Vocational/training school after high school|Highest Level of Education||Participants|Count of Participants|2|2.0||||||
3689991|NCT02234362|3531973|B1||High school or received GED|Highest Level of Education||Participants|Count of Participants|7|7.0||||||
3689992|NCT02234362|3531973|B1||Some high school|Highest Level of Education||Participants|Count of Participants|2|2.0||||||
3689993|NCT02234362|3531973|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3689994|NCT02234362|3531973|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3689995|NCT02234362|3531973|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689996|NCT02234362|3531973|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3689997|NCT02234362|3531973|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3689998|NCT02234362|3531973|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3689999|NCT02234362|3531973|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690000|NCT02234362|3531973|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3690001|NCT02234362|3531973|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3690002|NCT02234362|3531973|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3690003|NCT02234362|3531973|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3690004|NCT02234362|3531973|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3690005|NCT02234362|3531973|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3690006|NCT02234362|3531973|B1|||Age||years|Mean|52.1|52.1|Standard Deviation|4.8|4.8|||
3690007|NCT02234362|3531973|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3690008|NCT02234362|3531973|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3690009|NCT02234362|3531973|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3690010|NCT02234180|3531990|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3690011|NCT02234180|3531990|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3690012|NCT02234180|3531990|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3690013|NCT02234180|3531990|B1|||Age||years|Median|54.0|54.0|Full Range|||53.0|58.0|
3690014|NCT02234115|3531997|B1|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3690015|NCT02234115|3531997|B1|Lithuania||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3690016|NCT02234115|3531997|B1|Slovakia||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3690017|NCT02234115|3531997|B1|Poland||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3690018|NCT02234115|3531997|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3690019|NCT02234115|3531997|B1|Czechia||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3690020|NCT02234115|3531997|B1|United States||Region of Enrollment||Participants|Count of Participants|64|64.0||||||
3690021|NCT02234115|3531997|B1|Austria||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3690022|NCT02234115|3531997|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3690023|NCT02234115|3531997|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690024|NCT02234115|3531997|B1||White|Race (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
3690025|NCT02234115|3531997|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3690026|NCT02234115|3531997|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690027|NCT02234115|3531997|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3690028|NCT02234115|3531997|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690029|NCT02234115|3531997|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3690030|NCT02234115|3531997|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3690031|NCT02234115|3531997|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3690032|NCT02234115|3531997|B1||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3690033|NCT02234115|3531997|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3690034|NCT02234115|3531997|B1|||Age||years|Mean|71.1|71.1|Standard Deviation|8.70|8.7|||
3690035|NCT02233998|3532006|B4|Canada||Region of Enrollment||participants|Number|158|158.0||||||
3690036|NCT02233998|3532007|B3|Canada||Region of Enrollment||participants|Number|53|53.0||||||
3690037|NCT02233998|3532008|B2|Canada||Region of Enrollment||participants|Number|52|52.0||||||
3690038|NCT02233998|3532009|B1|Canada||Region of Enrollment||participants|Number|53|53.0||||||
3690039|NCT02233998|3532006|B4||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3690040|NCT02233998|3532007|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3690041|NCT02233998|3532008|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3690042|NCT02233998|3532009|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3690043|NCT02233998|3532006|B4||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3690044|NCT02233998|3532007|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3690045|NCT02233998|3532008|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3690046|NCT02233998|3532009|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3690047|NCT02233998|3532006|B4|||Age||years|Mean|44.5|44.5|Standard Deviation|11.66|11.66|||
3690048|NCT02233998|3532007|B3|||Age||years|Mean|45.5|45.5|Standard Deviation|11.18|11.18|||
3690049|NCT02233998|3532008|B2|||Age||years|Mean|41.7|41.7|Standard Deviation|12.48|12.48|||
3690050|NCT02233998|3532009|B1|||Age||years|Mean|46.2|46.2|Standard Deviation|10.97|10.97|||
3690051|NCT02233985|3532043|B3|Mexico||Region of Enrollment||Participants|Count of Participants|64|64.0||||||
3690052|NCT02233985|3532044|B2|Mexico||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3690053|NCT02233985|3532045|B1|Mexico||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3690054|NCT02233985|3532043|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690055|NCT02233985|3532044|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690056|NCT02233985|3532045|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690057|NCT02233985|3532043|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690058|NCT02233985|3532044|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690059|NCT02233985|3532045|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690060|NCT02233985|3532043|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3690061|NCT02233985|3532044|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3690062|NCT02233985|3532045|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3690063|NCT02233985|3532043|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3690064|NCT02233985|3532044|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3690065|NCT02233985|3532045|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3690066|NCT02233985|3532043|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3690067|NCT02233985|3532044|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3690068|NCT02233985|3532045|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3690069|NCT02233985|3532043|B3|||Age||months|Mean|8.2|8.2|Standard Deviation|5.5|5.5|||
3690070|NCT02233985|3532044|B2|||Age||months|Mean|8.8|8.8|Standard Deviation|5.7|5.7|||
3690071|NCT02233985|3532045|B1|||Age||months|Mean|7.7|7.7|Standard Deviation|5.7|5.7|||
3690072|NCT02233842|3532054|B1|Patients being screened for trial eligibility||Type of Trials Participants Were Enrolled||participants|Number|3|3.0||||||
3690073|NCT02233842|3532054|B1|Observational study||Type of Trials Participants Were Enrolled||participants|Number|6|6.0||||||
3690074|NCT02233842|3532054|B1|Tumor-directed therapy clinical trial||Type of Trials Participants Were Enrolled||participants|Number|21|21.0||||||
3690075|NCT02233842|3532054|B1|Thymus cancer||Diagnosis||participants|Number|4|4.0||||||
3690076|NCT02233842|3532054|B1|Pleural mesothelioma||Diagnosis||participants|Number|3|3.0||||||
3690077|NCT02233842|3532054|B1|Thyroid cancer||Diagnosis||participants|Number|1|1.0||||||
3690078|NCT02233842|3532054|B1|Testicular cancer||Diagnosis||participants|Number|1|1.0||||||
3690079|NCT02233842|3532054|B1|Pancreatic cancer||Diagnosis||participants|Number|1|1.0||||||
3690080|NCT02233842|3532054|B1|Lung cancer||Diagnosis||participants|Number|8|8.0||||||
3690081|NCT02233842|3532054|B1|Bladder cancer||Diagnosis||participants|Number|3|3.0||||||
3690082|NCT02233842|3532054|B1|Prostate cancer||Diagnosis||participants|Number|9|9.0||||||
3690083|NCT02233842|3532054|B1|Never (current cigar smoker)||Cigarette smoking status||participants|Number|1|1.0||||||
3690084|NCT02233842|3532054|B1|Current||Cigarette smoking status||participants|Number|6|6.0||||||
3690085|NCT02233842|3532054|B1|Former at enrollment;current at diagnosis||Cigarette smoking status||participants|Number|6|6.0||||||
3690086|NCT02233842|3532054|B1|Former (quit at least 1yr prior to diagnosis)||Cigarette smoking status||participants|Number|17|17.0||||||
3690087|NCT02233842|3532054|B1|Postgraduate degree||Education (highest level completed)||participants|Number|8|8.0||||||
3690088|NCT02233842|3532054|B1|College degree||Education (highest level completed)||participants|Number|4|4.0||||||
3690089|NCT02233842|3532054|B1|Some college||Education (highest level completed)||participants|Number|11|11.0||||||
3690090|NCT02233842|3532054|B1|High School/GED||Education (highest level completed)||participants|Number|7|7.0||||||
3690091|NCT02233842|3532054|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3690092|NCT02233842|3532054|B1|Asian/PI (Pacific Islander)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3690093|NCT02233842|3532054|B1|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3690094|NCT02233842|3532054|B1|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3690095|NCT02233842|3532054|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690157|NCT02233101|3532135|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3690096|NCT02233842|3532054|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3690097|NCT02233842|3532054|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3690098|NCT02233842|3532054|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3690099|NCT02233842|3532054|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3690100|NCT02233842|3532054|B1|Age 70-79||Age, Customized||participants|Number|7|7.0||||||
3690101|NCT02233842|3532054|B1|Age 60-69||Age, Customized||participants|Number|8|8.0||||||
3690102|NCT02233842|3532054|B1|Age 50-59||Age, Customized||participants|Number|13|13.0||||||
3690103|NCT02233842|3532054|B1|Age 40-49||Age, Customized||participants|Number|1|1.0||||||
3690104|NCT02233842|3532054|B1|Age 30-39||Age, Customized||participants|Number|0|0.0||||||
3690105|NCT02233842|3532054|B1|Age 20-29||Age, Customized||participants|Number|1|1.0||||||
3690106|NCT02233803|3532061|B1|White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|199|199.0||||||
3690107|NCT02233803|3532061|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3690108|NCT02233803|3532061|B1||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3690109|NCT02233803|3532061|B1|||Age||Years|Mean|46.2|46.2|Standard Deviation|15.26|15.26|||
3690110|NCT02233647|3532072|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3690111|NCT02233647|3532072|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690112|NCT02233647|3532072|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690113|NCT02233647|3532072|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3690114|NCT02233647|3532072|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3690115|NCT02233647|3532072|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690116|NCT02233647|3532072|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690117|NCT02233647|3532072|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690118|NCT02233647|3532072|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690119|NCT02233647|3532072|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3690120|NCT02233647|3532072|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3690121|NCT02233647|3532072|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3690122|NCT02233647|3532072|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3690123|NCT02233647|3532072|B1|||Age||years|Mean|43|43.0|Standard Deviation|4|4.0|||
3690124|NCT02233543|3532101|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3690125|NCT02233543|3532101|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3690126|NCT02233543|3532101|B1|||Age||Years|Mean|68.4|68.4|Standard Deviation|6.2|6.2|||
3690127|NCT02233309|3532110|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
3690128|NCT02233309|3532110|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3690129|NCT02233309|3532110|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3690130|NCT02233309|3532110|B1|||Age||years|Mean|2.21|2.21|Standard Deviation|2.2|2.2|||
3690131|NCT02233309|3532110|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3690132|NCT02233309|3532110|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3690133|NCT02233309|3532110|B1||<=18 years|Age||Participants|Count of Participants|36|36.0||||||
3690134|NCT02233296|3532114|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3690135|NCT02233296|3532115|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3690136|NCT02233296|3532116|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3690137|NCT02233296|3532114|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3690138|NCT02233296|3532115|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3690139|NCT02233296|3532116|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3690140|NCT02233296|3532114|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3690141|NCT02233296|3532115|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3690142|NCT02233296|3532116|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3690143|NCT02233296|3532114|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3690144|NCT02233296|3532115|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3690145|NCT02233296|3532116|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3690146|NCT02233296|3532114|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3690147|NCT02233296|3532115|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3690148|NCT02233296|3532116|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3690149|NCT02233101|3532133|B3|United States||Region of Enrollment||Participants|Count of Participants|167|167.0||||||
3690150|NCT02233101|3532134|B2|United States||Region of Enrollment||Participants|Count of Participants|81|81.0||||||
3690151|NCT02233101|3532135|B1|United States||Region of Enrollment||Participants|Count of Participants|86|86.0||||||
3690152|NCT02233101|3532133|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3690153|NCT02233101|3532134|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3690154|NCT02233101|3532135|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3690155|NCT02233101|3532133|B3||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3690156|NCT02233101|3532134|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3690158|NCT02233101|3532133|B3|||Age||years|Mean|60|60.0|Full Range|||30.0|87.0|
3690159|NCT02233101|3532134|B2|||Age||years|Mean|58|58.0|Full Range|||30.0|85.0|
3690160|NCT02233101|3532135|B1|||Age||years|Mean|61|61.0|Full Range|||37.0|87.0|
3690161|NCT02233101|3532133|B3||>=65 years|Age||Participants|Count of Participants|66|66.0||||||
3690162|NCT02233101|3532134|B2||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
3690163|NCT02233101|3532135|B1||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
3690164|NCT02233101|3532133|B3||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
3690165|NCT02233101|3532134|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3690166|NCT02233101|3532135|B1||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3690167|NCT02233101|3532133|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3690168|NCT02233101|3532134|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3690169|NCT02233101|3532135|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3690170|NCT02232880|3532144|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3690171|NCT02232880|3532144|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3690172|NCT02232880|3532144|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
3690173|NCT02232880|3532144|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3690174|NCT02232880|3532144|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3690175|NCT02232880|3532144|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3690176|NCT02232698|3532151|B3|||Screening HbA1c||mmol/mol|Mean|50.1|50.1|Standard Deviation|6.1|6.1|||
3690177|NCT02232698|3532152|B2|||Screening HbA1c||mmol/mol|Mean|50.2|50.2|Standard Deviation|6.5|6.5|||
3690178|NCT02232698|3532153|B1|||Screening HbA1c||mmol/mol|Mean|50.1|50.1|Standard Deviation|5.7|5.7|||
3690179|NCT02232698|3532151|B3|||Screening HbA1c||%|Mean|6.74|6.74|Standard Deviation|0.56|0.56|||
3690180|NCT02232698|3532152|B2|||Screening HbA1c||%|Mean|6.74|6.74|Standard Deviation|0.59|0.59|||
3690181|NCT02232698|3532153|B1|||Screening HbA1c||%|Mean|6.73|6.73|Standard Deviation|0.52|0.52|||
3690182|NCT02232698|3532151|B3||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3690183|NCT02232698|3532152|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3690184|NCT02232698|3532153|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3690185|NCT02232698|3532151|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3690186|NCT02232698|3532152|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3690187|NCT02232698|3532153|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3690188|NCT02232698|3532151|B3|||Age||years|Mean|43.7|43.7|Standard Deviation|13.9|13.9|||
3690189|NCT02232698|3532152|B2|||Age||years|Mean|45.0|45.0|Standard Deviation|14.6|14.6|||
3690190|NCT02232698|3532153|B1|||Age||years|Mean|42.4|42.4|Standard Deviation|13.1|13.1|||
3690191|NCT02232178|3532175|B4|United States||Region of Enrollment||participants|Number|64|64.0||||||
3690192|NCT02232178|3532176|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
3690193|NCT02232178|3532177|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3690194|NCT02232178|3532178|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
3690195|NCT02232178|3532175|B4||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3690196|NCT02232178|3532176|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3690197|NCT02232178|3532177|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3690198|NCT02232178|3532178|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3690199|NCT02232178|3532175|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3690200|NCT02232178|3532176|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3690201|NCT02232178|3532177|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3690202|NCT02232178|3532178|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3690203|NCT02232178|3532175|B4|||Age||years|Mean|45.2|45.2|Standard Deviation|11.90|11.9|||
3690204|NCT02232178|3532176|B3|||Age||years|Mean|48.2|48.2|Standard Deviation|12.76|12.76|||
3690205|NCT02232178|3532177|B2|||Age||years|Mean|46.1|46.1|Standard Deviation|11.40|11.4|||
3690206|NCT02232178|3532178|B1|||Age||years|Mean|42.7|42.7|Standard Deviation|11.93|11.93|||
3690207|NCT02232126|3532197|B3|No||Has Advance Directive||participants|Number|85|85.0||||||
3690208|NCT02232126|3532198|B2|No||Has Advance Directive||participants|Number|44|44.0||||||
3690209|NCT02232126|3532199|B1|No||Has Advance Directive||participants|Number|41|41.0||||||
3690210|NCT02232126|3532197|B3|Yes||Has Advance Directive||participants|Number|96|96.0||||||
3690211|NCT02232126|3532198|B2|Yes||Has Advance Directive||participants|Number|46|46.0||||||
3690212|NCT02232126|3532199|B1|Yes||Has Advance Directive||participants|Number|50|50.0||||||
3690213|NCT02232126|3532197|B3|No||Had inpatient stay or emergency department visit in previous 6 months||participants|Number|114|114.0||||||
3690214|NCT02232126|3532198|B2|No||Had inpatient stay or emergency department visit in previous 6 months||participants|Number|58|58.0||||||
3690215|NCT02232126|3532199|B1|No||Had inpatient stay or emergency department visit in previous 6 months||participants|Number|56|56.0||||||
3690216|NCT02232126|3532197|B3|Yes||Had inpatient stay or emergency department visit in previous 6 months||participants|Number|67|67.0||||||
3690217|NCT02232126|3532198|B2|Yes||Had inpatient stay or emergency department visit in previous 6 months||participants|Number|32|32.0||||||
3690218|NCT02232126|3532199|B1|Yes||Had inpatient stay or emergency department visit in previous 6 months||participants|Number|35|35.0||||||
3690219|NCT02232126|3532197|B3|No||Discharged home under self-care||participants|Number|53|53.0||||||
3690220|NCT02232126|3532198|B2|No||Discharged home under self-care||participants|Number|23|23.0||||||
3690221|NCT02232126|3532199|B1|No||Discharged home under self-care||participants|Number|30|30.0||||||
3690222|NCT02232126|3532197|B3|Yes||Discharged home under self-care||participants|Number|128|128.0||||||
3690223|NCT02232126|3532198|B2|Yes||Discharged home under self-care||participants|Number|67|67.0||||||
3690224|NCT02232126|3532199|B1|Yes||Discharged home under self-care||participants|Number|61|61.0||||||
3690225|NCT02232126|3532197|B3|||Number of daily medications||medications|Mean|7.81|7.81|Standard Deviation|3.8|3.8|||
3690226|NCT02232126|3532198|B2|||Number of daily medications||medications|Mean|8.00|8.0|Standard Deviation|3.8|3.8|||
3690227|NCT02232126|3532199|B1|||Number of daily medications||medications|Mean|7.61|7.61|Standard Deviation|3.8|3.8|||
3690228|NCT02232126|3532197|B3|||Number of health conditions||health conditions|Mean|6.17|6.17|Standard Deviation|3.5|3.5|||
3690229|NCT02232126|3532198|B2|||Number of health conditions||health conditions|Mean|5.88|5.88|Standard Deviation|2.9|2.9|||
3690230|NCT02232126|3532199|B1|||Number of health conditions||health conditions|Mean|6.35|6.35|Standard Deviation|4.1|4.1|||
3690231|NCT02232126|3532197|B3|||Cognition (SPMSQ score)|The Short Portable Mental Health Questionnaire (SPMSQ) is widely used tool to screen for cognitive impairment. This questionnaire consists of 10 questions and a total score is derived at the end. Scores can range from 0-10 where a low score indicates high cognitive impairment and a high score indicates higher cognitive functioning. The scale has an established cut-off score of 5 where those scoring 5 or higher are cognitively intact to participate in research, understand the study and associated activities, and provide consent. Those scoring below 5 are deemed ineligible.|units on a scale|Mean|9.13|9.13|Standard Deviation|1.15|1.15|||
3690232|NCT02232126|3532198|B2|||Cognition (SPMSQ score)|The Short Portable Mental Health Questionnaire (SPMSQ) is widely used tool to screen for cognitive impairment. This questionnaire consists of 10 questions and a total score is derived at the end. Scores can range from 0-10 where a low score indicates high cognitive impairment and a high score indicates higher cognitive functioning. The scale has an established cut-off score of 5 where those scoring 5 or higher are cognitively intact to participate in research, understand the study and associated activities, and provide consent. Those scoring below 5 are deemed ineligible.|units on a scale|Mean|9.18|9.18|Standard Deviation|1.1|1.1|||
3690233|NCT02232126|3532199|B1|||Cognition (SPMSQ score)|The Short Portable Mental Health Questionnaire (SPMSQ) is widely used tool to screen for cognitive impairment. This questionnaire consists of 10 questions and a total score is derived at the end. Scores can range from 0-10 where a low score indicates high cognitive impairment and a high score indicates higher cognitive functioning. The scale has an established cut-off score of 5 where those scoring 5 or higher are cognitively intact to participate in research, understand the study and associated activities, and provide consent. Those scoring below 5 are deemed ineligible.|units on a scale|Mean|9.08|9.08|Standard Deviation|1.2|1.2|||
3690234|NCT02232126|3532197|B3|||Physical Functioning Index (abbreviated Short Form-12)|The Short-Form, 12-item is a survey tool to measure physical health and functional level and an abbreviated version of this tool was used in the present study which constituted eight of the 12-items that focused on physical functioning. Response options ranged from 'not limited at all,' to 'limited a lot' and after assigning numerical values to response options, total scores ranged from 0-16 with a higher score corresponding to greater physical limitations.|units on a scale|Mean|7.43|7.43|Standard Deviation|5.1|5.1|||
3690235|NCT02232126|3532198|B2|||Physical Functioning Index (abbreviated Short Form-12)|The Short-Form, 12-item is a survey tool to measure physical health and functional level and an abbreviated version of this tool was used in the present study which constituted eight of the 12-items that focused on physical functioning. Response options ranged from 'not limited at all,' to 'limited a lot' and after assigning numerical values to response options, total scores ranged from 0-16 with a higher score corresponding to greater physical limitations.|units on a scale|Mean|7.18|7.18|Standard Deviation|5.08|5.08|||
3690236|NCT02232126|3532199|B1|||Physical Functioning Index (abbreviated Short Form-12)|The Short-Form, 12-item is a survey tool to measure physical health and functional level and an abbreviated version of this tool was used in the present study which constituted eight of the 12-items that focused on physical functioning. Response options ranged from 'not limited at all,' to 'limited a lot' and after assigning numerical values to response options, total scores ranged from 0-16 with a higher score corresponding to greater physical limitations.|units on a scale|Mean|7.67|7.67|Standard Deviation|5.12|5.12|||
3690237|NCT02232126|3532197|B3|||Pain (Number Rating Scale)|The Number Rating Scale is a self-reported measure for pain level that is widely used in US hospitals. Patients are asked to rate their level of pain felt over the last 24-hours on a scale ranging from 0-10, where zero indicates no pain, and 10 is the worst pain imaginable.|units on a scale|Mean|6.36|6.36|Standard Deviation|2.25|2.25|||
3690238|NCT02232126|3532198|B2|||Pain (Number Rating Scale)|The Number Rating Scale is a self-reported measure for pain level that is widely used in US hospitals. Patients are asked to rate their level of pain felt over the last 24-hours on a scale ranging from 0-10, where zero indicates no pain, and 10 is the worst pain imaginable.|units on a scale|Mean|9.18|9.18|Standard Deviation|1.1|1.1|||
3690239|NCT02232126|3532199|B1|||Pain (Number Rating Scale)|The Number Rating Scale is a self-reported measure for pain level that is widely used in US hospitals. Patients are asked to rate their level of pain felt over the last 24-hours on a scale ranging from 0-10, where zero indicates no pain, and 10 is the worst pain imaginable.|units on a scale|Mean|3.54|3.54|Standard Deviation|3.4|3.4|||
3690240|NCT02232126|3532197|B3|||Patient Health Questionnaire 9-item (PHQ-9)|"The Patient Health Questionnaire, 9-item uses nine questions to asses for depression and has been widely and successfully used in health care research since the early 1990's, particularly in investigations among older adults aged 65 years or more.~A total score is reported at the end of the questionnaire and scores can range from 0-27 with a higher value indicating more severe or worse depression. Total scores correspond to the following: 0 no depression, 1-4 minimal depression, 5-9 mild depression, 10-14 moderate depression, 15-19 moderate severe depression, and 20-27 severe depression."|units on a scale|Mean|5.24|5.24|Standard Deviation|4.5|4.5|||
3690280|NCT02232126|3532198|B2|Some college||Highest grade completed in school||participants|Number|20|20.0||||||
3690241|NCT02232126|3532198|B2|||Patient Health Questionnaire 9-item (PHQ-9)|"The Patient Health Questionnaire, 9-item uses nine questions to asses for depression and has been widely and successfully used in health care research since the early 1990's, particularly in investigations among older adults aged 65 years or more.~A total score is reported at the end of the questionnaire and scores can range from 0-27 with a higher value indicating more severe or worse depression. Total scores correspond to the following: 0 no depression, 1-4 minimal depression, 5-9 mild depression, 10-14 moderate depression, 15-19 moderate severe depression, and 20-27 severe depression."|units on a scale|Mean|6.15|6.15|Standard Deviation|5.1|5.1|||
3690242|NCT02232126|3532199|B1|||Patient Health Questionnaire 9-item (PHQ-9)|"The Patient Health Questionnaire, 9-item uses nine questions to asses for depression and has been widely and successfully used in health care research since the early 1990's, particularly in investigations among older adults aged 65 years or more.~A total score is reported at the end of the questionnaire and scores can range from 0-27 with a higher value indicating more severe or worse depression. Total scores correspond to the following: 0 no depression, 1-4 minimal depression, 5-9 mild depression, 10-14 moderate depression, 15-19 moderate severe depression, and 20-27 severe depression."|units on a scale|Mean|4.33|4.33|Standard Deviation|3.9|3.9|||
3690243|NCT02232126|3532197|B3|Stroke||Chronic condition inventory|Measure NOT mutually exclusive. Inventory of conditions|participants|Number|17|17.0||||||
3690244|NCT02232126|3532198|B2|Stroke||Chronic condition inventory|Measure NOT mutually exclusive. Inventory of conditions|participants|Number|10|10.0||||||
3690245|NCT02232126|3532199|B1|Stroke||Chronic condition inventory|Measure NOT mutually exclusive. Inventory of conditions|participants|Number|7|7.0||||||
3690246|NCT02232126|3532197|B3|Respiratory disease||Chronic condition inventory|Measure NOT mutually exclusive. Inventory of conditions|participants|Number|59|59.0||||||
3690247|NCT02232126|3532198|B2|Respiratory disease||Chronic condition inventory|Measure NOT mutually exclusive. Inventory of conditions|participants|Number|29|29.0||||||
3690248|NCT02232126|3532199|B1|Respiratory disease||Chronic condition inventory|Measure NOT mutually exclusive. Inventory of conditions|participants|Number|30|30.0||||||
3690249|NCT02232126|3532197|B3|Hypertension||Chronic condition inventory|Measure NOT mutually exclusive. Inventory of conditions|participants|Number|111|111.0||||||
3690250|NCT02232126|3532198|B2|Hypertension||Chronic condition inventory|Measure NOT mutually exclusive. Inventory of conditions|participants|Number|54|54.0||||||
3690251|NCT02232126|3532199|B1|Hypertension||Chronic condition inventory|Measure NOT mutually exclusive. Inventory of conditions|participants|Number|57|57.0||||||
3690252|NCT02232126|3532197|B3|Diabetes||Chronic condition inventory|Measure NOT mutually exclusive. Inventory of conditions|participants|Number|41|41.0||||||
3690253|NCT02232126|3532198|B2|Diabetes||Chronic condition inventory|Measure NOT mutually exclusive. Inventory of conditions|participants|Number|23|23.0||||||
3690254|NCT02232126|3532199|B1|Diabetes||Chronic condition inventory|Measure NOT mutually exclusive. Inventory of conditions|participants|Number|18|18.0||||||
3690255|NCT02232126|3532197|B3|Depression||Chronic condition inventory|Measure NOT mutually exclusive. Inventory of conditions|participants|Number|46|46.0||||||
3690256|NCT02232126|3532198|B2|Depression||Chronic condition inventory|Measure NOT mutually exclusive. Inventory of conditions|participants|Number|32|32.0||||||
3690257|NCT02232126|3532199|B1|Depression||Chronic condition inventory|Measure NOT mutually exclusive. Inventory of conditions|participants|Number|14|14.0||||||
3690258|NCT02232126|3532197|B3|Dementia/Alzheimer's disease||Chronic condition inventory|Measure NOT mutually exclusive. Inventory of conditions|participants|Number|7|7.0||||||
3690259|NCT02232126|3532198|B2|Dementia/Alzheimer's disease||Chronic condition inventory|Measure NOT mutually exclusive. Inventory of conditions|participants|Number|4|4.0||||||
3690260|NCT02232126|3532199|B1|Dementia/Alzheimer's disease||Chronic condition inventory|Measure NOT mutually exclusive. Inventory of conditions|participants|Number|3|3.0||||||
3690261|NCT02232126|3532197|B3|Cardiac disease||Chronic condition inventory|Measure NOT mutually exclusive. Inventory of conditions|participants|Number|113|113.0||||||
3690262|NCT02232126|3532198|B2|Cardiac disease||Chronic condition inventory|Measure NOT mutually exclusive. Inventory of conditions|participants|Number|55|55.0||||||
3690263|NCT02232126|3532199|B1|Cardiac disease||Chronic condition inventory|Measure NOT mutually exclusive. Inventory of conditions|participants|Number|58|58.0||||||
3690264|NCT02232126|3532197|B3|Cancer||Chronic condition inventory|Measure NOT mutually exclusive. Inventory of conditions|participants|Number|44|44.0||||||
3690265|NCT02232126|3532198|B2|Cancer||Chronic condition inventory|Measure NOT mutually exclusive. Inventory of conditions|participants|Number|20|20.0||||||
3690266|NCT02232126|3532199|B1|Cancer||Chronic condition inventory|Measure NOT mutually exclusive. Inventory of conditions|participants|Number|24|24.0||||||
3690267|NCT02232126|3532197|B3|Declined to provide response||Highest grade completed in school||participants|Number|18|18.0||||||
3690268|NCT02232126|3532198|B2|Declined to provide response||Highest grade completed in school||participants|Number|10|10.0||||||
3690269|NCT02232126|3532199|B1|Declined to provide response||Highest grade completed in school||participants|Number|8|8.0||||||
3690270|NCT02232126|3532197|B3|Doctoral degree||Highest grade completed in school||participants|Number|11|11.0||||||
3690271|NCT02232126|3532198|B2|Doctoral degree||Highest grade completed in school||participants|Number|4|4.0||||||
3690272|NCT02232126|3532199|B1|Doctoral degree||Highest grade completed in school||participants|Number|7|7.0||||||
3690273|NCT02232126|3532197|B3|Graduate degree||Highest grade completed in school||participants|Number|24|24.0||||||
3690274|NCT02232126|3532198|B2|Graduate degree||Highest grade completed in school||participants|Number|14|14.0||||||
3690275|NCT02232126|3532199|B1|Graduate degree||Highest grade completed in school||participants|Number|10|10.0||||||
3690276|NCT02232126|3532197|B3|College graduate||Highest grade completed in school||participants|Number|36|36.0||||||
3690277|NCT02232126|3532198|B2|College graduate||Highest grade completed in school||participants|Number|19|19.0||||||
3690278|NCT02232126|3532199|B1|College graduate||Highest grade completed in school||participants|Number|17|17.0||||||
3690279|NCT02232126|3532197|B3|Some college||Highest grade completed in school||participants|Number|47|47.0||||||
3690281|NCT02232126|3532199|B1|Some college||Highest grade completed in school||participants|Number|27|27.0||||||
3690282|NCT02232126|3532197|B3|High school graduate||Highest grade completed in school||participants|Number|30|30.0||||||
3690283|NCT02232126|3532198|B2|High school graduate||Highest grade completed in school||participants|Number|13|13.0||||||
3690284|NCT02232126|3532199|B1|High school graduate||Highest grade completed in school||participants|Number|17|17.0||||||
3690285|NCT02232126|3532197|B3|9th-11th grade||Highest grade completed in school||participants|Number|9|9.0||||||
3690286|NCT02232126|3532198|B2|9th-11th grade||Highest grade completed in school||participants|Number|5|5.0||||||
3690287|NCT02232126|3532199|B1|9th-11th grade||Highest grade completed in school||participants|Number|4|4.0||||||
3690288|NCT02232126|3532197|B3|8th grade or less||Highest grade completed in school||participants|Number|6|6.0||||||
3690289|NCT02232126|3532198|B2|8th grade or less||Highest grade completed in school||participants|Number|5|5.0||||||
3690290|NCT02232126|3532199|B1|8th grade or less||Highest grade completed in school||participants|Number|1|1.0||||||
3690291|NCT02232126|3532197|B3|Refused to respond||Current annual income||participants|Number|97|97.0||||||
3690292|NCT02232126|3532198|B2|Refused to respond||Current annual income||participants|Number|53|53.0||||||
3690293|NCT02232126|3532199|B1|Refused to respond||Current annual income||participants|Number|44|44.0||||||
3690294|NCT02232126|3532197|B3|$50,000 or more||Current annual income||participants|Number|22|22.0||||||
3690295|NCT02232126|3532198|B2|$50,000 or more||Current annual income||participants|Number|11|11.0||||||
3690296|NCT02232126|3532199|B1|$50,000 or more||Current annual income||participants|Number|11|11.0||||||
3690297|NCT02232126|3532197|B3|$40,000-$49,000||Current annual income||participants|Number|1|1.0||||||
3690298|NCT02232126|3532198|B2|$40,000-$49,000||Current annual income||participants|Number|1|1.0||||||
3690299|NCT02232126|3532199|B1|$40,000-$49,000||Current annual income||participants|Number|0|0.0||||||
3690300|NCT02232126|3532197|B3|$30,000-$39,000||Current annual income||participants|Number|4|4.0||||||
3690301|NCT02232126|3532198|B2|$30,000-$39,000||Current annual income||participants|Number|1|1.0||||||
3690302|NCT02232126|3532199|B1|$30,000-$39,000||Current annual income||participants|Number|3|3.0||||||
3690303|NCT02232126|3532197|B3|$20,000-$29,000||Current annual income||participants|Number|14|14.0||||||
3690304|NCT02232126|3532198|B2|$20,000-$29,000||Current annual income||participants|Number|5|5.0||||||
3690305|NCT02232126|3532199|B1|$20,000-$29,000||Current annual income||participants|Number|9|9.0||||||
3690306|NCT02232126|3532197|B3|$10,000-$19,000||Current annual income||participants|Number|19|19.0||||||
3690307|NCT02232126|3532198|B2|$10,000-$19,000||Current annual income||participants|Number|10|10.0||||||
3690308|NCT02232126|3532199|B1|$10,000-$19,000||Current annual income||participants|Number|9|9.0||||||
3690309|NCT02232126|3532197|B3|Under $10,000||Current annual income||participants|Number|24|24.0||||||
3690310|NCT02232126|3532198|B2|Under $10,000||Current annual income||participants|Number|9|9.0||||||
3690311|NCT02232126|3532199|B1|Under $10,000||Current annual income||participants|Number|15|15.0||||||
3690312|NCT02232126|3532197|B3|Declined to provide response||Who is your primary caregiver?||participants|Number|4|4.0||||||
3690313|NCT02232126|3532198|B2|Declined to provide response||Who is your primary caregiver?||participants|Number|4|4.0||||||
3690314|NCT02232126|3532199|B1|Declined to provide response||Who is your primary caregiver?||participants|Number|0|0.0||||||
3690315|NCT02232126|3532197|B3|Other||Who is your primary caregiver?||participants|Number|17|17.0||||||
3690316|NCT02232126|3532198|B2|Other||Who is your primary caregiver?||participants|Number|8|8.0||||||
3690317|NCT02232126|3532199|B1|Other||Who is your primary caregiver?||participants|Number|9|9.0||||||
3690318|NCT02232126|3532197|B3|Paid caregiver||Who is your primary caregiver?||participants|Number|15|15.0||||||
3690319|NCT02232126|3532198|B2|Paid caregiver||Who is your primary caregiver?||participants|Number|6|6.0||||||
3690320|NCT02232126|3532199|B1|Paid caregiver||Who is your primary caregiver?||participants|Number|9|9.0||||||
3690321|NCT02232126|3532197|B3|Child||Who is your primary caregiver?||participants|Number|22|22.0||||||
3690322|NCT02232126|3532198|B2|Child||Who is your primary caregiver?||participants|Number|11|11.0||||||
3690323|NCT02232126|3532199|B1|Child||Who is your primary caregiver?||participants|Number|11|11.0||||||
3690324|NCT02232126|3532197|B3|Significant other||Who is your primary caregiver?||participants|Number|4|4.0||||||
3690325|NCT02232126|3532198|B2|Significant other||Who is your primary caregiver?||participants|Number|4|4.0||||||
3690326|NCT02232126|3532199|B1|Significant other||Who is your primary caregiver?||participants|Number|0|0.0||||||
3690327|NCT02232126|3532197|B3|Spouse||Who is your primary caregiver?||participants|Number|43|43.0||||||
3690328|NCT02232126|3532198|B2|Spouse||Who is your primary caregiver?||participants|Number|24|24.0||||||
3690329|NCT02232126|3532199|B1|Spouse||Who is your primary caregiver?||participants|Number|19|19.0||||||
3690330|NCT02232126|3532197|B3|No one/self||Who is your primary caregiver?||participants|Number|76|76.0||||||
3690331|NCT02232126|3532198|B2|No one/self||Who is your primary caregiver?||participants|Number|33|33.0||||||
3690332|NCT02232126|3532199|B1|No one/self||Who is your primary caregiver?||participants|Number|43|43.0||||||
3690333|NCT02232126|3532197|B3|Declined to provide response||Who do you live with?||participants|Number|5|5.0||||||
3690334|NCT02232126|3532198|B2|Declined to provide response||Who do you live with?||participants|Number|5|5.0||||||
3690335|NCT02232126|3532199|B1|Declined to provide response||Who do you live with?||participants|Number|0|0.0||||||
3690336|NCT02232126|3532197|B3|Other||Who do you live with?||participants|Number|17|17.0||||||
3690337|NCT02232126|3532198|B2|Other||Who do you live with?||participants|Number|8|8.0||||||
3690338|NCT02232126|3532199|B1|Other||Who do you live with?||participants|Number|9|9.0||||||
3690339|NCT02232126|3532197|B3|Paid caregiver||Who do you live with?||participants|Number|3|3.0||||||
3690340|NCT02232126|3532198|B2|Paid caregiver||Who do you live with?||participants|Number|1|1.0||||||
3690341|NCT02232126|3532199|B1|Paid caregiver||Who do you live with?||participants|Number|2|2.0||||||
3690342|NCT02232126|3532197|B3|Child||Who do you live with?||participants|Number|27|27.0||||||
3690343|NCT02232126|3532198|B2|Child||Who do you live with?||participants|Number|13|13.0||||||
3690344|NCT02232126|3532199|B1|Child||Who do you live with?||participants|Number|14|14.0||||||
3690345|NCT02232126|3532197|B3|Spouse/partner||Who do you live with?||participants|Number|74|74.0||||||
3690346|NCT02232126|3532198|B2|Spouse/partner||Who do you live with?||participants|Number|43|43.0||||||
3690347|NCT02232126|3532199|B1|Spouse/partner||Who do you live with?||participants|Number|31|31.0||||||
3690348|NCT02232126|3532197|B3|Alone||Who do you live with?||participants|Number|55|55.0||||||
3690349|NCT02232126|3532198|B2|Alone||Who do you live with?||participants|Number|20|20.0||||||
3690350|NCT02232126|3532199|B1|Alone||Who do you live with?||participants|Number|35|35.0||||||
3690351|NCT02232126|3532197|B3|Declined to provide response||Current living situation||participants|Number|3|3.0||||||
3690352|NCT02232126|3532198|B2|Declined to provide response||Current living situation||participants|Number|3|3.0||||||
3690353|NCT02232126|3532199|B1|Declined to provide response||Current living situation||participants|Number|0|0.0||||||
3690354|NCT02232126|3532197|B3|Other||Current living situation||participants|Number|5|5.0||||||
3690355|NCT02232126|3532198|B2|Other||Current living situation||participants|Number|3|3.0||||||
3690356|NCT02232126|3532199|B1|Other||Current living situation||participants|Number|2|2.0||||||
3690357|NCT02232126|3532197|B3|Living in family member's home||Current living situation||participants|Number|13|13.0||||||
3690358|NCT02232126|3532198|B2|Living in family member's home||Current living situation||participants|Number|6|6.0||||||
3690359|NCT02232126|3532199|B1|Living in family member's home||Current living situation||participants|Number|7|7.0||||||
3690360|NCT02232126|3532197|B3|Own house/apartment||Current living situation||participants|Number|160|160.0||||||
3690361|NCT02232126|3532198|B2|Own house/apartment||Current living situation||participants|Number|78|78.0||||||
3690362|NCT02232126|3532199|B1|Own house/apartment||Current living situation||participants|Number|82|82.0||||||
3690363|NCT02232126|3532197|B3|Declined to provide response||Marital status||participants|Number|3|3.0||||||
3690364|NCT02232126|3532198|B2|Declined to provide response||Marital status||participants|Number|3|3.0||||||
3690365|NCT02232126|3532199|B1|Declined to provide response||Marital status||participants|Number|0|0.0||||||
3690366|NCT02232126|3532197|B3|Widowed||Marital status||participants|Number|54|54.0||||||
3690367|NCT02232126|3532198|B2|Widowed||Marital status||participants|Number|19|19.0||||||
3690368|NCT02232126|3532199|B1|Widowed||Marital status||participants|Number|35|35.0||||||
3690369|NCT02232126|3532197|B3|Divorced||Marital status||participants|Number|17|17.0||||||
3690370|NCT02232126|3532198|B2|Divorced||Marital status||participants|Number|7|7.0||||||
3690371|NCT02232126|3532199|B1|Divorced||Marital status||participants|Number|10|10.0||||||
3690372|NCT02232126|3532197|B3|Single||Marital status||participants|Number|27|27.0||||||
3690373|NCT02232126|3532198|B2|Single||Marital status||participants|Number|16|16.0||||||
3690374|NCT02232126|3532199|B1|Single||Marital status||participants|Number|11|11.0||||||
3690375|NCT02232126|3532197|B3|Married||Marital status||participants|Number|80|80.0||||||
3690376|NCT02232126|3532198|B2|Married||Marital status||participants|Number|45|45.0||||||
3690377|NCT02232126|3532199|B1|Married||Marital status||participants|Number|35|35.0||||||
3690378|NCT02232126|3532197|B3|United States||Region of Enrollment||participants|Number|181|181.0||||||
3690379|NCT02232126|3532198|B2|United States||Region of Enrollment||participants|Number|90|90.0||||||
3690380|NCT02232126|3532199|B1|United States||Region of Enrollment||participants|Number|91|91.0||||||
3690381|NCT02232126|3532197|B3|Declined to provide response||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3690382|NCT02232126|3532198|B2|Declined to provide response||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3690383|NCT02232126|3532199|B1|Declined to provide response||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3690384|NCT02232126|3532197|B3|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3690385|NCT02232126|3532198|B2|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3690386|NCT02232126|3532199|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3690387|NCT02232126|3532197|B3|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3690388|NCT02232126|3532198|B2|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3690389|NCT02232126|3532199|B1|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3690390|NCT02232126|3532197|B3|Native American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3690391|NCT02232126|3532198|B2|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3690392|NCT02232126|3532199|B1|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3690393|NCT02232126|3532197|B3|Latino||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3690394|NCT02232126|3532198|B2|Latino||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3690395|NCT02232126|3532199|B1|Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3690396|NCT02232126|3532197|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|109|109.0||||||
3690397|NCT02232126|3532198|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
3690398|NCT02232126|3532199|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
3690399|NCT02232126|3532197|B3|African American||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
3690400|NCT02232126|3532198|B2|African American||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3690401|NCT02232126|3532199|B1|African American||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3690402|NCT02232126|3532197|B3||Male|Gender||Participants|Count of Participants|93|93.0||||||
3690403|NCT02232126|3532198|B2||Male|Gender||Participants|Count of Participants|51|51.0||||||
3690404|NCT02232126|3532199|B1||Male|Gender||Participants|Count of Participants|42|42.0||||||
3690405|NCT02232126|3532197|B3||Female|Gender||Participants|Count of Participants|88|88.0||||||
3690406|NCT02232126|3532198|B2||Female|Gender||Participants|Count of Participants|39|39.0||||||
3690407|NCT02232126|3532199|B1||Female|Gender||Participants|Count of Participants|49|49.0||||||
3690408|NCT02232126|3532197|B3|||Age||years|Mean|78.8|78.8|Standard Deviation|8.3|8.3|||
3690409|NCT02232126|3532198|B2|||Age||years|Mean|78.4|78.4|Standard Deviation|7.8|7.8|||
3690410|NCT02232126|3532199|B1|||Age||years|Mean|79.2|79.2|Standard Deviation|8.8|8.8|||
3690411|NCT02232126|3532197|B3||>=65 years|Age||Participants|Count of Participants|181|181.0||||||
3690412|NCT02232126|3532198|B2||>=65 years|Age||Participants|Count of Participants|90|90.0||||||
3690413|NCT02232126|3532199|B1||>=65 years|Age||Participants|Count of Participants|91|91.0||||||
3690414|NCT02232126|3532197|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3690415|NCT02232126|3532198|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3690416|NCT02232126|3532199|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3690417|NCT02232126|3532197|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3690418|NCT02232126|3532198|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3690419|NCT02232126|3532199|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3690420|NCT02231918|3532208|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3690421|NCT02231918|3532209|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3690422|NCT02231918|3532210|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3690423|NCT02231918|3532211|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3690424|NCT02231918|3532208|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3690425|NCT02231918|3532209|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3690426|NCT02231918|3532210|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3690427|NCT02231918|3532211|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3690428|NCT02231918|3532208|B4|||Age||years|Mean|11.4|11.4|Standard Deviation|3.7|3.7|||
3690429|NCT02231918|3532209|B3|||Age||years|Mean|15.0|15.0|Standard Deviation|0.0|0.0|||
3690430|NCT02231918|3532210|B2|||Age||years|Mean|11.4|11.4|Standard Deviation|3.4|3.4|||
3690431|NCT02231918|3532211|B1|||Age||years|Mean|10.6|10.6|Standard Deviation|4.3|4.3|||
3690432|NCT02231749|3532275|B3||Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3690433|NCT02231749|3532276|B2||Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3690434|NCT02231749|3532277|B1||Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3690435|NCT02231749|3532275|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3690436|NCT02231749|3532276|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3690437|NCT02231749|3532277|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3690438|NCT02231749|3532275|B3||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3690439|NCT02231749|3532276|B2||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3690440|NCT02231749|3532277|B1||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3690441|NCT02231749|3532275|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3690442|NCT02231749|3532276|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3690443|NCT02231749|3532277|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3690444|NCT02231749|3532275|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|93|93.0||||||
3690445|NCT02231749|3532276|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
3690446|NCT02231749|3532277|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
3690447|NCT02231749|3532275|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3690448|NCT02231749|3532276|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3690449|NCT02231749|3532277|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3690450|NCT02231749|3532275|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|969|969.0||||||
3690451|NCT02231749|3532276|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|483|483.0||||||
3690452|NCT02231749|3532277|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|486|486.0||||||
3690453|NCT02231749|3532275|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|550|550.0||||||
3690454|NCT02231749|3532276|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|276|276.0||||||
3690455|NCT02231749|3532277|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|274|274.0||||||
3690456|NCT02231749|3532275|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|517|517.0||||||
3690457|NCT02231749|3532276|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|253|253.0||||||
3690458|NCT02231749|3532277|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|264|264.0||||||
3690459|NCT02231749|3532275|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3690460|NCT02231749|3532276|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3690461|NCT02231749|3532277|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3690462|NCT02231749|3532275|B3||Male|Sex: Female, Male||Participants|Count of Participants|808|808.0||||||
3690463|NCT02231749|3532276|B2||Male|Sex: Female, Male||Participants|Count of Participants|395|395.0||||||
3690464|NCT02231749|3532277|B1||Male|Sex: Female, Male||Participants|Count of Participants|413|413.0||||||
3690465|NCT02231749|3532275|B3||Female|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
3690466|NCT02231749|3532276|B2||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3690467|NCT02231749|3532277|B1||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3690468|NCT02231749|3532275|B3|||Age||Years|Mean|60.9|60.9|Standard Deviation|9.93|9.93|||
3690469|NCT02231749|3532276|B2|||Age||Years|Mean|60.7|60.7|Standard Deviation|10.10|10.1|||
3690470|NCT02231749|3532277|B1|||Age||Years|Mean|61.1|61.1|Standard Deviation|9.76|9.76|||
3690471|NCT02231580|3532294|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3690472|NCT02231580|3532295|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3690473|NCT02231580|3532296|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3690474|NCT02231580|3532294|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3690475|NCT02231580|3532295|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3690476|NCT02231580|3532296|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3690477|NCT02231580|3532294|B3|||Age||years|Mean|46.6|46.6|Standard Deviation|14.4|14.4|||
3690478|NCT02231580|3532295|B2|||Age||years|Mean|50.0|50.0|Standard Deviation|8.7|8.7|||
3690479|NCT02231580|3532296|B1|||Age||years|Mean|46.6|46.6|Standard Deviation|14.4|14.4|||
3690480|NCT02231177|3532353|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3690481|NCT02231177|3532353|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3690482|NCT02231177|3532353|B1|||Age||years|Mean|59.8|59.8|Standard Deviation|7.4|7.4|||
3690483|NCT02231164|3532412|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3690484|NCT02231164|3532413|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3690485|NCT02231164|3532414|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3690486|NCT02231164|3532412|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3690487|NCT02231164|3532413|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3690488|NCT02231164|3532414|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3690489|NCT02231164|3532412|B3|||Age||Years|Mean|61.5|61.5|Standard Deviation|10.1|10.1|||
3690490|NCT02231164|3532413|B2|||Age||Years|Mean|63.3|63.3|Standard Deviation|8.3|8.3|||
3690491|NCT02231164|3532414|B1|||Age||Years|Mean|59.7|59.7|Standard Deviation|12.2|12.2|||
3690492|NCT02230995|3532421|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3690493|NCT02230995|3532422|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3690494|NCT02230995|3532423|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3690495|NCT02230995|3532421|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3690496|NCT02230995|3532422|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3690497|NCT02230995|3532423|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3690498|NCT02230995|3532421|B3|||Age||Years|Mean|34.30|34.3|Standard Deviation|9.70|9.7|||
3690499|NCT02230995|3532422|B2|||Age||Years|Mean|32.00|32.0|Standard Deviation|9.80|9.8|||
3690500|NCT02230995|3532423|B1|||Age||Years|Mean|36.60|36.6|Standard Deviation|9.30|9.3|||
3690501|NCT02230956|3532440|B4||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3690502|NCT02230956|3532441|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3690503|NCT02230956|3532442|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3690504|NCT02230956|3532443|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3690505|NCT02230956|3532440|B4||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3690506|NCT02230956|3532441|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3690507|NCT02230956|3532442|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3690508|NCT02230956|3532443|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3690509|NCT02230956|3532440|B4|||Age||years|Mean|60.8|60.8|Standard Deviation|8.02|8.02|||
3690510|NCT02230956|3532441|B3|||Age||years|Mean|61.1|61.1|Standard Deviation|7.79|7.79|||
3690511|NCT02230956|3532442|B2|||Age||years|Mean|60.2|60.2|Standard Deviation|8.41|8.41|||
3690512|NCT02230956|3532443|B1|||Age||years|Mean|60.7|60.7|Standard Deviation|8.25|8.25|||
3690513|NCT02230904|3532465|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3690514|NCT02230904|3532466|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3690515|NCT02230904|3532467|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3690516|NCT02230904|3532465|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3690517|NCT02230904|3532466|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3690518|NCT02230904|3532467|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3690519|NCT02230904|3532465|B3|||Age||years|Mean|68.4|68.4|Standard Deviation|10.2|10.2|||
3690520|NCT02230904|3532466|B2|||Age||years|Mean|69.6|69.6|Standard Deviation|9.5|9.5|||
3690521|NCT02230904|3532467|B1|||Age||years|Mean|67.3|67.3|Standard Deviation|10.9|10.9|||
3690522|NCT02230904|3532465|B3||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
3690523|NCT02230904|3532466|B2||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3690524|NCT02230904|3532467|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3690525|NCT02230904|3532465|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3690526|NCT02230904|3532466|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3690527|NCT02230904|3532467|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3690528|NCT02230904|3532465|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3690529|NCT02230904|3532466|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3690530|NCT02230904|3532467|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3690531|NCT02230761|3532488|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3690532|NCT02230761|3532489|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3690533|NCT02230761|3532490|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3690534|NCT02230761|3532488|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3690535|NCT02230761|3532489|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3690536|NCT02230761|3532490|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3690537|NCT02230761|3532488|B3|||Age||years|Mean|54.5|54.5|Standard Deviation|7.4|7.4|||
3690538|NCT02230761|3532489|B2|||Age||years|Mean|55.1|55.1|Standard Deviation|7.5|7.5|||
3690539|NCT02230761|3532490|B1|||Age||years|Mean|54.2|54.2|Standard Deviation|7.4|7.4|||
3690540|NCT02230683|3532501|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
3690541|NCT02230683|3532501|B1||Male|Gender||Participants|Count of Participants|16|16.0||||||
3690542|NCT02230683|3532501|B1||Female|Gender||Participants|Count of Participants|7|7.0||||||
3690543|NCT02230683|3532501|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3690544|NCT02230683|3532501|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3690545|NCT02230683|3532501|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3690546|NCT02230670|3532516|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3690547|NCT02230670|3532517|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3690548|NCT02230670|3532518|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3690549|NCT02230670|3532516|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3690550|NCT02230670|3532517|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3690551|NCT02230670|3532518|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690552|NCT02230670|3532516|B3||White|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
3690553|NCT02230670|3532517|B2||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3690554|NCT02230670|3532518|B1||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3690555|NCT02230670|3532516|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3690556|NCT02230670|3532517|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3690557|NCT02230670|3532518|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3690558|NCT02230670|3532516|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690559|NCT02230670|3532517|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690560|NCT02230670|3532518|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690561|NCT02230670|3532516|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3690562|NCT02230670|3532517|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3690563|NCT02230670|3532518|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690564|NCT02230670|3532516|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690565|NCT02230670|3532517|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690566|NCT02230670|3532518|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690567|NCT02230670|3532516|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3690568|NCT02230670|3532517|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3690569|NCT02230670|3532518|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690570|NCT02230670|3532516|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3690571|NCT02230670|3532517|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3690572|NCT02230670|3532518|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3690573|NCT02230670|3532516|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3690574|NCT02230670|3532517|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3690575|NCT02230670|3532518|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3690576|NCT02230670|3532516|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3690577|NCT02230670|3532517|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3690578|NCT02230670|3532518|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3690579|NCT02230670|3532516|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3690580|NCT02230670|3532517|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3690581|NCT02230670|3532518|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3690582|NCT02230670|3532516|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3690583|NCT02230670|3532517|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3690584|NCT02230670|3532518|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3690585|NCT02230670|3532516|B3||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
3690586|NCT02230670|3532517|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3690587|NCT02230670|3532518|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3690588|NCT02230670|3532516|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3690589|NCT02230670|3532517|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3690590|NCT02230670|3532518|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3690591|NCT02230579|3532529|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3690592|NCT02230579|3532530|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3690593|NCT02230579|3532531|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3690594|NCT02230579|3532532|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690595|NCT02230579|3532533|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3690596|NCT02230579|3532534|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3690597|NCT02230579|3532535|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3690598|NCT02230579|3532536|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3690599|NCT02230579|3532529|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690600|NCT02230579|3532530|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690601|NCT02230579|3532531|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690602|NCT02230579|3532532|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690603|NCT02230579|3532533|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690604|NCT02230579|3532534|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690605|NCT02230579|3532535|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690606|NCT02230579|3532536|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690607|NCT02230579|3532529|B8||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3690608|NCT02230579|3532530|B7||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3690609|NCT02230579|3532531|B6||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690610|NCT02230579|3532532|B5||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690611|NCT02230579|3532533|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690612|NCT02230579|3532534|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690613|NCT02230579|3532535|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690614|NCT02230579|3532536|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690615|NCT02230579|3532529|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3690616|NCT02230579|3532530|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3690617|NCT02230579|3532531|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3690618|NCT02230579|3532532|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3690619|NCT02230579|3532533|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3690620|NCT02230579|3532534|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3690621|NCT02230579|3532535|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3690622|NCT02230579|3532536|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3690623|NCT02230579|3532529|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690624|NCT02230579|3532530|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690625|NCT02230579|3532531|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690626|NCT02230579|3532532|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690627|NCT02230579|3532533|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690628|NCT02230579|3532534|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690629|NCT02230579|3532535|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690630|NCT02230579|3532536|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690631|NCT02230579|3532529|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690632|NCT02230579|3532530|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690633|NCT02230579|3532531|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690634|NCT02230579|3532532|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690635|NCT02230579|3532533|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690636|NCT02230579|3532534|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690637|NCT02230579|3532535|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690638|NCT02230579|3532536|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690639|NCT02230579|3532529|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690640|NCT02230579|3532530|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690641|NCT02230579|3532531|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690642|NCT02230579|3532532|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690643|NCT02230579|3532533|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690644|NCT02230579|3532534|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690645|NCT02230579|3532535|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690646|NCT02230579|3532536|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690647|NCT02230579|3532529|B8||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3690648|NCT02230579|3532530|B7||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3690649|NCT02230579|3532531|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3690650|NCT02230579|3532532|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3690651|NCT02230579|3532533|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3690652|NCT02230579|3532534|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3690653|NCT02230579|3532535|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3690654|NCT02230579|3532536|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3690655|NCT02230579|3532529|B8||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3690656|NCT02230579|3532530|B7||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3690657|NCT02230579|3532531|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3690658|NCT02230579|3532532|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3690659|NCT02230579|3532533|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3690660|NCT02230579|3532534|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3690661|NCT02230579|3532535|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3690662|NCT02230579|3532536|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3690663|NCT02230579|3532529|B8|||Age||years|Mean|31.7|31.7|Full Range|||19.0|51.0|
3690664|NCT02230579|3532530|B7|||Age||years|Mean|32.7|32.7|Full Range|||19.0|50.0|
3690665|NCT02230579|3532531|B6|||Age||years|Mean|34|34.0|Full Range|||20.0|50.0|
3690666|NCT02230579|3532532|B5|||Age||years|Mean|23.7|23.7|Full Range|||19.0|30.0|
3690667|NCT02230579|3532533|B4|||Age||years|Mean|30|30.0|Full Range|||21.0|51.0|
3690668|NCT02230579|3532534|B3|||Age||years|Mean|37|37.0|Full Range|||29.0|49.0|
3690669|NCT02230579|3532535|B2|||Age||years|Mean|34|34.0|Full Range|||24.0|51.0|
3690670|NCT02230579|3532536|B1|||Age||years|Mean|29.3|29.3|Full Range|||19.0|44.0|
3690671|NCT02230566|3532576|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3690672|NCT02230566|3532577|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3690673|NCT02230566|3532578|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3690674|NCT02230566|3532579|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3690675|NCT02230566|3532580|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3690676|NCT02230566|3532576|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3690677|NCT02230566|3532577|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3690678|NCT02230566|3532578|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3690679|NCT02230566|3532579|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3690680|NCT02230566|3532580|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3690681|NCT02230566|3532576|B5|||Age||years|Mean|15.41|15.41|Standard Deviation|5.492|5.492|||
3690682|NCT02230566|3532577|B4|||Age||years|Mean|15.23|15.23|Standard Deviation|8.633|8.633|||
3690683|NCT02230566|3532578|B3|||Age||years|Mean|20.77|20.77|Standard Deviation|3.004|3.004|||
3690684|NCT02230566|3532579|B2|||Age||years|Mean|12.50|12.5|Standard Deviation|4.004|4.004|||
3690685|NCT02230566|3532580|B1|||Age||years|Mean|13.13|13.13|Standard Deviation|1.656|1.656|||
3690686|NCT02230540|3532598|B1|Denmark||Region of Enrollment||participants|Number|8|8.0||||||
3690687|NCT02230540|3532598|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3690688|NCT02230540|3532598|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3690689|NCT02230540|3532598|B1|||Age||years|Mean|49.5|49.5|Standard Deviation|8.8|8.8|||
3690690|NCT02230540|3532598|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3690691|NCT02230540|3532598|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3690692|NCT02230540|3532598|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3690693|NCT02230384|3532603|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
3690694|NCT02230384|3532604|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
3690695|NCT02230384|3532605|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3690696|NCT02230384|3532603|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3690697|NCT02230384|3532604|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3690698|NCT02230384|3532605|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3690699|NCT02230384|3532603|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3690700|NCT02230384|3532604|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3690701|NCT02230384|3532605|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3690702|NCT02230384|3532603|B3|||Age||years|Mean|46.19|46.19|Standard Deviation|11.04|11.04|||
3690703|NCT02230384|3532604|B2|||Age||years|Mean|46.31|46.31|Standard Deviation|10.97|10.97|||
3690704|NCT02230384|3532605|B1|||Age||years|Mean|46.06|46.06|Standard Deviation|11.31|11.31|||
3690705|NCT02230384|3532603|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3690706|NCT02230384|3532604|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3690707|NCT02230384|3532605|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3690708|NCT02230384|3532603|B3||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
3690709|NCT02230384|3532604|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3690710|NCT02230384|3532605|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3690711|NCT02230384|3532603|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3690712|NCT02230384|3532604|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3690713|NCT02230384|3532605|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3690714|NCT02230332|3532612|B3|||Salmeterol Protected Methcholine PC20|During the challenge, the patient inhales methacholine aerosols in increasing concentrations. Spirometry is performed before and after each methacholine dose, and the results are reported as a percent decrease in FEV1 from baseline for each increasing dose of methacholine. A positive reaction to methacholine is a 20% fall in FEV1, and the provocative concentration that causes a positive reaction (the PC20) is used to indicate the level of airway hyperresponsiveness. Smaller numbers indicate greater airway hyperresponsiveness.|mg/ml|Geometric Mean|4.5|4.5|Standard Deviation|0.9|0.9|||
3690715|NCT02230332|3532613|B2|||Salmeterol Protected Methcholine PC20|During the challenge, the patient inhales methacholine aerosols in increasing concentrations. Spirometry is performed before and after each methacholine dose, and the results are reported as a percent decrease in FEV1 from baseline for each increasing dose of methacholine. A positive reaction to methacholine is a 20% fall in FEV1, and the provocative concentration that causes a positive reaction (the PC20) is used to indicate the level of airway hyperresponsiveness. Smaller numbers indicate greater airway hyperresponsiveness.|mg/ml|Geometric Mean|3.7|3.7|Standard Deviation|1|1.0|||
3690716|NCT02230332|3532614|B1|||Salmeterol Protected Methcholine PC20|During the challenge, the patient inhales methacholine aerosols in increasing concentrations. Spirometry is performed before and after each methacholine dose, and the results are reported as a percent decrease in FEV1 from baseline for each increasing dose of methacholine. A positive reaction to methacholine is a 20% fall in FEV1, and the provocative concentration that causes a positive reaction (the PC20) is used to indicate the level of airway hyperresponsiveness. Smaller numbers indicate greater airway hyperresponsiveness.|mg/ml|Geometric Mean|5.4|5.4|Standard Deviation|0.8|0.8|||
3690717|NCT02230332|3532612|B3|||FEV1 - percent of predicted||percent of predicted|Mean|82.2|82.2|Standard Deviation|14.4|14.4|||
3690718|NCT02230332|3532613|B2|||FEV1 - percent of predicted||percent of predicted|Mean|83.1|83.1|Standard Deviation|14.0|14.0|||
3690719|NCT02230332|3532614|B1|||FEV1 - percent of predicted||percent of predicted|Mean|81.3|81.3|Standard Deviation|14.9|14.9|||
3690720|NCT02230332|3532612|B3|||Asthma Control Test score|Asthma Control Test : Score calculated as the sum total of a 5-item questionnaire. Each item ranges from 1 (poor control) to 5 (good control) so that the range of the total score is 5 to 25. Scores below 20 indicate that asthma is not well controlled.|units on a scale|Mean|21|21.0|Inter-Quartile Range|||19.0|23.0|
3690721|NCT02230332|3532613|B2|||Asthma Control Test score|Asthma Control Test : Score calculated as the sum total of a 5-item questionnaire. Each item ranges from 1 (poor control) to 5 (good control) so that the range of the total score is 5 to 25. Scores below 20 indicate that asthma is not well controlled.|units on a scale|Mean|21|21.0|Inter-Quartile Range|||19.0|23.0|
3690722|NCT02230332|3532614|B1|||Asthma Control Test score|Asthma Control Test : Score calculated as the sum total of a 5-item questionnaire. Each item ranges from 1 (poor control) to 5 (good control) so that the range of the total score is 5 to 25. Scores below 20 indicate that asthma is not well controlled.|units on a scale|Mean|21|21.0|Inter-Quartile Range|||18.0|23.0|
3690723|NCT02230332|3532612|B3|United States||Region of Enrollment||participants|Number|78|78.0||||||
3690724|NCT02230332|3532613|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
3690725|NCT02230332|3532614|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
3690726|NCT02230332|3532612|B3|Hispanic or Latio||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3690727|NCT02230332|3532613|B2|Hispanic or Latio||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3690728|NCT02230332|3532614|B1|Hispanic or Latio||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3690729|NCT02230332|3532612|B3|Asian/Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3690730|NCT02230332|3532613|B2|Asian/Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3690731|NCT02230332|3532614|B1|Asian/Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3690732|NCT02230332|3532612|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3690733|NCT02230332|3532613|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3690734|NCT02230332|3532614|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3690735|NCT02230332|3532612|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|45|45.0||||||
3690736|NCT02230332|3532613|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3690737|NCT02230332|3532614|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3690738|NCT02230332|3532612|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3690739|NCT02230332|3532613|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3690740|NCT02230332|3532614|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3690741|NCT02230332|3532612|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3690742|NCT02230332|3532613|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3690743|NCT02230332|3532614|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3690744|NCT02230332|3532612|B3|||Age||years|Mean|38.8|38.8|Standard Deviation|12.6|12.6|||
3690745|NCT02230332|3532613|B2|||Age||years|Mean|39.3|39.3|Standard Deviation|12.3|12.3|||
3690746|NCT02230332|3532614|B1|||Age||years|Mean|38.3|38.3|Standard Deviation|13.1|13.1|||
3690747|NCT02230306|3532631|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3690748|NCT02230306|3532631|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3690749|NCT02230306|3532631|B1|Patient 5||Age, Customized||years|Number|63|63.0||||||
3690750|NCT02230306|3532631|B1|Patient 4||Age, Customized||years|Number|33|33.0||||||
3690751|NCT02230306|3532631|B1|Patient 3||Age, Customized||years|Number|31|31.0||||||
3690752|NCT02230306|3532631|B1|Patient 2||Age, Customized||years|Number|65|65.0||||||
3690753|NCT02230306|3532631|B1|Patient 1||Age, Customized||years|Number|26|26.0||||||
3690754|NCT02230085|3532642|B1|United States||Region of Enrollment||participants|Number|103|103.0||||||
3690755|NCT02230085|3532642|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3690756|NCT02230085|3532642|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3690757|NCT02230085|3532642|B1|||Age||years|Mean|51|51.0|Full Range|||27.0|73.0|
3690758|NCT02229864|3532646|B1|||Stable Angina||Participants|Count of Participants|9|9.0||||||
3690759|NCT02229864|3532646|B1|||Prior Coronary Intervention||Participants|Count of Participants|1|1.0||||||
3690760|NCT02229864|3532646|B1|||Dyslipidemia Requiring Medication||Participants|Count of Participants|12|12.0||||||
3690761|NCT02229864|3532646|B1|||Hypertension Requiring Medication||Participants|Count of Participants|12|12.0||||||
3690762|NCT02229864|3532646|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3690763|NCT02229864|3532646|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3690764|NCT02229864|3532646|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3690765|NCT02229864|3532646|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|10.5|10.5|||
3690766|NCT02229539|3532698|B4||3 or more|Mucous Membrane Grade|Mucous membrane grade: > 0=no change over baseline, 1=injection/may experience mild pain not requiring analgesic, 2=patchy mucositis which may produce an inflammatory serosanguinitis discharge/ may experience moderate pain requiring analgesia, 3=confluent fibrinous mucositis/ may include severe pain requiring narcotic, 4=Ulceration, hemorrhage or necrosis.|Participants|Count of Participants|37|37.0||||||
3690767|NCT02229539|3532699|B3||3 or more|Mucous Membrane Grade|Mucous membrane grade: > 0=no change over baseline, 1=injection/may experience mild pain not requiring analgesic, 2=patchy mucositis which may produce an inflammatory serosanguinitis discharge/ may experience moderate pain requiring analgesia, 3=confluent fibrinous mucositis/ may include severe pain requiring narcotic, 4=Ulceration, hemorrhage or necrosis.|Participants|Count of Participants|11|11.0||||||
3690768|NCT02229539|3532700|B2||3 or more|Mucous Membrane Grade|Mucous membrane grade: > 0=no change over baseline, 1=injection/may experience mild pain not requiring analgesic, 2=patchy mucositis which may produce an inflammatory serosanguinitis discharge/ may experience moderate pain requiring analgesia, 3=confluent fibrinous mucositis/ may include severe pain requiring narcotic, 4=Ulceration, hemorrhage or necrosis.|Participants|Count of Participants|12|12.0||||||
3690769|NCT02229539|3532701|B1||3 or more|Mucous Membrane Grade|Mucous membrane grade: > 0=no change over baseline, 1=injection/may experience mild pain not requiring analgesic, 2=patchy mucositis which may produce an inflammatory serosanguinitis discharge/ may experience moderate pain requiring analgesia, 3=confluent fibrinous mucositis/ may include severe pain requiring narcotic, 4=Ulceration, hemorrhage or necrosis.|Participants|Count of Participants|14|14.0||||||
3690770|NCT02229539|3532698|B4||2|Mucous Membrane Grade|Mucous membrane grade: > 0=no change over baseline, 1=injection/may experience mild pain not requiring analgesic, 2=patchy mucositis which may produce an inflammatory serosanguinitis discharge/ may experience moderate pain requiring analgesia, 3=confluent fibrinous mucositis/ may include severe pain requiring narcotic, 4=Ulceration, hemorrhage or necrosis.|Participants|Count of Participants|143|143.0||||||
3690771|NCT02229539|3532699|B3||2|Mucous Membrane Grade|Mucous membrane grade: > 0=no change over baseline, 1=injection/may experience mild pain not requiring analgesic, 2=patchy mucositis which may produce an inflammatory serosanguinitis discharge/ may experience moderate pain requiring analgesia, 3=confluent fibrinous mucositis/ may include severe pain requiring narcotic, 4=Ulceration, hemorrhage or necrosis.|Participants|Count of Participants|48|48.0||||||
3690772|NCT02229539|3532700|B2||2|Mucous Membrane Grade|Mucous membrane grade: > 0=no change over baseline, 1=injection/may experience mild pain not requiring analgesic, 2=patchy mucositis which may produce an inflammatory serosanguinitis discharge/ may experience moderate pain requiring analgesia, 3=confluent fibrinous mucositis/ may include severe pain requiring narcotic, 4=Ulceration, hemorrhage or necrosis.|Participants|Count of Participants|48|48.0||||||
3690773|NCT02229539|3532701|B1||2|Mucous Membrane Grade|Mucous membrane grade: > 0=no change over baseline, 1=injection/may experience mild pain not requiring analgesic, 2=patchy mucositis which may produce an inflammatory serosanguinitis discharge/ may experience moderate pain requiring analgesia, 3=confluent fibrinous mucositis/ may include severe pain requiring narcotic, 4=Ulceration, hemorrhage or necrosis.|Participants|Count of Participants|47|47.0||||||
3690774|NCT02229539|3532698|B4||1|Mucous Membrane Grade|Mucous membrane grade: > 0=no change over baseline, 1=injection/may experience mild pain not requiring analgesic, 2=patchy mucositis which may produce an inflammatory serosanguinitis discharge/ may experience moderate pain requiring analgesia, 3=confluent fibrinous mucositis/ may include severe pain requiring narcotic, 4=Ulceration, hemorrhage or necrosis.|Participants|Count of Participants|48|48.0||||||
3690819|NCT02229539|3532699|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690820|NCT02229539|3532700|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690775|NCT02229539|3532699|B3||1|Mucous Membrane Grade|Mucous membrane grade: > 0=no change over baseline, 1=injection/may experience mild pain not requiring analgesic, 2=patchy mucositis which may produce an inflammatory serosanguinitis discharge/ may experience moderate pain requiring analgesia, 3=confluent fibrinous mucositis/ may include severe pain requiring narcotic, 4=Ulceration, hemorrhage or necrosis.|Participants|Count of Participants|16|16.0||||||
3690776|NCT02229539|3532700|B2||1|Mucous Membrane Grade|Mucous membrane grade: > 0=no change over baseline, 1=injection/may experience mild pain not requiring analgesic, 2=patchy mucositis which may produce an inflammatory serosanguinitis discharge/ may experience moderate pain requiring analgesia, 3=confluent fibrinous mucositis/ may include severe pain requiring narcotic, 4=Ulceration, hemorrhage or necrosis.|Participants|Count of Participants|16|16.0||||||
3690777|NCT02229539|3532701|B1||1|Mucous Membrane Grade|Mucous membrane grade: > 0=no change over baseline, 1=injection/may experience mild pain not requiring analgesic, 2=patchy mucositis which may produce an inflammatory serosanguinitis discharge/ may experience moderate pain requiring analgesia, 3=confluent fibrinous mucositis/ may include severe pain requiring narcotic, 4=Ulceration, hemorrhage or necrosis.|Participants|Count of Participants|16|16.0||||||
3690778|NCT02229539|3532698|B4||No|Concurrent use of chemotherapy||Participants|Count of Participants|43|43.0||||||
3690779|NCT02229539|3532699|B3||No|Concurrent use of chemotherapy||Participants|Count of Participants|13|13.0||||||
3690780|NCT02229539|3532700|B2||No|Concurrent use of chemotherapy||Participants|Count of Participants|14|14.0||||||
3690781|NCT02229539|3532701|B1||No|Concurrent use of chemotherapy||Participants|Count of Participants|16|16.0||||||
3690782|NCT02229539|3532698|B4||Yes|Concurrent use of chemotherapy||Participants|Count of Participants|185|185.0||||||
3690783|NCT02229539|3532699|B3||Yes|Concurrent use of chemotherapy||Participants|Count of Participants|62|62.0||||||
3690784|NCT02229539|3532700|B2||Yes|Concurrent use of chemotherapy||Participants|Count of Participants|62|62.0||||||
3690785|NCT02229539|3532701|B1||Yes|Concurrent use of chemotherapy||Participants|Count of Participants|61|61.0||||||
3690786|NCT02229539|3532698|B4||2=Symptomatic, <50% in bed during the day|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|10|10.0||||||
3690787|NCT02229539|3532699|B3||2=Symptomatic, <50% in bed during the day|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|3|3.0||||||
3690788|NCT02229539|3532700|B2||2=Symptomatic, <50% in bed during the day|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|6|6.0||||||
3690789|NCT02229539|3532701|B1||2=Symptomatic, <50% in bed during the day|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|1|1.0||||||
3690790|NCT02229539|3532698|B4||1=Symptomatic and fully ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|119|119.0||||||
3690791|NCT02229539|3532699|B3||1=Symptomatic and fully ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|40|40.0||||||
3690792|NCT02229539|3532700|B2||1=Symptomatic and fully ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|39|39.0||||||
3690793|NCT02229539|3532701|B1||1=Symptomatic and fully ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|40|40.0||||||
3690794|NCT02229539|3532698|B4||0=Asymptomatic and fully active|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|99|99.0||||||
3690795|NCT02229539|3532699|B3||0=Asymptomatic and fully active|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|32|32.0||||||
3690796|NCT02229539|3532700|B2||0=Asymptomatic and fully active|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|31|31.0||||||
3690797|NCT02229539|3532701|B1||0=Asymptomatic and fully active|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|36|36.0||||||
3690798|NCT02229539|3532698|B4|United States||Region of Enrollment||participants|Number|228|228.0||||||
3690799|NCT02229539|3532699|B3|United States||Region of Enrollment||participants|Number|75|75.0||||||
3690800|NCT02229539|3532700|B2|United States||Region of Enrollment||participants|Number|76|76.0||||||
3690801|NCT02229539|3532701|B1|United States||Region of Enrollment||participants|Number|77|77.0||||||
3690802|NCT02229539|3532698|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3690803|NCT02229539|3532699|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690804|NCT02229539|3532700|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3690805|NCT02229539|3532701|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690806|NCT02229539|3532698|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690807|NCT02229539|3532699|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690808|NCT02229539|3532700|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690809|NCT02229539|3532701|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690810|NCT02229539|3532698|B4||White|Race (NIH/OMB)||Participants|Count of Participants|210|210.0||||||
3690811|NCT02229539|3532699|B3||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3690812|NCT02229539|3532700|B2||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3690813|NCT02229539|3532701|B1||White|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3690814|NCT02229539|3532698|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3690815|NCT02229539|3532699|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3690816|NCT02229539|3532700|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3690817|NCT02229539|3532701|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3690818|NCT02229539|3532698|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690821|NCT02229539|3532701|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690822|NCT02229539|3532698|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3690823|NCT02229539|3532699|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3690824|NCT02229539|3532700|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3690825|NCT02229539|3532701|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3690826|NCT02229539|3532698|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690827|NCT02229539|3532699|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690828|NCT02229539|3532700|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690829|NCT02229539|3532701|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690830|NCT02229539|3532698|B4||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
3690831|NCT02229539|3532699|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3690832|NCT02229539|3532700|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3690833|NCT02229539|3532701|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3690834|NCT02229539|3532698|B4||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3690835|NCT02229539|3532699|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3690836|NCT02229539|3532700|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3690837|NCT02229539|3532701|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3690838|NCT02229539|3532698|B4||>=60 years old|Age, Customized||Participants|Count of Participants|125|125.0||||||
3690839|NCT02229539|3532699|B3||>=60 years old|Age, Customized||Participants|Count of Participants|38|38.0||||||
3690840|NCT02229539|3532700|B2||>=60 years old|Age, Customized||Participants|Count of Participants|43|43.0||||||
3690841|NCT02229539|3532701|B1||>=60 years old|Age, Customized||Participants|Count of Participants|44|44.0||||||
3690842|NCT02229539|3532698|B4||<60 years old|Age, Customized||Participants|Count of Participants|103|103.0||||||
3690843|NCT02229539|3532699|B3||<60 years old|Age, Customized||Participants|Count of Participants|37|37.0||||||
3690844|NCT02229539|3532700|B2||<60 years old|Age, Customized||Participants|Count of Participants|33|33.0||||||
3690845|NCT02229539|3532701|B1||<60 years old|Age, Customized||Participants|Count of Participants|33|33.0||||||
3690846|NCT02229539|3532698|B4|||Age||years|Median|60|60.0|Full Range|||23.0|94.0|
3690847|NCT02229539|3532699|B3|||Age||years|Median|60|60.0|Full Range|||31.0|94.0|
3690848|NCT02229539|3532700|B2|||Age||years|Median|60|60.0|Full Range|||23.0|82.0|
3690849|NCT02229539|3532701|B1|||Age||years|Median|62|62.0|Full Range|||26.0|87.0|
3690850|NCT02229513|3532711|B3|no||Pre-op Epidural||participants|Number|174|174.0||||||
3690851|NCT02229513|3532712|B2|no||Pre-op Epidural||participants|Number|83|83.0||||||
3690852|NCT02229513|3532713|B1|no||Pre-op Epidural||participants|Number|91|91.0||||||
3690853|NCT02229513|3532711|B3|yes||Pre-op Epidural||participants|Number|26|26.0||||||
3690854|NCT02229513|3532712|B2|yes||Pre-op Epidural||participants|Number|17|17.0||||||
3690855|NCT02229513|3532713|B1|yes||Pre-op Epidural||participants|Number|9|9.0||||||
3690856|NCT02229513|3532711|B3|no||Trial of Labor||participants|Number|177|177.0||||||
3690857|NCT02229513|3532712|B2|no||Trial of Labor||participants|Number|84|84.0||||||
3690858|NCT02229513|3532713|B1|no||Trial of Labor||participants|Number|93|93.0||||||
3690859|NCT02229513|3532711|B3|yes||Trial of Labor||participants|Number|23|23.0||||||
3690860|NCT02229513|3532712|B2|yes||Trial of Labor||participants|Number|16|16.0||||||
3690861|NCT02229513|3532713|B1|yes||Trial of Labor||participants|Number|7|7.0||||||
3690862|NCT02229513|3532711|B3|||Previous Cesareans||cesareans|Mean|0.8|0.8|Full Range|||0.0|3.0|
3690863|NCT02229513|3532712|B2|||Previous Cesareans||cesareans|Mean|0.7|0.7|Full Range|||0.0|3.0|
3690864|NCT02229513|3532713|B1|||Previous Cesareans||cesareans|Mean|0.8|0.8|Full Range|||0.0|3.0|
3690865|NCT02229513|3532711|B3|||Fetal Weight (g)||grams|Mean|3488|3488.0|Standard Deviation|835|835.0|||
3690866|NCT02229513|3532712|B2|||Fetal Weight (g)||grams|Mean|3471|3471.0|Standard Deviation|822|822.0|||
3690867|NCT02229513|3532713|B1|||Fetal Weight (g)||grams|Mean|3504|3504.0|Standard Deviation|852|852.0|||
3690868|NCT02229513|3532711|B3|no||Multiple Gestations||participants|Number|182|182.0||||||
3690869|NCT02229513|3532712|B2|no||Multiple Gestations||participants|Number|93|93.0||||||
3690870|NCT02229513|3532713|B1|no||Multiple Gestations||participants|Number|89|89.0||||||
3690871|NCT02229513|3532711|B3|yes||Multiple Gestations||participants|Number|18|18.0||||||
3690872|NCT02229513|3532712|B2|yes||Multiple Gestations||participants|Number|7|7.0||||||
3690873|NCT02229513|3532713|B1|yes||Multiple Gestations||participants|Number|11|11.0||||||
3690874|NCT02229513|3532711|B3|Compound||Fetal Presentation||participants|Number|1|1.0||||||
3690875|NCT02229513|3532712|B2|Compound||Fetal Presentation||participants|Number|1|1.0||||||
3690876|NCT02229513|3532713|B1|Compound||Fetal Presentation||participants|Number|0|0.0||||||
3690877|NCT02229513|3532711|B3|Oblique||Fetal Presentation||participants|Number|1|1.0||||||
3690878|NCT02229513|3532712|B2|Oblique||Fetal Presentation||participants|Number|0|0.0||||||
3690879|NCT02229513|3532713|B1|Oblique||Fetal Presentation||participants|Number|1|1.0||||||
3690880|NCT02229513|3532711|B3|Transverse||Fetal Presentation||participants|Number|3|3.0||||||
3690881|NCT02229513|3532712|B2|Transverse||Fetal Presentation||participants|Number|2|2.0||||||
3690882|NCT02229513|3532713|B1|Transverse||Fetal Presentation||participants|Number|1|1.0||||||
3690883|NCT02229513|3532711|B3|Breech||Fetal Presentation||participants|Number|28|28.0||||||
3690884|NCT02229513|3532712|B2|Breech||Fetal Presentation||participants|Number|14|14.0||||||
3690885|NCT02229513|3532713|B1|Breech||Fetal Presentation||participants|Number|14|14.0||||||
3690886|NCT02229513|3532711|B3|Cephalic||Fetal Presentation||participants|Number|167|167.0||||||
3690887|NCT02229513|3532712|B2|Cephalic||Fetal Presentation||participants|Number|83|83.0||||||
3690888|NCT02229513|3532713|B1|Cephalic||Fetal Presentation||participants|Number|84|84.0||||||
3690889|NCT02229513|3532711|B3|||Gestational Age (wks)||weeks|Mean|38.3|38.3|Standard Deviation|3.4|3.4|||
3690890|NCT02229513|3532712|B2|||Gestational Age (wks)||weeks|Mean|38.0|38.0|Standard Deviation|4.2|4.2|||
3690891|NCT02229513|3532713|B1|||Gestational Age (wks)||weeks|Mean|38.5|38.5|Standard Deviation|2.2|2.2|||
3690892|NCT02229513|3532711|B3|||Parity||births|Mean|1.0|1.0|Full Range|||0.0|5.0|
3690893|NCT02229513|3532712|B2|||Parity||births|Mean|1.0|1.0|Full Range|||0.0|4.0|
3690894|NCT02229513|3532713|B1|||Parity||births|Mean|1.0|1.0|Full Range|||0.0|5.0|
3690895|NCT02229513|3532711|B3|||Gravidity||pregnancies|Mean|2.5|2.5|Full Range|||1.0|9.0|
3690896|NCT02229513|3532712|B2|||Gravidity||pregnancies|Mean|2.4|2.4|Full Range|||1.0|9.0|
3690897|NCT02229513|3532713|B1|||Gravidity||pregnancies|Mean|2.5|2.5|Full Range|||1.0|7.0|
3690898|NCT02229513|3532711|B3|||Weight (lbs)||pounds|Mean|194|194.0|Standard Deviation|45|45.0|||
3690899|NCT02229513|3532712|B2|||Weight (lbs)||pounds|Mean|187|187.0|Standard Deviation|39|39.0|||
3690900|NCT02229513|3532713|B1|||Weight (lbs)||pounds|Mean|200|200.0|Standard Deviation|49|49.0|||
3690901|NCT02229513|3532711|B3|||Height (ft)||feet|Mean|5.4|5.4|Standard Deviation|0.3|0.3|||
3690902|NCT02229513|3532712|B2|||Height (ft)||feet|Mean|5.4|5.4|Standard Deviation|0.3|0.3|||
3690903|NCT02229513|3532713|B1|||Height (ft)||feet|Mean|5.4|5.4|Standard Deviation|0.2|0.2|||
3690904|NCT02229513|3532711|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690905|NCT02229513|3532712|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690906|NCT02229513|3532713|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690907|NCT02229513|3532711|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690908|NCT02229513|3532712|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690909|NCT02229513|3532713|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690910|NCT02229513|3532711|B3||White|Race (NIH/OMB)||Participants|Count of Participants|160|160.0||||||
3690911|NCT02229513|3532712|B2||White|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3690912|NCT02229513|3532713|B1||White|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3690913|NCT02229513|3532711|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3690914|NCT02229513|3532712|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3690915|NCT02229513|3532713|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3690916|NCT02229513|3532711|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690917|NCT02229513|3532712|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690918|NCT02229513|3532713|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690919|NCT02229513|3532711|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3690920|NCT02229513|3532712|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3690921|NCT02229513|3532713|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3690922|NCT02229513|3532711|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690923|NCT02229513|3532712|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690924|NCT02229513|3532713|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3690925|NCT02229513|3532711|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3690926|NCT02229513|3532712|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3690927|NCT02229513|3532713|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3690928|NCT02229513|3532711|B3||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
3690929|NCT02229513|3532712|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3690930|NCT02229513|3532713|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3690931|NCT02229513|3532711|B3|||Age||years|Mean|30.9|30.9|Standard Deviation|5.0|5.0|||
3690932|NCT02229513|3532712|B2|||Age||years|Mean|31.7|31.7|Standard Deviation|5.1|5.1|||
3690933|NCT02229513|3532713|B1|||Age||years|Mean|30.1|30.1|Standard Deviation|4.8|4.8|||
3690934|NCT02229487|3532748|B3|||BMI||kg/m^2|Mean|26.8|26.8|Standard Deviation|3.5|3.5|||
3690935|NCT02229487|3532749|B2|||BMI||kg/m^2|Mean|26.8|26.8|Standard Deviation|3.8|3.8|||
3690936|NCT02229487|3532750|B1|||BMI||kg/m^2|Mean|26.7|26.7|Standard Deviation|3.2|3.2|||
3690937|NCT02229487|3532748|B3|Thailand||Region of Enrollment||Participants|Count of Participants|51|51.0||||||
3690938|NCT02229487|3532749|B2|Thailand||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3690939|NCT02229487|3532750|B1|Thailand||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3690940|NCT02229487|3532748|B3|Thai||Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
3690941|NCT02229487|3532749|B2|Thai||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3690942|NCT02229487|3532750|B1|Thai||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3690943|NCT02229487|3532748|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3690944|NCT02229487|3532749|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3690945|NCT02229487|3532750|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3690946|NCT02229487|3532748|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3690947|NCT02229487|3532749|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3690948|NCT02229487|3532750|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3690949|NCT02229487|3532748|B3|||Age||years|Mean|55.7|55.7|Standard Deviation|8.2|8.2|||
3690950|NCT02229487|3532749|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|6.7|6.7|||
3690951|NCT02229487|3532750|B1|||Age||years|Mean|55.5|55.5|Standard Deviation|9.8|9.8|||
3690952|NCT02229474|3532757|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3690953|NCT02229474|3532758|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3690954|NCT02229474|3532759|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3690955|NCT02229474|3532757|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3690956|NCT02229474|3532758|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3690957|NCT02229474|3532759|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3690958|NCT02229474|3532757|B3|||Age||years|Median|80|80.0|Inter-Quartile Range|||76.0|85.0|
3690959|NCT02229474|3532758|B2|||Age||years|Median|80|80.0|Inter-Quartile Range|||74.0|86.0|
3690960|NCT02229474|3532759|B1|||Age||years|Median|81|81.0|Inter-Quartile Range|||76.0|86.0|
3690961|NCT02229461|3532786|B8||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3690962|NCT02229461|3532787|B7||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3690963|NCT02229461|3532788|B6||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3690964|NCT02229461|3532789|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3690965|NCT02229461|3532790|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3690966|NCT02229461|3532791|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3690967|NCT02229461|3532792|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3690968|NCT02229461|3532793|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3690969|NCT02229461|3532786|B8||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3690970|NCT02229461|3532787|B7||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3690971|NCT02229461|3532788|B6||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3690972|NCT02229461|3532789|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3690973|NCT02229461|3532790|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3690974|NCT02229461|3532791|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3690975|NCT02229461|3532792|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3690976|NCT02229461|3532793|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3690977|NCT02229461|3532786|B8|||Age||years|Mean|37.1|37.1|Standard Deviation|11.00|11.0|||
3690978|NCT02229461|3532787|B7|||Age||years|Mean|38.2|38.2|Standard Deviation|13.74|13.74|||
3690979|NCT02229461|3532788|B6|||Age||years|Mean|38.9|38.9|Standard Deviation|10.62|10.62|||
3690980|NCT02229461|3532789|B5|||Age||years|Mean|38.8|38.8|Standard Deviation|12.09|12.09|||
3690981|NCT02229461|3532790|B4|||Age||years|Mean|34.2|34.2|Standard Deviation|8.76|8.76|||
3690982|NCT02229461|3532791|B3|||Age||years|Mean|37.5|37.5|Standard Deviation|13.41|13.41|||
3690983|NCT02229461|3532792|B2|||Age||years|Mean|31.2|31.2|Standard Deviation|7.19|7.19|||
3690984|NCT02229461|3532793|B1|||Age||years|Mean|41.3|41.3|Standard Deviation|8.46|8.46|||
3690985|NCT02229396|3532831|B4|White||Race/Ethnicity, Customized||Participants|Number|573|573.0||||||
3690986|NCT02229396|3532832|B3|White||Race/Ethnicity, Customized||Participants|Number|194|194.0||||||
3690987|NCT02229396|3532833|B2|White||Race/Ethnicity, Customized||Participants|Number|190|190.0||||||
3690988|NCT02229396|3532834|B1|White||Race/Ethnicity, Customized||Participants|Number|189|189.0||||||
3690989|NCT02229396|3532831|B4|Other||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3690990|NCT02229396|3532832|B3|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3690991|NCT02229396|3532833|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3690992|NCT02229396|3532834|B1|Other||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3690993|NCT02229396|3532831|B4|Black Or African American||Race/Ethnicity, Customized||Participants|Number|94|94.0||||||
3690994|NCT02229396|3532832|B3|Black Or African American||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
3690995|NCT02229396|3532833|B2|Black Or African American||Race/Ethnicity, Customized||Participants|Number|34|34.0||||||
3690996|NCT02229396|3532834|B1|Black Or African American||Race/Ethnicity, Customized||Participants|Number|33|33.0||||||
3690997|NCT02229396|3532831|B4|Asian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3690998|NCT02229396|3532832|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3690999|NCT02229396|3532833|B2|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3691000|NCT02229396|3532834|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3691001|NCT02229396|3532831|B4|American Indian Or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3691002|NCT02229396|3532832|B3|American Indian Or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3691003|NCT02229396|3532833|B2|American Indian Or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3691004|NCT02229396|3532834|B1|American Indian Or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3691005|NCT02229396|3532831|B4||Male|Sex: Female, Male||Participants|Count of Participants|328|328.0||||||
3691006|NCT02229396|3532832|B3||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3691007|NCT02229396|3532833|B2||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3691008|NCT02229396|3532834|B1||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3691009|NCT02229396|3532831|B4||Female|Sex: Female, Male||Participants|Count of Participants|357|357.0||||||
3691010|NCT02229396|3532832|B3||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3691011|NCT02229396|3532833|B2||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3691012|NCT02229396|3532834|B1||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3691013|NCT02229396|3532831|B4|||Age||Years|Mean|54.2|54.2|Standard Deviation|9.53|9.53|26.0|80.0|
3691014|NCT02229396|3532832|B3|||Age||Years|Mean|54.2|54.2|Standard Deviation|9.62|9.62|29.0|80.0|
3691015|NCT02229396|3532833|B2|||Age||Years|Mean|53.8|53.8|Standard Deviation|9.82|9.82|26.0|80.0|
3691016|NCT02229396|3532834|B1|||Age||Years|Mean|54.5|54.5|Standard Deviation|9.16|9.16|28.0|75.0|
3691017|NCT02229383|3532865|B3|White||Race/Ethnicity, Customized||Participants|Number|401|401.0||||||
3691018|NCT02229383|3532866|B2|White||Race/Ethnicity, Customized||Participants|Number|196|196.0||||||
3691019|NCT02229383|3532867|B1|White||Race/Ethnicity, Customized||Participants|Number|205|205.0||||||
3691020|NCT02229383|3532865|B3|Other||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3691021|NCT02229383|3532866|B2|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3691022|NCT02229383|3532867|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3691023|NCT02229383|3532865|B3|Native Hawaiian Or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3691024|NCT02229383|3532866|B2|Native Hawaiian Or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3691025|NCT02229383|3532867|B1|Native Hawaiian Or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3691026|NCT02229383|3532865|B3|Black Or African American||Race/Ethnicity, Customized||Participants|Number|47|47.0||||||
3691027|NCT02229383|3532866|B2|Black Or African American||Race/Ethnicity, Customized||Participants|Number|28|28.0||||||
3691028|NCT02229383|3532867|B1|Black Or African American||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
3691029|NCT02229383|3532865|B3|Asian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3691030|NCT02229383|3532866|B2|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3691031|NCT02229383|3532867|B1|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3691032|NCT02229383|3532865|B3|American Indian Or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3691033|NCT02229383|3532866|B2|American Indian Or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3691034|NCT02229383|3532867|B1|American Indian Or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3691035|NCT02229383|3532865|B3||Male|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
3691036|NCT02229383|3532866|B2||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3691037|NCT02229383|3532867|B1||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3691038|NCT02229383|3532865|B3||Female|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
3691039|NCT02229383|3532866|B2||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3691040|NCT02229383|3532867|B1||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3691041|NCT02229383|3532865|B3|||Age||Years|Mean|57.7|57.7|Standard Deviation|9.66|9.66|20.0|80.0|
3691042|NCT02229383|3532866|B2|||Age||Years|Mean|57.6|57.6|Standard Deviation|10.28|10.28|20.0|79.0|
3691043|NCT02229383|3532867|B1|||Age||Years|Mean|57.8|57.8|Standard Deviation|9.02|9.02|26.0|80.0|
3691044|NCT02229318|3532886|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3691045|NCT02229318|3532886|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3691046|NCT02229318|3532886|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3691047|NCT02229318|3532886|B1|||Age||years|Mean|6.7|6.7|Full Range|||4.3|8.9|
3691048|NCT02229318|3532886|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3691049|NCT02229318|3532886|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3691050|NCT02229318|3532886|B1||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
3691051|NCT02229227|3532891|B3|Multiple-Black or African American and White||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3691052|NCT02229227|3532892|B2|Multiple-Black or African American and White||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3691053|NCT02229227|3532893|B1|Multiple-Black or African American and White||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3691054|NCT02229227|3532891|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|596|596.0||||||
3691055|NCT02229227|3532892|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|312|312.0||||||
3691056|NCT02229227|3532893|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|284|284.0||||||
3691057|NCT02229227|3532891|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3691058|NCT02229227|3532892|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3691059|NCT02229227|3532893|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3691060|NCT02229227|3532891|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|69|69.0||||||
3691061|NCT02229227|3532892|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3691062|NCT02229227|3532893|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
3691119|NCT02229214|3532979|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3691063|NCT02229227|3532891|B3|Asian-Japanese H/East AH/South East AH||Race/Ethnicity, Customized||Participants|Count of Participants|49|49.0||||||
3691064|NCT02229227|3532892|B2|Asian-Japanese H/East AH/South East AH||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3691065|NCT02229227|3532893|B1|Asian-Japanese H/East AH/South East AH||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3691066|NCT02229227|3532891|B3|Asian-Central/South Asian (A) Heritage (H)||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3691067|NCT02229227|3532892|B2|Asian-Central/South Asian (A) Heritage (H)||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3691068|NCT02229227|3532893|B1|Asian-Central/South Asian (A) Heritage (H)||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3691069|NCT02229227|3532891|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|71|71.0||||||
3691070|NCT02229227|3532892|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3691071|NCT02229227|3532893|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
3691072|NCT02229227|3532891|B3||Male|Sex: Female, Male||Participants|Count of Participants|372|372.0||||||
3691073|NCT02229227|3532892|B2||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
3691074|NCT02229227|3532893|B1||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3691075|NCT02229227|3532891|B3||Female|Sex: Female, Male||Participants|Count of Participants|442|442.0||||||
3691076|NCT02229227|3532892|B2||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
3691077|NCT02229227|3532893|B1||Female|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
3691078|NCT02229227|3532891|B3|||Age||Years|Mean|58.1|58.1|Standard Deviation|9.44|9.44|||
3691079|NCT02229227|3532892|B2|||Age||Years|Mean|58.1|58.1|Standard Deviation|9.49|9.49|||
3691080|NCT02229227|3532893|B1|||Age||Years|Mean|58.0|58.0|Standard Deviation|9.40|9.4|||
3691081|NCT02229214|3532977|B3|||iGFR||mL/min/1.73m^2|Mean|93.6|93.6|Standard Deviation|13.49|13.49|||
3691082|NCT02229214|3532978|B2|||iGFR||mL/min/1.73m^2|Mean|87.3|87.3|Standard Deviation|9.06|9.06|||
3691083|NCT02229214|3532979|B1|||iGFR||mL/min/1.73m^2|Mean|95.1|95.1|Standard Deviation|14.05|14.05|||
3691084|NCT02229214|3532977|B3|||BMI||Kg/m^2|Mean|32.8|32.8|Standard Deviation|4.46|4.46|||
3691085|NCT02229214|3532978|B2|||BMI||Kg/m^2|Mean|31.3|31.3|Standard Deviation|2.81|2.81|||
3691086|NCT02229214|3532979|B1|||BMI||Kg/m^2|Mean|33.2|33.2|Standard Deviation|4.72|4.72|||
3691087|NCT02229214|3532977|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
3691088|NCT02229214|3532978|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3691089|NCT02229214|3532979|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
3691090|NCT02229214|3532977|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3691091|NCT02229214|3532978|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3691092|NCT02229214|3532979|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3691093|NCT02229214|3532977|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691094|NCT02229214|3532978|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691095|NCT02229214|3532979|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691096|NCT02229214|3532977|B3||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3691097|NCT02229214|3532978|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3691098|NCT02229214|3532979|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3691099|NCT02229214|3532977|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3691100|NCT02229214|3532978|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3691101|NCT02229214|3532979|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3691102|NCT02229214|3532977|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691103|NCT02229214|3532978|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691104|NCT02229214|3532979|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691105|NCT02229214|3532977|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3691106|NCT02229214|3532978|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691107|NCT02229214|3532979|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3691108|NCT02229214|3532977|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3691109|NCT02229214|3532978|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691110|NCT02229214|3532979|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3691111|NCT02229214|3532977|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691112|NCT02229214|3532978|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691113|NCT02229214|3532979|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691114|NCT02229214|3532977|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3691115|NCT02229214|3532978|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3691116|NCT02229214|3532979|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3691117|NCT02229214|3532977|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3691118|NCT02229214|3532978|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3691120|NCT02229214|3532977|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3691121|NCT02229214|3532978|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3691122|NCT02229214|3532979|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3691123|NCT02229214|3532977|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3691124|NCT02229214|3532978|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3691125|NCT02229214|3532979|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3691126|NCT02229214|3532977|B3|||Age||Years|Mean|38.2|38.2|Standard Deviation|10.74|10.74|||
3691127|NCT02229214|3532978|B2|||Age||Years|Mean|37.6|37.6|Standard Deviation|9.80|9.8|||
3691128|NCT02229214|3532979|B1|||Age||Years|Mean|38.4|38.4|Standard Deviation|11.07|11.07|||
3691129|NCT02228980|3533000|B5|China||Region of Enrollment||Participants|Number|602|602.0||||||
3691130|NCT02228980|3533001|B4|China||Region of Enrollment||Participants|Number|151|151.0||||||
3691131|NCT02228980|3533002|B3|China||Region of Enrollment||Participants|Number|151|151.0||||||
3691132|NCT02228980|3533003|B2|China||Region of Enrollment||Participants|Number|150|150.0||||||
3691133|NCT02228980|3533004|B1|China||Region of Enrollment||Participants|Number|150|150.0||||||
3691134|NCT02228980|3533000|B5||Male|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
3691135|NCT02228980|3533001|B4||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3691136|NCT02228980|3533002|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3691137|NCT02228980|3533003|B2||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3691138|NCT02228980|3533004|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3691139|NCT02228980|3533000|B5||Female|Sex: Female, Male||Participants|Count of Participants|331|331.0||||||
3691140|NCT02228980|3533001|B4||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3691141|NCT02228980|3533002|B3||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3691142|NCT02228980|3533003|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3691143|NCT02228980|3533004|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3691144|NCT02228980|3533000|B5|||Age||Years|Mean|31.5|31.5|Standard Deviation|5.31425|5.31425|||
3691145|NCT02228980|3533001|B4|||Age||Years|Mean|69.8|69.8|Standard Deviation|6.37|6.37|||
3691146|NCT02228980|3533002|B3|||Age||Years|Mean|46.5|46.5|Standard Deviation|11.2|11.2|||
3691147|NCT02228980|3533003|B2|||Age||Years|Mean|8.55|8.55|Standard Deviation|3.09|3.09|||
3691148|NCT02228980|3533004|B1|||Age||Years|Mean|1.45|1.45|Standard Deviation|0.597|0.597|||
3691149|NCT02228980|3533000|B5||>=65 years|Age||Participants|Count of Participants|110|110.0||||||
3691150|NCT02228980|3533001|B4||>=65 years|Age||Participants|Count of Participants|110|110.0||||||
3691151|NCT02228980|3533002|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3691152|NCT02228980|3533003|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3691153|NCT02228980|3533004|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3691154|NCT02228980|3533000|B5||Between 18 and 65 years|Age||Participants|Count of Participants|192|192.0||||||
3691155|NCT02228980|3533001|B4||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3691156|NCT02228980|3533002|B3||Between 18 and 65 years|Age||Participants|Count of Participants|151|151.0||||||
3691157|NCT02228980|3533003|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3691158|NCT02228980|3533004|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3691159|NCT02228980|3533000|B5||<=18 years|Age||Participants|Count of Participants|300|300.0||||||
3691160|NCT02228980|3533001|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3691161|NCT02228980|3533002|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3691162|NCT02228980|3533003|B2||<=18 years|Age||Participants|Count of Participants|150|150.0||||||
3691163|NCT02228980|3533004|B1||<=18 years|Age||Participants|Count of Participants|150|150.0||||||
3691164|NCT02228824|3533029|B3|||Previous history of daily smoking|Those participants who reported having previously smoked daily, continuously for at least six months, were classified as past daily smokers|Participants|Count of Participants|118|118.0||||||
3691165|NCT02228824|3533030|B2|||Previous history of daily smoking|Those participants who reported having previously smoked daily, continuously for at least six months, were classified as past daily smokers|Participants|Count of Participants|61|61.0||||||
3691166|NCT02228824|3533031|B1|||Previous history of daily smoking|Those participants who reported having previously smoked daily, continuously for at least six months, were classified as past daily smokers|Participants|Count of Participants|57|57.0||||||
3691167|NCT02228824|3533029|B3|||Cigarettes per day at enrollment (smoking days only)|Average cigarettes per day (across smoking days only) in the month preceding initial visit, reported via calendar-based TimeLine Follow-Back|cigarettes per day|Mean|3.4|3.4|Standard Deviation|2.6|2.6|||
3691168|NCT02228824|3533030|B2|||Cigarettes per day at enrollment (smoking days only)|Average cigarettes per day (across smoking days only) in the month preceding initial visit, reported via calendar-based TimeLine Follow-Back|cigarettes per day|Mean|3.5|3.5|Standard Deviation|2.9|2.9|||
3691169|NCT02228824|3533031|B1|||Cigarettes per day at enrollment (smoking days only)|Average cigarettes per day (across smoking days only) in the month preceding initial visit, reported via calendar-based TimeLine Follow-Back|cigarettes per day|Mean|3.3|3.3|Standard Deviation|2.3|2.3|||
3691170|NCT02228824|3533029|B3|||Smoking days per week at enrollment|Average smoking days per week, across all calendar days in the month preceding initial visit, reported via calendar-based TimeLine Follow-Back|smoking days per week|Mean|3.7|3.7|Standard Deviation|1.4|1.4|||
3691171|NCT02228824|3533030|B2|||Smoking days per week at enrollment|Average smoking days per week, across all calendar days in the month preceding initial visit, reported via calendar-based TimeLine Follow-Back|smoking days per week|Mean|3.7|3.7|Standard Deviation|1.4|1.4|||
3691172|NCT02228824|3533031|B1|||Smoking days per week at enrollment|Average smoking days per week, across all calendar days in the month preceding initial visit, reported via calendar-based TimeLine Follow-Back|smoking days per week|Mean|3.7|3.7|Standard Deviation|1.4|1.4|||
3691173|NCT02228824|3533029|B3|||Cigarettes per day at enrollment (across all days)|Average cigarettes per day, across all calendar days in the month preceding initial visit, reported via calendar-based TimeLine Follow-Back|cigarettes per day|Mean|1.9|1.9|Standard Deviation|1.7|1.7|||
3691174|NCT02228824|3533030|B2|||Cigarettes per day at enrollment (across all days)|Average cigarettes per day, across all calendar days in the month preceding initial visit, reported via calendar-based TimeLine Follow-Back|cigarettes per day|Mean|1.9|1.9|Standard Deviation|1.7|1.7|||
3691175|NCT02228824|3533031|B1|||Cigarettes per day at enrollment (across all days)|Average cigarettes per day, across all calendar days in the month preceding initial visit, reported via calendar-based TimeLine Follow-Back|cigarettes per day|Mean|1.9|1.9|Standard Deviation|1.6|1.6|||
3691176|NCT02228824|3533029|B3|United States||Region of Enrollment||participants|Number|238|238.0||||||
3691177|NCT02228824|3533030|B2|United States||Region of Enrollment||participants|Number|120|120.0||||||
3691178|NCT02228824|3533031|B1|United States||Region of Enrollment||participants|Number|118|118.0||||||
3691179|NCT02228824|3533029|B3|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3691180|NCT02228824|3533030|B2|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3691181|NCT02228824|3533031|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3691182|NCT02228824|3533029|B3|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|61|61.0||||||
3691183|NCT02228824|3533030|B2|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3691184|NCT02228824|3533031|B1|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3691185|NCT02228824|3533029|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|152|152.0||||||
3691186|NCT02228824|3533030|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|76|76.0||||||
3691187|NCT02228824|3533031|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|76|76.0||||||
3691188|NCT02228824|3533029|B3||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3691189|NCT02228824|3533030|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3691190|NCT02228824|3533031|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3691191|NCT02228824|3533029|B3||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3691192|NCT02228824|3533030|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3691193|NCT02228824|3533031|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3691194|NCT02228824|3533029|B3|||Age||years|Mean|37.9|37.9|Standard Deviation|13.8|13.8|||
3691195|NCT02228824|3533030|B2|||Age||years|Mean|38.4|38.4|Standard Deviation|14.2|14.2|||
3691196|NCT02228824|3533031|B1|||Age||years|Mean|37.4|37.4|Standard Deviation|13.5|13.5|||
3691197|NCT02228720|3533046|B1|Maxillary Sinuses||Lund-Mackay Score (CT scan)|The severity of sinus mucosal inflammation or fluid accumulation scored as 0 (complete lucency), 1 (partial lucency) or 2 (complete opacity).|units on a scale|Mean|2.3|2.3|Standard Deviation|0.98|0.98|||
3691198|NCT02228720|3533046|B1|Frontal Sinuses||Lund-Mackay Score (CT scan)|The severity of sinus mucosal inflammation or fluid accumulation scored as 0 (complete lucency), 1 (partial lucency) or 2 (complete opacity).|units on a scale|Mean|2.5|2.5|Standard Deviation|1.19|1.19|||
3691199|NCT02228720|3533046|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3691200|NCT02228720|3533046|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3691201|NCT02228720|3533046|B1|||Age||years|Mean|50.6|50.6|Standard Deviation|13.24|13.24|||
3691202|NCT02228395|3533054|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3691203|NCT02228395|3533054|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3691204|NCT02228395|3533054|B1|||Age||years|Mean|35.8|35.8|Standard Deviation|11.1|11.1|||
3691205|NCT02227810|3533120|B3|Taiwan||Region of Enrollment||participants|Number|53|53.0||||||
3691206|NCT02227810|3533121|B2|Taiwan||Region of Enrollment||participants|Number|19|19.0||||||
3691207|NCT02227810|3533122|B1|Taiwan||Region of Enrollment||participants|Number|34|34.0||||||
3691208|NCT02227810|3533120|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691209|NCT02227810|3533121|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691210|NCT02227810|3533122|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691211|NCT02227810|3533120|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691212|NCT02227810|3533121|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691213|NCT02227810|3533122|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691214|NCT02227810|3533120|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691215|NCT02227810|3533121|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691216|NCT02227810|3533122|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691217|NCT02227810|3533120|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691218|NCT02227810|3533121|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691219|NCT02227810|3533122|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691220|NCT02227810|3533120|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691221|NCT02227810|3533121|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691222|NCT02227810|3533122|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691223|NCT02227810|3533120|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3691224|NCT02227810|3533121|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3691225|NCT02227810|3533122|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3691226|NCT02227810|3533120|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691227|NCT02227810|3533121|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691228|NCT02227810|3533122|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691229|NCT02227810|3533120|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3691230|NCT02227810|3533121|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3691231|NCT02227810|3533122|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3691232|NCT02227810|3533120|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3691233|NCT02227810|3533121|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3691234|NCT02227810|3533122|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3691235|NCT02227810|3533120|B3|||Age||years|Mean|74.5|74.5|Standard Deviation|15.4|15.4|||
3691236|NCT02227810|3533121|B2|||Age||years|Mean|71.9|71.9|Standard Deviation|17.8|17.8|||
3691237|NCT02227810|3533122|B1|||Age||years|Mean|75.2|75.2|Standard Deviation|15.4|15.4|||
3691238|NCT02227810|3533120|B3||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
3691239|NCT02227810|3533121|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3691240|NCT02227810|3533122|B1||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
3691241|NCT02227810|3533120|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3691242|NCT02227810|3533121|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3691243|NCT02227810|3533122|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3691244|NCT02227810|3533120|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3691245|NCT02227810|3533121|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3691246|NCT02227810|3533122|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3691247|NCT02227784|3533135|B5|United States||Region of Enrollment||Participants|Count of Participants|366|366.0||||||
3691248|NCT02227784|3533136|B4|United States||Region of Enrollment||Participants|Count of Participants|127|127.0||||||
3691249|NCT02227784|3533137|B3|United States||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
3691250|NCT02227784|3533138|B2|United States||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
3691251|NCT02227784|3533139|B1|United States||Region of Enrollment||Participants|Count of Participants|123|123.0||||||
3691252|NCT02227784|3533135|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691253|NCT02227784|3533136|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691254|NCT02227784|3533137|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691255|NCT02227784|3533138|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691256|NCT02227784|3533139|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691257|NCT02227784|3533135|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3691258|NCT02227784|3533136|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3691259|NCT02227784|3533137|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691260|NCT02227784|3533138|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3691261|NCT02227784|3533139|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3691262|NCT02227784|3533135|B5||White|Race (NIH/OMB)||Participants|Count of Participants|297|297.0||||||
3691263|NCT02227784|3533136|B4||White|Race (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
3691264|NCT02227784|3533137|B3||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3691265|NCT02227784|3533138|B2||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3691266|NCT02227784|3533139|B1||White|Race (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
3691267|NCT02227784|3533135|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3691268|NCT02227784|3533136|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3691269|NCT02227784|3533137|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3691270|NCT02227784|3533138|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3691271|NCT02227784|3533139|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3691272|NCT02227784|3533135|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691273|NCT02227784|3533136|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691274|NCT02227784|3533137|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691275|NCT02227784|3533138|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691276|NCT02227784|3533139|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691277|NCT02227784|3533135|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3691278|NCT02227784|3533136|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3691279|NCT02227784|3533137|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691280|NCT02227784|3533138|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3691281|NCT02227784|3533139|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3691282|NCT02227784|3533135|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3691283|NCT02227784|3533136|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3691284|NCT02227784|3533137|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3691285|NCT02227784|3533138|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691286|NCT02227784|3533139|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691287|NCT02227784|3533135|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691288|NCT02227784|3533136|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691289|NCT02227784|3533137|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691290|NCT02227784|3533138|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691291|NCT02227784|3533139|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691292|NCT02227784|3533135|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|328|328.0||||||
3691293|NCT02227784|3533136|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|114|114.0||||||
3691294|NCT02227784|3533137|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3691295|NCT02227784|3533138|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3691296|NCT02227784|3533139|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
3691297|NCT02227784|3533135|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3691298|NCT02227784|3533136|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3691299|NCT02227784|3533137|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3691300|NCT02227784|3533138|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3691301|NCT02227784|3533139|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3691302|NCT02227784|3533135|B5||Male|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
3691303|NCT02227784|3533136|B4||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3691304|NCT02227784|3533137|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3691305|NCT02227784|3533138|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3691306|NCT02227784|3533139|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3691307|NCT02227784|3533135|B5||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3691308|NCT02227784|3533136|B4||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3691309|NCT02227784|3533137|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3691310|NCT02227784|3533138|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3691311|NCT02227784|3533139|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3691312|NCT02227784|3533135|B5|||Age||years|Mean|63.4|63.4|Standard Deviation|9.2|9.2|||
3691313|NCT02227784|3533136|B4|||Age||years|Mean|64.7|64.7|Standard Deviation|8.9|8.9|||
3691314|NCT02227784|3533137|B3|||Age||years|Mean|61.7|61.7|Standard Deviation|10.2|10.2|||
3691315|NCT02227784|3533138|B2|||Age||years|Mean|62.7|62.7|Standard Deviation|9.3|9.3|||
3691316|NCT02227784|3533139|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|8.7|8.7|||
3691317|NCT02227758|3533178|B1|Spain||Region of Enrollment||participants|Number|6|6.0||||||
3691318|NCT02227758|3533178|B1|Germany||Region of Enrollment||participants|Number|83|83.0||||||
3691319|NCT02227758|3533178|B1|United Kingdom||Region of Enrollment||participants|Number|18|18.0||||||
3691320|NCT02227758|3533178|B1|Luxembourg||Region of Enrollment||participants|Number|1|1.0||||||
3691321|NCT02227758|3533178|B1|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
3691322|NCT02227758|3533178|B1|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
3691323|NCT02227758|3533178|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3691324|NCT02227758|3533178|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3691325|NCT02227758|3533178|B1|||Age||years|Mean|45.9|45.9|Full Range|||20.0|70.0|
3691326|NCT02227485|3533190|B3|||BP|The maximum arterial blood pressure|mm Hg|Mean|12.4|12.4|Standard Deviation|1.1|1.1|||
3691327|NCT02227485|3533191|B2|||BP|The maximum arterial blood pressure|mm Hg|Mean|12.5|12.5|Standard Deviation|1.2|1.2|||
3691328|NCT02227485|3533192|B1|||BP|The maximum arterial blood pressure|mm Hg|Mean|12.3|12.3|Standard Deviation|1|1.0|||
3691329|NCT02227485|3533190|B3|||Teeth number||teeth|Mean|24.9|24.9|Standard Deviation|3.4|3.4|||
3691330|NCT02227485|3533191|B2|||Teeth number||teeth|Mean|25.0|25.0|Standard Deviation|3.6|3.6|||
3691331|NCT02227485|3533192|B1|||Teeth number||teeth|Mean|24.7|24.7|Standard Deviation|3.3|3.3|||
3691332|NCT02227485|3533190|B3|||Disease duration||years|Mean|10|10.0|Standard Deviation|6.2|6.2|||
3691333|NCT02227485|3533191|B2|||Disease duration||years|Mean|9.7|9.7|Standard Deviation|6.3|6.3|||
3691334|NCT02227485|3533192|B1|||Disease duration||years|Mean|10.3|10.3|Standard Deviation|6.2|6.2|||
3691335|NCT02227485|3533190|B3|||Weight||kg|Mean|75.4|75.4|Standard Deviation|13.6|13.6|||
3691336|NCT02227485|3533191|B2|||Weight||kg|Mean|75.6|75.6|Standard Deviation|13.8|13.8|||
3691337|NCT02227485|3533192|B1|||Weight||kg|Mean|75.1|75.1|Standard Deviation|13.5|13.5|||
3691338|NCT02227485|3533190|B3|||Height|The height of patients in centimeter (cm)|cm|Mean|164|164.0|Standard Deviation|9.7|9.7|||
3691339|NCT02227485|3533191|B2|||Height|The height of patients in centimeter (cm)|cm|Mean|164.1|164.1|Standard Deviation|10.0|10.0|||
3691340|NCT02227485|3533192|B1|||Height|The height of patients in centimeter (cm)|cm|Mean|163.9|163.9|Standard Deviation|9.6|9.6|||
3691341|NCT02227485|3533190|B3|Iran, Islamic Republic of||Region of Enrollment||participants|Number|80|80.0||||||
3691342|NCT02227485|3533191|B2|Iran, Islamic Republic of||Region of Enrollment||participants|Number|40|40.0||||||
3691343|NCT02227485|3533192|B1|Iran, Islamic Republic of||Region of Enrollment||participants|Number|40|40.0||||||
3691344|NCT02227485|3533190|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3691345|NCT02227485|3533191|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3691346|NCT02227485|3533192|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3691347|NCT02227485|3533190|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3691348|NCT02227485|3533191|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3691349|NCT02227485|3533192|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3691350|NCT02227485|3533190|B3|||Age||years|Mean|51.33|51.33|Standard Deviation|6.8|6.8|||
3691351|NCT02227485|3533191|B2|||Age||years|Mean|50.35|50.35|Standard Deviation|6.9|6.9|||
3691352|NCT02227485|3533192|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|6.5|6.5|||
3691353|NCT02227368|3533209|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3691354|NCT02227368|3533210|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3691355|NCT02227368|3533211|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3691356|NCT02227368|3533209|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691357|NCT02227368|3533210|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691358|NCT02227368|3533211|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691359|NCT02227368|3533209|B3||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3691360|NCT02227368|3533210|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3691361|NCT02227368|3533211|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3691362|NCT02227368|3533209|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3691363|NCT02227368|3533210|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3691364|NCT02227368|3533211|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3691365|NCT02227368|3533209|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691366|NCT02227368|3533210|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691367|NCT02227368|3533211|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691368|NCT02227368|3533209|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691369|NCT02227368|3533210|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691370|NCT02227368|3533211|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691371|NCT02227368|3533209|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691372|NCT02227368|3533210|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691373|NCT02227368|3533211|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691374|NCT02227368|3533209|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691375|NCT02227368|3533210|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691376|NCT02227368|3533211|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691377|NCT02227368|3533209|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3691378|NCT02227368|3533210|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3691379|NCT02227368|3533211|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3691380|NCT02227368|3533209|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3691381|NCT02227368|3533210|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3691382|NCT02227368|3533211|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3691383|NCT02227368|3533209|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3691384|NCT02227368|3533210|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3691385|NCT02227368|3533211|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3691386|NCT02227368|3533209|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3691387|NCT02227368|3533210|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3691388|NCT02227368|3533211|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3691389|NCT02227368|3533209|B3|||Age||years|Mean|67.9|67.9|Standard Deviation|8.60|8.6|||
3691390|NCT02227368|3533210|B2|||Age||years|Mean|67.0|67.0|Standard Deviation|8.31|8.31|||
3691391|NCT02227368|3533211|B1|||Age||years|Mean|69.1|69.1|Standard Deviation|9.15|9.15|||
3691392|NCT02227329|3533220|B3|United States||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
3691393|NCT02227329|3533221|B2|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3691394|NCT02227329|3533222|B1|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3691395|NCT02227329|3533220|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3691396|NCT02227329|3533221|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3691397|NCT02227329|3533222|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3691398|NCT02227329|3533220|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3691399|NCT02227329|3533221|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3691400|NCT02227329|3533222|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3691401|NCT02227329|3533220|B3|||Age||years|Mean|51|51.0|Standard Deviation|15|15.0|||
3691402|NCT02227329|3533221|B2|||Age||years|Mean|52|52.0|Standard Deviation|16|16.0|||
3691403|NCT02227329|3533222|B1|||Age||years|Mean|49|49.0|Standard Deviation|16|16.0|||
3691404|NCT02227316|3533229|B5|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3691405|NCT02227316|3533230|B4|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3691406|NCT02227316|3533231|B3|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3691407|NCT02227316|3533232|B2|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3691408|NCT02227316|3533233|B1|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3691409|NCT02227316|3533229|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3691410|NCT02227316|3533230|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3691411|NCT02227316|3533231|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3691412|NCT02227316|3533232|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3691413|NCT02227316|3533233|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3691414|NCT02227316|3533229|B5||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3691415|NCT02227316|3533230|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3691416|NCT02227316|3533231|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3691417|NCT02227316|3533232|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3691418|NCT02227316|3533233|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3691419|NCT02227316|3533229|B5|||Age||years|Mean|44.25|44.25|Standard Deviation|4.27|4.27|||
3691420|NCT02227316|3533230|B4|||Age||years|Mean|44.49|44.49|Standard Deviation|4.12|4.12|||
3691421|NCT02227316|3533231|B3|||Age||years|Mean|44.33|44.33|Standard Deviation|4.32|4.32|||
3691422|NCT02227316|3533232|B2|||Age||years|Mean|45.24|45.24|Standard Deviation|6.31|6.31|||
3691423|NCT02227316|3533233|B1|||Age||years|Mean|41.96|41.96|Standard Deviation|3.22|3.22|||
3691424|NCT02227316|3533229|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3691425|NCT02227316|3533230|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3691426|NCT02227316|3533231|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3691427|NCT02227316|3533232|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3691428|NCT02227316|3533233|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3691429|NCT02227316|3533229|B5||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3691430|NCT02227316|3533230|B4||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3691431|NCT02227316|3533231|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3691432|NCT02227316|3533232|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3691433|NCT02227316|3533233|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3691434|NCT02227316|3533229|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3691435|NCT02227316|3533230|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3691436|NCT02227316|3533231|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3691437|NCT02227316|3533232|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3691438|NCT02227316|3533233|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3691439|NCT02227121|3533266|B1||Aortic Aneurysm|Primary Indication for Surgery||Participants|Count of Participants|1|1.0||||||
3691440|NCT02227121|3533266|B1||Surgery Related to S-ICD (subcutaneous ICD)|Primary Indication for Surgery||Participants|Count of Participants|5|5.0||||||
3691441|NCT02227121|3533266|B1||Surgery Related to ICD (transvenous)|Primary Indication for Surgery||Participants|Count of Participants|1|1.0||||||
3691442|NCT02227121|3533266|B1||Cardiac Surgery: Valve Repair|Primary Indication for Surgery||Participants|Count of Participants|2|2.0||||||
3691443|NCT02227121|3533266|B1||Cardiac Surgery: Valve Replacement|Primary Indication for Surgery||Participants|Count of Participants|5|5.0||||||
3691444|NCT02227121|3533266|B1||Cardiac Surgery: Coronary Artery Bypass Graft|Primary Indication for Surgery||Participants|Count of Participants|2|2.0||||||
3691445|NCT02227121|3533266|B1|United Kingdom|Netherlands|Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3691446|NCT02227121|3533266|B1|United Kingdom|Poland|Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3691447|NCT02227121|3533266|B1|United Kingdom|United Kingdom|Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3691448|NCT02227121|3533266|B1|United Kingdom|Hong Kong|Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3691449|NCT02227121|3533266|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691450|NCT02227121|3533266|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691451|NCT02227121|3533266|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3691452|NCT02227121|3533266|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691453|NCT02227121|3533266|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691454|NCT02227121|3533266|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3691455|NCT02227121|3533266|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691456|NCT02227121|3533266|B1||Male|Gender||Participants|Count of Participants|12|12.0||||||
3691457|NCT02227121|3533266|B1||Female|Gender||Participants|Count of Participants|4|4.0||||||
3691458|NCT02227121|3533266|B1|||Age||years|Mean|61.6|61.6|Inter-Quartile Range|||54.0|70.5|
3691459|NCT02227121|3533266|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3691460|NCT02227121|3533266|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3691461|NCT02227121|3533266|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3691462|NCT02227108|3533270|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3691463|NCT02227108|3533270|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3691464|NCT02227108|3533270|B1|||Age||Years|Mean|10.5|10.5|Standard Deviation|3.9|3.9|||
3691465|NCT02226653|3533297|B3|Japan||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
3691466|NCT02226653|3533298|B2|Japan||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3691467|NCT02226653|3533299|B1|Japan||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3691468|NCT02226653|3533297|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691469|NCT02226653|3533298|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691470|NCT02226653|3533299|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691471|NCT02226653|3533297|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691472|NCT02226653|3533298|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691473|NCT02226653|3533299|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691474|NCT02226653|3533297|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691475|NCT02226653|3533298|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691476|NCT02226653|3533299|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691477|NCT02226653|3533297|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691478|NCT02226653|3533298|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691479|NCT02226653|3533299|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691480|NCT02226653|3533297|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691481|NCT02226653|3533298|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691482|NCT02226653|3533299|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691483|NCT02226653|3533297|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3691484|NCT02226653|3533298|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3691485|NCT02226653|3533299|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3691486|NCT02226653|3533297|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691487|NCT02226653|3533298|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691488|NCT02226653|3533299|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691489|NCT02226653|3533297|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691490|NCT02226653|3533298|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691491|NCT02226653|3533299|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691492|NCT02226653|3533297|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3691493|NCT02226653|3533298|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3691494|NCT02226653|3533299|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3691495|NCT02226653|3533297|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691496|NCT02226653|3533298|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691497|NCT02226653|3533299|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691498|NCT02226653|3533297|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3691499|NCT02226653|3533298|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3691500|NCT02226653|3533299|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3691501|NCT02226653|3533297|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3691502|NCT02226653|3533298|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3691503|NCT02226653|3533299|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3691504|NCT02226653|3533297|B3|||Age||years|Mean|33.9|33.9|Standard Deviation|10.6|10.6|||
3691505|NCT02226653|3533298|B2|||Age||years|Mean|34.7|34.7|Standard Deviation|11.3|11.3|||
3691506|NCT02226653|3533299|B1|||Age||years|Mean|33.2|33.2|Standard Deviation|9.9|9.9|||
3691507|NCT02226562|3533322|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3691508|NCT02226562|3533323|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3691509|NCT02226562|3533324|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3691510|NCT02226562|3533322|B3||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3691511|NCT02226562|3533323|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3691512|NCT02226562|3533324|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3691513|NCT02226562|3533322|B3|||Age||Years|Mean|40.7|40.7|Standard Deviation|8.42|8.42|||
3691514|NCT02226562|3533323|B2|||Age||Years|Mean|39.7|39.7|Standard Deviation|8.14|8.14|||
3691515|NCT02226562|3533324|B1|||Age||Years|Mean|41.7|41.7|Standard Deviation|8.62|8.62|||
3691516|NCT02226549|3533341|B3|Missing||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3691517|NCT02226549|3533342|B2|Missing||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3691518|NCT02226549|3533343|B1|Missing||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3691519|NCT02226549|3533341|B3|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|12|12.0||||||
3691520|NCT02226549|3533342|B2|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|6|6.0||||||
3691521|NCT02226549|3533343|B1|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|6|6.0||||||
3691522|NCT02226549|3533341|B3|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|28|28.0||||||
3691523|NCT02226549|3533342|B2|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|16|16.0||||||
3691524|NCT02226549|3533343|B1|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|12|12.0||||||
3691525|NCT02226549|3533341|B3|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|5|5.0||||||
3691526|NCT02226549|3533342|B2|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3691527|NCT02226549|3533343|B1|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|4|4.0||||||
3691528|NCT02226549|3533341|B3|Genotype 1a,1b||HCV Genotype||participants|Number|1|1.0||||||
3691529|NCT02226549|3533342|B2|Genotype 1a,1b||HCV Genotype||participants|Number|0|0.0||||||
3691530|NCT02226549|3533343|B1|Genotype 1a,1b||HCV Genotype||participants|Number|1|1.0||||||
3691531|NCT02226549|3533341|B3|Genotype 1b||HCV Genotype||participants|Number|13|13.0||||||
3691532|NCT02226549|3533342|B2|Genotype 1b||HCV Genotype||participants|Number|6|6.0||||||
3691533|NCT02226549|3533343|B1|Genotype 1b||HCV Genotype||participants|Number|7|7.0||||||
3691534|NCT02226549|3533341|B3|Genotype 1a||HCV Genotype||participants|Number|32|32.0||||||
3691535|NCT02226549|3533342|B2|Genotype 1a||HCV Genotype||participants|Number|18|18.0||||||
3691536|NCT02226549|3533343|B1|Genotype 1a||HCV Genotype||participants|Number|14|14.0||||||
3691537|NCT02226549|3533341|B3|Not Permitted||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3691538|NCT02226549|3533342|B2|Not Permitted||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3691539|NCT02226549|3533343|B1|Not Permitted||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3691540|NCT02226549|3533341|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3691541|NCT02226549|3533342|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3691542|NCT02226549|3533343|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3691543|NCT02226549|3533341|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3691544|NCT02226549|3533342|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3691545|NCT02226549|3533343|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3691546|NCT02226549|3533341|B3|White||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
3691547|NCT02226549|3533342|B2|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3691548|NCT02226549|3533343|B1|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3691549|NCT02226549|3533341|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3691550|NCT02226549|3533342|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3691551|NCT02226549|3533343|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3691552|NCT02226549|3533341|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3691553|NCT02226549|3533342|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3691554|NCT02226549|3533343|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3691555|NCT02226549|3533341|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3691556|NCT02226549|3533342|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3691557|NCT02226549|3533343|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3691558|NCT02226549|3533341|B3|||Age||years|Mean|57|57.0|Standard Deviation|7.7|7.7|||
3691559|NCT02226549|3533342|B2|||Age||years|Mean|56|56.0|Standard Deviation|7.7|7.7|||
3691560|NCT02226549|3533343|B1|||Age||years|Mean|58|58.0|Standard Deviation|7.9|7.9|||
3691561|NCT02226198|3533354|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3691562|NCT02226198|3533354|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3691563|NCT02226198|3533354|B1|||Age||Years|Mean|10.9|10.9|Standard Deviation|2.70|2.7|||
3691564|NCT02226172|3533429|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3691565|NCT02226172|3533429|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3691566|NCT02226172|3533429|B1|||Age||Years|Mean|69.3|69.3|Standard Deviation|7.0|7.0|||
3691567|NCT02226003|3533448|B4||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3691568|NCT02226003|3533449|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3691569|NCT02226003|3533450|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3691570|NCT02226003|3533451|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3691571|NCT02226003|3533448|B4||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3691572|NCT02226003|3533449|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3691573|NCT02226003|3533450|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3691574|NCT02226003|3533451|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3691575|NCT02226003|3533448|B4|||Age||Years|Mean|55.6|55.6|Standard Deviation|10.0|10.0|||
3691576|NCT02226003|3533449|B3|||Age||Years|Mean|54.3|54.3|Standard Deviation|10.3|10.3|||
3691577|NCT02226003|3533450|B2|||Age||Years|Mean|56.1|56.1|Standard Deviation|10.1|10.1|||
3691578|NCT02226003|3533451|B1|||Age||Years|Mean|56.4|56.4|Standard Deviation|9.3|9.3|||
3691579|NCT02225860|3533485|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
3691580|NCT02225860|3533486|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3691581|NCT02225860|3533487|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3691582|NCT02225860|3533485|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3691583|NCT02225860|3533486|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3691584|NCT02225860|3533487|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3691585|NCT02225860|3533485|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3691586|NCT02225860|3533486|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3691587|NCT02225860|3533487|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3691588|NCT02225860|3533485|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3691589|NCT02225860|3533486|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3691590|NCT02225860|3533487|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3691591|NCT02225860|3533485|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3691592|NCT02225860|3533486|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3691593|NCT02225860|3533487|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3691594|NCT02225860|3533485|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3691595|NCT02225860|3533486|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3691596|NCT02225860|3533487|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3691597|NCT02225353|3533498|B4|||Medical History - Prior Pregnancy Premature Rupture of Membrane||Participants|Count of Participants|61|61.0||||||
3691598|NCT02225353|3533499|B3|||Medical History - Prior Pregnancy Premature Rupture of Membrane||Participants|Count of Participants|17|17.0||||||
3691599|NCT02225353|3533500|B2|||Medical History - Prior Pregnancy Premature Rupture of Membrane||Participants|Count of Participants|20|20.0||||||
3691600|NCT02225353|3533501|B1|||Medical History - Prior Pregnancy Premature Rupture of Membrane||Participants|Count of Participants|24|24.0||||||
3691601|NCT02225353|3533498|B4|||Medical History - Prior Preterm Birth||Participants|Count of Participants|160|160.0||||||
3691602|NCT02225353|3533499|B3|||Medical History - Prior Preterm Birth||Participants|Count of Participants|50|50.0||||||
3691603|NCT02225353|3533500|B2|||Medical History - Prior Preterm Birth||Participants|Count of Participants|55|55.0||||||
3691604|NCT02225353|3533501|B1|||Medical History - Prior Preterm Birth||Participants|Count of Participants|55|55.0||||||
3691605|NCT02225353|3533498|B4|||Body Mass Index (BMI)||kilogram per square meter|Mean|27.95|27.95|Standard Deviation|5.01|5.01|||
3691606|NCT02225353|3533499|B3|||Body Mass Index (BMI)||kilogram per square meter|Mean|28.23|28.23|Standard Deviation|4.56|4.56|||
3691607|NCT02225353|3533500|B2|||Body Mass Index (BMI)||kilogram per square meter|Mean|28.61|28.61|Standard Deviation|5.45|5.45|||
3691608|NCT02225353|3533501|B1|||Body Mass Index (BMI)||kilogram per square meter|Mean|27.03|27.03|Standard Deviation|4.92|4.92|||
3691609|NCT02225353|3533498|B4|||Weight||kilogram|Mean|69.50|69.5|Standard Deviation|13.50|13.5|||
3691610|NCT02225353|3533499|B3|||Weight||kilogram|Mean|70.62|70.62|Standard Deviation|12.73|12.73|||
3691611|NCT02225353|3533500|B2|||Weight||kilogram|Mean|71.26|71.26|Standard Deviation|14.06|14.06|||
3691612|NCT02225353|3533501|B1|||Weight||kilogram|Mean|66.65|66.65|Standard Deviation|13.36|13.36|||
3691613|NCT02225353|3533498|B4|||Height||meter|Mean|1.58|1.58|Standard Deviation|0.05|0.05|||
3691614|NCT02225353|3533499|B3|||Height||meter|Mean|1.58|1.58|Standard Deviation|0.05|0.05|||
3691615|NCT02225353|3533500|B2|||Height||meter|Mean|1.58|1.58|Standard Deviation|0.06|0.06|||
3691616|NCT02225353|3533501|B1|||Height||meter|Mean|1.57|1.57|Standard Deviation|0.06|0.06|||
3691617|NCT02225353|3533498|B4|Chile||Region of Enrollment||participants|Number|271|271.0||||||
3691618|NCT02225353|3533499|B3|Chile||Region of Enrollment||participants|Number|90|90.0||||||
3691619|NCT02225353|3533500|B2|Chile||Region of Enrollment||participants|Number|90|90.0||||||
3691620|NCT02225353|3533501|B1|Chile||Region of Enrollment||participants|Number|91|91.0||||||
3691621|NCT02225353|3533498|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|271|271.0||||||
3691622|NCT02225353|3533499|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
3691623|NCT02225353|3533500|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
3691624|NCT02225353|3533501|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3691625|NCT02225353|3533498|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691626|NCT02225353|3533499|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691627|NCT02225353|3533500|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691628|NCT02225353|3533501|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691629|NCT02225353|3533498|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691630|NCT02225353|3533499|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691631|NCT02225353|3533500|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691632|NCT02225353|3533501|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691633|NCT02225353|3533498|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691634|NCT02225353|3533499|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691635|NCT02225353|3533500|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691636|NCT02225353|3533501|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691637|NCT02225353|3533498|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691638|NCT02225353|3533499|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691639|NCT02225353|3533500|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691640|NCT02225353|3533501|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691641|NCT02225353|3533498|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691642|NCT02225353|3533499|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691643|NCT02225353|3533500|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691644|NCT02225353|3533501|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691645|NCT02225353|3533498|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691646|NCT02225353|3533499|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691647|NCT02225353|3533500|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691648|NCT02225353|3533501|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691649|NCT02225353|3533498|B4||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3691650|NCT02225353|3533499|B3||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Male was an exclusion criterion
3691651|NCT02225353|3533500|B2||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Male was an exclusion criterion
3691652|NCT02225353|3533501|B1||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Male was an exclusion criterion
3691653|NCT02225353|3533498|B4||Female|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
3691654|NCT02225353|3533499|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3691655|NCT02225353|3533500|B2||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3691656|NCT02225353|3533501|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3691657|NCT02225353|3533498|B4|||Age||years|Mean|27.78|27.78|Standard Deviation|5.97|5.97|||
3691658|NCT02225353|3533499|B3|||Age||years|Mean|28.18|28.18|Standard Deviation|5.16|5.16|||
3691659|NCT02225353|3533500|B2|||Age||years|Mean|27.60|27.6|Standard Deviation|6.20|6.2|||
3691660|NCT02225353|3533501|B1|||Age||years|Mean|27.57|27.57|Standard Deviation|6.50|6.5|||
3691661|NCT02225353|3533498|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3691662|NCT02225353|3533499|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3691663|NCT02225353|3533500|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3691664|NCT02225353|3533501|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3691665|NCT02225353|3533498|B4||Between 18 and 65 years|Age||Participants|Count of Participants|271|271.0||||||
3691666|NCT02225353|3533499|B3||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
3691667|NCT02225353|3533500|B2||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
3691668|NCT02225353|3533501|B1||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
3691669|NCT02225353|3533498|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3691670|NCT02225353|3533499|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3691671|NCT02225353|3533500|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3691672|NCT02225353|3533501|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3691673|NCT02225080|3533526|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3691674|NCT02225080|3533526|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3691675|NCT02225080|3533526|B1|||Age||years|Mean|53.1|53.1|Standard Deviation|14.76|14.76|||
3691676|NCT02224846|3533533|B3|China||Region of Enrollment||Participants|Count of Participants|635|635.0||||||
3691677|NCT02224846|3533534|B2|China||Region of Enrollment||Participants|Count of Participants|424|424.0||||||
3691678|NCT02224846|3533535|B1|China||Region of Enrollment||Participants|Count of Participants|211|211.0||||||
3691679|NCT02224846|3533533|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691680|NCT02224846|3533534|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691681|NCT02224846|3533535|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691682|NCT02224846|3533533|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691683|NCT02224846|3533534|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691684|NCT02224846|3533535|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691685|NCT02224846|3533533|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691686|NCT02224846|3533534|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691687|NCT02224846|3533535|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691688|NCT02224846|3533533|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691689|NCT02224846|3533534|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691690|NCT02224846|3533535|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691691|NCT02224846|3533533|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691692|NCT02224846|3533534|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691693|NCT02224846|3533535|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691694|NCT02224846|3533533|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|635|635.0||||||
3691695|NCT02224846|3533534|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|424|424.0||||||
3691696|NCT02224846|3533535|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|211|211.0||||||
3691697|NCT02224846|3533533|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691698|NCT02224846|3533534|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691699|NCT02224846|3533535|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691700|NCT02224846|3533533|B3||Male|Sex: Female, Male||Participants|Count of Participants|635|635.0||||||
3691701|NCT02224846|3533534|B2||Male|Sex: Female, Male||Participants|Count of Participants|424|424.0||||||
3691702|NCT02224846|3533535|B1||Male|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
3691703|NCT02224846|3533533|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3691704|NCT02224846|3533534|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3691705|NCT02224846|3533535|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3691706|NCT02224846|3533533|B3|||Age||years|Mean|43.6|43.6|Standard Deviation|10.98|10.98|||
3691707|NCT02224846|3533534|B2|||Age||years|Mean|44.1|44.1|Standard Deviation|10.90|10.9|||
3691708|NCT02224846|3533535|B1|||Age||years|Mean|42.6|42.6|Standard Deviation|11.11|11.11|||
3691709|NCT02224820|3533556|B1|||Height||cm|Mean|172.3|172.3|Standard Deviation|9.7|9.7|||
3691710|NCT02224820|3533556|B1|||BMI||kg/mg^2|Mean|25.1|25.1|Standard Deviation|4.5|4.5|||
3691711|NCT02224820|3533556|B1|||Weight (kg)||kg|Mean|74.5|74.5|Standard Deviation|14.5|14.5|||
3691712|NCT02224820|3533556|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691713|NCT02224820|3533556|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691714|NCT02224820|3533556|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3691715|NCT02224820|3533556|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691716|NCT02224820|3533556|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691717|NCT02224820|3533556|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691718|NCT02224820|3533556|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691719|NCT02224820|3533556|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
3691720|NCT02224820|3533556|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
3691721|NCT02224820|3533556|B1|||Age||years|Mean|50.5|50.5|Standard Deviation|11.9|11.9|||
3691722|NCT02224729|3533564|B1|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3691723|NCT02224729|3533564|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691724|NCT02224729|3533564|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691725|NCT02224729|3533564|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3691726|NCT02224729|3533564|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3691727|NCT02224729|3533564|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691728|NCT02224729|3533564|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691729|NCT02224729|3533564|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691730|NCT02224729|3533564|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691731|NCT02224729|3533564|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3691732|NCT02224729|3533564|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3691733|NCT02224729|3533564|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3691734|NCT02224729|3533564|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3691735|NCT02224729|3533564|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3691736|NCT02224729|3533564|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3691737|NCT02224729|3533564|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3691738|NCT02224690|3533572|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3691739|NCT02224690|3533573|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3691740|NCT02224690|3533574|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3691741|NCT02224690|3533572|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3691742|NCT02224690|3533573|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3691743|NCT02224690|3533574|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3691744|NCT02224690|3533572|B3|||Age||years|Mean|15.381|15.381|Standard Deviation|9.2264|9.2264|||
3691745|NCT02224690|3533573|B2|||Age||years|Mean|15.284|15.284|Standard Deviation|9.7945|9.7945|||
3691746|NCT02224690|3533574|B1|||Age||years|Mean|15.478|15.478|Standard Deviation|8.685|8.685|||
3691747|NCT02224664|3533587|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3691748|NCT02224664|3533587|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3691749|NCT02224664|3533587|B1|||Age||years|Mean|64.2|64.2|Standard Deviation|6.9|6.9|||
3691750|NCT02224638|3533671|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3691751|NCT02224638|3533672|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3691752|NCT02224638|3533673|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3691753|NCT02224638|3533671|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3691754|NCT02224638|3533672|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3691755|NCT02224638|3533673|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3691756|NCT02224638|3533671|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3691757|NCT02224638|3533672|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3691758|NCT02224638|3533673|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3691759|NCT02224638|3533671|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3691760|NCT02224638|3533672|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3691761|NCT02224638|3533673|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3691762|NCT02224638|3533671|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3691763|NCT02224638|3533672|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3691764|NCT02224638|3533673|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3691765|NCT02224625|3533682|B1|United States||Region of Enrollment||participants|Number|249|249.0||||||
3691766|NCT02224625|3533682|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3691767|NCT02224625|3533682|B1||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3691768|NCT02224625|3533682|B1|||Age||years|Mean|38|38.0|Full Range|||16.0|77.0|
3691769|NCT02224625|3533682|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3691770|NCT02224625|3533682|B1||Between 18 and 65 years|Age||Participants|Count of Participants|226|226.0||||||
3691771|NCT02224625|3533682|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
3691772|NCT02224560|3533694|B4||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3691773|NCT02224560|3533695|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3691774|NCT02224560|3533696|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3691775|NCT02224560|3533697|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3691776|NCT02224560|3533694|B4||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3691777|NCT02224560|3533695|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3691778|NCT02224560|3533696|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3691779|NCT02224560|3533697|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3691780|NCT02224560|3533694|B4|||Age||years|Mean|15.6|15.6|Standard Deviation|9.8|9.8|||
3691781|NCT02224560|3533695|B3|||Age||years|Mean|15.3|15.3|Standard Deviation|9.3|9.3|||
3691782|NCT02224560|3533696|B2|||Age||years|Mean|15.4|15.4|Standard Deviation|9.5|9.5|||
3691783|NCT02224560|3533697|B1|||Age||years|Mean|16.0|16.0|Standard Deviation|10.8|10.8|||
3691784|NCT02224508|3533716|B3||Missing|Employment status||Participants|Count of Participants|1|1.0||||||
3691785|NCT02224508|3533717|B2||Missing|Employment status||Participants|Count of Participants|0|0.0||||||
3691786|NCT02224508|3533718|B1||Missing|Employment status||Participants|Count of Participants|1|1.0||||||
3691787|NCT02224508|3533716|B3||Other|Employment status||Participants|Count of Participants|43|43.0||||||
3691788|NCT02224508|3533717|B2||Other|Employment status||Participants|Count of Participants|15|15.0||||||
3691789|NCT02224508|3533718|B1||Other|Employment status||Participants|Count of Participants|28|28.0||||||
3691790|NCT02224508|3533716|B3||Retired|Employment status||Participants|Count of Participants|655|655.0||||||
3691791|NCT02224508|3533717|B2||Retired|Employment status||Participants|Count of Participants|245|245.0||||||
3691792|NCT02224508|3533718|B1||Retired|Employment status||Participants|Count of Participants|410|410.0||||||
3691793|NCT02224508|3533716|B3||Disabled|Employment status||Participants|Count of Participants|352|352.0||||||
3691794|NCT02224508|3533717|B2||Disabled|Employment status||Participants|Count of Participants|170|170.0||||||
3691795|NCT02224508|3533718|B1||Disabled|Employment status||Participants|Count of Participants|182|182.0||||||
3691796|NCT02224508|3533716|B3||Employed full time/part time|Employment status||Participants|Count of Participants|537|537.0||||||
3691797|NCT02224508|3533717|B2||Employed full time/part time|Employment status||Participants|Count of Participants|223|223.0||||||
3691798|NCT02224508|3533718|B1||Employed full time/part time|Employment status||Participants|Count of Participants|314|314.0||||||
3691799|NCT02224508|3533716|B3||Yes|Continuously enrolled in health plan for past 24 months||Participants|Count of Participants|1442|1442.0||||||
3691800|NCT02224508|3533717|B2||Yes|Continuously enrolled in health plan for past 24 months||Participants|Count of Participants|555|555.0||||||
3691801|NCT02224508|3533718|B1||Yes|Continuously enrolled in health plan for past 24 months||Participants|Count of Participants|887|887.0||||||
3691802|NCT02224508|3533716|B3||No|Continuously enrolled in health plan for past 24 months||Participants|Count of Participants|146|146.0||||||
3691803|NCT02224508|3533717|B2||No|Continuously enrolled in health plan for past 24 months||Participants|Count of Participants|98|98.0||||||
3691804|NCT02224508|3533718|B1||No|Continuously enrolled in health plan for past 24 months||Participants|Count of Participants|48|48.0||||||
3691805|NCT02224508|3533716|B3|120 milligrams or greater||Average daily opioid dose in morphine equivalents||Participants|Count of Participants|183|183.0||||||
3691806|NCT02224508|3533717|B2|120 milligrams or greater||Average daily opioid dose in morphine equivalents||Participants|Count of Participants|111|111.0||||||
3691807|NCT02224508|3533718|B1|120 milligrams or greater||Average daily opioid dose in morphine equivalents||Participants|Count of Participants|72|72.0||||||
3691808|NCT02224508|3533716|B3|50 to less than 120 milligrams||Average daily opioid dose in morphine equivalents||Participants|Count of Participants|349|349.0||||||
3691809|NCT02224508|3533717|B2|50 to less than 120 milligrams||Average daily opioid dose in morphine equivalents||Participants|Count of Participants|150|150.0||||||
3691810|NCT02224508|3533718|B1|50 to less than 120 milligrams||Average daily opioid dose in morphine equivalents||Participants|Count of Participants|199|199.0||||||
3691811|NCT02224508|3533716|B3|15 to less than 50 milligrams||Average daily opioid dose in morphine equivalents||Participants|Count of Participants|728|728.0||||||
3691812|NCT02224508|3533717|B2|15 to less than 50 milligrams||Average daily opioid dose in morphine equivalents||Participants|Count of Participants|296|296.0||||||
3691813|NCT02224508|3533718|B1|15 to less than 50 milligrams||Average daily opioid dose in morphine equivalents||Participants|Count of Participants|432|432.0||||||
3691814|NCT02224508|3533716|B3|Less than 15 milligrams||Average daily opioid dose in morphine equivalents||Participants|Count of Participants|326|326.0||||||
3691815|NCT02224508|3533717|B2|Less than 15 milligrams||Average daily opioid dose in morphine equivalents||Participants|Count of Participants|94|94.0||||||
3691816|NCT02224508|3533718|B1|Less than 15 milligrams||Average daily opioid dose in morphine equivalents||Participants|Count of Participants|232|232.0||||||
3691817|NCT02224508|3533716|B3|No opioid use||Average daily opioid dose in morphine equivalents||Participants|Count of Participants|2|2.0||||||
3691818|NCT02224508|3533717|B2|No opioid use||Average daily opioid dose in morphine equivalents||Participants|Count of Participants|2|2.0||||||
3691819|NCT02224508|3533718|B1|No opioid use||Average daily opioid dose in morphine equivalents||Participants|Count of Participants|0|0.0||||||
3691820|NCT02224508|3533716|B3|Yes||Received excess days supply of 20% or greater in any of past 4 quarters||Participants|Count of Participants|361|361.0||||||
3691821|NCT02224508|3533717|B2|Yes||Received excess days supply of 20% or greater in any of past 4 quarters||Participants|Count of Participants|160|160.0||||||
3691822|NCT02224508|3533718|B1|Yes||Received excess days supply of 20% or greater in any of past 4 quarters||Participants|Count of Participants|201|201.0||||||
3691823|NCT02224508|3533716|B3|No||Received excess days supply of 20% or greater in any of past 4 quarters||Participants|Count of Participants|1227|1227.0||||||
3691824|NCT02224508|3533717|B2|No||Received excess days supply of 20% or greater in any of past 4 quarters||Participants|Count of Participants|493|493.0||||||
3691825|NCT02224508|3533718|B1|No||Received excess days supply of 20% or greater in any of past 4 quarters||Participants|Count of Participants|734|734.0||||||
3691826|NCT02224508|3533716|B3|Yes||Hepatitis C or cirrhosis diagnosis||Participants|Count of Participants|130|130.0||||||
3691827|NCT02224508|3533717|B2|Yes||Hepatitis C or cirrhosis diagnosis||Participants|Count of Participants|46|46.0||||||
3691828|NCT02224508|3533718|B1|Yes||Hepatitis C or cirrhosis diagnosis||Participants|Count of Participants|84|84.0||||||
3691829|NCT02224508|3533716|B3|No||Hepatitis C or cirrhosis diagnosis||Participants|Count of Participants|1458|1458.0||||||
3691830|NCT02224508|3533717|B2|No||Hepatitis C or cirrhosis diagnosis||Participants|Count of Participants|607|607.0||||||
3691831|NCT02224508|3533718|B1|No||Hepatitis C or cirrhosis diagnosis||Participants|Count of Participants|851|851.0||||||
3691832|NCT02224508|3533716|B3|6 or greater||Charlson Comorbidity Score (past 12 months)|The Charlson Comorbidity Score (Romano version) is assessed from electronic health care data for the year prior to the index date. There are 19 sets of conditions, which prior research has shown predict mortality, that are assessed to develop the Charlson Comorbidity Score. Each set of conditions is assigned a weighted score, depending on the estimated risk of subsequent mortality. The Charlson Comorbidity Score also predicts hospitalization risk. The possible total score ranges from 0 to 37, with higher scores indicating greater comorbidity and higher risk of dying.|Participants|Count of Participants|134|134.0||||||
3691833|NCT02224508|3533717|B2|6 or greater||Charlson Comorbidity Score (past 12 months)|The Charlson Comorbidity Score (Romano version) is assessed from electronic health care data for the year prior to the index date. There are 19 sets of conditions, which prior research has shown predict mortality, that are assessed to develop the Charlson Comorbidity Score. Each set of conditions is assigned a weighted score, depending on the estimated risk of subsequent mortality. The Charlson Comorbidity Score also predicts hospitalization risk. The possible total score ranges from 0 to 37, with higher scores indicating greater comorbidity and higher risk of dying.|Participants|Count of Participants|39|39.0||||||
3691834|NCT02224508|3533718|B1|6 or greater||Charlson Comorbidity Score (past 12 months)|The Charlson Comorbidity Score (Romano version) is assessed from electronic health care data for the year prior to the index date. There are 19 sets of conditions, which prior research has shown predict mortality, that are assessed to develop the Charlson Comorbidity Score. Each set of conditions is assigned a weighted score, depending on the estimated risk of subsequent mortality. The Charlson Comorbidity Score also predicts hospitalization risk. The possible total score ranges from 0 to 37, with higher scores indicating greater comorbidity and higher risk of dying.|Participants|Count of Participants|95|95.0||||||
3691835|NCT02224508|3533716|B3|3-5||Charlson Comorbidity Score (past 12 months)|The Charlson Comorbidity Score (Romano version) is assessed from electronic health care data for the year prior to the index date. There are 19 sets of conditions, which prior research has shown predict mortality, that are assessed to develop the Charlson Comorbidity Score. Each set of conditions is assigned a weighted score, depending on the estimated risk of subsequent mortality. The Charlson Comorbidity Score also predicts hospitalization risk. The possible total score ranges from 0 to 37, with higher scores indicating greater comorbidity and higher risk of dying.|Participants|Count of Participants|322|322.0||||||
3691836|NCT02224508|3533717|B2|3-5||Charlson Comorbidity Score (past 12 months)|The Charlson Comorbidity Score (Romano version) is assessed from electronic health care data for the year prior to the index date. There are 19 sets of conditions, which prior research has shown predict mortality, that are assessed to develop the Charlson Comorbidity Score. Each set of conditions is assigned a weighted score, depending on the estimated risk of subsequent mortality. The Charlson Comorbidity Score also predicts hospitalization risk. The possible total score ranges from 0 to 37, with higher scores indicating greater comorbidity and higher risk of dying.|Participants|Count of Participants|127|127.0||||||
3691837|NCT02224508|3533718|B1|3-5||Charlson Comorbidity Score (past 12 months)|The Charlson Comorbidity Score (Romano version) is assessed from electronic health care data for the year prior to the index date. There are 19 sets of conditions, which prior research has shown predict mortality, that are assessed to develop the Charlson Comorbidity Score. Each set of conditions is assigned a weighted score, depending on the estimated risk of subsequent mortality. The Charlson Comorbidity Score also predicts hospitalization risk. The possible total score ranges from 0 to 37, with higher scores indicating greater comorbidity and higher risk of dying.|Participants|Count of Participants|195|195.0||||||
3691838|NCT02224508|3533716|B3|2||Charlson Comorbidity Score (past 12 months)|The Charlson Comorbidity Score (Romano version) is assessed from electronic health care data for the year prior to the index date. There are 19 sets of conditions, which prior research has shown predict mortality, that are assessed to develop the Charlson Comorbidity Score. Each set of conditions is assigned a weighted score, depending on the estimated risk of subsequent mortality. The Charlson Comorbidity Score also predicts hospitalization risk. The possible total score ranges from 0 to 37, with higher scores indicating greater comorbidity and higher risk of dying.|Participants|Count of Participants|251|251.0||||||
3691839|NCT02224508|3533717|B2|2||Charlson Comorbidity Score (past 12 months)|The Charlson Comorbidity Score (Romano version) is assessed from electronic health care data for the year prior to the index date. There are 19 sets of conditions, which prior research has shown predict mortality, that are assessed to develop the Charlson Comorbidity Score. Each set of conditions is assigned a weighted score, depending on the estimated risk of subsequent mortality. The Charlson Comorbidity Score also predicts hospitalization risk. The possible total score ranges from 0 to 37, with higher scores indicating greater comorbidity and higher risk of dying.|Participants|Count of Participants|107|107.0||||||
3691840|NCT02224508|3533718|B1|2||Charlson Comorbidity Score (past 12 months)|The Charlson Comorbidity Score (Romano version) is assessed from electronic health care data for the year prior to the index date. There are 19 sets of conditions, which prior research has shown predict mortality, that are assessed to develop the Charlson Comorbidity Score. Each set of conditions is assigned a weighted score, depending on the estimated risk of subsequent mortality. The Charlson Comorbidity Score also predicts hospitalization risk. The possible total score ranges from 0 to 37, with higher scores indicating greater comorbidity and higher risk of dying.|Participants|Count of Participants|144|144.0||||||
3691841|NCT02224508|3533716|B3|1||Charlson Comorbidity Score (past 12 months)|The Charlson Comorbidity Score (Romano version) is assessed from electronic health care data for the year prior to the index date. There are 19 sets of conditions, which prior research has shown predict mortality, that are assessed to develop the Charlson Comorbidity Score. Each set of conditions is assigned a weighted score, depending on the estimated risk of subsequent mortality. The Charlson Comorbidity Score also predicts hospitalization risk. The possible total score ranges from 0 to 37, with higher scores indicating greater comorbidity and higher risk of dying.|Participants|Count of Participants|148|148.0||||||
3691842|NCT02224508|3533717|B2|1||Charlson Comorbidity Score (past 12 months)|The Charlson Comorbidity Score (Romano version) is assessed from electronic health care data for the year prior to the index date. There are 19 sets of conditions, which prior research has shown predict mortality, that are assessed to develop the Charlson Comorbidity Score. Each set of conditions is assigned a weighted score, depending on the estimated risk of subsequent mortality. The Charlson Comorbidity Score also predicts hospitalization risk. The possible total score ranges from 0 to 37, with higher scores indicating greater comorbidity and higher risk of dying.|Participants|Count of Participants|73|73.0||||||
3691843|NCT02224508|3533718|B1|1||Charlson Comorbidity Score (past 12 months)|The Charlson Comorbidity Score (Romano version) is assessed from electronic health care data for the year prior to the index date. There are 19 sets of conditions, which prior research has shown predict mortality, that are assessed to develop the Charlson Comorbidity Score. Each set of conditions is assigned a weighted score, depending on the estimated risk of subsequent mortality. The Charlson Comorbidity Score also predicts hospitalization risk. The possible total score ranges from 0 to 37, with higher scores indicating greater comorbidity and higher risk of dying.|Participants|Count of Participants|75|75.0||||||
3691844|NCT02224508|3533716|B3|0||Charlson Comorbidity Score (past 12 months)|The Charlson Comorbidity Score (Romano version) is assessed from electronic health care data for the year prior to the index date. There are 19 sets of conditions, which prior research has shown predict mortality, that are assessed to develop the Charlson Comorbidity Score. Each set of conditions is assigned a weighted score, depending on the estimated risk of subsequent mortality. The Charlson Comorbidity Score also predicts hospitalization risk. The possible total score ranges from 0 to 37, with higher scores indicating greater comorbidity and higher risk of dying.|Participants|Count of Participants|733|733.0||||||
3691845|NCT02224508|3533717|B2|0||Charlson Comorbidity Score (past 12 months)|The Charlson Comorbidity Score (Romano version) is assessed from electronic health care data for the year prior to the index date. There are 19 sets of conditions, which prior research has shown predict mortality, that are assessed to develop the Charlson Comorbidity Score. Each set of conditions is assigned a weighted score, depending on the estimated risk of subsequent mortality. The Charlson Comorbidity Score also predicts hospitalization risk. The possible total score ranges from 0 to 37, with higher scores indicating greater comorbidity and higher risk of dying.|Participants|Count of Participants|307|307.0||||||
3691846|NCT02224508|3533718|B1|0||Charlson Comorbidity Score (past 12 months)|The Charlson Comorbidity Score (Romano version) is assessed from electronic health care data for the year prior to the index date. There are 19 sets of conditions, which prior research has shown predict mortality, that are assessed to develop the Charlson Comorbidity Score. Each set of conditions is assigned a weighted score, depending on the estimated risk of subsequent mortality. The Charlson Comorbidity Score also predicts hospitalization risk. The possible total score ranges from 0 to 37, with higher scores indicating greater comorbidity and higher risk of dying.|Participants|Count of Participants|426|426.0||||||
3691847|NCT02224508|3533716|B3|Missing||Marital status||Participants|Count of Participants|3|3.0||||||
3691848|NCT02224508|3533717|B2|Missing||Marital status||Participants|Count of Participants|1|1.0||||||
3691849|NCT02224508|3533718|B1|Missing||Marital status||Participants|Count of Participants|2|2.0||||||
3691850|NCT02224508|3533716|B3|Married||Marital status||Participants|Count of Participants|1053|1053.0||||||
3691851|NCT02224508|3533717|B2|Married||Marital status||Participants|Count of Participants|438|438.0||||||
3691852|NCT02224508|3533718|B1|Married||Marital status||Participants|Count of Participants|615|615.0||||||
3691853|NCT02224508|3533716|B3|Not married||Marital status||Participants|Count of Participants|532|532.0||||||
3691854|NCT02224508|3533717|B2|Not married||Marital status||Participants|Count of Participants|214|214.0||||||
3691855|NCT02224508|3533718|B1|Not married||Marital status||Participants|Count of Participants|318|318.0||||||
3691856|NCT02224508|3533716|B3|Western Washington||Location in Washington State||Participants|Count of Participants|1051|1051.0||||||
3691857|NCT02224508|3533717|B2|Western Washington||Location in Washington State||Participants|Count of Participants|358|358.0||||||
3691858|NCT02224508|3533718|B1|Western Washington||Location in Washington State||Participants|Count of Participants|693|693.0||||||
3691859|NCT02224508|3533716|B3|Eastern Washington||Location in Washington State||Participants|Count of Participants|537|537.0||||||
3691860|NCT02224508|3533717|B2|Eastern Washington||Location in Washington State||Participants|Count of Participants|295|295.0||||||
3691861|NCT02224508|3533718|B1|Eastern Washington||Location in Washington State||Participants|Count of Participants|242|242.0||||||
3691862|NCT02224508|3533716|B3|Yes||Tobacco use disorder diagnosis, past 36 months||Participants|Count of Participants|375|375.0||||||
3691863|NCT02224508|3533717|B2|Yes||Tobacco use disorder diagnosis, past 36 months||Participants|Count of Participants|151|151.0||||||
3691864|NCT02224508|3533718|B1|Yes||Tobacco use disorder diagnosis, past 36 months||Participants|Count of Participants|224|224.0||||||
3691865|NCT02224508|3533716|B3|No||Tobacco use disorder diagnosis, past 36 months||Participants|Count of Participants|1213|1213.0||||||
3691866|NCT02224508|3533717|B2|No||Tobacco use disorder diagnosis, past 36 months||Participants|Count of Participants|502|502.0||||||
3691867|NCT02224508|3533718|B1|No||Tobacco use disorder diagnosis, past 36 months||Participants|Count of Participants|711|711.0||||||
3691868|NCT02224508|3533716|B3|Yes||Opioid drug use disorder diagnosis, past 36 months||Participants|Count of Participants|177|177.0||||||
3691869|NCT02224508|3533717|B2|Yes||Opioid drug use disorder diagnosis, past 36 months||Participants|Count of Participants|76|76.0||||||
3691870|NCT02224508|3533718|B1|Yes||Opioid drug use disorder diagnosis, past 36 months||Participants|Count of Participants|101|101.0||||||
3691871|NCT02224508|3533716|B3|No||Opioid drug use disorder diagnosis, past 36 months||Participants|Count of Participants|1411|1411.0||||||
3691872|NCT02224508|3533717|B2|No||Opioid drug use disorder diagnosis, past 36 months||Participants|Count of Participants|577|577.0||||||
3691873|NCT02224508|3533718|B1|No||Opioid drug use disorder diagnosis, past 36 months||Participants|Count of Participants|834|834.0||||||
3691874|NCT02224508|3533716|B3|Yes||Non-opioid drug use disorder diagnosis past 36 months||Participants|Count of Participants|123|123.0||||||
3691875|NCT02224508|3533717|B2|Yes||Non-opioid drug use disorder diagnosis past 36 months||Participants|Count of Participants|34|34.0||||||
3691876|NCT02224508|3533718|B1|Yes||Non-opioid drug use disorder diagnosis past 36 months||Participants|Count of Participants|89|89.0||||||
3691877|NCT02224508|3533716|B3|No||Non-opioid drug use disorder diagnosis past 36 months||Participants|Count of Participants|1465|1465.0||||||
3691878|NCT02224508|3533717|B2|No||Non-opioid drug use disorder diagnosis past 36 months||Participants|Count of Participants|619|619.0||||||
3691879|NCT02224508|3533718|B1|No||Non-opioid drug use disorder diagnosis past 36 months||Participants|Count of Participants|846|846.0||||||
3691880|NCT02224508|3533716|B3||Yes|Alcohol use disorder, past 36 months||Participants|Count of Participants|82|82.0||||||
3691881|NCT02224508|3533717|B2||Yes|Alcohol use disorder, past 36 months||Participants|Count of Participants|32|32.0||||||
3691882|NCT02224508|3533718|B1||Yes|Alcohol use disorder, past 36 months||Participants|Count of Participants|50|50.0||||||
3691883|NCT02224508|3533716|B3||No|Alcohol use disorder, past 36 months||Participants|Count of Participants|1506|1506.0||||||
3691884|NCT02224508|3533717|B2||No|Alcohol use disorder, past 36 months||Participants|Count of Participants|621|621.0||||||
3691885|NCT02224508|3533718|B1||No|Alcohol use disorder, past 36 months||Participants|Count of Participants|885|885.0||||||
3691886|NCT02224508|3533716|B3||Yes|Mental disorder diagnosis past 36 months||Participants|Count of Participants|1046|1046.0||||||
3691887|NCT02224508|3533717|B2||Yes|Mental disorder diagnosis past 36 months||Participants|Count of Participants|423|423.0||||||
3691888|NCT02224508|3533718|B1||Yes|Mental disorder diagnosis past 36 months||Participants|Count of Participants|623|623.0||||||
3691889|NCT02224508|3533716|B3||No|Mental disorder diagnosis past 36 months||Participants|Count of Participants|542|542.0||||||
3691890|NCT02224508|3533717|B2||No|Mental disorder diagnosis past 36 months||Participants|Count of Participants|230|230.0||||||
3691891|NCT02224508|3533718|B1||No|Mental disorder diagnosis past 36 months||Participants|Count of Participants|312|312.0||||||
3691892|NCT02224508|3533716|B3||Missing|Education||Participants|Count of Participants|3|3.0||||||
3691893|NCT02224508|3533717|B2||Missing|Education||Participants|Count of Participants|2|2.0||||||
3691894|NCT02224508|3533718|B1||Missing|Education||Participants|Count of Participants|1|1.0||||||
3691895|NCT02224508|3533716|B3||College graduate or post-college graduate|Education||Participants|Count of Participants|407|407.0||||||
3691896|NCT02224508|3533717|B2||College graduate or post-college graduate|Education||Participants|Count of Participants|152|152.0||||||
3691897|NCT02224508|3533718|B1||College graduate or post-college graduate|Education||Participants|Count of Participants|255|255.0||||||
3691898|NCT02224508|3533716|B3||Some college or technical school|Education||Participants|Count of Participants|732|732.0||||||
3691899|NCT02224508|3533717|B2||Some college or technical school|Education||Participants|Count of Participants|296|296.0||||||
3691900|NCT02224508|3533718|B1||Some college or technical school|Education||Participants|Count of Participants|436|436.0||||||
3691901|NCT02224508|3533716|B3||High school graduate or less|Education||Participants|Count of Participants|446|446.0||||||
3691902|NCT02224508|3533717|B2||High school graduate or less|Education||Participants|Count of Participants|203|203.0||||||
3691903|NCT02224508|3533718|B1||High school graduate or less|Education||Participants|Count of Participants|243|243.0||||||
3691904|NCT02224508|3533716|B3||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3691905|NCT02224508|3533717|B2||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3691906|NCT02224508|3533718|B1||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3691907|NCT02224508|3533716|B3||Multiple or other|Race/Ethnicity, Customized||Participants|Count of Participants|137|137.0||||||
3691908|NCT02224508|3533717|B2||Multiple or other|Race/Ethnicity, Customized||Participants|Count of Participants|54|54.0||||||
3691909|NCT02224508|3533718|B1||Multiple or other|Race/Ethnicity, Customized||Participants|Count of Participants|83|83.0||||||
3691910|NCT02224508|3533716|B3||Native American|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3691911|NCT02224508|3533717|B2||Native American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3691912|NCT02224508|3533718|B1||Native American|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3691913|NCT02224508|3533716|B3||Asian/Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3691914|NCT02224508|3533717|B2||Asian/Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3691915|NCT02224508|3533718|B1||Asian/Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3691916|NCT02224508|3533716|B3||African American|Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3691917|NCT02224508|3533717|B2||African American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3691918|NCT02224508|3533718|B1||African American|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3691919|NCT02224508|3533716|B3||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|1380|1380.0||||||
3691920|NCT02224508|3533717|B2||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|576|576.0||||||
3691921|NCT02224508|3533718|B1||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|804|804.0||||||
3691922|NCT02224508|3533716|B3||Male|Sex: Female, Male||Participants|Count of Participants|579|579.0||||||
3691923|NCT02224508|3533717|B2||Male|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
3691924|NCT02224508|3533718|B1||Male|Sex: Female, Male||Participants|Count of Participants|346|346.0||||||
3691925|NCT02224508|3533716|B3||Female|Sex: Female, Male||Participants|Count of Participants|1009|1009.0||||||
3691926|NCT02224508|3533717|B2||Female|Sex: Female, Male||Participants|Count of Participants|420|420.0||||||
3691927|NCT02224508|3533718|B1||Female|Sex: Female, Male||Participants|Count of Participants|589|589.0||||||
3691928|NCT02224508|3533716|B3|||Age||years|Mean|62.0|62.0|Standard Deviation|12.1|12.1|||
3691929|NCT02224508|3533717|B2|||Age||years|Mean|61.0|61.0|Standard Deviation|12.1|12.1|||
3691930|NCT02224508|3533718|B1|||Age||years|Mean|62.6|62.6|Standard Deviation|12.1|12.1|||
3691931|NCT02224508|3533716|B3||>=65 years|Age||Participants|Count of Participants|666|666.0||||||
3691932|NCT02224508|3533717|B2||>=65 years|Age||Participants|Count of Participants|238|238.0||||||
3691933|NCT02224508|3533718|B1||>=65 years|Age||Participants|Count of Participants|428|428.0||||||
3691934|NCT02224508|3533716|B3||Between 18 and 65 years|Age||Participants|Count of Participants|922|922.0||||||
3691935|NCT02224508|3533717|B2||Between 18 and 65 years|Age||Participants|Count of Participants|415|415.0||||||
3691936|NCT02224508|3533718|B1||Between 18 and 65 years|Age||Participants|Count of Participants|507|507.0||||||
3691937|NCT02224508|3533716|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3691938|NCT02224508|3533717|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3691939|NCT02224508|3533718|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3691940|NCT02224404|3533729|B1|Finland||Region of Enrollment||participants|Number|7|7.0||||||
3691941|NCT02224404|3533729|B1|Belgium||Region of Enrollment||participants|Number|14|14.0||||||
3691942|NCT02224404|3533729|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3691943|NCT02224404|3533729|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3691944|NCT02224404|3533729|B1|||Age||years|Mean|69.7|69.7|Standard Deviation|19.9|19.9|||
3691945|NCT02224053|3533734|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3691946|NCT02224053|3533734|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3691947|NCT02224053|3533734|B1|||Age||Years|Mean|34.0|34.0|Standard Deviation|11.08|11.08|||
3691948|NCT02223871|3533766|B1|Native Hawaiian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3691949|NCT02223871|3533766|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3691950|NCT02223871|3533766|B1|Indian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3691951|NCT02223871|3533766|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3691952|NCT02223871|3533766|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3691953|NCT02223871|3533766|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3691954|NCT02223871|3533766|B1|||Age||Years|Mean|24.1|24.1|Full Range|||19.0|38.0|
3691955|NCT02223754|3533778|B3|United States||Region of Enrollment||participants|Number|322|322.0||||||
3691956|NCT02223754|3533779|B2|United States||Region of Enrollment||participants|Number|159|159.0||||||
3691957|NCT02223754|3533780|B1|United States||Region of Enrollment||participants|Number|163|163.0||||||
3691958|NCT02223754|3533778|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3691959|NCT02223754|3533779|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3691960|NCT02223754|3533780|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3691961|NCT02223754|3533778|B3|White||Race/Ethnicity, Customized||participants|Number|291|291.0||||||
3691962|NCT02223754|3533779|B2|White||Race/Ethnicity, Customized||participants|Number|144|144.0||||||
3691963|NCT02223754|3533780|B1|White||Race/Ethnicity, Customized||participants|Number|147|147.0||||||
3692105|NCT02223429|3533854|B3|||Age||years|Mean|32.25|32.25|Standard Deviation|5.75|5.75|||
3691964|NCT02223754|3533778|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3691965|NCT02223754|3533779|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3691966|NCT02223754|3533780|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3691967|NCT02223754|3533778|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3691968|NCT02223754|3533779|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3691969|NCT02223754|3533780|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3691970|NCT02223754|3533778|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3691971|NCT02223754|3533779|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3691972|NCT02223754|3533780|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3691973|NCT02223754|3533778|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3691974|NCT02223754|3533779|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3691975|NCT02223754|3533780|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3691976|NCT02223754|3533778|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3691977|NCT02223754|3533779|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3691978|NCT02223754|3533780|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3691979|NCT02223754|3533778|B3||Female|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
3691980|NCT02223754|3533779|B2||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3691981|NCT02223754|3533780|B1||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3691982|NCT02223754|3533778|B3|Myopes, N=104, N=106, N=210||Age||years|Mean|49.4|49.4|Standard Deviation|5.92|5.92|||
3691983|NCT02223754|3533779|B2|Myopes, N=104, N=106, N=210||Age||years|Mean|49.5|49.5|Standard Deviation|5.77|5.77|||
3691984|NCT02223754|3533780|B1|Myopes, N=104, N=106, N=210||Age||years|Mean|49.3|49.3|Standard Deviation|6.10|6.1|||
3691985|NCT02223754|3533778|B3|Hyperopes, N=59, N=53, N=112||Age||years|Mean|52.1|52.1|Standard Deviation|6.78|6.78|||
3691986|NCT02223754|3533779|B2|Hyperopes, N=59, N=53, N=112||Age||years|Mean|51.9|51.9|Standard Deviation|7.04|7.04|||
3691987|NCT02223754|3533780|B1|Hyperopes, N=59, N=53, N=112||Age||years|Mean|52.3|52.3|Standard Deviation|6.59|6.59|||
3691988|NCT02223715|3533801|B1|Taiwan||Region of Enrollment||participants|Number|99|99.0||||||
3691989|NCT02223715|3533801|B1|Korea, Republic of||Region of Enrollment||participants|Number|99|99.0||||||
3691990|NCT02223715|3533801|B1|Malaysia||Region of Enrollment||participants|Number|2|2.0||||||
3691991|NCT02223715|3533801|B1|Vietnam||Region of Enrollment||participants|Number|64|64.0||||||
3691992|NCT02223715|3533801|B1|Thailand||Region of Enrollment||participants|Number|44|44.0||||||
3691993|NCT02223715|3533801|B1|Singapore||Region of Enrollment||participants|Number|66|66.0||||||
3691994|NCT02223715|3533801|B1|Philippines||Region of Enrollment||participants|Number|9|9.0||||||
3691995|NCT02223715|3533801|B1|Indonesia||Region of Enrollment||participants|Number|7|7.0||||||
3691996|NCT02223715|3533801|B1|India||Region of Enrollment||participants|Number|2|2.0||||||
3691997|NCT02223715|3533801|B1|Hong Kong||Region of Enrollment||participants|Number|36|36.0||||||
3691998|NCT02223715|3533801|B1|China||Region of Enrollment||participants|Number|64|64.0||||||
3691999|NCT02223715|3533801|B1|Australia||Region of Enrollment||participants|Number|60|60.0||||||
3692000|NCT02223715|3533801|B1|Japan||Region of Enrollment||participants|Number|48|48.0||||||
3692001|NCT02223715|3533801|B1||Male|Sex: Female, Male||Participants|Count of Participants|328|328.0||||||
3692002|NCT02223715|3533801|B1||Female|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
3692003|NCT02223715|3533801|B1|||Age||years|Median|63.0|63.0|Inter-Quartile Range|||45.0|75.0|
3692004|NCT02223715|3533801|B1||>=65 years|Age||Participants|Count of Participants|280|280.0||||||
3692005|NCT02223715|3533801|B1||Between 18 and 65 years|Age||Participants|Count of Participants|241|241.0||||||
3692006|NCT02223715|3533801|B1||<=18 years|Age||Participants|Count of Participants|79|79.0||||||
3692007|NCT02223702|3533808|B3|Turkey||Region of Enrollment||participants|Number|39|39.0||||||
3692008|NCT02223702|3533809|B2|Turkey||Region of Enrollment||participants|Number|19|19.0||||||
3692009|NCT02223702|3533810|B1|Turkey||Region of Enrollment||participants|Number|20|20.0||||||
3692010|NCT02223702|3533808|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3692011|NCT02223702|3533809|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3692012|NCT02223702|3533810|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3692013|NCT02223702|3533808|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3692014|NCT02223702|3533809|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3692015|NCT02223702|3533810|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3692016|NCT02223702|3533808|B3|years (older than 18 years, younger than 35 years)||Age, Customized||participants|Number|39|39.0||||||
3692017|NCT02223702|3533809|B2|years (older than 18 years, younger than 35 years)||Age, Customized||participants|Number|19|19.0||||||
3692018|NCT02223702|3533810|B1|years (older than 18 years, younger than 35 years)||Age, Customized||participants|Number|20|20.0||||||
3692019|NCT02223650|3533819|B3|>6.0||Accommodative convergence over accommodation (AC/A) ratio|Accommodative convergence over accommodation (AC/A) ratio calculated by taking the difference between the distance (6m) Prism Alternate Cover Test measurements with the participant wearing habitual correction and with the participant wearing -2.00D lenses over the habitual correction, and dividing the difference by 2.|participants|Number|6|6.0||||||
3692106|NCT02223429|3533855|B2|||Age||years|Mean|31.88|31.88|Standard Deviation|4.61|4.61|||
3692020|NCT02223650|3533820|B2|>6.0||Accommodative convergence over accommodation (AC/A) ratio|Accommodative convergence over accommodation (AC/A) ratio calculated by taking the difference between the distance (6m) Prism Alternate Cover Test measurements with the participant wearing habitual correction and with the participant wearing -2.00D lenses over the habitual correction, and dividing the difference by 2.|participants|Number|3|3.0||||||
3692021|NCT02223650|3533821|B1|>6.0||Accommodative convergence over accommodation (AC/A) ratio|Accommodative convergence over accommodation (AC/A) ratio calculated by taking the difference between the distance (6m) Prism Alternate Cover Test measurements with the participant wearing habitual correction and with the participant wearing -2.00D lenses over the habitual correction, and dividing the difference by 2.|participants|Number|3|3.0||||||
3692022|NCT02223650|3533819|B3|2.5 to 6.0||Accommodative convergence over accommodation (AC/A) ratio|Accommodative convergence over accommodation (AC/A) ratio calculated by taking the difference between the distance (6m) Prism Alternate Cover Test measurements with the participant wearing habitual correction and with the participant wearing -2.00D lenses over the habitual correction, and dividing the difference by 2.|participants|Number|27|27.0||||||
3692023|NCT02223650|3533820|B2|2.5 to 6.0||Accommodative convergence over accommodation (AC/A) ratio|Accommodative convergence over accommodation (AC/A) ratio calculated by taking the difference between the distance (6m) Prism Alternate Cover Test measurements with the participant wearing habitual correction and with the participant wearing -2.00D lenses over the habitual correction, and dividing the difference by 2.|participants|Number|15|15.0||||||
3692024|NCT02223650|3533821|B1|2.5 to 6.0||Accommodative convergence over accommodation (AC/A) ratio|Accommodative convergence over accommodation (AC/A) ratio calculated by taking the difference between the distance (6m) Prism Alternate Cover Test measurements with the participant wearing habitual correction and with the participant wearing -2.00D lenses over the habitual correction, and dividing the difference by 2.|participants|Number|12|12.0||||||
3692025|NCT02223650|3533819|B3|<2.5||Accommodative convergence over accommodation (AC/A) ratio|Accommodative convergence over accommodation (AC/A) ratio calculated by taking the difference between the distance (6m) Prism Alternate Cover Test measurements with the participant wearing habitual correction and with the participant wearing -2.00D lenses over the habitual correction, and dividing the difference by 2.|participants|Number|25|25.0||||||
3692026|NCT02223650|3533820|B2|<2.5||Accommodative convergence over accommodation (AC/A) ratio|Accommodative convergence over accommodation (AC/A) ratio calculated by taking the difference between the distance (6m) Prism Alternate Cover Test measurements with the participant wearing habitual correction and with the participant wearing -2.00D lenses over the habitual correction, and dividing the difference by 2.|participants|Number|13|13.0||||||
3692027|NCT02223650|3533821|B1|<2.5||Accommodative convergence over accommodation (AC/A) ratio|Accommodative convergence over accommodation (AC/A) ratio calculated by taking the difference between the distance (6m) Prism Alternate Cover Test measurements with the participant wearing habitual correction and with the participant wearing -2.00D lenses over the habitual correction, and dividing the difference by 2.|participants|Number|12|12.0||||||
3692028|NCT02223650|3533819|B3|<=-3.00||Refractive error in more myopic eye (spherical equivalent, D)||participants|Number|2|2.0||||||
3692029|NCT02223650|3533820|B2|<=-3.00||Refractive error in more myopic eye (spherical equivalent, D)||participants|Number|1|1.0||||||
3692030|NCT02223650|3533821|B1|<=-3.00||Refractive error in more myopic eye (spherical equivalent, D)||participants|Number|1|1.0||||||
3692031|NCT02223650|3533819|B3|-2.50 to >-3.00||Refractive error in more myopic eye (spherical equivalent, D)||participants|Number|2|2.0||||||
3692032|NCT02223650|3533820|B2|-2.50 to >-3.00||Refractive error in more myopic eye (spherical equivalent, D)||participants|Number|2|2.0||||||
3692033|NCT02223650|3533821|B1|-2.50 to >-3.00||Refractive error in more myopic eye (spherical equivalent, D)||participants|Number|0|0.0||||||
3692034|NCT02223650|3533819|B3|-2.00 to >-2.50||Refractive error in more myopic eye (spherical equivalent, D)||participants|Number|2|2.0||||||
3692035|NCT02223650|3533820|B2|-2.00 to >-2.50||Refractive error in more myopic eye (spherical equivalent, D)||participants|Number|2|2.0||||||
3692036|NCT02223650|3533821|B1|-2.00 to >-2.50||Refractive error in more myopic eye (spherical equivalent, D)||participants|Number|0|0.0||||||
3692037|NCT02223650|3533819|B3|-1.50 to >-2.00||Refractive error in more myopic eye (spherical equivalent, D)||participants|Number|1|1.0||||||
3692038|NCT02223650|3533820|B2|-1.50 to >-2.00||Refractive error in more myopic eye (spherical equivalent, D)||participants|Number|0|0.0||||||
3692039|NCT02223650|3533821|B1|-1.50 to >-2.00||Refractive error in more myopic eye (spherical equivalent, D)||participants|Number|1|1.0||||||
3692040|NCT02223650|3533819|B3|-1.00 to >-1.50||Refractive error in more myopic eye (spherical equivalent, D)||participants|Number|1|1.0||||||
3692041|NCT02223650|3533820|B2|-1.00 to >-1.50||Refractive error in more myopic eye (spherical equivalent, D)||participants|Number|0|0.0||||||
3692042|NCT02223650|3533821|B1|-1.00 to >-1.50||Refractive error in more myopic eye (spherical equivalent, D)||participants|Number|1|1.0||||||
3692043|NCT02223650|3533819|B3|-0.50 to >-1.00||Refractive error in more myopic eye (spherical equivalent, D)||participants|Number|5|5.0||||||
3692044|NCT02223650|3533820|B2|-0.50 to >-1.00||Refractive error in more myopic eye (spherical equivalent, D)||participants|Number|1|1.0||||||
3692045|NCT02223650|3533821|B1|-0.50 to >-1.00||Refractive error in more myopic eye (spherical equivalent, D)||participants|Number|4|4.0||||||
3692046|NCT02223650|3533819|B3|<0 to >-0.50||Refractive error in more myopic eye (spherical equivalent, D)||participants|Number|3|3.0||||||
3692047|NCT02223650|3533820|B2|<0 to >-0.50||Refractive error in more myopic eye (spherical equivalent, D)||participants|Number|1|1.0||||||
3692048|NCT02223650|3533821|B1|<0 to >-0.50||Refractive error in more myopic eye (spherical equivalent, D)||participants|Number|2|2.0||||||
3692049|NCT02223650|3533819|B3|0 to +0.50||Refractive error in more myopic eye (spherical equivalent, D)||participants|Number|14|14.0||||||
3692050|NCT02223650|3533820|B2|0 to +0.50||Refractive error in more myopic eye (spherical equivalent, D)||participants|Number|9|9.0||||||
3692051|NCT02223650|3533821|B1|0 to +0.50||Refractive error in more myopic eye (spherical equivalent, D)||participants|Number|5|5.0||||||
3692052|NCT02223650|3533819|B3|>+0.50 to +1.00||Refractive error in more myopic eye (spherical equivalent, D)||participants|Number|28|28.0||||||
3692053|NCT02223650|3533820|B2|>+0.50 to +1.00||Refractive error in more myopic eye (spherical equivalent, D)||participants|Number|15|15.0||||||
3692054|NCT02223650|3533821|B1|>+0.50 to +1.00||Refractive error in more myopic eye (spherical equivalent, D)||participants|Number|13|13.0||||||
3692055|NCT02223650|3533819|B3|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3692056|NCT02223650|3533820|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3692057|NCT02223650|3533821|B1|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3692058|NCT02223650|3533819|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3692059|NCT02223650|3533820|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3692060|NCT02223650|3533821|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3692061|NCT02223650|3533819|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3692062|NCT02223650|3533820|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3692063|NCT02223650|3533821|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3692064|NCT02223650|3533819|B3|White||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3692065|NCT02223650|3533820|B2|White||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3692066|NCT02223650|3533821|B1|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3692067|NCT02223650|3533819|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3692068|NCT02223650|3533820|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3692069|NCT02223650|3533821|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3692070|NCT02223650|3533819|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3692071|NCT02223650|3533820|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3692072|NCT02223650|3533821|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3692073|NCT02223650|3533819|B3|6 to <7 years||Age, Customized|Baseline age reflects age at randomization. The age eligibility requirement at enrollment was 3 to <7 years old.|participants|Number|14|14.0||||||
3692074|NCT02223650|3533820|B2|6 to <7 years||Age, Customized|Baseline age reflects age at randomization. The age eligibility requirement at enrollment was 3 to <7 years old.|participants|Number|7|7.0||||||
3692075|NCT02223650|3533821|B1|6 to <7 years||Age, Customized|Baseline age reflects age at randomization. The age eligibility requirement at enrollment was 3 to <7 years old.|participants|Number|7|7.0||||||
3692076|NCT02223650|3533819|B3|5 to <6 years||Age, Customized|Baseline age reflects age at randomization. The age eligibility requirement at enrollment was 3 to <7 years old.|participants|Number|19|19.0||||||
3692077|NCT02223650|3533820|B2|5 to <6 years||Age, Customized|Baseline age reflects age at randomization. The age eligibility requirement at enrollment was 3 to <7 years old.|participants|Number|10|10.0||||||
3692078|NCT02223650|3533821|B1|5 to <6 years||Age, Customized|Baseline age reflects age at randomization. The age eligibility requirement at enrollment was 3 to <7 years old.|participants|Number|9|9.0||||||
3692079|NCT02223650|3533819|B3|4 to <5 years||Age, Customized|Baseline age reflects age at randomization. The age eligibility requirement at enrollment was 3 to <7 years old.|participants|Number|15|15.0||||||
3692080|NCT02223650|3533820|B2|4 to <5 years||Age, Customized|Baseline age reflects age at randomization. The age eligibility requirement at enrollment was 3 to <7 years old.|participants|Number|11|11.0||||||
3692081|NCT02223650|3533821|B1|4 to <5 years||Age, Customized|Baseline age reflects age at randomization. The age eligibility requirement at enrollment was 3 to <7 years old.|participants|Number|4|4.0||||||
3692082|NCT02223650|3533819|B3|3 to <4 years||Age, Customized|Baseline age reflects age at randomization. The age eligibility requirement at enrollment was 3 to <7 years old.|participants|Number|10|10.0||||||
3692083|NCT02223650|3533820|B2|3 to <4 years||Age, Customized|Baseline age reflects age at randomization. The age eligibility requirement at enrollment was 3 to <7 years old.|participants|Number|3|3.0||||||
3692084|NCT02223650|3533821|B1|3 to <4 years||Age, Customized|Baseline age reflects age at randomization. The age eligibility requirement at enrollment was 3 to <7 years old.|participants|Number|7|7.0||||||
3692085|NCT02223650|3533819|B3|||Age||years|Mean|5.1|5.1|Standard Deviation|1.1|1.1|||
3692086|NCT02223650|3533820|B2|||Age||years|Mean|5.1|5.1|Standard Deviation|1.2|1.2|||
3692087|NCT02223650|3533821|B1|||Age||years|Mean|5.2|5.2|Standard Deviation|1|1.0|||
3692088|NCT02223429|3533852|B5|United States||Region of Enrollment||participants|Number|31|31.0||||||
3692089|NCT02223429|3533853|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
3692090|NCT02223429|3533854|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3692091|NCT02223429|3533855|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3692092|NCT02223429|3533856|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3692093|NCT02223429|3533852|B5||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3692094|NCT02223429|3533853|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3692095|NCT02223429|3533854|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3692096|NCT02223429|3533855|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3692097|NCT02223429|3533856|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3692098|NCT02223429|3533852|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3692099|NCT02223429|3533853|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3692100|NCT02223429|3533854|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3692101|NCT02223429|3533855|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3692102|NCT02223429|3533856|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3692103|NCT02223429|3533852|B5|||Age||years|Mean|32.81|32.81|Standard Deviation|4.70|4.7|||
3692104|NCT02223429|3533853|B4|||Age||years|Mean|34|34.0|Standard Deviation|4.75|4.75|||
3692107|NCT02223429|3533856|B1|||Age||years|Mean|33.14|33.14|Standard Deviation|4.14|4.14|||
3692108|NCT02223390|3533887|B3|PCL - Cluster E Arousal||PTSD Symptoms (PCL-5)|Self-report, measured by the PTSD checklist, civilian version (PCL-5). 20-item self-report questionnaire. Participants were asked to indicate the extent to which they were bothered by problems experienced in the past month in relation to a traumatic experience of abuse or act of violence (0 = not at all to 4 = extremely). Total severity score (range: 0-80; higher scores indicating higher symptom severity, >= 33 indicating PTSD) and subscale totals (Avoidance - Cluster C, range: 0-8; and Hyperarousal - Cluster E, range: 0-24) were examined.|units on a scale|Mean|10.59|10.59|Standard Deviation|7.15|7.15|||
3692109|NCT02223390|3533888|B2|PCL - Cluster E Arousal||PTSD Symptoms (PCL-5)|Self-report, measured by the PTSD checklist, civilian version (PCL-5). 20-item self-report questionnaire. Participants were asked to indicate the extent to which they were bothered by problems experienced in the past month in relation to a traumatic experience of abuse or act of violence (0 = not at all to 4 = extremely). Total severity score (range: 0-80; higher scores indicating higher symptom severity, >= 33 indicating PTSD) and subscale totals (Avoidance - Cluster C, range: 0-8; and Hyperarousal - Cluster E, range: 0-24) were examined.|units on a scale|Mean|8.31|8.31|Standard Deviation|6.34|6.34|||
3692110|NCT02223390|3533889|B1|PCL - Cluster E Arousal||PTSD Symptoms (PCL-5)|Self-report, measured by the PTSD checklist, civilian version (PCL-5). 20-item self-report questionnaire. Participants were asked to indicate the extent to which they were bothered by problems experienced in the past month in relation to a traumatic experience of abuse or act of violence (0 = not at all to 4 = extremely). Total severity score (range: 0-80; higher scores indicating higher symptom severity, >= 33 indicating PTSD) and subscale totals (Avoidance - Cluster C, range: 0-8; and Hyperarousal - Cluster E, range: 0-24) were examined.|units on a scale|Mean|12.88|12.88|Standard Deviation|7.25|7.25|||
3692111|NCT02223390|3533887|B3|PCL - Cluster C Avoidance||PTSD Symptoms (PCL-5)|Self-report, measured by the PTSD checklist, civilian version (PCL-5). 20-item self-report questionnaire. Participants were asked to indicate the extent to which they were bothered by problems experienced in the past month in relation to a traumatic experience of abuse or act of violence (0 = not at all to 4 = extremely). Total severity score (range: 0-80; higher scores indicating higher symptom severity, >= 33 indicating PTSD) and subscale totals (Avoidance - Cluster C, range: 0-8; and Hyperarousal - Cluster E, range: 0-24) were examined.|units on a scale|Mean|3.78|3.78|Standard Deviation|2.86|2.86|||
3692112|NCT02223390|3533888|B2|PCL - Cluster C Avoidance||PTSD Symptoms (PCL-5)|Self-report, measured by the PTSD checklist, civilian version (PCL-5). 20-item self-report questionnaire. Participants were asked to indicate the extent to which they were bothered by problems experienced in the past month in relation to a traumatic experience of abuse or act of violence (0 = not at all to 4 = extremely). Total severity score (range: 0-80; higher scores indicating higher symptom severity, >= 33 indicating PTSD) and subscale totals (Avoidance - Cluster C, range: 0-8; and Hyperarousal - Cluster E, range: 0-24) were examined.|units on a scale|Mean|3.03|3.03|Standard Deviation|2.62|2.62|||
3692113|NCT02223390|3533889|B1|PCL - Cluster C Avoidance||PTSD Symptoms (PCL-5)|Self-report, measured by the PTSD checklist, civilian version (PCL-5). 20-item self-report questionnaire. Participants were asked to indicate the extent to which they were bothered by problems experienced in the past month in relation to a traumatic experience of abuse or act of violence (0 = not at all to 4 = extremely). Total severity score (range: 0-80; higher scores indicating higher symptom severity, >= 33 indicating PTSD) and subscale totals (Avoidance - Cluster C, range: 0-8; and Hyperarousal - Cluster E, range: 0-24) were examined.|units on a scale|Mean|4.53|4.53|Standard Deviation|2.93|2.93|||
3692114|NCT02223390|3533887|B3|PCL - total symptom severity score||PTSD Symptoms (PCL-5)|Self-report, measured by the PTSD checklist, civilian version (PCL-5). 20-item self-report questionnaire. Participants were asked to indicate the extent to which they were bothered by problems experienced in the past month in relation to a traumatic experience of abuse or act of violence (0 = not at all to 4 = extremely). Total severity score (range: 0-80; higher scores indicating higher symptom severity, >= 33 indicating PTSD) and subscale totals (Avoidance - Cluster C, range: 0-8; and Hyperarousal - Cluster E, range: 0-24) were examined.|units on a scale|Mean|37.00|37.0|Standard Deviation|21.89|21.89|||
3692115|NCT02223390|3533888|B2|PCL - total symptom severity score||PTSD Symptoms (PCL-5)|Self-report, measured by the PTSD checklist, civilian version (PCL-5). 20-item self-report questionnaire. Participants were asked to indicate the extent to which they were bothered by problems experienced in the past month in relation to a traumatic experience of abuse or act of violence (0 = not at all to 4 = extremely). Total severity score (range: 0-80; higher scores indicating higher symptom severity, >= 33 indicating PTSD) and subscale totals (Avoidance - Cluster C, range: 0-8; and Hyperarousal - Cluster E, range: 0-24) were examined.|units on a scale|Mean|30.72|30.72|Standard Deviation|20.27|20.27|||
3692116|NCT02223390|3533889|B1|PCL - total symptom severity score||PTSD Symptoms (PCL-5)|Self-report, measured by the PTSD checklist, civilian version (PCL-5). 20-item self-report questionnaire. Participants were asked to indicate the extent to which they were bothered by problems experienced in the past month in relation to a traumatic experience of abuse or act of violence (0 = not at all to 4 = extremely). Total severity score (range: 0-80; higher scores indicating higher symptom severity, >= 33 indicating PTSD) and subscale totals (Avoidance - Cluster C, range: 0-8; and Hyperarousal - Cluster E, range: 0-24) were examined.|units on a scale|Mean|43.28|43.28|Standard Deviation|21.94|21.94|||
3692117|NCT02223390|3533887|B3|South Africa||Region of Enrollment||participants|Number|64|64.0||||||
3692118|NCT02223390|3533888|B2|South Africa||Region of Enrollment||participants|Number|32|32.0||||||
3692119|NCT02223390|3533889|B1|South Africa||Region of Enrollment||participants|Number|32|32.0||||||
3692120|NCT02223390|3533887|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3692121|NCT02223390|3533888|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3692122|NCT02223390|3533889|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3692123|NCT02223390|3533887|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3692124|NCT02223390|3533888|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3692125|NCT02223390|3533889|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3692126|NCT02223390|3533887|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3692127|NCT02223390|3533888|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3692128|NCT02223390|3533889|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3692129|NCT02223390|3533887|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3692130|NCT02223390|3533888|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3692131|NCT02223390|3533889|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3692132|NCT02223390|3533887|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3692133|NCT02223390|3533888|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3692134|NCT02223390|3533889|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3692135|NCT02223390|3533887|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3692136|NCT02223390|3533888|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3692137|NCT02223390|3533889|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3692138|NCT02223390|3533887|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3692139|NCT02223390|3533888|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3692140|NCT02223390|3533889|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3692141|NCT02223390|3533887|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3692142|NCT02223390|3533888|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3692143|NCT02223390|3533889|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3692144|NCT02223390|3533887|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3692145|NCT02223390|3533888|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3692146|NCT02223390|3533889|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3692147|NCT02223390|3533887|B3|||Age||years|Mean|29.1|29.1|Standard Deviation|7.5|7.5|||
3692148|NCT02223390|3533888|B2|||Age||years|Mean|29.0|29.0|Standard Deviation|8.4|8.4|||
3692149|NCT02223390|3533889|B1|||Age||years|Mean|29.2|29.2|Standard Deviation|6.6|6.6|||
3692150|NCT02223364|3533898|B4|United States||Region of Enrollment||Participants|Count of Participants|157|157.0||||||
3692151|NCT02223364|3533899|B3|United States||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
3692152|NCT02223364|3533900|B2|United States||Region of Enrollment||Participants|Count of Participants|55|55.0||||||
3692153|NCT02223364|3533901|B1|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3692154|NCT02223364|3533898|B4||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3692155|NCT02223364|3533899|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3692156|NCT02223364|3533900|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3692157|NCT02223364|3533901|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3692158|NCT02223364|3533898|B4||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3692159|NCT02223364|3533899|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3692160|NCT02223364|3533900|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3692161|NCT02223364|3533901|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3692162|NCT02223364|3533898|B4|||Age||years|Mean|67.7|67.7|Standard Deviation|8.8|8.8|||
3692163|NCT02223364|3533899|B3|||Age||years|Mean|67|67.0|Standard Deviation|8|8.0|||
3692164|NCT02223364|3533900|B2|||Age||years|Mean|68|68.0|Standard Deviation|8|8.0|||
3692165|NCT02223364|3533901|B1|||Age||years|Mean|67|67.0|Standard Deviation|9|9.0|||
3692166|NCT02223338|3533953|B3|United States||Region of Enrollment||participants|Number|120|120.0||||||
3692167|NCT02223338|3533954|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
3692168|NCT02223338|3533955|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
3692169|NCT02223338|3533953|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3692170|NCT02223338|3533954|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3692171|NCT02223338|3533955|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3692172|NCT02223338|3533953|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3692173|NCT02223338|3533954|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3692174|NCT02223338|3533955|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3692175|NCT02223338|3533953|B3|||Age||years|Mean|72.23|72.23|Standard Deviation|13.65|13.65|||
3692176|NCT02223338|3533954|B2|||Age||years|Mean|74.68|74.68|Standard Deviation|13.96|13.96|||
3692177|NCT02223338|3533955|B1|||Age||years|Mean|69.78|69.78|Standard Deviation|12.99|12.99|||
3692178|NCT02223338|3533953|B3||>=65 years|Age||Participants|Count of Participants|89|89.0||||||
3692179|NCT02223338|3533954|B2||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
3692180|NCT02223338|3533955|B1||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
3692181|NCT02223338|3533953|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3692182|NCT02223338|3533954|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3692183|NCT02223338|3533955|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3692184|NCT02223338|3533953|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3692185|NCT02223338|3533954|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3692186|NCT02223338|3533955|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3692187|NCT02223260|3533964|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3692188|NCT02223260|3533964|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3692189|NCT02223260|3533964|B1|||Age||Months|Mean|2.912|2.912|Standard Deviation|1.694|1.694|||
3692190|NCT02223065|3533980|B3|WHITE||Race/Ethnicity, Customized||Participants|Number|33|33.0||||||
3692191|NCT02223065|3533981|B2|WHITE||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
3692192|NCT02223065|3533982|B1|WHITE||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
3692193|NCT02223065|3533980|B3|BLACK/AFRICAN AMERICAN||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3692194|NCT02223065|3533981|B2|BLACK/AFRICAN AMERICAN||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3692195|NCT02223065|3533982|B1|BLACK/AFRICAN AMERICAN||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3692196|NCT02223065|3533980|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3692197|NCT02223065|3533981|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3692198|NCT02223065|3533982|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3692199|NCT02223065|3533980|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3692200|NCT02223065|3533981|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3692201|NCT02223065|3533982|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3692202|NCT02223065|3533980|B3|< 65||Age, Customized||Participants|Number|36|36.0||||||
3692203|NCT02223065|3533981|B2|< 65||Age, Customized||Participants|Number|18|18.0||||||
3692204|NCT02223065|3533982|B1|< 65||Age, Customized||Participants|Number|18|18.0||||||
3692205|NCT02223065|3533980|B3|||Age||YEARS|Mean|33.3|33.3|Standard Deviation|11.32|11.32|19.0|53.0|
3692206|NCT02223065|3533981|B2|||Age||YEARS|Mean|32.9|32.9|Standard Deviation|11.34|11.34|19.0|52.0|
3692207|NCT02223065|3533982|B1|||Age||YEARS|Mean|33.6|33.6|Standard Deviation|11.63|11.63|19.0|53.0|
3692208|NCT02222870|3533999|B3|United States||Region of Enrollment||Participants|Number|60|60.0||||||
3692209|NCT02222870|3534000|B2|United States||Region of Enrollment||Participants|Number|30|30.0||||||
3692210|NCT02222870|3534001|B1|United States||Region of Enrollment||Participants|Number|30|30.0||||||
3692211|NCT02222870|3533999|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3692212|NCT02222870|3534000|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3692213|NCT02222870|3534001|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3692214|NCT02222870|3533999|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3692215|NCT02222870|3534000|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3692216|NCT02222870|3534001|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3692217|NCT02222870|3533999|B3|Age Continuous||Age||Months|Mean|45.9|45.9|Standard Deviation|26.7|26.7|||
3692218|NCT02222870|3534000|B2|Age Continuous||Age||Months|Mean|66.9|66.9|Standard Deviation|21.8|21.8|||
3692219|NCT02222870|3534001|B1|Age Continuous||Age||Months|Mean|25.0|25.0|Standard Deviation|8.3|8.3|||
3692220|NCT02222870|3533999|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3692221|NCT02222870|3534000|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3692222|NCT02222870|3534001|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3692223|NCT02222870|3533999|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3692224|NCT02222870|3534000|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3692225|NCT02222870|3534001|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3692226|NCT02222870|3533999|B3||<=18 years|Age||Participants|Count of Participants|60|60.0||||||
3692227|NCT02222870|3534000|B2||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
3692228|NCT02222870|3534001|B1||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
3692229|NCT02222818|3534016|B3|Slovakia||Region of Enrollment||participants|Number|3|3.0||||||
3692230|NCT02222818|3534017|B2|Slovakia||Region of Enrollment||participants|Number|1|1.0||||||
3692231|NCT02222818|3534018|B1|Slovakia||Region of Enrollment||participants|Number|2|2.0||||||
3692232|NCT02222818|3534016|B3|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3692233|NCT02222818|3534017|B2|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3692234|NCT02222818|3534018|B1|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3692235|NCT02222818|3534016|B3|Italy||Region of Enrollment||participants|Number|9|9.0||||||
3692236|NCT02222818|3534017|B2|Italy||Region of Enrollment||participants|Number|4|4.0||||||
3692237|NCT02222818|3534018|B1|Italy||Region of Enrollment||participants|Number|5|5.0||||||
3692238|NCT02222818|3534016|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
3692239|NCT02222818|3534017|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3692240|NCT02222818|3534018|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3692241|NCT02222818|3534016|B3|Hungary||Region of Enrollment||participants|Number|8|8.0||||||
3692242|NCT02222818|3534017|B2|Hungary||Region of Enrollment||participants|Number|4|4.0||||||
3692243|NCT02222818|3534018|B1|Hungary||Region of Enrollment||participants|Number|4|4.0||||||
3692244|NCT02222818|3534016|B3|Saudi Arabia||Region of Enrollment||participants|Number|9|9.0||||||
3692245|NCT02222818|3534017|B2|Saudi Arabia||Region of Enrollment||participants|Number|4|4.0||||||
3692246|NCT02222818|3534018|B1|Saudi Arabia||Region of Enrollment||participants|Number|5|5.0||||||
3692247|NCT02222818|3534016|B3||Male|Gender||Participants|Count of Participants|61|61.0||||||
3692248|NCT02222818|3534017|B2||Male|Gender||Participants|Count of Participants|32|32.0||||||
3692249|NCT02222818|3534018|B1||Male|Gender||Participants|Count of Participants|29|29.0||||||
3692250|NCT02222818|3534016|B3||Female|Gender||Participants|Count of Participants|5|5.0||||||
3692251|NCT02222818|3534017|B2||Female|Gender||Participants|Count of Participants|1|1.0||||||
3692252|NCT02222818|3534018|B1||Female|Gender||Participants|Count of Participants|4|4.0||||||
3692253|NCT02222818|3534016|B3|||Age||years|Mean|71.6|71.6|Standard Deviation|10.4|10.4|||
3692254|NCT02222818|3534017|B2|||Age||years|Mean|72.4|72.4|Standard Deviation|9.1|9.1|||
3692255|NCT02222818|3534018|B1|||Age||years|Mean|70.7|70.7|Standard Deviation|11.6|11.6|||
3692256|NCT02222714|3534026|B6|||History of Diabetes||Participants|Count of Participants|36|36.0||||||
3692257|NCT02222714|3534027|B5|||History of Diabetes||Participants|Count of Participants|18|18.0||||||
3692258|NCT02222714|3534028|B4|||History of Diabetes||Participants|Count of Participants|4|4.0||||||
3692259|NCT02222714|3534029|B3|||History of Diabetes||Participants|Count of Participants|2|2.0||||||
3692260|NCT02222714|3534030|B2|||History of Diabetes||Participants|Count of Participants|6|6.0||||||
3692261|NCT02222714|3534031|B1|||History of Diabetes||Participants|Count of Participants|6|6.0||||||
3692262|NCT02222714|3534026|B6|||History of Hypertension||Participants|Count of Participants|85|85.0||||||
3692263|NCT02222714|3534027|B5|||History of Hypertension||Participants|Count of Participants|33|33.0||||||
3692264|NCT02222714|3534028|B4|||History of Hypertension||Participants|Count of Participants|11|11.0||||||
3692265|NCT02222714|3534029|B3|||History of Hypertension||Participants|Count of Participants|9|9.0||||||
3692266|NCT02222714|3534030|B2|||History of Hypertension||Participants|Count of Participants|21|21.0||||||
3692267|NCT02222714|3534031|B1|||History of Hypertension||Participants|Count of Participants|11|11.0||||||
3692268|NCT02222714|3534026|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3692269|NCT02222714|3534027|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3692270|NCT02222714|3534028|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3692271|NCT02222714|3534029|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3692272|NCT02222714|3534030|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3692273|NCT02222714|3534031|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3692274|NCT02222714|3534026|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3692275|NCT02222714|3534027|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3692276|NCT02222714|3534028|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3692277|NCT02222714|3534029|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3692278|NCT02222714|3534030|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3692279|NCT02222714|3534031|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3692280|NCT02222714|3534026|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3692281|NCT02222714|3534027|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3692282|NCT02222714|3534028|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3692283|NCT02222714|3534029|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3692284|NCT02222714|3534030|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3692285|NCT02222714|3534031|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3692286|NCT02222714|3534026|B6||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3692287|NCT02222714|3534027|B5||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3692288|NCT02222714|3534028|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3692289|NCT02222714|3534029|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3692290|NCT02222714|3534030|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3692291|NCT02222714|3534031|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3692292|NCT02222714|3534026|B6||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3692293|NCT02222714|3534027|B5||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3692294|NCT02222714|3534028|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3692295|NCT02222714|3534029|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3692296|NCT02222714|3534030|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3692297|NCT02222714|3534031|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3692298|NCT02222714|3534026|B6|||Age||years|Mean|63.7|63.7|Full Range|||28.0|89.0|
3692299|NCT02222714|3534027|B5|||Age||years|Mean|63.8|63.8|Full Range|||44.0|83.0|
3692300|NCT02222714|3534028|B4|||Age||years|Mean|66.2|66.2|Full Range|||42.0|89.0|
3692301|NCT02222714|3534029|B3|||Age||years|Mean|65.3|65.3|Full Range|||43.0|89.0|
3692302|NCT02222714|3534030|B2|||Age||years|Mean|61.4|61.4|Full Range|||33.0|88.0|
3692303|NCT02222714|3534031|B1|||Age||years|Mean|63.3|63.3|Full Range|||28.0|84.0|
3692304|NCT02222558|3534074|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3692305|NCT02222558|3534074|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3692306|NCT02222558|3534074|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3692307|NCT02222558|3534074|B1|||Age||years|Mean|54.4|54.4|Full Range|||31.0|70.0|
3692308|NCT02222558|3534074|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3692309|NCT02222558|3534074|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3692310|NCT02222558|3534074|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3692311|NCT02222493|3534093|B3||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3692312|NCT02222493|3534094|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3692313|NCT02222493|3534095|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3692314|NCT02222493|3534093|B3||Female|Sex: Female, Male||Participants|Count of Participants|522|522.0||||||
3692315|NCT02222493|3534094|B2||Female|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
3692316|NCT02222493|3534095|B1||Female|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
3692317|NCT02222493|3534093|B3|||Age||years|Mean|52.8|52.8|Standard Deviation|13.1|13.1|||
3692318|NCT02222493|3534094|B2|||Age||years|Mean|52.8|52.8|Standard Deviation|12.9|12.9|||
3692319|NCT02222493|3534095|B1|||Age||years|Mean|52.8|52.8|Standard Deviation|13.3|13.3|||
3692320|NCT02222246|3534212|B3|United States||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
3692321|NCT02222246|3534213|B2|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3692322|NCT02222246|3534214|B1|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3692323|NCT02222246|3534212|B3|Race/Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3692324|NCT02222246|3534213|B2|Race/Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3692325|NCT02222246|3534214|B1|Race/Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3692326|NCT02222246|3534212|B3|Race/Ethnicity|African American/Black|Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
3692327|NCT02222246|3534213|B2|Race/Ethnicity|African American/Black|Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3692328|NCT02222246|3534214|B1|Race/Ethnicity|African American/Black|Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3692329|NCT02222246|3534212|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3692330|NCT02222246|3534213|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3692331|NCT02222246|3534214|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3692332|NCT02222246|3534212|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3692333|NCT02222246|3534213|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3692334|NCT02222246|3534214|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3692335|NCT02222246|3534212|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3692336|NCT02222246|3534213|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3692337|NCT02222246|3534214|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3692338|NCT02222246|3534212|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3692339|NCT02222246|3534213|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3692340|NCT02222246|3534214|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3692341|NCT02222246|3534212|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3692342|NCT02222246|3534213|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3692343|NCT02222246|3534214|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3692344|NCT02222246|3534212|B3|||Age||years|Median|27.0|27.0|Inter-Quartile Range|||23.0|32.5|
3692345|NCT02222246|3534213|B2|||Age||years|Median|28.5|28.5|Inter-Quartile Range|||23.0|32.0|
3692346|NCT02222246|3534214|B1|||Age||years|Median|27.0|27.0|Inter-Quartile Range|||23.0|33.0|
3692347|NCT02222207|3534243|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3692348|NCT02222207|3534243|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3692349|NCT02222207|3534243|B1|||Age||years|Mean|75|75.0|Standard Deviation|8.4|8.4|||
3692350|NCT02222181|3534250|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3692351|NCT02222181|3534250|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3692352|NCT02222181|3534250|B1||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
3692353|NCT02222181|3534250|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3692354|NCT02222181|3534250|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3692355|NCT02222129|3534260|B3|||BMI||kg/m2|Median|28.7|28.7|Inter-Quartile Range|||25.6|33.3|
3692356|NCT02222129|3534261|B2|||BMI||kg/m2|Median|28.2|28.2|Inter-Quartile Range|||25.5|32.8|
3692357|NCT02222129|3534262|B1|||BMI||kg/m2|Median|28.9|28.9|Inter-Quartile Range|||25.6|34.8|
3692358|NCT02222129|3534260|B3|United States||Region of Enrollment||participants|Number|191|191.0||||||
3692359|NCT02222129|3534261|B2|United States||Region of Enrollment||participants|Number|97|97.0||||||
3692360|NCT02222129|3534262|B1|United States||Region of Enrollment||participants|Number|94|94.0||||||
3692361|NCT02222129|3534260|B3|Unknown||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3692362|NCT02222129|3534261|B2|Unknown||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3692363|NCT02222129|3534262|B1|Unknown||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3692364|NCT02222129|3534260|B3|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3692365|NCT02222129|3534261|B2|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3692366|NCT02222129|3534262|B1|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3692367|NCT02222129|3534260|B3|African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3692368|NCT02222129|3534261|B2|African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3692369|NCT02222129|3534262|B1|African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3692370|NCT02222129|3534260|B3|White||Race/Ethnicity, Customized||participants|Number|73|73.0||||||
3692371|NCT02222129|3534261|B2|White||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3692372|NCT02222129|3534262|B1|White||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
3692373|NCT02222129|3534260|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|100|100.0||||||
3692374|NCT02222129|3534261|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
3692375|NCT02222129|3534262|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
3692376|NCT02222129|3534260|B3||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3692377|NCT02222129|3534261|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3692378|NCT02222129|3534262|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3692379|NCT02222129|3534260|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3692380|NCT02222129|3534261|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3692381|NCT02222129|3534262|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3692382|NCT02222129|3534260|B3|Age||Age, Customized||years|Median|63|63.0|Inter-Quartile Range|||53.0|68.0|
3692383|NCT02222129|3534261|B2|Age||Age, Customized||years|Median|62|62.0|Inter-Quartile Range|||52.0|68.0|
3692384|NCT02222129|3534262|B1|Age||Age, Customized||years|Median|63|63.0|Inter-Quartile Range|||53.0|69.0|
3692385|NCT02221947|3534269|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
3692386|NCT02221947|3534270|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3692387|NCT02221947|3534271|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3692388|NCT02221947|3534269|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3692389|NCT02221947|3534270|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3692390|NCT02221947|3534271|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3692391|NCT02221947|3534269|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3692392|NCT02221947|3534270|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3692393|NCT02221947|3534271|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3692394|NCT02221947|3534269|B3|||Age||years|Mean|71.9|71.9|Standard Deviation|7.37|7.37|||
3692395|NCT02221947|3534270|B2|||Age||years|Mean|70.7|70.7|Standard Deviation|7.23|7.23|||
3692396|NCT02221947|3534271|B1|||Age||years|Mean|72.5|72.5|Standard Deviation|8.04|8.04|||
3692397|NCT02221947|3534269|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3692398|NCT02221947|3534270|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3692399|NCT02221947|3534271|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3692400|NCT02221947|3534269|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3692401|NCT02221947|3534270|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3692402|NCT02221947|3534271|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3692403|NCT02221947|3534269|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3692404|NCT02221947|3534270|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3692405|NCT02221947|3534271|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3692406|NCT02221674|3534284|B4|||Baseline Pain Intensity using the FLACC Scale|"Pain intensity using the Face, Legs, Activity, Cry, Consolability Scale (FLACC Scale) at baseline visit.~The FLACC Scale is a behavioral scale for scoring postoperative pain in young children. It includes five categories of pain behaviors, including facial expression, leg movement, activity, cry, and consolability. The scale is scored in a range of 0–10 with 0 representing no pain."|units on a scale|Mean|2.8|2.8|Standard Deviation|3.0|3.0|||
3692407|NCT02221674|3534285|B3|||Baseline Pain Intensity using the FLACC Scale|"Pain intensity using the Face, Legs, Activity, Cry, Consolability Scale (FLACC Scale) at baseline visit.~The FLACC Scale is a behavioral scale for scoring postoperative pain in young children. It includes five categories of pain behaviors, including facial expression, leg movement, activity, cry, and consolability. The scale is scored in a range of 0–10 with 0 representing no pain."|units on a scale|Mean|1.6|1.6|Standard Deviation|1.5|1.5|||
3692408|NCT02221674|3534286|B2|||Baseline Pain Intensity using the FLACC Scale|"Pain intensity using the Face, Legs, Activity, Cry, Consolability Scale (FLACC Scale) at baseline visit.~The FLACC Scale is a behavioral scale for scoring postoperative pain in young children. It includes five categories of pain behaviors, including facial expression, leg movement, activity, cry, and consolability. The scale is scored in a range of 0–10 with 0 representing no pain."|units on a scale|Mean|3.8|3.8|Standard Deviation|3.9|3.9|||
3692409|NCT02221674|3534287|B1|||Baseline Pain Intensity using the FLACC Scale|"Pain intensity using the Face, Legs, Activity, Cry, Consolability Scale (FLACC Scale) at baseline visit.~The FLACC Scale is a behavioral scale for scoring postoperative pain in young children. It includes five categories of pain behaviors, including facial expression, leg movement, activity, cry, and consolability. The scale is scored in a range of 0–10 with 0 representing no pain."|units on a scale|Mean|2.8|2.8|Standard Deviation|2.9|2.9|||
3692410|NCT02221674|3534284|B4|||Body Mass Index (BMI)||kilogram per square meter|Mean|15.55|15.55|Standard Deviation|2.24|2.24|||
3692411|NCT02221674|3534285|B3|||Body Mass Index (BMI)||kilogram per square meter|Mean|13.36|13.36|Standard Deviation|2.49|2.49|||
3692412|NCT02221674|3534286|B2|||Body Mass Index (BMI)||kilogram per square meter|Mean|15.28|15.28|Standard Deviation|1.31|1.31|||
3692413|NCT02221674|3534287|B1|||Body Mass Index (BMI)||kilogram per square meter|Mean|17.11|17.11|Standard Deviation|1.36|1.36|||
3692414|NCT02221674|3534284|B4|||Weight||kilogram|Mean|6.74|6.74|Standard Deviation|2.59|2.59|||
3692415|NCT02221674|3534285|B3|||Weight||kilogram|Mean|3.78|3.78|Standard Deviation|0.66|0.66|||
3692416|NCT02221674|3534286|B2|||Weight||kilogram|Mean|5.92|5.92|Standard Deviation|1.18|1.18|||
3692417|NCT02221674|3534287|B1|||Weight||kilogram|Mean|9.21|9.21|Standard Deviation|1.50|1.5|||
3692418|NCT02221674|3534284|B4|||Height||centimeter|Mean|64.5|64.5|Standard Deviation|9.5|9.5|||
3692419|NCT02221674|3534285|B3|||Height||centimeter|Mean|53.4|53.4|Standard Deviation|4.4|4.4|||
3692420|NCT02221674|3534286|B2|||Height||centimeter|Mean|62.0|62.0|Standard Deviation|4.3|4.3|||
3692421|NCT02221674|3534287|B1|||Height||centimeter|Mean|73.3|73.3|Standard Deviation|5.2|5.2|||
3692422|NCT02221674|3534284|B4|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3692423|NCT02221674|3534285|B3|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3692424|NCT02221674|3534286|B2|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3692425|NCT02221674|3534287|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3692426|NCT02221674|3534284|B4|Poland||Region of Enrollment||participants|Number|3|3.0||||||
3692427|NCT02221674|3534285|B3|Poland||Region of Enrollment||participants|Number|3|3.0||||||
3692428|NCT02221674|3534286|B2|Poland||Region of Enrollment||participants|Number|0|0.0||||||
3692429|NCT02221674|3534287|B1|Poland||Region of Enrollment||participants|Number|0|0.0||||||
3692430|NCT02221674|3534284|B4|United States||Region of Enrollment||participants|Number|15|15.0||||||
3692431|NCT02221674|3534285|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3692432|NCT02221674|3534286|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3692433|NCT02221674|3534287|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3692434|NCT02221674|3534284|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3692435|NCT02221674|3534285|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3692436|NCT02221674|3534286|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3692437|NCT02221674|3534287|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3692438|NCT02221674|3534284|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3692439|NCT02221674|3534285|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3692440|NCT02221674|3534286|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3692441|NCT02221674|3534287|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3692442|NCT02221674|3534284|B4|||Age||days|Mean|210.0|210.0|Standard Deviation|209.0|209.0|||
3692443|NCT02221674|3534285|B3|||Age||days|Mean|14.6|14.6|Standard Deviation|8.5|8.5|||
3692444|NCT02221674|3534286|B2|||Age||days|Mean|92.8|92.8|Standard Deviation|37.9|37.9|||
3692445|NCT02221674|3534287|B1|||Age||days|Mean|420.0|420.0|Standard Deviation|147.8|147.8|||
3692446|NCT02221674|3534284|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3692447|NCT02221674|3534285|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3692448|NCT02221674|3534286|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3692449|NCT02221674|3534287|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3692450|NCT02221674|3534284|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3692451|NCT02221674|3534285|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3692452|NCT02221674|3534286|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3692453|NCT02221674|3534287|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3692454|NCT02221674|3534284|B4||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
3692455|NCT02221674|3534285|B3||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3692456|NCT02221674|3534286|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3692457|NCT02221674|3534287|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
3692458|NCT02221648|3534303|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
3692459|NCT02221648|3534304|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
3692460|NCT02221648|3534305|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3692461|NCT02221648|3534303|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3692462|NCT02221648|3534304|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3692463|NCT02221648|3534305|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3692464|NCT02221648|3534303|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3692465|NCT02221648|3534304|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3692466|NCT02221648|3534305|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3692467|NCT02221648|3534303|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3692468|NCT02221648|3534304|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3692469|NCT02221648|3534305|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3692470|NCT02221648|3534303|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3692471|NCT02221648|3534304|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3692472|NCT02221648|3534305|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3692473|NCT02221648|3534303|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3692474|NCT02221648|3534304|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3692475|NCT02221648|3534305|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3692476|NCT02221557|3534316|B1|||Widest open||mm|Mean|8.3|8.3|Standard Deviation|2.5|2.5|||
3692477|NCT02221557|3534316|B1|||Deepest vertical depth||mm|Mean|10.0|10.0|Standard Deviation|2.3|2.3|||
3692478|NCT02221557|3534316|B1|||Widest ridge width||mm|Mean|9.3|9.3|Standard Deviation|2.5|2.5|||
3692479|NCT02221557|3534316|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3692480|NCT02221557|3534316|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3692481|NCT02221557|3534316|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3692482|NCT02221557|3534316|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3692483|NCT02221557|3534316|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3692484|NCT02221557|3534316|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3692485|NCT02221557|3534316|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3692486|NCT02221557|3534316|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3692487|NCT02221557|3534316|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3692488|NCT02221557|3534316|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3692489|NCT02221557|3534316|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3692490|NCT02221557|3534316|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3692491|NCT02221557|3534316|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3692492|NCT02221557|3534316|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3692493|NCT02221557|3534316|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3692494|NCT02220998|3534320|B3|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|212|212.0||||||
3692495|NCT02220998|3534321|B2|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|101|101.0||||||
3692496|NCT02220998|3534322|B1|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|111|111.0||||||
3692497|NCT02220998|3534320|B3|< 800,000 IU/mL||HCV RNA Category||participants|Number|54|54.0||||||
3692498|NCT02220998|3534321|B2|< 800,000 IU/mL||HCV RNA Category||participants|Number|31|31.0||||||
3692499|NCT02220998|3534322|B1|< 800,000 IU/mL||HCV RNA Category||participants|Number|23|23.0||||||
3692500|NCT02220998|3534320|B3|||HCV RNA||log10 IU/mL|Mean|6.4|6.4|Standard Deviation|0.76|0.76|||
3692501|NCT02220998|3534321|B2|||HCV RNA||log10 IU/mL|Mean|6.4|6.4|Standard Deviation|0.74|0.74|||
3692502|NCT02220998|3534322|B1|||HCV RNA||log10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.78|0.78|||
3692503|NCT02220998|3534320|B3|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|40|40.0||||||
3692504|NCT02220998|3534321|B2|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|22|22.0||||||
3692505|NCT02220998|3534322|B1|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|18|18.0||||||
3692506|NCT02220998|3534320|B3|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|125|125.0||||||
3692507|NCT02220998|3534321|B2|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|64|64.0||||||
3692508|NCT02220998|3534322|B1|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|61|61.0||||||
3692509|NCT02220998|3534320|B3|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|101|101.0||||||
3692510|NCT02220998|3534321|B2|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|46|46.0||||||
3692511|NCT02220998|3534322|B1|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|55|55.0||||||
3692512|NCT02220998|3534320|B3|Missing||Cirrhosis Status||participants|Number|1|1.0||||||
3692513|NCT02220998|3534321|B2|Missing||Cirrhosis Status||participants|Number|1|1.0||||||
3692514|NCT02220998|3534322|B1|Missing||Cirrhosis Status||participants|Number|0|0.0||||||
3692515|NCT02220998|3534320|B3|Absent||Cirrhosis Status||participants|Number|227|227.0||||||
3692516|NCT02220998|3534321|B2|Absent||Cirrhosis Status||participants|Number|112|112.0||||||
3692517|NCT02220998|3534322|B1|Absent||Cirrhosis Status||participants|Number|115|115.0||||||
3692518|NCT02220998|3534320|B3|Present||Cirrhosis Status||participants|Number|38|38.0||||||
3692519|NCT02220998|3534321|B2|Present||Cirrhosis Status||participants|Number|19|19.0||||||
3692520|NCT02220998|3534322|B1|Present||Cirrhosis Status||participants|Number|19|19.0||||||
3692521|NCT02220998|3534320|B3|Not Disclosed||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3692522|NCT02220998|3534321|B2|Not Disclosed||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3692523|NCT02220998|3534322|B1|Not Disclosed||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3692524|NCT02220998|3534320|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3692525|NCT02220998|3534321|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3692526|NCT02220998|3534322|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3692527|NCT02220998|3534320|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3692528|NCT02220998|3534321|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3692529|NCT02220998|3534322|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3692530|NCT02220998|3534320|B3|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3692531|NCT02220998|3534321|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3692532|NCT02220998|3534322|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3692533|NCT02220998|3534320|B3|White||Race/Ethnicity, Customized||participants|Number|235|235.0||||||
3692534|NCT02220998|3534321|B2|White||Race/Ethnicity, Customized||participants|Number|111|111.0||||||
3692535|NCT02220998|3534322|B1|White||Race/Ethnicity, Customized||participants|Number|124|124.0||||||
3692536|NCT02220998|3534320|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3692537|NCT02220998|3534321|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3692598|NCT02220764|3534373|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3692538|NCT02220998|3534322|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3692539|NCT02220998|3534320|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3692540|NCT02220998|3534321|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3692541|NCT02220998|3534322|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3692542|NCT02220998|3534320|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|211|211.0||||||
3692543|NCT02220998|3534321|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
3692544|NCT02220998|3534322|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
3692545|NCT02220998|3534320|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3692546|NCT02220998|3534321|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3692547|NCT02220998|3534322|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3692548|NCT02220998|3534320|B3||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3692549|NCT02220998|3534321|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3692550|NCT02220998|3534322|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3692551|NCT02220998|3534320|B3||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3692552|NCT02220998|3534321|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3692553|NCT02220998|3534322|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3692554|NCT02220998|3534320|B3|||Age||years|Mean|57|57.0|Standard Deviation|10.0|10.0|||
3692555|NCT02220998|3534321|B2|||Age||years|Mean|57|57.0|Standard Deviation|9.3|9.3|||
3692556|NCT02220998|3534322|B1|||Age||years|Mean|57|57.0|Standard Deviation|10.6|10.6|||
3692557|NCT02220920|3534339|B3||Male|Gender||Participants|Count of Participants|93|93.0||||||
3692558|NCT02220920|3534340|B2||Male|Gender||Participants|Count of Participants|49|49.0||||||
3692559|NCT02220920|3534341|B1||Male|Gender||Participants|Count of Participants|44|44.0||||||
3692560|NCT02220920|3534339|B3||Female|Gender||Participants|Count of Participants|53|53.0||||||
3692561|NCT02220920|3534340|B2||Female|Gender||Participants|Count of Participants|21|21.0||||||
3692562|NCT02220920|3534341|B1||Female|Gender||Participants|Count of Participants|32|32.0||||||
3692563|NCT02220920|3534339|B3||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
3692564|NCT02220920|3534340|B2||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3692565|NCT02220920|3534341|B1||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
3692566|NCT02220920|3534339|B3||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
3692567|NCT02220920|3534340|B2||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
3692568|NCT02220920|3534341|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3692569|NCT02220920|3534339|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3692570|NCT02220920|3534340|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3692571|NCT02220920|3534341|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3692572|NCT02220907|3534356|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3692573|NCT02220907|3534356|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3692574|NCT02220907|3534356|B1||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
3692575|NCT02220907|3534356|B1||Between 18 and 65 years|Age||Participants|Count of Participants|119|119.0||||||
3692576|NCT02220907|3534356|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3692577|NCT02220855|3534363|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3692578|NCT02220855|3534363|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3692579|NCT02220855|3534363|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3692580|NCT02220855|3534363|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3692581|NCT02220855|3534363|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3692582|NCT02220855|3534363|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3692583|NCT02220855|3534363|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3692584|NCT02220855|3534363|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3692585|NCT02220855|3534363|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3692586|NCT02220855|3534363|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3692587|NCT02220855|3534363|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3692588|NCT02220855|3534363|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3692589|NCT02220855|3534363|B1|||Age||years|Mean|53.5|53.5|Standard Deviation|12.81|12.81|||
3692590|NCT02220855|3534363|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3692591|NCT02220855|3534363|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3692592|NCT02220855|3534363|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3692593|NCT02220764|3534371|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3692594|NCT02220764|3534372|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3692595|NCT02220764|3534373|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3692596|NCT02220764|3534371|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3692597|NCT02220764|3534372|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3692599|NCT02220764|3534371|B3|||Age||years|Mean|54.9|54.9|Standard Deviation|9.4|9.4|||
3692600|NCT02220764|3534372|B2|||Age||years|Mean|53.9|53.9|Standard Deviation|10.9|10.9|||
3692601|NCT02220764|3534373|B1|||Age||years|Mean|56.2|56.2|Standard Deviation|9.01|9.01|||
3692602|NCT02220725|3534384|B5||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3692603|NCT02220725|3534385|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3692604|NCT02220725|3534386|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3692605|NCT02220725|3534387|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3692606|NCT02220725|3534388|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3692607|NCT02220725|3534384|B5||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3692608|NCT02220725|3534385|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3692609|NCT02220725|3534386|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3692610|NCT02220725|3534387|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3692611|NCT02220725|3534388|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3692612|NCT02220725|3534384|B5|||Age||years|Mean|56.2|56.2|Standard Deviation|4.61|4.61|||
3692613|NCT02220725|3534385|B4|||Age||years|Mean|57.0|57.0|Standard Deviation|5.08|5.08|||
3692614|NCT02220725|3534386|B3|||Age||years|Mean|58.1|58.1|Standard Deviation|5.45|5.45|||
3692615|NCT02220725|3534387|B2|||Age||years|Mean|55.6|55.6|Standard Deviation|3.79|3.79|||
3692616|NCT02220725|3534388|B1|||Age||years|Mean|54.4|54.4|Standard Deviation|3.84|3.84|||
3692617|NCT02220205|3534419|B3|0||Prior IUD insertions performed||exams|Number|51|51.0||||||
3692618|NCT02220205|3534420|B2|0||Prior IUD insertions performed||exams|Number|28|28.0||||||
3692619|NCT02220205|3534421|B1|0||Prior IUD insertions performed||exams|Number|23|23.0||||||
3692620|NCT02220205|3534419|B3|>=1||Prior IUD insertions performed||exams|Number|8|8.0||||||
3692621|NCT02220205|3534420|B2|>=1||Prior IUD insertions performed||exams|Number|2|2.0||||||
3692622|NCT02220205|3534421|B1|>=1||Prior IUD insertions performed||exams|Number|6|6.0||||||
3692623|NCT02220205|3534419|B3|>10||Prior pelvic exams||exams|Number|16|16.0||||||
3692624|NCT02220205|3534420|B2|>10||Prior pelvic exams||exams|Number|9|9.0||||||
3692625|NCT02220205|3534421|B1|>10||Prior pelvic exams||exams|Number|7|7.0||||||
3692626|NCT02220205|3534419|B3|6-10||Prior pelvic exams||exams|Number|8|8.0||||||
3692627|NCT02220205|3534420|B2|6-10||Prior pelvic exams||exams|Number|6|6.0||||||
3692628|NCT02220205|3534421|B1|6-10||Prior pelvic exams||exams|Number|2|2.0||||||
3692629|NCT02220205|3534419|B3|1-5||Prior pelvic exams||exams|Number|20|20.0||||||
3692630|NCT02220205|3534420|B2|1-5||Prior pelvic exams||exams|Number|10|10.0||||||
3692631|NCT02220205|3534421|B1|1-5||Prior pelvic exams||exams|Number|10|10.0||||||
3692632|NCT02220205|3534419|B3|0||Prior pelvic exams||exams|Number|15|15.0||||||
3692633|NCT02220205|3534420|B2|0||Prior pelvic exams||exams|Number|5|5.0||||||
3692634|NCT02220205|3534421|B1|0||Prior pelvic exams||exams|Number|10|10.0||||||
3692635|NCT02220205|3534419|B3|Nurse practitioner student||Occupation|Intern or NP student|participants|Number|39|39.0||||||
3692636|NCT02220205|3534420|B2|Nurse practitioner student||Occupation|Intern or NP student|participants|Number|18|18.0||||||
3692637|NCT02220205|3534421|B1|Nurse practitioner student||Occupation|Intern or NP student|participants|Number|21|21.0||||||
3692638|NCT02220205|3534419|B3|Intern||Occupation|Intern or NP student|participants|Number|20|20.0||||||
3692639|NCT02220205|3534420|B2|Intern||Occupation|Intern or NP student|participants|Number|12|12.0||||||
3692640|NCT02220205|3534421|B1|Intern||Occupation|Intern or NP student|participants|Number|8|8.0||||||
3692641|NCT02220205|3534419|B3|United States||Region of Enrollment||participants|Number|59|59.0||||||
3692642|NCT02220205|3534420|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3692643|NCT02220205|3534421|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3692644|NCT02220205|3534419|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3692645|NCT02220205|3534420|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3692646|NCT02220205|3534421|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3692647|NCT02220205|3534419|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3692648|NCT02220205|3534420|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3692649|NCT02220205|3534421|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3692650|NCT02220205|3534419|B3|||Age||years|Median|27|27.0|Inter-Quartile Range|||26.0|30.0|
3692651|NCT02220205|3534420|B2|||Age||years|Median|28|28.0|Inter-Quartile Range|||26.0|30.0|
3692652|NCT02220205|3534421|B1|||Age||years|Median|26|26.0|Inter-Quartile Range|||26.0|30.0|
3692653|NCT02219997|3534430|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3692654|NCT02219997|3534431|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3692655|NCT02219997|3534432|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3692656|NCT02219997|3534430|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3692657|NCT02219997|3534431|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3692658|NCT02219997|3534432|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3692659|NCT02219997|3534430|B3|||Age||years|Mean|70.6|70.6|Standard Deviation|3.0|3.0|||
3692660|NCT02219997|3534431|B2|||Age||years|Mean|70.3|70.3|Standard Deviation|2.8|2.8|||
3692661|NCT02219997|3534432|B1|||Age||years|Mean|70.8|70.8|Standard Deviation|3.2|3.2|||
3692662|NCT02219932|3534445|B3||Male|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
3692663|NCT02219932|3534446|B2||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3692664|NCT02219932|3534447|B1||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3692665|NCT02219932|3534445|B3||Female|Sex: Female, Male||Participants|Count of Participants|368|368.0||||||
3692666|NCT02219932|3534446|B2||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
3692667|NCT02219932|3534447|B1||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
3692668|NCT02219932|3534445|B3|||Age||years|Mean|48.9|48.9|Standard Deviation|10.16|10.16|||
3692669|NCT02219932|3534446|B2|||Age||years|Mean|49.0|49.0|Standard Deviation|9.82|9.82|||
3692670|NCT02219932|3534447|B1|||Age||years|Mean|48.8|48.8|Standard Deviation|10.50|10.5|||
3692671|NCT02219685|3534462|B3|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|28|28.0||||||
3692672|NCT02219685|3534463|B2|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|11|11.0||||||
3692673|NCT02219685|3534464|B1|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|17|17.0||||||
3692674|NCT02219685|3534462|B3|< 800,000 IU/mL||HCV RNA Category||participants|Number|12|12.0||||||
3692675|NCT02219685|3534463|B2|< 800,000 IU/mL||HCV RNA Category||participants|Number|3|3.0||||||
3692676|NCT02219685|3534464|B1|< 800,000 IU/mL||HCV RNA Category||participants|Number|9|9.0||||||
3692677|NCT02219685|3534462|B3|||HCV RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.58|0.58|||
3692678|NCT02219685|3534463|B2|||HCV RNA||log10 IU/mL|Mean|6.4|6.4|Standard Deviation|0.62|0.62|||
3692679|NCT02219685|3534464|B1|||HCV RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.57|0.57|||
3692680|NCT02219685|3534462|B3|TT||IL28B Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|6|6.0||||||
3692681|NCT02219685|3534463|B2|TT||IL28B Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
3692682|NCT02219685|3534464|B1|TT||IL28B Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
3692683|NCT02219685|3534462|B3|CT||IL28B Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|27|27.0||||||
3692684|NCT02219685|3534463|B2|CT||IL28B Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|8|8.0||||||
3692685|NCT02219685|3534464|B1|CT||IL28B Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|19|19.0||||||
3692686|NCT02219685|3534462|B3|CC||IL28B Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|7|7.0||||||
3692687|NCT02219685|3534463|B2|CC||IL28B Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
3692688|NCT02219685|3534464|B1|CC||IL28B Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|4|4.0||||||
3692689|NCT02219685|3534462|B3|Genotype 1b||HCV Genotype||participants|Number|5|5.0||||||
3692690|NCT02219685|3534463|B2|Genotype 1b||HCV Genotype||participants|Number|2|2.0||||||
3692691|NCT02219685|3534464|B1|Genotype 1b||HCV Genotype||participants|Number|3|3.0||||||
3692692|NCT02219685|3534462|B3|Genotype 1a||HCV Genotype||participants|Number|35|35.0||||||
3692693|NCT02219685|3534463|B2|Genotype 1a||HCV Genotype||participants|Number|12|12.0||||||
3692694|NCT02219685|3534464|B1|Genotype 1a||HCV Genotype||participants|Number|23|23.0||||||
3692695|NCT02219685|3534462|B3|Treatment-Experienced||Prior HCV Treatment Experience||participants|Number|17|17.0||||||
3692696|NCT02219685|3534463|B2|Treatment-Experienced||Prior HCV Treatment Experience||participants|Number|6|6.0||||||
3692697|NCT02219685|3534464|B1|Treatment-Experienced||Prior HCV Treatment Experience||participants|Number|11|11.0||||||
3692698|NCT02219685|3534462|B3|Treatment-Naive||Prior HCV Treatment Experience||participants|Number|23|23.0||||||
3692699|NCT02219685|3534463|B2|Treatment-Naive||Prior HCV Treatment Experience||participants|Number|8|8.0||||||
3692700|NCT02219685|3534464|B1|Treatment-Naive||Prior HCV Treatment Experience||participants|Number|15|15.0||||||
3692701|NCT02219685|3534462|B3|White||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3692702|NCT02219685|3534463|B2|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3692703|NCT02219685|3534464|B1|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3692704|NCT02219685|3534462|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3692705|NCT02219685|3534463|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3692706|NCT02219685|3534464|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3692707|NCT02219685|3534462|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3692708|NCT02219685|3534463|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3692709|NCT02219685|3534464|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3692710|NCT02219685|3534462|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3692711|NCT02219685|3534463|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3692712|NCT02219685|3534464|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3692713|NCT02219685|3534462|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3692714|NCT02219685|3534463|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3692715|NCT02219685|3534464|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3692716|NCT02219685|3534462|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3692717|NCT02219685|3534463|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3692718|NCT02219685|3534464|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3692719|NCT02219685|3534462|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3692720|NCT02219685|3534463|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3692721|NCT02219685|3534464|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3692722|NCT02219685|3534462|B3|||Age||years|Mean|45|45.0|Standard Deviation|11.5|11.5|||
3692723|NCT02219685|3534463|B2|||Age||years|Mean|47|47.0|Standard Deviation|9.8|9.8|||
3692724|NCT02219685|3534464|B1|||Age||years|Mean|44|44.0|Standard Deviation|12.4|12.4|||
3692725|NCT02219516|3534509|B5|United States||Region of Enrollment||Participants|Number|31|31.0||||||
3692726|NCT02219516|3534510|B4|United States||Region of Enrollment||Participants|Number|8|8.0||||||
3692727|NCT02219516|3534511|B3|United States||Region of Enrollment||Participants|Number|7|7.0||||||
3692728|NCT02219516|3534512|B2|United States||Region of Enrollment||Participants|Number|8|8.0||||||
3692729|NCT02219516|3534513|B1|United States||Region of Enrollment||Participants|Number|8|8.0||||||
3692730|NCT02219516|3534509|B5||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3692731|NCT02219516|3534510|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3692732|NCT02219516|3534511|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3692733|NCT02219516|3534512|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3692734|NCT02219516|3534513|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3692735|NCT02219516|3534509|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3692736|NCT02219516|3534510|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3692737|NCT02219516|3534511|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3692738|NCT02219516|3534512|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3692739|NCT02219516|3534513|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3692740|NCT02219516|3534509|B5|||Age||Years|Mean|61|61.0|Standard Deviation|9.3|9.3|||
3692741|NCT02219516|3534510|B4|||Age||Years|Mean|56|56.0|Standard Deviation|4.7|4.7|||
3692742|NCT02219516|3534511|B3|||Age||Years|Mean|58|58.0|Standard Deviation|11.1|11.1|||
3692743|NCT02219516|3534512|B2|||Age||Years|Mean|67|67.0|Standard Deviation|14.9|14.9|||
3692744|NCT02219516|3534513|B1|||Age||Years|Mean|63|63.0|Standard Deviation|6.4|6.4|||
3692745|NCT02219503|3534562|B1|Missing||Interleukin 28B (IL28B) Genotype||participants|Number|0|0.0||||||
3692746|NCT02219503|3534562|B1|TT||Interleukin 28B (IL28B) Genotype||participants|Number|14|14.0||||||
3692747|NCT02219503|3534562|B1|CT||Interleukin 28B (IL28B) Genotype||participants|Number|36|36.0||||||
3692748|NCT02219503|3534562|B1|CC||Interleukin 28B (IL28B) Genotype||participants|Number|10|10.0||||||
3692749|NCT02219503|3534562|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3692750|NCT02219503|3534562|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3692751|NCT02219503|3534562|B1|||Age||years|Mean|59.5|59.5|Standard Deviation|9.53|9.53|||
3692752|NCT02219477|3534568|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3692753|NCT02219477|3534569|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3692754|NCT02219477|3534570|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3692755|NCT02219477|3534571|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3692756|NCT02219477|3534568|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3692757|NCT02219477|3534569|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3692758|NCT02219477|3534570|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3692759|NCT02219477|3534571|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3692760|NCT02219477|3534568|B4|>= 65 years||Age, Customized||Participants|Count of Participants|7|7.0||||||
3692761|NCT02219477|3534569|B3|>= 65 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3692762|NCT02219477|3534570|B2|>= 65 years||Age, Customized||Participants|Count of Participants|4|4.0||||||
3692763|NCT02219477|3534571|B1|>= 65 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
3692764|NCT02219477|3534568|B4|< 65 years||Age, Customized||Participants|Count of Participants|29|29.0||||||
3692765|NCT02219477|3534569|B3|< 65 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
3692766|NCT02219477|3534570|B2|< 65 years||Age, Customized||Participants|Count of Participants|20|20.0||||||
3692767|NCT02219477|3534571|B1|< 65 years||Age, Customized||Participants|Count of Participants|7|7.0||||||
3692768|NCT02219464|3534599|B3|United States||Region of Enrollment||participants|Number|57|57.0||||||
3692769|NCT02219464|3534600|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3692770|NCT02219464|3534601|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3692771|NCT02219464|3534599|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3692772|NCT02219464|3534599|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3692773|NCT02219464|3534600|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3692774|NCT02219464|3534601|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3692775|NCT02219464|3534599|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3692776|NCT02219464|3534600|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3692777|NCT02219464|3534601|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3692778|NCT02219464|3534599|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3692779|NCT02219464|3534600|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3692780|NCT02219464|3534601|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3692781|NCT02219464|3534599|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3692782|NCT02219464|3534600|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3692783|NCT02219464|3534601|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3692784|NCT02219464|3534599|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3692785|NCT02219464|3534600|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3692786|NCT02219464|3534601|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3692787|NCT02219282|3534610|B3|Turkey||Region of Enrollment||participants|Number|66|66.0||||||
3692788|NCT02219282|3534611|B2|Turkey||Region of Enrollment||participants|Number|33|33.0||||||
3692789|NCT02219282|3534612|B1|Turkey||Region of Enrollment||participants|Number|33|33.0||||||
3692790|NCT02219282|3534610|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3692791|NCT02219282|3534611|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3692792|NCT02219282|3534612|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3692793|NCT02219282|3534610|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3692794|NCT02219282|3534611|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3692795|NCT02219282|3534612|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3692796|NCT02219282|3534610|B3||>=65 years|Age||Participants|Count of Participants|66|66.0||||||
3692797|NCT02219282|3534611|B2||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
3692798|NCT02219282|3534612|B1||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
3692799|NCT02219282|3534610|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3692800|NCT02219282|3534611|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3692801|NCT02219282|3534612|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3692802|NCT02219282|3534610|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3692803|NCT02219282|3534611|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3692804|NCT02219282|3534612|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3692805|NCT02219256|3534627|B13|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|24.18|24.18|Standard Deviation|2.553|2.553|||
3692806|NCT02219256|3534628|B12|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|23.98|23.98|Standard Deviation|3.064|3.064|||
3692807|NCT02219256|3534629|B11|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|25.22|25.22|Standard Deviation|2.225|2.225|||
3692808|NCT02219256|3534630|B10|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|22.85|22.85|Standard Deviation|1.947|1.947|||
3692809|NCT02219256|3534631|B9|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|25.52|25.52|Standard Deviation|2.763|2.763|||
3692810|NCT02219256|3534632|B8|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|24.80|24.8|Standard Deviation|3.311|3.311|||
3692811|NCT02219256|3534633|B7|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|23.60|23.6|Standard Deviation|1.383|1.383|||
3692812|NCT02219256|3534634|B6|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|22.45|22.45|Standard Deviation|2.118|2.118|||
3692813|NCT02219256|3534635|B5|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|24.93|24.93|Standard Deviation|3.420|3.42|||
3692814|NCT02219256|3534636|B4|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|22.33|22.33|Standard Deviation|1.176|1.176|||
3692815|NCT02219256|3534637|B3|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|25.05|25.05|Standard Deviation|2.456|2.456|||
3692816|NCT02219256|3534638|B2|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|24.53|24.53|Standard Deviation|2.337|2.337|||
3692817|NCT02219256|3534639|B1|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|24.32|24.32|Standard Deviation|2.507|2.507|||
3692818|NCT02219256|3534627|B13|||Weight||kilogram (kg)|Mean|75.20|75.2|Standard Deviation|9.149|9.149|||
3692819|NCT02219256|3534628|B12|||Weight||kilogram (kg)|Mean|71.25|71.25|Standard Deviation|9.434|9.434|||
3692820|NCT02219256|3534629|B11|||Weight||kilogram (kg)|Mean|79.73|79.73|Standard Deviation|8.311|8.311|||
3692821|NCT02219256|3534630|B10|||Weight||kilogram (kg)|Mean|75.18|75.18|Standard Deviation|9.887|9.887|||
3692822|NCT02219256|3534631|B9|||Weight||kilogram (kg)|Mean|79.77|79.77|Standard Deviation|8.584|8.584|||
3692823|NCT02219256|3534632|B8|||Weight||kilogram (kg)|Mean|78.53|78.53|Standard Deviation|12.508|12.508|||
3692824|NCT02219256|3534633|B7|||Weight||kilogram (kg)|Mean|71.32|71.32|Standard Deviation|6.187|6.187|||
3692825|NCT02219256|3534634|B6|||Weight||kilogram (kg)|Mean|69.12|69.12|Standard Deviation|8.043|8.043|||
3692826|NCT02219256|3534635|B5|||Weight||kilogram (kg)|Mean|75.45|75.45|Standard Deviation|11.042|11.042|||
3692827|NCT02219256|3534636|B4|||Weight||kilogram (kg)|Mean|72.10|72.1|Standard Deviation|9.090|9.09|||
3692828|NCT02219256|3534637|B3|||Weight||kilogram (kg)|Mean|76.68|76.68|Standard Deviation|9.011|9.011|||
3692829|NCT02219256|3534638|B2|||Weight||kilogram (kg)|Mean|80.63|80.63|Standard Deviation|8.768|8.768|||
3692830|NCT02219256|3534639|B1|||Weight||kilogram (kg)|Mean|73.98|73.98|Standard Deviation|7.355|7.355|||
3692831|NCT02219256|3534627|B13|||Height||centimeter (cm)|Mean|176.3|176.3|Standard Deviation|7.32|7.32|||
3692832|NCT02219256|3534628|B12|||Height||centimeter (cm)|Mean|172.3|172.3|Standard Deviation|4.32|4.32|||
3692833|NCT02219256|3534629|B11|||Height||centimeter (cm)|Mean|177.8|177.8|Standard Deviation|6.68|6.68|||
3692834|NCT02219256|3534630|B10|||Height||centimeter (cm)|Mean|181.2|181.2|Standard Deviation|8.80|8.8|||
3692835|NCT02219256|3534631|B9|||Height||centimeter (cm)|Mean|176.8|176.8|Standard Deviation|3.31|3.31|||
3692836|NCT02219256|3534632|B8|||Height||centimeter (cm)|Mean|177.8|177.8|Standard Deviation|7.91|7.91|||
3692837|NCT02219256|3534633|B7|||Height||centimeter (cm)|Mean|173.8|173.8|Standard Deviation|7.03|7.03|||
3692838|NCT02219256|3534634|B6|||Height||centimeter (cm)|Mean|175.5|175.5|Standard Deviation|7.97|7.97|||
3692839|NCT02219256|3534635|B5|||Height||centimeter (cm)|Mean|173.8|173.8|Standard Deviation|1.47|1.47|||
3692840|NCT02219256|3534636|B4|||Height||centimeter (cm)|Mean|179.5|179.5|Standard Deviation|10.91|10.91|||
3692841|NCT02219256|3534637|B3|||Height||centimeter (cm)|Mean|175.0|175.0|Standard Deviation|8.04|8.04|||
3692842|NCT02219256|3534638|B2|||Height||centimeter (cm)|Mean|181.3|181.3|Standard Deviation|6.90|6.9|||
3692843|NCT02219256|3534639|B1|||Height||centimeter (cm)|Mean|174.7|174.7|Standard Deviation|9.17|9.17|||
3692844|NCT02219256|3534627|B13|Never drank||Alcohol Classification||participants|Number|44|44.0||||||
3692845|NCT02219256|3534628|B12|Never drank||Alcohol Classification||participants|Number|2|2.0||||||
3692846|NCT02219256|3534629|B11|Never drank||Alcohol Classification||participants|Number|4|4.0||||||
3692847|NCT02219256|3534630|B10|Never drank||Alcohol Classification||participants|Number|5|5.0||||||
3692848|NCT02219256|3534631|B9|Never drank||Alcohol Classification||participants|Number|2|2.0||||||
3692849|NCT02219256|3534632|B8|Never drank||Alcohol Classification||participants|Number|6|6.0||||||
3692850|NCT02219256|3534633|B7|Never drank||Alcohol Classification||participants|Number|2|2.0||||||
3692851|NCT02219256|3534634|B6|Never drank||Alcohol Classification||participants|Number|5|5.0||||||
3692852|NCT02219256|3534635|B5|Never drank||Alcohol Classification||participants|Number|3|3.0||||||
3692853|NCT02219256|3534636|B4|Never drank||Alcohol Classification||participants|Number|3|3.0||||||
3692854|NCT02219256|3534637|B3|Never drank||Alcohol Classification||participants|Number|2|2.0||||||
3692855|NCT02219256|3534638|B2|Never drank||Alcohol Classification||participants|Number|3|3.0||||||
3692856|NCT02219256|3534639|B1|Never drank||Alcohol Classification||participants|Number|7|7.0||||||
3692857|NCT02219256|3534627|B13|Drinks everyday||Alcohol Classification||participants|Number|30|30.0||||||
3692858|NCT02219256|3534628|B12|Drinks everyday||Alcohol Classification||participants|Number|4|4.0||||||
3692859|NCT02219256|3534629|B11|Drinks everyday||Alcohol Classification||participants|Number|2|2.0||||||
3692860|NCT02219256|3534630|B10|Drinks everyday||Alcohol Classification||participants|Number|1|1.0||||||
3692861|NCT02219256|3534631|B9|Drinks everyday||Alcohol Classification||participants|Number|4|4.0||||||
3692862|NCT02219256|3534632|B8|Drinks everyday||Alcohol Classification||participants|Number|2|2.0||||||
3692863|NCT02219256|3534633|B7|Drinks everyday||Alcohol Classification||participants|Number|4|4.0||||||
3692864|NCT02219256|3534634|B6|Drinks everyday||Alcohol Classification||participants|Number|1|1.0||||||
3692865|NCT02219256|3534635|B5|Drinks everyday||Alcohol Classification||participants|Number|3|3.0||||||
3692866|NCT02219256|3534636|B4|Drinks everyday||Alcohol Classification||participants|Number|1|1.0||||||
3692867|NCT02219256|3534637|B3|Drinks everyday||Alcohol Classification||participants|Number|2|2.0||||||
3692868|NCT02219256|3534638|B2|Drinks everyday||Alcohol Classification||participants|Number|1|1.0||||||
3692869|NCT02219256|3534639|B1|Drinks everyday||Alcohol Classification||participants|Number|5|5.0||||||
3692870|NCT02219256|3534627|B13|Had no caffeine consumption||Caffeine Classification||participants|Number|24|24.0||||||
3692871|NCT02219256|3534628|B12|Had no caffeine consumption||Caffeine Classification||participants|Number|4|4.0||||||
3692872|NCT02219256|3534629|B11|Had no caffeine consumption||Caffeine Classification||participants|Number|1|1.0||||||
3692873|NCT02219256|3534630|B10|Had no caffeine consumption||Caffeine Classification||participants|Number|0|0.0||||||
3692874|NCT02219256|3534631|B9|Had no caffeine consumption||Caffeine Classification||participants|Number|3|3.0||||||
3692875|NCT02219256|3534632|B8|Had no caffeine consumption||Caffeine Classification||participants|Number|5|5.0||||||
3692876|NCT02219256|3534633|B7|Had no caffeine consumption||Caffeine Classification||participants|Number|3|3.0||||||
3692877|NCT02219256|3534634|B6|Had no caffeine consumption||Caffeine Classification||participants|Number|0|0.0||||||
3692878|NCT02219256|3534635|B5|Had no caffeine consumption||Caffeine Classification||participants|Number|0|0.0||||||
3692879|NCT02219256|3534636|B4|Had no caffeine consumption||Caffeine Classification||participants|Number|3|3.0||||||
3692880|NCT02219256|3534637|B3|Had no caffeine consumption||Caffeine Classification||participants|Number|1|1.0||||||
3692881|NCT02219256|3534638|B2|Had no caffeine consumption||Caffeine Classification||participants|Number|1|1.0||||||
3692882|NCT02219256|3534639|B1|Had no caffeine consumption||Caffeine Classification||participants|Number|3|3.0||||||
3692883|NCT02219256|3534627|B13|Had caffeine consumption||Caffeine Classification||participants|Number|50|50.0||||||
3692884|NCT02219256|3534628|B12|Had caffeine consumption||Caffeine Classification||participants|Number|2|2.0||||||
3692885|NCT02219256|3534629|B11|Had caffeine consumption||Caffeine Classification||participants|Number|5|5.0||||||
3692886|NCT02219256|3534630|B10|Had caffeine consumption||Caffeine Classification||participants|Number|6|6.0||||||
3692887|NCT02219256|3534631|B9|Had caffeine consumption||Caffeine Classification||participants|Number|3|3.0||||||
3692888|NCT02219256|3534632|B8|Had caffeine consumption||Caffeine Classification||participants|Number|3|3.0||||||
3692889|NCT02219256|3534633|B7|Had caffeine consumption||Caffeine Classification||participants|Number|3|3.0||||||
3692890|NCT02219256|3534634|B6|Had caffeine consumption||Caffeine Classification||participants|Number|6|6.0||||||
3692891|NCT02219256|3534635|B5|Had caffeine consumption||Caffeine Classification||participants|Number|6|6.0||||||
3692892|NCT02219256|3534636|B4|Had caffeine consumption||Caffeine Classification||participants|Number|1|1.0||||||
3692893|NCT02219256|3534637|B3|Had caffeine consumption||Caffeine Classification||participants|Number|3|3.0||||||
3692894|NCT02219256|3534638|B2|Had caffeine consumption||Caffeine Classification||participants|Number|3|3.0||||||
3692895|NCT02219256|3534639|B1|Had caffeine consumption||Caffeine Classification||participants|Number|9|9.0||||||
3692896|NCT02219256|3534627|B13|Ex-smoker||Smoking Classification||participants|Number|17|17.0||||||
3692897|NCT02219256|3534628|B12|Ex-smoker||Smoking Classification||participants|Number|1|1.0||||||
3692898|NCT02219256|3534629|B11|Ex-smoker||Smoking Classification||participants|Number|1|1.0||||||
3692899|NCT02219256|3534630|B10|Ex-smoker||Smoking Classification||participants|Number|1|1.0||||||
3692900|NCT02219256|3534631|B9|Ex-smoker||Smoking Classification||participants|Number|2|2.0||||||
3692901|NCT02219256|3534632|B8|Ex-smoker||Smoking Classification||participants|Number|1|1.0||||||
3692902|NCT02219256|3534633|B7|Ex-smoker||Smoking Classification||participants|Number|2|2.0||||||
3692903|NCT02219256|3534634|B6|Ex-smoker||Smoking Classification||participants|Number|1|1.0||||||
3692904|NCT02219256|3534635|B5|Ex-smoker||Smoking Classification||participants|Number|2|2.0||||||
3692905|NCT02219256|3534636|B4|Ex-smoker||Smoking Classification||participants|Number|1|1.0||||||
3692906|NCT02219256|3534637|B3|Ex-smoker||Smoking Classification||participants|Number|1|1.0||||||
3692907|NCT02219256|3534638|B2|Ex-smoker||Smoking Classification||participants|Number|2|2.0||||||
3692908|NCT02219256|3534639|B1|Ex-smoker||Smoking Classification||participants|Number|2|2.0||||||
3692909|NCT02219256|3534627|B13|Never smoked||Smoking Classification||participants|Number|44|44.0||||||
3692910|NCT02219256|3534628|B12|Never smoked||Smoking Classification||participants|Number|4|4.0||||||
3692911|NCT02219256|3534629|B11|Never smoked||Smoking Classification||participants|Number|4|4.0||||||
3692912|NCT02219256|3534630|B10|Never smoked||Smoking Classification||participants|Number|4|4.0||||||
3692913|NCT02219256|3534631|B9|Never smoked||Smoking Classification||participants|Number|3|3.0||||||
3692914|NCT02219256|3534632|B8|Never smoked||Smoking Classification||participants|Number|7|7.0||||||
3692915|NCT02219256|3534633|B7|Never smoked||Smoking Classification||participants|Number|4|4.0||||||
3692916|NCT02219256|3534634|B6|Never smoked||Smoking Classification||participants|Number|2|2.0||||||
3692917|NCT02219256|3534635|B5|Never smoked||Smoking Classification||participants|Number|3|3.0||||||
3692918|NCT02219256|3534636|B4|Never smoked||Smoking Classification||participants|Number|3|3.0||||||
3692919|NCT02219256|3534637|B3|Never smoked||Smoking Classification||participants|Number|2|2.0||||||
3692920|NCT02219256|3534638|B2|Never smoked||Smoking Classification||participants|Number|2|2.0||||||
3692921|NCT02219256|3534639|B1|Never smoked||Smoking Classification||participants|Number|6|6.0||||||
3692922|NCT02219256|3534627|B13|Currently smoking||Smoking Classification||participants|Number|13|13.0||||||
3692923|NCT02219256|3534628|B12|Currently smoking||Smoking Classification||participants|Number|1|1.0||||||
3692924|NCT02219256|3534629|B11|Currently smoking||Smoking Classification||participants|Number|1|1.0||||||
3692925|NCT02219256|3534630|B10|Currently smoking||Smoking Classification||participants|Number|1|1.0||||||
3692926|NCT02219256|3534631|B9|Currently smoking||Smoking Classification||participants|Number|1|1.0||||||
3692927|NCT02219256|3534632|B8|Currently smoking||Smoking Classification||participants|Number|0|0.0||||||
3692928|NCT02219256|3534633|B7|Currently smoking||Smoking Classification||participants|Number|0|0.0||||||
3692929|NCT02219256|3534634|B6|Currently smoking||Smoking Classification||participants|Number|3|3.0||||||
3692930|NCT02219256|3534635|B5|Currently smoking||Smoking Classification||participants|Number|1|1.0||||||
3692931|NCT02219256|3534636|B4|Currently smoking||Smoking Classification||participants|Number|0|0.0||||||
3692932|NCT02219256|3534637|B3|Currently smoking||Smoking Classification||participants|Number|1|1.0||||||
3692933|NCT02219256|3534638|B2|Currently smoking||Smoking Classification||participants|Number|0|0.0||||||
3692934|NCT02219256|3534639|B1|Currently smoking||Smoking Classification||participants|Number|4|4.0||||||
3692935|NCT02219256|3534627|B13|United Kingdom||Region of Enrollment||participants|Number|74|74.0||||||
3692936|NCT02219256|3534628|B12|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3692937|NCT02219256|3534629|B11|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3692938|NCT02219256|3534630|B10|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3692939|NCT02219256|3534631|B9|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3692940|NCT02219256|3534632|B8|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3692941|NCT02219256|3534633|B7|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3692942|NCT02219256|3534634|B6|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3692943|NCT02219256|3534635|B5|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3692944|NCT02219256|3534636|B4|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3692945|NCT02219256|3534637|B3|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3692946|NCT02219256|3534638|B2|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3692947|NCT02219256|3534639|B1|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
3692948|NCT02219256|3534627|B13|Multiracial||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3692949|NCT02219256|3534628|B12|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3692950|NCT02219256|3534629|B11|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3692951|NCT02219256|3534630|B10|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3692952|NCT02219256|3534631|B9|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3692953|NCT02219256|3534632|B8|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3692954|NCT02219256|3534633|B7|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3692955|NCT02219256|3534634|B6|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3692956|NCT02219256|3534635|B5|Multiracial||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3692957|NCT02219256|3534636|B4|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3692958|NCT02219256|3534637|B3|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3692959|NCT02219256|3534638|B2|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3692960|NCT02219256|3534639|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3692961|NCT02219256|3534627|B13|Asian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3692962|NCT02219256|3534628|B12|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3692963|NCT02219256|3534629|B11|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3692964|NCT02219256|3534630|B10|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3692965|NCT02219256|3534631|B9|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3692966|NCT02219256|3534632|B8|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3692967|NCT02219256|3534633|B7|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3692968|NCT02219256|3534634|B6|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3692969|NCT02219256|3534635|B5|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3692970|NCT02219256|3534636|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3692971|NCT02219256|3534637|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3692972|NCT02219256|3534638|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3692973|NCT02219256|3534639|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3692974|NCT02219256|3534627|B13|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3692975|NCT02219256|3534628|B12|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3692976|NCT02219256|3534629|B11|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3692977|NCT02219256|3534630|B10|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3692978|NCT02219256|3534631|B9|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3692979|NCT02219256|3534632|B8|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3692980|NCT02219256|3534633|B7|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3692981|NCT02219256|3534634|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3692982|NCT02219256|3534635|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3692983|NCT02219256|3534636|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3692984|NCT02219256|3534637|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3692985|NCT02219256|3534638|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3692986|NCT02219256|3534639|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3692987|NCT02219256|3534627|B13|White||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
3692988|NCT02219256|3534628|B12|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3692989|NCT02219256|3534629|B11|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3692990|NCT02219256|3534630|B10|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3692991|NCT02219256|3534631|B9|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3692992|NCT02219256|3534632|B8|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3692993|NCT02219256|3534633|B7|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3692994|NCT02219256|3534634|B6|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3692995|NCT02219256|3534635|B5|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3692996|NCT02219256|3534636|B4|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3692997|NCT02219256|3534637|B3|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3692998|NCT02219256|3534638|B2|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3692999|NCT02219256|3534639|B1|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3693000|NCT02219256|3534627|B13||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3693001|NCT02219256|3534628|B12||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3693002|NCT02219256|3534629|B11||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3693003|NCT02219256|3534630|B10||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3693004|NCT02219256|3534631|B9||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3693005|NCT02219256|3534632|B8||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3693006|NCT02219256|3534633|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3693007|NCT02219256|3534634|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3693008|NCT02219256|3534635|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3693009|NCT02219256|3534636|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3693010|NCT02219256|3534637|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3693011|NCT02219256|3534638|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3693012|NCT02219256|3534639|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3693013|NCT02219256|3534627|B13||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3693014|NCT02219256|3534628|B12||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3693015|NCT02219256|3534629|B11||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3693016|NCT02219256|3534630|B10||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3693017|NCT02219256|3534631|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3693018|NCT02219256|3534632|B8||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3693019|NCT02219256|3534633|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3693020|NCT02219256|3534634|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3693021|NCT02219256|3534635|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3693022|NCT02219256|3534636|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3693023|NCT02219256|3534637|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3693024|NCT02219256|3534638|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3693025|NCT02219256|3534639|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3693026|NCT02219256|3534627|B13|||Age||years|Mean|34.3|34.3|Standard Deviation|10.19|10.19|||
3693027|NCT02219256|3534628|B12|||Age||years|Mean|27.7|27.7|Standard Deviation|8.16|8.16|||
3693028|NCT02219256|3534629|B11|||Age||years|Mean|40.8|40.8|Standard Deviation|7.83|7.83|||
3693029|NCT02219256|3534630|B10|||Age||years|Mean|31.0|31.0|Standard Deviation|8.15|8.15|||
3693030|NCT02219256|3534631|B9|||Age||years|Mean|36.7|36.7|Standard Deviation|10.33|10.33|||
3693031|NCT02219256|3534632|B8|||Age||years|Mean|34.9|34.9|Standard Deviation|13.61|13.61|||
3693032|NCT02219256|3534633|B7|||Age||years|Mean|35.7|35.7|Standard Deviation|11.60|11.6|||
3693033|NCT02219256|3534634|B6|||Age||years|Mean|32.3|32.3|Standard Deviation|5.92|5.92|||
3693034|NCT02219256|3534635|B5|||Age||years|Mean|36.2|36.2|Standard Deviation|9.52|9.52|||
3693035|NCT02219256|3534636|B4|||Age||years|Mean|32.8|32.8|Standard Deviation|10.72|10.72|||
3693036|NCT02219256|3534637|B3|||Age||years|Mean|42.3|42.3|Standard Deviation|12.12|12.12|||
3693037|NCT02219256|3534638|B2|||Age||years|Mean|23.5|23.5|Standard Deviation|3.42|3.42|||
3693038|NCT02219256|3534639|B1|||Age||years|Mean|35.5|35.5|Standard Deviation|10.61|10.61|||
3693039|NCT02219087|3534760|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3693040|NCT02219087|3534761|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3693041|NCT02219087|3534762|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3693042|NCT02219087|3534760|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3693043|NCT02219087|3534761|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3693044|NCT02219087|3534762|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3693045|NCT02219087|3534760|B3|||Age||years|Mean|63.1|63.1|Standard Deviation|8.7|8.7|||
3693046|NCT02219087|3534761|B2|||Age||years|Mean|61.2|61.2|Standard Deviation|8.9|8.9|||
3693047|NCT02219087|3534762|B1|||Age||years|Mean|65.0|65.0|Standard Deviation|8.3|8.3|||
3693048|NCT02219009|3534781|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3693049|NCT02219009|3534782|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3693050|NCT02219009|3534783|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3693051|NCT02219009|3534781|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3693052|NCT02219009|3534782|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3693053|NCT02219009|3534783|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3693054|NCT02219009|3534781|B3|||Age||years|Mean|46.6|46.6|Standard Deviation|9.7|9.7|||
3693055|NCT02219009|3534782|B2|||Age||years|Mean|47.6|47.6|Standard Deviation|8.9|8.9|||
3693056|NCT02219009|3534783|B1|||Age||years|Mean|45.8|45.8|Standard Deviation|10.3|10.3|||
3693057|NCT02218697|3534794|B3|Mixed Origin||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3693058|NCT02218697|3534795|B2|Mixed Origin||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3693059|NCT02218697|3534796|B1|Mixed Origin||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3693060|NCT02218697|3534794|B3|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Number|347|347.0||||||
3693061|NCT02218697|3534795|B2|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Number|172|172.0||||||
3693062|NCT02218697|3534796|B1|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Number|175|175.0||||||
3693063|NCT02218697|3534794|B3|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3693064|NCT02218697|3534795|B2|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3693065|NCT02218697|3534796|B1|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3693066|NCT02218697|3534794|B3|African Heritage / African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3693067|NCT02218697|3534795|B2|African Heritage / African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3693068|NCT02218697|3534796|B1|African Heritage / African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3693069|NCT02218697|3534794|B3||Male|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
3693070|NCT02218697|3534795|B2||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3693071|NCT02218697|3534796|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3693072|NCT02218697|3534794|B3||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3693073|NCT02218697|3534795|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3693074|NCT02218697|3534796|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3693075|NCT02218697|3534794|B3|||Age||Years|Mean|68.3|68.3|Standard Deviation|9.2|9.2|||
3693076|NCT02218697|3534795|B2|||Age||Years|Mean|68.1|68.1|Standard Deviation|9.0|9.0|||
3693077|NCT02218697|3534796|B1|||Age||Years|Mean|68.4|68.4|Standard Deviation|9.4|9.4|||
3693078|NCT02218541|3534835|B3|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3693079|NCT02218541|3534836|B2|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3693080|NCT02218541|3534837|B1|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3693081|NCT02218541|3534835|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3693082|NCT02218541|3534836|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3693083|NCT02218541|3534837|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3693084|NCT02218541|3534835|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693085|NCT02218541|3534836|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693086|NCT02218541|3534837|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693087|NCT02218541|3534835|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3693088|NCT02218541|3534836|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3693089|NCT02218541|3534837|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3693090|NCT02218541|3534835|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3693091|NCT02218541|3534836|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3693092|NCT02218541|3534837|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3693093|NCT02218541|3534835|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693094|NCT02218541|3534836|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693095|NCT02218541|3534837|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693096|NCT02218541|3534835|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3693097|NCT02218541|3534836|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693098|NCT02218541|3534837|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3693099|NCT02218541|3534835|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693100|NCT02218541|3534836|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693101|NCT02218541|3534837|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693102|NCT02218541|3534835|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3693103|NCT02218541|3534836|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3693104|NCT02218541|3534837|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3693105|NCT02218541|3534835|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3693106|NCT02218541|3534836|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3693107|NCT02218541|3534837|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3693108|NCT02218541|3534835|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3693109|NCT02218541|3534836|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3693110|NCT02218541|3534837|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3693111|NCT02218541|3534835|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3693112|NCT02218541|3534836|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3693113|NCT02218541|3534837|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3693114|NCT02218541|3534835|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3693115|NCT02218541|3534836|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3693116|NCT02218541|3534837|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3693117|NCT02218424|3534848|B3|||Surgical Duration||Minutes|Median|35|35.0|Inter-Quartile Range|||33.0|40.0|
3693118|NCT02218424|3534849|B2|||Surgical Duration||Minutes|Median|35|35.0|Inter-Quartile Range|||33.0|39.0|
3693119|NCT02218424|3534850|B1|||Surgical Duration||Minutes|Median|36.5|36.5|Inter-Quartile Range|||32.0|40.0|
3693120|NCT02218424|3534848|B3||No|Obstructive Sleep Apnea (Yes/No)||Participants|Count of Participants|45|45.0||||||
3693121|NCT02218424|3534849|B2||No|Obstructive Sleep Apnea (Yes/No)||Participants|Count of Participants|22|22.0||||||
3693122|NCT02218424|3534850|B1||No|Obstructive Sleep Apnea (Yes/No)||Participants|Count of Participants|23|23.0||||||
3693123|NCT02218424|3534848|B3||Yes|Obstructive Sleep Apnea (Yes/No)||Participants|Count of Participants|15|15.0||||||
3693124|NCT02218424|3534849|B2||Yes|Obstructive Sleep Apnea (Yes/No)||Participants|Count of Participants|8|8.0||||||
3693125|NCT02218424|3534850|B1||Yes|Obstructive Sleep Apnea (Yes/No)||Participants|Count of Participants|7|7.0||||||
3693126|NCT02218424|3534848|B3|||Body Mass Index||kg/m2|Median|16.4|16.4|Inter-Quartile Range|||14.2|19.8|
3693127|NCT02218424|3534849|B2|||Body Mass Index||kg/m2|Median|16.9|16.9|Inter-Quartile Range|||14.4|20.0|
3693128|NCT02218424|3534850|B1|||Body Mass Index||kg/m2|Median|16.1|16.1|Inter-Quartile Range|||14.3|18.2|
3693129|NCT02218424|3534848|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
3693130|NCT02218424|3534849|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3693131|NCT02218424|3534850|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3693132|NCT02218424|3534848|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3693133|NCT02218424|3534849|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3693134|NCT02218424|3534850|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3693135|NCT02218424|3534848|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3693136|NCT02218424|3534849|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3693137|NCT02218424|3534850|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3693138|NCT02218424|3534848|B3|||Age||Months|Median|76.5|76.5|Inter-Quartile Range|||63.0|92.0|
3693139|NCT02218424|3534849|B2|||Age||Months|Median|76.5|76.5|Inter-Quartile Range|||61.0|92.0|
3693140|NCT02218424|3534850|B1|||Age||Months|Median|76.5|76.5|Inter-Quartile Range|||65.0|94.0|
3693141|NCT02218372|3534871|B3|Missing||Ethnicity||Participants|Count of Participants|12|12.0||||||
3693142|NCT02218372|3534872|B2|Missing||Ethnicity||Participants|Count of Participants|6|6.0||||||
3693143|NCT02218372|3534873|B1|Missing||Ethnicity||Participants|Count of Participants|6|6.0||||||
3693144|NCT02218372|3534871|B3|Not Hispanic or Latino||Ethnicity||Participants|Count of Participants|119|119.0||||||
3693145|NCT02218372|3534872|B2|Not Hispanic or Latino||Ethnicity||Participants|Count of Participants|37|37.0||||||
3693146|NCT02218372|3534873|B1|Not Hispanic or Latino||Ethnicity||Participants|Count of Participants|82|82.0||||||
3693147|NCT02218372|3534871|B3|Hispanic or Latino||Ethnicity||Participants|Count of Participants|17|17.0||||||
3693148|NCT02218372|3534872|B2|Hispanic or Latino||Ethnicity||Participants|Count of Participants|5|5.0||||||
3693149|NCT02218372|3534873|B1|Hispanic or Latino||Ethnicity||Participants|Count of Participants|12|12.0||||||
3693150|NCT02218372|3534871|B3|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3693151|NCT02218372|3534872|B2|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3693152|NCT02218372|3534873|B1|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3693153|NCT02218372|3534871|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3693154|NCT02218372|3534872|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3693155|NCT02218372|3534873|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3693156|NCT02218372|3534871|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3693157|NCT02218372|3534872|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3693158|NCT02218372|3534873|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3693159|NCT02218372|3534871|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3693160|NCT02218372|3534872|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3693161|NCT02218372|3534873|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3693162|NCT02218372|3534871|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|119|119.0||||||
3693163|NCT02218372|3534872|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3693164|NCT02218372|3534873|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|83|83.0||||||
3693165|NCT02218372|3534871|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3693166|NCT02218372|3534872|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3693167|NCT02218372|3534873|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3693168|NCT02218372|3534871|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3693169|NCT02218372|3534872|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3693170|NCT02218372|3534873|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3693171|NCT02218372|3534871|B3|||Age||months|Mean|79|79.0|Standard Deviation|60.8|60.8|||
3693172|NCT02218372|3534872|B2|||Age||months|Mean|77.5|77.5|Standard Deviation|59.2|59.2|||
3693173|NCT02218372|3534873|B1|||Age||months|Mean|79.7|79.7|Standard Deviation|61.8|61.8|||
3693174|NCT02218320|3534930|B3|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3693175|NCT02218320|3534931|B2|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3693176|NCT02218320|3534932|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3693177|NCT02218320|3534930|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693178|NCT02218320|3534931|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693179|NCT02218320|3534932|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693180|NCT02218320|3534930|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3693181|NCT02218320|3534931|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3693182|NCT02218320|3534932|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693183|NCT02218320|3534930|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3693184|NCT02218320|3534931|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3693185|NCT02218320|3534932|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3693186|NCT02218320|3534930|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3693187|NCT02218320|3534931|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3693188|NCT02218320|3534932|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3693189|NCT02218320|3534930|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693190|NCT02218320|3534931|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693191|NCT02218320|3534932|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693192|NCT02218320|3534930|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693193|NCT02218320|3534931|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693194|NCT02218320|3534932|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693195|NCT02218320|3534930|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693196|NCT02218320|3534931|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693197|NCT02218320|3534932|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693440|NCT02217878|3535091|B2|||BMI||kg/m^2|Mean|27.4|27.4|Standard Deviation|4.0|4.0|||
3693198|NCT02218320|3534930|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693199|NCT02218320|3534931|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693200|NCT02218320|3534932|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693201|NCT02218320|3534930|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3693202|NCT02218320|3534931|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3693203|NCT02218320|3534932|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3693204|NCT02218320|3534930|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693205|NCT02218320|3534931|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693206|NCT02218320|3534932|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693207|NCT02218320|3534930|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3693208|NCT02218320|3534931|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3693209|NCT02218320|3534932|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3693210|NCT02218320|3534930|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3693211|NCT02218320|3534931|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3693212|NCT02218320|3534932|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3693213|NCT02218320|3534930|B3|||Age||years|Median|52.5|52.5|Full Range|||32.0|64.0|
3693214|NCT02218320|3534931|B2|||Age||years|Median|49.5|49.5|Full Range|||32.0|56.0|
3693215|NCT02218320|3534932|B1|||Age||years|Median|54.5|54.5|Full Range|||48.0|64.0|
3693216|NCT02218320|3534930|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3693217|NCT02218320|3534931|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3693218|NCT02218320|3534932|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3693219|NCT02218320|3534930|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3693220|NCT02218320|3534931|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3693221|NCT02218320|3534932|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3693222|NCT02218320|3534930|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3693223|NCT02218320|3534931|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3693224|NCT02218320|3534932|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3693225|NCT02218307|3534943|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3693226|NCT02218307|3534944|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3693227|NCT02218307|3534945|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3693228|NCT02218307|3534943|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3693229|NCT02218307|3534944|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3693230|NCT02218307|3534945|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3693231|NCT02218307|3534943|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3693232|NCT02218307|3534944|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3693233|NCT02218307|3534945|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3693234|NCT02218307|3534943|B3||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
3693235|NCT02218307|3534944|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3693236|NCT02218307|3534945|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3693237|NCT02218307|3534943|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3693238|NCT02218307|3534944|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3693239|NCT02218307|3534945|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3693240|NCT02218268|3534954|B1|||HbA1c||percentage|Mean|7.86|7.86|Standard Deviation|0.96|0.96|||
3693241|NCT02218268|3534954|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
3693242|NCT02218268|3534954|B1||Male|Gender||Participants|Count of Participants|28|28.0||||||
3693243|NCT02218268|3534954|B1||Female|Gender||Participants|Count of Participants|32|32.0||||||
3693244|NCT02218268|3534954|B1|||Age||years|Mean|12.5|12.5|Standard Deviation|2.13|2.13|||
3693245|NCT02218242|3534961|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3693246|NCT02218242|3534961|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693247|NCT02218242|3534961|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693248|NCT02218242|3534961|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3693249|NCT02218242|3534961|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693250|NCT02218242|3534961|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693251|NCT02218242|3534961|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693252|NCT02218242|3534961|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693253|NCT02218242|3534961|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3693254|NCT02218242|3534961|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3693255|NCT02218242|3534961|B1||>=65 years|Age|Age information was collected at the time of consenting|Participants|Count of Participants|6|6.0||||||
3693256|NCT02218242|3534961|B1||Between 18 and 65 years|Age|Age information was collected at the time of consenting|Participants|Count of Participants|3|3.0||||||
3693441|NCT02217878|3535092|B1|||BMI||kg/m^2|Mean|27.6|27.6|Standard Deviation|4.3|4.3|||
3693257|NCT02218242|3534961|B1||<=18 years|Age|Age information was collected at the time of consenting|Participants|Count of Participants|0|0.0||||||
3693258|NCT02218216|3534965|B3|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3693259|NCT02218216|3534966|B2|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3693260|NCT02218216|3534967|B1|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3693261|NCT02218216|3534965|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3693262|NCT02218216|3534966|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3693263|NCT02218216|3534967|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3693264|NCT02218216|3534965|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3693265|NCT02218216|3534966|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3693266|NCT02218216|3534967|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3693267|NCT02218216|3534965|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3693268|NCT02218216|3534966|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3693269|NCT02218216|3534967|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3693270|NCT02218216|3534965|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3693271|NCT02218216|3534966|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3693272|NCT02218216|3534967|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3693273|NCT02218216|3534965|B3||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
3693274|NCT02218216|3534966|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3693275|NCT02218216|3534967|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
3693276|NCT02218203|3534977|B1|North America||Region of Enrollment||participants|Number|26|26.0||||||
3693277|NCT02218203|3534977|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3693278|NCT02218203|3534977|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3693279|NCT02218203|3534977|B1|||Age||years|Mean|46.84|46.84|Standard Deviation|11.32|11.32|||
3693280|NCT02218203|3534977|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3693281|NCT02218203|3534977|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3693282|NCT02218203|3534977|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3693283|NCT02218164|3534999|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3693284|NCT02218164|3534999|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3693285|NCT02218164|3534999|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3693286|NCT02218164|3534999|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3693287|NCT02218164|3534999|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3693288|NCT02218164|3534999|B1|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3693289|NCT02218164|3534999|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3693290|NCT02218164|3534999|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3693291|NCT02218164|3534999|B1|||Age||years|Mean|72|72.0|Full Range|||63.0|80.0|
3693292|NCT02217982|3535006|B3|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3693293|NCT02217982|3535007|B2|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3693294|NCT02217982|3535008|B1|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3693295|NCT02217982|3535006|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3693296|NCT02217982|3535007|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3693297|NCT02217982|3535008|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3693298|NCT02217982|3535006|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3693299|NCT02217982|3535007|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3693300|NCT02217982|3535008|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3693301|NCT02217982|3535006|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3693302|NCT02217982|3535007|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3693303|NCT02217982|3535008|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3693304|NCT02217982|3535006|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3693305|NCT02217982|3535007|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3693306|NCT02217982|3535008|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3693307|NCT02217982|3535006|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3693308|NCT02217982|3535007|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3693309|NCT02217982|3535008|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3693310|NCT02217904|3535017|B6|||Plasma HIV-1 Ribonucleic Acid (RNA)||log10 copies/mL|Mean|4.56|4.56|Standard Deviation|0.40|0.4|||
3693311|NCT02217904|3535018|B5|||Plasma HIV-1 Ribonucleic Acid (RNA)||log10 copies/mL|Mean|4.59|4.59|Standard Deviation|0.5|0.5|||
3693312|NCT02217904|3535019|B4|||Plasma HIV-1 Ribonucleic Acid (RNA)||log10 copies/mL|Mean|4.66|4.66|Standard Deviation|0.2|0.2|||
3693313|NCT02217904|3535020|B3|||Plasma HIV-1 Ribonucleic Acid (RNA)||log10 copies/mL|Mean|4.17|4.17|Standard Deviation|0.41|0.41|||
3693314|NCT02217904|3535021|B2|||Plasma HIV-1 Ribonucleic Acid (RNA)||log10 copies/mL|Mean|4.7|4.7|Standard Deviation|0.25|0.25|||
3693315|NCT02217904|3535022|B1|||Plasma HIV-1 Ribonucleic Acid (RNA)||log10 copies/mL|Mean|4.68|4.68|Standard Deviation|0.39|0.39|||
3693316|NCT02217904|3535017|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693317|NCT02217904|3535018|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693318|NCT02217904|3535019|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693319|NCT02217904|3535020|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693320|NCT02217904|3535021|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693321|NCT02217904|3535022|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693322|NCT02217904|3535017|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693323|NCT02217904|3535018|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693324|NCT02217904|3535019|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693325|NCT02217904|3535020|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693326|NCT02217904|3535021|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693327|NCT02217904|3535022|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693328|NCT02217904|3535017|B6||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3693329|NCT02217904|3535018|B5||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3693330|NCT02217904|3535019|B4||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3693331|NCT02217904|3535020|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3693332|NCT02217904|3535021|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3693333|NCT02217904|3535022|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3693334|NCT02217904|3535017|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693335|NCT02217904|3535018|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693336|NCT02217904|3535019|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693337|NCT02217904|3535020|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693338|NCT02217904|3535021|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693339|NCT02217904|3535022|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693340|NCT02217904|3535017|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693341|NCT02217904|3535018|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693342|NCT02217904|3535019|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693343|NCT02217904|3535020|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693344|NCT02217904|3535021|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693345|NCT02217904|3535022|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693346|NCT02217904|3535017|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3693347|NCT02217904|3535018|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693348|NCT02217904|3535019|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3693349|NCT02217904|3535020|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693350|NCT02217904|3535021|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693351|NCT02217904|3535022|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693352|NCT02217904|3535017|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693353|NCT02217904|3535018|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693354|NCT02217904|3535019|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693355|NCT02217904|3535020|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693356|NCT02217904|3535021|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693357|NCT02217904|3535022|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693358|NCT02217904|3535017|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693359|NCT02217904|3535018|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693360|NCT02217904|3535019|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693361|NCT02217904|3535020|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693362|NCT02217904|3535021|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693363|NCT02217904|3535022|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693364|NCT02217904|3535017|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3693365|NCT02217904|3535018|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3693366|NCT02217904|3535019|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3693367|NCT02217904|3535020|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3693368|NCT02217904|3535021|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3693369|NCT02217904|3535022|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3693370|NCT02217904|3535017|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3693371|NCT02217904|3535018|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693372|NCT02217904|3535019|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3693373|NCT02217904|3535020|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693374|NCT02217904|3535021|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693375|NCT02217904|3535022|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3693376|NCT02217904|3535017|B6||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3693377|NCT02217904|3535018|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3693378|NCT02217904|3535019|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3693379|NCT02217904|3535020|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3693380|NCT02217904|3535021|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3693381|NCT02217904|3535022|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3693382|NCT02217904|3535017|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3693383|NCT02217904|3535018|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3693384|NCT02217904|3535019|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3693385|NCT02217904|3535020|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3693386|NCT02217904|3535021|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3693387|NCT02217904|3535022|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3693388|NCT02217904|3535017|B6|||Age||Years|Mean|35.5|35.5|Standard Deviation|10.6|10.6|||
3693389|NCT02217904|3535018|B5|||Age||Years|Mean|35.5|35.5|Standard Deviation|11.3|11.3|||
3693390|NCT02217904|3535019|B4|||Age||Years|Mean|32.7|32.7|Standard Deviation|12.7|12.7|||
3693391|NCT02217904|3535020|B3|||Age||Years|Mean|35.5|35.5|Standard Deviation|9.1|9.1|||
3693392|NCT02217904|3535021|B2|||Age||Years|Mean|42.2|42.2|Standard Deviation|9.8|9.8|||
3693393|NCT02217904|3535022|B1|||Age||Years|Mean|31.5|31.5|Standard Deviation|10.0|10.0|||
3693394|NCT02217878|3535090|B3|||Gout||participants|Number|3|3.0||||||
3693395|NCT02217878|3535091|B2|||Gout||participants|Number|2|2.0||||||
3693396|NCT02217878|3535092|B1|||Gout||participants|Number|1|1.0||||||
3693397|NCT02217878|3535090|B3|||Chronic obstructive pulmonary disease||participants|Number|2|2.0||||||
3693398|NCT02217878|3535091|B2|||Chronic obstructive pulmonary disease||participants|Number|0|0.0||||||
3693399|NCT02217878|3535092|B1|||Chronic obstructive pulmonary disease||participants|Number|2|2.0||||||
3693400|NCT02217878|3535090|B3|||Chronic renal disease||participants|Number|3|3.0||||||
3693401|NCT02217878|3535091|B2|||Chronic renal disease||participants|Number|2|2.0||||||
3693402|NCT02217878|3535092|B1|||Chronic renal disease||participants|Number|1|1.0||||||
3693403|NCT02217878|3535090|B3|||Peripheral arterial disease||participants|Number|4|4.0||||||
3693404|NCT02217878|3535091|B2|||Peripheral arterial disease||participants|Number|1|1.0||||||
3693405|NCT02217878|3535092|B1|||Peripheral arterial disease||participants|Number|3|3.0||||||
3693406|NCT02217878|3535090|B3|||Prior non-haemorrhagic stroke||participants|Number|1|1.0||||||
3693407|NCT02217878|3535091|B2|||Prior non-haemorrhagic stroke||participants|Number|0|0.0||||||
3693408|NCT02217878|3535092|B1|||Prior non-haemorrhagic stroke||participants|Number|1|1.0||||||
3693409|NCT02217878|3535090|B3|||Prior non-severe heart failure||participants|Number|3|3.0||||||
3693410|NCT02217878|3535091|B2|||Prior non-severe heart failure||participants|Number|3|3.0||||||
3693411|NCT02217878|3535092|B1|||Prior non-severe heart failure||participants|Number|0|0.0||||||
3693412|NCT02217878|3535090|B3|||Prior CABG||participants|Number|0|0.0||||||
3693413|NCT02217878|3535091|B2|||Prior CABG||participants|Number|0|0.0||||||
3693414|NCT02217878|3535092|B1|||Prior CABG||participants|Number|0|0.0||||||
3693415|NCT02217878|3535090|B3|||Prior PCI||participants|Number|13|13.0||||||
3693416|NCT02217878|3535091|B2|||Prior PCI||participants|Number|9|9.0||||||
3693417|NCT02217878|3535092|B1|||Prior PCI||participants|Number|4|4.0||||||
3693418|NCT02217878|3535090|B3|||Prior AMI||participants|Number|13|13.0||||||
3693419|NCT02217878|3535091|B2|||Prior AMI||participants|Number|8|8.0||||||
3693420|NCT02217878|3535092|B1|||Prior AMI||participants|Number|5|5.0||||||
3693421|NCT02217878|3535090|B3|||Current smoker||participants|Number|31|31.0||||||
3693422|NCT02217878|3535091|B2|||Current smoker||participants|Number|14|14.0||||||
3693423|NCT02217878|3535092|B1|||Current smoker||participants|Number|17|17.0||||||
3693424|NCT02217878|3535090|B3|||Dyslipidaemia||participants|Number|61|61.0||||||
3693425|NCT02217878|3535091|B2|||Dyslipidaemia||participants|Number|31|31.0||||||
3693426|NCT02217878|3535092|B1|||Dyslipidaemia||participants|Number|30|30.0||||||
3693427|NCT02217878|3535090|B3|||Diabetes mellitus||participants|Number|13|13.0||||||
3693428|NCT02217878|3535091|B2|||Diabetes mellitus||participants|Number|5|5.0||||||
3693429|NCT02217878|3535092|B1|||Diabetes mellitus||participants|Number|8|8.0||||||
3693430|NCT02217878|3535090|B3|||Hypertension||participants|Number|36|36.0||||||
3693431|NCT02217878|3535091|B2|||Hypertension||participants|Number|21|21.0||||||
3693432|NCT02217878|3535092|B1|||Hypertension||participants|Number|15|15.0||||||
3693433|NCT02217878|3535090|B3|||GP IIb/IIIa administration||participants|Number|16|16.0||||||
3693434|NCT02217878|3535091|B2|||GP IIb/IIIa administration||participants|Number|6|6.0||||||
3693435|NCT02217878|3535092|B1|||GP IIb/IIIa administration||participants|Number|10|10.0||||||
3693436|NCT02217878|3535090|B3|||STEMI||participants|Number|45|45.0||||||
3693437|NCT02217878|3535091|B2|||STEMI||participants|Number|21|21.0||||||
3693438|NCT02217878|3535092|B1|||STEMI||participants|Number|24|24.0||||||
3693439|NCT02217878|3535090|B3|||BMI||kg/m^2|Mean|27.5|27.5|Standard Deviation|4.2|4.2|||
3693442|NCT02217878|3535090|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3693443|NCT02217878|3535091|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3693444|NCT02217878|3535092|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3693445|NCT02217878|3535090|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3693446|NCT02217878|3535091|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3693447|NCT02217878|3535092|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3693448|NCT02217878|3535090|B3|||Age||years|Mean|61.5|61.5|Standard Deviation|10.3|10.3|||
3693449|NCT02217878|3535091|B2|||Age||years|Mean|62.5|62.5|Standard Deviation|10.5|10.5|||
3693450|NCT02217878|3535092|B1|||Age||years|Mean|60.7|60.7|Standard Deviation|10.5|10.5|||
3693451|NCT02217800|3535173|B1|Ukraine||Region of Enrollment||participants|Number|8|8.0||||||
3693452|NCT02217800|3535173|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3693453|NCT02217800|3535173|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3693454|NCT02217800|3535173|B1|||Age||years|Mean|42.4|42.4|Standard Deviation|8.3|8.3|||
3693455|NCT02217618|3535185|B1|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3693456|NCT02217618|3535185|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693457|NCT02217618|3535185|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693458|NCT02217618|3535185|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3693459|NCT02217618|3535185|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3693460|NCT02217618|3535185|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693461|NCT02217618|3535185|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693462|NCT02217618|3535185|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693463|NCT02217618|3535185|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693464|NCT02217618|3535185|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3693465|NCT02217618|3535185|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3693466|NCT02217618|3535185|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3693467|NCT02217618|3535185|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3693468|NCT02217618|3535185|B1|||Age||years|Mean|48.4|48.4|Standard Deviation|13.3|13.3|||
3693469|NCT02217527|3535191|B3|||Fagerstrom Test of Nicotine Dependence (FTND) scale score|All completed the Fagerstrom Test of Nicotine Dependence (FTND) scale score at baseline, to assess severity of current nicotine dependence. FTND scores range from 0-10, and higher scores index more severe dependence. These scores were not used to determine eligibility, just to characterize dependence severity.|units on a scale|Mean|4.9|4.9|Standard Deviation|1.5|1.5|||
3693470|NCT02217527|3535192|B2|||Fagerstrom Test of Nicotine Dependence (FTND) scale score|All completed the Fagerstrom Test of Nicotine Dependence (FTND) scale score at baseline, to assess severity of current nicotine dependence. FTND scores range from 0-10, and higher scores index more severe dependence. These scores were not used to determine eligibility, just to characterize dependence severity.|units on a scale|Mean|4.9|4.9|Standard Deviation|1.5|1.5|||
3693471|NCT02217527|3535193|B1|||Fagerstrom Test of Nicotine Dependence (FTND) scale score|All completed the Fagerstrom Test of Nicotine Dependence (FTND) scale score at baseline, to assess severity of current nicotine dependence. FTND scores range from 0-10, and higher scores index more severe dependence. These scores were not used to determine eligibility, just to characterize dependence severity.|units on a scale|Mean|4.9|4.9|Standard Deviation|1.5|1.5|||
3693472|NCT02217527|3535191|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
3693473|NCT02217527|3535192|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
3693474|NCT02217527|3535193|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3693475|NCT02217527|3535191|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693476|NCT02217527|3535192|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693477|NCT02217527|3535193|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693478|NCT02217527|3535191|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3693479|NCT02217527|3535192|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3693480|NCT02217527|3535193|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3693481|NCT02217527|3535191|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693482|NCT02217527|3535192|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693483|NCT02217527|3535193|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693484|NCT02217527|3535191|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3693485|NCT02217527|3535192|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3693486|NCT02217527|3535193|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3693487|NCT02217527|3535191|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3693488|NCT02217527|3535192|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3693489|NCT02217527|3535193|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3693490|NCT02217527|3535191|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3693491|NCT02217527|3535192|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3693492|NCT02217527|3535193|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3693493|NCT02217527|3535191|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3693494|NCT02217527|3535192|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3693495|NCT02217527|3535193|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3693496|NCT02217527|3535191|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3693497|NCT02217527|3535192|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3693498|NCT02217527|3535193|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3693499|NCT02217410|3535204|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3693500|NCT02217410|3535205|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3693501|NCT02217410|3535206|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3693502|NCT02217410|3535207|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3693503|NCT02217410|3535204|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3693504|NCT02217410|3535205|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3693505|NCT02217410|3535206|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3693506|NCT02217410|3535207|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3693507|NCT02217410|3535204|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3693508|NCT02217410|3535205|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693509|NCT02217410|3535206|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3693510|NCT02217410|3535207|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693511|NCT02217410|3535204|B4||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3693512|NCT02217410|3535205|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3693513|NCT02217410|3535206|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3693514|NCT02217410|3535207|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3693515|NCT02217410|3535204|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3693516|NCT02217410|3535205|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3693517|NCT02217410|3535206|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3693518|NCT02217410|3535207|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3693519|NCT02217410|3535204|B4|||Age||years|Mean|50.1|50.1|Standard Deviation|15.91|15.91|||
3693520|NCT02217410|3535205|B3|||Age||years|Mean|53.4|53.4|Standard Deviation|18.01|18.01|||
3693521|NCT02217410|3535206|B2|||Age||years|Mean|49.0|49.0|Standard Deviation|15.79|15.79|||
3693522|NCT02217410|3535207|B1|||Age||years|Mean|48.1|48.1|Standard Deviation|9.30|9.3|||
3693523|NCT02217280|3535232|B1|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3693524|NCT02217280|3535232|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3693525|NCT02217280|3535232|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3693526|NCT02217280|3535232|B1|||Age||years|Mean|51.18|51.18|Full Range|||39.0|64.0|
3693527|NCT02217280|3535232|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3693528|NCT02217280|3535232|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3693529|NCT02217280|3535232|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3693530|NCT02216812|3535237|B3|||PROMIS Pain Interference CAT|The Patient Reported Outcome Information System (PROMIS) Pain Interference Computer Adaptive Test (CAT) is a computerized assessment measuring the amount pain interferes in the subjects' activities. It is scored using a T-score, and the average is 50 for the U.S. population. In a given PROMIS, a T scores above 50 represents more of the measured variable than the average. Investigators measured this at enrollment.|T-score|Mean|63|63.0|Standard Deviation|7.0|7.0|||
3693531|NCT02216812|3535238|B2|||PROMIS Pain Interference CAT|The Patient Reported Outcome Information System (PROMIS) Pain Interference Computer Adaptive Test (CAT) is a computerized assessment measuring the amount pain interferes in the subjects' activities. It is scored using a T-score, and the average is 50 for the U.S. population. In a given PROMIS, a T scores above 50 represents more of the measured variable than the average. Investigators measured this at enrollment.|T-score|Mean|61|61.0|Standard Deviation|7.1|7.1|||
3693532|NCT02216812|3535239|B1|||PROMIS Pain Interference CAT|The Patient Reported Outcome Information System (PROMIS) Pain Interference Computer Adaptive Test (CAT) is a computerized assessment measuring the amount pain interferes in the subjects' activities. It is scored using a T-score, and the average is 50 for the U.S. population. In a given PROMIS, a T scores above 50 represents more of the measured variable than the average. Investigators measured this at enrollment.|T-score|Mean|65|65.0|Standard Deviation|6.4|6.4|||
3693533|NCT02216812|3535237|B3|||Carpal tunnel release||Participants|Count of Participants|13|13.0||||||
3693534|NCT02216812|3535238|B2|||Carpal tunnel release||Participants|Count of Participants|9|9.0||||||
3693535|NCT02216812|3535239|B1|||Carpal tunnel release||Participants|Count of Participants|4|4.0||||||
3693536|NCT02216812|3535237|B3|||Non-operative treatment||Participants|Count of Participants|83|83.0||||||
3693537|NCT02216812|3535238|B2|||Non-operative treatment||Participants|Count of Participants|41|41.0||||||
3693538|NCT02216812|3535239|B1|||Non-operative treatment||Participants|Count of Participants|42|42.0||||||
3693539|NCT02216812|3535237|B3|||Dominant extremity injured|The number of participants whose injured arm is the same side as that of their dominant hand (i.e., the hand with which they write or perform fine motor skills).|Participants|Count of Participants|64|64.0||||||
3693540|NCT02216812|3535238|B2|||Dominant extremity injured|The number of participants whose injured arm is the same side as that of their dominant hand (i.e., the hand with which they write or perform fine motor skills).|Participants|Count of Participants|32|32.0||||||
3693541|NCT02216812|3535239|B1|||Dominant extremity injured|The number of participants whose injured arm is the same side as that of their dominant hand (i.e., the hand with which they write or perform fine motor skills).|Participants|Count of Participants|32|32.0||||||
3693542|NCT02216812|3535237|B3|United States||Region of Enrollment||Participants|Count of Participants|134|134.0||||||
3693543|NCT02216812|3535238|B2|United States||Region of Enrollment||Participants|Count of Participants|67|67.0||||||
3693544|NCT02216812|3535239|B1|United States||Region of Enrollment||Participants|Count of Participants|67|67.0||||||
3693545|NCT02216812|3535237|B3|Non-causcasian||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3693546|NCT02216812|3535238|B2|Non-causcasian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3693547|NCT02216812|3535239|B1|Non-causcasian||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3693548|NCT02216812|3535237|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3693549|NCT02216812|3535238|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3693550|NCT02216812|3535239|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3693551|NCT02216812|3535237|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3693552|NCT02216812|3535238|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3693553|NCT02216812|3535239|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3693554|NCT02216812|3535237|B3|||Age||Years|Mean|49|49.0|Standard Deviation|17|17.0|||
3693555|NCT02216812|3535238|B2|||Age||Years|Mean|50|50.0|Standard Deviation|17|17.0|||
3693556|NCT02216812|3535239|B1|||Age||Years|Mean|48|48.0|Standard Deviation|17|17.0|||
3693557|NCT02216695|3535254|B1|||AKI identified by ICD10 codes of N17||participants|Number|64882|64882.0||||||
3693558|NCT02216695|3535254|B1|United Kingdom||Region of Enrollment||participants|Number|64882|64882.0||||||
3693559|NCT02216695|3535254|B1||Male|Gender||Participants|Count of Participants|40023|40023.0||||||
3693560|NCT02216695|3535254|B1||Female|Gender||Participants|Count of Participants|24859|24859.0||||||
3693561|NCT02216695|3535254|B1|||Age||years|Mean|59.7|59.7|Inter-Quartile Range|||58.4|61.0|
3693562|NCT02216591|3535263|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
3693563|NCT02216591|3535264|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3693564|NCT02216591|3535265|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3693565|NCT02216591|3535263|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693566|NCT02216591|3535264|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693567|NCT02216591|3535265|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693568|NCT02216591|3535263|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693569|NCT02216591|3535264|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693570|NCT02216591|3535265|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693571|NCT02216591|3535263|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3693572|NCT02216591|3535264|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3693573|NCT02216591|3535265|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3693574|NCT02216591|3535263|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3693575|NCT02216591|3535264|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3693576|NCT02216591|3535265|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3693577|NCT02216591|3535263|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693578|NCT02216591|3535264|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693579|NCT02216591|3535265|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693580|NCT02216591|3535263|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693581|NCT02216591|3535264|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693582|NCT02216591|3535265|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693583|NCT02216591|3535263|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693584|NCT02216591|3535264|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693585|NCT02216591|3535265|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693586|NCT02216591|3535263|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693587|NCT02216591|3535264|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693588|NCT02216591|3535265|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693589|NCT02216591|3535263|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3693590|NCT02216591|3535264|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3693591|NCT02216591|3535265|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3693592|NCT02216591|3535263|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693593|NCT02216591|3535264|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693594|NCT02216591|3535265|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693595|NCT02216591|3535263|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3693596|NCT02216591|3535264|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3693597|NCT02216591|3535265|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3693598|NCT02216591|3535263|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3693599|NCT02216591|3535264|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3693600|NCT02216591|3535265|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3693601|NCT02216591|3535263|B3|||Age||years|Mean|47.90|47.9|Standard Deviation|11.15|11.15|||
3693602|NCT02216591|3535264|B2|||Age||years|Mean|44.20|44.2|Standard Deviation|13.01|13.01|||
3693603|NCT02216591|3535265|B1|||Age||years|Mean|51.27|51.27|Standard Deviation|8.37|8.37|||
3693604|NCT02216591|3535263|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3693605|NCT02216591|3535264|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3693606|NCT02216591|3535265|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3693607|NCT02216591|3535263|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3693608|NCT02216591|3535264|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3693609|NCT02216591|3535265|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3693610|NCT02216591|3535263|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3693611|NCT02216591|3535264|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3693612|NCT02216591|3535265|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3693613|NCT02216526|3535276|B4|Germany||Region of Enrollment||participants|Number|133|133.0||||||
3693614|NCT02216526|3535277|B3|Germany||Region of Enrollment||participants|Number|44|44.0||||||
3693615|NCT02216526|3535278|B2|Germany||Region of Enrollment||participants|Number|44|44.0||||||
3693616|NCT02216526|3535279|B1|Germany||Region of Enrollment||participants|Number|45|45.0||||||
3693617|NCT02216526|3535276|B4|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3693618|NCT02216526|3535276|B4||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3693619|NCT02216526|3535277|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3693620|NCT02216526|3535278|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3693621|NCT02216526|3535279|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3693622|NCT02216526|3535276|B4||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3693623|NCT02216526|3535277|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3693624|NCT02216526|3535278|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3693625|NCT02216526|3535279|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3693626|NCT02216526|3535276|B4||>=65 years|Age||Participants|Count of Participants|133|133.0||||||
3693627|NCT02216526|3535277|B3||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
3693628|NCT02216526|3535278|B2||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
3693629|NCT02216526|3535279|B1||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
3693630|NCT02216526|3535276|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3693631|NCT02216526|3535277|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3693632|NCT02216526|3535278|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3693633|NCT02216526|3535279|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3693634|NCT02216526|3535276|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3693635|NCT02216526|3535277|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3693636|NCT02216526|3535278|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3693637|NCT02216526|3535279|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3693638|NCT02216422|3535391|B1|Missing||Interleukin 28B (IL28B)||participants|Number|0|0.0||||||
3693639|NCT02216422|3535391|B1|TT||Interleukin 28B (IL28B)||participants|Number|7|7.0||||||
3693640|NCT02216422|3535391|B1|CT||Interleukin 28B (IL28B)||participants|Number|25|25.0||||||
3693641|NCT02216422|3535391|B1|CC||Interleukin 28B (IL28B)||participants|Number|4|4.0||||||
3693642|NCT02216422|3535391|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3693643|NCT02216422|3535391|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3693644|NCT02216422|3535391|B1|||Age||years|Mean|51.6|51.6|Standard Deviation|7.91|7.91|||
3693645|NCT02216357|3535397|B3|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3693646|NCT02216357|3535398|B2|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3693647|NCT02216357|3535399|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3693648|NCT02216357|3535397|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693649|NCT02216357|3535398|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693650|NCT02216357|3535399|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693651|NCT02216357|3535397|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693652|NCT02216357|3535398|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693653|NCT02216357|3535399|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693654|NCT02216357|3535397|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3693655|NCT02216357|3535398|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3693656|NCT02216357|3535399|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3693657|NCT02216357|3535397|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3693658|NCT02216357|3535398|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693659|NCT02216357|3535399|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3693660|NCT02216357|3535397|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693661|NCT02216357|3535398|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693662|NCT02216357|3535399|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693663|NCT02216357|3535397|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3693664|NCT02216357|3535398|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693665|NCT02216357|3535399|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3693666|NCT02216357|3535397|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693667|NCT02216357|3535398|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693668|NCT02216357|3535399|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693669|NCT02216357|3535397|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693670|NCT02216357|3535398|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693671|NCT02216357|3535399|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693672|NCT02216357|3535397|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3693673|NCT02216357|3535398|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3693674|NCT02216357|3535399|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3693675|NCT02216357|3535397|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3693676|NCT02216357|3535398|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3693677|NCT02216357|3535399|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3693678|NCT02216357|3535397|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3693679|NCT02216357|3535398|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3693680|NCT02216357|3535399|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3693681|NCT02216357|3535397|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3693682|NCT02216357|3535398|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3693683|NCT02216357|3535399|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3693684|NCT02216357|3535397|B3|||Age||years|Mean|45|45.0|Standard Deviation|11.7|11.7|||
3693685|NCT02216357|3535398|B2|||Age||years|Mean|43|43.0|Standard Deviation|13.4|13.4|||
3693686|NCT02216357|3535399|B1|||Age||years|Mean|46|46.0|Standard Deviation|11.6|11.6|||
3693687|NCT02216123|3535424|B3|African Amer/African Heritage/Amer Ind or Alaska N||Race/Ethnicity, Customized||Count of Participants|Number|55|55.0||||||
3693688|NCT02216123|3535425|B2|African Amer/African Heritage/Amer Ind or Alaska N||Race/Ethnicity, Customized||Count of Participants|Number|19|19.0||||||
3693689|NCT02216123|3535426|B1|African Amer/African Heritage/Amer Ind or Alaska N||Race/Ethnicity, Customized||Count of Participants|Number|36|36.0||||||
3693690|NCT02216123|3535424|B3|Black or African Amer||Race/Ethnicity, Customized||Count of Participants|Number|2|2.0||||||
3693691|NCT02216123|3535425|B2|Black or African Amer||Race/Ethnicity, Customized||Count of Participants|Number|0|0.0||||||
3693692|NCT02216123|3535426|B1|Black or African Amer||Race/Ethnicity, Customized||Count of Participants|Number|2|2.0||||||
3693693|NCT02216123|3535424|B3|Asian-South East Asian Heritage||Race/Ethnicity, Customized||Count of Participants|Number|55|55.0||||||
3693694|NCT02216123|3535425|B2|Asian-South East Asian Heritage||Race/Ethnicity, Customized||Count of Participants|Number|20|20.0||||||
3693695|NCT02216123|3535426|B1|Asian-South East Asian Heritage||Race/Ethnicity, Customized||Count of Participants|Number|35|35.0||||||
3693696|NCT02216123|3535424|B3|Asian-East Asian Heritage||Race/Ethnicity, Customized||Count of Participants|Number|9|9.0||||||
3693697|NCT02216123|3535425|B2|Asian-East Asian Heritage||Race/Ethnicity, Customized||Count of Participants|Number|3|3.0||||||
3693698|NCT02216123|3535426|B1|Asian-East Asian Heritage||Race/Ethnicity, Customized||Count of Participants|Number|6|6.0||||||
3693699|NCT02216123|3535424|B3|American (Amer) Indian (Ind) or Alaska Native (N)||Race/Ethnicity, Customized||Count of Participants|Number|130|130.0||||||
3693700|NCT02216123|3535425|B2|American (Amer) Indian (Ind) or Alaska Native (N)||Race/Ethnicity, Customized||Count of Participants|Number|43|43.0||||||
3693701|NCT02216123|3535426|B1|American (Amer) Indian (Ind) or Alaska Native (N)||Race/Ethnicity, Customized||Count of Participants|Number|87|87.0||||||
3693702|NCT02216123|3535424|B3||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3693703|NCT02216123|3535425|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3693704|NCT02216123|3535426|B1||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3693705|NCT02216123|3535424|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3693706|NCT02216123|3535425|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3693707|NCT02216123|3535426|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3693708|NCT02216123|3535424|B3|||Age||Years|Mean|37.6|37.6|Standard Deviation|14.39|14.39|||
3693709|NCT02216123|3535425|B2|||Age||Years|Mean|37.7|37.7|Standard Deviation|14.69|14.69|||
3693710|NCT02216123|3535426|B1|||Age||Years|Mean|37.5|37.5|Standard Deviation|14.28|14.28|||
3693711|NCT02216097|3535491|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3693712|NCT02216097|3535492|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3693713|NCT02216097|3535493|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3693714|NCT02216097|3535491|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3693715|NCT02216097|3535492|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3693716|NCT02216097|3535493|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3693717|NCT02216097|3535491|B3|||Age||Years|Mean|35.9|35.9|Standard Deviation|12.6|12.6|||
3693718|NCT02216097|3535492|B2|||Age||Years|Mean|36.2|36.2|Standard Deviation|15.1|15.1|||
3693719|NCT02216097|3535493|B1|||Age||Years|Mean|35.6|35.6|Standard Deviation|11.4|11.4|||
3693720|NCT02215954|3535516|B4|||Body Mass Index (BMI)||(kg/m2)|Mean|23.1|23.1|Standard Deviation|3.51|3.51|||
3693721|NCT02215954|3535517|B3|||Body Mass Index (BMI)||(kg/m2)|Mean|23.2|23.2|Standard Deviation|3.72|3.72|||
3693722|NCT02215954|3535518|B2|||Body Mass Index (BMI)||(kg/m2)|Mean|23.2|23.2|Standard Deviation|3.59|3.59|||
3693723|NCT02215954|3535519|B1|||Body Mass Index (BMI)||(kg/m2)|Mean|22.9|22.9|Standard Deviation|3.20|3.2|||
3693724|NCT02215954|3535516|B4|||Weight||(kg)|Mean|62.5|62.5|Standard Deviation|12.4|12.4|||
3693725|NCT02215954|3535517|B3|||Weight||(kg)|Mean|62.6|62.6|Standard Deviation|12.5|12.5|||
3693726|NCT02215954|3535518|B2|||Weight||(kg)|Mean|63.1|63.1|Standard Deviation|13.0|13.0|||
3693727|NCT02215954|3535519|B1|||Weight||(kg)|Mean|61.9|61.9|Standard Deviation|11.6|11.6|||
3693728|NCT02215954|3535516|B4|||Height||(m)|Mean|1.64|1.64|Standard Deviation|0.082|0.082|||
3693729|NCT02215954|3535517|B3|||Height||(m)|Mean|1.64|1.64|Standard Deviation|0.084|0.084|||
3693730|NCT02215954|3535518|B2|||Height||(m)|Mean|1.64|1.64|Standard Deviation|0.082|0.082|||
3693731|NCT02215954|3535519|B1|||Height||(m)|Mean|1.64|1.64|Standard Deviation|0.080|0.08|||
3693732|NCT02215954|3535516|B4||Male|Sex: Female, Male||Participants|Count of Participants|340|340.0||||||
3693733|NCT02215954|3535517|B3||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3693734|NCT02215954|3535518|B2||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3693735|NCT02215954|3535519|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3693736|NCT02215954|3535516|B4||Female|Sex: Female, Male||Participants|Count of Participants|297|297.0||||||
3693737|NCT02215954|3535517|B3||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3693738|NCT02215954|3535518|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3693739|NCT02215954|3535519|B1||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3693740|NCT02215954|3535516|B4|||Age||years|Mean|48.2|48.2|Standard Deviation|14.1|14.1|||
3693741|NCT02215954|3535517|B3|||Age||years|Mean|48.1|48.1|Standard Deviation|14.1|14.1|||
3693742|NCT02215954|3535518|B2|||Age||years|Mean|48.3|48.3|Standard Deviation|14.3|14.3|||
3693743|NCT02215954|3535519|B1|||Age||years|Mean|48.1|48.1|Standard Deviation|14.0|14.0|||
3693744|NCT02215252|3535541|B4||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3693745|NCT02215252|3535542|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3693746|NCT02215252|3535543|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3693747|NCT02215252|3535544|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3693748|NCT02215252|3535541|B4||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3693749|NCT02215252|3535542|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3693750|NCT02215252|3535543|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3693751|NCT02215252|3535544|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3693752|NCT02215252|3535541|B4|||Age||years|Mean|58.9|58.9|Standard Deviation|10.5|10.5|||
3693753|NCT02215252|3535542|B3|||Age||years|Mean|59.2|59.2|Standard Deviation|10.9|10.9|||
3693754|NCT02215252|3535543|B2|||Age||years|Mean|58.1|58.1|Standard Deviation|11.3|11.3|||
3693755|NCT02215252|3535544|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|9.4|9.4|||
3693756|NCT02215161|3535603|B1|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3693757|NCT02215161|3535603|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3693758|NCT02215161|3535603|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3693759|NCT02215161|3535603|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3693760|NCT02215161|3535603|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693761|NCT02215161|3535603|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693762|NCT02215161|3535603|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3693763|NCT02215161|3535603|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693764|NCT02215161|3535603|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3693765|NCT02215161|3535603|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3693766|NCT02215161|3535603|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3693767|NCT02215161|3535603|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3693768|NCT02215161|3535603|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3693769|NCT02215161|3535603|B1|Age Group|70 - 79|Age, Customized||Participants|Count of Participants|10|10.0||||||
3693770|NCT02215161|3535603|B1|Age Group|60 - 69|Age, Customized||Participants|Count of Participants|3|3.0||||||
3693771|NCT02215161|3535603|B1|Age Group|50 - 59|Age, Customized||Participants|Count of Participants|1|1.0||||||
3693772|NCT02214615|3535621|B3|||Erythromelalgia mutations S241T||participants|Number|2|2.0||||||
3693773|NCT02214615|3535622|B2|||Erythromelalgia mutations S241T||participants|Number|1|1.0||||||
3693774|NCT02214615|3535623|B1|||Erythromelalgia mutations S241T||participants|Number|1|1.0||||||
3693775|NCT02214615|3535621|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3693776|NCT02214615|3535622|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3693777|NCT02214615|3535623|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3693778|NCT02214615|3535621|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3693779|NCT02214615|3535622|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3693780|NCT02214615|3535623|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3693781|NCT02214615|3535621|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3693782|NCT02214615|3535622|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3693783|NCT02214615|3535623|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3693784|NCT02214615|3535621|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3693785|NCT02214615|3535622|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3693786|NCT02214615|3535623|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3693787|NCT02214615|3535621|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3693788|NCT02214615|3535622|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3693789|NCT02214615|3535623|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3693790|NCT02214615|3535621|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3693791|NCT02214615|3535622|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3693792|NCT02214615|3535623|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3693793|NCT02214420|3535632|B3|||BMI||kg/m^2|Mean|28.67|28.67|Full Range|||18.8|46.1|
3693794|NCT02214420|3535633|B2|||BMI||kg/m^2|Mean|27.56|27.56|Full Range|||19.1|42.9|
3693795|NCT02214420|3535634|B1|||BMI||kg/m^2|Mean|29.47|29.47|Full Range|||18.8|46.1|
3693796|NCT02214420|3535632|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3693797|NCT02214420|3535633|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3693798|NCT02214420|3535634|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3693799|NCT02214420|3535632|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3693800|NCT02214420|3535633|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3693801|NCT02214420|3535634|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3693802|NCT02214420|3535632|B3|||Age||years|Mean|53.95|53.95|Full Range|||22.0|76.0|
3693803|NCT02214420|3535633|B2|||Age||years|Mean|58.31|58.31|Full Range|||35.0|67.0|
3693804|NCT02214420|3535634|B1|||Age||years|Mean|50.84|50.84|Full Range|||22.0|76.0|
3693805|NCT02214277|3535641|B4|||History of Atrial Fibrillation||Participants|Count of Participants|115|115.0||||||
3693806|NCT02214277|3535642|B3|||History of Atrial Fibrillation||Participants|Count of Participants|36|36.0||||||
3693807|NCT02214277|3535643|B2|||History of Atrial Fibrillation||Participants|Count of Participants|42|42.0||||||
3693808|NCT02214277|3535644|B1|||History of Atrial Fibrillation||Participants|Count of Participants|37|37.0||||||
3693809|NCT02214277|3535641|B4|||STS PROM Score|The Society of Thoracic Surgeons’ (STS) predicted risk of mortality (PROM) score is used to predict the risk of operative mortality and morbidity of surgery. It is based on patient demographic and clinical variables, and scores are divided into four categories: low risk (<4%),intermediate risk (>=4% to <8%), high risk (>=8% to <12%) ,very high risk (>=12%).|units on a scale|Mean|6.7|6.7|Standard Deviation|3.79|3.79|||
3693810|NCT02214277|3535642|B3|||STS PROM Score|The Society of Thoracic Surgeons’ (STS) predicted risk of mortality (PROM) score is used to predict the risk of operative mortality and morbidity of surgery. It is based on patient demographic and clinical variables, and scores are divided into four categories: low risk (<4%),intermediate risk (>=4% to <8%), high risk (>=8% to <12%) ,very high risk (>=12%).|units on a scale|Mean|7.5|7.5|Standard Deviation|4.66|4.66|||
3693811|NCT02214277|3535643|B2|||STS PROM Score|The Society of Thoracic Surgeons’ (STS) predicted risk of mortality (PROM) score is used to predict the risk of operative mortality and morbidity of surgery. It is based on patient demographic and clinical variables, and scores are divided into four categories: low risk (<4%),intermediate risk (>=4% to <8%), high risk (>=8% to <12%) ,very high risk (>=12%).|units on a scale|Mean|6.4|6.4|Standard Deviation|3.28|3.28|||
3693812|NCT02214277|3535644|B1|||STS PROM Score|The Society of Thoracic Surgeons’ (STS) predicted risk of mortality (PROM) score is used to predict the risk of operative mortality and morbidity of surgery. It is based on patient demographic and clinical variables, and scores are divided into four categories: low risk (<4%),intermediate risk (>=4% to <8%), high risk (>=8% to <12%) ,very high risk (>=12%).|units on a scale|Mean|6.2|6.2|Standard Deviation|3.17|3.17|||
3693813|NCT02214277|3535641|B4|Germany||Region of Enrollment||participants|Number|74|74.0||||||
3693814|NCT02214277|3535642|B3|Germany||Region of Enrollment||participants|Number|23|23.0||||||
3693815|NCT02214277|3535643|B2|Germany||Region of Enrollment||participants|Number|26|26.0||||||
3693816|NCT02214277|3535644|B1|Germany||Region of Enrollment||participants|Number|25|25.0||||||
3693817|NCT02214277|3535641|B4|United States||Region of Enrollment||participants|Number|289|289.0||||||
3693818|NCT02214277|3535642|B3|United States||Region of Enrollment||participants|Number|96|96.0||||||
3693819|NCT02214277|3535643|B2|United States||Region of Enrollment||participants|Number|95|95.0||||||
3693820|NCT02214277|3535644|B1|United States||Region of Enrollment||participants|Number|98|98.0||||||
3693821|NCT02214277|3535641|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3693822|NCT02214277|3535642|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693823|NCT02214277|3535643|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3693824|NCT02214277|3535644|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3693825|NCT02214277|3535641|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3693826|NCT02214277|3535642|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3693827|NCT02214277|3535643|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3693828|NCT02214277|3535644|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3693829|NCT02214277|3535641|B4||White|Race (NIH/OMB)||Participants|Count of Participants|339|339.0||||||
3693830|NCT02214277|3535642|B3||White|Race (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
3693831|NCT02214277|3535643|B2||White|Race (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
3693832|NCT02214277|3535644|B1||White|Race (NIH/OMB)||Participants|Count of Participants|109|109.0||||||
3693833|NCT02214277|3535641|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3693834|NCT02214277|3535642|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3693835|NCT02214277|3535643|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3693836|NCT02214277|3535644|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3693837|NCT02214277|3535641|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693838|NCT02214277|3535642|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693839|NCT02214277|3535643|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693840|NCT02214277|3535644|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693841|NCT02214277|3535641|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3693842|NCT02214277|3535642|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693843|NCT02214277|3535643|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3693844|NCT02214277|3535644|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3693845|NCT02214277|3535641|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3693846|NCT02214277|3535642|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3693847|NCT02214277|3535643|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693848|NCT02214277|3535644|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693849|NCT02214277|3535641|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693850|NCT02214277|3535642|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693851|NCT02214277|3535643|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693852|NCT02214277|3535644|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693853|NCT02214277|3535641|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|359|359.0||||||
3693854|NCT02214277|3535642|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|118|118.0||||||
3693855|NCT02214277|3535643|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|118|118.0||||||
3693856|NCT02214277|3535644|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
3693857|NCT02214277|3535641|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3693858|NCT02214277|3535642|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3693859|NCT02214277|3535643|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3693860|NCT02214277|3535644|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3693861|NCT02214277|3535641|B4||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3693862|NCT02214277|3535642|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3693863|NCT02214277|3535643|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3693864|NCT02214277|3535644|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3693865|NCT02214277|3535641|B4||Female|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
3693866|NCT02214277|3535642|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3693867|NCT02214277|3535643|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3693868|NCT02214277|3535644|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3693869|NCT02214277|3535641|B4|||Age||years|Mean|82.3|82.3|Standard Deviation|8.31|8.31|||
3693870|NCT02214277|3535642|B3|||Age||years|Mean|83.4|83.4|Standard Deviation|7.90|7.9|||
3693871|NCT02214277|3535643|B2|||Age||years|Mean|82.0|82.0|Standard Deviation|7.95|7.95|||
3693872|NCT02214277|3535644|B1|||Age||years|Mean|81.5|81.5|Standard Deviation|8.98|8.98|||
3693873|NCT02214238|3535654|B3|New Zealand||Region of Enrollment||participants|Number|49|49.0||||||
3693874|NCT02214238|3535655|B2|New Zealand||Region of Enrollment||participants|Number|23|23.0||||||
3693875|NCT02214238|3535656|B1|New Zealand||Region of Enrollment||participants|Number|26|26.0||||||
3693876|NCT02214238|3535654|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3693877|NCT02214238|3535655|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3693878|NCT02214238|3535656|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3693879|NCT02214238|3535654|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3693880|NCT02214238|3535655|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3693881|NCT02214238|3535656|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3693882|NCT02214238|3535654|B3|||Age||years|Mean|60.9|60.9|Full Range|||32.0|81.0|
3693883|NCT02214238|3535655|B2|||Age||years|Mean|58.7|58.7|Full Range|||32.0|81.0|
3693884|NCT02214238|3535656|B1|||Age||years|Mean|63.2|63.2|Full Range|||48.0|81.0|
3693885|NCT02214225|3535667|B4|United States||Region of Enrollment||participants|Number|3484|3484.0||||||
3693886|NCT02214225|3535668|B3|United States||Region of Enrollment||participants|Number|872|872.0||||||
3693887|NCT02214225|3535669|B2|United States||Region of Enrollment||participants|Number|871|871.0||||||
3693888|NCT02214225|3535670|B1|United States||Region of Enrollment||participants|Number|1741|1741.0||||||
3693889|NCT02214225|3535667|B4||Male|Sex: Female, Male||Participants|Count of Participants|1492|1492.0||||||
3693890|NCT02214225|3535668|B3||Male|Sex: Female, Male||Participants|Count of Participants|362|362.0||||||
3693891|NCT02214225|3535669|B2||Male|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
3693892|NCT02214225|3535670|B1||Male|Sex: Female, Male||Participants|Count of Participants|770|770.0||||||
3693893|NCT02214225|3535667|B4||Female|Sex: Female, Male||Participants|Count of Participants|1992|1992.0||||||
3693894|NCT02214225|3535668|B3||Female|Sex: Female, Male||Participants|Count of Participants|510|510.0||||||
3693895|NCT02214225|3535669|B2||Female|Sex: Female, Male||Participants|Count of Participants|511|511.0||||||
3693896|NCT02214225|3535670|B1||Female|Sex: Female, Male||Participants|Count of Participants|971|971.0||||||
3693897|NCT02214225|3535667|B4|=> 75 years||Age, Customized|Number of participants allocated within each age subset category for each arm.|participants|Number|661|661.0||||||
3693898|NCT02214225|3535668|B3|=> 75 years||Age, Customized|Number of participants allocated within each age subset category for each arm.|participants|Number|166|166.0||||||
3693899|NCT02214225|3535669|B2|=> 75 years||Age, Customized|Number of participants allocated within each age subset category for each arm.|participants|Number|166|166.0||||||
3693900|NCT02214225|3535670|B1|=> 75 years||Age, Customized|Number of participants allocated within each age subset category for each arm.|participants|Number|329|329.0||||||
3693901|NCT02214225|3535667|B4|65 to 74 years||Age, Customized|Number of participants allocated within each age subset category for each arm.|participants|Number|1082|1082.0||||||
3693902|NCT02214225|3535668|B3|65 to 74 years||Age, Customized|Number of participants allocated within each age subset category for each arm.|participants|Number|270|270.0||||||
3693903|NCT02214225|3535669|B2|65 to 74 years||Age, Customized|Number of participants allocated within each age subset category for each arm.|participants|Number|271|271.0||||||
3693904|NCT02214225|3535670|B1|65 to 74 years||Age, Customized|Number of participants allocated within each age subset category for each arm.|participants|Number|541|541.0||||||
3693905|NCT02214225|3535667|B4|50 to 64 years||Age, Customized|Number of participants allocated within each age subset category for each arm.|participants|Number|721|721.0||||||
3693906|NCT02214225|3535668|B3|50 to 64 years||Age, Customized|Number of participants allocated within each age subset category for each arm.|participants|Number|181|181.0||||||
3693907|NCT02214225|3535669|B2|50 to 64 years||Age, Customized|Number of participants allocated within each age subset category for each arm.|participants|Number|179|179.0||||||
3693908|NCT02214225|3535670|B1|50 to 64 years||Age, Customized|Number of participants allocated within each age subset category for each arm.|participants|Number|361|361.0||||||
3693909|NCT02214225|3535667|B4|18 to 49 years||Age, Customized|Number of participants allocated within each age subset category for each arm.|participants|Number|1020|1020.0||||||
3693910|NCT02214225|3535668|B3|18 to 49 years||Age, Customized|Number of participants allocated within each age subset category for each arm.|participants|Number|255|255.0||||||
3693911|NCT02214225|3535669|B2|18 to 49 years||Age, Customized|Number of participants allocated within each age subset category for each arm.|participants|Number|255|255.0||||||
3693912|NCT02214225|3535670|B1|18 to 49 years||Age, Customized|Number of participants allocated within each age subset category for each arm.|participants|Number|510|510.0||||||
3693913|NCT02214225|3535667|B4|||Age||years|Mean|58.3|58.3|Standard Deviation|18.04|18.04|||
3693914|NCT02214225|3535668|B3|||Age||years|Mean|58.3|58.3|Standard Deviation|17.89|17.89|||
3693915|NCT02214225|3535669|B2|||Age||years|Mean|58.2|58.2|Standard Deviation|18.10|18.1|||
3693916|NCT02214225|3535670|B1|||Age||years|Mean|58.3|58.3|Standard Deviation|18.10|18.1|||
3693917|NCT02214186|3535729|B3|||Diastolic blood pressure (mmHg)||mmHg|Mean|102.42|102.42|Standard Deviation|13.75|13.75|||
3693918|NCT02214186|3535730|B2|||Diastolic blood pressure (mmHg)||mmHg|Mean|104.80|104.8|Standard Deviation|15.75|15.75|||
3693919|NCT02214186|3535731|B1|||Diastolic blood pressure (mmHg)||mmHg|Mean|100.05|100.05|Standard Deviation|11.75|11.75|||
3693920|NCT02214186|3535729|B3|||Systolic blood pressure (mmHg)||mmHg|Mean|165.5|165.5|Standard Deviation|18.5|18.5|||
3693921|NCT02214186|3535730|B2|||Systolic blood pressure (mmHg)||mmHg|Mean|170|170.0|Standard Deviation|20|20.0|||
3693922|NCT02214186|3535731|B1|||Systolic blood pressure (mmHg)||mmHg|Mean|161|161.0|Standard Deviation|17|17.0|||
3693923|NCT02214186|3535729|B3|no||Diabetes Mellitus||participants|Number|32|32.0||||||
3693924|NCT02214186|3535730|B2|no||Diabetes Mellitus||participants|Number|18|18.0||||||
3693925|NCT02214186|3535731|B1|no||Diabetes Mellitus||participants|Number|14|14.0||||||
3693926|NCT02214186|3535729|B3|yes||Diabetes Mellitus||participants|Number|14|14.0||||||
3693927|NCT02214186|3535730|B2|yes||Diabetes Mellitus||participants|Number|5|5.0||||||
3693928|NCT02214186|3535731|B1|yes||Diabetes Mellitus||participants|Number|9|9.0||||||
3693929|NCT02214186|3535729|B3|no||Previous preeclampsia||participants|Number|26|26.0||||||
3693930|NCT02214186|3535730|B2|no||Previous preeclampsia||participants|Number|12|12.0||||||
3693931|NCT02214186|3535731|B1|no||Previous preeclampsia||participants|Number|14|14.0||||||
3693932|NCT02214186|3535729|B3|yes||Previous preeclampsia||participants|Number|20|20.0||||||
3693933|NCT02214186|3535730|B2|yes||Previous preeclampsia||participants|Number|11|11.0||||||
3693934|NCT02214186|3535731|B1|yes||Previous preeclampsia||participants|Number|9|9.0||||||
3693935|NCT02214186|3535729|B3|no||Chronic hypertension||participants|Number|26|26.0||||||
3693936|NCT02214186|3535730|B2|no||Chronic hypertension||participants|Number|14|14.0||||||
3693937|NCT02214186|3535731|B1|no||Chronic hypertension||participants|Number|12|12.0||||||
3693938|NCT02214186|3535729|B3|yes||Chronic hypertension||participants|Number|20|20.0||||||
3693939|NCT02214186|3535730|B2|yes||Chronic hypertension||participants|Number|9|9.0||||||
3693940|NCT02214186|3535731|B1|yes||Chronic hypertension||participants|Number|11|11.0||||||
3693941|NCT02214186|3535729|B3|no||Twin pregnancy||participants|Number|38|38.0||||||
3693942|NCT02214186|3535730|B2|no||Twin pregnancy||participants|Number|20|20.0||||||
3693943|NCT02214186|3535731|B1|no||Twin pregnancy||participants|Number|21|21.0||||||
3693944|NCT02214186|3535729|B3|yes||Twin pregnancy||participants|Number|5|5.0||||||
3693945|NCT02214186|3535730|B2|yes||Twin pregnancy||participants|Number|3|3.0||||||
3693946|NCT02214186|3535731|B1|yes||Twin pregnancy||participants|Number|2|2.0||||||
3693947|NCT02214186|3535729|B3|||Body mass index (kg/m2)||kg/m2|Mean|32.88|32.88|Standard Deviation|6.37|6.37|||
3693948|NCT02214186|3535730|B2|||Body mass index (kg/m2)||kg/m2|Mean|31.98|31.98|Standard Deviation|5.58|5.58|||
3693949|NCT02214186|3535731|B1|||Body mass index (kg/m2)||kg/m2|Mean|33.78|33.78|Standard Deviation|7.17|7.17|||
3693950|NCT02214186|3535729|B3|||Gestational age (weeks)||weeks|Median|36.8|36.8|Inter-Quartile Range|||33.0|37.2|
3693951|NCT02214186|3535730|B2|||Gestational age (weeks)||weeks|Median|36.7|36.7|Inter-Quartile Range|||30.1|37.4|
3693952|NCT02214186|3535731|B1|||Gestational age (weeks)||weeks|Median|36.9|36.9|Inter-Quartile Range|||35.3|37.0|
3693953|NCT02214186|3535729|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3693954|NCT02214186|3535730|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3693955|NCT02214186|3535731|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3693956|NCT02214186|3535729|B3||Female|Gender||Participants|Count of Participants|46|46.0||||||
3693957|NCT02214186|3535730|B2||Female|Gender||Participants|Count of Participants|23|23.0||||||
3693958|NCT02214186|3535731|B1||Female|Gender||Participants|Count of Participants|23|23.0||||||
3693959|NCT02214186|3535729|B3|||Age||years|Mean|32.07|32.07|Standard Deviation|6.77|6.77|||
3693960|NCT02214186|3535730|B2|||Age||years|Mean|33|33.0|Standard Deviation|5|5.0|||
3693961|NCT02214186|3535731|B1|||Age||years|Mean|31|31.0|Standard Deviation|8|8.0|||
3693962|NCT02214147|3535754|B4|||Body surface area|Body surface area=square root[height(cm)*weight(kg)/3600]|m^2|Mean|1.986|1.986|Standard Deviation|0.3292|0.3292|||
3693963|NCT02214147|3535755|B3|||Body surface area|Body surface area=square root[height(cm)*weight(kg)/3600]|m^2|Mean|2.056|2.056|Standard Deviation|0.1970|0.197|||
3693964|NCT02214147|3535756|B2|||Body surface area|Body surface area=square root[height(cm)*weight(kg)/3600]|m^2|Mean|1.897|1.897|Standard Deviation|0.4028|0.4028|||
3693965|NCT02214147|3535757|B1|||Body surface area|Body surface area=square root[height(cm)*weight(kg)/3600]|m^2|Mean|2.030|2.03|Standard Deviation|0.3073|0.3073|||
3693966|NCT02214147|3535754|B4|||Weight||kg|Mean|85.2|85.2|Standard Deviation|24.044|24.044|||
3693967|NCT02214147|3535755|B3|||Weight||kg|Mean|85.8|85.8|Standard Deviation|11.847|11.847|||
3693968|NCT02214147|3535756|B2|||Weight||kg|Mean|85.5|85.5|Standard Deviation|33.881|33.881|||
3693969|NCT02214147|3535757|B1|||Weight||kg|Mean|84.6|84.6|Standard Deviation|20.997|20.997|||
3693970|NCT02214147|3535754|B4|||Height||cm|Mean|170.1|170.1|Standard Deviation|12.66|12.66|||
3693971|NCT02214147|3535755|B3|||Height||cm|Mean|178.2|178.2|Standard Deviation|8.10|8.1|||
3693972|NCT02214147|3535756|B2|||Height||cm|Mean|162.9|162.9|Standard Deviation|7.79|7.79|||
3693973|NCT02214147|3535757|B1|||Height||cm|Mean|172.9|172.9|Standard Deviation|14.62|14.62|||
3693974|NCT02214147|3535754|B4|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3693975|NCT02214147|3535755|B3|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3693976|NCT02214147|3535756|B2|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3693977|NCT02214147|3535757|B1|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3693978|NCT02214147|3535754|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3693979|NCT02214147|3535755|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3693980|NCT02214147|3535756|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3693981|NCT02214147|3535757|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3693982|NCT02214147|3535754|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3693983|NCT02214147|3535755|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3693984|NCT02214147|3535756|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3693985|NCT02214147|3535757|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3693986|NCT02214147|3535754|B4|Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3693987|NCT02214147|3535755|B3|Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3693988|NCT02214147|3535756|B2|Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3693989|NCT02214147|3535757|B1|Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3693990|NCT02214147|3535754|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3693991|NCT02214147|3535755|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3693992|NCT02214147|3535756|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3693993|NCT02214147|3535757|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3693994|NCT02214147|3535754|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3693995|NCT02214147|3535755|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3693996|NCT02214147|3535756|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3693997|NCT02214147|3535757|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3693998|NCT02214147|3535754|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3693999|NCT02214147|3535755|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3694000|NCT02214147|3535756|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3694001|NCT02214147|3535757|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3694002|NCT02214147|3535754|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3694003|NCT02214147|3535755|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3694004|NCT02214147|3535756|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3694005|NCT02214147|3535757|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3694006|NCT02214147|3535754|B4|||Age||years|Mean|57.5|57.5|Standard Deviation|9.77|9.77|||
3694007|NCT02214147|3535755|B3|||Age||years|Mean|54.0|54.0|Standard Deviation|7.05|7.05|||
3694008|NCT02214147|3535756|B2|||Age||years|Mean|54.9|54.9|Standard Deviation|9.89|9.89|||
3694009|NCT02214147|3535757|B1|||Age||years|Mean|61.2|61.2|Standard Deviation|10.07|10.07|||
3694010|NCT02214121|3535797|B4|Other||Race/Ethnicity, Customized|Relevant for the Part B period of the study.|Participants|Count of Participants|0|0.0||||||
3694011|NCT02214121|3535798|B3|Other||Race/Ethnicity, Customized|Relevant for the Part B period of the study.|Participants|Count of Participants|0|0.0||||||
3694012|NCT02214121|3535799|B2|Other||Race/Ethnicity, Customized|Relevant for the Part B period of the study.|Participants|Count of Participants|0|0.0||||||
3694013|NCT02214121|3535800|B1|Other||Race/Ethnicity, Customized|Relevant for the Part B period of the study.|Participants|Count of Participants|0|0.0||||||
3694014|NCT02214121|3535797|B4|American Indian or Alaska Native||Race/Ethnicity, Customized|Relevant for the Part B period of the study.|Participants|Count of Participants|0|0.0||||||
3694015|NCT02214121|3535798|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|Relevant for the Part B period of the study.|Participants|Count of Participants|0|0.0||||||
3694016|NCT02214121|3535799|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|Relevant for the Part B period of the study.|Participants|Count of Participants|0|0.0||||||
3694017|NCT02214121|3535800|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Relevant for the Part B period of the study.|Participants|Count of Participants|0|0.0||||||
3694018|NCT02214121|3535797|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Relevant for the Part B period of the study.|Participants|Count of Participants|0|0.0||||||
3694019|NCT02214121|3535798|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Relevant for the Part B period of the study.|Participants|Count of Participants|0|0.0||||||
3694020|NCT02214121|3535799|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Relevant for the Part B period of the study.|Participants|Count of Participants|0|0.0||||||
3694021|NCT02214121|3535800|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Relevant for the Part B period of the study.|Participants|Count of Participants|0|0.0||||||
3694022|NCT02214121|3535797|B4|Asian||Race/Ethnicity, Customized|Relevant for the Part B period of the study.|Participants|Count of Participants|0|0.0||||||
3694023|NCT02214121|3535798|B3|Asian||Race/Ethnicity, Customized|Relevant for the Part B period of the study.|Participants|Count of Participants|0|0.0||||||
3694024|NCT02214121|3535799|B2|Asian||Race/Ethnicity, Customized|Relevant for the Part B period of the study.|Participants|Count of Participants|0|0.0||||||
3694025|NCT02214121|3535800|B1|Asian||Race/Ethnicity, Customized|Relevant for the Part B period of the study.|Participants|Count of Participants|0|0.0||||||
3694026|NCT02214121|3535797|B4|Black or African American||Race/Ethnicity, Customized|Relevant for the Part B period of the study.|Participants|Count of Participants|22|22.0||||||
3694027|NCT02214121|3535798|B3|Black or African American||Race/Ethnicity, Customized|Relevant for the Part B period of the study.|Participants|Count of Participants|7|7.0||||||
3694028|NCT02214121|3535799|B2|Black or African American||Race/Ethnicity, Customized|Relevant for the Part B period of the study.|Participants|Count of Participants|15|15.0||||||
3694029|NCT02214121|3535800|B1|Black or African American||Race/Ethnicity, Customized|Relevant for the Part B period of the study.|Participants|Count of Participants|0|0.0||||||
3694030|NCT02214121|3535797|B4|White||Race/Ethnicity, Customized|Relevant for the Part B period of the study.|Participants|Count of Participants|1|1.0||||||
3694031|NCT02214121|3535798|B3|White||Race/Ethnicity, Customized|Relevant for the Part B period of the study.|Participants|Count of Participants|0|0.0||||||
3694032|NCT02214121|3535799|B2|White||Race/Ethnicity, Customized|Relevant for the Part B period of the study.|Participants|Count of Participants|1|1.0||||||
3694033|NCT02214121|3535800|B1|White||Race/Ethnicity, Customized|Relevant for the Part B period of the study.|Participants|Count of Participants|0|0.0||||||
3694034|NCT02214121|3535797|B4|Other||Race/Ethnicity, Customized|Relevant for the Part A period of the study|Participants|Count of Participants|0|0.0||||||
3694035|NCT02214121|3535798|B3|Other||Race/Ethnicity, Customized|Relevant for the Part A period of the study|Participants|Count of Participants|0|0.0||||||
3694036|NCT02214121|3535799|B2|Other||Race/Ethnicity, Customized|Relevant for the Part A period of the study|Participants|Count of Participants|0|0.0||||||
3694037|NCT02214121|3535800|B1|Other||Race/Ethnicity, Customized|Relevant for the Part A period of the study|Participants|Count of Participants|0|0.0||||||
3694038|NCT02214121|3535797|B4|American Indian or Alaska Native||Race/Ethnicity, Customized|Relevant for the Part A period of the study|Participants|Count of Participants|0|0.0||||||
3694039|NCT02214121|3535798|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|Relevant for the Part A period of the study|Participants|Count of Participants|0|0.0||||||
3694040|NCT02214121|3535799|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|Relevant for the Part A period of the study|Participants|Count of Participants|0|0.0||||||
3694041|NCT02214121|3535800|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Relevant for the Part A period of the study|Participants|Count of Participants|0|0.0||||||
3694179|NCT02213510|3535917|B1|2 - Usually burns, tans with difficulty||Fitzpatrick Skin Scale||participants|Number|1|1.0||||||
3694042|NCT02214121|3535797|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Relevant for the Part A period of the study|Participants|Count of Participants|0|0.0||||||
3694043|NCT02214121|3535798|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Relevant for the Part A period of the study|Participants|Count of Participants|0|0.0||||||
3694044|NCT02214121|3535799|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Relevant for the Part A period of the study|Participants|Count of Participants|0|0.0||||||
3694045|NCT02214121|3535800|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Relevant for the Part A period of the study|Participants|Count of Participants|0|0.0||||||
3694046|NCT02214121|3535797|B4|Asian||Race/Ethnicity, Customized|Relevant for the Part A period of the study|Participants|Count of Participants|0|0.0||||||
3694047|NCT02214121|3535798|B3|Asian||Race/Ethnicity, Customized|Relevant for the Part A period of the study|Participants|Count of Participants|0|0.0||||||
3694048|NCT02214121|3535799|B2|Asian||Race/Ethnicity, Customized|Relevant for the Part A period of the study|Participants|Count of Participants|0|0.0||||||
3694049|NCT02214121|3535800|B1|Asian||Race/Ethnicity, Customized|Relevant for the Part A period of the study|Participants|Count of Participants|0|0.0||||||
3694050|NCT02214121|3535797|B4|Black or African American||Race/Ethnicity, Customized|Relevant for the Part A period of the study|Participants|Count of Participants|35|35.0||||||
3694051|NCT02214121|3535798|B3|Black or African American||Race/Ethnicity, Customized|Relevant for the Part A period of the study|Participants|Count of Participants|0|0.0||||||
3694052|NCT02214121|3535799|B2|Black or African American||Race/Ethnicity, Customized|Relevant for the Part A period of the study|Participants|Count of Participants|0|0.0||||||
3694053|NCT02214121|3535800|B1|Black or African American||Race/Ethnicity, Customized|Relevant for the Part A period of the study|Participants|Count of Participants|35|35.0||||||
3694054|NCT02214121|3535797|B4|White||Race/Ethnicity, Customized|Relevant for the Part A period of the study|Participants|Count of Participants|10|10.0||||||
3694055|NCT02214121|3535798|B3|White||Race/Ethnicity, Customized|Relevant for the Part A period of the study|Participants|Count of Participants|0|0.0||||||
3694056|NCT02214121|3535799|B2|White||Race/Ethnicity, Customized|Relevant for the Part A period of the study|Participants|Count of Participants|0|0.0||||||
3694057|NCT02214121|3535800|B1|White||Race/Ethnicity, Customized|Relevant for the Part A period of the study|Participants|Count of Participants|10|10.0||||||
3694058|NCT02214121|3535797|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)|Relevant for the Part B period of the study.|Participants|Count of Participants|0|0.0||||||
3694059|NCT02214121|3535798|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)|Relevant for the Part B period of the study.|Participants|Count of Participants|0|0.0||||||
3694060|NCT02214121|3535799|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)|Relevant for the Part B period of the study.|Participants|Count of Participants|0|0.0||||||
3694061|NCT02214121|3535800|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|Relevant for the Part B period of the study.|Participants|Count of Participants|0|0.0||||||
3694062|NCT02214121|3535797|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Relevant for the Part B period of the study.|Participants|Count of Participants|22|22.0||||||
3694063|NCT02214121|3535798|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Relevant for the Part B period of the study.|Participants|Count of Participants|7|7.0||||||
3694064|NCT02214121|3535799|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Relevant for the Part B period of the study.|Participants|Count of Participants|15|15.0||||||
3694065|NCT02214121|3535800|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Relevant for the Part B period of the study.|Participants|Count of Participants|0|0.0||||||
3694066|NCT02214121|3535797|B4||Hispanic or Latino|Ethnicity (NIH/OMB)|Relevant for the Part B period of the study.|Participants|Count of Participants|1|1.0||||||
3694067|NCT02214121|3535798|B3||Hispanic or Latino|Ethnicity (NIH/OMB)|Relevant for the Part B period of the study.|Participants|Count of Participants|0|0.0||||||
3694068|NCT02214121|3535799|B2||Hispanic or Latino|Ethnicity (NIH/OMB)|Relevant for the Part B period of the study.|Participants|Count of Participants|1|1.0||||||
3694069|NCT02214121|3535800|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|Relevant for the Part B period of the study.|Participants|Count of Participants|0|0.0||||||
3694070|NCT02214121|3535797|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)|Relevant for the Part A period|Participants|Count of Participants|0|0.0||||||
3694071|NCT02214121|3535798|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)|Relevant for the Part A period|Participants|Count of Participants|0|0.0||||||
3694072|NCT02214121|3535799|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)|Relevant for the Part A period|Participants|Count of Participants|0|0.0||||||
3694073|NCT02214121|3535800|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|Relevant for the Part A period|Participants|Count of Participants|0|0.0||||||
3694074|NCT02214121|3535797|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Relevant for the Part A period|Participants|Count of Participants|44|44.0||||||
3694075|NCT02214121|3535798|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Relevant for the Part A period|Participants|Count of Participants|0|0.0||||||
3694076|NCT02214121|3535799|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Relevant for the Part A period|Participants|Count of Participants|0|0.0||||||
3694077|NCT02214121|3535800|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Relevant for the Part A period|Participants|Count of Participants|44|44.0||||||
3694078|NCT02214121|3535797|B4||Hispanic or Latino|Ethnicity (NIH/OMB)|Relevant for the Part A period|Participants|Count of Participants|1|1.0||||||
3694079|NCT02214121|3535798|B3||Hispanic or Latino|Ethnicity (NIH/OMB)|Relevant for the Part A period|Participants|Count of Participants|0|0.0||||||
3694080|NCT02214121|3535799|B2||Hispanic or Latino|Ethnicity (NIH/OMB)|Relevant for the Part A period|Participants|Count of Participants|0|0.0||||||
3694081|NCT02214121|3535800|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|Relevant for the Part A period|Participants|Count of Participants|1|1.0||||||
3694082|NCT02214121|3535797|B4||Male|Sex: Female, Male|Relevant for the Part B period of the study.|Participants|Count of Participants|12|12.0||||||
3694083|NCT02214121|3535798|B3||Male|Sex: Female, Male|Relevant for the Part B period of the study.|Participants|Count of Participants|5|5.0||||||
3694084|NCT02214121|3535799|B2||Male|Sex: Female, Male|Relevant for the Part B period of the study.|Participants|Count of Participants|7|7.0||||||
3694085|NCT02214121|3535800|B1||Male|Sex: Female, Male|Relevant for the Part B period of the study.|Participants|Count of Participants|0|0.0||||||
3694086|NCT02214121|3535797|B4||Female|Sex: Female, Male|Relevant for the Part B period of the study.|Participants|Count of Participants|11|11.0||||||
3694087|NCT02214121|3535798|B3||Female|Sex: Female, Male|Relevant for the Part B period of the study.|Participants|Count of Participants|2|2.0||||||
3694088|NCT02214121|3535799|B2||Female|Sex: Female, Male|Relevant for the Part B period of the study.|Participants|Count of Participants|9|9.0||||||
3694089|NCT02214121|3535800|B1||Female|Sex: Female, Male|Relevant for the Part B period of the study.|Participants|Count of Participants|0|0.0||||||
3694090|NCT02214121|3535797|B4||Male|Sex: Female, Male|Relevant for the Part A period of the study|Participants|Count of Participants|21|21.0||||||
3694091|NCT02214121|3535798|B3||Male|Sex: Female, Male|Relevant for the Part A period of the study|Participants|Count of Participants|0|0.0||||||
3694092|NCT02214121|3535799|B2||Male|Sex: Female, Male|Relevant for the Part A period of the study|Participants|Count of Participants|0|0.0||||||
3694093|NCT02214121|3535800|B1||Male|Sex: Female, Male|Relevant for the Part A period of the study|Participants|Count of Participants|21|21.0||||||
3694094|NCT02214121|3535797|B4||Female|Sex: Female, Male|Relevant for the Part A period of the study|Participants|Count of Participants|24|24.0||||||
3694095|NCT02214121|3535798|B3||Female|Sex: Female, Male|Relevant for the Part A period of the study|Participants|Count of Participants|0|0.0||||||
3694096|NCT02214121|3535799|B2||Female|Sex: Female, Male|Relevant for the Part A period of the study|Participants|Count of Participants|0|0.0||||||
3694097|NCT02214121|3535800|B1||Female|Sex: Female, Male|Relevant for the Part A period of the study|Participants|Count of Participants|24|24.0||||||
3694098|NCT02214121|3535797|B4|||Age|Relevant for the Part B period of the study.|Years|Mean|10.0|10.0|Standard Deviation|3.55|3.55|||
3694099|NCT02214121|3535798|B3|||Age|Relevant for the Part B period of the study.|Years|Mean|9.7|9.7|Standard Deviation|3.35|3.35|||
3694100|NCT02214121|3535799|B2|||Age|Relevant for the Part B period of the study.|Years|Mean|10.2|10.2|Standard Deviation|3.73|3.73|||
3694101|NCT02214121|3535797|B4|||Age|Relevant for the Part A period of the study.|Years|Mean|11.2|11.2|Standard Deviation|3.34|3.34|||
3694102|NCT02214121|3535800|B1|||Age|Relevant for the Part A period of the study.|Years|Mean|11.2|11.2|Standard Deviation|3.34|3.34|||
3694103|NCT02214017|3535879|B3|||insulin treatment||Participants|Count of Participants|15|15.0||||||
3694104|NCT02214017|3535880|B2|||insulin treatment||Participants|Count of Participants|8|8.0||||||
3694105|NCT02214017|3535881|B1|||insulin treatment||Participants|Count of Participants|7|7.0||||||
3694106|NCT02214017|3535879|B3|||duration of type 2 diabetes||years|Median|11|11.0|Full Range|||0.0|22.0|
3694107|NCT02214017|3535880|B2|||duration of type 2 diabetes||years|Median|11.5|11.5|Full Range|||2.0|21.0|
3694108|NCT02214017|3535881|B1|||duration of type 2 diabetes||years|Median|9.5|9.5|Full Range|||0.0|22.0|
3694109|NCT02214017|3535879|B3|||BMI||kg / m^2|Median|31.8|31.8|Full Range|||23.0|67.0|
3694110|NCT02214017|3535880|B2|||BMI||kg / m^2|Median|32.7|32.7|Full Range|||26.0|67.0|
3694111|NCT02214017|3535881|B1|||BMI||kg / m^2|Median|30|30.0|Full Range|||23.0|43.0|
3694112|NCT02214017|3535879|B3|Denmark||Region of Enrollment||participants|Number|40|40.0||||||
3694113|NCT02214017|3535880|B2|Denmark||Region of Enrollment||participants|Number|18|18.0||||||
3694114|NCT02214017|3535881|B1|Denmark||Region of Enrollment||participants|Number|22|22.0||||||
3694115|NCT02214017|3535879|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3694116|NCT02214017|3535879|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3694117|NCT02214017|3535880|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3694118|NCT02214017|3535881|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3694119|NCT02214017|3535879|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3694120|NCT02214017|3535880|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3694121|NCT02214017|3535881|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3694122|NCT02214017|3535879|B3|||Age||years|Median|64|64.0|Full Range|||36.0|83.0|
3694123|NCT02214017|3535880|B2|||Age||years|Median|59|59.0|Full Range|||46.0|83.0|
3694124|NCT02214017|3535881|B1|||Age||years|Median|68|68.0|Full Range|||36.0|80.0|
3694125|NCT02214017|3535879|B3||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3694126|NCT02214017|3535880|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3694127|NCT02214017|3535881|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3694128|NCT02214017|3535879|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3694129|NCT02214017|3535880|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3694130|NCT02214017|3535881|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3694131|NCT02214017|3535879|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3694132|NCT02214017|3535880|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3694133|NCT02214017|3535881|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3694134|NCT02213926|3535892|B1|3||ECOG (Eastern Cooperative Oncology Group) performance status|"Performance Status Score (reference http://www.ecog.org/general/perf_stat.html):~0-Fully active, able to carry on all pre-disease performance~Restricted physically strenuous activity but ambulatory and able to carry out work of a light/sedentary nature, eg light house/office work~Ambulatory, capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~Capable of only limited self-care, confined to bed or chair more than 50% of waking hours~Completely disabled Cannot carry on any self-care Totally confined to bed/chair~Dead"|Participants|Count of Participants|1|1.0||||||
3694180|NCT02213510|3535915|B3|1 - Always burns, never tans||Fitzpatrick Skin Scale||participants|Number|2|2.0||||||
3694181|NCT02213510|3535916|B2|1 - Always burns, never tans||Fitzpatrick Skin Scale||participants|Number|0|0.0||||||
3694135|NCT02213926|3535892|B1|2||ECOG (Eastern Cooperative Oncology Group) performance status|"Performance Status Score (reference http://www.ecog.org/general/perf_stat.html):~0-Fully active, able to carry on all pre-disease performance~Restricted physically strenuous activity but ambulatory and able to carry out work of a light/sedentary nature, eg light house/office work~Ambulatory, capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~Capable of only limited self-care, confined to bed or chair more than 50% of waking hours~Completely disabled Cannot carry on any self-care Totally confined to bed/chair~Dead"|Participants|Count of Participants|8|8.0||||||
3694136|NCT02213926|3535892|B1|1||ECOG (Eastern Cooperative Oncology Group) performance status|"Performance Status Score (reference http://www.ecog.org/general/perf_stat.html):~0-Fully active, able to carry on all pre-disease performance~Restricted physically strenuous activity but ambulatory and able to carry out work of a light/sedentary nature, eg light house/office work~Ambulatory, capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~Capable of only limited self-care, confined to bed or chair more than 50% of waking hours~Completely disabled Cannot carry on any self-care Totally confined to bed/chair~Dead"|Participants|Count of Participants|44|44.0||||||
3694137|NCT02213926|3535892|B1|0||ECOG (Eastern Cooperative Oncology Group) performance status|"Performance Status Score (reference http://www.ecog.org/general/perf_stat.html):~0-Fully active, able to carry on all pre-disease performance~Restricted physically strenuous activity but ambulatory and able to carry out work of a light/sedentary nature, eg light house/office work~Ambulatory, capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~Capable of only limited self-care, confined to bed or chair more than 50% of waking hours~Completely disabled Cannot carry on any self-care Totally confined to bed/chair~Dead"|Participants|Count of Participants|71|71.0||||||
3694138|NCT02213926|3535892|B1|||Number of prior therapies||number of prior therapies|Median|2|2.0|Full Range|||1.0|5.0|
3694139|NCT02213926|3535892|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3694140|NCT02213926|3535892|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694141|NCT02213926|3535892|B1||White|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
3694142|NCT02213926|3535892|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3694143|NCT02213926|3535892|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694144|NCT02213926|3535892|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694145|NCT02213926|3535892|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694146|NCT02213926|3535892|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3694147|NCT02213926|3535892|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
3694148|NCT02213926|3535892|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3694149|NCT02213926|3535892|B1||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3694150|NCT02213926|3535892|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3694151|NCT02213926|3535892|B1|||Age||years|Median|68|68.0|Full Range|||42.0|90.0|
3694152|NCT02213900|3535896|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3694153|NCT02213900|3535897|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3694154|NCT02213900|3535898|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3694155|NCT02213900|3535896|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3694156|NCT02213900|3535897|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3694157|NCT02213900|3535898|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3694158|NCT02213900|3535896|B3|||Age||years|Mean|59.6|59.6|Standard Deviation|13.2|13.2|||
3694159|NCT02213900|3535897|B2|||Age||years|Mean|59.6|59.6|Standard Deviation|14.0|14.0|||
3694160|NCT02213900|3535898|B1|||Age||years|Mean|59.6|59.6|Standard Deviation|12.4|12.4|||
3694161|NCT02213666|3535911|B1|United States||Region of Enrollment||participants|Number|72|72.0||||||
3694162|NCT02213666|3535911|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3694163|NCT02213666|3535911|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3694164|NCT02213666|3535911|B1|||Age||years|Mean|61|61.0|Standard Deviation|11|11.0|||
3694165|NCT02213510|3535915|B3|6 - Never burns, tans very easily||Fitzpatrick Skin Scale||participants|Number|3|3.0||||||
3694166|NCT02213510|3535916|B2|6 - Never burns, tans very easily||Fitzpatrick Skin Scale||participants|Number|2|2.0||||||
3694167|NCT02213510|3535917|B1|6 - Never burns, tans very easily||Fitzpatrick Skin Scale||participants|Number|1|1.0||||||
3694168|NCT02213510|3535915|B3|5 - Very rarely burns, tans very easily||Fitzpatrick Skin Scale||participants|Number|7|7.0||||||
3694169|NCT02213510|3535916|B2|5 - Very rarely burns, tans very easily||Fitzpatrick Skin Scale||participants|Number|3|3.0||||||
3694170|NCT02213510|3535917|B1|5 - Very rarely burns, tans very easily||Fitzpatrick Skin Scale||participants|Number|4|4.0||||||
3694171|NCT02213510|3535915|B3|4 - Rarely burns, tans with ease||Fitzpatrick Skin Scale||participants|Number|13|13.0||||||
3694172|NCT02213510|3535916|B2|4 - Rarely burns, tans with ease||Fitzpatrick Skin Scale||participants|Number|7|7.0||||||
3694173|NCT02213510|3535917|B1|4 - Rarely burns, tans with ease||Fitzpatrick Skin Scale||participants|Number|6|6.0||||||
3694174|NCT02213510|3535915|B3|3 - Somtimes mild burn, gradually tans||Fitzpatrick Skin Scale||participants|Number|13|13.0||||||
3694175|NCT02213510|3535916|B2|3 - Somtimes mild burn, gradually tans||Fitzpatrick Skin Scale||participants|Number|6|6.0||||||
3694176|NCT02213510|3535917|B1|3 - Somtimes mild burn, gradually tans||Fitzpatrick Skin Scale||participants|Number|7|7.0||||||
3694177|NCT02213510|3535915|B3|2 - Usually burns, tans with difficulty||Fitzpatrick Skin Scale||participants|Number|2|2.0||||||
3694178|NCT02213510|3535916|B2|2 - Usually burns, tans with difficulty||Fitzpatrick Skin Scale||participants|Number|1|1.0||||||
3694182|NCT02213510|3535917|B1|1 - Always burns, never tans||Fitzpatrick Skin Scale||participants|Number|2|2.0||||||
3694183|NCT02213510|3535915|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3694184|NCT02213510|3535916|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3694185|NCT02213510|3535917|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3694186|NCT02213510|3535915|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694187|NCT02213510|3535916|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694188|NCT02213510|3535917|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694189|NCT02213510|3535915|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694190|NCT02213510|3535916|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694191|NCT02213510|3535917|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694192|NCT02213510|3535915|B3||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3694193|NCT02213510|3535916|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3694194|NCT02213510|3535917|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3694195|NCT02213510|3535915|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3694196|NCT02213510|3535916|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3694197|NCT02213510|3535917|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3694198|NCT02213510|3535915|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694199|NCT02213510|3535916|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694200|NCT02213510|3535917|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694201|NCT02213510|3535915|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3694202|NCT02213510|3535916|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3694203|NCT02213510|3535917|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3694204|NCT02213510|3535915|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694205|NCT02213510|3535916|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694206|NCT02213510|3535917|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694207|NCT02213510|3535915|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3694208|NCT02213510|3535916|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3694209|NCT02213510|3535917|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3694210|NCT02213510|3535915|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3694211|NCT02213510|3535916|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3694212|NCT02213510|3535917|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3694213|NCT02213510|3535915|B3|||Age||years|Mean|70|70.0|Inter-Quartile Range|||41.0|100.0|
3694214|NCT02213510|3535916|B2|||Age||years|Mean|70|70.0|Inter-Quartile Range|||41.0|100.0|
3694215|NCT02213510|3535917|B1|||Age||years|Mean|71|71.0|Inter-Quartile Range|||44.0|99.0|
3694216|NCT02213263|3535944|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3694217|NCT02213263|3535945|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3694218|NCT02213263|3535946|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3694219|NCT02213263|3535944|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694220|NCT02213263|3535945|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694221|NCT02213263|3535946|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694222|NCT02213263|3535944|B3||White|Race (NIH/OMB)||Participants|Count of Participants|304|304.0||||||
3694223|NCT02213263|3535945|B2||White|Race (NIH/OMB)||Participants|Count of Participants|158|158.0||||||
3694224|NCT02213263|3535946|B1||White|Race (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
3694225|NCT02213263|3535944|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3694226|NCT02213263|3535945|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3694227|NCT02213263|3535946|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694228|NCT02213263|3535944|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694229|NCT02213263|3535945|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694230|NCT02213263|3535946|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694231|NCT02213263|3535944|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3694232|NCT02213263|3535945|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3694233|NCT02213263|3535946|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3694234|NCT02213263|3535944|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694235|NCT02213263|3535945|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694236|NCT02213263|3535946|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694237|NCT02213263|3535944|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694238|NCT02213263|3535945|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694239|NCT02213263|3535946|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694240|NCT02213263|3535944|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|337|337.0||||||
3694241|NCT02213263|3535945|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|165|165.0||||||
3694242|NCT02213263|3535946|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|172|172.0||||||
3694243|NCT02213263|3535944|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3694244|NCT02213263|3535945|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3694245|NCT02213263|3535946|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3694246|NCT02213263|3535944|B3||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
3694247|NCT02213263|3535945|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3694248|NCT02213263|3535946|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3694249|NCT02213263|3535944|B3||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
3694250|NCT02213263|3535945|B2||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3694251|NCT02213263|3535946|B1||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3694252|NCT02213263|3535944|B3|||Age||years|Mean|58.5|58.5|Standard Deviation|12.4|12.4|||
3694253|NCT02213263|3535945|B2|||Age||years|Mean|58.7|58.7|Standard Deviation|12.1|12.1|||
3694254|NCT02213263|3535946|B1|||Age||years|Mean|58.3|58.3|Standard Deviation|12.8|12.8|||
3694255|NCT02213250|3535983|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3694256|NCT02213250|3535983|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3694257|NCT02213250|3535983|B1|||Age||Years|Mean|24.8|24.8|Standard Deviation|15.4|15.4|||
3694258|NCT02213198|3536013|B3|United States||Region of Enrollment||participants|Number|326|326.0||||||
3694259|NCT02213198|3536014|B2|United States||Region of Enrollment||participants|Number|107|107.0||||||
3694260|NCT02213198|3536015|B1|United States||Region of Enrollment||participants|Number|219|219.0||||||
3694261|NCT02213198|3536013|B3||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3694262|NCT02213198|3536014|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3694263|NCT02213198|3536015|B1||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3694264|NCT02213198|3536013|B3||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
3694265|NCT02213198|3536014|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3694266|NCT02213198|3536015|B1||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3694267|NCT02213198|3536013|B3|||Age||years|Mean|38|38.0|Standard Deviation|11.9|11.9|||
3694268|NCT02213198|3536014|B2|||Age||years|Mean|39.9|39.9|Standard Deviation|13.1|13.1|||
3694269|NCT02213198|3536015|B1|||Age||years|Mean|37.1|37.1|Standard Deviation|11.4|11.4|||
3694270|NCT02213198|3536013|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3694271|NCT02213198|3536014|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3694272|NCT02213198|3536015|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3694273|NCT02213198|3536013|B3||Between 18 and 65 years|Age||Participants|Count of Participants|326|326.0||||||
3694274|NCT02213198|3536014|B2||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
3694275|NCT02213198|3536015|B1||Between 18 and 65 years|Age||Participants|Count of Participants|219|219.0||||||
3694276|NCT02213198|3536013|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3694277|NCT02213198|3536014|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3694278|NCT02213198|3536015|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3694279|NCT02213094|3536024|B3|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3694280|NCT02213094|3536025|B2|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3694281|NCT02213094|3536026|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3694282|NCT02213094|3536024|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3694283|NCT02213094|3536025|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3694284|NCT02213094|3536026|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3694285|NCT02213094|3536024|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3694286|NCT02213094|3536025|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3694287|NCT02213094|3536026|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3694288|NCT02213094|3536024|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3694289|NCT02213094|3536025|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3694290|NCT02213094|3536026|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3694291|NCT02213094|3536024|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3694292|NCT02213094|3536025|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3694293|NCT02213094|3536026|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3694294|NCT02213094|3536024|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3694295|NCT02213094|3536025|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3694296|NCT02213094|3536026|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3694297|NCT02213055|3536033|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
3694298|NCT02213055|3536035|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
3694299|NCT02213055|3536033|B3|Male||Gender||participants|Number|13|13.0||||||
3694300|NCT02213055|3536035|B1|Male||Gender||participants|Number|13|13.0||||||
3694301|NCT02213055|3536033|B3|Female||Gender||participants|Number|45|45.0||||||
3694302|NCT02213055|3536035|B1|Female||Gender||participants|Number|45|45.0||||||
3694303|NCT02213055|3536033|B3|||Age|There were 58 evaluable subjects in the experimental (LiceMD) arm of the study.|Years|Mean|6.98|6.98|Standard Deviation|1.73|1.73|||
3694304|NCT02213055|3536035|B1|||Age|There were 58 evaluable subjects in the experimental (LiceMD) arm of the study.|Years|Mean|6.98|6.98|Standard Deviation|1.73|1.73|||
3694305|NCT02213055|3536033|B3|>=65 years||Age||participants|Number|0|0.0||||||
3694306|NCT02213055|3536035|B1|>=65 years||Age||participants|Number|0|0.0||||||
3694307|NCT02213055|3536033|B3|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
3694308|NCT02213055|3536035|B1|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
3694309|NCT02213055|3536033|B3|<=18 years||Age||participants|Number|58|58.0||||||
3694310|NCT02213055|3536035|B1|<=18 years||Age||participants|Number|58|58.0||||||
3694311|NCT02212977|3536042|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3694312|NCT02212977|3536043|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3694313|NCT02212977|3536044|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3694314|NCT02212977|3536042|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3694315|NCT02212977|3536043|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3694316|NCT02212977|3536044|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3694317|NCT02212977|3536042|B3|||Age||years|Mean|58.7|58.7|Standard Deviation|7.6|7.6|||
3694318|NCT02212977|3536043|B2|||Age||years|Mean|58.3|58.3|Standard Deviation|7.6|7.6|||
3694319|NCT02212977|3536044|B1|||Age||years|Mean|59|59.0|Standard Deviation|7.5|7.5|||
3694320|NCT02212834|3536059|B3|Race/ethnicity at time of exam|Missing|Race/Ethnicity, Customized||surveillance exams|Count of Units|78|78.0||||||
3694321|NCT02212834|3536060|B2|Race/ethnicity at time of exam|Missing|Race/Ethnicity, Customized||surveillance exams|Count of Units|1|1.0||||||
3694322|NCT02212834|3536061|B1|Race/ethnicity at time of exam|Missing|Race/Ethnicity, Customized||surveillance exams|Count of Units|77|77.0||||||
3694323|NCT02212834|3536059|B3|Race/ethnicity at time of exam|Mixed or Other|Race/Ethnicity, Customized||surveillance exams|Count of Units|745|745.0||||||
3694324|NCT02212834|3536060|B2|Race/ethnicity at time of exam|Mixed or Other|Race/Ethnicity, Customized||surveillance exams|Count of Units|88|88.0||||||
3694325|NCT02212834|3536061|B1|Race/ethnicity at time of exam|Mixed or Other|Race/Ethnicity, Customized||surveillance exams|Count of Units|657|657.0||||||
3694326|NCT02212834|3536059|B3|Race/ethnicity at time of exam|Asian or Pacific Islander|Race/Ethnicity, Customized||surveillance exams|Count of Units|2802|2802.0||||||
3694327|NCT02212834|3536060|B2|Race/ethnicity at time of exam|Asian or Pacific Islander|Race/Ethnicity, Customized||surveillance exams|Count of Units|219|219.0||||||
3694328|NCT02212834|3536061|B1|Race/ethnicity at time of exam|Asian or Pacific Islander|Race/Ethnicity, Customized||surveillance exams|Count of Units|2,583|2.0||||||
3694329|NCT02212834|3536059|B3|Race/ethnicity at time of exam|Hispanic|Race/Ethnicity, Customized||surveillance exams|Count of Units|1109|1109.0||||||
3694330|NCT02212834|3536060|B2|Race/ethnicity at time of exam|Hispanic|Race/Ethnicity, Customized||surveillance exams|Count of Units|67|67.0||||||
3694331|NCT02212834|3536061|B1|Race/ethnicity at time of exam|Hispanic|Race/Ethnicity, Customized||surveillance exams|Count of Units|1,042|1.0||||||
3694332|NCT02212834|3536059|B3|Race/ethnicity at time of exam|Black, non-hispanic|Race/Ethnicity, Customized||surveillance exams|Count of Units|2924|2924.0||||||
3694333|NCT02212834|3536060|B2|Race/ethnicity at time of exam|Black, non-hispanic|Race/Ethnicity, Customized||surveillance exams|Count of Units|62|62.0||||||
3694334|NCT02212834|3536061|B1|Race/ethnicity at time of exam|Black, non-hispanic|Race/Ethnicity, Customized||surveillance exams|Count of Units|2,862|2.0||||||
3694335|NCT02212834|3536059|B3|Race/ethnicity at time of exam|White, non-hispanic|Race/Ethnicity, Customized||surveillance exams|Count of Units|28786|28786.0||||||
3694336|NCT02212834|3536060|B2|Race/ethnicity at time of exam|White, non-hispanic|Race/Ethnicity, Customized||surveillance exams|Count of Units|2,069|2.0||||||
3694337|NCT02212834|3536061|B1|Race/ethnicity at time of exam|White, non-hispanic|Race/Ethnicity, Customized||surveillance exams|Count of Units|26,717|26.0||||||
3694338|NCT02212834|3536059|B3||Male|Sex: Female, Male||surveillance exams|Count of Units|0|0.0||||||
3694339|NCT02212834|3536060|B2||Male|Sex: Female, Male||surveillance exams|Count of Units|0|0.0||||||
3694340|NCT02212834|3536061|B1||Male|Sex: Female, Male||surveillance exams|Count of Units|0|0.0||||||
3694341|NCT02212834|3536059|B3||Female|Sex: Female, Male||surveillance exams|Count of Units|36444|36444.0||||||
3694342|NCT02212834|3536060|B2||Female|Sex: Female, Male||surveillance exams|Count of Units|2,506|2.0||||||
3694343|NCT02212834|3536061|B1||Female|Sex: Female, Male||surveillance exams|Count of Units|33,938|33.0||||||
3694344|NCT02212834|3536059|B3|Age at exam|> or = 80 years|Age, Customized||surveillance exams|Count of Units|4279|4279.0||||||
3694345|NCT02212834|3536060|B2|Age at exam|> or = 80 years|Age, Customized||surveillance exams|Count of Units|9|9.0||||||
3694346|NCT02212834|3536061|B1|Age at exam|> or = 80 years|Age, Customized||surveillance exams|Count of Units|4,270|4.0||||||
3694347|NCT02212834|3536059|B3|Age at exam|70 - 79 years|Age, Customized||surveillance exams|Count of Units|7300|7300.0||||||
3694348|NCT02212834|3536060|B2|Age at exam|70 - 79 years|Age, Customized||surveillance exams|Count of Units|133|133.0||||||
3694349|NCT02212834|3536061|B1|Age at exam|70 - 79 years|Age, Customized||surveillance exams|Count of Units|7,167|7.0||||||
3694350|NCT02212834|3536059|B3|Age at exam|60 - 69 years|Age, Customized||surveillance exams|Count of Units|10484|10484.0||||||
3694351|NCT02212834|3536060|B2|Age at exam|60 - 69 years|Age, Customized||surveillance exams|Count of Units|632|632.0||||||
3694352|NCT02212834|3536061|B1|Age at exam|60 - 69 years|Age, Customized||surveillance exams|Count of Units|9,852|9.0||||||
3694353|NCT02212834|3536059|B3|Age at exam|50 - 59 years|Age, Customized||surveillance exams|Count of Units|9631|9631.0||||||
3694354|NCT02212834|3536060|B2|Age at exam|50 - 59 years|Age, Customized||surveillance exams|Count of Units|1,005|1.0||||||
3694355|NCT02212834|3536061|B1|Age at exam|50 - 59 years|Age, Customized||surveillance exams|Count of Units|8,626|8.0||||||
3694356|NCT02212834|3536059|B3|Age at exam|40 - 49 years|Age, Customized||surveillance exams|Count of Units|4209|4209.0||||||
3694357|NCT02212834|3536060|B2|Age at exam|40 - 49 years|Age, Customized||surveillance exams|Count of Units|574|574.0||||||
3694358|NCT02212834|3536061|B1|Age at exam|40 - 49 years|Age, Customized||surveillance exams|Count of Units|3,635|3.0||||||
3694359|NCT02212834|3536059|B3|Age at exam|18 - 39 years|Age, Customized||surveillance exams|Count of Units|541|541.0||||||
3694360|NCT02212834|3536060|B2|Age at exam|18 - 39 years|Age, Customized||surveillance exams|Count of Units|153|153.0||||||
3694361|NCT02212834|3536061|B1|Age at exam|18 - 39 years|Age, Customized||surveillance exams|Count of Units|388|388.0||||||
3694362|NCT02212457|3536068|B7||Male|Sex: Female, Male||Participants|Count of Participants|452|452.0||||||
3694363|NCT02212457|3536069|B6||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3694364|NCT02212457|3536070|B5||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3694365|NCT02212457|3536071|B4||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3694366|NCT02212457|3536072|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3694367|NCT02212457|3536073|B2||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3694368|NCT02212457|3536074|B1||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3694369|NCT02212457|3536068|B7||Female|Sex: Female, Male||Participants|Count of Participants|611|611.0||||||
3694370|NCT02212457|3536069|B6||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3694371|NCT02212457|3536070|B5||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3694372|NCT02212457|3536071|B4||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3694373|NCT02212457|3536072|B3||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3694374|NCT02212457|3536073|B2||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3694375|NCT02212457|3536074|B1||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3694376|NCT02212457|3536068|B7|||Age||Years|Mean|14.4|14.4|Standard Deviation|3.1|3.1|||
3694377|NCT02212457|3536069|B6|||Age||Years|Mean|14.3|14.3|Standard Deviation|3.16|3.16|||
3694378|NCT02212457|3536070|B5|||Age||Years|Mean|14.5|14.5|Standard Deviation|3.1|3.1|||
3694379|NCT02212457|3536071|B4|||Age||Years|Mean|14.4|14.4|Standard Deviation|3.06|3.06|||
3694380|NCT02212457|3536072|B3|||Age||Years|Mean|14.4|14.4|Standard Deviation|3.01|3.01|||
3694381|NCT02212457|3536073|B2|||Age||Years|Mean|14.2|14.2|Standard Deviation|3.17|3.17|||
3694382|NCT02212457|3536074|B1|||Age||Years|Mean|14.5|14.5|Standard Deviation|3.09|3.09|||
3694383|NCT02212301|3536117|B1|United Kingdom||Region of Enrollment||participants|Number|43|43.0||||||
3694384|NCT02212301|3536117|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3694385|NCT02212301|3536117|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3694386|NCT02212301|3536117|B1|||Age||Years|Mean|35.1|35.1|Standard Deviation|7.78|7.78|||
3694387|NCT02212197|3536126|B4|Finland||Region of Enrollment||participants|Number|31|31.0||||||
3694388|NCT02212197|3536127|B3|Finland||Region of Enrollment||participants|Number|8|8.0||||||
3694389|NCT02212197|3536128|B2|Finland||Region of Enrollment||participants|Number|10|10.0||||||
3694390|NCT02212197|3536129|B1|Finland||Region of Enrollment||participants|Number|13|13.0||||||
3694391|NCT02212197|3536126|B4|Hungary||Region of Enrollment||participants|Number|20|20.0||||||
3694392|NCT02212197|3536127|B3|Hungary||Region of Enrollment||participants|Number|9|9.0||||||
3694393|NCT02212197|3536128|B2|Hungary||Region of Enrollment||participants|Number|5|5.0||||||
3694394|NCT02212197|3536129|B1|Hungary||Region of Enrollment||participants|Number|6|6.0||||||
3694395|NCT02212197|3536126|B4||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3694396|NCT02212197|3536127|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3694397|NCT02212197|3536128|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3694398|NCT02212197|3536129|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3694399|NCT02212197|3536126|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3694400|NCT02212197|3536127|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3694401|NCT02212197|3536128|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3694402|NCT02212197|3536129|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3694403|NCT02212197|3536126|B4|||Age||years|Mean|70.8|70.8|Standard Deviation|7.8|7.8|||
3694404|NCT02212197|3536127|B3|||Age||years|Mean|70.9|70.9|Standard Deviation|7|7.0|||
3694405|NCT02212197|3536128|B2|||Age||years|Mean|71.9|71.9|Standard Deviation|6.3|6.3|||
3694406|NCT02212197|3536129|B1|||Age||years|Mean|69.7|69.7|Standard Deviation|9.5|9.5|||
3694407|NCT02212197|3536126|B4||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
3694408|NCT02212197|3536127|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3694409|NCT02212197|3536128|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3694410|NCT02212197|3536129|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3694411|NCT02212197|3536126|B4||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3694412|NCT02212197|3536127|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3694413|NCT02212197|3536128|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3694414|NCT02212197|3536129|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3694415|NCT02212197|3536126|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3694416|NCT02212197|3536127|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3694417|NCT02212197|3536128|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3694418|NCT02212197|3536129|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3694419|NCT02212106|3536154|B3|United States||Region of Enrollment||participants|Number|402|402.0||||||
3694420|NCT02212106|3536155|B2|United States||Region of Enrollment||participants|Number|100|100.0||||||
3694421|NCT02212106|3536156|B1|United States||Region of Enrollment||participants|Number|302|302.0||||||
3694422|NCT02212106|3536154|B3||Male|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
3694423|NCT02212106|3536155|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3694424|NCT02212106|3536156|B1||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3694425|NCT02212106|3536154|B3||Female|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
3694426|NCT02212106|3536155|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3694427|NCT02212106|3536156|B1||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3694428|NCT02212106|3536154|B3|Age 5 to < 9 years||Age, Customized||participants|Number|402|402.0||||||
3694429|NCT02212106|3536155|B2|Age 5 to < 9 years||Age, Customized||participants|Number|100|100.0||||||
3694430|NCT02212106|3536156|B1|Age 5 to < 9 years||Age, Customized||participants|Number|302|302.0||||||
3694431|NCT02212106|3536154|B3|||Age||years|Mean|6.6|6.6|Standard Deviation|1.04|1.04|||
3694432|NCT02212106|3536155|B2|||Age||years|Mean|6.6|6.6|Standard Deviation|1.02|1.02|||
3694433|NCT02212106|3536156|B1|||Age||years|Mean|6.7|6.7|Standard Deviation|1.05|1.05|||
3694434|NCT02212028|3536173|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694435|NCT02212028|3536174|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694436|NCT02212028|3536175|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694437|NCT02212028|3536173|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694438|NCT02212028|3536174|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694439|NCT02212028|3536175|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694440|NCT02212028|3536173|B3||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3694441|NCT02212028|3536174|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3694442|NCT02212028|3536175|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3694443|NCT02212028|3536173|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3694444|NCT02212028|3536174|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3694445|NCT02212028|3536175|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3694446|NCT02212028|3536173|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694447|NCT02212028|3536174|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694448|NCT02212028|3536175|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694449|NCT02212028|3536173|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694450|NCT02212028|3536174|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694451|NCT02212028|3536175|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694452|NCT02212028|3536173|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694453|NCT02212028|3536174|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694454|NCT02212028|3536175|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694455|NCT02212028|3536173|B3||Male|Gender||Participants|Count of Participants|37|37.0||||||
3694456|NCT02212028|3536174|B2||Male|Gender||Participants|Count of Participants|18|18.0||||||
3694457|NCT02212028|3536175|B1||Male|Gender||Participants|Count of Participants|19|19.0||||||
3694458|NCT02212028|3536173|B3||Female|Gender||Participants|Count of Participants|13|13.0||||||
3694459|NCT02212028|3536174|B2||Female|Gender||Participants|Count of Participants|6|6.0||||||
3694460|NCT02212028|3536175|B1||Female|Gender||Participants|Count of Participants|7|7.0||||||
3694461|NCT02212028|3536173|B3|||Age||years|Mean|58|58.0|Standard Deviation|10|10.0|||
3694462|NCT02212028|3536174|B2|||Age||years|Mean|58|58.0|Standard Deviation|10|10.0|||
3694463|NCT02212028|3536175|B1|||Age||years|Mean|57|57.0|Standard Deviation|9|9.0|||
3694464|NCT02211638|3536184|B1||Other|Focus on Blood Pressure (BP) Measurement|"Participants who were answered Home or Clinic for a question Which blood pressure are you focusing on? were reported."|Participants|Count of Participants|1495|1495.0||||||
3694465|NCT02211638|3536184|B1||Focus on Clinic BP than Home BP|Focus on Blood Pressure (BP) Measurement|"Participants who were answered Home or Clinic for a question Which blood pressure are you focusing on? were reported."|Participants|Count of Participants|8021|8021.0||||||
3694466|NCT02211638|3536184|B1||Focus on Home BP than Clinic BP|Focus on Blood Pressure (BP) Measurement|"Participants who were answered Home or Clinic for a question Which blood pressure are you focusing on? were reported."|Participants|Count of Participants|7614|7614.0||||||
3694467|NCT02211638|3536184|B1|||Salt Intake: NaCl24|NaCl24 = UNa24×0.0585 10 <= Spot Urine Sodium (mEq/L) < 500, 100 <= Spot Urine Creatinine (mg/L） < 5000|g/day|Mean|10.0|10.0|Standard Deviation|2.92|2.92|||
3694468|NCT02211638|3536184|B1|||Salt Intake: NaCl24|NaCl24 = UNa24×0.0585|g/day|Mean|13.5|13.5|Standard Deviation|14.41|14.41|||
3694537|NCT02211534|3536195|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3694469|NCT02211638|3536184|B1|||Estimated 24hr Sodium Excretion: UNa24|UNa24 = 21.98×[(NaS/CrS) ×UCr24]^0.392|mEq/day|Mean|230.70|230.7|Standard Deviation|246.267|246.267|||
3694470|NCT02211638|3536184|B1|||Estimated 24hr Creatinine Excretion: UCr24|UCr24 = -2.04×age（years）＋14.89×weight（kg）＋16.14×height（cm）－2244.45|mg/day|Mean|1099.52|1099.52|Standard Deviation|349.732|349.732|||
3694471|NCT02211638|3536184|B1|||Spot Urine Creatinine: CrS||mg/L|Mean|804.2|804.2|Standard Deviation|1002.82|1002.82|||
3694472|NCT02211638|3536184|B1|||Spot Urine Sodium: NaS||mEq/L|Mean|129.9|129.9|Standard Deviation|52.78|52.78|||
3694473|NCT02211638|3536184|B1|||Evening Home DBP (Ave)||mmHg|Mean|85.5|85.5|Standard Deviation|11.59|11.59|||
3694474|NCT02211638|3536184|B1|||Evening Home SBP (Ave)||mmHg|Mean|146.2|146.2|Standard Deviation|15.88|15.88|||
3694475|NCT02211638|3536184|B1|||Early Morning Home DBP (Ave)||mmHg|Mean|89.4|89.4|Standard Deviation|11.41|11.41|||
3694476|NCT02211638|3536184|B1|||Early Morning Home SBP (Ave)||mmHg|Mean|153.9|153.9|Standard Deviation|15.89|15.89|||
3694477|NCT02211638|3536184|B1|||Clinical Diastolic Blood Pressure (DBP) (Sitting)||mmHg|Mean|88.7|88.7|Standard Deviation|13.47|13.47|||
3694478|NCT02211638|3536184|B1|||Clinical Systolic Blood Pressure (SBP) (Sitting)||mmHg|Mean|156.1|156.1|Standard Deviation|18.67|18.67|||
3694479|NCT02211638|3536184|B1||Had Antihypertensive Drugs|Status of Administration of Antihypertensive Drugs|Had no Antihypertensive Drugs; Participants who had not received concomitant antihypertensive drugs and switching antihypertensive drugs prior to the start of study drug were reported. Had Antihypertensive Drugs; Participants who had received concomitant antihypertensive drugs or switching antihypertensive drugs prior to the start of study drug were reported.|Participants|Count of Participants|7075|7075.0||||||
3694480|NCT02211638|3536184|B1||Had no Antihypertensive Drugs|Status of Administration of Antihypertensive Drugs|Had no Antihypertensive Drugs; Participants who had not received concomitant antihypertensive drugs and switching antihypertensive drugs prior to the start of study drug were reported. Had Antihypertensive Drugs; Participants who had received concomitant antihypertensive drugs or switching antihypertensive drugs prior to the start of study drug were reported.|Participants|Count of Participants|10055|10055.0||||||
3694481|NCT02211638|3536184|B1||Had Switching Antihypertensive Drugs|Switching Antihypertensive Drugs||Participants|Count of Participants|4274|4274.0||||||
3694482|NCT02211638|3536184|B1||Had no Switching Antihypertensive Drugs|Switching Antihypertensive Drugs||Participants|Count of Participants|12856|12856.0||||||
3694483|NCT02211638|3536184|B1||Had Concomitant Antihypertensive Drugs|Concomitant Antihypertensive Drugs||Participants|Count of Participants|5162|5162.0||||||
3694484|NCT02211638|3536184|B1||Had no Concomitant Antihypertensive Drugs|Concomitant Antihypertensive Drugs||Participants|Count of Participants|11968|11968.0||||||
3694485|NCT02211638|3536184|B1||Other Initial Dose|Initial Dose of Study Drug||Participants|Count of Participants|11|11.0||||||
3694486|NCT02211638|3536184|B1||12mg/day|Initial Dose of Study Drug||Participants|Count of Participants|556|556.0||||||
3694487|NCT02211638|3536184|B1||8mg/day|Initial Dose of Study Drug||Participants|Count of Participants|11170|11170.0||||||
3694488|NCT02211638|3536184|B1||4mg/day|Initial Dose of Study Drug||Participants|Count of Participants|4865|4865.0||||||
3694489|NCT02211638|3536184|B1||2mg/day|Initial Dose of Study Drug||Participants|Count of Participants|528|528.0||||||
3694490|NCT02211638|3536184|B1||Had Medical History|Medical History|Medical history defined as a disease or a health condition for each participant before start of the study. Medical history was classified as congenital anomalies, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, GI disorders, hepatic and biliary disorders, renal disease and other medical history. Other medical history included all medical history except for those mentioned above. Participants may be represented in more than 1 category.|Participants|Count of Participants|2754|2754.0||||||
3694491|NCT02211638|3536184|B1||Had no Medical History|Medical History|Medical history defined as a disease or a health condition for each participant before start of the study. Medical history was classified as congenital anomalies, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, GI disorders, hepatic and biliary disorders, renal disease and other medical history. Other medical history included all medical history except for those mentioned above. Participants may be represented in more than 1 category.|Participants|Count of Participants|14376|14376.0||||||
3694492|NCT02211638|3536184|B1||Had Medical Complications|Medical Complications|Complications defined as a disease or a health condition for each participant at the start of study. Complications were classified as congenital anomalies, endocrine disorders, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, gastrointestinal (GI) disorders, renal disease and other complications. Other complications included all complications except for those mentioned above. Participants may be represented in more than 1 category.|Participants|Count of Participants|9142|9142.0||||||
3694493|NCT02211638|3536184|B1||Had no Medical Complications|Medical Complications|Complications defined as a disease or a health condition for each participant at the start of study. Complications were classified as congenital anomalies, endocrine disorders, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, gastrointestinal (GI) disorders, renal disease and other complications. Other complications included all complications except for those mentioned above. Participants may be represented in more than 1 category.|Participants|Count of Participants|7988|7988.0||||||
3694494|NCT02211638|3536184|B1||Unknown|Smoking Classification||Participants|Count of Participants|3415|3415.0||||||
3694495|NCT02211638|3536184|B1||Current Smoker|Smoking Classification||Participants|Count of Participants|2032|2032.0||||||
3694496|NCT02211638|3536184|B1||Never Smoked|Smoking Classification||Participants|Count of Participants|11683|11683.0||||||
3694497|NCT02211638|3536184|B1|||Weight||kg|Mean|61.3|61.3|Standard Deviation|13.46|13.46|||
3694498|NCT02211638|3536184|B1|Japan||Region of Enrollment||Participants|Number|17130|17130.0||||||
3694499|NCT02211638|3536184|B1||Male|Sex: Female, Male||Participants|Count of Participants|8490|8490.0||||||
3694500|NCT02211638|3536184|B1||Female|Sex: Female, Male||Participants|Count of Participants|8640|8640.0||||||
3694501|NCT02211638|3536184|B1|||Age||Years|Mean|65.9|65.9|Standard Deviation|12.85|12.85|||
3694595|NCT02211261|3536225|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3694502|NCT02211534|3536193|B3|||PainDETECT Questionnaire|PainDETECT Questionniare (PD-q): a self-reported assessment designed to identify the presence of a neuropathic pain component in subjects with pain. Subjects assessed current pain, strongest pain, average pain, areas of pain, course of pain and symptoms (such as burning, tingling, numbness and sensitivity). The scale ranged from 0 to 38 defined as follows: score 0-12 = neuropathic pain component unlikely; 13-18 = result is ambiguous; 19-38 = neuropathic pain component is likely.|units on a scale|Mean|12.8|12.8|Full Range|||1.0|31.0|
3694503|NCT02211534|3536194|B2|||PainDETECT Questionnaire|PainDETECT Questionniare (PD-q): a self-reported assessment designed to identify the presence of a neuropathic pain component in subjects with pain. Subjects assessed current pain, strongest pain, average pain, areas of pain, course of pain and symptoms (such as burning, tingling, numbness and sensitivity). The scale ranged from 0 to 38 defined as follows: score 0-12 = neuropathic pain component unlikely; 13-18 = result is ambiguous; 19-38 = neuropathic pain component is likely.|units on a scale|Mean|12.7|12.7|Full Range|||1.0|26.0|
3694504|NCT02211534|3536195|B1|||PainDETECT Questionnaire|PainDETECT Questionniare (PD-q): a self-reported assessment designed to identify the presence of a neuropathic pain component in subjects with pain. Subjects assessed current pain, strongest pain, average pain, areas of pain, course of pain and symptoms (such as burning, tingling, numbness and sensitivity). The scale ranged from 0 to 38 defined as follows: score 0-12 = neuropathic pain component unlikely; 13-18 = result is ambiguous; 19-38 = neuropathic pain component is likely.|units on a scale|Mean|12.8|12.8|Full Range|||4.0|31.0|
3694505|NCT02211534|3536193|B3|||BMI||kg/m^2|Mean|31.42|31.42|Full Range|||23.2|38.0|
3694506|NCT02211534|3536194|B2|||BMI||kg/m^2|Mean|31.7|31.7|Full Range|||28.0|38.0|
3694507|NCT02211534|3536195|B1|||BMI||kg/m^2|Mean|31.3|31.3|Full Range|||23.2|36.9|
3694508|NCT02211534|3536193|B3|||Pain Catastrophizing Score|"The Pain Catastrophizing Scale (PCS) is a validated assessment tool for the extent to which patients catastrophize their pain. The scale asks 13 questions about types of thoughts and feelings associated with pain. Responses are based upon a 5-point scale ranging from 0 to 4, where 0=not at all and 4=all the time. A total score is calculated ranging from 0 to 52. Higher scores represent a higher catastrophization of pain.~The PCS will be administered at the research center during the Screening Visit, and scored by research personnel."|units on a scale|Mean|18.59|18.59|Full Range|||0.0|45.0|
3694509|NCT02211534|3536194|B2|||Pain Catastrophizing Score|"The Pain Catastrophizing Scale (PCS) is a validated assessment tool for the extent to which patients catastrophize their pain. The scale asks 13 questions about types of thoughts and feelings associated with pain. Responses are based upon a 5-point scale ranging from 0 to 4, where 0=not at all and 4=all the time. A total score is calculated ranging from 0 to 52. Higher scores represent a higher catastrophization of pain.~The PCS will be administered at the research center during the Screening Visit, and scored by research personnel."|units on a scale|Mean|17.7|17.7|Full Range|||0.0|40.0|
3694510|NCT02211534|3536195|B1|||Pain Catastrophizing Score|"The Pain Catastrophizing Scale (PCS) is a validated assessment tool for the extent to which patients catastrophize their pain. The scale asks 13 questions about types of thoughts and feelings associated with pain. Responses are based upon a 5-point scale ranging from 0 to 4, where 0=not at all and 4=all the time. A total score is calculated ranging from 0 to 52. Higher scores represent a higher catastrophization of pain.~The PCS will be administered at the research center during the Screening Visit, and scored by research personnel."|units on a scale|Mean|19|19.0|Full Range|||0.0|45.0|
3694511|NCT02211534|3536193|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694512|NCT02211534|3536194|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694513|NCT02211534|3536195|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694514|NCT02211534|3536193|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694515|NCT02211534|3536194|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694516|NCT02211534|3536195|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694517|NCT02211534|3536193|B3||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3694518|NCT02211534|3536194|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3694519|NCT02211534|3536195|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3694520|NCT02211534|3536193|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3694521|NCT02211534|3536194|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3694522|NCT02211534|3536195|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3694523|NCT02211534|3536193|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694524|NCT02211534|3536194|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694525|NCT02211534|3536195|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694526|NCT02211534|3536193|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694527|NCT02211534|3536194|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694528|NCT02211534|3536195|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694529|NCT02211534|3536193|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694530|NCT02211534|3536194|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694531|NCT02211534|3536195|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694532|NCT02211534|3536193|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3694533|NCT02211534|3536194|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694534|NCT02211534|3536195|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3694535|NCT02211534|3536193|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3694536|NCT02211534|3536194|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3694538|NCT02211534|3536193|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3694539|NCT02211534|3536194|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3694540|NCT02211534|3536195|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3694541|NCT02211534|3536193|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3694542|NCT02211534|3536194|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3694543|NCT02211534|3536195|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3694544|NCT02211534|3536193|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3694545|NCT02211534|3536194|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3694546|NCT02211534|3536195|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3694547|NCT02211534|3536193|B3|||Age||Years|Mean|62.86|62.86|Full Range|||45.0|79.0|
3694548|NCT02211534|3536194|B2|||Age||Years|Mean|63.82|63.82|Full Range|||45.0|79.0|
3694549|NCT02211534|3536195|B1|||Age||Years|Mean|62.42|62.42|Full Range|||45.0|76.0|
3694550|NCT02211261|3536216|B12||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694551|NCT02211261|3536217|B11||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694552|NCT02211261|3536218|B10||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694553|NCT02211261|3536219|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694554|NCT02211261|3536220|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694555|NCT02211261|3536221|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694556|NCT02211261|3536222|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694557|NCT02211261|3536223|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694558|NCT02211261|3536224|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694559|NCT02211261|3536225|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694560|NCT02211261|3536226|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694561|NCT02211261|3536227|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694562|NCT02211261|3536216|B12||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3694563|NCT02211261|3536217|B11||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3694564|NCT02211261|3536218|B10||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3694565|NCT02211261|3536219|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3694566|NCT02211261|3536220|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3694567|NCT02211261|3536221|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3694568|NCT02211261|3536222|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694569|NCT02211261|3536223|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3694570|NCT02211261|3536224|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3694571|NCT02211261|3536225|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3694572|NCT02211261|3536226|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3694573|NCT02211261|3536227|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3694574|NCT02211261|3536216|B12||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3694575|NCT02211261|3536217|B11||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3694576|NCT02211261|3536218|B10||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3694577|NCT02211261|3536219|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3694578|NCT02211261|3536220|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3694579|NCT02211261|3536221|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3694580|NCT02211261|3536222|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3694581|NCT02211261|3536223|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3694582|NCT02211261|3536224|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3694583|NCT02211261|3536225|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3694584|NCT02211261|3536226|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3694585|NCT02211261|3536227|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3694586|NCT02211261|3536216|B12||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3694587|NCT02211261|3536217|B11||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3694588|NCT02211261|3536218|B10||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3694589|NCT02211261|3536219|B9||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3694590|NCT02211261|3536220|B8||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3694591|NCT02211261|3536221|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3694592|NCT02211261|3536222|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3694593|NCT02211261|3536223|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3694594|NCT02211261|3536224|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3694596|NCT02211261|3536226|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3694597|NCT02211261|3536227|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3694598|NCT02211261|3536216|B12||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3694599|NCT02211261|3536217|B11||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3694600|NCT02211261|3536218|B10||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3694601|NCT02211261|3536219|B9||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3694602|NCT02211261|3536220|B8||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3694603|NCT02211261|3536221|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3694604|NCT02211261|3536222|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3694605|NCT02211261|3536223|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3694606|NCT02211261|3536224|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3694607|NCT02211261|3536225|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3694608|NCT02211261|3536226|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3694609|NCT02211261|3536227|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3694610|NCT02211261|3536216|B12|>=65 years||Age, Customized||participants|Number|20|20.0||||||
3694611|NCT02211261|3536217|B11|>=65 years||Age, Customized||participants|Number|0|0.0||||||
3694612|NCT02211261|3536218|B10|>=65 years||Age, Customized||participants|Number|7|7.0||||||
3694613|NCT02211261|3536219|B9|>=65 years||Age, Customized||participants|Number|4|4.0||||||
3694614|NCT02211261|3536220|B8|>=65 years||Age, Customized||participants|Number|1|1.0||||||
3694615|NCT02211261|3536221|B7|>=65 years||Age, Customized||participants|Number|0|0.0||||||
3694616|NCT02211261|3536222|B6|>=65 years||Age, Customized||participants|Number|0|0.0||||||
3694617|NCT02211261|3536223|B5|>=65 years||Age, Customized||participants|Number|2|2.0||||||
3694618|NCT02211261|3536224|B4|>=65 years||Age, Customized||participants|Number|0|0.0||||||
3694619|NCT02211261|3536225|B3|>=65 years||Age, Customized||participants|Number|2|2.0||||||
3694620|NCT02211261|3536226|B2|>=65 years||Age, Customized||participants|Number|2|2.0||||||
3694621|NCT02211261|3536227|B1|>=65 years||Age, Customized||participants|Number|2|2.0||||||
3694622|NCT02211261|3536216|B12|45-64 years||Age, Customized||participants|Number|61|61.0||||||
3694623|NCT02211261|3536217|B11|45-64 years||Age, Customized||participants|Number|8|8.0||||||
3694624|NCT02211261|3536218|B10|45-64 years||Age, Customized||participants|Number|9|9.0||||||
3694625|NCT02211261|3536219|B9|45-64 years||Age, Customized||participants|Number|4|4.0||||||
3694626|NCT02211261|3536220|B8|45-64 years||Age, Customized||participants|Number|7|7.0||||||
3694627|NCT02211261|3536221|B7|45-64 years||Age, Customized||participants|Number|5|5.0||||||
3694628|NCT02211261|3536222|B6|45-64 years||Age, Customized||participants|Number|1|1.0||||||
3694629|NCT02211261|3536223|B5|45-64 years||Age, Customized||participants|Number|6|6.0||||||
3694630|NCT02211261|3536224|B4|45-64 years||Age, Customized||participants|Number|6|6.0||||||
3694631|NCT02211261|3536225|B3|45-64 years||Age, Customized||participants|Number|4|4.0||||||
3694632|NCT02211261|3536226|B2|45-64 years||Age, Customized||participants|Number|4|4.0||||||
3694633|NCT02211261|3536227|B1|45-64 years||Age, Customized||participants|Number|7|7.0||||||
3694634|NCT02211261|3536216|B12|18-44 years||Age, Customized||participants|Number|3|3.0||||||
3694635|NCT02211261|3536217|B11|18-44 years||Age, Customized||participants|Number|0|0.0||||||
3694636|NCT02211261|3536218|B10|18-44 years||Age, Customized||participants|Number|0|0.0||||||
3694637|NCT02211261|3536219|B9|18-44 years||Age, Customized||participants|Number|0|0.0||||||
3694638|NCT02211261|3536220|B8|18-44 years||Age, Customized||participants|Number|0|0.0||||||
3694639|NCT02211261|3536221|B7|18-44 years||Age, Customized||participants|Number|1|1.0||||||
3694640|NCT02211261|3536222|B6|18-44 years||Age, Customized||participants|Number|1|1.0||||||
3694641|NCT02211261|3536223|B5|18-44 years||Age, Customized||participants|Number|1|1.0||||||
3694642|NCT02211261|3536224|B4|18-44 years||Age, Customized||participants|Number|0|0.0||||||
3694643|NCT02211261|3536225|B3|18-44 years||Age, Customized||participants|Number|0|0.0||||||
3694644|NCT02211261|3536226|B2|18-44 years||Age, Customized||participants|Number|0|0.0||||||
3694645|NCT02211261|3536227|B1|18-44 years||Age, Customized||participants|Number|0|0.0||||||
3694646|NCT02211261|3536216|B12|<18 years||Age, Customized||participants|Number|0|0.0||||||
3694647|NCT02211261|3536217|B11|<18 years||Age, Customized||participants|Number|0|0.0||||||
3694648|NCT02211261|3536218|B10|<18 years||Age, Customized||participants|Number|0|0.0||||||
3694649|NCT02211261|3536219|B9|<18 years||Age, Customized||participants|Number|0|0.0||||||
3694650|NCT02211261|3536220|B8|<18 years||Age, Customized||participants|Number|0|0.0||||||
3694651|NCT02211261|3536221|B7|<18 years||Age, Customized||participants|Number|0|0.0||||||
3694652|NCT02211261|3536222|B6|<18 years||Age, Customized||participants|Number|0|0.0||||||
3694653|NCT02211261|3536223|B5|<18 years||Age, Customized||participants|Number|0|0.0||||||
3694654|NCT02211261|3536224|B4|<18 years||Age, Customized||participants|Number|0|0.0||||||
3694655|NCT02211261|3536225|B3|<18 years||Age, Customized||participants|Number|0|0.0||||||
3694656|NCT02211261|3536226|B2|<18 years||Age, Customized||participants|Number|0|0.0||||||
3694657|NCT02211261|3536227|B1|<18 years||Age, Customized||participants|Number|0|0.0||||||
3694658|NCT02210208|3536358|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3694659|NCT02210208|3536358|B1|Part B|Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3694660|NCT02210208|3536358|B1|Part B|Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3694721|NCT02210000|3536461|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3694661|NCT02210208|3536358|B1|Part A|Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3694662|NCT02210208|3536358|B1|Part A|Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3694663|NCT02210208|3536358|B1|Part B||Age||years|Mean|26.9|26.9|Full Range|||3.0|57.0|
3694664|NCT02210208|3536358|B1|Part A||Age||years|Mean|28.6|28.6|Full Range|||1.0|62.0|
3694665|NCT02210195|3536365|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3694666|NCT02210195|3536366|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3694667|NCT02210195|3536367|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3694668|NCT02210195|3536365|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3694669|NCT02210195|3536366|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3694670|NCT02210195|3536367|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3694671|NCT02210195|3536365|B3|||Age||years|Mean|35.0|35.0|Standard Deviation|11.3|11.3|||
3694672|NCT02210195|3536366|B2|||Age||years|Mean|35.5|35.5|Standard Deviation|9.3|9.3|||
3694673|NCT02210195|3536367|B1|||Age||years|Mean|34.5|34.5|Standard Deviation|13.5|13.5|||
3694674|NCT02210091|3536376|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3694675|NCT02210091|3536377|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3694676|NCT02210091|3536378|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3694677|NCT02210091|3536376|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3694678|NCT02210091|3536377|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3694679|NCT02210091|3536378|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3694680|NCT02210091|3536376|B3|||Age||Years|Mean|6.0|6.0|Standard Deviation|2.70|2.7|||
3694681|NCT02210091|3536377|B2|||Age||Years|Mean|8.1|8.1|Standard Deviation|1.92|1.92|||
3694682|NCT02210091|3536378|B1|||Age||Years|Mean|3.7|3.7|Standard Deviation|1.17|1.17|||
3694683|NCT02210052|3536451|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3694684|NCT02210052|3536451|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3694685|NCT02210052|3536451|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3694686|NCT02210052|3536451|B1|||Age||years|Mean|47.8|47.8|Full Range|||27.0|77.0|
3694687|NCT02210052|3536451|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3694688|NCT02210052|3536451|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3694689|NCT02210052|3536451|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3694690|NCT02210039|3536455|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3694691|NCT02210039|3536455|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694692|NCT02210039|3536455|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694693|NCT02210039|3536455|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3694694|NCT02210039|3536455|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694695|NCT02210039|3536455|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694696|NCT02210039|3536455|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694697|NCT02210039|3536455|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694698|NCT02210039|3536455|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3694699|NCT02210039|3536455|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3694700|NCT02210039|3536455|B1|||Age||years|Mean|65.16|65.16|Standard Deviation|12.20|12.2|||
3694701|NCT02210039|3536455|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3694702|NCT02210039|3536455|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3694703|NCT02210039|3536455|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3694704|NCT02210000|3536459|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694705|NCT02210000|3536460|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694706|NCT02210000|3536461|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694707|NCT02210000|3536459|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694708|NCT02210000|3536460|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694709|NCT02210000|3536461|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694710|NCT02210000|3536459|B3||White|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3694711|NCT02210000|3536460|B2||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3694712|NCT02210000|3536461|B1||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3694713|NCT02210000|3536459|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3694714|NCT02210000|3536460|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3694715|NCT02210000|3536461|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3694716|NCT02210000|3536459|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694717|NCT02210000|3536460|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694718|NCT02210000|3536461|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694719|NCT02210000|3536459|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3694720|NCT02210000|3536460|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3694722|NCT02210000|3536459|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3694723|NCT02210000|3536460|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694724|NCT02210000|3536461|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3694725|NCT02210000|3536459|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3694726|NCT02210000|3536460|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3694727|NCT02210000|3536461|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3694728|NCT02210000|3536459|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3694729|NCT02210000|3536460|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3694730|NCT02210000|3536461|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3694731|NCT02210000|3536459|B3|||Age||Years|Mean|57.8|57.8|Standard Deviation|11.20|11.2|||
3694732|NCT02210000|3536460|B2|||Age||Years|Mean|58.3|58.3|Standard Deviation|9.81|9.81|||
3694733|NCT02210000|3536461|B1|||Age||Years|Mean|57.3|57.3|Standard Deviation|12.47|12.47|||
3694734|NCT02209766|3536484|B5|||BMI||kg/m^2|Mean|21.82|21.82|Standard Deviation|1.559|1.559|||
3694735|NCT02209766|3536485|B4|||BMI||kg/m^2|Mean|21.40|21.4|Standard Deviation|1.370|1.37|||
3694736|NCT02209766|3536486|B3|||BMI||kg/m^2|Mean|22.55|22.55|Standard Deviation|1.724|1.724|||
3694737|NCT02209766|3536487|B2|||BMI||kg/m^2|Mean|22.67|22.67|Standard Deviation|1.517|1.517|||
3694738|NCT02209766|3536488|B1|||BMI||kg/m^2|Mean|20.67|20.67|Standard Deviation|0.852|0.852|||
3694739|NCT02209766|3536484|B5|||Weight||kg|Mean|66.26|66.26|Standard Deviation|9.078|9.078|||
3694740|NCT02209766|3536485|B4|||Weight||kg|Mean|62.63|62.63|Standard Deviation|6.371|6.371|||
3694741|NCT02209766|3536486|B3|||Weight||kg|Mean|72.92|72.92|Standard Deviation|10.169|10.169|||
3694742|NCT02209766|3536487|B2|||Weight||kg|Mean|69.08|69.08|Standard Deviation|7.059|7.059|||
3694743|NCT02209766|3536488|B1|||Weight||kg|Mean|60.42|60.42|Standard Deviation|8.109|8.109|||
3694744|NCT02209766|3536484|B5|Caucasian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3694745|NCT02209766|3536485|B4|Caucasian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3694746|NCT02209766|3536486|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3694747|NCT02209766|3536487|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3694748|NCT02209766|3536488|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3694749|NCT02209766|3536484|B5|Japanese||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
3694750|NCT02209766|3536485|B4|Japanese||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3694751|NCT02209766|3536486|B3|Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3694752|NCT02209766|3536487|B2|Japanese||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3694753|NCT02209766|3536488|B1|Japanese||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3694754|NCT02209766|3536484|B5||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3694755|NCT02209766|3536485|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3694756|NCT02209766|3536486|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3694757|NCT02209766|3536487|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3694758|NCT02209766|3536488|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3694759|NCT02209766|3536484|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3694760|NCT02209766|3536485|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3694761|NCT02209766|3536486|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3694762|NCT02209766|3536487|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3694763|NCT02209766|3536488|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3694764|NCT02209766|3536484|B5|||Age||years|Mean|30.3|30.3|Standard Deviation|6.93|6.93|||
3694765|NCT02209766|3536485|B4|||Age||years|Mean|32.3|32.3|Standard Deviation|6.12|6.12|||
3694766|NCT02209766|3536486|B3|||Age||years|Mean|34.0|34.0|Standard Deviation|5.25|5.25|||
3694767|NCT02209766|3536487|B2|||Age||years|Mean|28.3|28.3|Standard Deviation|6.15|6.15|||
3694768|NCT02209766|3536488|B1|||Age||years|Mean|26.7|26.7|Standard Deviation|8.71|8.71|||
3694769|NCT02209506|3536538|B6|Ex-Drinker||Alcohol Classification||participants|Number|2|2.0||||||
3694770|NCT02209506|3536539|B5|Ex-Drinker||Alcohol Classification||participants|Number|0|0.0||||||
3694771|NCT02209506|3536540|B4|Ex-Drinker||Alcohol Classification||participants|Number|0|0.0||||||
3694772|NCT02209506|3536541|B3|Ex-Drinker||Alcohol Classification||participants|Number|1|1.0||||||
3694773|NCT02209506|3536542|B2|Ex-Drinker||Alcohol Classification||participants|Number|1|1.0||||||
3694774|NCT02209506|3536543|B1|Ex-Drinker||Alcohol Classification||participants|Number|0|0.0||||||
3694775|NCT02209506|3536538|B6|Current Drinker||Alcohol Classification||participants|Number|14|14.0||||||
3694776|NCT02209506|3536539|B5|Current Drinker||Alcohol Classification||participants|Number|6|6.0||||||
3694777|NCT02209506|3536540|B4|Current Drinker||Alcohol Classification||participants|Number|2|2.0||||||
3694778|NCT02209506|3536541|B3|Current Drinker||Alcohol Classification||participants|Number|3|3.0||||||
3694779|NCT02209506|3536542|B2|Current Drinker||Alcohol Classification||participants|Number|1|1.0||||||
3694780|NCT02209506|3536543|B1|Current Drinker||Alcohol Classification||participants|Number|2|2.0||||||
3694781|NCT02209506|3536538|B6|Never Drunk||Alcohol Classification||participants|Number|7|7.0||||||
3694782|NCT02209506|3536539|B5|Never Drunk||Alcohol Classification||participants|Number|0|0.0||||||
3694783|NCT02209506|3536540|B4|Never Drunk||Alcohol Classification||participants|Number|0|0.0||||||
3694784|NCT02209506|3536541|B3|Never Drunk||Alcohol Classification||participants|Number|2|2.0||||||
3694785|NCT02209506|3536542|B2|Never Drunk||Alcohol Classification||participants|Number|4|4.0||||||
3694786|NCT02209506|3536543|B1|Never Drunk||Alcohol Classification||participants|Number|1|1.0||||||
3694787|NCT02209506|3536538|B6|Female of Childbearing Potential||Female Reproductive Status|This baseline characteristic was analyzed only in female participants.|participants|Number|6|6.0||||||
3694788|NCT02209506|3536539|B5|Female of Childbearing Potential||Female Reproductive Status|This baseline characteristic was analyzed only in female participants.|participants|Number|2|2.0||||||
3694789|NCT02209506|3536540|B4|Female of Childbearing Potential||Female Reproductive Status|This baseline characteristic was analyzed only in female participants.|participants|Number|0|0.0||||||
3694790|NCT02209506|3536541|B3|Female of Childbearing Potential||Female Reproductive Status|This baseline characteristic was analyzed only in female participants.|participants|Number|1|1.0||||||
3694791|NCT02209506|3536542|B2|Female of Childbearing Potential||Female Reproductive Status|This baseline characteristic was analyzed only in female participants.|participants|Number|1|1.0||||||
3694792|NCT02209506|3536543|B1|Female of Childbearing Potential||Female Reproductive Status|This baseline characteristic was analyzed only in female participants.|participants|Number|2|2.0||||||
3694793|NCT02209506|3536538|B6|Surgically Sterile||Female Reproductive Status|This baseline characteristic was analyzed only in female participants.|participants|Number|1|1.0||||||
3694794|NCT02209506|3536539|B5|Surgically Sterile||Female Reproductive Status|This baseline characteristic was analyzed only in female participants.|participants|Number|0|0.0||||||
3694795|NCT02209506|3536540|B4|Surgically Sterile||Female Reproductive Status|This baseline characteristic was analyzed only in female participants.|participants|Number|0|0.0||||||
3694796|NCT02209506|3536541|B3|Surgically Sterile||Female Reproductive Status|This baseline characteristic was analyzed only in female participants.|participants|Number|0|0.0||||||
3694797|NCT02209506|3536542|B2|Surgically Sterile||Female Reproductive Status|This baseline characteristic was analyzed only in female participants.|participants|Number|1|1.0||||||
3694798|NCT02209506|3536543|B1|Surgically Sterile||Female Reproductive Status|This baseline characteristic was analyzed only in female participants.|participants|Number|0|0.0||||||
3694799|NCT02209506|3536538|B6|Postmenopausal||Female Reproductive Status|This baseline characteristic was analyzed only in female participants.|participants|Number|1|1.0||||||
3694800|NCT02209506|3536539|B5|Postmenopausal||Female Reproductive Status|This baseline characteristic was analyzed only in female participants.|participants|Number|1|1.0||||||
3694801|NCT02209506|3536540|B4|Postmenopausal||Female Reproductive Status|This baseline characteristic was analyzed only in female participants.|participants|Number|0|0.0||||||
3694802|NCT02209506|3536541|B3|Postmenopausal||Female Reproductive Status|This baseline characteristic was analyzed only in female participants.|participants|Number|0|0.0||||||
3694803|NCT02209506|3536542|B2|Postmenopausal||Female Reproductive Status|This baseline characteristic was analyzed only in female participants.|participants|Number|0|0.0||||||
3694804|NCT02209506|3536543|B1|Postmenopausal||Female Reproductive Status|This baseline characteristic was analyzed only in female participants.|participants|Number|0|0.0||||||
3694805|NCT02209506|3536538|B6|Non-Consumer||Xanthine/Caffeine History||participants|Number|16|16.0||||||
3694806|NCT02209506|3536539|B5|Non-Consumer||Xanthine/Caffeine History||participants|Number|2|2.0||||||
3694807|NCT02209506|3536540|B4|Non-Consumer||Xanthine/Caffeine History||participants|Number|1|1.0||||||
3694808|NCT02209506|3536541|B3|Non-Consumer||Xanthine/Caffeine History||participants|Number|6|6.0||||||
3694809|NCT02209506|3536542|B2|Non-Consumer||Xanthine/Caffeine History||participants|Number|4|4.0||||||
3694810|NCT02209506|3536543|B1|Non-Consumer||Xanthine/Caffeine History||participants|Number|3|3.0||||||
3694811|NCT02209506|3536538|B6|Consumer||Xanthine/Caffeine History||participants|Number|7|7.0||||||
3694812|NCT02209506|3536539|B5|Consumer||Xanthine/Caffeine History||participants|Number|4|4.0||||||
3694813|NCT02209506|3536540|B4|Consumer||Xanthine/Caffeine History||participants|Number|1|1.0||||||
3694814|NCT02209506|3536541|B3|Consumer||Xanthine/Caffeine History||participants|Number|0|0.0||||||
3694815|NCT02209506|3536542|B2|Consumer||Xanthine/Caffeine History||participants|Number|2|2.0||||||
3694816|NCT02209506|3536543|B1|Consumer||Xanthine/Caffeine History||participants|Number|0|0.0||||||
3694817|NCT02209506|3536538|B6|Ex-Smoker||Smoking Classification||participants|Number|7|7.0||||||
3694818|NCT02209506|3536539|B5|Ex-Smoker||Smoking Classification||participants|Number|2|2.0||||||
3694819|NCT02209506|3536540|B4|Ex-Smoker||Smoking Classification||participants|Number|1|1.0||||||
3694820|NCT02209506|3536541|B3|Ex-Smoker||Smoking Classification||participants|Number|2|2.0||||||
3694821|NCT02209506|3536542|B2|Ex-Smoker||Smoking Classification||participants|Number|1|1.0||||||
3694822|NCT02209506|3536543|B1|Ex-Smoker||Smoking Classification||participants|Number|1|1.0||||||
3694823|NCT02209506|3536538|B6|Never Smoked||Smoking Classification||participants|Number|16|16.0||||||
3694824|NCT02209506|3536539|B5|Never Smoked||Smoking Classification||participants|Number|4|4.0||||||
3694825|NCT02209506|3536540|B4|Never Smoked||Smoking Classification||participants|Number|1|1.0||||||
3694826|NCT02209506|3536541|B3|Never Smoked||Smoking Classification||participants|Number|4|4.0||||||
3694827|NCT02209506|3536542|B2|Never Smoked||Smoking Classification||participants|Number|5|5.0||||||
3694828|NCT02209506|3536543|B1|Never Smoked||Smoking Classification||participants|Number|2|2.0||||||
3694829|NCT02209506|3536538|B6|||Body Mass Index||kilogram per square meter|Mean|26.27|26.27|Standard Deviation|2.531|2.531|||
3694830|NCT02209506|3536539|B5|||Body Mass Index||kilogram per square meter|Mean|23.94|23.94|Standard Deviation|1.559|1.559|||
3694831|NCT02209506|3536540|B4|||Body Mass Index||kilogram per square meter|Mean|25.77|25.77|Standard Deviation|0.564|0.564|||
3694832|NCT02209506|3536541|B3|||Body Mass Index||kilogram per square meter|Mean|27.25|27.25|Standard Deviation|2.547|2.547|||
3694833|NCT02209506|3536542|B2|||Body Mass Index||kilogram per square meter|Mean|27.36|27.36|Standard Deviation|2.080|2.08|||
3694834|NCT02209506|3536543|B1|||Body Mass Index||kilogram per square meter|Mean|27.13|27.13|Standard Deviation|3.616|3.616|||
3694835|NCT02209506|3536538|B6|||Weight||kilogram|Mean|76.12|76.12|Standard Deviation|14.004|14.004|||
3694836|NCT02209506|3536539|B5|||Weight||kilogram|Mean|64.15|64.15|Standard Deviation|10.227|10.227|||
3694837|NCT02209506|3536540|B4|||Weight||kilogram|Mean|74.45|74.45|Standard Deviation|3.323|3.323|||
3694838|NCT02209506|3536541|B3|||Weight||kilogram|Mean|79.50|79.5|Standard Deviation|13.435|13.435|||
3694839|NCT02209506|3536542|B2|||Weight||kilogram|Mean|82.50|82.5|Standard Deviation|15.920|15.92|||
3694840|NCT02209506|3536543|B1|||Weight||kilogram|Mean|81.70|81.7|Standard Deviation|13.023|13.023|||
3694841|NCT02209506|3536538|B6|||Height||centimeter|Mean|169.5|169.5|Standard Deviation|10.76|10.76|||
3694842|NCT02209506|3536539|B5|||Height||centimeter|Mean|163.2|163.2|Standard Deviation|9.33|9.33|||
3694843|NCT02209506|3536540|B4|||Height||centimeter|Mean|170.0|170.0|Standard Deviation|5.66|5.66|||
3694844|NCT02209506|3536541|B3|||Height||centimeter|Mean|170.3|170.3|Standard Deviation|10.84|10.84|||
3694845|NCT02209506|3536542|B2|||Height||centimeter|Mean|173.0|173.0|Standard Deviation|14.71|14.71|||
3694846|NCT02209506|3536543|B1|||Height||centimeter|Mean|173.3|173.3|Standard Deviation|4.93|4.93|||
3694847|NCT02209506|3536538|B6|United States||Region of Enrollment||participants|Number|23|23.0||||||
3694848|NCT02209506|3536539|B5|United States||Region of Enrollment||participants|Number|6|6.0||||||
3694849|NCT02209506|3536540|B4|United States||Region of Enrollment||participants|Number|2|2.0||||||
3694850|NCT02209506|3536541|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3694851|NCT02209506|3536542|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3694852|NCT02209506|3536543|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3694853|NCT02209506|3536538|B6|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3694854|NCT02209506|3536539|B5|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3694855|NCT02209506|3536540|B4|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3694856|NCT02209506|3536541|B3|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3694857|NCT02209506|3536542|B2|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3694858|NCT02209506|3536543|B1|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3694859|NCT02209506|3536538|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3694860|NCT02209506|3536539|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3694861|NCT02209506|3536540|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3694862|NCT02209506|3536541|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3694863|NCT02209506|3536542|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3694864|NCT02209506|3536543|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3694865|NCT02209506|3536538|B6|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3694866|NCT02209506|3536539|B5|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3694867|NCT02209506|3536540|B4|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3694868|NCT02209506|3536541|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3694869|NCT02209506|3536542|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3694870|NCT02209506|3536543|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3694871|NCT02209506|3536538|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3694872|NCT02209506|3536539|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3694873|NCT02209506|3536540|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3694874|NCT02209506|3536541|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3694875|NCT02209506|3536542|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3694876|NCT02209506|3536543|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3694877|NCT02209506|3536538|B6|Non Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3694878|NCT02209506|3536539|B5|Non Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3694879|NCT02209506|3536540|B4|Non Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3694880|NCT02209506|3536541|B3|Non Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3694881|NCT02209506|3536542|B2|Non Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3694882|NCT02209506|3536543|B1|Non Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3694883|NCT02209506|3536538|B6|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3694884|NCT02209506|3536539|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3694885|NCT02209506|3536540|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3694886|NCT02209506|3536541|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3694887|NCT02209506|3536542|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3694888|NCT02209506|3536543|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3694889|NCT02209506|3536538|B6||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3694890|NCT02209506|3536539|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3694891|NCT02209506|3536540|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3694892|NCT02209506|3536541|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3694893|NCT02209506|3536542|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3694894|NCT02209506|3536543|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3694895|NCT02209506|3536538|B6||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3694896|NCT02209506|3536539|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3694897|NCT02209506|3536540|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3694898|NCT02209506|3536541|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3694899|NCT02209506|3536542|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3694900|NCT02209506|3536543|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3694901|NCT02209506|3536538|B6|||Age||years|Mean|39.7|39.7|Standard Deviation|10.50|10.5|||
3694902|NCT02209506|3536539|B5|||Age||years|Mean|41.0|41.0|Standard Deviation|12.47|12.47|||
3694903|NCT02209506|3536540|B4|||Age||years|Mean|52.5|52.5|Standard Deviation|0.71|0.71|||
3694904|NCT02209506|3536541|B3|||Age||years|Mean|36.3|36.3|Standard Deviation|7.12|7.12|||
3694905|NCT02209506|3536542|B2|||Age||years|Mean|38.8|38.8|Standard Deviation|12.91|12.91|||
3694906|NCT02209506|3536543|B1|||Age||years|Mean|36.7|36.7|Standard Deviation|7.77|7.77|||
3694907|NCT02209454|3536622|B1|United Kingdom||Region of Enrollment||participants|Number|26|26.0||||||
3694908|NCT02209454|3536622|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3694909|NCT02209454|3536622|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3694910|NCT02209454|3536622|B1|||Age||years|Mean|28.9|28.9|Standard Deviation|6.39|6.39|||
3694911|NCT02209259|3536637|B4|United States||Region of Enrollment||participants|Number|168|168.0||||||
3694912|NCT02209259|3536638|B3|United States||Region of Enrollment||participants|Number|56|56.0||||||
3694913|NCT02209259|3536639|B2|United States||Region of Enrollment||participants|Number|56|56.0||||||
3694914|NCT02209259|3536640|B1|United States||Region of Enrollment||participants|Number|56|56.0||||||
3694915|NCT02209259|3536637|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694916|NCT02209259|3536638|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694917|NCT02209259|3536639|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694918|NCT02209259|3536640|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694919|NCT02209259|3536637|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3694920|NCT02209259|3536638|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3694921|NCT02209259|3536639|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3694922|NCT02209259|3536640|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3694923|NCT02209259|3536637|B4||White|Race (NIH/OMB)||Participants|Count of Participants|143|143.0||||||
3694924|NCT02209259|3536638|B3||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3694925|NCT02209259|3536639|B2||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3694926|NCT02209259|3536640|B1||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3694927|NCT02209259|3536637|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3694928|NCT02209259|3536638|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3694929|NCT02209259|3536639|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3694930|NCT02209259|3536640|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3694931|NCT02209259|3536637|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694932|NCT02209259|3536638|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694933|NCT02209259|3536639|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694934|NCT02209259|3536640|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694935|NCT02209259|3536637|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3694936|NCT02209259|3536638|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3694937|NCT02209259|3536639|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3694938|NCT02209259|3536640|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3694939|NCT02209259|3536637|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694940|NCT02209259|3536638|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694941|NCT02209259|3536639|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694942|NCT02209259|3536640|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3694943|NCT02209259|3536637|B4||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3694944|NCT02209259|3536638|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3694945|NCT02209259|3536639|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3694946|NCT02209259|3536640|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3694947|NCT02209259|3536637|B4||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3694948|NCT02209259|3536638|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3694949|NCT02209259|3536639|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3694950|NCT02209259|3536640|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3694951|NCT02209259|3536637|B4|||Age||years|Mean|52|52.0|Standard Deviation|17|17.0|||
3694952|NCT02209259|3536638|B3|||Age||years|Mean|56|56.0|Standard Deviation|15|15.0|||
3694953|NCT02209259|3536639|B2|||Age||years|Mean|51|51.0|Standard Deviation|18|18.0|||
3694954|NCT02209259|3536640|B1|||Age||years|Mean|53|53.0|Standard Deviation|16|16.0|||
3694955|NCT02209181|3536656|B5|USA||Region of Enrollment||participants|Number|269|269.0||||||
3694956|NCT02209181|3536657|B4|USA||Region of Enrollment||participants|Number|66|66.0||||||
3694957|NCT02209181|3536658|B3|USA||Region of Enrollment||participants|Number|69|69.0||||||
3694958|NCT02209181|3536659|B2|USA||Region of Enrollment||participants|Number|67|67.0||||||
3694959|NCT02209181|3536660|B1|USA||Region of Enrollment||participants|Number|67|67.0||||||
3694960|NCT02209181|3536656|B5||Male|Gender||Participants|Count of Participants|269|269.0||||||
3694961|NCT02209181|3536657|B4||Male|Gender||Participants|Count of Participants|66|66.0||||||
3694962|NCT02209181|3536658|B3||Male|Gender||Participants|Count of Participants|69|69.0||||||
3694963|NCT02209181|3536659|B2||Male|Gender||Participants|Count of Participants|67|67.0||||||
3694964|NCT02209181|3536660|B1||Male|Gender||Participants|Count of Participants|67|67.0||||||
3694965|NCT02209181|3536656|B5||Female|Gender||Participants|Count of Participants|0|0.0||||||
3694966|NCT02209181|3536657|B4||Female|Gender||Participants|Count of Participants|0|0.0||||||
3694967|NCT02209181|3536658|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
3694968|NCT02209181|3536659|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
3694969|NCT02209181|3536660|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3694970|NCT02209181|3536656|B5|||Age||years|Mean|19.1|19.1|Standard Deviation|2.13|2.13|||
3694971|NCT02209181|3536657|B4|||Age||years|Mean|19.3|19.3|Standard Deviation|1.95|1.95|||
3694972|NCT02209181|3536658|B3|||Age||years|Mean|19.0|19.0|Standard Deviation|2.13|2.13|||
3694973|NCT02209181|3536659|B2|||Age||years|Mean|19.0|19.0|Standard Deviation|1.64|1.64|||
3694974|NCT02209181|3536660|B1|||Age||years|Mean|19.2|19.2|Standard Deviation|2.69|2.69|||
3694975|NCT02209064|3536825|B1|France||Region of Enrollment||participants|Number|2|2.0||||||
3694976|NCT02209064|3536825|B1|Italy||Region of Enrollment||participants|Number|13|13.0||||||
3694977|NCT02209064|3536825|B1|Czech Republic||Region of Enrollment||participants|Number|10|10.0||||||
3694978|NCT02209064|3536825|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3694979|NCT02209064|3536825|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3694980|NCT02209064|3536825|B1|||Age||years|Mean|61.9|61.9|Full Range|||28.4|84.1|
3694981|NCT02209064|3536825|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3694982|NCT02209064|3536825|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3694983|NCT02209064|3536825|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3694984|NCT02208843|3536832|B1||Unknown or Not Reported|Race (NIH/OMB)|Number of subjects is categorized for race data. Ethnicity data were not collected for this study.|Participants|Count of Participants|0|0.0||||||
3694985|NCT02208843|3536832|B1||More than one race|Race (NIH/OMB)|Number of subjects is categorized for race data. Ethnicity data were not collected for this study.|Participants|Count of Participants|0|0.0||||||
3694986|NCT02208843|3536832|B1||White|Race (NIH/OMB)|Number of subjects is categorized for race data. Ethnicity data were not collected for this study.|Participants|Count of Participants|41|41.0||||||
3694987|NCT02208843|3536832|B1||Black or African American|Race (NIH/OMB)|Number of subjects is categorized for race data. Ethnicity data were not collected for this study.|Participants|Count of Participants|0|0.0||||||
3694988|NCT02208843|3536832|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Number of subjects is categorized for race data. Ethnicity data were not collected for this study.|Participants|Count of Participants|0|0.0||||||
3694989|NCT02208843|3536832|B1||Asian|Race (NIH/OMB)|Number of subjects is categorized for race data. Ethnicity data were not collected for this study.|Participants|Count of Participants|19|19.0||||||
3694990|NCT02208843|3536832|B1||American Indian or Alaska Native|Race (NIH/OMB)|Number of subjects is categorized for race data. Ethnicity data were not collected for this study.|Participants|Count of Participants|0|0.0||||||
3694991|NCT02208843|3536832|B1||Male|Sex: Female, Male|Number of subjects is categorized as Male or Female.|Participants|Count of Participants|27|27.0||||||
3694992|NCT02208843|3536832|B1||Female|Sex: Female, Male|Number of subjects is categorized as Male or Female.|Participants|Count of Participants|33|33.0||||||
3694993|NCT02208843|3536832|B1|||Age|Age at the time of signing informed consent form is presented.|Years|Mean|59.9|59.9|Standard Deviation|9.8|9.8|||
3694994|NCT02208349|3536838|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3694995|NCT02208349|3536839|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3694996|NCT02208349|3536840|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3694997|NCT02208349|3536838|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3694998|NCT02208349|3536839|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3694999|NCT02208349|3536840|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3695000|NCT02208349|3536838|B3|Age 60 and over||Age, Customized||Participants|Count of Participants|58|58.0||||||
3695001|NCT02208349|3536839|B2|Age 60 and over||Age, Customized||Participants|Count of Participants|29|29.0||||||
3695002|NCT02208349|3536840|B1|Age 60 and over||Age, Customized||Participants|Count of Participants|29|29.0||||||
3695003|NCT02208349|3536838|B3|Age 18-59||Age, Customized||Participants|Count of Participants|24|24.0||||||
3695004|NCT02208349|3536839|B2|Age 18-59||Age, Customized||Participants|Count of Participants|13|13.0||||||
3695005|NCT02208349|3536840|B1|Age 18-59||Age, Customized||Participants|Count of Participants|11|11.0||||||
3695006|NCT02208310|3536849|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3695007|NCT02208310|3536850|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3695008|NCT02208310|3536851|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3695009|NCT02208310|3536849|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3695010|NCT02208310|3536850|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3695011|NCT02208310|3536851|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3695012|NCT02208310|3536849|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3695013|NCT02208310|3536850|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3695014|NCT02208310|3536851|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3695015|NCT02208310|3536849|B3|||Age||years|Mean|34.6|34.6|Standard Deviation|11.5|11.5|||
3695016|NCT02208310|3536850|B2|||Age||years|Mean|35.2|35.2|Standard Deviation|9.0|9.0|||
3695017|NCT02208310|3536851|B1|||Age||years|Mean|34.2|34.2|Standard Deviation|14.2|14.2|||
3695018|NCT02208310|3536849|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3695019|NCT02208310|3536850|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3695020|NCT02208310|3536851|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3695021|NCT02208310|3536849|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3695022|NCT02208310|3536850|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3695023|NCT02208310|3536851|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3695024|NCT02208310|3536849|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3695025|NCT02208310|3536850|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3695026|NCT02208310|3536851|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3695027|NCT02207972|3536882|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3695028|NCT02207972|3536883|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3695029|NCT02207972|3536884|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3695030|NCT02207972|3536882|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3695031|NCT02207972|3536883|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3695032|NCT02207972|3536884|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3695033|NCT02207972|3536882|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3695034|NCT02207972|3536883|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3695035|NCT02207972|3536884|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3695036|NCT02207972|3536882|B3|||Age||years|Mean|31.84|31.84|Full Range|||19.0|39.0|
3695037|NCT02207972|3536883|B2|||Age||years|Mean|31.85|31.85|Full Range|||19.0|39.0|
3695038|NCT02207972|3536884|B1|||Age||years|Mean|31.83|31.83|Full Range|||19.0|39.0|
3695039|NCT02207907|3536895|B3||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3695040|NCT02207907|3536896|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3695041|NCT02207907|3536897|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3695042|NCT02207907|3536895|B3||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3695043|NCT02207907|3536896|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3695044|NCT02207907|3536897|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3695045|NCT02207907|3536895|B3|||Age||Years|Mean|36.03|36.03|Standard Deviation|13.631|13.631|||
3695046|NCT02207907|3536896|B2|||Age||Years|Mean|37.55|37.55|Standard Deviation|13.977|13.977|||
3695047|NCT02207907|3536897|B1|||Age||Years|Mean|34.52|34.52|Standard Deviation|13.162|13.162|||
3695048|NCT02207829|3536914|B3|African American/African Heritage & White||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3695049|NCT02207829|3536915|B2|African American/African Heritage & White||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3695050|NCT02207829|3536916|B1|African American/African Heritage & White||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3695051|NCT02207829|3536914|B3|White||Race/Ethnicity, Customized||Participants|Number|915|915.0||||||
3695052|NCT02207829|3536915|B2|White||Race/Ethnicity, Customized||Participants|Number|457|457.0||||||
3695053|NCT02207829|3536916|B1|White||Race/Ethnicity, Customized||Participants|Number|458|458.0||||||
3695054|NCT02207829|3536914|B3|Japanese/East Asian/South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|75|75.0||||||
3695055|NCT02207829|3536915|B2|Japanese/East Asian/South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
3695056|NCT02207829|3536916|B1|Japanese/East Asian/South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|38|38.0||||||
3695057|NCT02207829|3536914|B3|Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3695058|NCT02207829|3536915|B2|Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3695059|NCT02207829|3536916|B1|Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3695060|NCT02207829|3536914|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3695061|NCT02207829|3536915|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3695062|NCT02207829|3536916|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3695063|NCT02207829|3536914|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
3695064|NCT02207829|3536915|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3695065|NCT02207829|3536916|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3695066|NCT02207829|3536914|B3||Male|Sex: Female, Male||Participants|Count of Participants|735|735.0||||||
3695067|NCT02207829|3536915|B2||Male|Sex: Female, Male||Participants|Count of Participants|371|371.0||||||
3695068|NCT02207829|3536916|B1||Male|Sex: Female, Male||Participants|Count of Participants|364|364.0||||||
3695069|NCT02207829|3536914|B3||Female|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
3695070|NCT02207829|3536915|B2||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3695071|NCT02207829|3536916|B1||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3695072|NCT02207829|3536914|B3|||Age||Years|Mean|64.2|64.2|Standard Deviation|8.20|8.2|||
3695073|NCT02207829|3536915|B2|||Age||Years|Mean|64.1|64.1|Standard Deviation|8.28|8.28|||
3695074|NCT02207829|3536916|B1|||Age||Years|Mean|64.4|64.4|Standard Deviation|8.12|8.12|||
3695075|NCT02207803|3536923|B3|Mexico||Region of Enrollment||participants|Number|162|162.0||||||
3695076|NCT02207803|3536924|B2|Mexico||Region of Enrollment||participants|Number|81|81.0||||||
3695077|NCT02207803|3536925|B1|Mexico||Region of Enrollment||participants|Number|81|81.0||||||
3695078|NCT02207803|3536923|B3|Colombia||Region of Enrollment||participants|Number|88|88.0||||||
3695079|NCT02207803|3536924|B2|Colombia||Region of Enrollment||participants|Number|44|44.0||||||
3695080|NCT02207803|3536925|B1|Colombia||Region of Enrollment||participants|Number|44|44.0||||||
3695081|NCT02207803|3536923|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695082|NCT02207803|3536924|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695083|NCT02207803|3536925|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695084|NCT02207803|3536923|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695085|NCT02207803|3536924|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695086|NCT02207803|3536925|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695087|NCT02207803|3536923|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|250|250.0||||||
3695088|NCT02207803|3536924|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
3695089|NCT02207803|3536925|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
3695090|NCT02207803|3536923|B3||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3695091|NCT02207803|3536924|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3695092|NCT02207803|3536925|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3695093|NCT02207803|3536923|B3||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3695094|NCT02207803|3536924|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3695095|NCT02207803|3536925|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3695096|NCT02207803|3536923|B3|||Age||Years|Mean|38|38.0|Standard Deviation|14|14.0|||
3695097|NCT02207803|3536924|B2|||Age||Years|Mean|39|39.0|Standard Deviation|13|13.0|||
3695098|NCT02207803|3536925|B1|||Age||Years|Mean|37|37.0|Standard Deviation|14|14.0|||
3695099|NCT02207803|3536923|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3695100|NCT02207803|3536924|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3695101|NCT02207803|3536925|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3695102|NCT02207803|3536923|B3||Between 18 and 65 years|Age||Participants|Count of Participants|239|239.0||||||
3695103|NCT02207803|3536924|B2||Between 18 and 65 years|Age||Participants|Count of Participants|119|119.0||||||
3695104|NCT02207803|3536925|B1||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
3695105|NCT02207803|3536923|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3695106|NCT02207803|3536924|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3695107|NCT02207803|3536925|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3695108|NCT02207725|3536934|B5||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3695109|NCT02207725|3536935|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3695110|NCT02207725|3536936|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3695111|NCT02207725|3536937|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3695112|NCT02207725|3536938|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3695113|NCT02207725|3536934|B5||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3695114|NCT02207725|3536935|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3695115|NCT02207725|3536936|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3695116|NCT02207725|3536937|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3695117|NCT02207725|3536938|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3695118|NCT02207725|3536934|B5|||Age||years|Mean|59.9|59.9|Standard Deviation|6.64|6.64|||
3695119|NCT02207725|3536935|B4|||Age||years|Mean|59.4|59.4|Standard Deviation|7.83|7.83|||
3695120|NCT02207725|3536936|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|6.91|6.91|||
3695121|NCT02207725|3536937|B2|||Age||years|Mean|61.0|61.0|Standard Deviation|6.37|6.37|||
3695122|NCT02207725|3536938|B1|||Age||years|Mean|59.0|59.0|Standard Deviation|3.54|3.54|||
3695123|NCT02207634|3536969|B3|||Reaction Time Median 5-Choice Reaction Time Z Score|The CANTAB Reaction Time (RTI) test assessed psychomotor speed (detecting and responding to a stimulus). Participants held down a button until a spot appeared in 1 of 5 circles on the screen. As soon as possible after the spot flashed up, the patient moved their finger from the button to the circle in which the spot appeared. The RTI median 5-choice reaction time is the median duration between the onset of the stimulus and the release of the button. A higher Z score reflects better performance.|Z-score|Mean|-0.0383|-0.0383|Standard Deviation|1.0007|1.0007|||
3695185|NCT02207634|3536971|B1|||Age||years|Mean|62.7|62.7|Standard Deviation|8.7|8.7|||
3695309|NCT02207491|3537039|B3||White|Race (NIH/OMB)||Participants|Count of Participants|310|310.0||||||
3695124|NCT02207634|3536970|B2|||Reaction Time Median 5-Choice Reaction Time Z Score|The CANTAB Reaction Time (RTI) test assessed psychomotor speed (detecting and responding to a stimulus). Participants held down a button until a spot appeared in 1 of 5 circles on the screen. As soon as possible after the spot flashed up, the patient moved their finger from the button to the circle in which the spot appeared. The RTI median 5-choice reaction time is the median duration between the onset of the stimulus and the release of the button. A higher Z score reflects better performance.|Z-score|Mean|-0.0500|-0.05|Standard Deviation|0.9072|0.9072|||
3695125|NCT02207634|3536971|B1|||Reaction Time Median 5-Choice Reaction Time Z Score|The CANTAB Reaction Time (RTI) test assessed psychomotor speed (detecting and responding to a stimulus). Participants held down a button until a spot appeared in 1 of 5 circles on the screen. As soon as possible after the spot flashed up, the patient moved their finger from the button to the circle in which the spot appeared. The RTI median 5-choice reaction time is the median duration between the onset of the stimulus and the release of the button. A higher Z score reflects better performance.|Z-score|Mean|-0.0271|-0.0271|Standard Deviation|1.0829|1.0829|||
3695126|NCT02207634|3536969|B3|||Reaction Time Median 5-Choice Reaction Time Raw Score|The CANTAB Reaction Time (RTI) test assessed psychomotor speed (detecting and responding to a stimulus). Participants held down a button until a spot appeared in 1 of 5 circles on the screen. As soon as possible after the spot flashed up, the patient lifted their finger from the button and touched the circle in which the spot appeared. The RTI median 5-choice reaction time was the median duration between the onset of the stimulus and the release of the button. A lower score indicates better performance. The raw score ranges from 100 to 5100 msec.|msec|Mean|355.90|355.9|Standard Deviation|71.71|71.71|||
3695127|NCT02207634|3536970|B2|||Reaction Time Median 5-Choice Reaction Time Raw Score|The CANTAB Reaction Time (RTI) test assessed psychomotor speed (detecting and responding to a stimulus). Participants held down a button until a spot appeared in 1 of 5 circles on the screen. As soon as possible after the spot flashed up, the patient lifted their finger from the button and touched the circle in which the spot appeared. The RTI median 5-choice reaction time was the median duration between the onset of the stimulus and the release of the button. A lower score indicates better performance. The raw score ranges from 100 to 5100 msec.|msec|Mean|356.74|356.74|Standard Deviation|65.01|65.01|||
3695128|NCT02207634|3536971|B1|||Reaction Time Median 5-Choice Reaction Time Raw Score|The CANTAB Reaction Time (RTI) test assessed psychomotor speed (detecting and responding to a stimulus). Participants held down a button until a spot appeared in 1 of 5 circles on the screen. As soon as possible after the spot flashed up, the patient lifted their finger from the button and touched the circle in which the spot appeared. The RTI median 5-choice reaction time was the median duration between the onset of the stimulus and the release of the button. A lower score indicates better performance. The raw score ranges from 100 to 5100 msec.|msec|Mean|355.10|355.1|Standard Deviation|77.60|77.6|||
3695129|NCT02207634|3536969|B3|||Paired Associates Learning Total Errors Adjusted Z Score|The CANTAB PAL test assesses memory function (storing/retrieving information by associating an event with a time and place). Boxes on the screen open in turn to reveal a number of patterns. After all the boxes have been opened, each pattern was shown in a randomized order and the patient asked to touch the box where they think each pattern was hidden. The PAL total errors adjusted is the number of errors committed plus an adjustment for the estimated number of errors the patient would have made on any stages not reached. Higher Z scores indicate better performance.|Z score|Mean|0.0095|0.0095|Standard Deviation|1.0063|1.0063|||
3695130|NCT02207634|3536970|B2|||Paired Associates Learning Total Errors Adjusted Z Score|The CANTAB PAL test assesses memory function (storing/retrieving information by associating an event with a time and place). Boxes on the screen open in turn to reveal a number of patterns. After all the boxes have been opened, each pattern was shown in a randomized order and the patient asked to touch the box where they think each pattern was hidden. The PAL total errors adjusted is the number of errors committed plus an adjustment for the estimated number of errors the patient would have made on any stages not reached. Higher Z scores indicate better performance.|Z score|Mean|-0.0272|-0.0272|Standard Deviation|1.0294|1.0294|||
3695131|NCT02207634|3536971|B1|||Paired Associates Learning Total Errors Adjusted Z Score|The CANTAB PAL test assesses memory function (storing/retrieving information by associating an event with a time and place). Boxes on the screen open in turn to reveal a number of patterns. After all the boxes have been opened, each pattern was shown in a randomized order and the patient asked to touch the box where they think each pattern was hidden. The PAL total errors adjusted is the number of errors committed plus an adjustment for the estimated number of errors the patient would have made on any stages not reached. Higher Z scores indicate better performance.|Z score|Mean|0.0442|0.0442|Standard Deviation|0.9834|0.9834|||
3695132|NCT02207634|3536969|B3|||Paired Associates Learning (PAL) Total Errors Adjusted Raw Score|The CANTAB PAL test assesses memory function (storing/retrieving information by associating an event with a time and place). Boxes on the screen open in turn to reveal a number of patterns. After all the boxes were opened, each pattern was shown in a randomized order and the patient asked to touch the box where they think the pattern was hidden. The PAL total errors adjusted score is the number of errors made plus an adjustment for the estimated number of errors the patient would have made on any stages not reached. A lower score indicates better performance. The raw score ranges from 0 to 70.|units on a scale|Mean|25.8|25.8|Standard Deviation|18.9|18.9|||
3695133|NCT02207634|3536970|B2|||Paired Associates Learning (PAL) Total Errors Adjusted Raw Score|The CANTAB PAL test assesses memory function (storing/retrieving information by associating an event with a time and place). Boxes on the screen open in turn to reveal a number of patterns. After all the boxes were opened, each pattern was shown in a randomized order and the patient asked to touch the box where they think the pattern was hidden. The PAL total errors adjusted score is the number of errors made plus an adjustment for the estimated number of errors the patient would have made on any stages not reached. A lower score indicates better performance. The raw score ranges from 0 to 70.|units on a scale|Mean|26.5|26.5|Standard Deviation|19.3|19.3|||
3695186|NCT02207621|3536984|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3695187|NCT02207621|3536985|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3695188|NCT02207621|3536986|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3695189|NCT02207621|3536987|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695310|NCT02207491|3537040|B2||White|Race (NIH/OMB)||Participants|Count of Participants|153|153.0||||||
3695134|NCT02207634|3536971|B1|||Paired Associates Learning (PAL) Total Errors Adjusted Raw Score|The CANTAB PAL test assesses memory function (storing/retrieving information by associating an event with a time and place). Boxes on the screen open in turn to reveal a number of patterns. After all the boxes were opened, each pattern was shown in a randomized order and the patient asked to touch the box where they think the pattern was hidden. The PAL total errors adjusted score is the number of errors made plus an adjustment for the estimated number of errors the patient would have made on any stages not reached. A lower score indicates better performance. The raw score ranges from 0 to 70.|units on a scale|Mean|25.2|25.2|Standard Deviation|18.4|18.4|||
3695135|NCT02207634|3536969|B3|||Spatial Working Memory Between Errors Z Score|The CANTAB Spatial Working Memory (SWM) between-errors score test assesses the cognitive domain of working memory (holding material in mind while that material is being actively processed). Patients search for colored tokens hidden inside boxes on the screen. Tokens were never hidden inside the same box twice, so patients must not return to a box where a token was already found The SWM between-errors score is the number of times a patient revisited a box in which a token had already been found. A higher Z score reflects better performance.|Z score|Mean|-0.0055|-0.0055|Standard Deviation|0.9879|0.9879|||
3695136|NCT02207634|3536970|B2|||Spatial Working Memory Between Errors Z Score|The CANTAB Spatial Working Memory (SWM) between-errors score test assesses the cognitive domain of working memory (holding material in mind while that material is being actively processed). Patients search for colored tokens hidden inside boxes on the screen. Tokens were never hidden inside the same box twice, so patients must not return to a box where a token was already found The SWM between-errors score is the number of times a patient revisited a box in which a token had already been found. A higher Z score reflects better performance.|Z score|Mean|0.0024|0.0024|Standard Deviation|0.9675|0.9675|||
3695137|NCT02207634|3536971|B1|||Spatial Working Memory Between Errors Z Score|The CANTAB Spatial Working Memory (SWM) between-errors score test assesses the cognitive domain of working memory (holding material in mind while that material is being actively processed). Patients search for colored tokens hidden inside boxes on the screen. Tokens were never hidden inside the same box twice, so patients must not return to a box where a token was already found The SWM between-errors score is the number of times a patient revisited a box in which a token had already been found. A higher Z score reflects better performance.|Z score|Mean|-0.0130|-0.013|Standard Deviation|1.0075|1.0075|||
3695138|NCT02207634|3536969|B3|||Spatial Working Memory Between Errors Raw Score|The CANTAB Spatial Working Memory (SWM) between-errors score test assesses the cognitive domain of working memory (holding material in mind while that material is being actively processed). Patients search for colored tokens hidden inside boxes on the screen. Tokens were never hidden inside the same box twice, so patients must not return to a box where a token was already found. The SWM between-errors score is the number of times that a patient revisited a box in which a token had previously been found. A lower score indicates better performance. The raw score ranges from 0 to 279.|units on a scale|Mean|21.0|21.0|Standard Deviation|10.4|10.4|||
3695139|NCT02207634|3536970|B2|||Spatial Working Memory Between Errors Raw Score|The CANTAB Spatial Working Memory (SWM) between-errors score test assesses the cognitive domain of working memory (holding material in mind while that material is being actively processed). Patients search for colored tokens hidden inside boxes on the screen. Tokens were never hidden inside the same box twice, so patients must not return to a box where a token was already found. The SWM between-errors score is the number of times that a patient revisited a box in which a token had previously been found. A lower score indicates better performance. The raw score ranges from 0 to 279.|units on a scale|Mean|20.9|20.9|Standard Deviation|10.2|10.2|||
3695140|NCT02207634|3536971|B1|||Spatial Working Memory Between Errors Raw Score|The CANTAB Spatial Working Memory (SWM) between-errors score test assesses the cognitive domain of working memory (holding material in mind while that material is being actively processed). Patients search for colored tokens hidden inside boxes on the screen. Tokens were never hidden inside the same box twice, so patients must not return to a box where a token was already found. The SWM between-errors score is the number of times that a patient revisited a box in which a token had previously been found. A lower score indicates better performance. The raw score ranges from 0 to 279.|units on a scale|Mean|21.0|21.0|Standard Deviation|10.6|10.6|||
3695141|NCT02207634|3536969|B3|||Spatial Working Memory (SWM) Strategy Index of Executive Function Z Score|The CANTAB SWM test assesses the cognitive domain of executive function (high-level thinking and decision making). Patients search for colored tokens hidden inside boxes on the screen. Tokens were never hidden inside the same box twice, so patients must not return to a box where a token was already found. The SWM strategy index of executive function represents the number of times a patient began a search with a different box. The Z score represents the standardized measure of how far an individual deviates from the study cohort average at baseline. A higher Z score reflects better performance.|Z score|Mean|0.0026|0.0026|Standard Deviation|0.9983|0.9983|||
3695142|NCT02207634|3536970|B2|||Spatial Working Memory (SWM) Strategy Index of Executive Function Z Score|The CANTAB SWM test assesses the cognitive domain of executive function (high-level thinking and decision making). Patients search for colored tokens hidden inside boxes on the screen. Tokens were never hidden inside the same box twice, so patients must not return to a box where a token was already found. The SWM strategy index of executive function represents the number of times a patient began a search with a different box. The Z score represents the standardized measure of how far an individual deviates from the study cohort average at baseline. A higher Z score reflects better performance.|Z score|Mean|0.0166|0.0166|Standard Deviation|1.0066|1.0066|||
3695143|NCT02207634|3536971|B1|||Spatial Working Memory (SWM) Strategy Index of Executive Function Z Score|The CANTAB SWM test assesses the cognitive domain of executive function (high-level thinking and decision making). Patients search for colored tokens hidden inside boxes on the screen. Tokens were never hidden inside the same box twice, so patients must not return to a box where a token was already found. The SWM strategy index of executive function represents the number of times a patient began a search with a different box. The Z score represents the standardized measure of how far an individual deviates from the study cohort average at baseline. A higher Z score reflects better performance.|Z score|Mean|-0.0106|-0.0106|Standard Deviation|0.9910|0.991|||
3695190|NCT02207621|3536984|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3695191|NCT02207621|3536985|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3695192|NCT02207621|3536986|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3695144|NCT02207634|3536969|B3|||Spatial Working Memory (SWM) Strategy Index of Executive Function Raw Score|CANTAB is a series of computerized tests to assess cognitive function. The SWM test assesses the cognitive domain of executive function (high-level thinking and decision making). Patients search for colored tokens hidden inside boxes on the screen. Tokens were never hidden inside the same box twice, so patients must not return to a box where a token was already found. The SWM strategy index of executive function represents the number of times a patient began a search with a different box. A high score represents an inefficient use of strategy and planning. The raw score ranges from 4 to 28.|units on a scale|Mean|17.8|17.8|Standard Deviation|3.4|3.4|||
3695145|NCT02207634|3536970|B2|||Spatial Working Memory (SWM) Strategy Index of Executive Function Raw Score|CANTAB is a series of computerized tests to assess cognitive function. The SWM test assesses the cognitive domain of executive function (high-level thinking and decision making). Patients search for colored tokens hidden inside boxes on the screen. Tokens were never hidden inside the same box twice, so patients must not return to a box where a token was already found. The SWM strategy index of executive function represents the number of times a patient began a search with a different box. A high score represents an inefficient use of strategy and planning. The raw score ranges from 4 to 28.|units on a scale|Mean|17.8|17.8|Standard Deviation|3.5|3.5|||
3695146|NCT02207634|3536971|B1|||Spatial Working Memory (SWM) Strategy Index of Executive Function Raw Score|CANTAB is a series of computerized tests to assess cognitive function. The SWM test assesses the cognitive domain of executive function (high-level thinking and decision making). Patients search for colored tokens hidden inside boxes on the screen. Tokens were never hidden inside the same box twice, so patients must not return to a box where a token was already found. The SWM strategy index of executive function represents the number of times a patient began a search with a different box. A high score represents an inefficient use of strategy and planning. The raw score ranges from 4 to 28.|units on a scale|Mean|17.8|17.8|Standard Deviation|3.4|3.4|||
3695147|NCT02207634|3536969|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3695148|NCT02207634|3536970|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3695149|NCT02207634|3536971|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3695150|NCT02207634|3536969|B3||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3695151|NCT02207634|3536970|B2||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3695152|NCT02207634|3536971|B1||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3695153|NCT02207634|3536969|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|1818|1818.0||||||
3695154|NCT02207634|3536970|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|908|908.0||||||
3695155|NCT02207634|3536971|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|910|910.0||||||
3695156|NCT02207634|3536969|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3695157|NCT02207634|3536970|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3695158|NCT02207634|3536971|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3695159|NCT02207634|3536969|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|60|60.0||||||
3695160|NCT02207634|3536970|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3695161|NCT02207634|3536971|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3695162|NCT02207634|3536969|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|59|59.0||||||
3695163|NCT02207634|3536970|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3695164|NCT02207634|3536971|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3695165|NCT02207634|3536969|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3695166|NCT02207634|3536970|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3695167|NCT02207634|3536971|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3695168|NCT02207634|3536969|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695169|NCT02207634|3536970|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695170|NCT02207634|3536971|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695171|NCT02207634|3536969|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1951|1951.0||||||
3695172|NCT02207634|3536970|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|975|975.0||||||
3695173|NCT02207634|3536971|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|976|976.0||||||
3695174|NCT02207634|3536969|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3695175|NCT02207634|3536970|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3695176|NCT02207634|3536971|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3695177|NCT02207634|3536969|B3||Male|Sex: Female, Male||Participants|Count of Participants|1431|1431.0||||||
3695178|NCT02207634|3536970|B2||Male|Sex: Female, Male||Participants|Count of Participants|715|715.0||||||
3695179|NCT02207634|3536971|B1||Male|Sex: Female, Male||Participants|Count of Participants|716|716.0||||||
3695180|NCT02207634|3536969|B3||Female|Sex: Female, Male||Participants|Count of Participants|543|543.0||||||
3695181|NCT02207634|3536970|B2||Female|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
3695182|NCT02207634|3536971|B1||Female|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
3695183|NCT02207634|3536969|B3|||Age||years|Mean|62.8|62.8|Standard Deviation|8.7|8.7|||
3695184|NCT02207634|3536970|B2|||Age||years|Mean|62.9|62.9|Standard Deviation|8.7|8.7|||
3695193|NCT02207621|3536987|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695194|NCT02207621|3536984|B4||White|Race (NIH/OMB)||Participants|Count of Participants|521|521.0||||||
3695195|NCT02207621|3536985|B3||White|Race (NIH/OMB)||Participants|Count of Participants|177|177.0||||||
3695196|NCT02207621|3536986|B2||White|Race (NIH/OMB)||Participants|Count of Participants|166|166.0||||||
3695197|NCT02207621|3536987|B1||White|Race (NIH/OMB)||Participants|Count of Participants|178|178.0||||||
3695198|NCT02207621|3536984|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|214|214.0||||||
3695199|NCT02207621|3536985|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3695200|NCT02207621|3536986|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
3695201|NCT02207621|3536987|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3695202|NCT02207621|3536984|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695203|NCT02207621|3536985|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695204|NCT02207621|3536986|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695205|NCT02207621|3536987|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695206|NCT02207621|3536984|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3695207|NCT02207621|3536985|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3695208|NCT02207621|3536986|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3695209|NCT02207621|3536987|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3695210|NCT02207621|3536984|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3695211|NCT02207621|3536985|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695212|NCT02207621|3536986|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695213|NCT02207621|3536987|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3695214|NCT02207621|3536984|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695215|NCT02207621|3536985|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695216|NCT02207621|3536986|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695217|NCT02207621|3536987|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695218|NCT02207621|3536984|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|630|630.0||||||
3695219|NCT02207621|3536985|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|211|211.0||||||
3695220|NCT02207621|3536986|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|209|209.0||||||
3695221|NCT02207621|3536987|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|210|210.0||||||
3695222|NCT02207621|3536984|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
3695223|NCT02207621|3536985|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3695224|NCT02207621|3536986|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3695225|NCT02207621|3536987|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3695226|NCT02207621|3536984|B4||Male|Sex: Female, Male||Participants|Count of Participants|293|293.0||||||
3695227|NCT02207621|3536985|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3695228|NCT02207621|3536986|B2||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3695229|NCT02207621|3536987|B1||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3695230|NCT02207621|3536984|B4||Female|Sex: Female, Male||Participants|Count of Participants|463|463.0||||||
3695231|NCT02207621|3536985|B3||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3695232|NCT02207621|3536986|B2||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3695233|NCT02207621|3536987|B1||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3695234|NCT02207621|3536984|B4|||Age||Years|Mean|64.1|64.1|Standard Deviation|11.95|11.95|||
3695235|NCT02207621|3536985|B3|||Age||Years|Mean|64.1|64.1|Standard Deviation|12.46|12.46|||
3695236|NCT02207621|3536986|B2|||Age||Years|Mean|63|63.0|Standard Deviation|11.81|11.81|||
3695237|NCT02207621|3536987|B1|||Age||Years|Mean|65.3|65.3|Standard Deviation|11.48|11.48|||
3695238|NCT02207608|3537000|B3|Italy||Region of Enrollment||participants|Number|29|29.0||||||
3695239|NCT02207608|3537001|B2|Italy||Region of Enrollment||participants|Number|15|15.0||||||
3695240|NCT02207608|3537002|B1|Italy||Region of Enrollment||participants|Number|14|14.0||||||
3695241|NCT02207608|3537000|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695242|NCT02207608|3537001|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695243|NCT02207608|3537002|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695244|NCT02207608|3537000|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695245|NCT02207608|3537001|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695246|NCT02207608|3537002|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695247|NCT02207608|3537000|B3||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3695248|NCT02207608|3537001|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3695249|NCT02207608|3537002|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3695250|NCT02207608|3537000|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695251|NCT02207608|3537001|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695252|NCT02207608|3537002|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695253|NCT02207608|3537000|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695254|NCT02207608|3537001|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695255|NCT02207608|3537002|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695256|NCT02207608|3537000|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695257|NCT02207608|3537001|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695258|NCT02207608|3537002|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695259|NCT02207608|3537000|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695260|NCT02207608|3537001|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695261|NCT02207608|3537002|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695262|NCT02207608|3537000|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3695263|NCT02207608|3537001|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3695264|NCT02207608|3537002|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3695265|NCT02207608|3537000|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3695266|NCT02207608|3537001|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3695267|NCT02207608|3537002|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3695268|NCT02207608|3537000|B3|||Age||years|Mean|67|67.0|Full Range|||54.0|81.0|
3695269|NCT02207608|3537001|B2|||Age||years|Mean|68|68.0|Full Range|||54.0|75.0|
3695270|NCT02207608|3537002|B1|||Age||years|Mean|66|66.0|Full Range|||60.0|81.0|
3695271|NCT02207569|3537009|B1|United States||Region of Enrollment||participants|Number|241|241.0||||||
3695272|NCT02207569|3537009|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3695273|NCT02207569|3537009|B1||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3695274|NCT02207569|3537009|B1|||Age||years|Mean|84.4|84.4|Standard Deviation|6.8|6.8|||
3695275|NCT02207530|3537027|B1|Missing||WHO/ECOG performance status||Participants|Number|1|1.0||||||
3695276|NCT02207530|3537027|B1|(1) Restricted activity||WHO/ECOG performance status||Participants|Number|77|77.0||||||
3695277|NCT02207530|3537027|B1|(0) Normal activity||WHO/ECOG performance status||Participants|Number|34|34.0||||||
3695278|NCT02207530|3537027|B1|Unknown/ Not reported||HPV status||Participants|Number|3|3.0||||||
3695279|NCT02207530|3537027|B1|Negative||HPV status||Participants|Number|65|65.0||||||
3695280|NCT02207530|3537027|B1|Positive||HPV status||Participants|Number|34|34.0||||||
3695281|NCT02207530|3537027|B1|Never||Nicotine Use||Participants|Number|43|43.0||||||
3695282|NCT02207530|3537027|B1|Former||Nicotine Use||Participants|Number|59|59.0||||||
3695283|NCT02207530|3537027|B1|Current||Nicotine Use||Participants|Number|10|10.0||||||
3695284|NCT02207530|3537027|B1|Unknown/ Not reported||Smoking/ Nicotine status||Participants|Number|10|10.0||||||
3695285|NCT02207530|3537027|B1|<=10 pack years||Smoking/ Nicotine status||Participants|Number|53|53.0||||||
3695286|NCT02207530|3537027|B1|>10 Pack years||Smoking/ Nicotine status||Participants|Number|49|49.0||||||
3695287|NCT02207530|3537027|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3695288|NCT02207530|3537027|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695289|NCT02207530|3537027|B1||White|Race (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3695290|NCT02207530|3537027|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3695291|NCT02207530|3537027|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695292|NCT02207530|3537027|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3695293|NCT02207530|3537027|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695294|NCT02207530|3537027|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3695295|NCT02207530|3537027|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|109|109.0||||||
3695296|NCT02207530|3537027|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3695297|NCT02207530|3537027|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3695298|NCT02207530|3537027|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3695299|NCT02207530|3537027|B1|||Age||Years|Median|60.0|60.0|Full Range|||24.0|84.0|
3695300|NCT02207530|3537027|B1||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
3695301|NCT02207530|3537027|B1||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
3695302|NCT02207530|3537027|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3695303|NCT02207491|3537039|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3695304|NCT02207491|3537040|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3695305|NCT02207491|3537041|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695306|NCT02207491|3537039|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695307|NCT02207491|3537040|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695308|NCT02207491|3537041|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695311|NCT02207491|3537041|B1||White|Race (NIH/OMB)||Participants|Count of Participants|157|157.0||||||
3695312|NCT02207491|3537039|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3695313|NCT02207491|3537040|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3695314|NCT02207491|3537041|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3695315|NCT02207491|3537039|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695316|NCT02207491|3537040|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695317|NCT02207491|3537041|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695318|NCT02207491|3537039|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3695319|NCT02207491|3537040|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3695320|NCT02207491|3537041|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3695321|NCT02207491|3537039|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695322|NCT02207491|3537040|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695323|NCT02207491|3537041|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695324|NCT02207491|3537039|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695325|NCT02207491|3537040|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695326|NCT02207491|3537041|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695327|NCT02207491|3537039|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|356|356.0||||||
3695328|NCT02207491|3537040|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|181|181.0||||||
3695329|NCT02207491|3537041|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|175|175.0||||||
3695330|NCT02207491|3537039|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3695331|NCT02207491|3537040|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3695332|NCT02207491|3537041|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3695333|NCT02207491|3537039|B3||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3695334|NCT02207491|3537040|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3695335|NCT02207491|3537041|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3695336|NCT02207491|3537039|B3||Female|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
3695337|NCT02207491|3537040|B2||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3695338|NCT02207491|3537041|B1||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3695339|NCT02207491|3537039|B3|||Age||years|Mean|65.0|65.0|Standard Deviation|11.5|11.5|||
3695340|NCT02207491|3537040|B2|||Age||years|Mean|64.2|64.2|Standard Deviation|11.34|11.34|||
3695341|NCT02207491|3537041|B1|||Age||years|Mean|65.8|65.8|Standard Deviation|11.65|11.65|||
3695342|NCT02207478|3537050|B3|No||bronchus sign|The bronchus sign on CT represents the presence of a bronchus leading directly to a peripheral pulmonary lesion.|participants|Number|10|10.0||||||
3695343|NCT02207478|3537051|B2|No||bronchus sign|The bronchus sign on CT represents the presence of a bronchus leading directly to a peripheral pulmonary lesion.|participants|Number|3|3.0||||||
3695344|NCT02207478|3537052|B1|No||bronchus sign|The bronchus sign on CT represents the presence of a bronchus leading directly to a peripheral pulmonary lesion.|participants|Number|7|7.0||||||
3695345|NCT02207478|3537050|B3|Yes||bronchus sign|The bronchus sign on CT represents the presence of a bronchus leading directly to a peripheral pulmonary lesion.|participants|Number|70|70.0||||||
3695346|NCT02207478|3537051|B2|Yes||bronchus sign|The bronchus sign on CT represents the presence of a bronchus leading directly to a peripheral pulmonary lesion.|participants|Number|38|38.0||||||
3695347|NCT02207478|3537052|B1|Yes||bronchus sign|The bronchus sign on CT represents the presence of a bronchus leading directly to a peripheral pulmonary lesion.|participants|Number|32|32.0||||||
3695348|NCT02207478|3537050|B3|||distance from the lesion to the pleural|distance of the nodule to the pleural surface|mm|Mean|18.19|18.19|Standard Deviation|15.57|15.57|||
3695349|NCT02207478|3537051|B2|||distance from the lesion to the pleural|distance of the nodule to the pleural surface|mm|Mean|20.99|20.99|Standard Deviation|16.08|16.08|||
3695350|NCT02207478|3537052|B1|||distance from the lesion to the pleural|distance of the nodule to the pleural surface|mm|Mean|15.53|15.53|Standard Deviation|14.79|14.79|||
3695351|NCT02207478|3537050|B3|Lower lobes||lesion location||participants|Number|21|21.0||||||
3695352|NCT02207478|3537051|B2|Lower lobes||lesion location||participants|Number|11|11.0||||||
3695353|NCT02207478|3537052|B1|Lower lobes||lesion location||participants|Number|10|10.0||||||
3695354|NCT02207478|3537050|B3|Middle Lobes||lesion location||participants|Number|4|4.0||||||
3695355|NCT02207478|3537051|B2|Middle Lobes||lesion location||participants|Number|1|1.0||||||
3695356|NCT02207478|3537052|B1|Middle Lobes||lesion location||participants|Number|3|3.0||||||
3695357|NCT02207478|3537050|B3|Upper Lobes||lesion location||participants|Number|55|55.0||||||
3695358|NCT02207478|3537051|B2|Upper Lobes||lesion location||participants|Number|29|29.0||||||
3695359|NCT02207478|3537052|B1|Upper Lobes||lesion location||participants|Number|26|26.0||||||
3695360|NCT02207478|3537050|B3|||lesion size(short axis)||mm|Mean|21.96|21.96|Standard Deviation|10.47|10.47|||
3695361|NCT02207478|3537051|B2|||lesion size(short axis)||mm|Mean|22.28|22.28|Standard Deviation|10.66|10.66|||
3695362|NCT02207478|3537052|B1|||lesion size(short axis)||mm|Mean|21.64|21.64|Standard Deviation|10.42|10.42|||
3695363|NCT02207478|3537050|B3|||lesion size(long axis)||mm|Mean|31.39|31.39|Standard Deviation|12.51|12.51|||
3695364|NCT02207478|3537051|B2|||lesion size(long axis)||mm|Mean|33.07|33.07|Standard Deviation|13.8|13.8|||
3695365|NCT02207478|3537052|B1|||lesion size(long axis)||mm|Mean|29.7|29.7|Standard Deviation|11|11.0|||
3695366|NCT02207478|3537050|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3695367|NCT02207478|3537051|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3695368|NCT02207478|3537052|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3695369|NCT02207478|3537050|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3695370|NCT02207478|3537051|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3695371|NCT02207478|3537052|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3695372|NCT02207478|3537050|B3|||Age||years|Mean|60.28|60.28|Standard Deviation|8.67|8.67|||
3695373|NCT02207478|3537051|B2|||Age||years|Mean|59.32|59.32|Standard Deviation|9.57|9.57|||
3695374|NCT02207478|3537052|B1|||Age||years|Mean|61.28|61.28|Standard Deviation|7.61|7.61|||
3695375|NCT02207413|3537061|B7||Male|Sex: Female, Male||Participants|Count of Participants|990|990.0||||||
3695376|NCT02207413|3537062|B6||Male|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
3695377|NCT02207413|3537063|B5||Male|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
3695378|NCT02207413|3537064|B4||Male|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
3695379|NCT02207413|3537065|B3||Male|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
3695380|NCT02207413|3537066|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3695381|NCT02207413|3537067|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3695382|NCT02207413|3537061|B7||Female|Sex: Female, Male||Participants|Count of Participants|891|891.0||||||
3695383|NCT02207413|3537062|B6||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
3695384|NCT02207413|3537063|B5||Female|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
3695385|NCT02207413|3537064|B4||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
3695386|NCT02207413|3537065|B3||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
3695387|NCT02207413|3537066|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3695388|NCT02207413|3537067|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3695389|NCT02207413|3537061|B7|||Age||Months|Mean|19.8|19.8|Standard Deviation|8.15|8.15|||
3695390|NCT02207413|3537062|B6|||Age||Months|Mean|19.9|19.9|Standard Deviation|8.3|8.3|||
3695391|NCT02207413|3537063|B5|||Age||Months|Mean|19.7|19.7|Standard Deviation|8.0|8.0|||
3695392|NCT02207413|3537064|B4|||Age||Months|Mean|NA||Standard Deviation|NA||||Calculated in 'years' as per group definition.
3695393|NCT02207413|3537065|B3|||Age||Months|Mean|NA||Standard Deviation|NA||||Calculated in 'years' as per group definition.
3695394|NCT02207413|3537066|B2|||Age||Months|Mean|NA||Standard Deviation|NA||||Calculated in 'years' as per group definition.
3695395|NCT02207413|3537067|B1|||Age||Months|Mean|NA||Standard Deviation|NA||||Calculated in 'years' as per group definition.
3695396|NCT02207413|3537061|B7|||Age||Years|Mean|12.1|12.1|Standard Deviation|8.67|8.67|||
3695397|NCT02207413|3537062|B6|||Age||Years|Mean|NA||Standard Deviation|NA||||Calculated in 'months' as per group definition.
3695398|NCT02207413|3537063|B5|||Age||Years|Mean|NA||Standard Deviation|NA||||Calculated in 'months' as per group definition.
3695399|NCT02207413|3537064|B4|||Age||Years|Mean|9.4|9.4|Standard Deviation|4.2|4.2|||
3695400|NCT02207413|3537065|B3|||Age||Years|Mean|9.4|9.4|Standard Deviation|4.2|4.2|||
3695401|NCT02207413|3537066|B2|||Age||Years|Mean|31.2|31.2|Standard Deviation|9.3|9.3|||
3695402|NCT02207413|3537067|B1|||Age||Years|Mean|29.8|29.8|Standard Deviation|8.7|8.7|||
3695403|NCT02207400|3537166|B3||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3695404|NCT02207400|3537167|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3695405|NCT02207400|3537168|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3695406|NCT02207400|3537166|B3||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3695407|NCT02207400|3537167|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3695408|NCT02207400|3537168|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3695409|NCT02207400|3537166|B3|||Age||Years|Mean|38.58|38.58|Standard Deviation|13.473|13.473|||
3695410|NCT02207400|3537167|B2|||Age||Years|Mean|37.77|37.77|Standard Deviation|12.615|12.615|||
3695411|NCT02207400|3537168|B1|||Age||Years|Mean|39.39|39.39|Standard Deviation|14.284|14.284|||
3695412|NCT02207244|3537187|B4|Korea, Democratic People'S Republic Of||Region of Enrollment||participants|Number|98|98.0||||||
3695413|NCT02207244|3537188|B3|Korea, Democratic People'S Republic Of||Region of Enrollment||participants|Number|24|24.0||||||
3695414|NCT02207244|3537189|B2|Korea, Democratic People'S Republic Of||Region of Enrollment||participants|Number|51|51.0||||||
3695415|NCT02207244|3537190|B1|Korea, Democratic People'S Republic Of||Region of Enrollment||participants|Number|23|23.0||||||
3695416|NCT02207244|3537187|B4|Spain||Region of Enrollment||participants|Number|43|43.0||||||
3695417|NCT02207244|3537188|B3|Spain||Region of Enrollment||participants|Number|11|11.0||||||
3695418|NCT02207244|3537189|B2|Spain||Region of Enrollment||participants|Number|22|22.0||||||
3695419|NCT02207244|3537190|B1|Spain||Region of Enrollment||participants|Number|10|10.0||||||
3695420|NCT02207244|3537187|B4|Germany||Region of Enrollment||participants|Number|84|84.0||||||
3695421|NCT02207244|3537188|B3|Germany||Region of Enrollment||participants|Number|22|22.0||||||
3695422|NCT02207244|3537189|B2|Germany||Region of Enrollment||participants|Number|40|40.0||||||
3695423|NCT02207244|3537190|B1|Germany||Region of Enrollment||participants|Number|22|22.0||||||
3695424|NCT02207244|3537187|B4|United States||Region of Enrollment||participants|Number|190|190.0||||||
3695425|NCT02207244|3537188|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
3695426|NCT02207244|3537189|B2|United States||Region of Enrollment||participants|Number|93|93.0||||||
3695427|NCT02207244|3537190|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
3695428|NCT02207244|3537187|B4|Canada||Region of Enrollment||participants|Number|130|130.0||||||
3695429|NCT02207244|3537188|B3|Canada||Region of Enrollment||participants|Number|33|33.0||||||
3695430|NCT02207244|3537189|B2|Canada||Region of Enrollment||participants|Number|67|67.0||||||
3695431|NCT02207244|3537190|B1|Canada||Region of Enrollment||participants|Number|30|30.0||||||
3695432|NCT02207244|3537187|B4|Russia||Region of Enrollment||participants|Number|100|100.0||||||
3695433|NCT02207244|3537188|B3|Russia||Region of Enrollment||participants|Number|25|25.0||||||
3695434|NCT02207244|3537189|B2|Russia||Region of Enrollment||participants|Number|51|51.0||||||
3695435|NCT02207244|3537190|B1|Russia||Region of Enrollment||participants|Number|24|24.0||||||
3695436|NCT02207244|3537187|B4|Poland||Region of Enrollment||participants|Number|265|265.0||||||
3695437|NCT02207244|3537188|B3|Poland||Region of Enrollment||participants|Number|64|64.0||||||
3695438|NCT02207244|3537189|B2|Poland||Region of Enrollment||participants|Number|133|133.0||||||
3695439|NCT02207244|3537190|B1|Poland||Region of Enrollment||participants|Number|68|68.0||||||
3695440|NCT02207244|3537187|B4|Czech Republic||Region of Enrollment||participants|Number|31|31.0||||||
3695441|NCT02207244|3537188|B3|Czech Republic||Region of Enrollment||participants|Number|8|8.0||||||
3695442|NCT02207244|3537189|B2|Czech Republic||Region of Enrollment||participants|Number|14|14.0||||||
3695443|NCT02207244|3537190|B1|Czech Republic||Region of Enrollment||participants|Number|9|9.0||||||
3695444|NCT02207244|3537187|B4|Australia||Region of Enrollment||participants|Number|51|51.0||||||
3695445|NCT02207244|3537188|B3|Australia||Region of Enrollment||participants|Number|13|13.0||||||
3695446|NCT02207244|3537189|B2|Australia||Region of Enrollment||participants|Number|25|25.0||||||
3695447|NCT02207244|3537190|B1|Australia||Region of Enrollment||participants|Number|13|13.0||||||
3695448|NCT02207244|3537187|B4||Male|Sex: Female, Male||Participants|Count of Participants|692|692.0||||||
3695449|NCT02207244|3537188|B3||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
3695450|NCT02207244|3537189|B2||Male|Sex: Female, Male||Participants|Count of Participants|349|349.0||||||
3695451|NCT02207244|3537190|B1||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
3695452|NCT02207244|3537187|B4||Female|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
3695453|NCT02207244|3537188|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3695454|NCT02207244|3537189|B2||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3695455|NCT02207244|3537190|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3695456|NCT02207244|3537187|B4|||Age||years|Mean|43.5|43.5|Standard Deviation|12.18|12.18|||
3695457|NCT02207244|3537188|B3|||Age||years|Mean|43.2|43.2|Standard Deviation|11.92|11.92|||
3695458|NCT02207244|3537189|B2|||Age||years|Mean|43.7|43.7|Standard Deviation|12.23|12.23|||
3695459|NCT02207244|3537190|B1|||Age||years|Mean|43.3|43.3|Standard Deviation|12.38|12.38|||
3695460|NCT02207244|3537187|B4||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
3695461|NCT02207244|3537188|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3695462|NCT02207244|3537189|B2||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3695463|NCT02207244|3537190|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3695464|NCT02207244|3537187|B4||Between 18 and 65 years|Age||Participants|Count of Participants|941|941.0||||||
3695465|NCT02207244|3537188|B3||Between 18 and 65 years|Age||Participants|Count of Participants|237|237.0||||||
3695466|NCT02207244|3537189|B2||Between 18 and 65 years|Age||Participants|Count of Participants|470|470.0||||||
3695467|NCT02207244|3537190|B1||Between 18 and 65 years|Age||Participants|Count of Participants|234|234.0||||||
3695468|NCT02207244|3537187|B4||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
3695469|NCT02207244|3537188|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3695470|NCT02207244|3537189|B2||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3695471|NCT02207244|3537190|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3695472|NCT02207231|3537236|B4|Korea, Democratic People'S Republic Of||Region of Enrollment||participants|Number|28|28.0||||||
3695473|NCT02207231|3537237|B3|Korea, Democratic People'S Republic Of||Region of Enrollment||participants|Number|9|9.0||||||
3695474|NCT02207231|3537238|B2|Korea, Democratic People'S Republic Of||Region of Enrollment||participants|Number|12|12.0||||||
3695475|NCT02207231|3537239|B1|Korea, Democratic People'S Republic Of||Region of Enrollment||participants|Number|7|7.0||||||
3695476|NCT02207231|3537236|B4|Spain||Region of Enrollment||participants|Number|25|25.0||||||
3695477|NCT02207231|3537237|B3|Spain||Region of Enrollment||participants|Number|13|13.0||||||
3695478|NCT02207231|3537238|B2|Spain||Region of Enrollment||participants|Number|8|8.0||||||
3695479|NCT02207231|3537239|B1|Spain||Region of Enrollment||participants|Number|4|4.0||||||
3695480|NCT02207231|3537236|B4|Germany||Region of Enrollment||participants|Number|107|107.0||||||
3695481|NCT02207231|3537237|B3|Germany||Region of Enrollment||participants|Number|43|43.0||||||
3695482|NCT02207231|3537238|B2|Germany||Region of Enrollment||participants|Number|41|41.0||||||
3695483|NCT02207231|3537239|B1|Germany||Region of Enrollment||participants|Number|23|23.0||||||
3695484|NCT02207231|3537236|B4|United States||Region of Enrollment||participants|Number|170|170.0||||||
3695485|NCT02207231|3537237|B3|United States||Region of Enrollment||participants|Number|67|67.0||||||
3695486|NCT02207231|3537238|B2|United States||Region of Enrollment||participants|Number|65|65.0||||||
3695487|NCT02207231|3537239|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
3695488|NCT02207231|3537236|B4|Canada||Region of Enrollment||participants|Number|122|122.0||||||
3695489|NCT02207231|3537237|B3|Canada||Region of Enrollment||participants|Number|48|48.0||||||
3695490|NCT02207231|3537238|B2|Canada||Region of Enrollment||participants|Number|50|50.0||||||
3695491|NCT02207231|3537239|B1|Canada||Region of Enrollment||participants|Number|24|24.0||||||
3695492|NCT02207231|3537236|B4|Russia||Region of Enrollment||participants|Number|118|118.0||||||
3695493|NCT02207231|3537237|B3|Russia||Region of Enrollment||participants|Number|49|49.0||||||
3695494|NCT02207231|3537238|B2|Russia||Region of Enrollment||participants|Number|48|48.0||||||
3695495|NCT02207231|3537239|B1|Russia||Region of Enrollment||participants|Number|21|21.0||||||
3695496|NCT02207231|3537236|B4|Poland||Region of Enrollment||participants|Number|107|107.0||||||
3695497|NCT02207231|3537237|B3|Poland||Region of Enrollment||participants|Number|43|43.0||||||
3695498|NCT02207231|3537238|B2|Poland||Region of Enrollment||participants|Number|42|42.0||||||
3695499|NCT02207231|3537239|B1|Poland||Region of Enrollment||participants|Number|22|22.0||||||
3695500|NCT02207231|3537236|B4|Hungary||Region of Enrollment||participants|Number|30|30.0||||||
3695501|NCT02207231|3537237|B3|Hungary||Region of Enrollment||participants|Number|14|14.0||||||
3695502|NCT02207231|3537238|B2|Hungary||Region of Enrollment||participants|Number|9|9.0||||||
3695503|NCT02207231|3537239|B1|Hungary||Region of Enrollment||participants|Number|7|7.0||||||
3695504|NCT02207231|3537236|B4|Taiwan, Province Of China||Region of Enrollment||participants|Number|73|73.0||||||
3695505|NCT02207231|3537237|B3|Taiwan, Province Of China||Region of Enrollment||participants|Number|27|27.0||||||
3695506|NCT02207231|3537238|B2|Taiwan, Province Of China||Region of Enrollment||participants|Number|31|31.0||||||
3695507|NCT02207231|3537239|B1|Taiwan, Province Of China||Region of Enrollment||participants|Number|15|15.0||||||
3695508|NCT02207231|3537236|B4|Australia||Region of Enrollment||participants|Number|57|57.0||||||
3695509|NCT02207231|3537237|B3|Australia||Region of Enrollment||participants|Number|21|21.0||||||
3695510|NCT02207231|3537238|B2|Australia||Region of Enrollment||participants|Number|23|23.0||||||
3695511|NCT02207231|3537239|B1|Australia||Region of Enrollment||participants|Number|13|13.0||||||
3695512|NCT02207231|3537236|B4||Male|Sex: Female, Male||Participants|Count of Participants|608|608.0||||||
3695513|NCT02207231|3537237|B3||Male|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
3695514|NCT02207231|3537238|B2||Male|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
3695515|NCT02207231|3537239|B1||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3695516|NCT02207231|3537236|B4||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
3695517|NCT02207231|3537237|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3695518|NCT02207231|3537238|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3695519|NCT02207231|3537239|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3695520|NCT02207231|3537236|B4|||Age||years|Mean|43.7|43.7|Standard Deviation|12.72|12.72|||
3695521|NCT02207231|3537237|B3|||Age||years|Mean|42.9|42.9|Standard Deviation|12.58|12.58|||
3695522|NCT02207231|3537238|B2|||Age||years|Mean|43.9|43.9|Standard Deviation|12.74|12.74|||
3695523|NCT02207231|3537239|B1|||Age||years|Mean|44.9|44.9|Standard Deviation|12.9|12.9|||
3695524|NCT02207231|3537236|B4||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
3695525|NCT02207231|3537237|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3695526|NCT02207231|3537238|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3695527|NCT02207231|3537239|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3695528|NCT02207231|3537236|B4||Between 18 and 65 years|Age||Participants|Count of Participants|790|790.0||||||
3695529|NCT02207231|3537237|B3||Between 18 and 65 years|Age||Participants|Count of Participants|315|315.0||||||
3695530|NCT02207231|3537238|B2||Between 18 and 65 years|Age||Participants|Count of Participants|311|311.0||||||
3695531|NCT02207231|3537239|B1||Between 18 and 65 years|Age||Participants|Count of Participants|164|164.0||||||
3695532|NCT02207231|3537236|B4||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3695533|NCT02207231|3537237|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3695534|NCT02207231|3537238|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3695535|NCT02207231|3537239|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3695536|NCT02207088|3537273|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3695537|NCT02207088|3537273|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3695538|NCT02207088|3537273|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|7.00|7.0|||
3695539|NCT02206776|3537279|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695540|NCT02206776|3537280|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695541|NCT02206776|3537281|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695542|NCT02206776|3537279|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695543|NCT02206776|3537280|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695544|NCT02206776|3537281|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695545|NCT02206776|3537279|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3695546|NCT02206776|3537280|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695547|NCT02206776|3537281|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3695548|NCT02206776|3537279|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3695549|NCT02206776|3537280|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3695550|NCT02206776|3537281|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695551|NCT02206776|3537279|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695552|NCT02206776|3537280|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695553|NCT02206776|3537281|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695554|NCT02206776|3537279|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695555|NCT02206776|3537280|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695556|NCT02206776|3537281|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695557|NCT02206776|3537279|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695558|NCT02206776|3537280|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695559|NCT02206776|3537281|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695560|NCT02206776|3537279|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695561|NCT02206776|3537280|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695562|NCT02206776|3537281|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695563|NCT02206776|3537279|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3695564|NCT02206776|3537280|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3695565|NCT02206776|3537281|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3695566|NCT02206776|3537279|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695567|NCT02206776|3537280|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695568|NCT02206776|3537281|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695569|NCT02206776|3537279|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3695570|NCT02206776|3537280|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3695571|NCT02206776|3537281|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3695572|NCT02206776|3537279|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3695573|NCT02206776|3537280|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3695574|NCT02206776|3537281|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3695575|NCT02206776|3537279|B3|||Age||years|Mean|28|28.0|Standard Deviation|11|11.0|||
3695576|NCT02206776|3537280|B2|||Age||years|Mean|36|36.0|Standard Deviation|0|0.0|||
3695577|NCT02206776|3537281|B1|||Age||years|Mean|20|20.0|Standard Deviation|0|0.0|||
3695578|NCT02206607|3537288|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3695579|NCT02206607|3537288|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3695580|NCT02206607|3537288|B1|||Age||years|Mean|57.7|57.7|Standard Deviation|7.1|7.1|||
3695581|NCT02205983|3537344|B5|United States||Region of Enrollment||participants|Number|50|50.0||||||
3695582|NCT02205983|3537345|B4|United States||Region of Enrollment||participants|Number|13|13.0||||||
3695583|NCT02205983|3537346|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
3695584|NCT02205983|3537347|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3695585|NCT02205983|3537348|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3695586|NCT02205983|3537344|B5||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3695587|NCT02205983|3537345|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3695588|NCT02205983|3537346|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3695589|NCT02205983|3537347|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3695590|NCT02205983|3537348|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3695591|NCT02205983|3537344|B5||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3695592|NCT02205983|3537345|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3695593|NCT02205983|3537346|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3695594|NCT02205983|3537347|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3695595|NCT02205983|3537348|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3695596|NCT02205983|3537344|B5|||Age||years|Mean|22|22.0|Standard Deviation|4.5|4.5|||
3695597|NCT02205983|3537345|B4|||Age||years|Mean|23.1|23.1|Standard Deviation|4.4|4.4|||
3695598|NCT02205983|3537346|B3|||Age||years|Mean|23.6|23.6|Standard Deviation|6.6|6.6|||
3695599|NCT02205983|3537347|B2|||Age||years|Mean|21.2|21.2|Standard Deviation|2.8|2.8|||
3695600|NCT02205983|3537348|B1|||Age||years|Mean|19.9|19.9|Standard Deviation|1.8|1.8|||
3695601|NCT02205814|3537361|B5|||EQ VAS|The EQ visual analogue scale (EQ VAS) recorded the respondent’s self-rated health on a 20 cm vertical VAS with endpoints labelled ‘the best health you can imagine’ on top (equal to 100) and ‘the worst health you can imagine’ at the bottom (equal to 0).|units on a scale|Mean|65.1|65.1|Standard Deviation|18.89|18.89|||
3695602|NCT02205814|3537362|B4|||EQ VAS|The EQ visual analogue scale (EQ VAS) recorded the respondent’s self-rated health on a 20 cm vertical VAS with endpoints labelled ‘the best health you can imagine’ on top (equal to 100) and ‘the worst health you can imagine’ at the bottom (equal to 0).|units on a scale|Mean|65.7|65.7|Standard Deviation|19.47|19.47|||
3695603|NCT02205814|3537363|B3|||EQ VAS|The EQ visual analogue scale (EQ VAS) recorded the respondent’s self-rated health on a 20 cm vertical VAS with endpoints labelled ‘the best health you can imagine’ on top (equal to 100) and ‘the worst health you can imagine’ at the bottom (equal to 0).|units on a scale|Mean|67.4|67.4|Standard Deviation|18.18|18.18|||
3695604|NCT02205814|3537364|B2|||EQ VAS|The EQ visual analogue scale (EQ VAS) recorded the respondent’s self-rated health on a 20 cm vertical VAS with endpoints labelled ‘the best health you can imagine’ on top (equal to 100) and ‘the worst health you can imagine’ at the bottom (equal to 0).|units on a scale|Mean|64.3|64.3|Standard Deviation|17.21|17.21|||
3695605|NCT02205814|3537365|B1|||EQ VAS|The EQ visual analogue scale (EQ VAS) recorded the respondent’s self-rated health on a 20 cm vertical VAS with endpoints labelled ‘the best health you can imagine’ on top (equal to 100) and ‘the worst health you can imagine’ at the bottom (equal to 0).|units on a scale|Mean|63.1|63.1|Standard Deviation|20.54|20.54|||
3695606|NCT02205814|3537361|B5|||WOMAC INDEX|The WOMAC VA 3.1 Index score (WOMAC INDEX) is the sum of WOMAC A (total pain), WOMAC B (stiffness) and WOMAC C (functional impairment) subscores. The WOMAC INDEX score ranges from 0 to 2400 mm, with higher scores indicating higher disease burden.|units on a scale|Mean|1293.3|1293.3|Standard Deviation|269.35|269.35|||
3695607|NCT02205814|3537362|B4|||WOMAC INDEX|The WOMAC VA 3.1 Index score (WOMAC INDEX) is the sum of WOMAC A (total pain), WOMAC B (stiffness) and WOMAC C (functional impairment) subscores. The WOMAC INDEX score ranges from 0 to 2400 mm, with higher scores indicating higher disease burden.|units on a scale|Mean|1293.5|1293.5|Standard Deviation|239.73|239.73|||
3695608|NCT02205814|3537363|B3|||WOMAC INDEX|The WOMAC VA 3.1 Index score (WOMAC INDEX) is the sum of WOMAC A (total pain), WOMAC B (stiffness) and WOMAC C (functional impairment) subscores. The WOMAC INDEX score ranges from 0 to 2400 mm, with higher scores indicating higher disease burden.|units on a scale|Mean|1282.6|1282.6|Standard Deviation|274.50|274.5|||
3695609|NCT02205814|3537364|B2|||WOMAC INDEX|The WOMAC VA 3.1 Index score (WOMAC INDEX) is the sum of WOMAC A (total pain), WOMAC B (stiffness) and WOMAC C (functional impairment) subscores. The WOMAC INDEX score ranges from 0 to 2400 mm, with higher scores indicating higher disease burden.|units on a scale|Mean|1275.4|1275.4|Standard Deviation|283.60|283.6|||
3695610|NCT02205814|3537365|B1|||WOMAC INDEX|The WOMAC VA 3.1 Index score (WOMAC INDEX) is the sum of WOMAC A (total pain), WOMAC B (stiffness) and WOMAC C (functional impairment) subscores. The WOMAC INDEX score ranges from 0 to 2400 mm, with higher scores indicating higher disease burden.|units on a scale|Mean|1321.5|1321.5|Standard Deviation|278.88|278.88|||
3695611|NCT02205814|3537361|B5|||WOMAC A|The validated Western Ontario and McMaster University questionnaire (WOMAC) was used to measure total knee pain choosing its visual analogue scale version (VAS). The WOMAC VA 3.1 A subscore (WOMAC A) ranges from 0 to 500 mm (summing up five VAS 0-100 mm) with higher scores indicating more pain.|units on a scale|Mean|280.8|280.8|Standard Deviation|39.61|39.61|||
3695612|NCT02205814|3537362|B4|||WOMAC A|The validated Western Ontario and McMaster University questionnaire (WOMAC) was used to measure total knee pain choosing its visual analogue scale version (VAS). The WOMAC VA 3.1 A subscore (WOMAC A) ranges from 0 to 500 mm (summing up five VAS 0-100 mm) with higher scores indicating more pain.|units on a scale|Mean|275.5|275.5|Standard Deviation|39.81|39.81|||
3695613|NCT02205814|3537363|B3|||WOMAC A|The validated Western Ontario and McMaster University questionnaire (WOMAC) was used to measure total knee pain choosing its visual analogue scale version (VAS). The WOMAC VA 3.1 A subscore (WOMAC A) ranges from 0 to 500 mm (summing up five VAS 0-100 mm) with higher scores indicating more pain.|units on a scale|Mean|278.3|278.3|Standard Deviation|38.11|38.11|||
3695614|NCT02205814|3537364|B2|||WOMAC A|The validated Western Ontario and McMaster University questionnaire (WOMAC) was used to measure total knee pain choosing its visual analogue scale version (VAS). The WOMAC VA 3.1 A subscore (WOMAC A) ranges from 0 to 500 mm (summing up five VAS 0-100 mm) with higher scores indicating more pain.|units on a scale|Mean|282.7|282.7|Standard Deviation|40.08|40.08|||
3695615|NCT02205814|3537365|B1|||WOMAC A|The validated Western Ontario and McMaster University questionnaire (WOMAC) was used to measure total knee pain choosing its visual analogue scale version (VAS). The WOMAC VA 3.1 A subscore (WOMAC A) ranges from 0 to 500 mm (summing up five VAS 0-100 mm) with higher scores indicating more pain.|units on a scale|Mean|286.5|286.5|Standard Deviation|40.4|40.4|||
3695616|NCT02205814|3537361|B5|||BMI||kg/m2|Mean|26.9|26.9|Standard Deviation|2.50|2.5|||
3695617|NCT02205814|3537362|B4|||BMI||kg/m2|Mean|27.0|27.0|Standard Deviation|2.60|2.6|||
3695618|NCT02205814|3537363|B3|||BMI||kg/m2|Mean|27.1|27.1|Standard Deviation|2.35|2.35|||
3695619|NCT02205814|3537364|B2|||BMI||kg/m2|Mean|26.5|26.5|Standard Deviation|2.83|2.83|||
3695620|NCT02205814|3537365|B1|||BMI||kg/m2|Mean|27.1|27.1|Standard Deviation|2.12|2.12|||
3695621|NCT02205814|3537361|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695622|NCT02205814|3537362|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695623|NCT02205814|3537363|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695624|NCT02205814|3537364|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695625|NCT02205814|3537365|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695626|NCT02205814|3537361|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|427|427.0||||||
3695627|NCT02205814|3537362|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
3695628|NCT02205814|3537363|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
3695629|NCT02205814|3537364|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
3695630|NCT02205814|3537365|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
3695631|NCT02205814|3537361|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3695632|NCT02205814|3537362|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3695633|NCT02205814|3537363|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3695634|NCT02205814|3537364|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695635|NCT02205814|3537365|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3695636|NCT02205814|3537361|B5||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3695637|NCT02205814|3537362|B4||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3695638|NCT02205814|3537363|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3695639|NCT02205814|3537364|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3695640|NCT02205814|3537365|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3695641|NCT02205814|3537361|B5||Female|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
3695642|NCT02205814|3537362|B4||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3695643|NCT02205814|3537363|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3695644|NCT02205814|3537364|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3695645|NCT02205814|3537365|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3695646|NCT02205814|3537361|B5|Age||Age||years|Mean|64.4|64.4|Standard Deviation|8.34|8.34|||
3695647|NCT02205814|3537362|B4|Age||Age||years|Mean|64.4|64.4|Standard Deviation|8.50|8.5|||
3695648|NCT02205814|3537363|B3|Age||Age||years|Mean|64.7|64.7|Standard Deviation|8.43|8.43|||
3695649|NCT02205814|3537364|B2|Age||Age||years|Mean|63.2|63.2|Standard Deviation|8.73|8.73|||
3695650|NCT02205814|3537365|B1|Age||Age||years|Mean|65.3|65.3|Standard Deviation|7.61|7.61|||
3695651|NCT02205801|3537390|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695652|NCT02205801|3537391|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695653|NCT02205801|3537392|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695654|NCT02205801|3537393|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695655|NCT02205801|3537394|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695656|NCT02205801|3537390|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695657|NCT02205801|3537391|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695658|NCT02205801|3537392|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695659|NCT02205801|3537393|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695660|NCT02205801|3537394|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695661|NCT02205801|3537390|B5||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3695662|NCT02205801|3537391|B4||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3695663|NCT02205801|3537392|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3695664|NCT02205801|3537393|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3695665|NCT02205801|3537394|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3695666|NCT02205801|3537390|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3695667|NCT02205801|3537391|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3695668|NCT02205801|3537392|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3695669|NCT02205801|3537393|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3695670|NCT02205801|3537394|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3695671|NCT02205801|3537390|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695672|NCT02205801|3537391|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695673|NCT02205801|3537392|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695674|NCT02205801|3537393|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695675|NCT02205801|3537394|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695676|NCT02205801|3537390|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3695677|NCT02205801|3537391|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695678|NCT02205801|3537392|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695679|NCT02205801|3537393|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3695680|NCT02205801|3537394|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695681|NCT02205801|3537390|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695682|NCT02205801|3537391|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695683|NCT02205801|3537392|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695684|NCT02205801|3537393|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695685|NCT02205801|3537394|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695686|NCT02205801|3537390|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3695687|NCT02205801|3537391|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3695688|NCT02205801|3537392|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3695689|NCT02205801|3537393|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3695690|NCT02205801|3537394|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3695691|NCT02205801|3537390|B5||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3695692|NCT02205801|3537391|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3695693|NCT02205801|3537392|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3695694|NCT02205801|3537393|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3695695|NCT02205801|3537394|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3695696|NCT02205801|3537390|B5|||Age||years|Mean|49.4|49.4|Standard Deviation|13|13.0|||
3695697|NCT02205801|3537391|B4|||Age||years|Mean|51.6|51.6|Standard Deviation|15.3|15.3|||
3695698|NCT02205801|3537392|B3|||Age||years|Mean|48.2|48.2|Standard Deviation|9.5|9.5|||
3695699|NCT02205801|3537393|B2|||Age||years|Mean|47.4|47.4|Standard Deviation|15.5|15.5|||
3695700|NCT02205801|3537394|B1|||Age||years|Mean|52|52.0|Standard Deviation|13.1|13.1|||
3695701|NCT02205476|3537419|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3695702|NCT02205476|3537420|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3695703|NCT02205476|3537421|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3695704|NCT02205476|3537419|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3695705|NCT02205476|3537420|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3695706|NCT02205476|3537421|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3695707|NCT02205476|3537419|B3|||Age||years|Mean|40.2|40.2|Standard Deviation|9.08|9.08|||
3695708|NCT02205476|3537420|B2|||Age||years|Mean|39.0|39.0|Standard Deviation|15.13|15.13|||
3695709|NCT02205476|3537421|B1|||Age||years|Mean|40.7|40.7|Standard Deviation|6.80|6.8|||
3695710|NCT02205333|3537452|B10||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3695711|NCT02205333|3537453|B9||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3695712|NCT02205333|3537454|B8||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3695713|NCT02205333|3537455|B7||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3695714|NCT02205333|3537456|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3695715|NCT02205333|3537457|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3695716|NCT02205333|3537458|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3695717|NCT02205333|3537459|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3695718|NCT02205333|3537460|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3695719|NCT02205333|3537461|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3695720|NCT02205333|3537452|B10||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3695721|NCT02205333|3537453|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3695722|NCT02205333|3537454|B8||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3695723|NCT02205333|3537455|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3695724|NCT02205333|3537456|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3695725|NCT02205333|3537457|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3695726|NCT02205333|3537458|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3695727|NCT02205333|3537459|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3695728|NCT02205333|3537460|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3695729|NCT02205333|3537461|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3695730|NCT02205333|3537452|B10|||Age||Years|Mean|61.9|61.9|Standard Deviation|12.2|12.2|||
3695731|NCT02205333|3537453|B9|||Age||Years|Mean|73.0|73.0|Standard Deviation|NA||||Not evaluable due to insufficient number of participants.
3695732|NCT02205333|3537454|B8|||Age||Years|Mean|70.3|70.3|Standard Deviation|4.6|4.6|||
3695733|NCT02205333|3537455|B7|||Age||Years|Mean|62.6|62.6|Standard Deviation|9.1|9.1|||
3695734|NCT02205333|3537456|B6|||Age||Years|Mean|66.6|66.6|Standard Deviation|14.5|14.5|||
3695735|NCT02205333|3537457|B5|||Age||Years|Mean|57.5|57.5|Standard Deviation|19.4|19.4|||
3695736|NCT02205333|3537458|B4|||Age||Years|Mean|61.3|61.3|Standard Deviation|8.7|8.7|||
3695737|NCT02205333|3537459|B3|||Age||Years|Mean|48.0|48.0|Standard Deviation|6.9|6.9|||
3695738|NCT02205333|3537460|B2|||Age||Years|Mean|63.8|63.8|Standard Deviation|8.9|8.9|||
3695739|NCT02205333|3537461|B1|||Age||Years|Mean|60.5|60.5|Standard Deviation|12.6|12.6|||
3695740|NCT02204917|3537642|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3695741|NCT02204917|3537642|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695742|NCT02204917|3537642|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3695743|NCT02204917|3537642|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3695744|NCT02204917|3537642|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3695745|NCT02204917|3537642|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695746|NCT02204917|3537642|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3695747|NCT02204917|3537642|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695748|NCT02204917|3537642|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695749|NCT02204917|3537642|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3695750|NCT02204917|3537642|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3695751|NCT02204917|3537642|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3695752|NCT02204917|3537642|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3695753|NCT02204917|3537642|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3695754|NCT02204917|3537642|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3695755|NCT02204917|3537642|B1||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
3695756|NCT02204761|3537649|B1|||Number of participants with Grade 3+ toxicity from radiation||Participants|Count of Participants|0|0.0||||||
3695757|NCT02204761|3537649|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3695758|NCT02204761|3537649|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695759|NCT02204761|3537649|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695760|NCT02204761|3537649|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3695761|NCT02204761|3537649|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695762|NCT02204761|3537649|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695763|NCT02204761|3537649|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695764|NCT02204761|3537649|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695765|NCT02204761|3537649|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3695766|NCT02204761|3537649|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3695767|NCT02204761|3537649|B1|||Age||years|Mean|71.7|71.7|Standard Deviation|8.8|8.8|||
3695768|NCT02204748|3537656|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3695769|NCT02204748|3537656|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3695770|NCT02204748|3537656|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3695771|NCT02204748|3537656|B1|||Age||years|Mean|66.2|66.2|Standard Deviation|8.07|8.07|||
3695772|NCT02204748|3537656|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3695773|NCT02204748|3537656|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3695774|NCT02204748|3537656|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3695775|NCT02204657|3537668|B3|Malaysia||Region of Enrollment||participants|Number|50|50.0||||||
3695776|NCT02204657|3537669|B2|Malaysia||Region of Enrollment||participants|Number|25|25.0||||||
3695777|NCT02204657|3537670|B1|Malaysia||Region of Enrollment||participants|Number|25|25.0||||||
3695778|NCT02204657|3537668|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3695779|NCT02204657|3537669|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3695780|NCT02204657|3537670|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3695781|NCT02204657|3537668|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3695782|NCT02204657|3537669|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3695783|NCT02204657|3537670|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3695784|NCT02204657|3537668|B3|||Age||years|Mean|32.7|32.7|Standard Deviation|4.73|4.73|||
3695785|NCT02204657|3537669|B2|||Age||years|Mean|32.6|32.6|Standard Deviation|4.93|4.93|||
3695786|NCT02204657|3537670|B1|||Age||years|Mean|32.80|32.8|Standard Deviation|4.53|4.53|||
3695787|NCT02204657|3537668|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3695788|NCT02204657|3537669|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3695789|NCT02204657|3537670|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3695790|NCT02204657|3537668|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3695791|NCT02204657|3537669|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3695792|NCT02204657|3537670|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3695793|NCT02204657|3537668|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3695794|NCT02204657|3537669|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3695795|NCT02204657|3537670|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3695796|NCT02204579|3537679|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
3695797|NCT02204579|3537679|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
3695798|NCT02204579|3537679|B1|||Age||Years|Mean|39.8|39.8|Standard Deviation|15.2|15.2|||
3695799|NCT02204449|3537731|B3|Canada||Region of Enrollment||participants|Number|93|93.0||||||
3695800|NCT02204449|3537732|B2|Canada||Region of Enrollment||participants|Number|47|47.0||||||
3695801|NCT02204449|3537733|B1|Canada||Region of Enrollment||participants|Number|46|46.0||||||
3695802|NCT02204449|3537731|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3695803|NCT02204449|3537732|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3695804|NCT02204449|3537733|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3695805|NCT02204449|3537731|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3695806|NCT02204449|3537732|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3695807|NCT02204449|3537733|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3695808|NCT02204449|3537731|B3|||Age||years|Mean|62.7|62.7|Standard Deviation|14.8|14.8|||
3695809|NCT02204449|3537732|B2|||Age||years|Mean|62.6|62.6|Standard Deviation|13.1|13.1|||
3695810|NCT02204449|3537733|B1|||Age||years|Mean|62.7|62.7|Standard Deviation|16.5|16.5|||
3695811|NCT02204410|3537744|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3695812|NCT02204410|3537744|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3695813|NCT02204410|3537744|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3695814|NCT02204410|3537744|B1|||Age||years|Mean|10.6|10.6|Standard Deviation|2.6|2.6|||
3695815|NCT02204410|3537744|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3695816|NCT02204410|3537744|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3695817|NCT02204410|3537744|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
3695818|NCT02204371|3537749|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3695819|NCT02204371|3537749|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3695820|NCT02204371|3537749|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3695821|NCT02204371|3537749|B1|||Age||Years|Mean|57.3|57.3|Standard Deviation|9.14|9.14|||
3695822|NCT02204319|3537772|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3695823|NCT02204319|3537772|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3695824|NCT02204319|3537772|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3695825|NCT02204319|3537772|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3695826|NCT02204319|3537772|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3695827|NCT02204319|3537772|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3695828|NCT02204124|3537778|B3|||Body Mass Index (BMI) > 30 kg/m^2||Participants|Count of Participants|7|7.0||||||
3695829|NCT02204124|3537779|B2|||Body Mass Index (BMI) > 30 kg/m^2||Participants|Count of Participants|5|5.0||||||
3695830|NCT02204124|3537780|B1|||Body Mass Index (BMI) > 30 kg/m^2||Participants|Count of Participants|2|2.0||||||
3695831|NCT02204124|3537778|B3|||Received Neoadjuvant Therapy||Participants|Count of Participants|8|8.0||||||
3695832|NCT02204124|3537779|B2|||Received Neoadjuvant Therapy||Participants|Count of Participants|5|5.0||||||
3695833|NCT02204124|3537780|B1|||Received Neoadjuvant Therapy||Participants|Count of Participants|3|3.0||||||
3695834|NCT02204124|3537778|B3|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3695835|NCT02204124|3537779|B2|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3695836|NCT02204124|3537780|B1|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3695837|NCT02204124|3537778|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695838|NCT02204124|3537779|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695839|NCT02204124|3537780|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695840|NCT02204124|3537778|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695841|NCT02204124|3537779|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695842|NCT02204124|3537780|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695843|NCT02204124|3537778|B3||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3695844|NCT02204124|3537779|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3695845|NCT02204124|3537780|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3695846|NCT02204124|3537778|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3695847|NCT02204124|3537779|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3695848|NCT02204124|3537780|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695849|NCT02204124|3537778|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695850|NCT02204124|3537779|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695851|NCT02204124|3537780|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695852|NCT02204124|3537778|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3695853|NCT02204124|3537779|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695854|NCT02204124|3537780|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3695855|NCT02204124|3537778|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695856|NCT02204124|3537779|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695857|NCT02204124|3537780|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695858|NCT02204124|3537778|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695859|NCT02204124|3537779|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695860|NCT02204124|3537780|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695861|NCT02204124|3537778|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3695862|NCT02204124|3537779|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3695863|NCT02204124|3537780|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3695864|NCT02204124|3537778|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695865|NCT02204124|3537779|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695866|NCT02204124|3537780|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3695867|NCT02204124|3537778|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3695868|NCT02204124|3537779|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3695869|NCT02204124|3537780|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3695870|NCT02204124|3537778|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3695871|NCT02204124|3537779|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3695872|NCT02204124|3537780|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3695873|NCT02204124|3537778|B3|||Age||years|Mean|64.7|64.7|Standard Deviation|11.4|11.4|||
3695874|NCT02204124|3537779|B2|||Age||years|Mean|64.8|64.8|Standard Deviation|11.3|11.3|||
3695875|NCT02204124|3537780|B1|||Age||years|Mean|64.6|64.6|Standard Deviation|11.9|11.9|||
3695876|NCT02204007|3537799|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3695877|NCT02204007|3537800|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3695878|NCT02204007|3537801|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3695879|NCT02204007|3537799|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3695880|NCT02204007|3537800|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3695881|NCT02204007|3537801|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3695882|NCT02204007|3537799|B3|||Age||years|Mean|62.0|62.0|Full Range|||41.0|82.0|
3695883|NCT02204007|3537800|B2|||Age||years|Mean|58.6|58.6|Full Range|||41.0|82.0|
3695884|NCT02204007|3537801|B1|||Age||years|Mean|65.4|65.4|Full Range|||44.0|80.0|
3695885|NCT02203916|3537810|B4|No||Diabetes Status||participants|Number|289|289.0||||||
3695886|NCT02203916|3537811|B3|No||Diabetes Status||participants|Number|117|117.0||||||
3695887|NCT02203916|3537812|B2|No||Diabetes Status||participants|Number|111|111.0||||||
3695888|NCT02203916|3537813|B1|No||Diabetes Status||participants|Number|61|61.0||||||
3695889|NCT02203916|3537810|B4|Yes||Diabetes Status||participants|Number|38|38.0||||||
3695890|NCT02203916|3537811|B3|Yes||Diabetes Status||participants|Number|13|13.0||||||
3695891|NCT02203916|3537812|B2|Yes||Diabetes Status||participants|Number|21|21.0||||||
3695892|NCT02203916|3537813|B1|Yes||Diabetes Status||participants|Number|4|4.0||||||
3695893|NCT02203916|3537810|B4|||Estimated Glomerular Filtration Rate(eGFR)||mL/min/1.73m^2|Mean|87.59|87.59|Standard Deviation|17.740|17.74|||
3695894|NCT02203916|3537811|B3|||Estimated Glomerular Filtration Rate(eGFR)||mL/min/1.73m^2|Mean|88.68|88.68|Standard Deviation|18.443|18.443|||
3695895|NCT02203916|3537812|B2|||Estimated Glomerular Filtration Rate(eGFR)||mL/min/1.73m^2|Mean|87.44|87.44|Standard Deviation|18.393|18.393|||
3695896|NCT02203916|3537813|B1|||Estimated Glomerular Filtration Rate(eGFR)||mL/min/1.73m^2|Mean|85.72|85.72|Standard Deviation|14.798|14.798|||
3695897|NCT02203916|3537810|B4|Of Childbearing Potential||Female Reproductive Status|Female participants only (n=14, 37, 37)|participants|Number|18|18.0||||||
3695898|NCT02203916|3537811|B3|Of Childbearing Potential||Female Reproductive Status|Female participants only (n=14, 37, 37)|participants|Number|10|10.0||||||
3695899|NCT02203916|3537812|B2|Of Childbearing Potential||Female Reproductive Status|Female participants only (n=14, 37, 37)|participants|Number|5|5.0||||||
3695900|NCT02203916|3537813|B1|Of Childbearing Potential||Female Reproductive Status|Female participants only (n=14, 37, 37)|participants|Number|3|3.0||||||
3695901|NCT02203916|3537810|B4|Surgically Sterile||Female Reproductive Status|Female participants only (n=14, 37, 37)|participants|Number|9|9.0||||||
3695902|NCT02203916|3537811|B3|Surgically Sterile||Female Reproductive Status|Female participants only (n=14, 37, 37)|participants|Number|3|3.0||||||
3695903|NCT02203916|3537812|B2|Surgically Sterile||Female Reproductive Status|Female participants only (n=14, 37, 37)|participants|Number|4|4.0||||||
3695904|NCT02203916|3537813|B1|Surgically Sterile||Female Reproductive Status|Female participants only (n=14, 37, 37)|participants|Number|2|2.0||||||
3695905|NCT02203916|3537810|B4|Postmenopausal||Female Reproductive Status|Female participants only (n=14, 37, 37)|participants|Number|61|61.0||||||
3695906|NCT02203916|3537811|B3|Postmenopausal||Female Reproductive Status|Female participants only (n=14, 37, 37)|participants|Number|24|24.0||||||
3695907|NCT02203916|3537812|B2|Postmenopausal||Female Reproductive Status|Female participants only (n=14, 37, 37)|participants|Number|28|28.0||||||
3695908|NCT02203916|3537813|B1|Postmenopausal||Female Reproductive Status|Female participants only (n=14, 37, 37)|participants|Number|9|9.0||||||
3695909|NCT02203916|3537810|B4|Ex-smoker||Smoking Classification||participants|Number|102|102.0||||||
3695910|NCT02203916|3537811|B3|Ex-smoker||Smoking Classification||participants|Number|39|39.0||||||
3695911|NCT02203916|3537812|B2|Ex-smoker||Smoking Classification||participants|Number|39|39.0||||||
3695912|NCT02203916|3537813|B1|Ex-smoker||Smoking Classification||participants|Number|24|24.0||||||
3695913|NCT02203916|3537810|B4|Current smoker||Smoking Classification||participants|Number|60|60.0||||||
3695914|NCT02203916|3537811|B3|Current smoker||Smoking Classification||participants|Number|26|26.0||||||
3695915|NCT02203916|3537812|B2|Current smoker||Smoking Classification||participants|Number|22|22.0||||||
3695916|NCT02203916|3537813|B1|Current smoker||Smoking Classification||participants|Number|12|12.0||||||
3695917|NCT02203916|3537810|B4|Never smoked||Smoking Classification||participants|Number|165|165.0||||||
3695918|NCT02203916|3537811|B3|Never smoked||Smoking Classification||participants|Number|65|65.0||||||
3695919|NCT02203916|3537812|B2|Never smoked||Smoking Classification||participants|Number|71|71.0||||||
3695920|NCT02203916|3537813|B1|Never smoked||Smoking Classification||participants|Number|29|29.0||||||
3695921|NCT02203916|3537810|B4|||Body Mass Index (BMI)||kg/m^2|Mean|25.74|25.74|Standard Deviation|3.237|3.237|||
3695922|NCT02203916|3537811|B3|||Body Mass Index (BMI)||kg/m^2|Mean|25.50|25.5|Standard Deviation|3.460|3.46|||
3695923|NCT02203916|3537812|B2|||Body Mass Index (BMI)||kg/m^2|Mean|26.02|26.02|Standard Deviation|3.272|3.272|||
3695924|NCT02203916|3537813|B1|||Body Mass Index (BMI)||kg/m^2|Mean|25.64|25.64|Standard Deviation|2.653|2.653|||
3695925|NCT02203916|3537810|B4|||Weight||kg|Mean|70.69|70.69|Standard Deviation|12.291|12.291|||
3695926|NCT02203916|3537811|B3|||Weight||kg|Mean|70.32|70.32|Standard Deviation|13.070|13.07|||
3695927|NCT02203916|3537812|B2|||Weight||kg|Mean|70.97|70.97|Standard Deviation|12.636|12.636|||
3695928|NCT02203916|3537813|B1|||Weight||kg|Mean|70.85|70.85|Standard Deviation|9.892|9.892|||
3695929|NCT02203916|3537810|B4|||Height||cm|Mean|165.4|165.4|Standard Deviation|8.53|8.53|||
3695930|NCT02203916|3537811|B3|||Height||cm|Mean|165.6|165.6|Standard Deviation|8.00|8.0|||
3695931|NCT02203916|3537812|B2|||Height||cm|Mean|164.8|164.8|Standard Deviation|9.09|9.09|||
3695932|NCT02203916|3537813|B1|||Height||cm|Mean|166.1|166.1|Standard Deviation|8.43|8.43|||
3695933|NCT02203916|3537810|B4|Korea, Republic Of||Region of Enrollment||participants|Number|327|327.0||||||
3695934|NCT02203916|3537811|B3|Korea, Republic Of||Region of Enrollment||participants|Number|130|130.0||||||
3695935|NCT02203916|3537812|B2|Korea, Republic Of||Region of Enrollment||participants|Number|132|132.0||||||
3695936|NCT02203916|3537813|B1|Korea, Republic Of||Region of Enrollment||participants|Number|65|65.0||||||
3695937|NCT02203916|3537810|B4|Asian||Race/Ethnicity, Customized||participants|Number|327|327.0||||||
3695938|NCT02203916|3537811|B3|Asian||Race/Ethnicity, Customized||participants|Number|130|130.0||||||
3695939|NCT02203916|3537812|B2|Asian||Race/Ethnicity, Customized||participants|Number|132|132.0||||||
3695940|NCT02203916|3537813|B1|Asian||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
3695941|NCT02203916|3537810|B4||Male|Gender||Participants|Count of Participants|239|239.0||||||
3695942|NCT02203916|3537811|B3||Male|Gender||Participants|Count of Participants|93|93.0||||||
3695943|NCT02203916|3537812|B2||Male|Gender||Participants|Count of Participants|95|95.0||||||
3695944|NCT02203916|3537813|B1||Male|Gender||Participants|Count of Participants|51|51.0||||||
3695945|NCT02203916|3537810|B4||Female|Gender||Participants|Count of Participants|88|88.0||||||
3695946|NCT02203916|3537811|B3||Female|Gender||Participants|Count of Participants|37|37.0||||||
3695947|NCT02203916|3537812|B2||Female|Gender||Participants|Count of Participants|37|37.0||||||
3695948|NCT02203916|3537813|B1||Female|Gender||Participants|Count of Participants|14|14.0||||||
3695949|NCT02203916|3537810|B4|Overall Study||Age||years|Mean|59.0|59.0|Standard Deviation|10.97|10.97|||
3695950|NCT02203916|3537811|B3|Overall Study||Age||years|Mean|58.3|58.3|Standard Deviation|11.57|11.57|||
3695951|NCT02203916|3537812|B2|Overall Study||Age||years|Mean|59.8|59.8|Standard Deviation|10.75|10.75|||
3695952|NCT02203916|3537813|B1|Overall Study||Age||years|Mean|58.8|58.8|Standard Deviation|10.21|10.21|||
3695953|NCT02203838|3537835|B5|||Clinical Global Impression - Severity Scale (CGI-S)|"The CGI-S rating scale is a 7-point global assessment that measures the clinician's impression of the severity of illness exhibited by a participant. A rating of 1 is equivalent to Normal, not at all ill and a rating of 7 is equivalent to Among the most extremely ill participants."|units on a scale|Mean|3.4|3.4|Standard Deviation|0.71|0.71|||
3695954|NCT02203838|3537836|B4|||Clinical Global Impression - Severity Scale (CGI-S)|"The CGI-S rating scale is a 7-point global assessment that measures the clinician's impression of the severity of illness exhibited by a participant. A rating of 1 is equivalent to Normal, not at all ill and a rating of 7 is equivalent to Among the most extremely ill participants."|units on a scale|Mean|3.3|3.3|Standard Deviation|0.89|0.89|||
3695955|NCT02203838|3537837|B3|||Clinical Global Impression - Severity Scale (CGI-S)|"The CGI-S rating scale is a 7-point global assessment that measures the clinician's impression of the severity of illness exhibited by a participant. A rating of 1 is equivalent to Normal, not at all ill and a rating of 7 is equivalent to Among the most extremely ill participants."|units on a scale|Mean|3.8|3.8|Standard Deviation|0.95|0.95|||
3695956|NCT02203838|3537838|B2|||Clinical Global Impression - Severity Scale (CGI-S)|"The CGI-S rating scale is a 7-point global assessment that measures the clinician's impression of the severity of illness exhibited by a participant. A rating of 1 is equivalent to Normal, not at all ill and a rating of 7 is equivalent to Among the most extremely ill participants."|units on a scale|Mean|3.7|3.7|Standard Deviation|1.09|1.09|||
3695957|NCT02203838|3537839|B1|||Clinical Global Impression - Severity Scale (CGI-S)|"The CGI-S rating scale is a 7-point global assessment that measures the clinician's impression of the severity of illness exhibited by a participant. A rating of 1 is equivalent to Normal, not at all ill and a rating of 7 is equivalent to Among the most extremely ill participants."|units on a scale|Mean|3.3|3.3|Standard Deviation|0.62|0.62|||
3695958|NCT02203838|3537835|B5|||Positive and Negative Syndrome Scale (PANSS)|The PANSS is a 30-item scale designed to assess various symptoms of schizophrenia including delusions, grandiosity, blunted affect, poor judgement, poor attention, and poor impulse control. The 30 symptoms are rated on a 7-point scale that ranges from 1 (absent) to 7 (extreme psychopathology). The PANSS total score is the sum of all 30 PANSS items and ranges from 30 to 210, with 30 indicating absence of symptoms of schizophrenia and 210 indicating extreme ratings of all 30 symptoms.|units on a scale|Mean|60.9|60.9|Standard Deviation|12.04|12.04|||
3695959|NCT02203838|3537836|B4|||Positive and Negative Syndrome Scale (PANSS)|The PANSS is a 30-item scale designed to assess various symptoms of schizophrenia including delusions, grandiosity, blunted affect, poor judgement, poor attention, and poor impulse control. The 30 symptoms are rated on a 7-point scale that ranges from 1 (absent) to 7 (extreme psychopathology). The PANSS total score is the sum of all 30 PANSS items and ranges from 30 to 210, with 30 indicating absence of symptoms of schizophrenia and 210 indicating extreme ratings of all 30 symptoms.|units on a scale|Mean|71.0|71.0|Standard Deviation|13.93|13.93|||
3695960|NCT02203838|3537837|B3|||Positive and Negative Syndrome Scale (PANSS)|The PANSS is a 30-item scale designed to assess various symptoms of schizophrenia including delusions, grandiosity, blunted affect, poor judgement, poor attention, and poor impulse control. The 30 symptoms are rated on a 7-point scale that ranges from 1 (absent) to 7 (extreme psychopathology). The PANSS total score is the sum of all 30 PANSS items and ranges from 30 to 210, with 30 indicating absence of symptoms of schizophrenia and 210 indicating extreme ratings of all 30 symptoms.|units on a scale|Mean|76.4|76.4|Standard Deviation|15.99|15.99|||
3695961|NCT02203838|3537838|B2|||Positive and Negative Syndrome Scale (PANSS)|The PANSS is a 30-item scale designed to assess various symptoms of schizophrenia including delusions, grandiosity, blunted affect, poor judgement, poor attention, and poor impulse control. The 30 symptoms are rated on a 7-point scale that ranges from 1 (absent) to 7 (extreme psychopathology). The PANSS total score is the sum of all 30 PANSS items and ranges from 30 to 210, with 30 indicating absence of symptoms of schizophrenia and 210 indicating extreme ratings of all 30 symptoms.|units on a scale|Mean|72.9|72.9|Standard Deviation|20.99|20.99|||
3696012|NCT02203838|3537839|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized|Race|Participants|Count of Participants|1|1.0||||||
3696013|NCT02203838|3537835|B5||American Indian or Alaska Native|Race/Ethnicity, Customized|Race|Participants|Count of Participants|2|2.0||||||
3696014|NCT02203838|3537836|B4||American Indian or Alaska Native|Race/Ethnicity, Customized|Race|Participants|Count of Participants|0|0.0||||||
3695962|NCT02203838|3537839|B1|||Positive and Negative Syndrome Scale (PANSS)|The PANSS is a 30-item scale designed to assess various symptoms of schizophrenia including delusions, grandiosity, blunted affect, poor judgement, poor attention, and poor impulse control. The 30 symptoms are rated on a 7-point scale that ranges from 1 (absent) to 7 (extreme psychopathology). The PANSS total score is the sum of all 30 PANSS items and ranges from 30 to 210, with 30 indicating absence of symptoms of schizophrenia and 210 indicating extreme ratings of all 30 symptoms.|units on a scale|Mean|58.0|58.0|Standard Deviation|8.33|8.33|||
3695963|NCT02203838|3537835|B5||No|Child-bearing Potential||Participants|Count of Participants|95|95.0||||||
3695964|NCT02203838|3537836|B4||No|Child-bearing Potential||Participants|Count of Participants|8|8.0||||||
3695965|NCT02203838|3537837|B3||No|Child-bearing Potential||Participants|Count of Participants|3|3.0||||||
3695966|NCT02203838|3537838|B2||No|Child-bearing Potential||Participants|Count of Participants|5|5.0||||||
3695967|NCT02203838|3537839|B1||No|Child-bearing Potential||Participants|Count of Participants|79|79.0||||||
3695968|NCT02203838|3537835|B5||Yes|Child-bearing Potential||Participants|Count of Participants|66|66.0||||||
3695969|NCT02203838|3537836|B4||Yes|Child-bearing Potential||Participants|Count of Participants|5|5.0||||||
3695970|NCT02203838|3537837|B3||Yes|Child-bearing Potential||Participants|Count of Participants|3|3.0||||||
3695971|NCT02203838|3537838|B2||Yes|Child-bearing Potential||Participants|Count of Participants|4|4.0||||||
3695972|NCT02203838|3537839|B1||Yes|Child-bearing Potential||Participants|Count of Participants|54|54.0||||||
3695973|NCT02203838|3537835|B5|||Waist-to-Hip Ratio|A measurement of abdominal fat.|ratio|Mean|0.946|0.946|Standard Deviation|0.087|0.087|||
3695974|NCT02203838|3537836|B4|||Waist-to-Hip Ratio|A measurement of abdominal fat.|ratio|Mean|0.935|0.935|Standard Deviation|0.075|0.075|||
3695975|NCT02203838|3537837|B3|||Waist-to-Hip Ratio|A measurement of abdominal fat.|ratio|Mean|0.975|0.975|Standard Deviation|0.059|0.059|||
3695976|NCT02203838|3537838|B2|||Waist-to-Hip Ratio|A measurement of abdominal fat.|ratio|Mean|0.936|0.936|Standard Deviation|0.094|0.094|||
3695977|NCT02203838|3537839|B1|||Waist-to-Hip Ratio|A measurement of abdominal fat.|ratio|Mean|0.946|0.946|Standard Deviation|0.090|0.09|||
3695978|NCT02203838|3537835|B5|||Body Mass Index||kg/m^2|Mean|31.375|31.375|Standard Deviation|7.284|7.284|||
3695979|NCT02203838|3537836|B4|||Body Mass Index||kg/m^2|Mean|31.838|31.838|Standard Deviation|8.341|8.341|||
3695980|NCT02203838|3537837|B3|||Body Mass Index||kg/m^2|Mean|31.926|31.926|Standard Deviation|7.104|7.104|||
3695981|NCT02203838|3537838|B2|||Body Mass Index||kg/m^2|Mean|33.920|33.92|Standard Deviation|8.551|8.551|||
3695982|NCT02203838|3537839|B1|||Body Mass Index||kg/m^2|Mean|31.121|31.121|Standard Deviation|7.104|7.104|||
3695983|NCT02203838|3537835|B5|||Weight||kg|Mean|93.53|93.53|Standard Deviation|21.463|21.463|||
3695984|NCT02203838|3537836|B4|||Weight||kg|Mean|94.65|94.65|Standard Deviation|23.994|23.994|||
3695985|NCT02203838|3537837|B3|||Weight||kg|Mean|96.72|96.72|Standard Deviation|21.305|21.305|||
3695986|NCT02203838|3537838|B2|||Weight||kg|Mean|99.33|99.33|Standard Deviation|25.113|25.113|||
3695987|NCT02203838|3537839|B1|||Weight||kg|Mean|92.80|92.8|Standard Deviation|20.989|20.989|||
3695988|NCT02203838|3537835|B5||Unknown|Race/Ethnicity, Customized|Ethnicity|Participants|Count of Participants|1|1.0||||||
3695989|NCT02203838|3537836|B4||Unknown|Race/Ethnicity, Customized|Ethnicity|Participants|Count of Participants|0|0.0||||||
3695990|NCT02203838|3537837|B3||Unknown|Race/Ethnicity, Customized|Ethnicity|Participants|Count of Participants|0|0.0||||||
3695991|NCT02203838|3537838|B2||Unknown|Race/Ethnicity, Customized|Ethnicity|Participants|Count of Participants|0|0.0||||||
3695992|NCT02203838|3537839|B1||Unknown|Race/Ethnicity, Customized|Ethnicity|Participants|Count of Participants|1|1.0||||||
3695993|NCT02203838|3537835|B5||Not Hispanic or Latino|Race/Ethnicity, Customized|Ethnicity|Participants|Count of Participants|455|455.0||||||
3695994|NCT02203838|3537836|B4||Not Hispanic or Latino|Race/Ethnicity, Customized|Ethnicity|Participants|Count of Participants|31|31.0||||||
3695995|NCT02203838|3537837|B3||Not Hispanic or Latino|Race/Ethnicity, Customized|Ethnicity|Participants|Count of Participants|29|29.0||||||
3695996|NCT02203838|3537838|B2||Not Hispanic or Latino|Race/Ethnicity, Customized|Ethnicity|Participants|Count of Participants|24|24.0||||||
3695997|NCT02203838|3537839|B1||Not Hispanic or Latino|Race/Ethnicity, Customized|Ethnicity|Participants|Count of Participants|371|371.0||||||
3695998|NCT02203838|3537835|B5||Hispanic or Latino|Race/Ethnicity, Customized|Ethnicity|Participants|Count of Participants|44|44.0||||||
3695999|NCT02203838|3537836|B4||Hispanic or Latino|Race/Ethnicity, Customized|Ethnicity|Participants|Count of Participants|2|2.0||||||
3696000|NCT02203838|3537837|B3||Hispanic or Latino|Race/Ethnicity, Customized|Ethnicity|Participants|Count of Participants|2|2.0||||||
3696001|NCT02203838|3537838|B2||Hispanic or Latino|Race/Ethnicity, Customized|Ethnicity|Participants|Count of Participants|4|4.0||||||
3696002|NCT02203838|3537839|B1||Hispanic or Latino|Race/Ethnicity, Customized|Ethnicity|Participants|Count of Participants|36|36.0||||||
3696003|NCT02203838|3537835|B5||Other|Race/Ethnicity, Customized|Race|Participants|Count of Participants|1|1.0||||||
3696004|NCT02203838|3537836|B4||Other|Race/Ethnicity, Customized|Race|Participants|Count of Participants|0|0.0||||||
3696005|NCT02203838|3537837|B3||Other|Race/Ethnicity, Customized|Race|Participants|Count of Participants|0|0.0||||||
3696006|NCT02203838|3537838|B2||Other|Race/Ethnicity, Customized|Race|Participants|Count of Participants|0|0.0||||||
3696007|NCT02203838|3537839|B1||Other|Race/Ethnicity, Customized|Race|Participants|Count of Participants|1|1.0||||||
3696008|NCT02203838|3537835|B5||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized|Race|Participants|Count of Participants|3|3.0||||||
3696009|NCT02203838|3537836|B4||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized|Race|Participants|Count of Participants|1|1.0||||||
3696010|NCT02203838|3537837|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized|Race|Participants|Count of Participants|0|0.0||||||
3696011|NCT02203838|3537838|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized|Race|Participants|Count of Participants|1|1.0||||||
3696015|NCT02203838|3537837|B3||American Indian or Alaska Native|Race/Ethnicity, Customized|Race|Participants|Count of Participants|0|0.0||||||
3696016|NCT02203838|3537838|B2||American Indian or Alaska Native|Race/Ethnicity, Customized|Race|Participants|Count of Participants|0|0.0||||||
3696017|NCT02203838|3537839|B1||American Indian or Alaska Native|Race/Ethnicity, Customized|Race|Participants|Count of Participants|2|2.0||||||
3696018|NCT02203838|3537835|B5||Asian|Race/Ethnicity, Customized|Race|Participants|Count of Participants|4|4.0||||||
3696019|NCT02203838|3537836|B4||Asian|Race/Ethnicity, Customized|Race|Participants|Count of Participants|1|1.0||||||
3696020|NCT02203838|3537837|B3||Asian|Race/Ethnicity, Customized|Race|Participants|Count of Participants|0|0.0||||||
3696021|NCT02203838|3537838|B2||Asian|Race/Ethnicity, Customized|Race|Participants|Count of Participants|0|0.0||||||
3696022|NCT02203838|3537839|B1||Asian|Race/Ethnicity, Customized|Race|Participants|Count of Participants|3|3.0||||||
3696023|NCT02203838|3537835|B5||Black or African American|Race/Ethnicity, Customized|Race|Participants|Count of Participants|354|354.0||||||
3696024|NCT02203838|3537836|B4||Black or African American|Race/Ethnicity, Customized|Race|Participants|Count of Participants|22|22.0||||||
3696025|NCT02203838|3537837|B3||Black or African American|Race/Ethnicity, Customized|Race|Participants|Count of Participants|22|22.0||||||
3696026|NCT02203838|3537838|B2||Black or African American|Race/Ethnicity, Customized|Race|Participants|Count of Participants|18|18.0||||||
3696027|NCT02203838|3537839|B1||Black or African American|Race/Ethnicity, Customized|Race|Participants|Count of Participants|292|292.0||||||
3696028|NCT02203838|3537835|B5||White|Race/Ethnicity, Customized|Race|Participants|Count of Participants|136|136.0||||||
3696029|NCT02203838|3537836|B4||White|Race/Ethnicity, Customized|Race|Participants|Count of Participants|9|9.0||||||
3696030|NCT02203838|3537837|B3||White|Race/Ethnicity, Customized|Race|Participants|Count of Participants|9|9.0||||||
3696031|NCT02203838|3537838|B2||White|Race/Ethnicity, Customized|Race|Participants|Count of Participants|9|9.0||||||
3696032|NCT02203838|3537839|B1||White|Race/Ethnicity, Customized|Race|Participants|Count of Participants|109|109.0||||||
3696033|NCT02203838|3537835|B5||Male|Sex: Female, Male||Participants|Count of Participants|339|339.0||||||
3696034|NCT02203838|3537836|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3696035|NCT02203838|3537837|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3696036|NCT02203838|3537838|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3696037|NCT02203838|3537839|B1||Male|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
3696038|NCT02203838|3537835|B5||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3696039|NCT02203838|3537836|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3696040|NCT02203838|3537837|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3696041|NCT02203838|3537838|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3696042|NCT02203838|3537839|B1||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3696043|NCT02203838|3537835|B5||56 to 65 years|Age, Customized||Participants|Count of Participants|74|74.0||||||
3696044|NCT02203838|3537836|B4||56 to 65 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3696045|NCT02203838|3537837|B3||56 to 65 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
3696046|NCT02203838|3537838|B2||56 to 65 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3696047|NCT02203838|3537839|B1||56 to 65 years|Age, Customized||Participants|Count of Participants|73|73.0||||||
3696048|NCT02203838|3537835|B5||51 to 55 years|Age, Customized||Participants|Count of Participants|105|105.0||||||
3696049|NCT02203838|3537836|B4||51 to 55 years|Age, Customized||Participants|Count of Participants|9|9.0||||||
3696050|NCT02203838|3537837|B3||51 to 55 years|Age, Customized||Participants|Count of Participants|5|5.0||||||
3696051|NCT02203838|3537838|B2||51 to 55 years|Age, Customized||Participants|Count of Participants|6|6.0||||||
3696052|NCT02203838|3537839|B1||51 to 55 years|Age, Customized||Participants|Count of Participants|85|85.0||||||
3696053|NCT02203838|3537835|B5||41 to 50 years|Age, Customized||Participants|Count of Participants|163|163.0||||||
3696054|NCT02203838|3537836|B4||41 to 50 years|Age, Customized||Participants|Count of Participants|12|12.0||||||
3696055|NCT02203838|3537837|B3||41 to 50 years|Age, Customized||Participants|Count of Participants|11|11.0||||||
3696056|NCT02203838|3537838|B2||41 to 50 years|Age, Customized||Participants|Count of Participants|12|12.0||||||
3696057|NCT02203838|3537839|B1||41 to 50 years|Age, Customized||Participants|Count of Participants|128|128.0||||||
3696058|NCT02203838|3537835|B5||31 to 40 years|Age, Customized||Participants|Count of Participants|106|106.0||||||
3696059|NCT02203838|3537836|B4||31 to 40 years|Age, Customized||Participants|Count of Participants|6|6.0||||||
3696060|NCT02203838|3537837|B3||31 to 40 years|Age, Customized||Participants|Count of Participants|10|10.0||||||
3696061|NCT02203838|3537838|B2||31 to 40 years|Age, Customized||Participants|Count of Participants|9|9.0||||||
3696062|NCT02203838|3537839|B1||31 to 40 years|Age, Customized||Participants|Count of Participants|81|81.0||||||
3696063|NCT02203838|3537835|B5||21 to 30 years|Age, Customized||Participants|Count of Participants|49|49.0||||||
3696064|NCT02203838|3537836|B4||21 to 30 years|Age, Customized||Participants|Count of Participants|5|5.0||||||
3696065|NCT02203838|3537837|B3||21 to 30 years|Age, Customized||Participants|Count of Participants|4|4.0||||||
3696066|NCT02203838|3537838|B2||21 to 30 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
3696067|NCT02203838|3537839|B1||21 to 30 years|Age, Customized||Participants|Count of Participants|39|39.0||||||
3696068|NCT02203838|3537835|B5||20 years and under|Age, Customized||Participants|Count of Participants|3|3.0||||||
3696069|NCT02203838|3537836|B4||20 years and under|Age, Customized||Participants|Count of Participants|1|1.0||||||
3696070|NCT02203838|3537837|B3||20 years and under|Age, Customized||Participants|Count of Participants|0|0.0||||||
3696071|NCT02203838|3537838|B2||20 years and under|Age, Customized||Participants|Count of Participants|0|0.0||||||
3696072|NCT02203838|3537839|B1||20 years and under|Age, Customized||Participants|Count of Participants|2|2.0||||||
3696073|NCT02203838|3537835|B5|||Age||years|Mean|45.1|45.1|Standard Deviation|10.34|10.34|||
3696074|NCT02203838|3537836|B4|||Age||years|Mean|42.3|42.3|Standard Deviation|10.04|10.04|||
3696075|NCT02203838|3537837|B3|||Age||years|Mean|41.1|41.1|Standard Deviation|9.64|9.64|||
3696076|NCT02203838|3537838|B2|||Age||years|Mean|44.0|44.0|Standard Deviation|7.33|7.33|||
3696077|NCT02203838|3537839|B1|||Age||years|Mean|45.7|45.7|Standard Deviation|10.51|10.51|||
3696078|NCT02203786|3537872|B5|||Timeline Followback|number of alcoholic drinks per week|number of alcoholic drinks per week|Mean|1.7|1.7|Full Range|||0.0|8.0|
3696079|NCT02203786|3537873|B4|||Timeline Followback|number of alcoholic drinks per week|number of alcoholic drinks per week|Mean|1.8|1.8|Full Range|||0.0|5.5|
3696080|NCT02203786|3537874|B3|||Timeline Followback|number of alcoholic drinks per week|number of alcoholic drinks per week|Mean|1.5|1.5|Full Range|||0.0|6.0|
3696081|NCT02203786|3537875|B2|||Timeline Followback|number of alcoholic drinks per week|number of alcoholic drinks per week|Mean|1.5|1.5|Full Range|||0.0|3.0|
3696082|NCT02203786|3537876|B1|||Timeline Followback|number of alcoholic drinks per week|number of alcoholic drinks per week|Mean|2.3|2.3|Full Range|||0.0|8.0|
3696083|NCT02203786|3537872|B5|||Alcohol Dependence Scale|"This 25-item scale assesses severity of the Alcohol Dependence syndrome. Total scores range from 0-51. A score of 13 corresponds to the 1st quartile and scores from 0-13 are said to indicate low dependence. A score of 9 or more has been associated with alcohol abuse."|units on a scale|Mean|0.9|0.9|Full Range|||0.0|11.0|
3696084|NCT02203786|3537873|B4|||Alcohol Dependence Scale|"This 25-item scale assesses severity of the Alcohol Dependence syndrome. Total scores range from 0-51. A score of 13 corresponds to the 1st quartile and scores from 0-13 are said to indicate low dependence. A score of 9 or more has been associated with alcohol abuse."|units on a scale|Mean|0.3|0.3|Full Range|||0.0|4.0|
3696085|NCT02203786|3537874|B3|||Alcohol Dependence Scale|"This 25-item scale assesses severity of the Alcohol Dependence syndrome. Total scores range from 0-51. A score of 13 corresponds to the 1st quartile and scores from 0-13 are said to indicate low dependence. A score of 9 or more has been associated with alcohol abuse."|units on a scale|Mean|0.6|0.6|Full Range|||0.0|3.0|
3696086|NCT02203786|3537875|B2|||Alcohol Dependence Scale|"This 25-item scale assesses severity of the Alcohol Dependence syndrome. Total scores range from 0-51. A score of 13 corresponds to the 1st quartile and scores from 0-13 are said to indicate low dependence. A score of 9 or more has been associated with alcohol abuse."|units on a scale|Mean|1.6|1.6|Full Range|||0.0|11.0|
3696087|NCT02203786|3537876|B1|||Alcohol Dependence Scale|"This 25-item scale assesses severity of the Alcohol Dependence syndrome. Total scores range from 0-51. A score of 13 corresponds to the 1st quartile and scores from 0-13 are said to indicate low dependence. A score of 9 or more has been associated with alcohol abuse."|units on a scale|Mean|1.1|1.1|Full Range|||0.0|4.0|
3696088|NCT02203786|3537872|B5|||Eysenck Impulsivity Scale|This 19-item yes/no scale measures trait impulsivity. Scores range from 0-19. The normative mean in the general population is 9. The mean score in large samples of people with pathological gambling is also 9.|units on a scale|Mean|5.47|5.47|Standard Deviation|3.35|3.35|||
3696089|NCT02203786|3537873|B4|||Eysenck Impulsivity Scale|This 19-item yes/no scale measures trait impulsivity. Scores range from 0-19. The normative mean in the general population is 9. The mean score in large samples of people with pathological gambling is also 9.|units on a scale|Mean|1.6|1.6|Standard Deviation|2.5|2.5|||
3696090|NCT02203786|3537874|B3|||Eysenck Impulsivity Scale|This 19-item yes/no scale measures trait impulsivity. Scores range from 0-19. The normative mean in the general population is 9. The mean score in large samples of people with pathological gambling is also 9.|units on a scale|Mean|2.6|2.6|Standard Deviation|2.1|2.1|||
3696091|NCT02203786|3537875|B2|||Eysenck Impulsivity Scale|This 19-item yes/no scale measures trait impulsivity. Scores range from 0-19. The normative mean in the general population is 9. The mean score in large samples of people with pathological gambling is also 9.|units on a scale|Mean|8.5|8.5|Standard Deviation|4.4|4.4|||
3696092|NCT02203786|3537876|B1|||Eysenck Impulsivity Scale|This 19-item yes/no scale measures trait impulsivity. Scores range from 0-19. The normative mean in the general population is 9. The mean score in large samples of people with pathological gambling is also 9.|units on a scale|Mean|9.2|9.2|Standard Deviation|4.4|4.4|||
3696093|NCT02203786|3537872|B5|||Beck Depression Inventory - past 2 weeks|Measure of depressive symptoms in the past 2 weeks. The scale contains 13 items scored 0-3 in increasing severity (range of possible scores: 0-39). A score of 10 is considered the cut-off for clinically relevant depressive symptoms.|units on a scale|Mean|3.02|3.02|Standard Deviation|2.85|2.85|||
3696094|NCT02203786|3537873|B4|||Beck Depression Inventory - past 2 weeks|Measure of depressive symptoms in the past 2 weeks. The scale contains 13 items scored 0-3 in increasing severity (range of possible scores: 0-39). A score of 10 is considered the cut-off for clinically relevant depressive symptoms.|units on a scale|Mean|1.3|1.3|Standard Deviation|2.1|2.1|||
3696095|NCT02203786|3537874|B3|||Beck Depression Inventory - past 2 weeks|Measure of depressive symptoms in the past 2 weeks. The scale contains 13 items scored 0-3 in increasing severity (range of possible scores: 0-39). A score of 10 is considered the cut-off for clinically relevant depressive symptoms.|units on a scale|Mean|0.9|0.9|Standard Deviation|1.2|1.2|||
3696096|NCT02203786|3537875|B2|||Beck Depression Inventory - past 2 weeks|Measure of depressive symptoms in the past 2 weeks. The scale contains 13 items scored 0-3 in increasing severity (range of possible scores: 0-39). A score of 10 is considered the cut-off for clinically relevant depressive symptoms.|units on a scale|Mean|5.6|5.6|Standard Deviation|4.5|4.5|||
3696097|NCT02203786|3537876|B1|||Beck Depression Inventory - past 2 weeks|Measure of depressive symptoms in the past 2 weeks. The scale contains 13 items scored 0-3 in increasing severity (range of possible scores: 0-39). A score of 10 is considered the cut-off for clinically relevant depressive symptoms.|units on a scale|Mean|4.3|4.3|Standard Deviation|3.6|3.6|||
3696098|NCT02203786|3537872|B5|||South Oaks Gambling Screen (SOGS)|"Range of possible scores on the SOGS is 0-20. A score of 5 or more indicates probable pathological gambling with respect to DSM criteria."|units on a scale|Mean|5.7|5.7|Full Range|||0.0|20.0|
3696099|NCT02203786|3537873|B4|||South Oaks Gambling Screen (SOGS)|"Range of possible scores on the SOGS is 0-20. A score of 5 or more indicates probable pathological gambling with respect to DSM criteria."|units on a scale|Mean|0|0.0|Full Range|||0.0|0.0|
3696100|NCT02203786|3537874|B3|||South Oaks Gambling Screen (SOGS)|"Range of possible scores on the SOGS is 0-20. A score of 5 or more indicates probable pathological gambling with respect to DSM criteria."|units on a scale|Mean|0|0.0|Full Range|||0.0|0.0|
3696101|NCT02203786|3537875|B2|||South Oaks Gambling Screen (SOGS)|"Range of possible scores on the SOGS is 0-20. A score of 5 or more indicates probable pathological gambling with respect to DSM criteria."|units on a scale|Mean|11.7|11.7|Full Range|||5.0|20.0|
3696102|NCT02203786|3537876|B1|||South Oaks Gambling Screen (SOGS)|"Range of possible scores on the SOGS is 0-20. A score of 5 or more indicates probable pathological gambling with respect to DSM criteria."|units on a scale|Mean|11.1|11.1|Full Range|||6.0|18.0|
3696103|NCT02203786|3537872|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3696104|NCT02203786|3537873|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3696105|NCT02203786|3537874|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3696106|NCT02203786|3537875|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3696107|NCT02203786|3537876|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3696108|NCT02203786|3537872|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696109|NCT02203786|3537873|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696110|NCT02203786|3537874|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696111|NCT02203786|3537875|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696112|NCT02203786|3537876|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696113|NCT02203786|3537872|B5||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3696114|NCT02203786|3537873|B4||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3696115|NCT02203786|3537874|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3696116|NCT02203786|3537875|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3696117|NCT02203786|3537876|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3696118|NCT02203786|3537872|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696119|NCT02203786|3537873|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696120|NCT02203786|3537874|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696121|NCT02203786|3537875|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696122|NCT02203786|3537876|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696123|NCT02203786|3537872|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3696124|NCT02203786|3537873|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696125|NCT02203786|3537874|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3696126|NCT02203786|3537875|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696127|NCT02203786|3537876|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696128|NCT02203786|3537872|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3696129|NCT02203786|3537873|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3696130|NCT02203786|3537874|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3696131|NCT02203786|3537875|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3696132|NCT02203786|3537876|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3696133|NCT02203786|3537872|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696134|NCT02203786|3537873|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696135|NCT02203786|3537874|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696136|NCT02203786|3537875|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696137|NCT02203786|3537876|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696138|NCT02203786|3537872|B5||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3696139|NCT02203786|3537873|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3696140|NCT02203786|3537874|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3696141|NCT02203786|3537875|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3696142|NCT02203786|3537876|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3696143|NCT02203786|3537872|B5||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3696144|NCT02203786|3537873|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3696145|NCT02203786|3537874|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3696146|NCT02203786|3537875|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3696147|NCT02203786|3537876|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3696148|NCT02203786|3537872|B5|||Age||years|Mean|36.3|36.3|Full Range|||19.0|62.0|
3696149|NCT02203786|3537873|B4|||Age||years|Mean|39.9|39.9|Full Range|||23.0|62.0|
3696150|NCT02203786|3537874|B3|||Age||years|Mean|36.1|36.1|Full Range|||19.0|56.0|
3696151|NCT02203786|3537875|B2|||Age||years|Mean|33.5|33.5|Full Range|||19.0|49.0|
3696152|NCT02203786|3537876|B1|||Age||years|Mean|35.8|35.8|Full Range|||22.0|53.0|
3696153|NCT02203747|3537909|B3|United States||Region of Enrollment||participants|Number|79|79.0||||||
3696154|NCT02203747|3537910|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
3696155|NCT02203747|3537911|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
3696156|NCT02203747|3537909|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3696157|NCT02203747|3537910|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3696158|NCT02203747|3537911|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3696159|NCT02203747|3537909|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3696160|NCT02203747|3537910|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3696161|NCT02203747|3537911|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3696162|NCT02203747|3537909|B3|||Age||years|Mean|70.64|70.64|Standard Deviation|9.59|9.59|||
3696163|NCT02203747|3537910|B2|||Age||years|Mean|69.68|69.68|Standard Deviation|11.08|11.08|||
3696164|NCT02203747|3537911|B1|||Age||years|Mean|71.39|71.39|Standard Deviation|8.34|8.34|||
3696165|NCT02203747|3537909|B3|>=65 years||Age|"Total participants in the Pseudophakic implanted with toric IOL group is 45, but age was not reported for one subject."|participants|Number|61|61.0||||||
3696166|NCT02203747|3537910|B2|>=65 years||Age|"Total participants in the Pseudophakic implanted with toric IOL group is 45, but age was not reported for one subject."|participants|Number|25|25.0||||||
3696167|NCT02203747|3537911|B1|>=65 years||Age|"Total participants in the Pseudophakic implanted with toric IOL group is 45, but age was not reported for one subject."|participants|Number|36|36.0||||||
3696168|NCT02203747|3537909|B3|Between 18 and 65 years||Age|"Total participants in the Pseudophakic implanted with toric IOL group is 45, but age was not reported for one subject."|participants|Number|17|17.0||||||
3696169|NCT02203747|3537910|B2|Between 18 and 65 years||Age|"Total participants in the Pseudophakic implanted with toric IOL group is 45, but age was not reported for one subject."|participants|Number|9|9.0||||||
3696170|NCT02203747|3537911|B1|Between 18 and 65 years||Age|"Total participants in the Pseudophakic implanted with toric IOL group is 45, but age was not reported for one subject."|participants|Number|8|8.0||||||
3696171|NCT02203747|3537909|B3|<=18 years||Age|"Total participants in the Pseudophakic implanted with toric IOL group is 45, but age was not reported for one subject."|participants|Number|0|0.0||||||
3696172|NCT02203747|3537910|B2|<=18 years||Age|"Total participants in the Pseudophakic implanted with toric IOL group is 45, but age was not reported for one subject."|participants|Number|0|0.0||||||
3696173|NCT02203747|3537911|B1|<=18 years||Age|"Total participants in the Pseudophakic implanted with toric IOL group is 45, but age was not reported for one subject."|participants|Number|0|0.0||||||
3696174|NCT02203721|3537920|B3|United States||Region of Enrollment||participants|Number|299|299.0||||||
3696175|NCT02203721|3537921|B2|United States||Region of Enrollment||participants|Number|151|151.0||||||
3696176|NCT02203721|3537922|B1|United States||Region of Enrollment||participants|Number|148|148.0||||||
3696177|NCT02203721|3537920|B3||Male|Gender||Participants|Count of Participants|122|122.0||||||
3696178|NCT02203721|3537921|B2||Male|Gender||Participants|Count of Participants|65|65.0||||||
3696179|NCT02203721|3537922|B1||Male|Gender||Participants|Count of Participants|57|57.0||||||
3696180|NCT02203721|3537920|B3||Female|Gender||Participants|Count of Participants|177|177.0||||||
3696181|NCT02203721|3537921|B2||Female|Gender||Participants|Count of Participants|86|86.0||||||
3696182|NCT02203721|3537922|B1||Female|Gender||Participants|Count of Participants|91|91.0||||||
3696183|NCT02203721|3537920|B3|||Age||Years|Mean|67.9|67.9|Standard Deviation|7.7|7.7|||
3696184|NCT02203721|3537921|B2|||Age||Years|Mean|67.9|67.9|Standard Deviation|7.9|7.9|||
3696185|NCT02203721|3537922|B1|||Age||Years|Mean|68.0|68.0|Standard Deviation|7.5|7.5|||
3696186|NCT02203721|3537920|B3||>=65 years|Age||Participants|Count of Participants|129|129.0||||||
3696187|NCT02203721|3537921|B2||>=65 years|Age||Participants|Count of Participants|66|66.0||||||
3696188|NCT02203721|3537922|B1||>=65 years|Age||Participants|Count of Participants|63|63.0||||||
3696189|NCT02203721|3537920|B3||Between 18 and 65 years|Age||Participants|Count of Participants|170|170.0||||||
3696190|NCT02203721|3537921|B2||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
3696191|NCT02203721|3537922|B1||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
3696192|NCT02203721|3537920|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3696193|NCT02203721|3537921|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3696194|NCT02203721|3537922|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3696195|NCT02203630|3537931|B3|||Mean Blood Pressure||mm/Hg|Mean|66.7|66.7|Full Range|||51.0|95.0|
3696196|NCT02203630|3537932|B2|||Mean Blood Pressure||mm/Hg|Mean|66.2|66.2|Full Range|||54.0|79.0|
3696197|NCT02203630|3537933|B1|||Mean Blood Pressure||mm/Hg|Mean|67.4|67.4|Full Range|||51.0|95.0|
3696198|NCT02203630|3537931|B3|||Heart Rate||beats/minute|Mean|92.4|92.4|Full Range|||60.0|132.0|
3696199|NCT02203630|3537932|B2|||Heart Rate||beats/minute|Mean|97.3|97.3|Full Range|||60.0|132.0|
3696200|NCT02203630|3537933|B1|||Heart Rate||beats/minute|Mean|86.3|86.3|Full Range|||60.0|119.0|
3696201|NCT02203630|3537931|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
3696202|NCT02203630|3537932|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3696203|NCT02203630|3537933|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3696204|NCT02203630|3537931|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696205|NCT02203630|3537932|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696206|NCT02203630|3537933|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696207|NCT02203630|3537931|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696208|NCT02203630|3537932|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696209|NCT02203630|3537933|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696210|NCT02203630|3537931|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3696211|NCT02203630|3537932|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3696212|NCT02203630|3537933|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3696213|NCT02203630|3537931|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3696214|NCT02203630|3537932|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3696215|NCT02203630|3537933|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696216|NCT02203630|3537931|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696217|NCT02203630|3537932|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696218|NCT02203630|3537933|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696219|NCT02203630|3537931|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696220|NCT02203630|3537932|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696221|NCT02203630|3537933|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696222|NCT02203630|3537931|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696223|NCT02203630|3537932|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696224|NCT02203630|3537933|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696225|NCT02203630|3537931|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3696226|NCT02203630|3537932|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3696227|NCT02203630|3537933|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3696228|NCT02203630|3537931|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3696229|NCT02203630|3537932|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3696230|NCT02203630|3537933|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3696231|NCT02203630|3537931|B3|||Age||years|Mean|60.4|60.4|Full Range|||47.0|84.0|
3696232|NCT02203630|3537932|B2|||Age||years|Mean|58.4|58.4|Full Range|||47.0|73.0|
3696233|NCT02203630|3537933|B1|||Age||years|Mean|63|63.0|Full Range|||47.0|84.0|
3696234|NCT02203578|3538004|B1|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3696235|NCT02203578|3538004|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3696236|NCT02203578|3538004|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3696237|NCT02203578|3538004|B1|||Age||years|Median|49|49.0|Full Range|||49.0|49.0|
3696238|NCT02203578|3538004|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3696239|NCT02203578|3538004|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3696240|NCT02203578|3538004|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3696241|NCT02203565|3538016|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3696242|NCT02203565|3538016|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3696243|NCT02203565|3538016|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3696244|NCT02203565|3538016|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3696245|NCT02203565|3538016|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3696246|NCT02203565|3538016|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3696247|NCT02203331|3538020|B7|||Percentage of Days With Pain >=4|Higher numbers are associated with more days of pain above the 4 on the 11-point (0-10) NRS.|percentage of days|Mean|86.6042|86.6042|Standard Deviation|17.6568|17.6568|||
3696248|NCT02203331|3538021|B6|||Percentage of Days With Pain >=4|Higher numbers are associated with more days of pain above the 4 on the 11-point (0-10) NRS.|percentage of days|Mean|80.4397|80.4397|Standard Deviation|20.1004|20.1004|||
3696249|NCT02203331|3538022|B5|||Percentage of Days With Pain >=4|Higher numbers are associated with more days of pain above the 4 on the 11-point (0-10) NRS.|percentage of days|Mean|92.9141|92.9141|Standard Deviation|11.6008|11.6008|||
3696250|NCT02203331|3538023|B4|||Percentage of Days With Pain >=4|Higher numbers are associated with more days of pain above the 4 on the 11-point (0-10) NRS.|percentage of days|Mean|85.8451|85.8451|Standard Deviation|17.9466|17.9466|||
3696251|NCT02203331|3538024|B3|||Percentage of Days With Pain >=4|Higher numbers are associated with more days of pain above the 4 on the 11-point (0-10) NRS.|percentage of days|Mean|89.029|89.029|Standard Deviation|16.3667|16.3667|||
3696252|NCT02203331|3538025|B2|||Percentage of Days With Pain >=4|Higher numbers are associated with more days of pain above the 4 on the 11-point (0-10) NRS.|percentage of days|Mean|84.7239|84.7239|Standard Deviation|18.1713|18.1713|||
3696253|NCT02203331|3538026|B1|||Percentage of Days With Pain >=4|Higher numbers are associated with more days of pain above the 4 on the 11-point (0-10) NRS.|percentage of days|Mean|86.0058|86.0058|Standard Deviation|19.3136|19.3136|||
3696254|NCT02203331|3538020|B7|||Percentage of Days With Pain Greater Than or Equal to (>=) 7|Higher numbers are associated with more days of pain above the 7 on the 11-point (0-10) NRS.|percentage of days|Mean|45.8234|45.8234|Standard Deviation|33.1247|33.1247|||
3696255|NCT02203331|3538021|B6|||Percentage of Days With Pain Greater Than or Equal to (>=) 7|Higher numbers are associated with more days of pain above the 7 on the 11-point (0-10) NRS.|percentage of days|Mean|41.1847|41.1847|Standard Deviation|33.0479|33.0479|||
3696256|NCT02203331|3538022|B5|||Percentage of Days With Pain Greater Than or Equal to (>=) 7|Higher numbers are associated with more days of pain above the 7 on the 11-point (0-10) NRS.|percentage of days|Mean|48.7001|48.7001|Standard Deviation|33.6685|33.6685|||
3696285|NCT02203331|3538023|B4||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3696257|NCT02203331|3538023|B4|||Percentage of Days With Pain Greater Than or Equal to (>=) 7|Higher numbers are associated with more days of pain above the 7 on the 11-point (0-10) NRS.|percentage of days|Mean|37.3044|37.3044|Standard Deviation|30.2894|30.2894|||
3696258|NCT02203331|3538024|B3|||Percentage of Days With Pain Greater Than or Equal to (>=) 7|Higher numbers are associated with more days of pain above the 7 on the 11-point (0-10) NRS.|percentage of days|Mean|55.1155|55.1155|Standard Deviation|33.7625|33.7625|||
3696259|NCT02203331|3538025|B2|||Percentage of Days With Pain Greater Than or Equal to (>=) 7|Higher numbers are associated with more days of pain above the 7 on the 11-point (0-10) NRS.|percentage of days|Mean|40.1521|40.1521|Standard Deviation|29.8714|29.8714|||
3696260|NCT02203331|3538026|B1|||Percentage of Days With Pain Greater Than or Equal to (>=) 7|Higher numbers are associated with more days of pain above the 7 on the 11-point (0-10) NRS.|percentage of days|Mean|50.094|50.094|Standard Deviation|35.5201|35.5201|||
3696261|NCT02203331|3538020|B7|||Mean Pain of the 7 Days With Worst Endometriosis Associated Pelvic Pain (EAPP)|Pain intensity was assessed on 11-point (0-10) NRS by question 1. In question 1, participants were asked to rate the pain in the target area during the past 24 hours, where 0= no pain and 10= worst imaginable pain and responses were recorded in ESD. The mean pain of the 7 days with worst EAPP within a 28-day window was calculated as the sum of ESD item 1 on 7 days with worst EAPP within that 28-day window divided by 7.|units on a scale|Mean|7.7842|7.7842|Standard Deviation|1.1702|1.1702|||
3696262|NCT02203331|3538021|B6|||Mean Pain of the 7 Days With Worst Endometriosis Associated Pelvic Pain (EAPP)|Pain intensity was assessed on 11-point (0-10) NRS by question 1. In question 1, participants were asked to rate the pain in the target area during the past 24 hours, where 0= no pain and 10= worst imaginable pain and responses were recorded in ESD. The mean pain of the 7 days with worst EAPP within a 28-day window was calculated as the sum of ESD item 1 on 7 days with worst EAPP within that 28-day window divided by 7.|units on a scale|Mean|7.6886|7.6886|Standard Deviation|1.2389|1.2389|||
3696263|NCT02203331|3538022|B5|||Mean Pain of the 7 Days With Worst Endometriosis Associated Pelvic Pain (EAPP)|Pain intensity was assessed on 11-point (0-10) NRS by question 1. In question 1, participants were asked to rate the pain in the target area during the past 24 hours, where 0= no pain and 10= worst imaginable pain and responses were recorded in ESD. The mean pain of the 7 days with worst EAPP within a 28-day window was calculated as the sum of ESD item 1 on 7 days with worst EAPP within that 28-day window divided by 7.|units on a scale|Mean|7.8964|7.8964|Standard Deviation|1.1952|1.1952|||
3696264|NCT02203331|3538023|B4|||Mean Pain of the 7 Days With Worst Endometriosis Associated Pelvic Pain (EAPP)|Pain intensity was assessed on 11-point (0-10) NRS by question 1. In question 1, participants were asked to rate the pain in the target area during the past 24 hours, where 0= no pain and 10= worst imaginable pain and responses were recorded in ESD. The mean pain of the 7 days with worst EAPP within a 28-day window was calculated as the sum of ESD item 1 on 7 days with worst EAPP within that 28-day window divided by 7.|units on a scale|Mean|7.5429|7.5429|Standard Deviation|1.2568|1.2568|||
3696265|NCT02203331|3538024|B3|||Mean Pain of the 7 Days With Worst Endometriosis Associated Pelvic Pain (EAPP)|Pain intensity was assessed on 11-point (0-10) NRS by question 1. In question 1, participants were asked to rate the pain in the target area during the past 24 hours, where 0= no pain and 10= worst imaginable pain and responses were recorded in ESD. The mean pain of the 7 days with worst EAPP within a 28-day window was calculated as the sum of ESD item 1 on 7 days with worst EAPP within that 28-day window divided by 7.|units on a scale|Mean|8.1905|8.1905|Standard Deviation|1.068|1.068|||
3696266|NCT02203331|3538025|B2|||Mean Pain of the 7 Days With Worst Endometriosis Associated Pelvic Pain (EAPP)|Pain intensity was assessed on 11-point (0-10) NRS by question 1. In question 1, participants were asked to rate the pain in the target area during the past 24 hours, where 0= no pain and 10= worst imaginable pain and responses were recorded in ESD. The mean pain of the 7 days with worst EAPP within a 28-day window was calculated as the sum of ESD item 1 on 7 days with worst EAPP within that 28-day window divided by 7.|units on a scale|Mean|7.4664|7.4664|Standard Deviation|0.9893|0.9893|||
3696267|NCT02203331|3538026|B1|||Mean Pain of the 7 Days With Worst Endometriosis Associated Pelvic Pain (EAPP)|Pain intensity was assessed on 11-point (0-10) NRS by question 1. In question 1, participants were asked to rate the pain in the target area during the past 24 hours, where 0= no pain and 10= worst imaginable pain and responses were recorded in ESD. The mean pain of the 7 days with worst EAPP within a 28-day window was calculated as the sum of ESD item 1 on 7 days with worst EAPP within that 28-day window divided by 7.|units on a scale|Mean|7.8205|7.8205|Standard Deviation|1.171|1.171|||
3696268|NCT02203331|3538020|B7|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|24.91|24.91|Standard Deviation|5.67|5.67|||
3696269|NCT02203331|3538021|B6|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|24.43|24.43|Standard Deviation|5.08|5.08|||
3696270|NCT02203331|3538022|B5|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|25.47|25.47|Standard Deviation|5.51|5.51|||
3696271|NCT02203331|3538023|B4|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|25.47|25.47|Standard Deviation|5.68|5.68|||
3696272|NCT02203331|3538024|B3|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|23.84|23.84|Standard Deviation|6.15|6.15|||
3696273|NCT02203331|3538025|B2|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|26.07|26.07|Standard Deviation|6.71|6.71|||
3696274|NCT02203331|3538026|B1|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|24.19|24.19|Standard Deviation|4.52|4.52|||
3696275|NCT02203331|3538020|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3696276|NCT02203331|3538021|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3696277|NCT02203331|3538022|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3696278|NCT02203331|3538023|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3696279|NCT02203331|3538024|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3696280|NCT02203331|3538025|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3696281|NCT02203331|3538026|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3696282|NCT02203331|3538020|B7||Female|Sex: Female, Male||Participants|Count of Participants|319|319.0||||||
3696283|NCT02203331|3538021|B6||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3696284|NCT02203331|3538022|B5||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3696286|NCT02203331|3538024|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3696287|NCT02203331|3538025|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3696288|NCT02203331|3538026|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3696289|NCT02203331|3538020|B7|||Age||years|Mean|33.75|33.75|Standard Deviation|7.23|7.23|||
3696290|NCT02203331|3538021|B6|||Age||years|Mean|34.89|34.89|Standard Deviation|7.13|7.13|||
3696291|NCT02203331|3538022|B5|||Age||years|Mean|33.7|33.7|Standard Deviation|6.29|6.29|||
3696292|NCT02203331|3538023|B4|||Age||years|Mean|33.72|33.72|Standard Deviation|7.85|7.85|||
3696293|NCT02203331|3538024|B3|||Age||years|Mean|33.96|33.96|Standard Deviation|5.73|5.73|||
3696294|NCT02203331|3538025|B2|||Age||years|Mean|32.96|32.96|Standard Deviation|8.79|8.79|||
3696295|NCT02203331|3538026|B1|||Age||years|Mean|33.27|33.27|Standard Deviation|7.4|7.4|||
3696296|NCT02203162|3538081|B1|||cough reflex sensitivity||log C5|Mean|0.5|0.5|Standard Deviation|0.09|0.09|||
3696297|NCT02203162|3538081|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3696298|NCT02203162|3538081|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3696299|NCT02203162|3538081|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3696300|NCT02203162|3538081|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3696301|NCT02203162|3538081|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3696302|NCT02203162|3538081|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3696303|NCT02203149|3538085|B6||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3696304|NCT02203149|3538086|B5||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3696305|NCT02203149|3538087|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3696306|NCT02203149|3538088|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3696307|NCT02203149|3538089|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3696308|NCT02203149|3538090|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3696309|NCT02203149|3538085|B6||Female|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
3696310|NCT02203149|3538086|B5||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3696311|NCT02203149|3538087|B4||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3696312|NCT02203149|3538088|B3||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3696313|NCT02203149|3538089|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3696314|NCT02203149|3538090|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3696315|NCT02203149|3538085|B6|||Age||years|Mean|61.1|61.1|Standard Deviation|11.7|11.7|||
3696316|NCT02203149|3538086|B5|||Age||years|Mean|64.8|64.8|Standard Deviation|9.2|9.2|||
3696317|NCT02203149|3538087|B4|||Age||years|Mean|60.9|60.9|Standard Deviation|10.8|10.8|||
3696318|NCT02203149|3538088|B3|||Age||years|Mean|61.1|61.1|Standard Deviation|12.5|12.5|||
3696319|NCT02203149|3538089|B2|||Age||years|Mean|58.0|58.0|Standard Deviation|12.5|12.5|||
3696320|NCT02203149|3538090|B1|||Age||years|Mean|61.1|61.1|Standard Deviation|9.7|9.7|||
3696321|NCT02203032|3538127|B1|Taiwan, Province Of China||Region of Enrollment||participants|Number|55|55.0||||||
3696322|NCT02203032|3538127|B1|Korea, Republic Of||Region of Enrollment||participants|Number|29|29.0||||||
3696323|NCT02203032|3538127|B1|Australia||Region of Enrollment||participants|Number|19|19.0||||||
3696324|NCT02203032|3538127|B1|United States||Region of Enrollment||participants|Number|194|194.0||||||
3696325|NCT02203032|3538127|B1|Canada||Region of Enrollment||participants|Number|61|61.0||||||
3696326|NCT02203032|3538127|B1|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
3696327|NCT02203032|3538127|B1|Spain||Region of Enrollment||participants|Number|24|24.0||||||
3696328|NCT02203032|3538127|B1|Russia||Region of Enrollment||participants|Number|88|88.0||||||
3696329|NCT02203032|3538127|B1|Poland||Region of Enrollment||participants|Number|294|294.0||||||
3696330|NCT02203032|3538127|B1|Germany||Region of Enrollment||participants|Number|96|96.0||||||
3696331|NCT02203032|3538127|B1||Male|Sex: Female, Male||Participants|Count of Participants|566|566.0||||||
3696332|NCT02203032|3538127|B1||Female|Sex: Female, Male||Participants|Count of Participants|305|305.0||||||
3696333|NCT02203032|3538127|B1|||Age||years|Mean|43.1|43.1|Standard Deviation|13.21|13.21|||
3696334|NCT02203032|3538127|B1||>=65 years|Age||Participants|Count of Participants|53|53.0||||||
3696335|NCT02203032|3538127|B1||Between 18 and 65 years|Age||Participants|Count of Participants|814|814.0||||||
3696336|NCT02203032|3538127|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3696337|NCT02202980|3538144|B15|Treatment-Experienced||Prior HCV Treatment||Participants|Count of Participants|149|149.0||||||
3696338|NCT02202980|3538145|B14|Treatment-Experienced||Prior HCV Treatment||Participants|Count of Participants|4|4.0||||||
3696339|NCT02202980|3538146|B13|Treatment-Experienced||Prior HCV Treatment||Participants|Count of Participants|30|30.0||||||
3696340|NCT02202980|3538147|B12|Treatment-Experienced||Prior HCV Treatment||Participants|Count of Participants|28|28.0||||||
3696341|NCT02202980|3538148|B11|Treatment-Experienced||Prior HCV Treatment||Participants|Count of Participants|19|19.0||||||
3696342|NCT02202980|3538149|B10|Treatment-Experienced||Prior HCV Treatment||Participants|Count of Participants|17|17.0||||||
3696343|NCT02202980|3538150|B9|Treatment-Experienced||Prior HCV Treatment||Participants|Count of Participants|0|0.0||||||
3696344|NCT02202980|3538151|B8|Treatment-Experienced||Prior HCV Treatment||Participants|Count of Participants|0|0.0||||||
3696345|NCT02202980|3538152|B7|Treatment-Experienced||Prior HCV Treatment||Participants|Count of Participants|0|0.0||||||
3696346|NCT02202980|3538153|B6|Treatment-Experienced||Prior HCV Treatment||Participants|Count of Participants|0|0.0||||||
3696347|NCT02202980|3538154|B5|Treatment-Experienced||Prior HCV Treatment||Participants|Count of Participants|10|10.0||||||
3696348|NCT02202980|3538155|B4|Treatment-Experienced||Prior HCV Treatment||Participants|Count of Participants|15|15.0||||||
3696349|NCT02202980|3538156|B3|Treatment-Experienced||Prior HCV Treatment||Participants|Count of Participants|7|7.0||||||
3696350|NCT02202980|3538157|B2|Treatment-Experienced||Prior HCV Treatment||Participants|Count of Participants|5|5.0||||||
3696351|NCT02202980|3538158|B1|Treatment-Experienced||Prior HCV Treatment||Participants|Count of Participants|14|14.0||||||
3696352|NCT02202980|3538144|B15|Treatment-Naive||Prior HCV Treatment||Participants|Count of Participants|124|124.0||||||
3696353|NCT02202980|3538145|B14|Treatment-Naive||Prior HCV Treatment||Participants|Count of Participants|0|0.0||||||
3696354|NCT02202980|3538146|B13|Treatment-Naive||Prior HCV Treatment||Participants|Count of Participants|0|0.0||||||
3696355|NCT02202980|3538147|B12|Treatment-Naive||Prior HCV Treatment||Participants|Count of Participants|0|0.0||||||
3696356|NCT02202980|3538148|B11|Treatment-Naive||Prior HCV Treatment||Participants|Count of Participants|0|0.0||||||
3696357|NCT02202980|3538149|B10|Treatment-Naive||Prior HCV Treatment||Participants|Count of Participants|0|0.0||||||
3696358|NCT02202980|3538150|B9|Treatment-Naive||Prior HCV Treatment||Participants|Count of Participants|18|18.0||||||
3696359|NCT02202980|3538151|B8|Treatment-Naive||Prior HCV Treatment||Participants|Count of Participants|15|15.0||||||
3696360|NCT02202980|3538152|B7|Treatment-Naive||Prior HCV Treatment||Participants|Count of Participants|15|15.0||||||
3696361|NCT02202980|3538153|B6|Treatment-Naive||Prior HCV Treatment||Participants|Count of Participants|15|15.0||||||
3696362|NCT02202980|3538154|B5|Treatment-Naive||Prior HCV Treatment||Participants|Count of Participants|3|3.0||||||
3696363|NCT02202980|3538155|B4|Treatment-Naive||Prior HCV Treatment||Participants|Count of Participants|17|17.0||||||
3696364|NCT02202980|3538156|B3|Treatment-Naive||Prior HCV Treatment||Participants|Count of Participants|20|20.0||||||
3696365|NCT02202980|3538157|B2|Treatment-Naive||Prior HCV Treatment||Participants|Count of Participants|21|21.0||||||
3696366|NCT02202980|3538158|B1|Treatment-Naive||Prior HCV Treatment||Participants|Count of Participants|0|0.0||||||
3696367|NCT02202980|3538144|B15|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|205|205.0||||||
3696368|NCT02202980|3538145|B14|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|4|4.0||||||
3696369|NCT02202980|3538146|B13|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|25|25.0||||||
3696370|NCT02202980|3538147|B12|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|18|18.0||||||
3696371|NCT02202980|3538148|B11|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|16|16.0||||||
3696372|NCT02202980|3538149|B10|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|14|14.0||||||
3696373|NCT02202980|3538150|B9|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|13|13.0||||||
3696374|NCT02202980|3538151|B8|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|11|11.0||||||
3696375|NCT02202980|3538152|B7|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|11|11.0||||||
3696376|NCT02202980|3538153|B6|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|10|10.0||||||
3696377|NCT02202980|3538154|B5|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|9|9.0||||||
3696378|NCT02202980|3538155|B4|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|24|24.0||||||
3696379|NCT02202980|3538156|B3|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|22|22.0||||||
3696380|NCT02202980|3538157|B2|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|15|15.0||||||
3696381|NCT02202980|3538158|B1|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|13|13.0||||||
3696382|NCT02202980|3538144|B15|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|68|68.0||||||
3696383|NCT02202980|3538145|B14|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|0|0.0||||||
3696384|NCT02202980|3538146|B13|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|5|5.0||||||
3696385|NCT02202980|3538147|B12|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|10|10.0||||||
3696386|NCT02202980|3538148|B11|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|3|3.0||||||
3696387|NCT02202980|3538149|B10|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|3|3.0||||||
3696388|NCT02202980|3538150|B9|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|5|5.0||||||
3696389|NCT02202980|3538151|B8|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|4|4.0||||||
3696390|NCT02202980|3538152|B7|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|4|4.0||||||
3696391|NCT02202980|3538153|B6|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|5|5.0||||||
3696392|NCT02202980|3538154|B5|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|4|4.0||||||
3696393|NCT02202980|3538155|B4|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|8|8.0||||||
3696394|NCT02202980|3538156|B3|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|5|5.0||||||
3696395|NCT02202980|3538157|B2|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|11|11.0||||||
3696396|NCT02202980|3538158|B1|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|1|1.0||||||
3696397|NCT02202980|3538144|B15|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|31|31.0||||||
3696398|NCT02202980|3538145|B14|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|0|0.0||||||
3696399|NCT02202980|3538146|B13|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|6|6.0||||||
3696400|NCT02202980|3538147|B12|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|3|3.0||||||
3696401|NCT02202980|3538148|B11|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|2|2.0||||||
3696402|NCT02202980|3538149|B10|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|2|2.0||||||
3696403|NCT02202980|3538150|B9|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|2|2.0||||||
3696404|NCT02202980|3538151|B8|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|0|0.0||||||
3696405|NCT02202980|3538152|B7|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|0|0.0||||||
3696406|NCT02202980|3538153|B6|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|2|2.0||||||
3696407|NCT02202980|3538154|B5|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|3|3.0||||||
3696408|NCT02202980|3538155|B4|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|7|7.0||||||
3696409|NCT02202980|3538156|B3|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|3|3.0||||||
3696410|NCT02202980|3538157|B2|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|1|1.0||||||
3696411|NCT02202980|3538158|B1|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|0|0.0||||||
3696412|NCT02202980|3538144|B15|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|145|145.0||||||
3696413|NCT02202980|3538145|B14|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|1|1.0||||||
3696414|NCT02202980|3538146|B13|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|18|18.0||||||
3696415|NCT02202980|3538147|B12|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|21|21.0||||||
3696416|NCT02202980|3538148|B11|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|9|9.0||||||
3696417|NCT02202980|3538149|B10|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|9|9.0||||||
3696418|NCT02202980|3538150|B9|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|6|6.0||||||
3696419|NCT02202980|3538151|B8|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|7|7.0||||||
3696420|NCT02202980|3538152|B7|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|10|10.0||||||
3696421|NCT02202980|3538153|B6|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|8|8.0||||||
3696422|NCT02202980|3538154|B5|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|6|6.0||||||
3696423|NCT02202980|3538155|B4|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|18|18.0||||||
3696424|NCT02202980|3538156|B3|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|10|10.0||||||
3696425|NCT02202980|3538157|B2|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|15|15.0||||||
3696426|NCT02202980|3538158|B1|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|7|7.0||||||
3696427|NCT02202980|3538144|B15|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|96|96.0||||||
3696428|NCT02202980|3538145|B14|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|3|3.0||||||
3696429|NCT02202980|3538146|B13|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|6|6.0||||||
3696430|NCT02202980|3538147|B12|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|4|4.0||||||
3696431|NCT02202980|3538148|B11|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|8|8.0||||||
3696432|NCT02202980|3538149|B10|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|6|6.0||||||
3696433|NCT02202980|3538150|B9|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|10|10.0||||||
3696434|NCT02202980|3538151|B8|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|8|8.0||||||
3696435|NCT02202980|3538152|B7|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|5|5.0||||||
3696436|NCT02202980|3538153|B6|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|5|5.0||||||
3696437|NCT02202980|3538154|B5|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|4|4.0||||||
3696438|NCT02202980|3538155|B4|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|6|6.0||||||
3696439|NCT02202980|3538156|B3|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|14|14.0||||||
3696440|NCT02202980|3538157|B2|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|10|10.0||||||
3696441|NCT02202980|3538158|B1|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|7|7.0||||||
3696442|NCT02202980|3538144|B15|No||Cirrhosis Status||Participants|Count of Participants|161|161.0||||||
3696443|NCT02202980|3538145|B14|No||Cirrhosis Status||Participants|Count of Participants|2|2.0||||||
3696444|NCT02202980|3538146|B13|No||Cirrhosis Status||Participants|Count of Participants|25|25.0||||||
3696445|NCT02202980|3538147|B12|No||Cirrhosis Status||Participants|Count of Participants|17|17.0||||||
3696446|NCT02202980|3538148|B11|No||Cirrhosis Status||Participants|Count of Participants|0|0.0||||||
3696447|NCT02202980|3538149|B10|No||Cirrhosis Status||Participants|Count of Participants|0|0.0||||||
3696448|NCT02202980|3538150|B9|No||Cirrhosis Status||Participants|Count of Participants|0|0.0||||||
3696449|NCT02202980|3538151|B8|No||Cirrhosis Status||Participants|Count of Participants|0|0.0||||||
3696450|NCT02202980|3538152|B7|No||Cirrhosis Status||Participants|Count of Participants|15|15.0||||||
3696451|NCT02202980|3538153|B6|No||Cirrhosis Status||Participants|Count of Participants|15|15.0||||||
3696452|NCT02202980|3538154|B5|No||Cirrhosis Status||Participants|Count of Participants|3|3.0||||||
3696453|NCT02202980|3538155|B4|No||Cirrhosis Status||Participants|Count of Participants|23|23.0||||||
3696454|NCT02202980|3538156|B3|No||Cirrhosis Status||Participants|Count of Participants|27|27.0||||||
3696455|NCT02202980|3538157|B2|No||Cirrhosis Status||Participants|Count of Participants|24|24.0||||||
3696456|NCT02202980|3538158|B1|No||Cirrhosis Status||Participants|Count of Participants|10|10.0||||||
3696457|NCT02202980|3538144|B15|Yes||Cirrhosis Status||Participants|Count of Participants|112|112.0||||||
3696458|NCT02202980|3538145|B14|Yes||Cirrhosis Status||Participants|Count of Participants|2|2.0||||||
3696459|NCT02202980|3538146|B13|Yes||Cirrhosis Status||Participants|Count of Participants|5|5.0||||||
3696460|NCT02202980|3538147|B12|Yes||Cirrhosis Status||Participants|Count of Participants|11|11.0||||||
3696461|NCT02202980|3538148|B11|Yes||Cirrhosis Status||Participants|Count of Participants|19|19.0||||||
3696462|NCT02202980|3538149|B10|Yes||Cirrhosis Status||Participants|Count of Participants|17|17.0||||||
3696463|NCT02202980|3538150|B9|Yes||Cirrhosis Status||Participants|Count of Participants|18|18.0||||||
3696464|NCT02202980|3538151|B8|Yes||Cirrhosis Status||Participants|Count of Participants|15|15.0||||||
3696465|NCT02202980|3538152|B7|Yes||Cirrhosis Status||Participants|Count of Participants|0|0.0||||||
3696466|NCT02202980|3538153|B6|Yes||Cirrhosis Status||Participants|Count of Participants|0|0.0||||||
3696467|NCT02202980|3538154|B5|Yes||Cirrhosis Status||Participants|Count of Participants|10|10.0||||||
3696468|NCT02202980|3538155|B4|Yes||Cirrhosis Status||Participants|Count of Participants|9|9.0||||||
3696469|NCT02202980|3538156|B3|Yes||Cirrhosis Status||Participants|Count of Participants|0|0.0||||||
3696470|NCT02202980|3538157|B2|Yes||Cirrhosis Status||Participants|Count of Participants|2|2.0||||||
3696471|NCT02202980|3538158|B1|Yes||Cirrhosis Status||Participants|Count of Participants|4|4.0||||||
3696472|NCT02202980|3538144|B15|Indeterminate||HCV genotype||Participants|Count of Participants|2|2.0||||||
3696473|NCT02202980|3538145|B14|Indeterminate||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696474|NCT02202980|3538146|B13|Indeterminate||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696475|NCT02202980|3538147|B12|Indeterminate||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696476|NCT02202980|3538148|B11|Indeterminate||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696477|NCT02202980|3538149|B10|Indeterminate||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696478|NCT02202980|3538150|B9|Indeterminate||HCV genotype||Participants|Count of Participants|1|1.0||||||
3696479|NCT02202980|3538151|B8|Indeterminate||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696480|NCT02202980|3538152|B7|Indeterminate||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696481|NCT02202980|3538153|B6|Indeterminate||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696482|NCT02202980|3538154|B5|Indeterminate||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696483|NCT02202980|3538155|B4|Indeterminate||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696484|NCT02202980|3538156|B3|Indeterminate||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696485|NCT02202980|3538157|B2|Indeterminate||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696486|NCT02202980|3538158|B1|Indeterminate||HCV genotype||Participants|Count of Participants|1|1.0||||||
3696487|NCT02202980|3538144|B15|Genotype 4||HCV genotype||Participants|Count of Participants|1|1.0||||||
3696488|NCT02202980|3538145|B14|Genotype 4||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696489|NCT02202980|3538146|B13|Genotype 4||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696490|NCT02202980|3538147|B12|Genotype 4||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696491|NCT02202980|3538148|B11|Genotype 4||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696492|NCT02202980|3538149|B10|Genotype 4||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696493|NCT02202980|3538150|B9|Genotype 4||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696494|NCT02202980|3538151|B8|Genotype 4||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696495|NCT02202980|3538152|B7|Genotype 4||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696496|NCT02202980|3538153|B6|Genotype 4||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696497|NCT02202980|3538154|B5|Genotype 4||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696498|NCT02202980|3538155|B4|Genotype 4||HCV genotype||Participants|Count of Participants|1|1.0||||||
3696499|NCT02202980|3538156|B3|Genotype 4||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696500|NCT02202980|3538157|B2|Genotype 4||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696501|NCT02202980|3538158|B1|Genotype 4||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696502|NCT02202980|3538144|B15|Genotype 3a||HCV genotype||Participants|Count of Participants|4|4.0||||||
3696503|NCT02202980|3538145|B14|Genotype 3a||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696504|NCT02202980|3538146|B13|Genotype 3a||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696505|NCT02202980|3538147|B12|Genotype 3a||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696506|NCT02202980|3538148|B11|Genotype 3a||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696507|NCT02202980|3538149|B10|Genotype 3a||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696508|NCT02202980|3538150|B9|Genotype 3a||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696509|NCT02202980|3538151|B8|Genotype 3a||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696510|NCT02202980|3538152|B7|Genotype 3a||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696511|NCT02202980|3538153|B6|Genotype 3a||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696512|NCT02202980|3538154|B5|Genotype 3a||HCV genotype||Participants|Count of Participants|1|1.0||||||
3696513|NCT02202980|3538155|B4|Genotype 3a||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696514|NCT02202980|3538156|B3|Genotype 3a||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696515|NCT02202980|3538157|B2|Genotype 3a||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696516|NCT02202980|3538158|B1|Genotype 3a||HCV genotype||Participants|Count of Participants|3|3.0||||||
3696517|NCT02202980|3538144|B15|Genotype 3||HCV genotype||Participants|Count of Participants|54|54.0||||||
3696518|NCT02202980|3538145|B14|Genotype 3||HCV genotype||Participants|Count of Participants|4|4.0||||||
3696519|NCT02202980|3538146|B13|Genotype 3||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696520|NCT02202980|3538147|B12|Genotype 3||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696521|NCT02202980|3538148|B11|Genotype 3||HCV genotype||Participants|Count of Participants|19|19.0||||||
3696522|NCT02202980|3538149|B10|Genotype 3||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696523|NCT02202980|3538150|B9|Genotype 3||HCV genotype||Participants|Count of Participants|17|17.0||||||
3696524|NCT02202980|3538151|B8|Genotype 3||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696525|NCT02202980|3538152|B7|Genotype 3||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696526|NCT02202980|3538153|B6|Genotype 3||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696527|NCT02202980|3538154|B5|Genotype 3||HCV genotype||Participants|Count of Participants|12|12.0||||||
3696528|NCT02202980|3538155|B4|Genotype 3||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696529|NCT02202980|3538156|B3|Genotype 3||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696530|NCT02202980|3538157|B2|Genotype 3||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696531|NCT02202980|3538158|B1|Genotype 3||HCV genotype||Participants|Count of Participants|2|2.0||||||
3696532|NCT02202980|3538144|B15|Genotype 2b||HCV genotype||Participants|Count of Participants|16|16.0||||||
3696533|NCT02202980|3538145|B14|Genotype 2b||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696534|NCT02202980|3538146|B13|Genotype 2b||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696535|NCT02202980|3538147|B12|Genotype 2b||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696536|NCT02202980|3538148|B11|Genotype 2b||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696537|NCT02202980|3538149|B10|Genotype 2b||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696538|NCT02202980|3538150|B9|Genotype 2b||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696539|NCT02202980|3538151|B8|Genotype 2b||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696540|NCT02202980|3538152|B7|Genotype 2b||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696541|NCT02202980|3538153|B6|Genotype 2b||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696542|NCT02202980|3538154|B5|Genotype 2b||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696543|NCT02202980|3538155|B4|Genotype 2b||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696544|NCT02202980|3538156|B3|Genotype 2b||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696545|NCT02202980|3538157|B2|Genotype 2b||HCV genotype||Participants|Count of Participants|16|16.0||||||
3696546|NCT02202980|3538158|B1|Genotype 2b||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696547|NCT02202980|3538144|B15|Genotype 2a or 2c||HCV genotype||Participants|Count of Participants|8|8.0||||||
3696548|NCT02202980|3538145|B14|Genotype 2a or 2c||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696549|NCT02202980|3538146|B13|Genotype 2a or 2c||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696550|NCT02202980|3538147|B12|Genotype 2a or 2c||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696551|NCT02202980|3538148|B11|Genotype 2a or 2c||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696552|NCT02202980|3538149|B10|Genotype 2a or 2c||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696553|NCT02202980|3538150|B9|Genotype 2a or 2c||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696554|NCT02202980|3538151|B8|Genotype 2a or 2c||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696555|NCT02202980|3538152|B7|Genotype 2a or 2c||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696556|NCT02202980|3538153|B6|Genotype 2a or 2c||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696557|NCT02202980|3538154|B5|Genotype 2a or 2c||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696558|NCT02202980|3538155|B4|Genotype 2a or 2c||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696559|NCT02202980|3538156|B3|Genotype 2a or 2c||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696560|NCT02202980|3538157|B2|Genotype 2a or 2c||HCV genotype||Participants|Count of Participants|8|8.0||||||
3696561|NCT02202980|3538158|B1|Genotype 2a or 2c||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696562|NCT02202980|3538144|B15|Genotype 2||HCV genotype||Participants|Count of Participants|36|36.0||||||
3696563|NCT02202980|3538145|B14|Genotype 2||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696564|NCT02202980|3538146|B13|Genotype 2||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696565|NCT02202980|3538147|B12|Genotype 2||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696566|NCT02202980|3538148|B11|Genotype 2||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696567|NCT02202980|3538149|B10|Genotype 2||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696568|NCT02202980|3538150|B9|Genotype 2||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696569|NCT02202980|3538151|B8|Genotype 2||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696570|NCT02202980|3538152|B7|Genotype 2||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696571|NCT02202980|3538153|B6|Genotype 2||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696572|NCT02202980|3538154|B5|Genotype 2||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696573|NCT02202980|3538155|B4|Genotype 2||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696574|NCT02202980|3538156|B3|Genotype 2||HCV genotype||Participants|Count of Participants|27|27.0||||||
3696575|NCT02202980|3538157|B2|Genotype 2||HCV genotype||Participants|Count of Participants|2|2.0||||||
3696576|NCT02202980|3538158|B1|Genotype 2||HCV genotype||Participants|Count of Participants|7|7.0||||||
3696577|NCT02202980|3538144|B15|Genotype 1b||HCV genotype||Participants|Count of Participants|25|25.0||||||
3696578|NCT02202980|3538145|B14|Genotype 1b||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696579|NCT02202980|3538146|B13|Genotype 1b||HCV genotype||Participants|Count of Participants|7|7.0||||||
3696580|NCT02202980|3538147|B12|Genotype 1b||HCV genotype||Participants|Count of Participants|4|4.0||||||
3696581|NCT02202980|3538148|B11|Genotype 1b||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696582|NCT02202980|3538149|B10|Genotype 1b||HCV genotype||Participants|Count of Participants|2|2.0||||||
3696583|NCT02202980|3538150|B9|Genotype 1b||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696584|NCT02202980|3538151|B8|Genotype 1b||HCV genotype||Participants|Count of Participants|1|1.0||||||
3696585|NCT02202980|3538152|B7|Genotype 1b||HCV genotype||Participants|Count of Participants|4|4.0||||||
3696586|NCT02202980|3538153|B6|Genotype 1b||HCV genotype||Participants|Count of Participants|4|4.0||||||
3696587|NCT02202980|3538154|B5|Genotype 1b||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696588|NCT02202980|3538155|B4|Genotype 1b||HCV genotype||Participants|Count of Participants|3|3.0||||||
3696589|NCT02202980|3538156|B3|Genotype 1b||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696590|NCT02202980|3538157|B2|Genotype 1b||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696591|NCT02202980|3538158|B1|Genotype 1b||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696592|NCT02202980|3538144|B15|Genotype 1a||HCV genotype||Participants|Count of Participants|127|127.0||||||
3696593|NCT02202980|3538145|B14|Genotype 1a||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696594|NCT02202980|3538146|B13|Genotype 1a||HCV genotype||Participants|Count of Participants|23|23.0||||||
3696595|NCT02202980|3538147|B12|Genotype 1a||HCV genotype||Participants|Count of Participants|24|24.0||||||
3696596|NCT02202980|3538148|B11|Genotype 1a||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696597|NCT02202980|3538149|B10|Genotype 1a||HCV genotype||Participants|Count of Participants|15|15.0||||||
3696598|NCT02202980|3538150|B9|Genotype 1a||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696599|NCT02202980|3538151|B8|Genotype 1a||HCV genotype||Participants|Count of Participants|14|14.0||||||
3696600|NCT02202980|3538152|B7|Genotype 1a||HCV genotype||Participants|Count of Participants|11|11.0||||||
3696601|NCT02202980|3538153|B6|Genotype 1a||HCV genotype||Participants|Count of Participants|11|11.0||||||
3696602|NCT02202980|3538154|B5|Genotype 1a||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696603|NCT02202980|3538155|B4|Genotype 1a||HCV genotype||Participants|Count of Participants|28|28.0||||||
3696604|NCT02202980|3538156|B3|Genotype 1a||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696605|NCT02202980|3538157|B2|Genotype 1a||HCV genotype||Participants|Count of Participants|0|0.0||||||
3696606|NCT02202980|3538158|B1|Genotype 1a||HCV genotype||Participants|Count of Participants|1|1.0||||||
3696607|NCT02202980|3538144|B15|Other||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3696608|NCT02202980|3538145|B14|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3696609|NCT02202980|3538146|B13|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3696610|NCT02202980|3538147|B12|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3696611|NCT02202980|3538148|B11|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3696612|NCT02202980|3538149|B10|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3696613|NCT02202980|3538150|B9|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3696614|NCT02202980|3538151|B8|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3696615|NCT02202980|3538152|B7|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3696616|NCT02202980|3538153|B6|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3696617|NCT02202980|3538154|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3696618|NCT02202980|3538155|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3696619|NCT02202980|3538156|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3696620|NCT02202980|3538157|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3696621|NCT02202980|3538158|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3696622|NCT02202980|3538144|B15|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3696623|NCT02202980|3538145|B14|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3696624|NCT02202980|3538146|B13|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3696625|NCT02202980|3538147|B12|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3696626|NCT02202980|3538148|B11|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3696627|NCT02202980|3538149|B10|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3696628|NCT02202980|3538150|B9|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3696629|NCT02202980|3538151|B8|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3696630|NCT02202980|3538152|B7|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3696631|NCT02202980|3538153|B6|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3696632|NCT02202980|3538154|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3696633|NCT02202980|3538155|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3696634|NCT02202980|3538156|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3696635|NCT02202980|3538157|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3696636|NCT02202980|3538158|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3696637|NCT02202980|3538144|B15|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3696638|NCT02202980|3538145|B14|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3696639|NCT02202980|3538146|B13|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3696640|NCT02202980|3538147|B12|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3696641|NCT02202980|3538148|B11|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3696642|NCT02202980|3538149|B10|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3696643|NCT02202980|3538150|B9|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3696644|NCT02202980|3538151|B8|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3696645|NCT02202980|3538152|B7|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3696646|NCT02202980|3538153|B6|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3696647|NCT02202980|3538154|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3696648|NCT02202980|3538155|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3696649|NCT02202980|3538156|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3696650|NCT02202980|3538157|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3696651|NCT02202980|3538158|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3696652|NCT02202980|3538144|B15|White||Race/Ethnicity, Customized||Participants|Count of Participants|233|233.0||||||
3696653|NCT02202980|3538145|B14|White||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3696654|NCT02202980|3538146|B13|White||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3696655|NCT02202980|3538147|B12|White||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3696656|NCT02202980|3538148|B11|White||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3696657|NCT02202980|3538149|B10|White||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3696658|NCT02202980|3538150|B9|White||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3696659|NCT02202980|3538151|B8|White||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3696660|NCT02202980|3538152|B7|White||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3696661|NCT02202980|3538153|B6|White||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3696662|NCT02202980|3538154|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3696663|NCT02202980|3538155|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3696664|NCT02202980|3538156|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3696665|NCT02202980|3538157|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3696666|NCT02202980|3538158|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3696667|NCT02202980|3538144|B15||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696668|NCT02202980|3538145|B14||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696669|NCT02202980|3538146|B13||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696670|NCT02202980|3538147|B12||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696671|NCT02202980|3538148|B11||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696672|NCT02202980|3538149|B10||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696673|NCT02202980|3538150|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696674|NCT02202980|3538151|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696675|NCT02202980|3538152|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696676|NCT02202980|3538153|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696677|NCT02202980|3538154|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696678|NCT02202980|3538155|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696679|NCT02202980|3538156|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696680|NCT02202980|3538157|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696681|NCT02202980|3538158|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696682|NCT02202980|3538144|B15||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|272|272.0||||||
3696683|NCT02202980|3538145|B14||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3696684|NCT02202980|3538146|B13||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3696685|NCT02202980|3538147|B12||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3696686|NCT02202980|3538148|B11||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3696687|NCT02202980|3538149|B10||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3696688|NCT02202980|3538150|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3696689|NCT02202980|3538151|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3696690|NCT02202980|3538152|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3696691|NCT02202980|3538153|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3696692|NCT02202980|3538154|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3696693|NCT02202980|3538155|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3696694|NCT02202980|3538156|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3696695|NCT02202980|3538157|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3696696|NCT02202980|3538158|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3696697|NCT02202980|3538144|B15||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3696698|NCT02202980|3538145|B14||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696699|NCT02202980|3538146|B13||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696700|NCT02202980|3538147|B12||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696701|NCT02202980|3538148|B11||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696702|NCT02202980|3538149|B10||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696703|NCT02202980|3538150|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696704|NCT02202980|3538151|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696705|NCT02202980|3538152|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3696706|NCT02202980|3538153|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696707|NCT02202980|3538154|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696708|NCT02202980|3538155|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696709|NCT02202980|3538156|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696710|NCT02202980|3538157|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696711|NCT02202980|3538158|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696712|NCT02202980|3538144|B15||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
3696713|NCT02202980|3538145|B14||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3696714|NCT02202980|3538146|B13||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3696715|NCT02202980|3538147|B12||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3696716|NCT02202980|3538148|B11||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3696717|NCT02202980|3538149|B10||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3696718|NCT02202980|3538150|B9||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3696719|NCT02202980|3538151|B8||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3696720|NCT02202980|3538152|B7||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3696721|NCT02202980|3538153|B6||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3696722|NCT02202980|3538154|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3696723|NCT02202980|3538155|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3696724|NCT02202980|3538156|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3696725|NCT02202980|3538157|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3696726|NCT02202980|3538158|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3696727|NCT02202980|3538144|B15||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3696728|NCT02202980|3538145|B14||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3696729|NCT02202980|3538146|B13||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3696730|NCT02202980|3538147|B12||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3696731|NCT02202980|3538148|B11||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3696732|NCT02202980|3538149|B10||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3696733|NCT02202980|3538150|B9||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3696734|NCT02202980|3538151|B8||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3696735|NCT02202980|3538152|B7||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3696736|NCT02202980|3538153|B6||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3696737|NCT02202980|3538154|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3696738|NCT02202980|3538155|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3696739|NCT02202980|3538156|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3696740|NCT02202980|3538157|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3696741|NCT02202980|3538158|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3696742|NCT02202980|3538144|B15||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3696743|NCT02202980|3538145|B14||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3696744|NCT02202980|3538146|B13||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3696745|NCT02202980|3538147|B12||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3696746|NCT02202980|3538148|B11||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3696747|NCT02202980|3538149|B10||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3696748|NCT02202980|3538150|B9||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3696749|NCT02202980|3538151|B8||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3696750|NCT02202980|3538152|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3696751|NCT02202980|3538153|B6||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3696752|NCT02202980|3538154|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3696753|NCT02202980|3538155|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3696754|NCT02202980|3538156|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3696755|NCT02202980|3538157|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3696756|NCT02202980|3538158|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3696757|NCT02202980|3538144|B15||Between 18 and 65 years|Age||Participants|Count of Participants|257|257.0||||||
3696758|NCT02202980|3538145|B14||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3696759|NCT02202980|3538146|B13||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3696760|NCT02202980|3538147|B12||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3696761|NCT02202980|3538148|B11||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3696762|NCT02202980|3538149|B10||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3696763|NCT02202980|3538150|B9||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3696764|NCT02202980|3538151|B8||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3696765|NCT02202980|3538152|B7||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3696766|NCT02202980|3538153|B6||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3696767|NCT02202980|3538154|B5||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3696768|NCT02202980|3538155|B4||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3696769|NCT02202980|3538156|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3696770|NCT02202980|3538157|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3696771|NCT02202980|3538158|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3696772|NCT02202980|3538144|B15||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3696773|NCT02202980|3538145|B14||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3696774|NCT02202980|3538146|B13||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3696775|NCT02202980|3538147|B12||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3696776|NCT02202980|3538148|B11||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3696777|NCT02202980|3538149|B10||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3696778|NCT02202980|3538150|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3696779|NCT02202980|3538151|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3696780|NCT02202980|3538152|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3696781|NCT02202980|3538153|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3696782|NCT02202980|3538154|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3696783|NCT02202980|3538155|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3696784|NCT02202980|3538156|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3696785|NCT02202980|3538157|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3696786|NCT02202980|3538158|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3696787|NCT02202850|3538257|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3696788|NCT02202850|3538257|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3696789|NCT02202850|3538258|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3696790|NCT02202850|3538259|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3696791|NCT02202850|3538257|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3696792|NCT02202850|3538258|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3696793|NCT02202850|3538259|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3696794|NCT02202850|3538257|B3|||Age||years|Mean|42.58|42.58|Standard Deviation|13.20|13.2|||
3696795|NCT02202850|3538258|B2|||Age||years|Mean|41.37|41.37|Standard Deviation|9.74|9.74|||
3696796|NCT02202850|3538259|B1|||Age||years|Mean|42.83|42.83|Standard Deviation|13.84|13.84|||
3696797|NCT02202837|3538310|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3696798|NCT02202837|3538310|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3696799|NCT02202837|3538311|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3696800|NCT02202837|3538312|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3696801|NCT02202837|3538310|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3696802|NCT02202837|3538311|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3696803|NCT02202837|3538312|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3696804|NCT02202837|3538310|B3|||Age||years|Mean|56.21|56.21|Standard Deviation|13.32|13.32|||
3696805|NCT02202837|3538311|B2|||Age||years|Mean|56.16|56.16|Standard Deviation|11.63|11.63|||
3696806|NCT02202837|3538312|B1|||Age||years|Mean|56.21|56.21|Standard Deviation|13.55|13.55|||
3696807|NCT02202785|3538361|B4|||Body Surface Area||m^2|Mean|1.730|1.73|Standard Deviation|0.2814|0.2814|||
3696808|NCT02202785|3538362|B3|||Body Surface Area||m^2|Mean|1.827|1.827|Standard Deviation|0.2575|0.2575|||
3696809|NCT02202785|3538363|B2|||Body Surface Area||m^2|Mean|1.679|1.679|Standard Deviation|0.2761|0.2761|||
3696810|NCT02202785|3538364|B1|||Body Surface Area||m^2|Mean|1.650|1.65|Standard Deviation|0.3045|0.3045|||
3696811|NCT02202785|3538361|B4|||Weight||kg|Mean|65.88|65.88|Standard Deviation|18.261|18.261|||
3696812|NCT02202785|3538362|B3|||Weight||kg|Mean|71.20|71.2|Standard Deviation|17.456|17.456|||
3696813|NCT02202785|3538363|B2|||Weight||kg|Mean|63.45|63.45|Standard Deviation|18.465|18.465|||
3696814|NCT02202785|3538364|B1|||Weight||kg|Mean|60.98|60.98|Standard Deviation|18.769|18.769|||
3696815|NCT02202785|3538361|B4|||Height||cm|Mean|165.7|165.7|Standard Deviation|10.76|10.76|||
3696816|NCT02202785|3538362|B3|||Height||cm|Mean|170.6|170.6|Standard Deviation|8.51|8.51|||
3696817|NCT02202785|3538363|B2|||Height||cm|Mean|162.1|162.1|Standard Deviation|9.54|9.54|||
3696818|NCT02202785|3538364|B1|||Height||cm|Mean|163.0|163.0|Standard Deviation|13.20|13.2|||
3696819|NCT02202785|3538361|B4|Spain||Region of Enrollment||participants|Number|15|15.0||||||
3696820|NCT02202785|3538362|B3|Spain||Region of Enrollment||participants|Number|9|9.0||||||
3696821|NCT02202785|3538363|B2|Spain||Region of Enrollment||participants|Number|4|4.0||||||
3696822|NCT02202785|3538364|B1|Spain||Region of Enrollment||participants|Number|2|2.0||||||
3696823|NCT02202785|3538361|B4|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3696824|NCT02202785|3538362|B3|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3696825|NCT02202785|3538363|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3696826|NCT02202785|3538364|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3696827|NCT02202785|3538361|B4|United States||Region of Enrollment||participants|Number|20|20.0||||||
3696828|NCT02202785|3538362|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
3696829|NCT02202785|3538363|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3696830|NCT02202785|3538364|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3696831|NCT02202785|3538361|B4|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
3696832|NCT02202785|3538362|B3|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
3696833|NCT02202785|3538363|B2|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
3696834|NCT02202785|3538364|B1|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
3696835|NCT02202785|3538361|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|39|39.0||||||
3696836|NCT02202785|3538362|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
3696837|NCT02202785|3538363|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3696838|NCT02202785|3538364|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3696839|NCT02202785|3538361|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3696840|NCT02202785|3538362|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3696841|NCT02202785|3538363|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3696842|NCT02202785|3538364|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3696843|NCT02202785|3538361|B4|Not Reported||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3696844|NCT02202785|3538362|B3|Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3696845|NCT02202785|3538363|B2|Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3696846|NCT02202785|3538364|B1|Not Reported||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3696847|NCT02202785|3538361|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3696848|NCT02202785|3538362|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3696849|NCT02202785|3538363|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3696850|NCT02202785|3538364|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3696851|NCT02202785|3538361|B4|White||Race/Ethnicity, Customized||Participants|Number|41|41.0||||||
3696852|NCT02202785|3538362|B3|White||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
3696853|NCT02202785|3538363|B2|White||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
3696854|NCT02202785|3538364|B1|White||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3696855|NCT02202785|3538361|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3696856|NCT02202785|3538362|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3696857|NCT02202785|3538363|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3696858|NCT02202785|3538364|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3696859|NCT02202785|3538361|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3696860|NCT02202785|3538362|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3696861|NCT02202785|3538363|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3696862|NCT02202785|3538364|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3696863|NCT02202785|3538361|B4|||Age||years|Mean|63.9|63.9|Standard Deviation|9.74|9.74|||
3696864|NCT02202785|3538362|B3|||Age||years|Mean|62.9|62.9|Standard Deviation|10.88|10.88|||
3696865|NCT02202785|3538363|B2|||Age||years|Mean|65.5|65.5|Standard Deviation|7.41|7.41|||
3696866|NCT02202785|3538364|B1|||Age||years|Mean|63.1|63.1|Standard Deviation|11.20|11.2|||
3696867|NCT02202759|3538400|B4|||Body Surface Area||m^2|Mean|1.835|1.835|Standard Deviation|0.2113|0.2113|||
3696868|NCT02202759|3538401|B3|||Body Surface Area||m^2|Mean|1.854|1.854|Standard Deviation|0.2014|0.2014|||
3696869|NCT02202759|3538402|B2|||Body Surface Area||m^2|Mean|1.818|1.818|Standard Deviation|0.2520|0.252|||
3696870|NCT02202759|3538403|B1|||Body Surface Area||m^2|Mean|1.832|1.832|Standard Deviation|0.1683|0.1683|||
3696871|NCT02202759|3538400|B4|||Weight||kg|Mean|72.03|72.03|Standard Deviation|13.913|13.913|||
3696872|NCT02202759|3538401|B3|||Weight||kg|Mean|72.75|72.75|Standard Deviation|12.597|12.597|||
3696873|NCT02202759|3538402|B2|||Weight||kg|Mean|71.67|71.67|Standard Deviation|17.060|17.06|||
3696874|NCT02202759|3538403|B1|||Weight||kg|Mean|71.51|71.51|Standard Deviation|11.253|11.253|||
3696875|NCT02202759|3538400|B4|||Height||cm|Mean|169.4|169.4|Standard Deviation|9.05|9.05|||
3696876|NCT02202759|3538401|B3|||Height||cm|Mean|171.1|171.1|Standard Deviation|9.38|9.38|||
3696877|NCT02202759|3538402|B2|||Height||cm|Mean|167.8|167.8|Standard Deviation|9.85|9.85|||
3696878|NCT02202759|3538403|B1|||Height||cm|Mean|169.7|169.7|Standard Deviation|7.49|7.49|||
3696879|NCT02202759|3538400|B4|Spain||Region of Enrollment||participants|Number|10|10.0||||||
3696880|NCT02202759|3538401|B3|Spain||Region of Enrollment||participants|Number|3|3.0||||||
3696881|NCT02202759|3538402|B2|Spain||Region of Enrollment||participants|Number|5|5.0||||||
3696882|NCT02202759|3538403|B1|Spain||Region of Enrollment||participants|Number|2|2.0||||||
3696883|NCT02202759|3538400|B4|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3696884|NCT02202759|3538401|B3|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
3696885|NCT02202759|3538402|B2|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
3696886|NCT02202759|3538403|B1|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3696887|NCT02202759|3538400|B4|United States||Region of Enrollment||participants|Number|22|22.0||||||
3696888|NCT02202759|3538401|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3696889|NCT02202759|3538402|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3696890|NCT02202759|3538403|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3696891|NCT02202759|3538400|B4|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
3696892|NCT02202759|3538401|B3|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
3696893|NCT02202759|3538402|B2|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
3696894|NCT02202759|3538403|B1|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
3696895|NCT02202759|3538400|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3696896|NCT02202759|3538401|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3696897|NCT02202759|3538402|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3696898|NCT02202759|3538403|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3696899|NCT02202759|3538400|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3696900|NCT02202759|3538401|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3696901|NCT02202759|3538402|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3696902|NCT02202759|3538403|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3696903|NCT02202759|3538400|B4|White||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3696904|NCT02202759|3538401|B3|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3696905|NCT02202759|3538402|B2|White||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3696906|NCT02202759|3538403|B1|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3696907|NCT02202759|3538400|B4|Not Reported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3696908|NCT02202759|3538401|B3|Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3696909|NCT02202759|3538402|B2|Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3696910|NCT02202759|3538403|B1|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3696911|NCT02202759|3538400|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3696912|NCT02202759|3538401|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3696913|NCT02202759|3538402|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3696914|NCT02202759|3538403|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3696915|NCT02202759|3538400|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3696916|NCT02202759|3538401|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3696917|NCT02202759|3538402|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3696918|NCT02202759|3538403|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3696919|NCT02202759|3538400|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3696920|NCT02202759|3538401|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3696921|NCT02202759|3538402|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3696922|NCT02202759|3538403|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3696923|NCT02202759|3538400|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3696924|NCT02202759|3538401|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3696925|NCT02202759|3538402|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3696926|NCT02202759|3538403|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3696927|NCT02202759|3538400|B4|||Age||years|Mean|62.2|62.2|Standard Deviation|9.89|9.89|||
3696928|NCT02202759|3538401|B3|||Age||years|Mean|62.9|62.9|Standard Deviation|7.86|7.86|||
3696929|NCT02202759|3538402|B2|||Age||years|Mean|62.9|62.9|Standard Deviation|12.78|12.78|||
3696930|NCT02202759|3538403|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|7.70|7.7|||
3696931|NCT02202538|3538439|B1|D||ASIA Impairment Scale Score|"A: motor and sensory complete injury B: motor complete and sensory incomplete injury C: motor and sensory incomplete injury; half or more than half of affected muscles are less than grade 3/5 D: motor and sensory incomplete injury; half or more than half of affected muscles are more than grade 3/5~Reference: rehabmeasures.org"|participants|Number|1|1.0||||||
3696932|NCT02202538|3538439|B1|C||ASIA Impairment Scale Score|"A: motor and sensory complete injury B: motor complete and sensory incomplete injury C: motor and sensory incomplete injury; half or more than half of affected muscles are less than grade 3/5 D: motor and sensory incomplete injury; half or more than half of affected muscles are more than grade 3/5~Reference: rehabmeasures.org"|participants|Number|11|11.0||||||
3696933|NCT02202538|3538439|B1|B||ASIA Impairment Scale Score|"A: motor and sensory complete injury B: motor complete and sensory incomplete injury C: motor and sensory incomplete injury; half or more than half of affected muscles are less than grade 3/5 D: motor and sensory incomplete injury; half or more than half of affected muscles are more than grade 3/5~Reference: rehabmeasures.org"|participants|Number|5|5.0||||||
3696934|NCT02202538|3538439|B1|A||ASIA Impairment Scale Score|"A: motor and sensory complete injury B: motor complete and sensory incomplete injury C: motor and sensory incomplete injury; half or more than half of affected muscles are less than grade 3/5 D: motor and sensory incomplete injury; half or more than half of affected muscles are more than grade 3/5~Reference: rehabmeasures.org"|participants|Number|36|36.0||||||
3696935|NCT02202538|3538439|B1|L2||Level of Injury||participants|Number|1|1.0||||||
3696936|NCT02202538|3538439|B1|L1||Level of Injury||participants|Number|2|2.0||||||
3696937|NCT02202538|3538439|B1|T12||Level of Injury||participants|Number|5|5.0||||||
3696938|NCT02202538|3538439|B1|T11||Level of Injury||participants|Number|5|5.0||||||
3696939|NCT02202538|3538439|B1|T10||Level of Injury||participants|Number|7|7.0||||||
3696940|NCT02202538|3538439|B1|T9||Level of Injury||participants|Number|1|1.0||||||
3696941|NCT02202538|3538439|B1|T8||Level of Injury||participants|Number|6|6.0||||||
3696942|NCT02202538|3538439|B1|T7||Level of Injury||participants|Number|3|3.0||||||
3696943|NCT02202538|3538439|B1|T6||Level of Injury||participants|Number|5|5.0||||||
3696944|NCT02202538|3538439|B1|T5||Level of Injury||participants|Number|6|6.0||||||
3696945|NCT02202538|3538439|B1|T4||Level of Injury||participants|Number|9|9.0||||||
3696946|NCT02202538|3538439|B1|T3||Level of Injury||participants|Number|3|3.0||||||
3696947|NCT02202538|3538439|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
3696948|NCT02202538|3538439|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3696949|NCT02202538|3538439|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3696950|NCT02202538|3538439|B1|||Age||years|Mean|35.9|35.9|Standard Deviation|13.0|13.0|||
3696951|NCT02202317|3538450|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3696952|NCT02202317|3538450|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3696953|NCT02202317|3538450|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3696954|NCT02202317|3538450|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3696955|NCT02202317|3538450|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3696956|NCT02202252|3538456|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3696957|NCT02202252|3538457|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3696958|NCT02202252|3538458|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3696959|NCT02202252|3538456|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3696960|NCT02202252|3538457|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3696961|NCT02202252|3538458|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3696962|NCT02202252|3538456|B3|||Age||years|Mean|54|54.0|Standard Deviation|11.5|11.5|||
3696963|NCT02202252|3538457|B2|||Age||years|Mean|53.9|53.9|Standard Deviation|11.5|11.5|||
3696964|NCT02202252|3538458|B1|||Age||years|Mean|54.1|54.1|Standard Deviation|11.6|11.6|||
3696965|NCT02202161|3538469|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696966|NCT02202161|3538470|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696967|NCT02202161|3538471|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696968|NCT02202161|3538472|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696969|NCT02202161|3538473|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696970|NCT02202161|3538474|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696971|NCT02202161|3538475|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696972|NCT02202161|3538476|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696973|NCT02202161|3538477|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696974|NCT02202161|3538469|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696975|NCT02202161|3538470|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696976|NCT02202161|3538471|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696977|NCT02202161|3538472|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696978|NCT02202161|3538473|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696979|NCT02202161|3538474|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696980|NCT02202161|3538475|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696981|NCT02202161|3538476|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696982|NCT02202161|3538477|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696983|NCT02202161|3538469|B9||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3696984|NCT02202161|3538470|B8||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3696985|NCT02202161|3538471|B7||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3696986|NCT02202161|3538472|B6||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3696987|NCT02202161|3538473|B5||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3696988|NCT02202161|3538474|B4||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3696989|NCT02202161|3538475|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3696990|NCT02202161|3538476|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3696991|NCT02202161|3538477|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3696992|NCT02202161|3538469|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3696993|NCT02202161|3538470|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3696994|NCT02202161|3538471|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3696995|NCT02202161|3538472|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696996|NCT02202161|3538473|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3696997|NCT02202161|3538474|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3696998|NCT02202161|3538475|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3696999|NCT02202161|3538476|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3697000|NCT02202161|3538477|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3697001|NCT02202161|3538469|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3697002|NCT02202161|3538470|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697003|NCT02202161|3538471|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697004|NCT02202161|3538472|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697005|NCT02202161|3538473|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3697006|NCT02202161|3538474|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697007|NCT02202161|3538475|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3697008|NCT02202161|3538476|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697009|NCT02202161|3538477|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697010|NCT02202161|3538469|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3697011|NCT02202161|3538470|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697012|NCT02202161|3538471|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697013|NCT02202161|3538472|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3697014|NCT02202161|3538473|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697015|NCT02202161|3538474|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697016|NCT02202161|3538475|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697017|NCT02202161|3538476|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697018|NCT02202161|3538477|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697019|NCT02202161|3538469|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697020|NCT02202161|3538470|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697021|NCT02202161|3538471|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697022|NCT02202161|3538472|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697023|NCT02202161|3538473|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697024|NCT02202161|3538474|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697025|NCT02202161|3538475|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697026|NCT02202161|3538476|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697027|NCT02202161|3538477|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697028|NCT02202161|3538469|B9||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3697029|NCT02202161|3538470|B8||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3697030|NCT02202161|3538471|B7||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3697031|NCT02202161|3538472|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3697032|NCT02202161|3538473|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3697033|NCT02202161|3538474|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3697034|NCT02202161|3538475|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3697035|NCT02202161|3538476|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3697036|NCT02202161|3538477|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3697037|NCT02202161|3538469|B9||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3697038|NCT02202161|3538470|B8||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3697039|NCT02202161|3538471|B7||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3697040|NCT02202161|3538472|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3697041|NCT02202161|3538473|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3697042|NCT02202161|3538474|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3697043|NCT02202161|3538475|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3697044|NCT02202161|3538476|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3697045|NCT02202161|3538477|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3697046|NCT02202161|3538469|B9|||Age||Years|Mean|54.5|54.5|Standard Deviation|6.20|6.2|||
3697047|NCT02202161|3538470|B8|||Age||Years|Mean|55.5|55.5|Standard Deviation|3.51|3.51|||
3697048|NCT02202161|3538471|B7|||Age||Years|Mean|53.7|53.7|Standard Deviation|6.79|6.79|||
3697049|NCT02202161|3538472|B6|||Age||Years|Mean|54.8|54.8|Standard Deviation|7.47|7.47|||
3697050|NCT02202161|3538473|B5|||Age||Years|Mean|55.0|55.0|Standard Deviation|4.27|4.27|||
3697051|NCT02202161|3538474|B4|||Age||Years|Mean|57.1|57.1|Standard Deviation|5.86|5.86|||
3697052|NCT02202161|3538475|B3|||Age||Years|Mean|56.2|56.2|Standard Deviation|8.50|8.5|||
3697053|NCT02202161|3538476|B2|||Age||Years|Mean|54.0|54.0|Standard Deviation|4.30|4.3|||
3697054|NCT02202161|3538477|B1|||Age||Years|Mean|52.1|52.1|Standard Deviation|6.97|6.97|||
3697055|NCT02202135|3538638|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697056|NCT02202135|3538638|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697057|NCT02202135|3538638|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3697058|NCT02202135|3538638|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697059|NCT02202135|3538638|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697060|NCT02202135|3538638|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697061|NCT02202135|3538638|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697062|NCT02202135|3538638|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3697063|NCT02202135|3538638|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3697064|NCT02202135|3538638|B1|||Age||years|Mean|80.25|80.25|Standard Deviation|4.875|4.875|||
3697065|NCT02202109|3538642|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3697066|NCT02202109|3538643|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3697067|NCT02202109|3538644|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3697068|NCT02202109|3538642|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
3697069|NCT02202109|3538643|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3697070|NCT02202109|3538644|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3697071|NCT02202109|3538642|B3||White|Race (NIH/OMB)||Participants|Count of Participants|279|279.0||||||
3697072|NCT02202109|3538643|B2||White|Race (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
3697073|NCT02202109|3538644|B1||White|Race (NIH/OMB)||Participants|Count of Participants|141|141.0||||||
3697074|NCT02202109|3538642|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|219|219.0||||||
3697075|NCT02202109|3538643|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
3697076|NCT02202109|3538644|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
3697077|NCT02202109|3538642|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697078|NCT02202109|3538643|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697079|NCT02202109|3538644|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697080|NCT02202109|3538642|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697081|NCT02202109|3538643|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697082|NCT02202109|3538644|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697083|NCT02202109|3538642|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697084|NCT02202109|3538643|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697085|NCT02202109|3538644|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697086|NCT02202109|3538642|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3697087|NCT02202109|3538643|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697088|NCT02202109|3538644|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3697089|NCT02202109|3538642|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|206|206.0||||||
3697090|NCT02202109|3538643|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
3697091|NCT02202109|3538644|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
3697092|NCT02202109|3538642|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|395|395.0||||||
3697093|NCT02202109|3538643|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|197|197.0||||||
3697094|NCT02202109|3538644|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|198|198.0||||||
3697095|NCT02202109|3538642|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3697096|NCT02202109|3538643|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3697097|NCT02202109|3538644|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3697098|NCT02202109|3538642|B3||Female|Sex: Female, Male||Participants|Count of Participants|602|602.0||||||
3697099|NCT02202109|3538643|B2||Female|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
3697100|NCT02202109|3538644|B1||Female|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
3697101|NCT02202109|3538642|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3697102|NCT02202109|3538643|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3697103|NCT02202109|3538644|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3697104|NCT02202109|3538642|B3||Between 18 and 65 years|Age||Participants|Count of Participants|602|602.0||||||
3697105|NCT02202109|3538643|B2||Between 18 and 65 years|Age||Participants|Count of Participants|300|300.0||||||
3697106|NCT02202109|3538644|B1||Between 18 and 65 years|Age||Participants|Count of Participants|302|302.0||||||
3697107|NCT02202109|3538642|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3697108|NCT02202109|3538643|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3697109|NCT02202109|3538644|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3697110|NCT02201953|3538655|B3|Treatment-Experienced||Prior HCV Treatment Experience||participants|Number|142|142.0||||||
3697111|NCT02201953|3538656|B2|Treatment-Experienced||Prior HCV Treatment Experience||participants|Number|71|71.0||||||
3697112|NCT02201953|3538657|B1|Treatment-Experienced||Prior HCV Treatment Experience||participants|Number|71|71.0||||||
3697113|NCT02201953|3538655|B3|Treatment-Naive||Prior HCV Treatment Experience||participants|Number|410|410.0||||||
3697114|NCT02201953|3538656|B2|Treatment-Naive||Prior HCV Treatment Experience||participants|Number|204|204.0||||||
3697115|NCT02201953|3538657|B1|Treatment-Naive||Prior HCV Treatment Experience||participants|Number|206|206.0||||||
3697116|NCT02201953|3538655|B3|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|385|385.0||||||
3697117|NCT02201953|3538656|B2|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|194|194.0||||||
3697118|NCT02201953|3538657|B1|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|191|191.0||||||
3697119|NCT02201953|3538655|B3|< 800,000 IU/mL||HCV RNA Category||participants|Number|167|167.0||||||
3697120|NCT02201953|3538656|B2|< 800,000 IU/mL||HCV RNA Category||participants|Number|81|81.0||||||
3697121|NCT02201953|3538657|B1|< 800,000 IU/mL||HCV RNA Category||participants|Number|86|86.0||||||
3697122|NCT02201953|3538655|B3|||HCV RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.72|0.72|||
3697123|NCT02201953|3538656|B2|||HCV RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.71|0.71|||
3697124|NCT02201953|3538657|B1|||HCV RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.72|0.72|||
3697125|NCT02201953|3538655|B3|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|55|55.0||||||
3697126|NCT02201953|3538656|B2|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|31|31.0||||||
3697127|NCT02201953|3538657|B1|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|24|24.0||||||
3697128|NCT02201953|3538655|B3|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|281|281.0||||||
3697129|NCT02201953|3538656|B2|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|133|133.0||||||
3697130|NCT02201953|3538657|B1|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|148|148.0||||||
3697131|NCT02201953|3538655|B3|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|216|216.0||||||
3697132|NCT02201953|3538656|B2|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|111|111.0||||||
3697133|NCT02201953|3538657|B1|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|105|105.0||||||
3697134|NCT02201953|3538655|B3|Missing||Cirrhosis Status||participants|Number|5|5.0||||||
3697135|NCT02201953|3538656|B2|Missing||Cirrhosis Status||participants|Number|5|5.0||||||
3697136|NCT02201953|3538657|B1|Missing||Cirrhosis Status||participants|Number|0|0.0||||||
3697137|NCT02201953|3538655|B3|No||Cirrhosis Status||participants|Number|384|384.0||||||
3697138|NCT02201953|3538656|B2|No||Cirrhosis Status||participants|Number|187|187.0||||||
3697139|NCT02201953|3538657|B1|No||Cirrhosis Status||participants|Number|197|197.0||||||
3697140|NCT02201953|3538655|B3|Yes||Cirrhosis Status||participants|Number|163|163.0||||||
3697141|NCT02201953|3538656|B2|Yes||Cirrhosis Status||participants|Number|83|83.0||||||
3697142|NCT02201953|3538657|B1|Yes||Cirrhosis Status||participants|Number|80|80.0||||||
3697143|NCT02201953|3538655|B3|Genotype 3k||HCV Genotype||participants|Number|1|1.0||||||
3697144|NCT02201953|3538656|B2|Genotype 3k||HCV Genotype||participants|Number|0|0.0||||||
3697145|NCT02201953|3538657|B1|Genotype 3k||HCV Genotype||participants|Number|1|1.0||||||
3697146|NCT02201953|3538655|B3|Genotype 3h||HCV Genotype||participants|Number|2|2.0||||||
3697147|NCT02201953|3538656|B2|Genotype 3h||HCV Genotype||participants|Number|2|2.0||||||
3697148|NCT02201953|3538657|B1|Genotype 3h||HCV Genotype||participants|Number|0|0.0||||||
3697149|NCT02201953|3538655|B3|Genotype 3b||HCV Genotype||participants|Number|7|7.0||||||
3697150|NCT02201953|3538656|B2|Genotype 3b||HCV Genotype||participants|Number|5|5.0||||||
3697151|NCT02201953|3538657|B1|Genotype 3b||HCV Genotype||participants|Number|2|2.0||||||
3697152|NCT02201953|3538655|B3|Genotype 3a||HCV Genotype||participants|Number|515|515.0||||||
3697153|NCT02201953|3538656|B2|Genotype 3a||HCV Genotype||participants|Number|250|250.0||||||
3697154|NCT02201953|3538657|B1|Genotype 3a||HCV Genotype||participants|Number|265|265.0||||||
3697155|NCT02201953|3538655|B3|Genotype 3 (No Confirmed Subtype)||HCV Genotype||participants|Number|27|27.0||||||
3697156|NCT02201953|3538656|B2|Genotype 3 (No Confirmed Subtype)||HCV Genotype||participants|Number|18|18.0||||||
3697157|NCT02201953|3538657|B1|Genotype 3 (No Confirmed Subtype)||HCV Genotype||participants|Number|9|9.0||||||
3697158|NCT02201953|3538655|B3|Germany||Region of Enrollment||participants|Number|66|66.0||||||
3697159|NCT02201953|3538656|B2|Germany||Region of Enrollment||participants|Number|35|35.0||||||
3697160|NCT02201953|3538657|B1|Germany||Region of Enrollment||participants|Number|31|31.0||||||
3697161|NCT02201953|3538655|B3|France||Region of Enrollment||participants|Number|100|100.0||||||
3697162|NCT02201953|3538656|B2|France||Region of Enrollment||participants|Number|52|52.0||||||
3697163|NCT02201953|3538657|B1|France||Region of Enrollment||participants|Number|48|48.0||||||
3697164|NCT02201953|3538655|B3|Australia||Region of Enrollment||participants|Number|93|93.0||||||
3697165|NCT02201953|3538656|B2|Australia||Region of Enrollment||participants|Number|44|44.0||||||
3697166|NCT02201953|3538657|B1|Australia||Region of Enrollment||participants|Number|49|49.0||||||
3697167|NCT02201953|3538655|B3|United Kingdom||Region of Enrollment||participants|Number|105|105.0||||||
3697168|NCT02201953|3538656|B2|United Kingdom||Region of Enrollment||participants|Number|47|47.0||||||
3697169|NCT02201953|3538657|B1|United Kingdom||Region of Enrollment||participants|Number|58|58.0||||||
3697170|NCT02201953|3538655|B3|Italy||Region of Enrollment||participants|Number|18|18.0||||||
3697171|NCT02201953|3538656|B2|Italy||Region of Enrollment||participants|Number|11|11.0||||||
3697172|NCT02201953|3538657|B1|Italy||Region of Enrollment||participants|Number|7|7.0||||||
3697173|NCT02201953|3538655|B3|United States||Region of Enrollment||participants|Number|120|120.0||||||
3697174|NCT02201953|3538656|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
3697175|NCT02201953|3538657|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
3697176|NCT02201953|3538655|B3|Canada||Region of Enrollment||participants|Number|33|33.0||||||
3697177|NCT02201953|3538656|B2|Canada||Region of Enrollment||participants|Number|18|18.0||||||
3697178|NCT02201953|3538657|B1|Canada||Region of Enrollment||participants|Number|15|15.0||||||
3697179|NCT02201953|3538655|B3|New Zealand||Region of Enrollment||participants|Number|17|17.0||||||
3697180|NCT02201953|3538656|B2|New Zealand||Region of Enrollment||participants|Number|8|8.0||||||
3697181|NCT02201953|3538657|B1|New Zealand||Region of Enrollment||participants|Number|9|9.0||||||
3697182|NCT02201953|3538655|B3|Not Disclosed||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3697183|NCT02201953|3538656|B2|Not Disclosed||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3697184|NCT02201953|3538657|B1|Not Disclosed||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3697185|NCT02201953|3538655|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3697186|NCT02201953|3538656|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3697187|NCT02201953|3538657|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3697188|NCT02201953|3538655|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3697189|NCT02201953|3538656|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3697190|NCT02201953|3538657|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3697191|NCT02201953|3538655|B3|Asian||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
3697192|NCT02201953|3538656|B2|Asian||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3697193|NCT02201953|3538657|B1|Asian||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3697194|NCT02201953|3538655|B3|White||Race/Ethnicity, Customized||participants|Number|489|489.0||||||
3697195|NCT02201953|3538656|B2|White||Race/Ethnicity, Customized||participants|Number|239|239.0||||||
3697196|NCT02201953|3538657|B1|White||Race/Ethnicity, Customized||participants|Number|250|250.0||||||
3697197|NCT02201953|3538655|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3697198|NCT02201953|3538656|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3697199|NCT02201953|3538657|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3697200|NCT02201953|3538655|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3697201|NCT02201953|3538656|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3697202|NCT02201953|3538657|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697203|NCT02201953|3538655|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|529|529.0||||||
3697204|NCT02201953|3538656|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|263|263.0||||||
3697205|NCT02201953|3538657|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|266|266.0||||||
3697206|NCT02201953|3538655|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3697207|NCT02201953|3538656|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3697208|NCT02201953|3538657|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3697209|NCT02201953|3538655|B3||Male|Sex: Female, Male||Participants|Count of Participants|344|344.0||||||
3697210|NCT02201953|3538656|B2||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3697211|NCT02201953|3538657|B1||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
3697212|NCT02201953|3538655|B3||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
3697213|NCT02201953|3538656|B2||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3697214|NCT02201953|3538657|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3697215|NCT02201953|3538655|B3|||Age||years|Mean|50|50.0|Standard Deviation|10.2|10.2|||
3697216|NCT02201953|3538656|B2|||Age||years|Mean|50|50.0|Standard Deviation|10.0|10.0|||
3697217|NCT02201953|3538657|B1|||Age||years|Mean|49|49.0|Standard Deviation|10.4|10.4|||
3697218|NCT02201940|3538674|B3|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|548|548.0||||||
3697219|NCT02201940|3538675|B2|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|87|87.0||||||
3697220|NCT02201940|3538676|B1|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|461|461.0||||||
3697221|NCT02201940|3538674|B3|< 800,000 IU/mL||HCV RNA Category||participants|Number|192|192.0||||||
3697222|NCT02201940|3538675|B2|< 800,000 IU/mL||HCV RNA Category||participants|Number|29|29.0||||||
3697223|NCT02201940|3538676|B1|< 800,000 IU/mL||HCV RNA Category||participants|Number|163|163.0||||||
3697224|NCT02201940|3538674|B3|||HCV RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.65|0.65|||
3697225|NCT02201940|3538675|B2|||HCV RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.58|0.58|||
3697226|NCT02201940|3538676|B1|||HCV RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.66|0.66|||
3697227|NCT02201940|3538674|B3|Missing||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|6|6.0||||||
3697228|NCT02201940|3538675|B2|Missing||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3697229|NCT02201940|3538676|B1|Missing||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|5|5.0||||||
3697230|NCT02201940|3538674|B3|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|120|120.0||||||
3697231|NCT02201940|3538675|B2|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|26|26.0||||||
3697232|NCT02201940|3538676|B1|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|94|94.0||||||
3697233|NCT02201940|3538674|B3|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|392|392.0||||||
3697234|NCT02201940|3538675|B2|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|53|53.0||||||
3697235|NCT02201940|3538676|B1|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|339|339.0||||||
3697236|NCT02201940|3538674|B3|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|222|222.0||||||
3697237|NCT02201940|3538675|B2|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|36|36.0||||||
3697238|NCT02201940|3538676|B1|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|186|186.0||||||
3697239|NCT02201940|3538674|B3|Genotype 6||HCV Genotype||participants|Number|49|49.0||||||
3697240|NCT02201940|3538675|B2|Genotype 6||HCV Genotype||participants|Number|8|8.0||||||
3697241|NCT02201940|3538676|B1|Genotype 6||HCV Genotype||participants|Number|41|41.0||||||
3697242|NCT02201940|3538674|B3|Genotype 5||HCV Genotype||participants|Number|35|35.0||||||
3697243|NCT02201940|3538675|B2|Genotype 5||HCV Genotype||participants|Number|0|0.0||||||
3697244|NCT02201940|3538676|B1|Genotype 5||HCV Genotype||participants|Number|35|35.0||||||
3697245|NCT02201940|3538674|B3|Genotype 4||HCV Genotype||participants|Number|138|138.0||||||
3697246|NCT02201940|3538675|B2|Genotype 4||HCV Genotype||participants|Number|22|22.0||||||
3697247|NCT02201940|3538676|B1|Genotype 4||HCV Genotype||participants|Number|116|116.0||||||
3697248|NCT02201940|3538674|B3|Genotype 2||HCV Genotype||participants|Number|125|125.0||||||
3697249|NCT02201940|3538675|B2|Genotype 2||HCV Genotype||participants|Number|21|21.0||||||
3697250|NCT02201940|3538676|B1|Genotype 2||HCV Genotype||participants|Number|104|104.0||||||
3697251|NCT02201940|3538674|B3|Genotype 1||HCV Genotype||participants|Number|393|393.0||||||
3697252|NCT02201940|3538675|B2|Genotype 1||HCV Genotype||participants|Number|65|65.0||||||
3697253|NCT02201940|3538676|B1|Genotype 1||HCV Genotype||participants|Number|328|328.0||||||
3697254|NCT02201940|3538674|B3|Missing||Cirrhosis Status||participants|Number|2|2.0||||||
3697255|NCT02201940|3538675|B2|Missing||Cirrhosis Status||participants|Number|0|0.0||||||
3697256|NCT02201940|3538676|B1|Missing||Cirrhosis Status||participants|Number|2|2.0||||||
3697257|NCT02201940|3538674|B3|Absent||Cirrhosis Status||participants|Number|596|596.0||||||
3697258|NCT02201940|3538675|B2|Absent||Cirrhosis Status||participants|Number|95|95.0||||||
3697259|NCT02201940|3538676|B1|Absent||Cirrhosis Status||participants|Number|501|501.0||||||
3697260|NCT02201940|3538674|B3|Present||Cirrhosis Status||participants|Number|142|142.0||||||
3697261|NCT02201940|3538675|B2|Present||Cirrhosis Status||participants|Number|21|21.0||||||
3697262|NCT02201940|3538676|B1|Present||Cirrhosis Status||participants|Number|121|121.0||||||
3697263|NCT02201940|3538674|B3|Germany||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (N = 741).|participants|Number|52|52.0||||||
3697264|NCT02201940|3538675|B2|Germany||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (N = 741).|participants|Number|8|8.0||||||
3697265|NCT02201940|3538676|B1|Germany||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (N = 741).|participants|Number|44|44.0||||||
3697266|NCT02201940|3538674|B3|France||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (N = 741).|participants|Number|158|158.0||||||
3697375|NCT02201901|3538694|B3|Not Disclosed||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3697267|NCT02201940|3538675|B2|France||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (N = 741).|participants|Number|32|32.0||||||
3697268|NCT02201940|3538676|B1|France||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (N = 741).|participants|Number|126|126.0||||||
3697269|NCT02201940|3538674|B3|United Kingdom||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (N = 741).|participants|Number|104|104.0||||||
3697270|NCT02201940|3538675|B2|United Kingdom||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (N = 741).|participants|Number|13|13.0||||||
3697271|NCT02201940|3538676|B1|United Kingdom||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (N = 741).|participants|Number|91|91.0||||||
3697272|NCT02201940|3538674|B3|Italy||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (N = 741).|participants|Number|18|18.0||||||
3697273|NCT02201940|3538675|B2|Italy||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (N = 741).|participants|Number|2|2.0||||||
3697274|NCT02201940|3538676|B1|Italy||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (N = 741).|participants|Number|16|16.0||||||
3697275|NCT02201940|3538674|B3|China||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (N = 741).|participants|Number|23|23.0||||||
3697276|NCT02201940|3538675|B2|China||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (N = 741).|participants|Number|4|4.0||||||
3697277|NCT02201940|3538676|B1|China||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (N = 741).|participants|Number|19|19.0||||||
3697278|NCT02201940|3538674|B3|United States||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (N = 741).|participants|Number|279|279.0||||||
3697279|NCT02201940|3538675|B2|United States||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (N = 741).|participants|Number|45|45.0||||||
3697280|NCT02201940|3538676|B1|United States||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (N = 741).|participants|Number|234|234.0||||||
3697281|NCT02201940|3538674|B3|Belgium||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (N = 741).|participants|Number|45|45.0||||||
3697282|NCT02201940|3538675|B2|Belgium||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (N = 741).|participants|Number|5|5.0||||||
3697283|NCT02201940|3538676|B1|Belgium||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (N = 741).|participants|Number|40|40.0||||||
3697284|NCT02201940|3538674|B3|Canada||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (N = 741).|participants|Number|62|62.0||||||
3697285|NCT02201940|3538675|B2|Canada||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (N = 741).|participants|Number|7|7.0||||||
3697286|NCT02201940|3538676|B1|Canada||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (N = 741).|participants|Number|55|55.0||||||
3697287|NCT02201940|3538674|B3|Not Disclosed||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3697288|NCT02201940|3538675|B2|Not Disclosed||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3697289|NCT02201940|3538676|B1|Not Disclosed||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3697290|NCT02201940|3538674|B3|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3697291|NCT02201940|3538675|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3697292|NCT02201940|3538676|B1|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3697293|NCT02201940|3538674|B3|Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3697294|NCT02201940|3538675|B2|Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3697295|NCT02201940|3538676|B1|Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3697296|NCT02201940|3538674|B3|American Indian/ Alaska Native||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3697297|NCT02201940|3538675|B2|American Indian/ Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3697298|NCT02201940|3538676|B1|American Indian/ Alaska Native||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3697299|NCT02201940|3538674|B3|Asian||Race/Ethnicity, Customized||participants|Number|73|73.0||||||
3697300|NCT02201940|3538675|B2|Asian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3697301|NCT02201940|3538676|B1|Asian||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
3697302|NCT02201940|3538674|B3|White||Race/Ethnicity, Customized||participants|Number|582|582.0||||||
3697303|NCT02201940|3538675|B2|White||Race/Ethnicity, Customized||participants|Number|89|89.0||||||
3697304|NCT02201940|3538676|B1|White||Race/Ethnicity, Customized||participants|Number|493|493.0||||||
3697305|NCT02201940|3538674|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|64|64.0||||||
3697306|NCT02201940|3538675|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3697307|NCT02201940|3538676|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
3697308|NCT02201940|3538674|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3697309|NCT02201940|3538675|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697310|NCT02201940|3538676|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3697311|NCT02201940|3538674|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|700|700.0||||||
3697312|NCT02201940|3538675|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
3697313|NCT02201940|3538676|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|589|589.0||||||
3697314|NCT02201940|3538674|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3697315|NCT02201940|3538675|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3697316|NCT02201940|3538676|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3697317|NCT02201940|3538674|B3||Male|Sex: Female, Male||Participants|Count of Participants|442|442.0||||||
3697318|NCT02201940|3538675|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3697319|NCT02201940|3538676|B1||Male|Sex: Female, Male||Participants|Count of Participants|374|374.0||||||
3697320|NCT02201940|3538674|B3||Female|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
3697321|NCT02201940|3538675|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3697322|NCT02201940|3538676|B1||Female|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
3697323|NCT02201940|3538674|B3|||Age||years|Mean|54|54.0|Standard Deviation|10.8|10.8|||
3697324|NCT02201940|3538675|B2|||Age||years|Mean|53|53.0|Standard Deviation|10.4|10.4|||
3697325|NCT02201940|3538676|B1|||Age||years|Mean|54|54.0|Standard Deviation|10.9|10.9|||
3697326|NCT02201901|3538693|B4|Missing||IL28B|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|2|2.0||||||
3697327|NCT02201901|3538694|B3|Missing||IL28B|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|2|2.0||||||
3697328|NCT02201901|3538695|B2|Missing||IL28B|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3697329|NCT02201901|3538696|B1|Missing||IL28B|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3697330|NCT02201901|3538693|B4|TT||IL28B|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|57|57.0||||||
3697331|NCT02201901|3538694|B3|TT||IL28B|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|19|19.0||||||
3697332|NCT02201901|3538695|B2|TT||IL28B|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|19|19.0||||||
3697333|NCT02201901|3538696|B1|TT||IL28B|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|19|19.0||||||
3697334|NCT02201901|3538693|B4|CT||IL28B|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|146|146.0||||||
3697335|NCT02201901|3538694|B3|CT||IL28B|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|49|49.0||||||
3697336|NCT02201901|3538695|B2|CT||IL28B|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|46|46.0||||||
3697337|NCT02201901|3538696|B1|CT||IL28B|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|51|51.0||||||
3697338|NCT02201901|3538693|B4|CC||IL28B|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|62|62.0||||||
3697339|NCT02201901|3538694|B3|CC||IL28B|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|20|20.0||||||
3697340|NCT02201901|3538695|B2|CC||IL28B|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|22|22.0||||||
3697341|NCT02201901|3538696|B1|CC||IL28B|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|20|20.0||||||
3697342|NCT02201901|3538693|B4|Genotype 6||HCV Genotype||participants|Number|1|1.0||||||
3697343|NCT02201901|3538694|B3|Genotype 6||HCV Genotype||participants|Number|1|1.0||||||
3697344|NCT02201901|3538695|B2|Genotype 6||HCV Genotype||participants|Number|0|0.0||||||
3697345|NCT02201901|3538696|B1|Genotype 6||HCV Genotype||participants|Number|0|0.0||||||
3697346|NCT02201901|3538693|B4|Genotype 4||HCV Genotype||participants|Number|8|8.0||||||
3697347|NCT02201901|3538694|B3|Genotype 4||HCV Genotype||participants|Number|2|2.0||||||
3697348|NCT02201901|3538695|B2|Genotype 4||HCV Genotype||participants|Number|2|2.0||||||
3697349|NCT02201901|3538696|B1|Genotype 4||HCV Genotype||participants|Number|4|4.0||||||
3697350|NCT02201901|3538693|B4|Genotype 3||HCV Genotype||participants|Number|39|39.0||||||
3697351|NCT02201901|3538694|B3|Genotype 3||HCV Genotype||participants|Number|12|12.0||||||
3697352|NCT02201901|3538695|B2|Genotype 3||HCV Genotype||participants|Number|13|13.0||||||
3697353|NCT02201901|3538696|B1|Genotype 3||HCV Genotype||participants|Number|14|14.0||||||
3697354|NCT02201901|3538693|B4|Genotype 2||HCV Genotype||participants|Number|12|12.0||||||
3697355|NCT02201901|3538694|B3|Genotype 2||HCV Genotype||participants|Number|4|4.0||||||
3697356|NCT02201901|3538695|B2|Genotype 2||HCV Genotype||participants|Number|4|4.0||||||
3697357|NCT02201901|3538696|B1|Genotype 2||HCV Genotype||participants|Number|4|4.0||||||
3697358|NCT02201901|3538693|B4|Genotype 1||HCV Genotype||participants|Number|207|207.0||||||
3697359|NCT02201901|3538694|B3|Genotype 1||HCV Genotype||participants|Number|71|71.0||||||
3697360|NCT02201901|3538695|B2|Genotype 1||HCV Genotype||participants|Number|68|68.0||||||
3697361|NCT02201901|3538696|B1|Genotype 1||HCV Genotype||participants|Number|68|68.0||||||
3697362|NCT02201901|3538693|B4|||HCV RNA||log 10 IU/mL|Mean|5.9|5.9|Standard Deviation|0.60|0.6|||
3697363|NCT02201901|3538694|B3|||HCV RNA||log 10 IU/mL|Mean|5.9|5.9|Standard Deviation|0.63|0.63|||
3697364|NCT02201901|3538695|B2|||HCV RNA||log 10 IU/mL|Mean|5.8|5.8|Standard Deviation|0.61|0.61|||
3697365|NCT02201901|3538696|B1|||HCV RNA||log 10 IU/mL|Mean|6.0|6.0|Standard Deviation|0.54|0.54|||
3697366|NCT02201901|3538693|B4|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|149|149.0||||||
3697367|NCT02201901|3538694|B3|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|45|45.0||||||
3697368|NCT02201901|3538695|B2|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|45|45.0||||||
3697369|NCT02201901|3538696|B1|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|59|59.0||||||
3697370|NCT02201901|3538693|B4|< 800,000 IU/mL||HCV RNA Category||participants|Number|118|118.0||||||
3697371|NCT02201901|3538694|B3|< 800,000 IU/mL||HCV RNA Category||participants|Number|45|45.0||||||
3697372|NCT02201901|3538695|B2|< 800,000 IU/mL||HCV RNA Category||participants|Number|42|42.0||||||
3697373|NCT02201901|3538696|B1|< 800,000 IU/mL||HCV RNA Category||participants|Number|31|31.0||||||
3697374|NCT02201901|3538693|B4|Not Disclosed||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3697376|NCT02201901|3538695|B2|Not Disclosed||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3697377|NCT02201901|3538696|B1|Not Disclosed||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3697378|NCT02201901|3538693|B4|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3697379|NCT02201901|3538694|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3697380|NCT02201901|3538695|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3697381|NCT02201901|3538696|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3697382|NCT02201901|3538693|B4|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3697383|NCT02201901|3538694|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3697384|NCT02201901|3538695|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3697385|NCT02201901|3538696|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3697386|NCT02201901|3538693|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3697387|NCT02201901|3538694|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3697388|NCT02201901|3538695|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3697389|NCT02201901|3538696|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3697390|NCT02201901|3538693|B4|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3697391|NCT02201901|3538694|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3697392|NCT02201901|3538695|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3697393|NCT02201901|3538696|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3697394|NCT02201901|3538693|B4|White||Race/Ethnicity, Customized||participants|Number|239|239.0||||||
3697395|NCT02201901|3538694|B3|White||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
3697396|NCT02201901|3538695|B2|White||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
3697397|NCT02201901|3538696|B1|White||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
3697398|NCT02201901|3538693|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3697399|NCT02201901|3538694|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3697400|NCT02201901|3538695|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3697401|NCT02201901|3538696|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3697402|NCT02201901|3538693|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697403|NCT02201901|3538694|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697404|NCT02201901|3538695|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697405|NCT02201901|3538696|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697406|NCT02201901|3538693|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|228|228.0||||||
3697407|NCT02201901|3538694|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3697408|NCT02201901|3538695|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3697409|NCT02201901|3538696|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3697410|NCT02201901|3538693|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3697411|NCT02201901|3538694|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3697412|NCT02201901|3538695|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3697413|NCT02201901|3538696|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3697414|NCT02201901|3538693|B4||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
3697415|NCT02201901|3538694|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3697416|NCT02201901|3538695|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3697417|NCT02201901|3538696|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3697418|NCT02201901|3538693|B4||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3697419|NCT02201901|3538694|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3697420|NCT02201901|3538695|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3697421|NCT02201901|3538696|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3697422|NCT02201901|3538693|B4|||Age||years|Mean|58|58.0|Standard Deviation|6.3|6.3|||
3697423|NCT02201901|3538694|B3|||Age||years|Mean|58|58.0|Standard Deviation|5.8|5.8|||
3697424|NCT02201901|3538695|B2|||Age||years|Mean|58|58.0|Standard Deviation|6.9|6.9|||
3697425|NCT02201901|3538696|B1|||Age||years|Mean|58|58.0|Standard Deviation|6.3|6.3|||
3697426|NCT02201784|3538727|B3|||Weight||kg|Mean|55.5|55.5|Standard Deviation|8.27|8.27|||
3697427|NCT02201784|3538728|B2|||Weight||kg|Mean|57.17|57.17|Standard Deviation|6.65|6.65|||
3697428|NCT02201784|3538729|B1|||Weight||kg|Mean|53.83|53.83|Standard Deviation|9.44|9.44|||
3697429|NCT02201784|3538727|B3|India||Region of Enrollment||participants|Number|60|60.0||||||
3697430|NCT02201784|3538728|B2|India||Region of Enrollment||participants|Number|30|30.0||||||
3697431|NCT02201784|3538729|B1|India||Region of Enrollment||participants|Number|30|30.0||||||
3697432|NCT02201784|3538727|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3697433|NCT02201784|3538728|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3697434|NCT02201784|3538729|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3697435|NCT02201784|3538727|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3697436|NCT02201784|3538728|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3697437|NCT02201784|3538729|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3697438|NCT02201784|3538727|B3|||Age||years|Mean|37|37.0|Standard Deviation|16|16.0|||
3697439|NCT02201784|3538728|B2|||Age||years|Mean|35|35.0|Standard Deviation|16|16.0|||
3697440|NCT02201784|3538729|B1|||Age||years|Mean|38|38.0|Standard Deviation|17|17.0|||
3697441|NCT02201524|3538744|B5||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3697442|NCT02201524|3538745|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3697443|NCT02201524|3538746|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3697444|NCT02201524|3538747|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3697445|NCT02201524|3538748|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3697446|NCT02201524|3538744|B5||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3697447|NCT02201524|3538745|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3697448|NCT02201524|3538746|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3697449|NCT02201524|3538747|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3697450|NCT02201524|3538748|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3697451|NCT02201524|3538744|B5|||Age||years|Mean|45.7|45.7|Standard Deviation|11.5|11.5|||
3697452|NCT02201524|3538745|B4|||Age||years|Mean|52.1|52.1|Standard Deviation|9.7|9.7|||
3697453|NCT02201524|3538746|B3|||Age||years|Mean|42.8|42.8|Standard Deviation|11.6|11.6|||
3697454|NCT02201524|3538747|B2|||Age||years|Mean|42.9|42.9|Standard Deviation|12.3|12.3|||
3697455|NCT02201524|3538748|B1|||Age||years|Mean|45.4|45.4|Standard Deviation|10.8|10.8|||
3697456|NCT02201446|3538833|B3|||Day1 migration inhibitory factor (MIF)||ng/ml|Mean|73.64|73.64|Standard Deviation|23.27|23.27|||
3697457|NCT02201446|3538834|B2|||Day1 migration inhibitory factor (MIF)||ng/ml|Mean|NA||Standard Deviation|NA||||not collected for healthy volunteers
3697458|NCT02201446|3538835|B1|||Day1 migration inhibitory factor (MIF)||ng/ml|Mean|73.64|73.64|Standard Deviation|23.27|23.27|||
3697459|NCT02201446|3538833|B3|||Day1 interleukin-6 (IL-6)||pg/ml|Mean|101.63|101.63|Inter-Quartile Range|||79.5|138.9|
3697460|NCT02201446|3538834|B2|||Day1 interleukin-6 (IL-6)||pg/ml|Mean|NA||Inter-Quartile Range|||0.0|0.0|not collected for healthy volunteers
3697461|NCT02201446|3538835|B1|||Day1 interleukin-6 (IL-6)||pg/ml|Mean|101.63|101.63|Inter-Quartile Range|||79.5|138.9|
3697462|NCT02201446|3538833|B3|||Day1 tumor necrosis factor-α(TNF-α)||pg/ml|Mean|97.09|97.09|Inter-Quartile Range|||92.32|100.82|
3697463|NCT02201446|3538834|B2|||Day1 tumor necrosis factor-α(TNF-α)||pg/ml|Mean|NA||Inter-Quartile Range|||0.0|0.0|not collected for healthy volunteers
3697464|NCT02201446|3538835|B1|||Day1 tumor necrosis factor-α(TNF-α)||pg/ml|Mean|97.09|97.09|Inter-Quartile Range|||92.32|100.82|
3697465|NCT02201446|3538833|B3|||Blood diseases||participants|Number|0|0.0||||||
3697466|NCT02201446|3538834|B2|||Blood diseases||participants|Number|0|0.0||||||
3697467|NCT02201446|3538835|B1|||Blood diseases||participants|Number|0|0.0||||||
3697468|NCT02201446|3538833|B3|||Respiratory disease||participants|Number|2|2.0||||||
3697469|NCT02201446|3538834|B2|||Respiratory disease||participants|Number|0|0.0||||||
3697470|NCT02201446|3538835|B1|||Respiratory disease||participants|Number|2|2.0||||||
3697471|NCT02201446|3538833|B3|||Kidney disease||participants|Number|2|2.0||||||
3697472|NCT02201446|3538834|B2|||Kidney disease||participants|Number|0|0.0||||||
3697473|NCT02201446|3538835|B1|||Kidney disease||participants|Number|2|2.0||||||
3697474|NCT02201446|3538833|B3|||Hypertension||participants|Number|15|15.0||||||
3697475|NCT02201446|3538834|B2|||Hypertension||participants|Number|0|0.0||||||
3697476|NCT02201446|3538835|B1|||Hypertension||participants|Number|15|15.0||||||
3697477|NCT02201446|3538833|B3|||Diabetes mellitus||participants|Number|8|8.0||||||
3697478|NCT02201446|3538834|B2|||Diabetes mellitus||participants|Number|0|0.0||||||
3697479|NCT02201446|3538835|B1|||Diabetes mellitus||participants|Number|8|8.0||||||
3697480|NCT02201446|3538833|B3|||Inhalation injury||participants|Number|46|46.0||||||
3697481|NCT02201446|3538834|B2|||Inhalation injury||participants|Number|0|0.0||||||
3697482|NCT02201446|3538835|B1|||Inhalation injury||participants|Number|46|46.0||||||
3697483|NCT02201446|3538833|B3|||Trauma||participants|Number|35|35.0||||||
3697484|NCT02201446|3538834|B2|||Trauma||participants|Number|0|0.0||||||
3697485|NCT02201446|3538835|B1|||Trauma||participants|Number|35|35.0||||||
3697486|NCT02201446|3538833|B3|||Sequential Organ Failure Assessment(SOFA)|SOFA score ranges from 0 to 43. A higher values represent a worse outcome.|Scores on a scale|Mean|7.16|7.16|Standard Deviation|3.70|3.7|||
3697487|NCT02201446|3538834|B2|||Sequential Organ Failure Assessment(SOFA)|SOFA score ranges from 0 to 43. A higher values represent a worse outcome.|Scores on a scale|Mean|NA||Standard Deviation|NA||||Not collected for healthy volunteers
3697488|NCT02201446|3538835|B1|||Sequential Organ Failure Assessment(SOFA)|SOFA score ranges from 0 to 43. A higher values represent a worse outcome.|Scores on a scale|Mean|7.16|7.16|Standard Deviation|3.70|3.7|||
3697489|NCT02201446|3538833|B3||Male|Gender||Participants|Count of Participants|76|76.0||||||
3697490|NCT02201446|3538834|B2||Male|Gender||Participants|Count of Participants|32|32.0||||||
3697491|NCT02201446|3538835|B1||Male|Gender||Participants|Count of Participants|44|44.0||||||
3697492|NCT02201446|3538833|B3||Female|Gender||Participants|Count of Participants|63|63.0||||||
3697493|NCT02201446|3538834|B2||Female|Gender||Participants|Count of Participants|26|26.0||||||
3697494|NCT02201446|3538835|B1||Female|Gender||Participants|Count of Participants|37|37.0||||||
3697495|NCT02201446|3538833|B3|||Age|The age of participant.|years|Mean|44.47|44.47|Standard Deviation|14.58|14.58|||
3697496|NCT02201446|3538834|B2|||Age|The age of participant.|years|Mean|39.52|39.52|Standard Deviation|10.43|10.43|||
3697497|NCT02201446|3538835|B1|||Age|The age of participant.|years|Mean|48.02|48.02|Standard Deviation|16.05|16.05|||
3697498|NCT02201420|3538864|B1|HIV-||HIV Diagnosis||participants|Number|1|1.0||||||
3697499|NCT02201420|3538864|B1|HIV+||HIV Diagnosis||participants|Number|4|4.0||||||
3697500|NCT02201420|3538864|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3697501|NCT02201420|3538864|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697502|NCT02201420|3538864|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697503|NCT02201420|3538864|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3697504|NCT02201420|3538864|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3697505|NCT02201420|3538864|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697506|NCT02201420|3538864|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697507|NCT02201420|3538864|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697508|NCT02201420|3538864|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3697509|NCT02201420|3538864|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3697510|NCT02201420|3538864|B1|||Age||years|Mean|47.5|47.5|Standard Deviation|9.8|9.8|||
3697511|NCT02201394|3538869|B1||Never|Alcohol Use||Participants|Count of Participants|8|8.0||||||
3697512|NCT02201394|3538869|B1||Past|Alcohol Use||Participants|Count of Participants|3|3.0||||||
3697513|NCT02201394|3538869|B1||Current|Alcohol Use||Participants|Count of Participants|9|9.0||||||
3697514|NCT02201394|3538869|B1||Never|Smoking History||Participants|Count of Participants|10|10.0||||||
3697515|NCT02201394|3538869|B1||Past|Smoking History||Participants|Count of Participants|8|8.0||||||
3697516|NCT02201394|3538869|B1||Current|Smoking History||Participants|Count of Participants|2|2.0||||||
3697517|NCT02201394|3538869|B1|||HDL|high-density lipoprotein|mg/dL|Mean|42.5|42.5|Standard Deviation|12.6|12.6|||
3697518|NCT02201394|3538869|B1|||LDL level|low-density lipoprotein|mg/dL|Mean|85.6|85.6|Standard Deviation|51.7|51.7|||
3697519|NCT02201394|3538869|B1|||Triglycerides level||mg/dL|Mean|165.4|165.4|Standard Deviation|91.4|91.4|||
3697520|NCT02201394|3538869|B1|||Cholesterol level||mg/dL|Mean|158.7|158.7|Standard Deviation|62.0|62.0|||
3697521|NCT02201394|3538869|B1|||Hypercholesterolemia||Participants|Count of Participants|19|19.0||||||
3697522|NCT02201394|3538869|B1|||Diastolic blood pressure||mm Hg|Mean|70.6|70.6|Standard Deviation|9.0|9.0|||
3697523|NCT02201394|3538869|B1|||Systolic blood pressure||mm Hg|Mean|127.2|127.2|Standard Deviation|17.5|17.5|||
3697524|NCT02201394|3538869|B1|||Hypertension||Participants|Count of Participants|16|16.0||||||
3697525|NCT02201394|3538869|B1|||BMI|Body Mass Index|kg/m^2|Mean|30.7|30.7|Standard Deviation|4.5|4.5|||
3697526|NCT02201394|3538869|B1|||Diabetic||Participants|Count of Participants|15|15.0||||||
3697527|NCT02201394|3538869|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3697528|NCT02201394|3538869|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3697529|NCT02201394|3538869|B1|||Age||years|Mean|56.9|56.9|Standard Deviation|7.9|7.9|||
3697530|NCT02201329|3538876|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3697531|NCT02201329|3538876|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3697532|NCT02201329|3538876|B1|||Age||Years|Mean|73.2|73.2|Standard Deviation|4.6|4.6|||
3697533|NCT02201056|3538884|B8|||Body Mass Index (BMI)||kg/m^2|Mean|25.13|25.13|Standard Deviation|3.064|3.064|||
3697534|NCT02201056|3538885|B7|||Body Mass Index (BMI)||kg/m^2|Mean|25.34|25.34|Standard Deviation|4.251|4.251|||
3697535|NCT02201056|3538886|B6|||Body Mass Index (BMI)||kg/m^2|Mean|26.88|26.88|Standard Deviation|2.313|2.313|||
3697536|NCT02201056|3538887|B5|||Body Mass Index (BMI)||kg/m^2|Mean|25.51|25.51|Standard Deviation|2.539|2.539|||
3697537|NCT02201056|3538888|B4|||Body Mass Index (BMI)||kg/m^2|Mean|25.05|25.05|Standard Deviation|3.039|3.039|||
3697538|NCT02201056|3538889|B3|||Body Mass Index (BMI)||kg/m^2|Mean|25.44|25.44|Standard Deviation|3.361|3.361|||
3697539|NCT02201056|3538890|B2|||Body Mass Index (BMI)||kg/m^2|Mean|24.86|24.86|Standard Deviation|4.073|4.073|||
3697540|NCT02201056|3538891|B1|||Body Mass Index (BMI)||kg/m^2|Mean|24.00|24.0|Standard Deviation|2.532|2.532|||
3697541|NCT02201056|3538884|B8|||Weight||kg|Mean|73.00|73.0|Standard Deviation|12.178|12.178|||
3697542|NCT02201056|3538885|B7|||Weight||kg|Mean|69.28|69.28|Standard Deviation|10.981|10.981|||
3697543|NCT02201056|3538886|B6|||Weight||kg|Mean|70.10|70.1|Standard Deviation|6.214|6.214|||
3697544|NCT02201056|3538887|B5|||Weight||kg|Mean|76.85|76.85|Standard Deviation|9.465|9.465|||
3697545|NCT02201056|3538888|B4|||Weight||kg|Mean|80.18|80.18|Standard Deviation|12.039|12.039|||
3697546|NCT02201056|3538889|B3|||Weight||kg|Mean|78.25|78.25|Standard Deviation|13.623|13.623|||
3697547|NCT02201056|3538890|B2|||Weight||kg|Mean|68.88|68.88|Standard Deviation|19.873|19.873|||
3697548|NCT02201056|3538891|B1|||Weight||kg|Mean|70.23|70.23|Standard Deviation|10.478|10.478|||
3697549|NCT02201056|3538884|B8|||Height||cm|Mean|170.1|170.1|Standard Deviation|8.43|8.43|||
3697550|NCT02201056|3538885|B7|||Height||cm|Mean|165.5|165.5|Standard Deviation|2.59|2.59|||
3697551|NCT02201056|3538886|B6|||Height||cm|Mean|161.5|161.5|Standard Deviation|2.88|2.88|||
3697552|NCT02201056|3538887|B5|||Height||cm|Mean|173.5|173.5|Standard Deviation|8.89|8.89|||
3697553|NCT02201056|3538888|B4|||Height||cm|Mean|178.7|178.7|Standard Deviation|7.31|7.31|||
3697554|NCT02201056|3538889|B3|||Height||cm|Mean|175.0|175.0|Standard Deviation|5.59|5.59|||
3697555|NCT02201056|3538890|B2|||Height||cm|Mean|165.0|165.0|Standard Deviation|11.52|11.52|||
3697556|NCT02201056|3538891|B1|||Height||cm|Mean|170.8|170.8|Standard Deviation|5.99|5.99|||
3697557|NCT02201056|3538884|B8|United States||Region of Enrollment||participants|Number|48|48.0||||||
3697558|NCT02201056|3538885|B7|United States||Region of Enrollment||participants|Number|6|6.0||||||
3697559|NCT02201056|3538886|B6|United States||Region of Enrollment||participants|Number|6|6.0||||||
3697560|NCT02201056|3538887|B5|United States||Region of Enrollment||participants|Number|6|6.0||||||
3697561|NCT02201056|3538888|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
3697562|NCT02201056|3538889|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3697563|NCT02201056|3538890|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3697564|NCT02201056|3538891|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3697565|NCT02201056|3538884|B8|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
3697566|NCT02201056|3538885|B7|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3697567|NCT02201056|3538886|B6|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3697568|NCT02201056|3538887|B5|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3697569|NCT02201056|3538888|B4|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3697570|NCT02201056|3538889|B3|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3697571|NCT02201056|3538890|B2|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3697572|NCT02201056|3538891|B1|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3697573|NCT02201056|3538884|B8|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3697574|NCT02201056|3538885|B7|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3697575|NCT02201056|3538886|B6|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3697576|NCT02201056|3538887|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3697577|NCT02201056|3538888|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3697578|NCT02201056|3538889|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3697579|NCT02201056|3538890|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3697580|NCT02201056|3538891|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3697581|NCT02201056|3538884|B8|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3697582|NCT02201056|3538885|B7|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3697583|NCT02201056|3538886|B6|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3697584|NCT02201056|3538887|B5|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3697585|NCT02201056|3538888|B4|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3697586|NCT02201056|3538889|B3|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3697587|NCT02201056|3538890|B2|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3697588|NCT02201056|3538891|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3697589|NCT02201056|3538884|B8|White||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
3697590|NCT02201056|3538885|B7|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3697591|NCT02201056|3538886|B6|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3697592|NCT02201056|3538887|B5|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3697593|NCT02201056|3538888|B4|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3697594|NCT02201056|3538889|B3|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3697595|NCT02201056|3538890|B2|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3697596|NCT02201056|3538891|B1|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3697597|NCT02201056|3538884|B8|Black or African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3697598|NCT02201056|3538885|B7|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3697599|NCT02201056|3538886|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3697600|NCT02201056|3538887|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3697601|NCT02201056|3538888|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3697602|NCT02201056|3538889|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3697603|NCT02201056|3538890|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3697604|NCT02201056|3538891|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3697605|NCT02201056|3538884|B8||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3697606|NCT02201056|3538885|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3697607|NCT02201056|3538886|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3697608|NCT02201056|3538887|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3697609|NCT02201056|3538888|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3697610|NCT02201056|3538889|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3697611|NCT02201056|3538890|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3697612|NCT02201056|3538891|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3697613|NCT02201056|3538884|B8||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3697614|NCT02201056|3538885|B7||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3697615|NCT02201056|3538886|B6||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3697616|NCT02201056|3538887|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3697617|NCT02201056|3538888|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3697618|NCT02201056|3538889|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3697619|NCT02201056|3538890|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3697620|NCT02201056|3538891|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3697621|NCT02201056|3538884|B8|||Age||years|Mean|33.6|33.6|Standard Deviation|10.15|10.15|||
3697622|NCT02201056|3538885|B7|||Age||years|Mean|32.8|32.8|Standard Deviation|12.97|12.97|||
3697623|NCT02201056|3538886|B6|||Age||years|Mean|30.5|30.5|Standard Deviation|10.33|10.33|||
3697624|NCT02201056|3538887|B5|||Age||years|Mean|35.3|35.3|Standard Deviation|13.31|13.31|||
3697625|NCT02201056|3538888|B4|||Age||years|Mean|29.8|29.8|Standard Deviation|6.74|6.74|||
3697626|NCT02201056|3538889|B3|||Age||years|Mean|34.3|34.3|Standard Deviation|10.93|10.93|||
3697627|NCT02201056|3538890|B2|||Age||years|Mean|34.2|34.2|Standard Deviation|8.21|8.21|||
3697628|NCT02201056|3538891|B1|||Age||years|Mean|35.9|35.9|Standard Deviation|10.41|10.41|||
3697629|NCT02200536|3538952|B4||Male|Sex: Female, Male|Infant's gender, Male/Female|Participants|Count of Participants|33|33.0||||||
3697630|NCT02200536|3538953|B3||Male|Sex: Female, Male|Infant's gender, Male/Female|Participants|Count of Participants|11|11.0||||||
3697631|NCT02200536|3538954|B2||Male|Sex: Female, Male|Infant's gender, Male/Female|Participants|Count of Participants|9|9.0||||||
3697632|NCT02200536|3538955|B1||Male|Sex: Female, Male|Infant's gender, Male/Female|Participants|Count of Participants|13|13.0||||||
3697633|NCT02200536|3538952|B4||Female|Sex: Female, Male|Infant's gender, Male/Female|Participants|Count of Participants|59|59.0||||||
3697634|NCT02200536|3538953|B3||Female|Sex: Female, Male|Infant's gender, Male/Female|Participants|Count of Participants|19|19.0||||||
3697635|NCT02200536|3538954|B2||Female|Sex: Female, Male|Infant's gender, Male/Female|Participants|Count of Participants|21|21.0||||||
3697636|NCT02200536|3538955|B1||Female|Sex: Female, Male|Infant's gender, Male/Female|Participants|Count of Participants|19|19.0||||||
3697637|NCT02200536|3538952|B4|< 30 years old||Age, Customized|Mother's age|participants|Number|48|48.0||||||
3697638|NCT02200536|3538953|B3|< 30 years old||Age, Customized|Mother's age|participants|Number|13|13.0||||||
3697639|NCT02200536|3538954|B2|< 30 years old||Age, Customized|Mother's age|participants|Number|14|14.0||||||
3697640|NCT02200536|3538955|B1|< 30 years old||Age, Customized|Mother's age|participants|Number|21|21.0||||||
3697641|NCT02200536|3538952|B4|≥ 30 years old||Age, Customized|Mother's age|participants|Number|44|44.0||||||
3697642|NCT02200536|3538953|B3|≥ 30 years old||Age, Customized|Mother's age|participants|Number|17|17.0||||||
3697643|NCT02200536|3538954|B2|≥ 30 years old||Age, Customized|Mother's age|participants|Number|16|16.0||||||
3697644|NCT02200536|3538955|B1|≥ 30 years old||Age, Customized|Mother's age|participants|Number|11|11.0||||||
3697645|NCT02200510|3538968|B3|United States||Region of Enrollment||Participants|Count of Participants|66|66.0||||||
3697646|NCT02200510|3538969|B2|United States||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3697647|NCT02200510|3538970|B1|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3697648|NCT02200510|3538968|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697649|NCT02200510|3538969|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697650|NCT02200510|3538970|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697651|NCT02200510|3538968|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697652|NCT02200510|3538969|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697653|NCT02200510|3538970|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697654|NCT02200510|3538968|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697655|NCT02200510|3538969|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697656|NCT02200510|3538970|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697657|NCT02200510|3538968|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3697658|NCT02200510|3538969|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3697659|NCT02200510|3538970|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3697660|NCT02200510|3538968|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697661|NCT02200510|3538969|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697662|NCT02200510|3538970|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697663|NCT02200510|3538968|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697664|NCT02200510|3538969|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697665|NCT02200510|3538970|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697666|NCT02200510|3538968|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697667|NCT02200510|3538969|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697668|NCT02200510|3538970|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697669|NCT02200510|3538968|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3697670|NCT02200510|3538969|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3697671|NCT02200510|3538970|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3697672|NCT02200510|3538968|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3697673|NCT02200510|3538969|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3697674|NCT02200510|3538970|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3697675|NCT02200510|3538968|B3|||Age||years|Mean|18.795|18.795|Standard Deviation|2.47|2.47|||
3697676|NCT02200510|3538969|B2|||Age||years|Mean|18.82|18.82|Standard Deviation|2.72|2.72|||
3697677|NCT02200510|3538970|B1|||Age||years|Mean|18.77|18.77|Standard Deviation|2.22|2.22|||
3697678|NCT02200510|3538968|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3697679|NCT02200510|3538969|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3697680|NCT02200510|3538970|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3697681|NCT02200510|3538968|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3697682|NCT02200510|3538969|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3697683|NCT02200510|3538970|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3697684|NCT02200510|3538968|B3||<=18 years|Age||Participants|Count of Participants|39|39.0||||||
3697685|NCT02200510|3538969|B2||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
3697686|NCT02200510|3538970|B1||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
3697687|NCT02200458|3538977|B1|||Fitzpatrick|A numerical classification for human skin color: Type I (scores 0–6) Pale white, blond/red hair; blue eyes; freckles - Always burns/never tans. II (7–13) White/fair; blond/red hair; blue/green/hazel eyes - Usually burns/tans minimally. III (14–20) Cream white; fair with any hair/eye color; quite common - Sometimes mild burn/uniformly. IV (21–27) Olive to moderate brown; typical Mediterranean skin tone - Rarely burns/always tans well. V (28–34) Dark brown; South Asian skin types - Very rarely burns/tans very easily. VI (35+) Deeply pigmented dark brown to black - Never burns/tans very easily|Points|Mean|20.2|20.2|Standard Deviation|7|7.0|||
3697688|NCT02200458|3538977|B1|||Weight||kg|Mean|83.2|83.2|Standard Deviation|17.6|17.6|||
3697689|NCT02200458|3538977|B1|||Height||CM|Mean|168.7|168.7|Standard Deviation|10.5|10.5|||
3697690|NCT02200458|3538977|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697691|NCT02200458|3538977|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697692|NCT02200458|3538977|B1||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3697693|NCT02200458|3538977|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3697694|NCT02200458|3538977|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697695|NCT02200458|3538977|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3697696|NCT02200458|3538977|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697697|NCT02200458|3538977|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697698|NCT02200458|3538977|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3697699|NCT02200458|3538977|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697700|NCT02200458|3538977|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3697701|NCT02200458|3538977|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3697702|NCT02200458|3538977|B1|||Age|Average Age, Years|Years|Mean|37.5|37.5|Standard Deviation|10.8|10.8|||
3697703|NCT02200328|3538981|B3|United States||Region of Enrollment||participants|Number|76|76.0||||||
3697704|NCT02200328|3538982|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
3697705|NCT02200328|3538983|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
3697706|NCT02200328|3538981|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3697707|NCT02200328|3538982|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3697708|NCT02200328|3538983|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3697709|NCT02200328|3538981|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3697710|NCT02200328|3538982|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3697711|NCT02200328|3538983|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3697712|NCT02200328|3538981|B3|||Age||years|Mean|71.4|71.4|Full Range|||55.0|98.0|
3697713|NCT02200328|3538982|B2|||Age||years|Mean|71.8|71.8|Full Range|||58.0|98.0|
3697714|NCT02200328|3538983|B1|||Age||years|Mean|71|71.0|Full Range|||55.0|96.0|
3697715|NCT02200211|3538992|B5|Strabismus/anisometropia combined||Amblyopia Cause||Participants|Count of Participants|155|155.0||||||
3697716|NCT02200211|3538993|B4|Strabismus/anisometropia combined||Amblyopia Cause||Participants|Count of Participants|22|22.0||||||
3697717|NCT02200211|3538994|B3|Strabismus/anisometropia combined||Amblyopia Cause||Participants|Count of Participants|13|13.0||||||
3697718|NCT02200211|3538995|B2|Strabismus/anisometropia combined||Amblyopia Cause||Participants|Count of Participants|59|59.0||||||
3697719|NCT02200211|3538996|B1|Strabismus/anisometropia combined||Amblyopia Cause||Participants|Count of Participants|61|61.0||||||
3697720|NCT02200211|3538992|B5|Anisometropia||Amblyopia Cause||Participants|Count of Participants|250|250.0||||||
3697721|NCT02200211|3538993|B4|Anisometropia||Amblyopia Cause||Participants|Count of Participants|29|29.0||||||
3697722|NCT02200211|3538994|B3|Anisometropia||Amblyopia Cause||Participants|Count of Participants|22|22.0||||||
3697723|NCT02200211|3538995|B2|Anisometropia||Amblyopia Cause||Participants|Count of Participants|92|92.0||||||
3697724|NCT02200211|3538996|B1|Anisometropia||Amblyopia Cause||Participants|Count of Participants|107|107.0||||||
3697725|NCT02200211|3538992|B5|Strabismus||Amblyopia Cause||Participants|Count of Participants|80|80.0||||||
3697726|NCT02200211|3538993|B4|Strabismus||Amblyopia Cause||Participants|Count of Participants|9|9.0||||||
3697727|NCT02200211|3538994|B3|Strabismus||Amblyopia Cause||Participants|Count of Participants|5|5.0||||||
3697728|NCT02200211|3538995|B2|Strabismus||Amblyopia Cause||Participants|Count of Participants|44|44.0||||||
3697729|NCT02200211|3538996|B1|Strabismus||Amblyopia Cause||Participants|Count of Participants|22|22.0||||||
3697730|NCT02200211|3538992|B5|Participants with no history of strabismus||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity was tested at near in current refractive correction. Stereoacuity scores (measured as seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool (scores: 800, 400, 200, 100, 60 and 40) stereoacuity test methods as previously described. Lower scores indicate better stereoacuity.~A logarithm base 10 transformation was used to convert stereoacuity scores (Nil was assigned a score of 4000) to the log scale to calculate descriptive statistics (reported as seconds of arc)."|Seconds of Arc|Median|NA||Full Range|||40.0|4000.0|No overall median was calculated because the younger (age 5 to <7 years) and older (age 7 to <13 years) were analyzed as separate age cohorts in effectively separate studies.
3697731|NCT02200211|3538993|B4|Participants with no history of strabismus||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity was tested at near in current refractive correction. Stereoacuity scores (measured as seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool (scores: 800, 400, 200, 100, 60 and 40) stereoacuity test methods as previously described. Lower scores indicate better stereoacuity.~A logarithm base 10 transformation was used to convert stereoacuity scores (Nil was assigned a score of 4000) to the log scale to calculate descriptive statistics (reported as seconds of arc)."|Seconds of Arc|Median|800|800.0|Full Range|||60.0|4000.0|
3697732|NCT02200211|3538994|B3|Participants with no history of strabismus||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity was tested at near in current refractive correction. Stereoacuity scores (measured as seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool (scores: 800, 400, 200, 100, 60 and 40) stereoacuity test methods as previously described. Lower scores indicate better stereoacuity.~A logarithm base 10 transformation was used to convert stereoacuity scores (Nil was assigned a score of 4000) to the log scale to calculate descriptive statistics (reported as seconds of arc)."|Seconds of Arc|Median|400|400.0|Full Range|||60.0|4000.0|
3697733|NCT02200211|3538995|B2|Participants with no history of strabismus||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity was tested at near in current refractive correction. Stereoacuity scores (measured as seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool (scores: 800, 400, 200, 100, 60 and 40) stereoacuity test methods as previously described. Lower scores indicate better stereoacuity.~A logarithm base 10 transformation was used to convert stereoacuity scores (Nil was assigned a score of 4000) to the log scale to calculate descriptive statistics (reported as seconds of arc)."|Seconds of Arc|Median|400|400.0|Full Range|||40.0|4000.0|
3697734|NCT02200211|3538996|B1|Participants with no history of strabismus||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity was tested at near in current refractive correction. Stereoacuity scores (measured as seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool (scores: 800, 400, 200, 100, 60 and 40) stereoacuity test methods as previously described. Lower scores indicate better stereoacuity.~A logarithm base 10 transformation was used to convert stereoacuity scores (Nil was assigned a score of 4000) to the log scale to calculate descriptive statistics (reported as seconds of arc)."|Seconds of Arc|Median|400|400.0|Full Range|||40.0|4000.0|
3697735|NCT02200211|3538992|B5|All participants||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity was tested at near in current refractive correction. Stereoacuity scores (measured as seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool (scores: 800, 400, 200, 100, 60 and 40) stereoacuity test methods as previously described. Lower scores indicate better stereoacuity.~A logarithm base 10 transformation was used to convert stereoacuity scores (Nil was assigned a score of 4000) to the log scale to calculate descriptive statistics (reported as seconds of arc)."|Seconds of Arc|Median|NA||Full Range|||40.0|4000.0|No overall median was calculated because the younger (age 5 to <7 years) and older (age 7 to <13 years) were analyzed as separate age cohorts in effectively separate studies.
3697736|NCT02200211|3538993|B4|All participants||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity was tested at near in current refractive correction. Stereoacuity scores (measured as seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool (scores: 800, 400, 200, 100, 60 and 40) stereoacuity test methods as previously described. Lower scores indicate better stereoacuity.~A logarithm base 10 transformation was used to convert stereoacuity scores (Nil was assigned a score of 4000) to the log scale to calculate descriptive statistics (reported as seconds of arc)."|Seconds of Arc|Median|2000|2000.0|Full Range|||40.0|4000.0|
3697737|NCT02200211|3538994|B3|All participants||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity was tested at near in current refractive correction. Stereoacuity scores (measured as seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool (scores: 800, 400, 200, 100, 60 and 40) stereoacuity test methods as previously described. Lower scores indicate better stereoacuity.~A logarithm base 10 transformation was used to convert stereoacuity scores (Nil was assigned a score of 4000) to the log scale to calculate descriptive statistics (reported as seconds of arc)."|Seconds of Arc|Median|800|800.0|Full Range|||60.0|4000.0|
3697738|NCT02200211|3538995|B2|All participants||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity was tested at near in current refractive correction. Stereoacuity scores (measured as seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool (scores: 800, 400, 200, 100, 60 and 40) stereoacuity test methods as previously described. Lower scores indicate better stereoacuity.~A logarithm base 10 transformation was used to convert stereoacuity scores (Nil was assigned a score of 4000) to the log scale to calculate descriptive statistics (reported as seconds of arc)."|Seconds of Arc|Median|800|800.0|Full Range|||40.0|4000.0|
3697739|NCT02200211|3538996|B1|All participants||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity was tested at near in current refractive correction. Stereoacuity scores (measured as seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool (scores: 800, 400, 200, 100, 60 and 40) stereoacuity test methods as previously described. Lower scores indicate better stereoacuity.~A logarithm base 10 transformation was used to convert stereoacuity scores (Nil was assigned a score of 4000) to the log scale to calculate descriptive statistics (reported as seconds of arc)."|Seconds of Arc|Median|2000|2000.0|Full Range|||40.0|4000.0|
3697784|NCT02200211|3538996|B1|20/40 (68-72 Letters)||Distance Amblyopic-Eye Visual Acuity||Participants|Count of Participants|27|27.0||||||
3697785|NCT02200211|3538992|B5|20/50 (63-67 Letters)||Distance Amblyopic-Eye Visual Acuity||Participants|Count of Participants|139|139.0||||||
3697905|NCT02200055|3539095|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3697740|NCT02200211|3538992|B5|40||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity.~Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted."|Participants|Count of Participants|10|10.0||||||
3697741|NCT02200211|3538993|B4|40||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity.~Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted."|Participants|Count of Participants|2|2.0||||||
3697742|NCT02200211|3538994|B3|40||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity.~Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted."|Participants|Count of Participants|0|0.0||||||
3697743|NCT02200211|3538995|B2|40||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity.~Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted."|Participants|Count of Participants|6|6.0||||||
3697744|NCT02200211|3538996|B1|40||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity.~Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted."|Participants|Count of Participants|2|2.0||||||
3697745|NCT02200211|3538992|B5|60||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity.~Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted."|Participants|Count of Participants|21|21.0||||||
3697746|NCT02200211|3538993|B4|60||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity.~Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted."|Participants|Count of Participants|1|1.0||||||
3697747|NCT02200211|3538994|B3|60||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity.~Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted."|Participants|Count of Participants|1|1.0||||||
3697748|NCT02200211|3538995|B2|60||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity.~Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted."|Participants|Count of Participants|9|9.0||||||
3697749|NCT02200211|3538996|B1|60||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity.~Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted."|Participants|Count of Participants|10|10.0||||||
3697786|NCT02200211|3538993|B4|20/50 (63-67 Letters)||Distance Amblyopic-Eye Visual Acuity||Participants|Count of Participants|14|14.0||||||
3697787|NCT02200211|3538994|B3|20/50 (63-67 Letters)||Distance Amblyopic-Eye Visual Acuity||Participants|Count of Participants|12|12.0||||||
3697788|NCT02200211|3538995|B2|20/50 (63-67 Letters)||Distance Amblyopic-Eye Visual Acuity||Participants|Count of Participants|52|52.0||||||
3697789|NCT02200211|3538996|B1|20/50 (63-67 Letters)||Distance Amblyopic-Eye Visual Acuity||Participants|Count of Participants|61|61.0||||||
3697750|NCT02200211|3538992|B5|100||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity.~Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted."|Participants|Count of Participants|58|58.0||||||
3697751|NCT02200211|3538993|B4|100||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity.~Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted."|Participants|Count of Participants|6|6.0||||||
3697752|NCT02200211|3538994|B3|100||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity.~Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted."|Participants|Count of Participants|6|6.0||||||
3697753|NCT02200211|3538995|B2|100||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity.~Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted."|Participants|Count of Participants|23|23.0||||||
3697754|NCT02200211|3538996|B1|100||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity.~Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted."|Participants|Count of Participants|23|23.0||||||
3697755|NCT02200211|3538992|B5|200||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity.~Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted."|Participants|Count of Participants|47|47.0||||||
3697756|NCT02200211|3538993|B4|200||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity.~Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted."|Participants|Count of Participants|4|4.0||||||
3697757|NCT02200211|3538994|B3|200||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity.~Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted."|Participants|Count of Participants|2|2.0||||||
3697758|NCT02200211|3538995|B2|200||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity.~Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted."|Participants|Count of Participants|18|18.0||||||
3697759|NCT02200211|3538996|B1|200||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity.~Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted."|Participants|Count of Participants|23|23.0||||||
3697790|NCT02200211|3538992|B5|20/63 (58-62 Letters)||Distance Amblyopic-Eye Visual Acuity||Participants|Count of Participants|99|99.0||||||
3697791|NCT02200211|3538993|B4|20/63 (58-62 Letters)||Distance Amblyopic-Eye Visual Acuity||Participants|Count of Participants|10|10.0||||||
3697792|NCT02200211|3538994|B3|20/63 (58-62 Letters)||Distance Amblyopic-Eye Visual Acuity||Participants|Count of Participants|6|6.0||||||
3697793|NCT02200211|3538995|B2|20/63 (58-62 Letters)||Distance Amblyopic-Eye Visual Acuity||Participants|Count of Participants|46|46.0||||||
3697760|NCT02200211|3538992|B5|400||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity.~Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted."|Participants|Count of Participants|50|50.0||||||
3697761|NCT02200211|3538993|B4|400||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity.~Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted."|Participants|Count of Participants|7|7.0||||||
3697762|NCT02200211|3538994|B3|400||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity.~Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted."|Participants|Count of Participants|7|7.0||||||
3697763|NCT02200211|3538995|B2|400||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity.~Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted."|Participants|Count of Participants|19|19.0||||||
3697764|NCT02200211|3538996|B1|400||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity.~Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted."|Participants|Count of Participants|17|17.0||||||
3697765|NCT02200211|3538992|B5|800||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity.~Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted."|Participants|Count of Participants|53|53.0||||||
3697766|NCT02200211|3538993|B4|800||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity.~Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted."|Participants|Count of Participants|4|4.0||||||
3697767|NCT02200211|3538994|B3|800||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity.~Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted."|Participants|Count of Participants|5|5.0||||||
3697768|NCT02200211|3538995|B2|800||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity.~Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted."|Participants|Count of Participants|26|26.0||||||
3697769|NCT02200211|3538996|B1|800||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity.~Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted."|Participants|Count of Participants|18|18.0||||||
3697794|NCT02200211|3538996|B1|20/63 (58-62 Letters)||Distance Amblyopic-Eye Visual Acuity||Participants|Count of Participants|37|37.0||||||
3697795|NCT02200211|3538992|B5|20/80 (53-57 Letters)||Distance Amblyopic-Eye Visual Acuity||Participants|Count of Participants|73|73.0||||||
3697796|NCT02200211|3538993|B4|20/80 (53-57 Letters)||Distance Amblyopic-Eye Visual Acuity||Participants|Count of Participants|12|12.0||||||
3697797|NCT02200211|3538994|B3|20/80 (53-57 Letters)||Distance Amblyopic-Eye Visual Acuity||Participants|Count of Participants|7|7.0||||||
3697770|NCT02200211|3538992|B5|2000||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity.~Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted."|Participants|Count of Participants|75|75.0||||||
3697771|NCT02200211|3538993|B4|2000||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity.~Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted."|Participants|Count of Participants|7|7.0||||||
3697772|NCT02200211|3538994|B3|2000||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity.~Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted."|Participants|Count of Participants|3|3.0||||||
3697773|NCT02200211|3538995|B2|2000||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity.~Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted."|Participants|Count of Participants|37|37.0||||||
3697774|NCT02200211|3538996|B1|2000||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity.~Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted."|Participants|Count of Participants|28|28.0||||||
3697775|NCT02200211|3538992|B5|4000||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity.~Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted."|Participants|Count of Participants|171|171.0||||||
3697776|NCT02200211|3538993|B4|4000||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity.~Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted."|Participants|Count of Participants|29|29.0||||||
3697777|NCT02200211|3538994|B3|4000||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity.~Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted."|Participants|Count of Participants|16|16.0||||||
3697778|NCT02200211|3538995|B2|4000||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity.~Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted."|Participants|Count of Participants|57|57.0||||||
3697779|NCT02200211|3538996|B1|4000||Baseline Stereoacuity (Seconds of Arc)|"Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity.~Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted."|Participants|Count of Participants|69|69.0||||||
3697780|NCT02200211|3538992|B5|20/40 (68-72 Letters)||Distance Amblyopic-Eye Visual Acuity||Participants|Count of Participants|84|84.0||||||
3697781|NCT02200211|3538993|B4|20/40 (68-72 Letters)||Distance Amblyopic-Eye Visual Acuity||Participants|Count of Participants|5|5.0||||||
3697782|NCT02200211|3538994|B3|20/40 (68-72 Letters)||Distance Amblyopic-Eye Visual Acuity||Participants|Count of Participants|6|6.0||||||
3697783|NCT02200211|3538995|B2|20/40 (68-72 Letters)||Distance Amblyopic-Eye Visual Acuity||Participants|Count of Participants|46|46.0||||||
3697798|NCT02200211|3538995|B2|20/80 (53-57 Letters)||Distance Amblyopic-Eye Visual Acuity||Participants|Count of Participants|24|24.0||||||
3697799|NCT02200211|3538996|B1|20/80 (53-57 Letters)||Distance Amblyopic-Eye Visual Acuity||Participants|Count of Participants|30|30.0||||||
3697800|NCT02200211|3538992|B5|20/100 (48-52 Letters)||Distance Amblyopic-Eye Visual Acuity||Participants|Count of Participants|35|35.0||||||
3697801|NCT02200211|3538993|B4|20/100 (48-52 Letters)||Distance Amblyopic-Eye Visual Acuity||Participants|Count of Participants|4|4.0||||||
3697802|NCT02200211|3538994|B3|20/100 (48-52 Letters)||Distance Amblyopic-Eye Visual Acuity||Participants|Count of Participants|3|3.0||||||
3697803|NCT02200211|3538995|B2|20/100 (48-52 Letters)||Distance Amblyopic-Eye Visual Acuity||Participants|Count of Participants|12|12.0||||||
3697804|NCT02200211|3538996|B1|20/100 (48-52 Letters)||Distance Amblyopic-Eye Visual Acuity||Participants|Count of Participants|16|16.0||||||
3697805|NCT02200211|3538992|B5|20/125 (43-47 Letters)||Distance Amblyopic-Eye Visual Acuity||Participants|Count of Participants|24|24.0||||||
3697806|NCT02200211|3538993|B4|20/125 (43-47 Letters)||Distance Amblyopic-Eye Visual Acuity||Participants|Count of Participants|8|8.0||||||
3697807|NCT02200211|3538994|B3|20/125 (43-47 Letters)||Distance Amblyopic-Eye Visual Acuity||Participants|Count of Participants|4|4.0||||||
3697808|NCT02200211|3538995|B2|20/125 (43-47 Letters)||Distance Amblyopic-Eye Visual Acuity||Participants|Count of Participants|4|4.0||||||
3697809|NCT02200211|3538996|B1|20/125 (43-47 Letters)||Distance Amblyopic-Eye Visual Acuity||Participants|Count of Participants|8|8.0||||||
3697810|NCT02200211|3538992|B5|20/160 (38-42 Letters)||Distance Amblyopic-Eye Visual Acuity||Participants|Count of Participants|20|20.0||||||
3697811|NCT02200211|3538993|B4|20/160 (38-42 Letters)||Distance Amblyopic-Eye Visual Acuity||Participants|Count of Participants|5|5.0||||||
3697812|NCT02200211|3538994|B3|20/160 (38-42 Letters)||Distance Amblyopic-Eye Visual Acuity||Participants|Count of Participants|2|2.0||||||
3697813|NCT02200211|3538995|B2|20/160 (38-42 Letters)||Distance Amblyopic-Eye Visual Acuity||Participants|Count of Participants|7|7.0||||||
3697814|NCT02200211|3538996|B1|20/160 (38-42 Letters)||Distance Amblyopic-Eye Visual Acuity||Participants|Count of Participants|6|6.0||||||
3697815|NCT02200211|3538992|B5|20/200 (33-37 Letters)||Distance Amblyopic-Eye Visual Acuity||Participants|Count of Participants|11|11.0||||||
3697816|NCT02200211|3538993|B4|20/200 (33-37 Letters)||Distance Amblyopic-Eye Visual Acuity||Participants|Count of Participants|2|2.0||||||
3697817|NCT02200211|3538994|B3|20/200 (33-37 Letters)||Distance Amblyopic-Eye Visual Acuity||Participants|Count of Participants|0|0.0||||||
3697818|NCT02200211|3538995|B2|20/200 (33-37 Letters)||Distance Amblyopic-Eye Visual Acuity||Participants|Count of Participants|4|4.0||||||
3697819|NCT02200211|3538996|B1|20/200 (33-37 Letters)||Distance Amblyopic-Eye Visual Acuity||Participants|Count of Participants|5|5.0||||||
3697820|NCT02200211|3538992|B5|Unknown/not reported||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3697821|NCT02200211|3538993|B4|Unknown/not reported||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3697822|NCT02200211|3538994|B3|Unknown/not reported||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3697823|NCT02200211|3538995|B2|Unknown/not reported||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3697824|NCT02200211|3538996|B1|Unknown/not reported||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3697825|NCT02200211|3538992|B5|>1 Race||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3697826|NCT02200211|3538993|B4|>1 Race||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3697827|NCT02200211|3538994|B3|>1 Race||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3697828|NCT02200211|3538995|B2|>1 Race||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3697829|NCT02200211|3538996|B1|>1 Race||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3697830|NCT02200211|3538992|B5|Asian, American Indian, Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3697831|NCT02200211|3538993|B4|Asian, American Indian, Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3697832|NCT02200211|3538994|B3|Asian, American Indian, Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3697833|NCT02200211|3538995|B2|Asian, American Indian, Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3697834|NCT02200211|3538996|B1|Asian, American Indian, Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3697835|NCT02200211|3538992|B5|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|76|76.0||||||
3697836|NCT02200211|3538993|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3697837|NCT02200211|3538994|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3697838|NCT02200211|3538995|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3697839|NCT02200211|3538996|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3697840|NCT02200211|3538992|B5|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3697841|NCT02200211|3538993|B4|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3697842|NCT02200211|3538994|B3|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3697843|NCT02200211|3538995|B2|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3697844|NCT02200211|3538996|B1|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3697845|NCT02200211|3538992|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|352|352.0||||||
3697846|NCT02200211|3538993|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
3697847|NCT02200211|3538994|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3697848|NCT02200211|3538995|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|145|145.0||||||
3697849|NCT02200211|3538996|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|134|134.0||||||
3697850|NCT02200211|3538992|B5||Male|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
3697851|NCT02200211|3538993|B4||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3697852|NCT02200211|3538994|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3697853|NCT02200211|3538995|B2||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3697854|NCT02200211|3538996|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3697855|NCT02200211|3538992|B5||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
3697856|NCT02200211|3538993|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3697857|NCT02200211|3538994|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3697858|NCT02200211|3538995|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3697859|NCT02200211|3538996|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3697860|NCT02200211|3538992|B5|Age at enrollment, years : 13 to <17||Age, Customized||Participants|Count of Participants|100|100.0||||||
3697861|NCT02200211|3538993|B4|Age at enrollment, years : 13 to <17||Age, Customized||Participants|Count of Participants|60|60.0||||||
3697862|NCT02200211|3538994|B3|Age at enrollment, years : 13 to <17||Age, Customized||Participants|Count of Participants|40|40.0||||||
3697863|NCT02200211|3538995|B2|Age at enrollment, years : 13 to <17||Age, Customized||Participants|Count of Participants|0|0.0||||||
3697864|NCT02200211|3538996|B1|Age at enrollment, years : 13 to <17||Age, Customized||Participants|Count of Participants|0|0.0||||||
3697865|NCT02200211|3538992|B5|Age at enrollment, years : 9 to <13||Age, Customized||Participants|Count of Participants|152|152.0||||||
3697866|NCT02200211|3538993|B4|Age at enrollment, years : 9 to <13||Age, Customized||Participants|Count of Participants|0|0.0||||||
3697867|NCT02200211|3538994|B3|Age at enrollment, years : 9 to <13||Age, Customized||Participants|Count of Participants|0|0.0||||||
3697868|NCT02200211|3538995|B2|Age at enrollment, years : 9 to <13||Age, Customized||Participants|Count of Participants|83|83.0||||||
3697869|NCT02200211|3538996|B1|Age at enrollment, years : 9 to <13||Age, Customized||Participants|Count of Participants|69|69.0||||||
3697870|NCT02200211|3538992|B5|Age at enrollment, years : 7 to <9||Age, Customized||Participants|Count of Participants|140|140.0||||||
3697871|NCT02200211|3538993|B4|Age at enrollment, years : 7 to <9||Age, Customized||Participants|Count of Participants|0|0.0||||||
3697872|NCT02200211|3538994|B3|Age at enrollment, years : 7 to <9||Age, Customized||Participants|Count of Participants|0|0.0||||||
3697873|NCT02200211|3538995|B2|Age at enrollment, years : 7 to <9||Age, Customized||Participants|Count of Participants|62|62.0||||||
3697874|NCT02200211|3538996|B1|Age at enrollment, years : 7 to <9||Age, Customized||Participants|Count of Participants|78|78.0||||||
3697875|NCT02200211|3538992|B5|Age at enrollment, years : 5 to <7||Age, Customized||Participants|Count of Participants|93|93.0||||||
3697876|NCT02200211|3538993|B4|Age at enrollment, years : 5 to <7||Age, Customized||Participants|Count of Participants|0|0.0||||||
3697877|NCT02200211|3538994|B3|Age at enrollment, years : 5 to <7||Age, Customized||Participants|Count of Participants|0|0.0||||||
3697878|NCT02200211|3538995|B2|Age at enrollment, years : 5 to <7||Age, Customized||Participants|Count of Participants|50|50.0||||||
3697879|NCT02200211|3538996|B1|Age at enrollment, years : 5 to <7||Age, Customized||Participants|Count of Participants|43|43.0||||||
3697880|NCT02200211|3538992|B5|||Age||years|Mean|9.7|9.7|Standard Deviation|2.9|2.9|||
3697881|NCT02200211|3538993|B4|||Age||years|Mean|14.3|14.3|Standard Deviation|1.1|1.1|||
3697882|NCT02200211|3538994|B3|||Age||years|Mean|14.3|14.3|Standard Deviation|1.1|1.1|||
3697883|NCT02200211|3538995|B2|||Age||years|Mean|8.6|8.6|Standard Deviation|2.0|2.0|||
3697884|NCT02200211|3538996|B1|||Age||years|Mean|8.4|8.4|Standard Deviation|1.8|1.8|||
3697885|NCT02200211|3538992|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3697886|NCT02200211|3538993|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3697887|NCT02200211|3538994|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3697888|NCT02200211|3538995|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3697889|NCT02200211|3538996|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3697890|NCT02200211|3538992|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3697891|NCT02200211|3538993|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3697892|NCT02200211|3538994|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3697893|NCT02200211|3538995|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3697894|NCT02200211|3538996|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3697895|NCT02200211|3538992|B5||<=18 years|Age||Participants|Count of Participants|485|485.0||||||
3697896|NCT02200211|3538993|B4||<=18 years|Age||Participants|Count of Participants|60|60.0||||||
3697897|NCT02200211|3538994|B3||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
3697898|NCT02200211|3538995|B2||<=18 years|Age||Participants|Count of Participants|195|195.0||||||
3697899|NCT02200211|3538996|B1||<=18 years|Age||Participants|Count of Participants|190|190.0||||||
3697900|NCT02200055|3539095|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697901|NCT02200055|3539095|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3697902|NCT02200055|3539095|B1||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3697903|NCT02200055|3539095|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3697904|NCT02200055|3539095|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3697906|NCT02200055|3539095|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697907|NCT02200055|3539095|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3697908|NCT02200055|3539095|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3697909|NCT02200055|3539095|B1|||Age||years|Mean|44.5|44.5|Standard Deviation|13.9|13.9|||
3697910|NCT02199795|3539110|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3697911|NCT02199795|3539111|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3697912|NCT02199795|3539112|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3697913|NCT02199795|3539110|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3697914|NCT02199795|3539111|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3697915|NCT02199795|3539112|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3697916|NCT02199795|3539110|B3|||Age||years|Mean|44.2|44.2|Standard Deviation|28.7|28.7|||
3697917|NCT02199795|3539111|B2|||Age||years|Mean|57|57.0|Standard Deviation|31.8|31.8|||
3697918|NCT02199795|3539112|B1|||Age||years|Mean|25|25.0|Standard Deviation|7.1|7.1|||
3697919|NCT02199717|3539125|B1|Mild/Moderate||Severity of Hemophilia|Severe <1% FVIII (Factor 8 Deficiency/Hemophilia A) or FIX (Factor 9 Deficiency/Hemophilia B) Moderate/Mild >1% FVIII or FIX|Participants|Count of Participants|24|24.0||||||
3697920|NCT02199717|3539125|B1|Severe||Severity of Hemophilia|Severe <1% FVIII (Factor 8 Deficiency/Hemophilia A) or FIX (Factor 9 Deficiency/Hemophilia B) Moderate/Mild >1% FVIII or FIX|Participants|Count of Participants|42|42.0||||||
3697921|NCT02199717|3539125|B1|Mild/Moderate Hemophilia|On demand|On demand or Prophylaxis Regimen|On demand (only treated for bleeds) Prophylaxis (treated to prevent bleeds from occuring)|Participants|Count of Participants|19|19.0||||||
3697922|NCT02199717|3539125|B1|Mild/Moderate Hemophilia|On prophylaxis|On demand or Prophylaxis Regimen|On demand (only treated for bleeds) Prophylaxis (treated to prevent bleeds from occuring)|Participants|Count of Participants|5|5.0||||||
3697923|NCT02199717|3539125|B1|Severe Hemophilia|On demand|On demand or Prophylaxis Regimen|On demand (only treated for bleeds) Prophylaxis (treated to prevent bleeds from occuring)|Participants|Count of Participants|0|0.0||||||
3697924|NCT02199717|3539125|B1|Severe Hemophilia|On prophylaxis|On demand or Prophylaxis Regimen|On demand (only treated for bleeds) Prophylaxis (treated to prevent bleeds from occuring)|Participants|Count of Participants|42|42.0||||||
3697925|NCT02199717|3539125|B1|Mild/Moderate Hemophilia||BMI||kg/m2|Mean|21.93|21.93|Standard Deviation|5.34|5.34|||
3697926|NCT02199717|3539125|B1|Severe Hemophilia||BMI||kg/m2|Mean|20.05|20.05|Standard Deviation|5.82|5.82|||
3697927|NCT02199717|3539125|B1|Canada||Region of Enrollment|SickKids catchment area|participants|Number|66|66.0||||||
3697928|NCT02199717|3539125|B1|Male||Sex/Gender, Customized|All male|Participants|Number|66|66.0||||||
3697929|NCT02199717|3539125|B1|Female||Sex/Gender, Customized|All male|Participants|Number|0|0.0||||||
3697930|NCT02199717|3539125|B1|>=65 years||Age, Customized||participants|Number|0|0.0||||||
3697931|NCT02199717|3539125|B1|Between 18 and 65 years||Age, Customized||participants|Number|0|0.0||||||
3697932|NCT02199717|3539125|B1|<=18 years||Age, Customized||participants|Number|66|66.0||||||
3697933|NCT02199652|3539132|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3697934|NCT02199652|3539133|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3697935|NCT02199652|3539134|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3697936|NCT02199652|3539132|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697937|NCT02199652|3539133|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697938|NCT02199652|3539134|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697939|NCT02199652|3539132|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697940|NCT02199652|3539133|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697941|NCT02199652|3539134|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697942|NCT02199652|3539132|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3697943|NCT02199652|3539133|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3697944|NCT02199652|3539134|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3697945|NCT02199652|3539132|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3697946|NCT02199652|3539133|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3697947|NCT02199652|3539134|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3697948|NCT02199652|3539132|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697949|NCT02199652|3539133|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697950|NCT02199652|3539134|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697951|NCT02199652|3539132|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697952|NCT02199652|3539133|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697953|NCT02199652|3539134|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697954|NCT02199652|3539132|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697955|NCT02199652|3539133|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697956|NCT02199652|3539134|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3697957|NCT02199652|3539132|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3697958|NCT02199652|3539133|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3697959|NCT02199652|3539134|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3697960|NCT02199652|3539132|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3697961|NCT02199652|3539133|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3697962|NCT02199652|3539134|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3697963|NCT02199652|3539132|B3|||Age||years|Mean|39.8|39.8|Standard Deviation|14.5|14.5|||
3697964|NCT02199652|3539133|B2|||Age||years|Mean|36.3|36.3|Standard Deviation|15.9|15.9|||
3697965|NCT02199652|3539134|B1|||Age||years|Mean|43.2|43.2|Standard Deviation|12.7|12.7|||
3697966|NCT02199652|3539132|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3697967|NCT02199652|3539133|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3697968|NCT02199652|3539134|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3697969|NCT02199652|3539132|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3697970|NCT02199652|3539133|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3697971|NCT02199652|3539134|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3697972|NCT02199652|3539132|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3697973|NCT02199652|3539133|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3697974|NCT02199652|3539134|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3697975|NCT02199574|3539145|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3697976|NCT02199574|3539145|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3697977|NCT02199574|3539145|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3697978|NCT02199574|3539145|B1|||Age||years|Mean|35.6|35.6|Standard Deviation|13.30|13.3|||
3697979|NCT02199574|3539145|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3697980|NCT02199574|3539145|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3697981|NCT02199574|3539145|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3697982|NCT02199509|3539154|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3697983|NCT02199509|3539154|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3697984|NCT02199509|3539154|B1|||Age||years|Mean|65|65.0|Full Range|||42.0|79.0|
3697985|NCT02199041|3539167|B1||Relapse 2|Disease Status at HSCT|Complete remission (CR) defined as less than 5 percent leukemia blasts in a bone marrow with evidence of hematopoietic recovery. Relapse is defined as return of 5 percent leukemia blasts or more in a bone marrow after previous achieving CR. Refractory is defined as never achieving CR despite therapy, also known as induction failure. The disease status worsens going down the list with CR1 indicating the best prognosis and Relapse 2 the worst prognosis.|Participants|Count of Participants|1|1.0||||||
3697986|NCT02199041|3539167|B1||Refractory|Disease Status at HSCT|Complete remission (CR) defined as less than 5 percent leukemia blasts in a bone marrow with evidence of hematopoietic recovery. Relapse is defined as return of 5 percent leukemia blasts or more in a bone marrow after previous achieving CR. Refractory is defined as never achieving CR despite therapy, also known as induction failure. The disease status worsens going down the list with CR1 indicating the best prognosis and Relapse 2 the worst prognosis.|Participants|Count of Participants|4|4.0||||||
3697987|NCT02199041|3539167|B1||CR3|Disease Status at HSCT|Complete remission (CR) defined as less than 5 percent leukemia blasts in a bone marrow with evidence of hematopoietic recovery. Relapse is defined as return of 5 percent leukemia blasts or more in a bone marrow after previous achieving CR. Refractory is defined as never achieving CR despite therapy, also known as induction failure. The disease status worsens going down the list with CR1 indicating the best prognosis and Relapse 2 the worst prognosis.|Participants|Count of Participants|2|2.0||||||
3697988|NCT02199041|3539167|B1||CR2|Disease Status at HSCT|Complete remission (CR) defined as less than 5 percent leukemia blasts in a bone marrow with evidence of hematopoietic recovery. Relapse is defined as return of 5 percent leukemia blasts or more in a bone marrow after previous achieving CR. Refractory is defined as never achieving CR despite therapy, also known as induction failure. The disease status worsens going down the list with CR1 indicating the best prognosis and Relapse 2 the worst prognosis.|Participants|Count of Participants|3|3.0||||||
3697989|NCT02199041|3539167|B1||CR1|Disease Status at HSCT|Complete remission (CR) defined as less than 5 percent leukemia blasts in a bone marrow with evidence of hematopoietic recovery. Relapse is defined as return of 5 percent leukemia blasts or more in a bone marrow after previous achieving CR. Refractory is defined as never achieving CR despite therapy, also known as induction failure. The disease status worsens going down the list with CR1 indicating the best prognosis and Relapse 2 the worst prognosis.|Participants|Count of Participants|2|2.0||||||
3697990|NCT02199041|3539167|B1||Lymphoma, Non-Hodgkin's, Anaplastic Large Cell|Diagnosis|AL = Acute Leukemia; BM = Bone Marrow|Participants|Count of Participants|1|1.0||||||
3697991|NCT02199041|3539167|B1||AL, Myeloid, With Maturation, FAB M2, BM|Diagnosis|AL = Acute Leukemia; BM = Bone Marrow|Participants|Count of Participants|1|1.0||||||
3697992|NCT02199041|3539167|B1||AL, Myeloid, NOS, BM|Diagnosis|AL = Acute Leukemia; BM = Bone Marrow|Participants|Count of Participants|2|2.0||||||
3697993|NCT02199041|3539167|B1||AL, Myeloid, Minimal Differentiation, FAB M0, BM|Diagnosis|AL = Acute Leukemia; BM = Bone Marrow|Participants|Count of Participants|1|1.0||||||
3697994|NCT02199041|3539167|B1||AL, Monocytic, FAB M5, BM|Diagnosis|AL = Acute Leukemia; BM = Bone Marrow|Participants|Count of Participants|1|1.0||||||
3697995|NCT02199041|3539167|B1||AL, Megakaryoblastic, FAB M7, BM|Diagnosis|AL = Acute Leukemia; BM = Bone Marrow|Participants|Count of Participants|2|2.0||||||
3697996|NCT02199041|3539167|B1||AL, Lymphoblastic, Pre-T Cell, BM|Diagnosis|AL = Acute Leukemia; BM = Bone Marrow|Participants|Count of Participants|1|1.0||||||
3697997|NCT02199041|3539167|B1||AL, Lymphoblastic, Pre-B, BM|Diagnosis|AL = Acute Leukemia; BM = Bone Marrow|Participants|Count of Participants|2|2.0||||||
3697998|NCT02199041|3539167|B1||Acute Erythroleukemia, FAB M6, BM|Diagnosis|AL = Acute Leukemia; BM = Bone Marrow|Participants|Count of Participants|1|1.0||||||
3697999|NCT02199041|3539167|B1|Race|White|Race/Ethnicity, Customized|NOS = Not Otherwise Specified|Participants|Count of Participants|8|8.0||||||
3698000|NCT02199041|3539167|B1|Race|Multiple Race (NOS)|Race/Ethnicity, Customized|NOS = Not Otherwise Specified|Participants|Count of Participants|1|1.0||||||
3698001|NCT02199041|3539167|B1|Race|Black|Race/Ethnicity, Customized|NOS = Not Otherwise Specified|Participants|Count of Participants|3|3.0||||||
3698002|NCT02199041|3539167|B1|Ethnicity|South or Central American|Race/Ethnicity, Customized|NOS = Not Otherwise Specified|Participants|Count of Participants|2|2.0||||||
3698003|NCT02199041|3539167|B1|Ethnicity|Puerto Rican|Race/Ethnicity, Customized|NOS = Not Otherwise Specified|Participants|Count of Participants|1|1.0||||||
3698004|NCT02199041|3539167|B1|Ethnicity|Non Spanish Speaking, Non Hispanic|Race/Ethnicity, Customized|NOS = Not Otherwise Specified|Participants|Count of Participants|8|8.0||||||
3698005|NCT02199041|3539167|B1|Ethnicity|NOS Spanish, Hispanic, Latino|Race/Ethnicity, Customized|NOS = Not Otherwise Specified|Participants|Count of Participants|1|1.0||||||
3698006|NCT02199041|3539167|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3698007|NCT02199041|3539167|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3698008|NCT02199041|3539167|B1|||Age||years|Median|5.0|5.0|Full Range|||0.7|20.8|
3698009|NCT02199041|3539167|B1|||Age||years|Mean|8.7|8.7|Standard Deviation|7.5|7.5|||
3698010|NCT02198963|3539180|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
3698011|NCT02198963|3539180|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3698012|NCT02198963|3539180|B1|White||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
3698013|NCT02198963|3539180|B1|Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3698014|NCT02198963|3539180|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3698015|NCT02198963|3539180|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3698016|NCT02198963|3539180|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3698017|NCT02198963|3539180|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3698018|NCT02198963|3539180|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3698019|NCT02198963|3539180|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3698020|NCT02198963|3539180|B1|||Age||years|Median|35|35.0|Standard Deviation|13.3|13.3|||
3698021|NCT02198833|3539189|B3||Male|Sex: Female, Male||||0|0.0||||||
3698022|NCT02198833|3539189|B3||Female|Sex: Female, Male||||0|0.0||||||
3698023|NCT02198833|3539189|B3||>=65 years|Age||||0|0.0||||||
3698024|NCT02198833|3539189|B3||Between 18 and 65 years|Age||||0|0.0||||||
3698025|NCT02198833|3539189|B3||<=18 years|Age||||0|0.0||||||
3698026|NCT02198430|3539204|B3|Spain||Region of Enrollment||participants|Number|104|104.0||||||
3698027|NCT02198430|3539205|B2|Spain||Region of Enrollment||participants|Number|51|51.0||||||
3698028|NCT02198430|3539206|B1|Spain||Region of Enrollment||participants|Number|53|53.0||||||
3698029|NCT02198430|3539204|B3||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3698030|NCT02198430|3539205|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3698031|NCT02198430|3539206|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3698032|NCT02198430|3539204|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3698033|NCT02198430|3539205|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3698034|NCT02198430|3539206|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3698035|NCT02198430|3539204|B3|||Age||years|Mean|10.04|10.04|Standard Deviation|1.31|1.31|||
3698036|NCT02198430|3539205|B2|||Age||years|Mean|9.78|9.78|Standard Deviation|1.22|1.22|||
3698037|NCT02198430|3539206|B1|||Age||years|Mean|10.08|10.08|Standard Deviation|1.36|1.36|||
3698038|NCT02198235|3539219|B4|||BMI (Body Mass Index)||kg/m^2|Mean|26.6|26.6|Standard Deviation|5.05|5.05|||
3698039|NCT02198235|3539220|B3|||BMI (Body Mass Index)||kg/m^2|Mean|26.3|26.3|Standard Deviation|5.16|5.16|||
3698040|NCT02198235|3539221|B2|||BMI (Body Mass Index)||kg/m^2|Mean|26.3|26.3|Standard Deviation|4.37|4.37|||
3698041|NCT02198235|3539222|B1|||BMI (Body Mass Index)||kg/m^2|Mean|27.2|27.2|Standard Deviation|5.68|5.68|||
3698042|NCT02198235|3539219|B4|United States||Region of Enrollment||participants|Number|90|90.0||||||
3698043|NCT02198235|3539220|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3698044|NCT02198235|3539221|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3698045|NCT02198235|3539222|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3698046|NCT02198235|3539219|B4||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3698047|NCT02198235|3539220|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3698048|NCT02198235|3539221|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3698049|NCT02198235|3539222|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3698050|NCT02198235|3539219|B4||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3698051|NCT02198235|3539220|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3698052|NCT02198235|3539221|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3698053|NCT02198235|3539222|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3698054|NCT02198235|3539219|B4|||Age||years|Mean|51.7|51.7|Standard Deviation|15|15.0|||
3698055|NCT02198235|3539220|B3|||Age||years|Mean|52.8|52.8|Standard Deviation|14.2|14.2|||
3698056|NCT02198235|3539221|B2|||Age||years|Mean|51.1|51.1|Standard Deviation|15.3|15.3|||
3698057|NCT02198235|3539222|B1|||Age||years|Mean|51.2|51.2|Standard Deviation|15.9|15.9|||
3698109|NCT02197520|3539289|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3698058|NCT02198040|3539241|B4|||Radiological joint deterioration|Radiological joint deterioration of elbows with Pettersson score. Mean score (and standard deviation) for elbow joint evaluated in patients enrolled in the study. This scale has a range from 0 to 13 points (0 indicates no joint damage and 13 indicates maximum joint damage) to assess the hemophilic arthropathy.|units on a scale|Mean|8.61|8.61|Standard Deviation|2.809|2.809|||
3698059|NCT02198040|3539242|B3|||Radiological joint deterioration|Radiological joint deterioration of elbows with Pettersson score. Mean score (and standard deviation) for elbow joint evaluated in patients enrolled in the study. This scale has a range from 0 to 13 points (0 indicates no joint damage and 13 indicates maximum joint damage) to assess the hemophilic arthropathy.|units on a scale|Mean|7.57|7.57|Standard Deviation|2.90|2.9|||
3698060|NCT02198040|3539243|B2|||Radiological joint deterioration|Radiological joint deterioration of elbows with Pettersson score. Mean score (and standard deviation) for elbow joint evaluated in patients enrolled in the study. This scale has a range from 0 to 13 points (0 indicates no joint damage and 13 indicates maximum joint damage) to assess the hemophilic arthropathy.|units on a scale|Mean|8.50|8.5|Standard Deviation|3.40|3.4|||
3698061|NCT02198040|3539244|B1|||Radiological joint deterioration|Radiological joint deterioration of elbows with Pettersson score. Mean score (and standard deviation) for elbow joint evaluated in patients enrolled in the study. This scale has a range from 0 to 13 points (0 indicates no joint damage and 13 indicates maximum joint damage) to assess the hemophilic arthropathy.|units on a scale|Mean|9.63|9.63|Standard Deviation|1.62|1.62|||
3698062|NCT02198040|3539241|B4|Spain||Region of Enrollment||participants|Number|27|27.0||||||
3698063|NCT02198040|3539242|B3|Spain||Region of Enrollment||participants|Number|9|9.0||||||
3698064|NCT02198040|3539243|B2|Spain||Region of Enrollment||participants|Number|9|9.0||||||
3698065|NCT02198040|3539244|B1|Spain||Region of Enrollment||participants|Number|9|9.0||||||
3698066|NCT02198040|3539241|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3698067|NCT02198040|3539242|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3698068|NCT02198040|3539243|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3698069|NCT02198040|3539244|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3698070|NCT02198040|3539241|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3698071|NCT02198040|3539242|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3698072|NCT02198040|3539243|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3698073|NCT02198040|3539244|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3698074|NCT02198040|3539241|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3698075|NCT02198040|3539242|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3698076|NCT02198040|3539243|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3698077|NCT02198040|3539244|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3698078|NCT02198040|3539241|B4||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3698079|NCT02198040|3539242|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3698080|NCT02198040|3539243|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3698081|NCT02198040|3539244|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3698082|NCT02198040|3539241|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3698083|NCT02198040|3539242|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3698084|NCT02198040|3539243|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3698085|NCT02198040|3539244|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3698086|NCT02197806|3539272|B5||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3698087|NCT02197806|3539273|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3698088|NCT02197806|3539274|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3698089|NCT02197806|3539275|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3698090|NCT02197806|3539276|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3698091|NCT02197806|3539272|B5||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3698092|NCT02197806|3539273|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3698093|NCT02197806|3539274|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3698094|NCT02197806|3539275|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3698095|NCT02197806|3539276|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3698096|NCT02197806|3539272|B5|||Age||Years|Mean|49.2|49.2|Standard Deviation|3.81|3.81|||
3698097|NCT02197806|3539273|B4|||Age||Years|Mean|49.1|49.1|Standard Deviation|3.97|3.97|||
3698098|NCT02197806|3539274|B3|||Age||Years|Mean|48.7|48.7|Standard Deviation|4.16|4.16|||
3698099|NCT02197806|3539275|B2|||Age||Years|Mean|49.1|49.1|Standard Deviation|3.47|3.47|||
3698100|NCT02197806|3539276|B1|||Age||Years|Mean|49.9|49.9|Standard Deviation|3.88|3.88|||
3698101|NCT02197520|3539289|B1|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3698102|NCT02197520|3539289|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698103|NCT02197520|3539289|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698104|NCT02197520|3539289|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3698105|NCT02197520|3539289|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3698106|NCT02197520|3539289|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698107|NCT02197520|3539289|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3698108|NCT02197520|3539289|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698110|NCT02197520|3539289|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698111|NCT02197520|3539289|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698112|NCT02197520|3539289|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3698113|NCT02197520|3539289|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3698114|NCT02197520|3539289|B1|||Age||years|Mean|51.3|51.3|Standard Deviation|9.1|9.1|||
3698115|NCT02197481|3539306|B3|||Specimen weight||g|Mean|211.99|211.99|Standard Deviation|186.82|186.82|||
3698116|NCT02197481|3539307|B2|||Specimen weight||g|Mean|193.25|193.25|Standard Deviation|182.48|182.48|||
3698117|NCT02197481|3539308|B1|||Specimen weight||g|Mean|230.73|230.73|Standard Deviation|191.35|191.35|||
3698118|NCT02197481|3539306|B3|||Transection surface area||cm2|Mean|67.14|67.14|Standard Deviation|42.04|42.04|||
3698119|NCT02197481|3539307|B2|||Transection surface area||cm2|Mean|65.16|65.16|Standard Deviation|44.30|44.3|||
3698120|NCT02197481|3539308|B1|||Transection surface area||cm2|Mean|69.11|69.11|Standard Deviation|40.09|40.09|||
3698121|NCT02197481|3539306|B3|China||Region of Enrollment||participants|Number|86|86.0||||||
3698122|NCT02197481|3539307|B2|China||Region of Enrollment||participants|Number|43|43.0||||||
3698123|NCT02197481|3539308|B1|China||Region of Enrollment||participants|Number|43|43.0||||||
3698124|NCT02197481|3539306|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3698125|NCT02197481|3539307|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3698126|NCT02197481|3539308|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3698127|NCT02197481|3539306|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3698128|NCT02197481|3539307|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3698129|NCT02197481|3539308|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3698130|NCT02197481|3539306|B3|||Age||years|Mean|54.55|54.55|Standard Deviation|11.10|11.1|||
3698131|NCT02197481|3539307|B2|||Age||years|Mean|55.98|55.98|Standard Deviation|11.30|11.3|||
3698132|NCT02197481|3539308|B1|||Age||years|Mean|53.12|53.12|Standard Deviation|10.84|10.84|||
3698133|NCT02197455|3539329|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3698134|NCT02197455|3539329|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3698135|NCT02197455|3539329|B1|||Age||years|Mean|37.9|37.9|Standard Deviation|15.12|15.12|||
3698136|NCT02197377|3539334|B3|Turkey||Region of Enrollment|Three patients LMA supreme insertion failure occurred and these patients were excluded from further analysis.|participants|Number|57|57.0||||||
3698137|NCT02197377|3539335|B2|Turkey||Region of Enrollment|Three patients LMA supreme insertion failure occurred and these patients were excluded from further analysis.|participants|Number|27|27.0||||||
3698138|NCT02197377|3539336|B1|Turkey||Region of Enrollment|Three patients LMA supreme insertion failure occurred and these patients were excluded from further analysis.|participants|Number|30|30.0||||||
3698139|NCT02197377|3539334|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3698140|NCT02197377|3539335|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3698141|NCT02197377|3539336|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3698142|NCT02197377|3539334|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3698143|NCT02197377|3539335|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3698144|NCT02197377|3539336|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3698145|NCT02197377|3539334|B3||>=65 years|Age||Participants|Count of Participants|57|57.0||||||
3698146|NCT02197377|3539335|B2||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
3698147|NCT02197377|3539336|B1||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
3698148|NCT02197377|3539334|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3698149|NCT02197377|3539335|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3698150|NCT02197377|3539336|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3698151|NCT02197377|3539334|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3698152|NCT02197377|3539335|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3698153|NCT02197377|3539336|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3698154|NCT02197273|3539345|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3698155|NCT02197273|3539346|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3698156|NCT02197273|3539347|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3698157|NCT02197273|3539345|B3||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3698158|NCT02197273|3539346|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3698159|NCT02197273|3539347|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3698160|NCT02197273|3539345|B3|||Age||years|Mean|66.3|66.3|Standard Deviation|8.6|8.6|||
3698161|NCT02197273|3539346|B2|||Age||years|Mean|65.9|65.9|Standard Deviation|9.1|9.1|||
3698162|NCT02197273|3539347|B1|||Age||years|Mean|66.5|66.5|Standard Deviation|8.4|8.4|||
3698163|NCT02197247|3539358|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698164|NCT02197247|3539358|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698165|NCT02197247|3539358|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3698166|NCT02197247|3539358|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3698167|NCT02197247|3539358|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698168|NCT02197247|3539358|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3698169|NCT02197247|3539358|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698170|NCT02197247|3539358|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3698171|NCT02197247|3539358|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3698172|NCT02197247|3539358|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|11.74|11.74|||
3698173|NCT02197234|3539403|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698174|NCT02197234|3539403|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698175|NCT02197234|3539403|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3698176|NCT02197234|3539403|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698177|NCT02197234|3539403|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698178|NCT02197234|3539403|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3698179|NCT02197234|3539403|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698180|NCT02197234|3539403|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3698181|NCT02197234|3539403|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3698182|NCT02197234|3539403|B1|||Age||years|Mean|63.5|63.5|Standard Deviation|11.28|11.28|||
3698183|NCT02197130|3539422|B4||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3698184|NCT02197130|3539423|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3698185|NCT02197130|3539424|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3698186|NCT02197130|3539425|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3698187|NCT02197130|3539422|B4||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3698188|NCT02197130|3539423|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3698189|NCT02197130|3539424|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3698190|NCT02197130|3539425|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3698191|NCT02197130|3539422|B4|||Age||years|Mean|48.9|48.9|Standard Deviation|9.1|9.1|||
3698192|NCT02197130|3539423|B3|||Age||years|Mean|48.4|48.4|Standard Deviation|9.2|9.2|||
3698193|NCT02197130|3539424|B2|||Age||years|Mean|50.2|50.2|Standard Deviation|9.4|9.4|||
3698194|NCT02197130|3539425|B1|||Age||years|Mean|48.3|48.3|Standard Deviation|8.6|8.6|||
3698195|NCT02197065|3539477|B3|Hip fracture repair||Orthopedic procedure||Participants|Count of Participants|4|4.0||||||
3698196|NCT02197065|3539478|B2|Hip fracture repair||Orthopedic procedure||Participants|Count of Participants|2|2.0||||||
3698197|NCT02197065|3539479|B1|Hip fracture repair||Orthopedic procedure||Participants|Count of Participants|2|2.0||||||
3698198|NCT02197065|3539477|B3|Hip arthroplasty||Orthopedic procedure||Participants|Count of Participants|10|10.0||||||
3698199|NCT02197065|3539478|B2|Hip arthroplasty||Orthopedic procedure||Participants|Count of Participants|4|4.0||||||
3698200|NCT02197065|3539479|B1|Hip arthroplasty||Orthopedic procedure||Participants|Count of Participants|6|6.0||||||
3698201|NCT02197065|3539477|B3|Knee arthroplasty||Orthopedic procedure||Participants|Count of Participants|6|6.0||||||
3698202|NCT02197065|3539478|B2|Knee arthroplasty||Orthopedic procedure||Participants|Count of Participants|4|4.0||||||
3698203|NCT02197065|3539479|B1|Knee arthroplasty||Orthopedic procedure||Participants|Count of Participants|2|2.0||||||
3698204|NCT02197065|3539477|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3698205|NCT02197065|3539478|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3698206|NCT02197065|3539479|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3698207|NCT02197065|3539477|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698208|NCT02197065|3539478|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698209|NCT02197065|3539479|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698210|NCT02197065|3539477|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698211|NCT02197065|3539478|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698212|NCT02197065|3539479|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698213|NCT02197065|3539477|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3698214|NCT02197065|3539478|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3698215|NCT02197065|3539479|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3698216|NCT02197065|3539477|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3698217|NCT02197065|3539478|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3698218|NCT02197065|3539479|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698219|NCT02197065|3539477|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698220|NCT02197065|3539478|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698221|NCT02197065|3539479|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698222|NCT02197065|3539477|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3698223|NCT02197065|3539478|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698224|NCT02197065|3539479|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3698225|NCT02197065|3539477|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698226|NCT02197065|3539478|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698227|NCT02197065|3539479|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698228|NCT02197065|3539477|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698229|NCT02197065|3539478|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698230|NCT02197065|3539479|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698231|NCT02197065|3539477|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3698232|NCT02197065|3539478|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3698233|NCT02197065|3539479|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3698234|NCT02197065|3539477|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698235|NCT02197065|3539478|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698236|NCT02197065|3539479|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698237|NCT02197065|3539477|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3698238|NCT02197065|3539478|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3698239|NCT02197065|3539479|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3698240|NCT02197065|3539477|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3698241|NCT02197065|3539478|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3698242|NCT02197065|3539479|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3698243|NCT02197065|3539477|B3|||Age||years|Median|73|73.0|Inter-Quartile Range|||70.0|82.0|
3698244|NCT02197065|3539478|B2|||Age||years|Median|75|75.0|Inter-Quartile Range|||72.0|84.0|
3698245|NCT02197065|3539479|B1|||Age||years|Median|71|71.0|Inter-Quartile Range|||67.0|76.0|
3698246|NCT02196922|3539489|B3|United States||Region of Enrollment||participants|Number|104|104.0||||||
3698247|NCT02196922|3539490|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
3698248|NCT02196922|3539491|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
3698249|NCT02196922|3539489|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698250|NCT02196922|3539490|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698251|NCT02196922|3539491|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698252|NCT02196922|3539489|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698253|NCT02196922|3539490|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698254|NCT02196922|3539491|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698255|NCT02196922|3539489|B3||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3698256|NCT02196922|3539490|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3698257|NCT02196922|3539491|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3698258|NCT02196922|3539489|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3698259|NCT02196922|3539490|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3698260|NCT02196922|3539491|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3698261|NCT02196922|3539489|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698262|NCT02196922|3539490|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698263|NCT02196922|3539491|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698264|NCT02196922|3539489|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698265|NCT02196922|3539490|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698266|NCT02196922|3539491|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698267|NCT02196922|3539489|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698268|NCT02196922|3539490|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698269|NCT02196922|3539491|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698270|NCT02196922|3539489|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698271|NCT02196922|3539490|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698272|NCT02196922|3539491|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698273|NCT02196922|3539489|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3698274|NCT02196922|3539490|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3698275|NCT02196922|3539491|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3698276|NCT02196922|3539489|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3698277|NCT02196922|3539490|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3698278|NCT02196922|3539491|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3698279|NCT02196922|3539489|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3698280|NCT02196922|3539490|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3698281|NCT02196922|3539491|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3698282|NCT02196922|3539489|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3698283|NCT02196922|3539490|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3698284|NCT02196922|3539491|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3698285|NCT02196922|3539489|B3|||Age||years|Mean|59.9|59.9|Standard Deviation|15.1|15.1|||
3698286|NCT02196922|3539490|B2|||Age||years|Mean|58.4|58.4|Standard Deviation|15.2|15.2|||
3698287|NCT02196922|3539491|B1|||Age||years|Mean|61.1|61.1|Standard Deviation|15.0|15.0|||
3698288|NCT02196766|3539502|B1|Japan||Region of Enrollment||participants|Number|30|30.0||||||
3698289|NCT02196766|3539502|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3698290|NCT02196766|3539502|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3698291|NCT02196766|3539502|B1|||Age||years|Mean|31|31.0|Standard Deviation|7.4|7.4|||
3698292|NCT02196714|3539519|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3698293|NCT02196714|3539519|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3698294|NCT02196714|3539519|B1|||Age||Years|Mean|29.8|29.8|Standard Deviation|6.5|6.5|||
3698295|NCT02196701|3539642|B3|||Duration of Psoriasis||years|Mean|21.612|21.612|Standard Deviation|9.7253|9.7253|||
3698296|NCT02196701|3539643|B2|||Duration of Psoriasis||years|Mean|21.760|21.76|Standard Deviation|9.7403|9.7403|||
3698297|NCT02196701|3539644|B1|||Duration of Psoriasis||years|Mean|20.623|20.623|Standard Deviation|10.4819|10.4819|||
3698298|NCT02196701|3539642|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3698299|NCT02196701|3539643|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3698300|NCT02196701|3539644|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3698301|NCT02196701|3539642|B3||Black|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3698302|NCT02196701|3539643|B2||Black|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3698303|NCT02196701|3539644|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3698304|NCT02196701|3539642|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
3698305|NCT02196701|3539643|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3698306|NCT02196701|3539644|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3698307|NCT02196701|3539642|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698308|NCT02196701|3539643|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698309|NCT02196701|3539644|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698310|NCT02196701|3539642|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3698311|NCT02196701|3539643|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3698312|NCT02196701|3539644|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3698313|NCT02196701|3539642|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3698314|NCT02196701|3539643|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3698315|NCT02196701|3539644|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698316|NCT02196701|3539642|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3698317|NCT02196701|3539643|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3698318|NCT02196701|3539644|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3698319|NCT02196701|3539642|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3698320|NCT02196701|3539643|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3698321|NCT02196701|3539644|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3698322|NCT02196701|3539642|B3||≥ 65 years|Age, Customized||Participants|Count of Participants|5|5.0||||||
3698323|NCT02196701|3539643|B2||≥ 65 years|Age, Customized||Participants|Count of Participants|5|5.0||||||
3698324|NCT02196701|3539644|B1||≥ 65 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3698325|NCT02196701|3539642|B3||40 - 64 years|Age, Customized||Participants|Count of Participants|26|26.0||||||
3698326|NCT02196701|3539643|B2||40 - 64 years|Age, Customized||Participants|Count of Participants|22|22.0||||||
3698327|NCT02196701|3539644|B1||40 - 64 years|Age, Customized||Participants|Count of Participants|4|4.0||||||
3698328|NCT02196701|3539642|B3||< 40 years|Age, Customized||Participants|Count of Participants|15|15.0||||||
3698329|NCT02196701|3539643|B2||< 40 years|Age, Customized||Participants|Count of Participants|13|13.0||||||
3698330|NCT02196701|3539644|B1||< 40 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
3698331|NCT02196701|3539642|B3|||Age||years|Mean|46.5|46.5|Standard Deviation|12.20|12.2|||
3698332|NCT02196701|3539643|B2|||Age||years|Mean|47.3|47.3|Standard Deviation|11.91|11.91|||
3698333|NCT02196701|3539644|B1|||Age||years|Mean|41.0|41.0|Standard Deviation|13.84|13.84|||
3698334|NCT02196675|3539700|B4|Korea, Republic of||Region of Enrollment||participants|Number|103|103.0||||||
3698335|NCT02196675|3539701|B3|Korea, Republic of||Region of Enrollment||participants|Number|8|8.0||||||
3698336|NCT02196675|3539702|B2|Korea, Republic of||Region of Enrollment||participants|Number|69|69.0||||||
3698337|NCT02196675|3539703|B1|Korea, Republic of||Region of Enrollment||participants|Number|26|26.0||||||
3698338|NCT02196675|3539700|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698339|NCT02196675|3539701|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698340|NCT02196675|3539702|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698341|NCT02196675|3539703|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698342|NCT02196675|3539700|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698343|NCT02196675|3539701|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698344|NCT02196675|3539702|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698345|NCT02196675|3539703|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698346|NCT02196675|3539700|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698347|NCT02196675|3539701|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698348|NCT02196675|3539702|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698349|NCT02196675|3539703|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698350|NCT02196675|3539700|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698351|NCT02196675|3539701|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698352|NCT02196675|3539702|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698353|NCT02196675|3539703|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698354|NCT02196675|3539700|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698355|NCT02196675|3539701|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698356|NCT02196675|3539702|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698357|NCT02196675|3539703|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698358|NCT02196675|3539700|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
3698359|NCT02196675|3539701|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3698360|NCT02196675|3539702|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3698361|NCT02196675|3539703|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3698362|NCT02196675|3539700|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698363|NCT02196675|3539701|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698364|NCT02196675|3539702|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698365|NCT02196675|3539703|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698366|NCT02196675|3539700|B4||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3698367|NCT02196675|3539701|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3698368|NCT02196675|3539702|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3698369|NCT02196675|3539703|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3698370|NCT02196675|3539700|B4||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3698371|NCT02196675|3539701|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3698372|NCT02196675|3539702|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3698373|NCT02196675|3539703|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3698374|NCT02196675|3539700|B4|||Age||years|Mean|61.2|61.2|Standard Deviation|10.47|10.47|||
3698375|NCT02196675|3539701|B3|||Age||years|Mean|61.6|61.6|Standard Deviation|8.09|8.09|||
3698376|NCT02196675|3539702|B2|||Age||years|Mean|60.5|60.5|Standard Deviation|10.41|10.41|||
3698377|NCT02196675|3539703|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|11.39|11.39|||
3698378|NCT02196506|3539725|B3|Germany||Region of Enrollment||participants|Number|56|56.0||||||
3698379|NCT02196506|3539726|B2|Germany||Region of Enrollment||participants|Number|29|29.0||||||
3698380|NCT02196506|3539727|B1|Germany||Region of Enrollment||participants|Number|27|27.0||||||
3698381|NCT02196506|3539725|B3|Slovakia||Region of Enrollment||participants|Number|48|48.0||||||
3698382|NCT02196506|3539726|B2|Slovakia||Region of Enrollment||participants|Number|25|25.0||||||
3698383|NCT02196506|3539727|B1|Slovakia||Region of Enrollment||participants|Number|23|23.0||||||
3698384|NCT02196506|3539725|B3|Poland||Region of Enrollment||participants|Number|52|52.0||||||
3698385|NCT02196506|3539726|B2|Poland||Region of Enrollment||participants|Number|26|26.0||||||
3698386|NCT02196506|3539727|B1|Poland||Region of Enrollment||participants|Number|26|26.0||||||
3698387|NCT02196506|3539725|B3|United States||Region of Enrollment||participants|Number|206|206.0||||||
3698388|NCT02196506|3539726|B2|United States||Region of Enrollment||participants|Number|106|106.0||||||
3698389|NCT02196506|3539727|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
3698390|NCT02196506|3539725|B3|Hungary||Region of Enrollment||participants|Number|32|32.0||||||
3698391|NCT02196506|3539726|B2|Hungary||Region of Enrollment||participants|Number|16|16.0||||||
3698392|NCT02196506|3539727|B1|Hungary||Region of Enrollment||participants|Number|16|16.0||||||
3698393|NCT02196506|3539725|B3|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3698394|NCT02196506|3539726|B2|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3698395|NCT02196506|3539727|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3698396|NCT02196506|3539725|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|373|373.0||||||
3698397|NCT02196506|3539726|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|192|192.0||||||
3698398|NCT02196506|3539727|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|181|181.0||||||
3698399|NCT02196506|3539725|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3698400|NCT02196506|3539726|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3698401|NCT02196506|3539727|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3698402|NCT02196506|3539725|B3||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3698403|NCT02196506|3539726|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3698404|NCT02196506|3539727|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3698405|NCT02196506|3539725|B3||Female|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
3698406|NCT02196506|3539726|B2||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3698407|NCT02196506|3539727|B1||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3698408|NCT02196506|3539725|B3|||Age||years|Mean|42.9|42.9|Standard Deviation|12.6|12.6|||
3698409|NCT02196506|3539726|B2|||Age||years|Mean|42.7|42.7|Standard Deviation|12.5|12.5|||
3698410|NCT02196506|3539727|B1|||Age||years|Mean|43.0|43.0|Standard Deviation|12.7|12.7|||
3698411|NCT02196259|3539742|B4|United States||Region of Enrollment||participants|Number|13|13.0||||||
3698412|NCT02196259|3539743|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3698413|NCT02196259|3539744|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3698414|NCT02196259|3539745|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3698415|NCT02196259|3539742|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3698416|NCT02196259|3539743|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3698417|NCT02196259|3539744|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3698418|NCT02196259|3539745|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3698419|NCT02196259|3539742|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3698420|NCT02196259|3539743|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3698421|NCT02196259|3539744|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3698422|NCT02196259|3539745|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3698423|NCT02196259|3539742|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3698424|NCT02196259|3539743|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3698425|NCT02196259|3539744|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3698426|NCT02196259|3539745|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3698427|NCT02196259|3539742|B4||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3698428|NCT02196259|3539743|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3698429|NCT02196259|3539744|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3698430|NCT02196259|3539745|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3698431|NCT02196259|3539742|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3698432|NCT02196259|3539743|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3698433|NCT02196259|3539744|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3698434|NCT02196259|3539745|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3698435|NCT02196168|3539754|B3|Canada||Region of Enrollment||participants|Number|6|6.0||||||
3698436|NCT02196168|3539756|B1|Canada||Region of Enrollment||participants|Number|6|6.0||||||
3698437|NCT02196168|3539754|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3698438|NCT02196168|3539756|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3698439|NCT02196168|3539754|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3698440|NCT02196168|3539756|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3698441|NCT02196168|3539754|B3|||Age||years|Median|66|66.0|Full Range|||56.0|84.0|
3698442|NCT02196168|3539756|B1|||Age||years|Median|66|66.0|Full Range|||56.0|84.0|
3698443|NCT02196168|3539754|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3698444|NCT02196168|3539756|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3698445|NCT02196168|3539754|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3698446|NCT02196168|3539756|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3698447|NCT02196168|3539754|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3698448|NCT02196168|3539756|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3698449|NCT02196077|3539775|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3698450|NCT02196077|3539775|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3698451|NCT02196077|3539775|B1|||Age||Years|Mean|62.2|62.2|Standard Deviation|8.4|8.4|||
3698452|NCT02195986|3539822|B4|||BMI||kg/m^2|Mean|26.4|26.4|Standard Deviation|4.42|4.42|||
3698453|NCT02195986|3539823|B3|||BMI||kg/m^2|Mean|25.6|25.6|Standard Deviation|4.11|4.11|||
3698454|NCT02195986|3539824|B2|||BMI||kg/m^2|Mean|26.6|26.6|Standard Deviation|4.56|4.56|||
3698455|NCT02195986|3539825|B1|||BMI||kg/m^2|Mean|26.6|26.6|Standard Deviation|4.41|4.41|||
3698456|NCT02195986|3539822|B4|||Weight||kg|Mean|69.19|69.19|Standard Deviation|12.44|12.44|||
3698457|NCT02195986|3539823|B3|||Weight||kg|Mean|67.61|67.61|Standard Deviation|11.37|11.37|||
3698458|NCT02195986|3539824|B2|||Weight||kg|Mean|69.39|69.39|Standard Deviation|12.67|12.67|||
3698459|NCT02195986|3539825|B1|||Weight||kg|Mean|69.77|69.77|Standard Deviation|12.74|12.74|||
3698460|NCT02195986|3539822|B4|||Height||cm|Mean|161.9|161.9|Standard Deviation|6.35|6.35|||
3698461|NCT02195986|3539823|B3|||Height||cm|Mean|162.6|162.6|Standard Deviation|6.55|6.55|||
3698462|NCT02195986|3539824|B2|||Height||cm|Mean|161.5|161.5|Standard Deviation|6.18|6.18|||
3698463|NCT02195986|3539825|B1|||Height||cm|Mean|162.1|162.1|Standard Deviation|6.43|6.43|||
3698464|NCT02195986|3539822|B4|United States||Region of Enrollment||participants|Number|366|366.0||||||
3698465|NCT02195986|3539823|B3|United States||Region of Enrollment||participants|Number|73|73.0||||||
3698466|NCT02195986|3539824|B2|United States||Region of Enrollment||participants|Number|147|147.0||||||
3698467|NCT02195986|3539825|B1|United States||Region of Enrollment||participants|Number|146|146.0||||||
3698468|NCT02195986|3539822|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698469|NCT02195986|3539823|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698470|NCT02195986|3539824|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698471|NCT02195986|3539825|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698472|NCT02195986|3539822|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698473|NCT02195986|3539823|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698474|NCT02195986|3539824|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698475|NCT02195986|3539825|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698476|NCT02195986|3539822|B4||White|Race (NIH/OMB)||Participants|Count of Participants|316|316.0||||||
3698477|NCT02195986|3539823|B3||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3698478|NCT02195986|3539824|B2||White|Race (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
3698479|NCT02195986|3539825|B1||White|Race (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
3698480|NCT02195986|3539822|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3698481|NCT02195986|3539823|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3698482|NCT02195986|3539824|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3698483|NCT02195986|3539825|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3698484|NCT02195986|3539822|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698485|NCT02195986|3539823|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698486|NCT02195986|3539824|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698487|NCT02195986|3539825|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698488|NCT02195986|3539822|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3698489|NCT02195986|3539823|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3698490|NCT02195986|3539824|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3698491|NCT02195986|3539825|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3698492|NCT02195986|3539822|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3698493|NCT02195986|3539823|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698494|NCT02195986|3539824|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3698495|NCT02195986|3539825|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698496|NCT02195986|3539822|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698497|NCT02195986|3539823|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698498|NCT02195986|3539824|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698499|NCT02195986|3539825|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698500|NCT02195986|3539822|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|300|300.0||||||
3698501|NCT02195986|3539823|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3698502|NCT02195986|3539824|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
3698503|NCT02195986|3539825|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|116|116.0||||||
3698504|NCT02195986|3539822|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3698505|NCT02195986|3539823|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3698506|NCT02195986|3539824|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3698507|NCT02195986|3539825|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3698508|NCT02195986|3539822|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3698509|NCT02195986|3539823|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3698510|NCT02195986|3539824|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3698511|NCT02195986|3539825|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3698512|NCT02195986|3539822|B4||Female|Sex: Female, Male||Participants|Count of Participants|366|366.0||||||
3698513|NCT02195986|3539823|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3698514|NCT02195986|3539824|B2||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3698515|NCT02195986|3539825|B1||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3698516|NCT02195986|3539822|B4|||Age||years|Mean|59.4|59.4|Standard Deviation|5.61|5.61|||
3698517|NCT02195986|3539823|B3|||Age||years|Mean|59.4|59.4|Standard Deviation|5.82|5.82|||
3698518|NCT02195986|3539824|B2|||Age||years|Mean|59.6|59.6|Standard Deviation|5.88|5.88|||
3698519|NCT02195986|3539825|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|5.25|5.25|||
3698520|NCT02195986|3539822|B4||>=65 years|Age||Participants|Count of Participants|53|53.0||||||
3698521|NCT02195986|3539823|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3698522|NCT02195986|3539824|B2||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3698523|NCT02195986|3539825|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3698524|NCT02195986|3539822|B4||Between 18 and 65 years|Age||Participants|Count of Participants|313|313.0||||||
3698525|NCT02195986|3539823|B3||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
3698526|NCT02195986|3539824|B2||Between 18 and 65 years|Age||Participants|Count of Participants|124|124.0||||||
3698527|NCT02195986|3539825|B1||Between 18 and 65 years|Age||Participants|Count of Participants|128|128.0||||||
3698528|NCT02195986|3539822|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3698529|NCT02195986|3539823|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3698530|NCT02195986|3539824|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3698531|NCT02195986|3539825|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3698532|NCT02195895|3539842|B1||ASIA D (Motor Incomplete Injury)|American Spinal Injury Association (ASIA) Impairment Scale|"ASIA impairment scale describes a person's functional impairment as a result of their spinal cord injury.~A = Complete. No motor or sensory function in the lowest sacral spine segment (S4-5).~B = Sensory Incomplete. Sensory function below the neurological level of injury (NLI) and in S4-S5, no motor function below NLI.~C = Motor Incomplete. Motor function is preserved below NLI and more than half of the key muscle groups below NLI have a muscle grade < 3.~D = Motor Incomplete. Motor function is preserved below NLI and at least half of the key muscle groups below NLI have a muscle grade 3."|Participants|Count of Participants|0|0.0||||||
3698533|NCT02195895|3539842|B1||ASIA C (Motor Incomplete Injury)|American Spinal Injury Association (ASIA) Impairment Scale|"ASIA impairment scale describes a person's functional impairment as a result of their spinal cord injury.~A = Complete. No motor or sensory function in the lowest sacral spine segment (S4-5).~B = Sensory Incomplete. Sensory function below the neurological level of injury (NLI) and in S4-S5, no motor function below NLI.~C = Motor Incomplete. Motor function is preserved below NLI and more than half of the key muscle groups below NLI have a muscle grade < 3.~D = Motor Incomplete. Motor function is preserved below NLI and at least half of the key muscle groups below NLI have a muscle grade 3."|Participants|Count of Participants|4|4.0||||||
3698534|NCT02195895|3539842|B1||ASIA B (Sensory Incomplete Injury)|American Spinal Injury Association (ASIA) Impairment Scale|"ASIA impairment scale describes a person's functional impairment as a result of their spinal cord injury.~A = Complete. No motor or sensory function in the lowest sacral spine segment (S4-5).~B = Sensory Incomplete. Sensory function below the neurological level of injury (NLI) and in S4-S5, no motor function below NLI.~C = Motor Incomplete. Motor function is preserved below NLI and more than half of the key muscle groups below NLI have a muscle grade < 3.~D = Motor Incomplete. Motor function is preserved below NLI and at least half of the key muscle groups below NLI have a muscle grade 3."|Participants|Count of Participants|1|1.0||||||
3698535|NCT02195895|3539842|B1||ASIA A (Complete Injury)|American Spinal Injury Association (ASIA) Impairment Scale|"ASIA impairment scale describes a person's functional impairment as a result of their spinal cord injury.~A = Complete. No motor or sensory function in the lowest sacral spine segment (S4-5).~B = Sensory Incomplete. Sensory function below the neurological level of injury (NLI) and in S4-S5, no motor function below NLI.~C = Motor Incomplete. Motor function is preserved below NLI and more than half of the key muscle groups below NLI have a muscle grade < 3.~D = Motor Incomplete. Motor function is preserved below NLI and at least half of the key muscle groups below NLI have a muscle grade 3."|Participants|Count of Participants|12|12.0||||||
3698536|NCT02195895|3539842|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698537|NCT02195895|3539842|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698538|NCT02195895|3539842|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3698539|NCT02195895|3539842|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3698540|NCT02195895|3539842|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698541|NCT02195895|3539842|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3698542|NCT02195895|3539842|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698543|NCT02195895|3539842|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698544|NCT02195895|3539842|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3698545|NCT02195895|3539842|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3698546|NCT02195895|3539842|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3698547|NCT02195895|3539842|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3698548|NCT02195895|3539842|B1|||Age||years|Mean|23.24|23.24|Full Range|||17.22|42.32|
3698549|NCT02195713|3539850|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
3698550|NCT02195713|3539851|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3698551|NCT02195713|3539852|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3698552|NCT02195713|3539850|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3698553|NCT02195713|3539851|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3698554|NCT02195713|3539852|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3698555|NCT02195713|3539850|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3698556|NCT02195713|3539851|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3698557|NCT02195713|3539852|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3698558|NCT02195713|3539850|B3|||Age||years|Mean|49|49.0|Standard Deviation|20.2|20.2|||
3698559|NCT02195713|3539851|B2|||Age||years|Mean|52|52.0|Standard Deviation|17.9|17.9|||
3698560|NCT02195713|3539852|B1|||Age||years|Mean|44|44.0|Standard Deviation|22|22.0|||
3698588|NCT02195700|3539859|B3||=12 years or fewer of formal education|Education Level||Participants|Count of Participants|60|60.0||||||
3698561|NCT02195700|3539859|B3|||Modified Craniocervical Dystonia Questionnaire (CDQ-24)|The CDQ-24 is a disease-specific quality of life questionnaire developed for use in patients with craniocervical dystonia, including both cervical dystonia (CD) and blepharospasm (BPS). The CDQ 24 was modified such that the questions focus more directly on the impact of TD (as opposed to CD/BPS) on quality of life. Each of the 24 questions was rated by patients on a scale of 0=no impairment to 4=severest impairment for a total scale of 0 (no impairment) to 96 (severe impairment).|units on a scale|Mean|39.1|39.1|Standard Deviation|19.26|19.26|||
3698562|NCT02195700|3539860|B2|||Modified Craniocervical Dystonia Questionnaire (CDQ-24)|The CDQ-24 is a disease-specific quality of life questionnaire developed for use in patients with craniocervical dystonia, including both cervical dystonia (CD) and blepharospasm (BPS). The CDQ 24 was modified such that the questions focus more directly on the impact of TD (as opposed to CD/BPS) on quality of life. Each of the 24 questions was rated by patients on a scale of 0=no impairment to 4=severest impairment for a total scale of 0 (no impairment) to 96 (severe impairment).|units on a scale|Mean|39.7|39.7|Standard Deviation|18.17|18.17|||
3698563|NCT02195700|3539861|B1|||Modified Craniocervical Dystonia Questionnaire (CDQ-24)|The CDQ-24 is a disease-specific quality of life questionnaire developed for use in patients with craniocervical dystonia, including both cervical dystonia (CD) and blepharospasm (BPS). The CDQ 24 was modified such that the questions focus more directly on the impact of TD (as opposed to CD/BPS) on quality of life. Each of the 24 questions was rated by patients on a scale of 0=no impairment to 4=severest impairment for a total scale of 0 (no impairment) to 96 (severe impairment).|units on a scale|Mean|38.4|38.4|Standard Deviation|20.41|20.41|||
3698564|NCT02195700|3539859|B3|||Centrally Read Abnormal Involuntary Movement Scale (AIMS) Score|"AIMS is an assessment tool used to detect and follow the severity of TD over time. The AIMS is composed of 12 clinician-administered and scored items. AIMS was digitally video recorded using a standard protocol and independently reviewed by blinded central raters who were experts in movement disorders.~This data sums items 1 through 7 which cover orofacial movements, and extremity and truncal dyskinesia. Severity ratings were from 0 (none) to 4 (severe) for a total scale of 0 (no orofacial, truncal, and extremity dyskinesia) to 28 (severe orofacial, truncal, and extremity dyskinesia)."|units on a scale|Mean|9.6|9.6|Standard Deviation|3.90|3.9|||
3698565|NCT02195700|3539860|B2|||Centrally Read Abnormal Involuntary Movement Scale (AIMS) Score|"AIMS is an assessment tool used to detect and follow the severity of TD over time. The AIMS is composed of 12 clinician-administered and scored items. AIMS was digitally video recorded using a standard protocol and independently reviewed by blinded central raters who were experts in movement disorders.~This data sums items 1 through 7 which cover orofacial movements, and extremity and truncal dyskinesia. Severity ratings were from 0 (none) to 4 (severe) for a total scale of 0 (no orofacial, truncal, and extremity dyskinesia) to 28 (severe orofacial, truncal, and extremity dyskinesia)."|units on a scale|Mean|9.6|9.6|Standard Deviation|3.77|3.77|||
3698566|NCT02195700|3539861|B1|||Centrally Read Abnormal Involuntary Movement Scale (AIMS) Score|"AIMS is an assessment tool used to detect and follow the severity of TD over time. The AIMS is composed of 12 clinician-administered and scored items. AIMS was digitally video recorded using a standard protocol and independently reviewed by blinded central raters who were experts in movement disorders.~This data sums items 1 through 7 which cover orofacial movements, and extremity and truncal dyskinesia. Severity ratings were from 0 (none) to 4 (severe) for a total scale of 0 (no orofacial, truncal, and extremity dyskinesia) to 28 (severe orofacial, truncal, and extremity dyskinesia)."|units on a scale|Mean|9.6|9.6|Standard Deviation|4.07|4.07|||
3698567|NCT02195700|3539859|B3|||Duration of tardive dyskinesia||months|Mean|74.7|74.7|Standard Deviation|81.53|81.53|||
3698568|NCT02195700|3539860|B2|||Duration of tardive dyskinesia||months|Mean|76.8|76.8|Standard Deviation|82.05|82.05|||
3698569|NCT02195700|3539861|B1|||Duration of tardive dyskinesia||months|Mean|72.6|72.6|Standard Deviation|81.65|81.65|||
3698570|NCT02195700|3539859|B3||No|Using a Dopamine Receptor Antagonist (DRA)|The randomization was stratified by baseline use of DRA (currently taking versus not currently taking a DRA).|Participants|Count of Participants|23|23.0||||||
3698571|NCT02195700|3539860|B2||No|Using a Dopamine Receptor Antagonist (DRA)|The randomization was stratified by baseline use of DRA (currently taking versus not currently taking a DRA).|Participants|Count of Participants|10|10.0||||||
3698572|NCT02195700|3539861|B1||No|Using a Dopamine Receptor Antagonist (DRA)|The randomization was stratified by baseline use of DRA (currently taking versus not currently taking a DRA).|Participants|Count of Participants|13|13.0||||||
3698573|NCT02195700|3539859|B3||Yes|Using a Dopamine Receptor Antagonist (DRA)|The randomization was stratified by baseline use of DRA (currently taking versus not currently taking a DRA).|Participants|Count of Participants|94|94.0||||||
3698574|NCT02195700|3539860|B2||Yes|Using a Dopamine Receptor Antagonist (DRA)|The randomization was stratified by baseline use of DRA (currently taking versus not currently taking a DRA).|Participants|Count of Participants|49|49.0||||||
3698575|NCT02195700|3539861|B1||Yes|Using a Dopamine Receptor Antagonist (DRA)|The randomization was stratified by baseline use of DRA (currently taking versus not currently taking a DRA).|Participants|Count of Participants|45|45.0||||||
3698576|NCT02195700|3539859|B3|||Body Mass Index||kg/m^2|Mean|29.89|29.89|Standard Deviation|7.435|7.435|||
3698577|NCT02195700|3539860|B2|||Body Mass Index||kg/m^2|Mean|29.45|29.45|Standard Deviation|6.958|6.958|||
3698578|NCT02195700|3539861|B1|||Body Mass Index||kg/m^2|Mean|30.35|30.35|Standard Deviation|7.926|7.926|||
3698579|NCT02195700|3539859|B3|||Height||cm|Mean|169.48|169.48|Standard Deviation|10.752|10.752|||
3698580|NCT02195700|3539860|B2|||Height||cm|Mean|169.72|169.72|Standard Deviation|10.098|10.098|||
3698581|NCT02195700|3539861|B1|||Height||cm|Mean|169.23|169.23|Standard Deviation|11.462|11.462|||
3698582|NCT02195700|3539859|B3|||Weight||kg|Mean|85.94|85.94|Standard Deviation|22.493|22.493|||
3698583|NCT02195700|3539860|B2|||Weight||kg|Mean|84.95|84.95|Standard Deviation|20.975|20.975|||
3698584|NCT02195700|3539861|B1|||Weight||kg|Mean|86.94|86.94|Standard Deviation|24.081|24.081|||
3698585|NCT02195700|3539859|B3||>12 years of formal education|Education Level||Participants|Count of Participants|57|57.0||||||
3698586|NCT02195700|3539860|B2||>12 years of formal education|Education Level||Participants|Count of Participants|29|29.0||||||
3698587|NCT02195700|3539861|B1||>12 years of formal education|Education Level||Participants|Count of Participants|28|28.0||||||
3698589|NCT02195700|3539860|B2||=12 years or fewer of formal education|Education Level||Participants|Count of Participants|30|30.0||||||
3698590|NCT02195700|3539861|B1||=12 years or fewer of formal education|Education Level||Participants|Count of Participants|30|30.0||||||
3698591|NCT02195700|3539859|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698592|NCT02195700|3539860|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698593|NCT02195700|3539861|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698594|NCT02195700|3539859|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698595|NCT02195700|3539860|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698596|NCT02195700|3539861|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698597|NCT02195700|3539859|B3||White|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
3698598|NCT02195700|3539860|B2||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3698599|NCT02195700|3539861|B1||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3698600|NCT02195700|3539859|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3698601|NCT02195700|3539860|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3698602|NCT02195700|3539861|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3698603|NCT02195700|3539859|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698604|NCT02195700|3539860|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698605|NCT02195700|3539861|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698606|NCT02195700|3539859|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3698607|NCT02195700|3539860|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3698608|NCT02195700|3539861|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3698609|NCT02195700|3539859|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698610|NCT02195700|3539860|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698611|NCT02195700|3539861|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698612|NCT02195700|3539859|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3698613|NCT02195700|3539860|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3698614|NCT02195700|3539861|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3698615|NCT02195700|3539859|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3698616|NCT02195700|3539860|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3698617|NCT02195700|3539861|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3698618|NCT02195700|3539859|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3698619|NCT02195700|3539860|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3698620|NCT02195700|3539861|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3698621|NCT02195700|3539859|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3698622|NCT02195700|3539860|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3698623|NCT02195700|3539861|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3698624|NCT02195700|3539859|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3698625|NCT02195700|3539860|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3698626|NCT02195700|3539861|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3698627|NCT02195700|3539859|B3|||Age||years|Mean|54.6|54.6|Standard Deviation|10.28|10.28|||
3698628|NCT02195700|3539860|B2|||Age||years|Mean|53.3|53.3|Standard Deviation|10.64|10.64|||
3698629|NCT02195700|3539861|B1|||Age||years|Mean|55.9|55.9|Standard Deviation|9.82|9.82|||
3698630|NCT02195687|3539882|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3698631|NCT02195687|3539883|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3698632|NCT02195687|3539884|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3698633|NCT02195687|3539882|B3||Female|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
3698634|NCT02195687|3539883|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3698635|NCT02195687|3539884|B1||Female|Sex: Female, Male||Participants|Count of Participants|273|273.0||||||
3698636|NCT02195687|3539882|B3|||Age||Years|Mean|46.4|46.4|Standard Deviation|9.57|9.57|||
3698637|NCT02195687|3539883|B2|||Age||Years|Mean|46.6|46.6|Standard Deviation|9.39|9.39|||
3698638|NCT02195687|3539884|B1|||Age||Years|Mean|46.3|46.3|Standard Deviation|9.64|9.64|||
3698639|NCT02195583|3539901|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3698640|NCT02195583|3539901|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3698641|NCT02195583|3539901|B1|||Age||Years|Mean|40.7|40.7|Standard Deviation|12.03|12.03|||
3698642|NCT02195479|3539933|B3|||Time from multiple myeloma (MM) diagnosis|Time from multiple myeloma (MM) diagnosis is the time from diagnosis of multiple myeloma to randomization in each treatment group.|Months|Mean|1.18|1.18|Standard Deviation|1.442|1.442|||
3698643|NCT02195479|3539934|B2|||Time from multiple myeloma (MM) diagnosis|Time from multiple myeloma (MM) diagnosis is the time from diagnosis of multiple myeloma to randomization in each treatment group.|Months|Mean|1.09|1.09|Standard Deviation|1.056|1.056|||
3698644|NCT02195479|3539935|B1|||Time from multiple myeloma (MM) diagnosis|Time from multiple myeloma (MM) diagnosis is the time from diagnosis of multiple myeloma to randomization in each treatment group.|Months|Mean|1.27|1.27|Standard Deviation|1.737|1.737|||
3698645|NCT02195479|3539933|B3|III||Stage of Disease (ISS)|The International Staging System (ISS) consists of following 3 stages - Stage I: serum beta2-microglobulin less than (<)3.5 milligram per liter (mg/L) and albumin greater than or equal to (>=) 3.5 gram per 100 Milliliter (g/100 mL); Stage II: neither stage I nor stage III and Stage III: serum beta2-microglobulin >= 5.5 mg/L.|Participants|Count of Participants|106|106.0||||||
3698646|NCT02195479|3539934|B2|III||Stage of Disease (ISS)|The International Staging System (ISS) consists of following 3 stages - Stage I: serum beta2-microglobulin less than (<)3.5 milligram per liter (mg/L) and albumin greater than or equal to (>=) 3.5 gram per 100 Milliliter (g/100 mL); Stage II: neither stage I nor stage III and Stage III: serum beta2-microglobulin >= 5.5 mg/L.|Participants|Count of Participants|60|60.0||||||
3698647|NCT02195479|3539935|B1|III||Stage of Disease (ISS)|The International Staging System (ISS) consists of following 3 stages - Stage I: serum beta2-microglobulin less than (<)3.5 milligram per liter (mg/L) and albumin greater than or equal to (>=) 3.5 gram per 100 Milliliter (g/100 mL); Stage II: neither stage I nor stage III and Stage III: serum beta2-microglobulin >= 5.5 mg/L.|Participants|Count of Participants|46|46.0||||||
3698648|NCT02195479|3539933|B3|II||Stage of Disease (ISS)|The International Staging System (ISS) consists of following 3 stages - Stage I: serum beta2-microglobulin less than (<)3.5 milligram per liter (mg/L) and albumin greater than or equal to (>=) 3.5 gram per 100 Milliliter (g/100 mL); Stage II: neither stage I nor stage III and Stage III: serum beta2-microglobulin >= 5.5 mg/L.|Participants|Count of Participants|473|473.0||||||
3698649|NCT02195479|3539934|B2|II||Stage of Disease (ISS)|The International Staging System (ISS) consists of following 3 stages - Stage I: serum beta2-microglobulin less than (<)3.5 milligram per liter (mg/L) and albumin greater than or equal to (>=) 3.5 gram per 100 Milliliter (g/100 mL); Stage II: neither stage I nor stage III and Stage III: serum beta2-microglobulin >= 5.5 mg/L.|Participants|Count of Participants|226|226.0||||||
3698650|NCT02195479|3539935|B1|II||Stage of Disease (ISS)|The International Staging System (ISS) consists of following 3 stages - Stage I: serum beta2-microglobulin less than (<)3.5 milligram per liter (mg/L) and albumin greater than or equal to (>=) 3.5 gram per 100 Milliliter (g/100 mL); Stage II: neither stage I nor stage III and Stage III: serum beta2-microglobulin >= 5.5 mg/L.|Participants|Count of Participants|247|247.0||||||
3698651|NCT02195479|3539933|B3|I||Stage of Disease (ISS)|The International Staging System (ISS) consists of following 3 stages - Stage I: serum beta2-microglobulin less than (<)3.5 milligram per liter (mg/L) and albumin greater than or equal to (>=) 3.5 gram per 100 Milliliter (g/100 mL); Stage II: neither stage I nor stage III and Stage III: serum beta2-microglobulin >= 5.5 mg/L.|Participants|Count of Participants|85|85.0||||||
3698652|NCT02195479|3539934|B2|I||Stage of Disease (ISS)|The International Staging System (ISS) consists of following 3 stages - Stage I: serum beta2-microglobulin less than (<)3.5 milligram per liter (mg/L) and albumin greater than or equal to (>=) 3.5 gram per 100 Milliliter (g/100 mL); Stage II: neither stage I nor stage III and Stage III: serum beta2-microglobulin >= 5.5 mg/L.|Participants|Count of Participants|47|47.0||||||
3698653|NCT02195479|3539935|B1|I||Stage of Disease (ISS)|The International Staging System (ISS) consists of following 3 stages - Stage I: serum beta2-microglobulin less than (<)3.5 milligram per liter (mg/L) and albumin greater than or equal to (>=) 3.5 gram per 100 Milliliter (g/100 mL); Stage II: neither stage I nor stage III and Stage III: serum beta2-microglobulin >= 5.5 mg/L.|Participants|Count of Participants|38|38.0||||||
3698654|NCT02195479|3539933|B3|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3698655|NCT02195479|3539934|B2|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3698656|NCT02195479|3539935|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3698657|NCT02195479|3539933|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3698658|NCT02195479|3539934|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3698659|NCT02195479|3539935|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3698660|NCT02195479|3539933|B3|Ukraine||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
3698661|NCT02195479|3539934|B2|Ukraine||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3698662|NCT02195479|3539935|B1|Ukraine||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3698663|NCT02195479|3539933|B3|Turkey||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3698664|NCT02195479|3539934|B2|Turkey||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3698665|NCT02195479|3539935|B1|Turkey||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3698666|NCT02195479|3539933|B3|Spain||Region of Enrollment||Participants|Count of Participants|103|103.0||||||
3698667|NCT02195479|3539934|B2|Spain||Region of Enrollment||Participants|Count of Participants|56|56.0||||||
3698668|NCT02195479|3539935|B1|Spain||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
3698669|NCT02195479|3539933|B3|Korea, Democratic People'S Republic Of||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3698670|NCT02195479|3539934|B2|Korea, Democratic People'S Republic Of||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3698671|NCT02195479|3539935|B1|Korea, Democratic People'S Republic Of||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3698672|NCT02195479|3539933|B3|Serbia||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3698673|NCT02195479|3539934|B2|Serbia||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3698674|NCT02195479|3539935|B1|Serbia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3698675|NCT02195479|3539933|B3|Russia||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
3698676|NCT02195479|3539934|B2|Russia||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3698677|NCT02195479|3539935|B1|Russia||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3698678|NCT02195479|3539933|B3|Romania||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3698679|NCT02195479|3539934|B2|Romania||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3698680|NCT02195479|3539935|B1|Romania||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3698681|NCT02195479|3539933|B3|Macedonia||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3698682|NCT02195479|3539934|B2|Macedonia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3698683|NCT02195479|3539935|B1|Macedonia||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3698684|NCT02195479|3539933|B3|Portugal||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3698685|NCT02195479|3539934|B2|Portugal||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3698686|NCT02195479|3539935|B1|Portugal||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3698687|NCT02195479|3539933|B3|Poland||Region of Enrollment||Participants|Count of Participants|66|66.0||||||
3698688|NCT02195479|3539934|B2|Poland||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3698689|NCT02195479|3539935|B1|Poland||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3698690|NCT02195479|3539933|B3|Japan||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3698691|NCT02195479|3539934|B2|Japan||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3698692|NCT02195479|3539935|B1|Japan||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3698693|NCT02195479|3539933|B3|Italy||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
3698694|NCT02195479|3539934|B2|Italy||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3698695|NCT02195479|3539935|B1|Italy||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3698696|NCT02195479|3539933|B3|Hungary||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3698697|NCT02195479|3539934|B2|Hungary||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3698698|NCT02195479|3539935|B1|Hungary||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3698699|NCT02195479|3539933|B3|Greece||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3698700|NCT02195479|3539934|B2|Greece||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3698701|NCT02195479|3539935|B1|Greece||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3698702|NCT02195479|3539933|B3|Germany||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3698703|NCT02195479|3539934|B2|Germany||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3698704|NCT02195479|3539935|B1|Germany||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3698705|NCT02195479|3539933|B3|Georgia||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3698706|NCT02195479|3539934|B2|Georgia||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3698707|NCT02195479|3539935|B1|Georgia||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3698708|NCT02195479|3539933|B3|Czech Republic||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3698709|NCT02195479|3539934|B2|Czech Republic||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3698710|NCT02195479|3539935|B1|Czech Republic||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3698711|NCT02195479|3539933|B3|Croatia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3698712|NCT02195479|3539934|B2|Croatia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3698713|NCT02195479|3539935|B1|Croatia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3698714|NCT02195479|3539933|B3|Bulgaria||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3698715|NCT02195479|3539934|B2|Bulgaria||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3698716|NCT02195479|3539935|B1|Bulgaria||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3698717|NCT02195479|3539933|B3|Brazil||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3698718|NCT02195479|3539934|B2|Brazil||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3698719|NCT02195479|3539935|B1|Brazil||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3698720|NCT02195479|3539933|B3|Belgium||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3698721|NCT02195479|3539934|B2|Belgium||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3698722|NCT02195479|3539935|B1|Belgium||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3698723|NCT02195479|3539933|B3|Australia||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3698724|NCT02195479|3539934|B2|Australia||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3698725|NCT02195479|3539935|B1|Australia||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3698726|NCT02195479|3539933|B3|Argentina||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3698727|NCT02195479|3539934|B2|Argentina||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3698728|NCT02195479|3539935|B1|Argentina||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3698729|NCT02195479|3539933|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3698730|NCT02195479|3539934|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3698731|NCT02195479|3539935|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3698732|NCT02195479|3539933|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698733|NCT02195479|3539934|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698734|NCT02195479|3539935|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698735|NCT02195479|3539933|B3||White|Race (NIH/OMB)||Participants|Count of Participants|601|601.0||||||
3698736|NCT02195479|3539934|B2||White|Race (NIH/OMB)||Participants|Count of Participants|297|297.0||||||
3698737|NCT02195479|3539935|B1||White|Race (NIH/OMB)||Participants|Count of Participants|304|304.0||||||
3698738|NCT02195479|3539933|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3698739|NCT02195479|3539934|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3698740|NCT02195479|3539935|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3698741|NCT02195479|3539933|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698742|NCT02195479|3539934|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698743|NCT02195479|3539935|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698744|NCT02195479|3539933|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
3698745|NCT02195479|3539934|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3698746|NCT02195479|3539935|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3698747|NCT02195479|3539933|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698748|NCT02195479|3539934|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698749|NCT02195479|3539935|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698750|NCT02195479|3539933|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3698751|NCT02195479|3539934|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3698752|NCT02195479|3539935|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3698753|NCT02195479|3539933|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|652|652.0||||||
3698754|NCT02195479|3539934|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|320|320.0||||||
3698755|NCT02195479|3539935|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|332|332.0||||||
3698756|NCT02195479|3539933|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3698757|NCT02195479|3539934|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3698758|NCT02195479|3539935|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3698759|NCT02195479|3539933|B3||Male|Sex: Female, Male||Participants|Count of Participants|327|327.0||||||
3698760|NCT02195479|3539934|B2||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3698761|NCT02195479|3539935|B1||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3698762|NCT02195479|3539933|B3||Female|Sex: Female, Male||Participants|Count of Participants|379|379.0||||||
3698763|NCT02195479|3539934|B2||Female|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
3698764|NCT02195479|3539935|B1||Female|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
3698765|NCT02195479|3539933|B3|||Age||years|Mean|71.4|71.4|Standard Deviation|6.25|6.25|||
3698766|NCT02195479|3539934|B2|||Age||years|Mean|71.3|71.3|Standard Deviation|6.66|6.66|||
3698767|NCT02195479|3539935|B1|||Age||years|Mean|71.5|71.5|Standard Deviation|5.82|5.82|||
3698768|NCT02195427|3539972|B3|Types IV to VI||Fitzpatrick Skin Type|"The Fitzpatrick scale is a numerical classification schema for human skin color.~Type I - always burns, never tans (pale white; blond or red hair; blue eyes; freckles).~Type II - usually burns, tans minimally (white; fair; blond or red hair; blue, green, or hazel eyes) Type III - sometimes mild burn, tans uniformly (cream white; fair with any hair or eye color) Type IV - burns minimally, always tans well (moderate brown) Type V - very rarely burns, tans very easily (dark brown) Type VI - Never burns, never tans (deeply pigmented dark brown to darkest brown)"|Participants|Count of Participants|58|58.0||||||
3698769|NCT02195427|3539973|B2|Types IV to VI||Fitzpatrick Skin Type|"The Fitzpatrick scale is a numerical classification schema for human skin color.~Type I - always burns, never tans (pale white; blond or red hair; blue eyes; freckles).~Type II - usually burns, tans minimally (white; fair; blond or red hair; blue, green, or hazel eyes) Type III - sometimes mild burn, tans uniformly (cream white; fair with any hair or eye color) Type IV - burns minimally, always tans well (moderate brown) Type V - very rarely burns, tans very easily (dark brown) Type VI - Never burns, never tans (deeply pigmented dark brown to darkest brown)"|Participants|Count of Participants|30|30.0||||||
3698770|NCT02195427|3539974|B1|Types IV to VI||Fitzpatrick Skin Type|"The Fitzpatrick scale is a numerical classification schema for human skin color.~Type I - always burns, never tans (pale white; blond or red hair; blue eyes; freckles).~Type II - usually burns, tans minimally (white; fair; blond or red hair; blue, green, or hazel eyes) Type III - sometimes mild burn, tans uniformly (cream white; fair with any hair or eye color) Type IV - burns minimally, always tans well (moderate brown) Type V - very rarely burns, tans very easily (dark brown) Type VI - Never burns, never tans (deeply pigmented dark brown to darkest brown)"|Participants|Count of Participants|28|28.0||||||
3698771|NCT02195427|3539972|B3|Types I to III||Fitzpatrick Skin Type|"The Fitzpatrick scale is a numerical classification schema for human skin color.~Type I - always burns, never tans (pale white; blond or red hair; blue eyes; freckles).~Type II - usually burns, tans minimally (white; fair; blond or red hair; blue, green, or hazel eyes) Type III - sometimes mild burn, tans uniformly (cream white; fair with any hair or eye color) Type IV - burns minimally, always tans well (moderate brown) Type V - very rarely burns, tans very easily (dark brown) Type VI - Never burns, never tans (deeply pigmented dark brown to darkest brown)"|Participants|Count of Participants|89|89.0||||||
3698772|NCT02195427|3539973|B2|Types I to III||Fitzpatrick Skin Type|"The Fitzpatrick scale is a numerical classification schema for human skin color.~Type I - always burns, never tans (pale white; blond or red hair; blue eyes; freckles).~Type II - usually burns, tans minimally (white; fair; blond or red hair; blue, green, or hazel eyes) Type III - sometimes mild burn, tans uniformly (cream white; fair with any hair or eye color) Type IV - burns minimally, always tans well (moderate brown) Type V - very rarely burns, tans very easily (dark brown) Type VI - Never burns, never tans (deeply pigmented dark brown to darkest brown)"|Participants|Count of Participants|44|44.0||||||
3698773|NCT02195427|3539974|B1|Types I to III||Fitzpatrick Skin Type|"The Fitzpatrick scale is a numerical classification schema for human skin color.~Type I - always burns, never tans (pale white; blond or red hair; blue eyes; freckles).~Type II - usually burns, tans minimally (white; fair; blond or red hair; blue, green, or hazel eyes) Type III - sometimes mild burn, tans uniformly (cream white; fair with any hair or eye color) Type IV - burns minimally, always tans well (moderate brown) Type V - very rarely burns, tans very easily (dark brown) Type VI - Never burns, never tans (deeply pigmented dark brown to darkest brown)"|Participants|Count of Participants|45|45.0||||||
3698774|NCT02195427|3539972|B3|United States||Region of Enrollment||Participants|Count of Participants|147|147.0||||||
3698775|NCT02195427|3539973|B2|United States||Region of Enrollment||Participants|Count of Participants|74|74.0||||||
3698776|NCT02195427|3539974|B1|United States||Region of Enrollment||Participants|Count of Participants|73|73.0||||||
3698777|NCT02195427|3539972|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698778|NCT02195427|3539973|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698779|NCT02195427|3539974|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698780|NCT02195427|3539972|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3698781|NCT02195427|3539973|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3698782|NCT02195427|3539974|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3698783|NCT02195427|3539972|B3||White|Race (NIH/OMB)||Participants|Count of Participants|121|121.0||||||
3698784|NCT02195427|3539973|B2||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3698785|NCT02195427|3539974|B1||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3698786|NCT02195427|3539972|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3698787|NCT02195427|3539973|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3698788|NCT02195427|3539974|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3698789|NCT02195427|3539972|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698790|NCT02195427|3539973|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698791|NCT02195427|3539974|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698792|NCT02195427|3539972|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3698793|NCT02195427|3539973|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698794|NCT02195427|3539974|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3698795|NCT02195427|3539972|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698796|NCT02195427|3539973|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698797|NCT02195427|3539974|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698798|NCT02195427|3539972|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3698799|NCT02195427|3539973|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3698800|NCT02195427|3539974|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3698801|NCT02195427|3539972|B3||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3698802|NCT02195427|3539973|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3698803|NCT02195427|3539974|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3698804|NCT02195427|3539972|B3|||Age||years|Mean|55.6|55.6|Standard Deviation|9.9|9.9|||
3698805|NCT02195427|3539973|B2|||Age||years|Mean|55.7|55.7|Standard Deviation|9.4|9.4|||
3698806|NCT02195427|3539974|B1|||Age||years|Mean|55.5|55.5|Standard Deviation|10.9|10.9|||
3698807|NCT02195414|3540037|B1|||Stent length||millimeter|Mean|19.35|19.35|Standard Deviation|3.54|3.54|||
3698808|NCT02195414|3540037|B1|||Stent diameter||millimeter|Mean|3.35|3.35|Standard Deviation|0.23|0.23|||
3698809|NCT02195414|3540037|B1|Right coronary artery||Target vessel location||participants|Number|11|11.0||||||
3698810|NCT02195414|3540037|B1|Left circumflex artery||Target vessel location||participants|Number|3|3.0||||||
3698811|NCT02195414|3540037|B1|Left anterior descending artery||Target vessel location||participants|Number|17|17.0||||||
3698812|NCT02195414|3540037|B1|NSTEMI||Angina Categories||participants|Number|1|1.0||||||
3698813|NCT02195414|3540037|B1|Unstable angina||Angina Categories||participants|Number|23|23.0||||||
3698814|NCT02195414|3540037|B1|Stable angina||Angina Categories||participants|Number|7|7.0||||||
3698815|NCT02195414|3540037|B1|No||Hypertension||participants|Number|15|15.0||||||
3698816|NCT02195414|3540037|B1|Yes||Hypertension||participants|Number|16|16.0||||||
3698817|NCT02195414|3540037|B1|No||Diabetes Mellitus||participants|Number|24|24.0||||||
3698818|NCT02195414|3540037|B1|Yes||Diabetes Mellitus||participants|Number|7|7.0||||||
3698819|NCT02195414|3540037|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3698820|NCT02195414|3540037|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3698821|NCT02195414|3540037|B1|||Age|Age must be between 18 and 75 years.|years|Mean|59.1|59.1|Standard Deviation|8.7|8.7|||
3698822|NCT02195011|3540044|B3|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3698823|NCT02195011|3540045|B2|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3698824|NCT02195011|3540046|B1|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3698825|NCT02195011|3540044|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698826|NCT02195011|3540045|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698827|NCT02195011|3540046|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698828|NCT02195011|3540044|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698829|NCT02195011|3540045|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698830|NCT02195011|3540046|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698831|NCT02195011|3540044|B3||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3698832|NCT02195011|3540045|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3698833|NCT02195011|3540046|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3698834|NCT02195011|3540044|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3698835|NCT02195011|3540045|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698836|NCT02195011|3540046|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3698837|NCT02195011|3540044|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698838|NCT02195011|3540045|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698839|NCT02195011|3540046|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698840|NCT02195011|3540044|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698841|NCT02195011|3540045|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698842|NCT02195011|3540046|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698843|NCT02195011|3540044|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698844|NCT02195011|3540045|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698845|NCT02195011|3540046|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698846|NCT02195011|3540044|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3698847|NCT02195011|3540045|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3698848|NCT02195011|3540046|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3698849|NCT02195011|3540044|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3698850|NCT02195011|3540045|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3698851|NCT02195011|3540046|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3698852|NCT02195011|3540044|B3|||Age||years|Median|56|56.0|Full Range|||44.0|79.0|
3698853|NCT02195011|3540045|B2|||Age||years|Median|64|64.0|Full Range|||64.0|64.0|
3698854|NCT02195011|3540046|B1|||Age||years|Median|56|56.0|Full Range|||44.0|79.0|
3698855|NCT02195011|3540044|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3698856|NCT02195011|3540045|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3698857|NCT02195011|3540046|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3698858|NCT02195011|3540044|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3698859|NCT02195011|3540045|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3698860|NCT02195011|3540046|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3698861|NCT02195011|3540044|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3698862|NCT02195011|3540045|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3698863|NCT02195011|3540046|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3698864|NCT02194933|3540059|B3|Not Hispanic/Latino||Ethinicity||participants|Number|31|31.0||||||
3698865|NCT02194933|3540060|B2|Not Hispanic/Latino||Ethinicity||participants|Number|16|16.0||||||
3698866|NCT02194933|3540061|B1|Not Hispanic/Latino||Ethinicity||participants|Number|15|15.0||||||
3698867|NCT02194933|3540059|B3|Hispanic/Latino||Ethinicity||participants|Number|7|7.0||||||
3698868|NCT02194933|3540060|B2|Hispanic/Latino||Ethinicity||participants|Number|3|3.0||||||
3698869|NCT02194933|3540061|B1|Hispanic/Latino||Ethinicity||participants|Number|4|4.0||||||
3698870|NCT02194933|3540059|B3|Others||Race|Different races were involved in this study|participants|Number|3|3.0||||||
3698871|NCT02194933|3540060|B2|Others||Race|Different races were involved in this study|participants|Number|0|0.0||||||
3698872|NCT02194933|3540061|B1|Others||Race|Different races were involved in this study|participants|Number|3|3.0||||||
3698873|NCT02194933|3540059|B3|Asian||Race|Different races were involved in this study|participants|Number|2|2.0||||||
3698874|NCT02194933|3540060|B2|Asian||Race|Different races were involved in this study|participants|Number|0|0.0||||||
3698875|NCT02194933|3540061|B1|Asian||Race|Different races were involved in this study|participants|Number|2|2.0||||||
3698876|NCT02194933|3540059|B3|Black or African or American||Race|Different races were involved in this study|participants|Number|20|20.0||||||
3698877|NCT02194933|3540060|B2|Black or African or American||Race|Different races were involved in this study|participants|Number|12|12.0||||||
3698878|NCT02194933|3540061|B1|Black or African or American||Race|Different races were involved in this study|participants|Number|8|8.0||||||
3698879|NCT02194933|3540059|B3|Caucasian (White)||Race|Different races were involved in this study|participants|Number|13|13.0||||||
3698880|NCT02194933|3540060|B2|Caucasian (White)||Race|Different races were involved in this study|participants|Number|7|7.0||||||
3698881|NCT02194933|3540061|B1|Caucasian (White)||Race|Different races were involved in this study|participants|Number|6|6.0||||||
3698882|NCT02194933|3540059|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
3698883|NCT02194933|3540060|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3698884|NCT02194933|3540061|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3698885|NCT02194933|3540059|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3698886|NCT02194933|3540060|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3698887|NCT02194933|3540061|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3698888|NCT02194933|3540059|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3698889|NCT02194933|3540060|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3698890|NCT02194933|3540061|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3698891|NCT02194933|3540059|B3|||Age||Years|Mean|46.3|46.3|Standard Deviation|10.5|10.5|||
3698892|NCT02194933|3540060|B2|||Age||Years|Mean|47.4|47.4|Standard Deviation|11.1|11.1|||
3698893|NCT02194933|3540061|B1|||Age||Years|Mean|45.2|45.2|Standard Deviation|10.0|10.0|||
3698894|NCT02194933|3540059|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3698895|NCT02194933|3540060|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3698896|NCT02194933|3540061|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3698897|NCT02194933|3540059|B3||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3698898|NCT02194933|3540060|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3698899|NCT02194933|3540061|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3698900|NCT02194933|3540059|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3698901|NCT02194933|3540060|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3698902|NCT02194933|3540061|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3698903|NCT02194699|3540114|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3698904|NCT02194699|3540115|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3698905|NCT02194699|3540116|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3698906|NCT02194699|3540114|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698907|NCT02194699|3540115|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698908|NCT02194699|3540116|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698909|NCT02194699|3540114|B3||White|Race (NIH/OMB)||Participants|Count of Participants|564|564.0||||||
3698910|NCT02194699|3540115|B2||White|Race (NIH/OMB)||Participants|Count of Participants|281|281.0||||||
3698911|NCT02194699|3540116|B1||White|Race (NIH/OMB)||Participants|Count of Participants|283|283.0||||||
3698912|NCT02194699|3540114|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3698913|NCT02194699|3540115|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3698914|NCT02194699|3540116|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3698915|NCT02194699|3540114|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698916|NCT02194699|3540115|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698917|NCT02194699|3540116|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3698918|NCT02194699|3540114|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|171|171.0||||||
3698919|NCT02194699|3540115|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3698920|NCT02194699|3540116|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3698921|NCT02194699|3540114|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3698922|NCT02194699|3540115|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3698923|NCT02194699|3540116|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3698924|NCT02194699|3540114|B3||Male|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
3698925|NCT02194699|3540115|B2||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3698926|NCT02194699|3540116|B1||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3698927|NCT02194699|3540114|B3||Female|Sex: Female, Male||Participants|Count of Participants|566|566.0||||||
3698928|NCT02194699|3540115|B2||Female|Sex: Female, Male||Participants|Count of Participants|290|290.0||||||
3698929|NCT02194699|3540116|B1||Female|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
3698930|NCT02194699|3540114|B3|||Age||Years|Mean|47.6|47.6|Standard Deviation|15.5|15.5|||
3698931|NCT02194699|3540115|B2|||Age||Years|Mean|48.0|48.0|Standard Deviation|15.5|15.5|||
3698932|NCT02194699|3540116|B1|||Age||Years|Mean|47.3|47.3|Standard Deviation|15.6|15.6|||
3698933|NCT02194621|3540222|B4|United States||Region of Enrollment||participants|Number|128|128.0||||||
3698934|NCT02194621|3540223|B3|United States||Region of Enrollment||participants|Number|43|43.0||||||
3698935|NCT02194621|3540224|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
3698936|NCT02194621|3540225|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
3698937|NCT02194621|3540222|B4||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3698938|NCT02194621|3540223|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3698939|NCT02194621|3540224|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3698940|NCT02194621|3540225|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3698941|NCT02194621|3540222|B4||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3698942|NCT02194621|3540223|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3698943|NCT02194621|3540224|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3698944|NCT02194621|3540225|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3698945|NCT02194621|3540222|B4|||Age||years|Mean|35.4|35.4|Standard Deviation|10.82|10.82|||
3698946|NCT02194621|3540223|B3|||Age||years|Mean|35.9|35.9|Standard Deviation|12.08|12.08|||
3698947|NCT02194621|3540224|B2|||Age||years|Mean|34.2|34.2|Standard Deviation|10.34|10.34|||
3698948|NCT02194621|3540225|B1|||Age||years|Mean|36.6|36.6|Standard Deviation|10.2|10.2|||
3698949|NCT02194088|3540244|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
3698950|NCT02194088|3540245|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3698951|NCT02194088|3540246|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
3698952|NCT02194088|3540244|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3698953|NCT02194088|3540245|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3698954|NCT02194088|3540246|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3698955|NCT02194088|3540244|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3698956|NCT02194088|3540245|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3698957|NCT02194088|3540246|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3698958|NCT02194088|3540244|B3|||Age||years|Mean|23.82|23.82|Standard Deviation|4.56|4.56|||
3698959|NCT02194088|3540245|B2|||Age||years|Mean|23.16|23.16|Standard Deviation|3.94|3.94|||
3698960|NCT02194088|3540246|B1|||Age||years|Mean|24.04|24.04|Standard Deviation|4.75|4.75|||
3698961|NCT02194088|3540244|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3698962|NCT02194088|3540245|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3698963|NCT02194088|3540246|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3698964|NCT02194088|3540244|B3||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
3698965|NCT02194088|3540245|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3698966|NCT02194088|3540246|B1||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
3698967|NCT02194088|3540244|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3698968|NCT02194088|3540245|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3698969|NCT02194088|3540246|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3698970|NCT02194062|3540257|B4|no||asthma||participants|Number|17|17.0||||||
3698971|NCT02194062|3540258|B3|no||asthma||participants|Number|7|7.0||||||
3698972|NCT02194062|3540259|B2|no||asthma||participants|Number|5|5.0||||||
3698973|NCT02194062|3540260|B1|no||asthma||participants|Number|5|5.0||||||
3698974|NCT02194062|3540257|B4|yes||asthma||participants|Number|15|15.0||||||
3698975|NCT02194062|3540258|B3|yes||asthma||participants|Number|5|5.0||||||
3698976|NCT02194062|3540259|B2|yes||asthma||participants|Number|5|5.0||||||
3698977|NCT02194062|3540260|B1|yes||asthma||participants|Number|5|5.0||||||
3698978|NCT02194062|3540257|B4|United States||Region of Enrollment||participants|Number|32|32.0||||||
3698979|NCT02194062|3540258|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3698980|NCT02194062|3540259|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3698981|NCT02194062|3540260|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3698982|NCT02194062|3540257|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3698983|NCT02194062|3540258|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3698984|NCT02194062|3540259|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3698985|NCT02194062|3540260|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3698986|NCT02194062|3540257|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3698987|NCT02194062|3540258|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3698988|NCT02194062|3540259|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3698989|NCT02194062|3540260|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3698990|NCT02194062|3540257|B4|||Age||years|Mean|43.9|43.9|Standard Deviation|1|1.0|||
3698991|NCT02194062|3540258|B3|||Age||years|Mean|39.6|39.6|Standard Deviation|1|1.0|||
3698992|NCT02194062|3540259|B2|||Age||years|Mean|44.8|44.8|Standard Deviation|1|1.0|||
3698993|NCT02194062|3540260|B1|||Age||years|Mean|48.4|48.4|Standard Deviation|1|1.0|||
3698994|NCT02194062|3540257|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3698995|NCT02194062|3540258|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3698996|NCT02194062|3540259|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3698997|NCT02194062|3540260|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3698998|NCT02194062|3540257|B4||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3698999|NCT02194062|3540258|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3699000|NCT02194062|3540259|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3699001|NCT02194062|3540260|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3699002|NCT02194062|3540257|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3699003|NCT02194062|3540258|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3699004|NCT02194062|3540259|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3699005|NCT02194062|3540260|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3699006|NCT02193828|3540273|B5|Australia||Region of Enrollment||participants|Number|27|27.0||||||
3699007|NCT02193828|3540274|B4|Australia||Region of Enrollment||participants|Number|5|5.0||||||
3699008|NCT02193828|3540275|B3|Australia||Region of Enrollment||participants|Number|8|8.0||||||
3699009|NCT02193828|3540276|B2|Australia||Region of Enrollment||participants|Number|8|8.0||||||
3699010|NCT02193828|3540277|B1|Australia||Region of Enrollment||participants|Number|6|6.0||||||
3699011|NCT02193828|3540273|B5|United States||Region of Enrollment||participants|Number|48|48.0||||||
3699012|NCT02193828|3540274|B4|United States||Region of Enrollment||participants|Number|12|12.0||||||
3699013|NCT02193828|3540275|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
3699014|NCT02193828|3540276|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3699015|NCT02193828|3540277|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3699016|NCT02193828|3540273|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699017|NCT02193828|3540274|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699018|NCT02193828|3540275|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699019|NCT02193828|3540276|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699020|NCT02193828|3540277|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699021|NCT02193828|3540273|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699022|NCT02193828|3540274|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699023|NCT02193828|3540275|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699024|NCT02193828|3540276|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699025|NCT02193828|3540277|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699026|NCT02193828|3540273|B5||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3699027|NCT02193828|3540274|B4||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3699028|NCT02193828|3540275|B3||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3699029|NCT02193828|3540276|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3699030|NCT02193828|3540277|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3699031|NCT02193828|3540273|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699032|NCT02193828|3540274|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699033|NCT02193828|3540275|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699034|NCT02193828|3540276|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699035|NCT02193828|3540277|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699036|NCT02193828|3540273|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699037|NCT02193828|3540274|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699038|NCT02193828|3540275|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699039|NCT02193828|3540276|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699040|NCT02193828|3540277|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699041|NCT02193828|3540273|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699042|NCT02193828|3540274|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699043|NCT02193828|3540275|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699044|NCT02193828|3540276|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699045|NCT02193828|3540277|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699046|NCT02193828|3540273|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3699047|NCT02193828|3540274|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699048|NCT02193828|3540275|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699049|NCT02193828|3540276|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3699050|NCT02193828|3540277|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699051|NCT02193828|3540273|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699052|NCT02193828|3540274|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699053|NCT02193828|3540275|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699054|NCT02193828|3540276|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699055|NCT02193828|3540277|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699056|NCT02193828|3540273|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3699057|NCT02193828|3540274|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3699058|NCT02193828|3540275|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3699059|NCT02193828|3540276|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3699060|NCT02193828|3540277|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3699061|NCT02193828|3540273|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3699062|NCT02193828|3540274|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3699063|NCT02193828|3540275|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3699064|NCT02193828|3540276|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3699065|NCT02193828|3540277|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3699066|NCT02193828|3540273|B5||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3699067|NCT02193828|3540274|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3699068|NCT02193828|3540275|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3699069|NCT02193828|3540276|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3699070|NCT02193828|3540277|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3699071|NCT02193828|3540273|B5||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3699072|NCT02193828|3540274|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3699073|NCT02193828|3540275|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3699074|NCT02193828|3540276|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3699075|NCT02193828|3540277|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3699076|NCT02193828|3540273|B5|||Age||years|Median|58.0|58.0|Full Range|||32.0|84.0|
3699077|NCT02193828|3540274|B4|||Age||years|Median|58.0|58.0|Full Range|||45.0|73.0|
3699078|NCT02193828|3540275|B3|||Age||years|Median|57.0|57.0|Full Range|||32.0|73.0|
3699079|NCT02193828|3540276|B2|||Age||years|Median|60.0|60.0|Full Range|||37.0|75.0|
3699080|NCT02193828|3540277|B1|||Age||years|Median|62.0|62.0|Full Range|||41.0|84.0|
3699081|NCT02193828|3540273|B5||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3699082|NCT02193828|3540274|B4||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3699083|NCT02193828|3540275|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3699084|NCT02193828|3540276|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3699085|NCT02193828|3540277|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3699086|NCT02193828|3540273|B5||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3699087|NCT02193828|3540274|B4||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3699088|NCT02193828|3540275|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3699089|NCT02193828|3540276|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3699090|NCT02193828|3540277|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3699091|NCT02193828|3540273|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3699092|NCT02193828|3540274|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3699093|NCT02193828|3540275|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3699094|NCT02193828|3540276|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3699095|NCT02193828|3540277|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3699096|NCT02193815|3540318|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3699097|NCT02193815|3540318|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3699098|NCT02193815|3540318|B1|||Age||years|Mean|50.4|50.4|Standard Deviation|8.8|8.8|||
3699099|NCT02193178|3540353|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3699100|NCT02193178|3540353|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
3699101|NCT02193178|3540353|B1||Female|Gender||Participants|Count of Participants|11|11.0||||||
3699102|NCT02193178|3540353|B1|||Age||years|Mean|29|29.0|Standard Deviation|11|11.0|||
3699103|NCT02193178|3540353|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3699104|NCT02193178|3540353|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3699105|NCT02193178|3540353|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3699106|NCT02193165|3540400|B4|United States||Region of Enrollment||participants|Number|120|120.0||||||
3699107|NCT02193165|3540401|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3699108|NCT02193165|3540402|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
3699109|NCT02193165|3540403|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3699110|NCT02193165|3540400|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699111|NCT02193165|3540401|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699112|NCT02193165|3540402|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699113|NCT02193165|3540403|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699114|NCT02193165|3540400|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699115|NCT02193165|3540401|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699116|NCT02193165|3540402|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699117|NCT02193165|3540403|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699118|NCT02193165|3540400|B4||White|Race (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
3699119|NCT02193165|3540401|B3||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3699120|NCT02193165|3540402|B2||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3699121|NCT02193165|3540403|B1||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3699122|NCT02193165|3540400|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699123|NCT02193165|3540401|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699124|NCT02193165|3540402|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699125|NCT02193165|3540403|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699126|NCT02193165|3540400|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699127|NCT02193165|3540401|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699128|NCT02193165|3540402|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699129|NCT02193165|3540403|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699130|NCT02193165|3540400|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699131|NCT02193165|3540401|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699132|NCT02193165|3540402|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699133|NCT02193165|3540403|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699134|NCT02193165|3540400|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699135|NCT02193165|3540401|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699136|NCT02193165|3540402|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699137|NCT02193165|3540403|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699138|NCT02193165|3540400|B4||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3699139|NCT02193165|3540401|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3699140|NCT02193165|3540402|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3699141|NCT02193165|3540403|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3699142|NCT02193165|3540400|B4||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3699143|NCT02193165|3540401|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3699144|NCT02193165|3540402|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3699145|NCT02193165|3540403|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3699146|NCT02193165|3540400|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3699147|NCT02193165|3540401|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3699148|NCT02193165|3540402|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3699149|NCT02193165|3540403|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3699150|NCT02193165|3540400|B4||Between 18 and 65 years|Age||Participants|Count of Participants|116|116.0||||||
3699151|NCT02193165|3540401|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3699152|NCT02193165|3540402|B2||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3699153|NCT02193165|3540403|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3699154|NCT02193165|3540400|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3699155|NCT02193165|3540401|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3699156|NCT02193165|3540402|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3699157|NCT02193165|3540403|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3699158|NCT02193087|3540428|B5|||Body Mass Index (BMI)||kg/m^2|Mean|26.57|26.57|Standard Deviation|4.494|4.494|||
3699159|NCT02193087|3540429|B4|||Body Mass Index (BMI)||kg/m^2|Mean|26.53|26.53|Standard Deviation|4.513|4.513|||
3699160|NCT02193087|3540430|B3|||Body Mass Index (BMI)||kg/m^2|Mean|26.30|26.3|Standard Deviation|5.006|5.006|||
3699161|NCT02193087|3540431|B2|||Body Mass Index (BMI)||kg/m^2|Mean|26.81|26.81|Standard Deviation|4.496|4.496|||
3699162|NCT02193087|3540432|B1|||Body Mass Index (BMI)||kg/m^2|Mean|26.71|26.71|Standard Deviation|4.180|4.18|||
3699163|NCT02193087|3540428|B5|||Weight||kg|Mean|77.37|77.37|Standard Deviation|15.569|15.569|||
3699164|NCT02193087|3540429|B4|||Weight||kg|Mean|77.49|77.49|Standard Deviation|15.649|15.649|||
3699165|NCT02193087|3540430|B3|||Weight||kg|Mean|75.96|75.96|Standard Deviation|16.099|16.099|||
3699166|NCT02193087|3540431|B2|||Weight||kg|Mean|78.96|78.96|Standard Deviation|16.878|16.878|||
3699167|NCT02193087|3540432|B1|||Weight||kg|Mean|76.95|76.95|Standard Deviation|14.362|14.362|||
3699168|NCT02193087|3540428|B5|||Height||cm|Mean|170.42|170.42|Standard Deviation|9.689|9.689|||
3699169|NCT02193087|3540429|B4|||Height||cm|Mean|170.69|170.69|Standard Deviation|9.680|9.68|||
3699170|NCT02193087|3540430|B3|||Height||cm|Mean|169.84|169.84|Standard Deviation|9.727|9.727|||
3699171|NCT02193087|3540431|B2|||Height||cm|Mean|171.13|171.13|Standard Deviation|10.466|10.466|||
3699172|NCT02193087|3540432|B1|||Height||cm|Mean|169.55|169.55|Standard Deviation|9.284|9.284|||
3699173|NCT02193087|3540428|B5|United States||Region of Enrollment||participants|Number|1002|1002.0||||||
3699174|NCT02193087|3540429|B4|United States||Region of Enrollment||participants|Number|603|603.0||||||
3699175|NCT02193087|3540430|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
3699176|NCT02193087|3540431|B2|United States||Region of Enrollment||participants|Number|100|100.0||||||
3699177|NCT02193087|3540432|B1|United States||Region of Enrollment||participants|Number|199|199.0||||||
3699178|NCT02193087|3540428|B5|Missing||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3699179|NCT02193087|3540429|B4|Missing||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3699180|NCT02193087|3540430|B3|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3699181|NCT02193087|3540431|B2|Missing||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3699182|NCT02193087|3540432|B1|Missing||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3699183|NCT02193087|3540428|B5|Multiracial||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3699184|NCT02193087|3540429|B4|Multiracial||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3699185|NCT02193087|3540430|B3|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3699186|NCT02193087|3540431|B2|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3699187|NCT02193087|3540432|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3699188|NCT02193087|3540428|B5|White||Race/Ethnicity, Customized||participants|Number|668|668.0||||||
3699189|NCT02193087|3540429|B4|White||Race/Ethnicity, Customized||participants|Number|408|408.0||||||
3699190|NCT02193087|3540430|B3|White||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
3699191|NCT02193087|3540431|B2|White||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
3699192|NCT02193087|3540432|B1|White||Race/Ethnicity, Customized||participants|Number|125|125.0||||||
3699193|NCT02193087|3540428|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3699194|NCT02193087|3540429|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3699195|NCT02193087|3540430|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3699196|NCT02193087|3540431|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3699197|NCT02193087|3540432|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3699198|NCT02193087|3540428|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|250|250.0||||||
3699199|NCT02193087|3540429|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|146|146.0||||||
3699200|NCT02193087|3540430|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3699201|NCT02193087|3540431|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
3699202|NCT02193087|3540432|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
3699203|NCT02193087|3540428|B5|Asian||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3699204|NCT02193087|3540429|B4|Asian||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3699205|NCT02193087|3540430|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3699206|NCT02193087|3540431|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3699207|NCT02193087|3540432|B1|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3699208|NCT02193087|3540428|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3699209|NCT02193087|3540429|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3699210|NCT02193087|3540430|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3699211|NCT02193087|3540431|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3699212|NCT02193087|3540432|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3699213|NCT02193087|3540428|B5|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3699214|NCT02193087|3540429|B4|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3699215|NCT02193087|3540430|B3|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3699216|NCT02193087|3540431|B2|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3699217|NCT02193087|3540432|B1|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3699218|NCT02193087|3540428|B5|Unknown||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3699219|NCT02193087|3540429|B4|Unknown||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3699220|NCT02193087|3540430|B3|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3699221|NCT02193087|3540431|B2|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3699222|NCT02193087|3540432|B1|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3699223|NCT02193087|3540428|B5|Not Reported||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3699224|NCT02193087|3540429|B4|Not Reported||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3699225|NCT02193087|3540430|B3|Not Reported||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3699226|NCT02193087|3540431|B2|Not Reported||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3699227|NCT02193087|3540432|B1|Not Reported||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3699228|NCT02193087|3540428|B5|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|767|767.0||||||
3699229|NCT02193087|3540429|B4|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|464|464.0||||||
3699230|NCT02193087|3540430|B3|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
3699231|NCT02193087|3540431|B2|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|75|75.0||||||
3699232|NCT02193087|3540432|B1|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|152|152.0||||||
3699233|NCT02193087|3540428|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|203|203.0||||||
3699234|NCT02193087|3540429|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|120|120.0||||||
3699235|NCT02193087|3540430|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3699236|NCT02193087|3540431|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3699237|NCT02193087|3540432|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
3699238|NCT02193087|3540428|B5||Male|Sex: Female, Male||Participants|Count of Participants|497|497.0||||||
3699239|NCT02193087|3540429|B4||Male|Sex: Female, Male||Participants|Count of Participants|305|305.0||||||
3699240|NCT02193087|3540430|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3699241|NCT02193087|3540431|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3699242|NCT02193087|3540432|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3699243|NCT02193087|3540428|B5||Female|Sex: Female, Male||Participants|Count of Participants|505|505.0||||||
3699244|NCT02193087|3540429|B4||Female|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
3699245|NCT02193087|3540430|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3699246|NCT02193087|3540431|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3699247|NCT02193087|3540432|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3699248|NCT02193087|3540428|B5|Adults (18-64 Years)||Age, Customized||participants|Number|1002|1002.0||||||
3699249|NCT02193087|3540429|B4|Adults (18-64 Years)||Age, Customized||participants|Number|603|603.0||||||
3699250|NCT02193087|3540430|B3|Adults (18-64 Years)||Age, Customized||participants|Number|100|100.0||||||
3699251|NCT02193087|3540431|B2|Adults (18-64 Years)||Age, Customized||participants|Number|100|100.0||||||
3699252|NCT02193087|3540432|B1|Adults (18-64 Years)||Age, Customized||participants|Number|199|199.0||||||
3699253|NCT02193087|3540428|B5|||Age||years|Mean|32.1|32.1|Standard Deviation|8.88|8.88|||
3699254|NCT02193087|3540429|B4|||Age||years|Mean|31.9|31.9|Standard Deviation|8.89|8.89|||
3699255|NCT02193087|3540430|B3|||Age||years|Mean|34.1|34.1|Standard Deviation|9.20|9.2|||
3699256|NCT02193087|3540431|B2|||Age||years|Mean|30.9|30.9|Standard Deviation|8.72|8.72|||
3699257|NCT02193087|3540432|B1|||Age||years|Mean|32.1|32.1|Standard Deviation|8.66|8.66|||
3699258|NCT02193074|3540478|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3699259|NCT02193074|3540479|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3699260|NCT02193074|3540480|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3699261|NCT02193074|3540478|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3699262|NCT02193074|3540479|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3699263|NCT02193074|3540480|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3699264|NCT02193074|3540478|B3|Age at First Dose||Age||days|Mean|169.2|169.2|Standard Deviation|50.48|50.48|||
3699265|NCT02193074|3540479|B2|Age at First Dose||Age||days|Mean|163.4|163.4|Standard Deviation|49.57|49.57|||
3699266|NCT02193074|3540480|B1|Age at First Dose||Age||days|Mean|180.5|180.5|Standard Deviation|50.92|50.92|||
3699267|NCT02193074|3540478|B3|Age at Screening||Age||days|Mean|153.1|153.1|Standard Deviation|47.95|47.95|||
3699268|NCT02193074|3540479|B2|Age at Screening||Age||days|Mean|147.2|147.2|Standard Deviation|46.85|46.85|||
3699269|NCT02193074|3540480|B1|Age at Screening||Age||days|Mean|164.7|164.7|Standard Deviation|48.54|48.54|||
3699270|NCT02192905|3540513|B1||Uses Facebook daily or more|Facebook Use||Participants|Count of Participants|34|34.0||||||
3699271|NCT02192905|3540513|B1||Uses Facebook 5-6 times per week|Facebook Use||Participants|Count of Participants|9|9.0||||||
3699272|NCT02192905|3540513|B1|||Social-Problem Solving Inventory-Revised|The social problem solving inventory measures strengths and weaknesses in ability to solve problems. The measure includes sub scales (positive problem orientation, rational problem-solving, negative problem orientation, impulsivity/carelessness style, and avoidance style). The means of the subscales are summed and then matched against an age chart to achieve the total score for the age being studied. This is done for each participant. The total score is being reported in these results. The scoring range includes 28 to 140. The higher the score the higher the problem solving ability.|Total score|Mean|107.3|107.3|Standard Deviation|14.75|14.75|||
3699273|NCT02192905|3540513|B1|||Weight||pounds|Mean|202.02|202.02|Standard Deviation|42.6|42.6|||
3699274|NCT02192905|3540513|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
3699275|NCT02192905|3540513|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699276|NCT02192905|3540513|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3699277|NCT02192905|3540513|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3699278|NCT02192905|3540513|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3699279|NCT02192905|3540513|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699280|NCT02192905|3540513|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3699281|NCT02192905|3540513|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699282|NCT02192905|3540513|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699283|NCT02192905|3540513|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3699284|NCT02192905|3540513|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3699285|NCT02192905|3540513|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3699286|NCT02192905|3540513|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3699287|NCT02192905|3540513|B1|||Age||years|Mean|37.33|37.33|Standard Deviation|11.29|11.29|||
3699288|NCT02192879|3540524|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
3699289|NCT02192879|3540525|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3699290|NCT02192879|3540526|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3699291|NCT02192879|3540527|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3699292|NCT02192879|3540524|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3699293|NCT02192879|3540525|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3699294|NCT02192879|3540526|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3699295|NCT02192879|3540527|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3699296|NCT02192879|3540524|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3699297|NCT02192879|3540525|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3699298|NCT02192879|3540526|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3699299|NCT02192879|3540527|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3699300|NCT02192879|3540524|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3699301|NCT02192879|3540525|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3699302|NCT02192879|3540526|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3699303|NCT02192879|3540527|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3699304|NCT02192879|3540524|B4||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3699305|NCT02192879|3540525|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3699306|NCT02192879|3540526|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3699307|NCT02192879|3540527|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3699308|NCT02192879|3540524|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3699309|NCT02192879|3540525|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3699310|NCT02192879|3540526|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3699311|NCT02192879|3540527|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3699312|NCT02192814|3540555|B1|||Height||centimeter (cm)|Mean|159.07|159.07|Standard Deviation|8.63|8.63|||
3699313|NCT02192814|3540555|B1|||Weight||kilogram (kg)|Mean|55.99|55.99|Standard Deviation|13.13|13.13|||
3699314|NCT02192814|3540555|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3699315|NCT02192814|3540555|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3699316|NCT02192814|3540555|B1|||Age||years|Mean|26.9|26.9|Standard Deviation|10.0|10.0|||
3699317|NCT02192814|3540555|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3699318|NCT02192814|3540555|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3699319|NCT02192814|3540555|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3699320|NCT02192684|3540566|B3|||Insulin Sensitivity|Steady-state plasma glucose (mmol/L)|mmol/L|Mean|12.1|12.1|Standard Deviation|2.1|2.1|||
3699321|NCT02192684|3540567|B2|||Insulin Sensitivity|Steady-state plasma glucose (mmol/L)|mmol/L|Mean|12.3|12.3|Standard Deviation|2.0|2.0|||
3699322|NCT02192684|3540568|B1|||Insulin Sensitivity|Steady-state plasma glucose (mmol/L)|mmol/L|Mean|11.9|11.9|Standard Deviation|2.1|2.1|||
3699323|NCT02192684|3540566|B3|||Changes in sleep measure|apnea-hypopnea index (AHI) events per hour|Apnea-hypopnea index (AHI) events/hour|Mean|38.9|38.9|Standard Deviation|12.1|12.1|||
3699324|NCT02192684|3540567|B2|||Changes in sleep measure|apnea-hypopnea index (AHI) events per hour|Apnea-hypopnea index (AHI) events/hour|Mean|40.8|40.8|Standard Deviation|12.3|12.3|||
3699325|NCT02192684|3540568|B1|||Changes in sleep measure|apnea-hypopnea index (AHI) events per hour|Apnea-hypopnea index (AHI) events/hour|Mean|36.9|36.9|Standard Deviation|11.9|11.9|||
3699326|NCT02192684|3540566|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3699327|NCT02192684|3540567|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3699328|NCT02192684|3540568|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3699329|NCT02192684|3540566|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3699330|NCT02192684|3540567|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3699331|NCT02192684|3540568|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3699332|NCT02192684|3540566|B3|||Age||years|Mean|50.5|50.5|Standard Deviation|11.5|11.5|||
3699333|NCT02192684|3540567|B2|||Age||years|Mean|50|50.0|Standard Deviation|12|12.0|||
3699334|NCT02192684|3540568|B1|||Age||years|Mean|51|51.0|Standard Deviation|11|11.0|||
3699335|NCT02192606|3540575|B3|Denmark||Region of Enrollment||participants|Number|21|21.0||||||
3699336|NCT02192606|3540576|B2|Denmark||Region of Enrollment||participants|Number|10|10.0||||||
3699337|NCT02192606|3540577|B1|Denmark||Region of Enrollment||participants|Number|11|11.0||||||
3699338|NCT02192606|3540575|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
3699339|NCT02192606|3540576|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
3699340|NCT02192606|3540577|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3699341|NCT02192606|3540575|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3699342|NCT02192606|3540576|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3699343|NCT02192606|3540577|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3699344|NCT02192606|3540575|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699345|NCT02192606|3540576|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699346|NCT02192606|3540577|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699347|NCT02192606|3540575|B3||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3699348|NCT02192606|3540576|B2||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3699349|NCT02192606|3540577|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3699350|NCT02192606|3540575|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699351|NCT02192606|3540576|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699352|NCT02192606|3540577|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699353|NCT02192606|3540575|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699354|NCT02192606|3540576|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699355|NCT02192606|3540577|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699356|NCT02192606|3540575|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3699357|NCT02192606|3540576|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699358|NCT02192606|3540577|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3699359|NCT02192606|3540575|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699360|NCT02192606|3540576|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699361|NCT02192606|3540577|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699362|NCT02192606|3540575|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3699363|NCT02192606|3540576|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3699364|NCT02192606|3540577|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3699365|NCT02192606|3540575|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3699366|NCT02192606|3540576|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3699367|NCT02192606|3540577|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3699368|NCT02192606|3540575|B3|||Age||years|Mean|42.7|42.7|Standard Deviation|7.6|7.6|||
3699369|NCT02192606|3540576|B2|||Age||years|Mean|43.9|43.9|Standard Deviation|8.2|8.2|||
3699370|NCT02192606|3540577|B1|||Age||years|Mean|27.5|27.5|Standard Deviation|5.2|5.2|||
3699371|NCT02192541|3540586|B3|||Number of Prior Therapies||prior therapies|Median|8|8.0|Full Range|||5.0|15.0|
3699372|NCT02192541|3540587|B2|||Number of Prior Therapies||prior therapies|Median|8|8.0|Full Range|||6.0|15.0|
3699373|NCT02192541|3540588|B1|||Number of Prior Therapies||prior therapies|Median|6.5|6.5|Full Range|||5.0|8.0|
3699374|NCT02192541|3540586|B3|5: Dead||Eastern Cooperative Oncology Group (ECOG) Performance Status|The Eastern Cooperative Oncology Group (ECOG) Scale of Performance Status is graded on a scale of 0 to 5, with higher scores indicating lower levels of functioning in terms of ability to care for oneself, daily activities, and physical abilities (walking, working, etc.).|Participants|Count of Participants|0|0.0||||||
3699375|NCT02192541|3540587|B2|5: Dead||Eastern Cooperative Oncology Group (ECOG) Performance Status|The Eastern Cooperative Oncology Group (ECOG) Scale of Performance Status is graded on a scale of 0 to 5, with higher scores indicating lower levels of functioning in terms of ability to care for oneself, daily activities, and physical abilities (walking, working, etc.).|Participants|Count of Participants|0|0.0||||||
3699376|NCT02192541|3540588|B1|5: Dead||Eastern Cooperative Oncology Group (ECOG) Performance Status|The Eastern Cooperative Oncology Group (ECOG) Scale of Performance Status is graded on a scale of 0 to 5, with higher scores indicating lower levels of functioning in terms of ability to care for oneself, daily activities, and physical abilities (walking, working, etc.).|Participants|Count of Participants|0|0.0||||||
3699377|NCT02192541|3540586|B3|4: Completely disabled||Eastern Cooperative Oncology Group (ECOG) Performance Status|The Eastern Cooperative Oncology Group (ECOG) Scale of Performance Status is graded on a scale of 0 to 5, with higher scores indicating lower levels of functioning in terms of ability to care for oneself, daily activities, and physical abilities (walking, working, etc.).|Participants|Count of Participants|0|0.0||||||
3699378|NCT02192541|3540587|B2|4: Completely disabled||Eastern Cooperative Oncology Group (ECOG) Performance Status|The Eastern Cooperative Oncology Group (ECOG) Scale of Performance Status is graded on a scale of 0 to 5, with higher scores indicating lower levels of functioning in terms of ability to care for oneself, daily activities, and physical abilities (walking, working, etc.).|Participants|Count of Participants|0|0.0||||||
3699379|NCT02192541|3540588|B1|4: Completely disabled||Eastern Cooperative Oncology Group (ECOG) Performance Status|The Eastern Cooperative Oncology Group (ECOG) Scale of Performance Status is graded on a scale of 0 to 5, with higher scores indicating lower levels of functioning in terms of ability to care for oneself, daily activities, and physical abilities (walking, working, etc.).|Participants|Count of Participants|0|0.0||||||
3699380|NCT02192541|3540586|B3|3: Capable of only limited self-care||Eastern Cooperative Oncology Group (ECOG) Performance Status|The Eastern Cooperative Oncology Group (ECOG) Scale of Performance Status is graded on a scale of 0 to 5, with higher scores indicating lower levels of functioning in terms of ability to care for oneself, daily activities, and physical abilities (walking, working, etc.).|Participants|Count of Participants|0|0.0||||||
3699381|NCT02192541|3540587|B2|3: Capable of only limited self-care||Eastern Cooperative Oncology Group (ECOG) Performance Status|The Eastern Cooperative Oncology Group (ECOG) Scale of Performance Status is graded on a scale of 0 to 5, with higher scores indicating lower levels of functioning in terms of ability to care for oneself, daily activities, and physical abilities (walking, working, etc.).|Participants|Count of Participants|0|0.0||||||
3699382|NCT02192541|3540588|B1|3: Capable of only limited self-care||Eastern Cooperative Oncology Group (ECOG) Performance Status|The Eastern Cooperative Oncology Group (ECOG) Scale of Performance Status is graded on a scale of 0 to 5, with higher scores indicating lower levels of functioning in terms of ability to care for oneself, daily activities, and physical abilities (walking, working, etc.).|Participants|Count of Participants|0|0.0||||||
3699383|NCT02192541|3540586|B3|2: Unable to carry out any work activities||Eastern Cooperative Oncology Group (ECOG) Performance Status|The Eastern Cooperative Oncology Group (ECOG) Scale of Performance Status is graded on a scale of 0 to 5, with higher scores indicating lower levels of functioning in terms of ability to care for oneself, daily activities, and physical abilities (walking, working, etc.).|Participants|Count of Participants|0|0.0||||||
3699384|NCT02192541|3540587|B2|2: Unable to carry out any work activities||Eastern Cooperative Oncology Group (ECOG) Performance Status|The Eastern Cooperative Oncology Group (ECOG) Scale of Performance Status is graded on a scale of 0 to 5, with higher scores indicating lower levels of functioning in terms of ability to care for oneself, daily activities, and physical abilities (walking, working, etc.).|Participants|Count of Participants|0|0.0||||||
3699385|NCT02192541|3540588|B1|2: Unable to carry out any work activities||Eastern Cooperative Oncology Group (ECOG) Performance Status|The Eastern Cooperative Oncology Group (ECOG) Scale of Performance Status is graded on a scale of 0 to 5, with higher scores indicating lower levels of functioning in terms of ability to care for oneself, daily activities, and physical abilities (walking, working, etc.).|Participants|Count of Participants|0|0.0||||||
3699429|NCT02192541|3540587|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3699430|NCT02192541|3540588|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3699386|NCT02192541|3540586|B3|1: Restricted in physically strenuous activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|The Eastern Cooperative Oncology Group (ECOG) Scale of Performance Status is graded on a scale of 0 to 5, with higher scores indicating lower levels of functioning in terms of ability to care for oneself, daily activities, and physical abilities (walking, working, etc.).|Participants|Count of Participants|5|5.0||||||
3699387|NCT02192541|3540587|B2|1: Restricted in physically strenuous activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|The Eastern Cooperative Oncology Group (ECOG) Scale of Performance Status is graded on a scale of 0 to 5, with higher scores indicating lower levels of functioning in terms of ability to care for oneself, daily activities, and physical abilities (walking, working, etc.).|Participants|Count of Participants|3|3.0||||||
3699388|NCT02192541|3540588|B1|1: Restricted in physically strenuous activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|The Eastern Cooperative Oncology Group (ECOG) Scale of Performance Status is graded on a scale of 0 to 5, with higher scores indicating lower levels of functioning in terms of ability to care for oneself, daily activities, and physical abilities (walking, working, etc.).|Participants|Count of Participants|2|2.0||||||
3699389|NCT02192541|3540586|B3|0: Fully active||Eastern Cooperative Oncology Group (ECOG) Performance Status|The Eastern Cooperative Oncology Group (ECOG) Scale of Performance Status is graded on a scale of 0 to 5, with higher scores indicating lower levels of functioning in terms of ability to care for oneself, daily activities, and physical abilities (walking, working, etc.).|Participants|Count of Participants|0|0.0||||||
3699390|NCT02192541|3540587|B2|0: Fully active||Eastern Cooperative Oncology Group (ECOG) Performance Status|The Eastern Cooperative Oncology Group (ECOG) Scale of Performance Status is graded on a scale of 0 to 5, with higher scores indicating lower levels of functioning in terms of ability to care for oneself, daily activities, and physical abilities (walking, working, etc.).|Participants|Count of Participants|0|0.0||||||
3699391|NCT02192541|3540588|B1|0: Fully active||Eastern Cooperative Oncology Group (ECOG) Performance Status|The Eastern Cooperative Oncology Group (ECOG) Scale of Performance Status is graded on a scale of 0 to 5, with higher scores indicating lower levels of functioning in terms of ability to care for oneself, daily activities, and physical abilities (walking, working, etc.).|Participants|Count of Participants|0|0.0||||||
3699392|NCT02192541|3540586|B3|Rectal adenocarcinomas||Diagnosis||Participants|Count of Participants|1|1.0||||||
3699393|NCT02192541|3540587|B2|Rectal adenocarcinomas||Diagnosis||Participants|Count of Participants|0|0.0||||||
3699394|NCT02192541|3540588|B1|Rectal adenocarcinomas||Diagnosis||Participants|Count of Participants|1|1.0||||||
3699395|NCT02192541|3540586|B3|Small bowel adenocarcinomas||Diagnosis||Participants|Count of Participants|1|1.0||||||
3699396|NCT02192541|3540587|B2|Small bowel adenocarcinomas||Diagnosis||Participants|Count of Participants|1|1.0||||||
3699397|NCT02192541|3540588|B1|Small bowel adenocarcinomas||Diagnosis||Participants|Count of Participants|0|0.0||||||
3699398|NCT02192541|3540586|B3|Colon adenocarcinomas||Diagnosis||Participants|Count of Participants|3|3.0||||||
3699399|NCT02192541|3540587|B2|Colon adenocarcinomas||Diagnosis||Participants|Count of Participants|2|2.0||||||
3699400|NCT02192541|3540588|B1|Colon adenocarcinomas||Diagnosis||Participants|Count of Participants|1|1.0||||||
3699401|NCT02192541|3540586|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3699402|NCT02192541|3540587|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3699403|NCT02192541|3540588|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3699404|NCT02192541|3540586|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3699405|NCT02192541|3540587|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3699406|NCT02192541|3540588|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699407|NCT02192541|3540586|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699408|NCT02192541|3540587|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699409|NCT02192541|3540588|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699410|NCT02192541|3540586|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3699411|NCT02192541|3540587|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3699412|NCT02192541|3540588|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3699413|NCT02192541|3540586|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3699414|NCT02192541|3540587|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699415|NCT02192541|3540588|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3699416|NCT02192541|3540586|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699417|NCT02192541|3540587|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699418|NCT02192541|3540588|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699419|NCT02192541|3540586|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699420|NCT02192541|3540587|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699421|NCT02192541|3540588|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699422|NCT02192541|3540586|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699423|NCT02192541|3540587|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699424|NCT02192541|3540588|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699425|NCT02192541|3540586|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699426|NCT02192541|3540587|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699427|NCT02192541|3540588|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699428|NCT02192541|3540586|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3699431|NCT02192541|3540586|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3699432|NCT02192541|3540587|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3699433|NCT02192541|3540588|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699434|NCT02192541|3540586|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3699435|NCT02192541|3540587|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3699436|NCT02192541|3540588|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3699437|NCT02192541|3540586|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3699438|NCT02192541|3540587|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3699439|NCT02192541|3540588|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3699440|NCT02192541|3540586|B3|||Age||years|Median|60|60.0|Full Range|||50.0|67.0|
3699441|NCT02192541|3540587|B2|||Age||years|Median|60|60.0|Full Range|||50.0|63.0|
3699442|NCT02192541|3540588|B1|||Age||years|Median|59|59.0|Full Range|||51.0|67.0|
3699443|NCT02192541|3540586|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3699444|NCT02192541|3540587|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3699445|NCT02192541|3540588|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3699446|NCT02192541|3540586|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3699447|NCT02192541|3540587|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3699448|NCT02192541|3540588|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3699449|NCT02192541|3540586|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3699450|NCT02192541|3540587|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3699451|NCT02192541|3540588|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3699452|NCT02192190|3540609|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3699453|NCT02192190|3540610|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3699454|NCT02192190|3540611|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3699455|NCT02192190|3540612|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699456|NCT02192190|3540613|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699457|NCT02192190|3540614|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699458|NCT02192190|3540615|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3699459|NCT02192190|3540609|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699460|NCT02192190|3540610|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699461|NCT02192190|3540611|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699462|NCT02192190|3540612|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699463|NCT02192190|3540613|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699464|NCT02192190|3540614|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699465|NCT02192190|3540615|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699466|NCT02192190|3540609|B7||White|Race (NIH/OMB)||Participants|Count of Participants|181|181.0||||||
3699467|NCT02192190|3540610|B6||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3699468|NCT02192190|3540611|B5||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3699469|NCT02192190|3540612|B4||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3699470|NCT02192190|3540613|B3||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3699471|NCT02192190|3540614|B2||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3699472|NCT02192190|3540615|B1||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3699473|NCT02192190|3540609|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3699474|NCT02192190|3540610|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3699475|NCT02192190|3540611|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3699476|NCT02192190|3540612|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3699477|NCT02192190|3540613|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3699478|NCT02192190|3540614|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3699479|NCT02192190|3540615|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3699480|NCT02192190|3540609|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699481|NCT02192190|3540610|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699482|NCT02192190|3540611|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699483|NCT02192190|3540612|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699484|NCT02192190|3540613|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699485|NCT02192190|3540614|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699486|NCT02192190|3540615|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699487|NCT02192190|3540609|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3699488|NCT02192190|3540610|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699489|NCT02192190|3540611|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699490|NCT02192190|3540612|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699491|NCT02192190|3540613|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3699492|NCT02192190|3540614|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3699493|NCT02192190|3540615|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3699494|NCT02192190|3540609|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699495|NCT02192190|3540610|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699496|NCT02192190|3540611|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699497|NCT02192190|3540612|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699498|NCT02192190|3540613|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699499|NCT02192190|3540614|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699500|NCT02192190|3540615|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699501|NCT02192190|3540609|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3699502|NCT02192190|3540610|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699503|NCT02192190|3540611|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3699504|NCT02192190|3540612|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699505|NCT02192190|3540613|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699506|NCT02192190|3540614|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699507|NCT02192190|3540615|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699508|NCT02192190|3540609|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
3699509|NCT02192190|3540610|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3699510|NCT02192190|3540611|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3699511|NCT02192190|3540612|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3699512|NCT02192190|3540613|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3699513|NCT02192190|3540614|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3699514|NCT02192190|3540615|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3699515|NCT02192190|3540609|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|135|135.0||||||
3699516|NCT02192190|3540610|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3699517|NCT02192190|3540611|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3699518|NCT02192190|3540612|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3699519|NCT02192190|3540613|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3699520|NCT02192190|3540614|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3699521|NCT02192190|3540615|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3699522|NCT02192190|3540609|B7||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3699523|NCT02192190|3540610|B6||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3699524|NCT02192190|3540611|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3699525|NCT02192190|3540612|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3699526|NCT02192190|3540613|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3699527|NCT02192190|3540614|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3699528|NCT02192190|3540615|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3699529|NCT02192190|3540609|B7||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3699530|NCT02192190|3540610|B6||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3699531|NCT02192190|3540611|B5||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3699532|NCT02192190|3540612|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3699533|NCT02192190|3540613|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3699534|NCT02192190|3540614|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3699535|NCT02192190|3540615|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3699536|NCT02192190|3540609|B7|||Age||years|Mean|58.2|58.2|Standard Deviation|8.91|8.91|||
3699537|NCT02192190|3540610|B6|||Age||years|Mean|56.4|56.4|Standard Deviation|9.38|9.38|||
3699538|NCT02192190|3540611|B5|||Age||years|Mean|58|58.0|Standard Deviation|9.29|9.29|||
3699539|NCT02192190|3540612|B4|||Age||years|Mean|56.7|56.7|Standard Deviation|7.95|7.95|||
3699540|NCT02192190|3540613|B3|||Age||years|Mean|58.0|58.0|Standard Deviation|9.60|9.6|||
3699541|NCT02192190|3540614|B2|||Age||years|Mean|60.8|60.8|Standard Deviation|9.86|9.86|||
3699542|NCT02192190|3540615|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|7.94|7.94|||
3699543|NCT02192164|3540664|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3699544|NCT02192164|3540664|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3699545|NCT02192164|3540664|B1|||Age||years|Mean|47.37|47.37|Standard Deviation|15.59|15.59|||
3699546|NCT02191865|3540680|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3699547|NCT02191865|3540681|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3699548|NCT02191865|3540682|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3699549|NCT02191865|3540683|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3699550|NCT02191865|3540680|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3699551|NCT02191865|3540681|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3699552|NCT02191865|3540682|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3699553|NCT02191865|3540683|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3699554|NCT02191865|3540680|B4|||Age||years|Mean|58.1|58.1|Standard Deviation|7.8|7.8|||
3699555|NCT02191865|3540681|B3|||Age||years|Mean|57.6|57.6|Standard Deviation|8.4|8.4|||
3699556|NCT02191865|3540682|B2|||Age||years|Mean|56.6|56.6|Standard Deviation|6.5|6.5|||
3699557|NCT02191865|3540683|B1|||Age||years|Mean|60.6|60.6|Standard Deviation|8.1|8.1|||
3699558|NCT02191605|3540705|B6|||ASSIST marijuana score|The Alcohol Smoking and Substance Involvement Screening Test (ASSIST) was developed by the World Health Organization (WHO) and is used to detect and manage substance use and related problems. For this measure the sum of all the marijuana related items was calculated for each participant. We reported the median score for each intervention arm group. Scores on the marijuana subscale range from 0 to 33. Scores of 0 to 3 present low risk; 4 - 26 moderate risk (at risk of health & other problems from current pattern of use); and 27 - 33 high risk (severe problems & likely to be dependent).|scores on a scale|Median|8|8.0|Inter-Quartile Range|||2.0|13.0|
3699559|NCT02191605|3540706|B5|||ASSIST marijuana score|The Alcohol Smoking and Substance Involvement Screening Test (ASSIST) was developed by the World Health Organization (WHO) and is used to detect and manage substance use and related problems. For this measure the sum of all the marijuana related items was calculated for each participant. We reported the median score for each intervention arm group. Scores on the marijuana subscale range from 0 to 33. Scores of 0 to 3 present low risk; 4 - 26 moderate risk (at risk of health & other problems from current pattern of use); and 27 - 33 high risk (severe problems & likely to be dependent).|scores on a scale|Median|NA||Inter-Quartile Range|||0.0|0.0|ASSIST not given during screening
3699560|NCT02191605|3540707|B4|||ASSIST marijuana score|The Alcohol Smoking and Substance Involvement Screening Test (ASSIST) was developed by the World Health Organization (WHO) and is used to detect and manage substance use and related problems. For this measure the sum of all the marijuana related items was calculated for each participant. We reported the median score for each intervention arm group. Scores on the marijuana subscale range from 0 to 33. Scores of 0 to 3 present low risk; 4 - 26 moderate risk (at risk of health & other problems from current pattern of use); and 27 - 33 high risk (severe problems & likely to be dependent).|scores on a scale|Median|6|6.0|Inter-Quartile Range|||0.5|11.0|
3699561|NCT02191605|3540708|B3|||ASSIST marijuana score|The Alcohol Smoking and Substance Involvement Screening Test (ASSIST) was developed by the World Health Organization (WHO) and is used to detect and manage substance use and related problems. For this measure the sum of all the marijuana related items was calculated for each participant. We reported the median score for each intervention arm group. Scores on the marijuana subscale range from 0 to 33. Scores of 0 to 3 present low risk; 4 - 26 moderate risk (at risk of health & other problems from current pattern of use); and 27 - 33 high risk (severe problems & likely to be dependent).|scores on a scale|Median|6|6.0|Inter-Quartile Range|||5.0|12.0|
3699562|NCT02191605|3540709|B2|||ASSIST marijuana score|The Alcohol Smoking and Substance Involvement Screening Test (ASSIST) was developed by the World Health Organization (WHO) and is used to detect and manage substance use and related problems. For this measure the sum of all the marijuana related items was calculated for each participant. We reported the median score for each intervention arm group. Scores on the marijuana subscale range from 0 to 33. Scores of 0 to 3 present low risk; 4 - 26 moderate risk (at risk of health & other problems from current pattern of use); and 27 - 33 high risk (severe problems & likely to be dependent).|scores on a scale|Median|9|9.0|Inter-Quartile Range|||4.0|16.0|
3699563|NCT02191605|3540710|B1|||ASSIST marijuana score|The Alcohol Smoking and Substance Involvement Screening Test (ASSIST) was developed by the World Health Organization (WHO) and is used to detect and manage substance use and related problems. For this measure the sum of all the marijuana related items was calculated for each participant. We reported the median score for each intervention arm group. Scores on the marijuana subscale range from 0 to 33. Scores of 0 to 3 present low risk; 4 - 26 moderate risk (at risk of health & other problems from current pattern of use); and 27 - 33 high risk (severe problems & likely to be dependent).|scores on a scale|Median|9|9.0|Inter-Quartile Range|||0.0|12.0|
3699564|NCT02191605|3540705|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699565|NCT02191605|3540706|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699566|NCT02191605|3540707|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699567|NCT02191605|3540708|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699568|NCT02191605|3540709|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699569|NCT02191605|3540710|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699570|NCT02191605|3540705|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3699571|NCT02191605|3540706|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3699572|NCT02191605|3540707|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699573|NCT02191605|3540708|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699574|NCT02191605|3540709|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3699575|NCT02191605|3540710|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3699576|NCT02191605|3540705|B6||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3699577|NCT02191605|3540706|B5||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3699578|NCT02191605|3540707|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699579|NCT02191605|3540708|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699580|NCT02191605|3540709|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3699581|NCT02191605|3540710|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3699582|NCT02191605|3540705|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3699583|NCT02191605|3540706|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3699584|NCT02191605|3540707|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3699585|NCT02191605|3540708|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3699586|NCT02191605|3540709|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3699587|NCT02191605|3540710|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3699588|NCT02191605|3540705|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699589|NCT02191605|3540706|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699590|NCT02191605|3540707|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699591|NCT02191605|3540708|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699592|NCT02191605|3540709|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699593|NCT02191605|3540710|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699594|NCT02191605|3540705|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699595|NCT02191605|3540706|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699596|NCT02191605|3540707|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699597|NCT02191605|3540708|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699598|NCT02191605|3540709|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699599|NCT02191605|3540710|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699600|NCT02191605|3540705|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699601|NCT02191605|3540706|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699602|NCT02191605|3540707|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699603|NCT02191605|3540708|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699604|NCT02191605|3540709|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699605|NCT02191605|3540710|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699606|NCT02191605|3540705|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699607|NCT02191605|3540706|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699608|NCT02191605|3540707|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699609|NCT02191605|3540708|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699610|NCT02191605|3540709|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699611|NCT02191605|3540710|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699612|NCT02191605|3540705|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3699613|NCT02191605|3540706|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3699614|NCT02191605|3540707|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3699615|NCT02191605|3540708|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3699616|NCT02191605|3540709|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3699617|NCT02191605|3540710|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3699618|NCT02191605|3540705|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3699619|NCT02191605|3540706|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699620|NCT02191605|3540707|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699621|NCT02191605|3540708|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699622|NCT02191605|3540709|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699623|NCT02191605|3540710|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3699624|NCT02191605|3540705|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3699625|NCT02191605|3540706|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3699626|NCT02191605|3540707|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3699627|NCT02191605|3540708|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3699628|NCT02191605|3540709|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3699629|NCT02191605|3540710|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3699630|NCT02191605|3540705|B6||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3699631|NCT02191605|3540706|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3699632|NCT02191605|3540707|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3699633|NCT02191605|3540708|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3699634|NCT02191605|3540709|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3699635|NCT02191605|3540710|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3699636|NCT02191605|3540705|B6|||Age||years|Mean|24.6|24.6|Standard Deviation|5.0|5.0|||
3699637|NCT02191605|3540706|B5|||Age||years|Mean|NA||Standard Deviation|NA||||Only verified 18 and older during screening. Continuous measure of age asked during assessment.
3699638|NCT02191605|3540707|B4|||Age||years|Mean|22.6|22.6|Standard Deviation|3.2|3.2|||
3699639|NCT02191605|3540708|B3|||Age||years|Mean|27.2|27.2|Standard Deviation|5.4|5.4|||
3699640|NCT02191605|3540709|B2|||Age||years|Mean|23.5|23.5|Standard Deviation|3.7|3.7|||
3699641|NCT02191605|3540710|B1|||Age||years|Mean|24.3|24.3|Standard Deviation|5.9|5.9|||
3699642|NCT02191579|3540731|B3|||Use of Headache Prophylactic Treatment(s)||Participants|Count of Participants|51|51.0||||||
3699643|NCT02191579|3540732|B2|||Use of Headache Prophylactic Treatment(s)||Participants|Count of Participants|25|25.0||||||
3699644|NCT02191579|3540733|B1|||Use of Headache Prophylactic Treatment(s)||Participants|Count of Participants|26|26.0||||||
3699645|NCT02191579|3540731|B3|||Body Mass Index (BMI||kg/m^2|Mean|28.8|28.8|Standard Deviation|6.8|6.8|||
3699646|NCT02191579|3540732|B2|||Body Mass Index (BMI||kg/m^2|Mean|28.8|28.8|Standard Deviation|6.5|6.5|||
3699647|NCT02191579|3540733|B1|||Body Mass Index (BMI||kg/m^2|Mean|28.9|28.9|Standard Deviation|7.1|7.1|||
3699648|NCT02191579|3540731|B3|||Weight||kilogram (kg)|Mean|80.8|80.8|Standard Deviation|21.1|21.1|||
3699649|NCT02191579|3540732|B2|||Weight||kilogram (kg)|Mean|80.5|80.5|Standard Deviation|20.6|20.6|||
3699650|NCT02191579|3540733|B1|||Weight||kilogram (kg)|Mean|81.0|81.0|Standard Deviation|21.8|21.8|||
3699651|NCT02191579|3540731|B3|||Height||centimeter (cm)|Mean|167.2|167.2|Standard Deviation|8.5|8.5|||
3699652|NCT02191579|3540732|B2|||Height||centimeter (cm)|Mean|167.0|167.0|Standard Deviation|8.7|8.7|||
3699653|NCT02191579|3540733|B1|||Height||centimeter (cm)|Mean|167.4|167.4|Standard Deviation|8.5|8.5|||
3699654|NCT02191579|3540731|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3699655|NCT02191579|3540732|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3699656|NCT02191579|3540733|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3699657|NCT02191579|3540731|B3||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3699658|NCT02191579|3540732|B2||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3699659|NCT02191579|3540733|B1||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3699660|NCT02191579|3540731|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3699661|NCT02191579|3540732|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3699662|NCT02191579|3540733|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3699663|NCT02191579|3540731|B3||Black|Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3699664|NCT02191579|3540732|B2||Black|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3699665|NCT02191579|3540733|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3699666|NCT02191579|3540731|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|229|229.0||||||
3699667|NCT02191579|3540732|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|118|118.0||||||
3699668|NCT02191579|3540733|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|111|111.0||||||
3699669|NCT02191579|3540731|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3699670|NCT02191579|3540732|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3699671|NCT02191579|3540733|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3699672|NCT02191579|3540731|B3||Female|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
3699673|NCT02191579|3540732|B2||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3699674|NCT02191579|3540733|B1||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3699675|NCT02191579|3540731|B3|≥55||Age, Customized||Participants|Count of Participants|36|36.0||||||
3699676|NCT02191579|3540732|B2|≥55||Age, Customized||Participants|Count of Participants|18|18.0||||||
3699677|NCT02191579|3540733|B1|≥55||Age, Customized||Participants|Count of Participants|18|18.0||||||
3699678|NCT02191579|3540731|B3|45 to <55||Age, Customized||Participants|Count of Participants|67|67.0||||||
3699679|NCT02191579|3540732|B2|45 to <55||Age, Customized||Participants|Count of Participants|34|34.0||||||
3699680|NCT02191579|3540733|B1|45 to <55||Age, Customized||Participants|Count of Participants|33|33.0||||||
3699681|NCT02191579|3540731|B3|35 to <45||Age, Customized||Participants|Count of Participants|72|72.0||||||
3699682|NCT02191579|3540732|B2|35 to <45||Age, Customized||Participants|Count of Participants|29|29.0||||||
3699683|NCT02191579|3540733|B1|35 to <45||Age, Customized||Participants|Count of Participants|43|43.0||||||
3699684|NCT02191579|3540731|B3|25 to <35||Age, Customized||Participants|Count of Participants|70|70.0||||||
3699685|NCT02191579|3540732|B2|25 to <35||Age, Customized||Participants|Count of Participants|40|40.0||||||
3699686|NCT02191579|3540733|B1|25 to <35||Age, Customized||Participants|Count of Participants|30|30.0||||||
3699687|NCT02191579|3540731|B3|18 to <25||Age, Customized||Participants|Count of Participants|37|37.0||||||
3699688|NCT02191579|3540732|B2|18 to <25||Age, Customized||Participants|Count of Participants|21|21.0||||||
3699689|NCT02191579|3540733|B1|18 to <25||Age, Customized||Participants|Count of Participants|16|16.0||||||
3699690|NCT02191579|3540731|B3|||Age||years|Mean|39.8|39.8|Standard Deviation|12.1|12.1|||
3699691|NCT02191579|3540732|B2|||Age||years|Mean|39.4|39.4|Standard Deviation|12.6|12.6|||
3699692|NCT02191579|3540733|B1|||Age||years|Mean|40.2|40.2|Standard Deviation|11.7|11.7|||
3699693|NCT02191267|3540746|B4|United States||Region of Enrollment||participants|Number|29|29.0||||||
3699694|NCT02191267|3540747|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3699695|NCT02191267|3540748|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3699696|NCT02191267|3540749|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3699697|NCT02191267|3540746|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699698|NCT02191267|3540747|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699699|NCT02191267|3540748|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699700|NCT02191267|3540749|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699701|NCT02191267|3540746|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699702|NCT02191267|3540747|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699703|NCT02191267|3540748|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699704|NCT02191267|3540749|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699705|NCT02191267|3540746|B4||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3699706|NCT02191267|3540747|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3699707|NCT02191267|3540748|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3699708|NCT02191267|3540749|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3699709|NCT02191267|3540746|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3699710|NCT02191267|3540747|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699711|NCT02191267|3540748|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3699712|NCT02191267|3540749|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3699713|NCT02191267|3540746|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699714|NCT02191267|3540747|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699715|NCT02191267|3540748|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699716|NCT02191267|3540749|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699717|NCT02191267|3540746|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699718|NCT02191267|3540747|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699719|NCT02191267|3540748|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699720|NCT02191267|3540749|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699721|NCT02191267|3540746|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699722|NCT02191267|3540747|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699723|NCT02191267|3540748|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699724|NCT02191267|3540749|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699725|NCT02191267|3540746|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3699726|NCT02191267|3540747|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3699727|NCT02191267|3540748|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3699728|NCT02191267|3540749|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3699729|NCT02191267|3540746|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3699730|NCT02191267|3540747|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3699731|NCT02191267|3540748|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3699732|NCT02191267|3540749|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3699733|NCT02191267|3540746|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3699734|NCT02191267|3540747|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3699735|NCT02191267|3540748|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3699736|NCT02191267|3540749|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3699737|NCT02191267|3540746|B4||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3699738|NCT02191267|3540747|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3699739|NCT02191267|3540748|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3699740|NCT02191267|3540749|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3699741|NCT02191267|3540746|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3699742|NCT02191267|3540747|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3699743|NCT02191267|3540748|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3699744|NCT02191267|3540749|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3699745|NCT02191137|3540762|B1|||WLQ: Percentage of Productivity loss|The WLQ is an 8-item questionnaire that measures the degree to which employed individuals are experiencing limitations on-the-job due to their health problems, and health-related productivity loss (Presenteeism). The WLQ's terms are aggregated into four scales (i.e. Time Management, Physical demands, Mental-interpersonal demands, Output demands). Using an algorithm, WLQ scale scores can be converted into an estimate of productivity loss.|Percentage|Mean|8.85|8.85|Standard Deviation|6.62|6.62|||
3699774|NCT02191046|3540791|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3699775|NCT02191046|3540792|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3699776|NCT02191046|3540790|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3699746|NCT02191137|3540762|B1|Output demands scale||Work Limitations Questionnaire (WLQ)|The Work Limitations Questionnaire (WLQ) is an 8-item questionnaire that measures the degree to which employed individuals are experiencing limitations on-the-job due to their health problems, and health-related productivity loss (Presenteeism). The WLQ's terms are aggregated into four scales (i.e. Time Management, Physical demands, Mental-interpersonal demands, Output demands). Scale score range from 0 (limited none of the time) to 100 (limited all of the time) and represent the reported amount of time in the prior two weeks respondents were limited on-the-job.|Percentage|Mean|36.52|36.52|Standard Deviation|31.51|31.51|||
3699747|NCT02191137|3540762|B1|Mental-interpersonal demands scale||Work Limitations Questionnaire (WLQ)|The Work Limitations Questionnaire (WLQ) is an 8-item questionnaire that measures the degree to which employed individuals are experiencing limitations on-the-job due to their health problems, and health-related productivity loss (Presenteeism). The WLQ's terms are aggregated into four scales (i.e. Time Management, Physical demands, Mental-interpersonal demands, Output demands). Scale score range from 0 (limited none of the time) to 100 (limited all of the time) and represent the reported amount of time in the prior two weeks respondents were limited on-the-job.|Percentage|Mean|28.66|28.66|Standard Deviation|25.22|25.22|||
3699748|NCT02191137|3540762|B1|Physical demands scale||Work Limitations Questionnaire (WLQ)|The Work Limitations Questionnaire (WLQ) is an 8-item questionnaire that measures the degree to which employed individuals are experiencing limitations on-the-job due to their health problems, and health-related productivity loss (Presenteeism). The WLQ's terms are aggregated into four scales (i.e. Time Management, Physical demands, Mental-interpersonal demands, Output demands). Scale score range from 0 (limited none of the time) to 100 (limited all of the time) and represent the reported amount of time in the prior two weeks respondents were limited on-the-job.|Percentage|Mean|33.47|33.47|Standard Deviation|28.25|28.25|||
3699749|NCT02191137|3540762|B1|Time management scale||Work Limitations Questionnaire (WLQ)|The Work Limitations Questionnaire (WLQ) is an 8-item questionnaire that measures the degree to which employed individuals are experiencing limitations on-the-job due to their health problems, and health-related productivity loss (Presenteeism). The WLQ's terms are aggregated into four scales (i.e. Time Management, Physical demands, Mental-interpersonal demands, Output demands). Scale score range from 0 (limited none of the time) to 100 (limited all of the time) and represent the reported amount of time in the prior two weeks respondents were limited on-the-job.|Percentage|Mean|36.42|36.42|Standard Deviation|30.82|30.82|||
3699750|NCT02191137|3540762|B1|||Six-minute walk distance (6MWD)||Meters|Mean|310.259|310.259|Standard Deviation|89.578|89.578|||
3699751|NCT02191137|3540762|B1|||Modified Borg Dyspnea Scale||Scores|Mean|4.47|4.47|Standard Deviation|2.74|2.74|||
3699752|NCT02191137|3540762|B1|IV||WHO functional class||Percentage of participants|Number|1.3|1.3||||||
3699753|NCT02191137|3540762|B1|III||WHO functional class||Percentage of participants|Number|58.7|58.7||||||
3699754|NCT02191137|3540762|B1|II||WHO functional class||Percentage of participants|Number|30.7|30.7||||||
3699755|NCT02191137|3540762|B1|I||WHO functional class||Percentage of participants|Number|9.3|9.3||||||
3699756|NCT02191137|3540762|B1|Mental component summary||Short Form-12 Health Survey (SF-12) questionnaire||Scores|Mean|47.453|47.453|Standard Deviation|9.213|9.213|||
3699757|NCT02191137|3540762|B1|Physical component summary||Short Form-12 Health Survey (SF-12) questionnaire||Scores|Mean|36.660|36.66|Standard Deviation|8.577|8.577|||
3699758|NCT02191137|3540762|B1|Emotional dimension score||Living with Pulmonary Hypertension (LPH)|The LPH derived from the Minnesota Living with Heart Failure questionnaire comprises 21 items, responded to on a 6-point Likert scale ranging from 0 'No’ to 5 ’Very much’. A total score ranging from 0 to 105 is calculated by summing the responses to all 21 questions. A physical dimension score (range 0-40, 8 items) and an emotional dimension score (range 0-25, 5 items) can also be calculated. For all LPH scores, a higher score indicates that patients are more affected by their medical condition.|Scores|Mean|10.20|10.2|Standard Deviation|7.80|7.8|||
3699759|NCT02191137|3540762|B1|Physical dimension score||Living with Pulmonary Hypertension (LPH)|The LPH derived from the Minnesota Living with Heart Failure questionnaire comprises 21 items, responded to on a 6-point Likert scale ranging from 0 'No’ to 5 ’Very much’. A total score ranging from 0 to 105 is calculated by summing the responses to all 21 questions. A physical dimension score (range 0-40, 8 items) and an emotional dimension score (range 0-25, 5 items) can also be calculated. For all LPH scores, a higher score indicates that patients are more affected by their medical condition.|Scores|Mean|22.83|22.83|Standard Deviation|10.70|10.7|||
3699760|NCT02191137|3540762|B1|Total score||Living with Pulmonary Hypertension (LPH)|The LPH derived from the Minnesota Living with Heart Failure questionnaire comprises 21 items, responded to on a 6-point Likert scale ranging from 0 'No’ to 5 ’Very much’. A total score ranging from 0 to 105 is calculated by summing the responses to all 21 questions. A physical dimension score (range 0-40, 8 items) and an emotional dimension score (range 0-25, 5 items) can also be calculated. For all LPH scores, a higher score indicates that patients are more affected by their medical condition.|Scores|Mean|46.03|46.03|Standard Deviation|24.57|24.57|||
3699761|NCT02191137|3540762|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3699762|NCT02191137|3540762|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3699763|NCT02191137|3540762|B1|||Age||Years|Mean|61.7|61.7|Standard Deviation|11.4|11.4|||
3699764|NCT02191046|3540790|B3|Thailand||Region of Enrollment||participants|Number|74|74.0||||||
3699765|NCT02191046|3540791|B2|Thailand||Region of Enrollment||participants|Number|38|38.0||||||
3699766|NCT02191046|3540792|B1|Thailand||Region of Enrollment||participants|Number|36|36.0||||||
3699767|NCT02191046|3540790|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3699768|NCT02191046|3540791|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3699769|NCT02191046|3540792|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3699770|NCT02191046|3540790|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3699771|NCT02191046|3540791|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3699772|NCT02191046|3540792|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3699773|NCT02191046|3540790|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3699777|NCT02191046|3540791|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3699778|NCT02191046|3540792|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3699779|NCT02191046|3540790|B3||<=18 years|Age||Participants|Count of Participants|74|74.0||||||
3699780|NCT02191046|3540791|B2||<=18 years|Age||Participants|Count of Participants|38|38.0||||||
3699781|NCT02191046|3540792|B1||<=18 years|Age||Participants|Count of Participants|36|36.0||||||
3699782|NCT02191033|3540799|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3699783|NCT02191033|3540800|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3699784|NCT02191033|3540801|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3699785|NCT02191033|3540799|B3|Race|American Indian/Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3699786|NCT02191033|3540800|B2|Race|American Indian/Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3699787|NCT02191033|3540801|B1|Race|American Indian/Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3699788|NCT02191033|3540799|B3|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3699789|NCT02191033|3540800|B2|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3699790|NCT02191033|3540801|B1|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3699791|NCT02191033|3540799|B3|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3699792|NCT02191033|3540800|B2|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3699793|NCT02191033|3540801|B1|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3699794|NCT02191033|3540799|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3699795|NCT02191033|3540800|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3699796|NCT02191033|3540801|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3699797|NCT02191033|3540799|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3699798|NCT02191033|3540800|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3699799|NCT02191033|3540801|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3699800|NCT02191033|3540799|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3699801|NCT02191033|3540800|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3699802|NCT02191033|3540801|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3699803|NCT02191033|3540799|B3|||Age||years|Mean|20.2|20.2|Standard Deviation|1.6|1.6|||
3699804|NCT02191033|3540800|B2|||Age||years|Mean|20.5|20.5|Standard Deviation|1.5|1.5|||
3699805|NCT02191033|3540801|B1|||Age||years|Mean|19.9|19.9|Standard Deviation|1.7|1.7|||
3699806|NCT02190903|3540812|B3|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3699807|NCT02190903|3540813|B2|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3699808|NCT02190903|3540814|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3699809|NCT02190903|3540812|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3699810|NCT02190903|3540813|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3699811|NCT02190903|3540814|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3699812|NCT02190903|3540812|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3699813|NCT02190903|3540813|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3699814|NCT02190903|3540814|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3699815|NCT02190903|3540812|B3|||Age||years|Median|71.5|71.5|Inter-Quartile Range|||62.0|86.0|
3699816|NCT02190903|3540813|B2|||Age||years|Median|80.5|80.5|Inter-Quartile Range|||62.0|92.0|
3699817|NCT02190903|3540814|B1|||Age||years|Median|62.7|62.7|Inter-Quartile Range|||57.0|88.0|
3699818|NCT02190721|3540821|B4||Severe|Chemotherapy Administration|The chemotherapy (CTX) regimens administered included at least etoposide, doxorubicin, ifosfamide, or cyclophosphamide. The severity group (mild/moderate/severe) of myelotoxicity of the CTX regimens administered was assigned by a group of clinical experts, based on the scientific literature (Moreau et al 2009) and clinical experience.|Participants|Count of Participants|11|11.0||||||
3699819|NCT02190721|3540822|B3||Severe|Chemotherapy Administration|The chemotherapy (CTX) regimens administered included at least etoposide, doxorubicin, ifosfamide, or cyclophosphamide. The severity group (mild/moderate/severe) of myelotoxicity of the CTX regimens administered was assigned by a group of clinical experts, based on the scientific literature (Moreau et al 2009) and clinical experience.|Participants|Count of Participants|3|3.0||||||
3699820|NCT02190721|3540823|B2||Severe|Chemotherapy Administration|The chemotherapy (CTX) regimens administered included at least etoposide, doxorubicin, ifosfamide, or cyclophosphamide. The severity group (mild/moderate/severe) of myelotoxicity of the CTX regimens administered was assigned by a group of clinical experts, based on the scientific literature (Moreau et al 2009) and clinical experience.|Participants|Count of Participants|8|8.0||||||
3699821|NCT02190721|3540824|B1||Severe|Chemotherapy Administration|The chemotherapy (CTX) regimens administered included at least etoposide, doxorubicin, ifosfamide, or cyclophosphamide. The severity group (mild/moderate/severe) of myelotoxicity of the CTX regimens administered was assigned by a group of clinical experts, based on the scientific literature (Moreau et al 2009) and clinical experience.|Participants|Count of Participants|0|0.0||||||
3699822|NCT02190721|3540821|B4||Moderate|Chemotherapy Administration|The chemotherapy (CTX) regimens administered included at least etoposide, doxorubicin, ifosfamide, or cyclophosphamide. The severity group (mild/moderate/severe) of myelotoxicity of the CTX regimens administered was assigned by a group of clinical experts, based on the scientific literature (Moreau et al 2009) and clinical experience.|Participants|Count of Participants|25|25.0||||||
3699823|NCT02190721|3540822|B3||Moderate|Chemotherapy Administration|The chemotherapy (CTX) regimens administered included at least etoposide, doxorubicin, ifosfamide, or cyclophosphamide. The severity group (mild/moderate/severe) of myelotoxicity of the CTX regimens administered was assigned by a group of clinical experts, based on the scientific literature (Moreau et al 2009) and clinical experience.|Participants|Count of Participants|7|7.0||||||
3699824|NCT02190721|3540823|B2||Moderate|Chemotherapy Administration|The chemotherapy (CTX) regimens administered included at least etoposide, doxorubicin, ifosfamide, or cyclophosphamide. The severity group (mild/moderate/severe) of myelotoxicity of the CTX regimens administered was assigned by a group of clinical experts, based on the scientific literature (Moreau et al 2009) and clinical experience.|Participants|Count of Participants|16|16.0||||||
3699825|NCT02190721|3540824|B1||Moderate|Chemotherapy Administration|The chemotherapy (CTX) regimens administered included at least etoposide, doxorubicin, ifosfamide, or cyclophosphamide. The severity group (mild/moderate/severe) of myelotoxicity of the CTX regimens administered was assigned by a group of clinical experts, based on the scientific literature (Moreau et al 2009) and clinical experience.|Participants|Count of Participants|2|2.0||||||
3699826|NCT02190721|3540821|B4||Mild|Chemotherapy Administration|The chemotherapy (CTX) regimens administered included at least etoposide, doxorubicin, ifosfamide, or cyclophosphamide. The severity group (mild/moderate/severe) of myelotoxicity of the CTX regimens administered was assigned by a group of clinical experts, based on the scientific literature (Moreau et al 2009) and clinical experience.|Participants|Count of Participants|14|14.0||||||
3699827|NCT02190721|3540822|B3||Mild|Chemotherapy Administration|The chemotherapy (CTX) regimens administered included at least etoposide, doxorubicin, ifosfamide, or cyclophosphamide. The severity group (mild/moderate/severe) of myelotoxicity of the CTX regimens administered was assigned by a group of clinical experts, based on the scientific literature (Moreau et al 2009) and clinical experience.|Participants|Count of Participants|8|8.0||||||
3699828|NCT02190721|3540823|B2||Mild|Chemotherapy Administration|The chemotherapy (CTX) regimens administered included at least etoposide, doxorubicin, ifosfamide, or cyclophosphamide. The severity group (mild/moderate/severe) of myelotoxicity of the CTX regimens administered was assigned by a group of clinical experts, based on the scientific literature (Moreau et al 2009) and clinical experience.|Participants|Count of Participants|6|6.0||||||
3699829|NCT02190721|3540824|B1||Mild|Chemotherapy Administration|The chemotherapy (CTX) regimens administered included at least etoposide, doxorubicin, ifosfamide, or cyclophosphamide. The severity group (mild/moderate/severe) of myelotoxicity of the CTX regimens administered was assigned by a group of clinical experts, based on the scientific literature (Moreau et al 2009) and clinical experience.|Participants|Count of Participants|0|0.0||||||
3699830|NCT02190721|3540821|B4|||Body Mass Index||kg/m^2|Median|16.4|16.4|Full Range|||12.0|28.0|
3699831|NCT02190721|3540822|B3|||Body Mass Index||kg/m^2|Median|20.7|20.7|Full Range|||15.0|28.0|
3699832|NCT02190721|3540823|B2|||Body Mass Index||kg/m^2|Median|15.2|15.2|Full Range|||12.0|20.0|
3699833|NCT02190721|3540824|B1|||Body Mass Index||kg/m^2|Median|16.0|16.0|Full Range|||16.0|16.0|
3699834|NCT02190721|3540821|B4|||Height||cm|Median|130.50|130.5|Full Range|||76.0|185.0|
3699835|NCT02190721|3540822|B3|||Height||cm|Median|161.00|161.0|Full Range|||140.0|185.0|
3699836|NCT02190721|3540823|B2|||Height||cm|Median|121.00|121.0|Full Range|||89.0|163.0|
3699837|NCT02190721|3540824|B1|||Height||cm|Median|78.00|78.0|Full Range|||76.0|80.0|
3699838|NCT02190721|3540821|B4|||Weight||kg|Median|28.95|28.95|Full Range|||9.3|89.5|
3699839|NCT02190721|3540822|B3|||Weight||kg|Median|53.90|53.9|Full Range|||29.5|89.5|
3699840|NCT02190721|3540823|B2|||Weight||kg|Median|20.25|20.25|Full Range|||12.0|51.1|
3699841|NCT02190721|3540824|B1|||Weight||kg|Median|9.90|9.9|Full Range|||9.3|10.5|
3699842|NCT02190721|3540821|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699843|NCT02190721|3540822|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699844|NCT02190721|3540823|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699845|NCT02190721|3540824|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699846|NCT02190721|3540821|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699847|NCT02190721|3540822|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699848|NCT02190721|3540823|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699849|NCT02190721|3540824|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699850|NCT02190721|3540821|B4||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3699851|NCT02190721|3540822|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3699852|NCT02190721|3540823|B2||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3699853|NCT02190721|3540824|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3699854|NCT02190721|3540821|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699855|NCT02190721|3540822|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699856|NCT02190721|3540823|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699857|NCT02190721|3540824|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699858|NCT02190721|3540821|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699859|NCT02190721|3540822|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699860|NCT02190721|3540823|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699861|NCT02190721|3540824|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699862|NCT02190721|3540821|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699863|NCT02190721|3540822|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699864|NCT02190721|3540823|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699865|NCT02190721|3540824|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699866|NCT02190721|3540821|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699867|NCT02190721|3540822|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699868|NCT02190721|3540823|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699869|NCT02190721|3540824|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699870|NCT02190721|3540821|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699871|NCT02190721|3540822|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699872|NCT02190721|3540823|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699873|NCT02190721|3540824|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699874|NCT02190721|3540821|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3699875|NCT02190721|3540822|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3699876|NCT02190721|3540823|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3699877|NCT02190721|3540824|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3699878|NCT02190721|3540821|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699879|NCT02190721|3540822|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699880|NCT02190721|3540823|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699881|NCT02190721|3540824|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3699882|NCT02190721|3540821|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3699883|NCT02190721|3540822|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3699884|NCT02190721|3540823|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3699885|NCT02190721|3540824|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3699886|NCT02190721|3540821|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3699887|NCT02190721|3540822|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3699888|NCT02190721|3540823|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3699889|NCT02190721|3540824|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3699890|NCT02190721|3540821|B4|||Age||Years|Median|9.05|9.05|Full Range|||1.4|15.9|
3699891|NCT02190721|3540822|B3|||Age||Years|Median|13.80|13.8|Full Range|||12.0|15.9|
3699892|NCT02190721|3540823|B2|||Age||Years|Median|6.80|6.8|Full Range|||2.4|11.5|
3699893|NCT02190721|3540824|B1|||Age||Years|Median|1.65|1.65|Full Range|||1.4|1.9|
3699894|NCT02190604|3540930|B20||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3699895|NCT02190604|3540931|B19||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3699896|NCT02190604|3540932|B18||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3699897|NCT02190604|3540933|B17||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3699898|NCT02190604|3540934|B16||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3699899|NCT02190604|3540935|B15||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3699900|NCT02190604|3540936|B14||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3699901|NCT02190604|3540937|B13||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3699902|NCT02190604|3540938|B12||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3699903|NCT02190604|3540939|B11||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3699904|NCT02190604|3540940|B10||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3699905|NCT02190604|3540941|B9||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3699906|NCT02190604|3540942|B8||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3699907|NCT02190604|3540943|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3699908|NCT02190604|3540944|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3699909|NCT02190604|3540945|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3699910|NCT02190604|3540946|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3699911|NCT02190604|3540947|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3699912|NCT02190604|3540948|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3699913|NCT02190604|3540949|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3699914|NCT02190604|3540930|B20||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3699915|NCT02190604|3540931|B19||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3699916|NCT02190604|3540932|B18||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3699917|NCT02190604|3540933|B17||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3699918|NCT02190604|3540934|B16||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3699919|NCT02190604|3540935|B15||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3699920|NCT02190604|3540936|B14||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3699921|NCT02190604|3540937|B13||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3699922|NCT02190604|3540938|B12||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3699923|NCT02190604|3540939|B11||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3699924|NCT02190604|3540940|B10||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3699925|NCT02190604|3540941|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3699926|NCT02190604|3540942|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3699927|NCT02190604|3540943|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3699928|NCT02190604|3540944|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3699929|NCT02190604|3540945|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3699930|NCT02190604|3540946|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3699931|NCT02190604|3540947|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3699932|NCT02190604|3540948|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3699933|NCT02190604|3540949|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3699934|NCT02190604|3540930|B20|Part 3, CF patients (n=49)||Age||Years|Mean|30.1|30.1|Standard Deviation|9.18|9.18|||
3699935|NCT02190604|3540931|B19|Part 3, CF patients (n=49)||Age||Years|Mean|27.9|27.9|Standard Deviation|6.37|6.37|||
3699936|NCT02190604|3540932|B18|Part 3, CF patients (n=49)||Age||Years|Mean|27|27.0|Standard Deviation|5.44|5.44|||
3699937|NCT02190604|3540933|B17|Part 3, CF patients (n=49)||Age||Years|Mean|32.7|32.7|Standard Deviation|13.77|13.77|||
3699938|NCT02190604|3540934|B16|Part 3, CF patients (n=49)||Age||Years|Mean|39.3|39.3|Standard Deviation|5.47|5.47|||
3699939|NCT02190604|3540935|B15|Part 3, CF patients (n=49)||Age||Years|Mean|NA||Standard Deviation|NA||||This row is for Part 3 HV
3699940|NCT02190604|3540936|B14|Part 3, CF patients (n=49)||Age||Years|Mean|NA||Standard Deviation|NA||||This row is for Part 3 HV
3699941|NCT02190604|3540937|B13|Part 3, CF patients (n=49)||Age||Years|Mean|NA||Standard Deviation|NA||||This row is for Part 3 HV
3699942|NCT02190604|3540938|B12|Part 3, CF patients (n=49)||Age||Years|Mean|NA||Standard Deviation|NA||||This row is for Part 3 HV
3699943|NCT02190604|3540939|B11|Part 3, CF patients (n=49)||Age||Years|Mean|NA||Standard Deviation|NA||||This row is for Part 3 HV
3699944|NCT02190604|3540940|B10|Part 3, CF patients (n=49)||Age||Years|Mean|NA||Standard Deviation|NA||||This row is for Part 3 HV
3699945|NCT02190604|3540941|B9|Part 3, CF patients (n=49)||Age||Years|Mean|NA||Standard Deviation|NA||||This row is for Part 3 HV
3699946|NCT02190604|3540942|B8|Part 3, CF patients (n=49)||Age||Years|Mean|NA||Standard Deviation|NA||||This row is for Part 3 HV
3699947|NCT02190604|3540943|B7|Part 3, CF patients (n=49)||Age||Years|Mean|NA||Standard Deviation|NA||||This row is for Part 3 HV
3699948|NCT02190604|3540944|B6|Part 3, CF patients (n=49)||Age||Years|Mean|NA||Standard Deviation|NA||||This row is for Part 3 HV
3699949|NCT02190604|3540945|B5|Part 3, CF patients (n=49)||Age||Years|Mean|NA||Standard Deviation|NA||||This row is for Part 3 HV
3699950|NCT02190604|3540946|B4|Part 3, CF patients (n=49)||Age||Years|Mean|NA||Standard Deviation|NA||||This row is for Part 3 HV
3699951|NCT02190604|3540947|B3|Part 3, CF patients (n=49)||Age||Years|Mean|NA||Standard Deviation|NA||||This row is for Part 3 HV
3699952|NCT02190604|3540948|B2|Part 3, CF patients (n=49)||Age||Years|Mean|NA||Standard Deviation|NA||||This row is for Part 3 HV
3699953|NCT02190604|3540949|B1|Part 3, CF patients (n=49)||Age||Years|Mean|NA||Standard Deviation|NA||||This row is for Part 3 HV
3699954|NCT02190604|3540930|B20|Part 2, HV (n=40)||Age||Years|Mean|29.7|29.7|Standard Deviation|7.82|7.82|||
3699955|NCT02190604|3540931|B19|Part 2, HV (n=40)||Age||Years|Mean|NA||Standard Deviation|NA||||This row is for Part 2 HV
3699956|NCT02190604|3540932|B18|Part 2, HV (n=40)||Age||Years|Mean|NA||Standard Deviation|NA||||This row is for Part 2 HV
3699957|NCT02190604|3540933|B17|Part 2, HV (n=40)||Age||Years|Mean|NA||Standard Deviation|NA||||This row is for Part 2 HV
3699958|NCT02190604|3540934|B16|Part 2, HV (n=40)||Age||Years|Mean|NA||Standard Deviation|NA||||This row is for Part 2 HV
3699959|NCT02190604|3540935|B15|Part 2, HV (n=40)||Age||Years|Mean|29|29.0|Standard Deviation|6.22|6.22|||
3699960|NCT02190604|3540936|B14|Part 2, HV (n=40)||Age||Years|Mean|27.8|27.8|Standard Deviation|5|5.0|||
3699961|NCT02190604|3540937|B13|Part 2, HV (n=40)||Age||Years|Mean|31.7|31.7|Standard Deviation|13.22|13.22|||
3699962|NCT02190604|3540938|B12|Part 2, HV (n=40)||Age||Years|Mean|29.2|29.2|Standard Deviation|11.62|11.62|||
3699963|NCT02190604|3540939|B11|Part 2, HV (n=40)||Age||Years|Mean|30.5|30.5|Standard Deviation|5.89|5.89|||
3699964|NCT02190604|3540940|B10|Part 2, HV (n=40)||Age||Years|Mean|30.3|30.3|Standard Deviation|5.13|5.13|||
3699965|NCT02190604|3540941|B9|Part 2, HV (n=40)||Age||Years|Mean|NA||Standard Deviation|NA||||This row is for Part 2 HV
3699966|NCT02190604|3540942|B8|Part 2, HV (n=40)||Age||Years|Mean|NA||Standard Deviation|NA||||This row is for Part 2 HV
3699967|NCT02190604|3540943|B7|Part 2, HV (n=40)||Age||Years|Mean|NA||Standard Deviation|NA||||This row is for Part 2 HV
3699968|NCT02190604|3540944|B6|Part 2, HV (n=40)||Age||Years|Mean|NA||Standard Deviation|NA||||This row is for Part 2 HV
3699969|NCT02190604|3540945|B5|Part 2, HV (n=40)||Age||Years|Mean|NA||Standard Deviation|NA||||This row is for Part 2 HV
3699970|NCT02190604|3540946|B4|Part 2, HV (n=40)||Age||Years|Mean|NA||Standard Deviation|NA||||This row is for Part 2 HV
3699971|NCT02190604|3540947|B3|Part 2, HV (n=40)||Age||Years|Mean|NA||Standard Deviation|NA||||This row is for Part 2 HV
3699972|NCT02190604|3540948|B2|Part 2, HV (n=40)||Age||Years|Mean|NA||Standard Deviation|NA||||This row is for Part 2 HV
3699973|NCT02190604|3540949|B1|Part 2, HV (n=40)||Age||Years|Mean|NA||Standard Deviation|NA||||This row is for Part 2 HV
3699974|NCT02190604|3540930|B20|Part 1, HV (n= 64)||Age||Years|Mean|34.4|34.4|Standard Deviation|9.92|9.92|||
3699975|NCT02190604|3540931|B19|Part 1, HV (n= 64)||Age||Years|Mean|NA||Standard Deviation|NA||||This row is for Part 1 HV
3699976|NCT02190604|3540932|B18|Part 1, HV (n= 64)||Age||Years|Mean|NA||Standard Deviation|NA||||This row is for Part 1 HV
3699977|NCT02190604|3540933|B17|Part 1, HV (n= 64)||Age||Years|Mean|NA||Standard Deviation|NA||||This row is for Part 1 HV
3699978|NCT02190604|3540934|B16|Part 1, HV (n= 64)||Age||Years|Mean|NA||Standard Deviation|NA||||This row is for Part 1 HV
3699979|NCT02190604|3540935|B15|Part 1, HV (n= 64)||Age||Years|Mean|NA||Standard Deviation|NA||||This row is for Part 1 HV
3699980|NCT02190604|3540936|B14|Part 1, HV (n= 64)||Age||Years|Mean|NA||Standard Deviation|NA||||This row is for Part 1 HV
3699981|NCT02190604|3540937|B13|Part 1, HV (n= 64)||Age||Years|Mean|NA||Standard Deviation|NA||||This row is for Part 1 HV
3699982|NCT02190604|3540938|B12|Part 1, HV (n= 64)||Age||Years|Mean|NA||Standard Deviation|NA||||This row is for Part 1 HV
3699983|NCT02190604|3540939|B11|Part 1, HV (n= 64)||Age||Years|Mean|NA||Standard Deviation|NA||||This row is for Part 1 HV
3699984|NCT02190604|3540940|B10|Part 1, HV (n= 64)||Age||Years|Mean|NA||Standard Deviation|NA||||This row is for Part 1 HV
3699985|NCT02190604|3540941|B9|Part 1, HV (n= 64)||Age||Years|Mean|30.3|30.3|Standard Deviation|9.18|9.18|||
3699986|NCT02190604|3540942|B8|Part 1, HV (n= 64)||Age||Years|Mean|33.2|33.2|Standard Deviation|9.47|9.47|||
3699987|NCT02190604|3540943|B7|Part 1, HV (n= 64)||Age||Years|Mean|28.2|28.2|Standard Deviation|9.28|9.28|||
3699988|NCT02190604|3540944|B6|Part 1, HV (n= 64)||Age||Years|Mean|43.6|43.6|Standard Deviation|9.07|9.07|||
3699989|NCT02190604|3540945|B5|Part 1, HV (n= 64)||Age||Years|Mean|44.2|44.2|Standard Deviation|8.23|8.23|||
3699990|NCT02190604|3540946|B4|Part 1, HV (n= 64)||Age||Years|Mean|33.3|33.3|Standard Deviation|9.61|9.61|||
3699991|NCT02190604|3540947|B3|Part 1, HV (n= 64)||Age||Years|Mean|43.5|43.5|Standard Deviation|3.39|3.39|||
3699992|NCT02190604|3540948|B2|Part 1, HV (n= 64)||Age||Years|Mean|35|35.0|Standard Deviation|14.25|14.25|||
3699993|NCT02190604|3540949|B1|Part 1, HV (n= 64)||Age||Years|Mean|36.3|36.3|Standard Deviation|8.69|8.69|||
3699994|NCT02190591|3541156|B3|United States||Region of Enrollment||participants|Number|191|191.0||||||
3699995|NCT02190591|3541157|B2|United States||Region of Enrollment||participants|Number|91|91.0||||||
3699996|NCT02190591|3541158|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
3699997|NCT02190591|3541156|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3699998|NCT02190591|3541157|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3699999|NCT02190591|3541158|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3700000|NCT02190591|3541156|B3||Female|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
3700001|NCT02190591|3541157|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3700002|NCT02190591|3541158|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3700003|NCT02190591|3541156|B3|||Age||years|Mean|26.6|26.6|Standard Deviation|4.8|4.8|||
3700004|NCT02190591|3541157|B2|||Age||years|Mean|26.7|26.7|Standard Deviation|4.9|4.9|||
3700005|NCT02190591|3541158|B1|||Age||years|Mean|26.5|26.5|Standard Deviation|4.7|4.7|||
3700006|NCT02190435|3541169|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3700007|NCT02190435|3541170|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
3700008|NCT02190435|3541171|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
3700009|NCT02190435|3541169|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3700010|NCT02190435|3541170|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3700011|NCT02190435|3541171|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3700012|NCT02190435|3541169|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3700013|NCT02190435|3541170|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3700014|NCT02190435|3541171|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3700015|NCT02190435|3541169|B3||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
3700016|NCT02190435|3541170|B2||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3700017|NCT02190435|3541171|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3700018|NCT02190435|3541169|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3700019|NCT02190435|3541170|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3700020|NCT02190435|3541171|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3700021|NCT02190435|3541169|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3700022|NCT02190435|3541170|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3700023|NCT02190435|3541171|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3700024|NCT02190045|3541180|B3|||Berg Balance Scale||units on a scale|Mean|49.3|49.3|Standard Deviation|2.6|2.6|||
3700025|NCT02190045|3541181|B2|||Berg Balance Scale||units on a scale|Mean|50.1|50.1|Standard Deviation|2.5|2.5|||
3700026|NCT02190045|3541182|B1|||Berg Balance Scale||units on a scale|Mean|48.5|48.5|Standard Deviation|2.6|2.6|||
3700027|NCT02190045|3541180|B3|Race|Non-Hispanic African American|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3700028|NCT02190045|3541181|B2|Race|Non-Hispanic African American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3700029|NCT02190045|3541182|B1|Race|Non-Hispanic African American|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3700030|NCT02190045|3541180|B3|Race|Non-Hispanic Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3700031|NCT02190045|3541181|B2|Race|Non-Hispanic Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3700032|NCT02190045|3541182|B1|Race|Non-Hispanic Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3700033|NCT02190045|3541180|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3700034|NCT02190045|3541181|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3700035|NCT02190045|3541182|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3700036|NCT02190045|3541180|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3700037|NCT02190045|3541181|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3700038|NCT02190045|3541182|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3700039|NCT02190045|3541180|B3|||Age||years|Mean|68.0|68.0|Standard Deviation|6.7|6.7|||
3700040|NCT02190045|3541181|B2|||Age||years|Mean|69.0|69.0|Standard Deviation|3.8|3.8|||
3700041|NCT02190045|3541182|B1|||Age||years|Mean|67.5|67.5|Standard Deviation|8.1|8.1|||
3700042|NCT02189954|3541189|B3|Turkey||Region of Enrollment||participants|Number|90|90.0||||||
3700043|NCT02189954|3541190|B2|Turkey||Region of Enrollment||participants|Number|45|45.0||||||
3700044|NCT02189954|3541191|B1|Turkey||Region of Enrollment||participants|Number|45|45.0||||||
3700045|NCT02189954|3541189|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3700046|NCT02189954|3541190|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3700047|NCT02189954|3541191|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3700048|NCT02189954|3541189|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3700049|NCT02189954|3541190|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3700050|NCT02189954|3541191|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3700051|NCT02189954|3541189|B3|||Age||years|Mean|72.4|72.4|Standard Deviation|5.8|5.8|||
3700052|NCT02189954|3541190|B2|||Age||years|Mean|72.8|72.8|Standard Deviation|6.2|6.2|||
3700053|NCT02189954|3541191|B1|||Age||years|Mean|71.9|71.9|Standard Deviation|5.4|5.4|||
3700054|NCT02189941|3541200|B1|Canada||Region of Enrollment||participants|Number|11|11.0||||||
3700055|NCT02189941|3541200|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700056|NCT02189941|3541200|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3700057|NCT02189941|3541200|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3700058|NCT02189941|3541200|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3700059|NCT02189941|3541200|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700060|NCT02189941|3541200|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3700061|NCT02189941|3541200|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700062|NCT02189941|3541200|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700063|NCT02189941|3541200|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3700064|NCT02189941|3541200|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3700065|NCT02189941|3541200|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3700066|NCT02189941|3541200|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3700067|NCT02189941|3541200|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3700068|NCT02189941|3541200|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3700069|NCT02189941|3541200|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3700070|NCT02189915|3541225|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3700071|NCT02189915|3541225|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3700072|NCT02189915|3541225|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3700073|NCT02189915|3541225|B1|||Age||years|Mean|37.4|37.4|Standard Deviation|9.9|9.9|||
3700074|NCT02189915|3541225|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3700075|NCT02189915|3541225|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3700076|NCT02189915|3541225|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3700077|NCT02189863|3541230|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3700078|NCT02189863|3541230|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3700079|NCT02189863|3541230|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|5.4|5.4|||
3700080|NCT02189837|3541242|B5|||LDL-C Concentration|LDL-C was measured using ultracentrifugation|mg/dL|Mean|119.1|119.1|Standard Deviation|20.2|20.2|||
3700081|NCT02189837|3541243|B4|||LDL-C Concentration|LDL-C was measured using ultracentrifugation|mg/dL|Mean|116.5|116.5|Standard Deviation|23.7|23.7|||
3700082|NCT02189837|3541244|B3|||LDL-C Concentration|LDL-C was measured using ultracentrifugation|mg/dL|Mean|118.2|118.2|Standard Deviation|18.4|18.4|||
3700083|NCT02189837|3541245|B2|||LDL-C Concentration|LDL-C was measured using ultracentrifugation|mg/dL|Mean|123.2|123.2|Standard Deviation|21.3|21.3|||
3700084|NCT02189837|3541246|B1|||LDL-C Concentration|LDL-C was measured using ultracentrifugation|mg/dL|Mean|118.1|118.1|Standard Deviation|18.1|18.1|||
3700085|NCT02189837|3541242|B5|≥ 130 mg/dL||Screening LDL-C Level||participants|Number|50|50.0||||||
3700086|NCT02189837|3541243|B4|≥ 130 mg/dL||Screening LDL-C Level||participants|Number|12|12.0||||||
3700087|NCT02189837|3541244|B3|≥ 130 mg/dL||Screening LDL-C Level||participants|Number|13|13.0||||||
3700088|NCT02189837|3541245|B2|≥ 130 mg/dL||Screening LDL-C Level||participants|Number|13|13.0||||||
3700089|NCT02189837|3541246|B1|≥ 130 mg/dL||Screening LDL-C Level||participants|Number|12|12.0||||||
3700090|NCT02189837|3541242|B5|< 130 mg/dL||Screening LDL-C Level||participants|Number|35|35.0||||||
3700091|NCT02189837|3541243|B4|< 130 mg/dL||Screening LDL-C Level||participants|Number|8|8.0||||||
3700092|NCT02189837|3541244|B3|< 130 mg/dL||Screening LDL-C Level||participants|Number|9|9.0||||||
3700093|NCT02189837|3541245|B2|< 130 mg/dL||Screening LDL-C Level||participants|Number|9|9.0||||||
3700094|NCT02189837|3541246|B1|< 130 mg/dL||Screening LDL-C Level||participants|Number|9|9.0||||||
3700095|NCT02189837|3541242|B5|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3700096|NCT02189837|3541243|B4|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3700097|NCT02189837|3541244|B3|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3700098|NCT02189837|3541245|B2|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3700099|NCT02189837|3541246|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3700100|NCT02189837|3541242|B5|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3700101|NCT02189837|3541243|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3700102|NCT02189837|3541244|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3700103|NCT02189837|3541245|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3700104|NCT02189837|3541246|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3700105|NCT02189837|3541242|B5|White||Race/Ethnicity, Customized||participants|Number|73|73.0||||||
3700106|NCT02189837|3541243|B4|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3700107|NCT02189837|3541244|B3|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3700108|NCT02189837|3541245|B2|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3700109|NCT02189837|3541246|B1|White||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3700110|NCT02189837|3541242|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3700111|NCT02189837|3541243|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3700112|NCT02189837|3541244|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3700113|NCT02189837|3541245|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3700114|NCT02189837|3541246|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3700115|NCT02189837|3541242|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3700116|NCT02189837|3541243|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3700117|NCT02189837|3541244|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3700118|NCT02189837|3541245|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3700119|NCT02189837|3541246|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3700120|NCT02189837|3541242|B5|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3700121|NCT02189837|3541243|B4|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3700122|NCT02189837|3541244|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3700123|NCT02189837|3541245|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3700124|NCT02189837|3541246|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3700125|NCT02189837|3541242|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3700126|NCT02189837|3541243|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3700127|NCT02189837|3541244|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3700128|NCT02189837|3541245|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3700129|NCT02189837|3541246|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3700130|NCT02189837|3541242|B5||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3700131|NCT02189837|3541243|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3700132|NCT02189837|3541244|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3700133|NCT02189837|3541245|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3700134|NCT02189837|3541246|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3700135|NCT02189837|3541242|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3700136|NCT02189837|3541243|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3700137|NCT02189837|3541244|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3700138|NCT02189837|3541245|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3700139|NCT02189837|3541246|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3700140|NCT02189837|3541242|B5|||Age||years|Mean|32.2|32.2|Standard Deviation|10.5|10.5|||
3700141|NCT02189837|3541243|B4|||Age||years|Mean|31.0|31.0|Standard Deviation|9.8|9.8|||
3700142|NCT02189837|3541244|B3|||Age||years|Mean|33.5|33.5|Standard Deviation|11.6|11.6|||
3700143|NCT02189837|3541245|B2|||Age||years|Mean|30.4|30.4|Standard Deviation|7.4|7.4|||
3700144|NCT02189837|3541246|B1|||Age||years|Mean|33.9|33.9|Standard Deviation|12.7|12.7|||
3700145|NCT02189759|3541275|B5|Zambia||Region of Enrollment||Participants|Count of Participants|368|368.0||||||
3700146|NCT02189759|3541276|B4|Zambia||Region of Enrollment||Participants|Count of Participants|84|84.0||||||
3700147|NCT02189759|3541277|B3|Zambia||Region of Enrollment||Participants|Count of Participants|81|81.0||||||
3700148|NCT02189759|3541278|B2|Zambia||Region of Enrollment||Participants|Count of Participants|101|101.0||||||
3700149|NCT02189759|3541279|B1|Zambia||Region of Enrollment||Participants|Count of Participants|102|102.0||||||
3700150|NCT02189759|3541275|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700151|NCT02189759|3541276|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700152|NCT02189759|3541277|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700153|NCT02189759|3541278|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700154|NCT02189759|3541279|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700155|NCT02189759|3541275|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700156|NCT02189759|3541276|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700157|NCT02189759|3541277|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700158|NCT02189759|3541278|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700159|NCT02189759|3541279|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700160|NCT02189759|3541275|B5||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700161|NCT02189759|3541276|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700162|NCT02189759|3541277|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700163|NCT02189759|3541278|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700164|NCT02189759|3541279|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700165|NCT02189759|3541275|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|368|368.0||||||
3700166|NCT02189759|3541276|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3700167|NCT02189759|3541277|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
3700168|NCT02189759|3541278|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
3700169|NCT02189759|3541279|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
3700170|NCT02189759|3541275|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700171|NCT02189759|3541276|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700172|NCT02189759|3541277|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700173|NCT02189759|3541278|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700174|NCT02189759|3541279|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700175|NCT02189759|3541275|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700176|NCT02189759|3541276|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700177|NCT02189759|3541277|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700178|NCT02189759|3541278|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700179|NCT02189759|3541279|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700180|NCT02189759|3541275|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700181|NCT02189759|3541276|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700182|NCT02189759|3541277|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700183|NCT02189759|3541278|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700184|NCT02189759|3541279|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700185|NCT02189759|3541275|B5||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3700186|NCT02189759|3541276|B4||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3700187|NCT02189759|3541277|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3700188|NCT02189759|3541278|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3700189|NCT02189759|3541279|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3700190|NCT02189759|3541275|B5||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
3700191|NCT02189759|3541276|B4||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3700192|NCT02189759|3541277|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3700193|NCT02189759|3541278|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3700194|NCT02189759|3541279|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3700195|NCT02189759|3541275|B5|||Age||hours|Mean|6|6.0|Full Range|||1.0|12.0|
3700196|NCT02189759|3541276|B4|||Age||hours|Mean|6|6.0|Full Range|||1.0|12.0|
3700197|NCT02189759|3541277|B3|||Age||hours|Mean|6|6.0|Full Range|||1.0|12.0|
3700198|NCT02189759|3541278|B2|||Age||hours|Mean|1|1.0|Full Range|||0.5|1.0|
3700199|NCT02189759|3541279|B1|||Age||hours|Mean|1|1.0|Full Range|||0.5|1.0|
3700200|NCT02189759|3541275|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3700201|NCT02189759|3541276|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3700202|NCT02189759|3541277|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3700203|NCT02189759|3541278|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3700204|NCT02189759|3541279|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3700205|NCT02189759|3541275|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3700206|NCT02189759|3541276|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3700207|NCT02189759|3541277|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3700208|NCT02189759|3541278|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3700209|NCT02189759|3541279|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3700210|NCT02189759|3541275|B5||<=18 years|Age||Participants|Count of Participants|368|368.0||||||
3700211|NCT02189759|3541276|B4||<=18 years|Age||Participants|Count of Participants|84|84.0||||||
3700212|NCT02189759|3541277|B3||<=18 years|Age||Participants|Count of Participants|81|81.0||||||
3700213|NCT02189759|3541278|B2||<=18 years|Age||Participants|Count of Participants|101|101.0||||||
3700214|NCT02189759|3541279|B1||<=18 years|Age||Participants|Count of Participants|102|102.0||||||
3700215|NCT02189668|3541300|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700216|NCT02189668|3541301|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700217|NCT02189668|3541302|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700218|NCT02189668|3541300|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700219|NCT02189668|3541301|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700220|NCT02189668|3541302|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700221|NCT02189668|3541300|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3700222|NCT02189668|3541301|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3700223|NCT02189668|3541302|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3700224|NCT02189668|3541300|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3700225|NCT02189668|3541301|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3700226|NCT02189668|3541302|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3700227|NCT02189668|3541300|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700228|NCT02189668|3541301|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700229|NCT02189668|3541302|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700230|NCT02189668|3541300|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700231|NCT02189668|3541301|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700232|NCT02189668|3541302|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700233|NCT02189668|3541300|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700234|NCT02189668|3541301|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700235|NCT02189668|3541302|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700236|NCT02189668|3541300|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700237|NCT02189668|3541301|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700238|NCT02189668|3541302|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700239|NCT02189668|3541300|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3700240|NCT02189668|3541301|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3700241|NCT02189668|3541302|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3700242|NCT02189668|3541300|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3700243|NCT02189668|3541301|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3700244|NCT02189668|3541302|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700245|NCT02189668|3541300|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3700246|NCT02189668|3541301|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3700247|NCT02189668|3541302|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3700248|NCT02189668|3541300|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3700249|NCT02189668|3541301|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3700250|NCT02189668|3541302|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3700251|NCT02189668|3541300|B3|||Age||years|Median|12|12.0|Inter-Quartile Range|||11.0|14.0|
3700252|NCT02189668|3541301|B2|||Age||years|Median|11|11.0|Inter-Quartile Range|||9.0|15.0|
3700253|NCT02189668|3541302|B1|||Age||years|Median|14|14.0|Inter-Quartile Range|||13.0|14.0|
3700254|NCT02189382|3541311|B3|Ethnicity|Multi-Racial|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3700255|NCT02189382|3541312|B2|Ethnicity|Multi-Racial|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3700256|NCT02189382|3541313|B1|Ethnicity|Multi-Racial|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3700257|NCT02189382|3541311|B3|Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3700258|NCT02189382|3541312|B2|Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3700259|NCT02189382|3541313|B1|Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3700260|NCT02189382|3541311|B3|Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3700261|NCT02189382|3541312|B2|Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3700262|NCT02189382|3541313|B1|Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3700263|NCT02189382|3541311|B3|Ethnicity|Black|Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3700264|NCT02189382|3541312|B2|Ethnicity|Black|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3700265|NCT02189382|3541313|B1|Ethnicity|Black|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3700266|NCT02189382|3541311|B3|Ethnicity|Asian Oriental|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3700267|NCT02189382|3541312|B2|Ethnicity|Asian Oriental|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3700268|NCT02189382|3541313|B1|Ethnicity|Asian Oriental|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3700269|NCT02189382|3541311|B3|Ethnicity|Asian Indian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3700270|NCT02189382|3541312|B2|Ethnicity|Asian Indian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3700271|NCT02189382|3541313|B1|Ethnicity|Asian Indian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3700272|NCT02189382|3541311|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3700273|NCT02189382|3541312|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3700274|NCT02189382|3541313|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3700275|NCT02189382|3541311|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3700276|NCT02189382|3541312|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3700277|NCT02189382|3541313|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3700278|NCT02189382|3541311|B3|||Age||years|Mean|35.6|35.6|Standard Deviation|12.74|12.74|||
3700279|NCT02189382|3541312|B2|||Age||years|Mean|36.6|36.6|Standard Deviation|14.25|14.25|||
3700280|NCT02189382|3541313|B1|||Age||years|Mean|34.5|34.5|Standard Deviation|11.13|11.13|||
3700281|NCT02189317|3541322|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
3700282|NCT02189317|3541323|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3700283|NCT02189317|3541324|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3700284|NCT02189317|3541322|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3700285|NCT02189317|3541323|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3700286|NCT02189317|3541324|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3700287|NCT02189317|3541322|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3700288|NCT02189317|3541323|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3700289|NCT02189317|3541324|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3700290|NCT02189317|3541322|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3700291|NCT02189317|3541323|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3700292|NCT02189317|3541324|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3700293|NCT02189317|3541322|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3700294|NCT02189317|3541323|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3700295|NCT02189317|3541324|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3700296|NCT02189317|3541322|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3700297|NCT02189317|3541323|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3700298|NCT02189317|3541324|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3700299|NCT02189252|3541335|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3700300|NCT02189252|3541336|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3700301|NCT02189252|3541337|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3700302|NCT02189252|3541338|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3700303|NCT02189252|3541339|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3700304|NCT02189252|3541335|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3700305|NCT02189252|3541336|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3700306|NCT02189252|3541337|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3700307|NCT02189252|3541338|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3700308|NCT02189252|3541339|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3700309|NCT02189252|3541335|B5|||Age||years|Mean|49.8|49.8|Standard Deviation|11.16|11.16|||
3700310|NCT02189252|3541336|B4|||Age||years|Mean|53.5|53.5|Standard Deviation|11.27|11.27|||
3700311|NCT02189252|3541337|B3|||Age||years|Mean|53.0|53.0|Standard Deviation|16.46|16.46|||
3700312|NCT02189252|3541338|B2|||Age||years|Mean|46.0|46.0|Standard Deviation|13.09|13.09|||
3700313|NCT02189252|3541339|B1|||Age||years|Mean|47.5|47.5|Standard Deviation|6.86|6.86|||
3700314|NCT02189161|3541374|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3700315|NCT02189161|3541374|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3700316|NCT02189161|3541374|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3700317|NCT02189161|3541374|B1|||Age||years|Mean|51.5|51.5|Standard Deviation|12.35|12.35|||
3700318|NCT02189122|3541380|B3|||2,3-dinor-6-keto-PGF1alpha||ng/mg creatinine|Median|.121|0.121|Inter-Quartile Range|||0.095|0.158|
3700319|NCT02189122|3541381|B2|||2,3-dinor-6-keto-PGF1alpha||ng/mg creatinine|Median|.139|0.139|Inter-Quartile Range|||0.117|0.252|
3700320|NCT02189122|3541382|B1|||2,3-dinor-6-keto-PGF1alpha||ng/mg creatinine|Median|.1|0.1|Inter-Quartile Range|||0.089|0.139|
3700321|NCT02189122|3541380|B3|||11-dehydrothromboxane B2||ng/mg creatinine|Median|.206|0.206|Inter-Quartile Range|||0.172|0.272|
3700322|NCT02189122|3541381|B2|||11-dehydrothromboxane B2||ng/mg creatinine|Median|.214|0.214|Inter-Quartile Range|||0.191|0.296|
3700323|NCT02189122|3541382|B1|||11-dehydrothromboxane B2||ng/mg creatinine|Median|0.180|0.18|Inter-Quartile Range|||0.158|0.24|
3700324|NCT02189122|3541380|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700325|NCT02189122|3541381|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700326|NCT02189122|3541382|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700327|NCT02189122|3541380|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3700328|NCT02189122|3541381|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3700329|NCT02189122|3541382|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700330|NCT02189122|3541380|B3||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3700331|NCT02189122|3541381|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3700332|NCT02189122|3541382|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3700333|NCT02189122|3541380|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3700334|NCT02189122|3541381|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3700335|NCT02189122|3541382|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700336|NCT02189122|3541380|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700337|NCT02189122|3541381|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700338|NCT02189122|3541382|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700339|NCT02189122|3541380|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700340|NCT02189122|3541381|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700341|NCT02189122|3541382|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700342|NCT02189122|3541380|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700343|NCT02189122|3541381|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700344|NCT02189122|3541382|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700345|NCT02189122|3541380|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700346|NCT02189122|3541381|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700347|NCT02189122|3541382|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700348|NCT02189122|3541380|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3700349|NCT02189122|3541381|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3700350|NCT02189122|3541382|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3700351|NCT02189122|3541380|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3700352|NCT02189122|3541381|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3700353|NCT02189122|3541382|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3700354|NCT02189122|3541380|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3700355|NCT02189122|3541381|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3700356|NCT02189122|3541382|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3700357|NCT02189122|3541380|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3700358|NCT02189122|3541381|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3700359|NCT02189122|3541382|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3700360|NCT02189122|3541380|B3|||Age||years|Mean|27.1|27.1|Inter-Quartile Range|||24.1|33.4|
3700361|NCT02189122|3541381|B2|||Age||years|Mean|26.5|26.5|Inter-Quartile Range|||24.1|28.4|
3700362|NCT02189122|3541382|B1|||Age||years|Mean|27.4|27.4|Inter-Quartile Range|||24.2|33.6|
3700363|NCT02188849|3541399|B3|Chile||Region of Enrollment||participants|Number|50|50.0||||||
3700364|NCT02188849|3541400|B2|Chile||Region of Enrollment||participants|Number|25|25.0||||||
3700365|NCT02188849|3541401|B1|Chile||Region of Enrollment||participants|Number|25|25.0||||||
3700366|NCT02188849|3541399|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3700367|NCT02188849|3541400|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3700368|NCT02188849|3541401|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3700369|NCT02188849|3541399|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3700370|NCT02188849|3541400|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3700371|NCT02188849|3541401|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3700372|NCT02188849|3541399|B3|||Age||years|Mean|67.8|67.8|Standard Deviation|4.7|4.7|||
3700373|NCT02188849|3541400|B2|||Age||years|Mean|68.1|68.1|Standard Deviation|4.9|4.9|||
3700374|NCT02188849|3541401|B1|||Age||years|Mean|67.5|67.5|Standard Deviation|4.5|4.5|||
3700375|NCT02188784|3541414|B3|United States||Region of Enrollment||Participants|Count of Participants|225|225.0||||||
3700376|NCT02188784|3541415|B2|United States||Region of Enrollment||Participants|Count of Participants|114|114.0||||||
3700377|NCT02188784|3541416|B1|United States||Region of Enrollment||Participants|Count of Participants|111|111.0||||||
3700378|NCT02188784|3541414|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700379|NCT02188784|3541415|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700380|NCT02188784|3541416|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700381|NCT02188784|3541414|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3700382|NCT02188784|3541415|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3700383|NCT02188784|3541416|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700384|NCT02188784|3541414|B3||White|Race (NIH/OMB)||Participants|Count of Participants|164|164.0||||||
3700385|NCT02188784|3541415|B2||White|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3700386|NCT02188784|3541416|B1||White|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3700387|NCT02188784|3541414|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3700388|NCT02188784|3541415|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3700389|NCT02188784|3541416|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3700390|NCT02188784|3541414|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700391|NCT02188784|3541415|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700392|NCT02188784|3541416|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700393|NCT02188784|3541414|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3700394|NCT02188784|3541415|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3700395|NCT02188784|3541416|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3700396|NCT02188784|3541414|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700397|NCT02188784|3541415|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700398|NCT02188784|3541416|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700399|NCT02188784|3541414|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3700400|NCT02188784|3541415|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3700401|NCT02188784|3541416|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700402|NCT02188784|3541414|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|215|215.0||||||
3700403|NCT02188784|3541415|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
3700404|NCT02188784|3541416|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
3700405|NCT02188784|3541414|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3700406|NCT02188784|3541415|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3700407|NCT02188784|3541416|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3700408|NCT02188784|3541414|B3||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3700409|NCT02188784|3541415|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3700410|NCT02188784|3541416|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3700411|NCT02188784|3541414|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3700412|NCT02188784|3541415|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3700413|NCT02188784|3541416|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3700414|NCT02188784|3541414|B3|||Age||years|Mean|61.7|61.7|Standard Deviation|12.9|12.9|||
3700415|NCT02188784|3541415|B2|||Age||years|Mean|51.6|51.6|Standard Deviation|12.5|12.5|||
3700416|NCT02188784|3541416|B1|||Age||years|Mean|61.8|61.8|Standard Deviation|13.4|13.4|||
3700417|NCT02188589|3541433|B1||Male|Gender||Participants|Count of Participants|18|18.0||||||
3700418|NCT02188589|3541433|B1||Female|Gender||Participants|Count of Participants|12|12.0||||||
3700419|NCT02188589|3541433|B1|||Age||years|Mean|51.1|51.1|Standard Deviation|5.3|5.3|||
3700420|NCT02187887|3541438|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3700421|NCT02187887|3541439|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3700422|NCT02187887|3541440|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3700423|NCT02187887|3541438|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3700424|NCT02187887|3541439|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3700425|NCT02187887|3541440|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3700426|NCT02187887|3541438|B3||White|Race (NIH/OMB)||Participants|Count of Participants|664|664.0||||||
3700427|NCT02187887|3541439|B2||White|Race (NIH/OMB)||Participants|Count of Participants|334|334.0||||||
3700428|NCT02187887|3541440|B1||White|Race (NIH/OMB)||Participants|Count of Participants|330|330.0||||||
3700429|NCT02187887|3541438|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3700430|NCT02187887|3541439|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3700431|NCT02187887|3541440|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3700432|NCT02187887|3541438|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3700433|NCT02187887|3541439|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3700434|NCT02187887|3541440|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3700435|NCT02187887|3541438|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3700436|NCT02187887|3541439|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3700437|NCT02187887|3541440|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3700438|NCT02187887|3541438|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3700439|NCT02187887|3541439|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3700440|NCT02187887|3541440|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3700441|NCT02187887|3541438|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700442|NCT02187887|3541439|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700443|NCT02187887|3541440|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700444|NCT02187887|3541438|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|702|702.0||||||
3700445|NCT02187887|3541439|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|350|350.0||||||
3700446|NCT02187887|3541440|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|352|352.0||||||
3700447|NCT02187887|3541438|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3700448|NCT02187887|3541439|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3700449|NCT02187887|3541440|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3700450|NCT02187887|3541438|B3||Male|Sex: Female, Male||Participants|Count of Participants|653|653.0||||||
3700451|NCT02187887|3541439|B2||Male|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
3700452|NCT02187887|3541440|B1||Male|Sex: Female, Male||Participants|Count of Participants|327|327.0||||||
3700453|NCT02187887|3541438|B3||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3700454|NCT02187887|3541439|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3700455|NCT02187887|3541440|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3700456|NCT02187887|3541438|B3|||Age||years|Mean|28.9|28.9|Standard Deviation|3.4|3.4|||
3700457|NCT02187887|3541439|B2|||Age||years|Mean|28.9|28.9|Standard Deviation|3.5|3.5|||
3700458|NCT02187887|3541440|B1|||Age||years|Mean|28.8|28.8|Standard Deviation|3.3|3.3|||
3700459|NCT02187861|3541449|B5||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3700460|NCT02187861|3541450|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3700461|NCT02187861|3541451|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3700462|NCT02187861|3541452|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3700463|NCT02187861|3541453|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3700464|NCT02187861|3541449|B5||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3700465|NCT02187861|3541450|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3700466|NCT02187861|3541451|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3700467|NCT02187861|3541452|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3700468|NCT02187861|3541453|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3700469|NCT02187861|3541449|B5|||Age||years|Mean|62.4|62.4|Standard Deviation|11.3|11.3|||
3700470|NCT02187861|3541450|B4|||Age||years|Mean|61.0|61.0|Standard Deviation|11.6|11.6|||
3700471|NCT02187861|3541451|B3|||Age||years|Mean|64.9|64.9|Standard Deviation|9.8|9.8|||
3700472|NCT02187861|3541452|B2|||Age||years|Mean|62.0|62.0|Standard Deviation|11.9|11.9|||
3700473|NCT02187861|3541453|B1|||Age||years|Mean|57.9|57.9|Standard Deviation|12.7|12.7|||
3700474|NCT02187809|3541552|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3700475|NCT02187809|3541552|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3700476|NCT02187809|3541552|B1|||Age||years|Median|13|13.0|Full Range|||13.0|13.0|
3700477|NCT02187744|3541562|B3|Female||Sex/Gender, Customized||Participants|Number|226|226.0||||||
3700478|NCT02187744|3541563|B2|Female||Sex/Gender, Customized||Participants|Number|112|112.0||||||
3700479|NCT02187744|3541564|B1|Female||Sex/Gender, Customized||Participants|Number|114|114.0||||||
3700480|NCT02187744|3541562|B3|||Age||Years|Mean|52.6|52.6|Standard Deviation|12.3|12.3|||
3700481|NCT02187744|3541563|B2|||Age||Years|Mean|51.2|51.2|Standard Deviation|12.7|12.7|||
3700482|NCT02187744|3541564|B1|||Age||Years|Mean|54.0|54.0|Standard Deviation|11.9|11.9|||
3700483|NCT02187055|3541581|B4||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
3700484|NCT02187055|3541582|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3700485|NCT02187055|3541583|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3700486|NCT02187055|3541584|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3700487|NCT02187055|3541581|B4||Female|Sex: Female, Male||Participants|Count of Participants|950|950.0||||||
3700488|NCT02187055|3541582|B3||Female|Sex: Female, Male||Participants|Count of Participants|320|320.0||||||
3700489|NCT02187055|3541583|B2||Female|Sex: Female, Male||Participants|Count of Participants|311|311.0||||||
3700490|NCT02187055|3541584|B1||Female|Sex: Female, Male||Participants|Count of Participants|319|319.0||||||
3700491|NCT02187055|3541581|B4|||Age||Years|Mean|50.1|50.1|Standard Deviation|13.0|13.0|||
3700492|NCT02187055|3541582|B3|||Age||Years|Mean|50.7|50.7|Standard Deviation|13.4|13.4|||
3700493|NCT02187055|3541583|B2|||Age||Years|Mean|50.0|50.0|Standard Deviation|13.4|13.4|||
3700494|NCT02187055|3541584|B1|||Age||Years|Mean|49.7|49.7|Standard Deviation|12.2|12.2|||
3700495|NCT02187029|3541684|B5||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3700496|NCT02187029|3541685|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3700497|NCT02187029|3541686|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3700498|NCT02187029|3541687|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3700499|NCT02187029|3541688|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3700500|NCT02187029|3541684|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3700501|NCT02187029|3541685|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3700502|NCT02187029|3541686|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3700503|NCT02187029|3541687|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3700504|NCT02187029|3541688|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3700505|NCT02187029|3541684|B5|||Age||years|Mean|46.0|46.0|Standard Deviation|9.1|9.1|||
3700506|NCT02187029|3541685|B4|||Age||years|Mean|46.8|46.8|Standard Deviation|9.3|9.3|||
3700507|NCT02187029|3541686|B3|||Age||years|Mean|43.4|43.4|Standard Deviation|9.8|9.8|||
3700508|NCT02187029|3541687|B2|||Age||years|Mean|50.7|50.7|Standard Deviation|9.7|9.7|||
3700509|NCT02187029|3541688|B1|||Age||years|Mean|47.1|47.1|Standard Deviation|8.1|8.1|||
3700510|NCT02187016|3541763|B5|United States||Region of Enrollment||participants|Number|287|287.0||||||
3700511|NCT02187016|3541764|B4|United States||Region of Enrollment||participants|Number|51|51.0||||||
3700512|NCT02187016|3541765|B3|United States||Region of Enrollment||participants|Number|79|79.0||||||
3700513|NCT02187016|3541766|B2|United States||Region of Enrollment||participants|Number|78|78.0||||||
3700514|NCT02187016|3541767|B1|United States||Region of Enrollment||participants|Number|79|79.0||||||
3700515|NCT02187016|3541763|B5||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3700516|NCT02187016|3541764|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3700517|NCT02187016|3541765|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3700518|NCT02187016|3541766|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3700519|NCT02187016|3541767|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3700520|NCT02187016|3541763|B5||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3700521|NCT02187016|3541764|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3700522|NCT02187016|3541765|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3700523|NCT02187016|3541766|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3700524|NCT02187016|3541767|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3700525|NCT02187016|3541763|B5|||Age||years|Mean|35.7|35.7|Standard Deviation|11.50|11.5|||
3700526|NCT02187016|3541764|B4|||Age||years|Mean|35.1|35.1|Standard Deviation|12.10|12.1|||
3700527|NCT02187016|3541765|B3|||Age||years|Mean|34.9|34.9|Standard Deviation|11.00|11.0|||
3700528|NCT02187016|3541766|B2|||Age||years|Mean|35.6|35.6|Standard Deviation|10.70|10.7|||
3700529|NCT02187016|3541767|B1|||Age||years|Mean|37|37.0|Standard Deviation|12.20|12.2|||
3700530|NCT02186938|3541800|B3||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3700531|NCT02186938|3541801|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3700532|NCT02186938|3541802|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3700533|NCT02186938|3541800|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3700534|NCT02186938|3541801|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3700535|NCT02186938|3541802|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3700536|NCT02186938|3541800|B3|||Age||years|Mean|57.7|57.7|Full Range|||18.0|84.0|
3700537|NCT02186938|3541801|B2|||Age||years|Mean|57.6|57.6|Full Range|||18.0|84.0|
3700538|NCT02186938|3541802|B1|||Age||years|Mean|59.1|59.1|Full Range|||22.0|81.0|
3700539|NCT02186873|3541811|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
3700540|NCT02186873|3541812|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3700541|NCT02186873|3541813|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3700542|NCT02186873|3541811|B3|Ukraine||Region of Enrollment||participants|Number|59|59.0||||||
3700543|NCT02186873|3541812|B2|Ukraine||Region of Enrollment||participants|Number|34|34.0||||||
3700544|NCT02186873|3541813|B1|Ukraine||Region of Enrollment||participants|Number|25|25.0||||||
3700545|NCT02186873|3541811|B3|South Korea||Region of Enrollment||participants|Number|18|18.0||||||
3700546|NCT02186873|3541812|B2|South Korea||Region of Enrollment||participants|Number|10|10.0||||||
3700547|NCT02186873|3541813|B1|South Korea||Region of Enrollment||participants|Number|8|8.0||||||
3700548|NCT02186873|3541811|B3|Russian Federation||Region of Enrollment||participants|Number|30|30.0||||||
3700549|NCT02186873|3541812|B2|Russian Federation||Region of Enrollment||participants|Number|14|14.0||||||
3700550|NCT02186873|3541813|B1|Russian Federation||Region of Enrollment||participants|Number|16|16.0||||||
3700551|NCT02186873|3541811|B3|Poland||Region of Enrollment||participants|Number|68|68.0||||||
3700552|NCT02186873|3541812|B2|Poland||Region of Enrollment||participants|Number|30|30.0||||||
3700553|NCT02186873|3541813|B1|Poland||Region of Enrollment||participants|Number|38|38.0||||||
3700554|NCT02186873|3541811|B3|Mexico||Region of Enrollment||participants|Number|6|6.0||||||
3700555|NCT02186873|3541812|B2|Mexico||Region of Enrollment||participants|Number|3|3.0||||||
3700556|NCT02186873|3541813|B1|Mexico||Region of Enrollment||participants|Number|3|3.0||||||
3700557|NCT02186873|3541811|B3|Germany||Region of Enrollment||participants|Number|8|8.0||||||
3700558|NCT02186873|3541812|B2|Germany||Region of Enrollment||participants|Number|5|5.0||||||
3700559|NCT02186873|3541813|B1|Germany||Region of Enrollment||participants|Number|3|3.0||||||
3700560|NCT02186873|3541811|B3|Canada||Region of Enrollment||participants|Number|2|2.0||||||
3700561|NCT02186873|3541812|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3700562|NCT02186873|3541813|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3700563|NCT02186873|3541811|B3||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3700564|NCT02186873|3541812|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3700565|NCT02186873|3541813|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3700566|NCT02186873|3541811|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3700567|NCT02186873|3541812|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3700568|NCT02186873|3541813|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3700569|NCT02186873|3541811|B3|||Age||years|Mean|38.8|38.8|Standard Deviation|10.41|10.41|||
3700570|NCT02186873|3541812|B2|||Age||years|Mean|38.4|38.4|Standard Deviation|10.11|10.11|||
3700571|NCT02186873|3541813|B1|||Age||years|Mean|39.2|39.2|Standard Deviation|10.75|10.75|||
3700572|NCT02186873|3541811|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3700573|NCT02186873|3541812|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3700574|NCT02186873|3541813|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3700575|NCT02186873|3541811|B3||Between 18 and 65 years|Age||Participants|Count of Participants|207|207.0||||||
3700576|NCT02186873|3541812|B2||Between 18 and 65 years|Age||Participants|Count of Participants|105|105.0||||||
3700577|NCT02186873|3541813|B1||Between 18 and 65 years|Age||Participants|Count of Participants|102|102.0||||||
3700578|NCT02186873|3541811|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3700579|NCT02186873|3541812|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3700580|NCT02186873|3541813|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3700581|NCT02186808|3541837|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3700582|NCT02186808|3541837|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3700583|NCT02186808|3541837|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3700584|NCT02186808|3541837|B1||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
3700585|NCT02186808|3541837|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3700586|NCT02186665|3541842|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3700587|NCT02186665|3541843|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3700588|NCT02186665|3541844|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3700589|NCT02186665|3541842|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3700590|NCT02186665|3541843|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3700591|NCT02186665|3541844|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3700592|NCT02186665|3541842|B3|||Age||years|Mean|9.7|9.7|Standard Deviation|1.8|1.8|||
3700593|NCT02186665|3541843|B2|||Age||years|Mean|9.8|9.8|Standard Deviation|1.8|1.8|||
3700594|NCT02186665|3541844|B1|||Age||years|Mean|9.6|9.6|Standard Deviation|1.8|1.8|||
3700595|NCT02186587|3541851|B3||Male|Gender||Participants|Count of Participants|10|10.0||||||
3700596|NCT02186587|3541853|B1||Male|Gender||Participants|Count of Participants|10|10.0||||||
3700597|NCT02186587|3541851|B3||Female|Gender||Participants|Count of Participants|18|18.0||||||
3700598|NCT02186587|3541853|B1||Female|Gender||Participants|Count of Participants|18|18.0||||||
3700599|NCT02186587|3541851|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3700600|NCT02186587|3541853|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3700601|NCT02186587|3541851|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3700602|NCT02186587|3541853|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3700603|NCT02186587|3541851|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3700604|NCT02186587|3541853|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3700605|NCT02186223|3541859|B1|Other||Contraindications to anticoagulation||Participants|Count of Participants|11|11.0||||||
3700606|NCT02186223|3541859|B1|Severe thrombocytopenia||Contraindications to anticoagulation||Participants|Count of Participants|1|1.0||||||
3700607|NCT02186223|3541859|B1|History of severe heparin induced thrombocytopenia||Contraindications to anticoagulation||Participants|Count of Participants|0|0.0||||||
3700608|NCT02186223|3541859|B1|Hypersensitivity to anticoagulation||Contraindications to anticoagulation||Participants|Count of Participants|0|0.0||||||
3700609|NCT02186223|3541859|B1|Active or high risk for bleeding||Contraindications to anticoagulation||Participants|Count of Participants|153|153.0||||||
3700610|NCT02186223|3541859|B1|Prophylactic Use of Indications for the Angel® Cat||Indications for the Angel® Catheter Placement||Participants|Count of Participants|160|160.0||||||
3700611|NCT02186223|3541859|B1|Temporary interruption of anticoagulation||Indications for the Angel® Catheter Placement||Participants|Count of Participants|10|10.0||||||
3700612|NCT02186223|3541859|B1|Acute LE DVT or PE & contraindicated to anticoagul||Indications for the Angel® Catheter Placement||Participants|Count of Participants|8|8.0||||||
3700613|NCT02186223|3541859|B1|Recognized contraindications to anticoagulation||Indications for the Angel® Catheter Placement||Participants|Count of Participants|160|160.0||||||
3700614|NCT02186223|3541859|B1|Long term CVC||Other Central Venous Catheter (CVC) in place prior to Angel® Catheter insertion||Participants|Count of Participants|8|8.0||||||
3700615|NCT02186223|3541859|B1|Short term CVC||Other Central Venous Catheter (CVC) in place prior to Angel® Catheter insertion||Participants|Count of Participants|109|109.0||||||
3700616|NCT02186223|3541859|B1|None||Other Central Venous Catheter (CVC) in place prior to Angel® Catheter insertion||Participants|Count of Participants|46|46.0||||||
3700617|NCT02186223|3541859|B1|||Need for vasopressors before Angel® Catheter insertion||Participants|Count of Participants|40|40.0||||||
3700618|NCT02186223|3541859|B1|Other||Type of supplemental oxygen||Participants|Count of Participants|2|2.0||||||
3700619|NCT02186223|3541859|B1|Nasal cannula/face mask||Type of supplemental oxygen||Participants|Count of Participants|20|20.0||||||
3700620|NCT02186223|3541859|B1|CPAP-BiPAP||Type of supplemental oxygen||Participants|Count of Participants|0|0.0||||||
3700621|NCT02186223|3541859|B1|Mechanical ventilation||Type of supplemental oxygen||Participants|Count of Participants|127|127.0||||||
3700622|NCT02186223|3541859|B1|||Supplemental Oxygen at Enrollment||Participants|Count of Participants|150|150.0||||||
3700623|NCT02186223|3541859|B1|Other||Use of mechanical DVT preventive devices||Participants|Count of Participants|27|27.0||||||
3700624|NCT02186223|3541859|B1|Pneumatic compression||Use of mechanical DVT preventive devices||Participants|Count of Participants|113|113.0||||||
3700625|NCT02186223|3541859|B1|Compressive stockings||Use of mechanical DVT preventive devices||Participants|Count of Participants|10|10.0||||||
3700626|NCT02186223|3541859|B1|At least 1 type of preventive device used||Use of mechanical DVT preventive devices||Participants|Count of Participants|145|145.0||||||
3700627|NCT02186223|3541859|B1|PE and DVT||Subjects with Baseline Venous Thromboembolic (VTE) Disease per Site-reported Medical History||Participants|Count of Participants|1|1.0||||||
3700628|NCT02186223|3541859|B1|Deep Vein Thrombosis (DVT)||Subjects with Baseline Venous Thromboembolic (VTE) Disease per Site-reported Medical History||Participants|Count of Participants|16|16.0||||||
3700629|NCT02186223|3541859|B1|Pulmonary Embolism (PE)||Subjects with Baseline Venous Thromboembolic (VTE) Disease per Site-reported Medical History||Participants|Count of Participants|3|3.0||||||
3700630|NCT02186223|3541859|B1|Vascular disorders||Medical History & Concomitant Conditions||Participants|Count of Participants|73|73.0||||||
3700631|NCT02186223|3541859|B1|Surgical and medical procedures||Medical History & Concomitant Conditions||Participants|Count of Participants|78|78.0||||||
3700632|NCT02186223|3541859|B1|Social circumstances||Medical History & Concomitant Conditions||Participants|Count of Participants|3|3.0||||||
3700633|NCT02186223|3541859|B1|Skin and subcutaneous tissue disorders||Medical History & Concomitant Conditions||Participants|Count of Participants|5|5.0||||||
3700634|NCT02186223|3541859|B1|Respiratory, thoracic and mediastinal disorders||Medical History & Concomitant Conditions||Participants|Count of Participants|101|101.0||||||
3700635|NCT02186223|3541859|B1|Reproductive system and breast disorders||Medical History & Concomitant Conditions||Participants|Count of Participants|11|11.0||||||
3700636|NCT02186223|3541859|B1|Renal and urinary disorders||Medical History & Concomitant Conditions||Participants|Count of Participants|19|19.0||||||
3700637|NCT02186223|3541859|B1|Psychiatric disorders||Medical History & Concomitant Conditions||Participants|Count of Participants|24|24.0||||||
3700638|NCT02186223|3541859|B1|Nervous system disorders||Medical History & Concomitant Conditions||Participants|Count of Participants|111|111.0||||||
3700639|NCT02186223|3541859|B1|Neoplasms benign, malignant, and unspecified||Medical History & Concomitant Conditions||Participants|Count of Participants|12|12.0||||||
3700640|NCT02186223|3541859|B1|Musculoskeletal and connective tissue disorders||Medical History & Concomitant Conditions||Participants|Count of Participants|26|26.0||||||
3700641|NCT02186223|3541859|B1|Metabolism and nutrition disorders||Medical History & Concomitant Conditions||Participants|Count of Participants|58|58.0||||||
3700642|NCT02186223|3541859|B1|Investigations||Medical History & Concomitant Conditions||Participants|Count of Participants|43|43.0||||||
3700643|NCT02186223|3541859|B1|Injury, poisoning, and procedural complications||Medical History & Concomitant Conditions||Participants|Count of Participants|149|149.0||||||
3700644|NCT02186223|3541859|B1|Infections and infestations||Medical History & Concomitant Conditions||Participants|Count of Participants|28|28.0||||||
3700645|NCT02186223|3541859|B1|Immune system disorders||Medical History & Concomitant Conditions||Participants|Count of Participants|2|2.0||||||
3700646|NCT02186223|3541859|B1|Hepatobiliary disorders||Medical History & Concomitant Conditions||Participants|Count of Participants|8|8.0||||||
3700647|NCT02186223|3541859|B1|General disorders and administration site conditio||Medical History & Concomitant Conditions||Participants|Count of Participants|37|37.0||||||
3700648|NCT02186223|3541859|B1|Gastrointestinal disorders||Medical History & Concomitant Conditions||Participants|Count of Participants|38|38.0||||||
3700649|NCT02186223|3541859|B1|Eye disorders||Medical History & Concomitant Conditions||Participants|Count of Participants|2|2.0||||||
3700650|NCT02186223|3541859|B1|Ear and labyrinth disorders||Medical History & Concomitant Conditions||Participants|Count of Participants|2|2.0||||||
3700651|NCT02186223|3541859|B1|Endocrine disorders||Medical History & Concomitant Conditions||Participants|Count of Participants|7|7.0||||||
3700652|NCT02186223|3541859|B1|Cardiac disorders||Medical History & Concomitant Conditions||Participants|Count of Participants|43|43.0||||||
3700653|NCT02186223|3541859|B1|Blood and lymphatic system disorders||Medical History & Concomitant Conditions||Participants|Count of Participants|53|53.0||||||
3700654|NCT02186223|3541859|B1|Major bleeding||Severity of Active Bleeding||Participants|Count of Participants|56|56.0||||||
3700655|NCT02186223|3541859|B1|Minor bleeding||Severity of Active Bleeding||Participants|Count of Participants|11|11.0||||||
3700656|NCT02186223|3541859|B1|At high risk for bleeding||Bleeding Risk||Participants|Count of Participants|69|69.0||||||
3700657|NCT02186223|3541859|B1|History of bleeding||Bleeding Risk||Participants|Count of Participants|13|13.0||||||
3700658|NCT02186223|3541859|B1|Active bleeding||Bleeding Risk||Participants|Count of Participants|67|67.0||||||
3700659|NCT02186223|3541859|B1|Critical (25+)||Injury Classification|Trauma subjects were categorized based on their Injury Severity Score (ISS), with higher scores representing more serious or life-threating injuries. The ISS is an anatomical scoring system that provides an overall score for patients with multiple injuries. Each injury is assigned an Abbreviated Injury Scale (AIS) score and allocated to one of six body regions (Head, Face, Chest, Abdomen, Extremities (including Pelvis), External). The highest AIS score in each body region is used. The 3 most severely injured body regions have their score squared and added together to produce the ISS score.|Participants|Count of Participants|92|92.0||||||
3700660|NCT02186223|3541859|B1|Severe (16-24)||Injury Classification|Trauma subjects were categorized based on their Injury Severity Score (ISS), with higher scores representing more serious or life-threating injuries. The ISS is an anatomical scoring system that provides an overall score for patients with multiple injuries. Each injury is assigned an Abbreviated Injury Scale (AIS) score and allocated to one of six body regions (Head, Face, Chest, Abdomen, Extremities (including Pelvis), External). The highest AIS score in each body region is used. The 3 most severely injured body regions have their score squared and added together to produce the ISS score.|Participants|Count of Participants|41|41.0||||||
3700704|NCT02186210|3541870|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3700705|NCT02186210|3541868|B3|||Age||years|Mean|65|65.0|Standard Deviation|8|8.0|||
3700706|NCT02186210|3541869|B2|||Age||years|Mean|66|66.0|Standard Deviation|8|8.0|||
3700707|NCT02186210|3541870|B1|||Age||years|Mean|63|63.0|Standard Deviation|9|9.0|||
3700661|NCT02186223|3541859|B1|Moderate (10-15)||Injury Classification|Trauma subjects were categorized based on their Injury Severity Score (ISS), with higher scores representing more serious or life-threating injuries. The ISS is an anatomical scoring system that provides an overall score for patients with multiple injuries. Each injury is assigned an Abbreviated Injury Scale (AIS) score and allocated to one of six body regions (Head, Face, Chest, Abdomen, Extremities (including Pelvis), External). The highest AIS score in each body region is used. The 3 most severely injured body regions have their score squared and added together to produce the ISS score.|Participants|Count of Participants|11|11.0||||||
3700662|NCT02186223|3541859|B1|Minimal (1-9)||Injury Classification|Trauma subjects were categorized based on their Injury Severity Score (ISS), with higher scores representing more serious or life-threating injuries. The ISS is an anatomical scoring system that provides an overall score for patients with multiple injuries. Each injury is assigned an Abbreviated Injury Scale (AIS) score and allocated to one of six body regions (Head, Face, Chest, Abdomen, Extremities (including Pelvis), External). The highest AIS score in each body region is used. The 3 most severely injured body regions have their score squared and added together to produce the ISS score.|Participants|Count of Participants|7|7.0||||||
3700663|NCT02186223|3541859|B1|||Injury Severity Score (for trauma subjects)||Injury Severity Score|Median|26|26.0|Full Range|||5.0|66.0|
3700664|NCT02186223|3541859|B1|||Injury Severity Score (for trauma subjects)|Injury Severity Score (ISS) Scale: Minimal (1-9); Moderate (10-15); Severe (16-24); Critical (25+); Trauma subjects categorized by their ISS, with higher scores representing more serious/life-threating injuries. This anatomical scoring system providing an overall score for patients with multiple injuries. Each injury is assigned an Abbreviated Injury Scale (AIS) score and allocated to 1/6 body regions (Head, Face, Chest, Abdomen, Extremities & Pelvis, External). Highest score in each body region is used. 3 most severely injured regions have score squared and added to produce the ISS score.|Injury Severity Score|Mean|27.68|27.68|Standard Deviation|11.94|11.94|||
3700665|NCT02186223|3541859|B1|Head Bleed (Subcategory of Head/Spinal Trauma)||Type of trauma (for trauma subjects)||Participants|Count of Participants|102|102.0||||||
3700666|NCT02186223|3541859|B1|More than one area affected||Type of trauma (for trauma subjects)||Participants|Count of Participants|80|80.0||||||
3700667|NCT02186223|3541859|B1|Lower Extremity Trauma||Type of trauma (for trauma subjects)||Participants|Count of Participants|54|54.0||||||
3700668|NCT02186223|3541859|B1|Abdomen||Type of trauma (for trauma subjects)||Participants|Count of Participants|41|41.0||||||
3700669|NCT02186223|3541859|B1|Chest||Type of trauma (for trauma subjects)||Participants|Count of Participants|63|63.0||||||
3700670|NCT02186223|3541859|B1|Head/Spinal Trauma||Type of trauma (for trauma subjects)||Participants|Count of Participants|129|129.0||||||
3700671|NCT02186223|3541859|B1|Neurological||Primary ICU Admission Diagnosis||Participants|Count of Participants|4|4.0||||||
3700672|NCT02186223|3541859|B1|Medical||Primary ICU Admission Diagnosis||Participants|Count of Participants|6|6.0||||||
3700673|NCT02186223|3541859|B1|Surgical||Primary ICU Admission Diagnosis||Participants|Count of Participants|2|2.0||||||
3700674|NCT02186223|3541859|B1|Trauma||Primary ICU Admission Diagnosis||Participants|Count of Participants|151|151.0||||||
3700675|NCT02186223|3541859|B1|||Time from admission to the hospital to admission to ICU||hours|Median|2.07|2.07|Full Range|||0.0|292.33|
3700676|NCT02186223|3541859|B1|||Time from admission to the hospital to admission to ICU||hours|Mean|7.49|7.49|Standard Deviation|27.34|27.34|||
3700677|NCT02186223|3541859|B1|United States||Region of Enrollment||participants|Number|163|163.0||||||
3700678|NCT02186223|3541859|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3700679|NCT02186223|3541859|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3700680|NCT02186223|3541859|B1||White|Race (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
3700681|NCT02186223|3541859|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3700682|NCT02186223|3541859|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700683|NCT02186223|3541859|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3700684|NCT02186223|3541859|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700685|NCT02186223|3541859|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3700686|NCT02186223|3541859|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
3700687|NCT02186223|3541859|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3700688|NCT02186223|3541859|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3700689|NCT02186223|3541859|B1||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3700690|NCT02186223|3541859|B1|||Age, Customized||years|Median|43|43.0|Full Range|||18.0|88.0|
3700691|NCT02186223|3541859|B1|||Age||years|Mean|44.07|44.07|Standard Deviation|18.66|18.66|||
3700692|NCT02186223|3541859|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3700693|NCT02186223|3541859|B1||Between 18 and 65 years|Age||Participants|Count of Participants|139|139.0||||||
3700694|NCT02186223|3541859|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3700695|NCT02186210|3541868|B3|Korea, Republic of||Region of Enrollment||participants|Number|40|40.0||||||
3700696|NCT02186210|3541869|B2|Korea, Republic of||Region of Enrollment||participants|Number|20|20.0||||||
3700697|NCT02186210|3541870|B1|Korea, Republic of||Region of Enrollment||participants|Number|20|20.0||||||
3700698|NCT02186210|3541868|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3700699|NCT02186210|3541868|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3700700|NCT02186210|3541869|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3700701|NCT02186210|3541870|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3700702|NCT02186210|3541868|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3700703|NCT02186210|3541869|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3700708|NCT02185729|3541879|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3700709|NCT02185729|3541879|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3700710|NCT02185729|3541879|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3700711|NCT02185729|3541879|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3700712|NCT02185729|3541879|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3700713|NCT02185729|3541879|B1|||Age||years|Mean|41|41.0|Standard Deviation|7|7.0|||
3700714|NCT02185534|3541894|B7|||BMI (Body Mass Index)||kg/m^2|Mean|23.8|23.8|Standard Deviation|3.0|3.0|||
3700715|NCT02185534|3541895|B6|||BMI (Body Mass Index)||kg/m^2|Mean|23.9|23.9|Standard Deviation|3.1|3.1|||
3700716|NCT02185534|3541896|B5|||BMI (Body Mass Index)||kg/m^2|Mean|23.0|23.0|Standard Deviation|3.1|3.1|||
3700717|NCT02185534|3541897|B4|||BMI (Body Mass Index)||kg/m^2|Mean|24.1|24.1|Standard Deviation|2.7|2.7|||
3700718|NCT02185534|3541898|B3|||BMI (Body Mass Index)||kg/m^2|Mean|23.4|23.4|Standard Deviation|2.9|2.9|||
3700719|NCT02185534|3541899|B2|||BMI (Body Mass Index)||kg/m^2|Mean|24.7|24.7|Standard Deviation|3.5|3.5|||
3700720|NCT02185534|3541900|B1|||BMI (Body Mass Index)||kg/m^2|Mean|23.7|23.7|Standard Deviation|3.1|3.1|||
3700721|NCT02185534|3541894|B7|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
3700722|NCT02185534|3541895|B6|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3700723|NCT02185534|3541896|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3700724|NCT02185534|3541897|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3700725|NCT02185534|3541898|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3700726|NCT02185534|3541899|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3700727|NCT02185534|3541900|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3700728|NCT02185534|3541894|B7|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3700729|NCT02185534|3541895|B6|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3700730|NCT02185534|3541896|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3700731|NCT02185534|3541897|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3700732|NCT02185534|3541898|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3700733|NCT02185534|3541899|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3700734|NCT02185534|3541900|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3700735|NCT02185534|3541894|B7|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3700736|NCT02185534|3541895|B6|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3700737|NCT02185534|3541896|B5|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3700738|NCT02185534|3541897|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3700739|NCT02185534|3541898|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3700740|NCT02185534|3541899|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3700741|NCT02185534|3541900|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3700742|NCT02185534|3541894|B7|White||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
3700743|NCT02185534|3541895|B6|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3700744|NCT02185534|3541896|B5|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3700745|NCT02185534|3541897|B4|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3700746|NCT02185534|3541898|B3|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3700747|NCT02185534|3541899|B2|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3700748|NCT02185534|3541900|B1|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3700749|NCT02185534|3541894|B7|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3700750|NCT02185534|3541895|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3700751|NCT02185534|3541896|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3700752|NCT02185534|3541897|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3700753|NCT02185534|3541898|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3700754|NCT02185534|3541899|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3700755|NCT02185534|3541900|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3700756|NCT02185534|3541894|B7||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3700757|NCT02185534|3541895|B6||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3700758|NCT02185534|3541896|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3700759|NCT02185534|3541897|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3700760|NCT02185534|3541898|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3700761|NCT02185534|3541899|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3700762|NCT02185534|3541900|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3700763|NCT02185534|3541894|B7||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3700764|NCT02185534|3541895|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3700765|NCT02185534|3541896|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3700766|NCT02185534|3541897|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3700767|NCT02185534|3541898|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3700768|NCT02185534|3541899|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3700769|NCT02185534|3541900|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3700770|NCT02185534|3541894|B7|||Age||years|Mean|35|35.0|Standard Deviation|9|9.0|||
3700771|NCT02185534|3541895|B6|||Age||years|Mean|36|36.0|Standard Deviation|11|11.0|||
3700772|NCT02185534|3541896|B5|||Age||years|Mean|34|34.0|Standard Deviation|9|9.0|||
3700773|NCT02185534|3541897|B4|||Age||years|Mean|35|35.0|Standard Deviation|8|8.0|||
3700774|NCT02185534|3541898|B3|||Age||years|Mean|36|36.0|Standard Deviation|10|10.0|||
3700775|NCT02185534|3541899|B2|||Age||years|Mean|37|37.0|Standard Deviation|11|11.0|||
3700776|NCT02185534|3541900|B1|||Age||years|Mean|33|33.0|Standard Deviation|9|9.0|||
3700777|NCT02185339|3541920|B3|Korea, Republic of||Region of Enrollment||participants|Number|60|60.0||||||
3700778|NCT02185339|3541921|B2|Korea, Republic of||Region of Enrollment||participants|Number|30|30.0||||||
3700779|NCT02185339|3541922|B1|Korea, Republic of||Region of Enrollment||participants|Number|30|30.0||||||
3700780|NCT02185339|3541920|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700781|NCT02185339|3541921|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700782|NCT02185339|3541922|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700783|NCT02185339|3541920|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700784|NCT02185339|3541921|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700785|NCT02185339|3541922|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700786|NCT02185339|3541920|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700787|NCT02185339|3541921|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700788|NCT02185339|3541922|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700789|NCT02185339|3541920|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700790|NCT02185339|3541921|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700791|NCT02185339|3541922|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700792|NCT02185339|3541920|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700793|NCT02185339|3541921|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700794|NCT02185339|3541922|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700795|NCT02185339|3541920|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3700796|NCT02185339|3541921|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3700797|NCT02185339|3541922|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3700798|NCT02185339|3541920|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700799|NCT02185339|3541921|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700800|NCT02185339|3541922|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700801|NCT02185339|3541920|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3700802|NCT02185339|3541921|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3700803|NCT02185339|3541922|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3700804|NCT02185339|3541920|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3700805|NCT02185339|3541921|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3700806|NCT02185339|3541922|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3700807|NCT02185339|3541920|B3|||Age||years|Mean|49.1|49.1|Standard Deviation|10.8|10.8|||
3700808|NCT02185339|3541921|B2|||Age||years|Mean|49.8|49.8|Standard Deviation|11.0|11.0|||
3700809|NCT02185339|3541922|B1|||Age||years|Mean|48.3|48.3|Standard Deviation|10.7|10.7|||
3700810|NCT02185183|3541945|B1|||Crohn's disease activity index|On a sclae of 100 to 400, a decrease in the score suggests improvement of disease activity|units on a scale|Mean|303|303.0|Full Range|||100.0|400.0|
3700811|NCT02185183|3541945|B1|Israel||Region of Enrollment|14 participants followed for improvement of disease|participants|Number|14|14.0||||||
3700812|NCT02185183|3541945|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3700813|NCT02185183|3541945|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3700814|NCT02185183|3541945|B1|||Age||years|Mean|35|35.0|Full Range|||26.0|53.0|
3700815|NCT02185131|3541949|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3700816|NCT02185131|3541950|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3700817|NCT02185131|3541951|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3700818|NCT02185131|3541949|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3700819|NCT02185131|3541950|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3700820|NCT02185131|3541951|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3700821|NCT02185131|3541949|B3|||Age||Years|Mean|41.3|41.3|Standard Deviation|8.8|8.8|||
3700822|NCT02185131|3541950|B2|||Age||Years|Mean|37.4|37.4|Standard Deviation|9.8|9.8|||
3700823|NCT02185131|3541951|B1|||Age||Years|Mean|45.2|45.2|Standard Deviation|5.9|5.9|||
3700824|NCT02185105|3541960|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3700825|NCT02185105|3541960|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3700826|NCT02185105|3541960|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3700827|NCT02185105|3541960|B1|||Age||years|Mean|25|25.0|Standard Deviation|8|8.0|||
3700828|NCT02185105|3541960|B1|>=65 years||Age, Customized||participants|Number|0|0.0||||||
3700829|NCT02185105|3541960|B1|Between 18 and 65 years||Age, Customized||participants|Number|30|30.0||||||
3700830|NCT02185105|3541960|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
3700831|NCT02185014|3542003|B1|||Simplified endoscopic score for crohn's disease (SES-CD)|The SES-CD evaluates 4 endoscopic variables in 5 segments assessed during ileocolonoscopy. The SES-CD total score is the sum of the 4 endoscopic variable scores and range from 0 to 56, where higher scores indicate more severe disease.|units on a scale|Mean|14.2|14.2|Standard Deviation|6.74|6.74|||
3700832|NCT02185014|3542003|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700833|NCT02185014|3542003|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3700834|NCT02185014|3542003|B1||White|Race (NIH/OMB)||Participants|Count of Participants|229|229.0||||||
3700835|NCT02185014|3542003|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3700836|NCT02185014|3542003|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700837|NCT02185014|3542003|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3700838|NCT02185014|3542003|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700839|NCT02185014|3542003|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|245|245.0||||||
3700840|NCT02185014|3542003|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3700841|NCT02185014|3542003|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3700842|NCT02185014|3542003|B1||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3700843|NCT02185014|3542003|B1||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3700844|NCT02185014|3542003|B1|||Age||years|Mean|37.5|37.5|Standard Deviation|12.71|12.71|||
3700845|NCT02184624|3542007|B6|Unknown||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3700846|NCT02184624|3542008|B5|Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3700847|NCT02184624|3542009|B4|Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3700848|NCT02184624|3542010|B3|Unknown||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3700849|NCT02184624|3542011|B2|Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3700850|NCT02184624|3542012|B1|Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3700851|NCT02184624|3542007|B6|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|562|562.0||||||
3700852|NCT02184624|3542008|B5|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|96|96.0||||||
3700853|NCT02184624|3542009|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|118|118.0||||||
3700854|NCT02184624|3542010|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|99|99.0||||||
3700855|NCT02184624|3542011|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|78|78.0||||||
3700856|NCT02184624|3542012|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|171|171.0||||||
3700857|NCT02184624|3542007|B6|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3700858|NCT02184624|3542008|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3700859|NCT02184624|3542009|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3700860|NCT02184624|3542010|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3700861|NCT02184624|3542011|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3700862|NCT02184624|3542012|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3700863|NCT02184624|3542007|B6|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3700864|NCT02184624|3542008|B5|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3700865|NCT02184624|3542009|B4|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3700866|NCT02184624|3542010|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3700867|NCT02184624|3542011|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3700868|NCT02184624|3542012|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3700869|NCT02184624|3542007|B6|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3700870|NCT02184624|3542008|B5|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3700871|NCT02184624|3542009|B4|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3700872|NCT02184624|3542010|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3700873|NCT02184624|3542011|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3700874|NCT02184624|3542012|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3700875|NCT02184624|3542007|B6|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3700876|NCT02184624|3542008|B5|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3700877|NCT02184624|3542009|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3700878|NCT02184624|3542010|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3700879|NCT02184624|3542011|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3700880|NCT02184624|3542012|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3700881|NCT02184624|3542007|B6|Unknown||Sex/Gender, Customized||Participants|Number|2|2.0||||||
3700882|NCT02184624|3542008|B5|Unknown||Sex/Gender, Customized||Participants|Number|0|0.0||||||
3700883|NCT02184624|3542009|B4|Unknown||Sex/Gender, Customized||Participants|Number|0|0.0||||||
3700884|NCT02184624|3542010|B3|Unknown||Sex/Gender, Customized||Participants|Number|0|0.0||||||
3700885|NCT02184624|3542011|B2|Unknown||Sex/Gender, Customized||Participants|Number|1|1.0||||||
3700886|NCT02184624|3542012|B1|Unknown||Sex/Gender, Customized||Participants|Number|1|1.0||||||
3700887|NCT02184624|3542007|B6|Male||Sex/Gender, Customized||Participants|Number|342|342.0||||||
3700888|NCT02184624|3542008|B5|Male||Sex/Gender, Customized||Participants|Number|47|47.0||||||
3700889|NCT02184624|3542009|B4|Male||Sex/Gender, Customized||Participants|Number|72|72.0||||||
3700890|NCT02184624|3542010|B3|Male||Sex/Gender, Customized||Participants|Number|67|67.0||||||
3700891|NCT02184624|3542011|B2|Male||Sex/Gender, Customized||Participants|Number|53|53.0||||||
3700892|NCT02184624|3542012|B1|Male||Sex/Gender, Customized||Participants|Number|103|103.0||||||
3700893|NCT02184624|3542007|B6|Female||Sex/Gender, Customized||Participants|Number|223|223.0||||||
3700894|NCT02184624|3542008|B5|Female||Sex/Gender, Customized||Participants|Number|51|51.0||||||
3700895|NCT02184624|3542009|B4|Female||Sex/Gender, Customized||Participants|Number|46|46.0||||||
3700896|NCT02184624|3542010|B3|Female||Sex/Gender, Customized||Participants|Number|33|33.0||||||
3700897|NCT02184624|3542011|B2|Female||Sex/Gender, Customized||Participants|Number|26|26.0||||||
3700898|NCT02184624|3542012|B1|Female||Sex/Gender, Customized||Participants|Number|67|67.0||||||
3700899|NCT02184624|3542007|B6|||Age||Years|Mean|67.3|67.3|Standard Deviation|8.31|8.31|||
3700900|NCT02184624|3542008|B5|||Age||Years|Mean|67.2|67.2|Standard Deviation|8.17|8.17|||
3700901|NCT02184624|3542009|B4|||Age||Years|Mean|67.3|67.3|Standard Deviation|8.98|8.98|||
3700902|NCT02184624|3542010|B3|||Age||Years|Mean|68.1|68.1|Standard Deviation|8.66|8.66|||
3700903|NCT02184624|3542011|B2|||Age||Years|Mean|65.6|65.6|Standard Deviation|8.76|8.76|||
3700904|NCT02184624|3542012|B1|||Age||Years|Mean|67.8|67.8|Standard Deviation|7.41|7.41|||
3700905|NCT02184572|3542058|B3|Other||Race/Ethnicity, Customized||Participants|Number|136|136.0||||||
3700906|NCT02184572|3542059|B2|Other||Race/Ethnicity, Customized||Participants|Number|47|47.0||||||
3700907|NCT02184572|3542060|B1|Other||Race/Ethnicity, Customized||Participants|Number|89|89.0||||||
3700908|NCT02184572|3542058|B3|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Number|1193|1193.0||||||
3700909|NCT02184572|3542059|B2|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Number|385|385.0||||||
3700910|NCT02184572|3542060|B1|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Number|808|808.0||||||
3700911|NCT02184572|3542058|B3|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3700912|NCT02184572|3542059|B2|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3700913|NCT02184572|3542060|B1|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3700914|NCT02184572|3542058|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3700915|NCT02184572|3542059|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3700916|NCT02184572|3542060|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3700917|NCT02184572|3542058|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
3700918|NCT02184572|3542059|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3700919|NCT02184572|3542060|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|28|28.0||||||
3700920|NCT02184572|3542058|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3700921|NCT02184572|3542059|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3700922|NCT02184572|3542060|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3700923|NCT02184572|3542058|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|196|196.0||||||
3700924|NCT02184572|3542059|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|65|65.0||||||
3700925|NCT02184572|3542060|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|131|131.0||||||
3700926|NCT02184572|3542058|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
3700927|NCT02184572|3542059|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3700928|NCT02184572|3542060|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3700929|NCT02184572|3542058|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|45|45.0||||||
3700930|NCT02184572|3542059|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
3700931|NCT02184572|3542060|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
3700932|NCT02184572|3542058|B3|African Heritage / African American||Race/Ethnicity, Customized||Participants|Number|102|102.0||||||
3700933|NCT02184572|3542059|B2|African Heritage / African American||Race/Ethnicity, Customized||Participants|Number|38|38.0||||||
3700934|NCT02184572|3542060|B1|African Heritage / African American||Race/Ethnicity, Customized||Participants|Number|64|64.0||||||
3700935|NCT02184572|3542058|B3||Male|Sex: Female, Male||Participants|Count of Participants|915|915.0||||||
3700936|NCT02184572|3542059|B2||Male|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
3700937|NCT02184572|3542060|B1||Male|Sex: Female, Male||Participants|Count of Participants|613|613.0||||||
3700938|NCT02184572|3542058|B3||Female|Sex: Female, Male||Participants|Count of Participants|821|821.0||||||
3700939|NCT02184572|3542059|B2||Female|Sex: Female, Male||Participants|Count of Participants|270|270.0||||||
3700940|NCT02184572|3542060|B1||Female|Sex: Female, Male||Participants|Count of Participants|551|551.0||||||
3700941|NCT02184572|3542058|B3|||Age||Months|Mean|12.3|12.3|Standard Deviation|0.7|0.7|||
3700942|NCT02184572|3542059|B2|||Age||Months|Mean|12.3|12.3|Standard Deviation|0.7|0.7|||
3700943|NCT02184572|3542060|B1|||Age||Months|Mean|12.3|12.3|Standard Deviation|0.7|0.7|||
3700944|NCT02184494|3542097|B4|United States||Region of Enrollment||participants|Number|31|31.0||||||
3700945|NCT02184494|3542098|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3700946|NCT02184494|3542099|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3700947|NCT02184494|3542100|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3700948|NCT02184494|3542097|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3700949|NCT02184494|3542098|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3700950|NCT02184494|3542099|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3700951|NCT02184494|3542100|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3700952|NCT02184494|3542097|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3700953|NCT02184494|3542098|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3700954|NCT02184494|3542099|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3700955|NCT02184494|3542100|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3700956|NCT02184494|3542097|B4|||Age||years|Mean|59|59.0|Standard Deviation|14|14.0|||
3700957|NCT02184494|3542098|B3|||Age||years|Mean|50|50.0|Standard Deviation|10|10.0|||
3700958|NCT02184494|3542099|B2|||Age||years|Mean|52|52.0|Standard Deviation|10|10.0|||
3700959|NCT02184494|3542100|B1|||Age||years|Mean|72|72.0|Standard Deviation|9|9.0|||
3700960|NCT02184494|3542097|B4||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3700961|NCT02184494|3542098|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3700962|NCT02184494|3542099|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3700963|NCT02184494|3542100|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3700964|NCT02184494|3542097|B4||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3700965|NCT02184494|3542098|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3700966|NCT02184494|3542099|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3700967|NCT02184494|3542100|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3700968|NCT02184494|3542097|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3700969|NCT02184494|3542098|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3700970|NCT02184494|3542099|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3700971|NCT02184494|3542100|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3700972|NCT02184442|3542122|B3|||Frailty||Participants|Count of Participants|334|334.0||||||
3700973|NCT02184442|3542123|B2|||Frailty||Participants|Count of Participants|166|166.0||||||
3700974|NCT02184442|3542124|B1|||Frailty||Participants|Count of Participants|168|168.0||||||
3700975|NCT02184442|3542122|B3|||Coronary Artery Disease||Participants|Count of Participants|372|372.0||||||
3700976|NCT02184442|3542123|B2|||Coronary Artery Disease||Participants|Count of Participants|186|186.0||||||
3700977|NCT02184442|3542124|B1|||Coronary Artery Disease||Participants|Count of Participants|186|186.0||||||
3700978|NCT02184442|3542122|B3|||NYHA Class III/IV|New York Heart Association (NYHA), functional classification of heart failure based on how much a patient is limited during physical activity. The rating ranges from I-IV, with the lowest as no limitations and the highest unable to carry on any physical activity without discomfort.|Participants|Count of Participants|540|540.0||||||
3700979|NCT02184442|3542123|B2|||NYHA Class III/IV|New York Heart Association (NYHA), functional classification of heart failure based on how much a patient is limited during physical activity. The rating ranges from I-IV, with the lowest as no limitations and the highest unable to carry on any physical activity without discomfort.|Participants|Count of Participants|265|265.0||||||
3700980|NCT02184442|3542124|B1|||NYHA Class III/IV|New York Heart Association (NYHA), functional classification of heart failure based on how much a patient is limited during physical activity. The rating ranges from I-IV, with the lowest as no limitations and the highest unable to carry on any physical activity without discomfort.|Participants|Count of Participants|275|275.0||||||
3700981|NCT02184442|3542122|B3|||STS Score|The Society of Thoracic Surgeons (STS) Score measures patient risk of mortality and morbidity at the time of cardiovascular surgery on a scale that ranges from 0% to 100%, with higher numbers indicating greater risk.|units on a scale|Mean|10.6|10.6|Standard Deviation|5.55|5.55|||
3700982|NCT02184442|3542123|B2|||STS Score|The Society of Thoracic Surgeons (STS) Score measures patient risk of mortality and morbidity at the time of cardiovascular surgery on a scale that ranges from 0% to 100%, with higher numbers indicating greater risk.|units on a scale|Mean|11.0|11.0|Standard Deviation|5.71|5.71|||
3700983|NCT02184442|3542124|B1|||STS Score|The Society of Thoracic Surgeons (STS) Score measures patient risk of mortality and morbidity at the time of cardiovascular surgery on a scale that ranges from 0% to 100%, with higher numbers indicating greater risk.|units on a scale|Mean|10.3|10.3|Standard Deviation|5.38|5.38|||
3700984|NCT02184442|3542122|B3||Male|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
3700985|NCT02184442|3542123|B2||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3700986|NCT02184442|3542124|B1||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3700987|NCT02184442|3542122|B3||Female|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
3700988|NCT02184442|3542123|B2||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3700989|NCT02184442|3542124|B1||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3700990|NCT02184442|3542122|B3|||Age||Years|Mean|84.3|84.3|Standard Deviation|8.63|8.63|||
3700991|NCT02184442|3542123|B2|||Age||Years|Mean|84.6|84.6|Standard Deviation|8.61|8.61|||
3700992|NCT02184442|3542124|B1|||Age||Years|Mean|84.0|84.0|Standard Deviation|8.65|8.65|||
3700993|NCT02184208|3542137|B1|United States||Region of Enrollment||participants|Number|222|222.0||||||
3700994|NCT02184208|3542137|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3700995|NCT02184208|3542137|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3700996|NCT02184208|3542137|B1||White|Race (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
3700997|NCT02184208|3542137|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3700998|NCT02184208|3542137|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3700999|NCT02184208|3542137|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3701000|NCT02184208|3542137|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701001|NCT02184208|3542137|B1||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3701002|NCT02184208|3542137|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3701003|NCT02184208|3542137|B1|||Age||years|Median|3|3.0|Inter-Quartile Range|||0.7|12.3|
3701004|NCT02183675|3542143|B7||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3701005|NCT02183675|3542144|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3701006|NCT02183675|3542145|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3701007|NCT02183675|3542146|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3701008|NCT02183675|3542147|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3701009|NCT02183675|3542148|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3701010|NCT02183675|3542149|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3701011|NCT02183675|3542143|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3701012|NCT02183675|3542144|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3701013|NCT02183675|3542145|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3701014|NCT02183675|3542146|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3701015|NCT02183675|3542147|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3701016|NCT02183675|3542148|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3701017|NCT02183675|3542149|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3701018|NCT02183675|3542143|B7|||Age||Years|Mean|28.0|28.0|Standard Deviation|4.6|4.6|||
3701019|NCT02183675|3542144|B6|||Age||Years|Mean|29.3|29.3|Standard Deviation|4.9|4.9|||
3701020|NCT02183675|3542145|B5|||Age||Years|Mean|29.5|29.5|Standard Deviation|5.1|5.1|||
3701021|NCT02183675|3542146|B4|||Age||Years|Mean|25.8|25.8|Standard Deviation|4.1|4.1|||
3701022|NCT02183675|3542147|B3|||Age||Years|Mean|27.0|27.0|Standard Deviation|4.2|4.2|||
3701023|NCT02183675|3542148|B2|||Age||Years|Mean|27.3|27.3|Standard Deviation|5.2|5.2|||
3701024|NCT02183675|3542149|B1|||Age||Years|Mean|29.0|29.0|Standard Deviation|4.9|4.9|||
3701025|NCT02183519|3542176|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
3701026|NCT02183519|3542177|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3701027|NCT02183519|3542178|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3701028|NCT02183519|3542176|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3701029|NCT02183519|3542177|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3701030|NCT02183519|3542178|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3701031|NCT02183519|3542176|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3701032|NCT02183519|3542177|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3701033|NCT02183519|3542178|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3701034|NCT02183519|3542176|B3||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
3701035|NCT02183519|3542177|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3701036|NCT02183519|3542178|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3701037|NCT02183519|3542176|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3701038|NCT02183519|3542177|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3701039|NCT02183519|3542178|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3701040|NCT02183519|3542176|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701041|NCT02183519|3542177|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701042|NCT02183519|3542178|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701043|NCT02182999|3542185|B3|||BMI||kg/m²|Mean|24.9|24.9|Standard Deviation|4.2|4.2|||
3701044|NCT02182999|3542186|B2|||BMI||kg/m²|Mean|25.8|25.8|Standard Deviation|4.2|4.2|||
3701045|NCT02182999|3542187|B1|||BMI||kg/m²|Mean|24.0|24.0|Standard Deviation|4.0|4.0|||
3701046|NCT02182999|3542185|B3|Austria||Region of Enrollment||participants|Number|50|50.0||||||
3701047|NCT02182999|3542186|B2|Austria||Region of Enrollment||participants|Number|25|25.0||||||
3701048|NCT02182999|3542187|B1|Austria||Region of Enrollment||participants|Number|25|25.0||||||
3701049|NCT02182999|3542185|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3701050|NCT02182999|3542185|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3701051|NCT02182999|3542186|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3701052|NCT02182999|3542187|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3701053|NCT02182999|3542185|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3701054|NCT02182999|3542186|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3701055|NCT02182999|3542187|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3701056|NCT02182999|3542185|B3|||Age||years|Mean|55.2|55.2|Standard Deviation|15.4|15.4|||
3701057|NCT02182999|3542186|B2|||Age||years|Mean|58.0|58.0|Standard Deviation|13.1|13.1|||
3701058|NCT02182999|3542187|B1|||Age||years|Mean|52.5|52.5|Standard Deviation|17.2|17.2|||
3701059|NCT02182895|3542202|B3|||BMI||kg/m^2|Mean|33.6|33.6|Standard Deviation|10|10.0|||
3701060|NCT02182895|3542203|B2|||BMI||kg/m^2|Mean|32.6|32.6|Standard Deviation|6.5|6.5|||
3701061|NCT02182895|3542204|B1|||BMI||kg/m^2|Mean|34.5|34.5|Standard Deviation|12.2|12.2|||
3701062|NCT02182895|3542202|B3|United States||Region of Enrollment||participants|Number|66|66.0||||||
3701063|NCT02182895|3542203|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
3701064|NCT02182895|3542204|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
3701065|NCT02182895|3542202|B3|white||Race/Ethnicity, Customized||Participants|Count of Participants|56|56.0||||||
3701066|NCT02182895|3542203|B2|white||Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3701067|NCT02182895|3542204|B1|white||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3701068|NCT02182895|3542202|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3701069|NCT02182895|3542203|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3701070|NCT02182895|3542204|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3701071|NCT02182895|3542202|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3701072|NCT02182895|3542203|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3701073|NCT02182895|3542204|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3701074|NCT02182895|3542202|B3|||Age||years|Mean|68|68.0|Standard Deviation|10|10.0|||
3701075|NCT02182895|3542203|B2|||Age||years|Mean|67|67.0|Standard Deviation|10|10.0|||
3701076|NCT02182895|3542204|B1|||Age||years|Mean|69|69.0|Standard Deviation|10|10.0|||
3701077|NCT02182895|3542202|B3||>=65 years|Age||Participants|Count of Participants|47|47.0||||||
3701078|NCT02182895|3542203|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3701079|NCT02182895|3542204|B1||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
3701080|NCT02182895|3542202|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3701081|NCT02182895|3542203|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3701082|NCT02182895|3542204|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3701083|NCT02182895|3542202|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701084|NCT02182895|3542203|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701085|NCT02182895|3542204|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701086|NCT02182830|3542225|B3|||Baseline estimated glomerular filtration rate (eGFR)||mL/min/1.73m²|Mean|91.31|91.31|Standard Deviation|19.79|19.79|||
3701087|NCT02182830|3542226|B2|||Baseline estimated glomerular filtration rate (eGFR)||mL/min/1.73m²|Mean|91.15|91.15|Standard Deviation|18.95|18.95|||
3701088|NCT02182830|3542227|B1|||Baseline estimated glomerular filtration rate (eGFR)||mL/min/1.73m²|Mean|91.49|91.49|Standard Deviation|20.79|20.79|||
3701089|NCT02182830|3542225|B3|||Baseline hemoglobin A1c (HbA1c) [%]|Mean and standard deviation for Baseline HbA1c [%] is presented|percentage of HbA1c|Mean|8.59|8.59|Standard Deviation|1.02|1.02|||
3701090|NCT02182830|3542226|B2|||Baseline hemoglobin A1c (HbA1c) [%]|Mean and standard deviation for Baseline HbA1c [%] is presented|percentage of HbA1c|Mean|8.66|8.66|Standard Deviation|0.92|0.92|||
3701091|NCT02182830|3542227|B1|||Baseline hemoglobin A1c (HbA1c) [%]|Mean and standard deviation for Baseline HbA1c [%] is presented|percentage of HbA1c|Mean|8.51|8.51|Standard Deviation|1.12|1.12|||
3701092|NCT02182830|3542225|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701093|NCT02182830|3542226|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701094|NCT02182830|3542227|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701095|NCT02182830|3542225|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701096|NCT02182830|3542226|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701097|NCT02182830|3542227|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701098|NCT02182830|3542225|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701099|NCT02182830|3542226|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701100|NCT02182830|3542227|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701101|NCT02182830|3542225|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|150|150.0||||||
3701102|NCT02182830|3542226|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3701103|NCT02182830|3542227|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3701104|NCT02182830|3542225|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701105|NCT02182830|3542226|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701106|NCT02182830|3542227|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701107|NCT02182830|3542225|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701108|NCT02182830|3542226|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701109|NCT02182830|3542227|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701110|NCT02182830|3542225|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701111|NCT02182830|3542226|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701112|NCT02182830|3542227|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701113|NCT02182830|3542225|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701114|NCT02182830|3542226|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701115|NCT02182830|3542227|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701116|NCT02182830|3542225|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|150|150.0||||||
3701117|NCT02182830|3542226|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3701118|NCT02182830|3542227|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3701119|NCT02182830|3542225|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701120|NCT02182830|3542226|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701121|NCT02182830|3542227|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701122|NCT02182830|3542225|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3701123|NCT02182830|3542226|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3701124|NCT02182830|3542227|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3701125|NCT02182830|3542225|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3701126|NCT02182830|3542226|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3701127|NCT02182830|3542227|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3701128|NCT02182830|3542225|B3|||Age||years|Mean|56.8|56.8|Standard Deviation|9.3|9.3|||
3701129|NCT02182830|3542226|B2|||Age||years|Mean|56.5|56.5|Standard Deviation|9.3|9.3|||
3701130|NCT02182830|3542227|B1|||Age||years|Mean|57.2|57.2|Standard Deviation|9.3|9.3|||
3701131|NCT02182492|3542254|B3|China||Region of Enrollment||participants|Number|187|187.0||||||
3701132|NCT02182492|3542255|B2|China||Region of Enrollment||participants|Number|94|94.0||||||
3701133|NCT02182492|3542256|B1|China||Region of Enrollment||participants|Number|93|93.0||||||
3701134|NCT02182492|3542254|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3701135|NCT02182492|3542255|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3701136|NCT02182492|3542256|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3701137|NCT02182492|3542254|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3701138|NCT02182492|3542255|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3701139|NCT02182492|3542256|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3701140|NCT02182492|3542254|B3|||Age||years|Mean|40.2|40.2|Standard Deviation|13.4|13.4|||
3701141|NCT02182492|3542255|B2|||Age||years|Mean|39.9|39.9|Standard Deviation|14.2|14.2|||
3701142|NCT02182492|3542256|B1|||Age||years|Mean|40.4|40.4|Standard Deviation|12.6|12.6|||
3701143|NCT02182492|3542254|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3701144|NCT02182492|3542255|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3701145|NCT02182492|3542256|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3701146|NCT02182492|3542254|B3||Between 18 and 65 years|Age||Participants|Count of Participants|170|170.0||||||
3701147|NCT02182492|3542255|B2||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
3701148|NCT02182492|3542256|B1||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
3701149|NCT02182492|3542254|B3||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
3701150|NCT02182492|3542255|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3701151|NCT02182492|3542256|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
3701152|NCT02182115|3542265|B3|Methicillin resistant Staphylococcus aureus (MRSA)||STAPHYLOCOCCUS AUREUS TYPE||Participants|Count of Participants|11|11.0||||||
3701153|NCT02182115|3542266|B2|Methicillin resistant Staphylococcus aureus (MRSA)||STAPHYLOCOCCUS AUREUS TYPE||Participants|Count of Participants|6|6.0||||||
3701154|NCT02182115|3542267|B1|Methicillin resistant Staphylococcus aureus (MRSA)||STAPHYLOCOCCUS AUREUS TYPE||Participants|Count of Participants|5|5.0||||||
3701155|NCT02182115|3542265|B3|Methicillin sensitive Staphylococcus aureus (MSSA)||STAPHYLOCOCCUS AUREUS TYPE||Participants|Count of Participants|99|99.0||||||
3701156|NCT02182115|3542266|B2|Methicillin sensitive Staphylococcus aureus (MSSA)||STAPHYLOCOCCUS AUREUS TYPE||Participants|Count of Participants|51|51.0||||||
3701157|NCT02182115|3542267|B1|Methicillin sensitive Staphylococcus aureus (MSSA)||STAPHYLOCOCCUS AUREUS TYPE||Participants|Count of Participants|48|48.0||||||
3701158|NCT02182115|3542265|B3|||Staphylococcus aureus carriage||Participants|Count of Participants|110|110.0||||||
3701159|NCT02182115|3542266|B2|||Staphylococcus aureus carriage||Participants|Count of Participants|57|57.0||||||
3701160|NCT02182115|3542267|B1|||Staphylococcus aureus carriage||Participants|Count of Participants|53|53.0||||||
3701161|NCT02182115|3542265|B3|Unknown or incomplete racial/ethnic group||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3701162|NCT02182115|3542266|B2|Unknown or incomplete racial/ethnic group||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3701163|NCT02182115|3542267|B1|Unknown or incomplete racial/ethnic group||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3701164|NCT02182115|3542265|B3|Other racial/ethnic groups||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3701165|NCT02182115|3542266|B2|Other racial/ethnic groups||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3701166|NCT02182115|3542267|B1|Other racial/ethnic groups||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3701167|NCT02182115|3542265|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|95|95.0||||||
3701168|NCT02182115|3542266|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
3701169|NCT02182115|3542267|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
3701170|NCT02182115|3542265|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3701171|NCT02182115|3542266|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3701172|NCT02182115|3542267|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3701173|NCT02182115|3542265|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3701174|NCT02182115|3542266|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3701175|NCT02182115|3542267|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3701176|NCT02182115|3542265|B3|||Age||years|Mean|55.8|55.8|Standard Deviation|13.5|13.5|||
3701177|NCT02182115|3542266|B2|||Age||years|Mean|58.8|58.8|Standard Deviation|13.3|13.3|||
3701178|NCT02182115|3542267|B1|||Age||years|Mean|52.5|52.5|Standard Deviation|13.1|13.1|||
3701179|NCT02182115|3542265|B3||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
3701180|NCT02182115|3542266|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3701181|NCT02182115|3542267|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3701182|NCT02182115|3542265|B3||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
3701183|NCT02182115|3542266|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3701184|NCT02182115|3542267|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3701185|NCT02182115|3542265|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701186|NCT02182115|3542266|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701187|NCT02182115|3542267|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701188|NCT02181790|3542274|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3701189|NCT02181790|3542275|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3701190|NCT02181790|3542276|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3701191|NCT02181790|3542274|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3701192|NCT02181790|3542275|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3701193|NCT02181790|3542276|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3701194|NCT02181790|3542274|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3701195|NCT02181790|3542275|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3701196|NCT02181790|3542276|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3701197|NCT02181790|3542274|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3701198|NCT02181790|3542275|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3701199|NCT02181790|3542276|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3701200|NCT02181790|3542274|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701201|NCT02181790|3542275|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701202|NCT02181790|3542276|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701203|NCT02181738|3542285|B5|Other||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3701204|NCT02181738|3542286|B4|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3701205|NCT02181738|3542287|B3|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3701206|NCT02181738|3542288|B2|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3701207|NCT02181738|3542289|B1|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3701208|NCT02181738|3542285|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3701209|NCT02181738|3542286|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3701210|NCT02181738|3542287|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3701211|NCT02181738|3542288|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3701212|NCT02181738|3542289|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3701213|NCT02181738|3542285|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3701214|NCT02181738|3542286|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3701215|NCT02181738|3542287|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3701216|NCT02181738|3542288|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3701217|NCT02181738|3542289|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3701218|NCT02181738|3542285|B5|Asian||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3701219|NCT02181738|3542286|B4|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3701220|NCT02181738|3542287|B3|Asian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3701221|NCT02181738|3542288|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3701222|NCT02181738|3542289|B1|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3701223|NCT02181738|3542285|B5|Black or African||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3701224|NCT02181738|3542286|B4|Black or African||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3701225|NCT02181738|3542287|B3|Black or African||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3701226|NCT02181738|3542288|B2|Black or African||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3701227|NCT02181738|3542289|B1|Black or African||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3701228|NCT02181738|3542285|B5|White||Race/Ethnicity, Customized||Participants|Number|256|256.0||||||
3701229|NCT02181738|3542286|B4|White||Race/Ethnicity, Customized||Participants|Number|45|45.0||||||
3701230|NCT02181738|3542287|B3|White||Race/Ethnicity, Customized||Participants|Number|86|86.0||||||
3701231|NCT02181738|3542288|B2|White||Race/Ethnicity, Customized||Participants|Number|71|71.0||||||
3701232|NCT02181738|3542289|B1|White||Race/Ethnicity, Customized||Participants|Number|54|54.0||||||
3701233|NCT02181738|3542285|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3701234|NCT02181738|3542286|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3701235|NCT02181738|3542287|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3701236|NCT02181738|3542288|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3701237|NCT02181738|3542289|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3701238|NCT02181738|3542285|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|189|189.0||||||
3701239|NCT02181738|3542286|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3701240|NCT02181738|3542287|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3701241|NCT02181738|3542288|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3701242|NCT02181738|3542289|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3701243|NCT02181738|3542285|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3701244|NCT02181738|3542286|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701245|NCT02181738|3542287|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3701246|NCT02181738|3542288|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3701247|NCT02181738|3542289|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3701248|NCT02181738|3542285|B5||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
3701249|NCT02181738|3542286|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3701250|NCT02181738|3542287|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3701251|NCT02181738|3542288|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3701252|NCT02181738|3542289|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3701253|NCT02181738|3542285|B5||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3701254|NCT02181738|3542286|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3701255|NCT02181738|3542287|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3701256|NCT02181738|3542288|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3701257|NCT02181738|3542289|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3701258|NCT02181738|3542285|B5|||Age||Years|Mean|37.4|37.4|Standard Deviation|13.47|13.47|||
3701259|NCT02181738|3542286|B4|||Age||Years|Mean|39.0|39.0|Standard Deviation|16.88|16.88|||
3701260|NCT02181738|3542287|B3|||Age||Years|Mean|36.1|36.1|Standard Deviation|12.41|12.41|||
3701261|NCT02181738|3542288|B2|||Age||Years|Mean|38.7|38.7|Standard Deviation|13.00|13.0|||
3701262|NCT02181738|3542289|B1|||Age||Years|Mean|36.3|36.3|Standard Deviation|12.54|12.54|||
3701263|NCT02181673|3542331|B3|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3701264|NCT02181673|3542332|B2|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3701265|NCT02181673|3542333|B1|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3701266|NCT02181673|3542331|B3|Ukraine||Region of Enrollment||Participants|Count of Participants|147|147.0||||||
3701267|NCT02181673|3542332|B2|Ukraine||Region of Enrollment||Participants|Count of Participants|86|86.0||||||
3701268|NCT02181673|3542333|B1|Ukraine||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
3701269|NCT02181673|3542331|B3|Spain||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3701270|NCT02181673|3542332|B2|Spain||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3701271|NCT02181673|3542333|B1|Spain||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3701272|NCT02181673|3542331|B3|Russian Federation||Region of Enrollment||Participants|Count of Participants|153|153.0||||||
3701273|NCT02181673|3542332|B2|Russian Federation||Region of Enrollment||Participants|Count of Participants|74|74.0||||||
3701274|NCT02181673|3542333|B1|Russian Federation||Region of Enrollment||Participants|Count of Participants|79|79.0||||||
3701275|NCT02181673|3542331|B3|Romania||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3701276|NCT02181673|3542332|B2|Romania||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3701277|NCT02181673|3542333|B1|Romania||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3701278|NCT02181673|3542331|B3|Poland||Region of Enrollment||Participants|Count of Participants|77|77.0||||||
3701279|NCT02181673|3542332|B2|Poland||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3701280|NCT02181673|3542333|B1|Poland||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
3701281|NCT02181673|3542331|B3|Lithuania||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3701282|NCT02181673|3542332|B2|Lithuania||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3701283|NCT02181673|3542333|B1|Lithuania||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3701284|NCT02181673|3542331|B3|Hungary||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3701285|NCT02181673|3542332|B2|Hungary||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3701286|NCT02181673|3542333|B1|Hungary||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3701287|NCT02181673|3542331|B3|Germany||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3701288|NCT02181673|3542332|B2|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3701289|NCT02181673|3542333|B1|Germany||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3701290|NCT02181673|3542331|B3|Canada||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3701291|NCT02181673|3542332|B2|Canada||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3701292|NCT02181673|3542333|B1|Canada||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3701293|NCT02181673|3542331|B3|Belarus||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3701294|NCT02181673|3542332|B2|Belarus||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3701295|NCT02181673|3542333|B1|Belarus||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3701296|NCT02181673|3542331|B3||Male|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
3701297|NCT02181673|3542332|B2||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3701298|NCT02181673|3542333|B1||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3701299|NCT02181673|3542331|B3||Female|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
3701300|NCT02181673|3542332|B2||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3701301|NCT02181673|3542333|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3701302|NCT02181673|3542331|B3|||Age||years|Mean|46.2|46.2|Standard Deviation|11.9|11.9|||
3701303|NCT02181673|3542332|B2|||Age||years|Mean|45.7|45.7|Standard Deviation|11.25|11.25|||
3701304|NCT02181673|3542333|B1|||Age||years|Mean|46.7|46.7|Standard Deviation|12.53|12.53|||
3701305|NCT02181673|3542331|B3||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
3701306|NCT02181673|3542332|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3701307|NCT02181673|3542333|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3701308|NCT02181673|3542331|B3||Between 18 and 65 years|Age||Participants|Count of Participants|444|444.0||||||
3701309|NCT02181673|3542332|B2||Between 18 and 65 years|Age||Participants|Count of Participants|228|228.0||||||
3701310|NCT02181673|3542333|B1||Between 18 and 65 years|Age||Participants|Count of Participants|216|216.0||||||
3701311|NCT02181673|3542331|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3701312|NCT02181673|3542332|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701313|NCT02181673|3542333|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3701314|NCT02181634|3542362|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3701315|NCT02181634|3542362|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701316|NCT02181634|3542362|B1||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3701317|NCT02181634|3542362|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3701318|NCT02181634|3542362|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701319|NCT02181634|3542362|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3701320|NCT02181634|3542362|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701321|NCT02181634|3542362|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3701322|NCT02181634|3542362|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3701323|NCT02181634|3542362|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3701324|NCT02181634|3542362|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3701325|NCT02181634|3542362|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3701326|NCT02181634|3542362|B1|||Age||years|Median|62|62.0|Full Range|||36.0|87.0|
3701327|NCT02181530|3542373|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3701328|NCT02181530|3542373|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3701329|NCT02181530|3542373|B1|||Age||years|Mean|59.02|59.02|Standard Deviation|13.58|13.58|||
3701330|NCT02181517|3542383|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3701331|NCT02181517|3542384|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3701332|NCT02181517|3542385|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3701333|NCT02181517|3542386|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3701334|NCT02181517|3542383|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3701335|NCT02181517|3542384|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3701336|NCT02181517|3542385|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3701337|NCT02181517|3542386|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3701338|NCT02181517|3542383|B4|> 65 years||Age, Customized||participants|Number|25|25.0||||||
3701339|NCT02181517|3542384|B3|> 65 years||Age, Customized||participants|Number|5|5.0||||||
3701340|NCT02181517|3542385|B2|> 65 years||Age, Customized||participants|Number|10|10.0||||||
3701341|NCT02181517|3542386|B1|> 65 years||Age, Customized||participants|Number|10|10.0||||||
3701342|NCT02181517|3542383|B4|≤ 65 years||Age, Customized||participants|Number|0|0.0||||||
3701343|NCT02181517|3542384|B3|≤ 65 years||Age, Customized||participants|Number|0|0.0||||||
3701344|NCT02181517|3542385|B2|≤ 65 years||Age, Customized||participants|Number|0|0.0||||||
3701345|NCT02181517|3542386|B1|≤ 65 years||Age, Customized||participants|Number|0|0.0||||||
3701346|NCT02181504|3542408|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3701347|NCT02181504|3542409|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3701348|NCT02181504|3542410|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3701349|NCT02181504|3542411|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3701350|NCT02181504|3542408|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3701351|NCT02181504|3542409|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3701352|NCT02181504|3542410|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3701353|NCT02181504|3542411|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3701354|NCT02181504|3542408|B4|||Age||Years|Mean|74.3|74.3|Standard Deviation|7.10|7.1|||
3701355|NCT02181504|3542409|B3|||Age||Years|Mean|76.6|76.6|Standard Deviation|9.24|9.24|||
3701356|NCT02181504|3542410|B2|||Age||Years|Mean|75.6|75.6|Standard Deviation|7.18|7.18|||
3701357|NCT02181504|3542411|B1|||Age||Years|Mean|71.8|71.8|Standard Deviation|5.75|5.75|||
3701358|NCT02181426|3542433|B5|United States||Region of Enrollment||Participants|Count of Participants|112|112.0||||||
3701359|NCT02181426|3542434|B4|United States||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3701360|NCT02181426|3542435|B3|United States||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3701361|NCT02181426|3542436|B2|United States||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3701362|NCT02181426|3542437|B1|United States||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3701363|NCT02181426|3542433|B5||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3701364|NCT02181426|3542434|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3701365|NCT02181426|3542435|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3701366|NCT02181426|3542436|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3701367|NCT02181426|3542437|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3701368|NCT02181426|3542433|B5||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3701369|NCT02181426|3542434|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3701370|NCT02181426|3542435|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3701371|NCT02181426|3542436|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3701372|NCT02181426|3542437|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3701373|NCT02181426|3542433|B5|||Age||Years|Mean|45.7|45.7|Standard Deviation|13.0|13.0|||
3701374|NCT02181426|3542434|B4|||Age||Years|Mean|44.4|44.4|Standard Deviation|13|13.0|||
3701375|NCT02181426|3542435|B3|||Age||Years|Mean|44.7|44.7|Standard Deviation|14.2|14.2|||
3701376|NCT02181426|3542436|B2|||Age||Years|Mean|44.2|44.2|Standard Deviation|12.7|12.7|||
3701377|NCT02181426|3542437|B1|||Age||Years|Mean|49.4|49.4|Standard Deviation|11.9|11.9|||
3701378|NCT02181426|3542433|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3701379|NCT02181426|3542434|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3701380|NCT02181426|3542435|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3701381|NCT02181426|3542436|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3701382|NCT02181426|3542437|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3701383|NCT02181426|3542433|B5||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
3701384|NCT02181426|3542434|B4||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3701385|NCT02181426|3542435|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3701386|NCT02181426|3542436|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3701387|NCT02181426|3542437|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3701388|NCT02181426|3542433|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701389|NCT02181426|3542434|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701390|NCT02181426|3542435|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701391|NCT02181426|3542436|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701392|NCT02181426|3542437|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701393|NCT02181387|3542450|B3|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3701394|NCT02181387|3542451|B2|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3701395|NCT02181387|3542452|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3701396|NCT02181387|3542450|B3|hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3701397|NCT02181387|3542451|B2|hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3701398|NCT02181387|3542452|B1|hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3701399|NCT02181387|3542450|B3|african american||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3701400|NCT02181387|3542451|B2|african american||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3701401|NCT02181387|3542452|B1|african american||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3701402|NCT02181387|3542450|B3|white||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3701465|NCT02180828|3542502|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3701403|NCT02181387|3542451|B2|white||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3701404|NCT02181387|3542452|B1|white||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3701405|NCT02181387|3542450|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3701406|NCT02181387|3542451|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3701407|NCT02181387|3542452|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3701408|NCT02181387|3542450|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3701409|NCT02181387|3542451|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3701410|NCT02181387|3542452|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3701411|NCT02181387|3542450|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3701412|NCT02181387|3542451|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3701413|NCT02181387|3542452|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3701414|NCT02181387|3542450|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3701415|NCT02181387|3542451|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3701416|NCT02181387|3542452|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3701417|NCT02181387|3542450|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701418|NCT02181387|3542451|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701419|NCT02181387|3542452|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701420|NCT02181296|3542459|B3|United States||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3701421|NCT02181296|3542460|B2|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3701422|NCT02181296|3542461|B1|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3701423|NCT02181296|3542459|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3701424|NCT02181296|3542460|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3701425|NCT02181296|3542461|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3701426|NCT02181296|3542459|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3701427|NCT02181296|3542460|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3701428|NCT02181296|3542461|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3701429|NCT02181296|3542459|B3|||Age||years|Mean|44.4|44.4|Standard Deviation|15.25|15.25|||
3701430|NCT02181296|3542460|B2|||Age||years|Mean|48.3|48.3|Standard Deviation|14.7|14.7|||
3701431|NCT02181296|3542461|B1|||Age||years|Mean|40.5|40.5|Standard Deviation|15.8|15.8|||
3701432|NCT02181296|3542459|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3701433|NCT02181296|3542460|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3701434|NCT02181296|3542461|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3701435|NCT02181296|3542459|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3701436|NCT02181296|3542460|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3701437|NCT02181296|3542461|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3701438|NCT02181296|3542459|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701439|NCT02181296|3542460|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701440|NCT02181296|3542461|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701441|NCT02181140|3542474|B1|Germany||Region of Enrollment||participants|Number|56|56.0||||||
3701442|NCT02181140|3542474|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3701443|NCT02181140|3542474|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3701444|NCT02181140|3542474|B1|||Age||years|Mean|67.5|67.5|Full Range|||34.0|87.0|
3701445|NCT02181127|3542480|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3701446|NCT02181127|3542480|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3701447|NCT02181127|3542480|B1|||Age||years|Mean|41.9|41.9|Standard Deviation|15.2|15.2|||
3701448|NCT02181127|3542480|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3701449|NCT02181127|3542480|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3701450|NCT02181127|3542480|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701451|NCT02180893|3542485|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3701452|NCT02180893|3542486|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3701453|NCT02180893|3542487|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3701454|NCT02180893|3542485|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3701455|NCT02180893|3542486|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3701456|NCT02180893|3542487|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3701457|NCT02180893|3542485|B3|||Age||years|Mean|61.15|61.15|Standard Deviation|12.05|12.05|||
3701458|NCT02180893|3542486|B2|||Age||years|Mean|62.2|62.2|Standard Deviation|11.9|11.9|||
3701459|NCT02180893|3542487|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|12.2|12.2|||
3701460|NCT02180828|3542500|B3|China||Region of Enrollment||participants|Number|240|240.0||||||
3701461|NCT02180828|3542501|B2|China||Region of Enrollment||participants|Number|120|120.0||||||
3701462|NCT02180828|3542502|B1|China||Region of Enrollment||participants|Number|120|120.0||||||
3701463|NCT02180828|3542500|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3701464|NCT02180828|3542501|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3701466|NCT02180828|3542500|B3||Female|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
3701467|NCT02180828|3542501|B2||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3701468|NCT02180828|3542502|B1||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3701469|NCT02180828|3542500|B3|||Age||years|Mean|29|29.0|Standard Deviation|7|7.0|||
3701470|NCT02180828|3542501|B2|||Age||years|Mean|29|29.0|Standard Deviation|7|7.0|||
3701471|NCT02180828|3542502|B1|||Age||years|Mean|29|29.0|Standard Deviation|6|6.0|||
3701472|NCT02180828|3542500|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3701473|NCT02180828|3542501|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3701474|NCT02180828|3542502|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3701475|NCT02180828|3542500|B3||Between 18 and 65 years|Age||Participants|Count of Participants|240|240.0||||||
3701476|NCT02180828|3542501|B2||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
3701477|NCT02180828|3542502|B1||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
3701478|NCT02180828|3542500|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701479|NCT02180828|3542501|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701480|NCT02180828|3542502|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701481|NCT02180659|3542525|B3||8 mg/d|Dose of BPN treatment prior to randomization.||Participants|Count of Participants|128|128.0||||||
3701482|NCT02180659|3542526|B2||8 mg/d|Dose of BPN treatment prior to randomization.||Participants|Count of Participants|67|67.0||||||
3701483|NCT02180659|3542527|B1||8 mg/d|Dose of BPN treatment prior to randomization.||Participants|Count of Participants|61|61.0||||||
3701484|NCT02180659|3542525|B3||6 mg/d|Dose of BPN treatment prior to randomization.||Participants|Count of Participants|12|12.0||||||
3701485|NCT02180659|3542526|B2||6 mg/d|Dose of BPN treatment prior to randomization.||Participants|Count of Participants|4|4.0||||||
3701486|NCT02180659|3542527|B1||6 mg/d|Dose of BPN treatment prior to randomization.||Participants|Count of Participants|8|8.0||||||
3701487|NCT02180659|3542525|B3||4 mg/d|Dose of BPN treatment prior to randomization.||Participants|Count of Participants|27|27.0||||||
3701488|NCT02180659|3542526|B2||4 mg/d|Dose of BPN treatment prior to randomization.||Participants|Count of Participants|15|15.0||||||
3701489|NCT02180659|3542527|B1||4 mg/d|Dose of BPN treatment prior to randomization.||Participants|Count of Participants|12|12.0||||||
3701490|NCT02180659|3542525|B3||2 mg/d|Dose of BPN treatment prior to randomization.||Participants|Count of Participants|9|9.0||||||
3701491|NCT02180659|3542526|B2||2 mg/d|Dose of BPN treatment prior to randomization.||Participants|Count of Participants|3|3.0||||||
3701492|NCT02180659|3542527|B1||2 mg/d|Dose of BPN treatment prior to randomization.||Participants|Count of Participants|6|6.0||||||
3701493|NCT02180659|3542525|B3|||Highest Dose of Buprenorphine Treatment Ever Taken (mg/day)||mg/day|Mean|14|14.0|Inter-Quartile Range|||2.0|36.0|
3701494|NCT02180659|3542526|B2|||Highest Dose of Buprenorphine Treatment Ever Taken (mg/day)||mg/day|Mean|14|14.0|Inter-Quartile Range|||4.0|36.0|
3701495|NCT02180659|3542527|B1|||Highest Dose of Buprenorphine Treatment Ever Taken (mg/day)||mg/day|Mean|14|14.0|Inter-Quartile Range|||2.0|32.0|
3701496|NCT02180659|3542525|B3|||Buprenorphine Treatment (years)||years|Mean|3.5|3.5|Full Range|||0.4|10.0|
3701497|NCT02180659|3542526|B2|||Buprenorphine Treatment (years)||years|Mean|3.4|3.4|Full Range|||0.4|10.0|
3701498|NCT02180659|3542527|B1|||Buprenorphine Treatment (years)||years|Mean|3.5|3.5|Full Range|||0.5|10.0|
3701499|NCT02180659|3542525|B3|||Time from first diagnosis of opioid dependence||years|Mean|6.2|6.2|Full Range|||0.5|43.6|
3701500|NCT02180659|3542526|B2|||Time from first diagnosis of opioid dependence||years|Mean|6.2|6.2|Full Range|||0.6|43.6|
3701501|NCT02180659|3542527|B1|||Time from first diagnosis of opioid dependence||years|Mean|6.2|6.2|Full Range|||0.5|34.6|
3701502|NCT02180659|3542525|B3|||Time since first opioid abuse||Years|Mean|11.3|11.3|Full Range|||1.4|45.6|
3701503|NCT02180659|3542526|B2|||Time since first opioid abuse||Years|Mean|11.5|11.5|Full Range|||1.6|45.6|
3701504|NCT02180659|3542527|B1|||Time since first opioid abuse||Years|Mean|11.2|11.2|Full Range|||1.4|36.6|
3701505|NCT02180659|3542525|B3||Not reported|Primary opioid of abuse||Participants|Count of Participants|1|1.0||||||
3701506|NCT02180659|3542526|B2||Not reported|Primary opioid of abuse||Participants|Count of Participants|0|0.0||||||
3701507|NCT02180659|3542527|B1||Not reported|Primary opioid of abuse||Participants|Count of Participants|1|1.0||||||
3701508|NCT02180659|3542525|B3||Other|Primary opioid of abuse||Participants|Count of Participants|7|7.0||||||
3701509|NCT02180659|3542526|B2||Other|Primary opioid of abuse||Participants|Count of Participants|2|2.0||||||
3701510|NCT02180659|3542527|B1||Other|Primary opioid of abuse||Participants|Count of Participants|5|5.0||||||
3701511|NCT02180659|3542525|B3||Heroin|Primary opioid of abuse||Participants|Count of Participants|37|37.0||||||
3701512|NCT02180659|3542526|B2||Heroin|Primary opioid of abuse||Participants|Count of Participants|22|22.0||||||
3701513|NCT02180659|3542527|B1||Heroin|Primary opioid of abuse||Participants|Count of Participants|15|15.0||||||
3701514|NCT02180659|3542525|B3||Prescription opioid pain reliever|Primary opioid of abuse||Participants|Count of Participants|131|131.0||||||
3701515|NCT02180659|3542526|B2||Prescription opioid pain reliever|Primary opioid of abuse||Participants|Count of Participants|65|65.0||||||
3701516|NCT02180659|3542527|B1||Prescription opioid pain reliever|Primary opioid of abuse||Participants|Count of Participants|66|66.0||||||
3701517|NCT02180659|3542525|B3|||BMI||kg/m^2|Mean|28|28.0|Full Range|||14.0|50.6|
3701518|NCT02180659|3542526|B2|||BMI||kg/m^2|Mean|27|27.0|Full Range|||19.0|50.6|
3701519|NCT02180659|3542527|B1|||BMI||kg/m^2|Mean|28|28.0|Full Range|||14.0|46.4|
3701520|NCT02180659|3542525|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701521|NCT02180659|3542526|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701522|NCT02180659|3542527|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701523|NCT02180659|3542525|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701524|NCT02180659|3542526|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701525|NCT02180659|3542527|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701526|NCT02180659|3542525|B3||White|Race (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
3701527|NCT02180659|3542526|B2||White|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3701528|NCT02180659|3542527|B1||White|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3701529|NCT02180659|3542525|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3701530|NCT02180659|3542526|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3701531|NCT02180659|3542527|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3701532|NCT02180659|3542525|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3701533|NCT02180659|3542526|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3701534|NCT02180659|3542527|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701535|NCT02180659|3542525|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3701536|NCT02180659|3542526|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701537|NCT02180659|3542527|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3701538|NCT02180659|3542525|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3701539|NCT02180659|3542526|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3701540|NCT02180659|3542527|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3701541|NCT02180659|3542525|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701542|NCT02180659|3542526|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701543|NCT02180659|3542527|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701544|NCT02180659|3542525|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|170|170.0||||||
3701545|NCT02180659|3542526|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
3701546|NCT02180659|3542527|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3701547|NCT02180659|3542525|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3701548|NCT02180659|3542526|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3701549|NCT02180659|3542527|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3701550|NCT02180659|3542525|B3||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3701551|NCT02180659|3542526|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3701552|NCT02180659|3542527|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3701553|NCT02180659|3542525|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3701554|NCT02180659|3542526|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3701555|NCT02180659|3542527|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3701556|NCT02180659|3542525|B3|||Age||Years|Mean|39|39.0|Full Range|||21.0|64.0|
3701557|NCT02180659|3542526|B2|||Age||Years|Mean|39|39.0|Full Range|||22.0|64.0|
3701558|NCT02180659|3542527|B1|||Age||Years|Mean|38|38.0|Full Range|||21.0|63.0|
3701559|NCT02180646|3542548|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3701560|NCT02180646|3542549|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3701561|NCT02180646|3542550|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3701562|NCT02180646|3542548|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3701563|NCT02180646|3542549|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3701564|NCT02180646|3542550|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3701565|NCT02180646|3542548|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3701566|NCT02180646|3542549|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3701567|NCT02180646|3542550|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3701568|NCT02180646|3542548|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3701569|NCT02180646|3542549|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3701570|NCT02180646|3542550|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3701571|NCT02180646|3542548|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3701572|NCT02180646|3542549|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3701573|NCT02180646|3542550|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3701574|NCT02180646|3542548|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701575|NCT02180646|3542549|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701576|NCT02180646|3542550|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701577|NCT02180438|3542561|B1|Senegal||Region of Enrollment||participants|Number|30|30.0||||||
3701578|NCT02180438|3542561|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701579|NCT02180438|3542561|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701580|NCT02180438|3542561|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701581|NCT02180438|3542561|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3701582|NCT02180438|3542561|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701583|NCT02180438|3542561|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701584|NCT02180438|3542561|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701585|NCT02180438|3542561|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3701586|NCT02180438|3542561|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3701587|NCT02180438|3542561|B1|||Age||years|Median|49|49.0|Full Range|||24.0|65.0|
3701588|NCT02180438|3542561|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3701589|NCT02180438|3542561|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3701590|NCT02180438|3542561|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701591|NCT02180230|3542576|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3701592|NCT02180230|3542576|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3701593|NCT02180230|3542576|B1|||Age||years|Mean|52.2|52.2|Standard Deviation|4.39|4.39|||
3701594|NCT02180061|3542581|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3701595|NCT02180061|3542582|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3701596|NCT02180061|3542583|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3701597|NCT02180061|3542581|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3701598|NCT02180061|3542582|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3701599|NCT02180061|3542583|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3701600|NCT02180061|3542581|B3|||Age||Years|Mean|63.6|63.6|Standard Deviation|13.8|13.8|||
3701601|NCT02180061|3542582|B2|||Age||Years|Mean|58.6|58.6|Standard Deviation|15.5|15.5|||
3701602|NCT02180061|3542583|B1|||Age||Years|Mean|64.8|64.8|Standard Deviation|13.3|13.3|||
3701603|NCT02179918|3542598|B6|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3701604|NCT02179918|3542599|B5|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3701605|NCT02179918|3542600|B4|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3701606|NCT02179918|3542601|B3|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3701607|NCT02179918|3542602|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3701608|NCT02179918|3542603|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3701609|NCT02179918|3542598|B6|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3701610|NCT02179918|3542599|B5|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3701611|NCT02179918|3542600|B4|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3701612|NCT02179918|3542601|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3701613|NCT02179918|3542602|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3701614|NCT02179918|3542603|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3701615|NCT02179918|3542598|B6|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3701616|NCT02179918|3542599|B5|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3701617|NCT02179918|3542600|B4|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3701618|NCT02179918|3542601|B3|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3701619|NCT02179918|3542602|B2|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3701620|NCT02179918|3542603|B1|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3701621|NCT02179918|3542598|B6|White||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
3701622|NCT02179918|3542599|B5|White||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3701623|NCT02179918|3542600|B4|White||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3701624|NCT02179918|3542601|B3|White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3701625|NCT02179918|3542602|B2|White||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3701626|NCT02179918|3542603|B1|White||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3701627|NCT02179918|3542598|B6||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3701628|NCT02179918|3542599|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3701629|NCT02179918|3542600|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3701630|NCT02179918|3542601|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3701631|NCT02179918|3542602|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3701632|NCT02179918|3542603|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3701633|NCT02179918|3542598|B6||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3701634|NCT02179918|3542599|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3701635|NCT02179918|3542600|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3701636|NCT02179918|3542601|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3701637|NCT02179918|3542602|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3701638|NCT02179918|3542603|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3701639|NCT02179918|3542598|B6|||Age||years|Mean|58.0|58.0|Standard Deviation|16.9|16.9|||
3701640|NCT02179918|3542599|B5|||Age||years|Mean|58.8|58.8|Standard Deviation|19.4|19.4|||
3701641|NCT02179918|3542600|B4|||Age||years|Mean|54.7|54.7|Standard Deviation|21|21.0|||
3701642|NCT02179918|3542601|B3|||Age||years|Mean|51.7|51.7|Standard Deviation|22|22.0|||
3701643|NCT02179918|3542602|B2|||Age||years|Mean|62.0|62.0|Standard Deviation|11.4|11.4|||
3701644|NCT02179918|3542603|B1|||Age||years|Mean|60.0|60.0|Standard Deviation|15.4|15.4|||
3701645|NCT02179892|3542731|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
3701646|NCT02179892|3542732|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3701647|NCT02179892|3542733|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3701648|NCT02179892|3542731|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3701649|NCT02179892|3542731|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3701650|NCT02179892|3542732|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3701651|NCT02179892|3542733|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3701652|NCT02179892|3542731|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3701653|NCT02179892|3542732|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3701654|NCT02179892|3542733|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3701655|NCT02179892|3542731|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3701656|NCT02179892|3542732|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3701657|NCT02179892|3542733|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3701658|NCT02179892|3542731|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3701659|NCT02179892|3542732|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3701660|NCT02179892|3542733|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3701661|NCT02179892|3542731|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701662|NCT02179892|3542732|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701663|NCT02179892|3542733|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701664|NCT02179424|3542746|B5|China||Region of Enrollment||participants|Number|642|642.0||||||
3701665|NCT02179424|3542747|B4|China||Region of Enrollment||participants|Number|39|39.0||||||
3701666|NCT02179424|3542748|B3|China||Region of Enrollment||participants|Number|516|516.0||||||
3701667|NCT02179424|3542749|B2|China||Region of Enrollment||participants|Number|11|11.0||||||
3701668|NCT02179424|3542750|B1|China||Region of Enrollment||participants|Number|76|76.0||||||
3701669|NCT02179424|3542746|B5||Male|Gender||Participants|Count of Participants|539|539.0||||||
3701670|NCT02179424|3542747|B4||Male|Gender||Participants|Count of Participants|35|35.0||||||
3701671|NCT02179424|3542748|B3||Male|Gender||Participants|Count of Participants|427|427.0||||||
3701672|NCT02179424|3542749|B2||Male|Gender||Participants|Count of Participants|10|10.0||||||
3701673|NCT02179424|3542750|B1||Male|Gender||Participants|Count of Participants|67|67.0||||||
3701674|NCT02179424|3542746|B5||Female|Gender||Participants|Count of Participants|103|103.0||||||
3701675|NCT02179424|3542747|B4||Female|Gender||Participants|Count of Participants|4|4.0||||||
3701676|NCT02179424|3542748|B3||Female|Gender||Participants|Count of Participants|89|89.0||||||
3701677|NCT02179424|3542749|B2||Female|Gender||Participants|Count of Participants|1|1.0||||||
3701678|NCT02179424|3542750|B1||Female|Gender||Participants|Count of Participants|9|9.0||||||
3701679|NCT02179424|3542746|B5|||Age||years|Mean|78.9|78.9|Standard Deviation|28.6|28.6|||
3701680|NCT02179424|3542747|B4|||Age||years|Mean|60.0|60.0|Standard Deviation|26.6|26.6|||
3701681|NCT02179424|3542748|B3|||Age||years|Mean|81.5|81.5|Standard Deviation|28.0|28.0|||
3701682|NCT02179424|3542749|B2|||Age||years|Mean|51.1|51.1|Standard Deviation|19.3|19.3|||
3701683|NCT02179424|3542750|B1|||Age||years|Mean|74.8|74.8|Standard Deviation|28.5|28.5|||
3701684|NCT02179398|3542768|B3|||Presence of Serious Bacterial Infection (SBI)|SBI was defined as isolation of a bacterial pathogen from the blood, the urine, the cerebrospinal fluid, the synovial fluid, the bone, the stools, or by presence of pneumonia (defined as presence of fever, ≥38°C or ≥100.4°F, cough, tachypnea, and a radiographic lung infiltrate).|participants|Number|67|67.0||||||
3701685|NCT02179398|3542769|B2|||Presence of Serious Bacterial Infection (SBI)|SBI was defined as isolation of a bacterial pathogen from the blood, the urine, the cerebrospinal fluid, the synovial fluid, the bone, the stools, or by presence of pneumonia (defined as presence of fever, ≥38°C or ≥100.4°F, cough, tachypnea, and a radiographic lung infiltrate).|participants|Number|35|35.0||||||
3701686|NCT02179398|3542770|B1|||Presence of Serious Bacterial Infection (SBI)|SBI was defined as isolation of a bacterial pathogen from the blood, the urine, the cerebrospinal fluid, the synovial fluid, the bone, the stools, or by presence of pneumonia (defined as presence of fever, ≥38°C or ≥100.4°F, cough, tachypnea, and a radiographic lung infiltrate).|participants|Number|32|32.0||||||
3701687|NCT02179398|3542768|B3|||Lab-score value|Lab-score value ranges from 0 to 9. A cutoff point ≥3 was identified as the best Lab-score value for SBI prediction in the original derivation study. A child with a Lab-score < 3 has a low SBI risk, whereas a child with a Lab-score value ≥3 has a high >SBI risk.|units on a scale|Mean|2.04|2.04|Standard Deviation|2.74|2.74|||
3701688|NCT02179398|3542769|B2|||Lab-score value|Lab-score value ranges from 0 to 9. A cutoff point ≥3 was identified as the best Lab-score value for SBI prediction in the original derivation study. A child with a Lab-score < 3 has a low SBI risk, whereas a child with a Lab-score value ≥3 has a high >SBI risk.|units on a scale|Mean|2.04|2.04|Standard Deviation|2.86|2.86|||
3701689|NCT02179398|3542770|B1|||Lab-score value|Lab-score value ranges from 0 to 9. A cutoff point ≥3 was identified as the best Lab-score value for SBI prediction in the original derivation study. A child with a Lab-score < 3 has a low SBI risk, whereas a child with a Lab-score value ≥3 has a high >SBI risk.|units on a scale|Mean|2.03|2.03|Standard Deviation|2.62|2.62|||
3701690|NCT02179398|3542768|B3|||Maximum temperature||°C|Mean|39.3|39.3|Standard Deviation|0.78|0.78|||
3701691|NCT02179398|3542769|B2|||Maximum temperature||°C|Mean|39.3|39.3|Standard Deviation|0.8|0.8|||
3701692|NCT02179398|3542770|B1|||Maximum temperature||°C|Mean|39.3|39.3|Standard Deviation|0.8|0.8|||
3701693|NCT02179398|3542768|B3|> 24 hours||Fever duration||participants|Number|120|120.0||||||
3701694|NCT02179398|3542769|B2|> 24 hours||Fever duration||participants|Number|61|61.0||||||
3701695|NCT02179398|3542770|B1|> 24 hours||Fever duration||participants|Number|59|59.0||||||
3701696|NCT02179398|3542768|B3|12-24 hours||Fever duration||participants|Number|49|49.0||||||
3701697|NCT02179398|3542769|B2|12-24 hours||Fever duration||participants|Number|24|24.0||||||
3701698|NCT02179398|3542770|B1|12-24 hours||Fever duration||participants|Number|25|25.0||||||
3701699|NCT02179398|3542768|B3|< 12 hours||Fever duration||participants|Number|102|102.0||||||
3701700|NCT02179398|3542769|B2|< 12 hours||Fever duration||participants|Number|55|55.0||||||
3701701|NCT02179398|3542770|B1|< 12 hours||Fever duration||participants|Number|47|47.0||||||
3701702|NCT02179398|3542768|B3||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3701703|NCT02179398|3542769|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3701704|NCT02179398|3542770|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3701705|NCT02179398|3542768|B3||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3701706|NCT02179398|3542769|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3701707|NCT02179398|3542770|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3701708|NCT02179398|3542768|B3|||Age||months|Median|4.0|4.0|Inter-Quartile Range|||1.6|10.4|
3701709|NCT02179398|3542769|B2|||Age||months|Median|3.4|3.4|Inter-Quartile Range|||1.5|10.4|
3701710|NCT02179398|3542770|B1|||Age||months|Median|4.8|4.8|Inter-Quartile Range|||1.7|10.4|
3701711|NCT02179190|3542789|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3701712|NCT02179190|3542789|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Subjects with more than one race were not collected
3701713|NCT02179190|3542789|B1||White|Race (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
3701714|NCT02179190|3542789|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3701715|NCT02179190|3542789|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701716|NCT02179190|3542789|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3701717|NCT02179190|3542789|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701718|NCT02179190|3542789|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3701719|NCT02179190|3542789|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
3701720|NCT02179190|3542789|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3701721|NCT02179190|3542789|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3701722|NCT02179190|3542789|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3701723|NCT02179190|3542789|B1|Mean ± Standard Deviation||Age||years|Mean|60.4|60.4|Standard Deviation|11.1|11.1|||
3701724|NCT02178995|3542800|B3|Unclassified (GTCS)||Seizure type||participants|Number|3|3.0||||||
3701725|NCT02178995|3542801|B2|Unclassified (GTCS)||Seizure type||participants|Number|0|0.0||||||
3701726|NCT02178995|3542802|B1|Unclassified (GTCS)||Seizure type||participants|Number|3|3.0||||||
3701727|NCT02178995|3542800|B3|Generalized||Seizure type||participants|Number|6|6.0||||||
3701728|NCT02178995|3542801|B2|Generalized||Seizure type||participants|Number|0|0.0||||||
3701729|NCT02178995|3542802|B1|Generalized||Seizure type||participants|Number|6|6.0||||||
3701730|NCT02178995|3542800|B3|Focal||Seizure type||participants|Number|26|26.0||||||
3701731|NCT02178995|3542801|B2|Focal||Seizure type||participants|Number|0|0.0||||||
3701732|NCT02178995|3542802|B1|Focal||Seizure type||participants|Number|26|26.0||||||
3701733|NCT02178995|3542800|B3|||Mean duration of epilepsy||years|Mean|NA||Full Range|||0.0|0.0|Healthy controls do not have epilepsy.
3701734|NCT02178995|3542801|B2|||Mean duration of epilepsy||years|Mean|0|0.0|Full Range|||0.0|0.0|
3701735|NCT02178995|3542802|B1|||Mean duration of epilepsy||years|Mean|12.5|12.5|Full Range|||1.0|41.0|
3701736|NCT02178995|3542800|B3|||Mean years of education||years|Mean|15|15.0|Full Range|||12.0|20.0|
3701737|NCT02178995|3542801|B2|||Mean years of education||years|Mean|15|15.0|Full Range|||12.0|18.0|
3701738|NCT02178995|3542802|B1|||Mean years of education||years|Mean|15|15.0|Full Range|||12.0|20.0|
3701739|NCT02178995|3542800|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3701740|NCT02178995|3542801|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3701741|NCT02178995|3542802|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3701742|NCT02178995|3542800|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3701743|NCT02178995|3542801|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3701744|NCT02178995|3542802|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3701745|NCT02178995|3542800|B3|||Age||years|Mean|39.5|39.5|Full Range|||20.0|64.0|
3701746|NCT02178995|3542801|B2|||Age||years|Mean|45|45.0|Full Range|||22.0|62.0|
3701747|NCT02178995|3542802|B1|||Age||years|Mean|37|37.0|Full Range|||20.0|64.0|
3701748|NCT02178800|3542881|B3|South Africa||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3701749|NCT02178800|3542882|B2|South Africa||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3701750|NCT02178800|3542883|B1|South Africa||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3701751|NCT02178800|3542881|B3|Brazil||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3701752|NCT02178800|3542882|B2|Brazil||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3701753|NCT02178800|3542883|B1|Brazil||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3701754|NCT02178800|3542881|B3|Malawi||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3701755|NCT02178800|3542882|B2|Malawi||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3701756|NCT02178800|3542883|B1|Malawi||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3701757|NCT02178800|3542881|B3|United States||Region of Enrollment||Participants|Count of Participants|106|106.0||||||
3701758|NCT02178800|3542882|B2|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3701759|NCT02178800|3542883|B1|United States||Region of Enrollment||Participants|Count of Participants|80|80.0||||||
3701760|NCT02178800|3542881|B3|Non-hispanic mixed/other||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3701761|NCT02178800|3542882|B2|Non-hispanic mixed/other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3701762|NCT02178800|3542883|B1|Non-hispanic mixed/other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3701763|NCT02178800|3542881|B3|Non-hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|54|54.0||||||
3701764|NCT02178800|3542882|B2|Non-hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3701765|NCT02178800|3542883|B1|Non-hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3701766|NCT02178800|3542881|B3|Non-hispanic Black||Race/Ethnicity, Customized||Participants|Count of Participants|82|82.0||||||
3701767|NCT02178800|3542882|B2|Non-hispanic Black||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3701768|NCT02178800|3542883|B1|Non-hispanic Black||Race/Ethnicity, Customized||Participants|Count of Participants|64|64.0||||||
3701769|NCT02178800|3542881|B3|Non-hispanic Asian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3701770|NCT02178800|3542882|B2|Non-hispanic Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3701771|NCT02178800|3542883|B1|Non-hispanic Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3701772|NCT02178800|3542881|B3|Latino||Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
3701773|NCT02178800|3542882|B2|Latino||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3701774|NCT02178800|3542883|B1|Latino||Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3701775|NCT02178800|3542881|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3701776|NCT02178800|3542882|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3701777|NCT02178800|3542883|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3701778|NCT02178800|3542881|B3||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3701779|NCT02178800|3542882|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3701780|NCT02178800|3542883|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3701781|NCT02178800|3542881|B3|56 - 65||Age, Customized||Participants|Count of Participants|14|14.0||||||
3701782|NCT02178800|3542882|B2|56 - 65||Age, Customized||Participants|Count of Participants|4|4.0||||||
3701783|NCT02178800|3542883|B1|56 - 65||Age, Customized||Participants|Count of Participants|10|10.0||||||
3701784|NCT02178800|3542881|B3|46 - 55||Age, Customized||Participants|Count of Participants|19|19.0||||||
3701785|NCT02178800|3542882|B2|46 - 55||Age, Customized||Participants|Count of Participants|4|4.0||||||
3701786|NCT02178800|3542883|B1|46 - 55||Age, Customized||Participants|Count of Participants|15|15.0||||||
3701787|NCT02178800|3542881|B3|36 - 45||Age, Customized||Participants|Count of Participants|35|35.0||||||
3701788|NCT02178800|3542882|B2|36 - 45||Age, Customized||Participants|Count of Participants|14|14.0||||||
3701789|NCT02178800|3542883|B1|36 - 45||Age, Customized||Participants|Count of Participants|21|21.0||||||
3701790|NCT02178800|3542881|B3|26 - 35||Age, Customized||Participants|Count of Participants|70|70.0||||||
3701791|NCT02178800|3542882|B2|26 - 35||Age, Customized||Participants|Count of Participants|17|17.0||||||
3701792|NCT02178800|3542883|B1|26 - 35||Age, Customized||Participants|Count of Participants|53|53.0||||||
3701793|NCT02178800|3542881|B3|18 - 25||Age, Customized||Participants|Count of Participants|61|61.0||||||
3701794|NCT02178800|3542882|B2|18 - 25||Age, Customized||Participants|Count of Participants|9|9.0||||||
3701795|NCT02178800|3542883|B1|18 - 25||Age, Customized||Participants|Count of Participants|52|52.0||||||
3701796|NCT02178800|3542881|B3|||Age||years|Mean|33|33.0|Standard Deviation|11.3|11.3|||
3701797|NCT02178800|3542882|B2|||Age||years|Mean|35|35.0|Standard Deviation|11.0|11.0|||
3701798|NCT02178800|3542883|B1|||Age||years|Mean|33|33.0|Standard Deviation|11.4|11.4|||
3701799|NCT02178787|3542890|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3701800|NCT02178787|3542891|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3701801|NCT02178787|3542892|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3701802|NCT02178787|3542890|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3701803|NCT02178787|3542891|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3701804|NCT02178787|3542892|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3701805|NCT02178787|3542890|B3|||Age||years|Mean|66.48|66.48|Standard Deviation|8.93|8.93|||
3701806|NCT02178787|3542891|B2|||Age||years|Mean|66.31|66.31|Standard Deviation|9.95|9.95|||
3701807|NCT02178787|3542892|B1|||Age||years|Mean|67|67.0|Standard Deviation|7.91|7.91|||
3701808|NCT02178787|3542890|B3||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
3701809|NCT02178787|3542891|B2||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3701810|NCT02178787|3542892|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3701811|NCT02178787|3542890|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3701812|NCT02178787|3542891|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3701813|NCT02178787|3542892|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3701814|NCT02178787|3542890|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701815|NCT02178787|3542891|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701816|NCT02178787|3542892|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701817|NCT02178696|3542901|B1|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3701818|NCT02178696|3542901|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3701819|NCT02178696|3542901|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3701820|NCT02178696|3542901|B1|19 to 59 years||Age, Customized||Participants|Count of Participants|40|40.0||||||
3701821|NCT02178540|3542915|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3701822|NCT02178540|3542915|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3701823|NCT02178540|3542915|B1|||Age||Years|Mean|14.9|14.9|Standard Deviation|7.53|7.53|||
3701824|NCT02178475|3542922|B1||No|History of Febrile Neutropenia||Participants|Count of Participants|839|839.0||||||
3701825|NCT02178475|3542922|B1||Yes|History of Febrile Neutropenia||Participants|Count of Participants|5|5.0||||||
3701826|NCT02178475|3542922|B1||Missing|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|49|49.0||||||
3701827|NCT02178475|3542922|B1||4 (Disabled, confined to bed/chair)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|1|1.0||||||
3701828|NCT02178475|3542922|B1||3 (Limited self-care)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|6|6.0||||||
3701829|NCT02178475|3542922|B1||2 (Ambulatory but unable to work)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|14|14.0||||||
3701830|NCT02178475|3542922|B1||1 (Restrictive but ambulatory)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|129|129.0||||||
3701831|NCT02178475|3542922|B1||0 (Fully active)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|645|645.0||||||
3701832|NCT02178475|3542922|B1|Open wound||Baseline Comorbidities|COPD = chronic obstructive pulmonary disease|participants|Number|3|3.0||||||
3701833|NCT02178475|3542922|B1|Current infection||Baseline Comorbidities|COPD = chronic obstructive pulmonary disease|participants|Number|8|8.0||||||
3701834|NCT02178475|3542922|B1|Renal disease/impaired clearance||Baseline Comorbidities|COPD = chronic obstructive pulmonary disease|participants|Number|16|16.0||||||
3701835|NCT02178475|3542922|B1|COPD/Pulmonary disease||Baseline Comorbidities|COPD = chronic obstructive pulmonary disease|participants|Number|41|41.0||||||
3701836|NCT02178475|3542922|B1|Diabetes mellitus||Baseline Comorbidities|COPD = chronic obstructive pulmonary disease|participants|Number|75|75.0||||||
3701837|NCT02178475|3542922|B1|Cardiovascular disease||Baseline Comorbidities|COPD = chronic obstructive pulmonary disease|participants|Number|211|211.0||||||
3701838|NCT02178475|3542922|B1|Liver disease||Baseline Comorbidities|COPD = chronic obstructive pulmonary disease|participants|Number|18|18.0||||||
3701839|NCT02178475|3542922|B1||Breast cancer|Tumor Type||Participants|Count of Participants|654|654.0||||||
3701840|NCT02178475|3542922|B1||Non-Hodgkin's lymphoma (NHL)|Tumor Type||Participants|Count of Participants|190|190.0||||||
3701841|NCT02178475|3542922|B1||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|166|166.0||||||
3701842|NCT02178475|3542922|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3701843|NCT02178475|3542922|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|673|673.0||||||
3701844|NCT02178475|3542922|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3701845|NCT02178475|3542922|B1||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3701846|NCT02178475|3542922|B1||Female|Sex: Female, Male||Participants|Count of Participants|723|723.0||||||
3701847|NCT02178475|3542922|B1||≥ 65 years|Age, Customized||Participants|Count of Participants|281|281.0||||||
3701848|NCT02178475|3542922|B1||< 65 years|Age, Customized||Participants|Count of Participants|563|563.0||||||
3701849|NCT02178475|3542922|B1|||Age||years|Mean|57.2|57.2|Standard Deviation|12.2|12.2|||
3701850|NCT02178059|3542942|B1||Male|Gender||Participants|Count of Participants|16|16.0||||||
3701851|NCT02178059|3542942|B1||Female|Gender||Participants|Count of Participants|18|18.0||||||
3701852|NCT02178059|3542942|B1|||Age||years|Mean|42|42.0|Standard Deviation|11|11.0|||
3701853|NCT02177266|3542959|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3701854|NCT02177266|3542960|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3701855|NCT02177266|3542961|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3701856|NCT02177266|3542959|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3701857|NCT02177266|3542960|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3701858|NCT02177266|3542961|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3701859|NCT02177266|3542959|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3701860|NCT02177266|3542960|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3701861|NCT02177266|3542961|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3701862|NCT02177266|3542959|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3701863|NCT02177266|3542960|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3701864|NCT02177266|3542961|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3701865|NCT02177266|3542959|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3701866|NCT02177266|3542960|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3701867|NCT02177266|3542961|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3701868|NCT02177266|3542959|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701869|NCT02177266|3542960|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701870|NCT02177266|3542961|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701871|NCT02177201|3542972|B3|||Supplemental fluid administration for vomiting||participants|Number|160|160.0||||||
3701872|NCT02177201|3542973|B2|||Supplemental fluid administration for vomiting||participants|Number|80|80.0||||||
3701873|NCT02177201|3542974|B1|||Supplemental fluid administration for vomiting||participants|Number|80|80.0||||||
3701874|NCT02177201|3542972|B3|Turkey||Region of Enrollment||participants|Number|160|160.0||||||
3701875|NCT02177201|3542973|B2|Turkey||Region of Enrollment||participants|Number|80|80.0||||||
3701876|NCT02177201|3542974|B1|Turkey||Region of Enrollment||participants|Number|80|80.0||||||
3701877|NCT02177201|3542972|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3701878|NCT02177201|3542973|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3701879|NCT02177201|3542974|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3701880|NCT02177201|3542972|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3701881|NCT02177201|3542973|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3701882|NCT02177201|3542974|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3701883|NCT02177201|3542972|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3701884|NCT02177201|3542973|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3701885|NCT02177201|3542974|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3701886|NCT02177201|3542972|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3701887|NCT02177201|3542973|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3701888|NCT02177201|3542974|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3701889|NCT02177201|3542972|B3||<=18 years|Age||Participants|Count of Participants|160|160.0||||||
3701890|NCT02177201|3542973|B2||<=18 years|Age||Participants|Count of Participants|80|80.0||||||
3701891|NCT02177201|3542974|B1||<=18 years|Age||Participants|Count of Participants|80|80.0||||||
3701892|NCT02177136|3542981|B4|||International Normalized Ratio (INR)|The INR is the ratio of a patient's prothrombin time to a normal (control) sample and corrected for the analytical system being used.|ratio|Mean|1.0|1.0|Standard Deviation|0.08|0.08|||
3701893|NCT02177136|3542982|B3|||International Normalized Ratio (INR)|The INR is the ratio of a patient's prothrombin time to a normal (control) sample and corrected for the analytical system being used.|ratio|Mean|1.0|1.0|Standard Deviation|0.07|0.07|||
3701894|NCT02177136|3542983|B2|||International Normalized Ratio (INR)|The INR is the ratio of a patient's prothrombin time to a normal (control) sample and corrected for the analytical system being used.|ratio|Mean|1.0|1.0|Standard Deviation|0.10|0.1|||
3701895|NCT02177136|3542984|B1|||International Normalized Ratio (INR)|The INR is the ratio of a patient's prothrombin time to a normal (control) sample and corrected for the analytical system being used.|ratio|Mean|1.0|1.0|Standard Deviation|0.06|0.06|||
3701896|NCT02177136|3542981|B4|||BMI||kg/m2|Mean|24.8|24.8|Standard Deviation|3.92|3.92|||
3701897|NCT02177136|3542982|B3|||BMI||kg/m2|Mean|24.5|24.5|Standard Deviation|3.71|3.71|||
3701898|NCT02177136|3542983|B2|||BMI||kg/m2|Mean|25.3|25.3|Standard Deviation|3.74|3.74|||
3701899|NCT02177136|3542984|B1|||BMI||kg/m2|Mean|24.6|24.6|Standard Deviation|4.38|4.38|||
3701900|NCT02177136|3542981|B4|||Height||cm|Mean|172.4|172.4|Standard Deviation|10.49|10.49|||
3701901|NCT02177136|3542982|B3|||Height||cm|Mean|172.6|172.6|Standard Deviation|10.70|10.7|||
3701902|NCT02177136|3542983|B2|||Height||cm|Mean|170.4|170.4|Standard Deviation|11.61|11.61|||
3701903|NCT02177136|3542984|B1|||Height||cm|Mean|174.4|174.4|Standard Deviation|8.95|8.95|||
3701904|NCT02177136|3542981|B4|||Weight||kg|Mean|73.7|73.7|Standard Deviation|12.59|12.59|||
3701905|NCT02177136|3542982|B3|||Weight||kg|Mean|73.0|73.0|Standard Deviation|12.95|12.95|||
3701906|NCT02177136|3542983|B2|||Weight||kg|Mean|73.6|73.6|Standard Deviation|12.76|12.76|||
3701907|NCT02177136|3542984|B1|||Weight||kg|Mean|74.5|74.5|Standard Deviation|12.51|12.51|||
3701908|NCT02177136|3542981|B4|||Total Bilirubin||umol/L|Mean|18.9|18.9|Standard Deviation|10.35|10.35|||
3701909|NCT02177136|3542982|B3|||Total Bilirubin||umol/L|Mean|20.9|20.9|Standard Deviation|11.48|11.48|||
3701910|NCT02177136|3542983|B2|||Total Bilirubin||umol/L|Mean|19.4|19.4|Standard Deviation|10.94|10.94|||
3701911|NCT02177136|3542984|B1|||Total Bilirubin||umol/L|Mean|16.3|16.3|Standard Deviation|8.17|8.17|||
3701912|NCT02177136|3542981|B4|||Alkaline phosphatase (ALP)||U/L|Mean|470.7|470.7|Standard Deviation|220.20|220.2|||
3701913|NCT02177136|3542982|B3|||Alkaline phosphatase (ALP)||U/L|Mean|562.8|562.8|Standard Deviation|300.22|300.22|||
3701914|NCT02177136|3542983|B2|||Alkaline phosphatase (ALP)||U/L|Mean|428.5|428.5|Standard Deviation|178.19|178.19|||
3701915|NCT02177136|3542984|B1|||Alkaline phosphatase (ALP)||U/L|Mean|422.5|422.5|Standard Deviation|123.07|123.07|||
3701916|NCT02177136|3542981|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701917|NCT02177136|3542982|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701918|NCT02177136|3542983|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701919|NCT02177136|3542984|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701920|NCT02177136|3542981|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701921|NCT02177136|3542982|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701922|NCT02177136|3542983|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701923|NCT02177136|3542984|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701924|NCT02177136|3542981|B4||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3701925|NCT02177136|3542982|B3||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3701926|NCT02177136|3542983|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3701927|NCT02177136|3542984|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3701928|NCT02177136|3542981|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3701929|NCT02177136|3542982|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3701930|NCT02177136|3542983|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3701931|NCT02177136|3542984|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3701932|NCT02177136|3542981|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701933|NCT02177136|3542982|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701934|NCT02177136|3542983|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701935|NCT02177136|3542984|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701936|NCT02177136|3542981|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3701937|NCT02177136|3542982|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701938|NCT02177136|3542983|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701939|NCT02177136|3542984|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3701940|NCT02177136|3542981|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701941|NCT02177136|3542982|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701942|NCT02177136|3542983|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701943|NCT02177136|3542984|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701944|NCT02177136|3542981|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701945|NCT02177136|3542982|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701946|NCT02177136|3542983|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701947|NCT02177136|3542984|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701948|NCT02177136|3542981|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3701949|NCT02177136|3542982|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3701950|NCT02177136|3542983|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3701951|NCT02177136|3542984|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3701952|NCT02177136|3542981|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3701953|NCT02177136|3542982|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3701954|NCT02177136|3542983|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3701955|NCT02177136|3542984|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3701956|NCT02177136|3542981|B4||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3701957|NCT02177136|3542982|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3701958|NCT02177136|3542983|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3701959|NCT02177136|3542984|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3701960|NCT02177136|3542981|B4||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3701961|NCT02177136|3542982|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3701962|NCT02177136|3542983|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3701963|NCT02177136|3542984|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3701964|NCT02177136|3542981|B4|||Age||years|Mean|43.4|43.4|Standard Deviation|13.22|13.22|||
3701965|NCT02177136|3542982|B3|||Age||years|Mean|43.7|43.7|Standard Deviation|13.05|13.05|||
3701966|NCT02177136|3542983|B2|||Age||years|Mean|44.9|44.9|Standard Deviation|14.28|14.28|||
3701967|NCT02177136|3542984|B1|||Age||years|Mean|41.6|41.6|Standard Deviation|12.56|12.56|||
3701968|NCT02177136|3542981|B4||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3701969|NCT02177136|3542982|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3701970|NCT02177136|3542983|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3701971|NCT02177136|3542984|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3701972|NCT02177136|3542981|B4||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
3701973|NCT02177136|3542982|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3701974|NCT02177136|3542983|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3701975|NCT02177136|3542984|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3701976|NCT02177136|3542981|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701977|NCT02177136|3542982|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701978|NCT02177136|3542983|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701979|NCT02177136|3542984|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3701980|NCT02177032|3543015|B5||MALE|Sex: Female, Male||Participants|Count of Participants|409|409.0||||||
3701981|NCT02177032|3543016|B4||MALE|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3701982|NCT02177032|3543017|B3||MALE|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
3701983|NCT02177032|3543018|B2||MALE|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3701984|NCT02177032|3543019|B1||MALE|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3701985|NCT02177032|3543015|B5||FEMALE|Sex: Female, Male||Participants|Count of Participants|476|476.0||||||
3701986|NCT02177032|3543016|B4||FEMALE|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3701987|NCT02177032|3543017|B3||FEMALE|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
3701988|NCT02177032|3543018|B2||FEMALE|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3701989|NCT02177032|3543019|B1||FEMALE|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3701990|NCT02177032|3543015|B5|||Age||year|Mean|22.9|22.9|Standard Deviation|15.3|15.3|||
3701991|NCT02177032|3543016|B4|||Age||year|Mean|34.4|34.4|Standard Deviation|11.2|11.2|||
3701992|NCT02177032|3543017|B3|||Age||year|Mean|20.6|20.6|Standard Deviation|15.1|15.1|||
3701993|NCT02177032|3543018|B2|||Age||year|Mean|32.7|32.7|Standard Deviation|10.8|10.8|||
3701994|NCT02177032|3543019|B1|||Age||year|Mean|20.0|20.0|Standard Deviation|15.0|15.0|||
3701995|NCT02176837|3543056|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3701996|NCT02176837|3543056|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701997|NCT02176837|3543056|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3701998|NCT02176837|3543056|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3701999|NCT02176837|3543056|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702000|NCT02176837|3543056|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702001|NCT02176837|3543056|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702002|NCT02176837|3543056|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702003|NCT02176837|3543056|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702004|NCT02176837|3543056|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3702005|NCT02176837|3543056|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3702006|NCT02176837|3543056|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3702007|NCT02176837|3543056|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3702008|NCT02176837|3543056|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3702009|NCT02176837|3543056|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3702010|NCT02176837|3543056|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3702011|NCT02176655|3543060|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
3702012|NCT02176655|3543060|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3702013|NCT02176655|3543060|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3702014|NCT02176655|3543060|B1|||Age||years|Mean|35.19|35.19|Standard Deviation|11.29|11.29|||
3702015|NCT02176642|3543081|B3|United States||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3702016|NCT02176642|3543082|B2|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3702017|NCT02176642|3543083|B1|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3702018|NCT02176642|3543081|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702019|NCT02176642|3543082|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702020|NCT02176642|3543083|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702021|NCT02176642|3543081|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702022|NCT02176642|3543082|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702023|NCT02176642|3543083|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702024|NCT02176642|3543081|B3||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3702025|NCT02176642|3543082|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3702026|NCT02176642|3543083|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3702027|NCT02176642|3543081|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3702028|NCT02176642|3543082|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3702029|NCT02176642|3543083|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3702030|NCT02176642|3543081|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702031|NCT02176642|3543082|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702032|NCT02176642|3543083|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702033|NCT02176642|3543081|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702034|NCT02176642|3543082|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702035|NCT02176642|3543083|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702036|NCT02176642|3543081|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702037|NCT02176642|3543082|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702038|NCT02176642|3543083|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702039|NCT02176642|3543081|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702040|NCT02176642|3543082|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702041|NCT02176642|3543083|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702042|NCT02176642|3543081|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3702043|NCT02176642|3543082|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3702044|NCT02176642|3543083|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3702045|NCT02176642|3543081|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702046|NCT02176642|3543082|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702047|NCT02176642|3543083|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702048|NCT02176642|3543081|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3702049|NCT02176642|3543082|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3702050|NCT02176642|3543083|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3702051|NCT02176642|3543081|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3702052|NCT02176642|3543082|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3702053|NCT02176642|3543083|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3702054|NCT02176642|3543081|B3|||Age||years|Mean|71.6|71.6|Standard Deviation|9.2|9.2|||
3702055|NCT02176642|3543082|B2|||Age||years|Mean|70.4|70.4|Standard Deviation|8.5|8.5|||
3702056|NCT02176642|3543083|B1|||Age||years|Mean|72.7|72.7|Standard Deviation|9.8|9.8|||
3702057|NCT02176525|3543106|B9||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3702058|NCT02176525|3543107|B8||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3702059|NCT02176525|3543108|B7||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3702060|NCT02176525|3543109|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3702061|NCT02176525|3543110|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3702062|NCT02176525|3543111|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3702063|NCT02176525|3543112|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3702064|NCT02176525|3543113|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3702065|NCT02176525|3543114|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3702066|NCT02176525|3543106|B9||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3702067|NCT02176525|3543107|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3702068|NCT02176525|3543108|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3702069|NCT02176525|3543109|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3702070|NCT02176525|3543110|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3702071|NCT02176525|3543111|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3702072|NCT02176525|3543112|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3702073|NCT02176525|3543113|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3702074|NCT02176525|3543114|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3702075|NCT02176525|3543106|B9|||Age||years|Mean|50.24|50.24|Standard Deviation|9.56|9.56|||
3702076|NCT02176525|3543107|B8|||Age||years|Mean|46.8|46.8|Standard Deviation|8.6|8.6|||
3702077|NCT02176525|3543108|B7|||Age||years|Mean|47.3|47.3|Standard Deviation|12.7|12.7|||
3702078|NCT02176525|3543109|B6|||Age||years|Mean|56.2|56.2|Standard Deviation|8.1|8.1|||
3702079|NCT02176525|3543110|B5|||Age||years|Mean|55.4|55.4|Standard Deviation|7.0|7.0|||
3702080|NCT02176525|3543111|B4|||Age||years|Mean|52.3|52.3|Standard Deviation|8.7|8.7|||
3702081|NCT02176525|3543112|B3|||Age||years|Mean|51.7|51.7|Standard Deviation|8.5|8.5|||
3702082|NCT02176525|3543113|B2|||Age||years|Mean|50.3|50.3|Standard Deviation|11.9|11.9|||
3702083|NCT02176525|3543114|B1|||Age||years|Mean|47.2|47.2|Standard Deviation|9.1|9.1|||
3702084|NCT02176421|3543298|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3702085|NCT02176421|3543298|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3702086|NCT02176421|3543298|B1|||Age||Years|Mean|46.1|46.1|Standard Deviation|1|1.0|||
3702087|NCT02176356|3543307|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3702088|NCT02176356|3543307|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3702089|NCT02176356|3543307|B1|||Age||years|Mean|52.5|52.5|Standard Deviation|7.40|7.4|||
3702090|NCT02176343|3543324|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3702091|NCT02176343|3543324|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3702092|NCT02176343|3543324|B1|||Age||years|Mean|69.2|69.2|Standard Deviation|9.5|9.5|||
3702093|NCT02176291|3543335|B3|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3702094|NCT02176291|3543336|B2|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3702095|NCT02176291|3543337|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3702096|NCT02176291|3543335|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702097|NCT02176291|3543336|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702098|NCT02176291|3543337|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702099|NCT02176291|3543335|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702100|NCT02176291|3543336|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702101|NCT02176291|3543337|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702102|NCT02176291|3543335|B3||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3702103|NCT02176291|3543336|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3702104|NCT02176291|3543337|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3702105|NCT02176291|3543335|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3702106|NCT02176291|3543336|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702107|NCT02176291|3543337|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3702108|NCT02176291|3543335|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702109|NCT02176291|3543336|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702110|NCT02176291|3543337|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702111|NCT02176291|3543335|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702112|NCT02176291|3543336|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702113|NCT02176291|3543337|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702114|NCT02176291|3543335|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702115|NCT02176291|3543336|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702116|NCT02176291|3543337|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702117|NCT02176291|3543335|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3702118|NCT02176291|3543336|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3702119|NCT02176291|3543337|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3702120|NCT02176291|3543335|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3702121|NCT02176291|3543336|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3702122|NCT02176291|3543337|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3702123|NCT02176291|3543335|B3|||Age||years|Mean|65.0|65.0|Standard Deviation|8.9|8.9|||
3702124|NCT02176291|3543336|B2|||Age||years|Mean|65.6|65.6|Standard Deviation|7.5|7.5|||
3702125|NCT02176291|3543337|B1|||Age||years|Mean|64.7|64.7|Standard Deviation|9.7|9.7|||
3702126|NCT02176226|3543346|B1||Other|Recruitment Source||Participants|Count of Participants|40|40.0||||||
3702127|NCT02176226|3543346|B1||ResearchMatch|Recruitment Source||Participants|Count of Participants|11|11.0||||||
3702128|NCT02176226|3543346|B1||Web or social media|Recruitment Source||Participants|Count of Participants|16|16.0||||||
3702129|NCT02176226|3543346|B1||HealthPartners Healthcare system|Recruitment Source||Participants|Count of Participants|38|38.0||||||
3702130|NCT02176226|3543346|B1||None|Treatment||Participants|Count of Participants|16|16.0||||||
3702131|NCT02176226|3543346|B1||Pharmacotherapy|Treatment||Participants|Count of Participants|66|66.0||||||
3702132|NCT02176226|3543346|B1||Psychotherapy|Treatment||Participants|Count of Participants|23|23.0||||||
3702133|NCT02176226|3543346|B1|||Income, yearly personal gross income||USD|Median|35,000|35.0|Inter-Quartile Range|||15.0|58.0|
3702134|NCT02176226|3543346|B1|||Income, yearly household income||USD|Median|63,000|63.0|Inter-Quartile Range|||30.0|100.0|
3702135|NCT02176226|3543346|B1|||Number of hours per week spent working||hours per week spent working|Median|40|40.0|Inter-Quartile Range|||7.0|40.0|
3702136|NCT02176226|3543346|B1||Other|Employment status||Participants|Count of Participants|5|5.0||||||
3702137|NCT02176226|3543346|B1||Retired|Employment status||Participants|Count of Participants|5|5.0||||||
3702138|NCT02176226|3543346|B1||Disability|Employment status||Participants|Count of Participants|8|8.0||||||
3702139|NCT02176226|3543346|B1||Unemployed|Employment status||Participants|Count of Participants|11|11.0||||||
3702140|NCT02176226|3543346|B1||Employed|Employment status||Participants|Count of Participants|76|76.0||||||
3702141|NCT02176226|3543346|B1||Professional degree (MD, JD)|Education||Participants|Count of Participants|1|1.0||||||
3702142|NCT02176226|3543346|B1||Doctoral degree|Education||Participants|Count of Participants|4|4.0||||||
3702143|NCT02176226|3543346|B1||Master's degree|Education||Participants|Count of Participants|22|22.0||||||
3702144|NCT02176226|3543346|B1||4-year college (BA, BS)|Education||Participants|Count of Participants|37|37.0||||||
3702145|NCT02176226|3543346|B1||2-year college (Associate)|Education||Participants|Count of Participants|16|16.0||||||
3702146|NCT02176226|3543346|B1||Some college|Education||Participants|Count of Participants|20|20.0||||||
3702147|NCT02176226|3543346|B1||Completed high school or GED|Education||Participants|Count of Participants|4|4.0||||||
3702148|NCT02176226|3543346|B1||Some high school|Education||Participants|Count of Participants|1|1.0||||||
3702149|NCT02176226|3543346|B1||Living with significant other|Marital Status||Participants|Count of Participants|15|15.0||||||
3702150|NCT02176226|3543346|B1||Widowed|Marital Status||Participants|Count of Participants|3|3.0||||||
3702151|NCT02176226|3543346|B1||Divorced|Marital Status||Participants|Count of Participants|13|13.0||||||
3702152|NCT02176226|3543346|B1||Separated|Marital Status||Participants|Count of Participants|1|1.0||||||
3702153|NCT02176226|3543346|B1||Married or domestic partner|Marital Status||Participants|Count of Participants|38|38.0||||||
3702154|NCT02176226|3543346|B1||Single|Marital Status||Participants|Count of Participants|35|35.0||||||
3702155|NCT02176226|3543346|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3702156|NCT02176226|3543346|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3702157|NCT02176226|3543346|B1||White|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3702158|NCT02176226|3543346|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3702159|NCT02176226|3543346|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702160|NCT02176226|3543346|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3702161|NCT02176226|3543346|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3702162|NCT02176226|3543346|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3702163|NCT02176226|3543346|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3702164|NCT02176226|3543346|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3702165|NCT02176226|3543346|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3702166|NCT02176226|3543346|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3702167|NCT02176226|3543346|B1|||Age||years|Median|36|36.0|Inter-Quartile Range|||27.0|50.0|
3702168|NCT02176018|3543352|B3|||Acute Medication Use|Number of doses of acute medication taken, reported during the 28 day run-in period.|Number of medications|Mean|15.0|15.0|Standard Deviation|8.68|8.68|||
3702169|NCT02176018|3543353|B2|||Acute Medication Use|Number of doses of acute medication taken, reported during the 28 day run-in period.|Number of medications|Mean|13.4|13.4|Standard Deviation|7.44|7.44|||
3702170|NCT02176018|3543354|B1|||Acute Medication Use|Number of doses of acute medication taken, reported during the 28 day run-in period.|Number of medications|Mean|16.4|16.4|Standard Deviation|9.58|9.58|||
3702171|NCT02176018|3543352|B3|||Headache Duration|Average headache duration reported during the 28 day run-in period, measured in hours.|Hours|Mean|5.86|5.86|Standard Deviation|2.07|2.07|||
3702172|NCT02176018|3543353|B2|||Headache Duration|Average headache duration reported during the 28 day run-in period, measured in hours.|Hours|Mean|5.54|5.54|Standard Deviation|2.03|2.03|||
3702173|NCT02176018|3543354|B1|||Headache Duration|Average headache duration reported during the 28 day run-in period, measured in hours.|Hours|Mean|6.14|6.14|Standard Deviation|2.12|2.12|||
3702174|NCT02176018|3543352|B3|||Headache Severity|Headache pain severity reported during the 28 day run-in period. Measured on a scale from 1 = Mild, to 3 = Severe. Higher numbers indicating more severe headache pain.|units on a scale|Mean|2.09|2.09|Standard Deviation|0.362|0.362|||
3702175|NCT02176018|3543353|B2|||Headache Severity|Headache pain severity reported during the 28 day run-in period. Measured on a scale from 1 = Mild, to 3 = Severe. Higher numbers indicating more severe headache pain.|units on a scale|Mean|2.17|2.17|Standard Deviation|0.326|0.326|||
3702176|NCT02176018|3543354|B1|||Headache Severity|Headache pain severity reported during the 28 day run-in period. Measured on a scale from 1 = Mild, to 3 = Severe. Higher numbers indicating more severe headache pain.|units on a scale|Mean|2.02|2.02|Standard Deviation|0.386|0.386|||
3702177|NCT02176018|3543352|B3|||Migraine Days|Number of migraine days reported during the 28 day run-in period.|Number of Migraine days|Mean|8.54|8.54|Standard Deviation|2.34|2.34|||
3702178|NCT02176018|3543353|B2|||Migraine Days|Number of migraine days reported during the 28 day run-in period.|Number of Migraine days|Mean|8|8.0|Standard Deviation|2.5|2.5|||
3702179|NCT02176018|3543354|B1|||Migraine Days|Number of migraine days reported during the 28 day run-in period.|Number of Migraine days|Mean|9|9.0|Standard Deviation|2.15|2.15|||
3702180|NCT02176018|3543352|B3|||Headache Days|Number of headache days reported during the 28 day run-in period.|Number of Headache Days|Mean|10.4|10.4|Standard Deviation|3.96|3.96|||
3702181|NCT02176018|3543353|B2|||Headache Days|Number of headache days reported during the 28 day run-in period.|Number of Headache Days|Mean|10.29|10.29|Standard Deviation|5.28|5.28|||
3702182|NCT02176018|3543354|B1|||Headache Days|Number of headache days reported during the 28 day run-in period.|Number of Headache Days|Mean|10.5|10.5|Standard Deviation|2.5|2.5|||
3702183|NCT02176018|3543352|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
3702184|NCT02176018|3543353|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
3702185|NCT02176018|3543354|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3702186|NCT02176018|3543352|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702187|NCT02176018|3543353|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702188|NCT02176018|3543354|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702189|NCT02176018|3543352|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702190|NCT02176018|3543353|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702191|NCT02176018|3543354|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702192|NCT02176018|3543352|B3||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3702193|NCT02176018|3543353|B2||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3702194|NCT02176018|3543354|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3702195|NCT02176018|3543352|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3702196|NCT02176018|3543353|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3702197|NCT02176018|3543354|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3702198|NCT02176018|3543352|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702199|NCT02176018|3543353|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702200|NCT02176018|3543354|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702201|NCT02176018|3543352|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702202|NCT02176018|3543353|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702203|NCT02176018|3543354|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702204|NCT02176018|3543352|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702205|NCT02176018|3543353|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702206|NCT02176018|3543354|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702207|NCT02176018|3543352|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702208|NCT02176018|3543353|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702209|NCT02176018|3543354|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702210|NCT02176018|3543352|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3702211|NCT02176018|3543353|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3702212|NCT02176018|3543354|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3702213|NCT02176018|3543352|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702214|NCT02176018|3543353|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702215|NCT02176018|3543354|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702216|NCT02176018|3543352|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3702217|NCT02176018|3543353|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3702218|NCT02176018|3543354|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3702219|NCT02176018|3543352|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3702220|NCT02176018|3543353|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3702221|NCT02176018|3543354|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3702222|NCT02176018|3543352|B3|||Age||years|Mean|44.69|44.69|Standard Deviation|10.58|10.58|||
3702223|NCT02176018|3543353|B2|||Age||years|Mean|44.17|44.17|Standard Deviation|11.62|11.62|||
3702224|NCT02176018|3543354|B1|||Age||years|Mean|45.23|45.23|Standard Deviation|9.62|9.62|||
3702225|NCT02175771|3543379|B9|No tobacco use||History of Smoking||Participants|Count of Participants|551|551.0||||||
3702226|NCT02175771|3543380|B8|No tobacco use||History of Smoking||Participants|Count of Participants|36|36.0||||||
3702227|NCT02175771|3543381|B7|No tobacco use||History of Smoking||Participants|Count of Participants|109|109.0||||||
3702228|NCT02175771|3543382|B6|No tobacco use||History of Smoking||Participants|Count of Participants|34|34.0||||||
3702229|NCT02175771|3543383|B5|No tobacco use||History of Smoking||Participants|Count of Participants|97|97.0||||||
3702230|NCT02175771|3543384|B4|No tobacco use||History of Smoking||Participants|Count of Participants|36|36.0||||||
3702231|NCT02175771|3543385|B3|No tobacco use||History of Smoking||Participants|Count of Participants|106|106.0||||||
3702232|NCT02175771|3543386|B2|No tobacco use||History of Smoking||Participants|Count of Participants|32|32.0||||||
3702233|NCT02175771|3543387|B1|No tobacco use||History of Smoking||Participants|Count of Participants|101|101.0||||||
3702234|NCT02175771|3543379|B9|Prior smoker||History of Smoking||Participants|Count of Participants|123|123.0||||||
3702235|NCT02175771|3543380|B8|Prior smoker||History of Smoking||Participants|Count of Participants|8|8.0||||||
3702236|NCT02175771|3543381|B7|Prior smoker||History of Smoking||Participants|Count of Participants|24|24.0||||||
3702237|NCT02175771|3543382|B6|Prior smoker||History of Smoking||Participants|Count of Participants|7|7.0||||||
3702238|NCT02175771|3543383|B5|Prior smoker||History of Smoking||Participants|Count of Participants|23|23.0||||||
3702239|NCT02175771|3543384|B4|Prior smoker||History of Smoking||Participants|Count of Participants|5|5.0||||||
3702240|NCT02175771|3543385|B3|Prior smoker||History of Smoking||Participants|Count of Participants|20|20.0||||||
3702241|NCT02175771|3543386|B2|Prior smoker||History of Smoking||Participants|Count of Participants|10|10.0||||||
3702242|NCT02175771|3543387|B1|Prior smoker||History of Smoking||Participants|Count of Participants|26|26.0||||||
3702243|NCT02175771|3543379|B9|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3702244|NCT02175771|3543380|B8|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702245|NCT02175771|3543381|B7|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702246|NCT02175771|3543382|B6|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702247|NCT02175771|3543383|B5|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702248|NCT02175771|3543384|B4|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702249|NCT02175771|3543385|B3|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3702250|NCT02175771|3543386|B2|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702251|NCT02175771|3543387|B1|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702252|NCT02175771|3543379|B9|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3702253|NCT02175771|3543380|B8|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702254|NCT02175771|3543381|B7|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3702255|NCT02175771|3543382|B6|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702256|NCT02175771|3543383|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702257|NCT02175771|3543384|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702258|NCT02175771|3543385|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702259|NCT02175771|3543386|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3702260|NCT02175771|3543387|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702261|NCT02175771|3543379|B9|Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3702262|NCT02175771|3543380|B8|Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3702263|NCT02175771|3543381|B7|Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702264|NCT02175771|3543382|B6|Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702265|NCT02175771|3543383|B5|Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702266|NCT02175771|3543384|B4|Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702267|NCT02175771|3543385|B3|Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3702268|NCT02175771|3543386|B2|Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702269|NCT02175771|3543387|B1|Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702270|NCT02175771|3543379|B9|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3702271|NCT02175771|3543380|B8|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702272|NCT02175771|3543381|B7|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3702273|NCT02175771|3543382|B6|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702274|NCT02175771|3543383|B5|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702275|NCT02175771|3543384|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702276|NCT02175771|3543385|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702277|NCT02175771|3543386|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3702278|NCT02175771|3543387|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702279|NCT02175771|3543379|B9|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3702280|NCT02175771|3543380|B8|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702281|NCT02175771|3543381|B7|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3702282|NCT02175771|3543382|B6|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702283|NCT02175771|3543383|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3702284|NCT02175771|3543384|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702285|NCT02175771|3543385|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3702286|NCT02175771|3543386|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3702287|NCT02175771|3543387|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3702288|NCT02175771|3543379|B9|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|127|127.0||||||
3702289|NCT02175771|3543380|B8|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3702290|NCT02175771|3543381|B7|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3702291|NCT02175771|3543382|B6|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3702292|NCT02175771|3543383|B5|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3702293|NCT02175771|3543384|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3702294|NCT02175771|3543385|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3702295|NCT02175771|3543386|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3702296|NCT02175771|3543387|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3702297|NCT02175771|3543379|B9|White||Race/Ethnicity, Customized||Participants|Count of Participants|528|528.0||||||
3702298|NCT02175771|3543380|B8|White||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3702299|NCT02175771|3543381|B7|White||Race/Ethnicity, Customized||Participants|Count of Participants|95|95.0||||||
3702300|NCT02175771|3543382|B6|White||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3702301|NCT02175771|3543383|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|99|99.0||||||
3702302|NCT02175771|3543384|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3702303|NCT02175771|3543385|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|99|99.0||||||
3702304|NCT02175771|3543386|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3702305|NCT02175771|3543387|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|110|110.0||||||
3702306|NCT02175771|3543379|B9|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3702307|NCT02175771|3543380|B8|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702308|NCT02175771|3543381|B7|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702309|NCT02175771|3543382|B6|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702310|NCT02175771|3543383|B5|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702311|NCT02175771|3543384|B4|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702312|NCT02175771|3543385|B3|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3702313|NCT02175771|3543386|B2|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702314|NCT02175771|3543387|B1|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702315|NCT02175771|3543379|B9|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3702316|NCT02175771|3543380|B8|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702317|NCT02175771|3543381|B7|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3702318|NCT02175771|3543382|B6|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702319|NCT02175771|3543383|B5|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702320|NCT02175771|3543384|B4|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702321|NCT02175771|3543385|B3|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702322|NCT02175771|3543386|B2|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702323|NCT02175771|3543387|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702324|NCT02175771|3543379|B9|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|95|95.0||||||
3702325|NCT02175771|3543380|B8|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3702326|NCT02175771|3543381|B7|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3702327|NCT02175771|3543382|B6|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3702328|NCT02175771|3543383|B5|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3702329|NCT02175771|3543384|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3702330|NCT02175771|3543385|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3702331|NCT02175771|3543386|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3702332|NCT02175771|3543387|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3702333|NCT02175771|3543379|B9|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|576|576.0||||||
3702334|NCT02175771|3543380|B8|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
3702335|NCT02175771|3543381|B7|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|112|112.0||||||
3702336|NCT02175771|3543382|B6|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3702337|NCT02175771|3543383|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|99|99.0||||||
3702338|NCT02175771|3543384|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3702339|NCT02175771|3543385|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|100|100.0||||||
3702340|NCT02175771|3543386|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
3702341|NCT02175771|3543387|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|118|118.0||||||
3702342|NCT02175771|3543379|B9|Missing||Sex/Gender, Customized||Participants|Count of Participants|2|2.0||||||
3702343|NCT02175771|3543380|B8|Missing||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3702344|NCT02175771|3543381|B7|Missing||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3702345|NCT02175771|3543382|B6|Missing||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3702346|NCT02175771|3543383|B5|Missing||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3702347|NCT02175771|3543384|B4|Missing||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3702348|NCT02175771|3543385|B3|Missing||Sex/Gender, Customized||Participants|Count of Participants|2|2.0||||||
3702349|NCT02175771|3543386|B2|Missing||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3702350|NCT02175771|3543387|B1|Missing||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3702351|NCT02175771|3543379|B9|Female||Sex/Gender, Customized||Participants|Count of Participants|406|406.0||||||
3702352|NCT02175771|3543380|B8|Female||Sex/Gender, Customized||Participants|Count of Participants|23|23.0||||||
3702353|NCT02175771|3543381|B7|Female||Sex/Gender, Customized||Participants|Count of Participants|72|72.0||||||
3702354|NCT02175771|3543382|B6|Female||Sex/Gender, Customized||Participants|Count of Participants|20|20.0||||||
3702355|NCT02175771|3543383|B5|Female||Sex/Gender, Customized||Participants|Count of Participants|84|84.0||||||
3702356|NCT02175771|3543384|B4|Female||Sex/Gender, Customized||Participants|Count of Participants|25|25.0||||||
3702357|NCT02175771|3543385|B3|Female||Sex/Gender, Customized||Participants|Count of Participants|78|78.0||||||
3702358|NCT02175771|3543386|B2|Female||Sex/Gender, Customized||Participants|Count of Participants|26|26.0||||||
3702359|NCT02175771|3543387|B1|Female||Sex/Gender, Customized||Participants|Count of Participants|78|78.0||||||
3702360|NCT02175771|3543379|B9|Male||Sex/Gender, Customized||Participants|Count of Participants|266|266.0||||||
3702361|NCT02175771|3543380|B8|Male||Sex/Gender, Customized||Participants|Count of Participants|21|21.0||||||
3702362|NCT02175771|3543381|B7|Male||Sex/Gender, Customized||Participants|Count of Participants|61|61.0||||||
3702363|NCT02175771|3543382|B6|Male||Sex/Gender, Customized||Participants|Count of Participants|21|21.0||||||
3702364|NCT02175771|3543383|B5|Male||Sex/Gender, Customized||Participants|Count of Participants|36|36.0||||||
3702365|NCT02175771|3543384|B4|Male||Sex/Gender, Customized||Participants|Count of Participants|16|16.0||||||
3702366|NCT02175771|3543385|B3|Male||Sex/Gender, Customized||Participants|Count of Participants|46|46.0||||||
3702367|NCT02175771|3543386|B2|Male||Sex/Gender, Customized||Participants|Count of Participants|16|16.0||||||
3702368|NCT02175771|3543387|B1|Male||Sex/Gender, Customized||Participants|Count of Participants|49|49.0||||||
3702369|NCT02175771|3543379|B9|Missing||Age, Customized||Participants|Count of Participants|2|2.0||||||
3702370|NCT02175771|3543380|B8|Missing||Age, Customized||Participants|Count of Participants|0|0.0||||||
3702371|NCT02175771|3543381|B7|Missing||Age, Customized||Participants|Count of Participants|0|0.0||||||
3702372|NCT02175771|3543382|B6|Missing||Age, Customized||Participants|Count of Participants|0|0.0||||||
3702373|NCT02175771|3543383|B5|Missing||Age, Customized||Participants|Count of Participants|0|0.0||||||
3702374|NCT02175771|3543384|B4|Missing||Age, Customized||Participants|Count of Participants|0|0.0||||||
3702375|NCT02175771|3543385|B3|Missing||Age, Customized||Participants|Count of Participants|2|2.0||||||
3702376|NCT02175771|3543386|B2|Missing||Age, Customized||Participants|Count of Participants|0|0.0||||||
3702377|NCT02175771|3543387|B1|Missing||Age, Customized||Participants|Count of Participants|0|0.0||||||
3702378|NCT02175771|3543379|B9|Adults (65+ years)||Age, Customized||Participants|Count of Participants|68|68.0||||||
3702379|NCT02175771|3543380|B8|Adults (65+ years)||Age, Customized||Participants|Count of Participants|2|2.0||||||
3702380|NCT02175771|3543381|B7|Adults (65+ years)||Age, Customized||Participants|Count of Participants|18|18.0||||||
3702381|NCT02175771|3543382|B6|Adults (65+ years)||Age, Customized||Participants|Count of Participants|5|5.0||||||
3702382|NCT02175771|3543383|B5|Adults (65+ years)||Age, Customized||Participants|Count of Participants|13|13.0||||||
3702383|NCT02175771|3543384|B4|Adults (65+ years)||Age, Customized||Participants|Count of Participants|3|3.0||||||
3702384|NCT02175771|3543385|B3|Adults (65+ years)||Age, Customized||Participants|Count of Participants|12|12.0||||||
3702385|NCT02175771|3543386|B2|Adults (65+ years)||Age, Customized||Participants|Count of Participants|3|3.0||||||
3702386|NCT02175771|3543387|B1|Adults (65+ years)||Age, Customized||Participants|Count of Participants|12|12.0||||||
3702387|NCT02175771|3543379|B9|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|531|531.0||||||
3702388|NCT02175771|3543380|B8|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|41|41.0||||||
3702389|NCT02175771|3543381|B7|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|106|106.0||||||
3702390|NCT02175771|3543382|B6|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|31|31.0||||||
3702391|NCT02175771|3543383|B5|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|94|94.0||||||
3702392|NCT02175771|3543384|B4|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|35|35.0||||||
3702393|NCT02175771|3543385|B3|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|96|96.0||||||
3702394|NCT02175771|3543386|B2|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|32|32.0||||||
3702395|NCT02175771|3543387|B1|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|96|96.0||||||
3702396|NCT02175771|3543379|B9|Adolescents (12-17 years)||Age, Customized||Participants|Count of Participants|73|73.0||||||
3702397|NCT02175771|3543380|B8|Adolescents (12-17 years)||Age, Customized||Participants|Count of Participants|1|1.0||||||
3702398|NCT02175771|3543381|B7|Adolescents (12-17 years)||Age, Customized||Participants|Count of Participants|9|9.0||||||
3702399|NCT02175771|3543382|B6|Adolescents (12-17 years)||Age, Customized||Participants|Count of Participants|5|5.0||||||
3702400|NCT02175771|3543383|B5|Adolescents (12-17 years)||Age, Customized||Participants|Count of Participants|13|13.0||||||
3702401|NCT02175771|3543384|B4|Adolescents (12-17 years)||Age, Customized||Participants|Count of Participants|3|3.0||||||
3702402|NCT02175771|3543385|B3|Adolescents (12-17 years)||Age, Customized||Participants|Count of Participants|16|16.0||||||
3702403|NCT02175771|3543386|B2|Adolescents (12-17 years)||Age, Customized||Participants|Count of Participants|7|7.0||||||
3702404|NCT02175771|3543387|B1|Adolescents (12-17 years)||Age, Customized||Participants|Count of Participants|19|19.0||||||
3702405|NCT02175745|3543453|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3702406|NCT02175745|3543453|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3702407|NCT02175745|3543453|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702408|NCT02175745|3543453|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702409|NCT02175745|3543453|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702410|NCT02175745|3543453|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702411|NCT02175745|3543453|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3702412|NCT02175745|3543453|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702413|NCT02175745|3543453|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702414|NCT02175745|3543453|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3702415|NCT02175745|3543453|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702416|NCT02175745|3543453|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3702417|NCT02175745|3543453|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3702418|NCT02175745|3543453|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3702419|NCT02175745|3543453|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3702420|NCT02175745|3543453|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3702421|NCT02175472|3543458|B3|United States||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
3702422|NCT02175472|3543459|B2|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3702423|NCT02175472|3543460|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3702424|NCT02175472|3543458|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3702425|NCT02175472|3543459|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3702426|NCT02175472|3543460|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3702427|NCT02175472|3543458|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702428|NCT02175472|3543459|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702429|NCT02175472|3543460|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702430|NCT02175472|3543458|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702431|NCT02175472|3543459|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702432|NCT02175472|3543460|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702433|NCT02175472|3543458|B3||White|Race (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3702434|NCT02175472|3543459|B2||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3702435|NCT02175472|3543460|B1||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3702436|NCT02175472|3543458|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702437|NCT02175472|3543459|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702438|NCT02175472|3543460|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702439|NCT02175472|3543458|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702440|NCT02175472|3543459|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702441|NCT02175472|3543460|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702442|NCT02175472|3543458|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702443|NCT02175472|3543459|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702444|NCT02175472|3543460|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702445|NCT02175472|3543458|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3702446|NCT02175472|3543459|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3702447|NCT02175472|3543460|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702448|NCT02175472|3543458|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3702449|NCT02175472|3543459|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3702450|NCT02175472|3543460|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3702451|NCT02175472|3543458|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3702452|NCT02175472|3543459|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3702453|NCT02175472|3543460|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3702454|NCT02175472|3543458|B3|||Age||years|Mean|68.0|68.0|Standard Deviation|8.01|8.01|||
3702455|NCT02175472|3543459|B2|||Age||years|Mean|65.9|65.9|Standard Deviation|7.55|7.55|||
3702456|NCT02175472|3543460|B1|||Age||years|Mean|70.3|70.3|Standard Deviation|7.94|7.94|||
3702457|NCT02175368|3543475|B1|Liechtenstein||Region of Enrollment||participants|Number|28|28.0||||||
3702458|NCT02175368|3543475|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3702459|NCT02175368|3543475|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3702460|NCT02175368|3543475|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3702461|NCT02175368|3543475|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3702462|NCT02175368|3543475|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3702463|NCT02175277|3543479|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3702464|NCT02175277|3543479|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702465|NCT02175277|3543479|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3702466|NCT02175277|3543479|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3702467|NCT02175277|3543479|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3702468|NCT02175277|3543479|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3702469|NCT02175277|3543479|B1||≥ 85 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3702470|NCT02175277|3543479|B1||75 - 84 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
3702471|NCT02175277|3543479|B1||65 - 74 years|Age, Customized||Participants|Count of Participants|6|6.0||||||
3702472|NCT02175277|3543479|B1||18 - 64 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
3702473|NCT02175277|3543479|B1|||Age||years|Mean|71.3|71.3|Standard Deviation|7.9|7.9|||
3702474|NCT02175212|3543483|B3|Missing||Pelvic radiotherapy (categorical)|173 evaluable patients in short term group and 171 in the long term group|participants|Number|3|3.0||||||
3702475|NCT02175212|3543484|B2|Missing||Pelvic radiotherapy (categorical)|173 evaluable patients in short term group and 171 in the long term group|participants|Number|0|0.0||||||
3702476|NCT02175212|3543485|B1|Missing||Pelvic radiotherapy (categorical)|173 evaluable patients in short term group and 171 in the long term group|participants|Number|3|3.0||||||
3702477|NCT02175212|3543483|B3|No||Pelvic radiotherapy (categorical)|173 evaluable patients in short term group and 171 in the long term group|participants|Number|293|293.0||||||
3702478|NCT02175212|3543484|B2|No||Pelvic radiotherapy (categorical)|173 evaluable patients in short term group and 171 in the long term group|participants|Number|145|145.0||||||
3702479|NCT02175212|3543485|B1|No||Pelvic radiotherapy (categorical)|173 evaluable patients in short term group and 171 in the long term group|participants|Number|148|148.0||||||
3702480|NCT02175212|3543483|B3|Yes||Pelvic radiotherapy (categorical)|173 evaluable patients in short term group and 171 in the long term group|participants|Number|48|48.0||||||
3702481|NCT02175212|3543484|B2|Yes||Pelvic radiotherapy (categorical)|173 evaluable patients in short term group and 171 in the long term group|participants|Number|28|28.0||||||
3702482|NCT02175212|3543485|B1|Yes||Pelvic radiotherapy (categorical)|173 evaluable patients in short term group and 171 in the long term group|participants|Number|20|20.0||||||
3702483|NCT02175212|3543483|B3|>= 78 Gy||Prostate radiotherapy dose (categorical)|173 evaluable patients in short term group and 171 in the long term group|participants|Number|250|250.0||||||
3702484|NCT02175212|3543484|B2|>= 78 Gy||Prostate radiotherapy dose (categorical)|173 evaluable patients in short term group and 171 in the long term group|participants|Number|122|122.0||||||
3702485|NCT02175212|3543485|B1|>= 78 Gy||Prostate radiotherapy dose (categorical)|173 evaluable patients in short term group and 171 in the long term group|participants|Number|128|128.0||||||
3702486|NCT02175212|3543483|B3|<78 Gy||Prostate radiotherapy dose (categorical)|173 evaluable patients in short term group and 171 in the long term group|participants|Number|94|94.0||||||
3702487|NCT02175212|3543484|B2|<78 Gy||Prostate radiotherapy dose (categorical)|173 evaluable patients in short term group and 171 in the long term group|participants|Number|51|51.0||||||
3702488|NCT02175212|3543485|B1|<78 Gy||Prostate radiotherapy dose (categorical)|173 evaluable patients in short term group and 171 in the long term group|participants|Number|43|43.0||||||
3702489|NCT02175212|3543483|B3|||Prostate radiotherapy dose (continous)||Grays (Gy)|Median|78.0|78.0|Full Range|||30.6|88.4|
3702490|NCT02175212|3543484|B2|||Prostate radiotherapy dose (continous)||Grays (Gy)|Median|78.0|78.0|Full Range|||64.0|82.2|
3702491|NCT02175212|3543485|B1|||Prostate radiotherapy dose (continous)||Grays (Gy)|Median|78.0|78.0|Full Range|||30.6|88.4|
3702492|NCT02175212|3543483|B3|||Positive biopsy samples (continous)||number of cylindres|Median|4|4.0|Full Range|||1.0|16.0|
3702493|NCT02175212|3543484|B2|||Positive biopsy samples (continous)||number of cylindres|Median|4|4.0|Full Range|||1.0|16.0|
3702494|NCT02175212|3543485|B1|||Positive biopsy samples (continous)||number of cylindres|Median|4|4.0|Full Range|||1.0|13.0|
3702495|NCT02175212|3543483|B3|8-10||Gleason score (categorical)|Gleason classification for prostate cancer were used considering Gleason 6 as less aggressive and Gleason 10 most aggressive|participants|Number|91|91.0||||||
3702496|NCT02175212|3543484|B2|8-10||Gleason score (categorical)|Gleason classification for prostate cancer were used considering Gleason 6 as less aggressive and Gleason 10 most aggressive|participants|Number|45|45.0||||||
3702497|NCT02175212|3543485|B1|8-10||Gleason score (categorical)|Gleason classification for prostate cancer were used considering Gleason 6 as less aggressive and Gleason 10 most aggressive|participants|Number|46|46.0||||||
3702498|NCT02175212|3543483|B3|7||Gleason score (categorical)|Gleason classification for prostate cancer were used considering Gleason 6 as less aggressive and Gleason 10 most aggressive|participants|Number|213|213.0||||||
3702499|NCT02175212|3543484|B2|7||Gleason score (categorical)|Gleason classification for prostate cancer were used considering Gleason 6 as less aggressive and Gleason 10 most aggressive|participants|Number|103|103.0||||||
3702500|NCT02175212|3543485|B1|7||Gleason score (categorical)|Gleason classification for prostate cancer were used considering Gleason 6 as less aggressive and Gleason 10 most aggressive|participants|Number|110|110.0||||||
3702501|NCT02175212|3543483|B3|<=6||Gleason score (categorical)|Gleason classification for prostate cancer were used considering Gleason 6 as less aggressive and Gleason 10 most aggressive|participants|Number|51|51.0||||||
3702502|NCT02175212|3543484|B2|<=6||Gleason score (categorical)|Gleason classification for prostate cancer were used considering Gleason 6 as less aggressive and Gleason 10 most aggressive|participants|Number|30|30.0||||||
3702503|NCT02175212|3543485|B1|<=6||Gleason score (categorical)|Gleason classification for prostate cancer were used considering Gleason 6 as less aggressive and Gleason 10 most aggressive|participants|Number|21|21.0||||||
3702504|NCT02175212|3543483|B3|>20 ng/mL||PSA (categorical)||participants|Number|76|76.0||||||
3702505|NCT02175212|3543484|B2|>20 ng/mL||PSA (categorical)||participants|Number|40|40.0||||||
3702506|NCT02175212|3543485|B1|>20 ng/mL||PSA (categorical)||participants|Number|36|36.0||||||
3702507|NCT02175212|3543483|B3|10-20 ng/mL||PSA (categorical)||participants|Number|125|125.0||||||
3702508|NCT02175212|3543484|B2|10-20 ng/mL||PSA (categorical)||participants|Number|64|64.0||||||
3702509|NCT02175212|3543485|B1|10-20 ng/mL||PSA (categorical)||participants|Number|61|61.0||||||
3702510|NCT02175212|3543483|B3|<10 ng/mL||PSA (categorical)||participants|Number|154|154.0||||||
3702511|NCT02175212|3543484|B2|<10 ng/mL||PSA (categorical)||participants|Number|74|74.0||||||
3702512|NCT02175212|3543485|B1|<10 ng/mL||PSA (categorical)||participants|Number|80|80.0||||||
3702513|NCT02175212|3543483|B3|||PSA (continous)||nanogrames per milliliter (ng/mL)|Median|11|11.0|Full Range|||3.1|72.0|
3702514|NCT02175212|3543484|B2|||PSA (continous)||nanogrames per milliliter (ng/mL)|Median|11.0|11.0|Full Range|||3.4|66.0|
3702515|NCT02175212|3543485|B1|||PSA (continous)||nanogrames per milliliter (ng/mL)|Median|11.1|11.1|Full Range|||3.1|72.0|
3702516|NCT02175212|3543483|B3|T3: Tumor extends through the prostate capsule||T stage (categorical)|Patients were staged according to the AJCC Cancer Staging criteria, 6th edition. Intermediate-risk and high-risk factors were defined following the 2005 guidelines of the National Comprehensive Cancer Network.|participants|Number|72|72.0||||||
3702517|NCT02175212|3543484|B2|T3: Tumor extends through the prostate capsule||T stage (categorical)|Patients were staged according to the AJCC Cancer Staging criteria, 6th edition. Intermediate-risk and high-risk factors were defined following the 2005 guidelines of the National Comprehensive Cancer Network.|participants|Number|33|33.0||||||
3702518|NCT02175212|3543485|B1|T3: Tumor extends through the prostate capsule||T stage (categorical)|Patients were staged according to the AJCC Cancer Staging criteria, 6th edition. Intermediate-risk and high-risk factors were defined following the 2005 guidelines of the National Comprehensive Cancer Network.|participants|Number|39|39.0||||||
3702519|NCT02175212|3543483|B3|T2: Tumor confinent whitin prostate||T stage (categorical)|Patients were staged according to the AJCC Cancer Staging criteria, 6th edition. Intermediate-risk and high-risk factors were defined following the 2005 guidelines of the National Comprehensive Cancer Network.|participants|Number|203|203.0||||||
3702520|NCT02175212|3543484|B2|T2: Tumor confinent whitin prostate||T stage (categorical)|Patients were staged according to the AJCC Cancer Staging criteria, 6th edition. Intermediate-risk and high-risk factors were defined following the 2005 guidelines of the National Comprehensive Cancer Network.|participants|Number|103|103.0||||||
3702521|NCT02175212|3543485|B1|T2: Tumor confinent whitin prostate||T stage (categorical)|Patients were staged according to the AJCC Cancer Staging criteria, 6th edition. Intermediate-risk and high-risk factors were defined following the 2005 guidelines of the National Comprehensive Cancer Network.|participants|Number|100|100.0||||||
3702522|NCT02175212|3543483|B3|T1: tumor neither palpable not visible by imaging||T stage (categorical)|Patients were staged according to the AJCC Cancer Staging criteria, 6th edition. Intermediate-risk and high-risk factors were defined following the 2005 guidelines of the National Comprehensive Cancer Network.|participants|Number|80|80.0||||||
3702523|NCT02175212|3543484|B2|T1: tumor neither palpable not visible by imaging||T stage (categorical)|Patients were staged according to the AJCC Cancer Staging criteria, 6th edition. Intermediate-risk and high-risk factors were defined following the 2005 guidelines of the National Comprehensive Cancer Network.|participants|Number|42|42.0||||||
3702524|NCT02175212|3543485|B1|T1: tumor neither palpable not visible by imaging||T stage (categorical)|Patients were staged according to the AJCC Cancer Staging criteria, 6th edition. Intermediate-risk and high-risk factors were defined following the 2005 guidelines of the National Comprehensive Cancer Network.|participants|Number|38|38.0||||||
3702525|NCT02175212|3543483|B3|High||Risk subgroup (intermediate vs. high)||participants|Number|189|189.0||||||
3702526|NCT02175212|3543484|B2|High||Risk subgroup (intermediate vs. high)||participants|Number|97|97.0||||||
3702527|NCT02175212|3543485|B1|High||Risk subgroup (intermediate vs. high)||participants|Number|92|92.0||||||
3702528|NCT02175212|3543483|B3|Intermediate||Risk subgroup (intermediate vs. high)||participants|Number|166|166.0||||||
3702529|NCT02175212|3543484|B2|Intermediate||Risk subgroup (intermediate vs. high)||participants|Number|81|81.0||||||
3702530|NCT02175212|3543485|B1|Intermediate||Risk subgroup (intermediate vs. high)||participants|Number|85|85.0||||||
3702531|NCT02175212|3543483|B3||Male|Sex: Female, Male||Participants|Count of Participants|355|355.0||||||
3702532|NCT02175212|3543484|B2||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
3702533|NCT02175212|3543485|B1||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
3702534|NCT02175212|3543483|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3702535|NCT02175212|3543484|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3702536|NCT02175212|3543485|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3702537|NCT02175212|3543483|B3|||Age||Years|Median|71|71.0|Full Range|||54.0|85.0|
3702538|NCT02175212|3543484|B2|||Age||Years|Median|72|72.0|Full Range|||54.0|85.0|
3702539|NCT02175212|3543485|B1|||Age||Years|Median|71|71.0|Full Range|||56.0|82.0|
3702540|NCT02175199|3543500|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3702541|NCT02175199|3543501|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3702542|NCT02175199|3543502|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3702543|NCT02175199|3543500|B3||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3702544|NCT02175199|3543501|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3702545|NCT02175199|3543502|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3702546|NCT02175199|3543500|B3|||Age||years|Mean|29.7|29.7|Standard Deviation|7.74|7.74|||
3702547|NCT02175199|3543501|B2|||Age||years|Mean|29.4|29.4|Standard Deviation|7.62|7.62|||
3702548|NCT02175199|3543502|B1|||Age||years|Mean|29.9|29.9|Standard Deviation|7.91|7.91|||
3702549|NCT02175121|3543512|B6||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3702550|NCT02175121|3543513|B5||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3702551|NCT02175121|3543514|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3702552|NCT02175121|3543515|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3702553|NCT02175121|3543516|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3702554|NCT02175121|3543517|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3702555|NCT02175121|3543512|B6||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3702556|NCT02175121|3543513|B5||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3702557|NCT02175121|3543514|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3702558|NCT02175121|3543515|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3702559|NCT02175121|3543516|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3702560|NCT02175121|3543517|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3702561|NCT02175121|3543512|B6|||Age||years|Mean|56.7|56.7|Standard Deviation|7.7|7.7|||
3702562|NCT02175121|3543513|B5|||Age||years|Mean|55.2|55.2|Standard Deviation|7.5|7.5|||
3702563|NCT02175121|3543514|B4|||Age||years|Mean|55.5|55.5|Standard Deviation|7.6|7.6|||
3702564|NCT02175121|3543515|B3|||Age||years|Mean|57.8|57.8|Standard Deviation|7.5|7.5|||
3702565|NCT02175121|3543516|B2|||Age||years|Mean|56.1|56.1|Standard Deviation|9|9.0|||
3702566|NCT02175121|3543517|B1|||Age||years|Mean|58.9|58.9|Standard Deviation|6.3|6.3|||
3702567|NCT02174861|3543648|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3702568|NCT02174861|3543648|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|574|574.0||||||
3702569|NCT02174861|3543648|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702570|NCT02174861|3543648|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3702571|NCT02174861|3543648|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3702572|NCT02174861|3543648|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3702573|NCT02174861|3543648|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702574|NCT02174861|3543648|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|584|584.0||||||
3702575|NCT02174861|3543648|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3702576|NCT02174861|3543648|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3702577|NCT02174861|3543648|B1||Female|Sex: Female, Male||Participants|Count of Participants|509|509.0||||||
3702578|NCT02174861|3543648|B1||65 - 74 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
3702579|NCT02174861|3543648|B1||18 - 64 years|Age, Customized||Participants|Count of Participants|608|608.0||||||
3702580|NCT02174861|3543648|B1|||Age||years|Mean|42.5|42.5|Standard Deviation|11.3|11.3|||
3702581|NCT02173769|3543660|B1||Male|Sex: Female, Male||Participants|Count of Participants|1088|1088.0||||||
3702582|NCT02173769|3543660|B1||Female|Sex: Female, Male||Participants|Count of Participants|770|770.0||||||
3702583|NCT02173769|3543660|B1|||Age||Years|Mean|67.41|67.41|Standard Deviation|10.19|10.19|||
3702584|NCT02173704|3543671|B3||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3702585|NCT02173704|3543672|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3702586|NCT02173704|3543673|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3702587|NCT02173704|3543671|B3||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3702588|NCT02173704|3543672|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3702589|NCT02173704|3543673|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3702590|NCT02173704|3543671|B3|||Age||Days|Mean|68.3|68.3|Standard Deviation|6.60|6.6|||
3702591|NCT02173704|3543672|B2|||Age||Days|Mean|68.9|68.9|Standard Deviation|6.86|6.86|||
3702592|NCT02173704|3543673|B1|||Age||Days|Mean|67.9|67.9|Standard Deviation|6.46|6.46|||
3702593|NCT02173548|3543698|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
3702594|NCT02173548|3543699|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3702595|NCT02173548|3543700|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3702596|NCT02173548|3543698|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702597|NCT02173548|3543699|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702598|NCT02173548|3543700|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702599|NCT02173548|3543698|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702600|NCT02173548|3543699|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702601|NCT02173548|3543700|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702602|NCT02173548|3543698|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3702603|NCT02173548|3543699|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3702604|NCT02173548|3543700|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3702605|NCT02173548|3543698|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3702606|NCT02173548|3543699|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3702607|NCT02173548|3543700|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3702608|NCT02173548|3543698|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702609|NCT02173548|3543699|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702610|NCT02173548|3543700|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702611|NCT02173548|3543698|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702612|NCT02173548|3543699|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702613|NCT02173548|3543700|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702614|NCT02173548|3543698|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702615|NCT02173548|3543699|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702616|NCT02173548|3543700|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702617|NCT02173548|3543698|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3702618|NCT02173548|3543699|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3702619|NCT02173548|3543700|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3702620|NCT02173548|3543698|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3702621|NCT02173548|3543699|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3702622|NCT02173548|3543700|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3702623|NCT02173548|3543698|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3702624|NCT02173548|3543699|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3702625|NCT02173548|3543700|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3702626|NCT02173548|3543698|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3702627|NCT02173548|3543699|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3702628|NCT02173548|3543700|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3702629|NCT02173548|3543698|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3702630|NCT02173548|3543699|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3702631|NCT02173548|3543700|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3702632|NCT02173535|3543721|B21|China||Region of Enrollment||Participants|Number|240|240.0||||||
3702633|NCT02173535|3543722|B20|China||Region of Enrollment||Participants|Number|12|12.0||||||
3702634|NCT02173535|3543723|B19|China||Region of Enrollment||Participants|Number|12|12.0||||||
3702635|NCT02173535|3543724|B18|China||Region of Enrollment||Participants|Number|12|12.0||||||
3702636|NCT02173535|3543725|B17|China||Region of Enrollment||Participants|Number|12|12.0||||||
3702637|NCT02173535|3543726|B16|China||Region of Enrollment||Participants|Number|12|12.0||||||
3702638|NCT02173535|3543727|B15|China||Region of Enrollment||Participants|Number|12|12.0||||||
3702639|NCT02173535|3543728|B14|China||Region of Enrollment||Participants|Number|12|12.0||||||
3702640|NCT02173535|3543729|B13|China||Region of Enrollment||Participants|Number|12|12.0||||||
3702641|NCT02173535|3543730|B12|China||Region of Enrollment||Participants|Number|12|12.0||||||
3702642|NCT02173535|3543731|B11|China||Region of Enrollment||Participants|Number|12|12.0||||||
3702643|NCT02173535|3543732|B10|China||Region of Enrollment||Participants|Number|12|12.0||||||
3702644|NCT02173535|3543733|B9|China||Region of Enrollment||Participants|Number|12|12.0||||||
3702645|NCT02173535|3543734|B8|China||Region of Enrollment||Participants|Number|12|12.0||||||
3702646|NCT02173535|3543735|B7|China||Region of Enrollment||Participants|Number|12|12.0||||||
3702647|NCT02173535|3543736|B6|China||Region of Enrollment||Participants|Number|12|12.0||||||
3702648|NCT02173535|3543737|B5|China||Region of Enrollment||Participants|Number|12|12.0||||||
3702649|NCT02173535|3543738|B4|China||Region of Enrollment||Participants|Number|12|12.0||||||
3702650|NCT02173535|3543739|B3|China||Region of Enrollment||Participants|Number|12|12.0||||||
3702651|NCT02173535|3543740|B2|China||Region of Enrollment||Participants|Number|12|12.0||||||
3702652|NCT02173535|3543741|B1|China||Region of Enrollment||Participants|Number|12|12.0||||||
3702653|NCT02173535|3543721|B21|Chinese||Race/Ethnicity, Customized||Participants|Number|240|240.0||||||
3702654|NCT02173535|3543722|B20|Chinese||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3702655|NCT02173535|3543723|B19|Chinese||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3702656|NCT02173535|3543724|B18|Chinese||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3702657|NCT02173535|3543725|B17|Chinese||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3702658|NCT02173535|3543726|B16|Chinese||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3702659|NCT02173535|3543727|B15|Chinese||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3702660|NCT02173535|3543728|B14|Chinese||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3702661|NCT02173535|3543729|B13|Chinese||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3702662|NCT02173535|3543730|B12|Chinese||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3702663|NCT02173535|3543731|B11|Chinese||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3702664|NCT02173535|3543732|B10|Chinese||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3702665|NCT02173535|3543733|B9|Chinese||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3702666|NCT02173535|3543734|B8|Chinese||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3702667|NCT02173535|3543735|B7|Chinese||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3702668|NCT02173535|3543736|B6|Chinese||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3702669|NCT02173535|3543737|B5|Chinese||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3702670|NCT02173535|3543738|B4|Chinese||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3702671|NCT02173535|3543739|B3|Chinese||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3702672|NCT02173535|3543740|B2|Chinese||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3702673|NCT02173535|3543741|B1|Chinese||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3702674|NCT02173535|3543721|B21||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3702675|NCT02173535|3543722|B20||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3702676|NCT02173535|3543723|B19||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3702677|NCT02173535|3543724|B18||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3702678|NCT02173535|3543725|B17||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3702679|NCT02173535|3543726|B16||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3702680|NCT02173535|3543727|B15||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3702681|NCT02173535|3543728|B14||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3702682|NCT02173535|3543729|B13||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3702683|NCT02173535|3543730|B12||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3702684|NCT02173535|3543731|B11||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3702685|NCT02173535|3543732|B10||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3702686|NCT02173535|3543733|B9||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3702687|NCT02173535|3543734|B8||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3702688|NCT02173535|3543735|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3702689|NCT02173535|3543736|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3702690|NCT02173535|3543737|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3702691|NCT02173535|3543738|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3702692|NCT02173535|3543739|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3702693|NCT02173535|3543740|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3702694|NCT02173535|3543741|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3702695|NCT02173535|3543721|B21||Female|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
3702696|NCT02173535|3543722|B20||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3702697|NCT02173535|3543723|B19||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3702698|NCT02173535|3543724|B18||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3702699|NCT02173535|3543725|B17||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3702700|NCT02173535|3543726|B16||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3702701|NCT02173535|3543727|B15||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3702702|NCT02173535|3543728|B14||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3702703|NCT02173535|3543729|B13||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3702704|NCT02173535|3543730|B12||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3702705|NCT02173535|3543731|B11||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3702706|NCT02173535|3543732|B10||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3702707|NCT02173535|3543733|B9||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3702708|NCT02173535|3543734|B8||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3702709|NCT02173535|3543735|B7||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3702710|NCT02173535|3543736|B6||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3702711|NCT02173535|3543737|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3702712|NCT02173535|3543738|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3702713|NCT02173535|3543739|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3702714|NCT02173535|3543740|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3702715|NCT02173535|3543741|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3702716|NCT02173535|3543721|B21|||Age||Years|Mean|28.0|28.0|Standard Deviation|5.46|5.46|||
3702717|NCT02173535|3543722|B20|||Age||Years|Mean|30.1|30.1|Standard Deviation|5.11|5.11|||
3702718|NCT02173535|3543723|B19|||Age||Years|Mean|27.6|27.6|Standard Deviation|2.97|2.97|||
3702719|NCT02173535|3543724|B18|||Age||Years|Mean|29.9|29.9|Standard Deviation|6.53|6.53|||
3702720|NCT02173535|3543725|B17|||Age||Years|Mean|27.8|27.8|Standard Deviation|6.29|6.29|||
3702721|NCT02173535|3543726|B16|||Age||Years|Mean|26.3|26.3|Standard Deviation|5.80|5.8|||
3702722|NCT02173535|3543727|B15|||Age||Years|Mean|27.85|27.85|Standard Deviation|5.50|5.5|||
3702723|NCT02173535|3543728|B14|||Age||Years|Mean|26.8|26.8|Standard Deviation|4.37|4.37|||
3702724|NCT02173535|3543729|B13|||Age||Years|Mean|29.1|29.1|Standard Deviation|5.37|5.37|||
3702725|NCT02173535|3543730|B12|||Age||Years|Mean|27.3|27.3|Standard Deviation|5.88|5.88|||
3702726|NCT02173535|3543731|B11|||Age||Years|Mean|27.5|27.5|Standard Deviation|5.04|5.04|||
3702727|NCT02173535|3543732|B10|||Age||Years|Mean|26.6|26.6|Standard Deviation|4.27|4.27|||
3702728|NCT02173535|3543733|B9|||Age||Years|Mean|28.9|28.9|Standard Deviation|5.62|5.62|||
3702729|NCT02173535|3543734|B8|||Age||Years|Mean|26.8|26.8|Standard Deviation|6.58|6.58|||
3702730|NCT02173535|3543735|B7|||Age||Years|Mean|28.2|28.2|Standard Deviation|6.99|6.99|||
3702731|NCT02173535|3543736|B6|||Age||Years|Mean|27.5|27.5|Standard Deviation|4.93|4.93|||
3702732|NCT02173535|3543737|B5|||Age||Years|Mean|30.3|30.3|Standard Deviation|6.06|6.06|||
3702733|NCT02173535|3543738|B4|||Age||Years|Mean|28.0|28.0|Standard Deviation|5.80|5.8|||
3702734|NCT02173535|3543739|B3|||Age||Years|Mean|27.9|27.9|Standard Deviation|4.96|4.96|||
3702735|NCT02173535|3543740|B2|||Age||Years|Mean|26.9|26.9|Standard Deviation|5.78|5.78|||
3702736|NCT02173535|3543741|B1|||Age||Years|Mean|29.1|29.1|Standard Deviation|5.84|5.84|||
3702737|NCT02173392|3543797|B3||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3702738|NCT02173392|3543798|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3702739|NCT02173392|3543799|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3702740|NCT02173392|3543797|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3702741|NCT02173392|3543798|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3702742|NCT02173392|3543799|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3702743|NCT02173392|3543797|B3|||Age||years|Mean|40.8|40.8|Standard Deviation|10.7|10.7|||
3702744|NCT02173392|3543798|B2|||Age||years|Mean|41.1|41.1|Standard Deviation|10.8|10.8|||
3702745|NCT02173392|3543799|B1|||Age||years|Mean|40.6|40.6|Standard Deviation|10.7|10.7|||
3702746|NCT02173379|3543810|B3|Singapore||Region of Enrollment||participants|Number|5|5.0||||||
3702747|NCT02173379|3543811|B2|Singapore||Region of Enrollment||participants|Number|2|2.0||||||
3702748|NCT02173379|3543812|B1|Singapore||Region of Enrollment||participants|Number|3|3.0||||||
3702749|NCT02173379|3543810|B3|Germany||Region of Enrollment||participants|Number|335|335.0||||||
3702750|NCT02173379|3543811|B2|Germany||Region of Enrollment||participants|Number|171|171.0||||||
3702751|NCT02173379|3543812|B1|Germany||Region of Enrollment||participants|Number|164|164.0||||||
3702752|NCT02173379|3543810|B3|Australia||Region of Enrollment||participants|Number|148|148.0||||||
3702753|NCT02173379|3543811|B2|Australia||Region of Enrollment||participants|Number|68|68.0||||||
3702754|NCT02173379|3543812|B1|Australia||Region of Enrollment||participants|Number|80|80.0||||||
3702755|NCT02173379|3543810|B3|United States||Region of Enrollment||participants|Number|2062|2062.0||||||
3702756|NCT02173379|3543811|B2|United States||Region of Enrollment||participants|Number|1041|1041.0||||||
3702757|NCT02173379|3543812|B1|United States||Region of Enrollment||participants|Number|1021|1021.0||||||
3702758|NCT02173379|3543810|B3|Canada||Region of Enrollment||participants|Number|54|54.0||||||
3702759|NCT02173379|3543811|B2|Canada||Region of Enrollment||participants|Number|26|26.0||||||
3702760|NCT02173379|3543812|B1|Canada||Region of Enrollment||participants|Number|28|28.0||||||
3702761|NCT02173379|3543810|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3702762|NCT02173379|3543811|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3702763|NCT02173379|3543812|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3702764|NCT02173379|3543810|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702765|NCT02173379|3543811|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702766|NCT02173379|3543812|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702767|NCT02173379|3543810|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2295|2295.0||||||
3702768|NCT02173379|3543811|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1160|1160.0||||||
3702769|NCT02173379|3543812|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1135|1135.0||||||
3702770|NCT02173379|3543810|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
3702771|NCT02173379|3543811|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3702772|NCT02173379|3543812|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3702773|NCT02173379|3543810|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3702774|NCT02173379|3543811|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3702775|NCT02173379|3543812|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3702776|NCT02173379|3543810|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3702777|NCT02173379|3543811|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3702778|NCT02173379|3543812|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3702779|NCT02173379|3543810|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3702780|NCT02173379|3543811|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3702781|NCT02173379|3543812|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3702782|NCT02173379|3543810|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2535|2535.0||||||
3702783|NCT02173379|3543811|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1279|1279.0||||||
3702784|NCT02173379|3543812|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1256|1256.0||||||
3702785|NCT02173379|3543810|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702786|NCT02173379|3543811|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702787|NCT02173379|3543812|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702788|NCT02173379|3543810|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3702789|NCT02173379|3543811|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3702790|NCT02173379|3543812|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3702791|NCT02173379|3543810|B3||Male|Sex: Female, Male||Participants|Count of Participants|1874|1874.0||||||
3702792|NCT02173379|3543811|B2||Male|Sex: Female, Male||Participants|Count of Participants|947|947.0||||||
3702793|NCT02173379|3543812|B1||Male|Sex: Female, Male||Participants|Count of Participants|927|927.0||||||
3702794|NCT02173379|3543810|B3||Female|Sex: Female, Male||Participants|Count of Participants|730|730.0||||||
3702795|NCT02173379|3543811|B2||Female|Sex: Female, Male||Participants|Count of Participants|361|361.0||||||
3702796|NCT02173379|3543812|B1||Female|Sex: Female, Male||Participants|Count of Participants|369|369.0||||||
3702797|NCT02173379|3543810|B3|||Age||years|Mean|62.65|62.65|Standard Deviation|10.2|10.2|||
3702798|NCT02173379|3543811|B2|||Age||years|Mean|62.2|62.2|Standard Deviation|10.3|10.3|||
3702799|NCT02173379|3543812|B1|||Age||years|Mean|63.1|63.1|Standard Deviation|10.1|10.1|||
3702800|NCT02173158|3543879|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702801|NCT02173158|3543879|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702802|NCT02173158|3543879|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702803|NCT02173158|3543879|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702804|NCT02173158|3543879|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702805|NCT02173158|3543879|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3702806|NCT02173158|3543879|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702807|NCT02173158|3543879|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3702808|NCT02173158|3543879|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3702809|NCT02173158|3543879|B1|||Age||years|Mean|50.3|50.3|Standard Deviation|14.71|14.71|||
3702810|NCT02173054|3543893|B4|Thailand||Region of Enrollment||participants|Number|120|120.0||||||
3702811|NCT02173054|3543894|B3|Thailand||Region of Enrollment||participants|Number|40|40.0||||||
3702812|NCT02173054|3543895|B2|Thailand||Region of Enrollment||participants|Number|40|40.0||||||
3702813|NCT02173054|3543896|B1|Thailand||Region of Enrollment||participants|Number|40|40.0||||||
3702814|NCT02173054|3543893|B4||Male|Gender||Participants|Count of Participants|53|53.0||||||
3702815|NCT02173054|3543894|B3||Male|Gender||Participants|Count of Participants|14|14.0||||||
3702816|NCT02173054|3543895|B2||Male|Gender||Participants|Count of Participants|21|21.0||||||
3702817|NCT02173054|3543896|B1||Male|Gender||Participants|Count of Participants|18|18.0||||||
3702818|NCT02173054|3543893|B4||Female|Gender||Participants|Count of Participants|67|67.0||||||
3702819|NCT02173054|3543894|B3||Female|Gender||Participants|Count of Participants|26|26.0||||||
3702820|NCT02173054|3543895|B2||Female|Gender||Participants|Count of Participants|19|19.0||||||
3702821|NCT02173054|3543896|B1||Female|Gender||Participants|Count of Participants|22|22.0||||||
3702822|NCT02173054|3543893|B4|||Age||years|Mean|27.5|27.5|Full Range|||18.0|49.0|
3702823|NCT02173054|3543894|B3|||Age||years|Mean|28.1|28.1|Full Range|||18.0|49.0|
3702824|NCT02173054|3543895|B2|||Age||years|Mean|27.2|27.2|Full Range|||20.0|40.0|
3702825|NCT02173054|3543896|B1|||Age||years|Mean|27.3|27.3|Full Range|||19.0|43.0|
3702826|NCT02172755|3543918|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3702827|NCT02172755|3543919|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3702828|NCT02172755|3543920|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3702829|NCT02172755|3543918|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3702830|NCT02172755|3543919|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3702831|NCT02172755|3543920|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3702832|NCT02172755|3543918|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3702833|NCT02172755|3543919|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3702834|NCT02172755|3543920|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3702835|NCT02172755|3543918|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3702836|NCT02172755|3543919|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3702837|NCT02172755|3543920|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3702838|NCT02172755|3543918|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3702839|NCT02172755|3543919|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3702840|NCT02172755|3543920|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3702841|NCT02172742|3543931|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3702842|NCT02172742|3543932|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3702843|NCT02172742|3543933|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3702844|NCT02172742|3543931|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3702845|NCT02172742|3543932|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3702846|NCT02172742|3543933|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3702847|NCT02172742|3543931|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3702848|NCT02172742|3543932|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3702849|NCT02172742|3543933|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3702850|NCT02172742|3543931|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3702851|NCT02172742|3543932|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3702852|NCT02172742|3543933|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3702853|NCT02172742|3543931|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3702854|NCT02172742|3543932|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3702855|NCT02172742|3543933|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3702856|NCT02172625|3543941|B3|||Fasting Blood Glucose||mg/dL|Mean|90|90.0|Standard Deviation|7|7.0|||
3702857|NCT02172625|3543942|B2|||Fasting Blood Glucose||mg/dL|Mean|90|90.0|Standard Deviation|5|5.0|||
3702858|NCT02172625|3543943|B1|||Fasting Blood Glucose||mg/dL|Mean|89|89.0|Standard Deviation|9|9.0|||
3702859|NCT02172625|3543941|B3|||Weight||kg|Mean|66.4|66.4|Standard Deviation|11.2|11.2|||
3702860|NCT02172625|3543942|B2|||Weight||kg|Mean|68.1|68.1|Standard Deviation|11.4|11.4|||
3702861|NCT02172625|3543943|B1|||Weight||kg|Mean|64.6|64.6|Standard Deviation|11.1|11.1|||
3702862|NCT02172625|3543941|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
3702863|NCT02172625|3543942|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3702864|NCT02172625|3543943|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3702865|NCT02172625|3543941|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
3702866|NCT02172625|3543942|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3702867|NCT02172625|3543943|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3702868|NCT02172625|3543941|B3||Male|Gender||Participants|Count of Participants|20|20.0||||||
3702869|NCT02172625|3543942|B2||Male|Gender||Participants|Count of Participants|11|11.0||||||
3702870|NCT02172625|3543943|B1||Male|Gender||Participants|Count of Participants|9|9.0||||||
3702871|NCT02172625|3543941|B3||Female|Gender||Participants|Count of Participants|18|18.0||||||
3702872|NCT02172625|3543942|B2||Female|Gender||Participants|Count of Participants|8|8.0||||||
3702873|NCT02172625|3543943|B1||Female|Gender||Participants|Count of Participants|10|10.0||||||
3702874|NCT02172625|3543941|B3|||Age||years|Mean|34|34.0|Standard Deviation|7|7.0|||
3702875|NCT02172625|3543942|B2|||Age||years|Mean|34|34.0|Standard Deviation|6|6.0|||
3702876|NCT02172625|3543943|B1|||Age||years|Mean|35|35.0|Standard Deviation|8|8.0|||
3702877|NCT02172040|3543962|B5|||Average Daytime (9:00 to 21:00) Ambulatory Systolic Blood Pressure (SBPday)||mmHg|Mean|148.5|148.5|Standard Deviation|8.4|8.4|||
3702878|NCT02172040|3543963|B4|||Average Daytime (9:00 to 21:00) Ambulatory Systolic Blood Pressure (SBPday)||mmHg|Mean|147.3|147.3|Standard Deviation|8.6|8.6|||
3702879|NCT02172040|3543964|B3|||Average Daytime (9:00 to 21:00) Ambulatory Systolic Blood Pressure (SBPday)||mmHg|Mean|150.8|150.8|Standard Deviation|8.9|8.9|||
3702880|NCT02172040|3543965|B2|||Average Daytime (9:00 to 21:00) Ambulatory Systolic Blood Pressure (SBPday)||mmHg|Mean|147.6|147.6|Standard Deviation|8.7|8.7|||
3702881|NCT02172040|3543966|B1|||Average Daytime (9:00 to 21:00) Ambulatory Systolic Blood Pressure (SBPday)||mmHg|Mean|148.7|148.7|Standard Deviation|7.4|7.4|||
3702882|NCT02172040|3543962|B5|United Kingdom||Region of Enrollment||Participants|Count of Participants|152|152.0||||||
3702883|NCT02172040|3543963|B4|United Kingdom||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3702884|NCT02172040|3543964|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3702885|NCT02172040|3543965|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3702886|NCT02172040|3543966|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|49|49.0||||||
3702887|NCT02172040|3543962|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702888|NCT02172040|3543963|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702889|NCT02172040|3543964|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702890|NCT02172040|3543965|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702891|NCT02172040|3543966|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702892|NCT02172040|3543962|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702893|NCT02172040|3543963|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702894|NCT02172040|3543964|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702895|NCT02172040|3543965|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702896|NCT02172040|3543966|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702897|NCT02172040|3543962|B5||White|Race (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
3702898|NCT02172040|3543963|B4||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3702899|NCT02172040|3543964|B3||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3702900|NCT02172040|3543965|B2||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3702901|NCT02172040|3543966|B1||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3702902|NCT02172040|3543962|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3702903|NCT02172040|3543963|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702904|NCT02172040|3543964|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3702905|NCT02172040|3543965|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3702906|NCT02172040|3543966|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702907|NCT02172040|3543962|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702908|NCT02172040|3543963|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702909|NCT02172040|3543964|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702910|NCT02172040|3543965|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702911|NCT02172040|3543966|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702912|NCT02172040|3543962|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3702913|NCT02172040|3543963|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3702914|NCT02172040|3543964|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3702915|NCT02172040|3543965|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702916|NCT02172040|3543966|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3702917|NCT02172040|3543962|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702918|NCT02172040|3543963|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702919|NCT02172040|3543964|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702920|NCT02172040|3543965|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702921|NCT02172040|3543966|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702922|NCT02172040|3543962|B5||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3702923|NCT02172040|3543963|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3702924|NCT02172040|3543964|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3702925|NCT02172040|3543965|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3702926|NCT02172040|3543966|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3702927|NCT02172040|3543962|B5||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3702928|NCT02172040|3543963|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3702929|NCT02172040|3543964|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3702930|NCT02172040|3543965|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3702931|NCT02172040|3543966|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3702932|NCT02172040|3543962|B5|||Age||years|Mean|56.1|56.1|Standard Deviation|8.8|8.8|||
3702933|NCT02172040|3543963|B4|||Age||years|Mean|52.5|52.5|Standard Deviation|9.1|9.1|||
3702934|NCT02172040|3543964|B3|||Age||years|Mean|54.9|54.9|Standard Deviation|8.2|8.2|||
3702935|NCT02172040|3543965|B2|||Age||years|Mean|57.3|57.3|Standard Deviation|9.4|9.4|||
3702936|NCT02172040|3543966|B1|||Age||years|Mean|57.7|57.7|Standard Deviation|8.0|8.0|||
3702937|NCT02171611|3544015|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3702938|NCT02171611|3544015|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3702939|NCT02171611|3544015|B1|||Age||Years|Mean|39.8|39.8|Standard Deviation|8.2|8.2|||
3702940|NCT02171260|3544088|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3702941|NCT02171260|3544089|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3702942|NCT02171260|3544090|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702943|NCT02171260|3544091|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3702944|NCT02171260|3544092|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702945|NCT02171260|3544088|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702946|NCT02171260|3544089|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702947|NCT02171260|3544090|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702948|NCT02171260|3544091|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702949|NCT02171260|3544092|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702950|NCT02171260|3544088|B5||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3702951|NCT02171260|3544089|B4||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3702952|NCT02171260|3544090|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3702953|NCT02171260|3544091|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3702954|NCT02171260|3544092|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3702955|NCT02171260|3544088|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3702956|NCT02171260|3544089|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3702957|NCT02171260|3544090|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3702958|NCT02171260|3544091|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702959|NCT02171260|3544092|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3702960|NCT02171260|3544088|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702961|NCT02171260|3544089|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702962|NCT02171260|3544090|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702963|NCT02171260|3544091|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702964|NCT02171260|3544092|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702965|NCT02171260|3544088|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702966|NCT02171260|3544089|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702967|NCT02171260|3544090|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702968|NCT02171260|3544091|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702969|NCT02171260|3544092|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702970|NCT02171260|3544088|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702971|NCT02171260|3544089|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702972|NCT02171260|3544090|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702973|NCT02171260|3544091|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702974|NCT02171260|3544092|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702975|NCT02171260|3544088|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702976|NCT02171260|3544089|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702977|NCT02171260|3544090|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702978|NCT02171260|3544091|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702979|NCT02171260|3544092|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702980|NCT02171260|3544088|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3702981|NCT02171260|3544089|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3702982|NCT02171260|3544090|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3702983|NCT02171260|3544091|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3702984|NCT02171260|3544092|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3702985|NCT02171260|3544088|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3702986|NCT02171260|3544089|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3702987|NCT02171260|3544090|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3702988|NCT02171260|3544091|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3702989|NCT02171260|3544092|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3702990|NCT02171260|3544088|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3702991|NCT02171260|3544089|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3702992|NCT02171260|3544090|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3702993|NCT02171260|3544091|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3702994|NCT02171260|3544092|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3702995|NCT02171260|3544088|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3702996|NCT02171260|3544089|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3702997|NCT02171260|3544090|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3702998|NCT02171260|3544091|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3702999|NCT02171260|3544092|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3703000|NCT02171260|3544088|B5|||Age||years|Mean|12.5|12.5|Standard Deviation|3.69|3.69|||
3703001|NCT02171260|3544089|B4|||Age||years|Mean|12.6|12.6|Standard Deviation|5.50|5.5|||
3703002|NCT02171260|3544090|B3|||Age||years|Mean|13.0|13.0|Standard Deviation|3.24|3.24|||
3703003|NCT02171260|3544091|B2|||Age||years|Mean|10.7|10.7|Standard Deviation|2.25|2.25|||
3703004|NCT02171260|3544092|B1|||Age||years|Mean|14.0|14.0|Standard Deviation|3.52|3.52|||
3703005|NCT02171247|3544150|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
3703006|NCT02171247|3544151|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3703007|NCT02171247|3544152|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3703008|NCT02171247|3544150|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3703009|NCT02171247|3544151|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3703010|NCT02171247|3544152|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3703011|NCT02171247|3544150|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3703012|NCT02171247|3544151|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3703013|NCT02171247|3544152|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3703014|NCT02171247|3544150|B3|18 years and older||Age, Customized||participants|Number|33|33.0||||||
3703015|NCT02171247|3544151|B2|18 years and older||Age, Customized||participants|Number|17|17.0||||||
3703016|NCT02171247|3544152|B1|18 years and older||Age, Customized||participants|Number|16|16.0||||||
3703017|NCT02171234|3544165|B6||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3703018|NCT02171234|3544166|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3703019|NCT02171234|3544167|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3703020|NCT02171234|3544168|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3703021|NCT02171234|3544169|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3703022|NCT02171234|3544170|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3703023|NCT02171234|3544165|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703024|NCT02171234|3544166|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703025|NCT02171234|3544167|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703026|NCT02171234|3544168|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703027|NCT02171234|3544169|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703028|NCT02171234|3544170|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703029|NCT02171234|3544165|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703030|NCT02171234|3544166|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703031|NCT02171234|3544167|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703032|NCT02171234|3544168|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703033|NCT02171234|3544169|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703034|NCT02171234|3544170|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703035|NCT02171234|3544165|B6||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3703036|NCT02171234|3544166|B5||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3703037|NCT02171234|3544167|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3703038|NCT02171234|3544168|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3703039|NCT02171234|3544169|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3703040|NCT02171234|3544170|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3703041|NCT02171234|3544165|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703042|NCT02171234|3544166|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703043|NCT02171234|3544167|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703044|NCT02171234|3544168|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703045|NCT02171234|3544169|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703046|NCT02171234|3544170|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703047|NCT02171195|3544194|B10||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3703048|NCT02171195|3544195|B9||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3703049|NCT02171195|3544196|B8||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3703050|NCT02171195|3544197|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3703051|NCT02171195|3544198|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3703052|NCT02171195|3544199|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3703053|NCT02171195|3544200|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3703054|NCT02171195|3544201|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3703055|NCT02171195|3544202|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3703056|NCT02171195|3544203|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3703057|NCT02171195|3544194|B10||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703058|NCT02171195|3544195|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703059|NCT02171195|3544196|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703060|NCT02171195|3544197|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703061|NCT02171195|3544198|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703062|NCT02171195|3544199|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703063|NCT02171195|3544200|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703064|NCT02171195|3544201|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703065|NCT02171195|3544202|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703066|NCT02171195|3544203|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703067|NCT02171195|3544194|B10||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703068|NCT02171195|3544195|B9||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703069|NCT02171195|3544196|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703070|NCT02171195|3544197|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703071|NCT02171195|3544198|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703072|NCT02171195|3544199|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703073|NCT02171195|3544200|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703074|NCT02171195|3544201|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703075|NCT02171195|3544202|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703076|NCT02171195|3544203|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703077|NCT02171195|3544194|B10||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
3703078|NCT02171195|3544195|B9||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3703079|NCT02171195|3544196|B8||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3703080|NCT02171195|3544197|B7||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3703081|NCT02171195|3544198|B6||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3703082|NCT02171195|3544199|B5||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3703083|NCT02171195|3544200|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3703084|NCT02171195|3544201|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3703085|NCT02171195|3544202|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3703086|NCT02171195|3544203|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3703087|NCT02171195|3544194|B10||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703088|NCT02171195|3544195|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703089|NCT02171195|3544196|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703090|NCT02171195|3544197|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703091|NCT02171195|3544198|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703092|NCT02171195|3544199|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703093|NCT02171195|3544200|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703094|NCT02171195|3544201|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703095|NCT02171195|3544202|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703096|NCT02171195|3544203|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703097|NCT02170779|3544231|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3703098|NCT02170779|3544232|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3703099|NCT02170779|3544233|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3703100|NCT02170779|3544231|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3703101|NCT02170779|3544232|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3703102|NCT02170779|3544233|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3703103|NCT02170779|3544231|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3703104|NCT02170779|3544232|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3703105|NCT02170779|3544233|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3703106|NCT02170779|3544231|B3|||Age||years|Mean|53.1|53.1|Standard Deviation|12.56|12.56|||
3703107|NCT02170779|3544232|B2|||Age||years|Mean|52.83|52.83|Standard Deviation|12.34|12.34|||
3703108|NCT02170779|3544233|B1|||Age||years|Mean|53.38|53.38|Standard Deviation|12.79|12.79|||
3703109|NCT02170779|3544231|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3703110|NCT02170779|3544232|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3703111|NCT02170779|3544233|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3703112|NCT02170779|3544231|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3703113|NCT02170779|3544232|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3703114|NCT02170779|3544233|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3703115|NCT02170779|3544231|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703116|NCT02170779|3544232|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703117|NCT02170779|3544233|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703118|NCT02170688|3544256|B6|United States||Region of Enrollment||participants|Number|139|139.0||||||
3703119|NCT02170688|3544257|B5|United States||Region of Enrollment||participants|Number|25|25.0||||||
3703120|NCT02170688|3544258|B4|United States||Region of Enrollment||participants|Number|27|27.0||||||
3703121|NCT02170688|3544259|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
3703122|NCT02170688|3544260|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
3703123|NCT02170688|3544261|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3703124|NCT02170688|3544256|B6||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3703125|NCT02170688|3544257|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3703126|NCT02170688|3544258|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3703127|NCT02170688|3544259|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3703128|NCT02170688|3544260|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3703129|NCT02170688|3544261|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3703130|NCT02170688|3544256|B6||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3703131|NCT02170688|3544257|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3703132|NCT02170688|3544258|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3703133|NCT02170688|3544259|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3703134|NCT02170688|3544260|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3703135|NCT02170688|3544261|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3703136|NCT02170688|3544256|B6|≥18 years||Age, Customized||participants|Number|139|139.0||||||
3703137|NCT02170688|3544257|B5|≥18 years||Age, Customized||participants|Number|25|25.0||||||
3703138|NCT02170688|3544258|B4|≥18 years||Age, Customized||participants|Number|27|27.0||||||
3703139|NCT02170688|3544259|B3|≥18 years||Age, Customized||participants|Number|29|29.0||||||
3703140|NCT02170688|3544260|B2|≥18 years||Age, Customized||participants|Number|29|29.0||||||
3703141|NCT02170688|3544261|B1|≥18 years||Age, Customized||participants|Number|29|29.0||||||
3703142|NCT02170662|3544282|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
3703143|NCT02170662|3544283|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3703144|NCT02170662|3544284|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3703145|NCT02170662|3544282|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3703146|NCT02170662|3544283|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3703147|NCT02170662|3544284|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3703148|NCT02170662|3544282|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703149|NCT02170662|3544283|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703150|NCT02170662|3544284|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703151|NCT02170662|3544282|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703152|NCT02170662|3544283|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703153|NCT02170662|3544284|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703154|NCT02170662|3544282|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3703155|NCT02170662|3544283|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3703156|NCT02170662|3544284|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3703157|NCT02170662|3544282|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703158|NCT02170662|3544283|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703159|NCT02170662|3544284|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703160|NCT02170649|3544297|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3703161|NCT02170649|3544297|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703162|NCT02170649|3544297|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703163|NCT02170649|3544297|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3703164|NCT02170649|3544297|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703165|NCT02170532|3544304|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3703166|NCT02170532|3544304|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3703167|NCT02170532|3544304|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3703168|NCT02170532|3544304|B1|18 & older||Age, Customized||participants|Number|10|10.0||||||
3703169|NCT02170519|3544332|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
3703170|NCT02170519|3544333|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3703171|NCT02170519|3544334|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3703172|NCT02170519|3544332|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3703173|NCT02170519|3544333|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3703174|NCT02170519|3544334|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3703175|NCT02170519|3544332|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3703176|NCT02170519|3544333|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3703177|NCT02170519|3544334|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3703178|NCT02170519|3544332|B3|<=18 years||Age, Customized||participants|Number|1|1.0||||||
3703179|NCT02170519|3544333|B2|<=18 years||Age, Customized||participants|Number|0|0.0||||||
3703180|NCT02170519|3544334|B1|<=18 years||Age, Customized||participants|Number|1|1.0||||||
3703181|NCT02170519|3544332|B3|>18 years||Age, Customized||participants|Number|26|26.0||||||
3703182|NCT02170519|3544333|B2|>18 years||Age, Customized||participants|Number|5|5.0||||||
3703183|NCT02170519|3544334|B1|>18 years||Age, Customized||participants|Number|21|21.0||||||
3703184|NCT02170376|3544351|B6||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3703185|NCT02170376|3544352|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3703186|NCT02170376|3544353|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3703187|NCT02170376|3544354|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3703188|NCT02170376|3544355|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3703189|NCT02170376|3544356|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3703190|NCT02170376|3544351|B6||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3703191|NCT02170376|3544352|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3703192|NCT02170376|3544353|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3703193|NCT02170376|3544354|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3703194|NCT02170376|3544355|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3703195|NCT02170376|3544356|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3703196|NCT02170376|3544351|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703197|NCT02170376|3544352|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703198|NCT02170376|3544353|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703199|NCT02170376|3544354|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703200|NCT02170376|3544355|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703201|NCT02170376|3544356|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703202|NCT02170376|3544351|B6||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
3703203|NCT02170376|3544352|B5||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3703204|NCT02170376|3544353|B4||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3703205|NCT02170376|3544354|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3703206|NCT02170376|3544355|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3703207|NCT02170376|3544356|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3703208|NCT02170376|3544351|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703209|NCT02170376|3544352|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703210|NCT02170376|3544353|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703211|NCT02170376|3544354|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703212|NCT02170376|3544355|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703213|NCT02170376|3544356|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703214|NCT02170363|3544397|B1|||Cardiac Index|Cardiac index (CI) is a hemodynamic parameter that relates the cardiac output (CO) from left ventricle in one minute to body surface area (BSA), thus relating heart performance to the size of the individual. Values less than 2.2 L/min/m^2 indicate that the patient may be in cardiogenic shock.|L/min/m^2|Mean|1.8|1.8|Standard Deviation|0.5|0.5|||
3703215|NCT02170363|3544397|B1|||Body Surface Area|Body Surface Area (BSA) calculated from patients height and weight|M^2|Mean|2|2.0|Standard Deviation|0.2|0.2|||
3703216|NCT02170363|3544397|B1|Germany||Region of Enrollment||participants|Number|21|21.0||||||
3703217|NCT02170363|3544397|B1|Kazakhstan||Region of Enrollment||participants|Number|8|8.0||||||
3703218|NCT02170363|3544397|B1|Australia||Region of Enrollment||participants|Number|1|1.0||||||
3703219|NCT02170363|3544397|B1|Czech Republic||Region of Enrollment||participants|Number|10|10.0||||||
3703220|NCT02170363|3544397|B1|Austria||Region of Enrollment||participants|Number|7|7.0||||||
3703221|NCT02170363|3544397|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
3703222|NCT02170363|3544397|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3703223|NCT02170363|3544397|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3703224|NCT02170363|3544397|B1|||Age||Years|Mean|58.9|58.9|Standard Deviation|13.5|13.5|||
3703225|NCT02170220|3544409|B3|No||Caffeine Consumption||participants|Number|6|6.0||||||
3703226|NCT02170220|3544410|B2|No||Caffeine Consumption||participants|Number|3|3.0||||||
3703227|NCT02170220|3544411|B1|No||Caffeine Consumption||participants|Number|3|3.0||||||
3703228|NCT02170220|3544409|B3|Yes||Caffeine Consumption||participants|Number|6|6.0||||||
3703229|NCT02170220|3544410|B2|Yes||Caffeine Consumption||participants|Number|3|3.0||||||
3703230|NCT02170220|3544411|B1|Yes||Caffeine Consumption||participants|Number|3|3.0||||||
3703231|NCT02170220|3544409|B3|Ex-drinker||Alcohol Classification||participants|Number|0|0.0||||||
3703232|NCT02170220|3544410|B2|Ex-drinker||Alcohol Classification||participants|Number|0|0.0||||||
3703233|NCT02170220|3544411|B1|Ex-drinker||Alcohol Classification||participants|Number|0|0.0||||||
3703234|NCT02170220|3544409|B3|Current drinker||Alcohol Classification||participants|Number|4|4.0||||||
3703235|NCT02170220|3544410|B2|Current drinker||Alcohol Classification||participants|Number|3|3.0||||||
3703236|NCT02170220|3544411|B1|Current drinker||Alcohol Classification||participants|Number|1|1.0||||||
3703237|NCT02170220|3544409|B3|Never drank||Alcohol Classification||participants|Number|8|8.0||||||
3703238|NCT02170220|3544410|B2|Never drank||Alcohol Classification||participants|Number|3|3.0||||||
3703239|NCT02170220|3544411|B1|Never drank||Alcohol Classification||participants|Number|5|5.0||||||
3703240|NCT02170220|3544409|B3|Ex-smoker||Smoking Classification||participants|Number|2|2.0||||||
3703241|NCT02170220|3544410|B2|Ex-smoker||Smoking Classification||participants|Number|2|2.0||||||
3703242|NCT02170220|3544411|B1|Ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3703243|NCT02170220|3544409|B3|Current smoker||Smoking Classification||participants|Number|2|2.0||||||
3703244|NCT02170220|3544410|B2|Current smoker||Smoking Classification||participants|Number|1|1.0||||||
3703245|NCT02170220|3544411|B1|Current smoker||Smoking Classification||participants|Number|1|1.0||||||
3703246|NCT02170220|3544409|B3|Never smoked||Smoking Classification||participants|Number|8|8.0||||||
3703247|NCT02170220|3544410|B2|Never smoked||Smoking Classification||participants|Number|3|3.0||||||
3703248|NCT02170220|3544411|B1|Never smoked||Smoking Classification||participants|Number|5|5.0||||||
3703249|NCT02170220|3544409|B3|||Body Mass Index (BMI)||kg/m^2|Mean|28.73|28.73|Standard Deviation|5.512|5.512|||
3703250|NCT02170220|3544410|B2|||Body Mass Index (BMI)||kg/m^2|Mean|29.43|29.43|Standard Deviation|7.554|7.554|||
3703251|NCT02170220|3544411|B1|||Body Mass Index (BMI)||kg/m^2|Mean|28.02|28.02|Standard Deviation|2.927|2.927|||
3703252|NCT02170220|3544409|B3|||Weight||kg|Mean|81.41|81.41|Standard Deviation|21.537|21.537|||
3703253|NCT02170220|3544410|B2|||Weight||kg|Mean|82.17|82.17|Standard Deviation|29.038|29.038|||
3703254|NCT02170220|3544411|B1|||Weight||kg|Mean|80.65|80.65|Standard Deviation|13.261|13.261|||
3703255|NCT02170220|3544409|B3|||Height||cm|Mean|167.5|167.5|Standard Deviation|10.06|10.06|||
3703256|NCT02170220|3544410|B2|||Height||cm|Mean|165.7|165.7|Standard Deviation|10.41|10.41|||
3703257|NCT02170220|3544411|B1|||Height||cm|Mean|169.3|169.3|Standard Deviation|10.31|10.31|||
3703258|NCT02170220|3544409|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3703259|NCT02170220|3544410|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3703260|NCT02170220|3544411|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3703261|NCT02170220|3544409|B3|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3703262|NCT02170220|3544410|B2|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3703263|NCT02170220|3544411|B1|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3703264|NCT02170220|3544409|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3703265|NCT02170220|3544410|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3703266|NCT02170220|3544411|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3703267|NCT02170220|3544409|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3703268|NCT02170220|3544410|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3703269|NCT02170220|3544411|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3703270|NCT02170220|3544409|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3703271|NCT02170220|3544410|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3703272|NCT02170220|3544411|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3703273|NCT02170220|3544409|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3703274|NCT02170220|3544410|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3703275|NCT02170220|3544411|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3703276|NCT02170220|3544409|B3|||Age||years|Mean|52.6|52.6|Standard Deviation|5.43|5.43|||
3703277|NCT02170220|3544410|B2|||Age||years|Mean|54.8|54.8|Standard Deviation|6.79|6.79|||
3703278|NCT02170220|3544411|B1|||Age||years|Mean|50.3|50.3|Standard Deviation|2.58|2.58|||
3703279|NCT02170207|3544438|B1|Had no consumption||Prior Consumption of Drugs Affecting Coagulation System|The baseline characteristic was analyzed in participants who consumed drugs that affected the coagulation system during the month prior to administration of study drug.|participants|Number|46|46.0||||||
3703329|NCT02170207|3544438|B1|||Age||years|Mean|63.5|63.5|Standard Deviation|16.41|16.41|||
3703280|NCT02170207|3544438|B1|Had consumption||Prior Consumption of Drugs Affecting Coagulation System|The baseline characteristic was analyzed in participants who consumed drugs that affected the coagulation system during the month prior to administration of study drug.|participants|Number|12|12.0||||||
3703281|NCT02170207|3544438|B1|Other||Breakdown of Drugs|The baseline characteristic was analyzed in participants who consumed non steroidal anti-inflammatory drugs, platelet aggregation inhibitors, anticoagulants, and steroids that affected the coagulation system during the month prior to administration of study drug. Participants may be represented in more than 1 category.|participants|Number|1|1.0||||||
3703282|NCT02170207|3544438|B1|Steroids||Breakdown of Drugs|The baseline characteristic was analyzed in participants who consumed non steroidal anti-inflammatory drugs, platelet aggregation inhibitors, anticoagulants, and steroids that affected the coagulation system during the month prior to administration of study drug. Participants may be represented in more than 1 category.|participants|Number|0|0.0||||||
3703283|NCT02170207|3544438|B1|Anticoagulants||Breakdown of Drugs|The baseline characteristic was analyzed in participants who consumed non steroidal anti-inflammatory drugs, platelet aggregation inhibitors, anticoagulants, and steroids that affected the coagulation system during the month prior to administration of study drug. Participants may be represented in more than 1 category.|participants|Number|3|3.0||||||
3703284|NCT02170207|3544438|B1|Platelet aggregation inhibitors||Breakdown of Drugs|The baseline characteristic was analyzed in participants who consumed non steroidal anti-inflammatory drugs, platelet aggregation inhibitors, anticoagulants, and steroids that affected the coagulation system during the month prior to administration of study drug. Participants may be represented in more than 1 category.|participants|Number|5|5.0||||||
3703285|NCT02170207|3544438|B1|Non Steroidal Anti-Inflammatory Drugs||Breakdown of Drugs|The baseline characteristic was analyzed in participants who consumed non steroidal anti-inflammatory drugs, platelet aggregation inhibitors, anticoagulants, and steroids that affected the coagulation system during the month prior to administration of study drug. Participants may be represented in more than 1 category.|participants|Number|7|7.0||||||
3703286|NCT02170207|3544438|B1|Had no Stress||Emotional Stress||participants|Number|29|29.0||||||
3703287|NCT02170207|3544438|B1|Had Stress||Emotional Stress||participants|Number|29|29.0||||||
3703288|NCT02170207|3544438|B1|Other||Breakdown of Complications|This baseline characteristic was analyzed in participants who had hypertension, cardiac disorders, diabetes mellitus, hepatic dysfunction, anemia, malignant tumor, cerebrovascular accident, renal dysfunction and any other medical complications. Participants may be represented in more than 1 category.|participants|Number|18|18.0||||||
3703289|NCT02170207|3544438|B1|Renal dysfunction||Breakdown of Complications|This baseline characteristic was analyzed in participants who had hypertension, cardiac disorders, diabetes mellitus, hepatic dysfunction, anemia, malignant tumor, cerebrovascular accident, renal dysfunction and any other medical complications. Participants may be represented in more than 1 category.|participants|Number|1|1.0||||||
3703290|NCT02170207|3544438|B1|Cerebrovascular accident||Breakdown of Complications|This baseline characteristic was analyzed in participants who had hypertension, cardiac disorders, diabetes mellitus, hepatic dysfunction, anemia, malignant tumor, cerebrovascular accident, renal dysfunction and any other medical complications. Participants may be represented in more than 1 category.|participants|Number|1|1.0||||||
3703291|NCT02170207|3544438|B1|Malignant tumor||Breakdown of Complications|This baseline characteristic was analyzed in participants who had hypertension, cardiac disorders, diabetes mellitus, hepatic dysfunction, anemia, malignant tumor, cerebrovascular accident, renal dysfunction and any other medical complications. Participants may be represented in more than 1 category.|participants|Number|2|2.0||||||
3703292|NCT02170207|3544438|B1|Anemia||Breakdown of Complications|This baseline characteristic was analyzed in participants who had hypertension, cardiac disorders, diabetes mellitus, hepatic dysfunction, anemia, malignant tumor, cerebrovascular accident, renal dysfunction and any other medical complications. Participants may be represented in more than 1 category.|participants|Number|4|4.0||||||
3703293|NCT02170207|3544438|B1|Hepatic dysfunction||Breakdown of Complications|This baseline characteristic was analyzed in participants who had hypertension, cardiac disorders, diabetes mellitus, hepatic dysfunction, anemia, malignant tumor, cerebrovascular accident, renal dysfunction and any other medical complications. Participants may be represented in more than 1 category.|participants|Number|3|3.0||||||
3703294|NCT02170207|3544438|B1|Diabetes mellitus||Breakdown of Complications|This baseline characteristic was analyzed in participants who had hypertension, cardiac disorders, diabetes mellitus, hepatic dysfunction, anemia, malignant tumor, cerebrovascular accident, renal dysfunction and any other medical complications. Participants may be represented in more than 1 category.|participants|Number|5|5.0||||||
3703295|NCT02170207|3544438|B1|Cardiac disorders||Breakdown of Complications|This baseline characteristic was analyzed in participants who had hypertension, cardiac disorders, diabetes mellitus, hepatic dysfunction, anemia, malignant tumor, cerebrovascular accident, renal dysfunction and any other medical complications. Participants may be represented in more than 1 category.|participants|Number|4|4.0||||||
3703296|NCT02170207|3544438|B1|Hypertension||Breakdown of Complications|This baseline characteristic was analyzed in participants who had hypertension, cardiac disorders, diabetes mellitus, hepatic dysfunction, anemia, malignant tumor, cerebrovascular accident, renal dysfunction and any other medical complications. Participants may be represented in more than 1 category.|participants|Number|8|8.0||||||
3703297|NCT02170207|3544438|B1|Had no Complications||Medical Complications||participants|Number|30|30.0||||||
3703298|NCT02170207|3544438|B1|Had Complications||Medical Complications||participants|Number|28|28.0||||||
3703299|NCT02170207|3544438|B1|Other||Breakdown of Medical History|This baseline characteristic was analyzed in participants who had a medical history of peptic ulcer or upper gastrointestinal bleeding or cerebrovascular accident or malignant tumor or hepatic dysfunction or renal dysfunction or diabetes mellitus or cardiac disorders or hypertension or any other type of disease. Participants may be represented in more than 1 category.|participants|Number|11|11.0||||||
3703300|NCT02170207|3544438|B1|Hypertension||Breakdown of Medical History|This baseline characteristic was analyzed in participants who had a medical history of peptic ulcer or upper gastrointestinal bleeding or cerebrovascular accident or malignant tumor or hepatic dysfunction or renal dysfunction or diabetes mellitus or cardiac disorders or hypertension or any other type of disease. Participants may be represented in more than 1 category.|participants|Number|0|0.0||||||
3703301|NCT02170207|3544438|B1|Cardiac disorders||Breakdown of Medical History|This baseline characteristic was analyzed in participants who had a medical history of peptic ulcer or upper gastrointestinal bleeding or cerebrovascular accident or malignant tumor or hepatic dysfunction or renal dysfunction or diabetes mellitus or cardiac disorders or hypertension or any other type of disease. Participants may be represented in more than 1 category.|participants|Number|2|2.0||||||
3703302|NCT02170207|3544438|B1|Diabetes mellitus||Breakdown of Medical History|This baseline characteristic was analyzed in participants who had a medical history of peptic ulcer or upper gastrointestinal bleeding or cerebrovascular accident or malignant tumor or hepatic dysfunction or renal dysfunction or diabetes mellitus or cardiac disorders or hypertension or any other type of disease. Participants may be represented in more than 1 category.|participants|Number|2|2.0||||||
3703303|NCT02170207|3544438|B1|Renal dysfunction||Breakdown of Medical History|This baseline characteristic was analyzed in participants who had a medical history of peptic ulcer or upper gastrointestinal bleeding or cerebrovascular accident or malignant tumor or hepatic dysfunction or renal dysfunction or diabetes mellitus or cardiac disorders or hypertension or any other type of disease. Participants may be represented in more than 1 category.|participants|Number|0|0.0||||||
3703304|NCT02170207|3544438|B1|Hepatic dysfunction||Breakdown of Medical History|This baseline characteristic was analyzed in participants who had a medical history of peptic ulcer or upper gastrointestinal bleeding or cerebrovascular accident or malignant tumor or hepatic dysfunction or renal dysfunction or diabetes mellitus or cardiac disorders or hypertension or any other type of disease. Participants may be represented in more than 1 category.|participants|Number|3|3.0||||||
3703305|NCT02170207|3544438|B1|Malignant tumor||Breakdown of Medical History|This baseline characteristic was analyzed in participants who had a medical history of peptic ulcer or upper gastrointestinal bleeding or cerebrovascular accident or malignant tumor or hepatic dysfunction or renal dysfunction or diabetes mellitus or cardiac disorders or hypertension or any other type of disease. Participants may be represented in more than 1 category.|participants|Number|3|3.0||||||
3703306|NCT02170207|3544438|B1|Cerebrovascular accident||Breakdown of Medical History|This baseline characteristic was analyzed in participants who had a medical history of peptic ulcer or upper gastrointestinal bleeding or cerebrovascular accident or malignant tumor or hepatic dysfunction or renal dysfunction or diabetes mellitus or cardiac disorders or hypertension or any other type of disease. Participants may be represented in more than 1 category.|participants|Number|4|4.0||||||
3703307|NCT02170207|3544438|B1|Upper gastrointestinal bleeding||Breakdown of Medical History|This baseline characteristic was analyzed in participants who had a medical history of peptic ulcer or upper gastrointestinal bleeding or cerebrovascular accident or malignant tumor or hepatic dysfunction or renal dysfunction or diabetes mellitus or cardiac disorders or hypertension or any other type of disease. Participants may be represented in more than 1 category.|participants|Number|1|1.0||||||
3703308|NCT02170207|3544438|B1|Peptic ulcer||Breakdown of Medical History|This baseline characteristic was analyzed in participants who had a medical history of peptic ulcer or upper gastrointestinal bleeding or cerebrovascular accident or malignant tumor or hepatic dysfunction or renal dysfunction or diabetes mellitus or cardiac disorders or hypertension or any other type of disease. Participants may be represented in more than 1 category.|participants|Number|13|13.0||||||
3703309|NCT02170207|3544438|B1|Did not have medical history||Medical History||participants|Number|28|28.0||||||
3703310|NCT02170207|3544438|B1|Had medical history||Medical History||participants|Number|30|30.0||||||
3703311|NCT02170207|3544438|B1|Unknown||Smoking||participants|Number|4|4.0||||||
3703312|NCT02170207|3544438|B1|Non-Smoker||Smoking||participants|Number|40|40.0||||||
3703313|NCT02170207|3544438|B1|Smoker||Smoking||participants|Number|14|14.0||||||
3703314|NCT02170207|3544438|B1|Unknown||Alcohol consumption||participants|Number|5|5.0||||||
3703315|NCT02170207|3544438|B1|Alcohol Non-Consumer||Alcohol consumption||participants|Number|38|38.0||||||
3703316|NCT02170207|3544438|B1|Alcohol Consumer||Alcohol consumption||participants|Number|15|15.0||||||
3703317|NCT02170207|3544438|B1|Unknown||Helicobacter Pylori Infection|This baseline characteristic was analyzed in participants who tested either positive (had infection) or negative (did not have infection) for helicobacter pylori infection.|participants|Number|22|22.0||||||
3703318|NCT02170207|3544438|B1|Negative||Helicobacter Pylori Infection|This baseline characteristic was analyzed in participants who tested either positive (had infection) or negative (did not have infection) for helicobacter pylori infection.|participants|Number|16|16.0||||||
3703319|NCT02170207|3544438|B1|Positive||Helicobacter Pylori Infection|This baseline characteristic was analyzed in participants who tested either positive (had infection) or negative (did not have infection) for helicobacter pylori infection.|participants|Number|20|20.0||||||
3703320|NCT02170207|3544438|B1|Yes||Predisposition to Hypersensitivity|This baseline measure was analyzed in participants who had a tendency of suffering from hypersensitivity.|participants|Number|4|4.0||||||
3703321|NCT02170207|3544438|B1|No||Predisposition to Hypersensitivity|This baseline measure was analyzed in participants who had a tendency of suffering from hypersensitivity.|participants|Number|54|54.0||||||
3703322|NCT02170207|3544438|B1|||Healthcare Category|Participants were categorized as outpatient and inpatient. This baseline characteristic was analyzed for inpatient participants.|participants|Number|58|58.0||||||
3703323|NCT02170207|3544438|B1|Acute Gastric Mucosal Lesion||Target Disease|This baseline characteristic was analyzed for participants who were suffering from disease being targeted in the study, which were acute stress-induced ulcer and acute gastric mucosal lesion.|participants|Number|12|12.0||||||
3703324|NCT02170207|3544438|B1|Acute Stress-Induced Ulcer||Target Disease|This baseline characteristic was analyzed for participants who were suffering from disease being targeted in the study, which were acute stress-induced ulcer and acute gastric mucosal lesion.|participants|Number|46|46.0||||||
3703325|NCT02170207|3544438|B1|Pregnant||Pregnancy Status|This baseline characteristic was analyzed only in female participants.|participants|Number|0|0.0||||||
3703326|NCT02170207|3544438|B1|Not pregnant||Pregnancy Status|This baseline characteristic was analyzed only in female participants.|participants|Number|22|22.0||||||
3703327|NCT02170207|3544438|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3703328|NCT02170207|3544438|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3703330|NCT02170077|3544446|B4||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3703331|NCT02170077|3544447|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3703332|NCT02170077|3544448|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3703333|NCT02170077|3544449|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3703334|NCT02170077|3544446|B4||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3703335|NCT02170077|3544447|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3703336|NCT02170077|3544448|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3703337|NCT02170077|3544449|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3703338|NCT02170077|3544446|B4|||Age||years|Mean|39.8|39.8|Standard Deviation|11.3|11.3|||
3703339|NCT02170077|3544447|B3|||Age||years|Mean|40.4|40.4|Standard Deviation|10.8|10.8|||
3703340|NCT02170077|3544448|B2|||Age||years|Mean|39.8|39.8|Standard Deviation|11.9|11.9|||
3703341|NCT02170077|3544449|B1|||Age||years|Mean|39.3|39.3|Standard Deviation|11.4|11.4|||
3703342|NCT02170064|3544459|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3703343|NCT02170064|3544460|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3703344|NCT02170064|3544461|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3703345|NCT02170064|3544462|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3703346|NCT02170064|3544459|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3703347|NCT02170064|3544460|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3703348|NCT02170064|3544461|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3703349|NCT02170064|3544462|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3703350|NCT02170064|3544459|B4|||Age||years|Mean|9.1|9.1|Standard Deviation|4.73|4.73|||
3703351|NCT02170064|3544460|B3|||Age||years|Mean|14.5|14.5|Standard Deviation|1.58|1.58|||
3703352|NCT02170064|3544461|B2|||Age||years|Mean|9.1|9.1|Standard Deviation|1.55|1.55|||
3703353|NCT02170064|3544462|B1|||Age||years|Mean|4.1|4.1|Standard Deviation|1.38|1.38|||
3703354|NCT02170025|3544478|B3|||Sweat chloride content||mmol/L|Mean|95.53|95.53|Standard Deviation|15.03|15.03|||
3703355|NCT02170025|3544479|B2|||Sweat chloride content||mmol/L|Mean|94.50|94.5|Standard Deviation|12.82|12.82|||
3703356|NCT02170025|3544480|B1|||Sweat chloride content||mmol/L|Mean|96.33|96.33|Standard Deviation|17.28|17.28|||
3703357|NCT02170025|3544478|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3703358|NCT02170025|3544479|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3703359|NCT02170025|3544480|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3703360|NCT02170025|3544478|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3703361|NCT02170025|3544479|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3703362|NCT02170025|3544480|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3703363|NCT02170025|3544478|B3|||Age||Years|Mean|27.8|27.8|Standard Deviation|6.9|6.9|||
3703364|NCT02170025|3544479|B2|||Age||Years|Mean|29.1|29.1|Standard Deviation|7.2|7.2|||
3703365|NCT02170025|3544480|B1|||Age||Years|Mean|27.1|27.1|Standard Deviation|6.9|6.9|||
3703366|NCT02169895|3544489|B5||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3703367|NCT02169895|3544490|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3703368|NCT02169895|3544491|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3703369|NCT02169895|3544492|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3703370|NCT02169895|3544493|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3703371|NCT02169895|3544489|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703372|NCT02169895|3544490|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703373|NCT02169895|3544491|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703374|NCT02169895|3544492|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703375|NCT02169895|3544493|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703376|NCT02169895|3544489|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703377|NCT02169895|3544490|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703378|NCT02169895|3544491|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703379|NCT02169895|3544492|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703380|NCT02169895|3544493|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703381|NCT02169895|3544489|B5||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3703382|NCT02169895|3544490|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3703383|NCT02169895|3544491|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3703384|NCT02169895|3544492|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3703385|NCT02169895|3544493|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3703386|NCT02169895|3544489|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703387|NCT02169895|3544490|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703388|NCT02169895|3544491|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703389|NCT02169895|3544492|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703390|NCT02169895|3544493|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703391|NCT02169479|3544514|B5||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3703392|NCT02169479|3544515|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3703393|NCT02169479|3544516|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3703394|NCT02169479|3544517|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3703395|NCT02169479|3544518|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3703396|NCT02169479|3544514|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703397|NCT02169479|3544515|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703398|NCT02169479|3544516|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703399|NCT02169479|3544517|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703400|NCT02169479|3544518|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703401|NCT02169479|3544514|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703402|NCT02169479|3544515|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703403|NCT02169479|3544516|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703404|NCT02169479|3544517|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703405|NCT02169479|3544518|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703406|NCT02169479|3544514|B5||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3703407|NCT02169479|3544515|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3703408|NCT02169479|3544516|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3703409|NCT02169479|3544517|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3703410|NCT02169479|3544518|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3703411|NCT02169479|3544514|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703412|NCT02169479|3544515|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703413|NCT02169479|3544516|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703414|NCT02169479|3544517|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703415|NCT02169479|3544518|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703416|NCT02169466|3544539|B5||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3703417|NCT02169466|3544540|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3703418|NCT02169466|3544541|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3703419|NCT02169466|3544542|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3703420|NCT02169466|3544543|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3703421|NCT02169466|3544539|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703422|NCT02169466|3544540|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703423|NCT02169466|3544541|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703424|NCT02169466|3544542|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703425|NCT02169466|3544543|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703426|NCT02169466|3544539|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703427|NCT02169466|3544540|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703428|NCT02169466|3544541|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703429|NCT02169466|3544542|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703430|NCT02169466|3544543|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703431|NCT02169466|3544539|B5||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3703432|NCT02169466|3544540|B4||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3703433|NCT02169466|3544541|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3703434|NCT02169466|3544542|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3703435|NCT02169466|3544543|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3703436|NCT02169466|3544539|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703437|NCT02169466|3544540|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703438|NCT02169466|3544541|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703439|NCT02169466|3544542|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703440|NCT02169466|3544543|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703441|NCT02169453|3544568|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3703442|NCT02169453|3544569|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3703443|NCT02169453|3544570|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3703444|NCT02169453|3544571|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3703445|NCT02169453|3544572|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3703446|NCT02169453|3544568|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703447|NCT02169453|3544569|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703448|NCT02169453|3544570|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703449|NCT02169453|3544571|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703450|NCT02169453|3544572|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703451|NCT02169453|3544568|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703452|NCT02169453|3544569|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703453|NCT02169453|3544570|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703454|NCT02169453|3544571|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703455|NCT02169453|3544572|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703456|NCT02169453|3544568|B5||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3703457|NCT02169453|3544569|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3703458|NCT02169453|3544570|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3703459|NCT02169453|3544571|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3703460|NCT02169453|3544572|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3703461|NCT02169453|3544568|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703462|NCT02169453|3544569|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703463|NCT02169453|3544570|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703464|NCT02169453|3544571|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703465|NCT02169453|3544572|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703466|NCT02169440|3544605|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3703467|NCT02169440|3544606|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3703468|NCT02169440|3544607|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3703469|NCT02169440|3544605|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3703470|NCT02169440|3544606|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3703471|NCT02169440|3544607|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3703472|NCT02169440|3544605|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703473|NCT02169440|3544606|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703474|NCT02169440|3544607|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703475|NCT02169440|3544605|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3703476|NCT02169440|3544606|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3703477|NCT02169440|3544607|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3703478|NCT02169440|3544605|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703479|NCT02169440|3544606|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703480|NCT02169440|3544607|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703481|NCT02169427|3544621|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3703482|NCT02169427|3544621|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703483|NCT02169427|3544621|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703484|NCT02169427|3544621|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3703485|NCT02169427|3544621|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703486|NCT02169414|3544627|B5||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3703487|NCT02169414|3544628|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3703488|NCT02169414|3544629|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3703489|NCT02169414|3544630|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3703490|NCT02169414|3544631|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3703491|NCT02169414|3544627|B5||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3703492|NCT02169414|3544628|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3703493|NCT02169414|3544629|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3703494|NCT02169414|3544630|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3703495|NCT02169414|3544631|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3703496|NCT02169414|3544627|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703497|NCT02169414|3544628|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703498|NCT02169414|3544629|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703499|NCT02169414|3544630|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703500|NCT02169414|3544631|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703501|NCT02169414|3544627|B5||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
3703502|NCT02169414|3544628|B4||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3703503|NCT02169414|3544629|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3703504|NCT02169414|3544630|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3703505|NCT02169414|3544631|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3703506|NCT02169414|3544627|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703507|NCT02169414|3544628|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703508|NCT02169414|3544629|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703509|NCT02169414|3544630|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703510|NCT02169414|3544631|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703511|NCT02169336|3544672|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703512|NCT02169336|3544673|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703513|NCT02169336|3544674|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703514|NCT02169336|3544675|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703515|NCT02169336|3544672|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703516|NCT02169336|3544673|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703517|NCT02169336|3544674|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703518|NCT02169336|3544675|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703519|NCT02169336|3544672|B4||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3703520|NCT02169336|3544673|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3703521|NCT02169336|3544674|B2||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3703522|NCT02169336|3544675|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3703523|NCT02169336|3544672|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3703524|NCT02169336|3544673|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3703525|NCT02169336|3544674|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3703526|NCT02169336|3544675|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3703527|NCT02169336|3544672|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703528|NCT02169336|3544673|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703529|NCT02169336|3544674|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703530|NCT02169336|3544675|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703531|NCT02169336|3544672|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3703532|NCT02169336|3544673|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703533|NCT02169336|3544674|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703534|NCT02169336|3544675|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3703535|NCT02169336|3544672|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703536|NCT02169336|3544673|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703537|NCT02169336|3544674|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703538|NCT02169336|3544675|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703539|NCT02169336|3544672|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703540|NCT02169336|3544673|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703541|NCT02169336|3544674|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703542|NCT02169336|3544675|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703543|NCT02169336|3544672|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3703544|NCT02169336|3544673|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3703545|NCT02169336|3544674|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3703546|NCT02169336|3544675|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3703547|NCT02169336|3544672|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3703548|NCT02169336|3544673|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3703549|NCT02169336|3544674|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3703550|NCT02169336|3544675|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3703551|NCT02169336|3544672|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3703552|NCT02169336|3544673|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3703553|NCT02169336|3544674|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3703554|NCT02169336|3544675|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3703555|NCT02169336|3544672|B4||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3703556|NCT02169336|3544673|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3703557|NCT02169336|3544674|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3703558|NCT02169336|3544675|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3703559|NCT02169336|3544672|B4|||Age||years|Mean|44.2|44.2|Standard Deviation|13.44|13.44|||
3703560|NCT02169336|3544673|B3|||Age||years|Mean|44.6|44.6|Standard Deviation|13.93|13.93|||
3703561|NCT02169336|3544674|B2|||Age||years|Mean|44.6|44.6|Standard Deviation|12.21|12.21|||
3703562|NCT02169336|3544675|B1|||Age||years|Mean|43.6|43.6|Standard Deviation|14.53|14.53|||
3703563|NCT02169219|3544685|B1|Negative||anti-neutrophil cytoplasmic antibody (ANCA)|ANCA type and titer were determined by ELISA.|Participants|Count of Participants|2|2.0||||||
3703564|NCT02169219|3544685|B1|proteinase (PR3)||anti-neutrophil cytoplasmic antibody (ANCA)|ANCA type and titer were determined by ELISA.|Participants|Count of Participants|7|7.0||||||
3703565|NCT02169219|3544685|B1|myeloperoxidase (MPO)||anti-neutrophil cytoplasmic antibody (ANCA)|ANCA type and titer were determined by ELISA.|Participants|Count of Participants|11|11.0||||||
3703566|NCT02169219|3544685|B1|Indeterminate||Disease group|Disease type (GPA or MPA)|Participants|Count of Participants|0|0.0||||||
3703567|NCT02169219|3544685|B1|Microscopic polyangiitis (MPA)||Disease group|Disease type (GPA or MPA)|Participants|Count of Participants|6|6.0||||||
3703568|NCT02169219|3544685|B1|Granulomatosis with polyangiitis (GPA)||Disease group|Disease type (GPA or MPA)|Participants|Count of Participants|14|14.0||||||
3703623|NCT02168946|3544711|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3703624|NCT02168946|3544709|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703569|NCT02169219|3544685|B1|||Birmingham Vasculitis Activity Score for Wegener's Granulomatosis(BVAS/WG)|Birmingham Vasculitis Activity Score for Wegener’s Granulomatosis(BVAS/WG, range 0-64). The total score is composed of 34 predefined items, units on a scale, grouped into 9 organ systems. Each item carries a weight from 1-3, depending on disease severity. Subjects with a score of 3 or higher were invited to participate in the trial. A score of 0 indicates no disease activity; a higher score indicates worsening disease.|units on a scale|Mean|5|5.0|Full Range|||3.0|11.0|
3703570|NCT02169219|3544685|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3703571|NCT02169219|3544685|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3703572|NCT02169219|3544685|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3703573|NCT02169219|3544685|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3703574|NCT02169219|3544685|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3703575|NCT02169219|3544685|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703576|NCT02169115|3544696|B4|Germany||Region of Enrollment||participants|Number|61|61.0||||||
3703577|NCT02169115|3544697|B3|Germany||Region of Enrollment||participants|Number|21|21.0||||||
3703578|NCT02169115|3544698|B2|Germany||Region of Enrollment||participants|Number|21|21.0||||||
3703579|NCT02169115|3544699|B1|Germany||Region of Enrollment||participants|Number|19|19.0||||||
3703580|NCT02169115|3544696|B4||Male|Gender||Participants|Count of Participants|27|27.0||||||
3703581|NCT02169115|3544697|B3||Male|Gender||Participants|Count of Participants|9|9.0||||||
3703582|NCT02169115|3544698|B2||Male|Gender||Participants|Count of Participants|12|12.0||||||
3703583|NCT02169115|3544699|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
3703584|NCT02169115|3544696|B4||Female|Gender||Participants|Count of Participants|34|34.0||||||
3703585|NCT02169115|3544697|B3||Female|Gender||Participants|Count of Participants|12|12.0||||||
3703586|NCT02169115|3544698|B2||Female|Gender||Participants|Count of Participants|9|9.0||||||
3703587|NCT02169115|3544699|B1||Female|Gender||Participants|Count of Participants|13|13.0||||||
3703588|NCT02169115|3544696|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703589|NCT02169115|3544697|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703590|NCT02169115|3544698|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703591|NCT02169115|3544699|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703592|NCT02169115|3544696|B4||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
3703593|NCT02169115|3544697|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3703594|NCT02169115|3544698|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3703595|NCT02169115|3544699|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3703596|NCT02169115|3544696|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703597|NCT02169115|3544697|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703598|NCT02169115|3544698|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703599|NCT02169115|3544699|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703600|NCT02168946|3544709|B3|||Baseline Pathogen - Klebsiella pneumoniae||Participants|Count of Participants|44|44.0||||||
3703601|NCT02168946|3544710|B2|||Baseline Pathogen - Klebsiella pneumoniae||Participants|Count of Participants|14|14.0||||||
3703602|NCT02168946|3544711|B1|||Baseline Pathogen - Klebsiella pneumoniae||Participants|Count of Participants|30|30.0||||||
3703603|NCT02168946|3544709|B3|||Creatinine Clearance <50 mL/min||Participants|Count of Participants|21|21.0||||||
3703604|NCT02168946|3544710|B2|||Creatinine Clearance <50 mL/min||Participants|Count of Participants|9|9.0||||||
3703605|NCT02168946|3544711|B1|||Creatinine Clearance <50 mL/min||Participants|Count of Participants|12|12.0||||||
3703606|NCT02168946|3544709|B3|||Systemic Inflammatory Response Syndrome (SIRS) present|SIRS is a serious condition related to systemic inflammation, organ dysfunction, and organ failure.|Participants|Count of Participants|32|32.0||||||
3703607|NCT02168946|3544710|B2|||Systemic Inflammatory Response Syndrome (SIRS) present|SIRS is a serious condition related to systemic inflammation, organ dysfunction, and organ failure.|Participants|Count of Participants|10|10.0||||||
3703608|NCT02168946|3544711|B1|||Systemic Inflammatory Response Syndrome (SIRS) present|SIRS is a serious condition related to systemic inflammation, organ dysfunction, and organ failure.|Participants|Count of Participants|22|22.0||||||
3703609|NCT02168946|3544709|B3|||Body Mass Index||kg/m^2|Mean|27.64|27.64|Standard Deviation|8.029|8.029|||
3703610|NCT02168946|3544710|B2|||Body Mass Index||kg/m^2|Mean|27.14|27.14|Standard Deviation|7.522|7.522|||
3703611|NCT02168946|3544711|B1|||Body Mass Index||kg/m^2|Mean|27.90|27.9|Standard Deviation|8.340|8.34|||
3703612|NCT02168946|3544709|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3703613|NCT02168946|3544710|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703614|NCT02168946|3544711|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3703615|NCT02168946|3544709|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703616|NCT02168946|3544710|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703617|NCT02168946|3544711|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703618|NCT02168946|3544709|B3||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3703619|NCT02168946|3544710|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3703620|NCT02168946|3544711|B1||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3703621|NCT02168946|3544709|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3703622|NCT02168946|3544710|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3703625|NCT02168946|3544710|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703626|NCT02168946|3544711|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703627|NCT02168946|3544709|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3703628|NCT02168946|3544710|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3703629|NCT02168946|3544711|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3703630|NCT02168946|3544709|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703631|NCT02168946|3544710|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703632|NCT02168946|3544711|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703633|NCT02168946|3544709|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703634|NCT02168946|3544710|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703635|NCT02168946|3544711|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703636|NCT02168946|3544709|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3703637|NCT02168946|3544710|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3703638|NCT02168946|3544711|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3703639|NCT02168946|3544709|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3703640|NCT02168946|3544710|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3703641|NCT02168946|3544711|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3703642|NCT02168946|3544709|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3703643|NCT02168946|3544710|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3703644|NCT02168946|3544711|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3703645|NCT02168946|3544709|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3703646|NCT02168946|3544710|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3703647|NCT02168946|3544711|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3703648|NCT02168946|3544709|B3|||Age||years|Mean|63.5|63.5|Standard Deviation|14.51|14.51|||
3703649|NCT02168946|3544710|B2|||Age||years|Mean|63.2|63.2|Standard Deviation|13.10|13.1|||
3703650|NCT02168946|3544711|B1|||Age||years|Mean|63.6|63.6|Standard Deviation|15.30|15.3|||
3703651|NCT02168946|3544709|B3||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
3703652|NCT02168946|3544710|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3703653|NCT02168946|3544711|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3703654|NCT02168946|3544709|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3703655|NCT02168946|3544710|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3703656|NCT02168946|3544711|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3703657|NCT02168946|3544709|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703658|NCT02168946|3544710|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703659|NCT02168946|3544711|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703660|NCT02168816|3544748|B3||Yes|Comorbid Obesity||Participants|Count of Participants|1|1.0||||||
3703661|NCT02168816|3544749|B2||Yes|Comorbid Obesity||Participants|Count of Participants|0|0.0||||||
3703662|NCT02168816|3544750|B1||Yes|Comorbid Obesity||Participants|Count of Participants|1|1.0||||||
3703663|NCT02168816|3544748|B3||No|Comorbid Obesity||Participants|Count of Participants|11|11.0||||||
3703664|NCT02168816|3544749|B2||No|Comorbid Obesity||Participants|Count of Participants|5|5.0||||||
3703665|NCT02168816|3544750|B1||No|Comorbid Obesity||Participants|Count of Participants|6|6.0||||||
3703666|NCT02168816|3544748|B3||Yes|History of Heart Attack||Participants|Count of Participants|0|0.0||||||
3703667|NCT02168816|3544749|B2||Yes|History of Heart Attack||Participants|Count of Participants|0|0.0||||||
3703668|NCT02168816|3544750|B1||Yes|History of Heart Attack||Participants|Count of Participants|0|0.0||||||
3703669|NCT02168816|3544748|B3||No|History of Heart Attack||Participants|Count of Participants|12|12.0||||||
3703670|NCT02168816|3544749|B2||No|History of Heart Attack||Participants|Count of Participants|5|5.0||||||
3703671|NCT02168816|3544750|B1||No|History of Heart Attack||Participants|Count of Participants|7|7.0||||||
3703672|NCT02168816|3544748|B3||Yes|History of Stroke||Participants|Count of Participants|0|0.0||||||
3703673|NCT02168816|3544749|B2||Yes|History of Stroke||Participants|Count of Participants|0|0.0||||||
3703674|NCT02168816|3544750|B1||Yes|History of Stroke||Participants|Count of Participants|0|0.0||||||
3703675|NCT02168816|3544748|B3||No|History of Stroke||Participants|Count of Participants|12|12.0||||||
3703676|NCT02168816|3544749|B2||No|History of Stroke||Participants|Count of Participants|5|5.0||||||
3703677|NCT02168816|3544750|B1||No|History of Stroke||Participants|Count of Participants|7|7.0||||||
3703678|NCT02168816|3544748|B3||Yes|Comorbid Cancer||Participants|Count of Participants|0|0.0||||||
3703679|NCT02168816|3544749|B2||Yes|Comorbid Cancer||Participants|Count of Participants|0|0.0||||||
3703680|NCT02168816|3544750|B1||Yes|Comorbid Cancer||Participants|Count of Participants|0|0.0||||||
3703681|NCT02168816|3544748|B3||No|Comorbid Cancer||Participants|Count of Participants|12|12.0||||||
3703682|NCT02168816|3544749|B2||No|Comorbid Cancer||Participants|Count of Participants|5|5.0||||||
3703683|NCT02168816|3544750|B1||No|Comorbid Cancer||Participants|Count of Participants|7|7.0||||||
3703684|NCT02168816|3544748|B3||Yes|Comorbid Depression||Participants|Count of Participants|0|0.0||||||
3703685|NCT02168816|3544749|B2||Yes|Comorbid Depression||Participants|Count of Participants|0|0.0||||||
3703686|NCT02168816|3544750|B1||Yes|Comorbid Depression||Participants|Count of Participants|0|0.0||||||
3703687|NCT02168816|3544748|B3||No|Comorbid Depression||Participants|Count of Participants|12|12.0||||||
3703688|NCT02168816|3544749|B2||No|Comorbid Depression||Participants|Count of Participants|5|5.0||||||
3703689|NCT02168816|3544750|B1||No|Comorbid Depression||Participants|Count of Participants|7|7.0||||||
3703690|NCT02168816|3544748|B3||Yes|Comorbid Thyroid Disorder||Participants|Count of Participants|0|0.0||||||
3703691|NCT02168816|3544749|B2||Yes|Comorbid Thyroid Disorder||Participants|Count of Participants|0|0.0||||||
3703692|NCT02168816|3544750|B1||Yes|Comorbid Thyroid Disorder||Participants|Count of Participants|0|0.0||||||
3703693|NCT02168816|3544748|B3||No|Comorbid Thyroid Disorder||Participants|Count of Participants|12|12.0||||||
3703694|NCT02168816|3544749|B2||No|Comorbid Thyroid Disorder||Participants|Count of Participants|5|5.0||||||
3703695|NCT02168816|3544750|B1||No|Comorbid Thyroid Disorder||Participants|Count of Participants|7|7.0||||||
3703696|NCT02168816|3544748|B3||Yes|Comorbid Hyperlipidemia||Participants|Count of Participants|6|6.0||||||
3703697|NCT02168816|3544749|B2||Yes|Comorbid Hyperlipidemia||Participants|Count of Participants|2|2.0||||||
3703698|NCT02168816|3544750|B1||Yes|Comorbid Hyperlipidemia||Participants|Count of Participants|4|4.0||||||
3703699|NCT02168816|3544748|B3||No|Comorbid Hyperlipidemia||Participants|Count of Participants|6|6.0||||||
3703700|NCT02168816|3544749|B2||No|Comorbid Hyperlipidemia||Participants|Count of Participants|3|3.0||||||
3703701|NCT02168816|3544750|B1||No|Comorbid Hyperlipidemia||Participants|Count of Participants|3|3.0||||||
3703702|NCT02168816|3544748|B3||Yes|Comorbid Heart Disease||Participants|Count of Participants|1|1.0||||||
3703703|NCT02168816|3544749|B2||Yes|Comorbid Heart Disease||Participants|Count of Participants|1|1.0||||||
3703704|NCT02168816|3544750|B1||Yes|Comorbid Heart Disease||Participants|Count of Participants|0|0.0||||||
3703705|NCT02168816|3544748|B3||No|Comorbid Heart Disease||Participants|Count of Participants|11|11.0||||||
3703706|NCT02168816|3544749|B2||No|Comorbid Heart Disease||Participants|Count of Participants|4|4.0||||||
3703707|NCT02168816|3544750|B1||No|Comorbid Heart Disease||Participants|Count of Participants|7|7.0||||||
3703708|NCT02168816|3544748|B3||Yes|Comorbid Hypertension||Participants|Count of Participants|8|8.0||||||
3703709|NCT02168816|3544749|B2||Yes|Comorbid Hypertension||Participants|Count of Participants|3|3.0||||||
3703710|NCT02168816|3544750|B1||Yes|Comorbid Hypertension||Participants|Count of Participants|5|5.0||||||
3703711|NCT02168816|3544748|B3||No|Comorbid Hypertension||Participants|Count of Participants|4|4.0||||||
3703712|NCT02168816|3544749|B2||No|Comorbid Hypertension||Participants|Count of Participants|2|2.0||||||
3703713|NCT02168816|3544750|B1||No|Comorbid Hypertension||Participants|Count of Participants|2|2.0||||||
3703714|NCT02168816|3544748|B3||Yes|Comorbid Chronic Kidney Disease||Participants|Count of Participants|1|1.0||||||
3703715|NCT02168816|3544749|B2||Yes|Comorbid Chronic Kidney Disease||Participants|Count of Participants|1|1.0||||||
3703716|NCT02168816|3544750|B1||Yes|Comorbid Chronic Kidney Disease||Participants|Count of Participants|0|0.0||||||
3703717|NCT02168816|3544748|B3||No|Comorbid Chronic Kidney Disease||Participants|Count of Participants|11|11.0||||||
3703718|NCT02168816|3544749|B2||No|Comorbid Chronic Kidney Disease||Participants|Count of Participants|4|4.0||||||
3703719|NCT02168816|3544750|B1||No|Comorbid Chronic Kidney Disease||Participants|Count of Participants|7|7.0||||||
3703720|NCT02168816|3544748|B3||Yes|Comorbid Coronary Artery Disease||Participants|Count of Participants|2|2.0||||||
3703721|NCT02168816|3544749|B2||Yes|Comorbid Coronary Artery Disease||Participants|Count of Participants|1|1.0||||||
3703722|NCT02168816|3544750|B1||Yes|Comorbid Coronary Artery Disease||Participants|Count of Participants|1|1.0||||||
3703723|NCT02168816|3544748|B3||No|Comorbid Coronary Artery Disease||Participants|Count of Participants|10|10.0||||||
3703724|NCT02168816|3544749|B2||No|Comorbid Coronary Artery Disease||Participants|Count of Participants|4|4.0||||||
3703725|NCT02168816|3544750|B1||No|Comorbid Coronary Artery Disease||Participants|Count of Participants|6|6.0||||||
3703726|NCT02168816|3544748|B3||Yes|Comorbid Peripheral Vascular Disease||Participants|Count of Participants|1|1.0||||||
3703727|NCT02168816|3544749|B2||Yes|Comorbid Peripheral Vascular Disease||Participants|Count of Participants|0|0.0||||||
3703728|NCT02168816|3544750|B1||Yes|Comorbid Peripheral Vascular Disease||Participants|Count of Participants|1|1.0||||||
3703729|NCT02168816|3544748|B3||No|Comorbid Peripheral Vascular Disease||Participants|Count of Participants|11|11.0||||||
3703730|NCT02168816|3544749|B2||No|Comorbid Peripheral Vascular Disease||Participants|Count of Participants|5|5.0||||||
3703731|NCT02168816|3544750|B1||No|Comorbid Peripheral Vascular Disease||Participants|Count of Participants|6|6.0||||||
3703732|NCT02168816|3544748|B3||Yes|Comorbid Diabetes||Participants|Count of Participants|12|12.0||||||
3703733|NCT02168816|3544749|B2||Yes|Comorbid Diabetes||Participants|Count of Participants|5|5.0||||||
3703734|NCT02168816|3544750|B1||Yes|Comorbid Diabetes||Participants|Count of Participants|7|7.0||||||
3703735|NCT02168816|3544748|B3||No|Comorbid Diabetes||Participants|Count of Participants|0|0.0||||||
3703736|NCT02168816|3544749|B2||No|Comorbid Diabetes||Participants|Count of Participants|0|0.0||||||
3703737|NCT02168816|3544750|B1||No|Comorbid Diabetes||Participants|Count of Participants|0|0.0||||||
3703738|NCT02168816|3544748|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3703739|NCT02168816|3544749|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3703740|NCT02168816|3544750|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3703741|NCT02168816|3544748|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3703742|NCT02168816|3544749|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703743|NCT02168816|3544750|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3703744|NCT02168816|3544748|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703745|NCT02168816|3544749|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703746|NCT02168816|3544750|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703747|NCT02168816|3544748|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3703748|NCT02168816|3544749|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3703749|NCT02168816|3544750|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3703750|NCT02168816|3544748|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3703751|NCT02168816|3544749|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3703752|NCT02168816|3544750|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3703753|NCT02168816|3544748|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703754|NCT02168816|3544749|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703755|NCT02168816|3544750|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703756|NCT02168816|3544748|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703757|NCT02168816|3544749|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703758|NCT02168816|3544750|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703759|NCT02168816|3544748|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703760|NCT02168816|3544749|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703761|NCT02168816|3544750|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703762|NCT02168816|3544748|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703763|NCT02168816|3544749|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703764|NCT02168816|3544750|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703765|NCT02168816|3544748|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3703766|NCT02168816|3544749|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3703767|NCT02168816|3544750|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3703768|NCT02168816|3544748|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3703769|NCT02168816|3544749|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3703770|NCT02168816|3544750|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3703771|NCT02168816|3544748|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3703772|NCT02168816|3544749|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3703773|NCT02168816|3544750|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3703774|NCT02168816|3544748|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703775|NCT02168816|3544749|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703776|NCT02168816|3544750|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703777|NCT02168816|3544748|B3|||Age||years|Median|54.60|54.6|Inter-Quartile Range|||37.14|65.03|
3703778|NCT02168816|3544749|B2|||Age||years|Median|45.86|45.86|Inter-Quartile Range|||37.99|62.0|
3703779|NCT02168816|3544750|B1|||Age||years|Median|56.18|56.18|Inter-Quartile Range|||36.28|70.59|
3703780|NCT02168803|3544759|B4|United States||Region of Enrollment||Participants|Count of Participants|101|101.0||||||
3703781|NCT02168803|3544760|B3|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3703782|NCT02168803|3544761|B2|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3703783|NCT02168803|3544762|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3703784|NCT02168803|3544759|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703785|NCT02168803|3544760|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703786|NCT02168803|3544761|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703787|NCT02168803|3544762|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703788|NCT02168803|3544759|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703789|NCT02168803|3544760|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703790|NCT02168803|3544761|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703791|NCT02168803|3544762|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703792|NCT02168803|3544759|B4||White|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3703793|NCT02168803|3544760|B3||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3703794|NCT02168803|3544761|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3703795|NCT02168803|3544762|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3703796|NCT02168803|3544759|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3703797|NCT02168803|3544760|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3703798|NCT02168803|3544761|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3703799|NCT02168803|3544762|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3703800|NCT02168803|3544759|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703801|NCT02168803|3544760|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703802|NCT02168803|3544761|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703803|NCT02168803|3544762|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703804|NCT02168803|3544759|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3703805|NCT02168803|3544760|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3703806|NCT02168803|3544761|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3703807|NCT02168803|3544762|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703808|NCT02168803|3544759|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703809|NCT02168803|3544760|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703810|NCT02168803|3544761|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703811|NCT02168803|3544762|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703812|NCT02168803|3544759|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703813|NCT02168803|3544760|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703814|NCT02168803|3544761|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703815|NCT02168803|3544762|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703816|NCT02168803|3544759|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3703817|NCT02168803|3544760|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3703818|NCT02168803|3544761|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3703819|NCT02168803|3544762|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3703820|NCT02168803|3544759|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3703821|NCT02168803|3544760|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3703822|NCT02168803|3544761|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3703823|NCT02168803|3544762|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3703824|NCT02168803|3544759|B4||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3703825|NCT02168803|3544760|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3703826|NCT02168803|3544761|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3703827|NCT02168803|3544762|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3703828|NCT02168803|3544759|B4||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3703829|NCT02168803|3544760|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3703830|NCT02168803|3544761|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3703831|NCT02168803|3544762|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3703832|NCT02168803|3544759|B4|||Age||years|Mean|53.8|53.8|Standard Deviation|13.0|13.0|||
3703833|NCT02168803|3544760|B3|||Age||years|Mean|56.4|56.4|Standard Deviation|9.4|9.4|||
3703834|NCT02168803|3544761|B2|||Age||years|Mean|51.1|51.1|Standard Deviation|14.9|14.9|||
3703835|NCT02168803|3544762|B1|||Age||years|Mean|53.2|53.2|Standard Deviation|14.5|14.5|||
3703836|NCT02168777|3544791|B4|Pancreatic adenocarcinoma||Cancer types||Participants|Number|2|2.0||||||
3703837|NCT02168777|3544792|B3|Pancreatic adenocarcinoma||Cancer types||Participants|Number|2|2.0||||||
3703838|NCT02168777|3544793|B2|Pancreatic adenocarcinoma||Cancer types||Participants|Number|0|0.0||||||
3703839|NCT02168777|3544794|B1|Pancreatic adenocarcinoma||Cancer types||Participants|Number|0|0.0||||||
3703840|NCT02168777|3544791|B4|Breast cancer||Cancer types||Participants|Number|4|4.0||||||
3703841|NCT02168777|3544792|B3|Breast cancer||Cancer types||Participants|Number|2|2.0||||||
3703842|NCT02168777|3544793|B2|Breast cancer||Cancer types||Participants|Number|2|2.0||||||
3703843|NCT02168777|3544794|B1|Breast cancer||Cancer types||Participants|Number|0|0.0||||||
3703844|NCT02168777|3544791|B4|Non-small cell lung cancer||Cancer types||Participants|Number|4|4.0||||||
3703845|NCT02168777|3544792|B3|Non-small cell lung cancer||Cancer types||Participants|Number|1|1.0||||||
3703846|NCT02168777|3544793|B2|Non-small cell lung cancer||Cancer types||Participants|Number|3|3.0||||||
3703847|NCT02168777|3544794|B1|Non-small cell lung cancer||Cancer types||Participants|Number|0|0.0||||||
3703848|NCT02168777|3544791|B4|Other||Cancer types||Participants|Number|5|5.0||||||
3703849|NCT02168777|3544792|B3|Other||Cancer types||Participants|Number|2|2.0||||||
3703850|NCT02168777|3544793|B2|Other||Cancer types||Participants|Number|2|2.0||||||
3703851|NCT02168777|3544794|B1|Other||Cancer types||Participants|Number|1|1.0||||||
3703852|NCT02168777|3544791|B4|Colon and rectal cancer||Cancer types||Participants|Number|5|5.0||||||
3703853|NCT02168777|3544792|B3|Colon and rectal cancer||Cancer types||Participants|Number|4|4.0||||||
3703854|NCT02168777|3544793|B2|Colon and rectal cancer||Cancer types||Participants|Number|0|0.0||||||
3703855|NCT02168777|3544794|B1|Colon and rectal cancer||Cancer types||Participants|Number|1|1.0||||||
3703856|NCT02168777|3544791|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3703857|NCT02168777|3544792|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3703858|NCT02168777|3544793|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3703859|NCT02168777|3544794|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3703860|NCT02168777|3544791|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3703861|NCT02168777|3544792|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3703862|NCT02168777|3544793|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3703863|NCT02168777|3544794|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3703864|NCT02168777|3544791|B4|||Age||Years|Mean|57.8|57.8|Standard Deviation|7.1|7.1|||
3703865|NCT02168777|3544792|B3|||Age||Years|Mean|58.6|58.6|Standard Deviation|7.3|7.3|||
3703866|NCT02168777|3544793|B2|||Age||Years|Mean|56.6|56.6|Standard Deviation|5.7|5.7|||
3703867|NCT02168777|3544794|B1|||Age||Years|Mean|57.0|57.0|Standard Deviation|14.1|14.1|||
3703868|NCT02168491|3544873|B1|Austria||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3703869|NCT02168491|3544873|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703870|NCT02168491|3544873|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703871|NCT02168491|3544873|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3703872|NCT02168491|3544873|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703873|NCT02168491|3544873|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703874|NCT02168491|3544873|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703875|NCT02168491|3544873|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703876|NCT02168491|3544873|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3703877|NCT02168491|3544873|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3703878|NCT02168491|3544873|B1|||Age||years|Mean|65.6|65.6|Standard Deviation|6.0|6.0|||
3703879|NCT02168478|3544879|B1|United States||Region of Enrollment||participants|Number|202|202.0||||||
3703880|NCT02168478|3544879|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3703881|NCT02168478|3544879|B1||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3703882|NCT02168478|3544879|B1|||Age||years|Mean|48|48.0|Full Range|||18.0|79.0|
3703883|NCT02168478|3544879|B1||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
3703884|NCT02168478|3544879|B1||Between 18 and 65 years|Age||Participants|Count of Participants|170|170.0||||||
3703885|NCT02168478|3544879|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3703886|NCT02168439|3544883|B3|||Laceration length||centimeters|Mean|1.52|1.52|Standard Deviation|.79|0.79|||
3703887|NCT02168439|3544884|B2|||Laceration length||centimeters|Mean|1.44|1.44|Standard Deviation|.73|0.73|||
3703888|NCT02168439|3544885|B1|||Laceration length||centimeters|Mean|1.59|1.59|Standard Deviation|.87|0.87|||
3703889|NCT02168439|3544883|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
3703890|NCT02168439|3544884|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
3703891|NCT02168439|3544885|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3703892|NCT02168439|3544883|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3703893|NCT02168439|3544884|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3703894|NCT02168439|3544885|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3703895|NCT02168439|3544883|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3703896|NCT02168439|3544884|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3703897|NCT02168439|3544885|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3703898|NCT02168439|3544883|B3|||Age||years|Mean|3.21|3.21|Full Range|||1.0|5.4|
3703899|NCT02168439|3544884|B2|||Age||years|Mean|3.15|3.15|Full Range|||1.0|5.4|
3703900|NCT02168439|3544885|B1|||Age||years|Mean|3.44|3.44|Full Range|||1.6|5.4|
3703901|NCT02168387|3544902|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
3703902|NCT02168387|3544903|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3703903|NCT02168387|3544904|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3703904|NCT02168387|3544902|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3703905|NCT02168387|3544903|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3703906|NCT02168387|3544904|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3703907|NCT02168387|3544902|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3703908|NCT02168387|3544903|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3703909|NCT02168387|3544904|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3703910|NCT02168387|3544902|B3|greater than 1 year||Age, Customized||participants|Number|18|18.0||||||
3703911|NCT02168387|3544903|B2|greater than 1 year||Age, Customized||participants|Number|9|9.0||||||
3703912|NCT02168387|3544904|B1|greater than 1 year||Age, Customized||participants|Number|9|9.0||||||
3703913|NCT02168387|3544902|B3|less than or equal to 1 year||Age, Customized||participants|Number|21|21.0||||||
3703914|NCT02168387|3544903|B2|less than or equal to 1 year||Age, Customized||participants|Number|10|10.0||||||
3703915|NCT02168387|3544904|B1|less than or equal to 1 year||Age, Customized||participants|Number|11|11.0||||||
3703916|NCT02168361|3544915|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3703917|NCT02168361|3544916|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3703918|NCT02168361|3544917|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3703919|NCT02168361|3544915|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3703920|NCT02168361|3544916|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3703921|NCT02168361|3544917|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3703922|NCT02168361|3544915|B3|18 years or older||Age, Customized||participants|Number|82|82.0||||||
3703923|NCT02168361|3544916|B2|18 years or older||Age, Customized||participants|Number|24|24.0||||||
3703924|NCT02168361|3544917|B1|18 years or older||Age, Customized||participants|Number|58|58.0||||||
3703925|NCT02168361|3544915|B3|Younger than 18 years old||Age, Customized||participants|Number|0|0.0||||||
3703926|NCT02168361|3544916|B2|Younger than 18 years old||Age, Customized||participants|Number|0|0.0||||||
3703927|NCT02168361|3544917|B1|Younger than 18 years old||Age, Customized||participants|Number|0|0.0||||||
3703928|NCT02168309|3544926|B3|||Body Mass Index||kg/m^2|Mean|31.7|31.7|Standard Deviation|6.0|6.0|||
3703929|NCT02168309|3544927|B2|||Body Mass Index||kg/m^2|Mean|33.0|33.0|Standard Deviation|7.8|7.8|||
3703930|NCT02168309|3544928|B1|||Body Mass Index||kg/m^2|Mean|30.3|30.3|Standard Deviation|4.1|4.1|||
3703931|NCT02168309|3544926|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3703932|NCT02168309|3544927|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3703933|NCT02168309|3544928|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3703934|NCT02168309|3544926|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703935|NCT02168309|3544927|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703936|NCT02168309|3544928|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703937|NCT02168309|3544926|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3703938|NCT02168309|3544927|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3703939|NCT02168309|3544928|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3703940|NCT02168309|3544926|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3703941|NCT02168309|3544927|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3703942|NCT02168309|3544928|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3703943|NCT02168309|3544926|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703944|NCT02168309|3544927|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703945|NCT02168309|3544928|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3703946|NCT02168309|3544926|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3703947|NCT02168309|3544927|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3703948|NCT02168309|3544928|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3703949|NCT02168309|3544926|B3|||Age||years|Mean|33.7|33.7|Standard Deviation|6.9|6.9|||
3703950|NCT02168309|3544927|B2|||Age||years|Mean|33.3|33.3|Standard Deviation|6.4|6.4|||
3703951|NCT02168309|3544928|B1|||Age||years|Mean|34|34.0|Standard Deviation|7.4|7.4|||
3703952|NCT02168309|3544926|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703953|NCT02168309|3544927|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703954|NCT02168309|3544928|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3703955|NCT02168309|3544926|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3703956|NCT02168309|3544927|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3703957|NCT02168309|3544928|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3703958|NCT02168309|3544926|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703959|NCT02168309|3544927|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703960|NCT02168309|3544928|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3703961|NCT02168270|3544937|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3703962|NCT02168270|3544937|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703963|NCT02168270|3544937|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703964|NCT02168270|3544937|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3703965|NCT02168270|3544937|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703966|NCT02168270|3544937|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703967|NCT02168270|3544937|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703968|NCT02168270|3544937|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3703969|NCT02168270|3544937|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3703970|NCT02168270|3544937|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3703971|NCT02168270|3544937|B1|||Age||years|Mean|42|42.0|Full Range|||30.0|64.0|
3703972|NCT02167893|3544944|B1|Inpatient||Healthcare Category|Participants were categorized as outpatient and inpatient.|participants|Number|496|496.0||||||
3703973|NCT02167893|3544944|B1|Outpatient||Healthcare Category|Participants were categorized as outpatient and inpatient.|participants|Number|10629|10629.0||||||
3703974|NCT02167893|3544944|B1|Other treatments||Breakdown for Prior Treatment for Prostate Cancer|LH-RH (luteinizing hormone releasing hormone)|participants|Number|72|72.0||||||
3703975|NCT02167893|3544944|B1|Radiotherapy||Breakdown for Prior Treatment for Prostate Cancer|LH-RH (luteinizing hormone releasing hormone)|participants|Number|561|561.0||||||
3703976|NCT02167893|3544944|B1|Total prostatectomy||Breakdown for Prior Treatment for Prostate Cancer|LH-RH (luteinizing hormone releasing hormone)|participants|Number|734|734.0||||||
3703977|NCT02167893|3544944|B1|Other chemotherapies||Breakdown for Prior Treatment for Prostate Cancer|LH-RH (luteinizing hormone releasing hormone)|participants|Number|49|49.0||||||
3703978|NCT02167893|3544944|B1|Other endocrine therapies||Breakdown for Prior Treatment for Prostate Cancer|LH-RH (luteinizing hormone releasing hormone)|participants|Number|7596|7596.0||||||
3703979|NCT02167893|3544944|B1|LH-RH agonists (other than leuplin SR 11.25 mg)||Breakdown for Prior Treatment for Prostate Cancer|LH-RH (luteinizing hormone releasing hormone)|participants|Number|7220|7220.0||||||
3703980|NCT02167893|3544944|B1|Unknown||Prior Treatment for Prostate Cancer|This baseline measure was analyzed in participants who had treatment for prostate cancer prior to the start of treatment with leuplin SR 11.25 mg. Participants may be represented in more than 1 category.|participants|Number|2|2.0||||||
3703981|NCT02167893|3544944|B1|Had no prior treatment||Prior Treatment for Prostate Cancer|This baseline measure was analyzed in participants who had treatment for prostate cancer prior to the start of treatment with leuplin SR 11.25 mg. Participants may be represented in more than 1 category.|participants|Number|1799|1799.0||||||
3703982|NCT02167893|3544944|B1|Had prior treatment||Prior Treatment for Prostate Cancer|This baseline measure was analyzed in participants who had treatment for prostate cancer prior to the start of treatment with leuplin SR 11.25 mg. Participants may be represented in more than 1 category.|participants|Number|9324|9324.0||||||
3703983|NCT02167893|3544944|B1|Other||Breakdown of Complications|This baseline characteristic was analyzed in participants who had hypertension, heart disease, diabetes mellitus, hyperlipidemia, malignant tumor, cerebrovascular disease, and any other medical complications.|participants|Number|4617|4617.0||||||
3703984|NCT02167893|3544944|B1|Malignant tumor||Breakdown of Complications|This baseline characteristic was analyzed in participants who had hypertension, heart disease, diabetes mellitus, hyperlipidemia, malignant tumor, cerebrovascular disease, and any other medical complications.|participants|Number|456|456.0||||||
3703985|NCT02167893|3544944|B1|Cerebrovascular disease||Breakdown of Complications|This baseline characteristic was analyzed in participants who had hypertension, heart disease, diabetes mellitus, hyperlipidemia, malignant tumor, cerebrovascular disease, and any other medical complications.|participants|Number|547|547.0||||||
3703986|NCT02167893|3544944|B1|Hyperlipidemia||Breakdown of Complications|This baseline characteristic was analyzed in participants who had hypertension, heart disease, diabetes mellitus, hyperlipidemia, malignant tumor, cerebrovascular disease, and any other medical complications.|participants|Number|799|799.0||||||
3703987|NCT02167893|3544944|B1|Diabetes mellitus||Breakdown of Complications|This baseline characteristic was analyzed in participants who had hypertension, heart disease, diabetes mellitus, hyperlipidemia, malignant tumor, cerebrovascular disease, and any other medical complications.|participants|Number|1147|1147.0||||||
3703988|NCT02167893|3544944|B1|Heart disease||Breakdown of Complications|This baseline characteristic was analyzed in participants who had hypertension, heart disease, diabetes mellitus, hyperlipidemia, malignant tumor, cerebrovascular disease, and any other medical complications.|participants|Number|1208|1208.0||||||
3703989|NCT02167893|3544944|B1|Hypertension||Breakdown of Complications|This baseline characteristic was analyzed in participants who had hypertension, heart disease, diabetes mellitus, hyperlipidemia, malignant tumor, cerebrovascular disease, and any other medical complications.|participants|Number|3195|3195.0||||||
3703990|NCT02167893|3544944|B1|Unknown||Medical Complications|Participants may be represented in more than 1 category.|participants|Number|2|2.0||||||
3703991|NCT02167893|3544944|B1|Had no Complications||Medical Complications|Participants may be represented in more than 1 category.|participants|Number|3889|3889.0||||||
3703992|NCT02167893|3544944|B1|Had Complications||Medical Complications|Participants may be represented in more than 1 category.|participants|Number|7234|7234.0||||||
3703993|NCT02167893|3544944|B1|Unknown||Predisposition to Hypersensitivity||participants|Number|1|1.0||||||
3703994|NCT02167893|3544944|B1|Had no redisposition to Hypersensitivity||Predisposition to Hypersensitivity||participants|Number|10594|10594.0||||||
3703995|NCT02167893|3544944|B1|Had predisposition to Hypersensitivity||Predisposition to Hypersensitivity||participants|Number|530|530.0||||||
3703996|NCT02167893|3544944|B1|Unknown||Performance Status (at start of treatment with leuplin SR 11.25 mg injection)|Following are ECOG grades. 0: Fully active, perform all pre-disease activities without restriction. 1: Restricted in physically strenuous activity but ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of selfcare, unable to carry out any work activities, up and about more than (>) 50% of waking hours. 3: Capable of limited selfcare, confined to bed or chair >50% of waking hours. 4: Completely disabled, not capable of any selfcare, totally confined to bed or chair.|participants|Number|40|40.0||||||
3703997|NCT02167893|3544944|B1|4||Performance Status (at start of treatment with leuplin SR 11.25 mg injection)|Following are ECOG grades. 0: Fully active, perform all pre-disease activities without restriction. 1: Restricted in physically strenuous activity but ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of selfcare, unable to carry out any work activities, up and about more than (>) 50% of waking hours. 3: Capable of limited selfcare, confined to bed or chair >50% of waking hours. 4: Completely disabled, not capable of any selfcare, totally confined to bed or chair.|participants|Number|72|72.0||||||
3703998|NCT02167893|3544944|B1|3||Performance Status (at start of treatment with leuplin SR 11.25 mg injection)|Following are ECOG grades. 0: Fully active, perform all pre-disease activities without restriction. 1: Restricted in physically strenuous activity but ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of selfcare, unable to carry out any work activities, up and about more than (>) 50% of waking hours. 3: Capable of limited selfcare, confined to bed or chair >50% of waking hours. 4: Completely disabled, not capable of any selfcare, totally confined to bed or chair.|participants|Number|230|230.0||||||
3703999|NCT02167893|3544944|B1|2||Performance Status (at start of treatment with leuplin SR 11.25 mg injection)|Following are ECOG grades. 0: Fully active, perform all pre-disease activities without restriction. 1: Restricted in physically strenuous activity but ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of selfcare, unable to carry out any work activities, up and about more than (>) 50% of waking hours. 3: Capable of limited selfcare, confined to bed or chair >50% of waking hours. 4: Completely disabled, not capable of any selfcare, totally confined to bed or chair.|participants|Number|518|518.0||||||
3704015|NCT02167867|3544953|B3|||Body Weight||pounds|Mean|NA||Standard Deviation|NA||||Measure of weight was not recorded to Lay End Users as it is not relevant to this group; therefore, average values cannot be calculated.
3704016|NCT02167867|3544954|B2|||Body Weight||pounds|Mean|152.75|152.75|Standard Deviation|25.59|25.59|||
3704000|NCT02167893|3544944|B1|1||Performance Status (at start of treatment with leuplin SR 11.25 mg injection)|Following are ECOG grades. 0: Fully active, perform all pre-disease activities without restriction. 1: Restricted in physically strenuous activity but ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of selfcare, unable to carry out any work activities, up and about more than (>) 50% of waking hours. 3: Capable of limited selfcare, confined to bed or chair >50% of waking hours. 4: Completely disabled, not capable of any selfcare, totally confined to bed or chair.|participants|Number|1688|1688.0||||||
3704001|NCT02167893|3544944|B1|0||Performance Status (at start of treatment with leuplin SR 11.25 mg injection)|Following are ECOG grades. 0: Fully active, perform all pre-disease activities without restriction. 1: Restricted in physically strenuous activity but ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of selfcare, unable to carry out any work activities, up and about more than (>) 50% of waking hours. 3: Capable of limited selfcare, confined to bed or chair >50% of waking hours. 4: Completely disabled, not capable of any selfcare, totally confined to bed or chair.|participants|Number|8577|8577.0||||||
3704002|NCT02167893|3544944|B1|Unknown||Tumor Node Metastasis(TNM) Classification (at start of treatment with leuplin SR 11.25 mg injection)|TNM classification based on tumor size, if cancer cells had spread to nearby lymph nodes (LN), or distant metastasis. Stages included: stage 0(no evidence of cancer cells),stage 1(T1N0M0), stage IIA(T0N1M0, T1N1M0, T2N0M0), stage IIB(T2N1M0, T3N0M0), stage IIIA(T0N2M0, T1N2M0, T2N3M0, T3N1orN2M0),stage IIIb( T4 anyNM0, any TN3M0),stage IIIC(any TN3M0), stage IV(any T any NM1), where T0=early form of tumor, T1=<2 centimeter (cm), T2=2-5 cm, T3=>2 cm, T4=large sized, N0=not spread to LN, N1=spread to 1 to 3,N2=spread to 4 to 9,N3=spread >10 axillary LN, M0=no metastasis, M1= Metastasis.|participants|Number|1|1.0||||||
3704003|NCT02167893|3544944|B1|Cannot be assessed||Tumor Node Metastasis(TNM) Classification (at start of treatment with leuplin SR 11.25 mg injection)|TNM classification based on tumor size, if cancer cells had spread to nearby lymph nodes (LN), or distant metastasis. Stages included: stage 0(no evidence of cancer cells),stage 1(T1N0M0), stage IIA(T0N1M0, T1N1M0, T2N0M0), stage IIB(T2N1M0, T3N0M0), stage IIIA(T0N2M0, T1N2M0, T2N3M0, T3N1orN2M0),stage IIIb( T4 anyNM0, any TN3M0),stage IIIC(any TN3M0), stage IV(any T any NM1), where T0=early form of tumor, T1=<2 centimeter (cm), T2=2-5 cm, T3=>2 cm, T4=large sized, N0=not spread to LN, N1=spread to 1 to 3,N2=spread to 4 to 9,N3=spread >10 axillary LN, M0=no metastasis, M1= Metastasis.|participants|Number|391|391.0||||||
3704004|NCT02167893|3544944|B1|Stage IV||Tumor Node Metastasis(TNM) Classification (at start of treatment with leuplin SR 11.25 mg injection)|TNM classification based on tumor size, if cancer cells had spread to nearby lymph nodes (LN), or distant metastasis. Stages included: stage 0(no evidence of cancer cells),stage 1(T1N0M0), stage IIA(T0N1M0, T1N1M0, T2N0M0), stage IIB(T2N1M0, T3N0M0), stage IIIA(T0N2M0, T1N2M0, T2N3M0, T3N1orN2M0),stage IIIb( T4 anyNM0, any TN3M0),stage IIIC(any TN3M0), stage IV(any T any NM1), where T0=early form of tumor, T1=<2 centimeter (cm), T2=2-5 cm, T3=>2 cm, T4=large sized, N0=not spread to LN, N1=spread to 1 to 3,N2=spread to 4 to 9,N3=spread >10 axillary LN, M0=no metastasis, M1= Metastasis.|participants|Number|2608|2608.0||||||
3704005|NCT02167893|3544944|B1|Stage III||Tumor Node Metastasis(TNM) Classification (at start of treatment with leuplin SR 11.25 mg injection)|TNM classification based on tumor size, if cancer cells had spread to nearby lymph nodes (LN), or distant metastasis. Stages included: stage 0(no evidence of cancer cells),stage 1(T1N0M0), stage IIA(T0N1M0, T1N1M0, T2N0M0), stage IIB(T2N1M0, T3N0M0), stage IIIA(T0N2M0, T1N2M0, T2N3M0, T3N1orN2M0),stage IIIb( T4 anyNM0, any TN3M0),stage IIIC(any TN3M0), stage IV(any T any NM1), where T0=early form of tumor, T1=<2 centimeter (cm), T2=2-5 cm, T3=>2 cm, T4=large sized, N0=not spread to LN, N1=spread to 1 to 3,N2=spread to 4 to 9,N3=spread >10 axillary LN, M0=no metastasis, M1= Metastasis.|participants|Number|2066|2066.0||||||
3704006|NCT02167893|3544944|B1|Stage II||Tumor Node Metastasis(TNM) Classification (at start of treatment with leuplin SR 11.25 mg injection)|TNM classification based on tumor size, if cancer cells had spread to nearby lymph nodes (LN), or distant metastasis. Stages included: stage 0(no evidence of cancer cells),stage 1(T1N0M0), stage IIA(T0N1M0, T1N1M0, T2N0M0), stage IIB(T2N1M0, T3N0M0), stage IIIA(T0N2M0, T1N2M0, T2N3M0, T3N1orN2M0),stage IIIb( T4 anyNM0, any TN3M0),stage IIIC(any TN3M0), stage IV(any T any NM1), where T0=early form of tumor, T1=<2 centimeter (cm), T2=2-5 cm, T3=>2 cm, T4=large sized, N0=not spread to LN, N1=spread to 1 to 3,N2=spread to 4 to 9,N3=spread >10 axillary LN, M0=no metastasis, M1= Metastasis.|participants|Number|5197|5197.0||||||
3704007|NCT02167893|3544944|B1|Stage I||Tumor Node Metastasis(TNM) Classification (at start of treatment with leuplin SR 11.25 mg injection)|TNM classification based on tumor size, if cancer cells had spread to nearby lymph nodes (LN), or distant metastasis. Stages included: stage 0(no evidence of cancer cells),stage 1(T1N0M0), stage IIA(T0N1M0, T1N1M0, T2N0M0), stage IIB(T2N1M0, T3N0M0), stage IIIA(T0N2M0, T1N2M0, T2N3M0, T3N1orN2M0),stage IIIb( T4 anyNM0, any TN3M0),stage IIIC(any TN3M0), stage IV(any T any NM1), where T0=early form of tumor, T1=<2 centimeter (cm), T2=2-5 cm, T3=>2 cm, T4=large sized, N0=not spread to LN, N1=spread to 1 to 3,N2=spread to 4 to 9,N3=spread >10 axillary LN, M0=no metastasis, M1= Metastasis.|participants|Number|529|529.0||||||
3704008|NCT02167893|3544944|B1|No lesions||Tumor Node Metastasis(TNM) Classification (at start of treatment with leuplin SR 11.25 mg injection)|TNM classification based on tumor size, if cancer cells had spread to nearby lymph nodes (LN), or distant metastasis. Stages included: stage 0(no evidence of cancer cells),stage 1(T1N0M0), stage IIA(T0N1M0, T1N1M0, T2N0M0), stage IIB(T2N1M0, T3N0M0), stage IIIA(T0N2M0, T1N2M0, T2N3M0, T3N1orN2M0),stage IIIb( T4 anyNM0, any TN3M0),stage IIIC(any TN3M0), stage IV(any T any NM1), where T0=early form of tumor, T1=<2 centimeter (cm), T2=2-5 cm, T3=>2 cm, T4=large sized, N0=not spread to LN, N1=spread to 1 to 3,N2=spread to 4 to 9,N3=spread >10 axillary LN, M0=no metastasis, M1= Metastasis.|participants|Number|333|333.0||||||
3704009|NCT02167893|3544944|B1|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|22.87|22.87|Standard Deviation|3.10|3.1|||
3704010|NCT02167893|3544944|B1|Male||Sex/Gender, Customized||participants|Number|11125|11125.0||||||
3704011|NCT02167893|3544944|B1|||Age||years|Mean|75.88|75.88|Standard Deviation|7.04|7.04|||
3704012|NCT02167867|3544953|B3|||Body Mass Index (BMI)||kg/m2|Mean|NA||Standard Deviation|NA||||Body Mass Index was not measures for Lay End Users as the measure is not relevant to this group; therefore average values cannot be calculated.
3704013|NCT02167867|3544954|B2|||Body Mass Index (BMI)||kg/m2|Mean|24.68|24.68|Standard Deviation|2.06|2.06|||
3704014|NCT02167867|3544955|B1|||Body Mass Index (BMI)||kg/m2|Mean|NA||Standard Deviation|NA||||Body Mass Index was not measures for Lay End Users as the measure is not relevant to this group.
3704132|NCT02167035|3544999|B3||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
3704017|NCT02167867|3544955|B1|||Body Weight||pounds|Mean|NA||Standard Deviation|NA||||Measure of weight was not recorded to Lay End Users as it is not relevant to this group
3704018|NCT02167867|3544953|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
3704019|NCT02167867|3544954|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
3704020|NCT02167867|3544955|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3704021|NCT02167867|3544953|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704022|NCT02167867|3544954|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704023|NCT02167867|3544955|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704024|NCT02167867|3544953|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3704025|NCT02167867|3544954|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704026|NCT02167867|3544955|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3704027|NCT02167867|3544953|B3||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3704028|NCT02167867|3544954|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3704029|NCT02167867|3544955|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3704030|NCT02167867|3544953|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704031|NCT02167867|3544954|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704032|NCT02167867|3544955|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704033|NCT02167867|3544953|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704034|NCT02167867|3544954|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704035|NCT02167867|3544955|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704036|NCT02167867|3544953|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704037|NCT02167867|3544954|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704038|NCT02167867|3544955|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704039|NCT02167867|3544953|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704040|NCT02167867|3544954|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704041|NCT02167867|3544955|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704042|NCT02167867|3544953|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3704043|NCT02167867|3544954|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3704044|NCT02167867|3544955|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3704045|NCT02167867|3544953|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3704046|NCT02167867|3544954|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3704047|NCT02167867|3544955|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3704048|NCT02167867|3544953|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3704049|NCT02167867|3544954|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3704050|NCT02167867|3544955|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3704051|NCT02167867|3544953|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3704052|NCT02167867|3544954|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3704053|NCT02167867|3544955|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3704054|NCT02167867|3544953|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3704055|NCT02167867|3544954|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3704056|NCT02167867|3544955|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3704057|NCT02167815|3544962|B3|Czech Republic||Region of Enrollment||participants|Number|30|30.0||||||
3704058|NCT02167815|3544963|B2|Czech Republic||Region of Enrollment||participants|Number|21|21.0||||||
3704059|NCT02167815|3544964|B1|Czech Republic||Region of Enrollment||participants|Number|9|9.0||||||
3704060|NCT02167815|3544962|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3704061|NCT02167815|3544963|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3704062|NCT02167815|3544964|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3704063|NCT02167815|3544962|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3704064|NCT02167815|3544963|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3704065|NCT02167815|3544964|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3704066|NCT02167815|3544962|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3704067|NCT02167815|3544963|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3704068|NCT02167815|3544964|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3704069|NCT02167815|3544962|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3704070|NCT02167815|3544963|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3704071|NCT02167815|3544964|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3704072|NCT02167815|3544962|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3704073|NCT02167815|3544963|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3704074|NCT02167815|3544964|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3704133|NCT02167035|3545000|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3704075|NCT02167217|3544976|B1|||Bayley III Gross Motor Scaled Score|This scale is normed to typically developing children where at any age a child's expected score is 10 +/-3. This scale assesses gross motor function including sitting, standing and walking.|units on a scale|Mean|4.2|4.2|Standard Deviation|2.5|2.5|||
3704076|NCT02167217|3544976|B1|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3704077|NCT02167217|3544976|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3704078|NCT02167217|3544976|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704079|NCT02167217|3544976|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3704080|NCT02167217|3544976|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3704081|NCT02167217|3544976|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704082|NCT02167217|3544976|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3704083|NCT02167217|3544976|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704084|NCT02167217|3544976|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3704085|NCT02167217|3544976|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3704086|NCT02167217|3544976|B1|||Age||years|Mean|1.5|1.5|Standard Deviation|0.8|0.8|||
3704087|NCT02167217|3544976|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3704088|NCT02167217|3544976|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3704089|NCT02167217|3544976|B1||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
3704090|NCT02167139|3544980|B3||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3704091|NCT02167139|3544981|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3704092|NCT02167139|3544982|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3704093|NCT02167139|3544980|B3||Female|Sex: Female, Male||Participants|Count of Participants|441|441.0||||||
3704094|NCT02167139|3544981|B2||Female|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
3704095|NCT02167139|3544982|B1||Female|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
3704096|NCT02167139|3544980|B3|||Age||years|Mean|51.2|51.2|Standard Deviation|12.36|12.36|||
3704097|NCT02167139|3544981|B2|||Age||years|Mean|52.5|52.5|Standard Deviation|11.91|11.91|||
3704098|NCT02167139|3544982|B1|||Age||years|Mean|49.8|49.8|Standard Deviation|12.67|12.67|||
3704099|NCT02167035|3544999|B3|United States||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
3704100|NCT02167035|3545000|B2|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3704101|NCT02167035|3545001|B1|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3704102|NCT02167035|3544999|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704103|NCT02167035|3545000|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704104|NCT02167035|3545001|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704105|NCT02167035|3544999|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704106|NCT02167035|3545000|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704107|NCT02167035|3545001|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704108|NCT02167035|3544999|B3||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3704109|NCT02167035|3545000|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3704110|NCT02167035|3545001|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3704111|NCT02167035|3544999|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3704112|NCT02167035|3545000|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3704113|NCT02167035|3545001|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3704114|NCT02167035|3544999|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704115|NCT02167035|3545000|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704116|NCT02167035|3545001|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704117|NCT02167035|3544999|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704118|NCT02167035|3545000|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704119|NCT02167035|3545001|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704120|NCT02167035|3544999|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704121|NCT02167035|3545000|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704122|NCT02167035|3545001|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704123|NCT02167035|3544999|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3704124|NCT02167035|3545000|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3704125|NCT02167035|3545001|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3704126|NCT02167035|3544999|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3704127|NCT02167035|3545000|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3704128|NCT02167035|3545001|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3704129|NCT02167035|3544999|B3|||Age||years|Mean|67.8|67.8|Standard Deviation|9.89|9.89|||
3704130|NCT02167035|3545000|B2|||Age||years|Mean|67.7|67.7|Standard Deviation|8.43|8.43|||
3704131|NCT02167035|3545001|B1|||Age||years|Mean|67.9|67.9|Standard Deviation|11.43|11.43|||
3704134|NCT02167035|3545001|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3704135|NCT02167035|3544999|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3704136|NCT02167035|3545000|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3704137|NCT02167035|3545001|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3704138|NCT02167035|3544999|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3704139|NCT02167035|3545000|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3704140|NCT02167035|3545001|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3704141|NCT02166697|3545010|B1|||Pulse Wave Velocity|Pulse wave velocity (PWV) is a measure of arterial stiffness, or the rate at which pressure waves move down the vessel.|Centimeter per second (cm/s)|Mean|1713.8|1713.8|Standard Deviation|523.8|523.8|||
3704142|NCT02166697|3545010|B1|Other||Breakdown of Other Concomitant Medication|Participants may be represented in more than 1 category.|Participants|Number|3005|3005.0||||||
3704143|NCT02166697|3545010|B1|Antigout Drugs or Antihyperuricemic Drugs||Breakdown of Other Concomitant Medication|Participants may be represented in more than 1 category.|Participants|Number|903|903.0||||||
3704144|NCT02166697|3545010|B1|Antithrombotic Drugs||Breakdown of Other Concomitant Medication|Participants may be represented in more than 1 category.|Participants|Number|1322|1322.0||||||
3704145|NCT02166697|3545010|B1|Had Consumption||Consumption of Other Concomitant Medications||Participants|Number|4694|4694.0||||||
3704146|NCT02166697|3545010|B1|Had no Consumption||Consumption of Other Concomitant Medications||Participants|Number|9110|9110.0||||||
3704147|NCT02166697|3545010|B1|Other||Breakdown of Concomitant Antihyperlipidemic Drugs|Participants may be represented in more than 1 category.|Participants|Number|122|122.0||||||
3704148|NCT02166697|3545010|B1|Eicosapentaenoic Acid||Breakdown of Concomitant Antihyperlipidemic Drugs|Participants may be represented in more than 1 category.|Participants|Number|230|230.0||||||
3704149|NCT02166697|3545010|B1|Fibrates||Breakdown of Concomitant Antihyperlipidemic Drugs|Participants may be represented in more than 1 category.|Participants|Number|730|730.0||||||
3704150|NCT02166697|3545010|B1|Statins||Breakdown of Concomitant Antihyperlipidemic Drugs|Participants may be represented in more than 1 category.|Participants|Number|3784|3784.0||||||
3704151|NCT02166697|3545010|B1|Had Consumption||Consumption of Concomitant Antihyperlipidemic Drugs||Participants|Number|4692|4692.0||||||
3704152|NCT02166697|3545010|B1|Had no Consumption||Consumption of Concomitant Antihyperlipidemic Drugs||Participants|Number|9112|9112.0||||||
3704153|NCT02166697|3545010|B1|Other||Breakdown of Concomitant Antidiabetic Medications|Participants may be represented in more than 1 category.|Participants|Number|44|44.0||||||
3704154|NCT02166697|3545010|B1|Insulin||Breakdown of Concomitant Antidiabetic Medications|Participants may be represented in more than 1 category.|Participants|Number|364|364.0||||||
3704155|NCT02166697|3545010|B1|Biguanides||Breakdown of Concomitant Antidiabetic Medications|Participants may be represented in more than 1 category.|Participants|Number|686|686.0||||||
3704156|NCT02166697|3545010|B1|Short Acting Insulin Secretagogues||Breakdown of Concomitant Antidiabetic Medications|Participants may be represented in more than 1 category.|Participants|Number|306|306.0||||||
3704157|NCT02166697|3545010|B1|Sulfonylurea Drugs||Breakdown of Concomitant Antidiabetic Medications|Participants may be represented in more than 1 category.|Participants|Number|1728|1728.0||||||
3704158|NCT02166697|3545010|B1|Insulin Sensitizers||Breakdown of Concomitant Antidiabetic Medications|Participants may be represented in more than 1 category.|Participants|Number|1077|1077.0||||||
3704159|NCT02166697|3545010|B1|Alpha-Glucosidase Inhibitor||Breakdown of Concomitant Antidiabetic Medications|Participants may be represented in more than 1 category.|Participants|Number|1127|1127.0||||||
3704160|NCT02166697|3545010|B1|Had Consumption||Consumption of Concomitant Antidiabetic Medications||Participants|Number|3310|3310.0||||||
3704161|NCT02166697|3545010|B1|Had no consumption||Consumption of Concomitant Antidiabetic Medications||Participants|Number|10494|10494.0||||||
3704162|NCT02166697|3545010|B1|Other||Breakdown of Concomitant Antihypertensive Medications|Participants may be represented in more than 1 category.|Participants|Number|69|69.0||||||
3704163|NCT02166697|3545010|B1|Angiotensin2ReceptorBlockers(other than Blopress)||Breakdown of Concomitant Antihypertensive Medications|Participants may be represented in more than 1 category.|Participants|Number|131|131.0||||||
3704164|NCT02166697|3545010|B1|Angiotensin Converting Enzyme (ACE) Inhibitors||Breakdown of Concomitant Antihypertensive Medications|Participants may be represented in more than 1 category.|Participants|Number|262|262.0||||||
3704165|NCT02166697|3545010|B1|Calcium Blockers||Breakdown of Concomitant Antihypertensive Medications|Participants may be represented in more than 1 category.|Participants|Number|4886|4886.0||||||
3704166|NCT02166697|3545010|B1|Alpha-Beta or Beta-Blockers||Breakdown of Concomitant Antihypertensive Medications|Participants may be represented in more than 1 category.|Participants|Number|867|867.0||||||
3704167|NCT02166697|3545010|B1|Alpha-Blockers||Breakdown of Concomitant Antihypertensive Medications|Participants may be represented in more than 1 category.|Participants|Number|323|323.0||||||
3704168|NCT02166697|3545010|B1|Diuretics||Breakdown of Concomitant Antihypertensive Medications|Participants may be represented in more than 1 category.|Participants|Number|705|705.0||||||
3704169|NCT02166697|3545010|B1|Had Consumption||Consumption of Concomitant Antihypertensive Medications||Participants|Number|5798|5798.0||||||
3704170|NCT02166697|3545010|B1|Had no Consumption||Consumption of Concomitant Antihypertensive Medications||Participants|Number|8006|8006.0||||||
3704171|NCT02166697|3545010|B1|Atrial fibrillation||Breakdown of Medical History|Participants may be represented in more than 1 category.|Participants|Number|257|257.0||||||
3704172|NCT02166697|3545010|B1|Renal Dialysis||Breakdown of Medical History|Participants may be represented in more than 1 category.|Participants|Number|0|0.0||||||
3704173|NCT02166697|3545010|B1|Diabetic Retinopathy||Breakdown of Medical History|Participants may be represented in more than 1 category.|Participants|Number|3|3.0||||||
3704174|NCT02166697|3545010|B1|Other Cerebrovascular/Cardiovascular Diseases||Breakdown of Medical History|Participants may be represented in more than 1 category.|Participants|Number|615|615.0||||||
3704225|NCT02166697|3545010|B1|12 mg||Initial Daily Dose of Blopress||Participants|Number|1104|1104.0||||||
3704175|NCT02166697|3545010|B1|Hyperlipidemia||Breakdown of Medical History|Participants may be represented in more than 1 category.|Participants|Number|7841|7841.0||||||
3704176|NCT02166697|3545010|B1|Diabetes Mellitus||Breakdown of Medical History|Participants may be represented in more than 1 category.|Participants|Number|4755|4755.0||||||
3704177|NCT02166697|3545010|B1|Angina Pectoris||Breakdown of Medical History|Participants may be represented in more than 1 category.|Participants|Number|463|463.0||||||
3704178|NCT02166697|3545010|B1|Cardiac Failure||Breakdown of Medical History|Participants may be represented in more than 1 category.|Participants|Number|121|121.0||||||
3704179|NCT02166697|3545010|B1|Myocardial Infarction||Breakdown of Medical History|Participants may be represented in more than 1 category.|Participants|Number|153|153.0||||||
3704180|NCT02166697|3545010|B1|Subarachnoid Hemorrhage||Breakdown of Medical History|Participants may be represented in more than 1 category.|Participants|Number|22|22.0||||||
3704181|NCT02166697|3545010|B1|Cerebral Hemorrhage||Breakdown of Medical History|Participants may be represented in more than 1 category.|Participants|Number|63|63.0||||||
3704182|NCT02166697|3545010|B1|Cerebral Infarction||Breakdown of Medical History|Participants may be represented in more than 1 category.|Participants|Number|593|593.0||||||
3704183|NCT02166697|3545010|B1|Unknown||Medical History||Participants|Number|136|136.0||||||
3704184|NCT02166697|3545010|B1|Have Medical History||Medical History||Participants|Number|9835|9835.0||||||
3704185|NCT02166697|3545010|B1|Did not Have Medical History||Medical History||Participants|Number|3833|3833.0||||||
3704186|NCT02166697|3545010|B1|Unknown||Predisposition to Hypersensitivity||Participants|Number|854|854.0||||||
3704187|NCT02166697|3545010|B1|Had Predisposition to Hypersensitivity||Predisposition to Hypersensitivity||Participants|Number|691|691.0||||||
3704188|NCT02166697|3545010|B1|Had no Predisposition to Hypersensitivity||Predisposition to Hypersensitivity||Participants|Number|12259|12259.0||||||
3704189|NCT02166697|3545010|B1|Alcohol Consumer||Alcohol Consumption||Participants|Number|5539|5539.0||||||
3704190|NCT02166697|3545010|B1|Alcohol Non-Consumer||Alcohol Consumption||Participants|Number|8265|8265.0||||||
3704191|NCT02166697|3545010|B1|Smoker||Smoking Status||Participants|Number|2981|2981.0||||||
3704192|NCT02166697|3545010|B1|Non Smoker||Smoking Status||Participants|Number|10823|10823.0||||||
3704193|NCT02166697|3545010|B1|||Leptin||Nanogram per milliliter (ng/mL)|Mean|9.20|9.2|Standard Deviation|8.24|8.24|||
3704194|NCT02166697|3545010|B1|||Adiponectin||Microgram per milliliter (mcg/mL)|Mean|5.80|5.8|Standard Deviation|6.92|6.92|||
3704195|NCT02166697|3545010|B1|||Apoprotein B||mg/dL|Mean|104.1|104.1|Standard Deviation|27.5|27.5|||
3704196|NCT02166697|3545010|B1|||Apoprotein A||mg/dL|Mean|145.4|145.4|Standard Deviation|24.5|24.5|||
3704197|NCT02166697|3545010|B1|||Insulin|mcU/mL stands for micro international units per milliliter.|mcU/mL|Mean|11.09|11.09|Standard Deviation|11.38|11.38|||
3704198|NCT02166697|3545010|B1|||Microalbumin in Urine||Milligram per day (mg/day)|Mean|158.5|158.5|Standard Deviation|653.6|653.6|||
3704199|NCT02166697|3545010|B1|Unknown||Urinary Sugar||Participants|Number|2999|2999.0||||||
3704200|NCT02166697|3545010|B1|1000 mg/dL||Urinary Sugar||Participants|Number|566|566.0||||||
3704201|NCT02166697|3545010|B1|500 mg/dL||Urinary Sugar||Participants|Number|330|330.0||||||
3704202|NCT02166697|3545010|B1|250 mg/dL||Urinary Sugar||Participants|Number|596|596.0||||||
3704203|NCT02166697|3545010|B1|100 mg/dL||Urinary Sugar||Participants|Number|406|406.0||||||
3704204|NCT02166697|3545010|B1|0 mg/dL||Urinary Sugar||Participants|Number|8907|8907.0||||||
3704205|NCT02166697|3545010|B1|Unknown||Urinary Protein|Protein dipstick grading was used to analyze concentration of urinary protein.|Participants|Number|2973|2973.0||||||
3704206|NCT02166697|3545010|B1|300-1000mg/dL||Urinary Protein|Protein dipstick grading was used to analyze concentration of urinary protein.|Participants|Number|185|185.0||||||
3704207|NCT02166697|3545010|B1|100-300mg/dL||Urinary Protein|Protein dipstick grading was used to analyze concentration of urinary protein.|Participants|Number|440|440.0||||||
3704208|NCT02166697|3545010|B1|30-300mg/dL||Urinary Protein|Protein dipstick grading was used to analyze concentration of urinary protein.|Participants|Number|836|836.0||||||
3704209|NCT02166697|3545010|B1|15-30mg/dL||Urinary Protein|Protein dipstick grading was used to analyze concentration of urinary protein.|Participants|Number|1005|1005.0||||||
3704210|NCT02166697|3545010|B1|0 mg/dL||Urinary Protein|Protein dipstick grading was used to analyze concentration of urinary protein.|Participants|Number|8365|8365.0||||||
3704211|NCT02166697|3545010|B1|||Serum Creatinine||mg/dL|Mean|0.76|0.76|Standard Deviation|0.29|0.29|||
3704212|NCT02166697|3545010|B1|||Total Cholesterol||mg/dL|Mean|212.1|212.1|Standard Deviation|37.7|37.7|||
3704213|NCT02166697|3545010|B1|||Glycated Hemoglobin (HbA1c)|It is reported as per National Glycohemoglobin Standardization Program (NGSP) value.|Hemoglobin Percent|Mean|6.46|6.46|Standard Deviation|1.36|1.36|||
3704214|NCT02166697|3545010|B1|||Fasting Blood Glucose||mg/dL|Mean|118.4|118.4|Standard Deviation|41.9|41.9|||
3704215|NCT02166697|3545010|B1|||High Density Lipoprotein (HDL) Cholesterol||mg/dL|Mean|55.0|55.0|Standard Deviation|15.2|15.2|||
3704216|NCT02166697|3545010|B1|||Fasting Triglycerides||Milligrams per deciliter (mg/dL)|Mean|166.1|166.1|Standard Deviation|101.6|101.6|||
3704217|NCT02166697|3545010|B1|||Waist Circumference||cm|Mean|90.56|90.56|Standard Deviation|9.76|9.76|||
3704218|NCT02166697|3545010|B1|||Body Mass Index||Kilogram per square meter (kg/m^2)|Mean|26.40|26.4|Standard Deviation|3.84|3.84|||
3704219|NCT02166697|3545010|B1|||Weight||Kilogram (Kg)|Mean|68.07|68.07|Standard Deviation|12.84|12.84|||
3704220|NCT02166697|3545010|B1|||Height||Centimeter (cm)|Mean|160.28|160.28|Standard Deviation|9.42|9.42|||
3704221|NCT02166697|3545010|B1|||Pulse Rate||Pulse per minute|Mean|73.9|73.9|Standard Deviation|10.7|10.7|||
3704222|NCT02166697|3545010|B1|Diastolic Blood Pressure||Blood Pressure||Millimeter of mercury (mmHg)|Mean|90.2|90.2|Standard Deviation|12.6|12.6|||
3704223|NCT02166697|3545010|B1|Systolic Blood Pressure||Blood Pressure||Millimeter of mercury (mmHg)|Mean|156.2|156.2|Standard Deviation|17.9|17.9|||
3704224|NCT02166697|3545010|B1|Greater than (>) 12 mg||Initial Daily Dose of Blopress||Participants|Number|8|8.0||||||
3704226|NCT02166697|3545010|B1|10 mg||Initial Daily Dose of Blopress||Participants|Number|1|1.0||||||
3704227|NCT02166697|3545010|B1|8 mg||Initial Daily Dose of Blopress||Participants|Number|8505|8505.0||||||
3704228|NCT02166697|3545010|B1|6 mg||Initial Daily Dose of Blopress||Participants|Number|38|38.0||||||
3704229|NCT02166697|3545010|B1|4 mg||Initial Daily Dose of Blopress||Participants|Number|3934|3934.0||||||
3704230|NCT02166697|3545010|B1|Less than (<) 4 mg||Initial Daily Dose of Blopress||Participants|Number|214|214.0||||||
3704231|NCT02166697|3545010|B1||Male|Sex: Female, Male||Participants|Count of Participants|7717|7717.0||||||
3704232|NCT02166697|3545010|B1||Female|Sex: Female, Male||Participants|Count of Participants|6087|6087.0||||||
3704233|NCT02166697|3545010|B1|||Age||Years|Mean|60.5|60.5|Standard Deviation|9.8|9.8|||
3704234|NCT02166476|3545019|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704235|NCT02166476|3545020|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704236|NCT02166476|3545021|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704237|NCT02166476|3545019|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3704238|NCT02166476|3545020|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3704239|NCT02166476|3545021|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3704240|NCT02166476|3545019|B3||White|Race (NIH/OMB)||Participants|Count of Participants|506|506.0||||||
3704241|NCT02166476|3545020|B2||White|Race (NIH/OMB)||Participants|Count of Participants|252|252.0||||||
3704242|NCT02166476|3545021|B1||White|Race (NIH/OMB)||Participants|Count of Participants|254|254.0||||||
3704243|NCT02166476|3545019|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3704244|NCT02166476|3545020|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3704245|NCT02166476|3545021|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3704246|NCT02166476|3545019|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704247|NCT02166476|3545020|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704248|NCT02166476|3545021|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704249|NCT02166476|3545019|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3704250|NCT02166476|3545020|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3704251|NCT02166476|3545021|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3704252|NCT02166476|3545019|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704253|NCT02166476|3545020|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704254|NCT02166476|3545021|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704255|NCT02166476|3545019|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704256|NCT02166476|3545020|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704257|NCT02166476|3545021|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704258|NCT02166476|3545019|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|502|502.0||||||
3704259|NCT02166476|3545020|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|254|254.0||||||
3704260|NCT02166476|3545021|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|248|248.0||||||
3704261|NCT02166476|3545019|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3704262|NCT02166476|3545020|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3704263|NCT02166476|3545021|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3704264|NCT02166476|3545019|B3||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3704265|NCT02166476|3545020|B2||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3704266|NCT02166476|3545021|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3704267|NCT02166476|3545019|B3||Female|Sex: Female, Male||Participants|Count of Participants|361|361.0||||||
3704268|NCT02166476|3545020|B2||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3704269|NCT02166476|3545021|B1||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
3704270|NCT02166476|3545019|B3|||Age||years|Mean|52.8|52.8|Standard Deviation|20.17|20.17|||
3704271|NCT02166476|3545020|B2|||Age||years|Mean|52.6|52.6|Standard Deviation|20.93|20.93|||
3704272|NCT02166476|3545021|B1|||Age||years|Mean|53.0|53.0|Standard Deviation|19.42|19.42|||
3704273|NCT02166346|3545055|B1|||Lesion length by MRI|Vertebral length is defined as the number of vertebrae between the top of the T2 hyper intense lesion by MRI and the bottom of the lesion visualized on the middle sagittal section.|vertebral lengths|Mean|6|6.0|Full Range|||2.0|13.0|
3704274|NCT02166346|3545055|B1||Thoracic|Lesion location within spinal cord||Participants|Count of Participants|4|4.0||||||
3704275|NCT02166346|3545055|B1||Cervicothoracic|Lesion location within spinal cord||Participants|Count of Participants|5|5.0||||||
3704276|NCT02166346|3545055|B1||Cervical|Lesion location within spinal cord||Participants|Count of Participants|4|4.0||||||
3704277|NCT02166346|3545055|B1|||Expanded Disability Status Scale score|In this scale, 0 is normal and 10 is dead. Additional information can be found here: https://www.mstrust.org.uk/a-z/expanded-disability-status-scale-edss|units on a scale|Mean|4.9|4.9|Full Range|||3.5|6.0|
3704278|NCT02166346|3545055|B1|||Duration of Disease||years|Mean|7.2|7.2|Full Range|||3.0|31.0|
3704279|NCT02166346|3545055|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704280|NCT02166346|3545055|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704281|NCT02166346|3545055|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3704282|NCT02166346|3545055|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3704283|NCT02166346|3545055|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704284|NCT02166346|3545055|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704285|NCT02166346|3545055|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704286|NCT02166346|3545055|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3704287|NCT02166346|3545055|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3704288|NCT02166346|3545055|B1|||Age||years|Mean|55|55.0|Full Range|||33.0|71.0|
3704289|NCT02165826|3545064|B4|||Pre-Bronchodilator Forced Vital Capacity (FVC)||liters|Mean|2.307|2.307|Standard Deviation|0.7109|0.7109|||
3704290|NCT02165826|3545065|B3|||Pre-Bronchodilator Forced Vital Capacity (FVC)||liters|Mean|2.314|2.314|Standard Deviation|0.6822|0.6822|||
3704291|NCT02165826|3545066|B2|||Pre-Bronchodilator Forced Vital Capacity (FVC)||liters|Mean|2.303|2.303|Standard Deviation|0.7091|0.7091|||
3704292|NCT02165826|3545067|B1|||Pre-Bronchodilator Forced Vital Capacity (FVC)||liters|Mean|2.304|2.304|Standard Deviation|0.7418|0.7418|||
3704293|NCT02165826|3545064|B4|||Pre-bronchodilator Forced Expiratory Volume in the First Second (FEV1)||liters|Mean|1.023|1.023|Standard Deviation|0.3211|0.3211|||
3704294|NCT02165826|3545065|B3|||Pre-bronchodilator Forced Expiratory Volume in the First Second (FEV1)||liters|Mean|1.018|1.018|Standard Deviation|0.3289|0.3289|||
3704295|NCT02165826|3545066|B2|||Pre-bronchodilator Forced Expiratory Volume in the First Second (FEV1)||liters|Mean|1.028|1.028|Standard Deviation|0.3173|0.3173|||
3704296|NCT02165826|3545067|B1|||Pre-bronchodilator Forced Expiratory Volume in the First Second (FEV1)||liters|Mean|1.022|1.022|Standard Deviation|0.3177|0.3177|||
3704297|NCT02165826|3545064|B4|||Number of Cigarette Pack-Years|Number of pack-years = (number of cigarettes smoked per day/20) × number of years smoked|pack-years|Mean|38.6|38.6|Standard Deviation|18.17|18.17|||
3704298|NCT02165826|3545065|B3|||Number of Cigarette Pack-Years|Number of pack-years = (number of cigarettes smoked per day/20) × number of years smoked|pack-years|Mean|37.6|37.6|Standard Deviation|17.70|17.7|||
3704299|NCT02165826|3545066|B2|||Number of Cigarette Pack-Years|Number of pack-years = (number of cigarettes smoked per day/20) × number of years smoked|pack-years|Mean|40.2|40.2|Standard Deviation|19.22|19.22|||
3704300|NCT02165826|3545067|B1|||Number of Cigarette Pack-Years|Number of pack-years = (number of cigarettes smoked per day/20) × number of years smoked|pack-years|Mean|38.1|38.1|Standard Deviation|17.49|17.49|||
3704301|NCT02165826|3545064|B4|Ex-smoker||Smoking Classification||participants|Number|714|714.0||||||
3704302|NCT02165826|3545065|B3|Ex-smoker||Smoking Classification||participants|Number|247|247.0||||||
3704303|NCT02165826|3545066|B2|Ex-smoker||Smoking Classification||participants|Number|239|239.0||||||
3704304|NCT02165826|3545067|B1|Ex-smoker||Smoking Classification||participants|Number|228|228.0||||||
3704305|NCT02165826|3545064|B4|Current Smoker||Smoking Classification||participants|Number|607|607.0||||||
3704306|NCT02165826|3545065|B3|Current Smoker||Smoking Classification||participants|Number|196|196.0||||||
3704307|NCT02165826|3545066|B2|Current Smoker||Smoking Classification||participants|Number|198|198.0||||||
3704308|NCT02165826|3545067|B1|Current Smoker||Smoking Classification||participants|Number|213|213.0||||||
3704309|NCT02165826|3545064|B4|||Body Mass Index (BMI)||kg/m^2|Mean|26.26|26.26|Standard Deviation|5.822|5.822|||
3704310|NCT02165826|3545065|B3|||Body Mass Index (BMI)||kg/m^2|Mean|26.44|26.44|Standard Deviation|5.888|5.888|||
3704311|NCT02165826|3545066|B2|||Body Mass Index (BMI)||kg/m^2|Mean|25.98|25.98|Standard Deviation|5.614|5.614|||
3704312|NCT02165826|3545067|B1|||Body Mass Index (BMI)||kg/m^2|Mean|26.36|26.36|Standard Deviation|5.957|5.957|||
3704313|NCT02165826|3545064|B4|||Weight||kg|Mean|75.20|75.2|Standard Deviation|17.804|17.804|||
3704314|NCT02165826|3545065|B3|||Weight||kg|Mean|75.68|75.68|Standard Deviation|16.949|16.949|||
3704315|NCT02165826|3545066|B2|||Weight||kg|Mean|74.31|74.31|Standard Deviation|17.808|17.808|||
3704316|NCT02165826|3545067|B1|||Weight||kg|Mean|75.59|75.59|Standard Deviation|18.627|18.627|||
3704317|NCT02165826|3545064|B4|||Height||cm|Mean|169.0|169.0|Standard Deviation|8.64|8.64|||
3704318|NCT02165826|3545065|B3|||Height||cm|Mean|169.1|169.1|Standard Deviation|8.55|8.55|||
3704319|NCT02165826|3545066|B2|||Height||cm|Mean|168.8|168.8|Standard Deviation|8.66|8.66|||
3704320|NCT02165826|3545067|B1|||Height||cm|Mean|169.1|169.1|Standard Deviation|8.73|8.73|||
3704321|NCT02165826|3545064|B4|United Kingdom||Region of Enrollment||participants|Number|15|15.0||||||
3704322|NCT02165826|3545065|B3|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
3704323|NCT02165826|3545066|B2|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
3704324|NCT02165826|3545067|B1|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3704325|NCT02165826|3545064|B4|Ukraine||Region of Enrollment||participants|Number|168|168.0||||||
3704326|NCT02165826|3545065|B3|Ukraine||Region of Enrollment||participants|Number|54|54.0||||||
3704327|NCT02165826|3545066|B2|Ukraine||Region of Enrollment||participants|Number|58|58.0||||||
3704328|NCT02165826|3545067|B1|Ukraine||Region of Enrollment||participants|Number|56|56.0||||||
3704329|NCT02165826|3545064|B4|Thailand||Region of Enrollment||participants|Number|17|17.0||||||
3704330|NCT02165826|3545065|B3|Thailand||Region of Enrollment||participants|Number|9|9.0||||||
3704331|NCT02165826|3545066|B2|Thailand||Region of Enrollment||participants|Number|6|6.0||||||
3704332|NCT02165826|3545067|B1|Thailand||Region of Enrollment||participants|Number|2|2.0||||||
3704333|NCT02165826|3545064|B4|Spain||Region of Enrollment||participants|Number|5|5.0||||||
3704334|NCT02165826|3545065|B3|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3704335|NCT02165826|3545066|B2|Spain||Region of Enrollment||participants|Number|2|2.0||||||
3704336|NCT02165826|3545067|B1|Spain||Region of Enrollment||participants|Number|2|2.0||||||
3704337|NCT02165826|3545064|B4|South Africa||Region of Enrollment||participants|Number|61|61.0||||||
3704338|NCT02165826|3545065|B3|South Africa||Region of Enrollment||participants|Number|26|26.0||||||
3704339|NCT02165826|3545066|B2|South Africa||Region of Enrollment||participants|Number|18|18.0||||||
3704340|NCT02165826|3545067|B1|South Africa||Region of Enrollment||participants|Number|17|17.0||||||
3704341|NCT02165826|3545064|B4|Slovakia||Region of Enrollment||participants|Number|105|105.0||||||
3704342|NCT02165826|3545065|B3|Slovakia||Region of Enrollment||participants|Number|27|27.0||||||
3704343|NCT02165826|3545066|B2|Slovakia||Region of Enrollment||participants|Number|38|38.0||||||
3704344|NCT02165826|3545067|B1|Slovakia||Region of Enrollment||participants|Number|40|40.0||||||
3704345|NCT02165826|3545064|B4|Russia||Region of Enrollment||participants|Number|140|140.0||||||
3704346|NCT02165826|3545065|B3|Russia||Region of Enrollment||participants|Number|55|55.0||||||
3704347|NCT02165826|3545066|B2|Russia||Region of Enrollment||participants|Number|48|48.0||||||
3704348|NCT02165826|3545067|B1|Russia||Region of Enrollment||participants|Number|37|37.0||||||
3704349|NCT02165826|3545064|B4|Romania||Region of Enrollment||participants|Number|144|144.0||||||
3704350|NCT02165826|3545065|B3|Romania||Region of Enrollment||participants|Number|44|44.0||||||
3704351|NCT02165826|3545066|B2|Romania||Region of Enrollment||participants|Number|46|46.0||||||
3704352|NCT02165826|3545067|B1|Romania||Region of Enrollment||participants|Number|54|54.0||||||
3704353|NCT02165826|3545064|B4|Poland||Region of Enrollment||participants|Number|199|199.0||||||
3704354|NCT02165826|3545065|B3|Poland||Region of Enrollment||participants|Number|71|71.0||||||
3704355|NCT02165826|3545066|B2|Poland||Region of Enrollment||participants|Number|68|68.0||||||
3704356|NCT02165826|3545067|B1|Poland||Region of Enrollment||participants|Number|60|60.0||||||
3704357|NCT02165826|3545064|B4|Philippines||Region of Enrollment||participants|Number|30|30.0||||||
3704358|NCT02165826|3545065|B3|Philippines||Region of Enrollment||participants|Number|10|10.0||||||
3704359|NCT02165826|3545066|B2|Philippines||Region of Enrollment||participants|Number|13|13.0||||||
3704360|NCT02165826|3545067|B1|Philippines||Region of Enrollment||participants|Number|7|7.0||||||
3704361|NCT02165826|3545064|B4|Korea, Republic Of||Region of Enrollment||participants|Number|46|46.0||||||
3704362|NCT02165826|3545065|B3|Korea, Republic Of||Region of Enrollment||participants|Number|13|13.0||||||
3704363|NCT02165826|3545066|B2|Korea, Republic Of||Region of Enrollment||participants|Number|11|11.0||||||
3704364|NCT02165826|3545067|B1|Korea, Republic Of||Region of Enrollment||participants|Number|22|22.0||||||
3704365|NCT02165826|3545064|B4|Hungary||Region of Enrollment||participants|Number|235|235.0||||||
3704366|NCT02165826|3545065|B3|Hungary||Region of Enrollment||participants|Number|79|79.0||||||
3704367|NCT02165826|3545066|B2|Hungary||Region of Enrollment||participants|Number|74|74.0||||||
3704368|NCT02165826|3545067|B1|Hungary||Region of Enrollment||participants|Number|82|82.0||||||
3704369|NCT02165826|3545064|B4|Greece||Region of Enrollment||participants|Number|20|20.0||||||
3704370|NCT02165826|3545065|B3|Greece||Region of Enrollment||participants|Number|6|6.0||||||
3704371|NCT02165826|3545066|B2|Greece||Region of Enrollment||participants|Number|6|6.0||||||
3704372|NCT02165826|3545067|B1|Greece||Region of Enrollment||participants|Number|8|8.0||||||
3704373|NCT02165826|3545064|B4|Germany||Region of Enrollment||participants|Number|52|52.0||||||
3704374|NCT02165826|3545065|B3|Germany||Region of Enrollment||participants|Number|16|16.0||||||
3704375|NCT02165826|3545066|B2|Germany||Region of Enrollment||participants|Number|24|24.0||||||
3704376|NCT02165826|3545067|B1|Germany||Region of Enrollment||participants|Number|12|12.0||||||
3704377|NCT02165826|3545064|B4|Bulgaria||Region of Enrollment||participants|Number|84|84.0||||||
3704378|NCT02165826|3545065|B3|Bulgaria||Region of Enrollment||participants|Number|30|30.0||||||
3704379|NCT02165826|3545066|B2|Bulgaria||Region of Enrollment||participants|Number|18|18.0||||||
3704380|NCT02165826|3545067|B1|Bulgaria||Region of Enrollment||participants|Number|36|36.0||||||
3704381|NCT02165826|3545064|B4|White||Race/Ethnicity, Customized||participants|Number|1209|1209.0||||||
3704382|NCT02165826|3545065|B3|White||Race/Ethnicity, Customized||participants|Number|405|405.0||||||
3704383|NCT02165826|3545066|B2|White||Race/Ethnicity, Customized||participants|Number|399|399.0||||||
3704384|NCT02165826|3545067|B1|White||Race/Ethnicity, Customized||participants|Number|405|405.0||||||
3704385|NCT02165826|3545064|B4|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3704386|NCT02165826|3545065|B3|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3704387|NCT02165826|3545066|B2|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3704388|NCT02165826|3545067|B1|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3704389|NCT02165826|3545064|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3704390|NCT02165826|3545065|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3704391|NCT02165826|3545066|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3704392|NCT02165826|3545067|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3704393|NCT02165826|3545064|B4|Asian||Race/Ethnicity, Customized||participants|Number|94|94.0||||||
3704394|NCT02165826|3545065|B3|Asian||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3704395|NCT02165826|3545066|B2|Asian||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3704396|NCT02165826|3545067|B1|Asian||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3704397|NCT02165826|3545064|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3704398|NCT02165826|3545065|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3704399|NCT02165826|3545066|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3704400|NCT02165826|3545067|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3704401|NCT02165826|3545064|B4|Missing||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3704402|NCT02165826|3545065|B3|Missing||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3704403|NCT02165826|3545066|B2|Missing||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3704404|NCT02165826|3545067|B1|Missing||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3704405|NCT02165826|3545064|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1277|1277.0||||||
3704406|NCT02165826|3545065|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|426|426.0||||||
3704407|NCT02165826|3545066|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|423|423.0||||||
3704408|NCT02165826|3545067|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|428|428.0||||||
3704409|NCT02165826|3545064|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3704410|NCT02165826|3545065|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3704411|NCT02165826|3545066|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3704412|NCT02165826|3545067|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3704413|NCT02165826|3545064|B4||Male|Sex: Female, Male||Participants|Count of Participants|983|983.0||||||
3704414|NCT02165826|3545065|B3||Male|Sex: Female, Male||Participants|Count of Participants|338|338.0||||||
3704415|NCT02165826|3545066|B2||Male|Sex: Female, Male||Participants|Count of Participants|325|325.0||||||
3704416|NCT02165826|3545067|B1||Male|Sex: Female, Male||Participants|Count of Participants|320|320.0||||||
3704417|NCT02165826|3545064|B4||Female|Sex: Female, Male||Participants|Count of Participants|338|338.0||||||
3704418|NCT02165826|3545065|B3||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3704419|NCT02165826|3545066|B2||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3704420|NCT02165826|3545067|B1||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3704421|NCT02165826|3545064|B4|85 years and over||Age, Customized||participants|Number|2|2.0||||||
3704422|NCT02165826|3545065|B3|85 years and over||Age, Customized||participants|Number|2|2.0||||||
3704423|NCT02165826|3545066|B2|85 years and over||Age, Customized||participants|Number|0|0.0||||||
3704424|NCT02165826|3545067|B1|85 years and over||Age, Customized||participants|Number|0|0.0||||||
3704425|NCT02165826|3545064|B4|65-84 years||Age, Customized||participants|Number|651|651.0||||||
3704426|NCT02165826|3545065|B3|65-84 years||Age, Customized||participants|Number|217|217.0||||||
3704427|NCT02165826|3545066|B2|65-84 years||Age, Customized||participants|Number|235|235.0||||||
3704428|NCT02165826|3545067|B1|65-84 years||Age, Customized||participants|Number|199|199.0||||||
3704429|NCT02165826|3545064|B4|40-64 years||Age, Customized||participants|Number|668|668.0||||||
3704430|NCT02165826|3545065|B3|40-64 years||Age, Customized||participants|Number|224|224.0||||||
3704431|NCT02165826|3545066|B2|40-64 years||Age, Customized||participants|Number|202|202.0||||||
3704432|NCT02165826|3545067|B1|40-64 years||Age, Customized||participants|Number|242|242.0||||||
3704433|NCT02165826|3545064|B4|||Age||years|Mean|64.6|64.6|Standard Deviation|8.13|8.13|||
3704434|NCT02165826|3545065|B3|||Age||years|Mean|64.6|64.6|Standard Deviation|8.36|8.36|||
3704435|NCT02165826|3545066|B2|||Age||years|Mean|65.0|65.0|Standard Deviation|8.21|8.21|||
3704436|NCT02165826|3545067|B1|||Age||years|Mean|64.2|64.2|Standard Deviation|7.81|7.81|||
3704437|NCT02165761|3545126|B3|United States||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3704438|NCT02165761|3545127|B2|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3704439|NCT02165761|3545128|B1|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3704440|NCT02165761|3545126|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704441|NCT02165761|3545127|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704442|NCT02165761|3545128|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704443|NCT02165761|3545126|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704444|NCT02165761|3545127|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704445|NCT02165761|3545128|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704446|NCT02165761|3545126|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3704447|NCT02165761|3545127|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3704448|NCT02165761|3545128|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3704449|NCT02165761|3545126|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3704450|NCT02165761|3545127|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3704451|NCT02165761|3545128|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3704452|NCT02165761|3545126|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704453|NCT02165761|3545127|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704454|NCT02165761|3545128|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704455|NCT02165761|3545126|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704456|NCT02165761|3545127|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704457|NCT02165761|3545128|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704458|NCT02165761|3545126|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704459|NCT02165761|3545127|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704460|NCT02165761|3545128|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704461|NCT02165761|3545126|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704462|NCT02165761|3545127|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704463|NCT02165761|3545128|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704464|NCT02165761|3545126|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3704465|NCT02165761|3545127|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3704466|NCT02165761|3545128|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3704467|NCT02165761|3545126|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704468|NCT02165761|3545127|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704469|NCT02165761|3545128|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704470|NCT02165761|3545126|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3704471|NCT02165761|3545127|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3704472|NCT02165761|3545128|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3704473|NCT02165761|3545126|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3704474|NCT02165761|3545127|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3704475|NCT02165761|3545128|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3704476|NCT02165761|3545126|B3|||Age||years|Mean|60.4|60.4|Standard Deviation|12.5|12.5|||
3704477|NCT02165761|3545127|B2|||Age||years|Mean|58.7|58.7|Standard Deviation|12.2|12.2|||
3704478|NCT02165761|3545128|B1|||Age||years|Mean|61.8|61.8|Standard Deviation|12.9|12.9|||
3704479|NCT02165735|3545135|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3704480|NCT02165735|3545136|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3704481|NCT02165735|3545137|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3704482|NCT02165735|3545135|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3704483|NCT02165735|3545136|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3704484|NCT02165735|3545137|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3704485|NCT02165735|3545135|B3||White|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3704486|NCT02165735|3545136|B2||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3704487|NCT02165735|3545137|B1||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3704488|NCT02165735|3545135|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|187|187.0||||||
3704489|NCT02165735|3545136|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
3704490|NCT02165735|3545137|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3704491|NCT02165735|3545135|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704492|NCT02165735|3545136|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704493|NCT02165735|3545137|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704494|NCT02165735|3545135|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704495|NCT02165735|3545136|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704496|NCT02165735|3545137|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704497|NCT02165735|3545135|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3704498|NCT02165735|3545136|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704499|NCT02165735|3545137|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3704500|NCT02165735|3545135|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704501|NCT02165735|3545136|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704502|NCT02165735|3545137|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704503|NCT02165735|3545135|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|276|276.0||||||
3704504|NCT02165735|3545136|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
3704505|NCT02165735|3545137|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
3704506|NCT02165735|3545135|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3704507|NCT02165735|3545136|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3704508|NCT02165735|3545137|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3704509|NCT02165735|3545135|B3|Transgender||Sex/Gender, Customized||participants|Number|3|3.0||||||
3704510|NCT02165735|3545136|B2|Transgender||Sex/Gender, Customized||participants|Number|3|3.0||||||
3704511|NCT02165735|3545137|B1|Transgender||Sex/Gender, Customized||participants|Number|0|0.0||||||
3704512|NCT02165735|3545135|B3|Female||Sex/Gender, Customized||participants|Number|143|143.0||||||
3704513|NCT02165735|3545136|B2|Female||Sex/Gender, Customized||participants|Number|75|75.0||||||
3704514|NCT02165735|3545137|B1|Female||Sex/Gender, Customized||participants|Number|68|68.0||||||
3704515|NCT02165735|3545135|B3|Male||Sex/Gender, Customized||participants|Number|213|213.0||||||
3704516|NCT02165735|3545136|B2|Male||Sex/Gender, Customized||participants|Number|101|101.0||||||
3704517|NCT02165735|3545137|B1|Male||Sex/Gender, Customized||participants|Number|112|112.0||||||
3704518|NCT02165735|3545135|B3|||Age||years|Mean|51.48|51.48|Standard Deviation|11|11.0|||
3704519|NCT02165735|3545136|B2|||Age||years|Mean|51.24|51.24|Standard Deviation|11.31|11.31|||
3704520|NCT02165735|3545137|B1|||Age||years|Mean|51.71|51.71|Standard Deviation|10.71|10.71|||
3704521|NCT02165722|3545164|B3|||Commercial health insurance, %||percent of participants privt insurance|Number|64.7|64.7||||||
3704522|NCT02165722|3545165|B2|||Commercial health insurance, %||percent of participants privt insurance|Number|67.8|67.8||||||
3704523|NCT02165722|3545166|B1|||Commercial health insurance, %||percent of participants privt insurance|Number|62.2|62.2||||||
3704524|NCT02165722|3545164|B3|percent of Non-white participants||Race/Ethnicity, Customized||percent of Non-white participants|Number|18.2|18.2||||||
3704525|NCT02165722|3545165|B2|percent of Non-white participants||Race/Ethnicity, Customized||percent of Non-white participants|Number|23.4|23.4||||||
3704526|NCT02165722|3545166|B1|percent of Non-white participants||Race/Ethnicity, Customized||percent of Non-white participants|Number|12.0|12.0||||||
3704527|NCT02165722|3545164|B3|percent of female participants||Sex/Gender, Customized||percent of female participants|Number|50.3|50.3||||||
3704528|NCT02165722|3545165|B2|percent of female participants||Sex/Gender, Customized||percent of female participants|Number|51.1|51.1||||||
3704529|NCT02165722|3545166|B1|percent of female participants||Sex/Gender, Customized||percent of female participants|Number|49.6|49.6||||||
3704530|NCT02165722|3545164|B3|percent of participants aged 11-13 years||Age, Customized||percent of participants aged 11-13 years|Number|38.4|38.4||||||
3704531|NCT02165722|3545165|B2|percent of participants aged 11-13 years||Age, Customized||percent of participants aged 11-13 years|Number|37.2|37.2||||||
3704532|NCT02165722|3545166|B1|percent of participants aged 11-13 years||Age, Customized||percent of participants aged 11-13 years|Number|39.9|39.9||||||
3704533|NCT02165462|3545179|B1|Spain||Region of Enrollment||participants|Number|17|17.0||||||
3704534|NCT02165462|3545179|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3704535|NCT02165462|3545179|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3704536|NCT02165462|3545179|B1|||Age||years|Mean|32.47|32.47|Standard Deviation|7.82|7.82|||
3704537|NCT02165202|3545196|B3||College or university, complete|Education||Participants|Count of Participants|0|0.0||||||
3704538|NCT02165202|3545197|B2||College or university, complete|Education||Participants|Count of Participants|0|0.0||||||
3704539|NCT02165202|3545198|B1||College or university, complete|Education||Participants|Count of Participants|0|0.0||||||
3704540|NCT02165202|3545196|B3||College or university, not complete|Education||Participants|Count of Participants|0|0.0||||||
3704541|NCT02165202|3545197|B2||College or university, not complete|Education||Participants|Count of Participants|0|0.0||||||
3704542|NCT02165202|3545198|B1||College or university, not complete|Education||Participants|Count of Participants|0|0.0||||||
3704543|NCT02165202|3545196|B3||Technical training, complete|Education||Participants|Count of Participants|0|0.0||||||
3704544|NCT02165202|3545197|B2||Technical training, complete|Education||Participants|Count of Participants|0|0.0||||||
3704545|NCT02165202|3545198|B1||Technical training, complete|Education||Participants|Count of Participants|0|0.0||||||
3704546|NCT02165202|3545196|B3||Technical training, not complete|Education||Participants|Count of Participants|0|0.0||||||
3704547|NCT02165202|3545197|B2||Technical training, not complete|Education||Participants|Count of Participants|0|0.0||||||
3704548|NCT02165202|3545198|B1||Technical training, not complete|Education||Participants|Count of Participants|0|0.0||||||
3704549|NCT02165202|3545196|B3||Secondary school, complete|Education||Participants|Count of Participants|14|14.0||||||
3704550|NCT02165202|3545197|B2||Secondary school, complete|Education||Participants|Count of Participants|4|4.0||||||
3704551|NCT02165202|3545198|B1||Secondary school, complete|Education||Participants|Count of Participants|10|10.0||||||
3704552|NCT02165202|3545196|B3||Secondary school, not complete|Education||Participants|Count of Participants|10|10.0||||||
3704553|NCT02165202|3545197|B2||Secondary school, not complete|Education||Participants|Count of Participants|3|3.0||||||
3704554|NCT02165202|3545198|B1||Secondary school, not complete|Education||Participants|Count of Participants|7|7.0||||||
3704555|NCT02165202|3545196|B3||Primary school, complete|Education||Participants|Count of Participants|85|85.0||||||
3704556|NCT02165202|3545197|B2||Primary school, complete|Education||Participants|Count of Participants|27|27.0||||||
3704557|NCT02165202|3545198|B1||Primary school, complete|Education||Participants|Count of Participants|58|58.0||||||
3704558|NCT02165202|3545196|B3||Primary school, not complete|Education||Participants|Count of Participants|27|27.0||||||
3704559|NCT02165202|3545197|B2||Primary school, not complete|Education||Participants|Count of Participants|11|11.0||||||
3704560|NCT02165202|3545198|B1||Primary school, not complete|Education||Participants|Count of Participants|16|16.0||||||
3704561|NCT02165202|3545196|B3||No schooling|Education||Participants|Count of Participants|0|0.0||||||
3704562|NCT02165202|3545197|B2||No schooling|Education||Participants|Count of Participants|0|0.0||||||
3704563|NCT02165202|3545198|B1||No schooling|Education||Participants|Count of Participants|0|0.0||||||
3704564|NCT02165202|3545196|B3||Full-time employment|Employment Status||Participants|Count of Participants|23|23.0||||||
3704565|NCT02165202|3545197|B2||Full-time employment|Employment Status||Participants|Count of Participants|9|9.0||||||
3704566|NCT02165202|3545198|B1||Full-time employment|Employment Status||Participants|Count of Participants|14|14.0||||||
3704567|NCT02165202|3545196|B3||Part-time employment|Employment Status||Participants|Count of Participants|31|31.0||||||
3704568|NCT02165202|3545197|B2||Part-time employment|Employment Status||Participants|Count of Participants|14|14.0||||||
3704569|NCT02165202|3545198|B1||Part-time employment|Employment Status||Participants|Count of Participants|17|17.0||||||
3704570|NCT02165202|3545196|B3||Not employed|Employment Status||Participants|Count of Participants|82|82.0||||||
3704571|NCT02165202|3545197|B2||Not employed|Employment Status||Participants|Count of Participants|22|22.0||||||
3704572|NCT02165202|3545198|B1||Not employed|Employment Status||Participants|Count of Participants|60|60.0||||||
3704573|NCT02165202|3545196|B3||Other|Marital Status||Participants|Count of Participants|0|0.0||||||
3704574|NCT02165202|3545197|B2||Other|Marital Status||Participants|Count of Participants|0|0.0||||||
3704575|NCT02165202|3545198|B1||Other|Marital Status||Participants|Count of Participants|0|0.0||||||
3704576|NCT02165202|3545196|B3||Single/divorced/widowed|Marital Status||Participants|Count of Participants|45|45.0||||||
3704577|NCT02165202|3545197|B2||Single/divorced/widowed|Marital Status||Participants|Count of Participants|19|19.0||||||
3704578|NCT02165202|3545198|B1||Single/divorced/widowed|Marital Status||Participants|Count of Participants|26|26.0||||||
3704579|NCT02165202|3545196|B3||Have primary or main partner, not living|Marital Status||Participants|Count of Participants|21|21.0||||||
3704580|NCT02165202|3545197|B2||Have primary or main partner, not living|Marital Status||Participants|Count of Participants|6|6.0||||||
3704581|NCT02165202|3545198|B1||Have primary or main partner, not living|Marital Status||Participants|Count of Participants|15|15.0||||||
3704582|NCT02165202|3545196|B3||Living with primary or main partner|Marital Status||Participants|Count of Participants|7|7.0||||||
3704583|NCT02165202|3545197|B2||Living with primary or main partner|Marital Status||Participants|Count of Participants|2|2.0||||||
3704584|NCT02165202|3545198|B1||Living with primary or main partner|Marital Status||Participants|Count of Participants|5|5.0||||||
3704585|NCT02165202|3545196|B3||Married/civil union/legal partnership|Marital Status||Participants|Count of Participants|63|63.0||||||
3704586|NCT02165202|3545197|B2||Married/civil union/legal partnership|Marital Status||Participants|Count of Participants|18|18.0||||||
3704587|NCT02165202|3545198|B1||Married/civil union/legal partnership|Marital Status||Participants|Count of Participants|45|45.0||||||
3704588|NCT02165202|3545196|B3|||BMI||kg/m^2|Median|30|30.0|Inter-Quartile Range|||27.0|35.0|
3704589|NCT02165202|3545197|B2|||BMI||kg/m^2|Median|29|29.0|Inter-Quartile Range|||27.0|35.0|
3704590|NCT02165202|3545198|B1|||BMI||kg/m^2|Median|31|31.0|Inter-Quartile Range|||26.0|35.0|
3704591|NCT02165202|3545196|B3|||Weight||kg|Median|75|75.0|Inter-Quartile Range|||64.0|89.0|
3704592|NCT02165202|3545197|B2|||Weight||kg|Median|73|73.0|Inter-Quartile Range|||63.0|88.0|
3704593|NCT02165202|3545198|B1|||Weight||kg|Median|76|76.0|Inter-Quartile Range|||67.0|89.0|
3704594|NCT02165202|3545196|B3|||Height||cm|Median|158|158.0|Inter-Quartile Range|||153.0|165.0|
3704595|NCT02165202|3545197|B2|||Height||cm|Median|158|158.0|Inter-Quartile Range|||152.0|165.0|
3704596|NCT02165202|3545198|B1|||Height||cm|Median|159|159.0|Inter-Quartile Range|||153.0|165.0|
3704597|NCT02165202|3545196|B3|36-45||Age||Participants|Count of Participants|41|41.0||||||
3704598|NCT02165202|3545197|B2|36-45||Age||Participants|Count of Participants|17|17.0||||||
3704599|NCT02165202|3545198|B1|36-45||Age||Participants|Count of Participants|24|24.0||||||
3704600|NCT02165202|3545196|B3|26-35||Age||Participants|Count of Participants|59|59.0||||||
3704601|NCT02165202|3545197|B2|26-35||Age||Participants|Count of Participants|14|14.0||||||
3704602|NCT02165202|3545198|B1|26-35||Age||Participants|Count of Participants|45|45.0||||||
3704603|NCT02165202|3545196|B3|18-25||Age||Participants|Count of Participants|36|36.0||||||
3704604|NCT02165202|3545197|B2|18-25||Age||Participants|Count of Participants|14|14.0||||||
3704605|NCT02165202|3545198|B1|18-25||Age||Participants|Count of Participants|22|22.0||||||
3704606|NCT02165202|3545196|B3|South Africa||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
3704607|NCT02165202|3545197|B2|South Africa||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3704608|NCT02165202|3545198|B1|South Africa||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3704609|NCT02165202|3545196|B3|Zimbabwe||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
3704610|NCT02165202|3545197|B2|Zimbabwe||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3704611|NCT02165202|3545198|B1|Zimbabwe||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3704612|NCT02165202|3545196|B3|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3704613|NCT02165202|3545197|B2|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3704614|NCT02165202|3545198|B1|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3704615|NCT02165202|3545196|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3704616|NCT02165202|3545197|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3704617|NCT02165202|3545198|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3704618|NCT02165202|3545196|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3704619|NCT02165202|3545197|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3704620|NCT02165202|3545198|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704621|NCT02165202|3545196|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3704622|NCT02165202|3545197|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704623|NCT02165202|3545198|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3704624|NCT02165202|3545196|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
3704625|NCT02165202|3545197|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3704626|NCT02165202|3545198|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
3704627|NCT02165202|3545196|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704628|NCT02165202|3545197|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704629|NCT02165202|3545198|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704630|NCT02165202|3545196|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3704631|NCT02165202|3545197|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704632|NCT02165202|3545198|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3704633|NCT02165202|3545196|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704634|NCT02165202|3545197|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704635|NCT02165202|3545198|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704636|NCT02165202|3545196|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704637|NCT02165202|3545197|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704638|NCT02165202|3545198|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704639|NCT02165202|3545196|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|127|127.0||||||
3704640|NCT02165202|3545197|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3704641|NCT02165202|3545198|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3704642|NCT02165202|3545196|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3704643|NCT02165202|3545197|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3704644|NCT02165202|3545198|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3704645|NCT02165202|3545196|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3704646|NCT02165202|3545197|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3704647|NCT02165202|3545198|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3704648|NCT02165202|3545196|B3||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3704649|NCT02165202|3545197|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3704650|NCT02165202|3545198|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3704651|NCT02165202|3545196|B3|||Age||years|Median|31|31.0|Inter-Quartile Range|||25.0|38.0|
3704652|NCT02165202|3545197|B2|||Age||years|Median|30|30.0|Inter-Quartile Range|||25.0|39.0|
3704653|NCT02165202|3545198|B1|||Age||years|Median|31|31.0|Inter-Quartile Range|||26.0|36.0|
3704654|NCT02165124|3545205|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3704655|NCT02165124|3545205|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704656|NCT02165124|3545205|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704657|NCT02165124|3545205|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3704658|NCT02165124|3545205|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3704659|NCT02165124|3545205|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704660|NCT02165124|3545205|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704661|NCT02165124|3545205|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704662|NCT02165124|3545205|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3704663|NCT02165124|3545205|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3704664|NCT02165124|3545205|B1|||Age||years|Mean|44.5|44.5|Standard Deviation|10.7|10.7|||
3704665|NCT02165124|3545205|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3704666|NCT02165124|3545205|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3704667|NCT02165124|3545205|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3704668|NCT02165111|3545209|B3|||Laser Doppler Imaging Blood Flow|Laser Doppler Imaging measures blood flow using a low-energy laser beam that quantifies the Doppler effect between red blood cells and a scanner to determine blood flow speed, allowing non-invasive, objective measurement of superficial cutaneous blood flow.|LDI flux units|Mean|396.94|396.94|Standard Deviation|188.52|188.52|||
3704669|NCT02165111|3545210|B2|||Laser Doppler Imaging Blood Flow|Laser Doppler Imaging measures blood flow using a low-energy laser beam that quantifies the Doppler effect between red blood cells and a scanner to determine blood flow speed, allowing non-invasive, objective measurement of superficial cutaneous blood flow.|LDI flux units|Mean|395.65|395.65|Standard Deviation|189.17|189.17|||
3704670|NCT02165111|3545211|B1|||Laser Doppler Imaging Blood Flow|Laser Doppler Imaging measures blood flow using a low-energy laser beam that quantifies the Doppler effect between red blood cells and a scanner to determine blood flow speed, allowing non-invasive, objective measurement of superficial cutaneous blood flow.|LDI flux units|Mean|398.24|398.24|Standard Deviation|190.27|190.27|||
3704671|NCT02165111|3545209|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3704672|NCT02165111|3545210|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
3704673|NCT02165111|3545211|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3704674|NCT02165111|3545209|B3||Male|Gender||Hands|Count of Units|62|62.0||||||
3704675|NCT02165111|3545210|B2||Male|Gender||Hands|Count of Units|31|31.0||||||
3704676|NCT02165111|3545211|B1||Male|Gender||Hands|Count of Units|31|31.0||||||
3704677|NCT02165111|3545209|B3||Female|Gender||Hands|Count of Units|18|18.0||||||
3704678|NCT02165111|3545210|B2||Female|Gender||Hands|Count of Units|9|9.0||||||
3704679|NCT02165111|3545211|B1||Female|Gender||Hands|Count of Units|9|9.0||||||
3704680|NCT02165111|3545209|B3|||Age||years|Mean|51.9|51.9|Standard Deviation|12.33|12.33|||
3704681|NCT02165111|3545210|B2|||Age||years|Mean|51.9|51.9|Standard Deviation|12.33|12.33|||
3704682|NCT02165111|3545211|B1|||Age||years|Mean|51.9|51.9|Standard Deviation|12.33|12.33|||
3704683|NCT02165111|3545209|B3||>=65 years|Age||Hands|Count of Units|10|10.0||||||
3704684|NCT02165111|3545210|B2||>=65 years|Age||Hands|Count of Units|5|5.0||||||
3704685|NCT02165111|3545211|B1||>=65 years|Age||Hands|Count of Units|5|5.0||||||
3704686|NCT02165111|3545209|B3||Between 18 and 65 years|Age||Hands|Count of Units|70|70.0||||||
3704687|NCT02165111|3545210|B2||Between 18 and 65 years|Age||Hands|Count of Units|35|35.0||||||
3704688|NCT02165111|3545211|B1||Between 18 and 65 years|Age||Hands|Count of Units|35|35.0||||||
3704689|NCT02165111|3545209|B3||<=18 years|Age||Hands|Count of Units|0|0.0||||||
3704690|NCT02165111|3545210|B2||<=18 years|Age||Hands|Count of Units|0|0.0||||||
3704691|NCT02165111|3545211|B1||<=18 years|Age||Hands|Count of Units|0|0.0||||||
3704692|NCT02165072|3545228|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3704693|NCT02165072|3545228|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3704694|NCT02165072|3545228|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3704695|NCT02165072|3545228|B1|||Age||years|Mean|62.4|62.4|Standard Deviation|16.0|16.0|||
3704696|NCT02164981|3545233|B4|PANSS - negative||The Positive and Negative Syndrome Scale (PANSS) at Baseline (Day 3)|The Positive and Negative Syndrome Scale (PANSS) is a 30-item questionnaire used to evaluate schizophrenia symptoms; consisting of Positive (7 items), Negative (7 items), and General Psychopathological scales (16 items) sections. Each item (symptom) is scored on a 7-point scale, higher scores representing increasing levels of psychopathology: Positive scale: 7 Items, (min. score = 7, max. score = 49); Negative scale: 7 Items, (min. score = 7, max. score = 49). For this measure, only the positive and negative scales are included in the total score (min. total score = 14, max., score = 98)|units on a scale|Mean|20.8|20.8|Standard Deviation|15.1|15.1|||
3704697|NCT02164981|3545234|B3|PANSS - negative||The Positive and Negative Syndrome Scale (PANSS) at Baseline (Day 3)|The Positive and Negative Syndrome Scale (PANSS) is a 30-item questionnaire used to evaluate schizophrenia symptoms; consisting of Positive (7 items), Negative (7 items), and General Psychopathological scales (16 items) sections. Each item (symptom) is scored on a 7-point scale, higher scores representing increasing levels of psychopathology: Positive scale: 7 Items, (min. score = 7, max. score = 49); Negative scale: 7 Items, (min. score = 7, max. score = 49). For this measure, only the positive and negative scales are included in the total score (min. total score = 14, max., score = 98)|units on a scale|Mean|21.4|21.4|Standard Deviation|4.6|4.6|||
3704698|NCT02164981|3545235|B2|PANSS - negative||The Positive and Negative Syndrome Scale (PANSS) at Baseline (Day 3)|The Positive and Negative Syndrome Scale (PANSS) is a 30-item questionnaire used to evaluate schizophrenia symptoms; consisting of Positive (7 items), Negative (7 items), and General Psychopathological scales (16 items) sections. Each item (symptom) is scored on a 7-point scale, higher scores representing increasing levels of psychopathology: Positive scale: 7 Items, (min. score = 7, max. score = 49); Negative scale: 7 Items, (min. score = 7, max. score = 49). For this measure, only the positive and negative scales are included in the total score (min. total score = 14, max., score = 98)|units on a scale|Mean|20.3|20.3|Standard Deviation|5.0|5.0|||
3704699|NCT02164981|3545236|B1|PANSS - negative||The Positive and Negative Syndrome Scale (PANSS) at Baseline (Day 3)|The Positive and Negative Syndrome Scale (PANSS) is a 30-item questionnaire used to evaluate schizophrenia symptoms; consisting of Positive (7 items), Negative (7 items), and General Psychopathological scales (16 items) sections. Each item (symptom) is scored on a 7-point scale, higher scores representing increasing levels of psychopathology: Positive scale: 7 Items, (min. score = 7, max. score = 49); Negative scale: 7 Items, (min. score = 7, max. score = 49). For this measure, only the positive and negative scales are included in the total score (min. total score = 14, max., score = 98)|units on a scale|Mean|20.9|20.9|Standard Deviation|5.5|5.5|||
3704700|NCT02164981|3545233|B4|PANSS - positive||The Positive and Negative Syndrome Scale (PANSS) at Baseline (Day 3)|The Positive and Negative Syndrome Scale (PANSS) is a 30-item questionnaire used to evaluate schizophrenia symptoms; consisting of Positive (7 items), Negative (7 items), and General Psychopathological scales (16 items) sections. Each item (symptom) is scored on a 7-point scale, higher scores representing increasing levels of psychopathology: Positive scale: 7 Items, (min. score = 7, max. score = 49); Negative scale: 7 Items, (min. score = 7, max. score = 49). For this measure, only the positive and negative scales are included in the total score (min. total score = 14, max., score = 98)|units on a scale|Mean|23.26|23.26|Standard Deviation|3.3|3.3|||
3704701|NCT02164981|3545234|B3|PANSS - positive||The Positive and Negative Syndrome Scale (PANSS) at Baseline (Day 3)|The Positive and Negative Syndrome Scale (PANSS) is a 30-item questionnaire used to evaluate schizophrenia symptoms; consisting of Positive (7 items), Negative (7 items), and General Psychopathological scales (16 items) sections. Each item (symptom) is scored on a 7-point scale, higher scores representing increasing levels of psychopathology: Positive scale: 7 Items, (min. score = 7, max. score = 49); Negative scale: 7 Items, (min. score = 7, max. score = 49). For this measure, only the positive and negative scales are included in the total score (min. total score = 14, max., score = 98)|units on a scale|Mean|22.6|22.6|Standard Deviation|3.1|3.1|||
3704702|NCT02164981|3545235|B2|PANSS - positive||The Positive and Negative Syndrome Scale (PANSS) at Baseline (Day 3)|The Positive and Negative Syndrome Scale (PANSS) is a 30-item questionnaire used to evaluate schizophrenia symptoms; consisting of Positive (7 items), Negative (7 items), and General Psychopathological scales (16 items) sections. Each item (symptom) is scored on a 7-point scale, higher scores representing increasing levels of psychopathology: Positive scale: 7 Items, (min. score = 7, max. score = 49); Negative scale: 7 Items, (min. score = 7, max. score = 49). For this measure, only the positive and negative scales are included in the total score (min. total score = 14, max., score = 98)|units on a scale|Mean|22.3|22.3|Standard Deviation|3.4|3.4|||
3704736|NCT02164981|3545233|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3704737|NCT02164981|3545234|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3704738|NCT02164981|3545235|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3704739|NCT02164981|3545236|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3704703|NCT02164981|3545236|B1|PANSS - positive||The Positive and Negative Syndrome Scale (PANSS) at Baseline (Day 3)|The Positive and Negative Syndrome Scale (PANSS) is a 30-item questionnaire used to evaluate schizophrenia symptoms; consisting of Positive (7 items), Negative (7 items), and General Psychopathological scales (16 items) sections. Each item (symptom) is scored on a 7-point scale, higher scores representing increasing levels of psychopathology: Positive scale: 7 Items, (min. score = 7, max. score = 49); Negative scale: 7 Items, (min. score = 7, max. score = 49). For this measure, only the positive and negative scales are included in the total score (min. total score = 14, max., score = 98)|units on a scale|Mean|24.9|24.9|Standard Deviation|3.5|3.5|||
3704704|NCT02164981|3545233|B4|PANSS -total||The Positive and Negative Syndrome Scale (PANSS) at Baseline (Day 3)|The Positive and Negative Syndrome Scale (PANSS) is a 30-item questionnaire used to evaluate schizophrenia symptoms; consisting of Positive (7 items), Negative (7 items), and General Psychopathological scales (16 items) sections. Each item (symptom) is scored on a 7-point scale, higher scores representing increasing levels of psychopathology: Positive scale: 7 Items, (min. score = 7, max. score = 49); Negative scale: 7 Items, (min. score = 7, max. score = 49). For this measure, only the positive and negative scales are included in the total score (min. total score = 14, max., score = 98)|units on a scale|Mean|80.9|80.9|Standard Deviation|9.2|9.2|||
3704705|NCT02164981|3545234|B3|PANSS -total||The Positive and Negative Syndrome Scale (PANSS) at Baseline (Day 3)|The Positive and Negative Syndrome Scale (PANSS) is a 30-item questionnaire used to evaluate schizophrenia symptoms; consisting of Positive (7 items), Negative (7 items), and General Psychopathological scales (16 items) sections. Each item (symptom) is scored on a 7-point scale, higher scores representing increasing levels of psychopathology: Positive scale: 7 Items, (min. score = 7, max. score = 49); Negative scale: 7 Items, (min. score = 7, max. score = 49). For this measure, only the positive and negative scales are included in the total score (min. total score = 14, max., score = 98)|units on a scale|Mean|81.7|81.7|Standard Deviation|8.8|8.8|||
3704706|NCT02164981|3545235|B2|PANSS -total||The Positive and Negative Syndrome Scale (PANSS) at Baseline (Day 3)|The Positive and Negative Syndrome Scale (PANSS) is a 30-item questionnaire used to evaluate schizophrenia symptoms; consisting of Positive (7 items), Negative (7 items), and General Psychopathological scales (16 items) sections. Each item (symptom) is scored on a 7-point scale, higher scores representing increasing levels of psychopathology: Positive scale: 7 Items, (min. score = 7, max. score = 49); Negative scale: 7 Items, (min. score = 7, max. score = 49). For this measure, only the positive and negative scales are included in the total score (min. total score = 14, max., score = 98)|units on a scale|Mean|77.6|77.6|Standard Deviation|8.8|8.8|||
3704707|NCT02164981|3545236|B1|PANSS -total||The Positive and Negative Syndrome Scale (PANSS) at Baseline (Day 3)|The Positive and Negative Syndrome Scale (PANSS) is a 30-item questionnaire used to evaluate schizophrenia symptoms; consisting of Positive (7 items), Negative (7 items), and General Psychopathological scales (16 items) sections. Each item (symptom) is scored on a 7-point scale, higher scores representing increasing levels of psychopathology: Positive scale: 7 Items, (min. score = 7, max. score = 49); Negative scale: 7 Items, (min. score = 7, max. score = 49). For this measure, only the positive and negative scales are included in the total score (min. total score = 14, max., score = 98)|units on a scale|Mean|83.6|83.6|Standard Deviation|10.0|10.0|||
3704708|NCT02164981|3545233|B4|United States||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
3704709|NCT02164981|3545234|B3|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3704710|NCT02164981|3545235|B2|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3704711|NCT02164981|3545236|B1|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3704712|NCT02164981|3545233|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3704713|NCT02164981|3545234|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3704714|NCT02164981|3545235|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3704715|NCT02164981|3545236|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3704716|NCT02164981|3545233|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3704717|NCT02164981|3545234|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3704718|NCT02164981|3545235|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3704719|NCT02164981|3545236|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3704720|NCT02164981|3545233|B4|Black||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3704721|NCT02164981|3545234|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3704722|NCT02164981|3545235|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3704723|NCT02164981|3545236|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3704724|NCT02164981|3545233|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3704725|NCT02164981|3545234|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3704726|NCT02164981|3545235|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3704727|NCT02164981|3545236|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3704728|NCT02164981|3545233|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704729|NCT02164981|3545234|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704730|NCT02164981|3545235|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704731|NCT02164981|3545236|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704732|NCT02164981|3545233|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3704733|NCT02164981|3545234|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3704734|NCT02164981|3545235|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3704735|NCT02164981|3545236|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3704740|NCT02164981|3545233|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3704741|NCT02164981|3545234|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3704742|NCT02164981|3545235|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3704743|NCT02164981|3545236|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3704744|NCT02164981|3545233|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3704745|NCT02164981|3545234|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3704746|NCT02164981|3545235|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3704747|NCT02164981|3545236|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3704748|NCT02164981|3545233|B4|||Age||years|Mean|44.5|44.5|Standard Deviation|11.3|11.3|||
3704749|NCT02164981|3545234|B3|||Age||years|Mean|40.4|40.4|Standard Deviation|11.0|11.0|||
3704750|NCT02164981|3545235|B2|||Age||years|Mean|45.9|45.9|Standard Deviation|12.3|12.3|||
3704751|NCT02164981|3545236|B1|||Age||years|Mean|47.1|47.1|Standard Deviation|10.5|10.5|||
3704752|NCT02164929|3545307|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3704753|NCT02164929|3545308|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3704754|NCT02164929|3545309|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3704755|NCT02164929|3545310|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3704756|NCT02164929|3545311|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3704757|NCT02164929|3545307|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3704758|NCT02164929|3545308|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3704759|NCT02164929|3545309|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3704760|NCT02164929|3545310|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3704761|NCT02164929|3545311|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3704762|NCT02164929|3545307|B5|||Age||years|Mean|54.2|54.2|Standard Deviation|12.9|12.9|||
3704763|NCT02164929|3545308|B4|||Age||years|Mean|52|52.0|Standard Deviation|21.9|21.9|||
3704764|NCT02164929|3545309|B3|||Age||years|Mean|57.75|57.75|Standard Deviation|6.6|6.6|||
3704765|NCT02164929|3545310|B2|||Age||years|Mean|51|51.0|Standard Deviation|15|15.0|||
3704766|NCT02164929|3545311|B1|||Age||years|Mean|55.5|55.5|Standard Deviation|8.5|8.5|||
3704767|NCT02164916|3545356|B3|No||Prior treatment with Irinotecan||participants|Number|60|60.0||||||
3704768|NCT02164916|3545357|B2|No||Prior treatment with Irinotecan||participants|Number|29|29.0||||||
3704769|NCT02164916|3545358|B1|No||Prior treatment with Irinotecan||participants|Number|31|31.0||||||
3704770|NCT02164916|3545356|B3|Yes||Prior treatment with Irinotecan||participants|Number|39|39.0||||||
3704771|NCT02164916|3545357|B2|Yes||Prior treatment with Irinotecan||participants|Number|20|20.0||||||
3704772|NCT02164916|3545358|B1|Yes||Prior treatment with Irinotecan||participants|Number|19|19.0||||||
3704773|NCT02164916|3545356|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3704774|NCT02164916|3545357|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3704775|NCT02164916|3545358|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704776|NCT02164916|3545356|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704777|NCT02164916|3545357|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704778|NCT02164916|3545358|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704779|NCT02164916|3545356|B3||White|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
3704780|NCT02164916|3545357|B2||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3704781|NCT02164916|3545358|B1||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3704782|NCT02164916|3545356|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3704783|NCT02164916|3545357|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3704784|NCT02164916|3545358|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704785|NCT02164916|3545356|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704786|NCT02164916|3545357|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704787|NCT02164916|3545358|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704788|NCT02164916|3545356|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3704789|NCT02164916|3545357|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3704790|NCT02164916|3545358|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3704791|NCT02164916|3545356|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704792|NCT02164916|3545357|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704793|NCT02164916|3545358|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704794|NCT02164916|3545356|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3704795|NCT02164916|3545357|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3704796|NCT02164916|3545358|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3704797|NCT02164916|3545356|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3704798|NCT02164916|3545357|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3704799|NCT02164916|3545358|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3704800|NCT02164916|3545356|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3704801|NCT02164916|3545357|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3704802|NCT02164916|3545358|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3704803|NCT02164916|3545356|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3704804|NCT02164916|3545357|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3704805|NCT02164916|3545358|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3704806|NCT02164916|3545356|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3704807|NCT02164916|3545357|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3704808|NCT02164916|3545358|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3704809|NCT02164916|3545356|B3|||Age||years|Median|62|62.0|Full Range|||31.0|83.0|
3704810|NCT02164916|3545357|B2|||Age||years|Median|60|60.0|Full Range|||34.0|83.0|
3704811|NCT02164916|3545358|B1|||Age||years|Median|62|62.0|Full Range|||31.0|83.0|
3704812|NCT02164864|3545376|B4||Missing|Race/Ethnicity, Customized|The details on Race has been provided|Participants|Count of Participants|26|26.0||||||
3704813|NCT02164864|3545377|B3||Missing|Race/Ethnicity, Customized|The details on Race has been provided|Participants|Count of Participants|11|11.0||||||
3704814|NCT02164864|3545378|B2||Missing|Race/Ethnicity, Customized|The details on Race has been provided|Participants|Count of Participants|11|11.0||||||
3704815|NCT02164864|3545379|B1||Missing|Race/Ethnicity, Customized|The details on Race has been provided|Participants|Count of Participants|4|4.0||||||
3704816|NCT02164864|3545376|B4||Other|Race/Ethnicity, Customized|The details on Race has been provided|Participants|Count of Participants|20|20.0||||||
3704817|NCT02164864|3545377|B3||Other|Race/Ethnicity, Customized|The details on Race has been provided|Participants|Count of Participants|7|7.0||||||
3704818|NCT02164864|3545378|B2||Other|Race/Ethnicity, Customized|The details on Race has been provided|Participants|Count of Participants|8|8.0||||||
3704819|NCT02164864|3545379|B1||Other|Race/Ethnicity, Customized|The details on Race has been provided|Participants|Count of Participants|5|5.0||||||
3704820|NCT02164864|3545376|B4||White|Race/Ethnicity, Customized|The details on Race has been provided|Participants|Count of Participants|2344|2344.0||||||
3704821|NCT02164864|3545377|B3||White|Race/Ethnicity, Customized|The details on Race has been provided|Participants|Count of Participants|835|835.0||||||
3704822|NCT02164864|3545378|B2||White|Race/Ethnicity, Customized|The details on Race has been provided|Participants|Count of Participants|658|658.0||||||
3704823|NCT02164864|3545379|B1||White|Race/Ethnicity, Customized|The details on Race has been provided|Participants|Count of Participants|851|851.0||||||
3704824|NCT02164864|3545376|B4||Black|Race/Ethnicity, Customized|The details on Race has been provided|Participants|Count of Participants|15|15.0||||||
3704825|NCT02164864|3545377|B3||Black|Race/Ethnicity, Customized|The details on Race has been provided|Participants|Count of Participants|3|3.0||||||
3704826|NCT02164864|3545378|B2||Black|Race/Ethnicity, Customized|The details on Race has been provided|Participants|Count of Participants|7|7.0||||||
3704827|NCT02164864|3545379|B1||Black|Race/Ethnicity, Customized|The details on Race has been provided|Participants|Count of Participants|5|5.0||||||
3704828|NCT02164864|3545376|B4||Asian|Race/Ethnicity, Customized|The details on Race has been provided|Participants|Count of Participants|320|320.0||||||
3704829|NCT02164864|3545377|B3||Asian|Race/Ethnicity, Customized|The details on Race has been provided|Participants|Count of Participants|125|125.0||||||
3704830|NCT02164864|3545378|B2||Asian|Race/Ethnicity, Customized|The details on Race has been provided|Participants|Count of Participants|79|79.0||||||
3704831|NCT02164864|3545379|B1||Asian|Race/Ethnicity, Customized|The details on Race has been provided|Participants|Count of Participants|116|116.0||||||
3704832|NCT02164864|3545376|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3704833|NCT02164864|3545377|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3704834|NCT02164864|3545378|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3704835|NCT02164864|3545379|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3704836|NCT02164864|3545376|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2507|2507.0||||||
3704837|NCT02164864|3545377|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|904|904.0||||||
3704838|NCT02164864|3545378|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|700|700.0||||||
3704839|NCT02164864|3545379|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|903|903.0||||||
3704840|NCT02164864|3545376|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|175|175.0||||||
3704841|NCT02164864|3545377|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3704842|NCT02164864|3545378|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3704843|NCT02164864|3545379|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3704844|NCT02164864|3545376|B4||Male|Sex: Female, Male||Participants|Count of Participants|2070|2070.0||||||
3704845|NCT02164864|3545377|B3||Male|Sex: Female, Male||Participants|Count of Participants|750|750.0||||||
3704846|NCT02164864|3545378|B2||Male|Sex: Female, Male||Participants|Count of Participants|592|592.0||||||
3704847|NCT02164864|3545379|B1||Male|Sex: Female, Male||Participants|Count of Participants|728|728.0||||||
3704848|NCT02164864|3545376|B4||Female|Sex: Female, Male||Participants|Count of Participants|655|655.0||||||
3704849|NCT02164864|3545377|B3||Female|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
3704850|NCT02164864|3545378|B2||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3704851|NCT02164864|3545379|B1||Female|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
3704852|NCT02164864|3545376|B4||≥80: USA|Age, Customized||Participants|Count of Participants|31|31.0||||||
3704853|NCT02164864|3545377|B3||≥80: USA|Age, Customized||Participants|Count of Participants|10|10.0||||||
3704854|NCT02164864|3545378|B2||≥80: USA|Age, Customized||Participants|Count of Participants|8|8.0||||||
3704855|NCT02164864|3545379|B1||≥80: USA|Age, Customized||Participants|Count of Participants|13|13.0||||||
3704856|NCT02164864|3545376|B4||≥80: EU/ROW|Age, Customized||Participants|Count of Participants|384|384.0||||||
3704857|NCT02164864|3545377|B3||≥80: EU/ROW|Age, Customized||Participants|Count of Participants|192|192.0||||||
3704858|NCT02164864|3545378|B2||≥80: EU/ROW|Age, Customized||Participants|Count of Participants|3|3.0||||||
3704859|NCT02164864|3545379|B1||≥80: EU/ROW|Age, Customized||Participants|Count of Participants|189|189.0||||||
3704860|NCT02164864|3545376|B4||<80: USA|Age, Customized||Participants|Count of Participants|168|168.0||||||
3704861|NCT02164864|3545377|B3||<80: USA|Age, Customized||Participants|Count of Participants|61|61.0||||||
3704862|NCT02164864|3545378|B2||<80: USA|Age, Customized||Participants|Count of Participants|53|53.0||||||
3704863|NCT02164864|3545379|B1||<80: USA|Age, Customized||Participants|Count of Participants|54|54.0||||||
3704864|NCT02164864|3545376|B4||<80: EU/ROW|Age, Customized||Participants|Count of Participants|2142|2142.0||||||
3704865|NCT02164864|3545377|B3||<80: EU/ROW|Age, Customized||Participants|Count of Participants|718|718.0||||||
3704866|NCT02164864|3545378|B2||<80: EU/ROW|Age, Customized||Participants|Count of Participants|699|699.0||||||
3704867|NCT02164864|3545379|B1||<80: EU/ROW|Age, Customized||Participants|Count of Participants|725|725.0||||||
3704868|NCT02164864|3545376|B4|||Age|Age at the time of signing informed consent form is presented.|Years|Mean|70.8|70.8|Standard Deviation|8.66|8.66|||
3704869|NCT02164864|3545377|B3|||Age|Age at the time of signing informed consent form is presented.|Years|Mean|71.7|71.7|Standard Deviation|8.90|8.9|||
3704870|NCT02164864|3545378|B2|||Age|Age at the time of signing informed consent form is presented.|Years|Mean|68.6|68.6|Standard Deviation|7.65|7.65|||
3704871|NCT02164864|3545379|B1|||Age|Age at the time of signing informed consent form is presented.|Years|Mean|71.5|71.5|Standard Deviation|8.87|8.87|||
3704872|NCT02164539|3545440|B7|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3704873|NCT02164539|3545441|B6|Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3704874|NCT02164539|3545442|B5|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3704875|NCT02164539|3545443|B4|Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3704876|NCT02164539|3545444|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3704877|NCT02164539|3545445|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3704878|NCT02164539|3545446|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3704879|NCT02164539|3545440|B7|White- White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|329|329.0||||||
3704880|NCT02164539|3545441|B6|White- White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|83|83.0||||||
3704881|NCT02164539|3545442|B5|White- White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|81|81.0||||||
3704882|NCT02164539|3545443|B4|White- White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|44|44.0||||||
3704883|NCT02164539|3545444|B3|White- White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|39|39.0||||||
3704884|NCT02164539|3545445|B2|White- White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|42|42.0||||||
3704885|NCT02164539|3545446|B1|White- White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
3704886|NCT02164539|3545440|B7|White- Arabic/ North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3704887|NCT02164539|3545441|B6|White- Arabic/ North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3704888|NCT02164539|3545442|B5|White- Arabic/ North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3704889|NCT02164539|3545443|B4|White- Arabic/ North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3704890|NCT02164539|3545444|B3|White- Arabic/ North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3704891|NCT02164539|3545445|B2|White- Arabic/ North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3704892|NCT02164539|3545446|B1|White- Arabic/ North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3704893|NCT02164539|3545440|B7|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3704894|NCT02164539|3545441|B6|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3704895|NCT02164539|3545442|B5|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3704896|NCT02164539|3545443|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3704897|NCT02164539|3545444|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3704898|NCT02164539|3545445|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3704899|NCT02164539|3545446|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3704900|NCT02164539|3545440|B7||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
3704901|NCT02164539|3545441|B6||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3704902|NCT02164539|3545442|B5||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3704903|NCT02164539|3545443|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3704904|NCT02164539|3545444|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3704905|NCT02164539|3545445|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3704906|NCT02164539|3545446|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3704907|NCT02164539|3545440|B7||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3704908|NCT02164539|3545441|B6||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3704909|NCT02164539|3545442|B5||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3704910|NCT02164539|3545443|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3704911|NCT02164539|3545444|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3704912|NCT02164539|3545445|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3704913|NCT02164539|3545446|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3704914|NCT02164539|3545440|B7|||Age||Years|Mean|57.5|57.5|Standard Deviation|10.56|10.56|||
3704915|NCT02164539|3545441|B6|||Age||Years|Mean|57.6|57.6|Standard Deviation|10.95|10.95|||
3704916|NCT02164539|3545442|B5|||Age||Years|Mean|57.8|57.8|Standard Deviation|11.03|11.03|||
3704917|NCT02164539|3545443|B4|||Age||Years|Mean|58.2|58.2|Standard Deviation|10.47|10.47|||
3704918|NCT02164539|3545444|B3|||Age||Years|Mean|56.7|56.7|Standard Deviation|10.14|10.14|||
3704919|NCT02164539|3545445|B2|||Age||Years|Mean|55.5|55.5|Standard Deviation|11.33|11.33|||
3704920|NCT02164539|3545446|B1|||Age||Years|Mean|58.4|58.4|Standard Deviation|8.59|8.59|||
3704921|NCT02164513|3545497|B4|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3704922|NCT02164513|3545498|B3|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3704923|NCT02164513|3545499|B2|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3704924|NCT02164513|3545500|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3704925|NCT02164513|3545497|B4|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|103|103.0||||||
3704926|NCT02164513|3545498|B3|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3704927|NCT02164513|3545499|B2|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|45|45.0||||||
3704928|NCT02164513|3545500|B1|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
3704929|NCT02164513|3545497|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|7983|7983.0||||||
3704930|NCT02164513|3545498|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1604|1604.0||||||
3704931|NCT02164513|3545499|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|3179|3179.0||||||
3704932|NCT02164513|3545500|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|3200|3200.0||||||
3704933|NCT02164513|3545497|B4|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|100|100.0||||||
3704934|NCT02164513|3545498|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3704935|NCT02164513|3545499|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|45|45.0||||||
3704936|NCT02164513|3545500|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3704937|NCT02164513|3545497|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3704938|NCT02164513|3545498|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3704939|NCT02164513|3545499|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3704940|NCT02164513|3545500|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3704941|NCT02164513|3545497|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|264|264.0||||||
3704942|NCT02164513|3545498|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
3704943|NCT02164513|3545499|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|99|99.0||||||
3704944|NCT02164513|3545500|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|122|122.0||||||
3704945|NCT02164513|3545497|B4|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|371|371.0||||||
3704946|NCT02164513|3545498|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|75|75.0||||||
3704947|NCT02164513|3545499|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|147|147.0||||||
3704948|NCT02164513|3545500|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|149|149.0||||||
3704949|NCT02164513|3545497|B4|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|385|385.0||||||
3704950|NCT02164513|3545498|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|82|82.0||||||
3704951|NCT02164513|3545499|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|152|152.0||||||
3704952|NCT02164513|3545500|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|151|151.0||||||
3704953|NCT02164513|3545497|B4|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|913|913.0||||||
3704954|NCT02164513|3545498|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|177|177.0||||||
3704955|NCT02164513|3545499|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|374|374.0||||||
3704956|NCT02164513|3545500|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|362|362.0||||||
3704957|NCT02164513|3545497|B4|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3705097|NCT02164318|3545537|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3704958|NCT02164513|3545498|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3704959|NCT02164513|3545499|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3704960|NCT02164513|3545500|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3704961|NCT02164513|3545497|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|218|218.0||||||
3704962|NCT02164513|3545498|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|45|45.0||||||
3704963|NCT02164513|3545499|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|86|86.0||||||
3704964|NCT02164513|3545500|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|87|87.0||||||
3704965|NCT02164513|3545497|B4||Male|Sex: Female, Male||Participants|Count of Participants|6870|6870.0||||||
3704966|NCT02164513|3545498|B3||Male|Sex: Female, Male||Participants|Count of Participants|1356|1356.0||||||
3704967|NCT02164513|3545499|B2||Male|Sex: Female, Male||Participants|Count of Participants|2748|2748.0||||||
3704968|NCT02164513|3545500|B1||Male|Sex: Female, Male||Participants|Count of Participants|2766|2766.0||||||
3704969|NCT02164513|3545497|B4||Female|Sex: Female, Male||Participants|Count of Participants|3485|3485.0||||||
3704970|NCT02164513|3545498|B3||Female|Sex: Female, Male||Participants|Count of Participants|714|714.0||||||
3704971|NCT02164513|3545499|B2||Female|Sex: Female, Male||Participants|Count of Participants|1386|1386.0||||||
3704972|NCT02164513|3545500|B1||Female|Sex: Female, Male||Participants|Count of Participants|1385|1385.0||||||
3704973|NCT02164513|3545497|B4|||Age||Years|Mean|65.3|65.3|Standard Deviation|8.27|8.27|||
3704974|NCT02164513|3545498|B3|||Age||Years|Mean|65.2|65.2|Standard Deviation|8.26|8.26|||
3704975|NCT02164513|3545499|B2|||Age||Years|Mean|65.3|65.3|Standard Deviation|8.30|8.3|||
3704976|NCT02164513|3545500|B1|||Age||Years|Mean|65.3|65.3|Standard Deviation|8.24|8.24|||
3704977|NCT02164396|3545524|B4|Germany||Region of Enrollment||participants|Number|30|30.0||||||
3704978|NCT02164396|3545525|B3|Germany||Region of Enrollment||participants|Number|10|10.0||||||
3704979|NCT02164396|3545526|B2|Germany||Region of Enrollment||participants|Number|10|10.0||||||
3704980|NCT02164396|3545527|B1|Germany||Region of Enrollment||participants|Number|10|10.0||||||
3704981|NCT02164396|3545524|B4|White||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3704982|NCT02164396|3545525|B3|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3704983|NCT02164396|3545526|B2|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3704984|NCT02164396|3545527|B1|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3704985|NCT02164396|3545524|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3704986|NCT02164396|3545525|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3704987|NCT02164396|3545526|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3704988|NCT02164396|3545527|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3704989|NCT02164396|3545524|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3704990|NCT02164396|3545525|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3704991|NCT02164396|3545526|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3704992|NCT02164396|3545527|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3704993|NCT02164396|3545524|B4|||Age||years|Mean|32.67|32.67|Standard Deviation|10.613|10.613|||
3704994|NCT02164396|3545525|B3|||Age||years|Mean|29.0|29.0|Standard Deviation|9.821|9.821|||
3704995|NCT02164396|3545526|B2|||Age||years|Mean|33.60|33.6|Standard Deviation|11.918|11.918|||
3704996|NCT02164396|3545527|B1|||Age||years|Mean|35.40|35.4|Standard Deviation|10.013|10.013|||
3704997|NCT02164318|3545537|B5||Hyperlipidemia: No|Hyperlipidemia Status|Number of participants with a diagnosis of hyperlipidemia at time of enrollment|Participants|Count of Participants|5|5.0||||||
3704998|NCT02164318|3545538|B4||Hyperlipidemia: No|Hyperlipidemia Status|Number of participants with a diagnosis of hyperlipidemia at time of enrollment|Participants|Count of Participants|1|1.0||||||
3704999|NCT02164318|3545539|B3||Hyperlipidemia: No|Hyperlipidemia Status|Number of participants with a diagnosis of hyperlipidemia at time of enrollment|Participants|Count of Participants|1|1.0||||||
3705000|NCT02164318|3545540|B2||Hyperlipidemia: No|Hyperlipidemia Status|Number of participants with a diagnosis of hyperlipidemia at time of enrollment|Participants|Count of Participants|1|1.0||||||
3705001|NCT02164318|3545541|B1||Hyperlipidemia: No|Hyperlipidemia Status|Number of participants with a diagnosis of hyperlipidemia at time of enrollment|Participants|Count of Participants|2|2.0||||||
3705002|NCT02164318|3545537|B5||Hyperlipidemia: Yes|Hyperlipidemia Status|Number of participants with a diagnosis of hyperlipidemia at time of enrollment|Participants|Count of Participants|6|6.0||||||
3705003|NCT02164318|3545538|B4||Hyperlipidemia: Yes|Hyperlipidemia Status|Number of participants with a diagnosis of hyperlipidemia at time of enrollment|Participants|Count of Participants|2|2.0||||||
3705004|NCT02164318|3545539|B3||Hyperlipidemia: Yes|Hyperlipidemia Status|Number of participants with a diagnosis of hyperlipidemia at time of enrollment|Participants|Count of Participants|0|0.0||||||
3705005|NCT02164318|3545540|B2||Hyperlipidemia: Yes|Hyperlipidemia Status|Number of participants with a diagnosis of hyperlipidemia at time of enrollment|Participants|Count of Participants|2|2.0||||||
3705006|NCT02164318|3545541|B1||Hyperlipidemia: Yes|Hyperlipidemia Status|Number of participants with a diagnosis of hyperlipidemia at time of enrollment|Participants|Count of Participants|2|2.0||||||
3705007|NCT02164318|3545537|B5||TD: No|History of thrombotic disorder (TD)|Number of participants with a history of stroke, deep vein thrombosis or pulmonary embolism at time of enrollment|Participants|Count of Participants|8|8.0||||||
3705008|NCT02164318|3545538|B4||TD: No|History of thrombotic disorder (TD)|Number of participants with a history of stroke, deep vein thrombosis or pulmonary embolism at time of enrollment|Participants|Count of Participants|1|1.0||||||
3705009|NCT02164318|3545539|B3||TD: No|History of thrombotic disorder (TD)|Number of participants with a history of stroke, deep vein thrombosis or pulmonary embolism at time of enrollment|Participants|Count of Participants|1|1.0||||||
3705010|NCT02164318|3545540|B2||TD: No|History of thrombotic disorder (TD)|Number of participants with a history of stroke, deep vein thrombosis or pulmonary embolism at time of enrollment|Participants|Count of Participants|2|2.0||||||
3705011|NCT02164318|3545541|B1||TD: No|History of thrombotic disorder (TD)|Number of participants with a history of stroke, deep vein thrombosis or pulmonary embolism at time of enrollment|Participants|Count of Participants|4|4.0||||||
3705012|NCT02164318|3545537|B5||TD: Yes|History of thrombotic disorder (TD)|Number of participants with a history of stroke, deep vein thrombosis or pulmonary embolism at time of enrollment|Participants|Count of Participants|3|3.0||||||
3705013|NCT02164318|3545538|B4||TD: Yes|History of thrombotic disorder (TD)|Number of participants with a history of stroke, deep vein thrombosis or pulmonary embolism at time of enrollment|Participants|Count of Participants|2|2.0||||||
3705014|NCT02164318|3545539|B3||TD: Yes|History of thrombotic disorder (TD)|Number of participants with a history of stroke, deep vein thrombosis or pulmonary embolism at time of enrollment|Participants|Count of Participants|0|0.0||||||
3705015|NCT02164318|3545540|B2||TD: Yes|History of thrombotic disorder (TD)|Number of participants with a history of stroke, deep vein thrombosis or pulmonary embolism at time of enrollment|Participants|Count of Participants|1|1.0||||||
3705016|NCT02164318|3545541|B1||TD: Yes|History of thrombotic disorder (TD)|Number of participants with a history of stroke, deep vein thrombosis or pulmonary embolism at time of enrollment|Participants|Count of Participants|0|0.0||||||
3705017|NCT02164318|3545537|B5||DM: No|Diabetes Mellitus (DM) Status|Number of participants diagnosed with Diabetes Mellitus at enrollment|Participants|Count of Participants|6|6.0||||||
3705018|NCT02164318|3545538|B4||DM: No|Diabetes Mellitus (DM) Status|Number of participants diagnosed with Diabetes Mellitus at enrollment|Participants|Count of Participants|2|2.0||||||
3705019|NCT02164318|3545539|B3||DM: No|Diabetes Mellitus (DM) Status|Number of participants diagnosed with Diabetes Mellitus at enrollment|Participants|Count of Participants|1|1.0||||||
3705020|NCT02164318|3545540|B2||DM: No|Diabetes Mellitus (DM) Status|Number of participants diagnosed with Diabetes Mellitus at enrollment|Participants|Count of Participants|1|1.0||||||
3705021|NCT02164318|3545541|B1||DM: No|Diabetes Mellitus (DM) Status|Number of participants diagnosed with Diabetes Mellitus at enrollment|Participants|Count of Participants|2|2.0||||||
3705022|NCT02164318|3545537|B5||DM: Yes|Diabetes Mellitus (DM) Status|Number of participants diagnosed with Diabetes Mellitus at enrollment|Participants|Count of Participants|5|5.0||||||
3705023|NCT02164318|3545538|B4||DM: Yes|Diabetes Mellitus (DM) Status|Number of participants diagnosed with Diabetes Mellitus at enrollment|Participants|Count of Participants|1|1.0||||||
3705024|NCT02164318|3545539|B3||DM: Yes|Diabetes Mellitus (DM) Status|Number of participants diagnosed with Diabetes Mellitus at enrollment|Participants|Count of Participants|0|0.0||||||
3705025|NCT02164318|3545540|B2||DM: Yes|Diabetes Mellitus (DM) Status|Number of participants diagnosed with Diabetes Mellitus at enrollment|Participants|Count of Participants|2|2.0||||||
3705026|NCT02164318|3545541|B1||DM: Yes|Diabetes Mellitus (DM) Status|Number of participants diagnosed with Diabetes Mellitus at enrollment|Participants|Count of Participants|2|2.0||||||
3705027|NCT02164318|3545537|B5||CAD: No|Coronary Artery Disease (CAD) Status|Number of participants diagnosed with coronary artery disease at enrollment|Participants|Count of Participants|9|9.0||||||
3705028|NCT02164318|3545538|B4||CAD: No|Coronary Artery Disease (CAD) Status|Number of participants diagnosed with coronary artery disease at enrollment|Participants|Count of Participants|2|2.0||||||
3705029|NCT02164318|3545539|B3||CAD: No|Coronary Artery Disease (CAD) Status|Number of participants diagnosed with coronary artery disease at enrollment|Participants|Count of Participants|1|1.0||||||
3705030|NCT02164318|3545540|B2||CAD: No|Coronary Artery Disease (CAD) Status|Number of participants diagnosed with coronary artery disease at enrollment|Participants|Count of Participants|2|2.0||||||
3705031|NCT02164318|3545541|B1||CAD: No|Coronary Artery Disease (CAD) Status|Number of participants diagnosed with coronary artery disease at enrollment|Participants|Count of Participants|4|4.0||||||
3705032|NCT02164318|3545537|B5||CAD: Yes|Coronary Artery Disease (CAD) Status|Number of participants diagnosed with coronary artery disease at enrollment|Participants|Count of Participants|2|2.0||||||
3705033|NCT02164318|3545538|B4||CAD: Yes|Coronary Artery Disease (CAD) Status|Number of participants diagnosed with coronary artery disease at enrollment|Participants|Count of Participants|1|1.0||||||
3705034|NCT02164318|3545539|B3||CAD: Yes|Coronary Artery Disease (CAD) Status|Number of participants diagnosed with coronary artery disease at enrollment|Participants|Count of Participants|0|0.0||||||
3705035|NCT02164318|3545540|B2||CAD: Yes|Coronary Artery Disease (CAD) Status|Number of participants diagnosed with coronary artery disease at enrollment|Participants|Count of Participants|1|1.0||||||
3705036|NCT02164318|3545541|B1||CAD: Yes|Coronary Artery Disease (CAD) Status|Number of participants diagnosed with coronary artery disease at enrollment|Participants|Count of Participants|0|0.0||||||
3705037|NCT02164318|3545537|B5||Hypertension: No|Hypertension Status|Number of participants with diagnosis of hypertension at enrollment|Participants|Count of Participants|0|0.0||||||
3705038|NCT02164318|3545538|B4||Hypertension: No|Hypertension Status|Number of participants with diagnosis of hypertension at enrollment|Participants|Count of Participants|0|0.0||||||
3705039|NCT02164318|3545539|B3||Hypertension: No|Hypertension Status|Number of participants with diagnosis of hypertension at enrollment|Participants|Count of Participants|0|0.0||||||
3705040|NCT02164318|3545540|B2||Hypertension: No|Hypertension Status|Number of participants with diagnosis of hypertension at enrollment|Participants|Count of Participants|0|0.0||||||
3705041|NCT02164318|3545541|B1||Hypertension: No|Hypertension Status|Number of participants with diagnosis of hypertension at enrollment|Participants|Count of Participants|0|0.0||||||
3705042|NCT02164318|3545537|B5||Hypertension: Yes|Hypertension Status|Number of participants with diagnosis of hypertension at enrollment|Participants|Count of Participants|11|11.0||||||
3705043|NCT02164318|3545538|B4||Hypertension: Yes|Hypertension Status|Number of participants with diagnosis of hypertension at enrollment|Participants|Count of Participants|3|3.0||||||
3705098|NCT02164318|3545538|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3705044|NCT02164318|3545539|B3||Hypertension: Yes|Hypertension Status|Number of participants with diagnosis of hypertension at enrollment|Participants|Count of Participants|1|1.0||||||
3705045|NCT02164318|3545540|B2||Hypertension: Yes|Hypertension Status|Number of participants with diagnosis of hypertension at enrollment|Participants|Count of Participants|3|3.0||||||
3705046|NCT02164318|3545541|B1||Hypertension: Yes|Hypertension Status|Number of participants with diagnosis of hypertension at enrollment|Participants|Count of Participants|4|4.0||||||
3705047|NCT02164318|3545537|B5|||Body Mass Index|Body Mass Index calculated from weight/height|kg/m^2|Mean|30.0|30.0|Standard Deviation|9.7|9.7|||
3705048|NCT02164318|3545538|B4|||Body Mass Index|Body Mass Index calculated from weight/height|kg/m^2|Mean|27.2|27.2|Standard Deviation|8.0|8.0|||
3705049|NCT02164318|3545539|B3|||Body Mass Index|Body Mass Index calculated from weight/height|kg/m^2|Mean|33.1|33.1|Standard Deviation|0|0.0|||
3705050|NCT02164318|3545540|B2|||Body Mass Index|Body Mass Index calculated from weight/height|kg/m^2|Mean|27.6|27.6|Standard Deviation|5.8|5.8|||
3705051|NCT02164318|3545541|B1|||Body Mass Index|Body Mass Index calculated from weight/height|kg/m^2|Mean|33.1|33.1|Standard Deviation|14.7|14.7|||
3705052|NCT02164318|3545537|B5|||Dialysis Status|Indicates if patient had initiated dialysis at time of enrollment|Participants|Count of Participants|3|3.0||||||
3705053|NCT02164318|3545538|B4|||Dialysis Status|Indicates if patient had initiated dialysis at time of enrollment|Participants|Count of Participants|0|0.0||||||
3705054|NCT02164318|3545539|B3|||Dialysis Status|Indicates if patient had initiated dialysis at time of enrollment|Participants|Count of Participants|1|1.0||||||
3705055|NCT02164318|3545540|B2|||Dialysis Status|Indicates if patient had initiated dialysis at time of enrollment|Participants|Count of Participants|1|1.0||||||
3705056|NCT02164318|3545541|B1|||Dialysis Status|Indicates if patient had initiated dialysis at time of enrollment|Participants|Count of Participants|1|1.0||||||
3705057|NCT02164318|3545537|B5|United States||Region of Enrollment||participants|Number|11|11.0||||||
3705058|NCT02164318|3545538|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
3705059|NCT02164318|3545539|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3705060|NCT02164318|3545540|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3705061|NCT02164318|3545541|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3705062|NCT02164318|3545537|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705063|NCT02164318|3545538|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705064|NCT02164318|3545539|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705065|NCT02164318|3545540|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705066|NCT02164318|3545541|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705067|NCT02164318|3545537|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705068|NCT02164318|3545538|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705069|NCT02164318|3545539|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705070|NCT02164318|3545540|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705071|NCT02164318|3545541|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705072|NCT02164318|3545537|B5||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705073|NCT02164318|3545538|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705074|NCT02164318|3545539|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705075|NCT02164318|3545540|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705076|NCT02164318|3545541|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705077|NCT02164318|3545537|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3705078|NCT02164318|3545538|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3705079|NCT02164318|3545539|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3705080|NCT02164318|3545540|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3705081|NCT02164318|3545541|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3705082|NCT02164318|3545537|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705083|NCT02164318|3545538|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705084|NCT02164318|3545539|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705085|NCT02164318|3545540|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705086|NCT02164318|3545541|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705087|NCT02164318|3545537|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3705088|NCT02164318|3545538|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3705089|NCT02164318|3545539|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705090|NCT02164318|3545540|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705091|NCT02164318|3545541|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705092|NCT02164318|3545537|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705093|NCT02164318|3545538|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705094|NCT02164318|3545539|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705095|NCT02164318|3545540|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705096|NCT02164318|3545541|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705099|NCT02164318|3545539|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3705100|NCT02164318|3545540|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3705101|NCT02164318|3545541|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3705102|NCT02164318|3545537|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3705103|NCT02164318|3545538|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3705104|NCT02164318|3545539|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3705105|NCT02164318|3545540|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3705106|NCT02164318|3545541|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3705107|NCT02164318|3545537|B5|||Age||years|Mean|54.7|54.7|Standard Deviation|16.7|16.7|||
3705108|NCT02164318|3545538|B4|||Age||years|Mean|53.7|53.7|Standard Deviation|10.1|10.1|||
3705109|NCT02164318|3545539|B3|||Age||years|Mean|41|41.0|Standard Deviation|0|0.0|||
3705110|NCT02164318|3545540|B2|||Age||years|Mean|51.0|51.0|Standard Deviation|28.0|28.0|||
3705111|NCT02164318|3545541|B1|||Age||years|Mean|61.8|61.8|Standard Deviation|13.9|13.9|||
3705112|NCT02164318|3545537|B5||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3705113|NCT02164318|3545538|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3705114|NCT02164318|3545539|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3705115|NCT02164318|3545540|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3705116|NCT02164318|3545541|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3705117|NCT02164318|3545537|B5||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3705118|NCT02164318|3545538|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3705119|NCT02164318|3545539|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3705120|NCT02164318|3545540|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3705121|NCT02164318|3545541|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3705122|NCT02164318|3545537|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3705123|NCT02164318|3545538|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3705124|NCT02164318|3545539|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3705125|NCT02164318|3545540|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3705126|NCT02164318|3545541|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3705127|NCT02163993|3545562|B6|||Number of probable and migraine headache days|Probable Migraine Headache Day: A calendar day on which a probable migraine headache occurred.|Days|Mean|8.28|8.28|Standard Deviation|3.15|3.15|||
3705128|NCT02163993|3545563|B5|||Number of probable and migraine headache days|Probable Migraine Headache Day: A calendar day on which a probable migraine headache occurred.|Days|Mean|8.01|8.01|Standard Deviation|2.79|2.79|||
3705129|NCT02163993|3545564|B4|||Number of probable and migraine headache days|Probable Migraine Headache Day: A calendar day on which a probable migraine headache occurred.|Days|Mean|8.69|8.69|Standard Deviation|3.46|3.46|||
3705130|NCT02163993|3545565|B3|||Number of probable and migraine headache days|Probable Migraine Headache Day: A calendar day on which a probable migraine headache occurred.|Days|Mean|8.33|8.33|Standard Deviation|3.21|3.21|||
3705131|NCT02163993|3545566|B2|||Number of probable and migraine headache days|Probable Migraine Headache Day: A calendar day on which a probable migraine headache occurred.|Days|Mean|8.55|8.55|Standard Deviation|3.23|3.23|||
3705132|NCT02163993|3545567|B1|||Number of probable and migraine headache days|Probable Migraine Headache Day: A calendar day on which a probable migraine headache occurred.|Days|Mean|8.04|8.04|Standard Deviation|3.08|3.08|||
3705133|NCT02163993|3545562|B6|||Number of migraine headache days|Migraine Headache Day: A calendar day on which a migraine headache occurred.|Days|Mean|6.68|6.68|Standard Deviation|2.64|2.64|||
3705134|NCT02163993|3545563|B5|||Number of migraine headache days|Migraine Headache Day: A calendar day on which a migraine headache occurred.|Days|Mean|6.73|6.73|Standard Deviation|2.48|2.48|||
3705135|NCT02163993|3545564|B4|||Number of migraine headache days|Migraine Headache Day: A calendar day on which a migraine headache occurred.|Days|Mean|6.95|6.95|Standard Deviation|2.56|2.56|||
3705136|NCT02163993|3545565|B3|||Number of migraine headache days|Migraine Headache Day: A calendar day on which a migraine headache occurred.|Days|Mean|6.41|6.41|Standard Deviation|2.66|2.66|||
3705137|NCT02163993|3545566|B2|||Number of migraine headache days|Migraine Headache Day: A calendar day on which a migraine headache occurred.|Days|Mean|6.68|6.68|Standard Deviation|2.73|2.73|||
3705138|NCT02163993|3545567|B1|||Number of migraine headache days|Migraine Headache Day: A calendar day on which a migraine headache occurred.|Days|Mean|6.64|6.64|Standard Deviation|2.73|2.73|||
3705139|NCT02163993|3545562|B6|United States||Region of Enrollment||Participants|Count of Participants|410|410.0||||||
3705140|NCT02163993|3545563|B5|United States||Region of Enrollment||Participants|Count of Participants|67|67.0||||||
3705141|NCT02163993|3545564|B4|United States||Region of Enrollment||Participants|Count of Participants|70|70.0||||||
3705142|NCT02163993|3545565|B3|United States||Region of Enrollment||Participants|Count of Participants|68|68.0||||||
3705143|NCT02163993|3545566|B2|United States||Region of Enrollment||Participants|Count of Participants|68|68.0||||||
3705144|NCT02163993|3545567|B1|United States||Region of Enrollment||Participants|Count of Participants|137|137.0||||||
3705145|NCT02163993|3545562|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705146|NCT02163993|3545563|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705147|NCT02163993|3545564|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705148|NCT02163993|3545565|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705149|NCT02163993|3545566|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705150|NCT02163993|3545567|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705151|NCT02163993|3545562|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3705152|NCT02163993|3545563|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3705153|NCT02163993|3545564|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3705154|NCT02163993|3545565|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3705155|NCT02163993|3545566|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3705156|NCT02163993|3545567|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3705157|NCT02163993|3545562|B6||White|Race (NIH/OMB)||Participants|Count of Participants|307|307.0||||||
3705158|NCT02163993|3545563|B5||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3705159|NCT02163993|3545564|B4||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3705160|NCT02163993|3545565|B3||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3705161|NCT02163993|3545566|B2||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3705162|NCT02163993|3545567|B1||White|Race (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
3705163|NCT02163993|3545562|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3705164|NCT02163993|3545563|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3705165|NCT02163993|3545564|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3705166|NCT02163993|3545565|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3705167|NCT02163993|3545566|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3705168|NCT02163993|3545567|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3705169|NCT02163993|3545562|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705170|NCT02163993|3545563|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705171|NCT02163993|3545564|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705172|NCT02163993|3545565|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705173|NCT02163993|3545566|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705174|NCT02163993|3545567|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705175|NCT02163993|3545562|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3705176|NCT02163993|3545563|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3705177|NCT02163993|3545564|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3705178|NCT02163993|3545565|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705179|NCT02163993|3545566|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3705180|NCT02163993|3545567|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3705181|NCT02163993|3545562|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3705182|NCT02163993|3545563|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705183|NCT02163993|3545564|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705184|NCT02163993|3545565|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705185|NCT02163993|3545566|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705186|NCT02163993|3545567|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3705187|NCT02163993|3545562|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705188|NCT02163993|3545563|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705189|NCT02163993|3545564|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705190|NCT02163993|3545565|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705191|NCT02163993|3545566|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705192|NCT02163993|3545567|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705193|NCT02163993|3545562|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|343|343.0||||||
3705194|NCT02163993|3545563|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3705195|NCT02163993|3545564|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3705196|NCT02163993|3545565|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3705197|NCT02163993|3545566|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3705198|NCT02163993|3545567|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|117|117.0||||||
3705199|NCT02163993|3545562|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3705200|NCT02163993|3545563|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3705201|NCT02163993|3545564|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3705202|NCT02163993|3545565|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3705203|NCT02163993|3545566|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3705204|NCT02163993|3545567|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3705205|NCT02163993|3545562|B6||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3705206|NCT02163993|3545563|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3705207|NCT02163993|3545564|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3705208|NCT02163993|3545565|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3705209|NCT02163993|3545566|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3705210|NCT02163993|3545567|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3705211|NCT02163993|3545562|B6||Female|Sex: Female, Male||Participants|Count of Participants|340|340.0||||||
3705212|NCT02163993|3545563|B5||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3705213|NCT02163993|3545564|B4||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3705214|NCT02163993|3545565|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3705215|NCT02163993|3545566|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3705216|NCT02163993|3545567|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3705217|NCT02163993|3545562|B6|||Age||Years|Mean|40.24|40.24|Standard Deviation|11.96|11.96|||
3705218|NCT02163993|3545563|B5|||Age||Years|Mean|40.79|40.79|Standard Deviation|13.20|13.2|||
3705219|NCT02163993|3545564|B4|||Age||Years|Mean|40.57|40.57|Standard Deviation|10.92|10.92|||
3705220|NCT02163993|3545565|B3|||Age||Years|Mean|39.63|39.63|Standard Deviation|12.42|12.42|||
3705221|NCT02163993|3545566|B2|||Age||Years|Mean|41.40|41.4|Standard Deviation|11.15|11.15|||
3705222|NCT02163993|3545567|B1|||Age||Years|Mean|39.54|39.54|Standard Deviation|12.10|12.1|||
3705223|NCT02163915|3545647|B6|Inattentive||ADHD Category|As per national institute of mental health (NIMH) ADHA was categorized as Combined: participants who had greater than equal to (>=) 6 symptoms of inattention and hyperactivity-impulsivity; Hyperactive/impulsive: participants who had >=6 symptoms of hyperactivity-impulsivity and less than (<) 6 symptoms of inattention; and Inattentive; participants who had >=6 symptoms of inattention and <6 symptoms of hyperactivity-impulsivity. There were no participants available under hyperactive/impulsive.|participants|Number|4|4.0||||||
3705224|NCT02163915|3545648|B5|Inattentive||ADHD Category|As per national institute of mental health (NIMH) ADHA was categorized as Combined: participants who had greater than equal to (>=) 6 symptoms of inattention and hyperactivity-impulsivity; Hyperactive/impulsive: participants who had >=6 symptoms of hyperactivity-impulsivity and less than (<) 6 symptoms of inattention; and Inattentive; participants who had >=6 symptoms of inattention and <6 symptoms of hyperactivity-impulsivity. There were no participants available under hyperactive/impulsive.|participants|Number|1|1.0||||||
3705225|NCT02163915|3545649|B4|Inattentive||ADHD Category|As per national institute of mental health (NIMH) ADHA was categorized as Combined: participants who had greater than equal to (>=) 6 symptoms of inattention and hyperactivity-impulsivity; Hyperactive/impulsive: participants who had >=6 symptoms of hyperactivity-impulsivity and less than (<) 6 symptoms of inattention; and Inattentive; participants who had >=6 symptoms of inattention and <6 symptoms of hyperactivity-impulsivity. There were no participants available under hyperactive/impulsive.|participants|Number|0|0.0||||||
3705226|NCT02163915|3545650|B3|Inattentive||ADHD Category|As per national institute of mental health (NIMH) ADHA was categorized as Combined: participants who had greater than equal to (>=) 6 symptoms of inattention and hyperactivity-impulsivity; Hyperactive/impulsive: participants who had >=6 symptoms of hyperactivity-impulsivity and less than (<) 6 symptoms of inattention; and Inattentive; participants who had >=6 symptoms of inattention and <6 symptoms of hyperactivity-impulsivity. There were no participants available under hyperactive/impulsive.|participants|Number|2|2.0||||||
3705227|NCT02163915|3545651|B2|Inattentive||ADHD Category|As per national institute of mental health (NIMH) ADHA was categorized as Combined: participants who had greater than equal to (>=) 6 symptoms of inattention and hyperactivity-impulsivity; Hyperactive/impulsive: participants who had >=6 symptoms of hyperactivity-impulsivity and less than (<) 6 symptoms of inattention; and Inattentive; participants who had >=6 symptoms of inattention and <6 symptoms of hyperactivity-impulsivity. There were no participants available under hyperactive/impulsive.|participants|Number|0|0.0||||||
3705228|NCT02163915|3545652|B1|Inattentive||ADHD Category|As per national institute of mental health (NIMH) ADHA was categorized as Combined: participants who had greater than equal to (>=) 6 symptoms of inattention and hyperactivity-impulsivity; Hyperactive/impulsive: participants who had >=6 symptoms of hyperactivity-impulsivity and less than (<) 6 symptoms of inattention; and Inattentive; participants who had >=6 symptoms of inattention and <6 symptoms of hyperactivity-impulsivity. There were no participants available under hyperactive/impulsive.|participants|Number|1|1.0||||||
3705229|NCT02163915|3545647|B6|Combined||ADHD Category|As per national institute of mental health (NIMH) ADHA was categorized as Combined: participants who had greater than equal to (>=) 6 symptoms of inattention and hyperactivity-impulsivity; Hyperactive/impulsive: participants who had >=6 symptoms of hyperactivity-impulsivity and less than (<) 6 symptoms of inattention; and Inattentive; participants who had >=6 symptoms of inattention and <6 symptoms of hyperactivity-impulsivity. There were no participants available under hyperactive/impulsive.|participants|Number|43|43.0||||||
3705230|NCT02163915|3545648|B5|Combined||ADHD Category|As per national institute of mental health (NIMH) ADHA was categorized as Combined: participants who had greater than equal to (>=) 6 symptoms of inattention and hyperactivity-impulsivity; Hyperactive/impulsive: participants who had >=6 symptoms of hyperactivity-impulsivity and less than (<) 6 symptoms of inattention; and Inattentive; participants who had >=6 symptoms of inattention and <6 symptoms of hyperactivity-impulsivity. There were no participants available under hyperactive/impulsive.|participants|Number|9|9.0||||||
3705231|NCT02163915|3545649|B4|Combined||ADHD Category|As per national institute of mental health (NIMH) ADHA was categorized as Combined: participants who had greater than equal to (>=) 6 symptoms of inattention and hyperactivity-impulsivity; Hyperactive/impulsive: participants who had >=6 symptoms of hyperactivity-impulsivity and less than (<) 6 symptoms of inattention; and Inattentive; participants who had >=6 symptoms of inattention and <6 symptoms of hyperactivity-impulsivity. There were no participants available under hyperactive/impulsive.|participants|Number|9|9.0||||||
3705258|NCT02163915|3545652|B1|Ex-drinker||Alcohol consumption||participants|Number|1|1.0||||||
3705259|NCT02163915|3545647|B6|Current drinker||Alcohol consumption||participants|Number|17|17.0||||||
3705232|NCT02163915|3545650|B3|Combined||ADHD Category|As per national institute of mental health (NIMH) ADHA was categorized as Combined: participants who had greater than equal to (>=) 6 symptoms of inattention and hyperactivity-impulsivity; Hyperactive/impulsive: participants who had >=6 symptoms of hyperactivity-impulsivity and less than (<) 6 symptoms of inattention; and Inattentive; participants who had >=6 symptoms of inattention and <6 symptoms of hyperactivity-impulsivity. There were no participants available under hyperactive/impulsive.|participants|Number|8|8.0||||||
3705233|NCT02163915|3545651|B2|Combined||ADHD Category|As per national institute of mental health (NIMH) ADHA was categorized as Combined: participants who had greater than equal to (>=) 6 symptoms of inattention and hyperactivity-impulsivity; Hyperactive/impulsive: participants who had >=6 symptoms of hyperactivity-impulsivity and less than (<) 6 symptoms of inattention; and Inattentive; participants who had >=6 symptoms of inattention and <6 symptoms of hyperactivity-impulsivity. There were no participants available under hyperactive/impulsive.|participants|Number|8|8.0||||||
3705234|NCT02163915|3545652|B1|Combined||ADHD Category|As per national institute of mental health (NIMH) ADHA was categorized as Combined: participants who had greater than equal to (>=) 6 symptoms of inattention and hyperactivity-impulsivity; Hyperactive/impulsive: participants who had >=6 symptoms of hyperactivity-impulsivity and less than (<) 6 symptoms of inattention; and Inattentive; participants who had >=6 symptoms of inattention and <6 symptoms of hyperactivity-impulsivity. There were no participants available under hyperactive/impulsive.|participants|Number|9|9.0||||||
3705235|NCT02163915|3545647|B6|Not applicable||Female Reproductive Status|The baseline measure was categorized as Surgically sterile: permanent method of contraception; Female of childbearing potential; and Not applicable: participant was male.|participants|Number|35|35.0||||||
3705236|NCT02163915|3545648|B5|Not applicable||Female Reproductive Status|The baseline measure was categorized as Surgically sterile: permanent method of contraception; Female of childbearing potential; and Not applicable: participant was male.|participants|Number|7|7.0||||||
3705237|NCT02163915|3545649|B4|Not applicable||Female Reproductive Status|The baseline measure was categorized as Surgically sterile: permanent method of contraception; Female of childbearing potential; and Not applicable: participant was male.|participants|Number|7|7.0||||||
3705238|NCT02163915|3545650|B3|Not applicable||Female Reproductive Status|The baseline measure was categorized as Surgically sterile: permanent method of contraception; Female of childbearing potential; and Not applicable: participant was male.|participants|Number|9|9.0||||||
3705239|NCT02163915|3545651|B2|Not applicable||Female Reproductive Status|The baseline measure was categorized as Surgically sterile: permanent method of contraception; Female of childbearing potential; and Not applicable: participant was male.|participants|Number|7|7.0||||||
3705240|NCT02163915|3545652|B1|Not applicable||Female Reproductive Status|The baseline measure was categorized as Surgically sterile: permanent method of contraception; Female of childbearing potential; and Not applicable: participant was male.|participants|Number|5|5.0||||||
3705241|NCT02163915|3545647|B6|Female of childbearing potential||Female Reproductive Status|The baseline measure was categorized as Surgically sterile: permanent method of contraception; Female of childbearing potential; and Not applicable: participant was male.|participants|Number|9|9.0||||||
3705242|NCT02163915|3545648|B5|Female of childbearing potential||Female Reproductive Status|The baseline measure was categorized as Surgically sterile: permanent method of contraception; Female of childbearing potential; and Not applicable: participant was male.|participants|Number|3|3.0||||||
3705243|NCT02163915|3545649|B4|Female of childbearing potential||Female Reproductive Status|The baseline measure was categorized as Surgically sterile: permanent method of contraception; Female of childbearing potential; and Not applicable: participant was male.|participants|Number|1|1.0||||||
3705244|NCT02163915|3545650|B3|Female of childbearing potential||Female Reproductive Status|The baseline measure was categorized as Surgically sterile: permanent method of contraception; Female of childbearing potential; and Not applicable: participant was male.|participants|Number|1|1.0||||||
3705245|NCT02163915|3545651|B2|Female of childbearing potential||Female Reproductive Status|The baseline measure was categorized as Surgically sterile: permanent method of contraception; Female of childbearing potential; and Not applicable: participant was male.|participants|Number|0|0.0||||||
3705246|NCT02163915|3545652|B1|Female of childbearing potential||Female Reproductive Status|The baseline measure was categorized as Surgically sterile: permanent method of contraception; Female of childbearing potential; and Not applicable: participant was male.|participants|Number|4|4.0||||||
3705247|NCT02163915|3545647|B6|Surgically sterile||Female Reproductive Status|The baseline measure was categorized as Surgically sterile: permanent method of contraception; Female of childbearing potential; and Not applicable: participant was male.|participants|Number|3|3.0||||||
3705248|NCT02163915|3545648|B5|Surgically sterile||Female Reproductive Status|The baseline measure was categorized as Surgically sterile: permanent method of contraception; Female of childbearing potential; and Not applicable: participant was male.|participants|Number|0|0.0||||||
3705249|NCT02163915|3545649|B4|Surgically sterile||Female Reproductive Status|The baseline measure was categorized as Surgically sterile: permanent method of contraception; Female of childbearing potential; and Not applicable: participant was male.|participants|Number|1|1.0||||||
3705250|NCT02163915|3545650|B3|Surgically sterile||Female Reproductive Status|The baseline measure was categorized as Surgically sterile: permanent method of contraception; Female of childbearing potential; and Not applicable: participant was male.|participants|Number|0|0.0||||||
3705251|NCT02163915|3545651|B2|Surgically sterile||Female Reproductive Status|The baseline measure was categorized as Surgically sterile: permanent method of contraception; Female of childbearing potential; and Not applicable: participant was male.|participants|Number|1|1.0||||||
3705252|NCT02163915|3545652|B1|Surgically sterile||Female Reproductive Status|The baseline measure was categorized as Surgically sterile: permanent method of contraception; Female of childbearing potential; and Not applicable: participant was male.|participants|Number|1|1.0||||||
3705253|NCT02163915|3545647|B6|Ex-drinker||Alcohol consumption||participants|Number|3|3.0||||||
3705254|NCT02163915|3545648|B5|Ex-drinker||Alcohol consumption||participants|Number|0|0.0||||||
3705255|NCT02163915|3545649|B4|Ex-drinker||Alcohol consumption||participants|Number|1|1.0||||||
3705256|NCT02163915|3545650|B3|Ex-drinker||Alcohol consumption||participants|Number|0|0.0||||||
3705257|NCT02163915|3545651|B2|Ex-drinker||Alcohol consumption||participants|Number|1|1.0||||||
3705260|NCT02163915|3545648|B5|Current drinker||Alcohol consumption||participants|Number|1|1.0||||||
3705261|NCT02163915|3545649|B4|Current drinker||Alcohol consumption||participants|Number|4|4.0||||||
3705262|NCT02163915|3545650|B3|Current drinker||Alcohol consumption||participants|Number|5|5.0||||||
3705263|NCT02163915|3545651|B2|Current drinker||Alcohol consumption||participants|Number|3|3.0||||||
3705264|NCT02163915|3545652|B1|Current drinker||Alcohol consumption||participants|Number|4|4.0||||||
3705265|NCT02163915|3545647|B6|Never drank||Alcohol consumption||participants|Number|27|27.0||||||
3705266|NCT02163915|3545648|B5|Never drank||Alcohol consumption||participants|Number|9|9.0||||||
3705267|NCT02163915|3545649|B4|Never drank||Alcohol consumption||participants|Number|4|4.0||||||
3705268|NCT02163915|3545650|B3|Never drank||Alcohol consumption||participants|Number|5|5.0||||||
3705269|NCT02163915|3545651|B2|Never drank||Alcohol consumption||participants|Number|4|4.0||||||
3705270|NCT02163915|3545652|B1|Never drank||Alcohol consumption||participants|Number|5|5.0||||||
3705271|NCT02163915|3545647|B6|Ex-smoker||Smoking Status|The baseline characteristic was categorized as never smoked, current smoker and ex-smoker. There were no participants available under current smoker.|participants|Number|7|7.0||||||
3705272|NCT02163915|3545648|B5|Ex-smoker||Smoking Status|The baseline characteristic was categorized as never smoked, current smoker and ex-smoker. There were no participants available under current smoker.|participants|Number|1|1.0||||||
3705273|NCT02163915|3545649|B4|Ex-smoker||Smoking Status|The baseline characteristic was categorized as never smoked, current smoker and ex-smoker. There were no participants available under current smoker.|participants|Number|1|1.0||||||
3705274|NCT02163915|3545650|B3|Ex-smoker||Smoking Status|The baseline characteristic was categorized as never smoked, current smoker and ex-smoker. There were no participants available under current smoker.|participants|Number|2|2.0||||||
3705275|NCT02163915|3545651|B2|Ex-smoker||Smoking Status|The baseline characteristic was categorized as never smoked, current smoker and ex-smoker. There were no participants available under current smoker.|participants|Number|1|1.0||||||
3705276|NCT02163915|3545652|B1|Ex-smoker||Smoking Status|The baseline characteristic was categorized as never smoked, current smoker and ex-smoker. There were no participants available under current smoker.|participants|Number|2|2.0||||||
3705277|NCT02163915|3545647|B6|Never smoked||Smoking Status|The baseline characteristic was categorized as never smoked, current smoker and ex-smoker. There were no participants available under current smoker.|participants|Number|40|40.0||||||
3705278|NCT02163915|3545648|B5|Never smoked||Smoking Status|The baseline characteristic was categorized as never smoked, current smoker and ex-smoker. There were no participants available under current smoker.|participants|Number|9|9.0||||||
3705279|NCT02163915|3545649|B4|Never smoked||Smoking Status|The baseline characteristic was categorized as never smoked, current smoker and ex-smoker. There were no participants available under current smoker.|participants|Number|8|8.0||||||
3705280|NCT02163915|3545650|B3|Never smoked||Smoking Status|The baseline characteristic was categorized as never smoked, current smoker and ex-smoker. There were no participants available under current smoker.|participants|Number|8|8.0||||||
3705281|NCT02163915|3545651|B2|Never smoked||Smoking Status|The baseline characteristic was categorized as never smoked, current smoker and ex-smoker. There were no participants available under current smoker.|participants|Number|7|7.0||||||
3705282|NCT02163915|3545652|B1|Never smoked||Smoking Status|The baseline characteristic was categorized as never smoked, current smoker and ex-smoker. There were no participants available under current smoker.|participants|Number|8|8.0||||||
3705283|NCT02163915|3545647|B6|Had no caffeine consumption||Caffeine Consumption||participants|Number|18|18.0||||||
3705284|NCT02163915|3545648|B5|Had no caffeine consumption||Caffeine Consumption||participants|Number|6|6.0||||||
3705285|NCT02163915|3545649|B4|Had no caffeine consumption||Caffeine Consumption||participants|Number|2|2.0||||||
3705286|NCT02163915|3545650|B3|Had no caffeine consumption||Caffeine Consumption||participants|Number|4|4.0||||||
3705287|NCT02163915|3545651|B2|Had no caffeine consumption||Caffeine Consumption||participants|Number|3|3.0||||||
3705288|NCT02163915|3545652|B1|Had no caffeine consumption||Caffeine Consumption||participants|Number|3|3.0||||||
3705289|NCT02163915|3545647|B6|Had caffeine consumption||Caffeine Consumption||participants|Number|29|29.0||||||
3705290|NCT02163915|3545648|B5|Had caffeine consumption||Caffeine Consumption||participants|Number|4|4.0||||||
3705291|NCT02163915|3545649|B4|Had caffeine consumption||Caffeine Consumption||participants|Number|7|7.0||||||
3705292|NCT02163915|3545650|B3|Had caffeine consumption||Caffeine Consumption||participants|Number|6|6.0||||||
3705293|NCT02163915|3545651|B2|Had caffeine consumption||Caffeine Consumption||participants|Number|5|5.0||||||
3705294|NCT02163915|3545652|B1|Had caffeine consumption||Caffeine Consumption||participants|Number|7|7.0||||||
3705295|NCT02163915|3545647|B6|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|25.64|25.64|Standard Deviation|3.303|3.303|||
3705296|NCT02163915|3545648|B5|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|25.09|25.09|Standard Deviation|3.969|3.969|||
3705297|NCT02163915|3545649|B4|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|26.02|26.02|Standard Deviation|2.204|2.204|||
3705298|NCT02163915|3545650|B3|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|25.36|25.36|Standard Deviation|3.942|3.942|||
3705299|NCT02163915|3545651|B2|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|25.46|25.46|Standard Deviation|3.408|3.408|||
3705300|NCT02163915|3545652|B1|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|26.25|26.25|Standard Deviation|3.182|3.182|||
3705301|NCT02163915|3545647|B6|||Weight||kilogram (kg)|Mean|76.54|76.54|Standard Deviation|12.777|12.777|||
3705302|NCT02163915|3545648|B5|||Weight||kilogram (kg)|Mean|74.73|74.73|Standard Deviation|13.815|13.815|||
3705303|NCT02163915|3545649|B4|||Weight||kilogram (kg)|Mean|79.61|79.61|Standard Deviation|9.205|9.205|||
3705304|NCT02163915|3545650|B3|||Weight||kilogram (kg)|Mean|75.11|75.11|Standard Deviation|14.376|14.376|||
3705305|NCT02163915|3545651|B2|||Weight||kilogram (kg)|Mean|76.01|76.01|Standard Deviation|14.537|14.537|||
3705306|NCT02163915|3545652|B1|||Weight||kilogram (kg)|Mean|77.42|77.42|Standard Deviation|10.211|10.211|||
3705307|NCT02163915|3545647|B6|||Height||centimeter (cm)|Mean|172.6|172.6|Standard Deviation|7.13|7.13|||
3705308|NCT02163915|3545648|B5|||Height||centimeter (cm)|Mean|172.4|172.4|Standard Deviation|5.23|5.23|||
3705309|NCT02163915|3545649|B4|||Height||centimeter (cm)|Mean|174.8|174.8|Standard Deviation|7.36|7.36|||
3705310|NCT02163915|3545650|B3|||Height||centimeter (cm)|Mean|171.7|171.7|Standard Deviation|7.09|7.09|||
3705311|NCT02163915|3545651|B2|||Height||centimeter (cm)|Mean|172.4|172.4|Standard Deviation|9.07|9.07|||
3705312|NCT02163915|3545652|B1|||Height||centimeter (cm)|Mean|171.8|171.8|Standard Deviation|7.96|7.96|||
3705313|NCT02163915|3545647|B6|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
3705314|NCT02163915|3545648|B5|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3705315|NCT02163915|3545649|B4|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3705316|NCT02163915|3545650|B3|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3705317|NCT02163915|3545651|B2|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3705318|NCT02163915|3545652|B1|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3705319|NCT02163915|3545647|B6|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3705320|NCT02163915|3545648|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3705321|NCT02163915|3545649|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3705322|NCT02163915|3545650|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3705323|NCT02163915|3545651|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3705324|NCT02163915|3545652|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3705325|NCT02163915|3545647|B6|Multiracial||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3705326|NCT02163915|3545648|B5|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3705327|NCT02163915|3545649|B4|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3705328|NCT02163915|3545650|B3|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3705329|NCT02163915|3545651|B2|Multiracial||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3705330|NCT02163915|3545652|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3705331|NCT02163915|3545647|B6|White||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3705332|NCT02163915|3545648|B5|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3705333|NCT02163915|3545649|B4|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3705334|NCT02163915|3545650|B3|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3705335|NCT02163915|3545651|B2|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3705336|NCT02163915|3545652|B1|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3705337|NCT02163915|3545647|B6|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3705338|NCT02163915|3545648|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3705339|NCT02163915|3545649|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3705340|NCT02163915|3545650|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3705341|NCT02163915|3545651|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3705342|NCT02163915|3545652|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3705343|NCT02163915|3545647|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3705344|NCT02163915|3545648|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3705345|NCT02163915|3545649|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3705346|NCT02163915|3545650|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3705347|NCT02163915|3545651|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3705348|NCT02163915|3545652|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3705349|NCT02163915|3545647|B6||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3705350|NCT02163915|3545648|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3705351|NCT02163915|3545649|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3705352|NCT02163915|3545650|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3705353|NCT02163915|3545651|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3705354|NCT02163915|3545652|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3705355|NCT02163915|3545647|B6||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3705356|NCT02163915|3545648|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3705357|NCT02163915|3545649|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3705358|NCT02163915|3545650|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3705359|NCT02163915|3545651|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3705360|NCT02163915|3545652|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3705361|NCT02163915|3545647|B6|||Age||years|Mean|30.6|30.6|Standard Deviation|10.10|10.1|||
3705362|NCT02163915|3545648|B5|||Age||years|Mean|31.6|31.6|Standard Deviation|11.68|11.68|||
3705363|NCT02163915|3545649|B4|||Age||years|Mean|32.6|32.6|Standard Deviation|10.73|10.73|||
3705364|NCT02163915|3545650|B3|||Age||years|Mean|28.6|28.6|Standard Deviation|8.75|8.75|||
3705365|NCT02163915|3545651|B2|||Age||years|Mean|33.0|33.0|Standard Deviation|9.65|9.65|||
3705366|NCT02163915|3545652|B1|||Age||years|Mean|28.1|28.1|Standard Deviation|10.59|10.59|||
3705367|NCT02163733|3545709|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3705368|NCT02163733|3545710|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3705369|NCT02163733|3545711|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705370|NCT02163733|3545709|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705371|NCT02163733|3545710|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705372|NCT02163733|3545711|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705373|NCT02163733|3545709|B3||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3705374|NCT02163733|3545710|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3705375|NCT02163733|3545711|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3705376|NCT02163733|3545709|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705377|NCT02163733|3545710|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705378|NCT02163733|3545711|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705379|NCT02163733|3545709|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705380|NCT02163733|3545710|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705381|NCT02163733|3545711|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705382|NCT02163733|3545709|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3705383|NCT02163733|3545710|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3705384|NCT02163733|3545711|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3705385|NCT02163733|3545709|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705386|NCT02163733|3545710|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705387|NCT02163733|3545711|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705388|NCT02163733|3545709|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3705389|NCT02163733|3545710|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3705390|NCT02163733|3545711|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3705391|NCT02163733|3545709|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3705392|NCT02163733|3545710|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3705393|NCT02163733|3545711|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3705394|NCT02163733|3545709|B3|||Age||Years|Mean|62.7|62.7|Standard Deviation|11.40|11.4|||
3705395|NCT02163733|3545710|B2|||Age||Years|Mean|61.4|61.4|Standard Deviation|11.00|11.0|||
3705396|NCT02163733|3545711|B1|||Age||Years|Mean|64.1|64.1|Standard Deviation|11.98|11.98|||
3705397|NCT02163538|3545748|B3|United States||Region of Enrollment||participants|Number|140|140.0||||||
3705398|NCT02163538|3545749|B2|United States||Region of Enrollment||participants|Number|70|70.0||||||
3705399|NCT02163538|3545750|B1|United States||Region of Enrollment||participants|Number|70|70.0||||||
3705400|NCT02163538|3545748|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3705401|NCT02163538|3545749|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3705402|NCT02163538|3545750|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3705403|NCT02163538|3545748|B3||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3705404|NCT02163538|3545749|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3705405|NCT02163538|3545750|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3705406|NCT02163538|3545748|B3|||Age||years|Mean|41.4|41.4|Standard Deviation|7.2|7.2|||
3705407|NCT02163538|3545749|B2|||Age||years|Mean|41.3|41.3|Standard Deviation|7.7|7.7|||
3705408|NCT02163538|3545750|B1|||Age||years|Mean|41.6|41.6|Standard Deviation|6.9|6.9|||
3705409|NCT02163499|3545767|B1||≥6.0 mmol/L|Acute Phase baseline Serum Potassium||Participants|Count of Participants|126|126.0||||||
3705410|NCT02163499|3545767|B1||5.5<6.0 mmol/L|Acute Phase baseline Serum Potassium||Participants|Count of Participants|338|338.0||||||
3705411|NCT02163499|3545767|B1||<5.5 mmol/L|Acute Phase baseline Serum Potassium||Participants|Count of Participants|287|287.0||||||
3705412|NCT02163499|3545767|B1||Missing|Baseline eGFR||Participants|Count of Participants|9|9.0||||||
3705413|NCT02163499|3545767|B1||≥60|Baseline eGFR||Participants|Count of Participants|190|190.0||||||
3705414|NCT02163499|3545767|B1||30-<60|Baseline eGFR||Participants|Count of Participants|263|263.0||||||
3705415|NCT02163499|3545767|B1||15-<30|Baseline eGFR||Participants|Count of Participants|243|243.0||||||
3705416|NCT02163499|3545767|B1||<15|Baseline eGFR||Participants|Count of Participants|46|46.0||||||
3705417|NCT02163499|3545767|B1|Heart Failure||Co-morbidities at baseline||Participants|Count of Participants|285|285.0||||||
3705418|NCT02163499|3545767|B1|Chronic kidney disease||Co-morbidities at baseline||Participants|Count of Participants|513|513.0||||||
3705419|NCT02163499|3545767|B1|Diabetes mellitus||Co-morbidities at baseline||Participants|Count of Participants|471|471.0||||||
3705420|NCT02163499|3545767|B1|||Use of RAAS inhibitor medication||Participants|Count of Participants|527|527.0||||||
3705421|NCT02163499|3545767|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3705422|NCT02163499|3545767|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|624|624.0||||||
3705423|NCT02163499|3545767|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|89|89.0||||||
3705424|NCT02163499|3545767|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3705425|NCT02163499|3545767|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3705426|NCT02163499|3545767|B1||Male|Sex: Female, Male|Gender|Participants|Count of Participants|448|448.0||||||
3705427|NCT02163499|3545767|B1||Female|Sex: Female, Male|Gender|Participants|Count of Participants|303|303.0||||||
3705428|NCT02163499|3545767|B1|||Age||Years|Mean|63.6|63.6|Standard Deviation|13.03|13.03|||
3705429|NCT02163486|3545775|B3|Turkey||Region of Enrollment||participants|Number|100|100.0||||||
3705430|NCT02163486|3545776|B2|Turkey||Region of Enrollment||participants|Number|50|50.0||||||
3705431|NCT02163486|3545777|B1|Turkey||Region of Enrollment||participants|Number|50|50.0||||||
3705432|NCT02163486|3545775|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3705433|NCT02163486|3545776|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3705434|NCT02163486|3545777|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3705435|NCT02163486|3545775|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3705436|NCT02163486|3545776|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3705437|NCT02163486|3545777|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3705438|NCT02163486|3545775|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3705439|NCT02163486|3545776|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3705440|NCT02163486|3545777|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3705441|NCT02163486|3545775|B3||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
3705442|NCT02163486|3545776|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3705443|NCT02163486|3545777|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3705444|NCT02163486|3545775|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3705445|NCT02163486|3545776|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3705446|NCT02163486|3545777|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3705447|NCT02163447|3545792|B4||No sample collected|Detection of malaria parasites by LAMP||Participants|Count of Participants|1|1.0||||||
3705448|NCT02163447|3545793|B3||No sample collected|Detection of malaria parasites by LAMP||Participants|Count of Participants|0|0.0||||||
3705449|NCT02163447|3545794|B2||No sample collected|Detection of malaria parasites by LAMP||Participants|Count of Participants|1|1.0||||||
3705450|NCT02163447|3545795|B1||No sample collected|Detection of malaria parasites by LAMP||Participants|Count of Participants|0|0.0||||||
3705451|NCT02163447|3545792|B4||No|Detection of malaria parasites by LAMP||Participants|Count of Participants|128|128.0||||||
3705452|NCT02163447|3545793|B3||No|Detection of malaria parasites by LAMP||Participants|Count of Participants|43|43.0||||||
3705453|NCT02163447|3545794|B2||No|Detection of malaria parasites by LAMP||Participants|Count of Participants|38|38.0||||||
3705454|NCT02163447|3545795|B1||No|Detection of malaria parasites by LAMP||Participants|Count of Participants|47|47.0||||||
3705455|NCT02163447|3545792|B4||Yes|Detection of malaria parasites by LAMP||Participants|Count of Participants|171|171.0||||||
3705456|NCT02163447|3545793|B3||Yes|Detection of malaria parasites by LAMP||Participants|Count of Participants|57|57.0||||||
3705457|NCT02163447|3545794|B2||Yes|Detection of malaria parasites by LAMP||Participants|Count of Participants|55|55.0||||||
3705458|NCT02163447|3545795|B1||Yes|Detection of malaria parasites by LAMP||Participants|Count of Participants|59|59.0||||||
3705459|NCT02163447|3545792|B4|||Alanine aminotransferase level IU/L||IU/L|Mean|15.0|15.0|Standard Deviation|6.4|6.4|||
3705460|NCT02163447|3545793|B3|||Alanine aminotransferase level IU/L||IU/L|Mean|14.7|14.7|Standard Deviation|5.6|5.6|||
3705461|NCT02163447|3545794|B2|||Alanine aminotransferase level IU/L||IU/L|Mean|14.9|14.9|Standard Deviation|5.8|5.8|||
3705462|NCT02163447|3545795|B1|||Alanine aminotransferase level IU/L||IU/L|Mean|15.4|15.4|Standard Deviation|7.5|7.5|||
3705463|NCT02163447|3545792|B4|||Hemoglobin level g/dL||g/DL|Mean|11.9|11.9|Standard Deviation|1.3|1.3|||
3705464|NCT02163447|3545793|B3|||Hemoglobin level g/dL||g/DL|Mean|12.0|12.0|Standard Deviation|1.4|1.4|||
3705465|NCT02163447|3545794|B2|||Hemoglobin level g/dL||g/DL|Mean|11.9|11.9|Standard Deviation|1.1|1.1|||
3705466|NCT02163447|3545795|B1|||Hemoglobin level g/dL||g/DL|Mean|11.8|11.8|Standard Deviation|1.5|1.5|||
3705467|NCT02163447|3545792|B4|||Platelet cells per mm^3||cells per mm^3|Mean|198793|198793.0|Standard Deviation|62332|62332.0|||
3705468|NCT02163447|3545793|B3|||Platelet cells per mm^3||cells per mm^3|Mean|195840|195840.0|Standard Deviation|59593|59593.0|||
3705469|NCT02163447|3545794|B2|||Platelet cells per mm^3||cells per mm^3|Mean|201809|201809.0|Standard Deviation|67358|67358.0|||
3705470|NCT02163447|3545795|B1|||Platelet cells per mm^3||cells per mm^3|Mean|198906|198906.0|Standard Deviation|60665|60665.0|||
3705471|NCT02163447|3545792|B4|||Neutrophil cells per mm^3||cells per mm^3|Mean|3409|3409.0|Standard Deviation|1327|1327.0|||
3705472|NCT02163447|3545793|B3|||Neutrophil cells per mm^3||cells per mm^3|Mean|3351|3351.0|Standard Deviation|1175|1175.0|||
3705473|NCT02163447|3545794|B2|||Neutrophil cells per mm^3||cells per mm^3|Mean|3558|3558.0|Standard Deviation|1304|1304.0|||
3705474|NCT02163447|3545795|B1|||Neutrophil cells per mm^3||cells per mm^3|Mean|3330|3330.0|Standard Deviation|1477|1477.0|||
3705475|NCT02163447|3545792|B4|||White blood cells per mm^3||cells per mm^3|Mean|6113|6113.0|Standard Deviation|1802|1802.0|||
3705476|NCT02163447|3545793|B3|||White blood cells per mm^3||cells per mm^3|Mean|6040|6040.0|Standard Deviation|1572|1572.0|||
3705477|NCT02163447|3545794|B2|||White blood cells per mm^3||cells per mm^3|Mean|6279|6279.0|Standard Deviation|1713|1713.0|||
3705478|NCT02163447|3545795|B1|||White blood cells per mm^3||cells per mm^3|Mean|6036|6036.0|Standard Deviation|2070|2070.0|||
3705479|NCT02163447|3545792|B4|||Height (cm)||cm|Mean|162.5|162.5|Standard Deviation|7.1|7.1|||
3705480|NCT02163447|3545793|B3|||Height (cm)||cm|Mean|162.3|162.3|Standard Deviation|7.7|7.7|||
3705481|NCT02163447|3545794|B2|||Height (cm)||cm|Mean|162.5|162.5|Standard Deviation|6.7|6.7|||
3705482|NCT02163447|3545795|B1|||Height (cm)||cm|Mean|162.8|162.8|Standard Deviation|6.8|6.8|||
3705483|NCT02163447|3545792|B4|||Weight (kg)||kg|Mean|55.5|55.5|Standard Deviation|7.1|7.1|||
3705484|NCT02163447|3545793|B3|||Weight (kg)||kg|Mean|55.5|55.5|Standard Deviation|7.5|7.5|||
3705485|NCT02163447|3545794|B2|||Weight (kg)||kg|Mean|55.6|55.6|Standard Deviation|7.0|7.0|||
3705486|NCT02163447|3545795|B1|||Weight (kg)||kg|Mean|55.4|55.4|Standard Deviation|6.8|6.8|||
3705487|NCT02163447|3545792|B4||Highest third|Household wealth index||Participants|Count of Participants|100|100.0||||||
3705488|NCT02163447|3545793|B3||Highest third|Household wealth index||Participants|Count of Participants|36|36.0||||||
3705489|NCT02163447|3545794|B2||Highest third|Household wealth index||Participants|Count of Participants|28|28.0||||||
3705490|NCT02163447|3545795|B1||Highest third|Household wealth index||Participants|Count of Participants|36|36.0||||||
3705491|NCT02163447|3545792|B4||Middle third|Household wealth index||Participants|Count of Participants|100|100.0||||||
3705492|NCT02163447|3545793|B3||Middle third|Household wealth index||Participants|Count of Participants|31|31.0||||||
3705493|NCT02163447|3545794|B2||Middle third|Household wealth index||Participants|Count of Participants|37|37.0||||||
3705494|NCT02163447|3545795|B1||Middle third|Household wealth index||Participants|Count of Participants|32|32.0||||||
3705495|NCT02163447|3545792|B4||Lowest third|Household wealth index||Participants|Count of Participants|100|100.0||||||
3705496|NCT02163447|3545793|B3||Lowest third|Household wealth index||Participants|Count of Participants|33|33.0||||||
3705497|NCT02163447|3545794|B2||Lowest third|Household wealth index||Participants|Count of Participants|29|29.0||||||
3705498|NCT02163447|3545795|B1||Lowest third|Household wealth index||Participants|Count of Participants|38|38.0||||||
3705499|NCT02163447|3545792|B4||Long lasting insecticide- treated net|Bed-net ownership||Participants|Count of Participants|261|261.0||||||
3705500|NCT02163447|3545793|B3||Long lasting insecticide- treated net|Bed-net ownership||Participants|Count of Participants|89|89.0||||||
3705501|NCT02163447|3545794|B2||Long lasting insecticide- treated net|Bed-net ownership||Participants|Count of Participants|80|80.0||||||
3705502|NCT02163447|3545795|B1||Long lasting insecticide- treated net|Bed-net ownership||Participants|Count of Participants|92|92.0||||||
3705503|NCT02163447|3545792|B4||Untreated Net|Bed-net ownership||Participants|Count of Participants|9|9.0||||||
3705504|NCT02163447|3545793|B3||Untreated Net|Bed-net ownership||Participants|Count of Participants|2|2.0||||||
3705505|NCT02163447|3545794|B2||Untreated Net|Bed-net ownership||Participants|Count of Participants|6|6.0||||||
3705506|NCT02163447|3545795|B1||Untreated Net|Bed-net ownership||Participants|Count of Participants|1|1.0||||||
3705507|NCT02163447|3545792|B4||None|Bed-net ownership||Participants|Count of Participants|30|30.0||||||
3705508|NCT02163447|3545793|B3||None|Bed-net ownership||Participants|Count of Participants|9|9.0||||||
3705509|NCT02163447|3545794|B2||None|Bed-net ownership||Participants|Count of Participants|8|8.0||||||
3705510|NCT02163447|3545795|B1||None|Bed-net ownership||Participants|Count of Participants|13|13.0||||||
3705511|NCT02163447|3545792|B4||>= 3|Gravidity||Participants|Count of Participants|101|101.0||||||
3705512|NCT02163447|3545793|B3||>= 3|Gravidity||Participants|Count of Participants|36|36.0||||||
3705513|NCT02163447|3545794|B2||>= 3|Gravidity||Participants|Count of Participants|33|33.0||||||
3705514|NCT02163447|3545795|B1||>= 3|Gravidity||Participants|Count of Participants|32|32.0||||||
3705515|NCT02163447|3545792|B4||2|Gravidity||Participants|Count of Participants|88|88.0||||||
3705516|NCT02163447|3545793|B3||2|Gravidity||Participants|Count of Participants|28|28.0||||||
3705517|NCT02163447|3545794|B2||2|Gravidity||Participants|Count of Participants|28|28.0||||||
3705518|NCT02163447|3545795|B1||2|Gravidity||Participants|Count of Participants|32|32.0||||||
3705519|NCT02163447|3545792|B4||1|Gravidity||Participants|Count of Participants|111|111.0||||||
3705520|NCT02163447|3545793|B3||1|Gravidity||Participants|Count of Participants|36|36.0||||||
3705521|NCT02163447|3545794|B2||1|Gravidity||Participants|Count of Participants|33|33.0||||||
3705522|NCT02163447|3545795|B1||1|Gravidity||Participants|Count of Participants|42|42.0||||||
3705523|NCT02163447|3545792|B4||> 16 to 20 wk|Gestation (weeks)||Participants|Count of Participants|93|93.0||||||
3705524|NCT02163447|3545793|B3||> 16 to 20 wk|Gestation (weeks)||Participants|Count of Participants|33|33.0||||||
3705525|NCT02163447|3545794|B2||> 16 to 20 wk|Gestation (weeks)||Participants|Count of Participants|29|29.0||||||
3705526|NCT02163447|3545795|B1||> 16 to 20 wk|Gestation (weeks)||Participants|Count of Participants|31|31.0||||||
3705527|NCT02163447|3545792|B4||12 to 16 wk|Gestation (weeks)||Participants|Count of Participants|207|207.0||||||
3705528|NCT02163447|3545793|B3||12 to 16 wk|Gestation (weeks)||Participants|Count of Participants|67|67.0||||||
3705529|NCT02163447|3545794|B2||12 to 16 wk|Gestation (weeks)||Participants|Count of Participants|65|65.0||||||
3705530|NCT02163447|3545795|B1||12 to 16 wk|Gestation (weeks)||Participants|Count of Participants|75|75.0||||||
3705531|NCT02163447|3545792|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705532|NCT02163447|3545793|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705533|NCT02163447|3545794|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705534|NCT02163447|3545795|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705535|NCT02163447|3545792|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705536|NCT02163447|3545793|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705537|NCT02163447|3545794|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705538|NCT02163447|3545795|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705539|NCT02163447|3545792|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705540|NCT02163447|3545793|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705541|NCT02163447|3545794|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705542|NCT02163447|3545795|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705543|NCT02163447|3545792|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|300|300.0||||||
3705544|NCT02163447|3545793|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3705545|NCT02163447|3545794|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3705546|NCT02163447|3545795|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
3705547|NCT02163447|3545792|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705548|NCT02163447|3545793|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705549|NCT02163447|3545794|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705550|NCT02163447|3545795|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705551|NCT02163447|3545792|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705552|NCT02163447|3545793|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705553|NCT02163447|3545794|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705554|NCT02163447|3545795|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705555|NCT02163447|3545792|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705556|NCT02163447|3545793|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705557|NCT02163447|3545794|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705558|NCT02163447|3545795|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705559|NCT02163447|3545792|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3705560|NCT02163447|3545793|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3705561|NCT02163447|3545794|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3705562|NCT02163447|3545795|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3705563|NCT02163447|3545792|B4||Female|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
3705564|NCT02163447|3545793|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3705565|NCT02163447|3545794|B2||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3705566|NCT02163447|3545795|B1||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3705567|NCT02163447|3545792|B4|||Age||years|Mean|22.0|22.0|Standard Deviation|4.0|4.0|||
3705568|NCT02163447|3545793|B3|||Age||years|Mean|22.6|22.6|Standard Deviation|4.0|4.0|||
3705569|NCT02163447|3545794|B2|||Age||years|Mean|22.2|22.2|Standard Deviation|4.3|4.3|||
3705570|NCT02163447|3545795|B1|||Age||years|Mean|21.3|21.3|Standard Deviation|3.6|3.6|||
3705571|NCT02163421|3545823|B5|Not Applicable (Participant was Male)||Female Reproductive Status|Female reproductive status was classified as postmenopausal female and female of childbearing potential. None of the female was reported as surgically sterile.|participants|Number|29|29.0||||||
3705572|NCT02163421|3545824|B4|Not Applicable (Participant was Male)||Female Reproductive Status|Female reproductive status was classified as postmenopausal female and female of childbearing potential. None of the female was reported as surgically sterile.|participants|Number|7|7.0||||||
3705573|NCT02163421|3545825|B3|Not Applicable (Participant was Male)||Female Reproductive Status|Female reproductive status was classified as postmenopausal female and female of childbearing potential. None of the female was reported as surgically sterile.|participants|Number|7|7.0||||||
3705574|NCT02163421|3545826|B2|Not Applicable (Participant was Male)||Female Reproductive Status|Female reproductive status was classified as postmenopausal female and female of childbearing potential. None of the female was reported as surgically sterile.|participants|Number|7|7.0||||||
3705575|NCT02163421|3545827|B1|Not Applicable (Participant was Male)||Female Reproductive Status|Female reproductive status was classified as postmenopausal female and female of childbearing potential. None of the female was reported as surgically sterile.|participants|Number|8|8.0||||||
3705576|NCT02163421|3545823|B5|Female of Childbearing Potential||Female Reproductive Status|Female reproductive status was classified as postmenopausal female and female of childbearing potential. None of the female was reported as surgically sterile.|participants|Number|18|18.0||||||
3705577|NCT02163421|3545824|B4|Female of Childbearing Potential||Female Reproductive Status|Female reproductive status was classified as postmenopausal female and female of childbearing potential. None of the female was reported as surgically sterile.|participants|Number|5|5.0||||||
3705578|NCT02163421|3545825|B3|Female of Childbearing Potential||Female Reproductive Status|Female reproductive status was classified as postmenopausal female and female of childbearing potential. None of the female was reported as surgically sterile.|participants|Number|5|5.0||||||
3705579|NCT02163421|3545826|B2|Female of Childbearing Potential||Female Reproductive Status|Female reproductive status was classified as postmenopausal female and female of childbearing potential. None of the female was reported as surgically sterile.|participants|Number|4|4.0||||||
3705580|NCT02163421|3545827|B1|Female of Childbearing Potential||Female Reproductive Status|Female reproductive status was classified as postmenopausal female and female of childbearing potential. None of the female was reported as surgically sterile.|participants|Number|4|4.0||||||
3705635|NCT02163421|3545827|B1|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3705636|NCT02163421|3545823|B5|Asian||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3705581|NCT02163421|3545823|B5|Postmenopausal Female||Female Reproductive Status|Female reproductive status was classified as postmenopausal female and female of childbearing potential. None of the female was reported as surgically sterile.|participants|Number|1|1.0||||||
3705582|NCT02163421|3545824|B4|Postmenopausal Female||Female Reproductive Status|Female reproductive status was classified as postmenopausal female and female of childbearing potential. None of the female was reported as surgically sterile.|participants|Number|0|0.0||||||
3705583|NCT02163421|3545825|B3|Postmenopausal Female||Female Reproductive Status|Female reproductive status was classified as postmenopausal female and female of childbearing potential. None of the female was reported as surgically sterile.|participants|Number|0|0.0||||||
3705584|NCT02163421|3545826|B2|Postmenopausal Female||Female Reproductive Status|Female reproductive status was classified as postmenopausal female and female of childbearing potential. None of the female was reported as surgically sterile.|participants|Number|1|1.0||||||
3705585|NCT02163421|3545827|B1|Postmenopausal Female||Female Reproductive Status|Female reproductive status was classified as postmenopausal female and female of childbearing potential. None of the female was reported as surgically sterile.|participants|Number|0|0.0||||||
3705586|NCT02163421|3545823|B5|Ex-Drinker||Alcohol Classification||participants|Number|8|8.0||||||
3705587|NCT02163421|3545824|B4|Ex-Drinker||Alcohol Classification||participants|Number|2|2.0||||||
3705588|NCT02163421|3545825|B3|Ex-Drinker||Alcohol Classification||participants|Number|2|2.0||||||
3705589|NCT02163421|3545826|B2|Ex-Drinker||Alcohol Classification||participants|Number|3|3.0||||||
3705590|NCT02163421|3545827|B1|Ex-Drinker||Alcohol Classification||participants|Number|1|1.0||||||
3705591|NCT02163421|3545823|B5|Current Drinker||Alcohol Classification||participants|Number|38|38.0||||||
3705592|NCT02163421|3545824|B4|Current Drinker||Alcohol Classification||participants|Number|9|9.0||||||
3705593|NCT02163421|3545825|B3|Current Drinker||Alcohol Classification||participants|Number|9|9.0||||||
3705594|NCT02163421|3545826|B2|Current Drinker||Alcohol Classification||participants|Number|9|9.0||||||
3705595|NCT02163421|3545827|B1|Current Drinker||Alcohol Classification||participants|Number|11|11.0||||||
3705596|NCT02163421|3545823|B5|Had Never Drunk||Alcohol Classification||participants|Number|2|2.0||||||
3705597|NCT02163421|3545824|B4|Had Never Drunk||Alcohol Classification||participants|Number|1|1.0||||||
3705598|NCT02163421|3545825|B3|Had Never Drunk||Alcohol Classification||participants|Number|1|1.0||||||
3705599|NCT02163421|3545826|B2|Had Never Drunk||Alcohol Classification||participants|Number|0|0.0||||||
3705600|NCT02163421|3545827|B1|Had Never Drunk||Alcohol Classification||participants|Number|0|0.0||||||
3705601|NCT02163421|3545823|B5|Ex-Smoker||Smoking Classification||participants|Number|4|4.0||||||
3705602|NCT02163421|3545824|B4|Ex-Smoker||Smoking Classification||participants|Number|1|1.0||||||
3705603|NCT02163421|3545825|B3|Ex-Smoker||Smoking Classification||participants|Number|0|0.0||||||
3705604|NCT02163421|3545826|B2|Ex-Smoker||Smoking Classification||participants|Number|2|2.0||||||
3705605|NCT02163421|3545827|B1|Ex-Smoker||Smoking Classification||participants|Number|1|1.0||||||
3705606|NCT02163421|3545823|B5|Current Smoker||Smoking Classification||participants|Number|11|11.0||||||
3705607|NCT02163421|3545824|B4|Current Smoker||Smoking Classification||participants|Number|5|5.0||||||
3705608|NCT02163421|3545825|B3|Current Smoker||Smoking Classification||participants|Number|2|2.0||||||
3705609|NCT02163421|3545826|B2|Current Smoker||Smoking Classification||participants|Number|1|1.0||||||
3705610|NCT02163421|3545827|B1|Current Smoker||Smoking Classification||participants|Number|3|3.0||||||
3705611|NCT02163421|3545823|B5|Had Never Smoked||Smoking Classification||participants|Number|33|33.0||||||
3705612|NCT02163421|3545824|B4|Had Never Smoked||Smoking Classification||participants|Number|6|6.0||||||
3705613|NCT02163421|3545825|B3|Had Never Smoked||Smoking Classification||participants|Number|10|10.0||||||
3705614|NCT02163421|3545826|B2|Had Never Smoked||Smoking Classification||participants|Number|9|9.0||||||
3705615|NCT02163421|3545827|B1|Had Never Smoked||Smoking Classification||participants|Number|8|8.0||||||
3705616|NCT02163421|3545823|B5|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|22.4|22.4|Standard Deviation|2.90|2.9|||
3705617|NCT02163421|3545824|B4|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|22.0|22.0|Standard Deviation|3.41|3.41|||
3705618|NCT02163421|3545825|B3|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|22.8|22.8|Standard Deviation|2.44|2.44|||
3705619|NCT02163421|3545826|B2|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|23.0|23.0|Standard Deviation|2.98|2.98|||
3705620|NCT02163421|3545827|B1|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|21.8|21.8|Standard Deviation|2.90|2.9|||
3705621|NCT02163421|3545823|B5|||Weight||kilogram (kg)|Mean|66.4|66.4|Standard Deviation|13.35|13.35|||
3705622|NCT02163421|3545824|B4|||Weight||kilogram (kg)|Mean|64.3|64.3|Standard Deviation|14.58|14.58|||
3705623|NCT02163421|3545825|B3|||Weight||kilogram (kg)|Mean|67.6|67.6|Standard Deviation|13.42|13.42|||
3705624|NCT02163421|3545826|B2|||Weight||kilogram (kg)|Mean|68.0|68.0|Standard Deviation|12.96|12.96|||
3705625|NCT02163421|3545827|B1|||Weight||kilogram (kg)|Mean|65.8|65.8|Standard Deviation|13.84|13.84|||
3705626|NCT02163421|3545823|B5|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3705627|NCT02163421|3545824|B4|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3705628|NCT02163421|3545825|B3|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3705629|NCT02163421|3545826|B2|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3705630|NCT02163421|3545827|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3705631|NCT02163421|3545823|B5|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3705632|NCT02163421|3545824|B4|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3705633|NCT02163421|3545825|B3|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3705634|NCT02163421|3545826|B2|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3705637|NCT02163421|3545824|B4|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3705638|NCT02163421|3545825|B3|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3705639|NCT02163421|3545826|B2|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3705640|NCT02163421|3545827|B1|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3705641|NCT02163421|3545823|B5||Male|Gender||Participants|Count of Participants|29|29.0||||||
3705642|NCT02163421|3545824|B4||Male|Gender||Participants|Count of Participants|7|7.0||||||
3705643|NCT02163421|3545825|B3||Male|Gender||Participants|Count of Participants|7|7.0||||||
3705644|NCT02163421|3545826|B2||Male|Gender||Participants|Count of Participants|7|7.0||||||
3705645|NCT02163421|3545827|B1||Male|Gender||Participants|Count of Participants|8|8.0||||||
3705646|NCT02163421|3545823|B5||Female|Gender||Participants|Count of Participants|19|19.0||||||
3705647|NCT02163421|3545824|B4||Female|Gender||Participants|Count of Participants|5|5.0||||||
3705648|NCT02163421|3545825|B3||Female|Gender||Participants|Count of Participants|5|5.0||||||
3705649|NCT02163421|3545826|B2||Female|Gender||Participants|Count of Participants|5|5.0||||||
3705650|NCT02163421|3545827|B1||Female|Gender||Participants|Count of Participants|4|4.0||||||
3705651|NCT02163421|3545823|B5|||Age||years|Mean|35.3|35.3|Standard Deviation|12.21|12.21|||
3705652|NCT02163421|3545824|B4|||Age||years|Mean|35.2|35.2|Standard Deviation|12.89|12.89|||
3705653|NCT02163421|3545825|B3|||Age||years|Mean|31.1|31.1|Standard Deviation|9.59|9.59|||
3705654|NCT02163421|3545826|B2|||Age||years|Mean|41.0|41.0|Standard Deviation|13.06|13.06|||
3705655|NCT02163421|3545827|B1|||Age||years|Mean|33.9|33.9|Standard Deviation|12.30|12.3|||
3705656|NCT02163395|3545837|B1|Germany||Region of Enrollment||participants|Number|44|44.0||||||
3705657|NCT02163395|3545837|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3705658|NCT02163395|3545837|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3705659|NCT02163395|3545837|B1|||Age||years|Mean|48|48.0|Standard Deviation|14|14.0|||
3705660|NCT02163395|3545837|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3705661|NCT02163395|3545837|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3705662|NCT02163395|3545837|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3705663|NCT02163187|3545844|B3|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3705664|NCT02163187|3545846|B1|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3705665|NCT02163187|3545844|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705666|NCT02163187|3545846|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705667|NCT02163187|3545844|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705668|NCT02163187|3545846|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705669|NCT02163187|3545844|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3705670|NCT02163187|3545846|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3705671|NCT02163187|3545844|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705672|NCT02163187|3545846|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705673|NCT02163187|3545844|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705674|NCT02163187|3545846|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705675|NCT02163187|3545844|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705676|NCT02163187|3545846|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705677|NCT02163187|3545844|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705678|NCT02163187|3545846|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705679|NCT02163187|3545844|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705680|NCT02163187|3545846|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705681|NCT02163187|3545844|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3705682|NCT02163187|3545846|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3705683|NCT02163187|3545844|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705684|NCT02163187|3545846|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705685|NCT02163187|3545844|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3705686|NCT02163187|3545846|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3705687|NCT02163187|3545844|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3705688|NCT02163187|3545846|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3705689|NCT02163187|3545844|B3|||Age||years|Mean|53|53.0|Full Range|||46.0|66.0|
3705690|NCT02163187|3545846|B1|||Age||years|Mean|53|53.0|Full Range|||46.0|66.0|
3705691|NCT02162862|3545868|B4|United States||Region of Enrollment||participants|Number|99|99.0||||||
3705692|NCT02162862|3545869|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
3705693|NCT02162862|3545870|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
3705694|NCT02162862|3545871|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3705695|NCT02162862|3545868|B4||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3705696|NCT02162862|3545869|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3705697|NCT02162862|3545870|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3705698|NCT02162862|3545871|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3705699|NCT02162862|3545868|B4||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3705700|NCT02162862|3545869|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3705701|NCT02162862|3545870|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3705702|NCT02162862|3545871|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3705703|NCT02162862|3545868|B4|||Age||years|Mean|23.7|23.7|Standard Deviation|4.7|4.7|||
3705704|NCT02162862|3545869|B3|||Age||years|Mean|23.96|23.96|Standard Deviation|5.76|5.76|||
3705705|NCT02162862|3545870|B2|||Age||years|Mean|23.5|23.5|Standard Deviation|4.3|4.3|||
3705706|NCT02162862|3545871|B1|||Age||years|Mean|23.7|23.7|Standard Deviation|4.7|4.7|||
3705707|NCT02162862|3545868|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3705708|NCT02162862|3545869|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3705709|NCT02162862|3545870|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3705710|NCT02162862|3545871|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3705711|NCT02162862|3545868|B4||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
3705712|NCT02162862|3545869|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3705713|NCT02162862|3545870|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3705714|NCT02162862|3545871|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3705715|NCT02162862|3545868|B4||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
3705716|NCT02162862|3545869|B3||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3705717|NCT02162862|3545870|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3705718|NCT02162862|3545871|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3705719|NCT02162758|3545884|B3|Non-drinker||Current Alcohol Status||participants|Number|4|4.0||||||
3705720|NCT02162758|3545885|B2|Non-drinker||Current Alcohol Status||participants|Number|1|1.0||||||
3705721|NCT02162758|3545886|B1|Non-drinker||Current Alcohol Status||participants|Number|3|3.0||||||
3705722|NCT02162758|3545884|B3|Current drinker||Current Alcohol Status||participants|Number|2|2.0||||||
3705723|NCT02162758|3545885|B2|Current drinker||Current Alcohol Status||participants|Number|2|2.0||||||
3705724|NCT02162758|3545886|B1|Current drinker||Current Alcohol Status||participants|Number|0|0.0||||||
3705725|NCT02162758|3545884|B3|>30 drinks||Number of Drinks Per Week|Baseline measure was analyzed for those participants who currently or have ever drank alcohol.|participants|Number|1|1.0||||||
3705726|NCT02162758|3545885|B2|>30 drinks||Number of Drinks Per Week|Baseline measure was analyzed for those participants who currently or have ever drank alcohol.|participants|Number|0|0.0||||||
3705727|NCT02162758|3545886|B1|>30 drinks||Number of Drinks Per Week|Baseline measure was analyzed for those participants who currently or have ever drank alcohol.|participants|Number|1|1.0||||||
3705728|NCT02162758|3545884|B3|6-10 drinks||Number of Drinks Per Week|Baseline measure was analyzed for those participants who currently or have ever drank alcohol.|participants|Number|1|1.0||||||
3705729|NCT02162758|3545885|B2|6-10 drinks||Number of Drinks Per Week|Baseline measure was analyzed for those participants who currently or have ever drank alcohol.|participants|Number|1|1.0||||||
3705730|NCT02162758|3545886|B1|6-10 drinks||Number of Drinks Per Week|Baseline measure was analyzed for those participants who currently or have ever drank alcohol.|participants|Number|0|0.0||||||
3705731|NCT02162758|3545884|B3|0-5 drinks||Number of Drinks Per Week|Baseline measure was analyzed for those participants who currently or have ever drank alcohol.|participants|Number|1|1.0||||||
3705732|NCT02162758|3545885|B2|0-5 drinks||Number of Drinks Per Week|Baseline measure was analyzed for those participants who currently or have ever drank alcohol.|participants|Number|1|1.0||||||
3705733|NCT02162758|3545886|B1|0-5 drinks||Number of Drinks Per Week|Baseline measure was analyzed for those participants who currently or have ever drank alcohol.|participants|Number|0|0.0||||||
3705734|NCT02162758|3545884|B3|Unknown||Number of Drinking Years|Baseline measure was analyzed for those participants who currently or have ever drank alcohol.|participants|Number|2|2.0||||||
3705735|NCT02162758|3545885|B2|Unknown||Number of Drinking Years|Baseline measure was analyzed for those participants who currently or have ever drank alcohol.|participants|Number|1|1.0||||||
3705736|NCT02162758|3545886|B1|Unknown||Number of Drinking Years|Baseline measure was analyzed for those participants who currently or have ever drank alcohol.|participants|Number|1|1.0||||||
3705737|NCT02162758|3545884|B3|>20 years||Number of Drinking Years|Baseline measure was analyzed for those participants who currently or have ever drank alcohol.|participants|Number|1|1.0||||||
3705738|NCT02162758|3545885|B2|>20 years||Number of Drinking Years|Baseline measure was analyzed for those participants who currently or have ever drank alcohol.|participants|Number|1|1.0||||||
3705739|NCT02162758|3545886|B1|>20 years||Number of Drinking Years|Baseline measure was analyzed for those participants who currently or have ever drank alcohol.|participants|Number|0|0.0||||||
3705740|NCT02162758|3545884|B3|Drank alcohol||Alcohol History||participants|Number|3|3.0||||||
3705741|NCT02162758|3545885|B2|Drank alcohol||Alcohol History||participants|Number|2|2.0||||||
3705742|NCT02162758|3545886|B1|Drank alcohol||Alcohol History||participants|Number|1|1.0||||||
3705743|NCT02162758|3545884|B3|Never drank alcohol||Alcohol History||participants|Number|3|3.0||||||
3705744|NCT02162758|3545885|B2|Never drank alcohol||Alcohol History||participants|Number|1|1.0||||||
3705745|NCT02162758|3545886|B1|Never drank alcohol||Alcohol History||participants|Number|2|2.0||||||
3705746|NCT02162758|3545884|B3|Unknown||Number of Packs Per Year|Baseline measure was analyzed in the participants who currently or have ever smoked tobacco.|participants|Number|2|2.0||||||
3705747|NCT02162758|3545885|B2|Unknown||Number of Packs Per Year|Baseline measure was analyzed in the participants who currently or have ever smoked tobacco.|participants|Number|2|2.0||||||
3705748|NCT02162758|3545886|B1|Unknown||Number of Packs Per Year|Baseline measure was analyzed in the participants who currently or have ever smoked tobacco.|participants|Number|0|0.0||||||
3705749|NCT02162758|3545884|B3|>400 packs||Number of Packs Per Year|Baseline measure was analyzed in the participants who currently or have ever smoked tobacco.|participants|Number|1|1.0||||||
3705750|NCT02162758|3545885|B2|>400 packs||Number of Packs Per Year|Baseline measure was analyzed in the participants who currently or have ever smoked tobacco.|participants|Number|1|1.0||||||
3705751|NCT02162758|3545886|B1|>400 packs||Number of Packs Per Year|Baseline measure was analyzed in the participants who currently or have ever smoked tobacco.|participants|Number|0|0.0||||||
3705752|NCT02162758|3545884|B3|301-400 packs||Number of Packs Per Year|Baseline measure was analyzed in the participants who currently or have ever smoked tobacco.|participants|Number|1|1.0||||||
3705753|NCT02162758|3545885|B2|301-400 packs||Number of Packs Per Year|Baseline measure was analyzed in the participants who currently or have ever smoked tobacco.|participants|Number|0|0.0||||||
3705754|NCT02162758|3545886|B1|301-400 packs||Number of Packs Per Year|Baseline measure was analyzed in the participants who currently or have ever smoked tobacco.|participants|Number|1|1.0||||||
3705755|NCT02162758|3545884|B3|101-200 packs||Number of Packs Per Year|Baseline measure was analyzed in the participants who currently or have ever smoked tobacco.|participants|Number|1|1.0||||||
3705756|NCT02162758|3545885|B2|101-200 packs||Number of Packs Per Year|Baseline measure was analyzed in the participants who currently or have ever smoked tobacco.|participants|Number|0|0.0||||||
3705757|NCT02162758|3545886|B1|101-200 packs||Number of Packs Per Year|Baseline measure was analyzed in the participants who currently or have ever smoked tobacco.|participants|Number|1|1.0||||||
3705758|NCT02162758|3545884|B3|Smoker||Current Smoking Status||participants|Number|1|1.0||||||
3705759|NCT02162758|3545885|B2|Smoker||Current Smoking Status||participants|Number|0|0.0||||||
3705760|NCT02162758|3545886|B1|Smoker||Current Smoking Status||participants|Number|1|1.0||||||
3705761|NCT02162758|3545884|B3|Non smoker||Current Smoking Status||participants|Number|5|5.0||||||
3705762|NCT02162758|3545885|B2|Non smoker||Current Smoking Status||participants|Number|3|3.0||||||
3705763|NCT02162758|3545886|B1|Non smoker||Current Smoking Status||participants|Number|2|2.0||||||
3705764|NCT02162758|3545884|B3|Greater than (>) 20 years||Number of Smoking Years for Ever Smoked|Baseline measure was analyzed for those participants who have ever smoked tobacco.|participants|Number|3|3.0||||||
3705765|NCT02162758|3545885|B2|Greater than (>) 20 years||Number of Smoking Years for Ever Smoked|Baseline measure was analyzed for those participants who have ever smoked tobacco.|participants|Number|2|2.0||||||
3705766|NCT02162758|3545886|B1|Greater than (>) 20 years||Number of Smoking Years for Ever Smoked|Baseline measure was analyzed for those participants who have ever smoked tobacco.|participants|Number|1|1.0||||||
3705767|NCT02162758|3545884|B3|16-20 years||Number of Smoking Years for Ever Smoked|Baseline measure was analyzed for those participants who have ever smoked tobacco.|participants|Number|2|2.0||||||
3705768|NCT02162758|3545885|B2|16-20 years||Number of Smoking Years for Ever Smoked|Baseline measure was analyzed for those participants who have ever smoked tobacco.|participants|Number|1|1.0||||||
3705769|NCT02162758|3545886|B1|16-20 years||Number of Smoking Years for Ever Smoked|Baseline measure was analyzed for those participants who have ever smoked tobacco.|participants|Number|1|1.0||||||
3705770|NCT02162758|3545884|B3|Ever smoked||Smoking History||participants|Number|5|5.0||||||
3705771|NCT02162758|3545885|B2|Ever smoked||Smoking History||participants|Number|3|3.0||||||
3705772|NCT02162758|3545886|B1|Ever smoked||Smoking History||participants|Number|2|2.0||||||
3705773|NCT02162758|3545884|B3|Never smoked||Smoking History||participants|Number|1|1.0||||||
3705774|NCT02162758|3545885|B2|Never smoked||Smoking History||participants|Number|0|0.0||||||
3705775|NCT02162758|3545886|B1|Never smoked||Smoking History||participants|Number|1|1.0||||||
3705776|NCT02162758|3545884|B3|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|30.94|30.94|Standard Deviation|3.908|3.908|||
3705777|NCT02162758|3545885|B2|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|31.93|31.93|Standard Deviation|3.212|3.212|||
3705778|NCT02162758|3545886|B1|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|29.95|29.95|Standard Deviation|4.992|4.992|||
3705779|NCT02162758|3545884|B3|||Weight||kilogram (kg)|Mean|92.82|92.82|Standard Deviation|14.491|14.491|||
3705780|NCT02162758|3545885|B2|||Weight||kilogram (kg)|Mean|88.83|88.83|Standard Deviation|8.170|8.17|||
3705781|NCT02162758|3545886|B1|||Weight||kilogram (kg)|Mean|96.80|96.8|Standard Deviation|20.264|20.264|||
3705782|NCT02162758|3545884|B3|||Height||centimeter (cm)|Mean|173.3|173.3|Standard Deviation|12.09|12.09|||
3705783|NCT02162758|3545885|B2|||Height||centimeter (cm)|Mean|167.3|167.3|Standard Deviation|15.53|15.53|||
3705784|NCT02162758|3545886|B1|||Height||centimeter (cm)|Mean|179.3|179.3|Standard Deviation|4.04|4.04|||
3705785|NCT02162758|3545884|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3705786|NCT02162758|3545885|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3705787|NCT02162758|3545886|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3705788|NCT02162758|3545884|B3|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3705789|NCT02162758|3545885|B2|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3705790|NCT02162758|3545886|B1|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3705791|NCT02162758|3545884|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3705792|NCT02162758|3545885|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3705793|NCT02162758|3545886|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3705794|NCT02162758|3545884|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3705795|NCT02162758|3545885|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3705796|NCT02162758|3545886|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3705797|NCT02162758|3545884|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3705798|NCT02162758|3545885|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3705799|NCT02162758|3545886|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3705800|NCT02162758|3545884|B3|||Age||years|Mean|69.0|69.0|Standard Deviation|7.04|7.04|||
3705801|NCT02162758|3545885|B2|||Age||years|Mean|67.7|67.7|Standard Deviation|6.81|6.81|||
3705802|NCT02162758|3545886|B1|||Age||years|Mean|70.3|70.3|Standard Deviation|8.50|8.5|||
3705803|NCT02162680|3545899|B4|United States||Region of Enrollment||participants|Number|98|98.0||||||
3705804|NCT02162680|3545900|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
3705805|NCT02162680|3545901|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
3705806|NCT02162680|3545902|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
3705807|NCT02162680|3545899|B4|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3705808|NCT02162680|3545900|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3705809|NCT02162680|3545901|B2|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3705810|NCT02162680|3545902|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3705811|NCT02162680|3545899|B4|African American||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3705812|NCT02162680|3545900|B3|African American||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3705813|NCT02162680|3545901|B2|African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3705814|NCT02162680|3545902|B1|African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3705815|NCT02162680|3545899|B4|White||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
3705816|NCT02162680|3545900|B3|White||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3705817|NCT02162680|3545901|B2|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3705818|NCT02162680|3545902|B1|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3705819|NCT02162680|3545899|B4||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3705820|NCT02162680|3545900|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3705821|NCT02162680|3545901|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3705822|NCT02162680|3545902|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3705823|NCT02162680|3545899|B4||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3705824|NCT02162680|3545900|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3705825|NCT02162680|3545901|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3705826|NCT02162680|3545902|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3705827|NCT02162680|3545899|B4|18 and older||Age, Customized||participants|Number|98|98.0||||||
3705828|NCT02162680|3545900|B3|18 and older||Age, Customized||participants|Number|32|32.0||||||
3705829|NCT02162680|3545901|B2|18 and older||Age, Customized||participants|Number|33|33.0||||||
3705830|NCT02162680|3545902|B1|18 and older||Age, Customized||participants|Number|33|33.0||||||
3705831|NCT02162576|3545912|B1|||Asthma Control Test|ACT is a patient self-administred tool for identifying those with poorly controlled asthma. There are 5 items, with 4-week recall, that address symptoms and daily functioning topics. Each item is measured on 5-point scale. The ACT score ranges from 5 (poor control of asthma) to 25 (complete control of asthma), with higher scores reflecting greater asthma control. An ACT score >19 indicates well-controlled asthma.|units on a scale|Mean|17.51|17.51|Standard Deviation|4.45|4.45|||
3705832|NCT02162576|3545912|B1|United States||Region of Enrollment||participants|Number|95|95.0||||||
3705833|NCT02162576|3545912|B1|Male||Sex/Gender, Customized||participants|Number|42|42.0||||||
3705834|NCT02162576|3545912|B1|Female||Sex/Gender, Customized||participants|Number|53|53.0||||||
3705835|NCT02162576|3545912|B1|||Age||years|Mean|27.5|27.5|Standard Deviation|18.3|18.3|||
3705836|NCT02162576|3545912|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3705837|NCT02162576|3545912|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3705838|NCT02162576|3545912|B1||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
3705839|NCT02161757|3545918|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3705840|NCT02161757|3545919|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3705841|NCT02161757|3545920|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3705842|NCT02161757|3545921|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3705843|NCT02161757|3545918|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705844|NCT02161757|3545919|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705845|NCT02161757|3545920|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705846|NCT02161757|3545921|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705847|NCT02161757|3545918|B4||White|Race (NIH/OMB)||Participants|Count of Participants|870|870.0||||||
3705848|NCT02161757|3545919|B3||White|Race (NIH/OMB)||Participants|Count of Participants|288|288.0||||||
3705849|NCT02161757|3545920|B2||White|Race (NIH/OMB)||Participants|Count of Participants|297|297.0||||||
3705850|NCT02161757|3545921|B1||White|Race (NIH/OMB)||Participants|Count of Participants|285|285.0||||||
3705851|NCT02161757|3545918|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3705852|NCT02161757|3545919|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3705853|NCT02161757|3545920|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3705854|NCT02161757|3545921|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3705855|NCT02161757|3545918|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3705856|NCT02161757|3545919|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705857|NCT02161757|3545920|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705858|NCT02161757|3545921|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3705859|NCT02161757|3545918|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|163|163.0||||||
3705860|NCT02161757|3545919|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3705861|NCT02161757|3545920|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3705862|NCT02161757|3545921|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3705863|NCT02161757|3545918|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3705864|NCT02161757|3545919|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3705865|NCT02161757|3545920|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3705866|NCT02161757|3545921|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3705867|NCT02161757|3545918|B4||Male|Sex: Female, Male||Participants|Count of Participants|404|404.0||||||
3705868|NCT02161757|3545919|B3||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3705869|NCT02161757|3545920|B2||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3705870|NCT02161757|3545921|B1||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3705871|NCT02161757|3545918|B4||Female|Sex: Female, Male||Participants|Count of Participants|798|798.0||||||
3705872|NCT02161757|3545919|B3||Female|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
3705873|NCT02161757|3545920|B2||Female|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
3705874|NCT02161757|3545921|B1||Female|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
3705875|NCT02161757|3545918|B4|||Age||years|Mean|50.6|50.6|Standard Deviation|14.2|14.2|||
3705876|NCT02161757|3545919|B3|||Age||years|Mean|51.4|51.4|Standard Deviation|14.3|14.3|||
3705877|NCT02161757|3545920|B2|||Age||years|Mean|51.1|51.1|Standard Deviation|13.9|13.9|||
3705878|NCT02161757|3545921|B1|||Age||years|Mean|49.4|49.4|Standard Deviation|14.3|14.3|||
3705879|NCT02161731|3545981|B1|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3705880|NCT02161731|3545981|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705881|NCT02161731|3545981|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3705882|NCT02161731|3545981|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3705883|NCT02161731|3545981|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3705884|NCT02161731|3545981|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705885|NCT02161731|3545981|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3705886|NCT02161731|3545981|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705887|NCT02161731|3545981|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705888|NCT02161731|3545981|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3705889|NCT02161731|3545981|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3705890|NCT02161731|3545981|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3705891|NCT02161731|3545981|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3705892|NCT02161731|3545981|B1|||Age||years|Mean|36.0|36.0|Standard Deviation|9.4|9.4|||
3705893|NCT02161562|3545999|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3705894|NCT02161562|3546000|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3705895|NCT02161562|3546001|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3705896|NCT02161562|3545999|B3||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
3705897|NCT02161562|3546000|B2||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3705898|NCT02161562|3546001|B1||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3705899|NCT02161562|3545999|B3|||Age||Years|Mean|46.3|46.3|Standard Deviation|13.83|13.83|||
3705900|NCT02161562|3546000|B2|||Age||Years|Mean|45.8|45.8|Standard Deviation|13.60|13.6|||
3705901|NCT02161562|3546001|B1|||Age||Years|Mean|46.7|46.7|Standard Deviation|14.03|14.03|||
3705902|NCT02161549|3546028|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3705903|NCT02161549|3546029|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3705904|NCT02161549|3546030|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3705905|NCT02161549|3546028|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3705906|NCT02161549|3546029|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3705907|NCT02161549|3546030|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3705908|NCT02161549|3546028|B3|||Age||years|Mean|54|54.0|Standard Deviation|4.0|4.0|||
3705909|NCT02161549|3546029|B2|||Age||years|Mean|53|53.0|Standard Deviation|4.1|4.1|||
3705910|NCT02161549|3546030|B1|||Age||years|Mean|55|55.0|Standard Deviation|3.8|3.8|||
3705911|NCT02161536|3546037|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3705912|NCT02161536|3546038|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3705913|NCT02161536|3546039|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3705914|NCT02161536|3546040|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3705915|NCT02161536|3546037|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3705916|NCT02161536|3546038|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3705917|NCT02161536|3546039|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3705918|NCT02161536|3546040|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3705919|NCT02161536|3546037|B4|||Age||YEARS|Mean|51.4|51.4|Standard Deviation|9.6|9.6|||
3705920|NCT02161536|3546038|B3|||Age||YEARS|Mean|54.7|54.7|Standard Deviation|6.6|6.6|||
3705921|NCT02161536|3546039|B2|||Age||YEARS|Mean|49.2|49.2|Standard Deviation|11.6|11.6|||
3705922|NCT02161536|3546040|B1|||Age||YEARS|Mean|48|48.0|Standard Deviation|8.7|8.7|||
3705923|NCT02161484|3546050|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3705924|NCT02161484|3546051|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3705925|NCT02161484|3546052|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3705926|NCT02161484|3546050|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705927|NCT02161484|3546051|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705928|NCT02161484|3546052|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705929|NCT02161484|3546050|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705930|NCT02161484|3546051|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705931|NCT02161484|3546052|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705932|NCT02161484|3546050|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3705933|NCT02161484|3546051|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3705934|NCT02161484|3546052|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3705935|NCT02161484|3546050|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705936|NCT02161484|3546051|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705937|NCT02161484|3546052|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705938|NCT02161484|3546050|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705939|NCT02161484|3546051|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705940|NCT02161484|3546052|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705941|NCT02161484|3546050|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705942|NCT02161484|3546051|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705943|NCT02161484|3546052|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705944|NCT02161484|3546050|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705945|NCT02161484|3546051|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705946|NCT02161484|3546052|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705947|NCT02161484|3546050|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705948|NCT02161484|3546051|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705949|NCT02161484|3546052|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705950|NCT02161484|3546050|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3705951|NCT02161484|3546051|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3705952|NCT02161484|3546052|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3705953|NCT02161484|3546050|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705954|NCT02161484|3546051|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705955|NCT02161484|3546052|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3705956|NCT02161484|3546050|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3705957|NCT02161484|3546051|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3705958|NCT02161484|3546052|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3705959|NCT02161484|3546050|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3705960|NCT02161484|3546051|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3705961|NCT02161484|3546052|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3705962|NCT02161484|3546050|B3|||Age||years|Mean|57.7|57.7|Standard Deviation|5.54|5.54|||
3705963|NCT02161484|3546051|B2|||Age||years|Mean|58.6|58.6|Standard Deviation|7.67|7.67|||
3705964|NCT02161484|3546052|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|2.86|2.86|||
3705965|NCT02161146|3546075|B6||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3705966|NCT02161146|3546076|B5||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3705967|NCT02161146|3546077|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3705968|NCT02161146|3546078|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3705969|NCT02161146|3546079|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3705970|NCT02161146|3546080|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3705971|NCT02161146|3546075|B6||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3705972|NCT02161146|3546076|B5||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3705973|NCT02161146|3546077|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3705974|NCT02161146|3546078|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3705975|NCT02161146|3546079|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3705976|NCT02161146|3546080|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3705977|NCT02161146|3546075|B6|>40 years||Age, Customized||participants|Number|104|104.0||||||
3705978|NCT02161146|3546076|B5|>40 years||Age, Customized||participants|Number|22|22.0||||||
3705979|NCT02161146|3546077|B4|>40 years||Age, Customized||participants|Number|20|20.0||||||
3705980|NCT02161146|3546078|B3|>40 years||Age, Customized||participants|Number|26|26.0||||||
3705981|NCT02161146|3546079|B2|>40 years||Age, Customized||participants|Number|20|20.0||||||
3705982|NCT02161146|3546080|B1|>40 years||Age, Customized||participants|Number|16|16.0||||||
3705983|NCT02161146|3546075|B6|>30 to 40 years||Age, Customized||participants|Number|42|42.0||||||
3705984|NCT02161146|3546076|B5|>30 to 40 years||Age, Customized||participants|Number|7|7.0||||||
3705985|NCT02161146|3546077|B4|>30 to 40 years||Age, Customized||participants|Number|7|7.0||||||
3705986|NCT02161146|3546078|B3|>30 to 40 years||Age, Customized||participants|Number|7|7.0||||||
3705987|NCT02161146|3546079|B2|>30 to 40 years||Age, Customized||participants|Number|12|12.0||||||
3705988|NCT02161146|3546080|B1|>30 to 40 years||Age, Customized||participants|Number|9|9.0||||||
3705989|NCT02161146|3546075|B6|20 to 30 years||Age, Customized||participants|Number|94|94.0||||||
3705990|NCT02161146|3546076|B5|20 to 30 years||Age, Customized||participants|Number|20|20.0||||||
3705991|NCT02161146|3546077|B4|20 to 30 years||Age, Customized||participants|Number|21|21.0||||||
3705992|NCT02161146|3546078|B3|20 to 30 years||Age, Customized||participants|Number|16|16.0||||||
3705993|NCT02161146|3546079|B2|20 to 30 years||Age, Customized||participants|Number|15|15.0||||||
3705994|NCT02161146|3546080|B1|20 to 30 years||Age, Customized||participants|Number|22|22.0||||||
3705995|NCT02161016|3546097|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3705996|NCT02161016|3546097|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3705997|NCT02161016|3546097|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3705998|NCT02161016|3546097|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3705999|NCT02161016|3546097|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3706000|NCT02160990|3546105|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3706001|NCT02160990|3546106|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3706002|NCT02160990|3546107|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3706003|NCT02160990|3546105|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3706004|NCT02160990|3546106|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3706005|NCT02160990|3546107|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3706006|NCT02160990|3546105|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3706007|NCT02160990|3546106|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3706008|NCT02160990|3546107|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3706009|NCT02160990|3546105|B3|||Age||years|Median|39.3|39.3|Inter-Quartile Range|||25.3|49.5|
3706010|NCT02160990|3546106|B2|||Age||years|Median|42.5|42.5|Inter-Quartile Range|||25.3|49.5|
3706011|NCT02160990|3546107|B1|||Age||years|Median|34|34.0|Inter-Quartile Range|||33.0|46.8|
3706012|NCT02160977|3546126|B3|||Preoperative HSS score,Continuous|Scale Name:score scale range:0~100,and a higher values represent a better outcome|units on a scale|Mean|58.1|58.1|Standard Deviation|14.3|14.3|||
3706013|NCT02160977|3546127|B2|||Preoperative HSS score,Continuous|Scale Name:score scale range:0~100,and a higher values represent a better outcome|units on a scale|Mean|59.9|59.9|Standard Deviation|14.6|14.6|||
3706014|NCT02160977|3546128|B1|||Preoperative HSS score,Continuous|Scale Name:score scale range:0~100,and a higher values represent a better outcome|units on a scale|Mean|56.2|56.2|Standard Deviation|13.8|13.8|||
3706015|NCT02160977|3546126|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3706016|NCT02160977|3546127|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3706017|NCT02160977|3546128|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3706018|NCT02160977|3546126|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3706019|NCT02160977|3546127|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3706020|NCT02160977|3546128|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3706021|NCT02160977|3546126|B3|||Age||years|Mean|65.4|65.4|Standard Deviation|6.8|6.8|||
3706022|NCT02160977|3546127|B2|||Age||years|Mean|64.5|64.5|Standard Deviation|7.1|7.1|||
3706023|NCT02160977|3546128|B1|||Age||years|Mean|66.4|66.4|Standard Deviation|6.1|6.1|||
3706024|NCT02160873|3546139|B3|||Maximal oxygen consumption (ml/kg/min)||ml/kg/min|Mean|52.8|52.8|Standard Deviation|4.2|4.2|||
3706025|NCT02160873|3546140|B2|||Maximal oxygen consumption (ml/kg/min)||ml/kg/min|Mean|53.8|53.8|Standard Deviation|4.5|4.5|||
3706026|NCT02160873|3546141|B1|||Maximal oxygen consumption (ml/kg/min)||ml/kg/min|Mean|51.8|51.8|Standard Deviation|4.1|4.1|||
3706027|NCT02160873|3546139|B3|||Body fat (%)||%|Mean|21.8|21.8|Standard Deviation|5.1|5.1|||
3706028|NCT02160873|3546140|B2|||Body fat (%)||%|Mean|22.1|22.1|Standard Deviation|5.0|5.0|||
3706029|NCT02160873|3546141|B1|||Body fat (%)||%|Mean|21.4|21.4|Standard Deviation|5.7|5.7|||
3706030|NCT02160873|3546139|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3706031|NCT02160873|3546140|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3706032|NCT02160873|3546141|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3706033|NCT02160873|3546139|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3706034|NCT02160873|3546140|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3706035|NCT02160873|3546141|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3706036|NCT02160873|3546139|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3706037|NCT02160873|3546140|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3706038|NCT02160873|3546141|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3706039|NCT02160873|3546139|B3|||Age||years|Mean|29.8|29.8|Standard Deviation|6.5|6.5|||
3706040|NCT02160873|3546140|B2|||Age||years|Mean|29.3|29.3|Standard Deviation|7.1|7.1|||
3706041|NCT02160873|3546141|B1|||Age||years|Mean|30.3|30.3|Standard Deviation|6.4|6.4|||
3706042|NCT02160847|3546154|B3|Parent|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706043|NCT02160847|3546155|B2|Parent|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706044|NCT02160847|3546156|B1|Parent|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706045|NCT02160847|3546154|B3|Parent|More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706046|NCT02160847|3546155|B2|Parent|More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706047|NCT02160847|3546156|B1|Parent|More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706048|NCT02160847|3546154|B3|Parent|White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3706049|NCT02160847|3546155|B2|Parent|White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3706050|NCT02160847|3546156|B1|Parent|White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3706051|NCT02160847|3546154|B3|Parent|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3706052|NCT02160847|3546155|B2|Parent|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3706053|NCT02160847|3546156|B1|Parent|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3706054|NCT02160847|3546154|B3|Parent|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706055|NCT02160847|3546155|B2|Parent|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706056|NCT02160847|3546156|B1|Parent|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706057|NCT02160847|3546154|B3|Parent|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706058|NCT02160847|3546155|B2|Parent|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706059|NCT02160847|3546156|B1|Parent|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706060|NCT02160847|3546154|B3|Parent|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706061|NCT02160847|3546155|B2|Parent|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706062|NCT02160847|3546156|B1|Parent|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706063|NCT02160847|3546154|B3|Child|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706064|NCT02160847|3546155|B2|Child|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706065|NCT02160847|3546156|B1|Child|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706066|NCT02160847|3546154|B3|Child|More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3706067|NCT02160847|3546155|B2|Child|More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706068|NCT02160847|3546156|B1|Child|More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3706069|NCT02160847|3546154|B3|Child|White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3706070|NCT02160847|3546155|B2|Child|White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3706071|NCT02160847|3546156|B1|Child|White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3706072|NCT02160847|3546154|B3|Child|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3706073|NCT02160847|3546155|B2|Child|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3706074|NCT02160847|3546156|B1|Child|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3706075|NCT02160847|3546154|B3|Child|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706076|NCT02160847|3546155|B2|Child|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706077|NCT02160847|3546156|B1|Child|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706078|NCT02160847|3546154|B3|Child|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706079|NCT02160847|3546155|B2|Child|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706080|NCT02160847|3546156|B1|Child|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706081|NCT02160847|3546154|B3|Child|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706082|NCT02160847|3546155|B2|Child|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706083|NCT02160847|3546156|B1|Child|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706084|NCT02160847|3546154|B3|Parent|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706085|NCT02160847|3546155|B2|Parent|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706086|NCT02160847|3546156|B1|Parent|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706087|NCT02160847|3546154|B3|Parent|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3706088|NCT02160847|3546155|B2|Parent|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3706089|NCT02160847|3546156|B1|Parent|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3706090|NCT02160847|3546154|B3|Parent|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706091|NCT02160847|3546155|B2|Parent|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706092|NCT02160847|3546156|B1|Parent|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706093|NCT02160847|3546154|B3|Child|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706094|NCT02160847|3546155|B2|Child|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706095|NCT02160847|3546156|B1|Child|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706096|NCT02160847|3546154|B3|Child|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3706097|NCT02160847|3546155|B2|Child|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3706098|NCT02160847|3546156|B1|Child|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3706099|NCT02160847|3546154|B3|Child|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3706100|NCT02160847|3546155|B2|Child|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706101|NCT02160847|3546156|B1|Child|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3706102|NCT02160847|3546154|B3|Parent|Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3706103|NCT02160847|3546155|B2|Parent|Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3706104|NCT02160847|3546156|B1|Parent|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3706105|NCT02160847|3546154|B3|Parent|Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3706106|NCT02160847|3546155|B2|Parent|Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3706107|NCT02160847|3546156|B1|Parent|Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3706108|NCT02160847|3546154|B3|Child|Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3706109|NCT02160847|3546155|B2|Child|Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3706110|NCT02160847|3546156|B1|Child|Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3706111|NCT02160847|3546154|B3|Child|Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3706112|NCT02160847|3546155|B2|Child|Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3706113|NCT02160847|3546156|B1|Child|Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3706114|NCT02160847|3546154|B3|Parent||Age||years|Mean|35.13|35.13|Standard Deviation|5.32|5.32|||
3706115|NCT02160847|3546155|B2|Parent||Age||years|Mean|34.5|34.5|Standard Deviation|5.86|5.86|||
3706116|NCT02160847|3546156|B1|Parent||Age||years|Mean|35.75|35.75|Standard Deviation|5.04|5.04|||
3706117|NCT02160847|3546154|B3|Child||Age||years|Mean|4.06|4.06|Standard Deviation|1.69|1.69|||
3706118|NCT02160847|3546155|B2|Child||Age||years|Mean|4.25|4.25|Standard Deviation|1.67|1.67|||
3706119|NCT02160847|3546156|B1|Child||Age||years|Mean|3.88|3.88|Standard Deviation|1.81|1.81|||
3706120|NCT02160626|3546165|B4|6||Fitzpatrick skin type|Fitzpatrick skin type is a six point scale that evaluates the skin coloration of the patient with one being the lightest and 6 being the darkest skin coloration.|Participants|Count of Participants|0|0.0||||||
3706121|NCT02160626|3546166|B3|6||Fitzpatrick skin type|Fitzpatrick skin type is a six point scale that evaluates the skin coloration of the patient with one being the lightest and 6 being the darkest skin coloration.|Participants|Count of Participants|0|0.0||||||
3706122|NCT02160626|3546167|B2|6||Fitzpatrick skin type|Fitzpatrick skin type is a six point scale that evaluates the skin coloration of the patient with one being the lightest and 6 being the darkest skin coloration.|Participants|Count of Participants|0|0.0||||||
3706123|NCT02160626|3546168|B1|6||Fitzpatrick skin type|Fitzpatrick skin type is a six point scale that evaluates the skin coloration of the patient with one being the lightest and 6 being the darkest skin coloration.|Participants|Count of Participants|0|0.0||||||
3706124|NCT02160626|3546165|B4|5||Fitzpatrick skin type|Fitzpatrick skin type is a six point scale that evaluates the skin coloration of the patient with one being the lightest and 6 being the darkest skin coloration.|Participants|Count of Participants|1|1.0||||||
3706125|NCT02160626|3546166|B3|5||Fitzpatrick skin type|Fitzpatrick skin type is a six point scale that evaluates the skin coloration of the patient with one being the lightest and 6 being the darkest skin coloration.|Participants|Count of Participants|0|0.0||||||
3706126|NCT02160626|3546167|B2|5||Fitzpatrick skin type|Fitzpatrick skin type is a six point scale that evaluates the skin coloration of the patient with one being the lightest and 6 being the darkest skin coloration.|Participants|Count of Participants|1|1.0||||||
3706127|NCT02160626|3546168|B1|5||Fitzpatrick skin type|Fitzpatrick skin type is a six point scale that evaluates the skin coloration of the patient with one being the lightest and 6 being the darkest skin coloration.|Participants|Count of Participants|0|0.0||||||
3706128|NCT02160626|3546165|B4|4||Fitzpatrick skin type|Fitzpatrick skin type is a six point scale that evaluates the skin coloration of the patient with one being the lightest and 6 being the darkest skin coloration.|Participants|Count of Participants|27|27.0||||||
3706129|NCT02160626|3546166|B3|4||Fitzpatrick skin type|Fitzpatrick skin type is a six point scale that evaluates the skin coloration of the patient with one being the lightest and 6 being the darkest skin coloration.|Participants|Count of Participants|10|10.0||||||
3706130|NCT02160626|3546167|B2|4||Fitzpatrick skin type|Fitzpatrick skin type is a six point scale that evaluates the skin coloration of the patient with one being the lightest and 6 being the darkest skin coloration.|Participants|Count of Participants|6|6.0||||||
3706131|NCT02160626|3546168|B1|4||Fitzpatrick skin type|Fitzpatrick skin type is a six point scale that evaluates the skin coloration of the patient with one being the lightest and 6 being the darkest skin coloration.|Participants|Count of Participants|11|11.0||||||
3706132|NCT02160626|3546165|B4|3||Fitzpatrick skin type|Fitzpatrick skin type is a six point scale that evaluates the skin coloration of the patient with one being the lightest and 6 being the darkest skin coloration.|Participants|Count of Participants|69|69.0||||||
3706133|NCT02160626|3546166|B3|3||Fitzpatrick skin type|Fitzpatrick skin type is a six point scale that evaluates the skin coloration of the patient with one being the lightest and 6 being the darkest skin coloration.|Participants|Count of Participants|20|20.0||||||
3706134|NCT02160626|3546167|B2|3||Fitzpatrick skin type|Fitzpatrick skin type is a six point scale that evaluates the skin coloration of the patient with one being the lightest and 6 being the darkest skin coloration.|Participants|Count of Participants|19|19.0||||||
3706135|NCT02160626|3546168|B1|3||Fitzpatrick skin type|Fitzpatrick skin type is a six point scale that evaluates the skin coloration of the patient with one being the lightest and 6 being the darkest skin coloration.|Participants|Count of Participants|30|30.0||||||
3706136|NCT02160626|3546165|B4|2||Fitzpatrick skin type|Fitzpatrick skin type is a six point scale that evaluates the skin coloration of the patient with one being the lightest and 6 being the darkest skin coloration.|Participants|Count of Participants|64|64.0||||||
3706137|NCT02160626|3546166|B3|2||Fitzpatrick skin type|Fitzpatrick skin type is a six point scale that evaluates the skin coloration of the patient with one being the lightest and 6 being the darkest skin coloration.|Participants|Count of Participants|24|24.0||||||
3706138|NCT02160626|3546167|B2|2||Fitzpatrick skin type|Fitzpatrick skin type is a six point scale that evaluates the skin coloration of the patient with one being the lightest and 6 being the darkest skin coloration.|Participants|Count of Participants|27|27.0||||||
3706139|NCT02160626|3546168|B1|2||Fitzpatrick skin type|Fitzpatrick skin type is a six point scale that evaluates the skin coloration of the patient with one being the lightest and 6 being the darkest skin coloration.|Participants|Count of Participants|13|13.0||||||
3706140|NCT02160626|3546165|B4|1||Fitzpatrick skin type|Fitzpatrick skin type is a six point scale that evaluates the skin coloration of the patient with one being the lightest and 6 being the darkest skin coloration.|Participants|Count of Participants|11|11.0||||||
3706141|NCT02160626|3546166|B3|1||Fitzpatrick skin type|Fitzpatrick skin type is a six point scale that evaluates the skin coloration of the patient with one being the lightest and 6 being the darkest skin coloration.|Participants|Count of Participants|3|3.0||||||
3706142|NCT02160626|3546167|B2|1||Fitzpatrick skin type|Fitzpatrick skin type is a six point scale that evaluates the skin coloration of the patient with one being the lightest and 6 being the darkest skin coloration.|Participants|Count of Participants|4|4.0||||||
3706143|NCT02160626|3546168|B1|1||Fitzpatrick skin type|Fitzpatrick skin type is a six point scale that evaluates the skin coloration of the patient with one being the lightest and 6 being the darkest skin coloration.|Participants|Count of Participants|4|4.0||||||
3706144|NCT02160626|3546165|B4|United States||Region of Enrollment||participants|Number|172|172.0||||||
3706145|NCT02160626|3546166|B3|United States||Region of Enrollment||participants|Number|57|57.0||||||
3706146|NCT02160626|3546167|B2|United States||Region of Enrollment||participants|Number|57|57.0||||||
3706147|NCT02160626|3546168|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
3706148|NCT02160626|3546165|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706149|NCT02160626|3546166|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706150|NCT02160626|3546167|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706151|NCT02160626|3546168|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706152|NCT02160626|3546165|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3706153|NCT02160626|3546166|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706154|NCT02160626|3546167|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3706155|NCT02160626|3546168|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706156|NCT02160626|3546165|B4||White|Race (NIH/OMB)||Participants|Count of Participants|171|171.0||||||
3706157|NCT02160626|3546166|B3||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3706158|NCT02160626|3546167|B2||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3706159|NCT02160626|3546168|B1||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3706160|NCT02160626|3546165|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706161|NCT02160626|3546166|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706162|NCT02160626|3546167|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706163|NCT02160626|3546168|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706164|NCT02160626|3546165|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706165|NCT02160626|3546166|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706166|NCT02160626|3546167|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706167|NCT02160626|3546168|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706168|NCT02160626|3546165|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706169|NCT02160626|3546166|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706170|NCT02160626|3546167|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706171|NCT02160626|3546168|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706172|NCT02160626|3546165|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706173|NCT02160626|3546166|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706174|NCT02160626|3546167|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706292|NCT02159950|3546251|B2|Female||Gender||participants|Number|0|0.0||||||
3706175|NCT02160626|3546168|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706176|NCT02160626|3546165|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706177|NCT02160626|3546166|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706178|NCT02160626|3546167|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706179|NCT02160626|3546168|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706180|NCT02160626|3546165|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|171|171.0||||||
3706181|NCT02160626|3546166|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3706182|NCT02160626|3546167|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3706183|NCT02160626|3546168|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3706184|NCT02160626|3546165|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3706185|NCT02160626|3546166|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706186|NCT02160626|3546167|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706187|NCT02160626|3546168|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3706188|NCT02160626|3546165|B4||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3706189|NCT02160626|3546166|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3706190|NCT02160626|3546167|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3706191|NCT02160626|3546168|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3706192|NCT02160626|3546165|B4||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3706193|NCT02160626|3546166|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3706194|NCT02160626|3546167|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3706195|NCT02160626|3546168|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3706196|NCT02160626|3546165|B4|71 +||Age, Customized||Participants|Count of Participants|169|169.0||||||
3706197|NCT02160626|3546166|B3|71 +||Age, Customized||Participants|Count of Participants|57|57.0||||||
3706198|NCT02160626|3546167|B2|71 +||Age, Customized||Participants|Count of Participants|56|56.0||||||
3706199|NCT02160626|3546168|B1|71 +||Age, Customized||Participants|Count of Participants|56|56.0||||||
3706200|NCT02160626|3546165|B4|56-70||Age, Customized||Participants|Count of Participants|3|3.0||||||
3706201|NCT02160626|3546166|B3|56-70||Age, Customized||Participants|Count of Participants|0|0.0||||||
3706202|NCT02160626|3546167|B2|56-70||Age, Customized||Participants|Count of Participants|1|1.0||||||
3706203|NCT02160626|3546168|B1|56-70||Age, Customized||Participants|Count of Participants|2|2.0||||||
3706204|NCT02160626|3546165|B4|18-55||Age, Customized||Participants|Count of Participants|0|0.0||||||
3706205|NCT02160626|3546166|B3|18-55||Age, Customized||Participants|Count of Participants|0|0.0||||||
3706206|NCT02160626|3546167|B2|18-55||Age, Customized||Participants|Count of Participants|0|0.0||||||
3706207|NCT02160626|3546168|B1|18-55||Age, Customized||Participants|Count of Participants|0|0.0||||||
3706208|NCT02160535|3546184|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3706209|NCT02160535|3546184|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3706210|NCT02160535|3546184|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3706211|NCT02160535|3546184|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3706212|NCT02160535|3546184|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3706213|NCT02160535|3546184|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3706214|NCT02160314|3546191|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3706215|NCT02160314|3546192|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3706216|NCT02160314|3546193|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3706217|NCT02160314|3546191|B3||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3706218|NCT02160314|3546192|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3706219|NCT02160314|3546193|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3706220|NCT02160314|3546191|B3|||Age||years|Mean|53.6|53.6|Standard Deviation|11.3|11.3|||
3706221|NCT02160314|3546192|B2|||Age||years|Mean|53.9|53.9|Standard Deviation|12.36|12.36|||
3706222|NCT02160314|3546193|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|10.24|10.24|||
3706223|NCT02160145|3546200|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3706224|NCT02160145|3546201|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3706225|NCT02160145|3546202|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3706226|NCT02160145|3546200|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706227|NCT02160145|3546201|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706228|NCT02160145|3546202|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706229|NCT02160145|3546200|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1258|1258.0||||||
3706230|NCT02160145|3546201|B2||White|Race (NIH/OMB)||Participants|Count of Participants|632|632.0||||||
3706231|NCT02160145|3546202|B1||White|Race (NIH/OMB)||Participants|Count of Participants|626|626.0||||||
3706232|NCT02160145|3546200|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3706233|NCT02160145|3546201|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3706234|NCT02160145|3546202|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3706235|NCT02160145|3546200|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706236|NCT02160145|3546201|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706237|NCT02160145|3546202|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706238|NCT02160145|3546200|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3706239|NCT02160145|3546201|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3706240|NCT02160145|3546202|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3706241|NCT02160145|3546200|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3706242|NCT02160145|3546201|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3706243|NCT02160145|3546202|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3706244|NCT02160145|3546200|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3706245|NCT02160145|3546201|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3706246|NCT02160145|3546202|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3706247|NCT02160145|3546200|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1279|1279.0||||||
3706248|NCT02160145|3546201|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|647|647.0||||||
3706249|NCT02160145|3546202|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|632|632.0||||||
3706250|NCT02160145|3546200|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3706251|NCT02160145|3546201|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3706252|NCT02160145|3546202|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3706253|NCT02160145|3546200|B3||Male|Sex: Female, Male||Participants|Count of Participants|680|680.0||||||
3706254|NCT02160145|3546201|B2||Male|Sex: Female, Male||Participants|Count of Participants|333|333.0||||||
3706255|NCT02160145|3546202|B1||Male|Sex: Female, Male||Participants|Count of Participants|347|347.0||||||
3706256|NCT02160145|3546200|B3||Female|Sex: Female, Male||Participants|Count of Participants|690|690.0||||||
3706257|NCT02160145|3546201|B2||Female|Sex: Female, Male||Participants|Count of Participants|354|354.0||||||
3706258|NCT02160145|3546202|B1||Female|Sex: Female, Male||Participants|Count of Participants|336|336.0||||||
3706259|NCT02160145|3546200|B3|||Age||years|Mean|47.3|47.3|Standard Deviation|8.2|8.2|||
3706260|NCT02160145|3546201|B2|||Age||years|Mean|47.2|47.2|Standard Deviation|8.2|8.2|||
3706261|NCT02160145|3546202|B1|||Age||years|Mean|47.3|47.3|Standard Deviation|8.2|8.2|||
3706262|NCT02160002|3546217|B3|||Cesarean Delivery||Participants|Count of Participants|258|258.0||||||
3706263|NCT02160002|3546218|B2|||Cesarean Delivery||Participants|Count of Participants|122|122.0||||||
3706264|NCT02160002|3546219|B1|||Cesarean Delivery||Participants|Count of Participants|136|136.0||||||
3706265|NCT02160002|3546217|B3|||Maternal Age||years|Mean|28.8|28.8|Standard Deviation|5.9|5.9|||
3706266|NCT02160002|3546218|B2|||Maternal Age||years|Mean|28.9|28.9|Standard Deviation|6.1|6.1|||
3706267|NCT02160002|3546219|B1|||Maternal Age||years|Mean|28.8|28.8|Standard Deviation|5.8|5.8|||
3706268|NCT02160002|3546217|B3|||Postmenstrual (PMA) age at start of weaning||weeks|Mean|34.1|34.1|Standard Deviation|1.3|1.3|||
3706269|NCT02160002|3546218|B2|||Postmenstrual (PMA) age at start of weaning||weeks|Mean|34.3|34.3|Standard Deviation|1.2|1.2|||
3706270|NCT02160002|3546219|B1|||Postmenstrual (PMA) age at start of weaning||weeks|Mean|33.8|33.8|Standard Deviation|1.3|1.3|||
3706271|NCT02160002|3546217|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3706272|NCT02160002|3546218|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3706273|NCT02160002|3546219|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3706274|NCT02160002|3546217|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|196|196.0||||||
3706275|NCT02160002|3546218|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|97|97.0||||||
3706276|NCT02160002|3546219|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|99|99.0||||||
3706277|NCT02160002|3546217|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|148|148.0||||||
3706278|NCT02160002|3546218|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|72|72.0||||||
3706279|NCT02160002|3546219|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|76|76.0||||||
3706280|NCT02160002|3546217|B3||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
3706281|NCT02160002|3546218|B2||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3706282|NCT02160002|3546219|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3706283|NCT02160002|3546217|B3||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3706284|NCT02160002|3546218|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3706285|NCT02160002|3546219|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3706286|NCT02160002|3546217|B3|Gestational Age||Age, Customized||weeks|Mean|31.1|31.1|Standard Deviation|1.2|1.2|||
3706287|NCT02160002|3546218|B2|Gestational Age||Age, Customized||weeks|Mean|31.1|31.1|Standard Deviation|1.2|1.2|||
3706288|NCT02160002|3546219|B1|Gestational Age||Age, Customized||weeks|Mean|31.2|31.2|Standard Deviation|1.3|1.3|||
3706289|NCT02159950|3546250|B3|Male||Gender||participants|Number|2|2.0||||||
3706290|NCT02159950|3546251|B2|Male||Gender||participants|Number|2|2.0||||||
3706291|NCT02159950|3546250|B3|Female||Gender||participants|Number|0|0.0||||||
3706293|NCT02159950|3546250|B3|||Age||years|Mean|75.4|75.4|Standard Deviation|.70|0.7|||
3706294|NCT02159950|3546251|B2|||Age||years|Mean|75.4|75.4|Standard Deviation|.70|0.7|||
3706295|NCT02159950|3546250|B3|>=65 years||Age||participants|Number|2|2.0||||||
3706296|NCT02159950|3546251|B2|>=65 years||Age||participants|Number|2|2.0||||||
3706297|NCT02159950|3546250|B3|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
3706298|NCT02159950|3546251|B2|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
3706299|NCT02159950|3546250|B3|<=18 years||Age||participants|Number|0|0.0||||||
3706300|NCT02159950|3546251|B2|<=18 years||Age||participants|Number|0|0.0||||||
3706301|NCT02159898|3546285|B3|United States||Region of Enrollment||Participants|Count of Participants|59|59.0||||||
3706302|NCT02159898|3546286|B2|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3706303|NCT02159898|3546287|B1|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3706304|NCT02159898|3546285|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3706305|NCT02159898|3546286|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3706306|NCT02159898|3546287|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3706307|NCT02159898|3546285|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3706308|NCT02159898|3546286|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3706309|NCT02159898|3546287|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3706310|NCT02159898|3546285|B3||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
3706311|NCT02159898|3546286|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3706312|NCT02159898|3546287|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3706313|NCT02159898|3546285|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3706314|NCT02159898|3546286|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3706315|NCT02159898|3546287|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3706316|NCT02159898|3546285|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3706317|NCT02159898|3546286|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3706318|NCT02159898|3546287|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3706319|NCT02159859|3546296|B1|||weight||kilograms|Mean|77.7|77.7|Standard Deviation|18.3|18.3|||
3706320|NCT02159859|3546296|B1|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3706321|NCT02159859|3546296|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706322|NCT02159859|3546296|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706323|NCT02159859|3546296|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3706324|NCT02159859|3546296|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3706325|NCT02159859|3546296|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706326|NCT02159859|3546296|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706327|NCT02159859|3546296|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706328|NCT02159859|3546296|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3706329|NCT02159859|3546296|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3706330|NCT02159859|3546296|B1|||Age||years|Mean|60|60.0|Standard Deviation|11.4|11.4|||
3706331|NCT02159768|3546309|B1|Singapore||Region of Enrollment||participants|Number|30|30.0||||||
3706332|NCT02159768|3546309|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3706333|NCT02159768|3546309|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3706334|NCT02159768|3546309|B1|||Age||years|Mean|40|40.0|Standard Deviation|16.2|16.2|||
3706335|NCT02159768|3546309|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3706336|NCT02159768|3546309|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3706337|NCT02159768|3546309|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3706338|NCT02159547|3546314|B3|Turkey||Region of Enrollment||participants|Number|224|224.0||||||
3706339|NCT02159547|3546315|B2|Turkey||Region of Enrollment||participants|Number|112|112.0||||||
3706340|NCT02159547|3546316|B1|Turkey||Region of Enrollment||participants|Number|112|112.0||||||
3706341|NCT02159547|3546314|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3706342|NCT02159547|3546315|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3706343|NCT02159547|3546316|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3706344|NCT02159547|3546314|B3||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3706345|NCT02159547|3546315|B2||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3706346|NCT02159547|3546316|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3706347|NCT02159547|3546314|B3|||Age||years|Mean|36.9|36.9|Standard Deviation|11|11.0|||
3706348|NCT02159547|3546315|B2|||Age||years|Mean|37.6|37.6|Standard Deviation|10.7|10.7|||
3706349|NCT02159547|3546316|B1|||Age||years|Mean|36.3|36.3|Standard Deviation|11.1|11.1|||
3706350|NCT02159482|3546325|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3706351|NCT02159482|3546325|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706352|NCT02159482|3546325|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706353|NCT02159482|3546325|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3706354|NCT02159482|3546325|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706355|NCT02159482|3546325|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706356|NCT02159482|3546325|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3706357|NCT02159482|3546325|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706358|NCT02159482|3546325|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3706359|NCT02159482|3546325|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3706360|NCT02159482|3546325|B1|18 years and older||Age, Customized||participants|Number|11|11.0||||||
3706361|NCT02159469|3546330|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3706362|NCT02159469|3546330|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3706363|NCT02159469|3546330|B1||White|Race (NIH/OMB)||Participants|Count of Participants|133|133.0||||||
3706364|NCT02159469|3546330|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3706365|NCT02159469|3546330|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706366|NCT02159469|3546330|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3706367|NCT02159469|3546330|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706368|NCT02159469|3546330|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706369|NCT02159469|3546330|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|142|142.0||||||
3706370|NCT02159469|3546330|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3706371|NCT02159469|3546330|B1||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3706372|NCT02159469|3546330|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3706373|NCT02159469|3546330|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|12.04|12.04|||
3706374|NCT02159365|3546335|B1|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to discern patient status by rating categories such as disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all pre-disease performance without restriction and (worst score) 5=death.|Participants|Count of Participants|4|4.0||||||
3706375|NCT02159365|3546335|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to discern patient status by rating categories such as disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all pre-disease performance without restriction and (worst score) 5=death.|Participants|Count of Participants|32|32.0||||||
3706376|NCT02159365|3546335|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to discern patient status by rating categories such as disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all pre-disease performance without restriction and (worst score) 5=death.|Participants|Count of Participants|34|34.0||||||
3706377|NCT02159365|3546335|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3706378|NCT02159365|3546335|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3706379|NCT02159365|3546335|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3706380|NCT02159365|3546335|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3706381|NCT02159365|3546335|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3706382|NCT02159365|3546335|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|57|57.0||||||
3706383|NCT02159365|3546335|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706384|NCT02159365|3546335|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3706385|NCT02159365|3546335|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3706386|NCT02159365|3546335|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3706387|NCT02159365|3546335|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3706388|NCT02159365|3546335|B1|>= 75 years||Age, Customized||Participants|Count of Participants|21|21.0||||||
3706389|NCT02159365|3546335|B1|< 75 years||Age, Customized||Participants|Count of Participants|49|49.0||||||
3706390|NCT02159365|3546335|B1|||Age||years|Mean|67.4|67.4|Standard Deviation|9.40|9.4|||
3706391|NCT02159352|3546339|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3706392|NCT02159352|3546340|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3706393|NCT02159352|3546341|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3706394|NCT02159352|3546339|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3706395|NCT02159352|3546340|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3706396|NCT02159352|3546341|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3706397|NCT02159352|3546339|B3|Between 18 and 65 years||Age, Customized||participants|Number|28|28.0||||||
3706398|NCT02159352|3546340|B2|Between 18 and 65 years||Age, Customized||participants|Number|14|14.0||||||
3706399|NCT02159352|3546341|B1|Between 18 and 65 years||Age, Customized||participants|Number|14|14.0||||||
3706400|NCT02159118|3546392|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
3706401|NCT02159118|3546393|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
3706402|NCT02159118|3546394|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3706403|NCT02159118|3546392|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3706404|NCT02159118|3546393|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3706405|NCT02159118|3546394|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3706406|NCT02159118|3546392|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3706407|NCT02159118|3546393|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3706408|NCT02159118|3546394|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3706409|NCT02159118|3546392|B3|||Age||years|Mean|9.84|9.84|Standard Deviation|5.0|5.0|||
3706410|NCT02159118|3546393|B2|||Age||years|Mean|9.7|9.7|Standard Deviation|4.8|4.8|||
3706411|NCT02159118|3546394|B1|||Age||years|Mean|10|10.0|Standard Deviation|5.3|5.3|||
3706412|NCT02159040|3546417|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3706413|NCT02159040|3546417|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3706414|NCT02159040|3546417|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3706415|NCT02159040|3546417|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3706416|NCT02159040|3546417|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3706417|NCT02158975|3546430|B1||Peripheral T-cell Lymphoma (PTCL)|T-Cell Lymphoma Subtype||Participants|Count of Participants|7|7.0||||||
3706418|NCT02158975|3546430|B1||Cutaneous T-cell Lymphoma (CTCL)|T-Cell Lymphoma Subtype||Participants|Count of Participants|5|5.0||||||
3706419|NCT02158975|3546430|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3706420|NCT02158975|3546430|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3706421|NCT02158975|3546430|B1|||Age||years|Median|70|70.0|Full Range|||55.0|74.0|
3706422|NCT02158936|3546438|B3|No||Platelet transfusion dependence||participants|Number|290|290.0||||||
3706423|NCT02158936|3546439|B2|No||Platelet transfusion dependence||participants|Number|140|140.0||||||
3706424|NCT02158936|3546440|B1|No||Platelet transfusion dependence||participants|Number|150|150.0||||||
3706425|NCT02158936|3546438|B3|Yes||Platelet transfusion dependence||participants|Number|66|66.0||||||
3706426|NCT02158936|3546439|B2|Yes||Platelet transfusion dependence||participants|Number|37|37.0||||||
3706427|NCT02158936|3546440|B1|Yes||Platelet transfusion dependence||participants|Number|29|29.0||||||
3706428|NCT02158936|3546438|B3|missing||Platelet Count||participants|Number|2|2.0||||||
3706429|NCT02158936|3546439|B2|missing||Platelet Count||participants|Number|0|0.0||||||
3706430|NCT02158936|3546440|B1|missing||Platelet Count||participants|Number|2|2.0||||||
3706431|NCT02158936|3546438|B3|≥ 100||Platelet Count||participants|Number|0|0.0||||||
3706432|NCT02158936|3546439|B2|≥ 100||Platelet Count||participants|Number|0|0.0||||||
3706433|NCT02158936|3546440|B1|≥ 100||Platelet Count||participants|Number|0|0.0||||||
3706434|NCT02158936|3546438|B3|≥ 50 - <100||Platelet Count||participants|Number|102|102.0||||||
3706435|NCT02158936|3546439|B2|≥ 50 - <100||Platelet Count||participants|Number|53|53.0||||||
3706436|NCT02158936|3546440|B1|≥ 50 - <100||Platelet Count||participants|Number|49|49.0||||||
3706437|NCT02158936|3546438|B3|≥ 20 - <50||Platelet Count||participants|Number|167|167.0||||||
3706438|NCT02158936|3546439|B2|≥ 20 - <50||Platelet Count||participants|Number|84|84.0||||||
3706439|NCT02158936|3546440|B1|≥ 20 - <50||Platelet Count||participants|Number|83|83.0||||||
3706440|NCT02158936|3546438|B3|≥ 10 - <20||Platelet Count||participants|Number|65|65.0||||||
3706441|NCT02158936|3546439|B2|≥ 10 - <20||Platelet Count||participants|Number|30|30.0||||||
3706442|NCT02158936|3546440|B1|≥ 10 - <20||Platelet Count||participants|Number|35|35.0||||||
3706443|NCT02158936|3546438|B3|< 10||Platelet Count||participants|Number|20|20.0||||||
3706444|NCT02158936|3546439|B2|< 10||Platelet Count||participants|Number|10|10.0||||||
3706445|NCT02158936|3546440|B1|< 10||Platelet Count||participants|Number|10|10.0||||||
3706446|NCT02158936|3546438|B3|High Risk (≥ 2.5)||IPSS risk score|A bone marrow examination for the determination of IPSS was performed during the screening period, or within 3 months prior to randomization. Assessment of bone marrow blasts was to be completed by bone marrow slide review. The patient’s IPSS risk category is determined by adding together all of the IPSS scores within the three disease factors (blast cells, chromosomal changes, presence of cytopenias). That number is matched to one of the following four IPSS risk categories: Low, Intermediate-1, Intermediate-2, or High. The higher the score the higher the risk.|participants|Number|71|71.0||||||
3706447|NCT02158936|3546439|B2|High Risk (≥ 2.5)||IPSS risk score|A bone marrow examination for the determination of IPSS was performed during the screening period, or within 3 months prior to randomization. Assessment of bone marrow blasts was to be completed by bone marrow slide review. The patient’s IPSS risk category is determined by adding together all of the IPSS scores within the three disease factors (blast cells, chromosomal changes, presence of cytopenias). That number is matched to one of the following four IPSS risk categories: Low, Intermediate-1, Intermediate-2, or High. The higher the score the higher the risk.|participants|Number|33|33.0||||||
3706448|NCT02158936|3546440|B1|High Risk (≥ 2.5)||IPSS risk score|A bone marrow examination for the determination of IPSS was performed during the screening period, or within 3 months prior to randomization. Assessment of bone marrow blasts was to be completed by bone marrow slide review. The patient’s IPSS risk category is determined by adding together all of the IPSS scores within the three disease factors (blast cells, chromosomal changes, presence of cytopenias). That number is matched to one of the following four IPSS risk categories: Low, Intermediate-1, Intermediate-2, or High. The higher the score the higher the risk.|participants|Number|38|38.0||||||
3706449|NCT02158936|3546438|B3|Int - 2 (1.5 - 2.0)||IPSS risk score|A bone marrow examination for the determination of IPSS was performed during the screening period, or within 3 months prior to randomization. Assessment of bone marrow blasts was to be completed by bone marrow slide review. The patient’s IPSS risk category is determined by adding together all of the IPSS scores within the three disease factors (blast cells, chromosomal changes, presence of cytopenias). That number is matched to one of the following four IPSS risk categories: Low, Intermediate-1, Intermediate-2, or High. The higher the score the higher the risk.|participants|Number|160|160.0||||||
3706490|NCT02158728|3546483|B1|Slovakia||Region of Enrollment||participants|Number|13|13.0||||||
3706450|NCT02158936|3546439|B2|Int - 2 (1.5 - 2.0)||IPSS risk score|A bone marrow examination for the determination of IPSS was performed during the screening period, or within 3 months prior to randomization. Assessment of bone marrow blasts was to be completed by bone marrow slide review. The patient’s IPSS risk category is determined by adding together all of the IPSS scores within the three disease factors (blast cells, chromosomal changes, presence of cytopenias). That number is matched to one of the following four IPSS risk categories: Low, Intermediate-1, Intermediate-2, or High. The higher the score the higher the risk.|participants|Number|83|83.0||||||
3706451|NCT02158936|3546440|B1|Int - 2 (1.5 - 2.0)||IPSS risk score|A bone marrow examination for the determination of IPSS was performed during the screening period, or within 3 months prior to randomization. Assessment of bone marrow blasts was to be completed by bone marrow slide review. The patient’s IPSS risk category is determined by adding together all of the IPSS scores within the three disease factors (blast cells, chromosomal changes, presence of cytopenias). That number is matched to one of the following four IPSS risk categories: Low, Intermediate-1, Intermediate-2, or High. The higher the score the higher the risk.|participants|Number|77|77.0||||||
3706452|NCT02158936|3546438|B3|Int - 1 (0.5-1.0)||IPSS risk score|A bone marrow examination for the determination of IPSS was performed during the screening period, or within 3 months prior to randomization. Assessment of bone marrow blasts was to be completed by bone marrow slide review. The patient’s IPSS risk category is determined by adding together all of the IPSS scores within the three disease factors (blast cells, chromosomal changes, presence of cytopenias). That number is matched to one of the following four IPSS risk categories: Low, Intermediate-1, Intermediate-2, or High. The higher the score the higher the risk.|participants|Number|125|125.0||||||
3706453|NCT02158936|3546439|B2|Int - 1 (0.5-1.0)||IPSS risk score|A bone marrow examination for the determination of IPSS was performed during the screening period, or within 3 months prior to randomization. Assessment of bone marrow blasts was to be completed by bone marrow slide review. The patient’s IPSS risk category is determined by adding together all of the IPSS scores within the three disease factors (blast cells, chromosomal changes, presence of cytopenias). That number is matched to one of the following four IPSS risk categories: Low, Intermediate-1, Intermediate-2, or High. The higher the score the higher the risk.|participants|Number|61|61.0||||||
3706454|NCT02158936|3546440|B1|Int - 1 (0.5-1.0)||IPSS risk score|A bone marrow examination for the determination of IPSS was performed during the screening period, or within 3 months prior to randomization. Assessment of bone marrow blasts was to be completed by bone marrow slide review. The patient’s IPSS risk category is determined by adding together all of the IPSS scores within the three disease factors (blast cells, chromosomal changes, presence of cytopenias). That number is matched to one of the following four IPSS risk categories: Low, Intermediate-1, Intermediate-2, or High. The higher the score the higher the risk.|participants|Number|64|64.0||||||
3706455|NCT02158936|3546438|B3|Missing||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3706456|NCT02158936|3546439|B2|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3706457|NCT02158936|3546440|B1|Missing||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3706458|NCT02158936|3546438|B3|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3706459|NCT02158936|3546439|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3706460|NCT02158936|3546440|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3706461|NCT02158936|3546438|B3|Central/South Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3706462|NCT02158936|3546439|B2|Central/South Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3706463|NCT02158936|3546440|B1|Central/South Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3706464|NCT02158936|3546438|B3|East Asian/Japanese/S.E. Asian||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
3706465|NCT02158936|3546439|B2|East Asian/Japanese/S.E. Asian||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3706466|NCT02158936|3546440|B1|East Asian/Japanese/S.E. Asian||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3706467|NCT02158936|3546438|B3|White||Race/Ethnicity, Customized||participants|Number|294|294.0||||||
3706468|NCT02158936|3546439|B2|White||Race/Ethnicity, Customized||participants|Number|148|148.0||||||
3706469|NCT02158936|3546440|B1|White||Race/Ethnicity, Customized||participants|Number|146|146.0||||||
3706470|NCT02158936|3546438|B3||Male|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
3706471|NCT02158936|3546439|B2||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3706472|NCT02158936|3546440|B1||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3706473|NCT02158936|3546438|B3||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3706474|NCT02158936|3546439|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3706475|NCT02158936|3546440|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3706476|NCT02158936|3546438|B3|||Age||years|Mean|68.8|68.8|Standard Deviation|11.76|11.76|||
3706477|NCT02158936|3546439|B2|||Age||years|Mean|69.4|69.4|Standard Deviation|10.58|10.58|||
3706478|NCT02158936|3546440|B1|||Age||years|Mean|68.3|68.3|Standard Deviation|12.82|12.82|||
3706479|NCT02158728|3546483|B1|||Ventricular arrhythmias||participants|Number|42|42.0||||||
3706480|NCT02158728|3546483|B1|||Atrial arrhythmias||participants|Number|15|15.0||||||
3706481|NCT02158728|3546483|B1|||Sinus arrhythmias||participants|Number|13|13.0||||||
3706482|NCT02158728|3546483|B1|||Sinus atrioventricular (AV) junctional arrhythmias and blocks||participants|Number|23|23.0||||||
3706483|NCT02158728|3546483|B1|||Previous myocardial infarction||participants|Number|17|17.0||||||
3706484|NCT02158728|3546483|B1|||Coronary Artery Disease||participants|Number|24|24.0||||||
3706485|NCT02158728|3546483|B1|||Congestive Heart Failure||participants|Number|31|31.0||||||
3706486|NCT02158728|3546483|B1|||Hypertension||participants|Number|25|25.0||||||
3706487|NCT02158728|3546483|B1|||Indication for cardiac resynchronization therapy defibrillator (CRT-D)||participants|Number|6|6.0||||||
3706488|NCT02158728|3546483|B1|||Indication for implantable cardioverter defibrillator (ICD)||participants|Number|47|47.0||||||
3706489|NCT02158728|3546483|B1|China||Region of Enrollment||participants|Number|2|2.0||||||
3706491|NCT02158728|3546483|B1|Hong Kong||Region of Enrollment||participants|Number|11|11.0||||||
3706492|NCT02158728|3546483|B1|Taiwan||Region of Enrollment||participants|Number|21|21.0||||||
3706493|NCT02158728|3546483|B1|Hungary||Region of Enrollment||participants|Number|6|6.0||||||
3706494|NCT02158728|3546483|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3706495|NCT02158728|3546483|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3706496|NCT02158728|3546483|B1|||Age||years|Mean|57|57.0|Standard Deviation|14|14.0|||
3706497|NCT02158572|3546487|B1|United States||Region of Enrollment||Participants|Count of Participants|2031|2031.0||||||
3706498|NCT02158572|3546487|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3706499|NCT02158572|3546487|B1||Female|Sex: Female, Male||Participants|Count of Participants|2031|2031.0||||||
3706500|NCT02158572|3546487|B1|||Age||years|Mean|27.5|27.5|Standard Deviation|6.21|6.21|||
3706501|NCT02158572|3546487|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3706502|NCT02158572|3546487|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2031|2031.0||||||
3706503|NCT02158572|3546487|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3706504|NCT02158442|3546498|B3|Australia||Region of Enrollment||participants|Number|13|13.0||||||
3706505|NCT02158442|3546499|B2|Australia||Region of Enrollment||participants|Number|7|7.0||||||
3706506|NCT02158442|3546500|B1|Australia||Region of Enrollment||participants|Number|6|6.0||||||
3706507|NCT02158442|3546498|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3706508|NCT02158442|3546499|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3706509|NCT02158442|3546500|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3706510|NCT02158442|3546498|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3706511|NCT02158442|3546499|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3706512|NCT02158442|3546500|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3706513|NCT02158442|3546498|B3|||Age||years|Mean|63.5|63.5|Standard Deviation|6.8|6.8|||
3706514|NCT02158442|3546499|B2|||Age||years|Mean|63.0|63.0|Standard Deviation|5.9|5.9|||
3706515|NCT02158442|3546500|B1|||Age||years|Mean|64.2|64.2|Standard Deviation|8.3|8.3|||
3706516|NCT02158442|3546498|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3706517|NCT02158442|3546499|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3706518|NCT02158442|3546500|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3706519|NCT02158442|3546498|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3706520|NCT02158442|3546499|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3706521|NCT02158442|3546500|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3706522|NCT02158442|3546498|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3706523|NCT02158442|3546499|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3706524|NCT02158442|3546500|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3706525|NCT02158364|3546507|B1|Other, No||Type of Surveying Method after Vaccination|Type of surveying method after vaccination included questionnaire, consultation and other survey (for example, call). Participants may be represented in more than 1 category.|Participants|Number|3124|3124.0||||||
3706526|NCT02158364|3546507|B1|Other, Yes||Type of Surveying Method after Vaccination|Type of surveying method after vaccination included questionnaire, consultation and other survey (for example, call). Participants may be represented in more than 1 category.|Participants|Number|147|147.0||||||
3706527|NCT02158364|3546507|B1|Physician’s Visit, No||Type of Surveying Method after Vaccination|Type of surveying method after vaccination included questionnaire, consultation and other survey (for example, call). Participants may be represented in more than 1 category.|Participants|Number|2618|2618.0||||||
3706528|NCT02158364|3546507|B1|Physician’s Visit, Yes||Type of Surveying Method after Vaccination|Type of surveying method after vaccination included questionnaire, consultation and other survey (for example, call). Participants may be represented in more than 1 category.|Participants|Number|653|653.0||||||
3706529|NCT02158364|3546507|B1|Questionnaire, not Available||Type of Surveying Method after Vaccination|Type of surveying method after vaccination included questionnaire, consultation and other survey (for example, call). Participants may be represented in more than 1 category.|Participants|Number|248|248.0||||||
3706530|NCT02158364|3546507|B1|Questionnaire, Available||Type of Surveying Method after Vaccination|Type of surveying method after vaccination included questionnaire, consultation and other survey (for example, call). Participants may be represented in more than 1 category.|Participants|Number|3023|3023.0||||||
3706531|NCT02158364|3546507|B1|Unknown/not reported||History of Vaccination with Measles/Rubella Combined Vaccine||Participants|Count of Participants|2920|2920.0||||||
3706532|NCT02158364|3546507|B1|Received the Vaccine||History of Vaccination with Measles/Rubella Combined Vaccine||Participants|Count of Participants|351|351.0||||||
3706533|NCT02158364|3546507|B1|Unknown/not reported||History of Vaccination with Rubella Vaccine||Participants|Count of Participants|400|400.0||||||
3706534|NCT02158364|3546507|B1|Received the Vaccine||History of Vaccination with Rubella Vaccine||Participants|Count of Participants|2871|2871.0||||||
3706535|NCT02158364|3546507|B1|Unknown/not reported||History of Vaccination with Measles Vaccine||Participants|Count of Participants|369|369.0||||||
3706536|NCT02158364|3546507|B1|Received the Vaccine||History of Vaccination with Measles Vaccine||Participants|Count of Participants|2902|2902.0||||||
3706537|NCT02158364|3546507|B1|Had no Cautions||Cautions to Vaccination||Participants|Count of Participants|3102|3102.0||||||
3706538|NCT02158364|3546507|B1|Had Cautions||Cautions to Vaccination||Participants|Count of Participants|169|169.0||||||
3706539|NCT02158364|3546507|B1|Unknown/not reported||Concurrent Medication||Participants|Count of Participants|3|3.0||||||
3706540|NCT02158364|3546507|B1|Had No Concurrent Medication||Concurrent Medication||Participants|Count of Participants|3099|3099.0||||||
3706541|NCT02158364|3546507|B1|Had Concurrent Medication(s)||Concurrent Medication||Participants|Count of Participants|169|169.0||||||
3706542|NCT02158364|3546507|B1|Had No Medical History||Medical History|Medical history defined as a disease or a health condition for each participant before start of the study. Medical history was classified as congenital anomalies, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, GI disorders, hepatic and biliary disorders, renal disease and other medical history. Other medical history included all medical history except for those mentioned above.|Participants|Count of Participants|2779|2779.0||||||
3706543|NCT02158364|3546507|B1|Had Medical History||Medical History|Medical history defined as a disease or a health condition for each participant before start of the study. Medical history was classified as congenital anomalies, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, GI disorders, hepatic and biliary disorders, renal disease and other medical history. Other medical history included all medical history except for those mentioned above.|Participants|Count of Participants|492|492.0||||||
3706544|NCT02158364|3546507|B1|Had No Complications||Complications|Complications defined as a disease or a health condition for each participant at the start of study. Complications were classified as congenital anomalies, endocrine disorders, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, gastrointestinal (GI) disorders, renal disease and other complications. Other complications included all complications except for those mentioned above.|Participants|Count of Participants|3014|3014.0||||||
3706545|NCT02158364|3546507|B1|Had Complications||Complications|Complications defined as a disease or a health condition for each participant at the start of study. Complications were classified as congenital anomalies, endocrine disorders, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, gastrointestinal (GI) disorders, renal disease and other complications. Other complications included all complications except for those mentioned above.|Participants|Count of Participants|257|257.0||||||
3706546|NCT02158364|3546507|B1|Had no Predisposition to Hypersensitivity||Predisposition to Hypersensitivity||Participants|Count of Participants|2868|2868.0||||||
3706547|NCT02158364|3546507|B1|Had Predisposition to Hypersensitivity||Predisposition to Hypersensitivity||Participants|Count of Participants|403|403.0||||||
3706548|NCT02158364|3546507|B1|Japan||Region of Enrollment|All participants were enrolled in Japan.|Participants|Number|3271|3271.0||||||
3706549|NCT02158364|3546507|B1||Male|Sex: Female, Male||Participants|Count of Participants|1670|1670.0||||||
3706550|NCT02158364|3546507|B1||Female|Sex: Female, Male||Participants|Count of Participants|1601|1601.0||||||
3706551|NCT02158364|3546507|B1|||Age||years|Mean|5.5|5.5|Standard Deviation|1.21|1.21|||
3706552|NCT02158273|3546512|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3706553|NCT02158273|3546513|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3706554|NCT02158273|3546514|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3706555|NCT02158273|3546512|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3706556|NCT02158273|3546513|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3706557|NCT02158273|3546514|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3706558|NCT02158273|3546512|B3|||Age||years|Mean|37.58|37.58|Standard Deviation|12.04|12.04|||
3706559|NCT02158273|3546513|B2|||Age||years|Mean|36.64|36.64|Standard Deviation|11.84|11.84|||
3706560|NCT02158273|3546514|B1|||Age||years|Mean|38.52|38.52|Standard Deviation|12.40|12.4|||
3706561|NCT02158247|3546523|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3706562|NCT02158247|3546524|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3706563|NCT02158247|3546525|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3706564|NCT02158247|3546523|B3||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3706565|NCT02158247|3546524|B2||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3706566|NCT02158247|3546525|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3706567|NCT02158247|3546523|B3||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
3706568|NCT02158247|3546524|B2||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3706569|NCT02158247|3546525|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3706570|NCT02158247|3546523|B3||Between 18 and 65 years|Age||Participants|Count of Participants|144|144.0||||||
3706571|NCT02158247|3546524|B2||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
3706572|NCT02158247|3546525|B1||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
3706573|NCT02158247|3546523|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3706574|NCT02158247|3546524|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3706575|NCT02158247|3546525|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3706576|NCT02158091|3546541|B4|United States||Region of Enrollment||participants|Number|32|32.0||||||
3706577|NCT02158091|3546542|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3706578|NCT02158091|3546543|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3706579|NCT02158091|3546544|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3706580|NCT02158091|3546541|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3706581|NCT02158091|3546542|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3706582|NCT02158091|3546543|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706583|NCT02158091|3546544|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706584|NCT02158091|3546541|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706585|NCT02158091|3546542|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706586|NCT02158091|3546543|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706587|NCT02158091|3546544|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706588|NCT02158091|3546541|B4||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3706589|NCT02158091|3546542|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3706590|NCT02158091|3546543|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3706591|NCT02158091|3546544|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3706592|NCT02158091|3546541|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706593|NCT02158091|3546542|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706594|NCT02158091|3546543|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706595|NCT02158091|3546544|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706596|NCT02158091|3546541|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706597|NCT02158091|3546542|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706598|NCT02158091|3546543|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706599|NCT02158091|3546544|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706600|NCT02158091|3546541|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706601|NCT02158091|3546542|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706602|NCT02158091|3546543|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706603|NCT02158091|3546544|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706604|NCT02158091|3546541|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706605|NCT02158091|3546542|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706606|NCT02158091|3546543|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706607|NCT02158091|3546544|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706608|NCT02158091|3546541|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3706609|NCT02158091|3546542|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3706610|NCT02158091|3546543|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706611|NCT02158091|3546544|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706612|NCT02158091|3546541|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3706613|NCT02158091|3546542|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3706614|NCT02158091|3546543|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3706615|NCT02158091|3546544|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3706616|NCT02158091|3546541|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3706617|NCT02158091|3546542|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3706618|NCT02158091|3546543|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3706619|NCT02158091|3546544|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706620|NCT02158091|3546541|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3706621|NCT02158091|3546542|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3706622|NCT02158091|3546543|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3706623|NCT02158091|3546544|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3706624|NCT02158091|3546541|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3706625|NCT02158091|3546542|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3706626|NCT02158091|3546543|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3706627|NCT02158091|3546544|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3706628|NCT02158091|3546541|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3706629|NCT02158091|3546542|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3706630|NCT02158091|3546543|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3706631|NCT02158091|3546544|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3706632|NCT02158091|3546541|B4||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3706633|NCT02158091|3546542|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3706634|NCT02158091|3546543|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3706635|NCT02158091|3546544|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3706636|NCT02158091|3546541|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3706637|NCT02158091|3546542|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3706638|NCT02158091|3546543|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3706639|NCT02158091|3546544|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3706640|NCT02158039|3546554|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
3706641|NCT02158039|3546554|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3706642|NCT02158039|3546554|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3706643|NCT02158039|3546554|B1|||Age||years|Mean|70|70.0|Full Range|||53.0|86.0|
3706644|NCT02157948|3546559|B3|||Serum Procollagen Type 1 N-terminal Propeptide (P1NP)||μg/L|Median|59.3|59.3|Inter-Quartile Range|||45.4|75.0|
3706645|NCT02157948|3546560|B2|||Serum Procollagen Type 1 N-terminal Propeptide (P1NP)||μg/L|Median|61.5|61.5|Inter-Quartile Range|||45.1|75.6|
3706646|NCT02157948|3546561|B1|||Serum Procollagen Type 1 N-terminal Propeptide (P1NP)||μg/L|Median|56.6|56.6|Inter-Quartile Range|||45.7|73.4|
3706647|NCT02157948|3546559|B3|||Serum Type I Collagen C-telopeptide (CTX-1)||ng/mL|Median|0.452|0.452|Inter-Quartile Range|||0.295|0.618|
3706648|NCT02157948|3546560|B2|||Serum Type I Collagen C-telopeptide (CTX-1)||ng/mL|Median|0.462|0.462|Inter-Quartile Range|||0.328|0.641|
3706649|NCT02157948|3546561|B1|||Serum Type I Collagen C-telopeptide (CTX-1)||ng/mL|Median|0.433|0.433|Inter-Quartile Range|||0.268|0.61|
3706650|NCT02157948|3546559|B3|||Lumbar Spine Bone Mineral Density (BMD) Score|The T-score is the bone mineral density (BMD) at the site when compared to that of a healthy thirty-year-old. Normal is a T-score of −1.0 or higher; Osteopenia is defined as between −1.0 and −2.5; Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a thirty-year-old man/woman.|T-score|Mean|-2.75|-2.75|Standard Deviation|0.83|0.83|||
3706651|NCT02157948|3546560|B2|||Lumbar Spine Bone Mineral Density (BMD) Score|The T-score is the bone mineral density (BMD) at the site when compared to that of a healthy thirty-year-old. Normal is a T-score of −1.0 or higher; Osteopenia is defined as between −1.0 and −2.5; Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a thirty-year-old man/woman.|T-score|Mean|-2.75|-2.75|Standard Deviation|0.75|0.75|||
3706652|NCT02157948|3546561|B1|||Lumbar Spine Bone Mineral Density (BMD) Score|The T-score is the bone mineral density (BMD) at the site when compared to that of a healthy thirty-year-old. Normal is a T-score of −1.0 or higher; Osteopenia is defined as between −1.0 and −2.5; Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a thirty-year-old man/woman.|T-score|Mean|-2.75|-2.75|Standard Deviation|0.91|0.91|||
3706653|NCT02157948|3546559|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3706654|NCT02157948|3546560|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3706655|NCT02157948|3546561|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3706656|NCT02157948|3546559|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3706657|NCT02157948|3546560|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3706658|NCT02157948|3546561|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3706659|NCT02157948|3546559|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3706660|NCT02157948|3546560|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3706661|NCT02157948|3546561|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3706662|NCT02157948|3546559|B3|White||Race/Ethnicity, Customized||participants|Number|385|385.0||||||
3706663|NCT02157948|3546560|B2|White||Race/Ethnicity, Customized||participants|Number|195|195.0||||||
3706664|NCT02157948|3546561|B1|White||Race/Ethnicity, Customized||participants|Number|190|190.0||||||
3706665|NCT02157948|3546559|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3706666|NCT02157948|3546560|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3706667|NCT02157948|3546561|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3706668|NCT02157948|3546559|B3||Female|Sex: Female, Male||Participants|Count of Participants|394|394.0||||||
3706669|NCT02157948|3546560|B2||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
3706670|NCT02157948|3546561|B1||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
3706671|NCT02157948|3546559|B3|≥ 65 years||Age, Customized||participants|Number|259|259.0||||||
3706672|NCT02157948|3546560|B2|≥ 65 years||Age, Customized||participants|Number|127|127.0||||||
3706673|NCT02157948|3546561|B1|≥ 65 years||Age, Customized||participants|Number|132|132.0||||||
3706674|NCT02157948|3546559|B3|< 65 years||Age, Customized||participants|Number|135|135.0||||||
3706675|NCT02157948|3546560|B2|< 65 years||Age, Customized||participants|Number|70|70.0||||||
3706676|NCT02157948|3546561|B1|< 65 years||Age, Customized||participants|Number|65|65.0||||||
3706677|NCT02157948|3546559|B3|||Age||years|Mean|68.1|68.1|Standard Deviation|7.0|7.0|||
3706678|NCT02157948|3546560|B2|||Age||years|Mean|68.3|68.3|Standard Deviation|7.3|7.3|||
3706679|NCT02157948|3546561|B1|||Age||years|Mean|68.0|68.0|Standard Deviation|6.8|6.8|||
3706680|NCT02157935|3546572|B3|7||Number of exacerbations during 2 - 52 weeks prior to enrollment||Participants|Number|2|2.0||||||
3706681|NCT02157935|3546573|B2|7||Number of exacerbations during 2 - 52 weeks prior to enrollment||Participants|Number|0|0.0||||||
3706682|NCT02157935|3546574|B1|7||Number of exacerbations during 2 - 52 weeks prior to enrollment||Participants|Number|2|2.0||||||
3706683|NCT02157935|3546572|B3|6||Number of exacerbations during 2 - 52 weeks prior to enrollment||Participants|Number|1|1.0||||||
3706684|NCT02157935|3546573|B2|6||Number of exacerbations during 2 - 52 weeks prior to enrollment||Participants|Number|1|1.0||||||
3706685|NCT02157935|3546574|B1|6||Number of exacerbations during 2 - 52 weeks prior to enrollment||Participants|Number|0|0.0||||||
3706686|NCT02157935|3546572|B3|5||Number of exacerbations during 2 - 52 weeks prior to enrollment||Participants|Number|8|8.0||||||
3706687|NCT02157935|3546573|B2|5||Number of exacerbations during 2 - 52 weeks prior to enrollment||Participants|Number|6|6.0||||||
3706688|NCT02157935|3546574|B1|5||Number of exacerbations during 2 - 52 weeks prior to enrollment||Participants|Number|2|2.0||||||
3706689|NCT02157935|3546572|B3|4||Number of exacerbations during 2 - 52 weeks prior to enrollment||Participants|Number|20|20.0||||||
3706690|NCT02157935|3546573|B2|4||Number of exacerbations during 2 - 52 weeks prior to enrollment||Participants|Number|13|13.0||||||
3706691|NCT02157935|3546574|B1|4||Number of exacerbations during 2 - 52 weeks prior to enrollment||Participants|Number|7|7.0||||||
3706692|NCT02157935|3546572|B3|3||Number of exacerbations during 2 - 52 weeks prior to enrollment||Participants|Number|57|57.0||||||
3706693|NCT02157935|3546573|B2|3||Number of exacerbations during 2 - 52 weeks prior to enrollment||Participants|Number|28|28.0||||||
3706694|NCT02157935|3546574|B1|3||Number of exacerbations during 2 - 52 weeks prior to enrollment||Participants|Number|29|29.0||||||
3706695|NCT02157935|3546572|B3|2||Number of exacerbations during 2 - 52 weeks prior to enrollment||Participants|Number|253|253.0||||||
3706696|NCT02157935|3546573|B2|2||Number of exacerbations during 2 - 52 weeks prior to enrollment||Participants|Number|117|117.0||||||
3706697|NCT02157935|3546574|B1|2||Number of exacerbations during 2 - 52 weeks prior to enrollment||Participants|Number|136|136.0||||||
3706698|NCT02157935|3546572|B3|1||Number of exacerbations during 2 - 52 weeks prior to enrollment||Participants|Number|878|878.0||||||
3706699|NCT02157935|3546573|B2|1||Number of exacerbations during 2 - 52 weeks prior to enrollment||Participants|Number|448|448.0||||||
3706700|NCT02157935|3546574|B1|1||Number of exacerbations during 2 - 52 weeks prior to enrollment||Participants|Number|430|430.0||||||
3706701|NCT02157935|3546572|B3|>70%||FEV1 post-bronchodilator categories||Participants|Number|7|7.0||||||
3706702|NCT02157935|3546573|B2|>70%||FEV1 post-bronchodilator categories||Participants|Number|3|3.0||||||
3706703|NCT02157935|3546574|B1|>70%||FEV1 post-bronchodilator categories||Participants|Number|4|4.0||||||
3706704|NCT02157935|3546572|B3|>=50% to <=70%||FEV1 post-bronchodilator categories||Participants|Number|615|615.0||||||
3706705|NCT02157935|3546573|B2|>=50% to <=70%||FEV1 post-bronchodilator categories||Participants|Number|308|308.0||||||
3706706|NCT02157935|3546574|B1|>=50% to <=70%||FEV1 post-bronchodilator categories||Participants|Number|307|307.0||||||
3706707|NCT02157935|3546572|B3|>=30% to <50%||FEV1 post-bronchodilator categories||Participants|Number|481|481.0||||||
3706708|NCT02157935|3546573|B2|>=30% to <50%||FEV1 post-bronchodilator categories||Participants|Number|247|247.0||||||
3706709|NCT02157935|3546574|B1|>=30% to <50%||FEV1 post-bronchodilator categories||Participants|Number|234|234.0||||||
3706710|NCT02157935|3546572|B3|<30%||FEV1 post-bronchodilator categories||Participants|Number|113|113.0||||||
3706711|NCT02157935|3546573|B2|<30%||FEV1 post-bronchodilator categories||Participants|Number|54|54.0||||||
3706712|NCT02157935|3546574|B1|<30%||FEV1 post-bronchodilator categories||Participants|Number|59|59.0||||||
3706713|NCT02157935|3546572|B3||Male|Sex: Female, Male||Participants|Count of Participants|698|698.0||||||
3706714|NCT02157935|3546573|B2||Male|Sex: Female, Male||Participants|Count of Participants|343|343.0||||||
3706715|NCT02157935|3546574|B1||Male|Sex: Female, Male||Participants|Count of Participants|355|355.0||||||
3706716|NCT02157935|3546572|B3||Female|Sex: Female, Male||Participants|Count of Participants|521|521.0||||||
3706717|NCT02157935|3546573|B2||Female|Sex: Female, Male||Participants|Count of Participants|270|270.0||||||
3706718|NCT02157935|3546574|B1||Female|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
3706719|NCT02157935|3546572|B3|||Age||Years|Mean|63.5|63.5|Standard Deviation|8.67|8.67|||
3706720|NCT02157935|3546573|B2|||Age||Years|Mean|63.9|63.9|Standard Deviation|8.67|8.67|||
3706721|NCT02157935|3546574|B1|||Age||Years|Mean|63.1|63.1|Standard Deviation|8.65|8.65|||
3706722|NCT02157909|3546591|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3706723|NCT02157909|3546592|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3706724|NCT02157909|3546593|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3706725|NCT02157909|3546591|B3||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3706726|NCT02157909|3546592|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3706727|NCT02157909|3546593|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3706728|NCT02157909|3546591|B3|||Age||years|Mean|30.6|30.6|Standard Deviation|9.6|9.6|||
3706729|NCT02157909|3546592|B2|||Age||years|Mean|31.3|31.3|Standard Deviation|9.8|9.8|||
3706730|NCT02157909|3546593|B1|||Age||years|Mean|29.9|29.9|Standard Deviation|9.5|9.5|||
3706731|NCT02157883|3546601|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706732|NCT02157883|3546601|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706733|NCT02157883|3546601|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3706734|NCT02157883|3546601|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706735|NCT02157883|3546601|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706736|NCT02157883|3546601|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3706737|NCT02157883|3546601|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706738|NCT02157883|3546601|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3706739|NCT02157883|3546601|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3706740|NCT02157883|3546601|B1|||Age||years|Mean|58.8|58.8|Standard Deviation|10.73|10.73|||
3706741|NCT02157623|3546630|B3||Male|Sex: Female, Male||||0|0.0||||||
3706742|NCT02157623|3546630|B3||Female|Sex: Female, Male||||0|0.0||||||
3706743|NCT02157623|3546630|B3||>=65 years|Age||||0|0.0||||||
3706744|NCT02157623|3546631|B2||>=65 years|Age||||0|0.0||||||
3706745|NCT02157623|3546632|B1||>=65 years|Age||||0|0.0||||||
3706746|NCT02157623|3546630|B3||Between 18 and 65 years|Age||||0|0.0||||||
3706747|NCT02157623|3546631|B2||Between 18 and 65 years|Age||||0|0.0||||||
3706748|NCT02157623|3546632|B1||Between 18 and 65 years|Age||||0|0.0||||||
3706749|NCT02157623|3546630|B3||<=18 years|Age||||0|0.0||||||
3706750|NCT02157623|3546631|B2||<=18 years|Age||||0|0.0||||||
3706751|NCT02157623|3546632|B1||<=18 years|Age||||0|0.0||||||
3706752|NCT02157519|3546639|B3||Chemotherapy|Oral Therapy Type|Type of prescribed oral therapy was collected from the Electronic Health Record.|Participants|Count of Participants|60|60.0||||||
3706989|NCT02157103|3546722|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3706753|NCT02157519|3546640|B2||Chemotherapy|Oral Therapy Type|Type of prescribed oral therapy was collected from the Electronic Health Record.|Participants|Count of Participants|34|34.0||||||
3706754|NCT02157519|3546641|B1||Chemotherapy|Oral Therapy Type|Type of prescribed oral therapy was collected from the Electronic Health Record.|Participants|Count of Participants|26|26.0||||||
3706755|NCT02157519|3546639|B3||Targeted therapy|Oral Therapy Type|Type of prescribed oral therapy was collected from the Electronic Health Record.|Participants|Count of Participants|121|121.0||||||
3706756|NCT02157519|3546640|B2||Targeted therapy|Oral Therapy Type|Type of prescribed oral therapy was collected from the Electronic Health Record.|Participants|Count of Participants|56|56.0||||||
3706757|NCT02157519|3546641|B1||Targeted therapy|Oral Therapy Type|Type of prescribed oral therapy was collected from the Electronic Health Record.|Participants|Count of Participants|65|65.0||||||
3706758|NCT02157519|3546639|B3||Non-GIST Sarcoma|Cancer Type|Type of cancer was collected from the Electronic Health Record|Participants|Count of Participants|2|2.0||||||
3706759|NCT02157519|3546640|B2||Non-GIST Sarcoma|Cancer Type|Type of cancer was collected from the Electronic Health Record|Participants|Count of Participants|1|1.0||||||
3706760|NCT02157519|3546641|B1||Non-GIST Sarcoma|Cancer Type|Type of cancer was collected from the Electronic Health Record|Participants|Count of Participants|1|1.0||||||
3706761|NCT02157519|3546639|B3||Low grade Glioma|Cancer Type|Type of cancer was collected from the Electronic Health Record|Participants|Count of Participants|5|5.0||||||
3706762|NCT02157519|3546640|B2||Low grade Glioma|Cancer Type|Type of cancer was collected from the Electronic Health Record|Participants|Count of Participants|4|4.0||||||
3706763|NCT02157519|3546641|B1||Low grade Glioma|Cancer Type|Type of cancer was collected from the Electronic Health Record|Participants|Count of Participants|1|1.0||||||
3706764|NCT02157519|3546639|B3||Genito-urinary|Cancer Type|Type of cancer was collected from the Electronic Health Record|Participants|Count of Participants|7|7.0||||||
3706765|NCT02157519|3546640|B2||Genito-urinary|Cancer Type|Type of cancer was collected from the Electronic Health Record|Participants|Count of Participants|3|3.0||||||
3706766|NCT02157519|3546641|B1||Genito-urinary|Cancer Type|Type of cancer was collected from the Electronic Health Record|Participants|Count of Participants|4|4.0||||||
3706767|NCT02157519|3546639|B3||Melanoma|Cancer Type|Type of cancer was collected from the Electronic Health Record|Participants|Count of Participants|7|7.0||||||
3706768|NCT02157519|3546640|B2||Melanoma|Cancer Type|Type of cancer was collected from the Electronic Health Record|Participants|Count of Participants|3|3.0||||||
3706769|NCT02157519|3546641|B1||Melanoma|Cancer Type|Type of cancer was collected from the Electronic Health Record|Participants|Count of Participants|4|4.0||||||
3706770|NCT02157519|3546639|B3||Gastrointestinal|Cancer Type|Type of cancer was collected from the Electronic Health Record|Participants|Count of Participants|8|8.0||||||
3706771|NCT02157519|3546640|B2||Gastrointestinal|Cancer Type|Type of cancer was collected from the Electronic Health Record|Participants|Count of Participants|2|2.0||||||
3706772|NCT02157519|3546641|B1||Gastrointestinal|Cancer Type|Type of cancer was collected from the Electronic Health Record|Participants|Count of Participants|6|6.0||||||
3706773|NCT02157519|3546639|B3||Sarcoma|Cancer Type|Type of cancer was collected from the Electronic Health Record|Participants|Count of Participants|12|12.0||||||
3706774|NCT02157519|3546640|B2||Sarcoma|Cancer Type|Type of cancer was collected from the Electronic Health Record|Participants|Count of Participants|4|4.0||||||
3706775|NCT02157519|3546641|B1||Sarcoma|Cancer Type|Type of cancer was collected from the Electronic Health Record|Participants|Count of Participants|8|8.0||||||
3706776|NCT02157519|3546639|B3||High grade Glioma|Cancer Type|Type of cancer was collected from the Electronic Health Record|Participants|Count of Participants|21|21.0||||||
3706777|NCT02157519|3546640|B2||High grade Glioma|Cancer Type|Type of cancer was collected from the Electronic Health Record|Participants|Count of Participants|12|12.0||||||
3706778|NCT02157519|3546641|B1||High grade Glioma|Cancer Type|Type of cancer was collected from the Electronic Health Record|Participants|Count of Participants|9|9.0||||||
3706779|NCT02157519|3546639|B3||Breast|Cancer Type|Type of cancer was collected from the Electronic Health Record|Participants|Count of Participants|26|26.0||||||
3706780|NCT02157519|3546640|B2||Breast|Cancer Type|Type of cancer was collected from the Electronic Health Record|Participants|Count of Participants|15|15.0||||||
3706781|NCT02157519|3546641|B1||Breast|Cancer Type|Type of cancer was collected from the Electronic Health Record|Participants|Count of Participants|11|11.0||||||
3706782|NCT02157519|3546639|B3||Non-small cell lung cancer|Cancer Type|Type of cancer was collected from the Electronic Health Record|Participants|Count of Participants|33|33.0||||||
3706783|NCT02157519|3546640|B2||Non-small cell lung cancer|Cancer Type|Type of cancer was collected from the Electronic Health Record|Participants|Count of Participants|16|16.0||||||
3706784|NCT02157519|3546641|B1||Non-small cell lung cancer|Cancer Type|Type of cancer was collected from the Electronic Health Record|Participants|Count of Participants|17|17.0||||||
3706785|NCT02157519|3546639|B3||Hematologic|Cancer Type|Type of cancer was collected from the Electronic Health Record|Participants|Count of Participants|60|60.0||||||
3706786|NCT02157519|3546640|B2||Hematologic|Cancer Type|Type of cancer was collected from the Electronic Health Record|Participants|Count of Participants|30|30.0||||||
3706787|NCT02157519|3546641|B1||Hematologic|Cancer Type|Type of cancer was collected from the Electronic Health Record|Participants|Count of Participants|30|30.0||||||
3706788|NCT02157519|3546639|B3||ECOG = 2|Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status was collected from the Electronic Health Record based on oncologists' ratings.~Scoring for the ECOG is as follows, with lower scores indicating a greater performance status:~ECOG 0= Fully active, able to carry on all pre-disease performance without restriction ECOG 1= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work ECOG 2= Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|Participants|Count of Participants|5|5.0||||||
3706810|NCT02157519|3546640|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3706811|NCT02157519|3546641|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3706789|NCT02157519|3546640|B2||ECOG = 2|Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status was collected from the Electronic Health Record based on oncologists' ratings.~Scoring for the ECOG is as follows, with lower scores indicating a greater performance status:~ECOG 0= Fully active, able to carry on all pre-disease performance without restriction ECOG 1= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work ECOG 2= Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|Participants|Count of Participants|1|1.0||||||
3706790|NCT02157519|3546641|B1||ECOG = 2|Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status was collected from the Electronic Health Record based on oncologists' ratings.~Scoring for the ECOG is as follows, with lower scores indicating a greater performance status:~ECOG 0= Fully active, able to carry on all pre-disease performance without restriction ECOG 1= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work ECOG 2= Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|Participants|Count of Participants|4|4.0||||||
3706791|NCT02157519|3546639|B3||ECOG = 1|Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status was collected from the Electronic Health Record based on oncologists' ratings.~Scoring for the ECOG is as follows, with lower scores indicating a greater performance status:~ECOG 0= Fully active, able to carry on all pre-disease performance without restriction ECOG 1= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work ECOG 2= Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|Participants|Count of Participants|87|87.0||||||
3706792|NCT02157519|3546640|B2||ECOG = 1|Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status was collected from the Electronic Health Record based on oncologists' ratings.~Scoring for the ECOG is as follows, with lower scores indicating a greater performance status:~ECOG 0= Fully active, able to carry on all pre-disease performance without restriction ECOG 1= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work ECOG 2= Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|Participants|Count of Participants|40|40.0||||||
3706793|NCT02157519|3546641|B1||ECOG = 1|Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status was collected from the Electronic Health Record based on oncologists' ratings.~Scoring for the ECOG is as follows, with lower scores indicating a greater performance status:~ECOG 0= Fully active, able to carry on all pre-disease performance without restriction ECOG 1= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work ECOG 2= Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|Participants|Count of Participants|47|47.0||||||
3706794|NCT02157519|3546639|B3||ECOG = 0|Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status was collected from the Electronic Health Record based on oncologists' ratings.~Scoring for the ECOG is as follows, with lower scores indicating a greater performance status:~ECOG 0= Fully active, able to carry on all pre-disease performance without restriction ECOG 1= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work ECOG 2= Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|Participants|Count of Participants|89|89.0||||||
3706795|NCT02157519|3546640|B2||ECOG = 0|Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status was collected from the Electronic Health Record based on oncologists' ratings.~Scoring for the ECOG is as follows, with lower scores indicating a greater performance status:~ECOG 0= Fully active, able to carry on all pre-disease performance without restriction ECOG 1= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work ECOG 2= Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|Participants|Count of Participants|49|49.0||||||
3706796|NCT02157519|3546641|B1||ECOG = 0|Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status was collected from the Electronic Health Record based on oncologists' ratings.~Scoring for the ECOG is as follows, with lower scores indicating a greater performance status:~ECOG 0= Fully active, able to carry on all pre-disease performance without restriction ECOG 1= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work ECOG 2= Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|Participants|Count of Participants|40|40.0||||||
3706797|NCT02157519|3546639|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3706798|NCT02157519|3546640|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3706799|NCT02157519|3546641|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3706800|NCT02157519|3546639|B3|Multiracial||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3706801|NCT02157519|3546640|B2|Multiracial||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3706802|NCT02157519|3546641|B1|Multiracial||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3706803|NCT02157519|3546639|B3|Hispanic/Latino/a||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3706804|NCT02157519|3546640|B2|Hispanic/Latino/a||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3706805|NCT02157519|3546641|B1|Hispanic/Latino/a||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3706806|NCT02157519|3546639|B3|African American or Black||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3706807|NCT02157519|3546640|B2|African American or Black||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3706808|NCT02157519|3546641|B1|African American or Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3706809|NCT02157519|3546639|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3706812|NCT02157519|3546639|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|159|159.0||||||
3706813|NCT02157519|3546640|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|75|75.0||||||
3706814|NCT02157519|3546641|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|84|84.0||||||
3706815|NCT02157519|3546639|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3706816|NCT02157519|3546640|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3706817|NCT02157519|3546641|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3706818|NCT02157519|3546639|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|169|169.0||||||
3706819|NCT02157519|3546640|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3706820|NCT02157519|3546641|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3706821|NCT02157519|3546639|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3706822|NCT02157519|3546640|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3706823|NCT02157519|3546641|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706824|NCT02157519|3546639|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3706825|NCT02157519|3546640|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3706826|NCT02157519|3546641|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3706827|NCT02157519|3546639|B3||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3706828|NCT02157519|3546640|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3706829|NCT02157519|3546641|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3706830|NCT02157519|3546639|B3|||Age||years|Mean|53.3|53.3|Standard Deviation|12.9|12.9|||
3706831|NCT02157519|3546640|B2|||Age||years|Mean|53.8|53.8|Standard Deviation|12.1|12.1|||
3706832|NCT02157519|3546641|B1|||Age||years|Mean|52.9|52.9|Standard Deviation|13.7|13.7|||
3706833|NCT02157376|3546660|B3|Asian/Chinese||Race/Ethnicity, Customized||participants|Number|300|300.0||||||
3706834|NCT02157376|3546661|B2|Asian/Chinese||Race/Ethnicity, Customized||participants|Number|153|153.0||||||
3706835|NCT02157376|3546662|B1|Asian/Chinese||Race/Ethnicity, Customized||participants|Number|147|147.0||||||
3706836|NCT02157376|3546660|B3||Male|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
3706837|NCT02157376|3546661|B2||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3706838|NCT02157376|3546662|B1||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3706839|NCT02157376|3546660|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3706840|NCT02157376|3546661|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3706841|NCT02157376|3546662|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3706842|NCT02157376|3546660|B3|>=65 years||Age, Customized||participants|Number|37|37.0||||||
3706843|NCT02157376|3546661|B2|>=65 years||Age, Customized||participants|Number|21|21.0||||||
3706844|NCT02157376|3546662|B1|>=65 years||Age, Customized||participants|Number|16|16.0||||||
3706845|NCT02157376|3546660|B3|<65 years||Age, Customized||participants|Number|263|263.0||||||
3706846|NCT02157376|3546661|B2|<65 years||Age, Customized||participants|Number|132|132.0||||||
3706847|NCT02157376|3546662|B1|<65 years||Age, Customized||participants|Number|131|131.0||||||
3706848|NCT02157376|3546660|B3|||Age||years|Mean|50.4|50.4|Standard Deviation|12.1|12.1|||
3706849|NCT02157376|3546661|B2|||Age||years|Mean|50.1|50.1|Standard Deviation|12.4|12.4|||
3706850|NCT02157376|3546662|B1|||Age||years|Mean|50.6|50.6|Standard Deviation|11.8|11.8|||
3706851|NCT02157298|3546671|B3|No||DPP-4 Inhibitor Usage||participants|Number|101|101.0||||||
3706852|NCT02157298|3546672|B2|No||DPP-4 Inhibitor Usage||participants|Number|33|33.0||||||
3706853|NCT02157298|3546673|B1|No||DPP-4 Inhibitor Usage||participants|Number|68|68.0||||||
3706854|NCT02157298|3546671|B3|Yes||DPP-4 Inhibitor Usage||participants|Number|81|81.0||||||
3706855|NCT02157298|3546672|B2|Yes||DPP-4 Inhibitor Usage||participants|Number|27|27.0||||||
3706856|NCT02157298|3546673|B1|Yes||DPP-4 Inhibitor Usage||participants|Number|54|54.0||||||
3706857|NCT02157298|3546671|B3|||Calculated Mean Daily Insulin Dose||IU/Day|Mean|38.76|38.76|Standard Deviation|17.625|17.625|||
3706858|NCT02157298|3546672|B2|||Calculated Mean Daily Insulin Dose||IU/Day|Mean|40.58|40.58|Standard Deviation|16.764|16.764|||
3706859|NCT02157298|3546673|B1|||Calculated Mean Daily Insulin Dose||IU/Day|Mean|37.87|37.87|Standard Deviation|18.033|18.033|||
3706860|NCT02157298|3546671|B3|||Fasting Plasma Glucose||mg/dL|Mean|160.36|160.36|Standard Deviation|42.679|42.679|||
3706861|NCT02157298|3546672|B2|||Fasting Plasma Glucose||mg/dL|Mean|159.68|159.68|Standard Deviation|38.001|38.001|||
3706862|NCT02157298|3546673|B1|||Fasting Plasma Glucose||mg/dL|Mean|160.70|160.7|Standard Deviation|44.948|44.948|||
3706863|NCT02157298|3546671|B3|||HbA1c||percent of hemoglobin glycosylated|Mean|8.34|8.34|Standard Deviation|0.849|0.849|||
3706864|NCT02157298|3546672|B2|||HbA1c||percent of hemoglobin glycosylated|Mean|8.52|8.52|Standard Deviation|0.937|0.937|||
3706865|NCT02157298|3546673|B1|||HbA1c||percent of hemoglobin glycosylated|Mean|8.26|8.26|Standard Deviation|0.792|0.792|||
3706866|NCT02157298|3546671|B3|||Waist Circumference||cm|Mean|92.9|92.9|Standard Deviation|10.96|10.96|||
3706867|NCT02157298|3546672|B2|||Waist Circumference||cm|Mean|92.3|92.3|Standard Deviation|9.00|9.0|||
3706868|NCT02157298|3546673|B1|||Waist Circumference||cm|Mean|93.2|93.2|Standard Deviation|11.83|11.83|||
3706869|NCT02157298|3546671|B3|||Body Mass Index||kg/m^2|Mean|26.64|26.64|Standard Deviation|4.510|4.51|||
3706870|NCT02157298|3546672|B2|||Body Mass Index||kg/m^2|Mean|26.12|26.12|Standard Deviation|3.485|3.485|||
3706871|NCT02157298|3546673|B1|||Body Mass Index||kg/m^2|Mean|26.89|26.89|Standard Deviation|4.930|4.93|||
3706872|NCT02157298|3546671|B3|||Body Weight||kg|Mean|73.24|73.24|Standard Deviation|14.956|14.956|||
3706873|NCT02157298|3546672|B2|||Body Weight||kg|Mean|71.89|71.89|Standard Deviation|13.430|13.43|||
3706874|NCT02157298|3546673|B1|||Body Weight||kg|Mean|73.90|73.9|Standard Deviation|15.663|15.663|||
3706875|NCT02157298|3546671|B3|Japan||Region of Enrollment||participants|Number|182|182.0||||||
3706876|NCT02157298|3546672|B2|Japan||Region of Enrollment||participants|Number|60|60.0||||||
3706877|NCT02157298|3546673|B1|Japan||Region of Enrollment||participants|Number|122|122.0||||||
3706878|NCT02157298|3546671|B3||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3706879|NCT02157298|3546672|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3706880|NCT02157298|3546673|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3706881|NCT02157298|3546671|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3706882|NCT02157298|3546672|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3706883|NCT02157298|3546673|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3706884|NCT02157298|3546671|B3|>=75 years||Age, Customized||participants|Number|2|2.0||||||
3706885|NCT02157298|3546672|B2|>=75 years||Age, Customized||participants|Number|1|1.0||||||
3706886|NCT02157298|3546673|B1|>=75 years||Age, Customized||participants|Number|1|1.0||||||
3706887|NCT02157298|3546671|B3|Between 65 and 75 years||Age, Customized||participants|Number|53|53.0||||||
3706888|NCT02157298|3546672|B2|Between 65 and 75 years||Age, Customized||participants|Number|16|16.0||||||
3706889|NCT02157298|3546673|B1|Between 65 and 75 years||Age, Customized||participants|Number|37|37.0||||||
3706890|NCT02157298|3546671|B3|<=65 years||Age, Customized||participants|Number|127|127.0||||||
3706891|NCT02157298|3546672|B2|<=65 years||Age, Customized||participants|Number|43|43.0||||||
3706892|NCT02157298|3546673|B1|<=65 years||Age, Customized||participants|Number|84|84.0||||||
3706893|NCT02157298|3546671|B3|||Age||years|Mean|58.0|58.0|Standard Deviation|9.82|9.82|||
3706894|NCT02157298|3546672|B2|||Age||years|Mean|57.6|57.6|Standard Deviation|9.86|9.86|||
3706895|NCT02157298|3546673|B1|||Age||years|Mean|58.3|58.3|Standard Deviation|9.83|9.83|||
3706896|NCT02157168|3546688|B4|United States||Region of Enrollment||participants|Number|2267|2267.0||||||
3706897|NCT02157168|3546689|B3|United States||Region of Enrollment||participants|Number|1362|1362.0||||||
3706898|NCT02157168|3546690|B2|United States||Region of Enrollment||participants|Number|159|159.0||||||
3706899|NCT02157168|3546691|B1|United States||Region of Enrollment||participants|Number|746|746.0||||||
3706900|NCT02157168|3546688|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|327|327.0||||||
3706901|NCT02157168|3546689|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|195|195.0||||||
3706902|NCT02157168|3546690|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3706903|NCT02157168|3546691|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
3706904|NCT02157168|3546688|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3706905|NCT02157168|3546689|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706906|NCT02157168|3546690|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706907|NCT02157168|3546691|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3706908|NCT02157168|3546688|B4||White|Race (NIH/OMB)||Participants|Count of Participants|1606|1606.0||||||
3706909|NCT02157168|3546689|B3||White|Race (NIH/OMB)||Participants|Count of Participants|961|961.0||||||
3706910|NCT02157168|3546690|B2||White|Race (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
3706911|NCT02157168|3546691|B1||White|Race (NIH/OMB)||Participants|Count of Participants|523|523.0||||||
3706912|NCT02157168|3546688|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|193|193.0||||||
3706913|NCT02157168|3546689|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
3706914|NCT02157168|3546690|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3706915|NCT02157168|3546691|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3706916|NCT02157168|3546688|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706917|NCT02157168|3546689|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706918|NCT02157168|3546690|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706919|NCT02157168|3546691|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706920|NCT02157168|3546688|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3706921|NCT02157168|3546689|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3706922|NCT02157168|3546690|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706923|NCT02157168|3546691|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3706924|NCT02157168|3546688|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
3706925|NCT02157168|3546689|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3706926|NCT02157168|3546690|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3706927|NCT02157168|3546691|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3706928|NCT02157168|3546688|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|327|327.0||||||
3706929|NCT02157168|3546689|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|195|195.0||||||
3706930|NCT02157168|3546690|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3706931|NCT02157168|3546691|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
3706932|NCT02157168|3546688|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1221|1221.0||||||
3706933|NCT02157168|3546689|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|736|736.0||||||
3706934|NCT02157168|3546690|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3706935|NCT02157168|3546691|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|423|423.0||||||
3706936|NCT02157168|3546688|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|719|719.0||||||
3706937|NCT02157168|3546689|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|431|431.0||||||
3706938|NCT02157168|3546690|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3706939|NCT02157168|3546691|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|218|218.0||||||
3706940|NCT02157168|3546688|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3706941|NCT02157168|3546689|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3706942|NCT02157168|3546690|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3706943|NCT02157168|3546691|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3706944|NCT02157168|3546688|B4||Female|Sex: Female, Male||Participants|Count of Participants|2267|2267.0||||||
3706945|NCT02157168|3546689|B3||Female|Sex: Female, Male||Participants|Count of Participants|1362|1362.0||||||
3706946|NCT02157168|3546690|B2||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
3706947|NCT02157168|3546691|B1||Female|Sex: Female, Male||Participants|Count of Participants|746|746.0||||||
3706948|NCT02157168|3546688|B4|||Age||years|Mean|27.2|27.2|Standard Deviation|6.1|6.1|||
3706949|NCT02157168|3546689|B3|||Age||years|Mean|27.0|27.0|Standard Deviation|6.1|6.1|||
3706950|NCT02157168|3546690|B2|||Age||years|Mean|28.5|28.5|Standard Deviation|5.9|5.9|||
3706951|NCT02157168|3546691|B1|||Age||years|Mean|27.2|27.2|Standard Deviation|6.0|6.0|||
3706952|NCT02157168|3546688|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3706953|NCT02157168|3546689|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3706954|NCT02157168|3546690|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3706955|NCT02157168|3546691|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3706956|NCT02157168|3546688|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2267|2267.0||||||
3706957|NCT02157168|3546689|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1362|1362.0||||||
3706958|NCT02157168|3546690|B2||Between 18 and 65 years|Age||Participants|Count of Participants|159|159.0||||||
3706959|NCT02157168|3546691|B1||Between 18 and 65 years|Age||Participants|Count of Participants|746|746.0||||||
3706960|NCT02157168|3546688|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3706961|NCT02157168|3546689|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3706962|NCT02157168|3546690|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3706963|NCT02157168|3546691|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3706964|NCT02157116|3546713|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3706965|NCT02157116|3546713|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706966|NCT02157116|3546713|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706967|NCT02157116|3546713|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3706968|NCT02157116|3546713|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3706969|NCT02157116|3546713|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706970|NCT02157116|3546713|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706971|NCT02157116|3546713|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706972|NCT02157116|3546713|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3706973|NCT02157116|3546713|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3706974|NCT02157116|3546713|B1|>= 18 years||Age, Customized||years|Number|13|13.0||||||
3706975|NCT02157116|3546713|B1|<18 years||Age, Customized||years|Number|0|0.0||||||
3706976|NCT02157103|3546722|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3706977|NCT02157103|3546722|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706978|NCT02157103|3546722|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706979|NCT02157103|3546722|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3706980|NCT02157103|3546722|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706981|NCT02157103|3546722|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706982|NCT02157103|3546722|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706983|NCT02157103|3546722|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706984|NCT02157103|3546722|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706985|NCT02157103|3546722|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3706986|NCT02157103|3546722|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706987|NCT02157103|3546722|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3706988|NCT02157103|3546722|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3706990|NCT02157103|3546722|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3706991|NCT02157103|3546722|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3706992|NCT02156492|3546728|B4|China||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
3706993|NCT02156492|3546729|B3|China||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3706994|NCT02156492|3546730|B2|China||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3706995|NCT02156492|3546731|B1|China||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3706996|NCT02156492|3546728|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706997|NCT02156492|3546729|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706998|NCT02156492|3546730|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3706999|NCT02156492|3546731|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707000|NCT02156492|3546728|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707001|NCT02156492|3546729|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707002|NCT02156492|3546730|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707003|NCT02156492|3546731|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707004|NCT02156492|3546728|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707005|NCT02156492|3546729|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707006|NCT02156492|3546730|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707007|NCT02156492|3546731|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707008|NCT02156492|3546728|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707009|NCT02156492|3546729|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707010|NCT02156492|3546730|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707011|NCT02156492|3546731|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707012|NCT02156492|3546728|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707013|NCT02156492|3546729|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707014|NCT02156492|3546730|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707015|NCT02156492|3546731|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707016|NCT02156492|3546728|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3707017|NCT02156492|3546729|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3707018|NCT02156492|3546730|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3707019|NCT02156492|3546731|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3707020|NCT02156492|3546728|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707021|NCT02156492|3546729|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707022|NCT02156492|3546730|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707023|NCT02156492|3546731|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707024|NCT02156492|3546728|B4||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3707025|NCT02156492|3546729|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3707026|NCT02156492|3546730|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3707027|NCT02156492|3546731|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3707028|NCT02156492|3546728|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3707029|NCT02156492|3546729|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3707030|NCT02156492|3546730|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3707031|NCT02156492|3546731|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3707032|NCT02156492|3546728|B4|||Age||years|Mean|28.02|28.02|Standard Deviation|5.25|5.25|||
3707033|NCT02156492|3546729|B3|||Age||years|Mean|27.9|27.9|Standard Deviation|4.9|4.9|||
3707034|NCT02156492|3546730|B2|||Age||years|Mean|27.5|27.5|Standard Deviation|2.9|2.9|||
3707035|NCT02156492|3546731|B1|||Age||years|Mean|29.1|29.1|Standard Deviation|8.0|8.0|||
3707036|NCT02156466|3546754|B6||Male|Gender||Participants|Count of Participants|35|35.0||||||
3707037|NCT02156466|3546755|B5||Male|Gender||Participants|Count of Participants|6|6.0||||||
3707038|NCT02156466|3546756|B4||Male|Gender||Participants|Count of Participants|8|8.0||||||
3707039|NCT02156466|3546757|B3||Male|Gender||Participants|Count of Participants|6|6.0||||||
3707040|NCT02156466|3546758|B2||Male|Gender||Participants|Count of Participants|8|8.0||||||
3707041|NCT02156466|3546759|B1||Male|Gender||Participants|Count of Participants|7|7.0||||||
3707042|NCT02156466|3546754|B6||Female|Gender||Participants|Count of Participants|6|6.0||||||
3707043|NCT02156466|3546755|B5||Female|Gender||Participants|Count of Participants|2|2.0||||||
3707044|NCT02156466|3546756|B4||Female|Gender||Participants|Count of Participants|1|1.0||||||
3707045|NCT02156466|3546757|B3||Female|Gender||Participants|Count of Participants|2|2.0||||||
3707046|NCT02156466|3546758|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
3707047|NCT02156466|3546759|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
3707048|NCT02156466|3546754|B6|||Age||years|Mean|45.1|45.1|Standard Deviation|14.87|14.87|||
3707049|NCT02156466|3546755|B5|||Age||years|Mean|46.1|46.1|Standard Deviation|14.57|14.57|||
3707050|NCT02156466|3546756|B4|||Age||years|Mean|44.8|44.8|Standard Deviation|15.65|15.65|||
3707051|NCT02156466|3546757|B3|||Age||years|Mean|43.8|43.8|Standard Deviation|13.59|13.59|||
3707052|NCT02156466|3546758|B2|||Age||years|Mean|42.1|42.1|Standard Deviation|19.57|19.57|||
3707053|NCT02156466|3546759|B1|||Age||years|Mean|48.6|48.6|Standard Deviation|13.24|13.24|||
3707054|NCT02156271|3546942|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
3707055|NCT02156271|3546943|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3707056|NCT02156271|3546944|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
3707057|NCT02156271|3546942|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3707058|NCT02156271|3546943|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3707059|NCT02156271|3546944|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3707060|NCT02156271|3546942|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3707061|NCT02156271|3546943|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3707062|NCT02156271|3546944|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3707063|NCT02156271|3546942|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3707064|NCT02156271|3546943|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3707065|NCT02156271|3546944|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3707066|NCT02156271|3546942|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3707067|NCT02156271|3546943|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3707068|NCT02156271|3546944|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3707069|NCT02156271|3546942|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3707070|NCT02156271|3546943|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3707071|NCT02156271|3546944|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3707072|NCT02156167|3546977|B1|Germany||Region of Enrollment||participants|Number|15|15.0||||||
3707073|NCT02156167|3546977|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3707074|NCT02156167|3546977|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3707075|NCT02156167|3546977|B1|||Age||years|Mean|66|66.0|Full Range|||53.0|77.0|
3707076|NCT02156167|3546977|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3707077|NCT02156167|3546977|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3707078|NCT02156167|3546977|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3707079|NCT02155985|3546981|B4|||Hemoglobin, Continuous||g/dL|Median|14.2|14.2|Inter-Quartile Range|||13.4|15.1|
3707080|NCT02155985|3546982|B3|||Hemoglobin, Continuous||g/dL|Median|14.2|14.2|Inter-Quartile Range|||13.4|15.4|
3707081|NCT02155985|3546983|B2|||Hemoglobin, Continuous||g/dL|Median|14.1|14.1|Inter-Quartile Range|||13.6|15.0|
3707082|NCT02155985|3546984|B1|||Hemoglobin, Continuous||g/dL|Median|14.2|14.2|Inter-Quartile Range|||13.4|15.0|
3707083|NCT02155985|3546981|B4|||Platelets, Continuous||10^9/L|Median|226|226.0|Inter-Quartile Range|||192.0|261.0|
3707084|NCT02155985|3546982|B3|||Platelets, Continuous||10^9/L|Median|224.5|224.5|Inter-Quartile Range|||184.0|258.5|
3707085|NCT02155985|3546983|B2|||Platelets, Continuous||10^9/L|Median|229|229.0|Inter-Quartile Range|||200.0|271.0|
3707086|NCT02155985|3546984|B1|||Platelets, Continuous||10^9/L|Median|222.5|222.5|Inter-Quartile Range|||192.0|251.0|
3707087|NCT02155985|3546981|B4|162 copies/mL||HIV-1 RNA, Categorical||participants|Number|1|1.0||||||
3707088|NCT02155985|3546982|B3|162 copies/mL||HIV-1 RNA, Categorical||participants|Number|0|0.0||||||
3707089|NCT02155985|3546983|B2|162 copies/mL||HIV-1 RNA, Categorical||participants|Number|1|1.0||||||
3707090|NCT02155985|3546984|B1|162 copies/mL||HIV-1 RNA, Categorical||participants|Number|0|0.0||||||
3707091|NCT02155985|3546981|B4|45 copies/mL||HIV-1 RNA, Categorical||participants|Number|1|1.0||||||
3707092|NCT02155985|3546982|B3|45 copies/mL||HIV-1 RNA, Categorical||participants|Number|0|0.0||||||
3707093|NCT02155985|3546983|B2|45 copies/mL||HIV-1 RNA, Categorical||participants|Number|1|1.0||||||
3707094|NCT02155985|3546984|B1|45 copies/mL||HIV-1 RNA, Categorical||participants|Number|0|0.0||||||
3707095|NCT02155985|3546981|B4|41 copies/mL||HIV-1 RNA, Categorical||participants|Number|1|1.0||||||
3707096|NCT02155985|3546982|B3|41 copies/mL||HIV-1 RNA, Categorical||participants|Number|0|0.0||||||
3707097|NCT02155985|3546983|B2|41 copies/mL||HIV-1 RNA, Categorical||participants|Number|1|1.0||||||
3707098|NCT02155985|3546984|B1|41 copies/mL||HIV-1 RNA, Categorical||participants|Number|0|0.0||||||
3707099|NCT02155985|3546981|B4|<40 copies/mL||HIV-1 RNA, Categorical||participants|Number|118|118.0||||||
3707100|NCT02155985|3546982|B3|<40 copies/mL||HIV-1 RNA, Categorical||participants|Number|40|40.0||||||
3707101|NCT02155985|3546983|B2|<40 copies/mL||HIV-1 RNA, Categorical||participants|Number|38|38.0||||||
3707102|NCT02155985|3546984|B1|<40 copies/mL||HIV-1 RNA, Categorical||participants|Number|40|40.0||||||
3707103|NCT02155985|3546981|B4|||CD4 Count, Continuous||cells/mm^3|Median|599|599.0|Inter-Quartile Range|||456.0|777.0|
3707104|NCT02155985|3546982|B3|||CD4 Count, Continuous||cells/mm^3|Median|642|642.0|Inter-Quartile Range|||436.0|747.0|
3707105|NCT02155985|3546983|B2|||CD4 Count, Continuous||cells/mm^3|Median|629|629.0|Inter-Quartile Range|||481.0|856.0|
3707106|NCT02155985|3546984|B1|||CD4 Count, Continuous||cells/mm^3|Median|573|573.0|Inter-Quartile Range|||436.0|684.0|
3707107|NCT02155985|3546981|B4|||BMI, Continuous||kg/m^2|Median|26.0|26.0|Inter-Quartile Range|||23.4|29.2|
3707108|NCT02155985|3546982|B3|||BMI, Continuous||kg/m^2|Median|27.3|27.3|Inter-Quartile Range|||23.7|30.1|
3707109|NCT02155985|3546983|B2|||BMI, Continuous||kg/m^2|Median|25.8|25.8|Inter-Quartile Range|||22.8|30.2|
3707110|NCT02155985|3546984|B1|||BMI, Continuous||kg/m^2|Median|25.9|25.9|Inter-Quartile Range|||23.5|28.1|
3707111|NCT02155985|3546981|B4|Rosuvastatin||Statin Use||participants|Number|2|2.0||||||
3707112|NCT02155985|3546982|B3|Rosuvastatin||Statin Use||participants|Number|0|0.0||||||
3707113|NCT02155985|3546983|B2|Rosuvastatin||Statin Use||participants|Number|1|1.0||||||
3707114|NCT02155985|3546984|B1|Rosuvastatin||Statin Use||participants|Number|1|1.0||||||
3707115|NCT02155985|3546981|B4|Atorvastatin||Statin Use||participants|Number|11|11.0||||||
3707116|NCT02155985|3546982|B3|Atorvastatin||Statin Use||participants|Number|3|3.0||||||
3707117|NCT02155985|3546983|B2|Atorvastatin||Statin Use||participants|Number|5|5.0||||||
3707118|NCT02155985|3546984|B1|Atorvastatin||Statin Use||participants|Number|3|3.0||||||
3707119|NCT02155985|3546981|B4|Pravastatin||Statin Use||participants|Number|6|6.0||||||
3707120|NCT02155985|3546982|B3|Pravastatin||Statin Use||participants|Number|3|3.0||||||
3707121|NCT02155985|3546983|B2|Pravastatin||Statin Use||participants|Number|0|0.0||||||
3707122|NCT02155985|3546984|B1|Pravastatin||Statin Use||participants|Number|3|3.0||||||
3707123|NCT02155985|3546981|B4|Off Statins||Statin Use||participants|Number|102|102.0||||||
3707124|NCT02155985|3546982|B3|Off Statins||Statin Use||participants|Number|34|34.0||||||
3707125|NCT02155985|3546983|B2|Off Statins||Statin Use||participants|Number|35|35.0||||||
3707126|NCT02155985|3546984|B1|Off Statins||Statin Use||participants|Number|33|33.0||||||
3707127|NCT02155985|3546981|B4|Currently||Smoking Status||participants|Number|27|27.0||||||
3707128|NCT02155985|3546982|B3|Currently||Smoking Status||participants|Number|8|8.0||||||
3707129|NCT02155985|3546983|B2|Currently||Smoking Status||participants|Number|9|9.0||||||
3707130|NCT02155985|3546984|B1|Currently||Smoking Status||participants|Number|10|10.0||||||
3707131|NCT02155985|3546981|B4|Previously||Smoking Status||participants|Number|24|24.0||||||
3707132|NCT02155985|3546982|B3|Previously||Smoking Status||participants|Number|6|6.0||||||
3707133|NCT02155985|3546983|B2|Previously||Smoking Status||participants|Number|7|7.0||||||
3707134|NCT02155985|3546984|B1|Previously||Smoking Status||participants|Number|11|11.0||||||
3707135|NCT02155985|3546981|B4|Never||Smoking Status||participants|Number|70|70.0||||||
3707136|NCT02155985|3546982|B3|Never||Smoking Status||participants|Number|26|26.0||||||
3707137|NCT02155985|3546983|B2|Never||Smoking Status||participants|Number|25|25.0||||||
3707138|NCT02155985|3546984|B1|Never||Smoking Status||participants|Number|19|19.0||||||
3707139|NCT02155985|3546981|B4|United States||Region of Enrollment||participants|Number|121|121.0||||||
3707140|NCT02155985|3546982|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3707141|NCT02155985|3546983|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
3707142|NCT02155985|3546984|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3707143|NCT02155985|3546981|B4|Asian, Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3707144|NCT02155985|3546982|B3|Asian, Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3707145|NCT02155985|3546983|B2|Asian, Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3707146|NCT02155985|3546984|B1|Asian, Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3707147|NCT02155985|3546981|B4|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3707148|NCT02155985|3546982|B3|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3707149|NCT02155985|3546983|B2|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3707150|NCT02155985|3546984|B1|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3707151|NCT02155985|3546981|B4|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
3707152|NCT02155985|3546982|B3|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3707153|NCT02155985|3546983|B2|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3707154|NCT02155985|3546984|B1|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3707155|NCT02155985|3546981|B4|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
3707156|NCT02155985|3546982|B3|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3707157|NCT02155985|3546983|B2|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3707158|NCT02155985|3546984|B1|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3707159|NCT02155985|3546981|B4||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3707160|NCT02155985|3546982|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3707161|NCT02155985|3546983|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3707162|NCT02155985|3546984|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3707163|NCT02155985|3546981|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3707164|NCT02155985|3546982|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3707165|NCT02155985|3546983|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3707166|NCT02155985|3546984|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3707167|NCT02155985|3546981|B4|70 - 79 years||Age, Customized||participants|Number|2|2.0||||||
3707168|NCT02155985|3546982|B3|70 - 79 years||Age, Customized||participants|Number|1|1.0||||||
3707169|NCT02155985|3546983|B2|70 - 79 years||Age, Customized||participants|Number|1|1.0||||||
3707170|NCT02155985|3546984|B1|70 - 79 years||Age, Customized||participants|Number|0|0.0||||||
3707171|NCT02155985|3546981|B4|60 - 69 years||Age, Customized||participants|Number|12|12.0||||||
3707172|NCT02155985|3546982|B3|60 - 69 years||Age, Customized||participants|Number|5|5.0||||||
3707173|NCT02155985|3546983|B2|60 - 69 years||Age, Customized||participants|Number|4|4.0||||||
3707174|NCT02155985|3546984|B1|60 - 69 years||Age, Customized||participants|Number|3|3.0||||||
3707175|NCT02155985|3546981|B4|50 - 59 years||Age, Customized||participants|Number|46|46.0||||||
3707176|NCT02155985|3546982|B3|50 - 59 years||Age, Customized||participants|Number|13|13.0||||||
3707177|NCT02155985|3546983|B2|50 - 59 years||Age, Customized||participants|Number|18|18.0||||||
3707178|NCT02155985|3546984|B1|50 - 59 years||Age, Customized||participants|Number|15|15.0||||||
3707179|NCT02155985|3546981|B4|40 - 49 years||Age, Customized||participants|Number|35|35.0||||||
3707180|NCT02155985|3546982|B3|40 - 49 years||Age, Customized||participants|Number|13|13.0||||||
3707181|NCT02155985|3546983|B2|40 - 49 years||Age, Customized||participants|Number|12|12.0||||||
3707182|NCT02155985|3546984|B1|40 - 49 years||Age, Customized||participants|Number|10|10.0||||||
3707183|NCT02155985|3546981|B4|30 - 39 years||Age, Customized||participants|Number|19|19.0||||||
3707184|NCT02155985|3546982|B3|30 - 39 years||Age, Customized||participants|Number|7|7.0||||||
3707185|NCT02155985|3546983|B2|30 - 39 years||Age, Customized||participants|Number|5|5.0||||||
3707186|NCT02155985|3546984|B1|30 - 39 years||Age, Customized||participants|Number|7|7.0||||||
3707187|NCT02155985|3546981|B4|20 - 29 years||Age, Customized||participants|Number|7|7.0||||||
3707188|NCT02155985|3546982|B3|20 - 29 years||Age, Customized||participants|Number|1|1.0||||||
3707189|NCT02155985|3546983|B2|20 - 29 years||Age, Customized||participants|Number|1|1.0||||||
3707190|NCT02155985|3546984|B1|20 - 29 years||Age, Customized||participants|Number|5|5.0||||||
3707191|NCT02155985|3546981|B4|||Age||years|Median|49|49.0|Inter-Quartile Range|||42.0|55.0|
3707192|NCT02155985|3546982|B3|||Age||years|Median|49|49.0|Inter-Quartile Range|||42.0|57.0|
3707193|NCT02155985|3546983|B2|||Age||years|Median|50|50.0|Inter-Quartile Range|||46.0|56.0|
3707194|NCT02155985|3546984|B1|||Age||years|Median|48|48.0|Inter-Quartile Range|||38.0|54.0|
3707195|NCT02155881|3547051|B3|||Height||centimeter (cm)|Mean|168.95|168.95|Standard Deviation|9.16|9.16|||
3707196|NCT02155881|3547052|B2|||Height||centimeter (cm)|Mean|171.45|171.45|Standard Deviation|7.45|7.45|||
3707197|NCT02155881|3547053|B1|||Height||centimeter (cm)|Mean|166.45|166.45|Standard Deviation|10.87|10.87|||
3707198|NCT02155881|3547051|B3|||Weight||kilogram (kg)|Mean|71.27|71.27|Standard Deviation|16.75|16.75|||
3707199|NCT02155881|3547052|B2|||Weight||kilogram (kg)|Mean|72.51|72.51|Standard Deviation|16.81|16.81|||
3707200|NCT02155881|3547053|B1|||Weight||kilogram (kg)|Mean|70.03|70.03|Standard Deviation|16.69|16.69|||
3707201|NCT02155881|3547051|B3|Had Never Smoked||Smoking Status||participants|Number|71|71.0||||||
3707202|NCT02155881|3547052|B2|Had Never Smoked||Smoking Status||participants|Number|34|34.0||||||
3707203|NCT02155881|3547053|B1|Had Never Smoked||Smoking Status||participants|Number|37|37.0||||||
3707204|NCT02155881|3547051|B3|Ex-Smoker||Smoking Status||participants|Number|6|6.0||||||
3707205|NCT02155881|3547052|B2|Ex-Smoker||Smoking Status||participants|Number|5|5.0||||||
3707206|NCT02155881|3547053|B1|Ex-Smoker||Smoking Status||participants|Number|1|1.0||||||
3707207|NCT02155881|3547051|B3|Current Smoker||Smoking Status||participants|Number|3|3.0||||||
3707208|NCT02155881|3547052|B2|Current Smoker||Smoking Status||participants|Number|1|1.0||||||
3707209|NCT02155881|3547053|B1|Current Smoker||Smoking Status||participants|Number|2|2.0||||||
3707210|NCT02155881|3547051|B3|Russia||Region of Enrollment||participants|Number|80|80.0||||||
3707211|NCT02155881|3547052|B2|Russia||Region of Enrollment||participants|Number|40|40.0||||||
3707212|NCT02155881|3547053|B1|Russia||Region of Enrollment||participants|Number|40|40.0||||||
3707213|NCT02155881|3547051|B3|White||Race/Ethnicity, Customized||participants|Number|80|80.0||||||
3707214|NCT02155881|3547052|B2|White||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
3707215|NCT02155881|3547053|B1|White||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
3707216|NCT02155881|3547051|B3||Male|Gender||Participants|Count of Participants|35|35.0||||||
3707217|NCT02155881|3547052|B2||Male|Gender||Participants|Count of Participants|23|23.0||||||
3707218|NCT02155881|3547053|B1||Male|Gender||Participants|Count of Participants|12|12.0||||||
3707219|NCT02155881|3547051|B3||Female|Gender||Participants|Count of Participants|45|45.0||||||
3707220|NCT02155881|3547052|B2||Female|Gender||Participants|Count of Participants|17|17.0||||||
3707221|NCT02155881|3547053|B1||Female|Gender||Participants|Count of Participants|28|28.0||||||
3707222|NCT02155881|3547051|B3|||Age||years|Mean|39.76|39.76|Standard Deviation|12.55|12.55|||
3707223|NCT02155881|3547052|B2|||Age||years|Mean|38.55|38.55|Standard Deviation|11.94|11.94|||
3707224|NCT02155881|3547053|B1|||Age||years|Mean|40.98|40.98|Standard Deviation|13.16|13.16|||
3707225|NCT02155738|3547074|B5|||Baseline VAS Pain Score|VAS or Visual Analog Score is a quantitative measure, in this study, of pain that the subject is currently experiencing. The VAS is presented as a straight line which measures 100mm. The subject is instructed to mark an 'X' through this line reflecting the amount of pain that they are currently experiencing. Zero would indicate no pain, while '100' would indicate the most severe pain ever. Thus the total range for this scale would be 0-100 mm. Higher values indicate more pain; lower value indicate less pain.|units on a scale|Mean|5.75|5.75|Standard Deviation|13.45|13.45|||
3707226|NCT02155738|3547075|B4|||Baseline VAS Pain Score|VAS or Visual Analog Score is a quantitative measure, in this study, of pain that the subject is currently experiencing. The VAS is presented as a straight line which measures 100mm. The subject is instructed to mark an 'X' through this line reflecting the amount of pain that they are currently experiencing. Zero would indicate no pain, while '100' would indicate the most severe pain ever. Thus the total range for this scale would be 0-100 mm. Higher values indicate more pain; lower value indicate less pain.|units on a scale|Mean|6.91|6.91|Standard Deviation|12.75|12.75|||
3707242|NCT02155738|3547076|B3||Stage III|Baseline POPQ Stage|POP-Q Stage is the Pelvic Organ Prolapse Quantification Stage. This is a whole number which refers to the extend of the prolapse, and how far past the hymen it extends. POP-Q Stage is a whole number between 1 and 4. Stage 1 is prolapse which is fully contained within the vagina and above the hymen. Stage 4 is prolapse which extends at least 3 cm beyond the hymen.|Participants|Count of Participants|42|42.0||||||
3707227|NCT02155738|3547076|B3|||Baseline VAS Pain Score|VAS or Visual Analog Score is a quantitative measure, in this study, of pain that the subject is currently experiencing. The VAS is presented as a straight line which measures 100mm. The subject is instructed to mark an 'X' through this line reflecting the amount of pain that they are currently experiencing. Zero would indicate no pain, while '100' would indicate the most severe pain ever. Thus the total range for this scale would be 0-100 mm. Higher values indicate more pain; lower value indicate less pain.|units on a scale|Mean|5.57|5.57|Standard Deviation|15.60|15.6|||
3707228|NCT02155738|3547077|B2|||Baseline VAS Pain Score|VAS or Visual Analog Score is a quantitative measure, in this study, of pain that the subject is currently experiencing. The VAS is presented as a straight line which measures 100mm. The subject is instructed to mark an 'X' through this line reflecting the amount of pain that they are currently experiencing. Zero would indicate no pain, while '100' would indicate the most severe pain ever. Thus the total range for this scale would be 0-100 mm. Higher values indicate more pain; lower value indicate less pain.|units on a scale|Mean|3.41|3.41|Standard Deviation|8.71|8.71|||
3707229|NCT02155738|3547078|B1|||Baseline VAS Pain Score|VAS or Visual Analog Score is a quantitative measure, in this study, of pain that the subject is currently experiencing. The VAS is presented as a straight line which measures 100mm. The subject is instructed to mark an 'X' through this line reflecting the amount of pain that they are currently experiencing. Zero would indicate no pain, while '100' would indicate the most severe pain ever. Thus the total range for this scale would be 0-100 mm. Higher values indicate more pain; lower value indicate less pain.|units on a scale|Mean|7.32|7.32|Standard Deviation|15.73|15.73|||
3707230|NCT02155738|3547074|B5||Missing|Baseline POPQ Stage|POP-Q Stage is the Pelvic Organ Prolapse Quantification Stage. This is a whole number which refers to the extend of the prolapse, and how far past the hymen it extends. POP-Q Stage is a whole number between 1 and 4. Stage 1 is prolapse which is fully contained within the vagina and above the hymen. Stage 4 is prolapse which extends at least 3 cm beyond the hymen.|Participants|Count of Participants|2|2.0||||||
3707231|NCT02155738|3547075|B4||Missing|Baseline POPQ Stage|POP-Q Stage is the Pelvic Organ Prolapse Quantification Stage. This is a whole number which refers to the extend of the prolapse, and how far past the hymen it extends. POP-Q Stage is a whole number between 1 and 4. Stage 1 is prolapse which is fully contained within the vagina and above the hymen. Stage 4 is prolapse which extends at least 3 cm beyond the hymen.|Participants|Count of Participants|0|0.0||||||
3707232|NCT02155738|3547076|B3||Missing|Baseline POPQ Stage|POP-Q Stage is the Pelvic Organ Prolapse Quantification Stage. This is a whole number which refers to the extend of the prolapse, and how far past the hymen it extends. POP-Q Stage is a whole number between 1 and 4. Stage 1 is prolapse which is fully contained within the vagina and above the hymen. Stage 4 is prolapse which extends at least 3 cm beyond the hymen.|Participants|Count of Participants|0|0.0||||||
3707233|NCT02155738|3547077|B2||Missing|Baseline POPQ Stage|POP-Q Stage is the Pelvic Organ Prolapse Quantification Stage. This is a whole number which refers to the extend of the prolapse, and how far past the hymen it extends. POP-Q Stage is a whole number between 1 and 4. Stage 1 is prolapse which is fully contained within the vagina and above the hymen. Stage 4 is prolapse which extends at least 3 cm beyond the hymen.|Participants|Count of Participants|1|1.0||||||
3707234|NCT02155738|3547078|B1||Missing|Baseline POPQ Stage|POP-Q Stage is the Pelvic Organ Prolapse Quantification Stage. This is a whole number which refers to the extend of the prolapse, and how far past the hymen it extends. POP-Q Stage is a whole number between 1 and 4. Stage 1 is prolapse which is fully contained within the vagina and above the hymen. Stage 4 is prolapse which extends at least 3 cm beyond the hymen.|Participants|Count of Participants|1|1.0||||||
3707235|NCT02155738|3547074|B5||Stage IV|Baseline POPQ Stage|POP-Q Stage is the Pelvic Organ Prolapse Quantification Stage. This is a whole number which refers to the extend of the prolapse, and how far past the hymen it extends. POP-Q Stage is a whole number between 1 and 4. Stage 1 is prolapse which is fully contained within the vagina and above the hymen. Stage 4 is prolapse which extends at least 3 cm beyond the hymen.|Participants|Count of Participants|21|21.0||||||
3707236|NCT02155738|3547075|B4||Stage IV|Baseline POPQ Stage|POP-Q Stage is the Pelvic Organ Prolapse Quantification Stage. This is a whole number which refers to the extend of the prolapse, and how far past the hymen it extends. POP-Q Stage is a whole number between 1 and 4. Stage 1 is prolapse which is fully contained within the vagina and above the hymen. Stage 4 is prolapse which extends at least 3 cm beyond the hymen.|Participants|Count of Participants|8|8.0||||||
3707237|NCT02155738|3547076|B3||Stage IV|Baseline POPQ Stage|POP-Q Stage is the Pelvic Organ Prolapse Quantification Stage. This is a whole number which refers to the extend of the prolapse, and how far past the hymen it extends. POP-Q Stage is a whole number between 1 and 4. Stage 1 is prolapse which is fully contained within the vagina and above the hymen. Stage 4 is prolapse which extends at least 3 cm beyond the hymen.|Participants|Count of Participants|1|1.0||||||
3707238|NCT02155738|3547077|B2||Stage IV|Baseline POPQ Stage|POP-Q Stage is the Pelvic Organ Prolapse Quantification Stage. This is a whole number which refers to the extend of the prolapse, and how far past the hymen it extends. POP-Q Stage is a whole number between 1 and 4. Stage 1 is prolapse which is fully contained within the vagina and above the hymen. Stage 4 is prolapse which extends at least 3 cm beyond the hymen.|Participants|Count of Participants|7|7.0||||||
3707239|NCT02155738|3547078|B1||Stage IV|Baseline POPQ Stage|POP-Q Stage is the Pelvic Organ Prolapse Quantification Stage. This is a whole number which refers to the extend of the prolapse, and how far past the hymen it extends. POP-Q Stage is a whole number between 1 and 4. Stage 1 is prolapse which is fully contained within the vagina and above the hymen. Stage 4 is prolapse which extends at least 3 cm beyond the hymen.|Participants|Count of Participants|5|5.0||||||
3707240|NCT02155738|3547074|B5||Stage III|Baseline POPQ Stage|POP-Q Stage is the Pelvic Organ Prolapse Quantification Stage. This is a whole number which refers to the extend of the prolapse, and how far past the hymen it extends. POP-Q Stage is a whole number between 1 and 4. Stage 1 is prolapse which is fully contained within the vagina and above the hymen. Stage 4 is prolapse which extends at least 3 cm beyond the hymen.|Participants|Count of Participants|151|151.0||||||
3707241|NCT02155738|3547075|B4||Stage III|Baseline POPQ Stage|POP-Q Stage is the Pelvic Organ Prolapse Quantification Stage. This is a whole number which refers to the extend of the prolapse, and how far past the hymen it extends. POP-Q Stage is a whole number between 1 and 4. Stage 1 is prolapse which is fully contained within the vagina and above the hymen. Stage 4 is prolapse which extends at least 3 cm beyond the hymen.|Participants|Count of Participants|37|37.0||||||
3707243|NCT02155738|3547077|B2||Stage III|Baseline POPQ Stage|POP-Q Stage is the Pelvic Organ Prolapse Quantification Stage. This is a whole number which refers to the extend of the prolapse, and how far past the hymen it extends. POP-Q Stage is a whole number between 1 and 4. Stage 1 is prolapse which is fully contained within the vagina and above the hymen. Stage 4 is prolapse which extends at least 3 cm beyond the hymen.|Participants|Count of Participants|37|37.0||||||
3707244|NCT02155738|3547078|B1||Stage III|Baseline POPQ Stage|POP-Q Stage is the Pelvic Organ Prolapse Quantification Stage. This is a whole number which refers to the extend of the prolapse, and how far past the hymen it extends. POP-Q Stage is a whole number between 1 and 4. Stage 1 is prolapse which is fully contained within the vagina and above the hymen. Stage 4 is prolapse which extends at least 3 cm beyond the hymen.|Participants|Count of Participants|35|35.0||||||
3707245|NCT02155738|3547074|B5||Stage II|Baseline POPQ Stage|POP-Q Stage is the Pelvic Organ Prolapse Quantification Stage. This is a whole number which refers to the extend of the prolapse, and how far past the hymen it extends. POP-Q Stage is a whole number between 1 and 4. Stage 1 is prolapse which is fully contained within the vagina and above the hymen. Stage 4 is prolapse which extends at least 3 cm beyond the hymen.|Participants|Count of Participants|28|28.0||||||
3707246|NCT02155738|3547075|B4||Stage II|Baseline POPQ Stage|POP-Q Stage is the Pelvic Organ Prolapse Quantification Stage. This is a whole number which refers to the extend of the prolapse, and how far past the hymen it extends. POP-Q Stage is a whole number between 1 and 4. Stage 1 is prolapse which is fully contained within the vagina and above the hymen. Stage 4 is prolapse which extends at least 3 cm beyond the hymen.|Participants|Count of Participants|5|5.0||||||
3707247|NCT02155738|3547076|B3||Stage II|Baseline POPQ Stage|POP-Q Stage is the Pelvic Organ Prolapse Quantification Stage. This is a whole number which refers to the extend of the prolapse, and how far past the hymen it extends. POP-Q Stage is a whole number between 1 and 4. Stage 1 is prolapse which is fully contained within the vagina and above the hymen. Stage 4 is prolapse which extends at least 3 cm beyond the hymen.|Participants|Count of Participants|8|8.0||||||
3707248|NCT02155738|3547077|B2||Stage II|Baseline POPQ Stage|POP-Q Stage is the Pelvic Organ Prolapse Quantification Stage. This is a whole number which refers to the extend of the prolapse, and how far past the hymen it extends. POP-Q Stage is a whole number between 1 and 4. Stage 1 is prolapse which is fully contained within the vagina and above the hymen. Stage 4 is prolapse which extends at least 3 cm beyond the hymen.|Participants|Count of Participants|7|7.0||||||
3707249|NCT02155738|3547078|B1||Stage II|Baseline POPQ Stage|POP-Q Stage is the Pelvic Organ Prolapse Quantification Stage. This is a whole number which refers to the extend of the prolapse, and how far past the hymen it extends. POP-Q Stage is a whole number between 1 and 4. Stage 1 is prolapse which is fully contained within the vagina and above the hymen. Stage 4 is prolapse which extends at least 3 cm beyond the hymen.|Participants|Count of Participants|8|8.0||||||
3707250|NCT02155738|3547074|B5|||Parity|Parity refers to the number of times the subject gave birth to a baby more than 20 weeks gestation. Parity is expressed as a whole number.|births|Median|2|2.0|Inter-Quartile Range|||2.0|3.0|
3707251|NCT02155738|3547075|B4|||Parity|Parity refers to the number of times the subject gave birth to a baby more than 20 weeks gestation. Parity is expressed as a whole number.|births|Median|2|2.0|Inter-Quartile Range|||2.0|3.0|
3707252|NCT02155738|3547076|B3|||Parity|Parity refers to the number of times the subject gave birth to a baby more than 20 weeks gestation. Parity is expressed as a whole number.|births|Median|2|2.0|Inter-Quartile Range|||2.0|3.0|
3707253|NCT02155738|3547077|B2|||Parity|Parity refers to the number of times the subject gave birth to a baby more than 20 weeks gestation. Parity is expressed as a whole number.|births|Median|2|2.0|Inter-Quartile Range|||2.0|3.0|
3707254|NCT02155738|3547078|B1|||Parity|Parity refers to the number of times the subject gave birth to a baby more than 20 weeks gestation. Parity is expressed as a whole number.|births|Median|2|2.0|Inter-Quartile Range|||2.0|3.0|
3707255|NCT02155738|3547074|B5|||Current Smoker||Participants|Count of Participants|8|8.0||||||
3707256|NCT02155738|3547075|B4|||Current Smoker||Participants|Count of Participants|1|1.0||||||
3707257|NCT02155738|3547076|B3|||Current Smoker||Participants|Count of Participants|2|2.0||||||
3707258|NCT02155738|3547077|B2|||Current Smoker||Participants|Count of Participants|2|2.0||||||
3707259|NCT02155738|3547078|B1|||Current Smoker||Participants|Count of Participants|3|3.0||||||
3707260|NCT02155738|3547074|B5|||Postmenopausal||Participants|Count of Participants|181|181.0||||||
3707261|NCT02155738|3547075|B4|||Postmenopausal||Participants|Count of Participants|45|45.0||||||
3707262|NCT02155738|3547076|B3|||Postmenopausal||Participants|Count of Participants|44|44.0||||||
3707263|NCT02155738|3547077|B2|||Postmenopausal||Participants|Count of Participants|49|49.0||||||
3707264|NCT02155738|3547078|B1|||Postmenopausal||Participants|Count of Participants|43|43.0||||||
3707265|NCT02155738|3547074|B5|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3707266|NCT02155738|3547075|B4|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3707267|NCT02155738|3547076|B3|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3707268|NCT02155738|3547077|B2|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3707269|NCT02155738|3547078|B1|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3707270|NCT02155738|3547074|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3707271|NCT02155738|3547075|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3707272|NCT02155738|3547076|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3707273|NCT02155738|3547077|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3707274|NCT02155738|3547078|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3707275|NCT02155738|3547074|B5|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|196|196.0||||||
3707276|NCT02155738|3547075|B4|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
3707277|NCT02155738|3547076|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
3707278|NCT02155738|3547077|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
3707279|NCT02155738|3547078|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
3707280|NCT02155738|3547074|B5|African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3707281|NCT02155738|3547075|B4|African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3707282|NCT02155738|3547076|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3707283|NCT02155738|3547077|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3707284|NCT02155738|3547078|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3707285|NCT02155738|3547074|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3707286|NCT02155738|3547075|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3707287|NCT02155738|3547076|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3707288|NCT02155738|3547077|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3707289|NCT02155738|3547078|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3707290|NCT02155738|3547074|B5||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3707291|NCT02155738|3547075|B4||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3707292|NCT02155738|3547076|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3707293|NCT02155738|3547077|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3707294|NCT02155738|3547078|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3707295|NCT02155738|3547074|B5|||Age||years|Mean|65.5|65.5|Standard Deviation|9.9|9.9|||
3707296|NCT02155738|3547075|B4|||Age||years|Mean|62.08|62.08|Standard Deviation|7.00|7.0|||
3707297|NCT02155738|3547076|B3|||Age||years|Mean|60.22|60.22|Standard Deviation|8.00|8.0|||
3707298|NCT02155738|3547077|B2|||Age||years|Mean|70.5|70.5|Standard Deviation|9.20|9.2|||
3707299|NCT02155738|3547078|B1|||Age||years|Mean|69.24|69.24|Standard Deviation|10.87|10.87|||
3707300|NCT02155543|3547099|B8||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3707301|NCT02155543|3547100|B7||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3707302|NCT02155543|3547101|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3707303|NCT02155543|3547102|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3707304|NCT02155543|3547103|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3707305|NCT02155543|3547104|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3707306|NCT02155543|3547105|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3707307|NCT02155543|3547106|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3707308|NCT02155543|3547099|B8||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3707309|NCT02155543|3547100|B7||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3707310|NCT02155543|3547101|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3707311|NCT02155543|3547102|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3707312|NCT02155543|3547103|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3707313|NCT02155543|3547104|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3707314|NCT02155543|3547105|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3707315|NCT02155543|3547106|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3707316|NCT02155543|3547099|B8|Between 45 and 65 years||Age, Customized||Participants|Number|3|3.0||||||
3707317|NCT02155543|3547100|B7|Between 45 and 65 years||Age, Customized||Participants|Number|0|0.0||||||
3707318|NCT02155543|3547101|B6|Between 45 and 65 years||Age, Customized||Participants|Number|0|0.0||||||
3707319|NCT02155543|3547102|B5|Between 45 and 65 years||Age, Customized||Participants|Number|0|0.0||||||
3707320|NCT02155543|3547103|B4|Between 45 and 65 years||Age, Customized||Participants|Number|0|0.0||||||
3707321|NCT02155543|3547104|B3|Between 45 and 65 years||Age, Customized||Participants|Number|0|0.0||||||
3707322|NCT02155543|3547105|B2|Between 45 and 65 years||Age, Customized||Participants|Number|1|1.0||||||
3707323|NCT02155543|3547106|B1|Between 45 and 65 years||Age, Customized||Participants|Number|2|2.0||||||
3707324|NCT02155543|3547099|B8|<45 years||Age, Customized||Participants|Number|48|48.0||||||
3707325|NCT02155543|3547100|B7|<45 years||Age, Customized||Participants|Number|9|9.0||||||
3707326|NCT02155543|3547101|B6|<45 years||Age, Customized||Participants|Number|3|3.0||||||
3707327|NCT02155543|3547102|B5|<45 years||Age, Customized||Participants|Number|3|3.0||||||
3707328|NCT02155543|3547103|B4|<45 years||Age, Customized||Participants|Number|9|9.0||||||
3707329|NCT02155543|3547104|B3|<45 years||Age, Customized||Participants|Number|9|9.0||||||
3707330|NCT02155543|3547105|B2|<45 years||Age, Customized||Participants|Number|8|8.0||||||
3707331|NCT02155543|3547106|B1|<45 years||Age, Customized||Participants|Number|7|7.0||||||
3707332|NCT02155335|3547125|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3707333|NCT02155335|3547125|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3707334|NCT02155335|3547125|B1|||Age||years|Mean|42.6|42.6|Standard Deviation|14.4|14.4|||
3707335|NCT02155322|3547131|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3707336|NCT02155322|3547131|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3707337|NCT02155322|3547131|B1|||Age||Years|Mean|51.4|51.4|Standard Deviation|12.86|12.86|||
3707338|NCT02155309|3547136|B3|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3707339|NCT02155309|3547137|B2|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3707402|NCT02154243|3547217|B4|United States||Region of Enrollment||participants|Number|13|13.0||||||
3707340|NCT02155309|3547138|B1|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3707341|NCT02155309|3547136|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3707342|NCT02155309|3547137|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3707343|NCT02155309|3547138|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3707344|NCT02155309|3547136|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3707345|NCT02155309|3547137|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3707346|NCT02155309|3547138|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3707347|NCT02155309|3547136|B3|||Age||Years|Mean|30.72|30.72|Standard Deviation|11.16|11.16|||
3707348|NCT02155309|3547137|B2|||Age||Years|Mean|30.96|30.96|Standard Deviation|10.86|10.86|||
3707349|NCT02155309|3547138|B1|||Age||Years|Mean|30.31|30.31|Standard Deviation|12.59|12.59|||
3707350|NCT02155309|3547136|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3707351|NCT02155309|3547137|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3707352|NCT02155309|3547138|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3707353|NCT02155309|3547136|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3707354|NCT02155309|3547137|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3707355|NCT02155309|3547138|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3707356|NCT02155309|3547136|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3707357|NCT02155309|3547137|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3707358|NCT02155309|3547138|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3707359|NCT02155283|3547147|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3707360|NCT02155283|3547147|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3707361|NCT02155283|3547147|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3707362|NCT02155283|3547147|B1|||Age||years|Mean|53.75|53.75|Standard Deviation|14.2|14.2|||
3707363|NCT02155010|3547152|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3707364|NCT02155010|3547153|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3707365|NCT02155010|3547154|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3707366|NCT02155010|3547152|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3707367|NCT02155010|3547153|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3707368|NCT02155010|3547154|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3707369|NCT02155010|3547152|B3|||Age||years|Mean|37.31|37.31|Standard Deviation|11.75|11.75|||
3707370|NCT02155010|3547153|B2|||Age||years|Mean|35.87|35.87|Standard Deviation|11.22|11.22|||
3707371|NCT02155010|3547154|B1|||Age||years|Mean|38.74|38.74|Standard Deviation|12.27|12.27|||
3707372|NCT02154906|3547163|B3|||Clinical Attachment Level||mm|Mean|6.5|6.5|Full Range|||4.0|11.0|
3707373|NCT02154906|3547164|B2|||Clinical Attachment Level||mm|Mean|6.3|6.3|Full Range|||4.0|8.0|
3707374|NCT02154906|3547165|B1|||Clinical Attachment Level||mm|Mean|6.7|6.7|Full Range|||4.0|11.0|
3707375|NCT02154906|3547163|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
3707376|NCT02154906|3547164|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3707377|NCT02154906|3547165|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3707378|NCT02154906|3547163|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3707379|NCT02154906|3547164|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3707380|NCT02154906|3547165|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3707381|NCT02154906|3547163|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3707382|NCT02154906|3547164|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3707383|NCT02154906|3547165|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3707384|NCT02154906|3547163|B3|||Age||years|Mean|55.0|55.0|Full Range|||23.0|73.0|
3707385|NCT02154906|3547164|B2|||Age||years|Mean|57.2|57.2|Full Range|||38.0|73.0|
3707386|NCT02154906|3547165|B1|||Age||years|Mean|52.3|52.3|Full Range|||23.0|68.0|
3707387|NCT02154425|3547174|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3707388|NCT02154425|3547174|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3707389|NCT02154425|3547174|B1|arithmetic mean (standard deviation)||Age||years|Mean|33.7|33.7|Standard Deviation|4.2|4.2|||
3707390|NCT02154425|3547174|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3707391|NCT02154425|3547174|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3707392|NCT02154425|3547174|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3707393|NCT02154386|3547204|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3707394|NCT02154386|3547205|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3707395|NCT02154386|3547206|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3707396|NCT02154386|3547204|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3707397|NCT02154386|3547205|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3707398|NCT02154386|3547206|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3707399|NCT02154386|3547204|B3|||Age||years|Mean|55.7|55.7|Full Range|||23.0|81.0|
3707400|NCT02154386|3547205|B2|||Age||years|Mean|55.4|55.4|Full Range|||23.0|81.0|
3707401|NCT02154386|3547206|B1|||Age||years|Mean|56.1|56.1|Full Range|||29.0|81.0|
3707403|NCT02154243|3547218|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3707404|NCT02154243|3547219|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3707405|NCT02154243|3547220|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3707406|NCT02154243|3547217|B4|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3707407|NCT02154243|3547217|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3707408|NCT02154243|3547218|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3707409|NCT02154243|3547219|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3707410|NCT02154243|3547220|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3707411|NCT02154243|3547217|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3707412|NCT02154243|3547218|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3707413|NCT02154243|3547219|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3707414|NCT02154243|3547220|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3707415|NCT02154243|3547217|B4|||Age||years|Mean|55.9|55.9|Standard Deviation|11.2|11.2|||
3707416|NCT02154243|3547218|B3|||Age||years|Mean|57.7|57.7|Standard Deviation|11.2|11.2|||
3707417|NCT02154243|3547219|B2|||Age||years|Mean|55.7|55.7|Standard Deviation|11.2|11.2|||
3707418|NCT02154243|3547220|B1|||Age||years|Mean|54.6|54.6|Standard Deviation|11.3|11.3|||
3707419|NCT02154139|3547233|B1|4||Performance Status (at the start of treatment with leuprorelin acetate 11.25 mg for injection)|Following are ECOG grades. 0: Fully active, perform all pre-disease activities without restriction. 1: Restricted in physically strenuous activity but ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of selfcare, unable to carry out any work activities, up and about more than (>) 50% of waking hours. 3: Capable of limited selfcare, confined to bed or chair >50% of waking hours. 4: Completely disabled, not capable of any selfcare, totally confined to bed or chair.|participants|Number|2|2.0||||||
3707420|NCT02154139|3547233|B1|3||Performance Status (at the start of treatment with leuprorelin acetate 11.25 mg for injection)|Following are ECOG grades. 0: Fully active, perform all pre-disease activities without restriction. 1: Restricted in physically strenuous activity but ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of selfcare, unable to carry out any work activities, up and about more than (>) 50% of waking hours. 3: Capable of limited selfcare, confined to bed or chair >50% of waking hours. 4: Completely disabled, not capable of any selfcare, totally confined to bed or chair.|participants|Number|4|4.0||||||
3707421|NCT02154139|3547233|B1|2||Performance Status (at the start of treatment with leuprorelin acetate 11.25 mg for injection)|Following are ECOG grades. 0: Fully active, perform all pre-disease activities without restriction. 1: Restricted in physically strenuous activity but ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of selfcare, unable to carry out any work activities, up and about more than (>) 50% of waking hours. 3: Capable of limited selfcare, confined to bed or chair >50% of waking hours. 4: Completely disabled, not capable of any selfcare, totally confined to bed or chair.|participants|Number|3|3.0||||||
3707422|NCT02154139|3547233|B1|1||Performance Status (at the start of treatment with leuprorelin acetate 11.25 mg for injection)|Following are ECOG grades. 0: Fully active, perform all pre-disease activities without restriction. 1: Restricted in physically strenuous activity but ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of selfcare, unable to carry out any work activities, up and about more than (>) 50% of waking hours. 3: Capable of limited selfcare, confined to bed or chair >50% of waking hours. 4: Completely disabled, not capable of any selfcare, totally confined to bed or chair.|participants|Number|33|33.0||||||
3707423|NCT02154139|3547233|B1|0||Performance Status (at the start of treatment with leuprorelin acetate 11.25 mg for injection)|Following are ECOG grades. 0: Fully active, perform all pre-disease activities without restriction. 1: Restricted in physically strenuous activity but ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of selfcare, unable to carry out any work activities, up and about more than (>) 50% of waking hours. 3: Capable of limited selfcare, confined to bed or chair >50% of waking hours. 4: Completely disabled, not capable of any selfcare, totally confined to bed or chair.|participants|Number|602|602.0||||||
3707424|NCT02154139|3547233|B1|No recurrence observed||Recurrence prior to start of treatment with leuprorelin acetate 11.25 mg for injection||participants|Number|594|594.0||||||
3707425|NCT02154139|3547233|B1|Experienced recurrence||Recurrence prior to start of treatment with leuprorelin acetate 11.25 mg for injection||participants|Number|50|50.0||||||
3707426|NCT02154139|3547233|B1|Unclassifiable||Stage of primary lesion|Tumor Node Metastasis (TNM):based on tumor size, if cancer cells had spread to nearby lymph nodes (LN), or distant metastasis. Stages included: stage 0(no evidence of cancer cells),stage 1(T1N0M0), stage IIA(T0N1M0, T1N1M0, T2N0M0), stage IIB(T2N1M0, T3N0M0), stage IIIA(T0N2M0, T1N2M0, T2N3M0, T3N1orN2M0),stage IIIb( T4 anyNM0, any TN3M0),stage IIIC(any TN3M0), stage IV(any T any NM1), where T0=early form of tumor, T1=<2 centimeter (cm), T2=2-5 cm, T3=>2 cm, T4=large sized, N0=not spread to LN, N1=spread to 1 to 3,N2=spread to 4 to 9,N3=spread >10 axillary LN, M0=no metastasis, M1= Metastasis.|participants|Number|22|22.0||||||
3707427|NCT02154139|3547233|B1|Stage IV||Stage of primary lesion|Tumor Node Metastasis (TNM):based on tumor size, if cancer cells had spread to nearby lymph nodes (LN), or distant metastasis. Stages included: stage 0(no evidence of cancer cells),stage 1(T1N0M0), stage IIA(T0N1M0, T1N1M0, T2N0M0), stage IIB(T2N1M0, T3N0M0), stage IIIA(T0N2M0, T1N2M0, T2N3M0, T3N1orN2M0),stage IIIb( T4 anyNM0, any TN3M0),stage IIIC(any TN3M0), stage IV(any T any NM1), where T0=early form of tumor, T1=<2 centimeter (cm), T2=2-5 cm, T3=>2 cm, T4=large sized, N0=not spread to LN, N1=spread to 1 to 3,N2=spread to 4 to 9,N3=spread >10 axillary LN, M0=no metastasis, M1= Metastasis.|participants|Number|23|23.0||||||
3707453|NCT02154087|3547241|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3707454|NCT02154087|3547241|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3707455|NCT02154087|3547241|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3707456|NCT02154061|3547245|B3|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3707457|NCT02154061|3547246|B2|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3707428|NCT02154139|3547233|B1|Stage IIIC||Stage of primary lesion|Tumor Node Metastasis (TNM):based on tumor size, if cancer cells had spread to nearby lymph nodes (LN), or distant metastasis. Stages included: stage 0(no evidence of cancer cells),stage 1(T1N0M0), stage IIA(T0N1M0, T1N1M0, T2N0M0), stage IIB(T2N1M0, T3N0M0), stage IIIA(T0N2M0, T1N2M0, T2N3M0, T3N1orN2M0),stage IIIb( T4 anyNM0, any TN3M0),stage IIIC(any TN3M0), stage IV(any T any NM1), where T0=early form of tumor, T1=<2 centimeter (cm), T2=2-5 cm, T3=>2 cm, T4=large sized, N0=not spread to LN, N1=spread to 1 to 3,N2=spread to 4 to 9,N3=spread >10 axillary LN, M0=no metastasis, M1= Metastasis.|participants|Number|1|1.0||||||
3707429|NCT02154139|3547233|B1|Stage IIIB||Stage of primary lesion|Tumor Node Metastasis (TNM):based on tumor size, if cancer cells had spread to nearby lymph nodes (LN), or distant metastasis. Stages included: stage 0(no evidence of cancer cells),stage 1(T1N0M0), stage IIA(T0N1M0, T1N1M0, T2N0M0), stage IIB(T2N1M0, T3N0M0), stage IIIA(T0N2M0, T1N2M0, T2N3M0, T3N1orN2M0),stage IIIb( T4 anyNM0, any TN3M0),stage IIIC(any TN3M0), stage IV(any T any NM1), where T0=early form of tumor, T1=<2 centimeter (cm), T2=2-5 cm, T3=>2 cm, T4=large sized, N0=not spread to LN, N1=spread to 1 to 3,N2=spread to 4 to 9,N3=spread >10 axillary LN, M0=no metastasis, M1= Metastasis.|participants|Number|6|6.0||||||
3707430|NCT02154139|3547233|B1|Stage IIIA||Stage of primary lesion|Tumor Node Metastasis (TNM):based on tumor size, if cancer cells had spread to nearby lymph nodes (LN), or distant metastasis. Stages included: stage 0(no evidence of cancer cells),stage 1(T1N0M0), stage IIA(T0N1M0, T1N1M0, T2N0M0), stage IIB(T2N1M0, T3N0M0), stage IIIA(T0N2M0, T1N2M0, T2N3M0, T3N1orN2M0),stage IIIb( T4 anyNM0, any TN3M0),stage IIIC(any TN3M0), stage IV(any T any NM1), where T0=early form of tumor, T1=<2 centimeter (cm), T2=2-5 cm, T3=>2 cm, T4=large sized, N0=not spread to LN, N1=spread to 1 to 3,N2=spread to 4 to 9,N3=spread >10 axillary LN, M0=no metastasis, M1= Metastasis.|participants|Number|24|24.0||||||
3707431|NCT02154139|3547233|B1|Stage IIB||Stage of primary lesion|Tumor Node Metastasis (TNM):based on tumor size, if cancer cells had spread to nearby lymph nodes (LN), or distant metastasis. Stages included: stage 0(no evidence of cancer cells),stage 1(T1N0M0), stage IIA(T0N1M0, T1N1M0, T2N0M0), stage IIB(T2N1M0, T3N0M0), stage IIIA(T0N2M0, T1N2M0, T2N3M0, T3N1orN2M0),stage IIIb( T4 anyNM0, any TN3M0),stage IIIC(any TN3M0), stage IV(any T any NM1), where T0=early form of tumor, T1=<2 centimeter (cm), T2=2-5 cm, T3=>2 cm, T4=large sized, N0=not spread to LN, N1=spread to 1 to 3,N2=spread to 4 to 9,N3=spread >10 axillary LN, M0=no metastasis, M1= Metastasis.|participants|Number|85|85.0||||||
3707432|NCT02154139|3547233|B1|Stage IIA||Stage of primary lesion|Tumor Node Metastasis (TNM):based on tumor size, if cancer cells had spread to nearby lymph nodes (LN), or distant metastasis. Stages included: stage 0(no evidence of cancer cells),stage 1(T1N0M0), stage IIA(T0N1M0, T1N1M0, T2N0M0), stage IIB(T2N1M0, T3N0M0), stage IIIA(T0N2M0, T1N2M0, T2N3M0, T3N1orN2M0),stage IIIb( T4 anyNM0, any TN3M0),stage IIIC(any TN3M0), stage IV(any T any NM1), where T0=early form of tumor, T1=<2 centimeter (cm), T2=2-5 cm, T3=>2 cm, T4=large sized, N0=not spread to LN, N1=spread to 1 to 3,N2=spread to 4 to 9,N3=spread >10 axillary LN, M0=no metastasis, M1= Metastasis.|participants|Number|199|199.0||||||
3707433|NCT02154139|3547233|B1|Stage I||Stage of primary lesion|Tumor Node Metastasis (TNM):based on tumor size, if cancer cells had spread to nearby lymph nodes (LN), or distant metastasis. Stages included: stage 0(no evidence of cancer cells),stage 1(T1N0M0), stage IIA(T0N1M0, T1N1M0, T2N0M0), stage IIB(T2N1M0, T3N0M0), stage IIIA(T0N2M0, T1N2M0, T2N3M0, T3N1orN2M0),stage IIIb( T4 anyNM0, any TN3M0),stage IIIC(any TN3M0), stage IV(any T any NM1), where T0=early form of tumor, T1=<2 centimeter (cm), T2=2-5 cm, T3=>2 cm, T4=large sized, N0=not spread to LN, N1=spread to 1 to 3,N2=spread to 4 to 9,N3=spread >10 axillary LN, M0=no metastasis, M1= Metastasis.|participants|Number|265|265.0||||||
3707434|NCT02154139|3547233|B1|Stage 0||Stage of primary lesion|Tumor Node Metastasis (TNM):based on tumor size, if cancer cells had spread to nearby lymph nodes (LN), or distant metastasis. Stages included: stage 0(no evidence of cancer cells),stage 1(T1N0M0), stage IIA(T0N1M0, T1N1M0, T2N0M0), stage IIB(T2N1M0, T3N0M0), stage IIIA(T0N2M0, T1N2M0, T2N3M0, T3N1orN2M0),stage IIIb( T4 anyNM0, any TN3M0),stage IIIC(any TN3M0), stage IV(any T any NM1), where T0=early form of tumor, T1=<2 centimeter (cm), T2=2-5 cm, T3=>2 cm, T4=large sized, N0=not spread to LN, N1=spread to 1 to 3,N2=spread to 4 to 9,N3=spread >10 axillary LN, M0=no metastasis, M1= Metastasis.|participants|Number|17|17.0||||||
3707435|NCT02154139|3547233|B1|T0N0M0||Stage of primary lesion|Tumor Node Metastasis (TNM):based on tumor size, if cancer cells had spread to nearby lymph nodes (LN), or distant metastasis. Stages included: stage 0(no evidence of cancer cells),stage 1(T1N0M0), stage IIA(T0N1M0, T1N1M0, T2N0M0), stage IIB(T2N1M0, T3N0M0), stage IIIA(T0N2M0, T1N2M0, T2N3M0, T3N1orN2M0),stage IIIb( T4 anyNM0, any TN3M0),stage IIIC(any TN3M0), stage IV(any T any NM1), where T0=early form of tumor, T1=<2 centimeter (cm), T2=2-5 cm, T3=>2 cm, T4=large sized, N0=not spread to LN, N1=spread to 1 to 3,N2=spread to 4 to 9,N3=spread >10 axillary LN, M0=no metastasis, M1= Metastasis.|participants|Number|2|2.0||||||
3707436|NCT02154139|3547233|B1|||Sex/Gender, Customized|Only female participants were enrolled in the study.|participants|Number|644|644.0||||||
3707437|NCT02154139|3547233|B1|Unknown||Age, Customized||participants|Number|2|2.0||||||
3707438|NCT02154139|3547233|B1|50-55 years||Age, Customized||participants|Number|58|58.0||||||
3707439|NCT02154139|3547233|B1|45-49 years||Age, Customized||participants|Number|212|212.0||||||
3707440|NCT02154139|3547233|B1|40-44 years||Age, Customized||participants|Number|201|201.0||||||
3707441|NCT02154139|3547233|B1|35-39 years||Age, Customized||participants|Number|113|113.0||||||
3707442|NCT02154139|3547233|B1|30-34 years||Age, Customized||participants|Number|47|47.0||||||
3707443|NCT02154139|3547233|B1|20-29 years||Age, Customized||participants|Number|11|11.0||||||
3707444|NCT02154087|3547241|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707445|NCT02154087|3547241|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707446|NCT02154087|3547241|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3707447|NCT02154087|3547241|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707448|NCT02154087|3547241|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707449|NCT02154087|3547241|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707450|NCT02154087|3547241|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707451|NCT02154087|3547241|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3707452|NCT02154087|3547241|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3707458|NCT02154061|3547247|B1|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3707459|NCT02154061|3547245|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707460|NCT02154061|3547246|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707461|NCT02154061|3547247|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707462|NCT02154061|3547245|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3707463|NCT02154061|3547246|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707464|NCT02154061|3547247|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3707465|NCT02154061|3547245|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3707466|NCT02154061|3547246|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3707467|NCT02154061|3547247|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3707468|NCT02154061|3547245|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3707469|NCT02154061|3547246|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3707470|NCT02154061|3547247|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3707471|NCT02154061|3547245|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707472|NCT02154061|3547246|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707473|NCT02154061|3547247|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707474|NCT02154061|3547245|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3707475|NCT02154061|3547246|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3707476|NCT02154061|3547247|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707477|NCT02154061|3547245|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3707478|NCT02154061|3547246|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707479|NCT02154061|3547247|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3707480|NCT02154061|3547245|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3707481|NCT02154061|3547246|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3707482|NCT02154061|3547247|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3707483|NCT02154061|3547245|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3707484|NCT02154061|3547246|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3707485|NCT02154061|3547247|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3707486|NCT02154061|3547245|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3707487|NCT02154061|3547246|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3707488|NCT02154061|3547247|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3707489|NCT02154061|3547245|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3707490|NCT02154061|3547246|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3707491|NCT02154061|3547247|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3707492|NCT02154061|3547245|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3707493|NCT02154061|3547246|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3707494|NCT02154061|3547247|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3707495|NCT02154048|3547254|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707496|NCT02154048|3547255|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707497|NCT02154048|3547256|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707498|NCT02154048|3547257|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707499|NCT02154048|3547254|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707500|NCT02154048|3547255|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707501|NCT02154048|3547256|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707502|NCT02154048|3547257|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707503|NCT02154048|3547254|B4||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3707504|NCT02154048|3547255|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3707505|NCT02154048|3547256|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707506|NCT02154048|3547257|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3707507|NCT02154048|3547254|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3707508|NCT02154048|3547255|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707509|NCT02154048|3547256|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3707510|NCT02154048|3547257|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3707511|NCT02154048|3547254|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707512|NCT02154048|3547255|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707513|NCT02154048|3547256|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707514|NCT02154048|3547257|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707515|NCT02154048|3547254|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707516|NCT02154048|3547255|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707517|NCT02154048|3547256|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707518|NCT02154048|3547257|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707519|NCT02154048|3547254|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707520|NCT02154048|3547255|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707521|NCT02154048|3547256|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707522|NCT02154048|3547257|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707523|NCT02154048|3547254|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3707524|NCT02154048|3547255|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3707525|NCT02154048|3547256|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3707526|NCT02154048|3547257|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3707527|NCT02154048|3547254|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3707528|NCT02154048|3547255|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3707529|NCT02154048|3547256|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3707530|NCT02154048|3547257|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3707531|NCT02154048|3547254|B4|<=17 years||Age, Customized||participants|Number|0|0.0||||||
3707532|NCT02154048|3547255|B3|<=17 years||Age, Customized||participants|Number|0|0.0||||||
3707533|NCT02154048|3547256|B2|<=17 years||Age, Customized||participants|Number|0|0.0||||||
3707534|NCT02154048|3547257|B1|<=17 years||Age, Customized||participants|Number|0|0.0||||||
3707535|NCT02154048|3547254|B4|>= 18 years||Age, Customized||participants|Number|5|5.0||||||
3707536|NCT02154048|3547255|B3|>= 18 years||Age, Customized||participants|Number|1|1.0||||||
3707537|NCT02154048|3547256|B2|>= 18 years||Age, Customized||participants|Number|2|2.0||||||
3707538|NCT02154048|3547257|B1|>= 18 years||Age, Customized||participants|Number|2|2.0||||||
3707539|NCT02153918|3547267|B1|Gleason score 8-10||Number of Participants with Gleason Score 6-10 at Baseline|The higher the number on the Gleason scale, the worse the expected outcome.|Participants|Count of Participants|8|8.0||||||
3707540|NCT02153918|3547267|B1|Gleason score 7 (4+3)||Number of Participants with Gleason Score 6-10 at Baseline|The higher the number on the Gleason scale, the worse the expected outcome.|Participants|Count of Participants|8|8.0||||||
3707541|NCT02153918|3547267|B1|Gleason score 6-7 (3+4)||Number of Participants with Gleason Score 6-10 at Baseline|The higher the number on the Gleason scale, the worse the expected outcome.|Participants|Count of Participants|11|11.0||||||
3707542|NCT02153918|3547267|B1|||Largest Lesion Size at Baseline||cm|Mean|1.55|1.55|Standard Deviation|0.92|0.92|||
3707543|NCT02153918|3547267|B1|||Number of Lesions on MRI at Baseline||lesions|Mean|2.04|2.04|Standard Deviation|1.21|1.21|||
3707544|NCT02153918|3547267|B1|||Magnetic Resonance Imaging (MRI) Prostate Volume at Baseline||cc|Mean|45.70|45.7|Standard Deviation|17.24|17.24|||
3707545|NCT02153918|3547267|B1|||Baseline Prostatic Specific Antigen (PSA)|PSA levels of 4.0 ng/ml and lower are considered normal.|ng/ml|Mean|9.66|9.66|Standard Deviation|10.45|10.45|||
3707546|NCT02153918|3547267|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3707547|NCT02153918|3547267|B1|Multi-racial||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3707548|NCT02153918|3547267|B1|Not meeting definition for Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3707549|NCT02153918|3547267|B1|Mexican, Puerto Rican, Central or So. Amer. or Oth||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3707550|NCT02153918|3547267|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3707551|NCT02153918|3547267|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3707552|NCT02153918|3547267|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3707553|NCT02153918|3547267|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3707554|NCT02153918|3547267|B1|||Age||years|Mean|64.24|64.24|Standard Deviation|6.62|6.62|||
3707555|NCT02153918|3547267|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3707556|NCT02153918|3547267|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3707557|NCT02153918|3547267|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3707558|NCT02153827|3547276|B3|||Body mass||Kilograms|Mean|80.88|80.88|Standard Deviation|16.795|16.795|||
3707559|NCT02153827|3547277|B2|||Body mass||Kilograms|Mean|81.90|81.9|Standard Deviation|18.55|18.55|||
3707560|NCT02153827|3547278|B1|||Body mass||Kilograms|Mean|79.87|79.87|Standard Deviation|15.04|15.04|||
3707561|NCT02153827|3547276|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3707562|NCT02153827|3547277|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3707563|NCT02153827|3547278|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3707564|NCT02153827|3547276|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3707565|NCT02153827|3547277|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3707566|NCT02153827|3547278|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3707567|NCT02153827|3547276|B3|||Age||years|Mean|45.85|45.85|Standard Deviation|17.38|17.38|||
3707568|NCT02153827|3547277|B2|||Age||years|Mean|48.35|48.35|Standard Deviation|16.89|16.89|||
3707569|NCT02153827|3547278|B1|||Age||years|Mean|43.35|43.35|Standard Deviation|17.88|17.88|||
3707570|NCT02153788|3547293|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
3707571|NCT02153788|3547294|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3707572|NCT02153788|3547295|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3707573|NCT02153788|3547293|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3707574|NCT02153788|3547294|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3707575|NCT02153788|3547295|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3707576|NCT02153788|3547293|B3|African American||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3707577|NCT02153788|3547294|B2|African American||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3707578|NCT02153788|3547295|B1|African American||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3707579|NCT02153788|3547293|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3707580|NCT02153788|3547294|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3707581|NCT02153788|3547295|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3707582|NCT02153788|3547293|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3707583|NCT02153788|3547294|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3707584|NCT02153788|3547295|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3707585|NCT02153788|3547293|B3|21 - 69 years old||Age, Customized||participants|Number|44|44.0||||||
3707586|NCT02153788|3547294|B2|21 - 69 years old||Age, Customized||participants|Number|19|19.0||||||
3707587|NCT02153788|3547295|B1|21 - 69 years old||Age, Customized||participants|Number|25|25.0||||||
3707588|NCT02153736|3547314|B3|||Brain Injury (GIII/IV intraventricular hemorrhage , Periventricular leukomalacia, Hypoxic Ischemic E|Clinical cranial ultrasound in the neonatal period was used to document the presence of any reported intraventricular hemorrhage or periventricular leukomalacia as all included infants meet the clinical guidelines for having a cranial ultrasound in the neonatal intensive care unit. Radiology reports including a finding of Grade III/IV (severe) intraventricular hemorrhage, periventricular leukomalacia, or Diffuse brain injury were used to stratify infants into a severe brain injury group|Participants|Count of Participants|4|4.0||||||
3707589|NCT02153736|3547315|B2|||Brain Injury (GIII/IV intraventricular hemorrhage , Periventricular leukomalacia, Hypoxic Ischemic E|Clinical cranial ultrasound in the neonatal period was used to document the presence of any reported intraventricular hemorrhage or periventricular leukomalacia as all included infants meet the clinical guidelines for having a cranial ultrasound in the neonatal intensive care unit. Radiology reports including a finding of Grade III/IV (severe) intraventricular hemorrhage, periventricular leukomalacia, or Diffuse brain injury were used to stratify infants into a severe brain injury group|Participants|Count of Participants|2|2.0||||||
3707590|NCT02153736|3547316|B1|||Brain Injury (GIII/IV intraventricular hemorrhage , Periventricular leukomalacia, Hypoxic Ischemic E|Clinical cranial ultrasound in the neonatal period was used to document the presence of any reported intraventricular hemorrhage or periventricular leukomalacia as all included infants meet the clinical guidelines for having a cranial ultrasound in the neonatal intensive care unit. Radiology reports including a finding of Grade III/IV (severe) intraventricular hemorrhage, periventricular leukomalacia, or Diffuse brain injury were used to stratify infants into a severe brain injury group|Participants|Count of Participants|2|2.0||||||
3707591|NCT02153736|3547314|B3|||Gestational age||weeks of gestation|Median|25.5|25.5|Inter-Quartile Range|||25.0|27.0|
3707592|NCT02153736|3547315|B2|||Gestational age||weeks of gestation|Median|25|25.0|Inter-Quartile Range|||24.0|27.0|
3707593|NCT02153736|3547316|B1|||Gestational age||weeks of gestation|Median|26|26.0|Inter-Quartile Range|||25.0|28.0|
3707594|NCT02153736|3547314|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
3707595|NCT02153736|3547315|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3707596|NCT02153736|3547316|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3707597|NCT02153736|3547314|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3707598|NCT02153736|3547315|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707599|NCT02153736|3547316|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3707600|NCT02153736|3547314|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3707601|NCT02153736|3547315|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3707602|NCT02153736|3547316|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707603|NCT02153736|3547314|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3707604|NCT02153736|3547315|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3707605|NCT02153736|3547316|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3707606|NCT02153736|3547314|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3707607|NCT02153736|3547315|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3707608|NCT02153736|3547316|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3707609|NCT02153736|3547314|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707610|NCT02153736|3547315|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707611|NCT02153736|3547316|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707612|NCT02153736|3547314|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707613|NCT02153736|3547315|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707614|NCT02153736|3547316|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707615|NCT02153736|3547314|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707616|NCT02153736|3547315|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707617|NCT02153736|3547316|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707618|NCT02153736|3547314|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707619|NCT02153736|3547315|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707620|NCT02153736|3547316|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707621|NCT02153736|3547314|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3707622|NCT02153736|3547315|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3707623|NCT02153736|3547316|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3707624|NCT02153736|3547314|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3707625|NCT02153736|3547315|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3707626|NCT02153736|3547316|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3707627|NCT02153736|3547314|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3707628|NCT02153736|3547315|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3707629|NCT02153736|3547316|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3707630|NCT02153736|3547314|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3707631|NCT02153736|3547315|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3707632|NCT02153736|3547316|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3707633|NCT02153736|3547314|B3|||Age||Weeks of post menstrual age|Median|38|38.0|Inter-Quartile Range|||35.0|39.0|
3707634|NCT02153736|3547315|B2|||Age||Weeks of post menstrual age|Median|39|39.0|Inter-Quartile Range|||36.0|40.0|
3707635|NCT02153736|3547316|B1|||Age||Weeks of post menstrual age|Median|35|35.0|Inter-Quartile Range|||35.0|39.0|
3707636|NCT02153723|3547333|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3707637|NCT02153723|3547333|B1||Male|Sex: Female, Male|All participants were female|Participants|Count of Participants|0|0.0||||||
3707638|NCT02153723|3547333|B1||Female|Sex: Female, Male|All participants were female|Participants|Count of Participants|10|10.0||||||
3707639|NCT02153723|3547333|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3707640|NCT02153723|3547333|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3707641|NCT02153723|3547333|B1||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
3707642|NCT02153489|3547342|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3707643|NCT02153489|3547342|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3707644|NCT02153489|3547342|B1|||Age||Years|Mean|64.4|64.4|Standard Deviation|7.0|7.0|||
3707645|NCT02153476|3547381|B3|United States||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3707646|NCT02153476|3547382|B2|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3707647|NCT02153476|3547383|B1|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3707648|NCT02153476|3547381|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3707649|NCT02153476|3547382|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3707650|NCT02153476|3547383|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3707651|NCT02153476|3547381|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3707652|NCT02153476|3547382|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3707653|NCT02153476|3547383|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3707654|NCT02153476|3547381|B3|||Age||years|Mean|49|49.0|Full Range|||25.0|70.0|
3707655|NCT02153476|3547382|B2|||Age||years|Mean|49|49.0|Full Range|||25.0|70.0|
3707656|NCT02153476|3547383|B1|||Age||years|Mean|49|49.0|Full Range|||25.0|70.0|
3707657|NCT02153476|3547381|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3707658|NCT02153476|3547382|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3707659|NCT02153476|3547383|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3707660|NCT02153476|3547381|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3707661|NCT02153476|3547382|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3707662|NCT02153476|3547383|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3707663|NCT02153476|3547381|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3707664|NCT02153476|3547382|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3707665|NCT02153476|3547383|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3707666|NCT02153398|3547390|B6||Male|Gender||Participants|Count of Participants|24|24.0||||||
3707667|NCT02153398|3547391|B5||Male|Gender||Participants|Count of Participants|4|4.0||||||
3707668|NCT02153398|3547392|B4||Male|Gender||Participants|Count of Participants|3|3.0||||||
3707669|NCT02153398|3547393|B3||Male|Gender||Participants|Count of Participants|8|8.0||||||
3707670|NCT02153398|3547394|B2||Male|Gender||Participants|Count of Participants|4|4.0||||||
3707671|NCT02153398|3547395|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
3707672|NCT02153398|3547390|B6||Female|Gender||Participants|Count of Participants|26|26.0||||||
3707673|NCT02153398|3547391|B5||Female|Gender||Participants|Count of Participants|6|6.0||||||
3707674|NCT02153398|3547392|B4||Female|Gender||Participants|Count of Participants|7|7.0||||||
3707675|NCT02153398|3547393|B3||Female|Gender||Participants|Count of Participants|2|2.0||||||
3707676|NCT02153398|3547394|B2||Female|Gender||Participants|Count of Participants|6|6.0||||||
3707677|NCT02153398|3547395|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
3707678|NCT02153398|3547390|B6|12-14 years||Age, Customized||Participants|Number|20|20.0||||||
3707679|NCT02153398|3547391|B5|12-14 years||Age, Customized||Participants|Number|10|10.0||||||
3707680|NCT02153398|3547392|B4|12-14 years||Age, Customized||Participants|Number|10|10.0||||||
3707681|NCT02153398|3547393|B3|12-14 years||Age, Customized||Participants|Number|0|0.0||||||
3707682|NCT02153398|3547394|B2|12-14 years||Age, Customized||Participants|Number|0|0.0||||||
3707683|NCT02153398|3547395|B1|12-14 years||Age, Customized||Participants|Number|0|0.0||||||
3707684|NCT02153398|3547390|B6|10-11 years||Age, Customized||Participants|Number|5|5.0||||||
3707685|NCT02153398|3547391|B5|10-11 years||Age, Customized||Participants|Number|0|0.0||||||
3707686|NCT02153398|3547392|B4|10-11 years||Age, Customized||Participants|Number|0|0.0||||||
3707687|NCT02153398|3547393|B3|10-11 years||Age, Customized||Participants|Number|3|3.0||||||
3707688|NCT02153398|3547394|B2|10-11 years||Age, Customized||Participants|Number|2|2.0||||||
3707689|NCT02153398|3547395|B1|10-11 years||Age, Customized||Participants|Number|0|0.0||||||
3707690|NCT02153398|3547390|B6|8-9 years||Age, Customized||Participants|Number|11|11.0||||||
3707691|NCT02153398|3547391|B5|8-9 years||Age, Customized||Participants|Number|0|0.0||||||
3707692|NCT02153398|3547392|B4|8-9 years||Age, Customized||Participants|Number|0|0.0||||||
3707693|NCT02153398|3547393|B3|8-9 years||Age, Customized||Participants|Number|3|3.0||||||
3707694|NCT02153398|3547394|B2|8-9 years||Age, Customized||Participants|Number|8|8.0||||||
3707695|NCT02153398|3547395|B1|8-9 years||Age, Customized||Participants|Number|0|0.0||||||
3707696|NCT02153398|3547390|B6|6-7 years||Age, Customized||Participants|Number|7|7.0||||||
3707697|NCT02153398|3547391|B5|6-7 years||Age, Customized||Participants|Number|0|0.0||||||
3707698|NCT02153398|3547392|B4|6-7 years||Age, Customized||Participants|Number|0|0.0||||||
3707699|NCT02153398|3547393|B3|6-7 years||Age, Customized||Participants|Number|4|4.0||||||
3707700|NCT02153398|3547394|B2|6-7 years||Age, Customized||Participants|Number|0|0.0||||||
3707701|NCT02153398|3547395|B1|6-7 years||Age, Customized||Participants|Number|3|3.0||||||
3707702|NCT02153398|3547390|B6|4-5 years||Age, Customized||Participants|Number|2|2.0||||||
3707703|NCT02153398|3547391|B5|4-5 years||Age, Customized||Participants|Number|0|0.0||||||
3707704|NCT02153398|3547392|B4|4-5 years||Age, Customized||Participants|Number|0|0.0||||||
3707705|NCT02153398|3547393|B3|4-5 years||Age, Customized||Participants|Number|0|0.0||||||
3707706|NCT02153398|3547394|B2|4-5 years||Age, Customized||Participants|Number|0|0.0||||||
3707707|NCT02153398|3547395|B1|4-5 years||Age, Customized||Participants|Number|2|2.0||||||
3707708|NCT02153398|3547390|B6|<= 3 years||Age, Customized||Participants|Number|5|5.0||||||
3707709|NCT02153398|3547391|B5|<= 3 years||Age, Customized||Participants|Number|0|0.0||||||
3707710|NCT02153398|3547392|B4|<= 3 years||Age, Customized||Participants|Number|0|0.0||||||
3707711|NCT02153398|3547393|B3|<= 3 years||Age, Customized||Participants|Number|0|0.0||||||
3707712|NCT02153398|3547394|B2|<= 3 years||Age, Customized||Participants|Number|0|0.0||||||
3707713|NCT02153398|3547395|B1|<= 3 years||Age, Customized||Participants|Number|5|5.0||||||
3707714|NCT02153398|3547390|B6|||Age||Years|Mean|9.5|9.5|Standard Deviation|3.9|3.9|||
3707715|NCT02153398|3547391|B5|||Age||Years|Mean|13.1|13.1|Standard Deviation|0.9|0.9|||
3707716|NCT02153398|3547392|B4|||Age||Years|Mean|13.4|13.4|Standard Deviation|0.7|0.7|||
3707717|NCT02153398|3547393|B3|||Age||Years|Mean|8.4|8.4|Standard Deviation|1.8|1.8|||
3707718|NCT02153398|3547394|B2|||Age||Years|Mean|8.9|8.9|Standard Deviation|0.7|0.7|||
3707719|NCT02153398|3547395|B1|||Age||Years|Mean|3.6|3.6|Standard Deviation|2.2|2.2|||
3707720|NCT02153346|3547521|B1|Retired||Employment Status||Participants|Number|35|35.0||||||
3707721|NCT02153346|3547521|B1|Unemployed but seeking work||Employment Status||Participants|Number|1|1.0||||||
3707722|NCT02153346|3547521|B1|Work disability||Employment Status||Participants|Number|6|6.0||||||
3707723|NCT02153346|3547521|B1|Self-employed||Employment Status||Participants|Number|9|9.0||||||
3707724|NCT02153346|3547521|B1|Part-time as an employee||Employment Status||Participants|Number|13|13.0||||||
3707725|NCT02153346|3547521|B1|Full time||Employment Status||Participants|Number|37|37.0||||||
3707726|NCT02153346|3547521|B1|missing||Asthma severity|Mild asthma (no asthma medication; low daily dose of ICS monotherapy or LTRA, and Asthma Control Questionnaire (ACQ) < 1.5); Moderate asthma (medium to high daily dose of ICS monotherapy or low to medium daily dose of ICS plus LABA or LTRA, and ACQ < 1.5 or low daily dose ICS monotherapy or LTRA monotherapy, and ACQ ≥ 1.5); Severe asthma (high daily dose of ICS with LABA or LTRAs);Very severe asthma (Omalizumab and/or daily use of prednisone).|Participants|Number|18|18.0||||||
3707727|NCT02153346|3547521|B1|Severe||Asthma severity|Mild asthma (no asthma medication; low daily dose of ICS monotherapy or LTRA, and Asthma Control Questionnaire (ACQ) < 1.5); Moderate asthma (medium to high daily dose of ICS monotherapy or low to medium daily dose of ICS plus LABA or LTRA, and ACQ < 1.5 or low daily dose ICS monotherapy or LTRA monotherapy, and ACQ ≥ 1.5); Severe asthma (high daily dose of ICS with LABA or LTRAs);Very severe asthma (Omalizumab and/or daily use of prednisone).|Participants|Number|26|26.0||||||
3707728|NCT02153346|3547521|B1|Moderate||Asthma severity|Mild asthma (no asthma medication; low daily dose of ICS monotherapy or LTRA, and Asthma Control Questionnaire (ACQ) < 1.5); Moderate asthma (medium to high daily dose of ICS monotherapy or low to medium daily dose of ICS plus LABA or LTRA, and ACQ < 1.5 or low daily dose ICS monotherapy or LTRA monotherapy, and ACQ ≥ 1.5); Severe asthma (high daily dose of ICS with LABA or LTRAs);Very severe asthma (Omalizumab and/or daily use of prednisone).|Participants|Number|56|56.0||||||
3707782|NCT02153099|3547533|B3|Postmenopausal||Female Reproductive Status||participants|Number|1|1.0||||||
3707783|NCT02153099|3547534|B2|Postmenopausal||Female Reproductive Status||participants|Number|1|1.0||||||
3707784|NCT02153099|3547535|B1|Postmenopausal||Female Reproductive Status||participants|Number|1|1.0||||||
3707785|NCT02153099|3547528|B8|No||Caffeine Consumption||participants|Number|21|21.0||||||
3707729|NCT02153346|3547521|B1|Mild||Asthma severity|Mild asthma (no asthma medication; low daily dose of ICS monotherapy or LTRA, and Asthma Control Questionnaire (ACQ) < 1.5); Moderate asthma (medium to high daily dose of ICS monotherapy or low to medium daily dose of ICS plus LABA or LTRA, and ACQ < 1.5 or low daily dose ICS monotherapy or LTRA monotherapy, and ACQ ≥ 1.5); Severe asthma (high daily dose of ICS with LABA or LTRAs);Very severe asthma (Omalizumab and/or daily use of prednisone).|Participants|Number|1|1.0||||||
3707730|NCT02153346|3547521|B1|||Number of years at the HSCM asthma clinic||years|Mean|10.4|10.4|Standard Deviation|9.0|9.0|||
3707731|NCT02153346|3547521|B1|missing||BMI||Participants|Number|3|3.0||||||
3707732|NCT02153346|3547521|B1|>=30.0||BMI||Participants|Number|39|39.0||||||
3707733|NCT02153346|3547521|B1|25.0-29.9||BMI||Participants|Number|38|38.0||||||
3707734|NCT02153346|3547521|B1|18.5-24.9||BMI||Participants|Number|18|18.0||||||
3707735|NCT02153346|3547521|B1|<18.5||BMI||Participants|Number|3|3.0||||||
3707736|NCT02153346|3547521|B1|||FEV1/FVC|FEV1 is defined as forced expiratory volume in 1 second. FVC is defined as Forced vital capacity.|Percent|Mean|75.1|75.1|Standard Deviation|9.4|9.4|||
3707737|NCT02153346|3547521|B1|||FEV1|Within 90 days of registration date|Percent predicted|Mean|89.3|89.3|Standard Deviation|23.0|23.0|||
3707738|NCT02153346|3547521|B1|||Age of Asthma onset||Years|Mean|32.7|32.7|Standard Deviation|19.1|19.1|||
3707739|NCT02153346|3547521|B1|||Control|The Asthma Control Questionnaire (ACQ) is a 7-item questionnaire designed to measure the adequacy of asthma control and the change in asthma control (spontaneous or as a result of treatment). The items score symptoms, FEV1% predicted and daily use of rescue bronchodilator. Each item is scored on a 7 point scale (0=no impairment, 6=maximum impairment). Each item is equally weighted and the total score is the mean of the items (0=totally controlled, 6 severely uncontrolled).|ACQ Score|Mean|1.4|1.4|Standard Deviation|0.9|0.9|||
3707740|NCT02153346|3547521|B1|||Number of years with asthma||Years|Mean|20.7|20.7|Standard Deviation|16.7|16.7|||
3707741|NCT02153346|3547521|B1|missing||Smoking habits||Participants|Number|1|1.0||||||
3707742|NCT02153346|3547521|B1|Never smokers||Smoking habits||Participants|Number|46|46.0||||||
3707743|NCT02153346|3547521|B1|Current smokers||Smoking habits||Participants|Number|10|10.0||||||
3707744|NCT02153346|3547521|B1|Ex-smokers||Smoking habits||Participants|Number|44|44.0||||||
3707745|NCT02153346|3547521|B1|missing||Education||Participants|Number|1|1.0||||||
3707746|NCT02153346|3547521|B1|University||Education||Participants|Number|41|41.0||||||
3707747|NCT02153346|3547521|B1|College||Education||Participants|Number|15|15.0||||||
3707748|NCT02153346|3547521|B1|High school||Education||Participants|Number|27|27.0||||||
3707749|NCT02153346|3547521|B1|None||Education||Participants|Number|9|9.0||||||
3707750|NCT02153346|3547521|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3707751|NCT02153346|3547521|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3707752|NCT02153346|3547521|B1|||Age||Years|Mean|53.5|53.5|Standard Deviation|14.0|14.0|||
3707753|NCT02153099|3547528|B8|Subject is Male||Female Reproductive Status||participants|Number|39|39.0||||||
3707754|NCT02153099|3547529|B7|Subject is Male||Female Reproductive Status||participants|Number|10|10.0||||||
3707755|NCT02153099|3547530|B6|Subject is Male||Female Reproductive Status||participants|Number|6|6.0||||||
3707756|NCT02153099|3547531|B5|Subject is Male||Female Reproductive Status||participants|Number|5|5.0||||||
3707757|NCT02153099|3547532|B4|Subject is Male||Female Reproductive Status||participants|Number|4|4.0||||||
3707758|NCT02153099|3547533|B3|Subject is Male||Female Reproductive Status||participants|Number|4|4.0||||||
3707759|NCT02153099|3547534|B2|Subject is Male||Female Reproductive Status||participants|Number|5|5.0||||||
3707760|NCT02153099|3547535|B1|Subject is Male||Female Reproductive Status||participants|Number|5|5.0||||||
3707761|NCT02153099|3547528|B8|Female of Childbearing Potential||Female Reproductive Status||participants|Number|0|0.0||||||
3707762|NCT02153099|3547529|B7|Female of Childbearing Potential||Female Reproductive Status||participants|Number|0|0.0||||||
3707763|NCT02153099|3547530|B6|Female of Childbearing Potential||Female Reproductive Status||participants|Number|0|0.0||||||
3707764|NCT02153099|3547531|B5|Female of Childbearing Potential||Female Reproductive Status||participants|Number|0|0.0||||||
3707765|NCT02153099|3547532|B4|Female of Childbearing Potential||Female Reproductive Status||participants|Number|0|0.0||||||
3707766|NCT02153099|3547533|B3|Female of Childbearing Potential||Female Reproductive Status||participants|Number|0|0.0||||||
3707767|NCT02153099|3547534|B2|Female of Childbearing Potential||Female Reproductive Status||participants|Number|0|0.0||||||
3707768|NCT02153099|3547535|B1|Female of Childbearing Potential||Female Reproductive Status||participants|Number|0|0.0||||||
3707769|NCT02153099|3547528|B8|Surgically Sterile||Female Reproductive Status||participants|Number|6|6.0||||||
3707770|NCT02153099|3547529|B7|Surgically Sterile||Female Reproductive Status||participants|Number|2|2.0||||||
3707771|NCT02153099|3547530|B6|Surgically Sterile||Female Reproductive Status||participants|Number|0|0.0||||||
3707772|NCT02153099|3547531|B5|Surgically Sterile||Female Reproductive Status||participants|Number|1|1.0||||||
3707773|NCT02153099|3547532|B4|Surgically Sterile||Female Reproductive Status||participants|Number|2|2.0||||||
3707774|NCT02153099|3547533|B3|Surgically Sterile||Female Reproductive Status||participants|Number|1|1.0||||||
3707775|NCT02153099|3547534|B2|Surgically Sterile||Female Reproductive Status||participants|Number|0|0.0||||||
3707776|NCT02153099|3547535|B1|Surgically Sterile||Female Reproductive Status||participants|Number|0|0.0||||||
3707777|NCT02153099|3547528|B8|Postmenopausal||Female Reproductive Status||participants|Number|3|3.0||||||
3707778|NCT02153099|3547529|B7|Postmenopausal||Female Reproductive Status||participants|Number|0|0.0||||||
3707779|NCT02153099|3547530|B6|Postmenopausal||Female Reproductive Status||participants|Number|0|0.0||||||
3707780|NCT02153099|3547531|B5|Postmenopausal||Female Reproductive Status||participants|Number|0|0.0||||||
3707781|NCT02153099|3547532|B4|Postmenopausal||Female Reproductive Status||participants|Number|0|0.0||||||
3707786|NCT02153099|3547529|B7|No||Caffeine Consumption||participants|Number|6|6.0||||||
3707787|NCT02153099|3547530|B6|No||Caffeine Consumption||participants|Number|3|3.0||||||
3707788|NCT02153099|3547531|B5|No||Caffeine Consumption||participants|Number|2|2.0||||||
3707789|NCT02153099|3547532|B4|No||Caffeine Consumption||participants|Number|2|2.0||||||
3707790|NCT02153099|3547533|B3|No||Caffeine Consumption||participants|Number|2|2.0||||||
3707791|NCT02153099|3547534|B2|No||Caffeine Consumption||participants|Number|3|3.0||||||
3707792|NCT02153099|3547535|B1|No||Caffeine Consumption||participants|Number|3|3.0||||||
3707793|NCT02153099|3547528|B8|Yes||Caffeine Consumption||participants|Number|27|27.0||||||
3707794|NCT02153099|3547529|B7|Yes||Caffeine Consumption||participants|Number|6|6.0||||||
3707795|NCT02153099|3547530|B6|Yes||Caffeine Consumption||participants|Number|3|3.0||||||
3707796|NCT02153099|3547531|B5|Yes||Caffeine Consumption||participants|Number|4|4.0||||||
3707797|NCT02153099|3547532|B4|Yes||Caffeine Consumption||participants|Number|4|4.0||||||
3707798|NCT02153099|3547533|B3|Yes||Caffeine Consumption||participants|Number|4|4.0||||||
3707799|NCT02153099|3547534|B2|Yes||Caffeine Consumption||participants|Number|3|3.0||||||
3707800|NCT02153099|3547535|B1|Yes||Caffeine Consumption||participants|Number|3|3.0||||||
3707801|NCT02153099|3547528|B8|Ex-smoker||Smoking Status||participants|Number|6|6.0||||||
3707802|NCT02153099|3547529|B7|Ex-smoker||Smoking Status||participants|Number|1|1.0||||||
3707803|NCT02153099|3547530|B6|Ex-smoker||Smoking Status||participants|Number|1|1.0||||||
3707804|NCT02153099|3547531|B5|Ex-smoker||Smoking Status||participants|Number|1|1.0||||||
3707805|NCT02153099|3547532|B4|Ex-smoker||Smoking Status||participants|Number|0|0.0||||||
3707806|NCT02153099|3547533|B3|Ex-smoker||Smoking Status||participants|Number|1|1.0||||||
3707807|NCT02153099|3547534|B2|Ex-smoker||Smoking Status||participants|Number|1|1.0||||||
3707808|NCT02153099|3547535|B1|Ex-smoker||Smoking Status||participants|Number|1|1.0||||||
3707809|NCT02153099|3547528|B8|Current smoker||Smoking Status||participants|Number|0|0.0||||||
3707810|NCT02153099|3547529|B7|Current smoker||Smoking Status||participants|Number|0|0.0||||||
3707811|NCT02153099|3547530|B6|Current smoker||Smoking Status||participants|Number|0|0.0||||||
3707812|NCT02153099|3547531|B5|Current smoker||Smoking Status||participants|Number|0|0.0||||||
3707813|NCT02153099|3547532|B4|Current smoker||Smoking Status||participants|Number|0|0.0||||||
3707814|NCT02153099|3547533|B3|Current smoker||Smoking Status||participants|Number|0|0.0||||||
3707815|NCT02153099|3547534|B2|Current smoker||Smoking Status||participants|Number|0|0.0||||||
3707816|NCT02153099|3547535|B1|Current smoker||Smoking Status||participants|Number|0|0.0||||||
3707817|NCT02153099|3547528|B8|Never smoked||Smoking Status||participants|Number|42|42.0||||||
3707818|NCT02153099|3547529|B7|Never smoked||Smoking Status||participants|Number|11|11.0||||||
3707819|NCT02153099|3547530|B6|Never smoked||Smoking Status||participants|Number|5|5.0||||||
3707820|NCT02153099|3547531|B5|Never smoked||Smoking Status||participants|Number|5|5.0||||||
3707821|NCT02153099|3547532|B4|Never smoked||Smoking Status||participants|Number|6|6.0||||||
3707822|NCT02153099|3547533|B3|Never smoked||Smoking Status||participants|Number|5|5.0||||||
3707823|NCT02153099|3547534|B2|Never smoked||Smoking Status||participants|Number|5|5.0||||||
3707824|NCT02153099|3547535|B1|Never smoked||Smoking Status||participants|Number|5|5.0||||||
3707825|NCT02153099|3547528|B8|||Body Mass Index (BMI)||kg/m^2|Mean|25.40|25.4|Standard Deviation|2.770|2.77|||
3707826|NCT02153099|3547529|B7|||Body Mass Index (BMI)||kg/m^2|Mean|23.42|23.42|Standard Deviation|2.533|2.533|||
3707827|NCT02153099|3547530|B6|||Body Mass Index (BMI)||kg/m^2|Mean|25.89|25.89|Standard Deviation|2.728|2.728|||
3707828|NCT02153099|3547531|B5|||Body Mass Index (BMI)||kg/m^2|Mean|26.86|26.86|Standard Deviation|1.989|1.989|||
3707829|NCT02153099|3547532|B4|||Body Mass Index (BMI)||kg/m^2|Mean|27.39|27.39|Standard Deviation|2.440|2.44|||
3707830|NCT02153099|3547533|B3|||Body Mass Index (BMI)||kg/m^2|Mean|26.35|26.35|Standard Deviation|3.086|3.086|||
3707831|NCT02153099|3547534|B2|||Body Mass Index (BMI)||kg/m^2|Mean|25.11|25.11|Standard Deviation|1.674|1.674|||
3707832|NCT02153099|3547535|B1|||Body Mass Index (BMI)||kg/m^2|Mean|24.79|24.79|Standard Deviation|3.110|3.11|||
3707833|NCT02153099|3547528|B8|||Weight||kg|Mean|77.09|77.09|Standard Deviation|13.514|13.514|||
3707834|NCT02153099|3547529|B7|||Weight||kg|Mean|72.77|72.77|Standard Deviation|12.359|12.359|||
3707835|NCT02153099|3547530|B6|||Weight||kg|Mean|80.50|80.5|Standard Deviation|16.471|16.471|||
3707836|NCT02153099|3547531|B5|||Weight||kg|Mean|86.17|86.17|Standard Deviation|12.796|12.796|||
3707837|NCT02153099|3547532|B4|||Weight||kg|Mean|79.38|79.38|Standard Deviation|10.860|10.86|||
3707838|NCT02153099|3547533|B3|||Weight||kg|Mean|81.72|81.72|Standard Deviation|20.142|20.142|||
3707839|NCT02153099|3547534|B2|||Weight||kg|Mean|70.65|70.65|Standard Deviation|6.763|6.763|||
3707840|NCT02153099|3547535|B1|||Weight||kg|Mean|72.73|72.73|Standard Deviation|10.683|10.683|||
3707841|NCT02153099|3547528|B8|||Height||cm|Mean|173.8|173.8|Standard Deviation|10.49|10.49|||
3707842|NCT02153099|3547529|B7|||Height||cm|Mean|176.1|176.1|Standard Deviation|12.91|12.91|||
3707843|NCT02153099|3547530|B6|||Height||cm|Mean|175.5|175.5|Standard Deviation|8.69|8.69|||
3707844|NCT02153099|3547531|B5|||Height||cm|Mean|178.7|178.7|Standard Deviation|8.78|8.78|||
3707845|NCT02153099|3547532|B4|||Height||cm|Mean|170.2|170.2|Standard Deviation|10.42|10.42|||
3707846|NCT02153099|3547533|B3|||Height||cm|Mean|174.7|174.7|Standard Deviation|15.20|15.2|||
3707847|NCT02153099|3547534|B2|||Height||cm|Mean|167.7|167.7|Standard Deviation|6.44|6.44|||
3707848|NCT02153099|3547535|B1|||Height||cm|Mean|171.2|171.2|Standard Deviation|4.40|4.4|||
3707849|NCT02153099|3547528|B8|North America||Region of Enrollment||participants|Number|48|48.0||||||
3707850|NCT02153099|3547529|B7|North America||Region of Enrollment||participants|Number|12|12.0||||||
3707851|NCT02153099|3547530|B6|North America||Region of Enrollment||participants|Number|6|6.0||||||
3707852|NCT02153099|3547531|B5|North America||Region of Enrollment||participants|Number|6|6.0||||||
3707853|NCT02153099|3547532|B4|North America||Region of Enrollment||participants|Number|6|6.0||||||
3707854|NCT02153099|3547533|B3|North America||Region of Enrollment||participants|Number|6|6.0||||||
3707855|NCT02153099|3547534|B2|North America||Region of Enrollment||participants|Number|6|6.0||||||
3707856|NCT02153099|3547535|B1|North America||Region of Enrollment||participants|Number|6|6.0||||||
3707857|NCT02153099|3547528|B8|Non-Hispanic or non-Latino||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3707858|NCT02153099|3547529|B7|Non-Hispanic or non-Latino||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3707859|NCT02153099|3547530|B6|Non-Hispanic or non-Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3707860|NCT02153099|3547531|B5|Non-Hispanic or non-Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3707861|NCT02153099|3547532|B4|Non-Hispanic or non-Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3707862|NCT02153099|3547533|B3|Non-Hispanic or non-Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3707863|NCT02153099|3547534|B2|Non-Hispanic or non-Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3707864|NCT02153099|3547535|B1|Non-Hispanic or non-Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3707865|NCT02153099|3547528|B8|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3707866|NCT02153099|3547529|B7|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3707867|NCT02153099|3547530|B6|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3707868|NCT02153099|3547531|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3707869|NCT02153099|3547532|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3707870|NCT02153099|3547533|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3707871|NCT02153099|3547534|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3707872|NCT02153099|3547535|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3707873|NCT02153099|3547528|B8|White||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3707874|NCT02153099|3547529|B7|White||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3707875|NCT02153099|3547530|B6|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3707876|NCT02153099|3547531|B5|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3707877|NCT02153099|3547532|B4|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3707878|NCT02153099|3547533|B3|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3707879|NCT02153099|3547534|B2|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3707880|NCT02153099|3547535|B1|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3707881|NCT02153099|3547528|B8|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3707882|NCT02153099|3547529|B7|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3707883|NCT02153099|3547530|B6|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3707884|NCT02153099|3547531|B5|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3707885|NCT02153099|3547532|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3707886|NCT02153099|3547533|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3707887|NCT02153099|3547534|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3707888|NCT02153099|3547535|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3707889|NCT02153099|3547528|B8|Black or African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3707890|NCT02153099|3547529|B7|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3707891|NCT02153099|3547530|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3707892|NCT02153099|3547531|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3707893|NCT02153099|3547532|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3707894|NCT02153099|3547533|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3707895|NCT02153099|3547534|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3707896|NCT02153099|3547535|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3707897|NCT02153099|3547528|B8|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3707898|NCT02153099|3547529|B7|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3707899|NCT02153099|3547530|B6|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3707900|NCT02153099|3547531|B5|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3707901|NCT02153099|3547532|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3707902|NCT02153099|3547533|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3707903|NCT02153099|3547534|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3707904|NCT02153099|3547535|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3707905|NCT02153099|3547528|B8||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3707906|NCT02153099|3547529|B7||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3707907|NCT02153099|3547530|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3707908|NCT02153099|3547531|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3707909|NCT02153099|3547532|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3707910|NCT02153099|3547533|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3707911|NCT02153099|3547534|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3707912|NCT02153099|3547535|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3707913|NCT02153099|3547528|B8||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3707914|NCT02153099|3547529|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3707915|NCT02153099|3547530|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3707916|NCT02153099|3547531|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3707917|NCT02153099|3547532|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3707918|NCT02153099|3547533|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3707919|NCT02153099|3547534|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3707920|NCT02153099|3547535|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3707921|NCT02153099|3547528|B8|||Age||years|Mean|35.1|35.1|Standard Deviation|10.09|10.09|||
3707922|NCT02153099|3547529|B7|||Age||years|Mean|34.2|34.2|Standard Deviation|9.11|9.11|||
3707923|NCT02153099|3547530|B6|||Age||years|Mean|30.8|30.8|Standard Deviation|8.54|8.54|||
3707924|NCT02153099|3547531|B5|||Age||years|Mean|41.5|41.5|Standard Deviation|10.93|10.93|||
3707925|NCT02153099|3547532|B4|||Age||years|Mean|34.2|34.2|Standard Deviation|7.78|7.78|||
3707926|NCT02153099|3547533|B3|||Age||years|Mean|35.3|35.3|Standard Deviation|10.71|10.71|||
3707927|NCT02153099|3547534|B2|||Age||years|Mean|37.0|37.0|Standard Deviation|14.01|14.01|||
3707928|NCT02153099|3547535|B1|||Age||years|Mean|33.7|33.7|Standard Deviation|11.38|11.38|||
3707929|NCT02153086|3547595|B1|Renal and urinary disorders||Breakdown of complications|Complications were categorized as hypertension, dyslipidaemia, mental disease, allergic disease, diabetes mellitus, heart or cerebrovascular disease, and renal and urinary disorders. Participants may be represented in more than 1 category.|participants|Number|17|17.0||||||
3707930|NCT02153086|3547595|B1|Heart or cerebrovascular disease||Breakdown of complications|Complications were categorized as hypertension, dyslipidaemia, mental disease, allergic disease, diabetes mellitus, heart or cerebrovascular disease, and renal and urinary disorders. Participants may be represented in more than 1 category.|participants|Number|22|22.0||||||
3707931|NCT02153086|3547595|B1|Diabetes mellitus||Breakdown of complications|Complications were categorized as hypertension, dyslipidaemia, mental disease, allergic disease, diabetes mellitus, heart or cerebrovascular disease, and renal and urinary disorders. Participants may be represented in more than 1 category.|participants|Number|22|22.0||||||
3707932|NCT02153086|3547595|B1|Allergic disease||Breakdown of complications|Complications were categorized as hypertension, dyslipidaemia, mental disease, allergic disease, diabetes mellitus, heart or cerebrovascular disease, and renal and urinary disorders. Participants may be represented in more than 1 category.|participants|Number|23|23.0||||||
3707933|NCT02153086|3547595|B1|Mental disease||Breakdown of complications|Complications were categorized as hypertension, dyslipidaemia, mental disease, allergic disease, diabetes mellitus, heart or cerebrovascular disease, and renal and urinary disorders. Participants may be represented in more than 1 category.|participants|Number|32|32.0||||||
3707934|NCT02153086|3547595|B1|Dyslipidaemia||Breakdown of complications|Complications were categorized as hypertension, dyslipidaemia, mental disease, allergic disease, diabetes mellitus, heart or cerebrovascular disease, and renal and urinary disorders. Participants may be represented in more than 1 category.|participants|Number|57|57.0||||||
3707935|NCT02153086|3547595|B1|Hypertension||Breakdown of complications|Complications were categorized as hypertension, dyslipidaemia, mental disease, allergic disease, diabetes mellitus, heart or cerebrovascular disease, and renal and urinary disorders. Participants may be represented in more than 1 category.|participants|Number|86|86.0||||||
3707936|NCT02153086|3547595|B1|Had No Complications||Presence of complications||participants|Number|39|39.0||||||
3707937|NCT02153086|3547595|B1|Had Complications||Presence of complications||participants|Number|193|193.0||||||
3707938|NCT02153086|3547595|B1|Unknown||Duration of insomnia||participants|Number|90|90.0||||||
3707939|NCT02153086|3547595|B1|>=5 years||Duration of insomnia||participants|Number|11|11.0||||||
3707940|NCT02153086|3547595|B1|>=3 to <5 years||Duration of insomnia||participants|Number|14|14.0||||||
3707941|NCT02153086|3547595|B1|Greater than equal to (>=) 1 year to <3 years||Duration of insomnia||participants|Number|15|15.0||||||
3707942|NCT02153086|3547595|B1|Less than (<) 1 year||Duration of insomnia||participants|Number|102|102.0||2.71|2.71|||
3707943|NCT02153086|3547595|B1|Severe||Degree of sleep disorders|Degree of sleep disorders were categorized on the basis of severity, as mild, moderate or severe.|participants|Number|30|30.0||||||
3707944|NCT02153086|3547595|B1|Moderate||Degree of sleep disorders|Degree of sleep disorders were categorized on the basis of severity, as mild, moderate or severe.|participants|Number|130|130.0||||||
3707945|NCT02153086|3547595|B1|Mild||Degree of sleep disorders|Degree of sleep disorders were categorized on the basis of severity, as mild, moderate or severe.|participants|Number|72|72.0||||||
3707946|NCT02153086|3547595|B1|Unknown||Type of sleep disorders (Major symptoms)|Type of sleep disorders were classified on the basis of major symptoms as difficulty falling asleep, difficulty getting sound sleep, difficulty staying asleep, early morning awakening, and unknown.|participants|Number|43|43.0||||||
3707947|NCT02153086|3547595|B1|Early morning awakening||Type of sleep disorders (Major symptoms)|Type of sleep disorders were classified on the basis of major symptoms as difficulty falling asleep, difficulty getting sound sleep, difficulty staying asleep, early morning awakening, and unknown.|participants|Number|2|2.0||||||
3707948|NCT02153086|3547595|B1|Difficulty staying asleep||Type of sleep disorders (Major symptoms)|Type of sleep disorders were classified on the basis of major symptoms as difficulty falling asleep, difficulty getting sound sleep, difficulty staying asleep, early morning awakening, and unknown.|participants|Number|44|44.0||||||
3708004|NCT02152631|3547611|B1|Japan||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3707949|NCT02153086|3547595|B1|Difficulty getting sound sleep||Type of sleep disorders (Major symptoms)|Type of sleep disorders were classified on the basis of major symptoms as difficulty falling asleep, difficulty getting sound sleep, difficulty staying asleep, early morning awakening, and unknown.|participants|Number|16|16.0||||||
3707950|NCT02153086|3547595|B1|Difficulty falling asleep||Type of sleep disorders (Major symptoms)|Type of sleep disorders were classified on the basis of major symptoms as difficulty falling asleep, difficulty getting sound sleep, difficulty staying asleep, early morning awakening, and unknown.|participants|Number|127|127.0||||||
3707951|NCT02153086|3547595|B1||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3707952|NCT02153086|3547595|B1||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3707953|NCT02153086|3547595|B1|||Age||years|Mean|65.1|65.1|Standard Deviation|18.6|18.6|||
3707954|NCT02152631|3547609|B3|Germany||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3707955|NCT02152631|3547610|B2|Germany||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3707956|NCT02152631|3547611|B1|Germany||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3707957|NCT02152631|3547609|B3|France||Region of Enrollment||Participants|Count of Participants|67|67.0||||||
3707958|NCT02152631|3547610|B2|France||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3707959|NCT02152631|3547611|B1|France||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3707960|NCT02152631|3547609|B3|Israel||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3707961|NCT02152631|3547610|B2|Israel||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3707962|NCT02152631|3547611|B1|Israel||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3707963|NCT02152631|3547609|B3|Italy||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3707964|NCT02152631|3547610|B2|Italy||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3707965|NCT02152631|3547611|B1|Italy||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3707966|NCT02152631|3547609|B3|Poland||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3707967|NCT02152631|3547610|B2|Poland||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3707968|NCT02152631|3547611|B1|Poland||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3707969|NCT02152631|3547609|B3|Brazil||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3707970|NCT02152631|3547610|B2|Brazil||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3707971|NCT02152631|3547611|B1|Brazil||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3707972|NCT02152631|3547609|B3|Taiwan||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3707973|NCT02152631|3547610|B2|Taiwan||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3707974|NCT02152631|3547611|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3707975|NCT02152631|3547609|B3|China||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3707976|NCT02152631|3547610|B2|China||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3707977|NCT02152631|3547611|B1|China||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3707978|NCT02152631|3547609|B3|Turkey||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3707979|NCT02152631|3547610|B2|Turkey||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3707980|NCT02152631|3547611|B1|Turkey||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3707981|NCT02152631|3547609|B3|South Korea||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3707982|NCT02152631|3547610|B2|South Korea||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3707983|NCT02152631|3547611|B1|South Korea||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3707984|NCT02152631|3547609|B3|Austria||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3707985|NCT02152631|3547610|B2|Austria||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3707986|NCT02152631|3547611|B1|Austria||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3707987|NCT02152631|3547609|B3|Canada||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3707988|NCT02152631|3547610|B2|Canada||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3707989|NCT02152631|3547611|B1|Canada||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3707990|NCT02152631|3547609|B3|Greece||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3707991|NCT02152631|3547610|B2|Greece||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3707992|NCT02152631|3547611|B1|Greece||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3707993|NCT02152631|3547609|B3|Spain||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3707994|NCT02152631|3547610|B2|Spain||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3707995|NCT02152631|3547611|B1|Spain||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3707996|NCT02152631|3547609|B3|Russia||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3707997|NCT02152631|3547610|B2|Russia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3707998|NCT02152631|3547611|B1|Russia||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3707999|NCT02152631|3547609|B3|Ukraine||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3708000|NCT02152631|3547610|B2|Ukraine||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3708001|NCT02152631|3547611|B1|Ukraine||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3708002|NCT02152631|3547609|B3|Japan||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3708003|NCT02152631|3547610|B2|Japan||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3708005|NCT02152631|3547609|B3|United States||Region of Enrollment||Participants|Count of Participants|74|74.0||||||
3708006|NCT02152631|3547610|B2|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3708007|NCT02152631|3547611|B1|United States||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3708008|NCT02152631|3547609|B3|Romania||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3708009|NCT02152631|3547610|B2|Romania||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3708010|NCT02152631|3547611|B1|Romania||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3708011|NCT02152631|3547609|B3|Argentina||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3708012|NCT02152631|3547610|B2|Argentina||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3708013|NCT02152631|3547611|B1|Argentina||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3708014|NCT02152631|3547609|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3708015|NCT02152631|3547610|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3708016|NCT02152631|3547611|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3708017|NCT02152631|3547609|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3708018|NCT02152631|3547610|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3708019|NCT02152631|3547611|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3708020|NCT02152631|3547609|B3||White|Race (NIH/OMB)||Participants|Count of Participants|271|271.0||||||
3708021|NCT02152631|3547610|B2||White|Race (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
3708022|NCT02152631|3547611|B1||White|Race (NIH/OMB)||Participants|Count of Participants|165|165.0||||||
3708023|NCT02152631|3547609|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3708024|NCT02152631|3547610|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3708025|NCT02152631|3547611|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3708026|NCT02152631|3547609|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708027|NCT02152631|3547610|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708028|NCT02152631|3547611|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708029|NCT02152631|3547609|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
3708030|NCT02152631|3547610|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3708031|NCT02152631|3547611|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3708032|NCT02152631|3547609|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3708033|NCT02152631|3547610|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3708034|NCT02152631|3547611|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708035|NCT02152631|3547609|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3708036|NCT02152631|3547610|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3708037|NCT02152631|3547611|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3708038|NCT02152631|3547609|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|329|329.0||||||
3708039|NCT02152631|3547610|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
3708040|NCT02152631|3547611|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|197|197.0||||||
3708041|NCT02152631|3547609|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3708042|NCT02152631|3547610|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3708043|NCT02152631|3547611|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3708044|NCT02152631|3547609|B3||Male|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
3708045|NCT02152631|3547610|B2||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3708046|NCT02152631|3547611|B1||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3708047|NCT02152631|3547609|B3||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
3708048|NCT02152631|3547610|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3708049|NCT02152631|3547611|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3708050|NCT02152631|3547609|B3|||Age||years|Mean|62.5|62.5|Standard Deviation|8.7|8.7|||
3708051|NCT02152631|3547610|B2|||Age||years|Mean|62.9|62.9|Standard Deviation|8.4|8.4|||
3708052|NCT02152631|3547611|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|8.9|8.9|||
3708053|NCT02152605|3547629|B3|White - White/Caucasian/European||Race/Ethnicity, Customized||Participants|Number|489|489.0||||||
3708054|NCT02152605|3547630|B2|White - White/Caucasian/European||Race/Ethnicity, Customized||Participants|Number|244|244.0||||||
3708055|NCT02152605|3547631|B1|White - White/Caucasian/European||Race/Ethnicity, Customized||Participants|Number|245|245.0||||||
3708056|NCT02152605|3547629|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3708057|NCT02152605|3547630|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3708058|NCT02152605|3547631|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3708059|NCT02152605|3547629|B3||Male|Sex: Female, Male||Participants|Count of Participants|293|293.0||||||
3708060|NCT02152605|3547630|B2||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3708061|NCT02152605|3547631|B1||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3708062|NCT02152605|3547629|B3||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
3708063|NCT02152605|3547630|B2||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3708064|NCT02152605|3547631|B1||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3708065|NCT02152605|3547629|B3|||Age||Years|Mean|63.4|63.4|Standard Deviation|8.49|8.49|||
3708066|NCT02152605|3547630|B2|||Age||Years|Mean|64.1|64.1|Standard Deviation|8.70|8.7|||
3708067|NCT02152605|3547631|B1|||Age||Years|Mean|62.6|62.6|Standard Deviation|8.23|8.23|||
3708068|NCT02152566|3547642|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3708069|NCT02152566|3547642|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3708070|NCT02152566|3547642|B1|||Age||years|Mean|56.3|56.3|Standard Deviation|8.73|8.73|||
3708071|NCT02152371|3547646|B3|Not Treated with Metformin||Metformin Use at Baseline||participants|Number|35|35.0||||||
3708072|NCT02152371|3547647|B2|Not Treated with Metformin||Metformin Use at Baseline||participants|Number|19|19.0||||||
3708073|NCT02152371|3547648|B1|Not Treated with Metformin||Metformin Use at Baseline||participants|Number|16|16.0||||||
3708074|NCT02152371|3547646|B3|Treated with Metformin||Metformin Use at Baseline||participants|Number|265|265.0||||||
3708075|NCT02152371|3547647|B2|Treated with Metformin||Metformin Use at Baseline||participants|Number|131|131.0||||||
3708076|NCT02152371|3547648|B1|Treated with Metformin||Metformin Use at Baseline||participants|Number|134|134.0||||||
3708077|NCT02152371|3547646|B3|||Mean Insulin Glargine Dose||Units (U)|Mean|38.65|38.65|Standard Deviation|22.37|22.37|||
3708078|NCT02152371|3547647|B2|||Mean Insulin Glargine Dose||Units (U)|Mean|36.59|36.59|Standard Deviation|21.46|21.46|||
3708079|NCT02152371|3547648|B1|||Mean Insulin Glargine Dose||Units (U)|Mean|40.71|40.71|Standard Deviation|23.12|23.12|||
3708080|NCT02152371|3547646|B3|Spain||Region of Enrollment||participants|Number|55|55.0||||||
3708081|NCT02152371|3547647|B2|Spain||Region of Enrollment||participants|Number|26|26.0||||||
3708082|NCT02152371|3547648|B1|Spain||Region of Enrollment||participants|Number|29|29.0||||||
3708083|NCT02152371|3547646|B3|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3708084|NCT02152371|3547647|B2|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
3708085|NCT02152371|3547648|B1|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
3708086|NCT02152371|3547646|B3|Italy||Region of Enrollment||participants|Number|28|28.0||||||
3708087|NCT02152371|3547647|B2|Italy||Region of Enrollment||participants|Number|15|15.0||||||
3708088|NCT02152371|3547648|B1|Italy||Region of Enrollment||participants|Number|13|13.0||||||
3708089|NCT02152371|3547646|B3|United States||Region of Enrollment||participants|Number|61|61.0||||||
3708090|NCT02152371|3547647|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
3708091|NCT02152371|3547648|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
3708092|NCT02152371|3547646|B3|Hungary||Region of Enrollment||participants|Number|72|72.0||||||
3708093|NCT02152371|3547647|B2|Hungary||Region of Enrollment||participants|Number|35|35.0||||||
3708094|NCT02152371|3547648|B1|Hungary||Region of Enrollment||participants|Number|37|37.0||||||
3708095|NCT02152371|3547646|B3|Puerto Rico||Region of Enrollment||participants|Number|28|28.0||||||
3708096|NCT02152371|3547647|B2|Puerto Rico||Region of Enrollment||participants|Number|16|16.0||||||
3708097|NCT02152371|3547648|B1|Puerto Rico||Region of Enrollment||participants|Number|12|12.0||||||
3708098|NCT02152371|3547646|B3|Czech Republic||Region of Enrollment||participants|Number|52|52.0||||||
3708099|NCT02152371|3547647|B2|Czech Republic||Region of Enrollment||participants|Number|27|27.0||||||
3708100|NCT02152371|3547648|B1|Czech Republic||Region of Enrollment||participants|Number|25|25.0||||||
3708101|NCT02152371|3547646|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708102|NCT02152371|3547647|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708103|NCT02152371|3547648|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708104|NCT02152371|3547646|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3708105|NCT02152371|3547647|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3708106|NCT02152371|3547648|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3708107|NCT02152371|3547646|B3||White|Race (NIH/OMB)||Participants|Count of Participants|281|281.0||||||
3708108|NCT02152371|3547647|B2||White|Race (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
3708109|NCT02152371|3547648|B1||White|Race (NIH/OMB)||Participants|Count of Participants|143|143.0||||||
3708110|NCT02152371|3547646|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3708111|NCT02152371|3547647|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3708112|NCT02152371|3547648|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3708113|NCT02152371|3547646|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3708114|NCT02152371|3547647|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3708115|NCT02152371|3547648|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3708116|NCT02152371|3547646|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3708117|NCT02152371|3547647|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3708118|NCT02152371|3547648|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708119|NCT02152371|3547646|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708120|NCT02152371|3547647|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708121|NCT02152371|3547648|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708122|NCT02152371|3547646|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3708123|NCT02152371|3547647|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3708124|NCT02152371|3547648|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3708125|NCT02152371|3547646|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|208|208.0||||||
3708126|NCT02152371|3547647|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
3708127|NCT02152371|3547648|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
3708128|NCT02152371|3547646|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3708129|NCT02152371|3547647|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3708130|NCT02152371|3547648|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3708131|NCT02152371|3547646|B3||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
3708132|NCT02152371|3547647|B2||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3708133|NCT02152371|3547648|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3708134|NCT02152371|3547646|B3||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3708135|NCT02152371|3547647|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3708136|NCT02152371|3547648|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3708137|NCT02152371|3547646|B3|||Age||years|Mean|60.4|60.4|Standard Deviation|9.76|9.76|||
3708138|NCT02152371|3547647|B2|||Age||years|Mean|60.6|60.6|Standard Deviation|10.07|10.07|||
3708139|NCT02152371|3547648|B1|||Age||years|Mean|60.2|60.2|Standard Deviation|9.47|9.47|||
3708140|NCT02152007|3547685|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3708141|NCT02152007|3547685|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708142|NCT02152007|3547685|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708143|NCT02152007|3547685|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3708144|NCT02152007|3547685|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708145|NCT02152007|3547685|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708146|NCT02152007|3547685|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3708147|NCT02152007|3547685|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708148|NCT02152007|3547685|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3708149|NCT02152007|3547685|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3708150|NCT02152007|3547685|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3708151|NCT02152007|3547685|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3708152|NCT02152007|3547685|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3708153|NCT02151994|3547691|B4||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3708154|NCT02151994|3547692|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3708155|NCT02151994|3547693|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3708156|NCT02151994|3547694|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3708157|NCT02151994|3547691|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3708158|NCT02151994|3547692|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3708159|NCT02151994|3547693|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3708160|NCT02151994|3547694|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3708161|NCT02151994|3547691|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3708162|NCT02151994|3547692|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3708163|NCT02151994|3547693|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3708164|NCT02151994|3547694|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3708165|NCT02151994|3547691|B4||Between 18 and 65 years|Age||Participants|Count of Participants|122|122.0||||||
3708166|NCT02151994|3547692|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3708167|NCT02151994|3547693|B2||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3708168|NCT02151994|3547694|B1||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
3708169|NCT02151994|3547691|B4||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3708170|NCT02151994|3547692|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3708171|NCT02151994|3547693|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3708172|NCT02151994|3547694|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3708173|NCT02151981|3547744|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3708174|NCT02151981|3547745|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3708175|NCT02151981|3547746|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3708176|NCT02151981|3547744|B3|White||Race/Ethnicity, Customized||Participants|Number|134|134.0||||||
3708177|NCT02151981|3547745|B2|White||Race/Ethnicity, Customized||Participants|Number|45|45.0||||||
3708178|NCT02151981|3547746|B1|White||Race/Ethnicity, Customized||Participants|Number|89|89.0||||||
3708179|NCT02151981|3547744|B3|Other||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3708180|NCT02151981|3547745|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3708181|NCT02151981|3547746|B1|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3708182|NCT02151981|3547744|B3|Black Or African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3708183|NCT02151981|3547745|B2|Black Or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3708184|NCT02151981|3547746|B1|Black Or African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3708185|NCT02151981|3547744|B3|Asian||Race/Ethnicity, Customized||Participants|Number|274|274.0||||||
3708186|NCT02151981|3547745|B2|Asian||Race/Ethnicity, Customized||Participants|Number|92|92.0||||||
3708187|NCT02151981|3547746|B1|Asian||Race/Ethnicity, Customized||Participants|Number|182|182.0||||||
3708188|NCT02151981|3547744|B3||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3708189|NCT02151981|3547745|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3708190|NCT02151981|3547746|B1||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3708191|NCT02151981|3547744|B3||Female|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
3708192|NCT02151981|3547745|B2||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3708193|NCT02151981|3547746|B1||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3708194|NCT02151981|3547744|B3|||Age||Years|Mean|61.7|61.7|Standard Deviation|11.72|11.72|20.0|90.0|
3708195|NCT02151981|3547745|B2|||Age||Years|Mean|62.0|62.0|Standard Deviation|11.91|11.91|20.0|90.0|
3708196|NCT02151981|3547746|B1|||Age||Years|Mean|61.5|61.5|Standard Deviation|11.64|11.64|25.0|85.0|
3708197|NCT02151851|3547763|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3708198|NCT02151851|3547764|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3708199|NCT02151851|3547765|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3708200|NCT02151851|3547763|B3||Female|Sex: Female, Male||Participants|Count of Participants|363|363.0||||||
3708201|NCT02151851|3547764|B2||Female|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
3708202|NCT02151851|3547765|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3708203|NCT02151851|3547763|B3|||Age||years|Mean|47.9|47.9|Standard Deviation|11.6|11.6|||
3708204|NCT02151851|3547764|B2|||Age||years|Mean|48.2|48.2|Standard Deviation|11.8|11.8|||
3708205|NCT02151851|3547765|B1|||Age||years|Mean|47.1|47.1|Standard Deviation|11.1|11.1|||
3708206|NCT02151851|3547763|B3||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3708207|NCT02151851|3547764|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3708208|NCT02151851|3547765|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3708209|NCT02151851|3547763|B3||Between 18 and 65 years|Age||Participants|Count of Participants|405|405.0||||||
3708210|NCT02151851|3547764|B2||Between 18 and 65 years|Age||Participants|Count of Participants|298|298.0||||||
3708211|NCT02151851|3547765|B1||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
3708212|NCT02151851|3547763|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3708213|NCT02151851|3547764|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3708214|NCT02151851|3547765|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3708215|NCT02151786|3547778|B1|Other||Breakdown of Drugs|The participants with history of consumption of drugs affecting the coagulation system were categorized in this baseline measure on the basis of drugs which they have taken.|participants|Number|17|17.0||||||
3708216|NCT02151786|3547778|B1|Steroids||Breakdown of Drugs|The participants with history of consumption of drugs affecting the coagulation system were categorized in this baseline measure on the basis of drugs which they have taken.|participants|Number|31|31.0||||||
3708217|NCT02151786|3547778|B1|Anticoagulants||Breakdown of Drugs|The participants with history of consumption of drugs affecting the coagulation system were categorized in this baseline measure on the basis of drugs which they have taken.|participants|Number|49|49.0||||||
3708218|NCT02151786|3547778|B1|Platelet aggregation inhibitors||Breakdown of Drugs|The participants with history of consumption of drugs affecting the coagulation system were categorized in this baseline measure on the basis of drugs which they have taken.|participants|Number|152|152.0||||||
3708219|NCT02151786|3547778|B1|Non Steroidal Anti-Inflammatory Drugs||Breakdown of Drugs|The participants with history of consumption of drugs affecting the coagulation system were categorized in this baseline measure on the basis of drugs which they have taken.|participants|Number|158|158.0||||||
3708220|NCT02151786|3547778|B1|Unknown||Prior Consumption of Drugs Affecting Coagulation System|The participants with history of consumption of drugs affecting the coagulation system 1 month prior to study treatment were reported in this baseline measure.|participants|Number|1|1.0||||||
3708221|NCT02151786|3547778|B1|Yes||Prior Consumption of Drugs Affecting Coagulation System|The participants with history of consumption of drugs affecting the coagulation system 1 month prior to study treatment were reported in this baseline measure.|participants|Number|325|325.0||||||
3708222|NCT02151786|3547778|B1|No||Prior Consumption of Drugs Affecting Coagulation System|The participants with history of consumption of drugs affecting the coagulation system 1 month prior to study treatment were reported in this baseline measure.|participants|Number|758|758.0||||||
3708223|NCT02151786|3547778|B1|Had no Stress||Emotional Stress||participants|Number|955|955.0||||||
3708224|NCT02151786|3547778|B1|Had Stress||Emotional Stress||participants|Number|129|129.0||||||
3708225|NCT02151786|3547778|B1|Other||Breakdown of Complications||participants|Number|351|351.0||||||
3708226|NCT02151786|3547778|B1|Renal Dysfunction||Breakdown of Complications||participants|Number|61|61.0||||||
3708227|NCT02151786|3547778|B1|Cerebrovascular Accident||Breakdown of Complications||participants|Number|66|66.0||||||
3708228|NCT02151786|3547778|B1|Malignant Tumor||Breakdown of Complications||participants|Number|68|68.0||||||
3708229|NCT02151786|3547778|B1|Anemia||Breakdown of Complications||participants|Number|78|78.0||||||
3708230|NCT02151786|3547778|B1|Hepatic Dysfunction||Breakdown of Complications||participants|Number|115|115.0||||||
3708231|NCT02151786|3547778|B1|Diabetes Mellitus||Breakdown of Complications||participants|Number|118|118.0||||||
3708232|NCT02151786|3547778|B1|Cardiac Disorders||Breakdown of Complications||participants|Number|121|121.0||||||
3708233|NCT02151786|3547778|B1|Hypertension||Breakdown of Complications||participants|Number|206|206.0||||||
3708234|NCT02151786|3547778|B1|Had no Complications||Complications||participants|Number|452|452.0||||||
3708235|NCT02151786|3547778|B1|Had Complications||Complications||participants|Number|632|632.0||||||
3708236|NCT02151786|3547778|B1|Other||Breakdown of Medical History|Participants having more than 1 disease were reported in multiple categories.|participants|Number|187|187.0||||||
3708237|NCT02151786|3547778|B1|Renal Dysfunction||Breakdown of Medical History|Participants having more than 1 disease were reported in multiple categories.|participants|Number|13|13.0||||||
3708238|NCT02151786|3547778|B1|Diabetes Mellitus||Breakdown of Medical History|Participants having more than 1 disease were reported in multiple categories.|participants|Number|37|37.0||||||
3708239|NCT02151786|3547778|B1|Hepatic Dysfunction||Breakdown of Medical History|Participants having more than 1 disease were reported in multiple categories.|participants|Number|42|42.0||||||
3708240|NCT02151786|3547778|B1|Cardiac Disorders||Breakdown of Medical History|Participants having more than 1 disease were reported in multiple categories.|participants|Number|55|55.0||||||
3708241|NCT02151786|3547778|B1|Hypertension||Breakdown of Medical History|Participants having more than 1 disease were reported in multiple categories.|participants|Number|55|55.0||||||
3708242|NCT02151786|3547778|B1|Malignant Tumor||Breakdown of Medical History|Participants having more than 1 disease were reported in multiple categories.|participants|Number|59|59.0||||||
3708243|NCT02151786|3547778|B1|Cerebrovascular accident||Breakdown of Medical History|Participants having more than 1 disease were reported in multiple categories.|participants|Number|64|64.0||||||
3708244|NCT02151786|3547778|B1|Upper gastrointestinal bleeding||Breakdown of Medical History|Participants having more than 1 disease were reported in multiple categories.|participants|Number|97|97.0||||||
3708245|NCT02151786|3547778|B1|Peptic Ulcer||Breakdown of Medical History|Participants having more than 1 disease were reported in multiple categories.|participants|Number|241|241.0||||||
3708246|NCT02151786|3547778|B1|Did not Have Medical History||Medical History||participants|Number|510|510.0||||||
3708247|NCT02151786|3547778|B1|Have Medical History||Medical History||participants|Number|574|574.0||||||
3708248|NCT02151786|3547778|B1|Unknown||Smoking Status||participants|Number|168|168.0||||||
3708249|NCT02151786|3547778|B1|Non-Smoker||Smoking Status||participants|Number|599|599.0||||||
3708250|NCT02151786|3547778|B1|Smoker||Smoking Status||participants|Number|317|317.0||||||
3708251|NCT02151786|3547778|B1|Unknown||Alcohol Consumption||participants|Number|155|155.0||||||
3708252|NCT02151786|3547778|B1|Alcohol Non-Consumer||Alcohol Consumption||participants|Number|547|547.0||||||
3708253|NCT02151786|3547778|B1|Alcohol Consumer||Alcohol Consumption||participants|Number|382|382.0||||||
3708254|NCT02151786|3547778|B1|Unknown||Helicobacter pylori Infection|Participants diagnosed as positive or negative Helicobacter pylori infection were described in this baseline measure.|participants|Number|451|451.0||||||
3708255|NCT02151786|3547778|B1|Positive||Helicobacter pylori Infection|Participants diagnosed as positive or negative Helicobacter pylori infection were described in this baseline measure.|participants|Number|434|434.0||||||
3708256|NCT02151786|3547778|B1|Negative||Helicobacter pylori Infection|Participants diagnosed as positive or negative Helicobacter pylori infection were described in this baseline measure.|participants|Number|199|199.0||||||
3708257|NCT02151786|3547778|B1|Unknown||Predisposition to Hypersensitivity|Participants having tendency to suffer from hypersensitivity were classified in this baseline measure.|participants|Number|3|3.0||||||
3708258|NCT02151786|3547778|B1|Yes||Predisposition to Hypersensitivity|Participants having tendency to suffer from hypersensitivity were classified in this baseline measure.|participants|Number|39|39.0||||||
3708259|NCT02151786|3547778|B1|No||Predisposition to Hypersensitivity|Participants having tendency to suffer from hypersensitivity were classified in this baseline measure.|participants|Number|1042|1042.0||||||
3708260|NCT02151786|3547778|B1|Inpatient||Categories of Healthcare|Participants were categorized as outpatient and inpatient.|participants|Number|1073|1073.0||||||
3708261|NCT02151786|3547778|B1|Outpatient||Categories of Healthcare|Participants were categorized as outpatient and inpatient.|participants|Number|11|11.0||||||
3708262|NCT02151786|3547778|B1|Not Provided||Target Diseases|Number of participants suffering from different types of ulcer in the study were described in this baseline measure.|participants|Number|4|4.0||||||
3708263|NCT02151786|3547778|B1|Acute Gastric Mucosal Lesion||Target Diseases|Number of participants suffering from different types of ulcer in the study were described in this baseline measure.|participants|Number|60|60.0||||||
3708264|NCT02151786|3547778|B1|Acute Stress-Induced Ulcer||Target Diseases|Number of participants suffering from different types of ulcer in the study were described in this baseline measure.|participants|Number|8|8.0||||||
3708265|NCT02151786|3547778|B1|Gastroduodenal Ulcer||Target Diseases|Number of participants suffering from different types of ulcer in the study were described in this baseline measure.|participants|Number|23|23.0||||||
3708266|NCT02151786|3547778|B1|Duodenal Ulcer||Target Diseases|Number of participants suffering from different types of ulcer in the study were described in this baseline measure.|participants|Number|221|221.0||||||
3708267|NCT02151786|3547778|B1|Gastric Ulcer||Target Diseases|Number of participants suffering from different types of ulcer in the study were described in this baseline measure.|participants|Number|768|768.0||||||
3708268|NCT02151786|3547778|B1|Unknown||Pregnancy Status|This baseline characteristic was analysed only in female participants.|participants|Number|1|1.0||||||
3708269|NCT02151786|3547778|B1|Pregnant||Pregnancy Status|This baseline characteristic was analysed only in female participants.|participants|Number|0|0.0||||||
3708270|NCT02151786|3547778|B1|Not Pregnant||Pregnancy Status|This baseline characteristic was analysed only in female participants.|participants|Number|349|349.0||||||
3708271|NCT02151786|3547778|B1||Male|Sex: Female, Male||Participants|Count of Participants|734|734.0||||||
3708272|NCT02151786|3547778|B1||Female|Sex: Female, Male||Participants|Count of Participants|350|350.0||||||
3708273|NCT02151786|3547778|B1|||Age||years|Mean|66.2|66.2|Standard Deviation|14.74|14.74|||
3708274|NCT02151773|3547789|B1|Other survey||Type of surveying method after vaccination|Type of surveying method after vaccination included questionnaire, consultation and other survey (for example, call). Participants may be represented in more than 1 category.|participants|Number|154|154.0||||||
3708275|NCT02151773|3547789|B1|Consultation||Type of surveying method after vaccination|Type of surveying method after vaccination included questionnaire, consultation and other survey (for example, call). Participants may be represented in more than 1 category.|participants|Number|1230|1230.0||||||
3708276|NCT02151773|3547789|B1|Questionnaire||Type of surveying method after vaccination|Type of surveying method after vaccination included questionnaire, consultation and other survey (for example, call). Participants may be represented in more than 1 category.|participants|Number|3149|3149.0||||||
3708277|NCT02151773|3547789|B1|Not determined or not described||Experience with other vaccine||participants|Number|22|22.0||||||
3708278|NCT02151773|3547789|B1|No prior exposure to vaccine||Experience with other vaccine||participants|Number|92|92.0||||||
3708279|NCT02151773|3547789|B1|Prior exposure to vaccine||Experience with other vaccine||participants|Number|3315|3315.0||||||
3708280|NCT02151773|3547789|B1|Allergy to components of study vaccine||Items that require careful examination before vaccination|Participants were analyzed for any underlying disease such as cardiovascular disease. Allergy related to the components of the freeze-dried live attenuated measles and rubella combined vaccine was reported. Participants may be represented in more than 1 category.|participants|Number|49|49.0||||||
3708281|NCT02151773|3547789|B1|History of convulsions||Items that require careful examination before vaccination|Participants were analyzed for any underlying disease such as cardiovascular disease. Allergy related to the components of the freeze-dried live attenuated measles and rubella combined vaccine was reported. Participants may be represented in more than 1 category.|participants|Number|33|33.0||||||
3708282|NCT02151773|3547789|B1|Pyrexia and generalized rash||Items that require careful examination before vaccination|Participants were analyzed for any underlying disease such as cardiovascular disease. Allergy related to the components of the freeze-dried live attenuated measles and rubella combined vaccine was reported. Participants may be represented in more than 1 category.|participants|Number|4|4.0||||||
3708283|NCT02151773|3547789|B1|Underlying disease||Items that require careful examination before vaccination|Participants were analyzed for any underlying disease such as cardiovascular disease. Allergy related to the components of the freeze-dried live attenuated measles and rubella combined vaccine was reported. Participants may be represented in more than 1 category.|participants|Number|48|48.0||||||
3708284|NCT02151773|3547789|B1|Other concomitant medication||Concomitant medication|Participants may be represented in more than 1 category.|participants|Number|117|117.0||||||
3708285|NCT02151773|3547789|B1|GI drugs||Concomitant medication|Participants may be represented in more than 1 category.|participants|Number|21|21.0||||||
3708286|NCT02151773|3547789|B1|Neuropsychiatric drugs||Concomitant medication|Participants may be represented in more than 1 category.|participants|Number|5|5.0||||||
3708287|NCT02151773|3547789|B1|Antibiotic drugs||Concomitant medication|Participants may be represented in more than 1 category.|participants|Number|17|17.0||||||
3708288|NCT02151773|3547789|B1|Not determined or not described||Concomitant medication|Participants may be represented in more than 1 category.|participants|Number|10|10.0||||||
3708289|NCT02151773|3547789|B1|Other medical history||Medical history|Medical history defined as a disease or a health condition for each participant before start of the study. Medical history was classified as congenital anomalies, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, GI disorders, hepatic and biliary disorders, renal disease and other medical history. Other medical history included all medical history except for those mentioned above. Participants may be represented in more than 1 category.|participants|Number|177|177.0||||||
3708290|NCT02151773|3547789|B1|Renal disease||Medical history|Medical history defined as a disease or a health condition for each participant before start of the study. Medical history was classified as congenital anomalies, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, GI disorders, hepatic and biliary disorders, renal disease and other medical history. Other medical history included all medical history except for those mentioned above. Participants may be represented in more than 1 category.|participants|Number|2|2.0||||||
3708291|NCT02151773|3547789|B1|Hepatic and biliary disorders||Medical history|Medical history defined as a disease or a health condition for each participant before start of the study. Medical history was classified as congenital anomalies, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, GI disorders, hepatic and biliary disorders, renal disease and other medical history. Other medical history included all medical history except for those mentioned above. Participants may be represented in more than 1 category.|participants|Number|3|3.0||||||
3708292|NCT02151773|3547789|B1|GI disorders||Medical history|Medical history defined as a disease or a health condition for each participant before start of the study. Medical history was classified as congenital anomalies, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, GI disorders, hepatic and biliary disorders, renal disease and other medical history. Other medical history included all medical history except for those mentioned above. Participants may be represented in more than 1 category.|participants|Number|49|49.0||||||
3708293|NCT02151773|3547789|B1|Respiratory disorders||Medical history|Medical history defined as a disease or a health condition for each participant before start of the study. Medical history was classified as congenital anomalies, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, GI disorders, hepatic and biliary disorders, renal disease and other medical history. Other medical history included all medical history except for those mentioned above. Participants may be represented in more than 1 category.|participants|Number|149|149.0||||||
3708345|NCT02151643|3547799|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708346|NCT02151643|3547794|B6||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3708347|NCT02151643|3547795|B5||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3708294|NCT02151773|3547789|B1|Cardiovascular disorders||Medical history|Medical history defined as a disease or a health condition for each participant before start of the study. Medical history was classified as congenital anomalies, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, GI disorders, hepatic and biliary disorders, renal disease and other medical history. Other medical history included all medical history except for those mentioned above. Participants may be represented in more than 1 category.|participants|Number|25|25.0||||||
3708295|NCT02151773|3547789|B1|Psychiatric and nervous system disorders||Medical history|Medical history defined as a disease or a health condition for each participant before start of the study. Medical history was classified as congenital anomalies, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, GI disorders, hepatic and biliary disorders, renal disease and other medical history. Other medical history included all medical history except for those mentioned above. Participants may be represented in more than 1 category.|participants|Number|54|54.0||||||
3708296|NCT02151773|3547789|B1|Hematologic disorders||Medical history|Medical history defined as a disease or a health condition for each participant before start of the study. Medical history was classified as congenital anomalies, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, GI disorders, hepatic and biliary disorders, renal disease and other medical history. Other medical history included all medical history except for those mentioned above. Participants may be represented in more than 1 category.|participants|Number|10|10.0||||||
3708297|NCT02151773|3547789|B1|Congenital anomalies||Medical history|Medical history defined as a disease or a health condition for each participant before start of the study. Medical history was classified as congenital anomalies, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, GI disorders, hepatic and biliary disorders, renal disease and other medical history. Other medical history included all medical history except for those mentioned above. Participants may be represented in more than 1 category.|participants|Number|19|19.0||||||
3708298|NCT02151773|3547789|B1|Other complications||Complications|Complications defined as a disease or a health condition for each participant at the start of study. Complications were classified as congenital anomalies, endocrine disorders, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, gastrointestinal (GI) disorders, renal disease and other complications. Other complications included all complications except for those mentioned above. Participants may be represented in more than 1 category.|participants|Number|120|120.0||||||
3708299|NCT02151773|3547789|B1|Renal disease||Complications|Complications defined as a disease or a health condition for each participant at the start of study. Complications were classified as congenital anomalies, endocrine disorders, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, gastrointestinal (GI) disorders, renal disease and other complications. Other complications included all complications except for those mentioned above. Participants may be represented in more than 1 category.|participants|Number|4|4.0||||||
3708300|NCT02151773|3547789|B1|GI disorders||Complications|Complications defined as a disease or a health condition for each participant at the start of study. Complications were classified as congenital anomalies, endocrine disorders, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, gastrointestinal (GI) disorders, renal disease and other complications. Other complications included all complications except for those mentioned above. Participants may be represented in more than 1 category.|participants|Number|11|11.0||||||
3708301|NCT02151773|3547789|B1|Respiratory disorders||Complications|Complications defined as a disease or a health condition for each participant at the start of study. Complications were classified as congenital anomalies, endocrine disorders, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, gastrointestinal (GI) disorders, renal disease and other complications. Other complications included all complications except for those mentioned above. Participants may be represented in more than 1 category.|participants|Number|139|139.0||||||
3708302|NCT02151773|3547789|B1|Cardiovascular disorders||Complications|Complications defined as a disease or a health condition for each participant at the start of study. Complications were classified as congenital anomalies, endocrine disorders, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, gastrointestinal (GI) disorders, renal disease and other complications. Other complications included all complications except for those mentioned above. Participants may be represented in more than 1 category.|participants|Number|14|14.0||||||
3708303|NCT02151773|3547789|B1|Psychiatric and nervous system disorders||Complications|Complications defined as a disease or a health condition for each participant at the start of study. Complications were classified as congenital anomalies, endocrine disorders, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, gastrointestinal (GI) disorders, renal disease and other complications. Other complications included all complications except for those mentioned above. Participants may be represented in more than 1 category.|participants|Number|18|18.0||||||
3708304|NCT02151773|3547789|B1|Hematologic disorders||Complications|Complications defined as a disease or a health condition for each participant at the start of study. Complications were classified as congenital anomalies, endocrine disorders, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, gastrointestinal (GI) disorders, renal disease and other complications. Other complications included all complications except for those mentioned above. Participants may be represented in more than 1 category.|participants|Number|8|8.0||||||
3708305|NCT02151773|3547789|B1|Endocrine disorders||Complications|Complications defined as a disease or a health condition for each participant at the start of study. Complications were classified as congenital anomalies, endocrine disorders, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, gastrointestinal (GI) disorders, renal disease and other complications. Other complications included all complications except for those mentioned above. Participants may be represented in more than 1 category.|participants|Number|1|1.0||||||
3708348|NCT02151643|3547796|B4||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3708349|NCT02151643|3547797|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3708350|NCT02151643|3547798|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3708306|NCT02151773|3547789|B1|Congenital anomalies||Complications|Complications defined as a disease or a health condition for each participant at the start of study. Complications were classified as congenital anomalies, endocrine disorders, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, gastrointestinal (GI) disorders, renal disease and other complications. Other complications included all complications except for those mentioned above. Participants may be represented in more than 1 category.|participants|Number|20|20.0||||||
3708307|NCT02151773|3547789|B1|Not determined||Predisposition to hypersensitivity|Participants may be represented in more than 1 category.|participants|Number|41|41.0||||||
3708308|NCT02151773|3547789|B1|Other hypersensitivity||Predisposition to hypersensitivity|Participants may be represented in more than 1 category.|participants|Number|23|23.0||||||
3708309|NCT02151773|3547789|B1|Food hypersensitivity||Predisposition to hypersensitivity|Participants may be represented in more than 1 category.|participants|Number|187|187.0||||||
3708310|NCT02151773|3547789|B1|Drug hypersensitivity||Predisposition to hypersensitivity|Participants may be represented in more than 1 category.|participants|Number|10|10.0||||||
3708311|NCT02151773|3547789|B1|Japan||Region of Enrollment||participants|Number|3429|3429.0||||||
3708312|NCT02151773|3547789|B1||Male|Gender||Participants|Count of Participants|1759|1759.0||||||
3708313|NCT02151773|3547789|B1||Female|Gender||Participants|Count of Participants|1670|1670.0||||||
3708314|NCT02151773|3547789|B1|Greater than or equal to (>=) 18 months||Age, Customized||participants|Number|508|508.0||||||
3708315|NCT02151773|3547789|B1|>=12 to less than (<)18 months||Age, Customized||participants|Number|2921|2921.0||||||
3708316|NCT02151643|3547794|B6|≥ 7.5 mg/dL||Baseline Serum Phosphate Concentrations|Serum phosphate concentrations were used as stratum for randomisation. The pre-randomisation phosphate levels are summarised.|Participants|Count of Participants|62|62.0||||||
3708317|NCT02151643|3547795|B5|≥ 7.5 mg/dL||Baseline Serum Phosphate Concentrations|Serum phosphate concentrations were used as stratum for randomisation. The pre-randomisation phosphate levels are summarised.|Participants|Count of Participants|16|16.0||||||
3708318|NCT02151643|3547796|B4|≥ 7.5 mg/dL||Baseline Serum Phosphate Concentrations|Serum phosphate concentrations were used as stratum for randomisation. The pre-randomisation phosphate levels are summarised.|Participants|Count of Participants|16|16.0||||||
3708319|NCT02151643|3547797|B3|≥ 7.5 mg/dL||Baseline Serum Phosphate Concentrations|Serum phosphate concentrations were used as stratum for randomisation. The pre-randomisation phosphate levels are summarised.|Participants|Count of Participants|11|11.0||||||
3708320|NCT02151643|3547798|B2|≥ 7.5 mg/dL||Baseline Serum Phosphate Concentrations|Serum phosphate concentrations were used as stratum for randomisation. The pre-randomisation phosphate levels are summarised.|Participants|Count of Participants|8|8.0||||||
3708321|NCT02151643|3547799|B1|≥ 7.5 mg/dL||Baseline Serum Phosphate Concentrations|Serum phosphate concentrations were used as stratum for randomisation. The pre-randomisation phosphate levels are summarised.|Participants|Count of Participants|11|11.0||||||
3708322|NCT02151643|3547794|B6|< 7.5 mg/dL||Baseline Serum Phosphate Concentrations|Serum phosphate concentrations were used as stratum for randomisation. The pre-randomisation phosphate levels are summarised.|Participants|Count of Participants|79|79.0||||||
3708323|NCT02151643|3547795|B5|< 7.5 mg/dL||Baseline Serum Phosphate Concentrations|Serum phosphate concentrations were used as stratum for randomisation. The pre-randomisation phosphate levels are summarised.|Participants|Count of Participants|20|20.0||||||
3708324|NCT02151643|3547796|B4|< 7.5 mg/dL||Baseline Serum Phosphate Concentrations|Serum phosphate concentrations were used as stratum for randomisation. The pre-randomisation phosphate levels are summarised.|Participants|Count of Participants|20|20.0||||||
3708325|NCT02151643|3547797|B3|< 7.5 mg/dL||Baseline Serum Phosphate Concentrations|Serum phosphate concentrations were used as stratum for randomisation. The pre-randomisation phosphate levels are summarised.|Participants|Count of Participants|11|11.0||||||
3708326|NCT02151643|3547798|B2|< 7.5 mg/dL||Baseline Serum Phosphate Concentrations|Serum phosphate concentrations were used as stratum for randomisation. The pre-randomisation phosphate levels are summarised.|Participants|Count of Participants|15|15.0||||||
3708327|NCT02151643|3547799|B1|< 7.5 mg/dL||Baseline Serum Phosphate Concentrations|Serum phosphate concentrations were used as stratum for randomisation. The pre-randomisation phosphate levels are summarised.|Participants|Count of Participants|13|13.0||||||
3708328|NCT02151643|3547794|B6|United States||Region of Enrollment||Participants|Count of Participants|141|141.0||||||
3708329|NCT02151643|3547795|B5|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3708330|NCT02151643|3547796|B4|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3708331|NCT02151643|3547797|B3|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3708332|NCT02151643|3547798|B2|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3708333|NCT02151643|3547799|B1|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3708334|NCT02151643|3547794|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3708335|NCT02151643|3547795|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3708336|NCT02151643|3547796|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3708337|NCT02151643|3547797|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708338|NCT02151643|3547798|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3708339|NCT02151643|3547799|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3708340|NCT02151643|3547794|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708341|NCT02151643|3547795|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708342|NCT02151643|3547796|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708343|NCT02151643|3547797|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708344|NCT02151643|3547798|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708351|NCT02151643|3547799|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3708352|NCT02151643|3547794|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3708353|NCT02151643|3547795|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3708354|NCT02151643|3547796|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3708355|NCT02151643|3547797|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3708356|NCT02151643|3547798|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3708357|NCT02151643|3547799|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3708358|NCT02151643|3547794|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3708359|NCT02151643|3547795|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708360|NCT02151643|3547796|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708361|NCT02151643|3547797|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708362|NCT02151643|3547798|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3708363|NCT02151643|3547799|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3708364|NCT02151643|3547794|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3708365|NCT02151643|3547795|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3708366|NCT02151643|3547796|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3708367|NCT02151643|3547797|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708368|NCT02151643|3547798|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3708369|NCT02151643|3547799|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3708370|NCT02151643|3547794|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3708371|NCT02151643|3547795|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708372|NCT02151643|3547796|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708373|NCT02151643|3547797|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708374|NCT02151643|3547798|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708375|NCT02151643|3547799|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3708376|NCT02151643|3547794|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708377|NCT02151643|3547795|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708378|NCT02151643|3547796|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708379|NCT02151643|3547797|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708380|NCT02151643|3547798|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708381|NCT02151643|3547799|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708382|NCT02151643|3547794|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3708383|NCT02151643|3547795|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3708384|NCT02151643|3547796|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3708385|NCT02151643|3547797|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3708386|NCT02151643|3547798|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3708387|NCT02151643|3547799|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3708388|NCT02151643|3547794|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3708389|NCT02151643|3547795|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3708390|NCT02151643|3547796|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3708391|NCT02151643|3547797|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3708392|NCT02151643|3547798|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3708393|NCT02151643|3547799|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3708394|NCT02151643|3547794|B6||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3708395|NCT02151643|3547795|B5||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3708396|NCT02151643|3547796|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3708397|NCT02151643|3547797|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3708398|NCT02151643|3547798|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3708399|NCT02151643|3547799|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3708400|NCT02151643|3547794|B6||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3708401|NCT02151643|3547795|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3708402|NCT02151643|3547796|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3708403|NCT02151643|3547797|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3708404|NCT02151643|3547798|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3708405|NCT02151643|3547799|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3708406|NCT02151643|3547794|B6|||Age||years|Mean|57.5|57.5|Full Range|||23.0|86.0|
3708407|NCT02151643|3547795|B5|||Age||years|Mean|55.0|55.0|Full Range|||23.0|80.0|
3708408|NCT02151643|3547796|B4|||Age||years|Mean|55.9|55.9|Full Range|||26.0|77.0|
3708409|NCT02151643|3547797|B3|||Age||years|Mean|60.3|60.3|Full Range|||33.0|84.0|
3708410|NCT02151643|3547798|B2|||Age||years|Mean|58.0|58.0|Full Range|||30.0|78.0|
3708411|NCT02151643|3547799|B1|||Age||years|Mean|60.4|60.4|Full Range|||26.0|86.0|
3708412|NCT02151461|3547840|B5|Had Abdominal side effects from prior Metformin||Previous Metformin experience||Participants|Count of Participants|12|12.0||||||
3708413|NCT02151461|3547841|B4|Had Abdominal side effects from prior Metformin||Previous Metformin experience||Participants|Count of Participants|4|4.0||||||
3708414|NCT02151461|3547842|B3|Had Abdominal side effects from prior Metformin||Previous Metformin experience||Participants|Count of Participants|2|2.0||||||
3708415|NCT02151461|3547843|B2|Had Abdominal side effects from prior Metformin||Previous Metformin experience||Participants|Count of Participants|4|4.0||||||
3708416|NCT02151461|3547844|B1|Had Abdominal side effects from prior Metformin||Previous Metformin experience||Participants|Count of Participants|2|2.0||||||
3708417|NCT02151461|3547840|B5|No Abdominal side effects from prior Metformin||Previous Metformin experience||Participants|Count of Participants|71|71.0||||||
3708418|NCT02151461|3547841|B4|No Abdominal side effects from prior Metformin||Previous Metformin experience||Participants|Count of Participants|16|16.0||||||
3708419|NCT02151461|3547842|B3|No Abdominal side effects from prior Metformin||Previous Metformin experience||Participants|Count of Participants|17|17.0||||||
3708420|NCT02151461|3547843|B2|No Abdominal side effects from prior Metformin||Previous Metformin experience||Participants|Count of Participants|20|20.0||||||
3708421|NCT02151461|3547844|B1|No Abdominal side effects from prior Metformin||Previous Metformin experience||Participants|Count of Participants|18|18.0||||||
3708422|NCT02151461|3547840|B5|No Previous Experience||Previous Metformin experience||Participants|Count of Participants|13|13.0||||||
3708423|NCT02151461|3547841|B4|No Previous Experience||Previous Metformin experience||Participants|Count of Participants|3|3.0||||||
3708424|NCT02151461|3547842|B3|No Previous Experience||Previous Metformin experience||Participants|Count of Participants|5|5.0||||||
3708425|NCT02151461|3547843|B2|No Previous Experience||Previous Metformin experience||Participants|Count of Participants|1|1.0||||||
3708426|NCT02151461|3547844|B1|No Previous Experience||Previous Metformin experience||Participants|Count of Participants|4|4.0||||||
3708427|NCT02151461|3547840|B5|||Haemoglobin A1c (HbA1c)||%|Mean|8.00|8.0|Standard Deviation|0.747|0.747|||
3708428|NCT02151461|3547841|B4|||Haemoglobin A1c (HbA1c)||%|Mean|8.24|8.24|Standard Deviation|0.831|0.831|||
3708429|NCT02151461|3547842|B3|||Haemoglobin A1c (HbA1c)||%|Mean|7.82|7.82|Standard Deviation|0.563|0.563|||
3708430|NCT02151461|3547843|B2|||Haemoglobin A1c (HbA1c)||%|Mean|8.01|8.01|Standard Deviation|0.713|0.713|||
3708431|NCT02151461|3547844|B1|||Haemoglobin A1c (HbA1c)||%|Mean|7.95|7.95|Standard Deviation|0.837|0.837|||
3708432|NCT02151461|3547840|B5|||Fasting Plasma Glucose||mg/dL|Mean|182.9|182.9|Standard Deviation|46.93|46.93|||
3708433|NCT02151461|3547841|B4|||Fasting Plasma Glucose||mg/dL|Mean|184.7|184.7|Standard Deviation|50.87|50.87|||
3708434|NCT02151461|3547842|B3|||Fasting Plasma Glucose||mg/dL|Mean|182.8|182.8|Standard Deviation|40.97|40.97|||
3708435|NCT02151461|3547843|B2|||Fasting Plasma Glucose||mg/dL|Mean|170.3|170.3|Standard Deviation|44.28|44.28|||
3708436|NCT02151461|3547844|B1|||Fasting Plasma Glucose||mg/dL|Mean|194.3|194.3|Standard Deviation|50.86|50.86|||
3708437|NCT02151461|3547840|B5|||Body Mass Index (BMI)||kg/m^2|Mean|30.798|30.798|Standard Deviation|4.9778|4.9778|||
3708438|NCT02151461|3547841|B4|||Body Mass Index (BMI)||kg/m^2|Mean|31.146|31.146|Standard Deviation|4.5838|4.5838|||
3708439|NCT02151461|3547842|B3|||Body Mass Index (BMI)||kg/m^2|Mean|29.927|29.927|Standard Deviation|5.1504|5.1504|||
3708440|NCT02151461|3547843|B2|||Body Mass Index (BMI)||kg/m^2|Mean|30.985|30.985|Standard Deviation|5.5766|5.5766|||
3708441|NCT02151461|3547844|B1|||Body Mass Index (BMI)||kg/m^2|Mean|31.142|31.142|Standard Deviation|4.7113|4.7113|||
3708442|NCT02151461|3547840|B5|||Weight||kg|Mean|86.745|86.745|Standard Deviation|18.1696|18.1696|||
3708443|NCT02151461|3547841|B4|||Weight||kg|Mean|86.777|86.777|Standard Deviation|16.5700|16.57|||
3708444|NCT02151461|3547842|B3|||Weight||kg|Mean|84.493|84.493|Standard Deviation|19.8622|19.8622|||
3708445|NCT02151461|3547843|B2|||Weight||kg|Mean|88.584|88.584|Standard Deviation|19.4687|19.4687|||
3708446|NCT02151461|3547844|B1|||Weight||kg|Mean|87.049|87.049|Standard Deviation|17.3747|17.3747|||
3708447|NCT02151461|3547840|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708448|NCT02151461|3547841|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708449|NCT02151461|3547842|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708450|NCT02151461|3547843|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708451|NCT02151461|3547844|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708452|NCT02151461|3547840|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708453|NCT02151461|3547841|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708454|NCT02151461|3547842|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708455|NCT02151461|3547843|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708456|NCT02151461|3547844|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708457|NCT02151461|3547840|B5||White|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3708458|NCT02151461|3547841|B4||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3708459|NCT02151461|3547842|B3||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3708460|NCT02151461|3547843|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3708461|NCT02151461|3547844|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3708462|NCT02151461|3547840|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3708463|NCT02151461|3547841|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3708464|NCT02151461|3547842|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3708465|NCT02151461|3547843|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3708466|NCT02151461|3547844|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3708467|NCT02151461|3547840|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708468|NCT02151461|3547841|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708469|NCT02151461|3547842|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708470|NCT02151461|3547843|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708471|NCT02151461|3547844|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708472|NCT02151461|3547840|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3708473|NCT02151461|3547841|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3708474|NCT02151461|3547842|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708475|NCT02151461|3547843|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3708476|NCT02151461|3547844|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708477|NCT02151461|3547840|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3708478|NCT02151461|3547841|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708479|NCT02151461|3547842|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708480|NCT02151461|3547843|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3708481|NCT02151461|3547844|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708482|NCT02151461|3547840|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708483|NCT02151461|3547841|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708484|NCT02151461|3547842|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708485|NCT02151461|3547843|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708486|NCT02151461|3547844|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708487|NCT02151461|3547840|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3708488|NCT02151461|3547841|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3708489|NCT02151461|3547842|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3708490|NCT02151461|3547843|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3708491|NCT02151461|3547844|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3708492|NCT02151461|3547840|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3708493|NCT02151461|3547841|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3708494|NCT02151461|3547842|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3708495|NCT02151461|3547843|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3708496|NCT02151461|3547844|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3708497|NCT02151461|3547840|B5||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3708498|NCT02151461|3547841|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3708499|NCT02151461|3547842|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3708500|NCT02151461|3547843|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3708501|NCT02151461|3547844|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3708502|NCT02151461|3547840|B5||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3708503|NCT02151461|3547841|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3708504|NCT02151461|3547842|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3708505|NCT02151461|3547843|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3708506|NCT02151461|3547844|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3708507|NCT02151461|3547840|B5|≥65 years||Age, Customized||Participants|Count of Participants|21|21.0||||||
3708508|NCT02151461|3547841|B4|≥65 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
3708509|NCT02151461|3547842|B3|≥65 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
3708510|NCT02151461|3547843|B2|≥65 years||Age, Customized||Participants|Count of Participants|4|4.0||||||
3708511|NCT02151461|3547844|B1|≥65 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
3708512|NCT02151461|3547840|B5|<65 years||Age, Customized||Participants|Count of Participants|75|75.0||||||
3708513|NCT02151461|3547841|B4|<65 years||Age, Customized||Participants|Count of Participants|17|17.0||||||
3708514|NCT02151461|3547842|B3|<65 years||Age, Customized||Participants|Count of Participants|18|18.0||||||
3708515|NCT02151461|3547843|B2|<65 years||Age, Customized||Participants|Count of Participants|21|21.0||||||
3708516|NCT02151461|3547844|B1|<65 years||Age, Customized||Participants|Count of Participants|19|19.0||||||
3708517|NCT02151461|3547840|B5|||Age|Subjects who met the inclusion criteria, with FPG>126 to <220 mg/dL, HbA1c>7 to<8.5% and BMI<40kgm2|years|Mean|56.0|56.0|Standard Deviation|9.56|9.56|||
3708518|NCT02151461|3547841|B4|||Age|Subjects who met the inclusion criteria, with FPG>126 to <220 mg/dL, HbA1c>7 to<8.5% and BMI<40kgm2|years|Mean|59.3|59.3|Standard Deviation|9.64|9.64|||
3708519|NCT02151461|3547842|B3|||Age|Subjects who met the inclusion criteria, with FPG>126 to <220 mg/dL, HbA1c>7 to<8.5% and BMI<40kgm2|years|Mean|56.1|56.1|Standard Deviation|10.08|10.08|||
3708520|NCT02151461|3547843|B2|||Age|Subjects who met the inclusion criteria, with FPG>126 to <220 mg/dL, HbA1c>7 to<8.5% and BMI<40kgm2|years|Mean|55.1|55.1|Standard Deviation|8.3|8.3|||
3708521|NCT02151461|3547844|B1|||Age|Subjects who met the inclusion criteria, with FPG>126 to <220 mg/dL, HbA1c>7 to<8.5% and BMI<40kgm2|years|Mean|53.6|53.6|Standard Deviation|9.87|9.87|||
3708522|NCT02151331|3547885|B3|||Mood Disorder Symptoms (PHQ-9)|Mood disorder symptoms were measured using the Patient Health Questionnaire (9-question). The PHQ-9 has a scale range of 0-27 with lower values representing better outcomes.|units on a scale|Mean|12.08|12.08|Standard Deviation|6.73|6.73|||
3708523|NCT02151331|3547886|B2|||Mood Disorder Symptoms (PHQ-9)|Mood disorder symptoms were measured using the Patient Health Questionnaire (9-question). The PHQ-9 has a scale range of 0-27 with lower values representing better outcomes.|units on a scale|Mean|12.61|12.61|Standard Deviation|6.94|6.94|||
3708524|NCT02151331|3547887|B1|||Mood Disorder Symptoms (PHQ-9)|Mood disorder symptoms were measured using the Patient Health Questionnaire (9-question). The PHQ-9 has a scale range of 0-27 with lower values representing better outcomes.|units on a scale|Mean|11.45|11.45|Standard Deviation|6.46|6.46|||
3708525|NCT02151331|3547885|B3|||Mental Health Quality of Life|Mental Health Quality of Life was measured using the 12-Item Short Form Survey (SF-12). The SF-12 has a scale range of 0-100 with higher values representing better outcomes.|units on a scale|Mean|38.08|38.08|Standard Deviation|13.07|13.07|||
3708526|NCT02151331|3547886|B2|||Mental Health Quality of Life|Mental Health Quality of Life was measured using the 12-Item Short Form Survey (SF-12). The SF-12 has a scale range of 0-100 with higher values representing better outcomes.|units on a scale|Mean|36.66|36.66|Standard Deviation|13.10|13.1|||
3708527|NCT02151331|3547887|B1|||Mental Health Quality of Life|Mental Health Quality of Life was measured using the 12-Item Short Form Survey (SF-12). The SF-12 has a scale range of 0-100 with higher values representing better outcomes.|units on a scale|Mean|39.75|39.75|Standard Deviation|12.92|12.92|||
3708528|NCT02151331|3547885|B3|United States||Region of Enrollment||participants|Number|169|169.0||||||
3708529|NCT02151331|3547886|B2|United States||Region of Enrollment||participants|Number|92|92.0||||||
3708530|NCT02151331|3547887|B1|United States||Region of Enrollment||participants|Number|77|77.0||||||
3708531|NCT02151331|3547885|B3|Not Available||Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
3708532|NCT02151331|3547886|B2|Not Available||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3708533|NCT02151331|3547887|B1|Not Available||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3708534|NCT02151331|3547885|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|134|134.0||||||
3708535|NCT02151331|3547886|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|73|73.0||||||
3708536|NCT02151331|3547887|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|61|61.0||||||
3708537|NCT02151331|3547885|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3708538|NCT02151331|3547886|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3708539|NCT02151331|3547887|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3708540|NCT02151331|3547885|B3||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3708541|NCT02151331|3547886|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3708542|NCT02151331|3547887|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3708543|NCT02151331|3547885|B3|||Age||years|Mean|45.38|45.38|Standard Deviation|11.43|11.43|||
3708544|NCT02151331|3547886|B2|||Age||years|Mean|43.0|43.0|Standard Deviation|11.19|11.19|||
3708545|NCT02151331|3547887|B1|||Age||years|Mean|48.2|48.2|Standard Deviation|11.14|11.14|||
3708546|NCT02151253|3547900|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3708547|NCT02151253|3547900|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3708548|NCT02151253|3547900|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3708549|NCT02151253|3547900|B1|African American||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3708550|NCT02151253|3547900|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3708551|NCT02151253|3547900|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3708552|NCT02151253|3547900|B1|Between 18 and 90||Age, Customized||years|Mean|54.5|54.5|Standard Deviation|14.2|14.2|||
3708553|NCT02151149|3547915|B3||Data Missing|Number of Participants with Peripheral Neuropathy at Baseline|"Physician assessment for grading of peripheral neuropathy in participants receiving chemotherapy according to National Cancer Institute Common Toxicity Criteria (NCICTC):~Grade 1 = Asymptomatic: loss of deep tendon reflexes or paresthesia; Grade 2 = Moderate symptoms: limiting instrumental Activities of Daily Living (ADLs); Grade 3 = Severe symptoms: limiting self-care ADL; assistance device indicated; Grade 4 = Life-threatening consequences: urgent intervention indicated."|Participants|Count of Participants|4|4.0||||||
3708554|NCT02151149|3547916|B2||Data Missing|Number of Participants with Peripheral Neuropathy at Baseline|"Physician assessment for grading of peripheral neuropathy in participants receiving chemotherapy according to National Cancer Institute Common Toxicity Criteria (NCICTC):~Grade 1 = Asymptomatic: loss of deep tendon reflexes or paresthesia; Grade 2 = Moderate symptoms: limiting instrumental Activities of Daily Living (ADLs); Grade 3 = Severe symptoms: limiting self-care ADL; assistance device indicated; Grade 4 = Life-threatening consequences: urgent intervention indicated."|Participants|Count of Participants|2|2.0||||||
3708631|NCT02151149|3547915|B3||≥ 90 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
3708632|NCT02151149|3547916|B2||≥ 90 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
3708555|NCT02151149|3547917|B1||Data Missing|Number of Participants with Peripheral Neuropathy at Baseline|"Physician assessment for grading of peripheral neuropathy in participants receiving chemotherapy according to National Cancer Institute Common Toxicity Criteria (NCICTC):~Grade 1 = Asymptomatic: loss of deep tendon reflexes or paresthesia; Grade 2 = Moderate symptoms: limiting instrumental Activities of Daily Living (ADLs); Grade 3 = Severe symptoms: limiting self-care ADL; assistance device indicated; Grade 4 = Life-threatening consequences: urgent intervention indicated."|Participants|Count of Participants|2|2.0||||||
3708556|NCT02151149|3547915|B3||Grade 2|Number of Participants with Peripheral Neuropathy at Baseline|"Physician assessment for grading of peripheral neuropathy in participants receiving chemotherapy according to National Cancer Institute Common Toxicity Criteria (NCICTC):~Grade 1 = Asymptomatic: loss of deep tendon reflexes or paresthesia; Grade 2 = Moderate symptoms: limiting instrumental Activities of Daily Living (ADLs); Grade 3 = Severe symptoms: limiting self-care ADL; assistance device indicated; Grade 4 = Life-threatening consequences: urgent intervention indicated."|Participants|Count of Participants|1|1.0||||||
3708557|NCT02151149|3547916|B2||Grade 2|Number of Participants with Peripheral Neuropathy at Baseline|"Physician assessment for grading of peripheral neuropathy in participants receiving chemotherapy according to National Cancer Institute Common Toxicity Criteria (NCICTC):~Grade 1 = Asymptomatic: loss of deep tendon reflexes or paresthesia; Grade 2 = Moderate symptoms: limiting instrumental Activities of Daily Living (ADLs); Grade 3 = Severe symptoms: limiting self-care ADL; assistance device indicated; Grade 4 = Life-threatening consequences: urgent intervention indicated."|Participants|Count of Participants|0|0.0||||||
3708558|NCT02151149|3547917|B1||Grade 2|Number of Participants with Peripheral Neuropathy at Baseline|"Physician assessment for grading of peripheral neuropathy in participants receiving chemotherapy according to National Cancer Institute Common Toxicity Criteria (NCICTC):~Grade 1 = Asymptomatic: loss of deep tendon reflexes or paresthesia; Grade 2 = Moderate symptoms: limiting instrumental Activities of Daily Living (ADLs); Grade 3 = Severe symptoms: limiting self-care ADL; assistance device indicated; Grade 4 = Life-threatening consequences: urgent intervention indicated."|Participants|Count of Participants|1|1.0||||||
3708559|NCT02151149|3547915|B3||Grade 1|Number of Participants with Peripheral Neuropathy at Baseline|"Physician assessment for grading of peripheral neuropathy in participants receiving chemotherapy according to National Cancer Institute Common Toxicity Criteria (NCICTC):~Grade 1 = Asymptomatic: loss of deep tendon reflexes or paresthesia; Grade 2 = Moderate symptoms: limiting instrumental Activities of Daily Living (ADLs); Grade 3 = Severe symptoms: limiting self-care ADL; assistance device indicated; Grade 4 = Life-threatening consequences: urgent intervention indicated."|Participants|Count of Participants|27|27.0||||||
3708560|NCT02151149|3547916|B2||Grade 1|Number of Participants with Peripheral Neuropathy at Baseline|"Physician assessment for grading of peripheral neuropathy in participants receiving chemotherapy according to National Cancer Institute Common Toxicity Criteria (NCICTC):~Grade 1 = Asymptomatic: loss of deep tendon reflexes or paresthesia; Grade 2 = Moderate symptoms: limiting instrumental Activities of Daily Living (ADLs); Grade 3 = Severe symptoms: limiting self-care ADL; assistance device indicated; Grade 4 = Life-threatening consequences: urgent intervention indicated."|Participants|Count of Participants|13|13.0||||||
3708561|NCT02151149|3547917|B1||Grade 1|Number of Participants with Peripheral Neuropathy at Baseline|"Physician assessment for grading of peripheral neuropathy in participants receiving chemotherapy according to National Cancer Institute Common Toxicity Criteria (NCICTC):~Grade 1 = Asymptomatic: loss of deep tendon reflexes or paresthesia; Grade 2 = Moderate symptoms: limiting instrumental Activities of Daily Living (ADLs); Grade 3 = Severe symptoms: limiting self-care ADL; assistance device indicated; Grade 4 = Life-threatening consequences: urgent intervention indicated."|Participants|Count of Participants|14|14.0||||||
3708562|NCT02151149|3547915|B3||No Peripheral Neuropathy|Number of Participants with Peripheral Neuropathy at Baseline|"Physician assessment for grading of peripheral neuropathy in participants receiving chemotherapy according to National Cancer Institute Common Toxicity Criteria (NCICTC):~Grade 1 = Asymptomatic: loss of deep tendon reflexes or paresthesia; Grade 2 = Moderate symptoms: limiting instrumental Activities of Daily Living (ADLs); Grade 3 = Severe symptoms: limiting self-care ADL; assistance device indicated; Grade 4 = Life-threatening consequences: urgent intervention indicated."|Participants|Count of Participants|111|111.0||||||
3708563|NCT02151149|3547916|B2||No Peripheral Neuropathy|Number of Participants with Peripheral Neuropathy at Baseline|"Physician assessment for grading of peripheral neuropathy in participants receiving chemotherapy according to National Cancer Institute Common Toxicity Criteria (NCICTC):~Grade 1 = Asymptomatic: loss of deep tendon reflexes or paresthesia; Grade 2 = Moderate symptoms: limiting instrumental Activities of Daily Living (ADLs); Grade 3 = Severe symptoms: limiting self-care ADL; assistance device indicated; Grade 4 = Life-threatening consequences: urgent intervention indicated."|Participants|Count of Participants|57|57.0||||||
3708564|NCT02151149|3547917|B1||No Peripheral Neuropathy|Number of Participants with Peripheral Neuropathy at Baseline|"Physician assessment for grading of peripheral neuropathy in participants receiving chemotherapy according to National Cancer Institute Common Toxicity Criteria (NCICTC):~Grade 1 = Asymptomatic: loss of deep tendon reflexes or paresthesia; Grade 2 = Moderate symptoms: limiting instrumental Activities of Daily Living (ADLs); Grade 3 = Severe symptoms: limiting self-care ADL; assistance device indicated; Grade 4 = Life-threatening consequences: urgent intervention indicated."|Participants|Count of Participants|54|54.0||||||
3708565|NCT02151149|3547915|B3|||Body Mass Index (BMI)|Body Mass Index = (Weight in kg) / (Height in m)^2.|Kg/m^2|Mean|26.193|26.193|Standard Deviation|4.7051|4.7051|||
3708566|NCT02151149|3547916|B2|||Body Mass Index (BMI)|Body Mass Index = (Weight in kg) / (Height in m)^2.|Kg/m^2|Mean|26.033|26.033|Standard Deviation|4.7562|4.7562|||
3708567|NCT02151149|3547917|B1|||Body Mass Index (BMI)|Body Mass Index = (Weight in kg) / (Height in m)^2.|Kg/m^2|Mean|26.357|26.357|Standard Deviation|4.6805|4.6805|||
3708568|NCT02151149|3547915|B3|||Number of Prior Systemic Anticancer Therapies for Non-Small Cell Lung Cancer (NSCLC)||Therapies|Median|2.0|2.0|Full Range|||1.0|4.0|
3708569|NCT02151149|3547916|B2|||Number of Prior Systemic Anticancer Therapies for Non-Small Cell Lung Cancer (NSCLC)||Therapies|Median|2.0|2.0|Full Range|||2.0|4.0|
3708570|NCT02151149|3547917|B1|||Number of Prior Systemic Anticancer Therapies for Non-Small Cell Lung Cancer (NSCLC)||Therapies|Median|2.0|2.0|Full Range|||1.0|2.0|
3708633|NCT02151149|3547917|B1||≥ 90 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3708634|NCT02151149|3547915|B3||85-89 years|Age, Customized||Participants|Count of Participants|4|4.0||||||
3708571|NCT02151149|3547915|B3||Data Missing|Stage of Disease at Enrollment|Disease stage means how big the tumor is and how far it has spread. Disease stages range from 0 (not spread) to IV (spread throughout the body). Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes; if the tumor has spread only to the lymph nodes on the same side of the chest where the cancer started, it is Stage IIIA; if the tumor has spread to the lymph nodes on the opposite side or above the collar bone, it is Stage IIIb. Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|Participants|Count of Participants|1|1.0||||||
3708572|NCT02151149|3547916|B2||Data Missing|Stage of Disease at Enrollment|Disease stage means how big the tumor is and how far it has spread. Disease stages range from 0 (not spread) to IV (spread throughout the body). Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes; if the tumor has spread only to the lymph nodes on the same side of the chest where the cancer started, it is Stage IIIA; if the tumor has spread to the lymph nodes on the opposite side or above the collar bone, it is Stage IIIb. Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|Participants|Count of Participants|0|0.0||||||
3708573|NCT02151149|3547917|B1||Data Missing|Stage of Disease at Enrollment|Disease stage means how big the tumor is and how far it has spread. Disease stages range from 0 (not spread) to IV (spread throughout the body). Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes; if the tumor has spread only to the lymph nodes on the same side of the chest where the cancer started, it is Stage IIIA; if the tumor has spread to the lymph nodes on the opposite side or above the collar bone, it is Stage IIIb. Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|Participants|Count of Participants|1|1.0||||||
3708574|NCT02151149|3547915|B3||IV|Stage of Disease at Enrollment|Disease stage means how big the tumor is and how far it has spread. Disease stages range from 0 (not spread) to IV (spread throughout the body). Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes; if the tumor has spread only to the lymph nodes on the same side of the chest where the cancer started, it is Stage IIIA; if the tumor has spread to the lymph nodes on the opposite side or above the collar bone, it is Stage IIIb. Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|Participants|Count of Participants|119|119.0||||||
3708575|NCT02151149|3547916|B2||IV|Stage of Disease at Enrollment|Disease stage means how big the tumor is and how far it has spread. Disease stages range from 0 (not spread) to IV (spread throughout the body). Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes; if the tumor has spread only to the lymph nodes on the same side of the chest where the cancer started, it is Stage IIIA; if the tumor has spread to the lymph nodes on the opposite side or above the collar bone, it is Stage IIIb. Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|Participants|Count of Participants|59|59.0||||||
3708576|NCT02151149|3547917|B1||IV|Stage of Disease at Enrollment|Disease stage means how big the tumor is and how far it has spread. Disease stages range from 0 (not spread) to IV (spread throughout the body). Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes; if the tumor has spread only to the lymph nodes on the same side of the chest where the cancer started, it is Stage IIIA; if the tumor has spread to the lymph nodes on the opposite side or above the collar bone, it is Stage IIIb. Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|Participants|Count of Participants|60|60.0||||||
3708577|NCT02151149|3547915|B3||IIIb|Stage of Disease at Enrollment|Disease stage means how big the tumor is and how far it has spread. Disease stages range from 0 (not spread) to IV (spread throughout the body). Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes; if the tumor has spread only to the lymph nodes on the same side of the chest where the cancer started, it is Stage IIIA; if the tumor has spread to the lymph nodes on the opposite side or above the collar bone, it is Stage IIIb. Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|Participants|Count of Participants|14|14.0||||||
3708578|NCT02151149|3547916|B2||IIIb|Stage of Disease at Enrollment|Disease stage means how big the tumor is and how far it has spread. Disease stages range from 0 (not spread) to IV (spread throughout the body). Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes; if the tumor has spread only to the lymph nodes on the same side of the chest where the cancer started, it is Stage IIIA; if the tumor has spread to the lymph nodes on the opposite side or above the collar bone, it is Stage IIIb. Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|Participants|Count of Participants|8|8.0||||||
3708579|NCT02151149|3547917|B1||IIIb|Stage of Disease at Enrollment|Disease stage means how big the tumor is and how far it has spread. Disease stages range from 0 (not spread) to IV (spread throughout the body). Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes; if the tumor has spread only to the lymph nodes on the same side of the chest where the cancer started, it is Stage IIIA; if the tumor has spread to the lymph nodes on the opposite side or above the collar bone, it is Stage IIIb. Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|Participants|Count of Participants|6|6.0||||||
3708580|NCT02151149|3547915|B3||IIIa|Stage of Disease at Enrollment|Disease stage means how big the tumor is and how far it has spread. Disease stages range from 0 (not spread) to IV (spread throughout the body). Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes; if the tumor has spread only to the lymph nodes on the same side of the chest where the cancer started, it is Stage IIIA; if the tumor has spread to the lymph nodes on the opposite side or above the collar bone, it is Stage IIIb. Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|Participants|Count of Participants|9|9.0||||||
3708581|NCT02151149|3547916|B2||IIIa|Stage of Disease at Enrollment|Disease stage means how big the tumor is and how far it has spread. Disease stages range from 0 (not spread) to IV (spread throughout the body). Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes; if the tumor has spread only to the lymph nodes on the same side of the chest where the cancer started, it is Stage IIIA; if the tumor has spread to the lymph nodes on the opposite side or above the collar bone, it is Stage IIIb. Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|Participants|Count of Participants|5|5.0||||||
3708635|NCT02151149|3547916|B2||85-89 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
3708636|NCT02151149|3547917|B1||85-89 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
3708582|NCT02151149|3547917|B1||IIIa|Stage of Disease at Enrollment|Disease stage means how big the tumor is and how far it has spread. Disease stages range from 0 (not spread) to IV (spread throughout the body). Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes; if the tumor has spread only to the lymph nodes on the same side of the chest where the cancer started, it is Stage IIIA; if the tumor has spread to the lymph nodes on the opposite side or above the collar bone, it is Stage IIIb. Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|Participants|Count of Participants|4|4.0||||||
3708583|NCT02151149|3547915|B3||Non-Squamous Cell Carcinoma|Confirmed Histology||Participants|Count of Participants|88|88.0||||||
3708584|NCT02151149|3547916|B2||Non-Squamous Cell Carcinoma|Confirmed Histology||Participants|Count of Participants|44|44.0||||||
3708585|NCT02151149|3547917|B1||Non-Squamous Cell Carcinoma|Confirmed Histology||Participants|Count of Participants|44|44.0||||||
3708586|NCT02151149|3547915|B3||Squamous Cell Carcinoma|Confirmed Histology||Participants|Count of Participants|55|55.0||||||
3708587|NCT02151149|3547916|B2||Squamous Cell Carcinoma|Confirmed Histology||Participants|Count of Participants|28|28.0||||||
3708588|NCT02151149|3547917|B1||Squamous Cell Carcinoma|Confirmed Histology||Participants|Count of Participants|27|27.0||||||
3708589|NCT02151149|3547915|B3|4 = Completely Disabled.||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Number|0|0.0||||||
3708590|NCT02151149|3547916|B2|4 = Completely Disabled.||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Number|0|0.0||||||
3708591|NCT02151149|3547917|B1|4 = Completely Disabled.||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Number|0|0.0||||||
3708592|NCT02151149|3547915|B3|3 = Capable of Only Limited Self-care||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Number|0|0.0||||||
3708593|NCT02151149|3547916|B2|3 = Capable of Only Limited Self-care||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Number|0|0.0||||||
3708594|NCT02151149|3547917|B1|3 = Capable of Only Limited Self-care||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Number|0|0.0||||||
3708595|NCT02151149|3547915|B3|2 = Ambulatory and Capable of All Self-care||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Number|0|0.0||||||
3708596|NCT02151149|3547916|B2|2 = Ambulatory and Capable of All Self-care||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Number|0|0.0||||||
3708597|NCT02151149|3547917|B1|2 = Ambulatory and Capable of All Self-care||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Number|0|0.0||||||
3708637|NCT02151149|3547915|B3||80-84 years|Age, Customized||Participants|Count of Participants|36|36.0||||||
3708638|NCT02151149|3547916|B2||80-84 years|Age, Customized||Participants|Count of Participants|17|17.0||||||
3708639|NCT02151149|3547917|B1||80-84 years|Age, Customized||Participants|Count of Participants|19|19.0||||||
3708598|NCT02151149|3547915|B3|1 = Restricted in Physical Activity; Ambulatory||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Number|102|102.0||||||
3708599|NCT02151149|3547916|B2|1 = Restricted in Physical Activity; Ambulatory||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Number|52|52.0||||||
3708600|NCT02151149|3547917|B1|1 = Restricted in Physical Activity; Ambulatory||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Number|50|50.0||||||
3708601|NCT02151149|3547915|B3|0 = Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Number|41|41.0||||||
3708602|NCT02151149|3547916|B2|0 = Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Number|20|20.0||||||
3708603|NCT02151149|3547917|B1|0 = Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Number|21|21.0||||||
3708604|NCT02151149|3547915|B3||Data Missing|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3708605|NCT02151149|3547916|B2||Data Missing|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3708606|NCT02151149|3547917|B1||Data Missing|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3708607|NCT02151149|3547915|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3708608|NCT02151149|3547916|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3708609|NCT02151149|3547917|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3708610|NCT02151149|3547915|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|121|121.0||||||
3708611|NCT02151149|3547916|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|57|57.0||||||
3708612|NCT02151149|3547917|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|64|64.0||||||
3708613|NCT02151149|3547915|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3708614|NCT02151149|3547916|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3708615|NCT02151149|3547917|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3708616|NCT02151149|3547915|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3708617|NCT02151149|3547916|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3708618|NCT02151149|3547917|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3708619|NCT02151149|3547915|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3708620|NCT02151149|3547916|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3708621|NCT02151149|3547917|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3708622|NCT02151149|3547915|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3708623|NCT02151149|3547916|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3708624|NCT02151149|3547917|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3708625|NCT02151149|3547915|B3||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3708626|NCT02151149|3547916|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3708627|NCT02151149|3547917|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3708628|NCT02151149|3547915|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3708629|NCT02151149|3547916|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3708630|NCT02151149|3547917|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3708812|NCT02150044|3548116|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3708640|NCT02151149|3547915|B3||75-79 years|Age, Customized||Participants|Count of Participants|48|48.0||||||
3708641|NCT02151149|3547916|B2||75-79 years|Age, Customized||Participants|Count of Participants|18|18.0||||||
3708642|NCT02151149|3547917|B1||75-79 years|Age, Customized||Participants|Count of Participants|30|30.0||||||
3708643|NCT02151149|3547915|B3||70-74 years|Age, Customized||Participants|Count of Participants|53|53.0||||||
3708644|NCT02151149|3547916|B2||70-74 years|Age, Customized||Participants|Count of Participants|33|33.0||||||
3708645|NCT02151149|3547917|B1||70-74 years|Age, Customized||Participants|Count of Participants|20|20.0||||||
3708646|NCT02151149|3547915|B3|||Age||years|Mean|76.6|76.6|Standard Deviation|4.67|4.67|||
3708647|NCT02151149|3547916|B2|||Age||years|Mean|76.4|76.4|Standard Deviation|5.18|5.18|||
3708648|NCT02151149|3547917|B1|||Age||years|Mean|76.7|76.7|Standard Deviation|4.13|4.13|||
3708649|NCT02151058|3547942|B4|USA||Region of Enrollment||participants|Number|227|227.0||||||
3708650|NCT02151058|3547943|B3|USA||Region of Enrollment||participants|Number|91|91.0||||||
3708651|NCT02151058|3547944|B2|USA||Region of Enrollment||participants|Number|91|91.0||||||
3708652|NCT02151058|3547945|B1|USA||Region of Enrollment||participants|Number|45|45.0||||||
3708653|NCT02151058|3547942|B4||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3708654|NCT02151058|3547943|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3708655|NCT02151058|3547944|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3708656|NCT02151058|3547945|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3708657|NCT02151058|3547942|B4||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3708658|NCT02151058|3547943|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3708659|NCT02151058|3547944|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3708660|NCT02151058|3547945|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3708661|NCT02151058|3547942|B4|||Age||years|Mean|43.8|43.8|Standard Deviation|12.29|12.29|||
3708662|NCT02151058|3547943|B3|||Age||years|Mean|44.0|44.0|Standard Deviation|12.40|12.4|||
3708663|NCT02151058|3547944|B2|||Age||years|Mean|43.3|43.3|Standard Deviation|12.15|12.15|||
3708664|NCT02151058|3547945|B1|||Age||years|Mean|44.2|44.2|Standard Deviation|12.57|12.57|||
3708665|NCT02150954|3547979|B3|United States||Region of Enrollment||participants|Number|116|116.0||||||
3708666|NCT02150954|3547980|B2|United States||Region of Enrollment||participants|Number|59|59.0||||||
3708667|NCT02150954|3547981|B1|United States||Region of Enrollment||participants|Number|57|57.0||||||
3708668|NCT02150954|3547979|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3708669|NCT02150954|3547980|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3708670|NCT02150954|3547981|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3708671|NCT02150954|3547979|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708672|NCT02150954|3547980|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708673|NCT02150954|3547981|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708674|NCT02150954|3547979|B3||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3708675|NCT02150954|3547980|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3708676|NCT02150954|3547981|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3708677|NCT02150954|3547979|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3708678|NCT02150954|3547980|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3708679|NCT02150954|3547981|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3708680|NCT02150954|3547979|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708681|NCT02150954|3547980|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708682|NCT02150954|3547981|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708683|NCT02150954|3547979|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3708684|NCT02150954|3547980|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708685|NCT02150954|3547981|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3708686|NCT02150954|3547979|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3708687|NCT02150954|3547980|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3708688|NCT02150954|3547981|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708689|NCT02150954|3547979|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3708690|NCT02150954|3547980|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3708691|NCT02150954|3547981|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3708692|NCT02150954|3547979|B3||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3708693|NCT02150954|3547980|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3708694|NCT02150954|3547981|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3708695|NCT02150954|3547979|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3708696|NCT02150954|3547980|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3708697|NCT02150954|3547981|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3708698|NCT02150954|3547979|B3||Between 18 and 65 years|Age||Participants|Count of Participants|116|116.0||||||
3708699|NCT02150954|3547980|B2||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
3708700|NCT02150954|3547981|B1||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
3708701|NCT02150954|3547979|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3708702|NCT02150954|3547980|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3708703|NCT02150954|3547981|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3708704|NCT02150499|3548004|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
3708705|NCT02150499|3548005|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3708706|NCT02150499|3548006|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3708707|NCT02150499|3548004|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3708708|NCT02150499|3548005|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3708709|NCT02150499|3548006|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3708710|NCT02150499|3548004|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3708711|NCT02150499|3548005|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3708712|NCT02150499|3548006|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3708713|NCT02150499|3548004|B3|||Age||months|Mean|17.8|17.8|Standard Deviation|11.23|11.23|||
3708714|NCT02150499|3548005|B2|||Age||months|Mean|17.1|17.1|Standard Deviation|12.75|12.75|||
3708715|NCT02150499|3548006|B1|||Age||months|Mean|18.6|18.6|Standard Deviation|10.21|10.21|||
3708716|NCT02150499|3548004|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3708717|NCT02150499|3548005|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3708718|NCT02150499|3548006|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3708719|NCT02150499|3548004|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3708720|NCT02150499|3548005|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3708721|NCT02150499|3548006|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3708722|NCT02150499|3548004|B3||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
3708723|NCT02150499|3548005|B2||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
3708724|NCT02150499|3548006|B1||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
3708725|NCT02150460|3548027|B3|||Weight (kg)||kilogram|Mean|59.26|59.26|Standard Deviation|11.9|11.9|||
3708726|NCT02150460|3548028|B2|||Weight (kg)||kilogram|Mean|57.38|57.38|Standard Deviation|10.3|10.3|||
3708727|NCT02150460|3548029|B1|||Weight (kg)||kilogram|Mean|61.48|61.48|Standard Deviation|13.0|13.0|||
3708728|NCT02150460|3548027|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3708729|NCT02150460|3548028|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3708730|NCT02150460|3548029|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3708731|NCT02150460|3548027|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3708732|NCT02150460|3548028|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3708733|NCT02150460|3548029|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3708734|NCT02150460|3548027|B3|||Age||years|Mean|63.45|63.45|Standard Deviation|9.2|9.2|||
3708735|NCT02150460|3548028|B2|||Age||years|Mean|62.60|62.6|Standard Deviation|10.7|10.7|||
3708736|NCT02150460|3548029|B1|||Age||years|Mean|64.30|64.3|Standard Deviation|7.4|7.4|||
3708737|NCT02150343|3548054|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3708738|NCT02150343|3548055|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3708739|NCT02150343|3548056|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3708740|NCT02150343|3548057|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3708741|NCT02150343|3548058|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3708742|NCT02150343|3548054|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708743|NCT02150343|3548055|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708744|NCT02150343|3548056|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708745|NCT02150343|3548057|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708746|NCT02150343|3548058|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708747|NCT02150343|3548054|B5||White|Race (NIH/OMB)||Participants|Count of Participants|555|555.0||||||
3708748|NCT02150343|3548055|B4||White|Race (NIH/OMB)||Participants|Count of Participants|136|136.0||||||
3708749|NCT02150343|3548056|B3||White|Race (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
3708750|NCT02150343|3548057|B2||White|Race (NIH/OMB)||Participants|Count of Participants|133|133.0||||||
3708751|NCT02150343|3548058|B1||White|Race (NIH/OMB)||Participants|Count of Participants|142|142.0||||||
3708752|NCT02150343|3548054|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3708753|NCT02150343|3548055|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3708754|NCT02150343|3548056|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3708755|NCT02150343|3548057|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3708756|NCT02150343|3548058|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3708757|NCT02150343|3548054|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708758|NCT02150343|3548055|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708759|NCT02150343|3548056|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708760|NCT02150343|3548057|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708761|NCT02150343|3548058|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708762|NCT02150343|3548054|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3708763|NCT02150343|3548055|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3708764|NCT02150343|3548056|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3708765|NCT02150343|3548057|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3708766|NCT02150343|3548058|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3708767|NCT02150343|3548054|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3708768|NCT02150343|3548055|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708769|NCT02150343|3548056|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3708770|NCT02150343|3548057|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708771|NCT02150343|3548058|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3708772|NCT02150343|3548054|B5||Male|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
3708773|NCT02150343|3548055|B4||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3708774|NCT02150343|3548056|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3708775|NCT02150343|3548057|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3708776|NCT02150343|3548058|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3708777|NCT02150343|3548054|B5||Female|Sex: Female, Male||Participants|Count of Participants|453|453.0||||||
3708778|NCT02150343|3548055|B4||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3708779|NCT02150343|3548056|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3708780|NCT02150343|3548057|B2||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3708781|NCT02150343|3548058|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3708782|NCT02150343|3548054|B5|||Age||years|Mean|36.8|36.8|Standard Deviation|12.12|12.12|||
3708783|NCT02150343|3548055|B4|||Age||years|Mean|36.8|36.8|Standard Deviation|12.84|12.84|||
3708784|NCT02150343|3548056|B3|||Age||years|Mean|35.5|35.5|Standard Deviation|11.61|11.61|||
3708785|NCT02150343|3548057|B2|||Age||years|Mean|38.3|38.3|Standard Deviation|12.40|12.4|||
3708786|NCT02150343|3548058|B1|||Age||years|Mean|36.7|36.7|Standard Deviation|11.53|11.53|||
3708787|NCT02150213|3548099|B1||Male|Gender||Participants|Count of Participants|28|28.0||||||
3708788|NCT02150213|3548099|B1||Female|Gender||Participants|Count of Participants|31|31.0||||||
3708789|NCT02150213|3548099|B1|||Age||Years|Mean|43.2|43.2|Standard Deviation|11.58|11.58|||
3708790|NCT02150109|3548104|B1|United States||Region of Enrollment||participants|Number|372|372.0||||||
3708791|NCT02150109|3548104|B1|Unknown or Not Reported||Race (NIH/OMB)|Subjects provided more than one choice for Race, therefore the apparent frequency total for Race was different from number of subjects.|responses|Number|7|7.0||||||
3708792|NCT02150109|3548104|B1|More than one race||Race (NIH/OMB)|Subjects provided more than one choice for Race, therefore the apparent frequency total for Race was different from number of subjects.|responses|Number|6|6.0||||||
3708793|NCT02150109|3548104|B1|White||Race (NIH/OMB)|Subjects provided more than one choice for Race, therefore the apparent frequency total for Race was different from number of subjects.|responses|Number|305|305.0||||||
3708794|NCT02150109|3548104|B1|Black or African American||Race (NIH/OMB)|Subjects provided more than one choice for Race, therefore the apparent frequency total for Race was different from number of subjects.|responses|Number|32|32.0||||||
3708795|NCT02150109|3548104|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|Subjects provided more than one choice for Race, therefore the apparent frequency total for Race was different from number of subjects.|responses|Number|4|4.0||||||
3708796|NCT02150109|3548104|B1|Asian||Race (NIH/OMB)|Subjects provided more than one choice for Race, therefore the apparent frequency total for Race was different from number of subjects.|responses|Number|23|23.0||||||
3708797|NCT02150109|3548104|B1|American Indian or Alaska Native||Race (NIH/OMB)|Subjects provided more than one choice for Race, therefore the apparent frequency total for Race was different from number of subjects.|responses|Number|7|7.0||||||
3708798|NCT02150109|3548104|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3708799|NCT02150109|3548104|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|320|320.0||||||
3708800|NCT02150109|3548104|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3708801|NCT02150109|3548104|B1||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3708802|NCT02150109|3548104|B1||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3708803|NCT02150109|3548104|B1|||Age||years|Mean|51.1|51.1|Full Range|||18.0|82.0|
3708804|NCT02150044|3548116|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3708805|NCT02150044|3548116|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3708806|NCT02150044|3548116|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708807|NCT02150044|3548116|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3708808|NCT02150044|3548116|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3708809|NCT02150044|3548116|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708810|NCT02150044|3548116|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3708811|NCT02150044|3548116|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708813|NCT02150044|3548116|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3708814|NCT02150044|3548116|B1|||Age||years|Mean|3.7|3.7|Standard Deviation|3.1|3.1|||
3708815|NCT02149875|3548122|B4|||Barthel Index score|The scores range from 0, indicating complete dependence on help with activities of daily living, to 100, indicating independence.|units on a scale|Mean|21.33|21.33|Standard Deviation|6.83|6.83|||
3708816|NCT02149875|3548123|B3|||Barthel Index score|The scores range from 0, indicating complete dependence on help with activities of daily living, to 100, indicating independence.|units on a scale|Mean|22.00|22.0|Standard Deviation|6.96|6.96|||
3708817|NCT02149875|3548124|B2|||Barthel Index score|The scores range from 0, indicating complete dependence on help with activities of daily living, to 100, indicating independence.|units on a scale|Mean|22.25|22.25|Standard Deviation|7.16|7.16|||
3708818|NCT02149875|3548125|B1|||Barthel Index score|The scores range from 0, indicating complete dependence on help with activities of daily living, to 100, indicating independence.|units on a scale|Mean|19.75|19.75|Standard Deviation|6.38|6.38|||
3708819|NCT02149875|3548122|B4|||National Institutes of Health Stroke Scale score|The scores range from 0 to 42, with higher scores indicating increasing severity. A score of < 4 represented low-degree impairment, between 4 and 15 represented medium-degree impairment, and a score of > 15 represented severe-degree impairment.|units on a scale|Mean|11.1|11.1|Standard Deviation|4.28|4.28|||
3708820|NCT02149875|3548123|B3|||National Institutes of Health Stroke Scale score|The scores range from 0 to 42, with higher scores indicating increasing severity. A score of < 4 represented low-degree impairment, between 4 and 15 represented medium-degree impairment, and a score of > 15 represented severe-degree impairment.|units on a scale|Mean|10.2|10.2|Standard Deviation|3.72|3.72|||
3708821|NCT02149875|3548124|B2|||National Institutes of Health Stroke Scale score|The scores range from 0 to 42, with higher scores indicating increasing severity. A score of < 4 represented low-degree impairment, between 4 and 15 represented medium-degree impairment, and a score of > 15 represented severe-degree impairment.|units on a scale|Mean|10.6|10.6|Standard Deviation|4.74|4.74|||
3708822|NCT02149875|3548125|B1|||National Institutes of Health Stroke Scale score|The scores range from 0 to 42, with higher scores indicating increasing severity. A score of < 4 represented low-degree impairment, between 4 and 15 represented medium-degree impairment, and a score of > 15 represented severe-degree impairment.|units on a scale|Mean|12.4|12.4|Standard Deviation|4.38|4.38|||
3708823|NCT02149875|3548122|B4|||Diastolic blood pressure||mmHg|Mean|87.0|87.0|Standard Deviation|12.3|12.3|||
3708824|NCT02149875|3548123|B3|||Diastolic blood pressure||mmHg|Mean|87.2|87.2|Standard Deviation|12.5|12.5|||
3708825|NCT02149875|3548124|B2|||Diastolic blood pressure||mmHg|Mean|85.1|85.1|Standard Deviation|13.6|13.6|||
3708826|NCT02149875|3548125|B1|||Diastolic blood pressure||mmHg|Mean|88.7|88.7|Standard Deviation|10.7|10.7|||
3708827|NCT02149875|3548122|B4|||Systolic blood pressure||mmHg|Mean|150.6|150.6|Standard Deviation|13.7|13.7|||
3708828|NCT02149875|3548123|B3|||Systolic blood pressure||mmHg|Mean|152.5|152.5|Standard Deviation|12.8|12.8|||
3708829|NCT02149875|3548124|B2|||Systolic blood pressure||mmHg|Mean|150.7|150.7|Standard Deviation|13.7|13.7|||
3708830|NCT02149875|3548125|B1|||Systolic blood pressure||mmHg|Mean|148.6|148.6|Standard Deviation|14.6|14.6|||
3708831|NCT02149875|3548122|B4|||Time until treatment||hour|Mean|7.0|7.0|Standard Deviation|4.2|4.2|||
3708832|NCT02149875|3548123|B3|||Time until treatment||hour|Mean|5.6|5.6|Standard Deviation|3.0|3.0|||
3708833|NCT02149875|3548124|B2|||Time until treatment||hour|Mean|7.6|7.6|Standard Deviation|3.6|3.6|||
3708834|NCT02149875|3548125|B1|||Time until treatment||hour|Mean|7.7|7.7|Standard Deviation|5.9|5.9|||
3708835|NCT02149875|3548122|B4|||Time until admission||hour|Mean|5.1|5.1|Standard Deviation|3.3|3.3|||
3708836|NCT02149875|3548123|B3|||Time until admission||hour|Mean|4.8|4.8|Standard Deviation|3.7|3.7|||
3708837|NCT02149875|3548124|B2|||Time until admission||hour|Mean|5.0|5.0|Standard Deviation|3.3|3.3|||
3708838|NCT02149875|3548125|B1|||Time until admission||hour|Mean|5.4|5.4|Standard Deviation|3.0|3.0|||
3708839|NCT02149875|3548122|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3708840|NCT02149875|3548123|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3708841|NCT02149875|3548124|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3708842|NCT02149875|3548125|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3708843|NCT02149875|3548122|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3708844|NCT02149875|3548123|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3708845|NCT02149875|3548124|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3708846|NCT02149875|3548125|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3708847|NCT02149875|3548122|B4|||Age||years|Mean|67.3|67.3|Standard Deviation|6.2|6.2|||
3708848|NCT02149875|3548123|B3|||Age||years|Mean|68.4|68.4|Standard Deviation|4.2|4.2|||
3708849|NCT02149875|3548124|B2|||Age||years|Mean|66.5|66.5|Standard Deviation|8.1|8.1|||
3708850|NCT02149875|3548125|B1|||Age||years|Mean|67.1|67.1|Standard Deviation|6.3|6.3|||
3708851|NCT02149524|3548138|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3708852|NCT02149524|3548139|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3708853|NCT02149524|3548140|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3708854|NCT02149524|3548138|B3||Female|Sex: Female, Male||Participants|Count of Participants|875|875.0||||||
3708855|NCT02149524|3548139|B2||Female|Sex: Female, Male||Participants|Count of Participants|437|437.0||||||
3708856|NCT02149524|3548140|B1||Female|Sex: Female, Male||Participants|Count of Participants|438|438.0||||||
3708857|NCT02149524|3548138|B3|||Age||years|Mean|49.6|49.6|Standard Deviation|9.44|9.44|||
3708858|NCT02149524|3548139|B2|||Age||years|Mean|49.5|49.5|Standard Deviation|9.51|9.51|||
3708859|NCT02149524|3548140|B1|||Age||years|Mean|49.6|49.6|Standard Deviation|9.38|9.38|||
3708860|NCT02149342|3548155|B1|Finland||Region of Enrollment||participants|Number|14|14.0||||||
3708861|NCT02149342|3548155|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3708862|NCT02149342|3548155|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3708863|NCT02149342|3548155|B1|||Age||years|Mean|79|79.0|Full Range|||66.0|88.0|
3708864|NCT02149342|3548155|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3708865|NCT02149342|3548155|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3708866|NCT02149342|3548155|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3708867|NCT02149303|3548167|B1||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3708868|NCT02149303|3548167|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3708869|NCT02149303|3548167|B1|||Age||years|Mean|77.6|77.6|Standard Deviation|10.20|10.2|||
3708870|NCT02149264|3548173|B1|Mental Component Summary||Short Form -12 (SF-12) Health survey|"Data collected from the SF-12 questionnaire, based on the norm-based scores is used to assess improvement in the psychometrically-based physical component summary (PCS) and mental component summary (MCS). Both PCS and MCS contains four sub-domains (A total of 12 questions).~PCS and MCS composite scores are computed using the scores of the 12 questions and range from 0-100, where a zero score indicates the lowest level of health measured by the scales and 100 indicates the highest level of health. Positive change from baseline indicates improvement in physical and mental health."|units on a scale|Mean|43.7|43.7|Standard Deviation|11.0|11.0|||
3708871|NCT02149264|3548173|B1|Physical Component Summary||Short Form -12 (SF-12) Health survey|"Data collected from the SF-12 questionnaire, based on the norm-based scores is used to assess improvement in the psychometrically-based physical component summary (PCS) and mental component summary (MCS). Both PCS and MCS contains four sub-domains (A total of 12 questions).~PCS and MCS composite scores are computed using the scores of the 12 questions and range from 0-100, where a zero score indicates the lowest level of health measured by the scales and 100 indicates the highest level of health. Positive change from baseline indicates improvement in physical and mental health."|units on a scale|Mean|48.4|48.4|Standard Deviation|8.8|8.8|||
3708872|NCT02149264|3548173|B1|Global Fatigue Index (GFI)||Multidimensional Assessment of Fatigue|"The MAF have 16 questions (Q) divided into 4 domains:~Severity (Q 1-2) (Score range [SR]: 2-20)~Distress (Q 3) (SR: 1-10)~Degree of interference in activities of daily living (Q 4-14) (SR: 11-110)~Timing (Q 15-16) (SR: 5-20)~First 14 Q are scored from 1-10. Questions 15-16 are scored from 1-4 and converted to 1-10 scale by multiplying each score by 2.5. Lower score in each domain indicates improvement in fatigue.~GFI was calculated by summing up scores of Q 1, 2, 3, average of 4-14, and revised score of 15. The GFI ranged from 1 (no fatigue) to 50 (severe fatigue)."|units on a scale|Mean|27.5|27.5|Standard Deviation|11.1|11.1|||
3708873|NCT02149264|3548173|B1|Timing domain||Multidimensional Assessment of Fatigue|"The MAF have 16 questions (Q) divided into 4 domains:~Severity (Q 1-2) (Score range [SR]: 2-20)~Distress (Q 3) (SR: 1-10)~Degree of interference in activities of daily living (Q 4-14) (SR: 11-110)~Timing (Q 15-16) (SR: 5-20)~First 14 Q are scored from 1-10. Questions 15-16 are scored from 1-4 and converted to 1-10 scale by multiplying each score by 2.5. Lower score in each domain indicates improvement in fatigue.~GFI was calculated by summing up scores of Q 1, 2, 3, average of 4-14, and revised score of 15. The GFI ranged from 1 (no fatigue) to 50 (severe fatigue)."|units on a scale|Mean|13.0|13.0|Standard Deviation|3.0|3.0|||
3708874|NCT02149264|3548173|B1|Degree of interference domain||Multidimensional Assessment of Fatigue|"The MAF have 16 questions (Q) divided into 4 domains:~Severity (Q 1-2) (Score range [SR]: 2-20)~Distress (Q 3) (SR: 1-10)~Degree of interference in activities of daily living (Q 4-14) (SR: 11-110)~Timing (Q 15-16) (SR: 5-20)~First 14 Q are scored from 1-10. Questions 15-16 are scored from 1-4 and converted to 1-10 scale by multiplying each score by 2.5. Lower score in each domain indicates improvement in fatigue.~GFI was calculated by summing up scores of Q 1, 2, 3, average of 4-14, and revised score of 15. The GFI ranged from 1 (no fatigue) to 50 (severe fatigue)."|units on a scale|Mean|47.7|47.7|Standard Deviation|22.9|22.9|||
3708875|NCT02149264|3548173|B1|Distress domain||Multidimensional Assessment of Fatigue|"The MAF have 16 questions (Q) divided into 4 domains:~Severity (Q 1-2) (Score range [SR]: 2-20)~Distress (Q 3) (SR: 1-10)~Degree of interference in activities of daily living (Q 4-14) (SR: 11-110)~Timing (Q 15-16) (SR: 5-20)~First 14 Q are scored from 1-10. Questions 15-16 are scored from 1-4 and converted to 1-10 scale by multiplying each score by 2.5. Lower score in each domain indicates improvement in fatigue.~GFI was calculated by summing up scores of Q 1, 2, 3, average of 4-14, and revised score of 15. The GFI ranged from 1 (no fatigue) to 50 (severe fatigue)."|units on a scale|Mean|5.1|5.1|Standard Deviation|2.6|2.6|||
3708876|NCT02149264|3548173|B1|Severity domain||Multidimensional Assessment of Fatigue|"The MAF have 16 questions (Q) divided into 4 domains:~Severity (Q 1-2) (Score range [SR]: 2-20)~Distress (Q 3) (SR: 1-10)~Degree of interference in activities of daily living (Q 4-14) (SR: 11-110)~Timing (Q 15-16) (SR: 5-20)~First 14 Q are scored from 1-10. Questions 15-16 are scored from 1-4 and converted to 1-10 scale by multiplying each score by 2.5. Lower score in each domain indicates improvement in fatigue.~GFI was calculated by summing up scores of Q 1, 2, 3, average of 4-14, and revised score of 15. The GFI ranged from 1 (no fatigue) to 50 (severe fatigue)."|units on a scale|Mean|12.0|12.0|Standard Deviation|4.9|4.9|||
3708877|NCT02149264|3548173|B1|||Total International Index of Erectile Function Score - All Domains|"IIEF questionnaire have 15 questions (Q) divided into 5 domains-~Erectile function (6 items, Q 1-5 and 15) (Score range: 1-30)~Orgasmic function (2 items, Q 9-10) (Score range: 0-10)~Sexual desire (2 items, Q 11-12) (Score range: 2-10)~Intercourse satisfaction (3 items, Q 6-8) (Score range: 0-15)~Overall satisfaction (2 items, Q 13-14) (Score range: 2-10)~Total score was calculated by summing up scores of each domain and ranged from 5-75. Low score indicates severe dysfunction and a high score indicates no dysfunction in sexual function."|units on a scale|Mean|36.3|36.3|Standard Deviation|18.7|18.7|||
3708878|NCT02149264|3548173|B1|||BMI||kg/m^2|Mean|30.7|30.7|Standard Deviation|3.2|3.2|||
3708879|NCT02149264|3548173|B1|||Weight||lbs|Mean|213.2|213.2|Standard Deviation|28.2|28.2|||
3708880|NCT02149264|3548173|B1|||Height||inches|Mean|69.8|69.8|Standard Deviation|2.5|2.5|||
3708881|NCT02149264|3548173|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708882|NCT02149264|3548173|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3708883|NCT02149264|3548173|B1||White|Race (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
3708884|NCT02149264|3548173|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3708885|NCT02149264|3548173|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708886|NCT02149264|3548173|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3708887|NCT02149264|3548173|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708888|NCT02149264|3548173|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708889|NCT02149264|3548173|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|137|137.0||||||
3708890|NCT02149264|3548173|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3708891|NCT02149264|3548173|B1||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
3708892|NCT02149264|3548173|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3708893|NCT02149264|3548173|B1|||Age||years|Mean|54.1|54.1|Standard Deviation|9.3|9.3|||
3708894|NCT02149264|3548173|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3708895|NCT02149264|3548173|B1||Between 18 and 65 years|Age||Participants|Count of Participants|138|138.0||||||
3708896|NCT02149264|3548173|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3708897|NCT02149108|3548186|B3||Male|Sex: Female, Male||Participants|Count of Participants|454|454.0||||||
3708898|NCT02149108|3548187|B2||Male|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
3708899|NCT02149108|3548188|B1||Male|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
3708900|NCT02149108|3548186|B3||Female|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
3708901|NCT02149108|3548187|B2||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3708902|NCT02149108|3548188|B1||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3708903|NCT02149108|3548186|B3|||Age||Years|Mean|61.1|61.1|Standard Deviation|11.0|11.0|||
3708904|NCT02149108|3548187|B2|||Age||Years|Mean|61.0|61.0|Standard Deviation|11.3|11.3|||
3708905|NCT02149108|3548188|B1|||Age||Years|Mean|61.1|61.1|Standard Deviation|10.8|10.8|||
3708906|NCT02148835|3548201|B3|Germany||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3708907|NCT02148835|3548202|B2|Germany||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3708908|NCT02148835|3548203|B1|Germany||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3708909|NCT02148835|3548201|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3708910|NCT02148835|3548201|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3708911|NCT02148835|3548202|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3708912|NCT02148835|3548203|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3708913|NCT02148835|3548201|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3708914|NCT02148835|3548202|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3708915|NCT02148835|3548203|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3708916|NCT02148835|3548201|B3|||Age||years|Mean|26.0|26.0|Standard Deviation|6.1|6.1|||
3708917|NCT02148835|3548202|B2|||Age||years|Mean|25.6|25.6|Standard Deviation|4.1|4.1|||
3708918|NCT02148835|3548203|B1|||Age||years|Mean|26.4|26.4|Standard Deviation|8.0|8.0|||
3708919|NCT02148835|3548201|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3708920|NCT02148835|3548202|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3708921|NCT02148835|3548203|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3708922|NCT02148835|3548201|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3708923|NCT02148835|3548202|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3708924|NCT02148835|3548203|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3708925|NCT02148835|3548201|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3708926|NCT02148835|3548202|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3708927|NCT02148835|3548203|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3708928|NCT02148809|3548210|B1||Male|Sex: Female, Male|pilot study with fixed numbers|Participants|Count of Participants|7|7.0||||||
3708929|NCT02148809|3548210|B1||Female|Sex: Female, Male|pilot study with fixed numbers|Participants|Count of Participants|7|7.0||||||
3708930|NCT02148809|3548210|B1|||Age||years|Mean|63.8|63.8|Full Range|||52.0|74.0|
3708931|NCT02148718|3548215|B1|Spain||Region of Enrollment||participants|Number|86|86.0||||||
3708932|NCT02148718|3548215|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3708933|NCT02148718|3548215|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3708934|NCT02148718|3548215|B1|||Age||years|Mean|37.73|37.73|Standard Deviation|12.16|12.16|||
3708935|NCT02148588|3548236|B1|Denmark||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3708936|NCT02148588|3548236|B1|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3708937|NCT02148588|3548236|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708938|NCT02148588|3548236|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708939|NCT02148588|3548236|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3708940|NCT02148588|3548236|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3708941|NCT02148588|3548236|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708942|NCT02148588|3548236|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708943|NCT02148588|3548236|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708944|NCT02148588|3548236|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3708945|NCT02148588|3548236|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3708946|NCT02148588|3548236|B1|||Age||years|Mean|51.6|51.6|Standard Deviation|7.4|7.4|||
3708947|NCT02148523|3548245|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708948|NCT02148523|3548246|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708949|NCT02148523|3548247|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708950|NCT02148523|3548248|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708951|NCT02148523|3548245|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3708952|NCT02148523|3548246|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3708953|NCT02148523|3548247|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3708954|NCT02148523|3548248|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3708955|NCT02148523|3548245|B4||White|Race (NIH/OMB)||Participants|Count of Participants|173|173.0||||||
3708956|NCT02148523|3548246|B3||White|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3708957|NCT02148523|3548247|B2||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3708958|NCT02148523|3548248|B1||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3708959|NCT02148523|3548245|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3708960|NCT02148523|3548246|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3708961|NCT02148523|3548247|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3708962|NCT02148523|3548248|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3708963|NCT02148523|3548245|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708964|NCT02148523|3548246|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708965|NCT02148523|3548247|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708966|NCT02148523|3548248|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708967|NCT02148523|3548245|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3708968|NCT02148523|3548246|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3708969|NCT02148523|3548247|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3708970|NCT02148523|3548248|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3708971|NCT02148523|3548245|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3708972|NCT02148523|3548246|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708973|NCT02148523|3548247|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3708974|NCT02148523|3548248|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708975|NCT02148523|3548245|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708976|NCT02148523|3548246|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708977|NCT02148523|3548247|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708978|NCT02148523|3548248|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3708979|NCT02148523|3548245|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|193|193.0||||||
3708980|NCT02148523|3548246|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3708981|NCT02148523|3548247|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3708982|NCT02148523|3548248|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3708983|NCT02148523|3548245|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3708984|NCT02148523|3548246|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3708985|NCT02148523|3548247|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3708986|NCT02148523|3548248|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3708987|NCT02148523|3548245|B4||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3708988|NCT02148523|3548246|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3708989|NCT02148523|3548247|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3708990|NCT02148523|3548248|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3708991|NCT02148523|3548245|B4||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3708992|NCT02148523|3548246|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3708993|NCT02148523|3548247|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3708994|NCT02148523|3548248|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3708995|NCT02148523|3548245|B4|||Age||years|Mean|67|67.0|Standard Deviation|10|10.0|||
3708996|NCT02148523|3548246|B3|||Age||years|Mean|67|67.0|Standard Deviation|10|10.0|||
3708997|NCT02148523|3548247|B2|||Age||years|Mean|68|68.0|Standard Deviation|10|10.0|||
3708998|NCT02148523|3548248|B1|||Age||years|Mean|67|67.0|Standard Deviation|11|11.0|||
3708999|NCT02148445|3548261|B3|||Cotinine||ng/mg of creatinine|Mean|2421.6|2421.6|Standard Deviation|2310.39|2310.39|||
3709000|NCT02148445|3548262|B2|||Cotinine||ng/mg of creatinine|Mean|2447.2|2447.2|Standard Deviation|2433.58|2433.58|||
3709001|NCT02148445|3548263|B1|||Cotinine||ng/mg of creatinine|Mean|2395.8|2395.8|Standard Deviation|2184.80|2184.8|||
3709002|NCT02148445|3548261|B3|||Respiratory Function|As measured by spirometry, FEV1|% of predicted|Mean|57.0|57.0|Standard Deviation|19.84|19.84|||
3709003|NCT02148445|3548262|B2|||Respiratory Function|As measured by spirometry, FEV1|% of predicted|Mean|56.7|56.7|Standard Deviation|21.03|21.03|||
3709004|NCT02148445|3548263|B1|||Respiratory Function|As measured by spirometry, FEV1|% of predicted|Mean|57.3|57.3|Standard Deviation|18.61|18.61|||
3709005|NCT02148445|3548261|B3|||Respiratory Symptoms|Respiratory Symptoms as measured by the COPD Assessment (CAT) Test. This questionnaire measures the impact of Chronic Obstructive Pulmonary Disease (COPD) on well-being and daily life. Scores range from 0-40, with higher scores indicating higher levels of impact.|units on a scale|Mean|22.0|22.0|Standard Deviation|9.00|9.0|||
3709006|NCT02148445|3548262|B2|||Respiratory Symptoms|Respiratory Symptoms as measured by the COPD Assessment (CAT) Test. This questionnaire measures the impact of Chronic Obstructive Pulmonary Disease (COPD) on well-being and daily life. Scores range from 0-40, with higher scores indicating higher levels of impact.|units on a scale|Mean|22.9|22.9|Standard Deviation|8.32|8.32|||
3709007|NCT02148445|3548263|B1|||Respiratory Symptoms|Respiratory Symptoms as measured by the COPD Assessment (CAT) Test. This questionnaire measures the impact of Chronic Obstructive Pulmonary Disease (COPD) on well-being and daily life. Scores range from 0-40, with higher scores indicating higher levels of impact.|units on a scale|Mean|21.1|21.1|Standard Deviation|8.82|8.82|||
3709008|NCT02148445|3548261|B3||2 or more Visits|Number of cardiac-related hospital admissions and ED visits in the past 12 months||Participants|Count of Participants|25|25.0||||||
3709009|NCT02148445|3548262|B2||2 or more Visits|Number of cardiac-related hospital admissions and ED visits in the past 12 months||Participants|Count of Participants|12|12.0||||||
3709010|NCT02148445|3548263|B1||2 or more Visits|Number of cardiac-related hospital admissions and ED visits in the past 12 months||Participants|Count of Participants|13|13.0||||||
3709011|NCT02148445|3548261|B3||1 Visit|Number of cardiac-related hospital admissions and ED visits in the past 12 months||Participants|Count of Participants|24|24.0||||||
3709012|NCT02148445|3548262|B2||1 Visit|Number of cardiac-related hospital admissions and ED visits in the past 12 months||Participants|Count of Participants|17|17.0||||||
3709013|NCT02148445|3548263|B1||1 Visit|Number of cardiac-related hospital admissions and ED visits in the past 12 months||Participants|Count of Participants|7|7.0||||||
3709014|NCT02148445|3548261|B3||0 Visits|Number of cardiac-related hospital admissions and ED visits in the past 12 months||Participants|Count of Participants|349|349.0||||||
3709015|NCT02148445|3548262|B2||0 Visits|Number of cardiac-related hospital admissions and ED visits in the past 12 months||Participants|Count of Participants|171|171.0||||||
3709016|NCT02148445|3548263|B1||0 Visits|Number of cardiac-related hospital admissions and ED visits in the past 12 months||Participants|Count of Participants|178|178.0||||||
3709017|NCT02148445|3548261|B3||2 or more Visits|Number of respiratory-related hospital admissions and ED visits in the past 12 months||Participants|Count of Participants|76|76.0||||||
3709018|NCT02148445|3548262|B2||2 or more Visits|Number of respiratory-related hospital admissions and ED visits in the past 12 months||Participants|Count of Participants|30|30.0||||||
3709019|NCT02148445|3548263|B1||2 or more Visits|Number of respiratory-related hospital admissions and ED visits in the past 12 months||Participants|Count of Participants|46|46.0||||||
3709020|NCT02148445|3548261|B3||1 Visit|Number of respiratory-related hospital admissions and ED visits in the past 12 months||Participants|Count of Participants|66|66.0||||||
3709021|NCT02148445|3548262|B2||1 Visit|Number of respiratory-related hospital admissions and ED visits in the past 12 months||Participants|Count of Participants|36|36.0||||||
3709022|NCT02148445|3548263|B1||1 Visit|Number of respiratory-related hospital admissions and ED visits in the past 12 months||Participants|Count of Participants|30|30.0||||||
3709023|NCT02148445|3548261|B3||0 Visits|Number of respiratory-related hospital admissions and ED visits in the past 12 months||Participants|Count of Participants|256|256.0||||||
3709024|NCT02148445|3548262|B2||0 Visits|Number of respiratory-related hospital admissions and ED visits in the past 12 months||Participants|Count of Participants|134|134.0||||||
3709025|NCT02148445|3548263|B1||0 Visits|Number of respiratory-related hospital admissions and ED visits in the past 12 months||Participants|Count of Participants|122|122.0||||||
3709026|NCT02148445|3548261|B3|||Carcinogen Exposure (Creatinine Adjusted NNAL)||pg/mg|Mean|475.0|475.0|Standard Deviation|604.41|604.41|||
3709027|NCT02148445|3548262|B2|||Carcinogen Exposure (Creatinine Adjusted NNAL)||pg/mg|Mean|507.4|507.4|Standard Deviation|764.95|764.95|||
3709028|NCT02148445|3548263|B1|||Carcinogen Exposure (Creatinine Adjusted NNAL)||pg/mg|Mean|451.3|451.3|Standard Deviation|422.74|422.74|||
3709029|NCT02148445|3548261|B3|||Carbon Monoxide Exposure||parts per million|Mean|22.5|22.5|Standard Deviation|13.81|13.81|||
3709030|NCT02148445|3548262|B2|||Carbon Monoxide Exposure||parts per million|Mean|22.7|22.7|Standard Deviation|14.48|14.48|||
3709031|NCT02148445|3548263|B1|||Carbon Monoxide Exposure||parts per million|Mean|22.2|22.2|Standard Deviation|13.12|13.12|||
3709032|NCT02148445|3548261|B3|||Cigarettes Smoked per Day||cigarettes per day|Mean|23.0|23.0|Standard Deviation|12.26|12.26|||
3709033|NCT02148445|3548262|B2|||Cigarettes Smoked per Day||cigarettes per day|Mean|24.0|24.0|Standard Deviation|12.58|12.58|||
3709034|NCT02148445|3548263|B1|||Cigarettes Smoked per Day||cigarettes per day|Mean|22.1|22.1|Standard Deviation|11.87|11.87|||
3709035|NCT02148445|3548261|B3|||Number of Quit Attempts in the Past 12 Months||number of quit attempts|Mean|2.1|2.1|Standard Deviation|4.70|4.7|||
3709036|NCT02148445|3548262|B2|||Number of Quit Attempts in the Past 12 Months||number of quit attempts|Mean|1.9|1.9|Standard Deviation|4.29|4.29|||
3709037|NCT02148445|3548263|B1|||Number of Quit Attempts in the Past 12 Months||number of quit attempts|Mean|2.2|2.2|Standard Deviation|5.09|5.09|||
3709038|NCT02148445|3548261|B3|United States||Region of Enrollment||participants|Number|398|398.0||||||
3709039|NCT02148445|3548262|B2|United States||Region of Enrollment||participants|Number|200|200.0||||||
3709040|NCT02148445|3548263|B1|United States||Region of Enrollment||participants|Number|198|198.0||||||
3709041|NCT02148445|3548261|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709042|NCT02148445|3548262|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709043|NCT02148445|3548263|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709044|NCT02148445|3548261|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3709045|NCT02148445|3548262|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3709046|NCT02148445|3548263|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3709047|NCT02148445|3548261|B3||White|Race (NIH/OMB)||Participants|Count of Participants|236|236.0||||||
3709048|NCT02148445|3548262|B2||White|Race (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
3709049|NCT02148445|3548263|B1||White|Race (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
3709050|NCT02148445|3548261|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3709051|NCT02148445|3548262|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3709052|NCT02148445|3548263|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3709053|NCT02148445|3548261|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709054|NCT02148445|3548262|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709055|NCT02148445|3548263|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709056|NCT02148445|3548261|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709057|NCT02148445|3548262|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709058|NCT02148445|3548263|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709059|NCT02148445|3548261|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3709060|NCT02148445|3548262|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709061|NCT02148445|3548263|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3709062|NCT02148445|3548261|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709063|NCT02148445|3548262|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709064|NCT02148445|3548263|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709065|NCT02148445|3548261|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|385|385.0||||||
3709066|NCT02148445|3548262|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|195|195.0||||||
3709067|NCT02148445|3548263|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|190|190.0||||||
3709068|NCT02148445|3548261|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3709069|NCT02148445|3548262|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3709070|NCT02148445|3548263|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3709071|NCT02148445|3548261|B3||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3709072|NCT02148445|3548262|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3709073|NCT02148445|3548263|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3709074|NCT02148445|3548261|B3||Female|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
3709075|NCT02148445|3548262|B2||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3709076|NCT02148445|3548263|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3709077|NCT02148445|3548261|B3|||Age||years|Mean|55.9|55.9|Standard Deviation|9.29|9.29|||
3709078|NCT02148445|3548262|B2|||Age||years|Mean|55.7|55.7|Standard Deviation|9.88|9.88|||
3709079|NCT02148445|3548263|B1|||Age||years|Mean|56.3|56.3|Standard Deviation|8.66|8.66|||
3709080|NCT02148107|3548300|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3709081|NCT02148107|3548301|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3709082|NCT02148107|3548302|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3709083|NCT02148107|3548303|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3709084|NCT02148107|3548300|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3709085|NCT02148107|3548301|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3709086|NCT02148107|3548302|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3709087|NCT02148107|3548303|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3709088|NCT02148107|3548300|B4|||Age||Years|Mean|32.0|32.0|Standard Deviation|4.6|4.6|||
3709089|NCT02148107|3548301|B3|||Age||Years|Mean|33.3|33.3|Standard Deviation|2.1|2.1|||
3709090|NCT02148107|3548302|B2|||Age||Years|Mean|29.7|29.7|Standard Deviation|2.8|2.8|||
3709091|NCT02148107|3548303|B1|||Age||Years|Mean|33.5|33.5|Standard Deviation|5.9|5.9|||
3709092|NCT02147899|3548321|B4|United States||Region of Enrollment||participants|Number|215|215.0||||||
3709093|NCT02147899|3548322|B3|United States||Region of Enrollment||participants|Number|72|72.0||||||
3709094|NCT02147899|3548323|B2|United States||Region of Enrollment||participants|Number|72|72.0||||||
3709095|NCT02147899|3548324|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
3709096|NCT02147899|3548321|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709097|NCT02147899|3548322|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709098|NCT02147899|3548323|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709099|NCT02147899|3548324|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709100|NCT02147899|3548321|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|192|192.0||||||
3709101|NCT02147899|3548322|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3709102|NCT02147899|3548323|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3709103|NCT02147899|3548324|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3709104|NCT02147899|3548321|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3709105|NCT02147899|3548322|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3709106|NCT02147899|3548323|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3709107|NCT02147899|3548324|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3709108|NCT02147899|3548321|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3709109|NCT02147899|3548322|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3709110|NCT02147899|3548323|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3709111|NCT02147899|3548324|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3709112|NCT02147899|3548321|B4||Female|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
3709113|NCT02147899|3548322|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3709114|NCT02147899|3548323|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3709115|NCT02147899|3548324|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3709116|NCT02147899|3548321|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3709117|NCT02147899|3548322|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3709118|NCT02147899|3548323|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3709119|NCT02147899|3548324|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3709120|NCT02147899|3548321|B4||Between 18 and 65 years|Age||Participants|Count of Participants|215|215.0||||||
3709121|NCT02147899|3548322|B3||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
3709122|NCT02147899|3548323|B2||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
3709123|NCT02147899|3548324|B1||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
3709124|NCT02147899|3548321|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3709125|NCT02147899|3548322|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3709126|NCT02147899|3548323|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3709127|NCT02147899|3548324|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3709128|NCT02147691|3548337|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3709129|NCT02147691|3548338|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3709130|NCT02147691|3548339|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3709131|NCT02147691|3548337|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3709132|NCT02147691|3548338|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3709133|NCT02147691|3548339|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3709134|NCT02147691|3548337|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3709135|NCT02147691|3548338|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3709136|NCT02147691|3548339|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3709137|NCT02147691|3548337|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3709138|NCT02147691|3548338|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3709139|NCT02147691|3548339|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3709140|NCT02147691|3548337|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3709141|NCT02147691|3548338|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3709142|NCT02147691|3548339|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3709143|NCT02147587|3548384|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3709144|NCT02147587|3548385|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3709145|NCT02147587|3548386|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3709146|NCT02147587|3548384|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3709147|NCT02147587|3548385|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3709148|NCT02147587|3548386|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3709149|NCT02147587|3548384|B3|||Age||years|Mean|61.8|61.8|Standard Deviation|7.6|7.6|||
3709150|NCT02147587|3548385|B2|||Age||years|Mean|61.7|61.7|Standard Deviation|6.2|6.2|||
3709151|NCT02147587|3548386|B1|||Age||years|Mean|62.0|62.0|Standard Deviation|8.7|8.7|||
3709152|NCT02147561|3548407|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3709153|NCT02147561|3548407|B1||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
3709154|NCT02147561|3548407|B1|||Age||Years|Mean|49.81|49.81|Standard Deviation|14.56|14.56|||
3709155|NCT02147522|3548413|B3||Severe, PHQ-9 score 20+|Depression Severity, Categorial||Participants|Count of Participants|68|68.0||||||
3709156|NCT02147522|3548414|B2||Severe, PHQ-9 score 20+|Depression Severity, Categorial||Participants|Count of Participants|35|35.0||||||
3709157|NCT02147522|3548415|B1||Severe, PHQ-9 score 20+|Depression Severity, Categorial||Participants|Count of Participants|33|33.0||||||
3709158|NCT02147522|3548413|B3||Moderately severe, PHQ-9 score 15-19|Depression Severity, Categorial||Participants|Count of Participants|147|147.0||||||
3709159|NCT02147522|3548414|B2||Moderately severe, PHQ-9 score 15-19|Depression Severity, Categorial||Participants|Count of Participants|73|73.0||||||
3709160|NCT02147522|3548415|B1||Moderately severe, PHQ-9 score 15-19|Depression Severity, Categorial||Participants|Count of Participants|74|74.0||||||
3709161|NCT02147522|3548413|B3||Moderate, PHQ-9 score 10-14|Depression Severity, Categorial||Participants|Count of Participants|133|133.0||||||
3709162|NCT02147522|3548414|B2||Moderate, PHQ-9 score 10-14|Depression Severity, Categorial||Participants|Count of Participants|62|62.0||||||
3709163|NCT02147522|3548415|B1||Moderate, PHQ-9 score 10-14|Depression Severity, Categorial||Participants|Count of Participants|71|71.0||||||
3709164|NCT02147522|3548413|B3|United States||Region of Enrollment||participants|Number|348|348.0||||||
3709165|NCT02147522|3548414|B2|United States||Region of Enrollment||participants|Number|170|170.0||||||
3709166|NCT02147522|3548415|B1|United States||Region of Enrollment||participants|Number|178|178.0||||||
3709167|NCT02147522|3548413|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709168|NCT02147522|3548414|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709169|NCT02147522|3548415|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709170|NCT02147522|3548413|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3709171|NCT02147522|3548414|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3709172|NCT02147522|3548415|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3709173|NCT02147522|3548413|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|344|344.0||||||
3709174|NCT02147522|3548414|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|168|168.0||||||
3709175|NCT02147522|3548415|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|176|176.0||||||
3709176|NCT02147522|3548413|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3709177|NCT02147522|3548414|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3709178|NCT02147522|3548415|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3709179|NCT02147522|3548413|B3||Female|Sex: Female, Male||Participants|Count of Participants|296|296.0||||||
3709180|NCT02147522|3548414|B2||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3709181|NCT02147522|3548415|B1||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3709182|NCT02147522|3548413|B3|||Age||years|Mean|56.54|56.54|Standard Deviation|8.63|8.63|||
3709183|NCT02147522|3548414|B2|||Age||years|Mean|56.31|56.31|Standard Deviation|8.47|8.47|||
3709184|NCT02147522|3548415|B1|||Age||years|Mean|56.77|56.77|Standard Deviation|8.79|8.79|||
3709185|NCT02147288|3548426|B3|||Drain duration||days|Mean|15|15.0|Full Range|||8.0|27.0|
3709186|NCT02147288|3548427|B2|||Drain duration||days|Mean|14|14.0|Full Range|||9.0|27.0|
3709187|NCT02147288|3548428|B1|||Drain duration||days|Mean|16|16.0|Full Range|||8.0|25.0|
3709188|NCT02147288|3548426|B3|||Specimen weight||kilograms|Mean|2.83|2.83|Full Range|||0.66|8.52|
3709189|NCT02147288|3548427|B2|||Specimen weight||kilograms|Mean|2.61|2.61|Full Range|||0.66|5.5|
3709190|NCT02147288|3548428|B1|||Specimen weight||kilograms|Mean|3.07|3.07|Full Range|||0.74|8.52|
3709191|NCT02147288|3548426|B3|||Incision length||centimeters|Mean|54.5|54.5|Full Range|||26.0|96.0|
3709192|NCT02147288|3548427|B2|||Incision length||centimeters|Mean|56.6|56.6|Full Range|||26.0|78.5|
3709193|NCT02147288|3548428|B1|||Incision length||centimeters|Mean|52.3|52.3|Full Range|||26.0|96.0|
3709194|NCT02147288|3548426|B3|||Pre-operative prealbumin||milligrams per deciliter|Mean|20.9|20.9|Full Range|||8.9|34.6|
3709195|NCT02147288|3548427|B2|||Pre-operative prealbumin||milligrams per deciliter|Mean|21.4|21.4|Full Range|||10.3|25.2|
3709196|NCT02147288|3548428|B1|||Pre-operative prealbumin||milligrams per deciliter|Mean|20.3|20.3|Full Range|||8.9|34.6|
3709197|NCT02147288|3548426|B3|||Body mass Index||kg/m^2|Mean|31.32|31.32|Full Range|||23.1|49.1|
3709198|NCT02147288|3548427|B2|||Body mass Index||kg/m^2|Mean|30.4|30.4|Full Range|||25.1|42.0|
3709199|NCT02147288|3548428|B1|||Body mass Index||kg/m^2|Mean|32.3|32.3|Full Range|||23.1|49.1|
3709200|NCT02147288|3548426|B3|no||Prior abdominal surgery||participants|Number|9|9.0||||||
3709201|NCT02147288|3548427|B2|no||Prior abdominal surgery||participants|Number|3|3.0||||||
3709202|NCT02147288|3548428|B1|no||Prior abdominal surgery||participants|Number|6|6.0||||||
3709203|NCT02147288|3548426|B3|yes||Prior abdominal surgery||participants|Number|34|34.0||||||
3709204|NCT02147288|3548427|B2|yes||Prior abdominal surgery||participants|Number|19|19.0||||||
3709205|NCT02147288|3548428|B1|yes||Prior abdominal surgery||participants|Number|15|15.0||||||
3709206|NCT02147288|3548426|B3|non-smokers||Smoking status||participants|Number|36|36.0||||||
3709207|NCT02147288|3548427|B2|non-smokers||Smoking status||participants|Number|18|18.0||||||
3709208|NCT02147288|3548428|B1|non-smokers||Smoking status||participants|Number|18|18.0||||||
3709209|NCT02147288|3548426|B3|smokers||Smoking status||participants|Number|7|7.0||||||
3709210|NCT02147288|3548427|B2|smokers||Smoking status||participants|Number|4|4.0||||||
3709211|NCT02147288|3548428|B1|smokers||Smoking status||participants|Number|3|3.0||||||
3709212|NCT02147288|3548426|B3|non-diabetic||Diabetes history||participants|Number|34|34.0||||||
3709213|NCT02147288|3548427|B2|non-diabetic||Diabetes history||participants|Number|19|19.0||||||
3709214|NCT02147288|3548428|B1|non-diabetic||Diabetes history||participants|Number|15|15.0||||||
3709215|NCT02147288|3548426|B3|diabetic||Diabetes history||participants|Number|9|9.0||||||
3709216|NCT02147288|3548427|B2|diabetic||Diabetes history||participants|Number|3|3.0||||||
3709217|NCT02147288|3548428|B1|diabetic||Diabetes history||participants|Number|6|6.0||||||
3709218|NCT02147288|3548426|B3||Male|Gender||Participants|Count of Participants|4|4.0||||||
3709219|NCT02147288|3548427|B2||Male|Gender||Participants|Count of Participants|1|1.0||||||
3709220|NCT02147288|3548428|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
3709221|NCT02147288|3548426|B3||Female|Gender||Participants|Count of Participants|39|39.0||||||
3709222|NCT02147288|3548427|B2||Female|Gender||Participants|Count of Participants|21|21.0||||||
3709223|NCT02147288|3548428|B1||Female|Gender||Participants|Count of Participants|18|18.0||||||
3709224|NCT02147288|3548426|B3|||Age||years|Mean|43.6|43.6|Full Range|||24.0|65.0|
3709225|NCT02147288|3548427|B2|||Age||years|Mean|46|46.0|Full Range|||26.0|65.0|
3709226|NCT02147288|3548428|B1|||Age||years|Mean|41|41.0|Full Range|||24.0|58.0|
3709227|NCT02147184|3548443|B3|United States||Region of Enrollment||Participants|Count of Participants|264|264.0||||||
3709228|NCT02147184|3548444|B2|United States||Region of Enrollment||Participants|Count of Participants|137|137.0||||||
3709229|NCT02147184|3548445|B1|United States||Region of Enrollment||Participants|Count of Participants|127|127.0||||||
3709230|NCT02147184|3548443|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709231|NCT02147184|3548444|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709232|NCT02147184|3548445|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709233|NCT02147184|3548443|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709234|NCT02147184|3548444|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709235|NCT02147184|3548445|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709236|NCT02147184|3548443|B3||White|Race (NIH/OMB)||Participants|Count of Participants|233|233.0||||||
3709237|NCT02147184|3548444|B2||White|Race (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
3709238|NCT02147184|3548445|B1||White|Race (NIH/OMB)||Participants|Count of Participants|114|114.0||||||
3709239|NCT02147184|3548443|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3709240|NCT02147184|3548444|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3709241|NCT02147184|3548445|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3709242|NCT02147184|3548443|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709243|NCT02147184|3548444|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709244|NCT02147184|3548445|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709245|NCT02147184|3548443|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3709246|NCT02147184|3548444|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3709247|NCT02147184|3548445|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3709248|NCT02147184|3548443|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3709249|NCT02147184|3548444|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3709250|NCT02147184|3548445|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3709251|NCT02147184|3548443|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709252|NCT02147184|3548444|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709253|NCT02147184|3548445|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709254|NCT02147184|3548443|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|242|242.0||||||
3709255|NCT02147184|3548444|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
3709256|NCT02147184|3548445|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|116|116.0||||||
3709257|NCT02147184|3548443|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3709258|NCT02147184|3548444|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3709259|NCT02147184|3548445|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3709260|NCT02147184|3548443|B3||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3709261|NCT02147184|3548444|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3709262|NCT02147184|3548445|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3709263|NCT02147184|3548443|B3||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
3709264|NCT02147184|3548444|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3709265|NCT02147184|3548445|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3709266|NCT02147184|3548443|B3|||Age||years|Mean|18.9|18.9|Standard Deviation|1.6|1.6|||
3709267|NCT02147184|3548444|B2|||Age||years|Mean|19.0|19.0|Standard Deviation|1.5|1.5|||
3709268|NCT02147184|3548445|B1|||Age||years|Mean|18.8|18.8|Standard Deviation|1.7|1.7|||
3709269|NCT02147132|3548464|B1|||Current Methadone Dose||milligrams|Mean|109.9|109.9|Standard Deviation|35.0|35.0|||
3709270|NCT02147132|3548464|B1|||Years in Methadone Treatment||years|Mean|3.1|3.1|Standard Deviation|3.6|3.6|||
3709271|NCT02147132|3548464|B1|||Fagerström Test for Nicotine Dependence|Scores can range from a minimum of 0 to a maximum of 10. Higher scores represent more severe nicotine dependence.|units on a scale|Mean|5.3|5.3|Standard Deviation|1.0|1.0|||
3709272|NCT02147132|3548464|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3709273|NCT02147132|3548464|B1|Race, Ethnicity|Other, Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3709274|NCT02147132|3548464|B1|Race, Ethnicity|White, Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3709275|NCT02147132|3548464|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3709276|NCT02147132|3548464|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3709277|NCT02147132|3548464|B1|||Age||years|Mean|37.9|37.9|Standard Deviation|8.4|8.4|||
3709278|NCT02147093|3548485|B3|United Kingdom||Region of Enrollment||participants|Number|40|40.0||||||
3709279|NCT02147093|3548486|B2|United Kingdom||Region of Enrollment||participants|Number|20|20.0||||||
3709280|NCT02147093|3548487|B1|United Kingdom||Region of Enrollment||participants|Number|20|20.0||||||
3709281|NCT02147093|3548485|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3709282|NCT02147093|3548486|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3709283|NCT02147093|3548487|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3709284|NCT02147093|3548485|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3709285|NCT02147093|3548486|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3709286|NCT02147093|3548487|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3709287|NCT02147093|3548485|B3|||Age||years|Mean|56.78|56.78|Standard Deviation|8.490|8.49|||
3709288|NCT02147093|3548486|B2|||Age||years|Mean|58.00|58.0|Standard Deviation|9.067|9.067|||
3709289|NCT02147093|3548487|B1|||Age||years|Mean|56.20|56.2|Standard Deviation|7.682|7.682|||
3709290|NCT02146599|3548496|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3709291|NCT02146599|3548496|B1||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
3709292|NCT02146599|3548496|B1|||Age||years|Mean|68.79|68.79|Standard Deviation|8.23|8.23|||
3709293|NCT02146482|3548500|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
3709294|NCT02146482|3548501|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3709295|NCT02146482|3548502|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3709296|NCT02146482|3548500|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3709297|NCT02146482|3548501|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3709298|NCT02146482|3548502|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3709299|NCT02146482|3548500|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3709300|NCT02146482|3548501|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3709301|NCT02146482|3548502|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3709302|NCT02146482|3548500|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3709303|NCT02146482|3548501|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3709304|NCT02146482|3548502|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3709305|NCT02146482|3548500|B3||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
3709306|NCT02146482|3548501|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3709307|NCT02146482|3548502|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3709308|NCT02146482|3548500|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3709309|NCT02146482|3548501|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3709310|NCT02146482|3548502|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3709311|NCT02146352|3548509|B1|||Weight||pounds|Mean|172.9|172.9|Standard Deviation|36.8|36.8|||
3709312|NCT02146352|3548509|B1|||Height||inches|Mean|67.3|67.3|Standard Deviation|4.3|4.3|||
3709313|NCT02146352|3548509|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3709314|NCT02146352|3548509|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3709315|NCT02146352|3548509|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3709316|NCT02146352|3548509|B1|||Age||years|Mean|52.0|52.0|Standard Deviation|14.9|14.9|||
3709317|NCT02146326|3548523|B5|Missing/Unknown||Substance Use (Clients)|Diagnosis information from client medical record data were reviewed for the presence of any substance use diagnoses (excluding tobacco/nicotine only).|Participants|Count of Participants|18|18.0||||||
3709318|NCT02146326|3548524|B4|Missing/Unknown||Substance Use (Clients)|Diagnosis information from client medical record data were reviewed for the presence of any substance use diagnoses (excluding tobacco/nicotine only).|Participants|Count of Participants|9|9.0||||||
3709319|NCT02146326|3548525|B3|Missing/Unknown||Substance Use (Clients)|Diagnosis information from client medical record data were reviewed for the presence of any substance use diagnoses (excluding tobacco/nicotine only).|Participants|Count of Participants|9|9.0||||||
3709320|NCT02146326|3548523|B5|Substance Use Present||Substance Use (Clients)|Diagnosis information from client medical record data were reviewed for the presence of any substance use diagnoses (excluding tobacco/nicotine only).|Participants|Count of Participants|140|140.0||||||
3709321|NCT02146326|3548524|B4|Substance Use Present||Substance Use (Clients)|Diagnosis information from client medical record data were reviewed for the presence of any substance use diagnoses (excluding tobacco/nicotine only).|Participants|Count of Participants|80|80.0||||||
3709322|NCT02146326|3548525|B3|Substance Use Present||Substance Use (Clients)|Diagnosis information from client medical record data were reviewed for the presence of any substance use diagnoses (excluding tobacco/nicotine only).|Participants|Count of Participants|60|60.0||||||
3709323|NCT02146326|3548523|B5|Substance Use Not Present||Substance Use (Clients)|Diagnosis information from client medical record data were reviewed for the presence of any substance use diagnoses (excluding tobacco/nicotine only).|Participants|Count of Participants|311|311.0||||||
3709324|NCT02146326|3548524|B4|Substance Use Not Present||Substance Use (Clients)|Diagnosis information from client medical record data were reviewed for the presence of any substance use diagnoses (excluding tobacco/nicotine only).|Participants|Count of Participants|169|169.0||||||
3709401|NCT02146326|3548524|B4|Less than high school/GED||Education (Clients)|Highest grade of school completed (clients)|Participants|Count of Participants|80|80.0||||||
3709325|NCT02146326|3548525|B3|Substance Use Not Present||Substance Use (Clients)|Diagnosis information from client medical record data were reviewed for the presence of any substance use diagnoses (excluding tobacco/nicotine only).|Participants|Count of Participants|142|142.0||||||
3709326|NCT02146326|3548523|B5|Missing/Unknown||Primary Diagnosis Category (Clients)|Diagnosis information from client medical records were reviewed to determine the most common primary mental health diagnosis category.|Participants|Count of Participants|17|17.0||||||
3709327|NCT02146326|3548524|B4|Missing/Unknown||Primary Diagnosis Category (Clients)|Diagnosis information from client medical records were reviewed to determine the most common primary mental health diagnosis category.|Participants|Count of Participants|9|9.0||||||
3709328|NCT02146326|3548525|B3|Missing/Unknown||Primary Diagnosis Category (Clients)|Diagnosis information from client medical records were reviewed to determine the most common primary mental health diagnosis category.|Participants|Count of Participants|8|8.0||||||
3709329|NCT02146326|3548523|B5|Schizophrenia||Primary Diagnosis Category (Clients)|Diagnosis information from client medical records were reviewed to determine the most common primary mental health diagnosis category.|Participants|Count of Participants|213|213.0||||||
3709330|NCT02146326|3548524|B4|Schizophrenia||Primary Diagnosis Category (Clients)|Diagnosis information from client medical records were reviewed to determine the most common primary mental health diagnosis category.|Participants|Count of Participants|127|127.0||||||
3709331|NCT02146326|3548525|B3|Schizophrenia||Primary Diagnosis Category (Clients)|Diagnosis information from client medical records were reviewed to determine the most common primary mental health diagnosis category.|Participants|Count of Participants|86|86.0||||||
3709332|NCT02146326|3548523|B5|Other||Primary Diagnosis Category (Clients)|Diagnosis information from client medical records were reviewed to determine the most common primary mental health diagnosis category.|Participants|Count of Participants|20|20.0||||||
3709333|NCT02146326|3548524|B4|Other||Primary Diagnosis Category (Clients)|Diagnosis information from client medical records were reviewed to determine the most common primary mental health diagnosis category.|Participants|Count of Participants|12|12.0||||||
3709334|NCT02146326|3548525|B3|Other||Primary Diagnosis Category (Clients)|Diagnosis information from client medical records were reviewed to determine the most common primary mental health diagnosis category.|Participants|Count of Participants|8|8.0||||||
3709335|NCT02146326|3548523|B5|Major Depression||Primary Diagnosis Category (Clients)|Diagnosis information from client medical records were reviewed to determine the most common primary mental health diagnosis category.|Participants|Count of Participants|108|108.0||||||
3709336|NCT02146326|3548524|B4|Major Depression||Primary Diagnosis Category (Clients)|Diagnosis information from client medical records were reviewed to determine the most common primary mental health diagnosis category.|Participants|Count of Participants|53|53.0||||||
3709337|NCT02146326|3548525|B3|Major Depression||Primary Diagnosis Category (Clients)|Diagnosis information from client medical records were reviewed to determine the most common primary mental health diagnosis category.|Participants|Count of Participants|55|55.0||||||
3709338|NCT02146326|3548523|B5|Bipolar Disorder||Primary Diagnosis Category (Clients)|Diagnosis information from client medical records were reviewed to determine the most common primary mental health diagnosis category.|Participants|Count of Participants|80|80.0||||||
3709339|NCT02146326|3548524|B4|Bipolar Disorder||Primary Diagnosis Category (Clients)|Diagnosis information from client medical records were reviewed to determine the most common primary mental health diagnosis category.|Participants|Count of Participants|45|45.0||||||
3709340|NCT02146326|3548525|B3|Bipolar Disorder||Primary Diagnosis Category (Clients)|Diagnosis information from client medical records were reviewed to determine the most common primary mental health diagnosis category.|Participants|Count of Participants|35|35.0||||||
3709341|NCT02146326|3548523|B5|Anxiety Disorder||Primary Diagnosis Category (Clients)|Diagnosis information from client medical records were reviewed to determine the most common primary mental health diagnosis category.|Participants|Count of Participants|31|31.0||||||
3709342|NCT02146326|3548524|B4|Anxiety Disorder||Primary Diagnosis Category (Clients)|Diagnosis information from client medical records were reviewed to determine the most common primary mental health diagnosis category.|Participants|Count of Participants|12|12.0||||||
3709343|NCT02146326|3548525|B3|Anxiety Disorder||Primary Diagnosis Category (Clients)|Diagnosis information from client medical records were reviewed to determine the most common primary mental health diagnosis category.|Participants|Count of Participants|19|19.0||||||
3709344|NCT02146326|3548523|B5||No, does not want or unknown/refused|Wants to attend treatment (Clients)|Clients were asked if they want to attend treatment.|Participants|Count of Participants|36|36.0||||||
3709345|NCT02146326|3548524|B4||No, does not want or unknown/refused|Wants to attend treatment (Clients)|Clients were asked if they want to attend treatment.|Participants|Count of Participants|22|22.0||||||
3709346|NCT02146326|3548525|B3||No, does not want or unknown/refused|Wants to attend treatment (Clients)|Clients were asked if they want to attend treatment.|Participants|Count of Participants|14|14.0||||||
3709347|NCT02146326|3548526|B2||No, does not want or unknown/refused|Wants to attend treatment (Clients)|Clients were asked if they want to attend treatment.|Participants|Count of Participants|0|0.0||||||
3709348|NCT02146326|3548527|B1||No, does not want or unknown/refused|Wants to attend treatment (Clients)|Clients were asked if they want to attend treatment.|Participants|Count of Participants|0|0.0||||||
3709349|NCT02146326|3548523|B5||Yes, want to attend treatment|Wants to attend treatment (Clients)|Clients were asked if they want to attend treatment.|Participants|Count of Participants|433|433.0||||||
3709350|NCT02146326|3548524|B4||Yes, want to attend treatment|Wants to attend treatment (Clients)|Clients were asked if they want to attend treatment.|Participants|Count of Participants|236|236.0||||||
3709351|NCT02146326|3548525|B3||Yes, want to attend treatment|Wants to attend treatment (Clients)|Clients were asked if they want to attend treatment.|Participants|Count of Participants|197|197.0||||||
3709352|NCT02146326|3548526|B2||Yes, want to attend treatment|Wants to attend treatment (Clients)|Clients were asked if they want to attend treatment.|Participants|Count of Participants|0|0.0||||||
3709353|NCT02146326|3548527|B1||Yes, want to attend treatment|Wants to attend treatment (Clients)|Clients were asked if they want to attend treatment.|Participants|Count of Participants|0|0.0||||||
3709457|NCT02146248|3548692|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709354|NCT02146326|3548523|B5||No, not required or unknown/refused|Required to attend treatment (Clients)|Clients were asked if they were required to attend treatment at the agency due to involuntary commitment, court order, or other legal requirement.|Participants|Count of Participants|389|389.0||||||
3709355|NCT02146326|3548524|B4||No, not required or unknown/refused|Required to attend treatment (Clients)|Clients were asked if they were required to attend treatment at the agency due to involuntary commitment, court order, or other legal requirement.|Participants|Count of Participants|208|208.0||||||
3709356|NCT02146326|3548525|B3||No, not required or unknown/refused|Required to attend treatment (Clients)|Clients were asked if they were required to attend treatment at the agency due to involuntary commitment, court order, or other legal requirement.|Participants|Count of Participants|181|181.0||||||
3709357|NCT02146326|3548526|B2||No, not required or unknown/refused|Required to attend treatment (Clients)|Clients were asked if they were required to attend treatment at the agency due to involuntary commitment, court order, or other legal requirement.|Participants|Count of Participants|0|0.0||||||
3709358|NCT02146326|3548527|B1||No, not required or unknown/refused|Required to attend treatment (Clients)|Clients were asked if they were required to attend treatment at the agency due to involuntary commitment, court order, or other legal requirement.|Participants|Count of Participants|0|0.0||||||
3709359|NCT02146326|3548523|B5||Yes, required to attend treatment|Required to attend treatment (Clients)|Clients were asked if they were required to attend treatment at the agency due to involuntary commitment, court order, or other legal requirement.|Participants|Count of Participants|80|80.0||||||
3709360|NCT02146326|3548524|B4||Yes, required to attend treatment|Required to attend treatment (Clients)|Clients were asked if they were required to attend treatment at the agency due to involuntary commitment, court order, or other legal requirement.|Participants|Count of Participants|50|50.0||||||
3709361|NCT02146326|3548525|B3||Yes, required to attend treatment|Required to attend treatment (Clients)|Clients were asked if they were required to attend treatment at the agency due to involuntary commitment, court order, or other legal requirement.|Participants|Count of Participants|30|30.0||||||
3709362|NCT02146326|3548526|B2||Yes, required to attend treatment|Required to attend treatment (Clients)|Clients were asked if they were required to attend treatment at the agency due to involuntary commitment, court order, or other legal requirement.|Participants|Count of Participants|0|0.0||||||
3709363|NCT02146326|3548527|B1||Yes, required to attend treatment|Required to attend treatment (Clients)|Clients were asked if they were required to attend treatment at the agency due to involuntary commitment, court order, or other legal requirement.|Participants|Count of Participants|0|0.0||||||
3709364|NCT02146326|3548523|B5||Other|Housing (Clients)|Clients were asked what type of housing they currently live in. Housing codes included: homeless-on streets or in shelter, staying with friends or family temporarily, structured congregate living (e.g., nursing home, group home, residential facilities), semi-independing living (staff member lives on site, or foster family care), living with family (not spouse), own apartment or house (with spouse, living as married, with friends), own apartment or house-alone (includes boarding homes, hotels)|Participants|Count of Participants|165|165.0||||||
3709365|NCT02146326|3548524|B4||Other|Housing (Clients)|Clients were asked what type of housing they currently live in. Housing codes included: homeless-on streets or in shelter, staying with friends or family temporarily, structured congregate living (e.g., nursing home, group home, residential facilities), semi-independing living (staff member lives on site, or foster family care), living with family (not spouse), own apartment or house (with spouse, living as married, with friends), own apartment or house-alone (includes boarding homes, hotels)|Participants|Count of Participants|97|97.0||||||
3709366|NCT02146326|3548525|B3||Other|Housing (Clients)|Clients were asked what type of housing they currently live in. Housing codes included: homeless-on streets or in shelter, staying with friends or family temporarily, structured congregate living (e.g., nursing home, group home, residential facilities), semi-independing living (staff member lives on site, or foster family care), living with family (not spouse), own apartment or house (with spouse, living as married, with friends), own apartment or house-alone (includes boarding homes, hotels)|Participants|Count of Participants|68|68.0||||||
3709367|NCT02146326|3548523|B5||Independent living|Housing (Clients)|Clients were asked what type of housing they currently live in. Housing codes included: homeless-on streets or in shelter, staying with friends or family temporarily, structured congregate living (e.g., nursing home, group home, residential facilities), semi-independing living (staff member lives on site, or foster family care), living with family (not spouse), own apartment or house (with spouse, living as married, with friends), own apartment or house-alone (includes boarding homes, hotels)|Participants|Count of Participants|304|304.0||||||
3709368|NCT02146326|3548524|B4||Independent living|Housing (Clients)|Clients were asked what type of housing they currently live in. Housing codes included: homeless-on streets or in shelter, staying with friends or family temporarily, structured congregate living (e.g., nursing home, group home, residential facilities), semi-independing living (staff member lives on site, or foster family care), living with family (not spouse), own apartment or house (with spouse, living as married, with friends), own apartment or house-alone (includes boarding homes, hotels)|Participants|Count of Participants|161|161.0||||||
3709369|NCT02146326|3548525|B3||Independent living|Housing (Clients)|Clients were asked what type of housing they currently live in. Housing codes included: homeless-on streets or in shelter, staying with friends or family temporarily, structured congregate living (e.g., nursing home, group home, residential facilities), semi-independing living (staff member lives on site, or foster family care), living with family (not spouse), own apartment or house (with spouse, living as married, with friends), own apartment or house-alone (includes boarding homes, hotels)|Participants|Count of Participants|143|143.0||||||
3709370|NCT02146326|3548523|B5||Other|Employment (Clients)|Clients were asked if they were currently employed. Response choices were paid employment, casual work (i.e., babysitting, side jobs, etc.), student, unemployed and looking for work, unemployed and not looking for work, other, refused.|Participants|Count of Participants|407|407.0||||||
3709371|NCT02146326|3548524|B4||Other|Employment (Clients)|Clients were asked if they were currently employed. Response choices were paid employment, casual work (i.e., babysitting, side jobs, etc.), student, unemployed and looking for work, unemployed and not looking for work, other, refused.|Participants|Count of Participants|222|222.0||||||
3709402|NCT02146326|3548525|B3|Less than high school/GED||Education (Clients)|Highest grade of school completed (clients)|Participants|Count of Participants|61|61.0||||||
3709372|NCT02146326|3548525|B3||Other|Employment (Clients)|Clients were asked if they were currently employed. Response choices were paid employment, casual work (i.e., babysitting, side jobs, etc.), student, unemployed and looking for work, unemployed and not looking for work, other, refused.|Participants|Count of Participants|185|185.0||||||
3709373|NCT02146326|3548523|B5||Paid employment|Employment (Clients)|Clients were asked if they were currently employed. Response choices were paid employment, casual work (i.e., babysitting, side jobs, etc.), student, unemployed and looking for work, unemployed and not looking for work, other, refused.|Participants|Count of Participants|62|62.0||||||
3709374|NCT02146326|3548524|B4||Paid employment|Employment (Clients)|Clients were asked if they were currently employed. Response choices were paid employment, casual work (i.e., babysitting, side jobs, etc.), student, unemployed and looking for work, unemployed and not looking for work, other, refused.|Participants|Count of Participants|36|36.0||||||
3709375|NCT02146326|3548525|B3||Paid employment|Employment (Clients)|Clients were asked if they were currently employed. Response choices were paid employment, casual work (i.e., babysitting, side jobs, etc.), student, unemployed and looking for work, unemployed and not looking for work, other, refused.|Participants|Count of Participants|26|26.0||||||
3709376|NCT02146326|3548523|B5|||Actual number of work hours (Staff)|Staff were asked how many hours they actually work in a typical work week. One participant did not answer the question.|hours|Mean|41.6|41.6|Standard Deviation|6.7|6.7|||
3709377|NCT02146326|3548526|B2|||Actual number of work hours (Staff)|Staff were asked how many hours they actually work in a typical work week. One participant did not answer the question.|hours|Mean|41.6|41.6|Standard Deviation|7.0|7.0|||
3709378|NCT02146326|3548527|B1|||Actual number of work hours (Staff)|Staff were asked how many hours they actually work in a typical work week. One participant did not answer the question.|hours|Mean|41.6|41.6|Standard Deviation|6.4|6.4|||
3709379|NCT02146326|3548523|B5|||Official number of work hours (Staff)|Staff were asked how many official hours they are scheduled to work in a typical work week.|hours|Mean|38.8|38.8|Standard Deviation|5.0|5.0|||
3709380|NCT02146326|3548526|B2|||Official number of work hours (Staff)|Staff were asked how many official hours they are scheduled to work in a typical work week.|hours|Mean|38.5|38.5|Standard Deviation|5.4|5.4|||
3709381|NCT02146326|3548527|B1|||Official number of work hours (Staff)|Staff were asked how many official hours they are scheduled to work in a typical work week.|hours|Mean|39.1|39.1|Standard Deviation|4.6|4.6|||
3709382|NCT02146326|3548523|B5|||Hours of motivational interviewing training in past year (Staff)|Staff were asked how much training in motivational interviewing they had received in the past year.|hours|Mean|2.5|2.5|Standard Deviation|6.5|6.5|||
3709383|NCT02146326|3548526|B2|||Hours of motivational interviewing training in past year (Staff)|Staff were asked how much training in motivational interviewing they had received in the past year.|hours|Mean|1.9|1.9|Standard Deviation|4.5|4.5|||
3709384|NCT02146326|3548527|B1|||Hours of motivational interviewing training in past year (Staff)|Staff were asked how much training in motivational interviewing they had received in the past year.|hours|Mean|3.1|3.1|Standard Deviation|8.2|8.2|||
3709385|NCT02146326|3548523|B5|||Hours of burnout training in past year (Staff)|Staff were asked how much training in burnout prevention/reduction they had received in the past year.|hours|Mean|0.8|0.8|Standard Deviation|2.9|2.9|||
3709386|NCT02146326|3548526|B2|||Hours of burnout training in past year (Staff)|Staff were asked how much training in burnout prevention/reduction they had received in the past year.|hours|Mean|0.8|0.8|Standard Deviation|2.4|2.4|||
3709387|NCT02146326|3548527|B1|||Hours of burnout training in past year (Staff)|Staff were asked how much training in burnout prevention/reduction they had received in the past year.|hours|Mean|0.7|0.7|Standard Deviation|3.4|3.4|||
3709388|NCT02146326|3548523|B5|||Years in field (Staff)|Staff were asked how long they had been working in the mental health field (in years).|years|Mean|8.9|8.9|Standard Deviation|9.0|9.0|||
3709389|NCT02146326|3548526|B2|||Years in field (Staff)|Staff were asked how long they had been working in the mental health field (in years).|years|Mean|8.4|8.4|Standard Deviation|8.8|8.8|||
3709390|NCT02146326|3548527|B1|||Years in field (Staff)|Staff were asked how long they had been working in the mental health field (in years).|years|Mean|9.4|9.4|Standard Deviation|9.2|9.2|||
3709391|NCT02146326|3548523|B5|||Percentage of interactions with adult clients (Staff)|Staff were asked what percentage of client interactions are with adult clients (aged 18 or older). The data include those who reported at least 1%.|Participants|Count of Participants|174|174.0||||||
3709392|NCT02146326|3548526|B2|||Percentage of interactions with adult clients (Staff)|Staff were asked what percentage of client interactions are with adult clients (aged 18 or older). The data include those who reported at least 1%.|Participants|Count of Participants|94|94.0||||||
3709393|NCT02146326|3548527|B1|||Percentage of interactions with adult clients (Staff)|Staff were asked what percentage of client interactions are with adult clients (aged 18 or older). The data include those who reported at least 1%.|Participants|Count of Participants|80|80.0||||||
3709394|NCT02146326|3548523|B5|||Years at agency (Staff)|Staff were asked: How long have you been at Four County/Places for People? (in years)|years|Mean|5.0|5.0|Standard Deviation|6.3|6.3|||
3709395|NCT02146326|3548526|B2|||Years at agency (Staff)|Staff were asked: How long have you been at Four County/Places for People? (in years)|years|Mean|5.3|5.3|Standard Deviation|6.7|6.7|||
3709396|NCT02146326|3548527|B1|||Years at agency (Staff)|Staff were asked: How long have you been at Four County/Places for People? (in years)|years|Mean|4.8|4.8|Standard Deviation|5.7|5.7|||
3709397|NCT02146326|3548523|B5|||Years in position (Staff)|"Staff answered the question: How long have you been in your current position? (in years)"|years|Mean|3.3|3.3|Standard Deviation|4.7|4.7|||
3709398|NCT02146326|3548526|B2|||Years in position (Staff)|"Staff answered the question: How long have you been in your current position? (in years)"|years|Mean|3.1|3.1|Standard Deviation|4.7|4.7|||
3709399|NCT02146326|3548527|B1|||Years in position (Staff)|"Staff answered the question: How long have you been in your current position? (in years)"|years|Mean|3.5|3.5|Standard Deviation|4.7|4.7|||
3709400|NCT02146326|3548523|B5|Less than high school/GED||Education (Clients)|Highest grade of school completed (clients)|Participants|Count of Participants|141|141.0||||||
3709456|NCT02146248|3548692|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3709403|NCT02146326|3548523|B5|Completed at least high school/GED||Education (Clients)|Highest grade of school completed (clients)|Participants|Count of Participants|328|328.0||||||
3709404|NCT02146326|3548524|B4|Completed at least high school/GED||Education (Clients)|Highest grade of school completed (clients)|Participants|Count of Participants|178|178.0||||||
3709405|NCT02146326|3548525|B3|Completed at least high school/GED||Education (Clients)|Highest grade of school completed (clients)|Participants|Count of Participants|150|150.0||||||
3709406|NCT02146326|3548523|B5|Missing/Unknown||Education (Staff)|Highest level of education (staff)|Participants|Count of Participants|1|1.0||||||
3709407|NCT02146326|3548526|B2|Missing/Unknown||Education (Staff)|Highest level of education (staff)|Participants|Count of Participants|1|1.0||||||
3709408|NCT02146326|3548527|B1|Missing/Unknown||Education (Staff)|Highest level of education (staff)|Participants|Count of Participants|0|0.0||||||
3709409|NCT02146326|3548523|B5|Less than bachelors degree||Education (Staff)|Highest level of education (staff)|Participants|Count of Participants|34|34.0||||||
3709410|NCT02146326|3548526|B2|Less than bachelors degree||Education (Staff)|Highest level of education (staff)|Participants|Count of Participants|14|14.0||||||
3709411|NCT02146326|3548527|B1|Less than bachelors degree||Education (Staff)|Highest level of education (staff)|Participants|Count of Participants|20|20.0||||||
3709412|NCT02146326|3548523|B5|Bachelors degree or above||Education (Staff)|Highest level of education (staff)|Participants|Count of Participants|157|157.0||||||
3709413|NCT02146326|3548526|B2|Bachelors degree or above||Education (Staff)|Highest level of education (staff)|Participants|Count of Participants|88|88.0||||||
3709414|NCT02146326|3548527|B1|Bachelors degree or above||Education (Staff)|Highest level of education (staff)|Participants|Count of Participants|69|69.0||||||
3709415|NCT02146326|3548523|B5|Missing/Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3709416|NCT02146326|3548524|B4|Missing/Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3709417|NCT02146326|3548525|B3|Missing/Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3709418|NCT02146326|3548526|B2|Missing/Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3709419|NCT02146326|3548527|B1|Missing/Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3709420|NCT02146326|3548523|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3709421|NCT02146326|3548524|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3709422|NCT02146326|3548525|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3709423|NCT02146326|3548526|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3709424|NCT02146326|3548527|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3709425|NCT02146326|3548523|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|406|406.0||||||
3709426|NCT02146326|3548524|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|129|129.0||||||
3709427|NCT02146326|3548525|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|115|115.0||||||
3709428|NCT02146326|3548526|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|91|91.0||||||
3709429|NCT02146326|3548527|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|71|71.0||||||
3709430|NCT02146326|3548523|B5|African American||Race/Ethnicity, Customized||Participants|Count of Participants|221|221.0||||||
3709431|NCT02146326|3548524|B4|African American||Race/Ethnicity, Customized||Participants|Count of Participants|118|118.0||||||
3709432|NCT02146326|3548525|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|84|84.0||||||
3709433|NCT02146326|3548526|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3709434|NCT02146326|3548527|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3709435|NCT02146326|3548523|B5||Male|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
3709436|NCT02146326|3548524|B4||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3709437|NCT02146326|3548525|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3709438|NCT02146326|3548526|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3709439|NCT02146326|3548527|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3709440|NCT02146326|3548523|B5||Female|Sex: Female, Male||Participants|Count of Participants|395|395.0||||||
3709441|NCT02146326|3548524|B4||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3709442|NCT02146326|3548525|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3709443|NCT02146326|3548526|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3709444|NCT02146326|3548527|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3709445|NCT02146326|3548523|B5|||Age|Age of client population.|years|Mean|45.2|45.2|Standard Deviation|13.1|13.1|||
3709446|NCT02146326|3548524|B4|||Age|Age of client population.|years|Mean|45.2|45.2|Standard Deviation|12.7|12.7|||
3709447|NCT02146326|3548525|B3|||Age|Age of client population.|years|Mean|45.2|45.2|Standard Deviation|13.6|13.6|||
3709448|NCT02146326|3548523|B5|||Age|Age of staff population.|years|Mean|40.3|40.3|Standard Deviation|12.2|12.2|||
3709449|NCT02146326|3548526|B2|||Age|Age of staff population.|years|Mean|39.5|39.5|Standard Deviation|12.0|12.0|||
3709450|NCT02146326|3548527|B1|||Age|Age of staff population.|years|Mean|41.3|41.3|Standard Deviation|12.5|12.5|||
3709451|NCT02146248|3548692|B1|||One or more births||Participants|Count of Participants|5|5.0||||||
3709452|NCT02146248|3548692|B1|||Nulligravid||Participants|Count of Participants|6|6.0||||||
3709453|NCT02146248|3548692|B1|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3709454|NCT02146248|3548692|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709455|NCT02146248|3548692|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3709458|NCT02146248|3548692|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709459|NCT02146248|3548692|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3709460|NCT02146248|3548692|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709461|NCT02146248|3548692|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3709462|NCT02146248|3548692|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3709463|NCT02146248|3548692|B1|||Age||years|Mean|34|34.0|Standard Deviation|5|5.0|||
3709464|NCT02146131|3548700|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3709465|NCT02146131|3548701|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709466|NCT02146131|3548702|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3709467|NCT02146131|3548700|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709468|NCT02146131|3548701|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709469|NCT02146131|3548702|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709470|NCT02146131|3548700|B3||White|Race (NIH/OMB)||Participants|Count of Participants|161|161.0||||||
3709471|NCT02146131|3548701|B2||White|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3709472|NCT02146131|3548702|B1||White|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
3709473|NCT02146131|3548700|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3709474|NCT02146131|3548701|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3709475|NCT02146131|3548702|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3709476|NCT02146131|3548700|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709477|NCT02146131|3548701|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709478|NCT02146131|3548702|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709479|NCT02146131|3548700|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3709480|NCT02146131|3548701|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3709481|NCT02146131|3548702|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3709482|NCT02146131|3548700|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3709483|NCT02146131|3548701|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709484|NCT02146131|3548702|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3709485|NCT02146131|3548700|B3||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3709486|NCT02146131|3548701|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3709487|NCT02146131|3548702|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3709488|NCT02146131|3548700|B3||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3709489|NCT02146131|3548701|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3709490|NCT02146131|3548702|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3709491|NCT02146131|3548700|B3|||Age||years|Mean|68.9|68.9|Standard Deviation|10.6|10.6|||
3709492|NCT02146131|3548701|B2|||Age||years|Mean|70.1|70.1|Standard Deviation|9.9|9.9|||
3709493|NCT02146131|3548702|B1|||Age||years|Mean|67.6|67.6|Standard Deviation|11.2|11.2|||
3709494|NCT02146105|3548709|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3709495|NCT02146105|3548709|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3709496|NCT02146105|3548709|B1|||Age||years|Mean|61.0|61.0|Standard Deviation|6.8|6.8|||
3709497|NCT02146001|3548713|B3|||Body Mass Index, continuous||kg/m^2|Mean|28.6|28.6|Standard Deviation|5.5|5.5|||
3709498|NCT02146001|3548714|B2|||Body Mass Index, continuous||kg/m^2|Mean|28.3|28.3|Standard Deviation|4.8|4.8|||
3709499|NCT02146001|3548715|B1|||Body Mass Index, continuous||kg/m^2|Mean|28.9|28.9|Standard Deviation|6.3|6.3|||
3709500|NCT02146001|3548713|B3|Non-white||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3709501|NCT02146001|3548714|B2|Non-white||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3709502|NCT02146001|3548715|B1|Non-white||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3709503|NCT02146001|3548713|B3|White||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3709504|NCT02146001|3548714|B2|White||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3709505|NCT02146001|3548715|B1|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3709506|NCT02146001|3548713|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3709507|NCT02146001|3548714|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3709508|NCT02146001|3548715|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3709509|NCT02146001|3548713|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3709510|NCT02146001|3548714|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3709511|NCT02146001|3548715|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3709512|NCT02146001|3548713|B3|||Age||years|Mean|67.9|67.9|Standard Deviation|6.6|6.6|||
3709513|NCT02146001|3548714|B2|||Age||years|Mean|68.5|68.5|Standard Deviation|6.5|6.5|||
3709514|NCT02146001|3548715|B1|||Age||years|Mean|67.3|67.3|Standard Deviation|6.5|6.5|||
3709515|NCT02145754|3548726|B1|Slovenia||Region of Enrollment||participants|Number|235|235.0||||||
3709516|NCT02145754|3548726|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3709517|NCT02145754|3548726|B1||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3709518|NCT02145754|3548726|B1|||Age||years|Mean|57|57.0|Full Range|||21.0|93.0|
3709519|NCT02145754|3548726|B1||>=65 years|Age||Participants|Count of Participants|77|77.0||||||
3709520|NCT02145754|3548726|B1||Between 18 and 65 years|Age||Participants|Count of Participants|158|158.0||||||
3709521|NCT02145754|3548726|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3709522|NCT02145676|3548730|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3709523|NCT02145676|3548731|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3709524|NCT02145676|3548732|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3709525|NCT02145676|3548733|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3709526|NCT02145676|3548730|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3709527|NCT02145676|3548731|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3709528|NCT02145676|3548732|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3709529|NCT02145676|3548733|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3709530|NCT02145676|3548730|B4|||Age||Years|Mean|58.2|58.2|Standard Deviation|10.01|10.01|||
3709531|NCT02145676|3548731|B3|||Age||Years|Mean|56.2|56.2|Standard Deviation|8.30|8.3|||
3709532|NCT02145676|3548732|B2|||Age||Years|Mean|59.7|59.7|Standard Deviation|10.36|10.36|||
3709533|NCT02145676|3548733|B1|||Age||Years|Mean|58.8|58.8|Standard Deviation|11.46|11.46|||
3709534|NCT02145468|3548758|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3709535|NCT02145468|3548759|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709536|NCT02145468|3548760|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3709537|NCT02145468|3548758|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3709538|NCT02145468|3548759|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3709539|NCT02145468|3548760|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3709540|NCT02145468|3548758|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3201|3201.0||||||
3709541|NCT02145468|3548759|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1585|1585.0||||||
3709542|NCT02145468|3548760|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1616|1616.0||||||
3709543|NCT02145468|3548758|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3709544|NCT02145468|3548759|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3709545|NCT02145468|3548760|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3709546|NCT02145468|3548758|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3709547|NCT02145468|3548759|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3709548|NCT02145468|3548760|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3709549|NCT02145468|3548758|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|204|204.0||||||
3709550|NCT02145468|3548759|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
3709551|NCT02145468|3548760|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3709552|NCT02145468|3548758|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3709553|NCT02145468|3548759|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3709554|NCT02145468|3548760|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3709555|NCT02145468|3548758|B3||Male|Sex: Female, Male||Participants|Count of Participants|2457|2457.0||||||
3709556|NCT02145468|3548759|B2||Male|Sex: Female, Male||Participants|Count of Participants|1231|1231.0||||||
3709557|NCT02145468|3548760|B1||Male|Sex: Female, Male||Participants|Count of Participants|1226|1226.0||||||
3709558|NCT02145468|3548758|B3||Female|Sex: Female, Male||Participants|Count of Participants|1032|1032.0||||||
3709559|NCT02145468|3548759|B2||Female|Sex: Female, Male||Participants|Count of Participants|500|500.0||||||
3709560|NCT02145468|3548760|B1||Female|Sex: Female, Male||Participants|Count of Participants|532|532.0||||||
3709561|NCT02145468|3548758|B3|||Age||Years|Mean|66.6|66.6|Standard Deviation|9.86|9.86|||
3709562|NCT02145468|3548759|B2|||Age||Years|Mean|66.7|66.7|Standard Deviation|10.00|10.0|||
3709563|NCT02145468|3548760|B1|||Age||Years|Mean|66.5|66.5|Standard Deviation|9.72|9.72|||
3709564|NCT02145390|3548817|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3709565|NCT02145390|3548817|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709566|NCT02145390|3548817|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709567|NCT02145390|3548817|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3709568|NCT02145390|3548817|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709569|NCT02145390|3548817|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709570|NCT02145390|3548817|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709571|NCT02145390|3548817|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709572|NCT02145390|3548817|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709573|NCT02145390|3548817|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3709574|NCT02145390|3548817|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709575|NCT02145390|3548817|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3709576|NCT02145390|3548817|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3709577|NCT02145390|3548817|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3709578|NCT02145390|3548817|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3709579|NCT02145390|3548817|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3709580|NCT02145299|3548826|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3709581|NCT02145299|3548827|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3709582|NCT02145299|3548828|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3709583|NCT02145299|3548826|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3709584|NCT02145299|3548827|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3709585|NCT02145299|3548828|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3709586|NCT02145299|3548826|B3|||Age||years|Mean|67.8|67.8|Standard Deviation|9.1|9.1|||
3709587|NCT02145299|3548827|B2|||Age||years|Mean|64.0|64.0|Standard Deviation|11.0|11.0|||
3709588|NCT02145299|3548828|B1|||Age||years|Mean|69.0|69.0|Standard Deviation|7.1|7.1|||
3709589|NCT02145182|3548855|B3|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3709590|NCT02145182|3548856|B2|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3709591|NCT02145182|3548857|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3709592|NCT02145182|3548855|B3|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3709593|NCT02145182|3548856|B2|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3709594|NCT02145182|3548857|B1|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3709595|NCT02145182|3548855|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3709596|NCT02145182|3548856|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3709597|NCT02145182|3548857|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3709598|NCT02145182|3548855|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|180|180.0||||||
3709599|NCT02145182|3548856|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|92|92.0||||||
3709600|NCT02145182|3548857|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|88|88.0||||||
3709601|NCT02145182|3548855|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3709602|NCT02145182|3548856|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3709603|NCT02145182|3548857|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3709604|NCT02145182|3548855|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|75|75.0||||||
3709605|NCT02145182|3548856|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
3709606|NCT02145182|3548857|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
3709607|NCT02145182|3548855|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3709608|NCT02145182|3548856|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3709609|NCT02145182|3548857|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3709610|NCT02145182|3548855|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3709611|NCT02145182|3548856|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3709612|NCT02145182|3548857|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3709613|NCT02145182|3548855|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3709614|NCT02145182|3548856|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3709615|NCT02145182|3548857|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3709616|NCT02145182|3548855|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|221|221.0||||||
3709617|NCT02145182|3548856|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
3709618|NCT02145182|3548857|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
3709619|NCT02145182|3548855|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3709620|NCT02145182|3548856|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3709621|NCT02145182|3548857|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3709622|NCT02145182|3548855|B3||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
3709623|NCT02145182|3548856|B2||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3709624|NCT02145182|3548857|B1||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3709625|NCT02145182|3548855|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3709626|NCT02145182|3548856|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3709627|NCT02145182|3548857|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3709628|NCT02145182|3548855|B3|||Age||years|Mean|57.3|57.3|Standard Deviation|12.65|12.65|||
3709629|NCT02145182|3548856|B2|||Age||years|Mean|57.1|57.1|Standard Deviation|13.03|13.03|||
3709630|NCT02145182|3548857|B1|||Age||years|Mean|57.5|57.5|Standard Deviation|12.29|12.29|||
3709631|NCT02145156|3548872|B4|United States||Region of Enrollment||participants|Number|1294|1294.0||||||
3709632|NCT02145156|3548873|B3|United States||Region of Enrollment||participants|Number|439|439.0||||||
3709633|NCT02145156|3548874|B2|United States||Region of Enrollment||participants|Number|425|425.0||||||
3709634|NCT02145156|3548875|B1|United States||Region of Enrollment||participants|Number|430|430.0||||||
3709635|NCT02145156|3548872|B4|Other Race Adolescents||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3709636|NCT02145156|3548873|B3|Other Race Adolescents||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3709637|NCT02145156|3548874|B2|Other Race Adolescents||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3709638|NCT02145156|3548875|B1|Other Race Adolescents||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3709639|NCT02145156|3548872|B4|White Non-Hispanic Adolescents||Race/Ethnicity, Customized||Participants|Count of Participants|54|54.0||||||
3709640|NCT02145156|3548873|B3|White Non-Hispanic Adolescents||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3709641|NCT02145156|3548874|B2|White Non-Hispanic Adolescents||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3709642|NCT02145156|3548875|B1|White Non-Hispanic Adolescents||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3709643|NCT02145156|3548872|B4|Other Race Young Adults||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3709644|NCT02145156|3548873|B3|Other Race Young Adults||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3709645|NCT02145156|3548874|B2|Other Race Young Adults||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3709646|NCT02145156|3548875|B1|Other Race Young Adults||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3709647|NCT02145156|3548872|B4|White Non-Hispanic Young Adults||Race/Ethnicity, Customized||Participants|Count of Participants|56|56.0||||||
3709648|NCT02145156|3548873|B3|White Non-Hispanic Young Adults||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3709649|NCT02145156|3548874|B2|White Non-Hispanic Young Adults||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3709650|NCT02145156|3548875|B1|White Non-Hispanic Young Adults||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3709651|NCT02145156|3548872|B4|Self-Identify Hispanic Adolescents||Race/Ethnicity, Customized|"Number of people that indicated yes I consider myself Hispanic/Latino."|Participants|Count of Participants|789|789.0||||||
3709652|NCT02145156|3548873|B3|Self-Identify Hispanic Adolescents||Race/Ethnicity, Customized|"Number of people that indicated yes I consider myself Hispanic/Latino."|Participants|Count of Participants|269|269.0||||||
3709653|NCT02145156|3548874|B2|Self-Identify Hispanic Adolescents||Race/Ethnicity, Customized|"Number of people that indicated yes I consider myself Hispanic/Latino."|Participants|Count of Participants|254|254.0||||||
3709654|NCT02145156|3548875|B1|Self-Identify Hispanic Adolescents||Race/Ethnicity, Customized|"Number of people that indicated yes I consider myself Hispanic/Latino."|Participants|Count of Participants|266|266.0||||||
3709655|NCT02145156|3548872|B4|Self-Identify Hispanic Young Adults||Race/Ethnicity, Customized|"Number of people that indicated yes I consider myself Hispanic/Latino."|Participants|Count of Participants|380|380.0||||||
3709656|NCT02145156|3548873|B3|Self-Identify Hispanic Young Adults||Race/Ethnicity, Customized|"Number of people that indicated yes I consider myself Hispanic/Latino."|Participants|Count of Participants|130|130.0||||||
3709657|NCT02145156|3548874|B2|Self-Identify Hispanic Young Adults||Race/Ethnicity, Customized|"Number of people that indicated yes I consider myself Hispanic/Latino."|Participants|Count of Participants|127|127.0||||||
3709658|NCT02145156|3548875|B1|Self-Identify Hispanic Young Adults||Race/Ethnicity, Customized|"Number of people that indicated yes I consider myself Hispanic/Latino."|Participants|Count of Participants|123|123.0||||||
3709659|NCT02145156|3548872|B4|Male Adolescents||Sex/Gender, Customized||participants|Number|433|433.0||||||
3709660|NCT02145156|3548873|B3|Male Adolescents||Sex/Gender, Customized||participants|Number|148|148.0||||||
3709661|NCT02145156|3548874|B2|Male Adolescents||Sex/Gender, Customized||participants|Number|141|141.0||||||
3709662|NCT02145156|3548875|B1|Male Adolescents||Sex/Gender, Customized||participants|Number|144|144.0||||||
3709663|NCT02145156|3548872|B4|Female Adolescents||Sex/Gender, Customized||participants|Number|415|415.0||||||
3709664|NCT02145156|3548873|B3|Female Adolescents||Sex/Gender, Customized||participants|Number|139|139.0||||||
3709665|NCT02145156|3548874|B2|Female Adolescents||Sex/Gender, Customized||participants|Number|133|133.0||||||
3709666|NCT02145156|3548875|B1|Female Adolescents||Sex/Gender, Customized||participants|Number|143|143.0||||||
3709667|NCT02145156|3548872|B4|Male Young Adults||Sex/Gender, Customized||participants|Number|0|0.0||||||
3709668|NCT02145156|3548873|B3|Male Young Adults||Sex/Gender, Customized||participants|Number|0|0.0||||||
3709669|NCT02145156|3548874|B2|Male Young Adults||Sex/Gender, Customized||participants|Number|0|0.0||||||
3709670|NCT02145156|3548875|B1|Male Young Adults||Sex/Gender, Customized||participants|Number|0|0.0||||||
3709671|NCT02145156|3548872|B4|Female Young Adults||Sex/Gender, Customized||participants|Number|446|446.0||||||
3709672|NCT02145156|3548873|B3|Female Young Adults||Sex/Gender, Customized||participants|Number|152|152.0||||||
3709673|NCT02145156|3548874|B2|Female Young Adults||Sex/Gender, Customized||participants|Number|151|151.0||||||
3709674|NCT02145156|3548875|B1|Female Young Adults||Sex/Gender, Customized||participants|Number|143|143.0||||||
3709675|NCT02145156|3548872|B4|Adolescents||Age||Years|Median|12|12.0|Full Range|||9.0|17.0|
3709676|NCT02145156|3548873|B3|Adolescents||Age||Years|Median|12|12.0|Full Range|||9.0|17.0|
3709677|NCT02145156|3548874|B2|Adolescents||Age||Years|Median|12|12.0|Full Range|||9.0|17.0|
3709678|NCT02145156|3548875|B1|Adolescents||Age||Years|Median|12|12.0|Full Range|||9.0|17.0|
3709679|NCT02145156|3548872|B4|Young Adults||Age||Years|Median|22|22.0|Full Range|||18.0|26.0|
3709680|NCT02145156|3548873|B3|Young Adults||Age||Years|Median|23|23.0|Full Range|||18.0|26.0|
3709681|NCT02145156|3548874|B2|Young Adults||Age||Years|Median|23|23.0|Full Range|||18.0|26.0|
3709682|NCT02145156|3548875|B1|Young Adults||Age||Years|Median|22|22.0|Full Range|||18.0|26.0|
3709683|NCT02144714|3548918|B4|||BMI (kg/m^2)||kg/m^2|Mean|24.93|24.93|Standard Deviation|2.028|2.028|||
3709684|NCT02144714|3548919|B3|||BMI (kg/m^2)||kg/m^2|Mean|24.97|24.97|Standard Deviation|1.959|1.959|||
3709685|NCT02144714|3548920|B2|||BMI (kg/m^2)||kg/m^2|Mean|24.82|24.82|Standard Deviation|1.823|1.823|||
3709686|NCT02144714|3548921|B1|||BMI (kg/m^2)||kg/m^2|Mean|24.98|24.98|Standard Deviation|2.301|2.301|||
3709687|NCT02144714|3548918|B4|||Weight (kg)||kg|Mean|78.38|78.38|Standard Deviation|6.651|6.651|||
3709688|NCT02144714|3548919|B3|||Weight (kg)||kg|Mean|78.12|78.12|Standard Deviation|6.458|6.458|||
3709689|NCT02144714|3548920|B2|||Weight (kg)||kg|Mean|78.19|78.19|Standard Deviation|6.388|6.388|||
3709690|NCT02144714|3548921|B1|||Weight (kg)||kg|Mean|78.83|78.83|Standard Deviation|7.163|7.163|||
3709691|NCT02144714|3548918|B4|||Height (cm)||cm|Mean|177.4|177.4|Standard Deviation|6.56|6.56|||
3709692|NCT02144714|3548919|B3|||Height (cm)||cm|Mean|177.0|177.0|Standard Deviation|6.68|6.68|||
3709693|NCT02144714|3548920|B2|||Height (cm)||cm|Mean|177.5|177.5|Standard Deviation|6.34|6.34|||
3709694|NCT02144714|3548921|B1|||Height (cm)||cm|Mean|177.8|177.8|Standard Deviation|6.72|6.72|||
3709695|NCT02144714|3548918|B4|Race|Mixed|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3709696|NCT02144714|3548919|B3|Race|Mixed|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3709697|NCT02144714|3548920|B2|Race|Mixed|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3709698|NCT02144714|3548921|B1|Race|Mixed|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3709699|NCT02144714|3548918|B4|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3709700|NCT02144714|3548919|B3|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3709701|NCT02144714|3548920|B2|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3709702|NCT02144714|3548921|B1|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3709703|NCT02144714|3548918|B4|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3709704|NCT02144714|3548919|B3|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3709705|NCT02144714|3548920|B2|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3709706|NCT02144714|3548921|B1|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3709707|NCT02144714|3548918|B4|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|183|183.0||||||
3709708|NCT02144714|3548919|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|62|62.0||||||
3709709|NCT02144714|3548920|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|60|60.0||||||
3709710|NCT02144714|3548921|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|61|61.0||||||
3709711|NCT02144714|3548918|B4||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3709712|NCT02144714|3548919|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3709713|NCT02144714|3548920|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3709714|NCT02144714|3548921|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3709715|NCT02144714|3548918|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3709716|NCT02144714|3548919|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3709717|NCT02144714|3548920|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3709718|NCT02144714|3548921|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3709719|NCT02144714|3548918|B4|||Age||years|Mean|39.5|39.5|Standard Deviation|10.52|10.52|||
3709720|NCT02144714|3548919|B3|||Age||years|Mean|40.0|40.0|Standard Deviation|10.94|10.94|||
3709721|NCT02144714|3548920|B2|||Age||years|Mean|40.2|40.2|Standard Deviation|11.06|11.06|||
3709722|NCT02144714|3548921|B1|||Age||years|Mean|38.3|38.3|Standard Deviation|9.55|9.55|||
3709723|NCT02144701|3548940|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
3709724|NCT02144701|3548941|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3709725|NCT02144701|3548942|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3709726|NCT02144701|3548940|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3709727|NCT02144701|3548941|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3709728|NCT02144701|3548942|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3709729|NCT02144701|3548940|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709730|NCT02144701|3548941|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709731|NCT02144701|3548942|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709732|NCT02144701|3548940|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3709733|NCT02144701|3548941|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3709734|NCT02144701|3548942|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3709735|NCT02144701|3548940|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3709736|NCT02144701|3548941|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3709737|NCT02144701|3548942|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3709738|NCT02144701|3548940|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709739|NCT02144701|3548941|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709740|NCT02144701|3548942|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709741|NCT02144701|3548940|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709742|NCT02144701|3548941|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709743|NCT02144701|3548942|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709744|NCT02144701|3548940|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709745|NCT02144701|3548941|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709746|NCT02144701|3548942|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709747|NCT02144701|3548940|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709748|NCT02144701|3548941|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709749|NCT02144701|3548942|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709750|NCT02144701|3548940|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3709751|NCT02144701|3548941|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3709752|NCT02144701|3548942|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3709753|NCT02144701|3548940|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3709754|NCT02144701|3548941|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3709755|NCT02144701|3548942|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3709756|NCT02144701|3548940|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3709757|NCT02144701|3548941|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3709758|NCT02144701|3548942|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3709759|NCT02144701|3548940|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3709760|NCT02144701|3548941|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3709761|NCT02144701|3548942|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3709762|NCT02144701|3548940|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3709763|NCT02144701|3548941|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3709764|NCT02144701|3548942|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3709765|NCT02144701|3548940|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3709766|NCT02144701|3548941|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3709767|NCT02144701|3548942|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3709768|NCT02144701|3548940|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3709769|NCT02144701|3548941|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3709770|NCT02144701|3548942|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3709771|NCT02144675|3548959|B3|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3709772|NCT02144675|3548960|B2|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3709773|NCT02144675|3548961|B1|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3709774|NCT02144675|3548959|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709775|NCT02144675|3548960|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709776|NCT02144675|3548961|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709777|NCT02144675|3548959|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709778|NCT02144675|3548960|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709779|NCT02144675|3548961|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709780|NCT02144675|3548959|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3709781|NCT02144675|3548960|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3709782|NCT02144675|3548961|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3709783|NCT02144675|3548959|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3709784|NCT02144675|3548960|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709785|NCT02144675|3548961|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3709786|NCT02144675|3548959|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709787|NCT02144675|3548960|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709788|NCT02144675|3548961|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709789|NCT02144675|3548959|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3709790|NCT02144675|3548960|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3709791|NCT02144675|3548961|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709792|NCT02144675|3548959|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709793|NCT02144675|3548960|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709794|NCT02144675|3548961|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709795|NCT02144675|3548959|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709796|NCT02144675|3548960|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709797|NCT02144675|3548961|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709798|NCT02144675|3548959|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3709799|NCT02144675|3548960|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3709800|NCT02144675|3548961|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3709801|NCT02144675|3548959|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3709802|NCT02144675|3548960|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709803|NCT02144675|3548961|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3709804|NCT02144675|3548959|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3709805|NCT02144675|3548960|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3709806|NCT02144675|3548961|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3709807|NCT02144675|3548959|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3709808|NCT02144675|3548960|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3709809|NCT02144675|3548961|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3709810|NCT02144675|3548959|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3709811|NCT02144675|3548960|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3709812|NCT02144675|3548961|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3709813|NCT02144675|3548959|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3709814|NCT02144675|3548960|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3709815|NCT02144675|3548961|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3709816|NCT02144675|3548959|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3709817|NCT02144675|3548960|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3709818|NCT02144675|3548961|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3709819|NCT02144519|3548968|B3|Boys||Percentage of Achieving 30min Moderate-to-Vigorous Physical Activity (MVPA) Standard via acceleromtr|All children attending an ASP on unannounced measurement days had an opportunity to wear the ActiGraph GT3X+. The accelerometers were distilled using 5-second epochs. When children arrived to a program, they were fitted with an accelerometer and the arrival time was recorded (monitor time on). Before a child departed from a program, research staff removed the belt and recorded the time of departure (monitor time off). Children wore the monitors for their entire attendance at the ASPs.|% Achieving MVPA Standard|Number|33.2|33.2||||||
3709820|NCT02144519|3548969|B2|Boys||Percentage of Achieving 30min Moderate-to-Vigorous Physical Activity (MVPA) Standard via acceleromtr|All children attending an ASP on unannounced measurement days had an opportunity to wear the ActiGraph GT3X+. The accelerometers were distilled using 5-second epochs. When children arrived to a program, they were fitted with an accelerometer and the arrival time was recorded (monitor time on). Before a child departed from a program, research staff removed the belt and recorded the time of departure (monitor time off). Children wore the monitors for their entire attendance at the ASPs.|% Achieving MVPA Standard|Number|35.6|35.6||||||
3709821|NCT02144519|3548970|B1|Boys||Percentage of Achieving 30min Moderate-to-Vigorous Physical Activity (MVPA) Standard via acceleromtr|All children attending an ASP on unannounced measurement days had an opportunity to wear the ActiGraph GT3X+. The accelerometers were distilled using 5-second epochs. When children arrived to a program, they were fitted with an accelerometer and the arrival time was recorded (monitor time on). Before a child departed from a program, research staff removed the belt and recorded the time of departure (monitor time off). Children wore the monitors for their entire attendance at the ASPs.|% Achieving MVPA Standard|Number|31.8|31.8||||||
3709822|NCT02144519|3548968|B3|Girls||Percentage of Achieving 30min Moderate-to-Vigorous Physical Activity (MVPA) Standard via acceleromtr|All children attending an ASP on unannounced measurement days had an opportunity to wear the ActiGraph GT3X+. The accelerometers were distilled using 5-second epochs. When children arrived to a program, they were fitted with an accelerometer and the arrival time was recorded (monitor time on). Before a child departed from a program, research staff removed the belt and recorded the time of departure (monitor time off). Children wore the monitors for their entire attendance at the ASPs.|% Achieving MVPA Standard|Number|15.5|15.5||||||
3709823|NCT02144519|3548969|B2|Girls||Percentage of Achieving 30min Moderate-to-Vigorous Physical Activity (MVPA) Standard via acceleromtr|All children attending an ASP on unannounced measurement days had an opportunity to wear the ActiGraph GT3X+. The accelerometers were distilled using 5-second epochs. When children arrived to a program, they were fitted with an accelerometer and the arrival time was recorded (monitor time on). Before a child departed from a program, research staff removed the belt and recorded the time of departure (monitor time off). Children wore the monitors for their entire attendance at the ASPs.|% Achieving MVPA Standard|Number|16.2|16.2||||||
3709824|NCT02144519|3548970|B1|Girls||Percentage of Achieving 30min Moderate-to-Vigorous Physical Activity (MVPA) Standard via acceleromtr|All children attending an ASP on unannounced measurement days had an opportunity to wear the ActiGraph GT3X+. The accelerometers were distilled using 5-second epochs. When children arrived to a program, they were fitted with an accelerometer and the arrival time was recorded (monitor time on). Before a child departed from a program, research staff removed the belt and recorded the time of departure (monitor time off). Children wore the monitors for their entire attendance at the ASPs.|% Achieving MVPA Standard|Number|15|15.0||||||
3709825|NCT02144519|3548968|B3|United States||Region of Enrollment||Participants|Count of Participants|1765|1765.0||||||
3709826|NCT02144519|3548969|B2|United States||Region of Enrollment||Participants|Count of Participants|895|895.0||||||
3709827|NCT02144519|3548970|B1|United States||Region of Enrollment||Participants|Count of Participants|870|870.0||||||
3709828|NCT02144519|3548968|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|111|111.0||||||
3709829|NCT02144519|3548969|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
3709830|NCT02144519|3548970|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|60|60.0||||||
3709831|NCT02144519|3548968|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|655|655.0||||||
3709832|NCT02144519|3548969|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|266|266.0||||||
3709833|NCT02144519|3548970|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|389|389.0||||||
3709834|NCT02144519|3548968|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|999|999.0||||||
3709835|NCT02144519|3548969|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|578|578.0||||||
3709836|NCT02144519|3548970|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|421|421.0||||||
3709837|NCT02144519|3548968|B3||Male|Sex: Female, Male||Participants|Count of Participants|934|934.0||||||
3709838|NCT02144519|3548969|B2||Male|Sex: Female, Male||Participants|Count of Participants|478|478.0||||||
3709839|NCT02144519|3548970|B1||Male|Sex: Female, Male||Participants|Count of Participants|456|456.0||||||
3709840|NCT02144519|3548968|B3||Female|Sex: Female, Male||Participants|Count of Participants|831|831.0||||||
3709841|NCT02144519|3548969|B2||Female|Sex: Female, Male||Participants|Count of Participants|417|417.0||||||
3709842|NCT02144519|3548970|B1||Female|Sex: Female, Male||Participants|Count of Participants|414|414.0||||||
3709843|NCT02144519|3548968|B3|||Age||years|Mean|8.0|8.0|Standard Deviation|1.8|1.8|||
3709844|NCT02144519|3548969|B2|||Age||years|Mean|7.9|7.9|Standard Deviation|1.8|1.8|||
3709845|NCT02144519|3548970|B1|||Age||years|Mean|8.1|8.1|Standard Deviation|1.8|1.8|||
3709846|NCT02144337|3548979|B3|||HbA1c (mmol/mol)|"Glycaemic control measured in mmol/mol. UK recommended level for good diabetes control is currently <58mmol/mol for children.~Higher score indicates worse outcome. Lower score (<58mmol/mol) indicates better outcome."|mmol/mol|Mean|56.5|56.5|Standard Deviation|10.4|10.4|||
3709847|NCT02144337|3548980|B2|||HbA1c (mmol/mol)|"Glycaemic control measured in mmol/mol. UK recommended level for good diabetes control is currently <58mmol/mol for children.~Higher score indicates worse outcome. Lower score (<58mmol/mol) indicates better outcome."|mmol/mol|Mean|55.4|55.4|Standard Deviation|11.8|11.8|||
3709848|NCT02144337|3548981|B1|||HbA1c (mmol/mol)|"Glycaemic control measured in mmol/mol. UK recommended level for good diabetes control is currently <58mmol/mol for children.~Higher score indicates worse outcome. Lower score (<58mmol/mol) indicates better outcome."|mmol/mol|Mean|57.1|57.1|Standard Deviation|10.2|10.2|||
3709849|NCT02144337|3548979|B3|||PHFS Worry|15 items on the PHFS-worry subscale address specific worries that parents may have in relation to various aspects of hypoglycaemia (e.g., ‘child not having food, fruit or juice with him/her’). Items on the worry subscale assess worry about hypoglycaemia occurring when the child is alone or when there is no food or drink available, worry about the child having an accident or physical injury, and worry about the child being unable to function normally. Scores on the worry subscale range from 0-60. Higher score indicates greater worry (i.e., worse outcome).|units on a scale|Mean|20.8|20.8|Standard Deviation|12.2|12.2|||
3709850|NCT02144337|3548980|B2|||PHFS Worry|15 items on the PHFS-worry subscale address specific worries that parents may have in relation to various aspects of hypoglycaemia (e.g., ‘child not having food, fruit or juice with him/her’). Items on the worry subscale assess worry about hypoglycaemia occurring when the child is alone or when there is no food or drink available, worry about the child having an accident or physical injury, and worry about the child being unable to function normally. Scores on the worry subscale range from 0-60. Higher score indicates greater worry (i.e., worse outcome).|units on a scale|Mean|17.2|17.2|Standard Deviation|9.8|9.8|||
3709851|NCT02144337|3548981|B1|||PHFS Worry|15 items on the PHFS-worry subscale address specific worries that parents may have in relation to various aspects of hypoglycaemia (e.g., ‘child not having food, fruit or juice with him/her’). Items on the worry subscale assess worry about hypoglycaemia occurring when the child is alone or when there is no food or drink available, worry about the child having an accident or physical injury, and worry about the child being unable to function normally. Scores on the worry subscale range from 0-60. Higher score indicates greater worry (i.e., worse outcome).|units on a scale|Mean|21.2|21.2|Standard Deviation|14.1|14.1|||
3709852|NCT02144337|3548979|B3|||PHFS Behaviour|"11 items on the PHFS-behaviour subscale assess the behaviours that parents may engage in as a result of fear of hypoglycaemia (e.g., ‘avoid having my child being alone when his/her sugar is likely to be low’). Items refer to diabetes management behaviours parents may perform to reduce the chance of hypoglycaemia, the tendency to keep blood glucose levels high to avoid hypoglycaemia and behaviours aimed at avoiding the negative consequences of hypoglycaemia.~Scores range from 0-44. Higher score indicates more hypoglycaemia avoidance behaviours (i.e., worse outcome)."|units on a scale|Mean|21.8|21.8|Standard Deviation|4.4|4.4|||
3709853|NCT02144337|3548980|B2|||PHFS Behaviour|"11 items on the PHFS-behaviour subscale assess the behaviours that parents may engage in as a result of fear of hypoglycaemia (e.g., ‘avoid having my child being alone when his/her sugar is likely to be low’). Items refer to diabetes management behaviours parents may perform to reduce the chance of hypoglycaemia, the tendency to keep blood glucose levels high to avoid hypoglycaemia and behaviours aimed at avoiding the negative consequences of hypoglycaemia.~Scores range from 0-44. Higher score indicates more hypoglycaemia avoidance behaviours (i.e., worse outcome)."|units on a scale|Mean|20.2|20.2|Standard Deviation|2.6|2.6|||
3709854|NCT02144337|3548981|B1|||PHFS Behaviour|"11 items on the PHFS-behaviour subscale assess the behaviours that parents may engage in as a result of fear of hypoglycaemia (e.g., ‘avoid having my child being alone when his/her sugar is likely to be low’). Items refer to diabetes management behaviours parents may perform to reduce the chance of hypoglycaemia, the tendency to keep blood glucose levels high to avoid hypoglycaemia and behaviours aimed at avoiding the negative consequences of hypoglycaemia.~Scores range from 0-44. Higher score indicates more hypoglycaemia avoidance behaviours (i.e., worse outcome)."|units on a scale|Mean|21.9|21.9|Standard Deviation|7.5|7.5|||
3709855|NCT02144337|3548979|B3|||PHFS total|"PHFS = Parents' Hypoglycaemia Fear Survey The 26-item PHFS measured parents’ fear of hypoglycaemia and the negative consequences of these episodes, as well as behaviours used to avoid hypoglycaemia and its negative consequences. The measure comprises a behaviour subscale and a worry subscale.~Total score calculated as the sum of both sub-scales (PHFS Behaviour + PHFS Worry).~Scores range from 0-104. Higher score indicates greater fear of hypoglycaemia (i.e., worse outcome)."|units on a scale|Mean|42.7|42.7|Standard Deviation|13.3|13.3|||
3709925|NCT02144012|3549021|B1|||Age||years|Mean|53.7|53.7|Standard Deviation|9.5|9.5|||
3709982|NCT02143713|3549073|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3709983|NCT02143713|3549074|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3709856|NCT02144337|3548980|B2|||PHFS total|"PHFS = Parents' Hypoglycaemia Fear Survey The 26-item PHFS measured parents’ fear of hypoglycaemia and the negative consequences of these episodes, as well as behaviours used to avoid hypoglycaemia and its negative consequences. The measure comprises a behaviour subscale and a worry subscale.~Total score calculated as the sum of both sub-scales (PHFS Behaviour + PHFS Worry).~Scores range from 0-104. Higher score indicates greater fear of hypoglycaemia (i.e., worse outcome)."|units on a scale|Mean|37.4|37.4|Standard Deviation|11.5|11.5|||
3709857|NCT02144337|3548981|B1|||PHFS total|"PHFS = Parents' Hypoglycaemia Fear Survey The 26-item PHFS measured parents’ fear of hypoglycaemia and the negative consequences of these episodes, as well as behaviours used to avoid hypoglycaemia and its negative consequences. The measure comprises a behaviour subscale and a worry subscale.~Total score calculated as the sum of both sub-scales (PHFS Behaviour + PHFS Worry).~Scores range from 0-104. Higher score indicates greater fear of hypoglycaemia (i.e., worse outcome)."|units on a scale|Mean|42.8|42.8|Standard Deviation|17.6|17.6|||
3709858|NCT02144337|3548979|B3|||CSAPPA Enjoyment|Enjoyment (3 items) refers to enjoyment of Physical Education (P.E.) class. Range of scores 2 - 12 with higher scores indicating greater enjoyment of P.E (i.e., better outcome).|units on a scale|Mean|10.5|10.5|Standard Deviation|1.6|1.6|||
3709859|NCT02144337|3548980|B2|||CSAPPA Enjoyment|Enjoyment (3 items) refers to enjoyment of Physical Education (P.E.) class. Range of scores 2 - 12 with higher scores indicating greater enjoyment of P.E (i.e., better outcome).|units on a scale|Mean|10.3|10.3|Standard Deviation|1.5|1.5|||
3709860|NCT02144337|3548981|B1|||CSAPPA Enjoyment|Enjoyment (3 items) refers to enjoyment of Physical Education (P.E.) class. Range of scores 2 - 12 with higher scores indicating greater enjoyment of P.E (i.e., better outcome).|units on a scale|Mean|10.6|10.6|Standard Deviation|1.7|1.7|||
3709861|NCT02144337|3548979|B3|||CSAPPA Predilection|Predilection (9 items) refers to the preference for being active over being sedentary when given the choice. Range of scores 9 - 36 with higher scores indicating higher predilection towards physical activity (i.e., better outcome).|units on a scale|Mean|28.8|28.8|Standard Deviation|4.1|4.1|||
3709862|NCT02144337|3548980|B2|||CSAPPA Predilection|Predilection (9 items) refers to the preference for being active over being sedentary when given the choice. Range of scores 9 - 36 with higher scores indicating higher predilection towards physical activity (i.e., better outcome).|units on a scale|Mean|29.0|29.0|Standard Deviation|5.0|5.0|||
3709863|NCT02144337|3548981|B1|||CSAPPA Predilection|Predilection (9 items) refers to the preference for being active over being sedentary when given the choice. Range of scores 9 - 36 with higher scores indicating higher predilection towards physical activity (i.e., better outcome).|units on a scale|Mean|28.7|28.7|Standard Deviation|4.0|4.0|||
3709864|NCT02144337|3548979|B3|||CSAPPA Adequacy|Perceived adequacy (7 items) refers to the perception of one’s ability to achieve some acceptable standard of success, that standard being influenced by the self, parents, peers, teachers and society’s expectations. Range of scores 7 – 28, with higher scores indicating higher perceived adequacy (i.e., better outcome).|units on a scale|Mean|21.5|21.5|Standard Deviation|3.1|3.1|||
3709865|NCT02144337|3548980|B2|||CSAPPA Adequacy|Perceived adequacy (7 items) refers to the perception of one’s ability to achieve some acceptable standard of success, that standard being influenced by the self, parents, peers, teachers and society’s expectations. Range of scores 7 – 28, with higher scores indicating higher perceived adequacy (i.e., better outcome).|units on a scale|Mean|20.0|20.0|Standard Deviation|4.5|4.5|||
3709866|NCT02144337|3548981|B1|||CSAPPA Adequacy|Perceived adequacy (7 items) refers to the perception of one’s ability to achieve some acceptable standard of success, that standard being influenced by the self, parents, peers, teachers and society’s expectations. Range of scores 7 – 28, with higher scores indicating higher perceived adequacy (i.e., better outcome).|units on a scale|Mean|22.4|22.4|Standard Deviation|1.8|1.8|||
3709867|NCT02144337|3548979|B3|||CSAPPA total|"CSAPPA = Children’s Self-Perceptions of Adequacy in and Predilection for Physical Activity The CSAPPA scale measures generalised self-efficacy and attitudes towards participation in physical activity. The 19-item CSAPPA scale measures children’s perceived adequacy, predilection and enjoyment towards physical activity. Each item is scored from 1 to 4 and total CSAPPA scores range between 19 – 76 with higher scores indicative of greater self-efficacy (i.e., better outcome).~Total score calculated as the sum of all sub-scales (CSAPPA adequacy + CSAPPA predilection + CSAPPA enjoyment)"|units on a scale|Mean|60.8|60.8|Standard Deviation|7.1|7.1|||
3709868|NCT02144337|3548980|B2|||CSAPPA total|"CSAPPA = Children’s Self-Perceptions of Adequacy in and Predilection for Physical Activity The CSAPPA scale measures generalised self-efficacy and attitudes towards participation in physical activity. The 19-item CSAPPA scale measures children’s perceived adequacy, predilection and enjoyment towards physical activity. Each item is scored from 1 to 4 and total CSAPPA scores range between 19 – 76 with higher scores indicative of greater self-efficacy (i.e., better outcome).~Total score calculated as the sum of all sub-scales (CSAPPA adequacy + CSAPPA predilection + CSAPPA enjoyment)"|units on a scale|Mean|59.3|59.3|Standard Deviation|9.9|9.9|||
3709869|NCT02144337|3548981|B1|||CSAPPA total|"CSAPPA = Children’s Self-Perceptions of Adequacy in and Predilection for Physical Activity The CSAPPA scale measures generalised self-efficacy and attitudes towards participation in physical activity. The 19-item CSAPPA scale measures children’s perceived adequacy, predilection and enjoyment towards physical activity. Each item is scored from 1 to 4 and total CSAPPA scores range between 19 – 76 with higher scores indicative of greater self-efficacy (i.e., better outcome).~Total score calculated as the sum of all sub-scales (CSAPPA adequacy + CSAPPA predilection + CSAPPA enjoyment)"|units on a scale|Mean|61.7|61.7|Standard Deviation|5.7|5.7|||
3709870|NCT02144337|3548979|B3|||Self-reported physical activity|Children rate a range of activities on a three-point scale representing how much of that activity they did (none, a little, a lot) at three time points in the previous 24 hours; today before school (22 items), yesterday after school (22 items), and yesterday during school (11 items). Scores are summed to form a total score for physical activities (possible range 41-123). Higher values represent higher physical activity (i.e., better outcome).|units on a scale|Mean|54.16|54.16|Standard Deviation|8.5|8.5|||
3709926|NCT02143947|3549057|B3|||Visual Analogue Pain Scale|The visual analogue scale has a range from 0 to 10. 0 representing no pain, 10 representing the worse possible pain. Higher scores are considered worse.|units on a scale|Mean|7.0|7.0|Standard Deviation|1.8|1.8|||
3709984|NCT02143713|3549075|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3709871|NCT02144337|3548980|B2|||Self-reported physical activity|Children rate a range of activities on a three-point scale representing how much of that activity they did (none, a little, a lot) at three time points in the previous 24 hours; today before school (22 items), yesterday after school (22 items), and yesterday during school (11 items). Scores are summed to form a total score for physical activities (possible range 41-123). Higher values represent higher physical activity (i.e., better outcome).|units on a scale|Mean|49.8|49.8|Standard Deviation|5.7|5.7|||
3709872|NCT02144337|3548981|B1|||Self-reported physical activity|Children rate a range of activities on a three-point scale representing how much of that activity they did (none, a little, a lot) at three time points in the previous 24 hours; today before school (22 items), yesterday after school (22 items), and yesterday during school (11 items). Scores are summed to form a total score for physical activities (possible range 41-123). Higher values represent higher physical activity (i.e., better outcome).|units on a scale|Mean|56.8|56.8|Standard Deviation|9.1|9.1|||
3709873|NCT02144337|3548979|B3|||Years diagnosed||years|Mean|4.3|4.3|Standard Deviation|2.9|2.9|||
3709874|NCT02144337|3548980|B2|||Years diagnosed||years|Mean|2.9|2.9|Standard Deviation|2.3|2.3|||
3709875|NCT02144337|3548981|B1|||Years diagnosed||years|Mean|5.1|5.1|Standard Deviation|3.1|3.1|||
3709876|NCT02144337|3548979|B3|||BMI|Body mass index (calculated from height (cm) and weight (kg) measures from clinic records)|kg/m^2|Mean|19.9|19.9|Standard Deviation|3.5|3.5|||
3709877|NCT02144337|3548980|B2|||BMI|Body mass index (calculated from height (cm) and weight (kg) measures from clinic records)|kg/m^2|Mean|20.5|20.5|Standard Deviation|3.4|3.4|||
3709878|NCT02144337|3548981|B1|||BMI|Body mass index (calculated from height (cm) and weight (kg) measures from clinic records)|kg/m^2|Mean|19.5|19.5|Standard Deviation|3.8|3.8|||
3709879|NCT02144337|3548979|B3|Mixed race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3709880|NCT02144337|3548980|B2|Mixed race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3709881|NCT02144337|3548981|B1|Mixed race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3709882|NCT02144337|3548979|B3|Black African||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3709883|NCT02144337|3548980|B2|Black African||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3709884|NCT02144337|3548981|B1|Black African||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3709885|NCT02144337|3548979|B3|White British||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3709886|NCT02144337|3548980|B2|White British||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3709887|NCT02144337|3548981|B1|White British||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3709888|NCT02144337|3548979|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3709889|NCT02144337|3548980|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3709890|NCT02144337|3548981|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3709891|NCT02144337|3548979|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3709892|NCT02144337|3548980|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3709893|NCT02144337|3548981|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3709894|NCT02144337|3548979|B3|||Age||years|Mean|10.1|10.1|Standard Deviation|0.9|0.9|||
3709895|NCT02144337|3548980|B2|||Age||years|Mean|10.0|10.0|Standard Deviation|1|1.0|||
3709896|NCT02144337|3548981|B1|||Age||years|Mean|10.1|10.1|Standard Deviation|0.8|0.8|||
3709897|NCT02144259|3548992|B4|United States||Region of Enrollment||participants|Number|100|100.0||||||
3709898|NCT02144259|3548993|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
3709899|NCT02144259|3548994|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
3709900|NCT02144259|3548995|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
3709901|NCT02144259|3548992|B4||Male|Gender||Participants|Count of Participants|0|0.0||||||
3709902|NCT02144259|3548993|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3709903|NCT02144259|3548994|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3709904|NCT02144259|3548995|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3709905|NCT02144259|3548992|B4||Female|Gender||Participants|Count of Participants|100|100.0||||||
3709906|NCT02144259|3548993|B3||Female|Gender||Participants|Count of Participants|34|34.0||||||
3709907|NCT02144259|3548994|B2||Female|Gender||Participants|Count of Participants|33|33.0||||||
3709908|NCT02144259|3548995|B1||Female|Gender||Participants|Count of Participants|33|33.0||||||
3709909|NCT02144259|3548992|B4|||Age||years|Mean|24.02|24.02|Standard Deviation|4.63|4.63|||
3709910|NCT02144259|3548993|B3|||Age||years|Mean|26.59|26.59|Standard Deviation|5.42|5.42|||
3709911|NCT02144259|3548994|B2|||Age||years|Mean|22.42|22.42|Standard Deviation|3.81|3.81|||
3709912|NCT02144259|3548995|B1|||Age||years|Mean|23.06|23.06|Standard Deviation|4.68|4.68|||
3709913|NCT02144220|3549011|B1|United States||Region of Enrollment||participants|Number|277|277.0||||||
3709914|NCT02144220|3549011|B1||Male|Gender||Participants|Count of Participants|139|139.0||||||
3709915|NCT02144220|3549011|B1||Female|Gender||Participants|Count of Participants|138|138.0||||||
3709916|NCT02144220|3549011|B1|||Age||years|Mean|67.1|67.1|Standard Deviation|9.1|9.1|||
3709917|NCT02144012|3549019|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3709918|NCT02144012|3549020|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3709919|NCT02144012|3549021|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3709920|NCT02144012|3549019|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3709921|NCT02144012|3549020|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3709922|NCT02144012|3549021|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3709923|NCT02144012|3549019|B3|||Age||years|Mean|53.1|53.1|Standard Deviation|9.9|9.9|||
3709924|NCT02144012|3549020|B2|||Age||years|Mean|51.7|51.7|Standard Deviation|11.1|11.1|||
3709927|NCT02143947|3549058|B2|||Visual Analogue Pain Scale|The visual analogue scale has a range from 0 to 10. 0 representing no pain, 10 representing the worse possible pain. Higher scores are considered worse.|units on a scale|Mean|7.0|7.0|Standard Deviation|2.0|2.0|||
3709928|NCT02143947|3549059|B1|||Visual Analogue Pain Scale|The visual analogue scale has a range from 0 to 10. 0 representing no pain, 10 representing the worse possible pain. Higher scores are considered worse.|units on a scale|Mean|7.2|7.2|Standard Deviation|1.7|1.7|||
3709929|NCT02143947|3549057|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
3709930|NCT02143947|3549058|B2|United States||Region of Enrollment||participants|Number|44|44.0||||||
3709931|NCT02143947|3549059|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
3709932|NCT02143947|3549057|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3709933|NCT02143947|3549058|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3709934|NCT02143947|3549059|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3709935|NCT02143947|3549057|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709936|NCT02143947|3549058|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709937|NCT02143947|3549059|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709938|NCT02143947|3549057|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709939|NCT02143947|3549058|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709940|NCT02143947|3549059|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709941|NCT02143947|3549057|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709942|NCT02143947|3549058|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709943|NCT02143947|3549059|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709944|NCT02143947|3549057|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709945|NCT02143947|3549058|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709946|NCT02143947|3549059|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709947|NCT02143947|3549057|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709948|NCT02143947|3549058|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709949|NCT02143947|3549059|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709950|NCT02143947|3549057|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709951|NCT02143947|3549058|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709952|NCT02143947|3549059|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709953|NCT02143947|3549057|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3709954|NCT02143947|3549058|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3709955|NCT02143947|3549059|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3709956|NCT02143947|3549057|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3709957|NCT02143947|3549058|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3709958|NCT02143947|3549059|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3709959|NCT02143947|3549057|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3709960|NCT02143947|3549058|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3709961|NCT02143947|3549059|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3709962|NCT02143947|3549057|B3||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
3709963|NCT02143947|3549058|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3709964|NCT02143947|3549059|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3709965|NCT02143947|3549057|B3||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
3709966|NCT02143947|3549058|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3709967|NCT02143947|3549059|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
3709968|NCT02143947|3549057|B3|||Age||Years|Mean|20.9|20.9|Standard Deviation|4.6|4.6|||
3709969|NCT02143947|3549058|B2|||Age||Years|Mean|20.3|20.3|Standard Deviation|1.5|1.5|||
3709970|NCT02143947|3549059|B1|||Age||Years|Mean|21.7|21.7|Standard Deviation|6.6|6.6|||
3709971|NCT02143713|3549072|B5||Native Hawaiian or other pacific islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3709972|NCT02143713|3549073|B4||Native Hawaiian or other pacific islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3709973|NCT02143713|3549074|B3||Native Hawaiian or other pacific islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3709974|NCT02143713|3549075|B2||Native Hawaiian or other pacific islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3709975|NCT02143713|3549076|B1||Native Hawaiian or other pacific islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3709976|NCT02143713|3549072|B5||Multi race|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3709977|NCT02143713|3549073|B4||Multi race|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3709978|NCT02143713|3549074|B3||Multi race|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3709979|NCT02143713|3549075|B2||Multi race|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3709980|NCT02143713|3549076|B1||Multi race|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3709981|NCT02143713|3549072|B5||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3709985|NCT02143713|3549076|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3709986|NCT02143713|3549072|B5||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3709987|NCT02143713|3549073|B4||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3709988|NCT02143713|3549074|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3709989|NCT02143713|3549075|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3709990|NCT02143713|3549076|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3709991|NCT02143713|3549072|B5||White|Race/Ethnicity, Customized||Participants|Count of Participants|447|447.0||||||
3709992|NCT02143713|3549073|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|126|126.0||||||
3709993|NCT02143713|3549074|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|127|127.0||||||
3709994|NCT02143713|3549075|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|100|100.0||||||
3709995|NCT02143713|3549076|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|94|94.0||||||
3709996|NCT02143713|3549072|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709997|NCT02143713|3549073|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709998|NCT02143713|3549074|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3709999|NCT02143713|3549075|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710000|NCT02143713|3549076|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710001|NCT02143713|3549072|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|434|434.0||||||
3710002|NCT02143713|3549073|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
3710003|NCT02143713|3549074|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|127|127.0||||||
3710004|NCT02143713|3549075|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3710005|NCT02143713|3549076|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3710006|NCT02143713|3549072|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3710007|NCT02143713|3549073|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3710008|NCT02143713|3549074|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3710009|NCT02143713|3549075|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3710010|NCT02143713|3549076|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3710011|NCT02143713|3549072|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3710012|NCT02143713|3549073|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3710013|NCT02143713|3549074|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3710014|NCT02143713|3549075|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3710015|NCT02143713|3549076|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3710016|NCT02143713|3549072|B5||Female|Sex: Female, Male||Participants|Count of Participants|495|495.0||||||
3710017|NCT02143713|3549073|B4||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3710018|NCT02143713|3549074|B3||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3710019|NCT02143713|3549075|B2||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3710020|NCT02143713|3549076|B1||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3710021|NCT02143713|3549072|B5|||Age||years|Mean|33.5|33.5|Standard Deviation|6.76|6.76|||
3710022|NCT02143713|3549073|B4|||Age||years|Mean|34.1|34.1|Standard Deviation|6.70|6.7|||
3710023|NCT02143713|3549074|B3|||Age||years|Mean|33.2|33.2|Standard Deviation|7.02|7.02|||
3710024|NCT02143713|3549075|B2|||Age||years|Mean|33.2|33.2|Standard Deviation|6.32|6.32|||
3710025|NCT02143713|3549076|B1|||Age||years|Mean|33.5|33.5|Standard Deviation|7.00|7.0|||
3710026|NCT02143583|3549157|B4||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3710027|NCT02143583|3549158|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3710028|NCT02143583|3549159|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3710029|NCT02143583|3549160|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3710030|NCT02143583|3549157|B4||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3710031|NCT02143583|3549158|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3710032|NCT02143583|3549159|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3710033|NCT02143583|3549160|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3710034|NCT02143583|3549157|B4|||Age||years|Mean|37.4|37.4|Standard Deviation|9.3|9.3|||
3710035|NCT02143583|3549158|B3|||Age||years|Mean|35.5|35.5|Standard Deviation|9.3|9.3|||
3710036|NCT02143583|3549159|B2|||Age||years|Mean|37.9|37.9|Standard Deviation|9.4|9.4|||
3710037|NCT02143583|3549160|B1|||Age||years|Mean|39.0|39.0|Standard Deviation|9.0|9.0|||
3710038|NCT02143141|3549173|B3|||weight||pounds|Mean|186|186.0|Full Range|||130.0|267.0|
3710039|NCT02143141|3549174|B2|||weight||pounds|Mean|166|166.0|Full Range|||130.0|214.0|
3710040|NCT02143141|3549175|B1|||weight||pounds|Mean|206|206.0|Full Range|||160.0|267.0|
3710041|NCT02143141|3549173|B3|||height||inches|Mean|64.6|64.6|Full Range|||62.0|69.0|
3710042|NCT02143141|3549174|B2|||height||inches|Mean|64.5|64.5|Full Range|||62.0|69.0|
3710043|NCT02143141|3549175|B1|||height||inches|Mean|64.8|64.8|Full Range|||63.0|68.0|
3710044|NCT02143141|3549173|B3|||estimated gestational age of fetus||weeks|Mean|39|39.0|Full Range|||39.0|40.0|
3710045|NCT02143141|3549174|B2|||estimated gestational age of fetus||weeks|Mean|39|39.0|Full Range|||39.0|40.0|
3710046|NCT02143141|3549175|B1|||estimated gestational age of fetus||weeks|Mean|39|39.0|Full Range|||39.0|40.0|
3710047|NCT02143141|3549173|B3|||para|number of births a woman has had after 20 weeks of gestation|number|Mean|1|1.0|Full Range|||0.0|2.0|
3710048|NCT02143141|3549174|B2|||para|number of births a woman has had after 20 weeks of gestation|number|Mean|1|1.0|Full Range|||0.0|2.0|
3710049|NCT02143141|3549175|B1|||para|number of births a woman has had after 20 weeks of gestation|number|Mean|1|1.0|Full Range|||1.0|2.0|
3710050|NCT02143141|3549173|B3|||gravida|number of times a woman has been pregnant|number|Mean|2|2.0|Full Range|||1.0|5.0|
3710051|NCT02143141|3549174|B2|||gravida|number of times a woman has been pregnant|number|Mean|2|2.0|Full Range|||1.0|4.0|
3710052|NCT02143141|3549175|B1|||gravida|number of times a woman has been pregnant|number|Mean|3|3.0|Full Range|||2.0|5.0|
3710053|NCT02143141|3549173|B3|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3710054|NCT02143141|3549174|B2|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3710055|NCT02143141|3549175|B1|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3710056|NCT02143141|3549173|B3|female participants||Sex/Gender, Customized||Participants|Count of Participants|13|13.0||||||
3710057|NCT02143141|3549174|B2|female participants||Sex/Gender, Customized||Participants|Count of Participants|6|6.0||||||
3710058|NCT02143141|3549175|B1|female participants||Sex/Gender, Customized||Participants|Count of Participants|7|7.0||||||
3710059|NCT02143141|3549173|B3|||Age||years|Mean|31|31.0|Full Range|||21.0|36.0|
3710060|NCT02143141|3549174|B2|||Age||years|Mean|30|30.0|Full Range|||21.0|36.0|
3710061|NCT02143141|3549175|B1|||Age||years|Mean|32|32.0|Full Range|||27.0|35.0|
3710062|NCT02143102|3549186|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3710063|NCT02143102|3549187|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710064|NCT02143102|3549188|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3710065|NCT02143102|3549186|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3710066|NCT02143102|3549187|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3710067|NCT02143102|3549188|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3710068|NCT02143102|3549186|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
3710069|NCT02143102|3549187|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3710070|NCT02143102|3549188|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3710071|NCT02143102|3549186|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3710072|NCT02143102|3549187|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3710073|NCT02143102|3549188|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3710074|NCT02143102|3549186|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3710075|NCT02143102|3549187|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3710076|NCT02143102|3549188|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3710077|NCT02143102|3549186|B3|||Age||years|Mean|66.4|66.4|Standard Deviation|10.7|10.7|||
3710078|NCT02143102|3549187|B2|||Age||years|Mean|66.6|66.6|Standard Deviation|10.1|10.1|||
3710079|NCT02143102|3549188|B1|||Age||years|Mean|66.2|66.2|Standard Deviation|11|11.0|||
3710080|NCT02142738|3549197|B3||Male|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
3710081|NCT02142738|3549198|B2||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3710082|NCT02142738|3549199|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3710083|NCT02142738|3549197|B3||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3710084|NCT02142738|3549198|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3710085|NCT02142738|3549199|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3710086|NCT02142738|3549197|B3|||Age||Years|Mean|64.2|64.2|Standard Deviation|9.8|9.8|||
3710087|NCT02142738|3549198|B2|||Age||Years|Mean|64.6|64.6|Standard Deviation|9.5|9.5|||
3710088|NCT02142738|3549199|B1|||Age||Years|Mean|63.9|63.9|Standard Deviation|10.1|10.1|||
3710089|NCT02142712|3549210|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
3710090|NCT02142712|3549211|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3710091|NCT02142712|3549212|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3710092|NCT02142712|3549213|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3710093|NCT02142712|3549210|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3710094|NCT02142712|3549211|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3710095|NCT02142712|3549212|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3710096|NCT02142712|3549213|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3710097|NCT02142712|3549210|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3710098|NCT02142712|3549211|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3710099|NCT02142712|3549212|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3710100|NCT02142712|3549213|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3710101|NCT02142712|3549210|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3710102|NCT02142712|3549211|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3710103|NCT02142712|3549212|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3710104|NCT02142712|3549213|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3710105|NCT02142712|3549210|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3710106|NCT02142712|3549211|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3710107|NCT02142712|3549212|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3710108|NCT02142712|3549213|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3710109|NCT02142712|3549210|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3710110|NCT02142712|3549211|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3710111|NCT02142712|3549212|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3710112|NCT02142712|3549213|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3710113|NCT02142504|3549236|B4|||Body Mass Index (BMI)||kg/m^2|Mean|26.32|26.32|Standard Deviation|4.281|4.281|||
3710114|NCT02142504|3549237|B3|||Body Mass Index (BMI)||kg/m^2|Mean|26.14|26.14|Standard Deviation|4.313|4.313|||
3710115|NCT02142504|3549238|B2|||Body Mass Index (BMI)||kg/m^2|Mean|26.44|26.44|Standard Deviation|4.427|4.427|||
3710116|NCT02142504|3549239|B1|||Body Mass Index (BMI)||kg/m^2|Mean|26.40|26.4|Standard Deviation|4.125|4.125|||
3710117|NCT02142504|3549236|B4|||Weight||kg|Mean|76.33|76.33|Standard Deviation|15.068|15.068|||
3710118|NCT02142504|3549237|B3|||Weight||kg|Mean|76.91|76.91|Standard Deviation|15.598|15.598|||
3710119|NCT02142504|3549238|B2|||Weight||kg|Mean|75.56|75.56|Standard Deviation|14.720|14.72|||
3710120|NCT02142504|3549239|B1|||Weight||kg|Mean|76.50|76.5|Standard Deviation|14.924|14.924|||
3710121|NCT02142504|3549236|B4|||Height||cm|Mean|170.03|170.03|Standard Deviation|9.616|9.616|||
3710122|NCT02142504|3549237|B3|||Height||cm|Mean|171.24|171.24|Standard Deviation|9.859|9.859|||
3710123|NCT02142504|3549238|B2|||Height||cm|Mean|168.89|168.89|Standard Deviation|9.670|9.67|||
3710124|NCT02142504|3549239|B1|||Height||cm|Mean|169.91|169.91|Standard Deviation|9.228|9.228|||
3710125|NCT02142504|3549236|B4|United States||Region of Enrollment||participants|Number|454|454.0||||||
3710126|NCT02142504|3549237|B3|United States||Region of Enrollment||participants|Number|154|154.0||||||
3710127|NCT02142504|3549238|B2|United States||Region of Enrollment||participants|Number|147|147.0||||||
3710128|NCT02142504|3549239|B1|United States||Region of Enrollment||participants|Number|153|153.0||||||
3710129|NCT02142504|3549236|B4|Multiracial||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3710130|NCT02142504|3549237|B3|Multiracial||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3710131|NCT02142504|3549238|B2|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3710132|NCT02142504|3549239|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3710133|NCT02142504|3549236|B4|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3710134|NCT02142504|3549237|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3710135|NCT02142504|3549238|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3710136|NCT02142504|3549239|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3710137|NCT02142504|3549236|B4|White||Race/Ethnicity, Customized||participants|Number|285|285.0||||||
3710138|NCT02142504|3549237|B3|White||Race/Ethnicity, Customized||participants|Number|94|94.0||||||
3710139|NCT02142504|3549238|B2|White||Race/Ethnicity, Customized||participants|Number|91|91.0||||||
3710140|NCT02142504|3549239|B1|White||Race/Ethnicity, Customized||participants|Number|100|100.0||||||
3710141|NCT02142504|3549236|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3710142|NCT02142504|3549237|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3710143|NCT02142504|3549238|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3710144|NCT02142504|3549239|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3710145|NCT02142504|3549236|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|137|137.0||||||
3710146|NCT02142504|3549237|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
3710147|NCT02142504|3549238|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
3710148|NCT02142504|3549239|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
3710149|NCT02142504|3549236|B4|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3710150|NCT02142504|3549237|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3710151|NCT02142504|3549238|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3710152|NCT02142504|3549239|B1|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3710153|NCT02142504|3549236|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3710154|NCT02142504|3549237|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3710155|NCT02142504|3549238|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3710156|NCT02142504|3549239|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3710157|NCT02142504|3549236|B4|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3710158|NCT02142504|3549237|B3|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3710159|NCT02142504|3549238|B2|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3710160|NCT02142504|3549239|B1|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3710161|NCT02142504|3549236|B4|Not Reported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3710162|NCT02142504|3549237|B3|Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3710163|NCT02142504|3549238|B2|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3710164|NCT02142504|3549239|B1|Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3710165|NCT02142504|3549236|B4|Non-Hispanic and Latino||Race/Ethnicity, Customized||participants|Number|333|333.0||||||
3710166|NCT02142504|3549237|B3|Non-Hispanic and Latino||Race/Ethnicity, Customized||participants|Number|107|107.0||||||
3710167|NCT02142504|3549238|B2|Non-Hispanic and Latino||Race/Ethnicity, Customized||participants|Number|109|109.0||||||
3710168|NCT02142504|3549239|B1|Non-Hispanic and Latino||Race/Ethnicity, Customized||participants|Number|117|117.0||||||
3710169|NCT02142504|3549236|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|118|118.0||||||
3710170|NCT02142504|3549237|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
3710171|NCT02142504|3549238|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
3710172|NCT02142504|3549239|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
3710173|NCT02142504|3549236|B4||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3710174|NCT02142504|3549237|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3710175|NCT02142504|3549238|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3710176|NCT02142504|3549239|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3710177|NCT02142504|3549236|B4||Female|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
3710178|NCT02142504|3549237|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3710179|NCT02142504|3549238|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3710180|NCT02142504|3549239|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3710181|NCT02142504|3549236|B4|||Age||years|Mean|33.5|33.5|Standard Deviation|8.96|8.96|||
3710182|NCT02142504|3549237|B3|||Age||years|Mean|34.0|34.0|Standard Deviation|8.78|8.78|||
3710183|NCT02142504|3549238|B2|||Age||years|Mean|33.4|33.4|Standard Deviation|9.26|9.26|||
3710184|NCT02142504|3549239|B1|||Age||years|Mean|32.9|32.9|Standard Deviation|8.87|8.87|||
3710185|NCT02142361|3549327|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3710186|NCT02142361|3549327|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3710187|NCT02142361|3549327|B1|||Age||years|Mean|26|26.0|Standard Deviation|5.5|5.5|||
3710188|NCT02142283|3549428|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3710189|NCT02142283|3549429|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3710190|NCT02142283|3549430|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3710191|NCT02142283|3549428|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710192|NCT02142283|3549429|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710193|NCT02142283|3549430|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710194|NCT02142283|3549428|B3||White|Race (NIH/OMB)||Participants|Count of Participants|133|133.0||||||
3710195|NCT02142283|3549429|B2||White|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3710196|NCT02142283|3549430|B1||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3710197|NCT02142283|3549428|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3710198|NCT02142283|3549429|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3710199|NCT02142283|3549430|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3710200|NCT02142283|3549428|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3710201|NCT02142283|3549429|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3710202|NCT02142283|3549430|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710203|NCT02142283|3549428|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3710204|NCT02142283|3549429|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3710205|NCT02142283|3549430|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3710206|NCT02142283|3549428|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710207|NCT02142283|3549429|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710208|NCT02142283|3549430|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710209|NCT02142283|3549428|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3710210|NCT02142283|3549429|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3710211|NCT02142283|3549430|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3710212|NCT02142283|3549428|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|176|176.0||||||
3710213|NCT02142283|3549429|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3710214|NCT02142283|3549430|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3710215|NCT02142283|3549428|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3710216|NCT02142283|3549429|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3710217|NCT02142283|3549430|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3710218|NCT02142283|3549428|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3710219|NCT02142283|3549429|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3710220|NCT02142283|3549430|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3710221|NCT02142283|3549428|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3710222|NCT02142283|3549429|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3710223|NCT02142283|3549430|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3710224|NCT02142283|3549428|B3|||Age||Years|Mean|70.0|70.0|Standard Deviation|13.7|13.7|||
3710225|NCT02142283|3549429|B2|||Age||Years|Mean|70.7|70.7|Standard Deviation|13.2|13.2|||
3710226|NCT02142283|3549430|B1|||Age||Years|Mean|69.4|69.4|Standard Deviation|14.1|14.1|||
3710227|NCT02142153|3549451|B11|United Kingdom||Region of Enrollment||participants|Number|40|40.0||||||
3710228|NCT02142153|3549452|B10|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
3710229|NCT02142153|3549453|B9|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3710230|NCT02142153|3549454|B8|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
3710231|NCT02142153|3549455|B7|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3710232|NCT02142153|3549456|B6|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
3710233|NCT02142153|3549457|B5|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3710234|NCT02142153|3549458|B4|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
3710235|NCT02142153|3549459|B3|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3710236|NCT02142153|3549460|B2|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
3710237|NCT02142153|3549461|B1|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3710238|NCT02142153|3549451|B11||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710239|NCT02142153|3549452|B10||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710240|NCT02142153|3549453|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710241|NCT02142153|3549454|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710242|NCT02142153|3549455|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710243|NCT02142153|3549456|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710244|NCT02142153|3549457|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710245|NCT02142153|3549458|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710246|NCT02142153|3549459|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710247|NCT02142153|3549460|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710248|NCT02142153|3549461|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710249|NCT02142153|3549451|B11||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3710250|NCT02142153|3549452|B10||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3710251|NCT02142153|3549453|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3710252|NCT02142153|3549454|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3710253|NCT02142153|3549455|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3710254|NCT02142153|3549456|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3710255|NCT02142153|3549457|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3710256|NCT02142153|3549458|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3710257|NCT02142153|3549459|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3710258|NCT02142153|3549460|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3710259|NCT02142153|3549461|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3710260|NCT02142153|3549451|B11||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710261|NCT02142153|3549452|B10||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710262|NCT02142153|3549453|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710263|NCT02142153|3549454|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710264|NCT02142153|3549455|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710265|NCT02142153|3549456|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710266|NCT02142153|3549457|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710267|NCT02142153|3549458|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710268|NCT02142153|3549459|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710269|NCT02142153|3549460|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710270|NCT02142153|3549461|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710271|NCT02142153|3549451|B11||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3710272|NCT02142153|3549452|B10||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3710273|NCT02142153|3549453|B9||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3710274|NCT02142153|3549454|B8||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3710275|NCT02142153|3549455|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3710276|NCT02142153|3549456|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3710277|NCT02142153|3549457|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3710278|NCT02142153|3549458|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3710279|NCT02142153|3549459|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3710280|NCT02142153|3549460|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3710281|NCT02142153|3549461|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3710282|NCT02142153|3549451|B11||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3710283|NCT02142153|3549452|B10||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3710284|NCT02142153|3549453|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3710285|NCT02142153|3549454|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3710286|NCT02142153|3549455|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3710287|NCT02142153|3549456|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3710288|NCT02142153|3549457|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3710289|NCT02142153|3549458|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3710290|NCT02142153|3549459|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3710291|NCT02142153|3549460|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3710292|NCT02142153|3549461|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3710293|NCT02142153|3549451|B11||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3710294|NCT02142153|3549452|B10||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3710295|NCT02142153|3549453|B9||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3710296|NCT02142153|3549454|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3710297|NCT02142153|3549455|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3710298|NCT02142153|3549456|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3710299|NCT02142153|3549457|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3710300|NCT02142153|3549458|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3710301|NCT02142153|3549459|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3710302|NCT02142153|3549460|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3710303|NCT02142153|3549461|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3710304|NCT02142153|3549451|B11||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3710305|NCT02142153|3549452|B10||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3710306|NCT02142153|3549453|B9||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3710307|NCT02142153|3549454|B8||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3710308|NCT02142153|3549455|B7||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3710309|NCT02142153|3549456|B6||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3710310|NCT02142153|3549457|B5||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3710311|NCT02142153|3549458|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3710312|NCT02142153|3549459|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3710313|NCT02142153|3549460|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3710314|NCT02142153|3549461|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3710315|NCT02142153|3549451|B11||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3710316|NCT02142153|3549452|B10||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3710317|NCT02142153|3549453|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3710318|NCT02142153|3549454|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3710319|NCT02142153|3549455|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3710320|NCT02142153|3549456|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3710321|NCT02142153|3549457|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3710322|NCT02142153|3549458|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3710323|NCT02142153|3549459|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3710324|NCT02142153|3549460|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3710325|NCT02142153|3549461|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3710326|NCT02141997|3549502|B5||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3710327|NCT02141997|3549503|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3710328|NCT02141997|3549504|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3710329|NCT02141997|3549505|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3710330|NCT02141997|3549506|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3710331|NCT02141997|3549502|B5||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
3710332|NCT02141997|3549503|B4||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3710333|NCT02141997|3549504|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3710334|NCT02141997|3549505|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3710335|NCT02141997|3549506|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3710336|NCT02141997|3549502|B5|||Age||years|Mean|55.5|55.5|Standard Deviation|12.39|12.39|||
3710337|NCT02141997|3549503|B4|||Age||years|Mean|55.6|55.6|Standard Deviation|12.34|12.34|||
3710338|NCT02141997|3549504|B3|||Age||years|Mean|53.5|53.5|Standard Deviation|13.00|13.0|||
3710339|NCT02141997|3549505|B2|||Age||years|Mean|55.2|55.2|Standard Deviation|11.81|11.81|||
3710340|NCT02141997|3549506|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|12.36|12.36|||
3710341|NCT02141984|3549547|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3710342|NCT02141984|3549547|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3710343|NCT02141984|3549547|B1|||Age||years|Mean|17.68|17.68|Standard Deviation|5.69|5.69|||
3710344|NCT02141867|3549554|B1|Urgent/ Emergent surgery||Elective surgery||participants|Number|2120|2120.0||||||
3710345|NCT02141867|3549554|B1|Elective surgery||Elective surgery||participants|Number|1795|1795.0||||||
3710346|NCT02141867|3549554|B1||Male|Sex: Female, Male||Participants|Count of Participants|1994|1994.0||||||
3710347|NCT02141867|3549554|B1||Female|Sex: Female, Male||Participants|Count of Participants|1933|1933.0||||||
3710348|NCT02141867|3549554|B1|||Age||years|Mean|43.5|43.5|Standard Deviation|17.6|17.6|||
3710349|NCT02141854|3549561|B6|||Forced Expiratory Volume in 1 second (FEV1)||liters|Mean|2.105|2.105|Standard Deviation|0.6303|0.6303|||
3710350|NCT02141854|3549562|B5|||Forced Expiratory Volume in 1 second (FEV1)||liters|Mean|2.141|2.141|Standard Deviation|0.6849|0.6849|||
3710351|NCT02141854|3549563|B4|||Forced Expiratory Volume in 1 second (FEV1)||liters|Mean|2.069|2.069|Standard Deviation|0.6017|0.6017|||
3710352|NCT02141854|3549564|B3|||Forced Expiratory Volume in 1 second (FEV1)||liters|Mean|2.075|2.075|Standard Deviation|0.5696|0.5696|||
3710353|NCT02141854|3549565|B2|||Forced Expiratory Volume in 1 second (FEV1)||liters|Mean|2.157|2.157|Standard Deviation|0.6402|0.6402|||
3710354|NCT02141854|3549566|B1|||Forced Expiratory Volume in 1 second (FEV1)||liters|Mean|2.083|2.083|Standard Deviation|0.6532|0.6532|||
3710355|NCT02141854|3549561|B6|||Body Mass Index||kg/m^2|Mean|29.7|29.7|Standard Deviation|7.44|7.44|||
3710356|NCT02141854|3549562|B5|||Body Mass Index||kg/m^2|Mean|29.3|29.3|Standard Deviation|7.41|7.41|||
3710357|NCT02141854|3549563|B4|||Body Mass Index||kg/m^2|Mean|29.9|29.9|Standard Deviation|7.62|7.62|||
3710358|NCT02141854|3549564|B3|||Body Mass Index||kg/m^2|Mean|29.9|29.9|Standard Deviation|7.27|7.27|||
3710359|NCT02141854|3549565|B2|||Body Mass Index||kg/m^2|Mean|30.2|30.2|Standard Deviation|7.60|7.6|||
3710360|NCT02141854|3549566|B1|||Body Mass Index||kg/m^2|Mean|29.4|29.4|Standard Deviation|7.35|7.35|||
3710361|NCT02141854|3549561|B6||Inhaled corticosteroid/long-acting beta2-agonist|Previous Asthma Therapy||Participants|Count of Participants|399|399.0||||||
3710362|NCT02141854|3549562|B5||Inhaled corticosteroid/long-acting beta2-agonist|Previous Asthma Therapy||Participants|Count of Participants|77|77.0||||||
3710363|NCT02141854|3549563|B4||Inhaled corticosteroid/long-acting beta2-agonist|Previous Asthma Therapy||Participants|Count of Participants|88|88.0||||||
3710364|NCT02141854|3549564|B3||Inhaled corticosteroid/long-acting beta2-agonist|Previous Asthma Therapy||Participants|Count of Participants|83|83.0||||||
3710365|NCT02141854|3549565|B2||Inhaled corticosteroid/long-acting beta2-agonist|Previous Asthma Therapy||Participants|Count of Participants|78|78.0||||||
3710366|NCT02141854|3549566|B1||Inhaled corticosteroid/long-acting beta2-agonist|Previous Asthma Therapy||Participants|Count of Participants|73|73.0||||||
3710367|NCT02141854|3549561|B6||Inhaled corticosteroid|Previous Asthma Therapy||Participants|Count of Participants|329|329.0||||||
3710368|NCT02141854|3549562|B5||Inhaled corticosteroid|Previous Asthma Therapy||Participants|Count of Participants|68|68.0||||||
3710369|NCT02141854|3549563|B4||Inhaled corticosteroid|Previous Asthma Therapy||Participants|Count of Participants|58|58.0||||||
3710370|NCT02141854|3549564|B3||Inhaled corticosteroid|Previous Asthma Therapy||Participants|Count of Participants|63|63.0||||||
3710371|NCT02141854|3549565|B2||Inhaled corticosteroid|Previous Asthma Therapy||Participants|Count of Participants|67|67.0||||||
3710372|NCT02141854|3549566|B1||Inhaled corticosteroid|Previous Asthma Therapy||Participants|Count of Participants|73|73.0||||||
3710373|NCT02141854|3549561|B6||No tobacco use|History of Smoking||Participants|Count of Participants|608|608.0||||||
3710374|NCT02141854|3549562|B5||No tobacco use|History of Smoking||Participants|Count of Participants|122|122.0||||||
3710375|NCT02141854|3549563|B4||No tobacco use|History of Smoking||Participants|Count of Participants|118|118.0||||||
3710376|NCT02141854|3549564|B3||No tobacco use|History of Smoking||Participants|Count of Participants|125|125.0||||||
3710377|NCT02141854|3549565|B2||No tobacco use|History of Smoking||Participants|Count of Participants|117|117.0||||||
3710378|NCT02141854|3549566|B1||No tobacco use|History of Smoking||Participants|Count of Participants|126|126.0||||||
3710379|NCT02141854|3549561|B6||Prior Smoker|History of Smoking||Participants|Count of Participants|120|120.0||||||
3710380|NCT02141854|3549562|B5||Prior Smoker|History of Smoking||Participants|Count of Participants|23|23.0||||||
3710381|NCT02141854|3549563|B4||Prior Smoker|History of Smoking||Participants|Count of Participants|28|28.0||||||
3710382|NCT02141854|3549564|B3||Prior Smoker|History of Smoking||Participants|Count of Participants|21|21.0||||||
3710383|NCT02141854|3549565|B2||Prior Smoker|History of Smoking||Participants|Count of Participants|28|28.0||||||
3710384|NCT02141854|3549566|B1||Prior Smoker|History of Smoking||Participants|Count of Participants|20|20.0||||||
3710385|NCT02141854|3549561|B6|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3710386|NCT02141854|3549562|B5|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3710387|NCT02141854|3549563|B4|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3710388|NCT02141854|3549564|B3|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3710389|NCT02141854|3549565|B2|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3710390|NCT02141854|3549566|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3710391|NCT02141854|3549561|B6|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|49|49.0||||||
3710392|NCT02141854|3549562|B5|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3710446|NCT02141854|3549562|B5||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3710393|NCT02141854|3549563|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3710394|NCT02141854|3549564|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3710395|NCT02141854|3549565|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3710396|NCT02141854|3549566|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3710397|NCT02141854|3549561|B6|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|677|677.0||||||
3710398|NCT02141854|3549562|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|136|136.0||||||
3710399|NCT02141854|3549563|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|134|134.0||||||
3710400|NCT02141854|3549564|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|136|136.0||||||
3710401|NCT02141854|3549565|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|135|135.0||||||
3710402|NCT02141854|3549566|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|136|136.0||||||
3710403|NCT02141854|3549561|B6|Other||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3710404|NCT02141854|3549562|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3710405|NCT02141854|3549563|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3710406|NCT02141854|3549564|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3710407|NCT02141854|3549565|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3710408|NCT02141854|3549566|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3710409|NCT02141854|3549561|B6|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3710410|NCT02141854|3549562|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3710411|NCT02141854|3549563|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3710412|NCT02141854|3549564|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3710413|NCT02141854|3549565|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3710414|NCT02141854|3549566|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3710415|NCT02141854|3549561|B6|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3710416|NCT02141854|3549562|B5|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3710417|NCT02141854|3549563|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3710418|NCT02141854|3549564|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3710419|NCT02141854|3549565|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3710420|NCT02141854|3549566|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3710421|NCT02141854|3549561|B6|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3710422|NCT02141854|3549562|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3710423|NCT02141854|3549563|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3710424|NCT02141854|3549564|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3710425|NCT02141854|3549565|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3710426|NCT02141854|3549566|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3710427|NCT02141854|3549561|B6|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|120|120.0||||||
3710428|NCT02141854|3549562|B5|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3710429|NCT02141854|3549563|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3710430|NCT02141854|3549564|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3710431|NCT02141854|3549565|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3710432|NCT02141854|3549566|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3710433|NCT02141854|3549561|B6|White||Race/Ethnicity, Customized||Participants|Count of Participants|588|588.0||||||
3710434|NCT02141854|3549562|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|124|124.0||||||
3710435|NCT02141854|3549563|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|111|111.0||||||
3710436|NCT02141854|3549564|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|116|116.0||||||
3710437|NCT02141854|3549565|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|112|112.0||||||
3710438|NCT02141854|3549566|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|125|125.0||||||
3710439|NCT02141854|3549561|B6||Male|Sex: Female, Male||Participants|Count of Participants|289|289.0||||||
3710440|NCT02141854|3549562|B5||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3710441|NCT02141854|3549563|B4||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3710442|NCT02141854|3549564|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3710443|NCT02141854|3549565|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3710444|NCT02141854|3549566|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3710445|NCT02141854|3549561|B6||Female|Sex: Female, Male||Participants|Count of Participants|439|439.0||||||
3710447|NCT02141854|3549563|B4||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3710448|NCT02141854|3549564|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3710449|NCT02141854|3549565|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3710450|NCT02141854|3549566|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3710451|NCT02141854|3549561|B6|Adults (65-84 years)||Age, Customized||Participants|Count of Participants|75|75.0||||||
3710452|NCT02141854|3549562|B5|Adults (65-84 years)||Age, Customized||Participants|Count of Participants|14|14.0||||||
3710453|NCT02141854|3549563|B4|Adults (65-84 years)||Age, Customized||Participants|Count of Participants|13|13.0||||||
3710454|NCT02141854|3549564|B3|Adults (65-84 years)||Age, Customized||Participants|Count of Participants|17|17.0||||||
3710455|NCT02141854|3549565|B2|Adults (65-84 years)||Age, Customized||Participants|Count of Participants|12|12.0||||||
3710456|NCT02141854|3549566|B1|Adults (65-84 years)||Age, Customized||Participants|Count of Participants|19|19.0||||||
3710457|NCT02141854|3549561|B6|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|608|608.0||||||
3710458|NCT02141854|3549562|B5|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|125|125.0||||||
3710459|NCT02141854|3549563|B4|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|124|124.0||||||
3710460|NCT02141854|3549564|B3|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|119|119.0||||||
3710461|NCT02141854|3549565|B2|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|125|125.0||||||
3710462|NCT02141854|3549566|B1|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|115|115.0||||||
3710463|NCT02141854|3549561|B6|Adolescents (12-17 years)||Age, Customized||Participants|Count of Participants|45|45.0||||||
3710464|NCT02141854|3549562|B5|Adolescents (12-17 years)||Age, Customized||Participants|Count of Participants|6|6.0||||||
3710465|NCT02141854|3549563|B4|Adolescents (12-17 years)||Age, Customized||Participants|Count of Participants|9|9.0||||||
3710466|NCT02141854|3549564|B3|Adolescents (12-17 years)||Age, Customized||Participants|Count of Participants|10|10.0||||||
3710467|NCT02141854|3549565|B2|Adolescents (12-17 years)||Age, Customized||Participants|Count of Participants|8|8.0||||||
3710468|NCT02141854|3549566|B1|Adolescents (12-17 years)||Age, Customized||Participants|Count of Participants|12|12.0||||||
3710469|NCT02141854|3549561|B6|||Age||years|Mean|44.7|44.7|Standard Deviation|15.95|15.95|||
3710470|NCT02141854|3549562|B5|||Age||years|Mean|44.5|44.5|Standard Deviation|16.05|16.05|||
3710471|NCT02141854|3549563|B4|||Age||years|Mean|45.7|45.7|Standard Deviation|15.64|15.64|||
3710472|NCT02141854|3549564|B3|||Age||years|Mean|44.4|44.4|Standard Deviation|16.36|16.36|||
3710473|NCT02141854|3549565|B2|||Age||years|Mean|44.3|44.3|Standard Deviation|14.88|14.88|||
3710474|NCT02141854|3549566|B1|||Age||years|Mean|44.7|44.7|Standard Deviation|16.93|16.93|||
3710475|NCT02141659|3549623|B7|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|22.90|22.9|Standard Deviation|2.694|2.694|||
3710476|NCT02141659|3549624|B6|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|21.93|21.93|Standard Deviation|2.475|2.475|||
3710477|NCT02141659|3549625|B5|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|24.17|24.17|Standard Deviation|3.109|3.109|||
3710478|NCT02141659|3549626|B4|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|22.17|22.17|Standard Deviation|1.498|1.498|||
3710479|NCT02141659|3549627|B3|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|22.00|22.0|Standard Deviation|1.400|1.4|||
3710480|NCT02141659|3549628|B2|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|23.03|23.03|Standard Deviation|2.841|2.841|||
3710481|NCT02141659|3549629|B1|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|22.90|22.9|Standard Deviation|2.100|2.1|||
3710482|NCT02141659|3549623|B7|||Weight||kilogram (kg)|Mean|61.59|61.59|Standard Deviation|7.017|7.017|||
3710483|NCT02141659|3549624|B6|||Weight||kilogram (kg)|Mean|59.34|59.34|Standard Deviation|5.440|5.44|||
3710484|NCT02141659|3549625|B5|||Weight||kilogram (kg)|Mean|64.43|64.43|Standard Deviation|7.891|7.891|||
3710485|NCT02141659|3549626|B4|||Weight||kilogram (kg)|Mean|56.80|56.8|Standard Deviation|1.992|1.992|||
3710486|NCT02141659|3549627|B3|||Weight||kilogram (kg)|Mean|57.97|57.97|Standard Deviation|2.857|2.857|||
3710487|NCT02141659|3549628|B2|||Weight||kilogram (kg)|Mean|64.40|64.4|Standard Deviation|9.542|9.542|||
3710488|NCT02141659|3549629|B1|||Weight||kilogram (kg)|Mean|63.27|63.27|Standard Deviation|8.361|8.361|||
3710489|NCT02141659|3549623|B7|||Height||centimeter (cm)|Mean|164.1|164.1|Standard Deviation|4.57|4.57|||
3710490|NCT02141659|3549624|B6|||Height||centimeter (cm)|Mean|164.7|164.7|Standard Deviation|5.27|5.27|||
3710491|NCT02141659|3549625|B5|||Height||centimeter (cm)|Mean|163.4|163.4|Standard Deviation|3.94|3.94|||
3710492|NCT02141659|3549626|B4|||Height||centimeter (cm)|Mean|160.3|160.3|Standard Deviation|4.16|4.16|||
3710493|NCT02141659|3549627|B3|||Height||centimeter (cm)|Mean|162.3|162.3|Standard Deviation|3.06|3.06|||
3710494|NCT02141659|3549628|B2|||Height||centimeter (cm)|Mean|167.0|167.0|Standard Deviation|3.92|3.92|||
3710495|NCT02141659|3549629|B1|||Height||centimeter (cm)|Mean|166.0|166.0|Standard Deviation|5.57|5.57|||
3710496|NCT02141659|3549623|B7|Japan||Region of Enrollment||participants|Number|43|43.0||||||
3710497|NCT02141659|3549624|B6|Japan||Region of Enrollment||participants|Number|15|15.0||||||
3710498|NCT02141659|3549625|B5|Japan||Region of Enrollment||participants|Number|15|15.0||||||
3710499|NCT02141659|3549626|B4|Japan||Region of Enrollment||participants|Number|3|3.0||||||
3710500|NCT02141659|3549627|B3|Japan||Region of Enrollment||participants|Number|3|3.0||||||
3710501|NCT02141659|3549628|B2|Japan||Region of Enrollment||participants|Number|4|4.0||||||
3710502|NCT02141659|3549629|B1|Japan||Region of Enrollment||participants|Number|3|3.0||||||
3710503|NCT02141659|3549623|B7|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3710504|NCT02141659|3549623|B7||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3710505|NCT02141659|3549624|B6||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3710506|NCT02141659|3549625|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3710507|NCT02141659|3549626|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3710508|NCT02141659|3549627|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3710509|NCT02141659|3549628|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3710510|NCT02141659|3549629|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3710511|NCT02141659|3549623|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3710512|NCT02141659|3549624|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3710513|NCT02141659|3549625|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3710514|NCT02141659|3549626|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3710515|NCT02141659|3549627|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3710516|NCT02141659|3549628|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3710517|NCT02141659|3549629|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3710518|NCT02141659|3549623|B7|||Age||years|Mean|74.0|74.0|Standard Deviation|5.00|5.0|||
3710519|NCT02141659|3549624|B6|||Age||years|Mean|74.4|74.4|Standard Deviation|5.53|5.53|||
3710520|NCT02141659|3549625|B5|||Age||years|Mean|74.5|74.5|Standard Deviation|4.84|4.84|||
3710521|NCT02141659|3549626|B4|||Age||years|Mean|71.7|71.7|Standard Deviation|3.51|3.51|||
3710522|NCT02141659|3549627|B3|||Age||years|Mean|75.0|75.0|Standard Deviation|6.08|6.08|||
3710523|NCT02141659|3549628|B2|||Age||years|Mean|72.0|72.0|Standard Deviation|5.60|5.6|||
3710524|NCT02141659|3549629|B1|||Age||years|Mean|73.3|73.3|Standard Deviation|5.51|5.51|||
3710525|NCT02141633|3549688|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
3710526|NCT02141633|3549689|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3710527|NCT02141633|3549690|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3710528|NCT02141633|3549688|B3||Male|Gender||Participants|Count of Participants|12|12.0||||||
3710529|NCT02141633|3549689|B2||Male|Gender||Participants|Count of Participants|6|6.0||||||
3710530|NCT02141633|3549690|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
3710531|NCT02141633|3549688|B3||Female|Gender||Participants|Count of Participants|19|19.0||||||
3710532|NCT02141633|3549689|B2||Female|Gender||Participants|Count of Participants|9|9.0||||||
3710533|NCT02141633|3549690|B1||Female|Gender||Participants|Count of Participants|10|10.0||||||
3710534|NCT02141633|3549688|B3|||Age||years|Mean|46.2|46.2|Standard Deviation|2.0|2.0|||
3710535|NCT02141633|3549689|B2|||Age||years|Mean|44.7|44.7|Standard Deviation|2.0|2.0|||
3710536|NCT02141633|3549690|B1|||Age||years|Mean|47.6|47.6|Standard Deviation|2.0|2.0|||
3710537|NCT02141633|3549688|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3710538|NCT02141633|3549689|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3710539|NCT02141633|3549690|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3710540|NCT02141633|3549688|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3710541|NCT02141633|3549689|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3710542|NCT02141633|3549690|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3710543|NCT02141633|3549688|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3710544|NCT02141633|3549689|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3710545|NCT02141633|3549690|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3710546|NCT02141620|3549699|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3710547|NCT02141620|3549699|B1||Male|Gender||Participants|Count of Participants|11|11.0||||||
3710548|NCT02141620|3549699|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
3710549|NCT02141620|3549699|B1|||Age||years|Mean|42.6|42.6|Standard Deviation|5.4|5.4|||
3710550|NCT02141581|3549758|B4|United States||Region of Enrollment||Participants|Count of Participants|86|86.0||||||
3710551|NCT02141581|3549759|B3|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3710552|NCT02141581|3549760|B2|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3710553|NCT02141581|3549761|B1|United States||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3710554|NCT02141581|3549758|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3710555|NCT02141581|3549759|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710556|NCT02141581|3549760|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3710557|NCT02141581|3549761|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3710558|NCT02141581|3549758|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3710559|NCT02141581|3549759|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3710560|NCT02141581|3549760|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3710561|NCT02141581|3549761|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3710562|NCT02141581|3549758|B4||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3710563|NCT02141581|3549759|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3710564|NCT02141581|3549760|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3710565|NCT02141581|3549761|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3710566|NCT02141581|3549758|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710567|NCT02141581|3549759|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710568|NCT02141581|3549760|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710569|NCT02141581|3549761|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710570|NCT02141581|3549758|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3710571|NCT02141581|3549759|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710572|NCT02141581|3549760|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3710573|NCT02141581|3549761|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3710574|NCT02141581|3549758|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3710575|NCT02141581|3549759|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3710576|NCT02141581|3549760|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3710577|NCT02141581|3549761|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3710578|NCT02141581|3549758|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3710579|NCT02141581|3549759|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3710580|NCT02141581|3549760|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710581|NCT02141581|3549761|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3710582|NCT02141581|3549758|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710583|NCT02141581|3549759|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710584|NCT02141581|3549760|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710585|NCT02141581|3549761|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710586|NCT02141581|3549758|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3710587|NCT02141581|3549759|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3710588|NCT02141581|3549760|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3710589|NCT02141581|3549761|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3710590|NCT02141581|3549758|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3710591|NCT02141581|3549759|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3710592|NCT02141581|3549760|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3710593|NCT02141581|3549761|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3710594|NCT02141581|3549758|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3710595|NCT02141581|3549759|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3710596|NCT02141581|3549760|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3710597|NCT02141581|3549761|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3710598|NCT02141581|3549758|B4||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3710599|NCT02141581|3549759|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3710600|NCT02141581|3549760|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3710601|NCT02141581|3549761|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3710602|NCT02141581|3549758|B4|Age 8-17 years||Age, Customized||Participants|Count of Participants|10|10.0||||||
3710603|NCT02141581|3549759|B3|Age 8-17 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3710604|NCT02141581|3549760|B2|Age 8-17 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3710605|NCT02141581|3549761|B1|Age 8-17 years||Age, Customized||Participants|Count of Participants|10|10.0||||||
3710606|NCT02141581|3549758|B4|Age 18-30 years||Age, Customized||Participants|Count of Participants|76|76.0||||||
3710607|NCT02141581|3549759|B3|Age 18-30 years||Age, Customized||Participants|Count of Participants|25|25.0||||||
3710608|NCT02141581|3549760|B2|Age 18-30 years||Age, Customized||Participants|Count of Participants|19|19.0||||||
3710609|NCT02141581|3549761|B1|Age 18-30 years||Age, Customized||Participants|Count of Participants|32|32.0||||||
3710610|NCT02141516|3549774|B4|Male||Sex/Gender, Customized||participants|Number|132|132.0||||||
3710611|NCT02141516|3549775|B3|Male||Sex/Gender, Customized||participants|Number|43|43.0||||||
3710612|NCT02141516|3549776|B2|Male||Sex/Gender, Customized||participants|Number|66|66.0||||||
3710613|NCT02141516|3549777|B1|Male||Sex/Gender, Customized||participants|Number|23|23.0||||||
3710614|NCT02141516|3549774|B4|Female||Sex/Gender, Customized||participants|Number|107|107.0||||||
3710615|NCT02141516|3549775|B3|Female||Sex/Gender, Customized||participants|Number|44|44.0||||||
3710616|NCT02141516|3549776|B2|Female||Sex/Gender, Customized||participants|Number|46|46.0||||||
3710617|NCT02141516|3549777|B1|Female||Sex/Gender, Customized||participants|Number|17|17.0||||||
3710618|NCT02141516|3549774|B4|||Age||Years|Mean|10.3|10.3|Standard Deviation|4.07|4.07|||
3710619|NCT02141516|3549775|B3|||Age||Years|Mean|10.2|10.2|Standard Deviation|4.14|4.14|||
3710620|NCT02141516|3549776|B2|||Age||Years|Mean|11.1|11.1|Standard Deviation|3.7|3.7|||
3710621|NCT02141516|3549777|B1|||Age||Years|Mean|8.5|8.5|Standard Deviation|4.35|4.35|||
3710622|NCT02141399|3549827|B1|Germany||Region of Enrollment||participants|Number|66|66.0||||||
3710623|NCT02141399|3549827|B1|Bulgaria||Region of Enrollment||participants|Number|88|88.0||||||
3710624|NCT02141399|3549827|B1|Australia||Region of Enrollment||participants|Number|35|35.0||||||
3710625|NCT02141399|3549827|B1|Poland||Region of Enrollment||participants|Number|33|33.0||||||
3710626|NCT02141399|3549827|B1|United States||Region of Enrollment||participants|Number|1204|1204.0||||||
3710627|NCT02141399|3549827|B1|Hungary||Region of Enrollment||participants|Number|5|5.0||||||
3710628|NCT02141399|3549827|B1|Canada||Region of Enrollment||participants|Number|54|54.0||||||
3710629|NCT02141399|3549827|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710630|NCT02141399|3549827|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710631|NCT02141399|3549827|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1080|1080.0||||||
3710632|NCT02141399|3549827|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|362|362.0||||||
3710633|NCT02141399|3549827|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3710634|NCT02141399|3549827|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3710635|NCT02141399|3549827|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3710636|NCT02141399|3549827|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710637|NCT02141399|3549827|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1288|1288.0||||||
3710638|NCT02141399|3549827|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|197|197.0||||||
3710639|NCT02141399|3549827|B1||Male|Sex: Female, Male||Participants|Count of Participants|521|521.0||||||
3710640|NCT02141399|3549827|B1||Female|Sex: Female, Male||Participants|Count of Participants|964|964.0||||||
3710641|NCT02141399|3549827|B1|||Age||years|Mean|46.5|46.5|Standard Deviation|12.27|12.27|||
3710642|NCT02141360|3549831|B3|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3710643|NCT02141360|3549832|B2|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3710644|NCT02141360|3549833|B1|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3710645|NCT02141360|3549831|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3710646|NCT02141360|3549832|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3710647|NCT02141360|3549833|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3710648|NCT02141360|3549831|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3710649|NCT02141360|3549832|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3710650|NCT02141360|3549833|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3710651|NCT02141360|3549831|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3710652|NCT02141360|3549832|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3710653|NCT02141360|3549833|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3710654|NCT02141360|3549831|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3710655|NCT02141360|3549832|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3710656|NCT02141360|3549833|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3710657|NCT02141360|3549831|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3710658|NCT02141360|3549832|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3710659|NCT02141360|3549833|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3710660|NCT02141217|3549843|B3|Asian-South East Asian Heritage||Race/Ethnicity, Customized|Amongst the randomized par., 236 par. received amx+clv and 235 par. received clin as 2 par. randomized to the clin arm incorrectly received amx+clv and 1 par. randomized to amx+clv arm confirmed not consuming even a single dose of study drug.|Participants|Number|465|465.0||||||
3710661|NCT02141217|3549844|B2|Asian-South East Asian Heritage||Race/Ethnicity, Customized|Amongst the randomized par., 236 par. received amx+clv and 235 par. received clin as 2 par. randomized to the clin arm incorrectly received amx+clv and 1 par. randomized to amx+clv arm confirmed not consuming even a single dose of study drug.|Participants|Number|232|232.0||||||
3710662|NCT02141217|3549845|B1|Asian-South East Asian Heritage||Race/Ethnicity, Customized|Amongst the randomized par., 236 par. received amx+clv and 235 par. received clin as 2 par. randomized to the clin arm incorrectly received amx+clv and 1 par. randomized to amx+clv arm confirmed not consuming even a single dose of study drug.|Participants|Number|233|233.0||||||
3710663|NCT02141217|3549843|B3|Asian-East Asian Heritage||Race/Ethnicity, Customized|Amongst the randomized par., 236 par. received amx+clv and 235 par. received clin as 2 par. randomized to the clin arm incorrectly received amx+clv and 1 par. randomized to amx+clv arm confirmed not consuming even a single dose of study drug.|Participants|Number|5|5.0||||||
3710664|NCT02141217|3549844|B2|Asian-East Asian Heritage||Race/Ethnicity, Customized|Amongst the randomized par., 236 par. received amx+clv and 235 par. received clin as 2 par. randomized to the clin arm incorrectly received amx+clv and 1 par. randomized to amx+clv arm confirmed not consuming even a single dose of study drug.|Participants|Number|4|4.0||||||
3710665|NCT02141217|3549845|B1|Asian-East Asian Heritage||Race/Ethnicity, Customized|Amongst the randomized par., 236 par. received amx+clv and 235 par. received clin as 2 par. randomized to the clin arm incorrectly received amx+clv and 1 par. randomized to amx+clv arm confirmed not consuming even a single dose of study drug.|Participants|Number|1|1.0||||||
3710666|NCT02141217|3549843|B3|Asian-Central/South Asian Heritage||Race/Ethnicity, Customized|Amongst the randomized par., 236 par. received amx+clv and 235 par. received clin as 2 par. randomized to the clin arm incorrectly received amx+clv and 1 par. randomized to amx+clv arm confirmed not consuming even a single dose of study drug.|Participants|Number|1|1.0||||||
3710667|NCT02141217|3549844|B2|Asian-Central/South Asian Heritage||Race/Ethnicity, Customized|Amongst the randomized par., 236 par. received amx+clv and 235 par. received clin as 2 par. randomized to the clin arm incorrectly received amx+clv and 1 par. randomized to amx+clv arm confirmed not consuming even a single dose of study drug.|Participants|Number|1|1.0||||||
3710668|NCT02141217|3549845|B1|Asian-Central/South Asian Heritage||Race/Ethnicity, Customized|Amongst the randomized par., 236 par. received amx+clv and 235 par. received clin as 2 par. randomized to the clin arm incorrectly received amx+clv and 1 par. randomized to amx+clv arm confirmed not consuming even a single dose of study drug.|Participants|Number|0|0.0||||||
3710669|NCT02141217|3549843|B3||Male|Sex: Female, Male|Amongst the randomized par., 236 par. received amx+clv and 235 par. received clin as 2 par. randomized to the clin arm incorrectly received amx+clv and 1 par. randomized to amx+clv arm confirmed not consuming even a single dose of study drug.|Participants|Count of Participants|193|193.0||||||
3710670|NCT02141217|3549844|B2||Male|Sex: Female, Male|Amongst the randomized par., 236 par. received amx+clv and 235 par. received clin as 2 par. randomized to the clin arm incorrectly received amx+clv and 1 par. randomized to amx+clv arm confirmed not consuming even a single dose of study drug.|Participants|Count of Participants|94|94.0||||||
3710671|NCT02141217|3549845|B1||Male|Sex: Female, Male|Amongst the randomized par., 236 par. received amx+clv and 235 par. received clin as 2 par. randomized to the clin arm incorrectly received amx+clv and 1 par. randomized to amx+clv arm confirmed not consuming even a single dose of study drug.|Participants|Count of Participants|99|99.0||||||
3710672|NCT02141217|3549843|B3||Female|Sex: Female, Male|Amongst the randomized par., 236 par. received amx+clv and 235 par. received clin as 2 par. randomized to the clin arm incorrectly received amx+clv and 1 par. randomized to amx+clv arm confirmed not consuming even a single dose of study drug.|Participants|Count of Participants|278|278.0||||||
3710673|NCT02141217|3549844|B2||Female|Sex: Female, Male|Amongst the randomized par., 236 par. received amx+clv and 235 par. received clin as 2 par. randomized to the clin arm incorrectly received amx+clv and 1 par. randomized to amx+clv arm confirmed not consuming even a single dose of study drug.|Participants|Count of Participants|143|143.0||||||
3710674|NCT02141217|3549845|B1||Female|Sex: Female, Male|Amongst the randomized par., 236 par. received amx+clv and 235 par. received clin as 2 par. randomized to the clin arm incorrectly received amx+clv and 1 par. randomized to amx+clv arm confirmed not consuming even a single dose of study drug.|Participants|Count of Participants|135|135.0||||||
3710675|NCT02141217|3549843|B3|||Age|Amongst the randomized par., 236 par. received amx+clv and 235 par. received clin as 2 par. randomized to the clin arm incorrectly received amx+clv and 1 par. randomized to amx+clv arm confirmed not consuming even a single dose of study drug.|Years|Mean|32.9|32.9|Standard Deviation|12.4|12.4|||
3710676|NCT02141217|3549844|B2|||Age|Amongst the randomized par., 236 par. received amx+clv and 235 par. received clin as 2 par. randomized to the clin arm incorrectly received amx+clv and 1 par. randomized to amx+clv arm confirmed not consuming even a single dose of study drug.|Years|Mean|32.6|32.6|Standard Deviation|12.0|12.0|||
3710677|NCT02141217|3549845|B1|||Age|Amongst the randomized par., 236 par. received amx+clv and 235 par. received clin as 2 par. randomized to the clin arm incorrectly received amx+clv and 1 par. randomized to amx+clv arm confirmed not consuming even a single dose of study drug.|Years|Mean|33.1|33.1|Standard Deviation|12.8|12.8|||
3710678|NCT02140957|3549864|B3||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3710679|NCT02140957|3549865|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3710680|NCT02140957|3549866|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3710681|NCT02140957|3549864|B3||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3710682|NCT02140957|3549865|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3710683|NCT02140957|3549866|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3710684|NCT02140957|3549864|B3|||Age||months|Mean|9.25|9.25|Standard Deviation|0.40|0.4|||
3710685|NCT02140957|3549865|B2|||Age||months|Mean|9.24|9.24|Standard Deviation|0.41|0.41|||
3710686|NCT02140957|3549866|B1|||Age||months|Mean|9.25|9.25|Standard Deviation|0.38|0.38|||
3710687|NCT02140788|3549877|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
3710688|NCT02140788|3549877|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3710689|NCT02140788|3549877|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3710690|NCT02140788|3549877|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3710691|NCT02140788|3549877|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3710692|NCT02140788|3549877|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3710693|NCT02140762|3549906|B3|MALE||Sex/Gender, Customized||participants|Number|177|177.0||||||
3710694|NCT02140762|3549907|B2|MALE||Sex/Gender, Customized||participants|Number|90|90.0||||||
3710695|NCT02140762|3549908|B1|MALE||Sex/Gender, Customized||participants|Number|87|87.0||||||
3710696|NCT02140762|3549906|B3|FEMALE||Sex/Gender, Customized||participants|Number|128|128.0||||||
3710697|NCT02140762|3549907|B2|FEMALE||Sex/Gender, Customized||participants|Number|61|61.0||||||
3710698|NCT02140762|3549908|B1|FEMALE||Sex/Gender, Customized||participants|Number|67|67.0||||||
3710699|NCT02140762|3549906|B3|||Age||Years|Mean|12|12.0|Standard Deviation|2.3|2.3|||
3710700|NCT02140762|3549907|B2|||Age||Years|Mean|12.2|12.2|Standard Deviation|2.42|2.42|||
3710701|NCT02140762|3549908|B1|||Age||Years|Mean|11.9|11.9|Standard Deviation|2.18|2.18|||
3710702|NCT02140645|3549969|B7||Male|Gender||Participants|Count of Participants|4090|4090.0||||||
3710703|NCT02140645|3549970|B6||Male|Gender||Participants|Count of Participants|1718|1718.0||||||
3710704|NCT02140645|3549971|B5||Male|Gender||Participants|Count of Participants|76|76.0||||||
3710705|NCT02140645|3549972|B4||Male|Gender||Participants|Count of Participants|336|336.0||||||
3710706|NCT02140645|3549973|B3||Male|Gender||Participants|Count of Participants|104|104.0||||||
3710707|NCT02140645|3549974|B2||Male|Gender||Participants|Count of Participants|1731|1731.0||||||
3710708|NCT02140645|3549975|B1||Male|Gender||Participants|Count of Participants|125|125.0||||||
3710709|NCT02140645|3549969|B7||Female|Gender||Participants|Count of Participants|3129|3129.0||||||
3710710|NCT02140645|3549970|B6||Female|Gender||Participants|Count of Participants|1332|1332.0||||||
3710711|NCT02140645|3549971|B5||Female|Gender||Participants|Count of Participants|74|74.0||||||
3710712|NCT02140645|3549972|B4||Female|Gender||Participants|Count of Participants|194|194.0||||||
3710713|NCT02140645|3549973|B3||Female|Gender||Participants|Count of Participants|101|101.0||||||
3710714|NCT02140645|3549974|B2||Female|Gender||Participants|Count of Participants|1310|1310.0||||||
3710715|NCT02140645|3549975|B1||Female|Gender||Participants|Count of Participants|118|118.0||||||
3710716|NCT02140645|3549969|B7|||Age||Years|Mean|54.9|54.9|Standard Deviation|11.5|11.5|||
3710717|NCT02140645|3549970|B6|||Age||Years|Mean|54.8|54.8|Standard Deviation|11.7|11.7|||
3710718|NCT02140645|3549971|B5|||Age||Years|Mean|54.7|54.7|Standard Deviation|11.8|11.8|||
3710719|NCT02140645|3549972|B4|||Age||Years|Mean|54.7|54.7|Standard Deviation|11.1|11.1|||
3710720|NCT02140645|3549973|B3|||Age||Years|Mean|55.2|55.2|Standard Deviation|11.7|11.7|||
3710721|NCT02140645|3549974|B2|||Age||Years|Mean|54.8|54.8|Standard Deviation|11.2|11.2|||
3710722|NCT02140645|3549975|B1|||Age||Years|Mean|56.1|56.1|Standard Deviation|11.6|11.6|||
3710723|NCT02140593|3550067|B3|||Previous abdominal surgery||Participants|Count of Participants|85|85.0||||||
3710724|NCT02140593|3550068|B2|||Previous abdominal surgery||Participants|Count of Participants|46|46.0||||||
3710725|NCT02140593|3550069|B1|||Previous abdominal surgery||Participants|Count of Participants|39|39.0||||||
3710726|NCT02140593|3550067|B3|||Body mass index|body mass index (kg/m^2)|kg/m^2|Mean|25|25.0|Standard Deviation|5|5.0|||
3710727|NCT02140593|3550068|B2|||Body mass index|body mass index (kg/m^2)|kg/m^2|Mean|26|26.0|Standard Deviation|5|5.0|||
3710728|NCT02140593|3550069|B1|||Body mass index|body mass index (kg/m^2)|kg/m^2|Mean|25|25.0|Standard Deviation|5|5.0|||
3710729|NCT02140593|3550067|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3710730|NCT02140593|3550068|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3710731|NCT02140593|3550069|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3710732|NCT02140593|3550067|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3710733|NCT02140593|3550068|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3710734|NCT02140593|3550069|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3710735|NCT02140593|3550067|B3|||Age||years|Mean|64|64.0|Standard Deviation|10|10.0|||
3710736|NCT02140593|3550068|B2|||Age||years|Mean|63|63.0|Standard Deviation|11|11.0|||
3710737|NCT02140593|3550069|B1|||Age||years|Mean|65|65.0|Standard Deviation|10|10.0|||
3710738|NCT02140567|3550078|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3710739|NCT02140567|3550078|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3710740|NCT02140567|3550078|B1|||Age||years|Mean|37.2|37.2|Standard Deviation|15.1|15.1|||
3710741|NCT02140372|3550083|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3710742|NCT02140372|3550083|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710743|NCT02140372|3550083|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710744|NCT02140372|3550083|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3710745|NCT02140372|3550083|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3710746|NCT02140372|3550083|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710747|NCT02140372|3550083|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3710748|NCT02140372|3550083|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710749|NCT02140372|3550083|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710750|NCT02140372|3550083|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3710751|NCT02140372|3550083|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3710752|NCT02140372|3550083|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3710753|NCT02140372|3550083|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3710754|NCT02140372|3550083|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3710755|NCT02140372|3550083|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3710756|NCT02140372|3550083|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3710757|NCT02140164|3550094|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3710758|NCT02140164|3550094|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3710759|NCT02140164|3550094|B1|||Age||years|Mean|27.7|27.7|Standard Deviation|8.81|8.81|||
3710760|NCT02140164|3550094|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3710761|NCT02140164|3550094|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3710762|NCT02140164|3550094|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3710763|NCT02140060|3550109|B7||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3710764|NCT02140060|3550110|B6||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3710765|NCT02140060|3550111|B5||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3710766|NCT02140060|3550112|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3710767|NCT02140060|3550113|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3710768|NCT02140060|3550114|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3710769|NCT02140060|3550115|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3710770|NCT02140060|3550109|B7||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3710771|NCT02140060|3550110|B6||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3710772|NCT02140060|3550111|B5||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3710773|NCT02140060|3550112|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3710774|NCT02140060|3550113|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3710775|NCT02140060|3550114|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3710776|NCT02140060|3550115|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3710777|NCT02140060|3550109|B7|||Age||years|Mean|64.8|64.8|Standard Deviation|10.3|10.3|||
3710778|NCT02140060|3550110|B6|||Age||years|Mean|65.3|65.3|Standard Deviation|10.6|10.6|||
3710779|NCT02140060|3550111|B5|||Age||years|Mean|63.1|63.1|Standard Deviation|8.4|8.4|||
3710780|NCT02140060|3550112|B4|||Age||years|Mean|64.2|64.2|Standard Deviation|10.4|10.4|||
3710781|NCT02140060|3550113|B3|||Age||years|Mean|64.4|64.4|Standard Deviation|11.2|11.2|||
3710782|NCT02140060|3550114|B2|||Age||years|Mean|66.2|66.2|Standard Deviation|10.4|10.4|||
3710783|NCT02140060|3550115|B1|||Age||years|Mean|65.4|65.4|Standard Deviation|10.7|10.7|||
3710784|NCT02139982|3550135|B11|China||Region of Enrollment||participants|Number|110|110.0||||||
3710785|NCT02139982|3550136|B10|China||Region of Enrollment||participants|Number|13|13.0||||||
3710786|NCT02139982|3550137|B9|China||Region of Enrollment||participants|Number|13|13.0||||||
3710787|NCT02139982|3550138|B8|China||Region of Enrollment||participants|Number|13|13.0||||||
3710788|NCT02139982|3550139|B7|China||Region of Enrollment||participants|Number|13|13.0||||||
3710789|NCT02139982|3550140|B6|China||Region of Enrollment||participants|Number|13|13.0||||||
3710790|NCT02139982|3550141|B5|China||Region of Enrollment||participants|Number|13|13.0||||||
3710791|NCT02139982|3550142|B4|China||Region of Enrollment||participants|Number|8|8.0||||||
3710792|NCT02139982|3550143|B3|China||Region of Enrollment||participants|Number|8|8.0||||||
3710793|NCT02139982|3550144|B2|China||Region of Enrollment||participants|Number|8|8.0||||||
3710794|NCT02139982|3550145|B1|China||Region of Enrollment||participants|Number|8|8.0||||||
3710795|NCT02139982|3550135|B11||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3710796|NCT02139982|3550136|B10||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3710797|NCT02139982|3550137|B9||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3710798|NCT02139982|3550138|B8||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3710799|NCT02139982|3550139|B7||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3710800|NCT02139982|3550140|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3710801|NCT02139982|3550141|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3710802|NCT02139982|3550142|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3710803|NCT02139982|3550143|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3710804|NCT02139982|3550144|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3710805|NCT02139982|3550145|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3710806|NCT02139982|3550135|B11||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3710807|NCT02139982|3550136|B10||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3710808|NCT02139982|3550137|B9||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3710809|NCT02139982|3550138|B8||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3710810|NCT02139982|3550139|B7||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3710811|NCT02139982|3550140|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3710812|NCT02139982|3550141|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3710813|NCT02139982|3550142|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3710814|NCT02139982|3550143|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3710815|NCT02139982|3550144|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3710816|NCT02139982|3550145|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3710817|NCT02139982|3550135|B11|||Age||years|Mean|39|39.0|Standard Deviation|15|15.0|||
3710818|NCT02139982|3550136|B10|||Age||years|Mean|46|46.0|Standard Deviation|18|18.0|||
3710819|NCT02139982|3550137|B9|||Age||years|Mean|42|42.0|Standard Deviation|15|15.0|||
3710820|NCT02139982|3550138|B8|||Age||years|Mean|34|34.0|Standard Deviation|12|12.0|||
3710821|NCT02139982|3550139|B7|||Age||years|Mean|41|41.0|Standard Deviation|13|13.0|||
3710822|NCT02139982|3550140|B6|||Age||years|Mean|36|36.0|Standard Deviation|14|14.0|||
3710823|NCT02139982|3550141|B5|||Age||years|Mean|31|31.0|Standard Deviation|10|10.0|||
3710824|NCT02139982|3550142|B4|||Age||years|Mean|38|38.0|Standard Deviation|17|17.0|||
3710825|NCT02139982|3550143|B3|||Age||years|Mean|42|42.0|Standard Deviation|19|19.0|||
3710826|NCT02139982|3550144|B2|||Age||years|Mean|31|31.0|Standard Deviation|7|7.0|||
3710827|NCT02139982|3550145|B1|||Age||years|Mean|41|41.0|Standard Deviation|13|13.0|||
3710828|NCT02139943|3550196|B4|United Stats||Region Enroll||participants|Number|288|288.0||||||
3710829|NCT02139943|3550197|B3|United Stats||Region Enroll||participants|Number|97|97.0||||||
3710830|NCT02139943|3550198|B2|United Stats||Region Enroll||participants|Number|98|98.0||||||
3710831|NCT02139943|3550199|B1|United Stats||Region Enroll||participants|Number|93|93.0||||||
3710832|NCT02139943|3550196|B4|Canada||Region Enroll||participants|Number|63|63.0||||||
3710833|NCT02139943|3550197|B3|Canada||Region Enroll||participants|Number|20|20.0||||||
3710834|NCT02139943|3550198|B2|Canada||Region Enroll||participants|Number|19|19.0||||||
3710835|NCT02139943|3550199|B1|Canada||Region Enroll||participants|Number|24|24.0||||||
3710836|NCT02139943|3550196|B4||Male|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
3710837|NCT02139943|3550197|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3710838|NCT02139943|3550198|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3710839|NCT02139943|3550199|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3710840|NCT02139943|3550196|B4||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3710841|NCT02139943|3550197|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3710842|NCT02139943|3550198|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3710843|NCT02139943|3550199|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3710844|NCT02139943|3550196|B4|||Age||years|Mean|42.3|42.3|Standard Deviation|11.47|11.47|||
3710845|NCT02139943|3550197|B3|||Age||years|Mean|42.8|42.8|Standard Deviation|10.96|10.96|||
3710846|NCT02139943|3550198|B2|||Age||years|Mean|42|42.0|Standard Deviation|11.6|11.6|||
3710847|NCT02139943|3550199|B1|||Age||years|Mean|42|42.0|Standard Deviation|11.9|11.9|||
3710848|NCT02139943|3550196|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3710849|NCT02139943|3550197|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3710850|NCT02139943|3550198|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3710851|NCT02139943|3550199|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3710852|NCT02139943|3550196|B4||Between 18 and 65 years|Age||Participants|Count of Participants|347|347.0||||||
3710853|NCT02139943|3550197|B3||Between 18 and 65 years|Age||Participants|Count of Participants|115|115.0||||||
3710854|NCT02139943|3550198|B2||Between 18 and 65 years|Age||Participants|Count of Participants|115|115.0||||||
3710855|NCT02139943|3550199|B1||Between 18 and 65 years|Age||Participants|Count of Participants|117|117.0||||||
3710856|NCT02139943|3550196|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3710857|NCT02139943|3550197|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3710858|NCT02139943|3550198|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3710859|NCT02139943|3550199|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3710860|NCT02139878|3550212|B1|Canada||Region of Enrollment||participants|Number|19|19.0||||||
3710861|NCT02139878|3550212|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710862|NCT02139878|3550212|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710863|NCT02139878|3550212|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3710864|NCT02139878|3550212|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710865|NCT02139878|3550212|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710866|NCT02139878|3550212|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710867|NCT02139878|3550212|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3710868|NCT02139878|3550212|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3710869|NCT02139878|3550212|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3710870|NCT02139878|3550212|B1|||Age||years|Mean|53|53.0|Standard Deviation|6.3|6.3|||
3710871|NCT02139644|3550221|B6|||Forced Expiratory Volume in 1 second (FEV1)|participants with valid measurements (n=126, 128, 129, 129, 129)|liters|Mean|2.190|2.19|Standard Deviation|0.5977|0.5977|||
3710872|NCT02139644|3550222|B5|||Forced Expiratory Volume in 1 second (FEV1)|participants with valid measurements (n=126, 128, 129, 129, 129)|liters|Mean|2.188|2.188|Standard Deviation|0.5628|0.5628|||
3710873|NCT02139644|3550223|B4|||Forced Expiratory Volume in 1 second (FEV1)|participants with valid measurements (n=126, 128, 129, 129, 129)|liters|Mean|2.134|2.134|Standard Deviation|0.6362|0.6362|||
3710874|NCT02139644|3550224|B3|||Forced Expiratory Volume in 1 second (FEV1)|participants with valid measurements (n=126, 128, 129, 129, 129)|liters|Mean|2.166|2.166|Standard Deviation|0.5725|0.5725|||
3710875|NCT02139644|3550225|B2|||Forced Expiratory Volume in 1 second (FEV1)|participants with valid measurements (n=126, 128, 129, 129, 129)|liters|Mean|2.302|2.302|Standard Deviation|0.6526|0.6526|||
3710876|NCT02139644|3550226|B1|||Forced Expiratory Volume in 1 second (FEV1)|participants with valid measurements (n=126, 128, 129, 129, 129)|liters|Mean|2.162|2.162|Standard Deviation|0.5522|0.5522|||
3710877|NCT02139644|3550221|B6|Inhaled corticosteroid/long-acting beta2-agonist||Previous Asthma Therapy||Participants|Count of Participants|186|186.0||||||
3710878|NCT02139644|3550222|B5|Inhaled corticosteroid/long-acting beta2-agonist||Previous Asthma Therapy||Participants|Count of Participants|28|28.0||||||
3710879|NCT02139644|3550223|B4|Inhaled corticosteroid/long-acting beta2-agonist||Previous Asthma Therapy||Participants|Count of Participants|40|40.0||||||
3710880|NCT02139644|3550224|B3|Inhaled corticosteroid/long-acting beta2-agonist||Previous Asthma Therapy||Participants|Count of Participants|47|47.0||||||
3710881|NCT02139644|3550225|B2|Inhaled corticosteroid/long-acting beta2-agonist||Previous Asthma Therapy||Participants|Count of Participants|39|39.0||||||
3710882|NCT02139644|3550226|B1|Inhaled corticosteroid/long-acting beta2-agonist||Previous Asthma Therapy||Participants|Count of Participants|32|32.0||||||
3710883|NCT02139644|3550221|B6|Inhaled corticosteroid||Previous Asthma Therapy||Participants|Count of Participants|461|461.0||||||
3710884|NCT02139644|3550222|B5|Inhaled corticosteroid||Previous Asthma Therapy||Participants|Count of Participants|102|102.0||||||
3710885|NCT02139644|3550223|B4|Inhaled corticosteroid||Previous Asthma Therapy||Participants|Count of Participants|89|89.0||||||
3710886|NCT02139644|3550224|B3|Inhaled corticosteroid||Previous Asthma Therapy||Participants|Count of Participants|83|83.0||||||
3710887|NCT02139644|3550225|B2|Inhaled corticosteroid||Previous Asthma Therapy||Participants|Count of Participants|90|90.0||||||
3710888|NCT02139644|3550226|B1|Inhaled corticosteroid||Previous Asthma Therapy||Participants|Count of Participants|97|97.0||||||
3710889|NCT02139644|3550221|B6|No tobacco use||History of Smoking||Participants|Count of Participants|575|575.0||||||
3710890|NCT02139644|3550222|B5|No tobacco use||History of Smoking||Participants|Count of Participants|118|118.0||||||
3711062|NCT02139046|3550331|B6|Ex-Smoker||Smoking History||participants|Number|536|536.0||||||
3710891|NCT02139644|3550223|B4|No tobacco use||History of Smoking||Participants|Count of Participants|115|115.0||||||
3710892|NCT02139644|3550224|B3|No tobacco use||History of Smoking||Participants|Count of Participants|115|115.0||||||
3710893|NCT02139644|3550225|B2|No tobacco use||History of Smoking||Participants|Count of Participants|116|116.0||||||
3710894|NCT02139644|3550226|B1|No tobacco use||History of Smoking||Participants|Count of Participants|111|111.0||||||
3710895|NCT02139644|3550221|B6|Prior smoker||History of Smoking||Participants|Count of Participants|72|72.0||||||
3710896|NCT02139644|3550222|B5|Prior smoker||History of Smoking||Participants|Count of Participants|12|12.0||||||
3710897|NCT02139644|3550223|B4|Prior smoker||History of Smoking||Participants|Count of Participants|14|14.0||||||
3710898|NCT02139644|3550224|B3|Prior smoker||History of Smoking||Participants|Count of Participants|15|15.0||||||
3710899|NCT02139644|3550225|B2|Prior smoker||History of Smoking||Participants|Count of Participants|13|13.0||||||
3710900|NCT02139644|3550226|B1|Prior smoker||History of Smoking||Participants|Count of Participants|18|18.0||||||
3710901|NCT02139644|3550221|B6|||Body Mass Index||kg/m^2|Mean|27.90|27.9|Standard Deviation|6.897|6.897|||
3710902|NCT02139644|3550222|B5|||Body Mass Index||kg/m^2|Mean|27.99|27.99|Standard Deviation|6.849|6.849|||
3710903|NCT02139644|3550223|B4|||Body Mass Index||kg/m^2|Mean|27.94|27.94|Standard Deviation|7.259|7.259|||
3710904|NCT02139644|3550224|B3|||Body Mass Index||kg/m^2|Mean|27.63|27.63|Standard Deviation|6.603|6.603|||
3710905|NCT02139644|3550225|B2|||Body Mass Index||kg/m^2|Mean|28.00|28.0|Standard Deviation|7.166|7.166|||
3710906|NCT02139644|3550226|B1|||Body Mass Index||kg/m^2|Mean|27.94|27.94|Standard Deviation|6.686|6.686|||
3710907|NCT02139644|3550221|B6|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3710908|NCT02139644|3550222|B5|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3710909|NCT02139644|3550223|B4|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3710910|NCT02139644|3550224|B3|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3710911|NCT02139644|3550225|B2|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3710912|NCT02139644|3550226|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3710913|NCT02139644|3550221|B6|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|49|49.0||||||
3710914|NCT02139644|3550222|B5|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3710915|NCT02139644|3550223|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3710916|NCT02139644|3550224|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3710917|NCT02139644|3550225|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3710918|NCT02139644|3550226|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3710919|NCT02139644|3550221|B6|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|597|597.0||||||
3710920|NCT02139644|3550222|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|122|122.0||||||
3710921|NCT02139644|3550223|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|121|121.0||||||
3710922|NCT02139644|3550224|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|114|114.0||||||
3710923|NCT02139644|3550225|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|121|121.0||||||
3710924|NCT02139644|3550226|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|119|119.0||||||
3710925|NCT02139644|3550221|B6|Other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3710926|NCT02139644|3550222|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3710927|NCT02139644|3550223|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3710928|NCT02139644|3550224|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3710929|NCT02139644|3550225|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3710930|NCT02139644|3550226|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3710931|NCT02139644|3550221|B6|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3710932|NCT02139644|3550222|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3710933|NCT02139644|3550223|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3710934|NCT02139644|3550224|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3710935|NCT02139644|3550225|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3710936|NCT02139644|3550226|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3710937|NCT02139644|3550221|B6|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3710938|NCT02139644|3550222|B5|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3710939|NCT02139644|3550223|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3710940|NCT02139644|3550224|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3710941|NCT02139644|3550225|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3710942|NCT02139644|3550226|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3710943|NCT02139644|3550221|B6|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3710944|NCT02139644|3550222|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3710945|NCT02139644|3550223|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3710946|NCT02139644|3550224|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3710947|NCT02139644|3550225|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3710948|NCT02139644|3550226|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3710949|NCT02139644|3550221|B6|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|113|113.0||||||
3710950|NCT02139644|3550222|B5|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3710951|NCT02139644|3550223|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3710952|NCT02139644|3550224|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3710953|NCT02139644|3550225|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3710954|NCT02139644|3550226|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3710955|NCT02139644|3550221|B6|White||Race/Ethnicity, Customized||Participants|Count of Participants|515|515.0||||||
3710956|NCT02139644|3550222|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|101|101.0||||||
3710957|NCT02139644|3550223|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|107|107.0||||||
3710958|NCT02139644|3550224|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|93|93.0||||||
3710959|NCT02139644|3550225|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|109|109.0||||||
3710960|NCT02139644|3550226|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|105|105.0||||||
3710961|NCT02139644|3550221|B6||Male|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
3710962|NCT02139644|3550222|B5||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3710963|NCT02139644|3550223|B4||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3710964|NCT02139644|3550224|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3710965|NCT02139644|3550225|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3710966|NCT02139644|3550226|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3710967|NCT02139644|3550221|B6||Female|Sex: Female, Male||Participants|Count of Participants|364|364.0||||||
3710968|NCT02139644|3550222|B5||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3710969|NCT02139644|3550223|B4||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3710970|NCT02139644|3550224|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3710971|NCT02139644|3550225|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3710972|NCT02139644|3550226|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3710973|NCT02139644|3550221|B6|Adults (65+ years)||Age, Customized||Participants|Count of Participants|67|67.0||||||
3710974|NCT02139644|3550222|B5|Adults (65+ years)||Age, Customized||Participants|Count of Participants|11|11.0||||||
3710975|NCT02139644|3550223|B4|Adults (65+ years)||Age, Customized||Participants|Count of Participants|23|23.0||||||
3710976|NCT02139644|3550224|B3|Adults (65+ years)||Age, Customized||Participants|Count of Participants|10|10.0||||||
3710977|NCT02139644|3550225|B2|Adults (65+ years)||Age, Customized||Participants|Count of Participants|13|13.0||||||
3710978|NCT02139644|3550226|B1|Adults (65+ years)||Age, Customized||Participants|Count of Participants|10|10.0||||||
3710979|NCT02139644|3550221|B6|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|494|494.0||||||
3710980|NCT02139644|3550222|B5|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|102|102.0||||||
3710981|NCT02139644|3550223|B4|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|93|93.0||||||
3710982|NCT02139644|3550224|B3|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|102|102.0||||||
3710983|NCT02139644|3550225|B2|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|97|97.0||||||
3710984|NCT02139644|3550226|B1|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|100|100.0||||||
3710985|NCT02139644|3550221|B6|Adolescents (12-17 years)||Age, Customized||Participants|Count of Participants|86|86.0||||||
3710986|NCT02139644|3550222|B5|Adolescents (12-17 years)||Age, Customized||Participants|Count of Participants|17|17.0||||||
3710987|NCT02139644|3550223|B4|Adolescents (12-17 years)||Age, Customized||Participants|Count of Participants|13|13.0||||||
3710988|NCT02139644|3550224|B3|Adolescents (12-17 years)||Age, Customized||Participants|Count of Participants|18|18.0||||||
3710989|NCT02139644|3550225|B2|Adolescents (12-17 years)||Age, Customized||Participants|Count of Participants|19|19.0||||||
3710990|NCT02139644|3550226|B1|Adolescents (12-17 years)||Age, Customized||Participants|Count of Participants|19|19.0||||||
3710991|NCT02139644|3550221|B6|||Age||years|Mean|41.5|41.5|Standard Deviation|17.60|17.6|||
3710992|NCT02139644|3550222|B5|||Age||years|Mean|40.9|40.9|Standard Deviation|17.35|17.35|||
3710993|NCT02139644|3550223|B4|||Age||years|Mean|43.3|43.3|Standard Deviation|17.96|17.96|||
3710994|NCT02139644|3550224|B3|||Age||years|Mean|40.6|40.6|Standard Deviation|17.16|17.16|||
3710995|NCT02139644|3550225|B2|||Age||years|Mean|41.4|41.4|Standard Deviation|18.61|18.61|||
3710996|NCT02139644|3550226|B1|||Age||years|Mean|41.0|41.0|Standard Deviation|17.00|17.0|||
3710997|NCT02139358|3550283|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3710998|NCT02139358|3550283|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3710999|NCT02139358|3550283|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711000|NCT02139358|3550283|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3711001|NCT02139358|3550283|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3711002|NCT02139358|3550283|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711003|NCT02139358|3550283|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711004|NCT02139358|3550283|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711005|NCT02139358|3550283|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3711006|NCT02139358|3550283|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3711007|NCT02139358|3550283|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3711008|NCT02139358|3550283|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3711009|NCT02139358|3550283|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3711010|NCT02139358|3550283|B1|||Age||years|Mean|58.2|58.2|Full Range|||46.0|68.0|
3711011|NCT02139228|3550290|B3||Male|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
3711012|NCT02139228|3550291|B2||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3711013|NCT02139228|3550292|B1||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3711014|NCT02139228|3550290|B3||Female|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
3711015|NCT02139228|3550291|B2||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3711016|NCT02139228|3550292|B1||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3711017|NCT02139228|3550290|B3|Age||Age||years|Mean|5|5.0|Standard Deviation|0|0.0|||
3711018|NCT02139228|3550291|B2|Age||Age||years|Mean|5|5.0|Standard Deviation|0|0.0|||
3711019|NCT02139228|3550292|B1|Age||Age||years|Mean|5|5.0|Standard Deviation|0|0.0|||
3711020|NCT02139176|3550301|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3711021|NCT02139176|3550302|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3711022|NCT02139176|3550303|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3711023|NCT02139176|3550301|B3||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
3711024|NCT02139176|3550302|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3711025|NCT02139176|3550303|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3711026|NCT02139176|3550301|B3|||Age||years|Mean|26.6|26.6|Standard Deviation|0.35|0.35|||
3711027|NCT02139176|3550302|B2|||Age||years|Mean|26.6|26.6|Standard Deviation|0.50|0.5|||
3711028|NCT02139176|3550303|B1|||Age||years|Mean|26.5|26.5|Standard Deviation|0.49|0.49|||
3711029|NCT02139137|3550314|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3711030|NCT02139137|3550315|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3711031|NCT02139137|3550316|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3711032|NCT02139137|3550314|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3711033|NCT02139137|3550315|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3711034|NCT02139137|3550316|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3711035|NCT02139137|3550314|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3711036|NCT02139137|3550315|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3711037|NCT02139137|3550316|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3711038|NCT02139137|3550314|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3711039|NCT02139137|3550315|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3711040|NCT02139137|3550316|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3711041|NCT02139137|3550314|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3711042|NCT02139137|3550315|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3711043|NCT02139137|3550316|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3711044|NCT02139046|3550331|B6|Ex-Drinker||Alcohol Classification||participants|Number|261|261.0||||||
3711045|NCT02139046|3550332|B5|Ex-Drinker||Alcohol Classification||participants|Number|51|51.0||||||
3711046|NCT02139046|3550333|B4|Ex-Drinker||Alcohol Classification||participants|Number|55|55.0||||||
3711047|NCT02139046|3550334|B3|Ex-Drinker||Alcohol Classification||participants|Number|52|52.0||||||
3711048|NCT02139046|3550335|B2|Ex-Drinker||Alcohol Classification||participants|Number|61|61.0||||||
3711049|NCT02139046|3550336|B1|Ex-Drinker||Alcohol Classification||participants|Number|42|42.0||||||
3711050|NCT02139046|3550331|B6|Current Drinker||Alcohol Classification||participants|Number|1122|1122.0||||||
3711051|NCT02139046|3550332|B5|Current Drinker||Alcohol Classification||participants|Number|232|232.0||||||
3711052|NCT02139046|3550333|B4|Current Drinker||Alcohol Classification||participants|Number|234|234.0||||||
3711053|NCT02139046|3550334|B3|Current Drinker||Alcohol Classification||participants|Number|218|218.0||||||
3711054|NCT02139046|3550335|B2|Current Drinker||Alcohol Classification||participants|Number|204|204.0||||||
3711055|NCT02139046|3550336|B1|Current Drinker||Alcohol Classification||participants|Number|234|234.0||||||
3711056|NCT02139046|3550331|B6|Never Drank||Alcohol Classification||participants|Number|400|400.0||||||
3711057|NCT02139046|3550332|B5|Never Drank||Alcohol Classification||participants|Number|74|74.0||||||
3711058|NCT02139046|3550333|B4|Never Drank||Alcohol Classification||participants|Number|68|68.0||||||
3711059|NCT02139046|3550334|B3|Never Drank||Alcohol Classification||participants|Number|85|85.0||||||
3711060|NCT02139046|3550335|B2|Never Drank||Alcohol Classification||participants|Number|92|92.0||||||
3711061|NCT02139046|3550336|B1|Never Drank||Alcohol Classification||participants|Number|81|81.0||||||
3711063|NCT02139046|3550332|B5|Ex-Smoker||Smoking History||participants|Number|105|105.0||||||
3711064|NCT02139046|3550333|B4|Ex-Smoker||Smoking History||participants|Number|102|102.0||||||
3711065|NCT02139046|3550334|B3|Ex-Smoker||Smoking History||participants|Number|110|110.0||||||
3711066|NCT02139046|3550335|B2|Ex-Smoker||Smoking History||participants|Number|111|111.0||||||
3711067|NCT02139046|3550336|B1|Ex-Smoker||Smoking History||participants|Number|108|108.0||||||
3711068|NCT02139046|3550331|B6|Current Smoker||Smoking History||participants|Number|286|286.0||||||
3711069|NCT02139046|3550332|B5|Current Smoker||Smoking History||participants|Number|47|47.0||||||
3711070|NCT02139046|3550333|B4|Current Smoker||Smoking History||participants|Number|65|65.0||||||
3711071|NCT02139046|3550334|B3|Current Smoker||Smoking History||participants|Number|60|60.0||||||
3711072|NCT02139046|3550335|B2|Current Smoker||Smoking History||participants|Number|56|56.0||||||
3711073|NCT02139046|3550336|B1|Current Smoker||Smoking History||participants|Number|58|58.0||||||
3711074|NCT02139046|3550331|B6|Never Smoked||Smoking History||participants|Number|961|961.0||||||
3711075|NCT02139046|3550332|B5|Never Smoked||Smoking History||participants|Number|205|205.0||||||
3711076|NCT02139046|3550333|B4|Never Smoked||Smoking History||participants|Number|190|190.0||||||
3711077|NCT02139046|3550334|B3|Never Smoked||Smoking History||participants|Number|185|185.0||||||
3711078|NCT02139046|3550335|B2|Never Smoked||Smoking History||participants|Number|190|190.0||||||
3711079|NCT02139046|3550336|B1|Never Smoked||Smoking History||participants|Number|191|191.0||||||
3711080|NCT02139046|3550331|B6|||Body Mass Index (BMI)|BMI data is only available for 356, 357, 355, 357 and 357 participants, respectively.|kg/m^2|Mean|34.25|34.25|Standard Deviation|7.834|7.834|||
3711081|NCT02139046|3550332|B5|||Body Mass Index (BMI)|BMI data is only available for 356, 357, 355, 357 and 357 participants, respectively.|kg/m^2|Mean|34.08|34.08|Standard Deviation|7.205|7.205|||
3711082|NCT02139046|3550333|B4|||Body Mass Index (BMI)|BMI data is only available for 356, 357, 355, 357 and 357 participants, respectively.|kg/m^2|Mean|33.68|33.68|Standard Deviation|7.477|7.477|||
3711083|NCT02139046|3550334|B3|||Body Mass Index (BMI)|BMI data is only available for 356, 357, 355, 357 and 357 participants, respectively.|kg/m^2|Mean|34.29|34.29|Standard Deviation|8.141|8.141|||
3711084|NCT02139046|3550335|B2|||Body Mass Index (BMI)|BMI data is only available for 356, 357, 355, 357 and 357 participants, respectively.|kg/m^2|Mean|34.32|34.32|Standard Deviation|8.014|8.014|||
3711085|NCT02139046|3550336|B1|||Body Mass Index (BMI)|BMI data is only available for 356, 357, 355, 357 and 357 participants, respectively.|kg/m^2|Mean|34.88|34.88|Standard Deviation|8.276|8.276|||
3711086|NCT02139046|3550331|B6|||Weight||kg|Mean|104.60|104.6|Standard Deviation|24.745|24.745|||
3711087|NCT02139046|3550332|B5|||Weight||kg|Mean|104.64|104.64|Standard Deviation|23.033|23.033|||
3711088|NCT02139046|3550333|B4|||Weight||kg|Mean|102.16|102.16|Standard Deviation|22.832|22.832|||
3711089|NCT02139046|3550334|B3|||Weight||kg|Mean|104.71|104.71|Standard Deviation|27.995|27.995|||
3711090|NCT02139046|3550335|B2|||Weight||kg|Mean|104.65|104.65|Standard Deviation|24.157|24.157|||
3711091|NCT02139046|3550336|B1|||Weight||kg|Mean|106.83|106.83|Standard Deviation|25.285|25.285|||
3711092|NCT02139046|3550331|B6|||Height|Height data is only available for 356, 357, 355, 357 and 357 participants, respectively.|cm|Mean|174.8|174.8|Standard Deviation|9.96|9.96|||
3711093|NCT02139046|3550332|B5|||Height|Height data is only available for 356, 357, 355, 357 and 357 participants, respectively.|cm|Mean|175.3|175.3|Standard Deviation|9.50|9.5|||
3711094|NCT02139046|3550333|B4|||Height|Height data is only available for 356, 357, 355, 357 and 357 participants, respectively.|cm|Mean|174.3|174.3|Standard Deviation|9.42|9.42|||
3711095|NCT02139046|3550334|B3|||Height|Height data is only available for 356, 357, 355, 357 and 357 participants, respectively.|cm|Mean|174.4|174.4|Standard Deviation|10.45|10.45|||
3711096|NCT02139046|3550335|B2|||Height|Height data is only available for 356, 357, 355, 357 and 357 participants, respectively.|cm|Mean|174.8|174.8|Standard Deviation|10.46|10.46|||
3711097|NCT02139046|3550336|B1|||Height|Height data is only available for 356, 357, 355, 357 and 357 participants, respectively.|cm|Mean|175.2|175.2|Standard Deviation|9.95|9.95|||
3711098|NCT02139046|3550331|B6|United States||Region of Enrollment||participants|Number|1783|1783.0||||||
3711099|NCT02139046|3550332|B5|United States||Region of Enrollment||participants|Number|357|357.0||||||
3711100|NCT02139046|3550333|B4|United States||Region of Enrollment||participants|Number|357|357.0||||||
3711101|NCT02139046|3550334|B3|United States||Region of Enrollment||participants|Number|355|355.0||||||
3711102|NCT02139046|3550335|B2|United States||Region of Enrollment||participants|Number|357|357.0||||||
3711103|NCT02139046|3550336|B1|United States||Region of Enrollment||participants|Number|357|357.0||||||
3711104|NCT02139046|3550331|B6|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1517|1517.0||||||
3711105|NCT02139046|3550332|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|305|305.0||||||
3711106|NCT02139046|3550333|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|308|308.0||||||
3711107|NCT02139046|3550334|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|294|294.0||||||
3711108|NCT02139046|3550335|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|306|306.0||||||
3711109|NCT02139046|3550336|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|304|304.0||||||
3711110|NCT02139046|3550331|B6|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|266|266.0||||||
3711111|NCT02139046|3550332|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
3711112|NCT02139046|3550333|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
3711113|NCT02139046|3550334|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
3711114|NCT02139046|3550335|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
3711115|NCT02139046|3550336|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
3711116|NCT02139046|3550331|B6|Other: Multi-Racial||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3711117|NCT02139046|3550332|B5|Other: Multi-Racial||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3711118|NCT02139046|3550333|B4|Other: Multi-Racial||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3711119|NCT02139046|3550334|B3|Other: Multi-Racial||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3711120|NCT02139046|3550335|B2|Other: Multi-Racial||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3711121|NCT02139046|3550336|B1|Other: Multi-Racial||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3711122|NCT02139046|3550331|B6|White||Race/Ethnicity, Customized||participants|Number|1147|1147.0||||||
3711123|NCT02139046|3550332|B5|White||Race/Ethnicity, Customized||participants|Number|225|225.0||||||
3711124|NCT02139046|3550333|B4|White||Race/Ethnicity, Customized||participants|Number|230|230.0||||||
3711125|NCT02139046|3550334|B3|White||Race/Ethnicity, Customized||participants|Number|226|226.0||||||
3711126|NCT02139046|3550335|B2|White||Race/Ethnicity, Customized||participants|Number|235|235.0||||||
3711127|NCT02139046|3550336|B1|White||Race/Ethnicity, Customized||participants|Number|231|231.0||||||
3711128|NCT02139046|3550331|B6|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3711129|NCT02139046|3550332|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3711130|NCT02139046|3550333|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3711131|NCT02139046|3550334|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3711132|NCT02139046|3550335|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3711133|NCT02139046|3550336|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3711134|NCT02139046|3550331|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|474|474.0||||||
3711135|NCT02139046|3550332|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|93|93.0||||||
3711136|NCT02139046|3550333|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|98|98.0||||||
3711137|NCT02139046|3550334|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|100|100.0||||||
3711138|NCT02139046|3550335|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|89|89.0||||||
3711139|NCT02139046|3550336|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|94|94.0||||||
3711140|NCT02139046|3550331|B6|Asian||Race/Ethnicity, Customized||participants|Number|112|112.0||||||
3711141|NCT02139046|3550332|B5|Asian||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3711142|NCT02139046|3550333|B4|Asian||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3711143|NCT02139046|3550334|B3|Asian||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3711144|NCT02139046|3550335|B2|Asian||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3711145|NCT02139046|3550336|B1|Asian||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3711146|NCT02139046|3550331|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3711147|NCT02139046|3550332|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3711148|NCT02139046|3550333|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3711149|NCT02139046|3550334|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3711150|NCT02139046|3550335|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3711151|NCT02139046|3550336|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3711152|NCT02139046|3550331|B6||Male|Sex: Female, Male||Participants|Count of Participants|1577|1577.0||||||
3711153|NCT02139046|3550332|B5||Male|Sex: Female, Male||Participants|Count of Participants|323|323.0||||||
3711154|NCT02139046|3550333|B4||Male|Sex: Female, Male||Participants|Count of Participants|315|315.0||||||
3711155|NCT02139046|3550334|B3||Male|Sex: Female, Male||Participants|Count of Participants|312|312.0||||||
3711156|NCT02139046|3550335|B2||Male|Sex: Female, Male||Participants|Count of Participants|311|311.0||||||
3711157|NCT02139046|3550336|B1||Male|Sex: Female, Male||Participants|Count of Participants|316|316.0||||||
3711158|NCT02139046|3550331|B6||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
3711159|NCT02139046|3550332|B5||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3711160|NCT02139046|3550333|B4||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3711161|NCT02139046|3550334|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3711162|NCT02139046|3550335|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3711163|NCT02139046|3550336|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3711164|NCT02139046|3550331|B6|>= 85 years||Age, Customized||participants|Number|8|8.0||||||
3711165|NCT02139046|3550332|B5|>= 85 years||Age, Customized||participants|Number|1|1.0||||||
3711166|NCT02139046|3550333|B4|>= 85 years||Age, Customized||participants|Number|1|1.0||||||
3711167|NCT02139046|3550334|B3|>= 85 years||Age, Customized||participants|Number|2|2.0||||||
3711168|NCT02139046|3550335|B2|>= 85 years||Age, Customized||participants|Number|1|1.0||||||
3711169|NCT02139046|3550336|B1|>= 85 years||Age, Customized||participants|Number|3|3.0||||||
3711170|NCT02139046|3550331|B6|65 to < 85 years||Age, Customized||participants|Number|361|361.0||||||
3711171|NCT02139046|3550332|B5|65 to < 85 years||Age, Customized||participants|Number|73|73.0||||||
3711172|NCT02139046|3550333|B4|65 to < 85 years||Age, Customized||participants|Number|69|69.0||||||
3711173|NCT02139046|3550334|B3|65 to < 85 years||Age, Customized||participants|Number|86|86.0||||||
3711174|NCT02139046|3550335|B2|65 to < 85 years||Age, Customized||participants|Number|73|73.0||||||
3711175|NCT02139046|3550336|B1|65 to < 85 years||Age, Customized||participants|Number|60|60.0||||||
3711176|NCT02139046|3550331|B6|18 to < 65 years||Age, Customized||participants|Number|1414|1414.0||||||
3711177|NCT02139046|3550332|B5|18 to < 65 years||Age, Customized||participants|Number|283|283.0||||||
3711178|NCT02139046|3550333|B4|18 to < 65 years||Age, Customized||participants|Number|287|287.0||||||
3711179|NCT02139046|3550334|B3|18 to < 65 years||Age, Customized||participants|Number|267|267.0||||||
3711180|NCT02139046|3550335|B2|18 to < 65 years||Age, Customized||participants|Number|283|283.0||||||
3711181|NCT02139046|3550336|B1|18 to < 65 years||Age, Customized||participants|Number|294|294.0||||||
3711182|NCT02139046|3550331|B6|>= 65 years||Age, Customized||participants|Number|369|369.0||||||
3711183|NCT02139046|3550332|B5|>= 65 years||Age, Customized||participants|Number|74|74.0||||||
3711184|NCT02139046|3550333|B4|>= 65 years||Age, Customized||participants|Number|70|70.0||||||
3711185|NCT02139046|3550334|B3|>= 65 years||Age, Customized||participants|Number|88|88.0||||||
3711186|NCT02139046|3550335|B2|>= 65 years||Age, Customized||participants|Number|74|74.0||||||
3711187|NCT02139046|3550336|B1|>= 65 years||Age, Customized||participants|Number|63|63.0||||||
3711188|NCT02139046|3550331|B6|45 to < 65 years||Age, Customized||participants|Number|1082|1082.0||||||
3711189|NCT02139046|3550332|B5|45 to < 65 years||Age, Customized||participants|Number|222|222.0||||||
3711190|NCT02139046|3550333|B4|45 to < 65 years||Age, Customized||participants|Number|219|219.0||||||
3711191|NCT02139046|3550334|B3|45 to < 65 years||Age, Customized||participants|Number|193|193.0||||||
3711192|NCT02139046|3550335|B2|45 to < 65 years||Age, Customized||participants|Number|225|225.0||||||
3711193|NCT02139046|3550336|B1|45 to < 65 years||Age, Customized||participants|Number|223|223.0||||||
3711194|NCT02139046|3550331|B6|< 45 years||Age, Customized||participants|Number|332|332.0||||||
3711195|NCT02139046|3550332|B5|< 45 years||Age, Customized||participants|Number|61|61.0||||||
3711196|NCT02139046|3550333|B4|< 45 years||Age, Customized||participants|Number|68|68.0||||||
3711197|NCT02139046|3550334|B3|< 45 years||Age, Customized||participants|Number|74|74.0||||||
3711198|NCT02139046|3550335|B2|< 45 years||Age, Customized||participants|Number|58|58.0||||||
3711199|NCT02139046|3550336|B1|< 45 years||Age, Customized||participants|Number|71|71.0||||||
3711200|NCT02139046|3550331|B6|||Age||years|Mean|55.1|55.1|Standard Deviation|11.71|11.71|||
3711201|NCT02139046|3550332|B5|||Age||years|Mean|55.4|55.4|Standard Deviation|11.93|11.93|||
3711202|NCT02139046|3550333|B4|||Age||years|Mean|54.9|54.9|Standard Deviation|11.32|11.32|||
3711203|NCT02139046|3550334|B3|||Age||years|Mean|55.1|55.1|Standard Deviation|12.68|12.68|||
3711204|NCT02139046|3550335|B2|||Age||years|Mean|55.5|55.5|Standard Deviation|11.07|11.07|||
3711205|NCT02139046|3550336|B1|||Age||years|Mean|54.4|54.4|Standard Deviation|11.55|11.55|||
3711206|NCT02139007|3550362|B3|||Duration of Alendronate Use||Years|Mean|5.1|5.1|Standard Deviation|17|17.0|||
3711207|NCT02139007|3550363|B2|||Duration of Alendronate Use||Years|Mean|5.3|5.3|Standard Deviation|3.1|3.1|||
3711208|NCT02139007|3550364|B1|||Duration of Alendronate Use||Years|Mean|4.8|4.8|Standard Deviation|2.1|2.1|||
3711209|NCT02139007|3550362|B3|||Previous History of Fracture||Participants|Count of Participants|10|10.0||||||
3711210|NCT02139007|3550363|B2|||Previous History of Fracture||Participants|Count of Participants|5|5.0||||||
3711211|NCT02139007|3550364|B1|||Previous History of Fracture||Participants|Count of Participants|5|5.0||||||
3711212|NCT02139007|3550362|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
3711213|NCT02139007|3550363|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3711214|NCT02139007|3550364|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3711215|NCT02139007|3550362|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3711216|NCT02139007|3550363|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3711217|NCT02139007|3550364|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3711218|NCT02139007|3550362|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711219|NCT02139007|3550363|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711220|NCT02139007|3550364|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711221|NCT02139007|3550362|B3||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3711222|NCT02139007|3550363|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3711223|NCT02139007|3550364|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3711224|NCT02139007|3550362|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3711225|NCT02139007|3550363|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3711226|NCT02139007|3550364|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3711227|NCT02139007|3550362|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711228|NCT02139007|3550363|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711229|NCT02139007|3550364|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711230|NCT02139007|3550362|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711231|NCT02139007|3550363|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711232|NCT02139007|3550364|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711233|NCT02139007|3550362|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711234|NCT02139007|3550363|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711235|NCT02139007|3550364|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711236|NCT02139007|3550362|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3711237|NCT02139007|3550363|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3711238|NCT02139007|3550364|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3711239|NCT02139007|3550362|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3711240|NCT02139007|3550363|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3711241|NCT02139007|3550364|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3711242|NCT02139007|3550362|B3|||Age||Years|Mean|74.5|74.5|Standard Deviation|6.1|6.1|||
3711243|NCT02139007|3550363|B2|||Age||Years|Mean|74.5|74.5|Standard Deviation|5.9|5.9|||
3711244|NCT02139007|3550364|B1|||Age||Years|Mean|74.4|74.4|Standard Deviation|6.7|6.7|||
3711245|NCT02139007|3550362|B3||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
3711246|NCT02139007|3550363|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3711247|NCT02139007|3550364|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3711248|NCT02139007|3550362|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3711249|NCT02139007|3550363|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3711250|NCT02139007|3550364|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3711251|NCT02139007|3550362|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3711252|NCT02139007|3550363|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3711253|NCT02139007|3550364|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3711254|NCT02138838|3550378|B3|||Intact Parathyroid Hormone Level||pg/mL|Mean|1092.31|1092.31|Standard Deviation|695.53|695.53|||
3711255|NCT02138838|3550379|B2|||Intact Parathyroid Hormone Level||pg/mL|Mean|945.72|945.72|Standard Deviation|635.35|635.35|||
3711256|NCT02138838|3550380|B1|||Intact Parathyroid Hormone Level||pg/mL|Mean|1228.43|1228.43|Standard Deviation|732.08|732.08|||
3711257|NCT02138838|3550378|B3|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
3711258|NCT02138838|3550379|B2|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
3711259|NCT02138838|3550380|B1|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3711260|NCT02138838|3550378|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3711261|NCT02138838|3550379|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3711262|NCT02138838|3550380|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3711263|NCT02138838|3550378|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3711264|NCT02138838|3550379|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3711265|NCT02138838|3550380|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3711266|NCT02138838|3550378|B3|Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3711267|NCT02138838|3550379|B2|Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3711268|NCT02138838|3550380|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3711269|NCT02138838|3550378|B3|White||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
3711270|NCT02138838|3550379|B2|White||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3711271|NCT02138838|3550380|B1|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3711272|NCT02138838|3550378|B3|Black (or African American)||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3711273|NCT02138838|3550379|B2|Black (or African American)||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3711274|NCT02138838|3550380|B1|Black (or African American)||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3711275|NCT02138838|3550378|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3711276|NCT02138838|3550379|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3711277|NCT02138838|3550380|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3711278|NCT02138838|3550378|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3711279|NCT02138838|3550379|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3711280|NCT02138838|3550380|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3711281|NCT02138838|3550378|B3|12 to < 18 years||Age, Customized||participants|Number|37|37.0||||||
3711282|NCT02138838|3550379|B2|12 to < 18 years||Age, Customized||participants|Number|18|18.0||||||
3711283|NCT02138838|3550380|B1|12 to < 18 years||Age, Customized||participants|Number|19|19.0||||||
3711284|NCT02138838|3550378|B3|6 to < 12 years||Age, Customized||participants|Number|18|18.0||||||
3711285|NCT02138838|3550379|B2|6 to < 12 years||Age, Customized||participants|Number|9|9.0||||||
3711286|NCT02138838|3550380|B1|6 to < 12 years||Age, Customized||participants|Number|9|9.0||||||
3711287|NCT02138838|3550378|B3|||Age||years|Mean|12.6|12.6|Standard Deviation|3.6|3.6|||
3711288|NCT02138838|3550379|B2|||Age||years|Mean|12.8|12.8|Standard Deviation|3.9|3.9|||
3711289|NCT02138838|3550380|B1|||Age||years|Mean|12.4|12.4|Standard Deviation|3.5|3.5|||
3711290|NCT02138825|3550397|B3|>= 380 m||6 minute walking distance (6MWD) category|The 6MWD test is designed to evaluate a patient’s exercise capacity while performing an everyday activity.|Participants|Number|32|32.0||||||
3711291|NCT02138825|3550398|B2|>= 380 m||6 minute walking distance (6MWD) category|The 6MWD test is designed to evaluate a patient’s exercise capacity while performing an everyday activity.|Participants|Number|14|14.0||||||
3711292|NCT02138825|3550399|B1|>= 380 m||6 minute walking distance (6MWD) category|The 6MWD test is designed to evaluate a patient’s exercise capacity while performing an everyday activity.|Participants|Number|18|18.0||||||
3711465|NCT02138227|3550494|B2||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3711293|NCT02138825|3550397|B3|>= 320 m and <380m||6 minute walking distance (6MWD) category|The 6MWD test is designed to evaluate a patient’s exercise capacity while performing an everyday activity.|Participants|Number|40|40.0||||||
3711294|NCT02138825|3550398|B2|>= 320 m and <380m||6 minute walking distance (6MWD) category|The 6MWD test is designed to evaluate a patient’s exercise capacity while performing an everyday activity.|Participants|Number|28|28.0||||||
3711295|NCT02138825|3550399|B1|>= 320 m and <380m||6 minute walking distance (6MWD) category|The 6MWD test is designed to evaluate a patient’s exercise capacity while performing an everyday activity.|Participants|Number|12|12.0||||||
3711296|NCT02138825|3550397|B3|< 320 m||6 minute walking distance (6MWD) category|The 6MWD test is designed to evaluate a patient’s exercise capacity while performing an everyday activity.|Participants|Number|75|75.0||||||
3711297|NCT02138825|3550398|B2|< 320 m||6 minute walking distance (6MWD) category|The 6MWD test is designed to evaluate a patient’s exercise capacity while performing an everyday activity.|Participants|Number|32|32.0||||||
3711298|NCT02138825|3550399|B1|< 320 m||6 minute walking distance (6MWD) category|The 6MWD test is designed to evaluate a patient’s exercise capacity while performing an everyday activity.|Participants|Number|43|43.0||||||
3711299|NCT02138825|3550397|B3|Class IV||World Health Organization (WHO) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (Patients with PH but without resulting limitation of physical activity) to class IV (Patients with PH with inability to carry out any physical activity without symptoms. These patients manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement, changes to a higher functional class resemble deterioration of pulmonary arterial hypertension (PAH).|Participants|Number|14|14.0||||||
3711300|NCT02138825|3550398|B2|Class IV||World Health Organization (WHO) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (Patients with PH but without resulting limitation of physical activity) to class IV (Patients with PH with inability to carry out any physical activity without symptoms. These patients manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement, changes to a higher functional class resemble deterioration of pulmonary arterial hypertension (PAH).|Participants|Number|7|7.0||||||
3711301|NCT02138825|3550399|B1|Class IV||World Health Organization (WHO) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (Patients with PH but without resulting limitation of physical activity) to class IV (Patients with PH with inability to carry out any physical activity without symptoms. These patients manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement, changes to a higher functional class resemble deterioration of pulmonary arterial hypertension (PAH).|Participants|Number|7|7.0||||||
3711302|NCT02138825|3550397|B3|Class III||World Health Organization (WHO) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (Patients with PH but without resulting limitation of physical activity) to class IV (Patients with PH with inability to carry out any physical activity without symptoms. These patients manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement, changes to a higher functional class resemble deterioration of pulmonary arterial hypertension (PAH).|Participants|Number|95|95.0||||||
3711303|NCT02138825|3550398|B2|Class III||World Health Organization (WHO) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (Patients with PH but without resulting limitation of physical activity) to class IV (Patients with PH with inability to carry out any physical activity without symptoms. These patients manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement, changes to a higher functional class resemble deterioration of pulmonary arterial hypertension (PAH).|Participants|Number|45|45.0||||||
3711304|NCT02138825|3550399|B1|Class III||World Health Organization (WHO) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (Patients with PH but without resulting limitation of physical activity) to class IV (Patients with PH with inability to carry out any physical activity without symptoms. These patients manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement, changes to a higher functional class resemble deterioration of pulmonary arterial hypertension (PAH).|Participants|Number|50|50.0||||||
3711305|NCT02138825|3550397|B3|Class II||World Health Organization (WHO) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (Patients with PH but without resulting limitation of physical activity) to class IV (Patients with PH with inability to carry out any physical activity without symptoms. These patients manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement, changes to a higher functional class resemble deterioration of pulmonary arterial hypertension (PAH).|Participants|Number|38|38.0||||||
3711306|NCT02138825|3550398|B2|Class II||World Health Organization (WHO) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (Patients with PH but without resulting limitation of physical activity) to class IV (Patients with PH with inability to carry out any physical activity without symptoms. These patients manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement, changes to a higher functional class resemble deterioration of pulmonary arterial hypertension (PAH).|Participants|Number|22|22.0||||||
3711307|NCT02138825|3550399|B1|Class II||World Health Organization (WHO) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (Patients with PH but without resulting limitation of physical activity) to class IV (Patients with PH with inability to carry out any physical activity without symptoms. These patients manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement, changes to a higher functional class resemble deterioration of pulmonary arterial hypertension (PAH).|Participants|Number|16|16.0||||||
3711308|NCT02138825|3550397|B3|Unclassifiable idiopathic interstitial pneumonias||Classification of Idiopathic Interstitial Pneumonia||Participants|Number|16|16.0||||||
3711309|NCT02138825|3550398|B2|Unclassifiable idiopathic interstitial pneumonias||Classification of Idiopathic Interstitial Pneumonia||Participants|Number|7|7.0||||||
3711310|NCT02138825|3550399|B1|Unclassifiable idiopathic interstitial pneumonias||Classification of Idiopathic Interstitial Pneumonia||Participants|Number|9|9.0||||||
3711311|NCT02138825|3550397|B3|Idiopathic lymphoid interstitial pneumonia||Classification of Idiopathic Interstitial Pneumonia||Participants|Number|2|2.0||||||
3711312|NCT02138825|3550398|B2|Idiopathic lymphoid interstitial pneumonia||Classification of Idiopathic Interstitial Pneumonia||Participants|Number|2|2.0||||||
3711313|NCT02138825|3550399|B1|Idiopathic lymphoid interstitial pneumonia||Classification of Idiopathic Interstitial Pneumonia||Participants|Number|0|0.0||||||
3711314|NCT02138825|3550397|B3|Acute interstitial pneumonia||Classification of Idiopathic Interstitial Pneumonia||Participants|Number|1|1.0||||||
3711315|NCT02138825|3550398|B2|Acute interstitial pneumonia||Classification of Idiopathic Interstitial Pneumonia||Participants|Number|1|1.0||||||
3711316|NCT02138825|3550399|B1|Acute interstitial pneumonia||Classification of Idiopathic Interstitial Pneumonia||Participants|Number|0|0.0||||||
3711317|NCT02138825|3550397|B3|Cryptogenic organizing pneumonia||Classification of Idiopathic Interstitial Pneumonia||Participants|Number|1|1.0||||||
3711318|NCT02138825|3550398|B2|Cryptogenic organizing pneumonia||Classification of Idiopathic Interstitial Pneumonia||Participants|Number|1|1.0||||||
3711319|NCT02138825|3550399|B1|Cryptogenic organizing pneumonia||Classification of Idiopathic Interstitial Pneumonia||Participants|Number|0|0.0||||||
3711320|NCT02138825|3550397|B3|Resp. bronchiolitis-interstitial lung disease||Classification of Idiopathic Interstitial Pneumonia||Participants|Number|1|1.0||||||
3711321|NCT02138825|3550398|B2|Resp. bronchiolitis-interstitial lung disease||Classification of Idiopathic Interstitial Pneumonia||Participants|Number|0|0.0||||||
3711322|NCT02138825|3550399|B1|Resp. bronchiolitis-interstitial lung disease||Classification of Idiopathic Interstitial Pneumonia||Participants|Number|1|1.0||||||
3711323|NCT02138825|3550397|B3|Idiopathic nonspecific interstitial pneumonia||Classification of Idiopathic Interstitial Pneumonia||Participants|Number|23|23.0||||||
3711324|NCT02138825|3550398|B2|Idiopathic nonspecific interstitial pneumonia||Classification of Idiopathic Interstitial Pneumonia||Participants|Number|14|14.0||||||
3711325|NCT02138825|3550399|B1|Idiopathic nonspecific interstitial pneumonia||Classification of Idiopathic Interstitial Pneumonia||Participants|Number|9|9.0||||||
3711326|NCT02138825|3550397|B3|Idiopathic pulmonary fibrosis||Classification of Idiopathic Interstitial Pneumonia||Participants|Number|103|103.0||||||
3711327|NCT02138825|3550398|B2|Idiopathic pulmonary fibrosis||Classification of Idiopathic Interstitial Pneumonia||Participants|Number|49|49.0||||||
3711328|NCT02138825|3550399|B1|Idiopathic pulmonary fibrosis||Classification of Idiopathic Interstitial Pneumonia||Participants|Number|54|54.0||||||
3711329|NCT02138825|3550397|B3|Other||Pulmonary hypertension (PH) subtype (Nice Clinical Classification)||Participants|Number|0|0.0||||||
3711330|NCT02138825|3550398|B2|Other||Pulmonary hypertension (PH) subtype (Nice Clinical Classification)||Participants|Number|0|0.0||||||
3711331|NCT02138825|3550399|B1|Other||Pulmonary hypertension (PH) subtype (Nice Clinical Classification)||Participants|Number|0|0.0||||||
3711332|NCT02138825|3550397|B3|PH owing to respiratory disease and /or hypoxia||Pulmonary hypertension (PH) subtype (Nice Clinical Classification)||Participants|Number|147|147.0||||||
3711333|NCT02138825|3550398|B2|PH owing to respiratory disease and /or hypoxia||Pulmonary hypertension (PH) subtype (Nice Clinical Classification)||Participants|Number|74|74.0||||||
3711334|NCT02138825|3550399|B1|PH owing to respiratory disease and /or hypoxia||Pulmonary hypertension (PH) subtype (Nice Clinical Classification)||Participants|Number|73|73.0||||||
3711335|NCT02138825|3550397|B3||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3711336|NCT02138825|3550398|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3711337|NCT02138825|3550399|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3711338|NCT02138825|3550397|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3711339|NCT02138825|3550398|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3711340|NCT02138825|3550399|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3711341|NCT02138825|3550397|B3|>=75 years||Age, Customized||Participants|Number|30|30.0||||||
3711342|NCT02138825|3550398|B2|>=75 years||Age, Customized||Participants|Number|12|12.0||||||
3711343|NCT02138825|3550399|B1|>=75 years||Age, Customized||Participants|Number|18|18.0||||||
3711344|NCT02138825|3550397|B3|>=65 - <75 years||Age, Customized||Participants|Number|80|80.0||||||
3711345|NCT02138825|3550398|B2|>=65 - <75 years||Age, Customized||Participants|Number|45|45.0||||||
3711346|NCT02138825|3550399|B1|>=65 - <75 years||Age, Customized||Participants|Number|35|35.0||||||
3711347|NCT02138825|3550397|B3|<65 years||Age, Customized||Participants|Number|37|37.0||||||
3711348|NCT02138825|3550398|B2|<65 years||Age, Customized||Participants|Number|17|17.0||||||
3711349|NCT02138825|3550399|B1|<65 years||Age, Customized||Participants|Number|20|20.0||||||
3711350|NCT02138747|3550414|B5|No||Previous Nondrug Treatment for OAB||Participants|Number|360|360.0||||||
3711351|NCT02138747|3550415|B4|No||Previous Nondrug Treatment for OAB||Participants|Number|29|29.0||||||
3711352|NCT02138747|3550416|B3|No||Previous Nondrug Treatment for OAB||Participants|Number|30|30.0||||||
3711353|NCT02138747|3550417|B2|No||Previous Nondrug Treatment for OAB||Participants|Number|151|151.0||||||
3711354|NCT02138747|3550418|B1|No||Previous Nondrug Treatment for OAB||Participants|Number|150|150.0||||||
3711355|NCT02138747|3550414|B5|Yes||Previous Nondrug Treatment for OAB||Participants|Number|16|16.0||||||
3711356|NCT02138747|3550415|B4|Yes||Previous Nondrug Treatment for OAB||Participants|Number|3|3.0||||||
3711357|NCT02138747|3550416|B3|Yes||Previous Nondrug Treatment for OAB||Participants|Number|1|1.0||||||
3711358|NCT02138747|3550417|B2|Yes||Previous Nondrug Treatment for OAB||Participants|Number|6|6.0||||||
3711359|NCT02138747|3550418|B1|Yes||Previous Nondrug Treatment for OAB||Participants|Number|6|6.0||||||
3711360|NCT02138747|3550414|B5|Frequency urgency without incontinence||Type of OAB||Participants|Number|93|93.0||||||
3711361|NCT02138747|3550415|B4|Frequency urgency without incontinence||Type of OAB||Participants|Number|8|8.0||||||
3711362|NCT02138747|3550416|B3|Frequency urgency without incontinence||Type of OAB||Participants|Number|8|8.0||||||
3711363|NCT02138747|3550417|B2|Frequency urgency without incontinence||Type of OAB||Participants|Number|41|41.0||||||
3711364|NCT02138747|3550418|B1|Frequency urgency without incontinence||Type of OAB||Participants|Number|36|36.0||||||
3711365|NCT02138747|3550414|B5|Mixed||Type of OAB||Participants|Number|130|130.0||||||
3711366|NCT02138747|3550415|B4|Mixed||Type of OAB||Participants|Number|10|10.0||||||
3711367|NCT02138747|3550416|B3|Mixed||Type of OAB||Participants|Number|10|10.0||||||
3711368|NCT02138747|3550417|B2|Mixed||Type of OAB||Participants|Number|56|56.0||||||
3711369|NCT02138747|3550418|B1|Mixed||Type of OAB||Participants|Number|54|54.0||||||
3711370|NCT02138747|3550414|B5|Urgency||Type of OAB||Participants|Number|153|153.0||||||
3711371|NCT02138747|3550415|B4|Urgency||Type of OAB||Participants|Number|14|14.0||||||
3711372|NCT02138747|3550416|B3|Urgency||Type of OAB||Participants|Number|13|13.0||||||
3711373|NCT02138747|3550417|B2|Urgency||Type of OAB||Participants|Number|60|60.0||||||
3711374|NCT02138747|3550418|B1|Urgency||Type of OAB||Participants|Number|66|66.0||||||
3711375|NCT02138747|3550414|B5|Dry||Incontinence at Baseline of Period 1|Wet: at least 1 incontinence episode at baseline of period 1. Dry: 0 incontinence episodes at baseline of period 1.|Participants|Number|102|102.0||||||
3711376|NCT02138747|3550415|B4|Dry||Incontinence at Baseline of Period 1|Wet: at least 1 incontinence episode at baseline of period 1. Dry: 0 incontinence episodes at baseline of period 1.|Participants|Number|8|8.0||||||
3711377|NCT02138747|3550416|B3|Dry||Incontinence at Baseline of Period 1|Wet: at least 1 incontinence episode at baseline of period 1. Dry: 0 incontinence episodes at baseline of period 1.|Participants|Number|6|6.0||||||
3711378|NCT02138747|3550417|B2|Dry||Incontinence at Baseline of Period 1|Wet: at least 1 incontinence episode at baseline of period 1. Dry: 0 incontinence episodes at baseline of period 1.|Participants|Number|49|49.0||||||
3711379|NCT02138747|3550418|B1|Dry||Incontinence at Baseline of Period 1|Wet: at least 1 incontinence episode at baseline of period 1. Dry: 0 incontinence episodes at baseline of period 1.|Participants|Number|39|39.0||||||
3711380|NCT02138747|3550414|B5|Wet||Incontinence at Baseline of Period 1|Wet: at least 1 incontinence episode at baseline of period 1. Dry: 0 incontinence episodes at baseline of period 1.|Participants|Number|274|274.0||||||
3711381|NCT02138747|3550415|B4|Wet||Incontinence at Baseline of Period 1|Wet: at least 1 incontinence episode at baseline of period 1. Dry: 0 incontinence episodes at baseline of period 1.|Participants|Number|24|24.0||||||
3711382|NCT02138747|3550416|B3|Wet||Incontinence at Baseline of Period 1|Wet: at least 1 incontinence episode at baseline of period 1. Dry: 0 incontinence episodes at baseline of period 1.|Participants|Number|25|25.0||||||
3711383|NCT02138747|3550417|B2|Wet||Incontinence at Baseline of Period 1|Wet: at least 1 incontinence episode at baseline of period 1. Dry: 0 incontinence episodes at baseline of period 1.|Participants|Number|108|108.0||||||
3711384|NCT02138747|3550418|B1|Wet||Incontinence at Baseline of Period 1|Wet: at least 1 incontinence episode at baseline of period 1. Dry: 0 incontinence episodes at baseline of period 1.|Participants|Number|117|117.0||||||
3711385|NCT02138747|3550414|B5|||Duration of OAB Symptoms (Months)||Months|Mean|81.19|81.19|Standard Deviation|87.92|87.92|||
3711386|NCT02138747|3550415|B4|||Duration of OAB Symptoms (Months)||Months|Mean|67.54|67.54|Standard Deviation|58.21|58.21|||
3711387|NCT02138747|3550416|B3|||Duration of OAB Symptoms (Months)||Months|Mean|73.54|73.54|Standard Deviation|83.61|83.61|||
3711388|NCT02138747|3550417|B2|||Duration of OAB Symptoms (Months)||Months|Mean|83.92|83.92|Standard Deviation|104.56|104.56|||
3711389|NCT02138747|3550418|B1|||Duration of OAB Symptoms (Months)||Months|Mean|82.75|82.75|Standard Deviation|74.89|74.89|||
3711390|NCT02138747|3550414|B5|||Mean Number of Nocturia Episodes per 24 Hours|Number of participants with available data in treatment groups AB, BA, AA and BB are as follows; AB=138; BA=148; AA=29; BB=30.|Nocturia Episodes|Mean|1.62|1.62|Standard Deviation|1.03|1.03|||
3711391|NCT02138747|3550415|B4|||Mean Number of Nocturia Episodes per 24 Hours|Number of participants with available data in treatment groups AB, BA, AA and BB are as follows; AB=138; BA=148; AA=29; BB=30.|Nocturia Episodes|Mean|1.58|1.58|Standard Deviation|1.17|1.17|||
3711392|NCT02138747|3550416|B3|||Mean Number of Nocturia Episodes per 24 Hours|Number of participants with available data in treatment groups AB, BA, AA and BB are as follows; AB=138; BA=148; AA=29; BB=30.|Nocturia Episodes|Mean|2.23|2.23|Standard Deviation|1.05|1.05|||
3711393|NCT02138747|3550417|B2|||Mean Number of Nocturia Episodes per 24 Hours|Number of participants with available data in treatment groups AB, BA, AA and BB are as follows; AB=138; BA=148; AA=29; BB=30.|Nocturia Episodes|Mean|1.49|1.49|Standard Deviation|0.95|0.95|||
3711394|NCT02138747|3550418|B1|||Mean Number of Nocturia Episodes per 24 Hours|Number of participants with available data in treatment groups AB, BA, AA and BB are as follows; AB=138; BA=148; AA=29; BB=30.|Nocturia Episodes|Mean|1.63|1.63|Standard Deviation|1.03|1.03|||
3711395|NCT02138747|3550414|B5|||Mean Number of Urgency Episodes per 24 Hours||Urgency Episodes|Mean|5.59|5.59|Standard Deviation|4.38|4.38|||
3711396|NCT02138747|3550415|B4|||Mean Number of Urgency Episodes per 24 Hours||Urgency Episodes|Mean|6.29|6.29|Standard Deviation|4.55|4.55|||
3711397|NCT02138747|3550416|B3|||Mean Number of Urgency Episodes per 24 Hours||Urgency Episodes|Mean|6.23|6.23|Standard Deviation|4.47|4.47|||
3711398|NCT02138747|3550417|B2|||Mean Number of Urgency Episodes per 24 Hours||Urgency Episodes|Mean|5.61|5.61|Standard Deviation|4.61|4.61|||
3711399|NCT02138747|3550418|B1|||Mean Number of Urgency Episodes per 24 Hours||Urgency Episodes|Mean|5.3|5.3|Standard Deviation|4.1|4.1|||
3711400|NCT02138747|3550414|B5|||Mean Number of Micturitions per 24 Hours||Micturitions|Mean|11.59|11.59|Standard Deviation|3.12|3.12|||
3711401|NCT02138747|3550415|B4|||Mean Number of Micturitions per 24 Hours||Micturitions|Mean|11.85|11.85|Standard Deviation|2.57|2.57|||
3711402|NCT02138747|3550416|B3|||Mean Number of Micturitions per 24 Hours||Micturitions|Mean|12.76|12.76|Standard Deviation|2.63|2.63|||
3711403|NCT02138747|3550417|B2|||Mean Number of Micturitions per 24 Hours||Micturitions|Mean|11.65|11.65|Standard Deviation|3.68|3.68|||
3711404|NCT02138747|3550418|B1|||Mean Number of Micturitions per 24 Hours||Micturitions|Mean|11.24|11.24|Standard Deviation|2.62|2.62|||
3711405|NCT02138747|3550414|B5|||Mean Number of Urgency Incontinence Episodes per 24 Hours||Urgency Incontinence Episodes|Mean|2.96|2.96|Standard Deviation|4.35|4.35|||
3711406|NCT02138747|3550415|B4|||Mean Number of Urgency Incontinence Episodes per 24 Hours||Urgency Incontinence Episodes|Mean|3.54|3.54|Standard Deviation|4.83|4.83|||
3711407|NCT02138747|3550416|B3|||Mean Number of Urgency Incontinence Episodes per 24 Hours||Urgency Incontinence Episodes|Mean|3.68|3.68|Standard Deviation|5.19|5.19|||
3711408|NCT02138747|3550417|B2|||Mean Number of Urgency Incontinence Episodes per 24 Hours||Urgency Incontinence Episodes|Mean|2.83|2.83|Standard Deviation|4.25|4.25|||
3711409|NCT02138747|3550418|B1|||Mean Number of Urgency Incontinence Episodes per 24 Hours||Urgency Incontinence Episodes|Mean|2.82|2.82|Standard Deviation|4.18|4.18|||
3711410|NCT02138747|3550414|B5|||Mean Number of Incontinence Episodes per 24 Hours||Incontinence Episodes/24 Hours|Mean|3.29|3.29|Standard Deviation|4.51|4.51|||
3711411|NCT02138747|3550415|B4|||Mean Number of Incontinence Episodes per 24 Hours||Incontinence Episodes/24 Hours|Mean|3.73|3.73|Standard Deviation|4.92|4.92|||
3711412|NCT02138747|3550416|B3|||Mean Number of Incontinence Episodes per 24 Hours||Incontinence Episodes/24 Hours|Mean|3.76|3.76|Standard Deviation|5.17|5.17|||
3711413|NCT02138747|3550417|B2|||Mean Number of Incontinence Episodes per 24 Hours||Incontinence Episodes/24 Hours|Mean|3.29|3.29|Standard Deviation|4.6|4.6|||
3711414|NCT02138747|3550418|B1|||Mean Number of Incontinence Episodes per 24 Hours||Incontinence Episodes/24 Hours|Mean|3.11|3.11|Standard Deviation|4.2|4.2|||
3711415|NCT02138747|3550414|B5||Male|Gender||Participants|Count of Participants|99|99.0||||||
3711416|NCT02138747|3550415|B4||Male|Gender||Participants|Count of Participants|10|10.0||||||
3711417|NCT02138747|3550416|B3||Male|Gender||Participants|Count of Participants|12|12.0||||||
3711418|NCT02138747|3550417|B2||Male|Gender||Participants|Count of Participants|38|38.0||||||
3711419|NCT02138747|3550418|B1||Male|Gender||Participants|Count of Participants|39|39.0||||||
3711420|NCT02138747|3550414|B5||Female|Gender||Participants|Count of Participants|277|277.0||||||
3711421|NCT02138747|3550415|B4||Female|Gender||Participants|Count of Participants|22|22.0||||||
3711422|NCT02138747|3550416|B3||Female|Gender||Participants|Count of Participants|19|19.0||||||
3711423|NCT02138747|3550417|B2||Female|Gender||Participants|Count of Participants|119|119.0||||||
3711424|NCT02138747|3550418|B1||Female|Gender||Participants|Count of Participants|117|117.0||||||
3711425|NCT02138747|3550414|B5|>= 65 Years||Age, Customized||Participants|Number|85|85.0||||||
3711426|NCT02138747|3550415|B4|>= 65 Years||Age, Customized||Participants|Number|9|9.0||||||
3711427|NCT02138747|3550416|B3|>= 65 Years||Age, Customized||Participants|Number|11|11.0||||||
3711428|NCT02138747|3550417|B2|>= 65 Years||Age, Customized||Participants|Number|28|28.0||||||
3711429|NCT02138747|3550418|B1|>= 65 Years||Age, Customized||Participants|Number|37|37.0||||||
3711430|NCT02138747|3550414|B5|< 65 Years||Age, Customized||Participants|Number|291|291.0||||||
3711431|NCT02138747|3550415|B4|< 65 Years||Age, Customized||Participants|Number|23|23.0||||||
3711432|NCT02138747|3550416|B3|< 65 Years||Age, Customized||Participants|Number|20|20.0||||||
3711433|NCT02138747|3550417|B2|< 65 Years||Age, Customized||Participants|Number|129|129.0||||||
3711434|NCT02138747|3550418|B1|< 65 Years||Age, Customized||Participants|Number|119|119.0||||||
3711435|NCT02138747|3550414|B5|||Age||Years|Mean|53.7|53.7|Standard Deviation|13.75|13.75|||
3711436|NCT02138747|3550415|B4|||Age||Years|Mean|55.1|55.1|Standard Deviation|14.30|14.3|||
3711437|NCT02138747|3550416|B3|||Age||Years|Mean|59.3|59.3|Standard Deviation|12.95|12.95|||
3711438|NCT02138747|3550417|B2|||Age||Years|Mean|52.6|52.6|Standard Deviation|12.65|12.65|||
3711439|NCT02138747|3550418|B1|||Age||Years|Mean|53.5|53.5|Standard Deviation|14.68|14.68|||
3711440|NCT02138578|3550453|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3711441|NCT02138578|3550454|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3711442|NCT02138578|3550456|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3711443|NCT02138578|3550453|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3711444|NCT02138578|3550454|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3711445|NCT02138578|3550456|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3711446|NCT02138578|3550453|B4|||Age||years|Mean|71.25|71.25|Full Range|||51.0|87.0|
3711447|NCT02138578|3550454|B3|||Age||years|Mean|66|66.0|Full Range|||51.0|87.0|
3711448|NCT02138578|3550456|B1|||Age||years|Mean|87|87.0|Full Range|||87.0|87.0|
3711449|NCT02138461|3550484|B3|United States||Region of Enrollment||participants|Number|211|211.0||||||
3711450|NCT02138461|3550485|B2|United States||Region of Enrollment||participants|Number|110|110.0||||||
3711451|NCT02138461|3550486|B1|United States||Region of Enrollment||participants|Number|101|101.0||||||
3711452|NCT02138461|3550484|B3||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3711453|NCT02138461|3550485|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3711454|NCT02138461|3550486|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3711455|NCT02138461|3550484|B3||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3711456|NCT02138461|3550485|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3711457|NCT02138461|3550486|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3711458|NCT02138461|3550484|B3|||Age||years|Mean|74.4|74.4|Standard Deviation|12.0|12.0|||
3711459|NCT02138461|3550485|B2|||Age||years|Mean|73.4|73.4|Standard Deviation|12.1|12.1|||
3711460|NCT02138461|3550486|B1|||Age||years|Mean|75.3|75.3|Standard Deviation|12.0|12.0|||
3711461|NCT02138227|3550493|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3711462|NCT02138227|3550494|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3711463|NCT02138227|3550495|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3711464|NCT02138227|3550493|B3||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
3711466|NCT02138227|3550495|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3711467|NCT02138227|3550493|B3|||Age||years|Mean|44.88|44.88|Standard Deviation|9.57|9.57|||
3711468|NCT02138227|3550494|B2|||Age||years|Mean|44.42|44.42|Standard Deviation|9.46|9.46|||
3711469|NCT02138227|3550495|B1|||Age||years|Mean|46.72|46.72|Standard Deviation|9.96|9.96|||
3711470|NCT02138110|3550527|B1|||Body Mass Index||kg/m^2|Mean|28|28.0|Full Range|||20.0|38.0|
3711471|NCT02138110|3550527|B1|Vehicular||Cause of Injury||participants|Number|14|14.0||||||
3711472|NCT02138110|3550527|B1|Other-All Terrain Vehicle||Cause of Injury||participants|Number|1|1.0||||||
3711473|NCT02138110|3550527|B1|Fall||Cause of Injury||participants|Number|5|5.0||||||
3711474|NCT02138110|3550527|B1|||Weight||kg|Mean|83|83.0|Full Range|||58.0|127.0|
3711475|NCT02138110|3550527|B1|||Height||cm|Mean|172|172.0|Full Range|||147.0|185.0|
3711476|NCT02138110|3550527|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3711477|NCT02138110|3550527|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3711478|NCT02138110|3550527|B1|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3711479|NCT02138110|3550527|B1|Race|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3711480|NCT02138110|3550527|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711481|NCT02138110|3550527|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3711482|NCT02138110|3550527|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3711483|NCT02138110|3550527|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3711484|NCT02138110|3550527|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3711485|NCT02138110|3550527|B1|||Age||years|Mean|36|36.0|Full Range|||18.0|69.0|
3711486|NCT02138097|3550537|B19||Male|Sex: Female, Male||Participants|Count of Participants|336274|336274.0||||||
3711487|NCT02138097|3550538|B18||Male|Sex: Female, Male||Participants|Count of Participants|13343|13343.0||||||
3711488|NCT02138097|3550539|B17||Male|Sex: Female, Male||Participants|Count of Participants|1009|1009.0||||||
3711489|NCT02138097|3550540|B16||Male|Sex: Female, Male||Participants|Count of Participants|2886|2886.0||||||
3711490|NCT02138097|3550541|B15||Male|Sex: Female, Male||Participants|Count of Participants|13129|13129.0||||||
3711491|NCT02138097|3550542|B14||Male|Sex: Female, Male||Participants|Count of Participants|58754|58754.0||||||
3711492|NCT02138097|3550543|B13||Male|Sex: Female, Male||Participants|Count of Participants|108108|108108.0||||||
3711493|NCT02138097|3550544|B12||Male|Sex: Female, Male||Participants|Count of Participants|13712|13712.0||||||
3711494|NCT02138097|3550545|B11||Male|Sex: Female, Male||Participants|Count of Participants|32611|32611.0||||||
3711495|NCT02138097|3550546|B10||Male|Sex: Female, Male||Participants|Count of Participants|4340|4340.0||||||
3711496|NCT02138097|3550547|B9||Male|Sex: Female, Male||Participants|Count of Participants|4969|4969.0||||||
3711497|NCT02138097|3550548|B8||Male|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
3711498|NCT02138097|3550549|B7||Male|Sex: Female, Male||Participants|Count of Participants|20237|20237.0||||||
3711499|NCT02138097|3550550|B6||Male|Sex: Female, Male||Participants|Count of Participants|10891|10891.0||||||
3711500|NCT02138097|3550551|B5||Male|Sex: Female, Male||Participants|Count of Participants|4700|4700.0||||||
3711501|NCT02138097|3550552|B4||Male|Sex: Female, Male||Participants|Count of Participants|40443|40443.0||||||
3711502|NCT02138097|3550553|B3||Male|Sex: Female, Male||Participants|Count of Participants|679|679.0||||||
3711503|NCT02138097|3550554|B2||Male|Sex: Female, Male||Participants|Count of Participants|1645|1645.0||||||
3711504|NCT02138097|3550555|B1||Male|Sex: Female, Male||Participants|Count of Participants|4524|4524.0||||||
3711505|NCT02138097|3550537|B19||Female|Sex: Female, Male||Participants|Count of Participants|278793|278793.0||||||
3711506|NCT02138097|3550538|B18||Female|Sex: Female, Male||Participants|Count of Participants|16077|16077.0||||||
3711507|NCT02138097|3550539|B17||Female|Sex: Female, Male||Participants|Count of Participants|909|909.0||||||
3711508|NCT02138097|3550540|B16||Female|Sex: Female, Male||Participants|Count of Participants|2526|2526.0||||||
3711509|NCT02138097|3550541|B15||Female|Sex: Female, Male||Participants|Count of Participants|9181|9181.0||||||
3711510|NCT02138097|3550542|B14||Female|Sex: Female, Male||Participants|Count of Participants|45668|45668.0||||||
3711511|NCT02138097|3550543|B13||Female|Sex: Female, Male||Participants|Count of Participants|97105|97105.0||||||
3711512|NCT02138097|3550544|B12||Female|Sex: Female, Male||Participants|Count of Participants|10838|10838.0||||||
3711513|NCT02138097|3550545|B11||Female|Sex: Female, Male||Participants|Count of Participants|26158|26158.0||||||
3711514|NCT02138097|3550546|B10||Female|Sex: Female, Male||Participants|Count of Participants|3368|3368.0||||||
3711515|NCT02138097|3550547|B9||Female|Sex: Female, Male||Participants|Count of Participants|5521|5521.0||||||
3711516|NCT02138097|3550548|B8||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3711517|NCT02138097|3550549|B7||Female|Sex: Female, Male||Participants|Count of Participants|13631|13631.0||||||
3711518|NCT02138097|3550550|B6||Female|Sex: Female, Male||Participants|Count of Participants|7600|7600.0||||||
3711519|NCT02138097|3550551|B5||Female|Sex: Female, Male||Participants|Count of Participants|3400|3400.0||||||
3711520|NCT02138097|3550552|B4||Female|Sex: Female, Male||Participants|Count of Participants|32251|32251.0||||||
3711521|NCT02138097|3550553|B3||Female|Sex: Female, Male||Participants|Count of Participants|505|505.0||||||
3711522|NCT02138097|3550554|B2||Female|Sex: Female, Male||Participants|Count of Participants|1175|1175.0||||||
3711523|NCT02138097|3550555|B1||Female|Sex: Female, Male||Participants|Count of Participants|2679|2679.0||||||
3711524|NCT02138097|3550537|B19|||Age||years|Mean|55.05|55.05|Standard Deviation|11.22|11.22|||
3711525|NCT02138097|3550538|B18|||Age||years|Mean|54.28|54.28|Standard Deviation|10.02|10.02|||
3711526|NCT02138097|3550539|B17|||Age||years|Mean|59.96|59.96|Standard Deviation|12.00|12.0|||
3711527|NCT02138097|3550540|B16|||Age||years|Mean|62.50|62.5|Standard Deviation|12.60|12.6|||
3711528|NCT02138097|3550541|B15|||Age||years|Mean|57.40|57.4|Standard Deviation|11.66|11.66|||
3711529|NCT02138097|3550542|B14|||Age||years|Mean|57.94|57.94|Standard Deviation|12.49|12.49|||
3711530|NCT02138097|3550543|B13|||Age||years|Mean|55.91|55.91|Standard Deviation|12.08|12.08|||
3711531|NCT02138097|3550544|B12|||Age||years|Mean|56.84|56.84|Standard Deviation|11.39|11.39|||
3711532|NCT02138097|3550545|B11|||Age||years|Mean|58.42|58.42|Standard Deviation|11.98|11.98|||
3711533|NCT02138097|3550546|B10|||Age||years|Mean|58.72|58.72|Standard Deviation|11.66|11.66|||
3711534|NCT02138097|3550547|B9|||Age||years|Mean|52.35|52.35|Standard Deviation|9.54|9.54|||
3711535|NCT02138097|3550548|B8|||Age||years|Mean|55.93|55.93|Standard Deviation|10.67|10.67|||
3711536|NCT02138097|3550549|B7|||Age||years|Mean|53.75|53.75|Standard Deviation|10.40|10.4|||
3711537|NCT02138097|3550550|B6|||Age||years|Mean|54.40|54.4|Standard Deviation|10.16|10.16|||
3711538|NCT02138097|3550551|B5|||Age||years|Mean|53.68|53.68|Standard Deviation|9.66|9.66|||
3711539|NCT02138097|3550552|B4|||Age||years|Mean|52.57|52.57|Standard Deviation|10.56|10.56|||
3711540|NCT02138097|3550553|B3|||Age||years|Mean|57.08|57.08|Standard Deviation|10.46|10.46|||
3711541|NCT02138097|3550554|B2|||Age||years|Mean|55.90|55.9|Standard Deviation|10.06|10.06|||
3711542|NCT02138097|3550555|B1|||Age||years|Mean|53.67|53.67|Standard Deviation|9.99|9.99|||
3711543|NCT02138006|3550746|B3|Sweden||Region of Enrollment||participants|Number|102|102.0||||||
3711544|NCT02138006|3550747|B2|Sweden||Region of Enrollment||participants|Number|54|54.0||||||
3711545|NCT02138006|3550748|B1|Sweden||Region of Enrollment||participants|Number|48|48.0||||||
3711546|NCT02138006|3550746|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3711547|NCT02138006|3550747|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3711548|NCT02138006|3550748|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3711549|NCT02138006|3550746|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3711550|NCT02138006|3550747|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3711551|NCT02138006|3550748|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3711552|NCT02138006|3550746|B3|||Age||years|Mean|31|31.0|Standard Deviation|7|7.0|||
3711553|NCT02138006|3550747|B2|||Age||years|Mean|32|32.0|Standard Deviation|7|7.0|||
3711554|NCT02138006|3550748|B1|||Age||years|Mean|30|30.0|Standard Deviation|8|8.0|||
3711555|NCT02138006|3550746|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3711556|NCT02138006|3550747|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3711557|NCT02138006|3550748|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3711558|NCT02138006|3550746|B3||Between 18 and 65 years|Age||Participants|Count of Participants|102|102.0||||||
3711559|NCT02138006|3550747|B2||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3711560|NCT02138006|3550748|B1||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
3711561|NCT02138006|3550746|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3711562|NCT02138006|3550747|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3711563|NCT02138006|3550748|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3711564|NCT02137785|3550757|B3|||Total Number AK Lesions (Grade 1/2)||lesions per subject|Mean|8.5|8.5|Standard Deviation|3.5|3.5|||
3711565|NCT02137785|3550758|B2|||Total Number AK Lesions (Grade 1/2)||lesions per subject|Mean|8.6|8.6|Standard Deviation|3.4|3.4|||
3711566|NCT02137785|3550759|B1|||Total Number AK Lesions (Grade 1/2)||lesions per subject|Mean|8.5|8.5|Standard Deviation|3.6|3.6|||
3711567|NCT02137785|3550757|B3|Type VI||Skin Type|Fitzpatrick Skin Type I - Always burns easily; never tans (sensitive) II - Always burns easily; tans minimally (sensitive) III - Burns moderately; tans gradually (light brown) (normal) IV - Burns minimally, always tans well (moderate brown) (normal) V - Rarely burns; tans profusely (dark brown) (insensitive) VI - Never burns; deeply pigmented (insensitive)|participants|Number|0|0.0||||||
3711568|NCT02137785|3550758|B2|Type VI||Skin Type|Fitzpatrick Skin Type I - Always burns easily; never tans (sensitive) II - Always burns easily; tans minimally (sensitive) III - Burns moderately; tans gradually (light brown) (normal) IV - Burns minimally, always tans well (moderate brown) (normal) V - Rarely burns; tans profusely (dark brown) (insensitive) VI - Never burns; deeply pigmented (insensitive)|participants|Number|0|0.0||||||
3711569|NCT02137785|3550759|B1|Type VI||Skin Type|Fitzpatrick Skin Type I - Always burns easily; never tans (sensitive) II - Always burns easily; tans minimally (sensitive) III - Burns moderately; tans gradually (light brown) (normal) IV - Burns minimally, always tans well (moderate brown) (normal) V - Rarely burns; tans profusely (dark brown) (insensitive) VI - Never burns; deeply pigmented (insensitive)|participants|Number|0|0.0||||||
3711570|NCT02137785|3550757|B3|Type V||Skin Type|Fitzpatrick Skin Type I - Always burns easily; never tans (sensitive) II - Always burns easily; tans minimally (sensitive) III - Burns moderately; tans gradually (light brown) (normal) IV - Burns minimally, always tans well (moderate brown) (normal) V - Rarely burns; tans profusely (dark brown) (insensitive) VI - Never burns; deeply pigmented (insensitive)|participants|Number|0|0.0||||||
3711571|NCT02137785|3550758|B2|Type V||Skin Type|Fitzpatrick Skin Type I - Always burns easily; never tans (sensitive) II - Always burns easily; tans minimally (sensitive) III - Burns moderately; tans gradually (light brown) (normal) IV - Burns minimally, always tans well (moderate brown) (normal) V - Rarely burns; tans profusely (dark brown) (insensitive) VI - Never burns; deeply pigmented (insensitive)|participants|Number|0|0.0||||||
3711572|NCT02137785|3550759|B1|Type V||Skin Type|Fitzpatrick Skin Type I - Always burns easily; never tans (sensitive) II - Always burns easily; tans minimally (sensitive) III - Burns moderately; tans gradually (light brown) (normal) IV - Burns minimally, always tans well (moderate brown) (normal) V - Rarely burns; tans profusely (dark brown) (insensitive) VI - Never burns; deeply pigmented (insensitive)|participants|Number|0|0.0||||||
3711573|NCT02137785|3550757|B3|Type IV||Skin Type|Fitzpatrick Skin Type I - Always burns easily; never tans (sensitive) II - Always burns easily; tans minimally (sensitive) III - Burns moderately; tans gradually (light brown) (normal) IV - Burns minimally, always tans well (moderate brown) (normal) V - Rarely burns; tans profusely (dark brown) (insensitive) VI - Never burns; deeply pigmented (insensitive)|participants|Number|27|27.0||||||
3711574|NCT02137785|3550758|B2|Type IV||Skin Type|Fitzpatrick Skin Type I - Always burns easily; never tans (sensitive) II - Always burns easily; tans minimally (sensitive) III - Burns moderately; tans gradually (light brown) (normal) IV - Burns minimally, always tans well (moderate brown) (normal) V - Rarely burns; tans profusely (dark brown) (insensitive) VI - Never burns; deeply pigmented (insensitive)|participants|Number|13|13.0||||||
3711575|NCT02137785|3550759|B1|Type IV||Skin Type|Fitzpatrick Skin Type I - Always burns easily; never tans (sensitive) II - Always burns easily; tans minimally (sensitive) III - Burns moderately; tans gradually (light brown) (normal) IV - Burns minimally, always tans well (moderate brown) (normal) V - Rarely burns; tans profusely (dark brown) (insensitive) VI - Never burns; deeply pigmented (insensitive)|participants|Number|14|14.0||||||
3711576|NCT02137785|3550757|B3|Type III||Skin Type|Fitzpatrick Skin Type I - Always burns easily; never tans (sensitive) II - Always burns easily; tans minimally (sensitive) III - Burns moderately; tans gradually (light brown) (normal) IV - Burns minimally, always tans well (moderate brown) (normal) V - Rarely burns; tans profusely (dark brown) (insensitive) VI - Never burns; deeply pigmented (insensitive)|participants|Number|69|69.0||||||
3711577|NCT02137785|3550758|B2|Type III||Skin Type|Fitzpatrick Skin Type I - Always burns easily; never tans (sensitive) II - Always burns easily; tans minimally (sensitive) III - Burns moderately; tans gradually (light brown) (normal) IV - Burns minimally, always tans well (moderate brown) (normal) V - Rarely burns; tans profusely (dark brown) (insensitive) VI - Never burns; deeply pigmented (insensitive)|participants|Number|32|32.0||||||
3711578|NCT02137785|3550759|B1|Type III||Skin Type|Fitzpatrick Skin Type I - Always burns easily; never tans (sensitive) II - Always burns easily; tans minimally (sensitive) III - Burns moderately; tans gradually (light brown) (normal) IV - Burns minimally, always tans well (moderate brown) (normal) V - Rarely burns; tans profusely (dark brown) (insensitive) VI - Never burns; deeply pigmented (insensitive)|participants|Number|37|37.0||||||
3711579|NCT02137785|3550757|B3|Type II||Skin Type|Fitzpatrick Skin Type I - Always burns easily; never tans (sensitive) II - Always burns easily; tans minimally (sensitive) III - Burns moderately; tans gradually (light brown) (normal) IV - Burns minimally, always tans well (moderate brown) (normal) V - Rarely burns; tans profusely (dark brown) (insensitive) VI - Never burns; deeply pigmented (insensitive)|participants|Number|140|140.0||||||
3711580|NCT02137785|3550758|B2|Type II||Skin Type|Fitzpatrick Skin Type I - Always burns easily; never tans (sensitive) II - Always burns easily; tans minimally (sensitive) III - Burns moderately; tans gradually (light brown) (normal) IV - Burns minimally, always tans well (moderate brown) (normal) V - Rarely burns; tans profusely (dark brown) (insensitive) VI - Never burns; deeply pigmented (insensitive)|participants|Number|73|73.0||||||
3711581|NCT02137785|3550759|B1|Type II||Skin Type|Fitzpatrick Skin Type I - Always burns easily; never tans (sensitive) II - Always burns easily; tans minimally (sensitive) III - Burns moderately; tans gradually (light brown) (normal) IV - Burns minimally, always tans well (moderate brown) (normal) V - Rarely burns; tans profusely (dark brown) (insensitive) VI - Never burns; deeply pigmented (insensitive)|participants|Number|67|67.0||||||
3711582|NCT02137785|3550757|B3|Type I||Skin Type|Fitzpatrick Skin Type I - Always burns easily; never tans (sensitive) II - Always burns easily; tans minimally (sensitive) III - Burns moderately; tans gradually (light brown) (normal) IV - Burns minimally, always tans well (moderate brown) (normal) V - Rarely burns; tans profusely (dark brown) (insensitive) VI - Never burns; deeply pigmented (insensitive)|participants|Number|33|33.0||||||
3711583|NCT02137785|3550758|B2|Type I||Skin Type|Fitzpatrick Skin Type I - Always burns easily; never tans (sensitive) II - Always burns easily; tans minimally (sensitive) III - Burns moderately; tans gradually (light brown) (normal) IV - Burns minimally, always tans well (moderate brown) (normal) V - Rarely burns; tans profusely (dark brown) (insensitive) VI - Never burns; deeply pigmented (insensitive)|participants|Number|16|16.0||||||
3711584|NCT02137785|3550759|B1|Type I||Skin Type|Fitzpatrick Skin Type I - Always burns easily; never tans (sensitive) II - Always burns easily; tans minimally (sensitive) III - Burns moderately; tans gradually (light brown) (normal) IV - Burns minimally, always tans well (moderate brown) (normal) V - Rarely burns; tans profusely (dark brown) (insensitive) VI - Never burns; deeply pigmented (insensitive)|participants|Number|17|17.0||||||
3711585|NCT02137785|3550757|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711586|NCT02137785|3550758|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711587|NCT02137785|3550759|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711588|NCT02137785|3550757|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711589|NCT02137785|3550758|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711590|NCT02137785|3550759|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711591|NCT02137785|3550757|B3||White|Race (NIH/OMB)||Participants|Count of Participants|269|269.0||||||
3711592|NCT02137785|3550758|B2||White|Race (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
3711593|NCT02137785|3550759|B1||White|Race (NIH/OMB)||Participants|Count of Participants|135|135.0||||||
3711594|NCT02137785|3550757|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711595|NCT02137785|3550758|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711596|NCT02137785|3550759|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711597|NCT02137785|3550757|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711598|NCT02137785|3550758|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711599|NCT02137785|3550759|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711600|NCT02137785|3550757|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711601|NCT02137785|3550758|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711602|NCT02137785|3550759|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711603|NCT02137785|3550757|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711604|NCT02137785|3550758|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711605|NCT02137785|3550759|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711606|NCT02137785|3550757|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711607|NCT02137785|3550758|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711608|NCT02137785|3550759|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711609|NCT02137785|3550757|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|266|266.0||||||
3711610|NCT02137785|3550758|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
3711611|NCT02137785|3550759|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|135|135.0||||||
3711612|NCT02137785|3550757|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3711613|NCT02137785|3550758|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3711614|NCT02137785|3550759|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711615|NCT02137785|3550757|B3||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3711616|NCT02137785|3550758|B2||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3711617|NCT02137785|3550759|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3711618|NCT02137785|3550757|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3711619|NCT02137785|3550758|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3711620|NCT02137785|3550759|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3711621|NCT02137785|3550757|B3|||Age||years|Mean|67.6|67.6|Full Range|||45.0|90.0|
3711622|NCT02137785|3550758|B2|||Age||years|Mean|67.6|67.6|Full Range|||47.0|87.0|
3711623|NCT02137785|3550759|B1|||Age||years|Mean|67.6|67.6|Full Range|||45.0|90.0|
3711624|NCT02137772|3550866|B3|Low risk||Risk Stratum for CMV Reactivation|High risk: Participants meeting one or more of the following criteria at randomization: 1) Human leukocyte antigen (HLA)-related (sibling) donor with at least one mismatch at an HLA-A, -B or -DR gene loci 2) Haploidentical donor, 3) Unrelated donor with at least one mismatch at HLA- HLA-A, -B, -C or -DRB1 gene loci 4) Use of umbilical cord blood as stem cell source, 5) Use of ex vivo T-cell-depleted grafts, 6) Grade 2 or greater graft-versus-host disease requiring the use of systemic corticosteroids. Low risk: All other participants|Participants|Number|394|394.0||||||
3711625|NCT02137772|3550867|B2|Low risk||Risk Stratum for CMV Reactivation|High risk: Participants meeting one or more of the following criteria at randomization: 1) Human leukocyte antigen (HLA)-related (sibling) donor with at least one mismatch at an HLA-A, -B or -DR gene loci 2) Haploidentical donor, 3) Unrelated donor with at least one mismatch at HLA- HLA-A, -B, -C or -DRB1 gene loci 4) Use of umbilical cord blood as stem cell source, 5) Use of ex vivo T-cell-depleted grafts, 6) Grade 2 or greater graft-versus-host disease requiring the use of systemic corticosteroids. Low risk: All other participants|Participants|Number|140|140.0||||||
3711626|NCT02137772|3550868|B1|Low risk||Risk Stratum for CMV Reactivation|High risk: Participants meeting one or more of the following criteria at randomization: 1) Human leukocyte antigen (HLA)-related (sibling) donor with at least one mismatch at an HLA-A, -B or -DR gene loci 2) Haploidentical donor, 3) Unrelated donor with at least one mismatch at HLA- HLA-A, -B, -C or -DRB1 gene loci 4) Use of umbilical cord blood as stem cell source, 5) Use of ex vivo T-cell-depleted grafts, 6) Grade 2 or greater graft-versus-host disease requiring the use of systemic corticosteroids. Low risk: All other participants|Participants|Number|254|254.0||||||
3711627|NCT02137772|3550866|B3|High risk||Risk Stratum for CMV Reactivation|High risk: Participants meeting one or more of the following criteria at randomization: 1) Human leukocyte antigen (HLA)-related (sibling) donor with at least one mismatch at an HLA-A, -B or -DR gene loci 2) Haploidentical donor, 3) Unrelated donor with at least one mismatch at HLA- HLA-A, -B, -C or -DRB1 gene loci 4) Use of umbilical cord blood as stem cell source, 5) Use of ex vivo T-cell-depleted grafts, 6) Grade 2 or greater graft-versus-host disease requiring the use of systemic corticosteroids. Low risk: All other participants|Participants|Number|176|176.0||||||
3711628|NCT02137772|3550867|B2|High risk||Risk Stratum for CMV Reactivation|High risk: Participants meeting one or more of the following criteria at randomization: 1) Human leukocyte antigen (HLA)-related (sibling) donor with at least one mismatch at an HLA-A, -B or -DR gene loci 2) Haploidentical donor, 3) Unrelated donor with at least one mismatch at HLA- HLA-A, -B, -C or -DRB1 gene loci 4) Use of umbilical cord blood as stem cell source, 5) Use of ex vivo T-cell-depleted grafts, 6) Grade 2 or greater graft-versus-host disease requiring the use of systemic corticosteroids. Low risk: All other participants|Participants|Number|54|54.0||||||
3711629|NCT02137772|3550868|B1|High risk||Risk Stratum for CMV Reactivation|High risk: Participants meeting one or more of the following criteria at randomization: 1) Human leukocyte antigen (HLA)-related (sibling) donor with at least one mismatch at an HLA-A, -B or -DR gene loci 2) Haploidentical donor, 3) Unrelated donor with at least one mismatch at HLA- HLA-A, -B, -C or -DRB1 gene loci 4) Use of umbilical cord blood as stem cell source, 5) Use of ex vivo T-cell-depleted grafts, 6) Grade 2 or greater graft-versus-host disease requiring the use of systemic corticosteroids. Low risk: All other participants|Participants|Number|122|122.0||||||
3711630|NCT02137772|3550866|B3||Male|Sex: Female, Male||Participants|Count of Participants|331|331.0||||||
3711631|NCT02137772|3550867|B2||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3711632|NCT02137772|3550868|B1||Male|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
3711633|NCT02137772|3550866|B3||Female|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
3711634|NCT02137772|3550867|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3711635|NCT02137772|3550868|B1||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3711636|NCT02137772|3550866|B3|||Age||Years|Mean|50.8|50.8|Standard Deviation|13.9|13.9|||
3711637|NCT02137772|3550867|B2|||Age||Years|Mean|50.8|50.8|Standard Deviation|14.8|14.8|||
3711638|NCT02137772|3550868|B1|||Age||Years|Mean|50.8|50.8|Standard Deviation|13.4|13.4|||
3711639|NCT02137603|3550893|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
3711640|NCT02137603|3550894|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
3711641|NCT02137603|3550895|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3711642|NCT02137603|3550893|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3711643|NCT02137603|3550894|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3711644|NCT02137603|3550895|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3711645|NCT02137603|3550893|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3711646|NCT02137603|3550894|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3711647|NCT02137603|3550895|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3711648|NCT02137603|3550893|B3|||Age||years|Mean|11.2|11.2|Standard Deviation|3.4|3.4|||
3711649|NCT02137603|3550894|B2|||Age||years|Mean|11.6|11.6|Standard Deviation|3.5|3.5|||
3711650|NCT02137603|3550895|B1|||Age||years|Mean|10.8|10.8|Standard Deviation|3.4|3.4|||
3711651|NCT02137603|3550893|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3711652|NCT02137603|3550894|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3711653|NCT02137603|3550895|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3711654|NCT02137603|3550893|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3711655|NCT02137603|3550894|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3711656|NCT02137603|3550895|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3711657|NCT02137603|3550893|B3||<=18 years|Age||Participants|Count of Participants|36|36.0||||||
3711658|NCT02137603|3550894|B2||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
3711659|NCT02137603|3550895|B1||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
3711660|NCT02137512|3550904|B1|||Daily basal insulin||U/kg/day|Median|0.27|0.27|Inter-Quartile Range|||0.2|0.37|
3711661|NCT02137512|3550904|B1|||Daily total insulin dose||U/kg/day|Median|0.57|0.57|Inter-Quartile Range|||0.42|0.72|
3711662|NCT02137512|3550904|B1|||Hemoglobin A1c (HbA1c)||percent|Median|7.3|7.3|Inter-Quartile Range|||7.1|7.7|
3711663|NCT02137512|3550904|B1|||Body-mass index (BMI)||kg/m^2|Median|25|25.0|Inter-Quartile Range|||23.0|27.0|
3711664|NCT02137512|3550904|B1|||Diabetes duration||years|Median|19|19.0|Inter-Quartile Range|||13.0|28.0|
3711665|NCT02137512|3550904|B1|France||Region of Enrollment||participants|Number|5|5.0||||||
3711666|NCT02137512|3550904|B1|Israel||Region of Enrollment||participants|Number|5|5.0||||||
3711667|NCT02137512|3550904|B1|Italy||Region of Enrollment||participants|Number|5|5.0||||||
3711668|NCT02137512|3550904|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3711669|NCT02137512|3550904|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3711670|NCT02137512|3550904|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711671|NCT02137512|3550904|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3711672|NCT02137512|3550904|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711673|NCT02137512|3550904|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711674|NCT02137512|3550904|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3711675|NCT02137512|3550904|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711676|NCT02137512|3550904|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3711677|NCT02137512|3550904|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3711678|NCT02137512|3550904|B1|||Age||years|Median|44|44.0|Full Range|||18.0|66.0|
3711679|NCT02137447|3551057|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3711680|NCT02137447|3551057|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3711681|NCT02137447|3551057|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3711682|NCT02137447|3551057|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|10.8|10.8|||
3711683|NCT02137447|3551057|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3711684|NCT02137447|3551057|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3711685|NCT02137447|3551057|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3711686|NCT02137382|3551062|B1|Spain||Region of Enrollment||Participants|Number|26|26.0||||||
3711687|NCT02137382|3551062|B1|Hungary||Region of Enrollment||Participants|Number|15|15.0||||||
3711688|NCT02137382|3551062|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3711689|NCT02137382|3551062|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3711690|NCT02137382|3551062|B1|||Age||years|Mean|23.5|23.5|Standard Deviation|8.0|8.0|||
3711691|NCT02137382|3551062|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3711692|NCT02137382|3551062|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3711693|NCT02137382|3551062|B1||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
3711694|NCT02137226|3551081|B3||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3711695|NCT02137226|3551082|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3711696|NCT02137226|3551083|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3711697|NCT02137226|3551081|B3||Female|Sex: Female, Male||Participants|Count of Participants|536|536.0||||||
3711698|NCT02137226|3551082|B2||Female|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
3711699|NCT02137226|3551083|B1||Female|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
3711700|NCT02137226|3551081|B3|||Age||Years|Mean|53.6|53.6|Standard Deviation|11.68|11.68|||
3711701|NCT02137226|3551082|B2|||Age||Years|Mean|53.6|53.6|Standard Deviation|11.32|11.32|||
3711702|NCT02137226|3551083|B1|||Age||Years|Mean|53.7|53.7|Standard Deviation|12.04|12.04|||
3711703|NCT02136914|3551099|B3|Anticholinergics||Subjects taking Antiparkinson Medication|Patients may have been taking more than 1 antiparkinson medication at Baseline|Participants|Count of Participants|5|5.0||||||
3711704|NCT02136914|3551100|B2|Anticholinergics||Subjects taking Antiparkinson Medication|Patients may have been taking more than 1 antiparkinson medication at Baseline|Participants|Count of Participants|2|2.0||||||
3711705|NCT02136914|3551101|B1|Anticholinergics||Subjects taking Antiparkinson Medication|Patients may have been taking more than 1 antiparkinson medication at Baseline|Participants|Count of Participants|3|3.0||||||
3711706|NCT02136914|3551099|B3|COMT Inhibitor||Subjects taking Antiparkinson Medication|Patients may have been taking more than 1 antiparkinson medication at Baseline|Participants|Count of Participants|16|16.0||||||
3711707|NCT02136914|3551100|B2|COMT Inhibitor||Subjects taking Antiparkinson Medication|Patients may have been taking more than 1 antiparkinson medication at Baseline|Participants|Count of Participants|7|7.0||||||
3711708|NCT02136914|3551101|B1|COMT Inhibitor||Subjects taking Antiparkinson Medication|Patients may have been taking more than 1 antiparkinson medication at Baseline|Participants|Count of Participants|9|9.0||||||
3711709|NCT02136914|3551099|B3|MAO Inhibitors||Subjects taking Antiparkinson Medication|Patients may have been taking more than 1 antiparkinson medication at Baseline|Participants|Count of Participants|50|50.0||||||
3711710|NCT02136914|3551100|B2|MAO Inhibitors||Subjects taking Antiparkinson Medication|Patients may have been taking more than 1 antiparkinson medication at Baseline|Participants|Count of Participants|26|26.0||||||
3711711|NCT02136914|3551101|B1|MAO Inhibitors||Subjects taking Antiparkinson Medication|Patients may have been taking more than 1 antiparkinson medication at Baseline|Participants|Count of Participants|24|24.0||||||
3711712|NCT02136914|3551099|B3|Dopamine Agonist||Subjects taking Antiparkinson Medication|Patients may have been taking more than 1 antiparkinson medication at Baseline|Participants|Count of Participants|63|63.0||||||
3711713|NCT02136914|3551100|B2|Dopamine Agonist||Subjects taking Antiparkinson Medication|Patients may have been taking more than 1 antiparkinson medication at Baseline|Participants|Count of Participants|29|29.0||||||
3711714|NCT02136914|3551101|B1|Dopamine Agonist||Subjects taking Antiparkinson Medication|Patients may have been taking more than 1 antiparkinson medication at Baseline|Participants|Count of Participants|34|34.0||||||
3711715|NCT02136914|3551099|B3|Levodopa (Sinemet or Stalevo)||Subjects taking Antiparkinson Medication|Patients may have been taking more than 1 antiparkinson medication at Baseline|Participants|Count of Participants|123|123.0||||||
3711716|NCT02136914|3551100|B2|Levodopa (Sinemet or Stalevo)||Subjects taking Antiparkinson Medication|Patients may have been taking more than 1 antiparkinson medication at Baseline|Participants|Count of Participants|63|63.0||||||
3711717|NCT02136914|3551101|B1|Levodopa (Sinemet or Stalevo)||Subjects taking Antiparkinson Medication|Patients may have been taking more than 1 antiparkinson medication at Baseline|Participants|Count of Participants|60|60.0||||||
3711718|NCT02136914|3551099|B3|||Hoehn and Yahr Stage|The Hoehn and Yahr scale, from 1-5, describes the patient's PD progression. The higher the score the more severe the symptoms of PD.|units on a scale|Mean|2.3|2.3|Standard Deviation|0.55|0.55|||
3711719|NCT02136914|3551100|B2|||Hoehn and Yahr Stage|The Hoehn and Yahr scale, from 1-5, describes the patient's PD progression. The higher the score the more severe the symptoms of PD.|units on a scale|Mean|2.2|2.2|Standard Deviation|0.54|0.54|||
3711720|NCT02136914|3551101|B1|||Hoehn and Yahr Stage|The Hoehn and Yahr scale, from 1-5, describes the patient's PD progression. The higher the score the more severe the symptoms of PD.|units on a scale|Mean|2.3|2.3|Standard Deviation|0.56|0.56|||
3711721|NCT02136914|3551099|B3|||Duration of LID||years|Mean|3.64|3.64|Standard Deviation|2.831|2.831|||
3711722|NCT02136914|3551100|B2|||Duration of LID||years|Mean|4.05|4.05|Standard Deviation|3.085|3.085|||
3711723|NCT02136914|3551101|B1|||Duration of LID||years|Mean|3.21|3.21|Standard Deviation|2.491|2.491|||
3711724|NCT02136914|3551099|B3|||Duration of Levodopa Treatment||years|Mean|7.33|7.33|Standard Deviation|3.563|3.563|||
3711725|NCT02136914|3551100|B2|||Duration of Levodopa Treatment||years|Mean|7.82|7.82|Standard Deviation|3.719|3.719|||
3711726|NCT02136914|3551101|B1|||Duration of Levodopa Treatment||years|Mean|6.82|6.82|Standard Deviation|3.346|3.346|||
3711727|NCT02136914|3551099|B3|||Time Since PD Diagnosis||years|Mean|9.16|9.16|Standard Deviation|4.148|4.148|||
3711728|NCT02136914|3551100|B2|||Time Since PD Diagnosis||years|Mean|9.45|9.45|Standard Deviation|4.372|4.372|||
3711729|NCT02136914|3551101|B1|||Time Since PD Diagnosis||years|Mean|8.85|8.85|Standard Deviation|3.911|3.911|||
3711730|NCT02136914|3551099|B3|Part IV, Item 4.2||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|2.5|2.5|Standard Deviation|0.55|0.55|||
3711731|NCT02136914|3551100|B2|Part IV, Item 4.2||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|2.6|2.6|Standard Deviation|0.56|0.56|||
3711883|NCT02136420|3551133|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711732|NCT02136914|3551101|B1|Part IV, Item 4.2||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|2.5|2.5|Standard Deviation|0.54|0.54|||
3711733|NCT02136914|3551099|B3|Part IV, Item 4.1||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|2.5|2.5|Standard Deviation|0.89|0.89|||
3711734|NCT02136914|3551100|B2|Part IV, Item 4.1||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|2.6|2.6|Standard Deviation|0.94|0.94|||
3711735|NCT02136914|3551101|B1|Part IV, Item 4.1||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|2.4|2.4|Standard Deviation|0.82|0.82|||
3711736|NCT02136914|3551099|B3|Part IV||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|11.6|11.6|Standard Deviation|2.68|2.68|||
3711737|NCT02136914|3551100|B2|Part IV||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|11.8|11.8|Standard Deviation|2.95|2.95|||
3711738|NCT02136914|3551101|B1|Part IV||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|11.3|11.3|Standard Deviation|2.36|2.36|||
3711739|NCT02136914|3551099|B3|Combined Parts I, II, and III||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|53.1|53.1|Standard Deviation|18.75|18.75|||
3711740|NCT02136914|3551100|B2|Combined Parts I, II, and III||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|54.2|54.2|Standard Deviation|20.37|20.37|||
3711741|NCT02136914|3551101|B1|Combined Parts I, II, and III||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|51.9|51.9|Standard Deviation|16.95|16.95|||
3711742|NCT02136914|3551099|B3|Part III||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|25.3|25.3|Standard Deviation|13.34|13.34|||
3711743|NCT02136914|3551100|B2|Part III||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|25.9|25.9|Standard Deviation|14.49|14.49|||
3711744|NCT02136914|3551101|B1|Part III||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|24.6|24.6|Standard Deviation|12.10|12.1|||
3711745|NCT02136914|3551099|B3|Part II||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|15.8|15.8|Standard Deviation|6.29|6.29|||
3711746|NCT02136914|3551100|B2|Part II||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|15.7|15.7|Standard Deviation|6.77|6.77|||
3711747|NCT02136914|3551101|B1|Part II||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|15.8|15.8|Standard Deviation|5.80|5.8|||
3711748|NCT02136914|3551099|B3|Part I||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|12.0|12.0|Standard Deviation|5.31|5.31|||
3711749|NCT02136914|3551100|B2|Part I||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|12.5|12.5|Standard Deviation|6.18|6.18|||
3711750|NCT02136914|3551101|B1|Part I||Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)|The MDS-UPDRS Parts I, II, III, and IV examined non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications, respectively. Each Part contains items/questions, each rated on a scale from 0 (normal) to 4 (severe). The range of total scores for each Part is as follows: Part I, 0-52; Part II, 0-52; Part III, 0-132; Part IV, 0-24. Combined Parts I, II, and III is the sum of scores from Parts I, II, and III and has a scale range of 0-236. Parts 4.1 and 4.2 each has a scale range of 0-4. Higher scores indicate more severe PD.|units on a scale|Mean|11.5|11.5|Standard Deviation|4.17|4.17|||
3711751|NCT02136914|3551099|B3|ON with Troublesome Dyskinesia||PD Home Diary|A PD home diary was used to score 5 different conditions in 30-minute intervals: ASLEEP, OFF, ON (ie, had adequate control of PD symptoms) without dyskinesia, ON with non-troublesome dyskinesia, and ON with troublesome dyskinesia.|hours|Mean|4.59|4.59|Standard Deviation|2.257|2.257|||
3711752|NCT02136914|3551100|B2|ON with Troublesome Dyskinesia||PD Home Diary|A PD home diary was used to score 5 different conditions in 30-minute intervals: ASLEEP, OFF, ON (ie, had adequate control of PD symptoms) without dyskinesia, ON with non-troublesome dyskinesia, and ON with troublesome dyskinesia.|hours|Mean|4.72|4.72|Standard Deviation|2.537|2.537|||
3711753|NCT02136914|3551101|B1|ON with Troublesome Dyskinesia||PD Home Diary|A PD home diary was used to score 5 different conditions in 30-minute intervals: ASLEEP, OFF, ON (ie, had adequate control of PD symptoms) without dyskinesia, ON with non-troublesome dyskinesia, and ON with troublesome dyskinesia.|hours|Mean|4.46|4.46|Standard Deviation|1.933|1.933|||
3711754|NCT02136914|3551099|B3|ON without Troublesome Dyskinesia||PD Home Diary|A PD home diary was used to score 5 different conditions in 30-minute intervals: ASLEEP, OFF, ON (ie, had adequate control of PD symptoms) without dyskinesia, ON with non-troublesome dyskinesia, and ON with troublesome dyskinesia.|hours|Mean|8.46|8.46|Standard Deviation|3.155|3.155|||
3711755|NCT02136914|3551100|B2|ON without Troublesome Dyskinesia||PD Home Diary|A PD home diary was used to score 5 different conditions in 30-minute intervals: ASLEEP, OFF, ON (ie, had adequate control of PD symptoms) without dyskinesia, ON with non-troublesome dyskinesia, and ON with troublesome dyskinesia.|hours|Mean|8.34|8.34|Standard Deviation|3.466|3.466|||
3711756|NCT02136914|3551101|B1|ON without Troublesome Dyskinesia||PD Home Diary|A PD home diary was used to score 5 different conditions in 30-minute intervals: ASLEEP, OFF, ON (ie, had adequate control of PD symptoms) without dyskinesia, ON with non-troublesome dyskinesia, and ON with troublesome dyskinesia.|hours|Mean|8.59|8.59|Standard Deviation|2.815|2.815|||
3711757|NCT02136914|3551099|B3|Off||PD Home Diary|A PD home diary was used to score 5 different conditions in 30-minute intervals: ASLEEP, OFF, ON (ie, had adequate control of PD symptoms) without dyskinesia, ON with non-troublesome dyskinesia, and ON with troublesome dyskinesia.|hours|Mean|3.05|3.05|Standard Deviation|2.239|2.239|||
3711758|NCT02136914|3551100|B2|Off||PD Home Diary|A PD home diary was used to score 5 different conditions in 30-minute intervals: ASLEEP, OFF, ON (ie, had adequate control of PD symptoms) without dyskinesia, ON with non-troublesome dyskinesia, and ON with troublesome dyskinesia.|hours|Mean|3.16|3.16|Standard Deviation|2.372|2.372|||
3711759|NCT02136914|3551101|B1|Off||PD Home Diary|A PD home diary was used to score 5 different conditions in 30-minute intervals: ASLEEP, OFF, ON (ie, had adequate control of PD symptoms) without dyskinesia, ON with non-troublesome dyskinesia, and ON with troublesome dyskinesia.|hours|Mean|2.94|2.94|Standard Deviation|2.105|2.105|||
3711760|NCT02136914|3551099|B3|Asleep||PD Home Diary|A PD home diary was used to score 5 different conditions in 30-minute intervals: ASLEEP, OFF, ON (ie, had adequate control of PD symptoms) without dyskinesia, ON with non-troublesome dyskinesia, and ON with troublesome dyskinesia.|hours|Mean|7.90|7.9|Standard Deviation|1.597|1.597|||
3711761|NCT02136914|3551100|B2|Asleep||PD Home Diary|A PD home diary was used to score 5 different conditions in 30-minute intervals: ASLEEP, OFF, ON (ie, had adequate control of PD symptoms) without dyskinesia, ON with non-troublesome dyskinesia, and ON with troublesome dyskinesia.|hours|Mean|7.78|7.78|Standard Deviation|1.732|1.732|||
3711762|NCT02136914|3551101|B1|Asleep||PD Home Diary|A PD home diary was used to score 5 different conditions in 30-minute intervals: ASLEEP, OFF, ON (ie, had adequate control of PD symptoms) without dyskinesia, ON with non-troublesome dyskinesia, and ON with troublesome dyskinesia.|hours|Mean|8.02|8.02|Standard Deviation|1.446|1.446|||
3711763|NCT02136914|3551099|B3|Total Objective Score (Parts III, IV)||Unified Dyskinesia Rating Scale (UDysRS)|The UDysRS is a dyskinesia rating scale that evaluates involuntary movements associated with PD; the UDysRS consists of the following sub-parts: IA, IB, IIA, IIB, III, and IV. The total score is the sum of all individual sub-parts, and scores for this measure can range from 0-104. The total objective score is the sum of Part III (which measures objective impairment) and Part IV (which measures objective disability), and scores for this measure can range from 0-44. For both the total score and total objective score, a higher score indicates more severe PD.|units on a scale|Mean|15.9|15.9|Standard Deviation|7.21|7.21|||
3711764|NCT02136914|3551100|B2|Total Objective Score (Parts III, IV)||Unified Dyskinesia Rating Scale (UDysRS)|The UDysRS is a dyskinesia rating scale that evaluates involuntary movements associated with PD; the UDysRS consists of the following sub-parts: IA, IB, IIA, IIB, III, and IV. The total score is the sum of all individual sub-parts, and scores for this measure can range from 0-104. The total objective score is the sum of Part III (which measures objective impairment) and Part IV (which measures objective disability), and scores for this measure can range from 0-44. For both the total score and total objective score, a higher score indicates more severe PD.|units on a scale|Mean|16.4|16.4|Standard Deviation|7.72|7.72|||
3711765|NCT02136914|3551101|B1|Total Objective Score (Parts III, IV)||Unified Dyskinesia Rating Scale (UDysRS)|The UDysRS is a dyskinesia rating scale that evaluates involuntary movements associated with PD; the UDysRS consists of the following sub-parts: IA, IB, IIA, IIB, III, and IV. The total score is the sum of all individual sub-parts, and scores for this measure can range from 0-104. The total objective score is the sum of Part III (which measures objective impairment) and Part IV (which measures objective disability), and scores for this measure can range from 0-44. For both the total score and total objective score, a higher score indicates more severe PD.|units on a scale|Mean|15.3|15.3|Standard Deviation|6.66|6.66|||
3711766|NCT02136914|3551099|B3|Total Score||Unified Dyskinesia Rating Scale (UDysRS)|The UDysRS is a dyskinesia rating scale that evaluates involuntary movements associated with PD; the UDysRS consists of the following sub-parts: IA, IB, IIA, IIB, III, and IV. The total score is the sum of all individual sub-parts, and scores for this measure can range from 0-104. The total objective score is the sum of Part III (which measures objective impairment) and Part IV (which measures objective disability), and scores for this measure can range from 0-44. For both the total score and total objective score, a higher score indicates more severe PD.|units on a scale|Mean|39.6|39.6|Standard Deviation|12.37|12.37|||
3711767|NCT02136914|3551100|B2|Total Score||Unified Dyskinesia Rating Scale (UDysRS)|The UDysRS is a dyskinesia rating scale that evaluates involuntary movements associated with PD; the UDysRS consists of the following sub-parts: IA, IB, IIA, IIB, III, and IV. The total score is the sum of all individual sub-parts, and scores for this measure can range from 0-104. The total objective score is the sum of Part III (which measures objective impairment) and Part IV (which measures objective disability), and scores for this measure can range from 0-44. For both the total score and total objective score, a higher score indicates more severe PD.|units on a scale|Mean|40.9|40.9|Standard Deviation|13.34|13.34|||
3711822|NCT02136810|3551116|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3711823|NCT02136810|3551116|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711824|NCT02136810|3551116|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3711768|NCT02136914|3551101|B1|Total Score||Unified Dyskinesia Rating Scale (UDysRS)|The UDysRS is a dyskinesia rating scale that evaluates involuntary movements associated with PD; the UDysRS consists of the following sub-parts: IA, IB, IIA, IIB, III, and IV. The total score is the sum of all individual sub-parts, and scores for this measure can range from 0-104. The total objective score is the sum of Part III (which measures objective impairment) and Part IV (which measures objective disability), and scores for this measure can range from 0-44. For both the total score and total objective score, a higher score indicates more severe PD.|units on a scale|Mean|38.2|38.2|Standard Deviation|11.20|11.2|||
3711769|NCT02136914|3551099|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3711770|NCT02136914|3551100|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711771|NCT02136914|3551101|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3711772|NCT02136914|3551099|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711773|NCT02136914|3551100|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711774|NCT02136914|3551101|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711775|NCT02136914|3551099|B3||White|Race (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
3711776|NCT02136914|3551100|B2||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3711777|NCT02136914|3551101|B1||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3711778|NCT02136914|3551099|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3711779|NCT02136914|3551100|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711780|NCT02136914|3551101|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3711781|NCT02136914|3551099|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3711782|NCT02136914|3551100|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3711783|NCT02136914|3551101|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711784|NCT02136914|3551099|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3711785|NCT02136914|3551100|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3711786|NCT02136914|3551101|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3711787|NCT02136914|3551099|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711788|NCT02136914|3551100|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711789|NCT02136914|3551101|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711790|NCT02136914|3551099|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711791|NCT02136914|3551100|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711792|NCT02136914|3551101|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711793|NCT02136914|3551099|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
3711794|NCT02136914|3551100|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3711795|NCT02136914|3551101|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3711796|NCT02136914|3551099|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3711797|NCT02136914|3551100|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3711798|NCT02136914|3551101|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3711799|NCT02136914|3551099|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3711800|NCT02136914|3551100|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3711801|NCT02136914|3551101|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3711802|NCT02136914|3551099|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3711803|NCT02136914|3551100|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3711804|NCT02136914|3551101|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3711805|NCT02136914|3551099|B3|||Age||years|Mean|64.7|64.7|Standard Deviation|9.04|9.04|||
3711806|NCT02136914|3551100|B2|||Age||years|Mean|63.9|63.9|Standard Deviation|9.43|9.43|||
3711807|NCT02136914|3551101|B1|||Age||years|Mean|65.6|65.6|Standard Deviation|8.59|8.59|||
3711808|NCT02136914|3551099|B3||>=65 years|Age||Participants|Count of Participants|64|64.0||||||
3711809|NCT02136914|3551100|B2||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
3711810|NCT02136914|3551101|B1||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
3711811|NCT02136914|3551099|B3||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
3711812|NCT02136914|3551100|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3711813|NCT02136914|3551101|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3711814|NCT02136914|3551099|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3711815|NCT02136914|3551100|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3711816|NCT02136914|3551101|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3711817|NCT02136810|3551116|B1|||DBP||mmHg|Mean|88.39|88.39|Standard Deviation|9.81|9.81|||
3711818|NCT02136810|3551116|B1|||SBP||mmHg|Mean|156.26|156.26|Standard Deviation|14.11|14.11|||
3711819|NCT02136810|3551116|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3711820|NCT02136810|3551116|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711821|NCT02136810|3551116|B1||White|Race (NIH/OMB)||Participants|Count of Participants|149|149.0||||||
3711825|NCT02136810|3551116|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711826|NCT02136810|3551116|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3711827|NCT02136810|3551116|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|185|185.0||||||
3711828|NCT02136810|3551116|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3711829|NCT02136810|3551116|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3711830|NCT02136810|3551116|B1||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3711831|NCT02136810|3551116|B1|||Age||years|Mean|64.42|64.42|Standard Deviation|12.8|12.8|||
3711832|NCT02136498|3551120|B3|Never used varenicline||Prior use of varenicline||participants|Number|38|38.0||||||
3711833|NCT02136498|3551121|B2|Never used varenicline||Prior use of varenicline||participants|Number|19|19.0||||||
3711834|NCT02136498|3551122|B1|Never used varenicline||Prior use of varenicline||participants|Number|19|19.0||||||
3711835|NCT02136498|3551120|B3|Used varenicline previously||Prior use of varenicline||participants|Number|28|28.0||||||
3711836|NCT02136498|3551121|B2|Used varenicline previously||Prior use of varenicline||participants|Number|14|14.0||||||
3711837|NCT02136498|3551122|B1|Used varenicline previously||Prior use of varenicline||participants|Number|14|14.0||||||
3711838|NCT02136498|3551120|B3|||Cigarettes smoked per day||cigarettes|Mean|17.7|17.7|Standard Deviation|7.2|7.2|||
3711839|NCT02136498|3551121|B2|||Cigarettes smoked per day||cigarettes|Mean|18.5|18.5|Standard Deviation|9.1|9.1|||
3711840|NCT02136498|3551122|B1|||Cigarettes smoked per day||cigarettes|Mean|16.9|16.9|Standard Deviation|4.5|4.5|||
3711841|NCT02136498|3551120|B3|Non-white||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3711842|NCT02136498|3551121|B2|Non-white||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3711843|NCT02136498|3551122|B1|Non-white||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3711844|NCT02136498|3551120|B3|White||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
3711845|NCT02136498|3551121|B2|White||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3711846|NCT02136498|3551122|B1|White||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3711847|NCT02136498|3551120|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3711848|NCT02136498|3551121|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3711849|NCT02136498|3551122|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3711850|NCT02136498|3551120|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3711851|NCT02136498|3551121|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3711852|NCT02136498|3551122|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3711853|NCT02136498|3551120|B3|||Age||years|Mean|49.5|49.5|Standard Deviation|8.7|8.7|||
3711854|NCT02136498|3551121|B2|||Age||years|Mean|48.4|48.4|Standard Deviation|8.4|8.4|||
3711855|NCT02136498|3551122|B1|||Age||years|Mean|50.6|50.6|Standard Deviation|8.9|8.9|||
3711856|NCT02136420|3551131|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711857|NCT02136420|3551132|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711858|NCT02136420|3551133|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711859|NCT02136420|3551134|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711860|NCT02136420|3551135|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711861|NCT02136420|3551131|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3711862|NCT02136420|3551132|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3711863|NCT02136420|3551133|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711864|NCT02136420|3551134|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711865|NCT02136420|3551135|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711866|NCT02136420|3551131|B5||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3711867|NCT02136420|3551132|B4||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3711868|NCT02136420|3551133|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3711869|NCT02136420|3551134|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3711870|NCT02136420|3551135|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3711871|NCT02136420|3551131|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3711872|NCT02136420|3551132|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711873|NCT02136420|3551133|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3711874|NCT02136420|3551134|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711875|NCT02136420|3551135|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3711876|NCT02136420|3551131|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711877|NCT02136420|3551132|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711878|NCT02136420|3551133|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711879|NCT02136420|3551134|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711880|NCT02136420|3551135|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711881|NCT02136420|3551131|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3711882|NCT02136420|3551132|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711884|NCT02136420|3551134|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3711885|NCT02136420|3551135|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3711886|NCT02136420|3551131|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711887|NCT02136420|3551132|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711888|NCT02136420|3551133|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711889|NCT02136420|3551134|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711890|NCT02136420|3551135|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711891|NCT02136420|3551131|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711892|NCT02136420|3551132|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711893|NCT02136420|3551133|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711894|NCT02136420|3551134|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711895|NCT02136420|3551135|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3711896|NCT02136420|3551131|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3711897|NCT02136420|3551132|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3711898|NCT02136420|3551133|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3711899|NCT02136420|3551134|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3711900|NCT02136420|3551135|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3711901|NCT02136420|3551131|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3711902|NCT02136420|3551132|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3711903|NCT02136420|3551133|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3711904|NCT02136420|3551134|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3711905|NCT02136420|3551135|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3711906|NCT02136420|3551131|B5||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3711907|NCT02136420|3551132|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3711908|NCT02136420|3551133|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3711909|NCT02136420|3551134|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3711910|NCT02136420|3551135|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3711911|NCT02136420|3551131|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3711912|NCT02136420|3551132|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3711913|NCT02136420|3551133|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3711914|NCT02136420|3551134|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3711915|NCT02136420|3551135|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3711916|NCT02136420|3551131|B5|||Age||years|Mean|27.6|27.6|Standard Deviation|4.3|4.3|||
3711917|NCT02136420|3551132|B4|||Age||years|Mean|24.8|24.8|Standard Deviation|2.9|2.9|||
3711918|NCT02136420|3551133|B3|||Age||years|Mean|27.4|27.4|Standard Deviation|4.2|4.2|||
3711919|NCT02136420|3551134|B2|||Age||years|Mean|28.0|28.0|Standard Deviation|6.3|6.3|||
3711920|NCT02136420|3551135|B1|||Age||years|Mean|28.3|28.3|Standard Deviation|6.4|6.4|||
3711921|NCT02136238|3551164|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
3711922|NCT02136238|3551165|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3711923|NCT02136238|3551166|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3711924|NCT02136238|3551164|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3711925|NCT02136238|3551165|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3711926|NCT02136238|3551166|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3711927|NCT02136238|3551164|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3711928|NCT02136238|3551165|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3711929|NCT02136238|3551166|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3711930|NCT02136238|3551164|B3|||Age||years|Mean|39.9|39.9|Standard Deviation|8.2|8.2|||
3711931|NCT02136238|3551165|B2|||Age||years|Mean|56.1|56.1|Standard Deviation|10.4|10.4|||
3711932|NCT02136238|3551166|B1|||Age||years|Mean|23.6|23.6|Standard Deviation|6.0|6.0|||
3711933|NCT02136134|3551179|B3|>3||No. of Prior Lines of Therapy||participants|Number|50|50.0||||||
3711934|NCT02136134|3551180|B2|>3||No. of Prior Lines of Therapy||participants|Number|22|22.0||||||
3711935|NCT02136134|3551181|B1|>3||No. of Prior Lines of Therapy||participants|Number|28|28.0||||||
3711936|NCT02136134|3551179|B3|3||No. of Prior Lines of Therapy||participants|Number|69|69.0||||||
3711937|NCT02136134|3551180|B2|3||No. of Prior Lines of Therapy||participants|Number|37|37.0||||||
3711938|NCT02136134|3551181|B1|3||No. of Prior Lines of Therapy||participants|Number|32|32.0||||||
3711939|NCT02136134|3551179|B3|2||No. of Prior Lines of Therapy||participants|Number|144|144.0||||||
3711940|NCT02136134|3551180|B2|2||No. of Prior Lines of Therapy||participants|Number|70|70.0||||||
3711941|NCT02136134|3551181|B1|2||No. of Prior Lines of Therapy||participants|Number|74|74.0||||||
3711942|NCT02136134|3551179|B3|1||No. of Prior Lines of Therapy||participants|Number|235|235.0||||||
3711943|NCT02136134|3551180|B2|1||No. of Prior Lines of Therapy||participants|Number|122|122.0||||||
3711944|NCT02136134|3551181|B1|1||No. of Prior Lines of Therapy||participants|Number|113|113.0||||||
3711945|NCT02136134|3551179|B3|III||Stage of Disease (ISS)|The International Staging System (ISS) consists of following 3 stages - Stage I: serum beta2-microglobulin less than (<)3.5 milligram per liter (mg/l) and albumin greater than or equal to (>=) 3.5 gram per 100 Milliliter (g/100 ml); Stage II: neither stage I nor stage III and Stage III: serum beta2-microglobulin >= 5.5 mg/l.|participants|Number|110|110.0||||||
3711946|NCT02136134|3551180|B2|III||Stage of Disease (ISS)|The International Staging System (ISS) consists of following 3 stages - Stage I: serum beta2-microglobulin less than (<)3.5 milligram per liter (mg/l) and albumin greater than or equal to (>=) 3.5 gram per 100 Milliliter (g/100 ml); Stage II: neither stage I nor stage III and Stage III: serum beta2-microglobulin >= 5.5 mg/l.|participants|Number|59|59.0||||||
3711947|NCT02136134|3551181|B1|III||Stage of Disease (ISS)|The International Staging System (ISS) consists of following 3 stages - Stage I: serum beta2-microglobulin less than (<)3.5 milligram per liter (mg/l) and albumin greater than or equal to (>=) 3.5 gram per 100 Milliliter (g/100 ml); Stage II: neither stage I nor stage III and Stage III: serum beta2-microglobulin >= 5.5 mg/l.|participants|Number|51|51.0||||||
3711948|NCT02136134|3551179|B3|II||Stage of Disease (ISS)|The International Staging System (ISS) consists of following 3 stages - Stage I: serum beta2-microglobulin less than (<)3.5 milligram per liter (mg/l) and albumin greater than or equal to (>=) 3.5 gram per 100 Milliliter (g/100 ml); Stage II: neither stage I nor stage III and Stage III: serum beta2-microglobulin >= 5.5 mg/l.|participants|Number|194|194.0||||||
3711949|NCT02136134|3551180|B2|II||Stage of Disease (ISS)|The International Staging System (ISS) consists of following 3 stages - Stage I: serum beta2-microglobulin less than (<)3.5 milligram per liter (mg/l) and albumin greater than or equal to (>=) 3.5 gram per 100 Milliliter (g/100 ml); Stage II: neither stage I nor stage III and Stage III: serum beta2-microglobulin >= 5.5 mg/l.|participants|Number|94|94.0||||||
3711950|NCT02136134|3551181|B1|II||Stage of Disease (ISS)|The International Staging System (ISS) consists of following 3 stages - Stage I: serum beta2-microglobulin less than (<)3.5 milligram per liter (mg/l) and albumin greater than or equal to (>=) 3.5 gram per 100 Milliliter (g/100 ml); Stage II: neither stage I nor stage III and Stage III: serum beta2-microglobulin >= 5.5 mg/l.|participants|Number|100|100.0||||||
3711951|NCT02136134|3551179|B3|I||Stage of Disease (ISS)|The International Staging System (ISS) consists of following 3 stages - Stage I: serum beta2-microglobulin less than (<)3.5 milligram per liter (mg/l) and albumin greater than or equal to (>=) 3.5 gram per 100 Milliliter (g/100 ml); Stage II: neither stage I nor stage III and Stage III: serum beta2-microglobulin >= 5.5 mg/l.|participants|Number|194|194.0||||||
3711952|NCT02136134|3551180|B2|I||Stage of Disease (ISS)|The International Staging System (ISS) consists of following 3 stages - Stage I: serum beta2-microglobulin less than (<)3.5 milligram per liter (mg/l) and albumin greater than or equal to (>=) 3.5 gram per 100 Milliliter (g/100 ml); Stage II: neither stage I nor stage III and Stage III: serum beta2-microglobulin >= 5.5 mg/l.|participants|Number|98|98.0||||||
3711953|NCT02136134|3551181|B1|I||Stage of Disease (ISS)|The International Staging System (ISS) consists of following 3 stages - Stage I: serum beta2-microglobulin less than (<)3.5 milligram per liter (mg/l) and albumin greater than or equal to (>=) 3.5 gram per 100 Milliliter (g/100 ml); Stage II: neither stage I nor stage III and Stage III: serum beta2-microglobulin >= 5.5 mg/l.|participants|Number|96|96.0||||||
3711954|NCT02136134|3551179|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
3711955|NCT02136134|3551180|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3711956|NCT02136134|3551181|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3711957|NCT02136134|3551179|B3|Ukraine||Region of Enrollment||participants|Number|50|50.0||||||
3711958|NCT02136134|3551180|B2|Ukraine||Region of Enrollment||participants|Number|28|28.0||||||
3711959|NCT02136134|3551181|B1|Ukraine||Region of Enrollment||participants|Number|22|22.0||||||
3711960|NCT02136134|3551179|B3|Turkey||Region of Enrollment||participants|Number|28|28.0||||||
3711961|NCT02136134|3551180|B2|Turkey||Region of Enrollment||participants|Number|14|14.0||||||
3711962|NCT02136134|3551181|B1|Turkey||Region of Enrollment||participants|Number|14|14.0||||||
3711963|NCT02136134|3551179|B3|Sweden||Region of Enrollment||participants|Number|19|19.0||||||
3711964|NCT02136134|3551180|B2|Sweden||Region of Enrollment||participants|Number|10|10.0||||||
3711965|NCT02136134|3551181|B1|Sweden||Region of Enrollment||participants|Number|9|9.0||||||
3711966|NCT02136134|3551179|B3|Spain||Region of Enrollment||participants|Number|29|29.0||||||
3711967|NCT02136134|3551180|B2|Spain||Region of Enrollment||participants|Number|10|10.0||||||
3711968|NCT02136134|3551181|B1|Spain||Region of Enrollment||participants|Number|19|19.0||||||
3711969|NCT02136134|3551179|B3|Russian Federation||Region of Enrollment||participants|Number|34|34.0||||||
3711970|NCT02136134|3551180|B2|Russian Federation||Region of Enrollment||participants|Number|21|21.0||||||
3711971|NCT02136134|3551181|B1|Russian Federation||Region of Enrollment||participants|Number|13|13.0||||||
3711972|NCT02136134|3551179|B3|Poland||Region of Enrollment||participants|Number|34|34.0||||||
3711973|NCT02136134|3551180|B2|Poland||Region of Enrollment||participants|Number|16|16.0||||||
3711974|NCT02136134|3551181|B1|Poland||Region of Enrollment||participants|Number|18|18.0||||||
3711975|NCT02136134|3551179|B3|Netherlands||Region of Enrollment||participants|Number|25|25.0||||||
3711976|NCT02136134|3551180|B2|Netherlands||Region of Enrollment||participants|Number|11|11.0||||||
3711977|NCT02136134|3551181|B1|Netherlands||Region of Enrollment||participants|Number|14|14.0||||||
3711978|NCT02136134|3551179|B3|Mexico||Region of Enrollment||participants|Number|3|3.0||||||
3711979|NCT02136134|3551180|B2|Mexico||Region of Enrollment||participants|Number|2|2.0||||||
3711980|NCT02136134|3551181|B1|Mexico||Region of Enrollment||participants|Number|1|1.0||||||
3711981|NCT02136134|3551179|B3|Korea, Republic of||Region of Enrollment||participants|Number|18|18.0||||||
3711982|NCT02136134|3551180|B2|Korea, Republic of||Region of Enrollment||participants|Number|10|10.0||||||
3711983|NCT02136134|3551181|B1|Korea, Republic of||Region of Enrollment||participants|Number|8|8.0||||||
3711984|NCT02136134|3551179|B3|Italy||Region of Enrollment||participants|Number|49|49.0||||||
3711985|NCT02136134|3551180|B2|Italy||Region of Enrollment||participants|Number|24|24.0||||||
3711986|NCT02136134|3551181|B1|Italy||Region of Enrollment||participants|Number|25|25.0||||||
3711987|NCT02136134|3551179|B3|Hungary||Region of Enrollment||participants|Number|30|30.0||||||
3711988|NCT02136134|3551180|B2|Hungary||Region of Enrollment||participants|Number|16|16.0||||||
3711989|NCT02136134|3551181|B1|Hungary||Region of Enrollment||participants|Number|14|14.0||||||
3711990|NCT02136134|3551179|B3|Germany||Region of Enrollment||participants|Number|42|42.0||||||
3711991|NCT02136134|3551180|B2|Germany||Region of Enrollment||participants|Number|21|21.0||||||
3711992|NCT02136134|3551181|B1|Germany||Region of Enrollment||participants|Number|21|21.0||||||
3711993|NCT02136134|3551179|B3|Czech Republic||Region of Enrollment||participants|Number|35|35.0||||||
3711994|NCT02136134|3551180|B2|Czech Republic||Region of Enrollment||participants|Number|16|16.0||||||
3711995|NCT02136134|3551181|B1|Czech Republic||Region of Enrollment||participants|Number|19|19.0||||||
3711996|NCT02136134|3551179|B3|Brazil||Region of Enrollment||participants|Number|22|22.0||||||
3711997|NCT02136134|3551180|B2|Brazil||Region of Enrollment||participants|Number|13|13.0||||||
3711998|NCT02136134|3551181|B1|Brazil||Region of Enrollment||participants|Number|9|9.0||||||
3711999|NCT02136134|3551179|B3|Australia||Region of Enrollment||participants|Number|43|43.0||||||
3712000|NCT02136134|3551180|B2|Australia||Region of Enrollment||participants|Number|23|23.0||||||
3712001|NCT02136134|3551181|B1|Australia||Region of Enrollment||participants|Number|20|20.0||||||
3712002|NCT02136134|3551179|B3||Male|Sex: Female, Male||Participants|Count of Participants|284|284.0||||||
3712003|NCT02136134|3551180|B2||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3712004|NCT02136134|3551181|B1||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3712005|NCT02136134|3551179|B3||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
3712006|NCT02136134|3551180|B2||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3712007|NCT02136134|3551181|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3712008|NCT02136134|3551179|B3|||Age||years|Mean|63.3|63.3|Standard Deviation|9.74|9.74|||
3712009|NCT02136134|3551180|B2|||Age||years|Mean|62.8|62.8|Standard Deviation|9.66|9.66|||
3712010|NCT02136134|3551181|B1|||Age||years|Mean|63.9|63.9|Standard Deviation|9.81|9.81|||
3712011|NCT02136004|3551198|B3||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3712012|NCT02136004|3551199|B2||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3712013|NCT02136004|3551200|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3712014|NCT02136004|3551198|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3712015|NCT02136004|3551199|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3712016|NCT02136004|3551200|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3712017|NCT02136004|3551198|B3|||Age||years|Mean|63.9|63.9|Standard Deviation|9.5|9.5|||
3712018|NCT02136004|3551199|B2|||Age||years|Mean|64.7|64.7|Standard Deviation|8.7|8.7|||
3712019|NCT02136004|3551200|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|10.3|10.3|||
3712020|NCT02135900|3551211|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
3712021|NCT02135900|3551211|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3712022|NCT02135900|3551211|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3712023|NCT02135900|3551211|B1|||Age||years|Mean|52|52.0|Standard Deviation|7|7.0|||
3712024|NCT02135900|3551211|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3712025|NCT02135900|3551211|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3712026|NCT02135900|3551211|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3712027|NCT02135848|3551218|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712028|NCT02135848|3551219|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712029|NCT02135848|3551220|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712030|NCT02135848|3551218|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712031|NCT02135848|3551219|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712032|NCT02135848|3551220|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712033|NCT02135848|3551218|B3||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3712034|NCT02135848|3551219|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3712035|NCT02135848|3551220|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3712036|NCT02135848|3551218|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3712037|NCT02135848|3551219|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3712038|NCT02135848|3551220|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3712039|NCT02135848|3551218|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712040|NCT02135848|3551219|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712041|NCT02135848|3551220|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712042|NCT02135848|3551218|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3712043|NCT02135848|3551219|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3712044|NCT02135848|3551220|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712045|NCT02135848|3551218|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712046|NCT02135848|3551219|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712047|NCT02135848|3551220|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712048|NCT02135848|3551218|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3712049|NCT02135848|3551219|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3712050|NCT02135848|3551220|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3712051|NCT02135848|3551218|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3712052|NCT02135848|3551219|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3712053|NCT02135848|3551220|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3712054|NCT02135848|3551218|B3|||Age||Years|Mean|68.8|68.8|Standard Deviation|8.66|8.66|||
3712055|NCT02135848|3551219|B2|||Age||Years|Mean|69.4|69.4|Standard Deviation|7.65|7.65|||
3712056|NCT02135848|3551220|B1|||Age||Years|Mean|68.4|68.4|Standard Deviation|9.50|9.5|||
3712057|NCT02135692|3551279|B1|Race/ Ethnicity|White-White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|277|277.0||||||
3712058|NCT02135692|3551279|B1|Race/ Ethnicity|White-Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3712059|NCT02135692|3551279|B1|Race/ Ethnicity|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3712060|NCT02135692|3551279|B1|Race/ Ethnicity|Asian-South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3712061|NCT02135692|3551279|B1|Race/ Ethnicity|Asian-Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3712062|NCT02135692|3551279|B1|Race/ Ethnicity|Asian-East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3712063|NCT02135692|3551279|B1|Race/ Ethnicity|Asian-Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3712064|NCT02135692|3551279|B1||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3712065|NCT02135692|3551279|B1||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
3712066|NCT02135692|3551279|B1|||Age||Years|Mean|52.9|52.9|Standard Deviation|13.08|13.08|||
3712067|NCT02135614|3551296|B3|||Duration of Hospitalization Prior to First Dose|Duration of hospitalization prior to the first dose date of study drug was calculated as (the first dose date - the admission date of hospitalization).|days|Mean|3.0|3.0|Standard Deviation|5.52|5.52|||
3712068|NCT02135614|3551297|B2|||Duration of Hospitalization Prior to First Dose|Duration of hospitalization prior to the first dose date of study drug was calculated as (the first dose date - the admission date of hospitalization).|days|Mean|3.2|3.2|Standard Deviation|7.13|7.13|||
3712069|NCT02135614|3551298|B1|||Duration of Hospitalization Prior to First Dose|Duration of hospitalization prior to the first dose date of study drug was calculated as (the first dose date - the admission date of hospitalization).|days|Mean|2.9|2.9|Standard Deviation|3.14|3.14|||
3712070|NCT02135614|3551296|B3|||Flu-PRO score|Flu-PRO Score was calculated as the mean of 38 individual scores. Individual scores ranged from 0 (no symptoms) to 4 (worst symptoms).|units on a scale|Mean|1.07|1.07|Standard Deviation|0.559|0.559|||
3712071|NCT02135614|3551297|B2|||Flu-PRO score|Flu-PRO Score was calculated as the mean of 38 individual scores. Individual scores ranged from 0 (no symptoms) to 4 (worst symptoms).|units on a scale|Mean|1.04|1.04|Standard Deviation|0.566|0.566|||
3712072|NCT02135614|3551298|B1|||Flu-PRO score|Flu-PRO Score was calculated as the mean of 38 individual scores. Individual scores ranged from 0 (no symptoms) to 4 (worst symptoms).|units on a scale|Mean|1.11|1.11|Standard Deviation|0.553|0.553|||
3712073|NCT02135614|3551296|B3|||Nasal Viral Load||log10 copies/mL|Mean|5.32|5.32|Standard Deviation|2.337|2.337|||
3712074|NCT02135614|3551297|B2|||Nasal Viral Load||log10 copies/mL|Mean|5.07|5.07|Standard Deviation|2.528|2.528|||
3712075|NCT02135614|3551298|B1|||Nasal Viral Load||log10 copies/mL|Mean|5.58|5.58|Standard Deviation|2.104|2.104|||
3712076|NCT02135614|3551296|B3||Other Chronic Airways or Lung Disease|Stratification Factor: Disease Status||Participants|Count of Participants|23|23.0||||||
3712077|NCT02135614|3551297|B2||Other Chronic Airways or Lung Disease|Stratification Factor: Disease Status||Participants|Count of Participants|11|11.0||||||
3712078|NCT02135614|3551298|B1||Other Chronic Airways or Lung Disease|Stratification Factor: Disease Status||Participants|Count of Participants|12|12.0||||||
3712079|NCT02135614|3551296|B3||No Chronic Airways or Lung Disease|Stratification Factor: Disease Status||Participants|Count of Participants|62|62.0||||||
3712080|NCT02135614|3551297|B2||No Chronic Airways or Lung Disease|Stratification Factor: Disease Status||Participants|Count of Participants|31|31.0||||||
3712081|NCT02135614|3551298|B1||No Chronic Airways or Lung Disease|Stratification Factor: Disease Status||Participants|Count of Participants|31|31.0||||||
3712082|NCT02135614|3551296|B3||Chronic Obstructive Pulmonary Disease|Stratification Factor: Disease Status||Participants|Count of Participants|57|57.0||||||
3712083|NCT02135614|3551297|B2||Chronic Obstructive Pulmonary Disease|Stratification Factor: Disease Status||Participants|Count of Participants|30|30.0||||||
3712084|NCT02135614|3551298|B1||Chronic Obstructive Pulmonary Disease|Stratification Factor: Disease Status||Participants|Count of Participants|27|27.0||||||
3712085|NCT02135614|3551296|B3||Asthma|Stratification Factor: Disease Status||Participants|Count of Participants|44|44.0||||||
3712086|NCT02135614|3551297|B2||Asthma|Stratification Factor: Disease Status||Participants|Count of Participants|22|22.0||||||
3712087|NCT02135614|3551298|B1||Asthma|Stratification Factor: Disease Status||Participants|Count of Participants|22|22.0||||||
3712088|NCT02135614|3551296|B3|France||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3712089|NCT02135614|3551297|B2|France||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3712090|NCT02135614|3551298|B1|France||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3712091|NCT02135614|3551296|B3|Australia||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3712092|NCT02135614|3551297|B2|Australia||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3712093|NCT02135614|3551298|B1|Australia||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3712094|NCT02135614|3551296|B3|Israel||Region of Enrollment||Participants|Count of Participants|58|58.0||||||
3712095|NCT02135614|3551297|B2|Israel||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3712096|NCT02135614|3551298|B1|Israel||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3712097|NCT02135614|3551296|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3712098|NCT02135614|3551297|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3712099|NCT02135614|3551298|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3712100|NCT02135614|3551296|B3|Italy||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3712101|NCT02135614|3551297|B2|Italy||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3712102|NCT02135614|3551298|B1|Italy||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3712103|NCT02135614|3551296|B3|Poland||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3712104|NCT02135614|3551297|B2|Poland||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3712105|NCT02135614|3551298|B1|Poland||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3712106|NCT02135614|3551296|B3|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3712107|NCT02135614|3551297|B2|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3712108|NCT02135614|3551298|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3712109|NCT02135614|3551296|B3|Belgium||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3712110|NCT02135614|3551297|B2|Belgium||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3712111|NCT02135614|3551298|B1|Belgium||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3712112|NCT02135614|3551296|B3|South Korea||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3712113|NCT02135614|3551297|B2|South Korea||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3712114|NCT02135614|3551298|B1|South Korea||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3712115|NCT02135614|3551296|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3712116|NCT02135614|3551297|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3712117|NCT02135614|3551298|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3712118|NCT02135614|3551296|B3|New Zealand||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3712119|NCT02135614|3551297|B2|New Zealand||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3712120|NCT02135614|3551298|B1|New Zealand||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3712121|NCT02135614|3551296|B3||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3712122|NCT02135614|3551297|B2||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3712123|NCT02135614|3551298|B1||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3712124|NCT02135614|3551296|B3||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|176|176.0||||||
3712125|NCT02135614|3551297|B2||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|91|91.0||||||
3712126|NCT02135614|3551298|B1||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|85|85.0||||||
3712127|NCT02135614|3551296|B3||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3712128|NCT02135614|3551297|B2||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3712129|NCT02135614|3551298|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3712130|NCT02135614|3551296|B3||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3712131|NCT02135614|3551297|B2||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3712132|NCT02135614|3551298|B1||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3712133|NCT02135614|3551296|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3712134|NCT02135614|3551297|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3712135|NCT02135614|3551298|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3712136|NCT02135614|3551296|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|141|141.0||||||
3712137|NCT02135614|3551297|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|69|69.0||||||
3712138|NCT02135614|3551298|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|72|72.0||||||
3712139|NCT02135614|3551296|B3||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3712140|NCT02135614|3551297|B2||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3712141|NCT02135614|3551298|B1||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3712142|NCT02135614|3551296|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3712143|NCT02135614|3551297|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3712144|NCT02135614|3551298|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3712145|NCT02135614|3551296|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3712146|NCT02135614|3551297|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3712330|NCT02135445|3551313|B1|65 to 84 years||Age, Customized||participants|Number|55|55.0||||||
3712147|NCT02135614|3551298|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3712148|NCT02135614|3551296|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3712149|NCT02135614|3551297|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3712150|NCT02135614|3551298|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3712151|NCT02135614|3551296|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3712152|NCT02135614|3551297|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3712153|NCT02135614|3551298|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3712154|NCT02135614|3551296|B3||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3712155|NCT02135614|3551297|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3712156|NCT02135614|3551298|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3712157|NCT02135614|3551296|B3|||Age||years|Mean|67.6|67.6|Standard Deviation|14.13|14.13|||
3712158|NCT02135614|3551297|B2|||Age||years|Mean|65.9|65.9|Standard Deviation|13.87|13.87|||
3712159|NCT02135614|3551298|B1|||Age||years|Mean|69.4|69.4|Standard Deviation|14.24|14.24|||
3712160|NCT02135445|3551311|B3|Not available||Study entry: M|TNM: Distant metastasis stages included, M0: No distant metastasis.|participants|Number|24|24.0||||||
3712161|NCT02135445|3551312|B2|Not available||Study entry: M|TNM: Distant metastasis stages included, M0: No distant metastasis.|participants|Number|10|10.0||||||
3712162|NCT02135445|3551313|B1|Not available||Study entry: M|TNM: Distant metastasis stages included, M0: No distant metastasis.|participants|Number|14|14.0||||||
3712163|NCT02135445|3551311|B3|M0||Study entry: M|TNM: Distant metastasis stages included, M0: No distant metastasis.|participants|Number|79|79.0||||||
3712164|NCT02135445|3551312|B2|M0||Study entry: M|TNM: Distant metastasis stages included, M0: No distant metastasis.|participants|Number|28|28.0||||||
3712165|NCT02135445|3551313|B1|M0||Study entry: M|TNM: Distant metastasis stages included, M0: No distant metastasis.|participants|Number|51|51.0||||||
3712166|NCT02135445|3551311|B3|Not available||Study entry: N|TNM: Regional lymph nodes staging included NX: Regional lymph nodes were not assessed, and N0: No regional lymph node metastasis.|participants|Number|22|22.0||||||
3712167|NCT02135445|3551312|B2|Not available||Study entry: N|TNM: Regional lymph nodes staging included NX: Regional lymph nodes were not assessed, and N0: No regional lymph node metastasis.|participants|Number|9|9.0||||||
3712168|NCT02135445|3551313|B1|Not available||Study entry: N|TNM: Regional lymph nodes staging included NX: Regional lymph nodes were not assessed, and N0: No regional lymph node metastasis.|participants|Number|13|13.0||||||
3712169|NCT02135445|3551311|B3|NX||Study entry: N|TNM: Regional lymph nodes staging included NX: Regional lymph nodes were not assessed, and N0: No regional lymph node metastasis.|participants|Number|23|23.0||||||
3712170|NCT02135445|3551312|B2|NX||Study entry: N|TNM: Regional lymph nodes staging included NX: Regional lymph nodes were not assessed, and N0: No regional lymph node metastasis.|participants|Number|10|10.0||||||
3712171|NCT02135445|3551313|B1|NX||Study entry: N|TNM: Regional lymph nodes staging included NX: Regional lymph nodes were not assessed, and N0: No regional lymph node metastasis.|participants|Number|13|13.0||||||
3712172|NCT02135445|3551311|B3|N0||Study entry: N|TNM: Regional lymph nodes staging included NX: Regional lymph nodes were not assessed, and N0: No regional lymph node metastasis.|participants|Number|58|58.0||||||
3712173|NCT02135445|3551312|B2|N0||Study entry: N|TNM: Regional lymph nodes staging included NX: Regional lymph nodes were not assessed, and N0: No regional lymph node metastasis.|participants|Number|19|19.0||||||
3712174|NCT02135445|3551313|B1|N0||Study entry: N|TNM: Regional lymph nodes staging included NX: Regional lymph nodes were not assessed, and N0: No regional lymph node metastasis.|participants|Number|39|39.0||||||
3712175|NCT02135445|3551311|B3|Not available||Diagnosis of Primary Tumor at Study entry|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|19|19.0||||||
3712176|NCT02135445|3551312|B2|Not available||Diagnosis of Primary Tumor at Study entry|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|8|8.0||||||
3712177|NCT02135445|3551313|B1|Not available||Diagnosis of Primary Tumor at Study entry|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|11|11.0||||||
3712178|NCT02135445|3551311|B3|TX||Diagnosis of Primary Tumor at Study entry|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|1|1.0||||||
3712179|NCT02135445|3551312|B2|TX||Diagnosis of Primary Tumor at Study entry|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|1|1.0||||||
3712180|NCT02135445|3551313|B1|TX||Diagnosis of Primary Tumor at Study entry|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|0|0.0||||||
3712181|NCT02135445|3551311|B3|T3a||Diagnosis of Primary Tumor at Study entry|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|1|1.0||||||
3712182|NCT02135445|3551312|B2|T3a||Diagnosis of Primary Tumor at Study entry|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|0|0.0||||||
3712183|NCT02135445|3551313|B1|T3a||Diagnosis of Primary Tumor at Study entry|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|1|1.0||||||
3712184|NCT02135445|3551311|B3|T3||Diagnosis of Primary Tumor at Study entry|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|1|1.0||||||
3712185|NCT02135445|3551312|B2|T3||Diagnosis of Primary Tumor at Study entry|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|1|1.0||||||
3712186|NCT02135445|3551313|B1|T3||Diagnosis of Primary Tumor at Study entry|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|0|0.0||||||
3712187|NCT02135445|3551311|B3|T2c||Diagnosis of Primary Tumor at Study entry|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|14|14.0||||||
3712188|NCT02135445|3551312|B2|T2c||Diagnosis of Primary Tumor at Study entry|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|7|7.0||||||
3712189|NCT02135445|3551313|B1|T2c||Diagnosis of Primary Tumor at Study entry|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|7|7.0||||||
3712331|NCT02135445|3551311|B3|18 to 64 years||Age, Customized||participants|Number|16|16.0||||||
3712190|NCT02135445|3551311|B3|T2b||Diagnosis of Primary Tumor at Study entry|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|8|8.0||||||
3712191|NCT02135445|3551312|B2|T2b||Diagnosis of Primary Tumor at Study entry|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|1|1.0||||||
3712192|NCT02135445|3551313|B1|T2b||Diagnosis of Primary Tumor at Study entry|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|7|7.0||||||
3712193|NCT02135445|3551311|B3|T2a||Diagnosis of Primary Tumor at Study entry|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|15|15.0||||||
3712194|NCT02135445|3551312|B2|T2a||Diagnosis of Primary Tumor at Study entry|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|3|3.0||||||
3712195|NCT02135445|3551313|B1|T2a||Diagnosis of Primary Tumor at Study entry|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|12|12.0||||||
3712196|NCT02135445|3551311|B3|T2||Diagnosis of Primary Tumor at Study entry|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|11|11.0||||||
3712197|NCT02135445|3551312|B2|T2||Diagnosis of Primary Tumor at Study entry|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|5|5.0||||||
3712198|NCT02135445|3551313|B1|T2||Diagnosis of Primary Tumor at Study entry|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|6|6.0||||||
3712199|NCT02135445|3551311|B3|T1c||Diagnosis of Primary Tumor at Study entry|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|30|30.0||||||
3712200|NCT02135445|3551312|B2|T1c||Diagnosis of Primary Tumor at Study entry|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|10|10.0||||||
3712332|NCT02135445|3551312|B2|18 to 64 years||Age, Customized||participants|Number|7|7.0||||||
3712201|NCT02135445|3551313|B1|T1c||Diagnosis of Primary Tumor at Study entry|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|20|20.0||||||
3712202|NCT02135445|3551311|B3|T1a||Diagnosis of Primary Tumor at Study entry|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|1|1.0||||||
3712203|NCT02135445|3551312|B2|T1a||Diagnosis of Primary Tumor at Study entry|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|1|1.0||||||
3712204|NCT02135445|3551313|B1|T1a||Diagnosis of Primary Tumor at Study entry|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|0|0.0||||||
3712205|NCT02135445|3551311|B3|T1||Diagnosis of Primary Tumor at Study entry|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|2|2.0||||||
3712206|NCT02135445|3551312|B2|T1||Diagnosis of Primary Tumor at Study entry|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|1|1.0||||||
3712207|NCT02135445|3551313|B1|T1||Diagnosis of Primary Tumor at Study entry|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|1|1.0||||||
3712208|NCT02135445|3551311|B3|Not available||Initial diagnosis: Distant Metastasis (M)|TNM: Distant metastasis stages included, M0: No distant metastasis.|participants|Number|13|13.0||||||
3712209|NCT02135445|3551312|B2|Not available||Initial diagnosis: Distant Metastasis (M)|TNM: Distant metastasis stages included, M0: No distant metastasis.|participants|Number|4|4.0||||||
3712210|NCT02135445|3551313|B1|Not available||Initial diagnosis: Distant Metastasis (M)|TNM: Distant metastasis stages included, M0: No distant metastasis.|participants|Number|9|9.0||||||
3712211|NCT02135445|3551311|B3|M0||Initial diagnosis: Distant Metastasis (M)|TNM: Distant metastasis stages included, M0: No distant metastasis.|participants|Number|90|90.0||||||
3712212|NCT02135445|3551312|B2|M0||Initial diagnosis: Distant Metastasis (M)|TNM: Distant metastasis stages included, M0: No distant metastasis.|participants|Number|34|34.0||||||
3712213|NCT02135445|3551313|B1|M0||Initial diagnosis: Distant Metastasis (M)|TNM: Distant metastasis stages included, M0: No distant metastasis.|participants|Number|56|56.0||||||
3712214|NCT02135445|3551311|B3|Not available||Initial diagnosis: Regional Lymph Nodes (N)|TNM: Regional lymph nodes (N) staging included NX: Regional lymph nodes were not assessed, and N0: No regional lymph node metastasis.|participants|Number|10|10.0||||||
3712215|NCT02135445|3551312|B2|Not available||Initial diagnosis: Regional Lymph Nodes (N)|TNM: Regional lymph nodes (N) staging included NX: Regional lymph nodes were not assessed, and N0: No regional lymph node metastasis.|participants|Number|2|2.0||||||
3712216|NCT02135445|3551313|B1|Not available||Initial diagnosis: Regional Lymph Nodes (N)|TNM: Regional lymph nodes (N) staging included NX: Regional lymph nodes were not assessed, and N0: No regional lymph node metastasis.|participants|Number|8|8.0||||||
3712217|NCT02135445|3551311|B3|NX||Initial diagnosis: Regional Lymph Nodes (N)|TNM: Regional lymph nodes (N) staging included NX: Regional lymph nodes were not assessed, and N0: No regional lymph node metastasis.|participants|Number|34|34.0||||||
3712218|NCT02135445|3551312|B2|NX||Initial diagnosis: Regional Lymph Nodes (N)|TNM: Regional lymph nodes (N) staging included NX: Regional lymph nodes were not assessed, and N0: No regional lymph node metastasis.|participants|Number|18|18.0||||||
3712219|NCT02135445|3551313|B1|NX||Initial diagnosis: Regional Lymph Nodes (N)|TNM: Regional lymph nodes (N) staging included NX: Regional lymph nodes were not assessed, and N0: No regional lymph node metastasis.|participants|Number|16|16.0||||||
3712220|NCT02135445|3551311|B3|N0||Initial diagnosis: Regional Lymph Nodes (N)|TNM: Regional lymph nodes (N) staging included NX: Regional lymph nodes were not assessed, and N0: No regional lymph node metastasis.|participants|Number|59|59.0||||||
3712221|NCT02135445|3551312|B2|N0||Initial diagnosis: Regional Lymph Nodes (N)|TNM: Regional lymph nodes (N) staging included NX: Regional lymph nodes were not assessed, and N0: No regional lymph node metastasis.|participants|Number|18|18.0||||||
3712222|NCT02135445|3551313|B1|N0||Initial diagnosis: Regional Lymph Nodes (N)|TNM: Regional lymph nodes (N) staging included NX: Regional lymph nodes were not assessed, and N0: No regional lymph node metastasis.|participants|Number|41|41.0||||||
3712223|NCT02135445|3551311|B3|Not available||Initial diagnosis of Primary Tumor (T)|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|8|8.0||||||
3712224|NCT02135445|3551312|B2|Not available||Initial diagnosis of Primary Tumor (T)|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|1|1.0||||||
3712225|NCT02135445|3551313|B1|Not available||Initial diagnosis of Primary Tumor (T)|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|7|7.0||||||
3712226|NCT02135445|3551311|B3|T3||Initial diagnosis of Primary Tumor (T)|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|2|2.0||||||
3712227|NCT02135445|3551312|B2|T3||Initial diagnosis of Primary Tumor (T)|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|2|2.0||||||
3712228|NCT02135445|3551313|B1|T3||Initial diagnosis of Primary Tumor (T)|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|0|0.0||||||
3712229|NCT02135445|3551311|B3|T2c||Initial diagnosis of Primary Tumor (T)|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|15|15.0||||||
3712230|NCT02135445|3551312|B2|T2c||Initial diagnosis of Primary Tumor (T)|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|7|7.0||||||
3712231|NCT02135445|3551313|B1|T2c||Initial diagnosis of Primary Tumor (T)|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|8|8.0||||||
3712232|NCT02135445|3551311|B3|T2b||Initial diagnosis of Primary Tumor (T)|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|9|9.0||||||
3712233|NCT02135445|3551312|B2|T2b||Initial diagnosis of Primary Tumor (T)|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|2|2.0||||||
3712234|NCT02135445|3551313|B1|T2b||Initial diagnosis of Primary Tumor (T)|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|7|7.0||||||
3712235|NCT02135445|3551311|B3|T2a||Initial diagnosis of Primary Tumor (T)|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|15|15.0||||||
3712236|NCT02135445|3551312|B2|T2a||Initial diagnosis of Primary Tumor (T)|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|2|2.0||||||
3712237|NCT02135445|3551313|B1|T2a||Initial diagnosis of Primary Tumor (T)|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|13|13.0||||||
3712238|NCT02135445|3551311|B3|T2||Initial diagnosis of Primary Tumor (T)|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|8|8.0||||||
3712239|NCT02135445|3551312|B2|T2||Initial diagnosis of Primary Tumor (T)|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|4|4.0||||||
3712240|NCT02135445|3551313|B1|T2||Initial diagnosis of Primary Tumor (T)|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|4|4.0||||||
3712241|NCT02135445|3551311|B3|T1c||Initial diagnosis of Primary Tumor (T)|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|40|40.0||||||
3712242|NCT02135445|3551312|B2|T1c||Initial diagnosis of Primary Tumor (T)|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|16|16.0||||||
3712243|NCT02135445|3551313|B1|T1c||Initial diagnosis of Primary Tumor (T)|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|24|24.0||||||
3712333|NCT02135445|3551313|B1|18 to 64 years||Age, Customized||participants|Number|9|9.0||||||
3712244|NCT02135445|3551311|B3|T1a||Initial diagnosis of Primary Tumor (T)|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|1|1.0||||||
3712245|NCT02135445|3551312|B2|T1a||Initial diagnosis of Primary Tumor (T)|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|1|1.0||||||
3712246|NCT02135445|3551313|B1|T1a||Initial diagnosis of Primary Tumor (T)|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|0|0.0||||||
3712247|NCT02135445|3551311|B3|T1||Initial diagnosis of Primary Tumor (T)|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|5|5.0||||||
3712248|NCT02135445|3551312|B2|T1||Initial diagnosis of Primary Tumor (T)|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|3|3.0||||||
3712249|NCT02135445|3551313|B1|T1||Initial diagnosis of Primary Tumor (T)|TNM Stages: T1: unapparent neither palpable nor visible by imaging, T1a: histologic finding in 5% or less of tissue resected, T1b: histological finding in >5% of tissue resected, T1c: identified by needle biopsy, T2: confined within prostate, T2a: one-half of one lobe or less, T2b: involves more than one-half of one lobe but not both lobes, T2c: involves both lobes, T3: extends through prostate capsule, T3a: Extracapsular extension Including microscopic bladder neck involvement, T3b: invades seminal vesicles, T4: fixed or invades adjacent structures other than seminal vesicles|participants|Number|2|2.0||||||
3712250|NCT02135445|3551311|B3|Total Gleason score missing||Total Gleason Score|Gleason score is a histological score that, together with other clinical factors may be used to predict the potential aggressiveness of the cancer and thus its risk of eventually spreading. Gleason scores range from 2-10, where 2-4: lower risk; 5-6: moderate risk; 8-10: higher risk with lower score representing most well-differentiated tumors and higher score representing least-differentiated tumors. Primary grading in Gleason score is assigned to dominant pattern of tumor which has to be >50% of total pattern seen.|participants|Number|18|18.0||||||
3712251|NCT02135445|3551312|B2|Total Gleason score missing||Total Gleason Score|Gleason score is a histological score that, together with other clinical factors may be used to predict the potential aggressiveness of the cancer and thus its risk of eventually spreading. Gleason scores range from 2-10, where 2-4: lower risk; 5-6: moderate risk; 8-10: higher risk with lower score representing most well-differentiated tumors and higher score representing least-differentiated tumors. Primary grading in Gleason score is assigned to dominant pattern of tumor which has to be >50% of total pattern seen.|participants|Number|5|5.0||||||
3712252|NCT02135445|3551313|B1|Total Gleason score missing||Total Gleason Score|Gleason score is a histological score that, together with other clinical factors may be used to predict the potential aggressiveness of the cancer and thus its risk of eventually spreading. Gleason scores range from 2-10, where 2-4: lower risk; 5-6: moderate risk; 8-10: higher risk with lower score representing most well-differentiated tumors and higher score representing least-differentiated tumors. Primary grading in Gleason score is assigned to dominant pattern of tumor which has to be >50% of total pattern seen.|participants|Number|13|13.0||||||
3712253|NCT02135445|3551311|B3|Total Gleason score 9||Total Gleason Score|Gleason score is a histological score that, together with other clinical factors may be used to predict the potential aggressiveness of the cancer and thus its risk of eventually spreading. Gleason scores range from 2-10, where 2-4: lower risk; 5-6: moderate risk; 8-10: higher risk with lower score representing most well-differentiated tumors and higher score representing least-differentiated tumors. Primary grading in Gleason score is assigned to dominant pattern of tumor which has to be >50% of total pattern seen.|participants|Number|4|4.0||||||
3712254|NCT02135445|3551312|B2|Total Gleason score 9||Total Gleason Score|Gleason score is a histological score that, together with other clinical factors may be used to predict the potential aggressiveness of the cancer and thus its risk of eventually spreading. Gleason scores range from 2-10, where 2-4: lower risk; 5-6: moderate risk; 8-10: higher risk with lower score representing most well-differentiated tumors and higher score representing least-differentiated tumors. Primary grading in Gleason score is assigned to dominant pattern of tumor which has to be >50% of total pattern seen.|participants|Number|2|2.0||||||
3712334|NCT02135432|3551363|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3712335|NCT02135432|3551364|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3712336|NCT02135432|3551365|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3712255|NCT02135445|3551313|B1|Total Gleason score 9||Total Gleason Score|Gleason score is a histological score that, together with other clinical factors may be used to predict the potential aggressiveness of the cancer and thus its risk of eventually spreading. Gleason scores range from 2-10, where 2-4: lower risk; 5-6: moderate risk; 8-10: higher risk with lower score representing most well-differentiated tumors and higher score representing least-differentiated tumors. Primary grading in Gleason score is assigned to dominant pattern of tumor which has to be >50% of total pattern seen.|participants|Number|2|2.0||||||
3712256|NCT02135445|3551311|B3|Total Gleason score 8||Total Gleason Score|Gleason score is a histological score that, together with other clinical factors may be used to predict the potential aggressiveness of the cancer and thus its risk of eventually spreading. Gleason scores range from 2-10, where 2-4: lower risk; 5-6: moderate risk; 8-10: higher risk with lower score representing most well-differentiated tumors and higher score representing least-differentiated tumors. Primary grading in Gleason score is assigned to dominant pattern of tumor which has to be >50% of total pattern seen.|participants|Number|8|8.0||||||
3712257|NCT02135445|3551312|B2|Total Gleason score 8||Total Gleason Score|Gleason score is a histological score that, together with other clinical factors may be used to predict the potential aggressiveness of the cancer and thus its risk of eventually spreading. Gleason scores range from 2-10, where 2-4: lower risk; 5-6: moderate risk; 8-10: higher risk with lower score representing most well-differentiated tumors and higher score representing least-differentiated tumors. Primary grading in Gleason score is assigned to dominant pattern of tumor which has to be >50% of total pattern seen.|participants|Number|3|3.0||||||
3712258|NCT02135445|3551313|B1|Total Gleason score 8||Total Gleason Score|Gleason score is a histological score that, together with other clinical factors may be used to predict the potential aggressiveness of the cancer and thus its risk of eventually spreading. Gleason scores range from 2-10, where 2-4: lower risk; 5-6: moderate risk; 8-10: higher risk with lower score representing most well-differentiated tumors and higher score representing least-differentiated tumors. Primary grading in Gleason score is assigned to dominant pattern of tumor which has to be >50% of total pattern seen.|participants|Number|5|5.0||||||
3712259|NCT02135445|3551311|B3|Total Gleason score 7||Total Gleason Score|Gleason score is a histological score that, together with other clinical factors may be used to predict the potential aggressiveness of the cancer and thus its risk of eventually spreading. Gleason scores range from 2-10, where 2-4: lower risk; 5-6: moderate risk; 8-10: higher risk with lower score representing most well-differentiated tumors and higher score representing least-differentiated tumors. Primary grading in Gleason score is assigned to dominant pattern of tumor which has to be >50% of total pattern seen.|participants|Number|66|66.0||||||
3712260|NCT02135445|3551312|B2|Total Gleason score 7||Total Gleason Score|Gleason score is a histological score that, together with other clinical factors may be used to predict the potential aggressiveness of the cancer and thus its risk of eventually spreading. Gleason scores range from 2-10, where 2-4: lower risk; 5-6: moderate risk; 8-10: higher risk with lower score representing most well-differentiated tumors and higher score representing least-differentiated tumors. Primary grading in Gleason score is assigned to dominant pattern of tumor which has to be >50% of total pattern seen.|participants|Number|26|26.0||||||
3712261|NCT02135445|3551313|B1|Total Gleason score 7||Total Gleason Score|Gleason score is a histological score that, together with other clinical factors may be used to predict the potential aggressiveness of the cancer and thus its risk of eventually spreading. Gleason scores range from 2-10, where 2-4: lower risk; 5-6: moderate risk; 8-10: higher risk with lower score representing most well-differentiated tumors and higher score representing least-differentiated tumors. Primary grading in Gleason score is assigned to dominant pattern of tumor which has to be >50% of total pattern seen.|participants|Number|40|40.0||||||
3712262|NCT02135445|3551311|B3|Total Gleason score 6||Total Gleason Score|Gleason score is a histological score that, together with other clinical factors may be used to predict the potential aggressiveness of the cancer and thus its risk of eventually spreading. Gleason scores range from 2-10, where 2-4: lower risk; 5-6: moderate risk; 8-10: higher risk with lower score representing most well-differentiated tumors and higher score representing least-differentiated tumors. Primary grading in Gleason score is assigned to dominant pattern of tumor which has to be >50% of total pattern seen.|participants|Number|7|7.0||||||
3712263|NCT02135445|3551312|B2|Total Gleason score 6||Total Gleason Score|Gleason score is a histological score that, together with other clinical factors may be used to predict the potential aggressiveness of the cancer and thus its risk of eventually spreading. Gleason scores range from 2-10, where 2-4: lower risk; 5-6: moderate risk; 8-10: higher risk with lower score representing most well-differentiated tumors and higher score representing least-differentiated tumors. Primary grading in Gleason score is assigned to dominant pattern of tumor which has to be >50% of total pattern seen.|participants|Number|2|2.0||||||
3712264|NCT02135445|3551313|B1|Total Gleason score 6||Total Gleason Score|Gleason score is a histological score that, together with other clinical factors may be used to predict the potential aggressiveness of the cancer and thus its risk of eventually spreading. Gleason scores range from 2-10, where 2-4: lower risk; 5-6: moderate risk; 8-10: higher risk with lower score representing most well-differentiated tumors and higher score representing least-differentiated tumors. Primary grading in Gleason score is assigned to dominant pattern of tumor which has to be >50% of total pattern seen.|participants|Number|5|5.0||||||
3712265|NCT02135445|3551311|B3|Secondary grade missing||Secondary Gleason Score|Gleason score is a histological score that, together with other clinical factors may be used to predict the potential aggressiveness of the cancer and thus its risk of eventually spreading. Gleason scores range from 2-10, where 2-4: lower risk; 5-6: moderate risk; 8-10: higher risk with lower score representing most well-differentiated tumors and higher score representing least-differentiated tumors. Primary grading in Gleason score is assigned to dominant pattern of tumor which has to be >50% of total pattern seen.|participants|Number|18|18.0||||||
3712266|NCT02135445|3551312|B2|Secondary grade missing||Secondary Gleason Score|Gleason score is a histological score that, together with other clinical factors may be used to predict the potential aggressiveness of the cancer and thus its risk of eventually spreading. Gleason scores range from 2-10, where 2-4: lower risk; 5-6: moderate risk; 8-10: higher risk with lower score representing most well-differentiated tumors and higher score representing least-differentiated tumors. Primary grading in Gleason score is assigned to dominant pattern of tumor which has to be >50% of total pattern seen.|participants|Number|5|5.0||||||
3712337|NCT02135432|3551363|B3||Male|Gender||Participants|Count of Participants|7|7.0||||||
3712267|NCT02135445|3551313|B1|Secondary grade missing||Secondary Gleason Score|Gleason score is a histological score that, together with other clinical factors may be used to predict the potential aggressiveness of the cancer and thus its risk of eventually spreading. Gleason scores range from 2-10, where 2-4: lower risk; 5-6: moderate risk; 8-10: higher risk with lower score representing most well-differentiated tumors and higher score representing least-differentiated tumors. Primary grading in Gleason score is assigned to dominant pattern of tumor which has to be >50% of total pattern seen.|participants|Number|13|13.0||||||
3712268|NCT02135445|3551311|B3|Secondary grade 5||Secondary Gleason Score|Gleason score is a histological score that, together with other clinical factors may be used to predict the potential aggressiveness of the cancer and thus its risk of eventually spreading. Gleason scores range from 2-10, where 2-4: lower risk; 5-6: moderate risk; 8-10: higher risk with lower score representing most well-differentiated tumors and higher score representing least-differentiated tumors. Primary grading in Gleason score is assigned to dominant pattern of tumor which has to be >50% of total pattern seen.|participants|Number|4|4.0||||||
3712269|NCT02135445|3551312|B2|Secondary grade 5||Secondary Gleason Score|Gleason score is a histological score that, together with other clinical factors may be used to predict the potential aggressiveness of the cancer and thus its risk of eventually spreading. Gleason scores range from 2-10, where 2-4: lower risk; 5-6: moderate risk; 8-10: higher risk with lower score representing most well-differentiated tumors and higher score representing least-differentiated tumors. Primary grading in Gleason score is assigned to dominant pattern of tumor which has to be >50% of total pattern seen.|participants|Number|2|2.0||||||
3712270|NCT02135445|3551313|B1|Secondary grade 5||Secondary Gleason Score|Gleason score is a histological score that, together with other clinical factors may be used to predict the potential aggressiveness of the cancer and thus its risk of eventually spreading. Gleason scores range from 2-10, where 2-4: lower risk; 5-6: moderate risk; 8-10: higher risk with lower score representing most well-differentiated tumors and higher score representing least-differentiated tumors. Primary grading in Gleason score is assigned to dominant pattern of tumor which has to be >50% of total pattern seen.|participants|Number|2|2.0||||||
3712271|NCT02135445|3551311|B3|Secondary grade 4||Secondary Gleason Score|Gleason score is a histological score that, together with other clinical factors may be used to predict the potential aggressiveness of the cancer and thus its risk of eventually spreading. Gleason scores range from 2-10, where 2-4: lower risk; 5-6: moderate risk; 8-10: higher risk with lower score representing most well-differentiated tumors and higher score representing least-differentiated tumors. Primary grading in Gleason score is assigned to dominant pattern of tumor which has to be >50% of total pattern seen.|participants|Number|47|47.0||||||
3712272|NCT02135445|3551312|B2|Secondary grade 4||Secondary Gleason Score|Gleason score is a histological score that, together with other clinical factors may be used to predict the potential aggressiveness of the cancer and thus its risk of eventually spreading. Gleason scores range from 2-10, where 2-4: lower risk; 5-6: moderate risk; 8-10: higher risk with lower score representing most well-differentiated tumors and higher score representing least-differentiated tumors. Primary grading in Gleason score is assigned to dominant pattern of tumor which has to be >50% of total pattern seen.|participants|Number|19|19.0||||||
3712273|NCT02135445|3551313|B1|Secondary grade 4||Secondary Gleason Score|Gleason score is a histological score that, together with other clinical factors may be used to predict the potential aggressiveness of the cancer and thus its risk of eventually spreading. Gleason scores range from 2-10, where 2-4: lower risk; 5-6: moderate risk; 8-10: higher risk with lower score representing most well-differentiated tumors and higher score representing least-differentiated tumors. Primary grading in Gleason score is assigned to dominant pattern of tumor which has to be >50% of total pattern seen.|participants|Number|28|28.0||||||
3712274|NCT02135445|3551311|B3|Secondary grade 3||Secondary Gleason Score|Gleason score is a histological score that, together with other clinical factors may be used to predict the potential aggressiveness of the cancer and thus its risk of eventually spreading. Gleason scores range from 2-10, where 2-4: lower risk; 5-6: moderate risk; 8-10: higher risk with lower score representing most well-differentiated tumors and higher score representing least-differentiated tumors. Primary grading in Gleason score is assigned to dominant pattern of tumor which has to be >50% of total pattern seen.|participants|Number|34|34.0||||||
3712275|NCT02135445|3551312|B2|Secondary grade 3||Secondary Gleason Score|Gleason score is a histological score that, together with other clinical factors may be used to predict the potential aggressiveness of the cancer and thus its risk of eventually spreading. Gleason scores range from 2-10, where 2-4: lower risk; 5-6: moderate risk; 8-10: higher risk with lower score representing most well-differentiated tumors and higher score representing least-differentiated tumors. Primary grading in Gleason score is assigned to dominant pattern of tumor which has to be >50% of total pattern seen.|participants|Number|12|12.0||||||
3712276|NCT02135445|3551313|B1|Secondary grade 3||Secondary Gleason Score|Gleason score is a histological score that, together with other clinical factors may be used to predict the potential aggressiveness of the cancer and thus its risk of eventually spreading. Gleason scores range from 2-10, where 2-4: lower risk; 5-6: moderate risk; 8-10: higher risk with lower score representing most well-differentiated tumors and higher score representing least-differentiated tumors. Primary grading in Gleason score is assigned to dominant pattern of tumor which has to be >50% of total pattern seen.|participants|Number|22|22.0||||||
3712277|NCT02135445|3551311|B3|Primary grade missing||Primary Gleason Score|Gleason score is a histological score that, together with other clinical factors may be used to predict the potential aggressiveness of the cancer and thus its risk of eventually spreading. Gleason scores range from 2-10, where 2-4: lower risk; 5-6: moderate risk; 8-10: higher risk with lower score representing most well-differentiated tumors and higher score representing least-differentiated tumors. Primary grading in Gleason score is assigned to dominant pattern of tumor which has to be >50% of total pattern seen.|participants|Number|18|18.0||||||
3712278|NCT02135445|3551312|B2|Primary grade missing||Primary Gleason Score|Gleason score is a histological score that, together with other clinical factors may be used to predict the potential aggressiveness of the cancer and thus its risk of eventually spreading. Gleason scores range from 2-10, where 2-4: lower risk; 5-6: moderate risk; 8-10: higher risk with lower score representing most well-differentiated tumors and higher score representing least-differentiated tumors. Primary grading in Gleason score is assigned to dominant pattern of tumor which has to be >50% of total pattern seen.|participants|Number|5|5.0||||||
3712338|NCT02135432|3551364|B2||Male|Gender||Participants|Count of Participants|3|3.0||||||
3712279|NCT02135445|3551313|B1|Primary grade missing||Primary Gleason Score|Gleason score is a histological score that, together with other clinical factors may be used to predict the potential aggressiveness of the cancer and thus its risk of eventually spreading. Gleason scores range from 2-10, where 2-4: lower risk; 5-6: moderate risk; 8-10: higher risk with lower score representing most well-differentiated tumors and higher score representing least-differentiated tumors. Primary grading in Gleason score is assigned to dominant pattern of tumor which has to be >50% of total pattern seen.|participants|Number|13|13.0||||||
3712280|NCT02135445|3551311|B3|Primary grade 4||Primary Gleason Score|Gleason score is a histological score that, together with other clinical factors may be used to predict the potential aggressiveness of the cancer and thus its risk of eventually spreading. Gleason scores range from 2-10, where 2-4: lower risk; 5-6: moderate risk; 8-10: higher risk with lower score representing most well-differentiated tumors and higher score representing least-differentiated tumors. Primary grading in Gleason score is assigned to dominant pattern of tumor which has to be >50% of total pattern seen.|participants|Number|39|39.0||||||
3712281|NCT02135445|3551312|B2|Primary grade 4||Primary Gleason Score|Gleason score is a histological score that, together with other clinical factors may be used to predict the potential aggressiveness of the cancer and thus its risk of eventually spreading. Gleason scores range from 2-10, where 2-4: lower risk; 5-6: moderate risk; 8-10: higher risk with lower score representing most well-differentiated tumors and higher score representing least-differentiated tumors. Primary grading in Gleason score is assigned to dominant pattern of tumor which has to be >50% of total pattern seen.|participants|Number|15|15.0||||||
3712282|NCT02135445|3551313|B1|Primary grade 4||Primary Gleason Score|Gleason score is a histological score that, together with other clinical factors may be used to predict the potential aggressiveness of the cancer and thus its risk of eventually spreading. Gleason scores range from 2-10, where 2-4: lower risk; 5-6: moderate risk; 8-10: higher risk with lower score representing most well-differentiated tumors and higher score representing least-differentiated tumors. Primary grading in Gleason score is assigned to dominant pattern of tumor which has to be >50% of total pattern seen.|participants|Number|24|24.0||||||
3712283|NCT02135445|3551311|B3|Primary grade 3||Primary Gleason Score|Gleason score is a histological score that, together with other clinical factors may be used to predict the potential aggressiveness of the cancer and thus its risk of eventually spreading. Gleason scores range from 2-10, where 2-4: lower risk; 5-6: moderate risk; 8-10: higher risk with lower score representing most well-differentiated tumors and higher score representing least-differentiated tumors. Primary grading in Gleason score is assigned to dominant pattern of tumor which has to be >50% of total pattern seen.|participants|Number|46|46.0||||||
3712284|NCT02135445|3551312|B2|Primary grade 3||Primary Gleason Score|Gleason score is a histological score that, together with other clinical factors may be used to predict the potential aggressiveness of the cancer and thus its risk of eventually spreading. Gleason scores range from 2-10, where 2-4: lower risk; 5-6: moderate risk; 8-10: higher risk with lower score representing most well-differentiated tumors and higher score representing least-differentiated tumors. Primary grading in Gleason score is assigned to dominant pattern of tumor which has to be >50% of total pattern seen.|participants|Number|18|18.0||||||
3712285|NCT02135445|3551313|B1|Primary grade 3||Primary Gleason Score|Gleason score is a histological score that, together with other clinical factors may be used to predict the potential aggressiveness of the cancer and thus its risk of eventually spreading. Gleason scores range from 2-10, where 2-4: lower risk; 5-6: moderate risk; 8-10: higher risk with lower score representing most well-differentiated tumors and higher score representing least-differentiated tumors. Primary grading in Gleason score is assigned to dominant pattern of tumor which has to be >50% of total pattern seen.|participants|Number|28|28.0||||||
3712286|NCT02135445|3551311|B3|Other||Prostate Cancer Type||participants|Number|1|1.0||||||
3712287|NCT02135445|3551312|B2|Other||Prostate Cancer Type||participants|Number|0|0.0||||||
3712288|NCT02135445|3551313|B1|Other||Prostate Cancer Type||participants|Number|1|1.0||||||
3712289|NCT02135445|3551311|B3|Adenocarcinoma, NOS||Prostate Cancer Type||participants|Number|96|96.0||||||
3712290|NCT02135445|3551312|B2|Adenocarcinoma, NOS||Prostate Cancer Type||participants|Number|37|37.0||||||
3712291|NCT02135445|3551313|B1|Adenocarcinoma, NOS||Prostate Cancer Type||participants|Number|59|59.0||||||
3712292|NCT02135445|3551311|B3|Adenocarcinoma insitu,Not otherwise specified(NOS)||Prostate Cancer Type||participants|Number|6|6.0||||||
3712293|NCT02135445|3551312|B2|Adenocarcinoma insitu,Not otherwise specified(NOS)||Prostate Cancer Type||participants|Number|1|1.0||||||
3712294|NCT02135445|3551313|B1|Adenocarcinoma insitu,Not otherwise specified(NOS)||Prostate Cancer Type||participants|Number|5|5.0||||||
3712295|NCT02135445|3551311|B3|Missing||Eastern Cooperative Oncology Group (ECOG) Performance status|ECOG assessed participants performance status on a 6-point scale: 0: Fully active, able to carry on all predisease performance without restriction; 1: Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature; 2: Ambulatory, capable of selfcare, unable to carry out any work activities, up and about greater than (>)50 percent (%) of waking hours; 3:Capable of limited selfcare,confined to bed or chair >50% of waking hours; 4: Completely disabled, not capable of any selfcare, totally confined to bed or chair; 5:Dead.|participants|Number|2|2.0||||||
3712296|NCT02135445|3551312|B2|Missing||Eastern Cooperative Oncology Group (ECOG) Performance status|ECOG assessed participants performance status on a 6-point scale: 0: Fully active, able to carry on all predisease performance without restriction; 1: Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature; 2: Ambulatory, capable of selfcare, unable to carry out any work activities, up and about greater than (>)50 percent (%) of waking hours; 3:Capable of limited selfcare,confined to bed or chair >50% of waking hours; 4: Completely disabled, not capable of any selfcare, totally confined to bed or chair; 5:Dead.|participants|Number|1|1.0||||||
3712297|NCT02135445|3551313|B1|Missing||Eastern Cooperative Oncology Group (ECOG) Performance status|ECOG assessed participants performance status on a 6-point scale: 0: Fully active, able to carry on all predisease performance without restriction; 1: Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature; 2: Ambulatory, capable of selfcare, unable to carry out any work activities, up and about greater than (>)50 percent (%) of waking hours; 3:Capable of limited selfcare,confined to bed or chair >50% of waking hours; 4: Completely disabled, not capable of any selfcare, totally confined to bed or chair; 5:Dead.|participants|Number|1|1.0||||||
3712298|NCT02135445|3551311|B3|Grade 1||Eastern Cooperative Oncology Group (ECOG) Performance status|ECOG assessed participants performance status on a 6-point scale: 0: Fully active, able to carry on all predisease performance without restriction; 1: Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature; 2: Ambulatory, capable of selfcare, unable to carry out any work activities, up and about greater than (>)50 percent (%) of waking hours; 3:Capable of limited selfcare,confined to bed or chair >50% of waking hours; 4: Completely disabled, not capable of any selfcare, totally confined to bed or chair; 5:Dead.|participants|Number|8|8.0||||||
3712299|NCT02135445|3551312|B2|Grade 1||Eastern Cooperative Oncology Group (ECOG) Performance status|ECOG assessed participants performance status on a 6-point scale: 0: Fully active, able to carry on all predisease performance without restriction; 1: Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature; 2: Ambulatory, capable of selfcare, unable to carry out any work activities, up and about greater than (>)50 percent (%) of waking hours; 3:Capable of limited selfcare,confined to bed or chair >50% of waking hours; 4: Completely disabled, not capable of any selfcare, totally confined to bed or chair; 5:Dead.|participants|Number|4|4.0||||||
3712300|NCT02135445|3551313|B1|Grade 1||Eastern Cooperative Oncology Group (ECOG) Performance status|ECOG assessed participants performance status on a 6-point scale: 0: Fully active, able to carry on all predisease performance without restriction; 1: Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature; 2: Ambulatory, capable of selfcare, unable to carry out any work activities, up and about greater than (>)50 percent (%) of waking hours; 3:Capable of limited selfcare,confined to bed or chair >50% of waking hours; 4: Completely disabled, not capable of any selfcare, totally confined to bed or chair; 5:Dead.|participants|Number|4|4.0||||||
3712301|NCT02135445|3551311|B3|Grade 0||Eastern Cooperative Oncology Group (ECOG) Performance status|ECOG assessed participants performance status on a 6-point scale: 0: Fully active, able to carry on all predisease performance without restriction; 1: Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature; 2: Ambulatory, capable of selfcare, unable to carry out any work activities, up and about greater than (>)50 percent (%) of waking hours; 3:Capable of limited selfcare,confined to bed or chair >50% of waking hours; 4: Completely disabled, not capable of any selfcare, totally confined to bed or chair; 5:Dead.|participants|Number|93|93.0||||||
3712302|NCT02135445|3551312|B2|Grade 0||Eastern Cooperative Oncology Group (ECOG) Performance status|ECOG assessed participants performance status on a 6-point scale: 0: Fully active, able to carry on all predisease performance without restriction; 1: Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature; 2: Ambulatory, capable of selfcare, unable to carry out any work activities, up and about greater than (>)50 percent (%) of waking hours; 3:Capable of limited selfcare,confined to bed or chair >50% of waking hours; 4: Completely disabled, not capable of any selfcare, totally confined to bed or chair; 5:Dead.|participants|Number|33|33.0||||||
3712303|NCT02135445|3551313|B1|Grade 0||Eastern Cooperative Oncology Group (ECOG) Performance status|ECOG assessed participants performance status on a 6-point scale: 0: Fully active, able to carry on all predisease performance without restriction; 1: Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature; 2: Ambulatory, capable of selfcare, unable to carry out any work activities, up and about greater than (>)50 percent (%) of waking hours; 3:Capable of limited selfcare,confined to bed or chair >50% of waking hours; 4: Completely disabled, not capable of any selfcare, totally confined to bed or chair; 5:Dead.|participants|Number|60|60.0||||||
3712304|NCT02135445|3551311|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3712305|NCT02135445|3551312|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3712306|NCT02135445|3551313|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3712307|NCT02135445|3551311|B3|White||Race/Ethnicity, Customized||participants|Number|89|89.0||||||
3712308|NCT02135445|3551312|B2|White||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3712309|NCT02135445|3551313|B1|White||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
3712310|NCT02135445|3551311|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3712311|NCT02135445|3551312|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712312|NCT02135445|3551313|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3712313|NCT02135445|3551311|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
3712314|NCT02135445|3551312|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3712315|NCT02135445|3551313|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3712316|NCT02135445|3551311|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3712317|NCT02135445|3551312|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3712318|NCT02135445|3551313|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3712319|NCT02135445|3551311|B3||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3712320|NCT02135445|3551312|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3712321|NCT02135445|3551313|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3712322|NCT02135445|3551311|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3712323|NCT02135445|3551312|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3712324|NCT02135445|3551313|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3712325|NCT02135445|3551311|B3|Greater than or equal to (>=) 85 years||Age, Customized||participants|Number|1|1.0||||||
3712326|NCT02135445|3551312|B2|Greater than or equal to (>=) 85 years||Age, Customized||participants|Number|0|0.0||||||
3712327|NCT02135445|3551313|B1|Greater than or equal to (>=) 85 years||Age, Customized||participants|Number|1|1.0||||||
3712328|NCT02135445|3551311|B3|65 to 84 years||Age, Customized||participants|Number|86|86.0||||||
3712329|NCT02135445|3551312|B2|65 to 84 years||Age, Customized||participants|Number|31|31.0||||||
3712339|NCT02135432|3551365|B1||Male|Gender||Participants|Count of Participants|4|4.0||||||
3712340|NCT02135432|3551363|B3||Female|Gender||Participants|Count of Participants|5|5.0||||||
3712341|NCT02135432|3551364|B2||Female|Gender||Participants|Count of Participants|1|1.0||||||
3712342|NCT02135432|3551365|B1||Female|Gender||Participants|Count of Participants|4|4.0||||||
3712343|NCT02135432|3551363|B3|>=65 years||Age, Customized||participants|Number|3|3.0||||||
3712344|NCT02135432|3551364|B2|>=65 years||Age, Customized||participants|Number|1|1.0||||||
3712345|NCT02135432|3551365|B1|>=65 years||Age, Customized||participants|Number|2|2.0||||||
3712346|NCT02135432|3551363|B3|Between 18 and 65 years||Age, Customized||participants|Number|9|9.0||||||
3712347|NCT02135432|3551364|B2|Between 18 and 65 years||Age, Customized||participants|Number|3|3.0||||||
3712348|NCT02135432|3551365|B1|Between 18 and 65 years||Age, Customized||participants|Number|6|6.0||||||
3712349|NCT02135432|3551363|B3|<=18 years||Age, Customized||participants|Number|0|0.0||||||
3712350|NCT02135432|3551364|B2|<=18 years||Age, Customized||participants|Number|0|0.0||||||
3712351|NCT02135432|3551365|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
3712352|NCT02135432|3551363|B3|||Age||years|Mean|55|55.0|Full Range|||49.0|65.0|
3712353|NCT02135432|3551364|B2|||Age||years|Mean|62|62.0|Full Range|||60.0|65.0|
3712354|NCT02135432|3551365|B1|||Age||years|Mean|55|55.0|Full Range|||49.0|65.0|
3712355|NCT02135107|3551378|B3|Female||Sex/Gender, Customized||Participants|Count of Participants|204|204.0||||||
3712356|NCT02135107|3551379|B2|Female||Sex/Gender, Customized||Participants|Count of Participants|49|49.0||||||
3712357|NCT02135107|3551380|B1|Female||Sex/Gender, Customized||Participants|Count of Participants|155|155.0||||||
3712358|NCT02135107|3551378|B3|Male||Sex/Gender, Customized||Participants|Count of Participants|313|313.0||||||
3712359|NCT02135107|3551379|B2|Male||Sex/Gender, Customized||Participants|Count of Participants|31|31.0||||||
3712360|NCT02135107|3551380|B1|Male||Sex/Gender, Customized||Participants|Count of Participants|282|282.0||||||
3712361|NCT02135107|3551378|B3|||Age||Years|Mean|64.6|64.6|Standard Deviation|13.6|13.6|||
3712362|NCT02135107|3551379|B2|||Age||Years|Mean|70.2|70.2|Standard Deviation|12.7|12.7|||
3712363|NCT02135107|3551380|B1|||Age||Years|Mean|64.0|64.0|Standard Deviation|13.1|13.1|||
3712364|NCT02135094|3551409|B3|||Weight||kg|Mean|74.4|74.4|Standard Deviation|15.0|15.0|||
3712365|NCT02135094|3551410|B2|||Weight||kg|Mean|72.2|72.2|Standard Deviation|22.4|22.4|||
3712366|NCT02135094|3551411|B1|||Weight||kg|Mean|75.1|75.1|Standard Deviation|13.1|13.1|||
3712367|NCT02135094|3551409|B3|||Height||cm|Mean|169.6|169.6|Standard Deviation|11.4|11.4|||
3712368|NCT02135094|3551410|B2|||Height||cm|Mean|169.1|169.1|Standard Deviation|9.7|9.7|||
3712369|NCT02135094|3551411|B1|||Height||cm|Mean|169.8|169.8|Standard Deviation|12.1|12.1|||
3712370|NCT02135094|3551409|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
3712371|NCT02135094|3551410|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3712372|NCT02135094|3551411|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3712373|NCT02135094|3551409|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3712374|NCT02135094|3551410|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3712375|NCT02135094|3551411|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3712376|NCT02135094|3551409|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3712377|NCT02135094|3551410|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3712378|NCT02135094|3551411|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3712379|NCT02135094|3551409|B3|||Age||years|Mean|33.3|33.3|Standard Deviation|13.3|13.3|||
3712380|NCT02135094|3551410|B2|||Age||years|Mean|30.3|30.3|Standard Deviation|10.9|10.9|||
3712381|NCT02135094|3551411|B1|||Age||years|Mean|34.2|34.2|Standard Deviation|13.9|13.9|||
3712382|NCT02135029|3551426|B4||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3712383|NCT02135029|3551427|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3712384|NCT02135029|3551428|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3712385|NCT02135029|3551429|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3712386|NCT02135029|3551426|B4||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3712387|NCT02135029|3551427|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3712388|NCT02135029|3551428|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3712389|NCT02135029|3551429|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3712390|NCT02135029|3551426|B4|||Age||years|Mean|63.9|63.9|Standard Deviation|8.5|8.5|||
3712391|NCT02135029|3551427|B3|||Age||years|Mean|65.1|65.1|Standard Deviation|7.6|7.6|||
3712392|NCT02135029|3551428|B2|||Age||years|Mean|64|64.0|Standard Deviation|9.2|9.2|||
3712393|NCT02135029|3551429|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|8.4|8.4|||
3712394|NCT02135016|3551511|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3712395|NCT02135016|3551512|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3712396|NCT02135016|3551513|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3712397|NCT02135016|3551514|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3712398|NCT02135016|3551511|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3712399|NCT02135016|3551512|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3712400|NCT02135016|3551513|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3712401|NCT02135016|3551514|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3712402|NCT02135016|3551511|B4|||Age||years|Mean|56|56.0|Standard Deviation|6|6.0|||
3712403|NCT02135016|3551512|B3|||Age||years|Mean|56|56.0|Standard Deviation|4|4.0|||
3712404|NCT02135016|3551513|B2|||Age||years|Mean|57|57.0|Standard Deviation|7.0|7.0|||
3712405|NCT02135016|3551514|B1|||Age||years|Mean|58|58.0|Standard Deviation|6|6.0|||
3712406|NCT02134977|3551536|B1|Not determined||Time from surgery to the start of treatment||participants|Number|11|11.0||||||
3712407|NCT02134977|3551536|B1|>= 2 years||Time from surgery to the start of treatment||participants|Number|272|272.0||||||
3712408|NCT02134977|3551536|B1|>= 1 to <2 years||Time from surgery to the start of treatment||participants|Number|401|401.0||||||
3712409|NCT02134977|3551536|B1|Greater than or equal to (>=) 6 months to <1 year||Time from surgery to the start of treatment||participants|Number|596|596.0||||||
3712410|NCT02134977|3551536|B1|< 6 months||Time from surgery to the start of treatment||participants|Number|1434|1434.0||||||
3712411|NCT02134977|3551536|B1|||Blood Follicle-Stimulating Hormone (FSH) Level||milli-international units/milliliter|Mean|15.85|15.85|Standard Deviation|24.712|24.712|||
3712412|NCT02134977|3551536|B1|||Blood Estradiol Level|Only 492 participants had data available for blood estradiol levels.|pg/mL|Mean|96.07|96.07|Standard Deviation|192.148|192.148|||
3712413|NCT02134977|3551536|B1|Not measured||Number of Participants with Blood Estradiol Level||participants|Number|2222|2222.0||||||
3712414|NCT02134977|3551536|B1|Less than (<) 30 pg/mL||Number of Participants with Blood Estradiol Level||participants|Number|273|273.0||||||
3712415|NCT02134977|3551536|B1|>=30 picogram per milliliter (pg/mL)||Number of Participants with Blood Estradiol Level||participants|Number|219|219.0||||||
3712416|NCT02134977|3551536|B1|Not determined||Presence of Complications||participants|Number|1|1.0||||||
3712417|NCT02134977|3551536|B1|Had complications||Presence of Complications||participants|Number|355|355.0||||||
3712418|NCT02134977|3551536|B1|Had no complications||Presence of Complications||participants|Number|2358|2358.0||||||
3712419|NCT02134977|3551536|B1|Inpatient||Healthcare category|Participants were categorized as outpatient and inpatient.|participants|Number|5|5.0||||||
3712420|NCT02134977|3551536|B1|Outpatient||Healthcare category|Participants were categorized as outpatient and inpatient.|participants|Number|2709|2709.0||||||
3712421|NCT02134977|3551536|B1|Grade 1||Performance status|Following are Eastern Cooperative Oncology Group (ECOG) grades. 0: Fully active, perform all pre-disease activities without restriction. 1: Restricted in physically strenuous activity but ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of self-care, unable to carry out any work activities, up and about greater than (>)50% of waking hours. 3: Capable of limited self-care, confined to bed or chair >50% of waking hours. 4: Completely disabled, not capable of any self-care, totally confined to bed or chair.|participants|Number|28|28.0||||||
3712422|NCT02134977|3551536|B1|Grade 0||Performance status|Following are Eastern Cooperative Oncology Group (ECOG) grades. 0: Fully active, perform all pre-disease activities without restriction. 1: Restricted in physically strenuous activity but ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of self-care, unable to carry out any work activities, up and about greater than (>)50% of waking hours. 3: Capable of limited self-care, confined to bed or chair >50% of waking hours. 4: Completely disabled, not capable of any self-care, totally confined to bed or chair.|participants|Number|2686|2686.0||||||
3712423|NCT02134977|3551536|B1|Female||Sex/Gender, Customized||participants|Number|2714|2714.0||||||
3712424|NCT02134977|3551536|B1|||Age||years|Mean|43.5|43.5|Standard Deviation|5.27|5.27|||
3712425|NCT02134951|3551557|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3712426|NCT02134951|3551558|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3712427|NCT02134951|3551559|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3712428|NCT02134951|3551557|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3712429|NCT02134951|3551558|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3712430|NCT02134951|3551559|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3712431|NCT02134951|3551557|B3|||Age||years|Mean|31.5|31.5|Standard Deviation|9.8|9.8|||
3712432|NCT02134951|3551558|B2|||Age||years|Mean|32.2|32.2|Standard Deviation|10.2|10.2|||
3712433|NCT02134951|3551559|B1|||Age||years|Mean|31.1|31.1|Standard Deviation|9.6|9.6|||
3712434|NCT02134925|3551568|B3|1||Performance status (PS)|Eastern Cooperative Oncology Group PS Scale: 0) Fully active, able to carry on all pre-disease performance without restriction; 1) Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2) Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3) Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4) Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.|Participants|Count of Participants|7|7.0||||||
3712435|NCT02134925|3551569|B2|1||Performance status (PS)|Eastern Cooperative Oncology Group PS Scale: 0) Fully active, able to carry on all pre-disease performance without restriction; 1) Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2) Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3) Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4) Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.|Participants|Count of Participants|4|4.0||||||
3712436|NCT02134925|3551570|B1|1||Performance status (PS)|Eastern Cooperative Oncology Group PS Scale: 0) Fully active, able to carry on all pre-disease performance without restriction; 1) Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2) Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3) Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4) Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.|Participants|Count of Participants|3|3.0||||||
3712482|NCT02134522|3551594|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3712483|NCT02134522|3551594|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712437|NCT02134925|3551568|B3|0||Performance status (PS)|Eastern Cooperative Oncology Group PS Scale: 0) Fully active, able to carry on all pre-disease performance without restriction; 1) Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2) Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3) Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4) Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.|Participants|Count of Participants|95|95.0||||||
3712438|NCT02134925|3551569|B2|0||Performance status (PS)|Eastern Cooperative Oncology Group PS Scale: 0) Fully active, able to carry on all pre-disease performance without restriction; 1) Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2) Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3) Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4) Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.|Participants|Count of Participants|46|46.0||||||
3712439|NCT02134925|3551570|B1|0||Performance status (PS)|Eastern Cooperative Oncology Group PS Scale: 0) Fully active, able to carry on all pre-disease performance without restriction; 1) Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2) Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3) Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4) Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.|Participants|Count of Participants|49|49.0||||||
3712440|NCT02134925|3551568|B3|Unknown: Patient unsure||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3712441|NCT02134925|3551569|B2|Unknown: Patient unsure||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3712442|NCT02134925|3551570|B1|Unknown: Patient unsure||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3712443|NCT02134925|3551568|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3712444|NCT02134925|3551569|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3712445|NCT02134925|3551570|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3712446|NCT02134925|3551568|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3712447|NCT02134925|3551569|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3712448|NCT02134925|3551570|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3712449|NCT02134925|3551568|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|90|90.0||||||
3712450|NCT02134925|3551569|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
3712451|NCT02134925|3551570|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
3712452|NCT02134925|3551568|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3712453|NCT02134925|3551569|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3712454|NCT02134925|3551570|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712455|NCT02134925|3551568|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3712456|NCT02134925|3551569|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3712457|NCT02134925|3551570|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3712458|NCT02134925|3551568|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3712459|NCT02134925|3551569|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3712460|NCT02134925|3551570|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3712461|NCT02134925|3551568|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3712462|NCT02134925|3551569|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3712463|NCT02134925|3551570|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3712464|NCT02134925|3551568|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3712465|NCT02134925|3551569|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3712466|NCT02134925|3551570|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3712467|NCT02134925|3551568|B3|||Age||years|Median|59.5|59.5|Full Range|||40.0|70.0|
3712468|NCT02134925|3551569|B2|||Age||years|Median|59.5|59.5|Full Range|||47.0|70.0|
3712469|NCT02134925|3551570|B1|||Age||years|Median|59.5|59.5|Full Range|||40.0|70.0|
3712470|NCT02134717|3551579|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3712471|NCT02134717|3551579|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3712472|NCT02134717|3551579|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3712473|NCT02134717|3551579|B1|||Age||years|Mean|37|37.0|Full Range|||23.0|58.0|
3712474|NCT02134717|3551579|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3712475|NCT02134717|3551579|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3712476|NCT02134717|3551579|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3712477|NCT02134587|3551585|B1|Brazil||Region of Enrollment||participants|Number|173|173.0||||||
3712478|NCT02134587|3551585|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3712479|NCT02134587|3551585|B1||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3712480|NCT02134587|3551585|B1|||Age||years|Median|30.6|30.6|Standard Deviation|6.5|6.5|||
3712481|NCT02134522|3551594|B1|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3712484|NCT02134522|3551594|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712485|NCT02134522|3551594|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712486|NCT02134522|3551594|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712487|NCT02134522|3551594|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712488|NCT02134522|3551594|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712489|NCT02134522|3551594|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712490|NCT02134522|3551594|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712491|NCT02134522|3551594|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3712492|NCT02134522|3551594|B1|Gender|Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3712493|NCT02134522|3551594|B1|Gender|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3712494|NCT02134522|3551594|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3712495|NCT02134522|3551594|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3712496|NCT02134522|3551594|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3712497|NCT02134314|3551599|B3|||Treatment with Alemtuzumab at transplantation|Patients who received alemtuzumab (Campath) as an induction agent at transplant|Participants|Count of Participants|17|17.0||||||
3712498|NCT02134314|3551600|B2|||Treatment with Alemtuzumab at transplantation|Patients who received alemtuzumab (Campath) as an induction agent at transplant|Participants|Count of Participants|7|7.0||||||
3712499|NCT02134314|3551601|B1|||Treatment with Alemtuzumab at transplantation|Patients who received alemtuzumab (Campath) as an induction agent at transplant|Participants|Count of Participants|10|10.0||||||
3712500|NCT02134314|3551599|B3|||Treatment with Thymoglobulin at transplantation|Patients who received thymoglobulin as an induction agent at transplant|Participants|Count of Participants|53|53.0||||||
3712501|NCT02134314|3551600|B2|||Treatment with Thymoglobulin at transplantation|Patients who received thymoglobulin as an induction agent at transplant|Participants|Count of Participants|28|28.0||||||
3712502|NCT02134314|3551601|B1|||Treatment with Thymoglobulin at transplantation|Patients who received thymoglobulin as an induction agent at transplant|Participants|Count of Participants|25|25.0||||||
3712503|NCT02134314|3551599|B3|||HLA Class II Antibodies Present|Human leukocyte antigen (HLA) Class II Antibodies|Participants|Count of Participants|2|2.0||||||
3712504|NCT02134314|3551600|B2|||HLA Class II Antibodies Present|Human leukocyte antigen (HLA) Class II Antibodies|Participants|Count of Participants|1|1.0||||||
3712505|NCT02134314|3551601|B1|||HLA Class II Antibodies Present|Human leukocyte antigen (HLA) Class II Antibodies|Participants|Count of Participants|1|1.0||||||
3712506|NCT02134314|3551599|B3|||HLA Class I Antibodies Present|Human leukocyte antigen (HLA) Class I Antibodies|Participants|Count of Participants|3|3.0||||||
3712507|NCT02134314|3551600|B2|||HLA Class I Antibodies Present|Human leukocyte antigen (HLA) Class I Antibodies|Participants|Count of Participants|1|1.0||||||
3712508|NCT02134314|3551601|B1|||HLA Class I Antibodies Present|Human leukocyte antigen (HLA) Class I Antibodies|Participants|Count of Participants|2|2.0||||||
3712509|NCT02134314|3551599|B3|||Anti-HLA DSA|Anti-Human leukocyte antigen (HLA) Donor Specific Antibody (DSA)|Participants|Count of Participants|5|5.0||||||
3712510|NCT02134314|3551600|B2|||Anti-HLA DSA|Anti-Human leukocyte antigen (HLA) Donor Specific Antibody (DSA)|Participants|Count of Participants|2|2.0||||||
3712511|NCT02134314|3551601|B1|||Anti-HLA DSA|Anti-Human leukocyte antigen (HLA) Donor Specific Antibody (DSA)|Participants|Count of Participants|3|3.0||||||
3712512|NCT02134314|3551599|B3|||Transplant Cold Ischemia Time||hours|Mean|19.06|19.06|Standard Deviation|5.54|5.54|||
3712513|NCT02134314|3551600|B2|||Transplant Cold Ischemia Time||hours|Mean|19.84|19.84|Standard Deviation|6.10|6.1|||
3712514|NCT02134314|3551601|B1|||Transplant Cold Ischemia Time||hours|Mean|18.27|18.27|Standard Deviation|4.89|4.89|||
3712515|NCT02134314|3551599|B3|||Donor KDPI equal to or greater than 85%|The donor's Kidney Donor Profile Index (KDPI) was equal to or greater than 85%. Mean kidney transplant donor Kidney Donor Profile Index (KDPI), shown as a percentage. Kidneys with a high KDPI are associated with higher rates of DGF and worse long term survival in comparison to those with a low KDPI. In this study, the eligibility criteria included recipients of kidney allografts from ECD (or KDPI >/= 85) donors. A KDPI >/= 85 confers the highest risk for DGF and allograft loss.|Participants|Count of Participants|21|21.0||||||
3712516|NCT02134314|3551600|B2|||Donor KDPI equal to or greater than 85%|The donor's Kidney Donor Profile Index (KDPI) was equal to or greater than 85%. Mean kidney transplant donor Kidney Donor Profile Index (KDPI), shown as a percentage. Kidneys with a high KDPI are associated with higher rates of DGF and worse long term survival in comparison to those with a low KDPI. In this study, the eligibility criteria included recipients of kidney allografts from ECD (or KDPI >/= 85) donors. A KDPI >/= 85 confers the highest risk for DGF and allograft loss.|Participants|Count of Participants|11|11.0||||||
3712517|NCT02134314|3551601|B1|||Donor KDPI equal to or greater than 85%|The donor's Kidney Donor Profile Index (KDPI) was equal to or greater than 85%. Mean kidney transplant donor Kidney Donor Profile Index (KDPI), shown as a percentage. Kidneys with a high KDPI are associated with higher rates of DGF and worse long term survival in comparison to those with a low KDPI. In this study, the eligibility criteria included recipients of kidney allografts from ECD (or KDPI >/= 85) donors. A KDPI >/= 85 confers the highest risk for DGF and allograft loss.|Participants|Count of Participants|10|10.0||||||
3712518|NCT02134314|3551599|B3|||Donor KDPI|Mean kidney transplant donor Kidney Donor Profile Index (KDPI), shown as a percentage. Kidneys with a high KDPI are associated with higher rates of DGF and worse long term survival in comparison to those with a low KDPI. In this study, the eligibility criteria included recipients of kidney allografts from ECD (or KDPI >/= 85) donors. A KDPI >/= 85 confers the highest risk for DGF and allograft loss.|%|Mean|66.17|66.17|Standard Deviation|23.56|23.56|||
3712567|NCT02134184|3551635|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712568|NCT02134184|3551632|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712519|NCT02134314|3551600|B2|||Donor KDPI|Mean kidney transplant donor Kidney Donor Profile Index (KDPI), shown as a percentage. Kidneys with a high KDPI are associated with higher rates of DGF and worse long term survival in comparison to those with a low KDPI. In this study, the eligibility criteria included recipients of kidney allografts from ECD (or KDPI >/= 85) donors. A KDPI >/= 85 confers the highest risk for DGF and allograft loss.|%|Mean|64.63|64.63|Standard Deviation|25.39|25.39|||
3712520|NCT02134314|3551601|B1|||Donor KDPI|Mean kidney transplant donor Kidney Donor Profile Index (KDPI), shown as a percentage. Kidneys with a high KDPI are associated with higher rates of DGF and worse long term survival in comparison to those with a low KDPI. In this study, the eligibility criteria included recipients of kidney allografts from ECD (or KDPI >/= 85) donors. A KDPI >/= 85 confers the highest risk for DGF and allograft loss.|%|Mean|67.71|67.71|Standard Deviation|21.83|21.83|||
3712521|NCT02134314|3551599|B3|||Donor DCD Cause of Death|The kidney transplant donor was a Donor after Cardiac Death (DCD).|Participants|Count of Participants|23|23.0||||||
3712522|NCT02134314|3551600|B2|||Donor DCD Cause of Death|The kidney transplant donor was a Donor after Cardiac Death (DCD).|Participants|Count of Participants|12|12.0||||||
3712523|NCT02134314|3551601|B1|||Donor DCD Cause of Death|The kidney transplant donor was a Donor after Cardiac Death (DCD).|Participants|Count of Participants|11|11.0||||||
3712524|NCT02134314|3551599|B3|||Donor Creatinine||mg/dL|Mean|1.77|1.77|Standard Deviation|1.69|1.69|||
3712525|NCT02134314|3551600|B2|||Donor Creatinine||mg/dL|Mean|1.75|1.75|Standard Deviation|1.92|1.92|||
3712526|NCT02134314|3551601|B1|||Donor Creatinine||mg/dL|Mean|1.78|1.78|Standard Deviation|1.44|1.44|||
3712527|NCT02134314|3551599|B3|||Donor Age||years|Mean|47.37|47.37|Standard Deviation|14.13|14.13|||
3712528|NCT02134314|3551600|B2|||Donor Age||years|Mean|45.57|45.57|Standard Deviation|15.69|15.69|||
3712529|NCT02134314|3551601|B1|||Donor Age||years|Mean|49.17|49.17|Standard Deviation|12.35|12.35|||
3712530|NCT02134314|3551599|B3|||Diabetes||Participants|Count of Participants|41|41.0||||||
3712531|NCT02134314|3551600|B2|||Diabetes||Participants|Count of Participants|20|20.0||||||
3712532|NCT02134314|3551601|B1|||Diabetes||Participants|Count of Participants|21|21.0||||||
3712533|NCT02134314|3551599|B3|Not African-American||Race/Ethnicity, Customized|Patients were categorized as either African American or not African American.|Participants|Count of Participants|62|62.0||||||
3712534|NCT02134314|3551600|B2|Not African-American||Race/Ethnicity, Customized|Patients were categorized as either African American or not African American.|Participants|Count of Participants|31|31.0||||||
3712535|NCT02134314|3551601|B1|Not African-American||Race/Ethnicity, Customized|Patients were categorized as either African American or not African American.|Participants|Count of Participants|31|31.0||||||
3712536|NCT02134314|3551599|B3|African-American||Race/Ethnicity, Customized|Patients were categorized as either African American or not African American.|Participants|Count of Participants|8|8.0||||||
3712537|NCT02134314|3551600|B2|African-American||Race/Ethnicity, Customized|Patients were categorized as either African American or not African American.|Participants|Count of Participants|4|4.0||||||
3712538|NCT02134314|3551601|B1|African-American||Race/Ethnicity, Customized|Patients were categorized as either African American or not African American.|Participants|Count of Participants|4|4.0||||||
3712539|NCT02134314|3551599|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3712540|NCT02134314|3551600|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3712541|NCT02134314|3551601|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3712542|NCT02134314|3551599|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3712543|NCT02134314|3551600|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3712544|NCT02134314|3551601|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3712545|NCT02134314|3551599|B3|||Age||years|Mean|57.9|57.9|Standard Deviation|9.54|9.54|||
3712546|NCT02134314|3551600|B2|||Age||years|Mean|58.14|58.14|Standard Deviation|11.18|11.18|||
3712547|NCT02134314|3551601|B1|||Age||years|Mean|57.66|57.66|Standard Deviation|7.74|7.74|||
3712548|NCT02134184|3551632|B4|United States||Region of Enrollment||Participants|Count of Participants|78|78.0||||||
3712549|NCT02134184|3551633|B3|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3712550|NCT02134184|3551634|B2|United States||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3712551|NCT02134184|3551635|B1|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3712552|NCT02134184|3551632|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3712553|NCT02134184|3551633|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712554|NCT02134184|3551634|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712555|NCT02134184|3551635|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3712556|NCT02134184|3551632|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712557|NCT02134184|3551633|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712558|NCT02134184|3551634|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712559|NCT02134184|3551635|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712560|NCT02134184|3551632|B4||White|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3712561|NCT02134184|3551633|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3712562|NCT02134184|3551634|B2||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3712563|NCT02134184|3551635|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3712564|NCT02134184|3551632|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712565|NCT02134184|3551633|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712566|NCT02134184|3551634|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712569|NCT02134184|3551633|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712570|NCT02134184|3551634|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712571|NCT02134184|3551635|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712572|NCT02134184|3551632|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3712573|NCT02134184|3551633|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712574|NCT02134184|3551634|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3712575|NCT02134184|3551635|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3712576|NCT02134184|3551632|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712577|NCT02134184|3551633|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712578|NCT02134184|3551634|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712579|NCT02134184|3551635|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712580|NCT02134184|3551632|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712581|NCT02134184|3551633|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712582|NCT02134184|3551634|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712583|NCT02134184|3551635|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712584|NCT02134184|3551632|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3712585|NCT02134184|3551633|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3712586|NCT02134184|3551634|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3712587|NCT02134184|3551635|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3712588|NCT02134184|3551632|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3712589|NCT02134184|3551633|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712590|NCT02134184|3551634|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3712591|NCT02134184|3551635|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712592|NCT02134184|3551632|B4||Male|Gender||Participants|Count of Participants|41|41.0||||||
3712593|NCT02134184|3551633|B3||Male|Gender||Participants|Count of Participants|1|1.0||||||
3712594|NCT02134184|3551634|B2||Male|Gender||Participants|Count of Participants|17|17.0||||||
3712595|NCT02134184|3551635|B1||Male|Gender||Participants|Count of Participants|23|23.0||||||
3712596|NCT02134184|3551632|B4||Female|Gender||Participants|Count of Participants|37|37.0||||||
3712597|NCT02134184|3551633|B3||Female|Gender||Participants|Count of Participants|7|7.0||||||
3712598|NCT02134184|3551634|B2||Female|Gender||Participants|Count of Participants|20|20.0||||||
3712599|NCT02134184|3551635|B1||Female|Gender||Participants|Count of Participants|10|10.0||||||
3712600|NCT02134184|3551632|B4|||Age||years|Mean|67.21|67.21|Standard Deviation|4.80|4.8|||
3712601|NCT02134184|3551633|B3|||Age||years|Mean|66.75|66.75|Standard Deviation|3.53|3.53|||
3712602|NCT02134184|3551634|B2|||Age||years|Mean|67.46|67.46|Standard Deviation|5.26|5.26|||
3712603|NCT02134184|3551635|B1|||Age||years|Mean|66.96|66.96|Standard Deviation|4.52|4.52|||
3712604|NCT02134184|3551632|B4||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
3712605|NCT02134184|3551633|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3712606|NCT02134184|3551634|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3712607|NCT02134184|3551635|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3712608|NCT02134184|3551632|B4||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3712609|NCT02134184|3551633|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3712610|NCT02134184|3551634|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3712611|NCT02134184|3551635|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3712612|NCT02134184|3551632|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3712613|NCT02134184|3551633|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3712614|NCT02134184|3551634|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3712615|NCT02134184|3551635|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3712616|NCT02134119|3551648|B3||Male|Gender||Participants|Count of Participants|30|30.0||||||
3712617|NCT02134119|3551649|B2||Male|Gender||Participants|Count of Participants|8|8.0||||||
3712618|NCT02134119|3551650|B1||Male|Gender||Participants|Count of Participants|22|22.0||||||
3712619|NCT02134119|3551648|B3||Female|Gender||Participants|Count of Participants|15|15.0||||||
3712620|NCT02134119|3551649|B2||Female|Gender||Participants|Count of Participants|7|7.0||||||
3712621|NCT02134119|3551650|B1||Female|Gender||Participants|Count of Participants|8|8.0||||||
3712622|NCT02134119|3551648|B3|||Age||years|Mean|27.0|27.0|Standard Deviation|7.8|7.8|||
3712623|NCT02134119|3551649|B2|||Age||years|Mean|29.9|29.9|Standard Deviation|7.7|7.7|||
3712624|NCT02134119|3551650|B1|||Age||years|Mean|25.6|25.6|Standard Deviation|7.6|7.6|||
3712625|NCT02134015|3551689|B3||HRG Low|Heregulin (HRG) expression from Interactive Web/Voice Response System (IXRS)||Participants|Count of Participants|50|50.0||||||
3712626|NCT02134015|3551690|B2||HRG Low|Heregulin (HRG) expression from Interactive Web/Voice Response System (IXRS)||Participants|Count of Participants|27|27.0||||||
3712679|NCT02134015|3551689|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
3712627|NCT02134015|3551691|B1||HRG Low|Heregulin (HRG) expression from Interactive Web/Voice Response System (IXRS)||Participants|Count of Participants|23|23.0||||||
3712628|NCT02134015|3551689|B3||HRG High|Heregulin (HRG) expression from Interactive Web/Voice Response System (IXRS)||Participants|Count of Participants|95|95.0||||||
3712629|NCT02134015|3551690|B2||HRG High|Heregulin (HRG) expression from Interactive Web/Voice Response System (IXRS)||Participants|Count of Participants|47|47.0||||||
3712630|NCT02134015|3551691|B1||HRG High|Heregulin (HRG) expression from Interactive Web/Voice Response System (IXRS)||Participants|Count of Participants|48|48.0||||||
3712631|NCT02134015|3551689|B3||1 - Restricted in Physically Strenuous Activity|Eastern Cooperative Oncology Group (ECOG) Score||Participants|Count of Participants|96|96.0||||||
3712632|NCT02134015|3551690|B2||1 - Restricted in Physically Strenuous Activity|Eastern Cooperative Oncology Group (ECOG) Score||Participants|Count of Participants|49|49.0||||||
3712633|NCT02134015|3551691|B1||1 - Restricted in Physically Strenuous Activity|Eastern Cooperative Oncology Group (ECOG) Score||Participants|Count of Participants|47|47.0||||||
3712634|NCT02134015|3551689|B3||0 - Fully Active|Eastern Cooperative Oncology Group (ECOG) Score||Participants|Count of Participants|49|49.0||||||
3712635|NCT02134015|3551690|B2||0 - Fully Active|Eastern Cooperative Oncology Group (ECOG) Score||Participants|Count of Participants|25|25.0||||||
3712636|NCT02134015|3551691|B1||0 - Fully Active|Eastern Cooperative Oncology Group (ECOG) Score||Participants|Count of Participants|24|24.0||||||
3712637|NCT02134015|3551689|B3||Squamous-cell carcinoma/Not otherwise specified|Histology subtype (for randomization)||Participants|Count of Participants|67|67.0||||||
3712638|NCT02134015|3551690|B2||Squamous-cell carcinoma/Not otherwise specified|Histology subtype (for randomization)||Participants|Count of Participants|34|34.0||||||
3712639|NCT02134015|3551691|B1||Squamous-cell carcinoma/Not otherwise specified|Histology subtype (for randomization)||Participants|Count of Participants|33|33.0||||||
3712640|NCT02134015|3551689|B3||Adenocarcinoma|Histology subtype (for randomization)||Participants|Count of Participants|78|78.0||||||
3712641|NCT02134015|3551690|B2||Adenocarcinoma|Histology subtype (for randomization)||Participants|Count of Participants|40|40.0||||||
3712642|NCT02134015|3551691|B1||Adenocarcinoma|Histology subtype (for randomization)||Participants|Count of Participants|38|38.0||||||
3712643|NCT02134015|3551689|B3||Other|Histology subtype||Participants|Count of Participants|8|8.0||||||
3712644|NCT02134015|3551690|B2||Other|Histology subtype||Participants|Count of Participants|5|5.0||||||
3712645|NCT02134015|3551691|B1||Other|Histology subtype||Participants|Count of Participants|3|3.0||||||
3712646|NCT02134015|3551689|B3||Large Cell|Histology subtype||Participants|Count of Participants|2|2.0||||||
3712647|NCT02134015|3551690|B2||Large Cell|Histology subtype||Participants|Count of Participants|1|1.0||||||
3712648|NCT02134015|3551691|B1||Large Cell|Histology subtype||Participants|Count of Participants|1|1.0||||||
3712649|NCT02134015|3551689|B3||Squamous|Histology subtype||Participants|Count of Participants|56|56.0||||||
3712650|NCT02134015|3551690|B2||Squamous|Histology subtype||Participants|Count of Participants|28|28.0||||||
3712651|NCT02134015|3551691|B1||Squamous|Histology subtype||Participants|Count of Participants|28|28.0||||||
3712652|NCT02134015|3551689|B3||Adenocarcinoma|Histology subtype||Participants|Count of Participants|79|79.0||||||
3712653|NCT02134015|3551690|B2||Adenocarcinoma|Histology subtype||Participants|Count of Participants|40|40.0||||||
3712654|NCT02134015|3551691|B1||Adenocarcinoma|Histology subtype||Participants|Count of Participants|39|39.0||||||
3712655|NCT02134015|3551689|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712656|NCT02134015|3551690|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712657|NCT02134015|3551691|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712658|NCT02134015|3551689|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712659|NCT02134015|3551690|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712660|NCT02134015|3551691|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712661|NCT02134015|3551689|B3||White|Race (NIH/OMB)||Participants|Count of Participants|141|141.0||||||
3712662|NCT02134015|3551690|B2||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3712663|NCT02134015|3551691|B1||White|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3712664|NCT02134015|3551689|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3712665|NCT02134015|3551690|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3712666|NCT02134015|3551691|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712667|NCT02134015|3551689|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712668|NCT02134015|3551690|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712669|NCT02134015|3551691|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712670|NCT02134015|3551689|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3712671|NCT02134015|3551690|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3712672|NCT02134015|3551691|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712673|NCT02134015|3551689|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3712674|NCT02134015|3551690|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3712675|NCT02134015|3551691|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712676|NCT02134015|3551689|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3712677|NCT02134015|3551690|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3712678|NCT02134015|3551691|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3712680|NCT02134015|3551690|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3712681|NCT02134015|3551691|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3712682|NCT02134015|3551689|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3712683|NCT02134015|3551690|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3712684|NCT02134015|3551691|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3712685|NCT02134015|3551689|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3712686|NCT02134015|3551690|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3712687|NCT02134015|3551691|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3712688|NCT02134015|3551689|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3712689|NCT02134015|3551690|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3712690|NCT02134015|3551691|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3712691|NCT02134015|3551689|B3|||Age||years|Mean|63.6|63.6|Standard Deviation|8.68|8.68|||
3712692|NCT02134015|3551690|B2|||Age||years|Mean|63.9|63.9|Standard Deviation|8.25|8.25|||
3712693|NCT02134015|3551691|B1|||Age||years|Mean|63.3|63.3|Standard Deviation|9.15|9.15|||
3712694|NCT02134015|3551689|B3||>=65 years|Age||Participants|Count of Participants|67|67.0||||||
3712695|NCT02134015|3551690|B2||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
3712696|NCT02134015|3551691|B1||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
3712697|NCT02134015|3551689|B3||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
3712698|NCT02134015|3551690|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3712699|NCT02134015|3551691|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3712700|NCT02134015|3551689|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3712701|NCT02134015|3551690|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3712702|NCT02134015|3551691|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3712703|NCT02133781|3551712|B4|United States||Region of Enrollment||participants|Number|51|51.0||||||
3712704|NCT02133781|3551713|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
3712705|NCT02133781|3551714|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
3712706|NCT02133781|3551715|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3712707|NCT02133781|3551712|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3712708|NCT02133781|3551713|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712709|NCT02133781|3551714|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3712710|NCT02133781|3551715|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712711|NCT02133781|3551712|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3712712|NCT02133781|3551713|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712713|NCT02133781|3551714|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3712714|NCT02133781|3551715|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712715|NCT02133781|3551712|B4||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3712716|NCT02133781|3551713|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3712717|NCT02133781|3551714|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3712718|NCT02133781|3551715|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3712719|NCT02133781|3551712|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3712720|NCT02133781|3551713|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712721|NCT02133781|3551714|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3712722|NCT02133781|3551715|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712723|NCT02133781|3551712|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712724|NCT02133781|3551713|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712725|NCT02133781|3551714|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712726|NCT02133781|3551715|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712727|NCT02133781|3551712|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3712728|NCT02133781|3551713|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712729|NCT02133781|3551714|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3712730|NCT02133781|3551715|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712731|NCT02133781|3551712|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712732|NCT02133781|3551713|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712733|NCT02133781|3551714|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712734|NCT02133781|3551715|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712735|NCT02133781|3551712|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712736|NCT02133781|3551713|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712737|NCT02133781|3551714|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712738|NCT02133781|3551715|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712739|NCT02133781|3551712|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3712740|NCT02133781|3551713|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3712741|NCT02133781|3551714|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3712742|NCT02133781|3551715|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3712743|NCT02133781|3551712|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3712744|NCT02133781|3551713|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712745|NCT02133781|3551714|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3712746|NCT02133781|3551715|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712747|NCT02133781|3551712|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3712748|NCT02133781|3551713|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3712749|NCT02133781|3551714|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3712750|NCT02133781|3551715|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3712751|NCT02133781|3551712|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3712752|NCT02133781|3551713|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3712753|NCT02133781|3551714|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3712754|NCT02133781|3551715|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3712755|NCT02133781|3551712|B4||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3712756|NCT02133781|3551713|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3712757|NCT02133781|3551714|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3712758|NCT02133781|3551715|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3712759|NCT02133781|3551712|B4||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3712760|NCT02133781|3551713|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3712761|NCT02133781|3551714|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3712762|NCT02133781|3551715|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3712763|NCT02133781|3551712|B4||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3712764|NCT02133781|3551713|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3712765|NCT02133781|3551714|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3712766|NCT02133781|3551715|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3712767|NCT02133664|3551728|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
3712768|NCT02133664|3551729|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
3712769|NCT02133664|3551730|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
3712770|NCT02133664|3551728|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3712771|NCT02133664|3551729|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3712772|NCT02133664|3551730|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3712773|NCT02133664|3551728|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3712774|NCT02133664|3551729|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3712775|NCT02133664|3551730|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3712776|NCT02133664|3551728|B3|||Age||years|Mean|51.22|51.22|Standard Deviation|9.97|9.97|||
3712777|NCT02133664|3551729|B2|||Age||years|Mean|52.96|52.96|Standard Deviation|8.85|8.85|||
3712778|NCT02133664|3551730|B1|||Age||years|Mean|49.34|49.34|Standard Deviation|10.91|10.91|||
3712779|NCT02133664|3551728|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3712780|NCT02133664|3551729|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3712781|NCT02133664|3551730|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3712782|NCT02133664|3551728|B3||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
3712783|NCT02133664|3551729|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3712784|NCT02133664|3551730|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3712785|NCT02133664|3551728|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3712786|NCT02133664|3551729|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3712787|NCT02133664|3551730|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3712788|NCT02133534|3551743|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3712789|NCT02133534|3551743|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3712790|NCT02133534|3551743|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3712791|NCT02133534|3551743|B1|Greater than 18 Years||Age, Customized||participants|Number|1|1.0||||||
3712792|NCT02133508|3551747|B1||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3712793|NCT02133508|3551747|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3712794|NCT02133508|3551747|B1|||Age||years|Mean|68.4|68.4|Standard Deviation|8.9|8.9|||
3712795|NCT02133352|3551755|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3712796|NCT02133352|3551755|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3712797|NCT02133352|3551755|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3712798|NCT02133352|3551755|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3712799|NCT02133352|3551755|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3712800|NCT02133352|3551755|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3712801|NCT02133352|3551755|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|6.1|6.1|||
3712802|NCT02133235|3551764|B3|Taiwan||Region of Enrollment||participants|Number|112|112.0||||||
3712803|NCT02133235|3551765|B2|Taiwan||Region of Enrollment||participants|Number|55|55.0||||||
3712804|NCT02133235|3551766|B1|Taiwan||Region of Enrollment||participants|Number|57|57.0||||||
3712805|NCT02133235|3551764|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3712806|NCT02133235|3551765|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3712807|NCT02133235|3551766|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3712808|NCT02133235|3551764|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3712809|NCT02133235|3551765|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3712810|NCT02133235|3551766|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3712811|NCT02133235|3551764|B3|||Age||years|Mean|58|58.0|Full Range|||30.0|79.0|
3712812|NCT02133235|3551765|B2|||Age||years|Mean|58|58.0|Full Range|||35.0|79.0|
3712813|NCT02133235|3551766|B1|||Age||years|Mean|58|58.0|Full Range|||30.0|79.0|
3712814|NCT02133235|3551764|B3||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
3712815|NCT02133235|3551765|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3712816|NCT02133235|3551766|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3712817|NCT02133235|3551764|B3||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
3712818|NCT02133235|3551765|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3712819|NCT02133235|3551766|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
3712820|NCT02133235|3551764|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3712821|NCT02133235|3551765|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3712822|NCT02133235|3551766|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3712823|NCT02133131|3551779|B8||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3712824|NCT02133131|3551780|B7||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3712825|NCT02133131|3551781|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3712826|NCT02133131|3551782|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3712827|NCT02133131|3551783|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3712828|NCT02133131|3551784|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3712829|NCT02133131|3551785|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3712830|NCT02133131|3551786|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3712831|NCT02133131|3551779|B8||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3712832|NCT02133131|3551780|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3712833|NCT02133131|3551781|B6||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3712834|NCT02133131|3551782|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3712835|NCT02133131|3551783|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3712836|NCT02133131|3551784|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3712837|NCT02133131|3551785|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3712838|NCT02133131|3551786|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3712839|NCT02133131|3551779|B8|||Age||Years|Mean|52.3|52.3|Standard Deviation|9.9|9.9|||
3712840|NCT02133131|3551780|B7|||Age||Years|Mean|55.3|55.3|Standard Deviation|5.3|5.3|||
3712841|NCT02133131|3551781|B6|||Age||Years|Mean|42.2|42.2|Standard Deviation|11.7|11.7|||
3712842|NCT02133131|3551782|B5|||Age||Years|Mean|51.3|51.3|Standard Deviation|10.1|10.1|||
3712843|NCT02133131|3551783|B4|||Age||Years|Mean|56.8|56.8|Standard Deviation|8.8|8.8|||
3712844|NCT02133131|3551784|B3|||Age||Years|Mean|55.7|55.7|Standard Deviation|7.7|7.7|||
3712845|NCT02133131|3551785|B2|||Age||Years|Mean|51.2|51.2|Standard Deviation|9.5|9.5|||
3712846|NCT02133131|3551786|B1|||Age||Years|Mean|52.1|52.1|Standard Deviation|9.7|9.7|||
3712847|NCT02133066|3551829|B3|United States||Region of Enrollment||participants|Number|128|128.0||||||
3712848|NCT02133066|3551830|B2|United States||Region of Enrollment||participants|Number|64|64.0||||||
3712849|NCT02133066|3551831|B1|United States||Region of Enrollment||participants|Number|64|64.0||||||
3712850|NCT02133066|3551829|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3712851|NCT02133066|3551830|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3712852|NCT02133066|3551831|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3712853|NCT02133066|3551829|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3712854|NCT02133066|3551830|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3712855|NCT02133066|3551831|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3712856|NCT02133066|3551829|B3|||Age||days|Median|26|26.0|Full Range|||3.0|179.0|
3712857|NCT02133066|3551830|B2|||Age||days|Median|29|29.0|Full Range|||14.0|45.0|
3712858|NCT02133066|3551831|B1|||Age||days|Median|24|24.0|Full Range|||9.0|34.0|
3712859|NCT02133066|3551829|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3712860|NCT02133066|3551830|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3712861|NCT02133066|3551831|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3712862|NCT02133066|3551829|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3712863|NCT02133066|3551830|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3712864|NCT02133066|3551831|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3712865|NCT02133066|3551829|B3||<=18 years|Age||Participants|Count of Participants|128|128.0||||||
3712866|NCT02133066|3551830|B2||<=18 years|Age||Participants|Count of Participants|64|64.0||||||
3712867|NCT02133066|3551831|B1||<=18 years|Age||Participants|Count of Participants|64|64.0||||||
3712868|NCT02132949|3551844|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3712869|NCT02132949|3551845|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3712870|NCT02132949|3551846|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3712871|NCT02132949|3551844|B3||Female|Sex: Female, Male||Participants|Count of Participants|399|399.0||||||
3712872|NCT02132949|3551845|B2||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
3712873|NCT02132949|3551846|B1||Female|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
3712874|NCT02132949|3551844|B3|||Age||years|Mean|49.6|49.6|Standard Deviation|11.6|11.6|||
3712875|NCT02132949|3551845|B2|||Age||years|Mean|49.5|49.5|Standard Deviation|11.5|11.5|||
3712876|NCT02132949|3551846|B1|||Age||years|Mean|49.8|49.8|Standard Deviation|11.7|11.7|||
3712877|NCT02132936|3551875|B5||Male|Sex: Female, Male||Participants|Count of Participants|295|295.0||||||
3712878|NCT02132936|3551876|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3712879|NCT02132936|3551877|B3||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3712880|NCT02132936|3551878|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3712881|NCT02132936|3551879|B1||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3712882|NCT02132936|3551875|B5||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3712883|NCT02132936|3551876|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3712884|NCT02132936|3551877|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3712885|NCT02132936|3551878|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3712886|NCT02132936|3551879|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3712887|NCT02132936|3551875|B5|||Age||years|Mean|54.1|54.1|Standard Deviation|14.7|14.7|||
3712888|NCT02132936|3551876|B4|||Age||years|Mean|51.9|51.9|Standard Deviation|15.5|15.5|||
3712889|NCT02132936|3551877|B3|||Age||years|Mean|54.5|54.5|Standard Deviation|14.9|14.9|||
3712890|NCT02132936|3551878|B2|||Age||years|Mean|54.6|54.6|Standard Deviation|14.2|14.2|||
3712891|NCT02132936|3551879|B1|||Age||years|Mean|54.0|54.0|Standard Deviation|14.5|14.5|||
3712892|NCT02132832|3551907|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
3712893|NCT02132832|3551908|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
3712894|NCT02132832|3551909|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3712895|NCT02132832|3551907|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3712896|NCT02132832|3551908|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3712897|NCT02132832|3551909|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3712898|NCT02132832|3551907|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3712899|NCT02132832|3551908|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3712900|NCT02132832|3551909|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3712901|NCT02132832|3551907|B3|||Age||years|Mean|29.34|29.34|Standard Deviation|7.02|7.02|||
3712902|NCT02132832|3551908|B2|||Age||years|Mean|29.52|29.52|Standard Deviation|6.89|6.89|||
3712903|NCT02132832|3551909|B1|||Age||years|Mean|29.16|29.16|Standard Deviation|7.15|7.15|||
3712904|NCT02132767|3551938|B3|United States||Region of Enrollment||participants|Number|462|462.0||||||
3712905|NCT02132767|3551939|B2|United States||Region of Enrollment||participants|Number|232|232.0||||||
3712906|NCT02132767|3551940|B1|United States||Region of Enrollment||participants|Number|230|230.0||||||
3712907|NCT02132767|3551938|B3|Canada||Region of Enrollment||participants|Number|61|61.0||||||
3712908|NCT02132767|3551939|B2|Canada||Region of Enrollment||participants|Number|29|29.0||||||
3712909|NCT02132767|3551940|B1|Canada||Region of Enrollment||participants|Number|32|32.0||||||
3712910|NCT02132767|3551938|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3712911|NCT02132767|3551939|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3712912|NCT02132767|3551940|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712913|NCT02132767|3551938|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712914|NCT02132767|3551939|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712915|NCT02132767|3551940|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712916|NCT02132767|3551938|B3||White|Race (NIH/OMB)||Participants|Count of Participants|492|492.0||||||
3712917|NCT02132767|3551939|B2||White|Race (NIH/OMB)||Participants|Count of Participants|250|250.0||||||
3712918|NCT02132767|3551940|B1||White|Race (NIH/OMB)||Participants|Count of Participants|242|242.0||||||
3712919|NCT02132767|3551938|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3712920|NCT02132767|3551939|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3712921|NCT02132767|3551940|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3712922|NCT02132767|3551938|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3712923|NCT02132767|3551939|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712924|NCT02132767|3551940|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3712925|NCT02132767|3551938|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3712926|NCT02132767|3551939|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3712927|NCT02132767|3551940|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3712928|NCT02132767|3551938|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3712929|NCT02132767|3551939|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3712930|NCT02132767|3551940|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3712931|NCT02132767|3551938|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712932|NCT02132767|3551939|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712933|NCT02132767|3551940|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712934|NCT02132767|3551938|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|501|501.0||||||
3712935|NCT02132767|3551939|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|249|249.0||||||
3712936|NCT02132767|3551940|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|252|252.0||||||
3712937|NCT02132767|3551938|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3712938|NCT02132767|3551939|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3712939|NCT02132767|3551940|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3712940|NCT02132767|3551938|B3||Male|Gender||Participants|Count of Participants|396|396.0||||||
3712941|NCT02132767|3551939|B2||Male|Gender||Participants|Count of Participants|199|199.0||||||
3712942|NCT02132767|3551940|B1||Male|Gender||Participants|Count of Participants|197|197.0||||||
3712943|NCT02132767|3551938|B3||Female|Gender||Participants|Count of Participants|127|127.0||||||
3712944|NCT02132767|3551939|B2||Female|Gender||Participants|Count of Participants|62|62.0||||||
3712945|NCT02132767|3551940|B1||Female|Gender||Participants|Count of Participants|65|65.0||||||
3712946|NCT02132767|3551938|B3|||Age||years|Mean|68.8|68.8|Standard Deviation|9.1|9.1|||
3712947|NCT02132767|3551939|B2|||Age||years|Mean|68.4|68.4|Standard Deviation|8.4|8.4|||
3712948|NCT02132767|3551940|B1|||Age||years|Mean|69.2|69.2|Standard Deviation|9.8|9.8|||
3712949|NCT02132637|3551961|B3|Germany||Region of Enrollment||Participants|Count of Participants|58|58.0||||||
3712950|NCT02132637|3551962|B2|Germany||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3712951|NCT02132637|3551963|B1|Germany||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3712952|NCT02132637|3551961|B3|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3712953|NCT02132637|3551962|B2|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3712954|NCT02132637|3551963|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3712955|NCT02132637|3551961|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712956|NCT02132637|3551962|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712957|NCT02132637|3551963|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712958|NCT02132637|3551961|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712959|NCT02132637|3551962|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712960|NCT02132637|3551963|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712961|NCT02132637|3551961|B3||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3712962|NCT02132637|3551962|B2||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3712963|NCT02132637|3551963|B1||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3712964|NCT02132637|3551961|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712965|NCT02132637|3551962|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712966|NCT02132637|3551963|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712967|NCT02132637|3551961|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3712968|NCT02132637|3551962|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712969|NCT02132637|3551963|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3712970|NCT02132637|3551961|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3712971|NCT02132637|3551962|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712972|NCT02132637|3551963|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3712973|NCT02132637|3551961|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712974|NCT02132637|3551962|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712975|NCT02132637|3551963|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712976|NCT02132637|3551961|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712977|NCT02132637|3551962|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712978|NCT02132637|3551963|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3712979|NCT02132637|3551961|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3712980|NCT02132637|3551962|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3712981|NCT02132637|3551963|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3712982|NCT02132637|3551961|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3712983|NCT02132637|3551962|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3712984|NCT02132637|3551963|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3712985|NCT02132637|3551961|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3712986|NCT02132637|3551962|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3712987|NCT02132637|3551963|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3712988|NCT02132637|3551961|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3712989|NCT02132637|3551962|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3712990|NCT02132637|3551963|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3712991|NCT02132637|3551961|B3|||Age||years|Mean|57.78|57.78|Standard Deviation|6.99|6.99|||
3712992|NCT02132637|3551962|B2|||Age||years|Mean|57.74|57.74|Standard Deviation|5.86|5.86|||
3712993|NCT02132637|3551963|B1|||Age||years|Mean|57.82|57.82|Standard Deviation|8.06|8.06|||
3712994|NCT02132611|3551988|B1|Unspecified||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3712995|NCT02132611|3551988|B1|White||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
3712996|NCT02132611|3551988|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3712997|NCT02132611|3551988|B1|Japanese||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3712998|NCT02132611|3551988|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3712999|NCT02132611|3551988|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3713000|NCT02132611|3551988|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3713001|NCT02132611|3551988|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3713002|NCT02132611|3551988|B1|||Age||years|Mean|70.7|70.7|Full Range|||45.1|89.1|
3713003|NCT02132572|3551993|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3713004|NCT02132572|3551993|B1||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3713005|NCT02132572|3551993|B1|Missing age data||Age, Customized||Participants|Number|3|3.0||||||
3713006|NCT02132572|3551993|B1|61 to 70 years||Age, Customized||Participants|Number|3|3.0||||||
3713007|NCT02132572|3551993|B1|51 to 60 years||Age, Customized||Participants|Number|18|18.0||||||
3713008|NCT02132572|3551993|B1|41 to 50 years||Age, Customized||Participants|Number|36|36.0||||||
3713009|NCT02132572|3551993|B1|31 to 40 years||Age, Customized||Participants|Number|74|74.0||||||
3713010|NCT02132572|3551993|B1|17 to 30 years||Age, Customized||Participants|Number|67|67.0||||||
3713011|NCT02132468|3551997|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713012|NCT02132468|3551997|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713013|NCT02132468|3551997|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3713014|NCT02132468|3551997|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3713015|NCT02132468|3551997|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713016|NCT02132468|3551997|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713017|NCT02132468|3551997|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713018|NCT02132468|3551997|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3713019|NCT02132468|3551997|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3713020|NCT02132468|3551997|B1|||Age||years|Mean|57.8|57.8|Standard Deviation|9.28|9.28|||
3713021|NCT02132247|3552004|B3|||Weight||Pounds|Mean|114.7|114.7|Standard Deviation|50.2|50.2|||
3713022|NCT02132247|3552005|B2|||Weight||Pounds|Mean|149.0|149.0|Standard Deviation|43.6|43.6|||
3713023|NCT02132247|3552006|B1|||Weight||Pounds|Mean|80.3|80.3|Standard Deviation|28.1|28.1|||
3713024|NCT02132247|3552004|B3|||Height||Inches|Mean|60.2|60.2|Standard Deviation|7.4|7.4|||
3713025|NCT02132247|3552005|B2|||Height||Inches|Mean|66.4|66.4|Standard Deviation|3.5|3.5|||
3713026|NCT02132247|3552006|B1|||Height||Inches|Mean|54.1|54.1|Standard Deviation|4.8|4.8|||
3713027|NCT02132247|3552004|B3|||Injury-Associated Pain Assessment|Wong-Baker FACES Scale: No Hurt - 0; Hurts little bit - 1; Hurts little more - 2; Hurts even more - 3; Hurts whole lot - 4; Hurts worst - 5|units on a scale|Mean|3.47|3.47|Standard Deviation|0.61|0.61|||
3713028|NCT02132247|3552005|B2|||Injury-Associated Pain Assessment|Wong-Baker FACES Scale: No Hurt - 0; Hurts little bit - 1; Hurts little more - 2; Hurts even more - 3; Hurts whole lot - 4; Hurts worst - 5|units on a scale|Mean|3.58|3.58|Standard Deviation|0.64|0.64|||
3713029|NCT02132247|3552006|B1|||Injury-Associated Pain Assessment|Wong-Baker FACES Scale: No Hurt - 0; Hurts little bit - 1; Hurts little more - 2; Hurts even more - 3; Hurts whole lot - 4; Hurts worst - 5|units on a scale|Mean|3.37|3.37|Standard Deviation|.56|0.56|||
3713030|NCT02132247|3552004|B3|United States||Region of Enrollment||Participants|Count of Participants|104|104.0||||||
3713031|NCT02132247|3552005|B2|United States||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
3713032|NCT02132247|3552006|B1|United States||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
3713033|NCT02132247|3552004|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713034|NCT02132247|3552005|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713035|NCT02132247|3552006|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713036|NCT02132247|3552004|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3713037|NCT02132247|3552005|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3713038|NCT02132247|3552006|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3713039|NCT02132247|3552004|B3||White|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3713040|NCT02132247|3552005|B2||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3713041|NCT02132247|3552006|B1||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3713042|NCT02132247|3552004|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3713043|NCT02132247|3552005|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3713044|NCT02132247|3552006|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3713045|NCT02132247|3552004|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3713046|NCT02132247|3552005|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3713047|NCT02132247|3552006|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713048|NCT02132247|3552004|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3713049|NCT02132247|3552005|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3713050|NCT02132247|3552006|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713051|NCT02132247|3552004|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713052|NCT02132247|3552005|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713053|NCT02132247|3552006|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713054|NCT02132247|3552004|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3713055|NCT02132247|3552005|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3713056|NCT02132247|3552006|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3713057|NCT02132247|3552004|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3713058|NCT02132247|3552005|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3713059|NCT02132247|3552006|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3713060|NCT02132247|3552004|B3|||Age, Customized|Eligible patients between 6 and 16 years old were enrolled in equal numbers into two subgroups, 6-11 years old and 12-16 years old.|Participants|Count of Participants|104|104.0||||||
3713061|NCT02132247|3552005|B2|||Age, Customized|Eligible patients between 6 and 16 years old were enrolled in equal numbers into two subgroups, 6-11 years old and 12-16 years old.|Participants|Count of Participants|52|52.0||||||
3713062|NCT02132247|3552006|B1|||Age, Customized|Eligible patients between 6 and 16 years old were enrolled in equal numbers into two subgroups, 6-11 years old and 12-16 years old.|Participants|Count of Participants|52|52.0||||||
3713063|NCT02132169|3552019|B3|United States||Region of Enrollment||participants|Number|512|512.0||||||
3713064|NCT02132169|3552020|B2|United States||Region of Enrollment||participants|Number|171|171.0||||||
3713065|NCT02132169|3552021|B1|United States||Region of Enrollment||participants|Number|341|341.0||||||
3713066|NCT02132169|3552019|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3713067|NCT02132169|3552020|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3713068|NCT02132169|3552021|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3713069|NCT02132169|3552019|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713070|NCT02132169|3552020|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713071|NCT02132169|3552021|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713072|NCT02132169|3552019|B3||White|Race (NIH/OMB)||Participants|Count of Participants|447|447.0||||||
3713073|NCT02132169|3552020|B2||White|Race (NIH/OMB)||Participants|Count of Participants|149|149.0||||||
3713074|NCT02132169|3552021|B1||White|Race (NIH/OMB)||Participants|Count of Participants|298|298.0||||||
3713075|NCT02132169|3552019|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3713076|NCT02132169|3552020|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3713077|NCT02132169|3552021|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3713078|NCT02132169|3552019|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713079|NCT02132169|3552020|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713080|NCT02132169|3552021|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713081|NCT02132169|3552019|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3713082|NCT02132169|3552020|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3713083|NCT02132169|3552021|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3713084|NCT02132169|3552019|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3713085|NCT02132169|3552020|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3713086|NCT02132169|3552021|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3713087|NCT02132169|3552019|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713088|NCT02132169|3552020|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713089|NCT02132169|3552021|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713090|NCT02132169|3552019|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|481|481.0||||||
3713091|NCT02132169|3552020|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|160|160.0||||||
3713092|NCT02132169|3552021|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|321|321.0||||||
3713093|NCT02132169|3552019|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3713094|NCT02132169|3552020|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3713095|NCT02132169|3552021|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3713096|NCT02132169|3552019|B3||Male|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
3713097|NCT02132169|3552020|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3713098|NCT02132169|3552021|B1||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3713099|NCT02132169|3552019|B3||Female|Sex: Female, Male||Participants|Count of Participants|309|309.0||||||
3713100|NCT02132169|3552020|B2||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3713101|NCT02132169|3552021|B1||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
3713102|NCT02132169|3552019|B3|>/= 18 years old||Age, Customized||participants|Number|389|389.0||||||
3713103|NCT02132169|3552020|B2|>/= 18 years old||Age, Customized||participants|Number|130|130.0||||||
3713104|NCT02132169|3552021|B1|>/= 18 years old||Age, Customized||participants|Number|259|259.0||||||
3713105|NCT02132169|3552019|B3|13-17 years old||Age, Customized||participants|Number|50|50.0||||||
3713106|NCT02132169|3552020|B2|13-17 years old||Age, Customized||participants|Number|16|16.0||||||
3713107|NCT02132169|3552021|B1|13-17 years old||Age, Customized||participants|Number|34|34.0||||||
3713108|NCT02132169|3552019|B3|7-12 years old||Age, Customized||participants|Number|40|40.0||||||
3713109|NCT02132169|3552020|B2|7-12 years old||Age, Customized||participants|Number|12|12.0||||||
3713110|NCT02132169|3552021|B1|7-12 years old||Age, Customized||participants|Number|28|28.0||||||
3713111|NCT02132169|3552019|B3|2-6 years old||Age, Customized||participants|Number|33|33.0||||||
3713112|NCT02132169|3552020|B2|2-6 years old||Age, Customized||participants|Number|13|13.0||||||
3713113|NCT02132169|3552021|B1|2-6 years old||Age, Customized||participants|Number|20|20.0||||||
3713114|NCT02132169|3552019|B3|||Age||years|Mean|35.4|35.4|Standard Deviation|19.42|19.42|||
3713115|NCT02132169|3552020|B2|||Age||years|Mean|36.6|36.6|Standard Deviation|19.56|19.56|||
3713116|NCT02132169|3552021|B1|||Age||years|Mean|34.9|34.9|Standard Deviation|19.36|19.36|||
3713117|NCT02132117|3552034|B3||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3713118|NCT02132117|3552035|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3713119|NCT02132117|3552036|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3713120|NCT02132117|3552034|B3||Female|Sex: Female, Male||Participants|Count of Participants|350|350.0||||||
3713121|NCT02132117|3552035|B2||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
3713122|NCT02132117|3552036|B1||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
3713123|NCT02132117|3552034|B3|>=65 years||Age, Customized||participants|Number|54|54.0||||||
3713124|NCT02132117|3552035|B2|>=65 years||Age, Customized||participants|Number|28|28.0||||||
3713125|NCT02132117|3552036|B1|>=65 years||Age, Customized||participants|Number|26|26.0||||||
3713126|NCT02132117|3552034|B3|18-64 years||Age, Customized||participants|Number|391|391.0||||||
3713127|NCT02132117|3552035|B2|18-64 years||Age, Customized||participants|Number|193|193.0||||||
3713128|NCT02132117|3552036|B1|18-64 years||Age, Customized||participants|Number|198|198.0||||||
3713129|NCT02131662|3552053|B6|||Volume of largest fibroid by US||millilitre(s)|Mean|82.22|82.22|Standard Deviation|95.94|95.94|||
3713130|NCT02131662|3552054|B5|||Volume of largest fibroid by US||millilitre(s)|Mean|99.03|99.03|Standard Deviation|117.379|117.379|||
3713131|NCT02131662|3552055|B4|||Volume of largest fibroid by US||millilitre(s)|Mean|81.69|81.69|Standard Deviation|85.62|85.62|||
3713132|NCT02131662|3552056|B3|||Volume of largest fibroid by US||millilitre(s)|Mean|74.55|74.55|Standard Deviation|88.397|88.397|||
3713133|NCT02131662|3552057|B2|||Volume of largest fibroid by US||millilitre(s)|Mean|77.66|77.66|Standard Deviation|91.605|91.605|||
3713134|NCT02131662|3552058|B1|||Volume of largest fibroid by US||millilitre(s)|Mean|78.92|78.92|Standard Deviation|95.644|95.644|||
3713135|NCT02131662|3552053|B6|||Baseline menstrual blood loss by MP||millilitre(s)|Mean|173.2|173.2|Standard Deviation|107.21|107.21|||
3713136|NCT02131662|3552054|B5|||Baseline menstrual blood loss by MP||millilitre(s)|Mean|164.6|164.6|Standard Deviation|78.71|78.71|||
3713137|NCT02131662|3552055|B4|||Baseline menstrual blood loss by MP||millilitre(s)|Mean|173.6|173.6|Standard Deviation|94.62|94.62|||
3713138|NCT02131662|3552056|B3|||Baseline menstrual blood loss by MP||millilitre(s)|Mean|178.2|178.2|Standard Deviation|116.64|116.64|||
3713139|NCT02131662|3552057|B2|||Baseline menstrual blood loss by MP||millilitre(s)|Mean|176.9|176.9|Standard Deviation|128.71|128.71|||
3713140|NCT02131662|3552058|B1|||Baseline menstrual blood loss by MP||millilitre(s)|Mean|172.3|172.3|Standard Deviation|111.86|111.86|||
3713141|NCT02131662|3552053|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3713142|NCT02131662|3552054|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3713143|NCT02131662|3552055|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3713144|NCT02131662|3552056|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3713145|NCT02131662|3552057|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3713146|NCT02131662|3552058|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3713147|NCT02131662|3552053|B6||Female|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
3713148|NCT02131662|3552054|B5||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3713149|NCT02131662|3552055|B4||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3713150|NCT02131662|3552056|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3713151|NCT02131662|3552057|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3713152|NCT02131662|3552058|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3713153|NCT02131662|3552053|B6|||Age||years|Mean|42.6|42.6|Standard Deviation|4.7|4.7|||
3713154|NCT02131662|3552054|B5|||Age||years|Mean|42.8|42.8|Standard Deviation|5.1|5.1|||
3713155|NCT02131662|3552055|B4|||Age||years|Mean|41.7|41.7|Standard Deviation|4.9|4.9|||
3713156|NCT02131662|3552056|B3|||Age||years|Mean|41.9|41.9|Standard Deviation|4.5|4.5|||
3713157|NCT02131662|3552057|B2|||Age||years|Mean|43|43.0|Standard Deviation|4.6|4.6|||
3713158|NCT02131662|3552058|B1|||Age||years|Mean|43.5|43.5|Standard Deviation|4.2|4.2|||
3713159|NCT02131636|3552106|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3713160|NCT02131636|3552107|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3713161|NCT02131636|3552108|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3713162|NCT02131636|3552106|B3||Female|Sex: Female, Male||Participants|Count of Participants|347|347.0||||||
3713163|NCT02131636|3552107|B2||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
3713164|NCT02131636|3552108|B1||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3713165|NCT02131636|3552106|B3|>=65 years||Age, Customized||Participants|Number|57|57.0||||||
3713166|NCT02131636|3552107|B2|>=65 years||Age, Customized||Participants|Number|24|24.0||||||
3713167|NCT02131636|3552108|B1|>=65 years||Age, Customized||Participants|Number|33|33.0||||||
3713168|NCT02131636|3552106|B3|18 to 64 years||Age, Customized||Participants|Number|383|383.0||||||
3713169|NCT02131636|3552107|B2|18 to 64 years||Age, Customized||Participants|Number|194|194.0||||||
3713170|NCT02131636|3552108|B1|18 to 64 years||Age, Customized||Participants|Number|189|189.0||||||
3713171|NCT02131532|3552125|B1|||Stroke Impact Scale - Social Activity|The score ranges from 0 to 100, with higher scores indicating better outcomes.|units on a scale|Mean|67.85|67.85|Standard Deviation|24.55|24.55|||
3713172|NCT02131532|3552125|B1|||Stroke Impact Scale - Hand Function|The score ranges from 0 to 100, with higher scores indicating better outcomes.|units on a scale|Mean|93.75|93.75|Standard Deviation|9.54|9.54|||
3713173|NCT02131532|3552125|B1|||Stroke Impact Scale - Mobility|The score ranges from 0 to 100, with higher scores indicating better outcomes.|units on a scale|Mean|87.50|87.5|Standard Deviation|15.14|15.14|||
3713174|NCT02131532|3552125|B1|||Stroke Impact Scale - Daily Activities|The score ranges from 0 to 100, with higher scores indicating better outcomes.|units on a scale|Mean|93.44|93.44|Standard Deviation|6.54|6.54|||
3713175|NCT02131532|3552125|B1|||Stroke Impact Scale - Communication|The score ranges from 0 to 100, with higher scores indicating better outcomes.|units on a scale|Mean|80.36|80.36|Standard Deviation|23.30|23.3|||
3713176|NCT02131532|3552125|B1|||Stroke Impact Scale - Emotion|The score ranges from 0 to 100, with higher scores indicating better outcomes.|units on a scale|Mean|65.97|65.97|Standard Deviation|26.13|26.13|||
3713177|NCT02131532|3552125|B1|||Stroke Impact Scale - Memory and Thinking|The score ranges from 0 to 100, with higher scores indicating better outcomes.|units on a scale|Mean|75.45|75.45|Standard Deviation|21.29|21.29|||
3713178|NCT02131532|3552125|B1|||Stroke Impact Scale - Physical Strength|The score ranges from 0 to 100, with higher scores indicating better outcomes.|units on a scale|Mean|89.06|89.06|Standard Deviation|9.88|9.88|||
3713179|NCT02131532|3552125|B1|||Stroke Impact Scale - General rating of recovery|The score ranges from 0 to 100, presenting the percentage of recovery from stroke.|units on a scale|Mean|74.8|74.8|Standard Deviation|16.7|16.7|||
3713180|NCT02131532|3552125|B1|||Nottingham Extended Activities of Daily Living|The total score of NEADL ranges from 0 to 22, with higher scores indicating better outcomes|units on a scale|Mean|20.8|20.8|Standard Deviation|0.9|0.9|||
3713181|NCT02131532|3552125|B1|||Patient Health Questionnaire-9|The total score of PHQ-9 ranges from 0 to 27, with higher scores indicating worse outcomes.|units on a scale|Mean|7.6|7.6|Standard Deviation|4.3|4.3|||
3713182|NCT02131532|3552125|B1|Not fulfilling case definition||Case definition of post-stroke fatigue|To fulfill this case definition, the patient should describe feelings of tiredness, lack of energy or fatigue or increased need to rest as opposed to lack of motivation or boredom. Also the patient should have felt fatigue everyday or nearly everyday for at least 2 weeks in the past month. Finally, fatigue must be perceived as a problem and affect everyday activities.|participants|Number|3|3.0||||||
3713183|NCT02131532|3552125|B1|Fulfilling case definition||Case definition of post-stroke fatigue|To fulfill this case definition, the patient should describe feelings of tiredness, lack of energy or fatigue or increased need to rest as opposed to lack of motivation or boredom. Also the patient should have felt fatigue everyday or nearly everyday for at least 2 weeks in the past month. Finally, fatigue must be perceived as a problem and affect everyday activities.|participants|Number|5|5.0||||||
3713184|NCT02131532|3552125|B1|||Fatigue Assessment Scale|The total score of FAS ranges from 10 to 50, with higher scores indicating worse outcomes.|units on a scale|Mean|26.5|26.5|Standard Deviation|8.0|8.0|||
3713185|NCT02131532|3552125|B1|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3713186|NCT02131532|3552125|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3713187|NCT02131532|3552125|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3713188|NCT02131532|3552125|B1|||Age||years|Mean|62.0|62.0|Standard Deviation|14.7|14.7|||
3713189|NCT02131402|3552144|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3713190|NCT02131402|3552144|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3713191|NCT02131402|3552144|B1|||Age||years|Mean|25.78|25.78|Standard Deviation|5.34|5.34|||
3713192|NCT02131324|3552215|B3|||Body Surface Area (BSA) affected by psoriasis||cm^2|Mean|26.8|26.8|Standard Deviation|8.4|8.4|||
3713193|NCT02131324|3552216|B2|||Body Surface Area (BSA) affected by psoriasis||cm^2|Mean|27.0|27.0|Standard Deviation|8.3|8.3|||
3713194|NCT02131324|3552217|B1|||Body Surface Area (BSA) affected by psoriasis||cm^2|Mean|26.5|26.5|Standard Deviation|8.6|8.6|||
3713195|NCT02131324|3552215|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
3713196|NCT02131324|3552216|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
3713197|NCT02131324|3552217|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3713198|NCT02131324|3552215|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713199|NCT02131324|3552216|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713200|NCT02131324|3552217|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713201|NCT02131324|3552215|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713202|NCT02131324|3552216|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713203|NCT02131324|3552217|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713204|NCT02131324|3552215|B3||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3713205|NCT02131324|3552216|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3713206|NCT02131324|3552217|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3713207|NCT02131324|3552215|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713208|NCT02131324|3552216|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713209|NCT02131324|3552217|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713210|NCT02131324|3552215|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713211|NCT02131324|3552216|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713212|NCT02131324|3552217|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713213|NCT02131324|3552215|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713214|NCT02131324|3552216|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713215|NCT02131324|3552217|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713216|NCT02131324|3552215|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713217|NCT02131324|3552216|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713218|NCT02131324|3552217|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713219|NCT02131324|3552215|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713220|NCT02131324|3552216|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713221|NCT02131324|3552217|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713222|NCT02131324|3552215|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3713223|NCT02131324|3552216|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3713224|NCT02131324|3552217|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3713225|NCT02131324|3552215|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3713226|NCT02131324|3552216|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3713227|NCT02131324|3552217|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3713228|NCT02131324|3552215|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3713229|NCT02131324|3552216|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3713230|NCT02131324|3552217|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3713231|NCT02131324|3552215|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3713232|NCT02131324|3552216|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3713233|NCT02131324|3552217|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3713234|NCT02131324|3552215|B3|||Age||years|Mean|47.0|47.0|Standard Deviation|13.4|13.4|||
3713235|NCT02131324|3552216|B2|||Age||years|Mean|50.9|50.9|Standard Deviation|11.2|11.2|||
3713236|NCT02131324|3552217|B1|||Age||years|Mean|43.5|43.5|Standard Deviation|14.5|14.5|||
3713237|NCT02131324|3552215|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3713238|NCT02131324|3552216|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3713239|NCT02131324|3552217|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3713240|NCT02131324|3552215|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3713241|NCT02131324|3552216|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3713242|NCT02131324|3552217|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3713243|NCT02131324|3552215|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3713244|NCT02131324|3552216|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3713245|NCT02131324|3552217|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3713246|NCT02131311|3552224|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3713247|NCT02131311|3552224|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3713248|NCT02131311|3552224|B1|||Age||years|Mean|52|52.0|Standard Deviation|11.18|11.18|||
3713249|NCT02131272|3552234|B3|||Body weight standard deviation score|In order to reduce the variability in body weight measurements, standard deviation scores (SDS) were calculated. SDS for weight was derived by comparing the actual measurements with standard growth charts for the United States. Standard values provided by the standard growth charts according to the subject’s sex and age at the time of the measurement were used to calculate the SDS.|standard deviation score|Mean|1.390|1.39|Standard Deviation|0.771|0.771|||
3713250|NCT02131272|3552235|B2|||Body weight standard deviation score|In order to reduce the variability in body weight measurements, standard deviation scores (SDS) were calculated. SDS for weight was derived by comparing the actual measurements with standard growth charts for the United States. Standard values provided by the standard growth charts according to the subject’s sex and age at the time of the measurement were used to calculate the SDS.|standard deviation score|Mean|1.260|1.26|Standard Deviation|0.835|0.835|||
3713251|NCT02131272|3552236|B1|||Body weight standard deviation score|In order to reduce the variability in body weight measurements, standard deviation scores (SDS) were calculated. SDS for weight was derived by comparing the actual measurements with standard growth charts for the United States. Standard values provided by the standard growth charts according to the subject’s sex and age at the time of the measurement were used to calculate the SDS.|standard deviation score|Mean|1.532|1.532|Standard Deviation|0.685|0.685|||
3713252|NCT02131272|3552234|B3|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.84|8.84|Standard Deviation|0.96|0.96|||
3713253|NCT02131272|3552235|B2|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.95|8.95|Standard Deviation|1.05|1.05|||
3713254|NCT02131272|3552236|B1|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.72|8.72|Standard Deviation|0.86|0.86|||
3713255|NCT02131272|3552234|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3713256|NCT02131272|3552235|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3713257|NCT02131272|3552236|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3713258|NCT02131272|3552234|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3713259|NCT02131272|3552235|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3713260|NCT02131272|3552236|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3713261|NCT02131272|3552234|B3|||Age||Years|Mean|15.0|15.0|Standard Deviation|2.1|2.1|||
3713262|NCT02131272|3552235|B2|||Age||Years|Mean|15.0|15.0|Standard Deviation|2.2|2.2|||
3713263|NCT02131272|3552236|B1|||Age||Years|Mean|15.0|15.0|Standard Deviation|2.1|2.1|||
3713264|NCT02131259|3552255|B1||Male|Sex: Female, Male||Participants|Count of Participants|655|655.0||||||
3713265|NCT02131259|3552255|B1||Female|Sex: Female, Male||Participants|Count of Participants|947|947.0||||||
3713266|NCT02131259|3552255|B1|||Age||Years|Mean|65.9|65.9|Standard Deviation|10.2|10.2|||
3713267|NCT02131233|3552260|B3||Male|Sex: Female, Male||Participants|Count of Participants|674|674.0||||||
3713268|NCT02131233|3552261|B2||Male|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
3713269|NCT02131233|3552262|B1||Male|Sex: Female, Male||Participants|Count of Participants|440|440.0||||||
3713270|NCT02131233|3552260|B3||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3713271|NCT02131233|3552261|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3713272|NCT02131233|3552262|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3713273|NCT02131233|3552260|B3|||Age||Years|Mean|35.9|35.9|Standard Deviation|10.5|10.5|||
3713274|NCT02131233|3552261|B2|||Age||Years|Mean|36.9|36.9|Standard Deviation|11.0|11.0|||
3713275|NCT02131233|3552262|B1|||Age||Years|Mean|35.4|35.4|Standard Deviation|10.3|10.3|||
3713276|NCT02131064|3552295|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3713277|NCT02131064|3552296|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3713278|NCT02131064|3552297|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3713279|NCT02131064|3552295|B3||Female|Sex: Female, Male||Participants|Count of Participants|443|443.0||||||
3713280|NCT02131064|3552296|B2||Female|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
3713281|NCT02131064|3552297|B1||Female|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
3713282|NCT02131064|3552295|B3|||Age||years|Mean|49.9|49.9|Standard Deviation|10.9|10.9|||
3713283|NCT02131064|3552296|B2|||Age||years|Mean|50.5|50.5|Standard Deviation|10.6|10.6|||
3713284|NCT02131064|3552297|B1|||Age||years|Mean|49.3|49.3|Standard Deviation|11.2|11.2|||
3713285|NCT02130999|3552330|B1|||Height||(cm)|Mean|166.6|166.6|Standard Deviation|10.4|10.4|||
3713286|NCT02130999|3552330|B1|||Weight||(kg)|Mean|63.6|63.6|Standard Deviation|8|8.0|||
3713287|NCT02130999|3552330|B1|||Body Mass Index||(kg/m^2)|Mean|22.8|22.8|Standard Deviation|1.8|1.8|||
3713288|NCT02130999|3552330|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3713289|NCT02130999|3552330|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713290|NCT02130999|3552330|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713291|NCT02130999|3552330|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3713292|NCT02130999|3552330|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3713293|NCT02130999|3552330|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713294|NCT02130999|3552330|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713295|NCT02130999|3552330|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713296|NCT02130999|3552330|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713297|NCT02130999|3552330|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3713298|NCT02130999|3552330|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713299|NCT02130999|3552330|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3713300|NCT02130999|3552330|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3713301|NCT02130999|3552330|B1|||Age||years|Mean|31.2|31.2|Standard Deviation|10.6|10.6|||
3713302|NCT02130765|3552357|B5|France||Region of Enrollment||participants|Number|7|7.0||||||
3713303|NCT02130765|3552358|B4|France||Region of Enrollment||participants|Number|1|1.0||||||
3713304|NCT02130765|3552359|B3|France||Region of Enrollment||participants|Number|0|0.0||||||
3713305|NCT02130765|3552360|B2|France||Region of Enrollment||participants|Number|2|2.0||||||
3713306|NCT02130765|3552361|B1|France||Region of Enrollment||participants|Number|4|4.0||||||
3713307|NCT02130765|3552357|B5|Italy||Region of Enrollment||participants|Number|7|7.0||||||
3713308|NCT02130765|3552358|B4|Italy||Region of Enrollment||participants|Number|1|1.0||||||
3713309|NCT02130765|3552359|B3|Italy||Region of Enrollment||participants|Number|5|5.0||||||
3713310|NCT02130765|3552360|B2|Italy||Region of Enrollment||participants|Number|0|0.0||||||
3713311|NCT02130765|3552361|B1|Italy||Region of Enrollment||participants|Number|1|1.0||||||
3713312|NCT02130765|3552357|B5|United States||Region of Enrollment||participants|Number|50|50.0||||||
3713313|NCT02130765|3552358|B4|United States||Region of Enrollment||participants|Number|17|17.0||||||
3713314|NCT02130765|3552359|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
3713315|NCT02130765|3552360|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3713316|NCT02130765|3552361|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3713317|NCT02130765|3552357|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3713318|NCT02130765|3552358|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3713319|NCT02130765|3552359|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713320|NCT02130765|3552360|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3713321|NCT02130765|3552361|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3713322|NCT02130765|3552357|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713323|NCT02130765|3552358|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713324|NCT02130765|3552359|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713325|NCT02130765|3552360|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713326|NCT02130765|3552361|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713327|NCT02130765|3552357|B5||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3713328|NCT02130765|3552358|B4||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3713329|NCT02130765|3552359|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3713330|NCT02130765|3552360|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3713331|NCT02130765|3552361|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3713332|NCT02130765|3552357|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3713333|NCT02130765|3552358|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3713334|NCT02130765|3552359|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3713335|NCT02130765|3552360|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3713336|NCT02130765|3552361|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713337|NCT02130765|3552357|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713338|NCT02130765|3552358|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713339|NCT02130765|3552359|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713340|NCT02130765|3552360|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713341|NCT02130765|3552361|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713342|NCT02130765|3552357|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3713343|NCT02130765|3552358|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3713344|NCT02130765|3552359|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713345|NCT02130765|3552360|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713346|NCT02130765|3552361|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713347|NCT02130765|3552357|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713348|NCT02130765|3552358|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713349|NCT02130765|3552359|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713350|NCT02130765|3552360|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713351|NCT02130765|3552361|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713352|NCT02130765|3552357|B5||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3713353|NCT02130765|3552358|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3713354|NCT02130765|3552359|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3713355|NCT02130765|3552360|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3713356|NCT02130765|3552361|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3713357|NCT02130765|3552357|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3713358|NCT02130765|3552358|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3713359|NCT02130765|3552359|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3713360|NCT02130765|3552360|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3713361|NCT02130765|3552361|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3713362|NCT02130765|3552357|B5|||Age||years|Mean|60.9|60.9|Standard Deviation|11.3|11.3|||
3713363|NCT02130765|3552358|B4|||Age||years|Mean|58.4|58.4|Standard Deviation|15.0|15.0|||
3713364|NCT02130765|3552359|B3|||Age||years|Mean|60.6|60.6|Standard Deviation|10.8|10.8|||
3713365|NCT02130765|3552360|B2|||Age||years|Mean|61.3|61.3|Standard Deviation|7.3|7.3|||
3713366|NCT02130765|3552361|B1|||Age||years|Mean|65.6|65.6|Standard Deviation|5.9|5.9|||
3713367|NCT02130635|3552383|B10|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|64|64.0||||||
3713368|NCT02130635|3552384|B9|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3713369|NCT02130635|3552385|B8|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3713370|NCT02130635|3552386|B7|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3713371|NCT02130635|3552387|B6|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3713372|NCT02130635|3552388|B5|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3713373|NCT02130635|3552389|B4|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3713374|NCT02130635|3552390|B3|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3713375|NCT02130635|3552391|B2|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
3713376|NCT02130635|3552392|B1|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3713377|NCT02130635|3552383|B10||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3713378|NCT02130635|3552384|B9||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3713379|NCT02130635|3552385|B8||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3713380|NCT02130635|3552386|B7||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3713381|NCT02130635|3552387|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3713382|NCT02130635|3552388|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3713383|NCT02130635|3552389|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3713384|NCT02130635|3552390|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3713385|NCT02130635|3552391|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3713386|NCT02130635|3552392|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3713387|NCT02130635|3552383|B10||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3713388|NCT02130635|3552384|B9||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3713389|NCT02130635|3552385|B8||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3713390|NCT02130635|3552386|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3713391|NCT02130635|3552387|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3713392|NCT02130635|3552388|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3713393|NCT02130635|3552389|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3713394|NCT02130635|3552390|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3713395|NCT02130635|3552391|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3713396|NCT02130635|3552392|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3713397|NCT02130635|3552383|B10|||Age|Data for Part B is presented.|Years|Mean|63.3|63.3|Standard Deviation|6.34|6.34|||
3713398|NCT02130635|3552384|B9|||Age|Data for Part B is presented.|Years|Mean|62.4|62.4|Standard Deviation|6.43|6.43|||
3713399|NCT02130635|3552385|B8|||Age|Data for Part B is presented.|Years|Mean|62.4|62.4|Standard Deviation|9.24|9.24|||
3713400|NCT02130635|3552386|B7|||Age|Data for Part B is presented.|Years|Mean|64.7|64.7|Standard Deviation|7.26|7.26|||
3713401|NCT02130635|3552387|B6|||Age|Data for Part B is presented.|Years|Mean|65.4|65.4|Standard Deviation|5.81|5.81|||
3713402|NCT02130635|3552388|B5|||Age|Data for Part B is presented.|Years|Mean|62.2|62.2|Standard Deviation|8.23|8.23|||
3713403|NCT02130635|3552389|B4|||Age|Data for Part B is presented.|Years|Mean|61.6|61.6|Standard Deviation|4.56|4.56|||
3713404|NCT02130635|3552390|B3|||Age|Data for Part B is presented.|Years|Mean|64.4|64.4|Standard Deviation|4.45|4.45|||
3713405|NCT02130635|3552383|B10|||Age|Data provided for Part A|Years|Mean|61.7|61.7|Standard Deviation|6.68|6.68|||
3713406|NCT02130635|3552391|B2|||Age|Data provided for Part A|Years|Mean|60.5|60.5|Standard Deviation|6.68|6.68|||
3713407|NCT02130635|3552392|B1|||Age|Data provided for Part A|Years|Mean|65.1|65.1|Standard Deviation|5.81|5.81|||
3713408|NCT02130622|3552572|B3|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3713409|NCT02130622|3552573|B2|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3713410|NCT02130622|3552574|B1|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3713411|NCT02130622|3552572|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713412|NCT02130622|3552573|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713413|NCT02130622|3552574|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713414|NCT02130622|3552572|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713415|NCT02130622|3552573|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713416|NCT02130622|3552574|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713417|NCT02130622|3552572|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3713418|NCT02130622|3552573|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3713419|NCT02130622|3552574|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3713420|NCT02130622|3552572|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713421|NCT02130622|3552573|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713422|NCT02130622|3552574|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713423|NCT02130622|3552572|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713424|NCT02130622|3552573|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713425|NCT02130622|3552574|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713426|NCT02130622|3552572|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713427|NCT02130622|3552573|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713428|NCT02130622|3552574|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713429|NCT02130622|3552572|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713430|NCT02130622|3552573|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713431|NCT02130622|3552574|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713432|NCT02130622|3552572|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713433|NCT02130622|3552573|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713434|NCT02130622|3552574|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713435|NCT02130622|3552572|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3713436|NCT02130622|3552573|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3713437|NCT02130622|3552574|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3713438|NCT02130622|3552572|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713439|NCT02130622|3552573|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713440|NCT02130622|3552574|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713441|NCT02130622|3552572|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3713442|NCT02130622|3552573|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3713443|NCT02130622|3552574|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3713444|NCT02130622|3552572|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3713445|NCT02130622|3552573|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3713446|NCT02130622|3552574|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3713447|NCT02130622|3552572|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3713448|NCT02130622|3552573|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3713449|NCT02130622|3552574|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3713450|NCT02130622|3552572|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3713451|NCT02130622|3552573|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3713452|NCT02130622|3552574|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3713453|NCT02130622|3552572|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3713454|NCT02130622|3552573|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3713455|NCT02130622|3552574|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3713456|NCT02130557|3552587|B3||Male|Sex: Female, Male||Participants|Count of Participants|311|311.0||||||
3713457|NCT02130557|3552588|B2||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3713458|NCT02130557|3552589|B1||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3713459|NCT02130557|3552587|B3||Female|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
3713460|NCT02130557|3552588|B2||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3713461|NCT02130557|3552589|B1||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3713462|NCT02130557|3552587|B3|||Age||years|Median|53.0|53.0|Full Range|||18.0|84.0|
3713463|NCT02130557|3552588|B2|||Age||years|Median|53.0|53.0|Full Range|||19.0|84.0|
3713464|NCT02130557|3552589|B1|||Age||years|Median|53.0|53.0|Full Range|||18.0|84.0|
3713465|NCT02130284|3552622|B1|United States||Region of Enrollment||participants|Number|80|80.0||||||
3713466|NCT02130284|3552622|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3713467|NCT02130284|3552622|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3713468|NCT02130284|3552622|B1|||Age||years|Mean|35.0|35.0|Standard Deviation|16.90|16.9|||
3713469|NCT02130284|3552622|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3713470|NCT02130284|3552622|B1||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
3713471|NCT02130284|3552622|B1||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
3713472|NCT02130258|3552633|B3||Does not use opioids|Opioid Use||Participants|Count of Participants|13|13.0||||||
3713473|NCT02130258|3552634|B2||Does not use opioids|Opioid Use||Participants|Count of Participants|5|5.0||||||
3713474|NCT02130258|3552635|B1||Does not use opioids|Opioid Use||Participants|Count of Participants|8|8.0||||||
3713475|NCT02130258|3552633|B3||Uses opioids|Opioid Use||Participants|Count of Participants|7|7.0||||||
3713476|NCT02130258|3552634|B2||Uses opioids|Opioid Use||Participants|Count of Participants|6|6.0||||||
3713477|NCT02130258|3552635|B1||Uses opioids|Opioid Use||Participants|Count of Participants|1|1.0||||||
3713478|NCT02130258|3552633|B3|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3713479|NCT02130258|3552634|B2|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3713480|NCT02130258|3552635|B1|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3713481|NCT02130258|3552633|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3713482|NCT02130258|3552634|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3713483|NCT02130258|3552635|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713484|NCT02130258|3552633|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3713485|NCT02130258|3552634|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713486|NCT02130258|3552635|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3713487|NCT02130258|3552633|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3713488|NCT02130258|3552634|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3713489|NCT02130258|3552635|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3713490|NCT02130258|3552633|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3713491|NCT02130258|3552634|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713492|NCT02130258|3552635|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3713493|NCT02130258|3552633|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713494|NCT02130258|3552634|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713495|NCT02130258|3552635|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713496|NCT02130258|3552633|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3713497|NCT02130258|3552634|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713498|NCT02130258|3552635|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3713499|NCT02130258|3552633|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713500|NCT02130258|3552634|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713501|NCT02130258|3552635|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713502|NCT02130258|3552633|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3713503|NCT02130258|3552634|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3713504|NCT02130258|3552635|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3713505|NCT02130258|3552633|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3713506|NCT02130258|3552634|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3713507|NCT02130258|3552635|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3713508|NCT02130258|3552633|B3|||Age||years|Mean|56.15|56.15|Standard Deviation|12.68|12.68|||
3713509|NCT02130258|3552634|B2|||Age||years|Mean|54.44|54.44|Standard Deviation|11.56|11.56|||
3713510|NCT02130258|3552635|B1|||Age||years|Mean|57.55|57.55|Standard Deviation|14.49|14.49|||
3713511|NCT02130193|3552646|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|92|92.0||||||
3713512|NCT02130193|3552647|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|45|45.0||||||
3713513|NCT02130193|3552648|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|47|47.0||||||
3713514|NCT02130193|3552646|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3713515|NCT02130193|3552647|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3713516|NCT02130193|3552648|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3713517|NCT02130193|3552646|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3713518|NCT02130193|3552647|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3713519|NCT02130193|3552648|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3713520|NCT02130193|3552646|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3713521|NCT02130193|3552647|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3713522|NCT02130193|3552648|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3713523|NCT02130193|3552646|B3|||Age||Years|Mean|60.5|60.5|Standard Deviation|7.31|7.31|||
3713524|NCT02130193|3552647|B2|||Age||Years|Mean|62.4|62.4|Standard Deviation|6.91|6.91|||
3713525|NCT02130193|3552648|B1|||Age||Years|Mean|58.8|58.8|Standard Deviation|7.32|7.32|||
3713526|NCT02130063|3552714|B3|United States||Region of Enrollment||participants|Number|511|511.0||||||
3713527|NCT02130063|3552715|B2|United States||Region of Enrollment||participants|Number|169|169.0||||||
3713528|NCT02130063|3552716|B1|United States||Region of Enrollment||participants|Number|342|342.0||||||
3713529|NCT02130063|3552714|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3713530|NCT02130063|3552715|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3713531|NCT02130063|3552716|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3713532|NCT02130063|3552714|B3||Female|Sex: Female, Male||Participants|Count of Participants|463|463.0||||||
3713533|NCT02130063|3552715|B2||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3713534|NCT02130063|3552716|B1||Female|Sex: Female, Male||Participants|Count of Participants|309|309.0||||||
3713535|NCT02130063|3552714|B3|||Age||years|Mean|48.4|48.4|Standard Deviation|15.6|15.6|||
3713536|NCT02130063|3552715|B2|||Age||years|Mean|46.8|46.8|Standard Deviation|14.9|14.9|||
3713537|NCT02130063|3552716|B1|||Age||years|Mean|49.3|49.3|Standard Deviation|15.8|15.8|||
3713538|NCT02129777|3552729|B6|Ex-Smoker||Smoking Classification||participants|Number|36|36.0||||||
3713539|NCT02129777|3552730|B5|Ex-Smoker||Smoking Classification||participants|Number|8|8.0||||||
3713540|NCT02129777|3552731|B4|Ex-Smoker||Smoking Classification||participants|Number|5|5.0||||||
3713541|NCT02129777|3552732|B3|Ex-Smoker||Smoking Classification||participants|Number|6|6.0||||||
3713542|NCT02129777|3552733|B2|Ex-Smoker||Smoking Classification||participants|Number|8|8.0||||||
3713543|NCT02129777|3552734|B1|Ex-Smoker||Smoking Classification||participants|Number|9|9.0||||||
3713544|NCT02129777|3552729|B6|Current Smoker||Smoking Classification||participants|Number|34|34.0||||||
3713545|NCT02129777|3552730|B5|Current Smoker||Smoking Classification||participants|Number|5|5.0||||||
3713546|NCT02129777|3552731|B4|Current Smoker||Smoking Classification||participants|Number|7|7.0||||||
3713547|NCT02129777|3552732|B3|Current Smoker||Smoking Classification||participants|Number|9|9.0||||||
3713548|NCT02129777|3552733|B2|Current Smoker||Smoking Classification||participants|Number|5|5.0||||||
3713549|NCT02129777|3552734|B1|Current Smoker||Smoking Classification||participants|Number|8|8.0||||||
3713550|NCT02129777|3552729|B6|Never Smoked||Smoking Classification||participants|Number|52|52.0||||||
3713551|NCT02129777|3552730|B5|Never Smoked||Smoking Classification||participants|Number|12|12.0||||||
3713552|NCT02129777|3552731|B4|Never Smoked||Smoking Classification||participants|Number|13|13.0||||||
3713553|NCT02129777|3552732|B3|Never Smoked||Smoking Classification||participants|Number|9|9.0||||||
3713554|NCT02129777|3552733|B2|Never Smoked||Smoking Classification||participants|Number|11|11.0||||||
3713555|NCT02129777|3552734|B1|Never Smoked||Smoking Classification||participants|Number|7|7.0||||||
3713556|NCT02129777|3552729|B6|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|29.64|29.64|Standard Deviation|7.539|7.539|||
3713557|NCT02129777|3552730|B5|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|29.01|29.01|Standard Deviation|8.093|8.093|||
3713558|NCT02129777|3552731|B4|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|30.53|30.53|Standard Deviation|7.641|7.641|||
3713559|NCT02129777|3552732|B3|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|31.26|31.26|Standard Deviation|9.532|9.532|||
3713560|NCT02129777|3552733|B2|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|28.25|28.25|Standard Deviation|5.936|5.936|||
3713561|NCT02129777|3552734|B1|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|29.16|29.16|Standard Deviation|6.112|6.112|||
3713562|NCT02129777|3552729|B6|||Weight||kilogram|Mean|90.25|90.25|Standard Deviation|26.156|26.156|||
3713563|NCT02129777|3552730|B5|||Weight||kilogram|Mean|82.32|82.32|Standard Deviation|24.634|24.634|||
3713564|NCT02129777|3552731|B4|||Weight||kilogram|Mean|95.50|95.5|Standard Deviation|25.056|25.056|||
3713565|NCT02129777|3552732|B3|||Weight||kilogram|Mean|97.84|97.84|Standard Deviation|33.643|33.643|||
3713566|NCT02129777|3552733|B2|||Weight||kilogram|Mean|88.26|88.26|Standard Deviation|22.033|22.033|||
3713567|NCT02129777|3552734|B1|||Weight||kilogram|Mean|87.46|87.46|Standard Deviation|22.864|22.864|||
3713568|NCT02129777|3552729|B6|||Height||centimeter|Mean|173.9|173.9|Standard Deviation|9.61|9.61|||
3713569|NCT02129777|3552730|B5|||Height||centimeter|Mean|168.1|168.1|Standard Deviation|10.28|10.28|||
3713570|NCT02129777|3552731|B4|||Height||centimeter|Mean|176.8|176.8|Standard Deviation|8.59|8.59|||
3713571|NCT02129777|3552732|B3|||Height||centimeter|Mean|176.5|176.5|Standard Deviation|7.81|7.81|||
3713572|NCT02129777|3552733|B2|||Height||centimeter|Mean|176.1|176.1|Standard Deviation|7.73|7.73|||
3713573|NCT02129777|3552734|B1|||Height||centimeter|Mean|172.3|172.3|Standard Deviation|10.83|10.83|||
3713574|NCT02129777|3552729|B6|Poland||Region of Enrollment||participants|Number|46|46.0||||||
3713575|NCT02129777|3552730|B5|Poland||Region of Enrollment||participants|Number|9|9.0||||||
3713576|NCT02129777|3552731|B4|Poland||Region of Enrollment||participants|Number|10|10.0||||||
3713577|NCT02129777|3552732|B3|Poland||Region of Enrollment||participants|Number|10|10.0||||||
3713578|NCT02129777|3552733|B2|Poland||Region of Enrollment||participants|Number|8|8.0||||||
3713579|NCT02129777|3552734|B1|Poland||Region of Enrollment||participants|Number|9|9.0||||||
3713580|NCT02129777|3552729|B6|Latvia||Region of Enrollment||participants|Number|17|17.0||||||
3713581|NCT02129777|3552730|B5|Latvia||Region of Enrollment||participants|Number|2|2.0||||||
3713582|NCT02129777|3552731|B4|Latvia||Region of Enrollment||participants|Number|3|3.0||||||
3713583|NCT02129777|3552732|B3|Latvia||Region of Enrollment||participants|Number|2|2.0||||||
3713584|NCT02129777|3552733|B2|Latvia||Region of Enrollment||participants|Number|5|5.0||||||
3713585|NCT02129777|3552734|B1|Latvia||Region of Enrollment||participants|Number|5|5.0||||||
3713586|NCT02129777|3552729|B6|Germany||Region of Enrollment||participants|Number|1|1.0||||||
3713587|NCT02129777|3552730|B5|Germany||Region of Enrollment||participants|Number|1|1.0||||||
3713588|NCT02129777|3552731|B4|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3713589|NCT02129777|3552732|B3|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3713590|NCT02129777|3552733|B2|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3713591|NCT02129777|3552734|B1|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3713592|NCT02129777|3552729|B6|Denmark||Region of Enrollment||participants|Number|2|2.0||||||
3713593|NCT02129777|3552730|B5|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
3713594|NCT02129777|3552731|B4|Denmark||Region of Enrollment||participants|Number|0|0.0||||||
3713595|NCT02129777|3552732|B3|Denmark||Region of Enrollment||participants|Number|0|0.0||||||
3713596|NCT02129777|3552733|B2|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
3713597|NCT02129777|3552734|B1|Denmark||Region of Enrollment||participants|Number|0|0.0||||||
3713598|NCT02129777|3552729|B6|Canada||Region of Enrollment||participants|Number|56|56.0||||||
3713599|NCT02129777|3552730|B5|Canada||Region of Enrollment||participants|Number|12|12.0||||||
3713600|NCT02129777|3552731|B4|Canada||Region of Enrollment||participants|Number|12|12.0||||||
3713601|NCT02129777|3552732|B3|Canada||Region of Enrollment||participants|Number|12|12.0||||||
3713602|NCT02129777|3552733|B2|Canada||Region of Enrollment||participants|Number|10|10.0||||||
3713603|NCT02129777|3552734|B1|Canada||Region of Enrollment||participants|Number|10|10.0||||||
3713604|NCT02129777|3552729|B6|White||Race/Ethnicity, Customized||participants|Number|109|109.0||||||
3713605|NCT02129777|3552730|B5|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3713606|NCT02129777|3552731|B4|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3713607|NCT02129777|3552732|B3|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3713608|NCT02129777|3552733|B2|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3713609|NCT02129777|3552734|B1|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3713610|NCT02129777|3552729|B6|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3713611|NCT02129777|3552730|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3713612|NCT02129777|3552731|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3713613|NCT02129777|3552732|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3713614|NCT02129777|3552733|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3713615|NCT02129777|3552734|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3713616|NCT02129777|3552729|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3713617|NCT02129777|3552730|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3713618|NCT02129777|3552731|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3713619|NCT02129777|3552732|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3713620|NCT02129777|3552733|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3713621|NCT02129777|3552734|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3713622|NCT02129777|3552729|B6|Asian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3713623|NCT02129777|3552730|B5|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3713624|NCT02129777|3552731|B4|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3713625|NCT02129777|3552732|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3713626|NCT02129777|3552733|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3713627|NCT02129777|3552734|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3713628|NCT02129777|3552729|B6|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
3713629|NCT02129777|3552730|B5|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3713630|NCT02129777|3552731|B4|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3713631|NCT02129777|3552732|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3713632|NCT02129777|3552733|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3713633|NCT02129777|3552734|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3713634|NCT02129777|3552729|B6|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
3713635|NCT02129777|3552730|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3713636|NCT02129777|3552731|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3713637|NCT02129777|3552732|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3713638|NCT02129777|3552733|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3713639|NCT02129777|3552734|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3713640|NCT02129777|3552729|B6||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3713641|NCT02129777|3552730|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3713642|NCT02129777|3552731|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3713643|NCT02129777|3552732|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3713644|NCT02129777|3552733|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3713645|NCT02129777|3552734|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3713646|NCT02129777|3552729|B6||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3713647|NCT02129777|3552730|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3713648|NCT02129777|3552731|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3713649|NCT02129777|3552732|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3713650|NCT02129777|3552733|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3713651|NCT02129777|3552734|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3713652|NCT02129777|3552729|B6|||Age||years|Mean|40.6|40.6|Standard Deviation|11.80|11.8|||
3713653|NCT02129777|3552730|B5|||Age||years|Mean|39.8|39.8|Standard Deviation|9.62|9.62|||
3713654|NCT02129777|3552731|B4|||Age||years|Mean|39.0|39.0|Standard Deviation|12.04|12.04|||
3713655|NCT02129777|3552732|B3|||Age||years|Mean|42.3|42.3|Standard Deviation|10.92|10.92|||
3713656|NCT02129777|3552733|B2|||Age||years|Mean|41.1|41.1|Standard Deviation|11.28|11.28|||
3713657|NCT02129777|3552734|B1|||Age||years|Mean|40.8|40.8|Standard Deviation|15.20|15.2|||
3713658|NCT02129725|3552844|B3|||Two-hour glucose||mg/dL|Mean|128.0|128.0|Standard Deviation|41.0|41.0|||
3713659|NCT02129725|3552845|B2|||Two-hour glucose||mg/dL|Mean|134.3|134.3|Standard Deviation|37.9|37.9|||
3713660|NCT02129725|3552846|B1|||Two-hour glucose||mg/dL|Mean|122.6|122.6|Standard Deviation|45.4|45.4|||
3713661|NCT02129725|3552844|B3|||Fasting glucose||mg/dL|Mean|94.5|94.5|Standard Deviation|11.7|11.7|||
3713662|NCT02129725|3552845|B2|||Fasting glucose||mg/dL|Mean|91.4|91.4|Standard Deviation|13.4|13.4|||
3713663|NCT02129725|3552846|B1|||Fasting glucose||mg/dL|Mean|97.2|97.2|Standard Deviation|10.3|10.3|||
3713664|NCT02129725|3552844|B3|||Body mass index||mg/kg2|Mean|32.9|32.9|Standard Deviation|4.7|4.7|||
3713665|NCT02129725|3552845|B2|||Body mass index||mg/kg2|Mean|34.5|34.5|Standard Deviation|5.0|5.0|||
3713666|NCT02129725|3552846|B1|||Body mass index||mg/kg2|Mean|31.5|31.5|Standard Deviation|4.1|4.1|||
3713667|NCT02129725|3552844|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
3713668|NCT02129725|3552845|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3713669|NCT02129725|3552846|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3713670|NCT02129725|3552844|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713671|NCT02129725|3552845|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713672|NCT02129725|3552846|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713673|NCT02129725|3552844|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713674|NCT02129725|3552845|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713675|NCT02129725|3552846|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713676|NCT02129725|3552844|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3713677|NCT02129725|3552845|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3713678|NCT02129725|3552846|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3713679|NCT02129725|3552844|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3713680|NCT02129725|3552845|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3713681|NCT02129725|3552846|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3713682|NCT02129725|3552844|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713683|NCT02129725|3552845|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713684|NCT02129725|3552846|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713685|NCT02129725|3552844|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713686|NCT02129725|3552845|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713687|NCT02129725|3552846|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713688|NCT02129725|3552844|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713689|NCT02129725|3552845|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713690|NCT02129725|3552846|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713691|NCT02129725|3552844|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3713692|NCT02129725|3552845|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3713693|NCT02129725|3552846|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3713694|NCT02129725|3552844|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3713695|NCT02129725|3552845|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3713696|NCT02129725|3552846|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3713697|NCT02129725|3552844|B3|||Age||years|Mean|47.4|47.4|Standard Deviation|12.1|12.1|||
3713698|NCT02129725|3552845|B2|||Age||years|Mean|47.3|47.3|Standard Deviation|12.4|12.4|||
3713699|NCT02129725|3552846|B1|||Age||years|Mean|47.5|47.5|Standard Deviation|12.8|12.8|||
3713700|NCT02129660|3552853|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713701|NCT02129660|3552854|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713702|NCT02129660|3552855|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713703|NCT02129660|3552856|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713704|NCT02129660|3552857|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713705|NCT02129660|3552858|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713706|NCT02129660|3552853|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3713707|NCT02129660|3552854|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713708|NCT02129660|3552855|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713709|NCT02129660|3552856|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3713710|NCT02129660|3552857|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713711|NCT02129660|3552858|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713712|NCT02129660|3552853|B6||White|Race (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3713713|NCT02129660|3552854|B5||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3713714|NCT02129660|3552855|B4||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3713715|NCT02129660|3552856|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3713716|NCT02129660|3552857|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3713717|NCT02129660|3552858|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3713718|NCT02129660|3552853|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3713719|NCT02129660|3552854|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3713720|NCT02129660|3552855|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3713721|NCT02129660|3552856|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3713722|NCT02129660|3552857|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713723|NCT02129660|3552858|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3713724|NCT02129660|3552853|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713725|NCT02129660|3552854|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713726|NCT02129660|3552855|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713727|NCT02129660|3552856|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713728|NCT02129660|3552857|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713729|NCT02129660|3552858|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713730|NCT02129660|3552853|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713731|NCT02129660|3552854|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713732|NCT02129660|3552855|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713733|NCT02129660|3552856|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713734|NCT02129660|3552857|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713735|NCT02129660|3552858|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713736|NCT02129660|3552853|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713737|NCT02129660|3552854|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713738|NCT02129660|3552855|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713739|NCT02129660|3552856|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713740|NCT02129660|3552857|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713741|NCT02129660|3552858|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713742|NCT02129660|3552853|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713743|NCT02129660|3552854|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713744|NCT02129660|3552855|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713745|NCT02129660|3552856|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713746|NCT02129660|3552857|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713747|NCT02129660|3552858|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713748|NCT02129660|3552853|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3713749|NCT02129660|3552854|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3713750|NCT02129660|3552855|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3713751|NCT02129660|3552856|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3713752|NCT02129660|3552857|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3713753|NCT02129660|3552858|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3713754|NCT02129660|3552853|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3713755|NCT02129660|3552854|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713756|NCT02129660|3552855|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713757|NCT02129660|3552856|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3713758|NCT02129660|3552857|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3713759|NCT02129660|3552858|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3713760|NCT02129660|3552853|B6||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3713761|NCT02129660|3552854|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3713762|NCT02129660|3552855|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3713763|NCT02129660|3552856|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3713764|NCT02129660|3552857|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3713765|NCT02129660|3552858|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3713766|NCT02129660|3552853|B6||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3713767|NCT02129660|3552854|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3713768|NCT02129660|3552855|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3713769|NCT02129660|3552856|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3713770|NCT02129660|3552857|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3713771|NCT02129660|3552858|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3713772|NCT02129660|3552853|B6||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3713773|NCT02129660|3552854|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3713774|NCT02129660|3552855|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3713775|NCT02129660|3552856|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3713776|NCT02129660|3552857|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3713777|NCT02129660|3552858|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3713778|NCT02129660|3552853|B6||Between 18 and 65 years|Age||Participants|Count of Participants|99|99.0||||||
3713779|NCT02129660|3552854|B5||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3713780|NCT02129660|3552855|B4||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3713781|NCT02129660|3552856|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3713782|NCT02129660|3552857|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3713783|NCT02129660|3552858|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3713784|NCT02129660|3552853|B6||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3713785|NCT02129660|3552854|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3713786|NCT02129660|3552855|B4||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3713787|NCT02129660|3552856|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3713788|NCT02129660|3552857|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3713789|NCT02129660|3552858|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3713790|NCT02129608|3552904|B4|||waist circumference (in cm)||cm|Mean|104.7|104.7|Standard Deviation|12.6|12.6|||
3713791|NCT02129608|3552905|B3|||waist circumference (in cm)||cm|Mean|100.9|100.9|Standard Deviation|10.0|10.0|||
3713792|NCT02129608|3552906|B2|||waist circumference (in cm)||cm|Mean|108.0|108.0|Standard Deviation|15.7|15.7|||
3713793|NCT02129608|3552907|B1|||waist circumference (in cm)||cm|Mean|105.3|105.3|Standard Deviation|11.6|11.6|||
3713794|NCT02129608|3552904|B4|||Weight (in kgs)||kg|Mean|93.5|93.5|Standard Deviation|15.0|15.0|||
3713795|NCT02129608|3552905|B3|||Weight (in kgs)||kg|Mean|90.3|90.3|Standard Deviation|14.0|14.0|||
3713796|NCT02129608|3552906|B2|||Weight (in kgs)||kg|Mean|94.4|94.4|Standard Deviation|16.2|16.2|||
3713797|NCT02129608|3552907|B1|||Weight (in kgs)||kg|Mean|96.0|96.0|Standard Deviation|15.3|15.3|||
3713798|NCT02129608|3552904|B4|United States||Region of Enrollment||participants|Number|44|44.0||||||
3713799|NCT02129608|3552905|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
3713800|NCT02129608|3552906|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3713801|NCT02129608|3552907|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3713802|NCT02129608|3552904|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713803|NCT02129608|3552905|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713804|NCT02129608|3552906|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713805|NCT02129608|3552907|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713806|NCT02129608|3552904|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713807|NCT02129608|3552905|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713808|NCT02129608|3552906|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713809|NCT02129608|3552907|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713810|NCT02129608|3552904|B4||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3713811|NCT02129608|3552905|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3713812|NCT02129608|3552906|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3713813|NCT02129608|3552907|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3713814|NCT02129608|3552904|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713815|NCT02129608|3552905|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713816|NCT02129608|3552906|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713817|NCT02129608|3552907|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713818|NCT02129608|3552904|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713819|NCT02129608|3552905|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713820|NCT02129608|3552906|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713821|NCT02129608|3552907|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713822|NCT02129608|3552904|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713823|NCT02129608|3552905|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713824|NCT02129608|3552906|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713825|NCT02129608|3552907|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713826|NCT02129608|3552904|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713827|NCT02129608|3552905|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713828|NCT02129608|3552906|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713829|NCT02129608|3552907|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713830|NCT02129608|3552904|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713831|NCT02129608|3552905|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713832|NCT02129608|3552906|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713833|NCT02129608|3552907|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713834|NCT02129608|3552904|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3713835|NCT02129608|3552905|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3713836|NCT02129608|3552906|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3713837|NCT02129608|3552907|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3713838|NCT02129608|3552904|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3713839|NCT02129608|3552905|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713840|NCT02129608|3552906|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713841|NCT02129608|3552907|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3713842|NCT02129608|3552904|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3713843|NCT02129608|3552905|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3713844|NCT02129608|3552906|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3713845|NCT02129608|3552907|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3713846|NCT02129608|3552904|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3713847|NCT02129608|3552905|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3713848|NCT02129608|3552906|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3713849|NCT02129608|3552907|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3713850|NCT02129608|3552904|B4|||Age||years|Mean|43.9|43.9|Standard Deviation|11.6|11.6|||
3713851|NCT02129608|3552905|B3|||Age||years|Mean|45.4|45.4|Standard Deviation|13.3|13.3|||
3713852|NCT02129608|3552906|B2|||Age||years|Mean|40.6|40.6|Standard Deviation|11.5|11.5|||
3713853|NCT02129608|3552907|B1|||Age||years|Mean|45.4|45.4|Standard Deviation|9.9|9.9|||
3713854|NCT02129608|3552904|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3713855|NCT02129608|3552905|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3713856|NCT02129608|3552906|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3713857|NCT02129608|3552907|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3713858|NCT02129608|3552904|B4||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3713859|NCT02129608|3552905|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3713860|NCT02129608|3552906|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3713861|NCT02129608|3552907|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3713862|NCT02129608|3552904|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3713863|NCT02129608|3552905|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3713864|NCT02129608|3552906|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3713865|NCT02129608|3552907|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3713866|NCT02129192|3552920|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3713867|NCT02129192|3552921|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3713868|NCT02129192|3552922|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3713869|NCT02129192|3552920|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3713870|NCT02129192|3552921|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3713871|NCT02129192|3552922|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3713872|NCT02129192|3552920|B3|||Age||Years|Mean|26.6|26.6|Standard Deviation|4.0|4.0|||
3713873|NCT02129192|3552921|B2|||Age||Years|Mean|26.6|26.6|Standard Deviation|3.9|3.9|||
3713874|NCT02129192|3552922|B1|||Age||Years|Mean|26.6|26.6|Standard Deviation|4.2|4.2|||
3713875|NCT02129062|3552940|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3713876|NCT02129062|3552940|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
3713877|NCT02129062|3552940|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3713878|NCT02129062|3552940|B1|||Age||years|Median|25|25.0|Full Range|||24.0|86.0|
3713879|NCT02128997|3552945|B3|United States||Region of Enrollment||participants|Number|136|136.0||||||
3713880|NCT02128997|3552946|B2|United States||Region of Enrollment||participants|Number|69|69.0||||||
3713881|NCT02128997|3552947|B1|United States||Region of Enrollment||participants|Number|67|67.0||||||
3713882|NCT02128997|3552945|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713883|NCT02128997|3552946|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713884|NCT02128997|3552947|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713885|NCT02128997|3552945|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713886|NCT02128997|3552946|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713887|NCT02128997|3552947|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713888|NCT02128997|3552945|B3||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3713889|NCT02128997|3552946|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3713890|NCT02128997|3552947|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3713891|NCT02128997|3552945|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3713892|NCT02128997|3552946|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3713893|NCT02128997|3552947|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3713894|NCT02128997|3552945|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3713895|NCT02128997|3552946|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713896|NCT02128997|3552947|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3713897|NCT02128997|3552945|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3713898|NCT02128997|3552946|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3713899|NCT02128997|3552947|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713900|NCT02128997|3552945|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713901|NCT02128997|3552946|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713902|NCT02128997|3552947|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3713903|NCT02128997|3552945|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3713904|NCT02128997|3552946|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3713905|NCT02128997|3552947|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3713906|NCT02128997|3552945|B3||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3713907|NCT02128997|3552946|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3713908|NCT02128997|3552947|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3713909|NCT02128997|3552945|B3|||Age||Years|Median|28|28.0|Standard Deviation|4|4.0|||
3713910|NCT02128997|3552946|B2|||Age||Years|Median|29|29.0|Standard Deviation|3|3.0|||
3713911|NCT02128997|3552947|B1|||Age||Years|Median|27|27.0|Standard Deviation|5|5.0|||
3713912|NCT02128932|3552960|B4|||Systolic Blood Pressure||mmHg|Mean|132.06|132.06|Standard Deviation|15.31|15.31|||
3713913|NCT02128932|3552961|B3|||Systolic Blood Pressure||mmHg|Mean|132.38|132.38|Standard Deviation|15.77|15.77|||
3713914|NCT02128932|3552962|B2|||Systolic Blood Pressure||mmHg|Mean|132.21|132.21|Standard Deviation|16.05|16.05|||
3713915|NCT02128932|3552963|B1|||Systolic Blood Pressure||mmHg|Mean|131.57|131.57|Standard Deviation|14.06|14.06|||
3713916|NCT02128932|3552960|B4|||Diastolic Blood pressure||mmHg|Mean|79.72|79.72|Standard Deviation|8.53|8.53|||
3713917|NCT02128932|3552961|B3|||Diastolic Blood pressure||mmHg|Mean|79.78|79.78|Standard Deviation|9.20|9.2|||
3713918|NCT02128932|3552962|B2|||Diastolic Blood pressure||mmHg|Mean|80.32|80.32|Standard Deviation|8.32|8.32|||
3713919|NCT02128932|3552963|B1|||Diastolic Blood pressure||mmHg|Mean|79.67|79.67|Standard Deviation|8.04|8.04|||
3713920|NCT02128932|3552960|B4|||Body weight||kg|Mean|93.45|93.45|Standard Deviation|21.79|21.79|||
3713921|NCT02128932|3552961|B3|||Body weight||kg|Mean|92.61|92.61|Standard Deviation|21.52|21.52|||
3713922|NCT02128932|3552962|B2|||Body weight||kg|Mean|94.00|94.0|Standard Deviation|22.48|22.48|||
3713923|NCT02128932|3552963|B1|||Body weight||kg|Mean|93.73|93.73|Standard Deviation|21.39|21.39|||
3713924|NCT02128932|3552960|B4|||Fasting plasma glucose||mg/dL|Mean|175.3|175.3|Standard Deviation|51.18|51.18|||
3713925|NCT02128932|3552961|B3|||Fasting plasma glucose||mg/dL|Mean|174.2|174.2|Standard Deviation|49.06|49.06|||
3713926|NCT02128932|3552962|B2|||Fasting plasma glucose||mg/dL|Mean|179.2|179.2|Standard Deviation|53.74|53.74|||
3713927|NCT02128932|3552963|B1|||Fasting plasma glucose||mg/dL|Mean|172.4|172.4|Standard Deviation|50.52|50.52|||
3713928|NCT02128932|3552960|B4|||HbA1c||percentage|Mean|8.17|8.17|Standard Deviation|0.89|0.89|||
3713929|NCT02128932|3552961|B3|||HbA1c||percentage|Mean|8.13|8.13|Standard Deviation|0.88|0.88|||
3713930|NCT02128932|3552962|B2|||HbA1c||percentage|Mean|8.25|8.25|Standard Deviation|0.94|0.94|||
3713931|NCT02128932|3552963|B1|||HbA1c||percentage|Mean|8.13|8.13|Standard Deviation|0.85|0.85|||
3713932|NCT02128932|3552960|B4||Male|Sex: Female, Male||Participants|Count of Participants|574|574.0||||||
3713933|NCT02128932|3552961|B3||Male|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
3713934|NCT02128932|3552962|B2||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3713935|NCT02128932|3552963|B1||Male|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
3713936|NCT02128932|3552960|B4||Female|Sex: Female, Male||Participants|Count of Participants|508|508.0||||||
3713937|NCT02128932|3552961|B3||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3713938|NCT02128932|3552962|B2||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
3713939|NCT02128932|3552963|B1||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3713940|NCT02128932|3552960|B4|>=85 years||Age, Customized||Participants|Number|0|0.0||||||
3713941|NCT02128932|3552961|B3|>=85 years||Age, Customized||Participants|Number|0|0.0||||||
3713942|NCT02128932|3552962|B2|>=85 years||Age, Customized||Participants|Number|0|0.0||||||
3713943|NCT02128932|3552963|B1|>=85 years||Age, Customized||Participants|Number|0|0.0||||||
3713944|NCT02128932|3552960|B4|75-84 years||Age, Customized||Participants|Number|42|42.0||||||
3713945|NCT02128932|3552961|B3|75-84 years||Age, Customized||Participants|Number|12|12.0||||||
3713946|NCT02128932|3552962|B2|75-84 years||Age, Customized||Participants|Number|18|18.0||||||
3713947|NCT02128932|3552963|B1|75-84 years||Age, Customized||Participants|Number|12|12.0||||||
3713948|NCT02128932|3552960|B4|65-74 years||Age, Customized||Participants|Number|200|200.0||||||
3713949|NCT02128932|3552961|B3|65-74 years||Age, Customized||Participants|Number|67|67.0||||||
3713950|NCT02128932|3552962|B2|65-74 years||Age, Customized||Participants|Number|61|61.0||||||
3713951|NCT02128932|3552963|B1|65-74 years||Age, Customized||Participants|Number|72|72.0||||||
3713952|NCT02128932|3552960|B4|18-64 years||Age, Customized||Participants|Number|840|840.0||||||
3713953|NCT02128932|3552961|B3|18-64 years||Age, Customized||Participants|Number|281|281.0||||||
3713954|NCT02128932|3552962|B2|18-64 years||Age, Customized||Participants|Number|281|281.0||||||
3713955|NCT02128932|3552963|B1|18-64 years||Age, Customized||Participants|Number|278|278.0||||||
3713956|NCT02128932|3552960|B4|||Age||years|Mean|56.5|56.5|Standard Deviation|10.4|10.4|||
3713957|NCT02128932|3552961|B3|||Age||years|Mean|56.2|56.2|Standard Deviation|10.6|10.6|||
3713958|NCT02128932|3552962|B2|||Age||years|Mean|56.7|56.7|Standard Deviation|10.4|10.4|||
3713959|NCT02128932|3552963|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|10.3|10.3|||
3713960|NCT02128919|3552994|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
3713961|NCT02128919|3552995|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3713962|NCT02128919|3552996|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3713963|NCT02128919|3552994|B3|race/ethnicity|other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3713964|NCT02128919|3552995|B2|race/ethnicity|other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3713965|NCT02128919|3552996|B1|race/ethnicity|other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3713966|NCT02128919|3552994|B3|race/ethnicity|hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3713967|NCT02128919|3552995|B2|race/ethnicity|hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3713968|NCT02128919|3552996|B1|race/ethnicity|hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3713969|NCT02128919|3552994|B3|race/ethnicity|black-African american|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3713970|NCT02128919|3552995|B2|race/ethnicity|black-African american|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3713971|NCT02128919|3552996|B1|race/ethnicity|black-African american|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3713972|NCT02128919|3552994|B3|race/ethnicity|white|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3713973|NCT02128919|3552995|B2|race/ethnicity|white|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3713974|NCT02128919|3552996|B1|race/ethnicity|white|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3713975|NCT02128919|3552994|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3713976|NCT02128919|3552995|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3713977|NCT02128919|3552996|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3713978|NCT02128919|3552994|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3713979|NCT02128919|3552995|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3713980|NCT02128919|3552996|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3713981|NCT02128919|3552994|B3|||Age||years|Mean|45.9|45.9|Standard Deviation|10.1|10.1|||
3713982|NCT02128919|3552995|B2|||Age||years|Mean|44.9|44.9|Standard Deviation|9.2|9.2|||
3713983|NCT02128919|3552996|B1|||Age||years|Mean|46.7|46.7|Standard Deviation|11.1|11.1|||
3713984|NCT02128867|3553007|B4||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3713985|NCT02128867|3553008|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3713986|NCT02128867|3553009|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3713987|NCT02128867|3553010|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3713988|NCT02128867|3553007|B4||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3713989|NCT02128867|3553008|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3713990|NCT02128867|3553009|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3713991|NCT02128867|3553010|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3713992|NCT02128867|3553007|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3713993|NCT02128867|3553008|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3713994|NCT02128867|3553009|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3713995|NCT02128867|3553010|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3713996|NCT02128867|3553007|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3713997|NCT02128867|3553008|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3713998|NCT02128867|3553009|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3713999|NCT02128867|3553010|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3714000|NCT02128867|3553007|B4||<=18 years|Age||Participants|Count of Participants|150|150.0||||||
3714001|NCT02128867|3553008|B3||<=18 years|Age||Participants|Count of Participants|50|50.0||||||
3714002|NCT02128867|3553009|B2||<=18 years|Age||Participants|Count of Participants|50|50.0||||||
3714003|NCT02128867|3553010|B1||<=18 years|Age||Participants|Count of Participants|50|50.0||||||
3714004|NCT02128542|3553020|B3|Yes||Cirrhosis Status||participants|Number|66|66.0||||||
3714005|NCT02128542|3553021|B2|Yes||Cirrhosis Status||participants|Number|19|19.0||||||
3714006|NCT02128542|3553022|B1|Yes||Cirrhosis Status||participants|Number|47|47.0||||||
3714007|NCT02128542|3553020|B3|No||Cirrhosis Status||participants|Number|0|0.0||||||
3714008|NCT02128542|3553021|B2|No||Cirrhosis Status||participants|Number|0|0.0||||||
3714009|NCT02128542|3553022|B1|No||Cirrhosis Status||participants|Number|0|0.0||||||
3714010|NCT02128542|3553020|B3|Genotype 2a/2c||HCV Genotype||participants|Number|8|8.0||||||
3714011|NCT02128542|3553021|B2|Genotype 2a/2c||HCV Genotype||participants|Number|0|0.0||||||
3714012|NCT02128542|3553022|B1|Genotype 2a/2c||HCV Genotype||participants|Number|8|8.0||||||
3714013|NCT02128542|3553020|B3|Genotype 2b||HCV Genotype||participants|Number|54|54.0||||||
3714014|NCT02128542|3553021|B2|Genotype 2b||HCV Genotype||participants|Number|17|17.0||||||
3714015|NCT02128542|3553022|B1|Genotype 2b||HCV Genotype||participants|Number|37|37.0||||||
3714016|NCT02128542|3553020|B3|Genotype 2||HCV Genotype||participants|Number|4|4.0||||||
3714017|NCT02128542|3553021|B2|Genotype 2||HCV Genotype||participants|Number|2|2.0||||||
3714018|NCT02128542|3553022|B1|Genotype 2||HCV Genotype||participants|Number|2|2.0||||||
3714019|NCT02128542|3553020|B3|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|43|43.0||||||
3714020|NCT02128542|3553021|B2|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|17|17.0||||||
3714021|NCT02128542|3553022|B1|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|26|26.0||||||
3714022|NCT02128542|3553020|B3|< 800,000 IU/mL||HCV RNA Category||participants|Number|23|23.0||||||
3714023|NCT02128542|3553021|B2|< 800,000 IU/mL||HCV RNA Category||participants|Number|2|2.0||||||
3714024|NCT02128542|3553022|B1|< 800,000 IU/mL||HCV RNA Category||participants|Number|21|21.0||||||
3714025|NCT02128542|3553020|B3|||HCV RNA||log10 IU/mL|Mean|6.1|6.1|Standard Deviation|0.87|0.87|||
3714026|NCT02128542|3553021|B2|||HCV RNA||log10 IU/mL|Mean|6.6|6.6|Standard Deviation|0.48|0.48|||
3714027|NCT02128542|3553022|B1|||HCV RNA||log10 IU/mL|Mean|5.9|5.9|Standard Deviation|0.89|0.89|||
3714028|NCT02128542|3553020|B3|TT||IL28b Status||participants|Number|4|4.0||||||
3714029|NCT02128542|3553021|B2|TT||IL28b Status||participants|Number|1|1.0||||||
3714030|NCT02128542|3553022|B1|TT||IL28b Status||participants|Number|3|3.0||||||
3714031|NCT02128542|3553020|B3|CT||IL28b Status||participants|Number|29|29.0||||||
3714032|NCT02128542|3553021|B2|CT||IL28b Status||participants|Number|10|10.0||||||
3714033|NCT02128542|3553022|B1|CT||IL28b Status||participants|Number|19|19.0||||||
3714034|NCT02128542|3553020|B3|CC||IL28b Status||participants|Number|33|33.0||||||
3714035|NCT02128542|3553021|B2|CC||IL28b Status||participants|Number|8|8.0||||||
3714036|NCT02128542|3553022|B1|CC||IL28b Status||participants|Number|25|25.0||||||
3714037|NCT02128542|3553020|B3|United States||Region of Enrollment||participants|Number|66|66.0||||||
3714038|NCT02128542|3553021|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3714039|NCT02128542|3553022|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
3714040|NCT02128542|3553020|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3714041|NCT02128542|3553021|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3714042|NCT02128542|3553022|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3714043|NCT02128542|3553020|B3|Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3714044|NCT02128542|3553021|B2|Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3714045|NCT02128542|3553022|B1|Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3714046|NCT02128542|3553020|B3|White||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
3714047|NCT02128542|3553021|B2|White||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3714048|NCT02128542|3553022|B1|White||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
3714049|NCT02128542|3553020|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3714050|NCT02128542|3553021|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3714051|NCT02128542|3553022|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3714052|NCT02128542|3553020|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3714053|NCT02128542|3553021|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3714054|NCT02128542|3553022|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3714055|NCT02128542|3553020|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3714056|NCT02128542|3553021|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3714057|NCT02128542|3553022|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3714058|NCT02128542|3553020|B3|||Age||Years|Mean|63|63.0|Standard Deviation|5.8|5.8|||
3714059|NCT02128542|3553021|B2|||Age||Years|Mean|62|62.0|Standard Deviation|5.4|5.4|||
3714060|NCT02128542|3553022|B1|||Age||Years|Mean|64|64.0|Standard Deviation|6.0|6.0|||
3714061|NCT02128490|3553036|B6|Ex-Drinker||Alcohol Classification||participants|Number|35|35.0||||||
3714062|NCT02128490|3553037|B5|Ex-Drinker||Alcohol Classification||participants|Number|5|5.0||||||
3714063|NCT02128490|3553038|B4|Ex-Drinker||Alcohol Classification||participants|Number|4|4.0||||||
3714064|NCT02128490|3553039|B3|Ex-Drinker||Alcohol Classification||participants|Number|10|10.0||||||
3714065|NCT02128490|3553040|B2|Ex-Drinker||Alcohol Classification||participants|Number|8|8.0||||||
3714066|NCT02128490|3553041|B1|Ex-Drinker||Alcohol Classification||participants|Number|8|8.0||||||
3714067|NCT02128490|3553036|B6|Current Drinker||Alcohol Classification||participants|Number|79|79.0||||||
3714068|NCT02128490|3553037|B5|Current Drinker||Alcohol Classification||participants|Number|13|13.0||||||
3714069|NCT02128490|3553038|B4|Current Drinker||Alcohol Classification||participants|Number|14|14.0||||||
3714070|NCT02128490|3553039|B3|Current Drinker||Alcohol Classification||participants|Number|15|15.0||||||
3714071|NCT02128490|3553040|B2|Current Drinker||Alcohol Classification||participants|Number|15|15.0||||||
3714072|NCT02128490|3553041|B1|Current Drinker||Alcohol Classification||participants|Number|22|22.0||||||
3714073|NCT02128490|3553036|B6|Never Drank||Alcohol Classification||participants|Number|75|75.0||||||
3714074|NCT02128490|3553037|B5|Never Drank||Alcohol Classification||participants|Number|20|20.0||||||
3714075|NCT02128490|3553038|B4|Never Drank||Alcohol Classification||participants|Number|19|19.0||||||
3714076|NCT02128490|3553039|B3|Never Drank||Alcohol Classification||participants|Number|14|14.0||||||
3714077|NCT02128490|3553040|B2|Never Drank||Alcohol Classification||participants|Number|14|14.0||||||
3714078|NCT02128490|3553041|B1|Never Drank||Alcohol Classification||participants|Number|8|8.0||||||
3714079|NCT02128490|3553036|B6|Ex-Smoker||Smoking History||participants|Number|74|74.0||||||
3714080|NCT02128490|3553037|B5|Ex-Smoker||Smoking History||participants|Number|17|17.0||||||
3714081|NCT02128490|3553038|B4|Ex-Smoker||Smoking History||participants|Number|12|12.0||||||
3714082|NCT02128490|3553039|B3|Ex-Smoker||Smoking History||participants|Number|16|16.0||||||
3714083|NCT02128490|3553040|B2|Ex-Smoker||Smoking History||participants|Number|13|13.0||||||
3714084|NCT02128490|3553041|B1|Ex-Smoker||Smoking History||participants|Number|16|16.0||||||
3714085|NCT02128490|3553036|B6|Current Smoker||Smoking History||participants|Number|19|19.0||||||
3714086|NCT02128490|3553037|B5|Current Smoker||Smoking History||participants|Number|5|5.0||||||
3714087|NCT02128490|3553038|B4|Current Smoker||Smoking History||participants|Number|5|5.0||||||
3714088|NCT02128490|3553039|B3|Current Smoker||Smoking History||participants|Number|4|4.0||||||
3714089|NCT02128490|3553040|B2|Current Smoker||Smoking History||participants|Number|3|3.0||||||
3714090|NCT02128490|3553041|B1|Current Smoker||Smoking History||participants|Number|2|2.0||||||
3714091|NCT02128490|3553036|B6|Never Smoked||Smoking History||participants|Number|96|96.0||||||
3714092|NCT02128490|3553037|B5|Never Smoked||Smoking History||participants|Number|16|16.0||||||
3714093|NCT02128490|3553038|B4|Never Smoked||Smoking History||participants|Number|20|20.0||||||
3714094|NCT02128490|3553039|B3|Never Smoked||Smoking History||participants|Number|19|19.0||||||
3714095|NCT02128490|3553040|B2|Never Smoked||Smoking History||participants|Number|21|21.0||||||
3714096|NCT02128490|3553041|B1|Never Smoked||Smoking History||participants|Number|20|20.0||||||
3714097|NCT02128490|3553036|B6|||Body Mass Index (BMI)||kg/m^2|Mean|34.31|34.31|Standard Deviation|7.810|7.81|||
3714098|NCT02128490|3553037|B5|||Body Mass Index (BMI)||kg/m^2|Mean|32.62|32.62|Standard Deviation|6.609|6.609|||
3714099|NCT02128490|3553038|B4|||Body Mass Index (BMI)||kg/m^2|Mean|33.10|33.1|Standard Deviation|7.220|7.22|||
3714100|NCT02128490|3553039|B3|||Body Mass Index (BMI)||kg/m^2|Mean|35.23|35.23|Standard Deviation|8.655|8.655|||
3714101|NCT02128490|3553040|B2|||Body Mass Index (BMI)||kg/m^2|Mean|36.53|36.53|Standard Deviation|9.036|9.036|||
3714102|NCT02128490|3553041|B1|||Body Mass Index (BMI)||kg/m^2|Mean|34.08|34.08|Standard Deviation|6.993|6.993|||
3714103|NCT02128490|3553036|B6|||Weight||kg|Mean|101.58|101.58|Standard Deviation|24.749|24.749|||
3714104|NCT02128490|3553037|B5|||Weight||kg|Mean|98.44|98.44|Standard Deviation|22.844|22.844|||
3714105|NCT02128490|3553038|B4|||Weight||kg|Mean|96.43|96.43|Standard Deviation|21.749|21.749|||
3714106|NCT02128490|3553039|B3|||Weight||kg|Mean|103.75|103.75|Standard Deviation|27.027|27.027|||
3714107|NCT02128490|3553040|B2|||Weight||kg|Mean|108.52|108.52|Standard Deviation|25.451|25.451|||
3714108|NCT02128490|3553041|B1|||Weight||kg|Mean|100.76|100.76|Standard Deviation|25.675|25.675|||
3714109|NCT02128490|3553036|B6|||Height||cm|Mean|172.0|172.0|Standard Deviation|10.27|10.27|||
3714110|NCT02128490|3553037|B5|||Height||cm|Mean|173.4|173.4|Standard Deviation|9.63|9.63|||
3714111|NCT02128490|3553038|B4|||Height||cm|Mean|170.7|170.7|Standard Deviation|11.16|11.16|||
3714112|NCT02128490|3553039|B3|||Height||cm|Mean|171.6|171.6|Standard Deviation|9.99|9.99|||
3714113|NCT02128490|3553040|B2|||Height||cm|Mean|172.8|172.8|Standard Deviation|10.39|10.39|||
3714114|NCT02128490|3553041|B1|||Height||cm|Mean|171.5|171.5|Standard Deviation|10.47|10.47|||
3714115|NCT02128490|3553036|B6|United States||Region of Enrollment||participants|Number|189|189.0||||||
3714116|NCT02128490|3553037|B5|United States||Region of Enrollment||participants|Number|38|38.0||||||
3714117|NCT02128490|3553038|B4|United States||Region of Enrollment||participants|Number|37|37.0||||||
3714118|NCT02128490|3553039|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
3714119|NCT02128490|3553040|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
3714120|NCT02128490|3553041|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
3714121|NCT02128490|3553036|B6|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|165|165.0||||||
3714122|NCT02128490|3553037|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3714123|NCT02128490|3553038|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3714124|NCT02128490|3553039|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3714125|NCT02128490|3553040|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3714126|NCT02128490|3553041|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3714127|NCT02128490|3553036|B6|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3714128|NCT02128490|3553037|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3714129|NCT02128490|3553038|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3714130|NCT02128490|3553039|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3714131|NCT02128490|3553040|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3714132|NCT02128490|3553041|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3714133|NCT02128490|3553036|B6|Other: Multi-racial||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3714134|NCT02128490|3553037|B5|Other: Multi-racial||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3714135|NCT02128490|3553038|B4|Other: Multi-racial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3714136|NCT02128490|3553039|B3|Other: Multi-racial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3714137|NCT02128490|3553040|B2|Other: Multi-racial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3714138|NCT02128490|3553041|B1|Other: Multi-racial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3714139|NCT02128490|3553036|B6|White||Race/Ethnicity, Customized||participants|Number|126|126.0||||||
3714140|NCT02128490|3553037|B5|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3714141|NCT02128490|3553038|B4|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3714142|NCT02128490|3553039|B3|White||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3714143|NCT02128490|3553040|B2|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3714144|NCT02128490|3553041|B1|White||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
3714145|NCT02128490|3553036|B6|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3714146|NCT02128490|3553037|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3714147|NCT02128490|3553038|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3714148|NCT02128490|3553039|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3714149|NCT02128490|3553040|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3714150|NCT02128490|3553041|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3714151|NCT02128490|3553036|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
3714152|NCT02128490|3553037|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3714153|NCT02128490|3553038|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3714154|NCT02128490|3553039|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3714155|NCT02128490|3553040|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3714156|NCT02128490|3553041|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3714157|NCT02128490|3553036|B6|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3714158|NCT02128490|3553037|B5|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3714159|NCT02128490|3553038|B4|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3714160|NCT02128490|3553039|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3714161|NCT02128490|3553040|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3714162|NCT02128490|3553041|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3714163|NCT02128490|3553036|B6||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3714164|NCT02128490|3553037|B5||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3714165|NCT02128490|3553038|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3714166|NCT02128490|3553039|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3714167|NCT02128490|3553040|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3714168|NCT02128490|3553041|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3714169|NCT02128490|3553036|B6||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3714170|NCT02128490|3553037|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3714171|NCT02128490|3553038|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3714172|NCT02128490|3553039|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3714173|NCT02128490|3553040|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3714174|NCT02128490|3553041|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3714175|NCT02128490|3553036|B6|>= 85 years||Age, Customized||participants|Number|2|2.0||||||
3714176|NCT02128490|3553037|B5|>= 85 years||Age, Customized||participants|Number|0|0.0||||||
3714177|NCT02128490|3553038|B4|>= 85 years||Age, Customized||participants|Number|0|0.0||||||
3714178|NCT02128490|3553039|B3|>= 85 years||Age, Customized||participants|Number|0|0.0||||||
3714179|NCT02128490|3553040|B2|>= 85 years||Age, Customized||participants|Number|0|0.0||||||
3714180|NCT02128490|3553041|B1|>= 85 years||Age, Customized||participants|Number|2|2.0||||||
3714181|NCT02128490|3553036|B6|65 to < 85 years||Age, Customized||participants|Number|97|97.0||||||
3714182|NCT02128490|3553037|B5|65 to < 85 years||Age, Customized||participants|Number|16|16.0||||||
3714183|NCT02128490|3553038|B4|65 to < 85 years||Age, Customized||participants|Number|19|19.0||||||
3714184|NCT02128490|3553039|B3|65 to < 85 years||Age, Customized||participants|Number|23|23.0||||||
3714185|NCT02128490|3553040|B2|65 to < 85 years||Age, Customized||participants|Number|18|18.0||||||
3714186|NCT02128490|3553041|B1|65 to < 85 years||Age, Customized||participants|Number|21|21.0||||||
3714187|NCT02128490|3553036|B6|18 to < 65 years||Age, Customized||participants|Number|90|90.0||||||
3714188|NCT02128490|3553037|B5|18 to < 65 years||Age, Customized||participants|Number|22|22.0||||||
3714189|NCT02128490|3553038|B4|18 to < 65 years||Age, Customized||participants|Number|18|18.0||||||
3714190|NCT02128490|3553039|B3|18 to < 65 years||Age, Customized||participants|Number|16|16.0||||||
3714191|NCT02128490|3553040|B2|18 to < 65 years||Age, Customized||participants|Number|19|19.0||||||
3714192|NCT02128490|3553041|B1|18 to < 65 years||Age, Customized||participants|Number|15|15.0||||||
3714193|NCT02128490|3553036|B6|>= 65 years||Age, Customized||participants|Number|99|99.0||||||
3714194|NCT02128490|3553037|B5|>= 65 years||Age, Customized||participants|Number|16|16.0||||||
3714195|NCT02128490|3553038|B4|>= 65 years||Age, Customized||participants|Number|19|19.0||||||
3714196|NCT02128490|3553039|B3|>= 65 years||Age, Customized||participants|Number|23|23.0||||||
3714197|NCT02128490|3553040|B2|>= 65 years||Age, Customized||participants|Number|18|18.0||||||
3714198|NCT02128490|3553041|B1|>= 65 years||Age, Customized||participants|Number|23|23.0||||||
3714199|NCT02128490|3553036|B6|45 to < 65 years||Age, Customized||participants|Number|81|81.0||||||
3714200|NCT02128490|3553037|B5|45 to < 65 years||Age, Customized||participants|Number|18|18.0||||||
3714201|NCT02128490|3553038|B4|45 to < 65 years||Age, Customized||participants|Number|18|18.0||||||
3714202|NCT02128490|3553039|B3|45 to < 65 years||Age, Customized||participants|Number|15|15.0||||||
3714203|NCT02128490|3553040|B2|45 to < 65 years||Age, Customized||participants|Number|16|16.0||||||
3714204|NCT02128490|3553041|B1|45 to < 65 years||Age, Customized||participants|Number|14|14.0||||||
3714205|NCT02128490|3553036|B6|< 45 years||Age, Customized||participants|Number|9|9.0||||||
3714206|NCT02128490|3553037|B5|< 45 years||Age, Customized||participants|Number|4|4.0||||||
3714207|NCT02128490|3553038|B4|< 45 years||Age, Customized||participants|Number|0|0.0||||||
3714208|NCT02128490|3553039|B3|< 45 years||Age, Customized||participants|Number|1|1.0||||||
3714209|NCT02128490|3553040|B2|< 45 years||Age, Customized||participants|Number|3|3.0||||||
3714210|NCT02128490|3553041|B1|< 45 years||Age, Customized||participants|Number|1|1.0||||||
3714211|NCT02128490|3553036|B6|||Age||years|Mean|63.1|63.1|Standard Deviation|11.34|11.34|||
3714212|NCT02128490|3553037|B5|||Age||years|Mean|61.4|61.4|Standard Deviation|12.17|12.17|||
3714213|NCT02128490|3553038|B4|||Age||years|Mean|63.5|63.5|Standard Deviation|10.33|10.33|||
3714214|NCT02128490|3553039|B3|||Age||years|Mean|64.4|64.4|Standard Deviation|11.21|11.21|||
3714215|NCT02128490|3553040|B2|||Age||years|Mean|61.3|61.3|Standard Deviation|10.09|10.09|||
3714216|NCT02128490|3553041|B1|||Age||years|Mean|64.6|64.6|Standard Deviation|12.78|12.78|||
3714217|NCT02128269|3553067|B1|France||Region of Enrollment||participants|Number|2|2.0||||||
3714218|NCT02128269|3553067|B1|Italy||Region of Enrollment||participants|Number|1|1.0||||||
3714219|NCT02128269|3553067|B1|Japan||Region of Enrollment||participants|Number|2|2.0||||||
3714220|NCT02128269|3553067|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3714221|NCT02128269|3553067|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3714222|NCT02128269|3553067|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714223|NCT02128269|3553067|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3714224|NCT02128269|3553067|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714225|NCT02128269|3553067|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714226|NCT02128269|3553067|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3714227|NCT02128269|3553067|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714228|NCT02128269|3553067|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3714229|NCT02128269|3553067|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3714230|NCT02128269|3553067|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714231|NCT02128269|3553067|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3714232|NCT02128269|3553067|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3714233|NCT02128269|3553067|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3714234|NCT02128269|3553067|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3714235|NCT02128269|3553067|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3714236|NCT02128217|3553071|B3||No History of STI Diagnosis|History of Sexually Transmitted Infections||Participants|Count of Participants|25|25.0||||||
3714237|NCT02128217|3553072|B2||No History of STI Diagnosis|History of Sexually Transmitted Infections||Participants|Count of Participants|16|16.0||||||
3714238|NCT02128217|3553073|B1||No History of STI Diagnosis|History of Sexually Transmitted Infections||Participants|Count of Participants|9|9.0||||||
3714239|NCT02128217|3553071|B3||Reported History of STI Diagnosis|History of Sexually Transmitted Infections||Participants|Count of Participants|19|19.0||||||
3714240|NCT02128217|3553072|B2||Reported History of STI Diagnosis|History of Sexually Transmitted Infections||Participants|Count of Participants|11|11.0||||||
3714241|NCT02128217|3553073|B1||Reported History of STI Diagnosis|History of Sexually Transmitted Infections||Participants|Count of Participants|8|8.0||||||
3714242|NCT02128217|3553071|B3||No|Received HIV ARVs Prior to Study Entry||Participants|Count of Participants|1|1.0||||||
3714243|NCT02128217|3553072|B2||No|Received HIV ARVs Prior to Study Entry||Participants|Count of Participants|0|0.0||||||
3714244|NCT02128217|3553073|B1||No|Received HIV ARVs Prior to Study Entry||Participants|Count of Participants|1|1.0||||||
3714245|NCT02128217|3553071|B3||Yes|Received HIV ARVs Prior to Study Entry||Participants|Count of Participants|43|43.0||||||
3714246|NCT02128217|3553072|B2||Yes|Received HIV ARVs Prior to Study Entry||Participants|Count of Participants|27|27.0||||||
3714247|NCT02128217|3553073|B1||Yes|Received HIV ARVs Prior to Study Entry||Participants|Count of Participants|16|16.0||||||
3714248|NCT02128217|3553071|B3||>= 50 copies/mL|HIV RNA||Participants|Count of Participants|1|1.0||||||
3714249|NCT02128217|3553072|B2||>= 50 copies/mL|HIV RNA||Participants|Count of Participants|0|0.0||||||
3714250|NCT02128217|3553073|B1||>= 50 copies/mL|HIV RNA||Participants|Count of Participants|1|1.0||||||
3714251|NCT02128217|3553071|B3||<50 copies/mL|HIV RNA||Participants|Count of Participants|42|42.0||||||
3714252|NCT02128217|3553072|B2||<50 copies/mL|HIV RNA||Participants|Count of Participants|27|27.0||||||
3714253|NCT02128217|3553073|B1||<50 copies/mL|HIV RNA||Participants|Count of Participants|15|15.0||||||
3714254|NCT02128217|3553071|B3||>= 6 million IU/mL|HCV RNA Levels||Participants|Count of Participants|8|8.0||||||
3714255|NCT02128217|3553072|B2||>= 6 million IU/mL|HCV RNA Levels||Participants|Count of Participants|6|6.0||||||
3714256|NCT02128217|3553073|B1||>= 6 million IU/mL|HCV RNA Levels||Participants|Count of Participants|2|2.0||||||
3714257|NCT02128217|3553071|B3||< 6 million IU/mL|HCV RNA Levels||Participants|Count of Participants|36|36.0||||||
3714258|NCT02128217|3553072|B2||< 6 million IU/mL|HCV RNA Levels||Participants|Count of Participants|21|21.0||||||
3714259|NCT02128217|3553073|B1||< 6 million IU/mL|HCV RNA Levels||Participants|Count of Participants|15|15.0||||||
3714260|NCT02128217|3553071|B3|||HCV RNA||IU/mL|Median|1500000|1500000.0|Inter-Quartile Range|||117500.0|3895000.0|
3714261|NCT02128217|3553072|B2|||HCV RNA||IU/mL|Median|1490000|1490000.0|Inter-Quartile Range|||32500.0|3560000.0|
3714262|NCT02128217|3553073|B1|||HCV RNA||IU/mL|Median|2280000|2280000.0|Inter-Quartile Range|||272000.0|4230000.0|
3714263|NCT02128217|3553071|B3||TT|IL28B Genotype||Participants|Count of Participants|7|7.0||||||
3714264|NCT02128217|3553072|B2||TT|IL28B Genotype||Participants|Count of Participants|4|4.0||||||
3714265|NCT02128217|3553073|B1||TT|IL28B Genotype||Participants|Count of Participants|3|3.0||||||
3714266|NCT02128217|3553071|B3||CT|IL28B Genotype||Participants|Count of Participants|17|17.0||||||
3714267|NCT02128217|3553072|B2||CT|IL28B Genotype||Participants|Count of Participants|7|7.0||||||
3714268|NCT02128217|3553073|B1||CT|IL28B Genotype||Participants|Count of Participants|10|10.0||||||
3714269|NCT02128217|3553071|B3||CC|IL28B Genotype||Participants|Count of Participants|20|20.0||||||
3714270|NCT02128217|3553072|B2||CC|IL28B Genotype||Participants|Count of Participants|16|16.0||||||
3714271|NCT02128217|3553073|B1||CC|IL28B Genotype||Participants|Count of Participants|4|4.0||||||
3714272|NCT02128217|3553071|B3||Indeterminate|HCV Genotype||Participants|Count of Participants|1|1.0||||||
3714273|NCT02128217|3553072|B2||Indeterminate|HCV Genotype||Participants|Count of Participants|0|0.0||||||
3714274|NCT02128217|3553073|B1||Indeterminate|HCV Genotype||Participants|Count of Participants|1|1.0||||||
3714275|NCT02128217|3553071|B3||4|HCV Genotype||Participants|Count of Participants|1|1.0||||||
3714276|NCT02128217|3553072|B2||4|HCV Genotype||Participants|Count of Participants|1|1.0||||||
3714277|NCT02128217|3553073|B1||4|HCV Genotype||Participants|Count of Participants|0|0.0||||||
3714278|NCT02128217|3553071|B3||2b|HCV Genotype||Participants|Count of Participants|1|1.0||||||
3714279|NCT02128217|3553072|B2||2b|HCV Genotype||Participants|Count of Participants|0|0.0||||||
3714280|NCT02128217|3553073|B1||2b|HCV Genotype||Participants|Count of Participants|1|1.0||||||
3714281|NCT02128217|3553071|B3||1 (subtype unknown)|HCV Genotype||Participants|Count of Participants|2|2.0||||||
3714282|NCT02128217|3553072|B2||1 (subtype unknown)|HCV Genotype||Participants|Count of Participants|0|0.0||||||
3714283|NCT02128217|3553073|B1||1 (subtype unknown)|HCV Genotype||Participants|Count of Participants|2|2.0||||||
3714284|NCT02128217|3553071|B3||1b|HCV Genotype||Participants|Count of Participants|5|5.0||||||
3714285|NCT02128217|3553072|B2||1b|HCV Genotype||Participants|Count of Participants|3|3.0||||||
3714286|NCT02128217|3553073|B1||1b|HCV Genotype||Participants|Count of Participants|2|2.0||||||
3714287|NCT02128217|3553071|B3||1a|HCV Genotype||Participants|Count of Participants|34|34.0||||||
3714288|NCT02128217|3553072|B2||1a|HCV Genotype||Participants|Count of Participants|23|23.0||||||
3714289|NCT02128217|3553073|B1||1a|HCV Genotype||Participants|Count of Participants|11|11.0||||||
3714290|NCT02128217|3553071|B3||Reinfection|Type of Acute HCV Infection||Participants|Count of Participants|5|5.0||||||
3714291|NCT02128217|3553072|B2||Reinfection|Type of Acute HCV Infection||Participants|Count of Participants|5|5.0||||||
3714292|NCT02128217|3553073|B1||Reinfection|Type of Acute HCV Infection||Participants|Count of Participants|0|0.0||||||
3714293|NCT02128217|3553071|B3||New Infection|Type of Acute HCV Infection||Participants|Count of Participants|39|39.0||||||
3714294|NCT02128217|3553072|B2||New Infection|Type of Acute HCV Infection||Participants|Count of Participants|22|22.0||||||
3714295|NCT02128217|3553073|B1||New Infection|Type of Acute HCV Infection||Participants|Count of Participants|17|17.0||||||
3714296|NCT02128217|3553071|B3||Greater than or equal to 75 kg|Weight||Participants|Count of Participants|25|25.0||||||
3714297|NCT02128217|3553072|B2||Greater than or equal to 75 kg|Weight||Participants|Count of Participants|15|15.0||||||
3714298|NCT02128217|3553073|B1||Greater than or equal to 75 kg|Weight||Participants|Count of Participants|10|10.0||||||
3714299|NCT02128217|3553071|B3||Less than 75 kg|Weight||Participants|Count of Participants|19|19.0||||||
3714300|NCT02128217|3553072|B2||Less than 75 kg|Weight||Participants|Count of Participants|12|12.0||||||
3714301|NCT02128217|3553073|B1||Less than 75 kg|Weight||Participants|Count of Participants|7|7.0||||||
3714302|NCT02128217|3553071|B3||Previously|Intravenous Drug History||Participants|Count of Participants|8|8.0||||||
3714303|NCT02128217|3553072|B2||Previously|Intravenous Drug History||Participants|Count of Participants|4|4.0||||||
3714304|NCT02128217|3553073|B1||Previously|Intravenous Drug History||Participants|Count of Participants|4|4.0||||||
3714305|NCT02128217|3553071|B3||Currently|Intravenous Drug History||Participants|Count of Participants|1|1.0||||||
3714306|NCT02128217|3553072|B2||Currently|Intravenous Drug History||Participants|Count of Participants|1|1.0||||||
3714307|NCT02128217|3553073|B1||Currently|Intravenous Drug History||Participants|Count of Participants|0|0.0||||||
3714308|NCT02128217|3553071|B3||Never|Intravenous Drug History||Participants|Count of Participants|35|35.0||||||
3714309|NCT02128217|3553072|B2||Never|Intravenous Drug History||Participants|Count of Participants|22|22.0||||||
3714310|NCT02128217|3553073|B1||Never|Intravenous Drug History||Participants|Count of Participants|13|13.0||||||
3714311|NCT02128217|3553071|B3|United States||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3714312|NCT02128217|3553072|B2|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3714313|NCT02128217|3553073|B1|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3714314|NCT02128217|3553071|B3|Race/Ethnicity|Asian, Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3714315|NCT02128217|3553072|B2|Race/Ethnicity|Asian, Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3714316|NCT02128217|3553073|B1|Race/Ethnicity|Asian, Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3714317|NCT02128217|3553071|B3|Race/Ethnicity|Hispanic (Regardless of Race)|Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3714318|NCT02128217|3553072|B2|Race/Ethnicity|Hispanic (Regardless of Race)|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3714319|NCT02128217|3553073|B1|Race/Ethnicity|Hispanic (Regardless of Race)|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3714320|NCT02128217|3553071|B3|Race/Ethnicity|Black Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3714321|NCT02128217|3553072|B2|Race/Ethnicity|Black Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3714322|NCT02128217|3553073|B1|Race/Ethnicity|Black Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3714323|NCT02128217|3553071|B3|Race/Ethnicity|White Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3714324|NCT02128217|3553072|B2|Race/Ethnicity|White Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3714325|NCT02128217|3553073|B1|Race/Ethnicity|White Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3714326|NCT02128217|3553071|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3714327|NCT02128217|3553072|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3714328|NCT02128217|3553073|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3714329|NCT02128217|3553071|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3714330|NCT02128217|3553072|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3714331|NCT02128217|3553073|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3714332|NCT02128217|3553071|B3|Age|70+ years|Age, Customized||Participants|Count of Participants|1|1.0||||||
3714333|NCT02128217|3553072|B2|Age|70+ years|Age, Customized||Participants|Count of Participants|1|1.0||||||
3714334|NCT02128217|3553073|B1|Age|70+ years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3714335|NCT02128217|3553071|B3|Age|60-69 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
3714336|NCT02128217|3553072|B2|Age|60-69 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
3714337|NCT02128217|3553073|B1|Age|60-69 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
3714338|NCT02128217|3553071|B3|Age|50-59 years|Age, Customized||Participants|Count of Participants|8|8.0||||||
3714339|NCT02128217|3553072|B2|Age|50-59 years|Age, Customized||Participants|Count of Participants|6|6.0||||||
3714340|NCT02128217|3553073|B1|Age|50-59 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
3714341|NCT02128217|3553071|B3|Age|40-49 years|Age, Customized||Participants|Count of Participants|20|20.0||||||
3714342|NCT02128217|3553072|B2|Age|40-49 years|Age, Customized||Participants|Count of Participants|10|10.0||||||
3714343|NCT02128217|3553073|B1|Age|40-49 years|Age, Customized||Participants|Count of Participants|10|10.0||||||
3714344|NCT02128217|3553071|B3|Age|30-39 years|Age, Customized||Participants|Count of Participants|9|9.0||||||
3714345|NCT02128217|3553072|B2|Age|30-39 years|Age, Customized||Participants|Count of Participants|8|8.0||||||
3714346|NCT02128217|3553073|B1|Age|30-39 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
3714347|NCT02128217|3553071|B3|Age|20-29 years|Age, Customized||Participants|Count of Participants|4|4.0||||||
3714348|NCT02128217|3553072|B2|Age|20-29 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
3714349|NCT02128217|3553073|B1|Age|20-29 years|Age, Customized||Participants|Count of Participants|3|3.0||||||
3714350|NCT02128217|3553071|B3|||Age||Years|Median|45.5|45.5|Inter-Quartile Range|||38.5|49.5|
3714351|NCT02128217|3553072|B2|||Age||Years|Median|46|46.0|Inter-Quartile Range|||38.0|50.0|
3714352|NCT02128217|3553073|B1|||Age||Years|Median|45|45.0|Inter-Quartile Range|||41.0|47.0|
3714353|NCT02128074|3553116|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3714354|NCT02128074|3553116|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714355|NCT02128074|3553116|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3714356|NCT02128074|3553116|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714357|NCT02128074|3553116|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714358|NCT02128074|3553116|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714359|NCT02128074|3553116|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714360|NCT02128074|3553116|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714361|NCT02128074|3553116|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3714362|NCT02128074|3553116|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714363|NCT02128074|3553116|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3714364|NCT02128074|3553116|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3714365|NCT02128074|3553116|B1|||Age||years|Mean|69.3|69.3|Standard Deviation|12.47|12.47|||
3714366|NCT02128074|3553116|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3714367|NCT02128074|3553116|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3714368|NCT02128074|3553116|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3714369|NCT02127970|3553120|B3||Male|Sex: Female, Male||Participants|Count of Participants|407|407.0||||||
3714370|NCT02127970|3553121|B2||Male|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
3714371|NCT02127970|3553122|B1||Male|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
3714372|NCT02127970|3553120|B3||Female|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
3714373|NCT02127970|3553121|B2||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3714374|NCT02127970|3553122|B1||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3714375|NCT02127970|3553120|B3|||Age||years|Mean|48.2|48.2|Standard Deviation|14.78|14.78|||
3714376|NCT02127970|3553121|B2|||Age||years|Mean|48.3|48.3|Standard Deviation|14.74|14.74|||
3714377|NCT02127970|3553122|B1|||Age||years|Mean|48.0|48.0|Standard Deviation|14.83|14.83|||
3714378|NCT02127892|3553145|B5|United States||Region of Enrollment||participants|Number|9|9.0||||||
3714379|NCT02127892|3553148|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3714380|NCT02127892|3553149|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3714381|NCT02127892|3553145|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3714382|NCT02127892|3553148|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3714383|NCT02127892|3553149|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3714384|NCT02127892|3553145|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714385|NCT02127892|3553148|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714386|NCT02127892|3553149|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714387|NCT02127892|3553145|B5||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3714388|NCT02127892|3553148|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714389|NCT02127892|3553149|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3714390|NCT02127892|3553145|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714391|NCT02127892|3553148|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714392|NCT02127892|3553149|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714393|NCT02127892|3553145|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714394|NCT02127892|3553148|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714395|NCT02127892|3553149|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714396|NCT02127892|3553145|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3714397|NCT02127892|3553148|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714398|NCT02127892|3553149|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3714399|NCT02127892|3553145|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714400|NCT02127892|3553148|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714401|NCT02127892|3553149|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714402|NCT02127892|3553145|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3714403|NCT02127892|3553146|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714404|NCT02127892|3553147|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714405|NCT02127892|3553148|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714406|NCT02127892|3553149|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3714407|NCT02127892|3553145|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3714408|NCT02127892|3553146|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714409|NCT02127892|3553147|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714410|NCT02127892|3553148|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714411|NCT02127892|3553149|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3714412|NCT02127892|3553145|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3714413|NCT02127892|3553146|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714414|NCT02127892|3553147|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714415|NCT02127892|3553148|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3714416|NCT02127892|3553149|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3714417|NCT02127892|3553145|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3714418|NCT02127892|3553148|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3714419|NCT02127892|3553149|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3714420|NCT02127892|3553145|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3714421|NCT02127892|3553148|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3714422|NCT02127892|3553149|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3714423|NCT02127892|3553145|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3714424|NCT02127892|3553146|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3714425|NCT02127892|3553147|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3714426|NCT02127892|3553148|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3714427|NCT02127892|3553149|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3714428|NCT02127892|3553145|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3714429|NCT02127892|3553146|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3714430|NCT02127892|3553147|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3714431|NCT02127892|3553148|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3714432|NCT02127892|3553149|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3714433|NCT02127892|3553145|B5||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
3714434|NCT02127892|3553146|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3714435|NCT02127892|3553147|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3714436|NCT02127892|3553148|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3714437|NCT02127892|3553149|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
3714438|NCT02127710|3553178|B4|||Weight||Kg|Median|79.5|79.5|Full Range|||42.0|160.6|
3714439|NCT02127710|3553179|B3|||Weight||Kg|Median|86.0|86.0|Full Range|||48.4|101.6|
3714440|NCT02127710|3553180|B2|||Weight||Kg|Median|84.3|84.3|Full Range|||47.0|160.6|
3714441|NCT02127710|3553181|B1|||Weight||Kg|Median|76.5|76.5|Full Range|||42.0|134.0|
3714442|NCT02127710|3553178|B4|||Weight||kilograms|Mean|81.6|81.6|Standard Deviation|20.04|20.04|||
3714443|NCT02127710|3553179|B3|||Weight||kilograms|Mean|81.6|81.6|Standard Deviation|15.03|15.03|||
3714444|NCT02127710|3553180|B2|||Weight||kilograms|Mean|86.7|86.7|Standard Deviation|25.05|25.05|||
3714445|NCT02127710|3553181|B1|||Weight||kilograms|Mean|76.5|76.5|Standard Deviation|20.04|20.04|||
3714446|NCT02127710|3553178|B4||Missing|MSKCC Risk Group|Risk categories for patients were obtained from the Memorial Sloan Kettering Cancer Center (MSKCC) risk category prognostic model in advanced renal cell cancer, as follows: Favourable risk = 0 risk factors; Intermediate risk = 10 or 2 risk factors; Poor risk = 3 or more risk factors. Risk factors include: Karnofsky performance status < 80%; time from diagnosis to salvage treatment < 1 year; haemoglobin < lower limit of normal (LLN); corrected serum calcium > ULN; and serum lactate dehydrogenase > 1.5 x ULN.|Participants|Count of Participants|35|35.0||||||
3714447|NCT02127710|3553179|B3||Missing|MSKCC Risk Group|Risk categories for patients were obtained from the Memorial Sloan Kettering Cancer Center (MSKCC) risk category prognostic model in advanced renal cell cancer, as follows: Favourable risk = 0 risk factors; Intermediate risk = 10 or 2 risk factors; Poor risk = 3 or more risk factors. Risk factors include: Karnofsky performance status < 80%; time from diagnosis to salvage treatment < 1 year; haemoglobin < lower limit of normal (LLN); corrected serum calcium > ULN; and serum lactate dehydrogenase > 1.5 x ULN.|Participants|Count of Participants|6|6.0||||||
3714448|NCT02127710|3553180|B2||Missing|MSKCC Risk Group|Risk categories for patients were obtained from the Memorial Sloan Kettering Cancer Center (MSKCC) risk category prognostic model in advanced renal cell cancer, as follows: Favourable risk = 0 risk factors; Intermediate risk = 10 or 2 risk factors; Poor risk = 3 or more risk factors. Risk factors include: Karnofsky performance status < 80%; time from diagnosis to salvage treatment < 1 year; haemoglobin < lower limit of normal (LLN); corrected serum calcium > ULN; and serum lactate dehydrogenase > 1.5 x ULN.|Participants|Count of Participants|18|18.0||||||
3714449|NCT02127710|3553181|B1||Missing|MSKCC Risk Group|Risk categories for patients were obtained from the Memorial Sloan Kettering Cancer Center (MSKCC) risk category prognostic model in advanced renal cell cancer, as follows: Favourable risk = 0 risk factors; Intermediate risk = 10 or 2 risk factors; Poor risk = 3 or more risk factors. Risk factors include: Karnofsky performance status < 80%; time from diagnosis to salvage treatment < 1 year; haemoglobin < lower limit of normal (LLN); corrected serum calcium > ULN; and serum lactate dehydrogenase > 1.5 x ULN.|Participants|Count of Participants|11|11.0||||||
3714450|NCT02127710|3553178|B4||Poor Risk|MSKCC Risk Group|Risk categories for patients were obtained from the Memorial Sloan Kettering Cancer Center (MSKCC) risk category prognostic model in advanced renal cell cancer, as follows: Favourable risk = 0 risk factors; Intermediate risk = 10 or 2 risk factors; Poor risk = 3 or more risk factors. Risk factors include: Karnofsky performance status < 80%; time from diagnosis to salvage treatment < 1 year; haemoglobin < lower limit of normal (LLN); corrected serum calcium > ULN; and serum lactate dehydrogenase > 1.5 x ULN.|Participants|Count of Participants|10|10.0||||||
3714451|NCT02127710|3553179|B3||Poor Risk|MSKCC Risk Group|Risk categories for patients were obtained from the Memorial Sloan Kettering Cancer Center (MSKCC) risk category prognostic model in advanced renal cell cancer, as follows: Favourable risk = 0 risk factors; Intermediate risk = 10 or 2 risk factors; Poor risk = 3 or more risk factors. Risk factors include: Karnofsky performance status < 80%; time from diagnosis to salvage treatment < 1 year; haemoglobin < lower limit of normal (LLN); corrected serum calcium > ULN; and serum lactate dehydrogenase > 1.5 x ULN.|Participants|Count of Participants|4|4.0||||||
3714452|NCT02127710|3553180|B2||Poor Risk|MSKCC Risk Group|Risk categories for patients were obtained from the Memorial Sloan Kettering Cancer Center (MSKCC) risk category prognostic model in advanced renal cell cancer, as follows: Favourable risk = 0 risk factors; Intermediate risk = 10 or 2 risk factors; Poor risk = 3 or more risk factors. Risk factors include: Karnofsky performance status < 80%; time from diagnosis to salvage treatment < 1 year; haemoglobin < lower limit of normal (LLN); corrected serum calcium > ULN; and serum lactate dehydrogenase > 1.5 x ULN.|Participants|Count of Participants|4|4.0||||||
3714453|NCT02127710|3553181|B1||Poor Risk|MSKCC Risk Group|Risk categories for patients were obtained from the Memorial Sloan Kettering Cancer Center (MSKCC) risk category prognostic model in advanced renal cell cancer, as follows: Favourable risk = 0 risk factors; Intermediate risk = 10 or 2 risk factors; Poor risk = 3 or more risk factors. Risk factors include: Karnofsky performance status < 80%; time from diagnosis to salvage treatment < 1 year; haemoglobin < lower limit of normal (LLN); corrected serum calcium > ULN; and serum lactate dehydrogenase > 1.5 x ULN.|Participants|Count of Participants|2|2.0||||||
3714454|NCT02127710|3553178|B4||Intermediate Risk|MSKCC Risk Group|Risk categories for patients were obtained from the Memorial Sloan Kettering Cancer Center (MSKCC) risk category prognostic model in advanced renal cell cancer, as follows: Favourable risk = 0 risk factors; Intermediate risk = 10 or 2 risk factors; Poor risk = 3 or more risk factors. Risk factors include: Karnofsky performance status < 80%; time from diagnosis to salvage treatment < 1 year; haemoglobin < lower limit of normal (LLN); corrected serum calcium > ULN; and serum lactate dehydrogenase > 1.5 x ULN.|Participants|Count of Participants|49|49.0||||||
3714487|NCT02127710|3553179|B3||Low|Stage Classification||Participants|Count of Participants|1|1.0||||||
3714455|NCT02127710|3553179|B3||Intermediate Risk|MSKCC Risk Group|Risk categories for patients were obtained from the Memorial Sloan Kettering Cancer Center (MSKCC) risk category prognostic model in advanced renal cell cancer, as follows: Favourable risk = 0 risk factors; Intermediate risk = 10 or 2 risk factors; Poor risk = 3 or more risk factors. Risk factors include: Karnofsky performance status < 80%; time from diagnosis to salvage treatment < 1 year; haemoglobin < lower limit of normal (LLN); corrected serum calcium > ULN; and serum lactate dehydrogenase > 1.5 x ULN.|Participants|Count of Participants|7|7.0||||||
3714456|NCT02127710|3553180|B2||Intermediate Risk|MSKCC Risk Group|Risk categories for patients were obtained from the Memorial Sloan Kettering Cancer Center (MSKCC) risk category prognostic model in advanced renal cell cancer, as follows: Favourable risk = 0 risk factors; Intermediate risk = 10 or 2 risk factors; Poor risk = 3 or more risk factors. Risk factors include: Karnofsky performance status < 80%; time from diagnosis to salvage treatment < 1 year; haemoglobin < lower limit of normal (LLN); corrected serum calcium > ULN; and serum lactate dehydrogenase > 1.5 x ULN.|Participants|Count of Participants|14|14.0||||||
3714457|NCT02127710|3553181|B1||Intermediate Risk|MSKCC Risk Group|Risk categories for patients were obtained from the Memorial Sloan Kettering Cancer Center (MSKCC) risk category prognostic model in advanced renal cell cancer, as follows: Favourable risk = 0 risk factors; Intermediate risk = 10 or 2 risk factors; Poor risk = 3 or more risk factors. Risk factors include: Karnofsky performance status < 80%; time from diagnosis to salvage treatment < 1 year; haemoglobin < lower limit of normal (LLN); corrected serum calcium > ULN; and serum lactate dehydrogenase > 1.5 x ULN.|Participants|Count of Participants|28|28.0||||||
3714458|NCT02127710|3553178|B4||Favourable Risk|MSKCC Risk Group|Risk categories for patients were obtained from the Memorial Sloan Kettering Cancer Center (MSKCC) risk category prognostic model in advanced renal cell cancer, as follows: Favourable risk = 0 risk factors; Intermediate risk = 10 or 2 risk factors; Poor risk = 3 or more risk factors. Risk factors include: Karnofsky performance status < 80%; time from diagnosis to salvage treatment < 1 year; haemoglobin < lower limit of normal (LLN); corrected serum calcium > ULN; and serum lactate dehydrogenase > 1.5 x ULN.|Participants|Count of Participants|15|15.0||||||
3714459|NCT02127710|3553179|B3||Favourable Risk|MSKCC Risk Group|Risk categories for patients were obtained from the Memorial Sloan Kettering Cancer Center (MSKCC) risk category prognostic model in advanced renal cell cancer, as follows: Favourable risk = 0 risk factors; Intermediate risk = 10 or 2 risk factors; Poor risk = 3 or more risk factors. Risk factors include: Karnofsky performance status < 80%; time from diagnosis to salvage treatment < 1 year; haemoglobin < lower limit of normal (LLN); corrected serum calcium > ULN; and serum lactate dehydrogenase > 1.5 x ULN.|Participants|Count of Participants|2|2.0||||||
3714460|NCT02127710|3553180|B2||Favourable Risk|MSKCC Risk Group|Risk categories for patients were obtained from the Memorial Sloan Kettering Cancer Center (MSKCC) risk category prognostic model in advanced renal cell cancer, as follows: Favourable risk = 0 risk factors; Intermediate risk = 10 or 2 risk factors; Poor risk = 3 or more risk factors. Risk factors include: Karnofsky performance status < 80%; time from diagnosis to salvage treatment < 1 year; haemoglobin < lower limit of normal (LLN); corrected serum calcium > ULN; and serum lactate dehydrogenase > 1.5 x ULN.|Participants|Count of Participants|10|10.0||||||
3714461|NCT02127710|3553181|B1||Favourable Risk|MSKCC Risk Group|Risk categories for patients were obtained from the Memorial Sloan Kettering Cancer Center (MSKCC) risk category prognostic model in advanced renal cell cancer, as follows: Favourable risk = 0 risk factors; Intermediate risk = 10 or 2 risk factors; Poor risk = 3 or more risk factors. Risk factors include: Karnofsky performance status < 80%; time from diagnosis to salvage treatment < 1 year; haemoglobin < lower limit of normal (LLN); corrected serum calcium > ULN; and serum lactate dehydrogenase > 1.5 x ULN.|Participants|Count of Participants|3|3.0||||||
3714462|NCT02127710|3553178|B4||Missing|Renal Cell Classification||Participants|Count of Participants|25|25.0||||||
3714463|NCT02127710|3553179|B3||Missing|Renal Cell Classification||Participants|Count of Participants|9|9.0||||||
3714464|NCT02127710|3553180|B2||Missing|Renal Cell Classification||Participants|Count of Participants|7|7.0||||||
3714465|NCT02127710|3553181|B1||Missing|Renal Cell Classification||Participants|Count of Participants|9|9.0||||||
3714466|NCT02127710|3553178|B4||Type II PRCC|Renal Cell Classification||Participants|Count of Participants|68|68.0||||||
3714467|NCT02127710|3553179|B3||Type II PRCC|Renal Cell Classification||Participants|Count of Participants|8|8.0||||||
3714468|NCT02127710|3553180|B2||Type II PRCC|Renal Cell Classification||Participants|Count of Participants|37|37.0||||||
3714469|NCT02127710|3553181|B1||Type II PRCC|Renal Cell Classification||Participants|Count of Participants|23|23.0||||||
3714470|NCT02127710|3553178|B4||Type I PRCC|Renal Cell Classification||Participants|Count of Participants|16|16.0||||||
3714471|NCT02127710|3553179|B3||Type I PRCC|Renal Cell Classification||Participants|Count of Participants|2|2.0||||||
3714472|NCT02127710|3553180|B2||Type I PRCC|Renal Cell Classification||Participants|Count of Participants|2|2.0||||||
3714473|NCT02127710|3553181|B1||Type I PRCC|Renal Cell Classification||Participants|Count of Participants|12|12.0||||||
3714474|NCT02127710|3553178|B4||Missing|Stage Classification||Participants|Count of Participants|49|49.0||||||
3714475|NCT02127710|3553179|B3||Missing|Stage Classification||Participants|Count of Participants|9|9.0||||||
3714476|NCT02127710|3553180|B2||Missing|Stage Classification||Participants|Count of Participants|16|16.0||||||
3714477|NCT02127710|3553181|B1||Missing|Stage Classification||Participants|Count of Participants|24|24.0||||||
3714478|NCT02127710|3553178|B4||High|Stage Classification||Participants|Count of Participants|31|31.0||||||
3714479|NCT02127710|3553179|B3||High|Stage Classification||Participants|Count of Participants|4|4.0||||||
3714480|NCT02127710|3553180|B2||High|Stage Classification||Participants|Count of Participants|15|15.0||||||
3714481|NCT02127710|3553181|B1||High|Stage Classification||Participants|Count of Participants|12|12.0||||||
3714482|NCT02127710|3553178|B4||Intermediate|Stage Classification||Participants|Count of Participants|24|24.0||||||
3714483|NCT02127710|3553179|B3||Intermediate|Stage Classification||Participants|Count of Participants|5|5.0||||||
3714484|NCT02127710|3553180|B2||Intermediate|Stage Classification||Participants|Count of Participants|11|11.0||||||
3714485|NCT02127710|3553181|B1||Intermediate|Stage Classification||Participants|Count of Participants|8|8.0||||||
3714486|NCT02127710|3553178|B4||Low|Stage Classification||Participants|Count of Participants|5|5.0||||||
3714488|NCT02127710|3553180|B2||Low|Stage Classification||Participants|Count of Participants|4|4.0||||||
3714489|NCT02127710|3553181|B1||Low|Stage Classification||Participants|Count of Participants|0|0.0||||||
3714490|NCT02127710|3553178|B4||PRCC Confirmed|PRCC Confirmation from Central Laboratory||Participants|Count of Participants|84|84.0||||||
3714491|NCT02127710|3553179|B3||PRCC Confirmed|PRCC Confirmation from Central Laboratory||Participants|Count of Participants|10|10.0||||||
3714492|NCT02127710|3553180|B2||PRCC Confirmed|PRCC Confirmation from Central Laboratory||Participants|Count of Participants|39|39.0||||||
3714493|NCT02127710|3553181|B1||PRCC Confirmed|PRCC Confirmation from Central Laboratory||Participants|Count of Participants|35|35.0||||||
3714494|NCT02127710|3553178|B4||PRCC Not Confirmed|PRCC Confirmation from Central Laboratory||Participants|Count of Participants|25|25.0||||||
3714495|NCT02127710|3553179|B3||PRCC Not Confirmed|PRCC Confirmation from Central Laboratory||Participants|Count of Participants|9|9.0||||||
3714496|NCT02127710|3553180|B2||PRCC Not Confirmed|PRCC Confirmation from Central Laboratory||Participants|Count of Participants|7|7.0||||||
3714497|NCT02127710|3553181|B1||PRCC Not Confirmed|PRCC Confirmation from Central Laboratory||Participants|Count of Participants|9|9.0||||||
3714498|NCT02127710|3553178|B4||PS=4|ECOG Performance Status|ECOG Performance Status (PS): (0) = Fully active; (1) Restricted in physically strenuous activity; (2) Ambulatory and capable of self-care; (3) Capable of limited self-care; (4) Completely disabled|Participants|Count of Participants|0|0.0||||||
3714499|NCT02127710|3553179|B3||PS=4|ECOG Performance Status|ECOG Performance Status (PS): (0) = Fully active; (1) Restricted in physically strenuous activity; (2) Ambulatory and capable of self-care; (3) Capable of limited self-care; (4) Completely disabled|Participants|Count of Participants|0|0.0||||||
3714500|NCT02127710|3553180|B2||PS=4|ECOG Performance Status|ECOG Performance Status (PS): (0) = Fully active; (1) Restricted in physically strenuous activity; (2) Ambulatory and capable of self-care; (3) Capable of limited self-care; (4) Completely disabled|Participants|Count of Participants|0|0.0||||||
3714501|NCT02127710|3553181|B1||PS=4|ECOG Performance Status|ECOG Performance Status (PS): (0) = Fully active; (1) Restricted in physically strenuous activity; (2) Ambulatory and capable of self-care; (3) Capable of limited self-care; (4) Completely disabled|Participants|Count of Participants|0|0.0||||||
3714502|NCT02127710|3553178|B4||PS=3|ECOG Performance Status|ECOG Performance Status (PS): (0) = Fully active; (1) Restricted in physically strenuous activity; (2) Ambulatory and capable of self-care; (3) Capable of limited self-care; (4) Completely disabled|Participants|Count of Participants|0|0.0||||||
3714503|NCT02127710|3553179|B3||PS=3|ECOG Performance Status|ECOG Performance Status (PS): (0) = Fully active; (1) Restricted in physically strenuous activity; (2) Ambulatory and capable of self-care; (3) Capable of limited self-care; (4) Completely disabled|Participants|Count of Participants|0|0.0||||||
3714504|NCT02127710|3553180|B2||PS=3|ECOG Performance Status|ECOG Performance Status (PS): (0) = Fully active; (1) Restricted in physically strenuous activity; (2) Ambulatory and capable of self-care; (3) Capable of limited self-care; (4) Completely disabled|Participants|Count of Participants|0|0.0||||||
3714505|NCT02127710|3553181|B1||PS=3|ECOG Performance Status|ECOG Performance Status (PS): (0) = Fully active; (1) Restricted in physically strenuous activity; (2) Ambulatory and capable of self-care; (3) Capable of limited self-care; (4) Completely disabled|Participants|Count of Participants|0|0.0||||||
3714506|NCT02127710|3553178|B4||PS=2|ECOG Performance Status|ECOG Performance Status (PS): (0) = Fully active; (1) Restricted in physically strenuous activity; (2) Ambulatory and capable of self-care; (3) Capable of limited self-care; (4) Completely disabled|Participants|Count of Participants|0|0.0||||||
3714507|NCT02127710|3553179|B3||PS=2|ECOG Performance Status|ECOG Performance Status (PS): (0) = Fully active; (1) Restricted in physically strenuous activity; (2) Ambulatory and capable of self-care; (3) Capable of limited self-care; (4) Completely disabled|Participants|Count of Participants|0|0.0||||||
3714508|NCT02127710|3553180|B2||PS=2|ECOG Performance Status|ECOG Performance Status (PS): (0) = Fully active; (1) Restricted in physically strenuous activity; (2) Ambulatory and capable of self-care; (3) Capable of limited self-care; (4) Completely disabled|Participants|Count of Participants|0|0.0||||||
3714509|NCT02127710|3553181|B1||PS=2|ECOG Performance Status|ECOG Performance Status (PS): (0) = Fully active; (1) Restricted in physically strenuous activity; (2) Ambulatory and capable of self-care; (3) Capable of limited self-care; (4) Completely disabled|Participants|Count of Participants|0|0.0||||||
3714510|NCT02127710|3553178|B4||PS=1|ECOG Performance Status|ECOG Performance Status (PS): (0) = Fully active; (1) Restricted in physically strenuous activity; (2) Ambulatory and capable of self-care; (3) Capable of limited self-care; (4) Completely disabled|Participants|Count of Participants|58|58.0||||||
3714511|NCT02127710|3553179|B3||PS=1|ECOG Performance Status|ECOG Performance Status (PS): (0) = Fully active; (1) Restricted in physically strenuous activity; (2) Ambulatory and capable of self-care; (3) Capable of limited self-care; (4) Completely disabled|Participants|Count of Participants|11|11.0||||||
3714512|NCT02127710|3553180|B2||PS=1|ECOG Performance Status|ECOG Performance Status (PS): (0) = Fully active; (1) Restricted in physically strenuous activity; (2) Ambulatory and capable of self-care; (3) Capable of limited self-care; (4) Completely disabled|Participants|Count of Participants|21|21.0||||||
3714513|NCT02127710|3553181|B1||PS=1|ECOG Performance Status|ECOG Performance Status (PS): (0) = Fully active; (1) Restricted in physically strenuous activity; (2) Ambulatory and capable of self-care; (3) Capable of limited self-care; (4) Completely disabled|Participants|Count of Participants|26|26.0||||||
3714514|NCT02127710|3553178|B4||PS=0|ECOG Performance Status|ECOG Performance Status (PS): (0) = Fully active; (1) Restricted in physically strenuous activity; (2) Ambulatory and capable of self-care; (3) Capable of limited self-care; (4) Completely disabled|Participants|Count of Participants|51|51.0||||||
3714515|NCT02127710|3553179|B3||PS=0|ECOG Performance Status|ECOG Performance Status (PS): (0) = Fully active; (1) Restricted in physically strenuous activity; (2) Ambulatory and capable of self-care; (3) Capable of limited self-care; (4) Completely disabled|Participants|Count of Participants|8|8.0||||||
3714516|NCT02127710|3553180|B2||PS=0|ECOG Performance Status|ECOG Performance Status (PS): (0) = Fully active; (1) Restricted in physically strenuous activity; (2) Ambulatory and capable of self-care; (3) Capable of limited self-care; (4) Completely disabled|Participants|Count of Participants|25|25.0||||||
3714517|NCT02127710|3553181|B1||PS=0|ECOG Performance Status|ECOG Performance Status (PS): (0) = Fully active; (1) Restricted in physically strenuous activity; (2) Ambulatory and capable of self-care; (3) Capable of limited self-care; (4) Completely disabled|Participants|Count of Participants|18|18.0||||||
3714518|NCT02127710|3553178|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714519|NCT02127710|3553179|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714520|NCT02127710|3553180|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714521|NCT02127710|3553181|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714522|NCT02127710|3553178|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3714523|NCT02127710|3553179|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3714524|NCT02127710|3553180|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3714525|NCT02127710|3553181|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3714526|NCT02127710|3553178|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3714527|NCT02127710|3553179|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3714528|NCT02127710|3553180|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3714529|NCT02127710|3553181|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3714530|NCT02127710|3553178|B4||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3714531|NCT02127710|3553179|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3714532|NCT02127710|3553180|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3714533|NCT02127710|3553181|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3714534|NCT02127710|3553178|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3714535|NCT02127710|3553179|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3714536|NCT02127710|3553180|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3714537|NCT02127710|3553181|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3714538|NCT02127710|3553178|B4|||Age||years|Median|64|64.0|Full Range|||23.0|87.0|
3714539|NCT02127710|3553179|B3|||Age||years|Median|58|58.0|Full Range|||37.0|80.0|
3714540|NCT02127710|3553180|B2|||Age||years|Median|64|64.0|Full Range|||29.0|75.0|
3714541|NCT02127710|3553181|B1|||Age||years|Median|64|64.0|Full Range|||23.0|87.0|
3714542|NCT02127710|3553178|B4||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
3714543|NCT02127710|3553179|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3714544|NCT02127710|3553180|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3714545|NCT02127710|3553181|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3714546|NCT02127710|3553178|B4||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
3714547|NCT02127710|3553179|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3714548|NCT02127710|3553180|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3714549|NCT02127710|3553181|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3714550|NCT02127710|3553178|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3714551|NCT02127710|3553179|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3714552|NCT02127710|3553180|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3714553|NCT02127710|3553181|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3714554|NCT02127632|3553223|B3|Turkey||Region of Enrollment||participants|Number|100|100.0||||||
3714555|NCT02127632|3553224|B2|Turkey||Region of Enrollment||participants|Number|50|50.0||||||
3714556|NCT02127632|3553225|B1|Turkey||Region of Enrollment||participants|Number|50|50.0||||||
3714557|NCT02127632|3553223|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3714558|NCT02127632|3553224|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3714559|NCT02127632|3553225|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3714560|NCT02127632|3553223|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3714561|NCT02127632|3553224|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3714562|NCT02127632|3553225|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3714563|NCT02127632|3553223|B3|||Age||years|Mean|39.11|39.11|Standard Deviation|11.45|11.45|||
3714564|NCT02127632|3553224|B2|||Age||years|Mean|38.86|38.86|Standard Deviation|11.48|11.48|||
3714565|NCT02127632|3553225|B1|||Age||years|Mean|39.36|39.36|Standard Deviation|11.52|11.52|||
3714566|NCT02127567|3553236|B1|Not familiar with guidelines||Familiar with guidelines||participant|Number|17|17.0||||||
3714567|NCT02127567|3553236|B1|Familiar with guidelines||Familiar with guidelines||participant|Number|24|24.0||||||
3714568|NCT02127567|3553236|B1|masters students||Education|doctoral vs masters students|participants|Number|27|27.0||||||
3714569|NCT02127567|3553236|B1|doctoral students||Education|doctoral vs masters students|participants|Number|14|14.0||||||
3714570|NCT02127567|3553236|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3714571|NCT02127567|3553236|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3714572|NCT02127567|3553236|B1|||Age||years|Median|29|29.0|Inter-Quartile Range|||26.0|33.0|
3714573|NCT02127372|3553256|B3|United States||Region of Enrollment||participants|Number|43|43.0||||||
3714574|NCT02127372|3553257|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
3714575|NCT02127372|3553258|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3714576|NCT02127372|3553256|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3714577|NCT02127372|3553257|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3714578|NCT02127372|3553258|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3714579|NCT02127372|3553256|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3714580|NCT02127372|3553257|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3714581|NCT02127372|3553258|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3714582|NCT02127372|3553256|B3|||Age||years|Mean|57.7|57.7|Standard Deviation|11.3|11.3|||
3714583|NCT02127372|3553257|B2|||Age||years|Mean|60.0|60.0|Standard Deviation|9.5|9.5|||
3714584|NCT02127372|3553258|B1|||Age||years|Mean|52.0|52.0|Standard Deviation|12.5|12.5|||
3714585|NCT02127307|3553269|B1||Male|Sex: Female, Male||Participants|Count of Participants|772|772.0||||||
3714586|NCT02127307|3553269|B1||Female|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
3714587|NCT02127307|3553269|B1|||Age||years|Mean|62.4|62.4|Standard Deviation|11.85|11.85|||
3714588|NCT02127281|3553273|B3|>=3||American Society of Anesthesiologists score|American Society of Anesthesiologists score a global score that assesses the physical status of patients before surgery, based on five classes 1 to 5. A higher score indicated a higher level of illness.|Participants|Count of Participants|136|136.0||||||
3714589|NCT02127281|3553274|B2|>=3||American Society of Anesthesiologists score|American Society of Anesthesiologists score a global score that assesses the physical status of patients before surgery, based on five classes 1 to 5. A higher score indicated a higher level of illness.|Participants|Count of Participants|70|70.0||||||
3714590|NCT02127281|3553275|B1|>=3||American Society of Anesthesiologists score|American Society of Anesthesiologists score a global score that assesses the physical status of patients before surgery, based on five classes 1 to 5. A higher score indicated a higher level of illness.|Participants|Count of Participants|66|66.0||||||
3714591|NCT02127281|3553273|B3|=<2||American Society of Anesthesiologists score|American Society of Anesthesiologists score a global score that assesses the physical status of patients before surgery, based on five classes 1 to 5. A higher score indicated a higher level of illness.|Participants|Count of Participants|24|24.0||||||
3714592|NCT02127281|3553274|B2|=<2||American Society of Anesthesiologists score|American Society of Anesthesiologists score a global score that assesses the physical status of patients before surgery, based on five classes 1 to 5. A higher score indicated a higher level of illness.|Participants|Count of Participants|10|10.0||||||
3714593|NCT02127281|3553275|B1|=<2||American Society of Anesthesiologists score|American Society of Anesthesiologists score a global score that assesses the physical status of patients before surgery, based on five classes 1 to 5. A higher score indicated a higher level of illness.|Participants|Count of Participants|14|14.0||||||
3714594|NCT02127281|3553273|B3|>=2||Charlson comorbidity index|The Charlson Comorbidity Index contains 19 categories of comorbidity and predicts the ten-year mortality for a patient who may have a range of co-morbid conditions. Each condition is assigned with a score of 1,2,3 or 6 depending on the risk of dying associated with this condition. A higher score indicated a higher level of illness.|Participants|Count of Participants|64|64.0||||||
3714595|NCT02127281|3553274|B2|>=2||Charlson comorbidity index|The Charlson Comorbidity Index contains 19 categories of comorbidity and predicts the ten-year mortality for a patient who may have a range of co-morbid conditions. Each condition is assigned with a score of 1,2,3 or 6 depending on the risk of dying associated with this condition. A higher score indicated a higher level of illness.|Participants|Count of Participants|35|35.0||||||
3714596|NCT02127281|3553275|B1|>=2||Charlson comorbidity index|The Charlson Comorbidity Index contains 19 categories of comorbidity and predicts the ten-year mortality for a patient who may have a range of co-morbid conditions. Each condition is assigned with a score of 1,2,3 or 6 depending on the risk of dying associated with this condition. A higher score indicated a higher level of illness.|Participants|Count of Participants|29|29.0||||||
3714597|NCT02127281|3553273|B3|1||Charlson comorbidity index|The Charlson Comorbidity Index contains 19 categories of comorbidity and predicts the ten-year mortality for a patient who may have a range of co-morbid conditions. Each condition is assigned with a score of 1,2,3 or 6 depending on the risk of dying associated with this condition. A higher score indicated a higher level of illness.|Participants|Count of Participants|40|40.0||||||
3714598|NCT02127281|3553274|B2|1||Charlson comorbidity index|The Charlson Comorbidity Index contains 19 categories of comorbidity and predicts the ten-year mortality for a patient who may have a range of co-morbid conditions. Each condition is assigned with a score of 1,2,3 or 6 depending on the risk of dying associated with this condition. A higher score indicated a higher level of illness.|Participants|Count of Participants|21|21.0||||||
3714599|NCT02127281|3553275|B1|1||Charlson comorbidity index|The Charlson Comorbidity Index contains 19 categories of comorbidity and predicts the ten-year mortality for a patient who may have a range of co-morbid conditions. Each condition is assigned with a score of 1,2,3 or 6 depending on the risk of dying associated with this condition. A higher score indicated a higher level of illness.|Participants|Count of Participants|19|19.0||||||
3714600|NCT02127281|3553273|B3|0||Charlson comorbidity index|The Charlson Comorbidity Index contains 19 categories of comorbidity and predicts the ten-year mortality for a patient who may have a range of co-morbid conditions. Each condition is assigned with a score of 1,2,3 or 6 depending on the risk of dying associated with this condition. A higher score indicated a higher level of illness.|Participants|Count of Participants|56|56.0||||||
3714601|NCT02127281|3553274|B2|0||Charlson comorbidity index|The Charlson Comorbidity Index contains 19 categories of comorbidity and predicts the ten-year mortality for a patient who may have a range of co-morbid conditions. Each condition is assigned with a score of 1,2,3 or 6 depending on the risk of dying associated with this condition. A higher score indicated a higher level of illness.|Participants|Count of Participants|24|24.0||||||
3714602|NCT02127281|3553275|B1|0||Charlson comorbidity index|The Charlson Comorbidity Index contains 19 categories of comorbidity and predicts the ten-year mortality for a patient who may have a range of co-morbid conditions. Each condition is assigned with a score of 1,2,3 or 6 depending on the risk of dying associated with this condition. A higher score indicated a higher level of illness.|Participants|Count of Participants|32|32.0||||||
3714603|NCT02127281|3553273|B3|||Body mass index||kg/m^2|Mean|32.7|32.7|Full Range|||20.2|58.7|
3714604|NCT02127281|3553274|B2|||Body mass index||kg/m^2|Mean|33.4|33.4|Full Range|||20.4|58.7|
3714605|NCT02127281|3553275|B1|||Body mass index||kg/m^2|Mean|31.9|31.9|Full Range|||20.2|53.7|
3714606|NCT02127281|3553273|B3|Non-white||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3714607|NCT02127281|3553274|B2|Non-white||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3714608|NCT02127281|3553275|B1|Non-white||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3714609|NCT02127281|3553273|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|131|131.0||||||
3714610|NCT02127281|3553274|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|66|66.0||||||
3714611|NCT02127281|3553275|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|65|65.0||||||
3714612|NCT02127281|3553273|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3714613|NCT02127281|3553274|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3714614|NCT02127281|3553275|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3714615|NCT02127281|3553273|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3714616|NCT02127281|3553274|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3714617|NCT02127281|3553275|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3714618|NCT02127281|3553273|B3|||Age||years|Mean|65|65.0|Full Range|||27.0|93.0|
3714619|NCT02127281|3553274|B2|||Age||years|Mean|65|65.0|Full Range|||37.0|93.0|
3714620|NCT02127281|3553275|B1|||Age||years|Mean|65|65.0|Full Range|||27.0|90.0|
3714621|NCT02126839|3553302|B3|||Qualifying Airway Reversibility|For a patient to be eligible for study enrollment, a minimum of 15% increase from the baseline FEV1 must be demonstrated after receiving 180 mcg of albuterol, administered as 2 actuations 1 minute apart.|percentage increase from baseline FEV1|Mean|22.4|22.4|Standard Deviation|8.16|8.16|||
3714622|NCT02126839|3553303|B2|||Qualifying Airway Reversibility|For a patient to be eligible for study enrollment, a minimum of 15% increase from the baseline FEV1 must be demonstrated after receiving 180 mcg of albuterol, administered as 2 actuations 1 minute apart.|percentage increase from baseline FEV1|Mean|22.9|22.9|Standard Deviation|8.19|8.19|||
3714623|NCT02126839|3553304|B1|||Qualifying Airway Reversibility|For a patient to be eligible for study enrollment, a minimum of 15% increase from the baseline FEV1 must be demonstrated after receiving 180 mcg of albuterol, administered as 2 actuations 1 minute apart.|percentage increase from baseline FEV1|Mean|22.0|22.0|Standard Deviation|8.14|8.14|||
3714624|NCT02126839|3553302|B3|||Screening PPFEV1|PPFEV1 = percent-predicted forced expiratory volume in 1 second|percent of predicted FEV1|Mean|88.3|88.3|Standard Deviation|11.91|11.91|||
3714625|NCT02126839|3553303|B2|||Screening PPFEV1|PPFEV1 = percent-predicted forced expiratory volume in 1 second|percent of predicted FEV1|Mean|89.0|89.0|Standard Deviation|12.35|12.35|||
3714626|NCT02126839|3553304|B1|||Screening PPFEV1|PPFEV1 = percent-predicted forced expiratory volume in 1 second|percent of predicted FEV1|Mean|87.5|87.5|Standard Deviation|11.46|11.46|||
3714627|NCT02126839|3553302|B3|||Screening FEV1|FEV1 = forced expiratory volume in 1 second|liters|Mean|1.66|1.66|Standard Deviation|0.39|0.39|||
3714628|NCT02126839|3553303|B2|||Screening FEV1|FEV1 = forced expiratory volume in 1 second|liters|Mean|1.64|1.64|Standard Deviation|0.35|0.35|||
3714629|NCT02126839|3553304|B1|||Screening FEV1|FEV1 = forced expiratory volume in 1 second|liters|Mean|1.69|1.69|Standard Deviation|0.44|0.44|||
3714630|NCT02126839|3553302|B3|||Body Mass Index||kg/m^2|Mean|19.4|19.4|Standard Deviation|5.14|5.14|||
3714631|NCT02126839|3553303|B2|||Body Mass Index||kg/m^2|Mean|19.4|19.4|Standard Deviation|5.34|5.34|||
3714632|NCT02126839|3553304|B1|||Body Mass Index||kg/m^2|Mean|19.5|19.5|Standard Deviation|4.96|4.96|||
3714633|NCT02126839|3553302|B3|||Height||cm|Mean|136.0|136.0|Standard Deviation|12.13|12.13|||
3714634|NCT02126839|3553303|B2|||Height||cm|Mean|135.2|135.2|Standard Deviation|11.59|11.59|||
3714635|NCT02126839|3553304|B1|||Height||cm|Mean|136.9|136.9|Standard Deviation|12.67|12.67|||
3714636|NCT02126839|3553302|B3|||Weight||kg|Mean|36.7|36.7|Standard Deviation|13.42|13.42|||
3714637|NCT02126839|3553303|B2|||Weight||kg|Mean|36.1|36.1|Standard Deviation|13.46|13.46|||
3714638|NCT02126839|3553304|B1|||Weight||kg|Mean|37.2|37.2|Standard Deviation|13.42|13.42|||
3714639|NCT02126839|3553302|B3|Not Hispanic or Latino||Ethnicity||participants|Number|161|161.0||||||
3714640|NCT02126839|3553303|B2|Not Hispanic or Latino||Ethnicity||participants|Number|80|80.0||||||
3714641|NCT02126839|3553304|B1|Not Hispanic or Latino||Ethnicity||participants|Number|81|81.0||||||
3714642|NCT02126839|3553302|B3|Hispanic or Latino||Ethnicity||participants|Number|25|25.0||||||
3714643|NCT02126839|3553303|B2|Hispanic or Latino||Ethnicity||participants|Number|14|14.0||||||
3714644|NCT02126839|3553304|B1|Hispanic or Latino||Ethnicity||participants|Number|11|11.0||||||
3714645|NCT02126839|3553302|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3714646|NCT02126839|3553303|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3714647|NCT02126839|3553304|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3714648|NCT02126839|3553302|B3|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3714649|NCT02126839|3553303|B2|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3714650|NCT02126839|3553304|B1|Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3714651|NCT02126839|3553302|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3714652|NCT02126839|3553303|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3714653|NCT02126839|3553304|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3714654|NCT02126839|3553302|B3|Black||Race/Ethnicity, Customized||participants|Number|100|100.0||||||
3714655|NCT02126839|3553303|B2|Black||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
3714656|NCT02126839|3553304|B1|Black||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
3714657|NCT02126839|3553302|B3|White||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
3714658|NCT02126839|3553303|B2|White||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
3714659|NCT02126839|3553304|B1|White||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
3714660|NCT02126839|3553302|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3714661|NCT02126839|3553303|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3714662|NCT02126839|3553304|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3714663|NCT02126839|3553302|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3714664|NCT02126839|3553303|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3714665|NCT02126839|3553304|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3714666|NCT02126839|3553302|B3|8-11 years||Age, Customized||participants|Number|133|133.0||||||
3714667|NCT02126839|3553303|B2|8-11 years||Age, Customized||participants|Number|64|64.0||||||
3714668|NCT02126839|3553304|B1|8-11 years||Age, Customized||participants|Number|69|69.0||||||
3714669|NCT02126839|3553302|B3|4-7 years||Age, Customized||participants|Number|53|53.0||||||
3714670|NCT02126839|3553303|B2|4-7 years||Age, Customized||participants|Number|30|30.0||||||
3714671|NCT02126839|3553304|B1|4-7 years||Age, Customized||participants|Number|23|23.0||||||
3714672|NCT02126839|3553302|B3|||Age||years|Mean|8.4|8.4|Standard Deviation|1.76|1.76|||
3714673|NCT02126839|3553303|B2|||Age||years|Mean|8.3|8.3|Standard Deviation|1.69|1.69|||
3714674|NCT02126839|3553304|B1|||Age||years|Mean|8.5|8.5|Standard Deviation|1.83|1.83|||
3714675|NCT02126748|3553315|B4|Belgium||Region of Enrollment||participants|Number|93|93.0||||||
3714676|NCT02126748|3553316|B3|Belgium||Region of Enrollment||participants|Number|31|31.0||||||
3714677|NCT02126748|3553317|B2|Belgium||Region of Enrollment||participants|Number|31|31.0||||||
3714678|NCT02126748|3553318|B1|Belgium||Region of Enrollment||participants|Number|31|31.0||||||
3714679|NCT02126748|3553315|B4||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3714680|NCT02126748|3553316|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3714681|NCT02126748|3553317|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3714682|NCT02126748|3553318|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3714683|NCT02126748|3553315|B4||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3714684|NCT02126748|3553316|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3714685|NCT02126748|3553317|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3714686|NCT02126748|3553318|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3714687|NCT02126748|3553315|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3714688|NCT02126748|3553316|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3714689|NCT02126748|3553317|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3714690|NCT02126748|3553318|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3714691|NCT02126748|3553315|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3714692|NCT02126748|3553316|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3714693|NCT02126748|3553317|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3714694|NCT02126748|3553318|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3714695|NCT02126748|3553315|B4||<=18 years|Age||Participants|Count of Participants|93|93.0||||||
3714696|NCT02126748|3553316|B3||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
3714697|NCT02126748|3553317|B2||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
3714698|NCT02126748|3553318|B1||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
3714699|NCT02126670|3553328|B5|United States||Region of Enrollment||participants|Number|98|98.0||||||
3714700|NCT02126670|3553329|B4|United States||Region of Enrollment||participants|Number|24|24.0||||||
3714701|NCT02126670|3553330|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
3714702|NCT02126670|3553331|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
3714703|NCT02126670|3553332|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3714704|NCT02126670|3553328|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714705|NCT02126670|3553329|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714706|NCT02126670|3553330|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714707|NCT02126670|3553331|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714708|NCT02126670|3553332|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714709|NCT02126670|3553328|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714710|NCT02126670|3553329|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714711|NCT02126670|3553330|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714712|NCT02126670|3553331|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714713|NCT02126670|3553332|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714714|NCT02126670|3553328|B5||White|Race (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
3714715|NCT02126670|3553329|B4||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3714716|NCT02126670|3553330|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3714717|NCT02126670|3553331|B2||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3714718|NCT02126670|3553332|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3714719|NCT02126670|3553328|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714720|NCT02126670|3553329|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714721|NCT02126670|3553330|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714722|NCT02126670|3553331|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714723|NCT02126670|3553332|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714724|NCT02126670|3553328|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714725|NCT02126670|3553329|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714726|NCT02126670|3553330|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714727|NCT02126670|3553331|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714728|NCT02126670|3553332|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714729|NCT02126670|3553328|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3714730|NCT02126670|3553329|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714731|NCT02126670|3553330|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3714732|NCT02126670|3553331|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714733|NCT02126670|3553332|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714734|NCT02126670|3553328|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714735|NCT02126670|3553329|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714736|NCT02126670|3553330|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714737|NCT02126670|3553331|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714738|NCT02126670|3553332|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714739|NCT02126670|3553328|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714740|NCT02126670|3553329|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714741|NCT02126670|3553330|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714742|NCT02126670|3553331|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714743|NCT02126670|3553332|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714744|NCT02126670|3553328|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
3714745|NCT02126670|3553329|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3714746|NCT02126670|3553330|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3714747|NCT02126670|3553331|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3714748|NCT02126670|3553332|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3714749|NCT02126670|3553328|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3714750|NCT02126670|3553329|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3714751|NCT02126670|3553330|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714752|NCT02126670|3553331|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714753|NCT02126670|3553332|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714754|NCT02126670|3553328|B5||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3714755|NCT02126670|3553329|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3714756|NCT02126670|3553330|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3714757|NCT02126670|3553331|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3714758|NCT02126670|3553332|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3714759|NCT02126670|3553328|B5||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3714760|NCT02126670|3553329|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3714761|NCT02126670|3553330|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3714762|NCT02126670|3553331|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3714763|NCT02126670|3553332|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3714764|NCT02126670|3553328|B5|||Age||years|Mean|65.5|65.5|Standard Deviation|9.47|9.47|||
3714765|NCT02126670|3553329|B4|||Age||years|Mean|66.9|66.9|Standard Deviation|8.28|8.28|||
3714766|NCT02126670|3553330|B3|||Age||years|Mean|66.5|66.5|Standard Deviation|8.94|8.94|||
3714767|NCT02126670|3553331|B2|||Age||years|Mean|64.4|64.4|Standard Deviation|9.78|9.78|||
3714768|NCT02126670|3553332|B1|||Age||years|Mean|64.4|64.4|Standard Deviation|11.08|11.08|||
3714769|NCT02126319|3553349|B3|Low||Monitoring attentional style|Monitoring attentional style was assessed at baseline using the Monitoring Style Subscale (MBSS; Miller, 1987), which measures attentional responses to four structured stress-evoking scenarios. Each scenario is followed by four possible monitoring responses. Participants endorse all the responses that apply to them. A total monitoring score (range 0-16) is computed for each participant by summing the number of monitoring responses endorsed within each of the four scenarios. A median split was used to create a high (greater than 9) and a low (less or equal to 9) monitoring group.|participants|Number|69|69.0||||||
3714849|NCT02125877|3553387|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3714770|NCT02126319|3553350|B2|Low||Monitoring attentional style|Monitoring attentional style was assessed at baseline using the Monitoring Style Subscale (MBSS; Miller, 1987), which measures attentional responses to four structured stress-evoking scenarios. Each scenario is followed by four possible monitoring responses. Participants endorse all the responses that apply to them. A total monitoring score (range 0-16) is computed for each participant by summing the number of monitoring responses endorsed within each of the four scenarios. A median split was used to create a high (greater than 9) and a low (less or equal to 9) monitoring group.|participants|Number|36|36.0||||||
3714771|NCT02126319|3553351|B1|Low||Monitoring attentional style|Monitoring attentional style was assessed at baseline using the Monitoring Style Subscale (MBSS; Miller, 1987), which measures attentional responses to four structured stress-evoking scenarios. Each scenario is followed by four possible monitoring responses. Participants endorse all the responses that apply to them. A total monitoring score (range 0-16) is computed for each participant by summing the number of monitoring responses endorsed within each of the four scenarios. A median split was used to create a high (greater than 9) and a low (less or equal to 9) monitoring group.|participants|Number|33|33.0||||||
3714772|NCT02126319|3553349|B3|High||Monitoring attentional style|Monitoring attentional style was assessed at baseline using the Monitoring Style Subscale (MBSS; Miller, 1987), which measures attentional responses to four structured stress-evoking scenarios. Each scenario is followed by four possible monitoring responses. Participants endorse all the responses that apply to them. A total monitoring score (range 0-16) is computed for each participant by summing the number of monitoring responses endorsed within each of the four scenarios. A median split was used to create a high (greater than 9) and a low (less or equal to 9) monitoring group.|participants|Number|59|59.0||||||
3714773|NCT02126319|3553350|B2|High||Monitoring attentional style|Monitoring attentional style was assessed at baseline using the Monitoring Style Subscale (MBSS; Miller, 1987), which measures attentional responses to four structured stress-evoking scenarios. Each scenario is followed by four possible monitoring responses. Participants endorse all the responses that apply to them. A total monitoring score (range 0-16) is computed for each participant by summing the number of monitoring responses endorsed within each of the four scenarios. A median split was used to create a high (greater than 9) and a low (less or equal to 9) monitoring group.|participants|Number|31|31.0||||||
3714774|NCT02126319|3553351|B1|High||Monitoring attentional style|Monitoring attentional style was assessed at baseline using the Monitoring Style Subscale (MBSS; Miller, 1987), which measures attentional responses to four structured stress-evoking scenarios. Each scenario is followed by four possible monitoring responses. Participants endorse all the responses that apply to them. A total monitoring score (range 0-16) is computed for each participant by summing the number of monitoring responses endorsed within each of the four scenarios. A median split was used to create a high (greater than 9) and a low (less or equal to 9) monitoring group.|participants|Number|28|28.0||||||
3714775|NCT02126319|3553349|B3|||Pca related intrusive ideation|Intrusive ideation related to prostate cancer risk was assessed using the Impact of Events Scale (IES) (Horowitz et al., 1979). This instrument has been used extensively in the cancer literature (Schwartz et al., 2002). Only the intrusive ideation subscale was used in this study. The range of possible values is 0 to 35. Higher scores indicate higher level of intrusive ideation. Cronbach’s alpha for the intrusion subscale in the present study was 0.82. Because of high skewness, a median split was used to create a high and a low group.|units on a scale|Mean|3.89|3.89|Standard Deviation|5.10|5.1|||
3714776|NCT02126319|3553350|B2|||Pca related intrusive ideation|Intrusive ideation related to prostate cancer risk was assessed using the Impact of Events Scale (IES) (Horowitz et al., 1979). This instrument has been used extensively in the cancer literature (Schwartz et al., 2002). Only the intrusive ideation subscale was used in this study. The range of possible values is 0 to 35. Higher scores indicate higher level of intrusive ideation. Cronbach’s alpha for the intrusion subscale in the present study was 0.82. Because of high skewness, a median split was used to create a high and a low group.|units on a scale|Mean|3.33|3.33|Standard Deviation|4.32|4.32|||
3714777|NCT02126319|3553351|B1|||Pca related intrusive ideation|Intrusive ideation related to prostate cancer risk was assessed using the Impact of Events Scale (IES) (Horowitz et al., 1979). This instrument has been used extensively in the cancer literature (Schwartz et al., 2002). Only the intrusive ideation subscale was used in this study. The range of possible values is 0 to 35. Higher scores indicate higher level of intrusive ideation. Cronbach’s alpha for the intrusion subscale in the present study was 0.82. Because of high skewness, a median split was used to create a high and a low group.|units on a scale|Mean|4.51|4.51|Standard Deviation|5.81|5.81|||
3714778|NCT02126319|3553349|B3|||Pca related negative expectancies|Negative expectancies related to Pca screening comprised five items and assessed the costs and risks of screening, in terms of time and effort, fears of discrimination, insurance and employment, and financial concerns on a five-point scale (e.g., “Screening may have a negative impact on my health insurance”). Questionnaire items were author-constructed, based on prior work and cognitive-affective theory (Miller et al., 1996). Reported means are based on a scale from one to five. Higher scores indicate more negative expectancies. Cronbach’s alpha for the scale was 0.80.|units on a scale|Mean|1.72|1.72|Standard Deviation|0.78|0.78|||
3714779|NCT02126319|3553350|B2|||Pca related negative expectancies|Negative expectancies related to Pca screening comprised five items and assessed the costs and risks of screening, in terms of time and effort, fears of discrimination, insurance and employment, and financial concerns on a five-point scale (e.g., “Screening may have a negative impact on my health insurance”). Questionnaire items were author-constructed, based on prior work and cognitive-affective theory (Miller et al., 1996). Reported means are based on a scale from one to five. Higher scores indicate more negative expectancies. Cronbach’s alpha for the scale was 0.80.|units on a scale|Mean|1.72|1.72|Standard Deviation|0.78|0.78|||
3714780|NCT02126319|3553351|B1|||Pca related negative expectancies|Negative expectancies related to Pca screening comprised five items and assessed the costs and risks of screening, in terms of time and effort, fears of discrimination, insurance and employment, and financial concerns on a five-point scale (e.g., “Screening may have a negative impact on my health insurance”). Questionnaire items were author-constructed, based on prior work and cognitive-affective theory (Miller et al., 1996). Reported means are based on a scale from one to five. Higher scores indicate more negative expectancies. Cronbach’s alpha for the scale was 0.80.|units on a scale|Mean|1.72|1.72|Standard Deviation|0.78|0.78|||
3714850|NCT02125877|3553385|B3|||Age||Years|Mean|34.9|34.9|Standard Deviation|19.25|19.25|||
3714781|NCT02126319|3553349|B3|||Pca related positive expectancies|Positive expectancies regarding the effects of screening were assessed using two items on a five-point scale (“Regular screening will ensure that I stay healthy” and “Regular screening will prolong my life”). Questionnaire items were author-constructed, based on prior work and cognitive-affective theory (Miller et al., 1996). Reported means are based on a scale from one to five. Higher scores indicate more Pca related positive expectancies. Cronbach's alpha for the scale was 0.76.|units on a scale|Mean|3.92|3.92|Standard Deviation|0.99|0.99|||
3714782|NCT02126319|3553350|B2|||Pca related positive expectancies|Positive expectancies regarding the effects of screening were assessed using two items on a five-point scale (“Regular screening will ensure that I stay healthy” and “Regular screening will prolong my life”). Questionnaire items were author-constructed, based on prior work and cognitive-affective theory (Miller et al., 1996). Reported means are based on a scale from one to five. Higher scores indicate more Pca related positive expectancies. Cronbach's alpha for the scale was 0.76.|units on a scale|Mean|3.97|3.97|Standard Deviation|0.91|0.91|||
3714783|NCT02126319|3553351|B1|||Pca related positive expectancies|Positive expectancies regarding the effects of screening were assessed using two items on a five-point scale (“Regular screening will ensure that I stay healthy” and “Regular screening will prolong my life”). Questionnaire items were author-constructed, based on prior work and cognitive-affective theory (Miller et al., 1996). Reported means are based on a scale from one to five. Higher scores indicate more Pca related positive expectancies. Cronbach's alpha for the scale was 0.76.|units on a scale|Mean|3.86|3.86|Standard Deviation|1.09|1.09|||
3714784|NCT02126319|3553349|B3|||Pca related perceived risk|Perceived risk of Pca was assessed using four items where participants were asked to estimate their prostate cancer risk in general (e.g., “Do you feel as though you are the kind of person who is likely to develop prostate cancer?”) or comparing themselves to other men at risk for Pca (e.g., “Given your ethnicity, what are your chance of getting prostate cancer?”) on a five-point scale (Lerman et al., 1996). Reported means are based on a scale from one to five. Higher scores indicate higher Pca perceived risk i.e. 1=much lower risk; 5=much higher risk. Cronbach’s alpha for the scale was 0.83.|units on a scale|Mean|3.18|3.18|Standard Deviation|0.82|0.82|||
3714785|NCT02126319|3553350|B2|||Pca related perceived risk|Perceived risk of Pca was assessed using four items where participants were asked to estimate their prostate cancer risk in general (e.g., “Do you feel as though you are the kind of person who is likely to develop prostate cancer?”) or comparing themselves to other men at risk for Pca (e.g., “Given your ethnicity, what are your chance of getting prostate cancer?”) on a five-point scale (Lerman et al., 1996). Reported means are based on a scale from one to five. Higher scores indicate higher Pca perceived risk i.e. 1=much lower risk; 5=much higher risk. Cronbach’s alpha for the scale was 0.83.|units on a scale|Mean|3.25|3.25|Standard Deviation|0.77|0.77|||
3714786|NCT02126319|3553351|B1|||Pca related perceived risk|Perceived risk of Pca was assessed using four items where participants were asked to estimate their prostate cancer risk in general (e.g., “Do you feel as though you are the kind of person who is likely to develop prostate cancer?”) or comparing themselves to other men at risk for Pca (e.g., “Given your ethnicity, what are your chance of getting prostate cancer?”) on a five-point scale (Lerman et al., 1996). Reported means are based on a scale from one to five. Higher scores indicate higher Pca perceived risk i.e. 1=much lower risk; 5=much higher risk. Cronbach’s alpha for the scale was 0.83.|units on a scale|Mean|3.10|3.1|Standard Deviation|0.87|0.87|||
3714787|NCT02126319|3553349|B3|||Pca related knowledge|Knowledge about Pca risk was measured using an eight item scale prepared for this study. It consisted of true/false items (e.g., “An abnormal DRE and/or PSA could be the result of conditions other than prostate cancer”). Correct responses received a value of one, whereas false responses received a zero. Values ranged between zero and eight, with higher values indicating higher knwoledge.|units on a scale|Mean|6.37|6.37|Standard Deviation|1.40|1.4|||
3714788|NCT02126319|3553350|B2|||Pca related knowledge|Knowledge about Pca risk was measured using an eight item scale prepared for this study. It consisted of true/false items (e.g., “An abnormal DRE and/or PSA could be the result of conditions other than prostate cancer”). Correct responses received a value of one, whereas false responses received a zero. Values ranged between zero and eight, with higher values indicating higher knwoledge.|units on a scale|Mean|6.23|6.23|Standard Deviation|1.39|1.39|||
3714789|NCT02126319|3553351|B1|||Pca related knowledge|Knowledge about Pca risk was measured using an eight item scale prepared for this study. It consisted of true/false items (e.g., “An abnormal DRE and/or PSA could be the result of conditions other than prostate cancer”). Correct responses received a value of one, whereas false responses received a zero. Values ranged between zero and eight, with higher values indicating higher knwoledge.|units on a scale|Mean|6.53|6.53|Standard Deviation|1.40|1.4|||
3714790|NCT02126319|3553349|B3|No family history||family history of Pca|Baseline information regarding family history for prostate cancer was incomplete. A man was considered as having a positive family history for prostate cancer if Data at baseline was incomplete regarding this variable (20 men for the General Health Education Group and 16 men for the Cognitive Affective Preparation Group).|participants|Number|23|23.0||||||
3714791|NCT02126319|3553350|B2|No family history||family history of Pca|Baseline information regarding family history for prostate cancer was incomplete. A man was considered as having a positive family history for prostate cancer if Data at baseline was incomplete regarding this variable (20 men for the General Health Education Group and 16 men for the Cognitive Affective Preparation Group).|participants|Number|9|9.0||||||
3714792|NCT02126319|3553351|B1|No family history||family history of Pca|Baseline information regarding family history for prostate cancer was incomplete. A man was considered as having a positive family history for prostate cancer if Data at baseline was incomplete regarding this variable (20 men for the General Health Education Group and 16 men for the Cognitive Affective Preparation Group).|participants|Number|14|14.0||||||
3714793|NCT02126319|3553349|B3|With positive family history||family history of Pca|Baseline information regarding family history for prostate cancer was incomplete. A man was considered as having a positive family history for prostate cancer if Data at baseline was incomplete regarding this variable (20 men for the General Health Education Group and 16 men for the Cognitive Affective Preparation Group).|participants|Number|105|105.0||||||
3714851|NCT02125877|3553386|B2|||Age||Years|Mean|34.6|34.6|Standard Deviation|19.97|19.97|||
3714852|NCT02125877|3553387|B1|||Age||Years|Mean|35.1|35.1|Standard Deviation|18.60|18.6|||
3714853|NCT02125838|3553416|B3|Turkey||Region of Enrollment||participants|Number|108|108.0||||||
3714794|NCT02126319|3553350|B2|With positive family history||family history of Pca|Baseline information regarding family history for prostate cancer was incomplete. A man was considered as having a positive family history for prostate cancer if Data at baseline was incomplete regarding this variable (20 men for the General Health Education Group and 16 men for the Cognitive Affective Preparation Group).|participants|Number|58|58.0||||||
3714795|NCT02126319|3553351|B1|With positive family history||family history of Pca|Baseline information regarding family history for prostate cancer was incomplete. A man was considered as having a positive family history for prostate cancer if Data at baseline was incomplete regarding this variable (20 men for the General Health Education Group and 16 men for the Cognitive Affective Preparation Group).|participants|Number|47|47.0||||||
3714796|NCT02126319|3553349|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714797|NCT02126319|3553350|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714798|NCT02126319|3553351|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714799|NCT02126319|3553349|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714800|NCT02126319|3553350|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714801|NCT02126319|3553351|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714802|NCT02126319|3553349|B3||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3714803|NCT02126319|3553350|B2||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3714804|NCT02126319|3553351|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3714805|NCT02126319|3553349|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3714806|NCT02126319|3553350|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3714807|NCT02126319|3553351|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3714808|NCT02126319|3553349|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714809|NCT02126319|3553350|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714810|NCT02126319|3553351|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714811|NCT02126319|3553349|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714812|NCT02126319|3553350|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714813|NCT02126319|3553351|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714814|NCT02126319|3553349|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714815|NCT02126319|3553350|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714816|NCT02126319|3553351|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714817|NCT02126319|3553349|B3||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3714818|NCT02126319|3553350|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3714819|NCT02126319|3553351|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3714820|NCT02126319|3553349|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3714821|NCT02126319|3553350|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3714822|NCT02126319|3553351|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3714823|NCT02126319|3553349|B3|||Age||years|Mean|47.42|47.42|Standard Deviation|8.80|8.8|||
3714824|NCT02126319|3553350|B2|||Age||years|Mean|47.61|47.61|Standard Deviation|8.81|8.81|||
3714825|NCT02126319|3553351|B1|||Age||years|Mean|47.21|47.21|Standard Deviation|8.86|8.86|||
3714826|NCT02126306|3553376|B3|Israel||Region of Enrollment||participants|Number|23|23.0||||||
3714827|NCT02126306|3553377|B2|Israel||Region of Enrollment||participants|Number|13|13.0||||||
3714828|NCT02126306|3553378|B1|Israel||Region of Enrollment||participants|Number|10|10.0||||||
3714829|NCT02126306|3553376|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3714830|NCT02126306|3553377|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3714831|NCT02126306|3553378|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3714832|NCT02126306|3553376|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3714833|NCT02126306|3553377|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3714834|NCT02126306|3553378|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3714835|NCT02126306|3553376|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3714836|NCT02126306|3553377|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3714837|NCT02126306|3553378|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3714838|NCT02126306|3553376|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3714839|NCT02126306|3553377|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3714840|NCT02126306|3553378|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3714841|NCT02126306|3553376|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3714842|NCT02126306|3553377|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3714843|NCT02126306|3553378|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3714844|NCT02125877|3553385|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3714845|NCT02125877|3553386|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3714846|NCT02125877|3553387|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3714847|NCT02125877|3553385|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3714848|NCT02125877|3553386|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3714854|NCT02125838|3553417|B2|Turkey||Region of Enrollment||participants|Number|54|54.0||||||
3714855|NCT02125838|3553418|B1|Turkey||Region of Enrollment||participants|Number|54|54.0||||||
3714856|NCT02125838|3553416|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3714857|NCT02125838|3553417|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3714858|NCT02125838|3553418|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3714859|NCT02125838|3553416|B3||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3714860|NCT02125838|3553417|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3714861|NCT02125838|3553418|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3714862|NCT02125838|3553416|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3714863|NCT02125838|3553417|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3714864|NCT02125838|3553418|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3714865|NCT02125838|3553416|B3||Between 18 and 65 years|Age||Participants|Count of Participants|108|108.0||||||
3714866|NCT02125838|3553417|B2||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3714867|NCT02125838|3553418|B1||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3714868|NCT02125838|3553416|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3714869|NCT02125838|3553417|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3714870|NCT02125838|3553418|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3714871|NCT02125734|3553435|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3714872|NCT02125734|3553436|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3714873|NCT02125734|3553437|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3714874|NCT02125734|3553435|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3714875|NCT02125734|3553436|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3714876|NCT02125734|3553437|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3714877|NCT02125734|3553435|B3|||Age||Years|Mean|65|65.0|Standard Deviation|9.56|9.56|||
3714878|NCT02125734|3553436|B2|||Age||Years|Mean|66.0|66.0|Standard Deviation|9.31|9.31|||
3714879|NCT02125734|3553437|B1|||Age||Years|Mean|63.9|63.9|Standard Deviation|9.83|9.83|||
3714880|NCT02125604|3553448|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3714881|NCT02125604|3553448|B1||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3714882|NCT02125604|3553448|B1|||Age||years|Mean|40.09|40.09|Standard Deviation|10.97|10.97|||
3714883|NCT02125292|3553462|B1|||Body Mass Index||kg/m^2|Mean|24.348|24.348|Standard Deviation|3.4331|3.4331|||
3714884|NCT02125292|3553462|B1|||Height||centimeters|Mean|166.2|166.2|Standard Deviation|9.25|9.25|||
3714885|NCT02125292|3553462|B1|||Weight||kilograms|Mean|67.59|67.59|Standard Deviation|13.312|13.312|||
3714886|NCT02125292|3553462|B1|Non-white, black or African American||Race||participants|Number|2|2.0||||||
3714887|NCT02125292|3553462|B1|White||Race||participants|Number|16|16.0||||||
3714888|NCT02125292|3553462|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714889|NCT02125292|3553462|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3714890|NCT02125292|3553462|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3714891|NCT02125292|3553462|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3714892|NCT02125292|3553462|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3714893|NCT02125292|3553462|B1|||Age||years|Mean|30.1|30.1|Standard Deviation|11.31|11.31|||
3714894|NCT02124863|3553488|B1|Belgium||Region of Enrollment||participants|Number|50|50.0||||||
3714895|NCT02124863|3553488|B1||Male|Gender||Participants|Count of Participants|25|25.0||||||
3714896|NCT02124863|3553488|B1||Female|Gender||Participants|Count of Participants|25|25.0||||||
3714897|NCT02124863|3553488|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3714898|NCT02124863|3553488|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3714899|NCT02124863|3553488|B1||<=18 years|Age||Participants|Count of Participants|50|50.0||||||
3714900|NCT02124811|3553494|B3|||Interleukin 10 (IL-10)|Interleukin 10 (IL-10) is a cytokine impacting immunoregulation and inflammation. The normal range for IL-10 is <2 pg/ml.|pg/ml|Mean|0.44|0.44|Standard Deviation|0.44|0.44|||
3714901|NCT02124811|3553495|B2|||Interleukin 10 (IL-10)|Interleukin 10 (IL-10) is a cytokine impacting immunoregulation and inflammation. The normal range for IL-10 is <2 pg/ml.|pg/ml|Mean|0.23|0.23|Standard Deviation|0.13|0.13|||
3714902|NCT02124811|3553496|B1|||Interleukin 10 (IL-10)|Interleukin 10 (IL-10) is a cytokine impacting immunoregulation and inflammation. The normal range for IL-10 is <2 pg/ml.|pg/ml|Mean|0.64|0.64|Standard Deviation|0.56|0.56|||
3714903|NCT02124811|3553494|B3|||Interleukin 6 (IL-6)|Interleukin 6 (IL-6) is secreted by T cells and macrophages stimulating an immune response during infection and after trauma. The normal range for IL-6 is < 5 pg/ml.|pg/ml|Mean|2.12|2.12|Standard Deviation|3.05|3.05|||
3714904|NCT02124811|3553495|B2|||Interleukin 6 (IL-6)|Interleukin 6 (IL-6) is secreted by T cells and macrophages stimulating an immune response during infection and after trauma. The normal range for IL-6 is < 5 pg/ml.|pg/ml|Mean|1.11|1.11|Standard Deviation|0.21|0.21|||
3714905|NCT02124811|3553496|B1|||Interleukin 6 (IL-6)|Interleukin 6 (IL-6) is secreted by T cells and macrophages stimulating an immune response during infection and after trauma. The normal range for IL-6 is < 5 pg/ml.|pg/ml|Mean|3.12|3.12|Standard Deviation|4.29|4.29|||
3714906|NCT02124811|3553494|B3|||Interleukin 1 (IL-1) beta|Interleukin 1 (IL-1) beta is a pro-inflammatory cytokine implicated in pain, inflammation and autoimmune conditions. The normal range for IL-1 beta is <3.9 pg/ml.|pg/ml|Mean|0.67|0.67|Standard Deviation|0.21|0.21|||
3714999|NCT02124122|3553603|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714907|NCT02124811|3553495|B2|||Interleukin 1 (IL-1) beta|Interleukin 1 (IL-1) beta is a pro-inflammatory cytokine implicated in pain, inflammation and autoimmune conditions. The normal range for IL-1 beta is <3.9 pg/ml.|pg/ml|Mean|0.73|0.73|Standard Deviation|0.22|0.22|||
3714908|NCT02124811|3553496|B1|||Interleukin 1 (IL-1) beta|Interleukin 1 (IL-1) beta is a pro-inflammatory cytokine implicated in pain, inflammation and autoimmune conditions. The normal range for IL-1 beta is <3.9 pg/ml.|pg/ml|Mean|0.62|0.62|Standard Deviation|0.20|0.2|||
3714909|NCT02124811|3553494|B3|||Tumor Necrosis Factor (TNF) Alpha|Tumor necrosis factor (TNF) alpha is a cytokine associated with systemic inflammation and the normal range for TNF alpha is <5.6 picograms per milliliter (pg/ml).|pg/ml|Mean|5.71|5.71|Standard Deviation|2.48|2.48|||
3714910|NCT02124811|3553495|B2|||Tumor Necrosis Factor (TNF) Alpha|Tumor necrosis factor (TNF) alpha is a cytokine associated with systemic inflammation and the normal range for TNF alpha is <5.6 picograms per milliliter (pg/ml).|pg/ml|Mean|5.36|5.36|Standard Deviation|2.88|2.88|||
3714911|NCT02124811|3553496|B1|||Tumor Necrosis Factor (TNF) Alpha|Tumor necrosis factor (TNF) alpha is a cytokine associated with systemic inflammation and the normal range for TNF alpha is <5.6 picograms per milliliter (pg/ml).|pg/ml|Mean|6.07|6.07|Standard Deviation|2.29|2.29|||
3714912|NCT02124811|3553494|B3|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3714913|NCT02124811|3553495|B2|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3714914|NCT02124811|3553496|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3714915|NCT02124811|3553494|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3714916|NCT02124811|3553495|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3714917|NCT02124811|3553496|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3714918|NCT02124811|3553494|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3714919|NCT02124811|3553495|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3714920|NCT02124811|3553496|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3714921|NCT02124811|3553494|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3714922|NCT02124811|3553495|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3714923|NCT02124811|3553496|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3714924|NCT02124811|3553494|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3714925|NCT02124811|3553495|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3714926|NCT02124811|3553496|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3714927|NCT02124811|3553494|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3714928|NCT02124811|3553495|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3714929|NCT02124811|3553496|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3714930|NCT02124798|3553513|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714931|NCT02124798|3553513|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714932|NCT02124798|3553513|B1||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3714933|NCT02124798|3553513|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3714934|NCT02124798|3553513|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714935|NCT02124798|3553513|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3714936|NCT02124798|3553513|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714937|NCT02124798|3553513|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3714938|NCT02124798|3553513|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3714939|NCT02124798|3553513|B1|||Age||Years|Mean|44.8|44.8|Standard Deviation|12.50|12.5|||
3714940|NCT02124603|3553519|B1|Italy||Region of Enrollment||participants|Number|120|120.0||||||
3714941|NCT02124603|3553519|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3714942|NCT02124603|3553519|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3714943|NCT02124603|3553519|B1|||Age||years|Mean|72.3|72.3|Standard Deviation|8.4|8.4|||
3714944|NCT02124460|3553525|B3|||Parent Resource Empowerment|The five items in the scale assessed parents’ perceived knowledge of resources, ability to access resources, comfort with accessing resources, knowledge of how to find resources, and ability to acquire resources related to child weight management. Responses ranged from Strongly disagree to Strongly agree (range = 1-4). Items were averaged to create a summary parental resource empowerment score (range= 1-4), where a higher score indicated greater perceived knowledge and ability to access resources related to weight management. Cronbach’s α for this score was 0.87.|units on a scale|Mean|2.95|2.95|Standard Deviation|0.56|0.56|||
3714945|NCT02124460|3553526|B2|||Parent Resource Empowerment|The five items in the scale assessed parents’ perceived knowledge of resources, ability to access resources, comfort with accessing resources, knowledge of how to find resources, and ability to acquire resources related to child weight management. Responses ranged from Strongly disagree to Strongly agree (range = 1-4). Items were averaged to create a summary parental resource empowerment score (range= 1-4), where a higher score indicated greater perceived knowledge and ability to access resources related to weight management. Cronbach’s α for this score was 0.87.|units on a scale|Mean|2.96|2.96|Standard Deviation|0.53|0.53|||
3714946|NCT02124460|3553527|B1|||Parent Resource Empowerment|The five items in the scale assessed parents’ perceived knowledge of resources, ability to access resources, comfort with accessing resources, knowledge of how to find resources, and ability to acquire resources related to child weight management. Responses ranged from Strongly disagree to Strongly agree (range = 1-4). Items were averaged to create a summary parental resource empowerment score (range= 1-4), where a higher score indicated greater perceived knowledge and ability to access resources related to weight management. Cronbach’s α for this score was 0.87.|units on a scale|Mean|2.93|2.93|Standard Deviation|0.59|0.59|||
3714947|NCT02124460|3553525|B3|||Pediatric Quality of Life (PedsQL) Summary Score|Items are reverse-scored and linearly transformed to a 0–100 scale (0 = 100, 1 = 75, 2 = 50, 3 = 25, 4 = 0), so that higher scores indicate better HRQOL. Scale Scores are computed as the sum of the items divided by the number of items answered (this accounts for missing data). If more than 50% of the items in the scale are missing, the Scale Score is not computed.|units on a scale|Mean|85.7|85.7|Standard Deviation|11.1|11.1|||
3714948|NCT02124460|3553526|B2|||Pediatric Quality of Life (PedsQL) Summary Score|Items are reverse-scored and linearly transformed to a 0–100 scale (0 = 100, 1 = 75, 2 = 50, 3 = 25, 4 = 0), so that higher scores indicate better HRQOL. Scale Scores are computed as the sum of the items divided by the number of items answered (this accounts for missing data). If more than 50% of the items in the scale are missing, the Scale Score is not computed.|units on a scale|Mean|85.4|85.4|Standard Deviation|11.4|11.4|||
3714949|NCT02124460|3553527|B1|||Pediatric Quality of Life (PedsQL) Summary Score|Items are reverse-scored and linearly transformed to a 0–100 scale (0 = 100, 1 = 75, 2 = 50, 3 = 25, 4 = 0), so that higher scores indicate better HRQOL. Scale Scores are computed as the sum of the items divided by the number of items answered (this accounts for missing data). If more than 50% of the items in the scale are missing, the Scale Score is not computed.|units on a scale|Mean|86.0|86.0|Standard Deviation|10.8|10.8|||
3714950|NCT02124460|3553525|B3|||BMI z score||BMI z score units|Mean|1.88|1.88|Standard Deviation|0.52|0.52|||
3714951|NCT02124460|3553526|B2|||BMI z score||BMI z score units|Mean|1.86|1.86|Standard Deviation|0.52|0.52|||
3714952|NCT02124460|3553527|B1|||BMI z score||BMI z score units|Mean|1.90|1.9|Standard Deviation|0.51|0.51|||
3714953|NCT02124460|3553525|B3|United States||Region of Enrollment||participants|Number|721|721.0||||||
3714954|NCT02124460|3553526|B2|United States||Region of Enrollment||participants|Number|360|360.0||||||
3714955|NCT02124460|3553527|B1|United States||Region of Enrollment||participants|Number|361|361.0||||||
3714956|NCT02124460|3553525|B3||Male|Sex: Female, Male||Participants|Count of Participants|353|353.0||||||
3714957|NCT02124460|3553526|B2||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3714958|NCT02124460|3553527|B1||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
3714959|NCT02124460|3553525|B3||Female|Sex: Female, Male||Participants|Count of Participants|368|368.0||||||
3714960|NCT02124460|3553526|B2||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3714961|NCT02124460|3553527|B1||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3714962|NCT02124460|3553525|B3|||Age||years|Mean|8.0|8.0|Standard Deviation|3.0|3.0|||
3714963|NCT02124460|3553526|B2|||Age||years|Mean|8.1|8.1|Standard Deviation|3.0|3.0|||
3714964|NCT02124460|3553527|B1|||Age||years|Mean|8.0|8.0|Standard Deviation|3.0|3.0|||
3714965|NCT02124460|3553525|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3714966|NCT02124460|3553526|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3714967|NCT02124460|3553527|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3714968|NCT02124460|3553525|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3714969|NCT02124460|3553526|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3714970|NCT02124460|3553527|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3714971|NCT02124460|3553525|B3||<=18 years|Age||Participants|Count of Participants|721|721.0||||||
3714972|NCT02124460|3553526|B2||<=18 years|Age||Participants|Count of Participants|360|360.0||||||
3714973|NCT02124460|3553527|B1||<=18 years|Age||Participants|Count of Participants|361|361.0||||||
3714974|NCT02124304|3553558|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3714975|NCT02124304|3553559|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3714976|NCT02124304|3553560|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3714977|NCT02124304|3553558|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3714978|NCT02124304|3553559|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3714979|NCT02124304|3553560|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3714980|NCT02124304|3553558|B3|||Age||years|Mean|29.95|29.95|Full Range|||21.0|47.0|
3714981|NCT02124304|3553559|B2|||Age||years|Mean|28.1|28.1|Full Range|||21.0|36.0|
3714982|NCT02124304|3553560|B1|||Age||years|Mean|31.8|31.8|Full Range|||24.0|47.0|
3714983|NCT02124161|3553569|B3||Male|Sex: Female, Male||Participants|Count of Participants|393|393.0||||||
3714984|NCT02124161|3553570|B2||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3714985|NCT02124161|3553571|B1||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
3714986|NCT02124161|3553569|B3||Female|Sex: Female, Male||Participants|Count of Participants|483|483.0||||||
3714987|NCT02124161|3553570|B2||Female|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
3714988|NCT02124161|3553571|B1||Female|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
3714989|NCT02124161|3553569|B3|||Age||years|Mean|66.7|66.7|Standard Deviation|8.93|8.93|||
3714990|NCT02124161|3553570|B2|||Age||years|Mean|66.4|66.4|Standard Deviation|8.85|8.85|||
3714991|NCT02124161|3553571|B1|||Age||years|Mean|66.9|66.9|Standard Deviation|9|9.0|||
3714992|NCT02124122|3553602|B3|Peru||Region of Enrollment||participants|Number|60|60.0||||||
3714993|NCT02124122|3553603|B2|Peru||Region of Enrollment||participants|Number|19|19.0||||||
3714994|NCT02124122|3553604|B1|Peru||Region of Enrollment||participants|Number|41|41.0||||||
3714995|NCT02124122|3553602|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714996|NCT02124122|3553603|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714997|NCT02124122|3553604|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3714998|NCT02124122|3553602|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715171|NCT02123329|3553704|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3715000|NCT02124122|3553604|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715001|NCT02124122|3553602|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3715002|NCT02124122|3553603|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3715003|NCT02124122|3553604|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3715004|NCT02124122|3553602|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3715005|NCT02124122|3553603|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3715006|NCT02124122|3553604|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3715007|NCT02124122|3553602|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3715008|NCT02124122|3553603|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3715009|NCT02124122|3553604|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3715010|NCT02124122|3553602|B3|||Age||years|Mean|3.81|3.81|Standard Deviation|1.258|1.258|||
3715011|NCT02124122|3553603|B2|||Age||years|Mean|3.31|3.31|Standard Deviation|1.080|1.08|||
3715012|NCT02124122|3553604|B1|||Age||years|Mean|4.04|4.04|Standard Deviation|1.278|1.278|||
3715013|NCT02124083|3553613|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3715014|NCT02124083|3553613|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715015|NCT02124083|3553613|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3715016|NCT02124083|3553613|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715017|NCT02124083|3553613|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715018|NCT02124083|3553613|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715019|NCT02124083|3553613|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715020|NCT02124083|3553613|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715021|NCT02124083|3553613|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3715022|NCT02124083|3553613|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3715023|NCT02124083|3553613|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3715024|NCT02124083|3553613|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3715025|NCT02124083|3553613|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3715026|NCT02124083|3553613|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3715027|NCT02124083|3553613|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3715028|NCT02124044|3553622|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3715029|NCT02124044|3553623|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3715030|NCT02124044|3553624|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3715031|NCT02124044|3553622|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3715032|NCT02124044|3553623|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715033|NCT02124044|3553624|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3715034|NCT02124044|3553622|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3715035|NCT02124044|3553623|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715036|NCT02124044|3553624|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3715037|NCT02124044|3553622|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3715038|NCT02124044|3553623|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3715039|NCT02124044|3553624|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3715040|NCT02124044|3553622|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715041|NCT02124044|3553623|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715042|NCT02124044|3553624|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715043|NCT02124044|3553622|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715044|NCT02124044|3553623|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715045|NCT02124044|3553624|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715046|NCT02124044|3553622|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715047|NCT02124044|3553623|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715048|NCT02124044|3553624|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715049|NCT02124044|3553622|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3715050|NCT02124044|3553623|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3715051|NCT02124044|3553624|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3715052|NCT02124044|3553622|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3715053|NCT02124044|3553623|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3715054|NCT02124044|3553624|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3715055|NCT02124044|3553622|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3715056|NCT02124044|3553623|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715057|NCT02124044|3553624|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3715058|NCT02124044|3553622|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3715059|NCT02124044|3553623|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3715060|NCT02124044|3553624|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3715061|NCT02124044|3553622|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3715062|NCT02124044|3553623|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3715063|NCT02124044|3553624|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3715064|NCT02124044|3553622|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3715065|NCT02124044|3553623|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3715066|NCT02124044|3553624|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3715067|NCT02124044|3553622|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3715068|NCT02124044|3553623|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3715069|NCT02124044|3553624|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3715070|NCT02124044|3553622|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3715071|NCT02124044|3553623|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3715072|NCT02124044|3553624|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3715073|NCT02123966|3553631|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3715074|NCT02123966|3553631|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715075|NCT02123966|3553631|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715076|NCT02123966|3553631|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3715077|NCT02123966|3553631|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715078|NCT02123966|3553631|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715079|NCT02123966|3553631|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3715080|NCT02123966|3553631|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715081|NCT02123966|3553631|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3715082|NCT02123966|3553631|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3715083|NCT02123966|3553631|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3715084|NCT02123966|3553631|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3715085|NCT02123966|3553631|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3715086|NCT02123966|3553631|B1|||Age||years|Median|67|67.0|Full Range|||41.0|76.0|
3715087|NCT02123849|3553636|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715088|NCT02123849|3553637|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715089|NCT02123849|3553638|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715090|NCT02123849|3553636|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3715091|NCT02123849|3553637|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3715092|NCT02123849|3553638|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715093|NCT02123849|3553636|B3||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3715094|NCT02123849|3553637|B2||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3715095|NCT02123849|3553638|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3715096|NCT02123849|3553636|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3715097|NCT02123849|3553637|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3715098|NCT02123849|3553638|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3715099|NCT02123849|3553636|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715100|NCT02123849|3553637|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715101|NCT02123849|3553638|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715102|NCT02123849|3553636|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3715103|NCT02123849|3553637|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715104|NCT02123849|3553638|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3715105|NCT02123849|3553636|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3715106|NCT02123849|3553637|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3715107|NCT02123849|3553638|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715108|NCT02123849|3553636|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715109|NCT02123849|3553637|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715110|NCT02123849|3553638|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715111|NCT02123849|3553636|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3715112|NCT02123849|3553637|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3715113|NCT02123849|3553638|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3715114|NCT02123849|3553636|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3715115|NCT02123849|3553637|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3715116|NCT02123849|3553638|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3715117|NCT02123849|3553636|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3715118|NCT02123849|3553637|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3715119|NCT02123849|3553638|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3715120|NCT02123849|3553636|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3715121|NCT02123849|3553637|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3715122|NCT02123849|3553638|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3715123|NCT02123849|3553636|B3|||Age||years|Mean|52|52.0|Standard Deviation|8|8.0|||
3715124|NCT02123849|3553637|B2|||Age||years|Mean|52|52.0|Standard Deviation|8|8.0|||
3715125|NCT02123849|3553638|B1|||Age||years|Mean|52|52.0|Standard Deviation|8|8.0|||
3715126|NCT02123745|3553663|B1|||Skin Pigmentation|Skin pigmentation was scored from 1 to 3 where 1 represents light skin pigmentation, 2 represents medium skin pigmentation, and 3 represents dark skin pigmentation.|units on a scale|Mean|1.704|1.704|Standard Deviation|0.885|0.885|||
3715127|NCT02123745|3553663|B1|||Body Mass Index||kg/m^2|Mean|28.2|28.2|Standard Deviation|6.61|6.61|||
3715128|NCT02123745|3553663|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
3715129|NCT02123745|3553663|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3715130|NCT02123745|3553663|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3715131|NCT02123745|3553663|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3715132|NCT02123745|3553663|B1||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
3715133|NCT02123745|3553663|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3715134|NCT02123745|3553663|B1|||Age||years|Mean|38.2|38.2|Standard Deviation|13.2|13.2|||
3715135|NCT02123472|3553671|B1|Mexico||Region of Enrollment||participants|Number|28|28.0||||||
3715136|NCT02123472|3553671|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715137|NCT02123472|3553671|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715138|NCT02123472|3553671|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3715139|NCT02123472|3553671|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3715140|NCT02123472|3553671|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3715141|NCT02123472|3553671|B1|||Age||Years|Mean|28.3|28.3|Standard Deviation|5.11|5.11|||
3715142|NCT02123459|3553682|B1|Mexico||Region of Enrollment||participants|Number|28|28.0||||||
3715143|NCT02123459|3553682|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715144|NCT02123459|3553682|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715145|NCT02123459|3553682|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3715146|NCT02123459|3553682|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3715147|NCT02123459|3553682|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3715148|NCT02123459|3553682|B1|||Age||Years|Median|30.9|30.9|Standard Deviation|9.57|9.57|||
3715149|NCT02123446|3553693|B1|Mexico||Region of Enrollment||participants|Number|28|28.0||||||
3715150|NCT02123446|3553693|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715151|NCT02123446|3553693|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3715152|NCT02123446|3553693|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715153|NCT02123446|3553693|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3715154|NCT02123446|3553693|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3715155|NCT02123446|3553693|B1|||Age||Years|Mean|30.4|30.4|Standard Deviation|8.39|8.39|||
3715156|NCT02123329|3553704|B3|Unknown||Race/Ethnicity, Customized|Nationality|Participants|Count of Participants|3|3.0||||||
3715157|NCT02123329|3553705|B2|Unknown||Race/Ethnicity, Customized|Nationality|Participants|Count of Participants|1|1.0||||||
3715158|NCT02123329|3553706|B1|Unknown||Race/Ethnicity, Customized|Nationality|Participants|Count of Participants|2|2.0||||||
3715159|NCT02123329|3553704|B3|Other countries||Race/Ethnicity, Customized|Nationality|Participants|Count of Participants|156|156.0||||||
3715160|NCT02123329|3553705|B2|Other countries||Race/Ethnicity, Customized|Nationality|Participants|Count of Participants|96|96.0||||||
3715161|NCT02123329|3553706|B1|Other countries||Race/Ethnicity, Customized|Nationality|Participants|Count of Participants|60|60.0||||||
3715162|NCT02123329|3553704|B3|Egypt||Race/Ethnicity, Customized|Nationality|Participants|Count of Participants|90|90.0||||||
3715163|NCT02123329|3553705|B2|Egypt||Race/Ethnicity, Customized|Nationality|Participants|Count of Participants|41|41.0||||||
3715164|NCT02123329|3553706|B1|Egypt||Race/Ethnicity, Customized|Nationality|Participants|Count of Participants|49|49.0||||||
3715165|NCT02123329|3553704|B3|Qatar||Race/Ethnicity, Customized|Nationality|Participants|Count of Participants|61|61.0||||||
3715166|NCT02123329|3553705|B2|Qatar||Race/Ethnicity, Customized|Nationality|Participants|Count of Participants|25|25.0||||||
3715167|NCT02123329|3553706|B1|Qatar||Race/Ethnicity, Customized|Nationality|Participants|Count of Participants|36|36.0||||||
3715168|NCT02123329|3553704|B3||Male|Sex: Female, Male||Participants|Count of Participants|307|307.0||||||
3715169|NCT02123329|3553705|B2||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3715170|NCT02123329|3553706|B1||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3715172|NCT02123329|3553705|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3715173|NCT02123329|3553706|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3715174|NCT02123329|3553704|B3|Unknown||Age, Customized||Participants|Count of Participants|9|9.0||||||
3715175|NCT02123329|3553705|B2|Unknown||Age, Customized||Participants|Count of Participants|4|4.0||||||
3715176|NCT02123329|3553706|B1|Unknown||Age, Customized||Participants|Count of Participants|5|5.0||||||
3715177|NCT02123329|3553704|B3|50 years and above||Age, Customized||Participants|Count of Participants|51|51.0||||||
3715178|NCT02123329|3553705|B2|50 years and above||Age, Customized||Participants|Count of Participants|24|24.0||||||
3715179|NCT02123329|3553706|B1|50 years and above||Age, Customized||Participants|Count of Participants|27|27.0||||||
3715180|NCT02123329|3553704|B3|40-49 years||Age, Customized||Participants|Count of Participants|73|73.0||||||
3715181|NCT02123329|3553705|B2|40-49 years||Age, Customized||Participants|Count of Participants|46|46.0||||||
3715182|NCT02123329|3553706|B1|40-49 years||Age, Customized||Participants|Count of Participants|27|27.0||||||
3715183|NCT02123329|3553704|B3|30-39 years||Age, Customized||Participants|Count of Participants|108|108.0||||||
3715184|NCT02123329|3553705|B2|30-39 years||Age, Customized||Participants|Count of Participants|53|53.0||||||
3715185|NCT02123329|3553706|B1|30-39 years||Age, Customized||Participants|Count of Participants|55|55.0||||||
3715186|NCT02123329|3553704|B3|18-29 years||Age, Customized||Participants|Count of Participants|73|73.0||||||
3715187|NCT02123329|3553705|B2|18-29 years||Age, Customized||Participants|Count of Participants|40|40.0||||||
3715188|NCT02123329|3553706|B1|18-29 years||Age, Customized||Participants|Count of Participants|33|33.0||||||
3715189|NCT02123017|3553733|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715190|NCT02123017|3553734|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715191|NCT02123017|3553735|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715192|NCT02123017|3553736|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715193|NCT02123017|3553733|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715194|NCT02123017|3553734|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715195|NCT02123017|3553735|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715196|NCT02123017|3553736|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715197|NCT02123017|3553733|B4||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3715198|NCT02123017|3553734|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3715199|NCT02123017|3553735|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3715200|NCT02123017|3553736|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3715201|NCT02123017|3553733|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3715202|NCT02123017|3553734|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3715203|NCT02123017|3553735|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3715204|NCT02123017|3553736|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715205|NCT02123017|3553733|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715206|NCT02123017|3553734|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715207|NCT02123017|3553735|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715208|NCT02123017|3553736|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715209|NCT02123017|3553733|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715210|NCT02123017|3553734|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715211|NCT02123017|3553735|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715212|NCT02123017|3553736|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715213|NCT02123017|3553733|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715214|NCT02123017|3553734|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715215|NCT02123017|3553735|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715216|NCT02123017|3553736|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715217|NCT02123017|3553733|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715218|NCT02123017|3553734|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715219|NCT02123017|3553735|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715220|NCT02123017|3553736|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715221|NCT02123017|3553733|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3715222|NCT02123017|3553734|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3715223|NCT02123017|3553735|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3715224|NCT02123017|3553736|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3715225|NCT02123017|3553733|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3715226|NCT02123017|3553734|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3715227|NCT02123017|3553735|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715228|NCT02123017|3553736|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3715229|NCT02123017|3553733|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3715230|NCT02123017|3553734|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3715231|NCT02123017|3553735|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3715232|NCT02123017|3553736|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3715233|NCT02123017|3553733|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3715234|NCT02123017|3553734|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3715235|NCT02123017|3553735|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3715236|NCT02123017|3553736|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3715237|NCT02123017|3553733|B4|Subject Age at Enrollment||Age||years|Mean|55.0|55.0|Standard Deviation|8.7|8.7|||
3715238|NCT02123017|3553734|B3|Subject Age at Enrollment||Age||years|Mean|58.1|58.1|Standard Deviation|8.7|8.7|||
3715239|NCT02123017|3553735|B2|Subject Age at Enrollment||Age||years|Mean|57.0|57.0|Standard Deviation|7.4|7.4|||
3715240|NCT02123017|3553736|B1|Subject Age at Enrollment||Age||years|Mean|47.4|47.4|Standard Deviation|6.2|6.2|||
3715241|NCT02122796|3553755|B3|Never married||Marital Status||participants|Number|0|0.0||||||
3715242|NCT02122796|3553756|B2|Never married||Marital Status||participants|Number|0|0.0||||||
3715243|NCT02122796|3553757|B1|Never married||Marital Status||participants|Number|0|0.0||||||
3715244|NCT02122796|3553755|B3|Widowed||Marital Status||participants|Number|1|1.0||||||
3715245|NCT02122796|3553756|B2|Widowed||Marital Status||participants|Number|0|0.0||||||
3715246|NCT02122796|3553757|B1|Widowed||Marital Status||participants|Number|1|1.0||||||
3715247|NCT02122796|3553755|B3|Divorced/separated||Marital Status||participants|Number|5|5.0||||||
3715248|NCT02122796|3553756|B2|Divorced/separated||Marital Status||participants|Number|3|3.0||||||
3715249|NCT02122796|3553757|B1|Divorced/separated||Marital Status||participants|Number|2|2.0||||||
3715250|NCT02122796|3553755|B3|Living in marriage-like relationship||Marital Status||participants|Number|0|0.0||||||
3715251|NCT02122796|3553756|B2|Living in marriage-like relationship||Marital Status||participants|Number|0|0.0||||||
3715252|NCT02122796|3553757|B1|Living in marriage-like relationship||Marital Status||participants|Number|0|0.0||||||
3715253|NCT02122796|3553755|B3|Married||Marital Status||participants|Number|24|24.0||||||
3715254|NCT02122796|3553756|B2|Married||Marital Status||participants|Number|12|12.0||||||
3715255|NCT02122796|3553757|B1|Married||Marital Status||participants|Number|12|12.0||||||
3715256|NCT02122796|3553755|B3|Unknown||Family Income||participants|Number|2|2.0||||||
3715257|NCT02122796|3553756|B2|Unknown||Family Income||participants|Number|2|2.0||||||
3715258|NCT02122796|3553757|B1|Unknown||Family Income||participants|Number|0|0.0||||||
3715259|NCT02122796|3553755|B3|$75,000 or more||Family Income||participants|Number|15|15.0||||||
3715260|NCT02122796|3553756|B2|$75,000 or more||Family Income||participants|Number|7|7.0||||||
3715261|NCT02122796|3553757|B1|$75,000 or more||Family Income||participants|Number|8|8.0||||||
3715262|NCT02122796|3553755|B3|$55,000-74,999||Family Income||participants|Number|5|5.0||||||
3715263|NCT02122796|3553756|B2|$55,000-74,999||Family Income||participants|Number|3|3.0||||||
3715264|NCT02122796|3553757|B1|$55,000-74,999||Family Income||participants|Number|2|2.0||||||
3715265|NCT02122796|3553755|B3|$40,000-54,999||Family Income||participants|Number|5|5.0||||||
3715266|NCT02122796|3553756|B2|$40,000-54,999||Family Income||participants|Number|1|1.0||||||
3715267|NCT02122796|3553757|B1|$40,000-54,999||Family Income||participants|Number|4|4.0||||||
3715268|NCT02122796|3553755|B3|$25,000-39,999||Family Income||participants|Number|1|1.0||||||
3715269|NCT02122796|3553756|B2|$25,000-39,999||Family Income||participants|Number|0|0.0||||||
3715270|NCT02122796|3553757|B1|$25,000-39,999||Family Income||participants|Number|1|1.0||||||
3715271|NCT02122796|3553755|B3|<$24,999||Family Income||participants|Number|2|2.0||||||
3715272|NCT02122796|3553756|B2|<$24,999||Family Income||participants|Number|2|2.0||||||
3715273|NCT02122796|3553757|B1|<$24,999||Family Income||participants|Number|0|0.0||||||
3715274|NCT02122796|3553755|B3|Other||Employment Status||participants|Number|0|0.0||||||
3715275|NCT02122796|3553756|B2|Other||Employment Status||participants|Number|0|0.0||||||
3715276|NCT02122796|3553757|B1|Other||Employment Status||participants|Number|0|0.0||||||
3715277|NCT02122796|3553755|B3|Retired||Employment Status||participants|Number|8|8.0||||||
3715278|NCT02122796|3553756|B2|Retired||Employment Status||participants|Number|6|6.0||||||
3715279|NCT02122796|3553757|B1|Retired||Employment Status||participants|Number|2|2.0||||||
3715280|NCT02122796|3553755|B3|Homemaker||Employment Status||participants|Number|4|4.0||||||
3715281|NCT02122796|3553756|B2|Homemaker||Employment Status||participants|Number|2|2.0||||||
3715282|NCT02122796|3553757|B1|Homemaker||Employment Status||participants|Number|2|2.0||||||
3715283|NCT02122796|3553755|B3|Part-time||Employment Status||participants|Number|6|6.0||||||
3715284|NCT02122796|3553756|B2|Part-time||Employment Status||participants|Number|3|3.0||||||
3715285|NCT02122796|3553757|B1|Part-time||Employment Status||participants|Number|3|3.0||||||
3715286|NCT02122796|3553755|B3|Full-time||Employment Status||participants|Number|12|12.0||||||
3715287|NCT02122796|3553756|B2|Full-time||Employment Status||participants|Number|4|4.0||||||
3715288|NCT02122796|3553757|B1|Full-time||Employment Status||participants|Number|8|8.0||||||
3715289|NCT02122796|3553755|B3|Bachelor's Degree or Higher||Education||participants|Number|10|10.0||||||
3715290|NCT02122796|3553756|B2|Bachelor's Degree or Higher||Education||participants|Number|4|4.0||||||
3715291|NCT02122796|3553757|B1|Bachelor's Degree or Higher||Education||participants|Number|6|6.0||||||
3715292|NCT02122796|3553755|B3|Some College or Associate Degree||Education||participants|Number|12|12.0||||||
3715293|NCT02122796|3553756|B2|Some College or Associate Degree||Education||participants|Number|7|7.0||||||
3715294|NCT02122796|3553757|B1|Some College or Associate Degree||Education||participants|Number|5|5.0||||||
3715295|NCT02122796|3553755|B3|High School Graduate||Education||participants|Number|7|7.0||||||
3715296|NCT02122796|3553756|B2|High School Graduate||Education||participants|Number|3|3.0||||||
3715297|NCT02122796|3553757|B1|High School Graduate||Education||participants|Number|4|4.0||||||
3715298|NCT02122796|3553755|B3|9th to 12th Grade||Education||participants|Number|1|1.0||||||
3715299|NCT02122796|3553756|B2|9th to 12th Grade||Education||participants|Number|1|1.0||||||
3715300|NCT02122796|3553757|B1|9th to 12th Grade||Education||participants|Number|0|0.0||||||
3715301|NCT02122796|3553755|B3|<9th Grade||Education||participants|Number|0|0.0||||||
3715302|NCT02122796|3553756|B2|<9th Grade||Education||participants|Number|0|0.0||||||
3715303|NCT02122796|3553757|B1|<9th Grade||Education||participants|Number|0|0.0||||||
3715304|NCT02122796|3553755|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715305|NCT02122796|3553756|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715306|NCT02122796|3553757|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715307|NCT02122796|3553755|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715308|NCT02122796|3553756|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715309|NCT02122796|3553757|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715310|NCT02122796|3553755|B3||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3715311|NCT02122796|3553756|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3715312|NCT02122796|3553757|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3715313|NCT02122796|3553755|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715314|NCT02122796|3553756|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715315|NCT02122796|3553757|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715316|NCT02122796|3553755|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715317|NCT02122796|3553756|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715318|NCT02122796|3553757|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715319|NCT02122796|3553755|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715320|NCT02122796|3553756|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715321|NCT02122796|3553757|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715322|NCT02122796|3553755|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715323|NCT02122796|3553756|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715324|NCT02122796|3553757|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715325|NCT02122796|3553755|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715326|NCT02122796|3553756|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715327|NCT02122796|3553757|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715328|NCT02122796|3553755|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3715329|NCT02122796|3553756|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3715330|NCT02122796|3553757|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3715331|NCT02122796|3553755|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715332|NCT02122796|3553756|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715333|NCT02122796|3553757|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715334|NCT02122796|3553755|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3715335|NCT02122796|3553756|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3715336|NCT02122796|3553757|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3715337|NCT02122796|3553755|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3715338|NCT02122796|3553756|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3715339|NCT02122796|3553757|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3715340|NCT02122796|3553755|B3|||Age||years|Mean|57.52|57.52|Standard Deviation|11.27|11.27|||
3715341|NCT02122796|3553756|B2|||Age||years|Mean|62.47|62.47|Standard Deviation|11.47|11.47|||
3715342|NCT02122796|3553757|B1|||Age||years|Mean|53.74|53.74|Standard Deviation|9.41|9.41|||
3715343|NCT02122549|3553771|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3715344|NCT02122549|3553771|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3715345|NCT02122549|3553771|B1|||Age||Years|Mean|55.5|55.5|Standard Deviation|11.8|11.8|||
3715346|NCT02122445|3553775|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3715347|NCT02122445|3553775|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3715348|NCT02122445|3553775|B1|||Age||years|Mean|40.05|40.05|Full Range|||19.0|59.0|
3715407|NCT02121860|3554034|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715408|NCT02121860|3554035|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715349|NCT02122406|3553780|B1|||Disease Activity Score on 28 joints (DAS28)|"The Disease Activity Score 28 (DAS28) is a combined index that measures the disease activity in patients with Rheumatoid Arthritis. It is based on the assessment of the number of swollen and tender joints and measure of the ESR.~Lower values indicate lower disease activity levels. It ranges from 0.49 to 9.35."|units on a scale|Mean|3.01|3.01|Standard Deviation|1.07|1.07|||
3715350|NCT02122406|3553780|B1|||Disease Duration||years|Median|11.24|11.24|Inter-Quartile Range|||7.29|19.46|
3715351|NCT02122406|3553780|B1|Italy||Region of Enrollment||participants|Number|200|200.0||||||
3715352|NCT02122406|3553780|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3715353|NCT02122406|3553780|B1||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3715354|NCT02122406|3553780|B1|||Age||years|Median|62.35|62.35|Inter-Quartile Range|||54.09|76.03|
3715355|NCT02122146|3553784|B9||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3715356|NCT02122146|3553785|B8||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3715357|NCT02122146|3553786|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3715358|NCT02122146|3553787|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3715359|NCT02122146|3553788|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3715360|NCT02122146|3553789|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3715361|NCT02122146|3553790|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3715362|NCT02122146|3553791|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3715363|NCT02122146|3553792|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3715364|NCT02122146|3553784|B9||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3715365|NCT02122146|3553785|B8||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3715366|NCT02122146|3553786|B7||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3715367|NCT02122146|3553787|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3715368|NCT02122146|3553788|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3715369|NCT02122146|3553789|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3715370|NCT02122146|3553790|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3715371|NCT02122146|3553791|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3715372|NCT02122146|3553792|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3715373|NCT02122146|3553784|B9|||Age||years|Mean|57.1|57.1|Standard Deviation|13.2|13.2|||
3715374|NCT02122146|3553785|B8|||Age||years|Mean|61.1|61.1|Standard Deviation|6.6|6.6|||
3715375|NCT02122146|3553786|B7|||Age||years|Mean|63|63.0|Standard Deviation|0|0.0|||
3715376|NCT02122146|3553787|B6|||Age||years|Mean|53.7|53.7|Standard Deviation|11.8|11.8|||
3715377|NCT02122146|3553788|B5|||Age||years|Mean|46|46.0|Standard Deviation|11|11.0|||
3715378|NCT02122146|3553789|B4|||Age||years|Mean|52.8|52.8|Standard Deviation|20|20.0|||
3715379|NCT02122146|3553790|B3|||Age||years|Mean|61|61.0|Standard Deviation|17.9|17.9|||
3715380|NCT02122146|3553791|B2|||Age||years|Mean|75|75.0|Standard Deviation|11.3|11.3|||
3715381|NCT02122146|3553792|B1|||Age||years|Mean|54|54.0|Standard Deviation|7.1|7.1|||
3715382|NCT02121860|3554034|B5|United States||Region of Enrollment||participants|Number|36|36.0||||||
3715383|NCT02121860|3554035|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
3715384|NCT02121860|3554036|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3715385|NCT02121860|3554037|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3715386|NCT02121860|3554038|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3715387|NCT02121860|3554034|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715388|NCT02121860|3554035|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715389|NCT02121860|3554036|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715390|NCT02121860|3554037|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715391|NCT02121860|3554038|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715392|NCT02121860|3554034|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3715393|NCT02121860|3554035|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715394|NCT02121860|3554036|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715395|NCT02121860|3554037|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715396|NCT02121860|3554038|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3715397|NCT02121860|3554034|B5||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3715398|NCT02121860|3554035|B4||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3715399|NCT02121860|3554036|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3715400|NCT02121860|3554037|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3715401|NCT02121860|3554038|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3715402|NCT02121860|3554034|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3715403|NCT02121860|3554035|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3715404|NCT02121860|3554036|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715405|NCT02121860|3554037|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715406|NCT02121860|3554038|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715409|NCT02121860|3554036|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715410|NCT02121860|3554037|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715411|NCT02121860|3554038|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715412|NCT02121860|3554034|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3715413|NCT02121860|3554035|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715414|NCT02121860|3554036|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715415|NCT02121860|3554037|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715416|NCT02121860|3554038|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3715417|NCT02121860|3554034|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715418|NCT02121860|3554035|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715419|NCT02121860|3554036|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715420|NCT02121860|3554037|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715421|NCT02121860|3554038|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715422|NCT02121860|3554034|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715423|NCT02121860|3554035|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715424|NCT02121860|3554036|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715425|NCT02121860|3554037|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715426|NCT02121860|3554038|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715427|NCT02121860|3554034|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3715428|NCT02121860|3554035|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3715429|NCT02121860|3554036|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3715430|NCT02121860|3554037|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3715431|NCT02121860|3554038|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3715432|NCT02121860|3554034|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3715433|NCT02121860|3554035|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3715434|NCT02121860|3554036|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3715435|NCT02121860|3554037|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3715436|NCT02121860|3554038|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3715437|NCT02121860|3554034|B5||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3715438|NCT02121860|3554035|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3715439|NCT02121860|3554036|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3715440|NCT02121860|3554037|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3715441|NCT02121860|3554038|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3715442|NCT02121860|3554034|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3715443|NCT02121860|3554035|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3715444|NCT02121860|3554036|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3715445|NCT02121860|3554037|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3715446|NCT02121860|3554038|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3715447|NCT02121860|3554034|B5|||Age||years|Mean|55.9|55.9|Standard Deviation|6.8|6.8|||
3715448|NCT02121860|3554035|B4|||Age||years|Mean|57.6|57.6|Standard Deviation|4.9|4.9|||
3715449|NCT02121860|3554036|B3|||Age||years|Mean|57.4|57.4|Standard Deviation|4.8|4.8|||
3715450|NCT02121860|3554037|B2|||Age||years|Mean|54.1|54.1|Standard Deviation|7.1|7.1|||
3715451|NCT02121860|3554038|B1|||Age||years|Mean|54.8|54.8|Standard Deviation|8.8|8.8|||
3715452|NCT02121847|3554060|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3715453|NCT02121847|3554060|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3715454|NCT02121847|3554060|B1|||Age||Years|Mean|59.4|59.4|Standard Deviation|9.05|9.05|||
3715455|NCT02121834|3554079|B8|United States||Region of Enrollment||Participants|Count of Participants|63|63.0||||||
3715456|NCT02121834|3554080|B7|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3715457|NCT02121834|3554081|B6|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3715458|NCT02121834|3554082|B5|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3715459|NCT02121834|3554083|B4|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3715460|NCT02121834|3554084|B3|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3715461|NCT02121834|3554085|B2|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3715462|NCT02121834|3554086|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3715463|NCT02121834|3554079|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715464|NCT02121834|3554080|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715465|NCT02121834|3554081|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715466|NCT02121834|3554082|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715467|NCT02121834|3554083|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715468|NCT02121834|3554084|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715469|NCT02121834|3554085|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715470|NCT02121834|3554086|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715471|NCT02121834|3554079|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3715472|NCT02121834|3554080|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715473|NCT02121834|3554081|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3715474|NCT02121834|3554082|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715475|NCT02121834|3554083|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715476|NCT02121834|3554084|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715477|NCT02121834|3554085|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3715478|NCT02121834|3554086|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715479|NCT02121834|3554079|B8||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3715480|NCT02121834|3554080|B7||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3715481|NCT02121834|3554081|B6||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3715482|NCT02121834|3554082|B5||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3715483|NCT02121834|3554083|B4||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3715484|NCT02121834|3554084|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3715485|NCT02121834|3554085|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3715486|NCT02121834|3554086|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3715487|NCT02121834|3554079|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3715488|NCT02121834|3554080|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715489|NCT02121834|3554081|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3715490|NCT02121834|3554082|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3715491|NCT02121834|3554083|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3715492|NCT02121834|3554084|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3715493|NCT02121834|3554085|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3715494|NCT02121834|3554086|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3715495|NCT02121834|3554079|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715496|NCT02121834|3554080|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715497|NCT02121834|3554081|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715498|NCT02121834|3554082|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715499|NCT02121834|3554083|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715500|NCT02121834|3554084|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715501|NCT02121834|3554085|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715502|NCT02121834|3554086|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715503|NCT02121834|3554079|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3715504|NCT02121834|3554080|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3715505|NCT02121834|3554081|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3715506|NCT02121834|3554082|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3715507|NCT02121834|3554083|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3715508|NCT02121834|3554084|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3715509|NCT02121834|3554085|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3715510|NCT02121834|3554086|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3715511|NCT02121834|3554079|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715512|NCT02121834|3554080|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715513|NCT02121834|3554081|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715514|NCT02121834|3554082|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715515|NCT02121834|3554083|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715516|NCT02121834|3554084|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715517|NCT02121834|3554085|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715518|NCT02121834|3554086|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715519|NCT02121834|3554079|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715520|NCT02121834|3554080|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715521|NCT02121834|3554081|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715522|NCT02121834|3554082|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715523|NCT02121834|3554083|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715524|NCT02121834|3554084|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715525|NCT02121834|3554085|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715526|NCT02121834|3554086|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715527|NCT02121834|3554079|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3715528|NCT02121834|3554080|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3715529|NCT02121834|3554081|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3715530|NCT02121834|3554082|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3715531|NCT02121834|3554083|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3715532|NCT02121834|3554084|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3715533|NCT02121834|3554085|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3715534|NCT02121834|3554086|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3715535|NCT02121834|3554079|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3715536|NCT02121834|3554080|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3715537|NCT02121834|3554081|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3715538|NCT02121834|3554082|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715539|NCT02121834|3554083|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3715540|NCT02121834|3554084|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3715541|NCT02121834|3554085|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3715542|NCT02121834|3554086|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715543|NCT02121834|3554079|B8||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3715544|NCT02121834|3554080|B7||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3715545|NCT02121834|3554081|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3715546|NCT02121834|3554082|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3715547|NCT02121834|3554083|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3715548|NCT02121834|3554084|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3715549|NCT02121834|3554085|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3715550|NCT02121834|3554086|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3715551|NCT02121834|3554079|B8||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3715552|NCT02121834|3554080|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3715553|NCT02121834|3554081|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3715554|NCT02121834|3554082|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3715555|NCT02121834|3554083|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3715556|NCT02121834|3554084|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3715557|NCT02121834|3554085|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3715558|NCT02121834|3554086|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3715559|NCT02121834|3554079|B8|||Age||years|Mean|48.7|48.7|Standard Deviation|10.6|10.6|||
3715560|NCT02121834|3554080|B7|||Age||years|Mean|35.7|35.7|Standard Deviation|5.5|5.5|||
3715561|NCT02121834|3554081|B6|||Age||years|Mean|47.8|47.8|Standard Deviation|10.5|10.5|||
3715562|NCT02121834|3554082|B5|||Age||years|Mean|44.6|44.6|Standard Deviation|10.6|10.6|||
3715563|NCT02121834|3554083|B4|||Age||years|Mean|52.8|52.8|Standard Deviation|10.4|10.4|||
3715564|NCT02121834|3554084|B3|||Age||years|Mean|51.6|51.6|Standard Deviation|9.1|9.1|||
3715565|NCT02121834|3554085|B2|||Age||years|Mean|50.5|50.5|Standard Deviation|9.8|9.8|||
3715566|NCT02121834|3554086|B1|||Age||years|Mean|48.4|48.4|Standard Deviation|12.2|12.2|||
3715567|NCT02121808|3554118|B1|||Waist circumference||cm|Mean|143|143.0|Standard Deviation|17|17.0|||
3715568|NCT02121808|3554118|B1|||BMI||kg/m2|Mean|50|50.0|Standard Deviation|8|8.0|||
3715569|NCT02121808|3554118|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3715570|NCT02121808|3554118|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3715571|NCT02121808|3554118|B1|||Age||years|Mean|40|40.0|Standard Deviation|9.7|9.7|||
3715572|NCT02121795|3554127|B3|||CD4 Cell Count||cells/µL|Mean|679|679.0|Standard Deviation|272.5|272.5|||
3715573|NCT02121795|3554128|B2|||CD4 Cell Count||cells/µL|Mean|667|667.0|Standard Deviation|272.3|272.3|||
3715574|NCT02121795|3554129|B1|||CD4 Cell Count||cells/µL|Mean|691|691.0|Standard Deviation|272.6|272.6|||
3715575|NCT02121795|3554127|B3|>= 50 copies/mL||HIV-1 RNA Categories||participants|Number|8|8.0||||||
3715576|NCT02121795|3554128|B2|>= 50 copies/mL||HIV-1 RNA Categories||participants|Number|4|4.0||||||
3715577|NCT02121795|3554129|B1|>= 50 copies/mL||HIV-1 RNA Categories||participants|Number|4|4.0||||||
3715578|NCT02121795|3554127|B3|< 50 copies/mL||HIV-1 RNA Categories||participants|Number|655|655.0||||||
3715579|NCT02121795|3554128|B2|< 50 copies/mL||HIV-1 RNA Categories||participants|Number|326|326.0||||||
3715580|NCT02121795|3554129|B1|< 50 copies/mL||HIV-1 RNA Categories||participants|Number|329|329.0||||||
3715581|NCT02121795|3554127|B3|Rilpivirine (RPV)||Baseline Third Agent||participants|Number|9|9.0||||||
3715582|NCT02121795|3554128|B2|Rilpivirine (RPV)||Baseline Third Agent||participants|Number|6|6.0||||||
3715583|NCT02121795|3554129|B1|Rilpivirine (RPV)||Baseline Third Agent||participants|Number|3|3.0||||||
3715584|NCT02121795|3554127|B3|Raltegravir (RAL)||Baseline Third Agent||participants|Number|139|139.0||||||
3715585|NCT02121795|3554128|B2|Raltegravir (RAL)||Baseline Third Agent||participants|Number|73|73.0||||||
3715586|NCT02121795|3554129|B1|Raltegravir (RAL)||Baseline Third Agent||participants|Number|66|66.0||||||
3715587|NCT02121795|3554127|B3|Nevirapine (NVP)||Baseline Third Agent||participants|Number|140|140.0||||||
3715588|NCT02121795|3554128|B2|Nevirapine (NVP)||Baseline Third Agent||participants|Number|66|66.0||||||
3715589|NCT02121795|3554129|B1|Nevirapine (NVP)||Baseline Third Agent||participants|Number|74|74.0||||||
3715590|NCT02121795|3554127|B3|Maraviroc (MVC)||Baseline Third Agent||participants|Number|7|7.0||||||
3715591|NCT02121795|3554128|B2|Maraviroc (MVC)||Baseline Third Agent||participants|Number|6|6.0||||||
3715592|NCT02121795|3554129|B1|Maraviroc (MVC)||Baseline Third Agent||participants|Number|1|1.0||||||
3715593|NCT02121795|3554127|B3|Efavirenz (EFV)||Baseline Third Agent||participants|Number|14|14.0||||||
3715594|NCT02121795|3554128|B2|Efavirenz (EFV)||Baseline Third Agent||participants|Number|6|6.0||||||
3715595|NCT02121795|3554129|B1|Efavirenz (EFV)||Baseline Third Agent||participants|Number|8|8.0||||||
3715596|NCT02121795|3554127|B3|Dolutegravir (DTG)||Baseline Third Agent||participants|Number|49|49.0||||||
3715597|NCT02121795|3554128|B2|Dolutegravir (DTG)||Baseline Third Agent||participants|Number|23|23.0||||||
3715598|NCT02121795|3554129|B1|Dolutegravir (DTG)||Baseline Third Agent||participants|Number|26|26.0||||||
3715599|NCT02121795|3554127|B3|Lopinavir boosted with ritonavir (LPV/r)||Baseline Third Agent||participants|Number|36|36.0||||||
3715600|NCT02121795|3554128|B2|Lopinavir boosted with ritonavir (LPV/r)||Baseline Third Agent||participants|Number|18|18.0||||||
3715601|NCT02121795|3554129|B1|Lopinavir boosted with ritonavir (LPV/r)||Baseline Third Agent||participants|Number|18|18.0||||||
3715602|NCT02121795|3554127|B3|Darunavir boosted with ritonavir (DRV/r)||Baseline Third Agent||participants|Number|166|166.0||||||
3715603|NCT02121795|3554128|B2|Darunavir boosted with ritonavir (DRV/r)||Baseline Third Agent||participants|Number|82|82.0||||||
3715604|NCT02121795|3554129|B1|Darunavir boosted with ritonavir (DRV/r)||Baseline Third Agent||participants|Number|84|84.0||||||
3715605|NCT02121795|3554127|B3|Atazanavir boosted with ritonavir (ATV/r)||Baseline Third Agent||participants|Number|103|103.0||||||
3715606|NCT02121795|3554128|B2|Atazanavir boosted with ritonavir (ATV/r)||Baseline Third Agent||participants|Number|50|50.0||||||
3715607|NCT02121795|3554129|B1|Atazanavir boosted with ritonavir (ATV/r)||Baseline Third Agent||participants|Number|53|53.0||||||
3715608|NCT02121795|3554127|B3|France||Region of Enrollment||participants|Number|39|39.0||||||
3715609|NCT02121795|3554128|B2|France||Region of Enrollment||participants|Number|21|21.0||||||
3715610|NCT02121795|3554129|B1|France||Region of Enrollment||participants|Number|18|18.0||||||
3715611|NCT02121795|3554127|B3|United Kingdom||Region of Enrollment||participants|Number|40|40.0||||||
3715612|NCT02121795|3554128|B2|United Kingdom||Region of Enrollment||participants|Number|17|17.0||||||
3715613|NCT02121795|3554129|B1|United Kingdom||Region of Enrollment||participants|Number|23|23.0||||||
3715614|NCT02121795|3554127|B3|Italy||Region of Enrollment||participants|Number|8|8.0||||||
3715615|NCT02121795|3554128|B2|Italy||Region of Enrollment||participants|Number|6|6.0||||||
3715616|NCT02121795|3554129|B1|Italy||Region of Enrollment||participants|Number|2|2.0||||||
3715617|NCT02121795|3554127|B3|United States||Region of Enrollment||participants|Number|556|556.0||||||
3715618|NCT02121795|3554128|B2|United States||Region of Enrollment||participants|Number|274|274.0||||||
3715619|NCT02121795|3554129|B1|United States||Region of Enrollment||participants|Number|282|282.0||||||
3715620|NCT02121795|3554127|B3|Belgium||Region of Enrollment||participants|Number|6|6.0||||||
3715621|NCT02121795|3554128|B2|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
3715622|NCT02121795|3554129|B1|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
3715623|NCT02121795|3554127|B3|Canada||Region of Enrollment||participants|Number|14|14.0||||||
3715624|NCT02121795|3554128|B2|Canada||Region of Enrollment||participants|Number|9|9.0||||||
3715625|NCT02121795|3554129|B1|Canada||Region of Enrollment||participants|Number|5|5.0||||||
3715626|NCT02121795|3554127|B3|Other||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3715627|NCT02121795|3554128|B2|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3715628|NCT02121795|3554129|B1|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3715629|NCT02121795|3554127|B3|Not Permitted||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3715630|NCT02121795|3554128|B2|Not Permitted||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3715631|NCT02121795|3554129|B1|Not Permitted||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3715632|NCT02121795|3554127|B3|White||Race/Ethnicity, Customized||participants|Number|497|497.0||||||
3715633|NCT02121795|3554128|B2|White||Race/Ethnicity, Customized||participants|Number|253|253.0||||||
3715634|NCT02121795|3554129|B1|White||Race/Ethnicity, Customized||participants|Number|244|244.0||||||
3715635|NCT02121795|3554127|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3715636|NCT02121795|3554128|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3715637|NCT02121795|3554129|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3715638|NCT02121795|3554127|B3|Black||Race/Ethnicity, Customized||participants|Number|136|136.0||||||
3715639|NCT02121795|3554128|B2|Black||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
3715640|NCT02121795|3554129|B1|Black||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
3715641|NCT02121795|3554127|B3|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3715642|NCT02121795|3554128|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3715643|NCT02121795|3554129|B1|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3715644|NCT02121795|3554127|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3715645|NCT02121795|3554128|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3715646|NCT02121795|3554129|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3715647|NCT02121795|3554127|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715648|NCT02121795|3554128|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715649|NCT02121795|3554129|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715650|NCT02121795|3554127|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|537|537.0||||||
3715651|NCT02121795|3554128|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|252|252.0||||||
3715652|NCT02121795|3554129|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|285|285.0||||||
3715653|NCT02121795|3554127|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
3715654|NCT02121795|3554128|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3715655|NCT02121795|3554129|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3715656|NCT02121795|3554127|B3||Male|Sex: Female, Male||Participants|Count of Participants|561|561.0||||||
3715657|NCT02121795|3554128|B2||Male|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
3715658|NCT02121795|3554129|B1||Male|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
3715659|NCT02121795|3554127|B3||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3715660|NCT02121795|3554128|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3715661|NCT02121795|3554129|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3715662|NCT02121795|3554127|B3|||Age||Years|Mean|48|48.0|Standard Deviation|9.8|9.8|||
3715663|NCT02121795|3554128|B2|||Age||Years|Mean|48|48.0|Standard Deviation|9.7|9.7|||
3715664|NCT02121795|3554129|B1|||Age||Years|Mean|47|47.0|Standard Deviation|9.9|9.9|||
3715665|NCT02121535|3554144|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3715666|NCT02121535|3554145|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3715667|NCT02121535|3554146|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3715668|NCT02121535|3554144|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3715669|NCT02121535|3554145|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3715670|NCT02121535|3554146|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3715671|NCT02121535|3554144|B3|||Age||years|Mean|26.7|26.7|Standard Deviation|4.8|4.8|||
3715672|NCT02121535|3554145|B2|||Age||years|Mean|27.2|27.2|Standard Deviation|5.0|5.0|||
3715673|NCT02121535|3554146|B1|||Age||years|Mean|26.3|26.3|Standard Deviation|4.7|4.7|||
3715674|NCT02121522|3554170|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3715675|NCT02121522|3554170|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3715676|NCT02121522|3554170|B1|||Age||Years|Mean|75.0|75.0|Standard Deviation|7.8|7.8|||
3715677|NCT02121509|3554175|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3715678|NCT02121509|3554176|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3715679|NCT02121509|3554177|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3715680|NCT02121509|3554175|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3715681|NCT02121509|3554176|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3715682|NCT02121509|3554177|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3715683|NCT02121509|3554175|B3|||Age||years|Mean|39.8|39.8|Standard Deviation|9.8|9.8|||
3715684|NCT02121509|3554176|B2|||Age||years|Mean|42.8|42.8|Standard Deviation|10.1|10.1|||
3715685|NCT02121509|3554177|B1|||Age||years|Mean|39.0|39.0|Standard Deviation|9.6|9.6|||
3715686|NCT02121483|3554210|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3715687|NCT02121483|3554211|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3715688|NCT02121483|3554212|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3715689|NCT02121483|3554213|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3715690|NCT02121483|3554210|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3715691|NCT02121483|3554211|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3715692|NCT02121483|3554212|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3715693|NCT02121483|3554213|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3715694|NCT02121483|3554210|B4|||Age||Years|Mean|14.1|14.1|Standard Deviation|2.0|2.0|||
3715695|NCT02121483|3554211|B3|||Age||Years|Mean|14.2|14.2|Standard Deviation|2.1|2.1|||
3715696|NCT02121483|3554212|B2|||Age||Years|Mean|14.5|14.5|Standard Deviation|1.9|1.9|||
3715697|NCT02121483|3554213|B1|||Age||Years|Mean|13.7|13.7|Standard Deviation|2.0|2.0|||
3715698|NCT02121418|3554244|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3715699|NCT02121418|3554244|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3715700|NCT02121418|3554244|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3715701|NCT02121418|3554244|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3715702|NCT02121418|3554244|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715703|NCT02121418|3554244|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715704|NCT02121418|3554244|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3715705|NCT02121418|3554244|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3715706|NCT02121418|3554244|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3715707|NCT02121418|3554244|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3715708|NCT02121418|3554244|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3715709|NCT02121418|3554244|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3715710|NCT02121418|3554244|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3715711|NCT02121418|3554244|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3715712|NCT02121418|3554244|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3715713|NCT02121418|3554244|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3715714|NCT02121210|3554249|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3715715|NCT02121210|3554250|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3715716|NCT02121210|3554251|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3715717|NCT02121210|3554249|B3||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3715718|NCT02121210|3554250|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3715719|NCT02121210|3554251|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3715720|NCT02121210|3554249|B3|||Age||years|Mean|52.4|52.4|Standard Deviation|13.4|13.4|||
3715721|NCT02121210|3554250|B2|||Age||years|Mean|53.6|53.6|Standard Deviation|14.1|14.1|||
3715722|NCT02121210|3554251|B1|||Age||years|Mean|51.1|51.1|Standard Deviation|12.7|12.7|||
3715723|NCT02121067|3554260|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3715724|NCT02121067|3554260|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3715725|NCT02121067|3554260|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3715726|NCT02121067|3554260|B1|||Age||years|Median|30|30.0|Inter-Quartile Range|||24.0|36.0|
3715727|NCT02121067|3554260|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3715728|NCT02121067|3554260|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3715729|NCT02121067|3554260|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3715730|NCT02121041|3554266|B3||Male|Gender||Participants|Count of Participants|13|13.0||||||
3715731|NCT02121041|3554267|B2||Male|Gender||Participants|Count of Participants|7|7.0||||||
3715732|NCT02121041|3554268|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
3715733|NCT02121041|3554266|B3||Female|Gender||Participants|Count of Participants|15|15.0||||||
3715734|NCT02121041|3554267|B2||Female|Gender||Participants|Count of Participants|7|7.0||||||
3715735|NCT02121041|3554268|B1||Female|Gender||Participants|Count of Participants|8|8.0||||||
3715736|NCT02121041|3554266|B3|||Age, Customized||years|Mean|48.4|48.4|Standard Deviation|11|11.0|||
3715737|NCT02121041|3554267|B2|||Age, Customized||years|Mean|49.2|49.2|Standard Deviation|10|10.0|||
3715738|NCT02121041|3554268|B1|||Age, Customized||years|Mean|47.6|47.6|Standard Deviation|12|12.0|||
3715739|NCT02120833|3554275|B3|USA||Region of Enrollment||participants|Number|51|51.0||||||
3715740|NCT02120833|3554276|B2|USA||Region of Enrollment||participants|Number|12|12.0||||||
3715741|NCT02120833|3554277|B1|USA||Region of Enrollment||participants|Number|39|39.0||||||
3715742|NCT02120833|3554275|B3||Male|Gender||Participants|Count of Participants|26|26.0||||||
3715743|NCT02120833|3554276|B2||Male|Gender||Participants|Count of Participants|9|9.0||||||
3715744|NCT02120833|3554277|B1||Male|Gender||Participants|Count of Participants|17|17.0||||||
3715745|NCT02120833|3554275|B3||Female|Gender||Participants|Count of Participants|25|25.0||||||
3715746|NCT02120833|3554276|B2||Female|Gender||Participants|Count of Participants|3|3.0||||||
3715747|NCT02120833|3554277|B1||Female|Gender||Participants|Count of Participants|22|22.0||||||
3715748|NCT02120833|3554275|B3|||Age||months|Mean|20.1|20.1|Standard Deviation|9.88|9.88|||
3715749|NCT02120833|3554276|B2|||Age||months|Mean|22.3|22.3|Standard Deviation|10.29|10.29|||
3715750|NCT02120833|3554277|B1|||Age||months|Mean|19.4|19.4|Standard Deviation|9.78|9.78|||
3715751|NCT02120794|3554432|B1|United States||Region of Enrollment||particpants|Number|194|194.0||||||
3715752|NCT02120794|3554432|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3715753|NCT02120794|3554432|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|164|164.0||||||
3715754|NCT02120794|3554432|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3715755|NCT02120794|3554432|B1||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3715756|NCT02120794|3554432|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3715757|NCT02120794|3554432|B1|||Age||years|Mean|11.7|11.7|Standard Deviation|2.54|2.54|||
3715758|NCT02120716|3554439|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3715759|NCT02120716|3554440|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3715760|NCT02120716|3554441|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
3715761|NCT02120716|3554439|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3715762|NCT02120716|3554440|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3715763|NCT02120716|3554441|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3715764|NCT02120716|3554439|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3715765|NCT02120716|3554440|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3715766|NCT02120716|3554441|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3715767|NCT02120716|3554439|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3715768|NCT02120716|3554440|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3715769|NCT02120716|3554441|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3715770|NCT02120716|3554439|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3715771|NCT02120716|3554440|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3715772|NCT02120716|3554441|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3715773|NCT02120716|3554439|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715774|NCT02120716|3554440|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715775|NCT02120716|3554441|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715776|NCT02120716|3554439|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715777|NCT02120716|3554440|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715778|NCT02120716|3554441|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715779|NCT02120716|3554439|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3715780|NCT02120716|3554440|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715781|NCT02120716|3554441|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3715782|NCT02120716|3554439|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715783|NCT02120716|3554440|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715784|NCT02120716|3554441|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715785|NCT02120716|3554439|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3715786|NCT02120716|3554440|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3715787|NCT02120716|3554441|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3715788|NCT02120716|3554439|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3715789|NCT02120716|3554440|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3715790|NCT02120716|3554441|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3715791|NCT02120716|3554439|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3715792|NCT02120716|3554440|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3715793|NCT02120716|3554441|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3715794|NCT02120716|3554439|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3715795|NCT02120716|3554440|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3715796|NCT02120716|3554441|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3715797|NCT02120716|3554439|B3|||Age||Years|Mean|24.4|24.4|Standard Deviation|5.31|5.31|||
3715798|NCT02120716|3554440|B2|||Age||Years|Mean|23.2|23.2|Standard Deviation|4.3|4.3|||
3715799|NCT02120716|3554441|B1|||Age||Years|Mean|25.1|25.1|Standard Deviation|5.79|5.79|||
3715800|NCT02120664|3554451|B6|||Mini Mental Status Exam|Mini Mental Status Exam (MMSE) is a brief instrument used to assess cognitive function in elderly patients. The instrument is divided into 2 sections. The first section measures orientation, memory, and attention. The maximum score for the first section is 21. The second section tests the ability of the patient to name objects, follow verbal and written commands, write a sentence, and copy figures. The maximum score for the second section is 9. The range for the total MMSE score is 0 to 30. Higher scores indicate higher cognitive function.|units on a scale|Mean|26.3|26.3|Standard Deviation|3.55|3.55|||
3715801|NCT02120664|3554452|B5|||Mini Mental Status Exam|Mini Mental Status Exam (MMSE) is a brief instrument used to assess cognitive function in elderly patients. The instrument is divided into 2 sections. The first section measures orientation, memory, and attention. The maximum score for the first section is 21. The second section tests the ability of the patient to name objects, follow verbal and written commands, write a sentence, and copy figures. The maximum score for the second section is 9. The range for the total MMSE score is 0 to 30. Higher scores indicate higher cognitive function.|units on a scale|Mean|29.5|29.5|Standard Deviation|0.53|0.53|||
3715802|NCT02120664|3554453|B4|||Mini Mental Status Exam|Mini Mental Status Exam (MMSE) is a brief instrument used to assess cognitive function in elderly patients. The instrument is divided into 2 sections. The first section measures orientation, memory, and attention. The maximum score for the first section is 21. The second section tests the ability of the patient to name objects, follow verbal and written commands, write a sentence, and copy figures. The maximum score for the second section is 9. The range for the total MMSE score is 0 to 30. Higher scores indicate higher cognitive function.|units on a scale|Mean|29.3|29.3|Standard Deviation|0.96|0.96|||
3715803|NCT02120664|3554454|B3|||Mini Mental Status Exam|Mini Mental Status Exam (MMSE) is a brief instrument used to assess cognitive function in elderly patients. The instrument is divided into 2 sections. The first section measures orientation, memory, and attention. The maximum score for the first section is 21. The second section tests the ability of the patient to name objects, follow verbal and written commands, write a sentence, and copy figures. The maximum score for the second section is 9. The range for the total MMSE score is 0 to 30. Higher scores indicate higher cognitive function.|units on a scale|Mean|26.4|26.4|Standard Deviation|1.27|1.27|||
3715804|NCT02120664|3554455|B2|||Mini Mental Status Exam|Mini Mental Status Exam (MMSE) is a brief instrument used to assess cognitive function in elderly patients. The instrument is divided into 2 sections. The first section measures orientation, memory, and attention. The maximum score for the first section is 21. The second section tests the ability of the patient to name objects, follow verbal and written commands, write a sentence, and copy figures. The maximum score for the second section is 9. The range for the total MMSE score is 0 to 30. Higher scores indicate higher cognitive function.|units on a scale|Mean|21.8|21.8|Standard Deviation|4.92|4.92|||
3715805|NCT02120664|3554456|B1|||Mini Mental Status Exam|Mini Mental Status Exam (MMSE) is a brief instrument used to assess cognitive function in elderly patients. The instrument is divided into 2 sections. The first section measures orientation, memory, and attention. The maximum score for the first section is 21. The second section tests the ability of the patient to name objects, follow verbal and written commands, write a sentence, and copy figures. The maximum score for the second section is 9. The range for the total MMSE score is 0 to 30. Higher scores indicate higher cognitive function.|units on a scale|Mean|23.7|23.7|Standard Deviation|2.45|2.45|||
3715806|NCT02120664|3554451|B6||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3715807|NCT02120664|3554452|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3715808|NCT02120664|3554453|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3715809|NCT02120664|3554454|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3715810|NCT02120664|3554455|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3715811|NCT02120664|3554456|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3715812|NCT02120664|3554451|B6||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3715813|NCT02120664|3554452|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3715814|NCT02120664|3554453|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3715815|NCT02120664|3554454|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3715816|NCT02120664|3554455|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3715817|NCT02120664|3554456|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3715818|NCT02120664|3554451|B6|||Age||years|Mean|60.1|60.1|Standard Deviation|22.28|22.28|||
3715819|NCT02120664|3554452|B5|||Age||years|Mean|27.3|27.3|Standard Deviation|4.83|4.83|||
3715820|NCT02120664|3554453|B4|||Age||years|Mean|79.3|79.3|Standard Deviation|2.5|2.5|||
3715821|NCT02120664|3554454|B3|||Age||years|Mean|79.9|79.9|Standard Deviation|8.47|8.47|||
3715822|NCT02120664|3554455|B2|||Age||years|Mean|66|66.0|Standard Deviation|4.76|4.76|||
3715823|NCT02120664|3554456|B1|||Age||years|Mean|69.2|69.2|Standard Deviation|4.94|4.94|||
3715824|NCT02120625|3554478|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3715825|NCT02120625|3554478|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715826|NCT02120625|3554478|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715827|NCT02120625|3554478|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3715828|NCT02120625|3554478|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715829|NCT02120625|3554478|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715830|NCT02120625|3554478|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715831|NCT02120625|3554478|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715832|NCT02120625|3554478|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3715833|NCT02120625|3554478|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3715834|NCT02120625|3554478|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3715835|NCT02120625|3554478|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3715836|NCT02120625|3554478|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3715837|NCT02120443|3554485|B1|||Skin Pigmentation|Skin pigmentation was scored from 1 to 3 where 1 represents light skin pigmentation, 2 represents medium skin pigmentation, and 3 represents dark skin pigmentation.|units on a scale|Mean|1.84|1.84|Standard Deviation|0.84|0.84|||
3715838|NCT02120443|3554485|B1|||Body Mass Index||kg/m^2|Mean|26.3|26.3|Standard Deviation|5.4|5.4|||
3715839|NCT02120443|3554485|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
3715840|NCT02120443|3554485|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3715841|NCT02120443|3554485|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3715842|NCT02120443|3554485|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3715843|NCT02120443|3554485|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3715844|NCT02120443|3554485|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3715845|NCT02120443|3554485|B1|||Age||years|Mean|31.4|31.4|Standard Deviation|13.9|13.9|||
3715846|NCT02120417|3554491|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3715847|NCT02120417|3554492|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3715848|NCT02120417|3554493|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3715849|NCT02120417|3554491|B3||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3715850|NCT02120417|3554492|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3715851|NCT02120417|3554493|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3715852|NCT02120417|3554491|B3|||Age||years|Mean|54.6|54.6|Standard Deviation|11.85|11.85|||
3715853|NCT02120417|3554492|B2|||Age||years|Mean|55.0|55.0|Standard Deviation|12.75|12.75|||
3715854|NCT02120417|3554493|B1|||Age||years|Mean|54.3|54.3|Standard Deviation|11.00|11.0|||
3715855|NCT02120300|3554512|B5|Positive||HIV Status||participants|Number|26|26.0||||||
3715856|NCT02120300|3554513|B4|Positive||HIV Status||participants|Number|3|3.0||||||
3715857|NCT02120300|3554514|B3|Positive||HIV Status||participants|Number|4|4.0||||||
3715858|NCT02120300|3554515|B2|Positive||HIV Status||participants|Number|0|0.0||||||
3715859|NCT02120300|3554516|B1|Positive||HIV Status||participants|Number|19|19.0||||||
3715860|NCT02120300|3554512|B5|Negative||HIV Status||participants|Number|94|94.0||||||
3715861|NCT02120300|3554513|B4|Negative||HIV Status||participants|Number|3|3.0||||||
3715862|NCT02120300|3554514|B3|Negative||HIV Status||participants|Number|6|6.0||||||
3715863|NCT02120300|3554515|B2|Negative||HIV Status||participants|Number|5|5.0||||||
3715864|NCT02120300|3554516|B1|Negative||HIV Status||participants|Number|80|80.0||||||
3715865|NCT02120300|3554512|B5|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|19|19.0||||||
3715866|NCT02120300|3554513|B4|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3715867|NCT02120300|3554514|B3|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3715868|NCT02120300|3554515|B2|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|2|2.0||||||
3715869|NCT02120300|3554516|B1|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|17|17.0||||||
3715870|NCT02120300|3554512|B5|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|65|65.0||||||
3715871|NCT02120300|3554513|B4|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3715872|NCT02120300|3554514|B3|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
3715873|NCT02120300|3554515|B2|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3715874|NCT02120300|3554516|B1|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|60|60.0||||||
3715875|NCT02120300|3554512|B5|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|36|36.0||||||
3715876|NCT02120300|3554513|B4|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|5|5.0||||||
3715877|NCT02120300|3554514|B3|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|7|7.0||||||
3715878|NCT02120300|3554515|B2|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|2|2.0||||||
3715879|NCT02120300|3554516|B1|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|22|22.0||||||
3715880|NCT02120300|3554512|B5|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|92|92.0||||||
3715881|NCT02120300|3554513|B4|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|5|5.0||||||
3715882|NCT02120300|3554514|B3|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|8|8.0||||||
3715883|NCT02120300|3554515|B2|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|3|3.0||||||
3715884|NCT02120300|3554516|B1|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|76|76.0||||||
3715885|NCT02120300|3554512|B5|< 800,000 IU/mL||HCV RNA Category||participants|Number|28|28.0||||||
3715886|NCT02120300|3554513|B4|< 800,000 IU/mL||HCV RNA Category||participants|Number|1|1.0||||||
3715887|NCT02120300|3554514|B3|< 800,000 IU/mL||HCV RNA Category||participants|Number|2|2.0||||||
3715888|NCT02120300|3554515|B2|< 800,000 IU/mL||HCV RNA Category||participants|Number|2|2.0||||||
3715889|NCT02120300|3554516|B1|< 800,000 IU/mL||HCV RNA Category||participants|Number|23|23.0||||||
3715890|NCT02120300|3554512|B5|||HCV RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.71|0.71|||
3715891|NCT02120300|3554513|B4|||HCV RNA||log10 IU/mL|Mean|6.6|6.6|Standard Deviation|0.80|0.8|||
3715892|NCT02120300|3554514|B3|||HCV RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|1.00|1.0|||
3715893|NCT02120300|3554515|B2|||HCV RNA||log10 IU/mL|Mean|6.0|6.0|Standard Deviation|0.85|0.85|||
3715894|NCT02120300|3554516|B1|||HCV RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.67|0.67|||
3715895|NCT02120300|3554512|B5|Genotype 4||HCV Genotype||participants|Number|1|1.0||||||
3715896|NCT02120300|3554513|B4|Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3715897|NCT02120300|3554514|B3|Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3715898|NCT02120300|3554515|B2|Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3715899|NCT02120300|3554516|B1|Genotype 4||HCV Genotype||participants|Number|1|1.0||||||
3715900|NCT02120300|3554512|B5|Genotype 3||HCV Genotype||participants|Number|6|6.0||||||
3715901|NCT02120300|3554513|B4|Genotype 3||HCV Genotype||participants|Number|6|6.0||||||
3715902|NCT02120300|3554514|B3|Genotype 3||HCV Genotype||participants|Number|0|0.0||||||
3715903|NCT02120300|3554515|B2|Genotype 3||HCV Genotype||participants|Number|0|0.0||||||
3715904|NCT02120300|3554516|B1|Genotype 3||HCV Genotype||participants|Number|0|0.0||||||
3715905|NCT02120300|3554512|B5|Genotype 2||HCV Genotype||participants|Number|10|10.0||||||
3715906|NCT02120300|3554513|B4|Genotype 2||HCV Genotype||participants|Number|0|0.0||||||
3715907|NCT02120300|3554514|B3|Genotype 2||HCV Genotype||participants|Number|10|10.0||||||
3715908|NCT02120300|3554515|B2|Genotype 2||HCV Genotype||participants|Number|0|0.0||||||
3715909|NCT02120300|3554516|B1|Genotype 2||HCV Genotype||participants|Number|0|0.0||||||
3715910|NCT02120300|3554512|B5|Genotype 1||HCV Genotype||participants|Number|103|103.0||||||
3715911|NCT02120300|3554513|B4|Genotype 1||HCV Genotype||participants|Number|0|0.0||||||
3715912|NCT02120300|3554514|B3|Genotype 1||HCV Genotype||participants|Number|0|0.0||||||
3715913|NCT02120300|3554515|B2|Genotype 1||HCV Genotype||participants|Number|5|5.0||||||
3715914|NCT02120300|3554516|B1|Genotype 1||HCV Genotype||participants|Number|98|98.0||||||
3715915|NCT02120300|3554512|B5|Yes||Cirrhosis Status||participants|Number|37|37.0||||||
3715916|NCT02120300|3554513|B4|Yes||Cirrhosis Status||participants|Number|2|2.0||||||
3715917|NCT02120300|3554514|B3|Yes||Cirrhosis Status||participants|Number|2|2.0||||||
3715918|NCT02120300|3554515|B2|Yes||Cirrhosis Status||participants|Number|5|5.0||||||
3715919|NCT02120300|3554516|B1|Yes||Cirrhosis Status||participants|Number|28|28.0||||||
3715920|NCT02120300|3554512|B5|No||Cirrhosis Status||participants|Number|83|83.0||||||
3715921|NCT02120300|3554513|B4|No||Cirrhosis Status||participants|Number|4|4.0||||||
3715922|NCT02120300|3554514|B3|No||Cirrhosis Status||participants|Number|8|8.0||||||
3715923|NCT02120300|3554515|B2|No||Cirrhosis Status||participants|Number|0|0.0||||||
3715924|NCT02120300|3554516|B1|No||Cirrhosis Status||participants|Number|71|71.0||||||
3715925|NCT02120300|3554512|B5|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3715926|NCT02120300|3554513|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3715927|NCT02120300|3554514|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3715928|NCT02120300|3554515|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3715929|NCT02120300|3554516|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3715930|NCT02120300|3554512|B5|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3715931|NCT02120300|3554513|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3715932|NCT02120300|3554514|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3715933|NCT02120300|3554515|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3715934|NCT02120300|3554516|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3715935|NCT02120300|3554512|B5|White||Race/Ethnicity, Customized||participants|Number|92|92.0||||||
3715936|NCT02120300|3554513|B4|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3715937|NCT02120300|3554514|B3|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3715938|NCT02120300|3554515|B2|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3715939|NCT02120300|3554516|B1|White||Race/Ethnicity, Customized||participants|Number|75|75.0||||||
3715940|NCT02120300|3554512|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3715941|NCT02120300|3554513|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3715942|NCT02120300|3554514|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3715943|NCT02120300|3554515|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3715944|NCT02120300|3554516|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3715945|NCT02120300|3554512|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715946|NCT02120300|3554513|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715947|NCT02120300|3554514|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715948|NCT02120300|3554515|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715949|NCT02120300|3554516|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715950|NCT02120300|3554512|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
3715951|NCT02120300|3554513|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3715952|NCT02120300|3554514|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3715953|NCT02120300|3554515|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3715954|NCT02120300|3554516|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3715955|NCT02120300|3554512|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3715956|NCT02120300|3554513|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715957|NCT02120300|3554514|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3715958|NCT02120300|3554515|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3715959|NCT02120300|3554516|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3715960|NCT02120300|3554512|B5||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3715961|NCT02120300|3554513|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3715962|NCT02120300|3554514|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3715963|NCT02120300|3554515|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3715964|NCT02120300|3554516|B1||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3715965|NCT02120300|3554512|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3715966|NCT02120300|3554513|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3715967|NCT02120300|3554514|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3715968|NCT02120300|3554515|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3715969|NCT02120300|3554516|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3715970|NCT02120300|3554512|B5|||Age||Years|Mean|45|45.0|Standard Deviation|11.1|11.1|||
3715971|NCT02120300|3554513|B4|||Age||Years|Mean|47|47.0|Standard Deviation|6.7|6.7|||
3715972|NCT02120300|3554514|B3|||Age||Years|Mean|48|48.0|Standard Deviation|13.8|13.8|||
3715973|NCT02120300|3554515|B2|||Age||Years|Mean|49|49.0|Standard Deviation|11.1|11.1|||
3715974|NCT02120300|3554516|B1|||Age||Years|Mean|44|44.0|Standard Deviation|11.1|11.1|||
3715989|NCT02120027|3554557|B1||Abdominal Pain Severity ≥ 5 and < 8|Abdominal Pain Severity, Categorical|Worst abdominal pain on a 0 to 10 scale, where 0 corresponds to no pain and 10 corresponds to worst possible pain.|Participants|Count of Participants|172|172.0||||||
3715975|NCT02120027|3554555|B3||Severe IBS|IBS-Signs and Symptoms Score, Categorical|IBS-SSS score calculated from the questionnaire evaluating primarily the intensity of IBS symptoms during a 10-day period in the following domains: abdominal pain, distension, bowel habits (stool frequency and consistency), and interference with life in general. The IBS-SSS calculates the sum of five items each scored on a visual analog scale from 0 to 100. All five items contribute equally to the total score, yielding a range of 0 to 500 to categorize patients into three severity groups: mild (below 175), moderate (175-300), and severe (above 300).|Participants|Count of Participants|424|424.0||||||
3715976|NCT02120027|3554556|B2||Severe IBS|IBS-Signs and Symptoms Score, Categorical|IBS-SSS score calculated from the questionnaire evaluating primarily the intensity of IBS symptoms during a 10-day period in the following domains: abdominal pain, distension, bowel habits (stool frequency and consistency), and interference with life in general. The IBS-SSS calculates the sum of five items each scored on a visual analog scale from 0 to 100. All five items contribute equally to the total score, yielding a range of 0 to 500 to categorize patients into three severity groups: mild (below 175), moderate (175-300), and severe (above 300).|Participants|Count of Participants|214|214.0||||||
3715977|NCT02120027|3554557|B1||Severe IBS|IBS-Signs and Symptoms Score, Categorical|IBS-SSS score calculated from the questionnaire evaluating primarily the intensity of IBS symptoms during a 10-day period in the following domains: abdominal pain, distension, bowel habits (stool frequency and consistency), and interference with life in general. The IBS-SSS calculates the sum of five items each scored on a visual analog scale from 0 to 100. All five items contribute equally to the total score, yielding a range of 0 to 500 to categorize patients into three severity groups: mild (below 175), moderate (175-300), and severe (above 300).|Participants|Count of Participants|210|210.0||||||
3715978|NCT02120027|3554555|B3||Moderate IBS|IBS-Signs and Symptoms Score, Categorical|IBS-SSS score calculated from the questionnaire evaluating primarily the intensity of IBS symptoms during a 10-day period in the following domains: abdominal pain, distension, bowel habits (stool frequency and consistency), and interference with life in general. The IBS-SSS calculates the sum of five items each scored on a visual analog scale from 0 to 100. All five items contribute equally to the total score, yielding a range of 0 to 500 to categorize patients into three severity groups: mild (below 175), moderate (175-300), and severe (above 300).|Participants|Count of Participants|118|118.0||||||
3715979|NCT02120027|3554556|B2||Moderate IBS|IBS-Signs and Symptoms Score, Categorical|IBS-SSS score calculated from the questionnaire evaluating primarily the intensity of IBS symptoms during a 10-day period in the following domains: abdominal pain, distension, bowel habits (stool frequency and consistency), and interference with life in general. The IBS-SSS calculates the sum of five items each scored on a visual analog scale from 0 to 100. All five items contribute equally to the total score, yielding a range of 0 to 500 to categorize patients into three severity groups: mild (below 175), moderate (175-300), and severe (above 300).|Participants|Count of Participants|58|58.0||||||
3715980|NCT02120027|3554557|B1||Moderate IBS|IBS-Signs and Symptoms Score, Categorical|IBS-SSS score calculated from the questionnaire evaluating primarily the intensity of IBS symptoms during a 10-day period in the following domains: abdominal pain, distension, bowel habits (stool frequency and consistency), and interference with life in general. The IBS-SSS calculates the sum of five items each scored on a visual analog scale from 0 to 100. All five items contribute equally to the total score, yielding a range of 0 to 500 to categorize patients into three severity groups: mild (below 175), moderate (175-300), and severe (above 300).|Participants|Count of Participants|60|60.0||||||
3715981|NCT02120027|3554555|B3||Mild IBS|IBS-Signs and Symptoms Score, Categorical|IBS-SSS score calculated from the questionnaire evaluating primarily the intensity of IBS symptoms during a 10-day period in the following domains: abdominal pain, distension, bowel habits (stool frequency and consistency), and interference with life in general. The IBS-SSS calculates the sum of five items each scored on a visual analog scale from 0 to 100. All five items contribute equally to the total score, yielding a range of 0 to 500 to categorize patients into three severity groups: mild (below 175), moderate (175-300), and severe (above 300).|Participants|Count of Participants|14|14.0||||||
3715982|NCT02120027|3554556|B2||Mild IBS|IBS-Signs and Symptoms Score, Categorical|IBS-SSS score calculated from the questionnaire evaluating primarily the intensity of IBS symptoms during a 10-day period in the following domains: abdominal pain, distension, bowel habits (stool frequency and consistency), and interference with life in general. The IBS-SSS calculates the sum of five items each scored on a visual analog scale from 0 to 100. All five items contribute equally to the total score, yielding a range of 0 to 500 to categorize patients into three severity groups: mild (below 175), moderate (175-300), and severe (above 300).|Participants|Count of Participants|7|7.0||||||
3715983|NCT02120027|3554557|B1||Mild IBS|IBS-Signs and Symptoms Score, Categorical|IBS-SSS score calculated from the questionnaire evaluating primarily the intensity of IBS symptoms during a 10-day period in the following domains: abdominal pain, distension, bowel habits (stool frequency and consistency), and interference with life in general. The IBS-SSS calculates the sum of five items each scored on a visual analog scale from 0 to 100. All five items contribute equally to the total score, yielding a range of 0 to 500 to categorize patients into three severity groups: mild (below 175), moderate (175-300), and severe (above 300).|Participants|Count of Participants|7|7.0||||||
3715984|NCT02120027|3554555|B3||Abdominal Pain Severity ≥ 8|Abdominal Pain Severity, Categorical|Worst abdominal pain on a 0 to 10 scale, where 0 corresponds to no pain and 10 corresponds to worst possible pain.|Participants|Count of Participants|103|103.0||||||
3715985|NCT02120027|3554556|B2||Abdominal Pain Severity ≥ 8|Abdominal Pain Severity, Categorical|Worst abdominal pain on a 0 to 10 scale, where 0 corresponds to no pain and 10 corresponds to worst possible pain.|Participants|Count of Participants|53|53.0||||||
3715986|NCT02120027|3554557|B1||Abdominal Pain Severity ≥ 8|Abdominal Pain Severity, Categorical|Worst abdominal pain on a 0 to 10 scale, where 0 corresponds to no pain and 10 corresponds to worst possible pain.|Participants|Count of Participants|50|50.0||||||
3715987|NCT02120027|3554555|B3||Abdominal Pain Severity ≥ 5 and < 8|Abdominal Pain Severity, Categorical|Worst abdominal pain on a 0 to 10 scale, where 0 corresponds to no pain and 10 corresponds to worst possible pain.|Participants|Count of Participants|344|344.0||||||
3715988|NCT02120027|3554556|B2||Abdominal Pain Severity ≥ 5 and < 8|Abdominal Pain Severity, Categorical|Worst abdominal pain on a 0 to 10 scale, where 0 corresponds to no pain and 10 corresponds to worst possible pain.|Participants|Count of Participants|172|172.0||||||
3716044|NCT02120027|3554555|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3715990|NCT02120027|3554555|B3||Abdominal Pain Severity < 5|Abdominal Pain Severity, Categorical|Worst abdominal pain on a 0 to 10 scale, where 0 corresponds to no pain and 10 corresponds to worst possible pain.|Participants|Count of Participants|109|109.0||||||
3715991|NCT02120027|3554556|B2||Abdominal Pain Severity < 5|Abdominal Pain Severity, Categorical|Worst abdominal pain on a 0 to 10 scale, where 0 corresponds to no pain and 10 corresponds to worst possible pain.|Participants|Count of Participants|54|54.0||||||
3715992|NCT02120027|3554557|B1||Abdominal Pain Severity < 5|Abdominal Pain Severity, Categorical|Worst abdominal pain on a 0 to 10 scale, where 0 corresponds to no pain and 10 corresponds to worst possible pain.|Participants|Count of Participants|55|55.0||||||
3715993|NCT02120027|3554555|B3|||Body Mass Index, Continuous||kg/m²|Mean|29.6|29.6|Standard Deviation|6.96|6.96|||
3715994|NCT02120027|3554556|B2|||Body Mass Index, Continuous||kg/m²|Mean|29.6|29.6|Standard Deviation|7.02|7.02|||
3715995|NCT02120027|3554557|B1|||Body Mass Index, Continuous||kg/m²|Mean|29.6|29.6|Standard Deviation|6.92|6.92|||
3715996|NCT02120027|3554555|B3||Western Europe|Geographic Region||Participants|Count of Participants|66|66.0||||||
3715997|NCT02120027|3554556|B2||Western Europe|Geographic Region||Participants|Count of Participants|35|35.0||||||
3715998|NCT02120027|3554557|B1||Western Europe|Geographic Region||Participants|Count of Participants|31|31.0||||||
3715999|NCT02120027|3554555|B3||North America|Geographic Region||Participants|Count of Participants|425|425.0||||||
3716000|NCT02120027|3554556|B2||North America|Geographic Region||Participants|Count of Participants|214|214.0||||||
3716001|NCT02120027|3554557|B1||North America|Geographic Region||Participants|Count of Participants|211|211.0||||||
3716002|NCT02120027|3554555|B3||Eastern Europe|Geographic Region||Participants|Count of Participants|65|65.0||||||
3716003|NCT02120027|3554556|B2||Eastern Europe|Geographic Region||Participants|Count of Participants|30|30.0||||||
3716004|NCT02120027|3554557|B1||Eastern Europe|Geographic Region||Participants|Count of Participants|35|35.0||||||
3716005|NCT02120027|3554555|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3716006|NCT02120027|3554556|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3716007|NCT02120027|3554557|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3716008|NCT02120027|3554555|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716009|NCT02120027|3554556|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716010|NCT02120027|3554557|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716011|NCT02120027|3554555|B3||White|Race (NIH/OMB)||Participants|Count of Participants|488|488.0||||||
3716012|NCT02120027|3554556|B2||White|Race (NIH/OMB)||Participants|Count of Participants|247|247.0||||||
3716013|NCT02120027|3554557|B1||White|Race (NIH/OMB)||Participants|Count of Participants|241|241.0||||||
3716014|NCT02120027|3554555|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3716015|NCT02120027|3554556|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3716016|NCT02120027|3554557|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3716017|NCT02120027|3554555|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716018|NCT02120027|3554556|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716019|NCT02120027|3554557|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716020|NCT02120027|3554555|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3716021|NCT02120027|3554556|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3716022|NCT02120027|3554557|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3716023|NCT02120027|3554555|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3716024|NCT02120027|3554556|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3716025|NCT02120027|3554557|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716026|NCT02120027|3554555|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716027|NCT02120027|3554556|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716028|NCT02120027|3554557|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716029|NCT02120027|3554555|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|301|301.0||||||
3716030|NCT02120027|3554556|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|148|148.0||||||
3716031|NCT02120027|3554557|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|153|153.0||||||
3716032|NCT02120027|3554555|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|255|255.0||||||
3716033|NCT02120027|3554556|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
3716034|NCT02120027|3554557|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
3716035|NCT02120027|3554555|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3716036|NCT02120027|3554556|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3716037|NCT02120027|3554557|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3716038|NCT02120027|3554555|B3||Female|Sex: Female, Male||Participants|Count of Participants|556|556.0||||||
3716039|NCT02120027|3554556|B2||Female|Sex: Female, Male||Participants|Count of Participants|279|279.0||||||
3716040|NCT02120027|3554557|B1||Female|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
3716041|NCT02120027|3554555|B3|||Age||years|Mean|43.2|43.2|Standard Deviation|12.0|12.0|||
3716042|NCT02120027|3554556|B2|||Age||years|Mean|43.8|43.8|Standard Deviation|11.8|11.8|||
3716043|NCT02120027|3554557|B1|||Age||years|Mean|42.6|42.6|Standard Deviation|12.2|12.2|||
3716045|NCT02120027|3554556|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3716046|NCT02120027|3554557|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3716047|NCT02120027|3554555|B3||Between 18 and 65 years|Age||Participants|Count of Participants|538|538.0||||||
3716048|NCT02120027|3554556|B2||Between 18 and 65 years|Age||Participants|Count of Participants|269|269.0||||||
3716049|NCT02120027|3554557|B1||Between 18 and 65 years|Age||Participants|Count of Participants|269|269.0||||||
3716050|NCT02120027|3554555|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3716051|NCT02120027|3554556|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3716052|NCT02120027|3554557|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3716053|NCT02120001|3554572|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
3716054|NCT02120001|3554573|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3716055|NCT02120001|3554574|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3716056|NCT02120001|3554572|B3|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3716057|NCT02120001|3554573|B2|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3716058|NCT02120001|3554574|B1|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3716059|NCT02120001|3554572|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3716060|NCT02120001|3554573|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3716061|NCT02120001|3554574|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3716062|NCT02120001|3554572|B3|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3716063|NCT02120001|3554573|B2|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3716064|NCT02120001|3554574|B1|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3716065|NCT02120001|3554572|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3716066|NCT02120001|3554573|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3716067|NCT02120001|3554574|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3716068|NCT02120001|3554572|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3716069|NCT02120001|3554573|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3716070|NCT02120001|3554574|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3716071|NCT02120001|3554572|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3716072|NCT02120001|3554573|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3716073|NCT02120001|3554574|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3716074|NCT02120001|3554572|B3|||Age||years|Mean|63.2|63.2|Standard Deviation|4.0|4.0|||
3716075|NCT02120001|3554573|B2|||Age||years|Mean|61.2|61.2|Standard Deviation|3.5|3.5|||
3716076|NCT02120001|3554574|B1|||Age||years|Mean|65.6|65.6|Standard Deviation|4.1|4.1|||
3716077|NCT02119936|3554583|B1||Uninsured|Insurance provider||Participants|Count of Participants|0|0.0||||||
3716078|NCT02119936|3554583|B1||Tricare|Insurance provider||Participants|Count of Participants|0|0.0||||||
3716079|NCT02119936|3554583|B1||Private Insurance|Insurance provider||Participants|Count of Participants|5|5.0||||||
3716080|NCT02119936|3554583|B1||Medicaid|Insurance provider||Participants|Count of Participants|5|5.0||||||
3716081|NCT02119936|3554583|B1|Widowed||Relationship status|More than one category could be selected so not representative of participant count|participants|Number|0|0.0||||||
3716082|NCT02119936|3554583|B1|Divorced/separated||Relationship status|More than one category could be selected so not representative of participant count|participants|Number|2|2.0||||||
3716083|NCT02119936|3554583|B1|Married||Relationship status|More than one category could be selected so not representative of participant count|participants|Number|4|4.0||||||
3716084|NCT02119936|3554583|B1|Committed Relationship||Relationship status|More than one category could be selected so not representative of participant count|participants|Number|4|4.0||||||
3716085|NCT02119936|3554583|B1|Single/never married||Relationship status|More than one category could be selected so not representative of participant count|participants|Number|1|1.0||||||
3716086|NCT02119936|3554583|B1||Graduate level degree|Education status||Participants|Count of Participants|1|1.0||||||
3716087|NCT02119936|3554583|B1||Bachelor's degree|Education status||Participants|Count of Participants|1|1.0||||||
3716088|NCT02119936|3554583|B1||Associate's degree|Education status||Participants|Count of Participants|1|1.0||||||
3716089|NCT02119936|3554583|B1||Some college credit, no degree|Education status||Participants|Count of Participants|4|4.0||||||
3716090|NCT02119936|3554583|B1||High school diploma or GED equivalent|Education status||Participants|Count of Participants|2|2.0||||||
3716091|NCT02119936|3554583|B1||Less than high school|Education status||Participants|Count of Participants|1|1.0||||||
3716092|NCT02119936|3554583|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3716093|NCT02119936|3554583|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716094|NCT02119936|3554583|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716095|NCT02119936|3554583|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3716096|NCT02119936|3554583|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3716097|NCT02119936|3554583|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716098|NCT02119936|3554583|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716099|NCT02119936|3554583|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716100|NCT02119936|3554583|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716101|NCT02119936|3554583|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3716102|NCT02119936|3554583|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3716103|NCT02119936|3554583|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3716104|NCT02119936|3554583|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3716105|NCT02119936|3554583|B1|||Age||years|Mean|30.8|30.8|Standard Deviation|5.47|5.47|||
3716106|NCT02119871|3554592|B3|||Body surface area||m^2|Median|1.97|1.97|Inter-Quartile Range|||1.79|2.11|
3716107|NCT02119871|3554593|B2|||Body surface area||m^2|Median|1.93|1.93|Inter-Quartile Range|||1.79|2.11|
3716108|NCT02119871|3554594|B1|||Body surface area||m^2|Median|1.97|1.97|Inter-Quartile Range|||1.71|2.13|
3716109|NCT02119871|3554592|B3|Sweden||Region of Enrollment||participants|Number|20|20.0||||||
3716110|NCT02119871|3554593|B2|Sweden||Region of Enrollment||participants|Number|10|10.0||||||
3716111|NCT02119871|3554594|B1|Sweden||Region of Enrollment||participants|Number|10|10.0||||||
3716112|NCT02119871|3554592|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3716113|NCT02119871|3554592|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3716114|NCT02119871|3554593|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3716115|NCT02119871|3554594|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3716116|NCT02119871|3554592|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3716117|NCT02119871|3554593|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3716118|NCT02119871|3554594|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3716119|NCT02119871|3554592|B3|||Age||years|Median|70|70.0|Inter-Quartile Range|||65.0|74.0|
3716120|NCT02119871|3554593|B2|||Age||years|Median|71|71.0|Inter-Quartile Range|||64.0|79.0|
3716121|NCT02119871|3554594|B1|||Age||years|Median|69|69.0|Inter-Quartile Range|||65.0|74.0|
3716122|NCT02119676|3554613|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3716123|NCT02119676|3554614|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3716124|NCT02119676|3554615|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3716125|NCT02119676|3554616|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716126|NCT02119676|3554617|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716127|NCT02119676|3554613|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3716128|NCT02119676|3554614|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3716129|NCT02119676|3554615|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3716130|NCT02119676|3554616|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3716131|NCT02119676|3554617|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3716132|NCT02119676|3554613|B5||White|Race (NIH/OMB)||Participants|Count of Participants|304|304.0||||||
3716133|NCT02119676|3554614|B4||White|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3716134|NCT02119676|3554615|B3||White|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3716135|NCT02119676|3554616|B2||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3716136|NCT02119676|3554617|B1||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3716137|NCT02119676|3554613|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3716138|NCT02119676|3554614|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3716139|NCT02119676|3554615|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3716140|NCT02119676|3554616|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3716141|NCT02119676|3554617|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3716142|NCT02119676|3554613|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3716143|NCT02119676|3554614|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716144|NCT02119676|3554615|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3716145|NCT02119676|3554616|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716146|NCT02119676|3554617|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716147|NCT02119676|3554613|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3716148|NCT02119676|3554614|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3716149|NCT02119676|3554615|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3716150|NCT02119676|3554616|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3716151|NCT02119676|3554617|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716152|NCT02119676|3554613|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716153|NCT02119676|3554614|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716154|NCT02119676|3554615|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716155|NCT02119676|3554616|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716156|NCT02119676|3554617|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716157|NCT02119676|3554613|B5||Male|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
3716158|NCT02119676|3554614|B4||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3716159|NCT02119676|3554615|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3716160|NCT02119676|3554616|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3716161|NCT02119676|3554617|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3716162|NCT02119676|3554613|B5||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3716163|NCT02119676|3554614|B4||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3716164|NCT02119676|3554615|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3716165|NCT02119676|3554616|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3716166|NCT02119676|3554617|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3716167|NCT02119676|3554613|B5|||Age||years|Mean|59.6|59.6|Full Range|||19.0|84.0|
3716168|NCT02119676|3554614|B4|||Age||years|Mean|59.2|59.2|Full Range|||19.0|83.0|
3716169|NCT02119676|3554615|B3|||Age||years|Mean|59.0|59.0|Full Range|||37.0|79.0|
3716170|NCT02119676|3554616|B2|||Age||years|Mean|59.5|59.5|Full Range|||36.0|81.0|
3716171|NCT02119676|3554617|B1|||Age||years|Mean|60.8|60.8|Full Range|||34.0|84.0|
3716172|NCT02119663|3554650|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3716173|NCT02119663|3554651|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3716174|NCT02119663|3554652|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3716175|NCT02119663|3554650|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3716176|NCT02119663|3554651|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3716177|NCT02119663|3554652|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3716178|NCT02119663|3554650|B3|> 65 years||Age, Customized||Participants|Count of Participants|53|53.0||||||
3716179|NCT02119663|3554651|B2|> 65 years||Age, Customized||Participants|Count of Participants|30|30.0||||||
3716180|NCT02119663|3554652|B1|> 65 years||Age, Customized||Participants|Count of Participants|23|23.0||||||
3716181|NCT02119663|3554650|B3|≤ 65 years||Age, Customized||Participants|Count of Participants|33|33.0||||||
3716182|NCT02119663|3554651|B2|≤ 65 years||Age, Customized||Participants|Count of Participants|13|13.0||||||
3716183|NCT02119663|3554652|B1|≤ 65 years||Age, Customized||Participants|Count of Participants|20|20.0||||||
3716184|NCT02119663|3554650|B3|||Age||years|Mean|67.1|67.1|Standard Deviation|9.68|9.68|||
3716185|NCT02119663|3554651|B2|||Age||years|Mean|68.8|68.8|Standard Deviation|8.43|8.43|||
3716186|NCT02119663|3554652|B1|||Age||years|Mean|65.4|65.4|Standard Deviation|10.63|10.63|||
3716187|NCT02119650|3554669|B3|||Body Mass Index (BMI)||kg/m^2|Mean|27.66|27.66|Standard Deviation|6.787|6.787|||
3716188|NCT02119650|3554670|B2|||Body Mass Index (BMI)||kg/m^2|Mean|27.65|27.65|Standard Deviation|7.26|7.26|||
3716189|NCT02119650|3554671|B1|||Body Mass Index (BMI)||kg/m^2|Mean|27.67|27.67|Standard Deviation|6.402|6.402|||
3716190|NCT02119650|3554669|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3716191|NCT02119650|3554670|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3716192|NCT02119650|3554671|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3716193|NCT02119650|3554669|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716194|NCT02119650|3554670|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716195|NCT02119650|3554671|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716196|NCT02119650|3554669|B3||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3716197|NCT02119650|3554670|B2||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3716198|NCT02119650|3554671|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3716199|NCT02119650|3554669|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3716200|NCT02119650|3554670|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716201|NCT02119650|3554671|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3716202|NCT02119650|3554669|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716203|NCT02119650|3554670|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716204|NCT02119650|3554671|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716205|NCT02119650|3554669|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3716206|NCT02119650|3554670|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3716207|NCT02119650|3554671|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716208|NCT02119650|3554669|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716209|NCT02119650|3554670|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716210|NCT02119650|3554671|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716211|NCT02119650|3554669|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3716212|NCT02119650|3554670|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3716213|NCT02119650|3554671|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3716214|NCT02119650|3554669|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3716215|NCT02119650|3554670|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3716216|NCT02119650|3554671|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3716217|NCT02119650|3554669|B3|||Age||years|Mean|61.8|61.8|Standard Deviation|8.65|8.65|||
3716218|NCT02119650|3554670|B2|||Age||years|Mean|62.0|62.0|Standard Deviation|8.55|8.55|||
3716219|NCT02119650|3554671|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|8.85|8.85|||
3716220|NCT02119325|3554686|B1|No IFG||Impaired fasting glucose (IFG) status||participants|Number|70|70.0||||||
3716221|NCT02119325|3554686|B1|IFG||Impaired fasting glucose (IFG) status||participants|Number|26|26.0||||||
3716222|NCT02119325|3554686|B1||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3716223|NCT02119325|3554686|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3716224|NCT02119325|3554686|B1|||Age||Years|Mean|33.9|33.9|Standard Deviation|7.42|7.42|||
3716225|NCT02119299|3554731|B1|United States||Region of Enrollment||participants|Number|76|76.0||||||
3716226|NCT02119299|3554731|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3716227|NCT02119299|3554731|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3716228|NCT02119299|3554731|B1|||Age||years|Mean|34.8|34.8|Standard Deviation|7.92|7.92|||
3716229|NCT02119299|3554731|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3716230|NCT02119299|3554731|B1||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
3716231|NCT02119299|3554731|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3716232|NCT02119286|3554742|B4|Mixed Race||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3716233|NCT02119286|3554743|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3716234|NCT02119286|3554744|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3716235|NCT02119286|3554745|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3716236|NCT02119286|3554742|B4|White - White/Caucasian/European||Race/Ethnicity, Customized||Participants|Number|530|530.0||||||
3716237|NCT02119286|3554743|B3|White - White/Caucasian/European||Race/Ethnicity, Customized||Participants|Number|176|176.0||||||
3716238|NCT02119286|3554744|B2|White - White/Caucasian/European||Race/Ethnicity, Customized||Participants|Number|174|174.0||||||
3716239|NCT02119286|3554745|B1|White - White/Caucasian/European||Race/Ethnicity, Customized||Participants|Number|180|180.0||||||
3716240|NCT02119286|3554742|B4|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|69|69.0||||||
3716241|NCT02119286|3554743|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
3716242|NCT02119286|3554744|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
3716243|NCT02119286|3554745|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
3716244|NCT02119286|3554742|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
3716245|NCT02119286|3554743|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3716246|NCT02119286|3554744|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3716247|NCT02119286|3554745|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3716248|NCT02119286|3554742|B4||Male|Sex: Female, Male||Participants|Count of Participants|391|391.0||||||
3716249|NCT02119286|3554743|B3||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3716250|NCT02119286|3554744|B2||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3716251|NCT02119286|3554745|B1||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3716252|NCT02119286|3554742|B4||Female|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
3716253|NCT02119286|3554743|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3716254|NCT02119286|3554744|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3716255|NCT02119286|3554745|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3716256|NCT02119286|3554742|B4|||Age||Years|Mean|62.9|62.9|Standard Deviation|8.22|8.22|||
3716257|NCT02119286|3554743|B3|||Age||Years|Mean|63.4|63.4|Standard Deviation|7.49|7.49|||
3716258|NCT02119286|3554744|B2|||Age||Years|Mean|62.6|62.6|Standard Deviation|8.12|8.12|||
3716259|NCT02119286|3554745|B1|||Age||Years|Mean|62.6|62.6|Standard Deviation|9.00|9.0|||
3716260|NCT02119260|3554758|B8|Asian & White||Race/Ethnicity, Customized||Count of Participants|Number|1|1.0||||||
3716261|NCT02119260|3554759|B7|Asian & White||Race/Ethnicity, Customized||Count of Participants|Number|0|0.0||||||
3716262|NCT02119260|3554760|B6|Asian & White||Race/Ethnicity, Customized||Count of Participants|Number|0|0.0||||||
3716263|NCT02119260|3554761|B5|Asian & White||Race/Ethnicity, Customized||Count of Participants|Number|0|0.0||||||
3716264|NCT02119260|3554762|B4|Asian & White||Race/Ethnicity, Customized||Count of Participants|Number|0|0.0||||||
3716265|NCT02119260|3554763|B3|Asian & White||Race/Ethnicity, Customized||Count of Participants|Number|1|1.0||||||
3716266|NCT02119260|3554764|B2|Asian & White||Race/Ethnicity, Customized||Count of Participants|Number|0|0.0||||||
3716267|NCT02119260|3554765|B1|Asian & White||Race/Ethnicity, Customized||Count of Participants|Number|0|0.0||||||
3716268|NCT02119260|3554758|B8|African American/African Heritage & White||Race/Ethnicity, Customized||Count of Participants|Number|2|2.0||||||
3716269|NCT02119260|3554759|B7|African American/African Heritage & White||Race/Ethnicity, Customized||Count of Participants|Number|0|0.0||||||
3716270|NCT02119260|3554760|B6|African American/African Heritage & White||Race/Ethnicity, Customized||Count of Participants|Number|0|0.0||||||
3716271|NCT02119260|3554761|B5|African American/African Heritage & White||Race/Ethnicity, Customized||Count of Participants|Number|1|1.0||||||
3716272|NCT02119260|3554762|B4|African American/African Heritage & White||Race/Ethnicity, Customized||Count of Participants|Number|0|0.0||||||
3716273|NCT02119260|3554763|B3|African American/African Heritage & White||Race/Ethnicity, Customized||Count of Participants|Number|1|1.0||||||
3716330|NCT02118961|3554846|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3716274|NCT02119260|3554764|B2|African American/African Heritage & White||Race/Ethnicity, Customized||Count of Participants|Number|0|0.0||||||
3716275|NCT02119260|3554765|B1|African American/African Heritage & White||Race/Ethnicity, Customized||Count of Participants|Number|0|0.0||||||
3716276|NCT02119260|3554758|B8|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Count of Participants|Number|55|55.0||||||
3716277|NCT02119260|3554759|B7|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Count of Participants|Number|2|2.0||||||
3716278|NCT02119260|3554760|B6|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Count of Participants|Number|6|6.0||||||
3716279|NCT02119260|3554761|B5|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Count of Participants|Number|11|11.0||||||
3716280|NCT02119260|3554762|B4|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Count of Participants|Number|10|10.0||||||
3716281|NCT02119260|3554763|B3|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Count of Participants|Number|6|6.0||||||
3716282|NCT02119260|3554764|B2|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Count of Participants|Number|12|12.0||||||
3716283|NCT02119260|3554765|B1|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Count of Participants|Number|8|8.0||||||
3716284|NCT02119260|3554758|B8|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Count of Participants|Number|2|2.0||||||
3716285|NCT02119260|3554759|B7|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Count of Participants|Number|0|0.0||||||
3716286|NCT02119260|3554760|B6|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Count of Participants|Number|0|0.0||||||
3716287|NCT02119260|3554761|B5|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Count of Participants|Number|1|1.0||||||
3716288|NCT02119260|3554762|B4|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Count of Participants|Number|0|0.0||||||
3716289|NCT02119260|3554763|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Count of Participants|Number|0|0.0||||||
3716290|NCT02119260|3554764|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Count of Participants|Number|0|0.0||||||
3716291|NCT02119260|3554765|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Count of Participants|Number|1|1.0||||||
3716292|NCT02119260|3554758|B8||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3716293|NCT02119260|3554759|B7||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3716294|NCT02119260|3554760|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3716295|NCT02119260|3554761|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3716296|NCT02119260|3554762|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3716297|NCT02119260|3554763|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3716298|NCT02119260|3554764|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3716299|NCT02119260|3554765|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3716300|NCT02119260|3554758|B8||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3716301|NCT02119260|3554759|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3716302|NCT02119260|3554760|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3716303|NCT02119260|3554761|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3716304|NCT02119260|3554762|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3716305|NCT02119260|3554763|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3716306|NCT02119260|3554764|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3716307|NCT02119260|3554765|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3716308|NCT02119260|3554758|B8|||Age||Years|Mean|55.3|55.3|Standard Deviation|8.5|8.5|||
3716309|NCT02119260|3554759|B7|||Age||Years|Mean|54.0|54.0|Standard Deviation|9.90|9.9|||
3716310|NCT02119260|3554760|B6|||Age||Years|Mean|70.7|70.7|Standard Deviation|6.92|6.92|||
3716311|NCT02119260|3554761|B5|||Age||Years|Mean|64.1|64.1|Standard Deviation|7.87|7.87|||
3716312|NCT02119260|3554762|B4|||Age||Years|Mean|71.0|71.0|Standard Deviation|7.18|7.18|||
3716313|NCT02119260|3554763|B3|||Age||Years|Mean|43.0|43.0|Standard Deviation|10.43|10.43|||
3716314|NCT02119260|3554764|B2|||Age||Years|Mean|42.8|42.8|Standard Deviation|10.50|10.5|||
3716315|NCT02119260|3554765|B1|||Age||Years|Mean|41.3|41.3|Standard Deviation|6.40|6.4|||
3716316|NCT02119104|3554841|B1||Male|Sex: Female, Male||Participants|Count of Participants|570|570.0||||||
3716317|NCT02119104|3554841|B1||Female|Sex: Female, Male||Participants|Count of Participants|501|501.0||||||
3716318|NCT02119104|3554841|B1|6 to less than 7 months||Age, Customized|at the time of the first vaccination|Participants|Number|3|3.0||||||
3716319|NCT02119104|3554841|B1|5 to less than 6 months||Age, Customized|at the time of the first vaccination|Participants|Number|4|4.0||||||
3716320|NCT02119104|3554841|B1|4 to less than 5 months||Age, Customized|at the time of the first vaccination|Participants|Number|21|21.0||||||
3716321|NCT02119104|3554841|B1|3 to less than 4 months||Age, Customized|at the time of the first vaccination|Participants|Number|106|106.0||||||
3716322|NCT02119104|3554841|B1|2 to less than 3 months||Age, Customized|at the time of the first vaccination|Participants|Number|937|937.0||||||
3716323|NCT02118961|3554845|B3||Male|Gender||Participants|Count of Participants|229|229.0||||||
3716324|NCT02118961|3554846|B2||Male|Gender||Participants|Count of Participants|118|118.0||||||
3716325|NCT02118961|3554847|B1||Male|Gender||Participants|Count of Participants|111|111.0||||||
3716326|NCT02118961|3554845|B3||Female|Gender||Participants|Count of Participants|217|217.0||||||
3716327|NCT02118961|3554846|B2||Female|Gender||Participants|Count of Participants|104|104.0||||||
3716328|NCT02118961|3554847|B1||Female|Gender||Participants|Count of Participants|113|113.0||||||
3716329|NCT02118961|3554845|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3716331|NCT02118961|3554847|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3716332|NCT02118961|3554845|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3716333|NCT02118961|3554846|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3716334|NCT02118961|3554847|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3716335|NCT02118961|3554845|B3||<=18 years|Age||Participants|Count of Participants|446|446.0||||||
3716336|NCT02118961|3554846|B2||<=18 years|Age||Participants|Count of Participants|222|222.0||||||
3716337|NCT02118961|3554847|B1||<=18 years|Age||Participants|Count of Participants|224|224.0||||||
3716338|NCT02118896|3554866|B11||Male|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
3716339|NCT02118896|3554867|B10||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3716340|NCT02118896|3554868|B9||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3716341|NCT02118896|3554869|B8||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3716342|NCT02118896|3554870|B7||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3716343|NCT02118896|3554871|B6||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3716344|NCT02118896|3554872|B5||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3716345|NCT02118896|3554873|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3716346|NCT02118896|3554874|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3716347|NCT02118896|3554875|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3716348|NCT02118896|3554876|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3716349|NCT02118896|3554866|B11||Female|Sex: Female, Male||Participants|Count of Participants|581|581.0||||||
3716350|NCT02118896|3554867|B10||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3716351|NCT02118896|3554868|B9||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3716352|NCT02118896|3554869|B8||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3716353|NCT02118896|3554870|B7||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3716354|NCT02118896|3554871|B6||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3716355|NCT02118896|3554872|B5||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3716356|NCT02118896|3554873|B4||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3716357|NCT02118896|3554874|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3716358|NCT02118896|3554875|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3716359|NCT02118896|3554876|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3716360|NCT02118896|3554866|B11|||Age||years|Mean|49.6|49.6|Standard Deviation|11.7|11.7|||
3716361|NCT02118896|3554867|B10|||Age||years|Mean|36|36.0|Standard Deviation|13.3|13.3|||
3716362|NCT02118896|3554868|B9|||Age||years|Mean|53.8|53.8|Standard Deviation|11.1|11.1|||
3716363|NCT02118896|3554869|B8|||Age||years|Mean|49.4|49.4|Standard Deviation|12.1|12.1|||
3716364|NCT02118896|3554870|B7|||Age||years|Mean|53.2|53.2|Standard Deviation|10.3|10.3|||
3716365|NCT02118896|3554871|B6|||Age||years|Mean|46.9|46.9|Standard Deviation|12.1|12.1|||
3716366|NCT02118896|3554872|B5|||Age||years|Mean|53.9|53.9|Standard Deviation|8.4|8.4|||
3716367|NCT02118896|3554873|B4|||Age||years|Mean|51.3|51.3|Standard Deviation|11.4|11.4|||
3716368|NCT02118896|3554874|B3|||Age||years|Mean|44.7|44.7|Standard Deviation|12.4|12.4|||
3716369|NCT02118896|3554875|B2|||Age||years|Mean|44.0|44.0|Standard Deviation|11.6|11.6|||
3716370|NCT02118896|3554876|B1|||Age||years|Mean|47.9|47.9|Standard Deviation|9.5|9.5|||
3716371|NCT02118831|3554957|B4|United States||Region of Enrollment||participants|Number|56|56.0||||||
3716372|NCT02118831|3554958|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3716373|NCT02118831|3554959|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3716374|NCT02118831|3554960|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3716375|NCT02118831|3554957|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3716376|NCT02118831|3554958|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3716377|NCT02118831|3554959|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3716378|NCT02118831|3554960|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3716379|NCT02118831|3554957|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3716380|NCT02118831|3554958|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3716381|NCT02118831|3554959|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3716382|NCT02118831|3554960|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3716383|NCT02118831|3554957|B4|||Age||years|Mean|76|76.0|Standard Deviation|4|4.0|||
3716384|NCT02118831|3554958|B3|||Age||years|Mean|77|77.0|Standard Deviation|5|5.0|||
3716385|NCT02118831|3554959|B2|||Age||years|Mean|75|75.0|Standard Deviation|3|3.0|||
3716386|NCT02118831|3554960|B1|||Age||years|Mean|75|75.0|Standard Deviation|4|4.0|||
3716387|NCT02118792|3554973|B3||Male|Gender||Participants|Count of Participants|343|343.0||||||
3716388|NCT02118792|3554974|B2||Male|Gender||Participants|Count of Participants|112|112.0||||||
3716389|NCT02118792|3554975|B1||Male|Gender||Participants|Count of Participants|231|231.0||||||
3716390|NCT02118792|3554973|B3||Female|Gender||Participants|Count of Participants|420|420.0||||||
3716391|NCT02118792|3554974|B2||Female|Gender||Participants|Count of Participants|138|138.0||||||
3716392|NCT02118792|3554975|B1||Female|Gender||Participants|Count of Participants|282|282.0||||||
3716393|NCT02118792|3554973|B3|>=18 years||Age, Customized||Participants|Count of Participants|106|106.0||||||
3716394|NCT02118792|3554974|B2|>=18 years||Age, Customized||Participants|Count of Participants|29|29.0||||||
3716395|NCT02118792|3554975|B1|>=18 years||Age, Customized||Participants|Count of Participants|77|77.0||||||
3716396|NCT02118792|3554973|B3|12 -17 years||Age, Customized||Participants|Count of Participants|183|183.0||||||
3716397|NCT02118792|3554974|B2|12 -17 years||Age, Customized||Participants|Count of Participants|57|57.0||||||
3716398|NCT02118792|3554975|B1|12 -17 years||Age, Customized||Participants|Count of Participants|126|126.0||||||
3716399|NCT02118792|3554973|B3|2 -11 years||Age, Customized||Participants|Count of Participants|474|474.0||||||
3716400|NCT02118792|3554974|B2|2 -11 years||Age, Customized||Participants|Count of Participants|164|164.0||||||
3716401|NCT02118792|3554975|B1|2 -11 years||Age, Customized||Participants|Count of Participants|310|310.0||||||
3716402|NCT02118766|3555016|B3||Male|Gender||Participants|Count of Participants|332|332.0||||||
3716403|NCT02118766|3555017|B2||Male|Gender||Participants|Count of Participants|113|113.0||||||
3716404|NCT02118766|3555018|B1||Male|Gender||Participants|Count of Participants|219|219.0||||||
3716405|NCT02118766|3555016|B3||Female|Gender||Participants|Count of Participants|427|427.0||||||
3716406|NCT02118766|3555017|B2||Female|Gender||Participants|Count of Participants|143|143.0||||||
3716407|NCT02118766|3555018|B1||Female|Gender||Participants|Count of Participants|284|284.0||||||
3716408|NCT02118766|3555016|B3|greater than or equal to 18 years||Age, Customized||Participants|Count of Participants|103|103.0||||||
3716409|NCT02118766|3555017|B2|greater than or equal to 18 years||Age, Customized||Participants|Count of Participants|38|38.0||||||
3716410|NCT02118766|3555018|B1|greater than or equal to 18 years||Age, Customized||Participants|Count of Participants|65|65.0||||||
3716411|NCT02118766|3555016|B3|12–17 years||Age, Customized||Participants|Count of Participants|188|188.0||||||
3716412|NCT02118766|3555017|B2|12–17 years||Age, Customized||Participants|Count of Participants|67|67.0||||||
3716413|NCT02118766|3555018|B1|12–17 years||Age, Customized||Participants|Count of Participants|121|121.0||||||
3716414|NCT02118766|3555016|B3|7–11 years||Age, Customized||Participants|Count of Participants|228|228.0||||||
3716415|NCT02118766|3555017|B2|7–11 years||Age, Customized||Participants|Count of Participants|73|73.0||||||
3716416|NCT02118766|3555018|B1|7–11 years||Age, Customized||Participants|Count of Participants|155|155.0||||||
3716417|NCT02118766|3555016|B3|2–6 years||Age, Customized||Participants|Count of Participants|240|240.0||||||
3716418|NCT02118766|3555017|B2|2–6 years||Age, Customized||Participants|Count of Participants|78|78.0||||||
3716419|NCT02118766|3555018|B1|2–6 years||Age, Customized||Participants|Count of Participants|162|162.0||||||
3716420|NCT02118597|3555041|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3716421|NCT02118597|3555041|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3716422|NCT02118597|3555041|B1|||Age||years|Mean|52.73|52.73|Standard Deviation|10.85|10.85|||
3716423|NCT02118441|3555055|B3|||Systolic Blood Pressure||mm Hg|Mean|140|140.0|Standard Deviation|19.5|19.5|||
3716424|NCT02118441|3555056|B2|||Systolic Blood Pressure||mm Hg|Mean|140|140.0|Standard Deviation|21|21.0|||
3716425|NCT02118441|3555057|B1|||Systolic Blood Pressure||mm Hg|Mean|140|140.0|Standard Deviation|18|18.0|||
3716426|NCT02118441|3555055|B3|||Peripheral vascular disease||participants|Number|6|6.0||||||
3716427|NCT02118441|3555056|B2|||Peripheral vascular disease||participants|Number|3|3.0||||||
3716428|NCT02118441|3555057|B1|||Peripheral vascular disease||participants|Number|3|3.0||||||
3716429|NCT02118441|3555055|B3|||ASA physical status IV|American Society of Anesthesiologists (ASA) status is a system for assessing fitness for surgery. Class IV refers to patients who have severe systemic disease that is a constant threat to life. Status I refers to a healthy patient. Status II refers to patients with mild systemic disease. Status III refers to patients who have severe systemic disease. Thus ASA class IV patients are associated with higher morbidity and mortality compared to ASA 1 patients.|participants|Number|120|120.0||||||
3716430|NCT02118441|3555056|B2|||ASA physical status IV|American Society of Anesthesiologists (ASA) status is a system for assessing fitness for surgery. Class IV refers to patients who have severe systemic disease that is a constant threat to life. Status I refers to a healthy patient. Status II refers to patients with mild systemic disease. Status III refers to patients who have severe systemic disease. Thus ASA class IV patients are associated with higher morbidity and mortality compared to ASA 1 patients.|participants|Number|59|59.0||||||
3716431|NCT02118441|3555057|B1|||ASA physical status IV|American Society of Anesthesiologists (ASA) status is a system for assessing fitness for surgery. Class IV refers to patients who have severe systemic disease that is a constant threat to life. Status I refers to a healthy patient. Status II refers to patients with mild systemic disease. Status III refers to patients who have severe systemic disease. Thus ASA class IV patients are associated with higher morbidity and mortality compared to ASA 1 patients.|participants|Number|61|61.0||||||
3716432|NCT02118441|3555055|B3|||Body Mass Index||kg/m^2|Mean|26.5|26.5|Standard Deviation|4.5|4.5|||
3716433|NCT02118441|3555056|B2|||Body Mass Index||kg/m^2|Mean|26|26.0|Standard Deviation|4|4.0|||
3716434|NCT02118441|3555057|B1|||Body Mass Index||kg/m^2|Mean|27|27.0|Standard Deviation|5|5.0|||
3716435|NCT02118441|3555055|B3|Canada||Region of Enrollment||participants|Number|125|125.0||||||
3716436|NCT02118441|3555056|B2|Canada||Region of Enrollment||participants|Number|63|63.0||||||
3716437|NCT02118441|3555057|B1|Canada||Region of Enrollment||participants|Number|62|62.0||||||
3716438|NCT02118441|3555055|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3716439|NCT02118441|3555056|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3716440|NCT02118441|3555057|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3716441|NCT02118441|3555055|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3716442|NCT02118441|3555056|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3716443|NCT02118441|3555057|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3716444|NCT02118441|3555055|B3|||Age||years|Mean|67|67.0|Standard Deviation|14|14.0|||
3716445|NCT02118441|3555056|B2|||Age||years|Mean|67|67.0|Standard Deviation|14|14.0|||
3716446|NCT02118441|3555057|B1|||Age||years|Mean|67|67.0|Standard Deviation|14|14.0|||
3716447|NCT02117934|3555070|B3|United States||Region of Enrollment||Participants|Count of Participants|8368|8368.0||||||
3716448|NCT02117934|3555071|B2|United States||Region of Enrollment||Participants|Count of Participants|2781|2781.0||||||
3716449|NCT02117934|3555072|B1|United States||Region of Enrollment||Participants|Count of Participants|5587|5587.0||||||
3716450|NCT02117934|3555070|B3||Male|Sex: Female, Male||Participants|Count of Participants|4235|4235.0||||||
3716451|NCT02117934|3555071|B2||Male|Sex: Female, Male||Participants|Count of Participants|1391|1391.0||||||
3716452|NCT02117934|3555072|B1||Male|Sex: Female, Male||Participants|Count of Participants|2844|2844.0||||||
3716453|NCT02117934|3555070|B3||Female|Sex: Female, Male||Participants|Count of Participants|4133|4133.0||||||
3716454|NCT02117934|3555071|B2||Female|Sex: Female, Male||Participants|Count of Participants|1390|1390.0||||||
3716455|NCT02117934|3555072|B1||Female|Sex: Female, Male||Participants|Count of Participants|2743|2743.0||||||
3716456|NCT02117934|3555070|B3|Age ≥ 40 years||Age, Customized||Participants|Count of Participants|6675|6675.0||||||
3716457|NCT02117934|3555071|B2|Age ≥ 40 years||Age, Customized||Participants|Count of Participants|2220|2220.0||||||
3716458|NCT02117934|3555072|B1|Age ≥ 40 years||Age, Customized||Participants|Count of Participants|4455|4455.0||||||
3716459|NCT02117934|3555070|B3|Age ≥ 18 to ≤ 39 years||Age, Customized||Participants|Count of Participants|1693|1693.0||||||
3716460|NCT02117934|3555071|B2|Age ≥ 18 to ≤ 39 years||Age, Customized||Participants|Count of Participants|561|561.0||||||
3716461|NCT02117934|3555072|B1|Age ≥ 18 to ≤ 39 years||Age, Customized||Participants|Count of Participants|1132|1132.0||||||
3716462|NCT02117687|3555081|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3716463|NCT02117687|3555082|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3716464|NCT02117687|3555083|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3716465|NCT02117687|3555081|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3716466|NCT02117687|3555082|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3716467|NCT02117687|3555083|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3716468|NCT02117687|3555081|B3|≥65 years||Age, Customized||Participants|Number|38|38.0||||||
3716469|NCT02117687|3555082|B2|≥65 years||Age, Customized||Participants|Number|15|15.0||||||
3716470|NCT02117687|3555083|B1|≥65 years||Age, Customized||Participants|Number|23|23.0||||||
3716471|NCT02117687|3555081|B3|<65 years||Age, Customized||Participants|Number|42|42.0||||||
3716472|NCT02117687|3555082|B2|<65 years||Age, Customized||Participants|Number|25|25.0||||||
3716473|NCT02117687|3555083|B1|<65 years||Age, Customized||Participants|Number|17|17.0||||||
3716474|NCT02117648|3555116|B1|ECOG= 1||Eastern Cooperative Oncology Group (ECOG) Scale|"ECOG 0 = Fully active, able to carry on all predisease performance without restriction~ECOG 1 = Restricted in physically strenuous activity but ambulatory and able to carry out performance of a light or sedentary nature, for example, light housework, office work"|participants|Number|8|8.0||||||
3716475|NCT02117648|3555116|B1|ECOG= 0||Eastern Cooperative Oncology Group (ECOG) Scale|"ECOG 0 = Fully active, able to carry on all predisease performance without restriction~ECOG 1 = Restricted in physically strenuous activity but ambulatory and able to carry out performance of a light or sedentary nature, for example, light housework, office work"|participants|Number|18|18.0||||||
3716476|NCT02117648|3555116|B1|||Body Mass Index (BMI)||kilogram/square meter (kg/m2)|Mean|27.62|27.62|Standard Deviation|6.04|6.04|||
3716477|NCT02117648|3555116|B1|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3716478|NCT02117648|3555116|B1|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3716479|NCT02117648|3555116|B1|More than one race||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3716480|NCT02117648|3555116|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3716481|NCT02117648|3555116|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3716482|NCT02117648|3555116|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3716483|NCT02117648|3555116|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3716484|NCT02117648|3555116|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3716485|NCT02117648|3555116|B1|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3716486|NCT02117648|3555116|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3716487|NCT02117648|3555116|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3716488|NCT02117648|3555116|B1|Male||Sex/Gender, Customized||Participants|Count of Participants|7|7.0||||||
3716489|NCT02117648|3555116|B1|Female||Sex/Gender, Customized||Participants|Count of Participants|19|19.0||||||
3716490|NCT02117648|3555116|B1|||Age, Customized||years|Mean|60.0|60.0|Standard Deviation|9.2|9.2|||
3716491|NCT02117570|3555126|B4|Ages 65 to 85 years: Male||Sex/Gender, Customized||Participants|Number|56|56.0||||||
3716492|NCT02117570|3555127|B3|Ages 65 to 85 years: Male||Sex/Gender, Customized||Participants|Number|24|24.0||||||
3716493|NCT02117570|3555128|B2|Ages 65 to 85 years: Male||Sex/Gender, Customized||Participants|Number|24|24.0||||||
3716494|NCT02117570|3555129|B1|Ages 65 to 85 years: Male||Sex/Gender, Customized||Participants|Number|8|8.0||||||
3716495|NCT02117570|3555126|B4|Ages 65 to 85 years: Female||Sex/Gender, Customized||Participants|Number|86|86.0||||||
3716496|NCT02117570|3555127|B3|Ages 65 to 85 years: Female||Sex/Gender, Customized||Participants|Number|36|36.0||||||
3716497|NCT02117570|3555128|B2|Ages 65 to 85 years: Female||Sex/Gender, Customized||Participants|Number|37|37.0||||||
3716498|NCT02117570|3555129|B1|Ages 65 to 85 years: Female||Sex/Gender, Customized||Participants|Number|13|13.0||||||
3716499|NCT02117570|3555126|B4|Ages 50 to 64 years: Male||Sex/Gender, Customized||Participants|Number|27|27.0||||||
3716500|NCT02117570|3555127|B3|Ages 50 to 64 years: Male||Sex/Gender, Customized||Participants|Number|9|9.0||||||
3716501|NCT02117570|3555128|B2|Ages 50 to 64 years: Male||Sex/Gender, Customized||Participants|Number|13|13.0||||||
3716502|NCT02117570|3555129|B1|Ages 50 to 64 years: Male||Sex/Gender, Customized||Participants|Number|5|5.0||||||
3716503|NCT02117570|3555126|B4|Ages 50 to 64 years: Female||Sex/Gender, Customized||Participants|Number|15|15.0||||||
3716504|NCT02117570|3555127|B3|Ages 50 to 64 years: Female||Sex/Gender, Customized||Participants|Number|9|9.0||||||
3716505|NCT02117570|3555128|B2|Ages 50 to 64 years: Female||Sex/Gender, Customized||Participants|Number|5|5.0||||||
3716506|NCT02117570|3555129|B1|Ages 50 to 64 years: Female||Sex/Gender, Customized||Participants|Number|1|1.0||||||
3716507|NCT02117570|3555126|B4|Ages 65 to 85 years||Age, Customized||Participants|Number|142|142.0||||||
3716508|NCT02117570|3555127|B3|Ages 65 to 85 years||Age, Customized||Participants|Number|60|60.0||||||
3716509|NCT02117570|3555128|B2|Ages 65 to 85 years||Age, Customized||Participants|Number|61|61.0||||||
3716510|NCT02117570|3555129|B1|Ages 65 to 85 years||Age, Customized||Participants|Number|21|21.0||||||
3716511|NCT02117570|3555126|B4|Ages 50 to 64 years||Age, Customized||Participants|Number|42|42.0||||||
3716512|NCT02117570|3555127|B3|Ages 50 to 64 years||Age, Customized||Participants|Number|18|18.0||||||
3716513|NCT02117570|3555128|B2|Ages 50 to 64 years||Age, Customized||Participants|Number|18|18.0||||||
3716514|NCT02117570|3555129|B1|Ages 50 to 64 years||Age, Customized||Participants|Number|6|6.0||||||
3716515|NCT02117544|3555181|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3716516|NCT02117544|3555181|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3716517|NCT02117544|3555181|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|5.0|5.0|||
3716518|NCT02117479|3555195|B3||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
3716519|NCT02117479|3555196|B2||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3716520|NCT02117479|3555197|B1||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3716521|NCT02117479|3555195|B3||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3716522|NCT02117479|3555196|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3716523|NCT02117479|3555197|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3716524|NCT02117479|3555195|B3|> 65 years||Age, Customized||participants|Number|188|188.0||||||
3716525|NCT02117479|3555196|B2|> 65 years||Age, Customized||participants|Number|92|92.0||||||
3716526|NCT02117479|3555197|B1|> 65 years||Age, Customized||participants|Number|96|96.0||||||
3716527|NCT02117479|3555195|B3|≤ 65 years||Age, Customized||participants|Number|133|133.0||||||
3716528|NCT02117479|3555196|B2|≤ 65 years||Age, Customized||participants|Number|68|68.0||||||
3716529|NCT02117479|3555197|B1|≤ 65 years||Age, Customized||participants|Number|65|65.0||||||
3716530|NCT02117479|3555195|B3|||Age||years|Mean|66.4|66.4|Standard Deviation|9.48|9.48|||
3716531|NCT02117479|3555196|B2|||Age||years|Mean|65.6|65.6|Standard Deviation|9.55|9.55|||
3716532|NCT02117479|3555197|B1|||Age||years|Mean|67.3|67.3|Standard Deviation|9.35|9.35|||
3716533|NCT02117427|3555214|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716534|NCT02117427|3555215|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716535|NCT02117427|3555216|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716536|NCT02117427|3555217|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716537|NCT02117427|3555214|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716538|NCT02117427|3555215|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716539|NCT02117427|3555216|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716540|NCT02117427|3555217|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716541|NCT02117427|3555214|B4||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3716542|NCT02117427|3555215|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716543|NCT02117427|3555216|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3716544|NCT02117427|3555217|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3716545|NCT02117427|3555214|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3716546|NCT02117427|3555215|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716547|NCT02117427|3555216|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716548|NCT02117427|3555217|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3716549|NCT02117427|3555214|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716550|NCT02117427|3555215|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716551|NCT02117427|3555216|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716552|NCT02117427|3555217|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716553|NCT02117427|3555214|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3716554|NCT02117427|3555215|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716555|NCT02117427|3555216|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3716556|NCT02117427|3555217|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716557|NCT02117427|3555214|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716558|NCT02117427|3555215|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716559|NCT02117427|3555216|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716560|NCT02117427|3555217|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716561|NCT02117427|3555214|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3716562|NCT02117427|3555215|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3716563|NCT02117427|3555216|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3716564|NCT02117427|3555217|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3716565|NCT02117427|3555214|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3716566|NCT02117427|3555215|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3716567|NCT02117427|3555216|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3716568|NCT02117427|3555217|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3716569|NCT02117427|3555214|B4||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3716570|NCT02117427|3555215|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3716571|NCT02117427|3555216|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3716572|NCT02117427|3555217|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3716573|NCT02117427|3555214|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3716574|NCT02117427|3555215|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3716575|NCT02117427|3555216|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3716576|NCT02117427|3555217|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3716577|NCT02117427|3555214|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3716578|NCT02117427|3555215|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3716579|NCT02117427|3555216|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3716580|NCT02117427|3555217|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3716581|NCT02117414|3555227|B3||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3716582|NCT02117414|3555228|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3716583|NCT02117414|3555229|B1||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3716584|NCT02117414|3555227|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3716585|NCT02117414|3555228|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3716586|NCT02117414|3555229|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3716587|NCT02117414|3555227|B3|||Age||years|Mean|60.4|60.4|Standard Deviation|13.8|13.8|||
3716588|NCT02117414|3555228|B2|||Age||years|Mean|60.1|60.1|Standard Deviation|14.3|14.3|||
3716589|NCT02117414|3555229|B1|||Age||years|Mean|60.5|60.5|Standard Deviation|13.5|13.5|||
3716590|NCT02117310|3555248|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3716591|NCT02117310|3555248|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3716592|NCT02117310|3555248|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3716593|NCT02117310|3555248|B1|||Age||years|Mean|41.4|41.4|Full Range|||24.0|78.0|
3716594|NCT02117310|3555248|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3716595|NCT02117310|3555248|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3716596|NCT02117310|3555248|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3716597|NCT02117193|3555252|B1|||maximal oxygen uptake||ml.kg-1.min-1|Mean|44.8|44.8|Standard Deviation|2.4|2.4|||
3716598|NCT02117193|3555252|B1|Brazil||Region of Enrollment||participants|Number|10|10.0||||||
3716599|NCT02117193|3555252|B1||Male|Gender||Participants|Count of Participants|10|10.0||||||
3716600|NCT02117193|3555252|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3716601|NCT02117193|3555252|B1|||Age||years|Mean|23.5|23.5|Standard Deviation|3.3|3.3|||
3716602|NCT02117193|3555252|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3716603|NCT02117193|3555252|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3716604|NCT02117193|3555252|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3716605|NCT02117050|3555274|B1|Prefers not to identify||Sex/Gender, Customized||subject|Number|1|1.0||||||
3716606|NCT02117050|3555274|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3716607|NCT02117050|3555274|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3716608|NCT02117050|3555274|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3716609|NCT02116972|3555286|B4||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3716610|NCT02116972|3555287|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3716611|NCT02116972|3555288|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3716612|NCT02116972|3555289|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3716613|NCT02116972|3555286|B4||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3716614|NCT02116972|3555287|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3716615|NCT02116972|3555288|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3716616|NCT02116972|3555289|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3716617|NCT02116972|3555286|B4|||Age||years|Mean|58.8|58.8|Standard Deviation|8.20|8.2|||
3716618|NCT02116972|3555287|B3|||Age||years|Mean|59.7|59.7|Standard Deviation|8.23|8.23|||
3716619|NCT02116972|3555288|B2|||Age||years|Mean|58.7|58.7|Standard Deviation|8.06|8.06|||
3716620|NCT02116972|3555289|B1|||Age||years|Mean|58.2|58.2|Standard Deviation|8.34|8.34|||
3716621|NCT02116803|3555321|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3716622|NCT02116803|3555322|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3716623|NCT02116803|3555323|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3716624|NCT02116803|3555321|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3716625|NCT02116803|3555322|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3716626|NCT02116803|3555323|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3716627|NCT02116803|3555321|B3|||Age||Years|Mean|62.3|62.3|Standard Deviation|11.40|11.4|||
3716628|NCT02116803|3555322|B2|||Age||Years|Mean|72.0|72.0|Standard Deviation|14.14|14.14|||
3716629|NCT02116803|3555323|B1|||Age||Years|Mean|60.3|60.3|Standard Deviation|10.55|10.55|||
3716630|NCT02116621|3555330|B3|||Medication related shared decision making|Four questions from the Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey assessed patient-provider discussions on starting/stopping medications and comprise medication related shared decision making. Scores were computed only for patients who reported discussing medications with their clinician in the past 12 months. Medication related shared decision making scores range from 0-100. Higher scores indicate more shared decision making.|units on a scale|Mean|74.6|74.6|Standard Deviation|23.9|23.9|||
3716631|NCT02116621|3555331|B2|||Medication related shared decision making|Four questions from the Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey assessed patient-provider discussions on starting/stopping medications and comprise medication related shared decision making. Scores were computed only for patients who reported discussing medications with their clinician in the past 12 months. Medication related shared decision making scores range from 0-100. Higher scores indicate more shared decision making.|units on a scale|Mean|75.0|75.0|Standard Deviation|24.3|24.3|||
3716632|NCT02116621|3555332|B1|||Medication related shared decision making|Four questions from the Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey assessed patient-provider discussions on starting/stopping medications and comprise medication related shared decision making. Scores were computed only for patients who reported discussing medications with their clinician in the past 12 months. Medication related shared decision making scores range from 0-100. Higher scores indicate more shared decision making.|units on a scale|Mean|74.3|74.3|Standard Deviation|23.8|23.8|||
3716633|NCT02116621|3555330|B3|||Satisfaction with pain medication|The Pain Treatment Satisfaction Scale consists of 18 items assessing patient satisfaction, creating three subscales. Satisfaction with current pain medication is a subscale that includes 8 questions assessing current pain medications. Satisfaction with pain medication scores range from 0-100. Higher scores indicate greater patient satisfaction with current pain medications.|units on a scale|Mean|64.4|64.4|Standard Deviation|22.8|22.8|||
3716634|NCT02116621|3555331|B2|||Satisfaction with pain medication|The Pain Treatment Satisfaction Scale consists of 18 items assessing patient satisfaction, creating three subscales. Satisfaction with current pain medication is a subscale that includes 8 questions assessing current pain medications. Satisfaction with pain medication scores range from 0-100. Higher scores indicate greater patient satisfaction with current pain medications.|units on a scale|Mean|63.4|63.4|Standard Deviation|23.6|23.6|||
3716635|NCT02116621|3555332|B1|||Satisfaction with pain medication|The Pain Treatment Satisfaction Scale consists of 18 items assessing patient satisfaction, creating three subscales. Satisfaction with current pain medication is a subscale that includes 8 questions assessing current pain medications. Satisfaction with pain medication scores range from 0-100. Higher scores indicate greater patient satisfaction with current pain medications.|units on a scale|Mean|65.2|65.2|Standard Deviation|22.1|22.1|||
3716636|NCT02116621|3555330|B3|||Satisfaction with medical care|The Pain Treatment Satisfaction Scale consists of 18 items assessing patient satisfaction, creating three subscales. Satisfaction with medical care is a subscale that includes 5 questions assessing medical care for pain. Satisfaction with medical care scores range from 0 - 100. Higher scores indicate greater patient satisfaction with medical care.|units on a scale|Mean|82.2|82.2|Standard Deviation|17.7|17.7|||
3716637|NCT02116621|3555331|B2|||Satisfaction with medical care|The Pain Treatment Satisfaction Scale consists of 18 items assessing patient satisfaction, creating three subscales. Satisfaction with medical care is a subscale that includes 5 questions assessing medical care for pain. Satisfaction with medical care scores range from 0 - 100. Higher scores indicate greater patient satisfaction with medical care.|units on a scale|Mean|79.5|79.5|Standard Deviation|19.2|19.2|||
3716638|NCT02116621|3555332|B1|||Satisfaction with medical care|The Pain Treatment Satisfaction Scale consists of 18 items assessing patient satisfaction, creating three subscales. Satisfaction with medical care is a subscale that includes 5 questions assessing medical care for pain. Satisfaction with medical care scores range from 0 - 100. Higher scores indicate greater patient satisfaction with medical care.|units on a scale|Mean|84.7|84.7|Standard Deviation|15.7|15.7|||
3716639|NCT02116621|3555330|B3|||Satisfaction with pain information|The Pain Treatment Satisfaction Scale consists of 18 items assessing patient satisfaction, creating three subscales. Satisfaction with pain information is a subscale that includes 5 questions assessing information about pain and its treatment. Satisfaction with pain information range from 0-100. Higher scores indicate greater patient satisfaction with information received about pain and treatment for pain.|units on a scale|Mean|50.6|50.6|Standard Deviation|38.2|38.2|||
3716640|NCT02116621|3555331|B2|||Satisfaction with pain information|The Pain Treatment Satisfaction Scale consists of 18 items assessing patient satisfaction, creating three subscales. Satisfaction with pain information is a subscale that includes 5 questions assessing information about pain and its treatment. Satisfaction with pain information range from 0-100. Higher scores indicate greater patient satisfaction with information received about pain and treatment for pain.|units on a scale|Mean|50.7|50.7|Standard Deviation|37.8|37.8|||
3716690|NCT02116621|3555330|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|186|186.0||||||
3716691|NCT02116621|3555331|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3716692|NCT02116621|3555332|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3716641|NCT02116621|3555332|B1|||Satisfaction with pain information|The Pain Treatment Satisfaction Scale consists of 18 items assessing patient satisfaction, creating three subscales. Satisfaction with pain information is a subscale that includes 5 questions assessing information about pain and its treatment. Satisfaction with pain information range from 0-100. Higher scores indicate greater patient satisfaction with information received about pain and treatment for pain.|units on a scale|Mean|50.5|50.5|Standard Deviation|38.8|38.8|||
3716642|NCT02116621|3555330|B3|||Trust in clinician|Patient trust in physician measured with 11-item Trust in Physician Scale to assess the quality of the patient-clinician relationship. Trust in physician scores range from 0 - 100. Higher scores indicate greater patient trust in the clinician providing pain treatment.|units on a scale|Mean|76.1|76.1|Standard Deviation|16.4|16.4|||
3716643|NCT02116621|3555331|B2|||Trust in clinician|Patient trust in physician measured with 11-item Trust in Physician Scale to assess the quality of the patient-clinician relationship. Trust in physician scores range from 0 - 100. Higher scores indicate greater patient trust in the clinician providing pain treatment.|units on a scale|Mean|75.3|75.3|Standard Deviation|17.1|17.1|||
3716644|NCT02116621|3555332|B1|||Trust in clinician|Patient trust in physician measured with 11-item Trust in Physician Scale to assess the quality of the patient-clinician relationship. Trust in physician scores range from 0 - 100. Higher scores indicate greater patient trust in the clinician providing pain treatment.|units on a scale|Mean|76.8|76.8|Standard Deviation|15.8|15.8|||
3716645|NCT02116621|3555330|B3|||Analgesic adherence (underuse)|Four questions from the Pain Medication in Primary Care Patient Questionnaire measured adherence to medications. Two questions comprised a subscale assessing underuse of medications. Underuse scores range from 0-100. Higher scores indicate greater adherence and less underuse of medication.|units on a scale|Mean|75.4|75.4|Standard Deviation|23.4|23.4|||
3716646|NCT02116621|3555331|B2|||Analgesic adherence (underuse)|Four questions from the Pain Medication in Primary Care Patient Questionnaire measured adherence to medications. Two questions comprised a subscale assessing underuse of medications. Underuse scores range from 0-100. Higher scores indicate greater adherence and less underuse of medication.|units on a scale|Mean|75.6|75.6|Standard Deviation|24.6|24.6|||
3716647|NCT02116621|3555332|B1|||Analgesic adherence (underuse)|Four questions from the Pain Medication in Primary Care Patient Questionnaire measured adherence to medications. Two questions comprised a subscale assessing underuse of medications. Underuse scores range from 0-100. Higher scores indicate greater adherence and less underuse of medication.|units on a scale|Mean|75.2|75.2|Standard Deviation|22.3|22.3|||
3716648|NCT02116621|3555330|B3|||Analgesic adherence (overuse)|Four questions from the Pain Medication in Primary Care Patient Questionnaire measured adherence to medications. Two questions comprised a subscale assessing overuse of medications. Overuse scores range from 0 - 100. Higher scores indicate greater adherence and less overuse of medications.|units on a scale|Mean|89.8|89.8|Standard Deviation|12.9|12.9|||
3716649|NCT02116621|3555331|B2|||Analgesic adherence (overuse)|Four questions from the Pain Medication in Primary Care Patient Questionnaire measured adherence to medications. Two questions comprised a subscale assessing overuse of medications. Overuse scores range from 0 - 100. Higher scores indicate greater adherence and less overuse of medications.|units on a scale|Mean|89.4|89.4|Standard Deviation|13.4|13.4|||
3716650|NCT02116621|3555332|B1|||Analgesic adherence (overuse)|Four questions from the Pain Medication in Primary Care Patient Questionnaire measured adherence to medications. Two questions comprised a subscale assessing overuse of medications. Overuse scores range from 0 - 100. Higher scores indicate greater adherence and less overuse of medications.|units on a scale|Mean|90.2|90.2|Standard Deviation|12.4|12.4|||
3716651|NCT02116621|3555330|B3|||Global mental health|Global health measured with 10 item Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health scale, representing physical and mental health components. Global mental health measures mental health, quality of life, satisfaction with social activities and emotional problems. The final mental health score is represented by the T-score, a standardized score with a mean of 50 and a standard deviation of 10. Global mental health scores range from 0 - 100, and higher scores indicate better mental health.|units on a scale|Mean|44.1|44.1|Standard Deviation|8.6|8.6|||
3716652|NCT02116621|3555331|B2|||Global mental health|Global health measured with 10 item Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health scale, representing physical and mental health components. Global mental health measures mental health, quality of life, satisfaction with social activities and emotional problems. The final mental health score is represented by the T-score, a standardized score with a mean of 50 and a standard deviation of 10. Global mental health scores range from 0 - 100, and higher scores indicate better mental health.|units on a scale|Mean|43.2|43.2|Standard Deviation|7.9|7.9|||
3716653|NCT02116621|3555332|B1|||Global mental health|Global health measured with 10 item Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health scale, representing physical and mental health components. Global mental health measures mental health, quality of life, satisfaction with social activities and emotional problems. The final mental health score is represented by the T-score, a standardized score with a mean of 50 and a standard deviation of 10. Global mental health scores range from 0 - 100, and higher scores indicate better mental health.|units on a scale|Mean|44.9|44.9|Standard Deviation|9.1|9.1|||
3716654|NCT02116621|3555330|B3|||Global physical health|Global health measured with 10 item Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health scale, representing physical and mental health components. Global physical health measures overall physical health, physical function, pain and fatigue. The final physical health score is represented by the T-score, a standardized score with a mean of 50 and a standard deviation of 10. Physical global health scores range from 0 - 100, and higher scores indicate better physical health.|units on a scale|Mean|41.6|41.6|Standard Deviation|6.2|6.2|||
3716655|NCT02116621|3555331|B2|||Global physical health|Global health measured with 10 item Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health scale, representing physical and mental health components. Global physical health measures overall physical health, physical function, pain and fatigue. The final physical health score is represented by the T-score, a standardized score with a mean of 50 and a standard deviation of 10. Physical global health scores range from 0 - 100, and higher scores indicate better physical health.|units on a scale|Mean|40.6|40.6|Standard Deviation|5.5|5.5|||
3716693|NCT02116621|3555330|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3716656|NCT02116621|3555332|B1|||Global physical health|Global health measured with 10 item Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health scale, representing physical and mental health components. Global physical health measures overall physical health, physical function, pain and fatigue. The final physical health score is represented by the T-score, a standardized score with a mean of 50 and a standard deviation of 10. Physical global health scores range from 0 - 100, and higher scores indicate better physical health.|units on a scale|Mean|42.5|42.5|Standard Deviation|6.8|6.8|||
3716657|NCT02116621|3555330|B3|||Pain intensity|Pain intensity measured with Patient-Reported Outcomes Measurement Information System (PROMIS) 3a short form which measures self-reported estimate of how much a person hurts. The final score is represented by the T-score, a standardized score with a mean of 50 and a standard deviation of 10. Pain intensity scores range from 0 - 100. For pain intensity, higher scores indicate greater pain intensity.|units on a scale|Mean|53.7|53.7|Standard Deviation|5.2|5.2|||
3716658|NCT02116621|3555331|B2|||Pain intensity|Pain intensity measured with Patient-Reported Outcomes Measurement Information System (PROMIS) 3a short form which measures self-reported estimate of how much a person hurts. The final score is represented by the T-score, a standardized score with a mean of 50 and a standard deviation of 10. Pain intensity scores range from 0 - 100. For pain intensity, higher scores indicate greater pain intensity.|units on a scale|Mean|53.8|53.8|Standard Deviation|5.1|5.1|||
3716659|NCT02116621|3555332|B1|||Pain intensity|Pain intensity measured with Patient-Reported Outcomes Measurement Information System (PROMIS) 3a short form which measures self-reported estimate of how much a person hurts. The final score is represented by the T-score, a standardized score with a mean of 50 and a standard deviation of 10. Pain intensity scores range from 0 - 100. For pain intensity, higher scores indicate greater pain intensity.|units on a scale|Mean|53.5|53.5|Standard Deviation|5.4|5.4|||
3716660|NCT02116621|3555330|B3|||Pain interference|Pain interference measured with Patient-Reported Outcomes Measurement Information System (PROMIS) 8-item short form which measures self-reported consequences of pain on relevant aspects of one's life. The final score is represented by the T-score, a standardized score with a mean of 50 and a standard deviation of 10. Pain interference scores range from 0 - 100. For pain interference, higher scores indicate greater pain interference.|units on a scale|Mean|64.3|64.3|Standard Deviation|5.8|5.8|||
3716661|NCT02116621|3555331|B2|||Pain interference|Pain interference measured with Patient-Reported Outcomes Measurement Information System (PROMIS) 8-item short form which measures self-reported consequences of pain on relevant aspects of one's life. The final score is represented by the T-score, a standardized score with a mean of 50 and a standard deviation of 10. Pain interference scores range from 0 - 100. For pain interference, higher scores indicate greater pain interference.|units on a scale|Mean|64.7|64.7|Standard Deviation|5.8|5.8|||
3716662|NCT02116621|3555332|B1|||Pain interference|Pain interference measured with Patient-Reported Outcomes Measurement Information System (PROMIS) 8-item short form which measures self-reported consequences of pain on relevant aspects of one's life. The final score is represented by the T-score, a standardized score with a mean of 50 and a standard deviation of 10. Pain interference scores range from 0 - 100. For pain interference, higher scores indicate greater pain interference.|units on a scale|Mean|64.0|64.0|Standard Deviation|5.9|5.9|||
3716663|NCT02116621|3555330|B3|United States||Region of Enrollment||Participants|Count of Participants|215|215.0||||||
3716664|NCT02116621|3555331|B2|United States||Region of Enrollment||Participants|Count of Participants|107|107.0||||||
3716665|NCT02116621|3555332|B1|United States||Region of Enrollment||Participants|Count of Participants|108|108.0||||||
3716666|NCT02116621|3555330|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3716667|NCT02116621|3555331|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3716668|NCT02116621|3555332|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3716669|NCT02116621|3555330|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716670|NCT02116621|3555331|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716671|NCT02116621|3555332|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716672|NCT02116621|3555330|B3||White|Race (NIH/OMB)||Participants|Count of Participants|155|155.0||||||
3716673|NCT02116621|3555331|B2||White|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3716674|NCT02116621|3555332|B1||White|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3716675|NCT02116621|3555330|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3716676|NCT02116621|3555331|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3716677|NCT02116621|3555332|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3716678|NCT02116621|3555330|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716679|NCT02116621|3555331|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716680|NCT02116621|3555332|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716681|NCT02116621|3555330|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3716682|NCT02116621|3555331|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3716683|NCT02116621|3555332|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3716684|NCT02116621|3555330|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716685|NCT02116621|3555331|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716686|NCT02116621|3555332|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716687|NCT02116621|3555330|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3716688|NCT02116621|3555331|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3716689|NCT02116621|3555332|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3716694|NCT02116621|3555331|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3716695|NCT02116621|3555332|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3716696|NCT02116621|3555330|B3||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3716697|NCT02116621|3555331|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3716698|NCT02116621|3555332|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3716699|NCT02116621|3555330|B3||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3716700|NCT02116621|3555331|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3716701|NCT02116621|3555332|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3716702|NCT02116621|3555330|B3|||Age||years|Mean|55.5|55.5|Standard Deviation|11.1|11.1|||
3716703|NCT02116621|3555331|B2|||Age||years|Mean|55.6|55.6|Standard Deviation|11.5|11.5|||
3716704|NCT02116621|3555332|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|10.8|10.8|||
3716705|NCT02116582|3555421|B1|Not Reported||Race/Ethnicity, Customized|Race was not collected in France, because of country regulations. Ethnicity was not collected for this study.|Participants|Number|47|47.0||||||
3716706|NCT02116582|3555421|B1|Other||Race/Ethnicity, Customized|Race was not collected in France, because of country regulations. Ethnicity was not collected for this study.|Participants|Number|1|1.0||||||
3716707|NCT02116582|3555421|B1|Black or African American||Race/Ethnicity, Customized|Race was not collected in France, because of country regulations. Ethnicity was not collected for this study.|Participants|Number|2|2.0||||||
3716708|NCT02116582|3555421|B1|White||Race/Ethnicity, Customized|Race was not collected in France, because of country regulations. Ethnicity was not collected for this study.|Participants|Number|165|165.0||||||
3716709|NCT02116582|3555421|B1||Male|Sex: Female, Male|This was an all male study.|Participants|Count of Participants|215|215.0||||||
3716710|NCT02116582|3555421|B1||Female|Sex: Female, Male|This was an all male study.|Participants|Count of Participants|0|0.0||||||
3716711|NCT02116582|3555421|B1|||Age||Years|Mean|73.2|73.2|Standard Deviation|7.6|7.6|||
3716712|NCT02116530|3555429|B3||Not assessed|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|1|1.0||||||
3716713|NCT02116530|3555430|B2||Not assessed|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|0|0.0||||||
3716714|NCT02116530|3555431|B1||Not assessed|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|1|1.0||||||
3716715|NCT02116530|3555429|B3||2=Symptomatic, <50% in bed during the day|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|5|5.0||||||
3716716|NCT02116530|3555430|B2||2=Symptomatic, <50% in bed during the day|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|3|3.0||||||
3716717|NCT02116530|3555431|B1||2=Symptomatic, <50% in bed during the day|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|2|2.0||||||
3716718|NCT02116530|3555429|B3||1=Symptomatic and fully ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|81|81.0||||||
3716719|NCT02116530|3555430|B2||1=Symptomatic and fully ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|41|41.0||||||
3716720|NCT02116530|3555431|B1||1=Symptomatic and fully ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|40|40.0||||||
3716721|NCT02116530|3555429|B3||0=Asymptomatic and fully active|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|293|293.0||||||
3716722|NCT02116530|3555430|B2||0=Asymptomatic and fully active|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|144|144.0||||||
3716723|NCT02116530|3555431|B1||0=Asymptomatic and fully active|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|149|149.0||||||
3716724|NCT02116530|3555429|B3||Other|Primary site of disease||Participants|Count of Participants|89|89.0||||||
3716725|NCT02116530|3555430|B2||Other|Primary site of disease||Participants|Count of Participants|44|44.0||||||
3716726|NCT02116530|3555431|B1||Other|Primary site of disease||Participants|Count of Participants|45|45.0||||||
3716727|NCT02116530|3555429|B3||Lung|Primary site of disease||Participants|Count of Participants|49|49.0||||||
3716728|NCT02116530|3555430|B2||Lung|Primary site of disease||Participants|Count of Participants|22|22.0||||||
3716729|NCT02116530|3555431|B1||Lung|Primary site of disease||Participants|Count of Participants|27|27.0||||||
3716730|NCT02116530|3555429|B3||Breast|Primary site of disease||Participants|Count of Participants|242|242.0||||||
3716731|NCT02116530|3555430|B2||Breast|Primary site of disease||Participants|Count of Participants|122|122.0||||||
3716732|NCT02116530|3555431|B1||Breast|Primary site of disease||Participants|Count of Participants|120|120.0||||||
3716733|NCT02116530|3555429|B3||Anthracyline and cyclophosphamide|Chemotherapy regimen||Participants|Count of Participants|244|244.0||||||
3716734|NCT02116530|3555430|B2||Anthracyline and cyclophosphamide|Chemotherapy regimen||Participants|Count of Participants|123|123.0||||||
3716735|NCT02116530|3555431|B1||Anthracyline and cyclophosphamide|Chemotherapy regimen||Participants|Count of Participants|121|121.0||||||
3716736|NCT02116530|3555429|B3||Cisplatin-containing regimen|Chemotherapy regimen||Participants|Count of Participants|136|136.0||||||
3716737|NCT02116530|3555430|B2||Cisplatin-containing regimen|Chemotherapy regimen||Participants|Count of Participants|65|65.0||||||
3716738|NCT02116530|3555431|B1||Cisplatin-containing regimen|Chemotherapy regimen||Participants|Count of Participants|71|71.0||||||
3716739|NCT02116530|3555429|B3||Granisetron|5-hydroxytryptamine type 3 receptor antagonist||Participants|Count of Participants|2|2.0||||||
3716740|NCT02116530|3555430|B2||Granisetron|5-hydroxytryptamine type 3 receptor antagonist||Participants|Count of Participants|1|1.0||||||
3716741|NCT02116530|3555431|B1||Granisetron|5-hydroxytryptamine type 3 receptor antagonist||Participants|Count of Participants|1|1.0||||||
3716742|NCT02116530|3555429|B3||Ondansetron|5-hydroxytryptamine type 3 receptor antagonist||Participants|Count of Participants|90|90.0||||||
3716743|NCT02116530|3555430|B2||Ondansetron|5-hydroxytryptamine type 3 receptor antagonist||Participants|Count of Participants|44|44.0||||||
3716744|NCT02116530|3555431|B1||Ondansetron|5-hydroxytryptamine type 3 receptor antagonist||Participants|Count of Participants|46|46.0||||||
3716745|NCT02116530|3555429|B3||Palonosetron|5-hydroxytryptamine type 3 receptor antagonist||Participants|Count of Participants|288|288.0||||||
3716746|NCT02116530|3555430|B2||Palonosetron|5-hydroxytryptamine type 3 receptor antagonist||Participants|Count of Participants|143|143.0||||||
3716747|NCT02116530|3555431|B1||Palonosetron|5-hydroxytryptamine type 3 receptor antagonist||Participants|Count of Participants|145|145.0||||||
3716748|NCT02116530|3555429|B3|United States||Region of Enrollment||participants|Number|380|380.0||||||
3716749|NCT02116530|3555430|B2|United States||Region of Enrollment||participants|Number|188|188.0||||||
3716750|NCT02116530|3555431|B1|United States||Region of Enrollment||participants|Number|192|192.0||||||
3716751|NCT02116530|3555429|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3716752|NCT02116530|3555430|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3716753|NCT02116530|3555431|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3716754|NCT02116530|3555429|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716755|NCT02116530|3555430|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716756|NCT02116530|3555431|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716757|NCT02116530|3555429|B3||White|Race (NIH/OMB)||Participants|Count of Participants|343|343.0||||||
3716758|NCT02116530|3555430|B2||White|Race (NIH/OMB)||Participants|Count of Participants|171|171.0||||||
3716759|NCT02116530|3555431|B1||White|Race (NIH/OMB)||Participants|Count of Participants|172|172.0||||||
3716760|NCT02116530|3555429|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3716761|NCT02116530|3555430|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3716762|NCT02116530|3555431|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3716763|NCT02116530|3555429|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716764|NCT02116530|3555430|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716765|NCT02116530|3555431|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716766|NCT02116530|3555429|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3716767|NCT02116530|3555430|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3716768|NCT02116530|3555431|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3716769|NCT02116530|3555429|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3716770|NCT02116530|3555430|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3716771|NCT02116530|3555431|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3716772|NCT02116530|3555429|B3||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3716773|NCT02116530|3555430|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3716774|NCT02116530|3555431|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3716775|NCT02116530|3555429|B3||Female|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
3716776|NCT02116530|3555430|B2||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3716777|NCT02116530|3555431|B1||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3716778|NCT02116530|3555429|B3|||Age||years|Median|57|57.0|Full Range|||28.0|89.0|
3716779|NCT02116530|3555430|B2|||Age||years|Median|56|56.0|Full Range|||28.0|89.0|
3716780|NCT02116530|3555431|B1|||Age||years|Median|58|58.0|Full Range|||29.0|86.0|
3716781|NCT02116361|3555446|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3716782|NCT02116361|3555447|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3716783|NCT02116361|3555448|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3716784|NCT02116361|3555449|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3716785|NCT02116361|3555450|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3716786|NCT02116361|3555446|B5||Female|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
3716787|NCT02116361|3555447|B4||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3716788|NCT02116361|3555448|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3716789|NCT02116361|3555449|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3716790|NCT02116361|3555450|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3716791|NCT02116361|3555446|B5|≥ 40 years||Age, Customized||Participants|Number|161|161.0||||||
3716792|NCT02116361|3555447|B4|≥ 40 years||Age, Customized||Participants|Number|39|39.0||||||
3716793|NCT02116361|3555448|B3|≥ 40 years||Age, Customized||Participants|Number|37|37.0||||||
3716794|NCT02116361|3555449|B2|≥ 40 years||Age, Customized||Participants|Number|44|44.0||||||
3716795|NCT02116361|3555450|B1|≥ 40 years||Age, Customized||Participants|Number|41|41.0||||||
3716796|NCT02116361|3555446|B5|<40 years||Age, Customized||Participants|Number|94|94.0||||||
3716797|NCT02116361|3555447|B4|<40 years||Age, Customized||Participants|Number|26|26.0||||||
3716798|NCT02116361|3555448|B3|<40 years||Age, Customized||Participants|Number|21|21.0||||||
3716799|NCT02116361|3555449|B2|<40 years||Age, Customized||Participants|Number|21|21.0||||||
3716800|NCT02116361|3555450|B1|<40 years||Age, Customized||Participants|Number|26|26.0||||||
3716801|NCT02116322|3555483|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3716802|NCT02116322|3555483|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3716803|NCT02116322|3555483|B1|||Age||years|Mean|80|80.0|Full Range|||||
3716804|NCT02116322|3555483|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3716805|NCT02116322|3555483|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3716806|NCT02116322|3555483|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3716807|NCT02116309|3555488|B3||Male|Sex: Female, Male||Participants|Count of Participants|408|408.0||||||
3716808|NCT02116309|3555489|B2||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3716809|NCT02116309|3555490|B1||Male|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
3716810|NCT02116309|3555488|B3||Female|Sex: Female, Male||Participants|Count of Participants|551|551.0||||||
3716811|NCT02116309|3555489|B2||Female|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
3716812|NCT02116309|3555490|B1||Female|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
3716813|NCT02116309|3555488|B3|||Age||years|Mean|52.3|52.3|Standard Deviation|14.9|14.9|||
3716814|NCT02116309|3555489|B2|||Age||years|Mean|52.5|52.5|Standard Deviation|15.6|15.6|||
3716815|NCT02116309|3555490|B1|||Age||years|Mean|52.1|52.1|Standard Deviation|14.3|14.3|||
3716816|NCT02115984|3555499|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3716817|NCT02115984|3555500|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3716818|NCT02115984|3555501|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3716819|NCT02115984|3555499|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3716820|NCT02115984|3555500|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3716821|NCT02115984|3555501|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3716822|NCT02115984|3555499|B3|||Age||years|Mean|52|52.0|Standard Deviation|7|7.0|||
3716823|NCT02115984|3555500|B2|||Age||years|Mean|53|53.0|Standard Deviation|8|8.0|||
3716824|NCT02115984|3555501|B1|||Age||years|Mean|52|52.0|Standard Deviation|7|7.0|||
3716825|NCT02115828|3555508|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3716826|NCT02115828|3555508|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3716827|NCT02115828|3555508|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3716828|NCT02115828|3555508|B1|||Age||years|Median|65|65.0|Full Range|||58.0|79.0|
3716829|NCT02115828|3555508|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3716830|NCT02115828|3555508|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3716831|NCT02115828|3555508|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3716832|NCT02115815|3555516|B8||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3716833|NCT02115815|3555517|B7||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3716834|NCT02115815|3555518|B6||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3716835|NCT02115815|3555519|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3716836|NCT02115815|3555520|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3716837|NCT02115815|3555521|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3716838|NCT02115815|3555522|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3716839|NCT02115815|3555523|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3716840|NCT02115815|3555516|B8||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3716841|NCT02115815|3555517|B7||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3716842|NCT02115815|3555518|B6||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3716843|NCT02115815|3555519|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3716844|NCT02115815|3555520|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3716845|NCT02115815|3555521|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3716846|NCT02115815|3555522|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3716847|NCT02115815|3555523|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3716848|NCT02115815|3555516|B8|||Age||Years|Mean|68.7|68.7|Standard Deviation|6.4|6.4|||
3716849|NCT02115815|3555517|B7|||Age||Years|Mean|69.4|69.4|Standard Deviation|7.0|7.0|||
3716850|NCT02115815|3555518|B6|||Age||Years|Mean|70.0|70.0|Standard Deviation|7.0|7.0|||
3716851|NCT02115815|3555519|B5|||Age||Years|Mean|70.5|70.5|Standard Deviation|6.1|6.1|||
3716852|NCT02115815|3555520|B4|||Age||Years|Mean|69.3|69.3|Standard Deviation|5.6|5.6|||
3716853|NCT02115815|3555521|B3|||Age||Years|Mean|66.6|66.6|Standard Deviation|4.1|4.1|||
3716854|NCT02115815|3555522|B2|||Age||Years|Mean|66.5|66.5|Standard Deviation|6.0|6.0|||
3716855|NCT02115815|3555523|B1|||Age||Years|Mean|68.6|68.6|Standard Deviation|7.6|7.6|||
3716856|NCT02115646|3555622|B1|||POSAS|The Patient and Observer Scar Assessment Scale (POSAS) is a validated scale that measures both the patient assessment and the observer assessment on the quality (height, color, stiffness, thickness, symptoms, relief, surface area) of the scar. Scores range from 0-60, with 60 being the worst quality of scar.|units on a scale|Mean|27.2|27.2|Standard Deviation|1.8|1.8|||
3716857|NCT02115646|3555622|B1|||Quality of Life|The 36-Item Short Form Survey (SF-36) is a validated quality of life measurement tool. It measures 8 health concepts: physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perceptions. It also includes a single item that provides an indication of perceived change in health. It is scored on a 0-100 scale, with 100 being the least bothersome to quality of life.|units on a scale|Mean|91.25|91.25|Standard Deviation|8.56|8.56|||
3716858|NCT02115646|3555622|B1|||Scar thickness|This is an ultrasound measurement using the Dermascan Cyberderm to measure the thickness of the scar at baseline in millimeters.|mm|Mean|3.28|3.28|Standard Deviation|1.21|1.21|||
3716859|NCT02115646|3555622|B1|||Scar elasticity|This is the measure of the elasticity of the scar using a Torque-meter. It is measured on a 0-1 unit scale, with 0 being normal skin elasticity and 1 being completely inelastic.|units on a scale|Mean|0.65|0.65|Standard Deviation|0.12|0.12|||
3716860|NCT02115646|3555622|B1|||Scar pigmentation|This is a measurement of the pigmentation of the scar using a colorimeter device. The scale is rated using a range of 0-100 units, with 100 being the deepest hyperpigmentation, and 0 being no hyperpigmentation.|units on a scale|Mean|50.93|50.93|Full Range|||13.0|88.0|
3716861|NCT02115646|3555622|B1|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3716862|NCT02115646|3555622|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716863|NCT02115646|3555622|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716864|NCT02115646|3555622|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3716865|NCT02115646|3555622|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3716866|NCT02115646|3555622|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716867|NCT02115646|3555622|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3716868|NCT02115646|3555622|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3716869|NCT02115646|3555622|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3716870|NCT02115646|3555622|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3716871|NCT02115646|3555622|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3716872|NCT02115646|3555622|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3716873|NCT02115646|3555622|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3716874|NCT02115646|3555622|B1|||Age||years|Mean|28|28.0|Standard Deviation|16.8|16.8|||
3716875|NCT02115646|3555622|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3716876|NCT02115646|3555622|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3716877|NCT02115646|3555622|B1||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
3716878|NCT02115633|3555635|B3|||Functional Gait Assessment (FGA) Score|The FGA is a reliable and valid measure of gait function related to postural stability and has been shown to be effective in classifying fall risk in older adults and predicting unexplained falls in community-dwelling older adults. The FGA includes a 10-item scale where each item is scored from 0 to 3 (3 = normal, 2 = mild impairment, 1 = moderate impairment, 0 = severe impairment). The maximum score is 30; the minimum score is 0. Higher scores represent a better outcome. An increase >4 is considered the MCID for community-dwelling elderly individuals (Beninato et al. 2014).|units on a scale|Mean|15.2|15.2|Standard Deviation|4.9|4.9|||
3716879|NCT02115633|3555636|B2|||Functional Gait Assessment (FGA) Score|The FGA is a reliable and valid measure of gait function related to postural stability and has been shown to be effective in classifying fall risk in older adults and predicting unexplained falls in community-dwelling older adults. The FGA includes a 10-item scale where each item is scored from 0 to 3 (3 = normal, 2 = mild impairment, 1 = moderate impairment, 0 = severe impairment). The maximum score is 30; the minimum score is 0. Higher scores represent a better outcome. An increase >4 is considered the MCID for community-dwelling elderly individuals (Beninato et al. 2014).|units on a scale|Mean|15.4|15.4|Standard Deviation|5.2|5.2|||
3716880|NCT02115633|3555637|B1|||Functional Gait Assessment (FGA) Score|The FGA is a reliable and valid measure of gait function related to postural stability and has been shown to be effective in classifying fall risk in older adults and predicting unexplained falls in community-dwelling older adults. The FGA includes a 10-item scale where each item is scored from 0 to 3 (3 = normal, 2 = mild impairment, 1 = moderate impairment, 0 = severe impairment). The maximum score is 30; the minimum score is 0. Higher scores represent a better outcome. An increase >4 is considered the MCID for community-dwelling elderly individuals (Beninato et al. 2014).|units on a scale|Mean|15.0|15.0|Standard Deviation|4.5|4.5|||
3716881|NCT02115633|3555635|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
3716882|NCT02115633|3555636|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3716883|NCT02115633|3555637|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3716884|NCT02115633|3555635|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3716885|NCT02115633|3555635|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3716886|NCT02115633|3555636|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3716887|NCT02115633|3555637|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3716888|NCT02115633|3555635|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3716889|NCT02115633|3555636|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3716890|NCT02115633|3555637|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3716891|NCT02115633|3555635|B3|||Age||years|Mean|71.6|71.6|Standard Deviation|6.65|6.65|||
3716892|NCT02115633|3555636|B2|||Age||years|Mean|71.6|71.6|Standard Deviation|6.2|6.2|||
3716893|NCT02115633|3555637|B1|||Age||years|Mean|71.6|71.6|Standard Deviation|7.1|7.1|||
3716894|NCT02115581|3555650|B3|Iran, Islamic Republic of||Region of Enrollment||participants|Number|38|38.0||||||
3716895|NCT02115581|3555651|B2|Iran, Islamic Republic of||Region of Enrollment||participants|Number|21|21.0||||||
3716896|NCT02115581|3555652|B1|Iran, Islamic Republic of||Region of Enrollment||participants|Number|17|17.0||||||
3716897|NCT02115581|3555650|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3716898|NCT02115581|3555651|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3716899|NCT02115581|3555652|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3716900|NCT02115581|3555650|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3716901|NCT02115581|3555651|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3716902|NCT02115581|3555652|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3716903|NCT02115581|3555650|B3|||Age||years|Mean|6.9|6.9|Standard Deviation|5.5|5.5|||
3716904|NCT02115581|3555651|B2|||Age||years|Mean|7.3|7.3|Standard Deviation|5.2|5.2|||
3716905|NCT02115581|3555652|B1|||Age||years|Mean|6.3|6.3|Standard Deviation|4.5|4.5|||
3716906|NCT02115347|3555663|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3716907|NCT02115347|3555664|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3716908|NCT02115347|3555665|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3716909|NCT02115347|3555663|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3716910|NCT02115347|3555664|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3716911|NCT02115347|3555665|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3716912|NCT02115347|3555663|B3|||Age||Years|Mean|55.3|55.3|Full Range|||49.0|60.0|
3716913|NCT02115347|3555664|B2|||Age||Years|Mean|55.5|55.5|Full Range|3.0|3.0|51.0|59.0|
3716914|NCT02115347|3555665|B1|||Age||Years|Mean|55.1|55.1|Full Range|3.4|3.4|49.0|60.0|
3716915|NCT02115321|3555685|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3716916|NCT02115321|3555686|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3716917|NCT02115321|3555687|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3716918|NCT02115321|3555685|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3716919|NCT02115321|3555686|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3716920|NCT02115321|3555687|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3716921|NCT02115321|3555685|B3|||Age||Years|Mean|58.8|58.8|Standard Deviation|6.6|6.6|||
3716922|NCT02115321|3555686|B2|||Age||Years|Mean|60.4|60.4|Standard Deviation|5.3|5.3|||
3716923|NCT02115321|3555687|B1|||Age||Years|Mean|58.3|58.3|Standard Deviation|7.0|7.0|||
3716924|NCT02115308|3555708|B3|||BMI||kg/m^2|Mean|31|31.0|Standard Deviation|6|6.0|||
3716925|NCT02115308|3555709|B2|||BMI||kg/m^2|Mean|31|31.0|Standard Deviation|6|6.0|||
3716926|NCT02115308|3555710|B1|||BMI||kg/m^2|Mean|32|32.0|Standard Deviation|6|6.0|||
3716927|NCT02115308|3555708|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3716928|NCT02115308|3555708|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3716929|NCT02115308|3555709|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3716930|NCT02115308|3555710|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3716931|NCT02115308|3555708|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3716932|NCT02115308|3555709|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3716933|NCT02115308|3555710|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3716934|NCT02115308|3555708|B3|||Age||years|Mean|66|66.0|Standard Deviation|12|12.0|||
3716935|NCT02115308|3555709|B2|||Age||years|Mean|72|72.0|Standard Deviation|9|9.0|||
3716936|NCT02115308|3555710|B1|||Age||years|Mean|55|55.0|Standard Deviation|10|10.0|||
3716937|NCT02115269|3555727|B1|Kazakhstan||Region of Enrollment||Participants|Count of Participants|270|270.0||||||
3716938|NCT02115269|3555727|B1|Ukraine||Region of Enrollment||Participants|Count of Participants|432|432.0||||||
3716939|NCT02115269|3555727|B1||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3716940|NCT02115269|3555727|B1||Female|Sex: Female, Male||Participants|Count of Participants|542|542.0||||||
3716941|NCT02115269|3555727|B1|||Age||years|Mean|39.6|39.6|Standard Deviation|11.0|11.0|||
3716942|NCT02115256|3555745|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3716943|NCT02115256|3555746|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3716944|NCT02115256|3555747|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3716945|NCT02115256|3555745|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3716946|NCT02115256|3555746|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3716947|NCT02115256|3555747|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3716948|NCT02115256|3555745|B3|||Age||years|Mean|34|34.0|Standard Deviation|3|3.0|||
3716949|NCT02115256|3555746|B2|||Age||years|Mean|36|36.0|Standard Deviation|2|2.0|||
3716950|NCT02115256|3555747|B1|||Age||years|Mean|32|32.0|Standard Deviation|1|1.0|||
3716951|NCT02114931|3555760|B3|Latin America||Geographic Region||participants|Number|0|0.0||||||
3716952|NCT02114931|3555761|B2|Latin America||Geographic Region||participants|Number|0|0.0||||||
3716953|NCT02114931|3555762|B1|Latin America||Geographic Region||participants|Number|0|0.0||||||
3716954|NCT02114931|3555760|B3|North America||Geographic Region||participants|Number|127|127.0||||||
3716955|NCT02114931|3555761|B2|North America||Geographic Region||participants|Number|62|62.0||||||
3716956|NCT02114931|3555762|B1|North America||Geographic Region||participants|Number|65|65.0||||||
3716957|NCT02114931|3555760|B3|Western Europe||Geographic Region||participants|Number|31|31.0||||||
3716958|NCT02114931|3555761|B2|Western Europe||Geographic Region||participants|Number|19|19.0||||||
3716959|NCT02114931|3555762|B1|Western Europe||Geographic Region||participants|Number|12|12.0||||||
3716960|NCT02114931|3555760|B3|Eastern Europe||Geographic Region||participants|Number|309|309.0||||||
3716961|NCT02114931|3555761|B2|Eastern Europe||Geographic Region||participants|Number|156|156.0||||||
3716962|NCT02114931|3555762|B1|Eastern Europe||Geographic Region||participants|Number|153|153.0||||||
3716963|NCT02114931|3555760|B3|Not Allowed to Collect||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3716964|NCT02114931|3555761|B2|Not Allowed to Collect||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3716965|NCT02114931|3555762|B1|Not Allowed to Collect||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3716966|NCT02114931|3555760|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|419|419.0||||||
3716967|NCT02114931|3555761|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|217|217.0||||||
3716968|NCT02114931|3555762|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|202|202.0||||||
3716969|NCT02114931|3555760|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
3716970|NCT02114931|3555761|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3716971|NCT02114931|3555762|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
3716972|NCT02114931|3555760|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3716973|NCT02114931|3555761|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3716974|NCT02114931|3555762|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3716975|NCT02114931|3555760|B3|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3716976|NCT02114931|3555761|B2|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3716977|NCT02114931|3555762|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3716978|NCT02114931|3555760|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3716979|NCT02114931|3555761|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3716980|NCT02114931|3555762|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3716981|NCT02114931|3555760|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3716982|NCT02114931|3555761|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3716983|NCT02114931|3555762|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3716984|NCT02114931|3555760|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3716985|NCT02114931|3555761|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3716986|NCT02114931|3555762|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3716987|NCT02114931|3555760|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3716988|NCT02114931|3555761|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3716989|NCT02114931|3555762|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3716990|NCT02114931|3555760|B3|White||Race/Ethnicity, Customized||participants|Number|442|442.0||||||
3716991|NCT02114931|3555761|B2|White||Race/Ethnicity, Customized||participants|Number|224|224.0||||||
3716992|NCT02114931|3555762|B1|White||Race/Ethnicity, Customized||participants|Number|218|218.0||||||
3716993|NCT02114931|3555760|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3716994|NCT02114931|3555761|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3716995|NCT02114931|3555762|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3716996|NCT02114931|3555760|B3||Female|Sex: Female, Male||Participants|Count of Participants|379|379.0||||||
3716997|NCT02114931|3555761|B2||Female|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
3716998|NCT02114931|3555762|B1||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3716999|NCT02114931|3555760|B3|≥ 65 years||Age, Customized|Age at baseline of parent study|participants|Number|103|103.0||||||
3717000|NCT02114931|3555761|B2|≥ 65 years||Age, Customized|Age at baseline of parent study|participants|Number|56|56.0||||||
3717001|NCT02114931|3555762|B1|≥ 65 years||Age, Customized|Age at baseline of parent study|participants|Number|47|47.0||||||
3717002|NCT02114931|3555760|B3|Between 18 and 65 years||Age, Customized|Age at baseline of parent study|participants|Number|364|364.0||||||
3717003|NCT02114931|3555761|B2|Between 18 and 65 years||Age, Customized|Age at baseline of parent study|participants|Number|181|181.0||||||
3717004|NCT02114931|3555762|B1|Between 18 and 65 years||Age, Customized|Age at baseline of parent study|participants|Number|183|183.0||||||
3717005|NCT02114931|3555760|B3|||Age|Age at baseline of parent study|years|Mean|55.4|55.4|Standard Deviation|11.56|11.56|||
3717006|NCT02114931|3555761|B2|||Age|Age at baseline of parent study|years|Mean|56.1|56.1|Standard Deviation|11.40|11.4|||
3717007|NCT02114931|3555762|B1|||Age|Age at baseline of parent study|years|Mean|54.7|54.7|Standard Deviation|11.71|11.71|||
3717008|NCT02114892|3555777|B3|||Insulin sensitivity|Insulin sensitivity was calculated with Matsuda index [10,000 / √glucose 0’ x insulin 0’) (mean glucose oral glucose tolerance test (OGTT) x mean insulin OGTT)]|unitless|Mean|3.4|3.4|Standard Deviation|1.4|1.4|||
3717009|NCT02114892|3555778|B2|||Insulin sensitivity|Insulin sensitivity was calculated with Matsuda index [10,000 / √glucose 0’ x insulin 0’) (mean glucose oral glucose tolerance test (OGTT) x mean insulin OGTT)]|unitless|Mean|3.3|3.3|Standard Deviation|1.5|1.5|||
3717010|NCT02114892|3555779|B1|||Insulin sensitivity|Insulin sensitivity was calculated with Matsuda index [10,000 / √glucose 0’ x insulin 0’) (mean glucose oral glucose tolerance test (OGTT) x mean insulin OGTT)]|unitless|Mean|3.5|3.5|Standard Deviation|1.5|1.5|||
3717011|NCT02114892|3555777|B3|||First phase of insulin secretion|First phase of insulin secretion was estimated using the Stumvoll index (1283+ 1.829 x insulin 30’ – 138.7 x glucose 30’ + 3.772 x insulin 0’)|unitless|Mean|1348.3|1348.3|Standard Deviation|604.6|604.6|||
3717012|NCT02114892|3555778|B2|||First phase of insulin secretion|First phase of insulin secretion was estimated using the Stumvoll index (1283+ 1.829 x insulin 30’ – 138.7 x glucose 30’ + 3.772 x insulin 0’)|unitless|Mean|1440.0|1440.0|Standard Deviation|619.8|619.8|||
3717081|NCT02114892|3555778|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3717082|NCT02114892|3555779|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3717013|NCT02114892|3555779|B1|||First phase of insulin secretion|First phase of insulin secretion was estimated using the Stumvoll index (1283+ 1.829 x insulin 30’ – 138.7 x glucose 30’ + 3.772 x insulin 0’)|unitless|Mean|1256.6|1256.6|Standard Deviation|601.5|601.5|||
3717014|NCT02114892|3555777|B3|||Total insulin secretion|Total insulin secretion was calculated with the insulinogenic index (ΔABC insulin / ΔABC glucose).|unitless|Mean|0.54|0.54|Standard Deviation|0.26|0.26|||
3717015|NCT02114892|3555778|B2|||Total insulin secretion|Total insulin secretion was calculated with the insulinogenic index (ΔABC insulin / ΔABC glucose).|unitless|Mean|0.59|0.59|Standard Deviation|0.29|0.29|||
3717016|NCT02114892|3555779|B1|||Total insulin secretion|Total insulin secretion was calculated with the insulinogenic index (ΔABC insulin / ΔABC glucose).|unitless|Mean|0.48|0.48|Standard Deviation|0.22|0.22|||
3717017|NCT02114892|3555777|B3|||AUC insuline|Area under the curve (AUC) of glucose and insulin was calculated with the polygonal formula.|pmol*h/L|Mean|55687.1|55687.1|Standard Deviation|31282.6|31282.6|||
3717018|NCT02114892|3555778|B2|||AUC insuline|Area under the curve (AUC) of glucose and insulin was calculated with the polygonal formula.|pmol*h/L|Mean|62955.8|62955.8|Standard Deviation|37620.0|37620.0|||
3717019|NCT02114892|3555779|B1|||AUC insuline|Area under the curve (AUC) of glucose and insulin was calculated with the polygonal formula.|pmol*h/L|Mean|48418.5|48418.5|Standard Deviation|22707.4|22707.4|||
3717020|NCT02114892|3555777|B3|||AUC glucose|Area under the curve (AUC) of glucose and insulin was calculated with the polygonal formula.|mmol*h/L|Mean|943.3|943.3|Standard Deviation|174.6|174.6|||
3717021|NCT02114892|3555778|B2|||AUC glucose|Area under the curve (AUC) of glucose and insulin was calculated with the polygonal formula.|mmol*h/L|Mean|950.8|950.8|Standard Deviation|167.6|167.6|||
3717022|NCT02114892|3555779|B1|||AUC glucose|Area under the curve (AUC) of glucose and insulin was calculated with the polygonal formula.|mmol*h/L|Mean|935.8|935.8|Standard Deviation|188.6|188.6|||
3717023|NCT02114892|3555777|B3|||LDL-c|The blood samples were taken after the insertion of a catheter as an open path to facilitate the procedure. Blood was centrifuged at 2000 rpm and serum was separated into two aliquots: the first was immediately analyzed to determine glucose, lipid profile, hepatic enzymes, creatinine and uric acid.|mg/dL|Mean|120.2|120.2|Standard Deviation|39.0|39.0|||
3717024|NCT02114892|3555778|B2|||LDL-c|The blood samples were taken after the insertion of a catheter as an open path to facilitate the procedure. Blood was centrifuged at 2000 rpm and serum was separated into two aliquots: the first was immediately analyzed to determine glucose, lipid profile, hepatic enzymes, creatinine and uric acid.|mg/dL|Mean|119.8|119.8|Standard Deviation|46.5|46.5|||
3717025|NCT02114892|3555779|B1|||LDL-c|The blood samples were taken after the insertion of a catheter as an open path to facilitate the procedure. Blood was centrifuged at 2000 rpm and serum was separated into two aliquots: the first was immediately analyzed to determine glucose, lipid profile, hepatic enzymes, creatinine and uric acid.|mg/dL|Mean|120.7|120.7|Standard Deviation|32.0|32.0|||
3717026|NCT02114892|3555777|B3|||HDL-c|The blood samples were taken after the insertion of a catheter as an open path to facilitate the procedure. Blood was centrifuged at 2000 rpm and serum was separated into two aliquots: the first was immediately analyzed to determine glucose, lipid profile, hepatic enzymes, creatinine and uric acid.|mg/dL|Mean|37.6|37.6|Standard Deviation|5.9|5.9|||
3717027|NCT02114892|3555778|B2|||HDL-c|The blood samples were taken after the insertion of a catheter as an open path to facilitate the procedure. Blood was centrifuged at 2000 rpm and serum was separated into two aliquots: the first was immediately analyzed to determine glucose, lipid profile, hepatic enzymes, creatinine and uric acid.|mg/dL|Mean|37.9|37.9|Standard Deviation|7.7|7.7|||
3717028|NCT02114892|3555779|B1|||HDL-c|The blood samples were taken after the insertion of a catheter as an open path to facilitate the procedure. Blood was centrifuged at 2000 rpm and serum was separated into two aliquots: the first was immediately analyzed to determine glucose, lipid profile, hepatic enzymes, creatinine and uric acid.|mg/dL|Mean|37.3|37.3|Standard Deviation|3.7|3.7|||
3717029|NCT02114892|3555777|B3|||Triglycerides|The blood samples were taken after the insertion of a catheter as an open path to facilitate the procedure. Blood was centrifuged at 2000 rpm and serum was separated into two aliquots: the first was immediately analyzed to determine glucose, lipid profile, hepatic enzymes, creatinine and uric acid.|mg/dL|Mean|244.0|244.0|Standard Deviation|66.9|66.9|||
3717030|NCT02114892|3555778|B2|||Triglycerides|The blood samples were taken after the insertion of a catheter as an open path to facilitate the procedure. Blood was centrifuged at 2000 rpm and serum was separated into two aliquots: the first was immediately analyzed to determine glucose, lipid profile, hepatic enzymes, creatinine and uric acid.|mg/dL|Mean|233.8|233.8|Standard Deviation|77.7|77.7|||
3717031|NCT02114892|3555779|B1|||Triglycerides|The blood samples were taken after the insertion of a catheter as an open path to facilitate the procedure. Blood was centrifuged at 2000 rpm and serum was separated into two aliquots: the first was immediately analyzed to determine glucose, lipid profile, hepatic enzymes, creatinine and uric acid.|mg/dL|Mean|254.3|254.3|Standard Deviation|55.6|55.6|||
3717032|NCT02114892|3555777|B3|||Cholesterol|The blood samples were taken after the insertion of a catheter as an open path to facilitate the procedure. Blood was centrifuged at 2000 rpm and serum was separated into two aliquots: the first was immediately analyzed to determine glucose, lipid profile, hepatic enzymes, creatinine and uric acid.|mg/dL|Mean|200.7|200.7|Standard Deviation|33.1|33.1|||
3717033|NCT02114892|3555778|B2|||Cholesterol|The blood samples were taken after the insertion of a catheter as an open path to facilitate the procedure. Blood was centrifuged at 2000 rpm and serum was separated into two aliquots: the first was immediately analyzed to determine glucose, lipid profile, hepatic enzymes, creatinine and uric acid.|mg/dL|Mean|195.4|195.4|Standard Deviation|34.8|34.8|||
3717034|NCT02114892|3555779|B1|||Cholesterol|The blood samples were taken after the insertion of a catheter as an open path to facilitate the procedure. Blood was centrifuged at 2000 rpm and serum was separated into two aliquots: the first was immediately analyzed to determine glucose, lipid profile, hepatic enzymes, creatinine and uric acid.|mg/dL|Mean|206.0|206.0|Standard Deviation|32.0|32.0|||
3717083|NCT02114892|3555777|B3||Male|Gender||Participants|Count of Participants|7|7.0||||||
3717084|NCT02114892|3555778|B2||Male|Gender||Participants|Count of Participants|5|5.0||||||
3717085|NCT02114892|3555779|B1||Male|Gender||Participants|Count of Participants|2|2.0||||||
3717086|NCT02114892|3555777|B3||Female|Gender||Participants|Count of Participants|17|17.0||||||
3717035|NCT02114892|3555777|B3|||Glucose 120'|The blood samples were taken after the insertion of a catheter as an open path to facilitate the procedure. Blood samples were taken at the basal and at the minutes 30, 60, 90 and 120 after a 75 g oral dextrose load. Blood was centrifuged at 2000 rpm and serum was separated into two aliquots: the first was immediately analyzed to determine glucose, lipid profile, hepatic enzymes, creatinine and uric acid.|mmol/l|Mean|6.7|6.7|Standard Deviation|1.9|1.9|||
3717036|NCT02114892|3555778|B2|||Glucose 120'|The blood samples were taken after the insertion of a catheter as an open path to facilitate the procedure. Blood samples were taken at the basal and at the minutes 30, 60, 90 and 120 after a 75 g oral dextrose load. Blood was centrifuged at 2000 rpm and serum was separated into two aliquots: the first was immediately analyzed to determine glucose, lipid profile, hepatic enzymes, creatinine and uric acid.|mmol/l|Mean|6.9|6.9|Standard Deviation|2.2|2.2|||
3717037|NCT02114892|3555779|B1|||Glucose 120'|The blood samples were taken after the insertion of a catheter as an open path to facilitate the procedure. Blood samples were taken at the basal and at the minutes 30, 60, 90 and 120 after a 75 g oral dextrose load. Blood was centrifuged at 2000 rpm and serum was separated into two aliquots: the first was immediately analyzed to determine glucose, lipid profile, hepatic enzymes, creatinine and uric acid.|mmol/l|Mean|6.5|6.5|Standard Deviation|1.7|1.7|||
3717038|NCT02114892|3555777|B3|||Glucose 90'|The blood samples were taken after the insertion of a catheter as an open path to facilitate the procedure. Blood samples were taken at the basal and at the minutes 30, 60, 90 and 120 after a 75 g oral dextrose load. Blood was centrifuged at 2000 rpm and serum was separated into two aliquots: the first was immediately analyzed to determine glucose, lipid profile, hepatic enzymes, creatinine and uric acid.|mmol/l|Mean|8.2|8.2|Standard Deviation|2.0|2.0|||
3717039|NCT02114892|3555778|B2|||Glucose 90'|The blood samples were taken after the insertion of a catheter as an open path to facilitate the procedure. Blood samples were taken at the basal and at the minutes 30, 60, 90 and 120 after a 75 g oral dextrose load. Blood was centrifuged at 2000 rpm and serum was separated into two aliquots: the first was immediately analyzed to determine glucose, lipid profile, hepatic enzymes, creatinine and uric acid.|mmol/l|Mean|8.0|8.0|Standard Deviation|1.8|1.8|||
3717040|NCT02114892|3555779|B1|||Glucose 90'|The blood samples were taken after the insertion of a catheter as an open path to facilitate the procedure. Blood samples were taken at the basal and at the minutes 30, 60, 90 and 120 after a 75 g oral dextrose load. Blood was centrifuged at 2000 rpm and serum was separated into two aliquots: the first was immediately analyzed to determine glucose, lipid profile, hepatic enzymes, creatinine and uric acid.|mmol/l|Mean|8.3|8.3|Standard Deviation|2.3|2.3|||
3717041|NCT02114892|3555777|B3|||Glucose 60'|The blood samples were taken after the insertion of a catheter as an open path to facilitate the procedure. Blood samples were taken at the basal and at the minutes 30, 60, 90 and 120 after a 75 g oral dextrose load. Blood was centrifuged at 2000 rpm and serum was separated into two aliquots: the first was immediately analyzed to determine glucose, lipid profile, hepatic enzymes, creatinine and uric acid.|mmol/l|Mean|9.1|9.1|Standard Deviation|2.2|2.2|||
3717042|NCT02114892|3555778|B2|||Glucose 60'|The blood samples were taken after the insertion of a catheter as an open path to facilitate the procedure. Blood samples were taken at the basal and at the minutes 30, 60, 90 and 120 after a 75 g oral dextrose load. Blood was centrifuged at 2000 rpm and serum was separated into two aliquots: the first was immediately analyzed to determine glucose, lipid profile, hepatic enzymes, creatinine and uric acid.|mmol/l|Mean|9.3|9.3|Standard Deviation|1.8|1.8|||
3717043|NCT02114892|3555779|B1|||Glucose 60'|The blood samples were taken after the insertion of a catheter as an open path to facilitate the procedure. Blood samples were taken at the basal and at the minutes 30, 60, 90 and 120 after a 75 g oral dextrose load. Blood was centrifuged at 2000 rpm and serum was separated into two aliquots: the first was immediately analyzed to determine glucose, lipid profile, hepatic enzymes, creatinine and uric acid.|mmol/l|Mean|9.0|9.0|Standard Deviation|2.7|2.7|||
3717044|NCT02114892|3555777|B3|||Glucose 30'|The blood samples were taken after the insertion of a catheter as an open path to facilitate the procedure. Blood samples were taken at the basal and at the minutes 30, 60, 90 and 120 after a 75 g oral dextrose load. Blood was centrifuged at 2000 rpm and serum was separated into two aliquots: the first was immediately analyzed to determine glucose, lipid profile, hepatic enzymes, creatinine and uric acid.|mmol/l|Mean|8.4|8.4|Standard Deviation|1.4|1.4|||
3717045|NCT02114892|3555778|B2|||Glucose 30'|The blood samples were taken after the insertion of a catheter as an open path to facilitate the procedure. Blood samples were taken at the basal and at the minutes 30, 60, 90 and 120 after a 75 g oral dextrose load. Blood was centrifuged at 2000 rpm and serum was separated into two aliquots: the first was immediately analyzed to determine glucose, lipid profile, hepatic enzymes, creatinine and uric acid.|mmol/l|Mean|8.4|8.4|Standard Deviation|1.1|1.1|||
3717046|NCT02114892|3555779|B1|||Glucose 30'|The blood samples were taken after the insertion of a catheter as an open path to facilitate the procedure. Blood samples were taken at the basal and at the minutes 30, 60, 90 and 120 after a 75 g oral dextrose load. Blood was centrifuged at 2000 rpm and serum was separated into two aliquots: the first was immediately analyzed to determine glucose, lipid profile, hepatic enzymes, creatinine and uric acid.|mmol/l|Mean|8.5|8.5|Standard Deviation|1.8|1.8|||
3717047|NCT02114892|3555777|B3|||Glucose 0'|The blood samples were taken after the insertion of a catheter as an open path to facilitate the procedure. Blood samples were taken at the basal and at the minutes 30, 60, 90 and 120 after a 75 g oral dextrose load. Blood was centrifuged at 2500 rpm and serum was separated into two aliquots: the first was immediately analyzed to determine glucose, lipid profile, hepatic enzymes, creatinine and uric acid.|mmol/l|Mean|4.95|4.95|Standard Deviation|0.5|0.5|||
3717048|NCT02114892|3555778|B2|||Glucose 0'|The blood samples were taken after the insertion of a catheter as an open path to facilitate the procedure. Blood samples were taken at the basal and at the minutes 30, 60, 90 and 120 after a 75 g oral dextrose load. Blood was centrifuged at 2500 rpm and serum was separated into two aliquots: the first was immediately analyzed to determine glucose, lipid profile, hepatic enzymes, creatinine and uric acid.|mmol/l|Mean|5.1|5.1|Standard Deviation|0.4|0.4|||
3717087|NCT02114892|3555778|B2||Female|Gender||Participants|Count of Participants|7|7.0||||||
3717088|NCT02114892|3555779|B1||Female|Gender||Participants|Count of Participants|10|10.0||||||
3717089|NCT02114892|3555777|B3|||Age||years|Mean|40.04|40.04|Standard Deviation|5.29|5.29|||
3717090|NCT02114892|3555778|B2|||Age||years|Mean|40.33|40.33|Standard Deviation|5.41|5.41|||
3717049|NCT02114892|3555779|B1|||Glucose 0'|The blood samples were taken after the insertion of a catheter as an open path to facilitate the procedure. Blood samples were taken at the basal and at the minutes 30, 60, 90 and 120 after a 75 g oral dextrose load. Blood was centrifuged at 2500 rpm and serum was separated into two aliquots: the first was immediately analyzed to determine glucose, lipid profile, hepatic enzymes, creatinine and uric acid.|mmol/l|Mean|4.8|4.8|Standard Deviation|0.6|0.6|||
3717050|NCT02114892|3555777|B3|||Diastolic blood pressure|Blood pressure was evaluated with a digital sphygmomanometer with the subject sited down on a chair after a resting period of 5 minutes on three occasions. The mean of the three measures was considered as the value of systolic blood pressure (SBP) and diastolic (DBP). The value was expressed on mmHg|mmHg|Mean|77.76|77.76|Standard Deviation|8.4|8.4|||
3717051|NCT02114892|3555778|B2|||Diastolic blood pressure|Blood pressure was evaluated with a digital sphygmomanometer with the subject sited down on a chair after a resting period of 5 minutes on three occasions. The mean of the three measures was considered as the value of systolic blood pressure (SBP) and diastolic (DBP). The value was expressed on mmHg|mmHg|Mean|77.15|77.15|Standard Deviation|8.4|8.4|||
3717052|NCT02114892|3555779|B1|||Diastolic blood pressure|Blood pressure was evaluated with a digital sphygmomanometer with the subject sited down on a chair after a resting period of 5 minutes on three occasions. The mean of the three measures was considered as the value of systolic blood pressure (SBP) and diastolic (DBP). The value was expressed on mmHg|mmHg|Mean|78.36|78.36|Standard Deviation|8.7|8.7|||
3717053|NCT02114892|3555777|B3|||Systolic blood pressure|Blood pressure was evaluated with a digital sphygmomanometer with the subject sited down on a chair after a resting period of 5 minutes on three occasions. The mean of the three measures was considered as the value of systolic blood pressure (SBP) and diastolic (DBP). The value was expressed on mmHg|mmHg|Mean|117.99|117.99|Standard Deviation|13.0|13.0|||
3717054|NCT02114892|3555778|B2|||Systolic blood pressure|Blood pressure was evaluated with a digital sphygmomanometer with the subject sited down on a chair after a resting period of 5 minutes on three occasions. The mean of the three measures was considered as the value of systolic blood pressure (SBP) and diastolic (DBP). The value was expressed on mmHg|mmHg|Mean|116.03|116.03|Standard Deviation|13.2|13.2|||
3717055|NCT02114892|3555779|B1|||Systolic blood pressure|Blood pressure was evaluated with a digital sphygmomanometer with the subject sited down on a chair after a resting period of 5 minutes on three occasions. The mean of the three measures was considered as the value of systolic blood pressure (SBP) and diastolic (DBP). The value was expressed on mmHg|mmHg|Mean|119.96|119.96|Standard Deviation|13.1|13.1|||
3717056|NCT02114892|3555777|B3|||Waist circumference|Waist circumference was measured with a flexible tape in the midpoint between the lowest rib and the iliac crest and is expressed in centimeters.|cm|Mean|107.17|107.17|Standard Deviation|9.1|9.1|||
3717057|NCT02114892|3555778|B2|||Waist circumference|Waist circumference was measured with a flexible tape in the midpoint between the lowest rib and the iliac crest and is expressed in centimeters.|cm|Mean|104.50|104.5|Standard Deviation|8.5|8.5|||
3717058|NCT02114892|3555779|B1|||Waist circumference|Waist circumference was measured with a flexible tape in the midpoint between the lowest rib and the iliac crest and is expressed in centimeters.|cm|Mean|109.83|109.83|Standard Deviation|9.3|9.3|||
3717059|NCT02114892|3555777|B3|||Fat Mass|Fat mass was evaluated through a bioimpedance digital scale and results are reported in kg with a decimal|kg|Mean|38.66|38.66|Standard Deviation|8.8|8.8|||
3717060|NCT02114892|3555778|B2|||Fat Mass|Fat mass was evaluated through a bioimpedance digital scale and results are reported in kg with a decimal|kg|Mean|36.13|36.13|Standard Deviation|9.2|9.2|||
3717061|NCT02114892|3555779|B1|||Fat Mass|Fat mass was evaluated through a bioimpedance digital scale and results are reported in kg with a decimal|kg|Mean|41.18|41.18|Standard Deviation|7.9|7.9|||
3717062|NCT02114892|3555777|B3|||Body mass index (BMI)||kg/m2|Mean|34.65|34.65|Standard Deviation|3.5|3.5|||
3717063|NCT02114892|3555778|B2|||Body mass index (BMI)||kg/m2|Mean|33.73|33.73|Standard Deviation|3.7|3.7|||
3717064|NCT02114892|3555779|B1|||Body mass index (BMI)||kg/m2|Mean|35.56|35.56|Standard Deviation|3.2|3.2|||
3717065|NCT02114892|3555777|B3|||Height|Height was measured with subjects standing and the measurements were round to the nearest centimeter.|cm|Mean|163.50|163.5|Standard Deviation|7.1|7.1|||
3717066|NCT02114892|3555778|B2|||Height|Height was measured with subjects standing and the measurements were round to the nearest centimeter.|cm|Mean|164.33|164.33|Standard Deviation|7.2|7.2|||
3717067|NCT02114892|3555779|B1|||Height|Height was measured with subjects standing and the measurements were round to the nearest centimeter.|cm|Mean|162.67|162.67|Standard Deviation|7.2|7.2|||
3717068|NCT02114892|3555777|B3|||Body weight|Body weight was evaluated through a bioimpedance digital scale and results are reported in kg with a decimal.|kg|Mean|92.71|92.71|Standard Deviation|11.90|11.9|||
3717069|NCT02114892|3555778|B2|||Body weight|Body weight was evaluated through a bioimpedance digital scale and results are reported in kg with a decimal.|kg|Mean|91.0|91.0|Standard Deviation|10.7|10.7|||
3717070|NCT02114892|3555779|B1|||Body weight|Body weight was evaluated through a bioimpedance digital scale and results are reported in kg with a decimal.|kg|Mean|94.4|94.4|Standard Deviation|13.2|13.2|||
3717071|NCT02114892|3555777|B3|Mexico||Region of Enrollment||participants|Number|24|24.0||||||
3717072|NCT02114892|3555778|B2|Mexico||Region of Enrollment||participants|Number|12|12.0||||||
3717073|NCT02114892|3555779|B1|Mexico||Region of Enrollment||participants|Number|12|12.0||||||
3717074|NCT02114892|3555777|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717075|NCT02114892|3555778|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717076|NCT02114892|3555779|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717077|NCT02114892|3555777|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717078|NCT02114892|3555778|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717079|NCT02114892|3555779|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717080|NCT02114892|3555777|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3717091|NCT02114892|3555779|B1|||Age||years|Mean|39.75|39.75|Standard Deviation|5.38|5.38|||
3717092|NCT02114697|3555814|B3|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3717093|NCT02114697|3555815|B2|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3717094|NCT02114697|3555816|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3717095|NCT02114697|3555814|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3717096|NCT02114697|3555814|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3717097|NCT02114697|3555815|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3717098|NCT02114697|3555816|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3717099|NCT02114697|3555814|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3717100|NCT02114697|3555815|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3717101|NCT02114697|3555816|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3717102|NCT02114697|3555814|B3|||Age||years|Mean|61.33|61.33|Standard Deviation|2.06|2.06|||
3717103|NCT02114697|3555815|B2|||Age||years|Mean|62.25|62.25|Standard Deviation|1.70|1.7|||
3717104|NCT02114697|3555816|B1|||Age||years|Mean|60.60|60.6|Standard Deviation|3.64|3.64|||
3717105|NCT02114697|3555814|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3717106|NCT02114697|3555815|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3717107|NCT02114697|3555816|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3717108|NCT02114697|3555814|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3717109|NCT02114697|3555815|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3717110|NCT02114697|3555816|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3717111|NCT02114697|3555814|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3717112|NCT02114697|3555815|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3717113|NCT02114697|3555816|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3717114|NCT02114385|3555823|B3||Male|Sex: Female, Male||Participants|Count of Participants|500|500.0||||||
3717115|NCT02114385|3555824|B2||Male|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
3717116|NCT02114385|3555825|B1||Male|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
3717117|NCT02114385|3555823|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3717118|NCT02114385|3555824|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3717119|NCT02114385|3555825|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3717120|NCT02114385|3555823|B3|>=18 years old||Age, Customized||Participants|Number|425|425.0||||||
3717121|NCT02114385|3555824|B2|>=18 years old||Age, Customized||Participants|Number|213|213.0||||||
3717122|NCT02114385|3555825|B1|>=18 years old||Age, Customized||Participants|Number|212|212.0||||||
3717123|NCT02114385|3555823|B3|<18 years old||Age, Customized||Participants|Number|75|75.0||||||
3717124|NCT02114385|3555824|B2|<18 years old||Age, Customized||Participants|Number|38|38.0||||||
3717125|NCT02114385|3555825|B1|<18 years old||Age, Customized||Participants|Number|37|37.0||||||
3717126|NCT02114385|3555823|B3|||Age||Years|Mean|21.0|21.0|Standard Deviation|2.8|2.8|||
3717127|NCT02114385|3555824|B2|||Age||Years|Mean|21.3|21.3|Standard Deviation|3.0|3.0|||
3717128|NCT02114385|3555825|B1|||Age||Years|Mean|20.8|20.8|Standard Deviation|2.7|2.7|||
3717129|NCT02114268|3555848|B7||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3717130|NCT02114268|3555849|B6||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3717131|NCT02114268|3555850|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3717132|NCT02114268|3555851|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3717133|NCT02114268|3555852|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3717134|NCT02114268|3555853|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3717135|NCT02114268|3555854|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3717136|NCT02114268|3555848|B7||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3717137|NCT02114268|3555849|B6||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3717138|NCT02114268|3555850|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3717139|NCT02114268|3555851|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3717140|NCT02114268|3555852|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3717141|NCT02114268|3555853|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3717142|NCT02114268|3555854|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3717143|NCT02114268|3555848|B7|||Age||Years|Mean|30.5|30.5|Standard Deviation|8.0|8.0|||
3717144|NCT02114268|3555849|B6|||Age||Years|Mean|30.3|30.3|Standard Deviation|7.9|7.9|||
3717145|NCT02114268|3555850|B5|||Age||Years|Mean|30.7|30.7|Standard Deviation|7.8|7.8|||
3717146|NCT02114268|3555851|B4|||Age||Years|Mean|33.5|33.5|Standard Deviation|6.7|6.7|||
3717147|NCT02114268|3555852|B3|||Age||Years|Mean|34.3|34.3|Standard Deviation|5.6|5.6|||
3717148|NCT02114268|3555853|B2|||Age||Years|Mean|34.5|34.5|Standard Deviation|8.6|8.6|||
3717149|NCT02114268|3555854|B1|||Age||Years|Mean|29.2|29.2|Standard Deviation|8.6|8.6|||
3717150|NCT02114216|3555909|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3717151|NCT02114216|3555910|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3717152|NCT02114216|3555911|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3717153|NCT02114216|3555912|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3717154|NCT02114216|3555909|B4||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3717155|NCT02114216|3555910|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3717156|NCT02114216|3555911|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3717157|NCT02114216|3555912|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3717158|NCT02114216|3555909|B4|||Age||years|Mean|52.8|52.8|Standard Deviation|12.1|12.1|||
3717159|NCT02114216|3555910|B3|||Age||years|Mean|52.7|52.7|Standard Deviation|13.8|13.8|||
3717160|NCT02114216|3555911|B2|||Age||years|Mean|52.3|52.3|Standard Deviation|10.39|10.39|||
3717161|NCT02114216|3555912|B1|||Age||years|Mean|54.3|54.3|Standard Deviation|11.6|11.6|||
3717162|NCT02114203|3555925|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3717163|NCT02114203|3555926|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3717164|NCT02114203|3555927|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3717165|NCT02114203|3555928|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3717166|NCT02114203|3555925|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3717167|NCT02114203|3555926|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3717168|NCT02114203|3555927|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3717169|NCT02114203|3555928|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3717170|NCT02114203|3555925|B4|||Age||years|Mean|37.4|37.4|Standard Deviation|11.3|11.3|||
3717171|NCT02114203|3555926|B3|||Age||years|Mean|39.4|39.4|Standard Deviation|14.0|14.0|||
3717172|NCT02114203|3555927|B2|||Age||years|Mean|36.3|36.3|Standard Deviation|11.0|11.0|||
3717173|NCT02114203|3555928|B1|||Age||years|Mean|37.9|37.9|Standard Deviation|10.6|10.6|||
3717174|NCT02114177|3555962|B3||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3717175|NCT02114177|3555963|B2||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3717176|NCT02114177|3555964|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3717177|NCT02114177|3555962|B3||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3717178|NCT02114177|3555963|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3717179|NCT02114177|3555964|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3717180|NCT02114177|3555962|B3|||Age||years|Median|56|56.0|Full Range|||19.0|70.0|
3717181|NCT02114177|3555963|B2|||Age||years|Median|56|56.0|Full Range|||19.0|70.0|
3717182|NCT02114177|3555964|B1|||Age||years|Median|56|56.0|Full Range|||21.0|70.0|
3717183|NCT02114151|3555989|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3717184|NCT02114151|3555989|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3717185|NCT02114151|3555989|B1|||Age||years|Median|58|58.0|Full Range|||29.0|69.0|
3717186|NCT02113579|3556004|B3|USA||Region of Enrollment||participants|Number|375|375.0||||||
3717187|NCT02113579|3556005|B2|USA||Region of Enrollment||participants|Number|189|189.0||||||
3717188|NCT02113579|3556006|B1|USA||Region of Enrollment||participants|Number|186|186.0||||||
3717189|NCT02113579|3556004|B3||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3717190|NCT02113579|3556005|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3717191|NCT02113579|3556006|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3717192|NCT02113579|3556004|B3||Female|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
3717193|NCT02113579|3556005|B2||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3717194|NCT02113579|3556006|B1||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3717195|NCT02113579|3556004|B3|||Age||years|Mean|38.5|38.5|Standard Deviation|12.03|12.03|||
3717196|NCT02113579|3556005|B2|||Age||years|Mean|38.0|38.0|Standard Deviation|12.03|12.03|||
3717197|NCT02113579|3556006|B1|||Age||years|Mean|38.9|38.9|Standard Deviation|12.05|12.05|||
3717198|NCT02113449|3556031|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3717199|NCT02113449|3556031|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3717200|NCT02113449|3556031|B1|||Age||Years|Mean|51.7|51.7|Standard Deviation|14.55|14.55|||
3717201|NCT02113436|3556045|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|300|300.0||||||
3717202|NCT02113436|3556046|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|150|150.0||||||
3717203|NCT02113436|3556047|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|150|150.0||||||
3717204|NCT02113436|3556045|B3||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
3717205|NCT02113436|3556046|B2||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3717206|NCT02113436|3556047|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3717207|NCT02113436|3556045|B3||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3717208|NCT02113436|3556046|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3717209|NCT02113436|3556047|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3717210|NCT02113436|3556045|B3|Overall Study||Age||Months|Mean|39.5|39.5|Standard Deviation|14.11|14.11|||
3717211|NCT02113436|3556046|B2|Overall Study||Age||Months|Mean|40.5|40.5|Standard Deviation|14.07|14.07|||
3717212|NCT02113436|3556047|B1|Overall Study||Age||Months|Mean|38.4|38.4|Standard Deviation|14.10|14.1|||
3717213|NCT02113124|3556071|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3717214|NCT02113124|3556072|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3717215|NCT02113124|3556073|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3717216|NCT02113124|3556071|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3717217|NCT02113124|3556072|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3717218|NCT02113124|3556073|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3717219|NCT02113124|3556071|B3|||Age||years|Mean|46|46.0|Standard Deviation|13|13.0|||
3717220|NCT02113124|3556072|B2|||Age||years|Mean|45|45.0|Standard Deviation|15|15.0|||
3717221|NCT02113124|3556073|B1|||Age||years|Mean|49|49.0|Standard Deviation|10|10.0|||
3717222|NCT02113007|3556080|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3717223|NCT02113007|3556080|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3717224|NCT02113007|3556080|B1||Male|Gender||Participants|Count of Participants|1|1.0||||||
3717225|NCT02113007|3556080|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
3717226|NCT02113007|3556080|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3717227|NCT02113007|3556080|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3717228|NCT02113007|3556080|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3717229|NCT02112448|3556086|B3|||Surgical complexity scores|Surgical complexity scores are numbers assigned to a surgery type and range from 1-5 with 5 being the most complex. We added the surgical complexity scores of each patient and compared the sum between groups.|units on a scale|Number|120|120.0||||||
3717230|NCT02112448|3556087|B2|||Surgical complexity scores|Surgical complexity scores are numbers assigned to a surgery type and range from 1-5 with 5 being the most complex. We added the surgical complexity scores of each patient and compared the sum between groups.|units on a scale|Number|61|61.0||||||
3717231|NCT02112448|3556088|B1|||Surgical complexity scores|Surgical complexity scores are numbers assigned to a surgery type and range from 1-5 with 5 being the most complex. We added the surgical complexity scores of each patient and compared the sum between groups.|units on a scale|Number|59|59.0||||||
3717232|NCT02112448|3556086|B3|||Presence of Down syndrome||Participants|Count of Participants|9|9.0||||||
3717233|NCT02112448|3556087|B2|||Presence of Down syndrome||Participants|Count of Participants|4|4.0||||||
3717234|NCT02112448|3556088|B1|||Presence of Down syndrome||Participants|Count of Participants|5|5.0||||||
3717235|NCT02112448|3556086|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3717236|NCT02112448|3556087|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3717237|NCT02112448|3556088|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3717238|NCT02112448|3556086|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3717239|NCT02112448|3556087|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3717240|NCT02112448|3556088|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3717241|NCT02112448|3556086|B3|||Age||months|Mean|15.4|15.4|Standard Deviation|12.5|12.5|||
3717242|NCT02112448|3556087|B2|||Age||months|Mean|16|16.0|Standard Deviation|12.8|12.8|||
3717243|NCT02112448|3556088|B1|||Age||months|Mean|14.8|14.8|Standard Deviation|12.1|12.1|||
3717244|NCT02112370|3556097|B3|Total||Extent of operation (Right/Left/Total)||participants|Number|41|41.0||||||
3717245|NCT02112370|3556098|B2|Total||Extent of operation (Right/Left/Total)||participants|Number|21|21.0||||||
3717246|NCT02112370|3556099|B1|Total||Extent of operation (Right/Left/Total)||participants|Number|20|20.0||||||
3717247|NCT02112370|3556097|B3|Left||Extent of operation (Right/Left/Total)||participants|Number|52|52.0||||||
3717248|NCT02112370|3556098|B2|Left||Extent of operation (Right/Left/Total)||participants|Number|24|24.0||||||
3717249|NCT02112370|3556099|B1|Left||Extent of operation (Right/Left/Total)||participants|Number|28|28.0||||||
3717250|NCT02112370|3556097|B3|Right||Extent of operation (Right/Left/Total)||participants|Number|55|55.0||||||
3717251|NCT02112370|3556098|B2|Right||Extent of operation (Right/Left/Total)||participants|Number|29|29.0||||||
3717252|NCT02112370|3556099|B1|Right||Extent of operation (Right/Left/Total)||participants|Number|26|26.0||||||
3717253|NCT02112370|3556097|B3|Endoscopic||Method of operation (robotic/endoscopic)||participants|Number|40|40.0||||||
3717254|NCT02112370|3556098|B2|Endoscopic||Method of operation (robotic/endoscopic)||participants|Number|19|19.0||||||
3717255|NCT02112370|3556099|B1|Endoscopic||Method of operation (robotic/endoscopic)||participants|Number|21|21.0||||||
3717256|NCT02112370|3556097|B3|Robotic||Method of operation (robotic/endoscopic)||participants|Number|108|108.0||||||
3717257|NCT02112370|3556098|B2|Robotic||Method of operation (robotic/endoscopic)||participants|Number|55|55.0||||||
3717258|NCT02112370|3556099|B1|Robotic||Method of operation (robotic/endoscopic)||participants|Number|53|53.0||||||
3717259|NCT02112370|3556097|B3|||Preoperative thyroid function test (TSH, uIU/mL)||uIU/mL|Mean|2.0|2.0|Standard Deviation|1.4|1.4|||
3717260|NCT02112370|3556098|B2|||Preoperative thyroid function test (TSH, uIU/mL)||uIU/mL|Mean|2.2|2.2|Standard Deviation|1.7|1.7|||
3717261|NCT02112370|3556099|B1|||Preoperative thyroid function test (TSH, uIU/mL)||uIU/mL|Mean|1.8|1.8|Standard Deviation|1.0|1.0|||
3717262|NCT02112370|3556097|B3|||Preoperative thyroid function test (free T4, ng/dL)||ng/dL|Mean|1.2|1.2|Standard Deviation|0.4|0.4|||
3717263|NCT02112370|3556098|B2|||Preoperative thyroid function test (free T4, ng/dL)||ng/dL|Mean|1.2|1.2|Standard Deviation|0.4|0.4|||
3717264|NCT02112370|3556099|B1|||Preoperative thyroid function test (free T4, ng/dL)||ng/dL|Mean|1.2|1.2|Standard Deviation|0.3|0.3|||
3717265|NCT02112370|3556097|B3|||Preoperative thyroid function test (T3, ng/dL)||ng/dL|Mean|122.5|122.5|Standard Deviation|20.6|20.6|||
3717266|NCT02112370|3556098|B2|||Preoperative thyroid function test (T3, ng/dL)||ng/dL|Mean|123.3|123.3|Standard Deviation|25.1|25.1|||
3717267|NCT02112370|3556099|B1|||Preoperative thyroid function test (T3, ng/dL)||ng/dL|Mean|121.8|121.8|Standard Deviation|15.0|15.0|||
3717268|NCT02112370|3556097|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3717269|NCT02112370|3556098|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3717270|NCT02112370|3556099|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3717271|NCT02112370|3556097|B3||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3717272|NCT02112370|3556098|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3717273|NCT02112370|3556099|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3717274|NCT02112370|3556097|B3|||Age||years|Mean|36.1|36.1|Standard Deviation|9.7|9.7|||
3717275|NCT02112370|3556098|B2|||Age||years|Mean|35.5|35.5|Standard Deviation|8.8|8.8|||
3717276|NCT02112370|3556099|B1|||Age||years|Mean|38.0|38.0|Standard Deviation|9.3|9.3|||
3717277|NCT02111863|3556120|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3717278|NCT02111863|3556120|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717279|NCT02111863|3556120|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717280|NCT02111863|3556120|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3717281|NCT02111863|3556120|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717282|NCT02111863|3556120|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717283|NCT02111863|3556120|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717284|NCT02111863|3556120|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717285|NCT02111863|3556120|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717286|NCT02111863|3556120|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3717287|NCT02111863|3556120|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717288|NCT02111863|3556120|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3717289|NCT02111863|3556120|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3717290|NCT02111863|3556120|B1|||Age||years|Mean|49.8|49.8|Standard Deviation|10.4|10.4|||
3717291|NCT02111863|3556120|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3717292|NCT02111863|3556120|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3717293|NCT02111863|3556120|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3717294|NCT02111785|3556126|B5|United States||Region of Enrollment||participants|Number|10|10.0||||||
3717295|NCT02111785|3556127|B4|United States||Region of Enrollment||participants|Number|1|1.0||||||
3717296|NCT02111785|3556128|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3717297|NCT02111785|3556129|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3717298|NCT02111785|3556130|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3717299|NCT02111785|3556126|B5|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3717300|NCT02111785|3556126|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3717301|NCT02111785|3556127|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3717302|NCT02111785|3556128|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3717303|NCT02111785|3556129|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3717304|NCT02111785|3556130|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3717305|NCT02111785|3556126|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3717306|NCT02111785|3556127|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3717307|NCT02111785|3556128|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3717308|NCT02111785|3556129|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3717309|NCT02111785|3556130|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3717310|NCT02111785|3556126|B5|||Age||years|Mean|73.3|73.3|Full Range|||47.0|87.0|
3717311|NCT02111785|3556127|B4|||Age||years|Mean|74|74.0|Full Range|||74.0|74.0|
3717312|NCT02111785|3556128|B3|||Age||years|Mean|76|76.0|Full Range|||76.0|76.0|
3717313|NCT02111785|3556129|B2|||Age||years|Mean|72.6|72.6|Full Range|||47.0|87.0|
3717314|NCT02111785|3556130|B1|||Age||years|Mean|75.3|75.3|Full Range|||54.0|88.0|
3717315|NCT02111785|3556126|B5||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3717316|NCT02111785|3556127|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3717317|NCT02111785|3556128|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3717318|NCT02111785|3556129|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3717319|NCT02111785|3556130|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3717320|NCT02111785|3556126|B5||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3717321|NCT02111785|3556127|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3717322|NCT02111785|3556128|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3717323|NCT02111785|3556129|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3717324|NCT02111785|3556130|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3717325|NCT02111785|3556126|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3717326|NCT02111785|3556127|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3717327|NCT02111785|3556128|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3717328|NCT02111785|3556129|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3717329|NCT02111785|3556130|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3717330|NCT02111772|3556159|B3|||Negative serum antibody to Rhinovirus-16||Participants|Count of Participants|26|26.0||||||
3717446|NCT02111200|3556226|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3717331|NCT02111772|3556160|B2|||Negative serum antibody to Rhinovirus-16||Participants|Count of Participants|14|14.0||||||
3717332|NCT02111772|3556161|B1|||Negative serum antibody to Rhinovirus-16||Participants|Count of Participants|12|12.0||||||
3717333|NCT02111772|3556159|B3|||Total IgE level||International Units/ml|Geometric Mean|110|110.0|Full Range|||2.4|4692.0|
3717334|NCT02111772|3556160|B2|||Total IgE level||International Units/ml|Geometric Mean|14|14.0|Full Range|||2.4|42.5|
3717335|NCT02111772|3556161|B1|||Total IgE level||International Units/ml|Geometric Mean|1239|1239.0|Full Range|||596.0|4692.0|
3717336|NCT02111772|3556159|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717337|NCT02111772|3556160|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717338|NCT02111772|3556161|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717339|NCT02111772|3556159|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717340|NCT02111772|3556160|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717341|NCT02111772|3556161|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717342|NCT02111772|3556159|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3717343|NCT02111772|3556160|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3717344|NCT02111772|3556161|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3717345|NCT02111772|3556159|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3717346|NCT02111772|3556160|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717347|NCT02111772|3556161|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3717348|NCT02111772|3556159|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717349|NCT02111772|3556160|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717350|NCT02111772|3556161|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717351|NCT02111772|3556159|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717352|NCT02111772|3556160|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717353|NCT02111772|3556161|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717354|NCT02111772|3556159|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717355|NCT02111772|3556160|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717356|NCT02111772|3556161|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717357|NCT02111772|3556159|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717358|NCT02111772|3556160|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717359|NCT02111772|3556161|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717360|NCT02111772|3556159|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3717361|NCT02111772|3556160|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3717362|NCT02111772|3556161|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3717363|NCT02111772|3556159|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717364|NCT02111772|3556160|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717365|NCT02111772|3556161|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717366|NCT02111772|3556159|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3717367|NCT02111772|3556160|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3717368|NCT02111772|3556161|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3717369|NCT02111772|3556159|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3717370|NCT02111772|3556160|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3717371|NCT02111772|3556161|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3717372|NCT02111772|3556159|B3|||Age||years|Mean|22.9|22.9|Full Range|||19.0|39.0|
3717373|NCT02111772|3556160|B2|||Age||years|Mean|21.9|21.9|Full Range|||20.0|27.0|
3717374|NCT02111772|3556161|B1|||Age||years|Mean|24.1|24.1|Full Range|||19.0|39.0|
3717375|NCT02111746|3556170|B3|United States||Region of Enrollment||participants|Number|343|343.0||||||
3717376|NCT02111746|3556171|B2|United States||Region of Enrollment||participants|Number|171|171.0||||||
3717377|NCT02111746|3556172|B1|United States||Region of Enrollment||participants|Number|172|172.0||||||
3717378|NCT02111746|3556170|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3717379|NCT02111746|3556171|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3717380|NCT02111746|3556172|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3717381|NCT02111746|3556170|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717382|NCT02111746|3556171|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717383|NCT02111746|3556172|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717384|NCT02111746|3556170|B3||White|Race (NIH/OMB)||Participants|Count of Participants|201|201.0||||||
3717385|NCT02111746|3556171|B2||White|Race (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
3717386|NCT02111746|3556172|B1||White|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3717387|NCT02111746|3556170|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3717388|NCT02111746|3556171|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3717389|NCT02111746|3556172|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3717390|NCT02111746|3556170|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717391|NCT02111746|3556171|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717392|NCT02111746|3556172|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717393|NCT02111746|3556170|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3717394|NCT02111746|3556171|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3717395|NCT02111746|3556172|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3717396|NCT02111746|3556170|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717397|NCT02111746|3556171|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717398|NCT02111746|3556172|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717399|NCT02111746|3556170|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3717400|NCT02111746|3556171|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3717401|NCT02111746|3556172|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3717402|NCT02111746|3556170|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|271|271.0||||||
3717403|NCT02111746|3556171|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
3717404|NCT02111746|3556172|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|139|139.0||||||
3717405|NCT02111746|3556170|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3717406|NCT02111746|3556171|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3717407|NCT02111746|3556172|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3717408|NCT02111746|3556170|B3||Male|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
3717409|NCT02111746|3556171|B2||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3717410|NCT02111746|3556172|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3717411|NCT02111746|3556170|B3||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3717412|NCT02111746|3556171|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3717413|NCT02111746|3556172|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3717414|NCT02111746|3556170|B3|||Age||years|Mean|60.7|60.7|Standard Deviation|14.2|14.2|||
3717415|NCT02111746|3556171|B2|||Age||years|Mean|61|61.0|Standard Deviation|13.9|13.9|||
3717416|NCT02111746|3556172|B1|||Age||years|Mean|60.2|60.2|Standard Deviation|14.8|14.8|||
3717417|NCT02111603|3556195|B1|||Mean Body Mass Index (BMI)||kg/m^2|Mean|31.1|31.1|Standard Deviation|2.4|2.4|||
3717418|NCT02111603|3556195|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3717419|NCT02111603|3556195|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3717420|NCT02111603|3556195|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3717421|NCT02111603|3556195|B1|||Age||years|Mean|43.1|43.1|Standard Deviation|3.7|3.7|||
3717422|NCT02111369|3556204|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3717423|NCT02111369|3556204|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3717424|NCT02111369|3556204|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3717425|NCT02111369|3556204|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3717426|NCT02111369|3556204|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3717427|NCT02111369|3556204|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3717428|NCT02111252|3556212|B1|No||Influenza Vaccination History Within 1 Year||Number of participants|Number|55|55.0||||||
3717429|NCT02111252|3556212|B1|Yes||Influenza Vaccination History Within 1 Year||Number of participants|Number|0|0.0||||||
3717430|NCT02111252|3556212|B1|||Body Mass index (BMI)||kg/m^2|Mean|21.66|21.66|Standard Deviation|1.563|1.563|||
3717431|NCT02111252|3556212|B1|||Weight||kg|Mean|58.95|58.95|Standard Deviation|7.185|7.185|||
3717432|NCT02111252|3556212|B1|||Height||cm|Mean|164.8|164.8|Standard Deviation|7.82|7.82|||
3717433|NCT02111252|3556212|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3717434|NCT02111252|3556212|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3717435|NCT02111252|3556212|B1|||Age||years|Mean|33.2|33.2|Standard Deviation|8.75|8.75|||
3717436|NCT02111200|3556226|B5|United States||Region of Enrollment||participants|Number|7|7.0||||||
3717437|NCT02111200|3556227|B4|United States||Region of Enrollment||participants|Number|1|1.0||||||
3717438|NCT02111200|3556228|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3717439|NCT02111200|3556229|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3717440|NCT02111200|3556230|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3717441|NCT02111200|3556226|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3717442|NCT02111200|3556227|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3717443|NCT02111200|3556228|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3717444|NCT02111200|3556229|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3717445|NCT02111200|3556230|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3717447|NCT02111200|3556227|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3717448|NCT02111200|3556228|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3717449|NCT02111200|3556229|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3717450|NCT02111200|3556230|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3717451|NCT02111200|3556226|B5|||Age||years|Median|28|28.0|Full Range|||23.0|58.0|
3717452|NCT02111200|3556227|B4|||Age||years|Median|33|33.0|Full Range|||33.0|33.0|
3717453|NCT02111200|3556228|B3|||Age||years|Median|28|28.0|Full Range|||28.0|28.0|
3717454|NCT02111200|3556229|B2|||Age||years|Median|42.5|42.5|Full Range|||27.0|58.0|
3717455|NCT02111200|3556230|B1|||Age||years|Median|26|26.0|Full Range|||23.0|52.0|
3717456|NCT02111174|3556247|B3|||Motor subscale score at baseline|This will be assessed using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-CIPN20, a CIPN-specific questionnaire which includes two scales assessing sensory and motor symptoms and functioning with each question measured on a 0-3 scale. For motor there are 8 questions with a total score range from 0-24 with higher scores indicating more bothersome symptoms.|units on a scale|Mean|11.2|11.2|Standard Deviation|5.12|5.12|||
3717457|NCT02111174|3556248|B2|||Motor subscale score at baseline|This will be assessed using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-CIPN20, a CIPN-specific questionnaire which includes two scales assessing sensory and motor symptoms and functioning with each question measured on a 0-3 scale. For motor there are 8 questions with a total score range from 0-24 with higher scores indicating more bothersome symptoms.|units on a scale|Mean|11.83|11.83|Standard Deviation|5.09|5.09|||
3717458|NCT02111174|3556249|B1|||Motor subscale score at baseline|This will be assessed using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-CIPN20, a CIPN-specific questionnaire which includes two scales assessing sensory and motor symptoms and functioning with each question measured on a 0-3 scale. For motor there are 8 questions with a total score range from 0-24 with higher scores indicating more bothersome symptoms.|units on a scale|Mean|10.53|10.53|Standard Deviation|5.21|5.21|||
3717459|NCT02111174|3556247|B3|||Sensory subscale score at baseline|This was assessed using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-CIPN20, a CIPN-specific questionnaire which includes two scales assessing sensory and motor symptoms and functioning with each question measured on a 0-3 scale. For sensory there are 9 questions with a total score range from 0-27 with higher scores indicating more bothersome symptoms.|units on a scale|Mean|14.69|14.69|Standard Deviation|5.19|5.19|||
3717460|NCT02111174|3556248|B2|||Sensory subscale score at baseline|This was assessed using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-CIPN20, a CIPN-specific questionnaire which includes two scales assessing sensory and motor symptoms and functioning with each question measured on a 0-3 scale. For sensory there are 9 questions with a total score range from 0-27 with higher scores indicating more bothersome symptoms.|units on a scale|Mean|15.83|15.83|Standard Deviation|4.49|4.49|||
3717461|NCT02111174|3556249|B1|||Sensory subscale score at baseline|This was assessed using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-CIPN20, a CIPN-specific questionnaire which includes two scales assessing sensory and motor symptoms and functioning with each question measured on a 0-3 scale. For sensory there are 9 questions with a total score range from 0-27 with higher scores indicating more bothersome symptoms.|units on a scale|Mean|13.47|13.47|Standard Deviation|5.73|5.73|||
3717462|NCT02111174|3556247|B3|||Using neuroleptics at baseline or during treatment|This will be assessed by concomitant medication review by a study team member during the 10 days of treatment. Follow-up was assessed as participant self-report over the last 10 days; all opiates were further tabulated using a morphine oral dose equivalents table to allow better comparison between patients and arms.|Participants|Count of Participants|7|7.0||||||
3717463|NCT02111174|3556248|B2|||Using neuroleptics at baseline or during treatment|This will be assessed by concomitant medication review by a study team member during the 10 days of treatment. Follow-up was assessed as participant self-report over the last 10 days; all opiates were further tabulated using a morphine oral dose equivalents table to allow better comparison between patients and arms.|Participants|Count of Participants|4|4.0||||||
3717464|NCT02111174|3556249|B1|||Using neuroleptics at baseline or during treatment|This will be assessed by concomitant medication review by a study team member during the 10 days of treatment. Follow-up was assessed as participant self-report over the last 10 days; all opiates were further tabulated using a morphine oral dose equivalents table to allow better comparison between patients and arms.|Participants|Count of Participants|3|3.0||||||
3717465|NCT02111174|3556247|B3|||Using opioids at baseline or during treatment|This will be assessed by concomitant medication review by a study team member during the 10 days of treatment. Follow-up was assessed as participant self-report over the last 10 days; all opiates were further tabulated using a morphine oral dose equivalents table to allow better comparison between patients and arms.|Participants|Count of Participants|8|8.0||||||
3717466|NCT02111174|3556248|B2|||Using opioids at baseline or during treatment|This will be assessed by concomitant medication review by a study team member during the 10 days of treatment. Follow-up was assessed as participant self-report over the last 10 days; all opiates were further tabulated using a morphine oral dose equivalents table to allow better comparison between patients and arms.|Participants|Count of Participants|3|3.0||||||
3717467|NCT02111174|3556249|B1|||Using opioids at baseline or during treatment|This will be assessed by concomitant medication review by a study team member during the 10 days of treatment. Follow-up was assessed as participant self-report over the last 10 days; all opiates were further tabulated using a morphine oral dose equivalents table to allow better comparison between patients and arms.|Participants|Count of Participants|5|5.0||||||
3717468|NCT02111174|3556247|B3|||Baseline Pain Score|Change in pain as measured by the Modified Brief Pain Index (BPI), question #3. The BPI short form is a pain assessment tool used with cancer patients to measure both severity of pain and interference caused by pain on 0-10 scales with higher scores indicating more pain.|units on a scale|Mean|6.57|6.57|Standard Deviation|1.75|1.75|||
3717522|NCT02111096|3556276|B4|Greece||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3717523|NCT02111096|3556277|B3|Greece||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3717735|NCT02109640|3556435|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3717469|NCT02111174|3556248|B2|||Baseline Pain Score|Change in pain as measured by the Modified Brief Pain Index (BPI), question #3. The BPI short form is a pain assessment tool used with cancer patients to measure both severity of pain and interference caused by pain on 0-10 scales with higher scores indicating more pain.|units on a scale|Mean|6.83|6.83|Standard Deviation|1.62|1.62|||
3717470|NCT02111174|3556249|B1|||Baseline Pain Score|Change in pain as measured by the Modified Brief Pain Index (BPI), question #3. The BPI short form is a pain assessment tool used with cancer patients to measure both severity of pain and interference caused by pain on 0-10 scales with higher scores indicating more pain.|units on a scale|Mean|6.29|6.29|Standard Deviation|1.9|1.9|||
3717471|NCT02111174|3556247|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717472|NCT02111174|3556248|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717473|NCT02111174|3556249|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717474|NCT02111174|3556247|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717475|NCT02111174|3556248|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717476|NCT02111174|3556249|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717477|NCT02111174|3556247|B3||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3717478|NCT02111174|3556248|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3717479|NCT02111174|3556249|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3717480|NCT02111174|3556247|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3717481|NCT02111174|3556248|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3717482|NCT02111174|3556249|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3717483|NCT02111174|3556247|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717484|NCT02111174|3556248|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717485|NCT02111174|3556249|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717486|NCT02111174|3556247|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3717487|NCT02111174|3556248|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717488|NCT02111174|3556249|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3717489|NCT02111174|3556247|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717490|NCT02111174|3556248|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717491|NCT02111174|3556249|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717492|NCT02111174|3556247|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717493|NCT02111174|3556248|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717494|NCT02111174|3556249|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717495|NCT02111174|3556247|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3717496|NCT02111174|3556248|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3717497|NCT02111174|3556249|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3717498|NCT02111174|3556247|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717499|NCT02111174|3556248|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717500|NCT02111174|3556249|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717501|NCT02111174|3556247|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3717502|NCT02111174|3556248|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3717503|NCT02111174|3556249|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3717504|NCT02111174|3556247|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3717505|NCT02111174|3556248|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3717506|NCT02111174|3556249|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3717507|NCT02111174|3556247|B3|||Age||years|Mean|59.31|59.31|Standard Deviation|8.97|8.97|||
3717508|NCT02111174|3556248|B2|||Age||years|Mean|58.94|58.94|Standard Deviation|9.31|9.31|||
3717509|NCT02111174|3556249|B1|||Age||years|Mean|59.71|59.71|Standard Deviation|8.88|8.88|||
3717510|NCT02111096|3556276|B4|Taiwan||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3717511|NCT02111096|3556277|B3|Taiwan||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3717512|NCT02111096|3556278|B2|Taiwan||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3717513|NCT02111096|3556279|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3717514|NCT02111096|3556276|B4|United States||Region of Enrollment||Participants|Count of Participants|124|124.0||||||
3717515|NCT02111096|3556277|B3|United States||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3717516|NCT02111096|3556278|B2|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3717517|NCT02111096|3556279|B1|United States||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
3717518|NCT02111096|3556276|B4|Puerto Rico||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3717519|NCT02111096|3556277|B3|Puerto Rico||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3717520|NCT02111096|3556278|B2|Puerto Rico||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3717521|NCT02111096|3556279|B1|Puerto Rico||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3717524|NCT02111096|3556278|B2|Greece||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3717525|NCT02111096|3556279|B1|Greece||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3717526|NCT02111096|3556276|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717527|NCT02111096|3556277|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717528|NCT02111096|3556278|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717529|NCT02111096|3556279|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717530|NCT02111096|3556276|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3717531|NCT02111096|3556277|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3717532|NCT02111096|3556278|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3717533|NCT02111096|3556279|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3717534|NCT02111096|3556276|B4||White|Race (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
3717535|NCT02111096|3556277|B3||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3717536|NCT02111096|3556278|B2||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3717537|NCT02111096|3556279|B1||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3717538|NCT02111096|3556276|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3717539|NCT02111096|3556277|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3717540|NCT02111096|3556278|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3717541|NCT02111096|3556279|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3717542|NCT02111096|3556276|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717543|NCT02111096|3556277|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717544|NCT02111096|3556278|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717545|NCT02111096|3556279|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717546|NCT02111096|3556276|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3717547|NCT02111096|3556277|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3717548|NCT02111096|3556278|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3717549|NCT02111096|3556279|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3717550|NCT02111096|3556276|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717551|NCT02111096|3556277|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717552|NCT02111096|3556278|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717553|NCT02111096|3556279|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717554|NCT02111096|3556276|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3717555|NCT02111096|3556277|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3717556|NCT02111096|3556278|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3717557|NCT02111096|3556279|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3717558|NCT02111096|3556276|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3717559|NCT02111096|3556277|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3717560|NCT02111096|3556278|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3717561|NCT02111096|3556279|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3717562|NCT02111096|3556276|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3717563|NCT02111096|3556277|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3717564|NCT02111096|3556278|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3717565|NCT02111096|3556279|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3717566|NCT02111096|3556276|B4||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3717567|NCT02111096|3556277|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3717568|NCT02111096|3556278|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3717569|NCT02111096|3556279|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3717570|NCT02111096|3556276|B4||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3717571|NCT02111096|3556277|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3717572|NCT02111096|3556278|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3717573|NCT02111096|3556279|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3717574|NCT02111096|3556276|B4|||Age||years|Mean|57.3|57.3|Standard Deviation|8.41|8.41|||
3717575|NCT02111096|3556277|B3|||Age||years|Mean|57.8|57.8|Standard Deviation|8.21|8.21|||
3717576|NCT02111096|3556278|B2|||Age||years|Mean|57.1|57.1|Standard Deviation|8.99|8.99|||
3717577|NCT02111096|3556279|B1|||Age||years|Mean|56.9|56.9|Standard Deviation|8.33|8.33|||
3717578|NCT02111083|3556327|B3|Singapore||Region of Enrollment||participants|Number|38|38.0||||||
3717579|NCT02111083|3556328|B2|Singapore||Region of Enrollment||participants|Number|19|19.0||||||
3717580|NCT02111083|3556329|B1|Singapore||Region of Enrollment||participants|Number|19|19.0||||||
3717581|NCT02111083|3556327|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717582|NCT02111083|3556328|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717583|NCT02111083|3556329|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717584|NCT02111083|3556327|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3717585|NCT02111083|3556328|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3717586|NCT02111083|3556329|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3717587|NCT02111083|3556327|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717588|NCT02111083|3556328|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717589|NCT02111083|3556329|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717590|NCT02111083|3556327|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3717591|NCT02111083|3556328|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3717592|NCT02111083|3556329|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3717593|NCT02111083|3556327|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3717594|NCT02111083|3556328|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3717595|NCT02111083|3556329|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3717596|NCT02111083|3556327|B3|||Age||years|Mean|31.7|31.7|Standard Deviation|7.2|7.2|||
3717597|NCT02111083|3556328|B2|||Age||years|Mean|30.4|30.4|Standard Deviation|8.2|8.2|||
3717598|NCT02111083|3556329|B1|||Age||years|Mean|32.9|32.9|Standard Deviation|6.1|6.1|||
3717599|NCT02110706|3556348|B3|||Thymectomy||Participants|Count of Participants|12|12.0||||||
3717600|NCT02110706|3556349|B2|||Thymectomy||Participants|Count of Participants|4|4.0||||||
3717601|NCT02110706|3556350|B1|||Thymectomy||Participants|Count of Participants|8|8.0||||||
3717602|NCT02110706|3556348|B3||Class IV|Baseline MGFA Clinical Classification Grade|Class I- Any ocular muscle weakness, may have weakness of eye closure, all other muscle strength is normal. Class II – Mild weakness affecting other than ocular muscles, may also have ocular muscle weakness of any severity. Class III – Moderate weakness affecting other than ocular muscles, may also have ocular muscle weakness of any severity. Class IV – Severe weakness affecting other than ocular muscles, may also have ocular muscle weakness of any severity. A higher grade is indicative of a worse outcome.|Participants|Count of Participants|2|2.0||||||
3717603|NCT02110706|3556349|B2||Class IV|Baseline MGFA Clinical Classification Grade|Class I- Any ocular muscle weakness, may have weakness of eye closure, all other muscle strength is normal. Class II – Mild weakness affecting other than ocular muscles, may also have ocular muscle weakness of any severity. Class III – Moderate weakness affecting other than ocular muscles, may also have ocular muscle weakness of any severity. Class IV – Severe weakness affecting other than ocular muscles, may also have ocular muscle weakness of any severity. A higher grade is indicative of a worse outcome.|Participants|Count of Participants|1|1.0||||||
3717604|NCT02110706|3556350|B1||Class IV|Baseline MGFA Clinical Classification Grade|Class I- Any ocular muscle weakness, may have weakness of eye closure, all other muscle strength is normal. Class II – Mild weakness affecting other than ocular muscles, may also have ocular muscle weakness of any severity. Class III – Moderate weakness affecting other than ocular muscles, may also have ocular muscle weakness of any severity. Class IV – Severe weakness affecting other than ocular muscles, may also have ocular muscle weakness of any severity. A higher grade is indicative of a worse outcome.|Participants|Count of Participants|1|1.0||||||
3717605|NCT02110706|3556348|B3||Class III|Baseline MGFA Clinical Classification Grade|Class I- Any ocular muscle weakness, may have weakness of eye closure, all other muscle strength is normal. Class II – Mild weakness affecting other than ocular muscles, may also have ocular muscle weakness of any severity. Class III – Moderate weakness affecting other than ocular muscles, may also have ocular muscle weakness of any severity. Class IV – Severe weakness affecting other than ocular muscles, may also have ocular muscle weakness of any severity. A higher grade is indicative of a worse outcome.|Participants|Count of Participants|18|18.0||||||
3717606|NCT02110706|3556349|B2||Class III|Baseline MGFA Clinical Classification Grade|Class I- Any ocular muscle weakness, may have weakness of eye closure, all other muscle strength is normal. Class II – Mild weakness affecting other than ocular muscles, may also have ocular muscle weakness of any severity. Class III – Moderate weakness affecting other than ocular muscles, may also have ocular muscle weakness of any severity. Class IV – Severe weakness affecting other than ocular muscles, may also have ocular muscle weakness of any severity. A higher grade is indicative of a worse outcome.|Participants|Count of Participants|9|9.0||||||
3717607|NCT02110706|3556350|B1||Class III|Baseline MGFA Clinical Classification Grade|Class I- Any ocular muscle weakness, may have weakness of eye closure, all other muscle strength is normal. Class II – Mild weakness affecting other than ocular muscles, may also have ocular muscle weakness of any severity. Class III – Moderate weakness affecting other than ocular muscles, may also have ocular muscle weakness of any severity. Class IV – Severe weakness affecting other than ocular muscles, may also have ocular muscle weakness of any severity. A higher grade is indicative of a worse outcome.|Participants|Count of Participants|9|9.0||||||
3717608|NCT02110706|3556348|B3||Class II|Baseline MGFA Clinical Classification Grade|Class I- Any ocular muscle weakness, may have weakness of eye closure, all other muscle strength is normal. Class II – Mild weakness affecting other than ocular muscles, may also have ocular muscle weakness of any severity. Class III – Moderate weakness affecting other than ocular muscles, may also have ocular muscle weakness of any severity. Class IV – Severe weakness affecting other than ocular muscles, may also have ocular muscle weakness of any severity. A higher grade is indicative of a worse outcome.|Participants|Count of Participants|31|31.0||||||
3717670|NCT02110381|3556389|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717671|NCT02110381|3556390|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717672|NCT02110381|3556391|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717609|NCT02110706|3556349|B2||Class II|Baseline MGFA Clinical Classification Grade|Class I- Any ocular muscle weakness, may have weakness of eye closure, all other muscle strength is normal. Class II – Mild weakness affecting other than ocular muscles, may also have ocular muscle weakness of any severity. Class III – Moderate weakness affecting other than ocular muscles, may also have ocular muscle weakness of any severity. Class IV – Severe weakness affecting other than ocular muscles, may also have ocular muscle weakness of any severity. A higher grade is indicative of a worse outcome.|Participants|Count of Participants|16|16.0||||||
3717610|NCT02110706|3556350|B1||Class II|Baseline MGFA Clinical Classification Grade|Class I- Any ocular muscle weakness, may have weakness of eye closure, all other muscle strength is normal. Class II – Mild weakness affecting other than ocular muscles, may also have ocular muscle weakness of any severity. Class III – Moderate weakness affecting other than ocular muscles, may also have ocular muscle weakness of any severity. Class IV – Severe weakness affecting other than ocular muscles, may also have ocular muscle weakness of any severity. A higher grade is indicative of a worse outcome.|Participants|Count of Participants|15|15.0||||||
3717611|NCT02110706|3556348|B3||Class I|Baseline MGFA Clinical Classification Grade|Class I- Any ocular muscle weakness, may have weakness of eye closure, all other muscle strength is normal. Class II – Mild weakness affecting other than ocular muscles, may also have ocular muscle weakness of any severity. Class III – Moderate weakness affecting other than ocular muscles, may also have ocular muscle weakness of any severity. Class IV – Severe weakness affecting other than ocular muscles, may also have ocular muscle weakness of any severity. A higher grade is indicative of a worse outcome.|Participants|Count of Participants|1|1.0||||||
3717612|NCT02110706|3556349|B2||Class I|Baseline MGFA Clinical Classification Grade|Class I- Any ocular muscle weakness, may have weakness of eye closure, all other muscle strength is normal. Class II – Mild weakness affecting other than ocular muscles, may also have ocular muscle weakness of any severity. Class III – Moderate weakness affecting other than ocular muscles, may also have ocular muscle weakness of any severity. Class IV – Severe weakness affecting other than ocular muscles, may also have ocular muscle weakness of any severity. A higher grade is indicative of a worse outcome.|Participants|Count of Participants|1|1.0||||||
3717613|NCT02110706|3556350|B1||Class I|Baseline MGFA Clinical Classification Grade|Class I- Any ocular muscle weakness, may have weakness of eye closure, all other muscle strength is normal. Class II – Mild weakness affecting other than ocular muscles, may also have ocular muscle weakness of any severity. Class III – Moderate weakness affecting other than ocular muscles, may also have ocular muscle weakness of any severity. Class IV – Severe weakness affecting other than ocular muscles, may also have ocular muscle weakness of any severity. A higher grade is indicative of a worse outcome.|Participants|Count of Participants|0|0.0||||||
3717614|NCT02110706|3556348|B3|||Baseline MG-Quality of Life (MG-QOL) score|The subject completes the 15-question MG-QOL questionnaire and reports the effect of MG on their quality of life. The MG-QOL should be administered prior to other outcomes evaluations at each visit.The maximum score is 60 and the minimum is 0. A higher score indicates more severe disease.|units on a scale|Mean|20.1|20.1|Standard Deviation|12.5|12.5|||
3717615|NCT02110706|3556349|B2|||Baseline MG-Quality of Life (MG-QOL) score|The subject completes the 15-question MG-QOL questionnaire and reports the effect of MG on their quality of life. The MG-QOL should be administered prior to other outcomes evaluations at each visit.The maximum score is 60 and the minimum is 0. A higher score indicates more severe disease.|units on a scale|Mean|17.7|17.7|Standard Deviation|10.6|10.6|||
3717616|NCT02110706|3556350|B1|||Baseline MG-Quality of Life (MG-QOL) score|The subject completes the 15-question MG-QOL questionnaire and reports the effect of MG on their quality of life. The MG-QOL should be administered prior to other outcomes evaluations at each visit.The maximum score is 60 and the minimum is 0. A higher score indicates more severe disease.|units on a scale|Mean|22.7|22.7|Standard Deviation|14.1|14.1|||
3717617|NCT02110706|3556348|B3|||Baseline MG-Activities of Daily Living Score|This 8 point scale with a maximum score of 24 and a minimum of 0 assesses the subject’s ability to perform daily activities and can be performed in approximately 5 minutes. A higher score indicates more severe disease.|units on a scale|Mean|4.9|4.9|Standard Deviation|3.6|3.6|||
3717618|NCT02110706|3556349|B2|||Baseline MG-Activities of Daily Living Score|This 8 point scale with a maximum score of 24 and a minimum of 0 assesses the subject’s ability to perform daily activities and can be performed in approximately 5 minutes. A higher score indicates more severe disease.|units on a scale|Mean|4.0|4.0|Standard Deviation|3.4|3.4|||
3717619|NCT02110706|3556350|B1|||Baseline MG-Activities of Daily Living Score|This 8 point scale with a maximum score of 24 and a minimum of 0 assesses the subject’s ability to perform daily activities and can be performed in approximately 5 minutes. A higher score indicates more severe disease.|units on a scale|Mean|5.8|5.8|Standard Deviation|3.6|3.6|||
3717620|NCT02110706|3556348|B3|||Baseline Quantitative Myasthenia Gravis (QMG)|The Quantitative Myasthenia Gravis Score (QMG) is a commonly used objective outcome measure in myasthenia gravis (MG) comprising 13 items measuring ocular, bulbar, extremity fatigue/strength, and respiratory function (forced vital capacity), each with a possible score from 0 to 3, and a maximum possible of 39 points, where a higher score indicates more severe disease.|units on a scale|Mean|10.1|10.1|Standard Deviation|4.5|4.5|||
3717621|NCT02110706|3556349|B2|||Baseline Quantitative Myasthenia Gravis (QMG)|The Quantitative Myasthenia Gravis Score (QMG) is a commonly used objective outcome measure in myasthenia gravis (MG) comprising 13 items measuring ocular, bulbar, extremity fatigue/strength, and respiratory function (forced vital capacity), each with a possible score from 0 to 3, and a maximum possible of 39 points, where a higher score indicates more severe disease.|units on a scale|Mean|9.2|9.2|Standard Deviation|3.9|3.9|||
3717622|NCT02110706|3556350|B1|||Baseline Quantitative Myasthenia Gravis (QMG)|The Quantitative Myasthenia Gravis Score (QMG) is a commonly used objective outcome measure in myasthenia gravis (MG) comprising 13 items measuring ocular, bulbar, extremity fatigue/strength, and respiratory function (forced vital capacity), each with a possible score from 0 to 3, and a maximum possible of 39 points, where a higher score indicates more severe disease.|units on a scale|Mean|11.0|11.0|Standard Deviation|5.1|5.1|||
3717673|NCT02110381|3556389|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3717674|NCT02110381|3556390|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3717675|NCT02110381|3556391|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3717623|NCT02110706|3556348|B3|||Baseline Myasthenia Gravis Composite (MGC)|The Myasthenia Gravis Composite (MGC) scale consists of test items from the MG-ADL (Myasthenia Gravis Activities of Daily Living) scale and the QMG (Quantitative Myasthenia Gravis Scale) that measure symptoms and signs of MG, with weighted response options. The minimum score is 0, and the maximum score is 50. Higher scores correlate with clinical worsening of the disease.|units on a scale|Mean|9.8|9.8|Standard Deviation|5.2|5.2|||
3717624|NCT02110706|3556349|B2|||Baseline Myasthenia Gravis Composite (MGC)|The Myasthenia Gravis Composite (MGC) scale consists of test items from the MG-ADL (Myasthenia Gravis Activities of Daily Living) scale and the QMG (Quantitative Myasthenia Gravis Scale) that measure symptoms and signs of MG, with weighted response options. The minimum score is 0, and the maximum score is 50. Higher scores correlate with clinical worsening of the disease.|units on a scale|Mean|8.5|8.5|Standard Deviation|4.0|4.0|||
3717625|NCT02110706|3556350|B1|||Baseline Myasthenia Gravis Composite (MGC)|The Myasthenia Gravis Composite (MGC) scale consists of test items from the MG-ADL (Myasthenia Gravis Activities of Daily Living) scale and the QMG (Quantitative Myasthenia Gravis Scale) that measure symptoms and signs of MG, with weighted response options. The minimum score is 0, and the maximum score is 50. Higher scores correlate with clinical worsening of the disease.|units on a scale|Mean|11.1|11.1|Standard Deviation|6.1|6.1|||
3717626|NCT02110706|3556348|B3|||Baseline Prednisone Dose||mg/day|Mean|22.1|22.1|Standard Deviation|9.7|9.7|||
3717627|NCT02110706|3556349|B2|||Baseline Prednisone Dose||mg/day|Mean|21.3|21.3|Standard Deviation|8.3|8.3|||
3717628|NCT02110706|3556350|B1|||Baseline Prednisone Dose||mg/day|Mean|23|23.0|Standard Deviation|11.2|11.2|||
3717629|NCT02110706|3556348|B3|Race and ethnicity|Non-Hispanic white|Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
3717630|NCT02110706|3556349|B2|Race and ethnicity|Non-Hispanic white|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3717631|NCT02110706|3556350|B1|Race and ethnicity|Non-Hispanic white|Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3717632|NCT02110706|3556348|B3|Race and ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3717633|NCT02110706|3556349|B2|Race and ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3717634|NCT02110706|3556350|B1|Race and ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3717635|NCT02110706|3556348|B3|Race and ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3717636|NCT02110706|3556349|B2|Race and ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3717637|NCT02110706|3556350|B1|Race and ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3717638|NCT02110706|3556348|B3|Race and ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3717639|NCT02110706|3556349|B2|Race and ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3717640|NCT02110706|3556350|B1|Race and ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3717641|NCT02110706|3556348|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3717642|NCT02110706|3556349|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3717643|NCT02110706|3556350|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3717644|NCT02110706|3556348|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3717645|NCT02110706|3556349|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3717646|NCT02110706|3556350|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3717647|NCT02110706|3556348|B3|||Age||years|Mean|55.1|55.1|Standard Deviation|17.1|17.1|||
3717648|NCT02110706|3556349|B2|||Age||years|Mean|56.8|56.8|Standard Deviation|17.0|17.0|||
3717649|NCT02110706|3556350|B1|||Age||years|Mean|53.2|53.2|Standard Deviation|17.5|17.5|||
3717650|NCT02110693|3556363|B1|United States||Region of Enrollment||participants|Number|2000|2000.0||||||
3717651|NCT02110693|3556363|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
3717652|NCT02110693|3556363|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3717653|NCT02110693|3556363|B1||White|Race (NIH/OMB)||Participants|Count of Participants|667|667.0||||||
3717654|NCT02110693|3556363|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1112|1112.0||||||
3717655|NCT02110693|3556363|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717656|NCT02110693|3556363|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3717657|NCT02110693|3556363|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3717658|NCT02110693|3556363|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3717659|NCT02110693|3556363|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1761|1761.0||||||
3717660|NCT02110693|3556363|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|233|233.0||||||
3717661|NCT02110693|3556363|B1||Male|Sex: Female, Male||Participants|Count of Participants|874|874.0||||||
3717662|NCT02110693|3556363|B1||Female|Sex: Female, Male||Participants|Count of Participants|1124|1124.0||||||
3717663|NCT02110693|3556363|B1|||Age||years|Mean|46.0|46.0|Standard Deviation|14.7|14.7|||
3717664|NCT02110381|3556389|B3|||Systolic Blood pressure (mmHg)||mmHg|Mean|129.06|129.06|Standard Deviation|9.00|9.0|||
3717665|NCT02110381|3556390|B2|||Systolic Blood pressure (mmHg)||mmHg|Mean|133.57|133.57|Standard Deviation|17.89|17.89|||
3717666|NCT02110381|3556391|B1|||Systolic Blood pressure (mmHg)||mmHg|Mean|127.33|127.33|Standard Deviation|10.15|10.15|||
3717667|NCT02110381|3556389|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3717668|NCT02110381|3556390|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717669|NCT02110381|3556391|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3717676|NCT02110381|3556389|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3717677|NCT02110381|3556390|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3717678|NCT02110381|3556391|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717679|NCT02110381|3556389|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717680|NCT02110381|3556390|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717681|NCT02110381|3556391|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717682|NCT02110381|3556389|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3717683|NCT02110381|3556390|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3717684|NCT02110381|3556391|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717685|NCT02110381|3556389|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3717686|NCT02110381|3556390|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717687|NCT02110381|3556391|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3717688|NCT02110381|3556389|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3717689|NCT02110381|3556390|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3717690|NCT02110381|3556391|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3717691|NCT02110381|3556389|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3717692|NCT02110381|3556390|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3717693|NCT02110381|3556391|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3717694|NCT02110381|3556389|B3|||Age||years|Mean|54.59|54.59|Standard Deviation|14.85|14.85|||
3717695|NCT02110381|3556390|B2|||Age||years|Mean|52.67|52.67|Standard Deviation|15.48|15.48|||
3717696|NCT02110381|3556391|B1|||Age||years|Mean|56.75|56.75|Standard Deviation|14.85|14.85|||
3717697|NCT02110238|3556408|B3||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3717698|NCT02110238|3556409|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3717699|NCT02110238|3556410|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3717700|NCT02110238|3556408|B3||Female|Sex: Female, Male||Participants|Count of Participants|273|273.0||||||
3717701|NCT02110238|3556409|B2||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3717702|NCT02110238|3556410|B1||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3717703|NCT02110238|3556408|B3|||Age||years|Mean|60.1|60.1|Standard Deviation|9.34|9.34|||
3717704|NCT02110238|3556409|B2|||Age||years|Mean|59.3|59.3|Standard Deviation|9.30|9.3|||
3717705|NCT02110238|3556410|B1|||Age||years|Mean|60.9|60.9|Standard Deviation|9.33|9.33|||
3717706|NCT02110147|3556417|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3717707|NCT02110147|3556417|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3717708|NCT02110147|3556417|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3717709|NCT02110147|3556417|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3717710|NCT02110147|3556417|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3717711|NCT02110147|3556417|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3717712|NCT02109809|3556423|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3717713|NCT02109809|3556423|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3717714|NCT02109809|3556423|B1|||Age||years|Mean|46|46.0|Standard Deviation|16|16.0|||
3717715|NCT02109731|3556429|B1|||BMI||kilograms per meter squared|Mean|32.9|32.9|Standard Deviation|6.3|6.3|||
3717716|NCT02109731|3556429|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3717717|NCT02109731|3556429|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717718|NCT02109731|3556429|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717719|NCT02109731|3556429|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3717720|NCT02109731|3556429|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3717721|NCT02109731|3556429|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717722|NCT02109731|3556429|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717723|NCT02109731|3556429|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717724|NCT02109731|3556429|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3717725|NCT02109731|3556429|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3717726|NCT02109731|3556429|B1|||Age||years|Mean|57.8|57.8|Standard Deviation|13.27|13.27|||
3717727|NCT02109640|3556433|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717728|NCT02109640|3556434|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717729|NCT02109640|3556435|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717730|NCT02109640|3556433|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717731|NCT02109640|3556434|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717732|NCT02109640|3556435|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717733|NCT02109640|3556433|B3||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3717734|NCT02109640|3556434|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3717736|NCT02109640|3556433|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717737|NCT02109640|3556434|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717738|NCT02109640|3556435|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717739|NCT02109640|3556433|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717740|NCT02109640|3556434|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717741|NCT02109640|3556435|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717742|NCT02109640|3556433|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717743|NCT02109640|3556434|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717744|NCT02109640|3556435|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717745|NCT02109640|3556433|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717746|NCT02109640|3556434|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717747|NCT02109640|3556435|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717748|NCT02109640|3556433|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3717749|NCT02109640|3556434|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3717750|NCT02109640|3556435|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3717751|NCT02109640|3556433|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3717752|NCT02109640|3556434|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3717753|NCT02109640|3556435|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3717754|NCT02109640|3556433|B3||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
3717755|NCT02109640|3556434|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3717756|NCT02109640|3556435|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3717757|NCT02109640|3556433|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3717758|NCT02109640|3556434|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3717759|NCT02109640|3556435|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3717760|NCT02109640|3556433|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3717761|NCT02109640|3556434|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3717762|NCT02109640|3556435|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3717763|NCT02109562|3556446|B4|||Age at First Schizophrenia Diagnosis||years|Mean|26.3|26.3|Standard Deviation|8.66|8.66|||
3717764|NCT02109562|3556447|B3|||Age at First Schizophrenia Diagnosis||years|Mean|26.6|26.6|Standard Deviation|9.25|9.25|||
3717765|NCT02109562|3556448|B2|||Age at First Schizophrenia Diagnosis||years|Mean|26.9|26.9|Standard Deviation|8.48|8.48|||
3717766|NCT02109562|3556449|B1|||Age at First Schizophrenia Diagnosis||years|Mean|25.5|25.5|Standard Deviation|8.21|8.21|||
3717767|NCT02109562|3556446|B4||No|Previous Antipsychotic Treatment||Participants|Count of Participants|2|2.0||||||
3717768|NCT02109562|3556447|B3||No|Previous Antipsychotic Treatment||Participants|Count of Participants|0|0.0||||||
3717769|NCT02109562|3556448|B2||No|Previous Antipsychotic Treatment||Participants|Count of Participants|1|1.0||||||
3717770|NCT02109562|3556449|B1||No|Previous Antipsychotic Treatment||Participants|Count of Participants|1|1.0||||||
3717771|NCT02109562|3556446|B4||Yes|Previous Antipsychotic Treatment||Participants|Count of Participants|348|348.0||||||
3717772|NCT02109562|3556447|B3||Yes|Previous Antipsychotic Treatment||Participants|Count of Participants|118|118.0||||||
3717773|NCT02109562|3556448|B2||Yes|Previous Antipsychotic Treatment||Participants|Count of Participants|116|116.0||||||
3717774|NCT02109562|3556449|B1||Yes|Previous Antipsychotic Treatment||Participants|Count of Participants|114|114.0||||||
3717775|NCT02109562|3556446|B4|||Waist-to-Hip Ratio|A measurement of abdominal fat.|ratio|Mean|0.942|0.942|Standard Deviation|0.080|0.08|||
3717776|NCT02109562|3556447|B3|||Waist-to-Hip Ratio|A measurement of abdominal fat.|ratio|Mean|0.944|0.944|Standard Deviation|0.090|0.09|||
3717777|NCT02109562|3556448|B2|||Waist-to-Hip Ratio|A measurement of abdominal fat.|ratio|Mean|0.936|0.936|Standard Deviation|0.072|0.072|||
3717778|NCT02109562|3556449|B1|||Waist-to-Hip Ratio|A measurement of abdominal fat.|ratio|Mean|0.947|0.947|Standard Deviation|0.078|0.078|||
3717779|NCT02109562|3556446|B4|||Body Mass Index||kg/m^2|Mean|29.890|29.89|Standard Deviation|6.667|6.667|||
3717780|NCT02109562|3556447|B3|||Body Mass Index||kg/m^2|Mean|30.706|30.706|Standard Deviation|7.293|7.293|||
3717781|NCT02109562|3556448|B2|||Body Mass Index||kg/m^2|Mean|29.376|29.376|Standard Deviation|6.664|6.664|||
3717782|NCT02109562|3556449|B1|||Body Mass Index||kg/m^2|Mean|29.576|29.576|Standard Deviation|5.938|5.938|||
3717783|NCT02109562|3556446|B4|||Height||cm|Mean|174.1|174.1|Standard Deviation|10.02|10.02|||
3717784|NCT02109562|3556447|B3|||Height||cm|Mean|173.1|173.1|Standard Deviation|10.91|10.91|||
3717785|NCT02109562|3556448|B2|||Height||cm|Mean|174.3|174.3|Standard Deviation|9.95|9.95|||
3717786|NCT02109562|3556449|B1|||Height||cm|Mean|175.1|175.1|Standard Deviation|9.09|9.09|||
3717787|NCT02109562|3556446|B4|||Weight||kg|Mean|90.49|90.49|Standard Deviation|20.802|20.802|||
3717788|NCT02109562|3556447|B3|||Weight||kg|Mean|91.84|91.84|Standard Deviation|22.885|22.885|||
3717789|NCT02109562|3556448|B2|||Weight||kg|Mean|89.01|89.01|Standard Deviation|20.462|20.462|||
3717790|NCT02109562|3556449|B1|||Weight||kg|Mean|90.60|90.6|Standard Deviation|18.895|18.895|||
3717791|NCT02109562|3556446|B4||Other|Race/Ethnicity, Customized|Race|Participants|Count of Participants|3|3.0||||||
3717792|NCT02109562|3556447|B3||Other|Race/Ethnicity, Customized|Race|Participants|Count of Participants|1|1.0||||||
3717793|NCT02109562|3556448|B2||Other|Race/Ethnicity, Customized|Race|Participants|Count of Participants|0|0.0||||||
3717794|NCT02109562|3556449|B1||Other|Race/Ethnicity, Customized|Race|Participants|Count of Participants|2|2.0||||||
3717795|NCT02109562|3556446|B4||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized|Race|Participants|Count of Participants|3|3.0||||||
3717796|NCT02109562|3556447|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized|Race|Participants|Count of Participants|1|1.0||||||
3717797|NCT02109562|3556448|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized|Race|Participants|Count of Participants|1|1.0||||||
3717798|NCT02109562|3556449|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized|Race|Participants|Count of Participants|1|1.0||||||
3717799|NCT02109562|3556446|B4||American Indian or Alaska Native|Race/Ethnicity, Customized|Race|Participants|Count of Participants|0|0.0||||||
3717800|NCT02109562|3556447|B3||American Indian or Alaska Native|Race/Ethnicity, Customized|Race|Participants|Count of Participants|0|0.0||||||
3717801|NCT02109562|3556448|B2||American Indian or Alaska Native|Race/Ethnicity, Customized|Race|Participants|Count of Participants|0|0.0||||||
3717802|NCT02109562|3556449|B1||American Indian or Alaska Native|Race/Ethnicity, Customized|Race|Participants|Count of Participants|0|0.0||||||
3717803|NCT02109562|3556446|B4||Asian|Race/Ethnicity, Customized|Race|Participants|Count of Participants|5|5.0||||||
3717804|NCT02109562|3556447|B3||Asian|Race/Ethnicity, Customized|Race|Participants|Count of Participants|1|1.0||||||
3717805|NCT02109562|3556448|B2||Asian|Race/Ethnicity, Customized|Race|Participants|Count of Participants|3|3.0||||||
3717806|NCT02109562|3556449|B1||Asian|Race/Ethnicity, Customized|Race|Participants|Count of Participants|1|1.0||||||
3717807|NCT02109562|3556446|B4||Black or African American|Race/Ethnicity, Customized|Race|Participants|Count of Participants|254|254.0||||||
3717808|NCT02109562|3556447|B3||Black or African American|Race/Ethnicity, Customized|Race|Participants|Count of Participants|88|88.0||||||
3717809|NCT02109562|3556448|B2||Black or African American|Race/Ethnicity, Customized|Race|Participants|Count of Participants|83|83.0||||||
3717810|NCT02109562|3556449|B1||Black or African American|Race/Ethnicity, Customized|Race|Participants|Count of Participants|83|83.0||||||
3717811|NCT02109562|3556446|B4||White|Race/Ethnicity, Customized|Race|Participants|Count of Participants|85|85.0||||||
3717812|NCT02109562|3556447|B3||White|Race/Ethnicity, Customized|Race|Participants|Count of Participants|27|27.0||||||
3717813|NCT02109562|3556448|B2||White|Race/Ethnicity, Customized|Race|Participants|Count of Participants|30|30.0||||||
3717814|NCT02109562|3556449|B1||White|Race/Ethnicity, Customized|Race|Participants|Count of Participants|28|28.0||||||
3717815|NCT02109562|3556446|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3717816|NCT02109562|3556447|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3717817|NCT02109562|3556448|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3717818|NCT02109562|3556449|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717819|NCT02109562|3556446|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|322|322.0||||||
3717820|NCT02109562|3556447|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
3717821|NCT02109562|3556448|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
3717822|NCT02109562|3556449|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
3717823|NCT02109562|3556446|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3717824|NCT02109562|3556447|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3717825|NCT02109562|3556448|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3717826|NCT02109562|3556449|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3717827|NCT02109562|3556446|B4||Male|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
3717828|NCT02109562|3556447|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3717829|NCT02109562|3556448|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3717830|NCT02109562|3556449|B1||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3717831|NCT02109562|3556446|B4||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3717832|NCT02109562|3556447|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3717833|NCT02109562|3556448|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3717834|NCT02109562|3556449|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3717835|NCT02109562|3556446|B4||51 to 55 years|Age, Customized||Participants|Count of Participants|63|63.0||||||
3717836|NCT02109562|3556447|B3||51 to 55 years|Age, Customized||Participants|Count of Participants|24|24.0||||||
3717837|NCT02109562|3556448|B2||51 to 55 years|Age, Customized||Participants|Count of Participants|20|20.0||||||
3717838|NCT02109562|3556449|B1||51 to 55 years|Age, Customized||Participants|Count of Participants|19|19.0||||||
3717839|NCT02109562|3556446|B4||41 to 50 years|Age, Customized||Participants|Count of Participants|133|133.0||||||
3717840|NCT02109562|3556447|B3||41 to 50 years|Age, Customized||Participants|Count of Participants|49|49.0||||||
3717841|NCT02109562|3556448|B2||41 to 50 years|Age, Customized||Participants|Count of Participants|43|43.0||||||
3717842|NCT02109562|3556449|B1||41 to 50 years|Age, Customized||Participants|Count of Participants|41|41.0||||||
3717843|NCT02109562|3556446|B4||31 to 40 years|Age, Customized||Participants|Count of Participants|98|98.0||||||
3717844|NCT02109562|3556447|B3||31 to 40 years|Age, Customized||Participants|Count of Participants|28|28.0||||||
3717845|NCT02109562|3556448|B2||31 to 40 years|Age, Customized||Participants|Count of Participants|32|32.0||||||
3717846|NCT02109562|3556449|B1||31 to 40 years|Age, Customized||Participants|Count of Participants|38|38.0||||||
3717847|NCT02109562|3556446|B4||21 to 30 years|Age, Customized||Participants|Count of Participants|52|52.0||||||
3717848|NCT02109562|3556447|B3||21 to 30 years|Age, Customized||Participants|Count of Participants|16|16.0||||||
3717849|NCT02109562|3556448|B2||21 to 30 years|Age, Customized||Participants|Count of Participants|20|20.0||||||
3717850|NCT02109562|3556449|B1||21 to 30 years|Age, Customized||Participants|Count of Participants|16|16.0||||||
3717851|NCT02109562|3556446|B4||20 years and under|Age, Customized||Participants|Count of Participants|4|4.0||||||
3717852|NCT02109562|3556447|B3||20 years and under|Age, Customized||Participants|Count of Participants|1|1.0||||||
3717853|NCT02109562|3556448|B2||20 years and under|Age, Customized||Participants|Count of Participants|2|2.0||||||
3717854|NCT02109562|3556449|B1||20 years and under|Age, Customized||Participants|Count of Participants|1|1.0||||||
3717855|NCT02109562|3556446|B4|||Age||years|Mean|41.1|41.1|Standard Deviation|9.33|9.33|||
3717856|NCT02109562|3556447|B3|||Age||years|Mean|42.4|42.4|Standard Deviation|9.07|9.07|||
3717857|NCT02109562|3556448|B2|||Age||years|Mean|40.6|40.6|Standard Deviation|9.45|9.45|||
3717858|NCT02109562|3556449|B1|||Age||years|Mean|40.5|40.5|Standard Deviation|9.41|9.41|||
3717859|NCT02109497|3556465|B1|||BMI||kg/m^2|Mean|24.05|24.05|Standard Deviation|2.46|2.46|||
3717860|NCT02109497|3556465|B1|Australia||Region of Enrollment||participants|Number|18|18.0||||||
3717861|NCT02109497|3556465|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717862|NCT02109497|3556465|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717863|NCT02109497|3556465|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3717864|NCT02109497|3556465|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717865|NCT02109497|3556465|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717866|NCT02109497|3556465|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3717867|NCT02109497|3556465|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717868|NCT02109497|3556465|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717869|NCT02109497|3556465|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3717870|NCT02109497|3556465|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3717871|NCT02109497|3556465|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3717872|NCT02109497|3556465|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3717873|NCT02109497|3556465|B1|||Age||years|Mean|25.6|25.6|Standard Deviation|5.5|5.5|||
3717874|NCT02109484|3556470|B9|South Africa||Region of Enrollment||participants|Number|204|204.0||||||
3717875|NCT02109484|3556471|B8|South Africa||Region of Enrollment||participants|Number|50|50.0||||||
3717876|NCT02109484|3556472|B7|South Africa||Region of Enrollment||participants|Number|50|50.0||||||
3717877|NCT02109484|3556473|B6|South Africa||Region of Enrollment||participants|Number|12|12.0||||||
3717878|NCT02109484|3556474|B5|South Africa||Region of Enrollment||participants|Number|50|50.0||||||
3717879|NCT02109484|3556475|B4|South Africa||Region of Enrollment||participants|Number|12|12.0||||||
3717880|NCT02109484|3556476|B3|South Africa||Region of Enrollment||participants|Number|12|12.0||||||
3717881|NCT02109484|3556477|B2|South Africa||Region of Enrollment||participants|Number|13|13.0||||||
3717882|NCT02109484|3556478|B1|South Africa||Region of Enrollment||participants|Number|5|5.0||||||
3717883|NCT02109484|3556470|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717884|NCT02109484|3556471|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717885|NCT02109484|3556472|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717886|NCT02109484|3556473|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717887|NCT02109484|3556474|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717888|NCT02109484|3556475|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717889|NCT02109484|3556476|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717890|NCT02109484|3556477|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717891|NCT02109484|3556478|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717892|NCT02109484|3556470|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3717893|NCT02109484|3556471|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717894|NCT02109484|3556472|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3717895|NCT02109484|3556473|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717896|NCT02109484|3556474|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717897|NCT02109484|3556475|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717898|NCT02109484|3556476|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717899|NCT02109484|3556477|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3717900|NCT02109484|3556478|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717901|NCT02109484|3556470|B9||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717902|NCT02109484|3556471|B8||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717903|NCT02109484|3556472|B7||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717904|NCT02109484|3556473|B6||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717905|NCT02109484|3556474|B5||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717906|NCT02109484|3556475|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717907|NCT02109484|3556476|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717908|NCT02109484|3556477|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717909|NCT02109484|3556478|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717910|NCT02109484|3556470|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|202|202.0||||||
3717911|NCT02109484|3556471|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3717912|NCT02109484|3556472|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3717913|NCT02109484|3556473|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3717914|NCT02109484|3556474|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3717915|NCT02109484|3556475|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3717916|NCT02109484|3556476|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3717917|NCT02109484|3556477|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3717918|NCT02109484|3556478|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3717919|NCT02109484|3556470|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717920|NCT02109484|3556471|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717921|NCT02109484|3556472|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717922|NCT02109484|3556473|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717923|NCT02109484|3556474|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717924|NCT02109484|3556475|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717925|NCT02109484|3556476|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717926|NCT02109484|3556477|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717927|NCT02109484|3556478|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717928|NCT02109484|3556470|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717929|NCT02109484|3556471|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717930|NCT02109484|3556472|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717931|NCT02109484|3556473|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717932|NCT02109484|3556474|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717933|NCT02109484|3556475|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717934|NCT02109484|3556476|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717935|NCT02109484|3556477|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717936|NCT02109484|3556478|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717937|NCT02109484|3556470|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717938|NCT02109484|3556471|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717939|NCT02109484|3556472|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717940|NCT02109484|3556473|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717941|NCT02109484|3556474|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717942|NCT02109484|3556475|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717943|NCT02109484|3556476|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717944|NCT02109484|3556477|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717945|NCT02109484|3556478|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3717946|NCT02109484|3556470|B9||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3717947|NCT02109484|3556471|B8||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3717948|NCT02109484|3556472|B7||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3717949|NCT02109484|3556473|B6||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3717950|NCT02109484|3556474|B5||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3717951|NCT02109484|3556475|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3717952|NCT02109484|3556476|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3717953|NCT02109484|3556477|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3717954|NCT02109484|3556478|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3717955|NCT02109484|3556470|B9||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3717956|NCT02109484|3556471|B8||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3717957|NCT02109484|3556472|B7||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3717958|NCT02109484|3556473|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3717959|NCT02109484|3556474|B5||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3717960|NCT02109484|3556475|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3717961|NCT02109484|3556476|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3717962|NCT02109484|3556477|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3717963|NCT02109484|3556478|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3717964|NCT02109484|3556470|B9|||Age||weeks|Mean|72.8|72.8|Full Range|||6.1|152.0|
3717965|NCT02109484|3556471|B8|||Age||weeks|Mean|6.7|6.7|Full Range|||6.1|8.0|
3717966|NCT02109484|3556472|B7|||Age||weeks|Mean|6.6|6.6|Full Range|||6.1|7.7|
3717967|NCT02109484|3556473|B6|||Age||weeks|Mean|6.6|6.6|Full Range|||6.3|7.0|
3717968|NCT02109484|3556474|B5|||Age||weeks|Mean|6.6|6.6|Full Range|||6.1|7.7|
3717969|NCT02109484|3556475|B4|||Age||weeks|Mean|144.7|144.7|Full Range|||139.0|152.0|
3717970|NCT02109484|3556476|B3|||Age||weeks|Mean|139.0|139.0|Full Range|||126.0|152.0|
3717971|NCT02109484|3556477|B2|||Age||weeks|Mean|135.6|135.6|Full Range|||122.0|143.0|
3717972|NCT02109484|3556478|B1|||Age||weeks|Mean|136.4|136.4|Full Range|||126.0|143.0|
3717973|NCT02109458|3556534|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3717974|NCT02109458|3556534|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3717975|NCT02109458|3556534|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3717976|NCT02109458|3556534|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3717977|NCT02109458|3556534|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3717978|NCT02109458|3556534|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3717979|NCT02109445|3556541|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3717980|NCT02109445|3556541|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3717981|NCT02109445|3556541|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|4.7|4.7|||
3717982|NCT02109172|3556574|B1||Male|Gender||Participants|Count of Participants|37|37.0||||||
3717983|NCT02109172|3556574|B1||Female|Gender||Participants|Count of Participants|27|27.0||||||
3717984|NCT02109172|3556574|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3717985|NCT02109172|3556574|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3717986|NCT02109172|3556574|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3717987|NCT02109159|3556587|B3|Journals||Source of contact||participants|Number|5782|5782.0||||||
3717988|NCT02109159|3556588|B2|Journals||Source of contact||participants|Number|2912|2912.0||||||
3717989|NCT02109159|3556589|B1|Journals||Source of contact||participants|Number|2870|2870.0||||||
3717990|NCT02109159|3556587|B3|WOMAN trial contact list||Source of contact||participants|Number|2571|2571.0||||||
3717991|NCT02109159|3556588|B2|WOMAN trial contact list||Source of contact||participants|Number|1263|1263.0||||||
3717992|NCT02109159|3556589|B1|WOMAN trial contact list||Source of contact||participants|Number|1308|1308.0||||||
3717993|NCT02109159|3556587|B3|High income countries||Economic classification of countries||participants|Number|4604|4604.0||||||
3717994|NCT02109159|3556588|B2|High income countries||Economic classification of countries||participants|Number|2331|2331.0||||||
3717995|NCT02109159|3556589|B1|High income countries||Economic classification of countries||participants|Number|2273|2273.0||||||
3717996|NCT02109159|3556587|B3|Upper-middle income countries||Economic classification of countries||participants|Number|1050|1050.0||||||
3717997|NCT02109159|3556588|B2|Upper-middle income countries||Economic classification of countries||participants|Number|543|543.0||||||
3717998|NCT02109159|3556589|B1|Upper-middle income countries||Economic classification of countries||participants|Number|507|507.0||||||
3717999|NCT02109159|3556587|B3|Lower-middle income countries||Economic classification of countries||participants|Number|1778|1778.0||||||
3718000|NCT02109159|3556588|B2|Lower-middle income countries||Economic classification of countries||participants|Number|844|844.0||||||
3718001|NCT02109159|3556589|B1|Lower-middle income countries||Economic classification of countries||participants|Number|934|934.0||||||
3718002|NCT02109159|3556587|B3|Low income countries||Economic classification of countries||participants|Number|921|921.0||||||
3718003|NCT02109159|3556588|B2|Low income countries||Economic classification of countries||participants|Number|457|457.0||||||
3718004|NCT02109159|3556589|B1|Low income countries||Economic classification of countries||participants|Number|464|464.0||||||
3718005|NCT02109159|3556587|B3|Unknown||Sex/Gender, Customized||participants|Number|8353|8353.0||||||
3718006|NCT02109159|3556588|B2|Unknown||Sex/Gender, Customized||participants|Number|4175|4175.0||||||
3718007|NCT02109159|3556589|B1|Unknown||Sex/Gender, Customized||participants|Number|4178|4178.0||||||
3718008|NCT02109159|3556587|B3|Unknown||Age, Customized||participants|Number|8353|8353.0||||||
3718009|NCT02109159|3556588|B2|Unknown||Age, Customized||participants|Number|4175|4175.0||||||
3718010|NCT02109159|3556589|B1|Unknown||Age, Customized||participants|Number|4178|4178.0||||||
3718011|NCT02109133|3556598|B3|Korea, Republic of||Region of Enrollment||participants|Number|66|66.0||||||
3718012|NCT02109133|3556599|B2|Korea, Republic of||Region of Enrollment||participants|Number|34|34.0||||||
3718013|NCT02109133|3556600|B1|Korea, Republic of||Region of Enrollment||participants|Number|32|32.0||||||
3718014|NCT02109133|3556598|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718015|NCT02109133|3556599|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718016|NCT02109133|3556600|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718017|NCT02109133|3556598|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718018|NCT02109133|3556599|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718019|NCT02109133|3556600|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718020|NCT02109133|3556598|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718021|NCT02109133|3556599|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718022|NCT02109133|3556600|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718023|NCT02109133|3556598|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718024|NCT02109133|3556599|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718025|NCT02109133|3556600|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718026|NCT02109133|3556598|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718027|NCT02109133|3556599|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718028|NCT02109133|3556600|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718029|NCT02109133|3556598|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3718030|NCT02109133|3556599|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3718031|NCT02109133|3556600|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3718032|NCT02109133|3556598|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718033|NCT02109133|3556599|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718034|NCT02109133|3556600|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718035|NCT02109133|3556598|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3718036|NCT02109133|3556599|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3718037|NCT02109133|3556600|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3718038|NCT02109133|3556598|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3718039|NCT02109133|3556599|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3718040|NCT02109133|3556600|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3718041|NCT02109133|3556598|B3|||Age||years|Mean|62.7|62.7|Standard Deviation|5.7|5.7|||
3718042|NCT02109133|3556599|B2|||Age||years|Mean|61.5|61.5|Standard Deviation|5.4|5.4|||
3718043|NCT02109133|3556600|B1|||Age||years|Mean|63.9|63.9|Standard Deviation|6.1|6.1|||
3718044|NCT02109133|3556598|B3||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
3718045|NCT02109133|3556599|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3718046|NCT02109133|3556600|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3718047|NCT02109133|3556598|B3||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3718048|NCT02109133|3556599|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3718049|NCT02109133|3556600|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3718050|NCT02109133|3556598|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3718051|NCT02109133|3556599|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3718052|NCT02109133|3556600|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3718053|NCT02109107|3556613|B1|United States||Region of Enrollment||participants|Number|54|54.0||||||
3718054|NCT02109107|3556613|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718055|NCT02109107|3556613|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718056|NCT02109107|3556613|B1||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3718057|NCT02109107|3556613|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3718058|NCT02109107|3556613|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718059|NCT02109107|3556613|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3718060|NCT02109107|3556613|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718061|NCT02109107|3556613|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3718062|NCT02109107|3556613|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3718063|NCT02109107|3556613|B1|||Age||years|Mean|46.39|46.39|Standard Deviation|9.83|9.83|||
3718064|NCT02109042|3556620|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3718065|NCT02109042|3556620|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718066|NCT02109042|3556620|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718067|NCT02109042|3556620|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3718068|NCT02109042|3556620|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3718069|NCT02109042|3556620|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718070|NCT02109042|3556620|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718071|NCT02109042|3556620|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718072|NCT02109042|3556620|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718073|NCT02109042|3556620|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3718074|NCT02109042|3556620|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3718075|NCT02109042|3556620|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3718076|NCT02109042|3556620|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3718077|NCT02109042|3556620|B1|||Age||years|Mean|68.6|68.6|Standard Deviation|7.0|7.0|||
3718078|NCT02108977|3556626|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3718079|NCT02108977|3556627|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3718080|NCT02108977|3556628|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3718081|NCT02108977|3556626|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3718082|NCT02108977|3556627|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3718083|NCT02108977|3556628|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3718084|NCT02108977|3556626|B3|||Age, Customized|Age data was not collected|Not collected|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3718085|NCT02108977|3556627|B2|||Age, Customized|Age data was not collected|Not collected|Number|NA|||||||Age data was not collected
3718086|NCT02108977|3556628|B1|||Age, Customized|Age data was not collected|Not collected|Number|NA|||||||Age data was not collected
3718087|NCT02108951|3556641|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3718088|NCT02108951|3556641|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3718089|NCT02108951|3556641|B1|||Age||years|Mean|53.9|53.9|Standard Deviation|15.1|15.1|||
3718090|NCT02108691|3556658|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3718091|NCT02108691|3556659|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3718092|NCT02108691|3556660|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3718093|NCT02108691|3556658|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3718094|NCT02108691|3556659|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3718095|NCT02108691|3556660|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3718096|NCT02108691|3556658|B3|||Age||years|Mean|30.59|30.59|Standard Deviation|9.25|9.25|||
3718097|NCT02108691|3556659|B2|||Age||years|Mean|30.88|30.88|Standard Deviation|9.18|9.18|||
3718098|NCT02108691|3556660|B1|||Age||years|Mean|30.30|30.3|Standard Deviation|9.42|9.42|||
3718099|NCT02108652|3556679|B1||Male|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
3718100|NCT02108652|3556679|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3718101|NCT02108652|3556679|B1|||Age||years|Mean|65.6|65.6|Standard Deviation|10.1|10.1|||
3718102|NCT02108288|3556700|B4|Japan||Region of Enrollment||participants|Number|30|30.0||||||
3718103|NCT02108288|3556701|B3|Japan||Region of Enrollment||participants|Number|10|10.0||||||
3718104|NCT02108288|3556702|B2|Japan||Region of Enrollment||participants|Number|10|10.0||||||
3718105|NCT02108288|3556703|B1|Japan||Region of Enrollment||participants|Number|10|10.0||||||
3718106|NCT02108288|3556700|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3718107|NCT02108288|3556701|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3718108|NCT02108288|3556702|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3718109|NCT02108288|3556703|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3718110|NCT02108288|3556700|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3718111|NCT02108288|3556701|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3718112|NCT02108288|3556702|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3718113|NCT02108288|3556703|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3718114|NCT02108288|3556700|B4|||Age||years|Mean|25.4|25.4|Standard Deviation|4.1|4.1|||
3718115|NCT02108288|3556701|B3|||Age||years|Mean|24.0|24.0|Standard Deviation|2.8|2.8|||
3718116|NCT02108288|3556702|B2|||Age||years|Mean|25.5|25.5|Standard Deviation|3.0|3.0|||
3718117|NCT02108288|3556703|B1|||Age||years|Mean|26.7|26.7|Standard Deviation|5.7|5.7|||
3718118|NCT02108288|3556700|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3718119|NCT02108288|3556701|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3718120|NCT02108288|3556702|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3718121|NCT02108288|3556703|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3718122|NCT02108288|3556700|B4||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3718123|NCT02108288|3556701|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3718124|NCT02108288|3556702|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3718125|NCT02108288|3556703|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3718126|NCT02108288|3556700|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3718127|NCT02108288|3556701|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3718128|NCT02108288|3556702|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3718129|NCT02108288|3556703|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3718130|NCT02108223|3556718|B4|Turkey||Region of Enrollment||participants|Number|137|137.0||||||
3718131|NCT02108223|3556719|B3|Turkey||Region of Enrollment||participants|Number|35|35.0||||||
3718132|NCT02108223|3556720|B2|Turkey||Region of Enrollment||participants|Number|50|50.0||||||
3718133|NCT02108223|3556721|B1|Turkey||Region of Enrollment||participants|Number|52|52.0||||||
3718134|NCT02108223|3556718|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3718135|NCT02108223|3556719|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3718136|NCT02108223|3556720|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3718137|NCT02108223|3556721|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3718138|NCT02108223|3556718|B4||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3718139|NCT02108223|3556719|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3718140|NCT02108223|3556720|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3718141|NCT02108223|3556721|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3718142|NCT02108223|3556718|B4|||Age||years|Mean|29.5|29.5|Standard Deviation|4.7|4.7|||
3718143|NCT02108223|3556719|B3|||Age||years|Mean|29.4|29.4|Standard Deviation|5.1|5.1|||
3718144|NCT02108223|3556720|B2|||Age||years|Mean|30.3|30.3|Standard Deviation|5.1|5.1|||
3718145|NCT02108223|3556721|B1|||Age||years|Mean|28.7|28.7|Standard Deviation|3.9|3.9|||
3718146|NCT02108223|3556718|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3718147|NCT02108223|3556719|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3718148|NCT02108223|3556720|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3718149|NCT02108223|3556721|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3718150|NCT02108223|3556718|B4||Between 18 and 65 years|Age||Participants|Count of Participants|137|137.0||||||
3718151|NCT02108223|3556719|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3718152|NCT02108223|3556720|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3718153|NCT02108223|3556721|B1||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3718154|NCT02108223|3556718|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3718155|NCT02108223|3556719|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3718156|NCT02108223|3556720|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3718157|NCT02108223|3556721|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3718158|NCT02108171|3556743|B3|Duration of surgery||Duration time||min|Mean|23.7|23.7|Standard Deviation|20.1|20.1|||
3718159|NCT02108171|3556744|B2|Duration of surgery||Duration time||min|Mean|26.1|26.1|Standard Deviation|24.7|24.7|||
3718160|NCT02108171|3556745|B1|Duration of surgery||Duration time||min|Mean|21.4|21.4|Standard Deviation|14.1|14.1|||
3718161|NCT02108171|3556743|B3|from drug administration to intubation||Duration time||min|Mean|61.5|61.5|Standard Deviation|21.2|21.2|||
3718162|NCT02108171|3556744|B2|from drug administration to intubation||Duration time||min|Mean|60.8|60.8|Standard Deviation|18.9|18.9|||
3718163|NCT02108171|3556745|B1|from drug administration to intubation||Duration time||min|Mean|62.1|62.1|Standard Deviation|23.4|23.4|||
3718164|NCT02108171|3556743|B3|from drug administration to arrival at OR||Duration time||min|Mean|40.8|40.8|Standard Deviation|19.2|19.2|||
3718165|NCT02108171|3556744|B2|from drug administration to arrival at OR||Duration time||min|Mean|39.3|39.3|Standard Deviation|18.2|18.2|||
3718166|NCT02108171|3556745|B1|from drug administration to arrival at OR||Duration time||min|Mean|42.3|42.3|Standard Deviation|20.4|20.4|||
3718167|NCT02108171|3556743|B3|||Height||cm|Mean|162.4|162.4|Standard Deviation|7.1|7.1|||
3718168|NCT02108171|3556744|B2|||Height||cm|Mean|162.2|162.2|Standard Deviation|6.1|6.1|||
3718169|NCT02108171|3556745|B1|||Height||cm|Mean|162.5|162.5|Standard Deviation|8.0|8.0|||
3718170|NCT02108171|3556743|B3|||Weight||kg|Mean|59.76|59.76|Standard Deviation|9.7|9.7|||
3718171|NCT02108171|3556744|B2|||Weight||kg|Mean|60.1|60.1|Standard Deviation|10.4|10.4|||
3718172|NCT02108171|3556745|B1|||Weight||kg|Mean|59.4|59.4|Standard Deviation|9.1|9.1|||
3718173|NCT02108171|3556743|B3|||BMI||kg per square meter|Mean|22.62|22.62|Standard Deviation|3.04|3.04|||
3718174|NCT02108171|3556744|B2|||BMI||kg per square meter|Mean|22.75|22.75|Standard Deviation|3.07|3.07|||
3718175|NCT02108171|3556745|B1|||BMI||kg per square meter|Mean|22.49|22.49|Standard Deviation|3.03|3.03|||
3718176|NCT02108171|3556743|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3718177|NCT02108171|3556744|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3718178|NCT02108171|3556745|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3718179|NCT02108171|3556743|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3718180|NCT02108171|3556744|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3718181|NCT02108171|3556745|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3718182|NCT02108171|3556743|B3|||Age||years|Mean|44.75|44.75|Standard Deviation|9.6|9.6|||
3718183|NCT02108171|3556744|B2|||Age||years|Mean|43.6|43.6|Standard Deviation|9.2|9.2|||
3718184|NCT02108171|3556745|B1|||Age||years|Mean|45.9|45.9|Standard Deviation|10.1|10.1|||
3718185|NCT02108171|3556743|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3718186|NCT02108171|3556744|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3718187|NCT02108171|3556745|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3718188|NCT02108171|3556743|B3||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
3718189|NCT02108171|3556744|B2||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3718190|NCT02108171|3556745|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3718191|NCT02108171|3556743|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3718192|NCT02108171|3556744|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3718193|NCT02108171|3556745|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3718194|NCT02107898|3556846|B3|||Calculated LDL-C in mmol/L||mmol/L|Mean|3.656|3.656|Standard Deviation|0.691|0.691|||
3718195|NCT02107898|3556847|B2|||Calculated LDL-C in mmol/L||mmol/L|Mean|3.650|3.65|Standard Deviation|0.693|0.693|||
3718196|NCT02107898|3556848|B1|||Calculated LDL-C in mmol/L||mmol/L|Mean|3.668|3.668|Standard Deviation|0.691|0.691|||
3718197|NCT02107898|3556846|B3|||Calculated LDL-C in mg/dL|Calculated LDL-C in mg/dL from Friedewald formula (LDL-C = Total cholesterol - High-density lipoprotein cholesterol [HDL-C] - [Triglyceride/5]).|mg/dL|Mean|141.2|141.2|Standard Deviation|26.7|26.7|||
3718198|NCT02107898|3556847|B2|||Calculated LDL-C in mg/dL|Calculated LDL-C in mg/dL from Friedewald formula (LDL-C = Total cholesterol - High-density lipoprotein cholesterol [HDL-C] - [Triglyceride/5]).|mg/dL|Mean|140.9|140.9|Standard Deviation|26.8|26.8|||
3718255|NCT02107703|3556902|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3718199|NCT02107898|3556848|B1|||Calculated LDL-C in mg/dL|Calculated LDL-C in mg/dL from Friedewald formula (LDL-C = Total cholesterol - High-density lipoprotein cholesterol [HDL-C] - [Triglyceride/5]).|mg/dL|Mean|141.6|141.6|Standard Deviation|26.7|26.7|||
3718200|NCT02107898|3556846|B3||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3718201|NCT02107898|3556847|B2||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3718202|NCT02107898|3556848|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3718203|NCT02107898|3556846|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3718204|NCT02107898|3556847|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3718205|NCT02107898|3556848|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3718206|NCT02107898|3556846|B3|||Age||years|Mean|60.8|60.8|Standard Deviation|9.5|9.5|||
3718207|NCT02107898|3556847|B2|||Age||years|Mean|60.3|60.3|Standard Deviation|9.7|9.7|||
3718208|NCT02107898|3556848|B1|||Age||years|Mean|61.8|61.8|Standard Deviation|9.0|9.0|||
3718209|NCT02107703|3556901|B3|South Korea||Region of Enrollment||Participants|Count of Participants|78|78.0||||||
3718210|NCT02107703|3556902|B2|South Korea||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3718211|NCT02107703|3556903|B1|South Korea||Region of Enrollment||Participants|Count of Participants|58|58.0||||||
3718212|NCT02107703|3556901|B3|Japan||Region of Enrollment||Participants|Count of Participants|95|95.0||||||
3718213|NCT02107703|3556902|B2|Japan||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3718214|NCT02107703|3556903|B1|Japan||Region of Enrollment||Participants|Count of Participants|64|64.0||||||
3718215|NCT02107703|3556901|B3|Taiwan||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3718216|NCT02107703|3556902|B2|Taiwan||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3718217|NCT02107703|3556903|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3718218|NCT02107703|3556901|B3|Europe||Region of Enrollment||Participants|Count of Participants|279|279.0||||||
3718219|NCT02107703|3556902|B2|Europe||Region of Enrollment||Participants|Count of Participants|100|100.0||||||
3718220|NCT02107703|3556903|B1|Europe||Region of Enrollment||Participants|Count of Participants|179|179.0||||||
3718221|NCT02107703|3556901|B3|North America||Region of Enrollment||Participants|Count of Participants|178|178.0||||||
3718222|NCT02107703|3556902|B2|North America||Region of Enrollment||Participants|Count of Participants|58|58.0||||||
3718223|NCT02107703|3556903|B1|North America||Region of Enrollment||Participants|Count of Participants|120|120.0||||||
3718224|NCT02107703|3556901|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3718225|NCT02107703|3556902|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3718226|NCT02107703|3556903|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3718227|NCT02107703|3556901|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718228|NCT02107703|3556902|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718229|NCT02107703|3556903|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718230|NCT02107703|3556901|B3||White|Race (NIH/OMB)||Participants|Count of Participants|373|373.0||||||
3718231|NCT02107703|3556902|B2||White|Race (NIH/OMB)||Participants|Count of Participants|136|136.0||||||
3718232|NCT02107703|3556903|B1||White|Race (NIH/OMB)||Participants|Count of Participants|237|237.0||||||
3718233|NCT02107703|3556901|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3718234|NCT02107703|3556902|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3718235|NCT02107703|3556903|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3718236|NCT02107703|3556901|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718237|NCT02107703|3556902|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718238|NCT02107703|3556903|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718239|NCT02107703|3556901|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|214|214.0||||||
3718240|NCT02107703|3556902|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3718241|NCT02107703|3556903|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|149|149.0||||||
3718242|NCT02107703|3556901|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3718243|NCT02107703|3556902|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3718244|NCT02107703|3556903|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3718245|NCT02107703|3556901|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
3718246|NCT02107703|3556902|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3718247|NCT02107703|3556903|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3718248|NCT02107703|3556901|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|465|465.0||||||
3718249|NCT02107703|3556902|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|162|162.0||||||
3718250|NCT02107703|3556903|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|303|303.0||||||
3718251|NCT02107703|3556901|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3718252|NCT02107703|3556902|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3718253|NCT02107703|3556903|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3718254|NCT02107703|3556901|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3718256|NCT02107703|3556903|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3718257|NCT02107703|3556901|B3||Female|Sex: Female, Male||Participants|Count of Participants|669|669.0||||||
3718258|NCT02107703|3556902|B2||Female|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
3718259|NCT02107703|3556903|B1||Female|Sex: Female, Male||Participants|Count of Participants|446|446.0||||||
3718260|NCT02107703|3556901|B3|||Age||years|Mean|59.9|59.9|Standard Deviation|11.4|11.4|||
3718261|NCT02107703|3556902|B2|||Age||years|Mean|61.1|61.1|Standard Deviation|11.7|11.7|||
3718262|NCT02107703|3556903|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|11.2|11.2|||
3718263|NCT02107599|3556929|B1|United States||Region of Enrollment||participants|Number|96|96.0||||||
3718264|NCT02107599|3556929|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3718265|NCT02107599|3556929|B1|White||Race/Ethnicity, Customized||participants|Number|89|89.0||||||
3718266|NCT02107599|3556929|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3718267|NCT02107599|3556929|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3718268|NCT02107599|3556929|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718269|NCT02107599|3556929|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
3718270|NCT02107599|3556929|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3718271|NCT02107599|3556929|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3718272|NCT02107599|3556929|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3718273|NCT02107599|3556929|B1|||Age||years|Mean|76.9|76.9|Standard Deviation|10.23|10.23|||
3718274|NCT02107482|3556936|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3718275|NCT02107482|3556936|B1|African american||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3718276|NCT02107482|3556936|B1|white||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3718277|NCT02107482|3556936|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3718278|NCT02107482|3556936|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3718279|NCT02107482|3556936|B1|||Age||years|Mean|48.5|48.5|Full Range|||25.0|86.0|
3718280|NCT02107482|3556936|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3718281|NCT02107482|3556936|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3718282|NCT02107482|3556936|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3718283|NCT02107443|3556942|B3|||Number of Practice Sites||participants|Number|30|30.0||||||
3718284|NCT02107443|3556943|B2|||Number of Practice Sites||participants|Number|14|14.0||||||
3718285|NCT02107443|3556944|B1|||Number of Practice Sites||participants|Number|16|16.0||||||
3718286|NCT02107443|3556942|B3|||GA Impairments|There are 8 different GA domains in which impairments are measured, they include psychological status, cognition, social support, functional status, nutrition, co-morbidity, polypharmacy, and physical performance. The total number of GA-domain impairments were calculated. The total number of possible impairments range from 1-8 (patients had to have at least 1 GA impairment to be eligible for the study).|GA impairments|Mean|4.48|4.48|Standard Deviation|1.53|1.53|||
3718287|NCT02107443|3556943|B2|||GA Impairments|There are 8 different GA domains in which impairments are measured, they include psychological status, cognition, social support, functional status, nutrition, co-morbidity, polypharmacy, and physical performance. The total number of GA-domain impairments were calculated. The total number of possible impairments range from 1-8 (patients had to have at least 1 GA impairment to be eligible for the study).|GA impairments|Mean|4.45|4.45|Standard Deviation|1.52|1.52|||
3718288|NCT02107443|3556944|B1|||GA Impairments|There are 8 different GA domains in which impairments are measured, they include psychological status, cognition, social support, functional status, nutrition, co-morbidity, polypharmacy, and physical performance. The total number of GA-domain impairments were calculated. The total number of possible impairments range from 1-8 (patients had to have at least 1 GA impairment to be eligible for the study).|GA impairments|Mean|4.50|4.5|Standard Deviation|1.54|1.54|||
3718289|NCT02107443|3556942|B3||Other|Cancer Stage|"A diagnosis of advanced solid, incurable stage III or IV cancer was part of the eligibility criteria. Clinical staging without pathological confirmation of advanced disease was allowed. Cancer stage was collected on the Tumor & Treatment Characteristics measure which is completed at baseline by the clinical research associate under the direction of the oncology physician."|Participants|Count of Participants|13|13.0||||||
3718290|NCT02107443|3556943|B2||Other|Cancer Stage|"A diagnosis of advanced solid, incurable stage III or IV cancer was part of the eligibility criteria. Clinical staging without pathological confirmation of advanced disease was allowed. Cancer stage was collected on the Tumor & Treatment Characteristics measure which is completed at baseline by the clinical research associate under the direction of the oncology physician."|Participants|Count of Participants|10|10.0||||||
3718291|NCT02107443|3556944|B1||Other|Cancer Stage|"A diagnosis of advanced solid, incurable stage III or IV cancer was part of the eligibility criteria. Clinical staging without pathological confirmation of advanced disease was allowed. Cancer stage was collected on the Tumor & Treatment Characteristics measure which is completed at baseline by the clinical research associate under the direction of the oncology physician."|Participants|Count of Participants|3|3.0||||||
3718292|NCT02107443|3556942|B3||IV|Cancer Stage|"A diagnosis of advanced solid, incurable stage III or IV cancer was part of the eligibility criteria. Clinical staging without pathological confirmation of advanced disease was allowed. Cancer stage was collected on the Tumor & Treatment Characteristics measure which is completed at baseline by the clinical research associate under the direction of the oncology physician."|Participants|Count of Participants|480|480.0||||||
3718293|NCT02107443|3556943|B2||IV|Cancer Stage|"A diagnosis of advanced solid, incurable stage III or IV cancer was part of the eligibility criteria. Clinical staging without pathological confirmation of advanced disease was allowed. Cancer stage was collected on the Tumor & Treatment Characteristics measure which is completed at baseline by the clinical research associate under the direction of the oncology physician."|Participants|Count of Participants|219|219.0||||||
3718294|NCT02107443|3556944|B1||IV|Cancer Stage|"A diagnosis of advanced solid, incurable stage III or IV cancer was part of the eligibility criteria. Clinical staging without pathological confirmation of advanced disease was allowed. Cancer stage was collected on the Tumor & Treatment Characteristics measure which is completed at baseline by the clinical research associate under the direction of the oncology physician."|Participants|Count of Participants|261|261.0||||||
3718295|NCT02107443|3556942|B3||III|Cancer Stage|"A diagnosis of advanced solid, incurable stage III or IV cancer was part of the eligibility criteria. Clinical staging without pathological confirmation of advanced disease was allowed. Cancer stage was collected on the Tumor & Treatment Characteristics measure which is completed at baseline by the clinical research associate under the direction of the oncology physician."|Participants|Count of Participants|47|47.0||||||
3718296|NCT02107443|3556943|B2||III|Cancer Stage|"A diagnosis of advanced solid, incurable stage III or IV cancer was part of the eligibility criteria. Clinical staging without pathological confirmation of advanced disease was allowed. Cancer stage was collected on the Tumor & Treatment Characteristics measure which is completed at baseline by the clinical research associate under the direction of the oncology physician."|Participants|Count of Participants|19|19.0||||||
3718297|NCT02107443|3556944|B1||III|Cancer Stage|"A diagnosis of advanced solid, incurable stage III or IV cancer was part of the eligibility criteria. Clinical staging without pathological confirmation of advanced disease was allowed. Cancer stage was collected on the Tumor & Treatment Characteristics measure which is completed at baseline by the clinical research associate under the direction of the oncology physician."|Participants|Count of Participants|28|28.0||||||
3718298|NCT02107443|3556942|B3||Other|Cancer Type||Participants|Count of Participants|39|39.0||||||
3718299|NCT02107443|3556943|B2||Other|Cancer Type||Participants|Count of Participants|19|19.0||||||
3718300|NCT02107443|3556944|B1||Other|Cancer Type||Participants|Count of Participants|20|20.0||||||
3718301|NCT02107443|3556942|B3||Lymphoma|Cancer Type||Participants|Count of Participants|41|41.0||||||
3718302|NCT02107443|3556943|B2||Lymphoma|Cancer Type||Participants|Count of Participants|18|18.0||||||
3718303|NCT02107443|3556944|B1||Lymphoma|Cancer Type||Participants|Count of Participants|23|23.0||||||
3718304|NCT02107443|3556942|B3||Lung|Cancer Type||Participants|Count of Participants|140|140.0||||||
3718305|NCT02107443|3556943|B2||Lung|Cancer Type||Participants|Count of Participants|62|62.0||||||
3718306|NCT02107443|3556944|B1||Lung|Cancer Type||Participants|Count of Participants|78|78.0||||||
3718307|NCT02107443|3556942|B3||Gynecological|Cancer Type||Participants|Count of Participants|34|34.0||||||
3718308|NCT02107443|3556943|B2||Gynecological|Cancer Type||Participants|Count of Participants|12|12.0||||||
3718309|NCT02107443|3556944|B1||Gynecological|Cancer Type||Participants|Count of Participants|22|22.0||||||
3718310|NCT02107443|3556942|B3||Genitourinary|Cancer Type||Participants|Count of Participants|79|79.0||||||
3718311|NCT02107443|3556943|B2||Genitourinary|Cancer Type||Participants|Count of Participants|33|33.0||||||
3718312|NCT02107443|3556944|B1||Genitourinary|Cancer Type||Participants|Count of Participants|46|46.0||||||
3718313|NCT02107443|3556942|B3||Gastrointestinal|Cancer Type||Participants|Count of Participants|138|138.0||||||
3718314|NCT02107443|3556943|B2||Gastrointestinal|Cancer Type||Participants|Count of Participants|66|66.0||||||
3718315|NCT02107443|3556944|B1||Gastrointestinal|Cancer Type||Participants|Count of Participants|72|72.0||||||
3718316|NCT02107443|3556942|B3||Breast|Cancer Type||Participants|Count of Participants|69|69.0||||||
3718317|NCT02107443|3556943|B2||Breast|Cancer Type||Participants|Count of Participants|38|38.0||||||
3718318|NCT02107443|3556944|B1||Breast|Cancer Type||Participants|Count of Participants|31|31.0||||||
3718319|NCT02107443|3556942|B3||More than High School|Education||Participants|Count of Participants|279|279.0||||||
3718320|NCT02107443|3556943|B2||More than High School|Education||Participants|Count of Participants|137|137.0||||||
3718321|NCT02107443|3556944|B1||More than High School|Education||Participants|Count of Participants|142|142.0||||||
3718322|NCT02107443|3556942|B3||High School|Education||Participants|Count of Participants|195|195.0||||||
3718323|NCT02107443|3556943|B2||High School|Education||Participants|Count of Participants|81|81.0||||||
3718324|NCT02107443|3556944|B1||High School|Education||Participants|Count of Participants|114|114.0||||||
3718325|NCT02107443|3556942|B3||Less than High School|Education||Participants|Count of Participants|66|66.0||||||
3718326|NCT02107443|3556943|B2||Less than High School|Education||Participants|Count of Participants|30|30.0||||||
3718327|NCT02107443|3556944|B1||Less than High School|Education||Participants|Count of Participants|36|36.0||||||
3718328|NCT02107443|3556942|B3||Divorced|Marital Status||Participants|Count of Participants|68|68.0||||||
3718329|NCT02107443|3556943|B2||Divorced|Marital Status||Participants|Count of Participants|33|33.0||||||
3718330|NCT02107443|3556944|B1||Divorced|Marital Status||Participants|Count of Participants|35|35.0||||||
3718331|NCT02107443|3556942|B3||Widowed|Marital Status||Participants|Count of Participants|109|109.0||||||
3718332|NCT02107443|3556943|B2||Widowed|Marital Status||Participants|Count of Participants|50|50.0||||||
3718333|NCT02107443|3556944|B1||Widowed|Marital Status||Participants|Count of Participants|59|59.0||||||
3718334|NCT02107443|3556942|B3||Domestic Partnership|Marital Status||Participants|Count of Participants|8|8.0||||||
3718335|NCT02107443|3556943|B2||Domestic Partnership|Marital Status||Participants|Count of Participants|6|6.0||||||
3718336|NCT02107443|3556944|B1||Domestic Partnership|Marital Status||Participants|Count of Participants|2|2.0||||||
3718337|NCT02107443|3556942|B3||Separated|Marital Status||Participants|Count of Participants|8|8.0||||||
3718338|NCT02107443|3556943|B2||Separated|Marital Status||Participants|Count of Participants|7|7.0||||||
3718339|NCT02107443|3556944|B1||Separated|Marital Status||Participants|Count of Participants|1|1.0||||||
3718340|NCT02107443|3556942|B3||Married|Marital Status||Participants|Count of Participants|340|340.0||||||
3718341|NCT02107443|3556943|B2||Married|Marital Status||Participants|Count of Participants|148|148.0||||||
3718342|NCT02107443|3556944|B1||Married|Marital Status||Participants|Count of Participants|192|192.0||||||
3718343|NCT02107443|3556942|B3||Single, Never Married|Marital Status||Participants|Count of Participants|7|7.0||||||
3718344|NCT02107443|3556943|B2||Single, Never Married|Marital Status||Participants|Count of Participants|4|4.0||||||
3718345|NCT02107443|3556944|B1||Single, Never Married|Marital Status||Participants|Count of Participants|3|3.0||||||
3718346|NCT02107443|3556942|B3|United States||Region of Enrollment||participants|Number|540|540.0||||||
3718347|NCT02107443|3556943|B2|United States||Region of Enrollment||participants|Number|248|248.0||||||
3718348|NCT02107443|3556944|B1|United States||Region of Enrollment||participants|Number|292|292.0||||||
3718349|NCT02107443|3556942|B3|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3718350|NCT02107443|3556943|B2|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3718351|NCT02107443|3556944|B1|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3718352|NCT02107443|3556942|B3|Race/Ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3718353|NCT02107443|3556943|B2|Race/Ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3718354|NCT02107443|3556944|B1|Race/Ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3718355|NCT02107443|3556942|B3|Race/Ethnicity|Non-Hispanic White|Race/Ethnicity, Customized||Participants|Count of Participants|482|482.0||||||
3718356|NCT02107443|3556943|B2|Race/Ethnicity|Non-Hispanic White|Race/Ethnicity, Customized||Participants|Count of Participants|219|219.0||||||
3718357|NCT02107443|3556944|B1|Race/Ethnicity|Non-Hispanic White|Race/Ethnicity, Customized||Participants|Count of Participants|263|263.0||||||
3718358|NCT02107443|3556942|B3||Male|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
3718359|NCT02107443|3556943|B2||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3718360|NCT02107443|3556944|B1||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3718361|NCT02107443|3556942|B3||Female|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
3718362|NCT02107443|3556943|B2||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3718363|NCT02107443|3556944|B1||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3718364|NCT02107443|3556942|B3|||Age||years|Mean|76.57|76.57|Standard Deviation|5.22|5.22|||
3718365|NCT02107443|3556943|B2|||Age||years|Mean|76.41|76.41|Standard Deviation|5.27|5.27|||
3718366|NCT02107443|3556944|B1|||Age||years|Mean|76.71|76.71|Standard Deviation|5.19|5.19|||
3718367|NCT02107339|3556953|B3|United States||Region of Enrollment||participants|Number|115|115.0||||||
3718368|NCT02107339|3556954|B2|United States||Region of Enrollment||participants|Number|53|53.0||||||
3718369|NCT02107339|3556955|B1|United States||Region of Enrollment||participants|Number|62|62.0||||||
3718370|NCT02107339|3556953|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3718371|NCT02107339|3556954|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3718372|NCT02107339|3556955|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3718373|NCT02107339|3556953|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3718374|NCT02107339|3556954|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3718375|NCT02107339|3556955|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3718376|NCT02107339|3556953|B3|||Age||years|Median|62|62.0|Inter-Quartile Range|||48.0|69.0|
3718377|NCT02107339|3556954|B2|||Age||years|Median|60|60.0|Inter-Quartile Range|||45.0|66.0|
3718378|NCT02107339|3556955|B1|||Age||years|Median|64.5|64.5|Inter-Quartile Range|||57.0|71.0|
3718379|NCT02107339|3556953|B3||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
3718380|NCT02107339|3556954|B2||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3718381|NCT02107339|3556955|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3718382|NCT02107339|3556953|B3||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
3718383|NCT02107339|3556954|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3718384|NCT02107339|3556955|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3718385|NCT02107339|3556953|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3718386|NCT02107339|3556954|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3718387|NCT02107339|3556955|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3718388|NCT02107313|3556984|B1|Australia||Region of Enrollment||participants|Number|18|18.0||||||
3718389|NCT02107313|3556984|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718390|NCT02107313|3556984|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718391|NCT02107313|3556984|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3718392|NCT02107313|3556984|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718393|NCT02107313|3556984|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718394|NCT02107313|3556984|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3718395|NCT02107313|3556984|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718396|NCT02107313|3556984|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718397|NCT02107313|3556984|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3718398|NCT02107313|3556984|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3718399|NCT02107313|3556984|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3718400|NCT02107313|3556984|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3718401|NCT02107313|3556984|B1|||Age||years|Mean|25.7|25.7|Standard Deviation|3.6|3.6|||
3718402|NCT02107300|3556993|B3|||Overall Number of Baseline Participants||Participants|Count of Participants|31|31.0||||||
3718403|NCT02107300|3556994|B2|||Overall Number of Baseline Participants||Participants|Count of Participants|15|15.0||||||
3718404|NCT02107300|3556995|B1|||Overall Number of Baseline Participants||Participants|Count of Participants|16|16.0||||||
3718405|NCT02107300|3556993|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
3718406|NCT02107300|3556994|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3718407|NCT02107300|3556995|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3718408|NCT02107300|3556993|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3718409|NCT02107300|3556994|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3718410|NCT02107300|3556995|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3718411|NCT02107300|3556993|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718412|NCT02107300|3556994|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718413|NCT02107300|3556995|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718414|NCT02107300|3556993|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718415|NCT02107300|3556994|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718416|NCT02107300|3556995|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718417|NCT02107300|3556993|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718418|NCT02107300|3556994|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718419|NCT02107300|3556995|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718420|NCT02107300|3556993|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718421|NCT02107300|3556994|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718422|NCT02107300|3556995|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718423|NCT02107300|3556993|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718424|NCT02107300|3556994|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718425|NCT02107300|3556995|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718426|NCT02107300|3556993|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718427|NCT02107300|3556994|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718428|NCT02107300|3556995|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718429|NCT02107300|3556993|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3718430|NCT02107300|3556994|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3718431|NCT02107300|3556995|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3718432|NCT02107300|3556993|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718433|NCT02107300|3556994|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718434|NCT02107300|3556995|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718435|NCT02107300|3556993|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718436|NCT02107300|3556994|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718437|NCT02107300|3556995|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718438|NCT02107300|3556993|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3718439|NCT02107300|3556994|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3718440|NCT02107300|3556995|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3718441|NCT02107300|3556993|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3718442|NCT02107300|3556994|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3718443|NCT02107300|3556995|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3718444|NCT02107300|3556993|B3|||Age||years|Mean|53.5|53.5|Full Range|||27.0|80.0|
3718445|NCT02107300|3556994|B2|||Age||years|Mean|54|54.0|Full Range|||37.0|71.0|
3718446|NCT02107300|3556995|B1|||Age||years|Mean|53.5|53.5|Full Range|||27.0|80.0|
3718447|NCT02107274|3557004|B3|||Forced Vital Capacity (FVC)|Forced vital capacity (FVC) is a measurement of lung volume. Higher values reflect better reserve meanwhile lower values indicate poorer reserve.|Litres|Mean|1.63|1.63|Standard Deviation|0.70|0.7|||
3718448|NCT02107274|3557005|B2|||Forced Vital Capacity (FVC)|Forced vital capacity (FVC) is a measurement of lung volume. Higher values reflect better reserve meanwhile lower values indicate poorer reserve.|Litres|Mean|1.69|1.69|Standard Deviation|0.74|0.74|||
3718449|NCT02107274|3557006|B1|||Forced Vital Capacity (FVC)|Forced vital capacity (FVC) is a measurement of lung volume. Higher values reflect better reserve meanwhile lower values indicate poorer reserve.|Litres|Mean|1.56|1.56|Standard Deviation|0.65|0.65|||
3718450|NCT02107274|3557004|B3|||Forced Expiratory Volume at 1 second (FEV1)|Forced expiratory volume at 1 second (FEV1) is a reflection of lung volume. Higher values reflect less airflow limitation and good lung reserve. Lower values indicate poor airflow limitation and lower lung reserve.|Litres|Mean|1.13|1.13|Standard Deviation|0.48|0.48|||
3718451|NCT02107274|3557005|B2|||Forced Expiratory Volume at 1 second (FEV1)|Forced expiratory volume at 1 second (FEV1) is a reflection of lung volume. Higher values reflect less airflow limitation and good lung reserve. Lower values indicate poor airflow limitation and lower lung reserve.|Litres|Mean|1.17|1.17|Standard Deviation|0.54|0.54|||
3718452|NCT02107274|3557006|B1|||Forced Expiratory Volume at 1 second (FEV1)|Forced expiratory volume at 1 second (FEV1) is a reflection of lung volume. Higher values reflect less airflow limitation and good lung reserve. Lower values indicate poor airflow limitation and lower lung reserve.|Litres|Mean|1.08|1.08|Standard Deviation|0.41|0.41|||
3718453|NCT02107274|3557004|B3|||St George's Respiratory Questionnaire (SGRQ) score|St George's Respiratory Questionnaire (SGRQ) score measures quality of life in patients with chronic lung disease. Score can range from 10 (minimum) until 100 (maximum). Lower scores are associated with good quality of life and the higher scores indicates poor quality of life. Total score is a product of summation of individual scores per question.|Scores on a scale|Mean|38.66|38.66|Standard Deviation|10.47|10.47|||
3718454|NCT02107274|3557005|B2|||St George's Respiratory Questionnaire (SGRQ) score|St George's Respiratory Questionnaire (SGRQ) score measures quality of life in patients with chronic lung disease. Score can range from 10 (minimum) until 100 (maximum). Lower scores are associated with good quality of life and the higher scores indicates poor quality of life. Total score is a product of summation of individual scores per question.|Scores on a scale|Mean|36.40|36.4|Standard Deviation|10.59|10.59|||
3718455|NCT02107274|3557006|B1|||St George's Respiratory Questionnaire (SGRQ) score|St George's Respiratory Questionnaire (SGRQ) score measures quality of life in patients with chronic lung disease. Score can range from 10 (minimum) until 100 (maximum). Lower scores are associated with good quality of life and the higher scores indicates poor quality of life. Total score is a product of summation of individual scores per question.|Scores on a scale|Mean|41.06|41.06|Standard Deviation|9.95|9.95|||
3718456|NCT02107274|3557004|B3|||Sputum volume|Higher sputum volume indicates active disease process and poorer morbidity. Lower sputum volume is associated with better control of disease process.|gram|Mean|32.4|32.4|Standard Deviation|24.99|24.99|||
3718457|NCT02107274|3557005|B2|||Sputum volume|Higher sputum volume indicates active disease process and poorer morbidity. Lower sputum volume is associated with better control of disease process.|gram|Mean|23.6|23.6|Standard Deviation|20.67|20.67|||
3718458|NCT02107274|3557006|B1|||Sputum volume|Higher sputum volume indicates active disease process and poorer morbidity. Lower sputum volume is associated with better control of disease process.|gram|Mean|41.8|41.8|Standard Deviation|26.05|26.05|||
3718459|NCT02107274|3557004|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3718460|NCT02107274|3557005|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3718461|NCT02107274|3557006|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3718462|NCT02107274|3557004|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3718463|NCT02107274|3557005|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3718464|NCT02107274|3557006|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3718465|NCT02107274|3557004|B3|||Age||years|Mean|62.8|62.8|Standard Deviation|13.4|13.4|||
3718466|NCT02107274|3557005|B2|||Age||years|Mean|59.7|59.7|Standard Deviation|15.03|15.03|||
3718467|NCT02107274|3557006|B1|||Age||years|Mean|65.9|65.9|Standard Deviation|11.77|11.77|||
3718468|NCT02107196|3557019|B3|Missing||IBS-SSS Score|IBS-SSS score calculated from the questionnaire evaluating primarily the intensity of IBS symptoms during a 10-day period:abdominal pain, distension, stool frequency and consistency, and interference with life in general.The IBS-SSS calculates the sum of these 5 items each scored on a visual analog scale from 0 to 100.All four domains contribute equally to the total score, yielding a range of 0 to 500 to categorize patients into three severity groups:mild (below 175), moderate (175–300), and severe (above 300).|participants|Number|3|3.0||||||
3718469|NCT02107196|3557020|B2|Missing||IBS-SSS Score|IBS-SSS score calculated from the questionnaire evaluating primarily the intensity of IBS symptoms during a 10-day period:abdominal pain, distension, stool frequency and consistency, and interference with life in general.The IBS-SSS calculates the sum of these 5 items each scored on a visual analog scale from 0 to 100.All four domains contribute equally to the total score, yielding a range of 0 to 500 to categorize patients into three severity groups:mild (below 175), moderate (175–300), and severe (above 300).|participants|Number|2|2.0||||||
3718470|NCT02107196|3557021|B1|Missing||IBS-SSS Score|IBS-SSS score calculated from the questionnaire evaluating primarily the intensity of IBS symptoms during a 10-day period:abdominal pain, distension, stool frequency and consistency, and interference with life in general.The IBS-SSS calculates the sum of these 5 items each scored on a visual analog scale from 0 to 100.All four domains contribute equally to the total score, yielding a range of 0 to 500 to categorize patients into three severity groups:mild (below 175), moderate (175–300), and severe (above 300).|participants|Number|1|1.0||||||
3718471|NCT02107196|3557019|B3|Severe IBS (>=300)||IBS-SSS Score|IBS-SSS score calculated from the questionnaire evaluating primarily the intensity of IBS symptoms during a 10-day period:abdominal pain, distension, stool frequency and consistency, and interference with life in general.The IBS-SSS calculates the sum of these 5 items each scored on a visual analog scale from 0 to 100.All four domains contribute equally to the total score, yielding a range of 0 to 500 to categorize patients into three severity groups:mild (below 175), moderate (175–300), and severe (above 300).|participants|Number|445|445.0||||||
3718472|NCT02107196|3557020|B2|Severe IBS (>=300)||IBS-SSS Score|IBS-SSS score calculated from the questionnaire evaluating primarily the intensity of IBS symptoms during a 10-day period:abdominal pain, distension, stool frequency and consistency, and interference with life in general.The IBS-SSS calculates the sum of these 5 items each scored on a visual analog scale from 0 to 100.All four domains contribute equally to the total score, yielding a range of 0 to 500 to categorize patients into three severity groups:mild (below 175), moderate (175–300), and severe (above 300).|participants|Number|212|212.0||||||
3718473|NCT02107196|3557021|B1|Severe IBS (>=300)||IBS-SSS Score|IBS-SSS score calculated from the questionnaire evaluating primarily the intensity of IBS symptoms during a 10-day period:abdominal pain, distension, stool frequency and consistency, and interference with life in general.The IBS-SSS calculates the sum of these 5 items each scored on a visual analog scale from 0 to 100.All four domains contribute equally to the total score, yielding a range of 0 to 500 to categorize patients into three severity groups:mild (below 175), moderate (175–300), and severe (above 300).|participants|Number|233|233.0||||||
3718504|NCT02107196|3557019|B3||Female|Gender||Participants|Count of Participants|535|535.0||||||
3718505|NCT02107196|3557020|B2||Female|Gender||Participants|Count of Participants|264|264.0||||||
3718474|NCT02107196|3557019|B3|Moderate IBS (175 to <300)||IBS-SSS Score|IBS-SSS score calculated from the questionnaire evaluating primarily the intensity of IBS symptoms during a 10-day period:abdominal pain, distension, stool frequency and consistency, and interference with life in general.The IBS-SSS calculates the sum of these 5 items each scored on a visual analog scale from 0 to 100.All four domains contribute equally to the total score, yielding a range of 0 to 500 to categorize patients into three severity groups:mild (below 175), moderate (175–300), and severe (above 300).|participants|Number|79|79.0||||||
3718475|NCT02107196|3557020|B2|Moderate IBS (175 to <300)||IBS-SSS Score|IBS-SSS score calculated from the questionnaire evaluating primarily the intensity of IBS symptoms during a 10-day period:abdominal pain, distension, stool frequency and consistency, and interference with life in general.The IBS-SSS calculates the sum of these 5 items each scored on a visual analog scale from 0 to 100.All four domains contribute equally to the total score, yielding a range of 0 to 500 to categorize patients into three severity groups:mild (below 175), moderate (175–300), and severe (above 300).|participants|Number|44|44.0||||||
3718476|NCT02107196|3557021|B1|Moderate IBS (175 to <300)||IBS-SSS Score|IBS-SSS score calculated from the questionnaire evaluating primarily the intensity of IBS symptoms during a 10-day period:abdominal pain, distension, stool frequency and consistency, and interference with life in general.The IBS-SSS calculates the sum of these 5 items each scored on a visual analog scale from 0 to 100.All four domains contribute equally to the total score, yielding a range of 0 to 500 to categorize patients into three severity groups:mild (below 175), moderate (175–300), and severe (above 300).|participants|Number|35|35.0||||||
3718477|NCT02107196|3557019|B3|Mild IBS (<175)||IBS-SSS Score|IBS-SSS score calculated from the questionnaire evaluating primarily the intensity of IBS symptoms during a 10-day period:abdominal pain, distension, stool frequency and consistency, and interference with life in general.The IBS-SSS calculates the sum of these 5 items each scored on a visual analog scale from 0 to 100.All four domains contribute equally to the total score, yielding a range of 0 to 500 to categorize patients into three severity groups:mild (below 175), moderate (175–300), and severe (above 300).|participants|Number|8|8.0||||||
3718478|NCT02107196|3557020|B2|Mild IBS (<175)||IBS-SSS Score|IBS-SSS score calculated from the questionnaire evaluating primarily the intensity of IBS symptoms during a 10-day period:abdominal pain, distension, stool frequency and consistency, and interference with life in general.The IBS-SSS calculates the sum of these 5 items each scored on a visual analog scale from 0 to 100.All four domains contribute equally to the total score, yielding a range of 0 to 500 to categorize patients into three severity groups:mild (below 175), moderate (175–300), and severe (above 300).|participants|Number|6|6.0||||||
3718479|NCT02107196|3557021|B1|Mild IBS (<175)||IBS-SSS Score|IBS-SSS score calculated from the questionnaire evaluating primarily the intensity of IBS symptoms during a 10-day period:abdominal pain, distension, stool frequency and consistency, and interference with life in general.The IBS-SSS calculates the sum of these 5 items each scored on a visual analog scale from 0 to 100.All four domains contribute equally to the total score, yielding a range of 0 to 500 to categorize patients into three severity groups:mild (below 175), moderate (175–300), and severe (above 300).|participants|Number|2|2.0||||||
3718480|NCT02107196|3557019|B3|>=8||Abdominal Pain Severity Score|Worst abdominal pain on a 0 to 10 scale, where 0 corresponds to no pain and 10 corresponds to worst possible pain.|participants|Number|89|89.0||||||
3718481|NCT02107196|3557020|B2|>=8||Abdominal Pain Severity Score|Worst abdominal pain on a 0 to 10 scale, where 0 corresponds to no pain and 10 corresponds to worst possible pain.|participants|Number|40|40.0||||||
3718482|NCT02107196|3557021|B1|>=8||Abdominal Pain Severity Score|Worst abdominal pain on a 0 to 10 scale, where 0 corresponds to no pain and 10 corresponds to worst possible pain.|participants|Number|49|49.0||||||
3718483|NCT02107196|3557019|B3|>=5 to <8||Abdominal Pain Severity Score|Worst abdominal pain on a 0 to 10 scale, where 0 corresponds to no pain and 10 corresponds to worst possible pain.|participants|Number|363|363.0||||||
3718484|NCT02107196|3557020|B2|>=5 to <8||Abdominal Pain Severity Score|Worst abdominal pain on a 0 to 10 scale, where 0 corresponds to no pain and 10 corresponds to worst possible pain.|participants|Number|187|187.0||||||
3718485|NCT02107196|3557021|B1|>=5 to <8||Abdominal Pain Severity Score|Worst abdominal pain on a 0 to 10 scale, where 0 corresponds to no pain and 10 corresponds to worst possible pain.|participants|Number|176|176.0||||||
3718486|NCT02107196|3557019|B3|<5||Abdominal Pain Severity Score|Worst abdominal pain on a 0 to 10 scale, where 0 corresponds to no pain and 10 corresponds to worst possible pain.|participants|Number|83|83.0||||||
3718487|NCT02107196|3557020|B2|<5||Abdominal Pain Severity Score|Worst abdominal pain on a 0 to 10 scale, where 0 corresponds to no pain and 10 corresponds to worst possible pain.|participants|Number|37|37.0||||||
3718488|NCT02107196|3557021|B1|<5||Abdominal Pain Severity Score|Worst abdominal pain on a 0 to 10 scale, where 0 corresponds to no pain and 10 corresponds to worst possible pain.|participants|Number|46|46.0||||||
3718489|NCT02107196|3557019|B3|Europe||Region of Enrollment||participants|Number|135|135.0||||||
3718490|NCT02107196|3557020|B2|Europe||Region of Enrollment||participants|Number|66|66.0||||||
3718491|NCT02107196|3557021|B1|Europe||Region of Enrollment||participants|Number|69|69.0||||||
3718492|NCT02107196|3557019|B3|North America||Region of Enrollment||participants|Number|400|400.0||||||
3718493|NCT02107196|3557020|B2|North America||Region of Enrollment||participants|Number|198|198.0||||||
3718494|NCT02107196|3557021|B1|North America||Region of Enrollment||participants|Number|202|202.0||||||
3718495|NCT02107196|3557019|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|250|250.0||||||
3718496|NCT02107196|3557020|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|128|128.0||||||
3718497|NCT02107196|3557021|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|122|122.0||||||
3718498|NCT02107196|3557019|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|285|285.0||||||
3718499|NCT02107196|3557020|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|136|136.0||||||
3718500|NCT02107196|3557021|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|149|149.0||||||
3718501|NCT02107196|3557019|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3718502|NCT02107196|3557020|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3718503|NCT02107196|3557021|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3718506|NCT02107196|3557021|B1||Female|Gender||Participants|Count of Participants|271|271.0||||||
3718507|NCT02107196|3557019|B3|||Age||years|Mean|43.1|43.1|Standard Deviation|12.65|12.65|||
3718508|NCT02107196|3557020|B2|||Age||years|Mean|43.8|43.8|Standard Deviation|12.47|12.47|||
3718509|NCT02107196|3557021|B1|||Age||years|Mean|42.5|42.5|Standard Deviation|12.81|12.81|||
3718510|NCT02107131|3557035|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3718511|NCT02107131|3557035|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3718512|NCT02107131|3557036|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3718513|NCT02107131|3557037|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3718514|NCT02107131|3557035|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3718515|NCT02107131|3557036|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3718516|NCT02107131|3557037|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3718517|NCT02107131|3557035|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3718518|NCT02107131|3557036|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3718519|NCT02107131|3557037|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3718520|NCT02107131|3557035|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3718521|NCT02107131|3557036|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3718522|NCT02107131|3557037|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3718523|NCT02107131|3557035|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3718524|NCT02107131|3557036|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3718525|NCT02107131|3557037|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3718526|NCT02107092|3557050|B1|Heart failure||Cormordid conditions and concomitant medications which may contirubute to hyperkalemia|Categories are not mutually exclusive|Participants|Number|50|50.0||||||
3718527|NCT02107092|3557050|B1|Chronic kidney disease||Cormordid conditions and concomitant medications which may contirubute to hyperkalemia|Categories are not mutually exclusive|Participants|Number|76|76.0||||||
3718528|NCT02107092|3557050|B1|Diabetes mellitus||Cormordid conditions and concomitant medications which may contirubute to hyperkalemia|Categories are not mutually exclusive|Participants|Number|80|80.0||||||
3718529|NCT02107092|3557050|B1|RAAS inhibitor medication||Cormordid conditions and concomitant medications which may contirubute to hyperkalemia|Categories are not mutually exclusive|Participants|Number|83|83.0||||||
3718530|NCT02107092|3557050|B1||≥ 60 mL/min|Acute Phase eGFR at baseline|Acute Phase baseline from Study ZS-004|Participants|Count of Participants|31|31.0||||||
3718531|NCT02107092|3557050|B1||<60 mL/min|Acute Phase eGFR at baseline|Acute Phase baseline from Study ZS-004|Participants|Count of Participants|90|90.0||||||
3718532|NCT02107092|3557050|B1||≥ 6.0 mmol/L|Study ZS-004 Acute Phase S-K baseline|Acute Phase S-K baseline of participants in Study ZS-004|Participants|Count of Participants|14|14.0||||||
3718533|NCT02107092|3557050|B1||5.5-< 6.0 mmol/L|Study ZS-004 Acute Phase S-K baseline|Acute Phase S-K baseline of participants in Study ZS-004|Participants|Count of Participants|53|53.0||||||
3718534|NCT02107092|3557050|B1||< 5.5 mmol/L|Study ZS-004 Acute Phase S-K baseline|Acute Phase S-K baseline of participants in Study ZS-004|Participants|Count of Participants|54|54.0||||||
3718535|NCT02107092|3557050|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3718536|NCT02107092|3557050|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|107|107.0||||||
3718537|NCT02107092|3557050|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3718538|NCT02107092|3557050|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3718539|NCT02107092|3557050|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3718540|NCT02107092|3557050|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3718541|NCT02107092|3557050|B1|||Age||Years|Mean|63.7|63.7|Standard Deviation|12.29|12.29|||
3718542|NCT02107014|3557055|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3718543|NCT02107014|3557055|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3718544|NCT02107014|3557055|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718545|NCT02107014|3557055|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3718546|NCT02107014|3557055|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3718547|NCT02107014|3557055|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718548|NCT02107014|3557055|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718549|NCT02107014|3557055|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718550|NCT02107014|3557055|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718551|NCT02107014|3557055|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3718552|NCT02107014|3557055|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3718553|NCT02107014|3557055|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3718554|NCT02107014|3557055|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3718555|NCT02107014|3557055|B1|||Age||years|Mean|46.3|46.3|Standard Deviation|11.6|11.6|||
3718556|NCT02106962|3557123|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3718557|NCT02106962|3557124|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3718558|NCT02106962|3557125|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3718559|NCT02106962|3557123|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3718560|NCT02106962|3557124|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3718561|NCT02106962|3557125|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3718562|NCT02106962|3557123|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3718563|NCT02106962|3557124|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3718564|NCT02106962|3557125|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3718565|NCT02106962|3557123|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3718566|NCT02106962|3557124|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3718567|NCT02106962|3557125|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3718568|NCT02106962|3557123|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3718569|NCT02106962|3557124|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3718570|NCT02106962|3557125|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3718571|NCT02106923|3557134|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3718572|NCT02106923|3557135|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3718573|NCT02106923|3557136|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3718574|NCT02106923|3557137|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3718575|NCT02106923|3557134|B4||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3718576|NCT02106923|3557135|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3718577|NCT02106923|3557136|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3718578|NCT02106923|3557137|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3718579|NCT02106923|3557134|B4|||Age||years|Mean|30.7|30.7|Standard Deviation|8.9|8.9|||
3718580|NCT02106923|3557135|B3|||Age||years|Mean|31.3|31.3|Standard Deviation|8.7|8.7|||
3718581|NCT02106923|3557136|B2|||Age||years|Mean|32.4|32.4|Standard Deviation|9.1|9.1|||
3718582|NCT02106923|3557137|B1|||Age||years|Mean|28.5|28.5|Standard Deviation|8.7|8.7|||
3718583|NCT02106832|3557186|B5|||Forced Expiratory Volume in One Second (FEV1)|FEV1 was the maximal volume of air exhaled in the first second of a forced expiration from a position of full inspiration, expressed in liters at body temperature and ambient pressure saturated with water vapor (BTPS).|Liter|Mean|1.535|1.535|Standard Deviation|0.615|0.615|||
3718584|NCT02106832|3557187|B4|||Forced Expiratory Volume in One Second (FEV1)|FEV1 was the maximal volume of air exhaled in the first second of a forced expiration from a position of full inspiration, expressed in liters at body temperature and ambient pressure saturated with water vapor (BTPS).|Liter|Mean|1.477|1.477|Standard Deviation|0.558|0.558|||
3718585|NCT02106832|3557188|B3|||Forced Expiratory Volume in One Second (FEV1)|FEV1 was the maximal volume of air exhaled in the first second of a forced expiration from a position of full inspiration, expressed in liters at body temperature and ambient pressure saturated with water vapor (BTPS).|Liter|Mean|1.560|1.56|Standard Deviation|0.692|0.692|||
3718586|NCT02106832|3557189|B2|||Forced Expiratory Volume in One Second (FEV1)|FEV1 was the maximal volume of air exhaled in the first second of a forced expiration from a position of full inspiration, expressed in liters at body temperature and ambient pressure saturated with water vapor (BTPS).|Liter|Mean|1.519|1.519|Standard Deviation|0.617|0.617|||
3718587|NCT02106832|3557190|B1|||Forced Expiratory Volume in One Second (FEV1)|FEV1 was the maximal volume of air exhaled in the first second of a forced expiration from a position of full inspiration, expressed in liters at body temperature and ambient pressure saturated with water vapor (BTPS).|Liter|Mean|1.569|1.569|Standard Deviation|0.602|0.602|||
3718588|NCT02106832|3557186|B5|||Quality of Life Questionnaire for Bronchiectasis (QoL-B) Respiratory Symptoms Domain Score|The QoL-B was a disease-specific questionnaire developed for non-Cystic fibrosis Bronchiectasis. It covers 8 dimensions: physical functioning, role functioning, emotional functioning, social functioning, vitality, treatment burden, health perceptions, and respiratory symptoms. Each dimension was scored separately on a scale of 0 to 100, and higher scores represent better outcomes. For this baseline measure, the respiratory symptoms domain score was reported.|Score on a scale|Mean|51.22|51.22|Standard Deviation|18.16|18.16|||
3718589|NCT02106832|3557187|B4|||Quality of Life Questionnaire for Bronchiectasis (QoL-B) Respiratory Symptoms Domain Score|The QoL-B was a disease-specific questionnaire developed for non-Cystic fibrosis Bronchiectasis. It covers 8 dimensions: physical functioning, role functioning, emotional functioning, social functioning, vitality, treatment burden, health perceptions, and respiratory symptoms. Each dimension was scored separately on a scale of 0 to 100, and higher scores represent better outcomes. For this baseline measure, the respiratory symptoms domain score was reported.|Score on a scale|Mean|48.67|48.67|Standard Deviation|17.72|17.72|||
3718590|NCT02106832|3557188|B3|||Quality of Life Questionnaire for Bronchiectasis (QoL-B) Respiratory Symptoms Domain Score|The QoL-B was a disease-specific questionnaire developed for non-Cystic fibrosis Bronchiectasis. It covers 8 dimensions: physical functioning, role functioning, emotional functioning, social functioning, vitality, treatment burden, health perceptions, and respiratory symptoms. Each dimension was scored separately on a scale of 0 to 100, and higher scores represent better outcomes. For this baseline measure, the respiratory symptoms domain score was reported.|Score on a scale|Mean|53.95|53.95|Standard Deviation|16.00|16.0|||
3718591|NCT02106832|3557189|B2|||Quality of Life Questionnaire for Bronchiectasis (QoL-B) Respiratory Symptoms Domain Score|The QoL-B was a disease-specific questionnaire developed for non-Cystic fibrosis Bronchiectasis. It covers 8 dimensions: physical functioning, role functioning, emotional functioning, social functioning, vitality, treatment burden, health perceptions, and respiratory symptoms. Each dimension was scored separately on a scale of 0 to 100, and higher scores represent better outcomes. For this baseline measure, the respiratory symptoms domain score was reported.|Score on a scale|Mean|52.17|52.17|Standard Deviation|18.49|18.49|||
3718624|NCT02106728|3557228|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3718625|NCT02106728|3557226|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3718626|NCT02106728|3557227|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3718592|NCT02106832|3557190|B1|||Quality of Life Questionnaire for Bronchiectasis (QoL-B) Respiratory Symptoms Domain Score|The QoL-B was a disease-specific questionnaire developed for non-Cystic fibrosis Bronchiectasis. It covers 8 dimensions: physical functioning, role functioning, emotional functioning, social functioning, vitality, treatment burden, health perceptions, and respiratory symptoms. Each dimension was scored separately on a scale of 0 to 100, and higher scores represent better outcomes. For this baseline measure, the respiratory symptoms domain score was reported.|Score on a scale|Mean|50.14|50.14|Standard Deviation|19.07|19.07|||
3718593|NCT02106832|3557186|B5|||Saint George's Respiratory Questionnaire (SGRQ) Symptoms Component Score|The SGRQ was a validated, disease-specific instrument that measures health-related quality of life (HRQoL) in adults with chronic obstructive pulmonary disease (COPD) and asthma and was later validated for use in bronchiectasis. The SGRQ covers 3 dimensions: symptoms, activity and impact on daily life. To determine the outcome, a score ranging from 1 to 100 was calculated for each individual domain and for the total score, and smaller scores indicate better health status. For this baseline measure, the symptoms component score was reported.|Score on a scale|Mean|61.00|61.0|Standard Deviation|19.82|19.82|||
3718594|NCT02106832|3557187|B4|||Saint George's Respiratory Questionnaire (SGRQ) Symptoms Component Score|The SGRQ was a validated, disease-specific instrument that measures health-related quality of life (HRQoL) in adults with chronic obstructive pulmonary disease (COPD) and asthma and was later validated for use in bronchiectasis. The SGRQ covers 3 dimensions: symptoms, activity and impact on daily life. To determine the outcome, a score ranging from 1 to 100 was calculated for each individual domain and for the total score, and smaller scores indicate better health status. For this baseline measure, the symptoms component score was reported.|Score on a scale|Mean|63.47|63.47|Standard Deviation|19.48|19.48|||
3718595|NCT02106832|3557188|B3|||Saint George's Respiratory Questionnaire (SGRQ) Symptoms Component Score|The SGRQ was a validated, disease-specific instrument that measures health-related quality of life (HRQoL) in adults with chronic obstructive pulmonary disease (COPD) and asthma and was later validated for use in bronchiectasis. The SGRQ covers 3 dimensions: symptoms, activity and impact on daily life. To determine the outcome, a score ranging from 1 to 100 was calculated for each individual domain and for the total score, and smaller scores indicate better health status. For this baseline measure, the symptoms component score was reported.|Score on a scale|Mean|58.56|58.56|Standard Deviation|19.17|19.17|||
3718596|NCT02106832|3557189|B2|||Saint George's Respiratory Questionnaire (SGRQ) Symptoms Component Score|The SGRQ was a validated, disease-specific instrument that measures health-related quality of life (HRQoL) in adults with chronic obstructive pulmonary disease (COPD) and asthma and was later validated for use in bronchiectasis. The SGRQ covers 3 dimensions: symptoms, activity and impact on daily life. To determine the outcome, a score ranging from 1 to 100 was calculated for each individual domain and for the total score, and smaller scores indicate better health status. For this baseline measure, the symptoms component score was reported.|Score on a scale|Mean|61.26|61.26|Standard Deviation|19.54|19.54|||
3718597|NCT02106832|3557190|B1|||Saint George's Respiratory Questionnaire (SGRQ) Symptoms Component Score|The SGRQ was a validated, disease-specific instrument that measures health-related quality of life (HRQoL) in adults with chronic obstructive pulmonary disease (COPD) and asthma and was later validated for use in bronchiectasis. The SGRQ covers 3 dimensions: symptoms, activity and impact on daily life. To determine the outcome, a score ranging from 1 to 100 was calculated for each individual domain and for the total score, and smaller scores indicate better health status. For this baseline measure, the symptoms component score was reported.|Score on a scale|Mean|60.75|60.75|Standard Deviation|20.61|20.61|||
3718598|NCT02106832|3557186|B5||Male|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
3718599|NCT02106832|3557187|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3718600|NCT02106832|3557188|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3718601|NCT02106832|3557189|B2||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3718602|NCT02106832|3557190|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3718603|NCT02106832|3557186|B5||Female|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
3718604|NCT02106832|3557187|B4||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3718605|NCT02106832|3557188|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3718606|NCT02106832|3557189|B2||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3718607|NCT02106832|3557190|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3718608|NCT02106832|3557186|B5|||Age||Years|Mean|60.1|60.1|Standard Deviation|14.0|14.0|||
3718609|NCT02106832|3557187|B4|||Age||Years|Mean|60.4|60.4|Standard Deviation|15.0|15.0|||
3718610|NCT02106832|3557188|B3|||Age||Years|Mean|60.6|60.6|Standard Deviation|13.7|13.7|||
3718611|NCT02106832|3557189|B2|||Age||Years|Mean|60.4|60.4|Standard Deviation|13.7|13.7|||
3718612|NCT02106832|3557190|B1|||Age||Years|Mean|59.3|59.3|Standard Deviation|14.2|14.2|||
3718613|NCT02106728|3557226|B3|(Anorexia Nervosa (Binge Purge subtype)||Diagnosis of Patient Participant Subset||participants|Number|25|25.0||||||
3718614|NCT02106728|3557227|B2|(Anorexia Nervosa (Binge Purge subtype)||Diagnosis of Patient Participant Subset||participants|Number|12|12.0||||||
3718615|NCT02106728|3557228|B1|(Anorexia Nervosa (Binge Purge subtype)||Diagnosis of Patient Participant Subset||participants|Number|13|13.0||||||
3718616|NCT02106728|3557226|B3|Anorexia Nervosa (Restrictive Subtype)||Diagnosis of Patient Participant Subset||participants|Number|20|20.0||||||
3718617|NCT02106728|3557227|B2|Anorexia Nervosa (Restrictive Subtype)||Diagnosis of Patient Participant Subset||participants|Number|10|10.0||||||
3718618|NCT02106728|3557228|B1|Anorexia Nervosa (Restrictive Subtype)||Diagnosis of Patient Participant Subset||participants|Number|10|10.0||||||
3718619|NCT02106728|3557226|B3|Canada||Region of Enrollment||participants|Number|117|117.0||||||
3718620|NCT02106728|3557227|B2|Canada||Region of Enrollment||participants|Number|47|47.0||||||
3718621|NCT02106728|3557228|B1|Canada||Region of Enrollment||participants|Number|70|70.0||||||
3718622|NCT02106728|3557226|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3718623|NCT02106728|3557227|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3718627|NCT02106728|3557228|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3718628|NCT02106728|3557226|B3|||Age||years|Mean|26.20|26.2|Standard Deviation|7.36|7.36|||
3718629|NCT02106728|3557227|B2|||Age||years|Mean|26.20|26.2|Standard Deviation|7.36|7.36|||
3718630|NCT02106728|3557228|B1|||Age||years|Mean|26.20|26.2|Standard Deviation|7.36|7.36|||
3718631|NCT02106728|3557226|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3718632|NCT02106728|3557227|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3718633|NCT02106728|3557228|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3718634|NCT02106728|3557226|B3||Between 18 and 65 years|Age||Participants|Count of Participants|117|117.0||||||
3718635|NCT02106728|3557227|B2||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3718636|NCT02106728|3557228|B1||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
3718637|NCT02106728|3557226|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3718638|NCT02106728|3557227|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3718639|NCT02106728|3557228|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3718640|NCT02106494|3557243|B3||Male|Gender||Participants|Count of Participants|171|171.0||||||
3718641|NCT02106494|3557244|B2||Male|Gender||Participants|Count of Participants|79|79.0||||||
3718642|NCT02106494|3557245|B1||Male|Gender||Participants|Count of Participants|92|92.0||||||
3718643|NCT02106494|3557243|B3||Female|Gender||Participants|Count of Participants|731|731.0||||||
3718644|NCT02106494|3557244|B2||Female|Gender||Participants|Count of Participants|373|373.0||||||
3718645|NCT02106494|3557245|B1||Female|Gender||Participants|Count of Participants|358|358.0||||||
3718646|NCT02106494|3557243|B3|||Age||years|Mean|55.65|55.65|Standard Deviation|11.84|11.84|||
3718647|NCT02106494|3557244|B2|||Age||years|Mean|55.6|55.6|Standard Deviation|11.94|11.94|||
3718648|NCT02106494|3557245|B1|||Age||years|Mean|55.7|55.7|Standard Deviation|11.74|11.74|||
3718649|NCT02106494|3557243|B3||>=65 years|Age||Participants|Count of Participants|235|235.0||||||
3718650|NCT02106494|3557244|B2||>=65 years|Age||Participants|Count of Participants|118|118.0||||||
3718651|NCT02106494|3557245|B1||>=65 years|Age||Participants|Count of Participants|117|117.0||||||
3718652|NCT02106494|3557243|B3||Between 18 and 65 years|Age||Participants|Count of Participants|667|667.0||||||
3718653|NCT02106494|3557244|B2||Between 18 and 65 years|Age||Participants|Count of Participants|334|334.0||||||
3718654|NCT02106494|3557245|B1||Between 18 and 65 years|Age||Participants|Count of Participants|333|333.0||||||
3718655|NCT02106494|3557243|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3718656|NCT02106494|3557244|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3718657|NCT02106494|3557245|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3718658|NCT02106403|3557260|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3718659|NCT02106403|3557260|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3718660|NCT02106403|3557260|B1|||Age||Years|Mean|40.0|40.0|Standard Deviation|12.32|12.32|||
3718661|NCT02106390|3557285|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|696|696.0||||||
3718662|NCT02106390|3557286|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|231|231.0||||||
3718663|NCT02106390|3557287|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|230|230.0||||||
3718664|NCT02106390|3557288|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|235|235.0||||||
3718665|NCT02106390|3557285|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|54|54.0||||||
3718666|NCT02106390|3557286|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3718667|NCT02106390|3557287|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3718668|NCT02106390|3557288|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3718669|NCT02106390|3557285|B4||Male|Sex: Female, Male||Participants|Count of Participants|373|373.0||||||
3718670|NCT02106390|3557286|B3||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3718671|NCT02106390|3557287|B2||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3718672|NCT02106390|3557288|B1||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3718673|NCT02106390|3557285|B4||Female|Sex: Female, Male||Participants|Count of Participants|377|377.0||||||
3718674|NCT02106390|3557286|B3||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3718675|NCT02106390|3557287|B2||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3718676|NCT02106390|3557288|B1||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3718677|NCT02106390|3557285|B4|||Age||Days|Mean|102.7|102.7|Standard Deviation|10.77|10.77|||
3718678|NCT02106390|3557286|B3|||Age||Days|Mean|102.7|102.7|Standard Deviation|10.9|10.9|||
3718679|NCT02106390|3557287|B2|||Age||Days|Mean|101.4|101.4|Standard Deviation|10.57|10.57|||
3718680|NCT02106390|3557288|B1|||Age||Days|Mean|104.0|104.0|Standard Deviation|10.72|10.72|||
3718681|NCT02106325|3557364|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3718682|NCT02106325|3557365|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718683|NCT02106325|3557366|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3718684|NCT02106325|3557364|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718685|NCT02106325|3557365|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718686|NCT02106325|3557366|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718687|NCT02106325|3557364|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3718688|NCT02106325|3557365|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3718689|NCT02106325|3557366|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3718690|NCT02106325|3557364|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3718691|NCT02106325|3557365|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718692|NCT02106325|3557366|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3718693|NCT02106325|3557364|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718694|NCT02106325|3557365|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718695|NCT02106325|3557366|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718696|NCT02106325|3557364|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3718697|NCT02106325|3557365|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718698|NCT02106325|3557366|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3718699|NCT02106325|3557364|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718700|NCT02106325|3557365|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718701|NCT02106325|3557366|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718702|NCT02106325|3557364|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3718703|NCT02106325|3557365|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3718704|NCT02106325|3557366|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3718705|NCT02106325|3557364|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3718706|NCT02106325|3557365|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3718707|NCT02106325|3557366|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3718708|NCT02106325|3557364|B3|||Age||years|Mean|38|38.0|Full Range|||22.0|57.0|
3718709|NCT02106325|3557365|B2|||Age||years|Mean|31|31.0|Full Range|||22.0|48.0|
3718710|NCT02106325|3557366|B1|||Age||years|Mean|40|40.0|Full Range|||22.0|57.0|
3718711|NCT02106156|3557389|B4|Not determined/not assessable||Number of Participants With Low or High Viral Load|Low viral load was defined as </=1,000,000 copies/milliliter (copies/ml) or </=400,000 international units/milliliter (IU/ml). High viral load was defined as >1,000,000 copies/ml or >400,000 IU/ml.|participants|Number|103|103.0||||||
3718712|NCT02106156|3557390|B3|Not determined/not assessable||Number of Participants With Low or High Viral Load|Low viral load was defined as </=1,000,000 copies/milliliter (copies/ml) or </=400,000 international units/milliliter (IU/ml). High viral load was defined as >1,000,000 copies/ml or >400,000 IU/ml.|participants|Number|23|23.0||||||
3718713|NCT02106156|3557391|B2|Not determined/not assessable||Number of Participants With Low or High Viral Load|Low viral load was defined as </=1,000,000 copies/milliliter (copies/ml) or </=400,000 international units/milliliter (IU/ml). High viral load was defined as >1,000,000 copies/ml or >400,000 IU/ml.|participants|Number|0|0.0||||||
3718714|NCT02106156|3557392|B1|Not determined/not assessable||Number of Participants With Low or High Viral Load|Low viral load was defined as </=1,000,000 copies/milliliter (copies/ml) or </=400,000 international units/milliliter (IU/ml). High viral load was defined as >1,000,000 copies/ml or >400,000 IU/ml.|participants|Number|80|80.0||||||
3718715|NCT02106156|3557389|B4|High viral load||Number of Participants With Low or High Viral Load|Low viral load was defined as </=1,000,000 copies/milliliter (copies/ml) or </=400,000 international units/milliliter (IU/ml). High viral load was defined as >1,000,000 copies/ml or >400,000 IU/ml.|participants|Number|6193|6193.0||||||
3718716|NCT02106156|3557390|B3|High viral load||Number of Participants With Low or High Viral Load|Low viral load was defined as </=1,000,000 copies/milliliter (copies/ml) or </=400,000 international units/milliliter (IU/ml). High viral load was defined as >1,000,000 copies/ml or >400,000 IU/ml.|participants|Number|356|356.0||||||
3718717|NCT02106156|3557391|B2|High viral load||Number of Participants With Low or High Viral Load|Low viral load was defined as </=1,000,000 copies/milliliter (copies/ml) or </=400,000 international units/milliliter (IU/ml). High viral load was defined as >1,000,000 copies/ml or >400,000 IU/ml.|participants|Number|66|66.0||||||
3718718|NCT02106156|3557392|B1|High viral load||Number of Participants With Low or High Viral Load|Low viral load was defined as </=1,000,000 copies/milliliter (copies/ml) or </=400,000 international units/milliliter (IU/ml). High viral load was defined as >1,000,000 copies/ml or >400,000 IU/ml.|participants|Number|5771|5771.0||||||
3718719|NCT02106156|3557389|B4|Low viral load||Number of Participants With Low or High Viral Load|Low viral load was defined as </=1,000,000 copies/milliliter (copies/ml) or </=400,000 international units/milliliter (IU/ml). High viral load was defined as >1,000,000 copies/ml or >400,000 IU/ml.|participants|Number|3932|3932.0||||||
3718720|NCT02106156|3557390|B3|Low viral load||Number of Participants With Low or High Viral Load|Low viral load was defined as </=1,000,000 copies/milliliter (copies/ml) or </=400,000 international units/milliliter (IU/ml). High viral load was defined as >1,000,000 copies/ml or >400,000 IU/ml.|participants|Number|139|139.0||||||
3718721|NCT02106156|3557391|B2|Low viral load||Number of Participants With Low or High Viral Load|Low viral load was defined as </=1,000,000 copies/milliliter (copies/ml) or </=400,000 international units/milliliter (IU/ml). High viral load was defined as >1,000,000 copies/ml or >400,000 IU/ml.|participants|Number|24|24.0||||||
3718722|NCT02106156|3557392|B1|Low viral load||Number of Participants With Low or High Viral Load|Low viral load was defined as </=1,000,000 copies/milliliter (copies/ml) or </=400,000 international units/milliliter (IU/ml). High viral load was defined as >1,000,000 copies/ml or >400,000 IU/ml.|participants|Number|3769|3769.0||||||
3718723|NCT02106156|3557389|B4|Genotype unknown||Number of Participants With Each Hepatitis C Viral Genotype||participants|Number|41|41.0||||||
3718724|NCT02106156|3557390|B3|Genotype unknown||Number of Participants With Each Hepatitis C Viral Genotype||participants|Number|20|20.0||||||
3718725|NCT02106156|3557391|B2|Genotype unknown||Number of Participants With Each Hepatitis C Viral Genotype||participants|Number|0|0.0||||||
3718726|NCT02106156|3557392|B1|Genotype unknown||Number of Participants With Each Hepatitis C Viral Genotype||participants|Number|21|21.0||||||
3718727|NCT02106156|3557389|B4|Genotype 6||Number of Participants With Each Hepatitis C Viral Genotype||participants|Number|16|16.0||||||
3718728|NCT02106156|3557390|B3|Genotype 6||Number of Participants With Each Hepatitis C Viral Genotype||participants|Number|1|1.0||||||
3718729|NCT02106156|3557391|B2|Genotype 6||Number of Participants With Each Hepatitis C Viral Genotype||participants|Number|0|0.0||||||
3718730|NCT02106156|3557392|B1|Genotype 6||Number of Participants With Each Hepatitis C Viral Genotype||participants|Number|15|15.0||||||
3718731|NCT02106156|3557389|B4|Genotype 5||Number of Participants With Each Hepatitis C Viral Genotype||participants|Number|19|19.0||||||
3718732|NCT02106156|3557390|B3|Genotype 5||Number of Participants With Each Hepatitis C Viral Genotype||participants|Number|2|2.0||||||
3718733|NCT02106156|3557391|B2|Genotype 5||Number of Participants With Each Hepatitis C Viral Genotype||participants|Number|0|0.0||||||
3718734|NCT02106156|3557392|B1|Genotype 5||Number of Participants With Each Hepatitis C Viral Genotype||participants|Number|17|17.0||||||
3718735|NCT02106156|3557389|B4|Genotype 4||Number of Participants With Each Hepatitis C Viral Genotype||participants|Number|445|445.0||||||
3718736|NCT02106156|3557390|B3|Genotype 4||Number of Participants With Each Hepatitis C Viral Genotype||participants|Number|18|18.0||||||
3718737|NCT02106156|3557391|B2|Genotype 4||Number of Participants With Each Hepatitis C Viral Genotype||participants|Number|6|6.0||||||
3718738|NCT02106156|3557392|B1|Genotype 4||Number of Participants With Each Hepatitis C Viral Genotype||participants|Number|421|421.0||||||
3718739|NCT02106156|3557389|B4|Genotype 3||Number of Participants With Each Hepatitis C Viral Genotype||participants|Number|3022|3022.0||||||
3718740|NCT02106156|3557390|B3|Genotype 3||Number of Participants With Each Hepatitis C Viral Genotype||participants|Number|89|89.0||||||
3718741|NCT02106156|3557391|B2|Genotype 3||Number of Participants With Each Hepatitis C Viral Genotype||participants|Number|30|30.0||||||
3718742|NCT02106156|3557392|B1|Genotype 3||Number of Participants With Each Hepatitis C Viral Genotype||participants|Number|2903|2903.0||||||
3718743|NCT02106156|3557389|B4|Genotype 2||Number of Participants With Each Hepatitis C Viral Genotype||participants|Number|558|558.0||||||
3718744|NCT02106156|3557390|B3|Genotype 2||Number of Participants With Each Hepatitis C Viral Genotype||participants|Number|11|11.0||||||
3718745|NCT02106156|3557391|B2|Genotype 2||Number of Participants With Each Hepatitis C Viral Genotype||participants|Number|3|3.0||||||
3718746|NCT02106156|3557392|B1|Genotype 2||Number of Participants With Each Hepatitis C Viral Genotype||participants|Number|544|544.0||||||
3718747|NCT02106156|3557389|B4|Genotype 1||Number of Participants With Each Hepatitis C Viral Genotype||participants|Number|6127|6127.0||||||
3718748|NCT02106156|3557390|B3|Genotype 1||Number of Participants With Each Hepatitis C Viral Genotype||participants|Number|377|377.0||||||
3718749|NCT02106156|3557391|B2|Genotype 1||Number of Participants With Each Hepatitis C Viral Genotype||participants|Number|51|51.0||||||
3718750|NCT02106156|3557392|B1|Genotype 1||Number of Participants With Each Hepatitis C Viral Genotype||participants|Number|5699|5699.0||||||
3718751|NCT02106156|3557389|B4||Male|Sex: Female, Male||Participants|Count of Participants|6715|6715.0||||||
3718752|NCT02106156|3557390|B3||Male|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
3718753|NCT02106156|3557391|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3718754|NCT02106156|3557392|B1||Male|Sex: Female, Male||Participants|Count of Participants|6347|6347.0||||||
3718755|NCT02106156|3557389|B4||Female|Sex: Female, Male||Participants|Count of Participants|3513|3513.0||||||
3718756|NCT02106156|3557390|B3||Female|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
3718757|NCT02106156|3557391|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3718758|NCT02106156|3557392|B1||Female|Sex: Female, Male||Participants|Count of Participants|3273|3273.0||||||
3718759|NCT02106156|3557389|B4|||Age||years|Mean|42.6|42.6|Standard Deviation|11.6|11.6|||
3718760|NCT02106156|3557390|B3|||Age||years|Mean|51.1|51.1|Standard Deviation|12.8|12.8|||
3718761|NCT02106156|3557391|B2|||Age||years|Mean|44.9|44.9|Standard Deviation|10.5|10.5|||
3718762|NCT02106156|3557392|B1|||Age||years|Mean|42.2|42.2|Standard Deviation|11.4|11.4|||
3718763|NCT02105987|3557416|B3|Missing||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3718764|NCT02105987|3557417|B2|Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3718765|NCT02105987|3557418|B1|Missing||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3718766|NCT02105987|3557416|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3718767|NCT02105987|3557417|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3718768|NCT02105987|3557418|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3718769|NCT02105987|3557416|B3|White - Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3718770|NCT02105987|3557417|B2|White - Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3718771|NCT02105987|3557418|B1|White - Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3718772|NCT02105987|3557416|B3|White - Mixed Race||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3718773|NCT02105987|3557417|B2|White - Mixed Race||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3718774|NCT02105987|3557418|B1|White - Mixed Race||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3718775|NCT02105987|3557416|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|341|341.0||||||
3718776|NCT02105987|3557417|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|165|165.0||||||
3718777|NCT02105987|3557418|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|176|176.0||||||
3718778|NCT02105987|3557416|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3718779|NCT02105987|3557417|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3718780|NCT02105987|3557418|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3718781|NCT02105987|3557416|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3718782|NCT02105987|3557417|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3718783|NCT02105987|3557418|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3718784|NCT02105987|3557416|B3|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3718785|NCT02105987|3557417|B2|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3718786|NCT02105987|3557418|B1|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3718787|NCT02105987|3557416|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3718788|NCT02105987|3557417|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3718789|NCT02105987|3557418|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3718790|NCT02105987|3557416|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3718791|NCT02105987|3557417|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3718792|NCT02105987|3557418|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3718793|NCT02105987|3557416|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3718794|NCT02105987|3557417|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3718795|NCT02105987|3557418|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3718796|NCT02105987|3557416|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3718797|NCT02105987|3557417|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3718798|NCT02105987|3557418|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3718799|NCT02105987|3557416|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3718800|NCT02105987|3557417|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3718801|NCT02105987|3557418|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3718802|NCT02105987|3557416|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|144|144.0||||||
3718803|NCT02105987|3557417|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|63|63.0||||||
3718804|NCT02105987|3557418|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|81|81.0||||||
3718805|NCT02105987|3557416|B3||Male|Gender||Participants|Count of Participants|449|449.0||||||
3718806|NCT02105987|3557417|B2||Male|Gender||Participants|Count of Participants|212|212.0||||||
3718807|NCT02105987|3557418|B1||Male|Gender||Participants|Count of Participants|237|237.0||||||
3718808|NCT02105987|3557416|B3||Female|Gender||Participants|Count of Participants|70|70.0||||||
3718809|NCT02105987|3557417|B2||Female|Gender||Participants|Count of Participants|32|32.0||||||
3718810|NCT02105987|3557418|B1||Female|Gender||Participants|Count of Participants|38|38.0||||||
3718811|NCT02105987|3557416|B3|||Age||Years|Mean|44.8|44.8|Standard Deviation|10.93|10.93|||
3718812|NCT02105987|3557417|B2|||Age||Years|Mean|45.5|45.5|Standard Deviation|11.25|11.25|||
3718813|NCT02105987|3557418|B1|||Age||Years|Mean|44.1|44.1|Standard Deviation|10.61|10.61|||
3718814|NCT02105974|3557475|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3718815|NCT02105974|3557476|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3718816|NCT02105974|3557477|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3718817|NCT02105974|3557475|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|1079|1079.0||||||
3718818|NCT02105974|3557476|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|541|541.0||||||
3718819|NCT02105974|3557477|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|538|538.0||||||
3718820|NCT02105974|3557475|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|370|370.0||||||
3718821|NCT02105974|3557476|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|185|185.0||||||
3718822|NCT02105974|3557477|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|185|185.0||||||
3718823|NCT02105974|3557475|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|154|154.0||||||
3718824|NCT02105974|3557476|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|77|77.0||||||
3718825|NCT02105974|3557477|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|77|77.0||||||
3718826|NCT02105974|3557475|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
3718827|NCT02105974|3557476|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
3718828|NCT02105974|3557477|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3718829|NCT02105974|3557475|B3||Male|Sex: Female, Male||Participants|Count of Participants|1230|1230.0||||||
3718830|NCT02105974|3557476|B2||Male|Sex: Female, Male||Participants|Count of Participants|625|625.0||||||
3718831|NCT02105974|3557477|B1||Male|Sex: Female, Male||Participants|Count of Participants|605|605.0||||||
3718832|NCT02105974|3557475|B3||Female|Sex: Female, Male||Participants|Count of Participants|390|390.0||||||
3718833|NCT02105974|3557476|B2||Female|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
3718834|NCT02105974|3557477|B1||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3718835|NCT02105974|3557475|B3|||Age||Years|Mean|65.3|65.3|Standard Deviation|8.80|8.8|||
3718836|NCT02105974|3557476|B2|||Age||Years|Mean|65.4|65.4|Standard Deviation|9.02|9.02|||
3718837|NCT02105974|3557477|B1|||Age||Years|Mean|65.3|65.3|Standard Deviation|8.58|8.58|||
3718838|NCT02105961|3557489|B4|Race customized|White-White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|542|542.0||||||
3718839|NCT02105961|3557490|B3|Race customized|White-White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|182|182.0||||||
3718840|NCT02105961|3557491|B2|Race customized|White-White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|178|178.0||||||
3718841|NCT02105961|3557492|B1|Race customized|White-White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|182|182.0||||||
3718842|NCT02105961|3557489|B4|Race customized|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3718843|NCT02105961|3557490|B3|Race customized|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3718844|NCT02105961|3557491|B2|Race customized|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3718845|NCT02105961|3557492|B1|Race customized|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3718846|NCT02105961|3557489|B4|Race customized|Asian-South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3718847|NCT02105961|3557490|B3|Race customized|Asian-South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3718848|NCT02105961|3557491|B2|Race customized|Asian-South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3718849|NCT02105961|3557492|B1|Race customized|Asian-South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3718850|NCT02105961|3557489|B4|Race customized|Asian-Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3718851|NCT02105961|3557490|B3|Race customized|Asian-Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3718852|NCT02105961|3557491|B2|Race customized|Asian-Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3718853|NCT02105961|3557492|B1|Race customized|Asian-Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3718854|NCT02105961|3557489|B4|Race customized|Asian-East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|77|77.0||||||
3718855|NCT02105961|3557490|B3|Race customized|Asian-East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3718856|NCT02105961|3557491|B2|Race customized|Asian-East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3718857|NCT02105961|3557492|B1|Race customized|Asian-East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3718858|NCT02105961|3557489|B4|Race customized|Asian-Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3718859|NCT02105961|3557490|B3|Race customized|Asian-Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3718860|NCT02105961|3557491|B2|Race customized|Asian-Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3718861|NCT02105961|3557492|B1|Race customized|Asian-Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3718862|NCT02105961|3557489|B4||Male|Sex: Female, Male||Participants|Count of Participants|446|446.0||||||
3718863|NCT02105961|3557490|B3||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3718864|NCT02105961|3557491|B2||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3718865|NCT02105961|3557492|B1||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3718866|NCT02105961|3557489|B4||Female|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
3718867|NCT02105961|3557490|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3718868|NCT02105961|3557491|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3718869|NCT02105961|3557492|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3718870|NCT02105961|3557489|B4|||Age||Years|Mean|65.1|65.1|Standard Deviation|8.89|8.89|||
3718871|NCT02105961|3557490|B3|||Age||Years|Mean|64.8|64.8|Standard Deviation|8.96|8.96|||
3718872|NCT02105961|3557491|B2|||Age||Years|Mean|64.8|64.8|Standard Deviation|9.06|9.06|||
3718873|NCT02105961|3557492|B1|||Age||Years|Mean|65.8|65.8|Standard Deviation|8.64|8.64|||
3718874|NCT02105948|3557514|B5|Race customized|Multiple - American Indian/Alaska Native and White|Race/Ethnicity, Customized||Participants|Count of Participants|69|69.0||||||
3718875|NCT02105948|3557515|B4|Race customized|Multiple - American Indian/Alaska Native and White|Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3718876|NCT02105948|3557516|B3|Race customized|Multiple - American Indian/Alaska Native and White|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3718877|NCT02105948|3557517|B2|Race customized|Multiple - American Indian/Alaska Native and White|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3718878|NCT02105948|3557518|B1|Race customized|Multiple - American Indian/Alaska Native and White|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3718879|NCT02105948|3557514|B5|Race customized|White- White/ Caucasian/ European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|676|676.0||||||
3718880|NCT02105948|3557515|B4|Race customized|White- White/ Caucasian/ European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|143|143.0||||||
3718881|NCT02105948|3557516|B3|Race customized|White- White/ Caucasian/ European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|145|145.0||||||
3718882|NCT02105948|3557517|B2|Race customized|White- White/ Caucasian/ European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|198|198.0||||||
3718883|NCT02105948|3557518|B1|Race customized|White- White/ Caucasian/ European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|190|190.0||||||
3718884|NCT02105948|3557514|B5|Race customized|White- Arabic/ North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3718885|NCT02105948|3557515|B4|Race customized|White- Arabic/ North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3718886|NCT02105948|3557516|B3|Race customized|White- Arabic/ North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3718887|NCT02105948|3557517|B2|Race customized|White- Arabic/ North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3718888|NCT02105948|3557518|B1|Race customized|White- Arabic/ North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3718889|NCT02105948|3557514|B5|Race customized|Black/ African American Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3718890|NCT02105948|3557515|B4|Race customized|Black/ African American Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3718891|NCT02105948|3557516|B3|Race customized|Black/ African American Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3718892|NCT02105948|3557517|B2|Race customized|Black/ African American Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3718893|NCT02105948|3557518|B1|Race customized|Black/ African American Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3718894|NCT02105948|3557514|B5|Race customized|Asian- Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3718895|NCT02105948|3557515|B4|Race customized|Asian- Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3718896|NCT02105948|3557516|B3|Race customized|Asian- Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3718897|NCT02105948|3557517|B2|Race customized|Asian- Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3718898|NCT02105948|3557518|B1|Race customized|Asian- Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3718899|NCT02105948|3557514|B5|Race customized|Asian- East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3718900|NCT02105948|3557515|B4|Race customized|Asian- East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3718901|NCT02105948|3557516|B3|Race customized|Asian- East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3718902|NCT02105948|3557517|B2|Race customized|Asian- East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3718903|NCT02105948|3557518|B1|Race customized|Asian- East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3718904|NCT02105948|3557514|B5|Race customized|American Indian/ Alaska native Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|69|69.0||||||
3718905|NCT02105948|3557515|B4|Race customized|American Indian/ Alaska native Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3718906|NCT02105948|3557516|B3|Race customized|American Indian/ Alaska native Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3718907|NCT02105948|3557517|B2|Race customized|American Indian/ Alaska native Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3718908|NCT02105948|3557518|B1|Race customized|American Indian/ Alaska native Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3718909|NCT02105948|3557514|B5||Male|Sex: Female, Male||Participants|Count of Participants|520|520.0||||||
3718910|NCT02105948|3557515|B4||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3718911|NCT02105948|3557516|B3||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3718912|NCT02105948|3557517|B2||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3718913|NCT02105948|3557518|B1||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3718914|NCT02105948|3557514|B5||Female|Sex: Female, Male||Participants|Count of Participants|316|316.0||||||
3718915|NCT02105948|3557515|B4||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3718916|NCT02105948|3557516|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3718917|NCT02105948|3557517|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3718918|NCT02105948|3557518|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3718919|NCT02105948|3557514|B5|||Age||Years|Mean|65.4|65.4|Standard Deviation|8.64|8.64|||
3718920|NCT02105948|3557515|B4|||Age||Years|Mean|66.1|66.1|Standard Deviation|9.14|9.14|||
3718921|NCT02105948|3557516|B3|||Age||Years|Mean|65.2|65.2|Standard Deviation|8.62|8.62|||
3718922|NCT02105948|3557517|B2|||Age||Years|Mean|65.2|65.2|Standard Deviation|8.36|8.36|||
3718923|NCT02105948|3557518|B1|||Age||Years|Mean|65.3|65.3|Standard Deviation|8.53|8.53|||
3718924|NCT02105740|3557547|B3|||Depression|The Hospital Anxiety and Depression Scale has 14 questions, seven are aimed at evaluating anxiety (HADS-A) and seven for depression (HADS-D). Each item can be scored from zero to three, establish a maximum score of 21 points for each scale adopted as the cut points for both ≥ 9 subscales to the symptom diagnosis|units on a scale|Mean|9.4|9.4|Standard Deviation|4.5|4.5|||
3718925|NCT02105740|3557548|B2|||Depression|The Hospital Anxiety and Depression Scale has 14 questions, seven are aimed at evaluating anxiety (HADS-A) and seven for depression (HADS-D). Each item can be scored from zero to three, establish a maximum score of 21 points for each scale adopted as the cut points for both ≥ 9 subscales to the symptom diagnosis|units on a scale|Mean|9.0|9.0|Standard Deviation|3.8|3.8|||
3718926|NCT02105740|3557549|B1|||Depression|The Hospital Anxiety and Depression Scale has 14 questions, seven are aimed at evaluating anxiety (HADS-A) and seven for depression (HADS-D). Each item can be scored from zero to three, establish a maximum score of 21 points for each scale adopted as the cut points for both ≥ 9 subscales to the symptom diagnosis|units on a scale|Mean|9.8|9.8|Standard Deviation|5.3|5.3|||
3718975|NCT02105688|3557587|B3|||Age||years|Mean|47.1|47.1|Standard Deviation|9.9|9.9|||
3718976|NCT02105688|3557588|B2|||Age||years|Mean|46.4|46.4|Standard Deviation|9.9|9.9|||
3718927|NCT02105740|3557547|B3|||Anxiety|The Hospital Anxiety and Depression Scale (HADS) has 14 questions, seven are aimed at evaluating anxiety (HADS-A) and seven for depression (HADS-D). Each item can be scored from 0 to 3, establish a maximum score of 21 points for each subscale. Values ≥ 9 for each subscales indicate the symptom.|units on a scale|Mean|11.4|11.4|Standard Deviation|4.4|4.4|||
3718928|NCT02105740|3557548|B2|||Anxiety|The Hospital Anxiety and Depression Scale (HADS) has 14 questions, seven are aimed at evaluating anxiety (HADS-A) and seven for depression (HADS-D). Each item can be scored from 0 to 3, establish a maximum score of 21 points for each subscale. Values ≥ 9 for each subscales indicate the symptom.|units on a scale|Mean|11.3|11.3|Standard Deviation|4.4|4.4|||
3718929|NCT02105740|3557549|B1|||Anxiety|The Hospital Anxiety and Depression Scale (HADS) has 14 questions, seven are aimed at evaluating anxiety (HADS-A) and seven for depression (HADS-D). Each item can be scored from 0 to 3, establish a maximum score of 21 points for each subscale. Values ≥ 9 for each subscales indicate the symptom.|units on a scale|Mean|11.5|11.5|Standard Deviation|4.6|4.6|||
3718930|NCT02105740|3557547|B3|||Pain|The Visual Analogue Scale (VAS) consist in a straight line in ascending order from left to right, which may be numbered from 0 to 10, in which the patient report pain intensity. Values above 03 are already considered significant for pain.|units on a scale|Mean|6.4|6.4|Standard Deviation|2.3|2.3|||
3718931|NCT02105740|3557548|B2|||Pain|The Visual Analogue Scale (VAS) consist in a straight line in ascending order from left to right, which may be numbered from 0 to 10, in which the patient report pain intensity. Values above 03 are already considered significant for pain.|units on a scale|Mean|5.6|5.6|Standard Deviation|2.0|2.0|||
3718932|NCT02105740|3557549|B1|||Pain|The Visual Analogue Scale (VAS) consist in a straight line in ascending order from left to right, which may be numbered from 0 to 10, in which the patient report pain intensity. Values above 03 are already considered significant for pain.|units on a scale|Mean|7.3|7.3|Standard Deviation|2.4|2.4|||
3718933|NCT02105740|3557547|B3|Brazil||Region of Enrollment||participants|Number|24|24.0||||||
3718934|NCT02105740|3557548|B2|Brazil||Region of Enrollment||participants|Number|12|12.0||||||
3718935|NCT02105740|3557549|B1|Brazil||Region of Enrollment||participants|Number|12|12.0||||||
3718936|NCT02105740|3557547|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718937|NCT02105740|3557548|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718938|NCT02105740|3557549|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718939|NCT02105740|3557547|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718940|NCT02105740|3557548|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718941|NCT02105740|3557549|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3718942|NCT02105740|3557547|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3718943|NCT02105740|3557548|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3718944|NCT02105740|3557549|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3718945|NCT02105740|3557547|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3718946|NCT02105740|3557548|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3718947|NCT02105740|3557549|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3718948|NCT02105740|3557547|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3718949|NCT02105740|3557548|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3718950|NCT02105740|3557549|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3718951|NCT02105740|3557547|B3|||Age||years|Mean|55.5|55.5|Standard Deviation|6.5|6.5|||
3718952|NCT02105740|3557548|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|7.5|7.5|||
3718953|NCT02105740|3557549|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|6.6|6.6|||
3718954|NCT02105701|3557558|B5||Male|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
3718955|NCT02105701|3557559|B4||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3718956|NCT02105701|3557560|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3718957|NCT02105701|3557561|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3718958|NCT02105701|3557562|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3718959|NCT02105701|3557558|B5||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3718960|NCT02105701|3557559|B4||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3718961|NCT02105701|3557560|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3718962|NCT02105701|3557561|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3718963|NCT02105701|3557562|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3718964|NCT02105701|3557558|B5|||Age||Years|Mean|55.27|55.27|Standard Deviation|9.37|9.37|||
3718965|NCT02105701|3557559|B4|||Age||Years|Mean|54.98|54.98|Standard Deviation|9.61|9.61|||
3718966|NCT02105701|3557560|B3|||Age||Years|Mean|54.91|54.91|Standard Deviation|9.79|9.79|||
3718967|NCT02105701|3557561|B2|||Age||Years|Mean|55.46|55.46|Standard Deviation|8.26|8.26|||
3718968|NCT02105701|3557562|B1|||Age||Years|Mean|55.71|55.71|Standard Deviation|9.81|9.81|||
3718969|NCT02105688|3557587|B3||Male|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
3718970|NCT02105688|3557588|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3718971|NCT02105688|3557589|B1||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3718972|NCT02105688|3557587|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3718973|NCT02105688|3557588|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3718974|NCT02105688|3557589|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3718977|NCT02105688|3557589|B1|||Age||years|Mean|47.4|47.4|Standard Deviation|9.9|9.9|||
3718978|NCT02105662|3557600|B1||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3718979|NCT02105662|3557600|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3718980|NCT02105662|3557600|B1|||Age||years|Mean|48.7|48.7|Standard Deviation|8.9|8.9|||
3718981|NCT02105636|3557607|B3|Not Reported||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all pre-disease performance without restriction and (worst score) 5=death.|participants|Number|2|2.0||||||
3718982|NCT02105636|3557608|B2|Not Reported||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all pre-disease performance without restriction and (worst score) 5=death.|participants|Number|1|1.0||||||
3718983|NCT02105636|3557609|B1|Not Reported||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all pre-disease performance without restriction and (worst score) 5=death.|participants|Number|1|1.0||||||
3718984|NCT02105636|3557607|B3|>=2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all pre-disease performance without restriction and (worst score) 5=death.|participants|Number|4|4.0||||||
3718985|NCT02105636|3557608|B2|>=2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all pre-disease performance without restriction and (worst score) 5=death.|participants|Number|3|3.0||||||
3718986|NCT02105636|3557609|B1|>=2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all pre-disease performance without restriction and (worst score) 5=death.|participants|Number|1|1.0||||||
3718987|NCT02105636|3557607|B3|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all pre-disease performance without restriction and (worst score) 5=death.|participants|Number|283|283.0||||||
3718988|NCT02105636|3557608|B2|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all pre-disease performance without restriction and (worst score) 5=death.|participants|Number|94|94.0||||||
3718989|NCT02105636|3557609|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all pre-disease performance without restriction and (worst score) 5=death.|participants|Number|189|189.0||||||
3718990|NCT02105636|3557607|B3|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all pre-disease performance without restriction and (worst score) 5=death.|participants|Number|72|72.0||||||
3718991|NCT02105636|3557608|B2|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all pre-disease performance without restriction and (worst score) 5=death.|participants|Number|23|23.0||||||
3718992|NCT02105636|3557609|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all pre-disease performance without restriction and (worst score) 5=death.|participants|Number|49|49.0||||||
3718993|NCT02105636|3557607|B3|Not Reported||Race/Ethnicity, Customized||participants|Number|156|156.0||||||
3718994|NCT02105636|3557608|B2|Not Reported||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
3718995|NCT02105636|3557609|B1|Not Reported||Race/Ethnicity, Customized||participants|Number|99|99.0||||||
3718996|NCT02105636|3557607|B3|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|192|192.0||||||
3718997|NCT02105636|3557608|B2|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
3718998|NCT02105636|3557609|B1|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|132|132.0||||||
3718999|NCT02105636|3557607|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3719000|NCT02105636|3557608|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3719001|NCT02105636|3557609|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3719002|NCT02105636|3557607|B3|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3719003|NCT02105636|3557608|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3719004|NCT02105636|3557609|B1|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3719005|NCT02105636|3557607|B3|Asian||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
3719006|NCT02105636|3557608|B2|Asian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3719007|NCT02105636|3557609|B1|Asian||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3719008|NCT02105636|3557607|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3719009|NCT02105636|3557608|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3719010|NCT02105636|3557609|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3719011|NCT02105636|3557607|B3|White||Race/Ethnicity, Customized||participants|Number|300|300.0||||||
3719012|NCT02105636|3557608|B2|White||Race/Ethnicity, Customized||participants|Number|104|104.0||||||
3719013|NCT02105636|3557609|B1|White||Race/Ethnicity, Customized||participants|Number|196|196.0||||||
3719014|NCT02105636|3557607|B3||Male|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
3719015|NCT02105636|3557608|B2||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3719016|NCT02105636|3557609|B1||Male|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
3719017|NCT02105636|3557607|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3719018|NCT02105636|3557608|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3719019|NCT02105636|3557609|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3719020|NCT02105636|3557607|B3|>=75 years||Age, Customized||participants|Number|18|18.0||||||
3719021|NCT02105636|3557608|B2|>=75 years||Age, Customized||participants|Number|6|6.0||||||
3719022|NCT02105636|3557609|B1|>=75 years||Age, Customized||participants|Number|12|12.0||||||
3719023|NCT02105636|3557607|B3|>=65 and <75 years||Age, Customized||participants|Number|95|95.0||||||
3719024|NCT02105636|3557608|B2|>=65 and <75 years||Age, Customized||participants|Number|39|39.0||||||
3719025|NCT02105636|3557609|B1|>=65 and <75 years||Age, Customized||participants|Number|56|56.0||||||
3719026|NCT02105636|3557607|B3|< 65 years||Age, Customized||participants|Number|248|248.0||||||
3719027|NCT02105636|3557608|B2|< 65 years||Age, Customized||participants|Number|76|76.0||||||
3719028|NCT02105636|3557609|B1|< 65 years||Age, Customized||participants|Number|172|172.0||||||
3719029|NCT02105636|3557607|B3|||Age||years|Mean|59.1|59.1|Standard Deviation|10.43|10.43|||
3719030|NCT02105636|3557608|B2|||Age||years|Mean|59.4|59.4|Standard Deviation|11.00|11.0|||
3719031|NCT02105636|3557609|B1|||Age||years|Mean|59.0|59.0|Standard Deviation|10.15|10.15|||
3719032|NCT02105558|3557620|B3|||Actual fetal weight||grams|Mean|3346|3346.0|Standard Deviation|398|398.0|||
3719033|NCT02105558|3557621|B2|||Actual fetal weight||grams|Mean|3292|3292.0|Standard Deviation|369|369.0|||
3719034|NCT02105558|3557622|B1|||Actual fetal weight||grams|Mean|3453|3453.0|Standard Deviation|445|445.0|||
3719035|NCT02105558|3557620|B3|||Estimated fetal weight||grams|Mean|3341|3341.0|Standard Deviation|374|374.0|||
3719036|NCT02105558|3557621|B2|||Estimated fetal weight||grams|Mean|3264|3264.0|Standard Deviation|400|400.0|||
3719037|NCT02105558|3557622|B1|||Estimated fetal weight||grams|Mean|3484|3484.0|Standard Deviation|279|279.0|||
3719038|NCT02105558|3557620|B3|||Number of pregnancies||number of pregnancies|Mean|3.1|3.1|Standard Deviation|1.3|1.3|||
3719039|NCT02105558|3557621|B2|||Number of pregnancies||number of pregnancies|Mean|3.0|3.0|Standard Deviation|0.9|0.9|||
3719040|NCT02105558|3557622|B1|||Number of pregnancies||number of pregnancies|Mean|3.3|3.3|Standard Deviation|1.6|1.6|||
3719041|NCT02105558|3557620|B3||Gastrochisis|Reason for Previous Cesarean||Participants|Count of Participants|1|1.0||||||
3719042|NCT02105558|3557621|B2||Gastrochisis|Reason for Previous Cesarean||Participants|Count of Participants|0|0.0||||||
3719043|NCT02105558|3557622|B1||Gastrochisis|Reason for Previous Cesarean||Participants|Count of Participants|1|1.0||||||
3719044|NCT02105558|3557620|B3||Failed induction|Reason for Previous Cesarean||Participants|Count of Participants|1|1.0||||||
3719045|NCT02105558|3557621|B2||Failed induction|Reason for Previous Cesarean||Participants|Count of Participants|0|0.0||||||
3719046|NCT02105558|3557622|B1||Failed induction|Reason for Previous Cesarean||Participants|Count of Participants|1|1.0||||||
3719047|NCT02105558|3557620|B3||Malpresentation|Reason for Previous Cesarean||Participants|Count of Participants|1|1.0||||||
3719048|NCT02105558|3557621|B2||Malpresentation|Reason for Previous Cesarean||Participants|Count of Participants|0|0.0||||||
3719049|NCT02105558|3557622|B1||Malpresentation|Reason for Previous Cesarean||Participants|Count of Participants|1|1.0||||||
3719050|NCT02105558|3557620|B3||Nuchal cord|Reason for Previous Cesarean||Participants|Count of Participants|1|1.0||||||
3719051|NCT02105558|3557621|B2||Nuchal cord|Reason for Previous Cesarean||Participants|Count of Participants|1|1.0||||||
3719052|NCT02105558|3557622|B1||Nuchal cord|Reason for Previous Cesarean||Participants|Count of Participants|0|0.0||||||
3719053|NCT02105558|3557620|B3||Arrest of labor|Reason for Previous Cesarean||Participants|Count of Participants|1|1.0||||||
3719054|NCT02105558|3557621|B2||Arrest of labor|Reason for Previous Cesarean||Participants|Count of Participants|1|1.0||||||
3719055|NCT02105558|3557622|B1||Arrest of labor|Reason for Previous Cesarean||Participants|Count of Participants|0|0.0||||||
3719056|NCT02105558|3557620|B3||Fetal distress|Reason for Previous Cesarean||Participants|Count of Participants|2|2.0||||||
3719057|NCT02105558|3557621|B2||Fetal distress|Reason for Previous Cesarean||Participants|Count of Participants|1|1.0||||||
3719058|NCT02105558|3557622|B1||Fetal distress|Reason for Previous Cesarean||Participants|Count of Participants|1|1.0||||||
3719059|NCT02105558|3557620|B3||Low amniotic fluid|Reason for Previous Cesarean||Participants|Count of Participants|1|1.0||||||
3719060|NCT02105558|3557621|B2||Low amniotic fluid|Reason for Previous Cesarean||Participants|Count of Participants|1|1.0||||||
3719061|NCT02105558|3557622|B1||Low amniotic fluid|Reason for Previous Cesarean||Participants|Count of Participants|0|0.0||||||
3719062|NCT02105558|3557620|B3||Fetal bradycardia|Reason for Previous Cesarean||Participants|Count of Participants|2|2.0||||||
3719063|NCT02105558|3557621|B2||Fetal bradycardia|Reason for Previous Cesarean||Participants|Count of Participants|2|2.0||||||
3719064|NCT02105558|3557622|B1||Fetal bradycardia|Reason for Previous Cesarean||Participants|Count of Participants|0|0.0||||||
3719065|NCT02105558|3557620|B3||Placenta previa|Reason for Previous Cesarean||Participants|Count of Participants|1|1.0||||||
3719066|NCT02105558|3557621|B2||Placenta previa|Reason for Previous Cesarean||Participants|Count of Participants|1|1.0||||||
3719067|NCT02105558|3557622|B1||Placenta previa|Reason for Previous Cesarean||Participants|Count of Participants|0|0.0||||||
3719068|NCT02105558|3557620|B3||Macrosomia, breech|Reason for Previous Cesarean||Participants|Count of Participants|1|1.0||||||
3719069|NCT02105558|3557621|B2||Macrosomia, breech|Reason for Previous Cesarean||Participants|Count of Participants|1|1.0||||||
3719070|NCT02105558|3557622|B1||Macrosomia, breech|Reason for Previous Cesarean||Participants|Count of Participants|0|0.0||||||
3719071|NCT02105558|3557620|B3||Chorioamnionitis|Reason for Previous Cesarean||Participants|Count of Participants|1|1.0||||||
3719072|NCT02105558|3557621|B2||Chorioamnionitis|Reason for Previous Cesarean||Participants|Count of Participants|1|1.0||||||
3719073|NCT02105558|3557622|B1||Chorioamnionitis|Reason for Previous Cesarean||Participants|Count of Participants|0|0.0||||||
3719074|NCT02105558|3557620|B3||Scoliosis, nuchal cord|Reason for Previous Cesarean||Participants|Count of Participants|1|1.0||||||
3719075|NCT02105558|3557621|B2||Scoliosis, nuchal cord|Reason for Previous Cesarean||Participants|Count of Participants|0|0.0||||||
3719076|NCT02105558|3557622|B1||Scoliosis, nuchal cord|Reason for Previous Cesarean||Participants|Count of Participants|1|1.0||||||
3719077|NCT02105558|3557620|B3||Pre-eclampsia|Reason for Previous Cesarean||Participants|Count of Participants|1|1.0||||||
3719078|NCT02105558|3557621|B2||Pre-eclampsia|Reason for Previous Cesarean||Participants|Count of Participants|1|1.0||||||
3719079|NCT02105558|3557622|B1||Pre-eclampsia|Reason for Previous Cesarean||Participants|Count of Participants|0|0.0||||||
3719080|NCT02105558|3557620|B3||Congenital fetal heart anomaly|Reason for Previous Cesarean||Participants|Count of Participants|1|1.0||||||
3719081|NCT02105558|3557621|B2||Congenital fetal heart anomaly|Reason for Previous Cesarean||Participants|Count of Participants|1|1.0||||||
3719082|NCT02105558|3557622|B1||Congenital fetal heart anomaly|Reason for Previous Cesarean||Participants|Count of Participants|0|0.0||||||
3719083|NCT02105558|3557620|B3||Oligohydramnios|Reason for Previous Cesarean||Participants|Count of Participants|2|2.0||||||
3719084|NCT02105558|3557621|B2||Oligohydramnios|Reason for Previous Cesarean||Participants|Count of Participants|2|2.0||||||
3719085|NCT02105558|3557622|B1||Oligohydramnios|Reason for Previous Cesarean||Participants|Count of Participants|0|0.0||||||
3719086|NCT02105558|3557620|B3||Failure to progress|Reason for Previous Cesarean||Participants|Count of Participants|8|8.0||||||
3719087|NCT02105558|3557621|B2||Failure to progress|Reason for Previous Cesarean||Participants|Count of Participants|5|5.0||||||
3719088|NCT02105558|3557622|B1||Failure to progress|Reason for Previous Cesarean||Participants|Count of Participants|3|3.0||||||
3719089|NCT02105558|3557620|B3||Macrosomia|Reason for Previous Cesarean||Participants|Count of Participants|2|2.0||||||
3719090|NCT02105558|3557621|B2||Macrosomia|Reason for Previous Cesarean||Participants|Count of Participants|2|2.0||||||
3719091|NCT02105558|3557622|B1||Macrosomia|Reason for Previous Cesarean||Participants|Count of Participants|0|0.0||||||
3719092|NCT02105558|3557620|B3||Preterm premature rupture of the membranes (PPROM)|Reason for Previous Cesarean||Participants|Count of Participants|1|1.0||||||
3719093|NCT02105558|3557621|B2||Preterm premature rupture of the membranes (PPROM)|Reason for Previous Cesarean||Participants|Count of Participants|0|0.0||||||
3719094|NCT02105558|3557622|B1||Preterm premature rupture of the membranes (PPROM)|Reason for Previous Cesarean||Participants|Count of Participants|1|1.0||||||
3719095|NCT02105558|3557620|B3||Non-reassuring fetal heart tone|Reason for Previous Cesarean||Participants|Count of Participants|4|4.0||||||
3719096|NCT02105558|3557621|B2||Non-reassuring fetal heart tone|Reason for Previous Cesarean||Participants|Count of Participants|4|4.0||||||
3719097|NCT02105558|3557622|B1||Non-reassuring fetal heart tone|Reason for Previous Cesarean||Participants|Count of Participants|0|0.0||||||
3719098|NCT02105558|3557620|B3||Hydrocephalus|Reason for Previous Cesarean||Participants|Count of Participants|1|1.0||||||
3719099|NCT02105558|3557621|B2||Hydrocephalus|Reason for Previous Cesarean||Participants|Count of Participants|0|0.0||||||
3719100|NCT02105558|3557622|B1||Hydrocephalus|Reason for Previous Cesarean||Participants|Count of Participants|1|1.0||||||
3719101|NCT02105558|3557620|B3||Breech|Reason for Previous Cesarean||Participants|Count of Participants|9|9.0||||||
3719102|NCT02105558|3557621|B2||Breech|Reason for Previous Cesarean||Participants|Count of Participants|4|4.0||||||
3719103|NCT02105558|3557622|B1||Breech|Reason for Previous Cesarean||Participants|Count of Participants|5|5.0||||||
3719104|NCT02105558|3557620|B3|United States||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
3719105|NCT02105558|3557621|B2|United States||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3719106|NCT02105558|3557622|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3719107|NCT02105558|3557620|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719108|NCT02105558|3557621|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719109|NCT02105558|3557622|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719110|NCT02105558|3557620|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3719111|NCT02105558|3557621|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3719112|NCT02105558|3557622|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3719113|NCT02105558|3557620|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3719114|NCT02105558|3557621|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3719115|NCT02105558|3557622|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3719116|NCT02105558|3557620|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3719117|NCT02105558|3557621|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3719118|NCT02105558|3557622|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3719119|NCT02105558|3557620|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3719120|NCT02105558|3557621|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3719121|NCT02105558|3557622|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3719122|NCT02105558|3557620|B3|||Age||years|Mean|27.4|27.4|Standard Deviation|5.9|5.9|||
3719123|NCT02105558|3557621|B2|||Age||years|Mean|27.6|27.6|Standard Deviation|5.9|5.9|||
3719124|NCT02105558|3557622|B1|||Age||years|Mean|27.1|27.1|Standard Deviation|6.1|6.1|||
3719125|NCT02105467|3557651|B3|Genotype 6||HCV Genotype||Participants|Number|13|13.0||||||
3719126|NCT02105467|3557652|B2|Genotype 6||HCV Genotype||Participants|Number|3|3.0||||||
3719127|NCT02105467|3557653|B1|Genotype 6||HCV Genotype||Participants|Number|10|10.0||||||
3719128|NCT02105467|3557651|B3|Genotype 4||HCV Genotype||Participants|Number|26|26.0||||||
3719129|NCT02105467|3557652|B2|Genotype 4||HCV Genotype||Participants|Number|8|8.0||||||
3719130|NCT02105467|3557653|B1|Genotype 4||HCV Genotype||Participants|Number|18|18.0||||||
3719131|NCT02105467|3557651|B3|Genotype 1b||HCV Genotype||Participants|Number|171|171.0||||||
3719132|NCT02105467|3557652|B2|Genotype 1b||HCV Genotype||Participants|Number|40|40.0||||||
3719133|NCT02105467|3557653|B1|Genotype 1b||HCV Genotype||Participants|Number|131|131.0||||||
3719134|NCT02105467|3557651|B3|Genotype 1a||HCV Genotype||Participants|Number|211|211.0||||||
3719135|NCT02105467|3557652|B2|Genotype 1a||HCV Genotype||Participants|Number|54|54.0||||||
3719136|NCT02105467|3557653|B1|Genotype 1a||HCV Genotype||Participants|Number|157|157.0||||||
3719137|NCT02105467|3557651|B3||Male|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
3719138|NCT02105467|3557652|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3719139|NCT02105467|3557653|B1||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3719140|NCT02105467|3557651|B3||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
3719141|NCT02105467|3557652|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3719142|NCT02105467|3557653|B1||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3719143|NCT02105467|3557651|B3|||Age||Years|Mean|52.6|52.6|Standard Deviation|11.2|11.2|||
3719144|NCT02105467|3557652|B2|||Age||Years|Mean|53.8|53.8|Standard Deviation|11.2|11.2|||
3719145|NCT02105467|3557653|B1|||Age||Years|Mean|52.2|52.2|Standard Deviation|11.1|11.1|||
3719146|NCT02105454|3557666|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3719147|NCT02105454|3557666|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3719148|NCT02105454|3557666|B1|||Age||Years|Mean|54.4|54.4|Standard Deviation|9.6|9.6|||
3719149|NCT02105324|3557673|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3719150|NCT02105324|3557673|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3719151|NCT02105324|3557673|B1|||Age||years|Mean|9.8|9.8|Standard Deviation|1.6|1.6|||
3719152|NCT02105324|3557673|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3719153|NCT02105324|3557673|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3719154|NCT02105324|3557673|B1||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
3719155|NCT02105285|3557750|B4|Japan||Region of Enrollment||participants|Number|193|193.0||||||
3719156|NCT02105285|3557751|B3|Japan||Region of Enrollment||participants|Number|37|37.0||||||
3719157|NCT02105285|3557752|B2|Japan||Region of Enrollment||participants|Number|78|78.0||||||
3719158|NCT02105285|3557753|B1|Japan||Region of Enrollment||participants|Number|78|78.0||||||
3719159|NCT02105285|3557750|B4||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3719160|NCT02105285|3557751|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3719161|NCT02105285|3557752|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3719162|NCT02105285|3557753|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3719163|NCT02105285|3557750|B4||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3719164|NCT02105285|3557751|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3719165|NCT02105285|3557752|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3719166|NCT02105285|3557753|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3719167|NCT02105285|3557750|B4|||Age||years|Mean|58.8|58.8|Standard Deviation|11.7|11.7|||
3719168|NCT02105285|3557751|B3|||Age||years|Mean|56.6|56.6|Standard Deviation|12.6|12.6|||
3719169|NCT02105285|3557752|B2|||Age||years|Mean|60.6|60.6|Standard Deviation|10.6|10.6|||
3719170|NCT02105285|3557753|B1|||Age||years|Mean|57.9|57.9|Standard Deviation|12.1|12.1|||
3719171|NCT02105285|3557750|B4||>=65 years|Age||Participants|Count of Participants|78|78.0||||||
3719172|NCT02105285|3557751|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3719173|NCT02105285|3557752|B2||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
3719174|NCT02105285|3557753|B1||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
3719175|NCT02105285|3557750|B4||Between 18 and 65 years|Age||Participants|Count of Participants|115|115.0||||||
3719176|NCT02105285|3557751|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3719177|NCT02105285|3557752|B2||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3719178|NCT02105285|3557753|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3719179|NCT02105285|3557750|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3719180|NCT02105285|3557751|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3719181|NCT02105285|3557752|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3719182|NCT02105285|3557753|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3719183|NCT02105272|3557772|B3|Japan||Region of Enrollment||participants|Number|237|237.0||||||
3719184|NCT02105272|3557773|B2|Japan||Region of Enrollment||participants|Number|119|119.0||||||
3719185|NCT02105272|3557774|B1|Japan||Region of Enrollment||participants|Number|118|118.0||||||
3719186|NCT02105272|3557772|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3719187|NCT02105272|3557773|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3719188|NCT02105272|3557774|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3719189|NCT02105272|3557772|B3||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3719190|NCT02105272|3557773|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3719191|NCT02105272|3557774|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3719192|NCT02105272|3557772|B3|||Age||years|Mean|60.4|60.4|Standard Deviation|11.4|11.4|||
3719193|NCT02105272|3557773|B2|||Age||years|Mean|60.8|60.8|Standard Deviation|11.5|11.5|||
3719194|NCT02105272|3557774|B1|||Age||years|Mean|59.9|59.9|Standard Deviation|11.4|11.4|||
3719195|NCT02105272|3557772|B3||>=65 years|Age||Participants|Count of Participants|97|97.0||||||
3719196|NCT02105272|3557773|B2||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
3719197|NCT02105272|3557774|B1||>=65 years|Age||Participants|Count of Participants|47|47.0||||||
3719198|NCT02105272|3557772|B3||Between 18 and 65 years|Age||Participants|Count of Participants|140|140.0||||||
3719199|NCT02105272|3557773|B2||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
3719200|NCT02105272|3557774|B1||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
3719201|NCT02105272|3557772|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3719202|NCT02105272|3557773|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3719203|NCT02105272|3557774|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3719204|NCT02105116|3557791|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3719205|NCT02105116|3557791|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719206|NCT02105116|3557791|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719207|NCT02105116|3557791|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3719208|NCT02105116|3557791|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3719209|NCT02105116|3557791|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719210|NCT02105116|3557791|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3719211|NCT02105116|3557791|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719212|NCT02105116|3557791|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719213|NCT02105116|3557791|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3719214|NCT02105116|3557791|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3719215|NCT02105116|3557791|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3719216|NCT02105116|3557791|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3719217|NCT02105116|3557791|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3719218|NCT02105116|3557791|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3719219|NCT02105116|3557791|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3719220|NCT02105012|3557798|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3719221|NCT02105012|3557798|B1||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3719222|NCT02105012|3557798|B1|||Age||Years|Mean|45.7|45.7|Standard Deviation|11.2|11.2|||
3719223|NCT02104947|3557830|B3||Male|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
3719224|NCT02104947|3557831|B2||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3719225|NCT02104947|3557832|B1||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3719226|NCT02104947|3557830|B3||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
3719227|NCT02104947|3557831|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3719228|NCT02104947|3557832|B1||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3719229|NCT02104947|3557830|B3|||Age||Years|Mean|76.6|76.6|Standard Deviation|10.5|10.5|||
3719230|NCT02104947|3557831|B2|||Age||Years|Mean|75.9|75.9|Standard Deviation|10.5|10.5|||
3719231|NCT02104947|3557832|B1|||Age||Years|Mean|77.1|77.1|Standard Deviation|10.4|10.4|||
3719232|NCT02104895|3557849|B3|Italy||Region of Enrollment||participants|Number|520|520.0||||||
3719233|NCT02104895|3557850|B2|Italy||Region of Enrollment||participants|Number|260|260.0||||||
3719234|NCT02104895|3557851|B1|Italy||Region of Enrollment||participants|Number|260|260.0||||||
3719235|NCT02104895|3557849|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3719236|NCT02104895|3557850|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3719237|NCT02104895|3557851|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3719238|NCT02104895|3557849|B3||Female|Sex: Female, Male||Participants|Count of Participants|520|520.0||||||
3719239|NCT02104895|3557850|B2||Female|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
3719240|NCT02104895|3557851|B1||Female|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
3719241|NCT02104895|3557849|B3||>=65 years|Age||Participants|Count of Participants|220|220.0||||||
3719242|NCT02104895|3557850|B2||>=65 years|Age||Participants|Count of Participants|118|118.0||||||
3719243|NCT02104895|3557851|B1||>=65 years|Age||Participants|Count of Participants|102|102.0||||||
3719244|NCT02104895|3557849|B3||Between 18 and 65 years|Age||Participants|Count of Participants|300|300.0||||||
3719245|NCT02104895|3557850|B2||Between 18 and 65 years|Age||Participants|Count of Participants|142|142.0||||||
3719246|NCT02104895|3557851|B1||Between 18 and 65 years|Age||Participants|Count of Participants|158|158.0||||||
3719247|NCT02104895|3557849|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3719248|NCT02104895|3557850|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3719249|NCT02104895|3557851|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3719250|NCT02104830|3557862|B4|||Duration of a disease||months|Mean|11.0|11.0|Full Range|||1.0|144.0|
3719251|NCT02104830|3557863|B3|||Duration of a disease||months|Mean|5.37|5.37|Full Range|||1.0|51.0|
3719252|NCT02104830|3557864|B2|||Duration of a disease||months|Mean|11.62|11.62|Full Range|||1.0|144.0|
3719253|NCT02104830|3557865|B1|||Duration of a disease||months|Mean|16.14|16.14|Full Range|||1.0|144.0|
3719254|NCT02104830|3557862|B4|Any treatment||History previous therapy of breast cancer|Patients with previous therapy could be treated with several different types of therapy (for example surgery treatment and adjuvant chemotherapy)|participants|Number|83|83.0||||||
3719255|NCT02104830|3557863|B3|Any treatment||History previous therapy of breast cancer|Patients with previous therapy could be treated with several different types of therapy (for example surgery treatment and adjuvant chemotherapy)|participants|Number|26|26.0||||||
3719256|NCT02104830|3557864|B2|Any treatment||History previous therapy of breast cancer|Patients with previous therapy could be treated with several different types of therapy (for example surgery treatment and adjuvant chemotherapy)|participants|Number|29|29.0||||||
3719257|NCT02104830|3557865|B1|Any treatment||History previous therapy of breast cancer|Patients with previous therapy could be treated with several different types of therapy (for example surgery treatment and adjuvant chemotherapy)|participants|Number|28|28.0||||||
3719258|NCT02104830|3557862|B4|Surgery treatment||History previous therapy of breast cancer|Patients with previous therapy could be treated with several different types of therapy (for example surgery treatment and adjuvant chemotherapy)|participants|Number|77|77.0||||||
3719259|NCT02104830|3557863|B3|Surgery treatment||History previous therapy of breast cancer|Patients with previous therapy could be treated with several different types of therapy (for example surgery treatment and adjuvant chemotherapy)|participants|Number|22|22.0||||||
3719260|NCT02104830|3557864|B2|Surgery treatment||History previous therapy of breast cancer|Patients with previous therapy could be treated with several different types of therapy (for example surgery treatment and adjuvant chemotherapy)|participants|Number|27|27.0||||||
3719261|NCT02104830|3557865|B1|Surgery treatment||History previous therapy of breast cancer|Patients with previous therapy could be treated with several different types of therapy (for example surgery treatment and adjuvant chemotherapy)|participants|Number|28|28.0||||||
3719262|NCT02104830|3557862|B4|Hormone therapy||History previous therapy of breast cancer|Patients with previous therapy could be treated with several different types of therapy (for example surgery treatment and adjuvant chemotherapy)|participants|Number|17|17.0||||||
3719263|NCT02104830|3557863|B3|Hormone therapy||History previous therapy of breast cancer|Patients with previous therapy could be treated with several different types of therapy (for example surgery treatment and adjuvant chemotherapy)|participants|Number|4|4.0||||||
3719264|NCT02104830|3557864|B2|Hormone therapy||History previous therapy of breast cancer|Patients with previous therapy could be treated with several different types of therapy (for example surgery treatment and adjuvant chemotherapy)|participants|Number|7|7.0||||||
3719265|NCT02104830|3557865|B1|Hormone therapy||History previous therapy of breast cancer|Patients with previous therapy could be treated with several different types of therapy (for example surgery treatment and adjuvant chemotherapy)|participants|Number|6|6.0||||||
3719266|NCT02104830|3557862|B4|Radiotherapy||History previous therapy of breast cancer|Patients with previous therapy could be treated with several different types of therapy (for example surgery treatment and adjuvant chemotherapy)|participants|Number|15|15.0||||||
3719267|NCT02104830|3557863|B3|Radiotherapy||History previous therapy of breast cancer|Patients with previous therapy could be treated with several different types of therapy (for example surgery treatment and adjuvant chemotherapy)|participants|Number|3|3.0||||||
3719268|NCT02104830|3557864|B2|Radiotherapy||History previous therapy of breast cancer|Patients with previous therapy could be treated with several different types of therapy (for example surgery treatment and adjuvant chemotherapy)|participants|Number|4|4.0||||||
3719269|NCT02104830|3557865|B1|Radiotherapy||History previous therapy of breast cancer|Patients with previous therapy could be treated with several different types of therapy (for example surgery treatment and adjuvant chemotherapy)|participants|Number|8|8.0||||||
3719270|NCT02104830|3557862|B4|Neoadjuvant chemotherapy||History previous therapy of breast cancer|Patients with previous therapy could be treated with several different types of therapy (for example surgery treatment and adjuvant chemotherapy)|participants|Number|2|2.0||||||
3719271|NCT02104830|3557863|B3|Neoadjuvant chemotherapy||History previous therapy of breast cancer|Patients with previous therapy could be treated with several different types of therapy (for example surgery treatment and adjuvant chemotherapy)|participants|Number|0|0.0||||||
3719272|NCT02104830|3557864|B2|Neoadjuvant chemotherapy||History previous therapy of breast cancer|Patients with previous therapy could be treated with several different types of therapy (for example surgery treatment and adjuvant chemotherapy)|participants|Number|1|1.0||||||
3719273|NCT02104830|3557865|B1|Neoadjuvant chemotherapy||History previous therapy of breast cancer|Patients with previous therapy could be treated with several different types of therapy (for example surgery treatment and adjuvant chemotherapy)|participants|Number|1|1.0||||||
3719274|NCT02104830|3557862|B4|Adjuvant chemotherapy||History previous therapy of breast cancer|Patients with previous therapy could be treated with several different types of therapy (for example surgery treatment and adjuvant chemotherapy)|participants|Number|25|25.0||||||
3719275|NCT02104830|3557863|B3|Adjuvant chemotherapy||History previous therapy of breast cancer|Patients with previous therapy could be treated with several different types of therapy (for example surgery treatment and adjuvant chemotherapy)|participants|Number|10|10.0||||||
3719276|NCT02104830|3557864|B2|Adjuvant chemotherapy||History previous therapy of breast cancer|Patients with previous therapy could be treated with several different types of therapy (for example surgery treatment and adjuvant chemotherapy)|participants|Number|8|8.0||||||
3719277|NCT02104830|3557865|B1|Adjuvant chemotherapy||History previous therapy of breast cancer|Patients with previous therapy could be treated with several different types of therapy (for example surgery treatment and adjuvant chemotherapy)|participants|Number|7|7.0||||||
3719278|NCT02104830|3557862|B4|IV||Disease stage||participants|Number|17|17.0||||||
3719279|NCT02104830|3557863|B3|IV||Disease stage||participants|Number|6|6.0||||||
3719280|NCT02104830|3557864|B2|IV||Disease stage||participants|Number|6|6.0||||||
3719281|NCT02104830|3557865|B1|IV||Disease stage||participants|Number|5|5.0||||||
3719282|NCT02104830|3557862|B4|IIIС||Disease stage||participants|Number|3|3.0||||||
3719283|NCT02104830|3557863|B3|IIIС||Disease stage||participants|Number|0|0.0||||||
3719284|NCT02104830|3557864|B2|IIIС||Disease stage||participants|Number|1|1.0||||||
3719285|NCT02104830|3557865|B1|IIIС||Disease stage||participants|Number|2|2.0||||||
3719286|NCT02104830|3557862|B4|IIIB||Disease stage||participants|Number|30|30.0||||||
3719287|NCT02104830|3557863|B3|IIIB||Disease stage||participants|Number|8|8.0||||||
3719288|NCT02104830|3557864|B2|IIIB||Disease stage||participants|Number|10|10.0||||||
3719289|NCT02104830|3557865|B1|IIIB||Disease stage||participants|Number|12|12.0||||||
3719290|NCT02104830|3557862|B4|IIIA||Disease stage||participants|Number|22|22.0||||||
3719291|NCT02104830|3557863|B3|IIIA||Disease stage||participants|Number|10|10.0||||||
3719292|NCT02104830|3557864|B2|IIIA||Disease stage||participants|Number|7|7.0||||||
3719293|NCT02104830|3557865|B1|IIIA||Disease stage||participants|Number|5|5.0||||||
3719294|NCT02104830|3557862|B4|IIB||Disease stage||participants|Number|21|21.0||||||
3719295|NCT02104830|3557863|B3|IIB||Disease stage||participants|Number|9|9.0||||||
3719296|NCT02104830|3557864|B2|IIB||Disease stage||participants|Number|7|7.0||||||
3719297|NCT02104830|3557865|B1|IIB||Disease stage||participants|Number|5|5.0||||||
3719298|NCT02104830|3557862|B4|IIA||Disease stage||participants|Number|35|35.0||||||
3719299|NCT02104830|3557863|B3|IIA||Disease stage||participants|Number|10|10.0||||||
3719300|NCT02104830|3557864|B2|IIA||Disease stage||participants|Number|12|12.0||||||
3719301|NCT02104830|3557865|B1|IIA||Disease stage||participants|Number|13|13.0||||||
3719302|NCT02104830|3557862|B4|Undifferentiated cancer||Histologic type||participants|Number|8|8.0||||||
3719303|NCT02104830|3557863|B3|Undifferentiated cancer||Histologic type||participants|Number|3|3.0||||||
3719304|NCT02104830|3557864|B2|Undifferentiated cancer||Histologic type||participants|Number|2|2.0||||||
3719305|NCT02104830|3557865|B1|Undifferentiated cancer||Histologic type||participants|Number|3|3.0||||||
3719306|NCT02104830|3557862|B4|Low-grade differentiated carcinoma||Histologic type||participants|Number|6|6.0||||||
3719307|NCT02104830|3557863|B3|Low-grade differentiated carcinoma||Histologic type||participants|Number|1|1.0||||||
3719308|NCT02104830|3557864|B2|Low-grade differentiated carcinoma||Histologic type||participants|Number|3|3.0||||||
3719309|NCT02104830|3557865|B1|Low-grade differentiated carcinoma||Histologic type||participants|Number|2|2.0||||||
3719310|NCT02104830|3557862|B4|Infiltrative not specified||Histologic type||participants|Number|13|13.0||||||
3719311|NCT02104830|3557863|B3|Infiltrative not specified||Histologic type||participants|Number|4|4.0||||||
3719312|NCT02104830|3557864|B2|Infiltrative not specified||Histologic type||participants|Number|5|5.0||||||
3719313|NCT02104830|3557865|B1|Infiltrative not specified||Histologic type||participants|Number|4|4.0||||||
3719314|NCT02104830|3557862|B4|Squamous cell cancer||Histologic type||participants|Number|1|1.0||||||
3719315|NCT02104830|3557863|B3|Squamous cell cancer||Histologic type||participants|Number|0|0.0||||||
3719316|NCT02104830|3557864|B2|Squamous cell cancer||Histologic type||participants|Number|1|1.0||||||
3719317|NCT02104830|3557865|B1|Squamous cell cancer||Histologic type||participants|Number|0|0.0||||||
3719318|NCT02104830|3557862|B4|Medullar||Histologic type||participants|Number|1|1.0||||||
3719319|NCT02104830|3557863|B3|Medullar||Histologic type||participants|Number|0|0.0||||||
3719320|NCT02104830|3557864|B2|Medullar||Histologic type||participants|Number|1|1.0||||||
3719321|NCT02104830|3557865|B1|Medullar||Histologic type||participants|Number|0|0.0||||||
3719322|NCT02104830|3557862|B4|Infiltrative lobular||Histologic type||participants|Number|11|11.0||||||
3719323|NCT02104830|3557863|B3|Infiltrative lobular||Histologic type||participants|Number|2|2.0||||||
3719324|NCT02104830|3557864|B2|Infiltrative lobular||Histologic type||participants|Number|3|3.0||||||
3719325|NCT02104830|3557865|B1|Infiltrative lobular||Histologic type||participants|Number|6|6.0||||||
3719326|NCT02104830|3557862|B4|Infiltrative ductal||Histologic type||participants|Number|88|88.0||||||
3719327|NCT02104830|3557863|B3|Infiltrative ductal||Histologic type||participants|Number|33|33.0||||||
3719328|NCT02104830|3557864|B2|Infiltrative ductal||Histologic type||participants|Number|28|28.0||||||
3719329|NCT02104830|3557865|B1|Infiltrative ductal||Histologic type||participants|Number|27|27.0||||||
3719330|NCT02104830|3557862|B4|Russian Federation||Region of Enrollment||participants|Number|128|128.0||||||
3719331|NCT02104830|3557863|B3|Russian Federation||Region of Enrollment||participants|Number|43|43.0||||||
3719332|NCT02104830|3557864|B2|Russian Federation||Region of Enrollment||participants|Number|43|43.0||||||
3719333|NCT02104830|3557865|B1|Russian Federation||Region of Enrollment||participants|Number|42|42.0||||||
3719334|NCT02104830|3557862|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3719335|NCT02104830|3557863|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3719336|NCT02104830|3557864|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3719337|NCT02104830|3557865|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3719338|NCT02104830|3557862|B4||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3719339|NCT02104830|3557863|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3719340|NCT02104830|3557864|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3719341|NCT02104830|3557865|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3719342|NCT02104830|3557862|B4|||Age||years|Mean|50.23|50.23|Standard Deviation|10.03|10.03|||
3719343|NCT02104830|3557863|B3|||Age||years|Mean|51.86|51.86|Standard Deviation|9.68|9.68|||
3719344|NCT02104830|3557864|B2|||Age||years|Mean|50.42|50.42|Standard Deviation|9.19|9.19|||
3719345|NCT02104830|3557865|B1|||Age||years|Mean|48.38|48.38|Standard Deviation|11.07|11.07|||
3719346|NCT02104830|3557862|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3719347|NCT02104830|3557863|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3719348|NCT02104830|3557864|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3719349|NCT02104830|3557865|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3719350|NCT02104830|3557862|B4||Between 18 and 65 years|Age||Participants|Count of Participants|128|128.0||||||
3719351|NCT02104830|3557863|B3||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
3719352|NCT02104830|3557864|B2||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
3719353|NCT02104830|3557865|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3719354|NCT02104830|3557862|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3719355|NCT02104830|3557863|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3719356|NCT02104830|3557864|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3719357|NCT02104830|3557865|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3719358|NCT02104804|3557890|B3|||Mean Tolerated Daily Dose of Insulin||Insulin Dose Units|Mean|38.7|38.7|Standard Deviation|15.60|15.6|||
3719359|NCT02104804|3557891|B2|||Mean Tolerated Daily Dose of Insulin||Insulin Dose Units|Mean|38.9|38.9|Standard Deviation|14.68|14.68|||
3719360|NCT02104804|3557892|B1|||Mean Tolerated Daily Dose of Insulin||Insulin Dose Units|Mean|38.6|38.6|Standard Deviation|16.49|16.49|||
3719361|NCT02104804|3557890|B3|No||Metformin use at enrolment||Participants|Number|153|153.0||||||
3719362|NCT02104804|3557891|B2|No||Metformin use at enrolment||Participants|Number|76|76.0||||||
3719363|NCT02104804|3557892|B1|No||Metformin use at enrolment||Participants|Number|77|77.0||||||
3719364|NCT02104804|3557890|B3|Yes||Metformin use at enrolment||Participants|Number|309|309.0||||||
3719365|NCT02104804|3557891|B2|Yes||Metformin use at enrolment||Participants|Number|154|154.0||||||
3719366|NCT02104804|3557892|B1|Yes||Metformin use at enrolment||Participants|Number|155|155.0||||||
3719367|NCT02104804|3557890|B3|||Fasting C-peptide||ng/dL|Mean|1.020|1.02|Standard Deviation|0.55|0.55|||
3719368|NCT02104804|3557891|B2|||Fasting C-peptide||ng/dL|Mean|1.012|1.012|Standard Deviation|0.58|0.58|||
3719369|NCT02104804|3557892|B1|||Fasting C-peptide||ng/dL|Mean|1.029|1.029|Standard Deviation|0.52|0.52|||
3719370|NCT02104804|3557890|B3|||Fasting Glucagon||pg/dL|Mean|40.119|40.119|Standard Deviation|22.39|22.39|||
3719371|NCT02104804|3557891|B2|||Fasting Glucagon||pg/dL|Mean|40.231|40.231|Standard Deviation|21.06|21.06|||
3719372|NCT02104804|3557892|B1|||Fasting Glucagon||pg/dL|Mean|40.007|40.007|Standard Deviation|23.68|23.68|||
3719373|NCT02104804|3557890|B3|||120-min Post Prandial Glucose||mg/dL|Mean|274.0|274.0|Standard Deviation|60.76|60.76|||
3719374|NCT02104804|3557891|B2|||120-min Post Prandial Glucose||mg/dL|Mean|270.0|270.0|Standard Deviation|63.30|63.3|||
3719375|NCT02104804|3557892|B1|||120-min Post Prandial Glucose||mg/dL|Mean|278.0|278.0|Standard Deviation|58.00|58.0|||
3719376|NCT02104804|3557890|B3|||0-180 min Post Prandial Glucose AUC||mg*min/dL|Mean|44661.5|44661.5|Standard Deviation|8772.22|8772.22|||
3719377|NCT02104804|3557891|B2|||0-180 min Post Prandial Glucose AUC||mg*min/dL|Mean|43851.4|43851.4|Standard Deviation|9051.26|9051.26|||
3719378|NCT02104804|3557892|B1|||0-180 min Post Prandial Glucose AUC||mg*min/dL|Mean|45457.6|45457.6|Standard Deviation|8433.08|8433.08|||
3719379|NCT02104804|3557890|B3|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|167.64|167.64|Standard Deviation|32.10|32.1|||
3719380|NCT02104804|3557891|B2|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|167.34|167.34|Standard Deviation|32.86|32.86|||
3719381|NCT02104804|3557892|B1|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|167.94|167.94|Standard Deviation|31.39|31.39|||
3719382|NCT02104804|3557890|B3|||Duration of diabetes||Years|Mean|13.4|13.4|Standard Deviation|6.83|6.83|||
3719383|NCT02104804|3557891|B2|||Duration of diabetes||Years|Mean|13.3|13.3|Standard Deviation|6.35|6.35|||
3719384|NCT02104804|3557892|B1|||Duration of diabetes||Years|Mean|13.4|13.4|Standard Deviation|7.28|7.28|||
3719385|NCT02104804|3557890|B3|||Baseline HbA1C||%|Mean|8.53|8.53|Standard Deviation|0.69|0.69|||
3719386|NCT02104804|3557891|B2|||Baseline HbA1C||%|Mean|8.53|8.53|Standard Deviation|0.70|0.7|||
3719387|NCT02104804|3557892|B1|||Baseline HbA1C||%|Mean|8.52|8.52|Standard Deviation|0.69|0.69|||
3719388|NCT02104804|3557890|B3||Male|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
3719389|NCT02104804|3557891|B2||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3719390|NCT02104804|3557892|B1||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3719391|NCT02104804|3557890|B3||Female|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
3719392|NCT02104804|3557891|B2||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3719393|NCT02104804|3557892|B1||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3719394|NCT02104804|3557890|B3|||Age||Years|Mean|59.1|59.1|Standard Deviation|8.05|8.05|||
3719395|NCT02104804|3557891|B2|||Age||Years|Mean|58.9|58.9|Standard Deviation|8.17|8.17|||
3719396|NCT02104804|3557892|B1|||Age||Years|Mean|59.3|59.3|Standard Deviation|7.93|7.93|||
3719397|NCT02104739|3557909|B1|||Body Mass Index (BMI)||kilograms per meter squared|Mean|32.53|32.53|Standard Deviation|1.92|1.92|||
3719398|NCT02104739|3557909|B1|||Weight||kilograms|Mean|93.96|93.96|Standard Deviation|11.98|11.98|||
3719399|NCT02104739|3557909|B1|||Height||meters|Mean|1.7|1.7|Standard Deviation|0.11|0.11|||
3719400|NCT02104739|3557909|B1|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3719401|NCT02104739|3557909|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3719402|NCT02104739|3557909|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3719403|NCT02104739|3557909|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3719404|NCT02104739|3557909|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3719405|NCT02104739|3557909|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719406|NCT02104739|3557909|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3719407|NCT02104739|3557909|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719408|NCT02104739|3557909|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719409|NCT02104739|3557909|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3719410|NCT02104739|3557909|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3719411|NCT02104739|3557909|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3719412|NCT02104739|3557909|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3719413|NCT02104739|3557909|B1|||Age||years|Mean|50|50.0|Standard Deviation|8|8.0|||
3719414|NCT02104505|3557973|B3|||Forced expiratory volume in 1 second (FEV1) (%predicted)||percent predicted|Median|97|97.0|Full Range|||83.0|109.0|
3719415|NCT02104505|3557974|B2|||Forced expiratory volume in 1 second (FEV1) (%predicted)||percent predicted|Median|90|90.0|Full Range|||83.0|108.0|
3719416|NCT02104505|3557975|B1|||Forced expiratory volume in 1 second (FEV1) (%predicted)||percent predicted|Median|102.5|102.5|Full Range|||89.0|109.0|
3719417|NCT02104505|3557973|B3|||Body Mass Index (BMI)||kg/m2|Median|26|26.0|Full Range|||20.2|41.7|
3719418|NCT02104505|3557974|B2|||Body Mass Index (BMI)||kg/m2|Median|25.2|25.2|Full Range|||20.2|41.7|
3719419|NCT02104505|3557975|B1|||Body Mass Index (BMI)||kg/m2|Median|27.1|27.1|Full Range|||20.5|34.8|
3719420|NCT02104505|3557973|B3|||Atopy||Participants|Count of Participants|17|17.0||||||
3719421|NCT02104505|3557974|B2|||Atopy||Participants|Count of Participants|8|8.0||||||
3719422|NCT02104505|3557975|B1|||Atopy||Participants|Count of Participants|9|9.0||||||
3719423|NCT02104505|3557973|B3|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3719424|NCT02104505|3557974|B2|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3719425|NCT02104505|3557975|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3719426|NCT02104505|3557973|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719427|NCT02104505|3557974|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719428|NCT02104505|3557975|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719429|NCT02104505|3557973|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719430|NCT02104505|3557974|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719431|NCT02104505|3557975|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719432|NCT02104505|3557973|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3719433|NCT02104505|3557974|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3719434|NCT02104505|3557975|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3719435|NCT02104505|3557973|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3719436|NCT02104505|3557974|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3719437|NCT02104505|3557975|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3719438|NCT02104505|3557973|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719439|NCT02104505|3557974|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719440|NCT02104505|3557975|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719441|NCT02104505|3557973|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3719442|NCT02104505|3557974|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3719443|NCT02104505|3557975|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3719444|NCT02104505|3557973|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3719445|NCT02104505|3557974|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3719446|NCT02104505|3557975|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3719447|NCT02104505|3557973|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719448|NCT02104505|3557974|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719449|NCT02104505|3557975|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719450|NCT02104505|3557973|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3719451|NCT02104505|3557974|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3719452|NCT02104505|3557975|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3719453|NCT02104505|3557973|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3719454|NCT02104505|3557974|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719455|NCT02104505|3557975|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3719456|NCT02104505|3557973|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3719457|NCT02104505|3557974|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3719458|NCT02104505|3557975|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3719459|NCT02104505|3557973|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3719460|NCT02104505|3557974|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3719461|NCT02104505|3557975|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3719462|NCT02104505|3557973|B3|||Age||years|Median|26|26.0|Full Range|||20.0|47.0|
3719463|NCT02104505|3557974|B2|||Age||years|Median|30|30.0|Full Range|||21.0|47.0|
3719464|NCT02104505|3557975|B1|||Age||years|Median|23.5|23.5|Full Range|||20.0|42.0|
3719465|NCT02104505|3557973|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3719466|NCT02104505|3557974|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3719467|NCT02104505|3557975|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3719468|NCT02104505|3557973|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3719469|NCT02104505|3557974|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3719470|NCT02104505|3557975|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3719471|NCT02104505|3557973|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3719472|NCT02104505|3557974|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3719473|NCT02104505|3557975|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3719474|NCT02104427|3557988|B1|||BMI||kg/m^2|Mean|29.3|29.3|Full Range|||21.9|37.1|
3719475|NCT02104427|3557988|B1|||Weight||kg|Mean|82.4|82.4|Full Range|||54.6|114.0|
3719476|NCT02104427|3557988|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719477|NCT02104427|3557988|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719478|NCT02104427|3557988|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3719479|NCT02104427|3557988|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3719480|NCT02104427|3557988|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3719481|NCT02104427|3557988|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3719482|NCT02104427|3557988|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719483|NCT02104427|3557988|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3719484|NCT02104427|3557988|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3719485|NCT02104427|3557988|B1|||Age||years|Mean|58|58.0|Full Range|||41.0|69.0|
3719486|NCT02104414|3558011|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3719487|NCT02104414|3558012|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3719488|NCT02104414|3558013|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3719489|NCT02104414|3558014|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3719490|NCT02104414|3558011|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3719491|NCT02104414|3558012|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3719492|NCT02104414|3558013|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3719493|NCT02104414|3558014|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3719494|NCT02104414|3558011|B4|||Age||years|Mean|44.54|44.54|Standard Deviation|10.36|10.36|||
3719495|NCT02104414|3558012|B3|||Age||years|Mean|51.5|51.5|Standard Deviation|9.19|9.19|||
3719496|NCT02104414|3558013|B2|||Age||years|Mean|40.75|40.75|Standard Deviation|13.1|13.1|||
3719497|NCT02104414|3558014|B1|||Age||years|Mean|44.8|44.8|Standard Deviation|14.61|14.61|||
3719498|NCT02104219|3558039|B1|||Growth Measured by Weight Z-score|The Z-score indicates the number of standard deviations away from the mean 0. A Z-score of 0 is equal to the mean with negative numbers indicating values lower than the mean and positive values higher. Higher Z-scores indicate a better outcome.|Z-score|Median|-0.86|-0.86|Inter-Quartile Range|||-1.45|-0.49|
3719499|NCT02104219|3558039|B1|||Growth Measured by Height Z-score|The Z-score indicates the number of standard deviations away from the mean 0. A Z-score of 0 is equal to the mean with negative numbers indicating values lower than the mean and positive values higher. Higher Z-scores indicate a better outcome.|Z-score|Median|-0.86|-0.86|Inter-Quartile Range|||-1.57|-0.62|
3719500|NCT02104219|3558039|B1|||Rickets Severity Scale - RSS|The RSS is a 10-point scale, developed for nutritional rickets, that evaluates the degree of metaphyseal cupping and fraying and the proportion of growth plate affected (10 points = severe cupping/fraying, 0 points = absence of cupping/fraying).|units on a scale|Median|1.00|1.0|Inter-Quartile Range|||0.0|1.5|
3719501|NCT02104219|3558039|B1|Europe||Region of Enrollment||participants|Number|5|5.0||||||
3719502|NCT02104219|3558039|B1|North America||Region of Enrollment||participants|Number|25|25.0||||||
3719503|NCT02104219|3558039|B1|Australia||Region of Enrollment||participants|Number|2|2.0||||||
3719504|NCT02104219|3558039|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3719505|NCT02104219|3558039|B1|White||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3719506|NCT02104219|3558039|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3719507|NCT02104219|3558039|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3719508|NCT02104219|3558039|B1|||Age, Customized|Age at diagnosis|months|Mean|47|47.0|Standard Deviation|32.21|32.21|||
3719509|NCT02103855|3558046|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3719510|NCT02103855|3558046|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719511|NCT02103855|3558046|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719512|NCT02103855|3558046|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3719513|NCT02103855|3558046|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3719514|NCT02103855|3558046|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719515|NCT02103855|3558046|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719516|NCT02103855|3558046|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719517|NCT02103855|3558046|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3719518|NCT02103855|3558046|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3719519|NCT02103855|3558046|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3719520|NCT02103855|3558046|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3719521|NCT02103855|3558046|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3719522|NCT02103608|3558054|B1|||Hair count at baseline||hair strands/cm^2|Mean|22.7|22.7|Standard Deviation|14.6|14.6|||
3719523|NCT02103608|3558054|B1|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3719524|NCT02103608|3558054|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3719525|NCT02103608|3558054|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3719526|NCT02103608|3558054|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3719527|NCT02103608|3558054|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3719528|NCT02103608|3558054|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3719529|NCT02103439|3558058|B3|Russian Federation||Region of Enrollment||participants|Number|140|140.0||||||
3719530|NCT02103439|3558059|B2|Russian Federation||Region of Enrollment||participants|Number|70|70.0||||||
3719531|NCT02103439|3558060|B1|Russian Federation||Region of Enrollment||participants|Number|70|70.0||||||
3719532|NCT02103439|3558058|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719533|NCT02103439|3558059|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719534|NCT02103439|3558060|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719535|NCT02103439|3558058|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719536|NCT02103439|3558059|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719537|NCT02103439|3558060|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719538|NCT02103439|3558058|B3||White|Race (NIH/OMB)||Participants|Count of Participants|137|137.0||||||
3719539|NCT02103439|3558059|B2||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3719540|NCT02103439|3558060|B1||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3719541|NCT02103439|3558058|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719542|NCT02103439|3558059|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719543|NCT02103439|3558060|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719544|NCT02103439|3558058|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719545|NCT02103439|3558059|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719546|NCT02103439|3558060|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719547|NCT02103439|3558058|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3719548|NCT02103439|3558059|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3719549|NCT02103439|3558060|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3719550|NCT02103439|3558058|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719551|NCT02103439|3558059|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719552|NCT02103439|3558060|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719553|NCT02103439|3558058|B3||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3719554|NCT02103439|3558059|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3719555|NCT02103439|3558060|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3719556|NCT02103439|3558058|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3719557|NCT02103439|3558059|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3719558|NCT02103439|3558060|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3719559|NCT02103439|3558058|B3|||Age||years|Median|33.5|33.5|Inter-Quartile Range|||31.0|37.0|
3719560|NCT02103439|3558059|B2|||Age||years|Median|34|34.0|Inter-Quartile Range|||31.0|37.0|
3719561|NCT02103439|3558060|B1|||Age||years|Median|33|33.0|Inter-Quartile Range|||30.0|37.0|
3719562|NCT02103309|3558081|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3719563|NCT02103309|3558081|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3719564|NCT02103309|3558081|B1|||Age||years|Mean|22.5|22.5|Standard Deviation|2.4|2.4|||
3719565|NCT02103114|3558094|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3719566|NCT02103114|3558095|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3719567|NCT02103114|3558096|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3719568|NCT02103114|3558094|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3719569|NCT02103114|3558095|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3719570|NCT02103114|3558096|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3719571|NCT02103114|3558094|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3719572|NCT02103114|3558095|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3719573|NCT02103114|3558096|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3719574|NCT02103114|3558094|B3|||Age||days|Mean|14.6|14.6|Standard Deviation|26.1|26.1|||
3719575|NCT02103114|3558095|B2|||Age||days|Mean|17.2|17.2|Standard Deviation|30.2|30.2|||
3719576|NCT02103114|3558096|B1|||Age||days|Mean|9.8|9.8|Standard Deviation|19.7|19.7|||
3719577|NCT02103062|3558151|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3719578|NCT02103062|3558152|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3719579|NCT02103062|3558153|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3719580|NCT02103062|3558151|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3719581|NCT02103062|3558152|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3719582|NCT02103062|3558153|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3719583|NCT02103062|3558151|B3|||Age||years|Mean|63.0|63.0|Standard Deviation|11.31|11.31|||
3719584|NCT02103062|3558152|B2|||Age||years|Mean|61.9|61.9|Standard Deviation|10.56|10.56|||
3719585|NCT02103062|3558153|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|12.34|12.34|||
3719586|NCT02102932|3558172|B9||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3719587|NCT02102932|3558173|B8||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3719588|NCT02102932|3558174|B7||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3719589|NCT02102932|3558175|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3719590|NCT02102932|3558176|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3719591|NCT02102932|3558177|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3719592|NCT02102932|3558178|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3719593|NCT02102932|3558179|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3719594|NCT02102932|3558180|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3719595|NCT02102932|3558172|B9||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3719596|NCT02102932|3558173|B8||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3719597|NCT02102932|3558174|B7||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3719598|NCT02102932|3558175|B6||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3719599|NCT02102932|3558176|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3719600|NCT02102932|3558177|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3719601|NCT02102932|3558178|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3719602|NCT02102932|3558179|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3719603|NCT02102932|3558180|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3719604|NCT02102932|3558172|B9|||Age||years|Mean|25.5|25.5|Standard Deviation|4.5|4.5|||
3719605|NCT02102932|3558173|B8|||Age||years|Mean|25.6|25.6|Standard Deviation|4.8|4.8|||
3719606|NCT02102932|3558174|B7|||Age||years|Mean|24.6|24.6|Standard Deviation|3.7|3.7|||
3719607|NCT02102932|3558175|B6|||Age||years|Mean|24.4|24.4|Standard Deviation|3.9|3.9|||
3719608|NCT02102932|3558176|B5|||Age||years|Mean|24.8|24.8|Standard Deviation|4.3|4.3|||
3719609|NCT02102932|3558177|B4|||Age||years|Mean|24.3|24.3|Standard Deviation|3.4|3.4|||
3719610|NCT02102932|3558178|B3|||Age||years|Mean|26.8|26.8|Standard Deviation|5.3|5.3|||
3719611|NCT02102932|3558179|B2|||Age||years|Mean|27.0|27.0|Standard Deviation|5.3|5.3|||
3719612|NCT02102932|3558180|B1|||Age||years|Mean|26.9|26.9|Standard Deviation|4.8|4.8|||
3719613|NCT02102490|3558245|B1|Spain||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3719614|NCT02102490|3558245|B1|France||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3719615|NCT02102490|3558245|B1|United States||Region of Enrollment||Participants|Count of Participants|70|70.0||||||
3719616|NCT02102490|3558245|B1|Belgium||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3719617|NCT02102490|3558245|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3719618|NCT02102490|3558245|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719619|NCT02102490|3558245|B1||White|Race (NIH/OMB)||Participants|Count of Participants|112|112.0||||||
3719620|NCT02102490|3558245|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3719621|NCT02102490|3558245|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719622|NCT02102490|3558245|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3719623|NCT02102490|3558245|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719624|NCT02102490|3558245|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3719625|NCT02102490|3558245|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|112|112.0||||||
3719626|NCT02102490|3558245|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3719627|NCT02102490|3558245|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3719628|NCT02102490|3558245|B1||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3719629|NCT02102490|3558245|B1|||Age||Years|Mean|59.13|59.13|Standard Deviation|10.33|10.33|||
3719630|NCT02102464|3558257|B3|||Comfortable Contact Lens Wear Time|Subjects reported how long they wore their contact lenses each day (total contact lens wear time), and how long the contact lens wear was comfortable (comfortable contact lens wear time).|hours per day|Mean|4.9|4.9|Standard Deviation|3.3|3.3|||
3719631|NCT02102464|3558258|B2|||Comfortable Contact Lens Wear Time|Subjects reported how long they wore their contact lenses each day (total contact lens wear time), and how long the contact lens wear was comfortable (comfortable contact lens wear time).|hours per day|Mean|4.3|4.3|Standard Deviation|3.1|3.1|||
3719632|NCT02102464|3558259|B1|||Comfortable Contact Lens Wear Time|Subjects reported how long they wore their contact lenses each day (total contact lens wear time), and how long the contact lens wear was comfortable (comfortable contact lens wear time).|hours per day|Mean|5.4|5.4|Standard Deviation|3.4|3.4|||
3719633|NCT02102464|3558257|B3|||SPEED Score|Using Standard Patient Evaluation of Eye Dryness (SPEED) questionnaire, symptoms evaluated were dryness, grittiness or scratchiness; soreness or irritation; burning or watering; and eye fatigue. Frequency scale: 0 (never), 1 (sometimes), 2 (often) and 3 (constant). Severity scale: 0 (no problems), 1 (tolerable–not perfect but not uncomfortable), 2 (uncomfortable-irritating but does not interfere with my day), 3 (bothersome-irritating and interferes with my day) and 4 (intolerable-unable to perform my daily tasks). SPEED score is the sum of frequency and severity scores (range 0 to 28).|units on a scale|Mean|14.9|14.9|Standard Deviation|4.6|4.6|||
3719634|NCT02102464|3558258|B2|||SPEED Score|Using Standard Patient Evaluation of Eye Dryness (SPEED) questionnaire, symptoms evaluated were dryness, grittiness or scratchiness; soreness or irritation; burning or watering; and eye fatigue. Frequency scale: 0 (never), 1 (sometimes), 2 (often) and 3 (constant). Severity scale: 0 (no problems), 1 (tolerable–not perfect but not uncomfortable), 2 (uncomfortable-irritating but does not interfere with my day), 3 (bothersome-irritating and interferes with my day) and 4 (intolerable-unable to perform my daily tasks). SPEED score is the sum of frequency and severity scores (range 0 to 28).|units on a scale|Mean|15.3|15.3|Standard Deviation|4.5|4.5|||
3719635|NCT02102464|3558259|B1|||SPEED Score|Using Standard Patient Evaluation of Eye Dryness (SPEED) questionnaire, symptoms evaluated were dryness, grittiness or scratchiness; soreness or irritation; burning or watering; and eye fatigue. Frequency scale: 0 (never), 1 (sometimes), 2 (often) and 3 (constant). Severity scale: 0 (no problems), 1 (tolerable–not perfect but not uncomfortable), 2 (uncomfortable-irritating but does not interfere with my day), 3 (bothersome-irritating and interferes with my day) and 4 (intolerable-unable to perform my daily tasks). SPEED score is the sum of frequency and severity scores (range 0 to 28).|units on a scale|Mean|14.5|14.5|Standard Deviation|4.8|4.8|||
3719636|NCT02102464|3558257|B3|||Meibomian Gland Score|Along the lower lid, secretion characteristics of 15 meibomian glands were evaluated including five glands each in the temporal, central and nasal regions of the lower eyelid. For each gland, secretion characteristics were graded as 3 (clear liquid), 2 (cloudy liquid), 1 (inspissated/ toothpaste consistency) and 0 (no secretion). The total meibomian gland score is the sum of the grades for all 15 glands with a range between 0 and 45. A higher score reflects less meibomian gland dysfunction.|units on a scale|Mean|8.1|8.1|Standard Deviation|3.8|3.8|||
3719637|NCT02102464|3558258|B2|||Meibomian Gland Score|Along the lower lid, secretion characteristics of 15 meibomian glands were evaluated including five glands each in the temporal, central and nasal regions of the lower eyelid. For each gland, secretion characteristics were graded as 3 (clear liquid), 2 (cloudy liquid), 1 (inspissated/ toothpaste consistency) and 0 (no secretion). The total meibomian gland score is the sum of the grades for all 15 glands with a range between 0 and 45. A higher score reflects less meibomian gland dysfunction.|units on a scale|Mean|8.2|8.2|Standard Deviation|4.2|4.2|||
3719638|NCT02102464|3558259|B1|||Meibomian Gland Score|Along the lower lid, secretion characteristics of 15 meibomian glands were evaluated including five glands each in the temporal, central and nasal regions of the lower eyelid. For each gland, secretion characteristics were graded as 3 (clear liquid), 2 (cloudy liquid), 1 (inspissated/ toothpaste consistency) and 0 (no secretion). The total meibomian gland score is the sum of the grades for all 15 glands with a range between 0 and 45. A higher score reflects less meibomian gland dysfunction.|units on a scale|Mean|8.0|8.0|Standard Deviation|3.5|3.5|||
3719639|NCT02102464|3558257|B3|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3719640|NCT02102464|3558258|B2|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3719641|NCT02102464|3558259|B1|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3719642|NCT02102464|3558257|B3|Canada||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3719643|NCT02102464|3558258|B2|Canada||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3719644|NCT02102464|3558259|B1|Canada||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3719645|NCT02102464|3558257|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719646|NCT02102464|3558258|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719647|NCT02102464|3558259|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719648|NCT02102464|3558257|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3719649|NCT02102464|3558258|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719650|NCT02102464|3558259|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3719651|NCT02102464|3558257|B3||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3719652|NCT02102464|3558258|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3719653|NCT02102464|3558259|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3719654|NCT02102464|3558257|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3719655|NCT02102464|3558258|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3719710|NCT02101983|3558338|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3719656|NCT02102464|3558259|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3719657|NCT02102464|3558257|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719658|NCT02102464|3558258|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719659|NCT02102464|3558259|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719660|NCT02102464|3558257|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3719661|NCT02102464|3558258|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3719662|NCT02102464|3558259|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3719663|NCT02102464|3558257|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719664|NCT02102464|3558258|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719665|NCT02102464|3558259|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719666|NCT02102464|3558257|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719667|NCT02102464|3558258|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719668|NCT02102464|3558259|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719669|NCT02102464|3558257|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3719670|NCT02102464|3558258|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3719671|NCT02102464|3558259|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3719672|NCT02102464|3558257|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3719673|NCT02102464|3558258|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3719674|NCT02102464|3558259|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719675|NCT02102464|3558257|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3719676|NCT02102464|3558258|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3719677|NCT02102464|3558259|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3719678|NCT02102464|3558257|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3719679|NCT02102464|3558258|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3719680|NCT02102464|3558259|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3719681|NCT02102464|3558257|B3|||Age||years|Mean|41.7|41.7|Standard Deviation|14.5|14.5|||
3719682|NCT02102464|3558258|B2|||Age||years|Mean|43.5|43.5|Standard Deviation|15.9|15.9|||
3719683|NCT02102464|3558259|B1|||Age||years|Mean|40.0|40.0|Standard Deviation|13.1|13.1|||
3719684|NCT02102399|3558278|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3719685|NCT02102399|3558279|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3719686|NCT02102399|3558280|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3719687|NCT02102399|3558278|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3719688|NCT02102399|3558279|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3719689|NCT02102399|3558280|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3719690|NCT02102399|3558278|B3|||Age||years|Mean|44.6|44.6|Standard Deviation|9.9|9.9|||
3719691|NCT02102399|3558279|B2|||Age||years|Mean|43.6|43.6|Standard Deviation|11.4|11.4|||
3719692|NCT02102399|3558280|B1|||Age||years|Mean|45.8|45.8|Standard Deviation|8.1|8.1|||
3719693|NCT02102204|3558329|B1|||Phosphorus|Starting values are presented in this table, and are defined as the first non-missing measurement within the first 3 months on or after analysis day 1 (inclusive).|mg/dL|Mean|5.24|5.24|Standard Deviation|1.69|1.69|||
3719694|NCT02102204|3558329|B1|||Albumin Corrected Calcium|Starting values are presented in this table, and are defined as the first non-missing measurement within the first 3 months on or after analysis day 1 (inclusive).|mg/dL|Mean|8.94|8.94|Standard Deviation|0.79|0.79|||
3719695|NCT02102204|3558329|B1|||Parathyroid Hormone|Starting values are presented in this table, and are defined as the first non-missing measurement within the first 3 months on or after analysis day 1 (inclusive).|pg/mL|Mean|528.3|528.3|Standard Deviation|566.4|566.4|||
3719696|NCT02102204|3558329|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3719697|NCT02102204|3558329|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|657|657.0||||||
3719698|NCT02102204|3558329|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3719699|NCT02102204|3558329|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|192|192.0||||||
3719700|NCT02102204|3558329|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3719701|NCT02102204|3558329|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3719702|NCT02102204|3558329|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719703|NCT02102204|3558329|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|806|806.0||||||
3719704|NCT02102204|3558329|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3719705|NCT02102204|3558329|B1||Male|Sex: Female, Male||Participants|Count of Participants|527|527.0||||||
3719706|NCT02102204|3558329|B1||Female|Sex: Female, Male||Participants|Count of Participants|357|357.0||||||
3719707|NCT02102204|3558329|B1||≥ 65 years|Age, Customized||Participants|Count of Participants|302|302.0||||||
3719708|NCT02102204|3558329|B1||< 65 years|Age, Customized||Participants|Count of Participants|582|582.0||||||
3719709|NCT02102204|3558329|B1|||Age||years|Mean|57.7|57.7|Standard Deviation|14.3|14.3|||
3719711|NCT02101983|3558339|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3719712|NCT02101983|3558340|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3719713|NCT02101983|3558338|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3719714|NCT02101983|3558339|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3719715|NCT02101983|3558340|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3719716|NCT02101983|3558338|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3719717|NCT02101983|3558339|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3719718|NCT02101983|3558340|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3719719|NCT02101983|3558338|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3719720|NCT02101983|3558339|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3719721|NCT02101983|3558340|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3719722|NCT02101983|3558338|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3719723|NCT02101983|3558339|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3719724|NCT02101983|3558340|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3719725|NCT02101983|3558338|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3719726|NCT02101983|3558339|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3719727|NCT02101983|3558340|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3719728|NCT02101515|3558351|B3|||Epidural anesthesia||participants|Number|78|78.0||||||
3719729|NCT02101515|3558352|B2|||Epidural anesthesia||participants|Number|41|41.0||||||
3719730|NCT02101515|3558353|B1|||Epidural anesthesia||participants|Number|37|37.0||||||
3719731|NCT02101515|3558351|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719732|NCT02101515|3558352|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719733|NCT02101515|3558353|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719734|NCT02101515|3558351|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719735|NCT02101515|3558352|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719736|NCT02101515|3558353|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719737|NCT02101515|3558351|B3||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3719738|NCT02101515|3558352|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3719739|NCT02101515|3558353|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3719740|NCT02101515|3558351|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3719741|NCT02101515|3558352|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3719742|NCT02101515|3558353|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3719743|NCT02101515|3558351|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3719744|NCT02101515|3558352|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3719745|NCT02101515|3558353|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719746|NCT02101515|3558351|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3719747|NCT02101515|3558352|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3719748|NCT02101515|3558353|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3719749|NCT02101515|3558351|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719750|NCT02101515|3558352|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719751|NCT02101515|3558353|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719752|NCT02101515|3558351|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3719753|NCT02101515|3558352|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3719754|NCT02101515|3558353|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3719755|NCT02101515|3558351|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3719756|NCT02101515|3558352|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3719757|NCT02101515|3558353|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3719758|NCT02101515|3558351|B3|||Age||years|Mean|28.1|28.1|Standard Deviation|5.0|5.0|||
3719759|NCT02101515|3558352|B2|||Age||years|Mean|27.6|27.6|Standard Deviation|4.7|4.7|||
3719760|NCT02101515|3558353|B1|||Age||years|Mean|28.7|28.7|Standard Deviation|5.4|5.4|||
3719761|NCT02101359|3558392|B3|Portugal||Region of Enrollment||participants|Number|20|20.0||||||
3719762|NCT02101359|3558393|B2|Portugal||Region of Enrollment||participants|Number|12|12.0||||||
3719763|NCT02101359|3558394|B1|Portugal||Region of Enrollment||participants|Number|8|8.0||||||
3719764|NCT02101359|3558392|B3|Sweden||Region of Enrollment||participants|Number|18|18.0||||||
3719765|NCT02101359|3558393|B2|Sweden||Region of Enrollment||participants|Number|9|9.0||||||
3719766|NCT02101359|3558394|B1|Sweden||Region of Enrollment||participants|Number|9|9.0||||||
3719767|NCT02101359|3558392|B3|Spain||Region of Enrollment||participants|Number|17|17.0||||||
3719768|NCT02101359|3558393|B2|Spain||Region of Enrollment||participants|Number|11|11.0||||||
3719769|NCT02101359|3558394|B1|Spain||Region of Enrollment||participants|Number|6|6.0||||||
3719770|NCT02101359|3558392|B3|Italy||Region of Enrollment||participants|Number|22|22.0||||||
3719771|NCT02101359|3558393|B2|Italy||Region of Enrollment||participants|Number|11|11.0||||||
3719772|NCT02101359|3558394|B1|Italy||Region of Enrollment||participants|Number|11|11.0||||||
3719773|NCT02101359|3558392|B3|Germany||Region of Enrollment||participants|Number|17|17.0||||||
3719774|NCT02101359|3558393|B2|Germany||Region of Enrollment||participants|Number|8|8.0||||||
3719775|NCT02101359|3558394|B1|Germany||Region of Enrollment||participants|Number|9|9.0||||||
3719776|NCT02101359|3558392|B3|France||Region of Enrollment||participants|Number|380|380.0||||||
3719777|NCT02101359|3558393|B2|France||Region of Enrollment||participants|Number|188|188.0||||||
3719778|NCT02101359|3558394|B1|France||Region of Enrollment||participants|Number|192|192.0||||||
3719779|NCT02101359|3558392|B3|Belgium||Region of Enrollment||participants|Number|33|33.0||||||
3719780|NCT02101359|3558393|B2|Belgium||Region of Enrollment||participants|Number|16|16.0||||||
3719781|NCT02101359|3558394|B1|Belgium||Region of Enrollment||participants|Number|17|17.0||||||
3719782|NCT02101359|3558392|B3|Austria||Region of Enrollment||participants|Number|21|21.0||||||
3719783|NCT02101359|3558393|B2|Austria||Region of Enrollment||participants|Number|10|10.0||||||
3719784|NCT02101359|3558394|B1|Austria||Region of Enrollment||participants|Number|11|11.0||||||
3719785|NCT02101359|3558392|B3|Algeria||Region of Enrollment||participants|Number|63|63.0||||||
3719786|NCT02101359|3558393|B2|Algeria||Region of Enrollment||participants|Number|31|31.0||||||
3719787|NCT02101359|3558394|B1|Algeria||Region of Enrollment||participants|Number|32|32.0||||||
3719788|NCT02101359|3558392|B3||Male|Sex: Female, Male||Participants|Count of Participants|337|337.0||||||
3719789|NCT02101359|3558393|B2||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3719790|NCT02101359|3558394|B1||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
3719791|NCT02101359|3558392|B3||Female|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
3719792|NCT02101359|3558393|B2||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3719793|NCT02101359|3558394|B1||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3719794|NCT02101359|3558392|B3|||Age||years|Mean|69.9|69.9|Standard Deviation|9.3|9.3|||
3719795|NCT02101359|3558393|B2|||Age||years|Mean|70.6|70.6|Standard Deviation|9.2|9.2|||
3719796|NCT02101359|3558394|B1|||Age||years|Mean|69.2|69.2|Standard Deviation|9.4|9.4|||
3719797|NCT02101294|3558401|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3719798|NCT02101294|3558401|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3719799|NCT02101294|3558401|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3719800|NCT02101294|3558401|B1|||Age||years|Median|55|55.0|Full Range|||18.0|75.0|
3719801|NCT02101190|3558408|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3719802|NCT02101190|3558409|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3719803|NCT02101190|3558410|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3719804|NCT02101190|3558408|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3719805|NCT02101190|3558409|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3719806|NCT02101190|3558410|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3719807|NCT02101190|3558408|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3719808|NCT02101190|3558409|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3719809|NCT02101190|3558410|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3719810|NCT02101190|3558408|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3719811|NCT02101190|3558409|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3719812|NCT02101190|3558410|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3719813|NCT02101190|3558408|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3719814|NCT02101190|3558409|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3719815|NCT02101190|3558410|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3719816|NCT02101112|3558421|B1|||Body Mass Index (BMI)||kilograms per meter^2|Mean|26.14|26.14|Standard Deviation|2.166|2.166|||
3719817|NCT02101112|3558421|B1|||Height||centimeters|Mean|172.13|172.13|Standard Deviation|8.322|8.322|||
3719818|NCT02101112|3558421|B1|||Weight||kilograms|Mean|77.40|77.4|Standard Deviation|7.933|7.933|||
3719819|NCT02101112|3558421|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3719820|NCT02101112|3558421|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3719821|NCT02101112|3558421|B1|||Age||years|Mean|32.3|32.3|Standard Deviation|7.35|7.35|||
3719822|NCT02101021|3558451|B6|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3719823|NCT02101021|3558452|B5|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3719824|NCT02101021|3558453|B4|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3719825|NCT02101021|3558454|B3|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3719826|NCT02101021|3558455|B2|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3719827|NCT02101021|3558456|B1|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3719828|NCT02101021|3558451|B6||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3719829|NCT02101021|3558452|B5||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3719830|NCT02101021|3558453|B4||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3719831|NCT02101021|3558454|B3||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3719832|NCT02101021|3558455|B2||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3719833|NCT02101021|3558456|B1||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3719834|NCT02101021|3558451|B6||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3719835|NCT02101021|3558452|B5||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3719836|NCT02101021|3558453|B4||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3719837|NCT02101021|3558454|B3||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3719838|NCT02101021|3558455|B2||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3719839|NCT02101021|3558456|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3719840|NCT02101021|3558451|B6||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3719841|NCT02101021|3558452|B5||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3719842|NCT02101021|3558453|B4||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3719843|NCT02101021|3558454|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3719844|NCT02101021|3558455|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3719845|NCT02101021|3558456|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3719846|NCT02101021|3558451|B6||White|Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3719847|NCT02101021|3558452|B5||White|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3719848|NCT02101021|3558453|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3719849|NCT02101021|3558454|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3719850|NCT02101021|3558455|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3719851|NCT02101021|3558456|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3719852|NCT02101021|3558451|B6||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3719853|NCT02101021|3558452|B5||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3719854|NCT02101021|3558453|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3719855|NCT02101021|3558454|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3719856|NCT02101021|3558455|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3719857|NCT02101021|3558456|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3719858|NCT02101021|3558451|B6||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3719859|NCT02101021|3558452|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3719860|NCT02101021|3558453|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3719861|NCT02101021|3558454|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3719862|NCT02101021|3558455|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3719863|NCT02101021|3558456|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3719864|NCT02101021|3558451|B6||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3719865|NCT02101021|3558452|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3719866|NCT02101021|3558453|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3719867|NCT02101021|3558454|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3719868|NCT02101021|3558455|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3719869|NCT02101021|3558456|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3719870|NCT02101021|3558451|B6|||Age||years|Mean|60.7|60.7|Standard Deviation|10.21|10.21|||
3719871|NCT02101021|3558452|B5|||Age||years|Mean|59.0|59.0|Standard Deviation|9.13|9.13|||
3719872|NCT02101021|3558453|B4|||Age||years|Mean|52.0|52.0|Standard Deviation|5.00|5.0|||
3719873|NCT02101021|3558454|B3|||Age||years|Mean|64.7|64.7|Standard Deviation|8.79|8.79|||
3719874|NCT02101021|3558455|B2|||Age||years|Mean|63.5|63.5|Standard Deviation|12.12|12.12|||
3719875|NCT02101021|3558456|B1|||Age||years|Mean|59.9|59.9|Standard Deviation|12.32|12.32|||
3719876|NCT02101008|3558502|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3719877|NCT02101008|3558502|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3719878|NCT02101008|3558502|B1|||Age||years|Mean|65|65.0|Full Range|||52.0|77.0|
3719879|NCT02100839|3558507|B3|Australia||Region of Enrollment||participants|Number|52|52.0||||||
3719880|NCT02100839|3558508|B2|Australia||Region of Enrollment||participants|Number|15|15.0||||||
3719881|NCT02100839|3558509|B1|Australia||Region of Enrollment||participants|Number|37|37.0||||||
3719882|NCT02100839|3558507|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3719883|NCT02100839|3558508|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719884|NCT02100839|3558509|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3719885|NCT02100839|3558507|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719886|NCT02100839|3558508|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719887|NCT02100839|3558509|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719888|NCT02100839|3558507|B3||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3719889|NCT02100839|3558508|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3719890|NCT02100839|3558509|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3719891|NCT02100839|3558507|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3719892|NCT02100839|3558508|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3719893|NCT02100839|3558509|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3719894|NCT02100839|3558507|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719895|NCT02100839|3558508|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719896|NCT02100839|3558509|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719897|NCT02100839|3558507|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3719898|NCT02100839|3558508|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3719899|NCT02100839|3558509|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3719900|NCT02100839|3558507|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719901|NCT02100839|3558508|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719902|NCT02100839|3558509|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719903|NCT02100839|3558507|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719904|NCT02100839|3558508|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719905|NCT02100839|3558509|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719906|NCT02100839|3558507|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3719907|NCT02100839|3558508|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3719908|NCT02100839|3558509|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3719909|NCT02100839|3558507|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3719910|NCT02100839|3558508|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719911|NCT02100839|3558509|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3719912|NCT02100839|3558507|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3719913|NCT02100839|3558508|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3719914|NCT02100839|3558509|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3719915|NCT02100839|3558507|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3719916|NCT02100839|3558508|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3719917|NCT02100839|3558509|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3719918|NCT02100839|3558507|B3|||Age||years|Mean|34.6|34.6|Full Range|||18.0|67.0|
3719919|NCT02100839|3558508|B2|||Age||years|Mean|32|32.0|Full Range|||18.0|48.0|
3719920|NCT02100839|3558509|B1|||Age||years|Mean|35.7|35.7|Full Range|||18.0|67.0|
3719921|NCT02100839|3558507|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3719922|NCT02100839|3558508|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3719923|NCT02100839|3558509|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3719924|NCT02100839|3558507|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3719925|NCT02100839|3558508|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3719926|NCT02100839|3558509|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3719927|NCT02100839|3558507|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3719928|NCT02100839|3558508|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3719929|NCT02100839|3558509|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3719930|NCT02100826|3558522|B1|Mexico||Region of Enrollment||participants|Number|28|28.0||||||
3719931|NCT02100826|3558522|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719932|NCT02100826|3558522|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3719933|NCT02100826|3558522|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3719934|NCT02100826|3558522|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3719935|NCT02100826|3558522|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3719936|NCT02100826|3558522|B1|||Age||Years|Mean|31.2|31.2|Standard Deviation|8.47|8.47|||
3719937|NCT02100670|3558533|B5||Male|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
3719938|NCT02100670|3558534|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3719939|NCT02100670|3558535|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3719940|NCT02100670|3558536|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3719941|NCT02100670|3558537|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3719942|NCT02100670|3558533|B5||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3719943|NCT02100670|3558534|B4||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3719944|NCT02100670|3558535|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3719945|NCT02100670|3558536|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3719946|NCT02100670|3558537|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3719947|NCT02100670|3558533|B5|||Age||Years|Mean|32.8|32.8|Standard Deviation|11.70|11.7|||
3719948|NCT02100670|3558534|B4|||Age||Years|Mean|33.2|33.2|Standard Deviation|11.63|11.63|||
3719949|NCT02100670|3558535|B3|||Age||Years|Mean|33.8|33.8|Standard Deviation|12.15|12.15|||
3719950|NCT02100670|3558536|B2|||Age||Years|Mean|32.1|32.1|Standard Deviation|11.40|11.4|||
3719951|NCT02100670|3558537|B1|||Age||Years|Mean|32.4|32.4|Standard Deviation|11.83|11.83|||
3719952|NCT02100644|3558600|B1|Asian- Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|33|33.0||||||
3719953|NCT02100644|3558600|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3719954|NCT02100644|3558600|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3719955|NCT02100644|3558600|B1|||Age||Years|Mean|25.6|25.6|Standard Deviation|7.73|7.73|||
3719956|NCT02100579|3558612|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3719957|NCT02100579|3558613|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3719958|NCT02100579|3558614|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3719959|NCT02100579|3558612|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3719960|NCT02100579|3558613|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3719961|NCT02100579|3558614|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3719962|NCT02100579|3558612|B3|||Age||years|Median|67|67.0|Inter-Quartile Range|||62.0|72.0|
3719963|NCT02100579|3558613|B2|||Age||years|Median|67|67.0|Inter-Quartile Range|||59.0|72.0|
3719964|NCT02100579|3558614|B1|||Age||years|Median|68|68.0|Inter-Quartile Range|||62.0|73.0|
3719965|NCT02100579|3558612|B3||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3719966|NCT02100579|3558613|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3719967|NCT02100579|3558614|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3719968|NCT02100579|3558612|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3719969|NCT02100579|3558613|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3719970|NCT02100579|3558614|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3719971|NCT02100579|3558612|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3719972|NCT02100579|3558613|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3719973|NCT02100579|3558614|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3719974|NCT02100514|3558625|B3||Male|Sex: Female, Male||Participants|Count of Participants|416|416.0||||||
3719975|NCT02100514|3558626|B2||Male|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
3719976|NCT02100514|3558627|B1||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3719977|NCT02100514|3558625|B3||Female|Sex: Female, Male||Participants|Count of Participants|330|330.0||||||
3719978|NCT02100514|3558626|B2||Female|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
3719979|NCT02100514|3558627|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3719980|NCT02100514|3558625|B3|||Age||years|Mean|61.6|61.6|Standard Deviation|9.9|9.9|||
3719981|NCT02100514|3558626|B2|||Age||years|Mean|61.5|61.5|Standard Deviation|9.9|9.9|||
3719982|NCT02100514|3558627|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|10.0|10.0|||
3719983|NCT02100475|3558697|B3|||HbA1c||Percentage of glycosylated haemoglobin|Mean|7.6|7.6|Standard Deviation|0.8|0.8|||
3719984|NCT02100475|3558698|B2|||HbA1c||Percentage of glycosylated haemoglobin|Mean|7.7|7.7|Standard Deviation|0.7|0.7|||
3719985|NCT02100475|3558699|B1|||HbA1c||Percentage of glycosylated haemoglobin|Mean|7.6|7.6|Standard Deviation|0.9|0.9|||
3719986|NCT02100475|3558697|B3||Male|Gender||Participants|Count of Participants|14|14.0||||||
3719987|NCT02100475|3558698|B2||Male|Gender||Participants|Count of Participants|7|7.0||||||
3719988|NCT02100475|3558699|B1||Male|Gender||Participants|Count of Participants|7|7.0||||||
3719989|NCT02100475|3558697|B3||Female|Gender||Participants|Count of Participants|17|17.0||||||
3719990|NCT02100475|3558698|B2||Female|Gender||Participants|Count of Participants|8|8.0||||||
3719991|NCT02100475|3558699|B1||Female|Gender||Participants|Count of Participants|9|9.0||||||
3719992|NCT02100475|3558697|B3|||Age||Years|Mean|57.4|57.4|Standard Deviation|11.3|11.3|||
3719993|NCT02100475|3558698|B2|||Age||Years|Mean|57.4|57.4|Standard Deviation|11.2|11.2|||
3719994|NCT02100475|3558699|B1|||Age||Years|Mean|57.3|57.3|Standard Deviation|11.7|11.7|||
3719995|NCT02100410|3558710|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3719996|NCT02100410|3558710|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3719997|NCT02100410|3558710|B1|18 - 68 Years||Age, Customized||years|Mean|45.4|45.4|Standard Deviation|13.6|13.6|||
3719998|NCT02100280|3558731|B3|||stress response|Stress response were analyzed Cytokines(TNF-α, IL-1β, IL-6, IL-8, and C-reactive protein) Blood samples were collected from the antecubital vein of the arm not used for IV infusion at preoperatively, at the end of peritoneal closure, and at 2 and 48hrs after the end of operation for analysis of TNF-α, IL-1β, IL-6, IL-8, and C-reactive protein (CRP). Cytokines were analysed with enzyme-linked immunosorbent assay kit(R&D Systems, Minneapolis, Minnesota, USA) and CRP was determined by an institutional chemistry analyser(Beckman Coulter, Brea, Califonia, USA).|Participants|Count of Participants|88|88.0||||||
3719999|NCT02100280|3558732|B2|||stress response|Stress response were analyzed Cytokines(TNF-α, IL-1β, IL-6, IL-8, and C-reactive protein) Blood samples were collected from the antecubital vein of the arm not used for IV infusion at preoperatively, at the end of peritoneal closure, and at 2 and 48hrs after the end of operation for analysis of TNF-α, IL-1β, IL-6, IL-8, and C-reactive protein (CRP). Cytokines were analysed with enzyme-linked immunosorbent assay kit(R&D Systems, Minneapolis, Minnesota, USA) and CRP was determined by an institutional chemistry analyser(Beckman Coulter, Brea, Califonia, USA).|Participants|Count of Participants|44|44.0||||||
3720053|NCT02100228|3558749|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3720054|NCT02100228|3558750|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3720055|NCT02100228|3558748|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3720056|NCT02100228|3558749|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3720000|NCT02100280|3558733|B1|||stress response|Stress response were analyzed Cytokines(TNF-α, IL-1β, IL-6, IL-8, and C-reactive protein) Blood samples were collected from the antecubital vein of the arm not used for IV infusion at preoperatively, at the end of peritoneal closure, and at 2 and 48hrs after the end of operation for analysis of TNF-α, IL-1β, IL-6, IL-8, and C-reactive protein (CRP). Cytokines were analysed with enzyme-linked immunosorbent assay kit(R&D Systems, Minneapolis, Minnesota, USA) and CRP was determined by an institutional chemistry analyser(Beckman Coulter, Brea, Califonia, USA).|Participants|Count of Participants|44|44.0||||||
3720001|NCT02100280|3558731|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720002|NCT02100280|3558732|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720003|NCT02100280|3558733|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720004|NCT02100280|3558731|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720005|NCT02100280|3558732|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720006|NCT02100280|3558733|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720007|NCT02100280|3558731|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720008|NCT02100280|3558732|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720009|NCT02100280|3558733|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720010|NCT02100280|3558731|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720011|NCT02100280|3558732|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720012|NCT02100280|3558733|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720013|NCT02100280|3558731|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720014|NCT02100280|3558732|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720015|NCT02100280|3558733|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720016|NCT02100280|3558731|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3720017|NCT02100280|3558732|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3720018|NCT02100280|3558733|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3720019|NCT02100280|3558731|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720020|NCT02100280|3558732|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720021|NCT02100280|3558733|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720022|NCT02100280|3558731|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3720023|NCT02100280|3558732|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3720024|NCT02100280|3558733|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3720025|NCT02100280|3558731|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3720026|NCT02100280|3558732|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3720027|NCT02100280|3558733|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3720028|NCT02100280|3558731|B3||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3720029|NCT02100280|3558732|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3720030|NCT02100280|3558733|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3720031|NCT02100280|3558731|B3||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
3720032|NCT02100280|3558732|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3720033|NCT02100280|3558733|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3720034|NCT02100280|3558731|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3720035|NCT02100280|3558732|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3720036|NCT02100280|3558733|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3720037|NCT02100228|3558748|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3720038|NCT02100228|3558749|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3720039|NCT02100228|3558750|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3720040|NCT02100228|3558748|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|154|154.0||||||
3720041|NCT02100228|3558749|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|76|76.0||||||
3720042|NCT02100228|3558750|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|78|78.0||||||
3720043|NCT02100228|3558748|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
3720044|NCT02100228|3558749|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3720045|NCT02100228|3558750|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3720046|NCT02100228|3558748|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|1302|1302.0||||||
3720047|NCT02100228|3558749|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|648|648.0||||||
3720048|NCT02100228|3558750|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|654|654.0||||||
3720049|NCT02100228|3558748|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1284|1284.0||||||
3720050|NCT02100228|3558749|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|639|639.0||||||
3720051|NCT02100228|3558750|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|645|645.0||||||
3720052|NCT02100228|3558748|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|199|199.0||||||
3720057|NCT02100228|3558750|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3720058|NCT02100228|3558748|B3||Male|Sex: Female, Male||Participants|Count of Participants|1002|1002.0||||||
3720059|NCT02100228|3558749|B2||Male|Sex: Female, Male||Participants|Count of Participants|497|497.0||||||
3720060|NCT02100228|3558750|B1||Male|Sex: Female, Male||Participants|Count of Participants|505|505.0||||||
3720061|NCT02100228|3558748|B3||Female|Sex: Female, Male||Participants|Count of Participants|498|498.0||||||
3720062|NCT02100228|3558749|B2||Female|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
3720063|NCT02100228|3558750|B1||Female|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
3720064|NCT02100228|3558748|B3|||Age||years|Mean|64.6|64.6|Standard Deviation|12.47|12.47|||
3720065|NCT02100228|3558749|B2|||Age||years|Mean|64.5|64.5|Standard Deviation|12.76|12.76|||
3720066|NCT02100228|3558750|B1|||Age||years|Mean|64.7|64.7|Standard Deviation|12.19|12.19|||
3720067|NCT02100189|3558777|B1|||Number of participants with a history of PPI use||Participants|Count of Participants|39|39.0||||||
3720068|NCT02100189|3558777|B1|||Number of participants with history of Barrett's Esophagus||Participants|Count of Participants|28|28.0||||||
3720069|NCT02100189|3558777|B1|||Number of participants with history of GERD||Participants|Count of Participants|38|38.0||||||
3720070|NCT02100189|3558777|B1|||Body Mass Index, average||kg/m^2|Mean|29.5|29.5|Standard Deviation|7.66|7.66|||
3720071|NCT02100189|3558777|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3720072|NCT02100189|3558777|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3720073|NCT02100189|3558777|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3720074|NCT02100189|3558777|B1|||Age||years|Mean|64|64.0|Standard Deviation|13.4|13.4|||
3720075|NCT02100124|3558784|B4|United States||Region of Enrollment||participants|Number|984|984.0||||||
3720076|NCT02100124|3558785|B3|United States||Region of Enrollment||participants|Number|326|326.0||||||
3720077|NCT02100124|3558786|B2|United States||Region of Enrollment||participants|Number|329|329.0||||||
3720078|NCT02100124|3558787|B1|United States||Region of Enrollment||participants|Number|329|329.0||||||
3720079|NCT02100124|3558784|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3720080|NCT02100124|3558785|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3720081|NCT02100124|3558786|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3720082|NCT02100124|3558787|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3720083|NCT02100124|3558784|B4||Female|Sex: Female, Male||Participants|Count of Participants|984|984.0||||||
3720084|NCT02100124|3558785|B3||Female|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
3720085|NCT02100124|3558786|B2||Female|Sex: Female, Male||Participants|Count of Participants|329|329.0||||||
3720086|NCT02100124|3558787|B1||Female|Sex: Female, Male||Participants|Count of Participants|329|329.0||||||
3720087|NCT02100124|3558784|B4|||Age||years|Mean|27.13|27.13|Standard Deviation|5.99|5.99|||
3720088|NCT02100124|3558785|B3|||Age||years|Mean|27.28|27.28|Standard Deviation|5.92|5.92|||
3720089|NCT02100124|3558786|B2|||Age||years|Mean|27.08|27.08|Standard Deviation|6.13|6.13|||
3720090|NCT02100124|3558787|B1|||Age||years|Mean|27.02|27.02|Standard Deviation|5.95|5.95|||
3720091|NCT02100124|3558784|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3720092|NCT02100124|3558785|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3720093|NCT02100124|3558786|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3720094|NCT02100124|3558787|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3720095|NCT02100124|3558784|B4||Between 18 and 65 years|Age||Participants|Count of Participants|984|984.0||||||
3720096|NCT02100124|3558785|B3||Between 18 and 65 years|Age||Participants|Count of Participants|326|326.0||||||
3720097|NCT02100124|3558786|B2||Between 18 and 65 years|Age||Participants|Count of Participants|329|329.0||||||
3720098|NCT02100124|3558787|B1||Between 18 and 65 years|Age||Participants|Count of Participants|329|329.0||||||
3720099|NCT02100124|3558784|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3720100|NCT02100124|3558785|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3720101|NCT02100124|3558786|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3720102|NCT02100124|3558787|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3720103|NCT02100007|3558806|B1|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3720104|NCT02100007|3558806|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
3720105|NCT02100007|3558806|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3720106|NCT02100007|3558806|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3720107|NCT02100007|3558806|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3720108|NCT02100007|3558806|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3720109|NCT02100007|3558806|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3720110|NCT02100007|3558806|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3720111|NCT02100007|3558806|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3720112|NCT02100007|3558806|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3720113|NCT02100007|3558806|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3720114|NCT02100007|3558806|B1|||Age||Years|Median|59.5|59.5|Full Range|||26.0|78.0|
3720115|NCT02100007|3558806|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3720116|NCT02100007|3558806|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3720117|NCT02100007|3558806|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3720118|NCT02099838|3558817|B3|||Direct Bilirubin(DBil)||mmol/L|Mean|3.92|3.92|Standard Deviation|1.96|1.96|||
3720119|NCT02099838|3558818|B2|||Direct Bilirubin(DBil)||mmol/L|Mean|3.92|3.92|Standard Deviation|2.11|2.11|||
3720120|NCT02099838|3558819|B1|||Direct Bilirubin(DBil)||mmol/L|Mean|3.91|3.91|Standard Deviation|1.79|1.79|||
3720121|NCT02099838|3558817|B3|||Total Bilirubin(TBil)||mmol/L|Mean|14.64|14.64|Standard Deviation|5.42|5.42|||
3720122|NCT02099838|3558818|B2|||Total Bilirubin(TBil)||mmol/L|Mean|14.09|14.09|Standard Deviation|5.00|5.0|||
3720123|NCT02099838|3558819|B1|||Total Bilirubin(TBil)||mmol/L|Mean|15.26|15.26|Standard Deviation|5.87|5.87|||
3720124|NCT02099838|3558817|B3|||Glutamic-oxaloacetic Transaminase(AST)||U/L|Mean|21.42|21.42|Standard Deviation|7.43|7.43|||
3720125|NCT02099838|3558818|B2|||Glutamic-oxaloacetic Transaminase(AST)||U/L|Mean|22.25|22.25|Standard Deviation|7.82|7.82|||
3720126|NCT02099838|3558819|B1|||Glutamic-oxaloacetic Transaminase(AST)||U/L|Mean|20.47|20.47|Standard Deviation|6.92|6.92|||
3720127|NCT02099838|3558817|B3|||Glutamic-pyruvic Transaminase(ALT)||U/L|Mean|23.75|23.75|Standard Deviation|10.60|10.6|||
3720128|NCT02099838|3558818|B2|||Glutamic-pyruvic Transaminase(ALT)||U/L|Mean|25.35|25.35|Standard Deviation|12.00|12.0|||
3720129|NCT02099838|3558819|B1|||Glutamic-pyruvic Transaminase(ALT)||U/L|Mean|21.98|21.98|Standard Deviation|8.57|8.57|||
3720130|NCT02099838|3558817|B3|||ln(Low Density Lipoprotein(LDL))||ln(mmol/L)|Mean|0.88|0.88|Standard Deviation|0.39|0.39|||
3720131|NCT02099838|3558818|B2|||ln(Low Density Lipoprotein(LDL))||ln(mmol/L)|Mean|0.87|0.87|Standard Deviation|0.45|0.45|||
3720132|NCT02099838|3558819|B1|||ln(Low Density Lipoprotein(LDL))||ln(mmol/L)|Mean|0.90|0.9|Standard Deviation|0.32|0.32|||
3720133|NCT02099838|3558817|B3|||High Density Lipoprotein(HDL)||mmol/L|Mean|1.17|1.17|Standard Deviation|0.24|0.24|||
3720134|NCT02099838|3558818|B2|||High Density Lipoprotein(HDL)||mmol/L|Mean|1.13|1.13|Standard Deviation|0.22|0.22|||
3720135|NCT02099838|3558819|B1|||High Density Lipoprotein(HDL)||mmol/L|Mean|1.22|1.22|Standard Deviation|0.25|0.25|||
3720136|NCT02099838|3558817|B3|||Triglyceride(TG)||mmol/L|Mean|1.74|1.74|Standard Deviation|0.91|0.91|||
3720137|NCT02099838|3558818|B2|||Triglyceride(TG)||mmol/L|Mean|1.71|1.71|Standard Deviation|0.90|0.9|||
3720138|NCT02099838|3558819|B1|||Triglyceride(TG)||mmol/L|Mean|1.76|1.76|Standard Deviation|0.93|0.93|||
3720139|NCT02099838|3558817|B3|||Total Cholesterol(TC)||mmol/L|Mean|4.76|4.76|Standard Deviation|0.92|0.92|||
3720140|NCT02099838|3558818|B2|||Total Cholesterol(TC)||mmol/L|Mean|4.76|4.76|Standard Deviation|1.04|1.04|||
3720141|NCT02099838|3558819|B1|||Total Cholesterol(TC)||mmol/L|Mean|4.76|4.76|Standard Deviation|0.79|0.79|||
3720142|NCT02099838|3558817|B3|||ln(2-hour Postprandial Insulin)||ln(mU/L)|Mean|3.49|3.49|Standard Deviation|0.66|0.66|||
3720143|NCT02099838|3558818|B2|||ln(2-hour Postprandial Insulin)||ln(mU/L)|Mean|3.48|3.48|Standard Deviation|0.65|0.65|||
3720144|NCT02099838|3558819|B1|||ln(2-hour Postprandial Insulin)||ln(mU/L)|Mean|3.49|3.49|Standard Deviation|0.67|0.67|||
3720145|NCT02099838|3558817|B3|||ln(Fasting Insulin)||ln(mU/L)|Mean|2.19|2.19|Standard Deviation|0.60|0.6|||
3720146|NCT02099838|3558818|B2|||ln(Fasting Insulin)||ln(mU/L)|Mean|2.17|2.17|Standard Deviation|0.58|0.58|||
3720147|NCT02099838|3558819|B1|||ln(Fasting Insulin)||ln(mU/L)|Mean|2.21|2.21|Standard Deviation|0.62|0.62|||
3720148|NCT02099838|3558817|B3|||ln(HbA1c)||ln(percent)|Mean|2.12|2.12|Standard Deviation|0.19|0.19|||
3720149|NCT02099838|3558818|B2|||ln(HbA1c)||ln(percent)|Mean|2.10|2.1|Standard Deviation|0.14|0.14|||
3720150|NCT02099838|3558819|B1|||ln(HbA1c)||ln(percent)|Mean|2.14|2.14|Standard Deviation|0.12|0.12|||
3720151|NCT02099838|3558817|B3|||2-hour Postprandial Glucose(2hPPG)||mmol/L|Mean|16.02|16.02|Standard Deviation|3.86|3.86|||
3720152|NCT02099838|3558818|B2|||2-hour Postprandial Glucose(2hPPG)||mmol/L|Mean|15.59|15.59|Standard Deviation|3.81|3.81|||
3720153|NCT02099838|3558819|B1|||2-hour Postprandial Glucose(2hPPG)||mmol/L|Mean|16.47|16.47|Standard Deviation|3.96|3.96|||
3720154|NCT02099838|3558817|B3|||ln(Fasting Plasma Glucose(FPG))||ln(mmol/L)|Mean|2.12|2.12|Standard Deviation|0.21|0.21|||
3720155|NCT02099838|3558818|B2|||ln(Fasting Plasma Glucose(FPG))||ln(mmol/L)|Mean|2.08|2.08|Standard Deviation|0.18|0.18|||
3720156|NCT02099838|3558819|B1|||ln(Fasting Plasma Glucose(FPG))||ln(mmol/L)|Mean|2.16|2.16|Standard Deviation|0.23|0.23|||
3720157|NCT02099838|3558817|B3|||Weight(Female)||Kg|Mean|63.62|63.62|Standard Deviation|5.49|5.49|||
3720158|NCT02099838|3558818|B2|||Weight(Female)||Kg|Mean|63.00|63.0|Standard Deviation|5.49|5.49|||
3720159|NCT02099838|3558819|B1|||Weight(Female)||Kg|Mean|64.85|64.85|Standard Deviation|5.49|5.49|||
3720160|NCT02099838|3558817|B3|||Weight(Male)||Kg|Mean|72.05|72.05|Standard Deviation|9.39|9.39|||
3720161|NCT02099838|3558818|B2|||Weight(Male)||Kg|Mean|73.37|73.37|Standard Deviation|10.89|10.89|||
3720162|NCT02099838|3558819|B1|||Weight(Male)||Kg|Mean|71.18|71.18|Standard Deviation|8.03|8.03|||
3720163|NCT02099838|3558817|B3|||Height(Female)||cm|Mean|159.33|159.33|Standard Deviation|5.68|5.68|||
3720164|NCT02099838|3558818|B2|||Height(Female)||cm|Mean|159.88|159.88|Standard Deviation|5.54|5.54|||
3720165|NCT02099838|3558819|B1|||Height(Female)||cm|Mean|158.23|158.23|Standard Deviation|6.00|6.0|||
3720166|NCT02099838|3558817|B3|||Height(Male)||cm|Mean|169.49|169.49|Standard Deviation|5.69|5.69|||
3720167|NCT02099838|3558818|B2|||Height(Male)||cm|Mean|169.92|169.92|Standard Deviation|6.44|6.44|||
3720168|NCT02099838|3558819|B1|||Height(Male)||cm|Mean|169.17|169.17|Standard Deviation|5.03|5.03|||
3720169|NCT02099838|3558817|B3|||Diastolic Blood Pressure(DBP)||mmHg|Mean|76.87|76.87|Standard Deviation|7.86|7.86|||
3720170|NCT02099838|3558818|B2|||Diastolic Blood Pressure(DBP)||mmHg|Mean|77.83|77.83|Standard Deviation|8.78|8.78|||
3720171|NCT02099838|3558819|B1|||Diastolic Blood Pressure(DBP)||mmHg|Mean|76.24|76.24|Standard Deviation|6.38|6.38|||
3720172|NCT02099838|3558817|B3|||Systolic Blood Pressure(SBP)||mmHg|Mean|126.86|126.86|Standard Deviation|9.98|9.98|||
3720173|NCT02099838|3558818|B2|||Systolic Blood Pressure(SBP)||mmHg|Mean|128.46|128.46|Standard Deviation|10.38|10.38|||
3720174|NCT02099838|3558819|B1|||Systolic Blood Pressure(SBP)||mmHg|Mean|125.35|125.35|Standard Deviation|9.46|9.46|||
3720175|NCT02099838|3558817|B3|||Duration of Type 2 Diabetes||years|Mean|4.64|4.64|Standard Deviation|3.63|3.63|||
3720176|NCT02099838|3558818|B2|||Duration of Type 2 Diabetes||years|Mean|4.39|4.39|Standard Deviation|3.63|3.63|||
3720177|NCT02099838|3558819|B1|||Duration of Type 2 Diabetes||years|Mean|4.86|4.86|Standard Deviation|3.67|3.67|||
3720178|NCT02099838|3558817|B3|China||Region of Enrollment||participants|Number|97|97.0||||||
3720179|NCT02099838|3558818|B2|China||Region of Enrollment||participants|Number|51|51.0||||||
3720180|NCT02099838|3558819|B1|China||Region of Enrollment||participants|Number|46|46.0||||||
3720181|NCT02099838|3558817|B3|Other ethnicity||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3720182|NCT02099838|3558818|B2|Other ethnicity||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3720183|NCT02099838|3558819|B1|Other ethnicity||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3720184|NCT02099838|3558817|B3|Han||Race/Ethnicity, Customized||participants|Number|95|95.0||||||
3720185|NCT02099838|3558818|B2|Han||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
3720186|NCT02099838|3558819|B1|Han||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
3720187|NCT02099838|3558817|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3720188|NCT02099838|3558818|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3720189|NCT02099838|3558819|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3720190|NCT02099838|3558817|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3720191|NCT02099838|3558818|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3720192|NCT02099838|3558819|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3720193|NCT02099838|3558817|B3|||Age||years|Mean|54.61|54.61|Standard Deviation|8.54|8.54|||
3720194|NCT02099838|3558818|B2|||Age||years|Mean|54.51|54.51|Standard Deviation|7.23|7.23|||
3720195|NCT02099838|3558819|B1|||Age||years|Mean|54.65|54.65|Standard Deviation|9.91|9.91|||
3720196|NCT02099708|3558850|B1|Unknown||Presence or Absence of H. Pylori Infection||participants|Number|2971|2971.0||||||
3720197|NCT02099708|3558850|B1|Positive||Presence or Absence of H. Pylori Infection||participants|Number|55|55.0||||||
3720198|NCT02099708|3558850|B1|Negative||Presence or Absence of H. Pylori Infection||participants|Number|276|276.0||||||
3720199|NCT02099708|3558850|B1|Unknown||Details of the History of Gastric or Duodenal Ulcers: Time of Emergence||participants|Number|2629|2629.0||||||
3720200|NCT02099708|3558850|B1|≥ 1 year before treatment||Details of the History of Gastric or Duodenal Ulcers: Time of Emergence||participants|Number|449|449.0||||||
3720201|NCT02099708|3558850|B1|≥ 6 months to < 1 year before treatment||Details of the History of Gastric or Duodenal Ulcers: Time of Emergence||participants|Number|63|63.0||||||
3720202|NCT02099708|3558850|B1|<6 months before treatment||Details of the History of Gastric or Duodenal Ulcers: Time of Emergence||participants|Number|161|161.0||||||
3720203|NCT02099708|3558850|B1|Unknown||Details of the History of Gastric or Duodenal Ulcers: Site of Disease|Participants could be counted in more than 1 category (including duplicates).|participants|Number|490|490.0||||||
3720204|NCT02099708|3558850|B1|Gastroduodenal ulcer||Details of the History of Gastric or Duodenal Ulcers: Site of Disease|Participants could be counted in more than 1 category (including duplicates).|participants|Number|207|207.0||||||
3720205|NCT02099708|3558850|B1|Gastric ulcer||Details of the History of Gastric or Duodenal Ulcers: Site of Disease|Participants could be counted in more than 1 category (including duplicates).|participants|Number|2632|2632.0||||||
3720206|NCT02099708|3558850|B1|Other||Purpose of Non-steroidal Anti-Inflammatory Drug (NSAID) Treatment|Participants could be counted in more than 1 category (including duplicates).|participants|Number|1116|1116.0||||||
3720207|NCT02099708|3558850|B1|Osteoarthritis||Purpose of Non-steroidal Anti-Inflammatory Drug (NSAID) Treatment|Participants could be counted in more than 1 category (including duplicates).|participants|Number|1729|1729.0||||||
3720208|NCT02099708|3558850|B1|Rheumatoid arthritis||Purpose of Non-steroidal Anti-Inflammatory Drug (NSAID) Treatment|Participants could be counted in more than 1 category (including duplicates).|participants|Number|573|573.0||||||
3720209|NCT02099708|3558850|B1||Male|Sex: Female, Male||Participants|Count of Participants|1034|1034.0||||||
3720210|NCT02099708|3558850|B1||Female|Sex: Female, Male||Participants|Count of Participants|2268|2268.0||||||
3720211|NCT02099708|3558850|B1|||Age||years|Mean|67.9|67.9|Standard Deviation|14.21|14.21|||
3720212|NCT02099682|3558861|B1|Unknown||H. pylori infection||participants|Number|2659|2659.0||||||
3720213|NCT02099682|3558861|B1|Positive||H. pylori infection||participants|Number|171|171.0||||||
3720214|NCT02099682|3558861|B1|Negative||H. pylori infection||participants|Number|425|425.0||||||
3720215|NCT02099682|3558861|B1|Unknown||Gastric or Duodenal Ulcer History: Time of Onset||participants|Number|1927|1927.0||||||
3720216|NCT02099682|3558861|B1|1 year or longer before the start of treatment||Gastric or Duodenal Ulcer History: Time of Onset||participants|Number|977|977.0||||||
3720217|NCT02099682|3558861|B1|≥ 6 months, < 1 year before start of treatment||Gastric or Duodenal Ulcer History: Time of Onset||participants|Number|138|138.0||||||
3720218|NCT02099682|3558861|B1|Within 6 months of study drug administration||Gastric or Duodenal Ulcer History: Time of Onset||participants|Number|213|213.0||||||
3720219|NCT02099682|3558861|B1|Unknown||Gastric or Duodenal Ulcer History Breakdown|Participants could be counted in more than 1 category.|participants|Number|252|252.0||||||
3720220|NCT02099682|3558861|B1|Duodenal ulcer||Gastric or Duodenal Ulcer History Breakdown|Participants could be counted in more than 1 category.|participants|Number|313|313.0||||||
3720221|NCT02099682|3558861|B1|Gastric ulcer||Gastric or Duodenal Ulcer History Breakdown|Participants could be counted in more than 1 category.|participants|Number|2718|2718.0||||||
3720222|NCT02099682|3558861|B1|Other||Purpose for Low-Dose Aspirin Use|Participants could be counted in more than 1 category.|participants|Number|316|316.0||||||
3720223|NCT02099682|3558861|B1|PTCA||Purpose for Low-Dose Aspirin Use|Participants could be counted in more than 1 category.|participants|Number|398|398.0||||||
3720224|NCT02099682|3558861|B1|Post-coronary artery bypass (CABG)||Purpose for Low-Dose Aspirin Use|Participants could be counted in more than 1 category.|participants|Number|106|106.0||||||
3720225|NCT02099682|3558861|B1|Cerebral infarction||Purpose for Low-Dose Aspirin Use|Participants could be counted in more than 1 category.|participants|Number|1225|1225.0||||||
3720226|NCT02099682|3558861|B1|Transient ischaemic attack (TIA)||Purpose for Low-Dose Aspirin Use|Participants could be counted in more than 1 category.|participants|Number|221|221.0||||||
3720227|NCT02099682|3558861|B1|Myocardial infarction||Purpose for Low-Dose Aspirin Use|Participants could be counted in more than 1 category.|participants|Number|531|531.0||||||
3720228|NCT02099682|3558861|B1|Angina pectoris||Purpose for Low-Dose Aspirin Use|Participants could be counted in more than 1 category.|participants|Number|1182|1182.0||||||
3720229|NCT02099682|3558861|B1||Male|Sex: Female, Male||Participants|Count of Participants|1856|1856.0||||||
3720230|NCT02099682|3558861|B1||Female|Sex: Female, Male||Participants|Count of Participants|1399|1399.0||||||
3720231|NCT02099682|3558861|B1|||Age||years|Mean|72.4|72.4|Standard Deviation|11.02|11.02|||
3720232|NCT02099461|3558872|B4|Whte||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
3720233|NCT02099461|3558873|B3|Whte||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3720234|NCT02099461|3558874|B2|Whte||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3720235|NCT02099461|3558875|B1|Whte||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3720236|NCT02099461|3558872|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3720237|NCT02099461|3558873|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3720238|NCT02099461|3558874|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3720239|NCT02099461|3558875|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3720240|NCT02099461|3558872|B4|Multiple||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3720241|NCT02099461|3558873|B3|Multiple||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3720242|NCT02099461|3558874|B2|Multiple||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3720243|NCT02099461|3558875|B1|Multiple||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3720244|NCT02099461|3558872|B4|Black (or African American)||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3720245|NCT02099461|3558873|B3|Black (or African American)||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3720246|NCT02099461|3558874|B2|Black (or African American)||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3720247|NCT02099461|3558875|B1|Black (or African American)||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3720248|NCT02099461|3558872|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3720249|NCT02099461|3558873|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3720250|NCT02099461|3558874|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3720251|NCT02099461|3558875|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3720252|NCT02099461|3558872|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3720253|NCT02099461|3558873|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3720254|NCT02099461|3558874|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3720255|NCT02099461|3558875|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3720256|NCT02099461|3558872|B4||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3720257|NCT02099461|3558873|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3720258|NCT02099461|3558874|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3720259|NCT02099461|3558875|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3720260|NCT02099461|3558872|B4|||Age||years|Mean|32.5|32.5|Standard Deviation|8.2|8.2|||
3720261|NCT02099461|3558873|B3|||Age||years|Mean|32.8|32.8|Standard Deviation|8.8|8.8|||
3720262|NCT02099461|3558874|B2|||Age||years|Mean|32.2|32.2|Standard Deviation|7.6|7.6|||
3720263|NCT02099461|3558875|B1|||Age||years|Mean|29.9|29.9|Standard Deviation|7.3|7.3|||
3720264|NCT02099344|3558885|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3720265|NCT02099344|3558887|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3720266|NCT02099344|3558885|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3720267|NCT02099344|3558887|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3720268|NCT02099344|3558885|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3720269|NCT02099344|3558887|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3720270|NCT02099344|3558885|B3|||Age||years|Mean|56|56.0|Standard Deviation|||||
3720271|NCT02099344|3558887|B1|||Age||years|Mean|56|56.0|Standard Deviation|||||
3720272|NCT02099344|3558885|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3720273|NCT02099344|3558887|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3720274|NCT02099344|3558885|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3720275|NCT02099344|3558887|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3720276|NCT02099344|3558885|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3720277|NCT02099344|3558887|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3720278|NCT02099318|3558896|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3720279|NCT02099318|3558897|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3720280|NCT02099318|3558898|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3720281|NCT02099318|3558896|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3720282|NCT02099318|3558897|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3720283|NCT02099318|3558898|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3720284|NCT02099318|3558896|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3720285|NCT02099318|3558897|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3720286|NCT02099318|3558898|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3720287|NCT02099318|3558896|B3|||Age||years|Mean|52|52.0|Full Range|||32.0|72.0|
3720288|NCT02099318|3558897|B2|||Age||years|Mean|52|52.0|Full Range|||32.0|72.0|
3720289|NCT02099318|3558898|B1|||Age||years|Mean|52|52.0|Full Range|||32.0|72.0|
3720290|NCT02099318|3558896|B3|>=65 years||Age, Customized||Number|Number|9|9.0||||||
3720291|NCT02099318|3558897|B2|>=65 years||Age, Customized||Number|Number|5|5.0||||||
3720292|NCT02099318|3558898|B1|>=65 years||Age, Customized||Number|Number|4|4.0||||||
3720293|NCT02099318|3558896|B3|Between 18 and 65 years||Age, Customized||Number|Number|31|31.0||||||
3720294|NCT02099318|3558897|B2|Between 18 and 65 years||Age, Customized||Number|Number|15|15.0||||||
3720295|NCT02099318|3558898|B1|Between 18 and 65 years||Age, Customized||Number|Number|16|16.0||||||
3720296|NCT02099318|3558896|B3|<=18 years||Age, Customized||Number|Number|0|0.0||||||
3720297|NCT02099318|3558897|B2|<=18 years||Age, Customized||Number|Number|0|0.0||||||
3720298|NCT02099318|3558898|B1|<=18 years||Age, Customized||Number|Number|0|0.0||||||
3720299|NCT02099266|3558913|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3720300|NCT02099266|3558913|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3720301|NCT02099266|3558913|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3720302|NCT02099266|3558913|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3720303|NCT02099266|3558913|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3720304|NCT02099110|3558920|B6|||Baseline estimated glomerular filtration rate, eGFR|eGFR is a parameter used to assess kidney function.|mL/min/1.73m^2|Mean|92.4|92.4|Standard Deviation|20.0|20.0|||
3720305|NCT02099110|3558921|B5|||Baseline estimated glomerular filtration rate, eGFR|eGFR is a parameter used to assess kidney function.|mL/min/1.73m^2|Mean|92.6|92.6|Standard Deviation|19.2|19.2|||
3720306|NCT02099110|3558922|B4|||Baseline estimated glomerular filtration rate, eGFR|eGFR is a parameter used to assess kidney function.|mL/min/1.73m^2|Mean|91.9|91.9|Standard Deviation|20.4|20.4|||
3720307|NCT02099110|3558923|B3|||Baseline estimated glomerular filtration rate, eGFR|eGFR is a parameter used to assess kidney function.|mL/min/1.73m^2|Mean|92.6|92.6|Standard Deviation|18.2|18.2|||
3720308|NCT02099110|3558924|B2|||Baseline estimated glomerular filtration rate, eGFR|eGFR is a parameter used to assess kidney function.|mL/min/1.73m^2|Mean|92.8|92.8|Standard Deviation|21.4|21.4|||
3720309|NCT02099110|3558925|B1|||Baseline estimated glomerular filtration rate, eGFR|eGFR is a parameter used to assess kidney function.|mL/min/1.73m^2|Mean|91.9|91.9|Standard Deviation|20.6|20.6|||
3720310|NCT02099110|3558920|B6|||Sitting Systolic Blood Pressure||mm Hg|Mean|129.3|129.3|Standard Deviation|12.6|12.6|||
3720311|NCT02099110|3558921|B5|||Sitting Systolic Blood Pressure||mm Hg|Mean|129.1|129.1|Standard Deviation|13.3|13.3|||
3720312|NCT02099110|3558922|B4|||Sitting Systolic Blood Pressure||mm Hg|Mean|130.2|130.2|Standard Deviation|12.6|12.6|||
3720313|NCT02099110|3558923|B3|||Sitting Systolic Blood Pressure||mm Hg|Mean|128.3|128.3|Standard Deviation|12.2|12.2|||
3720314|NCT02099110|3558924|B2|||Sitting Systolic Blood Pressure||mm Hg|Mean|128.9|128.9|Standard Deviation|12.5|12.5|||
3720315|NCT02099110|3558925|B1|||Sitting Systolic Blood Pressure||mm Hg|Mean|129.7|129.7|Standard Deviation|12.5|12.5|||
3720316|NCT02099110|3558920|B6|||Static Beta-Cell Sensitivity to Glucose Index|Static beta-cell sensitivity to glucose index (SBCSGI) estimates the ratio of insulin secretion (expressed in pmol/min) related to above-basal glucose concentration (expressed in mmol/L * L) following a meal. Blood samples were collected before and after a standard meal and glucose, insulin, and C-peptide levels were analyzed. The C-peptides minimal model was used to estimate the insulin secretion rate. Analysis was performed with non-linear least squares using the Software Architecture Analysis Method (SAAM) II software. SBCSGI was expressed in units of 10^-9 min^-1.|SBCSGI (10^-9min^-1)|Mean|19.7|19.7|Standard Deviation|20.5|20.5|||
3720317|NCT02099110|3558921|B5|||Static Beta-Cell Sensitivity to Glucose Index|Static beta-cell sensitivity to glucose index (SBCSGI) estimates the ratio of insulin secretion (expressed in pmol/min) related to above-basal glucose concentration (expressed in mmol/L * L) following a meal. Blood samples were collected before and after a standard meal and glucose, insulin, and C-peptide levels were analyzed. The C-peptides minimal model was used to estimate the insulin secretion rate. Analysis was performed with non-linear least squares using the Software Architecture Analysis Method (SAAM) II software. SBCSGI was expressed in units of 10^-9 min^-1.|SBCSGI (10^-9min^-1)|Mean|19.3|19.3|Standard Deviation|21.0|21.0|||
3720318|NCT02099110|3558922|B4|||Static Beta-Cell Sensitivity to Glucose Index|Static beta-cell sensitivity to glucose index (SBCSGI) estimates the ratio of insulin secretion (expressed in pmol/min) related to above-basal glucose concentration (expressed in mmol/L * L) following a meal. Blood samples were collected before and after a standard meal and glucose, insulin, and C-peptide levels were analyzed. The C-peptides minimal model was used to estimate the insulin secretion rate. Analysis was performed with non-linear least squares using the Software Architecture Analysis Method (SAAM) II software. SBCSGI was expressed in units of 10^-9 min^-1.|SBCSGI (10^-9min^-1)|Mean|20.0|20.0|Standard Deviation|16.6|16.6|||
3720354|NCT02099110|3558922|B4|||Age||Years|Mean|55.2|55.2|Standard Deviation|10.4|10.4|||
3720355|NCT02099110|3558923|B3|||Age||Years|Mean|54.8|54.8|Standard Deviation|10.7|10.7|||
3720356|NCT02099110|3558924|B2|||Age||Years|Mean|55.3|55.3|Standard Deviation|9.5|9.5|||
3720357|NCT02099110|3558925|B1|||Age||Years|Mean|55.1|55.1|Standard Deviation|10.1|10.1|||
3720358|NCT02099084|3558976|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3720319|NCT02099110|3558923|B3|||Static Beta-Cell Sensitivity to Glucose Index|Static beta-cell sensitivity to glucose index (SBCSGI) estimates the ratio of insulin secretion (expressed in pmol/min) related to above-basal glucose concentration (expressed in mmol/L * L) following a meal. Blood samples were collected before and after a standard meal and glucose, insulin, and C-peptide levels were analyzed. The C-peptides minimal model was used to estimate the insulin secretion rate. Analysis was performed with non-linear least squares using the Software Architecture Analysis Method (SAAM) II software. SBCSGI was expressed in units of 10^-9 min^-1.|SBCSGI (10^-9min^-1)|Mean|20.2|20.2|Standard Deviation|21.2|21.2|||
3720320|NCT02099110|3558924|B2|||Static Beta-Cell Sensitivity to Glucose Index|Static beta-cell sensitivity to glucose index (SBCSGI) estimates the ratio of insulin secretion (expressed in pmol/min) related to above-basal glucose concentration (expressed in mmol/L * L) following a meal. Blood samples were collected before and after a standard meal and glucose, insulin, and C-peptide levels were analyzed. The C-peptides minimal model was used to estimate the insulin secretion rate. Analysis was performed with non-linear least squares using the Software Architecture Analysis Method (SAAM) II software. SBCSGI was expressed in units of 10^-9 min^-1.|SBCSGI (10^-9min^-1)|Mean|18.0|18.0|Standard Deviation|16.3|16.3|||
3720321|NCT02099110|3558925|B1|||Static Beta-Cell Sensitivity to Glucose Index|Static beta-cell sensitivity to glucose index (SBCSGI) estimates the ratio of insulin secretion (expressed in pmol/min) related to above-basal glucose concentration (expressed in mmol/L * L) following a meal. Blood samples were collected before and after a standard meal and glucose, insulin, and C-peptide levels were analyzed. The C-peptides minimal model was used to estimate the insulin secretion rate. Analysis was performed with non-linear least squares using the Software Architecture Analysis Method (SAAM) II software. SBCSGI was expressed in units of 10^-9 min^-1.|SBCSGI (10^-9min^-1)|Mean|20.9|20.9|Standard Deviation|26.1|26.1|||
3720322|NCT02099110|3558920|B6|||Baseline Fasting Plasma Glucose|Blood glucose was measured on a fasting basis after at least a 10-hour fast.|mg/dL|Mean|180.4|180.4|Standard Deviation|47.8|47.8|||
3720323|NCT02099110|3558921|B5|||Baseline Fasting Plasma Glucose|Blood glucose was measured on a fasting basis after at least a 10-hour fast.|mg/dL|Mean|177.2|177.2|Standard Deviation|49.4|49.4|||
3720324|NCT02099110|3558922|B4|||Baseline Fasting Plasma Glucose|Blood glucose was measured on a fasting basis after at least a 10-hour fast.|mg/dL|Mean|183.8|183.8|Standard Deviation|44.3|44.3|||
3720325|NCT02099110|3558923|B3|||Baseline Fasting Plasma Glucose|Blood glucose was measured on a fasting basis after at least a 10-hour fast.|mg/dL|Mean|177.4|177.4|Standard Deviation|46.6|46.6|||
3720326|NCT02099110|3558924|B2|||Baseline Fasting Plasma Glucose|Blood glucose was measured on a fasting basis after at least a 10-hour fast.|mg/dL|Mean|179.5|179.5|Standard Deviation|45.7|45.7|||
3720327|NCT02099110|3558925|B1|||Baseline Fasting Plasma Glucose|Blood glucose was measured on a fasting basis after at least a 10-hour fast.|mg/dL|Mean|184.1|184.1|Standard Deviation|52.2|52.2|||
3720328|NCT02099110|3558920|B6|||Baseline Body Weight||Kilograms|Mean|88.7|88.7|Standard Deviation|21.5|21.5|||
3720329|NCT02099110|3558921|B5|||Baseline Body Weight||Kilograms|Mean|87.5|87.5|Standard Deviation|20.5|20.5|||
3720330|NCT02099110|3558922|B4|||Baseline Body Weight||Kilograms|Mean|89.5|89.5|Standard Deviation|20.8|20.8|||
3720331|NCT02099110|3558923|B3|||Baseline Body Weight||Kilograms|Mean|89.8|89.8|Standard Deviation|23.4|23.4|||
3720332|NCT02099110|3558924|B2|||Baseline Body Weight||Kilograms|Mean|88.0|88.0|Standard Deviation|20.3|20.3|||
3720333|NCT02099110|3558925|B1|||Baseline Body Weight||Kilograms|Mean|88.6|88.6|Standard Deviation|22.2|22.2|||
3720334|NCT02099110|3558920|B6|||Baseline Hemoglobin A1C (A1C)|A1C is blood marker used to report average blood glucose levels over prolonged periods of time and is reported as a percentage (%).|Percent|Mean|8.6|8.6|Standard Deviation|1.0|1.0|||
3720335|NCT02099110|3558921|B5|||Baseline Hemoglobin A1C (A1C)|A1C is blood marker used to report average blood glucose levels over prolonged periods of time and is reported as a percentage (%).|Percent|Mean|8.6|8.6|Standard Deviation|1.0|1.0|||
3720336|NCT02099110|3558922|B4|||Baseline Hemoglobin A1C (A1C)|A1C is blood marker used to report average blood glucose levels over prolonged periods of time and is reported as a percentage (%).|Percent|Mean|8.6|8.6|Standard Deviation|1.0|1.0|||
3720337|NCT02099110|3558923|B3|||Baseline Hemoglobin A1C (A1C)|A1C is blood marker used to report average blood glucose levels over prolonged periods of time and is reported as a percentage (%).|Percent|Mean|8.5|8.5|Standard Deviation|1.0|1.0|||
3720338|NCT02099110|3558924|B2|||Baseline Hemoglobin A1C (A1C)|A1C is blood marker used to report average blood glucose levels over prolonged periods of time and is reported as a percentage (%).|Percent|Mean|8.6|8.6|Standard Deviation|1.0|1.0|||
3720339|NCT02099110|3558925|B1|||Baseline Hemoglobin A1C (A1C)|A1C is blood marker used to report average blood glucose levels over prolonged periods of time and is reported as a percentage (%).|Percent|Mean|8.6|8.6|Standard Deviation|1.0|1.0|||
3720340|NCT02099110|3558920|B6||Male|Sex: Female, Male||Participants|Count of Participants|664|664.0||||||
3720341|NCT02099110|3558921|B5||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3720342|NCT02099110|3558922|B4||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3720343|NCT02099110|3558923|B3||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3720344|NCT02099110|3558924|B2||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3720345|NCT02099110|3558925|B1||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3720346|NCT02099110|3558920|B6||Female|Sex: Female, Male||Participants|Count of Participants|568|568.0||||||
3720347|NCT02099110|3558921|B5||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3720348|NCT02099110|3558922|B4||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3720349|NCT02099110|3558923|B3||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3720350|NCT02099110|3558924|B2||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3720351|NCT02099110|3558925|B1||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3720352|NCT02099110|3558920|B6|||Age||Years|Mean|55.1|55.1|Standard Deviation|10.1|10.1|||
3720353|NCT02099110|3558921|B5|||Age||Years|Mean|55.1|55.1|Standard Deviation|9.8|9.8|||
3720359|NCT02099084|3558976|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3720360|NCT02099084|3558976|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3720361|NCT02099084|3558976|B1|||Age||years|Mean|54|54.0|Standard Deviation|13|13.0|||
3720362|NCT02099006|3558995|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3720363|NCT02099006|3558995|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3720364|NCT02099006|3558995|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3720365|NCT02099006|3558995|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3720366|NCT02099006|3558995|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3720367|NCT02099006|3558995|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3720368|NCT02098746|3559003|B1|Unknown||HbA1c, Categorical||participants|Number|25|25.0||||||
3720369|NCT02098746|3559003|B1|≥ 8.0%||HbA1c, Categorical||participants|Number|80|80.0||||||
3720370|NCT02098746|3559003|B1|≥ 7.0% to < 8.0%||HbA1c, Categorical||participants|Number|110|110.0||||||
3720371|NCT02098746|3559003|B1|≥ 6.0% to < 7.0%||HbA1c, Categorical||participants|Number|66|66.0||||||
3720372|NCT02098746|3559003|B1|< 6.0%||HbA1c, Categorical||participants|Number|8|8.0||||||
3720373|NCT02098746|3559003|B1|||Glycosylated hemoglobin A1c (HbA1c) (at Start of Treatment with Sonias Combination Tablets LD)|HbA1c data was available for 264 participants.|%|Mean|7.75|7.75|Standard Deviation|1.493|1.493|||
3720374|NCT02098746|3559003|B1|Not performed or compliance status is unknown||Compliance Rate with the Exercise Regimen (at Start of Treatment with Sonias Combination Tablets LD)||participants|Number|31|31.0||||||
3720375|NCT02098746|3559003|B1|< 50%||Compliance Rate with the Exercise Regimen (at Start of Treatment with Sonias Combination Tablets LD)||participants|Number|36|36.0||||||
3720376|NCT02098746|3559003|B1|≥ 50%||Compliance Rate with the Exercise Regimen (at Start of Treatment with Sonias Combination Tablets LD)||participants|Number|76|76.0||||||
3720377|NCT02098746|3559003|B1|≥ 70%||Compliance Rate with the Exercise Regimen (at Start of Treatment with Sonias Combination Tablets LD)||participants|Number|97|97.0||||||
3720378|NCT02098746|3559003|B1|≥ 90%||Compliance Rate with the Exercise Regimen (at Start of Treatment with Sonias Combination Tablets LD)||participants|Number|49|49.0||||||
3720379|NCT02098746|3559003|B1|Not performed or compliance status is unknown||Compliance Rate with the Diet Regimen (at the Start of Treatment with Sonias Combination Tablets LD)||participants|Number|27|27.0||||||
3720380|NCT02098746|3559003|B1|< 50%||Compliance Rate with the Diet Regimen (at the Start of Treatment with Sonias Combination Tablets LD)||participants|Number|18|18.0||||||
3720381|NCT02098746|3559003|B1|≥ 50%||Compliance Rate with the Diet Regimen (at the Start of Treatment with Sonias Combination Tablets LD)||participants|Number|53|53.0||||||
3720382|NCT02098746|3559003|B1|≥ 70%||Compliance Rate with the Diet Regimen (at the Start of Treatment with Sonias Combination Tablets LD)||participants|Number|118|118.0||||||
3720383|NCT02098746|3559003|B1|≥ 90%||Compliance Rate with the Diet Regimen (at the Start of Treatment with Sonias Combination Tablets LD)||participants|Number|73|73.0||||||
3720384|NCT02098746|3559003|B1|Unknown||Smoking Classification||participants|Number|46|46.0||||||
3720385|NCT02098746|3559003|B1|Ex-smoker||Smoking Classification||participants|Number|55|55.0||||||
3720386|NCT02098746|3559003|B1|Current Smoker||Smoking Classification||participants|Number|54|54.0||||||
3720387|NCT02098746|3559003|B1|Never Smoked||Smoking Classification||participants|Number|134|134.0||||||
3720388|NCT02098746|3559003|B1|Unknown||History of Alcohol (Drinking Alcohol-Containing Beverages Nearly Every Day)||participants|Number|41|41.0||||||
3720389|NCT02098746|3559003|B1|No||History of Alcohol (Drinking Alcohol-Containing Beverages Nearly Every Day)||participants|Number|81|81.0||||||
3720390|NCT02098746|3559003|B1|Yes||History of Alcohol (Drinking Alcohol-Containing Beverages Nearly Every Day)||participants|Number|167|167.0||||||
3720391|NCT02098746|3559003|B1|Unknown||BMI, Categorical||participants|Number|47|47.0||||||
3720392|NCT02098746|3559003|B1|≥30 kg/m^2||BMI, Categorical||participants|Number|30|30.0||||||
3720393|NCT02098746|3559003|B1|≥25 to <30 kg/m^2||BMI, Categorical||participants|Number|97|97.0||||||
3720394|NCT02098746|3559003|B1|≥18.5 to <25 kg/m^2||BMI, Categorical||participants|Number|107|107.0||||||
3720395|NCT02098746|3559003|B1|<18.5 kg/m^2||BMI, Categorical||participants|Number|8|8.0||||||
3720396|NCT02098746|3559003|B1|||Body Mass Index (BMI)|BMI data was available for 242 participants.|kg/m^2|Mean|25.45|25.45|Standard Deviation|4.230|4.23|||
3720397|NCT02098746|3559003|B1|Unmeasured||Weight, Categorical||participants|Number|39|39.0||||||
3720398|NCT02098746|3559003|B1|≥70 kg||Weight, Categorical||participants|Number|87|87.0||||||
3720399|NCT02098746|3559003|B1|≥60 to <70 kg||Weight, Categorical||participants|Number|81|81.0||||||
3720400|NCT02098746|3559003|B1|≥50 to <60 kg||Weight, Categorical||participants|Number|57|57.0||||||
3720401|NCT02098746|3559003|B1|≥40 to <50 kg||Weight, Categorical||participants|Number|24|24.0||||||
3720402|NCT02098746|3559003|B1|<40 kg||Weight, Categorical||participants|Number|1|1.0||||||
3720403|NCT02098746|3559003|B1|||Weight|Weight data was available for 250 participants.|kg|Mean|65.64|65.64|Standard Deviation|13.662|13.662|||
3720404|NCT02098746|3559003|B1|Unknown||Presence of Medical History||participants|Number|22|22.0||||||
3720405|NCT02098746|3559003|B1|Yes||Presence of Medical History||participants|Number|39|39.0||||||
3720406|NCT02098746|3559003|B1|No||Presence of Medical History||participants|Number|228|228.0||||||
3720407|NCT02098746|3559003|B1|Other||Breakdown of Complications (Tabulated in Duplicate)|Tabulated in duplicate = participants may be accounted for in more than one category.|participants|Number|12|12.0||||||
3720408|NCT02098746|3559003|B1|Malignant tumor||Breakdown of Complications (Tabulated in Duplicate)|Tabulated in duplicate = participants may be accounted for in more than one category.|participants|Number|1|1.0||||||
3720409|NCT02098746|3559003|B1|Cerebrovascular disease||Breakdown of Complications (Tabulated in Duplicate)|Tabulated in duplicate = participants may be accounted for in more than one category.|participants|Number|15|15.0||||||
3720410|NCT02098746|3559003|B1|Heart disease||Breakdown of Complications (Tabulated in Duplicate)|Tabulated in duplicate = participants may be accounted for in more than one category.|participants|Number|17|17.0||||||
3720411|NCT02098746|3559003|B1|Renal disease||Breakdown of Complications (Tabulated in Duplicate)|Tabulated in duplicate = participants may be accounted for in more than one category.|participants|Number|18|18.0||||||
3720412|NCT02098746|3559003|B1|Liver disease||Breakdown of Complications (Tabulated in Duplicate)|Tabulated in duplicate = participants may be accounted for in more than one category.|participants|Number|25|25.0||||||
3720413|NCT02098746|3559003|B1|Hyperuricaemia||Breakdown of Complications (Tabulated in Duplicate)|Tabulated in duplicate = participants may be accounted for in more than one category.|participants|Number|29|29.0||||||
3720414|NCT02098746|3559003|B1|Dyslipidaemia||Breakdown of Complications (Tabulated in Duplicate)|Tabulated in duplicate = participants may be accounted for in more than one category.|participants|Number|175|175.0||||||
3720415|NCT02098746|3559003|B1|Hypertension||Breakdown of Complications (Tabulated in Duplicate)|Tabulated in duplicate = participants may be accounted for in more than one category.|participants|Number|175|175.0||||||
3720416|NCT02098746|3559003|B1|Diabetic neuropathy||Breakdown of Complications (Tabulated in Duplicate)|Tabulated in duplicate = participants may be accounted for in more than one category.|participants|Number|12|12.0||||||
3720417|NCT02098746|3559003|B1|Diabetic retinopathy||Breakdown of Complications (Tabulated in Duplicate)|Tabulated in duplicate = participants may be accounted for in more than one category.|participants|Number|9|9.0||||||
3720418|NCT02098746|3559003|B1|Diabetic nephropathy||Breakdown of Complications (Tabulated in Duplicate)|Tabulated in duplicate = participants may be accounted for in more than one category.|participants|Number|17|17.0||||||
3720419|NCT02098746|3559003|B1|Microangiopathy||Breakdown of Complications (Tabulated in Duplicate)|Tabulated in duplicate = participants may be accounted for in more than one category.|participants|Number|31|31.0||||||
3720420|NCT02098746|3559003|B1|Yes||Complications of Type 2 Diabetes||participants|Number|264|264.0||||||
3720421|NCT02098746|3559003|B1|No||Complications of Type 2 Diabetes||participants|Number|25|25.0||||||
3720422|NCT02098746|3559003|B1|Unknown||History of Allergy||participants|Number|21|21.0||||||
3720423|NCT02098746|3559003|B1|Yes||History of Allergy||participants|Number|29|29.0||||||
3720424|NCT02098746|3559003|B1|No||History of Allergy||participants|Number|239|239.0||||||
3720425|NCT02098746|3559003|B1|Inpatient||Categories of Health Care||participants|Number|2|2.0||||||
3720426|NCT02098746|3559003|B1|Outpatient||Categories of Health Care||participants|Number|287|287.0||||||
3720427|NCT02098746|3559003|B1|Unknown||Duration of Type 2 Diabetes, Categorical||participants|Number|82|82.0||||||
3720428|NCT02098746|3559003|B1|≥10 years||Duration of Type 2 Diabetes, Categorical||participants|Number|49|49.0||||||
3720429|NCT02098746|3559003|B1|≥5 to <10 years||Duration of Type 2 Diabetes, Categorical||participants|Number|58|58.0||||||
3720430|NCT02098746|3559003|B1|≥2 to <5 years||Duration of Type 2 Diabetes, Categorical||participants|Number|44|44.0||||||
3720431|NCT02098746|3559003|B1|<2 years||Duration of Type 2 Diabetes, Categorical||participants|Number|56|56.0||||||
3720432|NCT02098746|3559003|B1|||Duration of Type 2 Diabetes|Duration of type 2 diabetes data was available for 207 participants.|years|Mean|6.19|6.19|Standard Deviation|5.444|5.444|||
3720433|NCT02098746|3559003|B1|Pregnant||Pregnancy Status (Females Only)|Data based on female participants only (N=117).|participants|Number|0|0.0||||||
3720434|NCT02098746|3559003|B1|Not pregnant||Pregnancy Status (Females Only)|Data based on female participants only (N=117).|participants|Number|117|117.0||||||
3720435|NCT02098746|3559003|B1||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3720436|NCT02098746|3559003|B1||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3720437|NCT02098746|3559003|B1|≥65 years||Age, Customized||participants|Number|177|177.0||||||
3720438|NCT02098746|3559003|B1|<65 years||Age, Customized||participants|Number|112|112.0||||||
3720439|NCT02098746|3559003|B1|||Age||years|Mean|65.8|65.8|Standard Deviation|12.56|12.56|||
3720440|NCT02098733|3559011|B1|||HbA1c at the Start of Study Treatment|HbA1c data was available for 1091 participants.|percentage of glycosylated haemoglobin|Mean|7.71|7.71|Standard Deviation|1.313|1.313|||
3720441|NCT02098733|3559011|B1|Unknown||Glycosylated Haemoglobin (HbA1c) at the Start of Study Treatment||participants|Number|67|67.0||||||
3720442|NCT02098733|3559011|B1|≥ 8.0%||Glycosylated Haemoglobin (HbA1c) at the Start of Study Treatment||participants|Number|355|355.0||||||
3720443|NCT02098733|3559011|B1|≥ 7.0% to < 8.0%||Glycosylated Haemoglobin (HbA1c) at the Start of Study Treatment||participants|Number|427|427.0||||||
3720444|NCT02098733|3559011|B1|≥ 6.0% to < 7.0%||Glycosylated Haemoglobin (HbA1c) at the Start of Study Treatment||participants|Number|274|274.0||||||
3720445|NCT02098733|3559011|B1|< 6.0%||Glycosylated Haemoglobin (HbA1c) at the Start of Study Treatment||participants|Number|35|35.0||||||
3720446|NCT02098733|3559011|B1|Unknown||Timing of Initiation of Pioglitazone and Glimepiride Before the Start of Study Treatment|Data is only available for participants who were administered both pioglitazone and glimepiride prior to beginning study treatment (n=558).|participants|Number|151|151.0||||||
3720447|NCT02098733|3559011|B1|Other||Timing of Initiation of Pioglitazone and Glimepiride Before the Start of Study Treatment|Data is only available for participants who were administered both pioglitazone and glimepiride prior to beginning study treatment (n=558).|participants|Number|60|60.0||||||
3720448|NCT02098733|3559011|B1|≥ 3 months||Timing of Initiation of Pioglitazone and Glimepiride Before the Start of Study Treatment|Data is only available for participants who were administered both pioglitazone and glimepiride prior to beginning study treatment (n=558).|participants|Number|347|347.0||||||
3720449|NCT02098733|3559011|B1|Unknown||Timing of Initiation of Glimepiride Before the Start of Study Treatment|Data is only available for participants who were administered glimepiride alone prior to beginning study treatment (n=338).|participants|Number|73|73.0||||||
3720450|NCT02098733|3559011|B1|< 3 months||Timing of Initiation of Glimepiride Before the Start of Study Treatment|Data is only available for participants who were administered glimepiride alone prior to beginning study treatment (n=338).|participants|Number|42|42.0||||||
3720737|NCT02097823|3559166|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3720451|NCT02098733|3559011|B1|≥ 3 months||Timing of Initiation of Glimepiride Before the Start of Study Treatment|Data is only available for participants who were administered glimepiride alone prior to beginning study treatment (n=338).|participants|Number|223|223.0||||||
3720452|NCT02098733|3559011|B1|Unknown||Timing of Initiation of Pioglitazone Before the Start of Study Treatment|Data is only available for participants who were administered pioglitazone alone prior to beginning study treatment (n=189).|participants|Number|68|68.0||||||
3720453|NCT02098733|3559011|B1|< 3 months||Timing of Initiation of Pioglitazone Before the Start of Study Treatment|Data is only available for participants who were administered pioglitazone alone prior to beginning study treatment (n=189).|participants|Number|17|17.0||||||
3720454|NCT02098733|3559011|B1|≥ 3 months||Timing of Initiation of Pioglitazone Before the Start of Study Treatment|Data is only available for participants who were administered pioglitazone alone prior to beginning study treatment (n=189).|participants|Number|104|104.0||||||
3720455|NCT02098733|3559011|B1|Undone or compliance status is unknown||Compliance rate with the Exercise Regimen (At the Start of Treatment)||participants|Number|165|165.0||||||
3720456|NCT02098733|3559011|B1|< 50%||Compliance rate with the Exercise Regimen (At the Start of Treatment)||participants|Number|147|147.0||||||
3720457|NCT02098733|3559011|B1|≥ 50%||Compliance rate with the Exercise Regimen (At the Start of Treatment)||participants|Number|348|348.0||||||
3720458|NCT02098733|3559011|B1|≥ 70%||Compliance rate with the Exercise Regimen (At the Start of Treatment)||participants|Number|279|279.0||||||
3720459|NCT02098733|3559011|B1|≥ 90%||Compliance rate with the Exercise Regimen (At the Start of Treatment)||participants|Number|219|219.0||||||
3720460|NCT02098733|3559011|B1|Undone or compliance status is unknown||Compliance Rate with the Diet Regimen (At the Start of Treatment)||participants|Number|125|125.0||||||
3720461|NCT02098733|3559011|B1|< 50%||Compliance Rate with the Diet Regimen (At the Start of Treatment)||participants|Number|91|91.0||||||
3720462|NCT02098733|3559011|B1|≥ 50%||Compliance Rate with the Diet Regimen (At the Start of Treatment)||participants|Number|286|286.0||||||
3720463|NCT02098733|3559011|B1|≥ 70%||Compliance Rate with the Diet Regimen (At the Start of Treatment)||participants|Number|371|371.0||||||
3720464|NCT02098733|3559011|B1|≥ 90%||Compliance Rate with the Diet Regimen (At the Start of Treatment)||participants|Number|285|285.0||||||
3720465|NCT02098733|3559011|B1|Unknown||Smoking Classification||participants|Number|223|223.0||||||
3720466|NCT02098733|3559011|B1|Ex-smoker||Smoking Classification||participants|Number|228|228.0||||||
3720467|NCT02098733|3559011|B1|Current Smoker||Smoking Classification||participants|Number|191|191.0||||||
3720468|NCT02098733|3559011|B1|Never Smoked||Smoking Classification||participants|Number|516|516.0||||||
3720469|NCT02098733|3559011|B1|Unknown||Alcohol History (Drinking Alcohol-Containing Beverages Most Days)||participants|Number|187|187.0||||||
3720470|NCT02098733|3559011|B1|No||Alcohol History (Drinking Alcohol-Containing Beverages Most Days)||participants|Number|375|375.0||||||
3720471|NCT02098733|3559011|B1|Yes||Alcohol History (Drinking Alcohol-Containing Beverages Most Days)||participants|Number|596|596.0||||||
3720472|NCT02098733|3559011|B1|Unknown||Presence of Medical History||participants|Number|104|104.0||||||
3720473|NCT02098733|3559011|B1|Yes||Presence of Medical History||participants|Number|157|157.0||||||
3720474|NCT02098733|3559011|B1|No||Presence of Medical History||participants|Number|897|897.0||||||
3720475|NCT02098733|3559011|B1|Other||Breakdown of Complications|Participants may be accounted for in more than 1 category.|participants|Number|19|19.0||||||
3720476|NCT02098733|3559011|B1|Malignant tumor||Breakdown of Complications|Participants may be accounted for in more than 1 category.|participants|Number|10|10.0||||||
3720477|NCT02098733|3559011|B1|Cerebrovascular disease||Breakdown of Complications|Participants may be accounted for in more than 1 category.|participants|Number|76|76.0||||||
3720478|NCT02098733|3559011|B1|Heart disease||Breakdown of Complications|Participants may be accounted for in more than 1 category.|participants|Number|134|134.0||||||
3720479|NCT02098733|3559011|B1|Renal disease||Breakdown of Complications|Participants may be accounted for in more than 1 category.|participants|Number|159|159.0||||||
3720480|NCT02098733|3559011|B1|Liver disease||Breakdown of Complications|Participants may be accounted for in more than 1 category.|participants|Number|154|154.0||||||
3720481|NCT02098733|3559011|B1|Hyperuricaemia||Breakdown of Complications|Participants may be accounted for in more than 1 category.|participants|Number|95|95.0||||||
3720482|NCT02098733|3559011|B1|Dyslipidaemia||Breakdown of Complications|Participants may be accounted for in more than 1 category.|participants|Number|787|787.0||||||
3720483|NCT02098733|3559011|B1|Hypertension||Breakdown of Complications|Participants may be accounted for in more than 1 category.|participants|Number|723|723.0||||||
3720484|NCT02098733|3559011|B1|Diabetic neuropathy||Breakdown of Complications|Participants may be accounted for in more than 1 category.|participants|Number|88|88.0||||||
3720485|NCT02098733|3559011|B1|Diabetic retinopathy||Breakdown of Complications|Participants may be accounted for in more than 1 category.|participants|Number|71|71.0||||||
3720486|NCT02098733|3559011|B1|Diabetic nephropathy||Breakdown of Complications|Participants may be accounted for in more than 1 category.|participants|Number|144|144.0||||||
3720487|NCT02098733|3559011|B1|Microangiopathy||Breakdown of Complications|Participants may be accounted for in more than 1 category.|participants|Number|227|227.0||||||
3720488|NCT02098733|3559011|B1|Yes||Presence of Complications||participants|Number|1050|1050.0||||||
3720489|NCT02098733|3559011|B1|No||Presence of Complications||participants|Number|108|108.0||||||
3720490|NCT02098733|3559011|B1|Unknown||History of Allergies||participants|Number|118|118.0||||||
3720491|NCT02098733|3559011|B1|Yes||History of Allergies||participants|Number|81|81.0||||||
3720492|NCT02098733|3559011|B1|No||History of Allergies||participants|Number|959|959.0||||||
3720493|NCT02098733|3559011|B1|Inpatient||Healthcare Category||participants|Number|3|3.0||||||
3720494|NCT02098733|3559011|B1|Outpatient||Healthcare Category||participants|Number|1155|1155.0||||||
3720495|NCT02098733|3559011|B1|Unknown||Duration of Type 2 Diabetes, Categorical||participants|Number|370|370.0||||||
3720496|NCT02098733|3559011|B1|≥10 years||Duration of Type 2 Diabetes, Categorical||participants|Number|274|274.0||||||
3720497|NCT02098733|3559011|B1|≥5 to <10 years||Duration of Type 2 Diabetes, Categorical||participants|Number|262|262.0||||||
3720498|NCT02098733|3559011|B1|≥2 to <5 years||Duration of Type 2 Diabetes, Categorical||participants|Number|160|160.0||||||
3720499|NCT02098733|3559011|B1|<2 years||Duration of Type 2 Diabetes, Categorical||participants|Number|92|92.0||||||
3720500|NCT02098733|3559011|B1|||Duration of Type 2 Diabetes|Duration of type 2 diabetes data was available for 788 participants.|years|Mean|9.12|9.12|Standard Deviation|8.188|8.188|||
3720501|NCT02098733|3559011|B1|Unknown||BMI Categorical||participants|Number|147|147.0||||||
3720502|NCT02098733|3559011|B1|≥30 kg/m^2||BMI Categorical||participants|Number|165|165.0||||||
3720503|NCT02098733|3559011|B1|≥25 to <30 kg/m^2||BMI Categorical||participants|Number|412|412.0||||||
3720504|NCT02098733|3559011|B1|≥18.5 to <25 kg/m^2||BMI Categorical||participants|Number|422|422.0||||||
3720505|NCT02098733|3559011|B1|<18.5 kg/m^2||BMI Categorical||participants|Number|12|12.0||||||
3720506|NCT02098733|3559011|B1|||Body Mass Index (BMI)|BMI data was available for 1011 participants.|kg/m^2|Mean|26.19|26.19|Standard Deviation|4.401|4.401|||
3720507|NCT02098733|3559011|B1|Unmeasured||Weight Categorical||participants|Number|100|100.0||||||
3720508|NCT02098733|3559011|B1|≥70 kg||Weight Categorical||participants|Number|427|427.0||||||
3720509|NCT02098733|3559011|B1|≥60 to <70 kg||Weight Categorical||participants|Number|327|327.0||||||
3720510|NCT02098733|3559011|B1|≥50 to <60 kg||Weight Categorical||participants|Number|223|223.0||||||
3720511|NCT02098733|3559011|B1|≥40 to <50 kg||Weight Categorical||participants|Number|74|74.0||||||
3720512|NCT02098733|3559011|B1|<40 kg||Weight Categorical||participants|Number|7|7.0||||||
3720513|NCT02098733|3559011|B1|||Weight||kg|Mean|67.86|67.86|Standard Deviation|14.281|14.281|||
3720514|NCT02098733|3559011|B1|Pregnant||Pregnancy Status <Females>|Female participants only (n=439)|participants|Number|0|0.0||||||
3720515|NCT02098733|3559011|B1|Not pregnant||Pregnancy Status <Females>|Female participants only (n=439)|participants|Number|439|439.0||||||
3720516|NCT02098733|3559011|B1||Male|Sex: Female, Male||Participants|Count of Participants|719|719.0||||||
3720517|NCT02098733|3559011|B1||Female|Sex: Female, Male||Participants|Count of Participants|439|439.0||||||
3720518|NCT02098733|3559011|B1|≥75 years||Age, Customized||participants|Number|265|265.0||||||
3720519|NCT02098733|3559011|B1|≥65 to <74 years||Age, Customized||participants|Number|354|354.0||||||
3720520|NCT02098733|3559011|B1|<65 years||Age, Customized||participants|Number|539|539.0||||||
3720521|NCT02098733|3559011|B1|≥65 years||Age, Customized||participants|Number|619|619.0||||||
3720522|NCT02098733|3559011|B1|<65 years||Age, Customized||participants|Number|539|539.0||||||
3720523|NCT02098733|3559011|B1|||Age||years|Mean|64.9|64.9|Standard Deviation|12.14|12.14|||
3720524|NCT02098395|3559021|B5|||Body Weight||kg|Mean|83.91|83.91|Standard Deviation|17.109|17.109|||
3720525|NCT02098395|3559022|B4|||Body Weight||kg|Mean|84.20|84.2|Standard Deviation|16.539|16.539|||
3720526|NCT02098395|3559023|B3|||Body Weight||kg|Mean|83.64|83.64|Standard Deviation|17.620|17.62|||
3720527|NCT02098395|3559024|B2|||Body Weight||kg|Mean|84.69|84.69|Standard Deviation|18.155|18.155|||
3720528|NCT02098395|3559025|B1|||Body Weight||kg|Mean|83.10|83.1|Standard Deviation|16.137|16.137|||
3720529|NCT02098395|3559021|B5|||Glycosylated Haemoglobin (HbA1c)||Percent (%) glycosylated haemoglobin|Mean|8.08|8.08|Standard Deviation|0.732|0.732|||
3720530|NCT02098395|3559022|B4|||Glycosylated Haemoglobin (HbA1c)||Percent (%) glycosylated haemoglobin|Mean|8.12|8.12|Standard Deviation|0.723|0.723|||
3720531|NCT02098395|3559023|B3|||Glycosylated Haemoglobin (HbA1c)||Percent (%) glycosylated haemoglobin|Mean|8.04|8.04|Standard Deviation|0.736|0.736|||
3720532|NCT02098395|3559024|B2|||Glycosylated Haemoglobin (HbA1c)||Percent (%) glycosylated haemoglobin|Mean|8.07|8.07|Standard Deviation|0.731|0.731|||
3720533|NCT02098395|3559025|B1|||Glycosylated Haemoglobin (HbA1c)||Percent (%) glycosylated haemoglobin|Mean|8.09|8.09|Standard Deviation|0.743|0.743|||
3720534|NCT02098395|3559021|B5||Male|Gender||Participants|Count of Participants|382|382.0||||||
3720535|NCT02098395|3559022|B4||Male|Gender||Participants|Count of Participants|94|94.0||||||
3720536|NCT02098395|3559023|B3||Male|Gender||Participants|Count of Participants|92|92.0||||||
3720537|NCT02098395|3559024|B2||Male|Gender||Participants|Count of Participants|103|103.0||||||
3720538|NCT02098395|3559025|B1||Male|Gender||Participants|Count of Participants|93|93.0||||||
3720539|NCT02098395|3559021|B5||Female|Gender||Participants|Count of Participants|449|449.0||||||
3720540|NCT02098395|3559022|B4||Female|Gender||Participants|Count of Participants|112|112.0||||||
3720541|NCT02098395|3559023|B3||Female|Gender||Participants|Count of Participants|113|113.0||||||
3720542|NCT02098395|3559024|B2||Female|Gender||Participants|Count of Participants|106|106.0||||||
3720543|NCT02098395|3559025|B1||Female|Gender||Participants|Count of Participants|118|118.0||||||
3720544|NCT02098395|3559021|B5|||Age||years|Mean|43.2|43.2|Standard Deviation|13.00|13.0|||
3720545|NCT02098395|3559022|B4|||Age||years|Mean|42.7|42.7|Standard Deviation|12.97|12.97|||
3720546|NCT02098395|3559023|B3|||Age||years|Mean|43.2|43.2|Standard Deviation|12.9|12.9|||
3720547|NCT02098395|3559024|B2|||Age||years|Mean|42.8|42.8|Standard Deviation|13.31|13.31|||
3720548|NCT02098395|3559025|B1|||Age||years|Mean|43.9|43.9|Standard Deviation|12.88|12.88|||
3720549|NCT02098369|3559046|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3720550|NCT02098369|3559047|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3720551|NCT02098369|3559048|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3720552|NCT02098369|3559049|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3720553|NCT02098369|3559046|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3720554|NCT02098369|3559047|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3720555|NCT02098369|3559048|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3720556|NCT02098369|3559049|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3720557|NCT02098369|3559046|B4||White|Race (NIH/OMB)||Participants|Count of Participants|344|344.0||||||
3720558|NCT02098369|3559047|B3||White|Race (NIH/OMB)||Participants|Count of Participants|117|117.0||||||
3720559|NCT02098369|3559048|B2||White|Race (NIH/OMB)||Participants|Count of Participants|116|116.0||||||
3720560|NCT02098369|3559049|B1||White|Race (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
3720561|NCT02098369|3559046|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3720562|NCT02098369|3559047|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3720563|NCT02098369|3559048|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3720564|NCT02098369|3559049|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3720565|NCT02098369|3559046|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720566|NCT02098369|3559047|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720567|NCT02098369|3559048|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720568|NCT02098369|3559049|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720569|NCT02098369|3559046|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720570|NCT02098369|3559047|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720571|NCT02098369|3559048|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720572|NCT02098369|3559049|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720573|NCT02098369|3559046|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3720574|NCT02098369|3559047|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3720575|NCT02098369|3559048|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720576|NCT02098369|3559049|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3720577|NCT02098369|3559046|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3720578|NCT02098369|3559047|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3720579|NCT02098369|3559048|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3720580|NCT02098369|3559049|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3720581|NCT02098369|3559046|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|428|428.0||||||
3720582|NCT02098369|3559047|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
3720583|NCT02098369|3559048|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
3720584|NCT02098369|3559049|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|136|136.0||||||
3720585|NCT02098369|3559046|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3720586|NCT02098369|3559047|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720587|NCT02098369|3559048|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3720588|NCT02098369|3559049|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3720589|NCT02098369|3559046|B4||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3720590|NCT02098369|3559047|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3720591|NCT02098369|3559048|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3720592|NCT02098369|3559049|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3720593|NCT02098369|3559046|B4||Female|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
3720594|NCT02098369|3559047|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3720595|NCT02098369|3559048|B2||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3720596|NCT02098369|3559049|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3720597|NCT02098369|3559046|B4|||Age||years|Mean|66.8|66.8|Standard Deviation|8.8|8.8|||
3720598|NCT02098369|3559047|B3|||Age||years|Mean|65.9|65.9|Standard Deviation|8.4|8.4|||
3720599|NCT02098369|3559048|B2|||Age||years|Mean|68.0|68.0|Standard Deviation|8.8|8.8|||
3720600|NCT02098369|3559049|B1|||Age||years|Mean|66.5|66.5|Standard Deviation|9.0|9.0|||
3720601|NCT02098304|3559080|B1|United Kingdom||Region of Enrollment||participants|Number|42|42.0||||||
3720602|NCT02098304|3559080|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3720603|NCT02098304|3559080|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3720604|NCT02098304|3559080|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3720605|NCT02098304|3559080|B1|Black African||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3720606|NCT02098304|3559080|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
3720607|NCT02098304|3559080|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3720608|NCT02098304|3559080|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3720609|NCT02098304|3559080|B1|||Age||years|Mean|21.7|21.7|Full Range|||17.0|25.0|
3720610|NCT02098109|3559087|B3|||Prior Radiation||Participants|Count of Participants|23|23.0||||||
3720611|NCT02098109|3559088|B2|||Prior Radiation||Participants|Count of Participants|13|13.0||||||
3720612|NCT02098109|3559089|B1|||Prior Radiation||Participants|Count of Participants|10|10.0||||||
3720613|NCT02098109|3559087|B3||Non-Hodgkin's Lymphoma|Diagnosis||Participants|Count of Participants|11|11.0||||||
3720614|NCT02098109|3559088|B2||Non-Hodgkin's Lymphoma|Diagnosis||Participants|Count of Participants|8|8.0||||||
3720615|NCT02098109|3559089|B1||Non-Hodgkin's Lymphoma|Diagnosis||Participants|Count of Participants|3|3.0||||||
3720616|NCT02098109|3559087|B3||Multiple myeloma|Diagnosis||Participants|Count of Participants|86|86.0||||||
3720617|NCT02098109|3559088|B2||Multiple myeloma|Diagnosis||Participants|Count of Participants|43|43.0||||||
3720618|NCT02098109|3559089|B1||Multiple myeloma|Diagnosis||Participants|Count of Participants|43|43.0||||||
3720619|NCT02098109|3559087|B3|||Prior Therapies||number of prior therapies|Mean|1.5|1.5|Standard Deviation|0.8|0.8|||
3720620|NCT02098109|3559088|B2|||Prior Therapies||number of prior therapies|Mean|1.4|1.4|Standard Deviation|0.8|0.8|||
3720621|NCT02098109|3559089|B1|||Prior Therapies||number of prior therapies|Mean|1.5|1.5|Standard Deviation|0.8|0.8|||
3720622|NCT02098109|3559087|B3|United States||Region of Enrollment||participants|Number|97|97.0||||||
3720623|NCT02098109|3559088|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
3720624|NCT02098109|3559089|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
3720625|NCT02098109|3559087|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3720626|NCT02098109|3559088|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3720627|NCT02098109|3559089|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720628|NCT02098109|3559087|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3720629|NCT02098109|3559088|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720630|NCT02098109|3559089|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3720631|NCT02098109|3559087|B3||White|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3720632|NCT02098109|3559088|B2||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3720633|NCT02098109|3559089|B1||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3720634|NCT02098109|3559087|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3720635|NCT02098109|3559088|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3720636|NCT02098109|3559089|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3720637|NCT02098109|3559087|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720638|NCT02098109|3559088|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720639|NCT02098109|3559089|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720640|NCT02098109|3559087|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720641|NCT02098109|3559088|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720642|NCT02098109|3559089|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720643|NCT02098109|3559087|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720644|NCT02098109|3559088|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720645|NCT02098109|3559089|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720646|NCT02098109|3559087|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3720647|NCT02098109|3559088|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3720648|NCT02098109|3559089|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3720649|NCT02098109|3559087|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3720650|NCT02098109|3559088|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3720651|NCT02098109|3559089|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3720652|NCT02098109|3559087|B3|||Age||years|Mean|60.6|60.6|Standard Deviation|8.9|8.9|||
3720653|NCT02098109|3559088|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|9.0|9.0|||
3720654|NCT02098109|3559089|B1|||Age||years|Mean|62.9|62.9|Standard Deviation|8.3|8.3|||
3720655|NCT02097992|3559112|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3720656|NCT02097992|3559113|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3720657|NCT02097992|3559114|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3720658|NCT02097992|3559115|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3720659|NCT02097992|3559116|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3720660|NCT02097992|3559112|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3720661|NCT02097992|3559113|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3720662|NCT02097992|3559114|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3720663|NCT02097992|3559115|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3720664|NCT02097992|3559116|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3720665|NCT02097992|3559112|B5||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3720666|NCT02097992|3559113|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3720667|NCT02097992|3559114|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3720668|NCT02097992|3559115|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3720669|NCT02097992|3559116|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3720670|NCT02097992|3559112|B5||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3720671|NCT02097992|3559113|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3720672|NCT02097992|3559114|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3720673|NCT02097992|3559115|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3720674|NCT02097992|3559116|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3720675|NCT02097992|3559112|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3720676|NCT02097992|3559113|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3720677|NCT02097992|3559114|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3720678|NCT02097992|3559115|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3720679|NCT02097992|3559116|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3720680|NCT02097849|3559127|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3720681|NCT02097849|3559128|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3720682|NCT02097849|3559129|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3720683|NCT02097849|3559127|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3720684|NCT02097849|3559128|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3720685|NCT02097849|3559129|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3720686|NCT02097849|3559127|B3|||Age||years|Mean|45.3|45.3|Standard Deviation|6.91|6.91|||
3720687|NCT02097849|3559128|B2|||Age||years|Mean|45.9|45.9|Standard Deviation|6.10|6.1|||
3720688|NCT02097849|3559129|B1|||Age||years|Mean|44.7|44.7|Standard Deviation|7.77|7.77|||
3720689|NCT02097823|3559166|B3|Cisplatin/Vincristine||Chemotherapy Regimen||participants|Number|1|1.0||||||
3720690|NCT02097823|3559167|B2|Cisplatin/Vincristine||Chemotherapy Regimen||participants|Number|0|0.0||||||
3720691|NCT02097823|3559168|B1|Cisplatin/Vincristine||Chemotherapy Regimen||participants|Number|1|1.0||||||
3720692|NCT02097823|3559166|B3|CHOP||Chemotherapy Regimen||participants|Number|1|1.0||||||
3720693|NCT02097823|3559167|B2|CHOP||Chemotherapy Regimen||participants|Number|1|1.0||||||
3720694|NCT02097823|3559168|B1|CHOP||Chemotherapy Regimen||participants|Number|0|0.0||||||
3720695|NCT02097823|3559166|B3|Cisplatin/Bleomycin/Etoposide||Chemotherapy Regimen||participants|Number|1|1.0||||||
3720696|NCT02097823|3559167|B2|Cisplatin/Bleomycin/Etoposide||Chemotherapy Regimen||participants|Number|0|0.0||||||
3720697|NCT02097823|3559168|B1|Cisplatin/Bleomycin/Etoposide||Chemotherapy Regimen||participants|Number|1|1.0||||||
3720698|NCT02097823|3559166|B3|ABVE-PC||Chemotherapy Regimen||participants|Number|1|1.0||||||
3720699|NCT02097823|3559167|B2|ABVE-PC||Chemotherapy Regimen||participants|Number|0|0.0||||||
3720700|NCT02097823|3559168|B1|ABVE-PC||Chemotherapy Regimen||participants|Number|1|1.0||||||
3720701|NCT02097823|3559166|B3|BEACOPP||Chemotherapy Regimen||participants|Number|1|1.0||||||
3720702|NCT02097823|3559167|B2|BEACOPP||Chemotherapy Regimen||participants|Number|0|0.0||||||
3720703|NCT02097823|3559168|B1|BEACOPP||Chemotherapy Regimen||participants|Number|1|1.0||||||
3720704|NCT02097823|3559166|B3|Cisplatin/Etoposide||Chemotherapy Regimen||participants|Number|2|2.0||||||
3720705|NCT02097823|3559167|B2|Cisplatin/Etoposide||Chemotherapy Regimen||participants|Number|0|0.0||||||
3720706|NCT02097823|3559168|B1|Cisplatin/Etoposide||Chemotherapy Regimen||participants|Number|2|2.0||||||
3720707|NCT02097823|3559166|B3|High Dose Methotrexate||Chemotherapy Regimen||participants|Number|1|1.0||||||
3720708|NCT02097823|3559167|B2|High Dose Methotrexate||Chemotherapy Regimen||participants|Number|0|0.0||||||
3720709|NCT02097823|3559168|B1|High Dose Methotrexate||Chemotherapy Regimen||participants|Number|1|1.0||||||
3720710|NCT02097823|3559166|B3|Cisplatin/Doxorubicin||Chemotherapy Regimen||participants|Number|3|3.0||||||
3720711|NCT02097823|3559167|B2|Cisplatin/Doxorubicin||Chemotherapy Regimen||participants|Number|1|1.0||||||
3720712|NCT02097823|3559168|B1|Cisplatin/Doxorubicin||Chemotherapy Regimen||participants|Number|2|2.0||||||
3720713|NCT02097823|3559166|B3|Vincristine/Cyclophosphamide/Doxorubicin||Chemotherapy Regimen||participants|Number|4|4.0||||||
3720714|NCT02097823|3559167|B2|Vincristine/Cyclophosphamide/Doxorubicin||Chemotherapy Regimen||participants|Number|2|2.0||||||
3720715|NCT02097823|3559168|B1|Vincristine/Cyclophosphamide/Doxorubicin||Chemotherapy Regimen||participants|Number|2|2.0||||||
3720716|NCT02097823|3559166|B3|Medulloblastoma||Diagnosis||participants|Number|1|1.0||||||
3720717|NCT02097823|3559167|B2|Medulloblastoma||Diagnosis||participants|Number|0|0.0||||||
3720718|NCT02097823|3559168|B1|Medulloblastoma||Diagnosis||participants|Number|1|1.0||||||
3720719|NCT02097823|3559166|B3|Histiocytic Sarcoma||Diagnosis||participants|Number|1|1.0||||||
3720720|NCT02097823|3559167|B2|Histiocytic Sarcoma||Diagnosis||participants|Number|1|1.0||||||
3720721|NCT02097823|3559168|B1|Histiocytic Sarcoma||Diagnosis||participants|Number|0|0.0||||||
3720722|NCT02097823|3559166|B3|Germ Cell Tumor||Diagnosis||participants|Number|1|1.0||||||
3720723|NCT02097823|3559167|B2|Germ Cell Tumor||Diagnosis||participants|Number|0|0.0||||||
3720724|NCT02097823|3559168|B1|Germ Cell Tumor||Diagnosis||participants|Number|1|1.0||||||
3720725|NCT02097823|3559166|B3|Hodgkins||Diagnosis||participants|Number|2|2.0||||||
3720726|NCT02097823|3559167|B2|Hodgkins||Diagnosis||participants|Number|0|0.0||||||
3720727|NCT02097823|3559168|B1|Hodgkins||Diagnosis||participants|Number|2|2.0||||||
3720728|NCT02097823|3559166|B3|Neuroblastoma||Diagnosis||participants|Number|2|2.0||||||
3720729|NCT02097823|3559167|B2|Neuroblastoma||Diagnosis||participants|Number|0|0.0||||||
3720730|NCT02097823|3559168|B1|Neuroblastoma||Diagnosis||participants|Number|2|2.0||||||
3720731|NCT02097823|3559166|B3|Osteosarcoma||Diagnosis||participants|Number|4|4.0||||||
3720732|NCT02097823|3559167|B2|Osteosarcoma||Diagnosis||participants|Number|1|1.0||||||
3720733|NCT02097823|3559168|B1|Osteosarcoma||Diagnosis||participants|Number|3|3.0||||||
3720734|NCT02097823|3559166|B3|Ewings||Diagnosis||participants|Number|4|4.0||||||
3720735|NCT02097823|3559167|B2|Ewings||Diagnosis||participants|Number|2|2.0||||||
3720736|NCT02097823|3559168|B1|Ewings||Diagnosis||participants|Number|2|2.0||||||
3720738|NCT02097823|3559167|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3720739|NCT02097823|3559168|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3720740|NCT02097823|3559166|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3720741|NCT02097823|3559167|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3720742|NCT02097823|3559168|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3720743|NCT02097823|3559166|B3|||Age||years|Mean|11.8|11.8|Full Range|||5.0|18.0|
3720744|NCT02097823|3559167|B2|||Age||years|Mean|14|14.0|Full Range|||13.0|18.0|
3720745|NCT02097823|3559168|B1|||Age||years|Mean|10.5|10.5|Full Range|||5.0|14.0|
3720746|NCT02097823|3559166|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3720747|NCT02097823|3559167|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3720748|NCT02097823|3559168|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3720749|NCT02097823|3559166|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3720750|NCT02097823|3559167|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3720751|NCT02097823|3559168|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3720752|NCT02097823|3559166|B3||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
3720753|NCT02097823|3559167|B2||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3720754|NCT02097823|3559168|B1||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
3720755|NCT02097745|3559184|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3720756|NCT02097745|3559184|B1||Female|Sex: Female, Male||Participants|Count of Participants|273|273.0||||||
3720757|NCT02097745|3559184|B1|||Age||years|Mean|53.1|53.1|Standard Deviation|11.81|11.81|||
3720758|NCT02097732|3559206|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3720759|NCT02097732|3559207|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3720760|NCT02097732|3559208|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3720761|NCT02097732|3559206|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3720762|NCT02097732|3559207|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3720763|NCT02097732|3559208|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3720764|NCT02097732|3559206|B3|||Age||years|Mean|58|58.0|Full Range|||48.0|69.0|
3720765|NCT02097732|3559207|B2|||Age||years|Mean|55|55.0|Full Range|||48.0|62.0|
3720766|NCT02097732|3559208|B1|||Age||years|Mean|69|69.0|Full Range|||69.0|69.0|
3720767|NCT02097719|3559218|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3720768|NCT02097719|3559219|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3720769|NCT02097719|3559220|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3720770|NCT02097719|3559218|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3720771|NCT02097719|3559219|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3720772|NCT02097719|3559220|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3720773|NCT02097719|3559218|B3|||Age||Years|Mean|64.5|64.5|Standard Deviation|10.86|10.86|||
3720774|NCT02097719|3559219|B2|||Age||Years|Mean|65.5|65.5|Standard Deviation|9.98|9.98|||
3720775|NCT02097719|3559220|B1|||Age||Years|Mean|63.5|63.5|Standard Deviation|11.73|11.73|||
3720776|NCT02097537|3559227|B1|Japan||Region of Enrollment||participants|Number|10|10.0||||||
3720777|NCT02097537|3559227|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3720778|NCT02097537|3559227|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3720779|NCT02097537|3559227|B1|||Age||years|Mean|10.7|10.7|Standard Deviation|2.4|2.4|||
3720780|NCT02097537|3559227|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3720781|NCT02097537|3559227|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3720782|NCT02097537|3559227|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
3720783|NCT02097472|3559233|B9|Kenya||Region of Enrollment||Participants|Count of Participants|304|304.0||||||
3720784|NCT02097472|3559234|B8|Kenya||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3720785|NCT02097472|3559235|B7|Kenya||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3720786|NCT02097472|3559236|B6|Kenya||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3720787|NCT02097472|3559237|B5|Kenya||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3720788|NCT02097472|3559238|B4|Kenya||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3720789|NCT02097472|3559239|B3|Kenya||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3720790|NCT02097472|3559240|B2|Kenya||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3720791|NCT02097472|3559241|B1|Kenya||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3720792|NCT02097472|3559233|B9||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3720793|NCT02097472|3559234|B8||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3720794|NCT02097472|3559235|B7||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3720795|NCT02097472|3559236|B6||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3720796|NCT02097472|3559237|B5||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3720797|NCT02097472|3559238|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3720798|NCT02097472|3559239|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3720799|NCT02097472|3559240|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3720800|NCT02097472|3559241|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3720801|NCT02097472|3559233|B9||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3720802|NCT02097472|3559234|B8||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3720803|NCT02097472|3559235|B7||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3720804|NCT02097472|3559236|B6||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3720805|NCT02097472|3559237|B5||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3720806|NCT02097472|3559238|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3720807|NCT02097472|3559239|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3720808|NCT02097472|3559240|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3720809|NCT02097472|3559241|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3720810|NCT02097472|3559233|B9|||Age||years|Mean|5.99|5.99|Standard Deviation|11.00|11.0|||
3720811|NCT02097472|3559234|B8|||Age||years|Mean|1.09|1.09|Standard Deviation|0.09|0.09|||
3720812|NCT02097472|3559235|B7|||Age||years|Mean|1.13|1.13|Standard Deviation|0.10|0.1|||
3720813|NCT02097472|3559236|B6|||Age||years|Mean|1.11|1.11|Standard Deviation|0.09|0.09|||
3720814|NCT02097472|3559237|B5|||Age||years|Mean|1.09|1.09|Standard Deviation|0.09|0.09|||
3720815|NCT02097472|3559238|B4|||Age||years|Mean|1.10|1.1|Standard Deviation|0.09|0.09|||
3720816|NCT02097472|3559239|B3|||Age||years|Mean|30.39|30.39|Standard Deviation|7.71|7.71|||
3720817|NCT02097472|3559240|B2|||Age||years|Mean|28.56|28.56|Standard Deviation|8.61|8.61|||
3720818|NCT02097472|3559241|B1|||Age||years|Mean|26.94|26.94|Standard Deviation|5.98|5.98|||
3720819|NCT02097303|3559669|B1|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3720820|NCT02097303|3559669|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3720821|NCT02097303|3559669|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3720822|NCT02097303|3559669|B1|Non-Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3720823|NCT02097303|3559669|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3720824|NCT02097303|3559669|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3720825|NCT02097303|3559669|B1|||Age||years|Median|75|75.0|Full Range|||51.0|90.0|
3720826|NCT02097290|3559679|B1|United States||Region of Enrollment||Participants|Count of Participants|210|210.0||||||
3720827|NCT02097290|3559679|B1|Undisclosed||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3720828|NCT02097290|3559679|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|170|170.0||||||
3720829|NCT02097290|3559679|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3720830|NCT02097290|3559679|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3720831|NCT02097290|3559679|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3720832|NCT02097290|3559679|B1|Multiple Races||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3720833|NCT02097290|3559679|B1|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3720834|NCT02097290|3559679|B1||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3720835|NCT02097290|3559679|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3720836|NCT02097290|3559679|B1|||Age||years|Mean|69.8|69.8|Standard Deviation|10.8|10.8|||
3720837|NCT02097238|3559689|B1|United States||Region of Enrollment||Participants|Number|17|17.0||||||
3720838|NCT02097238|3559689|B1|Canada||Region of Enrollment||Participants|Number|2|2.0||||||
3720839|NCT02097238|3559689|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3720840|NCT02097238|3559689|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720841|NCT02097238|3559689|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3720842|NCT02097238|3559689|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3720843|NCT02097238|3559689|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720844|NCT02097238|3559689|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720845|NCT02097238|3559689|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3720846|NCT02097238|3559689|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720847|NCT02097238|3559689|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3720848|NCT02097238|3559689|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3720849|NCT02097238|3559689|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3720850|NCT02097238|3559689|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3720851|NCT02097238|3559689|B1|||Age||Years|Mean|17|17.0|Full Range|||12.0|25.0|
3720852|NCT02097134|3559695|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3720853|NCT02097134|3559695|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3720854|NCT02097134|3559695|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720855|NCT02097134|3559695|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3720856|NCT02097134|3559695|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3720857|NCT02097134|3559695|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720858|NCT02097134|3559695|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3720859|NCT02097134|3559695|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720860|NCT02097134|3559695|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3720861|NCT02097134|3559695|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3720862|NCT02097134|3559695|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3720863|NCT02097134|3559695|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3720864|NCT02097134|3559695|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3720865|NCT02097134|3559695|B1|||Age||years|Mean|1.92|1.92|Standard Deviation|0.93|0.93|||
3720866|NCT02097108|3559699|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3720867|NCT02097108|3559699|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3720868|NCT02097108|3559699|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3720869|NCT02097108|3559699|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3720870|NCT02097108|3559699|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3720871|NCT02097056|3559706|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3720872|NCT02097056|3559706|B1||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3720873|NCT02097056|3559706|B1|||Age||Years|Mean|74.82|74.82|Standard Deviation|7.18|7.18|||
3720874|NCT02097030|3559712|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3720875|NCT02097030|3559713|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3720876|NCT02097030|3559714|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3720877|NCT02097030|3559712|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3720878|NCT02097030|3559713|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3720879|NCT02097030|3559714|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3720880|NCT02097030|3559712|B3|||Age||years|Mean|21.4|21.4|Standard Deviation|5.0|5.0|||
3720881|NCT02097030|3559713|B2|||Age||years|Mean|21.2|21.2|Standard Deviation|5.0|5.0|||
3720882|NCT02097030|3559714|B1|||Age||years|Mean|21.5|21.5|Standard Deviation|4.9|4.9|||
3720883|NCT02096952|3559776|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3720884|NCT02096952|3559776|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3720885|NCT02096952|3559776|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720886|NCT02096952|3559776|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3720887|NCT02096952|3559776|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720888|NCT02096952|3559776|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720889|NCT02096952|3559776|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720890|NCT02096952|3559776|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720891|NCT02096952|3559776|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720892|NCT02096952|3559776|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3720893|NCT02096952|3559776|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3720894|NCT02096952|3559776|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3720895|NCT02096952|3559776|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3720896|NCT02096952|3559776|B1|||Age||years|Mean|24.9|24.9|Standard Deviation|4.6|4.6|||
3720897|NCT02096952|3559776|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3720898|NCT02096952|3559776|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3720899|NCT02096952|3559776|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3720900|NCT02096900|3559780|B3|||Duration of anesthesia (minutes)||minutes|Mean|196.46|196.46|Standard Deviation|86.86|86.86|||
3720901|NCT02096900|3559781|B2|||Duration of anesthesia (minutes)||minutes|Mean|205.79|205.79|Standard Deviation|97.60|97.6|||
3720902|NCT02096900|3559782|B1|||Duration of anesthesia (minutes)||minutes|Mean|185.58|185.58|Standard Deviation|72.20|72.2|||
3720903|NCT02096900|3559780|B3|||Time from drug administration to parental separation (minutes)||minutes|Mean|33.13|33.13|Standard Deviation|14.31|14.31|||
3720904|NCT02096900|3559781|B2|||Time from drug administration to parental separation (minutes)||minutes|Mean|34.98|34.98|Standard Deviation|16.00|16.0|||
3720905|NCT02096900|3559782|B1|||Time from drug administration to parental separation (minutes)||minutes|Mean|31.53|31.53|Standard Deviation|12.20|12.2|||
3720906|NCT02096900|3559780|B3|AS PS II||ASA physical status|"The American Society of Anesthesiologists (ASA) physical status classification system provides assessment of the fitness of patients before surgery.~ASA PS I patient is a normal healthy patient. ASA PS II patient is a patient with mild systemic disease without substantive functional limitations, for example; well controlled diabetes/hypertension or mid lung disease."|Participants|Count of Participants|54|54.0||||||
3720907|NCT02096900|3559781|B2|AS PS II||ASA physical status|"The American Society of Anesthesiologists (ASA) physical status classification system provides assessment of the fitness of patients before surgery.~ASA PS I patient is a normal healthy patient. ASA PS II patient is a patient with mild systemic disease without substantive functional limitations, for example; well controlled diabetes/hypertension or mid lung disease."|Participants|Count of Participants|28|28.0||||||
3720908|NCT02096900|3559782|B1|AS PS II||ASA physical status|"The American Society of Anesthesiologists (ASA) physical status classification system provides assessment of the fitness of patients before surgery.~ASA PS I patient is a normal healthy patient. ASA PS II patient is a patient with mild systemic disease without substantive functional limitations, for example; well controlled diabetes/hypertension or mid lung disease."|Participants|Count of Participants|26|26.0||||||
3720958|NCT02096900|3559781|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3720909|NCT02096900|3559780|B3|ASA PS I||ASA physical status|"The American Society of Anesthesiologists (ASA) physical status classification system provides assessment of the fitness of patients before surgery.~ASA PS I patient is a normal healthy patient. ASA PS II patient is a patient with mild systemic disease without substantive functional limitations, for example; well controlled diabetes/hypertension or mid lung disease."|Participants|Count of Participants|26|26.0||||||
3720910|NCT02096900|3559781|B2|ASA PS I||ASA physical status|"The American Society of Anesthesiologists (ASA) physical status classification system provides assessment of the fitness of patients before surgery.~ASA PS I patient is a normal healthy patient. ASA PS II patient is a patient with mild systemic disease without substantive functional limitations, for example; well controlled diabetes/hypertension or mid lung disease."|Participants|Count of Participants|14|14.0||||||
3720911|NCT02096900|3559782|B1|ASA PS I||ASA physical status|"The American Society of Anesthesiologists (ASA) physical status classification system provides assessment of the fitness of patients before surgery.~ASA PS I patient is a normal healthy patient. ASA PS II patient is a patient with mild systemic disease without substantive functional limitations, for example; well controlled diabetes/hypertension or mid lung disease."|Participants|Count of Participants|12|12.0||||||
3720912|NCT02096900|3559780|B3|||BMI||kg/m^2|Mean|17.19|17.19|Standard Deviation|3.21|3.21|||
3720913|NCT02096900|3559781|B2|||BMI||kg/m^2|Mean|17.60|17.6|Standard Deviation|4.02|4.02|||
3720914|NCT02096900|3559782|B1|||BMI||kg/m^2|Mean|16.73|16.73|Standard Deviation|1.92|1.92|||
3720915|NCT02096900|3559780|B3|||Height (cm)||cm|Mean|116.29|116.29|Standard Deviation|15.23|15.23|||
3720916|NCT02096900|3559781|B2|||Height (cm)||cm|Mean|115.34|115.34|Standard Deviation|15.92|15.92|||
3720917|NCT02096900|3559782|B1|||Height (cm)||cm|Mean|117.32|117.32|Standard Deviation|14.55|14.55|||
3720918|NCT02096900|3559780|B3|||Weight (kg)||kg|Mean|23.17|23.17|Standard Deviation|6.71|6.71|||
3720919|NCT02096900|3559781|B2|||Weight (kg)||kg|Mean|23.18|23.18|Standard Deviation|7.21|7.21|||
3720920|NCT02096900|3559782|B1|||Weight (kg)||kg|Mean|23.16|23.16|Standard Deviation|6.20|6.2|||
3720921|NCT02096900|3559780|B3|United States||Region of Enrollment||Participants|Count of Participants|80|80.0||||||
3720922|NCT02096900|3559781|B2|United States||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3720923|NCT02096900|3559782|B1|United States||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
3720924|NCT02096900|3559780|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720925|NCT02096900|3559781|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720926|NCT02096900|3559782|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720927|NCT02096900|3559780|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720928|NCT02096900|3559781|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720929|NCT02096900|3559782|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720930|NCT02096900|3559780|B3||White|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
3720931|NCT02096900|3559781|B2||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3720932|NCT02096900|3559782|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3720933|NCT02096900|3559780|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3720934|NCT02096900|3559781|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3720935|NCT02096900|3559782|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720936|NCT02096900|3559780|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3720937|NCT02096900|3559781|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720938|NCT02096900|3559782|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3720939|NCT02096900|3559780|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3720940|NCT02096900|3559781|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720941|NCT02096900|3559782|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3720942|NCT02096900|3559780|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720943|NCT02096900|3559781|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720944|NCT02096900|3559782|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720945|NCT02096900|3559780|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720946|NCT02096900|3559781|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720947|NCT02096900|3559782|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3720948|NCT02096900|3559780|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3720949|NCT02096900|3559781|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3720950|NCT02096900|3559782|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3720951|NCT02096900|3559780|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3720952|NCT02096900|3559781|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3720953|NCT02096900|3559782|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3720954|NCT02096900|3559780|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3720955|NCT02096900|3559781|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3720956|NCT02096900|3559782|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3720957|NCT02096900|3559780|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3720959|NCT02096900|3559782|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3720960|NCT02096900|3559780|B3|||Age||years|Mean|6.20|6.2|Standard Deviation|2.27|2.27|||
3720961|NCT02096900|3559781|B2|||Age||years|Mean|6.07|6.07|Standard Deviation|2.34|2.34|||
3720962|NCT02096900|3559782|B1|||Age||years|Mean|6.34|6.34|Standard Deviation|2.21|2.21|||
3720963|NCT02096861|3559797|B5|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3720964|NCT02096861|3559798|B4|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3720965|NCT02096861|3559799|B3|United States||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3720966|NCT02096861|3559800|B2|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3720967|NCT02096861|3559801|B1|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3720968|NCT02096861|3559797|B5|Ukraine||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3720969|NCT02096861|3559798|B4|Ukraine||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3720970|NCT02096861|3559799|B3|Ukraine||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3720971|NCT02096861|3559800|B2|Ukraine||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3720972|NCT02096861|3559801|B1|Ukraine||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3720973|NCT02096861|3559797|B5|South Korea||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
3720974|NCT02096861|3559798|B4|South Korea||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3720975|NCT02096861|3559799|B3|South Korea||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3720976|NCT02096861|3559800|B2|South Korea||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3720977|NCT02096861|3559801|B1|South Korea||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3720978|NCT02096861|3559797|B5|Russia||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3720979|NCT02096861|3559798|B4|Russia||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3720980|NCT02096861|3559799|B3|Russia||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3720981|NCT02096861|3559800|B2|Russia||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3720982|NCT02096861|3559801|B1|Russia||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3720983|NCT02096861|3559797|B5|Romania||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3720984|NCT02096861|3559798|B4|Romania||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3720985|NCT02096861|3559799|B3|Romania||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3720986|NCT02096861|3559800|B2|Romania||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3720987|NCT02096861|3559801|B1|Romania||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3720988|NCT02096861|3559797|B5|Poland||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3720989|NCT02096861|3559798|B4|Poland||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3720990|NCT02096861|3559799|B3|Poland||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3720991|NCT02096861|3559800|B2|Poland||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3720992|NCT02096861|3559801|B1|Poland||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3720993|NCT02096861|3559797|B5|Netherlands||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3720994|NCT02096861|3559798|B4|Netherlands||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3720995|NCT02096861|3559799|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3720996|NCT02096861|3559800|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3720997|NCT02096861|3559801|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3720998|NCT02096861|3559797|B5|Mexico||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3720999|NCT02096861|3559798|B4|Mexico||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3721000|NCT02096861|3559799|B3|Mexico||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3721001|NCT02096861|3559800|B2|Mexico||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3721002|NCT02096861|3559801|B1|Mexico||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3721003|NCT02096861|3559797|B5|Italy||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3721004|NCT02096861|3559798|B4|Italy||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3721005|NCT02096861|3559799|B3|Italy||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3721006|NCT02096861|3559800|B2|Italy||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3721007|NCT02096861|3559801|B1|Italy||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3721008|NCT02096861|3559797|B5|Israel||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3721009|NCT02096861|3559798|B4|Israel||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3721010|NCT02096861|3559799|B3|Israel||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3721011|NCT02096861|3559800|B2|Israel||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3721012|NCT02096861|3559801|B1|Israel||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3721013|NCT02096861|3559797|B5|Hungary||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3721014|NCT02096861|3559798|B4|Hungary||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3721015|NCT02096861|3559799|B3|Hungary||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3721016|NCT02096861|3559800|B2|Hungary||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3721017|NCT02096861|3559801|B1|Hungary||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3721018|NCT02096861|3559797|B5|Germany||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3721019|NCT02096861|3559798|B4|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3721020|NCT02096861|3559799|B3|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3721021|NCT02096861|3559800|B2|Germany||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3721022|NCT02096861|3559801|B1|Germany||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3721023|NCT02096861|3559797|B5|France||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3721024|NCT02096861|3559798|B4|France||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3721025|NCT02096861|3559799|B3|France||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3721026|NCT02096861|3559800|B2|France||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3721027|NCT02096861|3559801|B1|France||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3721028|NCT02096861|3559797|B5|Denmark||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3721029|NCT02096861|3559798|B4|Denmark||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3721030|NCT02096861|3559799|B3|Denmark||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3721031|NCT02096861|3559800|B2|Denmark||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3721032|NCT02096861|3559801|B1|Denmark||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3721033|NCT02096861|3559797|B5|Brazil||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3721034|NCT02096861|3559798|B4|Brazil||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3721035|NCT02096861|3559799|B3|Brazil||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3721036|NCT02096861|3559800|B2|Brazil||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3721037|NCT02096861|3559801|B1|Brazil||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3721038|NCT02096861|3559797|B5|Belgium||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3721039|NCT02096861|3559798|B4|Belgium||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3721040|NCT02096861|3559799|B3|Belgium||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3721041|NCT02096861|3559800|B2|Belgium||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3721042|NCT02096861|3559801|B1|Belgium||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3721043|NCT02096861|3559797|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721044|NCT02096861|3559798|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721045|NCT02096861|3559799|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721046|NCT02096861|3559800|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721047|NCT02096861|3559801|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721048|NCT02096861|3559797|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721049|NCT02096861|3559798|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721050|NCT02096861|3559799|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721051|NCT02096861|3559800|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721052|NCT02096861|3559801|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721053|NCT02096861|3559797|B5||White|Race (NIH/OMB)||Participants|Count of Participants|165|165.0||||||
3721054|NCT02096861|3559798|B4||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3721055|NCT02096861|3559799|B3||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3721056|NCT02096861|3559800|B2||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3721057|NCT02096861|3559801|B1||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3721058|NCT02096861|3559797|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3721059|NCT02096861|3559798|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721060|NCT02096861|3559799|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3721061|NCT02096861|3559800|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721062|NCT02096861|3559801|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721063|NCT02096861|3559797|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721064|NCT02096861|3559798|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721065|NCT02096861|3559799|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721066|NCT02096861|3559800|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721067|NCT02096861|3559801|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721068|NCT02096861|3559797|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3721069|NCT02096861|3559798|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3721070|NCT02096861|3559799|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3721071|NCT02096861|3559800|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3721072|NCT02096861|3559801|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3721073|NCT02096861|3559797|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721074|NCT02096861|3559798|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721075|NCT02096861|3559799|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721076|NCT02096861|3559800|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721077|NCT02096861|3559801|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721078|NCT02096861|3559797|B5||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3721079|NCT02096861|3559798|B4||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3721080|NCT02096861|3559799|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3721081|NCT02096861|3559800|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3721082|NCT02096861|3559801|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3721083|NCT02096861|3559797|B5||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3721084|NCT02096861|3559798|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3721085|NCT02096861|3559799|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3721086|NCT02096861|3559800|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3721087|NCT02096861|3559801|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3721088|NCT02096861|3559797|B5|||Age||years|Median|33|33.0|Full Range|||18.0|69.0|
3721089|NCT02096861|3559798|B4|||Age||years|Median|35|35.0|Full Range|||19.0|63.0|
3721090|NCT02096861|3559799|B3|||Age||years|Median|31|31.0|Full Range|||18.0|69.0|
3721091|NCT02096861|3559800|B2|||Age||years|Median|31|31.0|Full Range|||18.0|69.0|
3721092|NCT02096861|3559801|B1|||Age||years|Median|39|39.0|Full Range|||19.0|68.0|
3721093|NCT02096861|3559797|B5||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3721094|NCT02096861|3559798|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3721095|NCT02096861|3559799|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3721096|NCT02096861|3559800|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3721097|NCT02096861|3559801|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3721098|NCT02096861|3559797|B5||Between 18 and 65 years|Age||Participants|Count of Participants|214|214.0||||||
3721099|NCT02096861|3559798|B4||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
3721100|NCT02096861|3559799|B3||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3721101|NCT02096861|3559800|B2||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
3721102|NCT02096861|3559801|B1||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3721103|NCT02096861|3559797|B5||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3721104|NCT02096861|3559798|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3721105|NCT02096861|3559799|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3721106|NCT02096861|3559800|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3721107|NCT02096861|3559801|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3721108|NCT02096835|3559832|B4|China||Region of Enrollment||participants|Number|153|153.0||||||
3721109|NCT02096835|3559833|B3|China||Region of Enrollment||participants|Number|50|50.0||||||
3721110|NCT02096835|3559834|B2|China||Region of Enrollment||participants|Number|53|53.0||||||
3721111|NCT02096835|3559835|B1|China||Region of Enrollment||participants|Number|50|50.0||||||
3721112|NCT02096835|3559832|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721113|NCT02096835|3559833|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721114|NCT02096835|3559834|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721115|NCT02096835|3559835|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721116|NCT02096835|3559832|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721117|NCT02096835|3559833|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721118|NCT02096835|3559834|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721119|NCT02096835|3559835|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721120|NCT02096835|3559832|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721121|NCT02096835|3559833|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721122|NCT02096835|3559834|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721123|NCT02096835|3559835|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721124|NCT02096835|3559832|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721125|NCT02096835|3559833|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721126|NCT02096835|3559834|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721127|NCT02096835|3559835|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721128|NCT02096835|3559832|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721129|NCT02096835|3559833|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721130|NCT02096835|3559834|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721131|NCT02096835|3559835|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721132|NCT02096835|3559832|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|153|153.0||||||
3721133|NCT02096835|3559833|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3721134|NCT02096835|3559834|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3721135|NCT02096835|3559835|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3721136|NCT02096835|3559832|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721137|NCT02096835|3559833|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721138|NCT02096835|3559834|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721139|NCT02096835|3559835|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721140|NCT02096835|3559832|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3721141|NCT02096835|3559833|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3721142|NCT02096835|3559834|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3721143|NCT02096835|3559835|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3721144|NCT02096835|3559832|B4||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3721145|NCT02096835|3559833|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3721146|NCT02096835|3559834|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3721147|NCT02096835|3559835|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3721148|NCT02096835|3559832|B4|||Age||years|Median|35|35.0|Full Range|||22.0|60.0|
3721149|NCT02096835|3559833|B3|||Age||years|Median|35|35.0|Full Range|||22.0|60.0|
3721150|NCT02096835|3559834|B2|||Age||years|Median|35|35.0|Full Range|||23.0|60.0|
3721151|NCT02096835|3559835|B1|||Age||years|Median|37|37.0|Full Range|||24.0|60.0|
3721152|NCT02096744|3559854|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3721153|NCT02096744|3559854|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3721154|NCT02096744|3559854|B1|||Age||years|Mean|41.3|41.3|Standard Deviation|13.0|13.0|||
3721155|NCT02096731|3559868|B3||Male|Gender||Participants|Count of Participants|54744|54744.0||||||
3721156|NCT02096731|3559869|B2||Male|Gender||Participants|Count of Participants|40043|40043.0||||||
3721157|NCT02096731|3559870|B1||Male|Gender||Participants|Count of Participants|14701|14701.0||||||
3721158|NCT02096731|3559868|B3||Female|Gender||Participants|Count of Participants|60653|60653.0||||||
3721159|NCT02096731|3559869|B2||Female|Gender||Participants|Count of Participants|48912|48912.0||||||
3721160|NCT02096731|3559870|B1||Female|Gender||Participants|Count of Participants|11741|11741.0||||||
3721161|NCT02096731|3559868|B3|||Age||Years|Mean|69.9|69.9|Standard Deviation|9.3|9.3|||
3721162|NCT02096731|3559869|B2|||Age||Years|Mean|69.4|69.4|Standard Deviation|9.4|9.4|||
3721163|NCT02096731|3559870|B1|||Age||Years|Mean|71.5|71.5|Standard Deviation|9.0|9.0|||
3721164|NCT02096718|3559885|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3721165|NCT02096718|3559886|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3721166|NCT02096718|3559887|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3721167|NCT02096718|3559888|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3721168|NCT02096718|3559885|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3721169|NCT02096718|3559886|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3721170|NCT02096718|3559887|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3721171|NCT02096718|3559888|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3721172|NCT02096718|3559885|B4|||Age||Years|Mean|63.6|63.6|Standard Deviation|11.5|11.5|||
3721173|NCT02096718|3559886|B3|||Age||Years|Mean|62.1|62.1|Standard Deviation|11.4|11.4|||
3721174|NCT02096718|3559887|B2|||Age||Years|Mean|61.0|61.0|Standard Deviation|11.9|11.9|||
3721175|NCT02096718|3559888|B1|||Age||Years|Mean|68.6|68.6|Standard Deviation|11.0|11.0|||
3721176|NCT02096705|3559907|B3||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3721177|NCT02096705|3559908|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3721178|NCT02096705|3559909|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3721179|NCT02096705|3559907|B3||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3721180|NCT02096705|3559908|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3721181|NCT02096705|3559909|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3721182|NCT02096705|3559907|B3|||Age||years|Mean|57.5|57.5|Standard Deviation|8.70|8.7|||
3721183|NCT02096705|3559908|B2|||Age||years|Mean|56.5|56.5|Standard Deviation|8.39|8.39|||
3721184|NCT02096705|3559909|B1|||Age||years|Mean|58.6|58.6|Standard Deviation|8.91|8.91|||
3721185|NCT02096705|3559907|B3||>=65 years|Age||Participants|Count of Participants|58|58.0||||||
3721186|NCT02096705|3559908|B2||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3721187|NCT02096705|3559909|B1||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
3721188|NCT02096705|3559907|B3||Between 18 and 65 years|Age||Participants|Count of Participants|214|214.0||||||
3721189|NCT02096705|3559908|B2||Between 18 and 65 years|Age||Participants|Count of Participants|117|117.0||||||
3721190|NCT02096705|3559909|B1||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
3721191|NCT02096705|3559907|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3721192|NCT02096705|3559908|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3721193|NCT02096705|3559909|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3721194|NCT02096692|3559922|B1||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3721195|NCT02096692|3559922|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3721196|NCT02096692|3559922|B1|||Age||years|Mean|60.0|60.0|Standard Deviation|12.8|12.8|||
3721197|NCT02096679|3559928|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721198|NCT02096679|3559928|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721199|NCT02096679|3559928|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3721200|NCT02096679|3559928|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3721201|NCT02096679|3559928|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721202|NCT02096679|3559928|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721203|NCT02096679|3559928|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721204|NCT02096679|3559928|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721205|NCT02096679|3559928|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3721206|NCT02096679|3559928|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721207|NCT02096679|3559928|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3721208|NCT02096679|3559928|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3721209|NCT02096679|3559928|B1|||Age||Years|Mean|42|42.0|Standard Deviation|13|13.0|||
3721210|NCT02096575|3559951|B3|United States||Region of Enrollment||participants|Number|135|135.0||||||
3721211|NCT02096575|3559952|B2|United States||Region of Enrollment||participants|Number|67|67.0||||||
3721212|NCT02096575|3559953|B1|United States||Region of Enrollment||participants|Number|68|68.0||||||
3721213|NCT02096575|3559951|B3|Unknown or Not reported||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3721214|NCT02096575|3559952|B2|Unknown or Not reported||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3721215|NCT02096575|3559953|B1|Unknown or Not reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3721216|NCT02096575|3559951|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3721217|NCT02096575|3559952|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3721218|NCT02096575|3559953|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3721219|NCT02096575|3559951|B3|Bi or Multiracial||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3721220|NCT02096575|3559952|B2|Bi or Multiracial||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3721221|NCT02096575|3559953|B1|Bi or Multiracial||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3721222|NCT02096575|3559951|B3|White||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
3721223|NCT02096575|3559952|B2|White||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
3721224|NCT02096575|3559953|B1|White||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
3721225|NCT02096575|3559951|B3|Hispanic/ Latino||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3721226|NCT02096575|3559952|B2|Hispanic/ Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3721227|NCT02096575|3559953|B1|Hispanic/ Latino||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3721228|NCT02096575|3559951|B3|Native Hawaiian/ Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3721229|NCT02096575|3559952|B2|Native Hawaiian/ Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3721230|NCT02096575|3559953|B1|Native Hawaiian/ Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3721231|NCT02096575|3559951|B3|Native American/ Alaska Native||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3721232|NCT02096575|3559952|B2|Native American/ Alaska Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3721233|NCT02096575|3559953|B1|Native American/ Alaska Native||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3721234|NCT02096575|3559951|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3721235|NCT02096575|3559952|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3721236|NCT02096575|3559953|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3721237|NCT02096575|3559951|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3721238|NCT02096575|3559952|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3721239|NCT02096575|3559953|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3721240|NCT02096575|3559951|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3721241|NCT02096575|3559952|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3721242|NCT02096575|3559953|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3721243|NCT02096575|3559951|B3||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3721244|NCT02096575|3559952|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3721245|NCT02096575|3559953|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3721246|NCT02096575|3559951|B3|||Age, Customized||years|Mean|26.38|26.38|Full Range|||18.0|48.0|
3721247|NCT02096575|3559952|B2|||Age, Customized||years|Mean|26.03|26.03|Full Range|||18.0|42.0|
3721248|NCT02096575|3559953|B1|||Age, Customized||years|Mean|26.72|26.72|Full Range|||18.0|48.0|
3721249|NCT02096458|3559969|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3721250|NCT02096458|3559969|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3721251|NCT02096458|3559969|B1|||Age||Years|Mean|56.5|56.5|Full Range|||35.0|67.0|
3721252|NCT02096263|3559973|B4|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3721253|NCT02096263|3559974|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3721254|NCT02096263|3559975|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3721255|NCT02096263|3559976|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3721256|NCT02096263|3559973|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3721257|NCT02096263|3559974|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3721258|NCT02096263|3559975|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3721259|NCT02096263|3559976|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3721260|NCT02096263|3559973|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
3721261|NCT02096263|3559974|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3721262|NCT02096263|3559975|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3721263|NCT02096263|3559976|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3721264|NCT02096263|3559973|B4|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|88|88.0||||||
3721265|NCT02096263|3559974|B3|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3721266|NCT02096263|3559975|B2|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3721267|NCT02096263|3559976|B1|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3721268|NCT02096263|3559973|B4|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3721269|NCT02096263|3559974|B3|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3721270|NCT02096263|3559975|B2|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3721271|NCT02096263|3559976|B1|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3721272|NCT02096263|3559973|B4|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3721273|NCT02096263|3559974|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3721274|NCT02096263|3559975|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3721275|NCT02096263|3559976|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3721276|NCT02096263|3559973|B4|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|361|361.0||||||
3721277|NCT02096263|3559974|B3|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|115|115.0||||||
3721278|NCT02096263|3559975|B2|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|128|128.0||||||
3721279|NCT02096263|3559976|B1|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|118|118.0||||||
3721280|NCT02096263|3559973|B4|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3721281|NCT02096263|3559974|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3721282|NCT02096263|3559975|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3721283|NCT02096263|3559976|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3721284|NCT02096263|3559973|B4|African Heritage / African American||Race/Ethnicity, Customized||Participants|Count of Participants|45|45.0||||||
3721285|NCT02096263|3559974|B3|African Heritage / African American||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3721286|NCT02096263|3559975|B2|African Heritage / African American||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3721287|NCT02096263|3559976|B1|African Heritage / African American||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3721288|NCT02096263|3559973|B4|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3721289|NCT02096263|3559974|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3721290|NCT02096263|3559975|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3721291|NCT02096263|3559976|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3721292|NCT02096263|3559973|B4||Male|Sex: Female, Male||Participants|Count of Participants|309|309.0||||||
3721293|NCT02096263|3559974|B3||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3721294|NCT02096263|3559975|B2||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3721295|NCT02096263|3559976|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3721296|NCT02096263|3559973|B4||Female|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
3721297|NCT02096263|3559974|B3||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3721298|NCT02096263|3559975|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3721299|NCT02096263|3559976|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3721300|NCT02096263|3559973|B4|||Age||Weeks|Mean|8.6|8.6|Standard Deviation|1.1|1.1|||
3721301|NCT02096263|3559974|B3|||Age||Weeks|Mean|8.6|8.6|Standard Deviation|1.1|1.1|||
3721302|NCT02096263|3559975|B2|||Age||Weeks|Mean|8.6|8.6|Standard Deviation|1.1|1.1|||
3721303|NCT02096263|3559976|B1|||Age||Weeks|Mean|8.5|8.5|Standard Deviation|1.0|1.0|||
3721304|NCT02096107|3560112|B3|||BMI||kg/m^2|Mean|28.7|28.7|Standard Deviation|4.6|4.6|||
3721305|NCT02096107|3560113|B2|||BMI||kg/m^2|Mean|28.7|28.7|Standard Deviation|4.5|4.5|||
3721306|NCT02096107|3560114|B1|||BMI||kg/m^2|Mean|28.6|28.6|Standard Deviation|4.8|4.8|||
3721307|NCT02096107|3560112|B3|||Weight||kg|Mean|86.9|86.9|Standard Deviation|16.8|16.8|||
3721308|NCT02096107|3560113|B2|||Weight||kg|Mean|84.7|84.7|Standard Deviation|16.6|16.6|||
3721309|NCT02096107|3560114|B1|||Weight||kg|Mean|89.1|89.1|Standard Deviation|17|17.0|||
3721310|NCT02096107|3560112|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721311|NCT02096107|3560113|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721312|NCT02096107|3560114|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721313|NCT02096107|3560112|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721314|NCT02096107|3560113|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721315|NCT02096107|3560114|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721316|NCT02096107|3560112|B3||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3721317|NCT02096107|3560113|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3721318|NCT02096107|3560114|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3721319|NCT02096107|3560112|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3721320|NCT02096107|3560113|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3721321|NCT02096107|3560114|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3721322|NCT02096107|3560112|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721323|NCT02096107|3560113|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721324|NCT02096107|3560114|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721325|NCT02096107|3560112|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721326|NCT02096107|3560113|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721327|NCT02096107|3560114|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721328|NCT02096107|3560112|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721329|NCT02096107|3560113|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721330|NCT02096107|3560114|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721331|NCT02096107|3560112|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3721332|NCT02096107|3560113|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3721333|NCT02096107|3560114|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3721334|NCT02096107|3560112|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3721335|NCT02096107|3560113|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3721336|NCT02096107|3560114|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3721337|NCT02096107|3560112|B3|||Age||years|Mean|51.3|51.3|Standard Deviation|12.85|12.85|||
3721338|NCT02096107|3560113|B2|||Age||years|Mean|51.6|51.6|Standard Deviation|12.1|12.1|||
3721339|NCT02096107|3560114|B1|||Age||years|Mean|51.0|51.0|Standard Deviation|13.6|13.6|||
3721340|NCT02096081|3560131|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3721341|NCT02096081|3560132|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3721342|NCT02096081|3560133|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721343|NCT02096081|3560131|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721344|NCT02096081|3560132|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721345|NCT02096081|3560133|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721346|NCT02096081|3560131|B3||White|Race (NIH/OMB)||Participants|Count of Participants|211|211.0||||||
3721347|NCT02096081|3560132|B2||White|Race (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
3721348|NCT02096081|3560133|B1||White|Race (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
3721349|NCT02096081|3560131|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3721350|NCT02096081|3560132|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3721351|NCT02096081|3560133|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3721352|NCT02096081|3560131|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721353|NCT02096081|3560132|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721354|NCT02096081|3560133|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721355|NCT02096081|3560131|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3721356|NCT02096081|3560132|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3721357|NCT02096081|3560133|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3721358|NCT02096081|3560131|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3721359|NCT02096081|3560132|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3721360|NCT02096081|3560133|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721361|NCT02096081|3560131|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721362|NCT02096081|3560132|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721363|NCT02096081|3560133|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721364|NCT02096081|3560131|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|192|192.0||||||
3721365|NCT02096081|3560132|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
3721366|NCT02096081|3560133|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3721367|NCT02096081|3560131|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3721368|NCT02096081|3560132|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3721369|NCT02096081|3560133|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3721370|NCT02096081|3560131|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3721371|NCT02096081|3560132|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3721372|NCT02096081|3560133|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3721373|NCT02096081|3560131|B3||Female|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
3721374|NCT02096081|3560132|B2||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3721375|NCT02096081|3560133|B1||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3721376|NCT02096081|3560131|B3|||Age||years|Mean|39.3|39.3|Standard Deviation|7.6|7.6|||
3721377|NCT02096081|3560132|B2|||Age||years|Mean|39.4|39.4|Standard Deviation|7.8|7.8|||
3721378|NCT02096081|3560133|B1|||Age||years|Mean|39.3|39.3|Standard Deviation|7.4|7.4|||
3721379|NCT02096042|3560166|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3721380|NCT02096042|3560166|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3721381|NCT02096042|3560166|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3721382|NCT02096042|3560166|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3721383|NCT02096042|3560166|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3721384|NCT02096042|3560166|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3721385|NCT02095951|3560175|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
3721386|NCT02095951|3560176|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3721387|NCT02095951|3560177|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3721388|NCT02095951|3560175|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3721389|NCT02095951|3560176|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3721390|NCT02095951|3560177|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3721391|NCT02095951|3560175|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3721392|NCT02095951|3560176|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3721393|NCT02095951|3560177|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3721394|NCT02095951|3560175|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3721395|NCT02095951|3560176|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3721396|NCT02095951|3560177|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3721397|NCT02095951|3560175|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3721398|NCT02095951|3560176|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3721399|NCT02095951|3560177|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3721400|NCT02095951|3560175|B3||<=18 years|Age||Participants|Count of Participants|27|27.0||||||
3721401|NCT02095951|3560176|B2||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
3721402|NCT02095951|3560177|B1||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
3721403|NCT02095873|3560196|B3|United Kingdom||Region of Enrollment||participants|Number|32|32.0||||||
3721404|NCT02095873|3560197|B2|United Kingdom||Region of Enrollment||participants|Number|17|17.0||||||
3721405|NCT02095873|3560198|B1|United Kingdom||Region of Enrollment||participants|Number|15|15.0||||||
3721406|NCT02095873|3560196|B3||Male|Gender||Participants|Count of Participants|10|10.0||||||
3721407|NCT02095873|3560197|B2||Male|Gender||Participants|Count of Participants|5|5.0||||||
3721408|NCT02095873|3560198|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
3721409|NCT02095873|3560196|B3||Female|Gender||Participants|Count of Participants|22|22.0||||||
3721410|NCT02095873|3560197|B2||Female|Gender||Participants|Count of Participants|12|12.0||||||
3721411|NCT02095873|3560198|B1||Female|Gender||Participants|Count of Participants|10|10.0||||||
3721412|NCT02095873|3560196|B3|||Age||years|Mean|45|45.0|Standard Deviation|13|13.0|||
3721413|NCT02095873|3560197|B2|||Age||years|Mean|44|44.0|Standard Deviation|13|13.0|||
3721414|NCT02095873|3560198|B1|||Age||years|Mean|45|45.0|Standard Deviation|12|12.0|||
3721415|NCT02095691|3560211|B1|Italy||Region of Enrollment||participants|Number|4|4.0||||||
3721416|NCT02095691|3560211|B1|Czech Republic||Region of Enrollment||participants|Number|9|9.0||||||
3721417|NCT02095691|3560211|B1|New Zealand||Region of Enrollment||participants|Number|6|6.0||||||
3721418|NCT02095691|3560211|B1|Not African Descent||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3721419|NCT02095691|3560211|B1|African Descent||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3721420|NCT02095691|3560211|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3721421|NCT02095691|3560211|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3721422|NCT02095691|3560211|B1|||Age||years|Mean|57.5|57.5|Standard Deviation|10.4|10.4|||
3721423|NCT02095561|3560228|B3|No||Pap test in last four years||participants|Number|4286|4286.0||||||
3721424|NCT02095561|3560229|B2|No||Pap test in last four years||participants|Number|2126|2126.0||||||
3721425|NCT02095561|3560230|B1|No||Pap test in last four years||participants|Number|2160|2160.0||||||
3721426|NCT02095561|3560228|B3|Yes||Pap test in last four years||participants|Number|1727|1727.0||||||
3721427|NCT02095561|3560229|B2|Yes||Pap test in last four years||participants|Number|838|838.0||||||
3721428|NCT02095561|3560230|B1|Yes||Pap test in last four years||participants|Number|889|889.0||||||
3721429|NCT02095561|3560228|B3|Missing cases||Health insurance||participants|Number|336|336.0||||||
3721430|NCT02095561|3560229|B2|Missing cases||Health insurance||participants|Number|168|168.0||||||
3721431|NCT02095561|3560230|B1|Missing cases||Health insurance||participants|Number|168|168.0||||||
3721432|NCT02095561|3560228|B3|private/social security||Health insurance||participants|Number|2650|2650.0||||||
3721433|NCT02095561|3560229|B2|private/social security||Health insurance||participants|Number|1241|1241.0||||||
3721434|NCT02095561|3560230|B1|private/social security||Health insurance||participants|Number|1409|1409.0||||||
3721435|NCT02095561|3560228|B3|Public system||Health insurance||participants|Number|3027|3027.0||||||
3721436|NCT02095561|3560229|B2|Public system||Health insurance||participants|Number|1555|1555.0||||||
3721437|NCT02095561|3560230|B1|Public system||Health insurance||participants|Number|1472|1472.0||||||
3721438|NCT02095561|3560228|B3|Missing cases||Education Level||participants|Number|414|414.0||||||
3721439|NCT02095561|3560229|B2|Missing cases||Education Level||participants|Number|227|227.0||||||
3721440|NCT02095561|3560230|B1|Missing cases||Education Level||participants|Number|187|187.0||||||
3721441|NCT02095561|3560228|B3|Tertiary (incomplete/complete)||Education Level||participants|Number|782|782.0||||||
3721442|NCT02095561|3560229|B2|Tertiary (incomplete/complete)||Education Level||participants|Number|381|381.0||||||
3721443|NCT02095561|3560230|B1|Tertiary (incomplete/complete)||Education Level||participants|Number|401|401.0||||||
3721444|NCT02095561|3560228|B3|Secondary complete||Education Level||participants|Number|1193|1193.0||||||
3721445|NCT02095561|3560229|B2|Secondary complete||Education Level||participants|Number|593|593.0||||||
3721446|NCT02095561|3560230|B1|Secondary complete||Education Level||participants|Number|600|600.0||||||
3721447|NCT02095561|3560228|B3|Primary (complete)/Secondary (incomplete)||Education Level||participants|Number|2664|2664.0||||||
3721448|NCT02095561|3560229|B2|Primary (complete)/Secondary (incomplete)||Education Level||participants|Number|1291|1291.0||||||
3721449|NCT02095561|3560230|B1|Primary (complete)/Secondary (incomplete)||Education Level||participants|Number|1373|1373.0||||||
3721450|NCT02095561|3560228|B3|Never went to school/Primary (incomplete)||Education Level||participants|Number|960|960.0||||||
3721451|NCT02095561|3560229|B2|Never went to school/Primary (incomplete)||Education Level||participants|Number|472|472.0||||||
3721452|NCT02095561|3560230|B1|Never went to school/Primary (incomplete)||Education Level||participants|Number|488|488.0||||||
3721453|NCT02095561|3560228|B3|Argentina||Region of Enrollment||participants|Number|6013|6013.0||||||
3721454|NCT02095561|3560229|B2|Argentina||Region of Enrollment||participants|Number|2964|2964.0||||||
3721455|NCT02095561|3560230|B1|Argentina||Region of Enrollment||participants|Number|3049|3049.0||||||
3721456|NCT02095561|3560228|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3721457|NCT02095561|3560229|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3721458|NCT02095561|3560230|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3721459|NCT02095561|3560228|B3||Female|Sex: Female, Male||Participants|Count of Participants|6013|6013.0||||||
3721460|NCT02095561|3560229|B2||Female|Sex: Female, Male||Participants|Count of Participants|2964|2964.0||||||
3721461|NCT02095561|3560230|B1||Female|Sex: Female, Male||Participants|Count of Participants|3049|3049.0||||||
3721462|NCT02095561|3560228|B3||>=65 years|Age||Participants|Count of Participants|386|386.0||||||
3721463|NCT02095561|3560229|B2||>=65 years|Age||Participants|Count of Participants|177|177.0||||||
3721464|NCT02095561|3560230|B1||>=65 years|Age||Participants|Count of Participants|209|209.0||||||
3721465|NCT02095561|3560228|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5627|5627.0||||||
3721466|NCT02095561|3560229|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2787|2787.0||||||
3721467|NCT02095561|3560230|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2840|2840.0||||||
3721468|NCT02095561|3560228|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3721469|NCT02095561|3560229|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3721470|NCT02095561|3560230|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3721471|NCT02095535|3560243|B1|Canada||Region of Enrollment||participants|Number|18|18.0||||||
3721472|NCT02095535|3560243|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3721473|NCT02095535|3560243|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3721474|NCT02095535|3560243|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3721475|NCT02095535|3560243|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3721476|NCT02095535|3560243|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3721477|NCT02095223|3560247|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3721478|NCT02095223|3560248|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3721479|NCT02095223|3560249|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3721480|NCT02095223|3560247|B3||Male|Gender||Participants|Count of Participants|1|1.0||||||
3721481|NCT02095223|3560248|B2||Male|Gender||Participants|Count of Participants|1|1.0||||||
3721482|NCT02095223|3560249|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3721483|NCT02095223|3560247|B3||Female|Gender||Participants|Count of Participants|3|3.0||||||
3721484|NCT02095223|3560248|B2||Female|Gender||Participants|Count of Participants|1|1.0||||||
3721485|NCT02095223|3560249|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
3721486|NCT02095223|3560247|B3|||Age||years|Mean|28.5|28.5|Standard Deviation|7.9|7.9|||
3721487|NCT02095223|3560248|B2|||Age||years|Mean|23.5|23.5|Standard Deviation|0.7|0.7|||
3721488|NCT02095223|3560249|B1|||Age||years|Mean|33.5|33.5|Standard Deviation|9.2|9.2|||
3721489|NCT02095197|3560258|B3|United States||Region of Enrollment||participants|Number|76|76.0||||||
3721490|NCT02095197|3560259|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
3721491|NCT02095197|3560260|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3721492|NCT02095197|3560258|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3721493|NCT02095197|3560259|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3721494|NCT02095197|3560260|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3721495|NCT02095197|3560258|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3721496|NCT02095197|3560259|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3721497|NCT02095197|3560260|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3721498|NCT02095197|3560258|B3|||Age||years|Median|49|49.0|Inter-Quartile Range|||42.0|58.0|
3721499|NCT02095197|3560259|B2|||Age||years|Median|50|50.0|Inter-Quartile Range|||45.0|60.0|
3721500|NCT02095197|3560260|B1|||Age||years|Median|47|47.0|Inter-Quartile Range|||39.0|56.0|
3721501|NCT02095197|3560258|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3721502|NCT02095197|3560259|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3721503|NCT02095197|3560260|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3721504|NCT02095197|3560258|B3||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
3721505|NCT02095197|3560259|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3721506|NCT02095197|3560260|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3721507|NCT02095197|3560258|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3721508|NCT02095197|3560259|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3721509|NCT02095197|3560260|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3721510|NCT02095158|3560273|B1||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3721511|NCT02095158|3560273|B1||Female|Sex: Female, Male||Participants|Count of Participants|335|335.0||||||
3721512|NCT02095158|3560273|B1|≥ 65 years||Age, Customized||participants|Number|70|70.0||||||
3721513|NCT02095158|3560273|B1|18 to 64 years||Age, Customized||participants|Number|370|370.0||||||
3721514|NCT02095106|3560278|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
3721515|NCT02095106|3560279|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3721516|NCT02095106|3560280|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3721517|NCT02095106|3560278|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3721518|NCT02095106|3560279|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3721519|NCT02095106|3560280|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3721520|NCT02095106|3560278|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3721521|NCT02095106|3560279|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3721522|NCT02095106|3560280|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3721523|NCT02095106|3560278|B3|||Age||years|Mean|9.4|9.4|Standard Deviation|2.17|2.17|||
3721524|NCT02095106|3560279|B2|||Age||years|Mean|10.3|10.3|Standard Deviation|1.7|1.7|||
3721525|NCT02095106|3560280|B1|||Age||years|Mean|8.6|8.6|Standard Deviation|2.3|2.3|||
3721526|NCT02095106|3560278|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3721527|NCT02095106|3560279|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3721528|NCT02095106|3560280|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3721529|NCT02095106|3560278|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3721530|NCT02095106|3560279|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3721531|NCT02095106|3560280|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3721532|NCT02095106|3560278|B3||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
3721533|NCT02095106|3560279|B2||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
3721534|NCT02095106|3560280|B1||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
3721535|NCT02094937|3560297|B1|Asian-Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|430|430.0||||||
3721536|NCT02094937|3560297|B1||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3721537|NCT02094937|3560297|B1||Female|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
3721538|NCT02094937|3560297|B1|||Age||Years|Mean|48.1|48.1|Standard Deviation|14.11|14.11|||
3721539|NCT02094898|3560330|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3721540|NCT02094898|3560330|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3721541|NCT02094898|3560330|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3721542|NCT02094898|3560330|B1|||Age||years|Mean|45.8|45.8|Standard Deviation|8|8.0|||
3721543|NCT02094885|3560375|B3|Never Smoked||Smoking Status||participants|Number|150|150.0||||||
3721544|NCT02094885|3560376|B2|Never Smoked||Smoking Status||participants|Number|79|79.0||||||
3721545|NCT02094885|3560377|B1|Never Smoked||Smoking Status||participants|Number|71|71.0||||||
3721546|NCT02094885|3560375|B3|Former Smoker||Smoking Status||participants|Number|32|32.0||||||
3721547|NCT02094885|3560376|B2|Former Smoker||Smoking Status||participants|Number|17|17.0||||||
3721548|NCT02094885|3560377|B1|Former Smoker||Smoking Status||participants|Number|15|15.0||||||
3721549|NCT02094885|3560375|B3|Current Smoker||Smoking Status||participants|Number|70|70.0||||||
3721550|NCT02094885|3560376|B2|Current Smoker||Smoking Status||participants|Number|31|31.0||||||
3721551|NCT02094885|3560377|B1|Current Smoker||Smoking Status||participants|Number|39|39.0||||||
3721552|NCT02094885|3560375|B3|||Weight||kg|Median|66.0|66.0|Full Range|||40.0|100.0|
3721553|NCT02094885|3560376|B2|||Weight||kg|Median|66.0|66.0|Full Range|||45.0|100.0|
3721554|NCT02094885|3560377|B1|||Weight||kg|Median|67.0|67.0|Full Range|||40.0|95.0|
3721555|NCT02094885|3560375|B3|||Weight||kg|Mean|66.7|66.7|Standard Deviation|11.4|11.4|||
3721556|NCT02094885|3560376|B2|||Weight||kg|Mean|66.3|66.3|Standard Deviation|11.2|11.2|||
3721557|NCT02094885|3560377|B1|||Weight||kg|Mean|67.1|67.1|Standard Deviation|11.6|11.6|||
3721558|NCT02094885|3560375|B3|||Height||cm|Median|168.0|168.0|Full Range|||145.0|190.0|
3721559|NCT02094885|3560376|B2|||Height||cm|Median|167.0|167.0|Full Range|||145.0|186.0|
3721560|NCT02094885|3560377|B1|||Height||cm|Median|168.0|168.0|Full Range|||152.0|190.0|
3721561|NCT02094885|3560375|B3|||Height||cm|Mean|166.9|166.9|Standard Deviation|7.4|7.4|||
3721562|NCT02094885|3560376|B2|||Height||cm|Mean|166.6|166.6|Standard Deviation|7.8|7.8|||
3721563|NCT02094885|3560377|B1|||Height||cm|Mean|167.2|167.2|Standard Deviation|7.0|7.0|||
3721564|NCT02094885|3560375|B3|Obese||BMI Group|"BMI Categories:~Underweight: <18.5 lb/inch^2; Normal: 18.5<=BMI<25; Overweight: 25<=BMI<30 Obese: 30<=BMI<40 Morbidly obese: BMI>=40"|participants|Number|6|6.0||||||
3721565|NCT02094885|3560376|B2|Obese||BMI Group|"BMI Categories:~Underweight: <18.5 lb/inch^2; Normal: 18.5<=BMI<25; Overweight: 25<=BMI<30 Obese: 30<=BMI<40 Morbidly obese: BMI>=40"|participants|Number|3|3.0||||||
3721566|NCT02094885|3560377|B1|Obese||BMI Group|"BMI Categories:~Underweight: <18.5 lb/inch^2; Normal: 18.5<=BMI<25; Overweight: 25<=BMI<30 Obese: 30<=BMI<40 Morbidly obese: BMI>=40"|participants|Number|3|3.0||||||
3721567|NCT02094885|3560375|B3|Overweight||BMI Group|"BMI Categories:~Underweight: <18.5 lb/inch^2; Normal: 18.5<=BMI<25; Overweight: 25<=BMI<30 Obese: 30<=BMI<40 Morbidly obese: BMI>=40"|participants|Number|80|80.0||||||
3721568|NCT02094885|3560376|B2|Overweight||BMI Group|"BMI Categories:~Underweight: <18.5 lb/inch^2; Normal: 18.5<=BMI<25; Overweight: 25<=BMI<30 Obese: 30<=BMI<40 Morbidly obese: BMI>=40"|participants|Number|39|39.0||||||
3721569|NCT02094885|3560377|B1|Overweight||BMI Group|"BMI Categories:~Underweight: <18.5 lb/inch^2; Normal: 18.5<=BMI<25; Overweight: 25<=BMI<30 Obese: 30<=BMI<40 Morbidly obese: BMI>=40"|participants|Number|41|41.0||||||
3721570|NCT02094885|3560375|B3|Normal||BMI Group|"BMI Categories:~Underweight: <18.5 lb/inch^2; Normal: 18.5<=BMI<25; Overweight: 25<=BMI<30 Obese: 30<=BMI<40 Morbidly obese: BMI>=40"|participants|Number|154|154.0||||||
3721571|NCT02094885|3560376|B2|Normal||BMI Group|"BMI Categories:~Underweight: <18.5 lb/inch^2; Normal: 18.5<=BMI<25; Overweight: 25<=BMI<30 Obese: 30<=BMI<40 Morbidly obese: BMI>=40"|participants|Number|79|79.0||||||
3721572|NCT02094885|3560377|B1|Normal||BMI Group|"BMI Categories:~Underweight: <18.5 lb/inch^2; Normal: 18.5<=BMI<25; Overweight: 25<=BMI<30 Obese: 30<=BMI<40 Morbidly obese: BMI>=40"|participants|Number|75|75.0||||||
3721573|NCT02094885|3560375|B3|Underweight||BMI Group|"BMI Categories:~Underweight: <18.5 lb/inch^2; Normal: 18.5<=BMI<25; Overweight: 25<=BMI<30 Obese: 30<=BMI<40 Morbidly obese: BMI>=40"|participants|Number|12|12.0||||||
3721574|NCT02094885|3560376|B2|Underweight||BMI Group|"BMI Categories:~Underweight: <18.5 lb/inch^2; Normal: 18.5<=BMI<25; Overweight: 25<=BMI<30 Obese: 30<=BMI<40 Morbidly obese: BMI>=40"|participants|Number|6|6.0||||||
3721575|NCT02094885|3560377|B1|Underweight||BMI Group|"BMI Categories:~Underweight: <18.5 lb/inch^2; Normal: 18.5<=BMI<25; Overweight: 25<=BMI<30 Obese: 30<=BMI<40 Morbidly obese: BMI>=40"|participants|Number|6|6.0||||||
3721576|NCT02094885|3560375|B3|||BMI||kg/m^2|Mean|23.9|23.9|Standard Deviation|3.3|3.3|||
3721577|NCT02094885|3560376|B2|||BMI||kg/m^2|Mean|23.8|23.8|Standard Deviation|3.2|3.2|||
3721578|NCT02094885|3560377|B1|||BMI||kg/m^2|Mean|23.9|23.9|Standard Deviation|3.4|3.4|||
3721579|NCT02094885|3560375|B3||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3721580|NCT02094885|3560376|B2||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3721581|NCT02094885|3560377|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3721582|NCT02094885|3560375|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3721583|NCT02094885|3560376|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3721584|NCT02094885|3560377|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3721585|NCT02094885|3560375|B3|>75||Age, Customized||Participants|Number|2|2.0||||||
3721586|NCT02094885|3560376|B2|>75||Age, Customized||Participants|Number|0|0.0||||||
3721587|NCT02094885|3560377|B1|>75||Age, Customized||Participants|Number|2|2.0||||||
3721588|NCT02094885|3560375|B3|>60,<=75 years||Age, Customized||Participants|Number|123|123.0||||||
3721589|NCT02094885|3560376|B2|>60,<=75 years||Age, Customized||Participants|Number|63|63.0||||||
3721590|NCT02094885|3560377|B1|>60,<=75 years||Age, Customized||Participants|Number|60|60.0||||||
3721591|NCT02094885|3560375|B3|<=60 years||Age, Customized||Participants|Number|127|127.0||||||
3721592|NCT02094885|3560376|B2|<=60 years||Age, Customized||Participants|Number|64|64.0||||||
3721593|NCT02094885|3560377|B1|<=60 years||Age, Customized||Participants|Number|63|63.0||||||
3721594|NCT02094885|3560375|B3|||Age||years|Mean|56.9|56.9|Standard Deviation|12.6|12.6|||
3721595|NCT02094885|3560376|B2|||Age||years|Mean|56.8|56.8|Standard Deviation|12.2|12.2|||
3721596|NCT02094885|3560377|B1|||Age||years|Mean|57.1|57.1|Standard Deviation|13.0|13.0|||
3721597|NCT02094677|3560390|B3|Canada||Region of Enrollment||participants|Number|70|70.0||||||
3721598|NCT02094677|3560391|B2|Canada||Region of Enrollment||participants|Number|30|30.0||||||
3721599|NCT02094677|3560392|B1|Canada||Region of Enrollment||participants|Number|40|40.0||||||
3721600|NCT02094677|3560390|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3721601|NCT02094677|3560391|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3721602|NCT02094677|3560392|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3721603|NCT02094677|3560390|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3721604|NCT02094677|3560391|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3721605|NCT02094677|3560392|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3721606|NCT02094677|3560390|B3|||Age||years|Mean|30.2|30.2|Standard Deviation|10.8|10.8|||
3721607|NCT02094677|3560391|B2|||Age||years|Mean|33.1|33.1|Standard Deviation|12.4|12.4|||
3721608|NCT02094677|3560392|B1|||Age||years|Mean|28|28.0|Standard Deviation|9|9.0|||
3721609|NCT02094664|3560455|B3|||Systemic steroids in emergency department||Participants|Count of Participants|11|11.0||||||
3721610|NCT02094664|3560456|B2|||Systemic steroids in emergency department||Participants|Count of Participants|6|6.0||||||
3721611|NCT02094664|3560457|B1|||Systemic steroids in emergency department||Participants|Count of Participants|5|5.0||||||
3721612|NCT02094664|3560455|B3|||Inhaled albuterol in emergency department||Participants|Count of Participants|19|19.0||||||
3721613|NCT02094664|3560456|B2|||Inhaled albuterol in emergency department||Participants|Count of Participants|9|9.0||||||
3721614|NCT02094664|3560457|B1|||Inhaled albuterol in emergency department||Participants|Count of Participants|10|10.0||||||
3721615|NCT02094664|3560455|B3|||Smoke exposure at home||Participants|Count of Participants|9|9.0||||||
3721616|NCT02094664|3560456|B2|||Smoke exposure at home||Participants|Count of Participants|3|3.0||||||
3721617|NCT02094664|3560457|B1|||Smoke exposure at home||Participants|Count of Participants|6|6.0||||||
3721618|NCT02094664|3560455|B3|||Family history of asthma||Participants|Count of Participants|14|14.0||||||
3721619|NCT02094664|3560456|B2|||Family history of asthma||Participants|Count of Participants|8|8.0||||||
3721620|NCT02094664|3560457|B1|||Family history of asthma||Participants|Count of Participants|6|6.0||||||
3721621|NCT02094664|3560455|B3|||Respiratory Syncytial Virus (RSV) positive||Participants|Count of Participants|24|24.0||||||
3721622|NCT02094664|3560456|B2|||Respiratory Syncytial Virus (RSV) positive||Participants|Count of Participants|13|13.0||||||
3721623|NCT02094664|3560457|B1|||Respiratory Syncytial Virus (RSV) positive||Participants|Count of Participants|11|11.0||||||
3721624|NCT02094664|3560455|B3|||Mean sick days||days|Mean|4.41|4.41|Standard Deviation|1.39|1.39|||
3721625|NCT02094664|3560456|B2|||Mean sick days||days|Mean|4.25|4.25|Standard Deviation|1.43|1.43|||
3721626|NCT02094664|3560457|B1|||Mean sick days||days|Mean|4.56|4.56|Standard Deviation|1.36|1.36|||
3721627|NCT02094664|3560455|B3|||Mean RR||bpm|Mean|46.8|46.8|Standard Deviation|11.9|11.9|||
3721628|NCT02094664|3560456|B2|||Mean RR||bpm|Mean|48.19|48.19|Standard Deviation|11.3|11.3|||
3721629|NCT02094664|3560457|B1|||Mean RR||bpm|Mean|45.44|45.44|Standard Deviation|12.74|12.74|||
3721630|NCT02094664|3560455|B3|||Mean RDAI|Respiratory Distress Assessment Instrument (RDAI) is a validated clinical assessment scale used to evaluate severity of respiratory illness in children with bronchiolitis. It is based on 2 variables, wheezing and retractions. Points are applied to each variable to give a score ranging from 0 to 17. Higher total score means subject is clinically more severe.|units on a scale|Mean|4.90|4.9|Standard Deviation|3.16|3.16|||
3721631|NCT02094664|3560456|B2|||Mean RDAI|Respiratory Distress Assessment Instrument (RDAI) is a validated clinical assessment scale used to evaluate severity of respiratory illness in children with bronchiolitis. It is based on 2 variables, wheezing and retractions. Points are applied to each variable to give a score ranging from 0 to 17. Higher total score means subject is clinically more severe.|units on a scale|Mean|4.44|4.44|Standard Deviation|2.61|2.61|||
3721632|NCT02094664|3560457|B1|||Mean RDAI|Respiratory Distress Assessment Instrument (RDAI) is a validated clinical assessment scale used to evaluate severity of respiratory illness in children with bronchiolitis. It is based on 2 variables, wheezing and retractions. Points are applied to each variable to give a score ranging from 0 to 17. Higher total score means subject is clinically more severe.|units on a scale|Mean|5.38|5.38|Standard Deviation|3.65|3.65|||
3721633|NCT02094664|3560455|B3|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3721634|NCT02094664|3560456|B2|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3721635|NCT02094664|3560457|B1|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3721636|NCT02094664|3560455|B3|Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3721637|NCT02094664|3560456|B2|Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3721638|NCT02094664|3560457|B1|Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3721639|NCT02094664|3560455|B3|Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3721640|NCT02094664|3560456|B2|Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3721641|NCT02094664|3560457|B1|Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3721642|NCT02094664|3560455|B3|Ethnicity|Black|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3721643|NCT02094664|3560456|B2|Ethnicity|Black|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3721644|NCT02094664|3560457|B1|Ethnicity|Black|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3721645|NCT02094664|3560455|B3|Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3721646|NCT02094664|3560456|B2|Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3721647|NCT02094664|3560457|B1|Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3721648|NCT02094664|3560455|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3721649|NCT02094664|3560456|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3721650|NCT02094664|3560457|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3721651|NCT02094664|3560455|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3721652|NCT02094664|3560456|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3721653|NCT02094664|3560457|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3721654|NCT02094664|3560455|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3721655|NCT02094664|3560456|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3721656|NCT02094664|3560457|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3721657|NCT02094664|3560455|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3721658|NCT02094664|3560456|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3721659|NCT02094664|3560457|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3721660|NCT02094664|3560455|B3||<=18 years|Age||Participants|Count of Participants|32|32.0||||||
3721661|NCT02094664|3560456|B2||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
3721662|NCT02094664|3560457|B1||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
3721663|NCT02094612|3560470|B3|United States||Region of Enrollment||Participants|Count of Participants|207|207.0||||||
3721664|NCT02094612|3560471|B2|United States||Region of Enrollment||Participants|Count of Participants|95|95.0||||||
3721665|NCT02094612|3560472|B1|United States||Region of Enrollment||Participants|Count of Participants|112|112.0||||||
3721666|NCT02094612|3560470|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3721667|NCT02094612|3560470|B3||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3721668|NCT02094612|3560471|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3721669|NCT02094612|3560472|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3721670|NCT02094612|3560470|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3721671|NCT02094612|3560471|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3721672|NCT02094612|3560472|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3721673|NCT02094612|3560470|B3|||Age||years|Mean|8.5|8.5|Standard Deviation|1.9|1.9|||
3721674|NCT02094612|3560471|B2|||Age||years|Mean|8.5|8.5|Standard Deviation|1.9|1.9|||
3721675|NCT02094612|3560472|B1|||Age||years|Mean|8.5|8.5|Standard Deviation|1.9|1.9|||
3721676|NCT02094612|3560470|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3721677|NCT02094612|3560471|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3721678|NCT02094612|3560472|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3721679|NCT02094612|3560470|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3721680|NCT02094612|3560471|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3721681|NCT02094612|3560472|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3721682|NCT02094612|3560470|B3||<=18 years|Age||Participants|Count of Participants|207|207.0||||||
3721683|NCT02094612|3560471|B2||<=18 years|Age||Participants|Count of Participants|95|95.0||||||
3721684|NCT02094612|3560472|B1||<=18 years|Age||Participants|Count of Participants|112|112.0||||||
3721685|NCT02094573|3560491|B3|Korea, Republic Of||Region of Enrollment||participants|Number|46|46.0||||||
3721686|NCT02094573|3560492|B2|Korea, Republic Of||Region of Enrollment||participants|Number|20|20.0||||||
3721687|NCT02094573|3560493|B1|Korea, Republic Of||Region of Enrollment||participants|Number|26|26.0||||||
3721688|NCT02094573|3560491|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
3721689|NCT02094573|3560492|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3721690|NCT02094573|3560493|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3721691|NCT02094573|3560491|B3|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3721692|NCT02094573|3560492|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3721693|NCT02094573|3560493|B1|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
3721694|NCT02094573|3560491|B3|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
3721695|NCT02094573|3560492|B2|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
3721696|NCT02094573|3560493|B1|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
3721697|NCT02094573|3560491|B3|Sweden||Region of Enrollment||participants|Number|4|4.0||||||
3721698|NCT02094573|3560492|B2|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
3721699|NCT02094573|3560493|B1|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
3721700|NCT02094573|3560491|B3|Spain||Region of Enrollment||participants|Number|12|12.0||||||
3721701|NCT02094573|3560492|B2|Spain||Region of Enrollment||participants|Number|7|7.0||||||
3721702|NCT02094573|3560493|B1|Spain||Region of Enrollment||participants|Number|5|5.0||||||
3721703|NCT02094573|3560491|B3|Singapore||Region of Enrollment||participants|Number|7|7.0||||||
3721704|NCT02094573|3560492|B2|Singapore||Region of Enrollment||participants|Number|3|3.0||||||
3721705|NCT02094573|3560493|B1|Singapore||Region of Enrollment||participants|Number|4|4.0||||||
3721706|NCT02094573|3560491|B3|Norway||Region of Enrollment||participants|Number|2|2.0||||||
3721707|NCT02094573|3560492|B2|Norway||Region of Enrollment||participants|Number|1|1.0||||||
3721708|NCT02094573|3560493|B1|Norway||Region of Enrollment||participants|Number|1|1.0||||||
3721709|NCT02094573|3560491|B3|Netherlands||Region of Enrollment||participants|Number|12|12.0||||||
3721710|NCT02094573|3560492|B2|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
3721711|NCT02094573|3560493|B1|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
3721712|NCT02094573|3560491|B3|Italy||Region of Enrollment||participants|Number|29|29.0||||||
3721713|NCT02094573|3560492|B2|Italy||Region of Enrollment||participants|Number|14|14.0||||||
3721714|NCT02094573|3560493|B1|Italy||Region of Enrollment||participants|Number|15|15.0||||||
3721715|NCT02094573|3560491|B3|Hong Kong||Region of Enrollment||participants|Number|6|6.0||||||
3721716|NCT02094573|3560492|B2|Hong Kong||Region of Enrollment||participants|Number|0|0.0||||||
3721717|NCT02094573|3560493|B1|Hong Kong||Region of Enrollment||participants|Number|6|6.0||||||
3721718|NCT02094573|3560491|B3|Germany||Region of Enrollment||participants|Number|14|14.0||||||
3721719|NCT02094573|3560492|B2|Germany||Region of Enrollment||participants|Number|7|7.0||||||
3721720|NCT02094573|3560493|B1|Germany||Region of Enrollment||participants|Number|7|7.0||||||
3721721|NCT02094573|3560491|B3|France||Region of Enrollment||participants|Number|6|6.0||||||
3721722|NCT02094573|3560492|B2|France||Region of Enrollment||participants|Number|2|2.0||||||
3721723|NCT02094573|3560493|B1|France||Region of Enrollment||participants|Number|4|4.0||||||
3721724|NCT02094573|3560491|B3|Denmark||Region of Enrollment||participants|Number|8|8.0||||||
3721725|NCT02094573|3560492|B2|Denmark||Region of Enrollment||participants|Number|6|6.0||||||
3721726|NCT02094573|3560493|B1|Denmark||Region of Enrollment||participants|Number|2|2.0||||||
3721727|NCT02094573|3560491|B3|Canada||Region of Enrollment||participants|Number|3|3.0||||||
3721728|NCT02094573|3560492|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3721729|NCT02094573|3560493|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
3721730|NCT02094573|3560491|B3|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
3721731|NCT02094573|3560492|B2|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
3721732|NCT02094573|3560493|B1|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
3721733|NCT02094573|3560491|B3|Austria||Region of Enrollment||participants|Number|9|9.0||||||
3721734|NCT02094573|3560492|B2|Austria||Region of Enrollment||participants|Number|6|6.0||||||
3721735|NCT02094573|3560493|B1|Austria||Region of Enrollment||participants|Number|3|3.0||||||
3721736|NCT02094573|3560491|B3|Australia||Region of Enrollment||participants|Number|9|9.0||||||
3721737|NCT02094573|3560492|B2|Australia||Region of Enrollment||participants|Number|6|6.0||||||
3721738|NCT02094573|3560493|B1|Australia||Region of Enrollment||participants|Number|3|3.0||||||
3721739|NCT02094573|3560491|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|209|209.0||||||
3721740|NCT02094573|3560492|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|102|102.0||||||
3721741|NCT02094573|3560493|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|107|107.0||||||
3721742|NCT02094573|3560491|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3721743|NCT02094573|3560492|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3721744|NCT02094573|3560493|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3721745|NCT02094573|3560491|B3|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3721746|NCT02094573|3560492|B2|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3721747|NCT02094573|3560493|B1|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3721748|NCT02094573|3560491|B3|Asian||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
3721749|NCT02094573|3560492|B2|Asian||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3721750|NCT02094573|3560493|B1|Asian||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
3721751|NCT02094573|3560491|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3721752|NCT02094573|3560492|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3721753|NCT02094573|3560493|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3721754|NCT02094573|3560491|B3|White||Race/Ethnicity, Customized||participants|Number|148|148.0||||||
3721755|NCT02094573|3560492|B2|White||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
3721756|NCT02094573|3560493|B1|White||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
3721757|NCT02094573|3560491|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3721758|NCT02094573|3560492|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3721759|NCT02094573|3560493|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3721760|NCT02094573|3560491|B3||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3721761|NCT02094573|3560492|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3721762|NCT02094573|3560493|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3721763|NCT02094573|3560491|B3|≥75 years||Age, Customized||participants|Number|9|9.0||||||
3721764|NCT02094573|3560492|B2|≥75 years||Age, Customized||participants|Number|7|7.0||||||
3721765|NCT02094573|3560493|B1|≥75 years||Age, Customized||participants|Number|2|2.0||||||
3721766|NCT02094573|3560491|B3|65-74 years||Age, Customized||participants|Number|43|43.0||||||
3721767|NCT02094573|3560492|B2|65-74 years||Age, Customized||participants|Number|23|23.0||||||
3721768|NCT02094573|3560493|B1|65-74 years||Age, Customized||participants|Number|20|20.0||||||
3721769|NCT02094573|3560491|B3|50-64 years||Age, Customized||participants|Number|87|87.0||||||
3721770|NCT02094573|3560492|B2|50-64 years||Age, Customized||participants|Number|47|47.0||||||
3721771|NCT02094573|3560493|B1|50-64 years||Age, Customized||participants|Number|40|40.0||||||
3721772|NCT02094573|3560491|B3|18-49 years||Age, Customized||participants|Number|83|83.0||||||
3721773|NCT02094573|3560492|B2|18-49 years||Age, Customized||participants|Number|33|33.0||||||
3721774|NCT02094573|3560493|B1|18-49 years||Age, Customized||participants|Number|50|50.0||||||
3721775|NCT02094573|3560491|B3|||Age||years|Mean|53.4|53.4|Standard Deviation|13.11|13.11|||
3721776|NCT02094573|3560492|B2|||Age||years|Mean|55.5|55.5|Standard Deviation|12.96|12.96|||
3721777|NCT02094573|3560493|B1|||Age||years|Mean|51.5|51.5|Standard Deviation|13.01|13.01|||
3721778|NCT02094534|3560526|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
3721779|NCT02094534|3560527|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3721780|NCT02094534|3560528|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3721781|NCT02094534|3560526|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3721782|NCT02094534|3560527|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3721783|NCT02094534|3560528|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3721784|NCT02094534|3560526|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3721785|NCT02094534|3560527|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3721786|NCT02094534|3560528|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3721787|NCT02094534|3560526|B3|||Age||years|Mean|38.255|38.255|Standard Deviation|15.343|15.343|||
3721788|NCT02094534|3560527|B2|||Age||years|Mean|37.61|37.61|Standard Deviation|9.642|9.642|||
3721789|NCT02094534|3560528|B1|||Age||years|Mean|38.90|38.9|Standard Deviation|11.936|11.936|||
3721790|NCT02094534|3560526|B3||>=65 years|Age|3 Day Placebo Run-in Period|Participants|Count of Participants|0|0.0||||||
3721791|NCT02094534|3560527|B2||>=65 years|Age|3 Day Placebo Run-in Period|Participants|Count of Participants|0|0.0||||||
3721792|NCT02094534|3560528|B1||>=65 years|Age|3 Day Placebo Run-in Period|Participants|Count of Participants|0|0.0||||||
3721793|NCT02094534|3560526|B3||Between 18 and 65 years|Age|3 Day Placebo Run-in Period|Participants|Count of Participants|25|25.0||||||
3721794|NCT02094534|3560527|B2||Between 18 and 65 years|Age|3 Day Placebo Run-in Period|Participants|Count of Participants|10|10.0||||||
3721795|NCT02094534|3560528|B1||Between 18 and 65 years|Age|3 Day Placebo Run-in Period|Participants|Count of Participants|15|15.0||||||
3721796|NCT02094534|3560526|B3||<=18 years|Age|3 Day Placebo Run-in Period|Participants|Count of Participants|0|0.0||||||
3721797|NCT02094534|3560527|B2||<=18 years|Age|3 Day Placebo Run-in Period|Participants|Count of Participants|0|0.0||||||
3721798|NCT02094534|3560528|B1||<=18 years|Age|3 Day Placebo Run-in Period|Participants|Count of Participants|0|0.0||||||
3721799|NCT02094443|3560537|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3721800|NCT02094443|3560538|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3721801|NCT02094443|3560539|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3721802|NCT02094443|3560537|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3721803|NCT02094443|3560538|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3721804|NCT02094443|3560539|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3721805|NCT02094443|3560537|B3|||Age||years|Mean|53.9|53.9|Standard Deviation|7.88|7.88|||
3721806|NCT02094443|3560538|B2|||Age||years|Mean|54.5|54.5|Standard Deviation|7.62|7.62|||
3721807|NCT02094443|3560539|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|8.25|8.25|||
3721808|NCT02094352|3560558|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3721809|NCT02094352|3560559|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3721810|NCT02094352|3560560|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3721811|NCT02094352|3560558|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3721812|NCT02094352|3560559|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3721813|NCT02094352|3560560|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3721814|NCT02094352|3560558|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3721815|NCT02094352|3560559|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3721816|NCT02094352|3560560|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3721817|NCT02094352|3560558|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3721818|NCT02094352|3560559|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3721819|NCT02094352|3560560|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3721820|NCT02094352|3560558|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3721821|NCT02094352|3560559|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3721822|NCT02094352|3560560|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3721823|NCT02094326|3560567|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3721824|NCT02094326|3560567|B1||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
3721825|NCT02094326|3560567|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|14|14.0|||
3721826|NCT02094300|3560576|B1||Male|Gender||Participants|Count of Participants|19|19.0||||||
3721827|NCT02094300|3560576|B1||Female|Gender||Participants|Count of Participants|7|7.0||||||
3721828|NCT02094300|3560576|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|15|15.0|||
3721829|NCT02094261|3560580|B1|White||Race/Ethnicity, Customized||Participants|Number|72|72.0||||||
3721830|NCT02094261|3560580|B1|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3721831|NCT02094261|3560580|B1|Native Hawaiian Or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3721832|NCT02094261|3560580|B1|Black Or African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3721833|NCT02094261|3560580|B1|Asian||Race/Ethnicity, Customized||Participants|Number|132|132.0||||||
3721834|NCT02094261|3560580|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3721835|NCT02094261|3560580|B1||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3721836|NCT02094261|3560580|B1|>=75 Years||Age, Customized||Participants|Number|33|33.0||||||
3721837|NCT02094261|3560580|B1|>=65-<75 Years||Age, Customized||Participants|Number|69|69.0||||||
3721838|NCT02094261|3560580|B1|>=50-<65 Years||Age, Customized||Participants|Number|88|88.0||||||
3721839|NCT02094261|3560580|B1|<50 Years||Age, Customized||Participants|Number|20|20.0||||||
3721840|NCT02094261|3560580|B1|||Age||Years|Mean|62.9|62.9|Standard Deviation|10.91|10.91|35.0|88.0|
3721841|NCT02093962|3560587|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3721842|NCT02093962|3560588|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3721843|NCT02093962|3560589|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721844|NCT02093962|3560587|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721845|NCT02093962|3560588|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721846|NCT02093962|3560589|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721847|NCT02093962|3560587|B3||White|Race (NIH/OMB)||Participants|Count of Participants|256|256.0||||||
3721848|NCT02093962|3560588|B2||White|Race (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
3721849|NCT02093962|3560589|B1||White|Race (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
3721850|NCT02093962|3560587|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3721851|NCT02093962|3560588|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3721852|NCT02093962|3560589|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3721853|NCT02093962|3560587|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3721854|NCT02093962|3560588|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3721855|NCT02093962|3560589|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3721856|NCT02093962|3560587|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721857|NCT02093962|3560588|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721858|NCT02093962|3560589|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721859|NCT02093962|3560587|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721860|NCT02093962|3560588|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721861|NCT02093962|3560589|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3721862|NCT02093962|3560587|B3||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3721863|NCT02093962|3560588|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3721864|NCT02093962|3560589|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3721865|NCT02093962|3560587|B3||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3721866|NCT02093962|3560588|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3721867|NCT02093962|3560589|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3721868|NCT02093962|3560587|B3||>=65 years|Age||Participants|Count of Participants|99|99.0||||||
3721869|NCT02093962|3560588|B2||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
3721870|NCT02093962|3560589|B1||>=65 years|Age||Participants|Count of Participants|53|53.0||||||
3721871|NCT02093962|3560587|B3||Between 18 and 65 years|Age||Participants|Count of Participants|166|166.0||||||
3721872|NCT02093962|3560588|B2||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
3721873|NCT02093962|3560589|B1||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
3721874|NCT02093962|3560587|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3721875|NCT02093962|3560588|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3721876|NCT02093962|3560589|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3721877|NCT02093949|3560596|B3|||Diabetes||participants|Number|18|18.0||||||
3721878|NCT02093949|3560597|B2|||Diabetes||participants|Number|5|5.0||||||
3721879|NCT02093949|3560598|B1|||Diabetes||participants|Number|13|13.0||||||
3721880|NCT02093949|3560596|B3|||Hypertension||participants|Number|68|68.0||||||
3721881|NCT02093949|3560597|B2|||Hypertension||participants|Number|20|20.0||||||
3721882|NCT02093949|3560598|B1|||Hypertension||participants|Number|48|48.0||||||
3721883|NCT02093949|3560596|B3|||Structural heart disease||participants|Number|52|52.0||||||
3721884|NCT02093949|3560597|B2|||Structural heart disease||participants|Number|14|14.0||||||
3721885|NCT02093949|3560598|B1|||Structural heart disease||participants|Number|38|38.0||||||
3721886|NCT02093949|3560596|B3|||Nonparoxysmal AF||participants|Number|119|119.0||||||
3721887|NCT02093949|3560597|B2|||Nonparoxysmal AF||participants|Number|38|38.0||||||
3721888|NCT02093949|3560598|B1|||Nonparoxysmal AF||participants|Number|81|81.0||||||
3721889|NCT02093949|3560596|B3|||Paroxysmal AF||participants|Number|33|33.0||||||
3721890|NCT02093949|3560597|B2|||Paroxysmal AF||participants|Number|9|9.0||||||
3721891|NCT02093949|3560598|B1|||Paroxysmal AF||participants|Number|24|24.0||||||
3721892|NCT02093949|3560596|B3||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3721893|NCT02093949|3560597|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3721894|NCT02093949|3560598|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3721895|NCT02093949|3560596|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3721896|NCT02093949|3560597|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3721897|NCT02093949|3560598|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3721898|NCT02093949|3560596|B3|||Age||year|Mean|61|61.0|Standard Deviation|13|13.0|||
3721899|NCT02093949|3560597|B2|||Age||year|Mean|58|58.0|Standard Deviation|11|11.0|||
3721900|NCT02093949|3560598|B1|||Age||year|Mean|63|63.0|Standard Deviation|11|11.0|||
3721901|NCT02093923|3560617|B6||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3721902|NCT02093923|3560618|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3721903|NCT02093923|3560619|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3721904|NCT02093923|3560620|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3721905|NCT02093923|3560621|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3721906|NCT02093923|3560622|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3721907|NCT02093923|3560617|B6||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3721908|NCT02093923|3560618|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3721909|NCT02093923|3560619|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3721910|NCT02093923|3560620|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3721911|NCT02093923|3560621|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3721912|NCT02093923|3560622|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3721913|NCT02093923|3560617|B6|>65 years||Age, Customized||participants|Number|2|2.0||||||
3721914|NCT02093923|3560618|B5|>65 years||Age, Customized||participants|Number|1|1.0||||||
3721915|NCT02093923|3560619|B4|>65 years||Age, Customized||participants|Number|1|1.0||||||
3721916|NCT02093923|3560620|B3|>65 years||Age, Customized||participants|Number|0|0.0||||||
3721917|NCT02093923|3560621|B2|>65 years||Age, Customized||participants|Number|0|0.0||||||
3721918|NCT02093923|3560622|B1|>65 years||Age, Customized||participants|Number|0|0.0||||||
3721919|NCT02093923|3560617|B6|Between 18 and 65 years||Age, Customized||participants|Number|35|35.0||||||
3721920|NCT02093923|3560618|B5|Between 18 and 65 years||Age, Customized||participants|Number|12|12.0||||||
3721921|NCT02093923|3560619|B4|Between 18 and 65 years||Age, Customized||participants|Number|10|10.0||||||
3721922|NCT02093923|3560620|B3|Between 18 and 65 years||Age, Customized||participants|Number|5|5.0||||||
3721923|NCT02093923|3560621|B2|Between 18 and 65 years||Age, Customized||participants|Number|4|4.0||||||
3721924|NCT02093923|3560622|B1|Between 18 and 65 years||Age, Customized||participants|Number|4|4.0||||||
3721925|NCT02093923|3560617|B6|<18 years||Age, Customized||participants|Number|0|0.0||||||
3721926|NCT02093923|3560618|B5|<18 years||Age, Customized||participants|Number|0|0.0||||||
3721927|NCT02093923|3560619|B4|<18 years||Age, Customized||participants|Number|0|0.0||||||
3721928|NCT02093923|3560620|B3|<18 years||Age, Customized||participants|Number|0|0.0||||||
3721929|NCT02093923|3560621|B2|<18 years||Age, Customized||participants|Number|0|0.0||||||
3721930|NCT02093923|3560622|B1|<18 years||Age, Customized||participants|Number|0|0.0||||||
3721931|NCT02093897|3560681|B1|On-Demand||Treatment modality of FVIII therapy before enrollment|Treatment modality of FVIII therapy within the 12 months before enrollment, ie, routine prophylaxis or on-demand treatment. If a subject used both modalities, only the most recent one was counted.|participants|Number|24|24.0||||||
3721932|NCT02093897|3560681|B1|Prophylaxis||Treatment modality of FVIII therapy before enrollment|Treatment modality of FVIII therapy within the 12 months before enrollment, ie, routine prophylaxis or on-demand treatment. If a subject used both modalities, only the most recent one was counted.|participants|Number|60|60.0||||||
3721933|NCT02093897|3560681|B1|Unknown||Type of FVIII product used before enrollment|Type of FVIII product used by the subjects within the 12 months before enrollment into the study. This could have been a plasma FVIII product or a recombinant FVIII product.|participants|Number|2|2.0||||||
3721934|NCT02093897|3560681|B1|Recombinant Product||Type of FVIII product used before enrollment|Type of FVIII product used by the subjects within the 12 months before enrollment into the study. This could have been a plasma FVIII product or a recombinant FVIII product.|participants|Number|49|49.0||||||
3721935|NCT02093897|3560681|B1|Plasma product||Type of FVIII product used before enrollment|Type of FVIII product used by the subjects within the 12 months before enrollment into the study. This could have been a plasma FVIII product or a recombinant FVIII product.|participants|Number|33|33.0||||||
3721936|NCT02093897|3560681|B1||Male|Gender||Participants|Count of Participants|84|84.0||||||
3721937|NCT02093897|3560681|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3721938|NCT02093897|3560681|B1|||Age||years|Mean|6.6|6.6|Standard Deviation|3.11|3.11|||
3721939|NCT02093897|3560681|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3721940|NCT02093897|3560681|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3721941|NCT02093897|3560681|B1||<=18 years|Age||Participants|Count of Participants|84|84.0||||||
3721942|NCT02093819|3560701|B9||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3721943|NCT02093819|3560702|B8||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3721944|NCT02093819|3560703|B7||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3721945|NCT02093819|3560704|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3721946|NCT02093819|3560705|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3721947|NCT02093819|3560706|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3721948|NCT02093819|3560707|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3721949|NCT02093819|3560708|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3721950|NCT02093819|3560709|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3721951|NCT02093819|3560701|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3721952|NCT02093819|3560702|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3721953|NCT02093819|3560703|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3721954|NCT02093819|3560704|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3721955|NCT02093819|3560705|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3721956|NCT02093819|3560706|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3721957|NCT02093819|3560707|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3721958|NCT02093819|3560708|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3721959|NCT02093819|3560709|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3721960|NCT02093819|3560701|B9|||Age||years|Mean|34.5|34.5|Standard Deviation|9.1|9.1|||
3721961|NCT02093819|3560702|B8|||Age||years|Mean|35.3|35.3|Standard Deviation|10.9|10.9|||
3721962|NCT02093819|3560703|B7|||Age||years|Mean|34.0|34.0|Standard Deviation|9.5|9.5|||
3721963|NCT02093819|3560704|B6|||Age||years|Mean|31.2|31.2|Standard Deviation|12.7|12.7|||
3721964|NCT02093819|3560705|B5|||Age||years|Mean|31.0|31.0|Standard Deviation|4.6|4.6|||
3721965|NCT02093819|3560706|B4|||Age||years|Mean|34.2|34.2|Standard Deviation|10.0|10.0|||
3721966|NCT02093819|3560707|B3|||Age||years|Mean|38.9|38.9|Standard Deviation|8.7|8.7|||
3721967|NCT02093819|3560708|B2|||Age||years|Mean|35.7|35.7|Standard Deviation|7.9|7.9|||
3721968|NCT02093819|3560709|B1|||Age||years|Mean|33.6|33.6|Standard Deviation|9.2|9.2|||
3721969|NCT02093702|3560750|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3721970|NCT02093702|3560751|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3721971|NCT02093702|3560752|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3721972|NCT02093702|3560750|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3721973|NCT02093702|3560751|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3721974|NCT02093702|3560752|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3721975|NCT02093702|3560750|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3721976|NCT02093702|3560751|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3721977|NCT02093702|3560752|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3721978|NCT02093702|3560750|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3721979|NCT02093702|3560751|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3721980|NCT02093702|3560752|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3721981|NCT02093702|3560750|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3721982|NCT02093702|3560751|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3721983|NCT02093702|3560752|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3721984|NCT02093689|3560781|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3721985|NCT02093689|3560782|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3721986|NCT02093689|3560783|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3721987|NCT02093689|3560784|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3721988|NCT02093689|3560781|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3721989|NCT02093689|3560782|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3721990|NCT02093689|3560783|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3721991|NCT02093689|3560784|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3721992|NCT02093689|3560781|B4||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3721993|NCT02093689|3560784|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3721994|NCT02093689|3560781|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3721995|NCT02093689|3560784|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3721996|NCT02093689|3560781|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3721997|NCT02093689|3560784|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3721998|NCT02093520|3560792|B3|Physical Function||ZCQ|"The Zurich Claudication Questionnaire (ZCQ) is a disease-specific self-report outcome. The ZCQ quantifies severity of symptoms, physical function characteristics, and patient's satisfaction after treatment. The scale relates to symptoms over the past month.~ZCQ consists of three subscales:~Symptom severity scale (questions I-VII) Possible range of the score is 1 to 5.~Physical function scale (questions VIII-XII): Possible range of scores is 1 to 4.~Patient's satisfaction with treatment scale (questions XIII-XVIII): the range of the scale is 1 to 4."|units on a scale|Mean|2.8|2.8|Standard Deviation|0.5|0.5|||
3721999|NCT02093520|3560793|B2|Physical Function||ZCQ|"The Zurich Claudication Questionnaire (ZCQ) is a disease-specific self-report outcome. The ZCQ quantifies severity of symptoms, physical function characteristics, and patient's satisfaction after treatment. The scale relates to symptoms over the past month.~ZCQ consists of three subscales:~Symptom severity scale (questions I-VII) Possible range of the score is 1 to 5.~Physical function scale (questions VIII-XII): Possible range of scores is 1 to 4.~Patient's satisfaction with treatment scale (questions XIII-XVIII): the range of the scale is 1 to 4."|units on a scale|Mean|2.8|2.8|Standard Deviation|0.4|0.4|||
3722000|NCT02093520|3560794|B1|Physical Function||ZCQ|"The Zurich Claudication Questionnaire (ZCQ) is a disease-specific self-report outcome. The ZCQ quantifies severity of symptoms, physical function characteristics, and patient's satisfaction after treatment. The scale relates to symptoms over the past month.~ZCQ consists of three subscales:~Symptom severity scale (questions I-VII) Possible range of the score is 1 to 5.~Physical function scale (questions VIII-XII): Possible range of scores is 1 to 4.~Patient's satisfaction with treatment scale (questions XIII-XVIII): the range of the scale is 1 to 4."|units on a scale|Mean|2.9|2.9|Standard Deviation|0.5|0.5|||
3722001|NCT02093520|3560792|B3|Symptom Severity||ZCQ|"The Zurich Claudication Questionnaire (ZCQ) is a disease-specific self-report outcome. The ZCQ quantifies severity of symptoms, physical function characteristics, and patient's satisfaction after treatment. The scale relates to symptoms over the past month.~ZCQ consists of three subscales:~Symptom severity scale (questions I-VII) Possible range of the score is 1 to 5.~Physical function scale (questions VIII-XII): Possible range of scores is 1 to 4.~Patient's satisfaction with treatment scale (questions XIII-XVIII): the range of the scale is 1 to 4."|units on a scale|Mean|3.5|3.5|Standard Deviation|0.6|0.6|||
3722002|NCT02093520|3560793|B2|Symptom Severity||ZCQ|"The Zurich Claudication Questionnaire (ZCQ) is a disease-specific self-report outcome. The ZCQ quantifies severity of symptoms, physical function characteristics, and patient's satisfaction after treatment. The scale relates to symptoms over the past month.~ZCQ consists of three subscales:~Symptom severity scale (questions I-VII) Possible range of the score is 1 to 5.~Physical function scale (questions VIII-XII): Possible range of scores is 1 to 4.~Patient's satisfaction with treatment scale (questions XIII-XVIII): the range of the scale is 1 to 4."|units on a scale|Mean|3.5|3.5|Standard Deviation|0.6|0.6|||
3722003|NCT02093520|3560794|B1|Symptom Severity||ZCQ|"The Zurich Claudication Questionnaire (ZCQ) is a disease-specific self-report outcome. The ZCQ quantifies severity of symptoms, physical function characteristics, and patient's satisfaction after treatment. The scale relates to symptoms over the past month.~ZCQ consists of three subscales:~Symptom severity scale (questions I-VII) Possible range of the score is 1 to 5.~Physical function scale (questions VIII-XII): Possible range of scores is 1 to 4.~Patient's satisfaction with treatment scale (questions XIII-XVIII): the range of the scale is 1 to 4."|units on a scale|Mean|3.5|3.5|Standard Deviation|0.5|0.5|||
3722004|NCT02093520|3560792|B3|||NPRS|The Numeric Pain Rating Scale (NPRS) is a unidimensional measure of pain intensity in adults. The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. “no pain”) to '10' representing the other pain extreme (e.g. “pain as bad as you can imagine” or “worst pain imaginable”).|units on a scale|Mean|7.8|7.8|Standard Deviation|1.4|1.4|||
3722005|NCT02093520|3560793|B2|||NPRS|The Numeric Pain Rating Scale (NPRS) is a unidimensional measure of pain intensity in adults. The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. “no pain”) to '10' representing the other pain extreme (e.g. “pain as bad as you can imagine” or “worst pain imaginable”).|units on a scale|Mean|7.8|7.8|Standard Deviation|1.3|1.3|||
3722006|NCT02093520|3560794|B1|||NPRS|The Numeric Pain Rating Scale (NPRS) is a unidimensional measure of pain intensity in adults. The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. “no pain”) to '10' representing the other pain extreme (e.g. “pain as bad as you can imagine” or “worst pain imaginable”).|units on a scale|Mean|7.7|7.7|Standard Deviation|1.4|1.4|||
3722007|NCT02093520|3560792|B3|||ODI|"The Oswestry Disability Index (ODI) is an index derived from the Oswestry Low Back Pain Questionnaire.~0 to 20: Minimal disability 21–40: Moderate Disability 41–60: Severe Disability 61–80: Crippling back pain 81–100: These patients are either bed-bound or have an exaggeration of their symptoms."|units on a scale|Mean|52.3|52.3|Standard Deviation|12.4|12.4|||
3722008|NCT02093520|3560793|B2|||ODI|"The Oswestry Disability Index (ODI) is an index derived from the Oswestry Low Back Pain Questionnaire.~0 to 20: Minimal disability 21–40: Moderate Disability 41–60: Severe Disability 61–80: Crippling back pain 81–100: These patients are either bed-bound or have an exaggeration of their symptoms."|units on a scale|Mean|51.7|51.7|Standard Deviation|12.0|12.0|||
3722009|NCT02093520|3560794|B1|||ODI|"The Oswestry Disability Index (ODI) is an index derived from the Oswestry Low Back Pain Questionnaire.~0 to 20: Minimal disability 21–40: Moderate Disability 41–60: Severe Disability 61–80: Crippling back pain 81–100: These patients are either bed-bound or have an exaggeration of their symptoms."|units on a scale|Mean|53.0|53.0|Standard Deviation|12.9|12.9|||
3722010|NCT02093520|3560792|B3|United States||Region of Enrollment||Participants|Count of Participants|302|302.0||||||
3722011|NCT02093520|3560793|B2|United States||Region of Enrollment||Participants|Count of Participants|153|153.0||||||
3722012|NCT02093520|3560794|B1|United States||Region of Enrollment||Participants|Count of Participants|149|149.0||||||
3722013|NCT02093520|3560792|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3722014|NCT02093520|3560792|B3||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3722015|NCT02093520|3560793|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3722016|NCT02093520|3560794|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3722017|NCT02093520|3560792|B3||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
3722018|NCT02093520|3560793|B2||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3722019|NCT02093520|3560794|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3722020|NCT02093520|3560792|B3|||Age||Years|Mean|75.3|75.3|Standard Deviation|7.0|7.0|||
3722021|NCT02093520|3560793|B2|||Age||Years|Mean|75.0|75.0|Standard Deviation|7.0|7.0|||
3722022|NCT02093520|3560794|B1|||Age||Years|Mean|75.6|75.6|Standard Deviation|7.0|7.0|||
3722023|NCT02093390|3560805|B3|||Body Mass Index (BMI)||kg/m^2|Mean|26.516|26.516|Standard Deviation|2.548|2.548|||
3722024|NCT02093390|3560806|B2|||Body Mass Index (BMI)||kg/m^2|Mean|26.567|26.567|Standard Deviation|2.838|2.838|||
3722025|NCT02093390|3560807|B1|||Body Mass Index (BMI)||kg/m^2|Mean|26.466|26.466|Standard Deviation|2.296|2.296|||
3722026|NCT02093390|3560805|B3|||Height||cm|Mean|163.4|163.4|Standard Deviation|11.65|11.65|||
3722027|NCT02093390|3560806|B2|||Height||cm|Mean|163.3|163.3|Standard Deviation|12.10|12.1|||
3722028|NCT02093390|3560807|B1|||Height||cm|Mean|163.6|163.6|Standard Deviation|11.51|11.51|||
3722029|NCT02093390|3560805|B3|||Weight||kg|Mean|71.36|71.36|Standard Deviation|10.933|10.933|||
3722030|NCT02093390|3560806|B2|||Weight||kg|Mean|71.96|71.96|Standard Deviation|12.693|12.693|||
3722031|NCT02093390|3560807|B1|||Weight||kg|Mean|70.77|70.77|Standard Deviation|9.137|9.137|||
3722032|NCT02093390|3560805|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3722033|NCT02093390|3560806|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3722034|NCT02093390|3560807|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3722035|NCT02093390|3560805|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3722036|NCT02093390|3560806|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3722037|NCT02093390|3560807|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3722038|NCT02093390|3560805|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3722039|NCT02093390|3560806|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3722040|NCT02093390|3560807|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3722041|NCT02093390|3560805|B3|White||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
3722042|NCT02093390|3560806|B2|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3722043|NCT02093390|3560807|B1|White||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3722044|NCT02093390|3560805|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3722045|NCT02093390|3560806|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3722046|NCT02093390|3560807|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3722047|NCT02093390|3560805|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3722048|NCT02093390|3560806|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3722049|NCT02093390|3560807|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3722050|NCT02093390|3560805|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3722051|NCT02093390|3560806|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3722052|NCT02093390|3560807|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3722053|NCT02093390|3560805|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3722054|NCT02093390|3560806|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3722055|NCT02093390|3560807|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3722056|NCT02093390|3560805|B3|||Age||years|Mean|38.8|38.8|Standard Deviation|9.72|9.72|||
3722057|NCT02093390|3560806|B2|||Age||years|Mean|40.2|40.2|Standard Deviation|9.71|9.71|||
3722058|NCT02093390|3560807|B1|||Age||years|Mean|37.3|37.3|Standard Deviation|9.74|9.74|||
3722059|NCT02093351|3560844|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3722060|NCT02093351|3560845|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722061|NCT02093351|3560846|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722062|NCT02093351|3560847|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3722063|NCT02093351|3560844|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722064|NCT02093351|3560845|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722065|NCT02093351|3560846|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722066|NCT02093351|3560847|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722067|NCT02093351|3560844|B4||White|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3722068|NCT02093351|3560845|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3722069|NCT02093351|3560846|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3722070|NCT02093351|3560847|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3722071|NCT02093351|3560844|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3722072|NCT02093351|3560845|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3722073|NCT02093351|3560846|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722074|NCT02093351|3560847|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3722075|NCT02093351|3560844|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722076|NCT02093351|3560845|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722077|NCT02093351|3560846|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722078|NCT02093351|3560847|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722079|NCT02093351|3560844|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3722080|NCT02093351|3560845|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722081|NCT02093351|3560846|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3722082|NCT02093351|3560847|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3722083|NCT02093351|3560844|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3722084|NCT02093351|3560845|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3722085|NCT02093351|3560846|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722086|NCT02093351|3560847|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722087|NCT02093351|3560844|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722088|NCT02093351|3560845|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722089|NCT02093351|3560846|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722090|NCT02093351|3560847|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722091|NCT02093351|3560844|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3722092|NCT02093351|3560845|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3722093|NCT02093351|3560846|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3722094|NCT02093351|3560847|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3722095|NCT02093351|3560844|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722096|NCT02093351|3560845|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722097|NCT02093351|3560846|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722098|NCT02093351|3560847|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722099|NCT02093351|3560844|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3722100|NCT02093351|3560845|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3722101|NCT02093351|3560846|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3722102|NCT02093351|3560847|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3722103|NCT02093351|3560844|B4||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3722104|NCT02093351|3560845|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3722105|NCT02093351|3560846|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3722106|NCT02093351|3560847|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3722107|NCT02093351|3560844|B4|||Age||years|Mean|58.3|58.3|Standard Deviation|11.37|11.37|||
3722108|NCT02093351|3560845|B3|||Age||years|Mean|64.0|64.0|Standard Deviation|7.79|7.79|||
3722109|NCT02093351|3560846|B2|||Age||years|Mean|59.4|59.4|Standard Deviation|11.68|11.68|||
3722110|NCT02093351|3560847|B1|||Age||years|Mean|52.6|52.6|Standard Deviation|11.32|11.32|||
3722111|NCT02093234|3560878|B4|Other race||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3722112|NCT02093234|3560879|B3|Other race||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3722113|NCT02093234|3560880|B2|Other race||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3722114|NCT02093234|3560881|B1|Other race||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3722115|NCT02093234|3560878|B4|Black||Race/Ethnicity, Customized||participants|Number|151|151.0||||||
3722116|NCT02093234|3560879|B3|Black||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
3722117|NCT02093234|3560880|B2|Black||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
3722118|NCT02093234|3560881|B1|Black||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
3722119|NCT02093234|3560878|B4||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3722120|NCT02093234|3560879|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3722121|NCT02093234|3560880|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3722122|NCT02093234|3560881|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3722123|NCT02093234|3560878|B4||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3722124|NCT02093234|3560879|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3722125|NCT02093234|3560880|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3722126|NCT02093234|3560881|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3722127|NCT02093234|3560878|B4|||Age||years|Mean|52.9|52.9|Standard Deviation|0.76|0.76|||
3722128|NCT02093234|3560879|B3|||Age||years|Mean|53.2|53.2|Standard Deviation|1.25|1.25|||
3722129|NCT02093234|3560880|B2|||Age||years|Mean|53.3|53.3|Standard Deviation|1.21|1.21|||
3722130|NCT02093234|3560881|B1|||Age||years|Mean|52.2|52.2|Standard Deviation|1.51|1.51|||
3722131|NCT02093221|3560900|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722132|NCT02093221|3560901|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722133|NCT02093221|3560902|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722134|NCT02093221|3560903|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722135|NCT02093221|3560904|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722136|NCT02093221|3560905|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722137|NCT02093221|3560900|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3722138|NCT02093221|3560901|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722139|NCT02093221|3560902|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722140|NCT02093221|3560903|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722141|NCT02093221|3560904|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3722142|NCT02093221|3560905|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3722143|NCT02093221|3560900|B6||White|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3722144|NCT02093221|3560901|B5||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3722145|NCT02093221|3560902|B4||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3722146|NCT02093221|3560903|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3722147|NCT02093221|3560904|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3722148|NCT02093221|3560905|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3722149|NCT02093221|3560900|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3722150|NCT02093221|3560901|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722151|NCT02093221|3560902|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3722152|NCT02093221|3560903|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722153|NCT02093221|3560904|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3722154|NCT02093221|3560905|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722155|NCT02093221|3560900|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722156|NCT02093221|3560901|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722157|NCT02093221|3560902|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722158|NCT02093221|3560903|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722159|NCT02093221|3560904|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722160|NCT02093221|3560905|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722161|NCT02093221|3560900|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722162|NCT02093221|3560901|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722163|NCT02093221|3560902|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722164|NCT02093221|3560903|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722165|NCT02093221|3560904|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722166|NCT02093221|3560905|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722167|NCT02093221|3560900|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722168|NCT02093221|3560901|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722169|NCT02093221|3560902|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722170|NCT02093221|3560903|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722171|NCT02093221|3560904|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722172|NCT02093221|3560905|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722173|NCT02093221|3560900|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722174|NCT02093221|3560901|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722175|NCT02093221|3560902|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722176|NCT02093221|3560903|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722177|NCT02093221|3560904|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722178|NCT02093221|3560905|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722179|NCT02093221|3560900|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3722180|NCT02093221|3560901|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3722181|NCT02093221|3560902|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3722182|NCT02093221|3560903|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3722183|NCT02093221|3560904|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3722184|NCT02093221|3560905|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3722185|NCT02093221|3560900|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3722186|NCT02093221|3560901|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722187|NCT02093221|3560902|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3722188|NCT02093221|3560903|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3722189|NCT02093221|3560904|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3722190|NCT02093221|3560905|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3722191|NCT02093221|3560900|B6||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3722192|NCT02093221|3560901|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3722193|NCT02093221|3560902|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3722194|NCT02093221|3560903|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3722195|NCT02093221|3560904|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3722196|NCT02093221|3560905|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3722197|NCT02093221|3560900|B6||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3722198|NCT02093221|3560901|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3722199|NCT02093221|3560902|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3722200|NCT02093221|3560903|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3722201|NCT02093221|3560904|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3722202|NCT02093221|3560905|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3722203|NCT02093221|3560900|B6|18 - 35 years||Age, Customized||Participants|Count of Participants|29|29.0||||||
3722204|NCT02093221|3560901|B5|18 - 35 years||Age, Customized||Participants|Count of Participants|7|7.0||||||
3722205|NCT02093221|3560902|B4|18 - 35 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
3722206|NCT02093221|3560903|B3|18 - 35 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
3722207|NCT02093221|3560904|B2|18 - 35 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
3722208|NCT02093221|3560905|B1|18 - 35 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
3722209|NCT02093221|3560900|B6|12 - 17 years||Age, Customized||Participants|Count of Participants|34|34.0||||||
3722210|NCT02093221|3560901|B5|12 - 17 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
3722211|NCT02093221|3560902|B4|12 - 17 years||Age, Customized||Participants|Count of Participants|7|7.0||||||
3722212|NCT02093221|3560903|B3|12 - 17 years||Age, Customized||Participants|Count of Participants|7|7.0||||||
3722275|NCT02092662|3561005|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3722213|NCT02093221|3560904|B2|12 - 17 years||Age, Customized||Participants|Count of Participants|7|7.0||||||
3722214|NCT02093221|3560905|B1|12 - 17 years||Age, Customized||Participants|Count of Participants|7|7.0||||||
3722215|NCT02093221|3560900|B6|6 - 11 years||Age, Customized||Participants|Count of Participants|13|13.0||||||
3722216|NCT02093221|3560901|B5|6 - 11 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
3722217|NCT02093221|3560902|B4|6 - 11 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
3722218|NCT02093221|3560903|B3|6 - 11 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
3722219|NCT02093221|3560904|B2|6 - 11 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
3722220|NCT02093221|3560905|B1|6 - 11 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
3722221|NCT02093026|3560946|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3722222|NCT02093026|3560946|B1||Female|Sex: Female, Male||Participants|Count of Participants|364|364.0||||||
3722223|NCT02093026|3560946|B1|||Age||years|Mean|51|51.0|Standard Deviation|12.01|12.01|||
3722224|NCT02092961|3560965|B4|Other||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3722225|NCT02092961|3560966|B3|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3722226|NCT02092961|3560967|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3722227|NCT02092961|3560968|B1|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3722228|NCT02092961|3560965|B4|Indian or Pakistani||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3722229|NCT02092961|3560966|B3|Indian or Pakistani||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3722230|NCT02092961|3560967|B2|Indian or Pakistani||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3722231|NCT02092961|3560968|B1|Indian or Pakistani||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3722232|NCT02092961|3560965|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3722233|NCT02092961|3560966|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3722234|NCT02092961|3560967|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3722235|NCT02092961|3560968|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3722236|NCT02092961|3560965|B4|White||Race/Ethnicity, Customized||Participants|Number|68|68.0||||||
3722237|NCT02092961|3560966|B3|White||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
3722238|NCT02092961|3560967|B2|White||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
3722239|NCT02092961|3560968|B1|White||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
3722240|NCT02092961|3560965|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3722241|NCT02092961|3560966|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3722242|NCT02092961|3560967|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3722243|NCT02092961|3560968|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3722244|NCT02092961|3560965|B4||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3722245|NCT02092961|3560966|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3722246|NCT02092961|3560967|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3722247|NCT02092961|3560968|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3722248|NCT02092961|3560965|B4|||Age||years|Mean|51|51.0|Standard Deviation|12.9|12.9|||
3722249|NCT02092961|3560966|B3|||Age||years|Mean|48|48.0|Standard Deviation|14.7|14.7|||
3722250|NCT02092961|3560967|B2|||Age||years|Mean|53|53.0|Standard Deviation|12.5|12.5|||
3722251|NCT02092961|3560968|B1|||Age||years|Mean|52|52.0|Standard Deviation|11.3|11.3|||
3722252|NCT02092857|3560991|B4|Canada||Region of Enrollment||participants|Number|89|89.0||||||
3722253|NCT02092857|3560992|B3|Canada||Region of Enrollment||participants|Number|29|29.0||||||
3722254|NCT02092857|3560993|B2|Canada||Region of Enrollment||participants|Number|30|30.0||||||
3722255|NCT02092857|3560994|B1|Canada||Region of Enrollment||participants|Number|30|30.0||||||
3722256|NCT02092857|3560991|B4||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3722257|NCT02092857|3560992|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3722258|NCT02092857|3560993|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3722259|NCT02092857|3560994|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3722260|NCT02092857|3560991|B4||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3722261|NCT02092857|3560992|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3722262|NCT02092857|3560993|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3722263|NCT02092857|3560994|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3722264|NCT02092857|3560991|B4|||Age||days|Mean|17|17.0|Standard Deviation|1.2|1.2|||
3722265|NCT02092857|3560992|B3|||Age||days|Mean|17.8|17.8|Standard Deviation|4.4|4.4|||
3722266|NCT02092857|3560993|B2|||Age||days|Mean|16.5|16.5|Standard Deviation|3.8|3.8|||
3722267|NCT02092857|3560994|B1|||Age||days|Mean|16.8|16.8|Standard Deviation|3.8|3.8|||
3722268|NCT02092662|3561004|B3|Israel||Region of Enrollment||participants|Number|57|57.0||||||
3722269|NCT02092662|3561005|B2|Israel||Region of Enrollment||participants|Number|19|19.0||||||
3722270|NCT02092662|3561006|B1|Israel||Region of Enrollment||participants|Number|38|38.0||||||
3722271|NCT02092662|3561004|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3722272|NCT02092662|3561005|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3722273|NCT02092662|3561006|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3722274|NCT02092662|3561004|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3722276|NCT02092662|3561006|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3722277|NCT02092662|3561004|B3|||Age||years|Mean|74|74.0|Standard Deviation|9.4|9.4|||
3722278|NCT02092662|3561005|B2|||Age||years|Mean|71|71.0|Standard Deviation|10.58|10.58|||
3722279|NCT02092662|3561006|B1|||Age||years|Mean|75.15|75.15|Standard Deviation|8.69|8.69|||
3722280|NCT02092662|3561004|B3||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
3722281|NCT02092662|3561005|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3722282|NCT02092662|3561006|B1||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
3722283|NCT02092662|3561004|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3722284|NCT02092662|3561005|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3722285|NCT02092662|3561006|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3722286|NCT02092662|3561004|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3722287|NCT02092662|3561005|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3722288|NCT02092662|3561006|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3722289|NCT02092649|3561014|B3|||Resting Metabolic Rate||kcal/day|Mean|2029|2029.0|Standard Deviation|204|204.0|||
3722290|NCT02092649|3561015|B2|||Resting Metabolic Rate||kcal/day|Mean|2016|2016.0|Standard Deviation|227|227.0|||
3722291|NCT02092649|3561016|B1|||Resting Metabolic Rate||kcal/day|Mean|2041|2041.0|Standard Deviation|187|187.0|||
3722292|NCT02092649|3561014|B3|Canada||Region of Enrollment||participants|Number|26|26.0||||||
3722293|NCT02092649|3561015|B2|Canada||Region of Enrollment||participants|Number|13|13.0||||||
3722294|NCT02092649|3561016|B1|Canada||Region of Enrollment||participants|Number|13|13.0||||||
3722295|NCT02092649|3561014|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3722296|NCT02092649|3561015|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3722297|NCT02092649|3561016|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3722298|NCT02092649|3561014|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3722299|NCT02092649|3561015|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3722300|NCT02092649|3561016|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3722301|NCT02092649|3561014|B3|||Age||years|Mean|23|23.0|Standard Deviation|2.57|2.57|||
3722302|NCT02092649|3561015|B2|||Age||years|Mean|22|22.0|Standard Deviation|1.61|1.61|||
3722303|NCT02092649|3561016|B1|||Age||years|Mean|23|23.0|Standard Deviation|3.29|3.29|||
3722304|NCT02092649|3561014|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3722305|NCT02092649|3561015|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3722306|NCT02092649|3561016|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3722307|NCT02092649|3561014|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3722308|NCT02092649|3561015|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3722309|NCT02092649|3561016|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3722310|NCT02092649|3561014|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3722311|NCT02092649|3561015|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3722312|NCT02092649|3561016|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3722313|NCT02092610|3561033|B3|||Implant stability measured by resonance frequence analysis|The ISQ value ranges from 1 to 100, the higher value, the higher the implant stabilty.|ISQ scores|Mean|68.5|68.5|Standard Deviation|3.4|3.4|||
3722314|NCT02092610|3561034|B2|||Implant stability measured by resonance frequence analysis|The ISQ value ranges from 1 to 100, the higher value, the higher the implant stabilty.|ISQ scores|Mean|70.1|70.1|Standard Deviation|2.4|2.4|||
3722315|NCT02092610|3561035|B1|||Implant stability measured by resonance frequence analysis|The ISQ value ranges from 1 to 100, the higher value, the higher the implant stabilty.|ISQ scores|Mean|65.4|65.4|Standard Deviation|3.2|3.2|||
3722316|NCT02092610|3561033|B3|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
3722317|NCT02092610|3561034|B2|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
3722318|NCT02092610|3561035|B1|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3722319|NCT02092610|3561033|B3|Netherlands||Region of Enrollment||participants|Number|37|37.0||||||
3722320|NCT02092610|3561034|B2|Netherlands||Region of Enrollment||participants|Number|26|26.0||||||
3722321|NCT02092610|3561035|B1|Netherlands||Region of Enrollment||participants|Number|11|11.0||||||
3722322|NCT02092610|3561033|B3|Sweden||Region of Enrollment||participants|Number|9|9.0||||||
3722323|NCT02092610|3561034|B2|Sweden||Region of Enrollment||participants|Number|7|7.0||||||
3722324|NCT02092610|3561035|B1|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
3722325|NCT02092610|3561033|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3722326|NCT02092610|3561034|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3722327|NCT02092610|3561035|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3722328|NCT02092610|3561033|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3722329|NCT02092610|3561034|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3722330|NCT02092610|3561035|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3722331|NCT02092610|3561033|B3|||Age||years|Mean|63.2|63.2|Standard Deviation|12.5|12.5|||
3722332|NCT02092610|3561034|B2|||Age||years|Mean|55.4|55.4|Standard Deviation|12.8|12.8|||
3722333|NCT02092610|3561035|B1|||Age||years|Mean|64.2|64.2|Standard Deviation|9.4|9.4|||
3722334|NCT02092610|3561033|B3||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
3722335|NCT02092610|3561034|B2||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3722336|NCT02092610|3561035|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3722337|NCT02092610|3561033|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3722338|NCT02092610|3561034|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3722339|NCT02092610|3561035|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3722340|NCT02092610|3561033|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3722341|NCT02092610|3561034|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3722342|NCT02092610|3561035|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3722343|NCT02092441|3561048|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3722344|NCT02092441|3561049|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3722345|NCT02092441|3561050|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3722346|NCT02092441|3561048|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3722347|NCT02092441|3561049|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3722348|NCT02092441|3561050|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3722349|NCT02092441|3561048|B3|||Age||years|Mean|33.9375|33.9375|Standard Deviation|13.3154|13.3154|||
3722350|NCT02092441|3561049|B2|||Age||years|Mean|31.94595|31.94595|Standard Deviation|12.12652|12.12652|||
3722351|NCT02092441|3561050|B1|||Age||years|Mean|35.65116|35.65116|Standard Deviation|14.17557|14.17557|||
3722352|NCT02092415|3561061|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3722353|NCT02092415|3561061|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3722354|NCT02092415|3561061|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3722355|NCT02092415|3561061|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3722356|NCT02092415|3561061|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3722357|NCT02092415|3561061|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3722358|NCT02092389|3561066|B1|||Fecal calprotectin (fC) levels at baseline|fC is a non-invasive surrogate marker of inflammation in the small intestine and levels below 250 ug/g is associated with mucosal healing. fC levels were measured using enzyme-linked immunosorbent assay (ELISA) and/or a validated quantitative rapid test. A total of 8 participants had fC baseline data available.|μg/g|Mean|440|440.0|Standard Deviation|393.6|393.6|||
3722359|NCT02092389|3561066|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
3722360|NCT02092389|3561066|B1||Female|Gender||Participants|Count of Participants|4|4.0||||||
3722361|NCT02092389|3561066|B1|||Age||years|Mean|51.8|51.8|Standard Deviation|16.88|16.88|||
3722362|NCT02092350|3561076|B3||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3722363|NCT02092350|3561077|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3722364|NCT02092350|3561078|B1||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3722365|NCT02092350|3561076|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3722366|NCT02092350|3561077|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3722367|NCT02092350|3561078|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3722368|NCT02092350|3561076|B3|||Age||Years|Mean|55.9|55.9|Standard Deviation|9.5|9.5|||
3722369|NCT02092350|3561077|B2|||Age||Years|Mean|55.2|55.2|Standard Deviation|10.0|10.0|||
3722370|NCT02092350|3561078|B1|||Age||Years|Mean|56.6|56.6|Standard Deviation|9.0|9.0|||
3722371|NCT02092311|3561094|B3|Iran, Islamic Republic of||Region of Enrollment||participants|Number|570|570.0||||||
3722372|NCT02092311|3561095|B2|Iran, Islamic Republic of||Region of Enrollment||participants|Number|285|285.0||||||
3722373|NCT02092311|3561096|B1|Iran, Islamic Republic of||Region of Enrollment||participants|Number|285|285.0||||||
3722374|NCT02092311|3561094|B3||Male|Sex: Female, Male||Participants|Count of Participants|570|570.0||||||
3722375|NCT02092311|3561095|B2||Male|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
3722376|NCT02092311|3561096|B1||Male|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
3722377|NCT02092311|3561094|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3722378|NCT02092311|3561095|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3722379|NCT02092311|3561096|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3722380|NCT02092311|3561094|B3|||Age||years|Mean|31.5|31.5|Full Range|||16.0|40.0|
3722381|NCT02092311|3561095|B2|||Age||years|Mean|31.8|31.8|Full Range|||22.0|39.0|
3722382|NCT02092311|3561096|B1|||Age||years|Mean|31.2|31.2|Full Range|||16.0|40.0|
3722383|NCT02092285|3561107|B1|||Partial Mayo Score|The Partial Mayo Score (Mayo Score without endoscopy) measures severity of ulcerative colitis. Three sub-scores for stool frequency, rectal bleeding, and physician’s global assessment are each graded from 0 to 3 with higher scores indicating more severe disease. Individual sub-scores are then summed to provide the total score ranging from 0 (normal or inactive disease) to 9 (severe disease).|Units on a scale|Mean|6.4|6.4|Standard Deviation|1.40|1.4|||
3722384|NCT02092285|3561107|B1||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3722385|NCT02092285|3561107|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3722386|NCT02092285|3561107|B1|From 65 to 84 years||Age, Customized||Participants|Number|18|18.0||||||
3722387|NCT02092285|3561107|B1|Adults (between 18 and 64 years)||Age, Customized||Participants|Number|184|184.0||||||
3722388|NCT02092285|3561107|B1|Adolescents (12-17 years)||Age, Customized||Participants|Number|3|3.0||||||
3722389|NCT02092285|3561107|B1|||Age||years|Mean|39.3|39.3|Standard Deviation|15.09|15.09|||
3722390|NCT02092220|3561111|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3722391|NCT02092220|3561111|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3722392|NCT02092220|3561111|B1|||Age||years|Mean|33.3|33.3|Standard Deviation|11.0|11.0|||
3722393|NCT02092220|3561111|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3722394|NCT02092220|3561111|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3722395|NCT02092220|3561111|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3722396|NCT02092168|3561170|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3722397|NCT02092168|3561171|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3722398|NCT02092168|3561172|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3722399|NCT02092168|3561170|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3722400|NCT02092168|3561171|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3722401|NCT02092168|3561172|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3722402|NCT02092168|3561170|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3722403|NCT02092168|3561171|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3722404|NCT02092168|3561172|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3722405|NCT02092168|3561170|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3722406|NCT02092168|3561171|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3722407|NCT02092168|3561172|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3722408|NCT02092168|3561170|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3722409|NCT02092168|3561171|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3722410|NCT02092168|3561172|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3722411|NCT02092116|3561183|B3|||Mean CD4+ T-cell counts||10^6 cells/L|Median|712.3|712.3|Full Range|||465.0|1645.0|
3722412|NCT02092116|3561184|B2|||Mean CD4+ T-cell counts||10^6 cells/L|Median|669.8|669.8|Full Range|||465.0|1645.0|
3722413|NCT02092116|3561185|B1|||Mean CD4+ T-cell counts||10^6 cells/L|Median|807.5|807.5|Full Range|||570.0|1015.0|
3722414|NCT02092116|3561183|B3|||Nadir CD4+ T-cell count||10^6 cells/L|Median|267.5|267.5|Full Range|||40.0|710.0|
3722415|NCT02092116|3561184|B2|||Nadir CD4+ T-cell count||10^6 cells/L|Median|280|280.0|Full Range|||60.0|710.0|
3722416|NCT02092116|3561185|B1|||Nadir CD4+ T-cell count||10^6 cells/L|Median|246.5|246.5|Full Range|||40.0|340.0|
3722417|NCT02092116|3561183|B3|||Latest pre-ART viral load||copies/mL|Median|72597.5|72597.5|Full Range|||1977.0|10000000.0|
3722418|NCT02092116|3561184|B2|||Latest pre-ART viral load||copies/mL|Median|67024|67024.0|Full Range|||3674.0|10000000.0|
3722419|NCT02092116|3561185|B1|||Latest pre-ART viral load||copies/mL|Median|123300|123300.0|Full Range|||1977.0|2450000.0|
3722420|NCT02092116|3561183|B3|||Time since ART initiation||years|Median|6.9|6.9|Full Range|||2.4|18.1|
3722421|NCT02092116|3561184|B2|||Time since ART initiation||years|Median|6.3|6.3|Full Range|||2.4|18.1|
3722422|NCT02092116|3561185|B1|||Time since ART initiation||years|Median|10.05|10.05|Full Range|||4.2|14.5|
3722423|NCT02092116|3561183|B3|||Time since HIV infection||years|Median|12.2|12.2|Full Range|||2.7|31.7|
3722424|NCT02092116|3561184|B2|||Time since HIV infection||years|Median|10.2|10.2|Full Range|||2.7|31.7|
3722425|NCT02092116|3561185|B1|||Time since HIV infection||years|Median|13.5|13.5|Full Range|||10.7|23.1|
3722426|NCT02092116|3561183|B3|||Time since HIV diagnosis||years|Median|9.85|9.85|Full Range|||2.6|28.7|
3722427|NCT02092116|3561184|B2|||Time since HIV diagnosis||years|Median|9.6|9.6|Full Range|||2.6|28.7|
3722428|NCT02092116|3561185|B1|||Time since HIV diagnosis||years|Median|13.3|13.3|Full Range|||7.0|22.6|
3722429|NCT02092116|3561183|B3|Denmark||Region of Enrollment||participants|Number|26|26.0||||||
3722430|NCT02092116|3561184|B2|Denmark||Region of Enrollment||participants|Number|20|20.0||||||
3722431|NCT02092116|3561185|B1|Denmark||Region of Enrollment||participants|Number|6|6.0||||||
3722432|NCT02092116|3561183|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3722433|NCT02092116|3561184|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3722434|NCT02092116|3561185|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722435|NCT02092116|3561183|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722436|NCT02092116|3561184|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722437|NCT02092116|3561185|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722438|NCT02092116|3561183|B3||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3722439|NCT02092116|3561184|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3722440|NCT02092116|3561185|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3722441|NCT02092116|3561183|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3722442|NCT02092116|3561184|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3722443|NCT02092116|3561185|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722444|NCT02092116|3561183|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722445|NCT02092116|3561184|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722446|NCT02092116|3561185|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722447|NCT02092116|3561183|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3722448|NCT02092116|3561184|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3722449|NCT02092116|3561185|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722450|NCT02092116|3561183|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722451|NCT02092116|3561184|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722452|NCT02092116|3561185|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722453|NCT02092116|3561183|B3||Male|Gender||Participants|Count of Participants|22|22.0||||||
3722454|NCT02092116|3561184|B2||Male|Gender||Participants|Count of Participants|17|17.0||||||
3722455|NCT02092116|3561185|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
3722456|NCT02092116|3561183|B3||Female|Gender||Participants|Count of Participants|4|4.0||||||
3722457|NCT02092116|3561184|B2||Female|Gender||Participants|Count of Participants|3|3.0||||||
3722458|NCT02092116|3561185|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
3722459|NCT02092116|3561183|B3|>18 years||Age, Customized||participants|Number|26|26.0||||||
3722460|NCT02092116|3561184|B2|>18 years||Age, Customized||participants|Number|20|20.0||||||
3722461|NCT02092116|3561185|B1|>18 years||Age, Customized||participants|Number|6|6.0||||||
3722462|NCT02091986|3561195|B4|||FEV1 at randomisation||Liters|Mean|1.59|1.59|Standard Deviation|0.37|0.37|||
3722463|NCT02091986|3561196|B3|||FEV1 at randomisation||Liters|Mean|1.62|1.62|Standard Deviation|0.36|0.36|||
3722464|NCT02091986|3561197|B2|||FEV1 at randomisation||Liters|Mean|1.57|1.57|Standard Deviation|0.33|0.33|||
3722465|NCT02091986|3561198|B1|||FEV1 at randomisation||Liters|Mean|1.58|1.58|Standard Deviation|0.42|0.42|||
3722466|NCT02091986|3561195|B4|||Duration of asthma||years|Mean|5.9|5.9|Standard Deviation|3.1|3.1|||
3722467|NCT02091986|3561196|B3|||Duration of asthma||years|Mean|6.2|6.2|Standard Deviation|3.1|3.1|||
3722468|NCT02091986|3561197|B2|||Duration of asthma||years|Mean|5.9|5.9|Standard Deviation|3.2|3.2|||
3722469|NCT02091986|3561198|B1|||Duration of asthma||years|Mean|5.8|5.8|Standard Deviation|3.0|3.0|||
3722470|NCT02091986|3561195|B4|||Height||cm|Mean|139|139.0|Standard Deviation|10.8|10.8|||
3722471|NCT02091986|3561196|B3|||Height||cm|Mean|141|141.0|Standard Deviation|10.5|10.5|||
3722472|NCT02091986|3561197|B2|||Height||cm|Mean|138|138.0|Standard Deviation|10.9|10.9|||
3722473|NCT02091986|3561198|B1|||Height||cm|Mean|139|139.0|Standard Deviation|11.1|11.1|||
3722474|NCT02091986|3561195|B4|||Weight||kg|Mean|39|39.0|Standard Deviation|13.1|13.1|||
3722475|NCT02091986|3561196|B3|||Weight||kg|Mean|40|40.0|Standard Deviation|13.6|13.6|||
3722476|NCT02091986|3561197|B2|||Weight||kg|Mean|38|38.0|Standard Deviation|12.9|12.9|||
3722477|NCT02091986|3561198|B1|||Weight||kg|Mean|38|38.0|Standard Deviation|12.9|12.9|||
3722478|NCT02091986|3561195|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3722479|NCT02091986|3561196|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3722480|NCT02091986|3561197|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3722481|NCT02091986|3561198|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722482|NCT02091986|3561195|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3722483|NCT02091986|3561196|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3722484|NCT02091986|3561197|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3722485|NCT02091986|3561198|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3722486|NCT02091986|3561195|B4||White|Race (NIH/OMB)||Participants|Count of Participants|174|174.0||||||
3722487|NCT02091986|3561196|B3||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3722488|NCT02091986|3561197|B2||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3722489|NCT02091986|3561198|B1||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3722490|NCT02091986|3561195|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
3722491|NCT02091986|3561196|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3722492|NCT02091986|3561197|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3722493|NCT02091986|3561198|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3722494|NCT02091986|3561195|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3722495|NCT02091986|3561196|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722496|NCT02091986|3561197|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722497|NCT02091986|3561198|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3722498|NCT02091986|3561195|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3722499|NCT02091986|3561196|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3722500|NCT02091986|3561197|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722501|NCT02091986|3561198|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722502|NCT02091986|3561195|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3722503|NCT02091986|3561196|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3722504|NCT02091986|3561197|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3722505|NCT02091986|3561198|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3722506|NCT02091986|3561195|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722507|NCT02091986|3561196|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722508|NCT02091986|3561197|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722569|NCT02091869|3561260|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3722509|NCT02091986|3561198|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722510|NCT02091986|3561195|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|173|173.0||||||
3722511|NCT02091986|3561196|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3722512|NCT02091986|3561197|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3722513|NCT02091986|3561198|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3722514|NCT02091986|3561195|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
3722515|NCT02091986|3561196|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3722516|NCT02091986|3561197|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3722517|NCT02091986|3561198|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3722518|NCT02091986|3561195|B4||Male|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3722519|NCT02091986|3561196|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3722520|NCT02091986|3561197|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3722521|NCT02091986|3561198|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3722522|NCT02091986|3561195|B4||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3722523|NCT02091986|3561196|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3722524|NCT02091986|3561197|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3722525|NCT02091986|3561198|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3722526|NCT02091986|3561195|B4|||Age||years|Mean|9|9.0|Standard Deviation|1.5|1.5|||
3722527|NCT02091986|3561196|B3|||Age||years|Mean|9|9.0|Standard Deviation|1.4|1.4|||
3722528|NCT02091986|3561197|B2|||Age||years|Mean|9|9.0|Standard Deviation|1.6|1.6|||
3722529|NCT02091986|3561198|B1|||Age||years|Mean|9|9.0|Standard Deviation|1.6|1.6|||
3722530|NCT02091960|3561247|B1||Unknown|Anatomic Stage|"Breast cancer staging is based on size of the tumor, whether cancer cells have spread to lymph nodes or to other parts of the body, how aggressive the cells appear when viewed under a microscope, whether the cancer cells have receptors for estrogen and progesterone or have a gene mutation that causes them to make excess HER2 protein, and the results of gene expression profiling tests.~The stages of breast cancer range from 0 to IV, where Stage 0 is noninvasive or contained within the milk ducts and Stage IV breast cancer, also called metastatic, has spread to other areas of the body."|Participants|Count of Participants|20|20.0||||||
3722531|NCT02091960|3561247|B1||Stage IV|Anatomic Stage|"Breast cancer staging is based on size of the tumor, whether cancer cells have spread to lymph nodes or to other parts of the body, how aggressive the cells appear when viewed under a microscope, whether the cancer cells have receptors for estrogen and progesterone or have a gene mutation that causes them to make excess HER2 protein, and the results of gene expression profiling tests.~The stages of breast cancer range from 0 to IV, where Stage 0 is noninvasive or contained within the milk ducts and Stage IV breast cancer, also called metastatic, has spread to other areas of the body."|Participants|Count of Participants|28|28.0||||||
3722532|NCT02091960|3561247|B1||Stage IIIC|Anatomic Stage|"Breast cancer staging is based on size of the tumor, whether cancer cells have spread to lymph nodes or to other parts of the body, how aggressive the cells appear when viewed under a microscope, whether the cancer cells have receptors for estrogen and progesterone or have a gene mutation that causes them to make excess HER2 protein, and the results of gene expression profiling tests.~The stages of breast cancer range from 0 to IV, where Stage 0 is noninvasive or contained within the milk ducts and Stage IV breast cancer, also called metastatic, has spread to other areas of the body."|Participants|Count of Participants|7|7.0||||||
3722533|NCT02091960|3561247|B1||Stage IIIB|Anatomic Stage|"Breast cancer staging is based on size of the tumor, whether cancer cells have spread to lymph nodes or to other parts of the body, how aggressive the cells appear when viewed under a microscope, whether the cancer cells have receptors for estrogen and progesterone or have a gene mutation that causes them to make excess HER2 protein, and the results of gene expression profiling tests.~The stages of breast cancer range from 0 to IV, where Stage 0 is noninvasive or contained within the milk ducts and Stage IV breast cancer, also called metastatic, has spread to other areas of the body."|Participants|Count of Participants|7|7.0||||||
3722534|NCT02091960|3561247|B1||Stage IIIA|Anatomic Stage|"Breast cancer staging is based on size of the tumor, whether cancer cells have spread to lymph nodes or to other parts of the body, how aggressive the cells appear when viewed under a microscope, whether the cancer cells have receptors for estrogen and progesterone or have a gene mutation that causes them to make excess HER2 protein, and the results of gene expression profiling tests.~The stages of breast cancer range from 0 to IV, where Stage 0 is noninvasive or contained within the milk ducts and Stage IV breast cancer, also called metastatic, has spread to other areas of the body."|Participants|Count of Participants|5|5.0||||||
3722535|NCT02091960|3561247|B1||Stage IIB|Anatomic Stage|"Breast cancer staging is based on size of the tumor, whether cancer cells have spread to lymph nodes or to other parts of the body, how aggressive the cells appear when viewed under a microscope, whether the cancer cells have receptors for estrogen and progesterone or have a gene mutation that causes them to make excess HER2 protein, and the results of gene expression profiling tests.~The stages of breast cancer range from 0 to IV, where Stage 0 is noninvasive or contained within the milk ducts and Stage IV breast cancer, also called metastatic, has spread to other areas of the body."|Participants|Count of Participants|12|12.0||||||
3722536|NCT02091960|3561247|B1||Stage IIA|Anatomic Stage|"Breast cancer staging is based on size of the tumor, whether cancer cells have spread to lymph nodes or to other parts of the body, how aggressive the cells appear when viewed under a microscope, whether the cancer cells have receptors for estrogen and progesterone or have a gene mutation that causes them to make excess HER2 protein, and the results of gene expression profiling tests.~The stages of breast cancer range from 0 to IV, where Stage 0 is noninvasive or contained within the milk ducts and Stage IV breast cancer, also called metastatic, has spread to other areas of the body."|Participants|Count of Participants|14|14.0||||||
3722570|NCT02091869|3561258|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3722537|NCT02091960|3561247|B1||Stage IB|Anatomic Stage|"Breast cancer staging is based on size of the tumor, whether cancer cells have spread to lymph nodes or to other parts of the body, how aggressive the cells appear when viewed under a microscope, whether the cancer cells have receptors for estrogen and progesterone or have a gene mutation that causes them to make excess HER2 protein, and the results of gene expression profiling tests.~The stages of breast cancer range from 0 to IV, where Stage 0 is noninvasive or contained within the milk ducts and Stage IV breast cancer, also called metastatic, has spread to other areas of the body."|Participants|Count of Participants|1|1.0||||||
3722538|NCT02091960|3561247|B1||Stage IA|Anatomic Stage|"Breast cancer staging is based on size of the tumor, whether cancer cells have spread to lymph nodes or to other parts of the body, how aggressive the cells appear when viewed under a microscope, whether the cancer cells have receptors for estrogen and progesterone or have a gene mutation that causes them to make excess HER2 protein, and the results of gene expression profiling tests.~The stages of breast cancer range from 0 to IV, where Stage 0 is noninvasive or contained within the milk ducts and Stage IV breast cancer, also called metastatic, has spread to other areas of the body."|Participants|Count of Participants|6|6.0||||||
3722539|NCT02091960|3561247|B1||Stage 0|Anatomic Stage|"Breast cancer staging is based on size of the tumor, whether cancer cells have spread to lymph nodes or to other parts of the body, how aggressive the cells appear when viewed under a microscope, whether the cancer cells have receptors for estrogen and progesterone or have a gene mutation that causes them to make excess HER2 protein, and the results of gene expression profiling tests.~The stages of breast cancer range from 0 to IV, where Stage 0 is noninvasive or contained within the milk ducts and Stage IV breast cancer, also called metastatic, has spread to other areas of the body."|Participants|Count of Participants|3|3.0||||||
3722540|NCT02091960|3561247|B1||Unknown|Histopathology at Diagnosis||Participants|Count of Participants|6|6.0||||||
3722541|NCT02091960|3561247|B1||Other|Histopathology at Diagnosis||Participants|Count of Participants|5|5.0||||||
3722542|NCT02091960|3561247|B1||Not otherwise specified|Histopathology at Diagnosis||Participants|Count of Participants|1|1.0||||||
3722543|NCT02091960|3561247|B1||Mixed|Histopathology at Diagnosis||Participants|Count of Participants|1|1.0||||||
3722544|NCT02091960|3561247|B1||Lobular|Histopathology at Diagnosis||Participants|Count of Participants|6|6.0||||||
3722545|NCT02091960|3561247|B1||Intraductal|Histopathology at Diagnosis||Participants|Count of Participants|6|6.0||||||
3722546|NCT02091960|3561247|B1||Inflammatory|Histopathology at Diagnosis||Participants|Count of Participants|5|5.0||||||
3722547|NCT02091960|3561247|B1||Ductal|Histopathology at Diagnosis||Participants|Count of Participants|73|73.0||||||
3722548|NCT02091960|3561247|B1|||Time from Initial Diagnosis of Primary Cancer to Enrollment||days|Median|1199|1199.0|Full Range|||30.0|4713.0|
3722549|NCT02091960|3561247|B1||Missing|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|1|1.0||||||
3722550|NCT02091960|3561247|B1||Grade 1|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|51|51.0||||||
3722551|NCT02091960|3561247|B1||Grade 0|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|51|51.0||||||
3722552|NCT02091960|3561247|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3722553|NCT02091960|3561247|B1|Race|Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3722554|NCT02091960|3561247|B1|Race|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3722555|NCT02091960|3561247|B1|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3722556|NCT02091960|3561247|B1|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3722557|NCT02091960|3561247|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|90|90.0||||||
3722558|NCT02091960|3561247|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722559|NCT02091960|3561247|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3722560|NCT02091960|3561247|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3722561|NCT02091960|3561247|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3722562|NCT02091960|3561247|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3722563|NCT02091960|3561247|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|10.0|10.0|||
3722564|NCT02091869|3561258|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
3722565|NCT02091869|3561259|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3722566|NCT02091869|3561260|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3722567|NCT02091869|3561258|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3722568|NCT02091869|3561259|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3722571|NCT02091869|3561259|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3722572|NCT02091869|3561260|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3722573|NCT02091869|3561258|B3|||Age||years|Median|15.4|15.4|Full Range|||14.5|16.3|
3722574|NCT02091869|3561259|B2|||Age||years|Median|15.3|15.3|Full Range|||14.4|16.8|
3722575|NCT02091869|3561260|B1|||Age||years|Median|15.4|15.4|Full Range|||13.4|16.1|
3722576|NCT02091869|3561258|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3722577|NCT02091869|3561259|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3722578|NCT02091869|3561260|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3722579|NCT02091869|3561258|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3722580|NCT02091869|3561259|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3722581|NCT02091869|3561260|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3722582|NCT02091869|3561258|B3||<=18 years|Age||Participants|Count of Participants|34|34.0||||||
3722583|NCT02091869|3561259|B2||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
3722584|NCT02091869|3561260|B1||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
3722585|NCT02091856|3561273|B4|Romania||Region of Enrollment||participants|Number|79|79.0||||||
3722586|NCT02091856|3561274|B3|Romania||Region of Enrollment||participants|Number|26|26.0||||||
3722587|NCT02091856|3561275|B2|Romania||Region of Enrollment||participants|Number|19|19.0||||||
3722588|NCT02091856|3561276|B1|Romania||Region of Enrollment||participants|Number|34|34.0||||||
3722589|NCT02091856|3561273|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3722590|NCT02091856|3561274|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3722591|NCT02091856|3561275|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3722592|NCT02091856|3561276|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3722593|NCT02091856|3561273|B4||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3722594|NCT02091856|3561274|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3722595|NCT02091856|3561275|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3722596|NCT02091856|3561276|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3722597|NCT02091856|3561273|B4|||Age||years|Mean|32.05|32.05|Standard Deviation|9.97|9.97|||
3722598|NCT02091856|3561274|B3|||Age||years|Mean|35.65|35.65|Standard Deviation|9.15|9.15|||
3722599|NCT02091856|3561275|B2|||Age||years|Mean|32.21|32.21|Standard Deviation|11.66|11.66|||
3722600|NCT02091856|3561276|B1|||Age||years|Mean|29.21|29.21|Standard Deviation|8.88|8.88|||
3722601|NCT02091856|3561273|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3722602|NCT02091856|3561274|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3722603|NCT02091856|3561275|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3722604|NCT02091856|3561276|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3722605|NCT02091856|3561273|B4||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
3722606|NCT02091856|3561274|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3722607|NCT02091856|3561275|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3722608|NCT02091856|3561276|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3722609|NCT02091856|3561273|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3722610|NCT02091856|3561274|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3722611|NCT02091856|3561275|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3722612|NCT02091856|3561276|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3722613|NCT02091778|3561298|B1|United Kingdom||Region of Enrollment||participants|Number|21|21.0||||||
3722614|NCT02091778|3561298|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722615|NCT02091778|3561298|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722616|NCT02091778|3561298|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3722617|NCT02091778|3561298|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722618|NCT02091778|3561298|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722619|NCT02091778|3561298|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722620|NCT02091778|3561298|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722621|NCT02091778|3561298|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3722622|NCT02091778|3561298|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3722623|NCT02091778|3561298|B1|||Age||years|Mean|59.9|59.9|Standard Deviation|12.1|12.1|||
3722624|NCT02091752|3561302|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3722625|NCT02091752|3561302|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3722626|NCT02091752|3561302|B1|||Age||Years|Mean|68.00|68.0|Standard Deviation|9.165|9.165|||
3722627|NCT02091739|3561313|B4|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|27.5|27.5|Standard Deviation|4.9|4.9|||
3722628|NCT02091739|3561314|B3|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|27.7|27.7|Standard Deviation|3.8|3.8|||
3722629|NCT02091739|3561315|B2|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|26.7|26.7|Standard Deviation|5.2|5.2|||
3722630|NCT02091739|3561316|B1|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|28.5|28.5|Standard Deviation|6|6.0|||
3722631|NCT02091739|3561313|B4|||Weight||kilogram (kg)|Mean|79.4|79.4|Standard Deviation|15.7|15.7|||
3722632|NCT02091739|3561314|B3|||Weight||kilogram (kg)|Mean|79.8|79.8|Standard Deviation|14|14.0|||
3722633|NCT02091739|3561315|B2|||Weight||kilogram (kg)|Mean|78.4|78.4|Standard Deviation|17.1|17.1|||
3722634|NCT02091739|3561316|B1|||Weight||kilogram (kg)|Mean|80.6|80.6|Standard Deviation|16.4|16.4|||
3722635|NCT02091739|3561313|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722636|NCT02091739|3561314|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722637|NCT02091739|3561315|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722638|NCT02091739|3561316|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722639|NCT02091739|3561313|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722640|NCT02091739|3561314|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722641|NCT02091739|3561315|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722642|NCT02091739|3561316|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722643|NCT02091739|3561313|B4||White|Race (NIH/OMB)||Participants|Count of Participants|183|183.0||||||
3722644|NCT02091739|3561314|B3||White|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3722645|NCT02091739|3561315|B2||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3722646|NCT02091739|3561316|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3722647|NCT02091739|3561313|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722648|NCT02091739|3561314|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722649|NCT02091739|3561315|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722650|NCT02091739|3561316|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722651|NCT02091739|3561313|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722652|NCT02091739|3561314|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722653|NCT02091739|3561315|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722654|NCT02091739|3561316|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722655|NCT02091739|3561313|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3722656|NCT02091739|3561314|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3722657|NCT02091739|3561315|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722658|NCT02091739|3561316|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722659|NCT02091739|3561313|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722660|NCT02091739|3561314|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722661|NCT02091739|3561315|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722662|NCT02091739|3561316|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722663|NCT02091739|3561313|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722664|NCT02091739|3561314|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722665|NCT02091739|3561315|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722666|NCT02091739|3561316|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722667|NCT02091739|3561313|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|183|183.0||||||
3722668|NCT02091739|3561314|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3722669|NCT02091739|3561315|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3722670|NCT02091739|3561316|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3722671|NCT02091739|3561313|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3722672|NCT02091739|3561314|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3722673|NCT02091739|3561315|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722674|NCT02091739|3561316|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722675|NCT02091739|3561313|B4||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3722676|NCT02091739|3561314|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3722677|NCT02091739|3561315|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3722678|NCT02091739|3561316|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3722679|NCT02091739|3561313|B4||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3722680|NCT02091739|3561314|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3722681|NCT02091739|3561315|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3722682|NCT02091739|3561316|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3722683|NCT02091739|3561313|B4||>=65 years|Age||Participants|Count of Participants|107|107.0||||||
3722684|NCT02091739|3561314|B3||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
3722685|NCT02091739|3561315|B2||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
3722686|NCT02091739|3561316|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3722687|NCT02091739|3561313|B4||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
3722688|NCT02091739|3561314|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3722689|NCT02091739|3561315|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3722690|NCT02091739|3561316|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3722691|NCT02091739|3561313|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3722692|NCT02091739|3561314|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3722693|NCT02091739|3561315|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3722694|NCT02091739|3561316|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3722695|NCT02091726|3561339|B1|South Africa||Region of Enrollment||participants|Number|110|110.0||||||
3722696|NCT02091726|3561339|B1||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3722697|NCT02091726|3561339|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3722698|NCT02091726|3561339|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3722699|NCT02091726|3561339|B1||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
3722700|NCT02091726|3561339|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3722701|NCT02091466|3561347|B3|Brazil||Region of Enrollment||participants|Number|40|40.0||||||
3722702|NCT02091466|3561348|B2|Brazil||Region of Enrollment||participants|Number|20|20.0||||||
3722703|NCT02091466|3561349|B1|Brazil||Region of Enrollment||participants|Number|20|20.0||||||
3722704|NCT02091466|3561347|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3722705|NCT02091466|3561348|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3722706|NCT02091466|3561349|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3722707|NCT02091466|3561347|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3722708|NCT02091466|3561348|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3722709|NCT02091466|3561349|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3722710|NCT02091466|3561347|B3|||Age||years|Mean|28.8|28.8|Standard Deviation|5.9|5.9|||
3722711|NCT02091466|3561348|B2|||Age||years|Mean|28.4|28.4|Standard Deviation|6.0|6.0|||
3722712|NCT02091466|3561349|B1|||Age||years|Mean|29.1|29.1|Standard Deviation|5.9|5.9|||
3722713|NCT02091414|3561356|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3722714|NCT02091414|3561356|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3722715|NCT02091414|3561356|B1|||Age||years|Mean|44.83|44.83|Standard Deviation|11.89|11.89|||
3722716|NCT02091375|3561368|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3722717|NCT02091375|3561369|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3722718|NCT02091375|3561370|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3722719|NCT02091375|3561368|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3722720|NCT02091375|3561369|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3722721|NCT02091375|3561370|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3722722|NCT02091375|3561368|B3|||Age||Years|Mean|9.757|9.757|Standard Deviation|4.7699|4.7699|||
3722723|NCT02091375|3561369|B2|||Age||Years|Mean|9.779|9.779|Standard Deviation|4.8505|4.8505|||
3722724|NCT02091375|3561370|B1|||Age||Years|Mean|9.736|9.736|Standard Deviation|4.7309|4.7309|||
3722725|NCT02091362|3561399|B3|< 7.5%||Hemoglobin A1c (HBA1c)||Participants|Count of Participants|170|170.0||||||
3722726|NCT02091362|3561400|B2|< 7.5%||Hemoglobin A1c (HBA1c)||Participants|Count of Participants|86|86.0||||||
3722727|NCT02091362|3561401|B1|< 7.5%||Hemoglobin A1c (HBA1c)||Participants|Count of Participants|84|84.0||||||
3722728|NCT02091362|3561399|B3|≥ 7.5 %||Hemoglobin A1c (HBA1c)||Participants|Count of Participants|100|100.0||||||
3722729|NCT02091362|3561400|B2|≥ 7.5 %||Hemoglobin A1c (HBA1c)||Participants|Count of Participants|51|51.0||||||
3722730|NCT02091362|3561401|B1|≥ 7.5 %||Hemoglobin A1c (HBA1c)||Participants|Count of Participants|49|49.0||||||
3722731|NCT02091362|3561399|B3|No||Diagnosis of Hypertension||Participants|Count of Participants|88|88.0||||||
3722732|NCT02091362|3561400|B2|No||Diagnosis of Hypertension||Participants|Count of Participants|44|44.0||||||
3722733|NCT02091362|3561401|B1|No||Diagnosis of Hypertension||Participants|Count of Participants|44|44.0||||||
3722734|NCT02091362|3561399|B3|Yes||Diagnosis of Hypertension||Participants|Count of Participants|182|182.0||||||
3722735|NCT02091362|3561400|B2|Yes||Diagnosis of Hypertension||Participants|Count of Participants|93|93.0||||||
3722736|NCT02091362|3561401|B1|Yes||Diagnosis of Hypertension||Participants|Count of Participants|89|89.0||||||
3722737|NCT02091362|3561399|B3|Mexico||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
3722738|NCT02091362|3561400|B2|Mexico||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3722739|NCT02091362|3561401|B1|Mexico||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3722740|NCT02091362|3561399|B3|Poland||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3722741|NCT02091362|3561400|B2|Poland||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3722742|NCT02091362|3561401|B1|Poland||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3722743|NCT02091362|3561399|B3|United States||Region of Enrollment||Participants|Count of Participants|146|146.0||||||
3722744|NCT02091362|3561400|B2|United States||Region of Enrollment||Participants|Count of Participants|74|74.0||||||
3722745|NCT02091362|3561401|B1|United States||Region of Enrollment||Participants|Count of Participants|72|72.0||||||
3722746|NCT02091362|3561399|B3|Czechia||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3722747|NCT02091362|3561400|B2|Czechia||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3722748|NCT02091362|3561401|B1|Czechia||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3722971|NCT02089659|3561586|B1|||Age||Years|Mean|59|59.0|Full Range|||54.0|64.0|
3722749|NCT02091362|3561399|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722750|NCT02091362|3561400|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722751|NCT02091362|3561401|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722752|NCT02091362|3561399|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3722753|NCT02091362|3561400|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3722754|NCT02091362|3561401|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3722755|NCT02091362|3561399|B3||White|Race (NIH/OMB)||Participants|Count of Participants|179|179.0||||||
3722756|NCT02091362|3561400|B2||White|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3722757|NCT02091362|3561401|B1||White|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
3722758|NCT02091362|3561399|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3722759|NCT02091362|3561400|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3722760|NCT02091362|3561401|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3722761|NCT02091362|3561399|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722762|NCT02091362|3561400|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722763|NCT02091362|3561401|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722764|NCT02091362|3561399|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3722765|NCT02091362|3561400|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3722766|NCT02091362|3561401|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3722767|NCT02091362|3561399|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3722768|NCT02091362|3561400|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3722769|NCT02091362|3561401|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3722770|NCT02091362|3561399|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3722771|NCT02091362|3561400|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3722772|NCT02091362|3561401|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3722773|NCT02091362|3561399|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
3722774|NCT02091362|3561400|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3722775|NCT02091362|3561401|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3722776|NCT02091362|3561399|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
3722777|NCT02091362|3561400|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3722778|NCT02091362|3561401|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3722779|NCT02091362|3561399|B3||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3722780|NCT02091362|3561400|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3722781|NCT02091362|3561401|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3722782|NCT02091362|3561399|B3||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3722783|NCT02091362|3561400|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3722784|NCT02091362|3561401|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3722785|NCT02091362|3561399|B3|||Age||years|Mean|57.7|57.7|Standard Deviation|8.9|8.9|||
3722786|NCT02091362|3561400|B2|||Age||years|Mean|57.2|57.2|Standard Deviation|8.9|8.9|||
3722787|NCT02091362|3561401|B1|||Age||years|Mean|58.3|58.3|Standard Deviation|8.9|8.9|||
3722788|NCT02091206|3561422|B5||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3722789|NCT02091206|3561423|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3722790|NCT02091206|3561424|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3722791|NCT02091206|3561425|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3722792|NCT02091206|3561426|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3722793|NCT02091206|3561422|B5||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3722794|NCT02091206|3561423|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3722795|NCT02091206|3561424|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3722796|NCT02091206|3561425|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3722797|NCT02091206|3561426|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3722798|NCT02091206|3561422|B5|||Age||Years|Mean|7.568|7.568|Standard Deviation|1.8300|1.83|||
3722799|NCT02091206|3561423|B4|||Age||Years|Mean|6.978|6.978|Standard Deviation|0.9476|0.9476|||
3722800|NCT02091206|3561424|B3|||Age||Years|Mean|8.671|8.671|Standard Deviation|1.7957|1.7957|||
3722801|NCT02091206|3561425|B2|||Age||Years|Mean|7.368|7.368|Standard Deviation|2.1229|2.1229|||
3722802|NCT02091206|3561426|B1|||Age||Years|Mean|7.150|7.15|Standard Deviation|1.8955|1.8955|||
3722803|NCT02090894|3561446|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3722804|NCT02090894|3561446|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722805|NCT02090894|3561446|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722806|NCT02090894|3561446|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3722807|NCT02090894|3561446|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722808|NCT02090894|3561446|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722809|NCT02090894|3561446|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722810|NCT02090894|3561446|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3722811|NCT02090894|3561446|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3722812|NCT02090894|3561446|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3722813|NCT02090894|3561446|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3722814|NCT02090894|3561446|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3722815|NCT02090894|3561446|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3722816|NCT02090855|3561451|B1|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3722817|NCT02090855|3561451|B1|United States||Region of Enrollment||participants|Number|102|102.0||||||
3722818|NCT02090855|3561451|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3722819|NCT02090855|3561451|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3722820|NCT02090855|3561451|B1||>=65 years|Age||Participants|Count of Participants|98|98.0||||||
3722821|NCT02090855|3561451|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3722822|NCT02090855|3561451|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3722823|NCT02090855|3561451|B1|||Age||years|Mean|80.8|80.8|Standard Deviation|8.87|8.87|||
3722824|NCT02090777|3561458|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3722825|NCT02090777|3561458|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3722826|NCT02090777|3561458|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3722827|NCT02090777|3561458|B1|||Age||years|Mean|73|73.0|Full Range|||69.0|83.0|
3722828|NCT02090777|3561458|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3722829|NCT02090777|3561458|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3722830|NCT02090777|3561458|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3722831|NCT02090764|3561462|B3|United States||Region of Enrollment||participants|Number|139|139.0||||||
3722832|NCT02090764|3561463|B2|United States||Region of Enrollment||participants|Number|74|74.0||||||
3722833|NCT02090764|3561464|B1|United States||Region of Enrollment||participants|Number|65|65.0||||||
3722834|NCT02090764|3561462|B3|Spain||Region of Enrollment||participants|Number|3|3.0||||||
3722835|NCT02090764|3561463|B2|Spain||Region of Enrollment||participants|Number|2|2.0||||||
3722836|NCT02090764|3561464|B1|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3722837|NCT02090764|3561462|B3|South Africa||Region of Enrollment||participants|Number|77|77.0||||||
3722838|NCT02090764|3561463|B2|South Africa||Region of Enrollment||participants|Number|34|34.0||||||
3722839|NCT02090764|3561464|B1|South Africa||Region of Enrollment||participants|Number|43|43.0||||||
3722840|NCT02090764|3561462|B3|Russian Federation||Region of Enrollment||participants|Number|57|57.0||||||
3722841|NCT02090764|3561463|B2|Russian Federation||Region of Enrollment||participants|Number|30|30.0||||||
3722842|NCT02090764|3561464|B1|Russian Federation||Region of Enrollment||participants|Number|27|27.0||||||
3722843|NCT02090764|3561462|B3|Romania||Region of Enrollment||participants|Number|52|52.0||||||
3722844|NCT02090764|3561463|B2|Romania||Region of Enrollment||participants|Number|26|26.0||||||
3722845|NCT02090764|3561464|B1|Romania||Region of Enrollment||participants|Number|26|26.0||||||
3722846|NCT02090764|3561462|B3|Germany||Region of Enrollment||participants|Number|37|37.0||||||
3722847|NCT02090764|3561463|B2|Germany||Region of Enrollment||participants|Number|16|16.0||||||
3722848|NCT02090764|3561464|B1|Germany||Region of Enrollment||participants|Number|21|21.0||||||
3722849|NCT02090764|3561462|B3|Puerto Rico||Region of Enrollment||participants|Number|46|46.0||||||
3722850|NCT02090764|3561463|B2|Puerto Rico||Region of Enrollment||participants|Number|23|23.0||||||
3722851|NCT02090764|3561464|B1|Puerto Rico||Region of Enrollment||participants|Number|23|23.0||||||
3722852|NCT02090764|3561462|B3|Mixed Race||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3722853|NCT02090764|3561463|B2|Mixed Race||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3722854|NCT02090764|3561464|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3722855|NCT02090764|3561462|B3|Asian||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3722856|NCT02090764|3561463|B2|Asian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3722857|NCT02090764|3561464|B1|Asian||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3722858|NCT02090764|3561462|B3|Black||Race/Ethnicity, Customized||participants|Number|91|91.0||||||
3722859|NCT02090764|3561463|B2|Black||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
3722860|NCT02090764|3561464|B1|Black||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
3722861|NCT02090764|3561462|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|261|261.0||||||
3722862|NCT02090764|3561463|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|139|139.0||||||
3722863|NCT02090764|3561464|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|122|122.0||||||
3722864|NCT02090764|3561462|B3||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
3722865|NCT02090764|3561463|B2||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3722866|NCT02090764|3561464|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3722867|NCT02090764|3561462|B3||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3722868|NCT02090764|3561463|B2||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3722869|NCT02090764|3561464|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3722870|NCT02090764|3561462|B3|>= 2 months to <12 years||Age, Customized||participants|Number|226|226.0||||||
3722871|NCT02090764|3561463|B2|>= 2 months to <12 years||Age, Customized||participants|Number|112|112.0||||||
3722872|NCT02090764|3561464|B1|>= 2 months to <12 years||Age, Customized||participants|Number|114|114.0||||||
3722873|NCT02090764|3561462|B3|>=12 years to <18 years||Age, Customized||participants|Number|46|46.0||||||
3722874|NCT02090764|3561463|B2|>=12 years to <18 years||Age, Customized||participants|Number|23|23.0||||||
3722875|NCT02090764|3561464|B1|>=12 years to <18 years||Age, Customized||participants|Number|23|23.0||||||
3722876|NCT02090764|3561462|B3|>=18 years||Age, Customized||participants|Number|139|139.0||||||
3722877|NCT02090764|3561463|B2|>=18 years||Age, Customized||participants|Number|70|70.0||||||
3722878|NCT02090764|3561464|B1|>=18 years||Age, Customized||participants|Number|69|69.0||||||
3722879|NCT02090413|3561471|B4||Male|Gender||Participants|Count of Participants|60|60.0||||||
3722880|NCT02090413|3561472|B3||Male|Gender||Participants|Count of Participants|20|20.0||||||
3722881|NCT02090413|3561473|B2||Male|Gender||Participants|Count of Participants|18|18.0||||||
3722882|NCT02090413|3561474|B1||Male|Gender||Participants|Count of Participants|22|22.0||||||
3722883|NCT02090413|3561471|B4||Female|Gender||Participants|Count of Participants|181|181.0||||||
3722884|NCT02090413|3561472|B3||Female|Gender||Participants|Count of Participants|60|60.0||||||
3722885|NCT02090413|3561473|B2||Female|Gender||Participants|Count of Participants|62|62.0||||||
3722886|NCT02090413|3561474|B1||Female|Gender||Participants|Count of Participants|59|59.0||||||
3722887|NCT02090413|3561471|B4|||Age||years|Mean|39.94|39.94|Standard Deviation|9.15|9.15|||
3722888|NCT02090413|3561472|B3|||Age||years|Mean|40.16|40.16|Standard Deviation|8.23|8.23|||
3722889|NCT02090413|3561473|B2|||Age||years|Mean|39.48|39.48|Standard Deviation|8.48|8.48|||
3722890|NCT02090413|3561474|B1|||Age||years|Mean|40.17|40.17|Standard Deviation|10.63|10.63|||
3722891|NCT02090088|3561550|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3722892|NCT02090088|3561550|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3722893|NCT02090088|3561550|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3722894|NCT02090088|3561550|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3722895|NCT02090088|3561550|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3722896|NCT02089997|3561562|B1|Had No Concomitant Medication||Concomitant Medication||Participants|Number|546|546.0||||||
3722897|NCT02089997|3561562|B1|Had Concomitant Medication||Concomitant Medication||Participants|Number|2512|2512.0||||||
3722898|NCT02089997|3561562|B1|Had No Treatment Drug||Pretreatment Osteoporosis Drug||Participants|Number|1909|1909.0||||||
3722899|NCT02089997|3561562|B1|Had Treatment Drug||Pretreatment Osteoporosis Drug||Participants|Number|1149|1149.0||||||
3722900|NCT02089997|3561562|B1|Unknown||Medical History（not Inclusive of a History of Fractures）|Medical history defined as a disease or a health condition for each participant before start of the study. Medical history was classified as congenital anomalies, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, GI disorders, hepatic and biliary disorders, renal disease and other medical history and Bone Fractures were out of scope for Medical history in this study. Other medical history included all medical history except for those mentioned above. Participants may be represented in more than 1 category.|Participants|Number|207|207.0||||||
3722901|NCT02089997|3561562|B1|Had No Medical History||Medical History（not Inclusive of a History of Fractures）|Medical history defined as a disease or a health condition for each participant before start of the study. Medical history was classified as congenital anomalies, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, GI disorders, hepatic and biliary disorders, renal disease and other medical history and Bone Fractures were out of scope for Medical history in this study. Other medical history included all medical history except for those mentioned above. Participants may be represented in more than 1 category.|Participants|Number|2264|2264.0||||||
3722902|NCT02089997|3561562|B1|Had Medical History||Medical History（not Inclusive of a History of Fractures）|Medical history defined as a disease or a health condition for each participant before start of the study. Medical history was classified as congenital anomalies, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, GI disorders, hepatic and biliary disorders, renal disease and other medical history and Bone Fractures were out of scope for Medical history in this study. Other medical history included all medical history except for those mentioned above. Participants may be represented in more than 1 category.|Participants|Number|587|587.0||||||
3722903|NCT02089997|3561562|B1|Had No Presence of Medical Complications||Medical Complications|Complications defined as a disease or a health condition for each participant at the start of study. Complications were classified as congenital anomalies, endocrine disorders, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, gastrointestinal (GI) disorders, renal disease and other complications. Other complications included all complications except for those mentioned above. Participants may be represented in more than 1 category.|Participants|Number|409|409.0||||||
3722904|NCT02089997|3561562|B1|Had Presence of Medical Complications||Medical Complications|Complications defined as a disease or a health condition for each participant at the start of study. Complications were classified as congenital anomalies, endocrine disorders, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, gastrointestinal (GI) disorders, renal disease and other complications. Other complications included all complications except for those mentioned above. Participants may be represented in more than 1 category.|Participants|Number|2649|2649.0||||||
3722905|NCT02089997|3561562|B1|Unknown||Predisposition to Hypersensitivity||Participants|Number|249|249.0||||||
3722906|NCT02089997|3561562|B1|Had Predisposition to Hypersensitivity||Predisposition to Hypersensitivity||Participants|Number|151|151.0||||||
3722907|NCT02089997|3561562|B1|Had No Predisposition to Hypersensitivity||Predisposition to Hypersensitivity||Participants|Number|2658|2658.0||||||
3722908|NCT02089997|3561562|B1|Unknown||Osteoporosis Class||Participants|Number|130|130.0||||||
3722909|NCT02089997|3561562|B1|Secondary Osteoporosis||Osteoporosis Class||Participants|Number|232|232.0||||||
3722910|NCT02089997|3561562|B1|Primary Osteoporosis||Osteoporosis Class||Participants|Number|2696|2696.0||||||
3722911|NCT02089997|3561562|B1|Unknown||BMI|Body Mass Index = weight (kg)/[height (m)^2]|Participants|Number|1497|1497.0||||||
3722912|NCT02089997|3561562|B1|≥ 25.0kg/m^2||BMI|Body Mass Index = weight (kg)/[height (m)^2]|Participants|Number|291|291.0||||||
3722913|NCT02089997|3561562|B1|≥ 18.5kg/m^2 < 25.0kg/m^2||BMI|Body Mass Index = weight (kg)/[height (m)^2]|Participants|Number|1108|1108.0||||||
3722914|NCT02089997|3561562|B1|< 18.5kg/m^2||BMI|Body Mass Index = weight (kg)/[height (m)^2]|Participants|Number|162|162.0||||||
3722915|NCT02089997|3561562|B1|Unknown||Weight||Participants|Number|1055|1055.0||||||
3722916|NCT02089997|3561562|B1|≥ 50.0 kg||Weight||Participants|Number|953|953.0||||||
3722917|NCT02089997|3561562|B1|< 50.0 kg||Weight||Participants|Number|1050|1050.0||||||
3722918|NCT02089997|3561562|B1|Unknown||Pregnancy Status|This baseline characteristic was analyzed only in female participants.|Participants|Number|488|488.0||||||
3722919|NCT02089997|3561562|B1|Not pregnant||Pregnancy Status|This baseline characteristic was analyzed only in female participants.|Participants|Number|2329|2329.0||||||
3722920|NCT02089997|3561562|B1|Pregnant||Pregnancy Status|This baseline characteristic was analyzed only in female participants.|Participants|Number|0|0.0||||||
3722921|NCT02089997|3561562|B1|Japan||Region of Enrollment|All participants were enrolled in Japan.|Participants|Number|3058|3058.0||||||
3722922|NCT02089997|3561562|B1||Male|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
3722923|NCT02089997|3561562|B1||Female|Sex: Female, Male||Participants|Count of Participants|2817|2817.0||||||
3722924|NCT02089997|3561562|B1|Unknown||Age, Customized||Participants|Number|7|7.0||||||
3722925|NCT02089997|3561562|B1|≥ 65 years||Age, Customized||Participants|Number|2678|2678.0||||||
3722926|NCT02089997|3561562|B1|< 65 years||Age, Customized||Participants|Number|373|373.0||||||
3722927|NCT02089737|3561577|B1|Unknown||Metastatic lesions/sites of relapse||Participants|Number|1|1.0||||||
3722928|NCT02089737|3561577|B1|Yes||Metastatic lesions/sites of relapse||Participants|Number|3046|3046.0||||||
3722929|NCT02089737|3561577|B1|No||Metastatic lesions/sites of relapse||Participants|Number|38|38.0||||||
3722930|NCT02089737|3561577|B1|Unknown||Eastern Cooperative Oncology Group Performance Status (ECOG-PS) at baseline|ECOG-PS is measured on 6-point scale to assess participant's performance status. 0=Fully active, able to carry on all pre-disease activities without restriction; 1=Restricted in physically strenuous activity, but ambulatory and able to carry out light or sedentary work; 2=Ambulatory (>50% of waking hours), capable of all selfcare, but unable to carry out any work activities; 3=Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours; 4=Completely disabled, cannot carry on any selfcare, totally confined to bed or chair; 5=Dead.|Participants|Number|0|0.0||||||
3722931|NCT02089737|3561577|B1|PS:4||Eastern Cooperative Oncology Group Performance Status (ECOG-PS) at baseline|ECOG-PS is measured on 6-point scale to assess participant's performance status. 0=Fully active, able to carry on all pre-disease activities without restriction; 1=Restricted in physically strenuous activity, but ambulatory and able to carry out light or sedentary work; 2=Ambulatory (>50% of waking hours), capable of all selfcare, but unable to carry out any work activities; 3=Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours; 4=Completely disabled, cannot carry on any selfcare, totally confined to bed or chair; 5=Dead.|Participants|Number|3|3.0||||||
3722932|NCT02089737|3561577|B1|PS:3||Eastern Cooperative Oncology Group Performance Status (ECOG-PS) at baseline|ECOG-PS is measured on 6-point scale to assess participant's performance status. 0=Fully active, able to carry on all pre-disease activities without restriction; 1=Restricted in physically strenuous activity, but ambulatory and able to carry out light or sedentary work; 2=Ambulatory (>50% of waking hours), capable of all selfcare, but unable to carry out any work activities; 3=Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours; 4=Completely disabled, cannot carry on any selfcare, totally confined to bed or chair; 5=Dead.|Participants|Number|22|22.0||||||
3722933|NCT02089737|3561577|B1|PS:2||Eastern Cooperative Oncology Group Performance Status (ECOG-PS) at baseline|ECOG-PS is measured on 6-point scale to assess participant's performance status. 0=Fully active, able to carry on all pre-disease activities without restriction; 1=Restricted in physically strenuous activity, but ambulatory and able to carry out light or sedentary work; 2=Ambulatory (>50% of waking hours), capable of all selfcare, but unable to carry out any work activities; 3=Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours; 4=Completely disabled, cannot carry on any selfcare, totally confined to bed or chair; 5=Dead.|Participants|Number|241|241.0||||||
3722934|NCT02089737|3561577|B1|PS:1||Eastern Cooperative Oncology Group Performance Status (ECOG-PS) at baseline|ECOG-PS is measured on 6-point scale to assess participant's performance status. 0=Fully active, able to carry on all pre-disease activities without restriction; 1=Restricted in physically strenuous activity, but ambulatory and able to carry out light or sedentary work; 2=Ambulatory (>50% of waking hours), capable of all selfcare, but unable to carry out any work activities; 3=Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours; 4=Completely disabled, cannot carry on any selfcare, totally confined to bed or chair; 5=Dead.|Participants|Number|942|942.0||||||
3722935|NCT02089737|3561577|B1|PS:0||Eastern Cooperative Oncology Group Performance Status (ECOG-PS) at baseline|ECOG-PS is measured on 6-point scale to assess participant's performance status. 0=Fully active, able to carry on all pre-disease activities without restriction; 1=Restricted in physically strenuous activity, but ambulatory and able to carry out light or sedentary work; 2=Ambulatory (>50% of waking hours), capable of all selfcare, but unable to carry out any work activities; 3=Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours; 4=Completely disabled, cannot carry on any selfcare, totally confined to bed or chair; 5=Dead.|Participants|Number|1877|1877.0||||||
3722936|NCT02089737|3561577|B1|Unknown||Treatment stage (excluding posteroperative adjuvant chemotherapy)||Participants|Number|0|0.0||||||
3722937|NCT02089737|3561577|B1|Third-line or later||Treatment stage (excluding posteroperative adjuvant chemotherapy)||Participants|Number|2232|2232.0||||||
3722938|NCT02089737|3561577|B1|Second-line||Treatment stage (excluding posteroperative adjuvant chemotherapy)||Participants|Number|543|543.0||||||
3722939|NCT02089737|3561577|B1|First-line||Treatment stage (excluding posteroperative adjuvant chemotherapy)||Participants|Number|310|310.0||||||
3722940|NCT02089737|3561577|B1|Unknown||KRAS genotype||Participants|Number|0|0.0||||||
3722941|NCT02089737|3561577|B1|Not determined||KRAS genotype||Participants|Number|1|1.0||||||
3722942|NCT02089737|3561577|B1|Mutant||KRAS genotype||Participants|Number|3|3.0||||||
3722943|NCT02089737|3561577|B1|Non-measurable/non-assessable||KRAS genotype||Participants|Number|78|78.0||||||
3722944|NCT02089737|3561577|B1|Wild type||KRAS genotype||Participants|Number|3003|3003.0||||||
3722945|NCT02089737|3561577|B1|Japan||Region of Enrollment||Participants|Number|3085|3085.0||||||
3722946|NCT02089737|3561577|B1|Asian||Race/Ethnicity, Customized||Participants|Number|3085|3085.0||||||
3722947|NCT02089737|3561577|B1||Male|Sex: Female, Male||Participants|Count of Participants|1965|1965.0||||||
3722948|NCT02089737|3561577|B1||Female|Sex: Female, Male||Participants|Count of Participants|1120|1120.0||||||
3722949|NCT02089737|3561577|B1|>= 75 years||Age, Customized||Participants|Number|503|503.0||||||
3722950|NCT02089737|3561577|B1|< 75 years||Age, Customized||Participants|Number|2582|2582.0||||||
3722951|NCT02089659|3561584|B3|||Weight||kg|Mean|80.9|80.9|Full Range|||55.6|119.0|
3722952|NCT02089659|3561585|B2|||Weight||kg|Mean|79.8|79.8|Full Range|||66.0|92.1|
3722953|NCT02089659|3561586|B1|||Weight||kg|Mean|82.0|82.0|Full Range|||55.6|119.0|
3722954|NCT02089659|3561584|B3||Total Score = 9|Child-Pugh Total Score|The Child-Pugh scale was used to classify the severity of liver disease in study participants. The total score is the sum of the scores on 5 clinical measures of liver disease, each on a 3-point scale where 3 is greatest severity: total bilirubin, serum albumin, INR, ascites, and hepatic encephalopathy. The total Child-Pugh score ranges from 5 to 15, where a score of 7 to 9 represents moderate hepatic insufficiency.|Participants|Count of Participants|2|2.0||||||
3722955|NCT02089659|3561585|B2||Total Score = 9|Child-Pugh Total Score|The Child-Pugh scale was used to classify the severity of liver disease in study participants. The total score is the sum of the scores on 5 clinical measures of liver disease, each on a 3-point scale where 3 is greatest severity: total bilirubin, serum albumin, INR, ascites, and hepatic encephalopathy. The total Child-Pugh score ranges from 5 to 15, where a score of 7 to 9 represents moderate hepatic insufficiency.|Participants|Count of Participants|0|0.0||||||
3722956|NCT02089659|3561586|B1||Total Score = 9|Child-Pugh Total Score|The Child-Pugh scale was used to classify the severity of liver disease in study participants. The total score is the sum of the scores on 5 clinical measures of liver disease, each on a 3-point scale where 3 is greatest severity: total bilirubin, serum albumin, INR, ascites, and hepatic encephalopathy. The total Child-Pugh score ranges from 5 to 15, where a score of 7 to 9 represents moderate hepatic insufficiency.|Participants|Count of Participants|2|2.0||||||
3722957|NCT02089659|3561584|B3||Total Score = 8|Child-Pugh Total Score|The Child-Pugh scale was used to classify the severity of liver disease in study participants. The total score is the sum of the scores on 5 clinical measures of liver disease, each on a 3-point scale where 3 is greatest severity: total bilirubin, serum albumin, INR, ascites, and hepatic encephalopathy. The total Child-Pugh score ranges from 5 to 15, where a score of 7 to 9 represents moderate hepatic insufficiency.|Participants|Count of Participants|4|4.0||||||
3722958|NCT02089659|3561585|B2||Total Score = 8|Child-Pugh Total Score|The Child-Pugh scale was used to classify the severity of liver disease in study participants. The total score is the sum of the scores on 5 clinical measures of liver disease, each on a 3-point scale where 3 is greatest severity: total bilirubin, serum albumin, INR, ascites, and hepatic encephalopathy. The total Child-Pugh score ranges from 5 to 15, where a score of 7 to 9 represents moderate hepatic insufficiency.|Participants|Count of Participants|0|0.0||||||
3722959|NCT02089659|3561586|B1||Total Score = 8|Child-Pugh Total Score|The Child-Pugh scale was used to classify the severity of liver disease in study participants. The total score is the sum of the scores on 5 clinical measures of liver disease, each on a 3-point scale where 3 is greatest severity: total bilirubin, serum albumin, INR, ascites, and hepatic encephalopathy. The total Child-Pugh score ranges from 5 to 15, where a score of 7 to 9 represents moderate hepatic insufficiency.|Participants|Count of Participants|4|4.0||||||
3722960|NCT02089659|3561584|B3||Total Score = 7|Child-Pugh Total Score|The Child-Pugh scale was used to classify the severity of liver disease in study participants. The total score is the sum of the scores on 5 clinical measures of liver disease, each on a 3-point scale where 3 is greatest severity: total bilirubin, serum albumin, INR, ascites, and hepatic encephalopathy. The total Child-Pugh score ranges from 5 to 15, where a score of 7 to 9 represents moderate hepatic insufficiency.|Participants|Count of Participants|2|2.0||||||
3722961|NCT02089659|3561585|B2||Total Score = 7|Child-Pugh Total Score|The Child-Pugh scale was used to classify the severity of liver disease in study participants. The total score is the sum of the scores on 5 clinical measures of liver disease, each on a 3-point scale where 3 is greatest severity: total bilirubin, serum albumin, INR, ascites, and hepatic encephalopathy. The total Child-Pugh score ranges from 5 to 15, where a score of 7 to 9 represents moderate hepatic insufficiency.|Participants|Count of Participants|0|0.0||||||
3722962|NCT02089659|3561586|B1||Total Score = 7|Child-Pugh Total Score|The Child-Pugh scale was used to classify the severity of liver disease in study participants. The total score is the sum of the scores on 5 clinical measures of liver disease, each on a 3-point scale where 3 is greatest severity: total bilirubin, serum albumin, INR, ascites, and hepatic encephalopathy. The total Child-Pugh score ranges from 5 to 15, where a score of 7 to 9 represents moderate hepatic insufficiency.|Participants|Count of Participants|2|2.0||||||
3722963|NCT02089659|3561584|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3722964|NCT02089659|3561585|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3722965|NCT02089659|3561586|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3722966|NCT02089659|3561584|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3722967|NCT02089659|3561585|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3722968|NCT02089659|3561586|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3722969|NCT02089659|3561584|B3|||Age||Years|Mean|57|57.0|Full Range|||44.0|64.0|
3722970|NCT02089659|3561585|B2|||Age||Years|Mean|56|56.0|Full Range|||44.0|63.0|
3722972|NCT02089347|3561600|B3|Japan||Region of Enrollment||Participants|Number|534|534.0||||||
3722973|NCT02089347|3561601|B2|Japan||Region of Enrollment||Participants|Number|178|178.0||||||
3722974|NCT02089347|3561602|B1|Japan||Region of Enrollment||Participants|Number|356|356.0||||||
3722975|NCT02089347|3561600|B3||Male|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
3722976|NCT02089347|3561601|B2||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3722977|NCT02089347|3561602|B1||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
3722978|NCT02089347|3561600|B3||Female|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
3722979|NCT02089347|3561601|B2||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3722980|NCT02089347|3561602|B1||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3722981|NCT02089347|3561600|B3|Age Continuous||Age||Years|Mean|11.2|11.2|Standard Deviation|0.4|0.4|||
3722982|NCT02089347|3561601|B2|Age Continuous||Age||Years|Mean|11.2|11.2|Standard Deviation|0.4|0.4|||
3722983|NCT02089347|3561602|B1|Age Continuous||Age||Years|Mean|11.2|11.2|Standard Deviation|0.4|0.4|||
3722984|NCT02089347|3561600|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3722985|NCT02089347|3561601|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3722986|NCT02089347|3561602|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3722987|NCT02089347|3561600|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3722988|NCT02089347|3561601|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3722989|NCT02089347|3561602|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3722990|NCT02089347|3561600|B3||<=18 years|Age||Participants|Count of Participants|534|534.0||||||
3722991|NCT02089347|3561601|B2||<=18 years|Age||Participants|Count of Participants|178|178.0||||||
3722992|NCT02089347|3561602|B1||<=18 years|Age||Participants|Count of Participants|356|356.0||||||
3722993|NCT02089191|3561625|B1|Germany||Region of Enrollment||participants|Number|31|31.0||||||
3722994|NCT02089191|3561625|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3722995|NCT02089191|3561625|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3722996|NCT02089191|3561625|B1|||Age||years|Mean|25.3|25.3|Standard Deviation|3.11|3.11|||
3722997|NCT02089113|3561634|B3||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3722998|NCT02089113|3561635|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3722999|NCT02089113|3561636|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3723000|NCT02089113|3561634|B3||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3723001|NCT02089113|3561635|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3723002|NCT02089113|3561636|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3723003|NCT02089113|3561634|B3||>=65 years|Age||Participants|Count of Participants|170|170.0||||||
3723004|NCT02089113|3561635|B2||>=65 years|Age||Participants|Count of Participants|58|58.0||||||
3723005|NCT02089113|3561636|B1||>=65 years|Age||Participants|Count of Participants|112|112.0||||||
3723006|NCT02089113|3561634|B3||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
3723007|NCT02089113|3561635|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3723008|NCT02089113|3561636|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3723009|NCT02089113|3561634|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3723010|NCT02089113|3561635|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3723011|NCT02089113|3561636|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3723012|NCT02088957|3561643|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3723013|NCT02088957|3561643|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3723014|NCT02088957|3561643|B1|||Age||years|Mean|18|18.0|Standard Deviation|0|0.0|||
3723015|NCT02088957|3561643|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3723016|NCT02088957|3561643|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3723017|NCT02088957|3561643|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3723018|NCT02088788|3561660|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3723019|NCT02088788|3561660|B3||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3723020|NCT02088788|3561661|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3723021|NCT02088788|3561662|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3723022|NCT02088788|3561660|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3723023|NCT02088788|3561661|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3723024|NCT02088788|3561662|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3723025|NCT02088788|3561660|B3|||Age||years|Mean|64.5|64.5|Standard Deviation|10.94|10.94|||
3723026|NCT02088788|3561661|B2|||Age||years|Mean|64.2|64.2|Standard Deviation|9.5|9.5|||
3723027|NCT02088788|3561662|B1|||Age||years|Mean|64.8|64.8|Standard Deviation|12.1|12.1|||
3723028|NCT02088177|3561671|B1||College Graduate|education level||Participants|Count of Participants|4|4.0||||||
3723029|NCT02088177|3561671|B1||post high school technical training|education level||Participants|Count of Participants|1|1.0||||||
3723030|NCT02088177|3561671|B1||Some College|education level||Participants|Count of Participants|1|1.0||||||
3723031|NCT02088177|3561671|B1||High School|education level||Participants|Count of Participants|6|6.0||||||
3723032|NCT02088177|3561671|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3723033|NCT02088177|3561671|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723034|NCT02088177|3561671|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3723035|NCT02088177|3561671|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3723036|NCT02088177|3561671|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723037|NCT02088177|3561671|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723038|NCT02088177|3561671|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723039|NCT02088177|3561671|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3723040|NCT02088177|3561671|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3723041|NCT02088177|3561671|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3723042|NCT02088177|3561671|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3723043|NCT02088177|3561671|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3723044|NCT02088177|3561671|B1|||Age||years|Mean|35.42|35.42|Standard Deviation|9.73|9.73|||
3723045|NCT02088073|3561676|B6|Heart failure, Maintenance Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|87|87.0||||||
3723046|NCT02088073|3561677|B5|Heart failure, Maintenance Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|25|25.0||||||
3723047|NCT02088073|3561678|B4|Heart failure, Maintenance Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|18|18.0||||||
3723048|NCT02088073|3561679|B3|Heart failure, Maintenance Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|18|18.0||||||
3723049|NCT02088073|3561680|B2|Heart failure, Maintenance Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|26|26.0||||||
3723050|NCT02088073|3561681|B1|Heart failure, Maintenance Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|0|0.0||||||
3723051|NCT02088073|3561676|B6|Chronic kidney disease, Maintenance Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|152|152.0||||||
3723052|NCT02088073|3561677|B5|Chronic kidney disease, Maintenance Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|37|37.0||||||
3723053|NCT02088073|3561678|B4|Chronic kidney disease, Maintenance Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|36|36.0||||||
3723054|NCT02088073|3561679|B3|Chronic kidney disease, Maintenance Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|29|29.0||||||
3723055|NCT02088073|3561680|B2|Chronic kidney disease, Maintenance Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|50|50.0||||||
3723056|NCT02088073|3561681|B1|Chronic kidney disease, Maintenance Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|0|0.0||||||
3723057|NCT02088073|3561676|B6|Diabetes mellitus, Maintenance Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|157|157.0||||||
3723058|NCT02088073|3561677|B5|Diabetes mellitus, Maintenance Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|39|39.0||||||
3723059|NCT02088073|3561678|B4|Diabetes mellitus, Maintenance Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|38|38.0||||||
3723060|NCT02088073|3561679|B3|Diabetes mellitus, Maintenance Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|26|26.0||||||
3723061|NCT02088073|3561680|B2|Diabetes mellitus, Maintenance Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|54|54.0||||||
3723062|NCT02088073|3561681|B1|Diabetes mellitus, Maintenance Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|0|0.0||||||
3723063|NCT02088073|3561676|B6|RAAS inhibitor medication, Maintenance Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|163|163.0||||||
3723064|NCT02088073|3561677|B5|RAAS inhibitor medication, Maintenance Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|33|33.0||||||
3723065|NCT02088073|3561678|B4|RAAS inhibitor medication, Maintenance Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|36|36.0||||||
3723066|NCT02088073|3561679|B3|RAAS inhibitor medication, Maintenance Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|33|33.0||||||
3723067|NCT02088073|3561680|B2|RAAS inhibitor medication, Maintenance Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|61|61.0||||||
3723068|NCT02088073|3561681|B1|RAAS inhibitor medication, Maintenance Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|0|0.0||||||
3723069|NCT02088073|3561676|B6|Heart failure, Acute Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|94|94.0||||||
3723070|NCT02088073|3561677|B5|Heart failure, Acute Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|0|0.0||||||
3723071|NCT02088073|3561678|B4|Heart failure, Acute Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|0|0.0||||||
3723072|NCT02088073|3561679|B3|Heart failure, Acute Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|0|0.0||||||
3723073|NCT02088073|3561680|B2|Heart failure, Acute Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|0|0.0||||||
3723074|NCT02088073|3561681|B1|Heart failure, Acute Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|94|94.0||||||
3723075|NCT02088073|3561676|B6|Chronic kidney disease, Acute Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|169|169.0||||||
3723076|NCT02088073|3561677|B5|Chronic kidney disease, Acute Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|0|0.0||||||
3723077|NCT02088073|3561678|B4|Chronic kidney disease, Acute Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|0|0.0||||||
3723078|NCT02088073|3561679|B3|Chronic kidney disease, Acute Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|0|0.0||||||
3723079|NCT02088073|3561680|B2|Chronic kidney disease, Acute Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|0|0.0||||||
3723080|NCT02088073|3561681|B1|Chronic kidney disease, Acute Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|169|169.0||||||
3723081|NCT02088073|3561676|B6|Diabetes mellitus, Acute Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|170|170.0||||||
3723082|NCT02088073|3561677|B5|Diabetes mellitus, Acute Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|0|0.0||||||
3723083|NCT02088073|3561678|B4|Diabetes mellitus, Acute Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|0|0.0||||||
3723084|NCT02088073|3561679|B3|Diabetes mellitus, Acute Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|0|0.0||||||
3723085|NCT02088073|3561680|B2|Diabetes mellitus, Acute Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|0|0.0||||||
3723086|NCT02088073|3561681|B1|Diabetes mellitus, Acute Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|170|170.0||||||
3723087|NCT02088073|3561676|B6|RAAS inhibitor medication, Acute Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|180|180.0||||||
3723088|NCT02088073|3561677|B5|RAAS inhibitor medication, Acute Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|0|0.0||||||
3723089|NCT02088073|3561678|B4|RAAS inhibitor medication, Acute Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|0|0.0||||||
3723090|NCT02088073|3561679|B3|RAAS inhibitor medication, Acute Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|0|0.0||||||
3723091|NCT02088073|3561680|B2|RAAS inhibitor medication, Acute Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|0|0.0||||||
3723092|NCT02088073|3561681|B1|RAAS inhibitor medication, Acute Phase||Etiology of elevated S-K levels during both the Acute and Maintenance phases|Categories not mutually exclusive|Participants|Number|180|180.0||||||
3723093|NCT02088073|3561676|B6|Not reported, Maintenance Phase||eGFR at baseline during both the Acute and Maintenance phases||Participants|Number|7|7.0||||||
3723094|NCT02088073|3561677|B5|Not reported, Maintenance Phase||eGFR at baseline during both the Acute and Maintenance phases||Participants|Number|0|0.0||||||
3723095|NCT02088073|3561678|B4|Not reported, Maintenance Phase||eGFR at baseline during both the Acute and Maintenance phases||Participants|Number|0|0.0||||||
3723096|NCT02088073|3561679|B3|Not reported, Maintenance Phase||eGFR at baseline during both the Acute and Maintenance phases||Participants|Number|2|2.0||||||
3723097|NCT02088073|3561680|B2|Not reported, Maintenance Phase||eGFR at baseline during both the Acute and Maintenance phases||Participants|Number|5|5.0||||||
3723098|NCT02088073|3561681|B1|Not reported, Maintenance Phase||eGFR at baseline during both the Acute and Maintenance phases||Participants|Number|0|0.0||||||
3723099|NCT02088073|3561676|B6|≥ 60 mL/min, Maintenance Phase||eGFR at baseline during both the Acute and Maintenance phases||Participants|Number|68|68.0||||||
3723100|NCT02088073|3561677|B5|≥ 60 mL/min, Maintenance Phase||eGFR at baseline during both the Acute and Maintenance phases||Participants|Number|15|15.0||||||
3723101|NCT02088073|3561678|B4|≥ 60 mL/min, Maintenance Phase||eGFR at baseline during both the Acute and Maintenance phases||Participants|Number|13|13.0||||||
3723102|NCT02088073|3561679|B3|≥ 60 mL/min, Maintenance Phase||eGFR at baseline during both the Acute and Maintenance phases||Participants|Number|12|12.0||||||
3723103|NCT02088073|3561680|B2|≥ 60 mL/min, Maintenance Phase||eGFR at baseline during both the Acute and Maintenance phases||Participants|Number|28|28.0||||||
3723104|NCT02088073|3561681|B1|≥ 60 mL/min, Maintenance Phase||eGFR at baseline during both the Acute and Maintenance phases||Participants|Number|0|0.0||||||
3723105|NCT02088073|3561676|B6|<60 mL/min, Maintenance Phase||eGFR at baseline during both the Acute and Maintenance phases||Participants|Number|162|162.0||||||
3723106|NCT02088073|3561677|B5|<60 mL/min, Maintenance Phase||eGFR at baseline during both the Acute and Maintenance phases||Participants|Number|41|41.0||||||
3723107|NCT02088073|3561678|B4|<60 mL/min, Maintenance Phase||eGFR at baseline during both the Acute and Maintenance phases||Participants|Number|38|38.0||||||
3723108|NCT02088073|3561679|B3|<60 mL/min, Maintenance Phase||eGFR at baseline during both the Acute and Maintenance phases||Participants|Number|31|31.0||||||
3723197|NCT02088073|3561678|B4|White, Maintenance Phase||Race/Ethnicity, Customized||Participants|Number|44|44.0||||||
3723109|NCT02088073|3561680|B2|<60 mL/min, Maintenance Phase||eGFR at baseline during both the Acute and Maintenance phases||Participants|Number|52|52.0||||||
3723110|NCT02088073|3561681|B1|<60 mL/min, Maintenance Phase||eGFR at baseline during both the Acute and Maintenance phases||Participants|Number|0|0.0||||||
3723111|NCT02088073|3561676|B6|Not reported, Acute Phase||eGFR at baseline during both the Acute and Maintenance phases||Participants|Number|7|7.0||||||
3723112|NCT02088073|3561677|B5|Not reported, Acute Phase||eGFR at baseline during both the Acute and Maintenance phases||Participants|Number|0|0.0||||||
3723113|NCT02088073|3561678|B4|Not reported, Acute Phase||eGFR at baseline during both the Acute and Maintenance phases||Participants|Number|0|0.0||||||
3723114|NCT02088073|3561679|B3|Not reported, Acute Phase||eGFR at baseline during both the Acute and Maintenance phases||Participants|Number|0|0.0||||||
3723115|NCT02088073|3561680|B2|Not reported, Acute Phase||eGFR at baseline during both the Acute and Maintenance phases||Participants|Number|0|0.0||||||
3723116|NCT02088073|3561681|B1|Not reported, Acute Phase||eGFR at baseline during both the Acute and Maintenance phases||Participants|Number|7|7.0||||||
3723117|NCT02088073|3561676|B6|≥ 60 mL/min, Acute Phase||eGFR at baseline during both the Acute and Maintenance phases||Participants|Number|72|72.0||||||
3723118|NCT02088073|3561677|B5|≥ 60 mL/min, Acute Phase||eGFR at baseline during both the Acute and Maintenance phases||Participants|Number|0|0.0||||||
3723119|NCT02088073|3561678|B4|≥ 60 mL/min, Acute Phase||eGFR at baseline during both the Acute and Maintenance phases||Participants|Number|0|0.0||||||
3723120|NCT02088073|3561679|B3|≥ 60 mL/min, Acute Phase||eGFR at baseline during both the Acute and Maintenance phases||Participants|Number|0|0.0||||||
3723121|NCT02088073|3561680|B2|≥ 60 mL/min, Acute Phase||eGFR at baseline during both the Acute and Maintenance phases||Participants|Number|0|0.0||||||
3723122|NCT02088073|3561681|B1|≥ 60 mL/min, Acute Phase||eGFR at baseline during both the Acute and Maintenance phases||Participants|Number|72|72.0||||||
3723123|NCT02088073|3561676|B6|<60 mL/min, Acute Phase||eGFR at baseline during both the Acute and Maintenance phases||Participants|Number|179|179.0||||||
3723124|NCT02088073|3561677|B5|<60 mL/min, Acute Phase||eGFR at baseline during both the Acute and Maintenance phases||Participants|Number|0|0.0||||||
3723125|NCT02088073|3561678|B4|<60 mL/min, Acute Phase||eGFR at baseline during both the Acute and Maintenance phases||Participants|Number|0|0.0||||||
3723126|NCT02088073|3561679|B3|<60 mL/min, Acute Phase||eGFR at baseline during both the Acute and Maintenance phases||Participants|Number|0|0.0||||||
3723127|NCT02088073|3561680|B2|<60 mL/min, Acute Phase||eGFR at baseline during both the Acute and Maintenance phases||Participants|Number|0|0.0||||||
3723128|NCT02088073|3561681|B1|<60 mL/min, Acute Phase||eGFR at baseline during both the Acute and Maintenance phases||Participants|Number|179|179.0||||||
3723129|NCT02088073|3561676|B6|≥ 6.0 mmol/L, Maintenance Phase||Baseline Serum potassium ( S-K ) levels during both the Acute and Maintenance phases||Participants|Number|32|32.0||||||
3723130|NCT02088073|3561677|B5|≥ 6.0 mmol/L, Maintenance Phase||Baseline Serum potassium ( S-K ) levels during both the Acute and Maintenance phases||Participants|Number|6|6.0||||||
3723131|NCT02088073|3561678|B4|≥ 6.0 mmol/L, Maintenance Phase||Baseline Serum potassium ( S-K ) levels during both the Acute and Maintenance phases||Participants|Number|9|9.0||||||
3723132|NCT02088073|3561679|B3|≥ 6.0 mmol/L, Maintenance Phase||Baseline Serum potassium ( S-K ) levels during both the Acute and Maintenance phases||Participants|Number|5|5.0||||||
3723133|NCT02088073|3561680|B2|≥ 6.0 mmol/L, Maintenance Phase||Baseline Serum potassium ( S-K ) levels during both the Acute and Maintenance phases||Participants|Number|12|12.0||||||
3723134|NCT02088073|3561681|B1|≥ 6.0 mmol/L, Maintenance Phase||Baseline Serum potassium ( S-K ) levels during both the Acute and Maintenance phases||Participants|Number|0|0.0||||||
3723135|NCT02088073|3561676|B6|5.5-<6.0 mmol/L, Maintenance Phase||Baseline Serum potassium ( S-K ) levels during both the Acute and Maintenance phases||Participants|Number|96|96.0||||||
3723136|NCT02088073|3561677|B5|5.5-<6.0 mmol/L, Maintenance Phase||Baseline Serum potassium ( S-K ) levels during both the Acute and Maintenance phases||Participants|Number|26|26.0||||||
3723137|NCT02088073|3561678|B4|5.5-<6.0 mmol/L, Maintenance Phase||Baseline Serum potassium ( S-K ) levels during both the Acute and Maintenance phases||Participants|Number|23|23.0||||||
3723138|NCT02088073|3561679|B3|5.5-<6.0 mmol/L, Maintenance Phase||Baseline Serum potassium ( S-K ) levels during both the Acute and Maintenance phases||Participants|Number|17|17.0||||||
3723139|NCT02088073|3561680|B2|5.5-<6.0 mmol/L, Maintenance Phase||Baseline Serum potassium ( S-K ) levels during both the Acute and Maintenance phases||Participants|Number|30|30.0||||||
3723140|NCT02088073|3561681|B1|5.5-<6.0 mmol/L, Maintenance Phase||Baseline Serum potassium ( S-K ) levels during both the Acute and Maintenance phases||Participants|Number|0|0.0||||||
3723141|NCT02088073|3561676|B6|<5.5 mmol/L, Maintenance Phase||Baseline Serum potassium ( S-K ) levels during both the Acute and Maintenance phases||Participants|Number|109|109.0||||||
3723142|NCT02088073|3561677|B5|<5.5 mmol/L, Maintenance Phase||Baseline Serum potassium ( S-K ) levels during both the Acute and Maintenance phases||Participants|Number|24|24.0||||||
3723143|NCT02088073|3561678|B4|<5.5 mmol/L, Maintenance Phase||Baseline Serum potassium ( S-K ) levels during both the Acute and Maintenance phases||Participants|Number|19|19.0||||||
3723144|NCT02088073|3561679|B3|<5.5 mmol/L, Maintenance Phase||Baseline Serum potassium ( S-K ) levels during both the Acute and Maintenance phases||Participants|Number|23|23.0||||||
3723145|NCT02088073|3561680|B2|<5.5 mmol/L, Maintenance Phase||Baseline Serum potassium ( S-K ) levels during both the Acute and Maintenance phases||Participants|Number|43|43.0||||||
3723146|NCT02088073|3561681|B1|<5.5 mmol/L, Maintenance Phase||Baseline Serum potassium ( S-K ) levels during both the Acute and Maintenance phases||Participants|Number|0|0.0||||||
3723147|NCT02088073|3561676|B6|≥ 6.0 mmol/L, Acute Phase||Baseline Serum potassium ( S-K ) levels during both the Acute and Maintenance phases||Participants|Number|39|39.0||||||
3723148|NCT02088073|3561677|B5|≥ 6.0 mmol/L, Acute Phase||Baseline Serum potassium ( S-K ) levels during both the Acute and Maintenance phases||Participants|Number|0|0.0||||||
3723149|NCT02088073|3561678|B4|≥ 6.0 mmol/L, Acute Phase||Baseline Serum potassium ( S-K ) levels during both the Acute and Maintenance phases||Participants|Number|0|0.0||||||
3723253|NCT02088073|3561680|B2|Male, Acute Phase||Sex/Gender, Customized||Participants|Number|0|0.0||||||
3723150|NCT02088073|3561679|B3|≥ 6.0 mmol/L, Acute Phase||Baseline Serum potassium ( S-K ) levels during both the Acute and Maintenance phases||Participants|Number|0|0.0||||||
3723151|NCT02088073|3561680|B2|≥ 6.0 mmol/L, Acute Phase||Baseline Serum potassium ( S-K ) levels during both the Acute and Maintenance phases||Participants|Number|0|0.0||||||
3723152|NCT02088073|3561681|B1|≥ 6.0 mmol/L, Acute Phase||Baseline Serum potassium ( S-K ) levels during both the Acute and Maintenance phases||Participants|Number|39|39.0||||||
3723153|NCT02088073|3561676|B6|5.5-<6.0 mmol/L, Acute Phase||Baseline Serum potassium ( S-K ) levels during both the Acute and Maintenance phases||Participants|Number|100|100.0||||||
3723154|NCT02088073|3561677|B5|5.5-<6.0 mmol/L, Acute Phase||Baseline Serum potassium ( S-K ) levels during both the Acute and Maintenance phases||Participants|Number|0|0.0||||||
3723155|NCT02088073|3561678|B4|5.5-<6.0 mmol/L, Acute Phase||Baseline Serum potassium ( S-K ) levels during both the Acute and Maintenance phases||Participants|Number|0|0.0||||||
3723156|NCT02088073|3561679|B3|5.5-<6.0 mmol/L, Acute Phase||Baseline Serum potassium ( S-K ) levels during both the Acute and Maintenance phases||Participants|Number|0|0.0||||||
3723157|NCT02088073|3561680|B2|5.5-<6.0 mmol/L, Acute Phase||Baseline Serum potassium ( S-K ) levels during both the Acute and Maintenance phases||Participants|Number|0|0.0||||||
3723158|NCT02088073|3561681|B1|5.5-<6.0 mmol/L, Acute Phase||Baseline Serum potassium ( S-K ) levels during both the Acute and Maintenance phases||Participants|Number|100|100.0||||||
3723159|NCT02088073|3561676|B6|<5.5 mmol/L, Acute Phase||Baseline Serum potassium ( S-K ) levels during both the Acute and Maintenance phases||Participants|Number|119|119.0||||||
3723160|NCT02088073|3561677|B5|<5.5 mmol/L, Acute Phase||Baseline Serum potassium ( S-K ) levels during both the Acute and Maintenance phases||Participants|Number|0|0.0||||||
3723161|NCT02088073|3561678|B4|<5.5 mmol/L, Acute Phase||Baseline Serum potassium ( S-K ) levels during both the Acute and Maintenance phases||Participants|Number|0|0.0||||||
3723162|NCT02088073|3561679|B3|<5.5 mmol/L, Acute Phase||Baseline Serum potassium ( S-K ) levels during both the Acute and Maintenance phases||Participants|Number|0|0.0||||||
3723163|NCT02088073|3561680|B2|<5.5 mmol/L, Acute Phase||Baseline Serum potassium ( S-K ) levels during both the Acute and Maintenance phases||Participants|Number|0|0.0||||||
3723164|NCT02088073|3561681|B1|<5.5 mmol/L, Acute Phase||Baseline Serum potassium ( S-K ) levels during both the Acute and Maintenance phases||Participants|Number|119|119.0||||||
3723165|NCT02088073|3561676|B6|Multiple Races indicated, Maintenance Phase||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3723166|NCT02088073|3561677|B5|Multiple Races indicated, Maintenance Phase||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3723167|NCT02088073|3561678|B4|Multiple Races indicated, Maintenance Phase||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3723168|NCT02088073|3561679|B3|Multiple Races indicated, Maintenance Phase||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3723169|NCT02088073|3561680|B2|Multiple Races indicated, Maintenance Phase||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3723170|NCT02088073|3561681|B1|Multiple Races indicated, Maintenance Phase||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3723171|NCT02088073|3561676|B6|Other, Maintenance Phase||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3723172|NCT02088073|3561677|B5|Other, Maintenance Phase||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3723173|NCT02088073|3561678|B4|Other, Maintenance Phase||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3723174|NCT02088073|3561679|B3|Other, Maintenance Phase||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3723175|NCT02088073|3561680|B2|Other, Maintenance Phase||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3723176|NCT02088073|3561681|B1|Other, Maintenance Phase||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3723177|NCT02088073|3561676|B6|Native Hawaiian or other Pacific Islander, MP||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3723178|NCT02088073|3561677|B5|Native Hawaiian or other Pacific Islander, MP||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3723179|NCT02088073|3561678|B4|Native Hawaiian or other Pacific Islander, MP||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3723180|NCT02088073|3561679|B3|Native Hawaiian or other Pacific Islander, MP||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3723181|NCT02088073|3561680|B2|Native Hawaiian or other Pacific Islander, MP||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3723182|NCT02088073|3561681|B1|Native Hawaiian or other Pacific Islander, MP||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3723183|NCT02088073|3561676|B6|Asian, Maintenance Phase||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3723184|NCT02088073|3561677|B5|Asian, Maintenance Phase||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3723185|NCT02088073|3561678|B4|Asian, Maintenance Phase||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3723186|NCT02088073|3561679|B3|Asian, Maintenance Phase||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3723187|NCT02088073|3561680|B2|Asian, Maintenance Phase||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3723188|NCT02088073|3561681|B1|Asian, Maintenance Phase||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3723189|NCT02088073|3561676|B6|Black or African American, Maintenance Phase||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
3723190|NCT02088073|3561677|B5|Black or African American, Maintenance Phase||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3723191|NCT02088073|3561678|B4|Black or African American, Maintenance Phase||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3723192|NCT02088073|3561679|B3|Black or African American, Maintenance Phase||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3723193|NCT02088073|3561680|B2|Black or African American, Maintenance Phase||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
3723194|NCT02088073|3561681|B1|Black or African American, Maintenance Phase||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3723195|NCT02088073|3561676|B6|White, Maintenance Phase||Race/Ethnicity, Customized||Participants|Number|199|199.0||||||
3723196|NCT02088073|3561677|B5|White, Maintenance Phase||Race/Ethnicity, Customized||Participants|Number|46|46.0||||||
3723198|NCT02088073|3561679|B3|White, Maintenance Phase||Race/Ethnicity, Customized||Participants|Number|36|36.0||||||
3723199|NCT02088073|3561680|B2|White, Maintenance Phase||Race/Ethnicity, Customized||Participants|Number|73|73.0||||||
3723200|NCT02088073|3561681|B1|White, Maintenance Phase||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3723201|NCT02088073|3561676|B6|Multiple Races indicated, Acute Phase||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3723202|NCT02088073|3561677|B5|Multiple Races indicated, Acute Phase||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3723203|NCT02088073|3561678|B4|Multiple Races indicated, Acute Phase||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3723204|NCT02088073|3561679|B3|Multiple Races indicated, Acute Phase||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3723205|NCT02088073|3561680|B2|Multiple Races indicated, Acute Phase||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3723206|NCT02088073|3561681|B1|Multiple Races indicated, Acute Phase||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3723207|NCT02088073|3561676|B6|Other, Acute Phase||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3723208|NCT02088073|3561677|B5|Other, Acute Phase||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3723209|NCT02088073|3561678|B4|Other, Acute Phase||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3723210|NCT02088073|3561679|B3|Other, Acute Phase||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3723211|NCT02088073|3561680|B2|Other, Acute Phase||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3723212|NCT02088073|3561681|B1|Other, Acute Phase||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3723213|NCT02088073|3561676|B6|Native Hawaiian or other Pacific Islander, AP||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3723214|NCT02088073|3561677|B5|Native Hawaiian or other Pacific Islander, AP||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3723215|NCT02088073|3561678|B4|Native Hawaiian or other Pacific Islander, AP||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3723216|NCT02088073|3561679|B3|Native Hawaiian or other Pacific Islander, AP||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3723217|NCT02088073|3561680|B2|Native Hawaiian or other Pacific Islander, AP||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3723218|NCT02088073|3561681|B1|Native Hawaiian or other Pacific Islander, AP||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3723219|NCT02088073|3561676|B6|Asian, Acute Phase||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3723220|NCT02088073|3561677|B5|Asian, Acute Phase||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3723221|NCT02088073|3561678|B4|Asian, Acute Phase||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3723222|NCT02088073|3561679|B3|Asian, Acute Phase||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3723223|NCT02088073|3561680|B2|Asian, Acute Phase||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3723224|NCT02088073|3561681|B1|Asian, Acute Phase||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3723225|NCT02088073|3561676|B6|Black or African American, Acute Phase||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
3723226|NCT02088073|3561677|B5|Black or African American, Acute Phase||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3723227|NCT02088073|3561678|B4|Black or African American, Acute Phase||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3723228|NCT02088073|3561679|B3|Black or African American, Acute Phase||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3723229|NCT02088073|3561680|B2|Black or African American, Acute Phase||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3723230|NCT02088073|3561681|B1|Black or African American, Acute Phase||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
3723231|NCT02088073|3561676|B6|White, Acute Phase||Race/Ethnicity, Customized||Participants|Number|215|215.0||||||
3723232|NCT02088073|3561677|B5|White, Acute Phase||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3723233|NCT02088073|3561678|B4|White, Acute Phase||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3723234|NCT02088073|3561679|B3|White, Acute Phase||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3723235|NCT02088073|3561680|B2|White, Acute Phase||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3723236|NCT02088073|3561681|B1|White, Acute Phase||Race/Ethnicity, Customized||Participants|Number|215|215.0||||||
3723237|NCT02088073|3561676|B6|Male, Maintenance Phase||Sex/Gender, Customized||Participants|Number|138|138.0||||||
3723238|NCT02088073|3561677|B5|Male, Maintenance Phase||Sex/Gender, Customized||Participants|Number|40|40.0||||||
3723239|NCT02088073|3561678|B4|Male, Maintenance Phase||Sex/Gender, Customized||Participants|Number|27|27.0||||||
3723240|NCT02088073|3561679|B3|Male, Maintenance Phase||Sex/Gender, Customized||Participants|Number|27|27.0||||||
3723241|NCT02088073|3561680|B2|Male, Maintenance Phase||Sex/Gender, Customized||Participants|Number|44|44.0||||||
3723242|NCT02088073|3561681|B1|Male, Maintenance Phase||Sex/Gender, Customized||Participants|Number|0|0.0||||||
3723243|NCT02088073|3561676|B6|Female, Maintenance Phase||Sex/Gender, Customized||Participants|Number|99|99.0||||||
3723244|NCT02088073|3561677|B5|Female, Maintenance Phase||Sex/Gender, Customized||Participants|Number|16|16.0||||||
3723245|NCT02088073|3561678|B4|Female, Maintenance Phase||Sex/Gender, Customized||Participants|Number|24|24.0||||||
3723246|NCT02088073|3561679|B3|Female, Maintenance Phase||Sex/Gender, Customized||Participants|Number|18|18.0||||||
3723247|NCT02088073|3561680|B2|Female, Maintenance Phase||Sex/Gender, Customized||Participants|Number|41|41.0||||||
3723248|NCT02088073|3561681|B1|Female, Maintenance Phase||Sex/Gender, Customized||Participants|Number|0|0.0||||||
3723249|NCT02088073|3561676|B6|Male, Acute Phase||Sex/Gender, Customized||Participants|Number|149|149.0||||||
3723250|NCT02088073|3561677|B5|Male, Acute Phase||Sex/Gender, Customized||Participants|Number|0|0.0||||||
3723251|NCT02088073|3561678|B4|Male, Acute Phase||Sex/Gender, Customized||Participants|Number|0|0.0||||||
3723252|NCT02088073|3561679|B3|Male, Acute Phase||Sex/Gender, Customized||Participants|Number|0|0.0||||||
3723254|NCT02088073|3561681|B1|Male, Acute Phase||Sex/Gender, Customized||Participants|Number|149|149.0||||||
3723255|NCT02088073|3561676|B6|Female, Acute Phase||Sex/Gender, Customized||Participants|Number|109|109.0||||||
3723256|NCT02088073|3561677|B5|Female, Acute Phase||Sex/Gender, Customized||Participants|Number|0|0.0||||||
3723257|NCT02088073|3561678|B4|Female, Acute Phase||Sex/Gender, Customized||Participants|Number|0|0.0||||||
3723258|NCT02088073|3561679|B3|Female, Acute Phase||Sex/Gender, Customized||Participants|Number|0|0.0||||||
3723259|NCT02088073|3561680|B2|Female, Acute Phase||Sex/Gender, Customized||Participants|Number|0|0.0||||||
3723260|NCT02088073|3561681|B1|Female, Acute Phase||Sex/Gender, Customized||Participants|Number|109|109.0||||||
3723261|NCT02088073|3561676|B6|Maintenance Phase||Age||Years|Mean|63.80|63.8|Standard Deviation|13.01|13.01|||
3723262|NCT02088073|3561677|B5|Maintenance Phase||Age||Years|Mean|64.9|64.9|Standard Deviation|12.85|12.85|||
3723263|NCT02088073|3561678|B4|Maintenance Phase||Age||Years|Mean|63.8|63.8|Standard Deviation|9.97|9.97|||
3723264|NCT02088073|3561679|B3|Maintenance Phase||Age||Years|Mean|61.5|61.5|Standard Deviation|16.89|16.89|||
3723265|NCT02088073|3561680|B2|Maintenance Phase||Age||Years|Mean|64.3|64.3|Standard Deviation|12.13|12.13|||
3723266|NCT02088073|3561681|B1|Maintenance Phase||Age||Years|Mean|NA||Standard Deviation|NA||||This field does not apply to the Maintenance Phase of the study.
3723267|NCT02088073|3561676|B6|Acute Phase||Age||Years|Mean|64.0|64.0|Standard Deviation|12.72|12.72|||
3723268|NCT02088073|3561677|B5|Acute Phase||Age||Years|Mean|NA||Standard Deviation|NA||||This field does not apply to the Acute Phase of the study.
3723269|NCT02088073|3561678|B4|Acute Phase||Age||Years|Mean|NA||Standard Deviation|NA||||This field does not apply to the Acute Phase of the study.
3723270|NCT02088073|3561679|B3|Acute Phase||Age||Years|Mean|NA||Standard Deviation|NA||||This field does not apply to the Acute Phase of the study.
3723271|NCT02088073|3561680|B2|Acute Phase||Age||Years|Mean|NA||Standard Deviation|NA||||This field does not apply to the Acute Phase of the study.
3723272|NCT02088073|3561681|B1|Acute Phase||Age||Years|Mean|64.0|64.0|Standard Deviation|12.72|12.72|||
3723273|NCT02087995|3561737|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
3723274|NCT02087995|3561737|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723275|NCT02087995|3561737|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3723276|NCT02087995|3561737|B1||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3723277|NCT02087995|3561737|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723278|NCT02087995|3561737|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3723279|NCT02087995|3561737|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723280|NCT02087995|3561737|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3723281|NCT02087995|3561737|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723282|NCT02087995|3561737|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3723283|NCT02087995|3561737|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3723284|NCT02087995|3561737|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3723285|NCT02087995|3561737|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3723286|NCT02087995|3561737|B1|||Age||years old|Mean|46.7|46.7|Standard Deviation|15.8|15.8|||
3723287|NCT02087943|3561741|B4||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3723288|NCT02087943|3561742|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3723289|NCT02087943|3561743|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3723290|NCT02087943|3561744|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3723291|NCT02087943|3561741|B4||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3723292|NCT02087943|3561742|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3723293|NCT02087943|3561743|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3723294|NCT02087943|3561744|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3723295|NCT02087943|3561741|B4|||Age||years|Mean|38.4|38.4|Standard Deviation|15.00|15.0|||
3723296|NCT02087943|3561742|B3|||Age||years|Mean|38.3|38.3|Standard Deviation|14.74|14.74|||
3723297|NCT02087943|3561743|B2|||Age||years|Mean|39.2|39.2|Standard Deviation|15.80|15.8|||
3723298|NCT02087943|3561744|B1|||Age||years|Mean|37.7|37.7|Standard Deviation|14.71|14.71|||
3723299|NCT02087774|3561772|B3|||After exercise- heart rate||beats per minute|Mean|163.9|163.9|Standard Deviation|25.9|25.9|||
3723300|NCT02087774|3561773|B2|||After exercise- heart rate||beats per minute|Mean|164.8|164.8|Standard Deviation|23.8|23.8|||
3723301|NCT02087774|3561774|B1|||After exercise- heart rate||beats per minute|Mean|163|163.0|Standard Deviation|27.9|27.9|||
3723302|NCT02087774|3561772|B3|||75 foot laps completed||laps completed|Mean|13.3|13.3|Standard Deviation|2|2.0|||
3723303|NCT02087774|3561773|B2|||75 foot laps completed||laps completed|Mean|13|13.0|Standard Deviation|2|2.0|||
3723304|NCT02087774|3561774|B1|||75 foot laps completed||laps completed|Mean|13.5|13.5|Standard Deviation|1.9|1.9|||
3723305|NCT02087774|3561772|B3|||Grade level||grade|Mean|3.0|3.0|Standard Deviation|1.4|1.4|||
3723306|NCT02087774|3561773|B2|||Grade level||grade|Mean|2.9|2.9|Standard Deviation|1.4|1.4|||
3723307|NCT02087774|3561774|B1|||Grade level||grade|Mean|3.1|3.1|Standard Deviation|1.4|1.4|||
3723308|NCT02087774|3561772|B3|United States||Region of Enrollment||participants|Number|272|272.0||||||
3723309|NCT02087774|3561773|B2|United States||Region of Enrollment||participants|Number|130|130.0||||||
3723310|NCT02087774|3561774|B1|United States||Region of Enrollment||participants|Number|142|142.0||||||
3723311|NCT02087774|3561772|B3||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3723312|NCT02087774|3561773|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3723313|NCT02087774|3561774|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3723314|NCT02087774|3561772|B3||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3723315|NCT02087774|3561773|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3723316|NCT02087774|3561774|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3723317|NCT02087774|3561772|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3723318|NCT02087774|3561773|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3723319|NCT02087774|3561774|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3723320|NCT02087774|3561772|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3723321|NCT02087774|3561773|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3723322|NCT02087774|3561774|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3723323|NCT02087774|3561772|B3||<=18 years|Age||Participants|Count of Participants|272|272.0||||||
3723324|NCT02087774|3561773|B2||<=18 years|Age||Participants|Count of Participants|130|130.0||||||
3723325|NCT02087774|3561774|B1||<=18 years|Age||Participants|Count of Participants|142|142.0||||||
3723326|NCT02087748|3561783|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723327|NCT02087748|3561783|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723328|NCT02087748|3561783|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3723329|NCT02087748|3561783|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3723330|NCT02087748|3561783|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723331|NCT02087748|3561783|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3723332|NCT02087748|3561783|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723333|NCT02087748|3561783|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723334|NCT02087748|3561783|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3723335|NCT02087748|3561783|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3723336|NCT02087748|3561783|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3723337|NCT02087748|3561783|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3723338|NCT02087748|3561783|B1|||Age||years|Mean|28.0|28.0|Standard Deviation|3.58|3.58|||
3723339|NCT02087670|3561793|B3|||Oxygen Consumption||ml/min|Mean|821|821.0|Standard Deviation|226|226.0|||
3723340|NCT02087670|3561794|B2|||Oxygen Consumption||ml/min|Mean|811|811.0|Standard Deviation|229|229.0|||
3723341|NCT02087670|3561795|B1|||Oxygen Consumption||ml/min|Mean|832|832.0|Standard Deviation|228|228.0|||
3723342|NCT02087670|3561793|B3|||Natriuretic Brain pro-peptide||pg/ml|Median|386|386.0|Full Range|||49.0|2506.0|
3723343|NCT02087670|3561794|B2|||Natriuretic Brain pro-peptide||pg/ml|Median|278|278.0|Full Range|||49.0|2506.0|
3723344|NCT02087670|3561795|B1|||Natriuretic Brain pro-peptide||pg/ml|Median|429|429.0|Full Range|||74.0|2128.0|
3723345|NCT02087670|3561793|B3|Colombia||Region of Enrollment||participants|Number|42|42.0||||||
3723346|NCT02087670|3561794|B2|Colombia||Region of Enrollment||participants|Number|22|22.0||||||
3723347|NCT02087670|3561795|B1|Colombia||Region of Enrollment||participants|Number|20|20.0||||||
3723348|NCT02087670|3561793|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3723349|NCT02087670|3561794|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3723350|NCT02087670|3561795|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3723351|NCT02087670|3561793|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3723352|NCT02087670|3561794|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3723353|NCT02087670|3561795|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3723354|NCT02087670|3561793|B3|||Age||years|Mean|55|55.0|Standard Deviation|11|11.0|||
3723355|NCT02087670|3561794|B2|||Age||years|Mean|55|55.0|Standard Deviation|13|13.0|||
3723356|NCT02087670|3561795|B1|||Age||years|Mean|57|57.0|Standard Deviation|14|14.0|||
3723357|NCT02087670|3561793|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3723358|NCT02087670|3561794|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3723359|NCT02087670|3561795|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3723360|NCT02087670|3561793|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3723361|NCT02087670|3561794|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3723362|NCT02087670|3561795|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3723363|NCT02087670|3561793|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3723364|NCT02087670|3561794|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3723365|NCT02087670|3561795|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3723366|NCT02087514|3561804|B7|United States||Region of Enrollment||participants|Number|52|52.0||||||
3723367|NCT02087514|3561805|B6|United States||Region of Enrollment||participants|Number|9|9.0||||||
3723368|NCT02087514|3561806|B5|United States||Region of Enrollment||participants|Number|10|10.0||||||
3723369|NCT02087514|3561807|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
3723370|NCT02087514|3561808|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
3723371|NCT02087514|3561809|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3723372|NCT02087514|3561810|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3723373|NCT02087514|3561804|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3723374|NCT02087514|3561805|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723375|NCT02087514|3561806|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3723376|NCT02087514|3561807|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3723377|NCT02087514|3561808|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3723378|NCT02087514|3561809|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723379|NCT02087514|3561810|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3723380|NCT02087514|3561804|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723381|NCT02087514|3561805|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723382|NCT02087514|3561806|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723383|NCT02087514|3561807|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723384|NCT02087514|3561808|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723385|NCT02087514|3561809|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723386|NCT02087514|3561810|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723387|NCT02087514|3561804|B7||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3723388|NCT02087514|3561805|B6||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3723389|NCT02087514|3561806|B5||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3723390|NCT02087514|3561807|B4||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3723391|NCT02087514|3561808|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3723392|NCT02087514|3561809|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3723393|NCT02087514|3561810|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3723394|NCT02087514|3561804|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3723395|NCT02087514|3561805|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3723396|NCT02087514|3561806|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723397|NCT02087514|3561807|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3723398|NCT02087514|3561808|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3723399|NCT02087514|3561809|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3723400|NCT02087514|3561810|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723401|NCT02087514|3561804|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723402|NCT02087514|3561805|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723403|NCT02087514|3561806|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723404|NCT02087514|3561807|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723405|NCT02087514|3561808|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723406|NCT02087514|3561809|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723407|NCT02087514|3561810|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723408|NCT02087514|3561804|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3723409|NCT02087514|3561805|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3723410|NCT02087514|3561806|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3723411|NCT02087514|3561807|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3723412|NCT02087514|3561808|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3723413|NCT02087514|3561809|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3723414|NCT02087514|3561810|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3723415|NCT02087514|3561804|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723416|NCT02087514|3561805|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723417|NCT02087514|3561806|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723418|NCT02087514|3561807|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723419|NCT02087514|3561808|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723420|NCT02087514|3561809|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723421|NCT02087514|3561810|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723422|NCT02087514|3561804|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723423|NCT02087514|3561805|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723424|NCT02087514|3561806|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723425|NCT02087514|3561807|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723426|NCT02087514|3561808|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723427|NCT02087514|3561809|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723846|NCT02086786|3561906|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3723428|NCT02087514|3561810|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723429|NCT02087514|3561804|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3723430|NCT02087514|3561805|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3723431|NCT02087514|3561806|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3723432|NCT02087514|3561807|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3723433|NCT02087514|3561808|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3723434|NCT02087514|3561809|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3723435|NCT02087514|3561810|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3723436|NCT02087514|3561804|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3723437|NCT02087514|3561805|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3723438|NCT02087514|3561806|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3723439|NCT02087514|3561807|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3723440|NCT02087514|3561808|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3723441|NCT02087514|3561809|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3723442|NCT02087514|3561810|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3723443|NCT02087514|3561804|B7||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3723444|NCT02087514|3561805|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3723445|NCT02087514|3561806|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3723446|NCT02087514|3561807|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3723447|NCT02087514|3561808|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3723448|NCT02087514|3561809|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3723449|NCT02087514|3561810|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3723450|NCT02087514|3561804|B7||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3723451|NCT02087514|3561805|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3723452|NCT02087514|3561806|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3723453|NCT02087514|3561807|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3723454|NCT02087514|3561808|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3723455|NCT02087514|3561809|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3723456|NCT02087514|3561810|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3723457|NCT02087514|3561804|B7|||Age||years|Median|27|27.0|Inter-Quartile Range|||25.0|31.0|
3723458|NCT02087514|3561805|B6|||Age||years|Median|26|26.0|Inter-Quartile Range|||25.0|43.0|
3723459|NCT02087514|3561806|B5|||Age||years|Median|28|28.0|Inter-Quartile Range|||26.0|33.0|
3723460|NCT02087514|3561807|B4|||Age||years|Median|28|28.0|Inter-Quartile Range|||25.0|32.0|
3723461|NCT02087514|3561808|B3|||Age||years|Median|28|28.0|Inter-Quartile Range|||26.0|29.0|
3723462|NCT02087514|3561809|B2|||Age||years|Median|25|25.0|Inter-Quartile Range|||25.0|31.0|
3723463|NCT02087514|3561810|B1|||Age||years|Median|25|25.0|Inter-Quartile Range|||23.0|31.0|
3723464|NCT02087423|3561829|B4|||Number of regimens of previous anti-cancer therapy||Number of regimens|Median|3|3.0|Standard Deviation|1.54|1.54|||
3723465|NCT02087423|3561830|B3|||Number of regimens of previous anti-cancer therapy||Number of regimens|Median|2|2.0|Standard Deviation|0.80|0.8|||
3723466|NCT02087423|3561831|B2|||Number of regimens of previous anti-cancer therapy||Number of regimens|Median|3|3.0|Standard Deviation|1.38|1.38|||
3723467|NCT02087423|3561832|B1|||Number of regimens of previous anti-cancer therapy||Number of regimens|Median|3|3.0|Standard Deviation|2.00|2.0|||
3723468|NCT02087423|3561829|B4||Missing|Smoking history|Patients who checked options Cigarettes, Cigarillos, Cigars, Pipe Tobacco, or Tobacco for Smoking are considered smokers.|Participants|Count of Participants|1|1.0||||||
3723469|NCT02087423|3561830|B3||Missing|Smoking history|Patients who checked options Cigarettes, Cigarillos, Cigars, Pipe Tobacco, or Tobacco for Smoking are considered smokers.|Participants|Count of Participants|0|0.0||||||
3723470|NCT02087423|3561831|B2||Missing|Smoking history|Patients who checked options Cigarettes, Cigarillos, Cigars, Pipe Tobacco, or Tobacco for Smoking are considered smokers.|Participants|Count of Participants|1|1.0||||||
3723471|NCT02087423|3561832|B1||Missing|Smoking history|Patients who checked options Cigarettes, Cigarillos, Cigars, Pipe Tobacco, or Tobacco for Smoking are considered smokers.|Participants|Count of Participants|0|0.0||||||
3723472|NCT02087423|3561829|B4||Smoker|Smoking history|Patients who checked options Cigarettes, Cigarillos, Cigars, Pipe Tobacco, or Tobacco for Smoking are considered smokers.|Participants|Count of Participants|330|330.0||||||
3723473|NCT02087423|3561830|B3||Smoker|Smoking history|Patients who checked options Cigarettes, Cigarillos, Cigars, Pipe Tobacco, or Tobacco for Smoking are considered smokers.|Participants|Count of Participants|59|59.0||||||
3723474|NCT02087423|3561831|B2||Smoker|Smoking history|Patients who checked options Cigarettes, Cigarillos, Cigars, Pipe Tobacco, or Tobacco for Smoking are considered smokers.|Participants|Count of Participants|225|225.0||||||
3723475|NCT02087423|3561832|B1||Smoker|Smoking history|Patients who checked options Cigarettes, Cigarillos, Cigars, Pipe Tobacco, or Tobacco for Smoking are considered smokers.|Participants|Count of Participants|46|46.0||||||
3723476|NCT02087423|3561829|B4||Non-smoker|Smoking history|Patients who checked options Cigarettes, Cigarillos, Cigars, Pipe Tobacco, or Tobacco for Smoking are considered smokers.|Participants|Count of Participants|113|113.0||||||
3723554|NCT02087423|3561831|B2||complete response|Best response to previous therapy|based on the last therapy received prior to entering the study|Participants|Count of Participants|1|1.0||||||
3723477|NCT02087423|3561830|B3||Non-smoker|Smoking history|Patients who checked options Cigarettes, Cigarillos, Cigars, Pipe Tobacco, or Tobacco for Smoking are considered smokers.|Participants|Count of Participants|9|9.0||||||
3723478|NCT02087423|3561831|B2||Non-smoker|Smoking history|Patients who checked options Cigarettes, Cigarillos, Cigars, Pipe Tobacco, or Tobacco for Smoking are considered smokers.|Participants|Count of Participants|39|39.0||||||
3723479|NCT02087423|3561832|B1||Non-smoker|Smoking history|Patients who checked options Cigarettes, Cigarillos, Cigars, Pipe Tobacco, or Tobacco for Smoking are considered smokers.|Participants|Count of Participants|65|65.0||||||
3723480|NCT02087423|3561829|B4|Total per cohort||PD-L1 expression level|% of tumor cells with membrane staining for PD-L1|Number of patients (per PD-L1 category)|Number|444|444.0||||||
3723481|NCT02087423|3561830|B3|Total per cohort||PD-L1 expression level|% of tumor cells with membrane staining for PD-L1|Number of patients (per PD-L1 category)|Number|68|68.0||||||
3723482|NCT02087423|3561831|B2|Total per cohort||PD-L1 expression level|% of tumor cells with membrane staining for PD-L1|Number of patients (per PD-L1 category)|Number|265|265.0||||||
3723483|NCT02087423|3561832|B1|Total per cohort||PD-L1 expression level|% of tumor cells with membrane staining for PD-L1|Number of patients (per PD-L1 category)|Number|111|111.0||||||
3723484|NCT02087423|3561829|B4|Missing||PD-L1 expression level|% of tumor cells with membrane staining for PD-L1|Number of patients (per PD-L1 category)|Number|1|1.0||||||
3723485|NCT02087423|3561830|B3|Missing||PD-L1 expression level|% of tumor cells with membrane staining for PD-L1|Number of patients (per PD-L1 category)|Number|0|0.0||||||
3723486|NCT02087423|3561831|B2|Missing||PD-L1 expression level|% of tumor cells with membrane staining for PD-L1|Number of patients (per PD-L1 category)|Number|0|0.0||||||
3723487|NCT02087423|3561832|B1|Missing||PD-L1 expression level|% of tumor cells with membrane staining for PD-L1|Number of patients (per PD-L1 category)|Number|1|1.0||||||
3723488|NCT02087423|3561829|B4|Unknown||PD-L1 expression level|% of tumor cells with membrane staining for PD-L1|Number of patients (per PD-L1 category)|Number|24|24.0||||||
3723489|NCT02087423|3561830|B3|Unknown||PD-L1 expression level|% of tumor cells with membrane staining for PD-L1|Number of patients (per PD-L1 category)|Number|0|0.0||||||
3723490|NCT02087423|3561831|B2|Unknown||PD-L1 expression level|% of tumor cells with membrane staining for PD-L1|Number of patients (per PD-L1 category)|Number|21|21.0||||||
3723491|NCT02087423|3561832|B1|Unknown||PD-L1 expression level|% of tumor cells with membrane staining for PD-L1|Number of patients (per PD-L1 category)|Number|3|3.0||||||
3723492|NCT02087423|3561829|B4|<90%||PD-L1 expression level|% of tumor cells with membrane staining for PD-L1|Number of patients (per PD-L1 category)|Number|155|155.0||||||
3723493|NCT02087423|3561830|B3|<90%||PD-L1 expression level|% of tumor cells with membrane staining for PD-L1|Number of patients (per PD-L1 category)|Number|0|0.0||||||
3723494|NCT02087423|3561831|B2|<90%||PD-L1 expression level|% of tumor cells with membrane staining for PD-L1|Number of patients (per PD-L1 category)|Number|122|122.0||||||
3723495|NCT02087423|3561832|B1|<90%||PD-L1 expression level|% of tumor cells with membrane staining for PD-L1|Number of patients (per PD-L1 category)|Number|33|33.0||||||
3723496|NCT02087423|3561829|B4|Positive (>=90%)||PD-L1 expression level|% of tumor cells with membrane staining for PD-L1|Number of patients (per PD-L1 category)|Number|186|186.0||||||
3723497|NCT02087423|3561830|B3|Positive (>=90%)||PD-L1 expression level|% of tumor cells with membrane staining for PD-L1|Number of patients (per PD-L1 category)|Number|67|67.0||||||
3723498|NCT02087423|3561831|B2|Positive (>=90%)||PD-L1 expression level|% of tumor cells with membrane staining for PD-L1|Number of patients (per PD-L1 category)|Number|72|72.0||||||
3723499|NCT02087423|3561832|B1|Positive (>=90%)||PD-L1 expression level|% of tumor cells with membrane staining for PD-L1|Number of patients (per PD-L1 category)|Number|47|47.0||||||
3723500|NCT02087423|3561829|B4|Negative (<25%)||PD-L1 expression level|% of tumor cells with membrane staining for PD-L1|Number of patients (per PD-L1 category)|Number|125|125.0||||||
3723501|NCT02087423|3561830|B3|Negative (<25%)||PD-L1 expression level|% of tumor cells with membrane staining for PD-L1|Number of patients (per PD-L1 category)|Number|0|0.0||||||
3723502|NCT02087423|3561831|B2|Negative (<25%)||PD-L1 expression level|% of tumor cells with membrane staining for PD-L1|Number of patients (per PD-L1 category)|Number|95|95.0||||||
3723503|NCT02087423|3561832|B1|Negative (<25%)||PD-L1 expression level|% of tumor cells with membrane staining for PD-L1|Number of patients (per PD-L1 category)|Number|30|30.0||||||
3723504|NCT02087423|3561829|B4|Positive (>=25%)||PD-L1 expression level|% of tumor cells with membrane staining for PD-L1|Number of patients (per PD-L1 category)|Number|294|294.0||||||
3723505|NCT02087423|3561830|B3|Positive (>=25%)||PD-L1 expression level|% of tumor cells with membrane staining for PD-L1|Number of patients (per PD-L1 category)|Number|68|68.0||||||
3723506|NCT02087423|3561831|B2|Positive (>=25%)||PD-L1 expression level|% of tumor cells with membrane staining for PD-L1|Number of patients (per PD-L1 category)|Number|149|149.0||||||
3723507|NCT02087423|3561832|B1|Positive (>=25%)||PD-L1 expression level|% of tumor cells with membrane staining for PD-L1|Number of patients (per PD-L1 category)|Number|77|77.0||||||
3723508|NCT02087423|3561829|B4||Locally advanced|Overall disease classification|either patient has any metastatic site of disease or has only locally advanced sites of disease|Participants|Count of Participants|36|36.0||||||
3723509|NCT02087423|3561830|B3||Locally advanced|Overall disease classification|either patient has any metastatic site of disease or has only locally advanced sites of disease|Participants|Count of Participants|7|7.0||||||
3723510|NCT02087423|3561831|B2||Locally advanced|Overall disease classification|either patient has any metastatic site of disease or has only locally advanced sites of disease|Participants|Count of Participants|20|20.0||||||
3723511|NCT02087423|3561832|B1||Locally advanced|Overall disease classification|either patient has any metastatic site of disease or has only locally advanced sites of disease|Participants|Count of Participants|9|9.0||||||
3723512|NCT02087423|3561829|B4||Metastatic|Overall disease classification|either patient has any metastatic site of disease or has only locally advanced sites of disease|Participants|Count of Participants|408|408.0||||||
3723513|NCT02087423|3561830|B3||Metastatic|Overall disease classification|either patient has any metastatic site of disease or has only locally advanced sites of disease|Participants|Count of Participants|61|61.0||||||
3723514|NCT02087423|3561831|B2||Metastatic|Overall disease classification|either patient has any metastatic site of disease or has only locally advanced sites of disease|Participants|Count of Participants|245|245.0||||||
3723515|NCT02087423|3561832|B1||Metastatic|Overall disease classification|either patient has any metastatic site of disease or has only locally advanced sites of disease|Participants|Count of Participants|102|102.0||||||
3723516|NCT02087423|3561829|B4||> 42 days|Time from informed consent to first dose||Participants|Count of Participants|17|17.0||||||
3723517|NCT02087423|3561830|B3||> 42 days|Time from informed consent to first dose||Participants|Count of Participants|3|3.0||||||
3723518|NCT02087423|3561831|B2||> 42 days|Time from informed consent to first dose||Participants|Count of Participants|13|13.0||||||
3723519|NCT02087423|3561832|B1||> 42 days|Time from informed consent to first dose||Participants|Count of Participants|1|1.0||||||
3723520|NCT02087423|3561829|B4||between 21 and 42 days|Time from informed consent to first dose||Participants|Count of Participants|221|221.0||||||
3723521|NCT02087423|3561830|B3||between 21 and 42 days|Time from informed consent to first dose||Participants|Count of Participants|45|45.0||||||
3723522|NCT02087423|3561831|B2||between 21 and 42 days|Time from informed consent to first dose||Participants|Count of Participants|111|111.0||||||
3723523|NCT02087423|3561832|B1||between 21 and 42 days|Time from informed consent to first dose||Participants|Count of Participants|65|65.0||||||
3723524|NCT02087423|3561829|B4||Between 14 and 21 days|Time from informed consent to first dose||Participants|Count of Participants|110|110.0||||||
3723525|NCT02087423|3561830|B3||Between 14 and 21 days|Time from informed consent to first dose||Participants|Count of Participants|13|13.0||||||
3723526|NCT02087423|3561831|B2||Between 14 and 21 days|Time from informed consent to first dose||Participants|Count of Participants|73|73.0||||||
3723527|NCT02087423|3561832|B1||Between 14 and 21 days|Time from informed consent to first dose||Participants|Count of Participants|24|24.0||||||
3723528|NCT02087423|3561829|B4||<=14 days|Time from informed consent to first dose||Participants|Count of Participants|96|96.0||||||
3723529|NCT02087423|3561830|B3||<=14 days|Time from informed consent to first dose||Participants|Count of Participants|7|7.0||||||
3723530|NCT02087423|3561831|B2||<=14 days|Time from informed consent to first dose||Participants|Count of Participants|68|68.0||||||
3723531|NCT02087423|3561832|B1||<=14 days|Time from informed consent to first dose||Participants|Count of Participants|21|21.0||||||
3723532|NCT02087423|3561829|B4||not applicable|Best response to previous therapy|based on the last therapy received prior to entering the study|Participants|Count of Participants|20|20.0||||||
3723533|NCT02087423|3561830|B3||not applicable|Best response to previous therapy|based on the last therapy received prior to entering the study|Participants|Count of Participants|4|4.0||||||
3723534|NCT02087423|3561831|B2||not applicable|Best response to previous therapy|based on the last therapy received prior to entering the study|Participants|Count of Participants|10|10.0||||||
3723535|NCT02087423|3561832|B1||not applicable|Best response to previous therapy|based on the last therapy received prior to entering the study|Participants|Count of Participants|6|6.0||||||
3723536|NCT02087423|3561829|B4||non-evaluable|Best response to previous therapy|based on the last therapy received prior to entering the study|Participants|Count of Participants|19|19.0||||||
3723537|NCT02087423|3561830|B3||non-evaluable|Best response to previous therapy|based on the last therapy received prior to entering the study|Participants|Count of Participants|2|2.0||||||
3723538|NCT02087423|3561831|B2||non-evaluable|Best response to previous therapy|based on the last therapy received prior to entering the study|Participants|Count of Participants|15|15.0||||||
3723539|NCT02087423|3561832|B1||non-evaluable|Best response to previous therapy|based on the last therapy received prior to entering the study|Participants|Count of Participants|2|2.0||||||
3723540|NCT02087423|3561829|B4||progression|Best response to previous therapy|based on the last therapy received prior to entering the study|Participants|Count of Participants|178|178.0||||||
3723541|NCT02087423|3561830|B3||progression|Best response to previous therapy|based on the last therapy received prior to entering the study|Participants|Count of Participants|26|26.0||||||
3723542|NCT02087423|3561831|B2||progression|Best response to previous therapy|based on the last therapy received prior to entering the study|Participants|Count of Participants|114|114.0||||||
3723543|NCT02087423|3561832|B1||progression|Best response to previous therapy|based on the last therapy received prior to entering the study|Participants|Count of Participants|38|38.0||||||
3723544|NCT02087423|3561829|B4||stable disease|Best response to previous therapy|based on the last therapy received prior to entering the study|Participants|Count of Participants|138|138.0||||||
3723545|NCT02087423|3561830|B3||stable disease|Best response to previous therapy|based on the last therapy received prior to entering the study|Participants|Count of Participants|18|18.0||||||
3723546|NCT02087423|3561831|B2||stable disease|Best response to previous therapy|based on the last therapy received prior to entering the study|Participants|Count of Participants|86|86.0||||||
3723547|NCT02087423|3561832|B1||stable disease|Best response to previous therapy|based on the last therapy received prior to entering the study|Participants|Count of Participants|34|34.0||||||
3723548|NCT02087423|3561829|B4||partial response|Best response to previous therapy|based on the last therapy received prior to entering the study|Participants|Count of Participants|88|88.0||||||
3723549|NCT02087423|3561830|B3||partial response|Best response to previous therapy|based on the last therapy received prior to entering the study|Participants|Count of Participants|18|18.0||||||
3723550|NCT02087423|3561831|B2||partial response|Best response to previous therapy|based on the last therapy received prior to entering the study|Participants|Count of Participants|39|39.0||||||
3723551|NCT02087423|3561832|B1||partial response|Best response to previous therapy|based on the last therapy received prior to entering the study|Participants|Count of Participants|31|31.0||||||
3723552|NCT02087423|3561829|B4||complete response|Best response to previous therapy|based on the last therapy received prior to entering the study|Participants|Count of Participants|1|1.0||||||
3723553|NCT02087423|3561830|B3||complete response|Best response to previous therapy|based on the last therapy received prior to entering the study|Participants|Count of Participants|0|0.0||||||
3723598|NCT02087423|3561831|B2||Non-squamous|Histology type||Participants|Count of Participants|210|210.0||||||
3723555|NCT02087423|3561832|B1||complete response|Best response to previous therapy|based on the last therapy received prior to entering the study|Participants|Count of Participants|0|0.0||||||
3723556|NCT02087423|3561829|B4||Missing|AJCC staging at initial diagnosis|Per tumor, node, metastasis (TNM) staging system as specified by American Joint Committee on Cancer (AJCC). The staging is determined by a number of different parameters and the higher the staging the worse the prognosis for survival.|Participants|Count of Participants|2|2.0||||||
3723557|NCT02087423|3561830|B3||Missing|AJCC staging at initial diagnosis|Per tumor, node, metastasis (TNM) staging system as specified by American Joint Committee on Cancer (AJCC). The staging is determined by a number of different parameters and the higher the staging the worse the prognosis for survival.|Participants|Count of Participants|0|0.0||||||
3723558|NCT02087423|3561831|B2||Missing|AJCC staging at initial diagnosis|Per tumor, node, metastasis (TNM) staging system as specified by American Joint Committee on Cancer (AJCC). The staging is determined by a number of different parameters and the higher the staging the worse the prognosis for survival.|Participants|Count of Participants|1|1.0||||||
3723559|NCT02087423|3561832|B1||Missing|AJCC staging at initial diagnosis|Per tumor, node, metastasis (TNM) staging system as specified by American Joint Committee on Cancer (AJCC). The staging is determined by a number of different parameters and the higher the staging the worse the prognosis for survival.|Participants|Count of Participants|1|1.0||||||
3723560|NCT02087423|3561829|B4||Stage IV|AJCC staging at initial diagnosis|Per tumor, node, metastasis (TNM) staging system as specified by American Joint Committee on Cancer (AJCC). The staging is determined by a number of different parameters and the higher the staging the worse the prognosis for survival.|Participants|Count of Participants|351|351.0||||||
3723561|NCT02087423|3561830|B3||Stage IV|AJCC staging at initial diagnosis|Per tumor, node, metastasis (TNM) staging system as specified by American Joint Committee on Cancer (AJCC). The staging is determined by a number of different parameters and the higher the staging the worse the prognosis for survival.|Participants|Count of Participants|53|53.0||||||
3723562|NCT02087423|3561831|B2||Stage IV|AJCC staging at initial diagnosis|Per tumor, node, metastasis (TNM) staging system as specified by American Joint Committee on Cancer (AJCC). The staging is determined by a number of different parameters and the higher the staging the worse the prognosis for survival.|Participants|Count of Participants|208|208.0||||||
3723563|NCT02087423|3561832|B1||Stage IV|AJCC staging at initial diagnosis|Per tumor, node, metastasis (TNM) staging system as specified by American Joint Committee on Cancer (AJCC). The staging is determined by a number of different parameters and the higher the staging the worse the prognosis for survival.|Participants|Count of Participants|90|90.0||||||
3723564|NCT02087423|3561829|B4||Stage IIIB|AJCC staging at initial diagnosis|Per tumor, node, metastasis (TNM) staging system as specified by American Joint Committee on Cancer (AJCC). The staging is determined by a number of different parameters and the higher the staging the worse the prognosis for survival.|Participants|Count of Participants|45|45.0||||||
3723565|NCT02087423|3561830|B3||Stage IIIB|AJCC staging at initial diagnosis|Per tumor, node, metastasis (TNM) staging system as specified by American Joint Committee on Cancer (AJCC). The staging is determined by a number of different parameters and the higher the staging the worse the prognosis for survival.|Participants|Count of Participants|9|9.0||||||
3723566|NCT02087423|3561831|B2||Stage IIIB|AJCC staging at initial diagnosis|Per tumor, node, metastasis (TNM) staging system as specified by American Joint Committee on Cancer (AJCC). The staging is determined by a number of different parameters and the higher the staging the worse the prognosis for survival.|Participants|Count of Participants|28|28.0||||||
3723567|NCT02087423|3561832|B1||Stage IIIB|AJCC staging at initial diagnosis|Per tumor, node, metastasis (TNM) staging system as specified by American Joint Committee on Cancer (AJCC). The staging is determined by a number of different parameters and the higher the staging the worse the prognosis for survival.|Participants|Count of Participants|8|8.0||||||
3723568|NCT02087423|3561829|B4||Stage IIIA|AJCC staging at initial diagnosis|Per tumor, node, metastasis (TNM) staging system as specified by American Joint Committee on Cancer (AJCC). The staging is determined by a number of different parameters and the higher the staging the worse the prognosis for survival.|Participants|Count of Participants|27|27.0||||||
3723569|NCT02087423|3561830|B3||Stage IIIA|AJCC staging at initial diagnosis|Per tumor, node, metastasis (TNM) staging system as specified by American Joint Committee on Cancer (AJCC). The staging is determined by a number of different parameters and the higher the staging the worse the prognosis for survival.|Participants|Count of Participants|5|5.0||||||
3723570|NCT02087423|3561831|B2||Stage IIIA|AJCC staging at initial diagnosis|Per tumor, node, metastasis (TNM) staging system as specified by American Joint Committee on Cancer (AJCC). The staging is determined by a number of different parameters and the higher the staging the worse the prognosis for survival.|Participants|Count of Participants|13|13.0||||||
3723571|NCT02087423|3561832|B1||Stage IIIA|AJCC staging at initial diagnosis|Per tumor, node, metastasis (TNM) staging system as specified by American Joint Committee on Cancer (AJCC). The staging is determined by a number of different parameters and the higher the staging the worse the prognosis for survival.|Participants|Count of Participants|9|9.0||||||
3723572|NCT02087423|3561829|B4||Stage III|AJCC staging at initial diagnosis|Per tumor, node, metastasis (TNM) staging system as specified by American Joint Committee on Cancer (AJCC). The staging is determined by a number of different parameters and the higher the staging the worse the prognosis for survival.|Participants|Count of Participants|1|1.0||||||
3723573|NCT02087423|3561830|B3||Stage III|AJCC staging at initial diagnosis|Per tumor, node, metastasis (TNM) staging system as specified by American Joint Committee on Cancer (AJCC). The staging is determined by a number of different parameters and the higher the staging the worse the prognosis for survival.|Participants|Count of Participants|0|0.0||||||
3723574|NCT02087423|3561831|B2||Stage III|AJCC staging at initial diagnosis|Per tumor, node, metastasis (TNM) staging system as specified by American Joint Committee on Cancer (AJCC). The staging is determined by a number of different parameters and the higher the staging the worse the prognosis for survival.|Participants|Count of Participants|1|1.0||||||
3723575|NCT02087423|3561832|B1||Stage III|AJCC staging at initial diagnosis|Per tumor, node, metastasis (TNM) staging system as specified by American Joint Committee on Cancer (AJCC). The staging is determined by a number of different parameters and the higher the staging the worse the prognosis for survival.|Participants|Count of Participants|0|0.0||||||
3723576|NCT02087423|3561829|B4||Stage IIB|AJCC staging at initial diagnosis|Per tumor, node, metastasis (TNM) staging system as specified by American Joint Committee on Cancer (AJCC). The staging is determined by a number of different parameters and the higher the staging the worse the prognosis for survival.|Participants|Count of Participants|5|5.0||||||
3723577|NCT02087423|3561830|B3||Stage IIB|AJCC staging at initial diagnosis|Per tumor, node, metastasis (TNM) staging system as specified by American Joint Committee on Cancer (AJCC). The staging is determined by a number of different parameters and the higher the staging the worse the prognosis for survival.|Participants|Count of Participants|0|0.0||||||
3723578|NCT02087423|3561831|B2||Stage IIB|AJCC staging at initial diagnosis|Per tumor, node, metastasis (TNM) staging system as specified by American Joint Committee on Cancer (AJCC). The staging is determined by a number of different parameters and the higher the staging the worse the prognosis for survival.|Participants|Count of Participants|5|5.0||||||
3723579|NCT02087423|3561832|B1||Stage IIB|AJCC staging at initial diagnosis|Per tumor, node, metastasis (TNM) staging system as specified by American Joint Committee on Cancer (AJCC). The staging is determined by a number of different parameters and the higher the staging the worse the prognosis for survival.|Participants|Count of Participants|0|0.0||||||
3723580|NCT02087423|3561829|B4||Stage IIA|AJCC staging at initial diagnosis|Per tumor, node, metastasis (TNM) staging system as specified by American Joint Committee on Cancer (AJCC). The staging is determined by a number of different parameters and the higher the staging the worse the prognosis for survival.|Participants|Count of Participants|3|3.0||||||
3723581|NCT02087423|3561830|B3||Stage IIA|AJCC staging at initial diagnosis|Per tumor, node, metastasis (TNM) staging system as specified by American Joint Committee on Cancer (AJCC). The staging is determined by a number of different parameters and the higher the staging the worse the prognosis for survival.|Participants|Count of Participants|1|1.0||||||
3723582|NCT02087423|3561831|B2||Stage IIA|AJCC staging at initial diagnosis|Per tumor, node, metastasis (TNM) staging system as specified by American Joint Committee on Cancer (AJCC). The staging is determined by a number of different parameters and the higher the staging the worse the prognosis for survival.|Participants|Count of Participants|1|1.0||||||
3723583|NCT02087423|3561832|B1||Stage IIA|AJCC staging at initial diagnosis|Per tumor, node, metastasis (TNM) staging system as specified by American Joint Committee on Cancer (AJCC). The staging is determined by a number of different parameters and the higher the staging the worse the prognosis for survival.|Participants|Count of Participants|1|1.0||||||
3723584|NCT02087423|3561829|B4||Stage II|AJCC staging at initial diagnosis|Per tumor, node, metastasis (TNM) staging system as specified by American Joint Committee on Cancer (AJCC). The staging is determined by a number of different parameters and the higher the staging the worse the prognosis for survival.|Participants|Count of Participants|1|1.0||||||
3723585|NCT02087423|3561830|B3||Stage II|AJCC staging at initial diagnosis|Per tumor, node, metastasis (TNM) staging system as specified by American Joint Committee on Cancer (AJCC). The staging is determined by a number of different parameters and the higher the staging the worse the prognosis for survival.|Participants|Count of Participants|0|0.0||||||
3723586|NCT02087423|3561831|B2||Stage II|AJCC staging at initial diagnosis|Per tumor, node, metastasis (TNM) staging system as specified by American Joint Committee on Cancer (AJCC). The staging is determined by a number of different parameters and the higher the staging the worse the prognosis for survival.|Participants|Count of Participants|1|1.0||||||
3723587|NCT02087423|3561832|B1||Stage II|AJCC staging at initial diagnosis|Per tumor, node, metastasis (TNM) staging system as specified by American Joint Committee on Cancer (AJCC). The staging is determined by a number of different parameters and the higher the staging the worse the prognosis for survival.|Participants|Count of Participants|0|0.0||||||
3723588|NCT02087423|3561829|B4||Stage IB|AJCC staging at initial diagnosis|Per tumor, node, metastasis (TNM) staging system as specified by American Joint Committee on Cancer (AJCC). The staging is determined by a number of different parameters and the higher the staging the worse the prognosis for survival.|Participants|Count of Participants|4|4.0||||||
3723589|NCT02087423|3561830|B3||Stage IB|AJCC staging at initial diagnosis|Per tumor, node, metastasis (TNM) staging system as specified by American Joint Committee on Cancer (AJCC). The staging is determined by a number of different parameters and the higher the staging the worse the prognosis for survival.|Participants|Count of Participants|0|0.0||||||
3723590|NCT02087423|3561831|B2||Stage IB|AJCC staging at initial diagnosis|Per tumor, node, metastasis (TNM) staging system as specified by American Joint Committee on Cancer (AJCC). The staging is determined by a number of different parameters and the higher the staging the worse the prognosis for survival.|Participants|Count of Participants|4|4.0||||||
3723591|NCT02087423|3561832|B1||Stage IB|AJCC staging at initial diagnosis|Per tumor, node, metastasis (TNM) staging system as specified by American Joint Committee on Cancer (AJCC). The staging is determined by a number of different parameters and the higher the staging the worse the prognosis for survival.|Participants|Count of Participants|0|0.0||||||
3723592|NCT02087423|3561829|B4||Stage IA|AJCC staging at initial diagnosis|Per tumor, node, metastasis (TNM) staging system as specified by American Joint Committee on Cancer (AJCC). The staging is determined by a number of different parameters and the higher the staging the worse the prognosis for survival.|Participants|Count of Participants|5|5.0||||||
3723593|NCT02087423|3561830|B3||Stage IA|AJCC staging at initial diagnosis|Per tumor, node, metastasis (TNM) staging system as specified by American Joint Committee on Cancer (AJCC). The staging is determined by a number of different parameters and the higher the staging the worse the prognosis for survival.|Participants|Count of Participants|0|0.0||||||
3723594|NCT02087423|3561831|B2||Stage IA|AJCC staging at initial diagnosis|Per tumor, node, metastasis (TNM) staging system as specified by American Joint Committee on Cancer (AJCC). The staging is determined by a number of different parameters and the higher the staging the worse the prognosis for survival.|Participants|Count of Participants|3|3.0||||||
3723595|NCT02087423|3561832|B1||Stage IA|AJCC staging at initial diagnosis|Per tumor, node, metastasis (TNM) staging system as specified by American Joint Committee on Cancer (AJCC). The staging is determined by a number of different parameters and the higher the staging the worse the prognosis for survival.|Participants|Count of Participants|2|2.0||||||
3723596|NCT02087423|3561829|B4||Non-squamous|Histology type||Participants|Count of Participants|368|368.0||||||
3723597|NCT02087423|3561830|B3||Non-squamous|Histology type||Participants|Count of Participants|48|48.0||||||
3723599|NCT02087423|3561832|B1||Non-squamous|Histology type||Participants|Count of Participants|110|110.0||||||
3723600|NCT02087423|3561829|B4||Squamous|Histology type||Participants|Count of Participants|76|76.0||||||
3723601|NCT02087423|3561830|B3||Squamous|Histology type||Participants|Count of Participants|20|20.0||||||
3723602|NCT02087423|3561831|B2||Squamous|Histology type||Participants|Count of Participants|55|55.0||||||
3723603|NCT02087423|3561832|B1||Squamous|Histology type||Participants|Count of Participants|1|1.0||||||
3723604|NCT02087423|3561829|B4|||Primary tumor location|Lung|Participants|Count of Participants|444|444.0||||||
3723605|NCT02087423|3561830|B3|||Primary tumor location|Lung|Participants|Count of Participants|68|68.0||||||
3723606|NCT02087423|3561831|B2|||Primary tumor location|Lung|Participants|Count of Participants|265|265.0||||||
3723607|NCT02087423|3561832|B1|||Primary tumor location|Lung|Participants|Count of Participants|111|111.0||||||
3723608|NCT02087423|3561829|B4||(4) 100% bed ridden|WHO performance status||Participants|Count of Participants|0|0.0||||||
3723609|NCT02087423|3561830|B3||(4) 100% bed ridden|WHO performance status||Participants|Count of Participants|0|0.0||||||
3723610|NCT02087423|3561831|B2||(4) 100% bed ridden|WHO performance status||Participants|Count of Participants|0|0.0||||||
3723611|NCT02087423|3561832|B1||(4) 100% bed ridden|WHO performance status||Participants|Count of Participants|0|0.0||||||
3723612|NCT02087423|3561829|B4||(3) In bed >50% of the time|WHO performance status||Participants|Count of Participants|0|0.0||||||
3723613|NCT02087423|3561830|B3||(3) In bed >50% of the time|WHO performance status||Participants|Count of Participants|0|0.0||||||
3723614|NCT02087423|3561831|B2||(3) In bed >50% of the time|WHO performance status||Participants|Count of Participants|0|0.0||||||
3723615|NCT02087423|3561832|B1||(3) In bed >50% of the time|WHO performance status||Participants|Count of Participants|0|0.0||||||
3723616|NCT02087423|3561829|B4||(2) In bed <=50% of the time|WHO performance status||Participants|Count of Participants|2|2.0||||||
3723617|NCT02087423|3561830|B3||(2) In bed <=50% of the time|WHO performance status||Participants|Count of Participants|0|0.0||||||
3723618|NCT02087423|3561831|B2||(2) In bed <=50% of the time|WHO performance status||Participants|Count of Participants|1|1.0||||||
3723619|NCT02087423|3561832|B1||(2) In bed <=50% of the time|WHO performance status||Participants|Count of Participants|1|1.0||||||
3723620|NCT02087423|3561829|B4||(1) Restricted activity|WHO performance status||Participants|Count of Participants|292|292.0||||||
3723621|NCT02087423|3561830|B3||(1) Restricted activity|WHO performance status||Participants|Count of Participants|49|49.0||||||
3723622|NCT02087423|3561831|B2||(1) Restricted activity|WHO performance status||Participants|Count of Participants|178|178.0||||||
3723623|NCT02087423|3561832|B1||(1) Restricted activity|WHO performance status||Participants|Count of Participants|65|65.0||||||
3723624|NCT02087423|3561829|B4||(0) Normal activity|WHO performance status||Participants|Count of Participants|150|150.0||||||
3723625|NCT02087423|3561830|B3||(0) Normal activity|WHO performance status||Participants|Count of Participants|19|19.0||||||
3723626|NCT02087423|3561831|B2||(0) Normal activity|WHO performance status||Participants|Count of Participants|86|86.0||||||
3723627|NCT02087423|3561832|B1||(0) Normal activity|WHO performance status||Participants|Count of Participants|45|45.0||||||
3723628|NCT02087423|3561829|B4||>90 kg|Weight group||Participants|Count of Participants|32|32.0||||||
3723629|NCT02087423|3561830|B3||>90 kg|Weight group||Participants|Count of Participants|7|7.0||||||
3723630|NCT02087423|3561831|B2||>90 kg|Weight group||Participants|Count of Participants|22|22.0||||||
3723631|NCT02087423|3561832|B1||>90 kg|Weight group||Participants|Count of Participants|3|3.0||||||
3723632|NCT02087423|3561829|B4||Between 70 and 90 kg|Weight group||Participants|Count of Participants|145|145.0||||||
3723633|NCT02087423|3561830|B3||Between 70 and 90 kg|Weight group||Participants|Count of Participants|21|21.0||||||
3723634|NCT02087423|3561831|B2||Between 70 and 90 kg|Weight group||Participants|Count of Participants|97|97.0||||||
3723635|NCT02087423|3561832|B1||Between 70 and 90 kg|Weight group||Participants|Count of Participants|27|27.0||||||
3723636|NCT02087423|3561829|B4||<70 kg|Weight group||Participants|Count of Participants|267|267.0||||||
3723637|NCT02087423|3561830|B3||<70 kg|Weight group||Participants|Count of Participants|40|40.0||||||
3723638|NCT02087423|3561831|B2||<70 kg|Weight group||Participants|Count of Participants|146|146.0||||||
3723639|NCT02087423|3561832|B1||<70 kg|Weight group||Participants|Count of Participants|81|81.0||||||
3723640|NCT02087423|3561829|B4|||Weight||kg|Median|66|66.0|Standard Deviation|14.93|14.93|||
3723641|NCT02087423|3561830|B3|||Weight||kg|Median|66|66.0|Standard Deviation|15.79|15.79|||
3723642|NCT02087423|3561831|B2|||Weight||kg|Median|68|68.0|Standard Deviation|14.52|14.52|||
3723643|NCT02087423|3561832|B1|||Weight||kg|Median|59|59.0|Standard Deviation|14.15|14.15|||
3723644|NCT02087423|3561829|B4||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|417|417.0||||||
3723645|NCT02087423|3561830|B3||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|66|66.0||||||
3723646|NCT02087423|3561831|B2||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|246|246.0||||||
3723647|NCT02087423|3561832|B1||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|105|105.0||||||
3723648|NCT02087423|3561829|B4||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3723649|NCT02087423|3561830|B3||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3723650|NCT02087423|3561831|B2||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3723651|NCT02087423|3561832|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3723652|NCT02087423|3561829|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|141|141.0||||||
3723653|NCT02087423|3561830|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3723654|NCT02087423|3561831|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
3723655|NCT02087423|3561832|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|66|66.0||||||
3723656|NCT02087423|3561829|B4||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3723657|NCT02087423|3561830|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3723658|NCT02087423|3561831|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3723659|NCT02087423|3561832|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3723660|NCT02087423|3561829|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|298|298.0||||||
3723661|NCT02087423|3561830|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3723662|NCT02087423|3561831|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|212|212.0||||||
3723663|NCT02087423|3561832|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
3723664|NCT02087423|3561829|B4||Male|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
3723665|NCT02087423|3561830|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3723666|NCT02087423|3561831|B2||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3723667|NCT02087423|3561832|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3723668|NCT02087423|3561829|B4||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3723669|NCT02087423|3561830|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3723670|NCT02087423|3561831|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3723671|NCT02087423|3561832|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3723672|NCT02087423|3561829|B4|||Age||years|Median|62.0|62.0|Standard Deviation|10.13|10.13|||
3723673|NCT02087423|3561830|B3|||Age||years|Median|61.0|61.0|Standard Deviation|10.58|10.58|||
3723674|NCT02087423|3561831|B2|||Age||years|Median|62.0|62.0|Standard Deviation|9.35|9.35|||
3723675|NCT02087423|3561832|B1|||Age||years|Median|61.0|61.0|Standard Deviation|11.45|11.45|||
3723676|NCT02087423|3561829|B4||>=65 years|Age|age groups of <=18, between 18 and 65, >=65,|Participants|Count of Participants|179|179.0||||||
3723677|NCT02087423|3561830|B3||>=65 years|Age|age groups of <=18, between 18 and 65, >=65,|Participants|Count of Participants|24|24.0||||||
3723678|NCT02087423|3561831|B2||>=65 years|Age|age groups of <=18, between 18 and 65, >=65,|Participants|Count of Participants|110|110.0||||||
3723679|NCT02087423|3561832|B1||>=65 years|Age|age groups of <=18, between 18 and 65, >=65,|Participants|Count of Participants|45|45.0||||||
3723680|NCT02087423|3561829|B4||Between 18 and 65 years|Age|age groups of <=18, between 18 and 65, >=65,|Participants|Count of Participants|265|265.0||||||
3723681|NCT02087423|3561830|B3||Between 18 and 65 years|Age|age groups of <=18, between 18 and 65, >=65,|Participants|Count of Participants|44|44.0||||||
3723682|NCT02087423|3561831|B2||Between 18 and 65 years|Age|age groups of <=18, between 18 and 65, >=65,|Participants|Count of Participants|155|155.0||||||
3723683|NCT02087423|3561832|B1||Between 18 and 65 years|Age|age groups of <=18, between 18 and 65, >=65,|Participants|Count of Participants|66|66.0||||||
3723684|NCT02087423|3561829|B4||<=18 years|Age|age groups of <=18, between 18 and 65, >=65,|Participants|Count of Participants|0|0.0||||||
3723685|NCT02087423|3561830|B3||<=18 years|Age|age groups of <=18, between 18 and 65, >=65,|Participants|Count of Participants|0|0.0||||||
3723686|NCT02087423|3561831|B2||<=18 years|Age|age groups of <=18, between 18 and 65, >=65,|Participants|Count of Participants|0|0.0||||||
3723687|NCT02087423|3561832|B1||<=18 years|Age|age groups of <=18, between 18 and 65, >=65,|Participants|Count of Participants|0|0.0||||||
3723688|NCT02087241|3561859|B5|ECOG Performance Status = 1||ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) scores are defined as follows: 0 = Asymptomatic (Fully active, able to carry on all predisease activities without restriction); 1 = Symptomatic but completely ambulatory (Restricted in physically strenuous activity and able to carry out work of a light or sedentary nature); 2 = Symptomatic, <50% in bed during the day; 3 = Symptomatic, >50% in bed, but not bedbound; 4 = Bedbound (Completely disabled. Cannot carry on any self-care; 5 = Dead|Participants|Number|8|8.0||||||
3723689|NCT02087241|3561860|B4|ECOG Performance Status = 1||ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) scores are defined as follows: 0 = Asymptomatic (Fully active, able to carry on all predisease activities without restriction); 1 = Symptomatic but completely ambulatory (Restricted in physically strenuous activity and able to carry out work of a light or sedentary nature); 2 = Symptomatic, <50% in bed during the day; 3 = Symptomatic, >50% in bed, but not bedbound; 4 = Bedbound (Completely disabled. Cannot carry on any self-care; 5 = Dead|Participants|Number|4|4.0||||||
3723690|NCT02087241|3561861|B3|ECOG Performance Status = 1||ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) scores are defined as follows: 0 = Asymptomatic (Fully active, able to carry on all predisease activities without restriction); 1 = Symptomatic but completely ambulatory (Restricted in physically strenuous activity and able to carry out work of a light or sedentary nature); 2 = Symptomatic, <50% in bed during the day; 3 = Symptomatic, >50% in bed, but not bedbound; 4 = Bedbound (Completely disabled. Cannot carry on any self-care; 5 = Dead|Participants|Number|0|0.0||||||
3723691|NCT02087241|3561862|B2|ECOG Performance Status = 1||ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) scores are defined as follows: 0 = Asymptomatic (Fully active, able to carry on all predisease activities without restriction); 1 = Symptomatic but completely ambulatory (Restricted in physically strenuous activity and able to carry out work of a light or sedentary nature); 2 = Symptomatic, <50% in bed during the day; 3 = Symptomatic, >50% in bed, but not bedbound; 4 = Bedbound (Completely disabled. Cannot carry on any self-care; 5 = Dead|Participants|Number|2|2.0||||||
3723692|NCT02087241|3561863|B1|ECOG Performance Status = 1||ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) scores are defined as follows: 0 = Asymptomatic (Fully active, able to carry on all predisease activities without restriction); 1 = Symptomatic but completely ambulatory (Restricted in physically strenuous activity and able to carry out work of a light or sedentary nature); 2 = Symptomatic, <50% in bed during the day; 3 = Symptomatic, >50% in bed, but not bedbound; 4 = Bedbound (Completely disabled. Cannot carry on any self-care; 5 = Dead|Participants|Number|2|2.0||||||
3723693|NCT02087241|3561859|B5|ECOG Performance Status = 0||ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) scores are defined as follows: 0 = Asymptomatic (Fully active, able to carry on all predisease activities without restriction); 1 = Symptomatic but completely ambulatory (Restricted in physically strenuous activity and able to carry out work of a light or sedentary nature); 2 = Symptomatic, <50% in bed during the day; 3 = Symptomatic, >50% in bed, but not bedbound; 4 = Bedbound (Completely disabled. Cannot carry on any self-care; 5 = Dead|Participants|Number|6|6.0||||||
3723694|NCT02087241|3561860|B4|ECOG Performance Status = 0||ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) scores are defined as follows: 0 = Asymptomatic (Fully active, able to carry on all predisease activities without restriction); 1 = Symptomatic but completely ambulatory (Restricted in physically strenuous activity and able to carry out work of a light or sedentary nature); 2 = Symptomatic, <50% in bed during the day; 3 = Symptomatic, >50% in bed, but not bedbound; 4 = Bedbound (Completely disabled. Cannot carry on any self-care; 5 = Dead|Participants|Number|3|3.0||||||
3723695|NCT02087241|3561861|B3|ECOG Performance Status = 0||ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) scores are defined as follows: 0 = Asymptomatic (Fully active, able to carry on all predisease activities without restriction); 1 = Symptomatic but completely ambulatory (Restricted in physically strenuous activity and able to carry out work of a light or sedentary nature); 2 = Symptomatic, <50% in bed during the day; 3 = Symptomatic, >50% in bed, but not bedbound; 4 = Bedbound (Completely disabled. Cannot carry on any self-care; 5 = Dead|Participants|Number|1|1.0||||||
3723696|NCT02087241|3561862|B2|ECOG Performance Status = 0||ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) scores are defined as follows: 0 = Asymptomatic (Fully active, able to carry on all predisease activities without restriction); 1 = Symptomatic but completely ambulatory (Restricted in physically strenuous activity and able to carry out work of a light or sedentary nature); 2 = Symptomatic, <50% in bed during the day; 3 = Symptomatic, >50% in bed, but not bedbound; 4 = Bedbound (Completely disabled. Cannot carry on any self-care; 5 = Dead|Participants|Number|1|1.0||||||
3723697|NCT02087241|3561863|B1|ECOG Performance Status = 0||ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) scores are defined as follows: 0 = Asymptomatic (Fully active, able to carry on all predisease activities without restriction); 1 = Symptomatic but completely ambulatory (Restricted in physically strenuous activity and able to carry out work of a light or sedentary nature); 2 = Symptomatic, <50% in bed during the day; 3 = Symptomatic, >50% in bed, but not bedbound; 4 = Bedbound (Completely disabled. Cannot carry on any self-care; 5 = Dead|Participants|Number|1|1.0||||||
3723698|NCT02087241|3561859|B5|Non-Smoker||Tobacco Use||Participants|Number|0|0.0||||||
3723699|NCT02087241|3561860|B4|Non-Smoker||Tobacco Use||Participants|Number|0|0.0||||||
3723700|NCT02087241|3561861|B3|Non-Smoker||Tobacco Use||Participants|Number|0|0.0||||||
3723701|NCT02087241|3561862|B2|Non-Smoker||Tobacco Use||Participants|Number|0|0.0||||||
3723702|NCT02087241|3561863|B1|Non-Smoker||Tobacco Use||Participants|Number|0|0.0||||||
3723703|NCT02087241|3561859|B5|Smoker||Tobacco Use||Participants|Number|14|14.0||||||
3723704|NCT02087241|3561860|B4|Smoker||Tobacco Use||Participants|Number|7|7.0||||||
3723705|NCT02087241|3561861|B3|Smoker||Tobacco Use||Participants|Number|1|1.0||||||
3723706|NCT02087241|3561862|B2|Smoker||Tobacco Use||Participants|Number|3|3.0||||||
3723707|NCT02087241|3561863|B1|Smoker||Tobacco Use||Participants|Number|3|3.0||||||
3723708|NCT02087241|3561859|B5|United States||Region of Enrollment||Participants|Number|14|14.0||||||
3723709|NCT02087241|3561860|B4|United States||Region of Enrollment||Participants|Number|7|7.0||||||
3723710|NCT02087241|3561861|B3|United States||Region of Enrollment||Participants|Number|1|1.0||||||
3723711|NCT02087241|3561862|B2|United States||Region of Enrollment||Participants|Number|3|3.0||||||
3723712|NCT02087241|3561863|B1|United States||Region of Enrollment||Participants|Number|3|3.0||||||
3723713|NCT02087241|3561859|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723714|NCT02087241|3561860|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723715|NCT02087241|3561861|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723716|NCT02087241|3561862|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723717|NCT02087241|3561863|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723718|NCT02087241|3561859|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723719|NCT02087241|3561860|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723720|NCT02087241|3561861|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723721|NCT02087241|3561862|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723722|NCT02087241|3561863|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723723|NCT02087241|3561859|B5||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3723724|NCT02087241|3561860|B4||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3723725|NCT02087241|3561861|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3723726|NCT02087241|3561862|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3723727|NCT02087241|3561863|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3723728|NCT02087241|3561859|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3723729|NCT02087241|3561860|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3723730|NCT02087241|3561861|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723731|NCT02087241|3561862|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723732|NCT02087241|3561863|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723733|NCT02087241|3561859|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723734|NCT02087241|3561860|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723735|NCT02087241|3561861|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723736|NCT02087241|3561862|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723737|NCT02087241|3561863|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723738|NCT02087241|3561859|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723739|NCT02087241|3561860|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723740|NCT02087241|3561861|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723741|NCT02087241|3561862|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723742|NCT02087241|3561863|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723743|NCT02087241|3561859|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723744|NCT02087241|3561860|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723745|NCT02087241|3561861|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723746|NCT02087241|3561862|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723747|NCT02087241|3561863|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723748|NCT02087241|3561859|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723749|NCT02087241|3561860|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723750|NCT02087241|3561861|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723751|NCT02087241|3561862|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723752|NCT02087241|3561863|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723753|NCT02087241|3561859|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3723754|NCT02087241|3561860|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3723755|NCT02087241|3561861|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3723756|NCT02087241|3561862|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3723757|NCT02087241|3561863|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3723758|NCT02087241|3561859|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3723759|NCT02087241|3561860|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723760|NCT02087241|3561861|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723761|NCT02087241|3561862|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3723762|NCT02087241|3561863|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723763|NCT02087241|3561859|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3723764|NCT02087241|3561860|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3723765|NCT02087241|3561861|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3723766|NCT02087241|3561862|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3723767|NCT02087241|3561863|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3723768|NCT02087241|3561859|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3723769|NCT02087241|3561860|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3723770|NCT02087241|3561861|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3723771|NCT02087241|3561862|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3723772|NCT02087241|3561863|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3723773|NCT02087241|3561859|B5|>= 65||Age, Customized||Participants|Number|6|6.0||||||
3723774|NCT02087241|3561860|B4|>= 65||Age, Customized||Participants|Number|3|3.0||||||
3723775|NCT02087241|3561861|B3|>= 65||Age, Customized||Participants|Number|1|1.0||||||
3723776|NCT02087241|3561862|B2|>= 65||Age, Customized||Participants|Number|0|0.0||||||
3723777|NCT02087241|3561863|B1|>= 65||Age, Customized||Participants|Number|2|2.0||||||
3723778|NCT02087241|3561859|B5|< 65||Age, Customized||Participants|Number|8|8.0||||||
3723779|NCT02087241|3561860|B4|< 65||Age, Customized||Participants|Number|4|4.0||||||
3723780|NCT02087241|3561861|B3|< 65||Age, Customized||Participants|Number|0|0.0||||||
3723781|NCT02087241|3561862|B2|< 65||Age, Customized||Participants|Number|3|3.0||||||
3723782|NCT02087241|3561863|B1|< 65||Age, Customized||Participants|Number|1|1.0||||||
3723783|NCT02087241|3561859|B5|||Age||Years|Median|63.0|63.0|Full Range|||46.0|81.0|
3723784|NCT02087241|3561860|B4|||Age||Years|Median|64.0|64.0|Full Range|||46.0|73.0|
3723785|NCT02087241|3561861|B3|||Age||Years|Median|81.0|81.0|Full Range|||81.0|81.0|
3723786|NCT02087241|3561862|B2|||Age||Years|Median|61.0|61.0|Full Range|||54.0|62.0|
3723787|NCT02087241|3561863|B1|||Age||Years|Median|66.0|66.0|Full Range|||59.0|71.0|
3723788|NCT02087241|3561859|B5|||Age||Years|Mean|63.7|63.7|Standard Deviation|8.88|8.88|||
3723789|NCT02087241|3561860|B4|||Age||Years|Mean|62.6|62.6|Standard Deviation|9.41|9.41|||
3723790|NCT02087241|3561861|B3|||Age||Years|Mean|81.0|81.0|Standard Deviation|0|0.0|||
3723791|NCT02087241|3561862|B2|||Age||Years|Mean|59.0|59.0|Standard Deviation|4.36|4.36|||
3723792|NCT02087241|3561863|B1|||Age||Years|Mean|65.3|65.3|Standard Deviation|6.03|6.03|||
3723844|NCT02086786|3561907|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3723845|NCT02086786|3561905|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3723793|NCT02087176|3561892|B1|ECOG Performance Status = 1||ECOG Performance Status|"ECOG scores are defined as follows:~0 – Asymptomatic (Fully active, able to carry on all predisease activities without restriction)~– Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature.)~– Symptomatic, < 50% of time in bed during the day.~– Symptomatic, >50% in bed, but not bedbound.~– Bedbound (Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair)~– Death"|Participants|Number|17|17.0||||||
3723794|NCT02087176|3561892|B1|ECOG Performance Status = 0||ECOG Performance Status|"ECOG scores are defined as follows:~0 – Asymptomatic (Fully active, able to carry on all predisease activities without restriction)~– Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature.)~– Symptomatic, < 50% of time in bed during the day.~– Symptomatic, >50% in bed, but not bedbound.~– Bedbound (Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair)~– Death"|Participants|Number|15|15.0||||||
3723795|NCT02087176|3561892|B1|Smoking Status Missing||Tobacco Use||Participants|Number|2|2.0||||||
3723796|NCT02087176|3561892|B1|Non-Smoker||Tobacco Use||Participants|Number|1|1.0||||||
3723797|NCT02087176|3561892|B1|Smoker||Tobacco Use||Participants|Number|29|29.0||||||
3723798|NCT02087176|3561892|B1|United States||Region of Enrollment||Participants|Number|32|32.0||||||
3723799|NCT02087176|3561892|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3723800|NCT02087176|3561892|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723801|NCT02087176|3561892|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3723802|NCT02087176|3561892|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3723803|NCT02087176|3561892|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723804|NCT02087176|3561892|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723805|NCT02087176|3561892|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723806|NCT02087176|3561892|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723807|NCT02087176|3561892|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3723808|NCT02087176|3561892|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3723809|NCT02087176|3561892|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3723810|NCT02087176|3561892|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3723811|NCT02087176|3561892|B1|>= 65||Age, Customized||Participants|Number|14|14.0||||||
3723812|NCT02087176|3561892|B1|< 65||Age, Customized||Participants|Number|18|18.0||||||
3723813|NCT02087176|3561892|B1|||Age||Years|Median|62.0|62.0|Full Range|||36.0|76.0|
3723814|NCT02087176|3561892|B1|||Age||Years|Mean|61.9|61.9|Standard Deviation|9.41|9.41|||
3723815|NCT02087059|3561897|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3723816|NCT02087059|3561897|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3723817|NCT02087059|3561897|B1|||Age||years|Mean|65.7|65.7|Standard Deviation|8.8|8.8|||
3723818|NCT02086786|3561905|B3|United States||Region of Enrollment||participants|Number|67|67.0||||||
3723819|NCT02086786|3561906|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
3723820|NCT02086786|3561907|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
3723821|NCT02086786|3561905|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723822|NCT02086786|3561906|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723823|NCT02086786|3561907|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723824|NCT02086786|3561905|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723825|NCT02086786|3561906|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723826|NCT02086786|3561907|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723827|NCT02086786|3561905|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3723828|NCT02086786|3561906|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3723829|NCT02086786|3561907|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3723830|NCT02086786|3561905|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3723831|NCT02086786|3561906|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3723832|NCT02086786|3561907|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3723833|NCT02086786|3561905|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723834|NCT02086786|3561906|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723835|NCT02086786|3561907|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723836|NCT02086786|3561905|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3723837|NCT02086786|3561906|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3723838|NCT02086786|3561907|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3723839|NCT02086786|3561905|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3723840|NCT02086786|3561906|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3723841|NCT02086786|3561907|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3723842|NCT02086786|3561905|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3723843|NCT02086786|3561906|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3723847|NCT02086786|3561907|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3723848|NCT02086786|3561905|B3|||Age||years|Mean|43|43.0|Standard Deviation|10.5|10.5|||
3723849|NCT02086786|3561906|B2|||Age||years|Mean|44|44.0|Standard Deviation|9.8|9.8|||
3723850|NCT02086786|3561907|B1|||Age||years|Mean|41|41.0|Standard Deviation|11.1|11.1|||
3723851|NCT02086786|3561905|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3723852|NCT02086786|3561906|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3723853|NCT02086786|3561907|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3723854|NCT02086786|3561905|B3||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
3723855|NCT02086786|3561906|B2||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3723856|NCT02086786|3561907|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3723857|NCT02086786|3561905|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3723858|NCT02086786|3561906|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3723859|NCT02086786|3561907|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3723860|NCT02086708|3561932|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3723861|NCT02086708|3561932|B1||Male|Gender||Participants|Count of Participants|13|13.0||||||
3723862|NCT02086708|3561932|B1||Female|Gender||Participants|Count of Participants|11|11.0||||||
3723863|NCT02086708|3561932|B1|||Age|"In this study:~The eligibility age range was 1-21 years.~We enrolled subjects with the age with the minimum age value of 1 years and the maximum age value of 21 years."|years|Mean|17|17.0|Full Range|||1.0|21.0|
3723864|NCT02086591|3561944|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3723865|NCT02086591|3561944|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
3723866|NCT02086591|3561944|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
3723867|NCT02086591|3561944|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3723868|NCT02086591|3561944|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3723869|NCT02086591|3561944|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3723870|NCT02086162|3561950|B3|||Fagerstrom dependence score|"The Fagerström Test for Nicotine Dependence is a standard instrument for assessing the intensity of physical addiction to nicotine. The test was designed to provide an ordinal measure of nicotine dependence related to cigarette smoking. It contains six items that evaluate the quantity of cigarette consumption, the compulsion to use, and dependence.~Yes/no items are scored from 0 to 1 and multiple-choice items are scored from 0 to 3. The items are summed to yield a total score of 0-10. The higher the total Fagerström score, the more intense is the patient's physical dependence on nicotine."|units on a scale|Mean|5.16|5.16|Standard Deviation|2.0|2.0|||
3723871|NCT02086162|3561951|B2|||Fagerstrom dependence score|"The Fagerström Test for Nicotine Dependence is a standard instrument for assessing the intensity of physical addiction to nicotine. The test was designed to provide an ordinal measure of nicotine dependence related to cigarette smoking. It contains six items that evaluate the quantity of cigarette consumption, the compulsion to use, and dependence.~Yes/no items are scored from 0 to 1 and multiple-choice items are scored from 0 to 3. The items are summed to yield a total score of 0-10. The higher the total Fagerström score, the more intense is the patient's physical dependence on nicotine."|units on a scale|Mean|5.30|5.3|Standard Deviation|1.80|1.8|||
3723872|NCT02086162|3561952|B1|||Fagerstrom dependence score|"The Fagerström Test for Nicotine Dependence is a standard instrument for assessing the intensity of physical addiction to nicotine. The test was designed to provide an ordinal measure of nicotine dependence related to cigarette smoking. It contains six items that evaluate the quantity of cigarette consumption, the compulsion to use, and dependence.~Yes/no items are scored from 0 to 1 and multiple-choice items are scored from 0 to 3. The items are summed to yield a total score of 0-10. The higher the total Fagerström score, the more intense is the patient's physical dependence on nicotine."|units on a scale|Mean|5.03|5.03|Standard Deviation|2.19|2.19|||
3723873|NCT02086162|3561950|B3|||Cigarettes per day|Self-reported number of cigarettes smoked per day.|cigarettes|Mean|14.56|14.56|Standard Deviation|10.49|10.49|||
3723874|NCT02086162|3561951|B2|||Cigarettes per day|Self-reported number of cigarettes smoked per day.|cigarettes|Mean|14.64|14.64|Standard Deviation|11.3|11.3|||
3723875|NCT02086162|3561952|B1|||Cigarettes per day|Self-reported number of cigarettes smoked per day.|cigarettes|Mean|14.48|14.48|Standard Deviation|9.62|9.62|||
3723876|NCT02086162|3561950|B3|||Cognition battery Z Scores|"We used a composite score of cognition measures including attention-concentration (Continuous Performance Test), verbal and working memory (Hopkins Verbal Learning Test), and processing speed (Trail Making Test Part A), as well as cognitive flexibility (Trail Making Test Part B) and inhibitory control (Stroop subtest) with measures from the DKEFS (Delis-Kaplan Executive Functioning System).~For each individual, we normalized each of their scale scores and calculated a mean of these scores. This mean served as the individual’s composite cognition score."|units on a scale|Mean|-.006|-0.006|Standard Deviation|0.69|0.69|||
3723877|NCT02086162|3561951|B2|||Cognition battery Z Scores|"We used a composite score of cognition measures including attention-concentration (Continuous Performance Test), verbal and working memory (Hopkins Verbal Learning Test), and processing speed (Trail Making Test Part A), as well as cognitive flexibility (Trail Making Test Part B) and inhibitory control (Stroop subtest) with measures from the DKEFS (Delis-Kaplan Executive Functioning System).~For each individual, we normalized each of their scale scores and calculated a mean of these scores. This mean served as the individual’s composite cognition score."|units on a scale|Mean|.016|0.016|Standard Deviation|0.70|0.7|||
3723878|NCT02086162|3561952|B1|||Cognition battery Z Scores|"We used a composite score of cognition measures including attention-concentration (Continuous Performance Test), verbal and working memory (Hopkins Verbal Learning Test), and processing speed (Trail Making Test Part A), as well as cognitive flexibility (Trail Making Test Part B) and inhibitory control (Stroop subtest) with measures from the DKEFS (Delis-Kaplan Executive Functioning System).~For each individual, we normalized each of their scale scores and calculated a mean of these scores. This mean served as the individual’s composite cognition score."|units on a scale|Mean|-.029|-0.029|Standard Deviation|0.68|0.68|||
3723879|NCT02086162|3561950|B3|||Positive and Negative Affect Schedule - Negative|10 Item self report measure of negative affect. Scores may range from 10 (low negative affect) to 50 (high negative affect).|units on a scale|Mean|12.05|12.05|Standard Deviation|9.25|9.25|||
3723880|NCT02086162|3561951|B2|||Positive and Negative Affect Schedule - Negative|10 Item self report measure of negative affect. Scores may range from 10 (low negative affect) to 50 (high negative affect).|units on a scale|Mean|12.06|12.06|Standard Deviation|9.45|9.45|||
3723881|NCT02086162|3561952|B1|||Positive and Negative Affect Schedule - Negative|10 Item self report measure of negative affect. Scores may range from 10 (low negative affect) to 50 (high negative affect).|units on a scale|Mean|12.04|12.04|Standard Deviation|9.09|9.09|||
3723882|NCT02086162|3561950|B3|||Positive and Negative Affect Schedule - Positive|Self report measure of positive affect. Scores range from 10 (low positive affect) to 50 (high positive affect).|units on a scale|Mean|22.33|22.33|Standard Deviation|8.54|8.54|||
3723883|NCT02086162|3561951|B2|||Positive and Negative Affect Schedule - Positive|Self report measure of positive affect. Scores range from 10 (low positive affect) to 50 (high positive affect).|units on a scale|Mean|22.31|22.31|Standard Deviation|8.48|8.48|||
3723884|NCT02086162|3561952|B1|||Positive and Negative Affect Schedule - Positive|Self report measure of positive affect. Scores range from 10 (low positive affect) to 50 (high positive affect).|units on a scale|Mean|22.36|22.36|Standard Deviation|8.66|8.66|||
3723885|NCT02086162|3561950|B3|||Brief Psychiatric Rating Scale|A structured assessment of psychopathology severity using structured interview, observation, and record review. Scores may range from 7 to 126.|units on a scale|Mean|41.06|41.06|Standard Deviation|11.11|11.11|||
3723886|NCT02086162|3561951|B2|||Brief Psychiatric Rating Scale|A structured assessment of psychopathology severity using structured interview, observation, and record review. Scores may range from 7 to 126.|units on a scale|Mean|40.38|40.38|Standard Deviation|10.32|10.32|||
3723887|NCT02086162|3561952|B1|||Brief Psychiatric Rating Scale|A structured assessment of psychopathology severity using structured interview, observation, and record review. Scores may range from 7 to 126.|units on a scale|Mean|41.79|41.79|Standard Deviation|11.95|11.95|||
3723888|NCT02086162|3561950|B3|United States||Region of Enrollment||participants|Number|162|162.0||||||
3723889|NCT02086162|3561951|B2|United States||Region of Enrollment||participants|Number|84|84.0||||||
3723890|NCT02086162|3561952|B1|United States||Region of Enrollment||participants|Number|78|78.0||||||
3723891|NCT02086162|3561950|B3||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3723892|NCT02086162|3561951|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3723893|NCT02086162|3561952|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3723894|NCT02086162|3561950|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3723895|NCT02086162|3561951|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3723896|NCT02086162|3561952|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3723897|NCT02086162|3561950|B3|||Age||years|Mean|45.91|45.91|Standard Deviation|11.32|11.32|||
3723898|NCT02086162|3561951|B2|||Age||years|Mean|44.32|44.32|Standard Deviation|11.18|11.18|||
3723899|NCT02086162|3561952|B1|||Age||years|Mean|47.62|47.62|Standard Deviation|11.29|11.29|||
3723900|NCT02085785|3561963|B3|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3723901|NCT02085785|3561964|B2|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3723902|NCT02085785|3561965|B1|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3723903|NCT02085785|3561963|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3723904|NCT02085785|3561964|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3723905|NCT02085785|3561965|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3723906|NCT02085785|3561963|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3723907|NCT02085785|3561964|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3723908|NCT02085785|3561965|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3723909|NCT02085785|3561963|B3|||Age||years|Mean|56.3|56.3|Standard Deviation|10.3|10.3|||
3723910|NCT02085785|3561964|B2|||Age||years|Mean|56.6|56.6|Standard Deviation|10.7|10.7|||
3723911|NCT02085785|3561965|B1|||Age||years|Mean|56.0|56.0|Standard Deviation|10.6|10.6|||
3723912|NCT02085720|3561978|B1|Female||Epworth Sleepiness Score|The ESS questionnaire is specific to symptoms of daytime sleepiness and subjects are asked to score the likelihood of falling asleep in eight different situations with different levels of stimulation, adding up to a total score of 0–24. The higher the score, the sleepy the subject is in the daytime. Usually the cut off of 10 is used to indicate abnormal sleepiness than usual.|units on a scale|Mean|6.5|6.5|Standard Deviation|5.2|5.2|||
3723913|NCT02085720|3561978|B1|Men||Epworth Sleepiness Score|The ESS questionnaire is specific to symptoms of daytime sleepiness and subjects are asked to score the likelihood of falling asleep in eight different situations with different levels of stimulation, adding up to a total score of 0–24. The higher the score, the sleepy the subject is in the daytime. Usually the cut off of 10 is used to indicate abnormal sleepiness than usual.|units on a scale|Mean|7.0|7.0|Standard Deviation|5.2|5.2|||
3723914|NCT02085720|3561978|B1|Total||Epworth Sleepiness Score|The ESS questionnaire is specific to symptoms of daytime sleepiness and subjects are asked to score the likelihood of falling asleep in eight different situations with different levels of stimulation, adding up to a total score of 0–24. The higher the score, the sleepy the subject is in the daytime. Usually the cut off of 10 is used to indicate abnormal sleepiness than usual.|units on a scale|Mean|6.6|6.6|Standard Deviation|5.2|5.2|||
3723915|NCT02085720|3561978|B1|drinker||Alcohol drinker||participants|Number|189|189.0||||||
3723916|NCT02085720|3561978|B1|Non drinker||Alcohol drinker||participants|Number|630|630.0||||||
3723917|NCT02085720|3561978|B1|Smoker||Smoking status||participants|Number|123|123.0||||||
3723918|NCT02085720|3561978|B1|Non smoker||Smoking status||participants|Number|696|696.0||||||
3723919|NCT02085720|3561978|B1|Female||Neck circumference||cm|Mean|33.8|33.8|Standard Deviation|2.9|2.9|||
3723920|NCT02085720|3561978|B1|Men||Neck circumference||cm|Mean|37.7|37.7|Standard Deviation|2.9|2.9|||
3723921|NCT02085720|3561978|B1|Total||Neck circumference||cm|Mean|34.9|34.9|Standard Deviation|3.4|3.4|||
3723922|NCT02085720|3561978|B1|Female||Body mass index (BMI)||kg/m^2|Mean|24.2|24.2|Standard Deviation|3.7|3.7|||
3723923|NCT02085720|3561978|B1|Men||Body mass index (BMI)||kg/m^2|Mean|24.3|24.3|Standard Deviation|3.3|3.3|||
3723924|NCT02085720|3561978|B1|Total||Body mass index (BMI)||kg/m^2|Mean|24.2|24.2|Standard Deviation|3.6|3.6|||
3723925|NCT02085720|3561978|B1|Hong Kong||Region of Enrollment||participants|Number|819|819.0||||||
3723926|NCT02085720|3561978|B1||Male|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
3723927|NCT02085720|3561978|B1||Female|Sex: Female, Male||Participants|Count of Participants|612|612.0||||||
3723928|NCT02085720|3561978|B1|Female||Age||years|Mean|74.1|74.1|Standard Deviation|7.6|7.6|||
3723929|NCT02085720|3561978|B1|Men||Age||years|Mean|73.4|73.4|Standard Deviation|6.9|6.9|||
3723930|NCT02085720|3561978|B1|Total||Age||years|Mean|73.9|73.9|Standard Deviation|7.5|7.5|||
3723931|NCT02085473|3561986|B5||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3723932|NCT02085473|3561987|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3723933|NCT02085473|3561988|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3723934|NCT02085473|3561989|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3723935|NCT02085473|3561990|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3723936|NCT02085473|3561986|B5||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3723937|NCT02085473|3561987|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3723938|NCT02085473|3561988|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3723939|NCT02085473|3561989|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3723940|NCT02085473|3561990|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3723941|NCT02085473|3561986|B5|||Age||Years|Mean|38.3|38.3|Standard Deviation|12.2|12.2|||
3723942|NCT02085473|3561987|B4|||Age||Years|Mean|38.4|38.4|Standard Deviation|12.3|12.3|||
3723943|NCT02085473|3561988|B3|||Age||Years|Mean|38.5|38.5|Standard Deviation|14.1|14.1|||
3723944|NCT02085473|3561989|B2|||Age||Years|Mean|39.7|39.7|Standard Deviation|13.5|13.5|||
3723945|NCT02085473|3561990|B1|||Age||Years|Mean|36.5|36.5|Standard Deviation|9.5|9.5|||
3723946|NCT02085161|3562055|B5||Male|Gender||Participants|Count of Participants|200|200.0||||||
3723947|NCT02085161|3562056|B4||Male|Gender||Participants|Count of Participants|45|45.0||||||
3723948|NCT02085161|3562057|B3||Male|Gender||Participants|Count of Participants|48|48.0||||||
3723949|NCT02085161|3562058|B2||Male|Gender||Participants|Count of Participants|55|55.0||||||
3723950|NCT02085161|3562059|B1||Male|Gender||Participants|Count of Participants|52|52.0||||||
3723951|NCT02085161|3562055|B5||Female|Gender||Participants|Count of Participants|103|103.0||||||
3723952|NCT02085161|3562056|B4||Female|Gender||Participants|Count of Participants|31|31.0||||||
3723953|NCT02085161|3562057|B3||Female|Gender||Participants|Count of Participants|28|28.0||||||
3723954|NCT02085161|3562058|B2||Female|Gender||Participants|Count of Participants|21|21.0||||||
3723955|NCT02085161|3562059|B1||Female|Gender||Participants|Count of Participants|23|23.0||||||
3723956|NCT02085161|3562055|B5|||Age||Years|Mean|64.8|64.8|Standard Deviation|6.6|6.6|||
3723957|NCT02085161|3562056|B4|||Age||Years|Mean|64.7|64.7|Standard Deviation|6.5|6.5|||
3723958|NCT02085161|3562057|B3|||Age||Years|Mean|65.0|65.0|Standard Deviation|6.9|6.9|||
3723959|NCT02085161|3562058|B2|||Age||Years|Mean|65.1|65.1|Standard Deviation|6.4|6.4|||
3723960|NCT02085161|3562059|B1|||Age||Years|Mean|64.4|64.4|Standard Deviation|6.6|6.6|||
3723961|NCT02084797|3562101|B1|||Peak treadmill running speed||mph|Mean|11.0|11.0|Standard Deviation|1.4|1.4|||
3723962|NCT02084797|3562101|B1|||VO2 Peak||ml/kg/minute|Mean|58.7|58.7|Standard Deviation|6.2|6.2|||
3723963|NCT02084797|3562101|B1|||BMI||kg/m2|Mean|22.5|22.5|Standard Deviation|3.3|3.3|||
3723964|NCT02084797|3562101|B1|||years of running experience||years|Mean|8.8|8.8|Standard Deviation|8.7|8.7|||
3723965|NCT02084797|3562101|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3723966|NCT02084797|3562101|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3723967|NCT02084797|3562101|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3723968|NCT02084797|3562101|B1|||Age||years|Mean|35.5|35.5|Standard Deviation|13.1|13.1|||
3723969|NCT02084706|3562108|B3|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3723970|NCT02084706|3562109|B2|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3723971|NCT02084706|3562110|B1|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3723972|NCT02084706|3562108|B3||Male|Gender||Participants|Count of Participants|26|26.0||||||
3723973|NCT02084706|3562109|B2||Male|Gender||Participants|Count of Participants|14|14.0||||||
3723974|NCT02084706|3562110|B1||Male|Gender||Participants|Count of Participants|12|12.0||||||
3723975|NCT02084706|3562108|B3||Female|Gender||Participants|Count of Participants|34|34.0||||||
3723976|NCT02084706|3562109|B2||Female|Gender||Participants|Count of Participants|17|17.0||||||
3723977|NCT02084706|3562110|B1||Female|Gender||Participants|Count of Participants|17|17.0||||||
3723978|NCT02084706|3562108|B3|||Age||years|Mean|65.8|65.8|Standard Deviation|10.6|10.6|||
3723979|NCT02084706|3562109|B2|||Age||years|Mean|65.4|65.4|Standard Deviation|10.3|10.3|||
3723980|NCT02084706|3562110|B1|||Age||years|Mean|66.3|66.3|Standard Deviation|11.2|11.2|||
3723981|NCT02084706|3562108|B3||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
3723982|NCT02084706|3562109|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3723983|NCT02084706|3562110|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3723984|NCT02084706|3562108|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3723985|NCT02084706|3562109|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3723986|NCT02084706|3562110|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3723987|NCT02084706|3562108|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3723988|NCT02084706|3562109|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3723989|NCT02084706|3562110|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3723990|NCT02084628|3562117|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3723991|NCT02084628|3562117|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3723992|NCT02084628|3562117|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3723993|NCT02084628|3562117|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3723994|NCT02084628|3562117|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3723995|NCT02084238|3562130|B1|||SELENA-SLEDAI score|All patients were SLE with moderate-to-severe disease activity (Safety of Estrogens in Lupus Erythematosus National Assessment version of the Systemic Lupus Erythematosus Disease Activity Index (SELENA-SLEDAI) > 8.The total score ranges from 0 to 105 points.The higher the points values represent the worse/serious of the disease. Generally, (SELENA-SLEDAI) > 8 means the disease is moderate-to-severe active.|score|Median|11.35|11.35|Standard Deviation|3.71|3.71|||
3723996|NCT02084238|3562130|B1|China||Region of Enrollment|Study location is in the Dept. of Rheumatology and Immunology, Peking University People’s Hospital.|partiipants|Number|38|38.0||||||
3723997|NCT02084238|3562130|B1||Male|Sex: Female, Male|Forty patients with active SLE were recruited; 38 patients completed three cycles of recombinant human IL-2 (rhIL-2). Two of the enrolled patients withdrew from the study at week 8: one changed to the belimumab treatment by personal preference; the other elected changed to the cyclophosphamide treatment to reduce the frequency of hospital visits.|Participants|Count of Participants|2|2.0||||||
3723998|NCT02084238|3562130|B1||Female|Sex: Female, Male|Forty patients with active SLE were recruited; 38 patients completed three cycles of recombinant human IL-2 (rhIL-2). Two of the enrolled patients withdrew from the study at week 8: one changed to the belimumab treatment by personal preference; the other elected changed to the cyclophosphamide treatment to reduce the frequency of hospital visits.|Participants|Count of Participants|36|36.0||||||
3723999|NCT02084238|3562130|B1|||Age||years|Median|31|31.0|Full Range|||18.0|60.0|
3724000|NCT02084238|3562130|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3724001|NCT02084238|3562130|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3724002|NCT02084238|3562130|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3724003|NCT02084134|3562141|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
3724004|NCT02084134|3562142|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3724005|NCT02084134|3562143|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3724006|NCT02084134|3562141|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3724007|NCT02084134|3562141|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3724008|NCT02084134|3562142|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3724009|NCT02084134|3562143|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3724010|NCT02084134|3562141|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3724011|NCT02084134|3562142|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3724012|NCT02084134|3562143|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3724013|NCT02084134|3562141|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3724014|NCT02084134|3562142|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3724015|NCT02084134|3562143|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3724016|NCT02084134|3562141|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3724017|NCT02084134|3562142|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3724018|NCT02084134|3562143|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3724019|NCT02084134|3562141|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3724020|NCT02084134|3562142|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3724021|NCT02084134|3562143|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3724022|NCT02084082|3562152|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3724023|NCT02084082|3562153|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3724024|NCT02084082|3562154|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3724025|NCT02084082|3562152|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3724026|NCT02084082|3562153|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3724027|NCT02084082|3562154|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3724028|NCT02084082|3562152|B3|||Age||years|Mean|35.0|35.0|Standard Deviation|10.7|10.7|||
3724029|NCT02084082|3562153|B2|||Age||years|Mean|36.1|36.1|Standard Deviation|11.9|11.9|||
3724030|NCT02084082|3562154|B1|||Age||years|Mean|34.7|34.7|Standard Deviation|10.4|10.4|||
3724031|NCT02084069|3562187|B3|Iran, Islamic Republic of||Region of Enrollment||participants|Number|58|58.0||||||
3724032|NCT02084069|3562188|B2|Iran, Islamic Republic of||Region of Enrollment||participants|Number|29|29.0||||||
3724033|NCT02084069|3562189|B1|Iran, Islamic Republic of||Region of Enrollment||participants|Number|29|29.0||||||
3724034|NCT02084069|3562187|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3724035|NCT02084069|3562188|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3724036|NCT02084069|3562189|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3724037|NCT02084069|3562187|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3724038|NCT02084069|3562188|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3724039|NCT02084069|3562189|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3724040|NCT02084069|3562187|B3|||Age||years|Median|49|49.0|Inter-Quartile Range|||41.0|60.0|
3724041|NCT02084069|3562188|B2|||Age||years|Median|45|45.0|Inter-Quartile Range|||39.0|52.0|
3724042|NCT02084069|3562189|B1|||Age||years|Median|54|54.0|Inter-Quartile Range|||48.0|61.0|
3724043|NCT02084056|3562196|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3724044|NCT02084056|3562197|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3724045|NCT02084056|3562198|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3724046|NCT02084056|3562196|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3724047|NCT02084056|3562197|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3724048|NCT02084056|3562198|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3724049|NCT02084056|3562196|B3|||Age||years|Mean|33.0|33.0|Standard Deviation|9.4|9.4|||
3724050|NCT02084056|3562197|B2|||Age||years|Mean|32.6|32.6|Standard Deviation|8.2|8.2|||
3724051|NCT02084056|3562198|B1|||Age||years|Mean|33.1|33.1|Standard Deviation|9.8|9.8|||
3724052|NCT02083965|3562231|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3724053|NCT02083965|3562232|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3724054|NCT02083965|3562233|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3724055|NCT02083965|3562231|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3724056|NCT02083965|3562232|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3724057|NCT02083965|3562233|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3724058|NCT02083965|3562231|B3|||Age||years|Mean|26.7|26.7|Standard Deviation|16.35|16.35|||
3724059|NCT02083965|3562232|B2|||Age||years|Mean|30.9|30.9|Standard Deviation|19.76|19.76|||
3724060|NCT02083965|3562233|B1|||Age||years|Mean|23|23.0|Standard Deviation|12.45|12.45|||
3724061|NCT02083861|3562290|B3|||BMI||kg/m2|Mean|34.7|34.7|Standard Deviation|8.6|8.6|||
3724062|NCT02083861|3562291|B2|||BMI||kg/m2|Mean|34.5|34.5|Standard Deviation|8.3|8.3|||
3724063|NCT02083861|3562292|B1|||BMI||kg/m2|Mean|34.9|34.9|Standard Deviation|8.9|8.9|||
3724064|NCT02083861|3562290|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3724065|NCT02083861|3562291|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3724066|NCT02083861|3562292|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3724067|NCT02083861|3562290|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3724068|NCT02083861|3562291|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3724069|NCT02083861|3562292|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3724070|NCT02083861|3562290|B3|||Age||Years|Mean|52.6|52.6|Full Range|||35.0|80.0|
3724071|NCT02083861|3562291|B2|||Age||Years|Mean|51.1|51.1|Full Range|||35.0|72.0|
3724072|NCT02083861|3562292|B1|||Age||Years|Mean|53.6|53.6|Full Range|||35.0|80.0|
3724073|NCT02083679|3562305|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3724074|NCT02083679|3562306|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3724075|NCT02083679|3562307|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3724076|NCT02083679|3562308|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3724077|NCT02083679|3562309|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3724078|NCT02083679|3562305|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3724079|NCT02083679|3562306|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3724080|NCT02083679|3562307|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3724081|NCT02083679|3562308|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3724082|NCT02083679|3562309|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3724083|NCT02083679|3562305|B5|||Age||years|Mean|56.7|56.7|Standard Deviation|9.78|9.78|||
3724084|NCT02083679|3562306|B4|||Age||years|Mean|44.8|44.8|Standard Deviation|10.86|10.86|||
3724085|NCT02083679|3562307|B3|||Age||years|Mean|58.9|58.9|Standard Deviation|11.09|11.09|||
3724086|NCT02083679|3562308|B2|||Age||years|Mean|59.1|59.1|Standard Deviation|6.44|6.44|||
3724087|NCT02083679|3562309|B1|||Age||years|Mean|61.8|61.8|Standard Deviation|7.05|7.05|||
3724088|NCT02083653|3562326|B4|||Body Mass Index (BMI)||kg/m^2|Mean|26.4|26.4|Standard Deviation|4.43|4.43|||
3724089|NCT02083653|3562327|B3|||Body Mass Index (BMI)||kg/m^2|Mean|26.8|26.8|Standard Deviation|4.59|4.59|||
3724090|NCT02083653|3562328|B2|||Body Mass Index (BMI)||kg/m^2|Mean|25.8|25.8|Standard Deviation|4.26|4.26|||
3724091|NCT02083653|3562329|B1|||Body Mass Index (BMI)||kg/m^2|Mean|26.5|26.5|Standard Deviation|4.43|4.43|||
3724092|NCT02083653|3562326|B4|||Weight||kilograms (kg)|Mean|75.1|75.1|Standard Deviation|14.61|14.61|||
3724093|NCT02083653|3562327|B3|||Weight||kilograms (kg)|Mean|76.0|76.0|Standard Deviation|16.13|16.13|||
3724094|NCT02083653|3562328|B2|||Weight||kilograms (kg)|Mean|74.0|74.0|Standard Deviation|14.14|14.14|||
3724095|NCT02083653|3562329|B1|||Weight||kilograms (kg)|Mean|75.3|75.3|Standard Deviation|13.51|13.51|||
3724096|NCT02083653|3562326|B4|||Height||centimeters (cm)|Mean|168.7|168.7|Standard Deviation|10.01|10.01|||
3724097|NCT02083653|3562327|B3|||Height||centimeters (cm)|Mean|167.9|167.9|Standard Deviation|9.56|9.56|||
3724098|NCT02083653|3562328|B2|||Height||centimeters (cm)|Mean|169.1|169.1|Standard Deviation|9.71|9.71|||
3724099|NCT02083653|3562329|B1|||Height||centimeters (cm)|Mean|168.9|168.9|Standard Deviation|10.82|10.82|||
3724100|NCT02083653|3562326|B4|Spain||Region of Enrollment||participants|Number|73|73.0||||||
3724101|NCT02083653|3562327|B3|Spain||Region of Enrollment||participants|Number|18|18.0||||||
3724102|NCT02083653|3562328|B2|Spain||Region of Enrollment||participants|Number|31|31.0||||||
3724103|NCT02083653|3562329|B1|Spain||Region of Enrollment||participants|Number|24|24.0||||||
3724104|NCT02083653|3562326|B4|Russia||Region of Enrollment||participants|Number|30|30.0||||||
3724105|NCT02083653|3562327|B3|Russia||Region of Enrollment||participants|Number|10|10.0||||||
3724106|NCT02083653|3562328|B2|Russia||Region of Enrollment||participants|Number|12|12.0||||||
3724107|NCT02083653|3562329|B1|Russia||Region of Enrollment||participants|Number|8|8.0||||||
3724108|NCT02083653|3562326|B4|Germany||Region of Enrollment||participants|Number|5|5.0||||||
3724109|NCT02083653|3562327|B3|Germany||Region of Enrollment||participants|Number|1|1.0||||||
3724110|NCT02083653|3562328|B2|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3724111|NCT02083653|3562329|B1|Germany||Region of Enrollment||participants|Number|4|4.0||||||
3724112|NCT02083653|3562326|B4|France||Region of Enrollment||participants|Number|28|28.0||||||
3724113|NCT02083653|3562327|B3|France||Region of Enrollment||participants|Number|10|10.0||||||
3724114|NCT02083653|3562328|B2|France||Region of Enrollment||participants|Number|9|9.0||||||
3724115|NCT02083653|3562329|B1|France||Region of Enrollment||participants|Number|9|9.0||||||
3724116|NCT02083653|3562326|B4|Italy||Region of Enrollment||participants|Number|49|49.0||||||
3724117|NCT02083653|3562327|B3|Italy||Region of Enrollment||participants|Number|20|20.0||||||
3724118|NCT02083653|3562328|B2|Italy||Region of Enrollment||participants|Number|12|12.0||||||
3724119|NCT02083653|3562329|B1|Italy||Region of Enrollment||participants|Number|17|17.0||||||
3724120|NCT02083653|3562326|B4|Poland||Region of Enrollment||participants|Number|25|25.0||||||
3724121|NCT02083653|3562327|B3|Poland||Region of Enrollment||participants|Number|7|7.0||||||
3724122|NCT02083653|3562328|B2|Poland||Region of Enrollment||participants|Number|8|8.0||||||
3724123|NCT02083653|3562329|B1|Poland||Region of Enrollment||participants|Number|10|10.0||||||
3724124|NCT02083653|3562326|B4|United States||Region of Enrollment||participants|Number|22|22.0||||||
3724125|NCT02083653|3562327|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3724126|NCT02083653|3562328|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3724127|NCT02083653|3562329|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3724128|NCT02083653|3562326|B4|Hungary||Region of Enrollment||participants|Number|6|6.0||||||
3724129|NCT02083653|3562327|B3|Hungary||Region of Enrollment||participants|Number|5|5.0||||||
3724130|NCT02083653|3562328|B2|Hungary||Region of Enrollment||participants|Number|1|1.0||||||
3724131|NCT02083653|3562329|B1|Hungary||Region of Enrollment||participants|Number|0|0.0||||||
3724132|NCT02083653|3562326|B4|Belgium||Region of Enrollment||participants|Number|14|14.0||||||
3724133|NCT02083653|3562327|B3|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
3724134|NCT02083653|3562328|B2|Belgium||Region of Enrollment||participants|Number|6|6.0||||||
3724135|NCT02083653|3562329|B1|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
3724136|NCT02083653|3562326|B4|Austria||Region of Enrollment||participants|Number|2|2.0||||||
3724137|NCT02083653|3562327|B3|Austria||Region of Enrollment||participants|Number|1|1.0||||||
3724138|NCT02083653|3562328|B2|Austria||Region of Enrollment||participants|Number|1|1.0||||||
3724139|NCT02083653|3562329|B1|Austria||Region of Enrollment||participants|Number|0|0.0||||||
3724140|NCT02083653|3562326|B4||Unknown or Not Reported|Race (NIH/OMB)|Race is presented as ‘Not Reported’ for subjects living in France.|Participants|Count of Participants|30|30.0||||||
3724141|NCT02083653|3562327|B3||Unknown or Not Reported|Race (NIH/OMB)|Race is presented as ‘Not Reported’ for subjects living in France.|Participants|Count of Participants|12|12.0||||||
3724142|NCT02083653|3562328|B2||Unknown or Not Reported|Race (NIH/OMB)|Race is presented as ‘Not Reported’ for subjects living in France.|Participants|Count of Participants|9|9.0||||||
3724143|NCT02083653|3562329|B1||Unknown or Not Reported|Race (NIH/OMB)|Race is presented as ‘Not Reported’ for subjects living in France.|Participants|Count of Participants|9|9.0||||||
3724144|NCT02083653|3562326|B4||More than one race|Race (NIH/OMB)|Race is presented as ‘Not Reported’ for subjects living in France.|Participants|Count of Participants|0|0.0||||||
3724145|NCT02083653|3562327|B3||More than one race|Race (NIH/OMB)|Race is presented as ‘Not Reported’ for subjects living in France.|Participants|Count of Participants|0|0.0||||||
3724146|NCT02083653|3562328|B2||More than one race|Race (NIH/OMB)|Race is presented as ‘Not Reported’ for subjects living in France.|Participants|Count of Participants|0|0.0||||||
3724147|NCT02083653|3562329|B1||More than one race|Race (NIH/OMB)|Race is presented as ‘Not Reported’ for subjects living in France.|Participants|Count of Participants|0|0.0||||||
3724148|NCT02083653|3562326|B4||White|Race (NIH/OMB)|Race is presented as ‘Not Reported’ for subjects living in France.|Participants|Count of Participants|220|220.0||||||
3724149|NCT02083653|3562327|B3||White|Race (NIH/OMB)|Race is presented as ‘Not Reported’ for subjects living in France.|Participants|Count of Participants|73|73.0||||||
3724150|NCT02083653|3562328|B2||White|Race (NIH/OMB)|Race is presented as ‘Not Reported’ for subjects living in France.|Participants|Count of Participants|75|75.0||||||
3724151|NCT02083653|3562329|B1||White|Race (NIH/OMB)|Race is presented as ‘Not Reported’ for subjects living in France.|Participants|Count of Participants|72|72.0||||||
3724193|NCT02083406|3562375|B3|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
3724152|NCT02083653|3562326|B4||Black or African American|Race (NIH/OMB)|Race is presented as ‘Not Reported’ for subjects living in France.|Participants|Count of Participants|3|3.0||||||
3724153|NCT02083653|3562327|B3||Black or African American|Race (NIH/OMB)|Race is presented as ‘Not Reported’ for subjects living in France.|Participants|Count of Participants|0|0.0||||||
3724154|NCT02083653|3562328|B2||Black or African American|Race (NIH/OMB)|Race is presented as ‘Not Reported’ for subjects living in France.|Participants|Count of Participants|2|2.0||||||
3724155|NCT02083653|3562329|B1||Black or African American|Race (NIH/OMB)|Race is presented as ‘Not Reported’ for subjects living in France.|Participants|Count of Participants|1|1.0||||||
3724156|NCT02083653|3562326|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race is presented as ‘Not Reported’ for subjects living in France.|Participants|Count of Participants|0|0.0||||||
3724157|NCT02083653|3562327|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race is presented as ‘Not Reported’ for subjects living in France.|Participants|Count of Participants|0|0.0||||||
3724158|NCT02083653|3562328|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race is presented as ‘Not Reported’ for subjects living in France.|Participants|Count of Participants|0|0.0||||||
3724159|NCT02083653|3562329|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race is presented as ‘Not Reported’ for subjects living in France.|Participants|Count of Participants|0|0.0||||||
3724160|NCT02083653|3562326|B4||Asian|Race (NIH/OMB)|Race is presented as ‘Not Reported’ for subjects living in France.|Participants|Count of Participants|1|1.0||||||
3724161|NCT02083653|3562327|B3||Asian|Race (NIH/OMB)|Race is presented as ‘Not Reported’ for subjects living in France.|Participants|Count of Participants|0|0.0||||||
3724162|NCT02083653|3562328|B2||Asian|Race (NIH/OMB)|Race is presented as ‘Not Reported’ for subjects living in France.|Participants|Count of Participants|0|0.0||||||
3724163|NCT02083653|3562329|B1||Asian|Race (NIH/OMB)|Race is presented as ‘Not Reported’ for subjects living in France.|Participants|Count of Participants|1|1.0||||||
3724164|NCT02083653|3562326|B4||American Indian or Alaska Native|Race (NIH/OMB)|Race is presented as ‘Not Reported’ for subjects living in France.|Participants|Count of Participants|0|0.0||||||
3724165|NCT02083653|3562327|B3||American Indian or Alaska Native|Race (NIH/OMB)|Race is presented as ‘Not Reported’ for subjects living in France.|Participants|Count of Participants|0|0.0||||||
3724166|NCT02083653|3562328|B2||American Indian or Alaska Native|Race (NIH/OMB)|Race is presented as ‘Not Reported’ for subjects living in France.|Participants|Count of Participants|0|0.0||||||
3724167|NCT02083653|3562329|B1||American Indian or Alaska Native|Race (NIH/OMB)|Race is presented as ‘Not Reported’ for subjects living in France.|Participants|Count of Participants|0|0.0||||||
3724168|NCT02083653|3562326|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)|Ethnicity is presented as 'Not Reported’ for subjects living in France.|Participants|Count of Participants|28|28.0||||||
3724169|NCT02083653|3562327|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)|Ethnicity is presented as 'Not Reported’ for subjects living in France.|Participants|Count of Participants|10|10.0||||||
3724170|NCT02083653|3562328|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)|Ethnicity is presented as 'Not Reported’ for subjects living in France.|Participants|Count of Participants|9|9.0||||||
3724171|NCT02083653|3562329|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|Ethnicity is presented as 'Not Reported’ for subjects living in France.|Participants|Count of Participants|9|9.0||||||
3724172|NCT02083653|3562326|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity is presented as 'Not Reported’ for subjects living in France.|Participants|Count of Participants|211|211.0||||||
3724173|NCT02083653|3562327|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity is presented as 'Not Reported’ for subjects living in France.|Participants|Count of Participants|70|70.0||||||
3724174|NCT02083653|3562328|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity is presented as 'Not Reported’ for subjects living in France.|Participants|Count of Participants|72|72.0||||||
3724175|NCT02083653|3562329|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity is presented as 'Not Reported’ for subjects living in France.|Participants|Count of Participants|69|69.0||||||
3724176|NCT02083653|3562326|B4||Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity is presented as 'Not Reported’ for subjects living in France.|Participants|Count of Participants|15|15.0||||||
3724177|NCT02083653|3562327|B3||Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity is presented as 'Not Reported’ for subjects living in France.|Participants|Count of Participants|5|5.0||||||
3724178|NCT02083653|3562328|B2||Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity is presented as 'Not Reported’ for subjects living in France.|Participants|Count of Participants|5|5.0||||||
3724179|NCT02083653|3562329|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity is presented as 'Not Reported’ for subjects living in France.|Participants|Count of Participants|5|5.0||||||
3724180|NCT02083653|3562326|B4||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3724181|NCT02083653|3562327|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3724182|NCT02083653|3562328|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3724183|NCT02083653|3562329|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3724184|NCT02083653|3562326|B4||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3724185|NCT02083653|3562327|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3724186|NCT02083653|3562328|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3724187|NCT02083653|3562329|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3724188|NCT02083653|3562326|B4|||Age|Age is relative to time of informed consent for this trial.|years|Mean|62.6|62.6|Standard Deviation|10.38|10.38|||
3724189|NCT02083653|3562327|B3|||Age|Age is relative to time of informed consent for this trial.|years|Mean|61.4|61.4|Standard Deviation|10.70|10.7|||
3724190|NCT02083653|3562328|B2|||Age|Age is relative to time of informed consent for this trial.|years|Mean|64.2|64.2|Standard Deviation|10.41|10.41|||
3724191|NCT02083653|3562329|B1|||Age|Age is relative to time of informed consent for this trial.|years|Mean|62.2|62.2|Standard Deviation|9.91|9.91|||
3724192|NCT02083406|3562374|B4|United Kingdom||Region of Enrollment||participants|Number|22|22.0||||||
3724194|NCT02083406|3562376|B2|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3724195|NCT02083406|3562377|B1|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
3724196|NCT02083406|3562374|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3724197|NCT02083406|3562375|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3724198|NCT02083406|3562376|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3724199|NCT02083406|3562377|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3724200|NCT02083406|3562374|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3724201|NCT02083406|3562375|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3724202|NCT02083406|3562376|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3724203|NCT02083406|3562377|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3724204|NCT02083406|3562374|B4|||Age||years|Mean|36.6|36.6|Standard Deviation|10.9|10.9|||
3724205|NCT02083406|3562375|B3|||Age||years|Mean|35.7|35.7|Standard Deviation|4.1|4.1|||
3724206|NCT02083406|3562376|B2|||Age||years|Mean|44.9|44.9|Standard Deviation|11.3|11.3|||
3724207|NCT02083406|3562377|B1|||Age||years|Mean|28|28.0|Standard Deviation|8.2|8.2|||
3724208|NCT02083380|3562396|B4||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3724209|NCT02083380|3562397|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3724210|NCT02083380|3562398|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3724211|NCT02083380|3562399|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3724212|NCT02083380|3562396|B4||Female|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
3724213|NCT02083380|3562397|B3||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3724214|NCT02083380|3562398|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3724215|NCT02083380|3562399|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3724216|NCT02083380|3562396|B4|>= 0.5 to <= 2 years||Age, Customized||participants|Number|77|77.0||||||
3724217|NCT02083380|3562397|B3|>= 0.5 to <= 2 years||Age, Customized||participants|Number|26|26.0||||||
3724218|NCT02083380|3562398|B2|>= 0.5 to <= 2 years||Age, Customized||participants|Number|26|26.0||||||
3724219|NCT02083380|3562399|B1|>= 0.5 to <= 2 years||Age, Customized||participants|Number|25|25.0||||||
3724220|NCT02083380|3562396|B4|> 2 to <= 5 years||Age, Customized||participants|Number|211|211.0||||||
3724221|NCT02083380|3562397|B3|> 2 to <= 5 years||Age, Customized||participants|Number|70|70.0||||||
3724222|NCT02083380|3562398|B2|> 2 to <= 5 years||Age, Customized||participants|Number|72|72.0||||||
3724223|NCT02083380|3562399|B1|> 2 to <= 5 years||Age, Customized||participants|Number|69|69.0||||||
3724224|NCT02083380|3562396|B4|> 5 to <= 15 years||Age, Customized||participants|Number|25|25.0||||||
3724225|NCT02083380|3562397|B3|> 5 to <= 15 years||Age, Customized||participants|Number|9|9.0||||||
3724226|NCT02083380|3562398|B2|> 5 to <= 15 years||Age, Customized||participants|Number|8|8.0||||||
3724227|NCT02083380|3562399|B1|> 5 to <= 15 years||Age, Customized||participants|Number|8|8.0||||||
3724228|NCT02083380|3562396|B4|> 15 years||Age, Customized||participants|Number|124|124.0||||||
3724229|NCT02083380|3562397|B3|> 15 years||Age, Customized||participants|Number|41|41.0||||||
3724230|NCT02083380|3562398|B2|> 15 years||Age, Customized||participants|Number|42|42.0||||||
3724231|NCT02083380|3562399|B1|> 15 years||Age, Customized||participants|Number|41|41.0||||||
3724232|NCT02083263|3562494|B3|Sweden||Region of Enrollment||participants|Number|32|32.0||||||
3724233|NCT02083263|3562495|B2|Sweden||Region of Enrollment||participants|Number|16|16.0||||||
3724234|NCT02083263|3562496|B1|Sweden||Region of Enrollment||participants|Number|16|16.0||||||
3724235|NCT02083263|3562494|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3724236|NCT02083263|3562495|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3724237|NCT02083263|3562496|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3724238|NCT02083263|3562494|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3724239|NCT02083263|3562495|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3724240|NCT02083263|3562496|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3724241|NCT02083263|3562494|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3724242|NCT02083263|3562495|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3724243|NCT02083263|3562496|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3724244|NCT02083263|3562494|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3724245|NCT02083263|3562495|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3724246|NCT02083263|3562496|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3724247|NCT02083263|3562494|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3724248|NCT02083263|3562495|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3724249|NCT02083263|3562496|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3724250|NCT02083263|3562494|B3|||Age||years|Mean|31|31.0|Standard Deviation|10|10.0|||
3724251|NCT02083263|3562495|B2|||Age||years|Mean|33|33.0|Standard Deviation|9|9.0|||
3724252|NCT02083263|3562496|B1|||Age||years|Mean|28|28.0|Standard Deviation|11|11.0|||
3724253|NCT02083185|3562503|B4|||Body Mass Index||kg/m^2|Mean|29.448|29.448|Full Range|||18.13|54.66|
3724254|NCT02083185|3562504|B3|||Body Mass Index||kg/m^2|Mean|30.452|30.452|Full Range|4.9601|4.9601|23.03|41.28|
3724255|NCT02083185|3562505|B2|||Body Mass Index||kg/m^2|Mean|29.077|29.077|Full Range|4.6509|4.6509|18.13|39.36|
3724315|NCT02083107|3562565|B2|||Parity||Births|Median|1|1.0|Inter-Quartile Range|||1.0|2.0|
3724256|NCT02083185|3562506|B1|||Body Mass Index||kg/m^2|Mean|28.815|28.815|Full Range|5.9592|5.9592|19.51|54.66|
3724257|NCT02083185|3562503|B4|||Weight||kg|Mean|92.92|92.92|Full Range|||56.4|193.2|
3724258|NCT02083185|3562504|B3|||Weight||kg|Mean|96.10|96.1|Full Range|17.297|17.297|68.2|145.9|
3724259|NCT02083185|3562505|B2|||Weight||kg|Mean|92.16|92.16|Full Range|17.645|17.645|57.3|149.5|
3724260|NCT02083185|3562506|B1|||Weight||kg|Mean|90.49|90.49|Full Range|21.632|21.632|56.4|193.2|
3724261|NCT02083185|3562503|B4|||Height||cm|Mean|177.46|177.46|Full Range|||149.9|198.1|
3724262|NCT02083185|3562504|B3|||Height||cm|Mean|177.63|177.63|Full Range|7.580|7.58|162.6|188.0|
3724263|NCT02083185|3562505|B2|||Height||cm|Mean|177.83|177.83|Full Range|8.459|8.459|157.5|198.1|
3724264|NCT02083185|3562506|B1|||Height||cm|Mean|176.92|176.92|Full Range|8.855|8.855|149.9|198.1|
3724265|NCT02083185|3562503|B4|Canada||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3724266|NCT02083185|3562504|B3|Canada||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3724267|NCT02083185|3562505|B2|Canada||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3724268|NCT02083185|3562506|B1|Canada||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3724269|NCT02083185|3562503|B4|United States||Region of Enrollment||Participants|Count of Participants|122|122.0||||||
3724270|NCT02083185|3562504|B3|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3724271|NCT02083185|3562505|B2|United States||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
3724272|NCT02083185|3562506|B1|United States||Region of Enrollment||Participants|Count of Participants|51|51.0||||||
3724273|NCT02083185|3562503|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3724274|NCT02083185|3562504|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3724275|NCT02083185|3562505|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3724276|NCT02083185|3562506|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3724277|NCT02083185|3562503|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3724278|NCT02083185|3562504|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3724279|NCT02083185|3562505|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3724280|NCT02083185|3562506|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3724281|NCT02083185|3562503|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|112|112.0||||||
3724282|NCT02083185|3562504|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3724283|NCT02083185|3562505|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
3724284|NCT02083185|3562506|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|45|45.0||||||
3724285|NCT02083185|3562503|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3724286|NCT02083185|3562504|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724287|NCT02083185|3562505|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724288|NCT02083185|3562506|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3724289|NCT02083185|3562503|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
3724290|NCT02083185|3562504|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3724291|NCT02083185|3562505|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3724292|NCT02083185|3562506|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3724293|NCT02083185|3562503|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3724294|NCT02083185|3562504|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3724295|NCT02083185|3562505|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3724296|NCT02083185|3562506|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3724297|NCT02083185|3562503|B4||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3724298|NCT02083185|3562504|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3724299|NCT02083185|3562505|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3724300|NCT02083185|3562506|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3724301|NCT02083185|3562503|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3724302|NCT02083185|3562504|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3724303|NCT02083185|3562505|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3724304|NCT02083185|3562506|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3724305|NCT02083185|3562503|B4|||Age||years|Mean|70.9|70.9|Full Range|||49.0|91.0|
3724306|NCT02083185|3562504|B3|||Age||years|Mean|68.3|68.3|Full Range|6.77|6.77|56.0|82.0|
3724307|NCT02083185|3562505|B2|||Age||years|Mean|72.1|72.1|Full Range|8.06|8.06|49.0|87.0|
3724308|NCT02083185|3562506|B1|||Age||years|Mean|72.3|72.3|Full Range|9.25|9.25|50.0|91.0|
3724309|NCT02083107|3562563|B4|||Gestational Age||Weeks|Mean|38.8|38.8|Standard Deviation|0.9|0.9|||
3724310|NCT02083107|3562564|B3|||Gestational Age||Weeks|Mean|38.8|38.8|Standard Deviation|0.9|0.9|||
3724311|NCT02083107|3562565|B2|||Gestational Age||Weeks|Mean|38.9|38.9|Standard Deviation|0.9|0.9|||
3724312|NCT02083107|3562566|B1|||Gestational Age||Weeks|Mean|38.9|38.9|Standard Deviation|1|1.0|||
3724313|NCT02083107|3562563|B4|||Parity||Births|Median|1|1.0|Inter-Quartile Range|||1.0|2.0|
3724314|NCT02083107|3562564|B3|||Parity||Births|Median|1|1.0|Inter-Quartile Range|||1.0|2.0|
3724316|NCT02083107|3562566|B1|||Parity||Births|Median|1|1.0|Inter-Quartile Range|||1.0|2.0|
3724317|NCT02083107|3562563|B4|||Body Mass Index (BMI)||Kg/m2|Mean|27.5|27.5|Standard Deviation|1.76|1.76|||
3724318|NCT02083107|3562564|B3|||Body Mass Index (BMI)||Kg/m2|Mean|27.4|27.4|Standard Deviation|1.7|1.7|||
3724319|NCT02083107|3562565|B2|||Body Mass Index (BMI)||Kg/m2|Mean|27.6|27.6|Standard Deviation|1.9|1.9|||
3724320|NCT02083107|3562566|B1|||Body Mass Index (BMI)||Kg/m2|Mean|27.5|27.5|Standard Deviation|1.7|1.7|||
3724321|NCT02083107|3562563|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3724322|NCT02083107|3562564|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3724323|NCT02083107|3562565|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3724324|NCT02083107|3562566|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3724325|NCT02083107|3562563|B4||Female|Sex: Female, Male||Participants|Count of Participants|636|636.0||||||
3724326|NCT02083107|3562564|B3||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
3724327|NCT02083107|3562565|B2||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
3724328|NCT02083107|3562566|B1||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
3724329|NCT02083107|3562563|B4|||Age||years|Mean|26.6|26.6|Standard Deviation|2.6|2.6|||
3724330|NCT02083107|3562564|B3|||Age||years|Mean|26.5|26.5|Standard Deviation|2.5|2.5|||
3724331|NCT02083107|3562565|B2|||Age||years|Mean|26.4|26.4|Standard Deviation|2.7|2.7|||
3724332|NCT02083107|3562566|B1|||Age||years|Mean|26.9|26.9|Standard Deviation|2.6|2.6|||
3724333|NCT02082912|3562603|B3|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3724334|NCT02082912|3562604|B2|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3724335|NCT02082912|3562605|B1|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3724336|NCT02082912|3562603|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724337|NCT02082912|3562604|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724338|NCT02082912|3562605|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724339|NCT02082912|3562603|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724340|NCT02082912|3562604|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724341|NCT02082912|3562605|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724342|NCT02082912|3562603|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3724343|NCT02082912|3562604|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3724344|NCT02082912|3562605|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3724345|NCT02082912|3562603|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3724346|NCT02082912|3562604|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3724347|NCT02082912|3562605|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3724348|NCT02082912|3562603|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724349|NCT02082912|3562604|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724350|NCT02082912|3562605|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724351|NCT02082912|3562603|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724352|NCT02082912|3562604|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724353|NCT02082912|3562605|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724354|NCT02082912|3562603|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724355|NCT02082912|3562604|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724356|NCT02082912|3562605|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724357|NCT02082912|3562603|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3724358|NCT02082912|3562604|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3724359|NCT02082912|3562605|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3724360|NCT02082912|3562603|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3724361|NCT02082912|3562604|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3724362|NCT02082912|3562605|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3724363|NCT02082912|3562603|B3|||Age||years|Mean|55.8|55.8|Standard Deviation|13.1|13.1|||
3724364|NCT02082912|3562604|B2|||Age||years|Mean|53.7|53.7|Standard Deviation|18.4|18.4|||
3724365|NCT02082912|3562605|B1|||Age||years|Mean|57.7|57.7|Standard Deviation|7.3|7.3|||
3724366|NCT02082769|3562620|B4|||Baseline serum urate level units||umol/l|Mean|566.7|566.7|Standard Deviation|75.2|75.2|||
3724367|NCT02082769|3562621|B3|||Baseline serum urate level units||umol/l|Mean|574.2|574.2|Standard Deviation|77.8|77.8|||
3724368|NCT02082769|3562622|B2|||Baseline serum urate level units||umol/l|Mean|565.1|565.1|Standard Deviation|75.5|75.5|||
3724369|NCT02082769|3562623|B1|||Baseline serum urate level units||umol/l|Mean|560.8|560.8|Standard Deviation|73.3|73.3|||
3724370|NCT02082769|3562620|B4|||Diastolic blood pressure (DBP)||mm Hg|Mean|78.5|78.5|Standard Deviation|8.1|8.1|||
3724371|NCT02082769|3562621|B3|||Diastolic blood pressure (DBP)||mm Hg|Mean|78.7|78.7|Standard Deviation|7.9|7.9|||
3724372|NCT02082769|3562622|B2|||Diastolic blood pressure (DBP)||mm Hg|Mean|77.6|77.6|Standard Deviation|8.1|8.1|||
3724373|NCT02082769|3562623|B1|||Diastolic blood pressure (DBP)||mm Hg|Mean|79.1|79.1|Standard Deviation|8.2|8.2|||
3724374|NCT02082769|3562620|B4|||Systolic blood pressure (SBP)||mm Hg|Mean|126.4|126.4|Standard Deviation|10.4|10.4|||
3724375|NCT02082769|3562621|B3|||Systolic blood pressure (SBP)||mm Hg|Mean|124.8|124.8|Standard Deviation|10.1|10.1|||
3724376|NCT02082769|3562622|B2|||Systolic blood pressure (SBP)||mm Hg|Mean|126.4|126.4|Standard Deviation|11.0|11.0|||
3724377|NCT02082769|3562623|B1|||Systolic blood pressure (SBP)||mm Hg|Mean|126.2|126.2|Standard Deviation|10.0|10.0|||
3724378|NCT02082769|3562620|B4|||Body Mass Index (BMI)||kg/m^2|Mean|25.2|25.2|Standard Deviation|2.8|2.8|||
3724379|NCT02082769|3562621|B3|||Body Mass Index (BMI)||kg/m^2|Mean|25.4|25.4|Standard Deviation|3.3|3.3|||
3724380|NCT02082769|3562622|B2|||Body Mass Index (BMI)||kg/m^2|Mean|25.1|25.1|Standard Deviation|2.6|2.6|||
3724381|NCT02082769|3562623|B1|||Body Mass Index (BMI)||kg/m^2|Mean|25.2|25.2|Standard Deviation|2.7|2.7|||
3724382|NCT02082769|3562620|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3724383|NCT02082769|3562621|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3724384|NCT02082769|3562622|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3724385|NCT02082769|3562623|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3724386|NCT02082769|3562620|B4||Female|Sex: Female, Male||Participants|Count of Participants|453|453.0||||||
3724387|NCT02082769|3562621|B3||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3724388|NCT02082769|3562622|B2||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3724389|NCT02082769|3562623|B1||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3724390|NCT02082769|3562620|B4|||Age||years|Mean|46.7|46.7|Standard Deviation|11.2|11.2|||
3724391|NCT02082769|3562621|B3|||Age||years|Mean|46.5|46.5|Standard Deviation|10.7|10.7|||
3724392|NCT02082769|3562622|B2|||Age||years|Mean|48.2|48.2|Standard Deviation|12.0|12.0|||
3724393|NCT02082769|3562623|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|11.9|11.9|||
3724394|NCT02082769|3562620|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3724395|NCT02082769|3562621|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3724396|NCT02082769|3562622|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3724397|NCT02082769|3562623|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3724398|NCT02082769|3562620|B4||Between 18 and 65 years|Age||Participants|Count of Participants|477|477.0||||||
3724399|NCT02082769|3562621|B3||Between 18 and 65 years|Age||Participants|Count of Participants|159|159.0||||||
3724400|NCT02082769|3562622|B2||Between 18 and 65 years|Age||Participants|Count of Participants|158|158.0||||||
3724401|NCT02082769|3562623|B1||Between 18 and 65 years|Age||Participants|Count of Participants|160|160.0||||||
3724402|NCT02082769|3562620|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3724403|NCT02082769|3562621|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3724404|NCT02082769|3562622|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3724405|NCT02082769|3562623|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3724406|NCT02082392|3562639|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3724407|NCT02082392|3562640|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3724408|NCT02082392|3562641|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3724409|NCT02082392|3562639|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3724410|NCT02082392|3562640|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3724411|NCT02082392|3562641|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3724412|NCT02082392|3562639|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3724413|NCT02082392|3562640|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3724414|NCT02082392|3562641|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3724415|NCT02082392|3562639|B3|||Age||years|Mean|46.67|46.67|Standard Deviation|8.08|8.08|||
3724416|NCT02082392|3562640|B2|||Age||years|Mean|48|48.0|Standard Deviation|0|0.0|||
3724417|NCT02082392|3562641|B1|||Age||years|Mean|46|46.0|Standard Deviation|11.3|11.3|||
3724418|NCT02082392|3562639|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3724419|NCT02082392|3562640|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3724420|NCT02082392|3562641|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3724421|NCT02082392|3562639|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3724422|NCT02082392|3562640|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3724423|NCT02082392|3562641|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3724424|NCT02082392|3562639|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3724425|NCT02082392|3562640|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3724426|NCT02082392|3562641|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3724427|NCT02082288|3562674|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3724428|NCT02082288|3562674|B1||Female|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
3724429|NCT02082288|3562674|B1|||Age||years|Mean|30.12|30.12|Standard Deviation|3.51|3.51|||
3724430|NCT02082262|3562678|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3724431|NCT02082262|3562678|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3724432|NCT02082262|3562678|B1|≥ 40 years||Age, Customized||Participants|Number|58|58.0||||||
3724433|NCT02082262|3562678|B1|≥ 20 to < 40 years||Age, Customized||Participants|Number|44|44.0||||||
3724434|NCT02082262|3562678|B1|≥ 10 to < 20 years||Age, Customized||Participants|Number|38|38.0||||||
3724435|NCT02082184|3562682|B3|||Screening HbA1c||mmol/mol|Mean|72.5|72.5|Standard Deviation|10.8|10.8|||
3724436|NCT02082184|3562683|B2|||Screening HbA1c||mmol/mol|Mean|73.5|73.5|Standard Deviation|11.3|11.3|||
3724437|NCT02082184|3562684|B1|||Screening HbA1c||mmol/mol|Mean|72.0|72.0|Standard Deviation|10.6|10.6|||
3724438|NCT02082184|3562682|B3|||Screening HbA1c||%|Mean|8.79|8.79|Standard Deviation|0.99|0.99|||
3724439|NCT02082184|3562683|B2|||Screening HbA1c||%|Mean|8.88|8.88|Standard Deviation|1.04|1.04|||
3724440|NCT02082184|3562684|B1|||Screening HbA1c||%|Mean|8.74|8.74|Standard Deviation|0.97|0.97|||
3724441|NCT02082184|3562682|B3||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3724442|NCT02082184|3562683|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3724443|NCT02082184|3562684|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3724444|NCT02082184|3562682|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3724445|NCT02082184|3562683|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3724446|NCT02082184|3562684|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3724447|NCT02082184|3562682|B3|||Age||years|Mean|59.2|59.2|Standard Deviation|10.3|10.3|||
3724448|NCT02082184|3562683|B2|||Age||years|Mean|59.5|59.5|Standard Deviation|11.0|11.0|||
3724449|NCT02082184|3562684|B1|||Age||years|Mean|59.0|59.0|Standard Deviation|9.9|9.9|||
3724450|NCT02082158|3562704|B7||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3724451|NCT02082158|3562705|B6||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3724452|NCT02082158|3562706|B5||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3724453|NCT02082158|3562707|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3724454|NCT02082158|3562708|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3724455|NCT02082158|3562709|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3724456|NCT02082158|3562710|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3724457|NCT02082158|3562704|B7||Female|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
3724458|NCT02082158|3562705|B6||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3724459|NCT02082158|3562706|B5||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3724460|NCT02082158|3562707|B4||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3724461|NCT02082158|3562708|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3724462|NCT02082158|3562709|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3724463|NCT02082158|3562710|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3724464|NCT02082158|3562704|B7|>=65 years||Age|One local respirator model participant did not answer the age question.|participants|Number|5|5.0||||||
3724465|NCT02082158|3562705|B6|>=65 years||Age|One local respirator model participant did not answer the age question.|participants|Number|1|1.0||||||
3724466|NCT02082158|3562706|B5|>=65 years||Age|One local respirator model participant did not answer the age question.|participants|Number|2|2.0||||||
3724467|NCT02082158|3562707|B4|>=65 years||Age|One local respirator model participant did not answer the age question.|participants|Number|0|0.0||||||
3724468|NCT02082158|3562708|B3|>=65 years||Age|One local respirator model participant did not answer the age question.|participants|Number|1|1.0||||||
3724469|NCT02082158|3562709|B2|>=65 years||Age|One local respirator model participant did not answer the age question.|participants|Number|0|0.0||||||
3724470|NCT02082158|3562710|B1|>=65 years||Age|One local respirator model participant did not answer the age question.|participants|Number|1|1.0||||||
3724471|NCT02082158|3562704|B7|Between 18 and 65 years||Age|One local respirator model participant did not answer the age question.|participants|Number|331|331.0||||||
3724472|NCT02082158|3562705|B6|Between 18 and 65 years||Age|One local respirator model participant did not answer the age question.|participants|Number|55|55.0||||||
3724473|NCT02082158|3562706|B5|Between 18 and 65 years||Age|One local respirator model participant did not answer the age question.|participants|Number|62|62.0||||||
3724474|NCT02082158|3562707|B4|Between 18 and 65 years||Age|One local respirator model participant did not answer the age question.|participants|Number|68|68.0||||||
3724475|NCT02082158|3562708|B3|Between 18 and 65 years||Age|One local respirator model participant did not answer the age question.|participants|Number|37|37.0||||||
3724476|NCT02082158|3562709|B2|Between 18 and 65 years||Age|One local respirator model participant did not answer the age question.|participants|Number|53|53.0||||||
3724477|NCT02082158|3562710|B1|Between 18 and 65 years||Age|One local respirator model participant did not answer the age question.|participants|Number|56|56.0||||||
3724478|NCT02082158|3562704|B7|<=18 years||Age|One local respirator model participant did not answer the age question.|participants|Number|0|0.0||||||
3724479|NCT02082158|3562705|B6|<=18 years||Age|One local respirator model participant did not answer the age question.|participants|Number|0|0.0||||||
3724480|NCT02082158|3562706|B5|<=18 years||Age|One local respirator model participant did not answer the age question.|participants|Number|0|0.0||||||
3724481|NCT02082158|3562707|B4|<=18 years||Age|One local respirator model participant did not answer the age question.|participants|Number|0|0.0||||||
3724482|NCT02082158|3562708|B3|<=18 years||Age|One local respirator model participant did not answer the age question.|participants|Number|0|0.0||||||
3724483|NCT02082158|3562709|B2|<=18 years||Age|One local respirator model participant did not answer the age question.|participants|Number|0|0.0||||||
3724484|NCT02082158|3562710|B1|<=18 years||Age|One local respirator model participant did not answer the age question.|participants|Number|0|0.0||||||
3724485|NCT02081859|3562735|B3|||Mean embryo transferred||embryo|Mean|1.95|1.95|Standard Deviation|0.5|0.5|||
3724486|NCT02081859|3562736|B2|||Mean embryo transferred||embryo|Mean|2.0|2.0|Standard Deviation|0.5|0.5|||
3724487|NCT02081859|3562737|B1|||Mean embryo transferred||embryo|Mean|1.9|1.9|Standard Deviation|0.6|0.6|||
3724488|NCT02081859|3562735|B3|||AMH||ng/mL|Mean|3.6|3.6|Standard Deviation|3.7|3.7|||
3724489|NCT02081859|3562736|B2|||AMH||ng/mL|Mean|3.7|3.7|Standard Deviation|4.2|4.2|||
3724490|NCT02081859|3562737|B1|||AMH||ng/mL|Mean|3.5|3.5|Standard Deviation|3.2|3.2|||
3724491|NCT02081859|3562735|B3|||Length of infertility||months|Mean|31.5|31.5|Standard Deviation|22.3|22.3|||
3724492|NCT02081859|3562736|B2|||Length of infertility||months|Mean|31.4|31.4|Standard Deviation|22.4|22.4|||
3724493|NCT02081859|3562737|B1|||Length of infertility||months|Mean|31.5|31.5|Standard Deviation|22.4|22.4|||
3724494|NCT02081859|3562735|B3|||Nulliparous||Participants|Count of Participants|191|191.0||||||
3724495|NCT02081859|3562736|B2|||Nulliparous||Participants|Count of Participants|94|94.0||||||
3724496|NCT02081859|3562737|B1|||Nulliparous||Participants|Count of Participants|97|97.0||||||
3724497|NCT02081859|3562735|B3|United States||Region of Enrollment||participants|Number|235|235.0||||||
3724498|NCT02081859|3562736|B2|United States||Region of Enrollment||participants|Number|119|119.0||||||
3724499|NCT02081859|3562737|B1|United States||Region of Enrollment||participants|Number|116|116.0||||||
3724500|NCT02081859|3562735|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3724501|NCT02081859|3562736|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3724502|NCT02081859|3562737|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3724503|NCT02081859|3562735|B3||Female|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
3724504|NCT02081859|3562736|B2||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3724505|NCT02081859|3562737|B1||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3724506|NCT02081859|3562735|B3|||Age||years|Mean|33.3|33.3|Standard Deviation|3.9|3.9|||
3724507|NCT02081859|3562736|B2|||Age||years|Mean|33.6|33.6|Standard Deviation|4|4.0|||
3724508|NCT02081859|3562737|B1|||Age||years|Mean|33.2|33.2|Standard Deviation|3.9|3.9|||
3724509|NCT02081690|3562746|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3724510|NCT02081690|3562746|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3724511|NCT02081690|3562746|B1|||Age||Years|Median|57.5|57.5|Inter-Quartile Range|||21.0|79.0|
3724512|NCT02081677|3562753|B5|India||Region of Enrollment||participants|Number|76|76.0||||||
3724513|NCT02081677|3562754|B4|India||Region of Enrollment||participants|Number|19|19.0||||||
3724514|NCT02081677|3562755|B3|India||Region of Enrollment||participants|Number|19|19.0||||||
3724515|NCT02081677|3562756|B2|India||Region of Enrollment||participants|Number|19|19.0||||||
3724516|NCT02081677|3562757|B1|India||Region of Enrollment||participants|Number|19|19.0||||||
3724517|NCT02081677|3562753|B5|Asian Indian||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
3724518|NCT02081677|3562754|B4|Asian Indian||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3724519|NCT02081677|3562755|B3|Asian Indian||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3724520|NCT02081677|3562756|B2|Asian Indian||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3724521|NCT02081677|3562757|B1|Asian Indian||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3724522|NCT02081677|3562753|B5||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3724523|NCT02081677|3562754|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3724524|NCT02081677|3562755|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3724525|NCT02081677|3562756|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3724526|NCT02081677|3562757|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3724527|NCT02081677|3562753|B5||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3724528|NCT02081677|3562754|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3724529|NCT02081677|3562755|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3724530|NCT02081677|3562756|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3724531|NCT02081677|3562757|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3724532|NCT02081677|3562753|B5|||Age||years|Mean|23.0|23.0|Standard Deviation|4.211|4.211|||
3724533|NCT02081677|3562754|B4|||Age||years|Mean|20.84|20.84|Standard Deviation|2.192|2.192|||
3724534|NCT02081677|3562755|B3|||Age||years|Mean|23.16|23.16|Standard Deviation|5.336|5.336|||
3724535|NCT02081677|3562756|B2|||Age||years|Mean|24.58|24.58|Standard Deviation|4.706|4.706|||
3724536|NCT02081677|3562757|B1|||Age||years|Mean|23.42|23.42|Standard Deviation|4.611|4.611|||
3724537|NCT02081599|3562850|B3||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3724538|NCT02081599|3562851|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3724539|NCT02081599|3562852|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3724540|NCT02081599|3562850|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3724541|NCT02081599|3562851|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3724542|NCT02081599|3562852|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3724543|NCT02081599|3562850|B3|>=65 years||Age, Customized||Participants|Count of Participants|53|53.0||||||
3724544|NCT02081599|3562851|B2|>=65 years||Age, Customized||Participants|Count of Participants|31|31.0||||||
3724545|NCT02081599|3562852|B1|>=65 years||Age, Customized||Participants|Count of Participants|22|22.0||||||
3724546|NCT02081599|3562850|B3|<65 years||Age, Customized||Participants|Count of Participants|95|95.0||||||
3724547|NCT02081599|3562851|B2|<65 years||Age, Customized||Participants|Count of Participants|46|46.0||||||
3724548|NCT02081599|3562852|B1|<65 years||Age, Customized||Participants|Count of Participants|49|49.0||||||
3724549|NCT02081586|3562867|B5|United States||Region of Enrollment||participants|Number|13|13.0||||||
3724550|NCT02081586|3562868|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
3724551|NCT02081586|3562869|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3724552|NCT02081586|3562870|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3724553|NCT02081586|3562871|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3724554|NCT02081586|3562867|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724555|NCT02081586|3562868|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724556|NCT02081586|3562869|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724557|NCT02081586|3562870|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724558|NCT02081586|3562871|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724559|NCT02081586|3562867|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724560|NCT02081586|3562868|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724561|NCT02081586|3562869|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724562|NCT02081586|3562870|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724563|NCT02081586|3562871|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724564|NCT02081586|3562867|B5||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3724565|NCT02081586|3562868|B4||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3724566|NCT02081586|3562869|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3724567|NCT02081586|3562870|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3724568|NCT02081586|3562871|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724569|NCT02081586|3562867|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3724570|NCT02081586|3562868|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3724571|NCT02081586|3562869|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3724572|NCT02081586|3562870|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3724573|NCT02081586|3562871|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3724574|NCT02081586|3562867|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724575|NCT02081586|3562868|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724576|NCT02081586|3562869|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724577|NCT02081586|3562870|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724578|NCT02081586|3562871|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724579|NCT02081586|3562867|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724580|NCT02081586|3562868|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724581|NCT02081586|3562869|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724582|NCT02081586|3562870|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724583|NCT02081586|3562871|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724584|NCT02081586|3562867|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724585|NCT02081586|3562868|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724586|NCT02081586|3562869|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724587|NCT02081586|3562870|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724588|NCT02081586|3562871|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724589|NCT02081586|3562867|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3724590|NCT02081586|3562868|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3724591|NCT02081586|3562869|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3724592|NCT02081586|3562870|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3724593|NCT02081586|3562871|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3724594|NCT02081586|3562867|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3724595|NCT02081586|3562868|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3724596|NCT02081586|3562869|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3724597|NCT02081586|3562870|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3724598|NCT02081586|3562871|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3724599|NCT02081586|3562867|B5|||Age||years|Mean|57.38|57.38|Standard Deviation|6.64|6.64|||
3724600|NCT02081586|3562868|B4|||Age||years|Mean|60.67|60.67|Standard Deviation|.58|0.58|||
3724601|NCT02081586|3562869|B3|||Age||years|Mean|59.50|59.5|Standard Deviation|3.42|3.42|||
3724602|NCT02081586|3562870|B2|||Age||years|Mean|50.67|50.67|Standard Deviation|12.34|12.34|||
3724603|NCT02081586|3562871|B1|||Age||years|Mean|58.0|58.0|Standard Deviation|1.0|1.0|||
3724604|NCT02081573|3562901|B1|||Distress (Diabetes Distress Scale)|"The Brief Diabetes Distress Scale is a 17 item scale assessing distress in managing diabetes. The scale is scored as an average with a potential range from 1 to 6. Scores of 3 or greater are considered indicating stress.~Fisher, L., Glasgow, R. E., Mullan, J. T., Skaff, M. M., & Polonsky, W. H. (2008). Development of a brief diabetes distress screening instrument. The Annals of Family Medicine, 6(3), 246-252.~https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2384991/"|mean result on scale|Mean|3.52|3.52|Standard Deviation|1.47|1.47|||
3724605|NCT02081573|3562901|B1|||HbA1C||percent|Mean|9.8|9.8|Standard Deviation|.9|0.9|||
3724606|NCT02081573|3562901|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3724607|NCT02081573|3562901|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3724608|NCT02081573|3562901|B1|||Age||years|Mean|47.7|47.7|Full Range|||36.0|69.0|
3724609|NCT02081456|3562910|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3724610|NCT02081456|3562911|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3724611|NCT02081456|3562912|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3724612|NCT02081456|3562910|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3724613|NCT02081456|3562911|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3724614|NCT02081456|3562912|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3724615|NCT02081456|3562910|B3|||Age||years|Mean|44.22|44.22|Standard Deviation|10.24|10.24|||
3724616|NCT02081456|3562911|B2|||Age||years|Mean|46.25|46.25|Standard Deviation|10.42|10.42|||
3724617|NCT02081456|3562912|B1|||Age||years|Mean|42.00|42.0|Standard Deviation|10.42|10.42|||
3724618|NCT02081443|3562925|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724619|NCT02081443|3562926|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724620|NCT02081443|3562927|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724621|NCT02081443|3562925|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724622|NCT02081443|3562926|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724623|NCT02081443|3562927|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724624|NCT02081443|3562925|B3||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3724625|NCT02081443|3562926|B2||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3724626|NCT02081443|3562927|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3724627|NCT02081443|3562925|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3724628|NCT02081443|3562926|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3724629|NCT02081443|3562927|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3724630|NCT02081443|3562925|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724631|NCT02081443|3562926|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724632|NCT02081443|3562927|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724633|NCT02081443|3562925|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724634|NCT02081443|3562926|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724635|NCT02081443|3562927|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724636|NCT02081443|3562925|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724637|NCT02081443|3562926|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724638|NCT02081443|3562927|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724639|NCT02081443|3562925|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3724640|NCT02081443|3562926|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3724641|NCT02081443|3562927|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3724642|NCT02081443|3562925|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3724643|NCT02081443|3562926|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3724644|NCT02081443|3562927|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3724645|NCT02081443|3562925|B3|||Age||years|Mean|58|58.0|Standard Deviation|9|9.0|||
3724646|NCT02081443|3562926|B2|||Age||years|Mean|57|57.0|Standard Deviation|8|8.0|||
3724647|NCT02081443|3562927|B1|||Age||years|Mean|58|58.0|Standard Deviation|9|9.0|||
3724648|NCT02081365|3562938|B3|||ADIS Specific Phobia Clinical Severity Rating|Anxiety Disorders Interview Schedule for DSM-IV Specific Phobia Module Clinical Severity Rating (0-8 scale) 0 (none) to 8 (very severe); a CSR > 4 indicated that the participant met criteria for diagnosis of dental phobia.|units on a scale|Mean|5.0|5.0|Standard Deviation|1.5|1.5|||
3724649|NCT02081365|3562939|B2|||ADIS Specific Phobia Clinical Severity Rating|Anxiety Disorders Interview Schedule for DSM-IV Specific Phobia Module Clinical Severity Rating (0-8 scale) 0 (none) to 8 (very severe); a CSR > 4 indicated that the participant met criteria for diagnosis of dental phobia.|units on a scale|Mean|4.8|4.8|Standard Deviation|1.6|1.6|||
3724650|NCT02081365|3562940|B1|||ADIS Specific Phobia Clinical Severity Rating|Anxiety Disorders Interview Schedule for DSM-IV Specific Phobia Module Clinical Severity Rating (0-8 scale) 0 (none) to 8 (very severe); a CSR > 4 indicated that the participant met criteria for diagnosis of dental phobia.|units on a scale|Mean|5.3|5.3|Standard Deviation|1.4|1.4|||
3724651|NCT02081365|3562938|B3|||ADIS Specific Phobia Avoidance Rating|Anxiety Disorders Interview Schedule for DSM-IV Specific Phobia Module Avoidance Rating (0-8 scale). 0 (none) to 8 (very severe).|units on a scale|Mean|4.2|4.2|Standard Deviation|2.4|2.4|||
3724652|NCT02081365|3562939|B2|||ADIS Specific Phobia Avoidance Rating|Anxiety Disorders Interview Schedule for DSM-IV Specific Phobia Module Avoidance Rating (0-8 scale). 0 (none) to 8 (very severe).|units on a scale|Mean|3.9|3.9|Standard Deviation|2.5|2.5|||
3724653|NCT02081365|3562940|B1|||ADIS Specific Phobia Avoidance Rating|Anxiety Disorders Interview Schedule for DSM-IV Specific Phobia Module Avoidance Rating (0-8 scale). 0 (none) to 8 (very severe).|units on a scale|Mean|4.6|4.6|Standard Deviation|2.2|2.2|||
3724654|NCT02081365|3562938|B3|||ADIS Specific Phobia Fear Rating|Anxiety Disorders Interview Schedule for DSM-IV Specific Phobia Module Fear Rating 0 (none) to 8 (very severe).|units on a scale|Mean|5.4|5.4|Standard Deviation|1.3|1.3|||
3724655|NCT02081365|3562939|B2|||ADIS Specific Phobia Fear Rating|Anxiety Disorders Interview Schedule for DSM-IV Specific Phobia Module Fear Rating 0 (none) to 8 (very severe).|units on a scale|Mean|5.2|5.2|Standard Deviation|1.4|1.4|||
3724656|NCT02081365|3562940|B1|||ADIS Specific Phobia Fear Rating|Anxiety Disorders Interview Schedule for DSM-IV Specific Phobia Module Fear Rating 0 (none) to 8 (very severe).|units on a scale|Mean|5.6|5.6|Standard Deviation|1.3|1.3|||
3724657|NCT02081365|3562938|B3|||MDAS Baseline Score|Modified Dental Anxiety Scale Baseline Score (0-25 scale). We considered patients who scored > 19 on the MDAS at baseline or endorsed at least two MDAS items > 4 to have high dental anxiety.|units on a scale|Mean|19.5|19.5|Standard Deviation|2.8|2.8|||
3724658|NCT02081365|3562939|B2|||MDAS Baseline Score|Modified Dental Anxiety Scale Baseline Score (0-25 scale). We considered patients who scored > 19 on the MDAS at baseline or endorsed at least two MDAS items > 4 to have high dental anxiety.|units on a scale|Mean|19.6|19.6|Standard Deviation|2.6|2.6|||
3724659|NCT02081365|3562940|B1|||MDAS Baseline Score|Modified Dental Anxiety Scale Baseline Score (0-25 scale). We considered patients who scored > 19 on the MDAS at baseline or endorsed at least two MDAS items > 4 to have high dental anxiety.|units on a scale|Mean|19.5|19.5|Standard Deviation|2.9|2.9|||
3724660|NCT02081365|3562938|B3|Not reported/missing||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3724661|NCT02081365|3562939|B2|Not reported/missing||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3724662|NCT02081365|3562940|B1|Not reported/missing||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3724663|NCT02081365|3562938|B3|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3724664|NCT02081365|3562939|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3724665|NCT02081365|3562940|B1|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3724666|NCT02081365|3562938|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3724667|NCT02081365|3562939|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3724668|NCT02081365|3562940|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3724669|NCT02081365|3562938|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|78|78.0||||||
3724670|NCT02081365|3562939|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
3724671|NCT02081365|3562940|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
3724672|NCT02081365|3562938|B3|White||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
3724673|NCT02081365|3562939|B2|White||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3724674|NCT02081365|3562940|B1|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3724675|NCT02081365|3562938|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3724676|NCT02081365|3562939|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3724677|NCT02081365|3562940|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3724678|NCT02081365|3562938|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
3724679|NCT02081365|3562939|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3724680|NCT02081365|3562940|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3724681|NCT02081365|3562938|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3724682|NCT02081365|3562939|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3724683|NCT02081365|3562940|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3724684|NCT02081365|3562938|B3||Male|Gender||Participants|Count of Participants|58|58.0||||||
3724685|NCT02081365|3562939|B2||Male|Gender||Participants|Count of Participants|36|36.0||||||
3724686|NCT02081365|3562940|B1||Male|Gender||Participants|Count of Participants|22|22.0||||||
3724687|NCT02081365|3562938|B3||Female|Gender||Participants|Count of Participants|93|93.0||||||
3724688|NCT02081365|3562939|B2||Female|Gender||Participants|Count of Participants|41|41.0||||||
3724689|NCT02081365|3562940|B1||Female|Gender||Participants|Count of Participants|52|52.0||||||
3724690|NCT02081365|3562938|B3|||Age||years|Mean|44.7|44.7|Standard Deviation|13.1|13.1|||
3724691|NCT02081365|3562939|B2|||Age||years|Mean|44.6|44.6|Standard Deviation|13.6|13.6|||
3724692|NCT02081365|3562940|B1|||Age||years|Mean|44.7|44.7|Standard Deviation|12.8|12.8|||
3724693|NCT02081248|3562953|B3||BMT CTN 1301|Parent Clinical Trial|Participants for the ETRIC (BMT CTN 1205) study were recruited from those that were potentially eligible for BMT CTN 0901, 1101, 1203, or 1301 (NCT01339910, NCT01597778, NCT02208037, and NCT02345850, respectively). The parent clinical trial is the BMT CTN trial for which the participant was potentially eligible.|Participants|Count of Participants|29|29.0||||||
3724694|NCT02081248|3562954|B2||BMT CTN 1301|Parent Clinical Trial|Participants for the ETRIC (BMT CTN 1205) study were recruited from those that were potentially eligible for BMT CTN 0901, 1101, 1203, or 1301 (NCT01339910, NCT01597778, NCT02208037, and NCT02345850, respectively). The parent clinical trial is the BMT CTN trial for which the participant was potentially eligible.|Participants|Count of Participants|16|16.0||||||
3724695|NCT02081248|3562955|B1||BMT CTN 1301|Parent Clinical Trial|Participants for the ETRIC (BMT CTN 1205) study were recruited from those that were potentially eligible for BMT CTN 0901, 1101, 1203, or 1301 (NCT01339910, NCT01597778, NCT02208037, and NCT02345850, respectively). The parent clinical trial is the BMT CTN trial for which the participant was potentially eligible.|Participants|Count of Participants|13|13.0||||||
3724696|NCT02081248|3562953|B3||BMT CTN 1203|Parent Clinical Trial|Participants for the ETRIC (BMT CTN 1205) study were recruited from those that were potentially eligible for BMT CTN 0901, 1101, 1203, or 1301 (NCT01339910, NCT01597778, NCT02208037, and NCT02345850, respectively). The parent clinical trial is the BMT CTN trial for which the participant was potentially eligible.|Participants|Count of Participants|101|101.0||||||
3724734|NCT02081248|3562955|B1||Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3724697|NCT02081248|3562954|B2||BMT CTN 1203|Parent Clinical Trial|Participants for the ETRIC (BMT CTN 1205) study were recruited from those that were potentially eligible for BMT CTN 0901, 1101, 1203, or 1301 (NCT01339910, NCT01597778, NCT02208037, and NCT02345850, respectively). The parent clinical trial is the BMT CTN trial for which the participant was potentially eligible.|Participants|Count of Participants|51|51.0||||||
3724698|NCT02081248|3562955|B1||BMT CTN 1203|Parent Clinical Trial|Participants for the ETRIC (BMT CTN 1205) study were recruited from those that were potentially eligible for BMT CTN 0901, 1101, 1203, or 1301 (NCT01339910, NCT01597778, NCT02208037, and NCT02345850, respectively). The parent clinical trial is the BMT CTN trial for which the participant was potentially eligible.|Participants|Count of Participants|50|50.0||||||
3724699|NCT02081248|3562953|B3||BMT CTN 1101|Parent Clinical Trial|Participants for the ETRIC (BMT CTN 1205) study were recruited from those that were potentially eligible for BMT CTN 0901, 1101, 1203, or 1301 (NCT01339910, NCT01597778, NCT02208037, and NCT02345850, respectively). The parent clinical trial is the BMT CTN trial for which the participant was potentially eligible.|Participants|Count of Participants|47|47.0||||||
3724700|NCT02081248|3562954|B2||BMT CTN 1101|Parent Clinical Trial|Participants for the ETRIC (BMT CTN 1205) study were recruited from those that were potentially eligible for BMT CTN 0901, 1101, 1203, or 1301 (NCT01339910, NCT01597778, NCT02208037, and NCT02345850, respectively). The parent clinical trial is the BMT CTN trial for which the participant was potentially eligible.|Participants|Count of Participants|22|22.0||||||
3724701|NCT02081248|3562955|B1||BMT CTN 1101|Parent Clinical Trial|Participants for the ETRIC (BMT CTN 1205) study were recruited from those that were potentially eligible for BMT CTN 0901, 1101, 1203, or 1301 (NCT01339910, NCT01597778, NCT02208037, and NCT02345850, respectively). The parent clinical trial is the BMT CTN trial for which the participant was potentially eligible.|Participants|Count of Participants|25|25.0||||||
3724702|NCT02081248|3562953|B3||BMT CTN 0901|Parent Clinical Trial|Participants for the ETRIC (BMT CTN 1205) study were recruited from those that were potentially eligible for BMT CTN 0901, 1101, 1203, or 1301 (NCT01339910, NCT01597778, NCT02208037, and NCT02345850, respectively). The parent clinical trial is the BMT CTN trial for which the participant was potentially eligible.|Participants|Count of Participants|21|21.0||||||
3724703|NCT02081248|3562954|B2||BMT CTN 0901|Parent Clinical Trial|Participants for the ETRIC (BMT CTN 1205) study were recruited from those that were potentially eligible for BMT CTN 0901, 1101, 1203, or 1301 (NCT01339910, NCT01597778, NCT02208037, and NCT02345850, respectively). The parent clinical trial is the BMT CTN trial for which the participant was potentially eligible.|Participants|Count of Participants|11|11.0||||||
3724704|NCT02081248|3562955|B1||BMT CTN 0901|Parent Clinical Trial|Participants for the ETRIC (BMT CTN 1205) study were recruited from those that were potentially eligible for BMT CTN 0901, 1101, 1203, or 1301 (NCT01339910, NCT01597778, NCT02208037, and NCT02345850, respectively). The parent clinical trial is the BMT CTN trial for which the participant was potentially eligible.|Participants|Count of Participants|10|10.0||||||
3724705|NCT02081248|3562953|B3||Unknown or Not Reported|Education Level||Participants|Count of Participants|50|50.0||||||
3724706|NCT02081248|3562954|B2||Unknown or Not Reported|Education Level||Participants|Count of Participants|21|21.0||||||
3724707|NCT02081248|3562955|B1||Unknown or Not Reported|Education Level||Participants|Count of Participants|29|29.0||||||
3724708|NCT02081248|3562953|B3||Other|Education Level||Participants|Count of Participants|11|11.0||||||
3724709|NCT02081248|3562954|B2||Other|Education Level||Participants|Count of Participants|6|6.0||||||
3724710|NCT02081248|3562955|B1||Other|Education Level||Participants|Count of Participants|5|5.0||||||
3724711|NCT02081248|3562953|B3||Graduate Degree or More|Education Level||Participants|Count of Participants|26|26.0||||||
3724712|NCT02081248|3562954|B2||Graduate Degree or More|Education Level||Participants|Count of Participants|11|11.0||||||
3724713|NCT02081248|3562955|B1||Graduate Degree or More|Education Level||Participants|Count of Participants|15|15.0||||||
3724714|NCT02081248|3562953|B3||Post-high School, but Less than Graduate Degree|Education Level||Participants|Count of Participants|56|56.0||||||
3724715|NCT02081248|3562954|B2||Post-high School, but Less than Graduate Degree|Education Level||Participants|Count of Participants|27|27.0||||||
3724716|NCT02081248|3562955|B1||Post-high School, but Less than Graduate Degree|Education Level||Participants|Count of Participants|29|29.0||||||
3724717|NCT02081248|3562953|B3||High School or Less|Education Level||Participants|Count of Participants|55|55.0||||||
3724718|NCT02081248|3562954|B2||High School or Less|Education Level||Participants|Count of Participants|35|35.0||||||
3724719|NCT02081248|3562955|B1||High School or Less|Education Level||Participants|Count of Participants|20|20.0||||||
3724720|NCT02081248|3562953|B3||Unknown or Not Reported|Annual Household Income||Participants|Count of Participants|75|75.0||||||
3724721|NCT02081248|3562954|B2||Unknown or Not Reported|Annual Household Income||Participants|Count of Participants|35|35.0||||||
3724722|NCT02081248|3562955|B1||Unknown or Not Reported|Annual Household Income||Participants|Count of Participants|40|40.0||||||
3724723|NCT02081248|3562953|B3||$80,000 or More|Annual Household Income||Participants|Count of Participants|48|48.0||||||
3724724|NCT02081248|3562954|B2||$80,000 or More|Annual Household Income||Participants|Count of Participants|26|26.0||||||
3724725|NCT02081248|3562955|B1||$80,000 or More|Annual Household Income||Participants|Count of Participants|22|22.0||||||
3724726|NCT02081248|3562953|B3||$40,000-79,999|Annual Household Income||Participants|Count of Participants|45|45.0||||||
3724727|NCT02081248|3562954|B2||$40,000-79,999|Annual Household Income||Participants|Count of Participants|20|20.0||||||
3724728|NCT02081248|3562955|B1||$40,000-79,999|Annual Household Income||Participants|Count of Participants|25|25.0||||||
3724729|NCT02081248|3562953|B3||Less than $40,000|Annual Household Income||Participants|Count of Participants|30|30.0||||||
3724730|NCT02081248|3562954|B2||Less than $40,000|Annual Household Income||Participants|Count of Participants|19|19.0||||||
3724731|NCT02081248|3562955|B1||Less than $40,000|Annual Household Income||Participants|Count of Participants|11|11.0||||||
3724732|NCT02081248|3562953|B3||Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3724733|NCT02081248|3562954|B2||Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3724913|NCT02081001|3563070|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3724735|NCT02081248|3562953|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3724736|NCT02081248|3562954|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3724737|NCT02081248|3562955|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3724738|NCT02081248|3562953|B3||Black|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3724739|NCT02081248|3562954|B2||Black|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3724740|NCT02081248|3562955|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3724741|NCT02081248|3562953|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|173|173.0||||||
3724742|NCT02081248|3562954|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|88|88.0||||||
3724743|NCT02081248|3562955|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|85|85.0||||||
3724744|NCT02081248|3562953|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3724745|NCT02081248|3562954|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3724746|NCT02081248|3562955|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3724747|NCT02081248|3562953|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|181|181.0||||||
3724748|NCT02081248|3562954|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3724749|NCT02081248|3562955|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3724750|NCT02081248|3562953|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3724751|NCT02081248|3562954|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3724752|NCT02081248|3562955|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3724753|NCT02081248|3562953|B3||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3724754|NCT02081248|3562954|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3724755|NCT02081248|3562955|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3724756|NCT02081248|3562953|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3724757|NCT02081248|3562954|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3724758|NCT02081248|3562955|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3724759|NCT02081248|3562953|B3|||Age||years|Median|61|61.0|Full Range|||21.0|76.0|
3724760|NCT02081248|3562954|B2|||Age||years|Median|61|61.0|Full Range|||21.0|76.0|
3724761|NCT02081248|3562955|B1|||Age||years|Median|61|61.0|Full Range|||27.0|73.0|
3724762|NCT02081183|3562978|B3|Venezuela||Region of Enrollment||participants|Number|11|11.0||||||
3724763|NCT02081183|3562979|B2|Venezuela||Region of Enrollment||participants|Number|6|6.0||||||
3724764|NCT02081183|3562980|B1|Venezuela||Region of Enrollment||participants|Number|5|5.0||||||
3724765|NCT02081183|3562978|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3724766|NCT02081183|3562979|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3724767|NCT02081183|3562980|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3724768|NCT02081183|3562978|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3724769|NCT02081183|3562979|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3724770|NCT02081183|3562980|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3724771|NCT02081183|3562978|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3724772|NCT02081183|3562979|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3724773|NCT02081183|3562980|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3724774|NCT02081183|3562978|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3724775|NCT02081183|3562979|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3724776|NCT02081183|3562980|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3724777|NCT02081183|3562978|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3724778|NCT02081183|3562979|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3724779|NCT02081183|3562980|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3724780|NCT02081079|3562993|B5|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|13|13.0||||||
3724781|NCT02081079|3562994|B4|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
3724782|NCT02081079|3562995|B3|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3724783|NCT02081079|3562996|B2|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|5|5.0||||||
3724784|NCT02081079|3562997|B1|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|4|4.0||||||
3724785|NCT02081079|3562993|B5|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|45|45.0||||||
3724786|NCT02081079|3562994|B4|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|11|11.0||||||
3724787|NCT02081079|3562995|B3|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|7|7.0||||||
3724788|NCT02081079|3562996|B2|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|16|16.0||||||
3724789|NCT02081079|3562997|B1|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|11|11.0||||||
3724790|NCT02081079|3562993|B5|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|27|27.0||||||
3724854|NCT02081014|3563020|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724791|NCT02081079|3562994|B4|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|6|6.0||||||
3724792|NCT02081079|3562995|B3|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|13|13.0||||||
3724793|NCT02081079|3562996|B2|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3724794|NCT02081079|3562997|B1|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|7|7.0||||||
3724795|NCT02081079|3562993|B5|Presence||Cirrhosis Status||participants|Number|19|19.0||||||
3724796|NCT02081079|3562994|B4|Presence||Cirrhosis Status||participants|Number|6|6.0||||||
3724797|NCT02081079|3562995|B3|Presence||Cirrhosis Status||participants|Number|3|3.0||||||
3724798|NCT02081079|3562996|B2|Presence||Cirrhosis Status||participants|Number|9|9.0||||||
3724799|NCT02081079|3562997|B1|Presence||Cirrhosis Status||participants|Number|1|1.0||||||
3724800|NCT02081079|3562993|B5|Absence||Cirrhosis Status||participants|Number|66|66.0||||||
3724801|NCT02081079|3562994|B4|Absence||Cirrhosis Status||participants|Number|14|14.0||||||
3724802|NCT02081079|3562995|B3|Absence||Cirrhosis Status||participants|Number|18|18.0||||||
3724803|NCT02081079|3562996|B2|Absence||Cirrhosis Status||participants|Number|13|13.0||||||
3724804|NCT02081079|3562997|B1|Absence||Cirrhosis Status||participants|Number|21|21.0||||||
3724805|NCT02081079|3562993|B5|Genotype 5||HCV Genotype||participants|Number|41|41.0||||||
3724806|NCT02081079|3562994|B4|Genotype 5||HCV Genotype||participants|Number|20|20.0||||||
3724807|NCT02081079|3562995|B3|Genotype 5||HCV Genotype||participants|Number|21|21.0||||||
3724808|NCT02081079|3562996|B2|Genotype 5||HCV Genotype||participants|Number|0|0.0||||||
3724809|NCT02081079|3562997|B1|Genotype 5||HCV Genotype||participants|Number|0|0.0||||||
3724810|NCT02081079|3562993|B5|Genotype 4||HCV Genotype||participants|Number|44|44.0||||||
3724811|NCT02081079|3562994|B4|Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3724812|NCT02081079|3562995|B3|Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3724813|NCT02081079|3562996|B2|Genotype 4||HCV Genotype||participants|Number|22|22.0||||||
3724814|NCT02081079|3562997|B1|Genotype 4||HCV Genotype||participants|Number|22|22.0||||||
3724815|NCT02081079|3562993|B5|||HCV RNA||log10 copies/mL|Mean|6.3|6.3|Standard Deviation|0.48|0.48|||
3724816|NCT02081079|3562994|B4|||HCV RNA||log10 copies/mL|Mean|6.6|6.6|Standard Deviation|0.39|0.39|||
3724817|NCT02081079|3562995|B3|||HCV RNA||log10 copies/mL|Mean|6.2|6.2|Standard Deviation|0.48|0.48|||
3724818|NCT02081079|3562996|B2|||HCV RNA||log10 copies/mL|Mean|6.3|6.3|Standard Deviation|0.48|0.48|||
3724819|NCT02081079|3562997|B1|||HCV RNA||log10 copies/mL|Mean|6.0|6.0|Standard Deviation|0.40|0.4|||
3724820|NCT02081079|3562993|B5|France||Region of Enrollment||participants|Number|85|85.0||||||
3724821|NCT02081079|3562994|B4|France||Region of Enrollment||participants|Number|20|20.0||||||
3724822|NCT02081079|3562995|B3|France||Region of Enrollment||participants|Number|21|21.0||||||
3724823|NCT02081079|3562996|B2|France||Region of Enrollment||participants|Number|22|22.0||||||
3724824|NCT02081079|3562997|B1|France||Region of Enrollment||participants|Number|22|22.0||||||
3724825|NCT02081079|3562993|B5|White||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
3724826|NCT02081079|3562994|B4|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3724827|NCT02081079|3562995|B3|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3724828|NCT02081079|3562996|B2|White||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3724829|NCT02081079|3562997|B1|White||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3724830|NCT02081079|3562993|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3724831|NCT02081079|3562994|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3724832|NCT02081079|3562995|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3724833|NCT02081079|3562996|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3724834|NCT02081079|3562997|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3724835|NCT02081079|3562993|B5||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3724836|NCT02081079|3562994|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3724837|NCT02081079|3562995|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3724838|NCT02081079|3562996|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3724839|NCT02081079|3562997|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3724840|NCT02081079|3562993|B5||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3724841|NCT02081079|3562994|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3724842|NCT02081079|3562995|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3724843|NCT02081079|3562996|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3724844|NCT02081079|3562997|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3724845|NCT02081079|3562993|B5|||Age||years|Mean|57|57.0|Standard Deviation|10.8|10.8|||
3724846|NCT02081079|3562994|B4|||Age||years|Mean|64|64.0|Standard Deviation|8.6|8.6|||
3724847|NCT02081079|3562995|B3|||Age||years|Mean|61|61.0|Standard Deviation|10.4|10.4|||
3724848|NCT02081079|3562996|B2|||Age||years|Mean|50|50.0|Standard Deviation|8.8|8.8|||
3724849|NCT02081079|3562997|B1|||Age||years|Mean|52|52.0|Standard Deviation|9.2|9.2|||
3724850|NCT02081014|3563020|B1|||Duration of Diabetes||years|Mean|11.6|11.6|Standard Deviation|6.02|6.02|||
3724851|NCT02081014|3563020|B1|||Body Weight||kg|Mean|73.6|73.6|Standard Deviation|12.08|12.08|||
3724852|NCT02081014|3563020|B1|||HbA1c||percent|Mean|7.7|7.7|Standard Deviation|0.48|0.48|||
3724853|NCT02081014|3563020|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3724855|NCT02081014|3563020|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724856|NCT02081014|3563020|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3724857|NCT02081014|3563020|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724858|NCT02081014|3563020|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724859|NCT02081014|3563020|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724860|NCT02081014|3563020|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724861|NCT02081014|3563020|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724862|NCT02081014|3563020|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3724863|NCT02081014|3563020|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724864|NCT02081014|3563020|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3724865|NCT02081014|3563020|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3724866|NCT02081014|3563020|B1|||Age||years|Mean|26.4|26.4|Standard Deviation|9.1|9.1|||
3724867|NCT02081014|3563020|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3724868|NCT02081014|3563020|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3724869|NCT02081014|3563020|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3724870|NCT02081001|3563069|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
3724871|NCT02081001|3563070|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3724872|NCT02081001|3563071|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3724873|NCT02081001|3563069|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724874|NCT02081001|3563070|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724875|NCT02081001|3563071|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724876|NCT02081001|3563069|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724877|NCT02081001|3563070|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724878|NCT02081001|3563071|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724879|NCT02081001|3563069|B3||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3724880|NCT02081001|3563070|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3724881|NCT02081001|3563071|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3724882|NCT02081001|3563069|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724883|NCT02081001|3563070|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724884|NCT02081001|3563071|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724885|NCT02081001|3563069|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724886|NCT02081001|3563070|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724887|NCT02081001|3563071|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724888|NCT02081001|3563069|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724889|NCT02081001|3563070|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724890|NCT02081001|3563071|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724891|NCT02081001|3563069|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724892|NCT02081001|3563070|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724893|NCT02081001|3563071|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724894|NCT02081001|3563069|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724895|NCT02081001|3563070|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724896|NCT02081001|3563071|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724897|NCT02081001|3563069|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3724898|NCT02081001|3563070|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3724899|NCT02081001|3563071|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3724900|NCT02081001|3563069|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3724901|NCT02081001|3563070|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3724902|NCT02081001|3563071|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3724903|NCT02081001|3563069|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3724904|NCT02081001|3563070|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3724905|NCT02081001|3563071|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3724906|NCT02081001|3563069|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3724907|NCT02081001|3563070|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3724908|NCT02081001|3563071|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3724909|NCT02081001|3563069|B3|||Age||years|Mean|35.3|35.3|Standard Deviation|9.21|9.21|||
3724910|NCT02081001|3563070|B2|||Age||years|Mean|32.2|32.2|Standard Deviation|8.38|8.38|||
3724911|NCT02081001|3563071|B1|||Age||years|Mean|36.7|36.7|Standard Deviation|9.54|9.54|||
3724912|NCT02081001|3563069|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3724914|NCT02081001|3563071|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3724915|NCT02081001|3563069|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3724916|NCT02081001|3563070|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3724917|NCT02081001|3563071|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3724918|NCT02081001|3563069|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3724919|NCT02081001|3563070|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3724920|NCT02081001|3563071|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3724921|NCT02080871|3563146|B1|United States||Region of Enrollment||Participants|Count of Participants|107|107.0||||||
3724922|NCT02080871|3563146|B1|New Zealand||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3724923|NCT02080871|3563146|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3724924|NCT02080871|3563146|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3724925|NCT02080871|3563146|B1||White|Race (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
3724926|NCT02080871|3563146|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3724927|NCT02080871|3563146|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724928|NCT02080871|3563146|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3724929|NCT02080871|3563146|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3724930|NCT02080871|3563146|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724931|NCT02080871|3563146|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
3724932|NCT02080871|3563146|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3724933|NCT02080871|3563146|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3724934|NCT02080871|3563146|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3724935|NCT02080871|3563146|B1|||Age|Adults >/= 18 years|years|Mean|66|66.0|Standard Deviation|9.5|9.5|||
3724936|NCT02080832|3563188|B4|United States||Region of Enrollment||participants|Number|54|54.0||||||
3724937|NCT02080832|3563189|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
3724938|NCT02080832|3563190|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3724939|NCT02080832|3563191|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3724940|NCT02080832|3563188|B4|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3724941|NCT02080832|3563189|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3724942|NCT02080832|3563190|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3724943|NCT02080832|3563191|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3724944|NCT02080832|3563188|B4|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3724945|NCT02080832|3563189|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3724946|NCT02080832|3563190|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3724947|NCT02080832|3563191|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3724948|NCT02080832|3563188|B4|African American||Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
3724949|NCT02080832|3563189|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3724950|NCT02080832|3563190|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3724951|NCT02080832|3563191|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3724952|NCT02080832|3563188|B4||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3724953|NCT02080832|3563189|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3724954|NCT02080832|3563190|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3724955|NCT02080832|3563191|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3724956|NCT02080832|3563188|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3724957|NCT02080832|3563189|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3724958|NCT02080832|3563190|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3724959|NCT02080832|3563191|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3724960|NCT02080832|3563188|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3724961|NCT02080832|3563189|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3724962|NCT02080832|3563190|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3724963|NCT02080832|3563191|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3724964|NCT02080832|3563188|B4||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3724965|NCT02080832|3563189|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3724966|NCT02080832|3563190|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3724967|NCT02080832|3563191|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3724968|NCT02080832|3563188|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3724969|NCT02080832|3563189|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3724970|NCT02080832|3563190|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3724971|NCT02080832|3563191|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3724972|NCT02080819|3563207|B4|United States||Region of Enrollment||participants|Number|30|30.0||||||
3724973|NCT02080819|3563208|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3724974|NCT02080819|3563209|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3724975|NCT02080819|3563210|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
3724976|NCT02080819|3563207|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724977|NCT02080819|3563208|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724978|NCT02080819|3563209|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724979|NCT02080819|3563210|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724980|NCT02080819|3563207|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3724981|NCT02080819|3563208|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724982|NCT02080819|3563209|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724983|NCT02080819|3563210|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3724984|NCT02080819|3563207|B4||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3724985|NCT02080819|3563208|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3724986|NCT02080819|3563209|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724987|NCT02080819|3563210|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3724988|NCT02080819|3563207|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3724989|NCT02080819|3563208|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3724990|NCT02080819|3563209|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3724991|NCT02080819|3563210|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3724992|NCT02080819|3563207|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3724993|NCT02080819|3563208|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724994|NCT02080819|3563209|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724995|NCT02080819|3563210|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3724996|NCT02080819|3563207|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3724997|NCT02080819|3563208|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724998|NCT02080819|3563209|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3724999|NCT02080819|3563210|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3725000|NCT02080819|3563207|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725001|NCT02080819|3563208|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725002|NCT02080819|3563209|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725003|NCT02080819|3563210|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725004|NCT02080819|3563207|B4||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3725005|NCT02080819|3563208|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3725006|NCT02080819|3563209|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3725007|NCT02080819|3563210|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3725008|NCT02080819|3563207|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3725009|NCT02080819|3563208|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3725010|NCT02080819|3563209|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3725011|NCT02080819|3563210|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3725012|NCT02080819|3563207|B4|||Age||years|Mean|33|33.0|Standard Deviation|12|12.0|||
3725013|NCT02080819|3563208|B3|||Age||years|Mean|35|35.0|Standard Deviation|8|8.0|||
3725014|NCT02080819|3563209|B2|||Age||years|Mean|33|33.0|Standard Deviation|7|7.0|||
3725015|NCT02080819|3563210|B1|||Age||years|Mean|30|30.0|Standard Deviation|12|12.0|||
3725016|NCT02080819|3563207|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3725017|NCT02080819|3563208|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3725018|NCT02080819|3563209|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3725019|NCT02080819|3563210|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3725020|NCT02080819|3563207|B4||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3725021|NCT02080819|3563208|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3725022|NCT02080819|3563209|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3725023|NCT02080819|3563210|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3725024|NCT02080819|3563207|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3725025|NCT02080819|3563208|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3725026|NCT02080819|3563209|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3725027|NCT02080819|3563210|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3725028|NCT02080780|3563220|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3725029|NCT02080780|3563220|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3725030|NCT02080780|3563220|B1|||Age||years|Mean|32.9|32.9|Standard Deviation|10.49|10.49|||
3725031|NCT02080546|3563227|B3|||Body Mass Index||kg/m^2|Median|32.5|32.5|Full Range|||20.0|54.0|
3725032|NCT02080546|3563228|B2|||Body Mass Index||kg/m^2|Median|32|32.0|Full Range|||20.0|50.0|
3725033|NCT02080546|3563229|B1|||Body Mass Index||kg/m^2|Median|33|33.0|Full Range|||20.0|54.0|
3725034|NCT02080546|3563227|B3|United States||Region of Enrollment||participants|Number|101|101.0||||||
3725035|NCT02080546|3563228|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
3725036|NCT02080546|3563229|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
3725037|NCT02080546|3563227|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725038|NCT02080546|3563228|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725039|NCT02080546|3563229|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725040|NCT02080546|3563227|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725041|NCT02080546|3563228|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725042|NCT02080546|3563229|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725043|NCT02080546|3563227|B3||White|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3725044|NCT02080546|3563228|B2||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3725045|NCT02080546|3563229|B1||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3725046|NCT02080546|3563227|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3725047|NCT02080546|3563228|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3725048|NCT02080546|3563229|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3725049|NCT02080546|3563227|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725050|NCT02080546|3563228|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725051|NCT02080546|3563229|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725052|NCT02080546|3563227|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3725053|NCT02080546|3563228|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3725054|NCT02080546|3563229|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3725055|NCT02080546|3563227|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3725056|NCT02080546|3563228|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3725057|NCT02080546|3563229|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725058|NCT02080546|3563227|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725059|NCT02080546|3563228|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725060|NCT02080546|3563229|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725061|NCT02080546|3563227|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3725062|NCT02080546|3563228|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3725063|NCT02080546|3563229|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3725064|NCT02080546|3563227|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3725065|NCT02080546|3563228|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3725066|NCT02080546|3563229|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3725067|NCT02080546|3563227|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3725068|NCT02080546|3563228|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3725069|NCT02080546|3563229|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3725070|NCT02080546|3563227|B3||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3725071|NCT02080546|3563228|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3725072|NCT02080546|3563229|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3725073|NCT02080546|3563227|B3|||Age||years|Mean|56.3|56.3|Standard Deviation|12.3|12.3|||
3725074|NCT02080546|3563228|B2|||Age||years|Mean|54|54.0|Standard Deviation|11.9|11.9|||
3725075|NCT02080546|3563229|B1|||Age||years|Mean|58|58.0|Standard Deviation|12.5|12.5|||
3725076|NCT02080546|3563227|B3||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3725077|NCT02080546|3563228|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3725078|NCT02080546|3563229|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3725079|NCT02080546|3563227|B3||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
3725080|NCT02080546|3563228|B2||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
3725081|NCT02080546|3563229|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3725082|NCT02080546|3563227|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3725083|NCT02080546|3563228|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3725084|NCT02080546|3563229|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3725085|NCT02080507|3563238|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3725086|NCT02080507|3563239|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3725087|NCT02080507|3563240|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3725088|NCT02080507|3563238|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3725089|NCT02080507|3563239|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3725090|NCT02080507|3563240|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3725091|NCT02080507|3563238|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3725092|NCT02080507|3563239|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3725093|NCT02080507|3563240|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3725094|NCT02080507|3563238|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3725095|NCT02080507|3563239|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3725096|NCT02080507|3563240|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3725097|NCT02080507|3563238|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3725098|NCT02080507|3563239|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3725099|NCT02080507|3563240|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3725100|NCT02080507|3563238|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3725101|NCT02080507|3563239|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3725102|NCT02080507|3563240|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3725103|NCT02080481|3563249|B3||Other|Intraoperative management strategy||Participants|Count of Participants|2|2.0||||||
3725104|NCT02080481|3563250|B2||Other|Intraoperative management strategy||Participants|Count of Participants|0|0.0||||||
3725105|NCT02080481|3563251|B1||Other|Intraoperative management strategy||Participants|Count of Participants|2|2.0||||||
3725106|NCT02080481|3563249|B3||Spinal anesthesia|Intraoperative management strategy||Participants|Count of Participants|54|54.0||||||
3725107|NCT02080481|3563250|B2||Spinal anesthesia|Intraoperative management strategy||Participants|Count of Participants|31|31.0||||||
3725108|NCT02080481|3563251|B1||Spinal anesthesia|Intraoperative management strategy||Participants|Count of Participants|23|23.0||||||
3725109|NCT02080481|3563249|B3||General anesthesia|Intraoperative management strategy||Participants|Count of Participants|78|78.0||||||
3725110|NCT02080481|3563250|B2||General anesthesia|Intraoperative management strategy||Participants|Count of Participants|36|36.0||||||
3725111|NCT02080481|3563251|B1||General anesthesia|Intraoperative management strategy||Participants|Count of Participants|42|42.0||||||
3725112|NCT02080481|3563249|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3725113|NCT02080481|3563250|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3725114|NCT02080481|3563251|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3725115|NCT02080481|3563249|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3725116|NCT02080481|3563250|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3725117|NCT02080481|3563251|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3725118|NCT02080481|3563249|B3|||Age||years|Mean|64.3|64.3|Standard Deviation|12.6|12.6|||
3725119|NCT02080481|3563250|B2|||Age||years|Mean|63.8|63.8|Standard Deviation|9.1|9.1|||
3725120|NCT02080481|3563251|B1|||Age||years|Mean|64.7|64.7|Standard Deviation|10.6|10.6|||
3725121|NCT02080312|3563264|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3725122|NCT02080312|3563264|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3725123|NCT02080312|3563264|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3725124|NCT02080312|3563264|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3725125|NCT02080312|3563264|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3725126|NCT02080312|3563264|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3725127|NCT02080195|3563270|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3725128|NCT02080195|3563270|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725129|NCT02080195|3563270|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725130|NCT02080195|3563270|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3725131|NCT02080195|3563270|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725132|NCT02080195|3563270|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725133|NCT02080195|3563270|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725134|NCT02080195|3563270|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725135|NCT02080195|3563270|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725136|NCT02080195|3563270|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3725137|NCT02080195|3563270|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725138|NCT02080195|3563270|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3725139|NCT02080195|3563270|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3725140|NCT02080195|3563270|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3725141|NCT02080195|3563270|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3725142|NCT02080195|3563270|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3725143|NCT02080091|3563279|B1|Germany||Region of Enrollment||participants|Number|23|23.0||||||
3725144|NCT02080091|3563279|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3725145|NCT02080091|3563279|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3725146|NCT02080091|3563279|B1|||Age||years|Mean|67.4|67.4|Standard Deviation|9.02|9.02|||
3725189|NCT02079909|3563287|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3725190|NCT02079909|3563288|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3725191|NCT02079909|3563285|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3725147|NCT02079909|3563285|B4|||MMSE|The Mini Mental Scale Examination (MMSE) is a validated, brief, frequently used screening instrument for Alzheimer’s disease drug studies. The MMSE scale evaluates orientation, memory, attention, concentration, naming, repetition, comprehension, and ability to create a sentence and to copy two overlapping pentagons. The MMSE is scored as the number of correctly completed items with a lower score indicative of poorer performance and greater cognitive impairment. The total score ranges from 0 (worse) to 30 (perfect performance).|units on a scale|Mean|18.3|18.3|Standard Deviation|3.8|3.8|||
3725148|NCT02079909|3563286|B3|||MMSE|The Mini Mental Scale Examination (MMSE) is a validated, brief, frequently used screening instrument for Alzheimer’s disease drug studies. The MMSE scale evaluates orientation, memory, attention, concentration, naming, repetition, comprehension, and ability to create a sentence and to copy two overlapping pentagons. The MMSE is scored as the number of correctly completed items with a lower score indicative of poorer performance and greater cognitive impairment. The total score ranges from 0 (worse) to 30 (perfect performance).|units on a scale|Mean|18.2|18.2|Standard Deviation|3.8|3.8|||
3725149|NCT02079909|3563287|B2|||MMSE|The Mini Mental Scale Examination (MMSE) is a validated, brief, frequently used screening instrument for Alzheimer’s disease drug studies. The MMSE scale evaluates orientation, memory, attention, concentration, naming, repetition, comprehension, and ability to create a sentence and to copy two overlapping pentagons. The MMSE is scored as the number of correctly completed items with a lower score indicative of poorer performance and greater cognitive impairment. The total score ranges from 0 (worse) to 30 (perfect performance).|units on a scale|Mean|18.2|18.2|Standard Deviation|3.8|3.8|||
3725150|NCT02079909|3563288|B1|||MMSE|The Mini Mental Scale Examination (MMSE) is a validated, brief, frequently used screening instrument for Alzheimer’s disease drug studies. The MMSE scale evaluates orientation, memory, attention, concentration, naming, repetition, comprehension, and ability to create a sentence and to copy two overlapping pentagons. The MMSE is scored as the number of correctly completed items with a lower score indicative of poorer performance and greater cognitive impairment. The total score ranges from 0 (worse) to 30 (perfect performance).|units on a scale|Mean|18.4|18.4|Standard Deviation|3.9|3.9|||
3725151|NCT02079909|3563285|B4||Unknown|ApoE4 genotype||Participants|Count of Participants|28|28.0||||||
3725152|NCT02079909|3563286|B3||Unknown|ApoE4 genotype||Participants|Count of Participants|8|8.0||||||
3725153|NCT02079909|3563287|B2||Unknown|ApoE4 genotype||Participants|Count of Participants|7|7.0||||||
3725154|NCT02079909|3563288|B1||Unknown|ApoE4 genotype||Participants|Count of Participants|13|13.0||||||
3725155|NCT02079909|3563285|B4||Homozygotes|ApoE4 genotype||Participants|Count of Participants|80|80.0||||||
3725156|NCT02079909|3563286|B3||Homozygotes|ApoE4 genotype||Participants|Count of Participants|27|27.0||||||
3725157|NCT02079909|3563287|B2||Homozygotes|ApoE4 genotype||Participants|Count of Participants|21|21.0||||||
3725158|NCT02079909|3563288|B1||Homozygotes|ApoE4 genotype||Participants|Count of Participants|32|32.0||||||
3725159|NCT02079909|3563285|B4||Heterozygotes|ApoE4 genotype||Participants|Count of Participants|200|200.0||||||
3725160|NCT02079909|3563286|B3||Heterozygotes|ApoE4 genotype||Participants|Count of Participants|71|71.0||||||
3725161|NCT02079909|3563287|B2||Heterozygotes|ApoE4 genotype||Participants|Count of Participants|74|74.0||||||
3725162|NCT02079909|3563288|B1||Heterozygotes|ApoE4 genotype||Participants|Count of Participants|55|55.0||||||
3725163|NCT02079909|3563285|B4||Non-carriers|ApoE4 genotype||Participants|Count of Participants|161|161.0||||||
3725164|NCT02079909|3563286|B3||Non-carriers|ApoE4 genotype||Participants|Count of Participants|50|50.0||||||
3725165|NCT02079909|3563287|B2||Non-carriers|ApoE4 genotype||Participants|Count of Participants|57|57.0||||||
3725166|NCT02079909|3563288|B1||Non-carriers|ApoE4 genotype||Participants|Count of Participants|54|54.0||||||
3725167|NCT02079909|3563285|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3725168|NCT02079909|3563286|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725169|NCT02079909|3563287|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3725170|NCT02079909|3563288|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3725171|NCT02079909|3563285|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3725172|NCT02079909|3563286|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3725173|NCT02079909|3563287|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3725174|NCT02079909|3563288|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725175|NCT02079909|3563285|B4||White|Race (NIH/OMB)||Participants|Count of Participants|428|428.0||||||
3725176|NCT02079909|3563286|B3||White|Race (NIH/OMB)||Participants|Count of Participants|142|142.0||||||
3725177|NCT02079909|3563287|B2||White|Race (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
3725178|NCT02079909|3563288|B1||White|Race (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
3725179|NCT02079909|3563285|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3725180|NCT02079909|3563286|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3725181|NCT02079909|3563287|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3725182|NCT02079909|3563288|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3725183|NCT02079909|3563285|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3725184|NCT02079909|3563286|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725185|NCT02079909|3563287|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725186|NCT02079909|3563288|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3725187|NCT02079909|3563285|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3725188|NCT02079909|3563286|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3725192|NCT02079909|3563286|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725193|NCT02079909|3563287|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3725194|NCT02079909|3563288|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725195|NCT02079909|3563285|B4||Male|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
3725196|NCT02079909|3563286|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3725197|NCT02079909|3563287|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3725198|NCT02079909|3563288|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3725199|NCT02079909|3563285|B4||Female|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
3725200|NCT02079909|3563286|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3725201|NCT02079909|3563287|B2||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3725202|NCT02079909|3563288|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3725203|NCT02079909|3563285|B4|||Age||years|Mean|71.9|71.9|Standard Deviation|7.8|7.8|||
3725204|NCT02079909|3563286|B3|||Age||years|Mean|71.8|71.8|Standard Deviation|7.5|7.5|||
3725205|NCT02079909|3563287|B2|||Age||years|Mean|71.9|71.9|Standard Deviation|8.2|8.2|||
3725206|NCT02079909|3563288|B1|||Age||years|Mean|71.8|71.8|Standard Deviation|7.8|7.8|||
3725207|NCT02079844|3563304|B4|Does not consume caffeine||Caffeine Classification||participants|Number|6|6.0||||||
3725208|NCT02079844|3563305|B3|Does not consume caffeine||Caffeine Classification||participants|Number|2|2.0||||||
3725209|NCT02079844|3563306|B2|Does not consume caffeine||Caffeine Classification||participants|Number|2|2.0||||||
3725210|NCT02079844|3563307|B1|Does not consume caffeine||Caffeine Classification||participants|Number|2|2.0||||||
3725211|NCT02079844|3563304|B4|Consumes caffeine||Caffeine Classification||participants|Number|14|14.0||||||
3725212|NCT02079844|3563305|B3|Consumes caffeine||Caffeine Classification||participants|Number|5|5.0||||||
3725213|NCT02079844|3563306|B2|Consumes caffeine||Caffeine Classification||participants|Number|5|5.0||||||
3725214|NCT02079844|3563307|B1|Consumes caffeine||Caffeine Classification||participants|Number|4|4.0||||||
3725215|NCT02079844|3563304|B4|Ex-tobacco user||Tobacco Classification||participants|Number|6|6.0||||||
3725216|NCT02079844|3563305|B3|Ex-tobacco user||Tobacco Classification||participants|Number|1|1.0||||||
3725217|NCT02079844|3563306|B2|Ex-tobacco user||Tobacco Classification||participants|Number|2|2.0||||||
3725218|NCT02079844|3563307|B1|Ex-tobacco user||Tobacco Classification||participants|Number|3|3.0||||||
3725219|NCT02079844|3563304|B4|Current tobacco user||Tobacco Classification||participants|Number|9|9.0||||||
3725220|NCT02079844|3563305|B3|Current tobacco user||Tobacco Classification||participants|Number|3|3.0||||||
3725221|NCT02079844|3563306|B2|Current tobacco user||Tobacco Classification||participants|Number|4|4.0||||||
3725222|NCT02079844|3563307|B1|Current tobacco user||Tobacco Classification||participants|Number|2|2.0||||||
3725223|NCT02079844|3563304|B4|Never used tobacco||Tobacco Classification||participants|Number|5|5.0||||||
3725224|NCT02079844|3563305|B3|Never used tobacco||Tobacco Classification||participants|Number|3|3.0||||||
3725225|NCT02079844|3563306|B2|Never used tobacco||Tobacco Classification||participants|Number|1|1.0||||||
3725226|NCT02079844|3563307|B1|Never used tobacco||Tobacco Classification||participants|Number|1|1.0||||||
3725227|NCT02079844|3563304|B4|||Body Mass Index (BMI)||kg/m^2|Mean|27.84|27.84|Standard Deviation|3.433|3.433|||
3725228|NCT02079844|3563305|B3|||Body Mass Index (BMI)||kg/m^2|Mean|28.20|28.2|Standard Deviation|3.158|3.158|||
3725229|NCT02079844|3563306|B2|||Body Mass Index (BMI)||kg/m^2|Mean|27.56|27.56|Standard Deviation|3.823|3.823|||
3725230|NCT02079844|3563307|B1|||Body Mass Index (BMI)||kg/m^2|Mean|27.75|27.75|Standard Deviation|3.871|3.871|||
3725231|NCT02079844|3563304|B4|||Weight||kg|Mean|82.09|82.09|Standard Deviation|13.532|13.532|||
3725232|NCT02079844|3563305|B3|||Weight||kg|Mean|81.41|81.41|Standard Deviation|15.470|15.47|||
3725233|NCT02079844|3563306|B2|||Weight||kg|Mean|85.09|85.09|Standard Deviation|17.406|17.406|||
3725234|NCT02079844|3563307|B1|||Weight||kg|Mean|79.38|79.38|Standard Deviation|4.804|4.804|||
3725235|NCT02079844|3563304|B4|||Height||cm|Mean|171.4|171.4|Standard Deviation|9.14|9.14|||
3725236|NCT02079844|3563305|B3|||Height||cm|Mean|169.1|169.1|Standard Deviation|10.96|10.96|||
3725237|NCT02079844|3563306|B2|||Height||cm|Mean|175.0|175.0|Standard Deviation|7.64|7.64|||
3725238|NCT02079844|3563307|B1|||Height||cm|Mean|169.8|169.8|Standard Deviation|8.68|8.68|||
3725239|NCT02079844|3563304|B4|United Kingdom||Region of Enrollment||participants|Number|20|20.0||||||
3725240|NCT02079844|3563305|B3|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
3725241|NCT02079844|3563306|B2|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
3725242|NCT02079844|3563307|B1|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3725243|NCT02079844|3563304|B4|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3725244|NCT02079844|3563305|B3|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3725245|NCT02079844|3563306|B2|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3725246|NCT02079844|3563307|B1|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3725247|NCT02079844|3563304|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3725248|NCT02079844|3563305|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3725249|NCT02079844|3563306|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3725250|NCT02079844|3563307|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3725251|NCT02079844|3563304|B4|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3725252|NCT02079844|3563305|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3725253|NCT02079844|3563306|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3725254|NCT02079844|3563307|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3725255|NCT02079844|3563304|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3725256|NCT02079844|3563305|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3725257|NCT02079844|3563306|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3725258|NCT02079844|3563307|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3725259|NCT02079844|3563304|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3725260|NCT02079844|3563305|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3725261|NCT02079844|3563306|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3725262|NCT02079844|3563307|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3725263|NCT02079844|3563304|B4|||Age||years|Mean|40.2|40.2|Standard Deviation|11.63|11.63|||
3725264|NCT02079844|3563305|B3|||Age||years|Mean|48.1|48.1|Standard Deviation|10.93|10.93|||
3725265|NCT02079844|3563306|B2|||Age||years|Mean|36.9|36.9|Standard Deviation|10.38|10.38|||
3725266|NCT02079844|3563307|B1|||Age||years|Mean|34.8|34.8|Standard Deviation|10.13|10.13|||
3725267|NCT02079805|3563365|B3|||Glycosylated Hemoglobin (HbA1c)|Glycosylated Hemoglobin (HbA1c) were caluculated by the concentration of glucose bound to hemoglobin as a percent of the absolute maximum that can be bound.|percent|Mean|6.72|6.72|Standard Deviation|0.454|0.454|||
3725268|NCT02079805|3563366|B2|||Glycosylated Hemoglobin (HbA1c)|Glycosylated Hemoglobin (HbA1c) were caluculated by the concentration of glucose bound to hemoglobin as a percent of the absolute maximum that can be bound.|percent|Mean|6.81|6.81|Standard Deviation|0.488|0.488|||
3725269|NCT02079805|3563367|B1|||Glycosylated Hemoglobin (HbA1c)|Glycosylated Hemoglobin (HbA1c) were caluculated by the concentration of glucose bound to hemoglobin as a percent of the absolute maximum that can be bound.|percent|Mean|6.63|6.63|Standard Deviation|0.411|0.411|||
3725270|NCT02079805|3563365|B3|||Blood Pressure Diastolic Mean||mmHg|Mean|89.0|89.0|Standard Deviation|8.87|8.87|||
3725271|NCT02079805|3563366|B2|||Blood Pressure Diastolic Mean||mmHg|Mean|88.8|88.8|Standard Deviation|7.19|7.19|||
3725272|NCT02079805|3563367|B1|||Blood Pressure Diastolic Mean||mmHg|Mean|89.3|89.3|Standard Deviation|10.61|10.61|||
3725273|NCT02079805|3563365|B3|||Blood Pressure Systolic Mean||mmHg|Mean|144.4|144.4|Standard Deviation|9.51|9.51|||
3725274|NCT02079805|3563366|B2|||Blood Pressure Systolic Mean||mmHg|Mean|143.3|143.3|Standard Deviation|9.28|9.28|||
3725275|NCT02079805|3563367|B1|||Blood Pressure Systolic Mean||mmHg|Mean|145.6|145.6|Standard Deviation|9.91|9.91|||
3725276|NCT02079805|3563365|B3|||Insulin Resistance Index (HOMA-R)|Insulin Resistance Index (HOMA-R) measures insulin resistance, calculated by fasting insulin (μU/mL) multiplied by fasting glucose (mg/dL), and divided by a constant (405). A higher score indicates higher insulin resistance.|HOMA-R Score|Mean|3.79|3.79|Standard Deviation|1.671|1.671|||
3725277|NCT02079805|3563366|B2|||Insulin Resistance Index (HOMA-R)|Insulin Resistance Index (HOMA-R) measures insulin resistance, calculated by fasting insulin (μU/mL) multiplied by fasting glucose (mg/dL), and divided by a constant (405). A higher score indicates higher insulin resistance.|HOMA-R Score|Mean|4.24|4.24|Standard Deviation|1.843|1.843|||
3725278|NCT02079805|3563367|B1|||Insulin Resistance Index (HOMA-R)|Insulin Resistance Index (HOMA-R) measures insulin resistance, calculated by fasting insulin (μU/mL) multiplied by fasting glucose (mg/dL), and divided by a constant (405). A higher score indicates higher insulin resistance.|HOMA-R Score|Mean|3.31|3.31|Standard Deviation|1.366|1.366|||
3725279|NCT02079805|3563365|B3|Not had taken||Taking Biguanides|Participants who had taken biguanides when study started were reported.|participants|Number|26|26.0||||||
3725280|NCT02079805|3563366|B2|Not had taken||Taking Biguanides|Participants who had taken biguanides when study started were reported.|participants|Number|13|13.0||||||
3725281|NCT02079805|3563367|B1|Not had taken||Taking Biguanides|Participants who had taken biguanides when study started were reported.|participants|Number|13|13.0||||||
3725282|NCT02079805|3563365|B3|Had taken||Taking Biguanides|Participants who had taken biguanides when study started were reported.|participants|Number|7|7.0||||||
3725283|NCT02079805|3563366|B2|Had taken||Taking Biguanides|Participants who had taken biguanides when study started were reported.|participants|Number|4|4.0||||||
3725284|NCT02079805|3563367|B1|Had taken||Taking Biguanides|Participants who had taken biguanides when study started were reported.|participants|Number|3|3.0||||||
3725285|NCT02079805|3563365|B3|||Duration of Diabetes Mellitus||Years|Mean|4.72|4.72|Standard Deviation|4.617|4.617|||
3725286|NCT02079805|3563366|B2|||Duration of Diabetes Mellitus||Years|Mean|4.89|4.89|Standard Deviation|5.039|5.039|||
3725287|NCT02079805|3563367|B1|||Duration of Diabetes Mellitus||Years|Mean|4.53|4.53|Standard Deviation|4.279|4.279|||
3725288|NCT02079805|3563365|B3|||Duration of Hypertention||Years|Mean|4.11|4.11|Standard Deviation|4.363|4.363|||
3725289|NCT02079805|3563366|B2|||Duration of Hypertention||Years|Mean|3.54|3.54|Standard Deviation|4.392|4.392|||
3725290|NCT02079805|3563367|B1|||Duration of Hypertention||Years|Mean|4.71|4.71|Standard Deviation|4.391|4.391|||
3725291|NCT02079805|3563365|B3|No||Alcohol Classification|"Participants who answered Yes or No for a question Drik Alcohol Almost Everyday? were reported."|participants|Number|22|22.0||||||
3725292|NCT02079805|3563366|B2|No||Alcohol Classification|"Participants who answered Yes or No for a question Drik Alcohol Almost Everyday? were reported."|participants|Number|12|12.0||||||
3725293|NCT02079805|3563367|B1|No||Alcohol Classification|"Participants who answered Yes or No for a question Drik Alcohol Almost Everyday? were reported."|participants|Number|10|10.0||||||
3725294|NCT02079805|3563365|B3|Yes||Alcohol Classification|"Participants who answered Yes or No for a question Drik Alcohol Almost Everyday? were reported."|participants|Number|11|11.0||||||
3725295|NCT02079805|3563366|B2|Yes||Alcohol Classification|"Participants who answered Yes or No for a question Drik Alcohol Almost Everyday? were reported."|participants|Number|5|5.0||||||
3725296|NCT02079805|3563367|B1|Yes||Alcohol Classification|"Participants who answered Yes or No for a question Drik Alcohol Almost Everyday? were reported."|participants|Number|6|6.0||||||
3725297|NCT02079805|3563365|B3|Ex-smoker||Smoking Classification||participants|Number|12|12.0||||||
3725298|NCT02079805|3563366|B2|Ex-smoker||Smoking Classification||participants|Number|6|6.0||||||
3725299|NCT02079805|3563367|B1|Ex-smoker||Smoking Classification||participants|Number|6|6.0||||||
3725300|NCT02079805|3563365|B3|Current smoker||Smoking Classification||participants|Number|5|5.0||||||
3725301|NCT02079805|3563366|B2|Current smoker||Smoking Classification||participants|Number|3|3.0||||||
3725302|NCT02079805|3563367|B1|Current smoker||Smoking Classification||participants|Number|2|2.0||||||
3725303|NCT02079805|3563365|B3|Never smoked||Smoking Classification||participants|Number|16|16.0||||||
3725304|NCT02079805|3563366|B2|Never smoked||Smoking Classification||participants|Number|8|8.0||||||
3725305|NCT02079805|3563367|B1|Never smoked||Smoking Classification||participants|Number|8|8.0||||||
3725306|NCT02079805|3563365|B3|||BMI|Body Mass Index = weight (kg)/[height (m)^2]|kg/m^2|Mean|27.19|27.19|Standard Deviation|4.154|4.154|||
3725307|NCT02079805|3563366|B2|||BMI|Body Mass Index = weight (kg)/[height (m)^2]|kg/m^2|Mean|27.19|27.19|Standard Deviation|4.642|4.642|||
3725308|NCT02079805|3563367|B1|||BMI|Body Mass Index = weight (kg)/[height (m)^2]|kg/m^2|Mean|27.18|27.18|Standard Deviation|3.720|3.72|||
3725309|NCT02079805|3563365|B3|||Weight||kg|Mean|70.67|70.67|Standard Deviation|15.534|15.534|||
3725310|NCT02079805|3563366|B2|||Weight||kg|Mean|70.41|70.41|Standard Deviation|14.878|14.878|||
3725311|NCT02079805|3563367|B1|||Weight||kg|Mean|70.95|70.95|Standard Deviation|16.689|16.689|||
3725312|NCT02079805|3563365|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3725313|NCT02079805|3563366|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3725314|NCT02079805|3563367|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3725315|NCT02079805|3563365|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3725316|NCT02079805|3563366|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3725317|NCT02079805|3563367|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3725318|NCT02079805|3563365|B3|||Age||Years|Mean|64.2|64.2|Standard Deviation|11.02|11.02|||
3725319|NCT02079805|3563366|B2|||Age||Years|Mean|63.2|63.2|Standard Deviation|12.76|12.76|||
3725320|NCT02079805|3563367|B1|||Age||Years|Mean|65.3|65.3|Standard Deviation|9.10|9.1|||
3725321|NCT02079649|3563386|B5||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3725322|NCT02079649|3563387|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3725323|NCT02079649|3563388|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3725324|NCT02079649|3563389|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3725325|NCT02079649|3563390|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3725326|NCT02079649|3563386|B5||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3725327|NCT02079649|3563387|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3725328|NCT02079649|3563388|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3725329|NCT02079649|3563389|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3725330|NCT02079649|3563390|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3725331|NCT02079649|3563386|B5|||Age||years|Mean|44.0|44.0|Standard Deviation|13.2|13.2|||
3725332|NCT02079649|3563387|B4|||Age||years|Mean|46.0|46.0|Standard Deviation|12.6|12.6|||
3725333|NCT02079649|3563388|B3|||Age||years|Mean|40.9|40.9|Standard Deviation|13.1|13.1|||
3725334|NCT02079649|3563389|B2|||Age||years|Mean|46.4|46.4|Standard Deviation|13.3|13.3|||
3725335|NCT02079649|3563390|B1|||Age||years|Mean|42.8|42.8|Standard Deviation|13.4|13.4|||
3725336|NCT02079610|3563408|B3|||Montgomery-Asberg Depression Scale|"The overall score ranges on MADRS are from from 0 to 60, with higher scores indicating more severe depression. Usual cutoff points are:~0 to 6 – normal /symptom absent 7 to 19 – mild depression 20 to 34 – moderate depression >34 – severe depression"|units on a scale|Mean|23.61|23.61|Standard Deviation|8.32|8.32|||
3725337|NCT02079610|3563409|B2|||Montgomery-Asberg Depression Scale|"The overall score ranges on MADRS are from from 0 to 60, with higher scores indicating more severe depression. Usual cutoff points are:~0 to 6 – normal /symptom absent 7 to 19 – mild depression 20 to 34 – moderate depression >34 – severe depression"|units on a scale|Mean|23.8|23.8|Standard Deviation|6.71|6.71|||
3725338|NCT02079610|3563410|B1|||Montgomery-Asberg Depression Scale|"The overall score ranges on MADRS are from from 0 to 60, with higher scores indicating more severe depression. Usual cutoff points are:~0 to 6 – normal /symptom absent 7 to 19 – mild depression 20 to 34 – moderate depression >34 – severe depression"|units on a scale|Mean|23.5|23.5|Standard Deviation|9.93|9.93|||
3725339|NCT02079610|3563408|B3|United States||Region of Enrollment||Count of participants|Number|36|36.0||||||
3725340|NCT02079610|3563409|B2|United States||Region of Enrollment||Count of participants|Number|17|17.0||||||
3725341|NCT02079610|3563410|B1|United States||Region of Enrollment||Count of participants|Number|19|19.0||||||
3725342|NCT02079610|3563408|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3725343|NCT02079610|3563409|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725344|NCT02079610|3563410|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3725345|NCT02079610|3563408|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725346|NCT02079610|3563409|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725347|NCT02079610|3563410|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725348|NCT02079610|3563408|B3||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3725349|NCT02079610|3563409|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3725350|NCT02079610|3563410|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3725351|NCT02079610|3563408|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3725352|NCT02079610|3563409|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725353|NCT02079610|3563410|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3725354|NCT02079610|3563408|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3725355|NCT02079610|3563409|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3725356|NCT02079610|3563410|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725357|NCT02079610|3563408|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3725358|NCT02079610|3563409|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3725359|NCT02079610|3563410|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3725360|NCT02079610|3563408|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725361|NCT02079610|3563409|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725362|NCT02079610|3563410|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725363|NCT02079610|3563408|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725364|NCT02079610|3563409|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725365|NCT02079610|3563410|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725366|NCT02079610|3563408|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3725367|NCT02079610|3563409|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3725368|NCT02079610|3563410|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3725369|NCT02079610|3563408|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3725370|NCT02079610|3563409|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725371|NCT02079610|3563410|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3725372|NCT02079610|3563408|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3725373|NCT02079610|3563409|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3725374|NCT02079610|3563410|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3725375|NCT02079610|3563408|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3725376|NCT02079610|3563409|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3725377|NCT02079610|3563410|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3725378|NCT02079610|3563408|B3|||Age||years|Mean|31.6|31.6|Standard Deviation|10.4|10.4|||
3725379|NCT02079610|3563409|B2|||Age||years|Mean|31|31.0|Standard Deviation|13|13.0|||
3725380|NCT02079610|3563410|B1|||Age||years|Mean|32|32.0|Standard Deviation|12|12.0|||
3725381|NCT02079532|3563421|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3725382|NCT02079532|3563421|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|301|301.0||||||
3725383|NCT02079532|3563421|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3725384|NCT02079532|3563421|B1||Female|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
3725385|NCT02079532|3563421|B1|||Age||years|Mean|54.4|54.4|Standard Deviation|18.77|18.77|||
3725386|NCT02079519|3563443|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3725387|NCT02079519|3563443|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3725388|NCT02079519|3563443|B1|||Age||years|Mean|68.6|68.6|Standard Deviation|9.9|9.9|||
3725389|NCT02079311|3563447|B3|United Kingdom||Region of Enrollment|2 subject were enrolled but not randomised.|participants|Number|10|10.0||||||
3725390|NCT02079311|3563448|B2|United Kingdom||Region of Enrollment|2 subject were enrolled but not randomised.|participants|Number|6|6.0||||||
3725391|NCT02079311|3563449|B1|United Kingdom||Region of Enrollment|2 subject were enrolled but not randomised.|participants|Number|4|4.0||||||
3725392|NCT02079311|3563447|B3|Norway||Region of Enrollment|2 subject were enrolled but not randomised.|participants|Number|14|14.0||||||
3725393|NCT02079311|3563448|B2|Norway||Region of Enrollment|2 subject were enrolled but not randomised.|participants|Number|7|7.0||||||
3725394|NCT02079311|3563449|B1|Norway||Region of Enrollment|2 subject were enrolled but not randomised.|participants|Number|7|7.0||||||
3725395|NCT02079311|3563447|B3|Germany||Region of Enrollment|2 subject were enrolled but not randomised.|participants|Number|29|29.0||||||
3725396|NCT02079311|3563448|B2|Germany||Region of Enrollment|2 subject were enrolled but not randomised.|participants|Number|14|14.0||||||
3725397|NCT02079311|3563449|B1|Germany||Region of Enrollment|2 subject were enrolled but not randomised.|participants|Number|15|15.0||||||
3725398|NCT02079311|3563447|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3725399|NCT02079311|3563448|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3725400|NCT02079311|3563449|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3725401|NCT02079311|3563447|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3725402|NCT02079311|3563448|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3725403|NCT02079311|3563449|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3725404|NCT02079311|3563447|B3|||Age||years|Median|49.5|49.5|Standard Deviation|13.82|13.82|||
3725405|NCT02079311|3563448|B2|||Age||years|Median|50|50.0|Standard Deviation|14.44|14.44|||
3725406|NCT02079311|3563449|B1|||Age||years|Median|49|49.0|Standard Deviation|13.2|13.2|||
3725407|NCT02079311|3563447|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3725408|NCT02079311|3563448|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3725409|NCT02079311|3563449|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3725410|NCT02079311|3563447|B3||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
3725411|NCT02079311|3563448|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3725412|NCT02079311|3563449|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3725413|NCT02079311|3563447|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3725414|NCT02079311|3563448|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3725415|NCT02079311|3563449|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3725416|NCT02079246|3563456|B1|Estonia||Region of Enrollment||participants|Number|44|44.0||||||
3725417|NCT02079246|3563456|B1|Germany||Region of Enrollment||participants|Number|52|52.0||||||
3725418|NCT02079246|3563456|B1|Israel||Region of Enrollment||participants|Number|5|5.0||||||
3725419|NCT02079246|3563456|B1|South Africa||Region of Enrollment||participants|Number|39|39.0||||||
3725420|NCT02079246|3563456|B1|Italy||Region of Enrollment||participants|Number|82|82.0||||||
3725421|NCT02079246|3563456|B1|Denmark||Region of Enrollment||participants|Number|11|11.0||||||
3725422|NCT02079246|3563456|B1|Taiwan||Region of Enrollment||participants|Number|15|15.0||||||
3725423|NCT02079246|3563456|B1|Finland||Region of Enrollment||participants|Number|13|13.0||||||
3725424|NCT02079246|3563456|B1|Belgium||Region of Enrollment||participants|Number|13|13.0||||||
3725425|NCT02079246|3563456|B1|Canada||Region of Enrollment||participants|Number|51|51.0||||||
3725426|NCT02079246|3563456|B1|Spain||Region of Enrollment||participants|Number|50|50.0||||||
3725427|NCT02079246|3563456|B1|United Kingdom||Region of Enrollment||participants|Number|66|66.0||||||
3725428|NCT02079246|3563456|B1|Ukraine||Region of Enrollment||participants|Number|47|47.0||||||
3725429|NCT02079246|3563456|B1|Hungary||Region of Enrollment||participants|Number|10|10.0||||||
3725430|NCT02079246|3563456|B1|Romania||Region of Enrollment||participants|Number|6|6.0||||||
3725431|NCT02079246|3563456|B1|Argentina||Region of Enrollment||participants|Number|119|119.0||||||
3725432|NCT02079246|3563456|B1|Croatia||Region of Enrollment||participants|Number|11|11.0||||||
3725433|NCT02079246|3563456|B1|Lithuania||Region of Enrollment||participants|Number|34|34.0||||||
3725434|NCT02079246|3563456|B1|France||Region of Enrollment||participants|Number|71|71.0||||||
3725435|NCT02079246|3563456|B1|Chile||Region of Enrollment||participants|Number|79|79.0||||||
3725436|NCT02079246|3563456|B1|Bulgaria||Region of Enrollment||participants|Number|52|52.0||||||
3725437|NCT02079246|3563456|B1|Poland||Region of Enrollment||participants|Number|139|139.0||||||
3725438|NCT02079246|3563456|B1|Brazil||Region of Enrollment||participants|Number|30|30.0||||||
3725439|NCT02079246|3563456|B1|South Korea||Region of Enrollment||participants|Number|40|40.0||||||
3725440|NCT02079246|3563456|B1|Portugal||Region of Enrollment||participants|Number|12|12.0||||||
3725441|NCT02079246|3563456|B1|United States||Region of Enrollment||participants|Number|236|236.0||||||
3725442|NCT02079246|3563456|B1|Czechia||Region of Enrollment||participants|Number|135|135.0||||||
3725443|NCT02079246|3563456|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3725444|NCT02079246|3563456|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Information has not been collected
3725445|NCT02079246|3563456|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1318|1318.0||||||
3725446|NCT02079246|3563456|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3725447|NCT02079246|3563456|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3725448|NCT02079246|3563456|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3725449|NCT02079246|3563456|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Information has not been collected
3725450|NCT02079246|3563456|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1224|1224.0||||||
3725451|NCT02079246|3563456|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|209|209.0||||||
3725452|NCT02079246|3563456|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3725453|NCT02079246|3563456|B1||Male|Sex: Female, Male||Participants|Count of Participants|540|540.0||||||
3725454|NCT02079246|3563456|B1||Female|Sex: Female, Male||Participants|Count of Participants|922|922.0||||||
3725455|NCT02079246|3563456|B1|||Age||years|Mean|73.7|73.7|Standard Deviation|8.2|8.2|||
3725456|NCT02078713|3563474|B5||Missing|Parity||Participants|Count of Participants|11|11.0||||||
3725457|NCT02078713|3563475|B4||Missing|Parity||Participants|Count of Participants|0|0.0||||||
3725458|NCT02078713|3563476|B3||Missing|Parity||Participants|Count of Participants|0|0.0||||||
3725459|NCT02078713|3563477|B2||Missing|Parity||Participants|Count of Participants|5|5.0||||||
3725460|NCT02078713|3563478|B1||Missing|Parity||Participants|Count of Participants|6|6.0||||||
3725461|NCT02078713|3563474|B5||Parous|Parity||Participants|Count of Participants|237|237.0||||||
3725462|NCT02078713|3563475|B4||Parous|Parity||Participants|Count of Participants|0|0.0||||||
3725463|NCT02078713|3563476|B3||Parous|Parity||Participants|Count of Participants|0|0.0||||||
3725464|NCT02078713|3563477|B2||Parous|Parity||Participants|Count of Participants|104|104.0||||||
3725465|NCT02078713|3563478|B1||Parous|Parity||Participants|Count of Participants|133|133.0||||||
3725466|NCT02078713|3563474|B5||Nulliparous|Parity||Participants|Count of Participants|501|501.0||||||
3725467|NCT02078713|3563475|B4||Nulliparous|Parity||Participants|Count of Participants|0|0.0||||||
3725468|NCT02078713|3563476|B3||Nulliparous|Parity||Participants|Count of Participants|0|0.0||||||
3725469|NCT02078713|3563477|B2||Nulliparous|Parity||Participants|Count of Participants|236|236.0||||||
3725470|NCT02078713|3563478|B1||Nulliparous|Parity||Participants|Count of Participants|265|265.0||||||
3725471|NCT02078713|3563474|B5||Missing|% Federal Poverty Line||Participants|Count of Participants|124|124.0||||||
3725472|NCT02078713|3563475|B4||Missing|% Federal Poverty Line||Participants|Count of Participants|0|0.0||||||
3725473|NCT02078713|3563476|B3||Missing|% Federal Poverty Line||Participants|Count of Participants|0|0.0||||||
3725474|NCT02078713|3563477|B2||Missing|% Federal Poverty Line||Participants|Count of Participants|60|60.0||||||
3725475|NCT02078713|3563478|B1||Missing|% Federal Poverty Line||Participants|Count of Participants|64|64.0||||||
3725476|NCT02078713|3563474|B5||>200%|% Federal Poverty Line||Participants|Count of Participants|141|141.0||||||
3725477|NCT02078713|3563475|B4||>200%|% Federal Poverty Line||Participants|Count of Participants|0|0.0||||||
3725478|NCT02078713|3563476|B3||>200%|% Federal Poverty Line||Participants|Count of Participants|0|0.0||||||
3725479|NCT02078713|3563477|B2||>200%|% Federal Poverty Line||Participants|Count of Participants|65|65.0||||||
3725480|NCT02078713|3563478|B1||>200%|% Federal Poverty Line||Participants|Count of Participants|76|76.0||||||
3725481|NCT02078713|3563474|B5||101-200%|% Federal Poverty Line||Participants|Count of Participants|160|160.0||||||
3725482|NCT02078713|3563475|B4||101-200%|% Federal Poverty Line||Participants|Count of Participants|0|0.0||||||
3725483|NCT02078713|3563476|B3||101-200%|% Federal Poverty Line||Participants|Count of Participants|0|0.0||||||
3725484|NCT02078713|3563477|B2||101-200%|% Federal Poverty Line||Participants|Count of Participants|79|79.0||||||
3725485|NCT02078713|3563478|B1||101-200%|% Federal Poverty Line||Participants|Count of Participants|81|81.0||||||
3725486|NCT02078713|3563474|B5||<100%|% Federal Poverty Line||Participants|Count of Participants|324|324.0||||||
3725487|NCT02078713|3563475|B4||<100%|% Federal Poverty Line||Participants|Count of Participants|0|0.0||||||
3725488|NCT02078713|3563476|B3||<100%|% Federal Poverty Line||Participants|Count of Participants|0|0.0||||||
3725489|NCT02078713|3563477|B2||<100%|% Federal Poverty Line||Participants|Count of Participants|141|141.0||||||
3725490|NCT02078713|3563478|B1||<100%|% Federal Poverty Line||Participants|Count of Participants|183|183.0||||||
3725491|NCT02078713|3563474|B5||Missing|Parental education||Participants|Count of Participants|10|10.0||||||
3725492|NCT02078713|3563475|B4||Missing|Parental education||Participants|Count of Participants|0|0.0||||||
3725493|NCT02078713|3563476|B3||Missing|Parental education||Participants|Count of Participants|0|0.0||||||
3725494|NCT02078713|3563477|B2||Missing|Parental education||Participants|Count of Participants|6|6.0||||||
3725495|NCT02078713|3563478|B1||Missing|Parental education||Participants|Count of Participants|4|4.0||||||
3725496|NCT02078713|3563474|B5||4-year college graduate or more|Parental education||Participants|Count of Participants|262|262.0||||||
3725497|NCT02078713|3563475|B4||4-year college graduate or more|Parental education||Participants|Count of Participants|0|0.0||||||
3725498|NCT02078713|3563476|B3||4-year college graduate or more|Parental education||Participants|Count of Participants|0|0.0||||||
3725499|NCT02078713|3563477|B2||4-year college graduate or more|Parental education||Participants|Count of Participants|133|133.0||||||
3725500|NCT02078713|3563478|B1||4-year college graduate or more|Parental education||Participants|Count of Participants|129|129.0||||||
3725501|NCT02078713|3563474|B5||Some college or 2-year degree|Parental education||Participants|Count of Participants|141|141.0||||||
3725502|NCT02078713|3563475|B4||Some college or 2-year degree|Parental education||Participants|Count of Participants|0|0.0||||||
3725503|NCT02078713|3563476|B3||Some college or 2-year degree|Parental education||Participants|Count of Participants|0|0.0||||||
3725504|NCT02078713|3563477|B2||Some college or 2-year degree|Parental education||Participants|Count of Participants|58|58.0||||||
3725505|NCT02078713|3563478|B1||Some college or 2-year degree|Parental education||Participants|Count of Participants|83|83.0||||||
3725506|NCT02078713|3563474|B5||High school graduate or GED|Parental education||Participants|Count of Participants|150|150.0||||||
3725507|NCT02078713|3563475|B4||High school graduate or GED|Parental education||Participants|Count of Participants|0|0.0||||||
3725508|NCT02078713|3563476|B3||High school graduate or GED|Parental education||Participants|Count of Participants|0|0.0||||||
3725509|NCT02078713|3563477|B2||High school graduate or GED|Parental education||Participants|Count of Participants|69|69.0||||||
3725510|NCT02078713|3563478|B1||High school graduate or GED|Parental education||Participants|Count of Participants|81|81.0||||||
3725511|NCT02078713|3563474|B5||Some high school, but did not graduate|Parental education||Participants|Count of Participants|67|67.0||||||
3725512|NCT02078713|3563475|B4||Some high school, but did not graduate|Parental education||Participants|Count of Participants|0|0.0||||||
3725513|NCT02078713|3563476|B3||Some high school, but did not graduate|Parental education||Participants|Count of Participants|0|0.0||||||
3725514|NCT02078713|3563477|B2||Some high school, but did not graduate|Parental education||Participants|Count of Participants|29|29.0||||||
3725515|NCT02078713|3563478|B1||Some high school, but did not graduate|Parental education||Participants|Count of Participants|38|38.0||||||
3725516|NCT02078713|3563474|B5||8th grade or less|Parental education||Participants|Count of Participants|119|119.0||||||
3725517|NCT02078713|3563475|B4||8th grade or less|Parental education||Participants|Count of Participants|0|0.0||||||
3725518|NCT02078713|3563476|B3||8th grade or less|Parental education||Participants|Count of Participants|0|0.0||||||
3725519|NCT02078713|3563477|B2||8th grade or less|Parental education||Participants|Count of Participants|50|50.0||||||
3725520|NCT02078713|3563478|B1||8th grade or less|Parental education||Participants|Count of Participants|69|69.0||||||
3725521|NCT02078713|3563474|B5||Spanish|Language spoken during study participation||Participants|Count of Participants|137|137.0||||||
3725522|NCT02078713|3563475|B4||Spanish|Language spoken during study participation||Participants|Count of Participants|0|0.0||||||
3725523|NCT02078713|3563476|B3||Spanish|Language spoken during study participation||Participants|Count of Participants|0|0.0||||||
3725524|NCT02078713|3563477|B2||Spanish|Language spoken during study participation||Participants|Count of Participants|62|62.0||||||
3725525|NCT02078713|3563478|B1||Spanish|Language spoken during study participation||Participants|Count of Participants|75|75.0||||||
3725526|NCT02078713|3563474|B5||English|Language spoken during study participation||Participants|Count of Participants|640|640.0||||||
3725527|NCT02078713|3563475|B4||English|Language spoken during study participation||Participants|Count of Participants|13|13.0||||||
3725528|NCT02078713|3563476|B3||English|Language spoken during study participation||Participants|Count of Participants|15|15.0||||||
3725529|NCT02078713|3563477|B2||English|Language spoken during study participation||Participants|Count of Participants|283|283.0||||||
3725530|NCT02078713|3563478|B1||English|Language spoken during study participation||Participants|Count of Participants|329|329.0||||||
3725531|NCT02078713|3563474|B5|Race/ethnicity|Missing|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3725532|NCT02078713|3563475|B4|Race/ethnicity|Missing|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3725533|NCT02078713|3563476|B3|Race/ethnicity|Missing|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3725534|NCT02078713|3563477|B2|Race/ethnicity|Missing|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3725535|NCT02078713|3563478|B1|Race/ethnicity|Missing|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3725536|NCT02078713|3563474|B5|Race/ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|84|84.0||||||
3725537|NCT02078713|3563475|B4|Race/ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3725538|NCT02078713|3563476|B3|Race/ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3725539|NCT02078713|3563477|B2|Race/ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3725540|NCT02078713|3563478|B1|Race/ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
3725541|NCT02078713|3563474|B5|Race/ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|188|188.0||||||
3725542|NCT02078713|3563475|B4|Race/ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3725543|NCT02078713|3563476|B3|Race/ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3725544|NCT02078713|3563477|B2|Race/ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|85|85.0||||||
3725545|NCT02078713|3563478|B1|Race/ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|86|86.0||||||
3725546|NCT02078713|3563474|B5|Race/ethnicity|Hispanic/Latina|Race/Ethnicity, Customized||Participants|Count of Participants|296|296.0||||||
3725547|NCT02078713|3563475|B4|Race/ethnicity|Hispanic/Latina|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3725548|NCT02078713|3563476|B3|Race/ethnicity|Hispanic/Latina|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3725549|NCT02078713|3563477|B2|Race/ethnicity|Hispanic/Latina|Race/Ethnicity, Customized||Participants|Count of Participants|128|128.0||||||
3725550|NCT02078713|3563478|B1|Race/ethnicity|Hispanic/Latina|Race/Ethnicity, Customized||Participants|Count of Participants|160|160.0||||||
3725551|NCT02078713|3563474|B5|Race/ethnicity|Asian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|123|123.0||||||
3725552|NCT02078713|3563475|B4|Race/ethnicity|Asian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3725553|NCT02078713|3563476|B3|Race/ethnicity|Asian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3725554|NCT02078713|3563477|B2|Race/ethnicity|Asian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|62|62.0||||||
3725555|NCT02078713|3563478|B1|Race/ethnicity|Asian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|59|59.0||||||
3725556|NCT02078713|3563474|B5|Race/ethnicity|African American/Black|Race/Ethnicity, Customized||Participants|Count of Participants|80|80.0||||||
3725557|NCT02078713|3563475|B4|Race/ethnicity|African American/Black|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3725558|NCT02078713|3563476|B3|Race/ethnicity|African American/Black|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3725559|NCT02078713|3563477|B2|Race/ethnicity|African American/Black|Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3725560|NCT02078713|3563478|B1|Race/ethnicity|African American/Black|Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
3725561|NCT02078713|3563474|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3725562|NCT02078713|3563475|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3725563|NCT02078713|3563476|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3725564|NCT02078713|3563477|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3725565|NCT02078713|3563478|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3725566|NCT02078713|3563474|B5||Female|Sex: Female, Male||Participants|Count of Participants|776|776.0||||||
3725567|NCT02078713|3563475|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3725568|NCT02078713|3563476|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3725569|NCT02078713|3563477|B2||Female|Sex: Female, Male||Participants|Count of Participants|345|345.0||||||
3725570|NCT02078713|3563478|B1||Female|Sex: Female, Male||Participants|Count of Participants|404|404.0||||||
3725571|NCT02078713|3563474|B5|Age category|Missing|Age, Customized||Participants|Count of Participants|7|7.0||||||
3725572|NCT02078713|3563475|B4|Age category|Missing|Age, Customized||Participants|Count of Participants|0|0.0||||||
3725573|NCT02078713|3563476|B3|Age category|Missing|Age, Customized||Participants|Count of Participants|0|0.0||||||
3725574|NCT02078713|3563477|B2|Age category|Missing|Age, Customized||Participants|Count of Participants|5|5.0||||||
3725575|NCT02078713|3563478|B1|Age category|Missing|Age, Customized||Participants|Count of Participants|2|2.0||||||
3725576|NCT02078713|3563474|B5|Age category|Over 45|Age, Customized||Participants|Count of Participants|8|8.0||||||
3725577|NCT02078713|3563475|B4|Age category|Over 45|Age, Customized||Participants|Count of Participants|4|4.0||||||
3725578|NCT02078713|3563476|B3|Age category|Over 45|Age, Customized||Participants|Count of Participants|4|4.0||||||
3725579|NCT02078713|3563477|B2|Age category|Over 45|Age, Customized||Participants|Count of Participants|0|0.0||||||
3725580|NCT02078713|3563478|B1|Age category|Over 45|Age, Customized||Participants|Count of Participants|0|0.0||||||
3725581|NCT02078713|3563474|B5|Age category|40-45|Age, Customized||Participants|Count of Participants|28|28.0||||||
3725582|NCT02078713|3563475|B4|Age category|40-45|Age, Customized||Participants|Count of Participants|1|1.0||||||
3725583|NCT02078713|3563476|B3|Age category|40-45|Age, Customized||Participants|Count of Participants|4|4.0||||||
3725584|NCT02078713|3563477|B2|Age category|40-45|Age, Customized||Participants|Count of Participants|10|10.0||||||
3725585|NCT02078713|3563478|B1|Age category|40-45|Age, Customized||Participants|Count of Participants|13|13.0||||||
3725586|NCT02078713|3563474|B5|Age category|35-39|Age, Customized||Participants|Count of Participants|58|58.0||||||
3725587|NCT02078713|3563475|B4|Age category|35-39|Age, Customized||Participants|Count of Participants|1|1.0||||||
3725588|NCT02078713|3563476|B3|Age category|35-39|Age, Customized||Participants|Count of Participants|2|2.0||||||
3725589|NCT02078713|3563477|B2|Age category|35-39|Age, Customized||Participants|Count of Participants|22|22.0||||||
3725590|NCT02078713|3563478|B1|Age category|35-39|Age, Customized||Participants|Count of Participants|33|33.0||||||
3725591|NCT02078713|3563474|B5|Age category|30-34|Age, Customized||Participants|Count of Participants|125|125.0||||||
3725592|NCT02078713|3563475|B4|Age category|30-34|Age, Customized||Participants|Count of Participants|3|3.0||||||
3725593|NCT02078713|3563476|B3|Age category|30-34|Age, Customized||Participants|Count of Participants|1|1.0||||||
3725594|NCT02078713|3563477|B2|Age category|30-34|Age, Customized||Participants|Count of Participants|53|53.0||||||
3725595|NCT02078713|3563478|B1|Age category|30-34|Age, Customized||Participants|Count of Participants|68|68.0||||||
3725596|NCT02078713|3563474|B5|Age category|25-29|Age, Customized||Participants|Count of Participants|206|206.0||||||
3725597|NCT02078713|3563475|B4|Age category|25-29|Age, Customized||Participants|Count of Participants|3|3.0||||||
3725598|NCT02078713|3563476|B3|Age category|25-29|Age, Customized||Participants|Count of Participants|2|2.0||||||
3725599|NCT02078713|3563477|B2|Age category|25-29|Age, Customized||Participants|Count of Participants|91|91.0||||||
3725600|NCT02078713|3563478|B1|Age category|25-29|Age, Customized||Participants|Count of Participants|110|110.0||||||
3725601|NCT02078713|3563474|B5|Age category|20-24|Age, Customized||Participants|Count of Participants|250|250.0||||||
3725602|NCT02078713|3563475|B4|Age category|20-24|Age, Customized||Participants|Count of Participants|1|1.0||||||
3725603|NCT02078713|3563476|B3|Age category|20-24|Age, Customized||Participants|Count of Participants|2|2.0||||||
3725604|NCT02078713|3563477|B2|Age category|20-24|Age, Customized||Participants|Count of Participants|121|121.0||||||
3725605|NCT02078713|3563478|B1|Age category|20-24|Age, Customized||Participants|Count of Participants|126|126.0||||||
3725606|NCT02078713|3563474|B5|Age category|15-19|Age, Customized||Participants|Count of Participants|95|95.0||||||
3725607|NCT02078713|3563475|B4|Age category|15-19|Age, Customized||Participants|Count of Participants|0|0.0||||||
3725608|NCT02078713|3563476|B3|Age category|15-19|Age, Customized||Participants|Count of Participants|0|0.0||||||
3725609|NCT02078713|3563477|B2|Age category|15-19|Age, Customized||Participants|Count of Participants|43|43.0||||||
3725610|NCT02078713|3563478|B1|Age category|15-19|Age, Customized||Participants|Count of Participants|52|52.0||||||
3725611|NCT02078557|3563533|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3725612|NCT02078557|3563533|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3725613|NCT02078557|3563533|B1|||Age||Years|Mean|60|60.0|Standard Deviation|5.6|5.6|||
3725614|NCT02078492|3563539|B4|United States||Region of Enrollment||participants|Number|240|240.0||||||
3725615|NCT02078492|3563540|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
3725616|NCT02078492|3563541|B2|United States||Region of Enrollment||participants|Number|80|80.0||||||
3725617|NCT02078492|3563542|B1|United States||Region of Enrollment||participants|Number|80|80.0||||||
3725618|NCT02078492|3563539|B4||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3725619|NCT02078492|3563540|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3725620|NCT02078492|3563541|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3725621|NCT02078492|3563542|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3725622|NCT02078492|3563539|B4||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3725623|NCT02078492|3563540|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3725624|NCT02078492|3563541|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3725625|NCT02078492|3563542|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3725626|NCT02078492|3563539|B4|||Age||years|Mean|40.2|40.2|Standard Deviation|11.9|11.9|||
3725627|NCT02078492|3563540|B3|||Age||years|Mean|38.8|38.8|Standard Deviation|11.6|11.6|||
3725628|NCT02078492|3563541|B2|||Age||years|Mean|40.1|40.1|Standard Deviation|12.1|12.1|||
3725629|NCT02078492|3563542|B1|||Age||years|Mean|41.5|41.5|Standard Deviation|12.1|12.1|||
3725630|NCT02078193|3563561|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3725631|NCT02078193|3563561|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725632|NCT02078193|3563561|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725633|NCT02078193|3563561|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3725634|NCT02078193|3563561|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3725635|NCT02078193|3563561|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725636|NCT02078193|3563561|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725637|NCT02078193|3563561|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725638|NCT02078193|3563561|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3725639|NCT02078193|3563561|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3725640|NCT02078193|3563561|B1|||Age||years|Mean|58.3|58.3|Standard Deviation|5.51|5.51|||
3725641|NCT02078180|3563567|B1|United States||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3725642|NCT02078180|3563567|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3725643|NCT02078180|3563567|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725644|NCT02078180|3563567|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3725645|NCT02078180|3563567|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3725646|NCT02078180|3563567|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725647|NCT02078180|3563567|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3725648|NCT02078180|3563567|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725649|NCT02078180|3563567|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3725650|NCT02078180|3563567|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3725651|NCT02078180|3563567|B1|>65 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3725652|NCT02078180|3563567|B1|25-65 years||Age, Customized||Participants|Count of Participants|34|34.0||||||
3725653|NCT02078180|3563567|B1|<25 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3725654|NCT02077374|3563582|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
3725655|NCT02077374|3563583|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3725656|NCT02077374|3563584|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3725657|NCT02077374|3563582|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3725658|NCT02077374|3563583|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3725659|NCT02077374|3563584|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3725660|NCT02077374|3563582|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3725661|NCT02077374|3563583|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3725662|NCT02077374|3563584|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3725663|NCT02077374|3563582|B3|||Age||years|Median|52|52.0|Full Range|||23.0|76.0|
3725664|NCT02077374|3563583|B2|||Age||years|Median|55|55.0|Full Range|||34.0|70.0|
3725665|NCT02077374|3563584|B1|||Age||years|Median|46|46.0|Full Range|||23.0|76.0|
3725666|NCT02077374|3563582|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3725667|NCT02077374|3563583|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3725668|NCT02077374|3563584|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3725669|NCT02077374|3563582|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3725670|NCT02077374|3563583|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3725671|NCT02077374|3563584|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3725672|NCT02077374|3563582|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3725673|NCT02077374|3563583|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3725674|NCT02077374|3563584|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3725675|NCT02077140|3563601|B6|||BMI||kg/m^2|Mean|27.6|27.6|Standard Deviation|4.45|4.45|||
3725676|NCT02077140|3563602|B5|||BMI||kg/m^2|Mean|28.0|28.0|Standard Deviation|4.55|4.55|||
3725677|NCT02077140|3563603|B4|||BMI||kg/m^2|Mean|27.6|27.6|Standard Deviation|4.44|4.44|||
3725678|NCT02077140|3563604|B3|||BMI||kg/m^2|Mean|27.4|27.4|Standard Deviation|4.07|4.07|||
3725679|NCT02077140|3563605|B2|||BMI||kg/m^2|Mean|27.3|27.3|Standard Deviation|4.51|4.51|||
3725680|NCT02077140|3563606|B1|||BMI||kg/m^2|Mean|27.3|27.3|Standard Deviation|4.82|4.82|||
3725681|NCT02077140|3563601|B6|||Height||cm|Mean|163.5|163.5|Standard Deviation|8.61|8.61|||
3725682|NCT02077140|3563602|B5|||Height||cm|Mean|165.2|165.2|Standard Deviation|8.67|8.67|||
3725683|NCT02077140|3563603|B4|||Height||cm|Mean|162.8|162.8|Standard Deviation|9.86|9.86|||
3725684|NCT02077140|3563604|B3|||Height||cm|Mean|163.8|163.8|Standard Deviation|8.92|8.92|||
3725685|NCT02077140|3563605|B2|||Height||cm|Mean|162.5|162.5|Standard Deviation|7.38|7.38|||
3725686|NCT02077140|3563606|B1|||Height||cm|Mean|162.8|162.8|Standard Deviation|8.12|8.12|||
3725687|NCT02077140|3563601|B6|||Weight||lbs|Mean|73.71|73.71|Standard Deviation|14.02|14.02|||
3725688|NCT02077140|3563602|B5|||Weight||lbs|Mean|76.12|76.12|Standard Deviation|14.24|14.24|||
3725689|NCT02077140|3563603|B4|||Weight||lbs|Mean|72.99|72.99|Standard Deviation|13.30|13.3|||
3725690|NCT02077140|3563604|B3|||Weight||lbs|Mean|73.94|73.94|Standard Deviation|14.51|14.51|||
3725691|NCT02077140|3563605|B2|||Weight||lbs|Mean|71.97|71.97|Standard Deviation|12.79|12.79|||
3725692|NCT02077140|3563606|B1|||Weight||lbs|Mean|72.71|72.71|Standard Deviation|15.41|15.41|||
3725693|NCT02077140|3563601|B6|Data missing||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3725694|NCT02077140|3563602|B5|Data missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3725695|NCT02077140|3563603|B4|Data missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3725696|NCT02077140|3563604|B3|Data missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3725697|NCT02077140|3563605|B2|Data missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3725698|NCT02077140|3563606|B1|Data missing||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3725699|NCT02077140|3563601|B6|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3725700|NCT02077140|3563602|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3725701|NCT02077140|3563603|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3725702|NCT02077140|3563604|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3725703|NCT02077140|3563605|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3725704|NCT02077140|3563606|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3725705|NCT02077140|3563601|B6|White||Race/Ethnicity, Customized||Participants|Count of Participants|159|159.0||||||
3725706|NCT02077140|3563602|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
3725707|NCT02077140|3563603|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3725708|NCT02077140|3563604|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3725709|NCT02077140|3563605|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3725710|NCT02077140|3563606|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3725711|NCT02077140|3563601|B6|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3725712|NCT02077140|3563602|B5|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3725713|NCT02077140|3563603|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3725714|NCT02077140|3563604|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3725715|NCT02077140|3563605|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3725716|NCT02077140|3563606|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3725717|NCT02077140|3563601|B6|Black or African-American||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3725718|NCT02077140|3563602|B5|Black or African-American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3725719|NCT02077140|3563603|B4|Black or African-American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3725720|NCT02077140|3563604|B3|Black or African-American||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3725721|NCT02077140|3563605|B2|Black or African-American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3725722|NCT02077140|3563606|B1|Black or African-American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3725723|NCT02077140|3563601|B6|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3725724|NCT02077140|3563602|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3725725|NCT02077140|3563603|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3725726|NCT02077140|3563604|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3725727|NCT02077140|3563605|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3725728|NCT02077140|3563606|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3725729|NCT02077140|3563601|B6|American-Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3725730|NCT02077140|3563602|B5|American-Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3725731|NCT02077140|3563603|B4|American-Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3725732|NCT02077140|3563604|B3|American-Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3725733|NCT02077140|3563605|B2|American-Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3725734|NCT02077140|3563606|B1|American-Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3725735|NCT02077140|3563601|B6||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3725736|NCT02077140|3563602|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3725737|NCT02077140|3563603|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3725738|NCT02077140|3563604|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3725739|NCT02077140|3563605|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3725740|NCT02077140|3563606|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3725741|NCT02077140|3563601|B6||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3725742|NCT02077140|3563602|B5||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3725743|NCT02077140|3563603|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3725744|NCT02077140|3563604|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3725745|NCT02077140|3563605|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3725746|NCT02077140|3563606|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3725747|NCT02077140|3563601|B6|||Age||years|Mean|41.8|41.8|Standard Deviation|12.71|12.71|||
3725748|NCT02077140|3563602|B5|||Age||years|Mean|40.7|40.7|Standard Deviation|11.78|11.78|||
3725749|NCT02077140|3563603|B4|||Age||years|Mean|41.1|41.1|Standard Deviation|13.49|13.49|||
3725750|NCT02077140|3563604|B3|||Age||years|Mean|40.4|40.4|Standard Deviation|12.37|12.37|||
3725751|NCT02077140|3563605|B2|||Age||years|Mean|39.7|39.7|Standard Deviation|11.90|11.9|||
3725752|NCT02077140|3563606|B1|||Age||years|Mean|47.6|47.6|Standard Deviation|13.22|13.22|||
3725753|NCT02076919|3563697|B13||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3725754|NCT02076919|3563698|B12||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3725755|NCT02076919|3563699|B11||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3725756|NCT02076919|3563700|B10||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3725757|NCT02076919|3563701|B9||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3725758|NCT02076919|3563702|B8||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3725759|NCT02076919|3563703|B7||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3725760|NCT02076919|3563704|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3725761|NCT02076919|3563705|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3725762|NCT02076919|3563706|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3725763|NCT02076919|3563707|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3725764|NCT02076919|3563708|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3725765|NCT02076919|3563709|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3725766|NCT02076919|3563697|B13||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3725767|NCT02076919|3563698|B12||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3725768|NCT02076919|3563699|B11||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3725769|NCT02076919|3563700|B10||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3725770|NCT02076919|3563701|B9||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3725771|NCT02076919|3563702|B8||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3725772|NCT02076919|3563703|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3725773|NCT02076919|3563704|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3725774|NCT02076919|3563705|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3725775|NCT02076919|3563706|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3725776|NCT02076919|3563707|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3725777|NCT02076919|3563708|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3725778|NCT02076919|3563709|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3725779|NCT02076919|3563697|B13|≥ 65 years||Age, Customized||participants|Number|66|66.0||||||
3725780|NCT02076919|3563698|B12|≥ 65 years||Age, Customized||participants|Number|12|12.0||||||
3725781|NCT02076919|3563699|B11|≥ 65 years||Age, Customized||participants|Number|6|6.0||||||
3725782|NCT02076919|3563700|B10|≥ 65 years||Age, Customized||participants|Number|5|5.0||||||
3725783|NCT02076919|3563701|B9|≥ 65 years||Age, Customized||participants|Number|6|6.0||||||
3725784|NCT02076919|3563702|B8|≥ 65 years||Age, Customized||participants|Number|6|6.0||||||
3725785|NCT02076919|3563703|B7|≥ 65 years||Age, Customized||participants|Number|6|6.0||||||
3725786|NCT02076919|3563704|B6|≥ 65 years||Age, Customized||participants|Number|6|6.0||||||
3725787|NCT02076919|3563705|B5|≥ 65 years||Age, Customized||participants|Number|6|6.0||||||
3725788|NCT02076919|3563706|B4|≥ 65 years||Age, Customized||participants|Number|4|4.0||||||
3725789|NCT02076919|3563707|B3|≥ 65 years||Age, Customized||participants|Number|2|2.0||||||
3725790|NCT02076919|3563708|B2|≥ 65 years||Age, Customized||participants|Number|3|3.0||||||
3725791|NCT02076919|3563709|B1|≥ 65 years||Age, Customized||participants|Number|4|4.0||||||
3725792|NCT02076919|3563697|B13|55-64 years||Age, Customized||participants|Number|14|14.0||||||
3725793|NCT02076919|3563698|B12|55-64 years||Age, Customized||participants|Number|0|0.0||||||
3725794|NCT02076919|3563699|B11|55-64 years||Age, Customized||participants|Number|0|0.0||||||
3725795|NCT02076919|3563700|B10|55-64 years||Age, Customized||participants|Number|1|1.0||||||
3725796|NCT02076919|3563701|B9|55-64 years||Age, Customized||participants|Number|0|0.0||||||
3725797|NCT02076919|3563702|B8|55-64 years||Age, Customized||participants|Number|0|0.0||||||
3725798|NCT02076919|3563703|B7|55-64 years||Age, Customized||participants|Number|0|0.0||||||
3725799|NCT02076919|3563704|B6|55-64 years||Age, Customized||participants|Number|0|0.0||||||
3725800|NCT02076919|3563705|B5|55-64 years||Age, Customized||participants|Number|2|2.0||||||
3725801|NCT02076919|3563706|B4|55-64 years||Age, Customized||participants|Number|2|2.0||||||
3725802|NCT02076919|3563707|B3|55-64 years||Age, Customized||participants|Number|4|4.0||||||
3725803|NCT02076919|3563708|B2|55-64 years||Age, Customized||participants|Number|3|3.0||||||
3725804|NCT02076919|3563709|B1|55-64 years||Age, Customized||participants|Number|2|2.0||||||
3725805|NCT02076776|3563810|B4|||Stroke Impact Scale|Quality of life questionnaire. Normalized Hand Function score is reported. Scores range from 0-100, with higher values indicating better self-reported quality of life.|units on a scale|Mean|38.50|38.5|Standard Deviation|31.29|31.29|||
3725806|NCT02076776|3563811|B3|||Stroke Impact Scale|Quality of life questionnaire. Normalized Hand Function score is reported. Scores range from 0-100, with higher values indicating better self-reported quality of life.|units on a scale|Mean|50.83|50.83|Standard Deviation|32.00|32.0|||
3725807|NCT02076776|3563812|B2|||Stroke Impact Scale|Quality of life questionnaire. Normalized Hand Function score is reported. Scores range from 0-100, with higher values indicating better self-reported quality of life.|units on a scale|Mean|34.38|34.38|Standard Deviation|28.72|28.72|||
3725854|NCT02076776|3563811|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3725808|NCT02076776|3563813|B1|||Stroke Impact Scale|Quality of life questionnaire. Normalized Hand Function score is reported. Scores range from 0-100, with higher values indicating better self-reported quality of life.|units on a scale|Mean|31.67|31.67|Standard Deviation|35.73|35.73|||
3725809|NCT02076776|3563810|B4|||Fugl-Meyer Assessment|Upper extremity motor test. Total score is reported. Scores range from 0-66 and higher scores indicate less impairment.|units on a scale|Mean|32.80|32.8|Standard Deviation|10.72|10.72|||
3725810|NCT02076776|3563811|B3|||Fugl-Meyer Assessment|Upper extremity motor test. Total score is reported. Scores range from 0-66 and higher scores indicate less impairment.|units on a scale|Mean|36.17|36.17|Standard Deviation|7.41|7.41|||
3725811|NCT02076776|3563812|B2|||Fugl-Meyer Assessment|Upper extremity motor test. Total score is reported. Scores range from 0-66 and higher scores indicate less impairment.|units on a scale|Mean|34.75|34.75|Standard Deviation|13.58|13.58|||
3725812|NCT02076776|3563813|B1|||Fugl-Meyer Assessment|Upper extremity motor test. Total score is reported. Scores range from 0-66 and higher scores indicate less impairment.|units on a scale|Mean|26.83|26.83|Standard Deviation|7.83|7.83|||
3725813|NCT02076776|3563810|B4|||Wolf Motor Function Test|Upper extremity function test. Total Functional Ability Score is reported. Scores range from 0-75 and higher scores indicate better function.|units on a scale|Mean|51.40|51.4|Standard Deviation|16.97|16.97|||
3725814|NCT02076776|3563811|B3|||Wolf Motor Function Test|Upper extremity function test. Total Functional Ability Score is reported. Scores range from 0-75 and higher scores indicate better function.|units on a scale|Mean|59.83|59.83|Standard Deviation|9.06|9.06|||
3725815|NCT02076776|3563812|B2|||Wolf Motor Function Test|Upper extremity function test. Total Functional Ability Score is reported. Scores range from 0-75 and higher scores indicate better function.|units on a scale|Mean|49.75|49.75|Standard Deviation|20.25|20.25|||
3725816|NCT02076776|3563813|B1|||Wolf Motor Function Test|Upper extremity function test. Total Functional Ability Score is reported. Scores range from 0-75 and higher scores indicate better function.|units on a scale|Mean|45.17|45.17|Standard Deviation|17.38|17.38|||
3725817|NCT02076776|3563810|B4|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3725818|NCT02076776|3563811|B3|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3725819|NCT02076776|3563812|B2|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3725820|NCT02076776|3563813|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3725821|NCT02076776|3563810|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725822|NCT02076776|3563811|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725823|NCT02076776|3563812|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725824|NCT02076776|3563813|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725825|NCT02076776|3563810|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725826|NCT02076776|3563811|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725827|NCT02076776|3563812|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725828|NCT02076776|3563813|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725829|NCT02076776|3563810|B4||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3725830|NCT02076776|3563811|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3725831|NCT02076776|3563812|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3725832|NCT02076776|3563813|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3725833|NCT02076776|3563810|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3725834|NCT02076776|3563811|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3725835|NCT02076776|3563812|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3725836|NCT02076776|3563813|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3725837|NCT02076776|3563810|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725838|NCT02076776|3563811|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725839|NCT02076776|3563812|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725840|NCT02076776|3563813|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725841|NCT02076776|3563810|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3725842|NCT02076776|3563811|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3725843|NCT02076776|3563812|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725844|NCT02076776|3563813|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725845|NCT02076776|3563810|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725846|NCT02076776|3563811|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725847|NCT02076776|3563812|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725848|NCT02076776|3563813|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725849|NCT02076776|3563810|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725850|NCT02076776|3563811|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725851|NCT02076776|3563812|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725852|NCT02076776|3563813|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725853|NCT02076776|3563810|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3725917|NCT02076334|3563831|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3725855|NCT02076776|3563812|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3725856|NCT02076776|3563813|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3725857|NCT02076776|3563810|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725858|NCT02076776|3563811|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725859|NCT02076776|3563812|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725860|NCT02076776|3563813|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3725861|NCT02076776|3563810|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3725862|NCT02076776|3563811|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3725863|NCT02076776|3563812|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3725864|NCT02076776|3563813|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3725865|NCT02076776|3563810|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3725866|NCT02076776|3563811|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3725867|NCT02076776|3563812|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3725868|NCT02076776|3563813|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3725869|NCT02076776|3563810|B4|||Age||years|Mean|55.70|55.7|Standard Deviation|13.94|13.94|||
3725870|NCT02076776|3563811|B3|||Age||years|Mean|44.83|44.83|Standard Deviation|11.72|11.72|||
3725871|NCT02076776|3563812|B2|||Age||years|Mean|59.38|59.38|Standard Deviation|15.57|15.57|||
3725872|NCT02076776|3563813|B1|||Age||years|Mean|61.67|61.67|Standard Deviation|7.45|7.45|||
3725873|NCT02076776|3563810|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3725874|NCT02076776|3563811|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3725875|NCT02076776|3563812|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3725876|NCT02076776|3563813|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3725877|NCT02076776|3563810|B4||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3725878|NCT02076776|3563811|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3725879|NCT02076776|3563812|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3725880|NCT02076776|3563813|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3725881|NCT02076776|3563810|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3725882|NCT02076776|3563811|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3725883|NCT02076776|3563812|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3725884|NCT02076776|3563813|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3725885|NCT02076334|3563829|B5|United States||Region of Enrollment||participants|Number|80|80.0||||||
3725886|NCT02076334|3563830|B4|United States||Region of Enrollment||participants|Number|20|20.0||||||
3725887|NCT02076334|3563831|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3725888|NCT02076334|3563832|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3725889|NCT02076334|3563833|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3725890|NCT02076334|3563829|B5||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3725891|NCT02076334|3563830|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3725892|NCT02076334|3563831|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3725893|NCT02076334|3563832|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3725894|NCT02076334|3563833|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3725895|NCT02076334|3563829|B5||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3725896|NCT02076334|3563830|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3725897|NCT02076334|3563831|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3725898|NCT02076334|3563832|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3725899|NCT02076334|3563833|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3725900|NCT02076334|3563829|B5|||Age||years|Mean|21|21.0|Standard Deviation|2.6|2.6|||
3725901|NCT02076334|3563830|B4|||Age||years|Mean|21.0|21.0|Standard Deviation|2.5|2.5|||
3725902|NCT02076334|3563831|B3|||Age||years|Mean|22.1|22.1|Standard Deviation|3.2|3.2|||
3725903|NCT02076334|3563832|B2|||Age||years|Mean|20.9|20.9|Standard Deviation|2.0|2.0|||
3725904|NCT02076334|3563833|B1|||Age||years|Mean|20.5|20.5|Standard Deviation|1.4|1.4|||
3725905|NCT02076334|3563829|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3725906|NCT02076334|3563830|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3725907|NCT02076334|3563831|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3725908|NCT02076334|3563832|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3725909|NCT02076334|3563833|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3725910|NCT02076334|3563829|B5||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
3725911|NCT02076334|3563830|B4||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3725912|NCT02076334|3563831|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3725913|NCT02076334|3563832|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3725914|NCT02076334|3563833|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3725915|NCT02076334|3563829|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3725916|NCT02076334|3563830|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3725918|NCT02076334|3563832|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3725919|NCT02076334|3563833|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3725920|NCT02076321|3563850|B3|United States||Region of Enrollment||Participants|Count of Participants|102|102.0||||||
3725921|NCT02076321|3563851|B2|United States||Region of Enrollment||Participants|Count of Participants|51|51.0||||||
3725922|NCT02076321|3563852|B1|United States||Region of Enrollment||Participants|Count of Participants|51|51.0||||||
3725923|NCT02076321|3563850|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3725924|NCT02076321|3563851|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3725925|NCT02076321|3563852|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3725926|NCT02076321|3563850|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3725927|NCT02076321|3563851|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3725928|NCT02076321|3563852|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3725929|NCT02076321|3563850|B3|||Age||years|Mean|7.56|7.56|Full Range|||1.5|16.0|
3725930|NCT02076321|3563851|B2|||Age||years|Mean|7.67|7.67|Full Range|||1.5|16.0|
3725931|NCT02076321|3563852|B1|||Age||years|Mean|7.44|7.44|Full Range|||2.0|16.0|
3725932|NCT02076321|3563850|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3725933|NCT02076321|3563851|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3725934|NCT02076321|3563852|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3725935|NCT02076321|3563850|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3725936|NCT02076321|3563851|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3725937|NCT02076321|3563852|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3725938|NCT02076321|3563850|B3||<=18 years|Age||Participants|Count of Participants|102|102.0||||||
3725939|NCT02076321|3563851|B2||<=18 years|Age||Participants|Count of Participants|51|51.0||||||
3725940|NCT02076321|3563852|B1||<=18 years|Age||Participants|Count of Participants|51|51.0||||||
3725941|NCT02076243|3563859|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3725942|NCT02076243|3563859|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3725943|NCT02076243|3563859|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3725944|NCT02076243|3563859|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3725945|NCT02076243|3563859|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3725946|NCT02076178|3563867|B3|Unknown||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3725947|NCT02076178|3563868|B2|Unknown||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3725948|NCT02076178|3563869|B1|Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3725949|NCT02076178|3563867|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|71|71.0||||||
3725950|NCT02076178|3563868|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|59|59.0||||||
3725951|NCT02076178|3563869|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3725952|NCT02076178|3563867|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3725953|NCT02076178|3563868|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3725954|NCT02076178|3563869|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3725955|NCT02076178|3563867|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3725956|NCT02076178|3563868|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3725957|NCT02076178|3563869|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3725958|NCT02076178|3563867|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3725959|NCT02076178|3563868|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3725960|NCT02076178|3563869|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3725961|NCT02076178|3563867|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3725962|NCT02076178|3563868|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3725963|NCT02076178|3563869|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3725964|NCT02076178|3563867|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3725965|NCT02076178|3563868|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3725966|NCT02076178|3563869|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3725967|NCT02076178|3563867|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3725968|NCT02076178|3563868|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3725969|NCT02076178|3563869|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3725970|NCT02076178|3563867|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
3725971|NCT02076178|3563868|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|33|33.0||||||
3725972|NCT02076178|3563869|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3725973|NCT02076178|3563867|B3||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3725974|NCT02076178|3563868|B2||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3725975|NCT02076178|3563869|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3725976|NCT02076178|3563867|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3725977|NCT02076178|3563868|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3725978|NCT02076178|3563869|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3725979|NCT02076178|3563867|B3|||Age||Years|Mean|34.9|34.9|Standard Deviation|11.68|11.68|||
3725980|NCT02076178|3563868|B2|||Age||Years|Mean|35.1|35.1|Standard Deviation|11.75|11.75|||
3725981|NCT02076178|3563869|B1|||Age||Years|Mean|33.7|33.7|Standard Deviation|11.56|11.56|||
3725982|NCT02076100|3563902|B8||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3725983|NCT02076100|3563903|B7||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3725984|NCT02076100|3563904|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3725985|NCT02076100|3563905|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3725986|NCT02076100|3563906|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3725987|NCT02076100|3563907|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3725988|NCT02076100|3563908|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3725989|NCT02076100|3563909|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3725990|NCT02076100|3563902|B8||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3725991|NCT02076100|3563903|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3725992|NCT02076100|3563904|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3725993|NCT02076100|3563905|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3725994|NCT02076100|3563906|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3725995|NCT02076100|3563907|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3725996|NCT02076100|3563908|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3725997|NCT02076100|3563909|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3725998|NCT02076100|3563902|B8|||Age||Years|Mean|45.0|45.0|Standard Deviation|9.9|9.9|||
3725999|NCT02076100|3563903|B7|||Age||Years|Mean|48.5|48.5|Standard Deviation|6.2|6.2|||
3726000|NCT02076100|3563904|B6|||Age||Years|Mean|54.0|54.0|Standard Deviation|6.2|6.2|||
3726001|NCT02076100|3563905|B5|||Age||Years|Mean|56.3|56.3|Standard Deviation|2.1|2.1|||
3726002|NCT02076100|3563906|B4|||Age||Years|Mean|40.7|40.7|Standard Deviation|13.6|13.6|||
3726003|NCT02076100|3563907|B3|||Age||Years|Mean|38.0|38.0|Standard Deviation|10.4|10.4|||
3726004|NCT02076100|3563908|B2|||Age||Years|Mean|36.0|36.0|Standard Deviation|3.5|3.5|||
3726005|NCT02076100|3563909|B1|||Age||Years|Mean|40.7|40.7|Standard Deviation|6.5|6.5|||
3726006|NCT02076009|3563946|B3|>3||No. of Prior Lines of Therapy||participants|Number|33|33.0||||||
3726007|NCT02076009|3563947|B2|>3||No. of Prior Lines of Therapy||participants|Number|14|14.0||||||
3726008|NCT02076009|3563948|B1|>3||No. of Prior Lines of Therapy||participants|Number|19|19.0||||||
3726009|NCT02076009|3563946|B3|3||No. of Prior Lines of Therapy||participants|Number|76|76.0||||||
3726010|NCT02076009|3563947|B2|3||No. of Prior Lines of Therapy||participants|Number|38|38.0||||||
3726011|NCT02076009|3563948|B1|3||No. of Prior Lines of Therapy||participants|Number|38|38.0||||||
3726012|NCT02076009|3563946|B3|2||No. of Prior Lines of Therapy||participants|Number|165|165.0||||||
3726013|NCT02076009|3563947|B2|2||No. of Prior Lines of Therapy||participants|Number|85|85.0||||||
3726014|NCT02076009|3563948|B1|2||No. of Prior Lines of Therapy||participants|Number|80|80.0||||||
3726015|NCT02076009|3563946|B3|1||No. of Prior Lines of Therapy||participants|Number|295|295.0||||||
3726016|NCT02076009|3563947|B2|1||No. of Prior Lines of Therapy||participants|Number|149|149.0||||||
3726017|NCT02076009|3563948|B1|1||No. of Prior Lines of Therapy||participants|Number|146|146.0||||||
3726018|NCT02076009|3563946|B3|III||Stage of Disease (ISS)|The International Staging System (ISS) consists of following 3 stages - Stage I: serum beta2-microglobulin less than (<)3.5 milligram per liter (mg/l) and albumin greater than or equal to (>=) 3.5 gram per 100 Milliliter (g/100 ml); Stage II: neither stage I nor stage III and Stage III: serum beta2-microglobulin >= 5.5 mg/l.|participants|Number|113|113.0||||||
3726019|NCT02076009|3563947|B2|III||Stage of Disease (ISS)|The International Staging System (ISS) consists of following 3 stages - Stage I: serum beta2-microglobulin less than (<)3.5 milligram per liter (mg/l) and albumin greater than or equal to (>=) 3.5 gram per 100 Milliliter (g/100 ml); Stage II: neither stage I nor stage III and Stage III: serum beta2-microglobulin >= 5.5 mg/l.|participants|Number|56|56.0||||||
3726020|NCT02076009|3563948|B1|III||Stage of Disease (ISS)|The International Staging System (ISS) consists of following 3 stages - Stage I: serum beta2-microglobulin less than (<)3.5 milligram per liter (mg/l) and albumin greater than or equal to (>=) 3.5 gram per 100 Milliliter (g/100 ml); Stage II: neither stage I nor stage III and Stage III: serum beta2-microglobulin >= 5.5 mg/l.|participants|Number|57|57.0||||||
3726021|NCT02076009|3563946|B3|II||Stage of Disease (ISS)|The International Staging System (ISS) consists of following 3 stages - Stage I: serum beta2-microglobulin less than (<)3.5 milligram per liter (mg/l) and albumin greater than or equal to (>=) 3.5 gram per 100 Milliliter (g/100 ml); Stage II: neither stage I nor stage III and Stage III: serum beta2-microglobulin >= 5.5 mg/l.|participants|Number|179|179.0||||||
3726022|NCT02076009|3563947|B2|II||Stage of Disease (ISS)|The International Staging System (ISS) consists of following 3 stages - Stage I: serum beta2-microglobulin less than (<)3.5 milligram per liter (mg/l) and albumin greater than or equal to (>=) 3.5 gram per 100 Milliliter (g/100 ml); Stage II: neither stage I nor stage III and Stage III: serum beta2-microglobulin >= 5.5 mg/l.|participants|Number|93|93.0||||||
3726023|NCT02076009|3563948|B1|II||Stage of Disease (ISS)|The International Staging System (ISS) consists of following 3 stages - Stage I: serum beta2-microglobulin less than (<)3.5 milligram per liter (mg/l) and albumin greater than or equal to (>=) 3.5 gram per 100 Milliliter (g/100 ml); Stage II: neither stage I nor stage III and Stage III: serum beta2-microglobulin >= 5.5 mg/l.|participants|Number|86|86.0||||||
3726024|NCT02076009|3563946|B3|I||Stage of Disease (ISS)|The International Staging System (ISS) consists of following 3 stages - Stage I: serum beta2-microglobulin less than (<)3.5 milligram per liter (mg/l) and albumin greater than or equal to (>=) 3.5 gram per 100 Milliliter (g/100 ml); Stage II: neither stage I nor stage III and Stage III: serum beta2-microglobulin >= 5.5 mg/l.|participants|Number|277|277.0||||||
3726025|NCT02076009|3563947|B2|I||Stage of Disease (ISS)|The International Staging System (ISS) consists of following 3 stages - Stage I: serum beta2-microglobulin less than (<)3.5 milligram per liter (mg/l) and albumin greater than or equal to (>=) 3.5 gram per 100 Milliliter (g/100 ml); Stage II: neither stage I nor stage III and Stage III: serum beta2-microglobulin >= 5.5 mg/l.|participants|Number|137|137.0||||||
3726026|NCT02076009|3563948|B1|I||Stage of Disease (ISS)|The International Staging System (ISS) consists of following 3 stages - Stage I: serum beta2-microglobulin less than (<)3.5 milligram per liter (mg/l) and albumin greater than or equal to (>=) 3.5 gram per 100 Milliliter (g/100 ml); Stage II: neither stage I nor stage III and Stage III: serum beta2-microglobulin >= 5.5 mg/l.|participants|Number|140|140.0||||||
3726027|NCT02076009|3563946|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
3726028|NCT02076009|3563947|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
3726029|NCT02076009|3563948|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3726030|NCT02076009|3563946|B3|United Kingdom||Region of Enrollment||participants|Number|51|51.0||||||
3726031|NCT02076009|3563947|B2|United Kingdom||Region of Enrollment||participants|Number|27|27.0||||||
3726032|NCT02076009|3563948|B1|United Kingdom||Region of Enrollment||participants|Number|24|24.0||||||
3726033|NCT02076009|3563946|B3|Taiwan, Province of China||Region of Enrollment||participants|Number|20|20.0||||||
3726034|NCT02076009|3563947|B2|Taiwan, Province of China||Region of Enrollment||participants|Number|11|11.0||||||
3726035|NCT02076009|3563948|B1|Taiwan, Province of China||Region of Enrollment||participants|Number|9|9.0||||||
3726036|NCT02076009|3563946|B3|Sweden||Region of Enrollment||participants|Number|31|31.0||||||
3726037|NCT02076009|3563947|B2|Sweden||Region of Enrollment||participants|Number|16|16.0||||||
3726038|NCT02076009|3563948|B1|Sweden||Region of Enrollment||participants|Number|15|15.0||||||
3726039|NCT02076009|3563946|B3|Spain||Region of Enrollment||participants|Number|51|51.0||||||
3726040|NCT02076009|3563947|B2|Spain||Region of Enrollment||participants|Number|26|26.0||||||
3726041|NCT02076009|3563948|B1|Spain||Region of Enrollment||participants|Number|25|25.0||||||
3726042|NCT02076009|3563946|B3|Russian Federation||Region of Enrollment||participants|Number|48|48.0||||||
3726043|NCT02076009|3563947|B2|Russian Federation||Region of Enrollment||participants|Number|18|18.0||||||
3726044|NCT02076009|3563948|B1|Russian Federation||Region of Enrollment||participants|Number|30|30.0||||||
3726045|NCT02076009|3563946|B3|Poland||Region of Enrollment||participants|Number|28|28.0||||||
3726046|NCT02076009|3563947|B2|Poland||Region of Enrollment||participants|Number|15|15.0||||||
3726047|NCT02076009|3563948|B1|Poland||Region of Enrollment||participants|Number|13|13.0||||||
3726048|NCT02076009|3563946|B3|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
3726049|NCT02076009|3563947|B2|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
3726050|NCT02076009|3563948|B1|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
3726051|NCT02076009|3563946|B3|Korea, Republic of||Region of Enrollment||participants|Number|40|40.0||||||
3726052|NCT02076009|3563947|B2|Korea, Republic of||Region of Enrollment||participants|Number|20|20.0||||||
3726053|NCT02076009|3563948|B1|Korea, Republic of||Region of Enrollment||participants|Number|20|20.0||||||
3726054|NCT02076009|3563946|B3|Japan||Region of Enrollment||participants|Number|36|36.0||||||
3726055|NCT02076009|3563947|B2|Japan||Region of Enrollment||participants|Number|21|21.0||||||
3726056|NCT02076009|3563948|B1|Japan||Region of Enrollment||participants|Number|15|15.0||||||
3726057|NCT02076009|3563946|B3|Israel||Region of Enrollment||participants|Number|39|39.0||||||
3726058|NCT02076009|3563947|B2|Israel||Region of Enrollment||participants|Number|19|19.0||||||
3726059|NCT02076009|3563948|B1|Israel||Region of Enrollment||participants|Number|20|20.0||||||
3726060|NCT02076009|3563946|B3|Greece||Region of Enrollment||participants|Number|19|19.0||||||
3726061|NCT02076009|3563947|B2|Greece||Region of Enrollment||participants|Number|11|11.0||||||
3726062|NCT02076009|3563948|B1|Greece||Region of Enrollment||participants|Number|8|8.0||||||
3726063|NCT02076009|3563946|B3|Germany||Region of Enrollment||participants|Number|18|18.0||||||
3726064|NCT02076009|3563947|B2|Germany||Region of Enrollment||participants|Number|11|11.0||||||
3726065|NCT02076009|3563948|B1|Germany||Region of Enrollment||participants|Number|7|7.0||||||
3726066|NCT02076009|3563946|B3|France||Region of Enrollment||participants|Number|57|57.0||||||
3726067|NCT02076009|3563947|B2|France||Region of Enrollment||participants|Number|21|21.0||||||
3726068|NCT02076009|3563948|B1|France||Region of Enrollment||participants|Number|36|36.0||||||
3726069|NCT02076009|3563946|B3|Denmark||Region of Enrollment||participants|Number|17|17.0||||||
3726070|NCT02076009|3563947|B2|Denmark||Region of Enrollment||participants|Number|10|10.0||||||
3726071|NCT02076009|3563948|B1|Denmark||Region of Enrollment||participants|Number|7|7.0||||||
3726072|NCT02076009|3563946|B3|Canada||Region of Enrollment||participants|Number|34|34.0||||||
3726073|NCT02076009|3563947|B2|Canada||Region of Enrollment||participants|Number|17|17.0||||||
3726074|NCT02076009|3563948|B1|Canada||Region of Enrollment||participants|Number|17|17.0||||||
3726075|NCT02076009|3563946|B3|Belgium||Region of Enrollment||participants|Number|22|22.0||||||
3726076|NCT02076009|3563947|B2|Belgium||Region of Enrollment||participants|Number|12|12.0||||||
3726077|NCT02076009|3563948|B1|Belgium||Region of Enrollment||participants|Number|10|10.0||||||
3726078|NCT02076009|3563946|B3|Australia||Region of Enrollment||participants|Number|18|18.0||||||
3726079|NCT02076009|3563947|B2|Australia||Region of Enrollment||participants|Number|9|9.0||||||
3726080|NCT02076009|3563948|B1|Australia||Region of Enrollment||participants|Number|9|9.0||||||
3726081|NCT02076009|3563946|B3||Male|Sex: Female, Male||Participants|Count of Participants|337|337.0||||||
3726082|NCT02076009|3563947|B2||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
3726083|NCT02076009|3563948|B1||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3726084|NCT02076009|3563946|B3||Female|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
3726085|NCT02076009|3563947|B2||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3726086|NCT02076009|3563948|B1||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3726087|NCT02076009|3563946|B3|||Age||years|Mean|64.4|64.4|Standard Deviation|8.93|8.93|||
3726088|NCT02076009|3563947|B2|||Age||years|Mean|64.4|64.4|Standard Deviation|9.03|9.03|||
3726089|NCT02076009|3563948|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|8.84|8.84|||
3726090|NCT02075840|3563969|B3|Race - Unknown||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3726091|NCT02075840|3563970|B2|Race - Unknown||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3726092|NCT02075840|3563971|B1|Race - Unknown||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3726093|NCT02075840|3563969|B3|Race - White||Race/Ethnicity, Customized||Participants|Number|151|151.0||||||
3726094|NCT02075840|3563970|B2|Race - White||Race/Ethnicity, Customized||Participants|Number|75|75.0||||||
3726095|NCT02075840|3563971|B1|Race - White||Race/Ethnicity, Customized||Participants|Number|76|76.0||||||
3726096|NCT02075840|3563969|B3|Race - Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3726097|NCT02075840|3563970|B2|Race - Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3726098|NCT02075840|3563971|B1|Race - Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3726099|NCT02075840|3563969|B3|Race - Black or African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3726100|NCT02075840|3563970|B2|Race - Black or African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3726101|NCT02075840|3563971|B1|Race - Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3726102|NCT02075840|3563969|B3|Race - Asian||Race/Ethnicity, Customized||Participants|Number|138|138.0||||||
3726103|NCT02075840|3563970|B2|Race - Asian||Race/Ethnicity, Customized||Participants|Number|69|69.0||||||
3726104|NCT02075840|3563971|B1|Race - Asian||Race/Ethnicity, Customized||Participants|Number|69|69.0||||||
3726105|NCT02075840|3563969|B3|Race - American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3726106|NCT02075840|3563970|B2|Race - American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3726107|NCT02075840|3563971|B1|Race - American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3726108|NCT02075840|3563969|B3|Ethnicity - Not Stated||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
3726109|NCT02075840|3563970|B2|Ethnicity - Not Stated||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3726110|NCT02075840|3563971|B1|Ethnicity - Not Stated||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3726111|NCT02075840|3563969|B3|Ethinicity - Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|274|274.0||||||
3726112|NCT02075840|3563970|B2|Ethinicity - Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|136|136.0||||||
3726113|NCT02075840|3563971|B1|Ethinicity - Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|138|138.0||||||
3726114|NCT02075840|3563969|B3|Ethnicity - Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
3726115|NCT02075840|3563970|B2|Ethnicity - Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3726116|NCT02075840|3563971|B1|Ethnicity - Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3726117|NCT02075840|3563969|B3||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3726118|NCT02075840|3563970|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3726119|NCT02075840|3563971|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3726120|NCT02075840|3563969|B3||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3726121|NCT02075840|3563970|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3726122|NCT02075840|3563971|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3726123|NCT02075840|3563969|B3|||Age||years|Mean|55.1|55.1|Standard Deviation|12.8|12.8|||
3726124|NCT02075840|3563970|B2|||Age||years|Mean|53.8|53.8|Standard Deviation|13.5|13.5|||
3726125|NCT02075840|3563971|B1|||Age||years|Mean|56.3|56.3|Standard Deviation|12.0|12.0|||
3726126|NCT02075658|3564026|B3|Retroperitoneal mass excision||Treatment||Participants|Count of Participants|1|1.0||||||
3726127|NCT02075658|3564027|B2|Retroperitoneal mass excision||Treatment||Participants|Count of Participants|0|0.0||||||
3726128|NCT02075658|3564028|B1|Retroperitoneal mass excision||Treatment||Participants|Count of Participants|1|1.0||||||
3726129|NCT02075658|3564026|B3|Ureteral implantation||Treatment||Participants|Count of Participants|1|1.0||||||
3726130|NCT02075658|3564027|B2|Ureteral implantation||Treatment||Participants|Count of Participants|1|1.0||||||
3726131|NCT02075658|3564028|B1|Ureteral implantation||Treatment||Participants|Count of Participants|0|0.0||||||
3726132|NCT02075658|3564026|B3|Pyeloplasty||Treatment||Participants|Count of Participants|3|3.0||||||
3726133|NCT02075658|3564027|B2|Pyeloplasty||Treatment||Participants|Count of Participants|2|2.0||||||
3726134|NCT02075658|3564028|B1|Pyeloplasty||Treatment||Participants|Count of Participants|1|1.0||||||
3726135|NCT02075658|3564026|B3|Cryoablation||Treatment||Participants|Count of Participants|9|9.0||||||
3726136|NCT02075658|3564027|B2|Cryoablation||Treatment||Participants|Count of Participants|4|4.0||||||
3726137|NCT02075658|3564028|B1|Cryoablation||Treatment||Participants|Count of Participants|5|5.0||||||
3726138|NCT02075658|3564026|B3|Nephroureterectomy||Treatment||Participants|Count of Participants|4|4.0||||||
3726139|NCT02075658|3564027|B2|Nephroureterectomy||Treatment||Participants|Count of Participants|3|3.0||||||
3726140|NCT02075658|3564028|B1|Nephroureterectomy||Treatment||Participants|Count of Participants|1|1.0||||||
3726141|NCT02075658|3564026|B3|Partial Nephrectomy||Treatment||Participants|Count of Participants|20|20.0||||||
3726142|NCT02075658|3564027|B2|Partial Nephrectomy||Treatment||Participants|Count of Participants|9|9.0||||||
3726143|NCT02075658|3564028|B1|Partial Nephrectomy||Treatment||Participants|Count of Participants|11|11.0||||||
3726144|NCT02075658|3564026|B3|Simple Nephrectomy||Treatment||Participants|Count of Participants|1|1.0||||||
3726145|NCT02075658|3564027|B2|Simple Nephrectomy||Treatment||Participants|Count of Participants|0|0.0||||||
3726146|NCT02075658|3564028|B1|Simple Nephrectomy||Treatment||Participants|Count of Participants|1|1.0||||||
3726147|NCT02075658|3564026|B3|Radical Nephrectomy||Treatment||Participants|Count of Participants|17|17.0||||||
3726148|NCT02075658|3564027|B2|Radical Nephrectomy||Treatment||Participants|Count of Participants|9|9.0||||||
3726149|NCT02075658|3564028|B1|Radical Nephrectomy||Treatment||Participants|Count of Participants|8|8.0||||||
3726150|NCT02075658|3564026|B3|||Charlson Comorbidity Index|0 = no comorbidities, minimal chance of mortality 43 = many comorbidities, very high chance of mortality CCI predicts a patients 10 year mortality rate based on comorbidities|units on a scale (0-43)|Mean|3.4|3.4|Standard Deviation|2.1|2.1|||
3726151|NCT02075658|3564027|B2|||Charlson Comorbidity Index|0 = no comorbidities, minimal chance of mortality 43 = many comorbidities, very high chance of mortality CCI predicts a patients 10 year mortality rate based on comorbidities|units on a scale (0-43)|Mean|3.6|3.6|Standard Deviation|2.4|2.4|||
3726152|NCT02075658|3564028|B1|||Charlson Comorbidity Index|0 = no comorbidities, minimal chance of mortality 43 = many comorbidities, very high chance of mortality CCI predicts a patients 10 year mortality rate based on comorbidities|units on a scale (0-43)|Mean|3.2|3.2|Standard Deviation|1.7|1.7|||
3726153|NCT02075658|3564026|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3726154|NCT02075658|3564027|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3726155|NCT02075658|3564028|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3726156|NCT02075658|3564026|B3|Hawaiian/PI||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3726157|NCT02075658|3564027|B2|Hawaiian/PI||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3726158|NCT02075658|3564028|B1|Hawaiian/PI||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3726159|NCT02075658|3564026|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3726160|NCT02075658|3564027|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3726161|NCT02075658|3564028|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3726162|NCT02075658|3564026|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3726163|NCT02075658|3564027|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3726164|NCT02075658|3564028|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3726165|NCT02075658|3564026|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
3726166|NCT02075658|3564027|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3726167|NCT02075658|3564028|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3726168|NCT02075658|3564026|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726169|NCT02075658|3564027|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726170|NCT02075658|3564028|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726171|NCT02075658|3564026|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3726172|NCT02075658|3564027|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3726173|NCT02075658|3564028|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3726174|NCT02075658|3564026|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3726175|NCT02075658|3564027|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3726176|NCT02075658|3564028|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3726177|NCT02075658|3564026|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3726178|NCT02075658|3564027|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3726179|NCT02075658|3564028|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3726180|NCT02075658|3564026|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3726181|NCT02075658|3564027|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3726182|NCT02075658|3564028|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3726183|NCT02075658|3564026|B3|||Age||years|Mean|63.7|63.7|Standard Deviation|28.3|28.3|||
3726184|NCT02075658|3564027|B2|||Age||years|Mean|62.5|62.5|Standard Deviation|15.3|15.3|||
3726185|NCT02075658|3564028|B1|||Age||years|Mean|64.8|64.8|Standard Deviation|13.1|13.1|||
3726186|NCT02075632|3564037|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3726187|NCT02075632|3564038|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3726188|NCT02075632|3564039|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3726189|NCT02075632|3564037|B3||Female|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
3726190|NCT02075632|3564038|B2||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3726191|NCT02075632|3564039|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3726192|NCT02075632|3564037|B3|||Age||Years|Mean|49|49.0|Standard Deviation|15.0|15.0|||
3726193|NCT02075632|3564038|B2|||Age||Years|Mean|50.6|50.6|Standard Deviation|14.10|14.1|||
3726194|NCT02075632|3564039|B1|||Age||Years|Mean|47.5|47.5|Standard Deviation|15.68|15.68|||
3726195|NCT02075541|3564050|B3|White- Caucasian/ European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|145|145.0||||||
3726196|NCT02075541|3564051|B2|White- Caucasian/ European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|72|72.0||||||
3726197|NCT02075541|3564052|B1|White- Caucasian/ European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|73|73.0||||||
3726198|NCT02075541|3564050|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3726199|NCT02075541|3564051|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3726200|NCT02075541|3564052|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3726201|NCT02075541|3564050|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3726202|NCT02075541|3564051|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3726203|NCT02075541|3564052|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3726204|NCT02075541|3564050|B3|||Age||Years|Mean|66.9|66.9|Standard Deviation|7.81|7.81|||
3726205|NCT02075541|3564051|B2|||Age||Years|Mean|66.8|66.8|Standard Deviation|7.21|7.21|||
3726206|NCT02075541|3564052|B1|||Age||Years|Mean|67|67.0|Standard Deviation|8.41|8.41|||
3726207|NCT02075515|3564099|B4||Male|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
3726208|NCT02075515|3564100|B3||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3726209|NCT02075515|3564101|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3726210|NCT02075515|3564102|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3726211|NCT02075515|3564099|B4||Female|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
3726212|NCT02075515|3564100|B3||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3726213|NCT02075515|3564101|B2||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3726214|NCT02075515|3564102|B1||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3726215|NCT02075515|3564099|B4|||Age||Years|Mean|64.5|64.5|Standard Deviation|8.99|8.99|||
3726216|NCT02075515|3564100|B3|||Age||Years|Mean|64.4|64.4|Standard Deviation|8.8|8.8|||
3726217|NCT02075515|3564101|B2|||Age||Years|Mean|64.3|64.3|Standard Deviation|9.4|9.4|||
3726218|NCT02075515|3564102|B1|||Age||Years|Mean|64.8|64.8|Standard Deviation|8.8|8.8|||
3726219|NCT02075463|3564139|B1|WHITE||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
3726220|NCT02075463|3564139|B1|BLACK OR AFRICAN AMERICAN||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3726221|NCT02075463|3564139|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3726222|NCT02075463|3564139|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3726223|NCT02075463|3564139|B1|||Age||Years|Mean|59.1|59.1|Standard Deviation|12.76|12.76|||
3726224|NCT02075411|3564164|B5|United States||Region of Enrollment||participants|Number|1|1.0||||||
3726225|NCT02075411|3564165|B4|United States||Region of Enrollment||participants|Number|1|1.0||||||
3726226|NCT02075411|3564164|B5|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
3726227|NCT02075411|3564165|B4|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
3726228|NCT02075411|3564164|B5|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
3726229|NCT02075411|3564165|B4|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
3726230|NCT02075411|3564164|B5|White||Race (NIH/OMB)||participants|Number|1|1.0||||||
3726231|NCT02075411|3564165|B4|White||Race (NIH/OMB)||participants|Number|1|1.0||||||
3726232|NCT02075411|3564164|B5|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
3726233|NCT02075411|3564165|B4|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
3726234|NCT02075411|3564164|B5|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
3726235|NCT02075411|3564165|B4|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
3726236|NCT02075411|3564164|B5|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
3726237|NCT02075411|3564165|B4|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
3726238|NCT02075411|3564164|B5|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
3726239|NCT02075411|3564165|B4|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
3726240|NCT02075411|3564164|B5|Male||Gender||participants|Number|0|0.0||||||
3726241|NCT02075411|3564165|B4|Male||Gender||participants|Number|0|0.0||||||
3726242|NCT02075411|3564164|B5|Female||Gender||participants|Number|1|1.0||||||
3726243|NCT02075411|3564165|B4|Female||Gender||participants|Number|1|1.0||||||
3726244|NCT02075411|3564164|B5|>=65 years||Age||participants|Number|0|0.0||||||
3726245|NCT02075411|3564165|B4|>=65 years||Age||participants|Number|0|0.0||||||
3726246|NCT02075411|3564164|B5|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
3726247|NCT02075411|3564165|B4|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
3726248|NCT02075411|3564164|B5|<=18 years||Age||participants|Number|1|1.0||||||
3726249|NCT02075411|3564165|B4|<=18 years||Age||participants|Number|1|1.0||||||
3726250|NCT02075320|3564189|B1|United States||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
3726251|NCT02075320|3564189|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726252|NCT02075320|3564189|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726253|NCT02075320|3564189|B1||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3726254|NCT02075320|3564189|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3726255|NCT02075320|3564189|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726256|NCT02075320|3564189|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726257|NCT02075320|3564189|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726258|NCT02075320|3564189|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726259|NCT02075320|3564189|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3726260|NCT02075320|3564189|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3726261|NCT02075320|3564189|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3726262|NCT02075320|3564189|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3726263|NCT02075320|3564189|B1|||Age||years|Mean|64|64.0|Standard Deviation|10|10.0|||
3726264|NCT02075320|3564189|B1||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
3726265|NCT02075320|3564189|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3726266|NCT02075320|3564189|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3726267|NCT02075255|3564196|B4||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3726268|NCT02075255|3564197|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3726269|NCT02075255|3564198|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3726270|NCT02075255|3564199|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3726271|NCT02075255|3564196|B4||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3726272|NCT02075255|3564197|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3726273|NCT02075255|3564198|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3726274|NCT02075255|3564199|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3726275|NCT02075255|3564196|B4|||Age||Years|Mean|51.0|51.0|Standard Deviation|11.3|11.3|||
3726276|NCT02075255|3564197|B3|||Age||Years|Mean|49.9|49.9|Standard Deviation|11.7|11.7|||
3726277|NCT02075255|3564198|B2|||Age||Years|Mean|52.9|52.9|Standard Deviation|10.1|10.1|||
3726278|NCT02075255|3564199|B1|||Age||Years|Mean|50.2|50.2|Standard Deviation|12.0|12.0|||
3726279|NCT02075125|3564308|B3|||Body Mass Index (BMI)||kg/m^2|Mean|24.9|24.9|Standard Deviation|2.4|2.4|||
3726280|NCT02075125|3564309|B2|||Body Mass Index (BMI)||kg/m^2|Mean|24.4|24.4|Standard Deviation|2.4|2.4|||
3726281|NCT02075125|3564310|B1|||Body Mass Index (BMI)||kg/m^2|Mean|25.3|25.3|Standard Deviation|2.7|2.7|||
3726282|NCT02075125|3564308|B3|Korea, Republic of||Region of Enrollment||participants|Number|39|39.0||||||
3726283|NCT02075125|3564309|B2|Korea, Republic of||Region of Enrollment||participants|Number|20|20.0||||||
3726284|NCT02075125|3564310|B1|Korea, Republic of||Region of Enrollment||participants|Number|19|19.0||||||
3726285|NCT02075125|3564308|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3726286|NCT02075125|3564309|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3726287|NCT02075125|3564310|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3726288|NCT02075125|3564308|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3726289|NCT02075125|3564309|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3726290|NCT02075125|3564310|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3726291|NCT02075125|3564308|B3|||Age||years|Mean|55|55.0|Standard Deviation|11|11.0|||
3726292|NCT02075125|3564309|B2|||Age||years|Mean|55|55.0|Standard Deviation|11|11.0|||
3726293|NCT02075125|3564310|B1|||Age||years|Mean|55|55.0|Standard Deviation|10|10.0|||
3726294|NCT02075073|3564329|B4||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3726295|NCT02075073|3564330|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3726296|NCT02075073|3564331|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3726297|NCT02075073|3564332|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3726298|NCT02075073|3564329|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3726299|NCT02075073|3564330|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3726300|NCT02075073|3564331|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3726301|NCT02075073|3564332|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3726302|NCT02075073|3564329|B4|||Age||years|Mean|38.8|38.8|Standard Deviation|10.75|10.75|||
3726303|NCT02075073|3564330|B3|||Age||years|Mean|38.7|38.7|Standard Deviation|11.40|11.4|||
3726304|NCT02075073|3564331|B2|||Age||years|Mean|39.3|39.3|Standard Deviation|10.80|10.8|||
3726305|NCT02075073|3564332|B1|||Age||years|Mean|38.4|38.4|Standard Deviation|10.29|10.29|||
3726306|NCT02075021|3564351|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3726307|NCT02075021|3564351|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3726308|NCT02075021|3564351|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3726309|NCT02075021|3564351|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3726310|NCT02075021|3564351|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3726311|NCT02075021|3564351|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3726312|NCT02075008|3564356|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3726313|NCT02075008|3564356|B1||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3726314|NCT02075008|3564356|B1|||Age||Years|Mean|48.2|48.2|Standard Deviation|13.17|13.17|||
3726315|NCT02074995|3564360|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3726316|NCT02074995|3564360|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3726317|NCT02074995|3564360|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3726318|NCT02074995|3564360|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3726319|NCT02074995|3564360|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3726320|NCT02074982|3564377|B3||Male|Sex: Female, Male||Participants|Count of Participants|481|481.0||||||
3726321|NCT02074982|3564378|B2||Male|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
3726322|NCT02074982|3564379|B1||Male|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
3726323|NCT02074982|3564377|B3||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
3726324|NCT02074982|3564378|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3726325|NCT02074982|3564379|B1||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3726326|NCT02074982|3564377|B3|||Age||years|Mean|44.9|44.9|Standard Deviation|13.81|13.81|||
3726327|NCT02074982|3564378|B2|||Age||years|Mean|44.6|44.6|Standard Deviation|13.67|13.67|||
3726328|NCT02074982|3564379|B1|||Age||years|Mean|45.2|45.2|Standard Deviation|13.95|13.95|||
3726329|NCT02074735|3564407|B3|United States||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
3726330|NCT02074735|3564408|B2|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3726331|NCT02074735|3564409|B1|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3726332|NCT02074735|3564407|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3726333|NCT02074735|3564408|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3726334|NCT02074735|3564409|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3726335|NCT02074735|3564407|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3726336|NCT02074735|3564408|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3726337|NCT02074735|3564409|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3726338|NCT02074735|3564407|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3726339|NCT02074735|3564408|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3726340|NCT02074735|3564409|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3726341|NCT02074735|3564407|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3726342|NCT02074735|3564408|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3726343|NCT02074735|3564409|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3726344|NCT02074735|3564407|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3726345|NCT02074735|3564408|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3726346|NCT02074735|3564409|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3726347|NCT02074735|3564407|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3726348|NCT02074735|3564408|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3726349|NCT02074735|3564409|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3726350|NCT02074735|3564407|B3|||Age||years|Mean|46.87|46.87|Standard Deviation|9.33|9.33|||
3726351|NCT02074735|3564408|B2|||Age||years|Mean|48.70|48.7|Standard Deviation|8.92|8.92|||
3726352|NCT02074735|3564409|B1|||Age||years|Mean|44.79|44.79|Standard Deviation|9.51|9.51|||
3726353|NCT02074709|3564416|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
3726354|NCT02074709|3564417|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
3726355|NCT02074709|3564418|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3726356|NCT02074709|3564416|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3726357|NCT02074709|3564417|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3726358|NCT02074709|3564418|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3726359|NCT02074709|3564416|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3726360|NCT02074709|3564417|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3726361|NCT02074709|3564418|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3726362|NCT02074709|3564416|B3|||Age||years|Mean|44|44.0|Standard Deviation|6.2|6.2|||
3726363|NCT02074709|3564417|B2|||Age||years|Mean|44.4|44.4|Standard Deviation|6.1|6.1|||
3726364|NCT02074709|3564418|B1|||Age||years|Mean|43.6|43.6|Standard Deviation|6.4|6.4|||
3726365|NCT02074553|3564425|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3726366|NCT02074553|3564426|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3726367|NCT02074553|3564427|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3726368|NCT02074553|3564425|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3726369|NCT02074553|3564426|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3726370|NCT02074553|3564427|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3726371|NCT02074553|3564425|B3|||Age||years|Mean|36.9|36.9|Standard Deviation|10.2|10.2|||
3726372|NCT02074553|3564426|B2|||Age||years|Mean|36.1|36.1|Standard Deviation|10.49|10.49|||
3726373|NCT02074553|3564427|B1|||Age||years|Mean|37.6|37.6|Standard Deviation|10.01|10.01|||
3726374|NCT02074514|3564612|B5|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|82|82.0||||||
3726375|NCT02074514|3564613|B4|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|24|24.0||||||
3726376|NCT02074514|3564614|B3|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|19|19.0||||||
3726377|NCT02074514|3564615|B2|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|14|14.0||||||
3726378|NCT02074514|3564616|B1|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|25|25.0||||||
3726379|NCT02074514|3564612|B5|< 800,000 IU/mL||HCV RNA Category||participants|Number|35|35.0||||||
3726380|NCT02074514|3564613|B4|< 800,000 IU/mL||HCV RNA Category||participants|Number|6|6.0||||||
3726381|NCT02074514|3564614|B3|< 800,000 IU/mL||HCV RNA Category||participants|Number|10|10.0||||||
3726382|NCT02074514|3564615|B2|< 800,000 IU/mL||HCV RNA Category||participants|Number|14|14.0||||||
3726383|NCT02074514|3564616|B1|< 800,000 IU/mL||HCV RNA Category||participants|Number|5|5.0||||||
3726384|NCT02074514|3564612|B5|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|9|9.0||||||
3726385|NCT02074514|3564613|B4|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3726386|NCT02074514|3564614|B3|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3726387|NCT02074514|3564615|B2|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|5|5.0||||||
3726388|NCT02074514|3564616|B1|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
3726389|NCT02074514|3564612|B5|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|39|39.0||||||
3726390|NCT02074514|3564613|B4|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|7|7.0||||||
3726391|NCT02074514|3564614|B3|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|11|11.0||||||
3726392|NCT02074514|3564615|B2|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|8|8.0||||||
3726393|NCT02074514|3564616|B1|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|13|13.0||||||
3726394|NCT02074514|3564612|B5|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|69|69.0||||||
3726395|NCT02074514|3564613|B4|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|23|23.0||||||
3726396|NCT02074514|3564614|B3|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|17|17.0||||||
3726397|NCT02074514|3564615|B2|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|15|15.0||||||
3726398|NCT02074514|3564616|B1|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|14|14.0||||||
3726399|NCT02074514|3564612|B5|||HCV RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.67|0.67|||
3726400|NCT02074514|3564613|B4|||HCV RNA||log10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.70|0.7|||
3726401|NCT02074514|3564614|B3|||HCV RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.68|0.68|||
3726402|NCT02074514|3564615|B2|||HCV RNA||log10 IU/mL|Mean|5.9|5.9|Standard Deviation|0.72|0.72|||
3726403|NCT02074514|3564616|B1|||HCV RNA||log10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.44|0.44|||
3726404|NCT02074514|3564612|B5|Presence||Cirrhosis Status||participants|Number|33|33.0||||||
3726405|NCT02074514|3564613|B4|Presence||Cirrhosis Status||participants|Number|7|7.0||||||
3726406|NCT02074514|3564614|B3|Presence||Cirrhosis Status||participants|Number|7|7.0||||||
3726407|NCT02074514|3564615|B2|Presence||Cirrhosis Status||participants|Number|9|9.0||||||
3726408|NCT02074514|3564616|B1|Presence||Cirrhosis Status||participants|Number|10|10.0||||||
3726409|NCT02074514|3564612|B5|Absence||Cirrhosis Status||participants|Number|84|84.0||||||
3726410|NCT02074514|3564613|B4|Absence||Cirrhosis Status||participants|Number|23|23.0||||||
3726411|NCT02074514|3564614|B3|Absence||Cirrhosis Status||participants|Number|22|22.0||||||
3726412|NCT02074514|3564615|B2|Absence||Cirrhosis Status||participants|Number|19|19.0||||||
3726413|NCT02074514|3564616|B1|Absence||Cirrhosis Status||participants|Number|20|20.0||||||
3726414|NCT02074514|3564612|B5|Genotype 3||HCV genotype||participants|Number|59|59.0||||||
3726415|NCT02074514|3564613|B4|Genotype 3||HCV genotype||participants|Number|30|30.0||||||
3726416|NCT02074514|3564614|B3|Genotype 3||HCV genotype||participants|Number|29|29.0||||||
3726417|NCT02074514|3564615|B2|Genotype 3||HCV genotype||participants|Number|0|0.0||||||
3726418|NCT02074514|3564616|B1|Genotype 3||HCV genotype||participants|Number|0|0.0||||||
3726419|NCT02074514|3564612|B5|Genotype 1b||HCV genotype||participants|Number|48|48.0||||||
3726420|NCT02074514|3564613|B4|Genotype 1b||HCV genotype||participants|Number|0|0.0||||||
3726421|NCT02074514|3564614|B3|Genotype 1b||HCV genotype||participants|Number|0|0.0||||||
3726422|NCT02074514|3564615|B2|Genotype 1b||HCV genotype||participants|Number|23|23.0||||||
3726423|NCT02074514|3564616|B1|Genotype 1b||HCV genotype||participants|Number|25|25.0||||||
3726424|NCT02074514|3564612|B5|Genotype 1a||HCV genotype||participants|Number|10|10.0||||||
3726425|NCT02074514|3564613|B4|Genotype 1a||HCV genotype||participants|Number|0|0.0||||||
3726426|NCT02074514|3564614|B3|Genotype 1a||HCV genotype||participants|Number|0|0.0||||||
3726427|NCT02074514|3564615|B2|Genotype 1a||HCV genotype||participants|Number|5|5.0||||||
3726428|NCT02074514|3564616|B1|Genotype 1a||HCV genotype||participants|Number|5|5.0||||||
3726429|NCT02074514|3564612|B5|Not Permitted||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3726430|NCT02074514|3564613|B4|Not Permitted||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3726431|NCT02074514|3564614|B3|Not Permitted||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3726432|NCT02074514|3564615|B2|Not Permitted||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3726433|NCT02074514|3564616|B1|Not Permitted||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3726434|NCT02074514|3564612|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|106|106.0||||||
3726435|NCT02074514|3564613|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3726436|NCT02074514|3564614|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3726437|NCT02074514|3564615|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3726438|NCT02074514|3564616|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3726439|NCT02074514|3564612|B5|Asian||Race/Ethnicity, Customized||participants|Number|117|117.0||||||
3726440|NCT02074514|3564613|B4|Asian||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3726441|NCT02074514|3564614|B3|Asian||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3726442|NCT02074514|3564615|B2|Asian||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3726443|NCT02074514|3564616|B1|Asian||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3726444|NCT02074514|3564612|B5||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3726445|NCT02074514|3564613|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3726446|NCT02074514|3564614|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3726447|NCT02074514|3564615|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3726448|NCT02074514|3564616|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3726449|NCT02074514|3564612|B5||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3726450|NCT02074514|3564613|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3726451|NCT02074514|3564614|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3726452|NCT02074514|3564615|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3726453|NCT02074514|3564616|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3726454|NCT02074514|3564612|B5|||Age||Years|Mean|42|42.0|Standard Deviation|12.4|12.4|||
3726455|NCT02074514|3564613|B4|||Age||Years|Mean|37|37.0|Standard Deviation|10.8|10.8|||
3726456|NCT02074514|3564614|B3|||Age||Years|Mean|40|40.0|Standard Deviation|12.7|12.7|||
3726457|NCT02074514|3564615|B2|||Age||Years|Mean|46|46.0|Standard Deviation|12.6|12.6|||
3726458|NCT02074514|3564616|B1|||Age||Years|Mean|45|45.0|Standard Deviation|11.7|11.7|||
3726459|NCT02074384|3564635|B4|United States||Region of Enrollment||participants|Number|161|161.0||||||
3726460|NCT02074384|3564636|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
3726461|NCT02074384|3564637|B2|United States||Region of Enrollment||participants|Number|70|70.0||||||
3726462|NCT02074384|3564638|B1|United States||Region of Enrollment||participants|Number|74|74.0||||||
3726463|NCT02074384|3564635|B4||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3726464|NCT02074384|3564636|B3||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Not collected
3726465|NCT02074384|3564637|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3726466|NCT02074384|3564638|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3726467|NCT02074384|3564635|B4||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3726468|NCT02074384|3564636|B3||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Not collected
3726469|NCT02074384|3564637|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3726470|NCT02074384|3564638|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3726471|NCT02074384|3564635|B4|||Age||years|Mean|26.4|26.4|Standard Deviation|16.8|16.8|||
3726472|NCT02074384|3564636|B3|||Age||years|Mean|NA||Standard Deviation|NA||||Not collected
3726473|NCT02074384|3564637|B2|||Age||years|Mean|28.8|28.8|Standard Deviation|18.7|18.7|||
3726474|NCT02074384|3564638|B1|||Age||years|Mean|24.0|24.0|Standard Deviation|14.5|14.5|||
3726475|NCT02074384|3564635|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3726476|NCT02074384|3564636|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3726477|NCT02074384|3564637|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3726478|NCT02074384|3564638|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3726479|NCT02074384|3564635|B4||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
3726480|NCT02074384|3564636|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3726481|NCT02074384|3564637|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3726482|NCT02074384|3564638|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3726483|NCT02074384|3564635|B4||<=18 years|Age||Participants|Count of Participants|72|72.0||||||
3726484|NCT02074384|3564636|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3726485|NCT02074384|3564637|B2||<=18 years|Age||Participants|Count of Participants|32|32.0||||||
3726486|NCT02074384|3564638|B1||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
3726487|NCT02074358|3564648|B1|||Weight||kilograms|Mean|76.5|76.5|Standard Deviation|7.96|7.96|||
3726488|NCT02074358|3564648|B1|||Body Mass Index (BMI)|BMI measured as kilograms of body weight divided by meter of height, squared (kg/m^2).|kg/m^2|Mean|24.5|24.5|Standard Deviation|2.50|2.5|||
3726489|NCT02074358|3564648|B1|Germany||Region of Enrollment||participants|Number|15|15.0||||||
3726490|NCT02074358|3564648|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3726491|NCT02074358|3564648|B1|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3726492|NCT02074358|3564648|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3726493|NCT02074358|3564648|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3726494|NCT02074358|3564648|B1|||Age||years|Mean|33.1|33.1|Standard Deviation|7.00|7.0|||
3726495|NCT02074345|3564742|B1|No||Simultaneous Vaccination of Measles-Rubella (MR) Vaccine|Yes = MR vaccine was administered on the same day in the booster vaccination period.|participants|Number|31|31.0||||||
3726549|NCT02074059|3564757|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3726496|NCT02074345|3564742|B1|Yes||Simultaneous Vaccination of Measles-Rubella (MR) Vaccine|Yes = MR vaccine was administered on the same day in the booster vaccination period.|participants|Number|0|0.0||||||
3726497|NCT02074345|3564742|B1|No||Simultaneous Vaccination of Rotavirus Vaccine|Yes = rotavirus vaccine was administered on the same day at least once in the primary immunization period.|participants|Number|4|4.0||||||
3726498|NCT02074345|3564742|B1|Yes||Simultaneous Vaccination of Rotavirus Vaccine|Yes = rotavirus vaccine was administered on the same day at least once in the primary immunization period.|participants|Number|27|27.0||||||
3726499|NCT02074345|3564742|B1|No||Simultaneous Vaccination of Diphtheria, Tetanus, Pertussis-Inactivated Polio Vaccine (DPT-IPV)|Yes = DPT-IPV vaccine was administered on the same day at least once in the primary immunization period.|participants|Number|31|31.0||||||
3726500|NCT02074345|3564742|B1|Yes||Simultaneous Vaccination of Diphtheria, Tetanus, Pertussis-Inactivated Polio Vaccine (DPT-IPV)|Yes = DPT-IPV vaccine was administered on the same day at least once in the primary immunization period.|participants|Number|0|0.0||||||
3726501|NCT02074345|3564742|B1|No||Simultaneous Vaccination of Pneumococcal Vaccine|Yes = pneumococcal vaccine was administered on the same day at least once in the primary immunization period.|participants|Number|31|31.0||||||
3726502|NCT02074345|3564742|B1|Yes||Simultaneous Vaccination of Pneumococcal Vaccine|Yes = pneumococcal vaccine was administered on the same day at least once in the primary immunization period.|participants|Number|0|0.0||||||
3726503|NCT02074345|3564742|B1|≥0.15 µg/mL||Anti-Polyribosylribitol Phosphate (PRP) Antibody Titer Before Primary Immunization||participants|Number|27|27.0||||||
3726504|NCT02074345|3564742|B1|<0.15 µg/mL||Anti-Polyribosylribitol Phosphate (PRP) Antibody Titer Before Primary Immunization||participants|Number|4|4.0||||||
3726505|NCT02074345|3564742|B1|||Weight||kg|Mean|5.62|5.62|Standard Deviation|0.551|0.551|||
3726506|NCT02074345|3564742|B1|||Height||cm|Mean|58.2|58.2|Standard Deviation|2.38|2.38|||
3726507|NCT02074345|3564742|B1|Japan||Region of Enrollment||participants|Number|31|31.0||||||
3726508|NCT02074345|3564742|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3726509|NCT02074345|3564742|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3726510|NCT02074345|3564742|B1|≥5 months||Age, Customized||participants|Number|0|0.0||||||
3726511|NCT02074345|3564742|B1|≥4 - <5 months||Age, Customized||participants|Number|1|1.0||||||
3726512|NCT02074345|3564742|B1|≥3 - <4 months||Age, Customized||participants|Number|8|8.0||||||
3726513|NCT02074345|3564742|B1|≥2 - <3 months||Age, Customized||participants|Number|22|22.0||||||
3726514|NCT02074345|3564742|B1|<2 months||Age, Customized||participants|Number|0|0.0||||||
3726515|NCT02074345|3564742|B1|||Age||months|Mean|2.54|2.54|Standard Deviation|0.587|0.587|||
3726516|NCT02074059|3564752|B7|||Gestational Age||weeks|Mean|31.7|31.7|Standard Deviation|1.74|1.74|||
3726517|NCT02074059|3564753|B6|||Gestational Age||weeks|Mean|31.5|31.5|Standard Deviation|1.56|1.56|||
3726518|NCT02074059|3564754|B5|||Gestational Age||weeks|Mean|32.3|32.3|Standard Deviation|1.95|1.95|||
3726519|NCT02074059|3564755|B4|||Gestational Age||weeks|Mean|31.7|31.7|Standard Deviation|2.10|2.1|||
3726520|NCT02074059|3564756|B3|||Gestational Age||weeks|Mean|33.3|33.3|Standard Deviation|2.11|2.11|||
3726521|NCT02074059|3564757|B2|||Gestational Age||weeks|Mean|31.8|31.8|Standard Deviation|1.50|1.5|||
3726522|NCT02074059|3564758|B1|||Gestational Age||weeks|Mean|30.5|30.5|Standard Deviation|0.81|0.81|||
3726523|NCT02074059|3564752|B7|United States||Region of Enrollment||participants|Number|80|80.0||||||
3726524|NCT02074059|3564753|B6|United States||Region of Enrollment||participants|Number|40|40.0||||||
3726525|NCT02074059|3564754|B5|United States||Region of Enrollment||participants|Number|8|8.0||||||
3726526|NCT02074059|3564755|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
3726527|NCT02074059|3564756|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3726528|NCT02074059|3564757|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3726529|NCT02074059|3564758|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3726530|NCT02074059|3564752|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3726531|NCT02074059|3564753|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3726532|NCT02074059|3564754|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3726533|NCT02074059|3564755|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3726534|NCT02074059|3564756|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3726535|NCT02074059|3564757|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3726536|NCT02074059|3564758|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3726537|NCT02074059|3564752|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3726538|NCT02074059|3564753|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726539|NCT02074059|3564754|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726540|NCT02074059|3564755|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726541|NCT02074059|3564756|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726542|NCT02074059|3564757|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726543|NCT02074059|3564758|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3726544|NCT02074059|3564752|B7||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3726545|NCT02074059|3564753|B6||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3726546|NCT02074059|3564754|B5||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3726547|NCT02074059|3564755|B4||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3726548|NCT02074059|3564756|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3726550|NCT02074059|3564758|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3726551|NCT02074059|3564752|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3726552|NCT02074059|3564753|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3726553|NCT02074059|3564754|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726554|NCT02074059|3564755|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3726555|NCT02074059|3564756|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726556|NCT02074059|3564757|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726557|NCT02074059|3564758|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3726558|NCT02074059|3564752|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726559|NCT02074059|3564753|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726560|NCT02074059|3564754|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726561|NCT02074059|3564755|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726562|NCT02074059|3564756|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726563|NCT02074059|3564757|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726564|NCT02074059|3564758|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726565|NCT02074059|3564752|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3726566|NCT02074059|3564753|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3726567|NCT02074059|3564754|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726568|NCT02074059|3564755|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726569|NCT02074059|3564756|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3726570|NCT02074059|3564757|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726571|NCT02074059|3564758|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726572|NCT02074059|3564752|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726573|NCT02074059|3564753|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726574|NCT02074059|3564754|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726575|NCT02074059|3564755|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726576|NCT02074059|3564756|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726577|NCT02074059|3564757|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726578|NCT02074059|3564758|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726579|NCT02074059|3564752|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726580|NCT02074059|3564753|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726581|NCT02074059|3564754|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726582|NCT02074059|3564755|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726583|NCT02074059|3564756|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726584|NCT02074059|3564757|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726585|NCT02074059|3564758|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726586|NCT02074059|3564752|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3726587|NCT02074059|3564753|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3726588|NCT02074059|3564754|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3726589|NCT02074059|3564755|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3726590|NCT02074059|3564756|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3726591|NCT02074059|3564757|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3726592|NCT02074059|3564758|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3726593|NCT02074059|3564752|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3726594|NCT02074059|3564753|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3726595|NCT02074059|3564754|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3726596|NCT02074059|3564755|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3726597|NCT02074059|3564756|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3726598|NCT02074059|3564757|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3726599|NCT02074059|3564758|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3726600|NCT02074059|3564752|B7||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3726601|NCT02074059|3564753|B6||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3726602|NCT02074059|3564754|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3726603|NCT02074059|3564755|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3726604|NCT02074059|3564756|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3726605|NCT02074059|3564757|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3726606|NCT02074059|3564758|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3726607|NCT02074059|3564752|B7||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3726608|NCT02074059|3564753|B6||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3726609|NCT02074059|3564754|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3726610|NCT02074059|3564755|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3726611|NCT02074059|3564756|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3726612|NCT02074059|3564757|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3726613|NCT02074059|3564758|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3726614|NCT02074059|3564752|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3726615|NCT02074059|3564753|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3726616|NCT02074059|3564754|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3726617|NCT02074059|3564755|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3726618|NCT02074059|3564756|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3726619|NCT02074059|3564757|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3726620|NCT02074059|3564758|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3726621|NCT02074059|3564752|B7||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3726622|NCT02074059|3564753|B6||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3726623|NCT02074059|3564754|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3726624|NCT02074059|3564755|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3726625|NCT02074059|3564756|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3726626|NCT02074059|3564757|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3726627|NCT02074059|3564758|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3726628|NCT02074059|3564752|B7||<=18 years|Age||Participants|Count of Participants|80|80.0||||||
3726629|NCT02074059|3564753|B6||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
3726630|NCT02074059|3564754|B5||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
3726631|NCT02074059|3564755|B4||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
3726632|NCT02074059|3564756|B3||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
3726633|NCT02074059|3564757|B2||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
3726634|NCT02074059|3564758|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
3726635|NCT02073747|3564801|B3|United States||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3726636|NCT02073747|3564802|B2|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3726637|NCT02073747|3564803|B1|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3726638|NCT02073747|3564801|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3726639|NCT02073747|3564802|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3726640|NCT02073747|3564803|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3726641|NCT02073747|3564801|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3726642|NCT02073747|3564802|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3726643|NCT02073747|3564803|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3726644|NCT02073747|3564801|B3|||Age||years|Median|28.5|28.5|Inter-Quartile Range|||26.0|32.3|
3726645|NCT02073747|3564802|B2|||Age||years|Median|28|28.0|Inter-Quartile Range|||26.3|34.5|
3726646|NCT02073747|3564803|B1|||Age||years|Median|29|29.0|Inter-Quartile Range|||24.5|30.0|
3726647|NCT02073682|3564810|B3|Solid Tumor and Haematological Malignancy||Type of Cancer||Participants|Count of Participants|3|3.0||||||
3726648|NCT02073682|3564811|B2|Solid Tumor and Haematological Malignancy||Type of Cancer||Participants|Count of Participants|2|2.0||||||
3726649|NCT02073682|3564812|B1|Solid Tumor and Haematological Malignancy||Type of Cancer||Participants|Count of Participants|1|1.0||||||
3726650|NCT02073682|3564810|B3|Haematological Malignancy||Type of Cancer||Participants|Count of Participants|111|111.0||||||
3726651|NCT02073682|3564811|B2|Haematological Malignancy||Type of Cancer||Participants|Count of Participants|55|55.0||||||
3726652|NCT02073682|3564812|B1|Haematological Malignancy||Type of Cancer||Participants|Count of Participants|56|56.0||||||
3726653|NCT02073682|3564810|B3|Solid Tumor||Type of Cancer||Participants|Count of Participants|932|932.0||||||
3726654|NCT02073682|3564811|B2|Solid Tumor||Type of Cancer||Participants|Count of Participants|467|467.0||||||
3726655|NCT02073682|3564812|B1|Solid Tumor||Type of Cancer||Participants|Count of Participants|465|465.0||||||
3726656|NCT02073682|3564810|B3|Canada||Region of Enrollment||participants|Number|200|200.0||||||
3726657|NCT02073682|3564811|B2|Canada||Region of Enrollment||participants|Number|102|102.0||||||
3726658|NCT02073682|3564812|B1|Canada||Region of Enrollment||participants|Number|98|98.0||||||
3726659|NCT02073682|3564810|B3|New Zealand||Region of Enrollment||participants|Number|25|25.0||||||
3726660|NCT02073682|3564811|B2|New Zealand||Region of Enrollment||participants|Number|13|13.0||||||
3726661|NCT02073682|3564812|B1|New Zealand||Region of Enrollment||participants|Number|12|12.0||||||
3726662|NCT02073682|3564810|B3|Australia||Region of Enrollment||participants|Number|32|32.0||||||
3726663|NCT02073682|3564811|B2|Australia||Region of Enrollment||participants|Number|16|16.0||||||
3726664|NCT02073682|3564812|B1|Australia||Region of Enrollment||participants|Number|16|16.0||||||
3726665|NCT02073682|3564810|B3|Spain||Region of Enrollment||participants|Number|70|70.0||||||
3726666|NCT02073682|3564811|B2|Spain||Region of Enrollment||participants|Number|35|35.0||||||
3726667|NCT02073682|3564812|B1|Spain||Region of Enrollment||participants|Number|35|35.0||||||
3726668|NCT02073682|3564810|B3|Czechia||Region of Enrollment||participants|Number|21|21.0||||||
3726669|NCT02073682|3564811|B2|Czechia||Region of Enrollment||participants|Number|10|10.0||||||
3726670|NCT02073682|3564812|B1|Czechia||Region of Enrollment||participants|Number|11|11.0||||||
3726671|NCT02073682|3564810|B3|Germany||Region of Enrollment||participants|Number|59|59.0||||||
3726672|NCT02073682|3564811|B2|Germany||Region of Enrollment||participants|Number|29|29.0||||||
3726673|NCT02073682|3564812|B1|Germany||Region of Enrollment||participants|Number|30|30.0||||||
3726674|NCT02073682|3564810|B3|Austria||Region of Enrollment||participants|Number|28|28.0||||||
3726675|NCT02073682|3564811|B2|Austria||Region of Enrollment||participants|Number|15|15.0||||||
3726676|NCT02073682|3564812|B1|Austria||Region of Enrollment||participants|Number|13|13.0||||||
3726677|NCT02073682|3564810|B3|France||Region of Enrollment||participants|Number|122|122.0||||||
3726678|NCT02073682|3564811|B2|France||Region of Enrollment||participants|Number|64|64.0||||||
3726679|NCT02073682|3564812|B1|France||Region of Enrollment||participants|Number|58|58.0||||||
3726680|NCT02073682|3564810|B3|Italy||Region of Enrollment||participants|Number|90|90.0||||||
3726681|NCT02073682|3564811|B2|Italy||Region of Enrollment||participants|Number|45|45.0||||||
3726682|NCT02073682|3564812|B1|Italy||Region of Enrollment||participants|Number|45|45.0||||||
3726683|NCT02073682|3564810|B3|United States||Region of Enrollment||participants|Number|207|207.0||||||
3726684|NCT02073682|3564811|B2|United States||Region of Enrollment||participants|Number|103|103.0||||||
3726685|NCT02073682|3564812|B1|United States||Region of Enrollment||participants|Number|104|104.0||||||
3726686|NCT02073682|3564810|B3|Hungary||Region of Enrollment||participants|Number|33|33.0||||||
3726687|NCT02073682|3564811|B2|Hungary||Region of Enrollment||participants|Number|16|16.0||||||
3726688|NCT02073682|3564812|B1|Hungary||Region of Enrollment||participants|Number|17|17.0||||||
3726689|NCT02073682|3564810|B3|Belgium||Region of Enrollment||participants|Number|41|41.0||||||
3726690|NCT02073682|3564811|B2|Belgium||Region of Enrollment||participants|Number|19|19.0||||||
3726691|NCT02073682|3564812|B1|Belgium||Region of Enrollment||participants|Number|22|22.0||||||
3726692|NCT02073682|3564810|B3|Netherlands||Region of Enrollment||participants|Number|118|118.0||||||
3726693|NCT02073682|3564811|B2|Netherlands||Region of Enrollment||participants|Number|57|57.0||||||
3726694|NCT02073682|3564812|B1|Netherlands||Region of Enrollment||participants|Number|61|61.0||||||
3726695|NCT02073682|3564810|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|77|77.0||||||
3726696|NCT02073682|3564811|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
3726697|NCT02073682|3564812|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3726698|NCT02073682|3564810|B3|Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3726699|NCT02073682|3564811|B2|Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3726700|NCT02073682|3564812|B1|Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3726701|NCT02073682|3564810|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3726702|NCT02073682|3564811|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3726703|NCT02073682|3564812|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3726704|NCT02073682|3564810|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
3726705|NCT02073682|3564811|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3726706|NCT02073682|3564812|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3726707|NCT02073682|3564810|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|880|880.0||||||
3726708|NCT02073682|3564811|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|427|427.0||||||
3726709|NCT02073682|3564812|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|453|453.0||||||
3726710|NCT02073682|3564810|B3||Male|Sex: Female, Male||Participants|Count of Participants|540|540.0||||||
3726711|NCT02073682|3564811|B2||Male|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
3726712|NCT02073682|3564812|B1||Male|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
3726713|NCT02073682|3564810|B3||Female|Sex: Female, Male||Participants|Count of Participants|506|506.0||||||
3726714|NCT02073682|3564811|B2||Female|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
3726715|NCT02073682|3564812|B1||Female|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
3726716|NCT02073682|3564810|B3|85 years and over||Age, Customized||Participants|Count of Participants|18|18.0||||||
3726717|NCT02073682|3564811|B2|85 years and over||Age, Customized||Participants|Count of Participants|9|9.0||||||
3726718|NCT02073682|3564812|B1|85 years and over||Age, Customized||Participants|Count of Participants|9|9.0||||||
3726719|NCT02073682|3564810|B3|65-84 Years||Age, Customized||Participants|Count of Participants|521|521.0||||||
3726720|NCT02073682|3564811|B2|65-84 Years||Age, Customized||Participants|Count of Participants|254|254.0||||||
3726721|NCT02073682|3564812|B1|65-84 Years||Age, Customized||Participants|Count of Participants|267|267.0||||||
3726722|NCT02073682|3564810|B3|18-64 Years||Age, Customized||Participants|Count of Participants|507|507.0||||||
3726723|NCT02073682|3564811|B2|18-64 Years||Age, Customized||Participants|Count of Participants|261|261.0||||||
3726724|NCT02073682|3564812|B1|18-64 Years||Age, Customized||Participants|Count of Participants|246|246.0||||||
3726725|NCT02073682|3564810|B3|||Age||years|Median|65|65.0|Full Range|||21.0|91.0|
3726726|NCT02073682|3564811|B2|||Age||years|Median|65|65.0|Full Range|||21.0|89.0|
3726727|NCT02073682|3564812|B1|||Age||years|Median|66|66.0|Full Range|||22.0|91.0|
3726728|NCT02073656|3564831|B1|Treatment-Experienced with Other||Prior HCV Treatment|"Acronyms for prior treatment:~DAA = direct-acting antiviral; Peg-IFN = pegylated interferon; RBV = ribavirin"|participants|Number|5|5.0||||||
3726729|NCT02073656|3564831|B1|Treatment-Experienced with DAA+RBV||Prior HCV Treatment|"Acronyms for prior treatment:~DAA = direct-acting antiviral; Peg-IFN = pegylated interferon; RBV = ribavirin"|participants|Number|14|14.0||||||
3726730|NCT02073656|3564831|B1|Treatment-Experienced with Peg-IFN+RBV||Prior HCV Treatment|"Acronyms for prior treatment:~DAA = direct-acting antiviral; Peg-IFN = pegylated interferon; RBV = ribavirin"|participants|Number|113|113.0||||||
3726731|NCT02073656|3564831|B1|Treatment-Experienced with DAA+Peg-IFN+RBV||Prior HCV Treatment|"Acronyms for prior treatment:~DAA = direct-acting antiviral; Peg-IFN = pegylated interferon; RBV = ribavirin"|participants|Number|53|53.0||||||
3726732|NCT02073656|3564831|B1|Treatment-Naive||Prior HCV Treatment|"Acronyms for prior treatment:~DAA = direct-acting antiviral; Peg-IFN = pegylated interferon; RBV = ribavirin"|participants|Number|150|150.0||||||
3726733|NCT02073656|3564831|B1|||Baseline CD4 Count||cells/uL|Mean|662|662.0|Standard Deviation|293.8|293.8|||
3726734|NCT02073656|3564831|B1|||Estimated Glomerular Filtration Rate Using the Cockcroft-Gault Equation||mL/min|Mean|101.6|101.6|Standard Deviation|30.78|30.78|||
3726735|NCT02073656|3564831|B1|||Baseline Serum Creatinine||mg/dL|Mean|1.00|1.0|Standard Deviation|0.210|0.21|||
3726736|NCT02073656|3564831|B1|≥ 800,000 IU/mL||Baseline HCV RNA Category||participants|Number|299|299.0||||||
3726737|NCT02073656|3564831|B1|< 800,000 IU/mL||Baseline HCV RNA Category||participants|Number|36|36.0||||||
3726738|NCT02073656|3564831|B1|||Baseline HCV RNA||log10 IU/mL|Mean|6.7|6.7|Standard Deviation|0.64|0.64|||
3726739|NCT02073656|3564831|B1|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|69|69.0||||||
3726740|NCT02073656|3564831|B1|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|185|185.0||||||
3726741|NCT02073656|3564831|B1|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|81|81.0||||||
3726742|NCT02073656|3564831|B1|Yes||Cirrhosis Status||participants|Number|67|67.0||||||
3726743|NCT02073656|3564831|B1|No||Cirrhosis Status||participants|Number|268|268.0||||||
3726744|NCT02073656|3564831|B1|Genotype 4||HCV Genotype||participants|Number|8|8.0||||||
3726745|NCT02073656|3564831|B1|Genotype 1b||HCV Genotype||participants|Number|77|77.0||||||
3726746|NCT02073656|3564831|B1|Genotype 1a||HCV Genotype||participants|Number|250|250.0||||||
3726747|NCT02073656|3564831|B1|Puerto Rico||Region of Enrollment||participants|Number|10|10.0||||||
3726748|NCT02073656|3564831|B1|United States||Region of Enrollment||participants|Number|290|290.0||||||
3726749|NCT02073656|3564831|B1|Canada||Region of Enrollment||participants|Number|26|26.0||||||
3726750|NCT02073656|3564831|B1|New Zealand||Region of Enrollment||participants|Number|9|9.0||||||
3726751|NCT02073656|3564831|B1|Not Disclosed||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3726752|NCT02073656|3564831|B1|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3726753|NCT02073656|3564831|B1|American Indian/ Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3726754|NCT02073656|3564831|B1|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3726755|NCT02073656|3564831|B1|White||Race/Ethnicity, Customized||participants|Number|203|203.0||||||
3726756|NCT02073656|3564831|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|115|115.0||||||
3726757|NCT02073656|3564831|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3726758|NCT02073656|3564831|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|276|276.0||||||
3726759|NCT02073656|3564831|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3726760|NCT02073656|3564831|B1||Male|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
3726761|NCT02073656|3564831|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3726762|NCT02073656|3564831|B1|||Age||years|Mean|52|52.0|Standard Deviation|8.0|8.0|||
3726763|NCT02073565|3564847|B3|||Planned Beta-blockers at 1 year||Participants|Count of Participants|203|203.0||||||
3726764|NCT02073565|3564848|B2|||Planned Beta-blockers at 1 year||Participants|Count of Participants|100|100.0||||||
3726765|NCT02073565|3564849|B1|||Planned Beta-blockers at 1 year||Participants|Count of Participants|103|103.0||||||
3726766|NCT02073565|3564847|B3|||Planned Statins at 1 year||Participants|Count of Participants|461|461.0||||||
3726767|NCT02073565|3564848|B2|||Planned Statins at 1 year||Participants|Count of Participants|228|228.0||||||
3726768|NCT02073565|3564849|B1|||Planned Statins at 1 year||Participants|Count of Participants|233|233.0||||||
3726769|NCT02073565|3564847|B3|||Planned Dual Antiplatelet Therapy (DAPT) at 1 year||Participants|Count of Participants|490|490.0||||||
3726770|NCT02073565|3564848|B2|||Planned Dual Antiplatelet Therapy (DAPT) at 1 year||Participants|Count of Participants|243|243.0||||||
3726771|NCT02073565|3564849|B1|||Planned Dual Antiplatelet Therapy (DAPT) at 1 year||Participants|Count of Participants|247|247.0||||||
3726772|NCT02073565|3564847|B3|||Planned Dual Antiplatelet Therapy (DAPT) at 6 months||Participants|Count of Participants|16|16.0||||||
3726773|NCT02073565|3564848|B2|||Planned Dual Antiplatelet Therapy (DAPT) at 6 months||Participants|Count of Participants|11|11.0||||||
3726774|NCT02073565|3564849|B1|||Planned Dual Antiplatelet Therapy (DAPT) at 6 months||Participants|Count of Participants|5|5.0||||||
3726775|NCT02073565|3564847|B3|||Hypercholesterolemia||Participants|Count of Participants|452|452.0||||||
3726776|NCT02073565|3564848|B2|||Hypercholesterolemia||Participants|Count of Participants|227|227.0||||||
3726777|NCT02073565|3564849|B1|||Hypercholesterolemia||Participants|Count of Participants|225|225.0||||||
3726778|NCT02073565|3564847|B3|||Chronic Renal Insufficiency||Participants|Count of Participants|16|16.0||||||
3726779|NCT02073565|3564848|B2|||Chronic Renal Insufficiency||Participants|Count of Participants|5|5.0||||||
3726780|NCT02073565|3564849|B1|||Chronic Renal Insufficiency||Participants|Count of Participants|11|11.0||||||
3726781|NCT02073565|3564847|B3|||Cigarette Smoking (current/former)||Participants|Count of Participants|366|366.0||||||
3726782|NCT02073565|3564848|B2|||Cigarette Smoking (current/former)||Participants|Count of Participants|175|175.0||||||
3726783|NCT02073565|3564849|B1|||Cigarette Smoking (current/former)||Participants|Count of Participants|191|191.0||||||
3726784|NCT02073565|3564847|B3||Participants without Diabetes|Diabetes||Participants|Count of Participants|362|362.0||||||
3726785|NCT02073565|3564848|B2||Participants without Diabetes|Diabetes||Participants|Count of Participants|192|192.0||||||
3726786|NCT02073565|3564849|B1||Participants without Diabetes|Diabetes||Participants|Count of Participants|170|170.0||||||
3726787|NCT02073565|3564847|B3||Diabetes: Non-insulin Dependent|Diabetes||Participants|Count of Participants|168|168.0||||||
3726788|NCT02073565|3564848|B2||Diabetes: Non-insulin Dependent|Diabetes||Participants|Count of Participants|75|75.0||||||
3726789|NCT02073565|3564849|B1||Diabetes: Non-insulin Dependent|Diabetes||Participants|Count of Participants|93|93.0||||||
3726790|NCT02073565|3564847|B3||Diabetes: Insulin Dependent|Diabetes||Participants|Count of Participants|42|42.0||||||
3726791|NCT02073565|3564848|B2||Diabetes: Insulin Dependent|Diabetes||Participants|Count of Participants|18|18.0||||||
3726792|NCT02073565|3564849|B1||Diabetes: Insulin Dependent|Diabetes||Participants|Count of Participants|24|24.0||||||
3726793|NCT02073565|3564847|B3|||Congestive Heart Failure||Participants|Count of Participants|35|35.0||||||
3726794|NCT02073565|3564848|B2|||Congestive Heart Failure||Participants|Count of Participants|24|24.0||||||
3726795|NCT02073565|3564849|B1|||Congestive Heart Failure||Participants|Count of Participants|11|11.0||||||
3726796|NCT02073565|3564847|B3|||Hypertension||Participants|Count of Participants|438|438.0||||||
3726797|NCT02073565|3564848|B2|||Hypertension||Participants|Count of Participants|220|220.0||||||
3726798|NCT02073565|3564849|B1|||Hypertension||Participants|Count of Participants|218|218.0||||||
3726799|NCT02073565|3564847|B3|||Previous Coronary Artery Bypass Grafting (CABG)||Participants|Count of Participants|9|9.0||||||
3726800|NCT02073565|3564848|B2|||Previous Coronary Artery Bypass Grafting (CABG)||Participants|Count of Participants|5|5.0||||||
3726801|NCT02073565|3564849|B1|||Previous Coronary Artery Bypass Grafting (CABG)||Participants|Count of Participants|4|4.0||||||
3726802|NCT02073565|3564847|B3|||Previous Percutaneous Coronary Intervention (PCI)||Participants|Count of Participants|155|155.0||||||
3726803|NCT02073565|3564848|B2|||Previous Percutaneous Coronary Intervention (PCI)||Participants|Count of Participants|83|83.0||||||
3726804|NCT02073565|3564849|B1|||Previous Percutaneous Coronary Intervention (PCI)||Participants|Count of Participants|72|72.0||||||
3726805|NCT02073565|3564847|B3|||Previous Myocardial Infarction (MI)||Participants|Count of Participants|90|90.0||||||
3726806|NCT02073565|3564848|B2|||Previous Myocardial Infarction (MI)||Participants|Count of Participants|45|45.0||||||
3726807|NCT02073565|3564849|B1|||Previous Myocardial Infarction (MI)||Participants|Count of Participants|45|45.0||||||
3726808|NCT02073565|3564847|B3|||Multivessel Coronary Artery Disease (MV CAD)||Participants|Count of Participants|64|64.0||||||
3726809|NCT02073565|3564848|B2|||Multivessel Coronary Artery Disease (MV CAD)||Participants|Count of Participants|31|31.0||||||
3726810|NCT02073565|3564849|B1|||Multivessel Coronary Artery Disease (MV CAD)||Participants|Count of Participants|33|33.0||||||
3726811|NCT02073565|3564847|B3|||Non-ST-segment elevation myocardial infarction (Non-STEMI) Presentation||Participants|Count of Participants|26|26.0||||||
3726812|NCT02073565|3564848|B2|||Non-ST-segment elevation myocardial infarction (Non-STEMI) Presentation||Participants|Count of Participants|12|12.0||||||
3726813|NCT02073565|3564849|B1|||Non-ST-segment elevation myocardial infarction (Non-STEMI) Presentation||Participants|Count of Participants|14|14.0||||||
3726814|NCT02073565|3564847|B3|Japan||Region of Enrollment||Participants|Count of Participants|439|439.0||||||
3726815|NCT02073565|3564848|B2|Japan||Region of Enrollment||Participants|Count of Participants|219|219.0||||||
3726816|NCT02073565|3564849|B1|Japan||Region of Enrollment||Participants|Count of Participants|220|220.0||||||
3726817|NCT02073565|3564847|B3|United States||Region of Enrollment||Participants|Count of Participants|133|133.0||||||
3726818|NCT02073565|3564848|B2|United States||Region of Enrollment||Participants|Count of Participants|66|66.0||||||
3726819|NCT02073565|3564849|B1|United States||Region of Enrollment||Participants|Count of Participants|67|67.0||||||
3726820|NCT02073565|3564847|B3|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3726821|NCT02073565|3564848|B2|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3726822|NCT02073565|3564849|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3726823|NCT02073565|3564847|B3|Race|White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|116|116.0||||||
3726824|NCT02073565|3564848|B2|Race|White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|59|59.0||||||
3726825|NCT02073565|3564849|B1|Race|White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|57|57.0||||||
3726826|NCT02073565|3564847|B3|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3726827|NCT02073565|3564848|B2|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3726828|NCT02073565|3564849|B1|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3726829|NCT02073565|3564847|B3|Race|Japanese|Race/Ethnicity, Customized||Participants|Count of Participants|438|438.0||||||
3726830|NCT02073565|3564848|B2|Race|Japanese|Race/Ethnicity, Customized||Participants|Count of Participants|219|219.0||||||
3726831|NCT02073565|3564849|B1|Race|Japanese|Race/Ethnicity, Customized||Participants|Count of Participants|219|219.0||||||
3726832|NCT02073565|3564847|B3|Race|Asian (non-Japanese)-|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3726833|NCT02073565|3564848|B2|Race|Asian (non-Japanese)-|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3726834|NCT02073565|3564849|B1|Race|Asian (non-Japanese)-|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3726835|NCT02073565|3564847|B3||Male|Sex: Female, Male||Participants|Count of Participants|423|423.0||||||
3726836|NCT02073565|3564848|B2||Male|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
3726837|NCT02073565|3564849|B1||Male|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
3726838|NCT02073565|3564847|B3||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3726839|NCT02073565|3564848|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3726840|NCT02073565|3564849|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3726841|NCT02073565|3564847|B3|||Age||years|Mean|67.0|67.0|Standard Deviation|10.0|10.0|||
3726842|NCT02073565|3564848|B2|||Age||years|Mean|66.5|66.5|Standard Deviation|10.4|10.4|||
3726843|NCT02073565|3564849|B1|||Age||years|Mean|67.6|67.6|Standard Deviation|9.6|9.6|||
3726844|NCT02073461|3564862|B4|Japan||Region of Enrollment||participants|Number|236|236.0||||||
3726845|NCT02073461|3564863|B3|Japan||Region of Enrollment||participants|Number|79|79.0||||||
3726846|NCT02073461|3564864|B2|Japan||Region of Enrollment||participants|Number|78|78.0||||||
3726847|NCT02073461|3564865|B1|Japan||Region of Enrollment||participants|Number|79|79.0||||||
3726848|NCT02073461|3564862|B4||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3726849|NCT02073461|3564863|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3726850|NCT02073461|3564864|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3726851|NCT02073461|3564865|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3726852|NCT02073461|3564862|B4||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3726853|NCT02073461|3564863|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3726854|NCT02073461|3564864|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3726855|NCT02073461|3564865|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3726856|NCT02073461|3564862|B4|||Age||years|Mean|21.4|21.4|Standard Deviation|6.3|6.3|||
3726857|NCT02073461|3564863|B3|||Age||years|Mean|21.0|21.0|Standard Deviation|6.3|6.3|||
3726858|NCT02073461|3564864|B2|||Age||years|Mean|21.1|21.1|Standard Deviation|5.6|5.6|||
3726859|NCT02073461|3564865|B1|||Age||years|Mean|22.1|22.1|Standard Deviation|7.0|7.0|||
3726860|NCT02073448|3564893|B4|Japan||Region of Enrollment||participants|Number|417|417.0||||||
3726861|NCT02073448|3564894|B3|Japan||Region of Enrollment||participants|Number|104|104.0||||||
3726862|NCT02073448|3564895|B2|Japan||Region of Enrollment||participants|Number|101|101.0||||||
3726863|NCT02073448|3564896|B1|Japan||Region of Enrollment||participants|Number|212|212.0||||||
3726864|NCT02073448|3564893|B4||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3726865|NCT02073448|3564894|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3726866|NCT02073448|3564895|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3726867|NCT02073448|3564896|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3726868|NCT02073448|3564893|B4||Female|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
3726869|NCT02073448|3564894|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3726870|NCT02073448|3564895|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3726871|NCT02073448|3564896|B1||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3726872|NCT02073448|3564893|B4|||Age||years|Mean|19.6|19.6|Standard Deviation|6.1|6.1|||
3726873|NCT02073448|3564894|B3|||Age||years|Mean|19.3|19.3|Standard Deviation|5.4|5.4|||
3726874|NCT02073448|3564895|B2|||Age||years|Mean|19.6|19.6|Standard Deviation|6.0|6.0|||
3726875|NCT02073448|3564896|B1|||Age||years|Mean|19.7|19.7|Standard Deviation|6.5|6.5|||
3726876|NCT02073448|3564893|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3726877|NCT02073448|3564894|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3726878|NCT02073448|3564895|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3726879|NCT02073448|3564896|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3726880|NCT02073448|3564893|B4||Between 18 and 65 years|Age||Participants|Count of Participants|189|189.0||||||
3726881|NCT02073448|3564894|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
3726882|NCT02073448|3564895|B2||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3726883|NCT02073448|3564896|B1||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
3726884|NCT02073448|3564893|B4||<=18 years|Age||Participants|Count of Participants|228|228.0||||||
3726885|NCT02073448|3564894|B3||<=18 years|Age||Participants|Count of Participants|56|56.0||||||
3726886|NCT02073448|3564895|B2||<=18 years|Age||Participants|Count of Participants|56|56.0||||||
3726887|NCT02073448|3564896|B1||<=18 years|Age||Participants|Count of Participants|116|116.0||||||
3726888|NCT02073435|3564924|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3726889|NCT02073435|3564925|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3726890|NCT02073435|3564926|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3726891|NCT02073435|3564924|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726892|NCT02073435|3564925|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726893|NCT02073435|3564926|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726894|NCT02073435|3564924|B3||White|Race (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
3726895|NCT02073435|3564925|B2||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3726896|NCT02073435|3564926|B1||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3726897|NCT02073435|3564924|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3726898|NCT02073435|3564925|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3726899|NCT02073435|3564926|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3726900|NCT02073435|3564924|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726901|NCT02073435|3564925|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726902|NCT02073435|3564926|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726903|NCT02073435|3564924|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3726904|NCT02073435|3564925|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3726905|NCT02073435|3564926|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3726906|NCT02073435|3564924|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726907|NCT02073435|3564925|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726908|NCT02073435|3564926|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726909|NCT02073435|3564924|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726910|NCT02073435|3564925|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726911|NCT02073435|3564926|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3726912|NCT02073435|3564924|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|153|153.0||||||
3726913|NCT02073435|3564925|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
3726914|NCT02073435|3564926|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3726915|NCT02073435|3564924|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3726916|NCT02073435|3564925|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3726917|NCT02073435|3564926|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3726918|NCT02073435|3564924|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3726919|NCT02073435|3564925|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3726920|NCT02073435|3564926|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3726921|NCT02073435|3564924|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3726922|NCT02073435|3564925|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3726923|NCT02073435|3564926|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3726924|NCT02073435|3564924|B3|||Age||Years|Mean|38.88|38.88|Standard Deviation|10.99|10.99|||
3726925|NCT02073435|3564925|B2|||Age||Years|Mean|38.81|38.81|Standard Deviation|11.04|11.04|||
3726926|NCT02073435|3564926|B1|||Age||Years|Mean|38.96|38.96|Standard Deviation|10.82|10.82|||
3726927|NCT02072980|3564935|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3726928|NCT02072980|3564935|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3726929|NCT02072980|3564935|B1|||Age||years|Mean|44.9|44.9|Standard Deviation|10.91|10.91|||
3726930|NCT02072928|3564942|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3726931|NCT02072928|3564942|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3726932|NCT02072928|3564942|B1|||Age||Years|Mean|44.5|44.5|Standard Deviation|16.0|16.0|||
3726933|NCT02072824|3564946|B4|||Weight||kilogram|Mean|11.5|11.5|Standard Deviation|3.3|3.3|||
3726934|NCT02072824|3564947|B3|||Weight||kilogram|Mean|11.4|11.4|Standard Deviation|3.1|3.1|||
3726935|NCT02072824|3564948|B2|||Weight||kilogram|Mean|11.4|11.4|Standard Deviation|3.4|3.4|||
3726936|NCT02072824|3564949|B1|||Weight||kilogram|Mean|11.7|11.7|Standard Deviation|3.5|3.5|||
3726937|NCT02072824|3564946|B4||Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3726938|NCT02072824|3564947|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3726939|NCT02072824|3564948|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3726940|NCT02072824|3564949|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3726941|NCT02072824|3564946|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|120|120.0||||||
3726942|NCT02072824|3564947|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|49|49.0||||||
3726943|NCT02072824|3564948|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3726944|NCT02072824|3564949|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
3726945|NCT02072824|3564946|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|52|52.0||||||
3726946|NCT02072824|3564947|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3726947|NCT02072824|3564948|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3726948|NCT02072824|3564949|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3726949|NCT02072824|3564946|B4||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3726950|NCT02072824|3564947|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3726951|NCT02072824|3564948|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3726952|NCT02072824|3564949|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3726953|NCT02072824|3564946|B4||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3726954|NCT02072824|3564947|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3726955|NCT02072824|3564948|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3726956|NCT02072824|3564949|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3726957|NCT02072824|3564946|B4|||Age||months|Mean|28.2|28.2|Standard Deviation|12.6|12.6|||
3726958|NCT02072824|3564947|B3|||Age||months|Mean|28.8|28.8|Standard Deviation|12.6|12.6|||
3726959|NCT02072824|3564948|B2|||Age||months|Mean|28.5|28.5|Standard Deviation|12.5|12.5|||
3726960|NCT02072824|3564949|B1|||Age||months|Mean|27.5|27.5|Standard Deviation|12.7|12.7|||
3726961|NCT02072421|3564986|B1|Other||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3726962|NCT02072421|3564986|B1|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3726963|NCT02072421|3564986|B1|Asian||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
3726964|NCT02072421|3564986|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|153|153.0||||||
3726965|NCT02072421|3564986|B1|Black||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
3726966|NCT02072421|3564986|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|2595|2595.0||||||
3726967|NCT02072421|3564986|B1|Female||Sex/Gender, Customized||participants|Number|924|924.0||||||
3726968|NCT02072421|3564986|B1|Male||Sex/Gender, Customized||participants|Number|1955|1955.0||||||
3726969|NCT02072421|3564986|B1|||Age||years|Mean|64.92|64.92|Standard Deviation|11.48|11.48|||
3726970|NCT02072226|3564994|B3|||Total National Institutes of Health Stroke Scale (NIHSS)|NIHSS measures stroke symptoms. It has 11 main items which score between 0 and 4. A score of 0 typically indicates normal function, and a higher score indicates more symptoms. The individual scores from each item are summed to calculate total NIHSS score. Total NIHSS score ranges from 0 to 42, with 0 indicating no stroke symptoms, and a higher score indicating more symptoms.|units on a scale|Mean|2.2|2.2|Standard Deviation|1.18|1.18|||
3726971|NCT02072226|3564995|B2|||Total National Institutes of Health Stroke Scale (NIHSS)|NIHSS measures stroke symptoms. It has 11 main items which score between 0 and 4. A score of 0 typically indicates normal function, and a higher score indicates more symptoms. The individual scores from each item are summed to calculate total NIHSS score. Total NIHSS score ranges from 0 to 42, with 0 indicating no stroke symptoms, and a higher score indicating more symptoms.|units on a scale|Mean|2.1|2.1|Standard Deviation|1.15|1.15|||
3726972|NCT02072226|3564996|B1|||Total National Institutes of Health Stroke Scale (NIHSS)|NIHSS measures stroke symptoms. It has 11 main items which score between 0 and 4. A score of 0 typically indicates normal function, and a higher score indicates more symptoms. The individual scores from each item are summed to calculate total NIHSS score. Total NIHSS score ranges from 0 to 42, with 0 indicating no stroke symptoms, and a higher score indicating more symptoms.|units on a scale|Mean|2.3|2.3|Standard Deviation|1.21|1.21|||
3726973|NCT02072226|3564994|B3|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3726974|NCT02072226|3564995|B2|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3726975|NCT02072226|3564996|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3726976|NCT02072226|3564994|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3726977|NCT02072226|3564995|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3726978|NCT02072226|3564996|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3726979|NCT02072226|3564994|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|243|243.0||||||
3726980|NCT02072226|3564995|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|126|126.0||||||
3726981|NCT02072226|3564996|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|117|117.0||||||
3726982|NCT02072226|3564994|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|62|62.0||||||
3726983|NCT02072226|3564995|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3726984|NCT02072226|3564996|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
3726985|NCT02072226|3564994|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3726986|NCT02072226|3564995|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3726987|NCT02072226|3564996|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3726988|NCT02072226|3564994|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3726989|NCT02072226|3564995|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3726990|NCT02072226|3564996|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3726991|NCT02072226|3564994|B3|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3726992|NCT02072226|3564995|B2|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3726993|NCT02072226|3564996|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3726994|NCT02072226|3564994|B3|Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3726995|NCT02072226|3564995|B2|Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3726996|NCT02072226|3564996|B1|Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3726997|NCT02072226|3564994|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|273|273.0||||||
3726998|NCT02072226|3564995|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|135|135.0||||||
3726999|NCT02072226|3564996|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|138|138.0||||||
3727000|NCT02072226|3564994|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3727001|NCT02072226|3564995|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3727002|NCT02072226|3564996|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3727003|NCT02072226|3564994|B3||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3727004|NCT02072226|3564995|B2||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3727005|NCT02072226|3564996|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3727006|NCT02072226|3564994|B3||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3727007|NCT02072226|3564995|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3727008|NCT02072226|3564996|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3727009|NCT02072226|3564994|B3|||Age||years|Mean|61.57|61.57|Standard Deviation|13.27|13.27|||
3727010|NCT02072226|3564995|B2|||Age||years|Mean|61.20|61.2|Standard Deviation|13.05|13.05|||
3727011|NCT02072226|3564996|B1|||Age||years|Mean|61.94|61.94|Standard Deviation|13.53|13.53|||
3727012|NCT02072200|3565019|B1|Korea, Republic of||Region of Enrollment||participants|Number|145|145.0||||||
3727013|NCT02072200|3565019|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3727014|NCT02072200|3565019|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3727015|NCT02072200|3565019|B1|||Age||participant|Mean|55.41|55.41|Standard Deviation|11.79|11.79|||
3727016|NCT02072096|3565025|B3|Germany||Region of Enrollment||participants|Number|36|36.0||||||
3727017|NCT02072096|3565026|B2|Germany||Region of Enrollment||participants|Number|17|17.0||||||
3727018|NCT02072096|3565027|B1|Germany||Region of Enrollment||participants|Number|19|19.0||||||
3727019|NCT02072096|3565025|B3|United Kingdom||Region of Enrollment||participants|Number|21|21.0||||||
3727020|NCT02072096|3565026|B2|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
3727021|NCT02072096|3565027|B1|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
3727022|NCT02072096|3565025|B3|United States||Region of Enrollment||participants|Number|64|64.0||||||
3727023|NCT02072096|3565026|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
3727024|NCT02072096|3565027|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3727025|NCT02072096|3565025|B3|Puerto Rico||Region of Enrollment||participants|Number|39|39.0||||||
3727026|NCT02072096|3565026|B2|Puerto Rico||Region of Enrollment||participants|Number|16|16.0||||||
3727027|NCT02072096|3565027|B1|Puerto Rico||Region of Enrollment||participants|Number|23|23.0||||||
3727028|NCT02072096|3565025|B3|Austria||Region of Enrollment||participants|Number|32|32.0||||||
3727029|NCT02072096|3565026|B2|Austria||Region of Enrollment||participants|Number|14|14.0||||||
3727030|NCT02072096|3565027|B1|Austria||Region of Enrollment||participants|Number|18|18.0||||||
3727031|NCT02072096|3565025|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727032|NCT02072096|3565026|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727033|NCT02072096|3565027|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727034|NCT02072096|3565025|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3727035|NCT02072096|3565026|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3727036|NCT02072096|3565027|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727037|NCT02072096|3565025|B3||White|Race (NIH/OMB)||Participants|Count of Participants|174|174.0||||||
3727038|NCT02072096|3565026|B2||White|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
3727039|NCT02072096|3565027|B1||White|Race (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
3727040|NCT02072096|3565025|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3727041|NCT02072096|3565026|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3727042|NCT02072096|3565027|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3727043|NCT02072096|3565025|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727044|NCT02072096|3565026|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727045|NCT02072096|3565027|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727046|NCT02072096|3565025|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727047|NCT02072096|3565026|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727048|NCT02072096|3565027|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727049|NCT02072096|3565025|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3727050|NCT02072096|3565026|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3727051|NCT02072096|3565027|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727052|NCT02072096|3565025|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3727053|NCT02072096|3565026|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3727054|NCT02072096|3565027|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3727055|NCT02072096|3565025|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
3727056|NCT02072096|3565026|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3727057|NCT02072096|3565027|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3727058|NCT02072096|3565025|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3727059|NCT02072096|3565026|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3727098|NCT02071849|3565050|B1|||Age||years|Mean|44.4|44.4|Standard Deviation|11.3|11.3|||
3727060|NCT02072096|3565027|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3727061|NCT02072096|3565025|B3||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3727062|NCT02072096|3565026|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3727063|NCT02072096|3565027|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3727064|NCT02072096|3565025|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3727065|NCT02072096|3565026|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3727066|NCT02072096|3565027|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3727067|NCT02072096|3565025|B3|||Age||years|Mean|70.7|70.7|Standard Deviation|4.9|4.9|||
3727068|NCT02072096|3565026|B2|||Age||years|Mean|70.7|70.7|Standard Deviation|4.4|4.4|||
3727069|NCT02072096|3565027|B1|||Age||years|Mean|70.7|70.7|Standard Deviation|5.3|5.3|||
3727070|NCT02071849|3565050|B1|||Cardiac index|Cardiac index is the cardiac output divided by body surface area.|l/min/m^2|Mean|3.88|3.88|Standard Deviation|1.16|1.16|||
3727071|NCT02071849|3565050|B1|||Cardiac output|Echocardiographic parameter determined by core laboratory.|l/min|Mean|7.926|7.926|Standard Deviation|2.365|2.365|||
3727072|NCT02071849|3565050|B1|||Left ventricular ejection fraction (LVEF)|Left ventricular ejection fraction. Echocardiographic parameter determined by core laboratory.|percentage of blood volume|Mean|53.86|53.86|Standard Deviation|8.76|8.76|||
3727073|NCT02071849|3565050|B1|||LV systolic volume|Left ventricular systolic volume. Echocardiographic parameter determined by core laboratory.|ml|Mean|69.1|69.1|Standard Deviation|36.6|36.6|||
3727074|NCT02071849|3565050|B1|||LV diastolic volume|Left ventricular diastolic volume. Echocardiographic parameter determined by core laboratory.|ml|Mean|144.5|144.5|Standard Deviation|57.6|57.6|||
3727075|NCT02071849|3565050|B1|||LVID systole|Left ventricular internal dimension. Echocardiographic parameter determined by core laboratory.|cm|Mean|3.527|3.527|Standard Deviation|0.793|0.793|||
3727076|NCT02071849|3565050|B1|||Left ventricular internal dimension (LVID) diastole|Left ventricular internal dimension. Echocardiographic parameter determined by core laboratory.|cm|Mean|5.408|5.408|Standard Deviation|0.952|0.952|||
3727077|NCT02071849|3565050|B1|||Left ventricular (LV) mass|Left ventricular mass. Echocardiographic parameter determined by core laboratory.|g|Mean|288.62|288.62|Standard Deviation|90.23|90.23|||
3727078|NCT02071849|3565050|B1|||Mean gradient|Echocardiographic parameter determined by core laboratory.|mm Hg|Mean|13.4|13.4|Standard Deviation|12.9|12.9|||
3727079|NCT02071849|3565050|B1|||Peak gradient|Echocardiographic parameter determined by core laboratory.|mm Hg|Mean|25.5|25.5|Standard Deviation|22.3|22.3|||
3727080|NCT02071849|3565050|B1|IV||New York Heart Association (NYHA) Functional Capacity|Four classes describing the effect of cardiac disease on physical activity: Class I - disease does not limit activity; Class II - slight limitation; Class III - marked limitation; Class IV - inability to carry out any physical activity without discomfort|Participants|Count of Participants|0|0.0||||||
3727081|NCT02071849|3565050|B1|III||New York Heart Association (NYHA) Functional Capacity|Four classes describing the effect of cardiac disease on physical activity: Class I - disease does not limit activity; Class II - slight limitation; Class III - marked limitation; Class IV - inability to carry out any physical activity without discomfort|Participants|Count of Participants|0|0.0||||||
3727082|NCT02071849|3565050|B1|II||New York Heart Association (NYHA) Functional Capacity|Four classes describing the effect of cardiac disease on physical activity: Class I - disease does not limit activity; Class II - slight limitation; Class III - marked limitation; Class IV - inability to carry out any physical activity without discomfort|Participants|Count of Participants|13|13.0||||||
3727083|NCT02071849|3565050|B1|I||New York Heart Association (NYHA) Functional Capacity|Four classes describing the effect of cardiac disease on physical activity: Class I - disease does not limit activity; Class II - slight limitation; Class III - marked limitation; Class IV - inability to carry out any physical activity without discomfort|Participants|Count of Participants|3|3.0||||||
3727084|NCT02071849|3565050|B1|Grade not available||Aortic Insufficiency|"Grade assigned to degree of aortic regurgitation determined by core laboratory analysis of echocardiogram:~0=None/trace,1+=Mild, 2+=Moderate, 3+=Moderately Severe, 4+=Severe"|Participants|Count of Participants|2|2.0||||||
3727085|NCT02071849|3565050|B1|4+||Aortic Insufficiency|"Grade assigned to degree of aortic regurgitation determined by core laboratory analysis of echocardiogram:~0=None/trace,1+=Mild, 2+=Moderate, 3+=Moderately Severe, 4+=Severe"|Participants|Count of Participants|3|3.0||||||
3727086|NCT02071849|3565050|B1|3+||Aortic Insufficiency|"Grade assigned to degree of aortic regurgitation determined by core laboratory analysis of echocardiogram:~0=None/trace,1+=Mild, 2+=Moderate, 3+=Moderately Severe, 4+=Severe"|Participants|Count of Participants|5|5.0||||||
3727087|NCT02071849|3565050|B1|2+||Aortic Insufficiency|"Grade assigned to degree of aortic regurgitation determined by core laboratory analysis of echocardiogram:~0=None/trace,1+=Mild, 2+=Moderate, 3+=Moderately Severe, 4+=Severe"|Participants|Count of Participants|2|2.0||||||
3727088|NCT02071849|3565050|B1|1+||Aortic Insufficiency|"Grade assigned to degree of aortic regurgitation determined by core laboratory analysis of echocardiogram:~0=None/trace,1+=Mild, 2+=Moderate, 3+=Moderately Severe, 4+=Severe"|Participants|Count of Participants|3|3.0||||||
3727089|NCT02071849|3565050|B1|0||Aortic Insufficiency|"Grade assigned to degree of aortic regurgitation determined by core laboratory analysis of echocardiogram:~0=None/trace,1+=Mild, 2+=Moderate, 3+=Moderately Severe, 4+=Severe"|Participants|Count of Participants|1|1.0||||||
3727090|NCT02071849|3565050|B1|Germany||Region of Enrollment||participants|Number|16|16.0||||||
3727091|NCT02071849|3565050|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3727092|NCT02071849|3565050|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3727093|NCT02071849|3565050|B1|60-69||Age, Customized||Participants|Count of Participants|1|1.0||||||
3727094|NCT02071849|3565050|B1|50-59||Age, Customized||Participants|Count of Participants|4|4.0||||||
3727095|NCT02071849|3565050|B1|40-49||Age, Customized||Participants|Count of Participants|6|6.0||||||
3727096|NCT02071849|3565050|B1|30-39||Age, Customized||Participants|Count of Participants|2|2.0||||||
3727097|NCT02071849|3565050|B1|18-29||Age, Customized||Participants|Count of Participants|3|3.0||||||
3727099|NCT02071823|3565082|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3727100|NCT02071823|3565083|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3727101|NCT02071823|3565084|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3727102|NCT02071823|3565082|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3727103|NCT02071823|3565083|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3727104|NCT02071823|3565084|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3727105|NCT02071823|3565082|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3727106|NCT02071823|3565083|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3727107|NCT02071823|3565084|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3727108|NCT02071823|3565082|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3727109|NCT02071823|3565083|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3727110|NCT02071823|3565084|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3727111|NCT02071823|3565082|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727112|NCT02071823|3565083|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727113|NCT02071823|3565084|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727114|NCT02071810|3565095|B6||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3727115|NCT02071810|3565096|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3727116|NCT02071810|3565097|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3727117|NCT02071810|3565098|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3727118|NCT02071810|3565099|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3727119|NCT02071810|3565100|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3727120|NCT02071810|3565095|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3727121|NCT02071810|3565096|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3727122|NCT02071810|3565097|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3727123|NCT02071810|3565098|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3727124|NCT02071810|3565099|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3727125|NCT02071810|3565100|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3727126|NCT02071810|3565095|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3727127|NCT02071810|3565096|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3727128|NCT02071810|3565097|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3727129|NCT02071810|3565098|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3727130|NCT02071810|3565099|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3727131|NCT02071810|3565100|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3727132|NCT02071810|3565095|B6||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3727133|NCT02071810|3565096|B5||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3727134|NCT02071810|3565097|B4||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3727135|NCT02071810|3565098|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3727136|NCT02071810|3565099|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3727137|NCT02071810|3565100|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3727138|NCT02071810|3565095|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727139|NCT02071810|3565096|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727140|NCT02071810|3565097|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727141|NCT02071810|3565098|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727142|NCT02071810|3565099|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727143|NCT02071810|3565100|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727144|NCT02071771|3565116|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3727145|NCT02071771|3565116|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3727146|NCT02071771|3565116|B1|||Age||years|Mean|32.9|32.9|Standard Deviation|9.4|9.4|||
3727147|NCT02071420|3565125|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
3727148|NCT02071420|3565126|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3727149|NCT02071420|3565127|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3727150|NCT02071420|3565125|B3|Male||Sex/Gender, Customized||participants|Number|18|18.0||||||
3727151|NCT02071420|3565126|B2|Male||Sex/Gender, Customized||participants|Number|9|9.0||||||
3727152|NCT02071420|3565127|B1|Male||Sex/Gender, Customized||participants|Number|9|9.0||||||
3727153|NCT02071420|3565125|B3|Female||Sex/Gender, Customized||participants|Number|42|42.0||||||
3727154|NCT02071420|3565126|B2|Female||Sex/Gender, Customized||participants|Number|21|21.0||||||
3727155|NCT02071420|3565127|B1|Female||Sex/Gender, Customized||participants|Number|21|21.0||||||
3727156|NCT02071420|3565125|B3|||Age||years|Mean|45.1|45.1|Standard Deviation|10.8|10.8|||
3727157|NCT02071420|3565126|B2|||Age||years|Mean|45.0|45.0|Standard Deviation|10.7|10.7|||
3727158|NCT02071420|3565127|B1|||Age||years|Mean|45.2|45.2|Standard Deviation|10.9|10.9|||
3727159|NCT02071420|3565125|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3727160|NCT02071420|3565126|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3727161|NCT02071420|3565127|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3727162|NCT02071420|3565125|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3727163|NCT02071420|3565126|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3727164|NCT02071420|3565127|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3727165|NCT02071420|3565125|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727166|NCT02071420|3565126|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727167|NCT02071420|3565127|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727168|NCT02071108|3565134|B1|Austria||Region of Enrollment||participants|Number|28|28.0||||||
3727169|NCT02071108|3565134|B1|New Zealand||Region of Enrollment||participants|Number|7|7.0||||||
3727170|NCT02071108|3565134|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3727171|NCT02071108|3565134|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3727172|NCT02071108|3565134|B1||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
3727173|NCT02071108|3565134|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3727174|NCT02071108|3565134|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727175|NCT02071095|3565153|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3727176|NCT02071095|3565154|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3727177|NCT02071095|3565155|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3727178|NCT02071095|3565153|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3727179|NCT02071095|3565154|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3727180|NCT02071095|3565155|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3727181|NCT02071095|3565153|B3|||Age||years|Mean|39.73|39.73|Standard Deviation|8.61|8.61|||
3727182|NCT02071095|3565154|B2|||Age||years|Mean|34.33|34.33|Standard Deviation|4.03|4.03|||
3727183|NCT02071095|3565155|B1|||Age||years|Mean|41.1|41.1|Standard Deviation|9.32|9.32|||
3727184|NCT02071082|3565170|B3|||Fibrotest® Score|The FibroTest® score is used to assess liver fibrosis. Scores range from 0.00 to 1.00, with higher scores indicating a greater degree of fibrosis.|units on a scale|Median|0.34|0.34|Inter-Quartile Range|||0.21|0.53|
3727185|NCT02071082|3565171|B2|||Fibrotest® Score|The FibroTest® score is used to assess liver fibrosis. Scores range from 0.00 to 1.00, with higher scores indicating a greater degree of fibrosis.|units on a scale|Median|0.35|0.35|Inter-Quartile Range|||0.21|0.54|
3727186|NCT02071082|3565172|B1|||Fibrotest® Score|The FibroTest® score is used to assess liver fibrosis. Scores range from 0.00 to 1.00, with higher scores indicating a greater degree of fibrosis.|units on a scale|Median|0.27|0.27|Inter-Quartile Range|||0.16|0.28|
3727187|NCT02071082|3565170|B3|Borderline||Hepatitis B e-Antibody Status||participants|Number|5|5.0||||||
3727188|NCT02071082|3565171|B2|Borderline||Hepatitis B e-Antibody Status||participants|Number|5|5.0||||||
3727189|NCT02071082|3565172|B1|Borderline||Hepatitis B e-Antibody Status||participants|Number|0|0.0||||||
3727190|NCT02071082|3565170|B3|Negative||Hepatitis B e-Antibody Status||participants|Number|46|46.0||||||
3727191|NCT02071082|3565171|B2|Negative||Hepatitis B e-Antibody Status||participants|Number|43|43.0||||||
3727192|NCT02071082|3565172|B1|Negative||Hepatitis B e-Antibody Status||participants|Number|3|3.0||||||
3727193|NCT02071082|3565170|B3|Positive||Hepatitis B e-Antibody Status||participants|Number|26|26.0||||||
3727194|NCT02071082|3565171|B2|Positive||Hepatitis B e-Antibody Status||participants|Number|26|26.0||||||
3727195|NCT02071082|3565172|B1|Positive||Hepatitis B e-Antibody Status||participants|Number|0|0.0||||||
3727196|NCT02071082|3565170|B3|Negative||Hepatitis B Surface Antigen Status||participants|Number|3|3.0||||||
3727197|NCT02071082|3565171|B2|Negative||Hepatitis B Surface Antigen Status||participants|Number|3|3.0||||||
3727198|NCT02071082|3565172|B1|Negative||Hepatitis B Surface Antigen Status||participants|Number|0|0.0||||||
3727199|NCT02071082|3565170|B3|Positive||Hepatitis B Surface Antigen Status||participants|Number|74|74.0||||||
3727200|NCT02071082|3565171|B2|Positive||Hepatitis B Surface Antigen Status||participants|Number|71|71.0||||||
3727201|NCT02071082|3565172|B1|Positive||Hepatitis B Surface Antigen Status||participants|Number|3|3.0||||||
3727202|NCT02071082|3565170|B3|||Alanine Aminotransferase (ALT)||U/L|Mean|33|33.0|Standard Deviation|23.9|23.9|||
3727203|NCT02071082|3565171|B2|||Alanine Aminotransferase (ALT)||U/L|Mean|31|31.0|Standard Deviation|21.1|21.1|||
3727204|NCT02071082|3565172|B1|||Alanine Aminotransferase (ALT)||U/L|Mean|84|84.0|Standard Deviation|38.9|38.9|||
3727205|NCT02071082|3565170|B3|≥ 29 IU/mL||HBV DNA Category||participants|Number|13|13.0||||||
3727206|NCT02071082|3565171|B2|≥ 29 IU/mL||HBV DNA Category||participants|Number|10|10.0||||||
3727207|NCT02071082|3565172|B1|≥ 29 IU/mL||HBV DNA Category||participants|Number|3|3.0||||||
3727208|NCT02071082|3565170|B3|< 29 IU/mL||HBV DNA Category||participants|Number|64|64.0||||||
3727209|NCT02071082|3565171|B2|< 29 IU/mL||HBV DNA Category||participants|Number|64|64.0||||||
3727210|NCT02071082|3565172|B1|< 29 IU/mL||HBV DNA Category||participants|Number|0|0.0||||||
3727211|NCT02071082|3565170|B3|||HBV DNA||log10 IU/mL|Mean|1.75|1.75|Standard Deviation|1.588|1.588|||
3727212|NCT02071082|3565171|B2|||HBV DNA||log10 IU/mL|Mean|1.49|1.49|Standard Deviation|0.883|0.883|||
3727213|NCT02071082|3565172|B1|||HBV DNA||log10 IU/mL|Mean|8.31|8.31|Standard Deviation|0.416|0.416|||
3727214|NCT02071082|3565170|B3|≥ 50 copies/mL||HIV-1 RNA Category||participants|Number|4|4.0||||||
3727215|NCT02071082|3565171|B2|≥ 50 copies/mL||HIV-1 RNA Category||participants|Number|1|1.0||||||
3727216|NCT02071082|3565172|B1|≥ 50 copies/mL||HIV-1 RNA Category||participants|Number|3|3.0||||||
3727217|NCT02071082|3565170|B3|< 50 copies/mL||HIV-1 RNA Category||participants|Number|73|73.0||||||
3727218|NCT02071082|3565171|B2|< 50 copies/mL||HIV-1 RNA Category||participants|Number|73|73.0||||||
3727219|NCT02071082|3565172|B1|< 50 copies/mL||HIV-1 RNA Category||participants|Number|0|0.0||||||
3727220|NCT02071082|3565170|B3|||HIV-1 RNA||log10 copies/mL|Mean|1.41|1.41|Standard Deviation|0.606|0.606|||
3727221|NCT02071082|3565171|B2|||HIV-1 RNA||log10 copies/mL|Mean|1.29|1.29|Standard Deviation|0.068|0.068|||
3727222|NCT02071082|3565172|B1|||HIV-1 RNA||log10 copies/mL|Mean|4.20|4.2|Standard Deviation|1.242|1.242|||
3727223|NCT02071082|3565170|B3|Japan||Region of Enrollment||participants|Number|4|4.0||||||
3727224|NCT02071082|3565171|B2|Japan||Region of Enrollment||participants|Number|2|2.0||||||
3727225|NCT02071082|3565172|B1|Japan||Region of Enrollment||participants|Number|2|2.0||||||
3727226|NCT02071082|3565170|B3|United States||Region of Enrollment||participants|Number|63|63.0||||||
3727227|NCT02071082|3565171|B2|United States||Region of Enrollment||participants|Number|62|62.0||||||
3727228|NCT02071082|3565172|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3727229|NCT02071082|3565170|B3|Canada||Region of Enrollment||participants|Number|10|10.0||||||
3727230|NCT02071082|3565171|B2|Canada||Region of Enrollment||participants|Number|10|10.0||||||
3727231|NCT02071082|3565172|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
3727232|NCT02071082|3565170|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
3727233|NCT02071082|3565171|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
3727234|NCT02071082|3565172|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3727235|NCT02071082|3565170|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3727236|NCT02071082|3565171|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3727237|NCT02071082|3565172|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3727238|NCT02071082|3565170|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3727239|NCT02071082|3565171|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3727240|NCT02071082|3565172|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3727241|NCT02071082|3565170|B3|White||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
3727242|NCT02071082|3565171|B2|White||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
3727243|NCT02071082|3565172|B1|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3727244|NCT02071082|3565170|B3|Black||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3727245|NCT02071082|3565171|B2|Black||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3727246|NCT02071082|3565172|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3727247|NCT02071082|3565170|B3|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3727248|NCT02071082|3565171|B2|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3727249|NCT02071082|3565172|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3727250|NCT02071082|3565170|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3727251|NCT02071082|3565171|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3727252|NCT02071082|3565172|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3727253|NCT02071082|3565170|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3727254|NCT02071082|3565171|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3727255|NCT02071082|3565172|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3727256|NCT02071082|3565170|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3727257|NCT02071082|3565171|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3727258|NCT02071082|3565172|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3727259|NCT02071082|3565170|B3|||Age||years|Mean|49|49.0|Standard Deviation|8.9|8.9|||
3727260|NCT02071082|3565171|B2|||Age||years|Mean|49|49.0|Standard Deviation|7.8|7.8|||
3727261|NCT02071082|3565172|B1|||Age||years|Mean|27|27.0|Standard Deviation|4.0|4.0|||
3727262|NCT02070965|3565201|B4|||Normal Adrenal Corticotropic Hormone (ACTH) test||Participants|Count of Participants|74|74.0||||||
3727263|NCT02070965|3565202|B3|||Normal Adrenal Corticotropic Hormone (ACTH) test||Participants|Count of Participants|25|25.0||||||
3727264|NCT02070965|3565203|B2|||Normal Adrenal Corticotropic Hormone (ACTH) test||Participants|Count of Participants|22|22.0||||||
3727265|NCT02070965|3565204|B1|||Normal Adrenal Corticotropic Hormone (ACTH) test||Participants|Count of Participants|27|27.0||||||
3727266|NCT02070965|3565201|B4||IGA 4 (Severe/Very Severe)|Investigator's Global Assessment (IGA)||Participants|Count of Participants|11|11.0||||||
3727267|NCT02070965|3565202|B3||IGA 4 (Severe/Very Severe)|Investigator's Global Assessment (IGA)||Participants|Count of Participants|3|3.0||||||
3727268|NCT02070965|3565203|B2||IGA 4 (Severe/Very Severe)|Investigator's Global Assessment (IGA)||Participants|Count of Participants|1|1.0||||||
3727269|NCT02070965|3565204|B1||IGA 4 (Severe/Very Severe)|Investigator's Global Assessment (IGA)||Participants|Count of Participants|7|7.0||||||
3727270|NCT02070965|3565201|B4||IGA 3 (Moderate)|Investigator's Global Assessment (IGA)||Participants|Count of Participants|63|63.0||||||
3727271|NCT02070965|3565202|B3||IGA 3 (Moderate)|Investigator's Global Assessment (IGA)||Participants|Count of Participants|22|22.0||||||
3727272|NCT02070965|3565203|B2||IGA 3 (Moderate)|Investigator's Global Assessment (IGA)||Participants|Count of Participants|21|21.0||||||
3727273|NCT02070965|3565204|B1||IGA 3 (Moderate)|Investigator's Global Assessment (IGA)||Participants|Count of Participants|20|20.0||||||
3727274|NCT02070965|3565201|B4|||Percent Body Surface Area (BSA) involved||Percent BSA affected|Mean|27.4|27.4|Standard Deviation|8.90|8.9|||
3727275|NCT02070965|3565202|B3|||Percent Body Surface Area (BSA) involved||Percent BSA affected|Mean|29.0|29.0|Standard Deviation|11.04|11.04|||
3727276|NCT02070965|3565203|B2|||Percent Body Surface Area (BSA) involved||Percent BSA affected|Mean|26.8|26.8|Standard Deviation|6.32|6.32|||
3727335|NCT02070744|3565217|B2|||Age||years|Mean|24.2|24.2|Standard Deviation|2.2|2.2|||
3727277|NCT02070965|3565204|B1|||Percent Body Surface Area (BSA) involved||Percent BSA affected|Mean|26.5|26.5|Standard Deviation|8.61|8.61|||
3727278|NCT02070965|3565201|B4|United States||Region of Enrollment||Participants|Count of Participants|74|74.0||||||
3727279|NCT02070965|3565202|B3|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3727280|NCT02070965|3565203|B2|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3727281|NCT02070965|3565204|B1|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3727282|NCT02070965|3565201|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727283|NCT02070965|3565202|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727284|NCT02070965|3565203|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727285|NCT02070965|3565204|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727286|NCT02070965|3565201|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727287|NCT02070965|3565202|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727288|NCT02070965|3565203|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727289|NCT02070965|3565204|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727290|NCT02070965|3565201|B4||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3727291|NCT02070965|3565202|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3727292|NCT02070965|3565203|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3727293|NCT02070965|3565204|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3727294|NCT02070965|3565201|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3727295|NCT02070965|3565202|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3727296|NCT02070965|3565203|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3727297|NCT02070965|3565204|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3727298|NCT02070965|3565201|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727299|NCT02070965|3565202|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727300|NCT02070965|3565203|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727301|NCT02070965|3565204|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727302|NCT02070965|3565201|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3727303|NCT02070965|3565202|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3727304|NCT02070965|3565203|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3727305|NCT02070965|3565204|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3727306|NCT02070965|3565201|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727307|NCT02070965|3565202|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727308|NCT02070965|3565203|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727309|NCT02070965|3565204|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727310|NCT02070965|3565201|B4||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3727311|NCT02070965|3565202|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3727312|NCT02070965|3565203|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3727313|NCT02070965|3565204|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3727314|NCT02070965|3565201|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3727315|NCT02070965|3565202|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3727316|NCT02070965|3565203|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3727317|NCT02070965|3565204|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3727318|NCT02070965|3565201|B4|||Age||years|Mean|46.7|46.7|Standard Deviation|11.55|11.55|||
3727319|NCT02070965|3565202|B3|||Age||years|Mean|47.6|47.6|Standard Deviation|13.71|13.71|||
3727320|NCT02070965|3565203|B2|||Age||years|Mean|45.4|45.4|Standard Deviation|11.32|11.32|||
3727321|NCT02070965|3565204|B1|||Age||years|Mean|46.8|46.8|Standard Deviation|9.99|9.99|||
3727322|NCT02070744|3565214|B5||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3727323|NCT02070744|3565215|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3727324|NCT02070744|3565216|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3727325|NCT02070744|3565217|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3727326|NCT02070744|3565218|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3727327|NCT02070744|3565214|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3727328|NCT02070744|3565215|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3727329|NCT02070744|3565216|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3727330|NCT02070744|3565217|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3727331|NCT02070744|3565218|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3727332|NCT02070744|3565214|B5|||Age||years|Mean|28.8|28.8|Standard Deviation|8.3|8.3|||
3727333|NCT02070744|3565215|B4|||Age||years|Mean|30.3|30.3|Standard Deviation|10.8|10.8|||
3727334|NCT02070744|3565216|B3|||Age||years|Mean|27.3|27.3|Standard Deviation|5.2|5.2|||
3727336|NCT02070744|3565218|B1|||Age||years|Mean|33.0|33.0|Standard Deviation|10.6|10.6|||
3727337|NCT02070692|3565272|B3|||Days of bleeding/spotting in 30 days prior to enrollment||days|Mean|19.75|19.75|Standard Deviation|7.9|7.9|||
3727338|NCT02070692|3565273|B2|||Days of bleeding/spotting in 30 days prior to enrollment||days|Mean|22.2|22.2|Standard Deviation|6.6|6.6|||
3727339|NCT02070692|3565274|B1|||Days of bleeding/spotting in 30 days prior to enrollment||days|Mean|17.3|17.3|Standard Deviation|8.5|8.5|||
3727340|NCT02070692|3565272|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3727341|NCT02070692|3565273|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3727342|NCT02070692|3565274|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727343|NCT02070692|3565272|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3727344|NCT02070692|3565273|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3727345|NCT02070692|3565274|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3727346|NCT02070692|3565272|B3||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3727347|NCT02070692|3565273|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3727348|NCT02070692|3565274|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3727349|NCT02070692|3565272|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3727350|NCT02070692|3565273|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3727351|NCT02070692|3565274|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3727352|NCT02070692|3565272|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3727353|NCT02070692|3565273|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3727354|NCT02070692|3565274|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727355|NCT02070692|3565272|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727356|NCT02070692|3565273|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727357|NCT02070692|3565274|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727358|NCT02070692|3565272|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3727359|NCT02070692|3565273|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3727360|NCT02070692|3565274|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3727361|NCT02070692|3565272|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3727362|NCT02070692|3565273|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3727363|NCT02070692|3565274|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3727364|NCT02070692|3565272|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3727365|NCT02070692|3565273|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3727366|NCT02070692|3565274|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3727367|NCT02070692|3565272|B3|||Age||years|Mean|24.6|24.6|Full Range|||15.0|38.0|
3727368|NCT02070692|3565273|B2|||Age||years|Mean|23.9|23.9|Full Range|||15.0|38.0|
3727369|NCT02070692|3565274|B1|||Age||years|Mean|25.4|25.4|Full Range|||18.0|36.0|
3727370|NCT02070640|3565289|B3|United States||Region of Enrollment||participants|Number|88|88.0||||||
3727371|NCT02070640|3565290|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3727372|NCT02070640|3565291|B1|United States||Region of Enrollment||participants|Number|82|82.0||||||
3727373|NCT02070640|3565289|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3727374|NCT02070640|3565290|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3727375|NCT02070640|3565291|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3727376|NCT02070640|3565289|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3727377|NCT02070640|3565290|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3727378|NCT02070640|3565291|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3727379|NCT02070640|3565289|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3727380|NCT02070640|3565290|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3727381|NCT02070640|3565291|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3727382|NCT02070640|3565289|B3||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
3727383|NCT02070640|3565290|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3727384|NCT02070640|3565291|B1||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
3727385|NCT02070640|3565289|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727386|NCT02070640|3565290|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727387|NCT02070640|3565291|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727388|NCT02070588|3565302|B4|United States||Region of Enrollment||Participants|Count of Participants|112|112.0||||||
3727389|NCT02070588|3565303|B3|United States||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3727390|NCT02070588|3565304|B2|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3727391|NCT02070588|3565305|B1|United States||Region of Enrollment||Participants|Count of Participants|86|86.0||||||
3727392|NCT02070588|3565302|B4||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3727393|NCT02070588|3565303|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3727394|NCT02070588|3565304|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3727395|NCT02070588|3565305|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3727396|NCT02070588|3565302|B4||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3727397|NCT02070588|3565303|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3727398|NCT02070588|3565304|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3727399|NCT02070588|3565305|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3727400|NCT02070588|3565302|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3727401|NCT02070588|3565303|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3727402|NCT02070588|3565304|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3727403|NCT02070588|3565305|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3727404|NCT02070588|3565302|B4||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
3727405|NCT02070588|3565303|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3727406|NCT02070588|3565304|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3727407|NCT02070588|3565305|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3727408|NCT02070588|3565302|B4||<=18 years|Age||Participants|Count of Participants|47|47.0||||||
3727409|NCT02070588|3565303|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727410|NCT02070588|3565304|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3727411|NCT02070588|3565305|B1||<=18 years|Age||Participants|Count of Participants|41|41.0||||||
3727412|NCT02070484|3565321|B3|||Oswestry Disability Index|The Oswestry Disability Index (ODI) measures disability on a scale of 0-100, where higher scores correspond to greater disability.|units on a scale|Mean|27.7|27.7|Full Range|||19.0|34.0|
3727413|NCT02070484|3565322|B2|||Oswestry Disability Index|The Oswestry Disability Index (ODI) measures disability on a scale of 0-100, where higher scores correspond to greater disability.|units on a scale|Mean|26.7|26.7|Full Range|||19.0|34.0|
3727414|NCT02070484|3565323|B1|||Oswestry Disability Index|The Oswestry Disability Index (ODI) measures disability on a scale of 0-100, where higher scores correspond to greater disability.|units on a scale|Mean|28.7|28.7|Full Range|||26.0|32.0|
3727415|NCT02070484|3565321|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3727416|NCT02070484|3565321|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3727417|NCT02070484|3565322|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3727418|NCT02070484|3565323|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3727419|NCT02070484|3565321|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3727420|NCT02070484|3565322|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3727421|NCT02070484|3565323|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3727422|NCT02070484|3565321|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3727423|NCT02070484|3565322|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3727424|NCT02070484|3565323|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3727425|NCT02070484|3565321|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3727426|NCT02070484|3565322|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3727427|NCT02070484|3565323|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3727428|NCT02070484|3565321|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727429|NCT02070484|3565322|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727430|NCT02070484|3565323|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727431|NCT02070380|3565342|B5|Europe||Region of Enrollment||participants|Number|90|90.0||||||
3727432|NCT02070380|3565343|B4|Europe||Region of Enrollment||participants|Number|25|25.0||||||
3727433|NCT02070380|3565344|B3|Europe||Region of Enrollment||participants|Number|29|29.0||||||
3727434|NCT02070380|3565345|B2|Europe||Region of Enrollment||participants|Number|17|17.0||||||
3727435|NCT02070380|3565346|B1|Europe||Region of Enrollment||participants|Number|19|19.0||||||
3727436|NCT02070380|3565342|B5|United States||Region of Enrollment||participants|Number|69|69.0||||||
3727437|NCT02070380|3565343|B4|United States||Region of Enrollment||participants|Number|21|21.0||||||
3727438|NCT02070380|3565344|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
3727439|NCT02070380|3565345|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3727440|NCT02070380|3565346|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3727441|NCT02070380|3565342|B5|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3727442|NCT02070380|3565343|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3727443|NCT02070380|3565344|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3727444|NCT02070380|3565345|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3727445|NCT02070380|3565346|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3727446|NCT02070380|3565342|B5|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3727447|NCT02070380|3565343|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3727448|NCT02070380|3565344|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3727449|NCT02070380|3565345|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3727450|NCT02070380|3565346|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3727451|NCT02070380|3565342|B5|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3727452|NCT02070380|3565343|B4|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3727453|NCT02070380|3565344|B3|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3727454|NCT02070380|3565345|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3727455|NCT02070380|3565346|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3727456|NCT02070380|3565342|B5|White||Race/Ethnicity, Customized||participants|Number|154|154.0||||||
3727457|NCT02070380|3565343|B4|White||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
3727458|NCT02070380|3565344|B3|White||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
3727459|NCT02070380|3565345|B2|White||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3727460|NCT02070380|3565346|B1|White||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3727461|NCT02070380|3565342|B5||Male|Gender||Participants|Count of Participants|72|72.0||||||
3727462|NCT02070380|3565343|B4||Male|Gender||Participants|Count of Participants|24|24.0||||||
3727463|NCT02070380|3565344|B3||Male|Gender||Participants|Count of Participants|25|25.0||||||
3727464|NCT02070380|3565345|B2||Male|Gender||Participants|Count of Participants|12|12.0||||||
3727465|NCT02070380|3565346|B1||Male|Gender||Participants|Count of Participants|11|11.0||||||
3727466|NCT02070380|3565342|B5||Female|Gender||Participants|Count of Participants|87|87.0||||||
3727467|NCT02070380|3565343|B4||Female|Gender||Participants|Count of Participants|22|22.0||||||
3727468|NCT02070380|3565344|B3||Female|Gender||Participants|Count of Participants|25|25.0||||||
3727469|NCT02070380|3565345|B2||Female|Gender||Participants|Count of Participants|20|20.0||||||
3727470|NCT02070380|3565346|B1||Female|Gender||Participants|Count of Participants|20|20.0||||||
3727471|NCT02070380|3565342|B5||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
3727472|NCT02070380|3565343|B4||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3727473|NCT02070380|3565344|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3727474|NCT02070380|3565345|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3727475|NCT02070380|3565346|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3727476|NCT02070380|3565342|B5||Between 18 and 65 years|Age||Participants|Count of Participants|108|108.0||||||
3727477|NCT02070380|3565343|B4||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3727478|NCT02070380|3565344|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3727479|NCT02070380|3565345|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3727480|NCT02070380|3565346|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3727481|NCT02070380|3565342|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727482|NCT02070380|3565343|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727483|NCT02070380|3565344|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727484|NCT02070380|3565345|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727485|NCT02070380|3565346|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727486|NCT02070302|3565397|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3727487|NCT02070302|3565398|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3727488|NCT02070302|3565399|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3727489|NCT02070302|3565397|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3727490|NCT02070302|3565398|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3727491|NCT02070302|3565399|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3727492|NCT02070302|3565397|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3727493|NCT02070302|3565398|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3727494|NCT02070302|3565399|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3727495|NCT02070302|3565397|B3|||Age||years|Mean|56.35|56.35|Standard Deviation|5.7|5.7|||
3727496|NCT02070302|3565398|B2|||Age||years|Mean|52.3|52.3|Standard Deviation|20.3|20.3|||
3727497|NCT02070302|3565399|B1|||Age||years|Mean|60.4|60.4|Standard Deviation|17.9|17.9|||
3727498|NCT02070302|3565397|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3727499|NCT02070302|3565398|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3727500|NCT02070302|3565399|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3727501|NCT02070302|3565397|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3727502|NCT02070302|3565398|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3727503|NCT02070302|3565399|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3727504|NCT02070302|3565397|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727505|NCT02070302|3565398|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727506|NCT02070302|3565399|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727507|NCT02070237|3565416|B3|United States||Region of Enrollment||participants|Number|90|90.0||||||
3727508|NCT02070237|3565417|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
3727509|NCT02070237|3565418|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
3727510|NCT02070237|3565416|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3727511|NCT02070237|3565417|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3727512|NCT02070237|3565418|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3727513|NCT02070237|3565416|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3727514|NCT02070237|3565417|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3727515|NCT02070237|3565418|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3727516|NCT02070237|3565416|B3|||Age||years|Mean|32|32.0|Standard Deviation|6.8|6.8|||
3727517|NCT02070237|3565417|B2|||Age||years|Mean|30|30.0|Standard Deviation|5.4|5.4|||
3727518|NCT02070237|3565418|B1|||Age||years|Mean|33|33.0|Standard Deviation|6.6|6.6|||
3727519|NCT02070237|3565416|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3727520|NCT02070237|3565417|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3727521|NCT02070237|3565418|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3727522|NCT02070237|3565416|B3||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
3727523|NCT02070237|3565417|B2||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3727524|NCT02070237|3565418|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3727525|NCT02070237|3565416|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727526|NCT02070237|3565417|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727527|NCT02070237|3565418|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727528|NCT02069379|3565427|B3|||HOMA Insulin Resistance (IR)||HOMA IR|Mean|2.56|2.56|Standard Deviation|1.12|1.12|||
3727529|NCT02069379|3565428|B2|||HOMA Insulin Resistance (IR)||HOMA IR|Mean|3.94|3.94|Standard Deviation|1.11|1.11|||
3727530|NCT02069379|3565429|B1|||HOMA Insulin Resistance (IR)||HOMA IR|Mean|2.01|2.01|Standard Deviation|0.42|0.42|||
3727531|NCT02069379|3565427|B3|||Plasma Insulin Levels||mIU/L|Mean|12.71|12.71|Standard Deviation|4.61|4.61|||
3727532|NCT02069379|3565428|B2|||Plasma Insulin Levels||mIU/L|Mean|18.61|18.61|Standard Deviation|3.36|3.36|||
3727533|NCT02069379|3565429|B1|||Plasma Insulin Levels||mIU/L|Mean|10.18|10.18|Standard Deviation|1.99|1.99|||
3727534|NCT02069379|3565427|B3|||Glucose||mg/dL|Mean|81.60|81.6|Standard Deviation|7.21|7.21|||
3727535|NCT02069379|3565428|B2|||Glucose||mg/dL|Mean|84.67|84.67|Standard Deviation|9.99|9.99|||
3727536|NCT02069379|3565429|B1|||Glucose||mg/dL|Mean|80.29|80.29|Standard Deviation|5.33|5.33|||
3727537|NCT02069379|3565427|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
3727538|NCT02069379|3565428|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3727539|NCT02069379|3565429|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3727540|NCT02069379|3565427|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3727541|NCT02069379|3565428|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727542|NCT02069379|3565429|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3727543|NCT02069379|3565427|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3727544|NCT02069379|3565428|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727545|NCT02069379|3565429|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3727546|NCT02069379|3565427|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3727547|NCT02069379|3565428|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3727548|NCT02069379|3565429|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3727549|NCT02069379|3565427|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3727550|NCT02069379|3565428|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3727551|NCT02069379|3565429|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3727552|NCT02069379|3565427|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727553|NCT02069379|3565428|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727554|NCT02069379|3565429|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727555|NCT02069379|3565427|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3727556|NCT02069379|3565428|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3727557|NCT02069379|3565429|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3727558|NCT02069379|3565427|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3727559|NCT02069379|3565428|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727560|NCT02069379|3565429|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3727561|NCT02069379|3565427|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3727562|NCT02069379|3565428|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3727563|NCT02069379|3565429|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3727564|NCT02069379|3565427|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727565|NCT02069379|3565428|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727566|NCT02069379|3565429|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727567|NCT02069379|3565427|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727568|NCT02069379|3565428|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727569|NCT02069379|3565429|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727570|NCT02069379|3565427|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3727571|NCT02069379|3565428|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3727572|NCT02069379|3565429|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3727573|NCT02069379|3565427|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3727574|NCT02069379|3565428|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3727575|NCT02069379|3565429|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3727576|NCT02069379|3565427|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3727577|NCT02069379|3565428|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3727578|NCT02069379|3565429|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3727579|NCT02069379|3565427|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3727580|NCT02069379|3565428|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3727581|NCT02069379|3565429|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3727582|NCT02069379|3565427|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727583|NCT02069379|3565428|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727584|NCT02069379|3565429|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727585|NCT02069119|3565458|B5|Japan||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
3727586|NCT02069119|3565459|B4|Japan||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3727587|NCT02069119|3565460|B3|Japan||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3727588|NCT02069119|3565461|B2|Japan||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3727589|NCT02069119|3565462|B1|Japan||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3727590|NCT02069119|3565458|B5||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3727591|NCT02069119|3565459|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3727592|NCT02069119|3565460|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3727593|NCT02069119|3565461|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3727594|NCT02069119|3565462|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3727595|NCT02069119|3565458|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3727596|NCT02069119|3565459|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3727597|NCT02069119|3565460|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3727598|NCT02069119|3565461|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3727599|NCT02069119|3565462|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3727600|NCT02069119|3565458|B5|||Age||years|Mean|67.1|67.1|Standard Deviation|8.8|8.8|||
3727601|NCT02069119|3565459|B4|||Age||years|Mean|60.0|60.0|Standard Deviation|13.3|13.3|||
3727602|NCT02069119|3565460|B3|||Age||years|Mean|65.4|65.4|Standard Deviation|8.8|8.8|||
3727603|NCT02069119|3565461|B2|||Age||years|Mean|67.5|67.5|Standard Deviation|3.8|3.8|||
3727604|NCT02069119|3565462|B1|||Age||years|Mean|70.1|70.1|Standard Deviation|7.7|7.7|||
3727605|NCT02069119|3565458|B5||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
3727606|NCT02069119|3565459|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3727607|NCT02069119|3565460|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3727608|NCT02069119|3565461|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3727609|NCT02069119|3565462|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3727610|NCT02069119|3565458|B5||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3727611|NCT02069119|3565459|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3727612|NCT02069119|3565460|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3727613|NCT02069119|3565461|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3727614|NCT02069119|3565462|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3727615|NCT02069119|3565458|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727616|NCT02069119|3565459|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727617|NCT02069119|3565460|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727618|NCT02069119|3565461|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727619|NCT02069119|3565462|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727620|NCT02069093|3565489|B1|Female||Sex/Gender, Customized||Participants|Number|86|86.0||||||
3727621|NCT02069093|3565489|B1|||Age||Years|Mean|61.02|61.02|Standard Deviation|10.921|10.921|||
3727622|NCT02069041|3565498|B1|Test Negative||Viral hepatitis B||Participants|Count of Participants|0|0.0||||||
3727623|NCT02069041|3565498|B1|Test Positive||Viral hepatitis B||Participants|Count of Participants|8|8.0||||||
3727624|NCT02069041|3565498|B1|Missing||Barcelona Clinic Liver Cancer (BCLC) Classification|"The following is BCLC classification:~Stage A: Early hepatocellular carcinoma. Stage B: Intermediate hepatocellular carcinoma. Stage C: Advanced hepatocellular carcinoma. Stage D: End stage hepatocellular carcinoma."|Participants|Count of Participants|0|0.0||||||
3727625|NCT02069041|3565498|B1|Stage D||Barcelona Clinic Liver Cancer (BCLC) Classification|"The following is BCLC classification:~Stage A: Early hepatocellular carcinoma. Stage B: Intermediate hepatocellular carcinoma. Stage C: Advanced hepatocellular carcinoma. Stage D: End stage hepatocellular carcinoma."|Participants|Count of Participants|0|0.0||||||
3727626|NCT02069041|3565498|B1|Stage C||Barcelona Clinic Liver Cancer (BCLC) Classification|"The following is BCLC classification:~Stage A: Early hepatocellular carcinoma. Stage B: Intermediate hepatocellular carcinoma. Stage C: Advanced hepatocellular carcinoma. Stage D: End stage hepatocellular carcinoma."|Participants|Count of Participants|7|7.0||||||
3727627|NCT02069041|3565498|B1|Stage B||Barcelona Clinic Liver Cancer (BCLC) Classification|"The following is BCLC classification:~Stage A: Early hepatocellular carcinoma. Stage B: Intermediate hepatocellular carcinoma. Stage C: Advanced hepatocellular carcinoma. Stage D: End stage hepatocellular carcinoma."|Participants|Count of Participants|1|1.0||||||
3727655|NCT02069041|3565498|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3727656|NCT02069041|3565498|B1|||Age||years|Mean|55.56|55.56|Standard Deviation|11.06|11.06|||
3727628|NCT02069041|3565498|B1|Stage A||Barcelona Clinic Liver Cancer (BCLC) Classification|"The following is BCLC classification:~Stage A: Early hepatocellular carcinoma. Stage B: Intermediate hepatocellular carcinoma. Stage C: Advanced hepatocellular carcinoma. Stage D: End stage hepatocellular carcinoma."|Participants|Count of Participants|0|0.0||||||
3727629|NCT02069041|3565498|B1|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Following are ECOG grades. 0: Fully active, perform all pre-disease activities without restriction. 1: Restricted in physically strenuous activity but ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of selfcare, unable to carry out any work activities, up and about more than (>) 50% of waking hours. 3: Capable of limited selfcare, confined to bed or chair >50% of waking hours. 4: Completely disabled, not capable of any selfcare, totally confined to bed or chair. 5: Dead. Participants in Not reported category were on study, had no data for this time point."|Participants|Count of Participants|0|0.0||||||
3727630|NCT02069041|3565498|B1|>2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Following are ECOG grades. 0: Fully active, perform all pre-disease activities without restriction. 1: Restricted in physically strenuous activity but ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of selfcare, unable to carry out any work activities, up and about more than (>) 50% of waking hours. 3: Capable of limited selfcare, confined to bed or chair >50% of waking hours. 4: Completely disabled, not capable of any selfcare, totally confined to bed or chair. 5: Dead. Participants in Not reported category were on study, had no data for this time point."|Participants|Count of Participants|0|0.0||||||
3727631|NCT02069041|3565498|B1|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Following are ECOG grades. 0: Fully active, perform all pre-disease activities without restriction. 1: Restricted in physically strenuous activity but ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of selfcare, unable to carry out any work activities, up and about more than (>) 50% of waking hours. 3: Capable of limited selfcare, confined to bed or chair >50% of waking hours. 4: Completely disabled, not capable of any selfcare, totally confined to bed or chair. 5: Dead. Participants in Not reported category were on study, had no data for this time point."|Participants|Count of Participants|0|0.0||||||
3727632|NCT02069041|3565498|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Following are ECOG grades. 0: Fully active, perform all pre-disease activities without restriction. 1: Restricted in physically strenuous activity but ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of selfcare, unable to carry out any work activities, up and about more than (>) 50% of waking hours. 3: Capable of limited selfcare, confined to bed or chair >50% of waking hours. 4: Completely disabled, not capable of any selfcare, totally confined to bed or chair. 5: Dead. Participants in Not reported category were on study, had no data for this time point."|Participants|Count of Participants|4|4.0||||||
3727633|NCT02069041|3565498|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Following are ECOG grades. 0: Fully active, perform all pre-disease activities without restriction. 1: Restricted in physically strenuous activity but ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of selfcare, unable to carry out any work activities, up and about more than (>) 50% of waking hours. 3: Capable of limited selfcare, confined to bed or chair >50% of waking hours. 4: Completely disabled, not capable of any selfcare, totally confined to bed or chair. 5: Dead. Participants in Not reported category were on study, had no data for this time point."|Participants|Count of Participants|4|4.0||||||
3727634|NCT02069041|3565498|B1|||Duration of Disease (months)|Duration of disease is time from date of histology/cytologic confirmation of advanced solid tumor to date of first dose.|months|Median|0.345|0.345|Full Range|||0.23|0.66|
3727635|NCT02069041|3565498|B1|Unknown||Disease Stage|Stage means how big the tumor is and how far it has spread. Stages range from I (spread to nearby tissue) to IV (spread throughout the body).|Participants|Count of Participants|0|0.0||||||
3727636|NCT02069041|3565498|B1|Stage IV||Disease Stage|Stage means how big the tumor is and how far it has spread. Stages range from I (spread to nearby tissue) to IV (spread throughout the body).|Participants|Count of Participants|1|1.0||||||
3727637|NCT02069041|3565498|B1|Stage III||Disease Stage|Stage means how big the tumor is and how far it has spread. Stages range from I (spread to nearby tissue) to IV (spread throughout the body).|Participants|Count of Participants|4|4.0||||||
3727638|NCT02069041|3565498|B1|Stage II||Disease Stage|Stage means how big the tumor is and how far it has spread. Stages range from I (spread to nearby tissue) to IV (spread throughout the body).|Participants|Count of Participants|1|1.0||||||
3727639|NCT02069041|3565498|B1|Stage I||Disease Stage|Stage means how big the tumor is and how far it has spread. Stages range from I (spread to nearby tissue) to IV (spread throughout the body).|Participants|Count of Participants|0|0.0||||||
3727640|NCT02069041|3565498|B1|Biochemical Assay and Imaging||Basis of Initial Pathological Diagnosis||Participants|Count of Participants|2|2.0||||||
3727641|NCT02069041|3565498|B1|Cytological||Basis of Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
3727642|NCT02069041|3565498|B1|Histopathological||Basis of Initial Pathological Diagnosis||Participants|Count of Participants|3|3.0||||||
3727643|NCT02069041|3565498|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3727644|NCT02069041|3565498|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727645|NCT02069041|3565498|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727646|NCT02069041|3565498|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727647|NCT02069041|3565498|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727648|NCT02069041|3565498|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727649|NCT02069041|3565498|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3727650|NCT02069041|3565498|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727651|NCT02069041|3565498|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727652|NCT02069041|3565498|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3727653|NCT02069041|3565498|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727654|NCT02069041|3565498|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3727657|NCT02068599|3565506|B4|||Body Mass Index||kg/m^2|Mean|28.174|28.174|Standard Deviation|3.1092|3.1092|||
3727658|NCT02068599|3565507|B3|||Body Mass Index||kg/m^2|Mean|28.340|28.34|Standard Deviation|3.2364|3.2364|||
3727659|NCT02068599|3565508|B2|||Body Mass Index||kg/m^2|Mean|28.190|28.19|Standard Deviation|3.0207|3.0207|||
3727660|NCT02068599|3565509|B1|||Body Mass Index||kg/m^2|Mean|27.992|27.992|Standard Deviation|3.0800|3.08|||
3727661|NCT02068599|3565506|B4|||Height||cm|Mean|168.48|168.48|Standard Deviation|10.095|10.095|||
3727662|NCT02068599|3565507|B3|||Height||cm|Mean|167.99|167.99|Standard Deviation|9.526|9.526|||
3727663|NCT02068599|3565508|B2|||Height||cm|Mean|169.06|169.06|Standard Deviation|9.927|9.927|||
3727664|NCT02068599|3565509|B1|||Height||cm|Mean|168.41|168.41|Standard Deviation|10.835|10.835|||
3727665|NCT02068599|3565506|B4|||Weight||kg|Mean|80.33|80.33|Standard Deviation|13.568|13.568|||
3727666|NCT02068599|3565507|B3|||Weight||kg|Mean|80.29|80.29|Standard Deviation|13.633|13.633|||
3727667|NCT02068599|3565508|B2|||Weight||kg|Mean|80.87|80.87|Standard Deviation|13.010|13.01|||
3727668|NCT02068599|3565509|B1|||Weight||kg|Mean|79.83|79.83|Standard Deviation|14.119|14.119|||
3727669|NCT02068599|3565506|B4||Homozygous common allele (negative, GG)|R1150W Polymorphism Status|Patients who carry the R1150W polymorphism have a nucleotide containing adenine (A) instead of guanine (G) in the rs6746030 single nucleotide polymorphism in the SCN9A gene. This change causes an arginine to tryptophan amino acid residue change at position 1150 in the alpha subunit of the voltage-gated sodium channel NaV1.7. Those who carry the R1150W polymorphism may be heterozygous (GA) or homozygous (AA) for the minor allele. This R1150W polymorphism in the SCN9A gene may affect pain perception (Reimann et al 2010).|Participants|Count of Participants|302|302.0||||||
3727670|NCT02068599|3565507|B3||Homozygous common allele (negative, GG)|R1150W Polymorphism Status|Patients who carry the R1150W polymorphism have a nucleotide containing adenine (A) instead of guanine (G) in the rs6746030 single nucleotide polymorphism in the SCN9A gene. This change causes an arginine to tryptophan amino acid residue change at position 1150 in the alpha subunit of the voltage-gated sodium channel NaV1.7. Those who carry the R1150W polymorphism may be heterozygous (GA) or homozygous (AA) for the minor allele. This R1150W polymorphism in the SCN9A gene may affect pain perception (Reimann et al 2010).|Participants|Count of Participants|103|103.0||||||
3727671|NCT02068599|3565508|B2||Homozygous common allele (negative, GG)|R1150W Polymorphism Status|Patients who carry the R1150W polymorphism have a nucleotide containing adenine (A) instead of guanine (G) in the rs6746030 single nucleotide polymorphism in the SCN9A gene. This change causes an arginine to tryptophan amino acid residue change at position 1150 in the alpha subunit of the voltage-gated sodium channel NaV1.7. Those who carry the R1150W polymorphism may be heterozygous (GA) or homozygous (AA) for the minor allele. This R1150W polymorphism in the SCN9A gene may affect pain perception (Reimann et al 2010).|Participants|Count of Participants|98|98.0||||||
3727672|NCT02068599|3565509|B1||Homozygous common allele (negative, GG)|R1150W Polymorphism Status|Patients who carry the R1150W polymorphism have a nucleotide containing adenine (A) instead of guanine (G) in the rs6746030 single nucleotide polymorphism in the SCN9A gene. This change causes an arginine to tryptophan amino acid residue change at position 1150 in the alpha subunit of the voltage-gated sodium channel NaV1.7. Those who carry the R1150W polymorphism may be heterozygous (GA) or homozygous (AA) for the minor allele. This R1150W polymorphism in the SCN9A gene may affect pain perception (Reimann et al 2010).|Participants|Count of Participants|101|101.0||||||
3727673|NCT02068599|3565506|B4||Heterozygous (positive, AG)|R1150W Polymorphism Status|Patients who carry the R1150W polymorphism have a nucleotide containing adenine (A) instead of guanine (G) in the rs6746030 single nucleotide polymorphism in the SCN9A gene. This change causes an arginine to tryptophan amino acid residue change at position 1150 in the alpha subunit of the voltage-gated sodium channel NaV1.7. Those who carry the R1150W polymorphism may be heterozygous (GA) or homozygous (AA) for the minor allele. This R1150W polymorphism in the SCN9A gene may affect pain perception (Reimann et al 2010).|Participants|Count of Participants|81|81.0||||||
3727674|NCT02068599|3565507|B3||Heterozygous (positive, AG)|R1150W Polymorphism Status|Patients who carry the R1150W polymorphism have a nucleotide containing adenine (A) instead of guanine (G) in the rs6746030 single nucleotide polymorphism in the SCN9A gene. This change causes an arginine to tryptophan amino acid residue change at position 1150 in the alpha subunit of the voltage-gated sodium channel NaV1.7. Those who carry the R1150W polymorphism may be heterozygous (GA) or homozygous (AA) for the minor allele. This R1150W polymorphism in the SCN9A gene may affect pain perception (Reimann et al 2010).|Participants|Count of Participants|26|26.0||||||
3727675|NCT02068599|3565508|B2||Heterozygous (positive, AG)|R1150W Polymorphism Status|Patients who carry the R1150W polymorphism have a nucleotide containing adenine (A) instead of guanine (G) in the rs6746030 single nucleotide polymorphism in the SCN9A gene. This change causes an arginine to tryptophan amino acid residue change at position 1150 in the alpha subunit of the voltage-gated sodium channel NaV1.7. Those who carry the R1150W polymorphism may be heterozygous (GA) or homozygous (AA) for the minor allele. This R1150W polymorphism in the SCN9A gene may affect pain perception (Reimann et al 2010).|Participants|Count of Participants|28|28.0||||||
3727676|NCT02068599|3565509|B1||Heterozygous (positive, AG)|R1150W Polymorphism Status|Patients who carry the R1150W polymorphism have a nucleotide containing adenine (A) instead of guanine (G) in the rs6746030 single nucleotide polymorphism in the SCN9A gene. This change causes an arginine to tryptophan amino acid residue change at position 1150 in the alpha subunit of the voltage-gated sodium channel NaV1.7. Those who carry the R1150W polymorphism may be heterozygous (GA) or homozygous (AA) for the minor allele. This R1150W polymorphism in the SCN9A gene may affect pain perception (Reimann et al 2010).|Participants|Count of Participants|27|27.0||||||
3727677|NCT02068599|3565506|B4||Homozygous minor allele (positive, AA)|R1150W Polymorphism Status|Patients who carry the R1150W polymorphism have a nucleotide containing adenine (A) instead of guanine (G) in the rs6746030 single nucleotide polymorphism in the SCN9A gene. This change causes an arginine to tryptophan amino acid residue change at position 1150 in the alpha subunit of the voltage-gated sodium channel NaV1.7. Those who carry the R1150W polymorphism may be heterozygous (GA) or homozygous (AA) for the minor allele. This R1150W polymorphism in the SCN9A gene may affect pain perception (Reimann et al 2010).|Participants|Count of Participants|6|6.0||||||
3727726|NCT02068599|3565507|B3|||Age||years|Mean|59.0|59.0|Standard Deviation|9.65|9.65|||
3727727|NCT02068599|3565508|B2|||Age||years|Mean|59.2|59.2|Standard Deviation|9.52|9.52|||
3727678|NCT02068599|3565507|B3||Homozygous minor allele (positive, AA)|R1150W Polymorphism Status|Patients who carry the R1150W polymorphism have a nucleotide containing adenine (A) instead of guanine (G) in the rs6746030 single nucleotide polymorphism in the SCN9A gene. This change causes an arginine to tryptophan amino acid residue change at position 1150 in the alpha subunit of the voltage-gated sodium channel NaV1.7. Those who carry the R1150W polymorphism may be heterozygous (GA) or homozygous (AA) for the minor allele. This R1150W polymorphism in the SCN9A gene may affect pain perception (Reimann et al 2010).|Participants|Count of Participants|1|1.0||||||
3727679|NCT02068599|3565508|B2||Homozygous minor allele (positive, AA)|R1150W Polymorphism Status|Patients who carry the R1150W polymorphism have a nucleotide containing adenine (A) instead of guanine (G) in the rs6746030 single nucleotide polymorphism in the SCN9A gene. This change causes an arginine to tryptophan amino acid residue change at position 1150 in the alpha subunit of the voltage-gated sodium channel NaV1.7. Those who carry the R1150W polymorphism may be heterozygous (GA) or homozygous (AA) for the minor allele. This R1150W polymorphism in the SCN9A gene may affect pain perception (Reimann et al 2010).|Participants|Count of Participants|3|3.0||||||
3727680|NCT02068599|3565509|B1||Homozygous minor allele (positive, AA)|R1150W Polymorphism Status|Patients who carry the R1150W polymorphism have a nucleotide containing adenine (A) instead of guanine (G) in the rs6746030 single nucleotide polymorphism in the SCN9A gene. This change causes an arginine to tryptophan amino acid residue change at position 1150 in the alpha subunit of the voltage-gated sodium channel NaV1.7. Those who carry the R1150W polymorphism may be heterozygous (GA) or homozygous (AA) for the minor allele. This R1150W polymorphism in the SCN9A gene may affect pain perception (Reimann et al 2010).|Participants|Count of Participants|2|2.0||||||
3727681|NCT02068599|3565506|B4||Other|Race||Participants|Count of Participants|7|7.0||||||
3727682|NCT02068599|3565507|B3||Other|Race||Participants|Count of Participants|1|1.0||||||
3727683|NCT02068599|3565508|B2||Other|Race||Participants|Count of Participants|4|4.0||||||
3727684|NCT02068599|3565509|B1||Other|Race||Participants|Count of Participants|2|2.0||||||
3727685|NCT02068599|3565506|B4||Pacific Islander|Race||Participants|Count of Participants|0|0.0||||||
3727686|NCT02068599|3565507|B3||Pacific Islander|Race||Participants|Count of Participants|0|0.0||||||
3727687|NCT02068599|3565508|B2||Pacific Islander|Race||Participants|Count of Participants|0|0.0||||||
3727688|NCT02068599|3565509|B1||Pacific Islander|Race||Participants|Count of Participants|0|0.0||||||
3727689|NCT02068599|3565506|B4||American Indian or Alaska Native|Race||Participants|Count of Participants|1|1.0||||||
3727690|NCT02068599|3565507|B3||American Indian or Alaska Native|Race||Participants|Count of Participants|0|0.0||||||
3727691|NCT02068599|3565508|B2||American Indian or Alaska Native|Race||Participants|Count of Participants|0|0.0||||||
3727692|NCT02068599|3565509|B1||American Indian or Alaska Native|Race||Participants|Count of Participants|1|1.0||||||
3727693|NCT02068599|3565506|B4||Asian|Race||Participants|Count of Participants|31|31.0||||||
3727694|NCT02068599|3565507|B3||Asian|Race||Participants|Count of Participants|8|8.0||||||
3727695|NCT02068599|3565508|B2||Asian|Race||Participants|Count of Participants|9|9.0||||||
3727696|NCT02068599|3565509|B1||Asian|Race||Participants|Count of Participants|14|14.0||||||
3727697|NCT02068599|3565506|B4||Black|Race||Participants|Count of Participants|91|91.0||||||
3727698|NCT02068599|3565507|B3||Black|Race||Participants|Count of Participants|33|33.0||||||
3727699|NCT02068599|3565508|B2||Black|Race||Participants|Count of Participants|33|33.0||||||
3727700|NCT02068599|3565509|B1||Black|Race||Participants|Count of Participants|25|25.0||||||
3727701|NCT02068599|3565506|B4||White|Race||Participants|Count of Participants|259|259.0||||||
3727702|NCT02068599|3565507|B3||White|Race||Participants|Count of Participants|88|88.0||||||
3727703|NCT02068599|3565508|B2||White|Race||Participants|Count of Participants|83|83.0||||||
3727704|NCT02068599|3565509|B1||White|Race||Participants|Count of Participants|88|88.0||||||
3727705|NCT02068599|3565506|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727706|NCT02068599|3565507|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727707|NCT02068599|3565508|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727708|NCT02068599|3565509|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727709|NCT02068599|3565506|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|315|315.0||||||
3727710|NCT02068599|3565507|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
3727711|NCT02068599|3565508|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
3727712|NCT02068599|3565509|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
3727713|NCT02068599|3565506|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3727714|NCT02068599|3565507|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3727715|NCT02068599|3565508|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3727716|NCT02068599|3565509|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3727717|NCT02068599|3565506|B4||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3727718|NCT02068599|3565507|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3727719|NCT02068599|3565508|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3727720|NCT02068599|3565509|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3727721|NCT02068599|3565506|B4||Female|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
3727722|NCT02068599|3565507|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3727723|NCT02068599|3565508|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3727724|NCT02068599|3565509|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3727725|NCT02068599|3565506|B4|||Age||years|Mean|59.5|59.5|Standard Deviation|9.44|9.44|||
3727728|NCT02068599|3565509|B1|||Age||years|Mean|60.2|60.2|Standard Deviation|9.17|9.17|||
3727729|NCT02068547|3565549|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3727730|NCT02068547|3565550|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3727731|NCT02068547|3565551|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3727732|NCT02068547|3565549|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727733|NCT02068547|3565550|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727734|NCT02068547|3565551|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727735|NCT02068547|3565549|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727736|NCT02068547|3565550|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727737|NCT02068547|3565551|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727738|NCT02068547|3565549|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3727739|NCT02068547|3565550|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3727740|NCT02068547|3565551|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3727741|NCT02068547|3565549|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3727742|NCT02068547|3565550|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3727743|NCT02068547|3565551|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3727744|NCT02068547|3565549|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727745|NCT02068547|3565550|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727746|NCT02068547|3565551|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727747|NCT02068547|3565549|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727748|NCT02068547|3565550|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727749|NCT02068547|3565551|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727750|NCT02068547|3565549|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727751|NCT02068547|3565550|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727752|NCT02068547|3565551|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727753|NCT02068547|3565549|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727754|NCT02068547|3565550|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727755|NCT02068547|3565551|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727756|NCT02068547|3565549|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3727757|NCT02068547|3565550|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3727758|NCT02068547|3565551|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3727759|NCT02068547|3565549|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727760|NCT02068547|3565550|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727761|NCT02068547|3565551|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727762|NCT02068547|3565549|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3727763|NCT02068547|3565550|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3727764|NCT02068547|3565551|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3727765|NCT02068547|3565549|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3727766|NCT02068547|3565550|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3727767|NCT02068547|3565551|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3727768|NCT02068547|3565549|B3|||Age||years|Mean|56.42|56.42|Full Range|||36.84|67.33|
3727769|NCT02068547|3565550|B2|||Age||years|Mean|59.75|59.75|Full Range|||55.87|62.66|
3727770|NCT02068547|3565551|B1|||Age||years|Mean|53.09|53.09|Full Range|||36.84|67.33|
3727771|NCT02068547|3565549|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3727772|NCT02068547|3565550|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3727773|NCT02068547|3565551|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3727774|NCT02068547|3565549|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3727775|NCT02068547|3565550|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3727776|NCT02068547|3565551|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3727777|NCT02068547|3565549|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727778|NCT02068547|3565550|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727779|NCT02068547|3565551|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727780|NCT02068495|3565562|B1||Had Used Antihypertensive Drug|Use of Antihypertensive Drug Prior to the Start of the Study Drug||Participants|Count of Participants|3100|3100.0||||||
3727781|NCT02068495|3565562|B1||Had Not Used Antihypertensive Drug|Use of Antihypertensive Drug Prior to the Start of the Study Drug||Participants|Count of Participants|200|200.0||||||
3727782|NCT02068495|3565562|B1||Unknown|Smoking Classification||Participants|Count of Participants|449|449.0||||||
3727783|NCT02068495|3565562|B1||Ex-Smoker|Smoking Classification||Participants|Count of Participants|383|383.0||||||
3727784|NCT02068495|3565562|B1||Current Smoker|Smoking Classification||Participants|Count of Participants|402|402.0||||||
3727785|NCT02068495|3565562|B1||Never Smoked|Smoking Classification||Participants|Count of Participants|2066|2066.0||||||
3727786|NCT02068495|3565562|B1||Unknown|Drinking Habits||Participants|Count of Participants|451|451.0||||||
3727787|NCT02068495|3565562|B1||Ex-Drinker|Drinking Habits||Participants|Count of Participants|200|200.0||||||
3727788|NCT02068495|3565562|B1||Current Drinker|Drinking Habits||Participants|Count of Participants|942|942.0||||||
3727789|NCT02068495|3565562|B1||Never Drank|Drinking Habits||Participants|Count of Participants|1707|1707.0||||||
3727790|NCT02068495|3565562|B1|||Waist Circumference||centimeter (cm)]|Mean|86.47|86.47|Standard Deviation|9.85|9.85|||
3727791|NCT02068495|3565562|B1|||BMI|Body Mass Index = weight (kg)/[height (m)^2]|kg/m^2|Mean|24.14|24.14|Standard Deviation|3.83|3.83|||
3727792|NCT02068495|3565562|B1|||Weight||kilograms (kg)|Mean|60.43|60.43|Standard Deviation|13.04|13.04|||
3727793|NCT02068495|3565562|B1||Unknown|Medical History||Participants|Count of Participants|103|103.0||||||
3727794|NCT02068495|3565562|B1||Had Presence of Medial History|Medical History||Participants|Count of Participants|630|630.0||||||
3727795|NCT02068495|3565562|B1||Had No Presence of Medical History|Medical History||Participants|Count of Participants|2567|2567.0||||||
3727796|NCT02068495|3565562|B1||Had Presence of Medical Complications|Medical Complications|Complications defined as a disease or a health condition for each participant at the start of study. Complications were classified as congenital anomalies, endocrine disorders, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, gastrointestinal (GI) disorders, renal disease and other complications. Other complications included all complications except for those mentioned above.|Participants|Count of Participants|2509|2509.0||||||
3727797|NCT02068495|3565562|B1||Had No Presence of Medical Complications|Medical Complications|Complications defined as a disease or a health condition for each participant at the start of study. Complications were classified as congenital anomalies, endocrine disorders, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, gastrointestinal (GI) disorders, renal disease and other complications. Other complications included all complications except for those mentioned above.|Participants|Count of Participants|791|791.0||||||
3727798|NCT02068495|3565562|B1||Unknown|History of Allergy||Participants|Count of Participants|206|206.0||||||
3727799|NCT02068495|3565562|B1||Had Presence of History of Allergy|History of Allergy||Participants|Count of Participants|222|222.0||||||
3727800|NCT02068495|3565562|B1||Had No Presence of History of Allergy|History of Allergy||Participants|Count of Participants|2872|2872.0||||||
3727801|NCT02068495|3565562|B1|||Non Breast-Feeding Females||Participants|Count of Participants|1692|1692.0||||||
3727802|NCT02068495|3565562|B1||Outpatient and Inpatient|Healthcare Category|Participants were categorized as outpatient, inpatient, and outpatient and inpatient (participants who were both outpatient and inpatient throughout study).|Participants|Count of Participants|70|70.0||||||
3727803|NCT02068495|3565562|B1||Inpatient|Healthcare Category|Participants were categorized as outpatient, inpatient, and outpatient and inpatient (participants who were both outpatient and inpatient throughout study).|Participants|Count of Participants|8|8.0||||||
3727804|NCT02068495|3565562|B1||Outpatient|Healthcare Category|Participants were categorized as outpatient, inpatient, and outpatient and inpatient (participants who were both outpatient and inpatient throughout study).|Participants|Count of Participants|3222|3222.0||3.83|3.83|||
3727805|NCT02068495|3565562|B1|||Duration of Hypertension|Mean Duration between start of study and first time of diagnosis of hypertension was reported.|Years|Mean|6.29|6.29|Standard Deviation|6.57|6.57|||
3727806|NCT02068495|3565562|B1|Japan||Region of Enrollment||Participants|Number|3300|3300.0||||||
3727807|NCT02068495|3565562|B1||Male|Sex: Female, Male||Participants|Count of Participants|1608|1608.0||||||
3727808|NCT02068495|3565562|B1||Female|Sex: Female, Male||Participants|Count of Participants|1692|1692.0||||||
3727809|NCT02068495|3565562|B1|||Age||Years|Mean|68.8|68.8|Standard Deviation|12.2|12.2|||
3727810|NCT02068443|3565571|B4|||Homeostasis Model Assessment Beta Cell Index (HOMA-β)||percent|Mean|35.82|35.82|Standard Deviation|26.464|26.464|||
3727811|NCT02068443|3565572|B3|||Homeostasis Model Assessment Beta Cell Index (HOMA-β)||percent|Mean|34.27|34.27|Standard Deviation|23.638|23.638|||
3727812|NCT02068443|3565573|B2|||Homeostasis Model Assessment Beta Cell Index (HOMA-β)||percent|Mean|36.05|36.05|Standard Deviation|27.848|27.848|||
3727813|NCT02068443|3565574|B1|||Homeostasis Model Assessment Beta Cell Index (HOMA-β)||percent|Mean|38.64|38.64|Standard Deviation|29.181|29.181|||
3727814|NCT02068443|3565571|B4|||Homeostasis Model Assessment of Insulin Resistance (HOMA-R)||unitless|Mean|3.93|3.93|Standard Deviation|2.916|2.916|||
3727815|NCT02068443|3565572|B3|||Homeostasis Model Assessment of Insulin Resistance (HOMA-R)||unitless|Mean|3.92|3.92|Standard Deviation|2.820|2.82|||
3727816|NCT02068443|3565573|B2|||Homeostasis Model Assessment of Insulin Resistance (HOMA-R)||unitless|Mean|3.87|3.87|Standard Deviation|2.869|2.869|||
3727817|NCT02068443|3565574|B1|||Homeostasis Model Assessment of Insulin Resistance (HOMA-R)||unitless|Mean|4.05|4.05|Standard Deviation|3.238|3.238|||
3727818|NCT02068443|3565571|B4|||Fasting Glucagon||pg/mL|Mean|88.8|88.8|Standard Deviation|25.89|25.89|||
3727819|NCT02068443|3565572|B3|||Fasting Glucagon||pg/mL|Mean|89.3|89.3|Standard Deviation|27.98|27.98|||
3727820|NCT02068443|3565573|B2|||Fasting Glucagon||pg/mL|Mean|86.8|86.8|Standard Deviation|21.27|21.27|||
3727821|NCT02068443|3565574|B1|||Fasting Glucagon||pg/mL|Mean|91.7|91.7|Standard Deviation|30.03|30.03|||
3727822|NCT02068443|3565571|B4|||Fasting Insulin||μU/mL|Mean|9.501|9.501|Standard Deviation|6.4990|6.499|||
3727823|NCT02068443|3565572|B3|||Fasting Insulin||μU/mL|Mean|9.342|9.342|Standard Deviation|6.0645|6.0645|||
3727824|NCT02068443|3565573|B2|||Fasting Insulin||μU/mL|Mean|9.464|9.464|Standard Deviation|6.7691|6.7691|||
3727825|NCT02068443|3565574|B1|||Fasting Insulin||μU/mL|Mean|9.918|9.918|Standard Deviation|6.8797|6.8797|||
3727826|NCT02068443|3565571|B4|||Fasting Blood Glucose||mg/dL|Mean|164.7|164.7|Standard Deviation|30.92|30.92|||
3727827|NCT02068443|3565572|B3|||Fasting Blood Glucose||mg/dL|Mean|165.9|165.9|Standard Deviation|30.92|30.92|||
3727828|NCT02068443|3565573|B2|||Fasting Blood Glucose||mg/dL|Mean|164.7|164.7|Standard Deviation|31.02|31.02|||
3727829|NCT02068443|3565574|B1|||Fasting Blood Glucose||mg/dL|Mean|162.4|162.4|Standard Deviation|31.03|31.03|||
3727830|NCT02068443|3565571|B4|||Hemoglobin A1c (HbA1c) [National Glycohemoglobin Standardization Program (NGSP)]||percent|Mean|7.84|7.84|Standard Deviation|0.800|0.8|||
3727831|NCT02068443|3565572|B3|||Hemoglobin A1c (HbA1c) [National Glycohemoglobin Standardization Program (NGSP)]||percent|Mean|7.89|7.89|Standard Deviation|0.791|0.791|||
3727832|NCT02068443|3565573|B2|||Hemoglobin A1c (HbA1c) [National Glycohemoglobin Standardization Program (NGSP)]||percent|Mean|7.82|7.82|Standard Deviation|0.820|0.82|||
3727833|NCT02068443|3565574|B1|||Hemoglobin A1c (HbA1c) [National Glycohemoglobin Standardization Program (NGSP)]||percent|Mean|7.77|7.77|Standard Deviation|0.780|0.78|||
3727834|NCT02068443|3565571|B4|||Estimated Glomerular Filtration Rate (eGFR)||mL/min/1.73 m^2|Mean|89.2|89.2|Standard Deviation|17.11|17.11|||
3727835|NCT02068443|3565572|B3|||Estimated Glomerular Filtration Rate (eGFR)||mL/min/1.73 m^2|Mean|87.9|87.9|Standard Deviation|17.86|17.86|||
3727836|NCT02068443|3565573|B2|||Estimated Glomerular Filtration Rate (eGFR)||mL/min/1.73 m^2|Mean|91.0|91.0|Standard Deviation|16.82|16.82|||
3727837|NCT02068443|3565574|B1|||Estimated Glomerular Filtration Rate (eGFR)||mL/min/1.73 m^2|Mean|88.2|88.2|Standard Deviation|15.99|15.99|||
3727838|NCT02068443|3565571|B4|||Duration of Type 2 Diabetes||years|Mean|7.16|7.16|Standard Deviation|5.195|5.195|||
3727839|NCT02068443|3565572|B3|||Duration of Type 2 Diabetes||years|Mean|7.04|7.04|Standard Deviation|5.380|5.38|||
3727840|NCT02068443|3565573|B2|||Duration of Type 2 Diabetes||years|Mean|7.02|7.02|Standard Deviation|5.257|5.257|||
3727841|NCT02068443|3565574|B1|||Duration of Type 2 Diabetes||years|Mean|7.73|7.73|Standard Deviation|4.666|4.666|||
3727842|NCT02068443|3565571|B4|||Body Mass Index (BMI)||kg/m^2|Mean|25.41|25.41|Standard Deviation|4.196|4.196|||
3727843|NCT02068443|3565572|B3|||Body Mass Index (BMI)||kg/m^2|Mean|25.52|25.52|Standard Deviation|4.344|4.344|||
3727844|NCT02068443|3565573|B2|||Body Mass Index (BMI)||kg/m^2|Mean|25.61|25.61|Standard Deviation|4.231|4.231|||
3727845|NCT02068443|3565574|B1|||Body Mass Index (BMI)||kg/m^2|Mean|24.72|24.72|Standard Deviation|3.764|3.764|||
3727846|NCT02068443|3565571|B4|||Body Weight||kg|Mean|69.23|69.23|Standard Deviation|13.943|13.943|||
3727847|NCT02068443|3565572|B3|||Body Weight||kg|Mean|69.55|69.55|Standard Deviation|14.927|14.927|||
3727848|NCT02068443|3565573|B2|||Body Weight||kg|Mean|69.48|69.48|Standard Deviation|13.074|13.074|||
3727849|NCT02068443|3565574|B1|||Body Weight||kg|Mean|68.00|68.0|Standard Deviation|13.702|13.702|||
3727850|NCT02068443|3565571|B4|||Height||cm|Mean|164.8|164.8|Standard Deviation|8.94|8.94|||
3727851|NCT02068443|3565572|B3|||Height||cm|Mean|164.6|164.6|Standard Deviation|9.12|9.12|||
3727852|NCT02068443|3565573|B2|||Height||cm|Mean|164.6|164.6|Standard Deviation|8.82|8.82|||
3727853|NCT02068443|3565574|B1|||Height||cm|Mean|165.3|165.3|Standard Deviation|8.89|8.89|||
3727854|NCT02068443|3565571|B4|Japan||Region of Enrollment||participants|Number|374|374.0||||||
3727855|NCT02068443|3565572|B3|Japan||Region of Enrollment||participants|Number|151|151.0||||||
3727856|NCT02068443|3565573|B2|Japan||Region of Enrollment||participants|Number|152|152.0||||||
3727857|NCT02068443|3565574|B1|Japan||Region of Enrollment||participants|Number|71|71.0||||||
3727858|NCT02068443|3565571|B4||Male|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
3727859|NCT02068443|3565572|B3||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3727860|NCT02068443|3565573|B2||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3727861|NCT02068443|3565574|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3727862|NCT02068443|3565571|B4||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3727863|NCT02068443|3565572|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3727864|NCT02068443|3565573|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3727865|NCT02068443|3565574|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3727866|NCT02068443|3565571|B4|≥ 65 years||Age, Customized||participants|Number|94|94.0||||||
3727867|NCT02068443|3565572|B3|≥ 65 years||Age, Customized||participants|Number|42|42.0||||||
3727868|NCT02068443|3565573|B2|≥ 65 years||Age, Customized||participants|Number|33|33.0||||||
3727869|NCT02068443|3565574|B1|≥ 65 years||Age, Customized||participants|Number|19|19.0||||||
3727870|NCT02068443|3565571|B4|< 65 years||Age, Customized||participants|Number|280|280.0||||||
3727871|NCT02068443|3565572|B3|< 65 years||Age, Customized||participants|Number|109|109.0||||||
3727872|NCT02068443|3565573|B2|< 65 years||Age, Customized||participants|Number|119|119.0||||||
3727873|NCT02068443|3565574|B1|< 65 years||Age, Customized||participants|Number|52|52.0||||||
3727874|NCT02068443|3565571|B4|||Age||years|Mean|57.2|57.2|Standard Deviation|9.40|9.4|||
3727875|NCT02068443|3565572|B3|||Age||years|Mean|57.6|57.6|Standard Deviation|9.72|9.72|||
3727876|NCT02068443|3565573|B2|||Age||years|Mean|56.9|56.9|Standard Deviation|8.79|8.79|||
3727877|NCT02068443|3565574|B1|||Age||years|Mean|57.2|57.2|Standard Deviation|10.07|10.07|||
3727878|NCT02068222|3565611|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3727879|NCT02068222|3565611|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3727880|NCT02068222|3565611|B1|||Age||years|Mean|52.5|52.5|Standard Deviation|10.19|10.19|||
3727881|NCT02068157|3565618|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727882|NCT02068157|3565618|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727883|NCT02068157|3565618|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3727884|NCT02068157|3565618|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3727885|NCT02068157|3565618|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727886|NCT02068157|3565618|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727887|NCT02068157|3565618|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727888|NCT02068157|3565618|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3727889|NCT02068157|3565618|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3727890|NCT02068157|3565618|B1|||Age||years|Mean|56.1|56.1|Standard Deviation|14.1|14.1|||
3727891|NCT02068157|3565618|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3727892|NCT02068157|3565618|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3727893|NCT02068157|3565618|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727894|NCT02068027|3565623|B3|United States||Region of Enrollment||participants|Number|260|260.0||||||
3727895|NCT02068027|3565624|B2|United States||Region of Enrollment||participants|Number|130|130.0||||||
3727896|NCT02068027|3565625|B1|United States||Region of Enrollment||participants|Number|130|130.0||||||
3727897|NCT02068027|3565623|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727898|NCT02068027|3565624|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727899|NCT02068027|3565625|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727900|NCT02068027|3565623|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727901|NCT02068027|3565624|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727902|NCT02068027|3565625|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727903|NCT02068027|3565623|B3||White|Race (NIH/OMB)||Participants|Count of Participants|192|192.0||||||
3727904|NCT02068027|3565624|B2||White|Race (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
3727905|NCT02068027|3565625|B1||White|Race (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3727906|NCT02068027|3565623|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3727907|NCT02068027|3565624|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3727908|NCT02068027|3565625|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3727909|NCT02068027|3565623|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727910|NCT02068027|3565624|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727911|NCT02068027|3565625|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727912|NCT02068027|3565623|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3727913|NCT02068027|3565624|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3727914|NCT02068027|3565625|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3727915|NCT02068027|3565623|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3727916|NCT02068027|3565624|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3727917|NCT02068027|3565625|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3727918|NCT02068027|3565623|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727919|NCT02068027|3565624|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727920|NCT02068027|3565625|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3727921|NCT02068027|3565623|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|210|210.0||||||
3727922|NCT02068027|3565624|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3727923|NCT02068027|3565625|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|112|112.0||||||
3727924|NCT02068027|3565623|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3727925|NCT02068027|3565624|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3727926|NCT02068027|3565625|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3727927|NCT02068027|3565623|B3||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3727928|NCT02068027|3565624|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3727929|NCT02068027|3565625|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3727930|NCT02068027|3565623|B3||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3727931|NCT02068027|3565624|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3727932|NCT02068027|3565625|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3727933|NCT02068027|3565623|B3|||Age||years|Mean|60.11|60.11|Standard Deviation|10.838|10.838|||
3727934|NCT02068027|3565624|B2|||Age||years|Mean|59.64|59.64|Standard Deviation|11.226|11.226|||
3727935|NCT02068027|3565625|B1|||Age||years|Mean|60.58|60.58|Standard Deviation|10.458|10.458|||
3727936|NCT02067858|3565634|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3727937|NCT02067858|3565634|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3727938|NCT02067858|3565634|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3727939|NCT02067858|3565634|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3727940|NCT02067858|3565634|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3727941|NCT02067728|3565640|B3|||Body Mass Index||kg/m²|Mean|19.9|19.9|Standard Deviation|5.1|5.1|||
3727942|NCT02067728|3565641|B2|||Body Mass Index||kg/m²|Mean|20.0|20.0|Standard Deviation|5.0|5.0|||
3727943|NCT02067728|3565642|B1|||Body Mass Index||kg/m²|Mean|19.8|19.8|Standard Deviation|5.1|5.1|||
3727944|NCT02067728|3565640|B3|United States||Region of Enrollment||participants|Number|430|430.0||||||
3727945|NCT02067728|3565641|B2|United States||Region of Enrollment||participants|Number|210|210.0||||||
3727946|NCT02067728|3565642|B1|United States||Region of Enrollment||participants|Number|220|220.0||||||
3727947|NCT02067728|3565640|B3||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
3727948|NCT02067728|3565641|B2||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3727949|NCT02067728|3565642|B1||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3727950|NCT02067728|3565640|B3||Female|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
3727951|NCT02067728|3565641|B2||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3727952|NCT02067728|3565642|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3727953|NCT02067728|3565640|B3|||Age||years|Mean|10.6|10.6|Standard Deviation|4.1|4.1|||
3727954|NCT02067728|3565641|B2|||Age||years|Mean|10.7|10.7|Standard Deviation|4.1|4.1|||
3727955|NCT02067728|3565642|B1|||Age||years|Mean|10.4|10.4|Standard Deviation|4.1|4.1|||
3727956|NCT02067728|3565640|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3727957|NCT02067728|3565641|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3727958|NCT02067728|3565642|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3727959|NCT02067728|3565640|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3727960|NCT02067728|3565641|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3727961|NCT02067728|3565642|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3727962|NCT02067728|3565640|B3||<=18 years|Age||Participants|Count of Participants|430|430.0||||||
3727963|NCT02067728|3565641|B2||<=18 years|Age||Participants|Count of Participants|210|210.0||||||
3727964|NCT02067728|3565642|B1||<=18 years|Age||Participants|Count of Participants|220|220.0||||||
3727965|NCT02067676|3565671|B7|United States||Region of Enrollment||participants|Number|48|48.0||||||
3727966|NCT02067676|3565672|B6|United States||Region of Enrollment||participants|Number|8|8.0||||||
3727967|NCT02067676|3565673|B5|United States||Region of Enrollment||participants|Number|8|8.0||||||
3727968|NCT02067676|3565674|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
3727969|NCT02067676|3565675|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3727970|NCT02067676|3565676|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3727971|NCT02067676|3565677|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3727972|NCT02067676|3565671|B7||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3727973|NCT02067676|3565672|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3727974|NCT02067676|3565673|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3727975|NCT02067676|3565674|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3727976|NCT02067676|3565675|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3727977|NCT02067676|3565676|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3727978|NCT02067676|3565677|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3727979|NCT02067676|3565671|B7||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3727980|NCT02067676|3565672|B6||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3727981|NCT02067676|3565673|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3727982|NCT02067676|3565674|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3727983|NCT02067676|3565675|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3727984|NCT02067676|3565676|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3727985|NCT02067676|3565677|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3727986|NCT02067676|3565671|B7|Age 18 to 50 years||Age, Customized||Participants|Count of Participants|48|48.0||||||
3727987|NCT02067676|3565672|B6|Age 18 to 50 years||Age, Customized||Participants|Count of Participants|8|8.0||||||
3727988|NCT02067676|3565673|B5|Age 18 to 50 years||Age, Customized||Participants|Count of Participants|8|8.0||||||
3727989|NCT02067676|3565674|B4|Age 18 to 50 years||Age, Customized||Participants|Count of Participants|8|8.0||||||
3727990|NCT02067676|3565675|B3|Age 18 to 50 years||Age, Customized||Participants|Count of Participants|8|8.0||||||
3727991|NCT02067676|3565676|B2|Age 18 to 50 years||Age, Customized||Participants|Count of Participants|8|8.0||||||
3727992|NCT02067676|3565677|B1|Age 18 to 50 years||Age, Customized||Participants|Count of Participants|8|8.0||||||
3727993|NCT02067585|3565757|B4|||Type 2 diabetes||Participants|Count of Participants|8|8.0||||||
3727994|NCT02067585|3565758|B3|||Type 2 diabetes||Participants|Count of Participants|3|3.0||||||
3727995|NCT02067585|3565759|B2|||Type 2 diabetes||Participants|Count of Participants|3|3.0||||||
3727996|NCT02067585|3565760|B1|||Type 2 diabetes||Participants|Count of Participants|2|2.0||||||
3727997|NCT02067585|3565757|B4|||waist circumference||cm|Mean|121|121.0|Standard Deviation|14|14.0|||
3727998|NCT02067585|3565758|B3|||waist circumference||cm|Mean|122|122.0|Standard Deviation|8|8.0|||
3727999|NCT02067585|3565759|B2|||waist circumference||cm|Mean|121|121.0|Standard Deviation|16|16.0|||
3728000|NCT02067585|3565760|B1|||waist circumference||cm|Mean|118|118.0|Standard Deviation|16|16.0|||
3728001|NCT02067585|3565757|B4|||weight current||kg|Mean|111.0|111.0|Standard Deviation|21.7|21.7|||
3728002|NCT02067585|3565758|B3|||weight current||kg|Mean|115.8|115.8|Standard Deviation|17.1|17.1|||
3728003|NCT02067585|3565759|B2|||weight current||kg|Mean|108.5|108.5|Standard Deviation|21.1|21.1|||
3728004|NCT02067585|3565760|B1|||weight current||kg|Mean|108.7|108.7|Standard Deviation|26.4|26.4|||
3728005|NCT02067585|3565757|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3728006|NCT02067585|3565758|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3728007|NCT02067585|3565759|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3728008|NCT02067585|3565760|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3728009|NCT02067585|3565757|B4||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3728010|NCT02067585|3565758|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3728011|NCT02067585|3565759|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3728012|NCT02067585|3565760|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3728013|NCT02067585|3565757|B4|||Age||years|Mean|46|46.0|Standard Deviation|9|9.0|||
3728014|NCT02067585|3565758|B3|||Age||years|Mean|46|46.0|Standard Deviation|9|9.0|||
3728015|NCT02067585|3565759|B2|||Age||years|Mean|48|48.0|Standard Deviation|10|10.0|||
3728016|NCT02067585|3565760|B1|||Age||years|Mean|45|45.0|Standard Deviation|9|9.0|||
3728017|NCT02067533|3565797|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3728018|NCT02067533|3565798|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3728019|NCT02067533|3565799|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3728020|NCT02067533|3565797|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3728021|NCT02067533|3565798|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3728022|NCT02067533|3565799|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3728023|NCT02067533|3565797|B3|||Age||years|Mean|67.14|67.14|Standard Deviation|4.7|4.7|||
3728024|NCT02067533|3565798|B2|||Age||years|Mean|67.5|67.5|Standard Deviation|7.6|7.6|||
3728025|NCT02067533|3565799|B1|||Age||years|Mean|66.7|66.7|Standard Deviation|8.6|8.6|||
3728026|NCT02067273|3565806|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
3728027|NCT02067273|3565807|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3728028|NCT02067273|3565808|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3728029|NCT02067273|3565806|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3728030|NCT02067273|3565807|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3728031|NCT02067273|3565808|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3728032|NCT02067273|3565806|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3728033|NCT02067273|3565807|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3728034|NCT02067273|3565808|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3728035|NCT02067273|3565806|B3|||Age|Only data from participants who completed the study were analyzed.|years|Mean|44.94|44.94|Standard Deviation|14.39|14.39|||
3728036|NCT02067273|3565807|B2|||Age|Only data from participants who completed the study were analyzed.|years|Mean|42.92|42.92|Standard Deviation|13.69|13.69|||
3728037|NCT02067273|3565808|B1|||Age|Only data from participants who completed the study were analyzed.|years|Mean|49.8|49.8|Standard Deviation|16.47|16.47|||
3728038|NCT02067273|3565806|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3728039|NCT02067273|3565807|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3728040|NCT02067273|3565808|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3728041|NCT02067273|3565806|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3728042|NCT02067273|3565807|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3728043|NCT02067273|3565808|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3728044|NCT02067273|3565806|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3728045|NCT02067273|3565807|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3728046|NCT02067273|3565808|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3728047|NCT02066922|3565815|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3728048|NCT02066922|3565815|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3728049|NCT02066922|3565815|B1|||Age||years|Mean|34.2|34.2|Standard Deviation|8.7|8.7|||
3728050|NCT02066896|3565823|B3|Brazil||Region of Enrollment||participants|Number|66|66.0||||||
3728051|NCT02066896|3565824|B2|Brazil||Region of Enrollment||participants|Number|33|33.0||||||
3728052|NCT02066896|3565825|B1|Brazil||Region of Enrollment||participants|Number|33|33.0||||||
3728053|NCT02066896|3565823|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3728054|NCT02066896|3565823|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3728055|NCT02066896|3565824|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3728056|NCT02066896|3565825|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3728057|NCT02066896|3565823|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3728058|NCT02066896|3565824|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3728059|NCT02066896|3565825|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3728060|NCT02066896|3565823|B3|||Age||years (SD)|Median|57|57.0|Standard Deviation|11.0|11.0|||
3728061|NCT02066896|3565824|B2|||Age||years (SD)|Median|54|54.0|Standard Deviation|11.3|11.3|||
3728062|NCT02066896|3565825|B1|||Age||years (SD)|Median|58|58.0|Standard Deviation|11.1|11.1|||
3728063|NCT02066857|3565836|B3|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3728064|NCT02066857|3565837|B2|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3728065|NCT02066857|3565838|B1|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3728066|NCT02066857|3565836|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3728067|NCT02066857|3565837|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3728068|NCT02066857|3565838|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3728069|NCT02066857|3565836|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3728070|NCT02066857|3565837|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3728071|NCT02066857|3565838|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3728072|NCT02066857|3565836|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3728073|NCT02066857|3565837|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3728074|NCT02066857|3565838|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3728075|NCT02066857|3565836|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3728076|NCT02066857|3565837|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3728077|NCT02066857|3565838|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3728078|NCT02066857|3565836|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3728079|NCT02066857|3565837|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3728080|NCT02066857|3565838|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3728081|NCT02066857|3565836|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3728082|NCT02066857|3565837|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3728083|NCT02066857|3565838|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3728084|NCT02066857|3565836|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3728085|NCT02066857|3565837|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3728086|NCT02066857|3565838|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3728087|NCT02066857|3565836|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3728088|NCT02066857|3565837|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3728089|NCT02066857|3565838|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3728090|NCT02066857|3565836|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3728091|NCT02066857|3565837|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3728092|NCT02066857|3565838|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3728093|NCT02066857|3565836|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3728094|NCT02066857|3565837|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3728095|NCT02066857|3565838|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3728096|NCT02066857|3565836|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3728097|NCT02066857|3565837|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3728098|NCT02066857|3565838|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3728099|NCT02066857|3565836|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3728100|NCT02066857|3565837|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3728101|NCT02066857|3565838|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3728102|NCT02066740|3565853|B1|Sweden||Region of Enrollment||participants|Number|7|7.0||||||
3728103|NCT02066740|3565853|B1|Germany||Region of Enrollment||participants|Number|27|27.0||||||
3728104|NCT02066740|3565853|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3728105|NCT02066740|3565853|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3728106|NCT02066740|3565853|B1|||Age||years|Mean|71.5|71.5|Standard Deviation|9.4|9.4|||
3728107|NCT02066727|3565858|B3|China||Region of Enrollment||participants|Number|60|60.0||||||
3728108|NCT02066727|3565859|B2|China||Region of Enrollment||participants|Number|30|30.0||||||
3728109|NCT02066727|3565860|B1|China||Region of Enrollment||participants|Number|30|30.0||||||
3728110|NCT02066727|3565858|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3728111|NCT02066727|3565859|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3728112|NCT02066727|3565860|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3728113|NCT02066727|3565858|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3728114|NCT02066727|3565859|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3728115|NCT02066727|3565860|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3728116|NCT02066727|3565858|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3728117|NCT02066727|3565859|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3728118|NCT02066727|3565860|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3728119|NCT02066727|3565858|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3728120|NCT02066727|3565859|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3728121|NCT02066727|3565860|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3728122|NCT02066727|3565858|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3728123|NCT02066727|3565859|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3728124|NCT02066727|3565860|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3728125|NCT02066727|3565858|B3|||Age||years|Mean|65|65.0|Standard Deviation|12|12.0|||
3728126|NCT02066727|3565859|B2|||Age||years|Mean|68|68.0|Standard Deviation|9|9.0|||
3728127|NCT02066727|3565860|B1|||Age||years|Mean|62|62.0|Standard Deviation|14|14.0|||
3728128|NCT02066415|3565867|B4|||Disease Duration of Migraine With or Without Aura||years|Mean|21.70|21.7|Standard Deviation|12.46|12.46|||
3728129|NCT02066415|3565868|B3|||Disease Duration of Migraine With or Without Aura||years|Mean|21.92|21.92|Standard Deviation|11.80|11.8|||
3728130|NCT02066415|3565869|B2|||Disease Duration of Migraine With or Without Aura||years|Mean|20.71|20.71|Standard Deviation|12.83|12.83|||
3728131|NCT02066415|3565870|B1|||Disease Duration of Migraine With or Without Aura||years|Mean|22.21|22.21|Standard Deviation|12.63|12.63|||
3728132|NCT02066415|3565867|B4|||Monthly Migraine Days|"A migraine day was any calendar day in which the participant experienced a qualified migraine headache (onset, continuation, or recurrence of the migraine headache). A qualified migraine headache was defined either as a migraine without aura or a migraine with aura.~Monthly migraine days were calculated as the number of migraine days in the 4-week baseline phase."|days|Mean|17.99|17.99|Standard Deviation|4.63|4.63|||
3728133|NCT02066415|3565868|B3|||Monthly Migraine Days|"A migraine day was any calendar day in which the participant experienced a qualified migraine headache (onset, continuation, or recurrence of the migraine headache). A qualified migraine headache was defined either as a migraine without aura or a migraine with aura.~Monthly migraine days were calculated as the number of migraine days in the 4-week baseline phase."|days|Mean|17.78|17.78|Standard Deviation|4.72|4.72|||
3728134|NCT02066415|3565869|B2|||Monthly Migraine Days|"A migraine day was any calendar day in which the participant experienced a qualified migraine headache (onset, continuation, or recurrence of the migraine headache). A qualified migraine headache was defined either as a migraine without aura or a migraine with aura.~Monthly migraine days were calculated as the number of migraine days in the 4-week baseline phase."|days|Mean|17.85|17.85|Standard Deviation|4.39|4.39|||
3728135|NCT02066415|3565870|B1|||Monthly Migraine Days|"A migraine day was any calendar day in which the participant experienced a qualified migraine headache (onset, continuation, or recurrence of the migraine headache). A qualified migraine headache was defined either as a migraine without aura or a migraine with aura.~Monthly migraine days were calculated as the number of migraine days in the 4-week baseline phase."|days|Mean|18.22|18.22|Standard Deviation|4.73|4.73|||
3728136|NCT02066415|3565867|B4||No|Medication Overuse Status|"Medication overuse was defined as any of the following criteria being met during the baseline (BL) phase:~≥ 15 days of simple analgesics (> 3 days/week in each week during BL with at least 5 diary days),~≥ 10 days of triptans (> 2 days/week in each week during BL with at least 5 diary days),~≥ 10 days of ergots (> 2 days/week in each week during BL with at least 5 diary days),~≥ 10 days of combination therapy intake of any combination of ergots, triptans, opiates, combination-analgesic medications or simple analgesics (> 2 days/week in each week during BL with at least 5 diary days)."|Participants|Count of Participants|393|393.0||||||
3728137|NCT02066415|3565868|B3||No|Medication Overuse Status|"Medication overuse was defined as any of the following criteria being met during the baseline (BL) phase:~≥ 15 days of simple analgesics (> 3 days/week in each week during BL with at least 5 diary days),~≥ 10 days of triptans (> 2 days/week in each week during BL with at least 5 diary days),~≥ 10 days of ergots (> 2 days/week in each week during BL with at least 5 diary days),~≥ 10 days of combination therapy intake of any combination of ergots, triptans, opiates, combination-analgesic medications or simple analgesics (> 2 days/week in each week during BL with at least 5 diary days)."|Participants|Count of Participants|112|112.0||||||
3728138|NCT02066415|3565869|B2||No|Medication Overuse Status|"Medication overuse was defined as any of the following criteria being met during the baseline (BL) phase:~≥ 15 days of simple analgesics (> 3 days/week in each week during BL with at least 5 diary days),~≥ 10 days of triptans (> 2 days/week in each week during BL with at least 5 diary days),~≥ 10 days of ergots (> 2 days/week in each week during BL with at least 5 diary days),~≥ 10 days of combination therapy intake of any combination of ergots, triptans, opiates, combination-analgesic medications or simple analgesics (> 2 days/week in each week during BL with at least 5 diary days)."|Participants|Count of Participants|112|112.0||||||
3728139|NCT02066415|3565870|B1||No|Medication Overuse Status|"Medication overuse was defined as any of the following criteria being met during the baseline (BL) phase:~≥ 15 days of simple analgesics (> 3 days/week in each week during BL with at least 5 diary days),~≥ 10 days of triptans (> 2 days/week in each week during BL with at least 5 diary days),~≥ 10 days of ergots (> 2 days/week in each week during BL with at least 5 diary days),~≥ 10 days of combination therapy intake of any combination of ergots, triptans, opiates, combination-analgesic medications or simple analgesics (> 2 days/week in each week during BL with at least 5 diary days)."|Participants|Count of Participants|169|169.0||||||
3728140|NCT02066415|3565867|B4||Yes|Medication Overuse Status|"Medication overuse was defined as any of the following criteria being met during the baseline (BL) phase:~≥ 15 days of simple analgesics (> 3 days/week in each week during BL with at least 5 diary days),~≥ 10 days of triptans (> 2 days/week in each week during BL with at least 5 diary days),~≥ 10 days of ergots (> 2 days/week in each week during BL with at least 5 diary days),~≥ 10 days of combination therapy intake of any combination of ergots, triptans, opiates, combination-analgesic medications or simple analgesics (> 2 days/week in each week during BL with at least 5 diary days)."|Participants|Count of Participants|274|274.0||||||
3728141|NCT02066415|3565868|B3||Yes|Medication Overuse Status|"Medication overuse was defined as any of the following criteria being met during the baseline (BL) phase:~≥ 15 days of simple analgesics (> 3 days/week in each week during BL with at least 5 diary days),~≥ 10 days of triptans (> 2 days/week in each week during BL with at least 5 diary days),~≥ 10 days of ergots (> 2 days/week in each week during BL with at least 5 diary days),~≥ 10 days of combination therapy intake of any combination of ergots, triptans, opiates, combination-analgesic medications or simple analgesics (> 2 days/week in each week during BL with at least 5 diary days)."|Participants|Count of Participants|78|78.0||||||
3728142|NCT02066415|3565869|B2||Yes|Medication Overuse Status|"Medication overuse was defined as any of the following criteria being met during the baseline (BL) phase:~≥ 15 days of simple analgesics (> 3 days/week in each week during BL with at least 5 diary days),~≥ 10 days of triptans (> 2 days/week in each week during BL with at least 5 diary days),~≥ 10 days of ergots (> 2 days/week in each week during BL with at least 5 diary days),~≥ 10 days of combination therapy intake of any combination of ergots, triptans, opiates, combination-analgesic medications or simple analgesics (> 2 days/week in each week during BL with at least 5 diary days)."|Participants|Count of Participants|79|79.0||||||
3728194|NCT02066415|3565869|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3728143|NCT02066415|3565870|B1||Yes|Medication Overuse Status|"Medication overuse was defined as any of the following criteria being met during the baseline (BL) phase:~≥ 15 days of simple analgesics (> 3 days/week in each week during BL with at least 5 diary days),~≥ 10 days of triptans (> 2 days/week in each week during BL with at least 5 diary days),~≥ 10 days of ergots (> 2 days/week in each week during BL with at least 5 diary days),~≥ 10 days of combination therapy intake of any combination of ergots, triptans, opiates, combination-analgesic medications or simple analgesics (> 2 days/week in each week during BL with at least 5 diary days)."|Participants|Count of Participants|117|117.0||||||
3728144|NCT02066415|3565867|B4||Other|Region||Participants|Count of Participants|352|352.0||||||
3728145|NCT02066415|3565868|B3||Other|Region||Participants|Count of Participants|101|101.0||||||
3728146|NCT02066415|3565869|B2||Other|Region||Participants|Count of Participants|100|100.0||||||
3728147|NCT02066415|3565870|B1||Other|Region||Participants|Count of Participants|151|151.0||||||
3728148|NCT02066415|3565867|B4||North America|Region||Participants|Count of Participants|315|315.0||||||
3728149|NCT02066415|3565868|B3||North America|Region||Participants|Count of Participants|89|89.0||||||
3728150|NCT02066415|3565869|B2||North America|Region||Participants|Count of Participants|91|91.0||||||
3728151|NCT02066415|3565870|B1||North America|Region||Participants|Count of Participants|135|135.0||||||
3728152|NCT02066415|3565867|B4||No|Prior Migraine Prophylactic Treatment Failure||Participants|Count of Participants|214|214.0||||||
3728153|NCT02066415|3565868|B3||No|Prior Migraine Prophylactic Treatment Failure||Participants|Count of Participants|64|64.0||||||
3728154|NCT02066415|3565869|B2||No|Prior Migraine Prophylactic Treatment Failure||Participants|Count of Participants|64|64.0||||||
3728155|NCT02066415|3565870|B1||No|Prior Migraine Prophylactic Treatment Failure||Participants|Count of Participants|86|86.0||||||
3728156|NCT02066415|3565867|B4||Yes|Prior Migraine Prophylactic Treatment Failure||Participants|Count of Participants|453|453.0||||||
3728157|NCT02066415|3565868|B3||Yes|Prior Migraine Prophylactic Treatment Failure||Participants|Count of Participants|126|126.0||||||
3728158|NCT02066415|3565869|B2||Yes|Prior Migraine Prophylactic Treatment Failure||Participants|Count of Participants|127|127.0||||||
3728159|NCT02066415|3565870|B1||Yes|Prior Migraine Prophylactic Treatment Failure||Participants|Count of Participants|200|200.0||||||
3728160|NCT02066415|3565867|B4||No|Prior Migraine Prophylactic Medication||Participants|Count of Participants|175|175.0||||||
3728161|NCT02066415|3565868|B3||No|Prior Migraine Prophylactic Medication||Participants|Count of Participants|54|54.0||||||
3728162|NCT02066415|3565869|B2||No|Prior Migraine Prophylactic Medication||Participants|Count of Participants|53|53.0||||||
3728163|NCT02066415|3565870|B1||No|Prior Migraine Prophylactic Medication||Participants|Count of Participants|68|68.0||||||
3728164|NCT02066415|3565867|B4||Yes|Prior Migraine Prophylactic Medication||Participants|Count of Participants|492|492.0||||||
3728165|NCT02066415|3565868|B3||Yes|Prior Migraine Prophylactic Medication||Participants|Count of Participants|136|136.0||||||
3728166|NCT02066415|3565869|B2||Yes|Prior Migraine Prophylactic Medication||Participants|Count of Participants|138|138.0||||||
3728167|NCT02066415|3565870|B1||Yes|Prior Migraine Prophylactic Medication||Participants|Count of Participants|218|218.0||||||
3728168|NCT02066415|3565867|B4||Other|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3728169|NCT02066415|3565868|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3728170|NCT02066415|3565869|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3728171|NCT02066415|3565870|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3728172|NCT02066415|3565867|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|628|628.0||||||
3728173|NCT02066415|3565868|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|184|184.0||||||
3728174|NCT02066415|3565869|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|176|176.0||||||
3728175|NCT02066415|3565870|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|268|268.0||||||
3728176|NCT02066415|3565867|B4||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3728177|NCT02066415|3565868|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3728178|NCT02066415|3565869|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3728179|NCT02066415|3565870|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3728180|NCT02066415|3565867|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3728181|NCT02066415|3565868|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3728182|NCT02066415|3565869|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3728183|NCT02066415|3565870|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3728184|NCT02066415|3565867|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3728185|NCT02066415|3565868|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3728186|NCT02066415|3565869|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3728187|NCT02066415|3565870|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3728188|NCT02066415|3565867|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|641|641.0||||||
3728189|NCT02066415|3565868|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|180|180.0||||||
3728190|NCT02066415|3565869|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|184|184.0||||||
3728191|NCT02066415|3565870|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|277|277.0||||||
3728192|NCT02066415|3565867|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3728193|NCT02066415|3565868|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3728195|NCT02066415|3565870|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3728196|NCT02066415|3565867|B4||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3728197|NCT02066415|3565868|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3728198|NCT02066415|3565869|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3728199|NCT02066415|3565870|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3728200|NCT02066415|3565867|B4||Female|Sex: Female, Male||Participants|Count of Participants|552|552.0||||||
3728201|NCT02066415|3565868|B3||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3728202|NCT02066415|3565869|B2||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3728203|NCT02066415|3565870|B1||Female|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
3728204|NCT02066415|3565867|B4||65 to 74 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
3728205|NCT02066415|3565868|B3||65 to 74 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3728206|NCT02066415|3565869|B2||65 to 74 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3728207|NCT02066415|3565870|B1||65 to 74 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
3728208|NCT02066415|3565867|B4||18 to 64 years|Age, Customized||Participants|Count of Participants|666|666.0||||||
3728209|NCT02066415|3565868|B3||18 to 64 years|Age, Customized||Participants|Count of Participants|190|190.0||||||
3728210|NCT02066415|3565869|B2||18 to 64 years|Age, Customized||Participants|Count of Participants|191|191.0||||||
3728211|NCT02066415|3565870|B1||18 to 64 years|Age, Customized||Participants|Count of Participants|285|285.0||||||
3728212|NCT02066415|3565867|B4|||Age||years|Mean|42.1|42.1|Standard Deviation|11.3|11.3|||
3728213|NCT02066415|3565868|B3|||Age||years|Mean|42.9|42.9|Standard Deviation|11.1|11.1|||
3728214|NCT02066415|3565869|B2|||Age||years|Mean|41.4|41.4|Standard Deviation|11.3|11.3|||
3728215|NCT02066415|3565870|B1|||Age||years|Mean|42.1|42.1|Standard Deviation|11.3|11.3|||
3728216|NCT02066402|3565895|B3|Wound infection||Type of acute bacterial skin and skin structure infections (ABSSSI) infection||Participants|Number|136|136.0||||||
3728217|NCT02066402|3565896|B2|Wound infection||Type of acute bacterial skin and skin structure infections (ABSSSI) infection||Participants|Number|68|68.0||||||
3728218|NCT02066402|3565897|B1|Wound infection||Type of acute bacterial skin and skin structure infections (ABSSSI) infection||Participants|Number|68|68.0||||||
3728219|NCT02066402|3565895|B3|Major cutaneous abscess||Type of acute bacterial skin and skin structure infections (ABSSSI) infection||Participants|Number|79|79.0||||||
3728220|NCT02066402|3565896|B2|Major cutaneous abscess||Type of acute bacterial skin and skin structure infections (ABSSSI) infection||Participants|Number|39|39.0||||||
3728221|NCT02066402|3565897|B1|Major cutaneous abscess||Type of acute bacterial skin and skin structure infections (ABSSSI) infection||Participants|Number|40|40.0||||||
3728222|NCT02066402|3565895|B3|Cellulitis/erysipelas||Type of acute bacterial skin and skin structure infections (ABSSSI) infection||Participants|Number|383|383.0||||||
3728223|NCT02066402|3565896|B2|Cellulitis/erysipelas||Type of acute bacterial skin and skin structure infections (ABSSSI) infection||Participants|Number|191|191.0||||||
3728224|NCT02066402|3565897|B1|Cellulitis/erysipelas||Type of acute bacterial skin and skin structure infections (ABSSSI) infection||Participants|Number|192|192.0||||||
3728225|NCT02066402|3565895|B3|||Wong-Baker faces rating scale (FRS) pain scores|The patient-reported level of pain were assessed by the faces rating scale (FRS) pain score. Ask the patient to rate their pain from 0 to 10 with 0 being no pain at all and 10 being the worst pain then enter the numerical value.|Units on a scale|Mean|5.6|5.6|Standard Deviation|2.7|2.7|||
3728226|NCT02066402|3565896|B2|||Wong-Baker faces rating scale (FRS) pain scores|The patient-reported level of pain were assessed by the faces rating scale (FRS) pain score. Ask the patient to rate their pain from 0 to 10 with 0 being no pain at all and 10 being the worst pain then enter the numerical value.|Units on a scale|Mean|5.7|5.7|Standard Deviation|2.7|2.7|||
3728227|NCT02066402|3565897|B1|||Wong-Baker faces rating scale (FRS) pain scores|The patient-reported level of pain were assessed by the faces rating scale (FRS) pain score. Ask the patient to rate their pain from 0 to 10 with 0 being no pain at all and 10 being the worst pain then enter the numerical value.|Units on a scale|Mean|5.6|5.6|Standard Deviation|2.6|2.6|||
3728228|NCT02066402|3565895|B3|||Visual analog scale (VAS) pain scores|The patient-reported level of pain were assessed by the visual analog scale (VAS) pain score. VAS pain score ranged from 0 mm (no pain) to 100 mm (worst pain ever). It used a 100 mm VAS to instruct the patient to indicate the point along the line that represents the pain they are feeling. Once the patient indicates how much pain they are feeling, measure the distance from no pain and enter the value.|Units on a scale|Mean|53.6|53.6|Standard Deviation|28.0|28.0|||
3728229|NCT02066402|3565896|B2|||Visual analog scale (VAS) pain scores|The patient-reported level of pain were assessed by the visual analog scale (VAS) pain score. VAS pain score ranged from 0 mm (no pain) to 100 mm (worst pain ever). It used a 100 mm VAS to instruct the patient to indicate the point along the line that represents the pain they are feeling. Once the patient indicates how much pain they are feeling, measure the distance from no pain and enter the value.|Units on a scale|Mean|53.9|53.9|Standard Deviation|28.7|28.7|||
3728230|NCT02066402|3565897|B1|||Visual analog scale (VAS) pain scores|The patient-reported level of pain were assessed by the visual analog scale (VAS) pain score. VAS pain score ranged from 0 mm (no pain) to 100 mm (worst pain ever). It used a 100 mm VAS to instruct the patient to indicate the point along the line that represents the pain they are feeling. Once the patient indicates how much pain they are feeling, measure the distance from no pain and enter the value.|Units on a scale|Mean|53.2|53.2|Standard Deviation|27.3|27.3|||
3728231|NCT02066402|3565895|B3||Male|Sex: Female, Male||Participants|Count of Participants|401|401.0||||||
3728232|NCT02066402|3565896|B2||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
3728233|NCT02066402|3565897|B1||Male|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
3728234|NCT02066402|3565895|B3||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
3728235|NCT02066402|3565896|B2||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3728236|NCT02066402|3565897|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3728237|NCT02066402|3565895|B3|> 75 years||Age, Customized||Participants|Number|26|26.0||||||
3728238|NCT02066402|3565896|B2|> 75 years||Age, Customized||Participants|Number|18|18.0||||||
3728239|NCT02066402|3565897|B1|> 75 years||Age, Customized||Participants|Number|8|8.0||||||
3728240|NCT02066402|3565895|B3|65 - 75 years||Age, Customized||Participants|Number|68|68.0||||||
3728241|NCT02066402|3565896|B2|65 - 75 years||Age, Customized||Participants|Number|35|35.0||||||
3728242|NCT02066402|3565897|B1|65 - 75 years||Age, Customized||Participants|Number|33|33.0||||||
3728243|NCT02066402|3565895|B3|< 65 years||Age, Customized||Participants|Number|504|504.0||||||
3728244|NCT02066402|3565896|B2|< 65 years||Age, Customized||Participants|Number|245|245.0||||||
3728245|NCT02066402|3565897|B1|< 65 years||Age, Customized||Participants|Number|259|259.0||||||
3728246|NCT02066233|3565924|B3|United States||Region of Enrollment||Participants|Count of Participants|100|100.0||||||
3728247|NCT02066233|3565925|B2|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3728248|NCT02066233|3565926|B1|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3728249|NCT02066233|3565924|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3728250|NCT02066233|3565925|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3728251|NCT02066233|3565926|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3728252|NCT02066233|3565924|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3728253|NCT02066233|3565925|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3728254|NCT02066233|3565926|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3728255|NCT02066233|3565924|B3|||Age||years|Mean|56.19|56.19|Standard Deviation|14.12|14.12|||
3728256|NCT02066233|3565925|B2|||Age||years|Mean|51.72|51.72|Standard Deviation|15.07|15.07|||
3728257|NCT02066233|3565926|B1|||Age||years|Mean|60.66|60.66|Standard Deviation|11.62|11.62|||
3728258|NCT02066129|3565935|B3|||At least one allergen specific immunoglobulin E (IgE) tests||Participants|Count of Participants|187|187.0||||||
3728259|NCT02066129|3565936|B2|||At least one allergen specific immunoglobulin E (IgE) tests||Participants|Count of Participants|99|99.0||||||
3728260|NCT02066129|3565937|B1|||At least one allergen specific immunoglobulin E (IgE) tests||Participants|Count of Participants|88|88.0||||||
3728261|NCT02066129|3565935|B3|||Post albuterol forced expiratory volume at one second (FEV1) % of predicted|FEV1 following 4 puffs of albuterol, expressed as percent of predicted (based on age, sex, race, and height).|percent|Mean|107.3|107.3|Standard Deviation|14.8|14.8|||
3728262|NCT02066129|3565936|B2|||Post albuterol forced expiratory volume at one second (FEV1) % of predicted|FEV1 following 4 puffs of albuterol, expressed as percent of predicted (based on age, sex, race, and height).|percent|Mean|107.8|107.8|Standard Deviation|13.9|13.9|||
3728263|NCT02066129|3565937|B1|||Post albuterol forced expiratory volume at one second (FEV1) % of predicted|FEV1 following 4 puffs of albuterol, expressed as percent of predicted (based on age, sex, race, and height).|percent|Mean|106.8|106.8|Standard Deviation|15.6|15.6|||
3728264|NCT02066129|3565935|B3|||Hospitalized in year prior to enrollment||Participants|Count of Participants|31|31.0||||||
3728265|NCT02066129|3565936|B2|||Hospitalized in year prior to enrollment||Participants|Count of Participants|15|15.0||||||
3728266|NCT02066129|3565937|B1|||Hospitalized in year prior to enrollment||Participants|Count of Participants|16|16.0||||||
3728267|NCT02066129|3565935|B3|||Number of positive allergen specific IgE tests||count|Mean|5.0|5.0|Standard Deviation|4.4|4.4|||
3728268|NCT02066129|3565936|B2|||Number of positive allergen specific IgE tests||count|Mean|5.2|5.2|Standard Deviation|4.5|4.5|||
3728269|NCT02066129|3565937|B1|||Number of positive allergen specific IgE tests||count|Mean|4.8|4.8|Standard Deviation|4.2|4.2|||
3728270|NCT02066129|3565935|B3|||Blood eosinophils||cells per cubic millimeter|Mean|346|346.0|Standard Deviation|268|268.0|||
3728271|NCT02066129|3565936|B2|||Blood eosinophils||cells per cubic millimeter|Mean|327|327.0|Standard Deviation|234|234.0|||
3728272|NCT02066129|3565937|B1|||Blood eosinophils||cells per cubic millimeter|Mean|367|367.0|Standard Deviation|300|300.0|||
3728273|NCT02066129|3565935|B3|United States||Region of Enrollment||participants|Number|254|254.0||||||
3728274|NCT02066129|3565936|B2|United States||Region of Enrollment||participants|Number|127|127.0||||||
3728275|NCT02066129|3565937|B1|United States||Region of Enrollment||participants|Number|127|127.0||||||
3728276|NCT02066129|3565935|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|58|58.0||||||
3728277|NCT02066129|3565936|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3728278|NCT02066129|3565937|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3728279|NCT02066129|3565935|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|56|56.0||||||
3728280|NCT02066129|3565936|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3728281|NCT02066129|3565937|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3728282|NCT02066129|3565935|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|140|140.0||||||
3728283|NCT02066129|3565936|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|76|76.0||||||
3728284|NCT02066129|3565937|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|64|64.0||||||
3728285|NCT02066129|3565935|B3||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3728286|NCT02066129|3565936|B2||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3728287|NCT02066129|3565937|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3728288|NCT02066129|3565935|B3||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3728289|NCT02066129|3565936|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3728290|NCT02066129|3565937|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3728291|NCT02066129|3565935|B3|||Age||years|Mean|8.0|8.0|Standard Deviation|1.9|1.9|||
3728292|NCT02066129|3565936|B2|||Age||years|Mean|8.1|8.1|Standard Deviation|1.8|1.8|||
3728293|NCT02066129|3565937|B1|||Age||years|Mean|7.9|7.9|Standard Deviation|1.9|1.9|||
3728294|NCT02066051|3565952|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3728295|NCT02066051|3565952|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3728296|NCT02066051|3565952|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3728297|NCT02066051|3565952|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3728298|NCT02066051|3565952|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3728299|NCT02066051|3565952|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3728300|NCT02065895|3565957|B1|||HbA1c||%|Mean|7.7|7.7|Full Range|||6.8|8.4|
3728301|NCT02065895|3565957|B1|||Daily insulin use||units/day|Mean|35.4|35.4|Full Range|||27.0|45.2|
3728302|NCT02065895|3565957|B1|||Median duration of diabetes||years|Median|47|47.0|Full Range|||11.0|62.0|
3728303|NCT02065895|3565957|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3728304|NCT02065895|3565957|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3728305|NCT02065895|3565957|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3728306|NCT02065895|3565957|B1|||Age||years|Median|57|57.0|Full Range|||40.0|71.0|
3728307|NCT02065453|3565979|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
3728308|NCT02065453|3565980|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
3728309|NCT02065453|3565981|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3728310|NCT02065453|3565979|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3728311|NCT02065453|3565980|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3728312|NCT02065453|3565981|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3728313|NCT02065453|3565979|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3728314|NCT02065453|3565980|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3728315|NCT02065453|3565981|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3728316|NCT02065453|3565979|B3|||Age||years|Median|39|39.0|Full Range|||24.0|48.0|
3728317|NCT02065453|3565980|B2|||Age||years|Median|39|39.0|Full Range|||24.0|48.0|
3728318|NCT02065453|3565981|B1|||Age||years|Median|39|39.0|Full Range|||24.0|48.0|
3728319|NCT02065453|3565979|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3728320|NCT02065453|3565980|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3728321|NCT02065453|3565981|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3728322|NCT02065453|3565979|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3728323|NCT02065453|3565980|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3728324|NCT02065453|3565981|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3728325|NCT02065453|3565979|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3728326|NCT02065453|3565980|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3728327|NCT02065453|3565981|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3728328|NCT02064985|3565987|B4|Asian||Race/Ethnicity, Customized||Participants|Number|36|36.0||||||
3728329|NCT02064985|3565988|B3|Asian||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3728330|NCT02064985|3565989|B2|Asian||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3728331|NCT02064985|3565990|B1|Asian||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3728332|NCT02064985|3565987|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3728333|NCT02064985|3565988|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3728334|NCT02064985|3565989|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3728335|NCT02064985|3565990|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3728336|NCT02064985|3565987|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3728337|NCT02064985|3565988|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3728338|NCT02064985|3565989|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3728339|NCT02064985|3565990|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3728340|NCT02064985|3565987|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3728341|NCT02064985|3565988|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3728342|NCT02064985|3565989|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3728343|NCT02064985|3565990|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3728344|NCT02064985|3565987|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3728345|NCT02064985|3565988|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3728346|NCT02064985|3565989|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3728347|NCT02064985|3565990|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3728348|NCT02064985|3565987|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3728349|NCT02064985|3565988|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3728350|NCT02064985|3565989|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3728351|NCT02064985|3565990|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3728352|NCT02064985|3565987|B4|>=65 years||Age, Customized||Participants|Number|11|11.0||||||
3728353|NCT02064985|3565988|B3|>=65 years||Age, Customized||Participants|Number|4|4.0||||||
3728354|NCT02064985|3565989|B2|>=65 years||Age, Customized||Participants|Number|4|4.0||||||
3728355|NCT02064985|3565990|B1|>=65 years||Age, Customized||Participants|Number|3|3.0||||||
3728356|NCT02064985|3565987|B4|< 65 years||Age, Customized||Participants|Number|25|25.0||||||
3728357|NCT02064985|3565988|B3|< 65 years||Age, Customized||Participants|Number|8|8.0||||||
3728358|NCT02064985|3565989|B2|< 65 years||Age, Customized||Participants|Number|8|8.0||||||
3728359|NCT02064985|3565990|B1|< 65 years||Age, Customized||Participants|Number|9|9.0||||||
3728360|NCT02064985|3565987|B4|||Age||years|Mean|59.5|59.5|Standard Deviation|9.9|9.9|||
3728361|NCT02064985|3565988|B3|||Age||years|Mean|57.9|57.9|Standard Deviation|12.6|12.6|||
3728362|NCT02064985|3565989|B2|||Age||years|Mean|61.3|61.3|Standard Deviation|7.0|7.0|||
3728363|NCT02064985|3565990|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|9.8|9.8|||
3728364|NCT02064920|3566153|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3728365|NCT02064920|3566154|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3728366|NCT02064920|3566155|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3728367|NCT02064920|3566153|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3728368|NCT02064920|3566154|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3728369|NCT02064920|3566155|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3728370|NCT02064920|3566153|B3|||Age||Years|Mean|73.4|73.4|Standard Deviation|8.7|8.7|||
3728371|NCT02064920|3566154|B2|||Age||Years|Mean|72.7|72.7|Standard Deviation|8.7|8.7|||
3728372|NCT02064920|3566155|B1|||Age||Years|Mean|76.7|76.7|Standard Deviation|8.6|8.6|||
3728373|NCT02064907|3566164|B3|No||Caffeine consumption||participants|Number|37|37.0||||||
3728374|NCT02064907|3566165|B2|No||Caffeine consumption||participants|Number|17|17.0||||||
3728375|NCT02064907|3566166|B1|No||Caffeine consumption||participants|Number|20|20.0||||||
3728376|NCT02064907|3566164|B3|Yes||Caffeine consumption||participants|Number|15|15.0||||||
3728377|NCT02064907|3566165|B2|Yes||Caffeine consumption||participants|Number|9|9.0||||||
3728378|NCT02064907|3566166|B1|Yes||Caffeine consumption||participants|Number|6|6.0||||||
3728379|NCT02064907|3566164|B3|Ex-drinker||Alcohol classification||participants|Number|6|6.0||||||
3728380|NCT02064907|3566165|B2|Ex-drinker||Alcohol classification||participants|Number|4|4.0||||||
3728381|NCT02064907|3566166|B1|Ex-drinker||Alcohol classification||participants|Number|2|2.0||||||
3728382|NCT02064907|3566164|B3|Current drinker||Alcohol classification||participants|Number|12|12.0||||||
3728383|NCT02064907|3566165|B2|Current drinker||Alcohol classification||participants|Number|6|6.0||||||
3728384|NCT02064907|3566166|B1|Current drinker||Alcohol classification||participants|Number|6|6.0||||||
3728385|NCT02064907|3566164|B3|Has never drunk||Alcohol classification||participants|Number|34|34.0||||||
3728386|NCT02064907|3566165|B2|Has never drunk||Alcohol classification||participants|Number|16|16.0||||||
3728387|NCT02064907|3566166|B1|Has never drunk||Alcohol classification||participants|Number|18|18.0||||||
3728388|NCT02064907|3566164|B3|Ex-smoker||Smoking classification||participants|Number|10|10.0||||||
3728389|NCT02064907|3566165|B2|Ex-smoker||Smoking classification||participants|Number|9|9.0||||||
3728390|NCT02064907|3566166|B1|Ex-smoker||Smoking classification||participants|Number|1|1.0||||||
3728391|NCT02064907|3566164|B3|Current smoker||Smoking classification||participants|Number|0|0.0||||||
3728392|NCT02064907|3566165|B2|Current smoker||Smoking classification||participants|Number|0|0.0||||||
3728393|NCT02064907|3566166|B1|Current smoker||Smoking classification||participants|Number|0|0.0||||||
3728394|NCT02064907|3566164|B3|Never smoked||Smoking classification||participants|Number|42|42.0||||||
3728395|NCT02064907|3566165|B2|Never smoked||Smoking classification||participants|Number|17|17.0||||||
3728396|NCT02064907|3566166|B1|Never smoked||Smoking classification||participants|Number|25|25.0||||||
3728397|NCT02064907|3566164|B3|||Body Mass Index||kg/m^2|Mean|26.18|26.18|Standard Deviation|2.401|2.401|||
3728398|NCT02064907|3566165|B2|||Body Mass Index||kg/m^2|Mean|26.44|26.44|Standard Deviation|2.274|2.274|||
3728399|NCT02064907|3566166|B1|||Body Mass Index||kg/m^2|Mean|25.92|25.92|Standard Deviation|2.540|2.54|||
3728400|NCT02064907|3566164|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3728401|NCT02064907|3566165|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3728402|NCT02064907|3566166|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3728403|NCT02064907|3566164|B3|White||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
3728404|NCT02064907|3566165|B2|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3728405|NCT02064907|3566166|B1|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3728406|NCT02064907|3566164|B3|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3728407|NCT02064907|3566165|B2|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3728408|NCT02064907|3566166|B1|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3728409|NCT02064907|3566164|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3728410|NCT02064907|3566165|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3728411|NCT02064907|3566166|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3728412|NCT02064907|3566164|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3728413|NCT02064907|3566165|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3728414|NCT02064907|3566166|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3728415|NCT02064907|3566164|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3728416|NCT02064907|3566165|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3728417|NCT02064907|3566166|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3728418|NCT02064907|3566164|B3|||Age||Years|Mean|37.6|37.6|Standard Deviation|10.42|10.42|||
3728419|NCT02064907|3566165|B2|||Age||Years|Mean|39.1|39.1|Standard Deviation|10.70|10.7|||
3728420|NCT02064907|3566166|B1|||Age||Years|Mean|36.1|36.1|Standard Deviation|10.11|10.11|||
3728421|NCT02064894|3566183|B4||Other|Injury location - n(%)||Participants|Count of Participants|118|118.0||||||
3728422|NCT02064894|3566184|B3||Other|Injury location - n(%)||Participants|Count of Participants|54|54.0||||||
3728423|NCT02064894|3566185|B2||Other|Injury location - n(%)||Participants|Count of Participants|51|51.0||||||
3728424|NCT02064894|3566186|B1||Other|Injury location - n(%)||Participants|Count of Participants|13|13.0||||||
3728425|NCT02064894|3566183|B4||Forearm|Injury location - n(%)||Participants|Count of Participants|29|29.0||||||
3728426|NCT02064894|3566184|B3||Forearm|Injury location - n(%)||Participants|Count of Participants|12|12.0||||||
3728427|NCT02064894|3566185|B2||Forearm|Injury location - n(%)||Participants|Count of Participants|11|11.0||||||
3728428|NCT02064894|3566186|B1||Forearm|Injury location - n(%)||Participants|Count of Participants|6|6.0||||||
3728429|NCT02064894|3566183|B4||Elbow|Injury location - n(%)||Participants|Count of Participants|30|30.0||||||
3728430|NCT02064894|3566184|B3||Elbow|Injury location - n(%)||Participants|Count of Participants|10|10.0||||||
3728431|NCT02064894|3566185|B2||Elbow|Injury location - n(%)||Participants|Count of Participants|14|14.0||||||
3728432|NCT02064894|3566186|B1||Elbow|Injury location - n(%)||Participants|Count of Participants|6|6.0||||||
3728433|NCT02064894|3566183|B4||Foot|Injury location - n(%)||Participants|Count of Participants|39|39.0||||||
3728434|NCT02064894|3566184|B3||Foot|Injury location - n(%)||Participants|Count of Participants|12|12.0||||||
3728435|NCT02064894|3566185|B2||Foot|Injury location - n(%)||Participants|Count of Participants|21|21.0||||||
3728436|NCT02064894|3566186|B1||Foot|Injury location - n(%)||Participants|Count of Participants|6|6.0||||||
3728437|NCT02064894|3566183|B4||Knee|Injury location - n(%)||Participants|Count of Participants|67|67.0||||||
3728438|NCT02064894|3566184|B3||Knee|Injury location - n(%)||Participants|Count of Participants|27|27.0||||||
3728439|NCT02064894|3566185|B2||Knee|Injury location - n(%)||Participants|Count of Participants|25|25.0||||||
3728440|NCT02064894|3566186|B1||Knee|Injury location - n(%)||Participants|Count of Participants|15|15.0||||||
3728441|NCT02064894|3566183|B4||Ankle|Injury location - n(%)||Participants|Count of Participants|96|96.0||||||
3728442|NCT02064894|3566184|B3||Ankle|Injury location - n(%)||Participants|Count of Participants|37|37.0||||||
3728443|NCT02064894|3566185|B2||Ankle|Injury location - n(%)||Participants|Count of Participants|38|38.0||||||
3728444|NCT02064894|3566186|B1||Ankle|Injury location - n(%)||Participants|Count of Participants|21|21.0||||||
3728445|NCT02064894|3566183|B4||Wrist|Injury location - n(%)||Participants|Count of Participants|77|77.0||||||
3728446|NCT02064894|3566184|B3||Wrist|Injury location - n(%)||Participants|Count of Participants|25|25.0||||||
3728447|NCT02064894|3566185|B2||Wrist|Injury location - n(%)||Participants|Count of Participants|28|28.0||||||
3728448|NCT02064894|3566186|B1||Wrist|Injury location - n(%)||Participants|Count of Participants|24|24.0||||||
3728449|NCT02064894|3566183|B4||Missing|Injury type - n(%)||Participants|Count of Participants|4|4.0||||||
3728450|NCT02064894|3566184|B3||Missing|Injury type - n(%)||Participants|Count of Participants|0|0.0||||||
3728451|NCT02064894|3566185|B2||Missing|Injury type - n(%)||Participants|Count of Participants|4|4.0||||||
3728452|NCT02064894|3566186|B1||Missing|Injury type - n(%)||Participants|Count of Participants|0|0.0||||||
3728453|NCT02064894|3566183|B4||Soft tissue injury|Injury type - n(%)||Participants|Count of Participants|277|277.0||||||
3728454|NCT02064894|3566184|B3||Soft tissue injury|Injury type - n(%)||Participants|Count of Participants|112|112.0||||||
3728455|NCT02064894|3566185|B2||Soft tissue injury|Injury type - n(%)||Participants|Count of Participants|117|117.0||||||
3728456|NCT02064894|3566186|B1||Soft tissue injury|Injury type - n(%)||Participants|Count of Participants|48|48.0||||||
3728457|NCT02064894|3566183|B4||Fracture|Injury type - n(%)||Participants|Count of Participants|175|175.0||||||
3728458|NCT02064894|3566184|B3||Fracture|Injury type - n(%)||Participants|Count of Participants|65|65.0||||||
3728459|NCT02064894|3566185|B2||Fracture|Injury type - n(%)||Participants|Count of Participants|67|67.0||||||
3728460|NCT02064894|3566186|B1||Fracture|Injury type - n(%)||Participants|Count of Participants|43|43.0||||||
3728461|NCT02064894|3566183|B4|> 69 mm||VAS score at Baseline stratified by pain intensity|"The Visual Analogue Scale is a 0 to 100 mm continuous scale measuring the pain intensity. Score of 0=No Pain; Score of 100=Worst imaginable pain"|Participants|Count of Participants|143|143.0||||||
3728462|NCT02064894|3566184|B3|> 69 mm||VAS score at Baseline stratified by pain intensity|"The Visual Analogue Scale is a 0 to 100 mm continuous scale measuring the pain intensity. Score of 0=No Pain; Score of 100=Worst imaginable pain"|Participants|Count of Participants|56|56.0||||||
3728463|NCT02064894|3566185|B2|> 69 mm||VAS score at Baseline stratified by pain intensity|"The Visual Analogue Scale is a 0 to 100 mm continuous scale measuring the pain intensity. Score of 0=No Pain; Score of 100=Worst imaginable pain"|Participants|Count of Participants|60|60.0||||||
3728464|NCT02064894|3566186|B1|> 69 mm||VAS score at Baseline stratified by pain intensity|"The Visual Analogue Scale is a 0 to 100 mm continuous scale measuring the pain intensity. Score of 0=No Pain; Score of 100=Worst imaginable pain"|Participants|Count of Participants|27|27.0||||||
3728465|NCT02064894|3566183|B4|30-69 mm||VAS score at Baseline stratified by pain intensity|"The Visual Analogue Scale is a 0 to 100 mm continuous scale measuring the pain intensity. Score of 0=No Pain; Score of 100=Worst imaginable pain"|Participants|Count of Participants|313|313.0||||||
3728466|NCT02064894|3566184|B3|30-69 mm||VAS score at Baseline stratified by pain intensity|"The Visual Analogue Scale is a 0 to 100 mm continuous scale measuring the pain intensity. Score of 0=No Pain; Score of 100=Worst imaginable pain"|Participants|Count of Participants|121|121.0||||||
3728467|NCT02064894|3566185|B2|30-69 mm||VAS score at Baseline stratified by pain intensity|"The Visual Analogue Scale is a 0 to 100 mm continuous scale measuring the pain intensity. Score of 0=No Pain; Score of 100=Worst imaginable pain"|Participants|Count of Participants|128|128.0||||||
3728468|NCT02064894|3566186|B1|30-69 mm||VAS score at Baseline stratified by pain intensity|"The Visual Analogue Scale is a 0 to 100 mm continuous scale measuring the pain intensity. Score of 0=No Pain; Score of 100=Worst imaginable pain"|Participants|Count of Participants|64|64.0||||||
3728469|NCT02064894|3566183|B4|||VAS score at Baseline - Continuous|"The Visual Analogue Scale is a 0 to 100 mm continuous scale measuring the pain intensity. Score of 0=No Pain; Score of 100=Worst imaginable pain"|units on a scale|Mean|60.9|60.9|Standard Deviation|16.2|16.2|||
3728470|NCT02064894|3566184|B3|||VAS score at Baseline - Continuous|"The Visual Analogue Scale is a 0 to 100 mm continuous scale measuring the pain intensity. Score of 0=No Pain; Score of 100=Worst imaginable pain"|units on a scale|Mean|61.0|61.0|Standard Deviation|17.1|17.1|||
3728471|NCT02064894|3566185|B2|||VAS score at Baseline - Continuous|"The Visual Analogue Scale is a 0 to 100 mm continuous scale measuring the pain intensity. Score of 0=No Pain; Score of 100=Worst imaginable pain"|units on a scale|Mean|60.8|60.8|Standard Deviation|15.8|15.8|||
3728472|NCT02064894|3566186|B1|||VAS score at Baseline - Continuous|"The Visual Analogue Scale is a 0 to 100 mm continuous scale measuring the pain intensity. Score of 0=No Pain; Score of 100=Worst imaginable pain"|units on a scale|Mean|60.9|60.9|Standard Deviation|15.5|15.5|||
3728473|NCT02064894|3566183|B4||Male|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
3728474|NCT02064894|3566184|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3728475|NCT02064894|3566185|B2||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3728476|NCT02064894|3566186|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3728477|NCT02064894|3566183|B4||Female|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
3728478|NCT02064894|3566184|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3728479|NCT02064894|3566185|B2||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3728480|NCT02064894|3566186|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3728481|NCT02064894|3566183|B4|12-17||Age, Customized||Participants|Count of Participants|258|258.0||||||
3728482|NCT02064894|3566184|B3|12-17||Age, Customized||Participants|Count of Participants|103|103.0||||||
3728483|NCT02064894|3566185|B2|12-17||Age, Customized||Participants|Count of Participants|103|103.0||||||
3728484|NCT02064894|3566186|B1|12-17||Age, Customized||Participants|Count of Participants|52|52.0||||||
3728485|NCT02064894|3566183|B4|6-11||Age, Customized||Participants|Count of Participants|198|198.0||||||
3728486|NCT02064894|3566184|B3|6-11||Age, Customized||Participants|Count of Participants|74|74.0||||||
3728487|NCT02064894|3566185|B2|6-11||Age, Customized||Participants|Count of Participants|85|85.0||||||
3728488|NCT02064894|3566186|B1|6-11||Age, Customized||Participants|Count of Participants|39|39.0||||||
3728489|NCT02064894|3566183|B4|||Age||years|Mean|11.9|11.9|Standard Deviation|2.7|2.7|||
3728490|NCT02064894|3566184|B3|||Age||years|Mean|12.0|12.0|Standard Deviation|2.7|2.7|||
3728491|NCT02064894|3566185|B2|||Age||years|Mean|11.7|11.7|Standard Deviation|2.7|2.7|||
3728492|NCT02064894|3566186|B1|||Age||years|Mean|12.2|12.2|Standard Deviation|2.6|2.6|||
3728493|NCT02064816|3566199|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3728494|NCT02064816|3566200|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3728495|NCT02064816|3566201|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3728496|NCT02064816|3566199|B3||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3728497|NCT02064816|3566200|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3728498|NCT02064816|3566201|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3728499|NCT02064816|3566199|B3|>64 years||Age, Customized||subjects|Number|0|0.0||||||
3728500|NCT02064816|3566200|B2|>64 years||Age, Customized||subjects|Number|0|0.0||||||
3728501|NCT02064816|3566201|B1|>64 years||Age, Customized||subjects|Number|0|0.0||||||
3728502|NCT02064816|3566199|B3|>=18 years to 64 years||Age, Customized||subjects|Number|200|200.0||||||
3728503|NCT02064816|3566200|B2|>=18 years to 64 years||Age, Customized||subjects|Number|96|96.0||||||
3728504|NCT02064816|3566201|B1|>=18 years to 64 years||Age, Customized||subjects|Number|104|104.0||||||
3728505|NCT02064816|3566199|B3|<18 years||Age, Customized||subjects|Number|0|0.0||||||
3728506|NCT02064816|3566200|B2|<18 years||Age, Customized||subjects|Number|0|0.0||||||
3728507|NCT02064816|3566201|B1|<18 years||Age, Customized||subjects|Number|0|0.0||||||
3728508|NCT02064439|3566240|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|402|402.0||||||
3728509|NCT02064439|3566241|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|141|141.0||||||
3728510|NCT02064439|3566242|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
3728511|NCT02064439|3566243|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|135|135.0||||||
3728512|NCT02064439|3566240|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3728513|NCT02064439|3566241|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3728514|NCT02064439|3566242|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3728515|NCT02064439|3566243|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3728516|NCT02064439|3566240|B4||White|Race (NIH/OMB)||Participants|Count of Participants|2344|2344.0||||||
3728517|NCT02064439|3566241|B3||White|Race (NIH/OMB)||Participants|Count of Participants|786|786.0||||||
3728518|NCT02064439|3566242|B2||White|Race (NIH/OMB)||Participants|Count of Participants|772|772.0||||||
3728519|NCT02064439|3566243|B1||White|Race (NIH/OMB)||Participants|Count of Participants|786|786.0||||||
3728520|NCT02064439|3566240|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
3728521|NCT02064439|3566241|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3728522|NCT02064439|3566242|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3728523|NCT02064439|3566243|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3728524|NCT02064439|3566240|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3728525|NCT02064439|3566241|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3728526|NCT02064439|3566242|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3728527|NCT02064439|3566243|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3728528|NCT02064439|3566240|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|479|479.0||||||
3728529|NCT02064439|3566241|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|159|159.0||||||
3728530|NCT02064439|3566242|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|159|159.0||||||
3728531|NCT02064439|3566243|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|161|161.0||||||
3728532|NCT02064439|3566240|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3728533|NCT02064439|3566241|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3728534|NCT02064439|3566242|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3728535|NCT02064439|3566243|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3728536|NCT02064439|3566240|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|593|593.0||||||
3728537|NCT02064439|3566241|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|212|212.0||||||
3728538|NCT02064439|3566242|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|177|177.0||||||
3728539|NCT02064439|3566243|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|204|204.0||||||
3728540|NCT02064439|3566240|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2680|2680.0||||||
3728541|NCT02064439|3566241|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|889|889.0||||||
3728542|NCT02064439|3566242|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|899|899.0||||||
3728543|NCT02064439|3566243|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|892|892.0||||||
3728544|NCT02064439|3566240|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
3728545|NCT02064439|3566241|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3728546|NCT02064439|3566242|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3728547|NCT02064439|3566243|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3728548|NCT02064439|3566240|B4||Male|Sex: Female, Male||Participants|Count of Participants|1865|1865.0||||||
3728549|NCT02064439|3566241|B3||Male|Sex: Female, Male||Participants|Count of Participants|643|643.0||||||
3728550|NCT02064439|3566242|B2||Male|Sex: Female, Male||Participants|Count of Participants|602|602.0||||||
3728551|NCT02064439|3566243|B1||Male|Sex: Female, Male||Participants|Count of Participants|620|620.0||||||
3728552|NCT02064439|3566240|B4||Female|Sex: Female, Male||Participants|Count of Participants|1500|1500.0||||||
3728553|NCT02064439|3566241|B3||Female|Sex: Female, Male||Participants|Count of Participants|488|488.0||||||
3728554|NCT02064439|3566242|B2||Female|Sex: Female, Male||Participants|Count of Participants|505|505.0||||||
3728555|NCT02064439|3566243|B1||Female|Sex: Female, Male||Participants|Count of Participants|507|507.0||||||
3728556|NCT02064439|3566240|B4|||Age||years|Mean|58.5|58.5|Standard Deviation|14.7|14.7|||
3728557|NCT02064439|3566241|B3|||Age||years|Mean|58.8|58.8|Standard Deviation|14.7|14.7|||
3728558|NCT02064439|3566242|B2|||Age||years|Mean|57.9|57.9|Standard Deviation|14.7|14.7|||
3728559|NCT02064439|3566243|B1|||Age||years|Mean|58.8|58.8|Standard Deviation|14.7|14.7|||
3728560|NCT02064270|3566262|B3|United States||Region of Enrollment||Participants|Count of Participants|432|432.0||||||
3728561|NCT02064270|3566263|B2|United States||Region of Enrollment||Participants|Count of Participants|231|231.0||||||
3728562|NCT02064270|3566264|B1|United States||Region of Enrollment||Participants|Count of Participants|201|201.0||||||
3728563|NCT02064270|3566262|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3728564|NCT02064270|3566262|B3||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3728565|NCT02064270|3566263|B2||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3728566|NCT02064270|3566264|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3728567|NCT02064270|3566262|B3||Female|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
3728568|NCT02064270|3566263|B2||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3728569|NCT02064270|3566264|B1||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3728570|NCT02064270|3566262|B3|||Age||years|Mean|60.6|60.6|Full Range|||33.0|86.0|
3728571|NCT02064270|3566263|B2|||Age||years|Mean|60.5|60.5|Full Range|||35.0|82.0|
3728572|NCT02064270|3566264|B1|||Age||years|Mean|60.7|60.7|Full Range|||33.0|86.0|
3728573|NCT02064231|3566280|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3728574|NCT02064231|3566280|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3728575|NCT02064231|3566280|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|12.4|12.4|||
3728576|NCT02064205|3566295|B1|||Dietary fiber intake||grams/day|Mean|18|18.0|Standard Deviation|4|4.0|||
3728577|NCT02064205|3566295|B1|||Dutch Eating Restraintness Score|Score ranges from 0 - 5 0 = unrestrained 5 = very restrained|units on a scale|Mean|2.4|2.4|Standard Deviation|0.4|0.4|||
3728578|NCT02064205|3566295|B1|||BPdia|Diastolic blood pressure|mm Hg|Mean|64.2|64.2|Standard Deviation|9.0|9.0|||
3728579|NCT02064205|3566295|B1|||BPsys|Systolic blood pressure|mm Hg|Mean|113.5|113.5|Standard Deviation|9.9|9.9|||
3728580|NCT02064205|3566295|B1|||BMI|Body Mass Index|kg/m^2|Mean|25.9|25.9|Standard Deviation|2.7|2.7|||
3728581|NCT02064205|3566295|B1|||Height||meter|Mean|1.70|1.7|Standard Deviation|0.04|0.04|||
3728582|NCT02064205|3566295|B1|||Body weight||kg|Mean|74.4|74.4|Standard Deviation|7.8|7.8|||
3728583|NCT02064205|3566295|B1|Netherlands||Region of Enrollment||participants|Number|32|32.0||||||
3728584|NCT02064205|3566295|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3728585|NCT02064205|3566295|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3728586|NCT02064205|3566295|B1|||Age||years|Mean|27.4|27.4|Standard Deviation|6.6|6.6|||
3728587|NCT02064205|3566295|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3728588|NCT02064205|3566295|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3728589|NCT02064205|3566295|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3728590|NCT02064166|3566311|B3|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3728591|NCT02064166|3566312|B2|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3728592|NCT02064166|3566313|B1|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3728593|NCT02064166|3566311|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3728594|NCT02064166|3566312|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3728595|NCT02064166|3566313|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3728596|NCT02064166|3566311|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3728597|NCT02064166|3566312|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3728598|NCT02064166|3566313|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3728599|NCT02064166|3566311|B3|||Age||years|Mean|62.9|62.9|Standard Deviation|7.2|7.2|||
3728600|NCT02064166|3566312|B2|||Age||years|Mean|62.2|62.2|Standard Deviation|9.6|9.6|||
3728601|NCT02064166|3566313|B1|||Age||years|Mean|63.4|63.4|Standard Deviation|5.7|5.7|||
3728602|NCT02064166|3566311|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3728603|NCT02064166|3566312|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3728604|NCT02064166|3566313|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3728605|NCT02064166|3566311|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3728606|NCT02064166|3566312|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3728607|NCT02064166|3566313|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3728608|NCT02064166|3566311|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3728609|NCT02064166|3566312|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3728610|NCT02064166|3566313|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3728611|NCT02063880|3566342|B3|||CD4%||%|Median|14.5|14.5|Inter-Quartile Range|||9.0|22.0|
3728612|NCT02063880|3566343|B2|||CD4%||%|Median|17|17.0|Inter-Quartile Range|||9.0|24.0|
3728613|NCT02063880|3566344|B1|||CD4%||%|Median|12.5|12.5|Inter-Quartile Range|||9.0|18.3|
3728614|NCT02063880|3566342|B3|Kenya||Region of Enrollment||participants|Number|181|181.0||||||
3728615|NCT02063880|3566343|B2|Kenya||Region of Enrollment||participants|Number|91|91.0||||||
3728616|NCT02063880|3566344|B1|Kenya||Region of Enrollment||participants|Number|90|90.0||||||
3728617|NCT02063880|3566342|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3728618|NCT02063880|3566343|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3728619|NCT02063880|3566344|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3728620|NCT02063880|3566342|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3728621|NCT02063880|3566343|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3728622|NCT02063880|3566344|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3728623|NCT02063880|3566342|B3|||Age||Years|Median|1.9|1.9|Inter-Quartile Range|||0.8|4.8|
3728624|NCT02063880|3566343|B2|||Age||Years|Median|1.8|1.8|Inter-Quartile Range|||0.8|4.5|
3728625|NCT02063880|3566344|B1|||Age||Years|Median|2|2.0|Inter-Quartile Range|||0.9|6.0|
3728626|NCT02063854|3566355|B8|||Urine Type 1 Collagen Cross-linked N-telopeptide (NTX)|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|nmol BCE/mmol-CRE|Mean|56.24|56.24|Standard Deviation|25.871|25.871|||
3728627|NCT02063854|3566356|B7|||Urine Type 1 Collagen Cross-linked N-telopeptide (NTX)|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|nmol BCE/mmol-CRE|Mean|53.66|53.66|Standard Deviation|23.911|23.911|||
3728628|NCT02063854|3566357|B6|||Urine Type 1 Collagen Cross-linked N-telopeptide (NTX)|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|nmol BCE/mmol-CRE|Mean|54.48|54.48|Standard Deviation|23.988|23.988|||
3728629|NCT02063854|3566358|B5|||Urine Type 1 Collagen Cross-linked N-telopeptide (NTX)|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|nmol BCE/mmol-CRE|Mean|64.44|64.44|Standard Deviation|29.535|29.535|||
3728748|NCT02063854|3566357|B6|2||Number of Existing Vertebral (Thoracic [Th4] -L4) Fractures|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|15|15.0||||||
3728630|NCT02063854|3566359|B4|||Urine Type 1 Collagen Cross-linked N-telopeptide (NTX)|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|nmol BCE/mmol-CRE|Mean|53.77|53.77|Standard Deviation|22.739|22.739|||
3728631|NCT02063854|3566360|B3|||Urine Type 1 Collagen Cross-linked N-telopeptide (NTX)|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|nmol BCE/mmol-CRE|Mean|54.98|54.98|Standard Deviation|23.928|23.928|||
3728632|NCT02063854|3566361|B2|||Urine Type 1 Collagen Cross-linked N-telopeptide (NTX)|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|nmol BCE/mmol-CRE|Mean|61.04|61.04|Standard Deviation|34.808|34.808|||
3728633|NCT02063854|3566362|B1|||Urine Type 1 Collagen Cross-linked N-telopeptide (NTX)|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|nmol BCE/mmol-CRE|Mean|56.76|56.76|Standard Deviation|26.169|26.169|||
3728634|NCT02063854|3566355|B8|||Serum Procollagen 1 N-terminal Peptide (P1NP)|Data was available for 198, 66, 206, 68, 64, 200 and 66 participants in each treatment arm, respectively.|μg/L|Mean|50.44|50.44|Standard Deviation|21.648|21.648|||
3728635|NCT02063854|3566356|B7|||Serum Procollagen 1 N-terminal Peptide (P1NP)|Data was available for 198, 66, 206, 68, 64, 200 and 66 participants in each treatment arm, respectively.|μg/L|Mean|46.04|46.04|Standard Deviation|21.714|21.714|||
3728636|NCT02063854|3566357|B6|||Serum Procollagen 1 N-terminal Peptide (P1NP)|Data was available for 198, 66, 206, 68, 64, 200 and 66 participants in each treatment arm, respectively.|μg/L|Mean|48.53|48.53|Standard Deviation|20.366|20.366|||
3728637|NCT02063854|3566358|B5|||Serum Procollagen 1 N-terminal Peptide (P1NP)|Data was available for 198, 66, 206, 68, 64, 200 and 66 participants in each treatment arm, respectively.|μg/L|Mean|53.43|53.43|Standard Deviation|22.783|22.783|||
3728638|NCT02063854|3566359|B4|||Serum Procollagen 1 N-terminal Peptide (P1NP)|Data was available for 198, 66, 206, 68, 64, 200 and 66 participants in each treatment arm, respectively.|μg/L|Mean|47.83|47.83|Standard Deviation|17.120|17.12|||
3728639|NCT02063854|3566360|B3|||Serum Procollagen 1 N-terminal Peptide (P1NP)|Data was available for 198, 66, 206, 68, 64, 200 and 66 participants in each treatment arm, respectively.|μg/L|Mean|50.89|50.89|Standard Deviation|22.635|22.635|||
3728640|NCT02063854|3566361|B2|||Serum Procollagen 1 N-terminal Peptide (P1NP)|Data was available for 198, 66, 206, 68, 64, 200 and 66 participants in each treatment arm, respectively.|μg/L|Mean|54.91|54.91|Standard Deviation|27.552|27.552|||
3728641|NCT02063854|3566362|B1|||Serum Procollagen 1 N-terminal Peptide (P1NP)|Data was available for 198, 66, 206, 68, 64, 200 and 66 participants in each treatment arm, respectively.|μg/L|Mean|51.79|51.79|Standard Deviation|20.357|20.357|||
3728642|NCT02063854|3566355|B8|||Serum Tartrate-resistant Acid Phosphatase 5b (TRACP-5b)|Data was available for 199, 66, 205, 68, 65, 200 and 66 participants in each treatment arm, respectively.|mU/dL|Mean|418.5|418.5|Standard Deviation|148.29|148.29|||
3728643|NCT02063854|3566356|B7|||Serum Tartrate-resistant Acid Phosphatase 5b (TRACP-5b)|Data was available for 199, 66, 205, 68, 65, 200 and 66 participants in each treatment arm, respectively.|mU/dL|Mean|395.0|395.0|Standard Deviation|128.38|128.38|||
3728644|NCT02063854|3566357|B6|||Serum Tartrate-resistant Acid Phosphatase 5b (TRACP-5b)|Data was available for 199, 66, 205, 68, 65, 200 and 66 participants in each treatment arm, respectively.|mU/dL|Mean|410.5|410.5|Standard Deviation|142.09|142.09|||
3728645|NCT02063854|3566358|B5|||Serum Tartrate-resistant Acid Phosphatase 5b (TRACP-5b)|Data was available for 199, 66, 205, 68, 65, 200 and 66 participants in each treatment arm, respectively.|mU/dL|Mean|444.7|444.7|Standard Deviation|142.90|142.9|||
3728646|NCT02063854|3566359|B4|||Serum Tartrate-resistant Acid Phosphatase 5b (TRACP-5b)|Data was available for 199, 66, 205, 68, 65, 200 and 66 participants in each treatment arm, respectively.|mU/dL|Mean|398.4|398.4|Standard Deviation|127.54|127.54|||
3728647|NCT02063854|3566360|B3|||Serum Tartrate-resistant Acid Phosphatase 5b (TRACP-5b)|Data was available for 199, 66, 205, 68, 65, 200 and 66 participants in each treatment arm, respectively.|mU/dL|Mean|422.1|422.1|Standard Deviation|162.07|162.07|||
3728648|NCT02063854|3566361|B2|||Serum Tartrate-resistant Acid Phosphatase 5b (TRACP-5b)|Data was available for 199, 66, 205, 68, 65, 200 and 66 participants in each treatment arm, respectively.|mU/dL|Mean|424.1|424.1|Standard Deviation|144.89|144.89|||
3728649|NCT02063854|3566362|B1|||Serum Tartrate-resistant Acid Phosphatase 5b (TRACP-5b)|Data was available for 199, 66, 205, 68, 65, 200 and 66 participants in each treatment arm, respectively.|mU/dL|Mean|427.1|427.1|Standard Deviation|154.67|154.67|||
3728650|NCT02063854|3566355|B8|||Serum Bone-type Alkaline Phosphatase (BAP)|Data was available for 199, 66, 205, 68, 65, 200 and 66 participants in each treatment arm, respectively.|μg/L|Mean|15.79|15.79|Standard Deviation|6.142|6.142|||
3728651|NCT02063854|3566356|B7|||Serum Bone-type Alkaline Phosphatase (BAP)|Data was available for 199, 66, 205, 68, 65, 200 and 66 participants in each treatment arm, respectively.|μg/L|Mean|15.13|15.13|Standard Deviation|6.815|6.815|||
3728652|NCT02063854|3566357|B6|||Serum Bone-type Alkaline Phosphatase (BAP)|Data was available for 199, 66, 205, 68, 65, 200 and 66 participants in each treatment arm, respectively.|μg/L|Mean|15.13|15.13|Standard Deviation|5.164|5.164|||
3728653|NCT02063854|3566358|B5|||Serum Bone-type Alkaline Phosphatase (BAP)|Data was available for 199, 66, 205, 68, 65, 200 and 66 participants in each treatment arm, respectively.|μg/L|Mean|17.17|17.17|Standard Deviation|7.354|7.354|||
3728654|NCT02063854|3566359|B4|||Serum Bone-type Alkaline Phosphatase (BAP)|Data was available for 199, 66, 205, 68, 65, 200 and 66 participants in each treatment arm, respectively.|μg/L|Mean|15.45|15.45|Standard Deviation|5.024|5.024|||
3728655|NCT02063854|3566360|B3|||Serum Bone-type Alkaline Phosphatase (BAP)|Data was available for 199, 66, 205, 68, 65, 200 and 66 participants in each treatment arm, respectively.|μg/L|Mean|15.83|15.83|Standard Deviation|6.035|6.035|||
3728656|NCT02063854|3566361|B2|||Serum Bone-type Alkaline Phosphatase (BAP)|Data was available for 199, 66, 205, 68, 65, 200 and 66 participants in each treatment arm, respectively.|μg/L|Mean|16.88|16.88|Standard Deviation|8.617|8.617|||
3728657|NCT02063854|3566362|B1|||Serum Bone-type Alkaline Phosphatase (BAP)|Data was available for 199, 66, 205, 68, 65, 200 and 66 participants in each treatment arm, respectively.|μg/L|Mean|15.91|15.91|Standard Deviation|5.809|5.809|||
3728658|NCT02063854|3566355|B8|||Serum C-telopeptide of Type 1 Collagen (CTX)|Data was available for 199, 66, 205, 68, 65, 200 and 66 participants in each treatment arm, respectively.|ng/mL|Mean|0.434|0.434|Standard Deviation|0.1696|0.1696|||
3728659|NCT02063854|3566356|B7|||Serum C-telopeptide of Type 1 Collagen (CTX)|Data was available for 199, 66, 205, 68, 65, 200 and 66 participants in each treatment arm, respectively.|ng/mL|Mean|0.399|0.399|Standard Deviation|0.1613|0.1613|||
3728660|NCT02063854|3566357|B6|||Serum C-telopeptide of Type 1 Collagen (CTX)|Data was available for 199, 66, 205, 68, 65, 200 and 66 participants in each treatment arm, respectively.|ng/mL|Mean|0.417|0.417|Standard Deviation|0.1592|0.1592|||
3728661|NCT02063854|3566358|B5|||Serum C-telopeptide of Type 1 Collagen (CTX)|Data was available for 199, 66, 205, 68, 65, 200 and 66 participants in each treatment arm, respectively.|ng/mL|Mean|0.497|0.497|Standard Deviation|0.1867|0.1867|||
3728662|NCT02063854|3566359|B4|||Serum C-telopeptide of Type 1 Collagen (CTX)|Data was available for 199, 66, 205, 68, 65, 200 and 66 participants in each treatment arm, respectively.|ng/mL|Mean|0.421|0.421|Standard Deviation|0.1437|0.1437|||
3728663|NCT02063854|3566360|B3|||Serum C-telopeptide of Type 1 Collagen (CTX)|Data was available for 199, 66, 205, 68, 65, 200 and 66 participants in each treatment arm, respectively.|ng/mL|Mean|0.426|0.426|Standard Deviation|0.1776|0.1776|||
3728664|NCT02063854|3566361|B2|||Serum C-telopeptide of Type 1 Collagen (CTX)|Data was available for 199, 66, 205, 68, 65, 200 and 66 participants in each treatment arm, respectively.|ng/mL|Mean|0.460|0.46|Standard Deviation|0.1855|0.1855|||
3728665|NCT02063854|3566362|B1|||Serum C-telopeptide of Type 1 Collagen (CTX)|Data was available for 199, 66, 205, 68, 65, 200 and 66 participants in each treatment arm, respectively.|ng/mL|Mean|0.444|0.444|Standard Deviation|0.1660|0.166|||
3728666|NCT02063854|3566355|B8|||Serum 25-OH-D|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|ng/mL|Mean|21.42|21.42|Standard Deviation|5.288|5.288|||
3728667|NCT02063854|3566356|B7|||Serum 25-OH-D|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|ng/mL|Mean|20.58|20.58|Standard Deviation|4.761|4.761|||
3728668|NCT02063854|3566357|B6|||Serum 25-OH-D|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|ng/mL|Mean|21.52|21.52|Standard Deviation|5.121|5.121|||
3728669|NCT02063854|3566358|B5|||Serum 25-OH-D|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|ng/mL|Mean|21.17|21.17|Standard Deviation|5.248|5.248|||
3728670|NCT02063854|3566359|B4|||Serum 25-OH-D|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|ng/mL|Mean|21.64|21.64|Standard Deviation|5.427|5.427|||
3728671|NCT02063854|3566360|B3|||Serum 25-OH-D|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|ng/mL|Mean|21.46|21.46|Standard Deviation|5.592|5.592|||
3728672|NCT02063854|3566361|B2|||Serum 25-OH-D|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|ng/mL|Mean|21.44|21.44|Standard Deviation|5.423|5.423|||
3728673|NCT02063854|3566362|B1|||Serum 25-OH-D|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|ng/mL|Mean|21.55|21.55|Standard Deviation|5.266|5.266|||
3728674|NCT02063854|3566355|B8|28.0 ng/mL - ≤Max||Serum 25-hydroxy Vitamin D (25-OH-D), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|96|96.0||||||
3728675|NCT02063854|3566356|B7|28.0 ng/mL - ≤Max||Serum 25-hydroxy Vitamin D (25-OH-D), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|5|5.0||||||
3728676|NCT02063854|3566357|B6|28.0 ng/mL - ≤Max||Serum 25-hydroxy Vitamin D (25-OH-D), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|19|19.0||||||
3728677|NCT02063854|3566358|B5|28.0 ng/mL - ≤Max||Serum 25-hydroxy Vitamin D (25-OH-D), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|7|7.0||||||
3728678|NCT02063854|3566359|B4|28.0 ng/mL - ≤Max||Serum 25-hydroxy Vitamin D (25-OH-D), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|10|10.0||||||
3728679|NCT02063854|3566360|B3|28.0 ng/mL - ≤Max||Serum 25-hydroxy Vitamin D (25-OH-D), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|28|28.0||||||
3728680|NCT02063854|3566361|B2|28.0 ng/mL - ≤Max||Serum 25-hydroxy Vitamin D (25-OH-D), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|7|7.0||||||
3728681|NCT02063854|3566362|B1|28.0 ng/mL - ≤Max||Serum 25-hydroxy Vitamin D (25-OH-D), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|20|20.0||||||
3728682|NCT02063854|3566355|B8|15.0 - ≤27.9 ng/mL||Serum 25-hydroxy Vitamin D (25-OH-D), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|685|685.0||||||
3728683|NCT02063854|3566356|B7|15.0 - ≤27.9 ng/mL||Serum 25-hydroxy Vitamin D (25-OH-D), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|53|53.0||||||
3728684|NCT02063854|3566357|B6|15.0 - ≤27.9 ng/mL||Serum 25-hydroxy Vitamin D (25-OH-D), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|160|160.0||||||
3728685|NCT02063854|3566358|B5|15.0 - ≤27.9 ng/mL||Serum 25-hydroxy Vitamin D (25-OH-D), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|50|50.0||||||
3728686|NCT02063854|3566359|B4|15.0 - ≤27.9 ng/mL||Serum 25-hydroxy Vitamin D (25-OH-D), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|53|53.0||||||
3728687|NCT02063854|3566360|B3|15.0 - ≤27.9 ng/mL||Serum 25-hydroxy Vitamin D (25-OH-D), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|157|157.0||||||
3728688|NCT02063854|3566361|B2|15.0 - ≤27.9 ng/mL||Serum 25-hydroxy Vitamin D (25-OH-D), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|51|51.0||||||
3728689|NCT02063854|3566362|B1|15.0 - ≤27.9 ng/mL||Serum 25-hydroxy Vitamin D (25-OH-D), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|161|161.0||||||
3728690|NCT02063854|3566355|B8|Min - ≤14.9 ng/mL||Serum 25-hydroxy Vitamin D (25-OH-D), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|89|89.0||||||
3728691|NCT02063854|3566356|B7|Min - ≤14.9 ng/mL||Serum 25-hydroxy Vitamin D (25-OH-D), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|8|8.0||||||
3728692|NCT02063854|3566357|B6|Min - ≤14.9 ng/mL||Serum 25-hydroxy Vitamin D (25-OH-D), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|21|21.0||||||
3728693|NCT02063854|3566358|B5|Min - ≤14.9 ng/mL||Serum 25-hydroxy Vitamin D (25-OH-D), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|8|8.0||||||
3728694|NCT02063854|3566359|B4|Min - ≤14.9 ng/mL||Serum 25-hydroxy Vitamin D (25-OH-D), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|5|5.0||||||
3728695|NCT02063854|3566360|B3|Min - ≤14.9 ng/mL||Serum 25-hydroxy Vitamin D (25-OH-D), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|21|21.0||||||
3728696|NCT02063854|3566361|B2|Min - ≤14.9 ng/mL||Serum 25-hydroxy Vitamin D (25-OH-D), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|8|8.0||||||
3728697|NCT02063854|3566362|B1|Min - ≤14.9 ng/mL||Serum 25-hydroxy Vitamin D (25-OH-D), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|18|18.0||||||
3728698|NCT02063854|3566355|B8|No Fragility Fracture and BMD<=YAM*70%||Primary Osteoporosis Diagnosis Criteria 2012|Data was available for 199, 66, 206, 67, 65, 201 and 66 participants in each treatment arm, respectively. YAM=young adult mean (lumbar spine: 20 to 44 years age range, proximal femur: 20 to 29 years age range).|participants|Number|453|453.0||||||
3728699|NCT02063854|3566356|B7|No Fragility Fracture and BMD<=YAM*70%||Primary Osteoporosis Diagnosis Criteria 2012|Data was available for 199, 66, 206, 67, 65, 201 and 66 participants in each treatment arm, respectively. YAM=young adult mean (lumbar spine: 20 to 44 years age range, proximal femur: 20 to 29 years age range).|participants|Number|30|30.0||||||
3728700|NCT02063854|3566357|B6|No Fragility Fracture and BMD<=YAM*70%||Primary Osteoporosis Diagnosis Criteria 2012|Data was available for 199, 66, 206, 67, 65, 201 and 66 participants in each treatment arm, respectively. YAM=young adult mean (lumbar spine: 20 to 44 years age range, proximal femur: 20 to 29 years age range).|participants|Number|97|97.0||||||
3728701|NCT02063854|3566358|B5|No Fragility Fracture and BMD<=YAM*70%||Primary Osteoporosis Diagnosis Criteria 2012|Data was available for 199, 66, 206, 67, 65, 201 and 66 participants in each treatment arm, respectively. YAM=young adult mean (lumbar spine: 20 to 44 years age range, proximal femur: 20 to 29 years age range).|participants|Number|34|34.0||||||
3728702|NCT02063854|3566359|B4|No Fragility Fracture and BMD<=YAM*70%||Primary Osteoporosis Diagnosis Criteria 2012|Data was available for 199, 66, 206, 67, 65, 201 and 66 participants in each treatment arm, respectively. YAM=young adult mean (lumbar spine: 20 to 44 years age range, proximal femur: 20 to 29 years age range).|participants|Number|35|35.0||||||
3728703|NCT02063854|3566360|B3|No Fragility Fracture and BMD<=YAM*70%||Primary Osteoporosis Diagnosis Criteria 2012|Data was available for 199, 66, 206, 67, 65, 201 and 66 participants in each treatment arm, respectively. YAM=young adult mean (lumbar spine: 20 to 44 years age range, proximal femur: 20 to 29 years age range).|participants|Number|115|115.0||||||
3728704|NCT02063854|3566361|B2|No Fragility Fracture and BMD<=YAM*70%||Primary Osteoporosis Diagnosis Criteria 2012|Data was available for 199, 66, 206, 67, 65, 201 and 66 participants in each treatment arm, respectively. YAM=young adult mean (lumbar spine: 20 to 44 years age range, proximal femur: 20 to 29 years age range).|participants|Number|29|29.0||||||
3728705|NCT02063854|3566362|B1|No Fragility Fracture and BMD<=YAM*70%||Primary Osteoporosis Diagnosis Criteria 2012|Data was available for 199, 66, 206, 67, 65, 201 and 66 participants in each treatment arm, respectively. YAM=young adult mean (lumbar spine: 20 to 44 years age range, proximal femur: 20 to 29 years age range).|participants|Number|113|113.0||||||
3728706|NCT02063854|3566355|B8|Fragility Fracture (Other and BMD<YAM*80%)||Primary Osteoporosis Diagnosis Criteria 2012|Data was available for 199, 66, 206, 67, 65, 201 and 66 participants in each treatment arm, respectively. YAM=young adult mean (lumbar spine: 20 to 44 years age range, proximal femur: 20 to 29 years age range).|participants|Number|74|74.0||||||
3728707|NCT02063854|3566356|B7|Fragility Fracture (Other and BMD<YAM*80%)||Primary Osteoporosis Diagnosis Criteria 2012|Data was available for 199, 66, 206, 67, 65, 201 and 66 participants in each treatment arm, respectively. YAM=young adult mean (lumbar spine: 20 to 44 years age range, proximal femur: 20 to 29 years age range).|participants|Number|4|4.0||||||
3728708|NCT02063854|3566357|B6|Fragility Fracture (Other and BMD<YAM*80%)||Primary Osteoporosis Diagnosis Criteria 2012|Data was available for 199, 66, 206, 67, 65, 201 and 66 participants in each treatment arm, respectively. YAM=young adult mean (lumbar spine: 20 to 44 years age range, proximal femur: 20 to 29 years age range).|participants|Number|24|24.0||||||
3728709|NCT02063854|3566358|B5|Fragility Fracture (Other and BMD<YAM*80%)||Primary Osteoporosis Diagnosis Criteria 2012|Data was available for 199, 66, 206, 67, 65, 201 and 66 participants in each treatment arm, respectively. YAM=young adult mean (lumbar spine: 20 to 44 years age range, proximal femur: 20 to 29 years age range).|participants|Number|6|6.0||||||
3728710|NCT02063854|3566359|B4|Fragility Fracture (Other and BMD<YAM*80%)||Primary Osteoporosis Diagnosis Criteria 2012|Data was available for 199, 66, 206, 67, 65, 201 and 66 participants in each treatment arm, respectively. YAM=young adult mean (lumbar spine: 20 to 44 years age range, proximal femur: 20 to 29 years age range).|participants|Number|3|3.0||||||
3728711|NCT02063854|3566360|B3|Fragility Fracture (Other and BMD<YAM*80%)||Primary Osteoporosis Diagnosis Criteria 2012|Data was available for 199, 66, 206, 67, 65, 201 and 66 participants in each treatment arm, respectively. YAM=young adult mean (lumbar spine: 20 to 44 years age range, proximal femur: 20 to 29 years age range).|participants|Number|9|9.0||||||
3728712|NCT02063854|3566361|B2|Fragility Fracture (Other and BMD<YAM*80%)||Primary Osteoporosis Diagnosis Criteria 2012|Data was available for 199, 66, 206, 67, 65, 201 and 66 participants in each treatment arm, respectively. YAM=young adult mean (lumbar spine: 20 to 44 years age range, proximal femur: 20 to 29 years age range).|participants|Number|7|7.0||||||
3728713|NCT02063854|3566362|B1|Fragility Fracture (Other and BMD<YAM*80%)||Primary Osteoporosis Diagnosis Criteria 2012|Data was available for 199, 66, 206, 67, 65, 201 and 66 participants in each treatment arm, respectively. YAM=young adult mean (lumbar spine: 20 to 44 years age range, proximal femur: 20 to 29 years age range).|participants|Number|21|21.0||||||
3728714|NCT02063854|3566355|B8|Fragility Fracture (Vertebrae or Proximal Femur)||Primary Osteoporosis Diagnosis Criteria 2012|Data was available for 199, 66, 206, 67, 65, 201 and 66 participants in each treatment arm, respectively. YAM=young adult mean (lumbar spine: 20 to 44 years age range, proximal femur: 20 to 29 years age range).|participants|Number|343|343.0||||||
3728715|NCT02063854|3566356|B7|Fragility Fracture (Vertebrae or Proximal Femur)||Primary Osteoporosis Diagnosis Criteria 2012|Data was available for 199, 66, 206, 67, 65, 201 and 66 participants in each treatment arm, respectively. YAM=young adult mean (lumbar spine: 20 to 44 years age range, proximal femur: 20 to 29 years age range).|participants|Number|32|32.0||||||
3728716|NCT02063854|3566357|B6|Fragility Fracture (Vertebrae or Proximal Femur)||Primary Osteoporosis Diagnosis Criteria 2012|Data was available for 199, 66, 206, 67, 65, 201 and 66 participants in each treatment arm, respectively. YAM=young adult mean (lumbar spine: 20 to 44 years age range, proximal femur: 20 to 29 years age range).|participants|Number|80|80.0||||||
3728717|NCT02063854|3566358|B5|Fragility Fracture (Vertebrae or Proximal Femur)||Primary Osteoporosis Diagnosis Criteria 2012|Data was available for 199, 66, 206, 67, 65, 201 and 66 participants in each treatment arm, respectively. YAM=young adult mean (lumbar spine: 20 to 44 years age range, proximal femur: 20 to 29 years age range).|participants|Number|25|25.0||||||
3728718|NCT02063854|3566359|B4|Fragility Fracture (Vertebrae or Proximal Femur)||Primary Osteoporosis Diagnosis Criteria 2012|Data was available for 199, 66, 206, 67, 65, 201 and 66 participants in each treatment arm, respectively. YAM=young adult mean (lumbar spine: 20 to 44 years age range, proximal femur: 20 to 29 years age range).|participants|Number|29|29.0||||||
3728719|NCT02063854|3566360|B3|Fragility Fracture (Vertebrae or Proximal Femur)||Primary Osteoporosis Diagnosis Criteria 2012|Data was available for 199, 66, 206, 67, 65, 201 and 66 participants in each treatment arm, respectively. YAM=young adult mean (lumbar spine: 20 to 44 years age range, proximal femur: 20 to 29 years age range).|participants|Number|82|82.0||||||
3728720|NCT02063854|3566361|B2|Fragility Fracture (Vertebrae or Proximal Femur)||Primary Osteoporosis Diagnosis Criteria 2012|Data was available for 199, 66, 206, 67, 65, 201 and 66 participants in each treatment arm, respectively. YAM=young adult mean (lumbar spine: 20 to 44 years age range, proximal femur: 20 to 29 years age range).|participants|Number|30|30.0||||||
3728721|NCT02063854|3566362|B1|Fragility Fracture (Vertebrae or Proximal Femur)||Primary Osteoporosis Diagnosis Criteria 2012|Data was available for 199, 66, 206, 67, 65, 201 and 66 participants in each treatment arm, respectively. YAM=young adult mean (lumbar spine: 20 to 44 years age range, proximal femur: 20 to 29 years age range).|participants|Number|65|65.0||||||
3728722|NCT02063854|3566355|B8|No||Fragility Fracture||participants|Number|454|454.0||||||
3728723|NCT02063854|3566356|B7|No||Fragility Fracture||participants|Number|30|30.0||||||
3728724|NCT02063854|3566357|B6|No||Fragility Fracture||participants|Number|97|97.0||||||
3728725|NCT02063854|3566358|B5|No||Fragility Fracture||participants|Number|34|34.0||||||
3728726|NCT02063854|3566359|B4|No||Fragility Fracture||participants|Number|36|36.0||||||
3728727|NCT02063854|3566360|B3|No||Fragility Fracture||participants|Number|115|115.0||||||
3728728|NCT02063854|3566361|B2|No||Fragility Fracture||participants|Number|29|29.0||||||
3728729|NCT02063854|3566362|B1|No||Fragility Fracture||participants|Number|113|113.0||||||
3728730|NCT02063854|3566355|B8|Yes||Fragility Fracture||participants|Number|417|417.0||||||
3728731|NCT02063854|3566356|B7|Yes||Fragility Fracture||participants|Number|36|36.0||||||
3728732|NCT02063854|3566357|B6|Yes||Fragility Fracture||participants|Number|104|104.0||||||
3728733|NCT02063854|3566358|B5|Yes||Fragility Fracture||participants|Number|31|31.0||||||
3728734|NCT02063854|3566359|B4|Yes||Fragility Fracture||participants|Number|32|32.0||||||
3728735|NCT02063854|3566360|B3|Yes||Fragility Fracture||participants|Number|91|91.0||||||
3728736|NCT02063854|3566361|B2|Yes||Fragility Fracture||participants|Number|37|37.0||||||
3728737|NCT02063854|3566362|B1|Yes||Fragility Fracture||participants|Number|86|86.0||||||
3728738|NCT02063854|3566355|B8|≥3||Number of Existing Vertebral (Thoracic [Th4] -L4) Fractures|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|34|34.0||||||
3728739|NCT02063854|3566356|B7|≥3||Number of Existing Vertebral (Thoracic [Th4] -L4) Fractures|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|0|0.0||||||
3728740|NCT02063854|3566357|B6|≥3||Number of Existing Vertebral (Thoracic [Th4] -L4) Fractures|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|6|6.0||||||
3728741|NCT02063854|3566358|B5|≥3||Number of Existing Vertebral (Thoracic [Th4] -L4) Fractures|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|3|3.0||||||
3728742|NCT02063854|3566359|B4|≥3||Number of Existing Vertebral (Thoracic [Th4] -L4) Fractures|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|2|2.0||||||
3728743|NCT02063854|3566360|B3|≥3||Number of Existing Vertebral (Thoracic [Th4] -L4) Fractures|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|8|8.0||||||
3728744|NCT02063854|3566361|B2|≥3||Number of Existing Vertebral (Thoracic [Th4] -L4) Fractures|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|5|5.0||||||
3728745|NCT02063854|3566362|B1|≥3||Number of Existing Vertebral (Thoracic [Th4] -L4) Fractures|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|10|10.0||||||
3728746|NCT02063854|3566355|B8|2||Number of Existing Vertebral (Thoracic [Th4] -L4) Fractures|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|66|66.0||||||
3728747|NCT02063854|3566356|B7|2||Number of Existing Vertebral (Thoracic [Th4] -L4) Fractures|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|6|6.0||||||
3728749|NCT02063854|3566358|B5|2||Number of Existing Vertebral (Thoracic [Th4] -L4) Fractures|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|6|6.0||||||
3728750|NCT02063854|3566359|B4|2||Number of Existing Vertebral (Thoracic [Th4] -L4) Fractures|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|7|7.0||||||
3728751|NCT02063854|3566360|B3|2||Number of Existing Vertebral (Thoracic [Th4] -L4) Fractures|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|12|12.0||||||
3728752|NCT02063854|3566361|B2|2||Number of Existing Vertebral (Thoracic [Th4] -L4) Fractures|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|8|8.0||||||
3728753|NCT02063854|3566362|B1|2||Number of Existing Vertebral (Thoracic [Th4] -L4) Fractures|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|12|12.0||||||
3728754|NCT02063854|3566355|B8|1||Number of Existing Vertebral (Thoracic [Th4] -L4) Fractures|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|239|239.0||||||
3728755|NCT02063854|3566356|B7|1||Number of Existing Vertebral (Thoracic [Th4] -L4) Fractures|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|25|25.0||||||
3728756|NCT02063854|3566357|B6|1||Number of Existing Vertebral (Thoracic [Th4] -L4) Fractures|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|58|58.0||||||
3728757|NCT02063854|3566358|B5|1||Number of Existing Vertebral (Thoracic [Th4] -L4) Fractures|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|18|18.0||||||
3728758|NCT02063854|3566359|B4|1||Number of Existing Vertebral (Thoracic [Th4] -L4) Fractures|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|17|17.0||||||
3728759|NCT02063854|3566360|B3|1||Number of Existing Vertebral (Thoracic [Th4] -L4) Fractures|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|61|61.0||||||
3728760|NCT02063854|3566361|B2|1||Number of Existing Vertebral (Thoracic [Th4] -L4) Fractures|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|21|21.0||||||
3728761|NCT02063854|3566362|B1|1||Number of Existing Vertebral (Thoracic [Th4] -L4) Fractures|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|39|39.0||||||
3728762|NCT02063854|3566355|B8|0||Number of Existing Vertebral (Thoracic [Th4] -L4) Fractures|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|531|531.0||||||
3728763|NCT02063854|3566356|B7|0||Number of Existing Vertebral (Thoracic [Th4] -L4) Fractures|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|35|35.0||||||
3728764|NCT02063854|3566357|B6|0||Number of Existing Vertebral (Thoracic [Th4] -L4) Fractures|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|121|121.0||||||
3728765|NCT02063854|3566358|B5|0||Number of Existing Vertebral (Thoracic [Th4] -L4) Fractures|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|38|38.0||||||
3728766|NCT02063854|3566359|B4|0||Number of Existing Vertebral (Thoracic [Th4] -L4) Fractures|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|42|42.0||||||
3728767|NCT02063854|3566360|B3|0||Number of Existing Vertebral (Thoracic [Th4] -L4) Fractures|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|125|125.0||||||
3728768|NCT02063854|3566361|B2|0||Number of Existing Vertebral (Thoracic [Th4] -L4) Fractures|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|32|32.0||||||
3728769|NCT02063854|3566362|B1|0||Number of Existing Vertebral (Thoracic [Th4] -L4) Fractures|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|138|138.0||||||
3728770|NCT02063854|3566355|B8|Explorer||Dual-Energy X-Ray Absorptiometry (DXA) Measuring Apparatus||participants|Number|192|192.0||||||
3728771|NCT02063854|3566356|B7|Explorer||Dual-Energy X-Ray Absorptiometry (DXA) Measuring Apparatus||participants|Number|17|17.0||||||
3728772|NCT02063854|3566357|B6|Explorer||Dual-Energy X-Ray Absorptiometry (DXA) Measuring Apparatus||participants|Number|45|45.0||||||
3728773|NCT02063854|3566358|B5|Explorer||Dual-Energy X-Ray Absorptiometry (DXA) Measuring Apparatus||participants|Number|15|15.0||||||
3728774|NCT02063854|3566359|B4|Explorer||Dual-Energy X-Ray Absorptiometry (DXA) Measuring Apparatus||participants|Number|15|15.0||||||
3728775|NCT02063854|3566360|B3|Explorer||Dual-Energy X-Ray Absorptiometry (DXA) Measuring Apparatus||participants|Number|43|43.0||||||
3728776|NCT02063854|3566361|B2|Explorer||Dual-Energy X-Ray Absorptiometry (DXA) Measuring Apparatus||participants|Number|14|14.0||||||
3728777|NCT02063854|3566362|B1|Explorer||Dual-Energy X-Ray Absorptiometry (DXA) Measuring Apparatus||participants|Number|43|43.0||||||
3728778|NCT02063854|3566355|B8|Discovery||Dual-Energy X-Ray Absorptiometry (DXA) Measuring Apparatus||participants|Number|499|499.0||||||
3728779|NCT02063854|3566356|B7|Discovery||Dual-Energy X-Ray Absorptiometry (DXA) Measuring Apparatus||participants|Number|35|35.0||||||
3728780|NCT02063854|3566357|B6|Discovery||Dual-Energy X-Ray Absorptiometry (DXA) Measuring Apparatus||participants|Number|118|118.0||||||
3728781|NCT02063854|3566358|B5|Discovery||Dual-Energy X-Ray Absorptiometry (DXA) Measuring Apparatus||participants|Number|35|35.0||||||
3728782|NCT02063854|3566359|B4|Discovery||Dual-Energy X-Ray Absorptiometry (DXA) Measuring Apparatus||participants|Number|39|39.0||||||
3728783|NCT02063854|3566360|B3|Discovery||Dual-Energy X-Ray Absorptiometry (DXA) Measuring Apparatus||participants|Number|120|120.0||||||
3728784|NCT02063854|3566361|B2|Discovery||Dual-Energy X-Ray Absorptiometry (DXA) Measuring Apparatus||participants|Number|38|38.0||||||
3728785|NCT02063854|3566362|B1|Discovery||Dual-Energy X-Ray Absorptiometry (DXA) Measuring Apparatus||participants|Number|114|114.0||||||
3728786|NCT02063854|3566355|B8|Delphi||Dual-Energy X-Ray Absorptiometry (DXA) Measuring Apparatus||participants|Number|118|118.0||||||
3728787|NCT02063854|3566356|B7|Delphi||Dual-Energy X-Ray Absorptiometry (DXA) Measuring Apparatus||participants|Number|8|8.0||||||
3728788|NCT02063854|3566357|B6|Delphi||Dual-Energy X-Ray Absorptiometry (DXA) Measuring Apparatus||participants|Number|26|26.0||||||
3728789|NCT02063854|3566358|B5|Delphi||Dual-Energy X-Ray Absorptiometry (DXA) Measuring Apparatus||participants|Number|9|9.0||||||
3728790|NCT02063854|3566359|B4|Delphi||Dual-Energy X-Ray Absorptiometry (DXA) Measuring Apparatus||participants|Number|9|9.0||||||
3728791|NCT02063854|3566360|B3|Delphi||Dual-Energy X-Ray Absorptiometry (DXA) Measuring Apparatus||participants|Number|29|29.0||||||
3728792|NCT02063854|3566361|B2|Delphi||Dual-Energy X-Ray Absorptiometry (DXA) Measuring Apparatus||participants|Number|9|9.0||||||
3728793|NCT02063854|3566362|B1|Delphi||Dual-Energy X-Ray Absorptiometry (DXA) Measuring Apparatus||participants|Number|28|28.0||||||
3728794|NCT02063854|3566355|B8|QDR-4500||Dual-Energy X-Ray Absorptiometry (DXA) Measuring Apparatus||participants|Number|62|62.0||||||
3728795|NCT02063854|3566356|B7|QDR-4500||Dual-Energy X-Ray Absorptiometry (DXA) Measuring Apparatus||participants|Number|6|6.0||||||
3728796|NCT02063854|3566357|B6|QDR-4500||Dual-Energy X-Ray Absorptiometry (DXA) Measuring Apparatus||participants|Number|12|12.0||||||
3728797|NCT02063854|3566358|B5|QDR-4500||Dual-Energy X-Ray Absorptiometry (DXA) Measuring Apparatus||participants|Number|6|6.0||||||
3728798|NCT02063854|3566359|B4|QDR-4500||Dual-Energy X-Ray Absorptiometry (DXA) Measuring Apparatus||participants|Number|5|5.0||||||
3728799|NCT02063854|3566360|B3|QDR-4500||Dual-Energy X-Ray Absorptiometry (DXA) Measuring Apparatus||participants|Number|14|14.0||||||
3728800|NCT02063854|3566361|B2|QDR-4500||Dual-Energy X-Ray Absorptiometry (DXA) Measuring Apparatus||participants|Number|5|5.0||||||
3728801|NCT02063854|3566362|B1|QDR-4500||Dual-Energy X-Ray Absorptiometry (DXA) Measuring Apparatus||participants|Number|14|14.0||||||
3728802|NCT02063854|3566355|B8|||Femoral Neck BMD T-score|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis. Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|score on a scale|Mean|-2.8594|-2.8594|Standard Deviation|0.85690|0.8569|||
3728803|NCT02063854|3566356|B7|||Femoral Neck BMD T-score|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis. Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|score on a scale|Mean|-2.8077|-2.8077|Standard Deviation|0.81618|0.81618|||
3728804|NCT02063854|3566357|B6|||Femoral Neck BMD T-score|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis. Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|score on a scale|Mean|-2.7652|-2.7652|Standard Deviation|0.89454|0.89454|||
3728805|NCT02063854|3566358|B5|||Femoral Neck BMD T-score|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis. Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|score on a scale|Mean|-2.9501|-2.9501|Standard Deviation|0.69920|0.6992|||
3728806|NCT02063854|3566359|B4|||Femoral Neck BMD T-score|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis. Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|score on a scale|Mean|-2.8360|-2.836|Standard Deviation|0.79487|0.79487|||
3728807|NCT02063854|3566360|B3|||Femoral Neck BMD T-score|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis. Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|score on a scale|Mean|-2.9135|-2.9135|Standard Deviation|0.88448|0.88448|||
3728808|NCT02063854|3566361|B2|||Femoral Neck BMD T-score|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis. Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|score on a scale|Mean|-2.9358|-2.9358|Standard Deviation|0.90523|0.90523|||
3728809|NCT02063854|3566362|B1|||Femoral Neck BMD T-score|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis. Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|score on a scale|Mean|-2.8683|-2.8683|Standard Deviation|0.85505|0.85505|||
3728810|NCT02063854|3566355|B8|||Femoral Neck BMD|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|g/cm^2|Mean|0.5327|0.5327|Standard Deviation|0.07712|0.07712|||
3728811|NCT02063854|3566356|B7|||Femoral Neck BMD|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|g/cm^2|Mean|0.5373|0.5373|Standard Deviation|0.07346|0.07346|||
3728812|NCT02063854|3566357|B6|||Femoral Neck BMD|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|g/cm^2|Mean|0.5411|0.5411|Standard Deviation|0.08051|0.08051|||
3728813|NCT02063854|3566358|B5|||Femoral Neck BMD|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|g/cm^2|Mean|0.5245|0.5245|Standard Deviation|0.06293|0.06293|||
3728814|NCT02063854|3566359|B4|||Femoral Neck BMD|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|g/cm^2|Mean|0.5348|0.5348|Standard Deviation|0.07154|0.07154|||
3728815|NCT02063854|3566360|B3|||Femoral Neck BMD|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|g/cm^2|Mean|0.5278|0.5278|Standard Deviation|0.07960|0.0796|||
3728816|NCT02063854|3566361|B2|||Femoral Neck BMD|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|g/cm^2|Mean|0.5258|0.5258|Standard Deviation|0.08147|0.08147|||
3728817|NCT02063854|3566362|B1|||Femoral Neck BMD|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|g/cm^2|Mean|0.5318|0.5318|Standard Deviation|0.07695|0.07695|||
3728818|NCT02063854|3566355|B8|||Trochanter BMD|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|g/cm^2|Mean|0.4925|0.4925|Standard Deviation|0.06914|0.06914|||
3728819|NCT02063854|3566356|B7|||Trochanter BMD|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|g/cm^2|Mean|0.4900|0.49|Standard Deviation|0.06824|0.06824|||
3728820|NCT02063854|3566357|B6|||Trochanter BMD|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|g/cm^2|Mean|0.5009|0.5009|Standard Deviation|0.06626|0.06626|||
3728821|NCT02063854|3566358|B5|||Trochanter BMD|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|g/cm^2|Mean|0.4879|0.4879|Standard Deviation|0.05653|0.05653|||
3728822|NCT02063854|3566359|B4|||Trochanter BMD|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|g/cm^2|Mean|0.4932|0.4932|Standard Deviation|0.07164|0.07164|||
3728823|NCT02063854|3566360|B3|||Trochanter BMD|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|g/cm^2|Mean|0.4844|0.4844|Standard Deviation|0.06610|0.0661|||
3728824|NCT02063854|3566361|B2|||Trochanter BMD|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|g/cm^2|Mean|0.4954|0.4954|Standard Deviation|0.06803|0.06803|||
3728825|NCT02063854|3566362|B1|||Trochanter BMD|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|g/cm^2|Mean|0.4938|0.4938|Standard Deviation|0.07793|0.07793|||
3728826|NCT02063854|3566355|B8|||Total Proximal Femur BMD T-score|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis. Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|score on a scale|Mean|-2.2021|-2.2021|Standard Deviation|0.84645|0.84645|||
3728827|NCT02063854|3566356|B7|||Total Proximal Femur BMD T-score|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis. Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|score on a scale|Mean|-2.2305|-2.2305|Standard Deviation|0.72892|0.72892|||
3728828|NCT02063854|3566357|B6|||Total Proximal Femur BMD T-score|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis. Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|score on a scale|Mean|-2.0978|-2.0978|Standard Deviation|0.84652|0.84652|||
3728829|NCT02063854|3566358|B5|||Total Proximal Femur BMD T-score|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis. Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|score on a scale|Mean|-2.2642|-2.2642|Standard Deviation|0.69731|0.69731|||
3728830|NCT02063854|3566359|B4|||Total Proximal Femur BMD T-score|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis. Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|score on a scale|Mean|-2.1699|-2.1699|Standard Deviation|0.79822|0.79822|||
3728831|NCT02063854|3566360|B3|||Total Proximal Femur BMD T-score|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis. Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|score on a scale|Mean|-2.2982|-2.2982|Standard Deviation|0.84903|0.84903|||
3728832|NCT02063854|3566361|B2|||Total Proximal Femur BMD T-score|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis. Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|score on a scale|Mean|-2.1770|-2.177|Standard Deviation|0.95369|0.95369|||
3728880|NCT02063854|3566361|B2|||L2-L4 (BMD)|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|g/cm^2|Mean|0.6690|0.669|Standard Deviation|0.11746|0.11746|||
3728833|NCT02063854|3566362|B1|||Total Proximal Femur BMD T-score|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis. Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|score on a scale|Mean|-2.1972|-2.1972|Standard Deviation|0.89971|0.89971|||
3728834|NCT02063854|3566355|B8|||Total Proximal Femur BMD|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|g/cm^2|Mean|0.6548|0.6548|Standard Deviation|0.08464|0.08464|||
3728835|NCT02063854|3566356|B7|||Total Proximal Femur BMD|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|g/cm^2|Mean|0.6520|0.652|Standard Deviation|0.07289|0.07289|||
3728836|NCT02063854|3566357|B6|||Total Proximal Femur BMD|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|g/cm^2|Mean|0.6652|0.6652|Standard Deviation|0.08465|0.08465|||
3728837|NCT02063854|3566358|B5|||Total Proximal Femur BMD|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|g/cm^2|Mean|0.6486|0.6486|Standard Deviation|0.06973|0.06973|||
3728838|NCT02063854|3566359|B4|||Total Proximal Femur BMD|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|g/cm^2|Mean|0.6580|0.658|Standard Deviation|0.07982|0.07982|||
3728839|NCT02063854|3566360|B3|||Total Proximal Femur BMD|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|g/cm^2|Mean|0.6452|0.6452|Standard Deviation|0.08490|0.0849|||
3728840|NCT02063854|3566361|B2|||Total Proximal Femur BMD|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|g/cm^2|Mean|0.6573|0.6573|Standard Deviation|0.09537|0.09537|||
3728841|NCT02063854|3566362|B1|||Total Proximal Femur BMD|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|g/cm^2|Mean|0.6553|0.6553|Standard Deviation|0.08997|0.08997|||
3728842|NCT02063854|3566355|B8|||L2-L4 BMD T-score|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis. Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|score on a scale|Mean|-2.9796|-2.9796|Standard Deviation|0.78178|0.78178|||
3728843|NCT02063854|3566356|B7|||L2-L4 BMD T-score|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis. Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|score on a scale|Mean|-2.8536|-2.8536|Standard Deviation|0.84030|0.8403|||
3728844|NCT02063854|3566357|B6|||L2-L4 BMD T-score|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis. Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|score on a scale|Mean|-2.9587|-2.9587|Standard Deviation|0.83135|0.83135|||
3728845|NCT02063854|3566358|B5|||L2-L4 BMD T-score|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis. Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|score on a scale|Mean|-3.0773|-3.0773|Standard Deviation|0.74863|0.74863|||
3728846|NCT02063854|3566359|B4|||L2-L4 BMD T-score|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis. Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|score on a scale|Mean|-2.9219|-2.9219|Standard Deviation|0.73670|0.7367|||
3728847|NCT02063854|3566360|B3|||L2-L4 BMD T-score|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis. Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|score on a scale|Mean|-3.0532|-3.0532|Standard Deviation|0.67537|0.67537|||
3728848|NCT02063854|3566361|B2|||L2-L4 BMD T-score|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis. Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|score on a scale|Mean|-2.8738|-2.8738|Standard Deviation|0.98709|0.98709|||
3728849|NCT02063854|3566362|B1|||L2-L4 BMD T-score|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis. Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|score on a scale|Mean|-2.9889|-2.9889|Standard Deviation|0.76130|0.7613|||
3728881|NCT02063854|3566362|B1|||L2-L4 (BMD)|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|g/cm^2|Mean|0.6553|0.6553|Standard Deviation|0.09060|0.0906|||
3728971|NCT02063854|3566356|B7|≥31 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|4|4.0||||||
3728850|NCT02063854|3566355|B8|-0.999 - ≤Max||L2-L4 BMD T-score, Categorical|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis.~Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|participants|Number|17|17.0||||||
3728851|NCT02063854|3566356|B7|-0.999 - ≤Max||L2-L4 BMD T-score, Categorical|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis.~Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|participants|Number|3|3.0||||||
3728852|NCT02063854|3566357|B6|-0.999 - ≤Max||L2-L4 BMD T-score, Categorical|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis.~Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|participants|Number|4|4.0||||||
3728853|NCT02063854|3566358|B5|-0.999 - ≤Max||L2-L4 BMD T-score, Categorical|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis.~Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|participants|Number|0|0.0||||||
3728854|NCT02063854|3566359|B4|-0.999 - ≤Max||L2-L4 BMD T-score, Categorical|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis.~Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|participants|Number|2|2.0||||||
3728855|NCT02063854|3566360|B3|-0.999 - ≤Max||L2-L4 BMD T-score, Categorical|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis.~Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|participants|Number|3|3.0||||||
3728856|NCT02063854|3566361|B2|-0.999 - ≤Max||L2-L4 BMD T-score, Categorical|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis.~Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|participants|Number|3|3.0||||||
3728857|NCT02063854|3566362|B1|-0.999 - ≤Max||L2-L4 BMD T-score, Categorical|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis.~Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|participants|Number|2|2.0||||||
3728858|NCT02063854|3566355|B8|-2.499 - ≤-1.000||L2-L4 BMD T-score, Categorical|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis.~Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|participants|Number|142|142.0||||||
3728859|NCT02063854|3566356|B7|-2.499 - ≤-1.000||L2-L4 BMD T-score, Categorical|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis.~Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|participants|Number|12|12.0||||||
3728860|NCT02063854|3566357|B6|-2.499 - ≤-1.000||L2-L4 BMD T-score, Categorical|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis.~Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|participants|Number|36|36.0||||||
3728861|NCT02063854|3566358|B5|-2.499 - ≤-1.000||L2-L4 BMD T-score, Categorical|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis.~Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|participants|Number|12|12.0||||||
3728862|NCT02063854|3566359|B4|-2.499 - ≤-1.000||L2-L4 BMD T-score, Categorical|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis.~Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|participants|Number|12|12.0||||||
3728969|NCT02063854|3566362|B1|Unknown, But >2 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|38|38.0||||||
3728863|NCT02063854|3566360|B3|-2.499 - ≤-1.000||L2-L4 BMD T-score, Categorical|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis.~Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|participants|Number|26|26.0||||||
3728864|NCT02063854|3566361|B2|-2.499 - ≤-1.000||L2-L4 BMD T-score, Categorical|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis.~Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|participants|Number|16|16.0||||||
3728865|NCT02063854|3566362|B1|-2.499 - ≤-1.000||L2-L4 BMD T-score, Categorical|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis.~Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|participants|Number|28|28.0||||||
3728866|NCT02063854|3566355|B8|Min - ≤-2.500||L2-L4 BMD T-score, Categorical|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis.~Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|participants|Number|711|711.0||||||
3728867|NCT02063854|3566356|B7|Min - ≤-2.500||L2-L4 BMD T-score, Categorical|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis.~Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|participants|Number|51|51.0||||||
3728868|NCT02063854|3566357|B6|Min - ≤-2.500||L2-L4 BMD T-score, Categorical|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis.~Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|participants|Number|160|160.0||||||
3728869|NCT02063854|3566358|B5|Min - ≤-2.500||L2-L4 BMD T-score, Categorical|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis.~Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|participants|Number|53|53.0||||||
3728870|NCT02063854|3566359|B4|Min - ≤-2.500||L2-L4 BMD T-score, Categorical|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis.~Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|participants|Number|54|54.0||||||
3728871|NCT02063854|3566360|B3|Min - ≤-2.500||L2-L4 BMD T-score, Categorical|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis.~Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|participants|Number|177|177.0||||||
3728872|NCT02063854|3566361|B2|Min - ≤-2.500||L2-L4 BMD T-score, Categorical|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis.~Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|participants|Number|47|47.0||||||
3728873|NCT02063854|3566362|B1|Min - ≤-2.500||L2-L4 BMD T-score, Categorical|"BMD T-score is a comparison of an individual's BMD compared to normal. Also, BMD T-score is the standard deviation of the difference between measured BMD and that of the healthy young adult normal. The T-score scale is as follows: -1 and above=normal, -1 to -2.5=osteopenia (below normal and may lead to osteoporosis), and -2.5 and below=osteoporosis.~Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively."|participants|Number|169|169.0||||||
3728874|NCT02063854|3566355|B8|||L2-L4 (BMD)|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|g/cm^2|Mean|0.6564|0.6564|Standard Deviation|0.09303|0.09303|||
3728875|NCT02063854|3566356|B7|||L2-L4 (BMD)|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|g/cm^2|Mean|0.6714|0.6714|Standard Deviation|0.09999|0.09999|||
3728876|NCT02063854|3566357|B6|||L2-L4 (BMD)|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|g/cm^2|Mean|0.6589|0.6589|Standard Deviation|0.09893|0.09893|||
3728877|NCT02063854|3566358|B5|||L2-L4 (BMD)|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|g/cm^2|Mean|0.6448|0.6448|Standard Deviation|0.08909|0.08909|||
3728878|NCT02063854|3566359|B4|||L2-L4 (BMD)|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|g/cm^2|Mean|0.6633|0.6633|Standard Deviation|0.08766|0.08766|||
3728879|NCT02063854|3566360|B3|||L2-L4 (BMD)|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|g/cm^2|Mean|0.6477|0.6477|Standard Deviation|0.08037|0.08037|||
3728882|NCT02063854|3566355|B8|0.809 (80%YAM) g/cm^2 - ≤Max||Lumbar Spine (L2-L4) Bone Mineral Density (BMD), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively. YAM=young adult mean (20 to 44 years age range).|participants|Number|50|50.0||||||
3728883|NCT02063854|3566356|B7|0.809 (80%YAM) g/cm^2 - ≤Max||Lumbar Spine (L2-L4) Bone Mineral Density (BMD), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively. YAM=young adult mean (20 to 44 years age range).|participants|Number|6|6.0||||||
3728884|NCT02063854|3566357|B6|0.809 (80%YAM) g/cm^2 - ≤Max||Lumbar Spine (L2-L4) Bone Mineral Density (BMD), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively. YAM=young adult mean (20 to 44 years age range).|participants|Number|14|14.0||||||
3728885|NCT02063854|3566358|B5|0.809 (80%YAM) g/cm^2 - ≤Max||Lumbar Spine (L2-L4) Bone Mineral Density (BMD), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively. YAM=young adult mean (20 to 44 years age range).|participants|Number|3|3.0||||||
3728886|NCT02063854|3566359|B4|0.809 (80%YAM) g/cm^2 - ≤Max||Lumbar Spine (L2-L4) Bone Mineral Density (BMD), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively. YAM=young adult mean (20 to 44 years age range).|participants|Number|3|3.0||||||
3728887|NCT02063854|3566360|B3|0.809 (80%YAM) g/cm^2 - ≤Max||Lumbar Spine (L2-L4) Bone Mineral Density (BMD), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively. YAM=young adult mean (20 to 44 years age range).|participants|Number|9|9.0||||||
3728888|NCT02063854|3566361|B2|0.809 (80%YAM) g/cm^2 - ≤Max||Lumbar Spine (L2-L4) Bone Mineral Density (BMD), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively. YAM=young adult mean (20 to 44 years age range).|participants|Number|7|7.0||||||
3728889|NCT02063854|3566362|B1|0.809 (80%YAM) g/cm^2 - ≤Max||Lumbar Spine (L2-L4) Bone Mineral Density (BMD), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively. YAM=young adult mean (20 to 44 years age range).|participants|Number|8|8.0||||||
3728890|NCT02063854|3566355|B8|0.708 (70%YAM) - ≤0.808 g/cm^2||Lumbar Spine (L2-L4) Bone Mineral Density (BMD), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively. YAM=young adult mean (20 to 44 years age range).|participants|Number|118|118.0||||||
3728891|NCT02063854|3566356|B7|0.708 (70%YAM) - ≤0.808 g/cm^2||Lumbar Spine (L2-L4) Bone Mineral Density (BMD), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively. YAM=young adult mean (20 to 44 years age range).|participants|Number|11|11.0||||||
3728892|NCT02063854|3566357|B6|0.708 (70%YAM) - ≤0.808 g/cm^2||Lumbar Spine (L2-L4) Bone Mineral Density (BMD), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively. YAM=young adult mean (20 to 44 years age range).|participants|Number|28|28.0||||||
3728893|NCT02063854|3566358|B5|0.708 (70%YAM) - ≤0.808 g/cm^2||Lumbar Spine (L2-L4) Bone Mineral Density (BMD), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively. YAM=young adult mean (20 to 44 years age range).|participants|Number|10|10.0||||||
3728894|NCT02063854|3566359|B4|0.708 (70%YAM) - ≤0.808 g/cm^2||Lumbar Spine (L2-L4) Bone Mineral Density (BMD), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively. YAM=young adult mean (20 to 44 years age range).|participants|Number|11|11.0||||||
3728895|NCT02063854|3566360|B3|0.708 (70%YAM) - ≤0.808 g/cm^2||Lumbar Spine (L2-L4) Bone Mineral Density (BMD), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively. YAM=young adult mean (20 to 44 years age range).|participants|Number|21|21.0||||||
3728896|NCT02063854|3566361|B2|0.708 (70%YAM) - ≤0.808 g/cm^2||Lumbar Spine (L2-L4) Bone Mineral Density (BMD), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively. YAM=young adult mean (20 to 44 years age range).|participants|Number|13|13.0||||||
3728897|NCT02063854|3566362|B1|0.708 (70%YAM) - ≤0.808 g/cm^2||Lumbar Spine (L2-L4) Bone Mineral Density (BMD), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively. YAM=young adult mean (20 to 44 years age range).|participants|Number|24|24.0||||||
3728898|NCT02063854|3566355|B8|Min - ≤0.707 g/cm^2||Lumbar Spine (L2-L4) Bone Mineral Density (BMD), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively. YAM=young adult mean (20 to 44 years age range).|participants|Number|702|702.0||||||
3728899|NCT02063854|3566356|B7|Min - ≤0.707 g/cm^2||Lumbar Spine (L2-L4) Bone Mineral Density (BMD), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively. YAM=young adult mean (20 to 44 years age range).|participants|Number|49|49.0||||||
3728900|NCT02063854|3566357|B6|Min - ≤0.707 g/cm^2||Lumbar Spine (L2-L4) Bone Mineral Density (BMD), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively. YAM=young adult mean (20 to 44 years age range).|participants|Number|158|158.0||||||
3728901|NCT02063854|3566358|B5|Min - ≤0.707 g/cm^2||Lumbar Spine (L2-L4) Bone Mineral Density (BMD), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively. YAM=young adult mean (20 to 44 years age range).|participants|Number|52|52.0||||||
3728902|NCT02063854|3566359|B4|Min - ≤0.707 g/cm^2||Lumbar Spine (L2-L4) Bone Mineral Density (BMD), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively. YAM=young adult mean (20 to 44 years age range).|participants|Number|54|54.0||||||
3728903|NCT02063854|3566360|B3|Min - ≤0.707 g/cm^2||Lumbar Spine (L2-L4) Bone Mineral Density (BMD), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively. YAM=young adult mean (20 to 44 years age range).|participants|Number|176|176.0||||||
3728904|NCT02063854|3566361|B2|Min - ≤0.707 g/cm^2||Lumbar Spine (L2-L4) Bone Mineral Density (BMD), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively. YAM=young adult mean (20 to 44 years age range).|participants|Number|46|46.0||||||
3728970|NCT02063854|3566355|B8|≥31 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|58|58.0||||||
3728905|NCT02063854|3566362|B1|Min - ≤0.707 g/cm^2||Lumbar Spine (L2-L4) Bone Mineral Density (BMD), Categorical|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively. YAM=young adult mean (20 to 44 years age range).|participants|Number|167|167.0||||||
3728906|NCT02063854|3566355|B8|2.5 to 4 Hours before Breakfast||Timing of Initial Delayed Release (DR) Tablet Administration on Awakening|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|27|27.0||||||
3728907|NCT02063854|3566356|B7|2.5 to 4 Hours before Breakfast||Timing of Initial Delayed Release (DR) Tablet Administration on Awakening|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|1|1.0||||||
3728908|NCT02063854|3566357|B6|2.5 to 4 Hours before Breakfast||Timing of Initial Delayed Release (DR) Tablet Administration on Awakening|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|8|8.0||||||
3728909|NCT02063854|3566358|B5|2.5 to 4 Hours before Breakfast||Timing of Initial Delayed Release (DR) Tablet Administration on Awakening|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|4|4.0||||||
3728910|NCT02063854|3566359|B4|2.5 to 4 Hours before Breakfast||Timing of Initial Delayed Release (DR) Tablet Administration on Awakening|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|3|3.0||||||
3728911|NCT02063854|3566360|B3|2.5 to 4 Hours before Breakfast||Timing of Initial Delayed Release (DR) Tablet Administration on Awakening|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|4|4.0||||||
3728912|NCT02063854|3566361|B2|2.5 to 4 Hours before Breakfast||Timing of Initial Delayed Release (DR) Tablet Administration on Awakening|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|2|2.0||||||
3728913|NCT02063854|3566362|B1|2.5 to 4 Hours before Breakfast||Timing of Initial Delayed Release (DR) Tablet Administration on Awakening|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|5|5.0||||||
3728914|NCT02063854|3566355|B8|1.5 to 2.5 Hours before Breakfast||Timing of Initial Delayed Release (DR) Tablet Administration on Awakening|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|135|135.0||||||
3728915|NCT02063854|3566356|B7|1.5 to 2.5 Hours before Breakfast||Timing of Initial Delayed Release (DR) Tablet Administration on Awakening|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|15|15.0||||||
3728916|NCT02063854|3566357|B6|1.5 to 2.5 Hours before Breakfast||Timing of Initial Delayed Release (DR) Tablet Administration on Awakening|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|27|27.0||||||
3728917|NCT02063854|3566358|B5|1.5 to 2.5 Hours before Breakfast||Timing of Initial Delayed Release (DR) Tablet Administration on Awakening|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|8|8.0||||||
3728918|NCT02063854|3566359|B4|1.5 to 2.5 Hours before Breakfast||Timing of Initial Delayed Release (DR) Tablet Administration on Awakening|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|13|13.0||||||
3728919|NCT02063854|3566360|B3|1.5 to 2.5 Hours before Breakfast||Timing of Initial Delayed Release (DR) Tablet Administration on Awakening|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|35|35.0||||||
3728920|NCT02063854|3566361|B2|1.5 to 2.5 Hours before Breakfast||Timing of Initial Delayed Release (DR) Tablet Administration on Awakening|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|8|8.0||||||
3728921|NCT02063854|3566362|B1|1.5 to 2.5 Hours before Breakfast||Timing of Initial Delayed Release (DR) Tablet Administration on Awakening|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|29|29.0||||||
3728922|NCT02063854|3566355|B8|0.5 to 1.5 Hours before Breakfast||Timing of Initial Delayed Release (DR) Tablet Administration on Awakening|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|707|707.0||||||
3728923|NCT02063854|3566356|B7|0.5 to 1.5 Hours before Breakfast||Timing of Initial Delayed Release (DR) Tablet Administration on Awakening|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|50|50.0||||||
3728924|NCT02063854|3566357|B6|0.5 to 1.5 Hours before Breakfast||Timing of Initial Delayed Release (DR) Tablet Administration on Awakening|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|164|164.0||||||
3728925|NCT02063854|3566358|B5|0.5 to 1.5 Hours before Breakfast||Timing of Initial Delayed Release (DR) Tablet Administration on Awakening|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|53|53.0||||||
3728926|NCT02063854|3566359|B4|0.5 to 1.5 Hours before Breakfast||Timing of Initial Delayed Release (DR) Tablet Administration on Awakening|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|52|52.0||||||
3728927|NCT02063854|3566360|B3|0.5 to 1.5 Hours before Breakfast||Timing of Initial Delayed Release (DR) Tablet Administration on Awakening|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|167|167.0||||||
3728928|NCT02063854|3566361|B2|0.5 to 1.5 Hours before Breakfast||Timing of Initial Delayed Release (DR) Tablet Administration on Awakening|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|56|56.0||||||
3728929|NCT02063854|3566362|B1|0.5 to 1.5 Hours before Breakfast||Timing of Initial Delayed Release (DR) Tablet Administration on Awakening|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|165|165.0||||||
3728930|NCT02063854|3566355|B8|Less than 30 Minutes before Breakfast||Timing of Initial Delayed Release (DR) Tablet Administration on Awakening|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|1|1.0||||||
3728931|NCT02063854|3566356|B7|Less than 30 Minutes before Breakfast||Timing of Initial Delayed Release (DR) Tablet Administration on Awakening|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|0|0.0||||||
3728932|NCT02063854|3566357|B6|Less than 30 Minutes before Breakfast||Timing of Initial Delayed Release (DR) Tablet Administration on Awakening|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|1|1.0||||||
3728933|NCT02063854|3566358|B5|Less than 30 Minutes before Breakfast||Timing of Initial Delayed Release (DR) Tablet Administration on Awakening|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|0|0.0||||||
3728934|NCT02063854|3566359|B4|Less than 30 Minutes before Breakfast||Timing of Initial Delayed Release (DR) Tablet Administration on Awakening|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|0|0.0||||||
3728935|NCT02063854|3566360|B3|Less than 30 Minutes before Breakfast||Timing of Initial Delayed Release (DR) Tablet Administration on Awakening|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|0|0.0||||||
3728936|NCT02063854|3566361|B2|Less than 30 Minutes before Breakfast||Timing of Initial Delayed Release (DR) Tablet Administration on Awakening|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|0|0.0||||||
3728937|NCT02063854|3566362|B1|Less than 30 Minutes before Breakfast||Timing of Initial Delayed Release (DR) Tablet Administration on Awakening|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|participants|Number|0|0.0||||||
3728938|NCT02063854|3566355|B8|No||History of Bisphosphonate Administration||participants|Number|773|773.0||||||
3728939|NCT02063854|3566356|B7|No||History of Bisphosphonate Administration||participants|Number|60|60.0||||||
3728940|NCT02063854|3566357|B6|No||History of Bisphosphonate Administration||participants|Number|175|175.0||||||
3728941|NCT02063854|3566358|B5|No||History of Bisphosphonate Administration||participants|Number|56|56.0||||||
3728942|NCT02063854|3566359|B4|No||History of Bisphosphonate Administration||participants|Number|60|60.0||||||
3728943|NCT02063854|3566360|B3|No||History of Bisphosphonate Administration||participants|Number|182|182.0||||||
3728944|NCT02063854|3566361|B2|No||History of Bisphosphonate Administration||participants|Number|60|60.0||||||
3728945|NCT02063854|3566362|B1|No||History of Bisphosphonate Administration||participants|Number|180|180.0||||||
3728946|NCT02063854|3566355|B8|Yes||History of Bisphosphonate Administration||participants|Number|98|98.0||||||
3728947|NCT02063854|3566356|B7|Yes||History of Bisphosphonate Administration||participants|Number|6|6.0||||||
3728948|NCT02063854|3566357|B6|Yes||History of Bisphosphonate Administration||participants|Number|26|26.0||||||
3728949|NCT02063854|3566358|B5|Yes||History of Bisphosphonate Administration||participants|Number|9|9.0||||||
3728950|NCT02063854|3566359|B4|Yes||History of Bisphosphonate Administration||participants|Number|8|8.0||||||
3728951|NCT02063854|3566360|B3|Yes||History of Bisphosphonate Administration||participants|Number|24|24.0||||||
3728952|NCT02063854|3566361|B2|Yes||History of Bisphosphonate Administration||participants|Number|6|6.0||||||
3728953|NCT02063854|3566362|B1|Yes||History of Bisphosphonate Administration||participants|Number|19|19.0||||||
3728954|NCT02063854|3566355|B8|||Number of Years After Menopause|Data was available for 152, 52, 159, 56, 54, 162 and 51 female participants in each treatment arm, respectively.|years|Mean|18.7|18.7|Standard Deviation|8.28|8.28|||
3728955|NCT02063854|3566356|B7|||Number of Years After Menopause|Data was available for 152, 52, 159, 56, 54, 162 and 51 female participants in each treatment arm, respectively.|years|Mean|20.1|20.1|Standard Deviation|7.84|7.84|||
3728956|NCT02063854|3566357|B6|||Number of Years After Menopause|Data was available for 152, 52, 159, 56, 54, 162 and 51 female participants in each treatment arm, respectively.|years|Mean|19.5|19.5|Standard Deviation|8.41|8.41|||
3728957|NCT02063854|3566358|B5|||Number of Years After Menopause|Data was available for 152, 52, 159, 56, 54, 162 and 51 female participants in each treatment arm, respectively.|years|Mean|19.2|19.2|Standard Deviation|8.36|8.36|||
3728958|NCT02063854|3566359|B4|||Number of Years After Menopause|Data was available for 152, 52, 159, 56, 54, 162 and 51 female participants in each treatment arm, respectively.|years|Mean|18.3|18.3|Standard Deviation|8.28|8.28|||
3728959|NCT02063854|3566360|B3|||Number of Years After Menopause|Data was available for 152, 52, 159, 56, 54, 162 and 51 female participants in each treatment arm, respectively.|years|Mean|17.2|17.2|Standard Deviation|8.44|8.44|||
3728960|NCT02063854|3566361|B2|||Number of Years After Menopause|Data was available for 152, 52, 159, 56, 54, 162 and 51 female participants in each treatment arm, respectively.|years|Mean|20.2|20.2|Standard Deviation|8.72|8.72|||
3728961|NCT02063854|3566362|B1|||Number of Years After Menopause|Data was available for 152, 52, 159, 56, 54, 162 and 51 female participants in each treatment arm, respectively.|years|Mean|18.6|18.6|Standard Deviation|7.81|7.81|||
3728962|NCT02063854|3566355|B8|Unknown, But >2 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|161|161.0||||||
3728963|NCT02063854|3566356|B7|Unknown, But >2 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|12|12.0||||||
3728964|NCT02063854|3566357|B6|Unknown, But >2 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|36|36.0||||||
3728965|NCT02063854|3566358|B5|Unknown, But >2 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|9|9.0||||||
3728966|NCT02063854|3566359|B4|Unknown, But >2 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|10|10.0||||||
3728967|NCT02063854|3566360|B3|Unknown, But >2 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|44|44.0||||||
3728968|NCT02063854|3566361|B2|Unknown, But >2 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|12|12.0||||||
3728972|NCT02063854|3566357|B6|≥31 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|17|17.0||||||
3728973|NCT02063854|3566358|B5|≥31 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|4|4.0||||||
3728974|NCT02063854|3566359|B4|≥31 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|7|7.0||||||
3728975|NCT02063854|3566360|B3|≥31 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|11|11.0||||||
3728976|NCT02063854|3566361|B2|≥31 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|6|6.0||||||
3728977|NCT02063854|3566362|B1|≥31 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|9|9.0||||||
3728978|NCT02063854|3566355|B8|21 - ≤30 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|224|224.0||||||
3728979|NCT02063854|3566356|B7|21 - ≤30 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|19|19.0||||||
3728980|NCT02063854|3566357|B6|21 - ≤30 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|58|58.0||||||
3728981|NCT02063854|3566358|B5|21 - ≤30 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|19|19.0||||||
3728982|NCT02063854|3566359|B4|21 - ≤30 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|12|12.0||||||
3728983|NCT02063854|3566360|B3|21 - ≤30 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|42|42.0||||||
3728984|NCT02063854|3566361|B2|21 - ≤30 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|19|19.0||||||
3728985|NCT02063854|3566362|B1|21 - ≤30 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|55|55.0||||||
3728986|NCT02063854|3566355|B8|11 - ≤20 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|281|281.0||||||
3728987|NCT02063854|3566356|B7|11 - ≤20 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|20|20.0||||||
3728988|NCT02063854|3566357|B6|11 - ≤20 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|61|61.0||||||
3728989|NCT02063854|3566358|B5|11 - ≤20 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|20|20.0||||||
3728990|NCT02063854|3566359|B4|11 - ≤20 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|29|29.0||||||
3728991|NCT02063854|3566360|B3|11 - ≤20 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|71|71.0||||||
3728992|NCT02063854|3566361|B2|11 - ≤20 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|21|21.0||||||
3728993|NCT02063854|3566362|B1|11 - ≤20 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|59|59.0||||||
3728994|NCT02063854|3566355|B8|6 - ≤10 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|92|92.0||||||
3728995|NCT02063854|3566356|B7|6 - ≤10 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|6|6.0||||||
3728996|NCT02063854|3566357|B6|6 - ≤10 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|22|22.0||||||
3728997|NCT02063854|3566358|B5|6 - ≤10 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|8|8.0||||||
3728998|NCT02063854|3566359|B4|6 - ≤10 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|4|4.0||||||
3728999|NCT02063854|3566360|B3|6 - ≤10 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|28|28.0||||||
3729000|NCT02063854|3566361|B2|6 - ≤10 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|1|1.0||||||
3729001|NCT02063854|3566362|B1|6 - ≤10 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|23|23.0||||||
3729002|NCT02063854|3566355|B8|Min - ≤5 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|31|31.0||||||
3729003|NCT02063854|3566356|B7|Min - ≤5 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|2|2.0||||||
3729004|NCT02063854|3566357|B6|Min - ≤5 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|4|4.0||||||
3729005|NCT02063854|3566358|B5|Min - ≤5 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|3|3.0||||||
3729006|NCT02063854|3566359|B4|Min - ≤5 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|4|4.0||||||
3729007|NCT02063854|3566360|B3|Min - ≤5 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|7|7.0||||||
3729008|NCT02063854|3566361|B2|Min - ≤5 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|5|5.0||||||
3729009|NCT02063854|3566362|B1|Min - ≤5 years||Number of Years After Menopause, Categorical|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|6|6.0||||||
3729010|NCT02063854|3566355|B8|Artificial Menopause||Menopausal Status|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|88|88.0||||||
3729011|NCT02063854|3566356|B7|Artificial Menopause||Menopausal Status|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|4|4.0||||||
3729012|NCT02063854|3566357|B6|Artificial Menopause||Menopausal Status|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|18|18.0||||||
3729013|NCT02063854|3566358|B5|Artificial Menopause||Menopausal Status|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|10|10.0||||||
3729014|NCT02063854|3566359|B4|Artificial Menopause||Menopausal Status|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|6|6.0||||||
3729015|NCT02063854|3566360|B3|Artificial Menopause||Menopausal Status|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|24|24.0||||||
3729016|NCT02063854|3566361|B2|Artificial Menopause||Menopausal Status|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|6|6.0||||||
3729017|NCT02063854|3566362|B1|Artificial Menopause||Menopausal Status|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|20|20.0||||||
3729018|NCT02063854|3566355|B8|Natural Menopause||Menopausal Status|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|759|759.0||||||
3729019|NCT02063854|3566356|B7|Natural Menopause||Menopausal Status|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|59|59.0||||||
3729020|NCT02063854|3566357|B6|Natural Menopause||Menopausal Status|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|180|180.0||||||
3729021|NCT02063854|3566358|B5|Natural Menopause||Menopausal Status|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|53|53.0||||||
3729022|NCT02063854|3566359|B4|Natural Menopause||Menopausal Status|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|60|60.0||||||
3729023|NCT02063854|3566360|B3|Natural Menopause||Menopausal Status|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|179|179.0||||||
3729024|NCT02063854|3566361|B2|Natural Menopause||Menopausal Status|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|58|58.0||||||
3729025|NCT02063854|3566362|B1|Natural Menopause||Menopausal Status|Female participants only (N=190, 64, 203, 66, 63, 198, 63).|participants|Number|170|170.0||||||
3729026|NCT02063854|3566355|B8|Ex-smoker||Smoking Classification||participants|Number|97|97.0||||||
3729027|NCT02063854|3566356|B7|Ex-smoker||Smoking Classification||participants|Number|5|5.0||||||
3729028|NCT02063854|3566357|B6|Ex-smoker||Smoking Classification||participants|Number|26|26.0||||||
3729029|NCT02063854|3566358|B5|Ex-smoker||Smoking Classification||participants|Number|8|8.0||||||
3729030|NCT02063854|3566359|B4|Ex-smoker||Smoking Classification||participants|Number|12|12.0||||||
3729031|NCT02063854|3566360|B3|Ex-smoker||Smoking Classification||participants|Number|17|17.0||||||
3729032|NCT02063854|3566361|B2|Ex-smoker||Smoking Classification||participants|Number|7|7.0||||||
3729033|NCT02063854|3566362|B1|Ex-smoker||Smoking Classification||participants|Number|22|22.0||||||
3729034|NCT02063854|3566355|B8|Current smoker||Smoking Classification||participants|Number|41|41.0||||||
3729035|NCT02063854|3566356|B7|Current smoker||Smoking Classification||participants|Number|3|3.0||||||
3729036|NCT02063854|3566357|B6|Current smoker||Smoking Classification||participants|Number|7|7.0||||||
3729037|NCT02063854|3566358|B5|Current smoker||Smoking Classification||participants|Number|3|3.0||||||
3729038|NCT02063854|3566359|B4|Current smoker||Smoking Classification||participants|Number|3|3.0||||||
3729039|NCT02063854|3566360|B3|Current smoker||Smoking Classification||participants|Number|11|11.0||||||
3729040|NCT02063854|3566361|B2|Current smoker||Smoking Classification||participants|Number|4|4.0||||||
3729041|NCT02063854|3566362|B1|Current smoker||Smoking Classification||participants|Number|10|10.0||||||
3729042|NCT02063854|3566355|B8|Never smoked||Smoking Classification||participants|Number|733|733.0||||||
3729043|NCT02063854|3566356|B7|Never smoked||Smoking Classification||participants|Number|58|58.0||||||
3729044|NCT02063854|3566357|B6|Never smoked||Smoking Classification||participants|Number|168|168.0||||||
3729045|NCT02063854|3566358|B5|Never smoked||Smoking Classification||participants|Number|54|54.0||||||
3729046|NCT02063854|3566359|B4|Never smoked||Smoking Classification||participants|Number|53|53.0||||||
3729047|NCT02063854|3566360|B3|Never smoked||Smoking Classification||participants|Number|178|178.0||||||
3729048|NCT02063854|3566361|B2|Never smoked||Smoking Classification||participants|Number|55|55.0||||||
3729049|NCT02063854|3566362|B1|Never smoked||Smoking Classification||participants|Number|167|167.0||||||
3729050|NCT02063854|3566355|B8|||Body Mass Index (BMI)|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|kg/m^2|Mean|21.87|21.87|Standard Deviation|3.092|3.092|||
3729051|NCT02063854|3566356|B7|||Body Mass Index (BMI)|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|kg/m^2|Mean|21.90|21.9|Standard Deviation|3.071|3.071|||
3729052|NCT02063854|3566357|B6|||Body Mass Index (BMI)|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|kg/m^2|Mean|22.00|22.0|Standard Deviation|3.105|3.105|||
3729053|NCT02063854|3566358|B5|||Body Mass Index (BMI)|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|kg/m^2|Mean|21.79|21.79|Standard Deviation|3.289|3.289|||
3729054|NCT02063854|3566359|B4|||Body Mass Index (BMI)|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|kg/m^2|Mean|21.97|21.97|Standard Deviation|3.875|3.875|||
3729055|NCT02063854|3566360|B3|||Body Mass Index (BMI)|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|kg/m^2|Mean|21.75|21.75|Standard Deviation|2.926|2.926|||
3729056|NCT02063854|3566361|B2|||Body Mass Index (BMI)|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|kg/m^2|Mean|21.93|21.93|Standard Deviation|2.830|2.83|||
3729057|NCT02063854|3566362|B1|||Body Mass Index (BMI)|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|kg/m^2|Mean|21.82|21.82|Standard Deviation|3.009|3.009|||
3729058|NCT02063854|3566355|B8|||Weight|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|kg|Mean|50.46|50.46|Standard Deviation|7.544|7.544|||
3729059|NCT02063854|3566356|B7|||Weight|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|kg|Mean|50.51|50.51|Standard Deviation|7.427|7.427|||
3729060|NCT02063854|3566357|B6|||Weight|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|kg|Mean|50.36|50.36|Standard Deviation|7.383|7.383|||
3729061|NCT02063854|3566358|B5|||Weight|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|kg|Mean|51.26|51.26|Standard Deviation|7.473|7.473|||
3729062|NCT02063854|3566359|B4|||Weight|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|kg|Mean|50.97|50.97|Standard Deviation|8.736|8.736|||
3729063|NCT02063854|3566360|B3|||Weight|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|kg|Mean|50.20|50.2|Standard Deviation|7.231|7.231|||
3729064|NCT02063854|3566361|B2|||Weight|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|kg|Mean|49.98|49.98|Standard Deviation|6.720|6.72|||
3729065|NCT02063854|3566362|B1|||Weight|Data was available for 199, 66, 206, 68, 65, 200 and 66 participants in each treatment arm, respectively.|kg|Mean|50.52|50.52|Standard Deviation|7.975|7.975|||
3729066|NCT02063854|3566355|B8|||Height||cm|Mean|151.9|151.9|Standard Deviation|6.00|6.0|||
3729067|NCT02063854|3566356|B7|||Height||cm|Mean|151.9|151.9|Standard Deviation|6.47|6.47|||
3729068|NCT02063854|3566357|B6|||Height||cm|Mean|151.3|151.3|Standard Deviation|5.20|5.2|||
3729069|NCT02063854|3566358|B5|||Height||cm|Mean|153.5|153.5|Standard Deviation|5.13|5.13|||
3729070|NCT02063854|3566359|B4|||Height||cm|Mean|152.5|152.5|Standard Deviation|5.49|5.49|||
3729071|NCT02063854|3566360|B3|||Height||cm|Mean|151.9|151.9|Standard Deviation|6.11|6.11|||
3729072|NCT02063854|3566361|B2|||Height||cm|Mean|151.0|151.0|Standard Deviation|6.64|6.64|||
3729073|NCT02063854|3566362|B1|||Height||cm|Mean|152.1|152.1|Standard Deviation|6.59|6.59|||
3729074|NCT02063854|3566355|B8|Japan||Region of Enrollment||participants|Number|871|871.0||||||
3729075|NCT02063854|3566356|B7|Japan||Region of Enrollment||participants|Number|66|66.0||||||
3729076|NCT02063854|3566357|B6|Japan||Region of Enrollment||participants|Number|201|201.0||||||
3729077|NCT02063854|3566358|B5|Japan||Region of Enrollment||participants|Number|65|65.0||||||
3729078|NCT02063854|3566359|B4|Japan||Region of Enrollment||participants|Number|68|68.0||||||
3729079|NCT02063854|3566360|B3|Japan||Region of Enrollment||participants|Number|206|206.0||||||
3729080|NCT02063854|3566361|B2|Japan||Region of Enrollment||participants|Number|66|66.0||||||
3729081|NCT02063854|3566362|B1|Japan||Region of Enrollment||participants|Number|199|199.0||||||
3729082|NCT02063854|3566355|B8||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3729083|NCT02063854|3566356|B7||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3729084|NCT02063854|3566357|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3729085|NCT02063854|3566358|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3729086|NCT02063854|3566359|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3729087|NCT02063854|3566360|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3729088|NCT02063854|3566361|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3729089|NCT02063854|3566362|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3729090|NCT02063854|3566355|B8||Female|Sex: Female, Male||Participants|Count of Participants|847|847.0||||||
3729091|NCT02063854|3566356|B7||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3729092|NCT02063854|3566357|B6||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
3729093|NCT02063854|3566358|B5||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3729094|NCT02063854|3566359|B4||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3729095|NCT02063854|3566360|B3||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
3729096|NCT02063854|3566361|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3729097|NCT02063854|3566362|B1||Female|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
3729098|NCT02063854|3566355|B8|||Age||years|Mean|68.9|68.9|Standard Deviation|7.45|7.45|||
3729099|NCT02063854|3566356|B7|||Age||years|Mean|69.8|69.8|Standard Deviation|7.87|7.87|||
3729100|NCT02063854|3566357|B6|||Age||years|Mean|69.6|69.6|Standard Deviation|7.19|7.19|||
3729101|NCT02063854|3566358|B5|||Age||years|Mean|69.0|69.0|Standard Deviation|6.98|6.98|||
3729102|NCT02063854|3566359|B4|||Age||years|Mean|68.4|68.4|Standard Deviation|7.24|7.24|||
3729103|NCT02063854|3566360|B3|||Age||years|Mean|68.2|68.2|Standard Deviation|7.68|7.68|||
3729104|NCT02063854|3566361|B2|||Age||years|Mean|69.0|69.0|Standard Deviation|8.18|8.18|||
3729105|NCT02063854|3566362|B1|||Age||years|Mean|68.9|68.9|Standard Deviation|7.32|7.32|||
3729106|NCT02063737|3566450|B3|Physician/Other||Certification/License||participants|Number|9|9.0||||||
3729107|NCT02063737|3566451|B2|Physician/Other||Certification/License||participants|Number|2|2.0||||||
3729108|NCT02063737|3566452|B1|Physician/Other||Certification/License||participants|Number|7|7.0||||||
3729109|NCT02063737|3566450|B3|Nurse||Certification/License||participants|Number|17|17.0||||||
3729110|NCT02063737|3566451|B2|Nurse||Certification/License||participants|Number|10|10.0||||||
3729111|NCT02063737|3566452|B1|Nurse||Certification/License||participants|Number|7|7.0||||||
3729112|NCT02063737|3566450|B3|Paramedic||Certification/License||participants|Number|65|65.0||||||
3729113|NCT02063737|3566451|B2|Paramedic||Certification/License||participants|Number|31|31.0||||||
3729114|NCT02063737|3566452|B1|Paramedic||Certification/License||participants|Number|34|34.0||||||
3729115|NCT02063737|3566450|B3|EMT-Basic||Certification/License||participants|Number|9|9.0||||||
3729116|NCT02063737|3566451|B2|EMT-Basic||Certification/License||participants|Number|5|5.0||||||
3729117|NCT02063737|3566452|B1|EMT-Basic||Certification/License||participants|Number|4|4.0||||||
3729118|NCT02063737|3566450|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3729119|NCT02063737|3566451|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3729120|NCT02063737|3566452|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3729121|NCT02063737|3566450|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3729122|NCT02063737|3566451|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3729123|NCT02063737|3566452|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3729124|NCT02063737|3566450|B3|||Age||years|Mean|35.6|35.6|Standard Deviation|10.0|10.0|||
3729125|NCT02063737|3566451|B2|||Age||years|Mean|35.0|35.0|Standard Deviation|9.7|9.7|||
3729126|NCT02063737|3566452|B1|||Age||years|Mean|36.1|36.1|Standard Deviation|10.2|10.2|||
3729127|NCT02063672|3566485|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729128|NCT02063672|3566486|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729129|NCT02063672|3566487|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729130|NCT02063672|3566485|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3729131|NCT02063672|3566486|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3729132|NCT02063672|3566487|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729133|NCT02063672|3566485|B3||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3729134|NCT02063672|3566486|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3729135|NCT02063672|3566487|B1||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3729136|NCT02063672|3566485|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3729137|NCT02063672|3566486|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3729138|NCT02063672|3566487|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3729139|NCT02063672|3566485|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729140|NCT02063672|3566486|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729141|NCT02063672|3566487|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729142|NCT02063672|3566485|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729143|NCT02063672|3566486|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729144|NCT02063672|3566487|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729145|NCT02063672|3566485|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729146|NCT02063672|3566486|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729147|NCT02063672|3566487|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729148|NCT02063672|3566485|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3729149|NCT02063672|3566486|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3729150|NCT02063672|3566487|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3729151|NCT02063672|3566485|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3729152|NCT02063672|3566486|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3729153|NCT02063672|3566487|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3729154|NCT02063672|3566485|B3|||Age||years|Mean|68.2|68.2|Standard Deviation|9.10|9.1|||
3729155|NCT02063672|3566486|B2|||Age||years|Mean|67.0|67.0|Standard Deviation|8.64|8.64|||
3729156|NCT02063672|3566487|B1|||Age||years|Mean|68.9|68.9|Standard Deviation|9.35|9.35|||
3729157|NCT02063659|3566532|B4|||Baseline Body Mass Index (BMI)|BMI was calculated by weight (kg) / (height [cm] × 0.01)^2.|kg/m^2|Mean|26.16|26.16|Standard Deviation|6.521|6.521|||
3729158|NCT02063659|3566533|B3|||Baseline Body Mass Index (BMI)|BMI was calculated by weight (kg) / (height [cm] × 0.01)^2.|kg/m^2|Mean|26.21|26.21|Standard Deviation|9.213|9.213|||
3729159|NCT02063659|3566534|B2|||Baseline Body Mass Index (BMI)|BMI was calculated by weight (kg) / (height [cm] × 0.01)^2.|kg/m^2|Mean|25.96|25.96|Standard Deviation|5.258|5.258|||
3729160|NCT02063659|3566535|B1|||Baseline Body Mass Index (BMI)|BMI was calculated by weight (kg) / (height [cm] × 0.01)^2.|kg/m^2|Mean|26.28|26.28|Standard Deviation|4.364|4.364|||
3729161|NCT02063659|3566532|B4|||Height||cm|Mean|169.76|169.76|Standard Deviation|9.327|9.327|||
3729162|NCT02063659|3566533|B3|||Height||cm|Mean|170.08|170.08|Standard Deviation|8.525|8.525|||
3729163|NCT02063659|3566534|B2|||Height||cm|Mean|169.74|169.74|Standard Deviation|10.025|10.025|||
3729164|NCT02063659|3566535|B1|||Height||cm|Mean|169.48|169.48|Standard Deviation|9.765|9.765|||
3729165|NCT02063659|3566532|B4|||Weight||kg|Mean|75.94|75.94|Standard Deviation|20.442|20.442|||
3729166|NCT02063659|3566533|B3|||Weight||kg|Mean|76.69|76.69|Standard Deviation|26.188|26.188|||
3729167|NCT02063659|3566534|B2|||Weight||kg|Mean|74.74|74.74|Standard Deviation|17.839|17.839|||
3729168|NCT02063659|3566535|B1|||Weight||kg|Mean|76.38|76.38|Standard Deviation|16.959|16.959|||
3729169|NCT02063659|3566532|B4||Rest of the World|Region||Participants|Count of Participants|14|14.0||||||
3729170|NCT02063659|3566533|B3||Rest of the World|Region||Participants|Count of Participants|5|5.0||||||
3729171|NCT02063659|3566534|B2||Rest of the World|Region||Participants|Count of Participants|3|3.0||||||
3729172|NCT02063659|3566535|B1||Rest of the World|Region||Participants|Count of Participants|6|6.0||||||
3729173|NCT02063659|3566532|B4||Europe|Region||Participants|Count of Participants|44|44.0||||||
3729174|NCT02063659|3566533|B3||Europe|Region||Participants|Count of Participants|12|12.0||||||
3729175|NCT02063659|3566534|B2||Europe|Region||Participants|Count of Participants|16|16.0||||||
3729176|NCT02063659|3566535|B1||Europe|Region||Participants|Count of Participants|16|16.0||||||
3729177|NCT02063659|3566532|B4||North America|Region||Participants|Count of Participants|18|18.0||||||
3729178|NCT02063659|3566533|B3||North America|Region||Participants|Count of Participants|8|8.0||||||
3729179|NCT02063659|3566534|B2||North America|Region||Participants|Count of Participants|6|6.0||||||
3729180|NCT02063659|3566535|B1||North America|Region||Participants|Count of Participants|4|4.0||||||
3729181|NCT02063659|3566532|B4||Unknown|Urinary 5-Hydroxyindoleacetic acid (5-HIAA) at Randomization|ULN=upper limit of normal.|Participants|Count of Participants|2|2.0||||||
3729182|NCT02063659|3566533|B3||Unknown|Urinary 5-Hydroxyindoleacetic acid (5-HIAA) at Randomization|ULN=upper limit of normal.|Participants|Count of Participants|0|0.0||||||
3729183|NCT02063659|3566534|B2||Unknown|Urinary 5-Hydroxyindoleacetic acid (5-HIAA) at Randomization|ULN=upper limit of normal.|Participants|Count of Participants|2|2.0||||||
3729184|NCT02063659|3566535|B1||Unknown|Urinary 5-Hydroxyindoleacetic acid (5-HIAA) at Randomization|ULN=upper limit of normal.|Participants|Count of Participants|0|0.0||||||
3729185|NCT02063659|3566532|B4||> ULN|Urinary 5-Hydroxyindoleacetic acid (5-HIAA) at Randomization|ULN=upper limit of normal.|Participants|Count of Participants|52|52.0||||||
3729186|NCT02063659|3566533|B3||> ULN|Urinary 5-Hydroxyindoleacetic acid (5-HIAA) at Randomization|ULN=upper limit of normal.|Participants|Count of Participants|17|17.0||||||
3729187|NCT02063659|3566534|B2||> ULN|Urinary 5-Hydroxyindoleacetic acid (5-HIAA) at Randomization|ULN=upper limit of normal.|Participants|Count of Participants|18|18.0||||||
3729188|NCT02063659|3566535|B1||> ULN|Urinary 5-Hydroxyindoleacetic acid (5-HIAA) at Randomization|ULN=upper limit of normal.|Participants|Count of Participants|17|17.0||||||
3729189|NCT02063659|3566532|B4||≤ ULN|Urinary 5-Hydroxyindoleacetic acid (5-HIAA) at Randomization|ULN=upper limit of normal.|Participants|Count of Participants|22|22.0||||||
3729190|NCT02063659|3566533|B3||≤ ULN|Urinary 5-Hydroxyindoleacetic acid (5-HIAA) at Randomization|ULN=upper limit of normal.|Participants|Count of Participants|8|8.0||||||
3729191|NCT02063659|3566534|B2||≤ ULN|Urinary 5-Hydroxyindoleacetic acid (5-HIAA) at Randomization|ULN=upper limit of normal.|Participants|Count of Participants|5|5.0||||||
3729192|NCT02063659|3566535|B1||≤ ULN|Urinary 5-Hydroxyindoleacetic acid (5-HIAA) at Randomization|ULN=upper limit of normal.|Participants|Count of Participants|9|9.0||||||
3729193|NCT02063659|3566532|B4||Not Applicable|Childbearing Potential||Participants|Count of Participants|42|42.0||||||
3729194|NCT02063659|3566533|B3||Not Applicable|Childbearing Potential||Participants|Count of Participants|15|15.0||||||
3729195|NCT02063659|3566534|B2||Not Applicable|Childbearing Potential||Participants|Count of Participants|14|14.0||||||
3729196|NCT02063659|3566535|B1||Not Applicable|Childbearing Potential||Participants|Count of Participants|13|13.0||||||
3729197|NCT02063659|3566532|B4||No|Childbearing Potential||Participants|Count of Participants|27|27.0||||||
3729198|NCT02063659|3566533|B3||No|Childbearing Potential||Participants|Count of Participants|9|9.0||||||
3729199|NCT02063659|3566534|B2||No|Childbearing Potential||Participants|Count of Participants|7|7.0||||||
3729200|NCT02063659|3566535|B1||No|Childbearing Potential||Participants|Count of Participants|11|11.0||||||
3729201|NCT02063659|3566532|B4||Yes|Childbearing Potential||Participants|Count of Participants|7|7.0||||||
3729202|NCT02063659|3566533|B3||Yes|Childbearing Potential||Participants|Count of Participants|1|1.0||||||
3729203|NCT02063659|3566534|B2||Yes|Childbearing Potential||Participants|Count of Participants|4|4.0||||||
3729204|NCT02063659|3566535|B1||Yes|Childbearing Potential||Participants|Count of Participants|2|2.0||||||
3729205|NCT02063659|3566532|B4||Not Applicable|SSA Therapy Name at Study Entry||Participants|Count of Participants|8|8.0||||||
3729206|NCT02063659|3566533|B3||Not Applicable|SSA Therapy Name at Study Entry||Participants|Count of Participants|5|5.0||||||
3729207|NCT02063659|3566534|B2||Not Applicable|SSA Therapy Name at Study Entry||Participants|Count of Participants|3|3.0||||||
3729208|NCT02063659|3566535|B1||Not Applicable|SSA Therapy Name at Study Entry||Participants|Count of Participants|0|0.0||||||
3729209|NCT02063659|3566532|B4||Unknown|SSA Therapy Name at Study Entry||Participants|Count of Participants|1|1.0||||||
3729210|NCT02063659|3566533|B3||Unknown|SSA Therapy Name at Study Entry||Participants|Count of Participants|1|1.0||||||
3729211|NCT02063659|3566534|B2||Unknown|SSA Therapy Name at Study Entry||Participants|Count of Participants|0|0.0||||||
3729212|NCT02063659|3566535|B1||Unknown|SSA Therapy Name at Study Entry||Participants|Count of Participants|0|0.0||||||
3729213|NCT02063659|3566532|B4||Lanreotide|SSA Therapy Name at Study Entry||Participants|Count of Participants|22|22.0||||||
3729214|NCT02063659|3566533|B3||Lanreotide|SSA Therapy Name at Study Entry||Participants|Count of Participants|3|3.0||||||
3729215|NCT02063659|3566534|B2||Lanreotide|SSA Therapy Name at Study Entry||Participants|Count of Participants|5|5.0||||||
3729216|NCT02063659|3566535|B1||Lanreotide|SSA Therapy Name at Study Entry||Participants|Count of Participants|14|14.0||||||
3729217|NCT02063659|3566532|B4||Octreotide|SSA Therapy Name at Study Entry||Participants|Count of Participants|45|45.0||||||
3729218|NCT02063659|3566533|B3||Octreotide|SSA Therapy Name at Study Entry||Participants|Count of Participants|16|16.0||||||
3729219|NCT02063659|3566534|B2||Octreotide|SSA Therapy Name at Study Entry||Participants|Count of Participants|17|17.0||||||
3729220|NCT02063659|3566535|B1||Octreotide|SSA Therapy Name at Study Entry||Participants|Count of Participants|12|12.0||||||
3729221|NCT02063659|3566532|B4||Not on SSA|Somatostatin Analog (SSA) Therapy Schedule at Study Entry|"Patients who were on a 2-week SSA therapy or receiving SSA therapy via a subcutaneous continuous infusion pump are included in the 4-week category."|Participants|Count of Participants|8|8.0||||||
3729265|NCT02063659|3566532|B4|Netherlands||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3729222|NCT02063659|3566533|B3||Not on SSA|Somatostatin Analog (SSA) Therapy Schedule at Study Entry|"Patients who were on a 2-week SSA therapy or receiving SSA therapy via a subcutaneous continuous infusion pump are included in the 4-week category."|Participants|Count of Participants|5|5.0||||||
3729223|NCT02063659|3566534|B2||Not on SSA|Somatostatin Analog (SSA) Therapy Schedule at Study Entry|"Patients who were on a 2-week SSA therapy or receiving SSA therapy via a subcutaneous continuous infusion pump are included in the 4-week category."|Participants|Count of Participants|3|3.0||||||
3729224|NCT02063659|3566535|B1||Not on SSA|Somatostatin Analog (SSA) Therapy Schedule at Study Entry|"Patients who were on a 2-week SSA therapy or receiving SSA therapy via a subcutaneous continuous infusion pump are included in the 4-week category."|Participants|Count of Participants|0|0.0||||||
3729225|NCT02063659|3566532|B4||4-Week|Somatostatin Analog (SSA) Therapy Schedule at Study Entry|"Patients who were on a 2-week SSA therapy or receiving SSA therapy via a subcutaneous continuous infusion pump are included in the 4-week category."|Participants|Count of Participants|46|46.0||||||
3729226|NCT02063659|3566533|B3||4-Week|Somatostatin Analog (SSA) Therapy Schedule at Study Entry|"Patients who were on a 2-week SSA therapy or receiving SSA therapy via a subcutaneous continuous infusion pump are included in the 4-week category."|Participants|Count of Participants|11|11.0||||||
3729227|NCT02063659|3566534|B2||4-Week|Somatostatin Analog (SSA) Therapy Schedule at Study Entry|"Patients who were on a 2-week SSA therapy or receiving SSA therapy via a subcutaneous continuous infusion pump are included in the 4-week category."|Participants|Count of Participants|15|15.0||||||
3729228|NCT02063659|3566535|B1||4-Week|Somatostatin Analog (SSA) Therapy Schedule at Study Entry|"Patients who were on a 2-week SSA therapy or receiving SSA therapy via a subcutaneous continuous infusion pump are included in the 4-week category."|Participants|Count of Participants|20|20.0||||||
3729229|NCT02063659|3566532|B4||3-Week|Somatostatin Analog (SSA) Therapy Schedule at Study Entry|"Patients who were on a 2-week SSA therapy or receiving SSA therapy via a subcutaneous continuous infusion pump are included in the 4-week category."|Participants|Count of Participants|22|22.0||||||
3729230|NCT02063659|3566533|B3||3-Week|Somatostatin Analog (SSA) Therapy Schedule at Study Entry|"Patients who were on a 2-week SSA therapy or receiving SSA therapy via a subcutaneous continuous infusion pump are included in the 4-week category."|Participants|Count of Participants|9|9.0||||||
3729231|NCT02063659|3566534|B2||3-Week|Somatostatin Analog (SSA) Therapy Schedule at Study Entry|"Patients who were on a 2-week SSA therapy or receiving SSA therapy via a subcutaneous continuous infusion pump are included in the 4-week category."|Participants|Count of Participants|7|7.0||||||
3729232|NCT02063659|3566535|B1||3-Week|Somatostatin Analog (SSA) Therapy Schedule at Study Entry|"Patients who were on a 2-week SSA therapy or receiving SSA therapy via a subcutaneous continuous infusion pump are included in the 4-week category."|Participants|Count of Participants|6|6.0||||||
3729233|NCT02063659|3566532|B4|Spain||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3729234|NCT02063659|3566533|B3|Spain||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3729235|NCT02063659|3566534|B2|Spain||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3729236|NCT02063659|3566535|B1|Spain||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3729237|NCT02063659|3566532|B4|Germany||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3729238|NCT02063659|3566533|B3|Germany||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3729239|NCT02063659|3566534|B2|Germany||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3729240|NCT02063659|3566535|B1|Germany||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3729241|NCT02063659|3566532|B4|France||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3729242|NCT02063659|3566533|B3|France||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3729243|NCT02063659|3566534|B2|France||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3729244|NCT02063659|3566535|B1|France||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3729245|NCT02063659|3566532|B4|Australia||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3729246|NCT02063659|3566533|B3|Australia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3729247|NCT02063659|3566534|B2|Australia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3729248|NCT02063659|3566535|B1|Australia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3729249|NCT02063659|3566532|B4|Israel||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3729250|NCT02063659|3566533|B3|Israel||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3729251|NCT02063659|3566534|B2|Israel||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3729252|NCT02063659|3566535|B1|Israel||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3729253|NCT02063659|3566532|B4|United Kingdom||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3729254|NCT02063659|3566533|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3729255|NCT02063659|3566534|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3729256|NCT02063659|3566535|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3729257|NCT02063659|3566532|B4|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3729258|NCT02063659|3566533|B3|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3729259|NCT02063659|3566534|B2|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3729260|NCT02063659|3566535|B1|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3729261|NCT02063659|3566532|B4|Belgium||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3729262|NCT02063659|3566533|B3|Belgium||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3729263|NCT02063659|3566534|B2|Belgium||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3729264|NCT02063659|3566535|B1|Belgium||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3729266|NCT02063659|3566533|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3729267|NCT02063659|3566534|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3729268|NCT02063659|3566535|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3729269|NCT02063659|3566532|B4|Sweden||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3729270|NCT02063659|3566533|B3|Sweden||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3729271|NCT02063659|3566534|B2|Sweden||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3729272|NCT02063659|3566535|B1|Sweden||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3729273|NCT02063659|3566532|B4|Canada||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3729274|NCT02063659|3566533|B3|Canada||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3729275|NCT02063659|3566534|B2|Canada||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3729276|NCT02063659|3566535|B1|Canada||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3729277|NCT02063659|3566532|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3729278|NCT02063659|3566533|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3729279|NCT02063659|3566534|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729280|NCT02063659|3566535|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3729281|NCT02063659|3566532|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729282|NCT02063659|3566533|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729283|NCT02063659|3566534|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729284|NCT02063659|3566535|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729285|NCT02063659|3566532|B4||White|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3729286|NCT02063659|3566533|B3||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3729287|NCT02063659|3566534|B2||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3729288|NCT02063659|3566535|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3729289|NCT02063659|3566532|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3729290|NCT02063659|3566533|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3729291|NCT02063659|3566534|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729292|NCT02063659|3566535|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729293|NCT02063659|3566532|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729294|NCT02063659|3566533|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729295|NCT02063659|3566534|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729296|NCT02063659|3566535|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729297|NCT02063659|3566532|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729298|NCT02063659|3566533|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729299|NCT02063659|3566534|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729300|NCT02063659|3566535|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729301|NCT02063659|3566532|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729302|NCT02063659|3566533|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729303|NCT02063659|3566534|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729304|NCT02063659|3566535|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729305|NCT02063659|3566532|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3729306|NCT02063659|3566533|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729307|NCT02063659|3566534|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729308|NCT02063659|3566535|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3729309|NCT02063659|3566532|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3729310|NCT02063659|3566533|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3729311|NCT02063659|3566534|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3729312|NCT02063659|3566535|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3729313|NCT02063659|3566532|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729314|NCT02063659|3566533|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729315|NCT02063659|3566534|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729316|NCT02063659|3566535|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729317|NCT02063659|3566532|B4||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3729318|NCT02063659|3566533|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3729319|NCT02063659|3566534|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3729320|NCT02063659|3566535|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3729321|NCT02063659|3566532|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3729322|NCT02063659|3566533|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3729323|NCT02063659|3566534|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3729324|NCT02063659|3566535|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3729325|NCT02063659|3566532|B4||≥ 65 years|Age, Customized||Participants|Count of Participants|35|35.0||||||
3729326|NCT02063659|3566533|B3||≥ 65 years|Age, Customized||Participants|Count of Participants|10|10.0||||||
3729327|NCT02063659|3566534|B2||≥ 65 years|Age, Customized||Participants|Count of Participants|11|11.0||||||
3729328|NCT02063659|3566535|B1||≥ 65 years|Age, Customized||Participants|Count of Participants|14|14.0||||||
3729329|NCT02063659|3566532|B4||< 65 years|Age, Customized||Participants|Count of Participants|41|41.0||||||
3729330|NCT02063659|3566533|B3||< 65 years|Age, Customized||Participants|Count of Participants|15|15.0||||||
3729331|NCT02063659|3566534|B2||< 65 years|Age, Customized||Participants|Count of Participants|14|14.0||||||
3729332|NCT02063659|3566535|B1||< 65 years|Age, Customized||Participants|Count of Participants|12|12.0||||||
3729333|NCT02063659|3566532|B4|||Age||years|Mean|62.8|62.8|Standard Deviation|11.52|11.52|||
3729334|NCT02063659|3566533|B3|||Age||years|Mean|62.7|62.7|Standard Deviation|11.97|11.97|||
3729335|NCT02063659|3566534|B2|||Age||years|Mean|63.6|63.6|Standard Deviation|12.62|12.62|||
3729336|NCT02063659|3566535|B1|||Age||years|Mean|62.2|62.2|Standard Deviation|10.32|10.32|||
3729337|NCT02063516|3566568|B3|General Surgery||Type of surgery||participants|Number|10|10.0||||||
3729338|NCT02063516|3566569|B2|General Surgery||Type of surgery||participants|Number|4|4.0||||||
3729339|NCT02063516|3566570|B1|General Surgery||Type of surgery||participants|Number|6|6.0||||||
3729340|NCT02063516|3566568|B3|Urology||Type of surgery||participants|Number|14|14.0||||||
3729341|NCT02063516|3566569|B2|Urology||Type of surgery||participants|Number|8|8.0||||||
3729342|NCT02063516|3566570|B1|Urology||Type of surgery||participants|Number|6|6.0||||||
3729343|NCT02063516|3566568|B3|Orthopedic||Type of surgery||participants|Number|18|18.0||||||
3729344|NCT02063516|3566569|B2|Orthopedic||Type of surgery||participants|Number|8|8.0||||||
3729345|NCT02063516|3566570|B1|Orthopedic||Type of surgery||participants|Number|10|10.0||||||
3729346|NCT02063516|3566568|B3|Gynecology||Type of surgery||participants|Number|38|38.0||||||
3729347|NCT02063516|3566569|B2|Gynecology||Type of surgery||participants|Number|20|20.0||||||
3729348|NCT02063516|3566570|B1|Gynecology||Type of surgery||participants|Number|18|18.0||||||
3729349|NCT02063516|3566568|B3|||BMI||kg/m^2|Mean|23.32|23.32|Standard Deviation|2.29|2.29|||
3729350|NCT02063516|3566569|B2|||BMI||kg/m^2|Mean|23.27|23.27|Standard Deviation|1.85|1.85|||
3729351|NCT02063516|3566570|B1|||BMI||kg/m^2|Mean|23.38|23.38|Standard Deviation|2.71|2.71|||
3729352|NCT02063516|3566568|B3|||Height||cm|Mean|161.22|161.22|Standard Deviation|4.54|4.54|||
3729353|NCT02063516|3566569|B2|||Height||cm|Mean|160.30|160.3|Standard Deviation|4.11|4.11|||
3729354|NCT02063516|3566570|B1|||Height||cm|Mean|162.20|162.2|Standard Deviation|4.86|4.86|||
3729355|NCT02063516|3566568|B3|||Weight||kilogram|Mean|60.70|60.7|Standard Deviation|7.12|7.12|||
3729356|NCT02063516|3566569|B2|||Weight||kilogram|Mean|59.75|59.75|Standard Deviation|4.72|4.72|||
3729357|NCT02063516|3566570|B1|||Weight||kilogram|Mean|61.65|61.65|Standard Deviation|8.95|8.95|||
3729358|NCT02063516|3566568|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3729359|NCT02063516|3566569|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3729360|NCT02063516|3566570|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3729361|NCT02063516|3566568|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3729362|NCT02063516|3566569|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3729363|NCT02063516|3566570|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3729364|NCT02063516|3566568|B3|||Age|Age group include age >18-<65 years|years|Mean|45.47|45.47|Standard Deviation|14.01|14.01|||
3729365|NCT02063516|3566569|B2|||Age|Age group include age >18-<65 years|years|Mean|45.20|45.2|Standard Deviation|14.78|14.78|||
3729366|NCT02063516|3566570|B1|||Age|Age group include age >18-<65 years|years|Mean|45.75|45.75|Standard Deviation|13.58|13.58|||
3729367|NCT02063230|3566581|B5||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3729368|NCT02063230|3566582|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3729369|NCT02063230|3566583|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3729370|NCT02063230|3566584|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3729371|NCT02063230|3566585|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3729372|NCT02063230|3566581|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3729373|NCT02063230|3566582|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3729374|NCT02063230|3566583|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3729375|NCT02063230|3566584|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3729376|NCT02063230|3566585|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3729377|NCT02063230|3566581|B5|||Age||Years|Mean|56|56.0|Standard Deviation|6|6.0|||
3729378|NCT02063230|3566582|B4|||Age||Years|Mean|57|57.0|Standard Deviation|7|7.0|||
3729379|NCT02063230|3566583|B3|||Age||Years|Mean|55|55.0|Standard Deviation|9|9.0|||
3729380|NCT02063230|3566584|B2|||Age||Years|Mean|57|57.0|Standard Deviation|5|5.0|||
3729381|NCT02063230|3566585|B1|||Age||Years|Mean|55|55.0|Standard Deviation|4|4.0|||
3729382|NCT02063217|3566618|B4|United States||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3729383|NCT02063217|3566619|B3|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3729384|NCT02063217|3566620|B2|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3729385|NCT02063217|3566621|B1|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3729386|NCT02063217|3566618|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3729387|NCT02063217|3566619|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3729388|NCT02063217|3566620|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3729389|NCT02063217|3566621|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3729390|NCT02063217|3566618|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3729391|NCT02063217|3566619|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3729392|NCT02063217|3566620|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3729393|NCT02063217|3566621|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3729394|NCT02063217|3566618|B4|||Age||years|Mean|43.3|43.3|Full Range|||18.8|58.6|
3729395|NCT02063217|3566619|B3|||Age||years|Mean|42.7|42.7|Full Range|||25.0|57.2|
3729396|NCT02063217|3566620|B2|||Age||years|Mean|42.0|42.0|Full Range|||18.8|58.6|
3729397|NCT02063217|3566621|B1|||Age||years|Mean|45.5|45.5|Full Range|||20.8|58.3|
3729398|NCT02063217|3566618|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3729399|NCT02063217|3566619|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3729400|NCT02063217|3566620|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3729401|NCT02063217|3566621|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3729402|NCT02063217|3566618|B4||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3729403|NCT02063217|3566619|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3729404|NCT02063217|3566620|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3729405|NCT02063217|3566621|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3729406|NCT02063217|3566618|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3729407|NCT02063217|3566619|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3729408|NCT02063217|3566620|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3729409|NCT02063217|3566621|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3729410|NCT02063035|3566631|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3729411|NCT02063035|3566632|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3729412|NCT02063035|3566633|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3729413|NCT02063035|3566631|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3729414|NCT02063035|3566632|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3729415|NCT02063035|3566633|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3729416|NCT02063035|3566631|B3|||Age||years|Mean|68|68.0|Inter-Quartile Range|||60.0|72.0|
3729417|NCT02063035|3566632|B2|||Age||years|Mean|66|66.0|Inter-Quartile Range|||50.0|73.0|
3729418|NCT02063035|3566633|B1|||Age||years|Mean|69|69.0|Inter-Quartile Range|||62.0|72.0|
3729419|NCT02062905|3566646|B3||Male|Gender||Participants|Count of Participants|33|33.0||||||
3729420|NCT02062905|3566647|B2||Male|Gender||Participants|Count of Participants|16|16.0||||||
3729421|NCT02062905|3566648|B1||Male|Gender||Participants|Count of Participants|17|17.0||||||
3729422|NCT02062905|3566646|B3||Female|Gender||Participants|Count of Participants|35|35.0||||||
3729423|NCT02062905|3566647|B2||Female|Gender||Participants|Count of Participants|17|17.0||||||
3729424|NCT02062905|3566648|B1||Female|Gender||Participants|Count of Participants|18|18.0||||||
3729425|NCT02062905|3566646|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3729426|NCT02062905|3566647|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3729427|NCT02062905|3566648|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3729428|NCT02062905|3566646|B3||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
3729429|NCT02062905|3566647|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3729430|NCT02062905|3566648|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3729431|NCT02062905|3566646|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3729432|NCT02062905|3566647|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3729433|NCT02062905|3566648|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3729434|NCT02062879|3566657|B3|||Penetrating Trauma||Participants|Count of Participants|1|1.0||||||
3729435|NCT02062879|3566658|B2|||Penetrating Trauma||Participants|Count of Participants|1|1.0||||||
3729436|NCT02062879|3566659|B1|||Penetrating Trauma||Participants|Count of Participants|0|0.0||||||
3729437|NCT02062879|3566657|B3|||Blunt Trauma||Participants|Count of Participants|19|19.0||||||
3729438|NCT02062879|3566658|B2|||Blunt Trauma||Participants|Count of Participants|9|9.0||||||
3729439|NCT02062879|3566659|B1|||Blunt Trauma||Participants|Count of Participants|10|10.0||||||
3729440|NCT02062879|3566657|B3|||Injury Severity Score|"The Injury Severity Score is an anatomical scoring system that correlates with morbidity and mortality. The value can range from 0 to 75. Higher values represent a worse outcome. Reference: Baker SP et al, The Injury Severity Score: a method for describing patients with multiple injuries and evaluating emergency care, J Trauma 14:187-196;1974."|scores on a scale|Median|29|29.0|Inter-Quartile Range|||26.0|29.0|
3729496|NCT02062645|3566700|B1|||Body mass index||kg/m^2|Mean|31.19|31.19|Standard Deviation|5.32|5.32|||
3729497|NCT02062645|3566700|B1|||Heart rate||beats/min|Mean|80.15|80.15|Standard Deviation|10.00|10.0|||
3729498|NCT02062645|3566700|B1|||Diastolic blood pressure||mmHg|Mean|96.7|96.7|Standard Deviation|12.7|12.7|||
3729441|NCT02062879|3566658|B2|||Injury Severity Score|"The Injury Severity Score is an anatomical scoring system that correlates with morbidity and mortality. The value can range from 0 to 75. Higher values represent a worse outcome. Reference: Baker SP et al, The Injury Severity Score: a method for describing patients with multiple injuries and evaluating emergency care, J Trauma 14:187-196;1974."|scores on a scale|Median|28|28.0|Inter-Quartile Range|||26.0|29.0|
3729442|NCT02062879|3566659|B1|||Injury Severity Score|"The Injury Severity Score is an anatomical scoring system that correlates with morbidity and mortality. The value can range from 0 to 75. Higher values represent a worse outcome. Reference: Baker SP et al, The Injury Severity Score: a method for describing patients with multiple injuries and evaluating emergency care, J Trauma 14:187-196;1974."|scores on a scale|Median|29|29.0|Inter-Quartile Range|||22.0|33.0|
3729443|NCT02062879|3566657|B3|||BMI||kg/m^2|Median|27|27.0|Inter-Quartile Range|||23.0|29.0|
3729444|NCT02062879|3566658|B2|||BMI||kg/m^2|Median|26.5|26.5|Inter-Quartile Range|||21.7|29.0|
3729445|NCT02062879|3566659|B1|||BMI||kg/m^2|Median|27|27.0|Inter-Quartile Range|||23.8|29.0|
3729446|NCT02062879|3566657|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3729447|NCT02062879|3566658|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729448|NCT02062879|3566659|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3729449|NCT02062879|3566657|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729450|NCT02062879|3566658|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729451|NCT02062879|3566659|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729452|NCT02062879|3566657|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3729453|NCT02062879|3566658|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3729454|NCT02062879|3566659|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3729455|NCT02062879|3566657|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3729456|NCT02062879|3566658|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3729457|NCT02062879|3566659|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3729458|NCT02062879|3566657|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729459|NCT02062879|3566658|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729460|NCT02062879|3566659|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729461|NCT02062879|3566657|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729462|NCT02062879|3566658|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729463|NCT02062879|3566659|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729464|NCT02062879|3566657|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729465|NCT02062879|3566658|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729466|NCT02062879|3566659|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729467|NCT02062879|3566657|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3729468|NCT02062879|3566658|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3729469|NCT02062879|3566659|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3729470|NCT02062879|3566657|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3729471|NCT02062879|3566658|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3729472|NCT02062879|3566659|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3729473|NCT02062879|3566657|B3|||Age||years|Median|30|30.0|Inter-Quartile Range|||25.0|47.0|
3729474|NCT02062879|3566658|B2|||Age||years|Median|26|26.0|Inter-Quartile Range|||22.0|30.0|
3729475|NCT02062879|3566659|B1|||Age||years|Median|39|39.0|Inter-Quartile Range|||28.0|47.0|
3729476|NCT02062801|3566670|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3729477|NCT02062801|3566671|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3729478|NCT02062801|3566672|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3729479|NCT02062801|3566670|B3||Female|Sex: Female, Male||Participants|Count of Participants|596|596.0||||||
3729480|NCT02062801|3566671|B2||Female|Sex: Female, Male||Participants|Count of Participants|297|297.0||||||
3729481|NCT02062801|3566672|B1||Female|Sex: Female, Male||Participants|Count of Participants|299|299.0||||||
3729482|NCT02062801|3566670|B3|||Age||years|Mean|30|30.0|Standard Deviation|5|5.0|||
3729483|NCT02062801|3566671|B2|||Age||years|Mean|30|30.0|Standard Deviation|5|5.0|||
3729484|NCT02062801|3566672|B1|||Age||years|Mean|29|29.0|Standard Deviation|6|6.0|||
3729485|NCT02062710|3566683|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3729486|NCT02062710|3566683|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3729487|NCT02062710|3566683|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3729488|NCT02062710|3566683|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3729489|NCT02062710|3566683|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3729490|NCT02062658|3566696|B1||Male|Gender||Participants|Count of Participants|9|9.0||||||
3729491|NCT02062658|3566696|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
3729492|NCT02062658|3566696|B1|||Age||years|Mean|35.3|35.3|Standard Deviation|10.6|10.6|||
3729493|NCT02062658|3566696|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3729494|NCT02062658|3566696|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3729495|NCT02062658|3566696|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3729499|NCT02062645|3566700|B1|||Systolic blood pressure||mmHG|Mean|164.3|164.3|Standard Deviation|13.2|13.2|||
3729500|NCT02062645|3566700|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3729501|NCT02062645|3566700|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3729502|NCT02062645|3566700|B1|||Age||years|Mean|55.06|55.06|Standard Deviation|11.22|11.22|||
3729503|NCT02062580|3566708|B3|no||Breastfed||participants|Number|126|126.0||||||
3729504|NCT02062580|3566709|B2|no||Breastfed||participants|Number|64|64.0||||||
3729505|NCT02062580|3566710|B1|no||Breastfed||participants|Number|62|62.0||||||
3729506|NCT02062580|3566708|B3|yes||Breastfed||participants|Number|20|20.0||||||
3729507|NCT02062580|3566709|B2|yes||Breastfed||participants|Number|12|12.0||||||
3729508|NCT02062580|3566710|B1|yes||Breastfed||participants|Number|8|8.0||||||
3729509|NCT02062580|3566708|B3|||Maternal CD4 T cell count||cells/mm^3|Median|362|362.0|Inter-Quartile Range|||263.0|513.0|
3729510|NCT02062580|3566709|B2|||Maternal CD4 T cell count||cells/mm^3|Median|366|366.0|Inter-Quartile Range|||271.0|477.0|
3729511|NCT02062580|3566710|B1|||Maternal CD4 T cell count||cells/mm^3|Median|358|358.0|Inter-Quartile Range|||254.0|548.0|
3729512|NCT02062580|3566708|B3|||Birth weight||kg|Median|3.13|3.13|Inter-Quartile Range|||2.9|3.4|
3729513|NCT02062580|3566709|B2|||Birth weight||kg|Median|3.12|3.12|Inter-Quartile Range|||2.8|3.4|
3729514|NCT02062580|3566710|B1|||Birth weight||kg|Median|3.15|3.15|Inter-Quartile Range|||2.85|3.3|
3729515|NCT02062580|3566708|B3|South Africa||Region of Enrollment||count of participants|Number|146|146.0||||||
3729516|NCT02062580|3566709|B2|South Africa||Region of Enrollment||count of participants|Number|76|76.0||||||
3729517|NCT02062580|3566710|B1|South Africa||Region of Enrollment||count of participants|Number|70|70.0||||||
3729518|NCT02062580|3566708|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3729519|NCT02062580|3566709|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3729520|NCT02062580|3566710|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3729521|NCT02062580|3566708|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3729522|NCT02062580|3566709|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3729523|NCT02062580|3566710|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3729524|NCT02062580|3566708|B3|||Age|Median gestational age, in weeks|weeks|Median|39.5|39.5|Inter-Quartile Range|||38.0|40.0|
3729525|NCT02062580|3566709|B2|||Age|Median gestational age, in weeks|weeks|Median|40|40.0|Inter-Quartile Range|||39.0|40.0|
3729526|NCT02062580|3566710|B1|||Age|Median gestational age, in weeks|weeks|Median|39|39.0|Inter-Quartile Range|||38.0|40.0|
3729527|NCT02062580|3566708|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3729528|NCT02062580|3566709|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3729529|NCT02062580|3566710|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3729530|NCT02062580|3566708|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3729531|NCT02062580|3566709|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3729532|NCT02062580|3566710|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3729533|NCT02062580|3566708|B3||<=18 years|Age||Participants|Count of Participants|149|149.0||||||
3729534|NCT02062580|3566709|B2||<=18 years|Age||Participants|Count of Participants|78|78.0||||||
3729535|NCT02062580|3566710|B1||<=18 years|Age||Participants|Count of Participants|71|71.0||||||
3729536|NCT02062502|3566719|B3||Male|Sex: Female, Male||Participants|Count of Participants|332|332.0||||||
3729537|NCT02062502|3566720|B2||Male|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3729538|NCT02062502|3566721|B1||Male|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3729539|NCT02062502|3566719|B3||Female|Sex: Female, Male||Participants|Count of Participants|279|279.0||||||
3729540|NCT02062502|3566720|B2||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3729541|NCT02062502|3566721|B1||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3729542|NCT02062502|3566719|B3|||Age||Months|Mean|12.9|12.9|Standard Deviation|1.8|1.8|||
3729543|NCT02062502|3566720|B2|||Age||Months|Mean|12.8|12.8|Standard Deviation|1.7|1.7|||
3729544|NCT02062502|3566721|B1|||Age||Months|Mean|12.9|12.9|Standard Deviation|1.9|1.9|||
3729545|NCT02062450|3566740|B3|France||Region of Enrollment||participants|Number|255|255.0||||||
3729546|NCT02062450|3566741|B2|France||Region of Enrollment||participants|Number|64|64.0||||||
3729547|NCT02062450|3566742|B1|France||Region of Enrollment||participants|Number|191|191.0||||||
3729548|NCT02062450|3566740|B3||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3729549|NCT02062450|3566741|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3729550|NCT02062450|3566742|B1||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3729551|NCT02062450|3566740|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3729552|NCT02062450|3566741|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3729553|NCT02062450|3566742|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3729554|NCT02062450|3566740|B3|||Age||years|Mean|72.2|72.2|Standard Deviation|10.5|10.5|||
3729555|NCT02062450|3566741|B2|||Age||years|Mean|71.3|71.3|Standard Deviation|11.5|11.5|||
3729556|NCT02062450|3566742|B1|||Age||years|Mean|72.7|72.7|Standard Deviation|9.4|9.4|||
3729557|NCT02062437|3566756|B1|France||Region of Enrollment||participants|Number|80|80.0||||||
3729558|NCT02062437|3566756|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3729559|NCT02062437|3566756|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3729560|NCT02062437|3566756|B1|||Age||years|Mean|59.8|59.8|Standard Deviation|9.0|9.0|||
3729561|NCT02062385|3566765|B5||Male|Sex: Female, Male||Participants|Count of Participants|2091|2091.0||||||
3729562|NCT02062385|3566766|B4||Male|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
3729563|NCT02062385|3566767|B3||Male|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
3729564|NCT02062385|3566768|B2||Male|Sex: Female, Male||Participants|Count of Participants|845|845.0||||||
3729565|NCT02062385|3566769|B1||Male|Sex: Female, Male||Participants|Count of Participants|814|814.0||||||
3729566|NCT02062385|3566765|B5||Female|Sex: Female, Male||Participants|Count of Participants|1949|1949.0||||||
3729567|NCT02062385|3566766|B4||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3729568|NCT02062385|3566767|B3||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
3729569|NCT02062385|3566768|B2||Female|Sex: Female, Male||Participants|Count of Participants|775|775.0||||||
3729570|NCT02062385|3566769|B1||Female|Sex: Female, Male||Participants|Count of Participants|806|806.0||||||
3729571|NCT02062385|3566765|B5|||Age||Days|Mean|59.5|59.5|Standard Deviation|10.2|10.2|||
3729572|NCT02062385|3566766|B4|||Age||Days|Mean|68.5|68.5|Standard Deviation|5.7|5.7|||
3729573|NCT02062385|3566767|B3|||Age||Days|Mean|68.3|68.3|Standard Deviation|5.7|5.7|||
3729574|NCT02062385|3566768|B2|||Age||Days|Mean|57.2|57.2|Standard Deviation|9.7|9.7|||
3729575|NCT02062385|3566769|B1|||Age||Days|Mean|57.5|57.5|Standard Deviation|10.0|10.0|||
3729576|NCT02062359|3566792|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3729577|NCT02062359|3566792|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729578|NCT02062359|3566792|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729579|NCT02062359|3566792|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3729580|NCT02062359|3566792|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729581|NCT02062359|3566792|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729582|NCT02062359|3566792|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729583|NCT02062359|3566792|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729584|NCT02062359|3566792|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729585|NCT02062359|3566792|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3729586|NCT02062359|3566792|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729587|NCT02062359|3566792|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3729588|NCT02062359|3566792|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3729589|NCT02062359|3566792|B1|||Age||years|Mean|45.0|45.0|Standard Deviation|1.4|1.4|||
3729590|NCT02062359|3566792|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3729591|NCT02062359|3566792|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3729592|NCT02062359|3566792|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3729593|NCT02062294|3566798|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3729594|NCT02062294|3566798|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3729595|NCT02062294|3566798|B1|||Age||Years|Median|48|48.0|Full Range|||17.0|62.0|
3729596|NCT02062294|3566798|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3729597|NCT02062294|3566798|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3729598|NCT02062294|3566798|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3729599|NCT02062177|3566803|B3|Italy||Region of Enrollment||participants|Number|140|140.0||||||
3729600|NCT02062177|3566804|B2|Italy||Region of Enrollment||participants|Number|70|70.0||||||
3729601|NCT02062177|3566805|B1|Italy||Region of Enrollment||participants|Number|70|70.0||||||
3729602|NCT02062177|3566803|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3729603|NCT02062177|3566804|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3729604|NCT02062177|3566805|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3729605|NCT02062177|3566803|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3729606|NCT02062177|3566804|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3729607|NCT02062177|3566805|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3729608|NCT02062177|3566803|B3||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
3729609|NCT02062177|3566804|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3729610|NCT02062177|3566805|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3729611|NCT02062177|3566803|B3||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
3729612|NCT02062177|3566804|B2||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
3729613|NCT02062177|3566805|B1||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
3729614|NCT02062177|3566803|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3729615|NCT02062177|3566804|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3729616|NCT02062177|3566805|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3729617|NCT02061969|3566816|B3|United States||Region of Enrollment||participants|Number|140|140.0||||||
3729618|NCT02061969|3566817|B2|United States||Region of Enrollment||participants|Number|67|67.0||||||
3729619|NCT02061969|3566818|B1|United States||Region of Enrollment||participants|Number|73|73.0||||||
3729620|NCT02061969|3566816|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729621|NCT02061969|3566817|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729622|NCT02061969|3566818|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729623|NCT02061969|3566816|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3729624|NCT02061969|3566817|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3729625|NCT02061969|3566818|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3729626|NCT02061969|3566816|B3||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3729627|NCT02061969|3566817|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3729628|NCT02061969|3566818|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3729629|NCT02061969|3566816|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3729630|NCT02061969|3566817|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3729631|NCT02061969|3566818|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3729632|NCT02061969|3566816|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729633|NCT02061969|3566817|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729634|NCT02061969|3566818|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729635|NCT02061969|3566816|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729636|NCT02061969|3566817|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729637|NCT02061969|3566818|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729638|NCT02061969|3566816|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729639|NCT02061969|3566817|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729640|NCT02061969|3566818|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729641|NCT02061969|3566816|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3729642|NCT02061969|3566817|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3729643|NCT02061969|3566818|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3729644|NCT02061969|3566816|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3729645|NCT02061969|3566817|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3729646|NCT02061969|3566818|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3729647|NCT02061969|3566816|B3|||Age||years|Mean|69.8|69.8|Standard Deviation|13|13.0|||
3729648|NCT02061969|3566817|B2|||Age||years|Mean|68|68.0|Standard Deviation|14|14.0|||
3729649|NCT02061969|3566818|B1|||Age||years|Mean|71.5|71.5|Standard Deviation|13|13.0|||
3729650|NCT02061748|3566847|B3|Unknown||Sex/Gender, Customized||Participants|Number|3|3.0||||||
3729651|NCT02061748|3566848|B2|Unknown||Sex/Gender, Customized||Participants|Number|3|3.0||||||
3729652|NCT02061748|3566849|B1|Unknown||Sex/Gender, Customized||Participants|Number|0|0.0||||||
3729653|NCT02061748|3566847|B3|Male||Sex/Gender, Customized||Participants|Number|21236|21236.0||||||
3729654|NCT02061748|3566848|B2|Male||Sex/Gender, Customized||Participants|Number|16906|16906.0||||||
3729655|NCT02061748|3566849|B1|Male||Sex/Gender, Customized||Participants|Number|4330|4330.0||||||
3729656|NCT02061748|3566847|B3|Female||Sex/Gender, Customized||Participants|Number|17260|17260.0||||||
3729657|NCT02061748|3566848|B2|Female||Sex/Gender, Customized||Participants|Number|13944|13944.0||||||
3729658|NCT02061748|3566849|B1|Female||Sex/Gender, Customized||Participants|Number|3316|3316.0||||||
3729659|NCT02061748|3566847|B3|||Age||Years|Mean|74.5|74.5|Standard Deviation|8.3|8.3|||
3729660|NCT02061748|3566848|B2|||Age||Years|Mean|74.8|74.8|Standard Deviation|8.2|8.2|||
3729661|NCT02061748|3566849|B1|||Age||Years|Mean|73.2|73.2|Standard Deviation|8.6|8.6|||
3729662|NCT02061696|3566922|B3|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3729663|NCT02061696|3566923|B2|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3729664|NCT02061696|3566924|B1|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3729665|NCT02061696|3566922|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3729666|NCT02061696|3566923|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3729667|NCT02061696|3566924|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3729668|NCT02061696|3566922|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3729669|NCT02061696|3566923|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3729670|NCT02061696|3566924|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3729671|NCT02061696|3566922|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3729672|NCT02061696|3566923|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3729673|NCT02061696|3566924|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3729674|NCT02061696|3566922|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3729675|NCT02061696|3566923|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3729676|NCT02061696|3566924|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3729677|NCT02061696|3566922|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3729678|NCT02061696|3566923|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3729679|NCT02061696|3566924|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3729680|NCT02061683|3566949|B1||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3729681|NCT02061683|3566949|B1||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3729682|NCT02061683|3566949|B1|||Age||Years|Mean|48.7|48.7|Standard Deviation|16.6|16.6|||
3729683|NCT02061592|3566954|B3|United States||Region of Enrollment||participants|Number|128|128.0||||||
3729684|NCT02061592|3566955|B2|United States||Region of Enrollment||participants|Number|62|62.0||||||
3729685|NCT02061592|3566956|B1|United States||Region of Enrollment||participants|Number|66|66.0||||||
3729686|NCT02061592|3566954|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729687|NCT02061592|3566955|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729688|NCT02061592|3566956|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729689|NCT02061592|3566954|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729690|NCT02061592|3566955|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729691|NCT02061592|3566956|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729692|NCT02061592|3566954|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729693|NCT02061592|3566955|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729694|NCT02061592|3566956|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729695|NCT02061592|3566954|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729696|NCT02061592|3566955|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729697|NCT02061592|3566956|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729698|NCT02061592|3566954|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729699|NCT02061592|3566955|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729700|NCT02061592|3566956|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729701|NCT02061592|3566954|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
3729702|NCT02061592|3566955|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3729703|NCT02061592|3566956|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3729704|NCT02061592|3566954|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729705|NCT02061592|3566955|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729706|NCT02061592|3566956|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729707|NCT02061592|3566954|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3729708|NCT02061592|3566955|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3729709|NCT02061592|3566956|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3729710|NCT02061592|3566954|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3729711|NCT02061592|3566955|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3729712|NCT02061592|3566956|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3729713|NCT02061592|3566954|B3|||Age||years|Mean|31.0|31.0|Standard Deviation|8.29|8.29|||
3729714|NCT02061592|3566955|B2|||Age||years|Mean|30.6|30.6|Standard Deviation|7.48|7.48|||
3729715|NCT02061592|3566956|B1|||Age||years|Mean|31.4|31.4|Standard Deviation|9.02|9.02|||
3729716|NCT02061540|3566969|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3729717|NCT02061540|3566969|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3729718|NCT02061540|3566969|B1|||Age||Years|Mean|43.7|43.7|Standard Deviation|11.35|11.35|||
3729719|NCT02061358|3566982|B10|||Body mass index||kg/m^2|Mean|25.77|25.77|Standard Deviation|2.47|2.47|||
3729720|NCT02061358|3566983|B9|||Body mass index||kg/m^2|Mean|24.89|24.89|Standard Deviation|2.82|2.82|||
3729721|NCT02061358|3566984|B8|||Body mass index||kg/m^2|Mean|24.93|24.93|Standard Deviation|1.6|1.6|||
3729722|NCT02061358|3566985|B7|||Body mass index||kg/m^2|Mean|24.86|24.86|Standard Deviation|2.93|2.93|||
3729723|NCT02061358|3566986|B6|||Body mass index||kg/m^2|Mean|26.13|26.13|Standard Deviation|2.07|2.07|||
3729724|NCT02061358|3566987|B5|||Body mass index||kg/m^2|Mean|27.05|27.05|Standard Deviation|1.84|1.84|||
3729725|NCT02061358|3566988|B4|||Body mass index||kg/m^2|Mean|24.76|24.76|Standard Deviation|2.71|2.71|||
3729726|NCT02061358|3566989|B3|||Body mass index||kg/m^2|Mean|26.44|26.44|Standard Deviation|2.36|2.36|||
3729727|NCT02061358|3566990|B2|||Body mass index||kg/m^2|Mean|26.88|26.88|Standard Deviation|2.6|2.6|||
3729728|NCT02061358|3566991|B1|||Body mass index||kg/m^2|Mean|27.44|27.44|Standard Deviation|1.28|1.28|||
3729729|NCT02061358|3566982|B10|||Weight||kg|Mean|78.36|78.36|Standard Deviation|10.4|10.4|||
3729730|NCT02061358|3566983|B9|||Weight||kg|Mean|76.2|76.2|Standard Deviation|11.5|11.5|||
3729731|NCT02061358|3566984|B8|||Weight||kg|Mean|75.0|75.0|Standard Deviation|5.5|5.5|||
3729732|NCT02061358|3566985|B7|||Weight||kg|Mean|74.1|74.1|Standard Deviation|11|11.0|||
3729733|NCT02061358|3566986|B6|||Weight||kg|Mean|80.1|80.1|Standard Deviation|10.5|10.5|||
3729734|NCT02061358|3566987|B5|||Weight||kg|Mean|84.0|84.0|Standard Deviation|8.5|8.5|||
3729735|NCT02061358|3566988|B4|||Weight||kg|Mean|75.9|75.9|Standard Deviation|8.3|8.3|||
3729736|NCT02061358|3566989|B3|||Weight||kg|Mean|80.8|80.8|Standard Deviation|9.7|9.7|||
3729737|NCT02061358|3566990|B2|||Weight||kg|Mean|79.6|79.6|Standard Deviation|13.8|13.8|||
3729738|NCT02061358|3566991|B1|||Weight||kg|Mean|82.9|82.9|Standard Deviation|12.1|12.1|||
3729739|NCT02061358|3566982|B10|||Height||cm|Mean|174.25|174.25|Standard Deviation|8.39|8.39|||
3729740|NCT02061358|3566983|B9|||Height||cm|Mean|174.9|174.9|Standard Deviation|8.1|8.1|||
3729741|NCT02061358|3566984|B8|||Height||cm|Mean|173.5|173.5|Standard Deviation|3.2|3.2|||
3729742|NCT02061358|3566985|B7|||Height||cm|Mean|172.6|172.6|Standard Deviation|8.2|8.2|||
3729743|NCT02061358|3566986|B6|||Height||cm|Mean|174.8|174.8|Standard Deviation|8.9|8.9|||
3729744|NCT02061358|3566987|B5|||Height||cm|Mean|176.2|176.2|Standard Deviation|9.9|9.9|||
3729745|NCT02061358|3566988|B4|||Height||cm|Mean|175.2|175.2|Standard Deviation|3.8|3.8|||
3729746|NCT02061358|3566989|B3|||Height||cm|Mean|175.0|175.0|Standard Deviation|11.3|11.3|||
3729747|NCT02061358|3566990|B2|||Height||cm|Mean|171.8|171.8|Standard Deviation|12.3|12.3|||
3729748|NCT02061358|3566991|B1|||Height||cm|Mean|173.4|173.4|Standard Deviation|11.1|11.1|||
3729749|NCT02061358|3566982|B10||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729750|NCT02061358|3566983|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729751|NCT02061358|3566984|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729752|NCT02061358|3566985|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729753|NCT02061358|3566986|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729754|NCT02061358|3566987|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729755|NCT02061358|3566988|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729756|NCT02061358|3566989|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729757|NCT02061358|3566990|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729758|NCT02061358|3566991|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729759|NCT02061358|3566982|B10||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729760|NCT02061358|3566983|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729761|NCT02061358|3566984|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729762|NCT02061358|3566985|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729763|NCT02061358|3566986|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729764|NCT02061358|3566987|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729765|NCT02061358|3566988|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729766|NCT02061358|3566989|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729767|NCT02061358|3566990|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729768|NCT02061358|3566991|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729769|NCT02061358|3566982|B10||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3729770|NCT02061358|3566983|B9||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3729771|NCT02061358|3566984|B8||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3729772|NCT02061358|3566985|B7||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3729773|NCT02061358|3566986|B6||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3729774|NCT02061358|3566987|B5||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3729775|NCT02061358|3566988|B4||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3729776|NCT02061358|3566989|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3729777|NCT02061358|3566990|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3729778|NCT02061358|3566991|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3729779|NCT02061358|3566982|B10||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3729780|NCT02061358|3566983|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3729781|NCT02061358|3566984|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729782|NCT02061358|3566985|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3729783|NCT02061358|3566986|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3729784|NCT02061358|3566987|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3729785|NCT02061358|3566988|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3729786|NCT02061358|3566989|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3729787|NCT02061358|3566990|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3729788|NCT02061358|3566991|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729789|NCT02061358|3566982|B10||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729790|NCT02061358|3566983|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729791|NCT02061358|3566984|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729792|NCT02061358|3566985|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729793|NCT02061358|3566986|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729794|NCT02061358|3566987|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729795|NCT02061358|3566988|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729796|NCT02061358|3566989|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729797|NCT02061358|3566990|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729854|NCT02061358|3566987|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3729798|NCT02061358|3566991|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729799|NCT02061358|3566982|B10||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729800|NCT02061358|3566983|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729801|NCT02061358|3566984|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729802|NCT02061358|3566985|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729803|NCT02061358|3566986|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729804|NCT02061358|3566987|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729805|NCT02061358|3566988|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729806|NCT02061358|3566989|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729807|NCT02061358|3566990|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729808|NCT02061358|3566991|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729809|NCT02061358|3566982|B10||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3729810|NCT02061358|3566983|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729811|NCT02061358|3566984|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729812|NCT02061358|3566985|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729813|NCT02061358|3566986|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729814|NCT02061358|3566987|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729815|NCT02061358|3566988|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729816|NCT02061358|3566989|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729817|NCT02061358|3566990|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3729818|NCT02061358|3566991|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729819|NCT02061358|3566982|B10||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729820|NCT02061358|3566983|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729821|NCT02061358|3566984|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729822|NCT02061358|3566985|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729823|NCT02061358|3566986|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729824|NCT02061358|3566987|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729825|NCT02061358|3566988|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729826|NCT02061358|3566989|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729827|NCT02061358|3566990|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729828|NCT02061358|3566991|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729829|NCT02061358|3566982|B10||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3729830|NCT02061358|3566983|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3729831|NCT02061358|3566984|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3729832|NCT02061358|3566985|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3729833|NCT02061358|3566986|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3729834|NCT02061358|3566987|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3729835|NCT02061358|3566988|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3729836|NCT02061358|3566989|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3729837|NCT02061358|3566990|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3729838|NCT02061358|3566991|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3729839|NCT02061358|3566982|B10||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3729840|NCT02061358|3566983|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3729841|NCT02061358|3566984|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3729842|NCT02061358|3566985|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729843|NCT02061358|3566986|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729844|NCT02061358|3566987|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3729845|NCT02061358|3566988|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3729846|NCT02061358|3566989|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729847|NCT02061358|3566990|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3729848|NCT02061358|3566991|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3729849|NCT02061358|3566982|B10||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3729850|NCT02061358|3566983|B9||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3729851|NCT02061358|3566984|B8||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3729852|NCT02061358|3566985|B7||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3729853|NCT02061358|3566986|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3729855|NCT02061358|3566988|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3729856|NCT02061358|3566989|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3729857|NCT02061358|3566990|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3729858|NCT02061358|3566991|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3729859|NCT02061358|3566982|B10||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3729860|NCT02061358|3566983|B9||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3729861|NCT02061358|3566984|B8||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3729862|NCT02061358|3566985|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3729863|NCT02061358|3566986|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3729864|NCT02061358|3566987|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3729865|NCT02061358|3566988|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3729866|NCT02061358|3566989|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3729867|NCT02061358|3566990|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3729868|NCT02061358|3566991|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3729869|NCT02061358|3566982|B10|||Age||years|Mean|27|27.0|Standard Deviation|7|7.0|||
3729870|NCT02061358|3566983|B9|||Age||years|Mean|28|28.0|Standard Deviation|8|8.0|||
3729871|NCT02061358|3566984|B8|||Age||years|Mean|27|27.0|Standard Deviation|8|8.0|||
3729872|NCT02061358|3566985|B7|||Age||years|Mean|25|25.0|Standard Deviation|9|9.0|||
3729873|NCT02061358|3566986|B6|||Age||years|Mean|29|29.0|Standard Deviation|9|9.0|||
3729874|NCT02061358|3566987|B5|||Age||years|Mean|28|28.0|Standard Deviation|9|9.0|||
3729875|NCT02061358|3566988|B4|||Age||years|Mean|28|28.0|Standard Deviation|9|9.0|||
3729876|NCT02061358|3566989|B3|||Age||years|Mean|27|27.0|Standard Deviation|4|4.0|||
3729877|NCT02061358|3566990|B2|||Age||years|Mean|27|27.0|Standard Deviation|8|8.0|||
3729878|NCT02061358|3566991|B1|||Age||years|Mean|25|25.0|Standard Deviation|5|5.0|||
3729879|NCT02061280|3567135|B3|||Unscheduled Health Care Visit in Past 12 Months||Participants|Count of Participants|32|32.0||||||
3729880|NCT02061280|3567136|B2|||Unscheduled Health Care Visit in Past 12 Months||Participants|Count of Participants|9|9.0||||||
3729881|NCT02061280|3567137|B1|||Unscheduled Health Care Visit in Past 12 Months||Participants|Count of Participants|23|23.0||||||
3729882|NCT02061280|3567135|B3|United States||Region of Enrollment||participants|Number|79|79.0||||||
3729883|NCT02061280|3567136|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3729884|NCT02061280|3567137|B1|United States||Region of Enrollment||participants|Number|54|54.0||||||
3729885|NCT02061280|3567135|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729886|NCT02061280|3567136|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729887|NCT02061280|3567137|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729888|NCT02061280|3567135|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3729889|NCT02061280|3567136|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729890|NCT02061280|3567137|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3729891|NCT02061280|3567135|B3||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3729892|NCT02061280|3567136|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3729893|NCT02061280|3567137|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3729894|NCT02061280|3567135|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3729895|NCT02061280|3567136|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3729896|NCT02061280|3567137|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3729897|NCT02061280|3567135|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729898|NCT02061280|3567136|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729899|NCT02061280|3567137|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729900|NCT02061280|3567135|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3729901|NCT02061280|3567136|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729902|NCT02061280|3567137|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3729903|NCT02061280|3567135|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3729904|NCT02061280|3567136|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729905|NCT02061280|3567137|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3729906|NCT02061280|3567135|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729907|NCT02061280|3567136|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729908|NCT02061280|3567137|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729909|NCT02061280|3567135|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3729910|NCT02061280|3567136|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3729911|NCT02061280|3567137|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3729912|NCT02061280|3567135|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3729913|NCT02061280|3567136|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3729914|NCT02061280|3567137|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3729915|NCT02061280|3567135|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3729916|NCT02061280|3567136|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3729917|NCT02061280|3567137|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3729918|NCT02061280|3567135|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3729919|NCT02061280|3567136|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3729920|NCT02061280|3567137|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3729921|NCT02061280|3567135|B3|||Age||years|Median|14|14.0|Inter-Quartile Range|||13.0|15.0|
3729922|NCT02061280|3567136|B2|||Age||years|Median|15|15.0|Inter-Quartile Range|||13.0|16.0|
3729923|NCT02061280|3567137|B1|||Age||years|Median|14|14.0|Inter-Quartile Range|||13.0|15.0|
3729924|NCT02060890|3567168|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3729925|NCT02060890|3567168|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729926|NCT02060890|3567168|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3729927|NCT02060890|3567168|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729928|NCT02060890|3567168|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729929|NCT02060890|3567168|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729930|NCT02060890|3567168|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3729931|NCT02060890|3567168|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3729932|NCT02060890|3567168|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3729933|NCT02060890|3567168|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3729934|NCT02060890|3567168|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3729935|NCT02060890|3567168|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3729936|NCT02060890|3567168|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3729937|NCT02060890|3567168|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3729938|NCT02060890|3567168|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3729939|NCT02060838|3567175|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3729940|NCT02060838|3567176|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3729941|NCT02060838|3567177|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3729942|NCT02060838|3567175|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3729943|NCT02060838|3567176|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3729944|NCT02060838|3567177|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3729945|NCT02060838|3567175|B3|||Age||years|Median|8.3|8.3|Inter-Quartile Range|||3.1|15.4|
3729946|NCT02060838|3567176|B2|||Age||years|Median|3.0|3.0|Inter-Quartile Range|||1.0|5.7|
3729947|NCT02060838|3567177|B1|||Age||years|Median|14.6|14.6|Inter-Quartile Range|||11.0|20.8|
3729948|NCT02060838|3567175|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3729949|NCT02060838|3567176|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3729950|NCT02060838|3567177|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3729951|NCT02060838|3567175|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3729952|NCT02060838|3567176|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3729953|NCT02060838|3567177|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3729954|NCT02060838|3567175|B3||<=18 years|Age||Participants|Count of Participants|41|41.0||||||
3729955|NCT02060838|3567176|B2||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
3729956|NCT02060838|3567177|B1||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
3729957|NCT02060539|3567186|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3729958|NCT02060539|3567186|B1|Canada||Region of Enrollment||participants|Number|4|4.0||||||
3729959|NCT02060539|3567186|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3729960|NCT02060539|3567186|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3729961|NCT02060539|3567186|B1|||Age||years|Mean|43|43.0|Standard Deviation|17|17.0|||
3729962|NCT02060526|3567231|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3729963|NCT02060526|3567232|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3729964|NCT02060526|3567233|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3729965|NCT02060526|3567234|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3729966|NCT02060526|3567231|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3729967|NCT02060526|3567232|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3729968|NCT02060526|3567233|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3729969|NCT02060526|3567234|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3729970|NCT02060526|3567231|B4|||Age||months|Mean|31.87|31.87|Standard Deviation|9.287|9.287|||
3729971|NCT02060526|3567232|B3|||Age||months|Mean|33.53|33.53|Standard Deviation|9.336|9.336|||
3729972|NCT02060526|3567233|B2|||Age||months|Mean|29.64|29.64|Standard Deviation|9.989|9.989|||
3729973|NCT02060526|3567234|B1|||Age||months|Mean|32.42|32.42|Standard Deviation|9.548|9.548|||
3729974|NCT02060461|3567272|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3729975|NCT02060461|3567272|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3729976|NCT02060461|3567272|B1|||Age||years|Mean|30.5|30.5|Standard Deviation|4|4.0|||
3729977|NCT02060058|3567278|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3729978|NCT02060058|3567279|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3729979|NCT02060058|3567281|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3729980|NCT02060058|3567278|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3729981|NCT02060058|3567279|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3729982|NCT02060058|3567281|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3729983|NCT02060058|3567278|B4|||Age||years|Mean|48.0|48.0|Standard Deviation|11.7|11.7|||
3729984|NCT02060058|3567279|B3|||Age||years|Mean|50.6|50.6|Standard Deviation|9.2|9.2|||
3729985|NCT02060058|3567281|B1|||Age||years|Mean|42.9|42.9|Standard Deviation|16.0|16.0|||
3729986|NCT02059993|3567297|B3|diastolic BP||morning systolic and diastolic BP (mmHg)|The morning BP was measured with a mercury sphygmomanometer by an experienced physician unaware of the patient's group assignment,which was the main end point.|mm Hg|Mean|83|83.0|Standard Deviation|7|7.0|||
3729987|NCT02059993|3567298|B2|diastolic BP||morning systolic and diastolic BP (mmHg)|The morning BP was measured with a mercury sphygmomanometer by an experienced physician unaware of the patient's group assignment,which was the main end point.|mm Hg|Mean|83|83.0|Standard Deviation|8|8.0|||
3729988|NCT02059993|3567299|B1|diastolic BP||morning systolic and diastolic BP (mmHg)|The morning BP was measured with a mercury sphygmomanometer by an experienced physician unaware of the patient's group assignment,which was the main end point.|mm Hg|Mean|83|83.0|Standard Deviation|7|7.0|||
3729989|NCT02059993|3567297|B3|systolic BP||morning systolic and diastolic BP (mmHg)|The morning BP was measured with a mercury sphygmomanometer by an experienced physician unaware of the patient's group assignment,which was the main end point.|mm Hg|Mean|147|147.0|Standard Deviation|9|9.0|||
3729990|NCT02059993|3567298|B2|systolic BP||morning systolic and diastolic BP (mmHg)|The morning BP was measured with a mercury sphygmomanometer by an experienced physician unaware of the patient's group assignment,which was the main end point.|mm Hg|Mean|148|148.0|Standard Deviation|11|11.0|||
3729991|NCT02059993|3567299|B1|systolic BP||morning systolic and diastolic BP (mmHg)|The morning BP was measured with a mercury sphygmomanometer by an experienced physician unaware of the patient's group assignment,which was the main end point.|mm Hg|Mean|146|146.0|Standard Deviation|8|8.0|||
3729992|NCT02059993|3567297|B3|China||Region of Enrollment||participants|Number|83|83.0||||||
3729993|NCT02059993|3567298|B2|China||Region of Enrollment||participants|Number|41|41.0||||||
3729994|NCT02059993|3567299|B1|China||Region of Enrollment||participants|Number|42|42.0||||||
3729995|NCT02059993|3567297|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3729996|NCT02059993|3567298|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3729997|NCT02059993|3567299|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3729998|NCT02059993|3567297|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3729999|NCT02059993|3567298|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3730000|NCT02059993|3567299|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3730001|NCT02059993|3567297|B3|||Age||years|Mean|62.4|62.4|Standard Deviation|6.6|6.6|||
3730002|NCT02059993|3567298|B2|||Age||years|Mean|62.7|62.7|Standard Deviation|6.7|6.7|||
3730003|NCT02059993|3567299|B1|||Age||years|Mean|62.0|62.0|Standard Deviation|6.8|6.8|||
3730004|NCT02059980|3567306|B3|||Obsessive-Compulsive Inventory-Revised|The Obsessive-Compulsive Inventory-Revised (OCI-R) is a widely used self-report measure for assessing symptoms of OCD. The possible range of the total scores is 0 ~ 72. The table reports the total scores on the OCI-R, with higher scores indicating a greater level of OCD symptom severity.|units on a scale|Mean|20.15|20.15|Standard Deviation|14.91|14.91|||
3730005|NCT02059980|3567307|B2|||Obsessive-Compulsive Inventory-Revised|The Obsessive-Compulsive Inventory-Revised (OCI-R) is a widely used self-report measure for assessing symptoms of OCD. The possible range of the total scores is 0 ~ 72. The table reports the total scores on the OCI-R, with higher scores indicating a greater level of OCD symptom severity.|units on a scale|Mean|19.60|19.6|Standard Deviation|12.57|12.57|||
3730006|NCT02059980|3567308|B1|||Obsessive-Compulsive Inventory-Revised|The Obsessive-Compulsive Inventory-Revised (OCI-R) is a widely used self-report measure for assessing symptoms of OCD. The possible range of the total scores is 0 ~ 72. The table reports the total scores on the OCI-R, with higher scores indicating a greater level of OCD symptom severity.|units on a scale|Mean|20.61|20.61|Standard Deviation|16.96|16.96|||
3730007|NCT02059980|3567306|B3|||Depression Anxiety and Stress - 21|The Depression Anxiety and Stress - 21 (DASS21) is a widely used questionnaire for assessment general emotional distress, including depression, anxiety, and stress symptoms. We examined the total score on the measure (range: 0 ~ 63), with the higher scores indicating a greater level of emotional distress.|units on a scale|Mean|28.55|28.55|Standard Deviation|20.88|20.88|||
3730008|NCT02059980|3567307|B2|||Depression Anxiety and Stress - 21|The Depression Anxiety and Stress - 21 (DASS21) is a widely used questionnaire for assessment general emotional distress, including depression, anxiety, and stress symptoms. We examined the total score on the measure (range: 0 ~ 63), with the higher scores indicating a greater level of emotional distress.|units on a scale|Mean|29.73|29.73|Standard Deviation|17.00|17.0|||
3730009|NCT02059980|3567308|B1|||Depression Anxiety and Stress - 21|The Depression Anxiety and Stress - 21 (DASS21) is a widely used questionnaire for assessment general emotional distress, including depression, anxiety, and stress symptoms. We examined the total score on the measure (range: 0 ~ 63), with the higher scores indicating a greater level of emotional distress.|units on a scale|Mean|27.56|27.56|Standard Deviation|24.08|24.08|||
3730010|NCT02059980|3567306|B3|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3730011|NCT02059980|3567307|B2|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3730012|NCT02059980|3567308|B1|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3730013|NCT02059980|3567306|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3730014|NCT02059980|3567307|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3730015|NCT02059980|3567308|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730016|NCT02059980|3567306|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730017|NCT02059980|3567307|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730018|NCT02059980|3567308|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730019|NCT02059980|3567306|B3||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3730020|NCT02059980|3567307|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3730021|NCT02059980|3567308|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3730022|NCT02059980|3567306|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3730023|NCT02059980|3567307|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730024|NCT02059980|3567308|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3730025|NCT02059980|3567306|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730026|NCT02059980|3567307|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730027|NCT02059980|3567308|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730028|NCT02059980|3567306|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730029|NCT02059980|3567307|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730030|NCT02059980|3567308|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730031|NCT02059980|3567306|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730032|NCT02059980|3567307|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730033|NCT02059980|3567308|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730034|NCT02059980|3567306|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730035|NCT02059980|3567307|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730036|NCT02059980|3567308|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730037|NCT02059980|3567306|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3730038|NCT02059980|3567307|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3730039|NCT02059980|3567308|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3730040|NCT02059980|3567306|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3730041|NCT02059980|3567307|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3730042|NCT02059980|3567308|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730043|NCT02059980|3567306|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3730044|NCT02059980|3567307|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3730045|NCT02059980|3567308|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3730046|NCT02059980|3567306|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3730047|NCT02059980|3567307|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3730048|NCT02059980|3567308|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3730049|NCT02059980|3567306|B3|||Age||years|Mean|28.67|28.67|Standard Deviation|10.24|10.24|||
3730050|NCT02059980|3567307|B2|||Age||years|Mean|24.47|24.47|Standard Deviation|5.48|5.48|||
3730051|NCT02059980|3567308|B1|||Age||years|Mean|32.17|32.17|Standard Deviation|12.01|12.01|||
3730052|NCT02059928|3567321|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3730053|NCT02059928|3567321|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3730054|NCT02059928|3567321|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3730055|NCT02059928|3567321|B1|||Age||years|Mean|60|60.0|Full Range|||45.0|81.0|
3730056|NCT02059902|3567325|B3|||Total Burn Surface Area||total percentage of body area burned|Mean|14.48|14.48|Full Range|||1.0|68.0|
3730057|NCT02059902|3567326|B2|||Total Burn Surface Area||total percentage of body area burned|Mean|11.18|11.18|Full Range|||1.0|48.39|
3730058|NCT02059902|3567327|B1|||Total Burn Surface Area||total percentage of body area burned|Mean|17.77|17.77|Full Range|||1.0|68.0|
3730059|NCT02059902|3567325|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
3730060|NCT02059902|3567326|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3730061|NCT02059902|3567327|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3730062|NCT02059902|3567325|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730063|NCT02059902|3567326|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730064|NCT02059902|3567327|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730065|NCT02059902|3567325|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3730066|NCT02059902|3567326|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3730067|NCT02059902|3567327|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3730068|NCT02059902|3567325|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3730069|NCT02059902|3567326|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3730070|NCT02059902|3567327|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730071|NCT02059902|3567325|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3730072|NCT02059902|3567326|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3730073|NCT02059902|3567327|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3730074|NCT02059902|3567325|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3730075|NCT02059902|3567326|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3730076|NCT02059902|3567327|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3730077|NCT02059902|3567325|B3|||Age||years|Mean|39.48|39.48|Full Range|||19.0|69.0|
3730078|NCT02059902|3567326|B2|||Age||years|Mean|35.7|35.7|Full Range|||19.0|58.0|
3730079|NCT02059902|3567327|B1|||Age||years|Mean|43.5|43.5|Full Range|||29.0|69.0|
3730080|NCT02059642|3567334|B3|||BMI||"kg/m^2"|Mean|28.295|28.295|Standard Deviation|6.3393|6.3393|||
3730081|NCT02059642|3567335|B2|||BMI||"kg/m^2"|Mean|28.345|28.345|Standard Deviation|27.230|27.23|||
3730082|NCT02059642|3567336|B1|||BMI||"kg/m^2"|Mean|28.243|28.243|Standard Deviation|6.3923|6.3923|||
3730083|NCT02059642|3567334|B3|Israel||Region of Enrollment||participants|Number|85|85.0||||||
3730084|NCT02059642|3567335|B2|Israel||Region of Enrollment||participants|Number|44|44.0||||||
3730085|NCT02059642|3567336|B1|Israel||Region of Enrollment||participants|Number|41|41.0||||||
3730086|NCT02059642|3567334|B3|United States||Region of Enrollment||participants|Number|213|213.0||||||
3730087|NCT02059642|3567335|B2|United States||Region of Enrollment||participants|Number|108|108.0||||||
3730088|NCT02059642|3567336|B1|United States||Region of Enrollment||participants|Number|105|105.0||||||
3730089|NCT02059642|3567334|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3730090|NCT02059642|3567335|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3730091|NCT02059642|3567336|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3730092|NCT02059642|3567334|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3730093|NCT02059642|3567335|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730094|NCT02059642|3567336|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3730095|NCT02059642|3567334|B3||White|Race (NIH/OMB)||Participants|Count of Participants|258|258.0||||||
3730096|NCT02059642|3567335|B2||White|Race (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
3730097|NCT02059642|3567336|B1||White|Race (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
3730098|NCT02059642|3567334|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3730099|NCT02059642|3567335|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3730100|NCT02059642|3567336|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3730101|NCT02059642|3567334|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730102|NCT02059642|3567335|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730103|NCT02059642|3567336|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730104|NCT02059642|3567334|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3730105|NCT02059642|3567335|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3730106|NCT02059642|3567336|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730107|NCT02059642|3567334|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730108|NCT02059642|3567335|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730109|NCT02059642|3567336|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730110|NCT02059642|3567334|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3730111|NCT02059642|3567335|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3730112|NCT02059642|3567336|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730113|NCT02059642|3567334|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|272|272.0||||||
3730114|NCT02059642|3567335|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|141|141.0||||||
3730115|NCT02059642|3567336|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
3730116|NCT02059642|3567334|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3730117|NCT02059642|3567335|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3730118|NCT02059642|3567336|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3730119|NCT02059642|3567334|B3||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3730120|NCT02059642|3567335|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3730121|NCT02059642|3567336|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3730122|NCT02059642|3567334|B3||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3730123|NCT02059642|3567335|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3730124|NCT02059642|3567336|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3730125|NCT02059642|3567334|B3|||Age||years|Mean|35.4|35.4|Standard Deviation|10.16|10.16|||
3730126|NCT02059642|3567335|B2|||Age||years|Mean|35.1|35.1|Standard Deviation|9.93|9.93|||
3730127|NCT02059642|3567336|B1|||Age||years|Mean|35.6|35.6|Standard Deviation|10.42|10.42|||
3730128|NCT02059642|3567334|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3730129|NCT02059642|3567335|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3730130|NCT02059642|3567336|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3730131|NCT02059642|3567334|B3||Between 18 and 65 years|Age||Participants|Count of Participants|298|298.0||||||
3730132|NCT02059642|3567335|B2||Between 18 and 65 years|Age||Participants|Count of Participants|152|152.0||||||
3730133|NCT02059642|3567336|B1||Between 18 and 65 years|Age||Participants|Count of Participants|146|146.0||||||
3730134|NCT02059642|3567334|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3730135|NCT02059642|3567335|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3730136|NCT02059642|3567336|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3730137|NCT02059395|3567345|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3730138|NCT02059395|3567345|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3730139|NCT02059395|3567346|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3730140|NCT02059395|3567347|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3730141|NCT02059395|3567345|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3730142|NCT02059395|3567346|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3730143|NCT02059395|3567347|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3730144|NCT02059395|3567345|B3|||Age||years|Mean|19.7|19.7|Inter-Quartile Range|||18.5|21.0|
3730145|NCT02059395|3567346|B2|||Age||years|Mean|20.0|20.0|Inter-Quartile Range|||18.75|21.0|
3730146|NCT02059395|3567347|B1|||Age||years|Mean|19.5|19.5|Inter-Quartile Range|||18.0|21.0|
3730147|NCT02059291|3567354|B10||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3730148|NCT02059291|3567355|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3730149|NCT02059291|3567356|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730150|NCT02059291|3567357|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730151|NCT02059291|3567358|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3730152|NCT02059291|3567359|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730153|NCT02059291|3567360|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3730154|NCT02059291|3567361|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3730155|NCT02059291|3567362|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3730156|NCT02059291|3567363|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3730157|NCT02059291|3567354|B10||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730158|NCT02059291|3567355|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730159|NCT02059291|3567356|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730160|NCT02059291|3567357|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730161|NCT02059291|3567358|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730162|NCT02059291|3567359|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730163|NCT02059291|3567360|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730164|NCT02059291|3567361|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730165|NCT02059291|3567362|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730166|NCT02059291|3567363|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730167|NCT02059291|3567354|B10||White|Race (NIH/OMB)||Participants|Count of Participants|174|174.0||||||
3730168|NCT02059291|3567355|B9||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3730169|NCT02059291|3567356|B8||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3730170|NCT02059291|3567357|B7||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730171|NCT02059291|3567358|B6||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3730172|NCT02059291|3567359|B5||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3730173|NCT02059291|3567360|B4||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3730174|NCT02059291|3567361|B3||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3730175|NCT02059291|3567362|B2||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3730176|NCT02059291|3567363|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3730177|NCT02059291|3567354|B10||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730178|NCT02059291|3567355|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730179|NCT02059291|3567356|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730180|NCT02059291|3567357|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730181|NCT02059291|3567358|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730182|NCT02059291|3567359|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730183|NCT02059291|3567360|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730184|NCT02059291|3567361|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730185|NCT02059291|3567362|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730186|NCT02059291|3567363|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730187|NCT02059291|3567354|B10||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730188|NCT02059291|3567355|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730189|NCT02059291|3567356|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730190|NCT02059291|3567357|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730191|NCT02059291|3567358|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730192|NCT02059291|3567359|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730193|NCT02059291|3567360|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730194|NCT02059291|3567361|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730195|NCT02059291|3567362|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730196|NCT02059291|3567363|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730197|NCT02059291|3567354|B10||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3730198|NCT02059291|3567355|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730199|NCT02059291|3567356|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3730200|NCT02059291|3567357|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3730201|NCT02059291|3567358|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3730202|NCT02059291|3567359|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3730203|NCT02059291|3567360|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3730204|NCT02059291|3567361|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730205|NCT02059291|3567362|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3730206|NCT02059291|3567363|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730207|NCT02059291|3567354|B10||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730208|NCT02059291|3567355|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730209|NCT02059291|3567356|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730210|NCT02059291|3567357|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730211|NCT02059291|3567358|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730212|NCT02059291|3567359|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730213|NCT02059291|3567360|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730214|NCT02059291|3567361|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730215|NCT02059291|3567362|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730216|NCT02059291|3567363|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730217|NCT02059291|3567354|B10||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3730218|NCT02059291|3567355|B9||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3730219|NCT02059291|3567356|B8||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3730220|NCT02059291|3567357|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3730221|NCT02059291|3567358|B6||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3730222|NCT02059291|3567359|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3730223|NCT02059291|3567360|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3730224|NCT02059291|3567361|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3730225|NCT02059291|3567362|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3730226|NCT02059291|3567363|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3730227|NCT02059291|3567354|B10||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3730228|NCT02059291|3567355|B9||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3730229|NCT02059291|3567356|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3730230|NCT02059291|3567357|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3730231|NCT02059291|3567358|B6||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3730232|NCT02059291|3567359|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3730233|NCT02059291|3567360|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3730234|NCT02059291|3567361|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3730235|NCT02059291|3567362|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3730236|NCT02059291|3567363|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3730237|NCT02059291|3567354|B10|roll-over TRAPS - non-randomized||Age||Years|Median|42.5|42.5|Full Range|||15.0|81.0|
3730238|NCT02059291|3567355|B9|roll-over TRAPS - non-randomized||Age||Years|Median|42.5|42.5|Full Range|||15.0|81.0|
3730239|NCT02059291|3567356|B8|roll-over TRAPS - non-randomized||Age||Years|Median|NA||Full Range|||0.0|0.0|This row reflects roll-over TRAPS non-randomized data only.
3730240|NCT02059291|3567357|B7|roll-over TRAPS - non-randomized||Age||Years|Median|NA||Full Range|||0.0|0.0|This row reflects roll-over TRAPS non-randomized data only.
3730287|NCT02059291|3567354|B10|crFMF cohort - randomized||Age||Years|Median|18|18.0|Full Range|14.10|14.1|2.0|69.0|
3730241|NCT02059291|3567358|B6|roll-over TRAPS - non-randomized||Age||Years|Median|NA||Full Range|||0.0|0.0|This row reflects roll-over TRAPS non-randomized data only.
3730242|NCT02059291|3567359|B5|roll-over TRAPS - non-randomized||Age||Years|Median|NA||Full Range|||0.0|0.0|This row reflects roll-over TRAPS non-randomized data only.
3730243|NCT02059291|3567360|B4|roll-over TRAPS - non-randomized||Age||Years|Median|NA||Full Range|||0.0|0.0|This row reflects roll-over TRAPS non-randomized data only.
3730244|NCT02059291|3567361|B3|roll-over TRAPS - non-randomized||Age||Years|Median|NA||Full Range|||0.0|0.0|This row reflects roll-over TRAPS non-randomized data only.
3730245|NCT02059291|3567362|B2|roll-over TRAPS - non-randomized||Age||Years|Median|NA||Full Range|||0.0|0.0|This row reflects roll-over TRAPS non-randomized data only.
3730246|NCT02059291|3567363|B1|roll-over TRAPS - non-randomized||Age||Years|Median|NA||Full Range|||0.0|0.0|This row reflects roll-over TRAPS non-randomized data only.
3730247|NCT02059291|3567354|B10|HIDS/MKD - non-randomized||Age||Years|Median|1.0|1.0|Full Range|||1.0|1.0|
3730248|NCT02059291|3567355|B9|HIDS/MKD - non-randomized||Age||Years|Median|NA||Full Range|||0.0|0.0|This row reflects HIDS/MIK non-randomized data only.
3730249|NCT02059291|3567356|B8|HIDS/MKD - non-randomized||Age||Years|Median|1.0|1.0|Full Range|||1.0|1.0|
3730250|NCT02059291|3567357|B7|HIDS/MKD - non-randomized||Age||Years|Median|NA||Full Range|||0.0|0.0|This row reflects HIDS/MIK non-randomized data only.
3730251|NCT02059291|3567358|B6|HIDS/MKD - non-randomized||Age||Years|Median|NA||Full Range|||0.0|0.0|This row reflects HIDS/MIK non-randomized data only.
3730252|NCT02059291|3567359|B5|HIDS/MKD - non-randomized||Age||Years|Median|NA||Full Range|||0.0|0.0|This row reflects HIDS/MIK non-randomized data only.
3730253|NCT02059291|3567360|B4|HIDS/MKD - non-randomized||Age||Years|Median|NA||Full Range|||0.0|0.0|This row reflects HIDS/MIK non-randomized data only.
3730254|NCT02059291|3567361|B3|HIDS/MKD - non-randomized||Age||Years|Median|NA||Full Range|||0.0|0.0|This row reflects HIDS/MIK non-randomized data only.
3730255|NCT02059291|3567362|B2|HIDS/MKD - non-randomized||Age||Years|Median|NA||Full Range|||0.0|0.0|This row reflects HIDS/MIK non-randomized data only.
3730256|NCT02059291|3567363|B1|HIDS/MKD - non-randomized||Age||Years|Median|NA||Full Range|||0.0|0.0|This row reflects HIDS/MIK non-randomized data only.
3730257|NCT02059291|3567354|B10|crFMF - non-randomized||Age||Years|Median|24.5|24.5|Full Range|||20.0|29.0|
3730258|NCT02059291|3567355|B9|crFMF - non-randomized||Age||Years|Median|NA||Full Range|||0.0|0.0|This row reflects crFMF non-randomized data only.
3730259|NCT02059291|3567356|B8|crFMF - non-randomized||Age||Years|Median|NA||Full Range|||0.0|0.0|This row reflects crFMF non-randomized data only.
3730260|NCT02059291|3567357|B7|crFMF - non-randomized||Age||Years|Median|24.5|24.5|Full Range|||20.0|29.0|
3730261|NCT02059291|3567358|B6|crFMF - non-randomized||Age||Years|Median|NA||Full Range|||0.0|0.0|This row reflects crFMF non-randomized data only.
3730262|NCT02059291|3567359|B5|crFMF - non-randomized||Age||Years|Median|NA||Full Range|||0.0|0.0|This row reflects crFMF non-randomized data only.
3730263|NCT02059291|3567360|B4|crFMF - non-randomized||Age||Years|Median|NA||Full Range|||0.0|0.0|This row reflects crFMF non-randomized data only.
3730264|NCT02059291|3567361|B3|crFMF - non-randomized||Age||Years|Median|NA||Full Range|||0.0|0.0|This row reflects crFMF non-randomized data only.
3730265|NCT02059291|3567362|B2|crFMF - non-randomized||Age||Years|Median|NA||Full Range|||0.0|0.0|This row reflects crFMF non-randomized data only.
3730266|NCT02059291|3567363|B1|crFMF - non-randomized||Age||Years|Median|NA||Full Range|||0.0|0.0|This row reflects crFMF non-randomized data only.
3730267|NCT02059291|3567354|B10|TRAPS cohort - randomized||Age||Years|Median|15.5|15.5|Full Range|18.55|18.55|2.0|76.0|
3730268|NCT02059291|3567355|B9|TRAPS cohort - randomized||Age||Years|Median|NA||Full Range|||0.0|0.0|This row reflect TRAPS cohort - randomized data only.
3730269|NCT02059291|3567356|B8|TRAPS cohort - randomized||Age||Years|Median|NA||Full Range|||0.0|0.0|This row reflect TRAPS cohort - randomized data only.
3730270|NCT02059291|3567357|B7|TRAPS cohort - randomized||Age||Years|Median|NA||Full Range|||0.0|0.0|This row reflect TRAPS cohort - randomized data only.
3730271|NCT02059291|3567358|B6|TRAPS cohort - randomized||Age||Years|Median|16.5|16.5|Full Range|18.25|18.25|2.0|57.0|
3730272|NCT02059291|3567359|B5|TRAPS cohort - randomized||Age||Years|Median|13.5|13.5|Full Range|19.22|19.22|3.0|76.0|
3730273|NCT02059291|3567360|B4|TRAPS cohort - randomized||Age||Years|Median|NA||Full Range|NA||0.0|0.0|This row reflect TRAPS cohort - randomized data only.
3730274|NCT02059291|3567361|B3|TRAPS cohort - randomized||Age||Years|Median|NA||Full Range|NA||0.0|0.0|This row reflect TRAPS cohort - randomized data only.
3730275|NCT02059291|3567362|B2|TRAPS cohort - randomized||Age||Years|Median|NA||Full Range|NA||0.0|0.0|This row reflect TRAPS cohort - randomized data only.
3730276|NCT02059291|3567363|B1|TRAPS cohort - randomized||Age||Years|Median|NA||Full Range|NA||0.0|0.0|This row reflect TRAPS cohort - randomized data only.
3730277|NCT02059291|3567354|B10|HIDS/MKD cohort - randomized||Age||Years|Median|11.0|11.0|Full Range|10.08|10.08|2.0|47.0|
3730278|NCT02059291|3567355|B9|HIDS/MKD cohort - randomized||Age||Years|Median|NA||Full Range|||0.0|0.0|This row reflect HIDS/MKD cohort - randomized data only.
3730279|NCT02059291|3567356|B8|HIDS/MKD cohort - randomized||Age||Years|Median|NA||Full Range|||0.0|0.0|This row reflect HIDS/MKD cohort - randomized data only.
3730280|NCT02059291|3567357|B7|HIDS/MKD cohort - randomized||Age||Years|Median|NA||Full Range|||0.0|0.0|This row reflect HIDS/MKD cohort - randomized data only.
3730281|NCT02059291|3567358|B6|HIDS/MKD cohort - randomized||Age||Years|Median|NA||Full Range|NA||0.0|0.0|This row reflect HIDS/MKD cohort - randomized data only.
3730282|NCT02059291|3567359|B5|HIDS/MKD cohort - randomized||Age||Years|Median|NA||Full Range|NA||0.0|0.0|This row reflect HIDS/MKD cohort - randomized data only.
3730283|NCT02059291|3567360|B4|HIDS/MKD cohort - randomized||Age||Years|Median|9.0|9.0|Full Range|11.64|11.64|3.0|47.0|
3730284|NCT02059291|3567361|B3|HIDS/MKD cohort - randomized||Age||Years|Median|12.0|12.0|Full Range|8.49|8.49|2.0|43.0|
3730285|NCT02059291|3567362|B2|HIDS/MKD cohort - randomized||Age||Years|Median|NA||Full Range|NA||0.0|0.0|This row reflect HIDS/MKD cohort - randomized data only.
3730286|NCT02059291|3567363|B1|HIDS/MKD cohort - randomized||Age||Years|Median|NA||Full Range|NA||0.0|0.0|This row reflect HIDS/MKD cohort - randomized data only.
3730288|NCT02059291|3567355|B9|crFMF cohort - randomized||Age||Years|Median|NA||Full Range|||0.0|0.0|This row reflects crFMF cohort - randomized data only.
3730289|NCT02059291|3567356|B8|crFMF cohort - randomized||Age||Years|Median|NA||Full Range|||0.0|0.0|This row reflects crFMF cohort - randomized data only.
3730290|NCT02059291|3567357|B7|crFMF cohort - randomized||Age||Years|Median|NA||Full Range|||0.0|0.0|This row reflects crFMF cohort - randomized data only.
3730291|NCT02059291|3567358|B6|crFMF cohort - randomized||Age||Years|Median|NA||Full Range|NA||0.0|0.0|This row reflects crFMF cohort - randomized data only.
3730292|NCT02059291|3567359|B5|crFMF cohort - randomized||Age||Years|Median|NA||Full Range|NA||0.0|0.0|This row reflects crFMF cohort - randomized data only.
3730293|NCT02059291|3567360|B4|crFMF cohort - randomized||Age||Years|Median|NA||Full Range|NA||0.0|0.0|This row reflects crFMF cohort - randomized data only.
3730294|NCT02059291|3567361|B3|crFMF cohort - randomized||Age||Years|Median|NA||Full Range|NA||0.0|0.0|This row reflects crFMF cohort - randomized data only.
3730295|NCT02059291|3567362|B2|crFMF cohort - randomized||Age||Years|Median|18.0|18.0|Full Range|13.38|13.38|4.0|69.0|
3730296|NCT02059291|3567363|B1|crFMF cohort - randomized||Age||Years|Median|18.0|18.0|Full Range|15.02|15.02|2.0|60.0|
3730297|NCT02059278|3567439|B3||Schaffer Angle Grade IV|Shaffer angle by gonioscopy, fellow eye|Shaffer Angle is a measure of the anterior chamber angle based on a scale from 0 (closed) to IV (wide open). Shaffer Angles Grade III and IV are considered to be angles where closure is not possible and normal drainage can occur to reduce intraocular pressure.|Participants|Count of Participants|167|167.0||||||
3730298|NCT02059278|3567440|B2||Schaffer Angle Grade IV|Shaffer angle by gonioscopy, fellow eye|Shaffer Angle is a measure of the anterior chamber angle based on a scale from 0 (closed) to IV (wide open). Shaffer Angles Grade III and IV are considered to be angles where closure is not possible and normal drainage can occur to reduce intraocular pressure.|Participants|Count of Participants|86|86.0||||||
3730299|NCT02059278|3567441|B1||Schaffer Angle Grade IV|Shaffer angle by gonioscopy, fellow eye|Shaffer Angle is a measure of the anterior chamber angle based on a scale from 0 (closed) to IV (wide open). Shaffer Angles Grade III and IV are considered to be angles where closure is not possible and normal drainage can occur to reduce intraocular pressure.|Participants|Count of Participants|81|81.0||||||
3730300|NCT02059278|3567439|B3||Schaffer Angle Grade III|Shaffer angle by gonioscopy, fellow eye|Shaffer Angle is a measure of the anterior chamber angle based on a scale from 0 (closed) to IV (wide open). Shaffer Angles Grade III and IV are considered to be angles where closure is not possible and normal drainage can occur to reduce intraocular pressure.|Participants|Count of Participants|167|167.0||||||
3730301|NCT02059278|3567440|B2||Schaffer Angle Grade III|Shaffer angle by gonioscopy, fellow eye|Shaffer Angle is a measure of the anterior chamber angle based on a scale from 0 (closed) to IV (wide open). Shaffer Angles Grade III and IV are considered to be angles where closure is not possible and normal drainage can occur to reduce intraocular pressure.|Participants|Count of Participants|84|84.0||||||
3730302|NCT02059278|3567441|B1||Schaffer Angle Grade III|Shaffer angle by gonioscopy, fellow eye|Shaffer Angle is a measure of the anterior chamber angle based on a scale from 0 (closed) to IV (wide open). Shaffer Angles Grade III and IV are considered to be angles where closure is not possible and normal drainage can occur to reduce intraocular pressure.|Participants|Count of Participants|83|83.0||||||
3730303|NCT02059278|3567439|B3||Schaffer Angle Grade IV|Shaffer angle by gonioscopy, study eye|Shaffer Angle is a measure of the anterior chamber angle based on a scale from 0 (closed) to IV (wide open). Shaffer Angles Grade III and IV are considered to be angles where closure is not possible and normal drainage can occur to reduce intraocular pressure.|Participants|Count of Participants|167|167.0||||||
3730304|NCT02059278|3567440|B2||Schaffer Angle Grade IV|Shaffer angle by gonioscopy, study eye|Shaffer Angle is a measure of the anterior chamber angle based on a scale from 0 (closed) to IV (wide open). Shaffer Angles Grade III and IV are considered to be angles where closure is not possible and normal drainage can occur to reduce intraocular pressure.|Participants|Count of Participants|86|86.0||||||
3730305|NCT02059278|3567441|B1||Schaffer Angle Grade IV|Shaffer angle by gonioscopy, study eye|Shaffer Angle is a measure of the anterior chamber angle based on a scale from 0 (closed) to IV (wide open). Shaffer Angles Grade III and IV are considered to be angles where closure is not possible and normal drainage can occur to reduce intraocular pressure.|Participants|Count of Participants|81|81.0||||||
3730306|NCT02059278|3567439|B3||Schaffer Angle Grade III|Shaffer angle by gonioscopy, study eye|Shaffer Angle is a measure of the anterior chamber angle based on a scale from 0 (closed) to IV (wide open). Shaffer Angles Grade III and IV are considered to be angles where closure is not possible and normal drainage can occur to reduce intraocular pressure.|Participants|Count of Participants|167|167.0||||||
3730307|NCT02059278|3567440|B2||Schaffer Angle Grade III|Shaffer angle by gonioscopy, study eye|Shaffer Angle is a measure of the anterior chamber angle based on a scale from 0 (closed) to IV (wide open). Shaffer Angles Grade III and IV are considered to be angles where closure is not possible and normal drainage can occur to reduce intraocular pressure.|Participants|Count of Participants|84|84.0||||||
3730308|NCT02059278|3567441|B1||Schaffer Angle Grade III|Shaffer angle by gonioscopy, study eye|Shaffer Angle is a measure of the anterior chamber angle based on a scale from 0 (closed) to IV (wide open). Shaffer Angles Grade III and IV are considered to be angles where closure is not possible and normal drainage can occur to reduce intraocular pressure.|Participants|Count of Participants|83|83.0||||||
3730309|NCT02059278|3567439|B3|||Corneal thickness, fellow eye (μm)||μm|Mean|550.7|550.7|Standard Deviation|33.6|33.6|||
3730310|NCT02059278|3567440|B2|||Corneal thickness, fellow eye (μm)||μm|Mean|549.4|549.4|Standard Deviation|33.6|33.6|||
3730311|NCT02059278|3567441|B1|||Corneal thickness, fellow eye (μm)||μm|Mean|552.1|552.1|Standard Deviation|33.7|33.7|||
3730312|NCT02059278|3567439|B3|||Corneal thickness, study eye (μm)||μm|Mean|549.6|549.6|Standard Deviation|34.2|34.2|||
3730313|NCT02059278|3567440|B2|||Corneal thickness, study eye (μm)||μm|Mean|548.7|548.7|Standard Deviation|34.5|34.5|||
3730314|NCT02059278|3567441|B1|||Corneal thickness, study eye (μm)||μm|Mean|550.7|550.7|Standard Deviation|33.9|33.9|||
3730315|NCT02059278|3567439|B3|United States||Region of Enrollment||participants|Number|334|334.0||||||
3730316|NCT02059278|3567440|B2|United States||Region of Enrollment||participants|Number|170|170.0||||||
3730317|NCT02059278|3567441|B1|United States||Region of Enrollment||participants|Number|164|164.0||||||
3730318|NCT02059278|3567439|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3730319|NCT02059278|3567440|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3730320|NCT02059278|3567441|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3730321|NCT02059278|3567439|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730322|NCT02059278|3567440|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730323|NCT02059278|3567441|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730324|NCT02059278|3567439|B3||White|Race (NIH/OMB)||Participants|Count of Participants|266|266.0||||||
3730325|NCT02059278|3567440|B2||White|Race (NIH/OMB)||Participants|Count of Participants|141|141.0||||||
3730326|NCT02059278|3567441|B1||White|Race (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
3730327|NCT02059278|3567439|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3730328|NCT02059278|3567440|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3730329|NCT02059278|3567441|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3730330|NCT02059278|3567439|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730331|NCT02059278|3567440|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730332|NCT02059278|3567441|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730333|NCT02059278|3567439|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3730334|NCT02059278|3567440|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730335|NCT02059278|3567441|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3730336|NCT02059278|3567439|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730337|NCT02059278|3567440|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730338|NCT02059278|3567441|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730339|NCT02059278|3567439|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730340|NCT02059278|3567440|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730341|NCT02059278|3567441|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730342|NCT02059278|3567439|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|294|294.0||||||
3730343|NCT02059278|3567440|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|148|148.0||||||
3730344|NCT02059278|3567441|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
3730345|NCT02059278|3567439|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3730346|NCT02059278|3567440|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3730347|NCT02059278|3567441|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3730348|NCT02059278|3567439|B3||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3730349|NCT02059278|3567440|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3730350|NCT02059278|3567441|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3730351|NCT02059278|3567439|B3||Female|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
3730352|NCT02059278|3567440|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3730353|NCT02059278|3567441|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3730354|NCT02059278|3567439|B3|||Age||Years|Mean|66.5|66.5|Standard Deviation|10.6|10.6|||
3730355|NCT02059278|3567440|B2|||Age||Years|Mean|66.1|66.1|Standard Deviation|11.0|11.0|||
3730356|NCT02059278|3567441|B1|||Age||Years|Mean|67.1|67.1|Standard Deviation|10.2|10.2|||
3730357|NCT02059187|3567456|B3||Male|Sex: Female, Male||Participants|Count of Participants|293|293.0||||||
3730358|NCT02059187|3567457|B2||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3730359|NCT02059187|3567458|B1||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3730360|NCT02059187|3567456|B3||Female|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
3730361|NCT02059187|3567457|B2||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3730362|NCT02059187|3567458|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3730363|NCT02059187|3567456|B3|||Age||Years|Mean|57.0|57.0|Standard Deviation|9.9|9.9|20.0|80.0|
3730364|NCT02059187|3567457|B2|||Age||Years|Mean|57.1|57.1|Standard Deviation|9.8|9.8|31.0|79.0|
3730365|NCT02059187|3567458|B1|||Age||Years|Mean|56.9|56.9|Standard Deviation|10.0|10.0|20.0|80.0|
3730366|NCT02059174|3567485|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3730367|NCT02059174|3567485|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3730368|NCT02059174|3567485|B1|||Age||Years|Mean|33.4|33.4|Standard Deviation|11.7|11.7|||
3730369|NCT02059161|3567508|B3||Male|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
3730370|NCT02059161|3567509|B2||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3730371|NCT02059161|3567510|B1||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3730372|NCT02059161|3567508|B3||Female|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
3730373|NCT02059161|3567509|B2||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3730374|NCT02059161|3567510|B1||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3730375|NCT02059161|3567508|B3|||Age||Years|Mean|41.7|41.7|Standard Deviation|14.6|14.6|||
3730376|NCT02059161|3567509|B2|||Age||Years|Mean|41.6|41.6|Standard Deviation|14.8|14.8|||
3730377|NCT02059161|3567510|B1|||Age||Years|Mean|41.8|41.8|Standard Deviation|14.5|14.5|||
3730378|NCT02059148|3567571|B1|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3730379|NCT02059148|3567571|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730380|NCT02059148|3567571|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730381|NCT02059148|3567571|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3730382|NCT02059148|3567571|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3730383|NCT02059148|3567571|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730384|NCT02059148|3567571|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730385|NCT02059148|3567571|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3730386|NCT02059148|3567571|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730387|NCT02059148|3567571|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3730388|NCT02059148|3567571|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3730389|NCT02059148|3567571|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3730390|NCT02059148|3567571|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3730391|NCT02059148|3567571|B1|||Age||Years|Mean|53.9|53.9|Standard Deviation|9.5|9.5|||
3730392|NCT02059135|3567593|B3||>5|Parity (number of previous live births)||Participants|Count of Participants|0|0.0||||||
3730393|NCT02059135|3567594|B2||>5|Parity (number of previous live births)||Participants|Count of Participants|0|0.0||||||
3730394|NCT02059135|3567595|B1||>5|Parity (number of previous live births)||Participants|Count of Participants|0|0.0||||||
3730395|NCT02059135|3567593|B3||5|Parity (number of previous live births)||Participants|Count of Participants|1|1.0||||||
3730396|NCT02059135|3567594|B2||5|Parity (number of previous live births)||Participants|Count of Participants|1|1.0||||||
3730397|NCT02059135|3567595|B1||5|Parity (number of previous live births)||Participants|Count of Participants|0|0.0||||||
3730398|NCT02059135|3567593|B3||4|Parity (number of previous live births)||Participants|Count of Participants|7|7.0||||||
3730399|NCT02059135|3567594|B2||4|Parity (number of previous live births)||Participants|Count of Participants|6|6.0||||||
3730400|NCT02059135|3567595|B1||4|Parity (number of previous live births)||Participants|Count of Participants|1|1.0||||||
3730401|NCT02059135|3567593|B3||3|Parity (number of previous live births)||Participants|Count of Participants|8|8.0||||||
3730402|NCT02059135|3567594|B2||3|Parity (number of previous live births)||Participants|Count of Participants|4|4.0||||||
3730403|NCT02059135|3567595|B1||3|Parity (number of previous live births)||Participants|Count of Participants|4|4.0||||||
3730404|NCT02059135|3567593|B3||2|Parity (number of previous live births)||Participants|Count of Participants|17|17.0||||||
3730405|NCT02059135|3567594|B2||2|Parity (number of previous live births)||Participants|Count of Participants|11|11.0||||||
3730406|NCT02059135|3567595|B1||2|Parity (number of previous live births)||Participants|Count of Participants|6|6.0||||||
3730407|NCT02059135|3567593|B3||1|Parity (number of previous live births)||Participants|Count of Participants|34|34.0||||||
3730408|NCT02059135|3567594|B2||1|Parity (number of previous live births)||Participants|Count of Participants|20|20.0||||||
3730409|NCT02059135|3567595|B1||1|Parity (number of previous live births)||Participants|Count of Participants|14|14.0||||||
3730410|NCT02059135|3567593|B3||0|Parity (number of previous live births)||Participants|Count of Participants|53|53.0||||||
3730411|NCT02059135|3567594|B2||0|Parity (number of previous live births)||Participants|Count of Participants|16|16.0||||||
3730412|NCT02059135|3567595|B1||0|Parity (number of previous live births)||Participants|Count of Participants|37|37.0||||||
3730413|NCT02059135|3567593|B3||Superimposed Preeclampsia|Type of Preeclampsia||Participants|Count of Participants|49|49.0||||||
3730414|NCT02059135|3567594|B2||Superimposed Preeclampsia|Type of Preeclampsia||Participants|Count of Participants|26|26.0||||||
3730415|NCT02059135|3567595|B1||Superimposed Preeclampsia|Type of Preeclampsia||Participants|Count of Participants|23|23.0||||||
3730416|NCT02059135|3567593|B3||Preeclampsia|Type of Preeclampsia||Participants|Count of Participants|71|71.0||||||
3730417|NCT02059135|3567594|B2||Preeclampsia|Type of Preeclampsia||Participants|Count of Participants|32|32.0||||||
3730418|NCT02059135|3567595|B1||Preeclampsia|Type of Preeclampsia||Participants|Count of Participants|39|39.0||||||
3730419|NCT02059135|3567593|B3|||Gestational Age at Randomization||weeks|Mean|27.25|27.25|Standard Deviation|2.00|2.0|||
3730420|NCT02059135|3567594|B2|||Gestational Age at Randomization||weeks|Mean|27.34|27.34|Standard Deviation|2.06|2.06|||
3730421|NCT02059135|3567595|B1|||Gestational Age at Randomization||weeks|Mean|27.18|27.18|Standard Deviation|1.96|1.96|||
3730422|NCT02059135|3567593|B3|United States||Region of Enrollment||participants|Number|120|120.0||||||
3730423|NCT02059135|3567594|B2|United States||Region of Enrollment||participants|Number|58|58.0||||||
3730424|NCT02059135|3567595|B1|United States||Region of Enrollment||participants|Number|62|62.0||||||
3730425|NCT02059135|3567593|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3730426|NCT02059135|3567594|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730427|NCT02059135|3567595|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3730428|NCT02059135|3567593|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3730429|NCT02059135|3567594|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730430|NCT02059135|3567595|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3730431|NCT02059135|3567593|B3||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3730432|NCT02059135|3567594|B2||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3730433|NCT02059135|3567595|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3730434|NCT02059135|3567593|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3730435|NCT02059135|3567594|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3730436|NCT02059135|3567595|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3730437|NCT02059135|3567593|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3730438|NCT02059135|3567594|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730439|NCT02059135|3567595|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3730440|NCT02059135|3567593|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3730441|NCT02059135|3567594|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3730442|NCT02059135|3567595|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3730443|NCT02059135|3567593|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730444|NCT02059135|3567594|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730445|NCT02059135|3567595|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730446|NCT02059135|3567593|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730447|NCT02059135|3567594|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730448|NCT02059135|3567595|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730449|NCT02059135|3567593|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
3730450|NCT02059135|3567594|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3730451|NCT02059135|3567595|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3730452|NCT02059135|3567593|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3730453|NCT02059135|3567594|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3730454|NCT02059135|3567595|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3730455|NCT02059135|3567593|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3730456|NCT02059135|3567594|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3730457|NCT02059135|3567595|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3730458|NCT02059135|3567593|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3730459|NCT02059135|3567594|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3730460|NCT02059135|3567595|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3730461|NCT02059135|3567593|B3|||Age||years|Mean|29.2|29.2|Standard Deviation|6.4|6.4|||
3730462|NCT02059135|3567594|B2|||Age||years|Mean|29.3|29.3|Standard Deviation|6.7|6.7|||
3730463|NCT02059135|3567595|B1|||Age||years|Mean|29.0|29.0|Standard Deviation|6.1|6.1|||
3730464|NCT02059070|3567608|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3730465|NCT02059070|3567609|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3730466|NCT02059070|3567610|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3730467|NCT02059070|3567608|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3730468|NCT02059070|3567609|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3730469|NCT02059070|3567610|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3730470|NCT02059070|3567608|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3730471|NCT02059070|3567609|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3730472|NCT02059070|3567610|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3730473|NCT02059070|3567608|B3|||Age||Years|Mean|51|51.0|Standard Deviation|18|18.0|||
3730474|NCT02059070|3567609|B2|||Age||Years|Mean|48|48.0|Standard Deviation|19|19.0|||
3730475|NCT02059070|3567610|B1|||Age||Years|Mean|54|54.0|Standard Deviation|18|18.0|||
3730476|NCT02059057|3567623|B1|||St. George's Respiratory Questionnaire (SGRQ)|"The SGRQ is designed to measure health impairment in patients with asthma and COPD.~It consists of 50 items and has two parts: Part I (Symptoms): several scales; Part II (Activity and Impacts): dichotomous (true/false) except last question (4-point Likert scale)~Scores range from 0 to 100, with higher scores indicating more limitations.~A negative change in score indicates improvement, with a mean change of 4 points being the minimal important difference."|units of a scale|Mean|57.9|57.9|Standard Deviation|15.6|15.6|||
3730477|NCT02059057|3567623|B1|||Residual Volume (RV)|Residual volume is the amount of air that remains in a person's lungs after fully exhaling. A decrease in residual volume indicates improvement in patients with higher residual volume measures.|Liters|Mean|5.2|5.2|Standard Deviation|1.3|1.3|||
3730478|NCT02059057|3567623|B1|||Forced Expiratory Volume in one second (FEV1)|The forced expiratory volume in one second (FEV1) measurement shows the amount of air a person can forcefully exhale in one second. Typically, lower FEV1 scores show more severe stages of lung disease. A positive change in FEV1 indicates improvement in lung function.|Liters|Mean|0.7|0.7|Standard Deviation|0.2|0.2|||
3730532|NCT02059005|3567631|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3730533|NCT02059005|3567632|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3730534|NCT02059005|3567630|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3730479|NCT02059057|3567623|B1|||Six Minute Walk Test (6MWT)|Mean absolute change from baseline to12 months. The six-minute walk test (6MWT) measures the distance an individual is able to walk over a total of six minutes on a hard, flat surface. The goal is for the individual to walk as far as possible in six minutes. The individual is allowed to self-pace and rest as needed as they traverse back and forth along a marked walkway.|meters|Mean|313.6|313.6|Standard Deviation|82.0|82.0|||
3730480|NCT02059057|3567623|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730481|NCT02059057|3567623|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
3730482|NCT02059057|3567623|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3730483|NCT02059057|3567623|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3730484|NCT02059057|3567623|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3730485|NCT02059057|3567623|B1|||Age||years|Mean|64.9|64.9|Standard Deviation|7.7|7.7|||
3730486|NCT02059005|3567630|B3|Rapid Rehospitalization||Index Medical Condition||Participants|Count of Participants|24|24.0||||||
3730487|NCT02059005|3567631|B2|Rapid Rehospitalization||Index Medical Condition||Participants|Count of Participants|13|13.0||||||
3730488|NCT02059005|3567632|B1|Rapid Rehospitalization||Index Medical Condition||Participants|Count of Participants|11|11.0||||||
3730489|NCT02059005|3567630|B3|Pneumonia||Index Medical Condition||Participants|Count of Participants|5|5.0||||||
3730490|NCT02059005|3567631|B2|Pneumonia||Index Medical Condition||Participants|Count of Participants|1|1.0||||||
3730491|NCT02059005|3567632|B1|Pneumonia||Index Medical Condition||Participants|Count of Participants|4|4.0||||||
3730492|NCT02059005|3567630|B3|End Stage Renal Disease||Index Medical Condition||Participants|Count of Participants|1|1.0||||||
3730493|NCT02059005|3567631|B2|End Stage Renal Disease||Index Medical Condition||Participants|Count of Participants|0|0.0||||||
3730494|NCT02059005|3567632|B1|End Stage Renal Disease||Index Medical Condition||Participants|Count of Participants|1|1.0||||||
3730495|NCT02059005|3567630|B3|Diabetes||Index Medical Condition||Participants|Count of Participants|9|9.0||||||
3730496|NCT02059005|3567631|B2|Diabetes||Index Medical Condition||Participants|Count of Participants|4|4.0||||||
3730497|NCT02059005|3567632|B1|Diabetes||Index Medical Condition||Participants|Count of Participants|5|5.0||||||
3730498|NCT02059005|3567630|B3|Chronic Obstructive Pulmonary Disease||Index Medical Condition||Participants|Count of Participants|14|14.0||||||
3730499|NCT02059005|3567631|B2|Chronic Obstructive Pulmonary Disease||Index Medical Condition||Participants|Count of Participants|8|8.0||||||
3730500|NCT02059005|3567632|B1|Chronic Obstructive Pulmonary Disease||Index Medical Condition||Participants|Count of Participants|6|6.0||||||
3730501|NCT02059005|3567630|B3|Congestive Heart Failure||Index Medical Condition||Participants|Count of Participants|39|39.0||||||
3730502|NCT02059005|3567631|B2|Congestive Heart Failure||Index Medical Condition||Participants|Count of Participants|18|18.0||||||
3730503|NCT02059005|3567632|B1|Congestive Heart Failure||Index Medical Condition||Participants|Count of Participants|21|21.0||||||
3730504|NCT02059005|3567630|B3|Acute Myocardial Infarction||Index Medical Condition||Participants|Count of Participants|5|5.0||||||
3730505|NCT02059005|3567631|B2|Acute Myocardial Infarction||Index Medical Condition||Participants|Count of Participants|4|4.0||||||
3730506|NCT02059005|3567632|B1|Acute Myocardial Infarction||Index Medical Condition||Participants|Count of Participants|1|1.0||||||
3730507|NCT02059005|3567630|B3|Other||Primary Substance of Use||Participants|Count of Participants|14|14.0||||||
3730508|NCT02059005|3567631|B2|Other||Primary Substance of Use||Participants|Count of Participants|6|6.0||||||
3730509|NCT02059005|3567632|B1|Other||Primary Substance of Use||Participants|Count of Participants|8|8.0||||||
3730510|NCT02059005|3567630|B3|Opioids||Primary Substance of Use||Participants|Count of Participants|7|7.0||||||
3730511|NCT02059005|3567631|B2|Opioids||Primary Substance of Use||Participants|Count of Participants|2|2.0||||||
3730512|NCT02059005|3567632|B1|Opioids||Primary Substance of Use||Participants|Count of Participants|5|5.0||||||
3730513|NCT02059005|3567630|B3|Cocaine||Primary Substance of Use||Participants|Count of Participants|33|33.0||||||
3730514|NCT02059005|3567631|B2|Cocaine||Primary Substance of Use||Participants|Count of Participants|14|14.0||||||
3730515|NCT02059005|3567632|B1|Cocaine||Primary Substance of Use||Participants|Count of Participants|19|19.0||||||
3730516|NCT02059005|3567630|B3|Marijuana||Primary Substance of Use||Participants|Count of Participants|7|7.0||||||
3730517|NCT02059005|3567631|B2|Marijuana||Primary Substance of Use||Participants|Count of Participants|6|6.0||||||
3730518|NCT02059005|3567632|B1|Marijuana||Primary Substance of Use||Participants|Count of Participants|1|1.0||||||
3730519|NCT02059005|3567630|B3|Alcohol||Primary Substance of Use||Participants|Count of Participants|34|34.0||||||
3730520|NCT02059005|3567631|B2|Alcohol||Primary Substance of Use||Participants|Count of Participants|18|18.0||||||
3730521|NCT02059005|3567632|B1|Alcohol||Primary Substance of Use||Participants|Count of Participants|16|16.0||||||
3730522|NCT02059005|3567630|B3|United States||Region of Enrollment||participants|Number|97|97.0||||||
3730523|NCT02059005|3567631|B2|United States||Region of Enrollment||participants|Number|48|48.0||||||
3730524|NCT02059005|3567632|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
3730525|NCT02059005|3567630|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3730526|NCT02059005|3567631|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3730527|NCT02059005|3567632|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3730528|NCT02059005|3567630|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3730529|NCT02059005|3567631|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730530|NCT02059005|3567632|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3730531|NCT02059005|3567630|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3730535|NCT02059005|3567631|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3730536|NCT02059005|3567632|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3730537|NCT02059005|3567630|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730538|NCT02059005|3567631|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730539|NCT02059005|3567632|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730540|NCT02059005|3567630|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730541|NCT02059005|3567631|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730542|NCT02059005|3567632|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730543|NCT02059005|3567630|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730544|NCT02059005|3567631|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730545|NCT02059005|3567632|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730546|NCT02059005|3567630|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730547|NCT02059005|3567631|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730548|NCT02059005|3567632|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730549|NCT02059005|3567630|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3730550|NCT02059005|3567631|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3730551|NCT02059005|3567632|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3730552|NCT02059005|3567630|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3730553|NCT02059005|3567631|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3730554|NCT02059005|3567632|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3730555|NCT02059005|3567630|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3730556|NCT02059005|3567631|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3730557|NCT02059005|3567632|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3730558|NCT02059005|3567630|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3730559|NCT02059005|3567631|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3730560|NCT02059005|3567632|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3730561|NCT02059005|3567630|B3|||Age||years|Mean|50.26|50.26|Standard Deviation|10.61|10.61|||
3730562|NCT02059005|3567631|B2|||Age||years|Mean|48.65|48.65|Standard Deviation|12.81|12.81|||
3730563|NCT02059005|3567632|B1|||Age||years|Mean|51.84|51.84|Standard Deviation|7.71|7.71|||
3730564|NCT02058992|3567643|B1|Hepatobiliary disorders||Breakdown of complications|Participants could be counted in more than 1 category (including duplicates).|participants|Number|133|133.0||||||
3730565|NCT02058992|3567643|B1|Renal and urinary disorders||Breakdown of complications|Participants could be counted in more than 1 category (including duplicates).|participants|Number|158|158.0||||||
3730566|NCT02058992|3567643|B1|Heart or cerebrovascular disease||Breakdown of complications|Participants could be counted in more than 1 category (including duplicates).|participants|Number|393|393.0||||||
3730567|NCT02058992|3567643|B1|Diabetes mellitus||Breakdown of complications|Participants could be counted in more than 1 category (including duplicates).|participants|Number|419|419.0||||||
3730568|NCT02058992|3567643|B1|Mental disease||Breakdown of complications|Participants could be counted in more than 1 category (including duplicates).|participants|Number|495|495.0||||||
3730569|NCT02058992|3567643|B1|Dyslipidaemia||Breakdown of complications|Participants could be counted in more than 1 category (including duplicates).|participants|Number|694|694.0||||||
3730570|NCT02058992|3567643|B1|Hypertension||Breakdown of complications|Participants could be counted in more than 1 category (including duplicates).|participants|Number|1206|1206.0||||||
3730571|NCT02058992|3567643|B1|Had No Complications||Presence of Complications||participants|Number|605|605.0||||||
3730572|NCT02058992|3567643|B1|Had Complications||Presence of Complications||participants|Number|2618|2618.0||||||
3730573|NCT02058992|3567643|B1|Unknown||Duration of Insomnia||participants|Number|1218|1218.0||||||
3730574|NCT02058992|3567643|B1|>=5 years||Duration of Insomnia||participants|Number|135|135.0||||||
3730575|NCT02058992|3567643|B1|>=3 to < 5 years||Duration of Insomnia||participants|Number|107|107.0||||||
3730576|NCT02058992|3567643|B1|>=1 year to <3 years||Duration of Insomnia||participants|Number|241|241.0||||||
3730577|NCT02058992|3567643|B1|< 1 year||Duration of Insomnia||participants|Number|1522|1522.0||||||
3730578|NCT02058992|3567643|B1|||Duration of Insomnia||years|Mean|1.13|1.13|Standard Deviation|2.45|2.45|||
3730579|NCT02058992|3567643|B1|Severe||Degree of Sleep Disorder|Degree of sleep disorder of participants were categorized on the basis of the judgement of the investigator as mild, moderate and severe.|participants|Number|300|300.0||||||
3730580|NCT02058992|3567643|B1|Moderate||Degree of Sleep Disorder|Degree of sleep disorder of participants were categorized on the basis of the judgement of the investigator as mild, moderate and severe.|participants|Number|1569|1569.0||||||
3730581|NCT02058992|3567643|B1|Mild||Degree of Sleep Disorder|Degree of sleep disorder of participants were categorized on the basis of the judgement of the investigator as mild, moderate and severe.|participants|Number|1354|1354.0||||||
3730582|NCT02058992|3567643|B1|Unknown||Type of Sleep Disorder (Major Symptoms)|Sleep disorder was categorized on the basis of symptoms found in participants.|participants|Number|447|447.0||||||
3730583|NCT02058992|3567643|B1|Early morning awakening||Type of Sleep Disorder (Major Symptoms)|Sleep disorder was categorized on the basis of symptoms found in participants.|participants|Number|50|50.0||||||
3730630|NCT02058836|3567676|B1|||Age||years|Mean|75.25|75.25|Standard Deviation|8.14|8.14|||
3730584|NCT02058992|3567643|B1|Difficulty staying asleep||Type of Sleep Disorder (Major Symptoms)|Sleep disorder was categorized on the basis of symptoms found in participants.|participants|Number|458|458.0||||||
3730585|NCT02058992|3567643|B1|Difficulty getting sound sleep||Type of Sleep Disorder (Major Symptoms)|Sleep disorder was categorized on the basis of symptoms found in participants.|participants|Number|302|302.0||||||
3730586|NCT02058992|3567643|B1|Difficulty falling asleep||Type of Sleep Disorder (Major Symptoms)|Sleep disorder was categorized on the basis of symptoms found in participants.|participants|Number|1966|1966.0||||||
3730587|NCT02058992|3567643|B1||Male|Sex: Female, Male||Participants|Count of Participants|1288|1288.0||||||
3730588|NCT02058992|3567643|B1||Female|Sex: Female, Male||Participants|Count of Participants|1935|1935.0||||||
3730589|NCT02058992|3567643|B1|>=75 years||Age, Customized||participants|Number|1111|1111.0||||||
3730590|NCT02058992|3567643|B1|Greater than or equal to (>=)65 years to <75 years||Age, Customized||participants|Number|733|733.0||||||
3730591|NCT02058992|3567643|B1|Less than (<) 65 years||Age, Customized||participants|Number|1379|1379.0||||||
3730592|NCT02058992|3567643|B1|||Age||years|Mean|63.5|63.5|Standard Deviation|18.9|18.9|||
3730593|NCT02058940|3567652|B1|Day 2||Intensive Care Unit (ICU) Day of Study Drug Administration||Participants|Count of Participants|4|4.0||||||
3730594|NCT02058940|3567652|B1|Day 1||Intensive Care Unit (ICU) Day of Study Drug Administration||Participants|Count of Participants|4|4.0||||||
3730595|NCT02058940|3567652|B1|||Glucose||mg/dL|Median|191.0|191.0|Inter-Quartile Range|||159.0|224.0|
3730596|NCT02058940|3567652|B1|||Hemoglobin A1c (%)||percent|Median|6.5|6.5|Inter-Quartile Range|||5.5|7.3|
3730597|NCT02058940|3567652|B1|Heart Failure||Past Medical History||Participants|Count of Participants|1|1.0||||||
3730598|NCT02058940|3567652|B1|Chronic Kidney Disease||Past Medical History||Participants|Count of Participants|3|3.0||||||
3730599|NCT02058940|3567652|B1|Cardiovascular Disease||Past Medical History||Participants|Count of Participants|5|5.0||||||
3730600|NCT02058940|3567652|B1|Hyperlipidemia||Past Medical History||Participants|Count of Participants|4|4.0||||||
3730601|NCT02058940|3567652|B1|Hypertension||Past Medical History||Participants|Count of Participants|6|6.0||||||
3730602|NCT02058940|3567652|B1|Diabetes||Past Medical History||Participants|Count of Participants|4|4.0||||||
3730603|NCT02058940|3567652|B1|||Modified Fisher Grade|The Modified Fisher Grade classifies the appearance of subarachnoid hemorrhage on CT scan. The appearance of the hemorrhage is determined on a scale of 0 (none evident) to 4 (most severe).|units on a scale|Number|3.0|3.0||||||
3730604|NCT02058940|3567652|B1|||Hunt and Hess Scale|The Hunt and Hess scale is one of the grading systems used to classify the severity of a subarachnoid hemorrhage. It gives an index of the mortality associated with the various grades. The mortality is lowest with grade 1 and highest with grade 5.|units on a scale|Number|2.0|2.0||||||
3730605|NCT02058940|3567652|B1|||Sequential Organ Failure Assessment (SOFA)|Sequential Organ Failure Assessment (SOFA) score evaluates six systems: respiratory, cardiovascular, coagulation, hepatic, renal and neurological. Each system gets a score from 0 (normal) to 4 (abnormal) and the sum of each score defines the final SOFA score, where 24 is the maximum score (high risk of mortality) and 0 is the minimum score (low risk of mortality).|units on a scale|Median|2.0|2.0|Inter-Quartile Range|||1.0|4.0|
3730606|NCT02058940|3567652|B1|||Glasgow Coma Scale (GCS)|The Glasgow Coma Scale (GCS) aims to give a reliable and objective way of recording the conscious state of a person in response to defined stimuli. A patient is assessed against criteria of the scale, and the resulting points give a patient score between 3 and 15. Lower scores reflect a deeper state of unconsciousness.|units on a scale|Median|10.5|10.5|Inter-Quartile Range|||7.0|14.0|
3730607|NCT02058940|3567652|B1|Subdural Hematoma||Primary Admitting Diagnosis||Participants|Count of Participants|1|1.0||||||
3730608|NCT02058940|3567652|B1|Subarachnoid Hemorrhage||Primary Admitting Diagnosis||Participants|Count of Participants|1|1.0||||||
3730609|NCT02058940|3567652|B1|Acute Ischemic Stroke||Primary Admitting Diagnosis||Participants|Count of Participants|3|3.0||||||
3730610|NCT02058940|3567652|B1|Intracerebral Hemorrhage||Primary Admitting Diagnosis||Participants|Count of Participants|3|3.0||||||
3730611|NCT02058940|3567652|B1|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3730612|NCT02058940|3567652|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3730613|NCT02058940|3567652|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730614|NCT02058940|3567652|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3730615|NCT02058940|3567652|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3730616|NCT02058940|3567652|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730617|NCT02058940|3567652|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730618|NCT02058940|3567652|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730619|NCT02058940|3567652|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3730620|NCT02058940|3567652|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3730621|NCT02058940|3567652|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730622|NCT02058940|3567652|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3730623|NCT02058940|3567652|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3730624|NCT02058940|3567652|B1|||Age||years|Median|64.0|64.0|Inter-Quartile Range|||58.8|67.8|
3730625|NCT02058836|3567674|B3|Male||Sex/Gender, Customized||Participants|Count of Participants|8|8.0||||||
3730626|NCT02058836|3567675|B2|Male||Sex/Gender, Customized||Participants|Count of Participants|4|4.0||||||
3730627|NCT02058836|3567676|B1|Male||Sex/Gender, Customized||Participants|Count of Participants|4|4.0||||||
3730628|NCT02058836|3567674|B3|||Age||years|Mean|65.75|65.75|Standard Deviation|14.10|14.1|||
3730629|NCT02058836|3567675|B2|||Age||years|Mean|56.25|56.25|Standard Deviation|12.5|12.5|||
3730631|NCT02058628|3567705|B3|Other||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3730632|NCT02058628|3567706|B2|Other||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3730633|NCT02058628|3567707|B1|Other||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3730634|NCT02058628|3567705|B3|African||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3730635|NCT02058628|3567706|B2|African||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3730636|NCT02058628|3567707|B1|African||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3730637|NCT02058628|3567705|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|196|196.0||||||
3730638|NCT02058628|3567706|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|102|102.0||||||
3730639|NCT02058628|3567707|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|94|94.0||||||
3730640|NCT02058628|3567705|B3|Asian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3730641|NCT02058628|3567706|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3730642|NCT02058628|3567707|B1|Asian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3730643|NCT02058628|3567705|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3730644|NCT02058628|3567706|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3730645|NCT02058628|3567707|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3730646|NCT02058628|3567705|B3||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3730647|NCT02058628|3567706|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3730648|NCT02058628|3567707|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3730649|NCT02058628|3567705|B3|||Age||Years|Mean|20.1|20.1|Standard Deviation|7.0|7.0|||
3730650|NCT02058628|3567706|B2|||Age||Years|Mean|20.0|20.0|Standard Deviation|6.9|6.9|||
3730651|NCT02058628|3567707|B1|||Age||Years|Mean|20.1|20.1|Standard Deviation|7.1|7.1|||
3730652|NCT02058589|3567738|B3|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3730653|NCT02058589|3567739|B2|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3730654|NCT02058589|3567740|B1|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3730655|NCT02058589|3567738|B3|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|185|185.0||||||
3730656|NCT02058589|3567739|B2|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|97|97.0||||||
3730657|NCT02058589|3567740|B1|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|88|88.0||||||
3730658|NCT02058589|3567738|B3|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3730659|NCT02058589|3567739|B2|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3730660|NCT02058589|3567740|B1|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3730661|NCT02058589|3567738|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3730662|NCT02058589|3567739|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3730663|NCT02058589|3567740|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3730664|NCT02058589|3567738|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3730665|NCT02058589|3567739|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3730666|NCT02058589|3567740|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3730667|NCT02058589|3567738|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3730668|NCT02058589|3567739|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3730669|NCT02058589|3567740|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3730670|NCT02058589|3567738|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3730671|NCT02058589|3567739|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3730672|NCT02058589|3567740|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3730673|NCT02058589|3567738|B3|African Heritage / African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3730674|NCT02058589|3567739|B2|African Heritage / African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3730675|NCT02058589|3567740|B1|African Heritage / African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3730676|NCT02058589|3567738|B3||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
3730677|NCT02058589|3567739|B2||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3730678|NCT02058589|3567740|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3730679|NCT02058589|3567738|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3730680|NCT02058589|3567739|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3730681|NCT02058589|3567740|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3730682|NCT02058589|3567738|B3|||Age||Years|Geometric Mean|52.4|52.4|Standard Deviation|12.6|12.6|||
3730683|NCT02058589|3567739|B2|||Age||Years|Geometric Mean|52.4|52.4|Standard Deviation|12.8|12.8|||
3730684|NCT02058589|3567740|B1|||Age||Years|Geometric Mean|52.3|52.3|Standard Deviation|12.5|12.5|||
3730685|NCT02058563|3567781|B3|Other||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3730686|NCT02058563|3567782|B2|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3730687|NCT02058563|3567783|B1|Other||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3730688|NCT02058563|3567781|B3|White - Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Number|678|678.0||||||
3730689|NCT02058563|3567782|B2|White - Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Number|344|344.0||||||
3730690|NCT02058563|3567783|B1|White - Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Number|334|334.0||||||
3730691|NCT02058563|3567781|B3|White - Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3730692|NCT02058563|3567782|B2|White - Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3730693|NCT02058563|3567783|B1|White - Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3730694|NCT02058563|3567781|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3730695|NCT02058563|3567782|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3730696|NCT02058563|3567783|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3730697|NCT02058563|3567781|B3|Asian - South East Asian heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3730698|NCT02058563|3567782|B2|Asian - South East Asian heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3730699|NCT02058563|3567783|B1|Asian - South East Asian heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3730700|NCT02058563|3567781|B3|Asian - Japanese heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3730701|NCT02058563|3567782|B2|Asian - Japanese heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3730702|NCT02058563|3567783|B1|Asian - Japanese heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3730703|NCT02058563|3567781|B3|Asian - East Asian heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3730704|NCT02058563|3567782|B2|Asian - East Asian heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3730705|NCT02058563|3567783|B1|Asian - East Asian heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3730706|NCT02058563|3567781|B3|Asian - Central/South Asian heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3730707|NCT02058563|3567782|B2|Asian - Central/South Asian heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3730708|NCT02058563|3567783|B1|Asian - Central/South Asian heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3730709|NCT02058563|3567781|B3|American Indian or Alaskan native||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3730710|NCT02058563|3567782|B2|American Indian or Alaskan native||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3730711|NCT02058563|3567783|B1|American Indian or Alaskan native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3730712|NCT02058563|3567781|B3|African Heritage/African American||Race/Ethnicity, Customized||Participants|Number|211|211.0||||||
3730713|NCT02058563|3567782|B2|African Heritage/African American||Race/Ethnicity, Customized||Participants|Number|103|103.0||||||
3730714|NCT02058563|3567783|B1|African Heritage/African American||Race/Ethnicity, Customized||Participants|Number|108|108.0||||||
3730715|NCT02058563|3567781|B3||Male|Sex: Female, Male||Participants|Count of Participants|409|409.0||||||
3730716|NCT02058563|3567782|B2||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
3730717|NCT02058563|3567783|B1||Male|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
3730718|NCT02058563|3567781|B3||Female|Sex: Female, Male||Participants|Count of Participants|502|502.0||||||
3730719|NCT02058563|3567782|B2||Female|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
3730720|NCT02058563|3567783|B1||Female|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
3730721|NCT02058563|3567781|B3|||Age||Months|Mean|25.7|25.7|Standard Deviation|13.8|13.8|||
3730722|NCT02058563|3567782|B2|||Age||Months|Mean|25.6|25.6|Standard Deviation|13.8|13.8|||
3730723|NCT02058563|3567783|B1|||Age||Months|Mean|25.9|25.9|Standard Deviation|13.9|13.9|||
3730724|NCT02058537|3567820|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3730725|NCT02058537|3567820|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3730726|NCT02058537|3567820|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3730727|NCT02058537|3567820|B1|||Age||years|Mean|30.67|30.67|Standard Deviation|16.86|16.86|||
3730728|NCT02058537|3567820|B1|>=65 years||Age||participants|Number|0|0.0||||||
3730729|NCT02058537|3567820|B1|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
3730730|NCT02058537|3567820|B1|<=18 years||Age||participants|Number|0|0.0||||||
3730731|NCT02058498|3567826|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3730732|NCT02058498|3567826|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3730733|NCT02058498|3567826|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730734|NCT02058498|3567826|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3730735|NCT02058498|3567826|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730736|NCT02058498|3567826|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730737|NCT02058498|3567826|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3730738|NCT02058498|3567826|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730739|NCT02058498|3567826|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3730740|NCT02058498|3567826|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3730741|NCT02058498|3567826|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3730742|NCT02058498|3567826|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3730743|NCT02058498|3567826|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3730744|NCT02058290|3567832|B3|||Patient's Pain Level 24 Hours Prior to Surgery|Patient’s Pain Level 24 Hours Prior to Surgery was measured on a scale from 0 to 10 where 0 = no pain and 10 = worst possible pain.|units on a scale|Mean|1.7|1.7|Standard Deviation|1.81|1.81|||
3730745|NCT02058290|3567833|B2|||Patient's Pain Level 24 Hours Prior to Surgery|Patient’s Pain Level 24 Hours Prior to Surgery was measured on a scale from 0 to 10 where 0 = no pain and 10 = worst possible pain.|units on a scale|Mean|1.3|1.3|Standard Deviation|0.86|0.86|||
3730746|NCT02058290|3567834|B1|||Patient's Pain Level 24 Hours Prior to Surgery|Patient’s Pain Level 24 Hours Prior to Surgery was measured on a scale from 0 to 10 where 0 = no pain and 10 = worst possible pain.|units on a scale|Mean|1.9|1.9|Standard Deviation|2.14|2.14|||
3730747|NCT02058290|3567832|B3|Severe Systemic Disease Threat to Life [4]||American Society of Anesthesiologist (ASA) Classification||participants|Number|2|2.0||||||
3730748|NCT02058290|3567833|B2|Severe Systemic Disease Threat to Life [4]||American Society of Anesthesiologist (ASA) Classification||participants|Number|0|0.0||||||
3730749|NCT02058290|3567834|B1|Severe Systemic Disease Threat to Life [4]||American Society of Anesthesiologist (ASA) Classification||participants|Number|2|2.0||||||
3730750|NCT02058290|3567832|B3|Severe Systemic Disease [3]||American Society of Anesthesiologist (ASA) Classification||participants|Number|45|45.0||||||
3730751|NCT02058290|3567833|B2|Severe Systemic Disease [3]||American Society of Anesthesiologist (ASA) Classification||participants|Number|13|13.0||||||
3730752|NCT02058290|3567834|B1|Severe Systemic Disease [3]||American Society of Anesthesiologist (ASA) Classification||participants|Number|32|32.0||||||
3730753|NCT02058290|3567832|B3|Mild Systemic Disease [2]||American Society of Anesthesiologist (ASA) Classification||participants|Number|57|57.0||||||
3730754|NCT02058290|3567833|B2|Mild Systemic Disease [2]||American Society of Anesthesiologist (ASA) Classification||participants|Number|25|25.0||||||
3730755|NCT02058290|3567834|B1|Mild Systemic Disease [2]||American Society of Anesthesiologist (ASA) Classification||participants|Number|32|32.0||||||
3730756|NCT02058290|3567832|B3|Normal [1]||American Society of Anesthesiologist (ASA) Classification||participants|Number|1|1.0||||||
3730757|NCT02058290|3567833|B2|Normal [1]||American Society of Anesthesiologist (ASA) Classification||participants|Number|0|0.0||||||
3730758|NCT02058290|3567834|B1|Normal [1]||American Society of Anesthesiologist (ASA) Classification||participants|Number|1|1.0||||||
3730759|NCT02058290|3567832|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|94|94.0||||||
3730760|NCT02058290|3567833|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
3730761|NCT02058290|3567834|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
3730762|NCT02058290|3567832|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3730763|NCT02058290|3567833|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3730764|NCT02058290|3567834|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3730765|NCT02058290|3567832|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3730766|NCT02058290|3567833|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3730767|NCT02058290|3567834|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3730768|NCT02058290|3567832|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3730769|NCT02058290|3567833|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3730770|NCT02058290|3567834|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3730771|NCT02058290|3567832|B3|||Age||years|Mean|58.3|58.3|Standard Deviation|13.45|13.45|||
3730772|NCT02058290|3567833|B2|||Age||years|Mean|57.8|57.8|Standard Deviation|11.86|11.86|||
3730773|NCT02058290|3567834|B1|||Age||years|Mean|58.6|58.6|Standard Deviation|14.35|14.35|||
3730774|NCT02058160|3567849|B3|||Fasting Plasma Glucose (FPG)||mmol/L|Mean|7.35|7.35|Standard Deviation|2.04|2.04|||
3730775|NCT02058160|3567850|B2|||Fasting Plasma Glucose (FPG)||mmol/L|Mean|7.36|7.36|Standard Deviation|2.12|2.12|||
3730776|NCT02058160|3567851|B1|||Fasting Plasma Glucose (FPG)||mmol/L|Mean|7.34|7.34|Standard Deviation|1.95|1.95|||
3730777|NCT02058160|3567849|B3|||Baseline HbA1c||percentage of HbA1c|Mean|8.08|8.08|Standard Deviation|0.71|0.71|||
3730778|NCT02058160|3567850|B2|||Baseline HbA1c||percentage of HbA1c|Mean|8.08|8.08|Standard Deviation|0.73|0.73|||
3730779|NCT02058160|3567851|B1|||Baseline HbA1c||percentage of HbA1c|Mean|8.07|8.07|Standard Deviation|0.68|0.68|||
3730780|NCT02058160|3567849|B3|||Screening Glycated Hemoglobin (HbA1c)||percentage of HbA1c|Mean|8.53|8.53|Standard Deviation|0.66|0.66|||
3730781|NCT02058160|3567850|B2|||Screening Glycated Hemoglobin (HbA1c)||percentage of HbA1c|Mean|8.54|8.54|Standard Deviation|0.67|0.67|||
3730782|NCT02058160|3567851|B1|||Screening Glycated Hemoglobin (HbA1c)||percentage of HbA1c|Mean|8.51|8.51|Standard Deviation|0.65|0.65|||
3730783|NCT02058160|3567849|B3|||Daily Dose of Metformin||mg|Mean|2062.4|2062.4|Standard Deviation|478.1|478.1|||
3730784|NCT02058160|3567850|B2|||Daily Dose of Metformin||mg|Mean|2042.0|2042.0|Standard Deviation|455.9|455.9|||
3730785|NCT02058160|3567851|B1|||Daily Dose of Metformin||mg|Mean|2082.8|2082.8|Standard Deviation|499.2|499.2|||
3730786|NCT02058160|3567849|B3|||Duration of Diabetes||years|Mean|12.08|12.08|Standard Deviation|6.74|6.74|||
3730787|NCT02058160|3567850|B2|||Duration of Diabetes||years|Mean|12.13|12.13|Standard Deviation|6.85|6.85|||
3730788|NCT02058160|3567851|B1|||Duration of Diabetes||years|Mean|12.02|12.02|Standard Deviation|6.64|6.64|||
3730789|NCT02058160|3567849|B3|||Body Mass Index (BMI)||kg/m^2|Mean|31.14|31.14|Standard Deviation|4.20|4.2|||
3730790|NCT02058160|3567850|B2|||Body Mass Index (BMI)||kg/m^2|Mean|30.96|30.96|Standard Deviation|4.15|4.15|||
3730791|NCT02058160|3567851|B1|||Body Mass Index (BMI)||kg/m^2|Mean|31.33|31.33|Standard Deviation|4.25|4.25|||
3730792|NCT02058160|3567849|B3|None||OAD Use at Screening by Class||Participants|Count of Participants|37|37.0||||||
3730793|NCT02058160|3567850|B2|None||OAD Use at Screening by Class||Participants|Count of Participants|19|19.0||||||
3730794|NCT02058160|3567851|B1|None||OAD Use at Screening by Class||Participants|Count of Participants|18|18.0||||||
3730795|NCT02058160|3567849|B3|Sulfonylurea + DPP-4 inhibitor||OAD Use at Screening by Class||Participants|Count of Participants|2|2.0||||||
3730796|NCT02058160|3567850|B2|Sulfonylurea + DPP-4 inhibitor||OAD Use at Screening by Class||Participants|Count of Participants|1|1.0||||||
3730797|NCT02058160|3567851|B1|Sulfonylurea + DPP-4 inhibitor||OAD Use at Screening by Class||Participants|Count of Participants|1|1.0||||||
3730798|NCT02058160|3567849|B3|Metfomrin + Glinide||OAD Use at Screening by Class||Participants|Count of Participants|5|5.0||||||
3730799|NCT02058160|3567850|B2|Metfomrin + Glinide||OAD Use at Screening by Class||Participants|Count of Participants|3|3.0||||||
3730800|NCT02058160|3567851|B1|Metfomrin + Glinide||OAD Use at Screening by Class||Participants|Count of Participants|2|2.0||||||
3730801|NCT02058160|3567849|B3|Metformin + DPP-4 inhibitor||OAD Use at Screening by Class||Participants|Count of Participants|38|38.0||||||
3730802|NCT02058160|3567850|B2|Metformin + DPP-4 inhibitor||OAD Use at Screening by Class||Participants|Count of Participants|18|18.0||||||
3730803|NCT02058160|3567851|B1|Metformin + DPP-4 inhibitor||OAD Use at Screening by Class||Participants|Count of Participants|20|20.0||||||
3730804|NCT02058160|3567849|B3|Metformin + Sulfonylurea||OAD Use at Screening by Class||Participants|Count of Participants|255|255.0||||||
3730805|NCT02058160|3567850|B2|Metformin + Sulfonylurea||OAD Use at Screening by Class||Participants|Count of Participants|118|118.0||||||
3730806|NCT02058160|3567851|B1|Metformin + Sulfonylurea||OAD Use at Screening by Class||Participants|Count of Participants|137|137.0||||||
3730807|NCT02058160|3567849|B3|Glinide||OAD Use at Screening by Class||Participants|Count of Participants|2|2.0||||||
3730808|NCT02058160|3567850|B2|Glinide||OAD Use at Screening by Class||Participants|Count of Participants|1|1.0||||||
3730809|NCT02058160|3567851|B1|Glinide||OAD Use at Screening by Class||Participants|Count of Participants|1|1.0||||||
3730810|NCT02058160|3567849|B3|Dipeptidyl-peptidase 4 (DPP-4) inhibitor||OAD Use at Screening by Class||Participants|Count of Participants|6|6.0||||||
3730811|NCT02058160|3567850|B2|Dipeptidyl-peptidase 4 (DPP-4) inhibitor||OAD Use at Screening by Class||Participants|Count of Participants|4|4.0||||||
3730812|NCT02058160|3567851|B1|Dipeptidyl-peptidase 4 (DPP-4) inhibitor||OAD Use at Screening by Class||Participants|Count of Participants|2|2.0||||||
3730813|NCT02058160|3567849|B3|Sodium glucose co-transporter 2 (SGLT-2) inhibitor||OAD Use at Screening by Class||Participants|Count of Participants|1|1.0||||||
3730814|NCT02058160|3567850|B2|Sodium glucose co-transporter 2 (SGLT-2) inhibitor||OAD Use at Screening by Class||Participants|Count of Participants|1|1.0||||||
3730815|NCT02058160|3567851|B1|Sodium glucose co-transporter 2 (SGLT-2) inhibitor||OAD Use at Screening by Class||Participants|Count of Participants|0|0.0||||||
3730816|NCT02058160|3567849|B3|Sulfonylurea||OAD Use at Screening by Class||Participants|Count of Participants|30|30.0||||||
3730817|NCT02058160|3567850|B2|Sulfonylurea||OAD Use at Screening by Class||Participants|Count of Participants|14|14.0||||||
3730818|NCT02058160|3567851|B1|Sulfonylurea||OAD Use at Screening by Class||Participants|Count of Participants|16|16.0||||||
3730819|NCT02058160|3567849|B3|Metformin||OAD Use at Screening by Class||Participants|Count of Participants|360|360.0||||||
3730820|NCT02058160|3567850|B2|Metformin||OAD Use at Screening by Class||Participants|Count of Participants|190|190.0||||||
3730821|NCT02058160|3567851|B1|Metformin||OAD Use at Screening by Class||Participants|Count of Participants|170|170.0||||||
3730822|NCT02058160|3567849|B3|No||OAD Use||Participants|Count of Participants|37|37.0||||||
3730823|NCT02058160|3567850|B2|No||OAD Use||Participants|Count of Participants|19|19.0||||||
3730824|NCT02058160|3567851|B1|No||OAD Use||Participants|Count of Participants|18|18.0||||||
3730825|NCT02058160|3567849|B3|Yes||OAD Use||Participants|Count of Participants|699|699.0||||||
3730826|NCT02058160|3567850|B2|Yes||OAD Use||Participants|Count of Participants|350|350.0||||||
3730827|NCT02058160|3567851|B1|Yes||OAD Use||Participants|Count of Participants|349|349.0||||||
3730828|NCT02058160|3567849|B3|Not Hispanic||Ethnicity||Participants|Count of Participants|604|604.0||||||
3730829|NCT02058160|3567850|B2|Not Hispanic||Ethnicity||Participants|Count of Participants|303|303.0||||||
3730830|NCT02058160|3567851|B1|Not Hispanic||Ethnicity||Participants|Count of Participants|301|301.0||||||
3730831|NCT02058160|3567849|B3|Hispanic||Ethnicity||Participants|Count of Participants|132|132.0||||||
3730832|NCT02058160|3567850|B2|Hispanic||Ethnicity||Participants|Count of Participants|66|66.0||||||
3730833|NCT02058160|3567851|B1|Hispanic||Ethnicity||Participants|Count of Participants|66|66.0||||||
3730834|NCT02058160|3567849|B3|Other||Race||Participants|Count of Participants|3|3.0||||||
3730835|NCT02058160|3567850|B2|Other||Race||Participants|Count of Participants|2|2.0||||||
3730836|NCT02058160|3567851|B1|Other||Race||Participants|Count of Participants|1|1.0||||||
3730837|NCT02058160|3567849|B3|Asian/Oriental||Race||Participants|Count of Participants|20|20.0||||||
3730838|NCT02058160|3567850|B2|Asian/Oriental||Race||Participants|Count of Participants|8|8.0||||||
3730839|NCT02058160|3567851|B1|Asian/Oriental||Race||Participants|Count of Participants|12|12.0||||||
3730840|NCT02058160|3567849|B3|Black||Race||Participants|Count of Participants|38|38.0||||||
3730841|NCT02058160|3567850|B2|Black||Race||Participants|Count of Participants|21|21.0||||||
3730842|NCT02058160|3567851|B1|Black||Race||Participants|Count of Participants|17|17.0||||||
3730843|NCT02058160|3567849|B3|Caucasian||Race||Participants|Count of Participants|675|675.0||||||
3730844|NCT02058160|3567850|B2|Caucasian||Race||Participants|Count of Participants|338|338.0||||||
3730845|NCT02058160|3567851|B1|Caucasian||Race||Participants|Count of Participants|337|337.0||||||
3730846|NCT02058160|3567849|B3||Male|Sex: Female, Male||Participants|Count of Participants|344|344.0||||||
3730847|NCT02058160|3567850|B2||Male|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
3730848|NCT02058160|3567851|B1||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3730849|NCT02058160|3567849|B3||Female|Sex: Female, Male||Participants|Count of Participants|392|392.0||||||
3730850|NCT02058160|3567850|B2||Female|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
3730851|NCT02058160|3567851|B1||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3730852|NCT02058160|3567849|B3|||Age||years|Mean|60.0|60.0|Standard Deviation|9.1|9.1|||
3730853|NCT02058160|3567850|B2|||Age||years|Mean|60.3|60.3|Standard Deviation|8.7|8.7|||
3730854|NCT02058160|3567851|B1|||Age||years|Mean|59.6|59.6|Standard Deviation|9.4|9.4|||
3730855|NCT02058147|3567886|B4|||Fasting Plasma Glucose (FPG)||mmol/L|Mean|9.80|9.8|Standard Deviation|2.31|2.31|||
3730856|NCT02058147|3567887|B3|||Fasting Plasma Glucose (FPG)||mmol/L|Mean|9.75|9.75|Standard Deviation|2.19|2.19|||
3730857|NCT02058147|3567888|B2|||Fasting Plasma Glucose (FPG)||mmol/L|Mean|9.75|9.75|Standard Deviation|2.32|2.32|||
3730858|NCT02058147|3567889|B1|||Fasting Plasma Glucose (FPG)||mmol/L|Mean|9.87|9.87|Standard Deviation|2.35|2.35|||
3730859|NCT02058147|3567886|B4|||HbA1c||percentage of HbA1c|Mean|8.09|8.09|Standard Deviation|0.70|0.7|||
3730860|NCT02058147|3567887|B3|||HbA1c||percentage of HbA1c|Mean|8.13|8.13|Standard Deviation|0.72|0.72|||
3730861|NCT02058147|3567888|B2|||HbA1c||percentage of HbA1c|Mean|8.08|8.08|Standard Deviation|0.69|0.69|||
3730862|NCT02058147|3567889|B1|||HbA1c||percentage of HbA1c|Mean|8.08|8.08|Standard Deviation|0.71|0.71|||
3730863|NCT02058147|3567886|B4|||Daily Dose of Metformin||mg|Mean|2249.8|2249.8|Standard Deviation|445.9|445.9|||
3730864|NCT02058147|3567887|B3|||Daily Dose of Metformin||mg|Mean|2267.3|2267.3|Standard Deviation|427.4|427.4|||
3730865|NCT02058147|3567888|B2|||Daily Dose of Metformin||mg|Mean|2244.7|2244.7|Standard Deviation|444.7|444.7|||
3730866|NCT02058147|3567889|B1|||Daily Dose of Metformin||mg|Mean|2246.1|2246.1|Standard Deviation|456.8|456.8|||
3730867|NCT02058147|3567886|B4|||Duration of Diabetes||years|Mean|8.80|8.8|Standard Deviation|5.69|5.69|||
3730868|NCT02058147|3567887|B3|||Duration of Diabetes||years|Mean|8.89|8.89|Standard Deviation|6.26|6.26|||
3730869|NCT02058147|3567888|B2|||Duration of Diabetes||years|Mean|8.66|8.66|Standard Deviation|5.59|5.59|||
3730870|NCT02058147|3567889|B1|||Duration of Diabetes||years|Mean|8.89|8.89|Standard Deviation|5.51|5.51|||
3730871|NCT02058147|3567886|B4|||Body Mass Index (BMI)||kg/m^2|Mean|31.72|31.72|Standard Deviation|4.44|4.44|||
3730872|NCT02058147|3567887|B3|||Body Mass Index (BMI)||kg/m^2|Mean|31.99|31.99|Standard Deviation|4.39|4.39|||
3730873|NCT02058147|3567888|B2|||Body Mass Index (BMI)||kg/m^2|Mean|31.66|31.66|Standard Deviation|4.51|4.51|||
3730874|NCT02058147|3567889|B1|||Body Mass Index (BMI)||kg/m^2|Mean|31.64|31.64|Standard Deviation|4.4|4.4|||
3730875|NCT02058147|3567886|B4|None||Second OAD Use at Screening by Class||Participants|Count of Participants|489|489.0||||||
3730876|NCT02058147|3567887|B3|None||Second OAD Use at Screening by Class||Participants|Count of Participants|101|101.0||||||
3730877|NCT02058147|3567888|B2|None||Second OAD Use at Screening by Class||Participants|Count of Participants|195|195.0||||||
3730878|NCT02058147|3567889|B1|None||Second OAD Use at Screening by Class||Participants|Count of Participants|193|193.0||||||
3730879|NCT02058147|3567886|B4|Dipeptidyl peptidase-4 inhibitor||Second OAD Use at Screening by Class||Participants|Count of Participants|28|28.0||||||
3730880|NCT02058147|3567887|B3|Dipeptidyl peptidase-4 inhibitor||Second OAD Use at Screening by Class||Participants|Count of Participants|5|5.0||||||
3730881|NCT02058147|3567888|B2|Dipeptidyl peptidase-4 inhibitor||Second OAD Use at Screening by Class||Participants|Count of Participants|11|11.0||||||
3730882|NCT02058147|3567889|B1|Dipeptidyl peptidase-4 inhibitor||Second OAD Use at Screening by Class||Participants|Count of Participants|12|12.0||||||
3730883|NCT02058147|3567886|B4|Sodium-glucose co-transporter-2 inhibitor||Second OAD Use at Screening by Class||Participants|Count of Participants|4|4.0||||||
3730884|NCT02058147|3567887|B3|Sodium-glucose co-transporter-2 inhibitor||Second OAD Use at Screening by Class||Participants|Count of Participants|0|0.0||||||
3730885|NCT02058147|3567888|B2|Sodium-glucose co-transporter-2 inhibitor||Second OAD Use at Screening by Class||Participants|Count of Participants|2|2.0||||||
3730886|NCT02058147|3567889|B1|Sodium-glucose co-transporter-2 inhibitor||Second OAD Use at Screening by Class||Participants|Count of Participants|2|2.0||||||
3730887|NCT02058147|3567886|B4|Glinide||Second OAD Use at Screening by Class||Participants|Count of Participants|18|18.0||||||
3730888|NCT02058147|3567887|B3|Glinide||Second OAD Use at Screening by Class||Participants|Count of Participants|5|5.0||||||
3730889|NCT02058147|3567888|B2|Glinide||Second OAD Use at Screening by Class||Participants|Count of Participants|10|10.0||||||
3730890|NCT02058147|3567889|B1|Glinide||Second OAD Use at Screening by Class||Participants|Count of Participants|3|3.0||||||
3730891|NCT02058147|3567886|B4|Sulfonylurea||Second OAD Use at Screening by Class||Participants|Count of Participants|631|631.0||||||
3730892|NCT02058147|3567887|B3|Sulfonylurea||Second OAD Use at Screening by Class||Participants|Count of Participants|123|123.0||||||
3730893|NCT02058147|3567888|B2|Sulfonylurea||Second OAD Use at Screening by Class||Participants|Count of Participants|249|249.0||||||
3730894|NCT02058147|3567889|B1|Sulfonylurea||Second OAD Use at Screening by Class||Participants|Count of Participants|259|259.0||||||
3730895|NCT02058147|3567886|B4|No||Second Oral Anti-diabetic Drug (OAD) Use||Participants|Count of Participants|493|493.0||||||
3730896|NCT02058147|3567887|B3|No||Second Oral Anti-diabetic Drug (OAD) Use||Participants|Count of Participants|101|101.0||||||
3730897|NCT02058147|3567888|B2|No||Second Oral Anti-diabetic Drug (OAD) Use||Participants|Count of Participants|197|197.0||||||
3730898|NCT02058147|3567889|B1|No||Second Oral Anti-diabetic Drug (OAD) Use||Participants|Count of Participants|195|195.0||||||
3730899|NCT02058147|3567886|B4|Yes||Second Oral Anti-diabetic Drug (OAD) Use||Participants|Count of Participants|677|677.0||||||
3730900|NCT02058147|3567887|B3|Yes||Second Oral Anti-diabetic Drug (OAD) Use||Participants|Count of Participants|133|133.0||||||
3730901|NCT02058147|3567888|B2|Yes||Second Oral Anti-diabetic Drug (OAD) Use||Participants|Count of Participants|270|270.0||||||
3730902|NCT02058147|3567889|B1|Yes||Second Oral Anti-diabetic Drug (OAD) Use||Participants|Count of Participants|274|274.0||||||
3730903|NCT02058147|3567886|B4|Not Hispanic||Ethnicity||Participants|Count of Participants|947|947.0||||||
3730904|NCT02058147|3567887|B3|Not Hispanic||Ethnicity||Participants|Count of Participants|183|183.0||||||
3730905|NCT02058147|3567888|B2|Not Hispanic||Ethnicity||Participants|Count of Participants|380|380.0||||||
3730906|NCT02058147|3567889|B1|Not Hispanic||Ethnicity||Participants|Count of Participants|384|384.0||||||
3730907|NCT02058147|3567886|B4|Hispanic||Ethnicity||Participants|Count of Participants|223|223.0||||||
3730908|NCT02058147|3567887|B3|Hispanic||Ethnicity||Participants|Count of Participants|51|51.0||||||
3730909|NCT02058147|3567888|B2|Hispanic||Ethnicity||Participants|Count of Participants|87|87.0||||||
3730910|NCT02058147|3567889|B1|Hispanic||Ethnicity||Participants|Count of Participants|85|85.0||||||
3730911|NCT02058147|3567886|B4|Other||Race||Participants|Count of Participants|20|20.0||||||
3730912|NCT02058147|3567887|B3|Other||Race||Participants|Count of Participants|3|3.0||||||
3730913|NCT02058147|3567888|B2|Other||Race||Participants|Count of Participants|6|6.0||||||
3730914|NCT02058147|3567889|B1|Other||Race||Participants|Count of Participants|11|11.0||||||
3730915|NCT02058147|3567886|B4|Asian/Oriental||Race||Participants|Count of Participants|18|18.0||||||
3730916|NCT02058147|3567887|B3|Asian/Oriental||Race||Participants|Count of Participants|3|3.0||||||
3730917|NCT02058147|3567888|B2|Asian/Oriental||Race||Participants|Count of Participants|7|7.0||||||
3730918|NCT02058147|3567889|B1|Asian/Oriental||Race||Participants|Count of Participants|8|8.0||||||
3730919|NCT02058147|3567886|B4|Black||Race||Participants|Count of Participants|78|78.0||||||
3730920|NCT02058147|3567887|B3|Black||Race||Participants|Count of Participants|12|12.0||||||
3730921|NCT02058147|3567888|B2|Black||Race||Participants|Count of Participants|33|33.0||||||
3730922|NCT02058147|3567889|B1|Black||Race||Participants|Count of Participants|33|33.0||||||
3730923|NCT02058147|3567886|B4|Caucasian||Race||Participants|Count of Participants|1054|1054.0||||||
3730924|NCT02058147|3567887|B3|Caucasian||Race||Participants|Count of Participants|216|216.0||||||
3730925|NCT02058147|3567888|B2|Caucasian||Race||Participants|Count of Participants|421|421.0||||||
3730926|NCT02058147|3567889|B1|Caucasian||Race||Participants|Count of Participants|417|417.0||||||
3730927|NCT02058147|3567886|B4||Male|Sex: Female, Male||Participants|Count of Participants|592|592.0||||||
3730928|NCT02058147|3567887|B3||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3730929|NCT02058147|3567888|B2||Male|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
3730930|NCT02058147|3567889|B1||Male|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
3730931|NCT02058147|3567886|B4||Female|Sex: Female, Male||Participants|Count of Participants|578|578.0||||||
3730932|NCT02058147|3567887|B3||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3730933|NCT02058147|3567888|B2||Female|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
3730934|NCT02058147|3567889|B1||Female|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
3730935|NCT02058147|3567886|B4|||Age||years|Mean|58.4|58.4|Standard Deviation|9.3|9.3|||
3730936|NCT02058147|3567887|B3|||Age||years|Mean|58.7|58.7|Standard Deviation|8.7|8.7|||
3730937|NCT02058147|3567888|B2|||Age||years|Mean|58.3|58.3|Standard Deviation|9.4|9.4|||
3730938|NCT02058147|3567889|B1|||Age||years|Mean|58.2|58.2|Standard Deviation|9.5|9.5|||
3730939|NCT02058069|3567940|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3730940|NCT02058069|3567940|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3730941|NCT02058069|3567940|B1|||Age||years|Mean|65.78|65.78|Standard Deviation|8.49|8.49|||
3730942|NCT02057952|3567949|B4|||Patient Health Questionnaire (range 0 [best] -27[worst]), continuous||standardized score|Mean|7.3|7.3|Standard Deviation|5.6|5.6|||
3730943|NCT02057952|3567950|B3|||Patient Health Questionnaire (range 0 [best] -27[worst]), continuous||standardized score|Mean|7.3|7.3|Standard Deviation|5.3|5.3|||
3730944|NCT02057952|3567951|B2|||Patient Health Questionnaire (range 0 [best] -27[worst]), continuous||standardized score|Mean|6.9|6.9|Standard Deviation|5.5|5.5|||
3730945|NCT02057952|3567952|B1|||Patient Health Questionnaire (range 0 [best] -27[worst]), continuous||standardized score|Mean|7.6|7.6|Standard Deviation|6.0|6.0|||
3730946|NCT02057952|3567949|B4|||Short Form 36 (RANGE 0 [Worst] -100 [Best]), continuous||standardized score|Mean|56.1|56.1|Standard Deviation|19.8|19.8|||
3730947|NCT02057952|3567950|B3|||Short Form 36 (RANGE 0 [Worst] -100 [Best]), continuous||standardized score|Mean|56.5|56.5|Standard Deviation|21.8|21.8|||
3730948|NCT02057952|3567951|B2|||Short Form 36 (RANGE 0 [Worst] -100 [Best]), continuous||standardized score|Mean|59.2|59.2|Standard Deviation|18.4|18.4|||
3730949|NCT02057952|3567952|B1|||Short Form 36 (RANGE 0 [Worst] -100 [Best]), continuous||standardized score|Mean|52.8|52.8|Standard Deviation|19.0|19.0|||
3730950|NCT02057952|3567949|B4|||body mass index, continuous||kilograms divided by meters squared|Mean|38.9|38.9|Standard Deviation|5.8|5.8|||
3730951|NCT02057952|3567950|B3|||body mass index, continuous||kilograms divided by meters squared|Mean|38.5|38.5|Standard Deviation|5.5|5.5|||
3730952|NCT02057952|3567951|B2|||body mass index, continuous||kilograms divided by meters squared|Mean|38.9|38.9|Standard Deviation|5.8|5.8|||
3730953|NCT02057952|3567952|B1|||body mass index, continuous||kilograms divided by meters squared|Mean|39.4|39.4|Standard Deviation|6.2|6.2|||
3730954|NCT02057952|3567949|B4|||weight, continuous||pounds|Mean|232.7|232.7|Standard Deviation|42.0|42.0|||
3730955|NCT02057952|3567950|B3|||weight, continuous||pounds|Mean|227.6|227.6|Standard Deviation|35.5|35.5|||
3730956|NCT02057952|3567951|B2|||weight, continuous||pounds|Mean|234.1|234.1|Standard Deviation|46.7|46.7|||
3730957|NCT02057952|3567952|B1|||weight, continuous||pounds|Mean|236.4|236.4|Standard Deviation|43.6|43.6|||
3730958|NCT02057952|3567949|B4|||Years of Education, continuous||Years|Mean|13.1|13.1|Standard Deviation|2.2|2.2|||
3730959|NCT02057952|3567950|B3|||Years of Education, continuous||Years|Mean|12.6|12.6|Standard Deviation|1.7|1.7|||
3730960|NCT02057952|3567951|B2|||Years of Education, continuous||Years|Mean|13.6|13.6|Standard Deviation|2.4|2.4|||
3730961|NCT02057952|3567952|B1|||Years of Education, continuous||Years|Mean|13.2|13.2|Standard Deviation|2.4|2.4|||
3730962|NCT02057952|3567949|B4|United States||Region of Enrollment||participants|Number|150|150.0||||||
3730963|NCT02057952|3567950|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3730964|NCT02057952|3567951|B2|United States||Region of Enrollment||participants|Number|49|49.0||||||
3730965|NCT02057952|3567952|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
3730966|NCT02057952|3567949|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|148|148.0||||||
3730967|NCT02057952|3567950|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3730968|NCT02057952|3567951|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3730969|NCT02057952|3567952|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3730970|NCT02057952|3567949|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730971|NCT02057952|3567950|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730972|NCT02057952|3567951|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730973|NCT02057952|3567952|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730974|NCT02057952|3567949|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3730975|NCT02057952|3567950|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730976|NCT02057952|3567951|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3730977|NCT02057952|3567952|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3730978|NCT02057952|3567949|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3730979|NCT02057952|3567950|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3730980|NCT02057952|3567951|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3730981|NCT02057952|3567952|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3730982|NCT02057952|3567949|B4||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3730983|NCT02057952|3567950|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3730984|NCT02057952|3567951|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3730985|NCT02057952|3567952|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3730986|NCT02057952|3567949|B4|||Age||YEAR OF AGE|Mean|53.4|53.4|Standard Deviation|6.8|6.8|||
3730987|NCT02057952|3567950|B3|||Age||YEAR OF AGE|Mean|53.2|53.2|Standard Deviation|6.1|6.1|||
3730988|NCT02057952|3567951|B2|||Age||YEAR OF AGE|Mean|53.2|53.2|Standard Deviation|8.1|8.1|||
3730989|NCT02057952|3567952|B1|||Age||YEAR OF AGE|Mean|53.9|53.9|Standard Deviation|6.1|6.1|||
3730990|NCT02057874|3567989|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3730991|NCT02057874|3567989|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3730992|NCT02057874|3567989|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3730993|NCT02057874|3567989|B1|||Age||years|Mean|60|60.0|Standard Deviation|3|3.0|||
3730994|NCT02057874|3567989|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3730995|NCT02057874|3567989|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3730996|NCT02057874|3567989|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3730997|NCT02057835|3567997|B11||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3730998|NCT02057835|3567998|B10||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3730999|NCT02057835|3567999|B9||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3731000|NCT02057835|3568000|B8||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3731001|NCT02057835|3568001|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3731002|NCT02057835|3568002|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3731003|NCT02057835|3568003|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3731004|NCT02057835|3568004|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3731005|NCT02057835|3568005|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3731006|NCT02057835|3568006|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3731007|NCT02057835|3568007|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3731008|NCT02057835|3567997|B11||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3731009|NCT02057835|3567998|B10||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3731010|NCT02057835|3567999|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3731011|NCT02057835|3568000|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3731012|NCT02057835|3568001|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3731013|NCT02057835|3568002|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3731014|NCT02057835|3568003|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3731015|NCT02057835|3568004|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3731016|NCT02057835|3568005|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3731017|NCT02057835|3568006|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3731018|NCT02057835|3568007|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3731019|NCT02057835|3567997|B11|||Age||Years|Mean|29.0|29.0|Standard Deviation|5.52|5.52|||
3731020|NCT02057835|3567998|B10|||Age||Years|Mean|34.5|34.5|Standard Deviation|0.84|0.84|||
3731021|NCT02057835|3567999|B9|||Age||Years|Mean|31.0|31.0|Standard Deviation|4.82|4.82|||
3731022|NCT02057835|3568000|B8|||Age||Years|Mean|36.5|36.5|Standard Deviation|2.74|2.74|||
3731023|NCT02057835|3568001|B7|||Age||Years|Mean|31.7|31.7|Standard Deviation|4.76|4.76|||
3731024|NCT02057835|3568002|B6|||Age||Years|Mean|29.5|29.5|Standard Deviation|3.82|3.82|||
3731025|NCT02057835|3568003|B5|||Age||Years|Mean|28.8|28.8|Standard Deviation|4.02|4.02|||
3731026|NCT02057835|3568004|B4|||Age||Years|Mean|26.3|26.3|Standard Deviation|4.55|4.55|||
3731027|NCT02057835|3568005|B3|||Age||Years|Mean|23.0|23.0|Standard Deviation|2.53|2.53|||
3731028|NCT02057835|3568006|B2|||Age||Years|Mean|24.5|24.5|Standard Deviation|3.73|3.73|||
3731029|NCT02057835|3568007|B1|||Age||Years|Mean|25.3|25.3|Standard Deviation|5.06|5.06|||
3731030|NCT02057757|3568093|B3|||BMI Z Score|The Z-score indicates the number of standard deviations away from a reference population matched for age and gender. A Z-score of 0 is equal to the reference population. Negative numbers indicate BMI values lower than the reference population and positive numbers indicate values higher than the reference population.|Z Score|Mean|-0.2|-0.2|Standard Deviation|2.3|2.3|||
3731031|NCT02057757|3568094|B2|||BMI Z Score|The Z-score indicates the number of standard deviations away from a reference population matched for age and gender. A Z-score of 0 is equal to the reference population. Negative numbers indicate BMI values lower than the reference population and positive numbers indicate values higher than the reference population.|Z Score|Mean|-0.6|-0.6|Standard Deviation|2.5|2.5|||
3731032|NCT02057757|3568095|B1|||BMI Z Score|The Z-score indicates the number of standard deviations away from a reference population matched for age and gender. A Z-score of 0 is equal to the reference population. Negative numbers indicate BMI values lower than the reference population and positive numbers indicate values higher than the reference population.|Z Score|Mean|0.2|0.2|Standard Deviation|2.0|2.0|||
3731033|NCT02057757|3568093|B3|||Body Mass Index (BMI)||kg/m^2|Mean|27.1|27.1|Standard Deviation|5.9|5.9|||
3731034|NCT02057757|3568094|B2|||Body Mass Index (BMI)||kg/m^2|Mean|27.0|27.0|Standard Deviation|5.6|5.6|||
3731035|NCT02057757|3568095|B1|||Body Mass Index (BMI)||kg/m^2|Mean|27.2|27.2|Standard Deviation|6.2|6.2|||
3731036|NCT02057757|3568093|B3|Mexico||Region of Enrollment||participants|Number|257|257.0||||||
3731037|NCT02057757|3568094|B2|Mexico||Region of Enrollment||participants|Number|127|127.0||||||
3731038|NCT02057757|3568095|B1|Mexico||Region of Enrollment||participants|Number|130|130.0||||||
3731039|NCT02057757|3568093|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731040|NCT02057757|3568094|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731041|NCT02057757|3568095|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731042|NCT02057757|3568093|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|256|256.0||||||
3731043|NCT02057757|3568094|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|127|127.0||||||
3731044|NCT02057757|3568095|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
3731045|NCT02057757|3568093|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3731046|NCT02057757|3568094|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731047|NCT02057757|3568095|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3731048|NCT02057757|3568093|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731049|NCT02057757|3568094|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731050|NCT02057757|3568095|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731051|NCT02057757|3568093|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731052|NCT02057757|3568094|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731053|NCT02057757|3568095|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731054|NCT02057757|3568093|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731055|NCT02057757|3568094|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731056|NCT02057757|3568095|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731057|NCT02057757|3568093|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731058|NCT02057757|3568094|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731059|NCT02057757|3568095|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731060|NCT02057757|3568093|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731061|NCT02057757|3568094|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731062|NCT02057757|3568095|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731063|NCT02057757|3568093|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731064|NCT02057757|3568094|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731065|NCT02057757|3568095|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731066|NCT02057757|3568093|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|257|257.0||||||
3731067|NCT02057757|3568094|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|127|127.0||||||
3731068|NCT02057757|3568095|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
3731069|NCT02057757|3568093|B3||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3731070|NCT02057757|3568094|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3731071|NCT02057757|3568095|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3731072|NCT02057757|3568093|B3||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3731073|NCT02057757|3568094|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3731074|NCT02057757|3568095|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3731075|NCT02057757|3568093|B3|||Age||years|Mean|23.1|23.1|Standard Deviation|24.2|24.2|||
3731076|NCT02057757|3568094|B2|||Age||years|Mean|23.6|23.6|Standard Deviation|24.4|24.4|||
3731077|NCT02057757|3568095|B1|||Age||years|Mean|22.6|22.6|Standard Deviation|24.0|24.0|||
3731078|NCT02057757|3568093|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3731079|NCT02057757|3568094|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3731080|NCT02057757|3568095|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3731081|NCT02057757|3568093|B3||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
3731082|NCT02057757|3568094|B2||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
3731083|NCT02057757|3568095|B1||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3731084|NCT02057757|3568093|B3||<=18 years|Age||Participants|Count of Participants|131|131.0||||||
3731085|NCT02057757|3568094|B2||<=18 years|Age||Participants|Count of Participants|64|64.0||||||
3731086|NCT02057757|3568095|B1||<=18 years|Age||Participants|Count of Participants|67|67.0||||||
3731087|NCT02057692|3568146|B5||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3731088|NCT02057692|3568147|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3731089|NCT02057692|3568148|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3731090|NCT02057692|3568149|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3731091|NCT02057692|3568150|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3731092|NCT02057692|3568146|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3731093|NCT02057692|3568147|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3731094|NCT02057692|3568148|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3731095|NCT02057692|3568149|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3731096|NCT02057692|3568150|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3731097|NCT02057692|3568146|B5|||Age||Years|Mean|6.8|6.8|Standard Deviation|4.48|4.48|||
3731098|NCT02057692|3568147|B4|||Age||Years|Mean|5.5|5.5|Standard Deviation|4.19|4.19|||
3731099|NCT02057692|3568148|B3|||Age||Years|Mean|5.5|5.5|Standard Deviation|4.76|4.76|||
3731100|NCT02057692|3568149|B2|||Age||Years|Mean|8.6|8.6|Standard Deviation|4.32|4.32|||
3731101|NCT02057692|3568150|B1|||Age||Years|Mean|7.4|7.4|Standard Deviation|4.75|4.75|||
3731102|NCT02057549|3568181|B3|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3731103|NCT02057549|3568182|B2|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3731104|NCT02057549|3568183|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3731105|NCT02057549|3568181|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3731106|NCT02057549|3568182|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3731107|NCT02057549|3568183|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3731108|NCT02057549|3568181|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3731109|NCT02057549|3568182|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3731110|NCT02057549|3568183|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3731111|NCT02057549|3568181|B3|||Age||years|Mean|46|46.0|Full Range|||20.0|57.0|
3731112|NCT02057549|3568182|B2|||Age||years|Mean|45|45.0|Full Range|||20.0|57.0|
3731113|NCT02057549|3568183|B1|||Age||years|Mean|47|47.0|Full Range|||21.0|56.0|
3731114|NCT02057406|3568204|B4|||Red Blood Cell/Plasma EPA|Red blood cell/plasma EPA levels are expressed as a percent of total identified fatty acids.|percentage of total fatty acids|Mean|0.49|0.49|Standard Deviation|0.24|0.24|||
3731115|NCT02057406|3568205|B3|||Red Blood Cell/Plasma EPA|Red blood cell/plasma EPA levels are expressed as a percent of total identified fatty acids.|percentage of total fatty acids|Mean|0.49|0.49|Standard Deviation|0.28|0.28|||
3731116|NCT02057406|3568206|B2|||Red Blood Cell/Plasma EPA|Red blood cell/plasma EPA levels are expressed as a percent of total identified fatty acids.|percentage of total fatty acids|Mean|0.51|0.51|Standard Deviation|0.24|0.24|||
3731117|NCT02057406|3568207|B1|||Red Blood Cell/Plasma EPA|Red blood cell/plasma EPA levels are expressed as a percent of total identified fatty acids.|percentage of total fatty acids|Mean|0.48|0.48|Standard Deviation|0.2|0.2|||
3731118|NCT02057406|3568204|B4|||Hamilton Depression Rating Scale (HDRS) Score|The range for the Hamilton Depression Rating Scale is 0 to 52 with higher scores indicating a greater severity of depressive symptoms.|units on a scale|Mean|22.82|22.82|Standard Deviation|4.19|4.19|||
3731119|NCT02057406|3568205|B3|||Hamilton Depression Rating Scale (HDRS) Score|The range for the Hamilton Depression Rating Scale is 0 to 52 with higher scores indicating a greater severity of depressive symptoms.|units on a scale|Mean|23.56|23.56|Standard Deviation|4.53|4.53|||
3731120|NCT02057406|3568206|B2|||Hamilton Depression Rating Scale (HDRS) Score|The range for the Hamilton Depression Rating Scale is 0 to 52 with higher scores indicating a greater severity of depressive symptoms.|units on a scale|Mean|22.67|22.67|Standard Deviation|4.24|4.24|||
3731121|NCT02057406|3568207|B1|||Hamilton Depression Rating Scale (HDRS) Score|The range for the Hamilton Depression Rating Scale is 0 to 52 with higher scores indicating a greater severity of depressive symptoms.|units on a scale|Mean|22.2|22.2|Standard Deviation|3.78|3.78|||
3731122|NCT02057406|3568204|B4||University of North Carolina|Treatment Site||Participants|Count of Participants|38|38.0||||||
3731123|NCT02057406|3568205|B3||University of North Carolina|Treatment Site||Participants|Count of Participants|13|13.0||||||
3731124|NCT02057406|3568206|B2||University of North Carolina|Treatment Site||Participants|Count of Participants|13|13.0||||||
3731125|NCT02057406|3568207|B1||University of North Carolina|Treatment Site||Participants|Count of Participants|12|12.0||||||
3731126|NCT02057406|3568204|B4||Thomas Jefferson University|Treatment Site||Participants|Count of Participants|32|32.0||||||
3731127|NCT02057406|3568205|B3||Thomas Jefferson University|Treatment Site||Participants|Count of Participants|10|10.0||||||
3731128|NCT02057406|3568206|B2||Thomas Jefferson University|Treatment Site||Participants|Count of Participants|10|10.0||||||
3731129|NCT02057406|3568207|B1||Thomas Jefferson University|Treatment Site||Participants|Count of Participants|12|12.0||||||
3731130|NCT02057406|3568204|B4||Duke Unviersity Medical Center|Treatment Site||Participants|Count of Participants|38|38.0||||||
3731131|NCT02057406|3568205|B3||Duke Unviersity Medical Center|Treatment Site||Participants|Count of Participants|13|13.0||||||
3731132|NCT02057406|3568206|B2||Duke Unviersity Medical Center|Treatment Site||Participants|Count of Participants|13|13.0||||||
3731133|NCT02057406|3568207|B1||Duke Unviersity Medical Center|Treatment Site||Participants|Count of Participants|12|12.0||||||
3731134|NCT02057406|3568204|B4|United States||Region of Enrollment||participants|Number|108|108.0||||||
3731135|NCT02057406|3568205|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
3731136|NCT02057406|3568206|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
3731137|NCT02057406|3568207|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
3731138|NCT02057406|3568204|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3731139|NCT02057406|3568205|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3731140|NCT02057406|3568206|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3731141|NCT02057406|3568207|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3731142|NCT02057406|3568204|B4|Black||Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
3731143|NCT02057406|3568205|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3731144|NCT02057406|3568206|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3731145|NCT02057406|3568207|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3731146|NCT02057406|3568204|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|58|58.0||||||
3731147|NCT02057406|3568205|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3731148|NCT02057406|3568206|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3731149|NCT02057406|3568207|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3731150|NCT02057406|3568204|B4||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3731151|NCT02057406|3568205|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3731152|NCT02057406|3568206|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3731153|NCT02057406|3568207|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3731154|NCT02057406|3568204|B4||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3731155|NCT02057406|3568205|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3731156|NCT02057406|3568206|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3731157|NCT02057406|3568207|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3731158|NCT02057406|3568204|B4|||Age||years|Mean|57.92|57.92|Standard Deviation|12.79|12.79|||
3731159|NCT02057406|3568205|B3|||Age||years|Mean|57.91|57.91|Standard Deviation|11.68|11.68|||
3731160|NCT02057406|3568206|B2|||Age||years|Mean|58.10|58.1|Standard Deviation|10.16|10.16|||
3731161|NCT02057406|3568207|B1|||Age||years|Mean|57.73|57.73|Standard Deviation|16.14|16.14|||
3731162|NCT02057393|3568220|B1|||BMI||kg/m2|Median|28|28.0|Full Range|||17.0|51.5|
3731163|NCT02057393|3568220|B1|United States||Region of Enrollment||Participants|Count of Participants|87|87.0||||||
3731164|NCT02057393|3568220|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3731165|NCT02057393|3568220|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3731166|NCT02057393|3568220|B1|||Age||years|Median|65|65.0|Full Range|||26.0|94.0|
3731167|NCT02057276|3568224|B3||Male|Sex: Female, Male||||0|0.0||||||
3731168|NCT02057276|3568224|B3||Female|Sex: Female, Male||||0|0.0||||||
3731169|NCT02057250|3568237|B5||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3731170|NCT02057250|3568238|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3731171|NCT02057250|3568239|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3731172|NCT02057250|3568240|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3731173|NCT02057250|3568241|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3731174|NCT02057250|3568237|B5||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
3731175|NCT02057250|3568238|B4||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3731176|NCT02057250|3568239|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3731177|NCT02057250|3568240|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3731178|NCT02057250|3568241|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3731179|NCT02057250|3568237|B5|||Age||years|Mean|53.5|53.5|Standard Deviation|13.4|13.4|||
3731180|NCT02057250|3568238|B4|||Age||years|Mean|50.3|50.3|Standard Deviation|12.8|12.8|||
3731181|NCT02057250|3568239|B3|||Age||years|Mean|55.9|55.9|Standard Deviation|12.3|12.3|||
3731182|NCT02057250|3568240|B2|||Age||years|Mean|54.2|54.2|Standard Deviation|14.2|14.2|||
3731183|NCT02057250|3568241|B1|||Age||years|Mean|53.7|53.7|Standard Deviation|13.8|13.8|||
3731184|NCT02057237|3568258|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3731185|NCT02057237|3568258|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3731186|NCT02057237|3568258|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3731187|NCT02057237|3568258|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3731188|NCT02057237|3568258|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3731189|NCT02057237|3568258|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3731190|NCT02057068|3568263|B3|United States||Region of Enrollment||Participants|Count of Participants|96|96.0||||||
3731191|NCT02057068|3568264|B2|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3731192|NCT02057068|3568265|B1|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3731193|NCT02057068|3568263|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3731194|NCT02057068|3568264|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3731195|NCT02057068|3568265|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3731196|NCT02057068|3568263|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3731197|NCT02057068|3568264|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3731198|NCT02057068|3568265|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3731199|NCT02057068|3568263|B3|||Age|"Baseline measures were collected in the home of the dyads by trained interviewers.~In addition dyads completed morning and evening daily diaries for 7 days."|Years|Mean|70.12|70.12|Standard Deviation|8.61|8.61|||
3731200|NCT02057068|3568264|B2|||Age|"Baseline measures were collected in the home of the dyads by trained interviewers.~In addition dyads completed morning and evening daily diaries for 7 days."|Years|Mean|70.11|70.11|Standard Deviation|9.43|9.43|||
3731201|NCT02057068|3568265|B1|||Age|"Baseline measures were collected in the home of the dyads by trained interviewers.~In addition dyads completed morning and evening daily diaries for 7 days."|Years|Mean|70.12|70.12|Standard Deviation|8.14|8.14|||
3731202|NCT02056834|3568276|B1|AO-OTA 42 (diaphyseal tibia fracture)||Fracture type|Patients can have more than one fracture type.|participants|Number|0|0.0||||||
3731203|NCT02056834|3568276|B1|AO-OTA 41 (proximal tibia fracture)||Fracture type|Patients can have more than one fracture type.|participants|Number|29|29.0||||||
3731204|NCT02056834|3568276|B1|Schatzker Type VI (split extends to metadiaphysis)||Fracture type|Patients can have more than one fracture type.|participants|Number|10|10.0||||||
3731205|NCT02056834|3568276|B1|Schatzker Type V (bicondylar)||Fracture type|Patients can have more than one fracture type.|participants|Number|6|6.0||||||
3731206|NCT02056834|3568276|B1|Schatzker Type IV (pure medial depression)||Fracture type|Patients can have more than one fracture type.|participants|Number|2|2.0||||||
3731207|NCT02056834|3568276|B1|Schatzker Type III (pure lateral depression)||Fracture type|Patients can have more than one fracture type.|participants|Number|0|0.0||||||
3731208|NCT02056834|3568276|B1|Schatzker Type II (split with depression)||Fracture type|Patients can have more than one fracture type.|participants|Number|14|14.0||||||
3731209|NCT02056834|3568276|B1|Schatzker Type I (lateral split)||Fracture type|Patients can have more than one fracture type.|participants|Number|1|1.0||||||
3731210|NCT02056834|3568276|B1|Other||Accident type|Patients can have more than one accident type.|participants|Number|2|2.0||||||
3731211|NCT02056834|3568276|B1|Car occupant in traffic accident||Accident type|Patients can have more than one accident type.|participants|Number|7|7.0||||||
3731212|NCT02056834|3568276|B1|Pedestrian in traffic accident||Accident type|Patients can have more than one accident type.|participants|Number|11|11.0||||||
3731213|NCT02056834|3568276|B1|Motorcycle accident||Accident type|Patients can have more than one accident type.|participants|Number|4|4.0||||||
3731214|NCT02056834|3568276|B1|Simple fall||Accident type|Patients can have more than one accident type.|participants|Number|3|3.0||||||
3731215|NCT02056834|3568276|B1|Fall from height||Accident type|Patients can have more than one accident type.|participants|Number|3|3.0||||||
3731216|NCT02056834|3568276|B1|Direct blow||Accident type|Patients can have more than one accident type.|participants|Number|9|9.0||||||
3731217|NCT02056834|3568276|B1|High energy||Accident type|Patients can have more than one accident type.|participants|Number|23|23.0||||||
3731218|NCT02056834|3568276|B1|Low energy||Accident type|Patients can have more than one accident type.|participants|Number|1|1.0||||||
3731219|NCT02056834|3568276|B1|Sport||Accident type|Patients can have more than one accident type.|participants|Number|1|1.0||||||
3731220|NCT02056834|3568276|B1|Other||Preoperative medical conditions (description)|Subjects can have more than one medical condition.|participants|Number|3|3.0||||||
3731221|NCT02056834|3568276|B1|Vascular||Preoperative medical conditions (description)|Subjects can have more than one medical condition.|participants|Number|3|3.0||||||
3731222|NCT02056834|3568276|B1|Urogenital||Preoperative medical conditions (description)|Subjects can have more than one medical condition.|participants|Number|0|0.0||||||
3731223|NCT02056834|3568276|B1|Respiratory||Preoperative medical conditions (description)|Subjects can have more than one medical condition.|participants|Number|2|2.0||||||
3731224|NCT02056834|3568276|B1|Psychiatric||Preoperative medical conditions (description)|Subjects can have more than one medical condition.|participants|Number|0|0.0||||||
3731225|NCT02056834|3568276|B1|Neurologic||Preoperative medical conditions (description)|Subjects can have more than one medical condition.|participants|Number|1|1.0||||||
3731226|NCT02056834|3568276|B1|Musculoskeletal including fractures||Preoperative medical conditions (description)|Subjects can have more than one medical condition.|participants|Number|0|0.0||||||
3731227|NCT02056834|3568276|B1|Infection||Preoperative medical conditions (description)|Subjects can have more than one medical condition.|participants|Number|0|0.0||||||
3731228|NCT02056834|3568276|B1|Implants/Prosthesis||Preoperative medical conditions (description)|Subjects can have more than one medical condition.|participants|Number|0|0.0||||||
3731229|NCT02056834|3568276|B1|Hematologic||Preoperative medical conditions (description)|Subjects can have more than one medical condition.|participants|Number|0|0.0||||||
3731230|NCT02056834|3568276|B1|Endocrine||Preoperative medical conditions (description)|Subjects can have more than one medical condition.|participants|Number|4|4.0||||||
3731231|NCT02056834|3568276|B1|Dermatological||Preoperative medical conditions (description)|Subjects can have more than one medical condition.|participants|Number|1|1.0||||||
3731232|NCT02056834|3568276|B1|Congenital||Preoperative medical conditions (description)|Subjects can have more than one medical condition.|participants|Number|0|0.0||||||
3731233|NCT02056834|3568276|B1|Cardiac||Preoperative medical conditions (description)|Subjects can have more than one medical condition.|participants|Number|4|4.0||||||
3731234|NCT02056834|3568276|B1|Cancer||Preoperative medical conditions (description)|Subjects can have more than one medical condition.|participants|Number|0|0.0||||||
3731235|NCT02056834|3568276|B1|Allergies||Preoperative medical conditions (description)|Subjects can have more than one medical condition.|participants|Number|0|0.0||||||
3731236|NCT02056834|3568276|B1|Adiposity||Preoperative medical conditions (description)|Subjects can have more than one medical condition.|participants|Number|1|1.0||||||
3731237|NCT02056834|3568276|B1|Any||Preoperative medical condition||participants|Number|14|14.0||||||
3731238|NCT02056834|3568276|B1|None||Preoperative medical condition||participants|Number|22|22.0||||||
3731239|NCT02056834|3568276|B1|Other||Occupation||participants|Number|4|4.0||||||
3731240|NCT02056834|3568276|B1|Moderate industrial or moderate physical labour||Occupation||participants|Number|5|5.0||||||
3731241|NCT02056834|3568276|B1|Light industrial or light industrial labour||Occupation||participants|Number|6|6.0||||||
3731242|NCT02056834|3568276|B1|Retired||Occupation||participants|Number|6|6.0||||||
3731243|NCT02056834|3568276|B1|Home worker||Occupation||participants|Number|7|7.0||||||
3731244|NCT02056834|3568276|B1|Office worker||Occupation||participants|Number|5|5.0||||||
3731245|NCT02056834|3568276|B1|Student||Occupation||participants|Number|3|3.0||||||
3731246|NCT02056834|3568276|B1|Missing||Health status||participants|Number|1|1.0||||||
3731247|NCT02056834|3568276|B1|Poor||Health status||participants|Number|0|0.0||||||
3731248|NCT02056834|3568276|B1|Fair||Health status||participants|Number|3|3.0||||||
3731249|NCT02056834|3568276|B1|Good||Health status||participants|Number|28|28.0||||||
3731250|NCT02056834|3568276|B1|Excellent||Health status||participants|Number|4|4.0||||||
3731251|NCT02056834|3568276|B1|5 or more times per week||Exercise per week||participants|Number|1|1.0||||||
3731252|NCT02056834|3568276|B1|3-4 times per week||Exercise per week||participants|Number|5|5.0||||||
3731253|NCT02056834|3568276|B1|1-2 times per week||Exercise per week||participants|Number|21|21.0||||||
3731254|NCT02056834|3568276|B1|Never||Exercise per week||participants|Number|9|9.0||||||
3731255|NCT02056834|3568276|B1|||Body mass index||kg/m2|Mean|23.3|23.3|Standard Deviation|3.67|3.67|||
3731256|NCT02056834|3568276|B1|||Weight||kg|Mean|62.6|62.6|Standard Deviation|12.15|12.15|||
3731257|NCT02056834|3568276|B1|||Height||cm|Mean|163.4|163.4|Standard Deviation|8.99|8.99|||
3731258|NCT02056834|3568276|B1|Current||Smoking status||participants|Number|9|9.0||||||
3731259|NCT02056834|3568276|B1|Former||Smoking status||participants|Number|4|4.0||||||
3731260|NCT02056834|3568276|B1|Never||Smoking status||participants|Number|23|23.0||||||
3731261|NCT02056834|3568276|B1|Korea, Republic of||Region of Enrollment||participants|Number|36|36.0||||||
3731262|NCT02056834|3568276|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731263|NCT02056834|3568276|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731264|NCT02056834|3568276|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731265|NCT02056834|3568276|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731266|NCT02056834|3568276|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731267|NCT02056834|3568276|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3731268|NCT02056834|3568276|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731269|NCT02056834|3568276|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3731270|NCT02056834|3568276|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3731271|NCT02056834|3568276|B1|Age group >58 years||Age, Customized||participants|Number|17|17.0||||||
3731272|NCT02056834|3568276|B1|Age group <=58 years||Age, Customized||participants|Number|19|19.0||||||
3731273|NCT02056834|3568276|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|14.6|14.6|||
3731274|NCT02056652|3568295|B3|United States||Region of Enrollment||Participants|Count of Participants|122|122.0||||||
3731275|NCT02056652|3568296|B2|United States||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
3731276|NCT02056652|3568297|B1|United States||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
3731277|NCT02056652|3568295|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3731278|NCT02056652|3568296|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3731279|NCT02056652|3568297|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3731280|NCT02056652|3568295|B3||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3731281|NCT02056652|3568296|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3731282|NCT02056652|3568297|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3731283|NCT02056652|3568295|B3|Maternal Age||Age, Customized||years|Mean|28.6|28.6|Full Range|||23.0|34.8|
3731284|NCT02056652|3568296|B2|Maternal Age||Age, Customized||years|Mean|29.5|29.5|Full Range|||23.0|34.8|
3731285|NCT02056652|3568297|B1|Maternal Age||Age, Customized||years|Mean|27.7|27.7|Full Range|||23.0|32.3|
3731286|NCT02056639|3568314|B3|United States||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
3731287|NCT02056639|3568315|B2|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3731288|NCT02056639|3568316|B1|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3731289|NCT02056639|3568314|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3731290|NCT02056639|3568315|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3731291|NCT02056639|3568316|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3731292|NCT02056639|3568314|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3731293|NCT02056639|3568315|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3731294|NCT02056639|3568316|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3731295|NCT02056639|3568314|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3731296|NCT02056639|3568315|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3731297|NCT02056639|3568316|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3731298|NCT02056639|3568314|B3||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
3731299|NCT02056639|3568315|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3731300|NCT02056639|3568316|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3731301|NCT02056639|3568314|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3731302|NCT02056639|3568315|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3731303|NCT02056639|3568316|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3731304|NCT02056431|3568331|B3|United States||Region of Enrollment||Participants|Count of Participants|1270|1270.0||||||
3731305|NCT02056431|3568332|B2|United States||Region of Enrollment||Participants|Count of Participants|666|666.0||||||
3731306|NCT02056431|3568333|B1|United States||Region of Enrollment||Participants|Count of Participants|604|604.0||||||
3731307|NCT02056431|3568331|B3|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3731308|NCT02056431|3568332|B2|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3731309|NCT02056431|3568333|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3731310|NCT02056431|3568331|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|248|248.0||||||
3731311|NCT02056431|3568332|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|133|133.0||||||
3731312|NCT02056431|3568333|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|115|115.0||||||
3731313|NCT02056431|3568331|B3|More than One Race||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3731314|NCT02056431|3568332|B2|More than One Race||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3731315|NCT02056431|3568333|B1|More than One Race||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3731316|NCT02056431|3568331|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|718|718.0||||||
3731317|NCT02056431|3568332|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|375|375.0||||||
3731318|NCT02056431|3568333|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|343|343.0||||||
3731319|NCT02056431|3568331|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|167|167.0||||||
3731320|NCT02056431|3568332|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|88|88.0||||||
3731321|NCT02056431|3568333|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|79|79.0||||||
3731322|NCT02056431|3568331|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3731323|NCT02056431|3568332|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3731324|NCT02056431|3568333|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3731325|NCT02056431|3568331|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|104|104.0||||||
3731326|NCT02056431|3568332|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
3731327|NCT02056431|3568333|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|54|54.0||||||
3731328|NCT02056431|3568331|B3|American Indian/Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3731329|NCT02056431|3568332|B2|American Indian/Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3731330|NCT02056431|3568333|B1|American Indian/Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3731331|NCT02056431|3568331|B3||Male|Sex: Female, Male||Participants|Count of Participants|592|592.0||||||
3731332|NCT02056431|3568332|B2||Male|Sex: Female, Male||Participants|Count of Participants|317|317.0||||||
3731333|NCT02056431|3568333|B1||Male|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
3731334|NCT02056431|3568331|B3||Female|Sex: Female, Male||Participants|Count of Participants|678|678.0||||||
3731335|NCT02056431|3568332|B2||Female|Sex: Female, Male||Participants|Count of Participants|349|349.0||||||
3731336|NCT02056431|3568333|B1||Female|Sex: Female, Male||Participants|Count of Participants|329|329.0||||||
3731337|NCT02056431|3568331|B3|||Age||years|Mean|67.0|67.0|Standard Deviation|11.8|11.8|||
3731338|NCT02056431|3568332|B2|||Age||years|Mean|67.0|67.0|Standard Deviation|11.5|11.5|||
3731339|NCT02056431|3568333|B1|||Age||years|Mean|67.1|67.1|Standard Deviation|12.0|12.0|||
3731340|NCT02056392|3568342|B7|Black or African American||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
3731341|NCT02056392|3568343|B6|Black or African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3731342|NCT02056392|3568344|B5|Black or African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3731343|NCT02056392|3568345|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3731344|NCT02056392|3568346|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3731345|NCT02056392|3568347|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3731346|NCT02056392|3568348|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3731347|NCT02056392|3568342|B7|White||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
3731348|NCT02056392|3568343|B6|White||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3731349|NCT02056392|3568344|B5|White||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3731350|NCT02056392|3568345|B4|White||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3731351|NCT02056392|3568346|B3|White||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3731352|NCT02056392|3568347|B2|White||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3731353|NCT02056392|3568348|B1|White||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3731354|NCT02056392|3568342|B7||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3731355|NCT02056392|3568343|B6||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3731356|NCT02056392|3568344|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3731357|NCT02056392|3568345|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3731358|NCT02056392|3568346|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3731359|NCT02056392|3568347|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3731360|NCT02056392|3568348|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3731361|NCT02056392|3568342|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3731362|NCT02056392|3568343|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3731363|NCT02056392|3568344|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3731364|NCT02056392|3568345|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3731365|NCT02056392|3568346|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3731366|NCT02056392|3568347|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3731367|NCT02056392|3568348|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3731368|NCT02056392|3568342|B7|||Age||Years|Mean|27|27.0|Standard Deviation|7|7.0|||
3731369|NCT02056392|3568343|B6|||Age||Years|Mean|30|30.0|Standard Deviation|9|9.0|||
3731370|NCT02056392|3568344|B5|||Age||Years|Mean|28|28.0|Standard Deviation|8|8.0|||
3731371|NCT02056392|3568345|B4|||Age||Years|Mean|31|31.0|Standard Deviation|8|8.0|||
3731372|NCT02056392|3568346|B3|||Age||Years|Mean|25|25.0|Standard Deviation|4|4.0|||
3731373|NCT02056392|3568347|B2|||Age||Years|Mean|25|25.0|Standard Deviation|5|5.0|||
3731374|NCT02056392|3568348|B1|||Age||Years|Mean|26|26.0|Standard Deviation|7|7.0|||
3731375|NCT02056171|3568388|B3|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3731376|NCT02056171|3568389|B2|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3731377|NCT02056171|3568390|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3731378|NCT02056171|3568388|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731379|NCT02056171|3568389|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731380|NCT02056171|3568390|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731381|NCT02056171|3568388|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731382|NCT02056171|3568389|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731383|NCT02056171|3568390|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731384|NCT02056171|3568388|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3731385|NCT02056171|3568389|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3731386|NCT02056171|3568390|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3731387|NCT02056171|3568388|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3731388|NCT02056171|3568389|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3731389|NCT02056171|3568390|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731390|NCT02056171|3568388|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731391|NCT02056171|3568389|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731392|NCT02056171|3568390|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731393|NCT02056171|3568388|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3731394|NCT02056171|3568389|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731395|NCT02056171|3568390|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3731396|NCT02056171|3568388|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731397|NCT02056171|3568389|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731398|NCT02056171|3568390|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731399|NCT02056171|3568388|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731400|NCT02056171|3568389|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731401|NCT02056171|3568390|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731402|NCT02056171|3568388|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3731403|NCT02056171|3568389|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3731677|NCT02054910|3568636|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3731404|NCT02056171|3568390|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3731405|NCT02056171|3568388|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3731406|NCT02056171|3568389|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3731407|NCT02056171|3568390|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3731408|NCT02056171|3568388|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3731409|NCT02056171|3568389|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3731410|NCT02056171|3568390|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3731411|NCT02056171|3568388|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3731412|NCT02056171|3568389|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3731413|NCT02056171|3568390|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3731414|NCT02056171|3568388|B3|||Age||years|Median|3|3.0|Full Range|||2.0|18.0|
3731415|NCT02056171|3568389|B2|||Age||years|Median|3|3.0|Full Range|||2.0|3.0|
3731416|NCT02056171|3568390|B1|||Age||years|Median|4|4.0|Full Range|||3.0|18.0|
3731417|NCT02056171|3568388|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3731418|NCT02056171|3568389|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3731419|NCT02056171|3568390|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3731420|NCT02056171|3568388|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3731421|NCT02056171|3568389|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3731422|NCT02056171|3568390|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3731423|NCT02056171|3568388|B3||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3731424|NCT02056171|3568389|B2||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3731425|NCT02056171|3568390|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3731426|NCT02055820|3568401|B11||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3731427|NCT02055820|3568402|B10||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3731428|NCT02055820|3568403|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3731429|NCT02055820|3568404|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3731430|NCT02055820|3568405|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3731431|NCT02055820|3568406|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731432|NCT02055820|3568407|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3731433|NCT02055820|3568408|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3731434|NCT02055820|3568409|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3731435|NCT02055820|3568410|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3731436|NCT02055820|3568411|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3731437|NCT02055820|3568401|B11||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731438|NCT02055820|3568402|B10||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731439|NCT02055820|3568403|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731440|NCT02055820|3568404|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731441|NCT02055820|3568405|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731442|NCT02055820|3568406|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731443|NCT02055820|3568407|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731444|NCT02055820|3568408|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731445|NCT02055820|3568409|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731446|NCT02055820|3568410|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731447|NCT02055820|3568411|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731448|NCT02055820|3568401|B11||White|Race (NIH/OMB)||Participants|Count of Participants|190|190.0||||||
3731449|NCT02055820|3568402|B10||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3731450|NCT02055820|3568403|B9||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3731451|NCT02055820|3568404|B8||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3731452|NCT02055820|3568405|B7||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3731453|NCT02055820|3568406|B6||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3731454|NCT02055820|3568407|B5||White|Race (NIH/OMB)||Participants|Count of Participants|157|157.0||||||
3731455|NCT02055820|3568408|B4||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3731456|NCT02055820|3568409|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3731457|NCT02055820|3568410|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3731458|NCT02055820|3568411|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3731459|NCT02055820|3568401|B11||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3731460|NCT02055820|3568402|B10||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731461|NCT02055820|3568403|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731462|NCT02055820|3568404|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731463|NCT02055820|3568405|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731464|NCT02055820|3568406|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731465|NCT02055820|3568407|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3731466|NCT02055820|3568408|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731467|NCT02055820|3568409|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731468|NCT02055820|3568410|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731469|NCT02055820|3568411|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731470|NCT02055820|3568401|B11||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3731471|NCT02055820|3568402|B10||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731472|NCT02055820|3568403|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731473|NCT02055820|3568404|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731474|NCT02055820|3568405|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731475|NCT02055820|3568406|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731476|NCT02055820|3568407|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3731477|NCT02055820|3568408|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731478|NCT02055820|3568409|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731479|NCT02055820|3568410|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731480|NCT02055820|3568411|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731481|NCT02055820|3568401|B11||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3731482|NCT02055820|3568402|B10||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731483|NCT02055820|3568403|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731484|NCT02055820|3568404|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731485|NCT02055820|3568405|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3731486|NCT02055820|3568406|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731487|NCT02055820|3568407|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3731488|NCT02055820|3568408|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731489|NCT02055820|3568409|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731490|NCT02055820|3568410|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731491|NCT02055820|3568411|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731492|NCT02055820|3568401|B11||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731493|NCT02055820|3568402|B10||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731494|NCT02055820|3568403|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731495|NCT02055820|3568404|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731496|NCT02055820|3568405|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731497|NCT02055820|3568406|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731498|NCT02055820|3568407|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731499|NCT02055820|3568408|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731500|NCT02055820|3568409|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731501|NCT02055820|3568410|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731502|NCT02055820|3568411|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731503|NCT02055820|3568401|B11||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3731504|NCT02055820|3568402|B10||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731505|NCT02055820|3568403|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3731506|NCT02055820|3568404|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3731507|NCT02055820|3568405|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3731508|NCT02055820|3568406|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3731509|NCT02055820|3568407|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3731510|NCT02055820|3568408|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3731511|NCT02055820|3568409|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3731512|NCT02055820|3568410|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3731513|NCT02055820|3568411|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3731514|NCT02055820|3568401|B11||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|190|190.0||||||
3731515|NCT02055820|3568402|B10||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3731516|NCT02055820|3568403|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3731517|NCT02055820|3568404|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3731518|NCT02055820|3568405|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3731519|NCT02055820|3568406|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3731520|NCT02055820|3568407|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|154|154.0||||||
3731521|NCT02055820|3568408|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3731522|NCT02055820|3568409|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3731523|NCT02055820|3568410|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3731524|NCT02055820|3568411|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3731525|NCT02055820|3568401|B11||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3731526|NCT02055820|3568402|B10||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731527|NCT02055820|3568403|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731528|NCT02055820|3568404|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731529|NCT02055820|3568405|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731530|NCT02055820|3568406|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731531|NCT02055820|3568407|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3731532|NCT02055820|3568408|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731533|NCT02055820|3568409|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731534|NCT02055820|3568410|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731535|NCT02055820|3568411|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731536|NCT02055820|3568401|B11||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3731537|NCT02055820|3568402|B10||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3731538|NCT02055820|3568403|B9||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3731539|NCT02055820|3568404|B8||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3731540|NCT02055820|3568405|B7||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3731541|NCT02055820|3568406|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3731542|NCT02055820|3568407|B5||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3731543|NCT02055820|3568408|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3731544|NCT02055820|3568409|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3731545|NCT02055820|3568410|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3731546|NCT02055820|3568411|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3731547|NCT02055820|3568401|B11||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3731548|NCT02055820|3568402|B10||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3731549|NCT02055820|3568403|B9||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3731550|NCT02055820|3568404|B8||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3731551|NCT02055820|3568405|B7||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3731552|NCT02055820|3568406|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3731553|NCT02055820|3568407|B5||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3731554|NCT02055820|3568408|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3731555|NCT02055820|3568409|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3731556|NCT02055820|3568410|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3731557|NCT02055820|3568411|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3731558|NCT02055820|3568401|B11|||Age||Years|Mean|61.2|61.2|Standard Deviation|12.4|12.4|||
3731559|NCT02055820|3568402|B10|||Age||Years|Mean|66.8|66.8|Standard Deviation|6.7|6.7|||
3731560|NCT02055820|3568403|B9|||Age||Years|Mean|60.5|60.5|Standard Deviation|13.7|13.7|||
3731561|NCT02055820|3568404|B8|||Age||Years|Mean|66.7|66.7|Standard Deviation|4.2|4.2|||
3731562|NCT02055820|3568405|B7|||Age||Years|Mean|60.9|60.9|Standard Deviation|6.3|6.3|||
3731563|NCT02055820|3568406|B6|||Age||Years|Mean|52.1|52.1|Standard Deviation|16.2|16.2|||
3731564|NCT02055820|3568407|B5|||Age||Years|Mean|61.4|61.4|Standard Deviation|12.8|12.8|||
3731565|NCT02055820|3568408|B4|||Age||Years|Mean|56.3|56.3|Standard Deviation|11.9|11.9|||
3731566|NCT02055820|3568409|B3|||Age||Years|Mean|57.0|57.0|Standard Deviation|9.5|9.5|||
3731567|NCT02055820|3568410|B2|||Age||Years|Mean|61.0|61.0|Standard Deviation|13.1|13.1|||
3731568|NCT02055820|3568411|B1|||Age||Years|Mean|67.0|67.0|Standard Deviation|9.2|9.2|||
3731569|NCT02055430|3568522|B3|patients with radioopaque stones||radiolucency of stones||participants|Number|35|35.0||||||
3731570|NCT02055430|3568523|B2|patients with radioopaque stones||radiolucency of stones||participants|Number|17|17.0||||||
3731571|NCT02055430|3568524|B1|patients with radioopaque stones||radiolucency of stones||participants|Number|18|18.0||||||
3731572|NCT02055430|3568522|B3|patients with radiolucent stones||radiolucency of stones||participants|Number|55|55.0||||||
3731573|NCT02055430|3568523|B2|patients with radiolucent stones||radiolucency of stones||participants|Number|28|28.0||||||
3731574|NCT02055430|3568524|B1|patients with radiolucent stones||radiolucency of stones||participants|Number|27|27.0||||||
3731618|NCT02055365|3568544|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3731575|NCT02055430|3568522|B3|lower ureter||site of stone (180 ureterorenal units)|each arm contains 90 ureterorenal units in 45 participants|ureterorenal units of participants|Number|75|75.0||||||
3731576|NCT02055430|3568523|B2|lower ureter||site of stone (180 ureterorenal units)|each arm contains 90 ureterorenal units in 45 participants|ureterorenal units of participants|Number|38|38.0||||||
3731577|NCT02055430|3568524|B1|lower ureter||site of stone (180 ureterorenal units)|each arm contains 90 ureterorenal units in 45 participants|ureterorenal units of participants|Number|37|37.0||||||
3731578|NCT02055430|3568522|B3|middle ureter||site of stone (180 ureterorenal units)|each arm contains 90 ureterorenal units in 45 participants|ureterorenal units of participants|Number|31|31.0||||||
3731579|NCT02055430|3568523|B2|middle ureter||site of stone (180 ureterorenal units)|each arm contains 90 ureterorenal units in 45 participants|ureterorenal units of participants|Number|15|15.0||||||
3731580|NCT02055430|3568524|B1|middle ureter||site of stone (180 ureterorenal units)|each arm contains 90 ureterorenal units in 45 participants|ureterorenal units of participants|Number|16|16.0||||||
3731581|NCT02055430|3568522|B3|upper ureter||site of stone (180 ureterorenal units)|each arm contains 90 ureterorenal units in 45 participants|ureterorenal units of participants|Number|74|74.0||||||
3731582|NCT02055430|3568523|B2|upper ureter||site of stone (180 ureterorenal units)|each arm contains 90 ureterorenal units in 45 participants|ureterorenal units of participants|Number|37|37.0||||||
3731583|NCT02055430|3568524|B1|upper ureter||site of stone (180 ureterorenal units)|each arm contains 90 ureterorenal units in 45 participants|ureterorenal units of participants|Number|37|37.0||||||
3731584|NCT02055430|3568522|B3|||size of stone||mm|Mean|14.1|14.1|Standard Deviation|5.2|5.2|||
3731585|NCT02055430|3568523|B2|||size of stone||mm|Mean|13.25|13.25|Standard Deviation|5.37|5.37|||
3731586|NCT02055430|3568524|B1|||size of stone||mm|Mean|15.011|15.011|Standard Deviation|4.22|4.22|||
3731587|NCT02055430|3568522|B3|grade 3-4||hydronephrosis|"Hydronephrosis was graded according to the Society for Fetal Urology grading system for hydronephrosis~Fernbach SK, Maizels M, Conway JJ. Ultrasound grading of hydronephrosis: introduction to the system used by the Society for Fetal Urology. PediatrRadiol 1993;23:478-80."|participants|Number|33|33.0||||||
3731588|NCT02055430|3568523|B2|grade 3-4||hydronephrosis|"Hydronephrosis was graded according to the Society for Fetal Urology grading system for hydronephrosis~Fernbach SK, Maizels M, Conway JJ. Ultrasound grading of hydronephrosis: introduction to the system used by the Society for Fetal Urology. PediatrRadiol 1993;23:478-80."|participants|Number|15|15.0||||||
3731589|NCT02055430|3568524|B1|grade 3-4||hydronephrosis|"Hydronephrosis was graded according to the Society for Fetal Urology grading system for hydronephrosis~Fernbach SK, Maizels M, Conway JJ. Ultrasound grading of hydronephrosis: introduction to the system used by the Society for Fetal Urology. PediatrRadiol 1993;23:478-80."|participants|Number|18|18.0||||||
3731590|NCT02055430|3568522|B3|grade 2||hydronephrosis|"Hydronephrosis was graded according to the Society for Fetal Urology grading system for hydronephrosis~Fernbach SK, Maizels M, Conway JJ. Ultrasound grading of hydronephrosis: introduction to the system used by the Society for Fetal Urology. PediatrRadiol 1993;23:478-80."|participants|Number|57|57.0||||||
3731591|NCT02055430|3568523|B2|grade 2||hydronephrosis|"Hydronephrosis was graded according to the Society for Fetal Urology grading system for hydronephrosis~Fernbach SK, Maizels M, Conway JJ. Ultrasound grading of hydronephrosis: introduction to the system used by the Society for Fetal Urology. PediatrRadiol 1993;23:478-80."|participants|Number|30|30.0||||||
3731592|NCT02055430|3568524|B1|grade 2||hydronephrosis|"Hydronephrosis was graded according to the Society for Fetal Urology grading system for hydronephrosis~Fernbach SK, Maizels M, Conway JJ. Ultrasound grading of hydronephrosis: introduction to the system used by the Society for Fetal Urology. PediatrRadiol 1993;23:478-80."|participants|Number|27|27.0||||||
3731593|NCT02055430|3568522|B3|||creatinine||mg/dL|Mean|4.59|4.59|Standard Deviation|1.901|1.901|||
3731594|NCT02055430|3568523|B2|||creatinine||mg/dL|Mean|4.8|4.8|Standard Deviation|1.9|1.9|||
3731595|NCT02055430|3568524|B1|||creatinine||mg/dL|Mean|4.3|4.3|Standard Deviation|1.8|1.8|||
3731596|NCT02055430|3568522|B3|Egypt||Region of Enrollment||participants|Number|90|90.0||||||
3731597|NCT02055430|3568523|B2|Egypt||Region of Enrollment||participants|Number|45|45.0||||||
3731598|NCT02055430|3568524|B1|Egypt||Region of Enrollment||participants|Number|45|45.0||||||
3731599|NCT02055430|3568522|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3731600|NCT02055430|3568523|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3731601|NCT02055430|3568524|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3731602|NCT02055430|3568522|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3731603|NCT02055430|3568523|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3731604|NCT02055430|3568524|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3731605|NCT02055430|3568522|B3|||Age||years|Mean|4.42|4.42|Standard Deviation|2.213|2.213|||
3731606|NCT02055430|3568523|B2|||Age||years|Mean|4.07|4.07|Standard Deviation|2.093|2.093|||
3731607|NCT02055430|3568524|B1|||Age||years|Mean|4.78|4.78|Standard Deviation|2.295|2.295|||
3731608|NCT02055404|3568531|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3731609|NCT02055404|3568531|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3731610|NCT02055404|3568531|B1|||Age||years|Mean|46.0|46.0|Standard Deviation|21.3|21.3|||
3731611|NCT02055365|3568544|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3731612|NCT02055365|3568544|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731613|NCT02055365|3568544|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3731614|NCT02055365|3568544|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3731615|NCT02055365|3568544|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731616|NCT02055365|3568544|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3731617|NCT02055365|3568544|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3731619|NCT02055365|3568544|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3731620|NCT02055365|3568544|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3731621|NCT02055365|3568544|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3731622|NCT02055365|3568544|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3731623|NCT02055365|3568544|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3731624|NCT02055365|3568544|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3731625|NCT02055365|3568544|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3731626|NCT02055352|3568555|B3||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3731627|NCT02055352|3568556|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3731628|NCT02055352|3568557|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3731629|NCT02055352|3568555|B3||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3731630|NCT02055352|3568556|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3731631|NCT02055352|3568557|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3731632|NCT02055352|3568555|B3|||Age||Years|Mean|67.2|67.2|Standard Deviation|8.70|8.7|||
3731633|NCT02055352|3568556|B2|||Age||Years|Mean|67.3|67.3|Standard Deviation|8.45|8.45|||
3731634|NCT02055352|3568557|B1|||Age||Years|Mean|67.1|67.1|Standard Deviation|9|9.0|||
3731635|NCT02055118|3568572|B4|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3731636|NCT02055118|3568573|B3|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3731637|NCT02055118|3568574|B2|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3731638|NCT02055118|3568575|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3731639|NCT02055118|3568572|B4|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3731640|NCT02055118|3568573|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3731641|NCT02055118|3568574|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3731642|NCT02055118|3568575|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3731643|NCT02055118|3568572|B4|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3731644|NCT02055118|3568573|B3|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3731645|NCT02055118|3568574|B2|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3731646|NCT02055118|3568575|B1|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3731647|NCT02055118|3568572|B4|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3731648|NCT02055118|3568573|B3|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3731649|NCT02055118|3568574|B2|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3731650|NCT02055118|3568575|B1|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3731651|NCT02055118|3568572|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3731652|NCT02055118|3568573|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731653|NCT02055118|3568574|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731654|NCT02055118|3568575|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3731655|NCT02055118|3568572|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3731656|NCT02055118|3568573|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3731657|NCT02055118|3568574|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3731658|NCT02055118|3568575|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3731659|NCT02055118|3568572|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3731660|NCT02055118|3568573|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3731661|NCT02055118|3568574|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3731662|NCT02055118|3568575|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3731663|NCT02055118|3568572|B4||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3731664|NCT02055118|3568573|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3731665|NCT02055118|3568574|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3731666|NCT02055118|3568575|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3731667|NCT02055118|3568572|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3731668|NCT02055118|3568573|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3731669|NCT02055118|3568574|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3731670|NCT02055118|3568575|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3731671|NCT02055118|3568572|B4|||Age||Years|Mean|4.65|4.65|Standard Deviation|1.980|1.98|||
3731672|NCT02055118|3568573|B3|||Age||Years|Mean|2.48|2.48|Standard Deviation|0.483|0.483|||
3731673|NCT02055118|3568574|B2|||Age||Years|Mean|4.95|4.95|Standard Deviation|1.496|1.496|||
3731674|NCT02055118|3568575|B1|||Age||Years|Mean|5.29|5.29|Standard Deviation|2.624|2.624|||
3731675|NCT02054910|3568634|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3731676|NCT02054910|3568635|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3731678|NCT02054910|3568634|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731679|NCT02054910|3568635|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731680|NCT02054910|3568636|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731681|NCT02054910|3568634|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731682|NCT02054910|3568635|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731683|NCT02054910|3568636|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731684|NCT02054910|3568634|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3731685|NCT02054910|3568635|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3731686|NCT02054910|3568636|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3731687|NCT02054910|3568634|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3731688|NCT02054910|3568635|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731689|NCT02054910|3568636|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3731690|NCT02054910|3568634|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731691|NCT02054910|3568635|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731692|NCT02054910|3568636|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731693|NCT02054910|3568634|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731694|NCT02054910|3568635|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731695|NCT02054910|3568636|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731696|NCT02054910|3568634|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731697|NCT02054910|3568635|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731698|NCT02054910|3568636|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731699|NCT02054910|3568634|B3||Male|Gender||Participants|Count of Participants|1|1.0||||||
3731700|NCT02054910|3568635|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3731701|NCT02054910|3568636|B1||Male|Gender||Participants|Count of Participants|1|1.0||||||
3731702|NCT02054910|3568634|B3||Female|Gender||Participants|Count of Participants|4|4.0||||||
3731703|NCT02054910|3568635|B2||Female|Gender||Participants|Count of Participants|1|1.0||||||
3731704|NCT02054910|3568636|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
3731705|NCT02054910|3568634|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3731706|NCT02054910|3568635|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3731707|NCT02054910|3568636|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3731708|NCT02054910|3568634|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3731709|NCT02054910|3568635|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3731710|NCT02054910|3568636|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3731711|NCT02054910|3568634|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3731712|NCT02054910|3568635|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3731713|NCT02054910|3568636|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3731714|NCT02054897|3568653|B4|||Systolic blood pressure||mmHg|Mean|128.78|128.78|Standard Deviation|13.18|13.18|||
3731715|NCT02054897|3568654|B3|||Systolic blood pressure||mmHg|Mean|129.57|129.57|Standard Deviation|13.50|13.5|||
3731716|NCT02054897|3568655|B2|||Systolic blood pressure||mmHg|Mean|128.89|128.89|Standard Deviation|12.92|12.92|||
3731717|NCT02054897|3568656|B1|||Systolic blood pressure||mmHg|Mean|127.87|127.87|Standard Deviation|13.15|13.15|||
3731718|NCT02054897|3568653|B4|||Diastolic blood pressure||mmHg|Mean|79.30|79.3|Standard Deviation|8.64|8.64|||
3731719|NCT02054897|3568654|B3|||Diastolic blood pressure||mmHg|Mean|79.14|79.14|Standard Deviation|8.39|8.39|||
3731720|NCT02054897|3568655|B2|||Diastolic blood pressure||mmHg|Mean|79.25|79.25|Standard Deviation|8.52|8.52|||
3731721|NCT02054897|3568656|B1|||Diastolic blood pressure||mmHg|Mean|79.52|79.52|Standard Deviation|9.06|9.06|||
3731722|NCT02054897|3568653|B4|||Body weight||kilogram(s)|Mean|91.93|91.93|Standard Deviation|23.83|23.83|||
3731723|NCT02054897|3568654|B3|||Body weight||kilogram(s)|Mean|89.05|89.05|Standard Deviation|22.16|22.16|||
3731724|NCT02054897|3568655|B2|||Body weight||kilogram(s)|Mean|96.87|96.87|Standard Deviation|25.59|25.59|||
3731725|NCT02054897|3568656|B1|||Body weight||kilogram(s)|Mean|89.81|89.81|Standard Deviation|22.96|22.96|||
3731726|NCT02054897|3568653|B4|||Fasting plasma glucose||mmol/L|Mean|9.75|9.75|Standard Deviation|2.67|2.67|||
3731727|NCT02054897|3568654|B3|||Fasting plasma glucose||mmol/L|Mean|9.68|9.68|Standard Deviation|2.77|2.77|||
3731728|NCT02054897|3568655|B2|||Fasting plasma glucose||mmol/L|Mean|9.90|9.9|Standard Deviation|2.50|2.5|||
3731729|NCT02054897|3568656|B1|||Fasting plasma glucose||mmol/L|Mean|9.66|9.66|Standard Deviation|2.77|2.77|||
3731730|NCT02054897|3568653|B4|||Glycosylated haemoglobin (HbA1c)||percentage of HbA1c|Mean|8.05|8.05|Standard Deviation|0.85|0.85|||
3731731|NCT02054897|3568654|B3|||Glycosylated haemoglobin (HbA1c)||percentage of HbA1c|Mean|7.95|7.95|Standard Deviation|0.85|0.85|||
3731732|NCT02054897|3568655|B2|||Glycosylated haemoglobin (HbA1c)||percentage of HbA1c|Mean|8.12|8.12|Standard Deviation|0.81|0.81|||
3731733|NCT02054897|3568656|B1|||Glycosylated haemoglobin (HbA1c)||percentage of HbA1c|Mean|8.09|8.09|Standard Deviation|0.89|0.89|||
3731734|NCT02054897|3568653|B4||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
3731735|NCT02054897|3568654|B3||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3731736|NCT02054897|3568655|B2||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3731737|NCT02054897|3568656|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3731738|NCT02054897|3568653|B4||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
3731739|NCT02054897|3568654|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3731740|NCT02054897|3568655|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3731741|NCT02054897|3568656|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3731742|NCT02054897|3568653|B4|||Age||Years|Mean|53.7|53.7|Standard Deviation|11.3|11.3|||
3731743|NCT02054897|3568654|B3|||Age||Years|Mean|53.9|53.9|Standard Deviation|11.0|11.0|||
3731744|NCT02054897|3568655|B2|||Age||Years|Mean|52.7|52.7|Standard Deviation|11.9|11.9|||
3731745|NCT02054897|3568656|B1|||Age||Years|Mean|54.6|54.6|Standard Deviation|11.1|11.1|||
3731746|NCT02054754|3568681|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3731747|NCT02054754|3568682|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3731748|NCT02054754|3568683|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3731749|NCT02054754|3568681|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3731750|NCT02054754|3568682|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3731751|NCT02054754|3568683|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3731752|NCT02054754|3568681|B3|||Age||years|Mean|31.1|31.1|Standard Deviation|8.5|8.5|||
3731753|NCT02054754|3568682|B2|||Age||years|Mean|28.1|28.1|Standard Deviation|8.3|8.3|||
3731754|NCT02054754|3568683|B1|||Age||years|Mean|32.8|32.8|Standard Deviation|8.5|8.5|||
3731755|NCT02054715|3568703|B3||Unknown|Marital Status||Participants|Count of Participants|2|2.0||||||
3731756|NCT02054715|3568704|B2||Unknown|Marital Status||Participants|Count of Participants|0|0.0||||||
3731757|NCT02054715|3568705|B1||Unknown|Marital Status||Participants|Count of Participants|2|2.0||||||
3731758|NCT02054715|3568703|B3||Widowed|Marital Status||Participants|Count of Participants|46|46.0||||||
3731759|NCT02054715|3568704|B2||Widowed|Marital Status||Participants|Count of Participants|28|28.0||||||
3731760|NCT02054715|3568705|B1||Widowed|Marital Status||Participants|Count of Participants|18|18.0||||||
3731761|NCT02054715|3568703|B3||Divorced|Marital Status||Participants|Count of Participants|72|72.0||||||
3731762|NCT02054715|3568704|B2||Divorced|Marital Status||Participants|Count of Participants|34|34.0||||||
3731763|NCT02054715|3568705|B1||Divorced|Marital Status||Participants|Count of Participants|38|38.0||||||
3731764|NCT02054715|3568703|B3||Separated|Marital Status||Participants|Count of Participants|13|13.0||||||
3731765|NCT02054715|3568704|B2||Separated|Marital Status||Participants|Count of Participants|4|4.0||||||
3731766|NCT02054715|3568705|B1||Separated|Marital Status||Participants|Count of Participants|9|9.0||||||
3731767|NCT02054715|3568703|B3||Currently Married|Marital Status||Participants|Count of Participants|246|246.0||||||
3731768|NCT02054715|3568704|B2||Currently Married|Marital Status||Participants|Count of Participants|113|113.0||||||
3731769|NCT02054715|3568705|B1||Currently Married|Marital Status||Participants|Count of Participants|133|133.0||||||
3731770|NCT02054715|3568703|B3||Never Married|Marital Status||Participants|Count of Participants|39|39.0||||||
3731771|NCT02054715|3568704|B2||Never Married|Marital Status||Participants|Count of Participants|20|20.0||||||
3731772|NCT02054715|3568705|B1||Never Married|Marital Status||Participants|Count of Participants|19|19.0||||||
3731773|NCT02054715|3568703|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3731774|NCT02054715|3568704|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3731775|NCT02054715|3568705|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3731776|NCT02054715|3568703|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731777|NCT02054715|3568704|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731778|NCT02054715|3568705|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731779|NCT02054715|3568703|B3||White|Race (NIH/OMB)||Participants|Count of Participants|372|372.0||||||
3731780|NCT02054715|3568704|B2||White|Race (NIH/OMB)||Participants|Count of Participants|177|177.0||||||
3731781|NCT02054715|3568705|B1||White|Race (NIH/OMB)||Participants|Count of Participants|195|195.0||||||
3731782|NCT02054715|3568703|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3731783|NCT02054715|3568704|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3731784|NCT02054715|3568705|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3731785|NCT02054715|3568703|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3731786|NCT02054715|3568704|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731787|NCT02054715|3568705|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3731788|NCT02054715|3568703|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3731789|NCT02054715|3568704|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3731790|NCT02054715|3568705|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3731791|NCT02054715|3568703|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731792|NCT02054715|3568704|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731793|NCT02054715|3568705|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731794|NCT02054715|3568703|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3731795|NCT02054715|3568704|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3731796|NCT02054715|3568705|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3731797|NCT02054715|3568703|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|406|406.0||||||
3731798|NCT02054715|3568704|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|192|192.0||||||
3731799|NCT02054715|3568705|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|214|214.0||||||
3731800|NCT02054715|3568703|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3731801|NCT02054715|3568704|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3731802|NCT02054715|3568705|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3731803|NCT02054715|3568703|B3||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3731804|NCT02054715|3568704|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3731805|NCT02054715|3568705|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3731806|NCT02054715|3568703|B3||Female|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
3731807|NCT02054715|3568704|B2||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3731808|NCT02054715|3568705|B1||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3731809|NCT02054715|3568703|B3|||Age||years|Mean|61.5|61.5|Standard Deviation|11.9|11.9|||
3731810|NCT02054715|3568704|B2|||Age||years|Mean|61.5|61.5|Standard Deviation|12.6|12.6|||
3731811|NCT02054715|3568705|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|11.2|11.2|||
3731812|NCT02054702|3568718|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3731813|NCT02054702|3568719|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3731814|NCT02054702|3568720|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3731815|NCT02054702|3568718|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3731816|NCT02054702|3568719|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3731817|NCT02054702|3568720|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3731818|NCT02054702|3568718|B3|||Age||Years|Mean|42.2|42.2|Standard Deviation|10.2|10.2|||
3731819|NCT02054702|3568719|B2|||Age||Years|Mean|42.1|42.1|Standard Deviation|10.4|10.4|||
3731820|NCT02054702|3568720|B1|||Age||Years|Mean|42.2|42.2|Standard Deviation|10.1|10.1|||
3731821|NCT02054572|3568749|B1|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3731822|NCT02054572|3568749|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3731823|NCT02054572|3568749|B1|Black (or African American)||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3731824|NCT02054572|3568749|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3731825|NCT02054572|3568749|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3731826|NCT02054572|3568749|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3731827|NCT02054572|3568749|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3731828|NCT02054572|3568749|B1|||Age||years|Mean|56.3|56.3|Standard Deviation|16.4|16.4|||
3731829|NCT02054481|3568772|B5||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3731830|NCT02054481|3568773|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3731831|NCT02054481|3568774|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3731832|NCT02054481|3568775|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3731833|NCT02054481|3568776|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3731834|NCT02054481|3568772|B5||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3731835|NCT02054481|3568773|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3731836|NCT02054481|3568774|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3731837|NCT02054481|3568775|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3731838|NCT02054481|3568776|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3731839|NCT02054481|3568772|B5|||Age||Years|Mean|45.9|45.9|Standard Deviation|13.5|13.5|||
3731840|NCT02054481|3568773|B4|||Age||Years|Mean|45.4|45.4|Standard Deviation|12.1|12.1|||
3731841|NCT02054481|3568774|B3|||Age||Years|Mean|44.9|44.9|Standard Deviation|14.0|14.0|||
3731842|NCT02054481|3568775|B2|||Age||Years|Mean|49.3|49.3|Standard Deviation|13.3|13.3|||
3731843|NCT02054481|3568776|B1|||Age||Years|Mean|44.1|44.1|Standard Deviation|14.2|14.2|||
3731844|NCT02054325|3568825|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3731845|NCT02054325|3568826|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3731846|NCT02054325|3568827|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3731847|NCT02054325|3568825|B3||Female|Gender||Participants|Count of Participants|93|93.0||||||
3731848|NCT02054325|3568826|B2||Female|Gender||Participants|Count of Participants|50|50.0||||||
3731849|NCT02054325|3568827|B1||Female|Gender||Participants|Count of Participants|43|43.0||||||
3731850|NCT02054325|3568825|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3731851|NCT02054325|3568826|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3731852|NCT02054325|3568827|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3731853|NCT02054325|3568825|B3||Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
3731854|NCT02054325|3568826|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3731855|NCT02054325|3568827|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
3731856|NCT02054325|3568825|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3731857|NCT02054325|3568826|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3731858|NCT02054325|3568827|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3731859|NCT02054130|3568836|B5|Multiple Categories Checked||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3731860|NCT02054130|3568837|B4|Multiple Categories Checked||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3731861|NCT02054130|3568838|B3|Multiple Categories Checked||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3731862|NCT02054130|3568839|B2|Multiple Categories Checked||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3731863|NCT02054130|3568840|B1|Multiple Categories Checked||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3731864|NCT02054130|3568836|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3731865|NCT02054130|3568837|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3731866|NCT02054130|3568838|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3731867|NCT02054130|3568839|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3731868|NCT02054130|3568840|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3731869|NCT02054130|3568836|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|504|504.0||||||
3731870|NCT02054130|3568837|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|122|122.0||||||
3731871|NCT02054130|3568838|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|128|128.0||||||
3731872|NCT02054130|3568839|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|131|131.0||||||
3731873|NCT02054130|3568840|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|123|123.0||||||
3731874|NCT02054130|3568836|B5|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3731875|NCT02054130|3568837|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3731876|NCT02054130|3568838|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3731877|NCT02054130|3568839|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3731878|NCT02054130|3568840|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3731879|NCT02054130|3568836|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3731880|NCT02054130|3568837|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3731881|NCT02054130|3568838|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3731882|NCT02054130|3568839|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3731883|NCT02054130|3568840|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3731884|NCT02054130|3568836|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731885|NCT02054130|3568837|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731886|NCT02054130|3568838|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731887|NCT02054130|3568839|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731888|NCT02054130|3568840|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731889|NCT02054130|3568836|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|546|546.0||||||
3731890|NCT02054130|3568837|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|135|135.0||||||
3731891|NCT02054130|3568838|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|136|136.0||||||
3731892|NCT02054130|3568839|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
3731893|NCT02054130|3568840|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|137|137.0||||||
3731894|NCT02054130|3568836|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3731895|NCT02054130|3568837|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3731896|NCT02054130|3568838|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3731897|NCT02054130|3568839|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731898|NCT02054130|3568840|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3731899|NCT02054130|3568836|B5||Male|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
3731900|NCT02054130|3568837|B4||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3731901|NCT02054130|3568838|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3731902|NCT02054130|3568839|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3731903|NCT02054130|3568840|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3731904|NCT02054130|3568836|B5||Female|Sex: Female, Male||Participants|Count of Participants|361|361.0||||||
3731905|NCT02054130|3568837|B4||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3731906|NCT02054130|3568838|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3731907|NCT02054130|3568839|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3731908|NCT02054130|3568840|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3731909|NCT02054130|3568836|B5|||Age||Years|Mean|51.55|51.55|Standard Deviation|12.25|12.25|||
3731910|NCT02054130|3568837|B4|||Age||Years|Mean|50.43|50.43|Standard Deviation|12.25|12.25|||
3731911|NCT02054130|3568838|B3|||Age||Years|Mean|52.66|52.66|Standard Deviation|12.67|12.67|||
3731912|NCT02054130|3568839|B2|||Age||Years|Mean|50.80|50.8|Standard Deviation|12.36|12.36|||
3731913|NCT02054130|3568840|B1|||Age||Years|Mean|52.32|52.32|Standard Deviation|11.71|11.71|||
3731914|NCT02053753|3568935|B3|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|99|99.0||||||
3731915|NCT02053753|3568936|B2|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
3731916|NCT02053753|3568937|B1|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
3731917|NCT02053753|3568935|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
3731918|NCT02053753|3568936|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3731919|NCT02053753|3568937|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3731920|NCT02053753|3568935|B3|White||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
3731921|NCT02053753|3568936|B2|White||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
3731922|NCT02053753|3568937|B1|White||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
3731923|NCT02053753|3568935|B3|Multiple||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3731924|NCT02053753|3568936|B2|Multiple||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3731925|NCT02053753|3568937|B1|Multiple||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3731926|NCT02053753|3568935|B3|Black (or African American)||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
3731927|NCT02053753|3568936|B2|Black (or African American)||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3731928|NCT02053753|3568937|B1|Black (or African American)||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3731929|NCT02053753|3568935|B3|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3731930|NCT02053753|3568936|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3731931|NCT02053753|3568937|B1|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3731932|NCT02053753|3568935|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3731933|NCT02053753|3568936|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3731934|NCT02053753|3568937|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3731935|NCT02053753|3568935|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3731936|NCT02053753|3568936|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3731937|NCT02053753|3568937|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3731938|NCT02053753|3568935|B3|||Age||years|Mean|38.3|38.3|Standard Deviation|11.1|11.1|||
3731939|NCT02053753|3568936|B2|||Age||years|Mean|37.6|37.6|Standard Deviation|11.3|11.3|||
3731940|NCT02053753|3568937|B1|||Age||years|Mean|38.9|38.9|Standard Deviation|10.9|10.9|||
3731941|NCT02053610|3568960|B3||Male|Sex: Female, Male||Participants|Count of Participants|407|407.0||||||
3731942|NCT02053610|3568961|B2||Male|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
3731943|NCT02053610|3568962|B1||Male|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
3731944|NCT02053610|3568960|B3||Female|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
3731945|NCT02053610|3568961|B2||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3731946|NCT02053610|3568962|B1||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3731947|NCT02053610|3568960|B3|||Age||years|Mean|71.7|71.7|Standard Deviation|8.75|8.75|||
3731948|NCT02053610|3568961|B2|||Age||years|Mean|71.9|71.9|Standard Deviation|8.68|8.68|||
3731949|NCT02053610|3568962|B1|||Age||years|Mean|71.5|71.5|Standard Deviation|8.82|8.82|||
3731950|NCT02053493|3568993|B3|United States||Region of Enrollment||participants|Number|110|110.0||||||
3731951|NCT02053493|3568994|B2|United States||Region of Enrollment||participants|Number|59|59.0||||||
3731952|NCT02053493|3568995|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
3731953|NCT02053493|3568993|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3731954|NCT02053493|3568994|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3731955|NCT02053493|3568995|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3731956|NCT02053493|3568993|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3731957|NCT02053493|3568994|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3731958|NCT02053493|3568995|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3731959|NCT02053493|3568993|B3|||Age||years|Mean|69.3|69.3|Standard Deviation|9.3|9.3|||
3731960|NCT02053493|3568994|B2|||Age||years|Mean|68.8|68.8|Standard Deviation|9.7|9.7|||
3731961|NCT02053493|3568995|B1|||Age||years|Mean|69.8|69.8|Standard Deviation|8.7|8.7|||
3731962|NCT02053168|3569034|B1|||Body Mass Index||kg/m^2|Mean|30.3|30.3|Standard Deviation|5.81|5.81|||
3731963|NCT02053168|3569034|B1|||Height||cm|Mean|166.9|166.9|Standard Deviation|7.53|7.53|||
3731964|NCT02053168|3569034|B1|||Weight||kg|Mean|84.3|84.3|Standard Deviation|17.16|17.16|||
3731965|NCT02053168|3569034|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3731966|NCT02053168|3569034|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3731967|NCT02053168|3569034|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3731968|NCT02053168|3569034|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3731969|NCT02053168|3569034|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3731970|NCT02053168|3569034|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3731971|NCT02053168|3569034|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|17.12|17.12|||
3731972|NCT02052895|3569048|B4||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3731973|NCT02052895|3569049|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3731974|NCT02052895|3569050|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3731975|NCT02052895|3569051|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3731976|NCT02052895|3569048|B4||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3731977|NCT02052895|3569049|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3731978|NCT02052895|3569050|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3731979|NCT02052895|3569051|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3731980|NCT02052895|3569048|B4|||Age||years|Mean|59.00|59.0|Standard Deviation|16.02|16.02|||
3731981|NCT02052895|3569049|B3|||Age||years|Mean|53.70|53.7|Standard Deviation|19.5|19.5|||
3731982|NCT02052895|3569050|B2|||Age||years|Mean|65.80|65.8|Standard Deviation|13.11|13.11|||
3731983|NCT02052895|3569051|B1|||Age||years|Mean|58.80|58.8|Standard Deviation|15.99|15.99|||
3731984|NCT02052752|3569060|B4||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3731985|NCT02052752|3569061|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||60.0|60.0|||
3731986|NCT02052752|3569062|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||43.3|43.3|||
3731987|NCT02052752|3569063|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||40.0|40.0|||
3731988|NCT02052752|3569060|B4||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3731989|NCT02052752|3569061|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||40.0|40.0|||
3731990|NCT02052752|3569062|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||56.7|56.7|||
3731991|NCT02052752|3569063|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||60.0|60.0|||
3731992|NCT02052752|3569060|B4|||Age||Years|Mean|20.1|20.1|Standard Deviation|8.11|8.11|||
3731993|NCT02052752|3569061|B3|||Age||Years|Mean|17.8|17.8|Standard Deviation|6.22|6.22|||
3731994|NCT02052752|3569062|B2|||Age||Years|Mean|20.3|20.3|Standard Deviation|7.47|7.47|||
3731995|NCT02052752|3569063|B1|||Age||Years|Mean|22.1|22.1|Standard Deviation|9.90|9.9|||
3731996|NCT02052661|3569088|B1||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3731997|NCT02052661|3569088|B1||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3731998|NCT02052661|3569088|B1|||Age||Years|Mean|12.3|12.3|Standard Deviation|0.5|0.5|||
3731999|NCT02052635|3569100|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3732000|NCT02052635|3569101|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3732001|NCT02052635|3569102|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3732002|NCT02052635|3569100|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3732003|NCT02052635|3569101|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3732004|NCT02052635|3569102|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3732005|NCT02052635|3569100|B3|||Age||Years|Mean|62.6|62.6|Standard Deviation|9.8|9.8|||
3732006|NCT02052635|3569101|B2|||Age||Years|Mean|61.2|61.2|Standard Deviation|14.7|14.7|||
3732007|NCT02052635|3569102|B1|||Age||Years|Mean|63.9|63.9|Standard Deviation|2.7|2.7|||
3732008|NCT02052596|3569111|B3|Geographic ancestry|Mixed Origin|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3732009|NCT02052596|3569112|B2|Geographic ancestry|Mixed Origin|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3732010|NCT02052596|3569113|B1|Geographic ancestry|Mixed Origin|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3732011|NCT02052596|3569111|B3|Geographic ancestry|White - Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|721|721.0||||||
3732012|NCT02052596|3569112|B2|Geographic ancestry|White - Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|357|357.0||||||
3732013|NCT02052596|3569113|B1|Geographic ancestry|White - Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|364|364.0||||||
3732014|NCT02052596|3569111|B3|Geographic ancestry|White - Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3732015|NCT02052596|3569112|B2|Geographic ancestry|White - Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3732016|NCT02052596|3569113|B1|Geographic ancestry|White - Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3732017|NCT02052596|3569111|B3|Geographic ancestry|Asian - Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3732018|NCT02052596|3569112|B2|Geographic ancestry|Asian - Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3732019|NCT02052596|3569113|B1|Geographic ancestry|Asian - Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3732020|NCT02052596|3569111|B3|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3732021|NCT02052596|3569112|B2|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3732022|NCT02052596|3569113|B1|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3732023|NCT02052596|3569111|B3|Geographic ancestry|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3732024|NCT02052596|3569112|B2|Geographic ancestry|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3732025|NCT02052596|3569113|B1|Geographic ancestry|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3732026|NCT02052596|3569111|B3|Geographic ancestry|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3732027|NCT02052596|3569112|B2|Geographic ancestry|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3732028|NCT02052596|3569113|B1|Geographic ancestry|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3732029|NCT02052596|3569111|B3|Geographic ancestry|African Heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|94|94.0||||||
3732030|NCT02052596|3569112|B2|Geographic ancestry|African Heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|53|53.0||||||
3732031|NCT02052596|3569113|B1|Geographic ancestry|African Heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
3732032|NCT02052596|3569111|B3||Male|Sex: Female, Male||Participants|Count of Participants|383|383.0||||||
3732033|NCT02052596|3569112|B2||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
3732034|NCT02052596|3569113|B1||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
3732035|NCT02052596|3569111|B3||Female|Sex: Female, Male||Participants|Count of Participants|447|447.0||||||
3732036|NCT02052596|3569112|B2||Female|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
3732037|NCT02052596|3569113|B1||Female|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
3732038|NCT02052596|3569111|B3|||Age||Years|Mean|63.25|63.25|Standard Deviation|8.7|8.7|||
3732039|NCT02052596|3569112|B2|||Age||Years|Mean|63.1|63.1|Standard Deviation|9.0|9.0|||
3732040|NCT02052596|3569113|B1|||Age||Years|Mean|63.4|63.4|Standard Deviation|8.4|8.4|||
3732041|NCT02052544|3569139|B1|Switzerland||Region of Enrollment||participants|Number|34|34.0||||||
3732042|NCT02052544|3569139|B1|Germany||Region of Enrollment||participants|Number|38|38.0||||||
3732043|NCT02052544|3569139|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
3732044|NCT02052544|3569139|B1|Hispanic||Race/Ethnicity, Customized||partecipants|Number|2|2.0||||||
3732045|NCT02052544|3569139|B1|Caucasian||Race/Ethnicity, Customized||partecipants|Number|114|114.0||||||
3732046|NCT02052544|3569139|B1|African American||Race/Ethnicity, Customized||partecipants|Number|6|6.0||||||
3732047|NCT02052544|3569139|B1|Oriental||Race/Ethnicity, Customized||partecipants|Number|1|1.0||||||
3732048|NCT02052544|3569139|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3732049|NCT02052544|3569139|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3732050|NCT02052544|3569139|B1|||Age||years|Mean|65.5|65.5|Full Range|||18.0|100.0|
3732051|NCT02052544|3569139|B1||>=65 years|Age||Participants|Count of Participants|67|67.0||||||
3732052|NCT02052544|3569139|B1||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
3732053|NCT02052544|3569139|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3732054|NCT02052466|3569144|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3732055|NCT02052466|3569144|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3732056|NCT02052466|3569144|B1|||Age||years|Mean|71.08|71.08|Standard Deviation|6.06|6.06|||
3732057|NCT02052440|3569159|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732058|NCT02052440|3569160|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732059|NCT02052440|3569161|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732060|NCT02052440|3569159|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3732061|NCT02052440|3569160|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732062|NCT02052440|3569161|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3732063|NCT02052440|3569159|B3||White|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3732064|NCT02052440|3569160|B2||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3732065|NCT02052440|3569161|B1||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3732066|NCT02052440|3569159|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3732067|NCT02052440|3569160|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3732068|NCT02052440|3569161|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3732069|NCT02052440|3569159|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732070|NCT02052440|3569160|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732071|NCT02052440|3569161|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732072|NCT02052440|3569159|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732073|NCT02052440|3569160|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732074|NCT02052440|3569161|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732075|NCT02052440|3569159|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3732076|NCT02052440|3569160|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3732077|NCT02052440|3569161|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3732078|NCT02052440|3569159|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3732079|NCT02052440|3569160|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3732080|NCT02052440|3569161|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3732081|NCT02052440|3569159|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3732082|NCT02052440|3569160|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3732083|NCT02052440|3569161|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3732084|NCT02052440|3569159|B3|||Age||Years|Mean|50|50.0|Standard Deviation|10|10.0|||
3732085|NCT02052440|3569160|B2|||Age||Years|Mean|51|51.0|Standard Deviation|11|11.0|||
3732086|NCT02052440|3569161|B1|||Age||Years|Mean|50|50.0|Standard Deviation|10|10.0|||
3732087|NCT02052414|3569174|B1|Non-Gabapentinoid naive||Gabapentinoid (Gabapentin/ pregabalin) Naive|Of all the subjects participated in this trial, 8 subjects were Gabapentinoid naïve.|participants|Number|26|26.0||||||
3732088|NCT02052414|3569174|B1|Gabapentinoid Naive||Gabapentinoid (Gabapentin/ pregabalin) Naive|Of all the subjects participated in this trial, 8 subjects were Gabapentinoid naïve.|participants|Number|8|8.0||||||
3732089|NCT02052414|3569174|B1|||Number of co-morbid conditions||co-morbid conditions present|Mean|5.3|5.3|Full Range|||2.0|14.0|
3732090|NCT02052414|3569174|B1|||Number of past medications||medications|Mean|1.6|1.6|Full Range|||0.0|7.0|
3732091|NCT02052414|3569174|B1|||Number of active medications||medications|Mean|1.3|1.3|Full Range|||1.0|2.0|
3732092|NCT02052414|3569174|B1|||Age of Fibromyalgia Diagnosis||years|Mean|6.96|6.96|Full Range|||1.0|7.0|
3732093|NCT02052414|3569174|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
3732094|NCT02052414|3569174|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3732095|NCT02052414|3569174|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3732096|NCT02052414|3569174|B1|||Age||years|Mean|55.25|55.25|Standard Deviation|10.15|10.15|||
3732097|NCT02052414|3569174|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3732098|NCT02052414|3569174|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3732099|NCT02052414|3569174|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3732100|NCT02052141|3569182|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732101|NCT02052141|3569183|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732102|NCT02052141|3569184|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732103|NCT02052141|3569182|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3732104|NCT02052141|3569183|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3732105|NCT02052141|3569184|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3732106|NCT02052141|3569182|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3732107|NCT02052141|3569183|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3732108|NCT02052141|3569184|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3732109|NCT02052141|3569182|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3732110|NCT02052141|3569183|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3732111|NCT02052141|3569184|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3732112|NCT02052141|3569182|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3732113|NCT02052141|3569183|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3732114|NCT02052141|3569184|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3732115|NCT02052141|3569182|B3|||Age|Age was calculated as the difference between date of birth and date of informed consent, truncated to years.|Years|Mean|9.8|9.8|Standard Deviation|1.29|1.29|||
3732116|NCT02052141|3569183|B2|||Age|Age was calculated as the difference between date of birth and date of informed consent, truncated to years.|Years|Mean|9.4|9.4|Standard Deviation|1.51|1.51|||
3732117|NCT02052141|3569184|B1|||Age|Age was calculated as the difference between date of birth and date of informed consent, truncated to years.|Years|Mean|10.2|10.2|Standard Deviation|0.84|0.84|||
3732118|NCT02052011|3569207|B3||4-7|TIMI Score|Thrombolysis in Myocardial Infarction (TIMI) Score measures mortality risk for unstable angina and myocardial infarction. The score ranges 0-7 with lower score indicating lower risk. 0-2 is considered low risk for acute coronary syndrome.|Participants|Count of Participants|0|0.0||||||
3732119|NCT02052011|3569208|B2||4-7|TIMI Score|Thrombolysis in Myocardial Infarction (TIMI) Score measures mortality risk for unstable angina and myocardial infarction. The score ranges 0-7 with lower score indicating lower risk. 0-2 is considered low risk for acute coronary syndrome.|Participants|Count of Participants|0|0.0||||||
3732120|NCT02052011|3569209|B1||4-7|TIMI Score|Thrombolysis in Myocardial Infarction (TIMI) Score measures mortality risk for unstable angina and myocardial infarction. The score ranges 0-7 with lower score indicating lower risk. 0-2 is considered low risk for acute coronary syndrome.|Participants|Count of Participants|0|0.0||||||
3732121|NCT02052011|3569207|B3||2-3|TIMI Score|Thrombolysis in Myocardial Infarction (TIMI) Score measures mortality risk for unstable angina and myocardial infarction. The score ranges 0-7 with lower score indicating lower risk. 0-2 is considered low risk for acute coronary syndrome.|Participants|Count of Participants|6|6.0||||||
3732122|NCT02052011|3569208|B2||2-3|TIMI Score|Thrombolysis in Myocardial Infarction (TIMI) Score measures mortality risk for unstable angina and myocardial infarction. The score ranges 0-7 with lower score indicating lower risk. 0-2 is considered low risk for acute coronary syndrome.|Participants|Count of Participants|1|1.0||||||
3732123|NCT02052011|3569209|B1||2-3|TIMI Score|Thrombolysis in Myocardial Infarction (TIMI) Score measures mortality risk for unstable angina and myocardial infarction. The score ranges 0-7 with lower score indicating lower risk. 0-2 is considered low risk for acute coronary syndrome.|Participants|Count of Participants|5|5.0||||||
3732124|NCT02052011|3569207|B3||0-1|TIMI Score|Thrombolysis in Myocardial Infarction (TIMI) Score measures mortality risk for unstable angina and myocardial infarction. The score ranges 0-7 with lower score indicating lower risk. 0-2 is considered low risk for acute coronary syndrome.|Participants|Count of Participants|25|25.0||||||
3732226|NCT02051816|3569216|B5|||Age||years|Mean|58|58.0|Standard Deviation|14|14.0|||
3732227|NCT02051816|3569217|B4|||Age||years|Mean|58|58.0|Standard Deviation|12|12.0|||
3732125|NCT02052011|3569208|B2||0-1|TIMI Score|Thrombolysis in Myocardial Infarction (TIMI) Score measures mortality risk for unstable angina and myocardial infarction. The score ranges 0-7 with lower score indicating lower risk. 0-2 is considered low risk for acute coronary syndrome.|Participants|Count of Participants|9|9.0||||||
3732126|NCT02052011|3569209|B1||0-1|TIMI Score|Thrombolysis in Myocardial Infarction (TIMI) Score measures mortality risk for unstable angina and myocardial infarction. The score ranges 0-7 with lower score indicating lower risk. 0-2 is considered low risk for acute coronary syndrome.|Participants|Count of Participants|16|16.0||||||
3732127|NCT02052011|3569207|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732128|NCT02052011|3569208|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732129|NCT02052011|3569209|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732130|NCT02052011|3569207|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3732131|NCT02052011|3569208|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||not asked
3732132|NCT02052011|3569209|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||not asked
3732133|NCT02052011|3569207|B3||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3732134|NCT02052011|3569208|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3732135|NCT02052011|3569209|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3732136|NCT02052011|3569207|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3732137|NCT02052011|3569208|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3732138|NCT02052011|3569209|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3732139|NCT02052011|3569207|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732140|NCT02052011|3569208|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732141|NCT02052011|3569209|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732142|NCT02052011|3569207|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732143|NCT02052011|3569208|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732144|NCT02052011|3569209|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732145|NCT02052011|3569207|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732146|NCT02052011|3569208|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732147|NCT02052011|3569209|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732148|NCT02052011|3569207|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732149|NCT02052011|3569208|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732150|NCT02052011|3569209|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732151|NCT02052011|3569207|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3732152|NCT02052011|3569208|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3732153|NCT02052011|3569209|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3732154|NCT02052011|3569207|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3732155|NCT02052011|3569208|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3732156|NCT02052011|3569209|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3732157|NCT02052011|3569207|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3732158|NCT02052011|3569208|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3732159|NCT02052011|3569209|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3732160|NCT02052011|3569207|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3732161|NCT02052011|3569208|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3732162|NCT02052011|3569209|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3732163|NCT02052011|3569207|B3|||Age||years|Mean|50|50.0|Standard Deviation|9|9.0|||
3732164|NCT02052011|3569208|B2|||Age||years|Mean|50|50.0|Standard Deviation|5|5.0|||
3732165|NCT02052011|3569209|B1|||Age||years|Mean|50|50.0|Standard Deviation|7|7.0|||
3732166|NCT02051816|3569216|B5|||Acute Physiology and Chronic Health Evaluation II Score|range of scale is minimum 0 - maximum 100 lower values describe less acute/chronic illness and more likely to survive higher values describe more acute/chronic illness and less likely to survive|units on a scale|Mean|21|21.0|Standard Deviation|7|7.0|||
3732167|NCT02051816|3569217|B4|||Acute Physiology and Chronic Health Evaluation II Score|range of scale is minimum 0 - maximum 100 lower values describe less acute/chronic illness and more likely to survive higher values describe more acute/chronic illness and less likely to survive|units on a scale|Mean|21|21.0|Standard Deviation|6|6.0|||
3732168|NCT02051816|3569218|B3|||Acute Physiology and Chronic Health Evaluation II Score|range of scale is minimum 0 - maximum 100 lower values describe less acute/chronic illness and more likely to survive higher values describe more acute/chronic illness and less likely to survive|units on a scale|Mean|23|23.0|Standard Deviation|6|6.0|||
3732169|NCT02051816|3569219|B2|||Acute Physiology and Chronic Health Evaluation II Score|range of scale is minimum 0 - maximum 100 lower values describe less acute/chronic illness and more likely to survive higher values describe more acute/chronic illness and less likely to survive|units on a scale|Mean|21|21.0|Standard Deviation|6|6.0|||
3732228|NCT02051816|3569218|B3|||Age||years|Mean|56|56.0|Standard Deviation|15|15.0|||
3732229|NCT02051816|3569219|B2|||Age||years|Mean|58|58.0|Standard Deviation|14|14.0|||
3732170|NCT02051816|3569220|B1|||Acute Physiology and Chronic Health Evaluation II Score|range of scale is minimum 0 - maximum 100 lower values describe less acute/chronic illness and more likely to survive higher values describe more acute/chronic illness and less likely to survive|units on a scale|Mean|21|21.0|Standard Deviation|9|9.0|||
3732171|NCT02051816|3569216|B5|||Body Mass Index||kg/m^2|Mean|29|29.0|Standard Deviation|8|8.0|||
3732172|NCT02051816|3569217|B4|||Body Mass Index||kg/m^2|Mean|29|29.0|Standard Deviation|8|8.0|||
3732173|NCT02051816|3569218|B3|||Body Mass Index||kg/m^2|Mean|28|28.0|Standard Deviation|5|5.0|||
3732174|NCT02051816|3569219|B2|||Body Mass Index||kg/m^2|Mean|29|29.0|Standard Deviation|9|9.0|||
3732175|NCT02051816|3569220|B1|||Body Mass Index||kg/m^2|Mean|29|29.0|Standard Deviation|8|8.0|||
3732176|NCT02051816|3569216|B5|United States||Region of Enrollment||participants|Number|150|150.0||||||
3732177|NCT02051816|3569217|B4|United States||Region of Enrollment||participants|Number|36|36.0||||||
3732178|NCT02051816|3569218|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
3732179|NCT02051816|3569219|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
3732180|NCT02051816|3569220|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
3732181|NCT02051816|3569216|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3732182|NCT02051816|3569217|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3732183|NCT02051816|3569218|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3732184|NCT02051816|3569219|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3732185|NCT02051816|3569220|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3732186|NCT02051816|3569216|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732187|NCT02051816|3569217|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732188|NCT02051816|3569218|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732189|NCT02051816|3569219|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732190|NCT02051816|3569220|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732191|NCT02051816|3569216|B5||White|Race (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
3732192|NCT02051816|3569217|B4||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3732193|NCT02051816|3569218|B3||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3732194|NCT02051816|3569219|B2||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3732195|NCT02051816|3569220|B1||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3732196|NCT02051816|3569216|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3732197|NCT02051816|3569217|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3732198|NCT02051816|3569218|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3732199|NCT02051816|3569219|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3732200|NCT02051816|3569220|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3732201|NCT02051816|3569216|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732202|NCT02051816|3569217|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732203|NCT02051816|3569218|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732204|NCT02051816|3569219|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732205|NCT02051816|3569220|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732206|NCT02051816|3569216|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732207|NCT02051816|3569217|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732208|NCT02051816|3569218|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732209|NCT02051816|3569219|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732210|NCT02051816|3569220|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732211|NCT02051816|3569216|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732212|NCT02051816|3569217|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732213|NCT02051816|3569218|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732214|NCT02051816|3569219|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732215|NCT02051816|3569220|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732216|NCT02051816|3569216|B5||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3732217|NCT02051816|3569217|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3732218|NCT02051816|3569218|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3732219|NCT02051816|3569219|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3732220|NCT02051816|3569220|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3732221|NCT02051816|3569216|B5||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3732222|NCT02051816|3569217|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3732223|NCT02051816|3569218|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3732224|NCT02051816|3569219|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3732225|NCT02051816|3569220|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3732230|NCT02051816|3569220|B1|||Age||years|Mean|58|58.0|Standard Deviation|15|15.0|||
3732231|NCT02051790|3569261|B1|United States||Region of Enrollment|All scans were collected from imaging centers in the US.|scans|Number|241|241.0||||||
3732232|NCT02051790|3569261|B1|Gender Unknown||Sex/Gender, Customized|Gender was not collected in this study.|scans|Number|241|241.0||||||
3732233|NCT02051790|3569261|B1|Age Unknown||Age, Customized|Age was not collected in this study.|scans|Number|241|241.0||||||
3732234|NCT02051686|3569265|B3|United States||Region of Enrollment||Participants|Count of Participants|88|88.0||||||
3732235|NCT02051686|3569266|B2|United States||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
3732236|NCT02051686|3569267|B1|United States||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3732237|NCT02051686|3569265|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3732238|NCT02051686|3569265|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3732239|NCT02051686|3569266|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3732240|NCT02051686|3569267|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3732241|NCT02051686|3569265|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3732242|NCT02051686|3569266|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3732243|NCT02051686|3569267|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3732244|NCT02051686|3569265|B3|||Age||years|Mean|40.7|40.7|Standard Deviation|15.9|15.9|||
3732245|NCT02051686|3569266|B2|||Age||years|Mean|39.7|39.7|Standard Deviation|16.1|16.1|||
3732246|NCT02051686|3569267|B1|||Age||years|Mean|41.7|41.7|Standard Deviation|15.6|15.6|||
3732247|NCT02051595|3569276|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3732248|NCT02051595|3569276|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3732249|NCT02051595|3569276|B1|||Age||years|Mean|54.7|54.7|Standard Deviation|16.1|16.1|||
3732250|NCT02051426|3569280|B3|male||Sex/Gender, Customized||participants|Number|22|22.0||||||
3732251|NCT02051426|3569281|B2|male||Sex/Gender, Customized||participants|Number|11|11.0||||||
3732252|NCT02051426|3569282|B1|male||Sex/Gender, Customized||participants|Number|11|11.0||||||
3732253|NCT02051426|3569280|B3|female||Sex/Gender, Customized||participants|Number|13|13.0||||||
3732254|NCT02051426|3569281|B2|female||Sex/Gender, Customized||participants|Number|8|8.0||||||
3732255|NCT02051426|3569282|B1|female||Sex/Gender, Customized||participants|Number|5|5.0||||||
3732256|NCT02051426|3569280|B3|||Age||years|Mean|26.58|26.58|Standard Deviation|3.0|3.0|||
3732257|NCT02051426|3569281|B2|||Age||years|Mean|26.58|26.58|Standard Deviation|3.0|3.0|||
3732258|NCT02051426|3569282|B1|||Age||years|Mean|26.58|26.58|Standard Deviation|3.0|3.0|||
3732259|NCT02051335|3569293|B5|Ex-smoker||Smoking Classification||participants|Number|1|1.0||||||
3732260|NCT02051335|3569294|B4|Ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3732261|NCT02051335|3569295|B3|Ex-smoker||Smoking Classification||participants|Number|1|1.0||||||
3732262|NCT02051335|3569296|B2|Ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3732263|NCT02051335|3569297|B1|Ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3732264|NCT02051335|3569293|B5|Current Smoker||Smoking Classification||participants|Number|0|0.0||||||
3732265|NCT02051335|3569294|B4|Current Smoker||Smoking Classification||participants|Number|0|0.0||||||
3732266|NCT02051335|3569295|B3|Current Smoker||Smoking Classification||participants|Number|0|0.0||||||
3732267|NCT02051335|3569296|B2|Current Smoker||Smoking Classification||participants|Number|0|0.0||||||
3732268|NCT02051335|3569297|B1|Current Smoker||Smoking Classification||participants|Number|0|0.0||||||
3732269|NCT02051335|3569293|B5|Never Smoked||Smoking Classification||participants|Number|26|26.0||||||
3732270|NCT02051335|3569294|B4|Never Smoked||Smoking Classification||participants|Number|6|6.0||||||
3732271|NCT02051335|3569295|B3|Never Smoked||Smoking Classification||participants|Number|6|6.0||||||
3732272|NCT02051335|3569296|B2|Never Smoked||Smoking Classification||participants|Number|7|7.0||||||
3732273|NCT02051335|3569297|B1|Never Smoked||Smoking Classification||participants|Number|7|7.0||||||
3732274|NCT02051335|3569293|B5|||Body Mass Index (BMI)||kg/m^2|Mean|25.27|25.27|Standard Deviation|2.462|2.462|||
3732275|NCT02051335|3569294|B4|||Body Mass Index (BMI)||kg/m^2|Mean|24.68|24.68|Standard Deviation|2.568|2.568|||
3732276|NCT02051335|3569295|B3|||Body Mass Index (BMI)||kg/m^2|Mean|25.49|25.49|Standard Deviation|1.670|1.67|||
3732277|NCT02051335|3569296|B2|||Body Mass Index (BMI)||kg/m^2|Mean|25.09|25.09|Standard Deviation|2.683|2.683|||
3732278|NCT02051335|3569297|B1|||Body Mass Index (BMI)||kg/m^2|Mean|25.76|25.76|Standard Deviation|3.173|3.173|||
3732279|NCT02051335|3569293|B5|||Weight||kg|Mean|79.50|79.5|Standard Deviation|7.473|7.473|||
3732280|NCT02051335|3569294|B4|||Weight||kg|Mean|75.05|75.05|Standard Deviation|7.036|7.036|||
3732281|NCT02051335|3569295|B3|||Weight||kg|Mean|81.53|81.53|Standard Deviation|4.476|4.476|||
3732282|NCT02051335|3569296|B2|||Weight||kg|Mean|78.61|78.61|Standard Deviation|7.189|7.189|||
3732283|NCT02051335|3569297|B1|||Weight||kg|Mean|82.16|82.16|Standard Deviation|9.759|9.759|||
3732284|NCT02051335|3569293|B5|||Height||cm|Mean|177.5|177.5|Standard Deviation|6.08|6.08|||
3732285|NCT02051335|3569294|B4|||Height||cm|Mean|174.5|174.5|Standard Deviation|5.79|5.79|||
3732286|NCT02051335|3569295|B3|||Height||cm|Mean|179.0|179.0|Standard Deviation|5.23|5.23|||
3732287|NCT02051335|3569296|B2|||Height||cm|Mean|177.3|177.3|Standard Deviation|6.87|6.87|||
3732288|NCT02051335|3569297|B1|||Height||cm|Mean|178.7|178.7|Standard Deviation|6.65|6.65|||
3732289|NCT02051335|3569293|B5|United Kingdom||Region of Enrollment||participants|Number|27|27.0||||||
3732290|NCT02051335|3569294|B4|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3732291|NCT02051335|3569295|B3|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
3732292|NCT02051335|3569296|B2|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
3732293|NCT02051335|3569297|B1|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
3732294|NCT02051335|3569293|B5|White||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3732295|NCT02051335|3569294|B4|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3732296|NCT02051335|3569295|B3|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3732297|NCT02051335|3569296|B2|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3732298|NCT02051335|3569297|B1|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3732299|NCT02051335|3569293|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3732300|NCT02051335|3569294|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3732301|NCT02051335|3569295|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3732302|NCT02051335|3569296|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3732303|NCT02051335|3569297|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3732304|NCT02051335|3569293|B5|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3732305|NCT02051335|3569294|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3732306|NCT02051335|3569295|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3732307|NCT02051335|3569296|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3732308|NCT02051335|3569297|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3732309|NCT02051335|3569293|B5||Male|Gender||Participants|Count of Participants|27|27.0||||||
3732310|NCT02051335|3569294|B4||Male|Gender||Participants|Count of Participants|6|6.0||||||
3732311|NCT02051335|3569295|B3||Male|Gender||Participants|Count of Participants|7|7.0||||||
3732312|NCT02051335|3569296|B2||Male|Gender||Participants|Count of Participants|7|7.0||||||
3732313|NCT02051335|3569297|B1||Male|Gender||Participants|Count of Participants|7|7.0||||||
3732314|NCT02051335|3569293|B5||Female|Gender||Participants|Count of Participants|0|0.0||||||
3732315|NCT02051335|3569294|B4||Female|Gender||Participants|Count of Participants|0|0.0||||||
3732316|NCT02051335|3569295|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
3732317|NCT02051335|3569296|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
3732318|NCT02051335|3569297|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3732319|NCT02051335|3569293|B5|||Age||years|Mean|31.1|31.1|Standard Deviation|6.71|6.71|||
3732320|NCT02051335|3569294|B4|||Age||years|Mean|29.8|29.8|Standard Deviation|5.12|5.12|||
3732321|NCT02051335|3569295|B3|||Age||years|Mean|34.1|34.1|Standard Deviation|6.89|6.89|||
3732322|NCT02051335|3569296|B2|||Age||years|Mean|28.4|28.4|Standard Deviation|6.73|6.73|||
3732323|NCT02051335|3569297|B1|||Age||years|Mean|31.9|31.9|Standard Deviation|7.69|7.69|||
3732324|NCT02051296|3569350|B3|Mental Component Score||RAND 36 Item Health Survey( short form(SF-36))|"All ques. are scored on a scale from 0(lowest)-100(highest) functioning (50 avg.)~Scoring: First, recoded per the scoring key. Scores represent the percentage of total possible score achieved. Second, avg. non missing items in same scale to create 8 scale scores .Scores represent the median for all items in the scale that the respondent answered.~Physical Functioning 10 Items Role Functioning/physical 4 Items Role Functioning/emotional 3 Items Energy/fatigue 4 Items Emotional well-being 5 Items Social functioning 2 Items Pain 2 Items General Health 5 Items Health Change 1 Item"|units on a scale|Median|47|47.0|Full Range|||33.0|62.0|
3732325|NCT02051296|3569351|B2|Mental Component Score||RAND 36 Item Health Survey( short form(SF-36))|"All ques. are scored on a scale from 0(lowest)-100(highest) functioning (50 avg.)~Scoring: First, recoded per the scoring key. Scores represent the percentage of total possible score achieved. Second, avg. non missing items in same scale to create 8 scale scores .Scores represent the median for all items in the scale that the respondent answered.~Physical Functioning 10 Items Role Functioning/physical 4 Items Role Functioning/emotional 3 Items Energy/fatigue 4 Items Emotional well-being 5 Items Social functioning 2 Items Pain 2 Items General Health 5 Items Health Change 1 Item"|units on a scale|Median|47|47.0|Full Range|||33.0|62.0|
3732326|NCT02051296|3569352|B1|Mental Component Score||RAND 36 Item Health Survey( short form(SF-36))|"All ques. are scored on a scale from 0(lowest)-100(highest) functioning (50 avg.)~Scoring: First, recoded per the scoring key. Scores represent the percentage of total possible score achieved. Second, avg. non missing items in same scale to create 8 scale scores .Scores represent the median for all items in the scale that the respondent answered.~Physical Functioning 10 Items Role Functioning/physical 4 Items Role Functioning/emotional 3 Items Energy/fatigue 4 Items Emotional well-being 5 Items Social functioning 2 Items Pain 2 Items General Health 5 Items Health Change 1 Item"|units on a scale|Median|48|48.0|Full Range|||35.0|56.0|
3732327|NCT02051296|3569350|B3|Physical Component Score||RAND 36 Item Health Survey( short form(SF-36))|"All ques. are scored on a scale from 0(lowest)-100(highest) functioning (50 avg.)~Scoring: First, recoded per the scoring key. Scores represent the percentage of total possible score achieved. Second, avg. non missing items in same scale to create 8 scale scores .Scores represent the median for all items in the scale that the respondent answered.~Physical Functioning 10 Items Role Functioning/physical 4 Items Role Functioning/emotional 3 Items Energy/fatigue 4 Items Emotional well-being 5 Items Social functioning 2 Items Pain 2 Items General Health 5 Items Health Change 1 Item"|units on a scale|Median|57|57.0|Full Range|||39.0|73.0|
3732328|NCT02051296|3569351|B2|Physical Component Score||RAND 36 Item Health Survey( short form(SF-36))|"All ques. are scored on a scale from 0(lowest)-100(highest) functioning (50 avg.)~Scoring: First, recoded per the scoring key. Scores represent the percentage of total possible score achieved. Second, avg. non missing items in same scale to create 8 scale scores .Scores represent the median for all items in the scale that the respondent answered.~Physical Functioning 10 Items Role Functioning/physical 4 Items Role Functioning/emotional 3 Items Energy/fatigue 4 Items Emotional well-being 5 Items Social functioning 2 Items Pain 2 Items General Health 5 Items Health Change 1 Item"|units on a scale|Median|58|58.0|Full Range|||39.0|73.0|
3732329|NCT02051296|3569352|B1|Physical Component Score||RAND 36 Item Health Survey( short form(SF-36))|"All ques. are scored on a scale from 0(lowest)-100(highest) functioning (50 avg.)~Scoring: First, recoded per the scoring key. Scores represent the percentage of total possible score achieved. Second, avg. non missing items in same scale to create 8 scale scores .Scores represent the median for all items in the scale that the respondent answered.~Physical Functioning 10 Items Role Functioning/physical 4 Items Role Functioning/emotional 3 Items Energy/fatigue 4 Items Emotional well-being 5 Items Social functioning 2 Items Pain 2 Items General Health 5 Items Health Change 1 Item"|units on a scale|Median|57|57.0|Full Range|||42.0|72.0|
3732330|NCT02051296|3569350|B3|||Beck Depression Inventory-II(BDI-II)|"Beck Depression Inventory-II (BDI-II) is a widely used validated measure of depressive symptoms. It consists of 21 groups if statements. A score greater than 16 is the cutoff for depression.~scoring: The sum of the score for each of the 21 questions.~depression ranges:~Low 1-10 Normal ups and downs 11-16 Mild mood disturbance Moderate 17-20 Borderline clinical depression 21-30 Moderate depression Significant 31-40 Severe depression Over 40 Extreme depression"|units on a scale|Median|8|8.0|Full Range|||0.0|39.0|
3732331|NCT02051296|3569351|B2|||Beck Depression Inventory-II(BDI-II)|"Beck Depression Inventory-II (BDI-II) is a widely used validated measure of depressive symptoms. It consists of 21 groups if statements. A score greater than 16 is the cutoff for depression.~scoring: The sum of the score for each of the 21 questions.~depression ranges:~Low 1-10 Normal ups and downs 11-16 Mild mood disturbance Moderate 17-20 Borderline clinical depression 21-30 Moderate depression Significant 31-40 Severe depression Over 40 Extreme depression"|units on a scale|Median|8|8.0|Full Range|||0.0|38.0|
3732332|NCT02051296|3569352|B1|||Beck Depression Inventory-II(BDI-II)|"Beck Depression Inventory-II (BDI-II) is a widely used validated measure of depressive symptoms. It consists of 21 groups if statements. A score greater than 16 is the cutoff for depression.~scoring: The sum of the score for each of the 21 questions.~depression ranges:~Low 1-10 Normal ups and downs 11-16 Mild mood disturbance Moderate 17-20 Borderline clinical depression 21-30 Moderate depression Significant 31-40 Severe depression Over 40 Extreme depression"|units on a scale|Median|9|9.0|Full Range|||0.0|39.0|
3732333|NCT02051296|3569350|B3|Arm Shoulder and Hand Play||Quick Disability Arm Shoulder and Hand(qDASH)|The Quick Disability Arm Shoulder and Hand (QDASH) is a continuous variable to measure upper extremity physical function and disability. The QDASH consists of 11 items from the original 30-item DASH and has similar reliability and correlation with psychological stress as the full DASH. The scores range from 0 (best function) to 100 (worst function).|units on a scale|Median|50|50.0|Full Range|||0.0|100.0|
3732334|NCT02051296|3569351|B2|Arm Shoulder and Hand Play||Quick Disability Arm Shoulder and Hand(qDASH)|The Quick Disability Arm Shoulder and Hand (QDASH) is a continuous variable to measure upper extremity physical function and disability. The QDASH consists of 11 items from the original 30-item DASH and has similar reliability and correlation with psychological stress as the full DASH. The scores range from 0 (best function) to 100 (worst function).|units on a scale|Median|56|56.0|Full Range|||0.0|100.0|
3732335|NCT02051296|3569352|B1|Arm Shoulder and Hand Play||Quick Disability Arm Shoulder and Hand(qDASH)|The Quick Disability Arm Shoulder and Hand (QDASH) is a continuous variable to measure upper extremity physical function and disability. The QDASH consists of 11 items from the original 30-item DASH and has similar reliability and correlation with psychological stress as the full DASH. The scores range from 0 (best function) to 100 (worst function).|units on a scale|Median|50|50.0|Full Range|||0.0|100.0|
3732336|NCT02051296|3569350|B3|Arm Shoulder and Hand Work||Quick Disability Arm Shoulder and Hand(qDASH)|The Quick Disability Arm Shoulder and Hand (QDASH) is a continuous variable to measure upper extremity physical function and disability. The QDASH consists of 11 items from the original 30-item DASH and has similar reliability and correlation with psychological stress as the full DASH. The scores range from 0 (best function) to 100 (worst function).|units on a scale|Median|44|44.0|Full Range|||0.0|100.0|
3732337|NCT02051296|3569351|B2|Arm Shoulder and Hand Work||Quick Disability Arm Shoulder and Hand(qDASH)|The Quick Disability Arm Shoulder and Hand (QDASH) is a continuous variable to measure upper extremity physical function and disability. The QDASH consists of 11 items from the original 30-item DASH and has similar reliability and correlation with psychological stress as the full DASH. The scores range from 0 (best function) to 100 (worst function).|units on a scale|Median|44|44.0|Full Range|||0.0|88.0|
3732338|NCT02051296|3569352|B1|Arm Shoulder and Hand Work||Quick Disability Arm Shoulder and Hand(qDASH)|The Quick Disability Arm Shoulder and Hand (QDASH) is a continuous variable to measure upper extremity physical function and disability. The QDASH consists of 11 items from the original 30-item DASH and has similar reliability and correlation with psychological stress as the full DASH. The scores range from 0 (best function) to 100 (worst function).|units on a scale|Median|44|44.0|Full Range|||0.0|44.0|
3732339|NCT02051296|3569350|B3|Quick Disability Arm Shoulder and Hand||Quick Disability Arm Shoulder and Hand(qDASH)|The Quick Disability Arm Shoulder and Hand (QDASH) is a continuous variable to measure upper extremity physical function and disability. The QDASH consists of 11 items from the original 30-item DASH and has similar reliability and correlation with psychological stress as the full DASH. The scores range from 0 (best function) to 100 (worst function).|units on a scale|Median|41|41.0|Full Range|||5.0|91.0|
3732340|NCT02051296|3569351|B2|Quick Disability Arm Shoulder and Hand||Quick Disability Arm Shoulder and Hand(qDASH)|The Quick Disability Arm Shoulder and Hand (QDASH) is a continuous variable to measure upper extremity physical function and disability. The QDASH consists of 11 items from the original 30-item DASH and has similar reliability and correlation with psychological stress as the full DASH. The scores range from 0 (best function) to 100 (worst function).|units on a scale|Median|45|45.0|Full Range|||5.0|91.0|
3732341|NCT02051296|3569352|B1|Quick Disability Arm Shoulder and Hand||Quick Disability Arm Shoulder and Hand(qDASH)|The Quick Disability Arm Shoulder and Hand (QDASH) is a continuous variable to measure upper extremity physical function and disability. The QDASH consists of 11 items from the original 30-item DASH and has similar reliability and correlation with psychological stress as the full DASH. The scores range from 0 (best function) to 100 (worst function).|units on a scale|Median|35|35.0|Full Range|||5.0|91.0|
3732363|NCT02051296|3569350|B3||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
3732364|NCT02051296|3569351|B2||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3732365|NCT02051296|3569352|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3732366|NCT02051296|3569350|B3||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
3732342|NCT02051296|3569350|B3|||screen for Posttraumatic Stess Symptoms(SPTSS)|"The Brief SPTSS is a 17-item self-report measure that assesses DSM-IV symptoms of PTSD. For this survey, the respondents rated items on an 4-point scale ranging from 0 (not at all) to 4 (more than once everyday). The points were sum across all items for each participant.~A median score of 12 or higher has been used as the cut-off for psychological distress on this scale. [Dr. Eve Carlson personal communication] We dichotomized as low distress with a score less than 16 and high score 16 or greater. the range was from 0 to 68 points."|units on a scale|Median|9|9.0|Full Range|||0.0|68.0|
3732343|NCT02051296|3569351|B2|||screen for Posttraumatic Stess Symptoms(SPTSS)|"The Brief SPTSS is a 17-item self-report measure that assesses DSM-IV symptoms of PTSD. For this survey, the respondents rated items on an 4-point scale ranging from 0 (not at all) to 4 (more than once everyday). The points were sum across all items for each participant.~A median score of 12 or higher has been used as the cut-off for psychological distress on this scale. [Dr. Eve Carlson personal communication] We dichotomized as low distress with a score less than 16 and high score 16 or greater. the range was from 0 to 68 points."|units on a scale|Median|9|9.0|Full Range|||0.0|68.0|
3732344|NCT02051296|3569352|B1|||screen for Posttraumatic Stess Symptoms(SPTSS)|"The Brief SPTSS is a 17-item self-report measure that assesses DSM-IV symptoms of PTSD. For this survey, the respondents rated items on an 4-point scale ranging from 0 (not at all) to 4 (more than once everyday). The points were sum across all items for each participant.~A median score of 12 or higher has been used as the cut-off for psychological distress on this scale. [Dr. Eve Carlson personal communication] We dichotomized as low distress with a score less than 16 and high score 16 or greater. the range was from 0 to 68 points."|units on a scale|Median|10|10.0|Full Range|||0.0|58.0|
3732345|NCT02051296|3569350|B3|Brief Pain Inventory Interference Score||Brief Pain Inventory(Short Form)|"The Brief Pain Inventory measures two constructs.~Each item is rated from 0, no pain/no interference, to 10, pain as bad as you can imagine/worst interference.~Pain severity score:calculated from the 4 items about pain intensity. It is scored as the mean/median of the seven interference items when all 4 items are not missing.~Pain interference score: It is scored as the mean/median of the seven interference items. This median can be used if more than 50%, or four of seven, of the total items have been completed on a given administration."|units on a scale|Median|3|3.0|Full Range|||0.0|9.0|
3732346|NCT02051296|3569351|B2|Brief Pain Inventory Interference Score||Brief Pain Inventory(Short Form)|"The Brief Pain Inventory measures two constructs.~Each item is rated from 0, no pain/no interference, to 10, pain as bad as you can imagine/worst interference.~Pain severity score:calculated from the 4 items about pain intensity. It is scored as the mean/median of the seven interference items when all 4 items are not missing.~Pain interference score: It is scored as the mean/median of the seven interference items. This median can be used if more than 50%, or four of seven, of the total items have been completed on a given administration."|units on a scale|Median|4|4.0|Full Range|||0.0|9.0|
3732347|NCT02051296|3569352|B1|Brief Pain Inventory Interference Score||Brief Pain Inventory(Short Form)|"The Brief Pain Inventory measures two constructs.~Each item is rated from 0, no pain/no interference, to 10, pain as bad as you can imagine/worst interference.~Pain severity score:calculated from the 4 items about pain intensity. It is scored as the mean/median of the seven interference items when all 4 items are not missing.~Pain interference score: It is scored as the mean/median of the seven interference items. This median can be used if more than 50%, or four of seven, of the total items have been completed on a given administration."|units on a scale|Median|3|3.0|Full Range|||0.0|9.0|
3732348|NCT02051296|3569350|B3|Brief Pain Inventory Severity Score||Brief Pain Inventory(Short Form)|"The Brief Pain Inventory measures two constructs.~Each item is rated from 0, no pain/no interference, to 10, pain as bad as you can imagine/worst interference.~Pain severity score:calculated from the 4 items about pain intensity. It is scored as the mean/median of the seven interference items when all 4 items are not missing.~Pain interference score: It is scored as the mean/median of the seven interference items. This median can be used if more than 50%, or four of seven, of the total items have been completed on a given administration."|units on a scale|Median|5|5.0|Full Range|||0.0|10.0|
3732349|NCT02051296|3569351|B2|Brief Pain Inventory Severity Score||Brief Pain Inventory(Short Form)|"The Brief Pain Inventory measures two constructs.~Each item is rated from 0, no pain/no interference, to 10, pain as bad as you can imagine/worst interference.~Pain severity score:calculated from the 4 items about pain intensity. It is scored as the mean/median of the seven interference items when all 4 items are not missing.~Pain interference score: It is scored as the mean/median of the seven interference items. This median can be used if more than 50%, or four of seven, of the total items have been completed on a given administration."|units on a scale|Median|5|5.0|Full Range|||1.0|10.0|
3732350|NCT02051296|3569352|B1|Brief Pain Inventory Severity Score||Brief Pain Inventory(Short Form)|"The Brief Pain Inventory measures two constructs.~Each item is rated from 0, no pain/no interference, to 10, pain as bad as you can imagine/worst interference.~Pain severity score:calculated from the 4 items about pain intensity. It is scored as the mean/median of the seven interference items when all 4 items are not missing.~Pain interference score: It is scored as the mean/median of the seven interference items. This median can be used if more than 50%, or four of seven, of the total items have been completed on a given administration."|units on a scale|Median|5|5.0|Full Range|||0.0|9.0|
3732351|NCT02051296|3569350|B3|United States||Region of Enrollment||participants|Number|114|114.0||||||
3732352|NCT02051296|3569351|B2|United States||Region of Enrollment||participants|Number|56|56.0||||||
3732353|NCT02051296|3569352|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
3732354|NCT02051296|3569350|B3||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3732355|NCT02051296|3569351|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3732356|NCT02051296|3569352|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3732357|NCT02051296|3569350|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3732358|NCT02051296|3569351|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3732359|NCT02051296|3569352|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3732360|NCT02051296|3569350|B3|||Age||years|Mean|60|60.0|Full Range|||26.0|79.0|
3732361|NCT02051296|3569351|B2|||Age||years|Mean|60|60.0|Full Range|||26.0|79.0|
3732362|NCT02051296|3569352|B1|||Age||years|Mean|60|60.0|Full Range|||27.0|76.0|
3732367|NCT02051296|3569351|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3732368|NCT02051296|3569352|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3732369|NCT02051296|3569350|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3732370|NCT02051296|3569351|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3732371|NCT02051296|3569352|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3732372|NCT02050334|3569359|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
3732373|NCT02050334|3569360|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3732374|NCT02050334|3569361|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3732375|NCT02050334|3569359|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732376|NCT02050334|3569360|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732377|NCT02050334|3569361|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732378|NCT02050334|3569359|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732379|NCT02050334|3569360|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732380|NCT02050334|3569361|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732381|NCT02050334|3569359|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3732382|NCT02050334|3569360|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3732383|NCT02050334|3569361|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3732384|NCT02050334|3569359|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3732385|NCT02050334|3569360|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3732386|NCT02050334|3569361|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3732387|NCT02050334|3569359|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732388|NCT02050334|3569360|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732389|NCT02050334|3569361|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732390|NCT02050334|3569359|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732391|NCT02050334|3569360|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732392|NCT02050334|3569361|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732393|NCT02050334|3569359|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732394|NCT02050334|3569360|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732395|NCT02050334|3569361|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732396|NCT02050334|3569359|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732397|NCT02050334|3569360|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732398|NCT02050334|3569361|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732399|NCT02050334|3569359|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3732400|NCT02050334|3569360|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3732401|NCT02050334|3569361|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3732402|NCT02050334|3569359|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732403|NCT02050334|3569360|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732404|NCT02050334|3569361|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732405|NCT02050334|3569359|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3732406|NCT02050334|3569360|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3732407|NCT02050334|3569361|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3732408|NCT02050334|3569359|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3732409|NCT02050334|3569360|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3732410|NCT02050334|3569361|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3732411|NCT02050334|3569359|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3732412|NCT02050334|3569360|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3732413|NCT02050334|3569361|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3732414|NCT02050334|3569359|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3732415|NCT02050334|3569360|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3732416|NCT02050334|3569361|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3732417|NCT02050334|3569359|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3732418|NCT02050334|3569360|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3732419|NCT02050334|3569361|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3732420|NCT02050321|3569370|B1|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3732421|NCT02050321|3569370|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3732422|NCT02050321|3569370|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3732423|NCT02050321|3569370|B1|||Age||years|Mean|53.5|53.5|Full Range|||52.0|55.0|
3732424|NCT02050321|3569370|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3732425|NCT02050321|3569370|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3732426|NCT02050321|3569370|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3732427|NCT02050048|3569375|B3|||Creatinine||mg/dL|Mean|0.86|0.86|Standard Deviation|0.21|0.21|||
3732428|NCT02050048|3569376|B2|||Creatinine||mg/dL|Mean|0.89|0.89|Standard Deviation|0.22|0.22|||
3732429|NCT02050048|3569377|B1|||Creatinine||mg/dL|Mean|0.83|0.83|Standard Deviation|0.20|0.2|||
3732430|NCT02050048|3569375|B3|||BMI||kg/m^2|Mean|27.7|27.7|Standard Deviation|5.5|5.5|||
3732431|NCT02050048|3569376|B2|||BMI||kg/m^2|Mean|25.6|25.6|Standard Deviation|3.4|3.4|||
3732432|NCT02050048|3569377|B1|||BMI||kg/m^2|Mean|29.6|29.6|Standard Deviation|6.6|6.6|||
3732433|NCT02050048|3569375|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
3732434|NCT02050048|3569376|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3732435|NCT02050048|3569377|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3732436|NCT02050048|3569375|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3732437|NCT02050048|3569376|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3732438|NCT02050048|3569377|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3732439|NCT02050048|3569375|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3732440|NCT02050048|3569376|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3732441|NCT02050048|3569377|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3732442|NCT02050048|3569375|B3|||Age||years|Mean|57.4|57.4|Standard Deviation|14.6|14.6|||
3732443|NCT02050048|3569376|B2|||Age||years|Mean|55.7|55.7|Standard Deviation|18.1|18.1|||
3732444|NCT02050048|3569377|B1|||Age||years|Mean|59.1|59.1|Standard Deviation|11.9|11.9|||
3732445|NCT02050048|3569375|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3732446|NCT02050048|3569376|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3732447|NCT02050048|3569377|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3732448|NCT02050048|3569375|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3732449|NCT02050048|3569376|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3732450|NCT02050048|3569377|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3732451|NCT02050048|3569375|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3732452|NCT02050048|3569376|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3732453|NCT02050048|3569377|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3732454|NCT02049931|3569384|B4|Korea, Republic of||Region of Enrollment||participants|Number|60|60.0||||||
3732455|NCT02049931|3569385|B3|Korea, Republic of||Region of Enrollment||participants|Number|20|20.0||||||
3732456|NCT02049931|3569386|B2|Korea, Republic of||Region of Enrollment||participants|Number|20|20.0||||||
3732457|NCT02049931|3569387|B1|Korea, Republic of||Region of Enrollment||participants|Number|20|20.0||||||
3732458|NCT02049931|3569384|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3732459|NCT02049931|3569385|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3732460|NCT02049931|3569386|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3732461|NCT02049931|3569387|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3732462|NCT02049931|3569384|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3732463|NCT02049931|3569385|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3732464|NCT02049931|3569386|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3732465|NCT02049931|3569387|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3732466|NCT02049931|3569384|B4|||Age||years|Mean|70.25|70.25|Standard Deviation|10.26|10.26|||
3732467|NCT02049931|3569385|B3|||Age||years|Mean|71.75|71.75|Standard Deviation|7.96|7.96|||
3732468|NCT02049931|3569386|B2|||Age||years|Mean|66.75|66.75|Standard Deviation|11.00|11.0|||
3732469|NCT02049931|3569387|B1|||Age||years|Mean|72.25|72.25|Standard Deviation|10.40|10.4|||
3732470|NCT02049450|3569409|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3732471|NCT02049450|3569409|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3732472|NCT02049450|3569409|B1|||Age||years|Mean|25.9|25.9|Standard Deviation|6.83|6.83|||
3732473|NCT02049385|3569423|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732474|NCT02049385|3569423|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732475|NCT02049385|3569423|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3732476|NCT02049385|3569423|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732477|NCT02049385|3569423|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732478|NCT02049385|3569423|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732479|NCT02049385|3569423|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732480|NCT02049385|3569423|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732481|NCT02049385|3569423|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3732482|NCT02049385|3569423|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3732483|NCT02049385|3569423|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3732484|NCT02049385|3569423|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3732485|NCT02049385|3569423|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3732486|NCT02049385|3569423|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3732487|NCT02049385|3569423|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3732488|NCT02049151|3569430|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3732489|NCT02049151|3569431|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3732490|NCT02049151|3569432|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3732491|NCT02049151|3569430|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3732492|NCT02049151|3569431|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3732493|NCT02049151|3569432|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3732494|NCT02049151|3569430|B3|Age Continuous||Age||years|Mean|65.0|65.0|Standard Deviation|8.60|8.6|||
3732495|NCT02049151|3569431|B2|Age Continuous||Age||years|Mean|63.9|63.9|Standard Deviation|10.45|10.45|||
3732496|NCT02049151|3569432|B1|Age Continuous||Age||years|Mean|66.2|66.2|Standard Deviation|5.99|5.99|||
3732497|NCT02049151|3569430|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3732498|NCT02049151|3569431|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3732499|NCT02049151|3569432|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3732500|NCT02049151|3569430|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3732501|NCT02049151|3569431|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3732502|NCT02049151|3569432|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3732503|NCT02049151|3569430|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3732504|NCT02049151|3569431|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3732505|NCT02049151|3569432|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3732506|NCT02048891|3569451|B3|Israel||Region of Enrollment||participants|Number|3|3.0||||||
3732507|NCT02048891|3569452|B2|Israel||Region of Enrollment||participants|Number|1|1.0||||||
3732508|NCT02048891|3569453|B1|Israel||Region of Enrollment||participants|Number|2|2.0||||||
3732509|NCT02048891|3569451|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3732510|NCT02048891|3569452|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3732511|NCT02048891|3569453|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3732512|NCT02048891|3569451|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3732513|NCT02048891|3569452|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3732514|NCT02048891|3569453|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3732515|NCT02048891|3569451|B3|||Age||years|Mean|41.7|41.7|Standard Deviation|1.5|1.5|||
3732516|NCT02048891|3569452|B2|||Age||years|Mean|42|42.0|Standard Deviation|0|0.0|||
3732517|NCT02048891|3569453|B1|||Age||years|Mean|41.5|41.5|Standard Deviation|2.1|2.1|||
3732518|NCT02048241|3569460|B3|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3732519|NCT02048241|3569461|B2|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3732520|NCT02048241|3569462|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3732521|NCT02048241|3569460|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3732522|NCT02048241|3569461|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3732523|NCT02048241|3569462|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3732524|NCT02048241|3569460|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3732525|NCT02048241|3569461|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3732526|NCT02048241|3569462|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3732527|NCT02048241|3569460|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3732528|NCT02048241|3569461|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3732529|NCT02048241|3569462|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3732530|NCT02048241|3569460|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3732531|NCT02048241|3569461|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3732532|NCT02048241|3569462|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3732533|NCT02048241|3569460|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3732534|NCT02048241|3569461|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3732535|NCT02048241|3569462|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3732536|NCT02048241|3569460|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3732537|NCT02048241|3569461|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3732538|NCT02048241|3569462|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3732539|NCT02048241|3569460|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3732540|NCT02048241|3569461|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3732541|NCT02048241|3569462|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3732542|NCT02048241|3569460|B3||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
3732543|NCT02048241|3569461|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3732544|NCT02048241|3569462|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3732545|NCT02048072|3569469|B1|||Body temperature||°C|Mean|36.58|36.58|Standard Deviation|0.45|0.45|||
3732546|NCT02048072|3569469|B1|||Height||cm|Mean|168.72|168.72|Standard Deviation|7.98|7.98|||
3732547|NCT02048072|3569469|B1|||Weight||kg|Mean|71.18|71.18|Standard Deviation|13.18|13.18|||
3732607|NCT02046993|3569510|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732548|NCT02048072|3569469|B1|||EDSS|Expanded Disability Status Scale Range 0-10 (no disability - death due to Multiple Sclerosis)|units on a scale|Mean|1.75|1.75|Standard Deviation|1.16|1.16|||
3732549|NCT02048072|3569469|B1|Switzerland||Region of Enrollment||participants|Number|33|33.0||||||
3732550|NCT02048072|3569469|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3732551|NCT02048072|3569469|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3732552|NCT02048072|3569469|B1|||Age||years|Mean|37.57|37.57|Standard Deviation|12.44|12.44|||
3732553|NCT02047747|3569473|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3732554|NCT02047747|3569473|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732555|NCT02047747|3569473|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732556|NCT02047747|3569473|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3732557|NCT02047747|3569473|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732558|NCT02047747|3569473|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732559|NCT02047747|3569473|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3732560|NCT02047747|3569473|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732561|NCT02047747|3569473|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3732562|NCT02047747|3569473|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3732563|NCT02047747|3569473|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3732564|NCT02047747|3569473|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3732565|NCT02047747|3569473|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3732566|NCT02047500|3569478|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3732567|NCT02047500|3569478|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3732568|NCT02047500|3569478|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3732569|NCT02047500|3569478|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3732570|NCT02047500|3569478|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3732571|NCT02047500|3569478|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3732572|NCT02047253|3569482|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
3732573|NCT02047253|3569482|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732574|NCT02047253|3569482|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732575|NCT02047253|3569482|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3732576|NCT02047253|3569482|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3732577|NCT02047253|3569482|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732578|NCT02047253|3569482|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732579|NCT02047253|3569482|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732580|NCT02047253|3569482|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3732581|NCT02047253|3569482|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3732582|NCT02047253|3569482|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3732583|NCT02047253|3569482|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3732584|NCT02047253|3569482|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3732585|NCT02047227|3569490|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3732586|NCT02047227|3569491|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3732587|NCT02047227|3569492|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3732588|NCT02047227|3569490|B3||Female|Sex: Female, Male||Participants|Count of Participants|939|939.0||||||
3732589|NCT02047227|3569491|B2||Female|Sex: Female, Male||Participants|Count of Participants|477|477.0||||||
3732590|NCT02047227|3569492|B1||Female|Sex: Female, Male||Participants|Count of Participants|462|462.0||||||
3732591|NCT02047227|3569490|B3|||Age||years|Mean|38.3|38.3|Standard Deviation|3.0|3.0|||
3732592|NCT02047227|3569491|B2|||Age||years|Mean|38.3|38.3|Standard Deviation|3.0|3.0|||
3732593|NCT02047227|3569492|B1|||Age||years|Mean|38.3|38.3|Standard Deviation|2.9|2.9|||
3732594|NCT02046993|3569509|B3|Hong Kong||Region of Enrollment||participants|Number|210|210.0||||||
3732595|NCT02046993|3569510|B2|Hong Kong||Region of Enrollment||participants|Number|105|105.0||||||
3732596|NCT02046993|3569511|B1|Hong Kong||Region of Enrollment||participants|Number|105|105.0||||||
3732597|NCT02046993|3569509|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732598|NCT02046993|3569510|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732599|NCT02046993|3569511|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732600|NCT02046993|3569509|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732601|NCT02046993|3569510|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732602|NCT02046993|3569511|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732603|NCT02046993|3569509|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732604|NCT02046993|3569510|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732605|NCT02046993|3569511|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732606|NCT02046993|3569509|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732608|NCT02046993|3569511|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732609|NCT02046993|3569509|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732610|NCT02046993|3569510|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732611|NCT02046993|3569511|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732612|NCT02046993|3569509|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|210|210.0||||||
3732613|NCT02046993|3569510|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
3732614|NCT02046993|3569511|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
3732615|NCT02046993|3569509|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732616|NCT02046993|3569510|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732617|NCT02046993|3569511|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732618|NCT02046993|3569509|B3||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3732619|NCT02046993|3569510|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3732620|NCT02046993|3569511|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3732621|NCT02046993|3569509|B3||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3732622|NCT02046993|3569510|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3732623|NCT02046993|3569511|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3732624|NCT02046993|3569509|B3|||Age||years|Mean|58.3|58.3|Standard Deviation|8.8|8.8|||
3732625|NCT02046993|3569510|B2|||Age||years|Mean|59.4|59.4|Standard Deviation|8.9|8.9|||
3732626|NCT02046993|3569511|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|8.7|8.7|||
3732627|NCT02046980|3569528|B4|Left side||Lesion side||participants|Number|98|98.0||||||
3732628|NCT02046980|3569529|B3|Left side||Lesion side||participants|Number|39|39.0||||||
3732629|NCT02046980|3569530|B2|Left side||Lesion side||participants|Number|30|30.0||||||
3732630|NCT02046980|3569531|B1|Left side||Lesion side||participants|Number|29|29.0||||||
3732631|NCT02046980|3569528|B4|Right side||Lesion side||participants|Number|111|111.0||||||
3732632|NCT02046980|3569529|B3|Right side||Lesion side||participants|Number|33|33.0||||||
3732633|NCT02046980|3569530|B2|Right side||Lesion side||participants|Number|37|37.0||||||
3732634|NCT02046980|3569531|B1|Right side||Lesion side||participants|Number|41|41.0||||||
3732635|NCT02046980|3569528|B4|||Symptom duration||days|Mean|2.9|2.9|Full Range|||0.0|14.0|
3732636|NCT02046980|3569529|B3|||Symptom duration||days|Mean|2.52|2.52|Full Range|||0.0|14.0|
3732637|NCT02046980|3569530|B2|||Symptom duration||days|Mean|2.70|2.7|Full Range|||0.0|14.0|
3732638|NCT02046980|3569531|B1|||Symptom duration||days|Mean|3.37|3.37|Full Range|||0.0|14.0|
3732639|NCT02046980|3569528|B4||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3732640|NCT02046980|3569529|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3732641|NCT02046980|3569530|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3732642|NCT02046980|3569531|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3732643|NCT02046980|3569528|B4||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3732644|NCT02046980|3569529|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3732645|NCT02046980|3569530|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3732646|NCT02046980|3569531|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3732647|NCT02046980|3569528|B4|||Age||years|Mean|61.9|61.9|Standard Deviation|12.7|12.7|||
3732648|NCT02046980|3569529|B3|||Age||years|Mean|61.44|61.44|Standard Deviation|13.48|13.48|||
3732649|NCT02046980|3569530|B2|||Age||years|Mean|62.22|62.22|Standard Deviation|13.25|13.25|||
3732650|NCT02046980|3569531|B1|||Age||years|Mean|62.00|62.0|Standard Deviation|11.58|11.58|||
3732651|NCT02046863|3569541|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3732652|NCT02046863|3569541|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3732653|NCT02046863|3569541|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3732654|NCT02046863|3569541|B1|||Age||years|Mean|62|62.0|Full Range|||54.0|71.0|
3732655|NCT02046863|3569541|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3732656|NCT02046863|3569541|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3732657|NCT02046863|3569541|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3732658|NCT02046772|3569545|B3|||Duration of surgery||minutes|Mean|24|24.0|Standard Deviation|10.8|10.8|||
3732659|NCT02046772|3569546|B2|||Duration of surgery||minutes|Mean|20.4|20.4|Standard Deviation|9.2|9.2|||
3732660|NCT02046772|3569547|B1|||Duration of surgery||minutes|Mean|28|28.0|Standard Deviation|11.1|11.1|||
3732661|NCT02046772|3569545|B3|No||Need of pre-surgery sedation||participants|Number|17|17.0||||||
3732662|NCT02046772|3569546|B2|No||Need of pre-surgery sedation||participants|Number|10|10.0||||||
3732663|NCT02046772|3569547|B1|No||Need of pre-surgery sedation||participants|Number|7|7.0||||||
3732664|NCT02046772|3569545|B3|Yes||Need of pre-surgery sedation||participants|Number|46|46.0||||||
3732665|NCT02046772|3569546|B2|Yes||Need of pre-surgery sedation||participants|Number|23|23.0||||||
3732666|NCT02046772|3569547|B1|Yes||Need of pre-surgery sedation||participants|Number|23|23.0||||||
3732667|NCT02046772|3569545|B3|Unavailable||Number of haemorrhoidal packs removed||participants|Number|2|2.0||||||
3732668|NCT02046772|3569546|B2|Unavailable||Number of haemorrhoidal packs removed||participants|Number|0|0.0||||||
3732669|NCT02046772|3569547|B1|Unavailable||Number of haemorrhoidal packs removed||participants|Number|2|2.0||||||
3732670|NCT02046772|3569545|B3|3 haemorrhoidal packs||Number of haemorrhoidal packs removed||participants|Number|16|16.0||||||
3732671|NCT02046772|3569546|B2|3 haemorrhoidal packs||Number of haemorrhoidal packs removed||participants|Number|8|8.0||||||
3732672|NCT02046772|3569547|B1|3 haemorrhoidal packs||Number of haemorrhoidal packs removed||participants|Number|8|8.0||||||
3732673|NCT02046772|3569545|B3|2 haemorrhoidal packs||Number of haemorrhoidal packs removed||participants|Number|25|25.0||||||
3732674|NCT02046772|3569546|B2|2 haemorrhoidal packs||Number of haemorrhoidal packs removed||participants|Number|13|13.0||||||
3732675|NCT02046772|3569547|B1|2 haemorrhoidal packs||Number of haemorrhoidal packs removed||participants|Number|12|12.0||||||
3732676|NCT02046772|3569545|B3|1 haemorrhoidal pack||Number of haemorrhoidal packs removed||participants|Number|20|20.0||||||
3732677|NCT02046772|3569546|B2|1 haemorrhoidal pack||Number of haemorrhoidal packs removed||participants|Number|12|12.0||||||
3732678|NCT02046772|3569547|B1|1 haemorrhoidal pack||Number of haemorrhoidal packs removed||participants|Number|8|8.0||||||
3732679|NCT02046772|3569545|B3|ASA III||ASA|"ASA is the clasification system created by the American Society of Anesthesiologists to set the risk of a patient that is about to receive surgery.~The score range goes from I, where the patient is completely healthy, to VI, where the patient is extremely in life threatening."|participants|Number|1|1.0||||||
3732680|NCT02046772|3569546|B2|ASA III||ASA|"ASA is the clasification system created by the American Society of Anesthesiologists to set the risk of a patient that is about to receive surgery.~The score range goes from I, where the patient is completely healthy, to VI, where the patient is extremely in life threatening."|participants|Number|0|0.0||||||
3732681|NCT02046772|3569547|B1|ASA III||ASA|"ASA is the clasification system created by the American Society of Anesthesiologists to set the risk of a patient that is about to receive surgery.~The score range goes from I, where the patient is completely healthy, to VI, where the patient is extremely in life threatening."|participants|Number|1|1.0||||||
3732682|NCT02046772|3569545|B3|ASA II||ASA|"ASA is the clasification system created by the American Society of Anesthesiologists to set the risk of a patient that is about to receive surgery.~The score range goes from I, where the patient is completely healthy, to VI, where the patient is extremely in life threatening."|participants|Number|47|47.0||||||
3732683|NCT02046772|3569546|B2|ASA II||ASA|"ASA is the clasification system created by the American Society of Anesthesiologists to set the risk of a patient that is about to receive surgery.~The score range goes from I, where the patient is completely healthy, to VI, where the patient is extremely in life threatening."|participants|Number|25|25.0||||||
3732684|NCT02046772|3569547|B1|ASA II||ASA|"ASA is the clasification system created by the American Society of Anesthesiologists to set the risk of a patient that is about to receive surgery.~The score range goes from I, where the patient is completely healthy, to VI, where the patient is extremely in life threatening."|participants|Number|22|22.0||||||
3732685|NCT02046772|3569545|B3|ASA I||ASA|"ASA is the clasification system created by the American Society of Anesthesiologists to set the risk of a patient that is about to receive surgery.~The score range goes from I, where the patient is completely healthy, to VI, where the patient is extremely in life threatening."|participants|Number|15|15.0||||||
3732686|NCT02046772|3569546|B2|ASA I||ASA|"ASA is the clasification system created by the American Society of Anesthesiologists to set the risk of a patient that is about to receive surgery.~The score range goes from I, where the patient is completely healthy, to VI, where the patient is extremely in life threatening."|participants|Number|8|8.0||||||
3732687|NCT02046772|3569547|B1|ASA I||ASA|"ASA is the clasification system created by the American Society of Anesthesiologists to set the risk of a patient that is about to receive surgery.~The score range goes from I, where the patient is completely healthy, to VI, where the patient is extremely in life threatening."|participants|Number|7|7.0||||||
3732688|NCT02046772|3569545|B3|||BMI||Kg*m^-2|Mean|26.2|26.2|Standard Deviation|3.9|3.9|||
3732689|NCT02046772|3569546|B2|||BMI||Kg*m^-2|Mean|27.2|27.2|Standard Deviation|4|4.0|||
3732690|NCT02046772|3569547|B1|||BMI||Kg*m^-2|Mean|25.1|25.1|Standard Deviation|3.3|3.3|||
3732691|NCT02046772|3569545|B3|Spain||Region of Enrollment||participants|Number|63|63.0||||||
3732692|NCT02046772|3569546|B2|Spain||Region of Enrollment||participants|Number|33|33.0||||||
3732693|NCT02046772|3569547|B1|Spain||Region of Enrollment||participants|Number|30|30.0||||||
3732694|NCT02046772|3569545|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3732695|NCT02046772|3569546|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3732696|NCT02046772|3569547|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3732697|NCT02046772|3569545|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3732698|NCT02046772|3569546|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3732699|NCT02046772|3569547|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3732700|NCT02046772|3569545|B3|||Age||years|Mean|48.7|48.7|Standard Deviation|10.9|10.9|||
3732701|NCT02046772|3569546|B2|||Age||years|Mean|51.3|51.3|Standard Deviation|10.8|10.8|||
3732702|NCT02046772|3569547|B1|||Age||years|Mean|45.8|45.8|Standard Deviation|10.5|10.5|||
3732703|NCT02046616|3569562|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3732704|NCT02046616|3569562|B1||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3732705|NCT02046616|3569562|B1|||Age||years|Mean|55.9|55.9|Standard Deviation|12.0|12.0|||
3732706|NCT02046603|3569582|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3732707|NCT02046603|3569583|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3732708|NCT02046603|3569584|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3732709|NCT02046603|3569582|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3732710|NCT02046603|3569583|B2||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3732711|NCT02046603|3569584|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3732712|NCT02046603|3569582|B3|||Age||years|Mean|55.1|55.1|Standard Deviation|11.14|11.14|||
3732713|NCT02046603|3569583|B2|||Age||years|Mean|55.3|55.3|Standard Deviation|10.76|10.76|||
3732714|NCT02046603|3569584|B1|||Age||years|Mean|53.9|53.9|Standard Deviation|13.63|13.63|||
3732715|NCT02046564|3569662|B3|Australia||Region of Enrollment||participants|Number|6|6.0||||||
3732716|NCT02046564|3569663|B2|Australia||Region of Enrollment||participants|Number|4|4.0||||||
3732717|NCT02046564|3569664|B1|Australia||Region of Enrollment||participants|Number|2|2.0||||||
3732718|NCT02046564|3569662|B3|Malaysia||Region of Enrollment||participants|Number|11|11.0||||||
3732719|NCT02046564|3569663|B2|Malaysia||Region of Enrollment||participants|Number|5|5.0||||||
3732720|NCT02046564|3569664|B1|Malaysia||Region of Enrollment||participants|Number|6|6.0||||||
3732721|NCT02046564|3569662|B3|Taiwan||Region of Enrollment||participants|Number|17|17.0||||||
3732722|NCT02046564|3569663|B2|Taiwan||Region of Enrollment||participants|Number|10|10.0||||||
3732723|NCT02046564|3569664|B1|Taiwan||Region of Enrollment||participants|Number|7|7.0||||||
3732724|NCT02046564|3569662|B3|Japan||Region of Enrollment||participants|Number|299|299.0||||||
3732725|NCT02046564|3569663|B2|Japan||Region of Enrollment||participants|Number|142|142.0||||||
3732726|NCT02046564|3569664|B1|Japan||Region of Enrollment||participants|Number|157|157.0||||||
3732727|NCT02046564|3569662|B3|South Korea||Region of Enrollment||participants|Number|78|78.0||||||
3732728|NCT02046564|3569663|B2|South Korea||Region of Enrollment||participants|Number|42|42.0||||||
3732729|NCT02046564|3569664|B1|South Korea||Region of Enrollment||participants|Number|36|36.0||||||
3732730|NCT02046564|3569662|B3||Male|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
3732731|NCT02046564|3569663|B2||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3732732|NCT02046564|3569664|B1||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3732733|NCT02046564|3569662|B3||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3732734|NCT02046564|3569663|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3732735|NCT02046564|3569664|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3732736|NCT02046564|3569662|B3|||Age||years|Mean|38.9|38.9|Standard Deviation|11.8|11.8|||
3732737|NCT02046564|3569663|B2|||Age||years|Mean|39.5|39.5|Standard Deviation|11.8|11.8|||
3732738|NCT02046564|3569664|B1|||Age||years|Mean|38.3|38.3|Standard Deviation|11.8|11.8|||
3732739|NCT02046564|3569662|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3732740|NCT02046564|3569663|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3732741|NCT02046564|3569664|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3732742|NCT02046564|3569662|B3||Between 18 and 65 years|Age||Participants|Count of Participants|411|411.0||||||
3732743|NCT02046564|3569663|B2||Between 18 and 65 years|Age||Participants|Count of Participants|203|203.0||||||
3732744|NCT02046564|3569664|B1||Between 18 and 65 years|Age||Participants|Count of Participants|208|208.0||||||
3732745|NCT02046564|3569662|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3732746|NCT02046564|3569663|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3732747|NCT02046564|3569664|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3732748|NCT02046382|3569687|B3|United States||Region of Enrollment||Participants|Count of Participants|104|104.0||||||
3732749|NCT02046382|3569688|B2|United States||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
3732750|NCT02046382|3569689|B1|United States||Region of Enrollment||Participants|Count of Participants|57|57.0||||||
3732751|NCT02046382|3569687|B3|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3732752|NCT02046382|3569688|B2|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3732753|NCT02046382|3569689|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3732754|NCT02046382|3569687|B3|Race|Multiracial|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3732755|NCT02046382|3569688|B2|Race|Multiracial|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3732756|NCT02046382|3569689|B1|Race|Multiracial|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3732757|NCT02046382|3569687|B3|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3732758|NCT02046382|3569688|B2|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3732759|NCT02046382|3569689|B1|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3732760|NCT02046382|3569687|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|60|60.0||||||
3732761|NCT02046382|3569688|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3732762|NCT02046382|3569689|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3732763|NCT02046382|3569687|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3732764|NCT02046382|3569688|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3732765|NCT02046382|3569689|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3732766|NCT02046382|3569687|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3732767|NCT02046382|3569688|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3732768|NCT02046382|3569689|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3732769|NCT02046382|3569687|B3|||Age||years|Mean|29.6|29.6|Standard Deviation|6.0|6.0|||
3732770|NCT02046382|3569688|B2|||Age||years|Mean|29.6|29.6|Standard Deviation|6.1|6.1|||
3732771|NCT02046382|3569689|B1|||Age||years|Mean|29.6|29.6|Standard Deviation|6.0|6.0|||
3732772|NCT02046369|3569702|B3|With 8 or more cycles within past 12 months||Bipolar I disorder history|the number of participants with the number of cycles in the past 12 months is measured.|Participants|Count of Participants|1|1.0||||||
3732773|NCT02046369|3569703|B2|With 8 or more cycles within past 12 months||Bipolar I disorder history|the number of participants with the number of cycles in the past 12 months is measured.|Participants|Count of Participants|1|1.0||||||
3732774|NCT02046369|3569704|B1|With 8 or more cycles within past 12 months||Bipolar I disorder history|the number of participants with the number of cycles in the past 12 months is measured.|Participants|Count of Participants|0|0.0||||||
3732775|NCT02046369|3569702|B3|Without rapid cycling(4-7 cycles past 12 months||Bipolar I disorder history|the number of participants with the number of cycles in the past 12 months is measured.|Participants|Count of Participants|50|50.0||||||
3732776|NCT02046369|3569703|B2|Without rapid cycling(4-7 cycles past 12 months||Bipolar I disorder history|the number of participants with the number of cycles in the past 12 months is measured.|Participants|Count of Participants|24|24.0||||||
3732777|NCT02046369|3569704|B1|Without rapid cycling(4-7 cycles past 12 months||Bipolar I disorder history|the number of participants with the number of cycles in the past 12 months is measured.|Participants|Count of Participants|26|26.0||||||
3732778|NCT02046369|3569702|B3|Without rapid cycling (0-3 cycles past 12 months||Bipolar I disorder history|the number of participants with the number of cycles in the past 12 months is measured.|Participants|Count of Participants|296|296.0||||||
3732779|NCT02046369|3569703|B2|Without rapid cycling (0-3 cycles past 12 months||Bipolar I disorder history|the number of participants with the number of cycles in the past 12 months is measured.|Participants|Count of Participants|147|147.0||||||
3732780|NCT02046369|3569704|B1|Without rapid cycling (0-3 cycles past 12 months||Bipolar I disorder history|the number of participants with the number of cycles in the past 12 months is measured.|Participants|Count of Participants|149|149.0||||||
3732781|NCT02046369|3569702|B3|||Psychiatric History||years|Mean|12.30|12.3|Standard Deviation|2.735|2.735|||
3732782|NCT02046369|3569703|B2|||Psychiatric History||years|Mean|12.17|12.17|Standard Deviation|2.680|2.68|||
3732783|NCT02046369|3569704|B1|||Psychiatric History||years|Mean|12.44|12.44|Standard Deviation|2.790|2.79|||
3732784|NCT02046369|3569702|B3|Russia||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3732785|NCT02046369|3569703|B2|Russia||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3732786|NCT02046369|3569704|B1|Russia||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3732787|NCT02046369|3569702|B3|France||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3732788|NCT02046369|3569703|B2|France||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3732789|NCT02046369|3569704|B1|France||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3732790|NCT02046369|3569702|B3|Bulgaria||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3732791|NCT02046369|3569703|B2|Bulgaria||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3732792|NCT02046369|3569704|B1|Bulgaria||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3732793|NCT02046369|3569702|B3|Mexico||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3732794|NCT02046369|3569703|B2|Mexico||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3732795|NCT02046369|3569704|B1|Mexico||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3732796|NCT02046369|3569702|B3|Poland||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3732797|NCT02046369|3569703|B2|Poland||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3732798|NCT02046369|3569704|B1|Poland||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3732799|NCT02046369|3569702|B3|Ukraine||Region of Enrollment||Participants|Count of Participants|66|66.0||||||
3732800|NCT02046369|3569703|B2|Ukraine||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3732801|NCT02046369|3569704|B1|Ukraine||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3732802|NCT02046369|3569702|B3|Philippines||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3732803|NCT02046369|3569703|B2|Philippines||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3732804|NCT02046369|3569704|B1|Philippines||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3732805|NCT02046369|3569702|B3|United States||Region of Enrollment||Participants|Count of Participants|150|150.0||||||
3732806|NCT02046369|3569703|B2|United States||Region of Enrollment||Participants|Count of Participants|75|75.0||||||
3732807|NCT02046369|3569704|B1|United States||Region of Enrollment||Participants|Count of Participants|75|75.0||||||
3732808|NCT02046369|3569702|B3|Hungary||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3732809|NCT02046369|3569703|B2|Hungary||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3732810|NCT02046369|3569704|B1|Hungary||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3732811|NCT02046369|3569702|B3|South Korea||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3732812|NCT02046369|3569703|B2|South Korea||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3732813|NCT02046369|3569704|B1|South Korea||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3732814|NCT02046369|3569702|B3|Colombia||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3732815|NCT02046369|3569703|B2|Colombia||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3732816|NCT02046369|3569704|B1|Colombia||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3732817|NCT02046369|3569702|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732818|NCT02046369|3569703|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732819|NCT02046369|3569704|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732820|NCT02046369|3569702|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3732821|NCT02046369|3569703|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3732822|NCT02046369|3569704|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3732823|NCT02046369|3569702|B3||White|Race (NIH/OMB)||Participants|Count of Participants|260|260.0||||||
3732824|NCT02046369|3569703|B2||White|Race (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
3732825|NCT02046369|3569704|B1||White|Race (NIH/OMB)||Participants|Count of Participants|135|135.0||||||
3732826|NCT02046369|3569702|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3732827|NCT02046369|3569703|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3732828|NCT02046369|3569704|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3732829|NCT02046369|3569702|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732830|NCT02046369|3569703|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732831|NCT02046369|3569704|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732832|NCT02046369|3569702|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3732833|NCT02046369|3569703|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3732834|NCT02046369|3569704|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3732835|NCT02046369|3569702|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3732836|NCT02046369|3569703|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732837|NCT02046369|3569704|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3732838|NCT02046369|3569702|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732839|NCT02046369|3569703|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732840|NCT02046369|3569704|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732841|NCT02046369|3569702|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|347|347.0||||||
3732842|NCT02046369|3569703|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|172|172.0||||||
3732843|NCT02046369|3569704|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|175|175.0||||||
3732844|NCT02046369|3569702|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732845|NCT02046369|3569703|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732846|NCT02046369|3569704|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732847|NCT02046369|3569702|B3||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
3732848|NCT02046369|3569703|B2||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3732849|NCT02046369|3569704|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3732850|NCT02046369|3569702|B3||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
3732851|NCT02046369|3569703|B2||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3732852|NCT02046369|3569704|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3732853|NCT02046369|3569702|B3|||Age||years|Mean|14.2|14.2|Standard Deviation|2.11|2.11|||
3732854|NCT02046369|3569703|B2|||Age||years|Mean|14.3|14.3|Standard Deviation|2.01|2.01|||
3732855|NCT02046369|3569704|B1|||Age||years|Mean|14.2|14.2|Standard Deviation|2.18|2.18|||
3732856|NCT02046369|3569702|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3732857|NCT02046369|3569703|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3732858|NCT02046369|3569704|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3732859|NCT02046369|3569702|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3732860|NCT02046369|3569703|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3732861|NCT02046369|3569704|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3732862|NCT02046369|3569702|B3||<=18 years|Age||Participants|Count of Participants|347|347.0||||||
3732863|NCT02046369|3569703|B2||<=18 years|Age||Participants|Count of Participants|172|172.0||||||
3732864|NCT02046369|3569704|B1||<=18 years|Age||Participants|Count of Participants|175|175.0||||||
3732865|NCT02046317|3569721|B3|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3732866|NCT02046317|3569722|B2|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3732867|NCT02046317|3569723|B1|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3732868|NCT02046317|3569721|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3732869|NCT02046317|3569722|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3732870|NCT02046317|3569723|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3732871|NCT02046317|3569721|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3732872|NCT02046317|3569722|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3732873|NCT02046317|3569723|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3732874|NCT02046317|3569721|B3|||Age||years|Mean|61.67|61.67|Standard Deviation|22.87|22.87|||
3732875|NCT02046317|3569722|B2|||Age||years|Mean|66.88|66.88|Standard Deviation|13.70|13.7|||
3732876|NCT02046317|3569723|B1|||Age||years|Mean|51.25|51.25|Standard Deviation|35.55|35.55|||
3732877|NCT02046265|3569732|B5|United States||Region of Enrollment||participants|Number|60|60.0||||||
3732878|NCT02046265|3569733|B4|United States||Region of Enrollment||participants|Number|14|14.0||||||
3732879|NCT02046265|3569734|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3732880|NCT02046265|3569735|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3732881|NCT02046265|3569736|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3732882|NCT02046265|3569732|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3732883|NCT02046265|3569733|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3732884|NCT02046265|3569734|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3732885|NCT02046265|3569735|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3732886|NCT02046265|3569736|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732887|NCT02046265|3569732|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732888|NCT02046265|3569733|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732889|NCT02046265|3569734|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732890|NCT02046265|3569735|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732891|NCT02046265|3569736|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732892|NCT02046265|3569732|B5||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3732893|NCT02046265|3569733|B4||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3732894|NCT02046265|3569734|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3732895|NCT02046265|3569735|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3732896|NCT02046265|3569736|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3732897|NCT02046265|3569732|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3732898|NCT02046265|3569733|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3732899|NCT02046265|3569734|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3732900|NCT02046265|3569735|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3732901|NCT02046265|3569736|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3732902|NCT02046265|3569732|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732903|NCT02046265|3569733|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732904|NCT02046265|3569734|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732905|NCT02046265|3569735|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732906|NCT02046265|3569736|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732907|NCT02046265|3569732|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3732908|NCT02046265|3569733|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3732909|NCT02046265|3569734|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3732910|NCT02046265|3569735|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732911|NCT02046265|3569736|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3732912|NCT02046265|3569732|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732913|NCT02046265|3569733|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732914|NCT02046265|3569734|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732915|NCT02046265|3569735|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732916|NCT02046265|3569736|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732917|NCT02046265|3569732|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3732918|NCT02046265|3569733|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3732919|NCT02046265|3569734|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3732920|NCT02046265|3569735|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3732921|NCT02046265|3569736|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3732922|NCT02046265|3569732|B5||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3732923|NCT02046265|3569733|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3732924|NCT02046265|3569734|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3732925|NCT02046265|3569735|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3732926|NCT02046265|3569736|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3732927|NCT02046265|3569732|B5|||Age||years|Mean|21.54|21.54|Standard Deviation|2.13|2.13|||
3732928|NCT02046265|3569733|B4|||Age||years|Mean|20.77|20.77|Standard Deviation|1.80|1.8|||
3732929|NCT02046265|3569734|B3|||Age||years|Mean|21.75|21.75|Standard Deviation|2.59|2.59|||
3732930|NCT02046265|3569735|B2|||Age||years|Mean|21.56|21.56|Standard Deviation|2.00|2.0|||
3732931|NCT02046265|3569736|B1|||Age||years|Mean|22.06|22.06|Standard Deviation|2.14|2.14|||
3732932|NCT02046226|3569749|B1||Male|Sex: Female, Male|Not applicable - subjects' gender information was not recorded.|Participants|Count of Participants|NA|||||||Study subjects' gender information was not recorded.
3732933|NCT02046226|3569749|B1||Female|Sex: Female, Male|Not applicable - subjects' gender information was not recorded.|Participants|Count of Participants|NA|||||||Study subjects' gender information was not recorded.
3732934|NCT02046226|3569749|B1||>=65 years|Age|Not applicable - subjects' ages were not collected.|Participants|Count of Participants|NA|||||||Study subjects' ages were not collected.
3732935|NCT02046226|3569749|B1||Between 18 and 65 years|Age|Not applicable - subjects' ages were not collected.|Participants|Count of Participants|NA|||||||Study subjects' ages were not collected.
3732936|NCT02046226|3569749|B1||<=18 years|Age|Not applicable - subjects' ages were not collected.|Participants|Count of Participants|NA|||||||Study subjects' ages were not collected.
3732937|NCT02046200|3569756|B1|||Meets criteria for DSM-V AD||participants|Number|11|11.0||||||
3732938|NCT02046200|3569756|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3732939|NCT02046200|3569756|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3732940|NCT02046200|3569756|B1|||Age||years|Mean|38.82|38.82|Standard Deviation|11.39|11.39|||
3732941|NCT02046148|3569795|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3732942|NCT02046148|3569796|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3732943|NCT02046148|3569797|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3732944|NCT02046148|3569795|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3732945|NCT02046148|3569796|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3732946|NCT02046148|3569797|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3732947|NCT02046148|3569795|B3|||Age||Years|Mean|29.4|29.4|Standard Deviation|4.5|4.5|||
3732948|NCT02046148|3569796|B2|||Age||Years|Mean|29.4|29.4|Standard Deviation|5.1|5.1|||
3732949|NCT02046148|3569797|B1|||Age||Years|Mean|29.4|29.4|Standard Deviation|4.2|4.2|||
3732950|NCT02046122|3569842|B1|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3732951|NCT02046122|3569842|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732952|NCT02046122|3569842|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3732953|NCT02046122|3569842|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3732954|NCT02046122|3569842|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3732955|NCT02046122|3569842|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732956|NCT02046122|3569842|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732957|NCT02046122|3569842|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732958|NCT02046122|3569842|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732959|NCT02046122|3569842|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3732960|NCT02046122|3569842|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3732961|NCT02046122|3569842|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3732962|NCT02046122|3569842|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3732963|NCT02046122|3569842|B1|||Age||years|Mean|71|71.0|Standard Deviation|5|5.0|||
3732964|NCT02046005|3569848|B4|Non-White||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3732965|NCT02046005|3569849|B3|Non-White||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3732966|NCT02046005|3569850|B2|Non-White||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3732967|NCT02046005|3569851|B1|Non-White||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3732968|NCT02046005|3569848|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|207|207.0||||||
3732969|NCT02046005|3569849|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|73|73.0||||||
3732970|NCT02046005|3569850|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|65|65.0||||||
3732971|NCT02046005|3569851|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|69|69.0||||||
3732972|NCT02046005|3569848|B4||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3732973|NCT02046005|3569849|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3732974|NCT02046005|3569850|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3732975|NCT02046005|3569851|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3732976|NCT02046005|3569848|B4||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3732977|NCT02046005|3569849|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3732978|NCT02046005|3569850|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3732979|NCT02046005|3569851|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3732980|NCT02046005|3569848|B4|||Age||years|Mean|45.6|45.6|Standard Deviation|14.5|14.5|||
3732981|NCT02046005|3569849|B3|||Age||years|Mean|48.3|48.3|Standard Deviation|13.7|13.7|||
3732982|NCT02046005|3569850|B2|||Age||years|Mean|45.0|45.0|Standard Deviation|14.9|14.9|||
3732983|NCT02046005|3569851|B1|||Age||years|Mean|43.4|43.4|Standard Deviation|14.7|14.7|||
3732984|NCT02045979|3569861|B4||Male|Sex: Female, Male||Participants|Count of Participants|324|324.0||||||
3732985|NCT02045979|3569862|B3||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3732986|NCT02045979|3569863|B2||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3732987|NCT02045979|3569864|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3732988|NCT02045979|3569861|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3732989|NCT02045979|3569862|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3732990|NCT02045979|3569863|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3732991|NCT02045979|3569864|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3732992|NCT02045979|3569861|B4|||Age||years|Mean|31|31.0|Standard Deviation|11|11.0|||
3732993|NCT02045979|3569862|B3|||Age||years|Mean|30|30.0|Standard Deviation|12|12.0|||
3732994|NCT02045979|3569863|B2|||Age||years|Mean|31|31.0|Standard Deviation|11|11.0|||
3732995|NCT02045979|3569864|B1|||Age||years|Mean|30|30.0|Standard Deviation|11|11.0|||
3732996|NCT02045875|3569901|B3|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3732997|NCT02045875|3569902|B2|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3732998|NCT02045875|3569903|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3732999|NCT02045875|3569901|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3733000|NCT02045875|3569901|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3733001|NCT02045875|3569902|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3733002|NCT02045875|3569903|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3733003|NCT02045875|3569901|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3733004|NCT02045875|3569902|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3733005|NCT02045875|3569903|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3733006|NCT02045875|3569901|B3|||Age||years|Mean|40|40.0|Full Range|||23.0|69.0|
3733007|NCT02045875|3569902|B2|||Age||years|Mean|39|39.0|Full Range|||26.0|69.0|
3733008|NCT02045875|3569903|B1|||Age||years|Mean|41|41.0|Full Range|||23.0|67.0|
3733009|NCT02045862|3569912|B4|||Number of Pads Used per Week|The number of pads used per week was the number of times a participant recorded a new pad used during the 7-day micturition diary period prior to the first dose of double-blind treatment.|pads/week|Mean|17.9|17.9|Standard Deviation|20.0|20.0|||
3733010|NCT02045862|3569913|B3|||Number of Pads Used per Week|The number of pads used per week was the number of times a participant recorded a new pad used during the 7-day micturition diary period prior to the first dose of double-blind treatment.|pads/week|Mean|17.7|17.7|Standard Deviation|17.6|17.6|||
3733011|NCT02045862|3569914|B2|||Number of Pads Used per Week|The number of pads used per week was the number of times a participant recorded a new pad used during the 7-day micturition diary period prior to the first dose of double-blind treatment.|pads/week|Mean|19.2|19.2|Standard Deviation|22.0|22.0|||
3733012|NCT02045862|3569915|B1|||Number of Pads Used per Week|The number of pads used per week was the number of times a participant recorded a new pad used during the 7-day micturition diary period prior to the first dose of double-blind treatment.|pads/week|Mean|17.3|17.3|Standard Deviation|26.1|26.1|||
3733013|NCT02045862|3569912|B4|||Mean Number of Pads Used per 24 Hours|The mean number of pads used per 24 hours was calculated from data recorded by the participant in a micturition diary for 7 days prior to the first dose of double-blind treatment.|pads/24 hours|Mean|2.60|2.6|Standard Deviation|2.91|2.91|||
3733014|NCT02045862|3569913|B3|||Mean Number of Pads Used per 24 Hours|The mean number of pads used per 24 hours was calculated from data recorded by the participant in a micturition diary for 7 days prior to the first dose of double-blind treatment.|pads/24 hours|Mean|2.58|2.58|Standard Deviation|2.59|2.59|||
3733015|NCT02045862|3569914|B2|||Mean Number of Pads Used per 24 Hours|The mean number of pads used per 24 hours was calculated from data recorded by the participant in a micturition diary for 7 days prior to the first dose of double-blind treatment.|pads/24 hours|Mean|2.77|2.77|Standard Deviation|3.15|3.15|||
3733016|NCT02045862|3569915|B1|||Mean Number of Pads Used per 24 Hours|The mean number of pads used per 24 hours was calculated from data recorded by the participant in a micturition diary for 7 days prior to the first dose of double-blind treatment.|pads/24 hours|Mean|2.51|2.51|Standard Deviation|3.76|3.76|||
3733017|NCT02045862|3569912|B4|||Number of Nocturia Episodes per Week|A nocturia episode was defined as waking at night 1 or more times to void (i.e., any voiding associated with sleep disturbance between the time the participant goes to bed with the intention to sleep until the time the participant gets up in the morning with the intention to stay awake). The number of nocturia episodes per week was the number of times a participant recorded a nocturia episode in a micturition diary for 7 days prior to the first dose of double-blind treatment.|nocturia episodes/week|Mean|10.4|10.4|Standard Deviation|6.5|6.5|||
3733018|NCT02045862|3569913|B3|||Number of Nocturia Episodes per Week|A nocturia episode was defined as waking at night 1 or more times to void (i.e., any voiding associated with sleep disturbance between the time the participant goes to bed with the intention to sleep until the time the participant gets up in the morning with the intention to stay awake). The number of nocturia episodes per week was the number of times a participant recorded a nocturia episode in a micturition diary for 7 days prior to the first dose of double-blind treatment.|nocturia episodes/week|Mean|10.4|10.4|Standard Deviation|6.5|6.5|||
3733019|NCT02045862|3569914|B2|||Number of Nocturia Episodes per Week|A nocturia episode was defined as waking at night 1 or more times to void (i.e., any voiding associated with sleep disturbance between the time the participant goes to bed with the intention to sleep until the time the participant gets up in the morning with the intention to stay awake). The number of nocturia episodes per week was the number of times a participant recorded a nocturia episode in a micturition diary for 7 days prior to the first dose of double-blind treatment.|nocturia episodes/week|Mean|11.0|11.0|Standard Deviation|6.6|6.6|||
3733020|NCT02045862|3569915|B1|||Number of Nocturia Episodes per Week|A nocturia episode was defined as waking at night 1 or more times to void (i.e., any voiding associated with sleep disturbance between the time the participant goes to bed with the intention to sleep until the time the participant gets up in the morning with the intention to stay awake). The number of nocturia episodes per week was the number of times a participant recorded a nocturia episode in a micturition diary for 7 days prior to the first dose of double-blind treatment.|nocturia episodes/week|Mean|10.3|10.3|Standard Deviation|6.6|6.6|||
3733021|NCT02045862|3569912|B4|||Mean Number of Nocturia Episodes per 24 Hours|A nocturia episode was defined as waking at night 1 or more times to void (i.e., any voiding associated with sleep disturbance between the time the participant goes to bed with the intention to sleep until the time the participant gets up in the morning with the intention to stay awake). The mean number of nocturia episodes per 24 hours was calculated from data recorded by the participant in a micturition diary for 7 days prior to the first dose of double-blind treatment.|nocturia episodes/24 hours|Mean|1.51|1.51|Standard Deviation|0.94|0.94|||
3733051|NCT02045862|3569914|B2|||Mean Number of Incontinence Episodes per 24 Hours|An incontinence episode was defined as the complaint of any involuntary leakage of urine. The mean number of incontinence episodes per 24 hours was calculated from data recorded by the participant in a micturition diary for 7 days prior to the first dose of double-blind treatment.|incontinence episodes/24 hours|Mean|3.10|3.1|Standard Deviation|3.58|3.58|||
3733022|NCT02045862|3569913|B3|||Mean Number of Nocturia Episodes per 24 Hours|A nocturia episode was defined as waking at night 1 or more times to void (i.e., any voiding associated with sleep disturbance between the time the participant goes to bed with the intention to sleep until the time the participant gets up in the morning with the intention to stay awake). The mean number of nocturia episodes per 24 hours was calculated from data recorded by the participant in a micturition diary for 7 days prior to the first dose of double-blind treatment.|nocturia episodes/24 hours|Mean|1.49|1.49|Standard Deviation|0.94|0.94|||
3733023|NCT02045862|3569914|B2|||Mean Number of Nocturia Episodes per 24 Hours|A nocturia episode was defined as waking at night 1 or more times to void (i.e., any voiding associated with sleep disturbance between the time the participant goes to bed with the intention to sleep until the time the participant gets up in the morning with the intention to stay awake). The mean number of nocturia episodes per 24 hours was calculated from data recorded by the participant in a micturition diary for 7 days prior to the first dose of double-blind treatment.|nocturia episodes/24 hours|Mean|1.58|1.58|Standard Deviation|0.94|0.94|||
3733024|NCT02045862|3569915|B1|||Mean Number of Nocturia Episodes per 24 Hours|A nocturia episode was defined as waking at night 1 or more times to void (i.e., any voiding associated with sleep disturbance between the time the participant goes to bed with the intention to sleep until the time the participant gets up in the morning with the intention to stay awake). The mean number of nocturia episodes per 24 hours was calculated from data recorded by the participant in a micturition diary for 7 days prior to the first dose of double-blind treatment.|nocturia episodes/24 hours|Mean|1.48|1.48|Standard Deviation|0.95|0.95|||
3733025|NCT02045862|3569912|B4|||Mean Number of Urgency Episodes (Grade 3 or 4) per 24 Hours|Urgency was defined as a complaint of a sudden, compelling desire to pass urine, which is difficult to defer. An urgency episode was defined as any micturition or incontinence episode recorded by the participant in a micturition diary for 7 days prior to the first dose of double-blind treatment as 3 or 4 on the Patient Perception of Intensity of Urgency Scale (PPIUS), where 0 = No urgency; 1 = Mild urgency; 2 = Moderate urgency, could delay voiding a short while; 3 = Severe urgency, could not delay voiding; 4 = Urge incontinence, leaked before arriving to the toilet.|urgency episodes/24 hours|Mean|6.51|6.51|Standard Deviation|3.84|3.84|||
3733026|NCT02045862|3569913|B3|||Mean Number of Urgency Episodes (Grade 3 or 4) per 24 Hours|Urgency was defined as a complaint of a sudden, compelling desire to pass urine, which is difficult to defer. An urgency episode was defined as any micturition or incontinence episode recorded by the participant in a micturition diary for 7 days prior to the first dose of double-blind treatment as 3 or 4 on the Patient Perception of Intensity of Urgency Scale (PPIUS), where 0 = No urgency; 1 = Mild urgency; 2 = Moderate urgency, could delay voiding a short while; 3 = Severe urgency, could not delay voiding; 4 = Urge incontinence, leaked before arriving to the toilet.|urgency episodes/24 hours|Mean|6.53|6.53|Standard Deviation|3.69|3.69|||
3733027|NCT02045862|3569914|B2|||Mean Number of Urgency Episodes (Grade 3 or 4) per 24 Hours|Urgency was defined as a complaint of a sudden, compelling desire to pass urine, which is difficult to defer. An urgency episode was defined as any micturition or incontinence episode recorded by the participant in a micturition diary for 7 days prior to the first dose of double-blind treatment as 3 or 4 on the Patient Perception of Intensity of Urgency Scale (PPIUS), where 0 = No urgency; 1 = Mild urgency; 2 = Moderate urgency, could delay voiding a short while; 3 = Severe urgency, could not delay voiding; 4 = Urge incontinence, leaked before arriving to the toilet.|urgency episodes/24 hours|Mean|6.63|6.63|Standard Deviation|4.08|4.08|||
3733028|NCT02045862|3569915|B1|||Mean Number of Urgency Episodes (Grade 3 or 4) per 24 Hours|Urgency was defined as a complaint of a sudden, compelling desire to pass urine, which is difficult to defer. An urgency episode was defined as any micturition or incontinence episode recorded by the participant in a micturition diary for 7 days prior to the first dose of double-blind treatment as 3 or 4 on the Patient Perception of Intensity of Urgency Scale (PPIUS), where 0 = No urgency; 1 = Mild urgency; 2 = Moderate urgency, could delay voiding a short while; 3 = Severe urgency, could not delay voiding; 4 = Urge incontinence, leaked before arriving to the toilet.|urgency episodes/24 hours|Mean|6.34|6.34|Standard Deviation|4.16|4.16|||
3733029|NCT02045862|3569912|B4|||Number of Urgency Incontinence Episodes per Week|An urgency incontinence episode was defined as the involuntary leakage of urine accompanied by or immediately preceded by urgency. The number of urgency incontinence episodes per week was the total number of times a participant recorded an urgency incontinence episode in a micturition diary for 7 days prior to the first dose of double-blind treatment.|urgency incontinence episodes/week|Mean|19.3|19.3|Standard Deviation|20.7|20.7|||
3733030|NCT02045862|3569913|B3|||Number of Urgency Incontinence Episodes per Week|An urgency incontinence episode was defined as the involuntary leakage of urine accompanied by or immediately preceded by urgency. The number of urgency incontinence episodes per week was the total number of times a participant recorded an urgency incontinence episode in a micturition diary for 7 days prior to the first dose of double-blind treatment.|urgency incontinence episodes/week|Mean|18.9|18.9|Standard Deviation|19.1|19.1|||
3733031|NCT02045862|3569914|B2|||Number of Urgency Incontinence Episodes per Week|An urgency incontinence episode was defined as the involuntary leakage of urine accompanied by or immediately preceded by urgency. The number of urgency incontinence episodes per week was the total number of times a participant recorded an urgency incontinence episode in a micturition diary for 7 days prior to the first dose of double-blind treatment.|urgency incontinence episodes/week|Mean|20.2|20.2|Standard Deviation|24.5|24.5|||
3733032|NCT02045862|3569915|B1|||Number of Urgency Incontinence Episodes per Week|An urgency incontinence episode was defined as the involuntary leakage of urine accompanied by or immediately preceded by urgency. The number of urgency incontinence episodes per week was the total number of times a participant recorded an urgency incontinence episode in a micturition diary for 7 days prior to the first dose of double-blind treatment.|urgency incontinence episodes/week|Mean|19.8|19.8|Standard Deviation|22.8|22.8|||
3733033|NCT02045862|3569912|B4|||Mean Number of Urgency Incontinence Episodes per 24 Hours|An urgency incontinence episode was defined as the involuntary leakage of urine accompanied by or immediately preceded by urgency. The mean number of urgency incontinence episodes per 24 hours was calculated from data recorded by the participant in a micturition diary for 7 days prior to the first dose of double-blind treatment.|urgency incontinence episodes/24 hours|Mean|2.79|2.79|Standard Deviation|3.00|3.0|||
3733104|NCT02045836|3570096|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3733034|NCT02045862|3569913|B3|||Mean Number of Urgency Incontinence Episodes per 24 Hours|An urgency incontinence episode was defined as the involuntary leakage of urine accompanied by or immediately preceded by urgency. The mean number of urgency incontinence episodes per 24 hours was calculated from data recorded by the participant in a micturition diary for 7 days prior to the first dose of double-blind treatment.|urgency incontinence episodes/24 hours|Mean|2.74|2.74|Standard Deviation|2.78|2.78|||
3733035|NCT02045862|3569914|B2|||Mean Number of Urgency Incontinence Episodes per 24 Hours|An urgency incontinence episode was defined as the involuntary leakage of urine accompanied by or immediately preceded by urgency. The mean number of urgency incontinence episodes per 24 hours was calculated from data recorded by the participant in a micturition diary for 7 days prior to the first dose of double-blind treatment.|urgency incontinence episodes/24 hours|Mean|2.91|2.91|Standard Deviation|3.49|3.49|||
3733036|NCT02045862|3569915|B1|||Mean Number of Urgency Incontinence Episodes per 24 Hours|An urgency incontinence episode was defined as the involuntary leakage of urine accompanied by or immediately preceded by urgency. The mean number of urgency incontinence episodes per 24 hours was calculated from data recorded by the participant in a micturition diary for 7 days prior to the first dose of double-blind treatment.|urgency incontinence episodes/24 hours|Mean|2.86|2.86|Standard Deviation|3.29|3.29|||
3733037|NCT02045862|3569912|B4|||Number of Incontinence Episodes per Week|An incontinence episode was defined as the complaint of any involuntary leakage of urine. The number of incontinence episodes per week was the total number of times a participant recorded an incontinence episode in a micturition diary for 7 days prior to the first dose of double-blind treatment.|incontinence episodes/week|Mean|21.2|21.2|Standard Deviation|22.9|22.9|||
3733038|NCT02045862|3569913|B3|||Number of Incontinence Episodes per Week|An incontinence episode was defined as the complaint of any involuntary leakage of urine. The number of incontinence episodes per week was the total number of times a participant recorded an incontinence episode in a micturition diary for 7 days prior to the first dose of double-blind treatment.|incontinence episodes/week|Mean|20.9|20.9|Standard Deviation|21.9|21.9|||
3733039|NCT02045862|3569914|B2|||Number of Incontinence Episodes per Week|An incontinence episode was defined as the complaint of any involuntary leakage of urine. The number of incontinence episodes per week was the total number of times a participant recorded an incontinence episode in a micturition diary for 7 days prior to the first dose of double-blind treatment.|incontinence episodes/week|Mean|21.6|21.6|Standard Deviation|25.0|25.0|||
3733040|NCT02045862|3569915|B1|||Number of Incontinence Episodes per Week|An incontinence episode was defined as the complaint of any involuntary leakage of urine. The number of incontinence episodes per week was the total number of times a participant recorded an incontinence episode in a micturition diary for 7 days prior to the first dose of double-blind treatment.|incontinence episodes/week|Mean|21.8|21.8|Standard Deviation|24.8|24.8|||
3733041|NCT02045862|3569912|B4|||Mean Volume Voided per Micturition|The mean volume voided per micturition was calculated from the data recorded by the participant during 3 consecutive days with volume measurements during the 7-day micturition diary period prior to first dose of double-blind treatment.|mL|Mean|159.82|159.82|Standard Deviation|58.69|58.69|||
3733042|NCT02045862|3569913|B3|||Mean Volume Voided per Micturition|The mean volume voided per micturition was calculated from the data recorded by the participant during 3 consecutive days with volume measurements during the 7-day micturition diary period prior to first dose of double-blind treatment.|mL|Mean|159.29|159.29|Standard Deviation|58.40|58.4|||
3733043|NCT02045862|3569914|B2|||Mean Volume Voided per Micturition|The mean volume voided per micturition was calculated from the data recorded by the participant during 3 consecutive days with volume measurements during the 7-day micturition diary period prior to first dose of double-blind treatment.|mL|Mean|160.70|160.7|Standard Deviation|58.49|58.49|||
3733044|NCT02045862|3569915|B1|||Mean Volume Voided per Micturition|The mean volume voided per micturition was calculated from the data recorded by the participant during 3 consecutive days with volume measurements during the 7-day micturition diary period prior to first dose of double-blind treatment.|mL|Mean|161.00|161.0|Standard Deviation|60.16|60.16|||
3733045|NCT02045862|3569912|B4|||Mean Number of Micturitions per 24 Hours|A micturition was defined as any voluntary act of passing urine (excluding incontinence only episodes). The mean number of micturitions per 24 hours was calculated from data recorded by the participant in a micturition diary for 7 days prior to the first dose of double-blind treatment.|micturitions/24 hours|Mean|10.58|10.58|Standard Deviation|2.70|2.7|||
3733046|NCT02045862|3569913|B3|||Mean Number of Micturitions per 24 Hours|A micturition was defined as any voluntary act of passing urine (excluding incontinence only episodes). The mean number of micturitions per 24 hours was calculated from data recorded by the participant in a micturition diary for 7 days prior to the first dose of double-blind treatment.|micturitions/24 hours|Mean|10.55|10.55|Standard Deviation|2.73|2.73|||
3733047|NCT02045862|3569914|B2|||Mean Number of Micturitions per 24 Hours|A micturition was defined as any voluntary act of passing urine (excluding incontinence only episodes). The mean number of micturitions per 24 hours was calculated from data recorded by the participant in a micturition diary for 7 days prior to the first dose of double-blind treatment.|micturitions/24 hours|Mean|10.76|10.76|Standard Deviation|2.83|2.83|||
3733048|NCT02045862|3569915|B1|||Mean Number of Micturitions per 24 Hours|A micturition was defined as any voluntary act of passing urine (excluding incontinence only episodes). The mean number of micturitions per 24 hours was calculated from data recorded by the participant in a micturition diary for 7 days prior to the first dose of double-blind treatment.|micturitions/24 hours|Mean|10.51|10.51|Standard Deviation|2.41|2.41|||
3733049|NCT02045862|3569912|B4|||Mean Number of Incontinence Episodes per 24 Hours|An incontinence episode was defined as the complaint of any involuntary leakage of urine. The mean number of incontinence episodes per 24 hours was calculated from data recorded by the participant in a micturition diary for 7 days prior to the first dose of double-blind treatment.|incontinence episodes/24 hours|Mean|3.07|3.07|Standard Deviation|3.31|3.31|||
3733050|NCT02045862|3569913|B3|||Mean Number of Incontinence Episodes per 24 Hours|An incontinence episode was defined as the complaint of any involuntary leakage of urine. The mean number of incontinence episodes per 24 hours was calculated from data recorded by the participant in a micturition diary for 7 days prior to the first dose of double-blind treatment.|incontinence episodes/24 hours|Mean|3.04|3.04|Standard Deviation|3.17|3.17|||
3733162|NCT02045732|3570276|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3733052|NCT02045862|3569915|B1|||Mean Number of Incontinence Episodes per 24 Hours|An incontinence episode was defined as the complaint of any involuntary leakage of urine. The mean number of incontinence episodes per 24 hours was calculated from data recorded by the participant in a micturition diary for 7 days prior to the first dose of double-blind treatment.|incontinence episodes/24 hours|Mean|3.15|3.15|Standard Deviation|3.56|3.56|||
3733053|NCT02045862|3569912|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|1745|1745.0||||||
3733054|NCT02045862|3569913|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|1164|1164.0||||||
3733055|NCT02045862|3569914|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|290|290.0||||||
3733056|NCT02045862|3569915|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|291|291.0||||||
3733057|NCT02045862|3569912|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|84|84.0||||||
3733058|NCT02045862|3569913|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|54|54.0||||||
3733059|NCT02045862|3569914|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3733060|NCT02045862|3569915|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3733061|NCT02045862|3569912|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3733062|NCT02045862|3569913|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3733063|NCT02045862|3569914|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3733064|NCT02045862|3569915|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3733065|NCT02045862|3569912|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|183|183.0||||||
3733066|NCT02045862|3569913|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|119|119.0||||||
3733067|NCT02045862|3569914|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3733068|NCT02045862|3569915|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3733069|NCT02045862|3569912|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3733070|NCT02045862|3569913|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3733071|NCT02045862|3569914|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3733072|NCT02045862|3569915|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3733073|NCT02045862|3569912|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|1597|1597.0||||||
3733074|NCT02045862|3569913|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|1066|1066.0||||||
3733075|NCT02045862|3569914|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|265|265.0||||||
3733076|NCT02045862|3569915|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|266|266.0||||||
3733077|NCT02045862|3569912|B4||Male|Sex: Female, Male||Participants|Count of Participants|368|368.0||||||
3733078|NCT02045862|3569913|B3||Male|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
3733079|NCT02045862|3569914|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3733080|NCT02045862|3569915|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3733081|NCT02045862|3569912|B4||Female|Sex: Female, Male||Participants|Count of Participants|1461|1461.0||||||
3733082|NCT02045862|3569913|B3||Female|Sex: Female, Male||Participants|Count of Participants|973|973.0||||||
3733083|NCT02045862|3569914|B2||Female|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
3733084|NCT02045862|3569915|B1||Female|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
3733085|NCT02045862|3569912|B4|||Age||years|Mean|58.5|58.5|Standard Deviation|13.0|13.0|||
3733086|NCT02045862|3569913|B3|||Age||years|Mean|58.3|58.3|Standard Deviation|13.0|13.0|||
3733087|NCT02045862|3569914|B2|||Age||years|Mean|59.0|59.0|Standard Deviation|13.3|13.3|||
3733088|NCT02045862|3569915|B1|||Age||years|Mean|58.8|58.8|Standard Deviation|12.7|12.7|||
3733089|NCT02045836|3570096|B3|Mixed Origin||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3733090|NCT02045836|3570097|B2|Mixed Origin||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3733091|NCT02045836|3570098|B1|Mixed Origin||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3733092|NCT02045836|3570096|B3|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3733093|NCT02045836|3570097|B2|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3733094|NCT02045836|3570098|B1|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3733095|NCT02045836|3570096|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3733096|NCT02045836|3570097|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3733097|NCT02045836|3570098|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3733098|NCT02045836|3570096|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3733099|NCT02045836|3570097|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3733100|NCT02045836|3570098|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3733101|NCT02045836|3570096|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3733102|NCT02045836|3570097|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3733103|NCT02045836|3570098|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3733105|NCT02045836|3570097|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3733106|NCT02045836|3570098|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3733107|NCT02045836|3570096|B3|African Heritage / African American||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3733108|NCT02045836|3570097|B2|African Heritage / African American||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3733109|NCT02045836|3570098|B1|African Heritage / African American||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3733110|NCT02045836|3570096|B3|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|814|814.0||||||
3733111|NCT02045836|3570097|B2|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|406|406.0||||||
3733112|NCT02045836|3570098|B1|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|408|408.0||||||
3733113|NCT02045836|3570096|B3||Male|Sex: Female, Male||Participants|Count of Participants|349|349.0||||||
3733114|NCT02045836|3570097|B2||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
3733115|NCT02045836|3570098|B1||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3733116|NCT02045836|3570096|B3||Female|Sex: Female, Male||Participants|Count of Participants|516|516.0||||||
3733117|NCT02045836|3570097|B2||Female|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
3733118|NCT02045836|3570098|B1||Female|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
3733119|NCT02045836|3570096|B3|||Age||Years|Mean|63.2|63.2|Standard Deviation|8.4|8.4|||
3733120|NCT02045836|3570097|B2|||Age||Years|Mean|63.2|63.2|Standard Deviation|8.4|8.4|||
3733121|NCT02045836|3570098|B1|||Age||Years|Mean|63.2|63.2|Standard Deviation|8.4|8.4|||
3733122|NCT02045797|3570128|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733123|NCT02045797|3570129|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733124|NCT02045797|3570130|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733125|NCT02045797|3570131|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733126|NCT02045797|3570128|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733127|NCT02045797|3570129|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733128|NCT02045797|3570130|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733129|NCT02045797|3570131|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733130|NCT02045797|3570128|B4||White|Race (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
3733131|NCT02045797|3570129|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3733132|NCT02045797|3570130|B2||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3733133|NCT02045797|3570131|B1||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3733134|NCT02045797|3570128|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3733135|NCT02045797|3570129|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733136|NCT02045797|3570130|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3733137|NCT02045797|3570131|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3733138|NCT02045797|3570128|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3733139|NCT02045797|3570129|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733140|NCT02045797|3570130|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733141|NCT02045797|3570131|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3733142|NCT02045797|3570128|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3733143|NCT02045797|3570129|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3733144|NCT02045797|3570130|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733145|NCT02045797|3570131|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733146|NCT02045797|3570128|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3733147|NCT02045797|3570129|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733148|NCT02045797|3570130|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3733149|NCT02045797|3570131|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3733150|NCT02045797|3570128|B4||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3733151|NCT02045797|3570129|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3733152|NCT02045797|3570130|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3733153|NCT02045797|3570131|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3733154|NCT02045797|3570128|B4||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3733155|NCT02045797|3570129|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3733156|NCT02045797|3570130|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3733157|NCT02045797|3570131|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3733158|NCT02045797|3570128|B4|||Age||Years|Mean|44.7|44.7|Standard Deviation|11.36|11.36|||
3733159|NCT02045797|3570129|B3|||Age||Years|Mean|45.8|45.8|Standard Deviation|12.64|12.64|||
3733160|NCT02045797|3570130|B2|||Age||Years|Mean|44.6|44.6|Standard Deviation|10.76|10.76|||
3733161|NCT02045797|3570131|B1|||Age||Years|Mean|44.3|44.3|Standard Deviation|11.35|11.35|||
3733163|NCT02045732|3570277|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3733164|NCT02045732|3570278|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3733165|NCT02045732|3570276|B3||Female|Gender||Participants|Count of Participants|4|4.0||||||
3733166|NCT02045732|3570277|B2||Female|Gender||Participants|Count of Participants|3|3.0||||||
3733167|NCT02045732|3570278|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
3733168|NCT02045732|3570276|B3|||Age||years|Mean|42.3|42.3|Standard Deviation|13.1|13.1|||
3733169|NCT02045732|3570277|B2|||Age||years|Mean|45.3|45.3|Standard Deviation|14.2|14.2|||
3733170|NCT02045732|3570278|B1|||Age||years|Mean|33|33.0|Standard Deviation|0|0.0|||
3733171|NCT02045511|3570297|B3|||SF-36 physical component (Quality of Life)|"Measure collected via one-on-one interview conducted by trained data collectors.~Standard scoring can be found at http://www.rand.org/health/surveys_tools/mos/36-item-short-form/scoring.html.~Higher scores indicate better physical health functioning; U.S. population norm: M = 50, SD = 9.95, range = [4-71]."|units on a scale|Median|46.3|46.3|Inter-Quartile Range|||41.5|59.9|
3733172|NCT02045511|3570298|B2|||SF-36 physical component (Quality of Life)|"Measure collected via one-on-one interview conducted by trained data collectors.~Standard scoring can be found at http://www.rand.org/health/surveys_tools/mos/36-item-short-form/scoring.html.~Higher scores indicate better physical health functioning; U.S. population norm: M = 50, SD = 9.95, range = [4-71]."|units on a scale|Median|50.6|50.6|Inter-Quartile Range|||47.5|60.0|
3733173|NCT02045511|3570299|B1|||SF-36 physical component (Quality of Life)|"Measure collected via one-on-one interview conducted by trained data collectors.~Standard scoring can be found at http://www.rand.org/health/surveys_tools/mos/36-item-short-form/scoring.html.~Higher scores indicate better physical health functioning; U.S. population norm: M = 50, SD = 9.95, range = [4-71]."|units on a scale|Median|41.5|41.5|Inter-Quartile Range|||40.1|47.0|
3733174|NCT02045511|3570297|B3|||Short Form - 36 (SF) -36 mental component (Quality of Life)|"Measure collected via one-on-one interview conducted by trained data collectors.~Standard scoring can be found at http://www.rand.org/health/surveys_tools/mos/36-item-short-form/scoring.html.~Higher scores indicate better mental health functioning; U.S. population norm: M = 50.0, SD = 10.0, range = [2-74]."|units on a scale|Median|54.4|54.4|Inter-Quartile Range|||41.9|58.6|
3733175|NCT02045511|3570298|B2|||Short Form - 36 (SF) -36 mental component (Quality of Life)|"Measure collected via one-on-one interview conducted by trained data collectors.~Standard scoring can be found at http://www.rand.org/health/surveys_tools/mos/36-item-short-form/scoring.html.~Higher scores indicate better mental health functioning; U.S. population norm: M = 50.0, SD = 10.0, range = [2-74]."|units on a scale|Median|56.6|56.6|Inter-Quartile Range|||49.7|59.3|
3733176|NCT02045511|3570299|B1|||Short Form - 36 (SF) -36 mental component (Quality of Life)|"Measure collected via one-on-one interview conducted by trained data collectors.~Standard scoring can be found at http://www.rand.org/health/surveys_tools/mos/36-item-short-form/scoring.html.~Higher scores indicate better mental health functioning; U.S. population norm: M = 50.0, SD = 10.0, range = [2-74]."|units on a scale|Median|50.9|50.9|Inter-Quartile Range|||38.0|57.2|
3733177|NCT02045511|3570297|B3|||Patient Health Questionnaire (PHQ)|"Measure collected via one-on-one interview conducted by trained data collectors.~Total of 9 questions, scored from 0 to 3. The score from each question are summed to a total score, which can range from 0 to 27.~Interpretation of Total Score Total Score Depression Severity 0 No depression 1-4 Minimal depression 5-9 Mild depression 10-14 Moderate depression 15-19 Moderately severe depression 20-27 Severe depression"|units on a scale|Median|8|8.0|Inter-Quartile Range|||4.0|11.5|
3733178|NCT02045511|3570298|B2|||Patient Health Questionnaire (PHQ)|"Measure collected via one-on-one interview conducted by trained data collectors.~Total of 9 questions, scored from 0 to 3. The score from each question are summed to a total score, which can range from 0 to 27.~Interpretation of Total Score Total Score Depression Severity 0 No depression 1-4 Minimal depression 5-9 Mild depression 10-14 Moderate depression 15-19 Moderately severe depression 20-27 Severe depression"|units on a scale|Median|8|8.0|Inter-Quartile Range|||3.0|8.5|
3733179|NCT02045511|3570299|B1|||Patient Health Questionnaire (PHQ)|"Measure collected via one-on-one interview conducted by trained data collectors.~Total of 9 questions, scored from 0 to 3. The score from each question are summed to a total score, which can range from 0 to 27.~Interpretation of Total Score Total Score Depression Severity 0 No depression 1-4 Minimal depression 5-9 Mild depression 10-14 Moderate depression 15-19 Moderately severe depression 20-27 Severe depression"|units on a scale|Median|9.5|9.5|Inter-Quartile Range|||4.8|13.8|
3733180|NCT02045511|3570297|B3|||Revised University of California Los Angeles (UCLA) Loneliness Scale|"Measure was collected via a one-on-one interview conducted by a trained data collector.~20-item Likert-type scale. Total score is sum of the 20 items, scores range from 20 to 80. Lower values equate to lower levels of loneliness and higher values equate to higher levels of loneliness.~Perry et al., 1990 uses the following score ranges:~20-34 - Low degree of loneliness 35-49 - Moderate degree of loneliness 50-64 - Moderately high degree of loneliness 65-80 - High degree of loneliness"|units on a scale|Median|46|46.0|Inter-Quartile Range|||41.5|55.5|
3733181|NCT02045511|3570298|B2|||Revised University of California Los Angeles (UCLA) Loneliness Scale|"Measure was collected via a one-on-one interview conducted by a trained data collector.~20-item Likert-type scale. Total score is sum of the 20 items, scores range from 20 to 80. Lower values equate to lower levels of loneliness and higher values equate to higher levels of loneliness.~Perry et al., 1990 uses the following score ranges:~20-34 - Low degree of loneliness 35-49 - Moderate degree of loneliness 50-64 - Moderately high degree of loneliness 65-80 - High degree of loneliness"|units on a scale|Median|46|46.0|Inter-Quartile Range|||37.5|55.5|
3733182|NCT02045511|3570299|B1|||Revised University of California Los Angeles (UCLA) Loneliness Scale|"Measure was collected via a one-on-one interview conducted by a trained data collector.~20-item Likert-type scale. Total score is sum of the 20 items, scores range from 20 to 80. Lower values equate to lower levels of loneliness and higher values equate to higher levels of loneliness.~Perry et al., 1990 uses the following score ranges:~20-34 - Low degree of loneliness 35-49 - Moderate degree of loneliness 50-64 - Moderately high degree of loneliness 65-80 - High degree of loneliness"|units on a scale|Median|46|46.0|Inter-Quartile Range|||43.8|54.0|
3733223|NCT02045238|3570331|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3733224|NCT02045238|3570332|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3733183|NCT02045511|3570297|B3|||Revised Quantified Denver Scale of Communication Function (QDS)|"Measure was collected through a one-on-one interview conducted by a trained data collector.~Survey includes 5 questions, scored Strongly disagree, Slightly disagree, neither, slightly agree, or strongly agree (1, 2, 3, 4, 5)~Scoring is from 1 (worst) to 5 (best).~The scores from the 5 questions are summed and reported as a total score. The range for the total score is 5 (worst) to 25 (best).~Although utilized in multiple studies, including Yueh et al., 2001, there are no numerical anchors for what would represent a clinically important difference."|units on a scale|Median|16|16.0|Inter-Quartile Range|||13.5|18.0|
3733184|NCT02045511|3570298|B2|||Revised Quantified Denver Scale of Communication Function (QDS)|"Measure was collected through a one-on-one interview conducted by a trained data collector.~Survey includes 5 questions, scored Strongly disagree, Slightly disagree, neither, slightly agree, or strongly agree (1, 2, 3, 4, 5)~Scoring is from 1 (worst) to 5 (best).~The scores from the 5 questions are summed and reported as a total score. The range for the total score is 5 (worst) to 25 (best).~Although utilized in multiple studies, including Yueh et al., 2001, there are no numerical anchors for what would represent a clinically important difference."|units on a scale|Median|16|16.0|Inter-Quartile Range|||12.5|16.5|
3733185|NCT02045511|3570299|B1|||Revised Quantified Denver Scale of Communication Function (QDS)|"Measure was collected through a one-on-one interview conducted by a trained data collector.~Survey includes 5 questions, scored Strongly disagree, Slightly disagree, neither, slightly agree, or strongly agree (1, 2, 3, 4, 5)~Scoring is from 1 (worst) to 5 (best).~The scores from the 5 questions are summed and reported as a total score. The range for the total score is 5 (worst) to 25 (best).~Although utilized in multiple studies, including Yueh et al., 2001, there are no numerical anchors for what would represent a clinically important difference."|units on a scale|Median|16|16.0|Inter-Quartile Range|||14.0|20.2|
3733186|NCT02045511|3570297|B3|||HHIE-S (Hearing handicap inventory for the elderly - screening)|"Measure was collected through a one-on-one interview with a trained data collector.~Scoring:~0-8 suggests no hearing handicap 10-24 suggests mild-moderate hearing handicap 26-40 suggests significant hearing handicap"|units on a scale|Median|20|20.0|Inter-Quartile Range|||16.0|22.0|
3733187|NCT02045511|3570298|B2|||HHIE-S (Hearing handicap inventory for the elderly - screening)|"Measure was collected through a one-on-one interview with a trained data collector.~Scoring:~0-8 suggests no hearing handicap 10-24 suggests mild-moderate hearing handicap 26-40 suggests significant hearing handicap"|units on a scale|Median|20|20.0|Inter-Quartile Range|||17.0|20.0|
3733188|NCT02045511|3570299|B1|||HHIE-S (Hearing handicap inventory for the elderly - screening)|"Measure was collected through a one-on-one interview with a trained data collector.~Scoring:~0-8 suggests no hearing handicap 10-24 suggests mild-moderate hearing handicap 26-40 suggests significant hearing handicap"|units on a scale|Median|19|19.0|Inter-Quartile Range|||14.5|27.5|
3733189|NCT02045511|3570297|B3|||Hearing screening threshold||dB HL|Median|40|40.0|Inter-Quartile Range|||32.5|53.3|
3733190|NCT02045511|3570298|B2|||Hearing screening threshold||dB HL|Median|31.7|31.7|Inter-Quartile Range|||30.0|43.3|
3733191|NCT02045511|3570299|B1|||Hearing screening threshold||dB HL|Median|45.8|45.8|Inter-Quartile Range|||38.8|59.2|
3733192|NCT02045511|3570297|B3|African American or Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3733193|NCT02045511|3570298|B2|African American or Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3733194|NCT02045511|3570299|B1|African American or Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3733195|NCT02045511|3570297|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3733196|NCT02045511|3570298|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3733197|NCT02045511|3570299|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3733198|NCT02045511|3570297|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3733199|NCT02045511|3570298|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3733200|NCT02045511|3570299|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3733201|NCT02045511|3570297|B3|||Age||years|Median|70.1|70.1|Inter-Quartile Range|||68.6|76.4|
3733202|NCT02045511|3570298|B2|||Age||years|Median|72.2|72.2|Inter-Quartile Range|||69.9|74.2|
3733203|NCT02045511|3570299|B1|||Age||years|Median|69.9|69.9|Inter-Quartile Range|||67.2|79.8|
3733204|NCT02045264|3570316|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3733205|NCT02045264|3570316|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3733206|NCT02045264|3570316|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3733207|NCT02045264|3570316|B1|||Age||years|Mean|30.7|30.7|Standard Deviation|8.08|8.08|||
3733208|NCT02045264|3570316|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3733209|NCT02045264|3570316|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3733210|NCT02045264|3570316|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3733211|NCT02045238|3570331|B3|Brazil||Region of Enrollment||participants|Number|31|31.0||||||
3733212|NCT02045238|3570332|B2|Brazil||Region of Enrollment||participants|Number|15|15.0||||||
3733213|NCT02045238|3570333|B1|Brazil||Region of Enrollment||participants|Number|16|16.0||||||
3733214|NCT02045238|3570331|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3733215|NCT02045238|3570332|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3733216|NCT02045238|3570333|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3733217|NCT02045238|3570331|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3733218|NCT02045238|3570332|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3733219|NCT02045238|3570333|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3733220|NCT02045238|3570331|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3733221|NCT02045238|3570332|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3733222|NCT02045238|3570333|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3733225|NCT02045238|3570333|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3733226|NCT02045238|3570331|B3||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
3733227|NCT02045238|3570332|B2||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
3733228|NCT02045238|3570333|B1||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
3733229|NCT02045108|3570342|B5||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3733230|NCT02045108|3570343|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3733231|NCT02045108|3570344|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3733232|NCT02045108|3570345|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3733233|NCT02045108|3570346|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3733234|NCT02045108|3570342|B5||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3733235|NCT02045108|3570343|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3733236|NCT02045108|3570344|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3733237|NCT02045108|3570345|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3733238|NCT02045108|3570346|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3733239|NCT02045108|3570342|B5|||Age||years|Mean|24.55|24.55|Standard Deviation|2.71|2.71|||
3733240|NCT02045108|3570343|B4|||Age||years|Mean|22.90|22.9|Standard Deviation|1.92|1.92|||
3733241|NCT02045108|3570344|B3|||Age||years|Mean|24.95|24.95|Standard Deviation|2.80|2.8|||
3733242|NCT02045108|3570345|B2|||Age||years|Mean|24.80|24.8|Standard Deviation|2.78|2.78|||
3733243|NCT02045108|3570346|B1|||Age||years|Mean|25.50|25.5|Standard Deviation|2.70|2.7|||
3733244|NCT02044991|3570395|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733245|NCT02044991|3570396|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733246|NCT02044991|3570397|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733247|NCT02044991|3570395|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733248|NCT02044991|3570396|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733249|NCT02044991|3570397|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733250|NCT02044991|3570395|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3733251|NCT02044991|3570396|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733252|NCT02044991|3570397|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3733253|NCT02044991|3570395|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733254|NCT02044991|3570396|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733255|NCT02044991|3570397|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733256|NCT02044991|3570395|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733257|NCT02044991|3570396|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733258|NCT02044991|3570397|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733259|NCT02044991|3570395|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733260|NCT02044991|3570396|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733261|NCT02044991|3570397|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733262|NCT02044991|3570395|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733263|NCT02044991|3570396|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733264|NCT02044991|3570397|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733265|NCT02044991|3570395|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3733266|NCT02044991|3570396|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3733267|NCT02044991|3570397|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3733268|NCT02044991|3570395|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3733269|NCT02044991|3570396|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3733270|NCT02044991|3570397|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3733271|NCT02044991|3570395|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3733272|NCT02044991|3570396|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3733273|NCT02044991|3570397|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3733274|NCT02044991|3570395|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3733275|NCT02044991|3570396|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3733276|NCT02044991|3570397|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3733277|NCT02044991|3570395|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3733278|NCT02044991|3570396|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3733279|NCT02044991|3570397|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3733280|NCT02044848|3570408|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3733281|NCT02044848|3570409|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3733282|NCT02044848|3570410|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3733283|NCT02044848|3570408|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3733284|NCT02044848|3570409|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3733285|NCT02044848|3570410|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3733286|NCT02044848|3570408|B3|||Age||years|Mean|24|24.0|Standard Deviation|2.45|2.45|||
3733287|NCT02044848|3570409|B2|||Age||years|Mean|24|24.0|Standard Deviation|1.73|1.73|||
3733288|NCT02044848|3570410|B1|||Age||years|Mean|24|24.0|Standard Deviation|4.24|4.24|||
3733289|NCT02044822|3570417|B1|France||Region of Enrollment||participants|Number|7|7.0||||||
3733290|NCT02044822|3570417|B1|Australia||Region of Enrollment||participants|Number|6|6.0||||||
3733291|NCT02044822|3570417|B1|Italy||Region of Enrollment||participants|Number|14|14.0||||||
3733292|NCT02044822|3570417|B1|Poland||Region of Enrollment||participants|Number|15|15.0||||||
3733293|NCT02044822|3570417|B1|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
3733294|NCT02044822|3570417|B1|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
3733295|NCT02044822|3570417|B1|Czech Republic||Region of Enrollment||participants|Number|9|9.0||||||
3733296|NCT02044822|3570417|B1|Austria||Region of Enrollment||participants|Number|3|3.0||||||
3733297|NCT02044822|3570417|B1|Spain||Region of Enrollment||participants|Number|7|7.0||||||
3733298|NCT02044822|3570417|B1|Portugal||Region of Enrollment||participants|Number|2|2.0||||||
3733299|NCT02044822|3570417|B1|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
3733300|NCT02044822|3570417|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3733301|NCT02044822|3570417|B1|Hungary||Region of Enrollment||participants|Number|2|2.0||||||
3733302|NCT02044822|3570417|B1|Romania||Region of Enrollment||participants|Number|4|4.0||||||
3733303|NCT02044822|3570417|B1|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3733304|NCT02044822|3570417|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|91|91.0||||||
3733305|NCT02044822|3570417|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3733306|NCT02044822|3570417|B1|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3733307|NCT02044822|3570417|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|94|94.0||||||
3733308|NCT02044822|3570417|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3733309|NCT02044822|3570417|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3733310|NCT02044822|3570417|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3733311|NCT02044822|3570417|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3733312|NCT02044822|3570417|B1|||Age||years|Mean|66|66.0|Standard Deviation|9.9|9.9|||
3733313|NCT02044458|3570427|B3|United States||Region of Enrollment||participants|Number|123|123.0||||||
3733314|NCT02044458|3570428|B2|United States||Region of Enrollment||participants|Number|61|61.0||||||
3733315|NCT02044458|3570429|B1|United States||Region of Enrollment||participants|Number|62|62.0||||||
3733316|NCT02044458|3570427|B3|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3733317|NCT02044458|3570428|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3733318|NCT02044458|3570429|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3733319|NCT02044458|3570427|B3|Hispanic/Latina||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3733320|NCT02044458|3570428|B2|Hispanic/Latina||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3733321|NCT02044458|3570429|B1|Hispanic/Latina||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3733322|NCT02044458|3570427|B3|African-American non-Hispanic||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
3733323|NCT02044458|3570428|B2|African-American non-Hispanic||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
3733324|NCT02044458|3570429|B1|African-American non-Hispanic||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
3733325|NCT02044458|3570427|B3|White non-Hispanic||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3733326|NCT02044458|3570428|B2|White non-Hispanic||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3733327|NCT02044458|3570429|B1|White non-Hispanic||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3733328|NCT02044458|3570427|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3733329|NCT02044458|3570428|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3733330|NCT02044458|3570429|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3733331|NCT02044458|3570427|B3||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3733332|NCT02044458|3570428|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3733333|NCT02044458|3570429|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3733334|NCT02044458|3570427|B3|||Age||years|Mean|26.9|26.9|Standard Deviation|6.28|6.28|||
3733335|NCT02044458|3570428|B2|||Age||years|Mean|26.9|26.9|Standard Deviation|6.98|6.98|||
3733336|NCT02044458|3570429|B1|||Age||years|Mean|26.9|26.9|Standard Deviation|5.56|5.56|||
3733337|NCT02044419|3570440|B4|United Kingdom||Region of Enrollment||participants|Number|32|32.0||||||
3733338|NCT02044419|3570441|B3|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
3733339|NCT02044419|3570442|B2|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
3733340|NCT02044419|3570443|B1|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
3733341|NCT02044419|3570440|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3733342|NCT02044419|3570441|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3733343|NCT02044419|3570442|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3733344|NCT02044419|3570443|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733403|NCT02044419|3570442|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3733345|NCT02044419|3570440|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733346|NCT02044419|3570441|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733347|NCT02044419|3570442|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733348|NCT02044419|3570443|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733349|NCT02044419|3570440|B4||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3733350|NCT02044419|3570441|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3733351|NCT02044419|3570442|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3733352|NCT02044419|3570443|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3733353|NCT02044419|3570440|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3733354|NCT02044419|3570441|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3733355|NCT02044419|3570442|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3733356|NCT02044419|3570443|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3733357|NCT02044419|3570440|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733358|NCT02044419|3570441|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733359|NCT02044419|3570442|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733360|NCT02044419|3570443|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733361|NCT02044419|3570440|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3733362|NCT02044419|3570441|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3733363|NCT02044419|3570442|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3733364|NCT02044419|3570443|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3733365|NCT02044419|3570440|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733366|NCT02044419|3570441|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733367|NCT02044419|3570442|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733368|NCT02044419|3570443|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733369|NCT02044419|3570440|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733370|NCT02044419|3570441|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733371|NCT02044419|3570442|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733372|NCT02044419|3570443|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733373|NCT02044419|3570440|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3733374|NCT02044419|3570441|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3733375|NCT02044419|3570442|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3733376|NCT02044419|3570443|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3733377|NCT02044419|3570440|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3733378|NCT02044419|3570441|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3733379|NCT02044419|3570442|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733380|NCT02044419|3570443|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733381|NCT02044419|3570440|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3733382|NCT02044419|3570441|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3733383|NCT02044419|3570442|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3733384|NCT02044419|3570443|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3733385|NCT02044419|3570440|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3733386|NCT02044419|3570441|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3733387|NCT02044419|3570442|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3733388|NCT02044419|3570443|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3733389|NCT02044419|3570440|B4|||Age||years|Mean|27.42|27.42|Standard Deviation|4.746|4.746|||
3733390|NCT02044419|3570441|B3|||Age||years|Mean|27.91|27.91|Standard Deviation|3.27|3.27|||
3733391|NCT02044419|3570442|B2|||Age||years|Mean|25.90|25.9|Standard Deviation|5.131|5.131|||
3733392|NCT02044419|3570443|B1|||Age||years|Mean|28.45|28.45|Standard Deviation|5.837|5.837|||
3733393|NCT02044419|3570440|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3733394|NCT02044419|3570441|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3733395|NCT02044419|3570442|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3733396|NCT02044419|3570443|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3733397|NCT02044419|3570440|B4||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3733398|NCT02044419|3570441|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3733399|NCT02044419|3570442|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3733400|NCT02044419|3570443|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3733401|NCT02044419|3570440|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3733402|NCT02044419|3570441|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3733404|NCT02044419|3570443|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3733405|NCT02044393|3570468|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3733406|NCT02044393|3570469|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3733407|NCT02044393|3570470|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3733408|NCT02044393|3570468|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3733409|NCT02044393|3570469|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3733410|NCT02044393|3570470|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3733411|NCT02044393|3570468|B3|||Age||years|Mean|36.3|36.3|Standard Deviation|8.3|8.3|||
3733412|NCT02044393|3570469|B2|||Age||years|Mean|37.4|37.4|Standard Deviation|6.6|6.6|||
3733413|NCT02044393|3570470|B1|||Age||years|Mean|35.1|35.1|Standard Deviation|9.9|9.9|||
3733414|NCT02044380|3570484|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3733415|NCT02044380|3570484|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3733416|NCT02044380|3570484|B1|||Age||Years|Mean|66.0|66.0|Standard Deviation|10.8|10.8|||
3733417|NCT02044367|3570488|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3733418|NCT02044367|3570488|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3733419|NCT02044367|3570488|B1|||Age||years|Mean|36.2|36.2|Standard Deviation|10.6|10.6|||
3733420|NCT02044302|3570514|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3733421|NCT02044302|3570515|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3733422|NCT02044302|3570516|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3733423|NCT02044302|3570514|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3733424|NCT02044302|3570515|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3733425|NCT02044302|3570516|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3733426|NCT02044302|3570514|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3733427|NCT02044302|3570515|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3733428|NCT02044302|3570516|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3733429|NCT02044302|3570514|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3733430|NCT02044302|3570515|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3733431|NCT02044302|3570516|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3733432|NCT02044302|3570514|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3733433|NCT02044302|3570515|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3733434|NCT02044302|3570516|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3733435|NCT02044094|3570523|B1|||Smoking History (Nicotine Use)||years|Mean|19.03|19.03|Standard Deviation|8.962|8.962|||
3733436|NCT02044094|3570523|B1|||Body Mass Index||kg/m^2|Mean|25.35|25.35|Standard Deviation|3.017|3.017|||
3733437|NCT02044094|3570523|B1|||Height||cm|Mean|176.99|176.99|Standard Deviation|6.421|6.421|||
3733438|NCT02044094|3570523|B1|||Weight||kg|Mean|79.55|79.55|Standard Deviation|11.178|11.178|||
3733439|NCT02044094|3570523|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733440|NCT02044094|3570523|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733441|NCT02044094|3570523|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3733442|NCT02044094|3570523|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3733443|NCT02044094|3570523|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733444|NCT02044094|3570523|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3733445|NCT02044094|3570523|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733446|NCT02044094|3570523|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733447|NCT02044094|3570523|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3733448|NCT02044094|3570523|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3733449|NCT02044094|3570523|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3733450|NCT02044094|3570523|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3733451|NCT02044094|3570523|B1|||Age||years|Mean|34.6|34.6|Standard Deviation|8.93|8.93|||
3733452|NCT02043938|3570580|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3733453|NCT02043938|3570580|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3733454|NCT02043938|3570580|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3733455|NCT02043938|3570580|B1|||Age||years|Mean|43.3|43.3|Full Range|||20.0|70.0|
3733456|NCT02043808|3570590|B3||Male|Sex: Female, Male||Participants|Count of Participants|15056|15056.0||||||
3733457|NCT02043808|3570591|B2||Male|Sex: Female, Male||Participants|Count of Participants|7540|7540.0||||||
3733458|NCT02043808|3570592|B1||Male|Sex: Female, Male||Participants|Count of Participants|7516|7516.0||||||
3733459|NCT02043808|3570590|B3||Female|Sex: Female, Male||Participants|Count of Participants|10530|10530.0||||||
3733460|NCT02043808|3570591|B2||Female|Sex: Female, Male||Participants|Count of Participants|5253|5253.0||||||
3733461|NCT02043808|3570592|B1||Female|Sex: Female, Male||Participants|Count of Participants|5277|5277.0||||||
3733462|NCT02043808|3570590|B3|||Age||years|Mean|73.9|73.9|Standard Deviation|9.2|9.2|||
3733463|NCT02043808|3570591|B2|||Age||years|Mean|74.0|74.0|Standard Deviation|9.0|9.0|||
3733464|NCT02043808|3570592|B1|||Age||years|Mean|73.8|73.8|Standard Deviation|9.3|9.3|||
3733465|NCT02043782|3570631|B1|Denmark||Region of Enrollment||participants|Number|38|38.0||||||
3733466|NCT02043782|3570631|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3733467|NCT02043782|3570631|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3733468|NCT02043782|3570631|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|13.6|13.6|||
3733469|NCT02043704|3570644|B3|United States||Region of Enrollment||Participants|Count of Participants|90|90.0||||||
3733470|NCT02043704|3570645|B2|United States||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
3733471|NCT02043704|3570646|B1|United States||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
3733472|NCT02043704|3570644|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733473|NCT02043704|3570645|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733474|NCT02043704|3570646|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733475|NCT02043704|3570644|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733476|NCT02043704|3570645|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733477|NCT02043704|3570646|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733478|NCT02043704|3570644|B3||White|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
3733479|NCT02043704|3570645|B2||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3733480|NCT02043704|3570646|B1||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3733481|NCT02043704|3570644|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733482|NCT02043704|3570645|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733483|NCT02043704|3570646|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733484|NCT02043704|3570644|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733485|NCT02043704|3570645|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733486|NCT02043704|3570646|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733487|NCT02043704|3570644|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733488|NCT02043704|3570645|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733489|NCT02043704|3570646|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733490|NCT02043704|3570644|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733491|NCT02043704|3570645|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733492|NCT02043704|3570646|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733493|NCT02043704|3570644|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3733494|NCT02043704|3570645|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3733495|NCT02043704|3570646|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3733496|NCT02043704|3570644|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3733497|NCT02043704|3570645|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3733498|NCT02043704|3570646|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3733499|NCT02043704|3570644|B3|||Age||years|Mean|58.3|58.3|Standard Deviation|12.12|12.12|||
3733500|NCT02043704|3570645|B2|||Age||years|Mean|59.4|59.4|Standard Deviation|11.4|11.4|||
3733501|NCT02043704|3570646|B1|||Age||years|Mean|57.3|57.3|Standard Deviation|12.8|12.8|||
3733502|NCT02043652|3570677|B1|Brazil||Region of Enrollment||Participants|Count of Participants|119|119.0||||||
3733503|NCT02043652|3570677|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3733504|NCT02043652|3570677|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3733505|NCT02043652|3570677|B1|||Age||years|Median|23.4|23.4|Full Range|||5.0|67.3|
3733506|NCT02043379|3570682|B3|No||Intubated Pre-operatively|Subjects requiring mechanical ventilation in the pre-operative period for either respiratory or cardiac support.|subjects|Number|40|40.0||||||
3733507|NCT02043379|3570683|B2|No||Intubated Pre-operatively|Subjects requiring mechanical ventilation in the pre-operative period for either respiratory or cardiac support.|subjects|Number|15|15.0||||||
3733508|NCT02043379|3570684|B1|No||Intubated Pre-operatively|Subjects requiring mechanical ventilation in the pre-operative period for either respiratory or cardiac support.|subjects|Number|25|25.0||||||
3733509|NCT02043379|3570682|B3|Yes||Intubated Pre-operatively|Subjects requiring mechanical ventilation in the pre-operative period for either respiratory or cardiac support.|subjects|Number|10|10.0||||||
3733510|NCT02043379|3570683|B2|Yes||Intubated Pre-operatively|Subjects requiring mechanical ventilation in the pre-operative period for either respiratory or cardiac support.|subjects|Number|5|5.0||||||
3733511|NCT02043379|3570684|B1|Yes||Intubated Pre-operatively|Subjects requiring mechanical ventilation in the pre-operative period for either respiratory or cardiac support.|subjects|Number|5|5.0||||||
3733512|NCT02043379|3570682|B3|||Aortic cross clamp time||minutes|Median|53.5|53.5|Inter-Quartile Range|||44.5|70.0|
3733513|NCT02043379|3570683|B2|||Aortic cross clamp time||minutes|Median|56|56.0|Inter-Quartile Range|||44.5|78.5|
3733514|NCT02043379|3570684|B1|||Aortic cross clamp time||minutes|Median|52|52.0|Inter-Quartile Range|||42.5|70.0|
3733515|NCT02043379|3570682|B3|||Cardiopulmonyar bypass time||minutes|Median|97.5|97.5|Inter-Quartile Range|||70.5|120.0|
3733516|NCT02043379|3570683|B2|||Cardiopulmonyar bypass time||minutes|Median|91.5|91.5|Inter-Quartile Range|||68.0|122.3|
3733517|NCT02043379|3570684|B1|||Cardiopulmonyar bypass time||minutes|Median|105.5|105.5|Inter-Quartile Range|||73.5|120.3|
3733548|NCT02043379|3570682|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3733518|NCT02043379|3570682|B3|5||STAT category|The Society of Thoracic Surgeons-European Association for Cardio-Thoracic Surgery) Congenital Heart Surgery Mortality Categories. The STAT Mortality Categories range from 1 to 5 with higher values indicating greater risk of mortality associated with operations for congenital heart disease|participants|Number|9|9.0||||||
3733519|NCT02043379|3570683|B2|5||STAT category|The Society of Thoracic Surgeons-European Association for Cardio-Thoracic Surgery) Congenital Heart Surgery Mortality Categories. The STAT Mortality Categories range from 1 to 5 with higher values indicating greater risk of mortality associated with operations for congenital heart disease|participants|Number|3|3.0||||||
3733520|NCT02043379|3570684|B1|5||STAT category|The Society of Thoracic Surgeons-European Association for Cardio-Thoracic Surgery) Congenital Heart Surgery Mortality Categories. The STAT Mortality Categories range from 1 to 5 with higher values indicating greater risk of mortality associated with operations for congenital heart disease|participants|Number|6|6.0||||||
3733521|NCT02043379|3570682|B3|4||STAT category|The Society of Thoracic Surgeons-European Association for Cardio-Thoracic Surgery) Congenital Heart Surgery Mortality Categories. The STAT Mortality Categories range from 1 to 5 with higher values indicating greater risk of mortality associated with operations for congenital heart disease|participants|Number|16|16.0||||||
3733522|NCT02043379|3570683|B2|4||STAT category|The Society of Thoracic Surgeons-European Association for Cardio-Thoracic Surgery) Congenital Heart Surgery Mortality Categories. The STAT Mortality Categories range from 1 to 5 with higher values indicating greater risk of mortality associated with operations for congenital heart disease|participants|Number|4|4.0||||||
3733523|NCT02043379|3570684|B1|4||STAT category|The Society of Thoracic Surgeons-European Association for Cardio-Thoracic Surgery) Congenital Heart Surgery Mortality Categories. The STAT Mortality Categories range from 1 to 5 with higher values indicating greater risk of mortality associated with operations for congenital heart disease|participants|Number|12|12.0||||||
3733524|NCT02043379|3570682|B3|3||STAT category|The Society of Thoracic Surgeons-European Association for Cardio-Thoracic Surgery) Congenital Heart Surgery Mortality Categories. The STAT Mortality Categories range from 1 to 5 with higher values indicating greater risk of mortality associated with operations for congenital heart disease|participants|Number|15|15.0||||||
3733525|NCT02043379|3570683|B2|3||STAT category|The Society of Thoracic Surgeons-European Association for Cardio-Thoracic Surgery) Congenital Heart Surgery Mortality Categories. The STAT Mortality Categories range from 1 to 5 with higher values indicating greater risk of mortality associated with operations for congenital heart disease|participants|Number|8|8.0||||||
3733526|NCT02043379|3570684|B1|3||STAT category|The Society of Thoracic Surgeons-European Association for Cardio-Thoracic Surgery) Congenital Heart Surgery Mortality Categories. The STAT Mortality Categories range from 1 to 5 with higher values indicating greater risk of mortality associated with operations for congenital heart disease|participants|Number|7|7.0||||||
3733527|NCT02043379|3570682|B3|2||STAT category|The Society of Thoracic Surgeons-European Association for Cardio-Thoracic Surgery) Congenital Heart Surgery Mortality Categories. The STAT Mortality Categories range from 1 to 5 with higher values indicating greater risk of mortality associated with operations for congenital heart disease|participants|Number|7|7.0||||||
3733528|NCT02043379|3570683|B2|2||STAT category|The Society of Thoracic Surgeons-European Association for Cardio-Thoracic Surgery) Congenital Heart Surgery Mortality Categories. The STAT Mortality Categories range from 1 to 5 with higher values indicating greater risk of mortality associated with operations for congenital heart disease|participants|Number|5|5.0||||||
3733529|NCT02043379|3570684|B1|2||STAT category|The Society of Thoracic Surgeons-European Association for Cardio-Thoracic Surgery) Congenital Heart Surgery Mortality Categories. The STAT Mortality Categories range from 1 to 5 with higher values indicating greater risk of mortality associated with operations for congenital heart disease|participants|Number|2|2.0||||||
3733530|NCT02043379|3570682|B3|1||STAT category|The Society of Thoracic Surgeons-European Association for Cardio-Thoracic Surgery) Congenital Heart Surgery Mortality Categories. The STAT Mortality Categories range from 1 to 5 with higher values indicating greater risk of mortality associated with operations for congenital heart disease|participants|Number|3|3.0||||||
3733531|NCT02043379|3570683|B2|1||STAT category|The Society of Thoracic Surgeons-European Association for Cardio-Thoracic Surgery) Congenital Heart Surgery Mortality Categories. The STAT Mortality Categories range from 1 to 5 with higher values indicating greater risk of mortality associated with operations for congenital heart disease|participants|Number|0|0.0||||||
3733532|NCT02043379|3570684|B1|1||STAT category|The Society of Thoracic Surgeons-European Association for Cardio-Thoracic Surgery) Congenital Heart Surgery Mortality Categories. The STAT Mortality Categories range from 1 to 5 with higher values indicating greater risk of mortality associated with operations for congenital heart disease|participants|Number|3|3.0||||||
3733533|NCT02043379|3570682|B3|||Gestational Age||weeks|Median|38|38.0|Inter-Quartile Range|||37.0|39.0|
3733534|NCT02043379|3570683|B2|||Gestational Age||weeks|Median|38.5|38.5|Inter-Quartile Range|||37.0|39.75|
3733535|NCT02043379|3570684|B1|||Gestational Age||weeks|Median|38|38.0|Inter-Quartile Range|||37.0|39.0|
3733536|NCT02043379|3570682|B3|||Weight||kilograms|Median|3.51|3.51|Inter-Quartile Range|||3.13|4.09|
3733537|NCT02043379|3570683|B2|||Weight||kilograms|Median|3.85|3.85|Inter-Quartile Range|||3.04|4.52|
3733538|NCT02043379|3570684|B1|||Weight||kilograms|Median|3.45|3.45|Inter-Quartile Range|||3.17|3.99|
3733539|NCT02043379|3570682|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733540|NCT02043379|3570683|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733541|NCT02043379|3570684|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733542|NCT02043379|3570682|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733543|NCT02043379|3570683|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733544|NCT02043379|3570684|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733545|NCT02043379|3570682|B3||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3733546|NCT02043379|3570683|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3733547|NCT02043379|3570684|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3733549|NCT02043379|3570683|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3733550|NCT02043379|3570684|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3733551|NCT02043379|3570682|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733552|NCT02043379|3570683|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733553|NCT02043379|3570684|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733554|NCT02043379|3570682|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733555|NCT02043379|3570683|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733556|NCT02043379|3570684|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733557|NCT02043379|3570682|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733558|NCT02043379|3570683|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733559|NCT02043379|3570684|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733560|NCT02043379|3570682|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3733561|NCT02043379|3570683|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3733562|NCT02043379|3570684|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3733563|NCT02043379|3570682|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3733564|NCT02043379|3570683|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3733565|NCT02043379|3570684|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3733566|NCT02043379|3570682|B3|||Age||days|Median|11.5|11.5|Inter-Quartile Range|||6.0|74.75|
3733567|NCT02043379|3570683|B2|||Age||days|Median|47|47.0|Inter-Quartile Range|||6.25|79.5|
3733568|NCT02043379|3570684|B1|||Age||days|Median|9|9.0|Inter-Quartile Range|||6.0|50.75|
3733569|NCT02043379|3570682|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3733570|NCT02043379|3570683|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3733571|NCT02043379|3570684|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3733572|NCT02043379|3570682|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3733573|NCT02043379|3570683|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3733574|NCT02043379|3570684|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3733575|NCT02043379|3570682|B3||<=18 years|Age||Participants|Count of Participants|50|50.0||||||
3733576|NCT02043379|3570683|B2||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
3733577|NCT02043379|3570684|B1||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
3733578|NCT02043366|3570741|B7|China||Region of Enrollment||participants|Number|168|168.0||||||
3733579|NCT02043366|3570742|B6|China||Region of Enrollment||participants|Number|28|28.0||||||
3733580|NCT02043366|3570743|B5|China||Region of Enrollment||participants|Number|28|28.0||||||
3733581|NCT02043366|3570744|B4|China||Region of Enrollment||participants|Number|28|28.0||||||
3733582|NCT02043366|3570745|B3|China||Region of Enrollment||participants|Number|28|28.0||||||
3733583|NCT02043366|3570746|B2|China||Region of Enrollment||participants|Number|28|28.0||||||
3733584|NCT02043366|3570747|B1|China||Region of Enrollment||participants|Number|28|28.0||||||
3733585|NCT02043366|3570741|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3733586|NCT02043366|3570742|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3733587|NCT02043366|3570743|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3733588|NCT02043366|3570744|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3733589|NCT02043366|3570745|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3733590|NCT02043366|3570746|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3733591|NCT02043366|3570747|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3733592|NCT02043366|3570741|B7||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3733593|NCT02043366|3570742|B6||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3733594|NCT02043366|3570743|B5||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3733595|NCT02043366|3570744|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3733596|NCT02043366|3570745|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3733597|NCT02043366|3570746|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3733598|NCT02043366|3570747|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3733599|NCT02043366|3570741|B7|||Age||years|Mean|45.5|45.5|Standard Deviation|9.8|9.8|||
3733600|NCT02043366|3570742|B6|||Age||years|Mean|43.5|43.5|Standard Deviation|10.8|10.8|||
3733601|NCT02043366|3570743|B5|||Age||years|Mean|45.1|45.1|Standard Deviation|7.9|7.9|||
3733602|NCT02043366|3570744|B4|||Age||years|Mean|46.5|46.5|Standard Deviation|9.7|9.7|||
3733603|NCT02043366|3570745|B3|||Age||years|Mean|47.9|47.9|Standard Deviation|10.0|10.0|||
3733604|NCT02043366|3570746|B2|||Age||years|Mean|45.3|45.3|Standard Deviation|9.7|9.7|||
3733605|NCT02043366|3570747|B1|||Age||years|Mean|44.2|44.2|Standard Deviation|11.0|11.0|||
3733606|NCT02043197|3570772|B1|Russian Federation||Region of Enrollment||participants|Number|299|299.0||||||
3733607|NCT02043197|3570772|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3733608|NCT02043197|3570772|B1||Female|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
3733609|NCT02043197|3570772|B1|||Age||years|Mean|50.51|50.51|Full Range|||21.0|85.0|
3733610|NCT02043197|3570772|B1||>=65 years|Age||Participants|Count of Participants|54|54.0||||||
3733611|NCT02043197|3570772|B1||Between 18 and 65 years|Age||Participants|Count of Participants|245|245.0||||||
3733612|NCT02043197|3570772|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3733613|NCT02043145|3570793|B4||Male|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
3733614|NCT02043145|3570794|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3733615|NCT02043145|3570795|B2||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
3733616|NCT02043145|3570796|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3733617|NCT02043145|3570793|B4||Female|Sex: Female, Male||Participants|Count of Participants|502|502.0||||||
3733618|NCT02043145|3570794|B3||Female|Sex: Female, Male||Participants|Count of Participants|376|376.0||||||
3733619|NCT02043145|3570795|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3733620|NCT02043145|3570796|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3733621|NCT02043145|3570793|B4|>=50 years||Age, Customized||Participants|Number|224|224.0||||||
3733622|NCT02043145|3570794|B3|>=50 years||Age, Customized||Participants|Number|90|90.0||||||
3733623|NCT02043145|3570795|B2|>=50 years||Age, Customized||Participants|Number|130|130.0||||||
3733624|NCT02043145|3570796|B1|>=50 years||Age, Customized||Participants|Number|4|4.0||||||
3733625|NCT02043145|3570793|B4|40 to 49 years||Age, Customized||Participants|Number|174|174.0||||||
3733626|NCT02043145|3570794|B3|40 to 49 years||Age, Customized||Participants|Number|112|112.0||||||
3733627|NCT02043145|3570795|B2|40 to 49 years||Age, Customized||Participants|Number|56|56.0||||||
3733628|NCT02043145|3570796|B1|40 to 49 years||Age, Customized||Participants|Number|6|6.0||||||
3733629|NCT02043145|3570793|B4|30 to 39 years||Age, Customized||Participants|Number|196|196.0||||||
3733630|NCT02043145|3570794|B3|30 to 39 years||Age, Customized||Participants|Number|154|154.0||||||
3733631|NCT02043145|3570795|B2|30 to 39 years||Age, Customized||Participants|Number|21|21.0||||||
3733632|NCT02043145|3570796|B1|30 to 39 years||Age, Customized||Participants|Number|21|21.0||||||
3733633|NCT02043145|3570793|B4|< 30 years||Age, Customized||Participants|Number|121|121.0||||||
3733634|NCT02043145|3570794|B3|< 30 years||Age, Customized||Participants|Number|67|67.0||||||
3733635|NCT02043145|3570795|B2|< 30 years||Age, Customized||Participants|Number|30|30.0||||||
3733636|NCT02043145|3570796|B1|< 30 years||Age, Customized||Participants|Number|24|24.0||||||
3733637|NCT02043132|3570809|B3|United States||Region of Enrollment||participants|Number|102|102.0||||||
3733638|NCT02043132|3570810|B2|United States||Region of Enrollment||participants|Number|49|49.0||||||
3733639|NCT02043132|3570811|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
3733640|NCT02043132|3570809|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3733641|NCT02043132|3570810|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3733642|NCT02043132|3570811|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3733643|NCT02043132|3570809|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3733644|NCT02043132|3570810|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3733645|NCT02043132|3570811|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3733646|NCT02043132|3570809|B3|||Age||years|Mean|67|67.0|Standard Deviation|9|9.0|||
3733647|NCT02043132|3570810|B2|||Age||years|Mean|66|66.0|Standard Deviation|9|9.0|||
3733648|NCT02043132|3570811|B1|||Age||years|Mean|67|67.0|Standard Deviation|9|9.0|||
3733649|NCT02043015|3570832|B1||HIV-Negative at Baseline|HIV Status at Baseline Visit||Participants|Count of Participants|80|80.0||||||
3733650|NCT02043015|3570832|B1||HIV-Positive at Baseline|HIV Status at Baseline Visit||Participants|Count of Participants|35|35.0||||||
3733651|NCT02043015|3570832|B1|South Africa||Region of Enrollment||Participants|Count of Participants|115|115.0||||||
3733652|NCT02043015|3570832|B1||Unknown or not reported|Race/Ethnicity, Customized|As part of demographic assessments, all participants were asked to self-identify their race as Black African, Coloured (a multiracial ethnic group in South Africa), Indian or Asian, White, or Other.|Participants|Count of Participants|1|1.0||||||
3733653|NCT02043015|3570832|B1||White|Race/Ethnicity, Customized|As part of demographic assessments, all participants were asked to self-identify their race as Black African, Coloured (a multiracial ethnic group in South Africa), Indian or Asian, White, or Other.|Participants|Count of Participants|4|4.0||||||
3733654|NCT02043015|3570832|B1||Coloured|Race/Ethnicity, Customized|As part of demographic assessments, all participants were asked to self-identify their race as Black African, Coloured (a multiracial ethnic group in South Africa), Indian or Asian, White, or Other.|Participants|Count of Participants|21|21.0||||||
3733655|NCT02043015|3570832|B1||Black African|Race/Ethnicity, Customized|As part of demographic assessments, all participants were asked to self-identify their race as Black African, Coloured (a multiracial ethnic group in South Africa), Indian or Asian, White, or Other.|Participants|Count of Participants|89|89.0||||||
3733656|NCT02043015|3570832|B1|Gender identification|Unknown or not reported|Sex/Gender, Customized|Eligible participants were male at birth. As part of demographic assessments, all participants were asked to self-identify their gender as Male, Female, Transgender, or Other.|Participants|Count of Participants|3|3.0||||||
3733657|NCT02043015|3570832|B1|Gender identification|Other|Sex/Gender, Customized|Eligible participants were male at birth. As part of demographic assessments, all participants were asked to self-identify their gender as Male, Female, Transgender, or Other.|Participants|Count of Participants|1|1.0||||||
3733658|NCT02043015|3570832|B1|Gender identification|Transgender|Sex/Gender, Customized|Eligible participants were male at birth. As part of demographic assessments, all participants were asked to self-identify their gender as Male, Female, Transgender, or Other.|Participants|Count of Participants|5|5.0||||||
3733659|NCT02043015|3570832|B1|Gender identification|Male|Sex/Gender, Customized|Eligible participants were male at birth. As part of demographic assessments, all participants were asked to self-identify their gender as Male, Female, Transgender, or Other.|Participants|Count of Participants|99|99.0||||||
3733660|NCT02043015|3570832|B1|Gender identification|Female|Sex/Gender, Customized|Eligible participants were male at birth. As part of demographic assessments, all participants were asked to self-identify their gender as Male, Female, Transgender, or Other.|Participants|Count of Participants|7|7.0||||||
3733661|NCT02043015|3570832|B1|||Age||years|Mean|26.3|26.3|Standard Deviation|7.4|7.4|||
3733662|NCT02043015|3570832|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3733663|NCT02043015|3570832|B1||Between 18 and 65 years|Age||Participants|Count of Participants|115|115.0||||||
3733664|NCT02043015|3570832|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3733665|NCT02042924|3570845|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3733666|NCT02042924|3570845|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3733667|NCT02042924|3570845|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3733668|NCT02042924|3570845|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3733669|NCT02042924|3570845|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3733670|NCT02042924|3570845|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3733671|NCT02042911|3570851|B1|||Age||years|Mean|69.8|69.8|Standard Deviation|8.9|8.9|||
3733672|NCT02042911|3570851|B1|||Body surface area||m^2|Mean|1.592|1.592|Standard Deviation|0.134|0.134|||
3733673|NCT02042911|3570851|B1|||Body weight||kg|Mean|56.51|56.51|Standard Deviation|9.43|9.43|||
3733674|NCT02042911|3570851|B1|||Height||cm|Mean|162.03|162.03|Standard Deviation|5.03|5.03|||
3733675|NCT02042911|3570851|B1|Present||Marrow examination for infiltration|Bone marrow aspirate and biopsy was done for assessment of response to evaluate the focal infiltration in the bone marrow sample.|participants|Number|9|9.0||||||
3733676|NCT02042911|3570851|B1|Absent||Marrow examination for infiltration|Bone marrow aspirate and biopsy was done for assessment of response to evaluate the focal infiltration in the bone marrow sample.|participants|Number|1|1.0||||||
3733677|NCT02042911|3570851|B1|Present||Marrow examination for lymphoid nodules|Bone marrow aspirate and biopsy was done for assessment of response to evaluate ³30% of the nucleated cells being lymphocyte in the bone marrow sample.|participants|Number|5|5.0||||||
3733678|NCT02042911|3570851|B1|Absent||Marrow examination for lymphoid nodules|Bone marrow aspirate and biopsy was done for assessment of response to evaluate ³30% of the nucleated cells being lymphocyte in the bone marrow sample.|participants|Number|5|5.0||||||
3733679|NCT02042911|3570851|B1|Positive (+)||Presence of Igλ|Presence of Igλ (positive or negative) was evaluated by flow cytometry in the diagnosis of CLL.|participants|Number|4|4.0||||||
3733680|NCT02042911|3570851|B1|Negative (-)||Presence of Igλ|Presence of Igλ (positive or negative) was evaluated by flow cytometry in the diagnosis of CLL.|participants|Number|6|6.0||||||
3733681|NCT02042911|3570851|B1|Positive (+)||Presence of Igκ|Presence of Igκ (positive or negative) was evaluated by flow cytometry in the diagnosis of CLL.|participants|Number|6|6.0||||||
3733682|NCT02042911|3570851|B1|Negative (-)||Presence of Igκ|Presence of Igκ (positive or negative) was evaluated by flow cytometry in the diagnosis of CLL.|participants|Number|4|4.0||||||
3733683|NCT02042911|3570851|B1|Positive (+)||Presence of CD23 antigen|Presence of CD23 antigen (positive or negative) was evaluated by flow cytometry in the diagnosis of CLL.|participants|Number|8|8.0||||||
3733684|NCT02042911|3570851|B1|Negative (-)||Presence of CD23 antigen|Presence of CD23 antigen (positive or negative) was evaluated by flow cytometry in the diagnosis of CLL.|participants|Number|2|2.0||||||
3733685|NCT02042911|3570851|B1|Positive (+)||Presence of CD20 antigen|Presence of CD20 antigen (positive or negative) was evaluated by flow cytometry in the diagnosis of CLL.|participants|Number|10|10.0||||||
3733686|NCT02042911|3570851|B1|Negative (-)||Presence of CD20 antigen|Presence of CD20 antigen (positive or negative) was evaluated by flow cytometry in the diagnosis of CLL.|participants|Number|0|0.0||||||
3733687|NCT02042911|3570851|B1|Positive (+)||Presence of CD19 antigen|Presence of CD19 antigen (positive or negative) was evaluated by flow cytometry in the diagnosis of CLL.|participants|Number|10|10.0||||||
3733688|NCT02042911|3570851|B1|Negative (-)||Presence of CD19 antigen|Presence of CD19 antigen (positive or negative) was evaluated by flow cytometry in the diagnosis of CLL.|participants|Number|0|0.0||||||
3733689|NCT02042911|3570851|B1|Positive (+)||Presence of cluster of differentiation (CD) 5 antigen|Presence of CD5 antigen (positive or negative) was evaluated by flow cytometry in the diagnosis of CLL.|participants|Number|10|10.0||||||
3733690|NCT02042911|3570851|B1|Negative (-)||Presence of cluster of differentiation (CD) 5 antigen|Presence of CD5 antigen (positive or negative) was evaluated by flow cytometry in the diagnosis of CLL.|participants|Number|0|0.0||||||
3733691|NCT02042911|3570851|B1|Present||B symptoms (Night Sweats)||participants|Number|2|2.0||||||
3733692|NCT02042911|3570851|B1|Absent||B symptoms (Night Sweats)||participants|Number|8|8.0||||||
3733693|NCT02042911|3570851|B1|Present||B symptoms (Fever)|Persistent or recurrent fever of unknown origin > 38 °C for 2 weeks or more|participants|Number|0|0.0||||||
3733694|NCT02042911|3570851|B1|Absent||B symptoms (Fever)|Persistent or recurrent fever of unknown origin > 38 °C for 2 weeks or more|participants|Number|10|10.0||||||
3733695|NCT02042911|3570851|B1|Present||B symptoms (Weight Loss)|>10% weight loss in the last 6 month|participants|Number|0|0.0||||||
3733696|NCT02042911|3570851|B1|Absent||B symptoms (Weight Loss)|>10% weight loss in the last 6 month|participants|Number|10|10.0||||||
3733697|NCT02042911|3570851|B1|Present||Splenomegaly||participants|Number|9|9.0||||||
3733698|NCT02042911|3570851|B1|Absent||Splenomegaly||participants|Number|1|1.0||||||
3733699|NCT02042911|3570851|B1|Present||Hepatomegaly||participants|Number|5|5.0||||||
3733700|NCT02042911|3570851|B1|Absent||Hepatomegaly||participants|Number|5|5.0||||||
3733701|NCT02042911|3570851|B1|Present||Lymphadenopathy||participants|Number|8|8.0||||||
3733702|NCT02042911|3570851|B1|Absent||Lymphadenopathy||participants|Number|2|2.0||||||
3733703|NCT02042911|3570851|B1|No||Diagnosis of chronic lymphocytic leukemia (CLL)||participants|Number|0|0.0||||||
3733704|NCT02042911|3570851|B1|Yes||Diagnosis of chronic lymphocytic leukemia (CLL)||participants|Number|10|10.0||||||
3733705|NCT02042911|3570851|B1|Present||Somatic hypermutation (SHM) analysis of immunoglobulin heavy chain variable (IgVH) genes||participants|Number|9|9.0||||||
3733706|NCT02042911|3570851|B1|Absent||Somatic hypermutation (SHM) analysis of immunoglobulin heavy chain variable (IgVH) genes||participants|Number|1|1.0||||||
3733707|NCT02042911|3570851|B1|Present||FISH detection of immunoglobulin heavy chain (IgH)/CyclinD1 (CCND1) (BCL1) t (11; 14)||participants|Number|0|0.0||||||
3733708|NCT02042911|3570851|B1|Absent||FISH detection of immunoglobulin heavy chain (IgH)/CyclinD1 (CCND1) (BCL1) t (11; 14)||participants|Number|10|10.0||||||
3733709|NCT02042911|3570851|B1|Present||FISH detection of del (17p13)||participants|Number|0|0.0||||||
3733710|NCT02042911|3570851|B1|Absent||FISH detection of del (17p13)||participants|Number|10|10.0||||||
3733711|NCT02042911|3570851|B1|Present||FISH detection of del (11q22-23)||participants|Number|0|0.0||||||
3733712|NCT02042911|3570851|B1|Absent||FISH detection of del (11q22-23)||participants|Number|10|10.0||||||
3733713|NCT02042911|3570851|B1|Present||FISH detection of del (13q14)||participants|Number|5|5.0||||||
3733714|NCT02042911|3570851|B1|Absent||FISH detection of del (13q14)||participants|Number|5|5.0||||||
3733715|NCT02042911|3570851|B1|Present||Fluorescence in situ hybridization (FISH) detection of trisomy 12||participants|Number|2|2.0||||||
3733716|NCT02042911|3570851|B1|Absent||Fluorescence in situ hybridization (FISH) detection of trisomy 12||participants|Number|8|8.0||||||
3733717|NCT02042911|3570851|B1|Present||Complication|Pathological processes or events developing in the course of a primary disease or condition.|participants|Number|9|9.0||||||
3733718|NCT02042911|3570851|B1|Absent||Complication|Pathological processes or events developing in the course of a primary disease or condition.|participants|Number|1|1.0||||||
3733719|NCT02042911|3570851|B1|Present||Medical history||participants|Number|6|6.0||||||
3733720|NCT02042911|3570851|B1|Absent||Medical history||participants|Number|4|4.0||||||
3733721|NCT02042911|3570851|B1|C||Clinical disease stage (Binet Staging System)|"The criteria of clinical disease stage (Binet Staging System) are shown as below:~Stage A: Hb ≧ 10g/dL + platelet count ≧ 100,000 /mm3 and fewer than 2 areas of enlarged lymphoid tissue Stage B: Hb ≧ 10g/dL + platelet count ≧ 100,000 /mm3 and 3 or more areas of enlarged lymphoid tissue~Stage C: Hb ＜ 10g/dL and/or platelet count ＜ 100,000 /mm3 :~Area of lymphoid tissue (one side in the case of two sides) includes: 1) head and neck; 2) axilla; 3) groin; 4) spleen and 5) liver."|participants|Number|7|7.0||||||
3733722|NCT02042911|3570851|B1|B||Clinical disease stage (Binet Staging System)|"The criteria of clinical disease stage (Binet Staging System) are shown as below:~Stage A: Hb ≧ 10g/dL + platelet count ≧ 100,000 /mm3 and fewer than 2 areas of enlarged lymphoid tissue Stage B: Hb ≧ 10g/dL + platelet count ≧ 100,000 /mm3 and 3 or more areas of enlarged lymphoid tissue~Stage C: Hb ＜ 10g/dL and/or platelet count ＜ 100,000 /mm3 :~Area of lymphoid tissue (one side in the case of two sides) includes: 1) head and neck; 2) axilla; 3) groin; 4) spleen and 5) liver."|participants|Number|3|3.0||||||
3733723|NCT02042911|3570851|B1|A||Clinical disease stage (Binet Staging System)|"The criteria of clinical disease stage (Binet Staging System) are shown as below:~Stage A: Hb ≧ 10g/dL + platelet count ≧ 100,000 /mm3 and fewer than 2 areas of enlarged lymphoid tissue Stage B: Hb ≧ 10g/dL + platelet count ≧ 100,000 /mm3 and 3 or more areas of enlarged lymphoid tissue~Stage C: Hb ＜ 10g/dL and/or platelet count ＜ 100,000 /mm3 :~Area of lymphoid tissue (one side in the case of two sides) includes: 1) head and neck; 2) axilla; 3) groin; 4) spleen and 5) liver."|participants|Number|0|0.0||||||
3733724|NCT02042911|3570851|B1|2||ECOG performance status|"The criteria of Eastern Cooperative Oncology Group (ECOG) performance status are shown as below:~0: Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours"|participants|Number|0|0.0||||||
3733725|NCT02042911|3570851|B1|1||ECOG performance status|"The criteria of Eastern Cooperative Oncology Group (ECOG) performance status are shown as below:~0: Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours"|participants|Number|2|2.0||||||
3733726|NCT02042911|3570851|B1|0||ECOG performance status|"The criteria of Eastern Cooperative Oncology Group (ECOG) performance status are shown as below:~0: Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours"|participants|Number|8|8.0||||||
3733727|NCT02042911|3570851|B1|Present||Prior therapy||participants|Number|2|2.0||||||
3733728|NCT02042911|3570851|B1|Absent||Prior therapy||participants|Number|8|8.0||||||
3733729|NCT02042911|3570851|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
3733730|NCT02042911|3570851|B1||Female|Gender||Participants|Count of Participants|4|4.0||||||
3733731|NCT02042911|3570851|B1|>=65 years||Age, Customized||participants|Number|8|8.0||||||
3733732|NCT02042911|3570851|B1|<65 years||Age, Customized||participants|Number|2|2.0||||||
3733733|NCT02042872|3570863|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
3733734|NCT02042872|3570864|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3733735|NCT02042872|3570865|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3733736|NCT02042872|3570863|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3733737|NCT02042872|3570864|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3733738|NCT02042872|3570865|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3733739|NCT02042872|3570863|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3733740|NCT02042872|3570864|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3733741|NCT02042872|3570865|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3733742|NCT02042872|3570863|B3|||Age|Subject self reported date of birth used to calculate age|years|Mean|29.3|29.3|Standard Deviation|20.7|20.7|||
3733743|NCT02042872|3570864|B2|||Age|Subject self reported date of birth used to calculate age|years|Mean|33.0|33.0|Standard Deviation|11.0|11.0|||
3733744|NCT02042872|3570865|B1|||Age|Subject self reported date of birth used to calculate age|years|Mean|25.5|25.5|Standard Deviation|9.6|9.6|||
3733745|NCT02042534|3570874|B3|||Body Mass Index||kg/㎡|Mean|24.0|24.0|Standard Deviation|3.2|3.2|||
3733746|NCT02042534|3570875|B2|||Body Mass Index||kg/㎡|Mean|23.6|23.6|Standard Deviation|3.1|3.1|||
3733747|NCT02042534|3570876|B1|||Body Mass Index||kg/㎡|Mean|24.4|24.4|Standard Deviation|3.3|3.3|||
3733748|NCT02042534|3570874|B3||Male|Gender||Participants|Count of Participants|107|107.0||||||
3733749|NCT02042534|3570875|B2||Male|Gender||Participants|Count of Participants|52|52.0||||||
3733750|NCT02042534|3570876|B1||Male|Gender||Participants|Count of Participants|55|55.0||||||
3733751|NCT02042534|3570874|B3||Female|Gender||Participants|Count of Participants|76|76.0||||||
3733752|NCT02042534|3570875|B2||Female|Gender||Participants|Count of Participants|36|36.0||||||
3733753|NCT02042534|3570876|B1||Female|Gender||Participants|Count of Participants|40|40.0||||||
3733754|NCT02042534|3570874|B3|||Age||years|Mean|70.4|70.4|Standard Deviation|10.4|10.4|||
3733755|NCT02042534|3570875|B2|||Age||years|Mean|70.6|70.6|Standard Deviation|10.9|10.9|||
3733756|NCT02042534|3570876|B1|||Age||years|Mean|70.2|70.2|Standard Deviation|10.1|10.1|||
3733757|NCT02042443|3570891|B3|Gall bladder||Site of Disease||Participants|Count of Participants|10|10.0||||||
3733758|NCT02042443|3570892|B2|Gall bladder||Site of Disease||Participants|Count of Participants|5|5.0||||||
3733759|NCT02042443|3570893|B1|Gall bladder||Site of Disease||Participants|Count of Participants|5|5.0||||||
3733760|NCT02042443|3570891|B3|Cholangiocarcinoma||Site of Disease||Participants|Count of Participants|34|34.0||||||
3733761|NCT02042443|3570892|B2|Cholangiocarcinoma||Site of Disease||Participants|Count of Participants|15|15.0||||||
3733762|NCT02042443|3570893|B1|Cholangiocarcinoma||Site of Disease||Participants|Count of Participants|19|19.0||||||
3733763|NCT02042443|3570891|B3|Capecitabine||Planned Chemotherapy||Participants|Count of Participants|31|31.0||||||
3733764|NCT02042443|3570892|B2|Capecitabine||Planned Chemotherapy||Participants|Count of Participants|14|14.0||||||
3733765|NCT02042443|3570893|B1|Capecitabine||Planned Chemotherapy||Participants|Count of Participants|17|17.0||||||
3733766|NCT02042443|3570891|B3|5FU/LV||Planned Chemotherapy||Participants|Count of Participants|13|13.0||||||
3733767|NCT02042443|3570892|B2|5FU/LV||Planned Chemotherapy||Participants|Count of Participants|6|6.0||||||
3733768|NCT02042443|3570893|B1|5FU/LV||Planned Chemotherapy||Participants|Count of Participants|7|7.0||||||
3733769|NCT02042443|3570891|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3733770|NCT02042443|3570892|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733771|NCT02042443|3570893|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3733772|NCT02042443|3570891|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733773|NCT02042443|3570892|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733774|NCT02042443|3570893|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733775|NCT02042443|3570891|B3||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3733776|NCT02042443|3570892|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3733777|NCT02042443|3570893|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3733778|NCT02042443|3570891|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3733779|NCT02042443|3570892|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3733780|NCT02042443|3570893|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3733781|NCT02042443|3570891|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733782|NCT02042443|3570892|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733783|NCT02042443|3570893|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733784|NCT02042443|3570891|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3733785|NCT02042443|3570892|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3733786|NCT02042443|3570893|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3733787|NCT02042443|3570891|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733788|NCT02042443|3570892|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733789|NCT02042443|3570893|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733790|NCT02042443|3570891|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3733791|NCT02042443|3570892|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733792|NCT02042443|3570893|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3733793|NCT02042443|3570891|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3733794|NCT02042443|3570892|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3733795|NCT02042443|3570893|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3733796|NCT02042443|3570891|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3733797|NCT02042443|3570892|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3733798|NCT02042443|3570893|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3733799|NCT02042443|3570891|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3733800|NCT02042443|3570892|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3733801|NCT02042443|3570893|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3733802|NCT02042443|3570891|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3733803|NCT02042443|3570892|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3733804|NCT02042443|3570893|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3733805|NCT02042443|3570891|B3|||Age||years|Median|62|62.0|Full Range|||40.0|81.0|
3733806|NCT02042443|3570892|B2|||Age||years|Median|61|61.0|Full Range|||41.0|81.0|
3733807|NCT02042443|3570893|B1|||Age||years|Median|63|63.0|Full Range|||40.0|78.0|
3733808|NCT02042404|3570906|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733809|NCT02042404|3570906|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733810|NCT02042404|3570906|B1||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3733811|NCT02042404|3570906|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3733812|NCT02042404|3570906|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733813|NCT02042404|3570906|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3733814|NCT02042404|3570906|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733815|NCT02042404|3570906|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733816|NCT02042404|3570906|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3733817|NCT02042404|3570906|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3733818|NCT02042404|3570906|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3733819|NCT02042404|3570906|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3733820|NCT02042404|3570906|B1|||Age||years|Mean|68.6|68.6|Standard Deviation|10.1|10.1|||
3733821|NCT02042274|3570918|B1|||Triglycerides||mmol/L|Mean|0.9|0.9|Standard Deviation|0.3|0.3|||
3733822|NCT02042274|3570918|B1|Canada||Region of Enrollment|Subjects were recruited through a poster campaign at the University of Guelph campus.|Participants|Count of Participants|12|12.0||||||
3733823|NCT02042274|3570918|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3733824|NCT02042274|3570918|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3733825|NCT02042274|3570918|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3733826|NCT02042274|3570918|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3733827|NCT02042274|3570918|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3733828|NCT02042131|3570923|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733829|NCT02042131|3570924|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733830|NCT02042131|3570925|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733831|NCT02042131|3570926|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733832|NCT02042131|3570923|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3733833|NCT02042131|3570924|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3733834|NCT02042131|3570925|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3733835|NCT02042131|3570926|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3733836|NCT02042131|3570923|B4||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3733837|NCT02042131|3570924|B3||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3733838|NCT02042131|3570925|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3733839|NCT02042131|3570926|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3733840|NCT02042131|3570923|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3733841|NCT02042131|3570924|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3733842|NCT02042131|3570925|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3733843|NCT02042131|3570926|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3733844|NCT02042131|3570923|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3733845|NCT02042131|3570924|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733846|NCT02042131|3570925|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3733847|NCT02042131|3570926|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3733848|NCT02042131|3570923|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3733849|NCT02042131|3570924|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3733850|NCT02042131|3570925|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3733851|NCT02042131|3570926|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733852|NCT02042131|3570923|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3733853|NCT02042131|3570924|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3733854|NCT02042131|3570925|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733855|NCT02042131|3570926|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3733856|NCT02042131|3570923|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733857|NCT02042131|3570924|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733858|NCT02042131|3570925|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733859|NCT02042131|3570926|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733860|NCT02042131|3570923|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
3733861|NCT02042131|3570924|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3733862|NCT02042131|3570925|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3733863|NCT02042131|3570926|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3733864|NCT02042131|3570923|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3733865|NCT02042131|3570924|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3733866|NCT02042131|3570925|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3733867|NCT02042131|3570926|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3733868|NCT02042131|3570923|B4||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3733869|NCT02042131|3570924|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3733870|NCT02042131|3570925|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3733871|NCT02042131|3570926|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3733872|NCT02042131|3570923|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3733873|NCT02042131|3570924|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3733874|NCT02042131|3570925|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3733875|NCT02042131|3570926|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3733876|NCT02042131|3570923|B4|||Age||years|Mean|26.1|26.1|Standard Deviation|6.4|6.4|||
3733877|NCT02042131|3570924|B3|||Age||years|Mean|26.0|26.0|Standard Deviation|6.8|6.8|||
3733878|NCT02042131|3570925|B2|||Age||years|Mean|27.0|27.0|Standard Deviation|6.9|6.9|||
3733879|NCT02042131|3570926|B1|||Age||years|Mean|25.4|25.4|Standard Deviation|5.3|5.3|||
3733880|NCT02041533|3570945|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3733881|NCT02041533|3570946|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3733882|NCT02041533|3570947|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3733883|NCT02041533|3570945|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733884|NCT02041533|3570946|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733885|NCT02041533|3570947|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733886|NCT02041533|3570945|B3||White|Race (NIH/OMB)||Participants|Count of Participants|470|470.0||||||
3733887|NCT02041533|3570946|B2||White|Race (NIH/OMB)||Participants|Count of Participants|242|242.0||||||
3733888|NCT02041533|3570947|B1||White|Race (NIH/OMB)||Participants|Count of Participants|228|228.0||||||
3733889|NCT02041533|3570945|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3733890|NCT02041533|3570946|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3733891|NCT02041533|3570947|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3733892|NCT02041533|3570945|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733893|NCT02041533|3570946|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733894|NCT02041533|3570947|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733895|NCT02041533|3570945|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3733896|NCT02041533|3570946|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3733897|NCT02041533|3570947|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3733898|NCT02041533|3570945|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3733899|NCT02041533|3570946|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3733900|NCT02041533|3570947|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3733901|NCT02041533|3570945|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|254|254.0||||||
3733902|NCT02041533|3570946|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
3733903|NCT02041533|3570947|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
3733904|NCT02041533|3570945|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|280|280.0||||||
3733905|NCT02041533|3570946|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|139|139.0||||||
3733906|NCT02041533|3570947|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|141|141.0||||||
3733907|NCT02041533|3570945|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3733908|NCT02041533|3570946|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3733909|NCT02041533|3570947|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3733910|NCT02041533|3570945|B3||Male|Sex: Female, Male||Participants|Count of Participants|332|332.0||||||
3733911|NCT02041533|3570946|B2||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3733912|NCT02041533|3570947|B1||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3733913|NCT02041533|3570945|B3||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
3733914|NCT02041533|3570946|B2||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3733915|NCT02041533|3570947|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3733916|NCT02041533|3570945|B3|||Age||years|Mean|63.1|63.1|Standard Deviation|9.94|9.94|||
3733917|NCT02041533|3570946|B2|||Age||years|Mean|63.4|63.4|Standard Deviation|9.63|9.63|||
3733918|NCT02041533|3570947|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|10.25|10.25|||
3733919|NCT02041520|3570968|B3|||CD8||cel/µL|Median|1017|1017.0|Inter-Quartile Range|||708.0|1553.0|
3733920|NCT02041520|3570969|B2|||CD8||cel/µL|Median|1117|1117.0|Inter-Quartile Range|||742.0|1553.0|
3733921|NCT02041520|3570970|B1|||CD8||cel/µL|Median|985|985.0|Inter-Quartile Range|||652.0|1082.0|
3733922|NCT02041520|3570968|B3|||CD4||cel/µL|Median|488|488.0|Inter-Quartile Range|||407.0|729.0|
3733923|NCT02041520|3570969|B2|||CD4||cel/µL|Median|595|595.0|Inter-Quartile Range|||421.0|765.0|
3733924|NCT02041520|3570970|B1|||CD4||cel/µL|Median|473|473.0|Inter-Quartile Range|||398.0|555.0|
3733925|NCT02041520|3570968|B3|||Nitric oxide catabolites||μM/ml|Mean|37.9|37.9|Standard Deviation|13.6|13.6|||
3733926|NCT02041520|3570969|B2|||Nitric oxide catabolites||μM/ml|Mean|39.0|39.0|Standard Deviation|13.2|13.2|||
3733927|NCT02041520|3570970|B1|||Nitric oxide catabolites||μM/ml|Mean|36.8|36.8|Standard Deviation|14.2|14.2|||
3733928|NCT02041520|3570968|B3|||Reduced-glutathione||μM|Median|3.4|3.4|Inter-Quartile Range|||0.0|26.8|
3733929|NCT02041520|3570969|B2|||Reduced-glutathione||μM|Median|2.5|2.5|Inter-Quartile Range|||0.0|23.1|
3733930|NCT02041520|3570970|B1|||Reduced-glutathione||μM|Median|4.4|4.4|Inter-Quartile Range|||0.0|28.8|
3733931|NCT02041520|3570968|B3|||Oxidized-glutathione||μM|Median|0.2|0.2|Inter-Quartile Range|||0.0|2.6|
3733932|NCT02041520|3570969|B2|||Oxidized-glutathione||μM|Median|0.1|0.1|Inter-Quartile Range|||0.0|2.2|
3733933|NCT02041520|3570970|B1|||Oxidized-glutathione||μM|Median|0.3|0.3|Inter-Quartile Range|||0.0|11.9|
3733934|NCT02041520|3570968|B3|||Total-glutathione||μM|Median|5.2|5.2|Inter-Quartile Range|||1.8|28.8|
3733935|NCT02041520|3570969|B2|||Total-glutathione||μM|Median|4.0|4.0|Inter-Quartile Range|||0.0|26.4|
3733936|NCT02041520|3570970|B1|||Total-glutathione||μM|Median|6.5|6.5|Inter-Quartile Range|||2.6|30.6|
3733937|NCT02041520|3570968|B3|||Lipoperoxides||nM/mg protein|Median|2.0|2.0|Inter-Quartile Range|||1.6|2.8|
3733938|NCT02041520|3570969|B2|||Lipoperoxides||nM/mg protein|Median|2.0|2.0|Inter-Quartile Range|||1.6|2.8|
3733939|NCT02041520|3570970|B1|||Lipoperoxides||nM/mg protein|Median|1.94|1.94|Inter-Quartile Range|||1.6|3.1|
3733940|NCT02041520|3570968|B3|||Aspartate aminotransferase||UI/L|Median|30|30.0|Inter-Quartile Range|||22.0|36.0|
3733941|NCT02041520|3570969|B2|||Aspartate aminotransferase||UI/L|Median|28|28.0|Inter-Quartile Range|||21.0|37.0|
3733942|NCT02041520|3570970|B1|||Aspartate aminotransferase||UI/L|Median|31|31.0|Inter-Quartile Range|||24.0|36.0|
3733943|NCT02041520|3570968|B3|||Alanine aminotransferase||UI/L|Median|36|36.0|Inter-Quartile Range|||28.0|46.0|
3733944|NCT02041520|3570969|B2|||Alanine aminotransferase||UI/L|Median|35.5|35.5|Inter-Quartile Range|||28.0|48.0|
3733945|NCT02041520|3570970|B1|||Alanine aminotransferase||UI/L|Median|36|36.0|Inter-Quartile Range|||28.0|46.0|
3733946|NCT02041520|3570968|B3|||Time in HAART||months|Median|45.5|45.5|Inter-Quartile Range|||27.0|84.0|
3733947|NCT02041520|3570969|B2|||Time in HAART||months|Median|48|48.0|Inter-Quartile Range|||25.0|100.0|
3733948|NCT02041520|3570970|B1|||Time in HAART||months|Median|36|36.0|Inter-Quartile Range|||27.0|82.0|
3733949|NCT02041520|3570968|B3|||VLDL cholesterol||mg/dL|Median|33|33.0|Inter-Quartile Range|||25.9|44.5|
3733950|NCT02041520|3570969|B2|||VLDL cholesterol||mg/dL|Median|29|29.0|Inter-Quartile Range|||25.0|45.0|
3733951|NCT02041520|3570970|B1|||VLDL cholesterol||mg/dL|Median|37|37.0|Inter-Quartile Range|||27.0|44.0|
3733952|NCT02041520|3570968|B3|||LDL cholesterol||mg/dL|Median|107|107.0|Inter-Quartile Range|||88.0|123.0|
3733953|NCT02041520|3570969|B2|||LDL cholesterol||mg/dL|Median|109.7|109.7|Inter-Quartile Range|||99.9|122.5|
3733954|NCT02041520|3570970|B1|||LDL cholesterol||mg/dL|Median|102|102.0|Inter-Quartile Range|||82.0|131.0|
3733955|NCT02041520|3570968|B3|||HDL cholesterol||mg/dL|Median|46|46.0|Inter-Quartile Range|||38.0|52.0|
3733956|NCT02041520|3570969|B2|||HDL cholesterol||mg/dL|Median|46|46.0|Inter-Quartile Range|||38.0|52.0|
3733957|NCT02041520|3570970|B1|||HDL cholesterol||mg/dL|Median|45|45.0|Inter-Quartile Range|||38.0|52.0|
3733958|NCT02041520|3570968|B3|||Triglycerides||mg/dL|Median|173|173.0|Inter-Quartile Range|||126.0|214.0|
3733959|NCT02041520|3570969|B2|||Triglycerides||mg/dL|Median|142|142.0|Inter-Quartile Range|||119.0|206.0|
3733960|NCT02041520|3570970|B1|||Triglycerides||mg/dL|Median|190|190.0|Inter-Quartile Range|||131.0|228.0|
3733961|NCT02041520|3570968|B3|||Total cholesterol||mg/dL|Median|194.5|194.5|Inter-Quartile Range|||165.0|219.0|
3733962|NCT02041520|3570969|B2|||Total cholesterol||mg/dL|Median|197|197.0|Inter-Quartile Range|||171.0|215.0|
3733963|NCT02041520|3570970|B1|||Total cholesterol||mg/dL|Median|184|184.0|Inter-Quartile Range|||162.0|222.0|
3733964|NCT02041520|3570968|B3|||Glucose||mg/dL|Mean|90.9|90.9|Standard Deviation|9.2|9.2|||
3733965|NCT02041520|3570969|B2|||Glucose||mg/dL|Mean|91.5|91.5|Standard Deviation|11.1|11.1|||
3733966|NCT02041520|3570970|B1|||Glucose||mg/dL|Mean|90.3|90.3|Standard Deviation|7.0|7.0|||
3733967|NCT02041520|3570968|B3|||Diastolic blood pressure||mmHg|Mean|74.6|74.6|Standard Deviation|9.5|9.5|||
3733968|NCT02041520|3570969|B2|||Diastolic blood pressure||mmHg|Mean|73.0|73.0|Standard Deviation|10.6|10.6|||
3733969|NCT02041520|3570970|B1|||Diastolic blood pressure||mmHg|Mean|76.2|76.2|Standard Deviation|8.1|8.1|||
3733970|NCT02041520|3570968|B3|||Systolic blood pressure||mmHg|Mean|112.5|112.5|Standard Deviation|12.3|12.3|||
3733971|NCT02041520|3570969|B2|||Systolic blood pressure||mmHg|Mean|113.4|113.4|Standard Deviation|13.2|13.2|||
3733972|NCT02041520|3570970|B1|||Systolic blood pressure||mmHg|Mean|111.7|111.7|Standard Deviation|11.3|11.3|||
3733973|NCT02041520|3570968|B3|||Body mass index||kg/m^2|Mean|25.9|25.9|Standard Deviation|4.5|4.5|||
3733974|NCT02041520|3570969|B2|||Body mass index||kg/m^2|Mean|26.5|26.5|Standard Deviation|4.7|4.7|||
3733975|NCT02041520|3570970|B1|||Body mass index||kg/m^2|Mean|25.4|25.4|Standard Deviation|4.3|4.3|||
3733976|NCT02041520|3570968|B3|Mexico||Region of Enrollment||participants|Number|70|70.0||||||
3733977|NCT02041520|3570969|B2|Mexico||Region of Enrollment||participants|Number|35|35.0||||||
3733978|NCT02041520|3570970|B1|Mexico||Region of Enrollment||participants|Number|35|35.0||||||
3733979|NCT02041520|3570968|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3733980|NCT02041520|3570969|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3733981|NCT02041520|3570970|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3733982|NCT02041520|3570968|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3733983|NCT02041520|3570969|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3733984|NCT02041520|3570970|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3733985|NCT02041520|3570968|B3|||Age||years|Mean|39.9|39.9|Standard Deviation|8.7|8.7|||
3733986|NCT02041520|3570969|B2|||Age||years|Mean|39.9|39.9|Standard Deviation|8.0|8.0|||
3733987|NCT02041520|3570970|B1|||Age||years|Mean|39.9|39.9|Standard Deviation|9.5|9.5|||
3733988|NCT02041377|3570991|B1|United States||Region of Enrollment||participants|Number|134|134.0||||||
3733989|NCT02041377|3570991|B1|Unknown or Not Reported||Race (NIH/OMB)|Subjects provided more than one choice for Race, therefore the apparent frequency total for Race was n=139.|responses|Number|6|6.0||||||
3733990|NCT02041377|3570991|B1|More than one race||Race (NIH/OMB)|Subjects provided more than one choice for Race, therefore the apparent frequency total for Race was n=139.|responses|Number|5|5.0||||||
3733991|NCT02041377|3570991|B1|White||Race (NIH/OMB)|Subjects provided more than one choice for Race, therefore the apparent frequency total for Race was n=139.|responses|Number|108|108.0||||||
3733992|NCT02041377|3570991|B1|Black or African American||Race (NIH/OMB)|Subjects provided more than one choice for Race, therefore the apparent frequency total for Race was n=139.|responses|Number|11|11.0||||||
3733993|NCT02041377|3570991|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|Subjects provided more than one choice for Race, therefore the apparent frequency total for Race was n=139.|responses|Number|3|3.0||||||
3733994|NCT02041377|3570991|B1|Asian||Race (NIH/OMB)|Subjects provided more than one choice for Race, therefore the apparent frequency total for Race was n=139.|responses|Number|8|8.0||||||
3733995|NCT02041377|3570991|B1|American Indian or Alaska Native||Race (NIH/OMB)|Subjects provided more than one choice for Race, therefore the apparent frequency total for Race was n=139.|responses|Number|3|3.0||||||
3733996|NCT02041377|3570991|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3733997|NCT02041377|3570991|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|121|121.0||||||
3733998|NCT02041377|3570991|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3733999|NCT02041377|3570991|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3734000|NCT02041377|3570991|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3734001|NCT02041377|3570991|B1|Age of enrolled subjects||Age, Customized||years|Mean|53.8|53.8|Full Range|||19.0|82.0|
3734002|NCT02041325|3570999|B3|United States||Region of Enrollment||Participants|Number|38|38.0||||||
3734003|NCT02041325|3571000|B2|United States||Region of Enrollment||Participants|Number|16|16.0||||||
3734004|NCT02041325|3571001|B1|United States||Region of Enrollment||Participants|Number|22|22.0||||||
3734005|NCT02041325|3570999|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3734006|NCT02041325|3571000|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3734007|NCT02041325|3571001|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3734008|NCT02041325|3570999|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3734009|NCT02041325|3571000|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3734010|NCT02041325|3571001|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3734011|NCT02041325|3570999|B3|||Age||years|Mean|72.3|72.3|Full Range|||46.0|90.0|
3734012|NCT02041325|3571000|B2|||Age||years|Mean|67.5|67.5|Full Range|||47.0|78.0|
3734013|NCT02041325|3571001|B1|||Age||years|Mean|77|77.0|Full Range|||46.0|90.0|
3734014|NCT02041286|3571014|B1|United States||Region of Enrollment||participants|Number|136|136.0||||||
3734015|NCT02041286|3571014|B1|Unknown or Not Reported||Race (NIH/OMB)|Subjects provided more than one choice for Race, therefore the apparent frequency total for Race was different from number of subjects.|participants|Number|1|1.0||||||
3734016|NCT02041286|3571014|B1|More than one race||Race (NIH/OMB)|Subjects provided more than one choice for Race, therefore the apparent frequency total for Race was different from number of subjects.|participants|Number|3|3.0||||||
3734017|NCT02041286|3571014|B1|White||Race (NIH/OMB)|Subjects provided more than one choice for Race, therefore the apparent frequency total for Race was different from number of subjects.|participants|Number|118|118.0||||||
3734018|NCT02041286|3571014|B1|Black or African American||Race (NIH/OMB)|Subjects provided more than one choice for Race, therefore the apparent frequency total for Race was different from number of subjects.|participants|Number|10|10.0||||||
3734019|NCT02041286|3571014|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|Subjects provided more than one choice for Race, therefore the apparent frequency total for Race was different from number of subjects.|participants|Number|1|1.0||||||
3734020|NCT02041286|3571014|B1|Asian||Race (NIH/OMB)|Subjects provided more than one choice for Race, therefore the apparent frequency total for Race was different from number of subjects.|participants|Number|7|7.0||||||
3734021|NCT02041286|3571014|B1|American Indian or Alaska Native||Race (NIH/OMB)|Subjects provided more than one choice for Race, therefore the apparent frequency total for Race was different from number of subjects.|participants|Number|2|2.0||||||
3734022|NCT02041286|3571014|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3734023|NCT02041286|3571014|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
3734024|NCT02041286|3571014|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3734025|NCT02041286|3571014|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3734026|NCT02041286|3571014|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3734027|NCT02041286|3571014|B1|Age of enrolled subjects||Age, Customized||years|Mean|52.5|52.5|Full Range|||18.0|83.0|
3734028|NCT02041221|3571022|B7||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3734029|NCT02041221|3571023|B6||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3734030|NCT02041221|3571024|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3734031|NCT02041221|3571025|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3734032|NCT02041221|3571026|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3734033|NCT02041221|3571027|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3734034|NCT02041221|3571028|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3734035|NCT02041221|3571022|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3734036|NCT02041221|3571023|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3734037|NCT02041221|3571024|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3734038|NCT02041221|3571025|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3734039|NCT02041221|3571026|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3734040|NCT02041221|3571027|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3734041|NCT02041221|3571028|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3734042|NCT02041221|3571022|B7|||Age, Customized||years|Mean|29|29.0|Standard Deviation|6.3|6.3|||
3734043|NCT02041221|3571023|B6|||Age, Customized||years|Mean|27|27.0|Standard Deviation|5.3|5.3|||
3734044|NCT02041221|3571024|B5|||Age, Customized||years|Mean|31|31.0|Standard Deviation|5.8|5.8|||
3734045|NCT02041221|3571025|B4|||Age, Customized||years|Mean|27|27.0|Standard Deviation|8.8|8.8|||
3734046|NCT02041221|3571026|B3|||Age, Customized||years|Mean|28|28.0|Standard Deviation|4.9|4.9|||
3734047|NCT02041221|3571027|B2|||Age, Customized||years|Mean|28|28.0|Standard Deviation|8.2|8.2|||
3734048|NCT02041221|3571028|B1|||Age, Customized||years|Mean|33|33.0|Standard Deviation|3.9|3.9|||
3734049|NCT02041091|3571047|B3|South Korea||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3734050|NCT02041091|3571048|B2|South Korea||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3734051|NCT02041091|3571049|B1|South Korea||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3734052|NCT02041091|3571047|B3|United States||Region of Enrollment||Participants|Count of Participants|200|200.0||||||
3734053|NCT02041091|3571048|B2|United States||Region of Enrollment||Participants|Count of Participants|101|101.0||||||
3734054|NCT02041091|3571049|B1|United States||Region of Enrollment||Participants|Count of Participants|99|99.0||||||
3734055|NCT02041091|3571047|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734056|NCT02041091|3571048|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734057|NCT02041091|3571049|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734058|NCT02041091|3571047|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3734059|NCT02041091|3571048|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3734060|NCT02041091|3571049|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734061|NCT02041091|3571047|B3||White|Race (NIH/OMB)||Participants|Count of Participants|158|158.0||||||
3734062|NCT02041091|3571048|B2||White|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
3734063|NCT02041091|3571049|B1||White|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3734064|NCT02041091|3571047|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3734065|NCT02041091|3571048|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3734066|NCT02041091|3571049|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3734067|NCT02041091|3571047|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734068|NCT02041091|3571048|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734069|NCT02041091|3571049|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734070|NCT02041091|3571047|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3734071|NCT02041091|3571048|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3734072|NCT02041091|3571049|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3734073|NCT02041091|3571047|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734074|NCT02041091|3571048|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734075|NCT02041091|3571049|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734076|NCT02041091|3571047|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3734077|NCT02041091|3571048|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3734078|NCT02041091|3571049|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3734079|NCT02041091|3571047|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|164|164.0||||||
3734080|NCT02041091|3571048|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3734081|NCT02041091|3571049|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3734082|NCT02041091|3571047|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3734083|NCT02041091|3571048|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3734084|NCT02041091|3571049|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3734085|NCT02041091|3571047|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3734086|NCT02041091|3571048|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3734087|NCT02041091|3571049|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3734088|NCT02041091|3571047|B3||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
3734089|NCT02041091|3571048|B2||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3734090|NCT02041091|3571049|B1||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3734091|NCT02041091|3571047|B3|||Age||years|Mean|45.97|45.97|Standard Deviation|13.018|13.018|||
3734092|NCT02041091|3571048|B2|||Age||years|Mean|44.93|44.93|Standard Deviation|13.306|13.306|||
3734093|NCT02041091|3571049|B1|||Age||years|Mean|47.03|47.03|Standard Deviation|12.691|12.691|||
3734094|NCT02040844|3571072|B4|Canada||Region of Enrollment||Subjects|Number|110|110.0||||||
3734095|NCT02040844|3571073|B3|Canada||Region of Enrollment||Subjects|Number|35|35.0||||||
3734096|NCT02040844|3571074|B2|Canada||Region of Enrollment||Subjects|Number|36|36.0||||||
3734097|NCT02040844|3571075|B1|Canada||Region of Enrollment||Subjects|Number|39|39.0||||||
3734098|NCT02040844|3571072|B4|Europe||Region of Enrollment||Subjects|Number|218|218.0||||||
3734099|NCT02040844|3571073|B3|Europe||Region of Enrollment||Subjects|Number|68|68.0||||||
3734100|NCT02040844|3571074|B2|Europe||Region of Enrollment||Subjects|Number|82|82.0||||||
3734101|NCT02040844|3571075|B1|Europe||Region of Enrollment||Subjects|Number|68|68.0||||||
3734102|NCT02040844|3571072|B4|United States||Region of Enrollment||Subjects|Number|102|102.0||||||
3734103|NCT02040844|3571073|B3|United States||Region of Enrollment||Subjects|Number|41|41.0||||||
3734104|NCT02040844|3571074|B2|United States||Region of Enrollment||Subjects|Number|30|30.0||||||
3734105|NCT02040844|3571075|B1|United States||Region of Enrollment||Subjects|Number|31|31.0||||||
3734106|NCT02040844|3571072|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3734107|NCT02040844|3571073|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3734108|NCT02040844|3571074|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3734109|NCT02040844|3571075|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3734110|NCT02040844|3571072|B4|American hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3734111|NCT02040844|3571073|B3|American hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3734112|NCT02040844|3571074|B2|American hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3734113|NCT02040844|3571075|B1|American hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3734114|NCT02040844|3571072|B4|Asian (Oriental)||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3734115|NCT02040844|3571073|B3|Asian (Oriental)||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3734116|NCT02040844|3571074|B2|Asian (Oriental)||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3734117|NCT02040844|3571075|B1|Asian (Oriental)||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3734118|NCT02040844|3571072|B4|Asian (Indian)||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3734119|NCT02040844|3571073|B3|Asian (Indian)||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3734120|NCT02040844|3571074|B2|Asian (Indian)||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3734121|NCT02040844|3571075|B1|Asian (Indian)||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3734122|NCT02040844|3571072|B4|Black||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3734123|NCT02040844|3571073|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3734124|NCT02040844|3571074|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3734125|NCT02040844|3571075|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3734126|NCT02040844|3571072|B4|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|419|419.0||||||
3734127|NCT02040844|3571073|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|139|139.0||||||
3734128|NCT02040844|3571074|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|145|145.0||||||
3734129|NCT02040844|3571075|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|135|135.0||||||
3734130|NCT02040844|3571072|B4||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3734131|NCT02040844|3571073|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3734132|NCT02040844|3571074|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3734133|NCT02040844|3571075|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3734134|NCT02040844|3571072|B4||Female|Sex: Female, Male||Participants|Count of Participants|292|292.0||||||
3734135|NCT02040844|3571073|B3||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3734136|NCT02040844|3571074|B2||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3734137|NCT02040844|3571075|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3734138|NCT02040844|3571072|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3734139|NCT02040844|3571073|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3734140|NCT02040844|3571074|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3734141|NCT02040844|3571075|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3734142|NCT02040844|3571072|B4||Between 18 and 65 years|Age||Participants|Count of Participants|405|405.0||||||
3734143|NCT02040844|3571073|B3||Between 18 and 65 years|Age||Participants|Count of Participants|135|135.0||||||
3734144|NCT02040844|3571074|B2||Between 18 and 65 years|Age||Participants|Count of Participants|137|137.0||||||
3734145|NCT02040844|3571075|B1||Between 18 and 65 years|Age||Participants|Count of Participants|133|133.0||||||
3734146|NCT02040844|3571072|B4||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
3734147|NCT02040844|3571073|B3||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
3734148|NCT02040844|3571074|B2||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
3734149|NCT02040844|3571075|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3734150|NCT02040792|3571100|B6||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
3734151|NCT02040792|3571101|B5||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3734152|NCT02040792|3571102|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3734153|NCT02040792|3571103|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3734154|NCT02040792|3571104|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3734155|NCT02040792|3571105|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3734156|NCT02040792|3571100|B6||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
3734157|NCT02040792|3571101|B5||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3734158|NCT02040792|3571102|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3734159|NCT02040792|3571103|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3734160|NCT02040792|3571104|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3734161|NCT02040792|3571105|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3734162|NCT02040792|3571100|B6|||Age||years|Mean|61.9|61.9|Standard Deviation|8.63|8.63|||
3734163|NCT02040792|3571101|B5|||Age||years|Mean|61.4|61.4|Standard Deviation|8.98|8.98|||
3734164|NCT02040792|3571102|B4|||Age||years|Mean|64.5|64.5|Standard Deviation|7.69|7.69|||
3734165|NCT02040792|3571103|B3|||Age||years|Mean|60.4|60.4|Standard Deviation|7.98|7.98|||
3734166|NCT02040792|3571104|B2|||Age||years|Mean|60.9|60.9|Standard Deviation|8.87|8.87|||
3734167|NCT02040792|3571105|B1|||Age||years|Mean|62.2|62.2|Standard Deviation|9.17|9.17|||
3734168|NCT02040779|3571121|B4||Non-corticosteroid|Current Asthma Therapy||Participants|Count of Participants|169|169.0||||||
3734169|NCT02040779|3571122|B3||Non-corticosteroid|Current Asthma Therapy||Participants|Count of Participants|57|57.0||||||
3734170|NCT02040779|3571123|B2||Non-corticosteroid|Current Asthma Therapy||Participants|Count of Participants|56|56.0||||||
3734171|NCT02040779|3571124|B1||Non-corticosteroid|Current Asthma Therapy||Participants|Count of Participants|56|56.0||||||
3734172|NCT02040779|3571121|B4||Inhaled corticosteroid|Current Asthma Therapy||Participants|Count of Participants|104|104.0||||||
3734173|NCT02040779|3571122|B3||Inhaled corticosteroid|Current Asthma Therapy||Participants|Count of Participants|35|35.0||||||
3734174|NCT02040779|3571123|B2||Inhaled corticosteroid|Current Asthma Therapy||Participants|Count of Participants|34|34.0||||||
3734175|NCT02040779|3571124|B1||Inhaled corticosteroid|Current Asthma Therapy||Participants|Count of Participants|35|35.0||||||
3734176|NCT02040779|3571121|B4||>=15 years|Duration of Asthma||Participants|Count of Participants|187|187.0||||||
3734177|NCT02040779|3571122|B3||>=15 years|Duration of Asthma||Participants|Count of Participants|62|62.0||||||
3734178|NCT02040779|3571123|B2||>=15 years|Duration of Asthma||Participants|Count of Participants|60|60.0||||||
3734179|NCT02040779|3571124|B1||>=15 years|Duration of Asthma||Participants|Count of Participants|65|65.0||||||
3734180|NCT02040779|3571121|B4||10 years to <15 years|Duration of Asthma||Participants|Count of Participants|46|46.0||||||
3734181|NCT02040779|3571122|B3||10 years to <15 years|Duration of Asthma||Participants|Count of Participants|18|18.0||||||
3734182|NCT02040779|3571123|B2||10 years to <15 years|Duration of Asthma||Participants|Count of Participants|16|16.0||||||
3734183|NCT02040779|3571124|B1||10 years to <15 years|Duration of Asthma||Participants|Count of Participants|12|12.0||||||
3734184|NCT02040779|3571121|B4||5 years to <10 years|Duration of Asthma||Participants|Count of Participants|27|27.0||||||
3734185|NCT02040779|3571122|B3||5 years to <10 years|Duration of Asthma||Participants|Count of Participants|10|10.0||||||
3734186|NCT02040779|3571123|B2||5 years to <10 years|Duration of Asthma||Participants|Count of Participants|8|8.0||||||
3734187|NCT02040779|3571124|B1||5 years to <10 years|Duration of Asthma||Participants|Count of Participants|9|9.0||||||
3734188|NCT02040779|3571121|B4||1 year to < 5 years|Duration of Asthma||Participants|Count of Participants|10|10.0||||||
3734189|NCT02040779|3571122|B3||1 year to < 5 years|Duration of Asthma||Participants|Count of Participants|2|2.0||||||
3734190|NCT02040779|3571123|B2||1 year to < 5 years|Duration of Asthma||Participants|Count of Participants|4|4.0||||||
3734191|NCT02040779|3571124|B1||1 year to < 5 years|Duration of Asthma||Participants|Count of Participants|4|4.0||||||
3734192|NCT02040779|3571121|B4||6 months to <1 year|Duration of Asthma||Participants|Count of Participants|2|2.0||||||
3734193|NCT02040779|3571122|B3||6 months to <1 year|Duration of Asthma||Participants|Count of Participants|0|0.0||||||
3734194|NCT02040779|3571123|B2||6 months to <1 year|Duration of Asthma||Participants|Count of Participants|1|1.0||||||
3734195|NCT02040779|3571124|B1||6 months to <1 year|Duration of Asthma||Participants|Count of Participants|1|1.0||||||
3734196|NCT02040779|3571121|B4||3 months to <6 months|Duration of Asthma||Participants|Count of Participants|1|1.0||||||
3734197|NCT02040779|3571122|B3||3 months to <6 months|Duration of Asthma||Participants|Count of Participants|0|0.0||||||
3734198|NCT02040779|3571123|B2||3 months to <6 months|Duration of Asthma||Participants|Count of Participants|1|1.0||||||
3734199|NCT02040779|3571124|B1||3 months to <6 months|Duration of Asthma||Participants|Count of Participants|0|0.0||||||
3734200|NCT02040779|3571121|B4||<3 months|Duration of Asthma||Participants|Count of Participants|0|0.0||||||
3734201|NCT02040779|3571122|B3||<3 months|Duration of Asthma||Participants|Count of Participants|0|0.0||||||
3734202|NCT02040779|3571123|B2||<3 months|Duration of Asthma||Participants|Count of Participants|0|0.0||||||
3734203|NCT02040779|3571124|B1||<3 months|Duration of Asthma||Participants|Count of Participants|0|0.0||||||
3734204|NCT02040779|3571121|B4|||Body Mass Index||kg/m^2|Mean|28.591|28.591|Standard Deviation|7.2109|7.2109|||
3734205|NCT02040779|3571122|B3|||Body Mass Index||kg/m^2|Mean|28.136|28.136|Standard Deviation|6.7751|6.7751|||
3734206|NCT02040779|3571123|B2|||Body Mass Index||kg/m^2|Mean|29.266|29.266|Standard Deviation|7.9371|7.9371|||
3734207|NCT02040779|3571124|B1|||Body Mass Index||kg/m^2|Mean|28.383|28.383|Standard Deviation|6.9051|6.9051|||
3734208|NCT02040779|3571121|B4|||Height||cm|Mean|169.64|169.64|Standard Deviation|9.554|9.554|||
3734209|NCT02040779|3571122|B3|||Height||cm|Mean|168.78|168.78|Standard Deviation|8.657|8.657|||
3734210|NCT02040779|3571123|B2|||Height||cm|Mean|170.88|170.88|Standard Deviation|10.447|10.447|||
3734211|NCT02040779|3571124|B1|||Height||cm|Mean|169.28|169.28|Standard Deviation|9.473|9.473|||
3734212|NCT02040779|3571121|B4|||Weight||kg|Mean|82.60|82.6|Standard Deviation|22.316|22.316|||
3734213|NCT02040779|3571122|B3|||Weight||kg|Mean|80.29|80.29|Standard Deviation|20.577|20.577|||
3734214|NCT02040779|3571123|B2|||Weight||kg|Mean|85.30|85.3|Standard Deviation|22.382|22.382|||
3734215|NCT02040779|3571124|B1|||Weight||kg|Mean|82.27|82.27|Standard Deviation|23.848|23.848|||
3734216|NCT02040779|3571121|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3734217|NCT02040779|3571122|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3734218|NCT02040779|3571123|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3734219|NCT02040779|3571124|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3734220|NCT02040779|3571121|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734221|NCT02040779|3571122|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734222|NCT02040779|3571123|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734223|NCT02040779|3571124|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734224|NCT02040779|3571121|B4||White|Race (NIH/OMB)||Participants|Count of Participants|209|209.0||||||
3734225|NCT02040779|3571122|B3||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3734226|NCT02040779|3571123|B2||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3734227|NCT02040779|3571124|B1||White|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3734228|NCT02040779|3571121|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3734229|NCT02040779|3571122|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3734230|NCT02040779|3571123|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3734231|NCT02040779|3571124|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3734232|NCT02040779|3571121|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3734233|NCT02040779|3571122|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734234|NCT02040779|3571123|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734235|NCT02040779|3571124|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3734236|NCT02040779|3571121|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3734237|NCT02040779|3571122|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3734238|NCT02040779|3571123|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3734239|NCT02040779|3571124|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3734240|NCT02040779|3571121|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734241|NCT02040779|3571122|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734242|NCT02040779|3571123|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734243|NCT02040779|3571124|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734244|NCT02040779|3571121|B4||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3734245|NCT02040779|3571122|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3734246|NCT02040779|3571123|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3734247|NCT02040779|3571124|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3734248|NCT02040779|3571121|B4||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3734249|NCT02040779|3571122|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3734250|NCT02040779|3571123|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3734251|NCT02040779|3571124|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3734252|NCT02040779|3571121|B4|||Age||years|Mean|37.8|37.8|Standard Deviation|15.27|15.27|||
3734253|NCT02040779|3571122|B3|||Age||years|Mean|37.4|37.4|Standard Deviation|16.05|16.05|||
3734254|NCT02040779|3571123|B2|||Age||years|Mean|38.8|38.8|Standard Deviation|15.02|15.02|||
3734255|NCT02040779|3571124|B1|||Age||years|Mean|37.2|37.2|Standard Deviation|14.82|14.82|||
3734256|NCT02040766|3571161|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3734257|NCT02040766|3571162|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3734258|NCT02040766|3571163|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3734259|NCT02040766|3571164|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3734260|NCT02040766|3571165|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3734261|NCT02040766|3571166|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3734262|NCT02040766|3571161|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734263|NCT02040766|3571162|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734264|NCT02040766|3571163|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734265|NCT02040766|3571164|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734266|NCT02040766|3571165|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734267|NCT02040766|3571166|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734268|NCT02040766|3571161|B6||White|Race (NIH/OMB)||Participants|Count of Participants|348|348.0||||||
3734269|NCT02040766|3571162|B5||White|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3734270|NCT02040766|3571163|B4||White|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
3734271|NCT02040766|3571164|B3||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3734272|NCT02040766|3571165|B2||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3734273|NCT02040766|3571166|B1||White|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3734274|NCT02040766|3571161|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|195|195.0||||||
3734275|NCT02040766|3571162|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3734276|NCT02040766|3571163|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3734277|NCT02040766|3571164|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3734278|NCT02040766|3571165|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3734279|NCT02040766|3571166|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3734280|NCT02040766|3571161|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734281|NCT02040766|3571162|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734282|NCT02040766|3571163|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734283|NCT02040766|3571164|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734284|NCT02040766|3571165|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734285|NCT02040766|3571166|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734286|NCT02040766|3571161|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3734287|NCT02040766|3571162|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734288|NCT02040766|3571163|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734289|NCT02040766|3571164|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3734290|NCT02040766|3571165|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3734291|NCT02040766|3571166|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734292|NCT02040766|3571161|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3734293|NCT02040766|3571162|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3734294|NCT02040766|3571163|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3734295|NCT02040766|3571164|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3734296|NCT02040766|3571165|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3734297|NCT02040766|3571166|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3734298|NCT02040766|3571161|B6||Male|Sex: Female, Male||Participants|Count of Participants|390|390.0||||||
3734299|NCT02040766|3571162|B5||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3734300|NCT02040766|3571163|B4||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3734301|NCT02040766|3571164|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3734302|NCT02040766|3571165|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3734303|NCT02040766|3571166|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3734304|NCT02040766|3571161|B6||Female|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
3734305|NCT02040766|3571162|B5||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3734306|NCT02040766|3571163|B4||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3734307|NCT02040766|3571164|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3734308|NCT02040766|3571165|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3734309|NCT02040766|3571166|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3734310|NCT02040766|3571161|B6|||Age||years|Mean|8.3|8.3|Standard Deviation|1.93|1.93|||
3734311|NCT02040766|3571162|B5|||Age||years|Mean|8.4|8.4|Standard Deviation|1.86|1.86|||
3734312|NCT02040766|3571163|B4|||Age||years|Mean|8.2|8.2|Standard Deviation|1.78|1.78|||
3734313|NCT02040766|3571164|B3|||Age||years|Mean|8.4|8.4|Standard Deviation|1.24|1.24|||
3734314|NCT02040766|3571165|B2|||Age||years|Mean|8.5|8.5|Standard Deviation|2.10|2.1|||
3734315|NCT02040766|3571166|B1|||Age||years|Mean|8.2|8.2|Standard Deviation|2.06|2.06|||
3734316|NCT02040623|3571208|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3734317|NCT02040623|3571209|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3734318|NCT02040623|3571210|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3734319|NCT02040623|3571211|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3734320|NCT02040623|3571208|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3734321|NCT02040623|3571209|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3734322|NCT02040623|3571210|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3734323|NCT02040623|3571211|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3734324|NCT02040623|3571208|B4|||Age||years|Mean|55.13|55.13|Standard Deviation|10.81|10.81|||
3734325|NCT02040623|3571209|B3|||Age||years|Mean|52.5|52.5|Standard Deviation|15.96|15.96|||
3734326|NCT02040623|3571210|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|17.15|17.15|||
3734327|NCT02040623|3571211|B1|||Age||years|Mean|57.1|57.1|Standard Deviation|9.34|9.34|||
3734328|NCT02040532|3571221|B1||Does not have Doctor/Nurse Providing Regular Care|Provider Status||Participants|Count of Participants|1|1.0||||||
3734329|NCT02040532|3571221|B1||Has Doctor/Nurse Providing Regular Care|Provider Status||Participants|Count of Participants|25|25.0||||||
3734330|NCT02040532|3571221|B1|||Baseline BMI||kg/m^2|Mean|29.4|29.4|Standard Deviation|6.6|6.6|||
3734331|NCT02040532|3571221|B1||Non-Current Smoker|Smoking History||Participants|Count of Participants|22|22.0||||||
3734332|NCT02040532|3571221|B1||Current Smoker|Smoking History||Participants|Count of Participants|4|4.0||||||
3734333|NCT02040532|3571221|B1||1 to 4 Children|Number of Children||Participants|Count of Participants|14|14.0||||||
3734334|NCT02040532|3571221|B1||No Children|Number of Children||Participants|Count of Participants|12|12.0||||||
3734335|NCT02040532|3571221|B1||>5 Years|Years since last menstrual period (LMP)||Participants|Count of Participants|8|8.0||||||
3734336|NCT02040532|3571221|B1||1-5 Years|Years since last menstrual period (LMP)||Participants|Count of Participants|13|13.0||||||
3734337|NCT02040532|3571221|B1||<1 Years|Years since last menstrual period (LMP)||Participants|Count of Participants|5|5.0||||||
3734338|NCT02040532|3571221|B1||Surgically Postmenopausal|Gynecological History||Participants|Count of Participants|3|3.0||||||
3734339|NCT02040532|3571221|B1||Naturally Postmenopausal|Gynecological History||Participants|Count of Participants|18|18.0||||||
3734340|NCT02040532|3571221|B1||Perimenopausal|Gynecological History||Participants|Count of Participants|5|5.0||||||
3734341|NCT02040532|3571221|B1||Presently Married or Living with Partner|Marital Status||Participants|Count of Participants|12|12.0||||||
3734342|NCT02040532|3571221|B1||Widowed|Marital Status||Participants|Count of Participants|2|2.0||||||
3734343|NCT02040532|3571221|B1||Divorced or Separated|Marital Status||Participants|Count of Participants|5|5.0||||||
3734344|NCT02040532|3571221|B1||Never Married|Marital Status||Participants|Count of Participants|7|7.0||||||
3734345|NCT02040532|3571221|B1||Disabled, Unable to work, on Medical Leave|Employment||Participants|Count of Participants|4|4.0||||||
3734346|NCT02040532|3571221|B1||Retired or Unemployed|Employment||Participants|Count of Participants|8|8.0||||||
3734347|NCT02040532|3571221|B1||Employed Part-Time|Employment||Participants|Count of Participants|6|6.0||||||
3734348|NCT02040532|3571221|B1||Employed Full-Time|Employment||Participants|Count of Participants|8|8.0||||||
3734349|NCT02040532|3571221|B1||Graduate Degree|Highest Level of Education||Participants|Count of Participants|4|4.0||||||
3734350|NCT02040532|3571221|B1||College Graduate/Baccalaureate Degree|Highest Level of Education||Participants|Count of Participants|4|4.0||||||
3734351|NCT02040532|3571221|B1||Less than College Graduate|Highest Level of Education||Participants|Count of Participants|18|18.0||||||
3734352|NCT02040532|3571221|B1|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3734353|NCT02040532|3571221|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734354|NCT02040532|3571221|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734355|NCT02040532|3571221|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3734356|NCT02040532|3571221|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3734357|NCT02040532|3571221|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734358|NCT02040532|3571221|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734359|NCT02040532|3571221|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734360|NCT02040532|3571221|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734361|NCT02040532|3571221|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3734362|NCT02040532|3571221|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3734363|NCT02040532|3571221|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3734364|NCT02040532|3571221|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3734365|NCT02040532|3571221|B1|||Age||years|Mean|55.31|55.31|Standard Deviation|4.5|4.5|||
3734366|NCT02040428|3571232|B3|Morbidly obese||BMI Category||Participants|Number|3|3.0||||||
3734367|NCT02040428|3571233|B2|Morbidly obese||BMI Category||Participants|Number|1|1.0||||||
3734368|NCT02040428|3571234|B1|Morbidly obese||BMI Category||Participants|Number|2|2.0||||||
3734369|NCT02040428|3571232|B3|Obese||BMI Category||Participants|Number|50|50.0||||||
3734370|NCT02040428|3571233|B2|Obese||BMI Category||Participants|Number|30|30.0||||||
3734371|NCT02040428|3571234|B1|Obese||BMI Category||Participants|Number|20|20.0||||||
3734372|NCT02040428|3571232|B3|Overweight||BMI Category||Participants|Number|63|63.0||||||
3734373|NCT02040428|3571233|B2|Overweight||BMI Category||Participants|Number|32|32.0||||||
3734374|NCT02040428|3571234|B1|Overweight||BMI Category||Participants|Number|31|31.0||||||
3734375|NCT02040428|3571232|B3|Normal||BMI Category||Participants|Number|38|38.0||||||
3734376|NCT02040428|3571233|B2|Normal||BMI Category||Participants|Number|18|18.0||||||
3734377|NCT02040428|3571234|B1|Normal||BMI Category||Participants|Number|20|20.0||||||
3734378|NCT02040428|3571232|B3|Underweight||BMI Category||Participants|Number|2|2.0||||||
3734379|NCT02040428|3571233|B2|Underweight||BMI Category||Participants|Number|0|0.0||||||
3734380|NCT02040428|3571234|B1|Underweight||BMI Category||Participants|Number|2|2.0||||||
3734381|NCT02040428|3571232|B3|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3734382|NCT02040428|3571233|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3734383|NCT02040428|3571234|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3734384|NCT02040428|3571232|B3|Asian||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
3734385|NCT02040428|3571233|B2|Asian||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3734386|NCT02040428|3571234|B1|Asian||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
3734387|NCT02040428|3571232|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3734388|NCT02040428|3571233|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3734389|NCT02040428|3571234|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3734390|NCT02040428|3571232|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3734391|NCT02040428|3571233|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3734392|NCT02040428|3571234|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3734393|NCT02040428|3571232|B3|White/Caucasian||Race/Ethnicity, Customized||Participants|Number|128|128.0||||||
3734394|NCT02040428|3571233|B2|White/Caucasian||Race/Ethnicity, Customized||Participants|Number|66|66.0||||||
3734395|NCT02040428|3571234|B1|White/Caucasian||Race/Ethnicity, Customized||Participants|Number|62|62.0||||||
3734396|NCT02040428|3571232|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3734397|NCT02040428|3571233|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3734398|NCT02040428|3571234|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3734399|NCT02040428|3571232|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
3734400|NCT02040428|3571233|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
3734401|NCT02040428|3571234|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3734402|NCT02040428|3571232|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3734403|NCT02040428|3571233|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3734404|NCT02040428|3571234|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3734405|NCT02040428|3571232|B3||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3734406|NCT02040428|3571233|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3734407|NCT02040428|3571234|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3734408|NCT02040428|3571232|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3734409|NCT02040428|3571233|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3734410|NCT02040428|3571234|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3734411|NCT02040428|3571232|B3|>= 75||Age, Customized||Participants|Number|30|30.0||||||
3734412|NCT02040428|3571233|B2|>= 75||Age, Customized||Participants|Number|12|12.0||||||
3734413|NCT02040428|3571234|B1|>= 75||Age, Customized||Participants|Number|18|18.0||||||
3734414|NCT02040428|3571232|B3|65 < 75||Age, Customized||Participants|Number|47|47.0||||||
3734415|NCT02040428|3571233|B2|65 < 75||Age, Customized||Participants|Number|25|25.0||||||
3734416|NCT02040428|3571234|B1|65 < 75||Age, Customized||Participants|Number|22|22.0||||||
3734417|NCT02040428|3571232|B3|50 < 65 years||Age, Customized||Participants|Number|53|53.0||||||
3734418|NCT02040428|3571233|B2|50 < 65 years||Age, Customized||Participants|Number|32|32.0||||||
3734419|NCT02040428|3571234|B1|50 < 65 years||Age, Customized||Participants|Number|21|21.0||||||
3734420|NCT02040428|3571232|B3|Between 18 < 50 years||Age, Customized||Participants|Number|26|26.0||||||
3734421|NCT02040428|3571233|B2|Between 18 < 50 years||Age, Customized||Participants|Number|12|12.0||||||
3734422|NCT02040428|3571234|B1|Between 18 < 50 years||Age, Customized||Participants|Number|14|14.0||||||
3734423|NCT02040428|3571232|B3|<=18 years||Age, Customized||Participants|Number|0|0.0||||||
3734424|NCT02040428|3571233|B2|<=18 years||Age, Customized||Participants|Number|0|0.0||||||
3734425|NCT02040428|3571234|B1|<=18 years||Age, Customized||Participants|Number|0|0.0||||||
3734426|NCT02040116|3571247|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3734427|NCT02040116|3571247|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3734428|NCT02040116|3571247|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3734429|NCT02040116|3571247|B1|||Age||years|Median|40|40.0|Full Range|||30.0|60.0|
3734430|NCT02040116|3571247|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3734431|NCT02040116|3571247|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3734432|NCT02040116|3571247|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3734433|NCT02040077|3571255|B4|United States||Region of Enrollment||Participants|Count of Participants|76|76.0||||||
3734434|NCT02040077|3571256|B3|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3734435|NCT02040077|3571257|B2|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3734436|NCT02040077|3571258|B1|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3734437|NCT02040077|3571255|B4||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3734438|NCT02040077|3571256|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3734439|NCT02040077|3571257|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3734440|NCT02040077|3571258|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3734441|NCT02040077|3571255|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3734442|NCT02040077|3571256|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3734443|NCT02040077|3571257|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3734444|NCT02040077|3571258|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3734445|NCT02040077|3571255|B4|||Age||years|Mean|39.9|39.9|Standard Deviation|12.6|12.6|||
3734446|NCT02040077|3571256|B3|||Age||years|Mean|41.9|41.9|Standard Deviation|14.1|14.1|||
3734447|NCT02040077|3571257|B2|||Age||years|Mean|37.8|37.8|Standard Deviation|10.6|10.6|||
3734448|NCT02040077|3571258|B1|||Age||years|Mean|40.0|40.0|Standard Deviation|13.1|13.1|||
3734449|NCT02039817|3571271|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
3734450|NCT02039817|3571272|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3734451|NCT02039817|3571273|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3734452|NCT02039817|3571271|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734453|NCT02039817|3571272|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734454|NCT02039817|3571273|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734455|NCT02039817|3571271|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734456|NCT02039817|3571272|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734457|NCT02039817|3571273|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734458|NCT02039817|3571271|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3734459|NCT02039817|3571272|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3734460|NCT02039817|3571273|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3734461|NCT02039817|3571271|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734462|NCT02039817|3571272|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734463|NCT02039817|3571273|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734464|NCT02039817|3571271|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734465|NCT02039817|3571272|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734466|NCT02039817|3571273|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734467|NCT02039817|3571271|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734468|NCT02039817|3571272|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734469|NCT02039817|3571273|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734470|NCT02039817|3571271|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734471|NCT02039817|3571272|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734472|NCT02039817|3571273|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734473|NCT02039817|3571271|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734474|NCT02039817|3571272|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734475|NCT02039817|3571273|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734476|NCT02039817|3571271|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3734477|NCT02039817|3571272|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3734478|NCT02039817|3571273|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3734479|NCT02039817|3571271|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3734480|NCT02039817|3571272|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3734481|NCT02039817|3571273|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3734482|NCT02039817|3571271|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3734483|NCT02039817|3571272|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3734484|NCT02039817|3571273|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3734485|NCT02039817|3571271|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3734486|NCT02039817|3571272|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3734487|NCT02039817|3571273|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3734488|NCT02039817|3571271|B3|||Age||years|Median|62.0|62.0|Full Range|||51.0|69.0|
3734489|NCT02039817|3571272|B2|||Age||years|Median|64.0|64.0|Full Range|||54.0|68.0|
3734490|NCT02039817|3571273|B1|||Age||years|Median|61.0|61.0|Full Range|||51.0|69.0|
3734491|NCT02039778|3571283|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3734492|NCT02039778|3571283|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3734493|NCT02039778|3571283|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3734494|NCT02039778|3571283|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3734495|NCT02039778|3571283|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3734496|NCT02039687|3571291|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734497|NCT02039687|3571292|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734498|NCT02039687|3571293|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734499|NCT02039687|3571294|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734500|NCT02039687|3571295|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734501|NCT02039687|3571291|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734502|NCT02039687|3571292|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734503|NCT02039687|3571293|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734504|NCT02039687|3571294|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734505|NCT02039687|3571295|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734506|NCT02039687|3571291|B5||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3734507|NCT02039687|3571292|B4||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3734508|NCT02039687|3571293|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3734509|NCT02039687|3571294|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3734510|NCT02039687|3571295|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3734511|NCT02039687|3571291|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3734512|NCT02039687|3571292|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734513|NCT02039687|3571293|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734514|NCT02039687|3571294|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3734515|NCT02039687|3571295|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734516|NCT02039687|3571291|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734517|NCT02039687|3571292|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734518|NCT02039687|3571293|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734519|NCT02039687|3571294|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734520|NCT02039687|3571295|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734521|NCT02039687|3571291|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734522|NCT02039687|3571292|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734523|NCT02039687|3571293|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734524|NCT02039687|3571294|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734525|NCT02039687|3571295|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734526|NCT02039687|3571291|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734527|NCT02039687|3571292|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734528|NCT02039687|3571293|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734529|NCT02039687|3571294|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734530|NCT02039687|3571295|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734531|NCT02039687|3571291|B5||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3734532|NCT02039687|3571292|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3734533|NCT02039687|3571293|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3734534|NCT02039687|3571294|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3734535|NCT02039687|3571295|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3734536|NCT02039687|3571291|B5||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3734537|NCT02039687|3571292|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3734538|NCT02039687|3571293|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3734539|NCT02039687|3571294|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3734540|NCT02039687|3571295|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3734541|NCT02039687|3571291|B5|||Age||years|Mean|50.8|50.8|Standard Deviation|9.55|9.55|||
3734542|NCT02039687|3571292|B4|||Age||years|Mean|47.8|47.8|Standard Deviation|10.66|10.66|||
3734543|NCT02039687|3571293|B3|||Age||years|Mean|52.2|52.2|Standard Deviation|9.17|9.17|||
3734544|NCT02039687|3571294|B2|||Age||years|Mean|51.8|51.8|Standard Deviation|10.75|10.75|||
3734545|NCT02039687|3571295|B1|||Age||years|Mean|51.4|51.4|Standard Deviation|7.47|7.47|||
3734546|NCT02039674|3571324|B10||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3734547|NCT02039674|3571325|B9||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3734548|NCT02039674|3571326|B8||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3734549|NCT02039674|3571327|B7||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3734550|NCT02039674|3571328|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3734551|NCT02039674|3571329|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3734552|NCT02039674|3571330|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3734553|NCT02039674|3571331|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3734554|NCT02039674|3571332|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3734555|NCT02039674|3571333|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3734556|NCT02039674|3571324|B10||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3734557|NCT02039674|3571325|B9||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3734558|NCT02039674|3571326|B8||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3734559|NCT02039674|3571327|B7||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3734560|NCT02039674|3571328|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3734561|NCT02039674|3571329|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3734562|NCT02039674|3571330|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3734563|NCT02039674|3571331|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3734564|NCT02039674|3571332|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3734565|NCT02039674|3571333|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3734566|NCT02039674|3571324|B10|||Age||Years|Mean|61.8|61.8|Standard Deviation|9.5|9.5|||
3734567|NCT02039674|3571325|B9|||Age||Years|Mean|60.4|60.4|Standard Deviation|11.2|11.2|||
3734568|NCT02039674|3571326|B8|||Age||Years|Mean|63.2|63.2|Standard Deviation|9.6|9.6|||
3734569|NCT02039674|3571327|B7|||Age||Years|Mean|61.8|61.8|Standard Deviation|9.2|9.2|||
3734570|NCT02039674|3571328|B6|||Age||Years|Mean|62.7|62.7|Standard Deviation|12.0|12.0|||
3734571|NCT02039674|3571329|B5|||Age||Years|Mean|60.2|60.2|Standard Deviation|8.0|8.0|||
3734572|NCT02039674|3571330|B4|||Age||Years|Mean|64.3|64.3|Standard Deviation|7.5|7.5|||
3734573|NCT02039674|3571331|B3|||Age||Years|Mean|61.8|61.8|Standard Deviation|9.7|9.7|||
3734574|NCT02039674|3571332|B2|||Age||Years|Mean|60.3|60.3|Standard Deviation|7.3|7.3|||
3734575|NCT02039674|3571333|B1|||Age||Years|Mean|63.0|63.0|Standard Deviation|8.6|8.6|||
3734576|NCT02039427|3571373|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3734577|NCT02039427|3571374|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3734578|NCT02039427|3571375|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3734579|NCT02039427|3571376|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3734580|NCT02039427|3571377|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3734581|NCT02039427|3571373|B5||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3734582|NCT02039427|3571374|B4||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3734583|NCT02039427|3571375|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3734584|NCT02039427|3571376|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3734585|NCT02039427|3571377|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3734586|NCT02039427|3571373|B5|||Age||years|Mean|47.8|47.8|Standard Deviation|9.9|9.9|||
3734587|NCT02039427|3571374|B4|||Age||years|Mean|46.0|46.0|Standard Deviation|11.1|11.1|||
3734588|NCT02039427|3571375|B3|||Age||years|Mean|47.3|47.3|Standard Deviation|9.3|9.3|||
3734589|NCT02039427|3571376|B2|||Age||years|Mean|49.5|49.5|Standard Deviation|9.2|9.2|||
3734590|NCT02039427|3571377|B1|||Age||years|Mean|48.2|48.2|Standard Deviation|10.1|10.1|||
3734591|NCT02039427|3571373|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3734592|NCT02039427|3571374|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3734593|NCT02039427|3571375|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3734594|NCT02039427|3571376|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3734595|NCT02039427|3571377|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3734596|NCT02039427|3571373|B5||Between 18 and 65 years|Age||Participants|Count of Participants|180|180.0||||||
3734597|NCT02039427|3571374|B4||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
3734598|NCT02039427|3571375|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3734599|NCT02039427|3571376|B2||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3734600|NCT02039427|3571377|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3734601|NCT02039427|3571373|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3734602|NCT02039427|3571374|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3734603|NCT02039427|3571375|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3734604|NCT02039427|3571376|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3734605|NCT02039427|3571377|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3734606|NCT02039414|3571398|B3|||Low Income|Women were considered low-income for this study if they were recruited from a specialized clinic that required it's patients to either be on Medicaid or have no insurance. Thus, because they qualified for Medicaid or had no insurance, they were considered low-income.|participants|Number|15|15.0||||||
3734660|NCT02039115|3571413|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734607|NCT02039414|3571399|B2|||Low Income|Women were considered low-income for this study if they were recruited from a specialized clinic that required it's patients to either be on Medicaid or have no insurance. Thus, because they qualified for Medicaid or had no insurance, they were considered low-income.|participants|Number|5|5.0||||||
3734608|NCT02039414|3571400|B1|||Low Income|Women were considered low-income for this study if they were recruited from a specialized clinic that required it's patients to either be on Medicaid or have no insurance. Thus, because they qualified for Medicaid or had no insurance, they were considered low-income.|participants|Number|10|10.0||||||
3734609|NCT02039414|3571398|B3|||Nulliparous|Nulliparous: A woman who has never borne offspring (i.e. has not had a child)|participants|Number|21|21.0||||||
3734610|NCT02039414|3571399|B2|||Nulliparous|Nulliparous: A woman who has never borne offspring (i.e. has not had a child)|participants|Number|9|9.0||||||
3734611|NCT02039414|3571400|B1|||Nulliparous|Nulliparous: A woman who has never borne offspring (i.e. has not had a child)|participants|Number|12|12.0||||||
3734612|NCT02039414|3571398|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734613|NCT02039414|3571399|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734614|NCT02039414|3571400|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734615|NCT02039414|3571398|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734616|NCT02039414|3571399|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734617|NCT02039414|3571400|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734618|NCT02039414|3571398|B3||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3734619|NCT02039414|3571399|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3734620|NCT02039414|3571400|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3734621|NCT02039414|3571398|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3734622|NCT02039414|3571399|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3734623|NCT02039414|3571400|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3734624|NCT02039414|3571398|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734625|NCT02039414|3571399|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734626|NCT02039414|3571400|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734627|NCT02039414|3571398|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3734628|NCT02039414|3571399|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3734629|NCT02039414|3571400|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3734630|NCT02039414|3571398|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734631|NCT02039414|3571399|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734632|NCT02039414|3571400|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734633|NCT02039414|3571398|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3734634|NCT02039414|3571399|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3734635|NCT02039414|3571400|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3734636|NCT02039414|3571398|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3734637|NCT02039414|3571399|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3734638|NCT02039414|3571400|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3734639|NCT02039414|3571398|B3|||Age||Years|Mean|26.95|26.95|Standard Deviation|4.8|4.8|||
3734640|NCT02039414|3571399|B2|||Age||Years|Mean|28.9|28.9|Standard Deviation|4.8|4.8|||
3734641|NCT02039414|3571400|B1|||Age||Years|Mean|25.0|25.0|Standard Deviation|4.8|4.8|||
3734642|NCT02039115|3571413|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734643|NCT02039115|3571414|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734644|NCT02039115|3571415|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734645|NCT02039115|3571413|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734646|NCT02039115|3571414|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734647|NCT02039115|3571415|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734648|NCT02039115|3571413|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3734649|NCT02039115|3571414|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734650|NCT02039115|3571415|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3734651|NCT02039115|3571413|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734652|NCT02039115|3571414|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734653|NCT02039115|3571415|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734654|NCT02039115|3571413|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734655|NCT02039115|3571414|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734656|NCT02039115|3571415|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734657|NCT02039115|3571413|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734658|NCT02039115|3571414|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734659|NCT02039115|3571415|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734661|NCT02039115|3571414|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734662|NCT02039115|3571415|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734663|NCT02039115|3571413|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3734664|NCT02039115|3571414|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3734665|NCT02039115|3571415|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3734666|NCT02039115|3571413|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3734667|NCT02039115|3571414|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3734668|NCT02039115|3571415|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3734669|NCT02039115|3571413|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3734670|NCT02039115|3571414|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3734671|NCT02039115|3571415|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3734672|NCT02039115|3571413|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3734673|NCT02039115|3571414|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3734674|NCT02039115|3571415|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3734675|NCT02039115|3571413|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3734676|NCT02039115|3571414|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3734677|NCT02039115|3571415|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3734678|NCT02038959|3571422|B3|||Minutes spent with Parkinson disease provider|Time spent with the provider at the participants last appointment was collected in minutes. At baseline this would be the time the participant spent with their provider at their last appointment prior to enrolling in the study.|minutes|Median|30|30.0|Inter-Quartile Range|||20.0|45.0|
3734679|NCT02038959|3571423|B2|||Minutes spent with Parkinson disease provider|Time spent with the provider at the participants last appointment was collected in minutes. At baseline this would be the time the participant spent with their provider at their last appointment prior to enrolling in the study.|minutes|Median|30|30.0|Inter-Quartile Range|||20.0|45.0|
3734680|NCT02038959|3571424|B1|||Minutes spent with Parkinson disease provider|Time spent with the provider at the participants last appointment was collected in minutes. At baseline this would be the time the participant spent with their provider at their last appointment prior to enrolling in the study.|minutes|Median|30|30.0|Inter-Quartile Range|||20.0|45.0|
3734681|NCT02038959|3571422|B3|United States||Region of Enrollment||Participants|Count of Participants|195|195.0||||||
3734682|NCT02038959|3571423|B2|United States||Region of Enrollment||Participants|Count of Participants|97|97.0||||||
3734683|NCT02038959|3571424|B1|United States||Region of Enrollment||Participants|Count of Participants|98|98.0||||||
3734684|NCT02038959|3571422|B3||Male|Gender||Participants|Count of Participants|104|104.0||||||
3734685|NCT02038959|3571423|B2||Male|Gender||Participants|Count of Participants|48|48.0||||||
3734686|NCT02038959|3571424|B1||Male|Gender||Participants|Count of Participants|56|56.0||||||
3734687|NCT02038959|3571422|B3||Female|Gender||Participants|Count of Participants|91|91.0||||||
3734688|NCT02038959|3571423|B2||Female|Gender||Participants|Count of Participants|49|49.0||||||
3734689|NCT02038959|3571424|B1||Female|Gender||Participants|Count of Participants|42|42.0||||||
3734690|NCT02038959|3571422|B3|||Age||years|Mean|66.4|66.4|Standard Deviation|8.1|8.1|||
3734691|NCT02038959|3571423|B2|||Age||years|Mean|65.9|65.9|Standard Deviation|7.8|7.8|||
3734692|NCT02038959|3571424|B1|||Age||years|Mean|66.9|66.9|Standard Deviation|8.5|8.5|||
3734693|NCT02038946|3571451|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3734694|NCT02038946|3571451|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734695|NCT02038946|3571451|B1||White|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3734696|NCT02038946|3571451|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3734697|NCT02038946|3571451|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734698|NCT02038946|3571451|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3734699|NCT02038946|3571451|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734700|NCT02038946|3571451|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3734701|NCT02038946|3571451|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3734702|NCT02038946|3571451|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3734703|NCT02038946|3571451|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3734704|NCT02038946|3571451|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3734705|NCT02038946|3571451|B1|||Age||years|Mean|65.2|65.2|Standard Deviation|10.50|10.5|||
3734706|NCT02038933|3571460|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3734707|NCT02038933|3571461|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734708|NCT02038933|3571462|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3734709|NCT02038933|3571460|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734710|NCT02038933|3571461|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734711|NCT02038933|3571462|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734712|NCT02038933|3571460|B3||White|Race (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
3734713|NCT02038933|3571461|B2||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3734714|NCT02038933|3571462|B1||White|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3734715|NCT02038933|3571460|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3734716|NCT02038933|3571461|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3734717|NCT02038933|3571462|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3734718|NCT02038933|3571460|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734719|NCT02038933|3571461|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734720|NCT02038933|3571462|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734721|NCT02038933|3571460|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3734722|NCT02038933|3571461|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3734723|NCT02038933|3571462|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3734724|NCT02038933|3571460|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734725|NCT02038933|3571461|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734726|NCT02038933|3571462|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734727|NCT02038933|3571460|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3734728|NCT02038933|3571461|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3734729|NCT02038933|3571462|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3734730|NCT02038933|3571460|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3734731|NCT02038933|3571461|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3734732|NCT02038933|3571462|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3734733|NCT02038933|3571460|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3734734|NCT02038933|3571461|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3734735|NCT02038933|3571462|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3734736|NCT02038933|3571460|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3734737|NCT02038933|3571461|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3734738|NCT02038933|3571462|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3734739|NCT02038933|3571460|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3734740|NCT02038933|3571461|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3734741|NCT02038933|3571462|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3734742|NCT02038933|3571460|B3|||Age||years|Mean|61.1|61.1|Standard Deviation|11.96|11.96|||
3734743|NCT02038933|3571461|B2|||Age||years|Mean|66.4|66.4|Standard Deviation|12.98|12.98|||
3734744|NCT02038933|3571462|B1|||Age||years|Mean|59.1|59.1|Standard Deviation|10.94|10.94|||
3734745|NCT02038907|3571481|B15|||Body Mass Index (BMI)||kg/m^2|Median|24.52|24.52|Full Range|||14.9|34.6|
3734746|NCT02038907|3571482|B14|||Body Mass Index (BMI)||kg/m^2|Median|24.54|24.54|Full Range|||17.9|33.5|
3734747|NCT02038907|3571483|B13|||Body Mass Index (BMI)||kg/m^2|Median|23.19|23.19|Full Range|||18.7|33.8|
3734748|NCT02038907|3571484|B12|||Body Mass Index (BMI)||kg/m^2|Median|24.24|24.24|Full Range|||14.9|32.7|
3734749|NCT02038907|3571485|B11|||Body Mass Index (BMI)||kg/m^2|Median|23.66|23.66|Full Range|||18.1|32.3|
3734750|NCT02038907|3571486|B10|||Body Mass Index (BMI)||kg/m^2|Median|25.02|25.02|Full Range|||20.0|34.4|
3734751|NCT02038907|3571487|B9|||Body Mass Index (BMI)||kg/m^2|Median|26.06|26.06|Full Range|||19.0|34.6|
3734752|NCT02038907|3571488|B8|||Body Mass Index (BMI)||kg/m^2|Median|24.06|24.06|Full Range|||17.8|33.2|
3734753|NCT02038907|3571489|B7|||Body Mass Index (BMI)||kg/m^2|Median|24.40|24.4|Full Range|||18.1|33.7|
3734754|NCT02038907|3571490|B6|||Body Mass Index (BMI)||kg/m^2|Median|24.73|24.73|Full Range|||17.6|34.4|
3734755|NCT02038907|3571491|B5|||Body Mass Index (BMI)||kg/m^2|Median|24.51|24.51|Full Range|||18.6|34.2|
3734756|NCT02038907|3571492|B4|||Body Mass Index (BMI)||kg/m^2|Median|23.62|23.62|Full Range|||18.7|33.7|
3734757|NCT02038907|3571493|B3|||Body Mass Index (BMI)||kg/m^2|Median|26.11|26.11|Full Range|||17.3|33.4|
3734758|NCT02038907|3571494|B2|||Body Mass Index (BMI)||kg/m^2|Median|23.97|23.97|Full Range|||18.9|34.2|
3734759|NCT02038907|3571495|B1|||Body Mass Index (BMI)||kg/m^2|Median|25.22|25.22|Full Range|||16.7|33.6|
3734760|NCT02038907|3571481|B15|||Weight||kg|Median|70.8|70.8|Full Range|||42.2|111.8|
3734761|NCT02038907|3571482|B14|||Weight||kg|Median|69.90|69.9|Full Range|||51.0|111.3|
3734762|NCT02038907|3571483|B13|||Weight||kg|Median|70.60|70.6|Full Range|||49.2|111.8|
3734763|NCT02038907|3571484|B12|||Weight||kg|Median|75.50|75.5|Full Range|||42.5|92.5|
3734764|NCT02038907|3571485|B11|||Weight||kg|Median|70.00|70.0|Full Range|||49.6|94.0|
3734765|NCT02038907|3571486|B10|||Weight||kg|Median|69.85|69.85|Full Range|||50.5|92.6|
3734766|NCT02038907|3571487|B9|||Weight||kg|Median|76.00|76.0|Full Range|||54.8|101.2|
3734767|NCT02038907|3571488|B8|||Weight||kg|Median|74.35|74.35|Full Range|||52.0|110.3|
3734768|NCT02038907|3571489|B7|||Weight||kg|Median|72.50|72.5|Full Range|||45.8|104.5|
3734769|NCT02038907|3571490|B6|||Weight||kg|Median|68.50|68.5|Full Range|||44.0|96.0|
3734770|NCT02038907|3571491|B5|||Weight||kg|Median|71.60|71.6|Full Range|||47.6|101.9|
3734771|NCT02038907|3571492|B4|||Weight||kg|Median|66.60|66.6|Full Range|||42.2|103.3|
3734772|NCT02038907|3571493|B3|||Weight||kg|Median|70.60|70.6|Full Range|||50.8|104.0|
3734773|NCT02038907|3571494|B2|||Weight||kg|Median|65.60|65.6|Full Range|||49.1|103.0|
3734774|NCT02038907|3571495|B1|||Weight||kg|Median|69.50|69.5|Full Range|||49.4|105.2|
3734775|NCT02038907|3571481|B15|||Height||cm|Median|170.0|170.0|Full Range|||146.0|199.0|
3734776|NCT02038907|3571482|B14|||Height||cm|Median|175.0|175.0|Full Range|||146.0|192.0|
3734777|NCT02038907|3571483|B13|||Height||cm|Median|170.0|170.0|Full Range|||153.0|187.0|
3734778|NCT02038907|3571484|B12|||Height||cm|Median|171.5|171.5|Full Range|||161.0|192.0|
3734779|NCT02038907|3571485|B11|||Height||cm|Median|172.0|172.0|Full Range|||156.0|199.0|
3734780|NCT02038907|3571486|B10|||Height||cm|Median|167.0|167.0|Full Range|||153.0|186.0|
3734781|NCT02038907|3571487|B9|||Height||cm|Median|171.0|171.0|Full Range|||153.0|193.0|
3734782|NCT02038907|3571488|B8|||Height||cm|Median|169.5|169.5|Full Range|||161.0|192.0|
3734783|NCT02038907|3571489|B7|||Height||cm|Median|173.5|173.5|Full Range|||154.0|189.0|
3734784|NCT02038907|3571490|B6|||Height||cm|Median|169.0|169.0|Full Range|||153.0|190.0|
3734785|NCT02038907|3571491|B5|||Height||cm|Median|171.0|171.0|Full Range|||155.0|186.0|
3734786|NCT02038907|3571492|B4|||Height||cm|Median|167.0|167.0|Full Range|||149.0|187.0|
3734787|NCT02038907|3571493|B3|||Height||cm|Median|166.5|166.5|Full Range|||153.0|191.0|
3734788|NCT02038907|3571494|B2|||Height||cm|Median|167.0|167.0|Full Range|||154.0|193.0|
3734789|NCT02038907|3571495|B1|||Height||cm|Median|173.0|173.0|Full Range|||156.0|187.0|
3734790|NCT02038907|3571481|B15|Belgium||Region of Enrollment||participants|Number|420|420.0||||||
3734791|NCT02038907|3571482|B14|Belgium||Region of Enrollment||participants|Number|31|31.0||||||
3734792|NCT02038907|3571483|B13|Belgium||Region of Enrollment||participants|Number|29|29.0||||||
3734793|NCT02038907|3571484|B12|Belgium||Region of Enrollment||participants|Number|28|28.0||||||
3734794|NCT02038907|3571485|B11|Belgium||Region of Enrollment||participants|Number|29|29.0||||||
3734795|NCT02038907|3571486|B10|Belgium||Region of Enrollment||participants|Number|30|30.0||||||
3734796|NCT02038907|3571487|B9|Belgium||Region of Enrollment||participants|Number|29|29.0||||||
3734797|NCT02038907|3571488|B8|Belgium||Region of Enrollment||participants|Number|32|32.0||||||
3734798|NCT02038907|3571489|B7|Belgium||Region of Enrollment||participants|Number|30|30.0||||||
3734799|NCT02038907|3571490|B6|Belgium||Region of Enrollment||participants|Number|31|31.0||||||
3734800|NCT02038907|3571491|B5|Belgium||Region of Enrollment||participants|Number|30|30.0||||||
3734801|NCT02038907|3571492|B4|Belgium||Region of Enrollment||participants|Number|31|31.0||||||
3734802|NCT02038907|3571493|B3|Belgium||Region of Enrollment||participants|Number|30|30.0||||||
3734803|NCT02038907|3571494|B2|Belgium||Region of Enrollment||participants|Number|30|30.0||||||
3734804|NCT02038907|3571495|B1|Belgium||Region of Enrollment||participants|Number|30|30.0||||||
3734805|NCT02038907|3571481|B15|White||Race/Ethnicity, Customized||participants|Number|414|414.0||||||
3734806|NCT02038907|3571482|B14|White||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3734807|NCT02038907|3571483|B13|White||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3734808|NCT02038907|3571484|B12|White||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3734809|NCT02038907|3571485|B11|White||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3734810|NCT02038907|3571486|B10|White||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3734811|NCT02038907|3571487|B9|White||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3734812|NCT02038907|3571488|B8|White||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3734813|NCT02038907|3571489|B7|White||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3734814|NCT02038907|3571490|B6|White||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3734815|NCT02038907|3571491|B5|White||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3734816|NCT02038907|3571492|B4|White||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3734817|NCT02038907|3571493|B3|White||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3734818|NCT02038907|3571494|B2|White||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3734819|NCT02038907|3571495|B1|White||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3734820|NCT02038907|3571481|B15|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3734821|NCT02038907|3571482|B14|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3734822|NCT02038907|3571483|B13|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3734823|NCT02038907|3571484|B12|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3734824|NCT02038907|3571485|B11|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3734825|NCT02038907|3571486|B10|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3734826|NCT02038907|3571487|B9|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3734827|NCT02038907|3571488|B8|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3734828|NCT02038907|3571489|B7|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3734829|NCT02038907|3571490|B6|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3734830|NCT02038907|3571491|B5|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3734831|NCT02038907|3571492|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3734832|NCT02038907|3571493|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3734833|NCT02038907|3571494|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3734834|NCT02038907|3571495|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3734835|NCT02038907|3571481|B15|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3734836|NCT02038907|3571482|B14|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3734837|NCT02038907|3571483|B13|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3734838|NCT02038907|3571484|B12|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3734839|NCT02038907|3571485|B11|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3734840|NCT02038907|3571486|B10|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3734841|NCT02038907|3571487|B9|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3734842|NCT02038907|3571488|B8|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3734843|NCT02038907|3571489|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3734844|NCT02038907|3571490|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3734845|NCT02038907|3571491|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3734846|NCT02038907|3571492|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3734847|NCT02038907|3571493|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3734848|NCT02038907|3571494|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3734849|NCT02038907|3571495|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3734850|NCT02038907|3571481|B15||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3734851|NCT02038907|3571482|B14||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3734852|NCT02038907|3571483|B13||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3734853|NCT02038907|3571484|B12||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3734854|NCT02038907|3571485|B11||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3734855|NCT02038907|3571486|B10||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3734856|NCT02038907|3571487|B9||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3734857|NCT02038907|3571488|B8||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3734858|NCT02038907|3571489|B7||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3734859|NCT02038907|3571490|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3734860|NCT02038907|3571491|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3734861|NCT02038907|3571492|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3734862|NCT02038907|3571493|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3734863|NCT02038907|3571494|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3734864|NCT02038907|3571495|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3734865|NCT02038907|3571481|B15||Female|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
3734866|NCT02038907|3571482|B14||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3734867|NCT02038907|3571483|B13||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3734868|NCT02038907|3571484|B12||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3734869|NCT02038907|3571485|B11||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3734870|NCT02038907|3571486|B10||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3734871|NCT02038907|3571487|B9||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3734872|NCT02038907|3571488|B8||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3734873|NCT02038907|3571489|B7||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3734874|NCT02038907|3571490|B6||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3734875|NCT02038907|3571491|B5||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3734876|NCT02038907|3571492|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3734877|NCT02038907|3571493|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3734878|NCT02038907|3571494|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3734879|NCT02038907|3571495|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3734880|NCT02038907|3571481|B15|50-64 Years||Age, Customized||participants|Number|210|210.0||||||
3734881|NCT02038907|3571482|B14|50-64 Years||Age, Customized||participants|Number|15|15.0||||||
3734882|NCT02038907|3571483|B13|50-64 Years||Age, Customized||participants|Number|14|14.0||||||
3734883|NCT02038907|3571484|B12|50-64 Years||Age, Customized||participants|Number|14|14.0||||||
3734884|NCT02038907|3571485|B11|50-64 Years||Age, Customized||participants|Number|14|14.0||||||
3734885|NCT02038907|3571486|B10|50-64 Years||Age, Customized||participants|Number|15|15.0||||||
3734886|NCT02038907|3571487|B9|50-64 Years||Age, Customized||participants|Number|14|14.0||||||
3734887|NCT02038907|3571488|B8|50-64 Years||Age, Customized||participants|Number|16|16.0||||||
3734888|NCT02038907|3571489|B7|50-64 Years||Age, Customized||participants|Number|15|15.0||||||
3734889|NCT02038907|3571490|B6|50-64 Years||Age, Customized||participants|Number|16|16.0||||||
3734890|NCT02038907|3571491|B5|50-64 Years||Age, Customized||participants|Number|15|15.0||||||
3734891|NCT02038907|3571492|B4|50-64 Years||Age, Customized||participants|Number|16|16.0||||||
3734892|NCT02038907|3571493|B3|50-64 Years||Age, Customized||participants|Number|15|15.0||||||
3734893|NCT02038907|3571494|B2|50-64 Years||Age, Customized||participants|Number|16|16.0||||||
3734894|NCT02038907|3571495|B1|50-64 Years||Age, Customized||participants|Number|15|15.0||||||
3734895|NCT02038907|3571481|B15|18-49 Years||Age, Customized||participants|Number|210|210.0||||||
3734896|NCT02038907|3571482|B14|18-49 Years||Age, Customized||participants|Number|16|16.0||||||
3734897|NCT02038907|3571483|B13|18-49 Years||Age, Customized||participants|Number|15|15.0||||||
3734898|NCT02038907|3571484|B12|18-49 Years||Age, Customized||participants|Number|14|14.0||||||
3734899|NCT02038907|3571485|B11|18-49 Years||Age, Customized||participants|Number|15|15.0||||||
3734900|NCT02038907|3571486|B10|18-49 Years||Age, Customized||participants|Number|15|15.0||||||
3734901|NCT02038907|3571487|B9|18-49 Years||Age, Customized||participants|Number|15|15.0||||||
3734902|NCT02038907|3571488|B8|18-49 Years||Age, Customized||participants|Number|16|16.0||||||
3734903|NCT02038907|3571489|B7|18-49 Years||Age, Customized||participants|Number|15|15.0||||||
3734904|NCT02038907|3571490|B6|18-49 Years||Age, Customized||participants|Number|15|15.0||||||
3734905|NCT02038907|3571491|B5|18-49 Years||Age, Customized||participants|Number|15|15.0||||||
3734906|NCT02038907|3571492|B4|18-49 Years||Age, Customized||participants|Number|15|15.0||||||
3734907|NCT02038907|3571493|B3|18-49 Years||Age, Customized||participants|Number|15|15.0||||||
3734908|NCT02038907|3571494|B2|18-49 Years||Age, Customized||participants|Number|14|14.0||||||
3734909|NCT02038907|3571495|B1|18-49 Years||Age, Customized||participants|Number|15|15.0||||||
3734910|NCT02038907|3571481|B15|||Age||years|Median|49.5|49.5|Full Range|||18.0|64.0|
3734911|NCT02038907|3571482|B14|||Age||years|Median|44.0|44.0|Full Range|16.11|16.11|19.0|64.0|
3734912|NCT02038907|3571483|B13|||Age||years|Median|48.0|48.0|Full Range|15.06|15.06|22.0|63.0|
3734913|NCT02038907|3571484|B12|||Age||years|Median|48.5|48.5|Full Range|14.05|14.05|23.0|64.0|
3734914|NCT02038907|3571485|B11|||Age||years|Median|49.0|49.0|Full Range|15.41|15.41|21.0|62.0|
3734915|NCT02038907|3571486|B10|||Age||years|Median|51.0|51.0|Full Range|15.26|15.26|20.0|63.0|
3734916|NCT02038907|3571487|B9|||Age||years|Median|41.0|41.0|Full Range|14.82|14.82|21.0|63.0|
3734917|NCT02038907|3571488|B8|||Age||years|Median|48.5|48.5|Full Range|14.13|14.13|18.0|63.0|
3734918|NCT02038907|3571489|B7|||Age||years|Median|49.5|49.5|Full Range|14.19|14.19|18.0|64.0|
3734919|NCT02038907|3571490|B6|||Age||years|Median|50.0|50.0|Full Range|14.39|14.39|20.0|64.0|
3734920|NCT02038907|3571491|B5|||Age||years|Median|49.5|49.5|Full Range|13.79|13.79|20.0|64.0|
3734921|NCT02038907|3571492|B4|||Age||years|Median|50.0|50.0|Full Range|14.95|14.95|20.0|64.0|
3734922|NCT02038907|3571493|B3|||Age||years|Median|50.0|50.0|Full Range|12.95|12.95|22.0|64.0|
3734923|NCT02038907|3571494|B2|||Age||years|Median|51.0|51.0|Full Range|14.36|14.36|20.0|64.0|
3734924|NCT02038907|3571495|B1|||Age||years|Median|50.0|50.0|Full Range|14.70|14.7|19.0|63.0|
3734925|NCT02038829|3572036|B1|United States||Region of Enrollment||Participants|Count of Participants|96|96.0||||||
3734926|NCT02038829|3572036|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734927|NCT02038829|3572036|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734928|NCT02038829|3572036|B1||White|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
3734929|NCT02038829|3572036|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3734930|NCT02038829|3572036|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734931|NCT02038829|3572036|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734932|NCT02038829|3572036|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734933|NCT02038829|3572036|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734934|NCT02038829|3572036|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3734935|NCT02038829|3572036|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734936|NCT02038829|3572036|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3734937|NCT02038829|3572036|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3734938|NCT02038829|3572036|B1|||Age||years|Mean|54.6|54.6|Standard Deviation|5.88|5.88|||
3734939|NCT02038829|3572036|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3734940|NCT02038829|3572036|B1||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
3734941|NCT02038829|3572036|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3734942|NCT02038790|3572081|B1|White||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
3734943|NCT02038790|3572081|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3734944|NCT02038790|3572081|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3734945|NCT02038790|3572081|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3734946|NCT02038790|3572081|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3734947|NCT02038790|3572081|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3734948|NCT02038790|3572081|B1|||Age||years|Mean|38|38.0|Standard Deviation|13|13.0|||
3734949|NCT02038764|3572113|B6||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3734950|NCT02038764|3572114|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3734951|NCT02038764|3572115|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3734952|NCT02038764|3572116|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3734953|NCT02038764|3572117|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3734954|NCT02038764|3572118|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3734955|NCT02038764|3572113|B6||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3734956|NCT02038764|3572114|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3734957|NCT02038764|3572115|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3734958|NCT02038764|3572116|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3734959|NCT02038764|3572117|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3734960|NCT02038764|3572118|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3734961|NCT02038764|3572113|B6|||Age||years|Mean|31.7|31.7|Standard Deviation|11.8|11.8|||
3734962|NCT02038764|3572114|B5|||Age||years|Mean|30.8|30.8|Standard Deviation|7.7|7.7|||
3734963|NCT02038764|3572115|B4|||Age||years|Mean|29|29.0|Standard Deviation|12.3|12.3|||
3734964|NCT02038764|3572116|B3|||Age||years|Mean|37.8|37.8|Standard Deviation|15.8|15.8|||
3734965|NCT02038764|3572117|B2|||Age||years|Mean|25.6|25.6|Standard Deviation|8.5|8.5|||
3734966|NCT02038764|3572118|B1|||Age||years|Mean|33.9|33.9|Standard Deviation|11.1|11.1|||
3734967|NCT02038647|3572222|B3|||Body Surface Area|Body surface area=square root of (height [cm]*weight [kg]/3600).|m^2|Mean|1.891|1.891|Standard Deviation|0.2637|0.2637|||
3734968|NCT02038647|3572223|B2|||Body Surface Area|Body surface area=square root of (height [cm]*weight [kg]/3600).|m^2|Mean|1.872|1.872|Standard Deviation|0.2433|0.2433|||
3734969|NCT02038647|3572224|B1|||Body Surface Area|Body surface area=square root of (height [cm]*weight [kg]/3600).|m^2|Mean|1.911|1.911|Standard Deviation|0.2829|0.2829|||
3734970|NCT02038647|3572222|B3|||Weight||kg|Mean|76.87|76.87|Standard Deviation|19.153|19.153|||
3734971|NCT02038647|3572223|B2|||Weight||kg|Mean|75.26|75.26|Standard Deviation|17.602|17.602|||
3734972|NCT02038647|3572224|B1|||Weight||kg|Mean|78.47|78.47|Standard Deviation|20.561|20.561|||
3734973|NCT02038647|3572222|B3|||Height||cm|Mean|169.2|169.2|Standard Deviation|9.96|9.96|||
3734974|NCT02038647|3572223|B2|||Height||cm|Mean|168.8|168.8|Standard Deviation|9.52|9.52|||
3734975|NCT02038647|3572224|B1|||Height||cm|Mean|169.5|169.5|Standard Deviation|10.43|10.43|||
3734976|NCT02038647|3572222|B3|United States||Region of Enrollment||participants|Number|70|70.0||||||
3734977|NCT02038647|3572223|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
3734978|NCT02038647|3572224|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3734979|NCT02038647|3572222|B3|Canada||Region of Enrollment||participants|Number|12|12.0||||||
3734980|NCT02038647|3572223|B2|Canada||Region of Enrollment||participants|Number|6|6.0||||||
3734981|NCT02038647|3572224|B1|Canada||Region of Enrollment||participants|Number|6|6.0||||||
3734982|NCT02038647|3572222|B3|Spain||Region of Enrollment||participants|Number|17|17.0||||||
3734983|NCT02038647|3572223|B2|Spain||Region of Enrollment||participants|Number|11|11.0||||||
3734984|NCT02038647|3572224|B1|Spain||Region of Enrollment||participants|Number|6|6.0||||||
3734985|NCT02038647|3572222|B3|Poland||Region of Enrollment||participants|Number|4|4.0||||||
3734986|NCT02038647|3572223|B2|Poland||Region of Enrollment||participants|Number|3|3.0||||||
3734987|NCT02038647|3572224|B1|Poland||Region of Enrollment||participants|Number|1|1.0||||||
3734988|NCT02038647|3572222|B3|Italy||Region of Enrollment||participants|Number|2|2.0||||||
3734989|NCT02038647|3572223|B2|Italy||Region of Enrollment||participants|Number|0|0.0||||||
3734990|NCT02038647|3572224|B1|Italy||Region of Enrollment||participants|Number|2|2.0||||||
3734991|NCT02038647|3572222|B3|Hungary||Region of Enrollment||participants|Number|31|31.0||||||
3734992|NCT02038647|3572223|B2|Hungary||Region of Enrollment||participants|Number|15|15.0||||||
3734993|NCT02038647|3572224|B1|Hungary||Region of Enrollment||participants|Number|16|16.0||||||
3734994|NCT02038647|3572222|B3|Germany||Region of Enrollment||participants|Number|3|3.0||||||
3734995|NCT02038647|3572223|B2|Germany||Region of Enrollment||participants|Number|1|1.0||||||
3734996|NCT02038647|3572224|B1|Germany||Region of Enrollment||participants|Number|2|2.0||||||
3734997|NCT02038647|3572222|B3|France||Region of Enrollment||participants|Number|12|12.0||||||
3734998|NCT02038647|3572223|B2|France||Region of Enrollment||participants|Number|5|5.0||||||
3734999|NCT02038647|3572224|B1|France||Region of Enrollment||participants|Number|7|7.0||||||
3735000|NCT02038647|3572222|B3|Czech Republic||Region of Enrollment||participants|Number|11|11.0||||||
3735001|NCT02038647|3572223|B2|Czech Republic||Region of Enrollment||participants|Number|5|5.0||||||
3735002|NCT02038647|3572224|B1|Czech Republic||Region of Enrollment||participants|Number|6|6.0||||||
3735003|NCT02038647|3572222|B3|Belgium||Region of Enrollment||participants|Number|16|16.0||||||
3735004|NCT02038647|3572223|B2|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
3735005|NCT02038647|3572224|B1|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
3735006|NCT02038647|3572222|B3|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3735007|NCT02038647|3572223|B2|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3735008|NCT02038647|3572224|B1|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3735009|NCT02038647|3572222|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3735010|NCT02038647|3572223|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3735011|NCT02038647|3572224|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3735012|NCT02038647|3572222|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3735013|NCT02038647|3572223|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3735014|NCT02038647|3572224|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3735015|NCT02038647|3572222|B3|Not reported||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3735016|NCT02038647|3572223|B2|Not reported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3735017|NCT02038647|3572224|B1|Not reported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3735018|NCT02038647|3572222|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3735019|NCT02038647|3572223|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3735020|NCT02038647|3572224|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3735021|NCT02038647|3572222|B3|White||Race/Ethnicity, Customized||participants|Number|166|166.0||||||
3735022|NCT02038647|3572223|B2|White||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
3735023|NCT02038647|3572224|B1|White||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
3735024|NCT02038647|3572222|B3|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3735025|NCT02038647|3572223|B2|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3735026|NCT02038647|3572224|B1|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3735027|NCT02038647|3572222|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3735028|NCT02038647|3572223|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3735029|NCT02038647|3572224|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3735030|NCT02038647|3572222|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|165|165.0||||||
3735031|NCT02038647|3572223|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|84|84.0||||||
3735032|NCT02038647|3572224|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
3735033|NCT02038647|3572222|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3735034|NCT02038647|3572223|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3735035|NCT02038647|3572224|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3735036|NCT02038647|3572222|B3||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3735037|NCT02038647|3572223|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3735038|NCT02038647|3572224|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3735039|NCT02038647|3572222|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3735040|NCT02038647|3572223|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3735041|NCT02038647|3572224|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3735042|NCT02038647|3572222|B3|||Age||years|Mean|62.6|62.6|Standard Deviation|8.57|8.57|||
3735043|NCT02038647|3572223|B2|||Age||years|Mean|63.4|63.4|Standard Deviation|8.56|8.56|||
3735044|NCT02038647|3572224|B1|||Age||years|Mean|61.8|61.8|Standard Deviation|8.55|8.55|||
3735045|NCT02038569|3572257|B1|Severe||Patient's global assessment of disease severity on body||Participants|Count of Participants|4|4.0||||||
3735046|NCT02038569|3572257|B1|Moderate||Patient's global assessment of disease severity on body||Participants|Count of Participants|77|77.0||||||
3735047|NCT02038569|3572257|B1|Mild||Patient's global assessment of disease severity on body||Participants|Count of Participants|21|21.0||||||
3735048|NCT02038569|3572257|B1|Very Mild||Patient's global assessment of disease severity on body||Participants|Count of Participants|5|5.0||||||
3735049|NCT02038569|3572257|B1|||Investigator’s assessment of extent of psoriasis on the body and scalp (%)||% of body surface area affected|Mean|14.9|14.9|Standard Deviation|8.3|8.3|||
3735050|NCT02038569|3572257|B1|||Psoriasis Area and Severity Index Score|Psoriasis area and severity index (PASI) assesses extent and severity of clinical signs of psoriasis vulgaris. Body surface is divided in 4 ares: head (incl. neck), arms (incl. hands), trunk (incl. flexures) and legs (incl. buttocks and feet). Each area is scored from 0-6 for extent of psoriasis and from 0-4 for redness, thickness, and scaliness, and an area PASI score is calculated. The total PASI score is calculated from each area's score. The PASI score ranges from 0 (clear skin) to 72 (maximum disease), a PASI score higher than 10 generally corresponds to moderate-to-severe disease.|score on a scale|Mean|10.70|10.7|Standard Deviation|4.41|4.41|||
3735051|NCT02038569|3572257|B1|Severe||Investigator’s global assessment of disease severity on body||Participants|Count of Participants|6|6.0||||||
3735052|NCT02038569|3572257|B1|Moderate||Investigator’s global assessment of disease severity on body||Participants|Count of Participants|87|87.0||||||
3735053|NCT02038569|3572257|B1|Mild||Investigator’s global assessment of disease severity on body||Participants|Count of Participants|14|14.0||||||
3735054|NCT02038569|3572257|B1|||Duration of psoriasis vulgaris||years|Mean|4.1|4.1|Standard Deviation|3.2|3.2|||
3735055|NCT02038569|3572257|B1|Type VI||Fitzpatrick Skin Type|"Fitzpatrick skin type is based on skin reaction to first 30-45 minutes sun exposure after a winter with no sun exposure:~Type I: Unexposed skin color: white, always burns easily, never tans. Type II: Unexposed skin color: white, always burns easily, tans minimally. Type III: Unexposed skin color: white, burns moderately, tans gradually (light brown).~Type IV: Unexposed skin color: white, burns minimally, always tans well (moderate brown).~Type V: Unexposed skin color: brown, rarely burns, tans profusely (dark brown). Type VI: Unexposed skin color: black, never burns, deeply pigmented."|Participants|Count of Participants|2|2.0||||||
3735056|NCT02038569|3572257|B1|Type V||Fitzpatrick Skin Type|"Fitzpatrick skin type is based on skin reaction to first 30-45 minutes sun exposure after a winter with no sun exposure:~Type I: Unexposed skin color: white, always burns easily, never tans. Type II: Unexposed skin color: white, always burns easily, tans minimally. Type III: Unexposed skin color: white, burns moderately, tans gradually (light brown).~Type IV: Unexposed skin color: white, burns minimally, always tans well (moderate brown).~Type V: Unexposed skin color: brown, rarely burns, tans profusely (dark brown). Type VI: Unexposed skin color: black, never burns, deeply pigmented."|Participants|Count of Participants|2|2.0||||||
3735057|NCT02038569|3572257|B1|Type IV||Fitzpatrick Skin Type|"Fitzpatrick skin type is based on skin reaction to first 30-45 minutes sun exposure after a winter with no sun exposure:~Type I: Unexposed skin color: white, always burns easily, never tans. Type II: Unexposed skin color: white, always burns easily, tans minimally. Type III: Unexposed skin color: white, burns moderately, tans gradually (light brown).~Type IV: Unexposed skin color: white, burns minimally, always tans well (moderate brown).~Type V: Unexposed skin color: brown, rarely burns, tans profusely (dark brown). Type VI: Unexposed skin color: black, never burns, deeply pigmented."|Participants|Count of Participants|20|20.0||||||
3735058|NCT02038569|3572257|B1|Type III||Fitzpatrick Skin Type|"Fitzpatrick skin type is based on skin reaction to first 30-45 minutes sun exposure after a winter with no sun exposure:~Type I: Unexposed skin color: white, always burns easily, never tans. Type II: Unexposed skin color: white, always burns easily, tans minimally. Type III: Unexposed skin color: white, burns moderately, tans gradually (light brown).~Type IV: Unexposed skin color: white, burns minimally, always tans well (moderate brown).~Type V: Unexposed skin color: brown, rarely burns, tans profusely (dark brown). Type VI: Unexposed skin color: black, never burns, deeply pigmented."|Participants|Count of Participants|34|34.0||||||
3735059|NCT02038569|3572257|B1|Type II||Fitzpatrick Skin Type|"Fitzpatrick skin type is based on skin reaction to first 30-45 minutes sun exposure after a winter with no sun exposure:~Type I: Unexposed skin color: white, always burns easily, never tans. Type II: Unexposed skin color: white, always burns easily, tans minimally. Type III: Unexposed skin color: white, burns moderately, tans gradually (light brown).~Type IV: Unexposed skin color: white, burns minimally, always tans well (moderate brown).~Type V: Unexposed skin color: brown, rarely burns, tans profusely (dark brown). Type VI: Unexposed skin color: black, never burns, deeply pigmented."|Participants|Count of Participants|47|47.0||||||
3735060|NCT02038569|3572257|B1|Type I||Fitzpatrick Skin Type|"Fitzpatrick skin type is based on skin reaction to first 30-45 minutes sun exposure after a winter with no sun exposure:~Type I: Unexposed skin color: white, always burns easily, never tans. Type II: Unexposed skin color: white, always burns easily, tans minimally. Type III: Unexposed skin color: white, burns moderately, tans gradually (light brown).~Type IV: Unexposed skin color: white, burns minimally, always tans well (moderate brown).~Type V: Unexposed skin color: brown, rarely burns, tans profusely (dark brown). Type VI: Unexposed skin color: black, never burns, deeply pigmented."|Participants|Count of Participants|2|2.0||||||
3735061|NCT02038569|3572257|B1|Germany||Region of Enrollment||participants|Number|20|20.0||||||
3735062|NCT02038569|3572257|B1|France||Region of Enrollment||participants|Number|5|5.0||||||
3735063|NCT02038569|3572257|B1|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3735064|NCT02038569|3572257|B1|Poland||Region of Enrollment||participants|Number|14|14.0||||||
3735065|NCT02038569|3572257|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3735066|NCT02038569|3572257|B1|Romania||Region of Enrollment||participants|Number|42|42.0||||||
3735067|NCT02038569|3572257|B1|Canada||Region of Enrollment||participants|Number|6|6.0||||||
3735068|NCT02038569|3572257|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3735069|NCT02038569|3572257|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3735070|NCT02038569|3572257|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3735071|NCT02038569|3572257|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|97|97.0||||||
3735072|NCT02038569|3572257|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735073|NCT02038569|3572257|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3735074|NCT02038569|3572257|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3735075|NCT02038569|3572257|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3735076|NCT02038569|3572257|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3735077|NCT02038569|3572257|B1|||Age||years|Mean|14.2|14.2|Standard Deviation|1.4|1.4|||
3735078|NCT02038543|3572284|B5|United States||Region of Enrollment||participants|Number|22|22.0||||||
3735079|NCT02038543|3572285|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
3735080|NCT02038543|3572286|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3735081|NCT02038543|3572287|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3735082|NCT02038543|3572288|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3735083|NCT02038543|3572284|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3735084|NCT02038543|3572285|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3735085|NCT02038543|3572286|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3735086|NCT02038543|3572287|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3735087|NCT02038543|3572288|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3735088|NCT02038543|3572284|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3735089|NCT02038543|3572285|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3735090|NCT02038543|3572286|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3735091|NCT02038543|3572287|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3735092|NCT02038543|3572288|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3735093|NCT02038543|3572284|B5||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3735094|NCT02038543|3572285|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3735095|NCT02038543|3572286|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3735096|NCT02038543|3572287|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3735097|NCT02038543|3572288|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3735098|NCT02038543|3572284|B5||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3735099|NCT02038543|3572285|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3735100|NCT02038543|3572286|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3735101|NCT02038543|3572287|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3735102|NCT02038543|3572288|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3735103|NCT02038543|3572284|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3735104|NCT02038543|3572285|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3735105|NCT02038543|3572286|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3735106|NCT02038543|3572287|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3735107|NCT02038543|3572288|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3735108|NCT02038075|3572305|B3|||PTSD Checklist, Military Version|The intensity of posttraumatic stress symptoms during the past month was measured using the 17-item self-report PTSD Checklist, Military Version. Scores range from 17 to 85, with higher scores indicating more severe PTSD symptoms.|units on a scale|Mean|56.27|56.27|Standard Deviation|16.89|16.89|||
3735109|NCT02038075|3572306|B2|||PTSD Checklist, Military Version|The intensity of posttraumatic stress symptoms during the past month was measured using the 17-item self-report PTSD Checklist, Military Version. Scores range from 17 to 85, with higher scores indicating more severe PTSD symptoms.|units on a scale|Mean|57.39|57.39|Standard Deviation|15.63|15.63|||
3735110|NCT02038075|3572307|B1|||PTSD Checklist, Military Version|The intensity of posttraumatic stress symptoms during the past month was measured using the 17-item self-report PTSD Checklist, Military Version. Scores range from 17 to 85, with higher scores indicating more severe PTSD symptoms.|units on a scale|Mean|55.15|55.15|Standard Deviation|18.10|18.1|||
3735111|NCT02038075|3572305|B3|||Beck Anxiety Inventory|The intensity of physiological anxiety symptoms was measured using the 20-item self-report Beck Anxiety Inventory. Scores range from 0 to 60, with higher scores indicating more severe anxiety.|units on a scale|Mean|29.30|29.3|Standard Deviation|14.33|14.33|||
3735112|NCT02038075|3572306|B2|||Beck Anxiety Inventory|The intensity of physiological anxiety symptoms was measured using the 20-item self-report Beck Anxiety Inventory. Scores range from 0 to 60, with higher scores indicating more severe anxiety.|units on a scale|Mean|29.74|29.74|Standard Deviation|13.96|13.96|||
3735113|NCT02038075|3572307|B1|||Beck Anxiety Inventory|The intensity of physiological anxiety symptoms was measured using the 20-item self-report Beck Anxiety Inventory. Scores range from 0 to 60, with higher scores indicating more severe anxiety.|units on a scale|Mean|28.87|28.87|Standard Deviation|14.78|14.78|||
3735114|NCT02038075|3572305|B3|||Beck Depression Inventory, 2nd Edition|The intensity of depression symptoms was measured using the 21-item self-report Beck Depression Inventory, Second Edition. Scores range from 0 to 63, with higher scores indicating more severe depression.|units on a scale|Mean|32.73|32.73|Standard Deviation|13.81|13.81|||
3735115|NCT02038075|3572306|B2|||Beck Depression Inventory, 2nd Edition|The intensity of depression symptoms was measured using the 21-item self-report Beck Depression Inventory, Second Edition. Scores range from 0 to 63, with higher scores indicating more severe depression.|units on a scale|Mean|33.51|33.51|Standard Deviation|13.39|13.39|||
3735116|NCT02038075|3572307|B1|||Beck Depression Inventory, 2nd Edition|The intensity of depression symptoms was measured using the 21-item self-report Beck Depression Inventory, Second Edition. Scores range from 0 to 63, with higher scores indicating more severe depression.|units on a scale|Mean|31.95|31.95|Standard Deviation|14.26|14.26|||
3735117|NCT02038075|3572305|B3|||Beck Hopelessness Scale|The intensity of hopelessness was measured using the 20-item self-report Beck Hopelessness Scale. Scores range from 0 to 20, with higher scores indicating more severe hopelessness.|units on a scale|Mean|12.80|12.8|Standard Deviation|6.05|6.05|||
3735118|NCT02038075|3572306|B2|||Beck Hopelessness Scale|The intensity of hopelessness was measured using the 20-item self-report Beck Hopelessness Scale. Scores range from 0 to 20, with higher scores indicating more severe hopelessness.|units on a scale|Mean|12.72|12.72|Standard Deviation|6.02|6.02|||
3735119|NCT02038075|3572307|B1|||Beck Hopelessness Scale|The intensity of hopelessness was measured using the 20-item self-report Beck Hopelessness Scale. Scores range from 0 to 20, with higher scores indicating more severe hopelessness.|units on a scale|Mean|12.87|12.87|Standard Deviation|6.12|6.12|||
3735120|NCT02038075|3572305|B3|||Beck Scale for Suicide Ideation, Worst|The intensity of the most severe suicidal ideation since the last assessment period was measured using the 19-item self-report Beck Scale for Suicide Ideation, Worst. Scores range from 0 to 38, with higher scores indicating more severe thoughts and plans about suicide.|units on a scale|Mean|19.11|19.11|Standard Deviation|8.97|8.97|||
3735121|NCT02038075|3572306|B2|||Beck Scale for Suicide Ideation, Worst|The intensity of the most severe suicidal ideation since the last assessment period was measured using the 19-item self-report Beck Scale for Suicide Ideation, Worst. Scores range from 0 to 38, with higher scores indicating more severe thoughts and plans about suicide.|units on a scale|Mean|19.07|19.07|Standard Deviation|8.69|8.69|||
3735122|NCT02038075|3572307|B1|||Beck Scale for Suicide Ideation, Worst|The intensity of the most severe suicidal ideation since the last assessment period was measured using the 19-item self-report Beck Scale for Suicide Ideation, Worst. Scores range from 0 to 38, with higher scores indicating more severe thoughts and plans about suicide.|units on a scale|Mean|19.16|19.16|Standard Deviation|9.30|9.3|||
3735123|NCT02038075|3572305|B3|||Beck Scale for Suicide Ideation, Current|The intensity of current (i.e., past week) suicidal ideation was measured using the 19-item self-report Beck Scale for Suicide Ideation. Scores range from 0 to 38, with higher scores indicating more severe thoughts and plans about suicide.|units on a scale|Mean|10.95|10.95|Standard Deviation|8.53|8.53|||
3735124|NCT02038075|3572306|B2|||Beck Scale for Suicide Ideation, Current|The intensity of current (i.e., past week) suicidal ideation was measured using the 19-item self-report Beck Scale for Suicide Ideation. Scores range from 0 to 38, with higher scores indicating more severe thoughts and plans about suicide.|units on a scale|Mean|11.07|11.07|Standard Deviation|8.43|8.43|||
3735125|NCT02038075|3572307|B1|||Beck Scale for Suicide Ideation, Current|The intensity of current (i.e., past week) suicidal ideation was measured using the 19-item self-report Beck Scale for Suicide Ideation. Scores range from 0 to 38, with higher scores indicating more severe thoughts and plans about suicide.|units on a scale|Mean|10.83|10.83|Standard Deviation|8.67|8.67|||
3735126|NCT02038075|3572305|B3|Other||Medications|Based on self-report and medical record review|participants|Number|34|34.0||||||
3735127|NCT02038075|3572306|B2|Other||Medications|Based on self-report and medical record review|participants|Number|18|18.0||||||
3735128|NCT02038075|3572307|B1|Other||Medications|Based on self-report and medical record review|participants|Number|16|16.0||||||
3735129|NCT02038075|3572305|B3|Stimulant||Medications|Based on self-report and medical record review|participants|Number|5|5.0||||||
3735130|NCT02038075|3572306|B2|Stimulant||Medications|Based on self-report and medical record review|participants|Number|3|3.0||||||
3735131|NCT02038075|3572307|B1|Stimulant||Medications|Based on self-report and medical record review|participants|Number|2|2.0||||||
3735132|NCT02038075|3572305|B3|Sleep/hypnotic||Medications|Based on self-report and medical record review|participants|Number|26|26.0||||||
3735133|NCT02038075|3572306|B2|Sleep/hypnotic||Medications|Based on self-report and medical record review|participants|Number|14|14.0||||||
3735134|NCT02038075|3572307|B1|Sleep/hypnotic||Medications|Based on self-report and medical record review|participants|Number|12|12.0||||||
3735135|NCT02038075|3572305|B3|Opioid antagonis||Medications|Based on self-report and medical record review|participants|Number|4|4.0||||||
3735136|NCT02038075|3572306|B2|Opioid antagonis||Medications|Based on self-report and medical record review|participants|Number|1|1.0||||||
3735137|NCT02038075|3572307|B1|Opioid antagonis||Medications|Based on self-report and medical record review|participants|Number|3|3.0||||||
3735138|NCT02038075|3572305|B3|Opioid||Medications|Based on self-report and medical record review|participants|Number|13|13.0||||||
3735139|NCT02038075|3572306|B2|Opioid||Medications|Based on self-report and medical record review|participants|Number|7|7.0||||||
3735140|NCT02038075|3572307|B1|Opioid||Medications|Based on self-report and medical record review|participants|Number|6|6.0||||||
3735141|NCT02038075|3572305|B3|Muscle relaxer||Medications|Based on self-report and medical record review|participants|Number|8|8.0||||||
3735142|NCT02038075|3572306|B2|Muscle relaxer||Medications|Based on self-report and medical record review|participants|Number|2|2.0||||||
3735143|NCT02038075|3572307|B1|Muscle relaxer||Medications|Based on self-report and medical record review|participants|Number|6|6.0||||||
3735144|NCT02038075|3572305|B3|Benzodiazepine||Medications|Based on self-report and medical record review|participants|Number|18|18.0||||||
3735145|NCT02038075|3572306|B2|Benzodiazepine||Medications|Based on self-report and medical record review|participants|Number|12|12.0||||||
3735146|NCT02038075|3572307|B1|Benzodiazepine||Medications|Based on self-report and medical record review|participants|Number|6|6.0||||||
3735147|NCT02038075|3572305|B3|Anxiolytic||Medications|Based on self-report and medical record review|participants|Number|5|5.0||||||
3735148|NCT02038075|3572306|B2|Anxiolytic||Medications|Based on self-report and medical record review|participants|Number|2|2.0||||||
3735149|NCT02038075|3572307|B1|Anxiolytic||Medications|Based on self-report and medical record review|participants|Number|3|3.0||||||
3735150|NCT02038075|3572305|B3|Antipsychotic||Medications|Based on self-report and medical record review|participants|Number|23|23.0||||||
3735151|NCT02038075|3572306|B2|Antipsychotic||Medications|Based on self-report and medical record review|participants|Number|13|13.0||||||
3735152|NCT02038075|3572307|B1|Antipsychotic||Medications|Based on self-report and medical record review|participants|Number|10|10.0||||||
3735153|NCT02038075|3572305|B3|Antihypertensive||Medications|Based on self-report and medical record review|participants|Number|27|27.0||||||
3735154|NCT02038075|3572306|B2|Antihypertensive||Medications|Based on self-report and medical record review|participants|Number|16|16.0||||||
3735155|NCT02038075|3572307|B1|Antihypertensive||Medications|Based on self-report and medical record review|participants|Number|11|11.0||||||
3735156|NCT02038075|3572305|B3|Anticonvulsant||Medications|Based on self-report and medical record review|participants|Number|14|14.0||||||
3735157|NCT02038075|3572306|B2|Anticonvulsant||Medications|Based on self-report and medical record review|participants|Number|5|5.0||||||
3735158|NCT02038075|3572307|B1|Anticonvulsant||Medications|Based on self-report and medical record review|participants|Number|9|9.0||||||
3735159|NCT02038075|3572305|B3|Antidepressant||Medications|Based on self-report and medical record review|participants|Number|94|94.0||||||
3735160|NCT02038075|3572306|B2|Antidepressant||Medications|Based on self-report and medical record review|participants|Number|47|47.0||||||
3735161|NCT02038075|3572307|B1|Antidepressant||Medications|Based on self-report and medical record review|participants|Number|47|47.0||||||
3735162|NCT02038075|3572305|B3|Antisocial personality||Psychiatric diagnosis (SCID)|Only includes diagnoses occurring in 5% or greater of participants in at least one treatment arm. Determined using Structured Clinical Interview for DSM-IV, Axis I and Axis II.|participants|Number|8|8.0||||||
3735163|NCT02038075|3572306|B2|Antisocial personality||Psychiatric diagnosis (SCID)|Only includes diagnoses occurring in 5% or greater of participants in at least one treatment arm. Determined using Structured Clinical Interview for DSM-IV, Axis I and Axis II.|participants|Number|3|3.0||||||
3735164|NCT02038075|3572307|B1|Antisocial personality||Psychiatric diagnosis (SCID)|Only includes diagnoses occurring in 5% or greater of participants in at least one treatment arm. Determined using Structured Clinical Interview for DSM-IV, Axis I and Axis II.|participants|Number|5|5.0||||||
3735165|NCT02038075|3572305|B3|Borderline personality||Psychiatric diagnosis (SCID)|Only includes diagnoses occurring in 5% or greater of participants in at least one treatment arm. Determined using Structured Clinical Interview for DSM-IV, Axis I and Axis II.|participants|Number|15|15.0||||||
3735166|NCT02038075|3572306|B2|Borderline personality||Psychiatric diagnosis (SCID)|Only includes diagnoses occurring in 5% or greater of participants in at least one treatment arm. Determined using Structured Clinical Interview for DSM-IV, Axis I and Axis II.|participants|Number|8|8.0||||||
3735167|NCT02038075|3572307|B1|Borderline personality||Psychiatric diagnosis (SCID)|Only includes diagnoses occurring in 5% or greater of participants in at least one treatment arm. Determined using Structured Clinical Interview for DSM-IV, Axis I and Axis II.|participants|Number|7|7.0||||||
3735168|NCT02038075|3572305|B3|Depressive personality||Psychiatric diagnosis (SCID)|Only includes diagnoses occurring in 5% or greater of participants in at least one treatment arm. Determined using Structured Clinical Interview for DSM-IV, Axis I and Axis II.|participants|Number|14|14.0||||||
3735169|NCT02038075|3572306|B2|Depressive personality||Psychiatric diagnosis (SCID)|Only includes diagnoses occurring in 5% or greater of participants in at least one treatment arm. Determined using Structured Clinical Interview for DSM-IV, Axis I and Axis II.|participants|Number|5|5.0||||||
3735170|NCT02038075|3572307|B1|Depressive personality||Psychiatric diagnosis (SCID)|Only includes diagnoses occurring in 5% or greater of participants in at least one treatment arm. Determined using Structured Clinical Interview for DSM-IV, Axis I and Axis II.|participants|Number|9|9.0||||||
3735171|NCT02038075|3572305|B3|Anxiety||Psychiatric diagnosis (SCID)|Only includes diagnoses occurring in 5% or greater of participants in at least one treatment arm. Determined using Structured Clinical Interview for DSM-IV, Axis I and Axis II.|participants|Number|6|6.0||||||
3735172|NCT02038075|3572306|B2|Anxiety||Psychiatric diagnosis (SCID)|Only includes diagnoses occurring in 5% or greater of participants in at least one treatment arm. Determined using Structured Clinical Interview for DSM-IV, Axis I and Axis II.|participants|Number|2|2.0||||||
3735209|NCT02038075|3572307|B1|None||Deployment history||participants|Number|18|18.0||||||
3735173|NCT02038075|3572307|B1|Anxiety||Psychiatric diagnosis (SCID)|Only includes diagnoses occurring in 5% or greater of participants in at least one treatment arm. Determined using Structured Clinical Interview for DSM-IV, Axis I and Axis II.|participants|Number|4|4.0||||||
3735174|NCT02038075|3572305|B3|Panic||Psychiatric diagnosis (SCID)|Only includes diagnoses occurring in 5% or greater of participants in at least one treatment arm. Determined using Structured Clinical Interview for DSM-IV, Axis I and Axis II.|participants|Number|7|7.0||||||
3735175|NCT02038075|3572306|B2|Panic||Psychiatric diagnosis (SCID)|Only includes diagnoses occurring in 5% or greater of participants in at least one treatment arm. Determined using Structured Clinical Interview for DSM-IV, Axis I and Axis II.|participants|Number|3|3.0||||||
3735176|NCT02038075|3572307|B1|Panic||Psychiatric diagnosis (SCID)|Only includes diagnoses occurring in 5% or greater of participants in at least one treatment arm. Determined using Structured Clinical Interview for DSM-IV, Axis I and Axis II.|participants|Number|4|4.0||||||
3735177|NCT02038075|3572305|B3|Social phobia||Psychiatric diagnosis (SCID)|Only includes diagnoses occurring in 5% or greater of participants in at least one treatment arm. Determined using Structured Clinical Interview for DSM-IV, Axis I and Axis II.|participants|Number|12|12.0||||||
3735178|NCT02038075|3572306|B2|Social phobia||Psychiatric diagnosis (SCID)|Only includes diagnoses occurring in 5% or greater of participants in at least one treatment arm. Determined using Structured Clinical Interview for DSM-IV, Axis I and Axis II.|participants|Number|5|5.0||||||
3735179|NCT02038075|3572307|B1|Social phobia||Psychiatric diagnosis (SCID)|Only includes diagnoses occurring in 5% or greater of participants in at least one treatment arm. Determined using Structured Clinical Interview for DSM-IV, Axis I and Axis II.|participants|Number|7|7.0||||||
3735180|NCT02038075|3572305|B3|Alcohol dependence||Psychiatric diagnosis (SCID)|Only includes diagnoses occurring in 5% or greater of participants in at least one treatment arm. Determined using Structured Clinical Interview for DSM-IV, Axis I and Axis II.|participants|Number|18|18.0||||||
3735181|NCT02038075|3572306|B2|Alcohol dependence||Psychiatric diagnosis (SCID)|Only includes diagnoses occurring in 5% or greater of participants in at least one treatment arm. Determined using Structured Clinical Interview for DSM-IV, Axis I and Axis II.|participants|Number|7|7.0||||||
3735182|NCT02038075|3572307|B1|Alcohol dependence||Psychiatric diagnosis (SCID)|Only includes diagnoses occurring in 5% or greater of participants in at least one treatment arm. Determined using Structured Clinical Interview for DSM-IV, Axis I and Axis II.|participants|Number|11|11.0||||||
3735183|NCT02038075|3572305|B3|Substance dependence||Psychiatric diagnosis (SCID)|Only includes diagnoses occurring in 5% or greater of participants in at least one treatment arm. Determined using Structured Clinical Interview for DSM-IV, Axis I and Axis II.|participants|Number|20|20.0||||||
3735184|NCT02038075|3572306|B2|Substance dependence||Psychiatric diagnosis (SCID)|Only includes diagnoses occurring in 5% or greater of participants in at least one treatment arm. Determined using Structured Clinical Interview for DSM-IV, Axis I and Axis II.|participants|Number|7|7.0||||||
3735185|NCT02038075|3572307|B1|Substance dependence||Psychiatric diagnosis (SCID)|Only includes diagnoses occurring in 5% or greater of participants in at least one treatment arm. Determined using Structured Clinical Interview for DSM-IV, Axis I and Axis II.|participants|Number|13|13.0||||||
3735186|NCT02038075|3572305|B3|Posttraumatic stress||Psychiatric diagnosis (SCID)|Only includes diagnoses occurring in 5% or greater of participants in at least one treatment arm. Determined using Structured Clinical Interview for DSM-IV, Axis I and Axis II.|participants|Number|60|60.0||||||
3735187|NCT02038075|3572306|B2|Posttraumatic stress||Psychiatric diagnosis (SCID)|Only includes diagnoses occurring in 5% or greater of participants in at least one treatment arm. Determined using Structured Clinical Interview for DSM-IV, Axis I and Axis II.|participants|Number|34|34.0||||||
3735188|NCT02038075|3572307|B1|Posttraumatic stress||Psychiatric diagnosis (SCID)|Only includes diagnoses occurring in 5% or greater of participants in at least one treatment arm. Determined using Structured Clinical Interview for DSM-IV, Axis I and Axis II.|participants|Number|26|26.0||||||
3735189|NCT02038075|3572305|B3|Major depressive||Psychiatric diagnosis (SCID)|Only includes diagnoses occurring in 5% or greater of participants in at least one treatment arm. Determined using Structured Clinical Interview for DSM-IV, Axis I and Axis II.|participants|Number|118|118.0||||||
3735190|NCT02038075|3572306|B2|Major depressive||Psychiatric diagnosis (SCID)|Only includes diagnoses occurring in 5% or greater of participants in at least one treatment arm. Determined using Structured Clinical Interview for DSM-IV, Axis I and Axis II.|participants|Number|63|63.0||||||
3735191|NCT02038075|3572307|B1|Major depressive||Psychiatric diagnosis (SCID)|Only includes diagnoses occurring in 5% or greater of participants in at least one treatment arm. Determined using Structured Clinical Interview for DSM-IV, Axis I and Axis II.|participants|Number|55|55.0||||||
3735192|NCT02038075|3572305|B3|Multiple (2+)||Prior suicide attempts||participants|Number|58|58.0||||||
3735193|NCT02038075|3572306|B2|Multiple (2+)||Prior suicide attempts||participants|Number|23|23.0||||||
3735194|NCT02038075|3572307|B1|Multiple (2+)||Prior suicide attempts||participants|Number|35|35.0||||||
3735195|NCT02038075|3572305|B3|One||Prior suicide attempts||participants|Number|58|58.0||||||
3735196|NCT02038075|3572306|B2|One||Prior suicide attempts||participants|Number|34|34.0||||||
3735197|NCT02038075|3572307|B1|One||Prior suicide attempts||participants|Number|24|24.0||||||
3735198|NCT02038075|3572305|B3|None||Prior suicide attempts||participants|Number|36|36.0||||||
3735199|NCT02038075|3572306|B2|None||Prior suicide attempts||participants|Number|19|19.0||||||
3735200|NCT02038075|3572307|B1|None||Prior suicide attempts||participants|Number|17|17.0||||||
3735201|NCT02038075|3572305|B3|Multiple (2+)||Deployment history||participants|Number|65|65.0||||||
3735202|NCT02038075|3572306|B2|Multiple (2+)||Deployment history||participants|Number|35|35.0||||||
3735203|NCT02038075|3572307|B1|Multiple (2+)||Deployment history||participants|Number|30|30.0||||||
3735204|NCT02038075|3572305|B3|One||Deployment history||participants|Number|59|59.0||||||
3735205|NCT02038075|3572306|B2|One||Deployment history||participants|Number|31|31.0||||||
3735206|NCT02038075|3572307|B1|One||Deployment history||participants|Number|28|28.0||||||
3735207|NCT02038075|3572305|B3|None||Deployment history||participants|Number|28|28.0||||||
3735208|NCT02038075|3572306|B2|None||Deployment history||participants|Number|10|10.0||||||
3735210|NCT02038075|3572305|B3|Warrant Officer||Military rank||participants|Number|1|1.0||||||
3735211|NCT02038075|3572306|B2|Warrant Officer||Military rank||participants|Number|1|1.0||||||
3735212|NCT02038075|3572307|B1|Warrant Officer||Military rank||participants|Number|0|0.0||||||
3735213|NCT02038075|3572305|B3|E7-E9||Military rank||participants|Number|5|5.0||||||
3735214|NCT02038075|3572306|B2|E7-E9||Military rank||participants|Number|4|4.0||||||
3735215|NCT02038075|3572307|B1|E7-E9||Military rank||participants|Number|1|1.0||||||
3735216|NCT02038075|3572305|B3|E5-E6||Military rank||participants|Number|35|35.0||||||
3735217|NCT02038075|3572306|B2|E5-E6||Military rank||participants|Number|20|20.0||||||
3735218|NCT02038075|3572307|B1|E5-E6||Military rank||participants|Number|15|15.0||||||
3735219|NCT02038075|3572305|B3|E1-E4||Military rank||participants|Number|111|111.0||||||
3735220|NCT02038075|3572306|B2|E1-E4||Military rank||participants|Number|51|51.0||||||
3735221|NCT02038075|3572307|B1|E1-E4||Military rank||participants|Number|60|60.0||||||
3735222|NCT02038075|3572305|B3|Unknown or Not Reported||Race (NIH/OMB)|Participants allowed to select more than one racial identity|participants|Number|1|1.0||||||
3735223|NCT02038075|3572306|B2|Unknown or Not Reported||Race (NIH/OMB)|Participants allowed to select more than one racial identity|participants|Number|1|1.0||||||
3735224|NCT02038075|3572307|B1|Unknown or Not Reported||Race (NIH/OMB)|Participants allowed to select more than one racial identity|participants|Number|0|0.0||||||
3735225|NCT02038075|3572305|B3|More than one race||Race (NIH/OMB)|Participants allowed to select more than one racial identity|participants|Number|12|12.0||||||
3735226|NCT02038075|3572306|B2|More than one race||Race (NIH/OMB)|Participants allowed to select more than one racial identity|participants|Number|7|7.0||||||
3735227|NCT02038075|3572307|B1|More than one race||Race (NIH/OMB)|Participants allowed to select more than one racial identity|participants|Number|5|5.0||||||
3735228|NCT02038075|3572305|B3|White||Race (NIH/OMB)|Participants allowed to select more than one racial identity|participants|Number|110|110.0||||||
3735229|NCT02038075|3572306|B2|White||Race (NIH/OMB)|Participants allowed to select more than one racial identity|participants|Number|52|52.0||||||
3735230|NCT02038075|3572307|B1|White||Race (NIH/OMB)|Participants allowed to select more than one racial identity|participants|Number|58|58.0||||||
3735231|NCT02038075|3572305|B3|Black or African American||Race (NIH/OMB)|Participants allowed to select more than one racial identity|participants|Number|20|20.0||||||
3735232|NCT02038075|3572306|B2|Black or African American||Race (NIH/OMB)|Participants allowed to select more than one racial identity|participants|Number|10|10.0||||||
3735233|NCT02038075|3572307|B1|Black or African American||Race (NIH/OMB)|Participants allowed to select more than one racial identity|participants|Number|10|10.0||||||
3735234|NCT02038075|3572305|B3|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|Participants allowed to select more than one racial identity|participants|Number|3|3.0||||||
3735235|NCT02038075|3572306|B2|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|Participants allowed to select more than one racial identity|participants|Number|1|1.0||||||
3735236|NCT02038075|3572307|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|Participants allowed to select more than one racial identity|participants|Number|2|2.0||||||
3735237|NCT02038075|3572305|B3|Asian||Race (NIH/OMB)|Participants allowed to select more than one racial identity|participants|Number|3|3.0||||||
3735238|NCT02038075|3572306|B2|Asian||Race (NIH/OMB)|Participants allowed to select more than one racial identity|participants|Number|2|2.0||||||
3735239|NCT02038075|3572307|B1|Asian||Race (NIH/OMB)|Participants allowed to select more than one racial identity|participants|Number|1|1.0||||||
3735240|NCT02038075|3572305|B3|American Indian or Alaska Native||Race (NIH/OMB)|Participants allowed to select more than one racial identity|participants|Number|7|7.0||||||
3735241|NCT02038075|3572306|B2|American Indian or Alaska Native||Race (NIH/OMB)|Participants allowed to select more than one racial identity|participants|Number|3|3.0||||||
3735242|NCT02038075|3572307|B1|American Indian or Alaska Native||Race (NIH/OMB)|Participants allowed to select more than one racial identity|participants|Number|4|4.0||||||
3735243|NCT02038075|3572305|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735244|NCT02038075|3572306|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735245|NCT02038075|3572307|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735246|NCT02038075|3572305|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|118|118.0||||||
3735247|NCT02038075|3572306|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3735248|NCT02038075|3572307|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3735249|NCT02038075|3572305|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3735250|NCT02038075|3572306|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3735251|NCT02038075|3572307|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3735252|NCT02038075|3572305|B3||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3735253|NCT02038075|3572306|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3735254|NCT02038075|3572307|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3735255|NCT02038075|3572305|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3735256|NCT02038075|3572306|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3735257|NCT02038075|3572307|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3735258|NCT02038075|3572305|B3|||Age||years|Mean|27.40|27.4|Standard Deviation|6.20|6.2|||
3735259|NCT02038075|3572306|B2|||Age||years|Mean|27.62|27.62|Standard Deviation|621|621.0|||
3735260|NCT02038075|3572307|B1|||Age||years|Mean|27.18|27.18|Standard Deviation|6.25|6.25|||
3735261|NCT02038023|3572314|B1|||Percent Transferrin Saturation||percent saturation (Fe/TIBC)|Mean|11.72|11.72|Standard Deviation|9.14|9.14|||
3735262|NCT02038023|3572314|B1|||Serum ferritin||ng/mL|Mean|14.53|14.53|Standard Deviation|24.61|24.61|||
3735263|NCT02038023|3572314|B1|||Iron Deficient Pregnant Gravidas||Participants|Count of Participants|74|74.0||||||
3735264|NCT02038023|3572314|B1|||Pretreatment Hb||g/dL|Mean|9.65|9.65|Standard Deviation|0.70|0.7|||
3735265|NCT02038023|3572314|B1|United States||Region of Enrollment||participants|Number|74|74.0||||||
3735266|NCT02038023|3572314|B1|All female||Sex/Gender, Customized||Participants|Count of Participants|74|74.0||||||
3735267|NCT02038023|3572314|B1|||Age||years|Mean|24|24.0|Full Range|||18.0|42.0|
3735268|NCT02037893|3572321|B5|United States||Region of Enrollment||participants|Number|112|112.0||||||
3735269|NCT02037893|3572322|B4|United States||Region of Enrollment||participants|Number|28|28.0||||||
3735270|NCT02037893|3572323|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
3735271|NCT02037893|3572324|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3735272|NCT02037893|3572325|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
3735273|NCT02037893|3572321|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735274|NCT02037893|3572322|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735275|NCT02037893|3572323|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735276|NCT02037893|3572324|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735277|NCT02037893|3572325|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735278|NCT02037893|3572321|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3735279|NCT02037893|3572322|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3735280|NCT02037893|3572323|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3735281|NCT02037893|3572324|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3735282|NCT02037893|3572325|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3735283|NCT02037893|3572321|B5||White|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3735284|NCT02037893|3572322|B4||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3735285|NCT02037893|3572323|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3735286|NCT02037893|3572324|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3735287|NCT02037893|3572325|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3735288|NCT02037893|3572321|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3735289|NCT02037893|3572322|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3735290|NCT02037893|3572323|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3735291|NCT02037893|3572324|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3735292|NCT02037893|3572325|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3735293|NCT02037893|3572321|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3735294|NCT02037893|3572322|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735295|NCT02037893|3572323|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735296|NCT02037893|3572324|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735297|NCT02037893|3572325|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3735298|NCT02037893|3572321|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735299|NCT02037893|3572322|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735300|NCT02037893|3572323|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735301|NCT02037893|3572324|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735302|NCT02037893|3572325|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735303|NCT02037893|3572321|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735304|NCT02037893|3572322|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735305|NCT02037893|3572323|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735306|NCT02037893|3572324|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735307|NCT02037893|3572325|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735308|NCT02037893|3572321|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3735309|NCT02037893|3572322|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735310|NCT02037893|3572323|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3735311|NCT02037893|3572324|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735312|NCT02037893|3572325|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735313|NCT02037893|3572321|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3735314|NCT02037893|3572322|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3735315|NCT02037893|3572323|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3735316|NCT02037893|3572324|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3735317|NCT02037893|3572325|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3735318|NCT02037893|3572321|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3735319|NCT02037893|3572322|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3735320|NCT02037893|3572323|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3735321|NCT02037893|3572324|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3735322|NCT02037893|3572325|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3735323|NCT02037893|3572321|B5||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3735324|NCT02037893|3572322|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3735325|NCT02037893|3572323|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3735326|NCT02037893|3572324|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3735327|NCT02037893|3572325|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3735328|NCT02037893|3572321|B5||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3735329|NCT02037893|3572322|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3735330|NCT02037893|3572323|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3735331|NCT02037893|3572324|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3735332|NCT02037893|3572325|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3735333|NCT02037893|3572321|B5|||Age||years|Mean|4.2|4.2|Standard Deviation|3.41|3.41|||
3735334|NCT02037893|3572322|B4|||Age||years|Mean|3.5|3.5|Standard Deviation|3.35|3.35|||
3735335|NCT02037893|3572323|B3|||Age||years|Mean|4.5|4.5|Standard Deviation|3.75|3.75|||
3735336|NCT02037893|3572324|B2|||Age||years|Mean|4.4|4.4|Standard Deviation|3.36|3.36|||
3735337|NCT02037893|3572325|B1|||Age||years|Mean|4.4|4.4|Standard Deviation|3.27|3.27|||
3735338|NCT02037776|3572378|B3||≥1 year|Duration of FD||Participants|Count of Participants|82|82.0||||||
3735339|NCT02037776|3572379|B2||≥1 year|Duration of FD||Participants|Count of Participants|40|40.0||||||
3735340|NCT02037776|3572380|B1||≥1 year|Duration of FD||Participants|Count of Participants|42|42.0||||||
3735341|NCT02037776|3572378|B3||≥6 months to <1 year|Duration of FD||Participants|Count of Participants|43|43.0||||||
3735342|NCT02037776|3572379|B2||≥6 months to <1 year|Duration of FD||Participants|Count of Participants|24|24.0||||||
3735343|NCT02037776|3572380|B1||≥6 months to <1 year|Duration of FD||Participants|Count of Participants|19|19.0||||||
3735344|NCT02037776|3572378|B3||Both|Subtype of functional dyspepsia (FD)|The subtype of FD was diagnosed according to the Rome III Diagnostic Criteria for Functional Gastrointestinal Disorders. The Rome III criteria have divided functional dyspepsia into postprandial distress syndrome (PDS), characterized by postprandial fullness occurring after ordinary-sized meals at least several times per week and early satiation that prevents finishing a regular meal, at least several times per week, and epigastric pain syndrome (EPS), characterized by epigastric pain or burning of at least moderate severity at least once per week.|Participants|Count of Participants|34|34.0||||||
3735345|NCT02037776|3572379|B2||Both|Subtype of functional dyspepsia (FD)|The subtype of FD was diagnosed according to the Rome III Diagnostic Criteria for Functional Gastrointestinal Disorders. The Rome III criteria have divided functional dyspepsia into postprandial distress syndrome (PDS), characterized by postprandial fullness occurring after ordinary-sized meals at least several times per week and early satiation that prevents finishing a regular meal, at least several times per week, and epigastric pain syndrome (EPS), characterized by epigastric pain or burning of at least moderate severity at least once per week.|Participants|Count of Participants|14|14.0||||||
3735346|NCT02037776|3572380|B1||Both|Subtype of functional dyspepsia (FD)|The subtype of FD was diagnosed according to the Rome III Diagnostic Criteria for Functional Gastrointestinal Disorders. The Rome III criteria have divided functional dyspepsia into postprandial distress syndrome (PDS), characterized by postprandial fullness occurring after ordinary-sized meals at least several times per week and early satiation that prevents finishing a regular meal, at least several times per week, and epigastric pain syndrome (EPS), characterized by epigastric pain or burning of at least moderate severity at least once per week.|Participants|Count of Participants|20|20.0||||||
3735347|NCT02037776|3572378|B3||Epigastric pain syndrome (EPS)|Subtype of functional dyspepsia (FD)|The subtype of FD was diagnosed according to the Rome III Diagnostic Criteria for Functional Gastrointestinal Disorders. The Rome III criteria have divided functional dyspepsia into postprandial distress syndrome (PDS), characterized by postprandial fullness occurring after ordinary-sized meals at least several times per week and early satiation that prevents finishing a regular meal, at least several times per week, and epigastric pain syndrome (EPS), characterized by epigastric pain or burning of at least moderate severity at least once per week.|Participants|Count of Participants|42|42.0||||||
3735348|NCT02037776|3572379|B2||Epigastric pain syndrome (EPS)|Subtype of functional dyspepsia (FD)|The subtype of FD was diagnosed according to the Rome III Diagnostic Criteria for Functional Gastrointestinal Disorders. The Rome III criteria have divided functional dyspepsia into postprandial distress syndrome (PDS), characterized by postprandial fullness occurring after ordinary-sized meals at least several times per week and early satiation that prevents finishing a regular meal, at least several times per week, and epigastric pain syndrome (EPS), characterized by epigastric pain or burning of at least moderate severity at least once per week.|Participants|Count of Participants|24|24.0||||||
3735349|NCT02037776|3572380|B1||Epigastric pain syndrome (EPS)|Subtype of functional dyspepsia (FD)|The subtype of FD was diagnosed according to the Rome III Diagnostic Criteria for Functional Gastrointestinal Disorders. The Rome III criteria have divided functional dyspepsia into postprandial distress syndrome (PDS), characterized by postprandial fullness occurring after ordinary-sized meals at least several times per week and early satiation that prevents finishing a regular meal, at least several times per week, and epigastric pain syndrome (EPS), characterized by epigastric pain or burning of at least moderate severity at least once per week.|Participants|Count of Participants|18|18.0||||||
3735389|NCT02037568|3572403|B1||Lymphoma|Patient Diagnosis|Abbreviations: MDS, myelodysplastic syndrome; MPS, myeloproliferative syndrome; MM, multiple myeloma; SAA, severe aplastic anemia.|Participants|Count of Participants|11|11.0||||||
3735350|NCT02037776|3572378|B3||Postprandial distress syndrome (PDS)|Subtype of functional dyspepsia (FD)|The subtype of FD was diagnosed according to the Rome III Diagnostic Criteria for Functional Gastrointestinal Disorders. The Rome III criteria have divided functional dyspepsia into postprandial distress syndrome (PDS), characterized by postprandial fullness occurring after ordinary-sized meals at least several times per week and early satiation that prevents finishing a regular meal, at least several times per week, and epigastric pain syndrome (EPS), characterized by epigastric pain or burning of at least moderate severity at least once per week.|Participants|Count of Participants|49|49.0||||||
3735351|NCT02037776|3572379|B2||Postprandial distress syndrome (PDS)|Subtype of functional dyspepsia (FD)|The subtype of FD was diagnosed according to the Rome III Diagnostic Criteria for Functional Gastrointestinal Disorders. The Rome III criteria have divided functional dyspepsia into postprandial distress syndrome (PDS), characterized by postprandial fullness occurring after ordinary-sized meals at least several times per week and early satiation that prevents finishing a regular meal, at least several times per week, and epigastric pain syndrome (EPS), characterized by epigastric pain or burning of at least moderate severity at least once per week.|Participants|Count of Participants|26|26.0||||||
3735352|NCT02037776|3572380|B1||Postprandial distress syndrome (PDS)|Subtype of functional dyspepsia (FD)|The subtype of FD was diagnosed according to the Rome III Diagnostic Criteria for Functional Gastrointestinal Disorders. The Rome III criteria have divided functional dyspepsia into postprandial distress syndrome (PDS), characterized by postprandial fullness occurring after ordinary-sized meals at least several times per week and early satiation that prevents finishing a regular meal, at least several times per week, and epigastric pain syndrome (EPS), characterized by epigastric pain or burning of at least moderate severity at least once per week.|Participants|Count of Participants|23|23.0||||||
3735353|NCT02037776|3572378|B3|Japan||Region of Enrollment||Participants|Count of Participants|125|125.0||||||
3735354|NCT02037776|3572379|B2|Japan||Region of Enrollment||Participants|Count of Participants|64|64.0||||||
3735355|NCT02037776|3572380|B1|Japan||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
3735356|NCT02037776|3572378|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3735357|NCT02037776|3572379|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3735358|NCT02037776|3572380|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3735359|NCT02037776|3572378|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3735360|NCT02037776|3572379|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3735361|NCT02037776|3572380|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3735362|NCT02037776|3572378|B3|Age||Age||years|Mean|50.4|50.4|Standard Deviation|14.3|14.3|||
3735363|NCT02037776|3572379|B2|Age||Age||years|Mean|50.4|50.4|Standard Deviation|14.9|14.9|||
3735364|NCT02037776|3572380|B1|Age||Age||years|Mean|50.4|50.4|Standard Deviation|13.7|13.7|||
3735365|NCT02037776|3572378|B3||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3735366|NCT02037776|3572379|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3735367|NCT02037776|3572380|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3735368|NCT02037776|3572378|B3||Between 18 and 65 years|Age||Participants|Count of Participants|102|102.0||||||
3735369|NCT02037776|3572379|B2||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
3735370|NCT02037776|3572380|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3735371|NCT02037776|3572378|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3735372|NCT02037776|3572379|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3735373|NCT02037776|3572380|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3735374|NCT02037607|3572397|B1|||Received baseline ultrasound||Participants|Count of Participants|91|91.0||||||
3735375|NCT02037607|3572397|B1|United States||Region of Enrollment||participants|Number|91|91.0||||||
3735376|NCT02037607|3572397|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3735377|NCT02037607|3572397|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3735378|NCT02037607|3572397|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3735379|NCT02037607|3572397|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3735380|NCT02037607|3572397|B1||<=18 years|Age||Participants|Count of Participants|91|91.0||||||
3735381|NCT02037568|3572401|B3||Other (MM, SAA)|Patient Diagnosis|Abbreviations: MDS, myelodysplastic syndrome; MPS, myeloproliferative syndrome; MM, multiple myeloma; SAA, severe aplastic anemia.|Participants|Count of Participants|6|6.0||||||
3735382|NCT02037568|3572402|B2||Other (MM, SAA)|Patient Diagnosis|Abbreviations: MDS, myelodysplastic syndrome; MPS, myeloproliferative syndrome; MM, multiple myeloma; SAA, severe aplastic anemia.|Participants|Count of Participants|3|3.0||||||
3735383|NCT02037568|3572403|B1||Other (MM, SAA)|Patient Diagnosis|Abbreviations: MDS, myelodysplastic syndrome; MPS, myeloproliferative syndrome; MM, multiple myeloma; SAA, severe aplastic anemia.|Participants|Count of Participants|3|3.0||||||
3735384|NCT02037568|3572401|B3||MDS/MPS|Patient Diagnosis|Abbreviations: MDS, myelodysplastic syndrome; MPS, myeloproliferative syndrome; MM, multiple myeloma; SAA, severe aplastic anemia.|Participants|Count of Participants|35|35.0||||||
3735385|NCT02037568|3572402|B2||MDS/MPS|Patient Diagnosis|Abbreviations: MDS, myelodysplastic syndrome; MPS, myeloproliferative syndrome; MM, multiple myeloma; SAA, severe aplastic anemia.|Participants|Count of Participants|19|19.0||||||
3735386|NCT02037568|3572403|B1||MDS/MPS|Patient Diagnosis|Abbreviations: MDS, myelodysplastic syndrome; MPS, myeloproliferative syndrome; MM, multiple myeloma; SAA, severe aplastic anemia.|Participants|Count of Participants|16|16.0||||||
3735387|NCT02037568|3572401|B3||Lymphoma|Patient Diagnosis|Abbreviations: MDS, myelodysplastic syndrome; MPS, myeloproliferative syndrome; MM, multiple myeloma; SAA, severe aplastic anemia.|Participants|Count of Participants|21|21.0||||||
3735388|NCT02037568|3572402|B2||Lymphoma|Patient Diagnosis|Abbreviations: MDS, myelodysplastic syndrome; MPS, myeloproliferative syndrome; MM, multiple myeloma; SAA, severe aplastic anemia.|Participants|Count of Participants|10|10.0||||||
3735390|NCT02037568|3572401|B3||Leukemia|Patient Diagnosis|Abbreviations: MDS, myelodysplastic syndrome; MPS, myeloproliferative syndrome; MM, multiple myeloma; SAA, severe aplastic anemia.|Participants|Count of Participants|97|97.0||||||
3735391|NCT02037568|3572402|B2||Leukemia|Patient Diagnosis|Abbreviations: MDS, myelodysplastic syndrome; MPS, myeloproliferative syndrome; MM, multiple myeloma; SAA, severe aplastic anemia.|Participants|Count of Participants|44|44.0||||||
3735392|NCT02037568|3572403|B1||Leukemia|Patient Diagnosis|Abbreviations: MDS, myelodysplastic syndrome; MPS, myeloproliferative syndrome; MM, multiple myeloma; SAA, severe aplastic anemia.|Participants|Count of Participants|53|53.0||||||
3735393|NCT02037568|3572401|B3||Male|Patient Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3735394|NCT02037568|3572402|B2||Male|Patient Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3735395|NCT02037568|3572403|B1||Male|Patient Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3735396|NCT02037568|3572401|B3||Female|Patient Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3735397|NCT02037568|3572402|B2||Female|Patient Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3735398|NCT02037568|3572403|B1||Female|Patient Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3735399|NCT02037568|3572401|B3|||Patient Age, Continuous||years|Mean|53.3|53.3|Standard Deviation|14.8|14.8|||
3735400|NCT02037568|3572402|B2|||Patient Age, Continuous||years|Mean|51.9|51.9|Standard Deviation|15.3|15.3|||
3735401|NCT02037568|3572403|B1|||Patient Age, Continuous||years|Mean|54.6|54.6|Standard Deviation|14.2|14.2|||
3735402|NCT02037568|3572401|B3||Unknown or Not Reported|Employment Status (During Caregiving)||Participants|Count of Participants|11|11.0||||||
3735403|NCT02037568|3572402|B2||Unknown or Not Reported|Employment Status (During Caregiving)||Participants|Count of Participants|2|2.0||||||
3735404|NCT02037568|3572403|B1||Unknown or Not Reported|Employment Status (During Caregiving)||Participants|Count of Participants|9|9.0||||||
3735405|NCT02037568|3572401|B3||Retired|Employment Status (During Caregiving)||Participants|Count of Participants|37|37.0||||||
3735406|NCT02037568|3572402|B2||Retired|Employment Status (During Caregiving)||Participants|Count of Participants|17|17.0||||||
3735407|NCT02037568|3572403|B1||Retired|Employment Status (During Caregiving)||Participants|Count of Participants|20|20.0||||||
3735408|NCT02037568|3572401|B3||On leave|Employment Status (During Caregiving)||Participants|Count of Participants|28|28.0||||||
3735409|NCT02037568|3572402|B2||On leave|Employment Status (During Caregiving)||Participants|Count of Participants|13|13.0||||||
3735410|NCT02037568|3572403|B1||On leave|Employment Status (During Caregiving)||Participants|Count of Participants|15|15.0||||||
3735411|NCT02037568|3572401|B3||Unemployed|Employment Status (During Caregiving)||Participants|Count of Participants|21|21.0||||||
3735412|NCT02037568|3572402|B2||Unemployed|Employment Status (During Caregiving)||Participants|Count of Participants|12|12.0||||||
3735413|NCT02037568|3572403|B1||Unemployed|Employment Status (During Caregiving)||Participants|Count of Participants|9|9.0||||||
3735414|NCT02037568|3572401|B3||Part-time|Employment Status (During Caregiving)||Participants|Count of Participants|29|29.0||||||
3735415|NCT02037568|3572402|B2||Part-time|Employment Status (During Caregiving)||Participants|Count of Participants|14|14.0||||||
3735416|NCT02037568|3572403|B1||Part-time|Employment Status (During Caregiving)||Participants|Count of Participants|15|15.0||||||
3735417|NCT02037568|3572401|B3||Full-time|Employment Status (During Caregiving)||Participants|Count of Participants|33|33.0||||||
3735418|NCT02037568|3572402|B2||Full-time|Employment Status (During Caregiving)||Participants|Count of Participants|18|18.0||||||
3735419|NCT02037568|3572403|B1||Full-time|Employment Status (During Caregiving)||Participants|Count of Participants|15|15.0||||||
3735420|NCT02037568|3572401|B3||Unknown or Not Reported|Employment Status (Before Caregiving)||Participants|Count of Participants|9|9.0||||||
3735421|NCT02037568|3572402|B2||Unknown or Not Reported|Employment Status (Before Caregiving)||Participants|Count of Participants|1|1.0||||||
3735422|NCT02037568|3572403|B1||Unknown or Not Reported|Employment Status (Before Caregiving)||Participants|Count of Participants|8|8.0||||||
3735423|NCT02037568|3572401|B3||Retired|Employment Status (Before Caregiving)||Participants|Count of Participants|40|40.0||||||
3735424|NCT02037568|3572402|B2||Retired|Employment Status (Before Caregiving)||Participants|Count of Participants|20|20.0||||||
3735425|NCT02037568|3572403|B1||Retired|Employment Status (Before Caregiving)||Participants|Count of Participants|20|20.0||||||
3735426|NCT02037568|3572401|B3||On leave|Employment Status (Before Caregiving)||Participants|Count of Participants|2|2.0||||||
3735427|NCT02037568|3572402|B2||On leave|Employment Status (Before Caregiving)||Participants|Count of Participants|1|1.0||||||
3735428|NCT02037568|3572403|B1||On leave|Employment Status (Before Caregiving)||Participants|Count of Participants|1|1.0||||||
3735429|NCT02037568|3572401|B3||Unemployed|Employment Status (Before Caregiving)||Participants|Count of Participants|16|16.0||||||
3735430|NCT02037568|3572402|B2||Unemployed|Employment Status (Before Caregiving)||Participants|Count of Participants|7|7.0||||||
3735431|NCT02037568|3572403|B1||Unemployed|Employment Status (Before Caregiving)||Participants|Count of Participants|9|9.0||||||
3735432|NCT02037568|3572401|B3||Part-time|Employment Status (Before Caregiving)||Participants|Count of Participants|27|27.0||||||
3735433|NCT02037568|3572402|B2||Part-time|Employment Status (Before Caregiving)||Participants|Count of Participants|12|12.0||||||
3735434|NCT02037568|3572403|B1||Part-time|Employment Status (Before Caregiving)||Participants|Count of Participants|15|15.0||||||
3735435|NCT02037568|3572401|B3||Full-time|Employment Status (Before Caregiving)||Participants|Count of Participants|65|65.0||||||
3735436|NCT02037568|3572402|B2||Full-time|Employment Status (Before Caregiving)||Participants|Count of Participants|35|35.0||||||
3735437|NCT02037568|3572403|B1||Full-time|Employment Status (Before Caregiving)||Participants|Count of Participants|30|30.0||||||
3735438|NCT02037568|3572401|B3||Unknown or Not Reported|Relationship to patient||Participants|Count of Participants|8|8.0||||||
3735439|NCT02037568|3572402|B2||Unknown or Not Reported|Relationship to patient||Participants|Count of Participants|1|1.0||||||
3735440|NCT02037568|3572403|B1||Unknown or Not Reported|Relationship to patient||Participants|Count of Participants|7|7.0||||||
3735441|NCT02037568|3572401|B3||Other|Relationship to patient||Participants|Count of Participants|7|7.0||||||
3735442|NCT02037568|3572402|B2||Other|Relationship to patient||Participants|Count of Participants|7|7.0||||||
3735443|NCT02037568|3572403|B1||Other|Relationship to patient||Participants|Count of Participants|0|0.0||||||
3735444|NCT02037568|3572401|B3||Child|Relationship to patient||Participants|Count of Participants|9|9.0||||||
3735445|NCT02037568|3572402|B2||Child|Relationship to patient||Participants|Count of Participants|3|3.0||||||
3735446|NCT02037568|3572403|B1||Child|Relationship to patient||Participants|Count of Participants|6|6.0||||||
3735447|NCT02037568|3572401|B3||Parent|Relationship to patient||Participants|Count of Participants|20|20.0||||||
3735448|NCT02037568|3572402|B2||Parent|Relationship to patient||Participants|Count of Participants|9|9.0||||||
3735449|NCT02037568|3572403|B1||Parent|Relationship to patient||Participants|Count of Participants|11|11.0||||||
3735450|NCT02037568|3572401|B3||Sibling|Relationship to patient||Participants|Count of Participants|13|13.0||||||
3735451|NCT02037568|3572402|B2||Sibling|Relationship to patient||Participants|Count of Participants|8|8.0||||||
3735452|NCT02037568|3572403|B1||Sibling|Relationship to patient||Participants|Count of Participants|5|5.0||||||
3735453|NCT02037568|3572401|B3||Spouse/Civil Partner|Relationship to patient||Participants|Count of Participants|102|102.0||||||
3735454|NCT02037568|3572402|B2||Spouse/Civil Partner|Relationship to patient||Participants|Count of Participants|48|48.0||||||
3735455|NCT02037568|3572403|B1||Spouse/Civil Partner|Relationship to patient||Participants|Count of Participants|54|54.0||||||
3735456|NCT02037568|3572401|B3||Unknown or Not Reported|Annual income||Participants|Count of Participants|22|22.0||||||
3735457|NCT02037568|3572402|B2||Unknown or Not Reported|Annual income||Participants|Count of Participants|8|8.0||||||
3735458|NCT02037568|3572403|B1||Unknown or Not Reported|Annual income||Participants|Count of Participants|14|14.0||||||
3735459|NCT02037568|3572401|B3||> 65,000|Annual income||Participants|Count of Participants|29|29.0||||||
3735460|NCT02037568|3572402|B2||> 65,000|Annual income||Participants|Count of Participants|16|16.0||||||
3735461|NCT02037568|3572403|B1||> 65,000|Annual income||Participants|Count of Participants|13|13.0||||||
3735462|NCT02037568|3572401|B3||45,000-64,999|Annual income||Participants|Count of Participants|31|31.0||||||
3735463|NCT02037568|3572402|B2||45,000-64,999|Annual income||Participants|Count of Participants|18|18.0||||||
3735464|NCT02037568|3572403|B1||45,000-64,999|Annual income||Participants|Count of Participants|13|13.0||||||
3735465|NCT02037568|3572401|B3||25,000-44,999|Annual income||Participants|Count of Participants|27|27.0||||||
3735466|NCT02037568|3572402|B2||25,000-44,999|Annual income||Participants|Count of Participants|13|13.0||||||
3735467|NCT02037568|3572403|B1||25,000-44,999|Annual income||Participants|Count of Participants|14|14.0||||||
3735468|NCT02037568|3572401|B3||< 25,000|Annual income||Participants|Count of Participants|50|50.0||||||
3735469|NCT02037568|3572402|B2||< 25,000|Annual income||Participants|Count of Participants|21|21.0||||||
3735470|NCT02037568|3572403|B1||< 25,000|Annual income||Participants|Count of Participants|29|29.0||||||
3735471|NCT02037568|3572401|B3|United States||Region of Enrollment||participants|Number|159|159.0||||||
3735472|NCT02037568|3572402|B2|United States||Region of Enrollment||participants|Number|76|76.0||||||
3735473|NCT02037568|3572403|B1|United States||Region of Enrollment||participants|Number|83|83.0||||||
3735474|NCT02037568|3572401|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3735475|NCT02037568|3572402|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3735476|NCT02037568|3572403|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3735477|NCT02037568|3572401|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3735478|NCT02037568|3572402|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3735479|NCT02037568|3572403|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3735480|NCT02037568|3572401|B3||White|Race (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
3735481|NCT02037568|3572402|B2||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3735482|NCT02037568|3572403|B1||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3735483|NCT02037568|3572401|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3735484|NCT02037568|3572402|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3735485|NCT02037568|3572403|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735486|NCT02037568|3572401|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735487|NCT02037568|3572402|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735488|NCT02037568|3572403|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735489|NCT02037568|3572401|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735490|NCT02037568|3572402|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735491|NCT02037568|3572403|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735492|NCT02037568|3572401|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3735493|NCT02037568|3572402|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735494|NCT02037568|3572403|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3735495|NCT02037568|3572401|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3735496|NCT02037568|3572402|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3735497|NCT02037568|3572403|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3735498|NCT02037568|3572401|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
3735499|NCT02037568|3572402|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3735500|NCT02037568|3572403|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3735501|NCT02037568|3572401|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3735502|NCT02037568|3572402|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3735503|NCT02037568|3572403|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3735504|NCT02037568|3572401|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3735505|NCT02037568|3572402|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3735506|NCT02037568|3572403|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3735507|NCT02037568|3572401|B3||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3735508|NCT02037568|3572402|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3735509|NCT02037568|3572403|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3735510|NCT02037568|3572401|B3|||Age||years|Mean|54.1|54.1|Standard Deviation|13.7|13.7|||
3735511|NCT02037568|3572402|B2|||Age||years|Mean|53.6|53.6|Standard Deviation|14.7|14.7|||
3735512|NCT02037568|3572403|B1|||Age||years|Mean|54.6|54.6|Standard Deviation|12.8|12.8|||
3735513|NCT02037477|3572426|B5|Poor Metabolizer (PM)||CPY2C19 Genotype Test (N)||participants|Number|0|0.0||||||
3735514|NCT02037477|3572427|B4|Poor Metabolizer (PM)||CPY2C19 Genotype Test (N)||participants|Number|0|0.0||||||
3735515|NCT02037477|3572428|B3|Poor Metabolizer (PM)||CPY2C19 Genotype Test (N)||participants|Number|0|0.0||||||
3735516|NCT02037477|3572429|B2|Poor Metabolizer (PM)||CPY2C19 Genotype Test (N)||participants|Number|0|0.0||||||
3735517|NCT02037477|3572430|B1|Poor Metabolizer (PM)||CPY2C19 Genotype Test (N)||participants|Number|0|0.0||||||
3735518|NCT02037477|3572426|B5|Hetero EM||CPY2C19 Genotype Test (N)||participants|Number|10|10.0||||||
3735519|NCT02037477|3572427|B4|Hetero EM||CPY2C19 Genotype Test (N)||participants|Number|3|3.0||||||
3735520|NCT02037477|3572428|B3|Hetero EM||CPY2C19 Genotype Test (N)||participants|Number|2|2.0||||||
3735521|NCT02037477|3572429|B2|Hetero EM||CPY2C19 Genotype Test (N)||participants|Number|2|2.0||||||
3735522|NCT02037477|3572430|B1|Hetero EM||CPY2C19 Genotype Test (N)||participants|Number|3|3.0||||||
3735523|NCT02037477|3572426|B5|Homo Extensive Metabolizer (EM)||CPY2C19 Genotype Test (N)||participants|Number|10|10.0||||||
3735524|NCT02037477|3572427|B4|Homo Extensive Metabolizer (EM)||CPY2C19 Genotype Test (N)||participants|Number|2|2.0||||||
3735525|NCT02037477|3572428|B3|Homo Extensive Metabolizer (EM)||CPY2C19 Genotype Test (N)||participants|Number|3|3.0||||||
3735526|NCT02037477|3572429|B2|Homo Extensive Metabolizer (EM)||CPY2C19 Genotype Test (N)||participants|Number|3|3.0||||||
3735527|NCT02037477|3572430|B1|Homo Extensive Metabolizer (EM)||CPY2C19 Genotype Test (N)||participants|Number|2|2.0||||||
3735528|NCT02037477|3572426|B5|||Body Mass Index (BMI)||kg/m^2|Mean|21.05|21.05|Standard Deviation|1.387|1.387|||
3735529|NCT02037477|3572427|B4|||Body Mass Index (BMI)||kg/m^2|Mean|20.34|20.34|Standard Deviation|1.222|1.222|||
3735530|NCT02037477|3572428|B3|||Body Mass Index (BMI)||kg/m^2|Mean|20.96|20.96|Standard Deviation|0.808|0.808|||
3735531|NCT02037477|3572429|B2|||Body Mass Index (BMI)||kg/m^2|Mean|21.32|21.32|Standard Deviation|1.844|1.844|||
3735532|NCT02037477|3572430|B1|||Body Mass Index (BMI)||kg/m^2|Mean|21.56|21.56|Standard Deviation|1.674|1.674|||
3735533|NCT02037477|3572426|B5|||Weight||kg|Mean|62.31|62.31|Standard Deviation|7.245|7.245|||
3735534|NCT02037477|3572427|B4|||Weight||kg|Mean|58.34|58.34|Standard Deviation|5.227|5.227|||
3735535|NCT02037477|3572428|B3|||Weight||kg|Mean|62.68|62.68|Standard Deviation|5.008|5.008|||
3735536|NCT02037477|3572429|B2|||Weight||kg|Mean|64.10|64.1|Standard Deviation|9.813|9.813|||
3735537|NCT02037477|3572430|B1|||Weight||kg|Mean|64.10|64.1|Standard Deviation|8.930|8.93|||
3735538|NCT02037477|3572426|B5|||Height||cm|Mean|171.8|171.8|Standard Deviation|6.48|6.48|||
3735539|NCT02037477|3572427|B4|||Height||cm|Mean|169.4|169.4|Standard Deviation|4.88|4.88|||
3735540|NCT02037477|3572428|B3|||Height||cm|Mean|172.8|172.8|Standard Deviation|6.76|6.76|||
3735541|NCT02037477|3572429|B2|||Height||cm|Mean|173.0|173.0|Standard Deviation|6.52|6.52|||
3735542|NCT02037477|3572430|B1|||Height||cm|Mean|172.0|172.0|Standard Deviation|7.75|7.75|||
3735543|NCT02037477|3572426|B5|Japan||Region of Enrollment||participants|Number|20|20.0||||||
3735544|NCT02037477|3572427|B4|Japan||Region of Enrollment||participants|Number|5|5.0||||||
3735545|NCT02037477|3572428|B3|Japan||Region of Enrollment||participants|Number|5|5.0||||||
3735546|NCT02037477|3572429|B2|Japan||Region of Enrollment||participants|Number|5|5.0||||||
3735547|NCT02037477|3572430|B1|Japan||Region of Enrollment||participants|Number|5|5.0||||||
3735548|NCT02037477|3572426|B5||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3735549|NCT02037477|3572427|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3735550|NCT02037477|3572428|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3735551|NCT02037477|3572429|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3735552|NCT02037477|3572430|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3735553|NCT02037477|3572426|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3735554|NCT02037477|3572427|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3735555|NCT02037477|3572428|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3735556|NCT02037477|3572429|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3735557|NCT02037477|3572430|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3735558|NCT02037477|3572426|B5|||Age||years|Mean|25.2|25.2|Standard Deviation|5.31|5.31|||
3735559|NCT02037477|3572427|B4|||Age||years|Mean|25.2|25.2|Standard Deviation|2.95|2.95|||
3735560|NCT02037477|3572428|B3|||Age||years|Mean|22.2|22.2|Standard Deviation|2.95|2.95|||
3735561|NCT02037477|3572429|B2|||Age||years|Mean|23.8|23.8|Standard Deviation|5.17|5.17|||
3735562|NCT02037477|3572430|B1|||Age||years|Mean|34.0|34.0|Standard Deviation|6.93|6.93|||
3735563|NCT02037425|3572459|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
3735564|NCT02037425|3572459|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3735565|NCT02037425|3572459|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3735566|NCT02037425|3572459|B1|||Age||years|Mean|40.56|40.56|Standard Deviation|9.22|9.22|||
3735567|NCT02037425|3572459|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3735568|NCT02037425|3572459|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3735569|NCT02037425|3572459|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3735570|NCT02037347|3572501|B1|Male||Sex/Gender, Customized||participants|Number|1|1.0||||||
3735571|NCT02037347|3572501|B1|Age||Age, Customized||years|Number|73|73.0||||||
3735572|NCT02036840|3572507|B1|United States||Region of Enrollment||participants|Number|513|513.0||||||
3735573|NCT02036840|3572507|B1||Male|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
3735574|NCT02036840|3572507|B1||Female|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
3735575|NCT02036840|3572507|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3735576|NCT02036840|3572507|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3735577|NCT02036840|3572507|B1||<=18 years|Age||Participants|Count of Participants|513|513.0||||||
3735578|NCT02036775|3572511|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3735579|NCT02036775|3572511|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3735580|NCT02036775|3572511|B1|||Age||years|Mean|25.04|25.04|Standard Deviation|6.423|6.423|||
3735581|NCT02036580|3572554|B4||Male|Gender||Participants|Count of Participants|16|16.0||||||
3735582|NCT02036580|3572555|B3||Male|Gender||Participants|Count of Participants|4|4.0||||||
3735583|NCT02036580|3572556|B2||Male|Gender||Participants|Count of Participants|6|6.0||||||
3735584|NCT02036580|3572557|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
3735585|NCT02036580|3572554|B4||Female|Gender||Participants|Count of Participants|4|4.0||||||
3735586|NCT02036580|3572555|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
3735587|NCT02036580|3572556|B2||Female|Gender||Participants|Count of Participants|2|2.0||||||
3735588|NCT02036580|3572557|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
3735589|NCT02036580|3572554|B4|||Age||Years|Mean|66.5|66.5|Standard Deviation|8.0|8.0|||
3735590|NCT02036580|3572555|B3|||Age||Years|Mean|68.3|68.3|Standard Deviation|8.5|8.5|||
3735591|NCT02036580|3572556|B2|||Age||Years|Mean|65.0|65.0|Standard Deviation|9.4|9.4|||
3735592|NCT02036580|3572557|B1|||Age||Years|Mean|67.0|67.0|Standard Deviation|7.1|7.1|||
3735593|NCT02036541|3572572|B1|No prior glaucoma procedure||Prior Glaucoma Procedure||Participants|Count of Participants|10|10.0||||||
3735594|NCT02036541|3572572|B1|Prior laser trabeculoplasty||Prior Glaucoma Procedure||Participants|Count of Participants|14|14.0||||||
3735595|NCT02036541|3572572|B1|Prior incisional glaucoma procedure||Prior Glaucoma Procedure||Participants|Count of Participants|41|41.0||||||
3735596|NCT02036541|3572572|B1|||Previous Cataract Surgery||Participants|Count of Participants|45|45.0||||||
3735597|NCT02036541|3572572|B1|Mixed Mechanism Glaucoma||Glaucoma Type||Participants|Count of Participants|1|1.0||||||
3735598|NCT02036541|3572572|B1|Pigmentary Glaucoma||Glaucoma Type||Participants|Count of Participants|1|1.0||||||
3735599|NCT02036541|3572572|B1|Pseudoexfolative Glaucoma||Glaucoma Type||Participants|Count of Participants|6|6.0||||||
3735600|NCT02036541|3572572|B1|Primary Open Angle Glaucoma||Glaucoma Type||Participants|Count of Participants|57|57.0||||||
3735601|NCT02036541|3572572|B1|United States||Region of Enrollment||participants|Number|65|65.0||||||
3735602|NCT02036541|3572572|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735603|NCT02036541|3572572|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3735604|NCT02036541|3572572|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3735605|NCT02036541|3572572|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3735606|NCT02036541|3572572|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3735607|NCT02036541|3572572|B1|||Age||years|Mean|70|70.0|Standard Deviation|12.3|12.3|||
3735608|NCT02036515|3572577|B4|||Estimated glomerular filtration rate (eGFR)||mL/min/1.73m^2|Mean|87.9|87.9|Standard Deviation|16.9|16.9|||
3735609|NCT02036515|3572578|B3|||Estimated glomerular filtration rate (eGFR)||mL/min/1.73m^2|Mean|89.9|89.9|Standard Deviation|17.5|17.5|||
3735610|NCT02036515|3572579|B2|||Estimated glomerular filtration rate (eGFR)||mL/min/1.73m^2|Mean|86.9|86.9|Standard Deviation|15.6|15.6|||
3735611|NCT02036515|3572580|B1|||Estimated glomerular filtration rate (eGFR)||mL/min/1.73m^2|Mean|87.0|87.0|Standard Deviation|17.5|17.5|||
3735612|NCT02036515|3572577|B4|||Body weight||Kilograms|Mean|86.9|86.9|Standard Deviation|19.6|19.6|||
3735613|NCT02036515|3572578|B3|||Body weight||Kilograms|Mean|86.4|86.4|Standard Deviation|20.8|20.8|||
3735614|NCT02036515|3572579|B2|||Body weight||Kilograms|Mean|86.6|86.6|Standard Deviation|19.5|19.5|||
3735615|NCT02036515|3572580|B1|||Body weight||Kilograms|Mean|87.6|87.6|Standard Deviation|18.6|18.6|||
3735670|NCT02035748|3572681|B1||Female|Sex: Female, Male||Participants|Count of Participants|345|345.0||||||
3735616|NCT02036515|3572577|B4|||Fasting plasma glucose|Participants with baseline data: ertugliflozin 5 mg, n=156; ertugliflozin 15 mg, n=152; placebo, n=152; total, n=460|mg/dL|Mean|169.7|169.7|Standard Deviation|38.2|38.2|||
3735617|NCT02036515|3572578|B3|||Fasting plasma glucose|Participants with baseline data: ertugliflozin 5 mg, n=156; ertugliflozin 15 mg, n=152; placebo, n=152; total, n=460|mg/dL|Mean|169.6|169.6|Standard Deviation|37.8|37.8|||
3735618|NCT02036515|3572579|B2|||Fasting plasma glucose|Participants with baseline data: ertugliflozin 5 mg, n=156; ertugliflozin 15 mg, n=152; placebo, n=152; total, n=460|mg/dL|Mean|171.7|171.7|Standard Deviation|39.1|39.1|||
3735619|NCT02036515|3572580|B1|||Fasting plasma glucose|Participants with baseline data: ertugliflozin 5 mg, n=156; ertugliflozin 15 mg, n=152; placebo, n=152; total, n=460|mg/dL|Mean|167.7|167.7|Standard Deviation|37.7|37.7|||
3735620|NCT02036515|3572577|B4|||Hemoglobin A1c (A1C)|Participants with baseline data: ertugliflozin 5 mg, n=155; ertugliflozin 15 mg, n=152; placebo, n=152; total, n=459|Percent|Mean|8.03|8.03|Standard Deviation|0.88|0.88|||
3735621|NCT02036515|3572578|B3|||Hemoglobin A1c (A1C)|Participants with baseline data: ertugliflozin 5 mg, n=155; ertugliflozin 15 mg, n=152; placebo, n=152; total, n=459|Percent|Mean|8.03|8.03|Standard Deviation|0.93|0.93|||
3735622|NCT02036515|3572579|B2|||Hemoglobin A1c (A1C)|Participants with baseline data: ertugliflozin 5 mg, n=155; ertugliflozin 15 mg, n=152; placebo, n=152; total, n=459|Percent|Mean|8.00|8.0|Standard Deviation|0.83|0.83|||
3735623|NCT02036515|3572580|B1|||Hemoglobin A1c (A1C)|Participants with baseline data: ertugliflozin 5 mg, n=155; ertugliflozin 15 mg, n=152; placebo, n=152; total, n=459|Percent|Mean|8.05|8.05|Standard Deviation|0.86|0.86|||
3735624|NCT02036515|3572577|B4||Male|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
3735625|NCT02036515|3572578|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3735626|NCT02036515|3572579|B2||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3735627|NCT02036515|3572580|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3735628|NCT02036515|3572577|B4||Female|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
3735629|NCT02036515|3572578|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3735630|NCT02036515|3572579|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3735631|NCT02036515|3572580|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3735632|NCT02036515|3572577|B4|||Age||Years|Mean|59.1|59.1|Standard Deviation|9.0|9.0|||
3735633|NCT02036515|3572578|B3|||Age||Years|Mean|58.3|58.3|Standard Deviation|9.2|9.2|||
3735634|NCT02036515|3572579|B2|||Age||Years|Mean|59.7|59.7|Standard Deviation|8.6|8.6|||
3735635|NCT02036515|3572580|B1|||Age||Years|Mean|59.2|59.2|Standard Deviation|9.3|9.3|||
3735636|NCT02036424|3572659|B3|United States||Region of Enrollment||study eyes|Number|50|50.0||||||
3735637|NCT02036424|3572660|B2|United States||Region of Enrollment||study eyes|Number|27|27.0||||||
3735638|NCT02036424|3572661|B1|United States||Region of Enrollment||study eyes|Number|23|23.0||||||
3735639|NCT02036424|3572659|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3735640|NCT02036424|3572660|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3735641|NCT02036424|3572661|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3735642|NCT02036424|3572659|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3735643|NCT02036424|3572660|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3735644|NCT02036424|3572661|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3735645|NCT02036424|3572659|B3|||Age||years|Mean|63|63.0|Standard Deviation|10|10.0|||
3735646|NCT02036424|3572660|B2|||Age||years|Mean|65|65.0|Standard Deviation|11|11.0|||
3735647|NCT02036424|3572661|B1|||Age||years|Mean|61|61.0|Standard Deviation|9|9.0|||
3735648|NCT02036424|3572659|B3||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3735649|NCT02036424|3572660|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3735650|NCT02036424|3572661|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3735651|NCT02036424|3572659|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3735652|NCT02036424|3572660|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3735653|NCT02036424|3572661|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3735654|NCT02036424|3572659|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3735655|NCT02036424|3572660|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3735656|NCT02036424|3572661|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3735657|NCT02036320|3572670|B1|Canada||Region of Enrollment||participants|Number|29|29.0||||||
3735658|NCT02036320|3572670|B1|United States||Region of Enrollment||participants|Number|161|161.0||||||
3735659|NCT02036320|3572670|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735660|NCT02036320|3572670|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735661|NCT02036320|3572670|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735662|NCT02036320|3572670|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735663|NCT02036320|3572670|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735664|NCT02036320|3572670|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|190|190.0||||||
3735665|NCT02036320|3572670|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735666|NCT02036320|3572670|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3735667|NCT02036320|3572670|B1||Female|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
3735668|NCT02036320|3572670|B1|||Age||years|Mean|24.75|24.75|Standard Deviation|4.416|4.416|||
3735669|NCT02035748|3572681|B1||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3735671|NCT02035748|3572681|B1|||Age||years|Mean|71.7|71.7|Standard Deviation|8.3|8.3|||
3735672|NCT02035696|3572691|B5||MALE|Sex: Female, Male||Participants|Count of Participants|341|341.0||||||
3735673|NCT02035696|3572692|B4||MALE|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3735674|NCT02035696|3572693|B3||MALE|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3735675|NCT02035696|3572694|B2||MALE|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3735676|NCT02035696|3572695|B1||MALE|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3735677|NCT02035696|3572691|B5||FEMALE|Sex: Female, Male||Participants|Count of Participants|330|330.0||||||
3735678|NCT02035696|3572692|B4||FEMALE|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3735679|NCT02035696|3572693|B3||FEMALE|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3735680|NCT02035696|3572694|B2||FEMALE|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3735681|NCT02035696|3572695|B1||FEMALE|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3735682|NCT02035696|3572691|B5|||Age||Months|Mean|25.3|25.3|Standard Deviation|11.6|11.6|||
3735683|NCT02035696|3572692|B4|||Age||Months|Mean|25.3|25.3|Standard Deviation|11.9|11.9|||
3735684|NCT02035696|3572693|B3|||Age||Months|Mean|25.6|25.6|Standard Deviation|11.5|11.5|||
3735685|NCT02035696|3572694|B2|||Age||Months|Mean|25.0|25.0|Standard Deviation|11.5|11.5|||
3735686|NCT02035696|3572695|B1|||Age||Months|Mean|25.3|25.3|Standard Deviation|11.5|11.5|||
3735687|NCT02035553|3572752|B3|United Kingdom||Region of Enrollment||participants|Number|181|181.0||||||
3735688|NCT02035553|3572753|B2|United Kingdom||Region of Enrollment||participants|Number|90|90.0||||||
3735689|NCT02035553|3572754|B1|United Kingdom||Region of Enrollment||participants|Number|91|91.0||||||
3735690|NCT02035553|3572752|B3|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3735691|NCT02035553|3572753|B2|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3735692|NCT02035553|3572754|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3735693|NCT02035553|3572752|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|173|173.0||||||
3735694|NCT02035553|3572753|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|84|84.0||||||
3735695|NCT02035553|3572754|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|89|89.0||||||
3735696|NCT02035553|3572752|B3|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3735697|NCT02035553|3572753|B2|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3735698|NCT02035553|3572754|B1|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3735699|NCT02035553|3572752|B3|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3735700|NCT02035553|3572753|B2|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3735701|NCT02035553|3572754|B1|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3735702|NCT02035553|3572752|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735703|NCT02035553|3572753|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735704|NCT02035553|3572754|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735705|NCT02035553|3572752|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|181|181.0||||||
3735706|NCT02035553|3572753|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
3735707|NCT02035553|3572754|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3735708|NCT02035553|3572752|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735709|NCT02035553|3572753|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735710|NCT02035553|3572754|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735711|NCT02035553|3572752|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3735712|NCT02035553|3572753|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3735713|NCT02035553|3572754|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3735714|NCT02035553|3572752|B3||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3735715|NCT02035553|3572753|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3735716|NCT02035553|3572754|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3735717|NCT02035553|3572752|B3|Age|>85|Age, Customized||Participants|Count of Participants|99|99.0||||||
3735718|NCT02035553|3572753|B2|Age|>85|Age, Customized||Participants|Count of Participants|49|49.0||||||
3735719|NCT02035553|3572754|B1|Age|>85|Age, Customized||Participants|Count of Participants|50|50.0||||||
3735720|NCT02035553|3572752|B3|Age|<=85|Age, Customized||Participants|Count of Participants|82|82.0||||||
3735721|NCT02035553|3572753|B2|Age|<=85|Age, Customized||Participants|Count of Participants|41|41.0||||||
3735722|NCT02035553|3572754|B1|Age|<=85|Age, Customized||Participants|Count of Participants|41|41.0||||||
3735723|NCT02035553|3572752|B3|||Age||years|Mean|85.9|85.9|Standard Deviation|6.51|6.51|||
3735724|NCT02035553|3572753|B2|||Age||years|Mean|85.7|85.7|Standard Deviation|7.05|7.05|||
3735725|NCT02035553|3572754|B1|||Age||years|Mean|86.1|86.1|Standard Deviation|5.96|5.96|||
3735726|NCT02035475|3572761|B1||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3735727|NCT02035475|3572761|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3735728|NCT02035475|3572761|B1|||Age||years|Mean|62.2|62.2|Standard Deviation|7.4|7.4|||
3735729|NCT02035345|3572767|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3735730|NCT02035345|3572767|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735731|NCT02035345|3572767|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3735732|NCT02035345|3572767|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735733|NCT02035345|3572767|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735734|NCT02035345|3572767|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735735|NCT02035345|3572767|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735736|NCT02035345|3572767|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3735737|NCT02035345|3572767|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3735738|NCT02035345|3572767|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3735739|NCT02035345|3572767|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3735740|NCT02035345|3572767|B1||Female|Gender||Participants|Count of Participants|15|15.0||||||
3735741|NCT02035345|3572767|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3735742|NCT02035345|3572767|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3735743|NCT02035345|3572767|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3735744|NCT02035332|3572772|B1|||PBLAC Score (assessment of menstrual blood loss)|Pictorial Blood Loss Assessment Chart (PBLAC) is a tool used to assess menstrual blood loss. The PBLAC score takes into account the number of menstrual pads and tampons used as well as amount of saturation. A score of 0 represents no bleeding. Although the PBLAC score does not yield an exact measure of blood loss, it has been found to correlate well with menstrual blood volume. A score greater than 100 is correlated with a blood loss of at least 80 mL.|units on a scale|Mean|419.2|419.2|Standard Deviation|152.2|152.2|||
3735745|NCT02035332|3572772|B1|Hungary||Region of Enrollment||participants|Number|23|23.0||||||
3735746|NCT02035332|3572772|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3735747|NCT02035332|3572772|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3735748|NCT02035332|3572772|B1|||Age||years|Mean|43.9|43.9|Standard Deviation|3.5|3.5|||
3735749|NCT02034916|3572778|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3735750|NCT02034916|3572779|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3735751|NCT02034916|3572780|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3735752|NCT02034916|3572778|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3735753|NCT02034916|3572779|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3735754|NCT02034916|3572780|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3735755|NCT02034916|3572778|B3|||Age||years|Mean|51.5|51.5|Standard Deviation|11.35|11.35|||
3735756|NCT02034916|3572779|B2|||Age||years|Mean|53.4|53.4|Standard Deviation|11.05|11.05|||
3735757|NCT02034916|3572780|B1|||Age||years|Mean|50.1|50.1|Standard Deviation|11.48|11.48|||
3735758|NCT02034877|3572814|B3||Male|Sex: Female, Male||Participants|Count of Participants|678|678.0||||||
3735759|NCT02034877|3572815|B2||Male|Sex: Female, Male||Participants|Count of Participants|585|585.0||||||
3735760|NCT02034877|3572816|B1||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3735761|NCT02034877|3572814|B3||Female|Sex: Female, Male||Participants|Count of Participants|521|521.0||||||
3735762|NCT02034877|3572815|B2||Female|Sex: Female, Male||Participants|Count of Participants|414|414.0||||||
3735763|NCT02034877|3572816|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3735764|NCT02034877|3572814|B3|65 to 84 years||Age, Customized||Participants|Number|2|2.0||||||
3735765|NCT02034877|3572815|B2|65 to 84 years||Age, Customized||Participants|Number|2|2.0||||||
3735766|NCT02034877|3572816|B1|65 to 84 years||Age, Customized||Participants|Number|0|0.0||||||
3735767|NCT02034877|3572814|B3|50 to 64 years||Age, Customized||Participants|Number|997|997.0||||||
3735768|NCT02034877|3572815|B2|50 to 64 years||Age, Customized||Participants|Number|997|997.0||||||
3735769|NCT02034877|3572816|B1|50 to 64 years||Age, Customized||Participants|Number|0|0.0||||||
3735770|NCT02034877|3572814|B3|12 to 17 years||Age, Customized||Participants|Number|43|43.0||||||
3735771|NCT02034877|3572815|B2|12 to 17 years||Age, Customized||Participants|Number|0|0.0||||||
3735772|NCT02034877|3572816|B1|12 to 17 years||Age, Customized||Participants|Number|43|43.0||||||
3735773|NCT02034877|3572814|B3|6 to 11 years||Age, Customized||Participants|Number|157|157.0||||||
3735774|NCT02034877|3572815|B2|6 to 11 years||Age, Customized||Participants|Number|0|0.0||||||
3735775|NCT02034877|3572816|B1|6 to 11 years||Age, Customized||Participants|Number|157|157.0||||||
3735776|NCT02034799|3572833|B3|Never Smoked||Smoking Status||participants|Number|219|219.0||||||
3735777|NCT02034799|3572834|B2|Never Smoked||Smoking Status||participants|Number|112|112.0||||||
3735778|NCT02034799|3572835|B1|Never Smoked||Smoking Status||participants|Number|107|107.0||||||
3735779|NCT02034799|3572833|B3|Former Smoker||Smoking Status||participants|Number|7|7.0||||||
3735780|NCT02034799|3572834|B2|Former Smoker||Smoking Status||participants|Number|3|3.0||||||
3735781|NCT02034799|3572835|B1|Former Smoker||Smoking Status||participants|Number|4|4.0||||||
3735782|NCT02034799|3572833|B3|Current Smoker||Smoking Status||participants|Number|30|30.0||||||
3735783|NCT02034799|3572834|B2|Current Smoker||Smoking Status||participants|Number|12|12.0||||||
3735784|NCT02034799|3572835|B1|Current Smoker||Smoking Status||participants|Number|18|18.0||||||
3735785|NCT02034799|3572833|B3|Obese||BMI Group||participants|Number|11|11.0||||||
3735786|NCT02034799|3572834|B2|Obese||BMI Group||participants|Number|3|3.0||||||
3735787|NCT02034799|3572835|B1|Obese||BMI Group||participants|Number|8|8.0||||||
3735788|NCT02034799|3572833|B3|Overweight||BMI Group||participants|Number|49|49.0||||||
3735789|NCT02034799|3572834|B2|Overweight||BMI Group||participants|Number|27|27.0||||||
3735790|NCT02034799|3572835|B1|Overweight||BMI Group||participants|Number|22|22.0||||||
3735791|NCT02034799|3572833|B3|Normal||BMI Group||participants|Number|191|191.0||||||
3735792|NCT02034799|3572834|B2|Normal||BMI Group||participants|Number|95|95.0||||||
3735793|NCT02034799|3572835|B1|Normal||BMI Group||participants|Number|96|96.0||||||
3735794|NCT02034799|3572833|B3|Underweight||BMI Group||participants|Number|5|5.0||||||
3735795|NCT02034799|3572834|B2|Underweight||BMI Group||participants|Number|2|2.0||||||
3735796|NCT02034799|3572835|B1|Underweight||BMI Group||participants|Number|3|3.0||||||
3735797|NCT02034799|3572833|B3|||BMI||(kg/m^2)|Median|22.8|22.8|Full Range|||17.0|34.7|
3735798|NCT02034799|3572834|B2|||BMI||(kg/m^2)|Median|23.1|23.1|Full Range|||17.0|31.2|
3735799|NCT02034799|3572835|B1|||BMI||(kg/m^2)|Median|22.5|22.5|Full Range|||17.8|34.7|
3735800|NCT02034799|3572833|B3|||BMI||(kg/m^2)|Mean|23.2|23.2|Standard Deviation|3.1|3.1|||
3735801|NCT02034799|3572834|B2|||BMI||(kg/m^2)|Mean|23.2|23.2|Standard Deviation|2.8|2.8|||
3735802|NCT02034799|3572835|B1|||BMI||(kg/m^2)|Mean|23.2|23.2|Standard Deviation|3.4|3.4|||
3735803|NCT02034799|3572833|B3|||Weight||kg|Median|61|61.0|Full Range|||40.0|98.0|
3735804|NCT02034799|3572834|B2|||Weight||kg|Median|60|60.0|Full Range|||40.0|85.0|
3735805|NCT02034799|3572835|B1|||Weight||kg|Median|62|62.0|Full Range|||45.0|98.0|
3735806|NCT02034799|3572833|B3|||Weight||kg|Mean|62.6|62.6|Standard Deviation|9.6|9.6|||
3735807|NCT02034799|3572834|B2|||Weight||kg|Mean|62.2|62.2|Standard Deviation|8.8|8.8|||
3735808|NCT02034799|3572835|B1|||Weight||kg|Mean|62.9|62.9|Standard Deviation|10.3|10.3|||
3735809|NCT02034799|3572833|B3|||Height||cm|Median|162|162.0|Full Range|||141.0|180.0|
3735810|NCT02034799|3572834|B2|||Height||cm|Median|161|161.0|Full Range|||141.0|180.0|
3735811|NCT02034799|3572835|B1|||Height||cm|Median|163|163.0|Full Range|||152.0|180.0|
3735812|NCT02034799|3572833|B3|||Height||cm|Mean|164.1|164.1|Standard Deviation|7.3|7.3|||
3735813|NCT02034799|3572834|B2|||Height||cm|Mean|163.6|163.6|Standard Deviation|7.6|7.6|||
3735814|NCT02034799|3572835|B1|||Height||cm|Mean|164.5|164.5|Standard Deviation|7.0|7.0|||
3735815|NCT02034799|3572833|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3735816|NCT02034799|3572834|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3735817|NCT02034799|3572835|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3735818|NCT02034799|3572833|B3||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3735819|NCT02034799|3572834|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3735820|NCT02034799|3572835|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3735821|NCT02034799|3572833|B3|||Age||years|Mean|49.8|49.8|Standard Deviation|11.5|11.5|||
3735822|NCT02034799|3572834|B2|||Age||years|Mean|50.7|50.7|Standard Deviation|11.7|11.7|||
3735823|NCT02034799|3572835|B1|||Age||years|Mean|48.9|48.9|Standard Deviation|11.3|11.3|||
3735824|NCT02034799|3572833|B3||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
3735825|NCT02034799|3572834|B2||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
3735826|NCT02034799|3572835|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3735827|NCT02034799|3572833|B3||Between 18 and 65 years|Age||Participants|Count of Participants|204|204.0||||||
3735828|NCT02034799|3572834|B2||Between 18 and 65 years|Age||Participants|Count of Participants|98|98.0||||||
3735829|NCT02034799|3572835|B1||Between 18 and 65 years|Age||Participants|Count of Participants|106|106.0||||||
3735830|NCT02034799|3572833|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3735831|NCT02034799|3572834|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3735832|NCT02034799|3572835|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3735833|NCT02034708|3572848|B3|||Body Mass Index||kg per square metre|Mean|27.66|27.66|Standard Deviation|5.28|5.28|||
3735834|NCT02034708|3572849|B2|||Body Mass Index||kg per square metre|Mean|27.62|27.62|Standard Deviation|5.23|5.23|||
3735835|NCT02034708|3572850|B1|||Body Mass Index||kg per square metre|Mean|27.71|27.71|Standard Deviation|5.35|5.35|||
3735836|NCT02034708|3572848|B3|Mexico||Region of Enrollment||participants|Number|103|103.0||||||
3735837|NCT02034708|3572849|B2|Mexico||Region of Enrollment||participants|Number|51|51.0||||||
3735838|NCT02034708|3572850|B1|Mexico||Region of Enrollment||participants|Number|52|52.0||||||
3735839|NCT02034708|3572848|B3|Korea, Republic of||Region of Enrollment||participants|Number|47|47.0||||||
3735840|NCT02034708|3572849|B2|Korea, Republic of||Region of Enrollment||participants|Number|23|23.0||||||
3735841|NCT02034708|3572850|B1|Korea, Republic of||Region of Enrollment||participants|Number|24|24.0||||||
3735842|NCT02034708|3572848|B3|United States||Region of Enrollment||participants|Number|86|86.0||||||
3735843|NCT02034708|3572849|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
3735844|NCT02034708|3572850|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
3735845|NCT02034708|3572848|B3|Colombia||Region of Enrollment||participants|Number|32|32.0||||||
3735846|NCT02034708|3572849|B2|Colombia||Region of Enrollment||participants|Number|16|16.0||||||
3735847|NCT02034708|3572850|B1|Colombia||Region of Enrollment||participants|Number|16|16.0||||||
3735848|NCT02034708|3572848|B3||Male|Gender||Participants|Count of Participants|96|96.0||||||
3735849|NCT02034708|3572849|B2||Male|Gender||Participants|Count of Participants|45|45.0||||||
3735850|NCT02034708|3572850|B1||Male|Gender||Participants|Count of Participants|51|51.0||||||
3735851|NCT02034708|3572848|B3||Female|Gender||Participants|Count of Participants|172|172.0||||||
3735852|NCT02034708|3572849|B2||Female|Gender||Participants|Count of Participants|85|85.0||||||
3735853|NCT02034708|3572850|B1||Female|Gender||Participants|Count of Participants|87|87.0||||||
3735854|NCT02034708|3572848|B3|||Age||years|Mean|53.6|53.6|Standard Deviation|15.1|15.1|||
3735855|NCT02034708|3572849|B2|||Age||years|Mean|54.4|54.4|Standard Deviation|15.1|15.1|||
3735856|NCT02034708|3572850|B1|||Age||years|Mean|52.9|52.9|Standard Deviation|15.2|15.2|||
3735857|NCT02034591|3572862|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3735858|NCT02034591|3572862|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3735859|NCT02034591|3572862|B1|||Age||years|Mean|36.7|36.7|Full Range|||22.0|45.0|
3735860|NCT02034578|3572890|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3735861|NCT02034578|3572890|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3735862|NCT02034578|3572890|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3735863|NCT02034578|3572890|B1|||Age||years|Mean|33|33.0|Standard Deviation|6.7|6.7|||
3735864|NCT02034565|3572922|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3735865|NCT02034565|3572922|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3735866|NCT02034565|3572922|B1|||Age||years|Mean|36|36.0|Full Range|||28.0|44.0|
3735867|NCT02034552|3572937|B4||PS1|Eastern Cooperative Oncology Group|ECOG = Eastern cooperative oncology group PS levels are 0 (Fully active, able to carry on all pre-disease performance), 1 (ambulatory and able to carry out work of a light or sedentary), 2 (Ambulatory and capable of all selfcare but unable to carry out any work activities), 3 (Capable of only limited selfcare, confined to bed or chair more than 50% of awake time), 4 (Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair) and 5 (death).|Participants|Count of Participants|27|27.0||||||
3735868|NCT02034552|3572938|B3||PS1|Eastern Cooperative Oncology Group|ECOG = Eastern cooperative oncology group PS levels are 0 (Fully active, able to carry on all pre-disease performance), 1 (ambulatory and able to carry out work of a light or sedentary), 2 (Ambulatory and capable of all selfcare but unable to carry out any work activities), 3 (Capable of only limited selfcare, confined to bed or chair more than 50% of awake time), 4 (Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair) and 5 (death).|Participants|Count of Participants|9|9.0||||||
3735869|NCT02034552|3572939|B2||PS1|Eastern Cooperative Oncology Group|ECOG = Eastern cooperative oncology group PS levels are 0 (Fully active, able to carry on all pre-disease performance), 1 (ambulatory and able to carry out work of a light or sedentary), 2 (Ambulatory and capable of all selfcare but unable to carry out any work activities), 3 (Capable of only limited selfcare, confined to bed or chair more than 50% of awake time), 4 (Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair) and 5 (death).|Participants|Count of Participants|10|10.0||||||
3735870|NCT02034552|3572940|B1||PS1|Eastern Cooperative Oncology Group|ECOG = Eastern cooperative oncology group PS levels are 0 (Fully active, able to carry on all pre-disease performance), 1 (ambulatory and able to carry out work of a light or sedentary), 2 (Ambulatory and capable of all selfcare but unable to carry out any work activities), 3 (Capable of only limited selfcare, confined to bed or chair more than 50% of awake time), 4 (Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair) and 5 (death).|Participants|Count of Participants|8|8.0||||||
3735871|NCT02034552|3572937|B4||PS 0|Eastern Cooperative Oncology Group|ECOG = Eastern cooperative oncology group PS levels are 0 (Fully active, able to carry on all pre-disease performance), 1 (ambulatory and able to carry out work of a light or sedentary), 2 (Ambulatory and capable of all selfcare but unable to carry out any work activities), 3 (Capable of only limited selfcare, confined to bed or chair more than 50% of awake time), 4 (Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair) and 5 (death).|Participants|Count of Participants|36|36.0||||||
3735872|NCT02034552|3572938|B3||PS 0|Eastern Cooperative Oncology Group|ECOG = Eastern cooperative oncology group PS levels are 0 (Fully active, able to carry on all pre-disease performance), 1 (ambulatory and able to carry out work of a light or sedentary), 2 (Ambulatory and capable of all selfcare but unable to carry out any work activities), 3 (Capable of only limited selfcare, confined to bed or chair more than 50% of awake time), 4 (Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair) and 5 (death).|Participants|Count of Participants|13|13.0||||||
3735873|NCT02034552|3572939|B2||PS 0|Eastern Cooperative Oncology Group|ECOG = Eastern cooperative oncology group PS levels are 0 (Fully active, able to carry on all pre-disease performance), 1 (ambulatory and able to carry out work of a light or sedentary), 2 (Ambulatory and capable of all selfcare but unable to carry out any work activities), 3 (Capable of only limited selfcare, confined to bed or chair more than 50% of awake time), 4 (Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair) and 5 (death).|Participants|Count of Participants|12|12.0||||||
3735874|NCT02034552|3572940|B1||PS 0|Eastern Cooperative Oncology Group|ECOG = Eastern cooperative oncology group PS levels are 0 (Fully active, able to carry on all pre-disease performance), 1 (ambulatory and able to carry out work of a light or sedentary), 2 (Ambulatory and capable of all selfcare but unable to carry out any work activities), 3 (Capable of only limited selfcare, confined to bed or chair more than 50% of awake time), 4 (Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair) and 5 (death).|Participants|Count of Participants|11|11.0||||||
3735875|NCT02034552|3572937|B4||Missing|Eastern Cooperative Oncology Group|ECOG = Eastern cooperative oncology group PS levels are 0 (Fully active, able to carry on all pre-disease performance), 1 (ambulatory and able to carry out work of a light or sedentary), 2 (Ambulatory and capable of all selfcare but unable to carry out any work activities), 3 (Capable of only limited selfcare, confined to bed or chair more than 50% of awake time), 4 (Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair) and 5 (death).|Participants|Count of Participants|5|5.0||||||
3735876|NCT02034552|3572938|B3||Missing|Eastern Cooperative Oncology Group|ECOG = Eastern cooperative oncology group PS levels are 0 (Fully active, able to carry on all pre-disease performance), 1 (ambulatory and able to carry out work of a light or sedentary), 2 (Ambulatory and capable of all selfcare but unable to carry out any work activities), 3 (Capable of only limited selfcare, confined to bed or chair more than 50% of awake time), 4 (Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair) and 5 (death).|Participants|Count of Participants|0|0.0||||||
3735921|NCT02034474|3572984|B3|||PANSS Total|Positive and Negative Symptom Scale, Total Score (Sum of all subscales) Minimum = 30, Maximum = 210 Higher score = greater symptomatology|panss score|Mean|72.22|72.22|Standard Deviation|14.24|14.24|||
3735877|NCT02034552|3572939|B2||Missing|Eastern Cooperative Oncology Group|ECOG = Eastern cooperative oncology group PS levels are 0 (Fully active, able to carry on all pre-disease performance), 1 (ambulatory and able to carry out work of a light or sedentary), 2 (Ambulatory and capable of all selfcare but unable to carry out any work activities), 3 (Capable of only limited selfcare, confined to bed or chair more than 50% of awake time), 4 (Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair) and 5 (death).|Participants|Count of Participants|2|2.0||||||
3735878|NCT02034552|3572940|B1||Missing|Eastern Cooperative Oncology Group|ECOG = Eastern cooperative oncology group PS levels are 0 (Fully active, able to carry on all pre-disease performance), 1 (ambulatory and able to carry out work of a light or sedentary), 2 (Ambulatory and capable of all selfcare but unable to carry out any work activities), 3 (Capable of only limited selfcare, confined to bed or chair more than 50% of awake time), 4 (Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair) and 5 (death).|Participants|Count of Participants|3|3.0||||||
3735879|NCT02034552|3572937|B4||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3735880|NCT02034552|3572938|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3735881|NCT02034552|3572939|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3735882|NCT02034552|3572940|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3735883|NCT02034552|3572937|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3735884|NCT02034552|3572938|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3735885|NCT02034552|3572939|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3735886|NCT02034552|3572940|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3735887|NCT02034552|3572937|B4|||Age||Years|Mean|70.3|70.3|Standard Deviation|9.1|9.1|||
3735888|NCT02034552|3572938|B3|||Age||Years|Mean|71.0|71.0|Standard Deviation|8.7|8.7|||
3735889|NCT02034552|3572939|B2|||Age||Years|Mean|68.6|68.6|Standard Deviation|8.6|8.6|||
3735890|NCT02034552|3572940|B1|||Age||Years|Mean|71.5|71.5|Standard Deviation|10.2|10.2|||
3735891|NCT02034513|3572965|B3|||Fasting plasma glucose (FPG)||mg/dL|Mean|169.8|169.8|Standard Deviation|79.6|79.6|||
3735892|NCT02034513|3572966|B2|||Fasting plasma glucose (FPG)||mg/dL|Mean|174.4|174.4|Standard Deviation|81.7|81.7|||
3735893|NCT02034513|3572967|B1|||Fasting plasma glucose (FPG)||mg/dL|Mean|165.1|165.1|Standard Deviation|77.3|77.3|||
3735894|NCT02034513|3572965|B3|||Glycosylated hemoglobin (HbA1c)||Percentage of HbA1c|Mean|7.6|7.6|Standard Deviation|1.0|1.0|||
3735895|NCT02034513|3572966|B2|||Glycosylated hemoglobin (HbA1c)||Percentage of HbA1c|Mean|7.5|7.5|Standard Deviation|1.0|1.0|||
3735896|NCT02034513|3572967|B1|||Glycosylated hemoglobin (HbA1c)||Percentage of HbA1c|Mean|7.7|7.7|Standard Deviation|1.0|1.0|||
3735897|NCT02034513|3572965|B3||Male|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
3735898|NCT02034513|3572966|B2||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3735899|NCT02034513|3572967|B1||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3735900|NCT02034513|3572965|B3||Female|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
3735901|NCT02034513|3572966|B2||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3735902|NCT02034513|3572967|B1||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3735903|NCT02034513|3572965|B3|||Age||years|Mean|45.9|45.9|Standard Deviation|14.2|14.2|||
3735904|NCT02034513|3572966|B2|||Age||years|Mean|46.4|46.4|Standard Deviation|14.6|14.6|||
3735905|NCT02034513|3572967|B1|||Age||years|Mean|45.4|45.4|Standard Deviation|13.7|13.7|||
3735906|NCT02034474|3572984|B3|||Clinical Global Impression - Severity Scale|"Clinician-rated severity of illness~Normal, not at all ill~Borderline mentally ill~Mildly ill~Moderately ill~Markedly ill~Severely ill~Among the most extremely ill patients"|units on a scale|Mean|4|4.0|Standard Deviation|0.5|0.5|||
3735907|NCT02034474|3572985|B2|||Clinical Global Impression - Severity Scale|"Clinician-rated severity of illness~Normal, not at all ill~Borderline mentally ill~Mildly ill~Moderately ill~Markedly ill~Severely ill~Among the most extremely ill patients"|units on a scale|Mean|4|4.0|Standard Deviation|0.3|0.3|||
3735908|NCT02034474|3572986|B1|||Clinical Global Impression - Severity Scale|"Clinician-rated severity of illness~Normal, not at all ill~Borderline mentally ill~Mildly ill~Moderately ill~Markedly ill~Severely ill~Among the most extremely ill patients"|units on a scale|Mean|4|4.0|Standard Deviation|0.4|0.4|||
3735909|NCT02034474|3572984|B3|||weight||pounds|Mean|211.36|211.36|Standard Deviation|44.01|44.01|||
3735910|NCT02034474|3572985|B2|||weight||pounds|Mean|218.63|218.63|Standard Deviation|45.24|45.24|||
3735911|NCT02034474|3572986|B1|||weight||pounds|Mean|203.24|203.24|Standard Deviation|51.95|51.95|||
3735912|NCT02034474|3572984|B3|||chlorpromazine equivalents|Dosages of antipsychotic medications for each individual were converted to corresponding equivalent dose of chlorpromazine, in milligrams|milligrams|Mean|310|310.0|Standard Deviation|396|396.0|||
3735913|NCT02034474|3572985|B2|||chlorpromazine equivalents|Dosages of antipsychotic medications for each individual were converted to corresponding equivalent dose of chlorpromazine, in milligrams|milligrams|Mean|257|257.0|Standard Deviation|192|192.0|||
3735914|NCT02034474|3572986|B1|||chlorpromazine equivalents|Dosages of antipsychotic medications for each individual were converted to corresponding equivalent dose of chlorpromazine, in milligrams|milligrams|Mean|377|377.0|Standard Deviation|346|346.0|||
3735915|NCT02034474|3572984|B3|||cigs /day||cigarettes per day|Mean|9|9.0|Standard Deviation|4|4.0|||
3735916|NCT02034474|3572985|B2|||cigs /day||cigarettes per day|Mean|10|10.0|Standard Deviation|5|5.0|||
3735917|NCT02034474|3572986|B1|||cigs /day||cigarettes per day|Mean|8|8.0|Standard Deviation|3|3.0|||
3735918|NCT02034474|3572984|B3|||Smoker||Participants|Count of Participants|15|15.0||||||
3735919|NCT02034474|3572985|B2|||Smoker||Participants|Count of Participants|8|8.0||||||
3735920|NCT02034474|3572986|B1|||Smoker||Participants|Count of Participants|7|7.0||||||
3735978|NCT02034162|3572997|B3|ETHIOPIA||Region of Enrollment||participants|Number|255|255.0||||||
3735922|NCT02034474|3572985|B2|||PANSS Total|Positive and Negative Symptom Scale, Total Score (Sum of all subscales) Minimum = 30, Maximum = 210 Higher score = greater symptomatology|panss score|Mean|70.68|70.68|Standard Deviation|11.2|11.2|||
3735923|NCT02034474|3572986|B1|||PANSS Total|Positive and Negative Symptom Scale, Total Score (Sum of all subscales) Minimum = 30, Maximum = 210 Higher score = greater symptomatology|panss score|Mean|73.94|73.94|Standard Deviation|15.52|15.52|||
3735924|NCT02034474|3572984|B3|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3735925|NCT02034474|3572985|B2|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3735926|NCT02034474|3572986|B1|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3735927|NCT02034474|3572984|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735928|NCT02034474|3572985|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735929|NCT02034474|3572986|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735930|NCT02034474|3572984|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3735931|NCT02034474|3572985|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3735932|NCT02034474|3572986|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3735933|NCT02034474|3572984|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3735934|NCT02034474|3572985|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3735935|NCT02034474|3572986|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3735936|NCT02034474|3572984|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3735937|NCT02034474|3572985|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3735938|NCT02034474|3572986|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3735939|NCT02034474|3572984|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735940|NCT02034474|3572985|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735941|NCT02034474|3572986|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735942|NCT02034474|3572984|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3735943|NCT02034474|3572985|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735944|NCT02034474|3572986|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3735945|NCT02034474|3572984|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735946|NCT02034474|3572985|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735947|NCT02034474|3572986|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735948|NCT02034474|3572984|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735949|NCT02034474|3572985|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735950|NCT02034474|3572986|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3735951|NCT02034474|3572984|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3735952|NCT02034474|3572985|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3735953|NCT02034474|3572986|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3735954|NCT02034474|3572984|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3735955|NCT02034474|3572985|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3735956|NCT02034474|3572986|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3735957|NCT02034474|3572984|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3735958|NCT02034474|3572985|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3735959|NCT02034474|3572986|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3735960|NCT02034474|3572984|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3735961|NCT02034474|3572985|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3735962|NCT02034474|3572986|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3735963|NCT02034474|3572984|B3|||Age||yrs|Mean|42.50|42.5|Standard Deviation|10.76|10.76|||
3735964|NCT02034474|3572985|B2|||Age||yrs|Mean|43.24|43.24|Standard Deviation|11.42|11.42|||
3735965|NCT02034474|3572986|B1|||Age||yrs|Mean|41.67|41.67|Standard Deviation|10.25|10.25|||
3735966|NCT02034474|3572984|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3735967|NCT02034474|3572985|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3735968|NCT02034474|3572986|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3735969|NCT02034474|3572984|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3735970|NCT02034474|3572985|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3735971|NCT02034474|3572986|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3735972|NCT02034474|3572984|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3735973|NCT02034474|3572985|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3735974|NCT02034474|3572986|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3735975|NCT02034162|3572997|B3|RWANDA||Region of Enrollment||participants|Number|40|40.0||||||
3735976|NCT02034162|3572998|B2|RWANDA||Region of Enrollment||participants|Number|21|21.0||||||
3735977|NCT02034162|3572999|B1|RWANDA||Region of Enrollment||participants|Number|19|19.0||||||
3735979|NCT02034162|3572998|B2|ETHIOPIA||Region of Enrollment||participants|Number|128|128.0||||||
3735980|NCT02034162|3572999|B1|ETHIOPIA||Region of Enrollment||participants|Number|127|127.0||||||
3735981|NCT02034162|3572997|B3||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3735982|NCT02034162|3572998|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3735983|NCT02034162|3572999|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3735984|NCT02034162|3572997|B3||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3735985|NCT02034162|3572998|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3735986|NCT02034162|3572999|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3735987|NCT02034162|3572997|B3|||Age||years|Mean|7.8|7.8|Standard Deviation|3.18|3.18|||
3735988|NCT02034162|3572998|B2|||Age||years|Mean|7.9|7.9|Standard Deviation|3.27|3.27|||
3735989|NCT02034162|3572999|B1|||Age||years|Mean|7.7|7.7|Standard Deviation|3.09|3.09|||
3735990|NCT02033889|3573029|B4|||Estimated Glomerular Filtration Rate (eGFR)||mL/min/1.73 m^2|Mean|90.5|90.5|Standard Deviation|19.3|19.3|||
3735991|NCT02033889|3573030|B3|||Estimated Glomerular Filtration Rate (eGFR)||mL/min/1.73 m^2|Mean|91.1|91.1|Standard Deviation|20.6|20.6|||
3735992|NCT02033889|3573031|B2|||Estimated Glomerular Filtration Rate (eGFR)||mL/min/1.73 m^2|Mean|88.9|88.9|Standard Deviation|17.5|17.5|||
3735993|NCT02033889|3573032|B1|||Estimated Glomerular Filtration Rate (eGFR)||mL/min/1.73 m^2|Mean|91.6|91.6|Standard Deviation|19.8|19.8|||
3735994|NCT02033889|3573029|B4|Women ≥3 years postmenopausal||Menopausal Status|Menopausal status includes men, premenopausal women, women who are perimenopausal or <3 years postmenopausal, women who are ≥3 years postmenopausal.|Participants|Count of Participants|254|254.0||||||
3735995|NCT02033889|3573030|B3|Women ≥3 years postmenopausal||Menopausal Status|Menopausal status includes men, premenopausal women, women who are perimenopausal or <3 years postmenopausal, women who are ≥3 years postmenopausal.|Participants|Count of Participants|85|85.0||||||
3735996|NCT02033889|3573031|B2|Women ≥3 years postmenopausal||Menopausal Status|Menopausal status includes men, premenopausal women, women who are perimenopausal or <3 years postmenopausal, women who are ≥3 years postmenopausal.|Participants|Count of Participants|83|83.0||||||
3735997|NCT02033889|3573032|B1|Women ≥3 years postmenopausal||Menopausal Status|Menopausal status includes men, premenopausal women, women who are perimenopausal or <3 years postmenopausal, women who are ≥3 years postmenopausal.|Participants|Count of Participants|86|86.0||||||
3735998|NCT02033889|3573029|B4|Perimenopausal or <3 yrs. postmen.||Menopausal Status|Menopausal status includes men, premenopausal women, women who are perimenopausal or <3 years postmenopausal, women who are ≥3 years postmenopausal.|Participants|Count of Participants|30|30.0||||||
3735999|NCT02033889|3573030|B3|Perimenopausal or <3 yrs. postmen.||Menopausal Status|Menopausal status includes men, premenopausal women, women who are perimenopausal or <3 years postmenopausal, women who are ≥3 years postmenopausal.|Participants|Count of Participants|11|11.0||||||
3736000|NCT02033889|3573031|B2|Perimenopausal or <3 yrs. postmen.||Menopausal Status|Menopausal status includes men, premenopausal women, women who are perimenopausal or <3 years postmenopausal, women who are ≥3 years postmenopausal.|Participants|Count of Participants|10|10.0||||||
3736001|NCT02033889|3573032|B1|Perimenopausal or <3 yrs. postmen.||Menopausal Status|Menopausal status includes men, premenopausal women, women who are perimenopausal or <3 years postmenopausal, women who are ≥3 years postmenopausal.|Participants|Count of Participants|9|9.0||||||
3736002|NCT02033889|3573029|B4|Premenopausal Women||Menopausal Status|Menopausal status includes men, premenopausal women, women who are perimenopausal or <3 years postmenopausal, women who are ≥3 years postmenopausal.|Participants|Count of Participants|49|49.0||||||
3736003|NCT02033889|3573030|B3|Premenopausal Women||Menopausal Status|Menopausal status includes men, premenopausal women, women who are perimenopausal or <3 years postmenopausal, women who are ≥3 years postmenopausal.|Participants|Count of Participants|16|16.0||||||
3736004|NCT02033889|3573031|B2|Premenopausal Women||Menopausal Status|Menopausal status includes men, premenopausal women, women who are perimenopausal or <3 years postmenopausal, women who are ≥3 years postmenopausal.|Participants|Count of Participants|17|17.0||||||
3736005|NCT02033889|3573032|B1|Premenopausal Women||Menopausal Status|Menopausal status includes men, premenopausal women, women who are perimenopausal or <3 years postmenopausal, women who are ≥3 years postmenopausal.|Participants|Count of Participants|16|16.0||||||
3736006|NCT02033889|3573029|B4|Male||Menopausal Status|Menopausal status includes men, premenopausal women, women who are perimenopausal or <3 years postmenopausal, women who are ≥3 years postmenopausal.|Participants|Count of Participants|288|288.0||||||
3736007|NCT02033889|3573030|B3|Male||Menopausal Status|Menopausal status includes men, premenopausal women, women who are perimenopausal or <3 years postmenopausal, women who are ≥3 years postmenopausal.|Participants|Count of Participants|93|93.0||||||
3736008|NCT02033889|3573031|B2|Male||Menopausal Status|Menopausal status includes men, premenopausal women, women who are perimenopausal or <3 years postmenopausal, women who are ≥3 years postmenopausal.|Participants|Count of Participants|97|97.0||||||
3736009|NCT02033889|3573032|B1|Male||Menopausal Status|Menopausal status includes men, premenopausal women, women who are perimenopausal or <3 years postmenopausal, women who are ≥3 years postmenopausal.|Participants|Count of Participants|98|98.0||||||
3736010|NCT02033889|3573029|B4|||Bone Biomarker Parathyroid Hormone (PTH)|PTH is a biochemical marker of bone resorption.|ng/L|Mean|19.59|19.59|Standard Deviation|7.62|7.62|||
3736011|NCT02033889|3573030|B3|||Bone Biomarker Parathyroid Hormone (PTH)|PTH is a biochemical marker of bone resorption.|ng/L|Mean|19.97|19.97|Standard Deviation|7.73|7.73|||
3736012|NCT02033889|3573031|B2|||Bone Biomarker Parathyroid Hormone (PTH)|PTH is a biochemical marker of bone resorption.|ng/L|Mean|19.52|19.52|Standard Deviation|6.91|6.91|||
3736013|NCT02033889|3573032|B1|||Bone Biomarker Parathyroid Hormone (PTH)|PTH is a biochemical marker of bone resorption.|ng/L|Mean|19.29|19.29|Standard Deviation|8.17|8.17|||
3736014|NCT02033889|3573029|B4|||Bone Biomarker Procollagen Type I N-terminal Propeptide (P1NP)|P1NP is a biochemical marker of bone resorption.|microgm/L|Mean|32.1|32.1|Standard Deviation|15.3|15.3|||
3736015|NCT02033889|3573030|B3|||Bone Biomarker Procollagen Type I N-terminal Propeptide (P1NP)|P1NP is a biochemical marker of bone resorption.|microgm/L|Mean|31.6|31.6|Standard Deviation|16.5|16.5|||
3736016|NCT02033889|3573031|B2|||Bone Biomarker Procollagen Type I N-terminal Propeptide (P1NP)|P1NP is a biochemical marker of bone resorption.|microgm/L|Mean|32.8|32.8|Standard Deviation|14.5|14.5|||
3736017|NCT02033889|3573032|B1|||Bone Biomarker Procollagen Type I N-terminal Propeptide (P1NP)|P1NP is a biochemical marker of bone resorption.|microgm/L|Mean|32.0|32.0|Standard Deviation|15.0|15.0|||
3736018|NCT02033889|3573029|B4|||Bone Biomarker Carboxy-Terminal Cross-Linking Telopeptides of Type I Collagen (CTX)|CTX is a biochemical marker of bone resorption.|ng/L|Mean|269.4|269.4|Standard Deviation|132.5|132.5|||
3736019|NCT02033889|3573030|B3|||Bone Biomarker Carboxy-Terminal Cross-Linking Telopeptides of Type I Collagen (CTX)|CTX is a biochemical marker of bone resorption.|ng/L|Mean|273.0|273.0|Standard Deviation|135.2|135.2|||
3736020|NCT02033889|3573031|B2|||Bone Biomarker Carboxy-Terminal Cross-Linking Telopeptides of Type I Collagen (CTX)|CTX is a biochemical marker of bone resorption.|ng/L|Mean|266.9|266.9|Standard Deviation|129.9|129.9|||
3736021|NCT02033889|3573032|B1|||Bone Biomarker Carboxy-Terminal Cross-Linking Telopeptides of Type I Collagen (CTX)|CTX is a biochemical marker of bone resorption.|ng/L|Mean|268.3|268.3|Standard Deviation|132.9|132.9|||
3736022|NCT02033889|3573029|B4|||BMD as Measured by DXA at the Distal Forearm|BMD at the distal forearm was assessed by DXA at baseline.|g/cm^2|Mean|0.80|0.8|Standard Deviation|0.14|0.14|||
3736023|NCT02033889|3573030|B3|||BMD as Measured by DXA at the Distal Forearm|BMD at the distal forearm was assessed by DXA at baseline.|g/cm^2|Mean|0.79|0.79|Standard Deviation|0.13|0.13|||
3736024|NCT02033889|3573031|B2|||BMD as Measured by DXA at the Distal Forearm|BMD at the distal forearm was assessed by DXA at baseline.|g/cm^2|Mean|0.81|0.81|Standard Deviation|0.14|0.14|||
3736025|NCT02033889|3573032|B1|||BMD as Measured by DXA at the Distal Forearm|BMD at the distal forearm was assessed by DXA at baseline.|g/cm^2|Mean|0.81|0.81|Standard Deviation|0.14|0.14|||
3736026|NCT02033889|3573029|B4|||BMD as Measured by DXA of the Total hip|BMD at the total hip was assessed by DXA at baseline.|g/cm^2|Mean|1.06|1.06|Standard Deviation|0.15|0.15|||
3736027|NCT02033889|3573030|B3|||BMD as Measured by DXA of the Total hip|BMD at the total hip was assessed by DXA at baseline.|g/cm^2|Mean|1.04|1.04|Standard Deviation|0.14|0.14|||
3736028|NCT02033889|3573031|B2|||BMD as Measured by DXA of the Total hip|BMD at the total hip was assessed by DXA at baseline.|g/cm^2|Mean|1.07|1.07|Standard Deviation|0.15|0.15|||
3736029|NCT02033889|3573032|B1|||BMD as Measured by DXA of the Total hip|BMD at the total hip was assessed by DXA at baseline.|g/cm^2|Mean|1.06|1.06|Standard Deviation|0.15|0.15|||
3736030|NCT02033889|3573029|B4|||BMD as Measured by DXA of the Lumbar Spine (L1-L4)|BMD at the lumbar spine (L1-L4) was assessed by DXA at baseline.|g/cm^2|Mean|1.13|1.13|Standard Deviation|0.18|0.18|||
3736031|NCT02033889|3573030|B3|||BMD as Measured by DXA of the Lumbar Spine (L1-L4)|BMD at the lumbar spine (L1-L4) was assessed by DXA at baseline.|g/cm^2|Mean|1.10|1.1|Standard Deviation|0.17|0.17|||
3736032|NCT02033889|3573031|B2|||BMD as Measured by DXA of the Lumbar Spine (L1-L4)|BMD at the lumbar spine (L1-L4) was assessed by DXA at baseline.|g/cm^2|Mean|1.13|1.13|Standard Deviation|0.18|0.18|||
3736033|NCT02033889|3573032|B1|||BMD as Measured by DXA of the Lumbar Spine (L1-L4)|BMD at the lumbar spine (L1-L4) was assessed by DXA at baseline.|g/cm^2|Mean|1.15|1.15|Standard Deviation|0.18|0.18|||
3736034|NCT02033889|3573029|B4|||Bone Mineral Density (BMD) as Measured by Dual Energy X-Ray Absorptiometry (DXA) of the Femoral Neck|BMD at the femoral neck was assessed by DXA at baseline.|g/cm^2|Mean|0.91|0.91|Standard Deviation|0.16|0.16|||
3736035|NCT02033889|3573030|B3|||Bone Mineral Density (BMD) as Measured by Dual Energy X-Ray Absorptiometry (DXA) of the Femoral Neck|BMD at the femoral neck was assessed by DXA at baseline.|g/cm^2|Mean|0.89|0.89|Standard Deviation|0.15|0.15|||
3736036|NCT02033889|3573031|B2|||Bone Mineral Density (BMD) as Measured by Dual Energy X-Ray Absorptiometry (DXA) of the Femoral Neck|BMD at the femoral neck was assessed by DXA at baseline.|g/cm^2|Mean|0.92|0.92|Standard Deviation|0.16|0.16|||
3736037|NCT02033889|3573032|B1|||Bone Mineral Density (BMD) as Measured by Dual Energy X-Ray Absorptiometry (DXA) of the Femoral Neck|BMD at the femoral neck was assessed by DXA at baseline.|g/cm^2|Mean|0.92|0.92|Standard Deviation|0.17|0.17|||
3736038|NCT02033889|3573029|B4|||Diastolic Blood Pressure (DBP)||mmHg|Mean|77.99|77.99|Standard Deviation|7.78|7.78|||
3736039|NCT02033889|3573030|B3|||Diastolic Blood Pressure (DBP)||mmHg|Mean|78.08|78.08|Standard Deviation|7.45|7.45|||
3736040|NCT02033889|3573031|B2|||Diastolic Blood Pressure (DBP)||mmHg|Mean|78.45|78.45|Standard Deviation|8.32|8.32|||
3736041|NCT02033889|3573032|B1|||Diastolic Blood Pressure (DBP)||mmHg|Mean|77.45|77.45|Standard Deviation|7.55|7.55|||
3736042|NCT02033889|3573029|B4|||Sitting Systolic Blood Pressure (SBP)||mmHg|Mean|130.05|130.05|Standard Deviation|13.80|13.8|||
3736043|NCT02033889|3573030|B3|||Sitting Systolic Blood Pressure (SBP)||mmHg|Mean|130.37|130.37|Standard Deviation|12.00|12.0|||
3736044|NCT02033889|3573031|B2|||Sitting Systolic Blood Pressure (SBP)||mmHg|Mean|130.48|130.48|Standard Deviation|13.77|13.77|||
3736045|NCT02033889|3573032|B1|||Sitting Systolic Blood Pressure (SBP)||mmHg|Mean|129.30|129.3|Standard Deviation|15.43|15.43|||
3736046|NCT02033889|3573029|B4|||Body Weight||Kilograms|Mean|84.9|84.9|Standard Deviation|16.9|16.9|||
3736047|NCT02033889|3573030|B3|||Body Weight||Kilograms|Mean|85.3|85.3|Standard Deviation|16.5|16.5|||
3736048|NCT02033889|3573031|B2|||Body Weight||Kilograms|Mean|84.8|84.8|Standard Deviation|17.2|17.2|||
3736049|NCT02033889|3573032|B1|||Body Weight||Kilograms|Mean|84.5|84.5|Standard Deviation|17.1|17.1|||
3736050|NCT02033889|3573029|B4|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|168.3|168.3|Standard Deviation|43.8|43.8|||
3736051|NCT02033889|3573030|B3|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|167.5|167.5|Standard Deviation|44.4|44.4|||
3736052|NCT02033889|3573031|B2|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|168.1|168.1|Standard Deviation|45.5|45.5|||
3736053|NCT02033889|3573032|B1|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|169.1|169.1|Standard Deviation|41.7|41.7|||
3736054|NCT02033889|3573029|B4|||Baseline Hemoglobin A1C (A1C)|Percentage A1C is the ratio of glycated hemoglobin to total hemoglobin x 100.|Percentage A1C|Mean|8.12|8.12|Standard Deviation|0.90|0.9|||
3736055|NCT02033889|3573030|B3|||Baseline Hemoglobin A1C (A1C)|Percentage A1C is the ratio of glycated hemoglobin to total hemoglobin x 100.|Percentage A1C|Mean|8.13|8.13|Standard Deviation|0.93|0.93|||
3736056|NCT02033889|3573031|B2|||Baseline Hemoglobin A1C (A1C)|Percentage A1C is the ratio of glycated hemoglobin to total hemoglobin x 100.|Percentage A1C|Mean|8.06|8.06|Standard Deviation|0.89|0.89|||
3736057|NCT02033889|3573032|B1|||Baseline Hemoglobin A1C (A1C)|Percentage A1C is the ratio of glycated hemoglobin to total hemoglobin x 100.|Percentage A1C|Mean|8.17|8.17|Standard Deviation|0.90|0.9|||
3736058|NCT02033889|3573029|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736059|NCT02033889|3573030|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736060|NCT02033889|3573031|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736061|NCT02033889|3573032|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736062|NCT02033889|3573029|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3736063|NCT02033889|3573030|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3736064|NCT02033889|3573031|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3736065|NCT02033889|3573032|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3736066|NCT02033889|3573029|B4||White|Race (NIH/OMB)||Participants|Count of Participants|411|411.0||||||
3736067|NCT02033889|3573030|B3||White|Race (NIH/OMB)||Participants|Count of Participants|133|133.0||||||
3736068|NCT02033889|3573031|B2||White|Race (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
3736069|NCT02033889|3573032|B1||White|Race (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
3736070|NCT02033889|3573029|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3736071|NCT02033889|3573030|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3736072|NCT02033889|3573031|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3736073|NCT02033889|3573032|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3736074|NCT02033889|3573029|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736075|NCT02033889|3573030|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736076|NCT02033889|3573031|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736077|NCT02033889|3573032|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736078|NCT02033889|3573029|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3736079|NCT02033889|3573030|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3736080|NCT02033889|3573031|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3736081|NCT02033889|3573032|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3736082|NCT02033889|3573029|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736083|NCT02033889|3573030|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736084|NCT02033889|3573031|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736085|NCT02033889|3573032|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736086|NCT02033889|3573029|B4||Male|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
3736087|NCT02033889|3573030|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3736088|NCT02033889|3573031|B2||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3736089|NCT02033889|3573032|B1||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3736090|NCT02033889|3573029|B4||Female|Sex: Female, Male||Participants|Count of Participants|333|333.0||||||
3736091|NCT02033889|3573030|B3||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3736092|NCT02033889|3573031|B2||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3736093|NCT02033889|3573032|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3736094|NCT02033889|3573029|B4|||Age||Years|Mean|56.6|56.6|Standard Deviation|8.8|8.8|||
3736095|NCT02033889|3573030|B3|||Age||Years|Mean|56.9|56.9|Standard Deviation|9.4|9.4|||
3736096|NCT02033889|3573031|B2|||Age||Years|Mean|56.6|56.6|Standard Deviation|8.2|8.2|||
3736097|NCT02033889|3573032|B1|||Age||Years|Mean|56.5|56.5|Standard Deviation|8.7|8.7|||
3736098|NCT02033499|3573186|B4|United States||Region of Enrollment||participants|Number|450|450.0||||||
3736099|NCT02033499|3573187|B3|United States||Region of Enrollment||participants|Number|148|148.0||||||
3736100|NCT02033499|3573188|B2|United States||Region of Enrollment||participants|Number|150|150.0||||||
3736101|NCT02033499|3573189|B1|United States||Region of Enrollment||participants|Number|152|152.0||||||
3736102|NCT02033499|3573186|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3736103|NCT02033499|3573187|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3736104|NCT02033499|3573188|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3736105|NCT02033499|3573189|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736106|NCT02033499|3573186|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3736107|NCT02033499|3573187|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3736108|NCT02033499|3573188|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3736109|NCT02033499|3573189|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3736110|NCT02033499|3573186|B4||White|Race (NIH/OMB)||Participants|Count of Participants|279|279.0||||||
3736111|NCT02033499|3573187|B3||White|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
3736112|NCT02033499|3573188|B2||White|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
3736113|NCT02033499|3573189|B1||White|Race (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
3736114|NCT02033499|3573186|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|148|148.0||||||
3736115|NCT02033499|3573187|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3736116|NCT02033499|3573188|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3736117|NCT02033499|3573189|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3736118|NCT02033499|3573186|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3736119|NCT02033499|3573187|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3736120|NCT02033499|3573188|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736121|NCT02033499|3573189|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736122|NCT02033499|3573186|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3736123|NCT02033499|3573187|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3736124|NCT02033499|3573188|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3736125|NCT02033499|3573189|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3736126|NCT02033499|3573186|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3736127|NCT02033499|3573187|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3736128|NCT02033499|3573188|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736129|NCT02033499|3573189|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3736130|NCT02033499|3573186|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3736131|NCT02033499|3573187|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736132|NCT02033499|3573188|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3736133|NCT02033499|3573189|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736134|NCT02033499|3573186|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|441|441.0||||||
3736135|NCT02033499|3573187|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
3736136|NCT02033499|3573188|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|147|147.0||||||
3736137|NCT02033499|3573189|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|148|148.0||||||
3736138|NCT02033499|3573186|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3736139|NCT02033499|3573187|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3736140|NCT02033499|3573188|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3736141|NCT02033499|3573189|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3736142|NCT02033499|3573186|B4||Male|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
3736143|NCT02033499|3573187|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3736144|NCT02033499|3573188|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3736145|NCT02033499|3573189|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3736146|NCT02033499|3573186|B4||Female|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
3736147|NCT02033499|3573187|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3736148|NCT02033499|3573188|B2||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3736149|NCT02033499|3573189|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3736150|NCT02033499|3573186|B4|||Age||Years|Mean|60.5|60.5|Standard Deviation|11.5|11.5|||
3736151|NCT02033499|3573187|B3|||Age||Years|Mean|60.7|60.7|Standard Deviation|11.5|11.5|||
3736152|NCT02033499|3573188|B2|||Age||Years|Mean|59.9|59.9|Standard Deviation|11.4|11.4|||
3736153|NCT02033499|3573189|B1|||Age||Years|Mean|60.9|60.9|Standard Deviation|11.6|11.6|||
3736154|NCT02033369|3573229|B3|||Temporal Experience of Pleasure Scale - Consummatory Subscale|"A validated self-rated subscale assessing consummatory pleasure. It will be used for exploratory analyses of anhedonia.~18 items were measured on a scale of 1 (very false for me) to 6 (very true for me). Higher scores indicate higher pleasure. Item scores were added for a lowest possible score of 18 and highest possible score of 108."|units on a scale|Mean|34.1|34.1|Standard Deviation|8.5|8.5|||
3736155|NCT02033369|3573230|B2|||Temporal Experience of Pleasure Scale - Consummatory Subscale|"A validated self-rated subscale assessing consummatory pleasure. It will be used for exploratory analyses of anhedonia.~18 items were measured on a scale of 1 (very false for me) to 6 (very true for me). Higher scores indicate higher pleasure. Item scores were added for a lowest possible score of 18 and highest possible score of 108."|units on a scale|Mean|38.4|38.4|Standard Deviation|7.2|7.2|||
3736156|NCT02033369|3573231|B1|||Temporal Experience of Pleasure Scale - Consummatory Subscale|"A validated self-rated subscale assessing consummatory pleasure. It will be used for exploratory analyses of anhedonia.~18 items were measured on a scale of 1 (very false for me) to 6 (very true for me). Higher scores indicate higher pleasure. Item scores were added for a lowest possible score of 18 and highest possible score of 108."|units on a scale|Mean|29.9|29.9|Standard Deviation|7.6|7.6|||
3736157|NCT02033369|3573229|B3|||Clinical Global Impression Severity|Clinical Global Impression - severity. Seven-point likert scale rating clinical severity of mental illness from 1 (least severe) to 7 ( most severe). Physician-rated scale. One item|units on a scale|Mean|1.9|1.9|Standard Deviation|0.4|0.4|||
3736158|NCT02033369|3573230|B2|||Clinical Global Impression Severity|Clinical Global Impression - severity. Seven-point likert scale rating clinical severity of mental illness from 1 (least severe) to 7 ( most severe). Physician-rated scale. One item|units on a scale|Mean|1.0|1.0|Standard Deviation|0|0.0|||
3736159|NCT02033369|3573231|B1|||Clinical Global Impression Severity|Clinical Global Impression - severity. Seven-point likert scale rating clinical severity of mental illness from 1 (least severe) to 7 ( most severe). Physician-rated scale. One item|units on a scale|Mean|3.9|3.9|Standard Deviation|0.7|0.7|||
3736160|NCT02033369|3573229|B3|||Apathy Evaluation Rating Scale|A validated self-rated 18 item scale assessing apathy. Items were rated from 1 (not at all true) to 4 (very true). Higher scores indicate lower apathy, lower scores indicate higher apathy. Lowest possible score is 18, highest possible score is 72.|units on a scale|Mean|33.0|33.0|Standard Deviation|11.8|11.8|||
3736161|NCT02033369|3573230|B2|||Apathy Evaluation Rating Scale|A validated self-rated 18 item scale assessing apathy. Items were rated from 1 (not at all true) to 4 (very true). Higher scores indicate lower apathy, lower scores indicate higher apathy. Lowest possible score is 18, highest possible score is 72.|units on a scale|Mean|23.8|23.8|Standard Deviation|4.9|4.9|||
3736162|NCT02033369|3573231|B1|||Apathy Evaluation Rating Scale|A validated self-rated 18 item scale assessing apathy. Items were rated from 1 (not at all true) to 4 (very true). Higher scores indicate lower apathy, lower scores indicate higher apathy. Lowest possible score is 18, highest possible score is 72.|units on a scale|Mean|41.8|41.8|Standard Deviation|9.7|9.7|||
3736163|NCT02033369|3573229|B3|||Mood and Anxiety Symptom Questionnaire|Change in Mood and Anxiety Symptom Questionnaire, Short Form. A 62-item scale assessing anxiety and depression. Items were measured on a scale of 1-5, higher number indicating higher levels of symptoms.The lowest possible score was 62, and the highest 310.|units on a scale|Mean|130.1|130.1|Standard Deviation|50.8|50.8|||
3736164|NCT02033369|3573230|B2|||Mood and Anxiety Symptom Questionnaire|Change in Mood and Anxiety Symptom Questionnaire, Short Form. A 62-item scale assessing anxiety and depression. Items were measured on a scale of 1-5, higher number indicating higher levels of symptoms.The lowest possible score was 62, and the highest 310.|units on a scale|Mean|83.9|83.9|Standard Deviation|13.3|13.3|||
3736165|NCT02033369|3573231|B1|||Mood and Anxiety Symptom Questionnaire|Change in Mood and Anxiety Symptom Questionnaire, Short Form. A 62-item scale assessing anxiety and depression. Items were measured on a scale of 1-5, higher number indicating higher levels of symptoms.The lowest possible score was 62, and the highest 310.|units on a scale|Mean|174.5|174.5|Standard Deviation|28.6|28.6|||
3736166|NCT02033369|3573229|B3|||Temporal Experience of Pleasure Scale - Anticipatory Subscale|"A validated self-rated subscale assessing anticipatory pleasure. It will be used for exploratory analyses of anhedonia.~18 items were measured on a scale of 1 (very false for me) to 6 (very true for me). Higher scores indicate higher pleasure. Item scores were added for a lowest possible score of 18 and highest possible score of 108."|units on a scale|Mean|42.4|42.4|Standard Deviation|9.3|9.3|||
3736167|NCT02033369|3573230|B2|||Temporal Experience of Pleasure Scale - Anticipatory Subscale|"A validated self-rated subscale assessing anticipatory pleasure. It will be used for exploratory analyses of anhedonia.~18 items were measured on a scale of 1 (very false for me) to 6 (very true for me). Higher scores indicate higher pleasure. Item scores were added for a lowest possible score of 18 and highest possible score of 108."|units on a scale|Mean|49.0|49.0|Standard Deviation|5.2|5.2|||
3736168|NCT02033369|3573231|B1|||Temporal Experience of Pleasure Scale - Anticipatory Subscale|"A validated self-rated subscale assessing anticipatory pleasure. It will be used for exploratory analyses of anhedonia.~18 items were measured on a scale of 1 (very false for me) to 6 (very true for me). Higher scores indicate higher pleasure. Item scores were added for a lowest possible score of 18 and highest possible score of 108."|units on a scale|Mean|36.1|36.1|Standard Deviation|8.0|8.0|||
3736169|NCT02033369|3573229|B3|||Snaith Hamilton Pleasure Scale|"Fourteen-item self-rated anhedonia scale. Items were comprised of statements that participants rated as strongly disagree (1), disagree (2), agree (3), or strongly agree (4). The lowest possible score was 14, the highest possible score was 56."|units on a scale|Mean|25.7|25.7|Standard Deviation|8.7|8.7|||
3736170|NCT02033369|3573230|B2|||Snaith Hamilton Pleasure Scale|"Fourteen-item self-rated anhedonia scale. Items were comprised of statements that participants rated as strongly disagree (1), disagree (2), agree (3), or strongly agree (4). The lowest possible score was 14, the highest possible score was 56."|units on a scale|Mean|18.9|18.9|Standard Deviation|4.8|4.8|||
3736171|NCT02033369|3573231|B1|||Snaith Hamilton Pleasure Scale|"Fourteen-item self-rated anhedonia scale. Items were comprised of statements that participants rated as strongly disagree (1), disagree (2), agree (3), or strongly agree (4). The lowest possible score was 14, the highest possible score was 56."|units on a scale|Mean|31.9|31.9|Standard Deviation|6.5|6.5|||
3736172|NCT02033369|3573229|B3|||Hamilton Rating Scale for Depression|Hamilton Rating Scale for Depression (HRSD), 17-item version. This standard scale will be used to assess severity of depression, looking at change in total score from baseline to week 6, rating severity of depression on a scale from 0 (least depression) to 50 (greatest depression)|units on a scale|Mean|10.4|10.4|Standard Deviation|10.3|10.3|||
3736173|NCT02033369|3573230|B2|||Hamilton Rating Scale for Depression|Hamilton Rating Scale for Depression (HRSD), 17-item version. This standard scale will be used to assess severity of depression, looking at change in total score from baseline to week 6, rating severity of depression on a scale from 0 (least depression) to 50 (greatest depression)|units on a scale|Mean|0.2|0.2|Standard Deviation|0.4|0.4|||
3736174|NCT02033369|3573231|B1|||Hamilton Rating Scale for Depression|Hamilton Rating Scale for Depression (HRSD), 17-item version. This standard scale will be used to assess severity of depression, looking at change in total score from baseline to week 6, rating severity of depression on a scale from 0 (least depression) to 50 (greatest depression)|units on a scale|Mean|20.3|20.3|Standard Deviation|2.7|2.7|||
3736175|NCT02033369|3573229|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3736176|NCT02033369|3573230|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3736177|NCT02033369|3573231|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3736178|NCT02033369|3573229|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736179|NCT02033369|3573230|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736180|NCT02033369|3573231|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736181|NCT02033369|3573229|B3||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3736182|NCT02033369|3573230|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3736183|NCT02033369|3573231|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3736184|NCT02033369|3573229|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3736185|NCT02033369|3573230|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3736186|NCT02033369|3573231|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3736187|NCT02033369|3573229|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736188|NCT02033369|3573230|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736189|NCT02033369|3573231|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736190|NCT02033369|3573229|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3736191|NCT02033369|3573230|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3736192|NCT02033369|3573231|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3736193|NCT02033369|3573229|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736194|NCT02033369|3573230|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736195|NCT02033369|3573231|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736196|NCT02033369|3573229|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736197|NCT02033369|3573230|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736198|NCT02033369|3573231|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736199|NCT02033369|3573229|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3736200|NCT02033369|3573230|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3736201|NCT02033369|3573231|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3736202|NCT02033369|3573229|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3736203|NCT02033369|3573230|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3736204|NCT02033369|3573231|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3736205|NCT02033369|3573229|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3736206|NCT02033369|3573230|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3736207|NCT02033369|3573231|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3736208|NCT02033369|3573229|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3736209|NCT02033369|3573230|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3736210|NCT02033369|3573231|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3736211|NCT02033369|3573229|B3|||Age||years|Mean|26.5|26.5|Standard Deviation|5.8|5.8|||
3736212|NCT02033369|3573230|B2|||Age||years|Mean|26.5|26.5|Standard Deviation|5.6|5.6|||
3736213|NCT02033369|3573231|B1|||Age||years|Mean|26.5|26.5|Standard Deviation|6.1|6.1|||
3736214|NCT02033317|3573242|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3736215|NCT02033317|3573242|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3736216|NCT02033317|3573242|B1|||Age||years|Mean|49.7|49.7|Full Range|||44.0|56.0|
3736217|NCT02033317|3573242|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3736218|NCT02033317|3573242|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3736219|NCT02033317|3573242|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3736220|NCT02033213|3573247|B3|||Body weight||kg|Mean|68.11|68.11|Standard Deviation|17.61|17.61|||
3736221|NCT02033213|3573248|B2|||Body weight||kg|Mean|66.31|66.31|Standard Deviation|12.61|12.61|||
3736222|NCT02033213|3573249|B1|||Body weight||kg|Mean|70.01|70.01|Standard Deviation|18.91|18.91|||
3736223|NCT02033213|3573247|B3|||ASA score|"The American Society of Anesthesiologists (ASA) Physical Status classification system consists of six categories, as described below:~ASA PS 1: Normal healthy patient. ASA PS 2: Patients with mild systemic disease. ASA PS 3: Patients with severe systemic disease. ASA PS 4: Patients with severe systemic disease that is a constant threat to life. ASA PS 5: Moribund patients who are not expected to survive without the operation. ASA PS 6: A declared brain-dead patient who organs are being removed for donor purposes.~Smaller number is better."|units on a scale|Mean|2.71|2.71|Standard Deviation|0.48|0.48|||
3736224|NCT02033213|3573248|B2|||ASA score|"The American Society of Anesthesiologists (ASA) Physical Status classification system consists of six categories, as described below:~ASA PS 1: Normal healthy patient. ASA PS 2: Patients with mild systemic disease. ASA PS 3: Patients with severe systemic disease. ASA PS 4: Patients with severe systemic disease that is a constant threat to life. ASA PS 5: Moribund patients who are not expected to survive without the operation. ASA PS 6: A declared brain-dead patient who organs are being removed for donor purposes.~Smaller number is better."|units on a scale|Mean|2.75|2.75|Standard Deviation|0.46|0.46|||
3736225|NCT02033213|3573249|B1|||ASA score|"The American Society of Anesthesiologists (ASA) Physical Status classification system consists of six categories, as described below:~ASA PS 1: Normal healthy patient. ASA PS 2: Patients with mild systemic disease. ASA PS 3: Patients with severe systemic disease. ASA PS 4: Patients with severe systemic disease that is a constant threat to life. ASA PS 5: Moribund patients who are not expected to survive without the operation. ASA PS 6: A declared brain-dead patient who organs are being removed for donor purposes.~Smaller number is better."|units on a scale|Mean|2.61|2.61|Standard Deviation|0.51|0.51|||
3736226|NCT02033213|3573247|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3736227|NCT02033213|3573248|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3736228|NCT02033213|3573249|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3736229|NCT02033213|3573247|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3736230|NCT02033213|3573248|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3736231|NCT02033213|3573249|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3736232|NCT02033213|3573247|B3|||Age||years|Mean|53.12|53.12|Standard Deviation|1.81|1.81|||
3736233|NCT02033213|3573248|B2|||Age||years|Mean|52.41|52.41|Standard Deviation|13.41|13.41|||
3736234|NCT02033213|3573249|B1|||Age||years|Mean|53.91|53.91|Standard Deviation|8.31|8.31|||
3736235|NCT02033200|3573266|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
3736236|NCT02033200|3573267|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
3736237|NCT02033200|3573268|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3736238|NCT02033200|3573266|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736239|NCT02033200|3573267|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736240|NCT02033200|3573268|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736241|NCT02033200|3573266|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3736242|NCT02033200|3573267|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3736243|NCT02033200|3573268|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736244|NCT02033200|3573266|B3||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3736245|NCT02033200|3573267|B2||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3736246|NCT02033200|3573268|B1||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3736247|NCT02033200|3573266|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3736248|NCT02033200|3573267|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3736249|NCT02033200|3573268|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3736250|NCT02033200|3573266|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736251|NCT02033200|3573267|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736252|NCT02033200|3573268|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736253|NCT02033200|3573266|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3736254|NCT02033200|3573267|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736255|NCT02033200|3573268|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3736256|NCT02033200|3573266|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3736257|NCT02033200|3573267|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3736258|NCT02033200|3573268|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3736259|NCT02033200|3573266|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736260|NCT02033200|3573267|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736261|NCT02033200|3573268|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736262|NCT02033200|3573266|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3736263|NCT02033200|3573267|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3736264|NCT02033200|3573268|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3736265|NCT02033200|3573266|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3736266|NCT02033200|3573267|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3736267|NCT02033200|3573268|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3736268|NCT02033200|3573266|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3736269|NCT02033200|3573267|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3736270|NCT02033200|3573268|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3736271|NCT02033200|3573266|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3736272|NCT02033200|3573267|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3736273|NCT02033200|3573268|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3736274|NCT02033200|3573266|B3|||Age||years|Mean|35.0|35.0|Standard Deviation|7.62|7.62|||
3736275|NCT02033200|3573267|B2|||Age||years|Mean|35.1|35.1|Standard Deviation|7.67|7.67|||
3736276|NCT02033200|3573268|B1|||Age||years|Mean|34.9|34.9|Standard Deviation|7.67|7.67|||
3736277|NCT02033174|3573289|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736278|NCT02033174|3573289|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736279|NCT02033174|3573289|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3736280|NCT02033174|3573289|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736281|NCT02033174|3573289|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736282|NCT02033174|3573289|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736283|NCT02033174|3573289|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736284|NCT02033174|3573289|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3736285|NCT02033174|3573289|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3736286|NCT02033174|3573289|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3736287|NCT02033174|3573289|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3736288|NCT02033174|3573289|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3736289|NCT02033083|3573296|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3736290|NCT02033083|3573297|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3736291|NCT02033083|3573298|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3736292|NCT02033083|3573296|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3736293|NCT02033083|3573297|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3736294|NCT02033083|3573298|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3736295|NCT02033083|3573296|B3|Hispanic or Latina||Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
3736296|NCT02033083|3573297|B2|Hispanic or Latina||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3736297|NCT02033083|3573298|B1|Hispanic or Latina||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3736298|NCT02033083|3573296|B3|African-American or Black||Race/Ethnicity, Customized||Participants|Count of Participants|87|87.0||||||
3736299|NCT02033083|3573297|B2|African-American or Black||Race/Ethnicity, Customized||Participants|Count of Participants|45|45.0||||||
3736300|NCT02033083|3573298|B1|African-American or Black||Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3736301|NCT02033083|3573296|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3736302|NCT02033083|3573297|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3736303|NCT02033083|3573298|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3736304|NCT02033083|3573296|B3||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
3736305|NCT02033083|3573297|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3736306|NCT02033083|3573298|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3736307|NCT02033083|3573296|B3|||Age||years|Mean|23.90|23.9|Standard Deviation|4.55|4.55|||
3736308|NCT02033083|3573297|B2|||Age||years|Mean|23.80|23.8|Standard Deviation|4.61|4.61|||
3736309|NCT02033083|3573298|B1|||Age||years|Mean|23.99|23.99|Standard Deviation|4.49|4.49|||
3736310|NCT02032901|3573305|B3||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3736311|NCT02032901|3573306|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3736312|NCT02032901|3573307|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3736313|NCT02032901|3573305|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3736314|NCT02032901|3573306|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3736315|NCT02032901|3573307|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3736316|NCT02032901|3573305|B3|>= 65 years||Age, Customized||participants|Number|10|10.0||||||
3736317|NCT02032901|3573306|B2|>= 65 years||Age, Customized||participants|Number|4|4.0||||||
3736318|NCT02032901|3573307|B1|>= 65 years||Age, Customized||participants|Number|6|6.0||||||
3736319|NCT02032901|3573305|B3|<65 years||Age, Customized||participants|Number|142|142.0||||||
3736320|NCT02032901|3573306|B2|<65 years||Age, Customized||participants|Number|47|47.0||||||
3736321|NCT02032901|3573307|B1|<65 years||Age, Customized||participants|Number|95|95.0||||||
3736322|NCT02032901|3573305|B3|||Age||years|Mean|52.3|52.3|Standard Deviation|9.94|9.94|||
3736323|NCT02032901|3573306|B2|||Age||years|Mean|56.3|56.3|Standard Deviation|6.64|6.64|||
3736324|NCT02032901|3573307|B1|||Age||years|Mean|50.3|50.3|Standard Deviation|10.73|10.73|||
3736325|NCT02032888|3573329|B4|≥800,000 IU/mL||Hepatitis C Virus RNA distribution||participants|Number|167|167.0||||||
3736326|NCT02032888|3573330|B3|≥800,000 IU/mL||Hepatitis C Virus RNA distribution||participants|Number|44|44.0||||||
3736327|NCT02032888|3573331|B2|≥800,000 IU/mL||Hepatitis C Virus RNA distribution||participants|Number|44|44.0||||||
3736328|NCT02032888|3573332|B1|≥800,000 IU/mL||Hepatitis C Virus RNA distribution||participants|Number|79|79.0||||||
3736329|NCT02032888|3573329|B4|<800,000 IU/mL||Hepatitis C Virus RNA distribution||participants|Number|36|36.0||||||
3736330|NCT02032888|3573330|B3|<800,000 IU/mL||Hepatitis C Virus RNA distribution||participants|Number|8|8.0||||||
3736331|NCT02032888|3573331|B2|<800,000 IU/mL||Hepatitis C Virus RNA distribution||participants|Number|6|6.0||||||
3736332|NCT02032888|3573332|B1|<800,000 IU/mL||Hepatitis C Virus RNA distribution||participants|Number|22|22.0||||||
3736333|NCT02032888|3573329|B4|||Hepatitis C Virus RNA||log10 IU/mL|Mean|6.48|6.48|Standard Deviation|0.753|0.753|||
3736334|NCT02032888|3573330|B3|||Hepatitis C Virus RNA||log10 IU/mL|Mean|6.52|6.52|Standard Deviation|0.789|0.789|||
3736335|NCT02032888|3573331|B2|||Hepatitis C Virus RNA||log10 IU/mL|Mean|6.40|6.4|Standard Deviation|0.71|0.71|||
3736336|NCT02032888|3573332|B1|||Hepatitis C Virus RNA||log10 IU/mL|Mean|6.50|6.5|Standard Deviation|0.758|0.758|||
3736337|NCT02032888|3573329|B4||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
3736338|NCT02032888|3573330|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3736339|NCT02032888|3573331|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3736340|NCT02032888|3573332|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3736341|NCT02032888|3573329|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3736342|NCT02032888|3573330|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3736343|NCT02032888|3573331|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3736344|NCT02032888|3573332|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3736345|NCT02032888|3573329|B4|>=65 years||Age, Customized||participants|Number|11|11.0||||||
3736346|NCT02032888|3573330|B3|>=65 years||Age, Customized||participants|Number|3|3.0||||||
3736347|NCT02032888|3573331|B2|>=65 years||Age, Customized||participants|Number|3|3.0||||||
3736348|NCT02032888|3573332|B1|>=65 years||Age, Customized||participants|Number|5|5.0||||||
3736349|NCT02032888|3573329|B4|<65 years||Age, Customized||participants|Number|192|192.0||||||
3736350|NCT02032888|3573330|B3|<65 years||Age, Customized||participants|Number|49|49.0||||||
3736351|NCT02032888|3573331|B2|<65 years||Age, Customized||participants|Number|47|47.0||||||
3736352|NCT02032888|3573332|B1|<65 years||Age, Customized||participants|Number|96|96.0||||||
3736353|NCT02032888|3573329|B4|||Age||years|Mean|51.7|51.7|Standard Deviation|9.12|9.12|||
3736354|NCT02032888|3573330|B3|||Age||years|Mean|55.7|55.7|Standard Deviation|6.21|6.21|||
3736355|NCT02032888|3573331|B2|||Age||years|Mean|50.8|50.8|Standard Deviation|9.19|9.19|||
3736356|NCT02032888|3573332|B1|||Age||years|Mean|50.1|50.1|Standard Deviation|9.77|9.77|||
3736357|NCT02032875|3573363|B3|TT||IL-28B rs1297860 Genotype||participants|Number|23|23.0||||||
3736358|NCT02032875|3573364|B2|TT||IL-28B rs1297860 Genotype||participants|Number|14|14.0||||||
3736359|NCT02032875|3573365|B1|TT||IL-28B rs1297860 Genotype||participants|Number|9|9.0||||||
3736360|NCT02032875|3573363|B3|CT||IL-28B rs1297860 Genotype||participants|Number|64|64.0||||||
3736361|NCT02032875|3573364|B2|CT||IL-28B rs1297860 Genotype||participants|Number|33|33.0||||||
3736362|NCT02032875|3573365|B1|CT||IL-28B rs1297860 Genotype||participants|Number|31|31.0||||||
3736363|NCT02032875|3573363|B3|CC||IL-28B rs1297860 Genotype||participants|Number|26|26.0||||||
3736364|NCT02032875|3573364|B2|CC||IL-28B rs1297860 Genotype||participants|Number|13|13.0||||||
3736365|NCT02032875|3573365|B1|CC||IL-28B rs1297860 Genotype||participants|Number|13|13.0||||||
3736366|NCT02032875|3573363|B3|Hepatitis C Virus genotype 6||HCV genotype subtype||participants|Number|1|1.0||||||
3736367|NCT02032875|3573364|B2|Hepatitis C Virus genotype 6||HCV genotype subtype||participants|Number|0|0.0||||||
3736368|NCT02032875|3573365|B1|Hepatitis C Virus genotype 6||HCV genotype subtype||participants|Number|1|1.0||||||
3736369|NCT02032875|3573363|B3|Hepatitis C Virus genotype 5||HCV genotype subtype||participants|Number|0|0.0||||||
3736370|NCT02032875|3573364|B2|Hepatitis C Virus genotype 5||HCV genotype subtype||participants|Number|0|0.0||||||
3736371|NCT02032875|3573365|B1|Hepatitis C Virus genotype 5||HCV genotype subtype||participants|Number|0|0.0||||||
3736372|NCT02032875|3573363|B3|Hepatitis C Virus genotype 4||HCV genotype subtype||participants|Number|4|4.0||||||
3736373|NCT02032875|3573364|B2|Hepatitis C Virus genotype 4||HCV genotype subtype||participants|Number|4|4.0||||||
3736374|NCT02032875|3573365|B1|Hepatitis C Virus genotype 4||HCV genotype subtype||participants|Number|0|0.0||||||
3736375|NCT02032875|3573363|B3|Hepatitis C Virus genotype 3||HCV genotype subtype||participants|Number|17|17.0||||||
3736376|NCT02032875|3573364|B2|Hepatitis C Virus genotype 3||HCV genotype subtype||participants|Number|6|6.0||||||
3736377|NCT02032875|3573365|B1|Hepatitis C Virus genotype 3||HCV genotype subtype||participants|Number|11|11.0||||||
3736378|NCT02032875|3573363|B3|Hepatitis C Virus genotype 2||HCV genotype subtype||participants|Number|5|5.0||||||
3736379|NCT02032875|3573364|B2|Hepatitis C Virus genotype 2||HCV genotype subtype||participants|Number|5|5.0||||||
3736380|NCT02032875|3573365|B1|Hepatitis C Virus genotype 2||HCV genotype subtype||participants|Number|0|0.0||||||
3736381|NCT02032875|3573363|B3|Hepatitis C Virus genotype 1b||HCV genotype subtype||participants|Number|21|21.0||||||
3736382|NCT02032875|3573364|B2|Hepatitis C Virus genotype 1b||HCV genotype subtype||participants|Number|11|11.0||||||
3736383|NCT02032875|3573365|B1|Hepatitis C Virus genotype 1b||HCV genotype subtype||participants|Number|10|10.0||||||
3736384|NCT02032875|3573363|B3|Hepatitis C Virus genotype 1a||HCV genotype subtype||participants|Number|65|65.0||||||
3736385|NCT02032875|3573364|B2|Hepatitis C Virus genotype 1a||HCV genotype subtype||participants|Number|34|34.0||||||
3736386|NCT02032875|3573365|B1|Hepatitis C Virus genotype 1a||HCV genotype subtype||participants|Number|31|31.0||||||
3736387|NCT02032875|3573363|B3|≥800,000 IU/mL||Hepatitis C Virus RNA distribution||participants|Number|80|80.0||||||
3736388|NCT02032875|3573364|B2|≥800,000 IU/mL||Hepatitis C Virus RNA distribution||participants|Number|33|33.0||||||
3736389|NCT02032875|3573365|B1|≥800,000 IU/mL||Hepatitis C Virus RNA distribution||participants|Number|47|47.0||||||
3736390|NCT02032875|3573363|B3|<800,000 IU/mL||Hepatitis C Virus RNA distribution||participants|Number|33|33.0||||||
3736391|NCT02032875|3573364|B2|<800,000 IU/mL||Hepatitis C Virus RNA distribution||participants|Number|27|27.0||||||
3736392|NCT02032875|3573365|B1|<800,000 IU/mL||Hepatitis C Virus RNA distribution||participants|Number|6|6.0||||||
3736393|NCT02032875|3573363|B3|||Hepatitis C Virus RNA||log10 IU/mL|Mean|6.29|6.29|Standard Deviation|0.724|0.724|||
3736394|NCT02032875|3573364|B2|||Hepatitis C Virus RNA||log10 IU/mL|Mean|6.01|6.01|Standard Deviation|0.617|0.617|||
3736395|NCT02032875|3573365|B1|||Hepatitis C Virus RNA||log10 IU/mL|Mean|6.61|6.61|Standard Deviation|0.711|0.711|||
3736396|NCT02032875|3573363|B3||Male|Gender||Participants|Count of Participants|76|76.0||||||
3736397|NCT02032875|3573364|B2||Male|Gender||Participants|Count of Participants|38|38.0||||||
3736398|NCT02032875|3573365|B1||Male|Gender||Participants|Count of Participants|38|38.0||||||
3736399|NCT02032875|3573363|B3||Female|Gender||Participants|Count of Participants|37|37.0||||||
3736400|NCT02032875|3573364|B2||Female|Gender||Participants|Count of Participants|22|22.0||||||
3736401|NCT02032875|3573365|B1||Female|Gender||Participants|Count of Participants|15|15.0||||||
3736402|NCT02032875|3573363|B3|>=65 years||Age, Customized||participants|Number|21|21.0||||||
3736403|NCT02032875|3573364|B2|>=65 years||Age, Customized||participants|Number|10|10.0||||||
3736404|NCT02032875|3573365|B1|>=65 years||Age, Customized||participants|Number|11|11.0||||||
3736405|NCT02032875|3573363|B3|<65 years||Age, Customized||participants|Number|92|92.0||||||
3736406|NCT02032875|3573364|B2|<65 years||Age, Customized||participants|Number|50|50.0||||||
3736407|NCT02032875|3573365|B1|<65 years||Age, Customized||participants|Number|42|42.0||||||
3736408|NCT02032875|3573363|B3|||Age||years|Mean|58.7|58.7|Standard Deviation|8.91|8.91|||
3736409|NCT02032875|3573364|B2|||Age||years|Mean|57.9|57.9|Standard Deviation|9.45|9.45|||
3736410|NCT02032875|3573365|B1|||Age||years|Mean|59.6|59.6|Standard Deviation|8.25|8.25|||
3736411|NCT02032758|3573384|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
3736412|NCT02032758|3573385|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3736413|NCT02032758|3573386|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3736414|NCT02032758|3573384|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3736415|NCT02032758|3573385|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3736416|NCT02032758|3573386|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3736417|NCT02032758|3573384|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3736418|NCT02032758|3573385|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3736419|NCT02032758|3573386|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3736420|NCT02032758|3573384|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3736421|NCT02032758|3573385|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3736422|NCT02032758|3573386|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3736423|NCT02032758|3573384|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3736424|NCT02032758|3573385|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3736425|NCT02032758|3573386|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3736426|NCT02032758|3573384|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3736427|NCT02032758|3573385|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3736428|NCT02032758|3573386|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3736429|NCT02032706|3573395|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
3736430|NCT02032706|3573395|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3736431|NCT02032706|3573395|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3736432|NCT02032706|3573395|B1|||Age||years|Mean|50|50.0|Standard Deviation|9.4|9.4|||
3736433|NCT02032641|3573408|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3736434|NCT02032641|3573408|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3736435|NCT02032641|3573408|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3736436|NCT02032641|3573408|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3736437|NCT02032641|3573408|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3736438|NCT02032433|3573418|B3|Late randomization||Randomization status||Participants|Count of Participants|353|353.0||||||
3736439|NCT02032433|3573419|B2|Late randomization||Randomization status||Participants|Count of Participants|177|177.0||||||
3736440|NCT02032433|3573420|B1|Late randomization||Randomization status||Participants|Count of Participants|176|176.0||||||
3736441|NCT02032433|3573418|B3|Early randomization||Randomization status||Participants|Count of Participants|217|217.0||||||
3736442|NCT02032433|3573419|B2|Early randomization||Randomization status||Participants|Count of Participants|110|110.0||||||
3736443|NCT02032433|3573420|B1|Early randomization||Randomization status||Participants|Count of Participants|107|107.0||||||
3736444|NCT02032433|3573418|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3736445|NCT02032433|3573419|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3736446|NCT02032433|3573420|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3736447|NCT02032433|3573418|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3736448|NCT02032433|3573419|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3736449|NCT02032433|3573420|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3736450|NCT02032433|3573418|B3||White|Race (NIH/OMB)||Participants|Count of Participants|421|421.0||||||
3736451|NCT02032433|3573419|B2||White|Race (NIH/OMB)||Participants|Count of Participants|215|215.0||||||
3736452|NCT02032433|3573420|B1||White|Race (NIH/OMB)||Participants|Count of Participants|206|206.0||||||
3736453|NCT02032433|3573418|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3736454|NCT02032433|3573419|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3736455|NCT02032433|3573420|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3736456|NCT02032433|3573418|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736457|NCT02032433|3573419|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736458|NCT02032433|3573420|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736459|NCT02032433|3573418|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3736460|NCT02032433|3573419|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3736461|NCT02032433|3573420|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3736462|NCT02032433|3573418|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3736463|NCT02032433|3573419|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3736464|NCT02032433|3573420|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3736465|NCT02032433|3573418|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736466|NCT02032433|3573419|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736467|NCT02032433|3573420|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736468|NCT02032433|3573418|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|471|471.0||||||
3736469|NCT02032433|3573419|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|233|233.0||||||
3736470|NCT02032433|3573420|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|238|238.0||||||
3736471|NCT02032433|3573418|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3736472|NCT02032433|3573419|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3736473|NCT02032433|3573420|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3736474|NCT02032433|3573418|B3||Male|Sex: Female, Male||Participants|Count of Participants|401|401.0||||||
3736475|NCT02032433|3573419|B2||Male|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
3736476|NCT02032433|3573420|B1||Male|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
3736477|NCT02032433|3573418|B3||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3736478|NCT02032433|3573419|B2||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3736479|NCT02032433|3573420|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3736480|NCT02032433|3573418|B3|||Age||years|Mean|33.9|33.9|Standard Deviation|9.63|9.63|||
3736481|NCT02032433|3573419|B2|||Age||years|Mean|33.7|33.7|Standard Deviation|9.8|9.8|||
3736482|NCT02032433|3573420|B1|||Age||years|Mean|34.0|34.0|Standard Deviation|9.5|9.5|||
3736483|NCT02032420|3573437|B3|||Plays video games||participants|Number|15|15.0||||||
3736484|NCT02032420|3573438|B2|||Plays video games||participants|Number|8|8.0||||||
3736485|NCT02032420|3573439|B1|||Plays video games||participants|Number|7|7.0||||||
3736486|NCT02032420|3573437|B3||Male|Gender||Participants|Count of Participants|16|16.0||||||
3736487|NCT02032420|3573438|B2||Male|Gender||Participants|Count of Participants|5|5.0||||||
3736488|NCT02032420|3573439|B1||Male|Gender||Participants|Count of Participants|11|11.0||||||
3736489|NCT02032420|3573437|B3||Female|Gender||Participants|Count of Participants|19|19.0||||||
3736490|NCT02032420|3573438|B2||Female|Gender||Participants|Count of Participants|12|12.0||||||
3736491|NCT02032420|3573439|B1||Female|Gender||Participants|Count of Participants|7|7.0||||||
3736492|NCT02032420|3573437|B3|||Age||years|Median|21|21.0|Inter-Quartile Range|||19.0|23.0|
3736493|NCT02032420|3573438|B2|||Age||years|Median|21|21.0|Inter-Quartile Range|||19.0|23.5|
3736494|NCT02032420|3573439|B1|||Age||years|Median|21|21.0|Inter-Quartile Range|||19.0|23.25|
3736495|NCT02032407|3573452|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3736496|NCT02032407|3573452|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3736497|NCT02032407|3573452|B1|≥50 years||Age, Customized||participants|Number|3|3.0||||||
3736498|NCT02032407|3573452|B1|≥30 to <50 years||Age, Customized||participants|Number|32|32.0||||||
3736499|NCT02032407|3573452|B1|18 to <30 years||Age, Customized||participants|Number|32|32.0||||||
3736500|NCT02032238|3573463|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3736501|NCT02032238|3573465|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3736502|NCT02032238|3573463|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3736503|NCT02032238|3573465|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3736504|NCT02032238|3573463|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3736505|NCT02032238|3573465|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3736506|NCT02032238|3573463|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3736507|NCT02032238|3573465|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3736508|NCT02032238|3573463|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3736509|NCT02032238|3573465|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3736510|NCT02032212|3573472|B5|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
3736511|NCT02032212|3573473|B4|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3736512|NCT02032212|3573474|B3|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3736513|NCT02032212|3573475|B2|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3736514|NCT02032212|3573476|B1|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3736515|NCT02032212|3573472|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3736516|NCT02032212|3573473|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3736517|NCT02032212|3573474|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3736518|NCT02032212|3573475|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3736519|NCT02032212|3573476|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3736520|NCT02032212|3573472|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3736521|NCT02032212|3573473|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3736522|NCT02032212|3573474|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3736523|NCT02032212|3573475|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3736524|NCT02032212|3573476|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3736525|NCT02032212|3573472|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3736526|NCT02032212|3573473|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3736527|NCT02032212|3573474|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3736528|NCT02032212|3573475|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3736529|NCT02032212|3573476|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3736530|NCT02032212|3573472|B5||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3736531|NCT02032212|3573473|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3736532|NCT02032212|3573474|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3736533|NCT02032212|3573475|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3736534|NCT02032212|3573476|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3736535|NCT02032212|3573472|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3736536|NCT02032212|3573473|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3736537|NCT02032212|3573474|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3736538|NCT02032212|3573475|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3736539|NCT02032212|3573476|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3736540|NCT02031679|3573505|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
3736541|NCT02031679|3573506|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3736542|NCT02031679|3573507|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3736543|NCT02031679|3573505|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736544|NCT02031679|3573506|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736545|NCT02031679|3573507|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736546|NCT02031679|3573505|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3736547|NCT02031679|3573506|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3736548|NCT02031679|3573507|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3736549|NCT02031679|3573505|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3736550|NCT02031679|3573506|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3736551|NCT02031679|3573507|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3736552|NCT02031679|3573505|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3736553|NCT02031679|3573506|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3736554|NCT02031679|3573507|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3736555|NCT02031679|3573505|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3736556|NCT02031679|3573506|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3736557|NCT02031679|3573507|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736558|NCT02031679|3573505|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3736559|NCT02031679|3573506|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3736560|NCT02031679|3573507|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3736561|NCT02031679|3573505|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736562|NCT02031679|3573506|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736563|NCT02031679|3573507|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736564|NCT02031679|3573505|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736565|NCT02031679|3573506|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736566|NCT02031679|3573507|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736567|NCT02031679|3573505|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3736568|NCT02031679|3573506|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3736569|NCT02031679|3573507|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3736570|NCT02031679|3573505|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736571|NCT02031679|3573506|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736572|NCT02031679|3573507|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736573|NCT02031679|3573505|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3736574|NCT02031679|3573506|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3736575|NCT02031679|3573507|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3736576|NCT02031679|3573505|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3736577|NCT02031679|3573506|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3736578|NCT02031679|3573507|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3736579|NCT02031679|3573505|B3|||Age||years|Median|43.38|43.38|Full Range|||23.0|65.0|
3736580|NCT02031679|3573506|B2|||Age||years|Median|45.17|45.17|Full Range|||23.0|64.0|
3736581|NCT02031679|3573507|B1|||Age||years|Median|41.85|41.85|Full Range|||23.0|65.0|
3736582|NCT02031679|3573505|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3736583|NCT02031679|3573506|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3736584|NCT02031679|3573507|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3736585|NCT02031679|3573505|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3736586|NCT02031679|3573506|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3736587|NCT02031679|3573507|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3736588|NCT02031679|3573505|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3736589|NCT02031679|3573506|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3736590|NCT02031679|3573507|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3736591|NCT02031640|3573518|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736592|NCT02031640|3573519|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736593|NCT02031640|3573520|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736594|NCT02031640|3573521|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736595|NCT02031640|3573522|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736596|NCT02031640|3573523|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736597|NCT02031640|3573518|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736598|NCT02031640|3573519|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736599|NCT02031640|3573520|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736600|NCT02031640|3573521|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736601|NCT02031640|3573522|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736602|NCT02031640|3573523|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736603|NCT02031640|3573518|B6||White|Race (NIH/OMB)||Participants|Count of Participants|415|415.0||||||
3736604|NCT02031640|3573519|B5||White|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
3736605|NCT02031640|3573520|B4||White|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
3736606|NCT02031640|3573521|B3||White|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3736607|NCT02031640|3573522|B2||White|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3736608|NCT02031640|3573523|B1||White|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3736609|NCT02031640|3573518|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3736610|NCT02031640|3573519|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3736611|NCT02031640|3573520|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3736612|NCT02031640|3573521|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3736613|NCT02031640|3573522|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3736614|NCT02031640|3573523|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3736615|NCT02031640|3573518|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3736616|NCT02031640|3573519|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3736617|NCT02031640|3573520|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3736618|NCT02031640|3573521|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3736619|NCT02031640|3573522|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3736620|NCT02031640|3573523|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3736621|NCT02031640|3573518|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736622|NCT02031640|3573519|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736623|NCT02031640|3573520|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736624|NCT02031640|3573521|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736625|NCT02031640|3573522|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736626|NCT02031640|3573523|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736627|NCT02031640|3573518|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736628|NCT02031640|3573519|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736629|NCT02031640|3573520|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736630|NCT02031640|3573521|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736631|NCT02031640|3573522|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736632|NCT02031640|3573523|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736633|NCT02031640|3573518|B6||Male|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
3736634|NCT02031640|3573519|B5||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3736635|NCT02031640|3573520|B4||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3736636|NCT02031640|3573521|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3736637|NCT02031640|3573522|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3736638|NCT02031640|3573523|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3736639|NCT02031640|3573518|B6||Female|Sex: Female, Male||Participants|Count of Participants|335|335.0||||||
3736640|NCT02031640|3573519|B5||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3736641|NCT02031640|3573520|B4||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3736642|NCT02031640|3573521|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3736643|NCT02031640|3573522|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3736644|NCT02031640|3573523|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3736645|NCT02031640|3573518|B6||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
3736646|NCT02031640|3573519|B5||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3736647|NCT02031640|3573520|B4||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3736648|NCT02031640|3573521|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3736649|NCT02031640|3573522|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3736650|NCT02031640|3573523|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3736651|NCT02031640|3573518|B6||Between 18 and 65 years|Age||Participants|Count of Participants|457|457.0||||||
3736652|NCT02031640|3573519|B5||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
3736653|NCT02031640|3573520|B4||Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
3736654|NCT02031640|3573521|B3||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
3736655|NCT02031640|3573522|B2||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
3736656|NCT02031640|3573523|B1||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
3736657|NCT02031640|3573518|B6||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
3736658|NCT02031640|3573519|B5||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3736659|NCT02031640|3573520|B4||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3736660|NCT02031640|3573521|B3||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
3736661|NCT02031640|3573522|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3736662|NCT02031640|3573523|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3736663|NCT02031471|3573571|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3736664|NCT02031471|3573571|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3736665|NCT02031471|3573571|B1|||Age||years|Mean|54.49|54.49|Standard Deviation|11.08|11.08|||
3736666|NCT02031458|3573601|B4||Male|Sex: Female, Male||Participants|Count of Participants|388|388.0||||||
3736667|NCT02031458|3573602|B3||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3736668|NCT02031458|3573603|B2||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3736669|NCT02031458|3573604|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3736670|NCT02031458|3573601|B4||Female|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
3736671|NCT02031458|3573602|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3736672|NCT02031458|3573603|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3736673|NCT02031458|3573604|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3736674|NCT02031458|3573601|B4|||Age||years|Median|63.7|63.7|Standard Deviation|10.0|10.0|||
3736675|NCT02031458|3573602|B3|||Age||years|Median|63.6|63.6|Standard Deviation|9.3|9.3|||
3736676|NCT02031458|3573603|B2|||Age||years|Median|62.4|62.4|Standard Deviation|10.2|10.2|||
3736677|NCT02031458|3573604|B1|||Age||years|Median|66.7|66.7|Standard Deviation|10.4|10.4|||
3736678|NCT02031276|3573700|B4||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3736679|NCT02031276|3573701|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3736680|NCT02031276|3573702|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3736681|NCT02031276|3573703|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3736682|NCT02031276|3573700|B4||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3736683|NCT02031276|3573701|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3736684|NCT02031276|3573702|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3736685|NCT02031276|3573703|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3736686|NCT02031276|3573700|B4|||Age||years|Mean|38.1|38.1|Standard Deviation|13.48|13.48|||
3736687|NCT02031276|3573701|B3|||Age||years|Mean|39.9|39.9|Standard Deviation|13.26|13.26|||
3736688|NCT02031276|3573702|B2|||Age||years|Mean|38.8|38.8|Standard Deviation|13.27|13.27|||
3736689|NCT02031276|3573703|B1|||Age||years|Mean|35.5|35.5|Standard Deviation|13.86|13.86|||
3736690|NCT02030821|3573737|B5|United States||Region of Enrollment||Participants|Count of Participants|235|235.0||||||
3736691|NCT02030821|3573738|B4|United States||Region of Enrollment||Participants|Count of Participants|72|72.0||||||
3736692|NCT02030821|3573739|B3|United States||Region of Enrollment||Participants|Count of Participants|73|73.0||||||
3736693|NCT02030821|3573740|B2|United States||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3736694|NCT02030821|3573741|B1|United States||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
3736695|NCT02030821|3573737|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3736696|NCT02030821|3573738|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3736697|NCT02030821|3573739|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3736698|NCT02030821|3573740|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3736699|NCT02030821|3573741|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3736700|NCT02030821|3573737|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736701|NCT02030821|3573738|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736702|NCT02030821|3573739|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736703|NCT02030821|3573740|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736704|NCT02030821|3573741|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736705|NCT02030821|3573737|B5||White|Race (NIH/OMB)||Participants|Count of Participants|183|183.0||||||
3736706|NCT02030821|3573738|B4||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3736707|NCT02030821|3573739|B3||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3736708|NCT02030821|3573740|B2||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3736709|NCT02030821|3573741|B1||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3736710|NCT02030821|3573737|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3736711|NCT02030821|3573738|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3736712|NCT02030821|3573739|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3736713|NCT02030821|3573740|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3736714|NCT02030821|3573741|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3736715|NCT02030821|3573737|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736716|NCT02030821|3573738|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736717|NCT02030821|3573739|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736718|NCT02030821|3573740|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736719|NCT02030821|3573741|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736720|NCT02030821|3573737|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736721|NCT02030821|3573738|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736722|NCT02030821|3573739|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736723|NCT02030821|3573740|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736724|NCT02030821|3573741|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736725|NCT02030821|3573737|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736726|NCT02030821|3573738|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736727|NCT02030821|3573739|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736728|NCT02030821|3573740|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736729|NCT02030821|3573741|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736730|NCT02030821|3573737|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3736731|NCT02030821|3573738|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736732|NCT02030821|3573739|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3736733|NCT02030821|3573740|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736734|NCT02030821|3573741|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736735|NCT02030821|3573737|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|233|233.0||||||
3736736|NCT02030821|3573738|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3736737|NCT02030821|3573739|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3736738|NCT02030821|3573740|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3736739|NCT02030821|3573741|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3736740|NCT02030821|3573737|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3736741|NCT02030821|3573738|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736742|NCT02030821|3573739|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736743|NCT02030821|3573740|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736744|NCT02030821|3573741|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3736745|NCT02030821|3573737|B5||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3736746|NCT02030821|3573738|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3736747|NCT02030821|3573739|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3736748|NCT02030821|3573740|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3736749|NCT02030821|3573741|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3736750|NCT02030821|3573737|B5||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3736751|NCT02030821|3573738|B4||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3736752|NCT02030821|3573739|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3736753|NCT02030821|3573740|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3736754|NCT02030821|3573741|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3736755|NCT02030821|3573737|B5||>=65 years|Age||Participants|Count of Participants|108|108.0||||||
3736756|NCT02030821|3573738|B4||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
3736757|NCT02030821|3573739|B3||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
3736758|NCT02030821|3573740|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3736759|NCT02030821|3573741|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3736760|NCT02030821|3573737|B5||Between 18 and 65 years|Age||Participants|Count of Participants|127|127.0||||||
3736761|NCT02030821|3573738|B4||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3736762|NCT02030821|3573739|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3736763|NCT02030821|3573740|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3736764|NCT02030821|3573741|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3736765|NCT02030821|3573737|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3736766|NCT02030821|3573738|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3736767|NCT02030821|3573739|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3736768|NCT02030821|3573740|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3736769|NCT02030821|3573741|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3736770|NCT02030600|3573770|B3|||Fasting plasma glucose|Number of subjects analyzed=355 for IDeg/IGlar arm, 358 for IGlar/IDeg arm and 713 for total.|mg/dL|Mean|137.0|137.0|Standard Deviation|52.6|52.6|||
3736771|NCT02030600|3573771|B2|||Fasting plasma glucose|Number of subjects analyzed=355 for IDeg/IGlar arm, 358 for IGlar/IDeg arm and 713 for total.|mg/dL|Mean|134.9|134.9|Standard Deviation|51.6|51.6|||
3736772|NCT02030600|3573772|B1|||Fasting plasma glucose|Number of subjects analyzed=355 for IDeg/IGlar arm, 358 for IGlar/IDeg arm and 713 for total.|mg/dL|Mean|139.2|139.2|Standard Deviation|53.5|53.5|||
3736773|NCT02030600|3573770|B3|||Glycosylated haemoglobin||percentage of glycosylated haemoglobin|Mean|7.6|7.6|Standard Deviation|1.1|1.1|||
3736774|NCT02030600|3573771|B2|||Glycosylated haemoglobin||percentage of glycosylated haemoglobin|Mean|7.6|7.6|Standard Deviation|1.1|1.1|||
3736775|NCT02030600|3573772|B1|||Glycosylated haemoglobin||percentage of glycosylated haemoglobin|Mean|7.6|7.6|Standard Deviation|1.1|1.1|||
3736776|NCT02030600|3573770|B3||Male|Sex: Female, Male||Participants|Count of Participants|382|382.0||||||
3736777|NCT02030600|3573771|B2||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
3736778|NCT02030600|3573772|B1||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
3736779|NCT02030600|3573770|B3||Female|Sex: Female, Male||Participants|Count of Participants|338|338.0||||||
3736780|NCT02030600|3573771|B2||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3736781|NCT02030600|3573772|B1||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3736782|NCT02030600|3573770|B3|||Age||years|Mean|61.4|61.4|Standard Deviation|10.5|10.5|||
3736783|NCT02030600|3573771|B2|||Age||years|Mean|61.2|61.2|Standard Deviation|10.3|10.3|||
3736784|NCT02030600|3573772|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|10.7|10.7|||
3736785|NCT02030574|3573789|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3736786|NCT02030574|3573789|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3736787|NCT02030574|3573789|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3736788|NCT02030574|3573789|B1|||Age||years|Mean|63.5|63.5|Full Range|||51.0|76.0|
3736789|NCT02030574|3573789|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3736790|NCT02030574|3573789|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3736791|NCT02030574|3573789|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3736792|NCT02030535|3573794|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3736793|NCT02030535|3573794|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3736794|NCT02030535|3573794|B1|||Age||years|Mean|64.4|64.4|Standard Deviation|6.8|6.8|||
3736795|NCT02030405|3573862|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3736796|NCT02030405|3573862|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736797|NCT02030405|3573862|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3736798|NCT02030405|3573862|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3736799|NCT02030405|3573862|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736800|NCT02030405|3573862|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736801|NCT02030405|3573862|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736802|NCT02030405|3573862|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736803|NCT02030405|3573862|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3736804|NCT02030405|3573862|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3736805|NCT02030405|3573862|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3736806|NCT02030405|3573862|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3736807|NCT02030405|3573862|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3736808|NCT02030405|3573862|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3736809|NCT02030405|3573862|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3736810|NCT02030119|3573867|B5|||Number of Participants with iPhone smartphone||Participants|Count of Participants|183|183.0||||||
3736811|NCT02030119|3573868|B4|||Number of Participants with iPhone smartphone||Participants|Count of Participants|49|49.0||||||
3736812|NCT02030119|3573869|B3|||Number of Participants with iPhone smartphone||Participants|Count of Participants|45|45.0||||||
3736813|NCT02030119|3573870|B2|||Number of Participants with iPhone smartphone||Participants|Count of Participants|43|43.0||||||
3736814|NCT02030119|3573871|B1|||Number of Participants with iPhone smartphone||Participants|Count of Participants|46|46.0||||||
3736815|NCT02030119|3573867|B5|>$100,000||Annual household income||Participants|Count of Participants|70|70.0||||||
3736816|NCT02030119|3573868|B4|>$100,000||Annual household income||Participants|Count of Participants|18|18.0||||||
3736817|NCT02030119|3573869|B3|>$100,000||Annual household income||Participants|Count of Participants|20|20.0||||||
3736818|NCT02030119|3573870|B2|>$100,000||Annual household income||Participants|Count of Participants|12|12.0||||||
3736819|NCT02030119|3573871|B1|>$100,000||Annual household income||Participants|Count of Participants|20|20.0||||||
3736820|NCT02030119|3573867|B5|$50,000-$100,000||Annual household income||Participants|Count of Participants|108|108.0||||||
3736821|NCT02030119|3573868|B4|$50,000-$100,000||Annual household income||Participants|Count of Participants|29|29.0||||||
3736822|NCT02030119|3573869|B3|$50,000-$100,000||Annual household income||Participants|Count of Participants|22|22.0||||||
3736823|NCT02030119|3573870|B2|$50,000-$100,000||Annual household income||Participants|Count of Participants|32|32.0||||||
3736824|NCT02030119|3573871|B1|$50,000-$100,000||Annual household income||Participants|Count of Participants|25|25.0||||||
3736825|NCT02030119|3573867|B5|<$50,000||Annual household income||Participants|Count of Participants|84|84.0||||||
3736826|NCT02030119|3573868|B4|<$50,000||Annual household income||Participants|Count of Participants|15|15.0||||||
3736827|NCT02030119|3573869|B3|<$50,000||Annual household income||Participants|Count of Participants|24|24.0||||||
3736828|NCT02030119|3573870|B2|<$50,000||Annual household income||Participants|Count of Participants|24|24.0||||||
3736829|NCT02030119|3573871|B1|<$50,000||Annual household income||Participants|Count of Participants|21|21.0||||||
3736830|NCT02030119|3573867|B5|Other||Marital status||Participants|Count of Participants|44|44.0||||||
3736831|NCT02030119|3573868|B4|Other||Marital status||Participants|Count of Participants|9|9.0||||||
3736832|NCT02030119|3573869|B3|Other||Marital status||Participants|Count of Participants|11|11.0||||||
3736833|NCT02030119|3573870|B2|Other||Marital status||Participants|Count of Participants|12|12.0||||||
3736834|NCT02030119|3573871|B1|Other||Marital status||Participants|Count of Participants|12|12.0||||||
3736835|NCT02030119|3573867|B5|Married||Marital status||Participants|Count of Participants|130|130.0||||||
3736836|NCT02030119|3573868|B4|Married||Marital status||Participants|Count of Participants|36|36.0||||||
3736837|NCT02030119|3573869|B3|Married||Marital status||Participants|Count of Participants|32|32.0||||||
3736838|NCT02030119|3573870|B2|Married||Marital status||Participants|Count of Participants|31|31.0||||||
3736839|NCT02030119|3573871|B1|Married||Marital status||Participants|Count of Participants|31|31.0||||||
3736840|NCT02030119|3573867|B5|Single||Marital status||Participants|Count of Participants|105|105.0||||||
3736841|NCT02030119|3573868|B4|Single||Marital status||Participants|Count of Participants|25|25.0||||||
3736842|NCT02030119|3573869|B3|Single||Marital status||Participants|Count of Participants|27|27.0||||||
3736843|NCT02030119|3573870|B2|Single||Marital status||Participants|Count of Participants|26|26.0||||||
3736844|NCT02030119|3573871|B1|Single||Marital status||Participants|Count of Participants|27|27.0||||||
3736845|NCT02030119|3573867|B5|College graduate||Education||Participants|Count of Participants|217|217.0||||||
3736846|NCT02030119|3573868|B4|College graduate||Education||Participants|Count of Participants|56|56.0||||||
3736847|NCT02030119|3573869|B3|College graduate||Education||Participants|Count of Participants|55|55.0||||||
3736848|NCT02030119|3573870|B2|College graduate||Education||Participants|Count of Participants|52|52.0||||||
3736849|NCT02030119|3573871|B1|College graduate||Education||Participants|Count of Participants|54|54.0||||||
3736850|NCT02030119|3573867|B5|Some college||Education||Participants|Count of Participants|55|55.0||||||
3736851|NCT02030119|3573868|B4|Some college||Education||Participants|Count of Participants|12|12.0||||||
3736852|NCT02030119|3573869|B3|Some college||Education||Participants|Count of Participants|13|13.0||||||
3736853|NCT02030119|3573870|B2|Some college||Education||Participants|Count of Participants|15|15.0||||||
3736854|NCT02030119|3573871|B1|Some college||Education||Participants|Count of Participants|15|15.0||||||
3736855|NCT02030119|3573867|B5|Less than college||Education||Participants|Count of Participants|7|7.0||||||
3736856|NCT02030119|3573868|B4|Less than college||Education||Participants|Count of Participants|2|2.0||||||
3736857|NCT02030119|3573869|B3|Less than college||Education||Participants|Count of Participants|2|2.0||||||
3736858|NCT02030119|3573870|B2|Less than college||Education||Participants|Count of Participants|2|2.0||||||
3736859|NCT02030119|3573871|B1|Less than college||Education||Participants|Count of Participants|1|1.0||||||
3736860|NCT02030119|3573867|B5|Hispanic||Race/ethnicity||Participants|Count of Participants|10|10.0||||||
3736861|NCT02030119|3573868|B4|Hispanic||Race/ethnicity||Participants|Count of Participants|2|2.0||||||
3736862|NCT02030119|3573869|B3|Hispanic||Race/ethnicity||Participants|Count of Participants|3|3.0||||||
3736863|NCT02030119|3573870|B2|Hispanic||Race/ethnicity||Participants|Count of Participants|2|2.0||||||
3736864|NCT02030119|3573871|B1|Hispanic||Race/ethnicity||Participants|Count of Participants|3|3.0||||||
3736865|NCT02030119|3573867|B5|Other non-Hispanic||Race/ethnicity||Participants|Count of Participants|29|29.0||||||
3736866|NCT02030119|3573868|B4|Other non-Hispanic||Race/ethnicity||Participants|Count of Participants|6|6.0||||||
3736867|NCT02030119|3573869|B3|Other non-Hispanic||Race/ethnicity||Participants|Count of Participants|7|7.0||||||
3736868|NCT02030119|3573870|B2|Other non-Hispanic||Race/ethnicity||Participants|Count of Participants|10|10.0||||||
3736869|NCT02030119|3573871|B1|Other non-Hispanic||Race/ethnicity||Participants|Count of Participants|6|6.0||||||
3736870|NCT02030119|3573867|B5|African American non-Hispanic||Race/ethnicity||Participants|Count of Participants|61|61.0||||||
3736871|NCT02030119|3573868|B4|African American non-Hispanic||Race/ethnicity||Participants|Count of Participants|13|13.0||||||
3736872|NCT02030119|3573869|B3|African American non-Hispanic||Race/ethnicity||Participants|Count of Participants|16|16.0||||||
3736873|NCT02030119|3573870|B2|African American non-Hispanic||Race/ethnicity||Participants|Count of Participants|16|16.0||||||
3736954|NCT02030080|3573892|B1|Single||Marital status||Participants|Count of Participants|36|36.0||||||
3736874|NCT02030119|3573871|B1|African American non-Hispanic||Race/ethnicity||Participants|Count of Participants|16|16.0||||||
3736875|NCT02030119|3573867|B5|White non-Hispanic||Race/ethnicity||Participants|Count of Participants|179|179.0||||||
3736876|NCT02030119|3573868|B4|White non-Hispanic||Race/ethnicity||Participants|Count of Participants|49|49.0||||||
3736877|NCT02030119|3573869|B3|White non-Hispanic||Race/ethnicity||Participants|Count of Participants|44|44.0||||||
3736878|NCT02030119|3573870|B2|White non-Hispanic||Race/ethnicity||Participants|Count of Participants|41|41.0||||||
3736879|NCT02030119|3573871|B1|White non-Hispanic||Race/ethnicity||Participants|Count of Participants|45|45.0||||||
3736880|NCT02030119|3573867|B5|||Median physical activity in the past 7 d, MET-min|International Physical Activity Questionnaire (IPAQ) was used to calculate the number of metabolic equivalent minutes (MET-min) per participant in the past 7 days. MET-min is the physiologic measure of energy expenditure, with light-intensity activities having an MET<3, moderate-intensity activities having an MET of 3 to 6, and more vigorous-intensity activities with an MET>6.|Metabolic equivalent minutes (MET-min)|Median|2709.3|2709.3|Inter-Quartile Range|||1299.5|4896.0|
3736881|NCT02030119|3573868|B4|||Median physical activity in the past 7 d, MET-min|International Physical Activity Questionnaire (IPAQ) was used to calculate the number of metabolic equivalent minutes (MET-min) per participant in the past 7 days. MET-min is the physiologic measure of energy expenditure, with light-intensity activities having an MET<3, moderate-intensity activities having an MET of 3 to 6, and more vigorous-intensity activities with an MET>6.|Metabolic equivalent minutes (MET-min)|Median|2764.5|2764.5|Inter-Quartile Range|||933.0|4456.0|
3736882|NCT02030119|3573869|B3|||Median physical activity in the past 7 d, MET-min|International Physical Activity Questionnaire (IPAQ) was used to calculate the number of metabolic equivalent minutes (MET-min) per participant in the past 7 days. MET-min is the physiologic measure of energy expenditure, with light-intensity activities having an MET<3, moderate-intensity activities having an MET of 3 to 6, and more vigorous-intensity activities with an MET>6.|Metabolic equivalent minutes (MET-min)|Median|2785.0|2785.0|Inter-Quartile Range|||1336.5|4965.5|
3736883|NCT02030119|3573870|B2|||Median physical activity in the past 7 d, MET-min|International Physical Activity Questionnaire (IPAQ) was used to calculate the number of metabolic equivalent minutes (MET-min) per participant in the past 7 days. MET-min is the physiologic measure of energy expenditure, with light-intensity activities having an MET<3, moderate-intensity activities having an MET of 3 to 6, and more vigorous-intensity activities with an MET>6.|Metabolic equivalent minutes (MET-min)|Median|2812.2|2812.2|Inter-Quartile Range|||1408.0|4806.0|
3736884|NCT02030119|3573871|B1|||Median physical activity in the past 7 d, MET-min|International Physical Activity Questionnaire (IPAQ) was used to calculate the number of metabolic equivalent minutes (MET-min) per participant in the past 7 days. MET-min is the physiologic measure of energy expenditure, with light-intensity activities having an MET<3, moderate-intensity activities having an MET of 3 to 6, and more vigorous-intensity activities with an MET>6.|Metabolic equivalent minutes (MET-min)|Median|2568.8|2568.8|Inter-Quartile Range|||1077.0|4941.0|
3736885|NCT02030119|3573867|B5|||Mean BMI||kg/m^2|Mean|33.2|33.2|Standard Deviation|5.6|5.6|||
3736886|NCT02030119|3573868|B4|||Mean BMI||kg/m^2|Mean|33.8|33.8|Standard Deviation|6.8|6.8|||
3736887|NCT02030119|3573869|B3|||Mean BMI||kg/m^2|Mean|33.1|33.1|Standard Deviation|5.6|5.6|||
3736888|NCT02030119|3573870|B2|||Mean BMI||kg/m^2|Mean|32.6|32.6|Standard Deviation|4.5|4.5|||
3736889|NCT02030119|3573871|B1|||Mean BMI||kg/m^2|Mean|33.2|33.2|Standard Deviation|5.3|5.3|||
3736890|NCT02030119|3573867|B5||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3736891|NCT02030119|3573868|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3736892|NCT02030119|3573869|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3736893|NCT02030119|3573870|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3736894|NCT02030119|3573871|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3736895|NCT02030119|3573867|B5||Female|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
3736896|NCT02030119|3573868|B4||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3736897|NCT02030119|3573869|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3736898|NCT02030119|3573870|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3736899|NCT02030119|3573871|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3736900|NCT02030119|3573867|B5|||Age||years of age|Mean|39.7|39.7|Standard Deviation|11.6|11.6|||
3736901|NCT02030119|3573868|B4|||Age||years of age|Mean|41.9|41.9|Standard Deviation|11.6|11.6|||
3736902|NCT02030119|3573869|B3|||Age||years of age|Mean|40.3|40.3|Standard Deviation|11.2|11.2|||
3736903|NCT02030119|3573870|B2|||Age||years of age|Mean|37.1|37.1|Standard Deviation|10.9|10.9|||
3736904|NCT02030119|3573871|B1|||Age||years of age|Mean|39.4|39.4|Standard Deviation|12.2|12.2|||
3736905|NCT02030080|3573888|B5|||Physical activity in the last 7 days (MET-min)|The International Physical Activity Questionnaire (IPAQ) was used to calculate the number of metabolic equivalent minutes (MET-min) per participant in the most recent 7 days. The MET is a physiologic measure of energy expenditure, with light-intensity activities having an MET <3, moderate-intensity activities having an MET of 3 to 6, and more vigorous-intensity activities with an MET>6.|Metabolic equivalent minutes (MET-min)|Median|4533.3|4533.3|Inter-Quartile Range|||2329.5|7929.0|
3736906|NCT02030080|3573889|B4|||Physical activity in the last 7 days (MET-min)|The International Physical Activity Questionnaire (IPAQ) was used to calculate the number of metabolic equivalent minutes (MET-min) per participant in the most recent 7 days. The MET is a physiologic measure of energy expenditure, with light-intensity activities having an MET <3, moderate-intensity activities having an MET of 3 to 6, and more vigorous-intensity activities with an MET>6.|Metabolic equivalent minutes (MET-min)|Median|3630.0|3630.0|Inter-Quartile Range|||2208.0|9588.0|
3736955|NCT02030080|3573888|B5|College graduate||Education||Participants|Count of Participants|204|204.0||||||
3736956|NCT02030080|3573889|B4|College graduate||Education||Participants|Count of Participants|30|30.0||||||
3736957|NCT02030080|3573890|B3|College graduate||Education||Participants|Count of Participants|60|60.0||||||
3736907|NCT02030080|3573890|B3|||Physical activity in the last 7 days (MET-min)|The International Physical Activity Questionnaire (IPAQ) was used to calculate the number of metabolic equivalent minutes (MET-min) per participant in the most recent 7 days. The MET is a physiologic measure of energy expenditure, with light-intensity activities having an MET <3, moderate-intensity activities having an MET of 3 to 6, and more vigorous-intensity activities with an MET>6.|Metabolic equivalent minutes (MET-min)|Median|4186.0|4186.0|Inter-Quartile Range|||1711.5|7173.0|
3736908|NCT02030080|3573891|B2|||Physical activity in the last 7 days (MET-min)|The International Physical Activity Questionnaire (IPAQ) was used to calculate the number of metabolic equivalent minutes (MET-min) per participant in the most recent 7 days. The MET is a physiologic measure of energy expenditure, with light-intensity activities having an MET <3, moderate-intensity activities having an MET of 3 to 6, and more vigorous-intensity activities with an MET>6.|Metabolic equivalent minutes (MET-min)|Median|4702.5|4702.5|Inter-Quartile Range|||2914.5|8071.5|
3736909|NCT02030080|3573892|B1|||Physical activity in the last 7 days (MET-min)|The International Physical Activity Questionnaire (IPAQ) was used to calculate the number of metabolic equivalent minutes (MET-min) per participant in the most recent 7 days. The MET is a physiologic measure of energy expenditure, with light-intensity activities having an MET <3, moderate-intensity activities having an MET of 3 to 6, and more vigorous-intensity activities with an MET>6.|Metabolic equivalent minutes (MET-min)|Median|4698.0|4698.0|Inter-Quartile Range|||2424.0|7740.0|
3736910|NCT02030080|3573888|B5|||Body mass index||kg/m^2|Mean|28.4|28.4|Standard Deviation|6.5|6.5|||
3736911|NCT02030080|3573889|B4|||Body mass index||kg/m^2|Mean|28.5|28.5|Standard Deviation|6.2|6.2|||
3736912|NCT02030080|3573890|B3|||Body mass index||kg/m^2|Mean|27.5|27.5|Standard Deviation|5.8|5.8|||
3736913|NCT02030080|3573891|B2|||Body mass index||kg/m^2|Mean|28.7|28.7|Standard Deviation|6.1|6.1|||
3736914|NCT02030080|3573892|B1|||Body mass index||kg/m^2|Mean|29|29.0|Standard Deviation|7.4|7.4|||
3736915|NCT02030080|3573888|B5|||Number of Participants with iPhone smartphone||Participants|Count of Participants|209|209.0||||||
3736916|NCT02030080|3573889|B4|||Number of Participants with iPhone smartphone||Participants|Count of Participants|34|34.0||||||
3736917|NCT02030080|3573890|B3|||Number of Participants with iPhone smartphone||Participants|Count of Participants|56|56.0||||||
3736918|NCT02030080|3573891|B2|||Number of Participants with iPhone smartphone||Participants|Count of Participants|48|48.0||||||
3736919|NCT02030080|3573892|B1|||Number of Participants with iPhone smartphone||Participants|Count of Participants|71|71.0||||||
3736920|NCT02030080|3573888|B5||Missing Data|Annual household income||Participants|Count of Participants|31|31.0||||||
3736921|NCT02030080|3573889|B4||Missing Data|Annual household income||Participants|Count of Participants|2|2.0||||||
3736922|NCT02030080|3573890|B3||Missing Data|Annual household income||Participants|Count of Participants|10|10.0||||||
3736923|NCT02030080|3573891|B2||Missing Data|Annual household income||Participants|Count of Participants|4|4.0||||||
3736924|NCT02030080|3573892|B1||Missing Data|Annual household income||Participants|Count of Participants|15|15.0||||||
3736925|NCT02030080|3573888|B5||Greater than $100,000|Annual household income||Participants|Count of Participants|106|106.0||||||
3736926|NCT02030080|3573889|B4||Greater than $100,000|Annual household income||Participants|Count of Participants|12|12.0||||||
3736927|NCT02030080|3573890|B3||Greater than $100,000|Annual household income||Participants|Count of Participants|29|29.0||||||
3736928|NCT02030080|3573891|B2||Greater than $100,000|Annual household income||Participants|Count of Participants|30|30.0||||||
3736929|NCT02030080|3573892|B1||Greater than $100,000|Annual household income||Participants|Count of Participants|35|35.0||||||
3736930|NCT02030080|3573888|B5||$50,000-$100,000|Annual household income||Participants|Count of Participants|96|96.0||||||
3736931|NCT02030080|3573889|B4||$50,000-$100,000|Annual household income||Participants|Count of Participants|20|20.0||||||
3736932|NCT02030080|3573890|B3||$50,000-$100,000|Annual household income||Participants|Count of Participants|28|28.0||||||
3736933|NCT02030080|3573891|B2||$50,000-$100,000|Annual household income||Participants|Count of Participants|17|17.0||||||
3736934|NCT02030080|3573892|B1||$50,000-$100,000|Annual household income||Participants|Count of Participants|31|31.0||||||
3736935|NCT02030080|3573888|B5||Less than $50,000|Annual household income||Participants|Count of Participants|53|53.0||||||
3736936|NCT02030080|3573889|B4||Less than $50,000|Annual household income||Participants|Count of Participants|8|8.0||||||
3736937|NCT02030080|3573890|B3||Less than $50,000|Annual household income||Participants|Count of Participants|13|13.0||||||
3736938|NCT02030080|3573891|B2||Less than $50,000|Annual household income||Participants|Count of Participants|13|13.0||||||
3736939|NCT02030080|3573892|B1||Less than $50,000|Annual household income||Participants|Count of Participants|19|19.0||||||
3736940|NCT02030080|3573888|B5|Other||Marital status||Participants|Count of Participants|28|28.0||||||
3736941|NCT02030080|3573889|B4|Other||Marital status||Participants|Count of Participants|4|4.0||||||
3736942|NCT02030080|3573890|B3|Other||Marital status||Participants|Count of Participants|11|11.0||||||
3736943|NCT02030080|3573891|B2|Other||Marital status||Participants|Count of Participants|4|4.0||||||
3736944|NCT02030080|3573892|B1|Other||Marital status||Participants|Count of Participants|9|9.0||||||
3736945|NCT02030080|3573888|B5|Married||Marital status||Participants|Count of Participants|153|153.0||||||
3736946|NCT02030080|3573889|B4|Married||Marital status||Participants|Count of Participants|24|24.0||||||
3736947|NCT02030080|3573890|B3|Married||Marital status||Participants|Count of Participants|39|39.0||||||
3736948|NCT02030080|3573891|B2|Married||Marital status||Participants|Count of Participants|35|35.0||||||
3736949|NCT02030080|3573892|B1|Married||Marital status||Participants|Count of Participants|55|55.0||||||
3736950|NCT02030080|3573888|B5|Single||Marital status||Participants|Count of Participants|105|105.0||||||
3736951|NCT02030080|3573889|B4|Single||Marital status||Participants|Count of Participants|14|14.0||||||
3736952|NCT02030080|3573890|B3|Single||Marital status||Participants|Count of Participants|30|30.0||||||
3736953|NCT02030080|3573891|B2|Single||Marital status||Participants|Count of Participants|25|25.0||||||
3736958|NCT02030080|3573891|B2|College graduate||Education||Participants|Count of Participants|36|36.0||||||
3736959|NCT02030080|3573892|B1|College graduate||Education||Participants|Count of Participants|78|78.0||||||
3736960|NCT02030080|3573888|B5|Some college||Education||Participants|Count of Participants|62|62.0||||||
3736961|NCT02030080|3573889|B4|Some college||Education||Participants|Count of Participants|8|8.0||||||
3736962|NCT02030080|3573890|B3|Some college||Education||Participants|Count of Participants|16|16.0||||||
3736963|NCT02030080|3573891|B2|Some college||Education||Participants|Count of Participants|22|22.0||||||
3736964|NCT02030080|3573892|B1|Some college||Education||Participants|Count of Participants|16|16.0||||||
3736965|NCT02030080|3573888|B5|Less than college||Education||Participants|Count of Participants|20|20.0||||||
3736966|NCT02030080|3573889|B4|Less than college||Education||Participants|Count of Participants|4|4.0||||||
3736967|NCT02030080|3573890|B3|Less than college||Education||Participants|Count of Participants|4|4.0||||||
3736968|NCT02030080|3573891|B2|Less than college||Education||Participants|Count of Participants|6|6.0||||||
3736969|NCT02030080|3573892|B1|Less than college||Education||Participants|Count of Participants|6|6.0||||||
3736970|NCT02030080|3573888|B5||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3736971|NCT02030080|3573889|B4||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3736972|NCT02030080|3573890|B3||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3736973|NCT02030080|3573891|B2||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3736974|NCT02030080|3573892|B1||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3736975|NCT02030080|3573888|B5||Other non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3736976|NCT02030080|3573889|B4||Other non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3736977|NCT02030080|3573890|B3||Other non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3736978|NCT02030080|3573891|B2||Other non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3736979|NCT02030080|3573892|B1||Other non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3736980|NCT02030080|3573888|B5||African American non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|58|58.0||||||
3736981|NCT02030080|3573889|B4||African American non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3736982|NCT02030080|3573890|B3||African American non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3736983|NCT02030080|3573891|B2||African American non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3736984|NCT02030080|3573892|B1||African American non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3736985|NCT02030080|3573888|B5||White non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|192|192.0||||||
3736986|NCT02030080|3573889|B4||White non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3736987|NCT02030080|3573890|B3||White non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
3736988|NCT02030080|3573891|B2||White non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|49|49.0||||||
3736989|NCT02030080|3573892|B1||White non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|65|65.0||||||
3736990|NCT02030080|3573888|B5||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3736991|NCT02030080|3573889|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3736992|NCT02030080|3573890|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3736993|NCT02030080|3573891|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3736994|NCT02030080|3573892|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3736995|NCT02030080|3573888|B5||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
3736996|NCT02030080|3573889|B4||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3736997|NCT02030080|3573890|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3736998|NCT02030080|3573891|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3736999|NCT02030080|3573892|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3737000|NCT02030080|3573888|B5|||Age||Years|Mean|41.3|41.3|Standard Deviation|12|12.0|||
3737001|NCT02030080|3573889|B4|||Age||Years|Mean|40.8|40.8|Standard Deviation|13.2|13.2|||
3737002|NCT02030080|3573890|B3|||Age||Years|Mean|40.7|40.7|Standard Deviation|12.2|12.2|||
3737003|NCT02030080|3573891|B2|||Age||Years|Mean|43.1|43.1|Standard Deviation|10.5|10.5|||
3737004|NCT02030080|3573892|B1|||Age||Years|Mean|40.9|40.9|Standard Deviation|12.2|12.2|||
3737005|NCT02030041|3573909|B4|||Skeletal muscle citrate synthase activity|Skeletal muscle citrate synthase activity is a validated marker of mitochondrial content.Skeletal muscle biopsy is obtained from vastus lateralis muscle of five patients in either groups before and after the intervention. Under aseptic conditions, samples were taken in protease inhibitor cocktail and stored at -80ºcelsius. Mitochondrial citrate synthase activity (the working range of the kit was 1.56-100 µg/mL, with intra and inter assay coefficient of variation (CV) of 4.35-6.55 % and 8.3 % respectively) is measured using ELISA Kit (Abcam, Cambridge, UK) as per manufacturer’s instructions.|change in mOD/min at 412nm|Mean|0.0046|0.0046|Standard Deviation|0.0013|0.0013|||
3737026|NCT02030041|3573910|B3|||HbA1c||%|Mean|6.9|6.9|Standard Deviation|0.5|0.5|||
3737027|NCT02030041|3573911|B2|||HbA1c||%|Mean|6.9|6.9|Standard Deviation|0.5|0.5|||
3737028|NCT02030041|3573912|B1|||HbA1c||%|Mean|6.9|6.9|Standard Deviation|0.4|0.4|||
3737029|NCT02030041|3573909|B4|||Body mass index(BMI)||kg/m2|Mean|27.8|27.8|Standard Deviation|2.4|2.4|||
3737030|NCT02030041|3573910|B3|||Body mass index(BMI)||kg/m2|Mean|27.4|27.4|Standard Deviation|2.2|2.2|||
3737006|NCT02030041|3573910|B3|||Skeletal muscle citrate synthase activity|Skeletal muscle citrate synthase activity is a validated marker of mitochondrial content.Skeletal muscle biopsy is obtained from vastus lateralis muscle of five patients in either groups before and after the intervention. Under aseptic conditions, samples were taken in protease inhibitor cocktail and stored at -80ºcelsius. Mitochondrial citrate synthase activity (the working range of the kit was 1.56-100 µg/mL, with intra and inter assay coefficient of variation (CV) of 4.35-6.55 % and 8.3 % respectively) is measured using ELISA Kit (Abcam, Cambridge, UK) as per manufacturer’s instructions.|change in mOD/min at 412nm|Mean|0.0043|0.0043|Standard Deviation|0.0017|0.0017|||
3737007|NCT02030041|3573911|B2|||Skeletal muscle citrate synthase activity|Skeletal muscle citrate synthase activity is a validated marker of mitochondrial content.Skeletal muscle biopsy is obtained from vastus lateralis muscle of five patients in either groups before and after the intervention. Under aseptic conditions, samples were taken in protease inhibitor cocktail and stored at -80ºcelsius. Mitochondrial citrate synthase activity (the working range of the kit was 1.56-100 µg/mL, with intra and inter assay coefficient of variation (CV) of 4.35-6.55 % and 8.3 % respectively) is measured using ELISA Kit (Abcam, Cambridge, UK) as per manufacturer’s instructions.|change in mOD/min at 412nm|Mean|0.0042|0.0042|Standard Deviation|0.0019|0.0019|||
3737008|NCT02030041|3573912|B1|||Skeletal muscle citrate synthase activity|Skeletal muscle citrate synthase activity is a validated marker of mitochondrial content.Skeletal muscle biopsy is obtained from vastus lateralis muscle of five patients in either groups before and after the intervention. Under aseptic conditions, samples were taken in protease inhibitor cocktail and stored at -80ºcelsius. Mitochondrial citrate synthase activity (the working range of the kit was 1.56-100 µg/mL, with intra and inter assay coefficient of variation (CV) of 4.35-6.55 % and 8.3 % respectively) is measured using ELISA Kit (Abcam, Cambridge, UK) as per manufacturer’s instructions.|change in mOD/min at 412nm|Mean|0.0051|0.0051|Standard Deviation|0.0001|0.0001|||
3737009|NCT02030041|3573909|B4|||Peak oxygen consumption percentage of predicted value (VO2peak%)|As VO2peak (expressed as liters of oxygen consumed per minute) is also dependent on age, sex, and body size, it was also expressed as percentage of the predicted value(VO2peak%).|%|Mean|50.1|50.1|Standard Deviation|9.2|9.2|||
3737010|NCT02030041|3573910|B3|||Peak oxygen consumption percentage of predicted value (VO2peak%)|As VO2peak (expressed as liters of oxygen consumed per minute) is also dependent on age, sex, and body size, it was also expressed as percentage of the predicted value(VO2peak%).|%|Mean|46.4|46.4|Standard Deviation|8.6|8.6|||
3737011|NCT02030041|3573911|B2|||Peak oxygen consumption percentage of predicted value (VO2peak%)|As VO2peak (expressed as liters of oxygen consumed per minute) is also dependent on age, sex, and body size, it was also expressed as percentage of the predicted value(VO2peak%).|%|Mean|52.2|52.2|Standard Deviation|8.9|8.9|||
3737012|NCT02030041|3573912|B1|||Peak oxygen consumption percentage of predicted value (VO2peak%)|As VO2peak (expressed as liters of oxygen consumed per minute) is also dependent on age, sex, and body size, it was also expressed as percentage of the predicted value(VO2peak%).|%|Mean|52.2|52.2|Standard Deviation|9.8|9.8|||
3737013|NCT02030041|3573909|B4|||Peak oxygen consumption(VO2peak)|Peak oxygen consumption (VO2peak) is defined as highest rate at which oxygen can be taken up and utilized by body during severe exercise during bicycle ergometry The participants were encouraged to exercise to exhaustion with progressive 2-minutes increments in the power output during the test. VO2peak was obtained when participants reached volitional exhaustion and met one of the following criteria: plateau in oxygen consumption despite increase in workload, rating of perceived exertion >18, Respiratory exchange ratio > 1.10 and peak heart rate within 10 beats of age predicted maximum.|L/min|Mean|1.2|1.2|Standard Deviation|0.4|0.4|||
3737014|NCT02030041|3573910|B3|||Peak oxygen consumption(VO2peak)|Peak oxygen consumption (VO2peak) is defined as highest rate at which oxygen can be taken up and utilized by body during severe exercise during bicycle ergometry The participants were encouraged to exercise to exhaustion with progressive 2-minutes increments in the power output during the test. VO2peak was obtained when participants reached volitional exhaustion and met one of the following criteria: plateau in oxygen consumption despite increase in workload, rating of perceived exertion >18, Respiratory exchange ratio > 1.10 and peak heart rate within 10 beats of age predicted maximum.|L/min|Mean|1.1|1.1|Standard Deviation|0.2|0.2|||
3737015|NCT02030041|3573911|B2|||Peak oxygen consumption(VO2peak)|Peak oxygen consumption (VO2peak) is defined as highest rate at which oxygen can be taken up and utilized by body during severe exercise during bicycle ergometry The participants were encouraged to exercise to exhaustion with progressive 2-minutes increments in the power output during the test. VO2peak was obtained when participants reached volitional exhaustion and met one of the following criteria: plateau in oxygen consumption despite increase in workload, rating of perceived exertion >18, Respiratory exchange ratio > 1.10 and peak heart rate within 10 beats of age predicted maximum.|L/min|Mean|1.13|1.13|Standard Deviation|0.4|0.4|||
3737016|NCT02030041|3573912|B1|||Peak oxygen consumption(VO2peak)|Peak oxygen consumption (VO2peak) is defined as highest rate at which oxygen can be taken up and utilized by body during severe exercise during bicycle ergometry The participants were encouraged to exercise to exhaustion with progressive 2-minutes increments in the power output during the test. VO2peak was obtained when participants reached volitional exhaustion and met one of the following criteria: plateau in oxygen consumption despite increase in workload, rating of perceived exertion >18, Respiratory exchange ratio > 1.10 and peak heart rate within 10 beats of age predicted maximum.|L/min|Mean|1.33|1.33|Standard Deviation|0.5|0.5|||
3737017|NCT02030041|3573909|B4|||Low density Cholesterol (LDL-C)||mg/dl|Mean|115.2|115.2|Standard Deviation|9.3|9.3|||
3737018|NCT02030041|3573910|B3|||Low density Cholesterol (LDL-C)||mg/dl|Mean|112|112.0|Standard Deviation|6.8|6.8|||
3737019|NCT02030041|3573911|B2|||Low density Cholesterol (LDL-C)||mg/dl|Mean|116.4|116.4|Standard Deviation|11.4|11.4|||
3737020|NCT02030041|3573912|B1|||Low density Cholesterol (LDL-C)||mg/dl|Mean|117.4|117.4|Standard Deviation|9.4|9.4|||
3737021|NCT02030041|3573909|B4|||Fasting plasma Insulin||microIU/ml|Mean|13.1|13.1|Standard Deviation|5.2|5.2|||
3737022|NCT02030041|3573910|B3|||Fasting plasma Insulin||microIU/ml|Mean|13.2|13.2|Standard Deviation|4.5|4.5|||
3737023|NCT02030041|3573911|B2|||Fasting plasma Insulin||microIU/ml|Mean|12.1|12.1|Standard Deviation|5|5.0|||
3737024|NCT02030041|3573912|B1|||Fasting plasma Insulin||microIU/ml|Mean|13.6|13.6|Standard Deviation|6.3|6.3|||
3737025|NCT02030041|3573909|B4|||HbA1c||%|Mean|6.9|6.9|Standard Deviation|0.5|0.5|||
3737031|NCT02030041|3573911|B2|||Body mass index(BMI)||kg/m2|Mean|28.1|28.1|Standard Deviation|2.5|2.5|||
3737032|NCT02030041|3573912|B1|||Body mass index(BMI)||kg/m2|Mean|27.9|27.9|Standard Deviation|2.4|2.4|||
3737033|NCT02030041|3573909|B4|India||Region of Enrollment||participants|Number|28|28.0||||||
3737034|NCT02030041|3573910|B3|India||Region of Enrollment||participants|Number|10|10.0||||||
3737035|NCT02030041|3573911|B2|India||Region of Enrollment||participants|Number|9|9.0||||||
3737036|NCT02030041|3573912|B1|India||Region of Enrollment||participants|Number|9|9.0||||||
3737037|NCT02030041|3573909|B4|Asian Indian||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3737038|NCT02030041|3573910|B3|Asian Indian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3737039|NCT02030041|3573911|B2|Asian Indian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3737040|NCT02030041|3573912|B1|Asian Indian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3737041|NCT02030041|3573909|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3737042|NCT02030041|3573910|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3737043|NCT02030041|3573911|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3737044|NCT02030041|3573912|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3737045|NCT02030041|3573909|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3737046|NCT02030041|3573910|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3737047|NCT02030041|3573911|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3737048|NCT02030041|3573912|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3737049|NCT02030041|3573909|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3737050|NCT02030041|3573910|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3737051|NCT02030041|3573911|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3737052|NCT02030041|3573912|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3737053|NCT02030041|3573909|B4||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3737054|NCT02030041|3573910|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3737055|NCT02030041|3573911|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3737056|NCT02030041|3573912|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3737057|NCT02030041|3573909|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3737058|NCT02030041|3573910|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3737059|NCT02030041|3573911|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3737060|NCT02030041|3573912|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3737061|NCT02029989|3573925|B3|||Diabetes Risk|Risk is defined as glycosylated hemoglobin A1c greater or equal to 6.5% was found in 10.3% of the NCS group and 12.5% of the PCS group. Data was not available for 6 subjects. This explains why the sum of this baseline measure does not equal the overall baseline participants.|participants|Number|13|13.0||||||
3737062|NCT02029989|3573926|B2|||Diabetes Risk|Risk is defined as glycosylated hemoglobin A1c greater or equal to 6.5% was found in 10.3% of the NCS group and 12.5% of the PCS group. Data was not available for 6 subjects. This explains why the sum of this baseline measure does not equal the overall baseline participants.|participants|Number|6|6.0||||||
3737063|NCT02029989|3573927|B1|||Diabetes Risk|Risk is defined as glycosylated hemoglobin A1c greater or equal to 6.5% was found in 10.3% of the NCS group and 12.5% of the PCS group. Data was not available for 6 subjects. This explains why the sum of this baseline measure does not equal the overall baseline participants.|participants|Number|7|7.0||||||
3737064|NCT02029989|3573925|B3|||Hypertension Risk|Risk is defined as blood pressures greater than 130 mmHg systolic and/or greater than 85 mmHg diastolic was 48.1% in the NCS group and 51.9% in the PCS group. Data was not available for 2 subjects. This explains why the sum of this baseline measure does not equal the overall baseline participants.|participants|Number|52|52.0||||||
3737065|NCT02029989|3573926|B2|||Hypertension Risk|Risk is defined as blood pressures greater than 130 mmHg systolic and/or greater than 85 mmHg diastolic was 48.1% in the NCS group and 51.9% in the PCS group. Data was not available for 2 subjects. This explains why the sum of this baseline measure does not equal the overall baseline participants.|participants|Number|25|25.0||||||
3737066|NCT02029989|3573927|B1|||Hypertension Risk|Risk is defined as blood pressures greater than 130 mmHg systolic and/or greater than 85 mmHg diastolic was 48.1% in the NCS group and 51.9% in the PCS group. Data was not available for 2 subjects. This explains why the sum of this baseline measure does not equal the overall baseline participants.|participants|Number|27|27.0||||||
3737067|NCT02029989|3573925|B3|||High Density Lipoprotein (HDL) Risk|Risk is defined as: Males < 40 mg/dL; Females < 50 mg/dL was 75% in the NCS group and 73.3% in the PCS group. Data was not available for 7 subjects. This explains why the sum of this baseline measure does not equal the overall baseline participants.|participants|Number|89|89.0||||||
3737068|NCT02029989|3573926|B2|||High Density Lipoprotein (HDL) Risk|Risk is defined as: Males < 40 mg/dL; Females < 50 mg/dL was 75% in the NCS group and 73.3% in the PCS group. Data was not available for 7 subjects. This explains why the sum of this baseline measure does not equal the overall baseline participants.|participants|Number|45|45.0||||||
3737069|NCT02029989|3573927|B1|||High Density Lipoprotein (HDL) Risk|Risk is defined as: Males < 40 mg/dL; Females < 50 mg/dL was 75% in the NCS group and 73.3% in the PCS group. Data was not available for 7 subjects. This explains why the sum of this baseline measure does not equal the overall baseline participants.|participants|Number|44|44.0||||||
3737070|NCT02029989|3573925|B3|||Triglyceride Risk|Risk is defined as greater than 150 mg/dL was 54.2% in the NCS group and 42.1% in the PCS group. Data was not available for 4 subjects. This explains why the sum of this baseline measure does not equal the overall baseline participants.|participants|Number|56|56.0||||||
3737105|NCT02029989|3573927|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737106|NCT02029989|3573925|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3737071|NCT02029989|3573926|B2|||Triglyceride Risk|Risk is defined as greater than 150 mg/dL was 54.2% in the NCS group and 42.1% in the PCS group. Data was not available for 4 subjects. This explains why the sum of this baseline measure does not equal the overall baseline participants.|participants|Number|32|32.0||||||
3737072|NCT02029989|3573927|B1|||Triglyceride Risk|Risk is defined as greater than 150 mg/dL was 54.2% in the NCS group and 42.1% in the PCS group. Data was not available for 4 subjects. This explains why the sum of this baseline measure does not equal the overall baseline participants.|participants|Number|24|24.0||||||
3737073|NCT02029989|3573925|B3|||Low Density Lipoprotein (LDL) Risk|Risk is defined as greater than 130 mg/dL was 24.5% in the NCS group and 25.5% in the PCS group. Data was not available for 20 subjects. This explains why the sum of this baseline measure does not equal the overall baseline participants.|participants|Number|25|25.0||||||
3737074|NCT02029989|3573926|B2|||Low Density Lipoprotein (LDL) Risk|Risk is defined as greater than 130 mg/dL was 24.5% in the NCS group and 25.5% in the PCS group. Data was not available for 20 subjects. This explains why the sum of this baseline measure does not equal the overall baseline participants.|participants|Number|12|12.0||||||
3737075|NCT02029989|3573927|B1|||Low Density Lipoprotein (LDL) Risk|Risk is defined as greater than 130 mg/dL was 24.5% in the NCS group and 25.5% in the PCS group. Data was not available for 20 subjects. This explains why the sum of this baseline measure does not equal the overall baseline participants.|participants|Number|13|13.0||||||
3737076|NCT02029989|3573925|B3|||Total Cholesterol Risk|Risk is defined as greater than 200 mg/dL was 41.7% in the NCS group and 38.6% in the PCS group. Data was not available for 3 subjects. This explains why the sum of this baseline measure does not equal the overall baseline participants.|participants|Number|47|47.0||||||
3737077|NCT02029989|3573926|B2|||Total Cholesterol Risk|Risk is defined as greater than 200 mg/dL was 41.7% in the NCS group and 38.6% in the PCS group. Data was not available for 3 subjects. This explains why the sum of this baseline measure does not equal the overall baseline participants.|participants|Number|25|25.0||||||
3737078|NCT02029989|3573927|B1|||Total Cholesterol Risk|Risk is defined as greater than 200 mg/dL was 41.7% in the NCS group and 38.6% in the PCS group. Data was not available for 3 subjects. This explains why the sum of this baseline measure does not equal the overall baseline participants.|participants|Number|22|22.0||||||
3737079|NCT02029989|3573925|B3|||Abdominal Obesity|Waist Circumference Risk (Males: > 40 inches, Females: > 35 inches) was 86.4% in the NCS group and 87.7% in the PCS Group. Data was not available for 4 subjects. This explains why the sum of this baseline measure does not equal the overall baseline participants.|participants|Number|101|101.0||||||
3737080|NCT02029989|3573926|B2|||Abdominal Obesity|Waist Circumference Risk (Males: > 40 inches, Females: > 35 inches) was 86.4% in the NCS group and 87.7% in the PCS Group. Data was not available for 4 subjects. This explains why the sum of this baseline measure does not equal the overall baseline participants.|participants|Number|51|51.0||||||
3737081|NCT02029989|3573927|B1|||Abdominal Obesity|Waist Circumference Risk (Males: > 40 inches, Females: > 35 inches) was 86.4% in the NCS group and 87.7% in the PCS Group. Data was not available for 4 subjects. This explains why the sum of this baseline measure does not equal the overall baseline participants.|participants|Number|50|50.0||||||
3737082|NCT02029989|3573925|B3|||Subjects with Metabolic Syndrome based on Point of Care analyses|Metabolic syndrome was identified in 71.2% of the NCS group and in 85.2% of the PCS group. Data was not available for 7 subjects. This explains why the sum of this baseline measure does not equal the overall baseline participants.|participants|Number|88|88.0||||||
3737083|NCT02029989|3573926|B2|||Subjects with Metabolic Syndrome based on Point of Care analyses|Metabolic syndrome was identified in 71.2% of the NCS group and in 85.2% of the PCS group. Data was not available for 7 subjects. This explains why the sum of this baseline measure does not equal the overall baseline participants.|participants|Number|42|42.0||||||
3737084|NCT02029989|3573927|B1|||Subjects with Metabolic Syndrome based on Point of Care analyses|Metabolic syndrome was identified in 71.2% of the NCS group and in 85.2% of the PCS group. Data was not available for 7 subjects. This explains why the sum of this baseline measure does not equal the overall baseline participants.|participants|Number|46|46.0||||||
3737085|NCT02029989|3573925|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3737086|NCT02029989|3573926|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3737087|NCT02029989|3573927|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3737088|NCT02029989|3573925|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737089|NCT02029989|3573926|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737090|NCT02029989|3573927|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737091|NCT02029989|3573925|B3||White|Race (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
3737092|NCT02029989|3573926|B2||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3737093|NCT02029989|3573927|B1||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3737094|NCT02029989|3573925|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3737095|NCT02029989|3573926|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3737096|NCT02029989|3573927|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3737097|NCT02029989|3573925|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737098|NCT02029989|3573926|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737099|NCT02029989|3573927|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737100|NCT02029989|3573925|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3737101|NCT02029989|3573926|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3737102|NCT02029989|3573927|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3737103|NCT02029989|3573925|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3737104|NCT02029989|3573926|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3737107|NCT02029989|3573926|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3737108|NCT02029989|3573927|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3737109|NCT02029989|3573925|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3737110|NCT02029989|3573926|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3737111|NCT02029989|3573927|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3737112|NCT02029989|3573925|B3|||Age||years|Mean|42.9|42.9|Standard Deviation|11.3|11.3|||
3737113|NCT02029989|3573926|B2|||Age||years|Mean|43.5|43.5|Standard Deviation|10.62|10.62|||
3737114|NCT02029989|3573927|B1|||Age||years|Mean|42.32|42.32|Standard Deviation|11.95|11.95|||
3737115|NCT02029911|3573934|B1|||PBLAC Score (assessment of menstrual blood loss)|Pictorial Blood Loss Assessment Chart (PBLAC) is a tool used to assess menstrual blood loss. The PBLAC score takes into account the number of menstrual pads and tampons used as well as amount of saturation. A score of 0 represents no bleeding. Although the PBLAC score does not yield an exact measure of blood loss, it has been found to correlate well with menstrual blood volume. A score greater than 100 is correlated with a blood loss of at least 80 mL.|units on a scale|Mean|503.0|503.0|Standard Deviation|412.3|412.3|||
3737116|NCT02029911|3573934|B1|Canada||Region of Enrollment||participants|Number|60|60.0||||||
3737117|NCT02029911|3573934|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3737118|NCT02029911|3573934|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3737119|NCT02029911|3573934|B1|||Age||years|Mean|42.5|42.5|Standard Deviation|5|5.0|||
3737120|NCT02029872|3573940|B3|||HIV Viral Load of <20 detectable copies of HIV viral load||Participants|Count of Participants|14|14.0||||||
3737121|NCT02029872|3573941|B2|||HIV Viral Load of <20 detectable copies of HIV viral load||Participants|Count of Participants|8|8.0||||||
3737122|NCT02029872|3573942|B1|||HIV Viral Load of <20 detectable copies of HIV viral load||Participants|Count of Participants|6|6.0||||||
3737123|NCT02029872|3573940|B3|||Cluster of Differentiation 4 (CD4) T-cell count|CD4 cells per cubic millimeter of blood|cells/mm^3|Mean|682|682.0|Standard Deviation|345|345.0|||
3737124|NCT02029872|3573941|B2|||Cluster of Differentiation 4 (CD4) T-cell count|CD4 cells per cubic millimeter of blood|cells/mm^3|Mean|687|687.0|Standard Deviation|223|223.0|||
3737125|NCT02029872|3573942|B1|||Cluster of Differentiation 4 (CD4) T-cell count|CD4 cells per cubic millimeter of blood|cells/mm^3|Mean|676|676.0|Standard Deviation|451|451.0|||
3737126|NCT02029872|3573940|B3|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3737127|NCT02029872|3573941|B2|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3737128|NCT02029872|3573942|B1|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3737129|NCT02029872|3573940|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737130|NCT02029872|3573941|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737131|NCT02029872|3573942|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737132|NCT02029872|3573940|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3737133|NCT02029872|3573941|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3737134|NCT02029872|3573942|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3737135|NCT02029872|3573940|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3737136|NCT02029872|3573941|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3737137|NCT02029872|3573942|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3737138|NCT02029872|3573940|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3737139|NCT02029872|3573941|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3737140|NCT02029872|3573942|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3737141|NCT02029872|3573940|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737142|NCT02029872|3573941|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737143|NCT02029872|3573942|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737144|NCT02029872|3573940|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737145|NCT02029872|3573941|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737146|NCT02029872|3573942|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737147|NCT02029872|3573940|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737148|NCT02029872|3573941|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737149|NCT02029872|3573942|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737150|NCT02029872|3573940|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737151|NCT02029872|3573941|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737152|NCT02029872|3573942|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737153|NCT02029872|3573940|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3737154|NCT02029872|3573941|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3737155|NCT02029872|3573942|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3737156|NCT02029872|3573940|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737157|NCT02029872|3573941|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737158|NCT02029872|3573942|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737159|NCT02029872|3573940|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3737160|NCT02029872|3573941|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3737161|NCT02029872|3573942|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3737162|NCT02029872|3573940|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3737163|NCT02029872|3573941|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3737164|NCT02029872|3573942|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3737165|NCT02029872|3573940|B3|||Age||years|Mean|50.7|50.7|Standard Deviation|10.0|10.0|||
3737166|NCT02029872|3573941|B2|||Age||years|Mean|51.4|51.4|Standard Deviation|12.2|12.2|||
3737167|NCT02029872|3573942|B1|||Age||years|Mean|50.6|50.6|Standard Deviation|4.2|4.2|||
3737168|NCT02029872|3573940|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3737169|NCT02029872|3573941|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3737170|NCT02029872|3573942|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3737171|NCT02029872|3573940|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3737172|NCT02029872|3573941|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3737173|NCT02029872|3573942|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3737174|NCT02029872|3573940|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3737175|NCT02029872|3573941|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3737176|NCT02029872|3573942|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3737177|NCT02029846|3573949|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3737178|NCT02029846|3573950|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3737179|NCT02029846|3573951|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3737180|NCT02029846|3573949|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737181|NCT02029846|3573950|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737182|NCT02029846|3573951|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737183|NCT02029846|3573949|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737184|NCT02029846|3573950|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737185|NCT02029846|3573951|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737186|NCT02029846|3573949|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737187|NCT02029846|3573950|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737188|NCT02029846|3573951|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737189|NCT02029846|3573949|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737190|NCT02029846|3573950|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737191|NCT02029846|3573951|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737192|NCT02029846|3573949|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737193|NCT02029846|3573950|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737194|NCT02029846|3573951|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737195|NCT02029846|3573949|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737196|NCT02029846|3573950|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737197|NCT02029846|3573951|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737198|NCT02029846|3573949|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737199|NCT02029846|3573950|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737200|NCT02029846|3573951|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737201|NCT02029846|3573949|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3737202|NCT02029846|3573950|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3737203|NCT02029846|3573951|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3737204|NCT02029846|3573949|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737205|NCT02029846|3573950|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737206|NCT02029846|3573951|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737207|NCT02029846|3573949|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3737208|NCT02029846|3573950|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3737209|NCT02029846|3573951|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3737210|NCT02029846|3573949|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3737211|NCT02029846|3573950|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3737212|NCT02029846|3573951|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3737213|NCT02029846|3573949|B3|||Age||years|Mean|72.5|72.5|Full Range|||67.0|78.0|
3737214|NCT02029846|3573950|B2|||Age||years|Mean|67|67.0|Full Range|||67.0|67.0|
3737215|NCT02029846|3573951|B1|||Age||years|Mean|78|78.0|Full Range|||78.0|78.0|
3737216|NCT02029846|3573949|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3737217|NCT02029846|3573950|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3737218|NCT02029846|3573951|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3737219|NCT02029846|3573949|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3737220|NCT02029846|3573950|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3737221|NCT02029846|3573951|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3737222|NCT02029846|3573949|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3737223|NCT02029846|3573950|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3737224|NCT02029846|3573951|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3737225|NCT02029755|3573962|B4|Taiwan||Region of Enrollment||participants|Number|108|108.0||||||
3737226|NCT02029755|3573963|B3|Taiwan||Region of Enrollment||participants|Number|36|36.0||||||
3737227|NCT02029755|3573964|B2|Taiwan||Region of Enrollment||participants|Number|36|36.0||||||
3737228|NCT02029755|3573965|B1|Taiwan||Region of Enrollment||participants|Number|36|36.0||||||
3737229|NCT02029755|3573962|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737230|NCT02029755|3573963|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737231|NCT02029755|3573964|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737232|NCT02029755|3573965|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737233|NCT02029755|3573962|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737234|NCT02029755|3573963|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737235|NCT02029755|3573964|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737236|NCT02029755|3573965|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737237|NCT02029755|3573962|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737238|NCT02029755|3573963|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737239|NCT02029755|3573964|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737240|NCT02029755|3573965|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737241|NCT02029755|3573962|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737242|NCT02029755|3573963|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737243|NCT02029755|3573964|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737244|NCT02029755|3573965|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737245|NCT02029755|3573962|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737246|NCT02029755|3573963|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737247|NCT02029755|3573964|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737248|NCT02029755|3573965|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737249|NCT02029755|3573962|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
3737250|NCT02029755|3573963|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3737251|NCT02029755|3573964|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3737252|NCT02029755|3573965|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3737253|NCT02029755|3573962|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737254|NCT02029755|3573963|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737255|NCT02029755|3573964|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737256|NCT02029755|3573965|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737257|NCT02029755|3573962|B4|Female||Sex/Gender, Customized||participants|Number|108|108.0||||||
3737258|NCT02029755|3573963|B3|Female||Sex/Gender, Customized||participants|Number|36|36.0||||||
3737259|NCT02029755|3573964|B2|Female||Sex/Gender, Customized||participants|Number|36|36.0||||||
3737260|NCT02029755|3573965|B1|Female||Sex/Gender, Customized||participants|Number|36|36.0||||||
3737261|NCT02029755|3573962|B4|||Age||years|Mean|40.85|40.85|Standard Deviation|6.65|6.65|||
3737262|NCT02029755|3573963|B3|||Age||years|Mean|42.69|42.69|Standard Deviation|6.93|6.93|||
3737263|NCT02029755|3573964|B2|||Age||years|Mean|39.69|39.69|Standard Deviation|5.38|5.38|||
3737264|NCT02029755|3573965|B1|||Age||years|Mean|40.17|40.17|Standard Deviation|7.28|7.28|||
3737265|NCT02029703|3573978|B3|||Number of Participants||Participants|Count of Participants|42|42.0||||||
3737266|NCT02029703|3573979|B2|||Number of Participants||Participants|Count of Participants|22|22.0||||||
3737267|NCT02029703|3573980|B1|||Number of Participants||Participants|Count of Participants|20|20.0||||||
3737268|NCT02029703|3573978|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3737269|NCT02029703|3573979|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3737270|NCT02029703|3573980|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3737271|NCT02029703|3573978|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3737272|NCT02029703|3573979|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3737273|NCT02029703|3573980|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3737274|NCT02029703|3573978|B3|||Age||years|Mean|60.1|60.1|Standard Deviation|11.7|11.7|||
3737275|NCT02029703|3573979|B2|||Age||years|Mean|59.2|59.2|Standard Deviation|10.2|10.2|||
3737276|NCT02029703|3573980|B1|||Age||years|Mean|61.2|61.2|Standard Deviation|13.4|13.4|||
3737314|NCT02029638|3573988|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737315|NCT02029638|3573989|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737277|NCT02029638|3573987|B4|||Serum Creatinine|Serum creatinine (Cr) is an indicator of kidney function. Cr is a substance formed from the metabolism of creatine, commonly found in blood, urine, and muscle tissue. It is removed from the blood by the kidneys and excreted in urine.The baseline Cr interval per protocol is defined as the interval prior to immunosuppressive maintenance withdrawal (IMW) initiation.This is the 2 to 4 week interval post-kidney transplant, calculated using the lowest 3 serum Cr values during this pre-defined interval (excluded:days on dialysis). Normal:adult males, 0.7 to 1.3 mg/dL; adult females, 0.6 to 1.1 mg/dL.|mg/dL|Mean|2.1|2.1|Standard Deviation|NA||||Standard deviation cannot be calculated for one participant.
3737278|NCT02029638|3573988|B3|||Serum Creatinine|Serum creatinine (Cr) is an indicator of kidney function. Cr is a substance formed from the metabolism of creatine, commonly found in blood, urine, and muscle tissue. It is removed from the blood by the kidneys and excreted in urine.The baseline Cr interval per protocol is defined as the interval prior to immunosuppressive maintenance withdrawal (IMW) initiation.This is the 2 to 4 week interval post-kidney transplant, calculated using the lowest 3 serum Cr values during this pre-defined interval (excluded:days on dialysis). Normal:adult males, 0.7 to 1.3 mg/dL; adult females, 0.6 to 1.1 mg/dL.|mg/dL|Mean|2.1|2.1|Standard Deviation|NA||||Standard deviation cannot be calculated for one participant.
3737279|NCT02029638|3573989|B2|||Serum Creatinine|Serum creatinine (Cr) is an indicator of kidney function. Cr is a substance formed from the metabolism of creatine, commonly found in blood, urine, and muscle tissue. It is removed from the blood by the kidneys and excreted in urine.The baseline Cr interval per protocol is defined as the interval prior to immunosuppressive maintenance withdrawal (IMW) initiation.This is the 2 to 4 week interval post-kidney transplant, calculated using the lowest 3 serum Cr values during this pre-defined interval (excluded:days on dialysis). Normal:adult males, 0.7 to 1.3 mg/dL; adult females, 0.6 to 1.1 mg/dL.|mg/dL|Mean|NA||Standard Deviation|NA||||Participants in this group did not have data to contribute to this baseline measure since they did not receive a transplant.
3737280|NCT02029638|3573990|B1|||Serum Creatinine|Serum creatinine (Cr) is an indicator of kidney function. Cr is a substance formed from the metabolism of creatine, commonly found in blood, urine, and muscle tissue. It is removed from the blood by the kidneys and excreted in urine.The baseline Cr interval per protocol is defined as the interval prior to immunosuppressive maintenance withdrawal (IMW) initiation.This is the 2 to 4 week interval post-kidney transplant, calculated using the lowest 3 serum Cr values during this pre-defined interval (excluded:days on dialysis). Normal:adult males, 0.7 to 1.3 mg/dL; adult females, 0.6 to 1.1 mg/dL.|mg/dL|Mean|NA||Standard Deviation|NA||||Participants in this group did not have data to contribute to this baseline measure since they did not receive a transplant.
3737281|NCT02029638|3573987|B4|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3737282|NCT02029638|3573988|B3|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3737283|NCT02029638|3573989|B2|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3737284|NCT02029638|3573990|B1|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3737285|NCT02029638|3573987|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737286|NCT02029638|3573988|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737287|NCT02029638|3573989|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737288|NCT02029638|3573990|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737289|NCT02029638|3573987|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737290|NCT02029638|3573988|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737291|NCT02029638|3573989|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737292|NCT02029638|3573990|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737293|NCT02029638|3573987|B4||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3737294|NCT02029638|3573988|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3737295|NCT02029638|3573989|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737296|NCT02029638|3573990|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3737297|NCT02029638|3573987|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3737298|NCT02029638|3573988|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737299|NCT02029638|3573989|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3737300|NCT02029638|3573990|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737301|NCT02029638|3573987|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737302|NCT02029638|3573988|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737303|NCT02029638|3573989|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737304|NCT02029638|3573990|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737305|NCT02029638|3573987|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3737306|NCT02029638|3573988|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737307|NCT02029638|3573989|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737308|NCT02029638|3573990|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3737309|NCT02029638|3573987|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737310|NCT02029638|3573988|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737311|NCT02029638|3573989|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737312|NCT02029638|3573990|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737313|NCT02029638|3573987|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737316|NCT02029638|3573990|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737317|NCT02029638|3573987|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3737318|NCT02029638|3573988|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3737319|NCT02029638|3573989|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3737320|NCT02029638|3573990|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3737321|NCT02029638|3573987|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737322|NCT02029638|3573988|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737323|NCT02029638|3573989|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737324|NCT02029638|3573990|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737325|NCT02029638|3573987|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3737326|NCT02029638|3573988|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3737327|NCT02029638|3573989|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3737328|NCT02029638|3573990|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3737329|NCT02029638|3573987|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3737330|NCT02029638|3573988|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3737331|NCT02029638|3573989|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3737332|NCT02029638|3573990|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3737333|NCT02029638|3573987|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3737334|NCT02029638|3573988|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3737335|NCT02029638|3573989|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3737336|NCT02029638|3573990|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3737337|NCT02029638|3573987|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3737338|NCT02029638|3573988|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3737339|NCT02029638|3573989|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3737340|NCT02029638|3573990|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3737341|NCT02029638|3573987|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3737342|NCT02029638|3573988|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3737343|NCT02029638|3573989|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3737344|NCT02029638|3573990|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3737345|NCT02029521|3574019|B3|4- serious||Severity of Less Than 2 Bowel Movements Per Week|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|0|0.0||||||
3737346|NCT02029521|3574020|B2|4- serious||Severity of Less Than 2 Bowel Movements Per Week|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|0|0.0||||||
3737347|NCT02029521|3574021|B1|4- serious||Severity of Less Than 2 Bowel Movements Per Week|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|0|0.0||||||
3737348|NCT02029521|3574019|B3|3- moderate||Severity of Less Than 2 Bowel Movements Per Week|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|6|6.0||||||
3737349|NCT02029521|3574020|B2|3- moderate||Severity of Less Than 2 Bowel Movements Per Week|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|2|2.0||||||
3737350|NCT02029521|3574021|B1|3- moderate||Severity of Less Than 2 Bowel Movements Per Week|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|4|4.0||||||
3737351|NCT02029521|3574019|B3|2- light||Severity of Less Than 2 Bowel Movements Per Week|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|3|3.0||||||
3737352|NCT02029521|3574020|B2|2- light||Severity of Less Than 2 Bowel Movements Per Week|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|3|3.0||||||
3737353|NCT02029521|3574021|B1|2- light||Severity of Less Than 2 Bowel Movements Per Week|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|0|0.0||||||
3737354|NCT02029521|3574019|B3|1- absent||Severity of Less Than 2 Bowel Movements Per Week|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|35|35.0||||||
3737355|NCT02029521|3574020|B2|1- absent||Severity of Less Than 2 Bowel Movements Per Week|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|17|17.0||||||
3737356|NCT02029521|3574021|B1|1- absent||Severity of Less Than 2 Bowel Movements Per Week|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|18|18.0||||||
3737357|NCT02029521|3574019|B3|4- constantly||Frequency of Less Than 2 Bowel Movements Per Week|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|0|0.0||||||
3737358|NCT02029521|3574020|B2|4- constantly||Frequency of Less Than 2 Bowel Movements Per Week|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|0|0.0||||||
3737359|NCT02029521|3574021|B1|4- constantly||Frequency of Less Than 2 Bowel Movements Per Week|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|0|0.0||||||
3737360|NCT02029521|3574019|B3|3- frequently||Frequency of Less Than 2 Bowel Movements Per Week|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|7|7.0||||||
3737361|NCT02029521|3574020|B2|3- frequently||Frequency of Less Than 2 Bowel Movements Per Week|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|3|3.0||||||
3737362|NCT02029521|3574021|B1|3- frequently||Frequency of Less Than 2 Bowel Movements Per Week|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|4|4.0||||||
3737363|NCT02029521|3574019|B3|2- rare||Frequency of Less Than 2 Bowel Movements Per Week|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|2|2.0||||||
3737364|NCT02029521|3574020|B2|2- rare||Frequency of Less Than 2 Bowel Movements Per Week|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|2|2.0||||||
3737365|NCT02029521|3574021|B1|2- rare||Frequency of Less Than 2 Bowel Movements Per Week|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|0|0.0||||||
3737366|NCT02029521|3574019|B3|1- never||Frequency of Less Than 2 Bowel Movements Per Week|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|35|35.0||||||
3737367|NCT02029521|3574020|B2|1- never||Frequency of Less Than 2 Bowel Movements Per Week|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|17|17.0||||||
3737368|NCT02029521|3574021|B1|1- never||Frequency of Less Than 2 Bowel Movements Per Week|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|18|18.0||||||
3737369|NCT02029521|3574019|B3|4- serious||Severity of More Than 2 Bowel Movements Per Day|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|1|1.0||||||
3737370|NCT02029521|3574020|B2|4- serious||Severity of More Than 2 Bowel Movements Per Day|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|0|0.0||||||
3737371|NCT02029521|3574021|B1|4- serious||Severity of More Than 2 Bowel Movements Per Day|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|1|1.0||||||
3737372|NCT02029521|3574019|B3|3- moderate||Severity of More Than 2 Bowel Movements Per Day|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|9|9.0||||||
3737373|NCT02029521|3574020|B2|3- moderate||Severity of More Than 2 Bowel Movements Per Day|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|4|4.0||||||
3737374|NCT02029521|3574021|B1|3- moderate||Severity of More Than 2 Bowel Movements Per Day|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|5|5.0||||||
3737375|NCT02029521|3574019|B3|2- light||Severity of More Than 2 Bowel Movements Per Day|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|20|20.0||||||
3737376|NCT02029521|3574020|B2|2- light||Severity of More Than 2 Bowel Movements Per Day|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|8|8.0||||||
3737377|NCT02029521|3574021|B1|2- light||Severity of More Than 2 Bowel Movements Per Day|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|12|12.0||||||
3737378|NCT02029521|3574019|B3|1- absent||Severity of More Than 2 Bowel Movements Per Day|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|14|14.0||||||
3737379|NCT02029521|3574020|B2|1- absent||Severity of More Than 2 Bowel Movements Per Day|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|10|10.0||||||
3737380|NCT02029521|3574021|B1|1- absent||Severity of More Than 2 Bowel Movements Per Day|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|4|4.0||||||
3737381|NCT02029521|3574019|B3|4- constantly||Frequency of More than 2 Bowel Movements Per Day|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|1|1.0||||||
3737382|NCT02029521|3574020|B2|4- constantly||Frequency of More than 2 Bowel Movements Per Day|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|0|0.0||||||
3737383|NCT02029521|3574021|B1|4- constantly||Frequency of More than 2 Bowel Movements Per Day|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|1|1.0||||||
3737384|NCT02029521|3574019|B3|3- frequently||Frequency of More than 2 Bowel Movements Per Day|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|11|11.0||||||
3737385|NCT02029521|3574020|B2|3- frequently||Frequency of More than 2 Bowel Movements Per Day|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|6|6.0||||||
3737386|NCT02029521|3574021|B1|3- frequently||Frequency of More than 2 Bowel Movements Per Day|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|5|5.0||||||
3737387|NCT02029521|3574019|B3|2- rare||Frequency of More than 2 Bowel Movements Per Day|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|18|18.0||||||
3737388|NCT02029521|3574020|B2|2- rare||Frequency of More than 2 Bowel Movements Per Day|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|6|6.0||||||
3737389|NCT02029521|3574021|B1|2- rare||Frequency of More than 2 Bowel Movements Per Day|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|12|12.0||||||
3737390|NCT02029521|3574019|B3|1- never||Frequency of More than 2 Bowel Movements Per Day|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|14|14.0||||||
3737391|NCT02029521|3574020|B2|1- never||Frequency of More than 2 Bowel Movements Per Day|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|10|10.0||||||
3737392|NCT02029521|3574021|B1|1- never||Frequency of More than 2 Bowel Movements Per Day|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|4|4.0||||||
3737393|NCT02029521|3574019|B3|4- serious||Severity of Diarrhea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|0|0.0||||||
3737394|NCT02029521|3574020|B2|4- serious||Severity of Diarrhea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|0|0.0||||||
3737395|NCT02029521|3574021|B1|4- serious||Severity of Diarrhea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|0|0.0||||||
3737396|NCT02029521|3574019|B3|3- moderate||Severity of Diarrhea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|5|5.0||||||
3737397|NCT02029521|3574020|B2|3- moderate||Severity of Diarrhea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|2|2.0||||||
3737398|NCT02029521|3574021|B1|3- moderate||Severity of Diarrhea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|3|3.0||||||
3737399|NCT02029521|3574019|B3|2- light||Severity of Diarrhea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|20|20.0||||||
3737400|NCT02029521|3574020|B2|2- light||Severity of Diarrhea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|10|10.0||||||
3737401|NCT02029521|3574021|B1|2- light||Severity of Diarrhea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|10|10.0||||||
3737402|NCT02029521|3574019|B3|1- absent||Severity of Diarrhea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|19|19.0||||||
3737403|NCT02029521|3574020|B2|1- absent||Severity of Diarrhea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|10|10.0||||||
3737404|NCT02029521|3574021|B1|1- absent||Severity of Diarrhea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|9|9.0||||||
3737405|NCT02029521|3574019|B3|4- constantly||Frequency of Diarrhea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|0|0.0||||||
3737406|NCT02029521|3574020|B2|4- constantly||Frequency of Diarrhea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|0|0.0||||||
3737407|NCT02029521|3574021|B1|4- constantly||Frequency of Diarrhea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|0|0.0||||||
3737408|NCT02029521|3574019|B3|3- frequently||Frequency of Diarrhea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|6|6.0||||||
3737409|NCT02029521|3574020|B2|3- frequently||Frequency of Diarrhea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|2|2.0||||||
3737410|NCT02029521|3574021|B1|3- frequently||Frequency of Diarrhea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|4|4.0||||||
3737411|NCT02029521|3574019|B3|2- rare||Frequency of Diarrhea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|20|20.0||||||
3737412|NCT02029521|3574020|B2|2- rare||Frequency of Diarrhea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|11|11.0||||||
3737413|NCT02029521|3574021|B1|2- rare||Frequency of Diarrhea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|9|9.0||||||
3737414|NCT02029521|3574019|B3|1- never||Frequency of Diarrhea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|18|18.0||||||
3737415|NCT02029521|3574020|B2|1- never||Frequency of Diarrhea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|9|9.0||||||
3737416|NCT02029521|3574021|B1|1- never||Frequency of Diarrhea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|9|9.0||||||
3737417|NCT02029521|3574019|B3|4- serious||Severity of Heart Burn|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|0|0.0||||||
3737418|NCT02029521|3574020|B2|4- serious||Severity of Heart Burn|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|0|0.0||||||
3737419|NCT02029521|3574021|B1|4- serious||Severity of Heart Burn|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|0|0.0||||||
3737420|NCT02029521|3574019|B3|3- moderate||Severity of Heart Burn|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|7|7.0||||||
3737421|NCT02029521|3574020|B2|3- moderate||Severity of Heart Burn|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|3|3.0||||||
3737422|NCT02029521|3574021|B1|3- moderate||Severity of Heart Burn|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|4|4.0||||||
3737423|NCT02029521|3574019|B3|2- light||Severity of Heart Burn|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|2|2.0||||||
3737424|NCT02029521|3574020|B2|2- light||Severity of Heart Burn|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|1|1.0||||||
3737425|NCT02029521|3574021|B1|2- light||Severity of Heart Burn|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|1|1.0||||||
3737426|NCT02029521|3574019|B3|1- absent||Severity of Heart Burn|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|35|35.0||||||
3737427|NCT02029521|3574020|B2|1- absent||Severity of Heart Burn|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|18|18.0||||||
3737428|NCT02029521|3574021|B1|1- absent||Severity of Heart Burn|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|17|17.0||||||
3737429|NCT02029521|3574019|B3|4- constantly||Frequency of Heart Burn|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|0|0.0||||||
3737430|NCT02029521|3574020|B2|4- constantly||Frequency of Heart Burn|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|0|0.0||||||
3737431|NCT02029521|3574021|B1|4- constantly||Frequency of Heart Burn|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|0|0.0||||||
3737432|NCT02029521|3574019|B3|3- frequently||Frequency of Heart Burn|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|6|6.0||||||
3737433|NCT02029521|3574020|B2|3- frequently||Frequency of Heart Burn|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|2|2.0||||||
3737434|NCT02029521|3574021|B1|3- frequently||Frequency of Heart Burn|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|4|4.0||||||
3737435|NCT02029521|3574019|B3|2- rare||Frequency of Heart Burn|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|3|3.0||||||
3737436|NCT02029521|3574020|B2|2- rare||Frequency of Heart Burn|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|2|2.0||||||
3737437|NCT02029521|3574021|B1|2- rare||Frequency of Heart Burn|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|1|1.0||||||
3737438|NCT02029521|3574019|B3|1- never||Frequency of Heart Burn|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|35|35.0||||||
3737439|NCT02029521|3574020|B2|1- never||Frequency of Heart Burn|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|18|18.0||||||
3737440|NCT02029521|3574021|B1|1- never||Frequency of Heart Burn|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|17|17.0||||||
3737441|NCT02029521|3574019|B3|4- serious||Severity of Vomiting|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|0|0.0||||||
3737442|NCT02029521|3574020|B2|4- serious||Severity of Vomiting|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|0|0.0||||||
3737443|NCT02029521|3574021|B1|4- serious||Severity of Vomiting|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|0|0.0||||||
3737444|NCT02029521|3574019|B3|3- moderate||Severity of Vomiting|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|0|0.0||||||
3737445|NCT02029521|3574020|B2|3- moderate||Severity of Vomiting|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|0|0.0||||||
3737446|NCT02029521|3574021|B1|3- moderate||Severity of Vomiting|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|0|0.0||||||
3737447|NCT02029521|3574019|B3|2- light||Severity of Vomiting|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|10|10.0||||||
3737448|NCT02029521|3574020|B2|2- light||Severity of Vomiting|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|4|4.0||||||
3737449|NCT02029521|3574021|B1|2- light||Severity of Vomiting|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|6|6.0||||||
3737450|NCT02029521|3574019|B3|1- absent||Severity of Vomiting|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|34|34.0||||||
3737451|NCT02029521|3574020|B2|1- absent||Severity of Vomiting|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|18|18.0||||||
3737452|NCT02029521|3574021|B1|1- absent||Severity of Vomiting|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|16|16.0||||||
3737453|NCT02029521|3574019|B3|4- constantly||Frequency of Vomiting|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|0|0.0||||||
3737454|NCT02029521|3574020|B2|4- constantly||Frequency of Vomiting|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|0|0.0||||||
3737455|NCT02029521|3574021|B1|4- constantly||Frequency of Vomiting|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|0|0.0||||||
3737456|NCT02029521|3574019|B3|3- frequently||Frequency of Vomiting|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|0|0.0||||||
3737457|NCT02029521|3574020|B2|3- frequently||Frequency of Vomiting|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|0|0.0||||||
3737458|NCT02029521|3574021|B1|3- frequently||Frequency of Vomiting|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|0|0.0||||||
3737459|NCT02029521|3574019|B3|2- rare||Frequency of Vomiting|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|10|10.0||||||
3737460|NCT02029521|3574020|B2|2- rare||Frequency of Vomiting|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|4|4.0||||||
3737461|NCT02029521|3574021|B1|2- rare||Frequency of Vomiting|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|6|6.0||||||
3737462|NCT02029521|3574019|B3|1- never||Frequency of Vomiting|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|34|34.0||||||
3737463|NCT02029521|3574020|B2|1- never||Frequency of Vomiting|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|18|18.0||||||
3737464|NCT02029521|3574021|B1|1- never||Frequency of Vomiting|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|16|16.0||||||
3737465|NCT02029521|3574019|B3|4- serious||Severity of Nausea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|0|0.0||||||
3737466|NCT02029521|3574020|B2|4- serious||Severity of Nausea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|0|0.0||||||
3737467|NCT02029521|3574021|B1|4- serious||Severity of Nausea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|0|0.0||||||
3737468|NCT02029521|3574019|B3|3- moderate||Severity of Nausea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|3|3.0||||||
3737469|NCT02029521|3574020|B2|3- moderate||Severity of Nausea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|1|1.0||||||
3737470|NCT02029521|3574021|B1|3- moderate||Severity of Nausea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|2|2.0||||||
3737471|NCT02029521|3574019|B3|2- light||Severity of Nausea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|15|15.0||||||
3737472|NCT02029521|3574020|B2|2- light||Severity of Nausea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|6|6.0||||||
3737473|NCT02029521|3574021|B1|2- light||Severity of Nausea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|9|9.0||||||
3737474|NCT02029521|3574019|B3|1- absent||Severity of Nausea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|26|26.0||||||
3737475|NCT02029521|3574020|B2|1- absent||Severity of Nausea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|15|15.0||||||
3737476|NCT02029521|3574021|B1|1- absent||Severity of Nausea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|11|11.0||||||
3737477|NCT02029521|3574019|B3|4- constantly||Frequency of Nausea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|0|0.0||||||
3737478|NCT02029521|3574020|B2|4- constantly||Frequency of Nausea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|0|0.0||||||
3737479|NCT02029521|3574021|B1|4- constantly||Frequency of Nausea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|0|0.0||||||
3737480|NCT02029521|3574019|B3|3- frequently||Frequency of Nausea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|3|3.0||||||
3737481|NCT02029521|3574020|B2|3- frequently||Frequency of Nausea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|0|0.0||||||
3737482|NCT02029521|3574021|B1|3- frequently||Frequency of Nausea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|3|3.0||||||
3737483|NCT02029521|3574019|B3|2- rare||Frequency of Nausea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|15|15.0||||||
3737484|NCT02029521|3574020|B2|2- rare||Frequency of Nausea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|7|7.0||||||
3737485|NCT02029521|3574021|B1|2- rare||Frequency of Nausea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|8|8.0||||||
3737486|NCT02029521|3574019|B3|1- never||Frequency of Nausea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|26|26.0||||||
3737487|NCT02029521|3574020|B2|1- never||Frequency of Nausea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|15|15.0||||||
3737488|NCT02029521|3574021|B1|1- never||Frequency of Nausea|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|11|11.0||||||
3737489|NCT02029521|3574019|B3|4- serious||Severity of Bloating|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|1|1.0||||||
3737490|NCT02029521|3574020|B2|4- serious||Severity of Bloating|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|1|1.0||||||
3737491|NCT02029521|3574021|B1|4- serious||Severity of Bloating|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|0|0.0||||||
3737492|NCT02029521|3574019|B3|3- moderate||Severity of Bloating|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|23|23.0||||||
3737493|NCT02029521|3574020|B2|3- moderate||Severity of Bloating|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|10|10.0||||||
3737494|NCT02029521|3574021|B1|3- moderate||Severity of Bloating|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|13|13.0||||||
3737495|NCT02029521|3574019|B3|2- light||Severity of Bloating|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|14|14.0||||||
3737496|NCT02029521|3574020|B2|2- light||Severity of Bloating|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|7|7.0||||||
3737497|NCT02029521|3574021|B1|2- light||Severity of Bloating|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|7|7.0||||||
3737498|NCT02029521|3574019|B3|1- absent||Severity of Bloating|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|6|6.0||||||
3737499|NCT02029521|3574020|B2|1- absent||Severity of Bloating|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|4|4.0||||||
3737500|NCT02029521|3574021|B1|1- absent||Severity of Bloating|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|2|2.0||||||
3737501|NCT02029521|3574019|B3|4- constantly||Frequency of Bloating|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|2|2.0||||||
3737502|NCT02029521|3574020|B2|4- constantly||Frequency of Bloating|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|1|1.0||||||
3737503|NCT02029521|3574021|B1|4- constantly||Frequency of Bloating|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|1|1.0||||||
3737504|NCT02029521|3574019|B3|3- frequently||Frequency of Bloating|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|22|22.0||||||
3737505|NCT02029521|3574020|B2|3- frequently||Frequency of Bloating|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|10|10.0||||||
3737506|NCT02029521|3574021|B1|3- frequently||Frequency of Bloating|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|12|12.0||||||
3737507|NCT02029521|3574019|B3|2- rare||Frequency of Bloating|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|14|14.0||||||
3737508|NCT02029521|3574020|B2|2- rare||Frequency of Bloating|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|7|7.0||||||
3737509|NCT02029521|3574021|B1|2- rare||Frequency of Bloating|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|7|7.0||||||
3737510|NCT02029521|3574019|B3|1- never||Frequency of Bloating|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|6|6.0||||||
3737511|NCT02029521|3574020|B2|1- never||Frequency of Bloating|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|4|4.0||||||
3737512|NCT02029521|3574021|B1|1- never||Frequency of Bloating|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|2|2.0||||||
3737513|NCT02029521|3574019|B3|4- serious||Severity of Lack of Appetite|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|3|3.0||||||
3737514|NCT02029521|3574020|B2|4- serious||Severity of Lack of Appetite|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|0|0.0||||||
3737515|NCT02029521|3574021|B1|4- serious||Severity of Lack of Appetite|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|3|3.0||||||
3737516|NCT02029521|3574019|B3|3- moderate||Severity of Lack of Appetite|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|11|11.0||||||
3737517|NCT02029521|3574020|B2|3- moderate||Severity of Lack of Appetite|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|4|4.0||||||
3737518|NCT02029521|3574021|B1|3- moderate||Severity of Lack of Appetite|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|7|7.0||||||
3737519|NCT02029521|3574019|B3|2- light||Severity of Lack of Appetite|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|24|24.0||||||
3737520|NCT02029521|3574020|B2|2- light||Severity of Lack of Appetite|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|13|13.0||||||
3737521|NCT02029521|3574021|B1|2- light||Severity of Lack of Appetite|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|11|11.0||||||
3737522|NCT02029521|3574019|B3|1- absent||Severity of Lack of Appetite|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|6|6.0||||||
3737523|NCT02029521|3574020|B2|1- absent||Severity of Lack of Appetite|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|5|5.0||||||
3737524|NCT02029521|3574021|B1|1- absent||Severity of Lack of Appetite|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|1|1.0||||||
3737525|NCT02029521|3574019|B3|4- constantly||Frequency of Lack of Appetite|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|3|3.0||||||
3737526|NCT02029521|3574020|B2|4- constantly||Frequency of Lack of Appetite|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|0|0.0||||||
3737527|NCT02029521|3574021|B1|4- constantly||Frequency of Lack of Appetite|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|3|3.0||||||
3737528|NCT02029521|3574019|B3|3- frequently||Frequency of Lack of Appetite|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|12|12.0||||||
3737529|NCT02029521|3574020|B2|3- frequently||Frequency of Lack of Appetite|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|4|4.0||||||
3737530|NCT02029521|3574021|B1|3- frequently||Frequency of Lack of Appetite|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|8|8.0||||||
3737531|NCT02029521|3574019|B3|2- rare||Frequency of Lack of Appetite|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|23|23.0||||||
3737532|NCT02029521|3574020|B2|2- rare||Frequency of Lack of Appetite|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|13|13.0||||||
3737533|NCT02029521|3574021|B1|2- rare||Frequency of Lack of Appetite|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|10|10.0||||||
3737534|NCT02029521|3574019|B3|1- never||Frequency of Lack of Appetite|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|6|6.0||||||
3737535|NCT02029521|3574020|B2|1- never||Frequency of Lack of Appetite|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|5|5.0||||||
3737536|NCT02029521|3574021|B1|1- never||Frequency of Lack of Appetite|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|1|1.0||||||
3737537|NCT02029521|3574019|B3|4- serious||Severity of Flatulence|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|0|0.0||||||
3737538|NCT02029521|3574020|B2|4- serious||Severity of Flatulence|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|0|0.0||||||
3737539|NCT02029521|3574021|B1|4- serious||Severity of Flatulence|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|0|0.0||||||
3737540|NCT02029521|3574019|B3|3- moderate||Severity of Flatulence|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|16|16.0||||||
3737541|NCT02029521|3574020|B2|3- moderate||Severity of Flatulence|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|8|8.0||||||
3737542|NCT02029521|3574021|B1|3- moderate||Severity of Flatulence|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|8|8.0||||||
3737543|NCT02029521|3574019|B3|2- light||Severity of Flatulence|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|21|21.0||||||
3737544|NCT02029521|3574020|B2|2- light||Severity of Flatulence|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|10|10.0||||||
3737545|NCT02029521|3574021|B1|2- light||Severity of Flatulence|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|11|11.0||||||
3737546|NCT02029521|3574019|B3|1- absent||Severity of Flatulence|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|7|7.0||||||
3737547|NCT02029521|3574020|B2|1- absent||Severity of Flatulence|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|4|4.0||||||
3737548|NCT02029521|3574021|B1|1- absent||Severity of Flatulence|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|3|3.0||||||
3737549|NCT02029521|3574019|B3|4- constantly||Frequency of Flatulence|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|1|1.0||||||
3737550|NCT02029521|3574020|B2|4- constantly||Frequency of Flatulence|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|0|0.0||||||
3737551|NCT02029521|3574021|B1|4- constantly||Frequency of Flatulence|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|1|1.0||||||
3737552|NCT02029521|3574019|B3|3- frequently||Frequency of Flatulence|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|17|17.0||||||
3737553|NCT02029521|3574020|B2|3- frequently||Frequency of Flatulence|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|9|9.0||||||
3737554|NCT02029521|3574021|B1|3- frequently||Frequency of Flatulence|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|8|8.0||||||
3737555|NCT02029521|3574019|B3|2- rare||Frequency of Flatulence|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|19|19.0||||||
3737556|NCT02029521|3574020|B2|2- rare||Frequency of Flatulence|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|9|9.0||||||
3737557|NCT02029521|3574021|B1|2- rare||Frequency of Flatulence|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|10|10.0||||||
3737558|NCT02029521|3574019|B3|1- never||Frequency of Flatulence|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|7|7.0||||||
3737559|NCT02029521|3574020|B2|1- never||Frequency of Flatulence|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|4|4.0||||||
3737560|NCT02029521|3574021|B1|1- never||Frequency of Flatulence|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|3|3.0||||||
3737561|NCT02029521|3574019|B3|4- serious||Severity of Belching|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|1|1.0||||||
3737562|NCT02029521|3574020|B2|4- serious||Severity of Belching|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|1|1.0||||||
3737563|NCT02029521|3574021|B1|4- serious||Severity of Belching|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|0|0.0||||||
3737564|NCT02029521|3574019|B3|3- moderate||Severity of Belching|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|11|11.0||||||
3737565|NCT02029521|3574020|B2|3- moderate||Severity of Belching|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|8|8.0||||||
3737566|NCT02029521|3574021|B1|3- moderate||Severity of Belching|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|3|3.0||||||
3737567|NCT02029521|3574019|B3|2- light||Severity of Belching|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|15|15.0||||||
3737568|NCT02029521|3574020|B2|2- light||Severity of Belching|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|10|10.0||||||
3737569|NCT02029521|3574021|B1|2- light||Severity of Belching|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|5|5.0||||||
3737570|NCT02029521|3574019|B3|1- absent||Severity of Belching|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|17|17.0||||||
3737571|NCT02029521|3574020|B2|1- absent||Severity of Belching|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|3|3.0||||||
3737572|NCT02029521|3574021|B1|1- absent||Severity of Belching|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|14|14.0||||||
3737573|NCT02029521|3574019|B3|4- constantly||Frequency of Belching|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|0|0.0||||||
3737574|NCT02029521|3574020|B2|4- constantly||Frequency of Belching|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|0|0.0||||||
3737575|NCT02029521|3574021|B1|4- constantly||Frequency of Belching|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|0|0.0||||||
3737576|NCT02029521|3574019|B3|3- frequently||Frequency of Belching|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|9|9.0||||||
3737577|NCT02029521|3574020|B2|3- frequently||Frequency of Belching|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|4|4.0||||||
3737578|NCT02029521|3574021|B1|3- frequently||Frequency of Belching|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|5|5.0||||||
3737579|NCT02029521|3574019|B3|2- rare||Frequency of Belching|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|6|6.0||||||
3737580|NCT02029521|3574020|B2|2- rare||Frequency of Belching|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|3|3.0||||||
3737581|NCT02029521|3574021|B1|2- rare||Frequency of Belching|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|3|3.0||||||
3737582|NCT02029521|3574019|B3|1- never||Frequency of Belching|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|29|29.0||||||
3737583|NCT02029521|3574020|B2|1- never||Frequency of Belching|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|15|15.0||||||
3737623|NCT02029521|3574021|B1|Staph and A. xylososidans||Bacteriology||participants|Number|1|1.0||||||
3737584|NCT02029521|3574021|B1|1- never||Frequency of Belching|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|14|14.0||||||
3737585|NCT02029521|3574019|B3|4- serious||Severity of Abdominal Pain|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|1|1.0||||||
3737586|NCT02029521|3574020|B2|4- serious||Severity of Abdominal Pain|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|0|0.0||||||
3737587|NCT02029521|3574021|B1|4- serious||Severity of Abdominal Pain|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|1|1.0||||||
3737588|NCT02029521|3574019|B3|3- moderate||Severity of Abdominal Pain|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|10|10.0||||||
3737589|NCT02029521|3574020|B2|3- moderate||Severity of Abdominal Pain|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|7|7.0||||||
3737590|NCT02029521|3574021|B1|3- moderate||Severity of Abdominal Pain|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|3|3.0||||||
3737591|NCT02029521|3574019|B3|2- light||Severity of Abdominal Pain|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|16|16.0||||||
3737592|NCT02029521|3574020|B2|2- light||Severity of Abdominal Pain|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|4|4.0||||||
3737593|NCT02029521|3574021|B1|2- light||Severity of Abdominal Pain|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|12|12.0||||||
3737594|NCT02029521|3574019|B3|1- absent||Severity of Abdominal Pain|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|17|17.0||||||
3737595|NCT02029521|3574020|B2|1- absent||Severity of Abdominal Pain|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|11|11.0||||||
3737596|NCT02029521|3574021|B1|1- absent||Severity of Abdominal Pain|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most severe|participants|Number|6|6.0||||||
3737597|NCT02029521|3574019|B3|4- constantly||Frequency of Abdominal Pain|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|2|2.0||||||
3737598|NCT02029521|3574020|B2|4- constantly||Frequency of Abdominal Pain|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|1|1.0||||||
3737599|NCT02029521|3574021|B1|4- constantly||Frequency of Abdominal Pain|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|1|1.0||||||
3737600|NCT02029521|3574019|B3|3- frequently||Frequency of Abdominal Pain|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|10|10.0||||||
3737601|NCT02029521|3574020|B2|3- frequently||Frequency of Abdominal Pain|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|6|6.0||||||
3737602|NCT02029521|3574021|B1|3- frequently||Frequency of Abdominal Pain|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|4|4.0||||||
3737603|NCT02029521|3574019|B3|2- rare||Frequency of Abdominal Pain|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|14|14.0||||||
3737604|NCT02029521|3574020|B2|2- rare||Frequency of Abdominal Pain|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|4|4.0||||||
3737605|NCT02029521|3574021|B1|2- rare||Frequency of Abdominal Pain|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|10|10.0||||||
3737606|NCT02029521|3574019|B3|1- never||Frequency of Abdominal Pain|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|18|18.0||||||
3737607|NCT02029521|3574020|B2|1- never||Frequency of Abdominal Pain|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|11|11.0||||||
3737608|NCT02029521|3574021|B1|1- never||Frequency of Abdominal Pain|Part of the Qualitative Symptom Assessment; scaled from 1-4 with 4 being the most frequent|participants|Number|7|7.0||||||
3737609|NCT02029521|3574019|B3|||C-Reactive Protein|C-Reactive Protein in peripheral blood|miligrams per liter|Mean|12.7|12.7|Standard Deviation|7.1|7.1|||
3737610|NCT02029521|3574020|B2|||C-Reactive Protein|C-Reactive Protein in peripheral blood|miligrams per liter|Mean|12.1|12.1|Standard Deviation|6.6|6.6|||
3737611|NCT02029521|3574021|B1|||C-Reactive Protein|C-Reactive Protein in peripheral blood|miligrams per liter|Mean|13.3|13.3|Standard Deviation|7.7|7.7|||
3737612|NCT02029521|3574019|B3|||Vitamin E|Peripheral blood vitamin E, micrograms per ml.|micrograms per ml.|Mean|7.6|7.6|Standard Deviation|1.6|1.6|||
3737613|NCT02029521|3574020|B2|||Vitamin E|Peripheral blood vitamin E, micrograms per ml.|micrograms per ml.|Mean|7.5|7.5|Standard Deviation|1.6|1.6|||
3737614|NCT02029521|3574021|B1|||Vitamin E|Peripheral blood vitamin E, micrograms per ml.|micrograms per ml.|Mean|7.7|7.7|Standard Deviation|1.6|1.6|||
3737615|NCT02029521|3574019|B3|||ALT|peripheral blood Alanine AminoTransferase|units per liter|Mean|22.9|22.9|Standard Deviation|10.3|10.3|||
3737616|NCT02029521|3574020|B2|||ALT|peripheral blood Alanine AminoTransferase|units per liter|Mean|22.6|22.6|Standard Deviation|11.4|11.4|||
3737617|NCT02029521|3574021|B1|||ALT|peripheral blood Alanine AminoTransferase|units per liter|Mean|23.2|23.2|Standard Deviation|9.3|9.3|||
3737618|NCT02029521|3574019|B3|||White Blood Cell Count|Total White Blood Cell Count. 1000 per cubic millimeter|1000 cells/mm^3|Mean|9.0|9.0|Standard Deviation|2.4|2.4|||
3737619|NCT02029521|3574020|B2|||White Blood Cell Count|Total White Blood Cell Count. 1000 per cubic millimeter|1000 cells/mm^3|Mean|8.9|8.9|Standard Deviation|2.7|2.7|||
3737620|NCT02029521|3574021|B1|||White Blood Cell Count|Total White Blood Cell Count. 1000 per cubic millimeter|1000 cells/mm^3|Mean|9.1|9.1|Standard Deviation|2.0|2.0|||
3737621|NCT02029521|3574019|B3|Staph and A. xylososidans||Bacteriology||participants|Number|1|1.0||||||
3737622|NCT02029521|3574020|B2|Staph and A. xylososidans||Bacteriology||participants|Number|0|0.0||||||
3737624|NCT02029521|3574019|B3|PA and Staph||Bacteriology||participants|Number|11|11.0||||||
3737625|NCT02029521|3574020|B2|PA and Staph||Bacteriology||participants|Number|6|6.0||||||
3737626|NCT02029521|3574021|B1|PA and Staph||Bacteriology||participants|Number|5|5.0||||||
3737627|NCT02029521|3574019|B3|PA and S. maltophilia||Bacteriology||participants|Number|1|1.0||||||
3737628|NCT02029521|3574020|B2|PA and S. maltophilia||Bacteriology||participants|Number|0|0.0||||||
3737629|NCT02029521|3574021|B1|PA and S. maltophilia||Bacteriology||participants|Number|1|1.0||||||
3737630|NCT02029521|3574019|B3|Normal flora||Bacteriology||participants|Number|5|5.0||||||
3737631|NCT02029521|3574020|B2|Normal flora||Bacteriology||participants|Number|2|2.0||||||
3737632|NCT02029521|3574021|B1|Normal flora||Bacteriology||participants|Number|3|3.0||||||
3737633|NCT02029521|3574019|B3|Staph||Bacteriology||participants|Number|16|16.0||||||
3737634|NCT02029521|3574020|B2|Staph||Bacteriology||participants|Number|9|9.0||||||
3737635|NCT02029521|3574021|B1|Staph||Bacteriology||participants|Number|7|7.0||||||
3737636|NCT02029521|3574019|B3|PA||Bacteriology||participants|Number|5|5.0||||||
3737637|NCT02029521|3574020|B2|PA||Bacteriology||participants|Number|3|3.0||||||
3737638|NCT02029521|3574021|B1|PA||Bacteriology||participants|Number|2|2.0||||||
3737639|NCT02029521|3574019|B3|MRSA||Bacteriology||participants|Number|1|1.0||||||
3737640|NCT02029521|3574020|B2|MRSA||Bacteriology||participants|Number|1|1.0||||||
3737641|NCT02029521|3574021|B1|MRSA||Bacteriology||participants|Number|0|0.0||||||
3737642|NCT02029521|3574019|B3|A. xylososidans||Bacteriology||participants|Number|4|4.0||||||
3737643|NCT02029521|3574020|B2|A. xylososidans||Bacteriology||participants|Number|1|1.0||||||
3737644|NCT02029521|3574021|B1|A. xylososidans||Bacteriology||participants|Number|3|3.0||||||
3737645|NCT02029521|3574019|B3|||Participants' Lipase Intake in Units Per Day||units of lipase|Mean|127045.5|127045.5|Standard Deviation|50512.7|50512.7|||
3737646|NCT02029521|3574020|B2|||Participants' Lipase Intake in Units Per Day||units of lipase|Mean|123181.8|123181.8|Standard Deviation|47044.7|47044.7|||
3737647|NCT02029521|3574021|B1|||Participants' Lipase Intake in Units Per Day||units of lipase|Mean|130909.1|130909.1|Standard Deviation|54590.2|54590.2|||
3737648|NCT02029521|3574019|B3|||Sweat Chloride Test||mmol/L|Mean|86.3|86.3|Standard Deviation|15.6|15.6|||
3737649|NCT02029521|3574020|B2|||Sweat Chloride Test||mmol/L|Mean|85.0|85.0|Standard Deviation|15.6|15.6|||
3737650|NCT02029521|3574021|B1|||Sweat Chloride Test||mmol/L|Mean|87.7|87.7|Standard Deviation|15.8|15.8|||
3737651|NCT02029521|3574019|B3|N1303k/G542X||Gene Mutations||participants|Number|2|2.0||||||
3737652|NCT02029521|3574020|B2|N1303k/G542X||Gene Mutations||participants|Number|2|2.0||||||
3737653|NCT02029521|3574021|B1|N1303k/G542X||Gene Mutations||participants|Number|0|0.0||||||
3737654|NCT02029521|3574019|B3|R117H/R117H||Gene Mutations||participants|Number|1|1.0||||||
3737655|NCT02029521|3574020|B2|R117H/R117H||Gene Mutations||participants|Number|1|1.0||||||
3737656|NCT02029521|3574021|B1|R117H/R117H||Gene Mutations||participants|Number|0|0.0||||||
3737657|NCT02029521|3574019|B3|DelF508/R347P||Gene Mutations||participants|Number|1|1.0||||||
3737658|NCT02029521|3574020|B2|DelF508/R347P||Gene Mutations||participants|Number|1|1.0||||||
3737659|NCT02029521|3574021|B1|DelF508/R347P||Gene Mutations||participants|Number|0|0.0||||||
3737660|NCT02029521|3574019|B3|G542X/G542X||Gene Mutations||participants|Number|1|1.0||||||
3737661|NCT02029521|3574020|B2|G542X/G542X||Gene Mutations||participants|Number|1|1.0||||||
3737662|NCT02029521|3574021|B1|G542X/G542X||Gene Mutations||participants|Number|0|0.0||||||
3737663|NCT02029521|3574019|B3|DelF508/S489X||Gene Mutations||participants|Number|1|1.0||||||
3737664|NCT02029521|3574020|B2|DelF508/S489X||Gene Mutations||participants|Number|1|1.0||||||
3737665|NCT02029521|3574021|B1|DelF508/S489X||Gene Mutations||participants|Number|0|0.0||||||
3737666|NCT02029521|3574019|B3|DelF508/G576X||Gene Mutations||participants|Number|1|1.0||||||
3737667|NCT02029521|3574020|B2|DelF508/G576X||Gene Mutations||participants|Number|1|1.0||||||
3737668|NCT02029521|3574021|B1|DelF508/G576X||Gene Mutations||participants|Number|0|0.0||||||
3737669|NCT02029521|3574019|B3|R117H/1466delAATT||Gene Mutations||participants|Number|1|1.0||||||
3737670|NCT02029521|3574020|B2|R117H/1466delAATT||Gene Mutations||participants|Number|0|0.0||||||
3737671|NCT02029521|3574021|B1|R117H/1466delAATT||Gene Mutations||participants|Number|1|1.0||||||
3737672|NCT02029521|3574019|B3|G551D/DelF508||Gene Mutations||participants|Number|3|3.0||||||
3737673|NCT02029521|3574020|B2|G551D/DelF508||Gene Mutations||participants|Number|2|2.0||||||
3737674|NCT02029521|3574021|B1|G551D/DelF508||Gene Mutations||participants|Number|1|1.0||||||
3737675|NCT02029521|3574019|B3|N1303K/R553X||Gene Mutations||participants|Number|1|1.0||||||
3737676|NCT02029521|3574020|B2|N1303K/R553X||Gene Mutations||participants|Number|0|0.0||||||
3737677|NCT02029521|3574021|B1|N1303K/R553X||Gene Mutations||participants|Number|1|1.0||||||
3737678|NCT02029521|3574019|B3|3849+10kb/N1303k||Gene Mutations||participants|Number|1|1.0||||||
3737679|NCT02029521|3574020|B2|3849+10kb/N1303k||Gene Mutations||participants|Number|0|0.0||||||
3737680|NCT02029521|3574021|B1|3849+10kb/N1303k||Gene Mutations||participants|Number|1|1.0||||||
3737681|NCT02029521|3574019|B3|DelF508/G542X||Gene Mutations||participants|Number|3|3.0||||||
3737682|NCT02029521|3574020|B2|DelF508/G542X||Gene Mutations||participants|Number|2|2.0||||||
3737683|NCT02029521|3574021|B1|DelF508/G542X||Gene Mutations||participants|Number|1|1.0||||||
3737684|NCT02029521|3574019|B3|R117H/W1282X||Gene Mutations||participants|Number|1|1.0||||||
3737685|NCT02029521|3574020|B2|R117H/W1282X||Gene Mutations||participants|Number|0|0.0||||||
3737686|NCT02029521|3574021|B1|R117H/W1282X||Gene Mutations||participants|Number|1|1.0||||||
3737687|NCT02029521|3574019|B3|R117H/R347P||Gene Mutations||participants|Number|2|2.0||||||
3737688|NCT02029521|3574020|B2|R117H/R347P||Gene Mutations||participants|Number|1|1.0||||||
3737689|NCT02029521|3574021|B1|R117H/R347P||Gene Mutations||participants|Number|1|1.0||||||
3737690|NCT02029521|3574019|B3|W1282X/DelF508||Gene Mutations||participants|Number|3|3.0||||||
3737691|NCT02029521|3574020|B2|W1282X/DelF508||Gene Mutations||participants|Number|1|1.0||||||
3737692|NCT02029521|3574021|B1|W1282X/DelF508||Gene Mutations||participants|Number|2|2.0||||||
3737693|NCT02029521|3574019|B3|G551D/621+1GT||Gene Mutations||participants|Number|1|1.0||||||
3737694|NCT02029521|3574020|B2|G551D/621+1GT||Gene Mutations||participants|Number|0|0.0||||||
3737695|NCT02029521|3574021|B1|G551D/621+1GT||Gene Mutations||participants|Number|1|1.0||||||
3737696|NCT02029521|3574019|B3|DelF508/3849+10KBCT||Gene Mutations||participants|Number|2|2.0||||||
3737697|NCT02029521|3574020|B2|DelF508/3849+10KBCT||Gene Mutations||participants|Number|1|1.0||||||
3737698|NCT02029521|3574021|B1|DelF508/3849+10KBCT||Gene Mutations||participants|Number|1|1.0||||||
3737699|NCT02029521|3574019|B3|DelF508/N1303K||Gene Mutations||participants|Number|2|2.0||||||
3737700|NCT02029521|3574020|B2|DelF508/N1303K||Gene Mutations||participants|Number|1|1.0||||||
3737701|NCT02029521|3574021|B1|DelF508/N1303K||Gene Mutations||participants|Number|1|1.0||||||
3737702|NCT02029521|3574019|B3|W1282X/R347P||Gene Mutations||participants|Number|1|1.0||||||
3737703|NCT02029521|3574020|B2|W1282X/R347P||Gene Mutations||participants|Number|0|0.0||||||
3737704|NCT02029521|3574021|B1|W1282X/R347P||Gene Mutations||participants|Number|1|1.0||||||
3737705|NCT02029521|3574019|B3|DelF508/R553X||Gene Mutations||participants|Number|2|2.0||||||
3737706|NCT02029521|3574020|B2|DelF508/R553X||Gene Mutations||participants|Number|0|0.0||||||
3737707|NCT02029521|3574021|B1|DelF508/R553X||Gene Mutations||participants|Number|2|2.0||||||
3737708|NCT02029521|3574019|B3|DelF508/DelF508||Gene Mutations||participants|Number|9|9.0||||||
3737709|NCT02029521|3574020|B2|DelF508/DelF508||Gene Mutations||participants|Number|5|5.0||||||
3737710|NCT02029521|3574021|B1|DelF508/DelF508||Gene Mutations||participants|Number|4|4.0||||||
3737711|NCT02029521|3574019|B3|R117H/G542X||Gene Mutations||participants|Number|3|3.0||||||
3737712|NCT02029521|3574020|B2|R117H/G542X||Gene Mutations||participants|Number|2|2.0||||||
3737713|NCT02029521|3574021|B1|R117H/G542X||Gene Mutations||participants|Number|1|1.0||||||
3737714|NCT02029521|3574019|B3|DelF508/R117H||Gene Mutations||participants|Number|1|1.0||||||
3737715|NCT02029521|3574020|B2|DelF508/R117H||Gene Mutations||participants|Number|0|0.0||||||
3737716|NCT02029521|3574021|B1|DelF508/R117H||Gene Mutations||participants|Number|1|1.0||||||
3737717|NCT02029521|3574019|B3|G551D/1303K||Gene Mutations||participants|Number|1|1.0||||||
3737718|NCT02029521|3574020|B2|G551D/1303K||Gene Mutations||participants|Number|0|0.0||||||
3737719|NCT02029521|3574021|B1|G551D/1303K||Gene Mutations||participants|Number|1|1.0||||||
3737720|NCT02029521|3574019|B3|||Forced Vital Capacity|Forced Vital Capacity percentile normalized by age, height and gender|Percent Predicted|Mean|84.7|84.7|Standard Deviation|9.4|9.4|||
3737721|NCT02029521|3574020|B2|||Forced Vital Capacity|Forced Vital Capacity percentile normalized by age, height and gender|Percent Predicted|Mean|88.2|88.2|Standard Deviation|9.6|9.6|||
3737722|NCT02029521|3574021|B1|||Forced Vital Capacity|Forced Vital Capacity percentile normalized by age, height and gender|Percent Predicted|Mean|81.8|81.8|Standard Deviation|8.7|8.7|||
3737723|NCT02029521|3574019|B3|||Forced Expiratory Volume at one second.|Forced Expiratory Volume at one second. Percentile normalized by age, height and gender.|Percent predicted|Mean|66.9|66.9|Standard Deviation|7.3|7.3|||
3737724|NCT02029521|3574020|B2|||Forced Expiratory Volume at one second.|Forced Expiratory Volume at one second. Percentile normalized by age, height and gender.|Percent predicted|Mean|71|71.0|Standard Deviation|7.8|7.8|||
3737725|NCT02029521|3574021|B1|||Forced Expiratory Volume at one second.|Forced Expiratory Volume at one second. Percentile normalized by age, height and gender.|Percent predicted|Mean|63.5|63.5|Standard Deviation|4.8|4.8|||
3737726|NCT02029521|3574019|B3|||Fecal Calprotectin||micrograms/gram feces|Mean|94.6|94.6|Standard Deviation|47|47.0|||
3737727|NCT02029521|3574020|B2|||Fecal Calprotectin||micrograms/gram feces|Mean|76.1|76.1|Standard Deviation|32.2|32.2|||
3737728|NCT02029521|3574021|B1|||Fecal Calprotectin||micrograms/gram feces|Mean|113.2|113.2|Standard Deviation|52.5|52.5|||
3737729|NCT02029521|3574019|B3|||Height Percentile||Percentile adjusted for weight and heigh|Mean|37.7|37.7|Standard Deviation|13.9|13.9|||
3737730|NCT02029521|3574020|B2|||Height Percentile||Percentile adjusted for weight and heigh|Mean|39.3|39.3|Standard Deviation|13.5|13.5|||
3737731|NCT02029521|3574021|B1|||Height Percentile||Percentile adjusted for weight and heigh|Mean|36.3|36.3|Standard Deviation|14.4|14.4|||
3737732|NCT02029521|3574019|B3|||Weight Percentile||Percentile adjusted for sex and age|Mean|26.9|26.9|Standard Deviation|13.6|13.6|||
3737733|NCT02029521|3574020|B2|||Weight Percentile||Percentile adjusted for sex and age|Mean|33.5|33.5|Standard Deviation|13.4|13.4|||
3737734|NCT02029521|3574021|B1|||Weight Percentile||Percentile adjusted for sex and age|Mean|24.2|24.2|Standard Deviation|13.7|13.7|||
3737735|NCT02029521|3574019|B3|||Body Mass Index Percentile|Body Mass Index for patients with standardized percentile|Percentile adjusted for age and sex|Mean|28.3|28.3|Standard Deviation|15.1|15.1|||
3737736|NCT02029521|3574020|B2|||Body Mass Index Percentile|Body Mass Index for patients with standardized percentile|Percentile adjusted for age and sex|Mean|31.1|31.1|Standard Deviation|14.1|14.1|||
3737737|NCT02029521|3574021|B1|||Body Mass Index Percentile|Body Mass Index for patients with standardized percentile|Percentile adjusted for age and sex|Mean|25.1|25.1|Standard Deviation|15.9|15.9|||
3737738|NCT02029521|3574019|B3|Italy||Region of Enrollment||participants|Number|44|44.0||||||
3737739|NCT02029521|3574020|B2|Italy||Region of Enrollment||participants|Number|22|22.0||||||
3737740|NCT02029521|3574021|B1|Italy||Region of Enrollment||participants|Number|22|22.0||||||
3737741|NCT02029521|3574019|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3737742|NCT02029521|3574020|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3737743|NCT02029521|3574021|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3737744|NCT02029521|3574019|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3737745|NCT02029521|3574020|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3737746|NCT02029521|3574021|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3737747|NCT02029521|3574019|B3|3 years to 10 years||Age, Customized|15 months to 3 years and greater than 3 years|participants|Number|32|32.0||||||
3737748|NCT02029521|3574020|B2|3 years to 10 years||Age, Customized|15 months to 3 years and greater than 3 years|participants|Number|16|16.0||||||
3737749|NCT02029521|3574021|B1|3 years to 10 years||Age, Customized|15 months to 3 years and greater than 3 years|participants|Number|16|16.0||||||
3737750|NCT02029521|3574019|B3|15 months to 3 years||Age, Customized|15 months to 3 years and greater than 3 years|participants|Number|12|12.0||||||
3737751|NCT02029521|3574020|B2|15 months to 3 years||Age, Customized|15 months to 3 years and greater than 3 years|participants|Number|6|6.0||||||
3737752|NCT02029521|3574021|B1|15 months to 3 years||Age, Customized|15 months to 3 years and greater than 3 years|participants|Number|6|6.0||||||
3737753|NCT02029495|3574104|B4|Estonia||Region of Enrollment||participants|Number|9|9.0||||||
3737754|NCT02029495|3574105|B3|Estonia||Region of Enrollment||participants|Number|2|2.0||||||
3737755|NCT02029495|3574106|B2|Estonia||Region of Enrollment||participants|Number|3|3.0||||||
3737756|NCT02029495|3574107|B1|Estonia||Region of Enrollment||participants|Number|4|4.0||||||
3737757|NCT02029495|3574104|B4|Bulgaria||Region of Enrollment||participants|Number|9|9.0||||||
3737758|NCT02029495|3574105|B3|Bulgaria||Region of Enrollment||participants|Number|3|3.0||||||
3737759|NCT02029495|3574106|B2|Bulgaria||Region of Enrollment||participants|Number|4|4.0||||||
3737760|NCT02029495|3574107|B1|Bulgaria||Region of Enrollment||participants|Number|2|2.0||||||
3737761|NCT02029495|3574104|B4|France||Region of Enrollment||participants|Number|8|8.0||||||
3737762|NCT02029495|3574105|B3|France||Region of Enrollment||participants|Number|2|2.0||||||
3737763|NCT02029495|3574106|B2|France||Region of Enrollment||participants|Number|2|2.0||||||
3737764|NCT02029495|3574107|B1|France||Region of Enrollment||participants|Number|4|4.0||||||
3737765|NCT02029495|3574104|B4|Slovakia||Region of Enrollment||participants|Number|15|15.0||||||
3737766|NCT02029495|3574105|B3|Slovakia||Region of Enrollment||participants|Number|5|5.0||||||
3737767|NCT02029495|3574106|B2|Slovakia||Region of Enrollment||participants|Number|5|5.0||||||
3737768|NCT02029495|3574107|B1|Slovakia||Region of Enrollment||participants|Number|5|5.0||||||
3737769|NCT02029495|3574104|B4|Mexico||Region of Enrollment||participants|Number|12|12.0||||||
3737770|NCT02029495|3574105|B3|Mexico||Region of Enrollment||participants|Number|4|4.0||||||
3737771|NCT02029495|3574106|B2|Mexico||Region of Enrollment||participants|Number|3|3.0||||||
3737772|NCT02029495|3574107|B1|Mexico||Region of Enrollment||participants|Number|5|5.0||||||
3737773|NCT02029495|3574104|B4|Italy||Region of Enrollment||participants|Number|9|9.0||||||
3737774|NCT02029495|3574105|B3|Italy||Region of Enrollment||participants|Number|2|2.0||||||
3737775|NCT02029495|3574106|B2|Italy||Region of Enrollment||participants|Number|5|5.0||||||
3737776|NCT02029495|3574107|B1|Italy||Region of Enrollment||participants|Number|2|2.0||||||
3737777|NCT02029495|3574104|B4|Poland||Region of Enrollment||participants|Number|139|139.0||||||
3737778|NCT02029495|3574105|B3|Poland||Region of Enrollment||participants|Number|44|44.0||||||
3737779|NCT02029495|3574106|B2|Poland||Region of Enrollment||participants|Number|45|45.0||||||
3737780|NCT02029495|3574107|B1|Poland||Region of Enrollment||participants|Number|50|50.0||||||
3737781|NCT02029495|3574104|B4|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
3737782|NCT02029495|3574105|B3|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
3737783|NCT02029495|3574106|B2|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
3737784|NCT02029495|3574107|B1|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
3737785|NCT02029495|3574104|B4|Czech Republic||Region of Enrollment||participants|Number|19|19.0||||||
3737786|NCT02029495|3574105|B3|Czech Republic||Region of Enrollment||participants|Number|9|9.0||||||
3737787|NCT02029495|3574106|B2|Czech Republic||Region of Enrollment||participants|Number|8|8.0||||||
3737788|NCT02029495|3574107|B1|Czech Republic||Region of Enrollment||participants|Number|2|2.0||||||
3737789|NCT02029495|3574104|B4|Canada||Region of Enrollment||participants|Number|9|9.0||||||
3737790|NCT02029495|3574105|B3|Canada||Region of Enrollment||participants|Number|2|2.0||||||
3737791|NCT02029495|3574106|B2|Canada||Region of Enrollment||participants|Number|3|3.0||||||
3737792|NCT02029495|3574107|B1|Canada||Region of Enrollment||participants|Number|4|4.0||||||
3737793|NCT02029495|3574104|B4|Greece||Region of Enrollment||participants|Number|6|6.0||||||
3737794|NCT02029495|3574105|B3|Greece||Region of Enrollment||participants|Number|2|2.0||||||
3737795|NCT02029495|3574106|B2|Greece||Region of Enrollment||participants|Number|2|2.0||||||
3737796|NCT02029495|3574107|B1|Greece||Region of Enrollment||participants|Number|2|2.0||||||
3737797|NCT02029495|3574104|B4|Spain||Region of Enrollment||participants|Number|21|21.0||||||
3737798|NCT02029495|3574105|B3|Spain||Region of Enrollment||participants|Number|7|7.0||||||
3737799|NCT02029495|3574106|B2|Spain||Region of Enrollment||participants|Number|4|4.0||||||
3737800|NCT02029495|3574107|B1|Spain||Region of Enrollment||participants|Number|10|10.0||||||
3737801|NCT02029495|3574104|B4|Switzerland||Region of Enrollment||participants|Number|12|12.0||||||
3737802|NCT02029495|3574105|B3|Switzerland||Region of Enrollment||participants|Number|5|5.0||||||
3737803|NCT02029495|3574106|B2|Switzerland||Region of Enrollment||participants|Number|6|6.0||||||
3737804|NCT02029495|3574107|B1|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
3737805|NCT02029495|3574104|B4|United Kingdom||Region of Enrollment||participants|Number|15|15.0||||||
3737806|NCT02029495|3574105|B3|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3737807|NCT02029495|3574106|B2|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3737808|NCT02029495|3574107|B1|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3737809|NCT02029495|3574104|B4|United States||Region of Enrollment||participants|Number|107|107.0||||||
3737810|NCT02029495|3574105|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
3737811|NCT02029495|3574106|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
3737812|NCT02029495|3574107|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3737813|NCT02029495|3574104|B4|Hungary||Region of Enrollment||participants|Number|15|15.0||||||
3737814|NCT02029495|3574105|B3|Hungary||Region of Enrollment||participants|Number|4|4.0||||||
3737815|NCT02029495|3574106|B2|Hungary||Region of Enrollment||participants|Number|6|6.0||||||
3737816|NCT02029495|3574107|B1|Hungary||Region of Enrollment||participants|Number|5|5.0||||||
3737817|NCT02029495|3574104|B4|Russian Federation||Region of Enrollment||participants|Number|71|71.0||||||
3737818|NCT02029495|3574105|B3|Russian Federation||Region of Enrollment||participants|Number|27|27.0||||||
3737819|NCT02029495|3574106|B2|Russian Federation||Region of Enrollment||participants|Number|22|22.0||||||
3737820|NCT02029495|3574107|B1|Russian Federation||Region of Enrollment||participants|Number|22|22.0||||||
3737821|NCT02029495|3574104|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3737822|NCT02029495|3574105|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3737823|NCT02029495|3574106|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3737824|NCT02029495|3574107|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3737825|NCT02029495|3574104|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737826|NCT02029495|3574105|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737827|NCT02029495|3574106|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737828|NCT02029495|3574107|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737829|NCT02029495|3574104|B4||White|Race (NIH/OMB)||Participants|Count of Participants|459|459.0||||||
3737830|NCT02029495|3574105|B3||White|Race (NIH/OMB)||Participants|Count of Participants|152|152.0||||||
3737831|NCT02029495|3574106|B2||White|Race (NIH/OMB)||Participants|Count of Participants|152|152.0||||||
3737832|NCT02029495|3574107|B1||White|Race (NIH/OMB)||Participants|Count of Participants|155|155.0||||||
3737833|NCT02029495|3574104|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737834|NCT02029495|3574105|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737835|NCT02029495|3574106|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737836|NCT02029495|3574107|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737837|NCT02029495|3574104|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737838|NCT02029495|3574105|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737839|NCT02029495|3574106|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737840|NCT02029495|3574107|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737841|NCT02029495|3574104|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3737842|NCT02029495|3574105|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3737843|NCT02029495|3574106|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737844|NCT02029495|3574107|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737845|NCT02029495|3574104|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3737846|NCT02029495|3574105|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737847|NCT02029495|3574106|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737848|NCT02029495|3574107|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3737849|NCT02029495|3574104|B4||Male|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
3737850|NCT02029495|3574105|B3||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3737851|NCT02029495|3574106|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3737852|NCT02029495|3574107|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3737853|NCT02029495|3574104|B4||Female|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
3737854|NCT02029495|3574105|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3737855|NCT02029495|3574106|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3737856|NCT02029495|3574107|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3737857|NCT02029495|3574104|B4|||Age||years|Mean|49|49.0|Standard Deviation|12.28|12.28|||
3737858|NCT02029495|3574105|B3|||Age||years|Mean|48.1|48.1|Standard Deviation|11.79|11.79|||
3737859|NCT02029495|3574106|B2|||Age||years|Mean|49.9|49.9|Standard Deviation|12.80|12.8|||
3737860|NCT02029495|3574107|B1|||Age||years|Mean|49.1|49.1|Standard Deviation|12.24|12.24|||
3737861|NCT02029495|3574104|B4||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
3737862|NCT02029495|3574105|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3737863|NCT02029495|3574106|B2||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3737864|NCT02029495|3574107|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3737865|NCT02029495|3574104|B4||Between 18 and 65 years|Age||Participants|Count of Participants|427|427.0||||||
3737866|NCT02029495|3574105|B3||Between 18 and 65 years|Age||Participants|Count of Participants|145|145.0||||||
3737867|NCT02029495|3574106|B2||Between 18 and 65 years|Age||Participants|Count of Participants|138|138.0||||||
3737868|NCT02029495|3574107|B1||Between 18 and 65 years|Age||Participants|Count of Participants|144|144.0||||||
3737869|NCT02029495|3574104|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3737870|NCT02029495|3574105|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3737871|NCT02029495|3574106|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3737872|NCT02029495|3574107|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3737873|NCT02029417|3574120|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3737874|NCT02029417|3574120|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3737875|NCT02029417|3574120|B1|||Age||years|Mean|75|75.0|Standard Deviation|1.8|1.8|||
3737876|NCT02029235|3574125|B3|||Patient Health Questionnaire (PHQ-9)|"The Patient Health Questionnaire (PHQ-0) objectifies degree of depression severity.~It provides a total score on a scale of 0 - 27, with higher being worse (i.e. more severe depression)."|units on a scale (total score)|Mean|2.23|2.23|Full Range|||0.0|14.0|
3737877|NCT02029235|3574126|B2|||Patient Health Questionnaire (PHQ-9)|"The Patient Health Questionnaire (PHQ-0) objectifies degree of depression severity.~It provides a total score on a scale of 0 - 27, with higher being worse (i.e. more severe depression)."|units on a scale (total score)|Mean|2.63|2.63|Full Range|||0.0|14.0|
3737878|NCT02029235|3574127|B1|||Patient Health Questionnaire (PHQ-9)|"The Patient Health Questionnaire (PHQ-0) objectifies degree of depression severity.~It provides a total score on a scale of 0 - 27, with higher being worse (i.e. more severe depression)."|units on a scale (total score)|Mean|1.83|1.83|Full Range|||0.0|12.0|
3737879|NCT02029235|3574125|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
3737880|NCT02029235|3574126|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3737881|NCT02029235|3574127|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3737882|NCT02029235|3574125|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3737883|NCT02029235|3574125|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3737884|NCT02029235|3574126|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3737885|NCT02029235|3574127|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3737886|NCT02029235|3574125|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3737887|NCT02029235|3574126|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3737888|NCT02029235|3574127|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3737889|NCT02029235|3574125|B3|||Age||years|Mean|53|53.0|Full Range|||18.0|86.0|
3737890|NCT02029235|3574126|B2|||Age||years|Mean|53|53.0|Full Range|||18.0|75.0|
3737891|NCT02029235|3574127|B1|||Age||years|Mean|52|52.0|Full Range|||18.0|86.0|
3737892|NCT02029196|3574136|B3|||Exhaled Carbon Monoxide (eCO)||parts per million (ppm)|Mean|16.0|16.0|Standard Deviation|6.6|6.6|||
3737893|NCT02029196|3574137|B2|||Exhaled Carbon Monoxide (eCO)||parts per million (ppm)|Mean|16.7|16.7|Standard Deviation|7.3|7.3|||
3737894|NCT02029196|3574138|B1|||Exhaled Carbon Monoxide (eCO)||parts per million (ppm)|Mean|15.8|15.8|Standard Deviation|6.3|6.3|||
3737895|NCT02029196|3574136|B3||Male|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
3737896|NCT02029196|3574137|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3737897|NCT02029196|3574138|B1||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3737898|NCT02029196|3574136|B3||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3737899|NCT02029196|3574137|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3737900|NCT02029196|3574138|B1||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3737901|NCT02029196|3574136|B3|||Age||years|Mean|34.3|34.3|Standard Deviation|10.5|10.5|||
3737902|NCT02029196|3574137|B2|||Age||years|Mean|35.1|35.1|Standard Deviation|10.6|10.6|||
3737903|NCT02029196|3574138|B1|||Age||years|Mean|34.1|34.1|Standard Deviation|10.6|10.6|||
3737904|NCT02028871|3574147|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
3737905|NCT02028871|3574148|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3737906|NCT02028871|3574149|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3737907|NCT02028871|3574147|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737908|NCT02028871|3574148|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737909|NCT02028871|3574149|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737910|NCT02028871|3574147|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3737911|NCT02028871|3574148|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3737912|NCT02028871|3574149|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3737913|NCT02028871|3574147|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3737914|NCT02028871|3574148|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3737915|NCT02028871|3574149|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3737916|NCT02028871|3574147|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3737917|NCT02028871|3574148|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737918|NCT02028871|3574149|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3737919|NCT02028871|3574147|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737920|NCT02028871|3574148|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737921|NCT02028871|3574149|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737922|NCT02028871|3574147|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737923|NCT02028871|3574148|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737924|NCT02028871|3574149|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737925|NCT02028871|3574147|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737926|NCT02028871|3574148|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737927|NCT02028871|3574149|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737928|NCT02028871|3574147|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737929|NCT02028871|3574148|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737930|NCT02028871|3574149|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737931|NCT02028871|3574147|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3737932|NCT02028871|3574148|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3737933|NCT02028871|3574149|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3737934|NCT02028871|3574147|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3737935|NCT02028871|3574148|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3737936|NCT02028871|3574149|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3737937|NCT02028871|3574147|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3737938|NCT02028871|3574148|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3737939|NCT02028871|3574149|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3737940|NCT02028871|3574147|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3737941|NCT02028871|3574148|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3737942|NCT02028871|3574149|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3737943|NCT02028871|3574147|B3|||Age||years|Mean|33.57895|33.57895|Standard Deviation|10.81198|10.81198|||
3737944|NCT02028871|3574148|B2|||Age||years|Mean|29.30|29.3|Standard Deviation|7.14|7.14|||
3737945|NCT02028871|3574149|B1|||Age||years|Mean|38.33|38.33|Standard Deviation|12.82|12.82|||
3737946|NCT02028871|3574147|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3737947|NCT02028871|3574148|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3737948|NCT02028871|3574149|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3737949|NCT02028871|3574147|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3737950|NCT02028871|3574148|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3737951|NCT02028871|3574149|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3737952|NCT02028871|3574147|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3737953|NCT02028871|3574148|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3737954|NCT02028871|3574149|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3737955|NCT02028780|3574159|B13||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3737956|NCT02028780|3574160|B12||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3737957|NCT02028780|3574161|B11||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3737958|NCT02028780|3574162|B10||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3737959|NCT02028780|3574163|B9||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3737960|NCT02028780|3574164|B8||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3737961|NCT02028780|3574165|B7||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3737962|NCT02028780|3574166|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3737963|NCT02028780|3574167|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3737964|NCT02028780|3574168|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3737965|NCT02028780|3574169|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3737966|NCT02028780|3574170|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3737967|NCT02028780|3574171|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3737968|NCT02028780|3574159|B13||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3737969|NCT02028780|3574160|B12||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3737970|NCT02028780|3574161|B11||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3737971|NCT02028780|3574162|B10||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3737972|NCT02028780|3574163|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3737973|NCT02028780|3574164|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3737974|NCT02028780|3574165|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3737975|NCT02028780|3574166|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3737976|NCT02028780|3574167|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3737977|NCT02028780|3574168|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3737978|NCT02028780|3574169|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3737979|NCT02028780|3574170|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3737980|NCT02028780|3574171|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3737981|NCT02028780|3574159|B13|||Age||Years|Mean|27.3|27.3|Standard Deviation|6.4|6.4|||
3737982|NCT02028780|3574160|B12|||Age||Years|Mean|24.4|24.4|Standard Deviation|1.4|1.4|||
3737983|NCT02028780|3574161|B11|||Age||Years|Mean|25.4|25.4|Standard Deviation|2.7|2.7|||
3737984|NCT02028780|3574162|B10|||Age||Years|Mean|25.7|25.7|Standard Deviation|3.1|3.1|||
3737985|NCT02028780|3574163|B9|||Age||Years|Mean|23.8|23.8|Standard Deviation|3.1|3.1|||
3737986|NCT02028780|3574164|B8|||Age||Years|Mean|29.7|29.7|Standard Deviation|5.0|5.0|||
3737987|NCT02028780|3574165|B7|||Age||Years|Mean|24.7|24.7|Standard Deviation|3.3|3.3|||
3737988|NCT02028780|3574166|B6|||Age||Years|Mean|32.2|32.2|Standard Deviation|8.1|8.1|||
3737989|NCT02028780|3574167|B5|||Age||Years|Mean|31.5|31.5|Standard Deviation|8.3|8.3|||
3737990|NCT02028780|3574168|B4|||Age||Years|Mean|27.8|27.8|Standard Deviation|7.7|7.7|||
3737991|NCT02028780|3574169|B3|||Age||Years|Mean|31.5|31.5|Standard Deviation|10.9|10.9|||
3737992|NCT02028780|3574170|B2|||Age||Years|Mean|32.5|32.5|Standard Deviation|4.9|4.9|||
3737993|NCT02028780|3574171|B1|||Age||Years|Mean|28.7|28.7|Standard Deviation|10.5|10.5|||
3737994|NCT02028767|3574247|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3737995|NCT02028767|3574247|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3737996|NCT02028767|3574247|B1|||Age||years|Mean|36.1|36.1|Standard Deviation|10.0|10.0|||
3737997|NCT02028754|3574258|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3737998|NCT02028754|3574259|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3737999|NCT02028754|3574260|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3738000|NCT02028754|3574258|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3738001|NCT02028754|3574259|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3738002|NCT02028754|3574260|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3738003|NCT02028754|3574258|B3|||Age||Years|Mean|68.9|68.9|Standard Deviation|7.1|7.1|||
3738004|NCT02028754|3574259|B2|||Age||Years|Mean|69.0|69.0|Standard Deviation|7.1|7.1|||
3738005|NCT02028754|3574260|B1|||Age||Years|Mean|68.8|68.8|Standard Deviation|7.1|7.1|||
3738006|NCT02028715|3574279|B3|United States||Region of Enrollment||Participants|Count of Participants|59|59.0||||||
3738007|NCT02028715|3574280|B2|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3738008|NCT02028715|3574281|B1|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3738009|NCT02028715|3574279|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3738010|NCT02028715|3574279|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3738011|NCT02028715|3574280|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3738012|NCT02028715|3574281|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3738013|NCT02028715|3574279|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3738014|NCT02028715|3574280|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3738015|NCT02028715|3574281|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3738016|NCT02028715|3574279|B3|||Age||years|Mean|51.05|51.05|Standard Deviation|14.358|14.358|||
3738017|NCT02028715|3574280|B2|||Age||years|Mean|51.73|51.73|Standard Deviation|12.690|12.69|||
3738018|NCT02028715|3574281|B1|||Age||years|Mean|50.34|50.34|Standard Deviation|16.101|16.101|||
3738019|NCT02028676|3574300|B10|||Weight-for-age Z-score: Period 4 (randomization to stop versus continue cotrimoxazole)|Weight-for-age Z-score at the time of the secondary randomization to stop versus continue cotrimoxazole prophylaxis (in those children eligible and randomized).|Z-score|Median|-1.3|-1.3|Inter-Quartile Range|||-1.9|-0.6|
3738020|NCT02028676|3574301|B9|||Weight-for-age Z-score: Period 4 (randomization to stop versus continue cotrimoxazole)|Weight-for-age Z-score at the time of the secondary randomization to stop versus continue cotrimoxazole prophylaxis (in those children eligible and randomized).|Z-score|Median|-1.3|-1.3|Inter-Quartile Range|||-1.9|-0.7|
3738021|NCT02028676|3574302|B8|||Weight-for-age Z-score: Period 4 (randomization to stop versus continue cotrimoxazole)|Weight-for-age Z-score at the time of the secondary randomization to stop versus continue cotrimoxazole prophylaxis (in those children eligible and randomized).|Z-score|Median|-1.3|-1.3|Inter-Quartile Range|||-1.9|-0.6|
3738022|NCT02028676|3574303|B7|||Weight-for-age Z-score: Period 4 (randomization to stop versus continue cotrimoxazole)|Weight-for-age Z-score at the time of the secondary randomization to stop versus continue cotrimoxazole prophylaxis (in those children eligible and randomized).|Z-score|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738023|NCT02028676|3574304|B6|||Weight-for-age Z-score: Period 4 (randomization to stop versus continue cotrimoxazole)|Weight-for-age Z-score at the time of the secondary randomization to stop versus continue cotrimoxazole prophylaxis (in those children eligible and randomized).|Z-score|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738024|NCT02028676|3574305|B5|||Weight-for-age Z-score: Period 4 (randomization to stop versus continue cotrimoxazole)|Weight-for-age Z-score at the time of the secondary randomization to stop versus continue cotrimoxazole prophylaxis (in those children eligible and randomized).|Z-score|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738025|NCT02028676|3574306|B4|||Weight-for-age Z-score: Period 4 (randomization to stop versus continue cotrimoxazole)|Weight-for-age Z-score at the time of the secondary randomization to stop versus continue cotrimoxazole prophylaxis (in those children eligible and randomized).|Z-score|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738432|NCT02027883|3574534|B2||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3738026|NCT02028676|3574307|B3|||Weight-for-age Z-score: Period 4 (randomization to stop versus continue cotrimoxazole)|Weight-for-age Z-score at the time of the secondary randomization to stop versus continue cotrimoxazole prophylaxis (in those children eligible and randomized).|Z-score|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738027|NCT02028676|3574308|B2|||Weight-for-age Z-score: Period 4 (randomization to stop versus continue cotrimoxazole)|Weight-for-age Z-score at the time of the secondary randomization to stop versus continue cotrimoxazole prophylaxis (in those children eligible and randomized).|Z-score|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738028|NCT02028676|3574309|B1|||Weight-for-age Z-score: Period 4 (randomization to stop versus continue cotrimoxazole)|Weight-for-age Z-score at the time of the secondary randomization to stop versus continue cotrimoxazole prophylaxis (in those children eligible and randomized).|Z-score|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738029|NCT02028676|3574300|B10|||Weight-for-age Z-score: Period 3 (randomization to once vs twice daily ABC+3TC)|Weight-for-age Z-score at the time of the secondary randomization to once versus twice daily abacavir+lamivudine (in those children eligible and randomized).|Z-score|Median|-1.4|-1.4|Inter-Quartile Range|||-2.0|-0.7|
3738030|NCT02028676|3574301|B9|||Weight-for-age Z-score: Period 3 (randomization to once vs twice daily ABC+3TC)|Weight-for-age Z-score at the time of the secondary randomization to once versus twice daily abacavir+lamivudine (in those children eligible and randomized).|Z-score|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738031|NCT02028676|3574302|B8|||Weight-for-age Z-score: Period 3 (randomization to once vs twice daily ABC+3TC)|Weight-for-age Z-score at the time of the secondary randomization to once versus twice daily abacavir+lamivudine (in those children eligible and randomized).|Z-score|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738032|NCT02028676|3574303|B7|||Weight-for-age Z-score: Period 3 (randomization to once vs twice daily ABC+3TC)|Weight-for-age Z-score at the time of the secondary randomization to once versus twice daily abacavir+lamivudine (in those children eligible and randomized).|Z-score|Median|-1.3|-1.3|Inter-Quartile Range|||-2.0|-0.6|
3738033|NCT02028676|3574304|B6|||Weight-for-age Z-score: Period 3 (randomization to once vs twice daily ABC+3TC)|Weight-for-age Z-score at the time of the secondary randomization to once versus twice daily abacavir+lamivudine (in those children eligible and randomized).|Z-score|Median|-1.4|-1.4|Inter-Quartile Range|||-2.0|-0.7|
3738034|NCT02028676|3574305|B5|||Weight-for-age Z-score: Period 3 (randomization to once vs twice daily ABC+3TC)|Weight-for-age Z-score at the time of the secondary randomization to once versus twice daily abacavir+lamivudine (in those children eligible and randomized).|Z-score|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738035|NCT02028676|3574306|B4|||Weight-for-age Z-score: Period 3 (randomization to once vs twice daily ABC+3TC)|Weight-for-age Z-score at the time of the secondary randomization to once versus twice daily abacavir+lamivudine (in those children eligible and randomized).|Z-score|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738036|NCT02028676|3574307|B3|||Weight-for-age Z-score: Period 3 (randomization to once vs twice daily ABC+3TC)|Weight-for-age Z-score at the time of the secondary randomization to once versus twice daily abacavir+lamivudine (in those children eligible and randomized).|Z-score|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738037|NCT02028676|3574308|B2|||Weight-for-age Z-score: Period 3 (randomization to once vs twice daily ABC+3TC)|Weight-for-age Z-score at the time of the secondary randomization to once versus twice daily abacavir+lamivudine (in those children eligible and randomized).|Z-score|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparisonDifferent randomized comparison
3738038|NCT02028676|3574309|B1|||Weight-for-age Z-score: Period 3 (randomization to once vs twice daily ABC+3TC)|Weight-for-age Z-score at the time of the secondary randomization to once versus twice daily abacavir+lamivudine (in those children eligible and randomized).|Z-score|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738039|NCT02028676|3574300|B10|||Weight-for-age Z-score: Period 2 (trial enrollment, induction ART)|Weight-for-age Z-score at trial enrollment (antiretroviral therapy initiation).|Z-score|Median|-2.2|-2.2|Inter-Quartile Range|||-3.3|-1.3|
3738040|NCT02028676|3574301|B9|||Weight-for-age Z-score: Period 2 (trial enrollment, induction ART)|Weight-for-age Z-score at trial enrollment (antiretroviral therapy initiation).|Z-score|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738041|NCT02028676|3574302|B8|||Weight-for-age Z-score: Period 2 (trial enrollment, induction ART)|Weight-for-age Z-score at trial enrollment (antiretroviral therapy initiation).|Z-score|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738042|NCT02028676|3574303|B7|||Weight-for-age Z-score: Period 2 (trial enrollment, induction ART)|Weight-for-age Z-score at trial enrollment (antiretroviral therapy initiation).|Z-score|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738043|NCT02028676|3574304|B6|||Weight-for-age Z-score: Period 2 (trial enrollment, induction ART)|Weight-for-age Z-score at trial enrollment (antiretroviral therapy initiation).|Z-score|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738044|NCT02028676|3574305|B5|||Weight-for-age Z-score: Period 2 (trial enrollment, induction ART)|Weight-for-age Z-score at trial enrollment (antiretroviral therapy initiation).|Z-score|Median|-2.2|-2.2|Inter-Quartile Range|||-3.4|-1.3|
3738045|NCT02028676|3574306|B4|||Weight-for-age Z-score: Period 2 (trial enrollment, induction ART)|Weight-for-age Z-score at trial enrollment (antiretroviral therapy initiation).|Z-score|Median|-2.2|-2.2|Inter-Quartile Range|||-3.2|-1.4|
3738046|NCT02028676|3574307|B3|||Weight-for-age Z-score: Period 2 (trial enrollment, induction ART)|Weight-for-age Z-score at trial enrollment (antiretroviral therapy initiation).|Z-score|Median|-2.3|-2.3|Inter-Quartile Range|||-3.5|-1.3|
3738047|NCT02028676|3574308|B2|||Weight-for-age Z-score: Period 2 (trial enrollment, induction ART)|Weight-for-age Z-score at trial enrollment (antiretroviral therapy initiation).|Z-score|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738048|NCT02028676|3574309|B1|||Weight-for-age Z-score: Period 2 (trial enrollment, induction ART)|Weight-for-age Z-score at trial enrollment (antiretroviral therapy initiation).|Z-score|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738049|NCT02028676|3574300|B10|||Weight-for-age Z-score: Period 1 (trial enrollment, CDM vs LCM)|Weight-for-age Z-score at trial enrollment (antiretroviral therapy initiation).|Z-score|Median|-2.2|-2.2|Inter-Quartile Range|||-3.3|-1.3|
3738050|NCT02028676|3574301|B9|||Weight-for-age Z-score: Period 1 (trial enrollment, CDM vs LCM)|Weight-for-age Z-score at trial enrollment (antiretroviral therapy initiation).|Z-score|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738051|NCT02028676|3574302|B8|||Weight-for-age Z-score: Period 1 (trial enrollment, CDM vs LCM)|Weight-for-age Z-score at trial enrollment (antiretroviral therapy initiation).|Z-score|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738052|NCT02028676|3574303|B7|||Weight-for-age Z-score: Period 1 (trial enrollment, CDM vs LCM)|Weight-for-age Z-score at trial enrollment (antiretroviral therapy initiation).|Z-score|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738053|NCT02028676|3574304|B6|||Weight-for-age Z-score: Period 1 (trial enrollment, CDM vs LCM)|Weight-for-age Z-score at trial enrollment (antiretroviral therapy initiation).|Z-score|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738054|NCT02028676|3574305|B5|||Weight-for-age Z-score: Period 1 (trial enrollment, CDM vs LCM)|Weight-for-age Z-score at trial enrollment (antiretroviral therapy initiation).|Z-score|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738055|NCT02028676|3574306|B4|||Weight-for-age Z-score: Period 1 (trial enrollment, CDM vs LCM)|Weight-for-age Z-score at trial enrollment (antiretroviral therapy initiation).|Z-score|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738056|NCT02028676|3574307|B3|||Weight-for-age Z-score: Period 1 (trial enrollment, CDM vs LCM)|Weight-for-age Z-score at trial enrollment (antiretroviral therapy initiation).|Z-score|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738057|NCT02028676|3574308|B2|||Weight-for-age Z-score: Period 1 (trial enrollment, CDM vs LCM)|Weight-for-age Z-score at trial enrollment (antiretroviral therapy initiation).|Z-score|Median|-2.2|-2.2|Inter-Quartile Range|||-3.3|-1.3|
3738058|NCT02028676|3574309|B1|||Weight-for-age Z-score: Period 1 (trial enrollment, CDM vs LCM)|Weight-for-age Z-score at trial enrollment (antiretroviral therapy initiation).|Z-score|Median|-2.3|-2.3|Inter-Quartile Range|||-3.4|-1.3|
3738059|NCT02028676|3574300|B10|||Duration of antiretroviral therapy: Period 4 (randomization to stop versus continue cotrimoxazole)|Years on antiretroviral therapy at the time of the secondary randomization to stop versus continue cotrimoxazole prophylaxis (in those children eligible and randomized).|years|Median|2.1|2.1|Full Range|||1.6|3.2|
3738060|NCT02028676|3574301|B9|||Duration of antiretroviral therapy: Period 4 (randomization to stop versus continue cotrimoxazole)|Years on antiretroviral therapy at the time of the secondary randomization to stop versus continue cotrimoxazole prophylaxis (in those children eligible and randomized).|years|Median|2.1|2.1|Full Range|||1.8|3.2|
3738061|NCT02028676|3574302|B8|||Duration of antiretroviral therapy: Period 4 (randomization to stop versus continue cotrimoxazole)|Years on antiretroviral therapy at the time of the secondary randomization to stop versus continue cotrimoxazole prophylaxis (in those children eligible and randomized).|years|Median|2.1|2.1|Full Range|||1.6|3.2|
3738062|NCT02028676|3574303|B7|||Duration of antiretroviral therapy: Period 4 (randomization to stop versus continue cotrimoxazole)|Years on antiretroviral therapy at the time of the secondary randomization to stop versus continue cotrimoxazole prophylaxis (in those children eligible and randomized).|years|Median|NA||Full Range|||0.0|0.0|Different randomized comparison
3738063|NCT02028676|3574304|B6|||Duration of antiretroviral therapy: Period 4 (randomization to stop versus continue cotrimoxazole)|Years on antiretroviral therapy at the time of the secondary randomization to stop versus continue cotrimoxazole prophylaxis (in those children eligible and randomized).|years|Median|NA||Full Range|||0.0|0.0|Different randomized comparison
3738064|NCT02028676|3574305|B5|||Duration of antiretroviral therapy: Period 4 (randomization to stop versus continue cotrimoxazole)|Years on antiretroviral therapy at the time of the secondary randomization to stop versus continue cotrimoxazole prophylaxis (in those children eligible and randomized).|years|Median|NA||Full Range|||0.0|0.0|Different randomized comparison
3738065|NCT02028676|3574306|B4|||Duration of antiretroviral therapy: Period 4 (randomization to stop versus continue cotrimoxazole)|Years on antiretroviral therapy at the time of the secondary randomization to stop versus continue cotrimoxazole prophylaxis (in those children eligible and randomized).|years|Median|NA||Full Range|||0.0|0.0|Different randomized comparison
3738066|NCT02028676|3574307|B3|||Duration of antiretroviral therapy: Period 4 (randomization to stop versus continue cotrimoxazole)|Years on antiretroviral therapy at the time of the secondary randomization to stop versus continue cotrimoxazole prophylaxis (in those children eligible and randomized).|years|Median|NA||Full Range|||0.0|0.0|Different randomized comparison
3738067|NCT02028676|3574308|B2|||Duration of antiretroviral therapy: Period 4 (randomization to stop versus continue cotrimoxazole)|Years on antiretroviral therapy at the time of the secondary randomization to stop versus continue cotrimoxazole prophylaxis (in those children eligible and randomized).|years|Median|NA||Full Range|||0.0|0.0|Different randomized comparison
3738068|NCT02028676|3574309|B1|||Duration of antiretroviral therapy: Period 4 (randomization to stop versus continue cotrimoxazole)|Years on antiretroviral therapy at the time of the secondary randomization to stop versus continue cotrimoxazole prophylaxis (in those children eligible and randomized).|years|Median|NA||Full Range|||0.0|0.0|Different randomized comparison
3738069|NCT02028676|3574300|B10|||Duration of antiretroviral therapy: Period 3 (randomization to once vs twice daily ABC+3TC)|Years on antiretroviral therapy at the time of the secondary randomization to once versus twice daily abacavir+lamivudine (in those children eligible and randomized).|years|Median|1.8|1.8|Full Range|||0.9|3.0|
3738070|NCT02028676|3574301|B9|||Duration of antiretroviral therapy: Period 3 (randomization to once vs twice daily ABC+3TC)|Years on antiretroviral therapy at the time of the secondary randomization to once versus twice daily abacavir+lamivudine (in those children eligible and randomized).|years|Median|NA||Full Range|||0.0|0.0|Different randomized comparison
3738071|NCT02028676|3574302|B8|||Duration of antiretroviral therapy: Period 3 (randomization to once vs twice daily ABC+3TC)|Years on antiretroviral therapy at the time of the secondary randomization to once versus twice daily abacavir+lamivudine (in those children eligible and randomized).|years|Median|NA||Full Range|||0.0|0.0|Different randomized comparison
3738072|NCT02028676|3574303|B7|||Duration of antiretroviral therapy: Period 3 (randomization to once vs twice daily ABC+3TC)|Years on antiretroviral therapy at the time of the secondary randomization to once versus twice daily abacavir+lamivudine (in those children eligible and randomized).|years|Median|1.8|1.8|Full Range|||0.9|3.0|
3738073|NCT02028676|3574304|B6|||Duration of antiretroviral therapy: Period 3 (randomization to once vs twice daily ABC+3TC)|Years on antiretroviral therapy at the time of the secondary randomization to once versus twice daily abacavir+lamivudine (in those children eligible and randomized).|years|Median|1.8|1.8|Full Range|||0.9|3.0|
3738074|NCT02028676|3574305|B5|||Duration of antiretroviral therapy: Period 3 (randomization to once vs twice daily ABC+3TC)|Years on antiretroviral therapy at the time of the secondary randomization to once versus twice daily abacavir+lamivudine (in those children eligible and randomized).|years|Median|NA||Full Range|||0.0|0.0|Different randomized comparison
3738075|NCT02028676|3574306|B4|||Duration of antiretroviral therapy: Period 3 (randomization to once vs twice daily ABC+3TC)|Years on antiretroviral therapy at the time of the secondary randomization to once versus twice daily abacavir+lamivudine (in those children eligible and randomized).|years|Median|NA||Full Range|||0.0|0.0|Different randomized comparison
3738076|NCT02028676|3574307|B3|||Duration of antiretroviral therapy: Period 3 (randomization to once vs twice daily ABC+3TC)|Years on antiretroviral therapy at the time of the secondary randomization to once versus twice daily abacavir+lamivudine (in those children eligible and randomized).|years|Median|NA||Full Range|||0.0|0.0|Different randomized comparison
3738077|NCT02028676|3574308|B2|||Duration of antiretroviral therapy: Period 3 (randomization to once vs twice daily ABC+3TC)|Years on antiretroviral therapy at the time of the secondary randomization to once versus twice daily abacavir+lamivudine (in those children eligible and randomized).|years|Median|NA||Full Range|||0.0|0.0|Different randomized comparison
3738078|NCT02028676|3574309|B1|||Duration of antiretroviral therapy: Period 3 (randomization to once vs twice daily ABC+3TC)|Years on antiretroviral therapy at the time of the secondary randomization to once versus twice daily abacavir+lamivudine (in those children eligible and randomized).|years|Median|NA||Full Range|||0.0|0.0|Different randomized comparison
3738079|NCT02028676|3574300|B10|||CD4 T cell percentage: Period 4 (randomization to stop versus continue cotrimoxazole)|CD4 T cell percentage at the time of the secondary randomization to stop versus continue cotrimoxazole prophylaxis (in those children eligible and randomized).|percentage of total lymphocytes|Median|33.0|33.0|Inter-Quartile Range|||26.0|39.0|
3738080|NCT02028676|3574301|B9|||CD4 T cell percentage: Period 4 (randomization to stop versus continue cotrimoxazole)|CD4 T cell percentage at the time of the secondary randomization to stop versus continue cotrimoxazole prophylaxis (in those children eligible and randomized).|percentage of total lymphocytes|Median|32.0|32.0|Inter-Quartile Range|||26.0|39.0|
3738081|NCT02028676|3574302|B8|||CD4 T cell percentage: Period 4 (randomization to stop versus continue cotrimoxazole)|CD4 T cell percentage at the time of the secondary randomization to stop versus continue cotrimoxazole prophylaxis (in those children eligible and randomized).|percentage of total lymphocytes|Median|33.0|33.0|Inter-Quartile Range|||26.0|39.0|
3738082|NCT02028676|3574303|B7|||CD4 T cell percentage: Period 4 (randomization to stop versus continue cotrimoxazole)|CD4 T cell percentage at the time of the secondary randomization to stop versus continue cotrimoxazole prophylaxis (in those children eligible and randomized).|percentage of total lymphocytes|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738083|NCT02028676|3574304|B6|||CD4 T cell percentage: Period 4 (randomization to stop versus continue cotrimoxazole)|CD4 T cell percentage at the time of the secondary randomization to stop versus continue cotrimoxazole prophylaxis (in those children eligible and randomized).|percentage of total lymphocytes|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738084|NCT02028676|3574305|B5|||CD4 T cell percentage: Period 4 (randomization to stop versus continue cotrimoxazole)|CD4 T cell percentage at the time of the secondary randomization to stop versus continue cotrimoxazole prophylaxis (in those children eligible and randomized).|percentage of total lymphocytes|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738085|NCT02028676|3574306|B4|||CD4 T cell percentage: Period 4 (randomization to stop versus continue cotrimoxazole)|CD4 T cell percentage at the time of the secondary randomization to stop versus continue cotrimoxazole prophylaxis (in those children eligible and randomized).|percentage of total lymphocytes|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738086|NCT02028676|3574307|B3|||CD4 T cell percentage: Period 4 (randomization to stop versus continue cotrimoxazole)|CD4 T cell percentage at the time of the secondary randomization to stop versus continue cotrimoxazole prophylaxis (in those children eligible and randomized).|percentage of total lymphocytes|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738087|NCT02028676|3574308|B2|||CD4 T cell percentage: Period 4 (randomization to stop versus continue cotrimoxazole)|CD4 T cell percentage at the time of the secondary randomization to stop versus continue cotrimoxazole prophylaxis (in those children eligible and randomized).|percentage of total lymphocytes|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738088|NCT02028676|3574309|B1|||CD4 T cell percentage: Period 4 (randomization to stop versus continue cotrimoxazole)|CD4 T cell percentage at the time of the secondary randomization to stop versus continue cotrimoxazole prophylaxis (in those children eligible and randomized).|percentage of total lymphocytes|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738089|NCT02028676|3574300|B10|||CD4 T cell percentage: Period 3 (randomization to once vs twice daily ABC+3TC)|CD4 T cell percentage at the time of the secondary randomization to once versus twice daily abacavir+lamivudine (in those children eligible and randomized).|percentage of total lymphocytes|Median|33.0|33.0|Inter-Quartile Range|||28.0|39.0|
3738090|NCT02028676|3574301|B9|||CD4 T cell percentage: Period 3 (randomization to once vs twice daily ABC+3TC)|CD4 T cell percentage at the time of the secondary randomization to once versus twice daily abacavir+lamivudine (in those children eligible and randomized).|percentage of total lymphocytes|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738091|NCT02028676|3574302|B8|||CD4 T cell percentage: Period 3 (randomization to once vs twice daily ABC+3TC)|CD4 T cell percentage at the time of the secondary randomization to once versus twice daily abacavir+lamivudine (in those children eligible and randomized).|percentage of total lymphocytes|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738092|NCT02028676|3574303|B7|||CD4 T cell percentage: Period 3 (randomization to once vs twice daily ABC+3TC)|CD4 T cell percentage at the time of the secondary randomization to once versus twice daily abacavir+lamivudine (in those children eligible and randomized).|percentage of total lymphocytes|Median|33.0|33.0|Inter-Quartile Range|||27.0|39.0|
3738433|NCT02027883|3574535|B1||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3738093|NCT02028676|3574304|B6|||CD4 T cell percentage: Period 3 (randomization to once vs twice daily ABC+3TC)|CD4 T cell percentage at the time of the secondary randomization to once versus twice daily abacavir+lamivudine (in those children eligible and randomized).|percentage of total lymphocytes|Median|33.0|33.0|Inter-Quartile Range|||28.0|39.0|
3738094|NCT02028676|3574305|B5|||CD4 T cell percentage: Period 3 (randomization to once vs twice daily ABC+3TC)|CD4 T cell percentage at the time of the secondary randomization to once versus twice daily abacavir+lamivudine (in those children eligible and randomized).|percentage of total lymphocytes|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738095|NCT02028676|3574306|B4|||CD4 T cell percentage: Period 3 (randomization to once vs twice daily ABC+3TC)|CD4 T cell percentage at the time of the secondary randomization to once versus twice daily abacavir+lamivudine (in those children eligible and randomized).|percentage of total lymphocytes|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738096|NCT02028676|3574307|B3|||CD4 T cell percentage: Period 3 (randomization to once vs twice daily ABC+3TC)|CD4 T cell percentage at the time of the secondary randomization to once versus twice daily abacavir+lamivudine (in those children eligible and randomized).|percentage of total lymphocytes|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738097|NCT02028676|3574308|B2|||CD4 T cell percentage: Period 3 (randomization to once vs twice daily ABC+3TC)|CD4 T cell percentage at the time of the secondary randomization to once versus twice daily abacavir+lamivudine (in those children eligible and randomized).|percentage of total lymphocytes|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738098|NCT02028676|3574309|B1|||CD4 T cell percentage: Period 3 (randomization to once vs twice daily ABC+3TC)|CD4 T cell percentage at the time of the secondary randomization to once versus twice daily abacavir+lamivudine (in those children eligible and randomized).|percentage of total lymphocytes|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738099|NCT02028676|3574300|B10|||CD4 T cell percentage: Period 2 (trial enrollment, induction ART)|CD4 T cell percentage at trial enrollment (antiretroviral therapy initiation).|percentage of total lymphocytes|Median|12.0|12.0|Inter-Quartile Range|||7.3|17.1|
3738100|NCT02028676|3574301|B9|||CD4 T cell percentage: Period 2 (trial enrollment, induction ART)|CD4 T cell percentage at trial enrollment (antiretroviral therapy initiation).|percentage of total lymphocytes|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738101|NCT02028676|3574302|B8|||CD4 T cell percentage: Period 2 (trial enrollment, induction ART)|CD4 T cell percentage at trial enrollment (antiretroviral therapy initiation).|percentage of total lymphocytes|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738102|NCT02028676|3574303|B7|||CD4 T cell percentage: Period 2 (trial enrollment, induction ART)|CD4 T cell percentage at trial enrollment (antiretroviral therapy initiation).|percentage of total lymphocytes|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738103|NCT02028676|3574304|B6|||CD4 T cell percentage: Period 2 (trial enrollment, induction ART)|CD4 T cell percentage at trial enrollment (antiretroviral therapy initiation).|percentage of total lymphocytes|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738104|NCT02028676|3574305|B5|||CD4 T cell percentage: Period 2 (trial enrollment, induction ART)|CD4 T cell percentage at trial enrollment (antiretroviral therapy initiation).|percentage of total lymphocytes|Median|12.5|12.5|Inter-Quartile Range|||8.0|17.0|
3738105|NCT02028676|3574306|B4|||CD4 T cell percentage: Period 2 (trial enrollment, induction ART)|CD4 T cell percentage at trial enrollment (antiretroviral therapy initiation).|percentage of total lymphocytes|Median|12.0|12.0|Inter-Quartile Range|||7.1|17.0|
3738106|NCT02028676|3574307|B3|||CD4 T cell percentage: Period 2 (trial enrollment, induction ART)|CD4 T cell percentage at trial enrollment (antiretroviral therapy initiation).|percentage of total lymphocytes|Median|11.7|11.7|Inter-Quartile Range|||6.9|17.5|
3738107|NCT02028676|3574308|B2|||CD4 T cell percentage: Period 2 (trial enrollment, induction ART)|CD4 T cell percentage at trial enrollment (antiretroviral therapy initiation).|percentage of total lymphocytes|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738108|NCT02028676|3574309|B1|||CD4 T cell percentage: Period 2 (trial enrollment, induction ART)|CD4 T cell percentage at trial enrollment (antiretroviral therapy initiation).|percentage of total lymphocytes|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738109|NCT02028676|3574300|B10|||CD4 T cell percentage|CD4 T cell percentage at trial enrollment (antiretroviral therapy initiation).|percentage of total lymphocytes|Median|12.0|12.0|Inter-Quartile Range|||7.3|17.1|
3738110|NCT02028676|3574301|B9|||CD4 T cell percentage|CD4 T cell percentage at trial enrollment (antiretroviral therapy initiation).|percentage of total lymphocytes|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738111|NCT02028676|3574302|B8|||CD4 T cell percentage|CD4 T cell percentage at trial enrollment (antiretroviral therapy initiation).|percentage of total lymphocytes|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738112|NCT02028676|3574303|B7|||CD4 T cell percentage|CD4 T cell percentage at trial enrollment (antiretroviral therapy initiation).|percentage of total lymphocytes|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738113|NCT02028676|3574304|B6|||CD4 T cell percentage|CD4 T cell percentage at trial enrollment (antiretroviral therapy initiation).|percentage of total lymphocytes|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738114|NCT02028676|3574305|B5|||CD4 T cell percentage|CD4 T cell percentage at trial enrollment (antiretroviral therapy initiation).|percentage of total lymphocytes|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738115|NCT02028676|3574306|B4|||CD4 T cell percentage|CD4 T cell percentage at trial enrollment (antiretroviral therapy initiation).|percentage of total lymphocytes|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738116|NCT02028676|3574307|B3|||CD4 T cell percentage|CD4 T cell percentage at trial enrollment (antiretroviral therapy initiation).|percentage of total lymphocytes|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738117|NCT02028676|3574308|B2|||CD4 T cell percentage|CD4 T cell percentage at trial enrollment (antiretroviral therapy initiation).|percentage of total lymphocytes|Median|12.0|12.0|Inter-Quartile Range|||7.0|17.0|
3738118|NCT02028676|3574309|B1|||CD4 T cell percentage|CD4 T cell percentage at trial enrollment (antiretroviral therapy initiation).|percentage of total lymphocytes|Median|12.5|12.5|Inter-Quartile Range|||7.5|17.3|
3738119|NCT02028676|3574300|B10|Zimbabwe||Region of Enrollment: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3738120|NCT02028676|3574301|B9|Zimbabwe||Region of Enrollment: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|96|96.0||||||
3738121|NCT02028676|3574302|B8|Zimbabwe||Region of Enrollment: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|93|93.0||||||
3738122|NCT02028676|3574303|B7|Zimbabwe||Region of Enrollment: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738123|NCT02028676|3574304|B6|Zimbabwe||Region of Enrollment: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738124|NCT02028676|3574305|B5|Zimbabwe||Region of Enrollment: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738125|NCT02028676|3574306|B4|Zimbabwe||Region of Enrollment: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738126|NCT02028676|3574307|B3|Zimbabwe||Region of Enrollment: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738127|NCT02028676|3574308|B2|Zimbabwe||Region of Enrollment: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738128|NCT02028676|3574309|B1|Zimbabwe||Region of Enrollment: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738129|NCT02028676|3574300|B10|Uganda||Region of Enrollment: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3738130|NCT02028676|3574301|B9|Uganda||Region of Enrollment: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|286|286.0||||||
3738131|NCT02028676|3574302|B8|Uganda||Region of Enrollment: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|283|283.0||||||
3738132|NCT02028676|3574303|B7|Uganda||Region of Enrollment: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738133|NCT02028676|3574304|B6|Uganda||Region of Enrollment: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738134|NCT02028676|3574305|B5|Uganda||Region of Enrollment: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738135|NCT02028676|3574306|B4|Uganda||Region of Enrollment: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738136|NCT02028676|3574307|B3|Uganda||Region of Enrollment: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738137|NCT02028676|3574308|B2|Uganda||Region of Enrollment: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738138|NCT02028676|3574309|B1|Uganda||Region of Enrollment: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738139|NCT02028676|3574300|B10|Zimbabwe||Region of Enrollment: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3738140|NCT02028676|3574301|B9|Zimbabwe||Region of Enrollment: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738141|NCT02028676|3574302|B8|Zimbabwe||Region of Enrollment: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738142|NCT02028676|3574303|B7|Zimbabwe||Region of Enrollment: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|87|87.0||||||
3738143|NCT02028676|3574304|B6|Zimbabwe||Region of Enrollment: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|87|87.0||||||
3738144|NCT02028676|3574305|B5|Zimbabwe||Region of Enrollment: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738145|NCT02028676|3574306|B4|Zimbabwe||Region of Enrollment: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738146|NCT02028676|3574307|B3|Zimbabwe||Region of Enrollment: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparisonDifferent randomized comparison
3738147|NCT02028676|3574308|B2|Zimbabwe||Region of Enrollment: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738148|NCT02028676|3574309|B1|Zimbabwe||Region of Enrollment: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738149|NCT02028676|3574300|B10|Uganda||Region of Enrollment: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3738150|NCT02028676|3574301|B9|Uganda||Region of Enrollment: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738151|NCT02028676|3574302|B8|Uganda||Region of Enrollment: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738152|NCT02028676|3574303|B7|Uganda||Region of Enrollment: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|246|246.0||||||
3738153|NCT02028676|3574304|B6|Uganda||Region of Enrollment: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|249|249.0||||||
3738154|NCT02028676|3574305|B5|Uganda||Region of Enrollment: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738155|NCT02028676|3574306|B4|Uganda||Region of Enrollment: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738156|NCT02028676|3574307|B3|Uganda||Region of Enrollment: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738157|NCT02028676|3574308|B2|Uganda||Region of Enrollment: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738158|NCT02028676|3574309|B1|Uganda||Region of Enrollment: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738159|NCT02028676|3574300|B10|Zimbabwe||Region of Enrollment: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3738160|NCT02028676|3574301|B9|Zimbabwe||Region of Enrollment: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Different randomized comparison
3738161|NCT02028676|3574302|B8|Zimbabwe||Region of Enrollment: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Different randomized comparison
3738162|NCT02028676|3574303|B7|Zimbabwe||Region of Enrollment: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Different randomized comparison
3738163|NCT02028676|3574304|B6|Zimbabwe||Region of Enrollment: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Different randomized comparison
3738164|NCT02028676|3574305|B5|Zimbabwe||Region of Enrollment: Period 2 (trial enrollment, induction ART)||participants|Number|133|133.0||||||
3738165|NCT02028676|3574306|B4|Zimbabwe||Region of Enrollment: Period 2 (trial enrollment, induction ART)||participants|Number|136|136.0||||||
3738166|NCT02028676|3574307|B3|Zimbabwe||Region of Enrollment: Period 2 (trial enrollment, induction ART)||participants|Number|131|131.0||||||
3738167|NCT02028676|3574308|B2|Zimbabwe||Region of Enrollment: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Different randomized comparison
3738168|NCT02028676|3574309|B1|Zimbabwe||Region of Enrollment: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Different randomized comparison
3738169|NCT02028676|3574300|B10|Uganda||Region of Enrollment: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3738170|NCT02028676|3574301|B9|Uganda||Region of Enrollment: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Different randomized comparisonDifferent randomized comparison
3738171|NCT02028676|3574302|B8|Uganda||Region of Enrollment: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Different randomized comparison
3738172|NCT02028676|3574303|B7|Uganda||Region of Enrollment: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Different randomized comparison
3738173|NCT02028676|3574304|B6|Uganda||Region of Enrollment: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Different randomized comparison
3738174|NCT02028676|3574305|B5|Uganda||Region of Enrollment: Period 2 (trial enrollment, induction ART)||participants|Number|272|272.0||||||
3738175|NCT02028676|3574306|B4|Uganda||Region of Enrollment: Period 2 (trial enrollment, induction ART)||participants|Number|268|268.0||||||
3738176|NCT02028676|3574307|B3|Uganda||Region of Enrollment: Period 2 (trial enrollment, induction ART)||participants|Number|266|266.0||||||
3738177|NCT02028676|3574308|B2|Uganda||Region of Enrollment: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Different randomized comparison
3738178|NCT02028676|3574309|B1|Uganda||Region of Enrollment: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Different randomized comparison
3738179|NCT02028676|3574300|B10|Male||Gender, Male/Female: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3738180|NCT02028676|3574301|B9|Male||Gender, Male/Female: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|179|179.0||||||
3738181|NCT02028676|3574302|B8|Male||Gender, Male/Female: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|181|181.0||||||
3738182|NCT02028676|3574303|B7|Male||Gender, Male/Female: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738183|NCT02028676|3574304|B6|Male||Gender, Male/Female: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738184|NCT02028676|3574305|B5|Male||Gender, Male/Female: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparisonDifferent randomized comparison
3738185|NCT02028676|3574306|B4|Male||Gender, Male/Female: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738186|NCT02028676|3574307|B3|Male||Gender, Male/Female: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738187|NCT02028676|3574308|B2|Male||Gender, Male/Female: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738188|NCT02028676|3574309|B1|Male||Gender, Male/Female: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738189|NCT02028676|3574300|B10|Female||Gender, Male/Female: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3738190|NCT02028676|3574301|B9|Female||Gender, Male/Female: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|203|203.0||||||
3738191|NCT02028676|3574302|B8|Female||Gender, Male/Female: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|195|195.0||||||
3738192|NCT02028676|3574303|B7|Female||Gender, Male/Female: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738193|NCT02028676|3574304|B6|Female||Gender, Male/Female: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738194|NCT02028676|3574305|B5|Female||Gender, Male/Female: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738195|NCT02028676|3574306|B4|Female||Gender, Male/Female: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738196|NCT02028676|3574307|B3|Female||Gender, Male/Female: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738197|NCT02028676|3574308|B2|Female||Gender, Male/Female: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738198|NCT02028676|3574309|B1|Female||Gender, Male/Female: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738199|NCT02028676|3574300|B10|Male||Gender, Male/Female: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3738200|NCT02028676|3574301|B9|Male||Gender, Male/Female: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738201|NCT02028676|3574302|B8|Male||Gender, Male/Female: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738202|NCT02028676|3574303|B7|Male||Gender, Male/Female: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|161|161.0||||||
3738203|NCT02028676|3574304|B6|Male||Gender, Male/Female: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|163|163.0||||||
3738204|NCT02028676|3574305|B5|Male||Gender, Male/Female: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738205|NCT02028676|3574306|B4|Male||Gender, Male/Female: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738206|NCT02028676|3574307|B3|Male||Gender, Male/Female: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738207|NCT02028676|3574308|B2|Male||Gender, Male/Female: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738208|NCT02028676|3574309|B1|Male||Gender, Male/Female: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738209|NCT02028676|3574300|B10|Female||Gender, Male/Female: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3738210|NCT02028676|3574301|B9|Female||Gender, Male/Female: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738211|NCT02028676|3574302|B8|Female||Gender, Male/Female: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738212|NCT02028676|3574303|B7|Female||Gender, Male/Female: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|172|172.0||||||
3738213|NCT02028676|3574304|B6|Female||Gender, Male/Female: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|173|173.0||||||
3738214|NCT02028676|3574305|B5|Female||Gender, Male/Female: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738215|NCT02028676|3574306|B4|Female||Gender, Male/Female: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738216|NCT02028676|3574307|B3|Female||Gender, Male/Female: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738217|NCT02028676|3574308|B2|Female||Gender, Male/Female: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738218|NCT02028676|3574309|B1|Female||Gender, Male/Female: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738219|NCT02028676|3574300|B10|Male||Gender, Male/Female: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3738220|NCT02028676|3574301|B9|Male||Gender, Male/Female: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Different randomized comparison
3738221|NCT02028676|3574302|B8|Male||Gender, Male/Female: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Different randomized comparison
3738222|NCT02028676|3574303|B7|Male||Gender, Male/Female: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Different randomized comparison
3738223|NCT02028676|3574304|B6|Male||Gender, Male/Female: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Different randomized comparison
3738224|NCT02028676|3574305|B5|Male||Gender, Male/Female: Period 2 (trial enrollment, induction ART)||participants|Number|196|196.0||||||
3738225|NCT02028676|3574306|B4|Male||Gender, Male/Female: Period 2 (trial enrollment, induction ART)||participants|Number|207|207.0||||||
3738226|NCT02028676|3574307|B3|Male||Gender, Male/Female: Period 2 (trial enrollment, induction ART)||participants|Number|193|193.0||||||
3738227|NCT02028676|3574308|B2|Male||Gender, Male/Female: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Different randomized comparison
3738228|NCT02028676|3574309|B1|Male||Gender, Male/Female: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Different randomized comparison
3738229|NCT02028676|3574300|B10|Female||Gender, Male/Female: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3738230|NCT02028676|3574301|B9|Female||Gender, Male/Female: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Different randomized comparison
3738231|NCT02028676|3574302|B8|Female||Gender, Male/Female: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Different randomized comparison
3738232|NCT02028676|3574303|B7|Female||Gender, Male/Female: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Different randomized comparison
3738233|NCT02028676|3574304|B6|Female||Gender, Male/Female: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Different randomized comparison
3738234|NCT02028676|3574305|B5|Female||Gender, Male/Female: Period 2 (trial enrollment, induction ART)||participants|Number|209|209.0||||||
3738235|NCT02028676|3574306|B4|Female||Gender, Male/Female: Period 2 (trial enrollment, induction ART)||participants|Number|197|197.0||||||
3738236|NCT02028676|3574307|B3|Female||Gender, Male/Female: Period 2 (trial enrollment, induction ART)||participants|Number|204|204.0||||||
3738237|NCT02028676|3574308|B2|Female||Gender, Male/Female: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Different randomized comparison
3738238|NCT02028676|3574309|B1|Female||Gender, Male/Female: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Different randomized comparison
3738434|NCT02027883|3574533|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738239|NCT02028676|3574300|B10|3 years and older||Age, categorical: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3738240|NCT02028676|3574301|B9|3 years and older||Age, categorical: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|382|382.0||||||
3738241|NCT02028676|3574302|B8|3 years and older||Age, categorical: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|376|376.0||||||
3738242|NCT02028676|3574303|B7|3 years and older||Age, categorical: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738243|NCT02028676|3574304|B6|3 years and older||Age, categorical: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738244|NCT02028676|3574305|B5|3 years and older||Age, categorical: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738245|NCT02028676|3574306|B4|3 years and older||Age, categorical: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738246|NCT02028676|3574307|B3|3 years and older||Age, categorical: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738247|NCT02028676|3574308|B2|3 years and older||Age, categorical: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738248|NCT02028676|3574309|B1|3 years and older||Age, categorical: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738249|NCT02028676|3574300|B10|<3 years||Age, categorical: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3738250|NCT02028676|3574301|B9|<3 years||Age, categorical: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|0|0.0||||||
3738251|NCT02028676|3574302|B8|<3 years||Age, categorical: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|0|0.0||||||
3738252|NCT02028676|3574303|B7|<3 years||Age, categorical: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738253|NCT02028676|3574304|B6|<3 years||Age, categorical: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738254|NCT02028676|3574305|B5|<3 years||Age, categorical: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738255|NCT02028676|3574306|B4|<3 years||Age, categorical: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738256|NCT02028676|3574307|B3|<3 years||Age, categorical: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738257|NCT02028676|3574308|B2|<3 years||Age, categorical: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738258|NCT02028676|3574309|B1|<3 years||Age, categorical: Period 4 (randomization to stop versus continue cotrimoxazole)||participants|Number|NA|||||||Different randomized comparison
3738259|NCT02028676|3574300|B10|3 years and older||Age, categorical: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3738260|NCT02028676|3574301|B9|3 years and older||Age, categorical: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738261|NCT02028676|3574302|B8|3 years and older||Age, categorical: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738262|NCT02028676|3574303|B7|3 years and older||Age, categorical: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|295|295.0||||||
3738263|NCT02028676|3574304|B6|3 years and older||Age, categorical: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|300|300.0||||||
3738264|NCT02028676|3574305|B5|3 years and older||Age, categorical: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738265|NCT02028676|3574306|B4|3 years and older||Age, categorical: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738266|NCT02028676|3574307|B3|3 years and older||Age, categorical: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738267|NCT02028676|3574308|B2|3 years and older||Age, categorical: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738268|NCT02028676|3574309|B1|3 years and older||Age, categorical: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738269|NCT02028676|3574300|B10|<3 years||Age, categorical: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3738270|NCT02028676|3574301|B9|<3 years||Age, categorical: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738271|NCT02028676|3574302|B8|<3 years||Age, categorical: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738272|NCT02028676|3574303|B7|<3 years||Age, categorical: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|38|38.0||||||
3738273|NCT02028676|3574304|B6|<3 years||Age, categorical: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|36|36.0||||||
3738274|NCT02028676|3574305|B5|<3 years||Age, categorical: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738275|NCT02028676|3574306|B4|<3 years||Age, categorical: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738276|NCT02028676|3574307|B3|<3 years||Age, categorical: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738277|NCT02028676|3574308|B2|<3 years||Age, categorical: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738278|NCT02028676|3574309|B1|<3 years||Age, categorical: Period 3 (randomization to once vs twice daily ABC+3TC)||participants|Number|NA|||||||Different randomized comparison
3738279|NCT02028676|3574300|B10|3 years or older||Age, categorical: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3738280|NCT02028676|3574301|B9|3 years or older||Age, categorical: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Different randomized comparison
3738281|NCT02028676|3574302|B8|3 years or older||Age, categorical: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Different randomized comparison
3738282|NCT02028676|3574303|B7|3 years or older||Age, categorical: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Different randomized comparison
3738283|NCT02028676|3574304|B6|3 years or older||Age, categorical: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Different randomized comparison
3738284|NCT02028676|3574305|B5|3 years or older||Age, categorical: Period 2 (trial enrollment, induction ART)||participants|Number|273|273.0||||||
3738285|NCT02028676|3574306|B4|3 years or older||Age, categorical: Period 2 (trial enrollment, induction ART)||participants|Number|287|287.0||||||
3738286|NCT02028676|3574307|B3|3 years or older||Age, categorical: Period 2 (trial enrollment, induction ART)||participants|Number|276|276.0||||||
3738287|NCT02028676|3574308|B2|3 years or older||Age, categorical: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Different randomized comparison
3738288|NCT02028676|3574309|B1|3 years or older||Age, categorical: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Different randomized comparison
3738289|NCT02028676|3574300|B10|<3 years||Age, categorical: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3738290|NCT02028676|3574301|B9|<3 years||Age, categorical: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Different randomized comparison
3738291|NCT02028676|3574302|B8|<3 years||Age, categorical: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Different randomized comparison
3738292|NCT02028676|3574303|B7|<3 years||Age, categorical: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Different randomized comparison
3738293|NCT02028676|3574304|B6|<3 years||Age, categorical: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Different randomized comparison
3738294|NCT02028676|3574305|B5|<3 years||Age, categorical: Period 2 (trial enrollment, induction ART)||participants|Number|132|132.0||||||
3738295|NCT02028676|3574306|B4|<3 years||Age, categorical: Period 2 (trial enrollment, induction ART)||participants|Number|117|117.0||||||
3738296|NCT02028676|3574307|B3|<3 years||Age, categorical: Period 2 (trial enrollment, induction ART)||participants|Number|121|121.0||||||
3738297|NCT02028676|3574308|B2|<3 years||Age, categorical: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Different randomized comparison
3738298|NCT02028676|3574309|B1|<3 years||Age, categorical: Period 2 (trial enrollment, induction ART)||participants|Number|NA|||||||Different randomized comparison
3738299|NCT02028676|3574300|B10|||Age, continuous: Period 4 (randomization to stop versus continue cotrimoxazole)|Age at the time of the secondary randomization to stop versus continue cotrimoxazole prophylaxis (in those children eligible and randomized).|years|Median|7.9|7.9|Inter-Quartile Range|||4.6|11.1|
3738300|NCT02028676|3574301|B9|||Age, continuous: Period 4 (randomization to stop versus continue cotrimoxazole)|Age at the time of the secondary randomization to stop versus continue cotrimoxazole prophylaxis (in those children eligible and randomized).|years|Median|8.3|8.3|Inter-Quartile Range|||4.5|11.0|
3738301|NCT02028676|3574302|B8|||Age, continuous: Period 4 (randomization to stop versus continue cotrimoxazole)|Age at the time of the secondary randomization to stop versus continue cotrimoxazole prophylaxis (in those children eligible and randomized).|years|Median|7.5|7.5|Inter-Quartile Range|||4.6|11.1|
3738302|NCT02028676|3574303|B7|||Age, continuous: Period 4 (randomization to stop versus continue cotrimoxazole)|Age at the time of the secondary randomization to stop versus continue cotrimoxazole prophylaxis (in those children eligible and randomized).|years|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738303|NCT02028676|3574304|B6|||Age, continuous: Period 4 (randomization to stop versus continue cotrimoxazole)|Age at the time of the secondary randomization to stop versus continue cotrimoxazole prophylaxis (in those children eligible and randomized).|years|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738304|NCT02028676|3574305|B5|||Age, continuous: Period 4 (randomization to stop versus continue cotrimoxazole)|Age at the time of the secondary randomization to stop versus continue cotrimoxazole prophylaxis (in those children eligible and randomized).|years|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738305|NCT02028676|3574306|B4|||Age, continuous: Period 4 (randomization to stop versus continue cotrimoxazole)|Age at the time of the secondary randomization to stop versus continue cotrimoxazole prophylaxis (in those children eligible and randomized).|years|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738306|NCT02028676|3574307|B3|||Age, continuous: Period 4 (randomization to stop versus continue cotrimoxazole)|Age at the time of the secondary randomization to stop versus continue cotrimoxazole prophylaxis (in those children eligible and randomized).|years|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738307|NCT02028676|3574308|B2|||Age, continuous: Period 4 (randomization to stop versus continue cotrimoxazole)|Age at the time of the secondary randomization to stop versus continue cotrimoxazole prophylaxis (in those children eligible and randomized).|years|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738308|NCT02028676|3574309|B1|||Age, continuous: Period 4 (randomization to stop versus continue cotrimoxazole)|Age at the time of the secondary randomization to stop versus continue cotrimoxazole prophylaxis (in those children eligible and randomized).|years|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738309|NCT02028676|3574300|B10|||Age, continuous: Period 3 (randomization to once vs twice daily ABC+3TC)|Age at the time of the secondary randomization to once versus twice daily abacavir+lamivudine (in those children eligible and randomized).|years|Median|5.5|5.5|Inter-Quartile Range|||3.7|8.5|
3738310|NCT02028676|3574301|B9|||Age, continuous: Period 3 (randomization to once vs twice daily ABC+3TC)|Age at the time of the secondary randomization to once versus twice daily abacavir+lamivudine (in those children eligible and randomized).|years|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738311|NCT02028676|3574302|B8|||Age, continuous: Period 3 (randomization to once vs twice daily ABC+3TC)|Age at the time of the secondary randomization to once versus twice daily abacavir+lamivudine (in those children eligible and randomized).|years|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738312|NCT02028676|3574303|B7|||Age, continuous: Period 3 (randomization to once vs twice daily ABC+3TC)|Age at the time of the secondary randomization to once versus twice daily abacavir+lamivudine (in those children eligible and randomized).|years|Median|5.1|5.1|Inter-Quartile Range|||3.6|8.3|
3738313|NCT02028676|3574304|B6|||Age, continuous: Period 3 (randomization to once vs twice daily ABC+3TC)|Age at the time of the secondary randomization to once versus twice daily abacavir+lamivudine (in those children eligible and randomized).|years|Median|5.9|5.9|Inter-Quartile Range|||3.8|8.6|
3738314|NCT02028676|3574305|B5|||Age, continuous: Period 3 (randomization to once vs twice daily ABC+3TC)|Age at the time of the secondary randomization to once versus twice daily abacavir+lamivudine (in those children eligible and randomized).|years|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738315|NCT02028676|3574306|B4|||Age, continuous: Period 3 (randomization to once vs twice daily ABC+3TC)|Age at the time of the secondary randomization to once versus twice daily abacavir+lamivudine (in those children eligible and randomized).|years|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738316|NCT02028676|3574307|B3|||Age, continuous: Period 3 (randomization to once vs twice daily ABC+3TC)|Age at the time of the secondary randomization to once versus twice daily abacavir+lamivudine (in those children eligible and randomized).|years|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738317|NCT02028676|3574308|B2|||Age, continuous: Period 3 (randomization to once vs twice daily ABC+3TC)|Age at the time of the secondary randomization to once versus twice daily abacavir+lamivudine (in those children eligible and randomized).|years|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738318|NCT02028676|3574309|B1|||Age, continuous: Period 3 (randomization to once vs twice daily ABC+3TC)|Age at the time of the secondary randomization to once versus twice daily abacavir+lamivudine (in those children eligible and randomized).|years|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738319|NCT02028676|3574300|B10|||Age, continuous: Period 2 (trial enrollment, induction ART)|Age at trial enrollment (antiretroviral therapy initiation).|years|Median|6.0|6.0|Inter-Quartile Range|||2.4|9.4|
3738320|NCT02028676|3574301|B9|||Age, continuous: Period 2 (trial enrollment, induction ART)|Age at trial enrollment (antiretroviral therapy initiation).|years|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738321|NCT02028676|3574302|B8|||Age, continuous: Period 2 (trial enrollment, induction ART)|Age at trial enrollment (antiretroviral therapy initiation).|years|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738322|NCT02028676|3574303|B7|||Age, continuous: Period 2 (trial enrollment, induction ART)|Age at trial enrollment (antiretroviral therapy initiation).|years|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738323|NCT02028676|3574304|B6|||Age, continuous: Period 2 (trial enrollment, induction ART)|Age at trial enrollment (antiretroviral therapy initiation).|years|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738324|NCT02028676|3574305|B5|||Age, continuous: Period 2 (trial enrollment, induction ART)|Age at trial enrollment (antiretroviral therapy initiation).|years|Median|5.7|5.7|Inter-Quartile Range|||2.3|9.3|
3738325|NCT02028676|3574306|B4|||Age, continuous: Period 2 (trial enrollment, induction ART)|Age at trial enrollment (antiretroviral therapy initiation).|years|Median|6.2|6.2|Inter-Quartile Range|||2.5|9.4|
3738326|NCT02028676|3574307|B3|||Age, continuous: Period 2 (trial enrollment, induction ART)|Age at trial enrollment (antiretroviral therapy initiation).|years|Median|6.1|6.1|Inter-Quartile Range|||2.4|9.3|
3738327|NCT02028676|3574308|B2|||Age, continuous: Period 2 (trial enrollment, induction ART)|Age at trial enrollment (antiretroviral therapy initiation).|years|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738328|NCT02028676|3574309|B1|||Age, continuous: Period 2 (trial enrollment, induction ART)|Age at trial enrollment (antiretroviral therapy initiation).|years|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738329|NCT02028676|3574300|B10|Zimbabwe||Region of Enrollment|Region of enrollment at trial enrollment (antiretroviral therapy initiation).|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3738330|NCT02028676|3574301|B9|Zimbabwe||Region of Enrollment|Region of enrollment at trial enrollment (antiretroviral therapy initiation).|participants|Number|NA|||||||Different randomized comparison
3738331|NCT02028676|3574302|B8|Zimbabwe||Region of Enrollment|Region of enrollment at trial enrollment (antiretroviral therapy initiation).|participants|Number|NA|||||||Different randomized comparison
3738332|NCT02028676|3574303|B7|Zimbabwe||Region of Enrollment|Region of enrollment at trial enrollment (antiretroviral therapy initiation).|participants|Number|NA|||||||Different randomized comparison
3738333|NCT02028676|3574304|B6|Zimbabwe||Region of Enrollment|Region of enrollment at trial enrollment (antiretroviral therapy initiation).|participants|Number|NA|||||||Different randomized comparison
3738334|NCT02028676|3574305|B5|Zimbabwe||Region of Enrollment|Region of enrollment at trial enrollment (antiretroviral therapy initiation).|participants|Number|NA|||||||Different randomized comparison
3738335|NCT02028676|3574306|B4|Zimbabwe||Region of Enrollment|Region of enrollment at trial enrollment (antiretroviral therapy initiation).|participants|Number|NA|||||||Different randomized comparison
3738336|NCT02028676|3574307|B3|Zimbabwe||Region of Enrollment|Region of enrollment at trial enrollment (antiretroviral therapy initiation).|participants|Number|NA|||||||Different randomized comparison
3738337|NCT02028676|3574308|B2|Zimbabwe||Region of Enrollment|Region of enrollment at trial enrollment (antiretroviral therapy initiation).|participants|Number|199|199.0||||||
3738338|NCT02028676|3574309|B1|Zimbabwe||Region of Enrollment|Region of enrollment at trial enrollment (antiretroviral therapy initiation).|participants|Number|201|201.0||||||
3738435|NCT02027883|3574534|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738339|NCT02028676|3574300|B10|Uganda||Region of Enrollment|Region of enrollment at trial enrollment (antiretroviral therapy initiation).|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3738340|NCT02028676|3574301|B9|Uganda||Region of Enrollment|Region of enrollment at trial enrollment (antiretroviral therapy initiation).|participants|Number|NA|||||||Different randomized comparison
3738341|NCT02028676|3574302|B8|Uganda||Region of Enrollment|Region of enrollment at trial enrollment (antiretroviral therapy initiation).|participants|Number|NA|||||||Different randomized comparison
3738342|NCT02028676|3574303|B7|Uganda||Region of Enrollment|Region of enrollment at trial enrollment (antiretroviral therapy initiation).|participants|Number|NA|||||||Different randomized comparison
3738343|NCT02028676|3574304|B6|Uganda||Region of Enrollment|Region of enrollment at trial enrollment (antiretroviral therapy initiation).|participants|Number|NA|||||||Different randomized comparisonDifferent randomized comparison
3738344|NCT02028676|3574305|B5|Uganda||Region of Enrollment|Region of enrollment at trial enrollment (antiretroviral therapy initiation).|participants|Number|NA|||||||Different randomized comparison
3738345|NCT02028676|3574306|B4|Uganda||Region of Enrollment|Region of enrollment at trial enrollment (antiretroviral therapy initiation).|participants|Number|NA|||||||Different randomized comparison
3738346|NCT02028676|3574307|B3|Uganda||Region of Enrollment|Region of enrollment at trial enrollment (antiretroviral therapy initiation).|participants|Number|NA|||||||Different randomized comparison
3738347|NCT02028676|3574308|B2|Uganda||Region of Enrollment|Region of enrollment at trial enrollment (antiretroviral therapy initiation).|participants|Number|401|401.0||||||
3738348|NCT02028676|3574309|B1|Uganda||Region of Enrollment|Region of enrollment at trial enrollment (antiretroviral therapy initiation).|participants|Number|405|405.0||||||
3738349|NCT02028676|3574300|B10||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3738350|NCT02028676|3574301|B9||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Different randomized comparison
3738351|NCT02028676|3574302|B8||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Different randomized comparison
3738352|NCT02028676|3574303|B7||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Different randomized comparison
3738353|NCT02028676|3574304|B6||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Different randomized comparison
3738354|NCT02028676|3574305|B5||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Different randomized comparison
3738355|NCT02028676|3574306|B4||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Different randomized comparison
3738356|NCT02028676|3574307|B3||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Different randomized comparison
3738357|NCT02028676|3574308|B2||Male|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
3738358|NCT02028676|3574309|B1||Male|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
3738359|NCT02028676|3574300|B10||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3738360|NCT02028676|3574301|B9||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Different randomized comparison
3738361|NCT02028676|3574302|B8||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Different randomized comparison
3738362|NCT02028676|3574303|B7||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Different randomized comparison
3738363|NCT02028676|3574304|B6||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Different randomized comparison
3738364|NCT02028676|3574305|B5||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Different randomized comparison
3738365|NCT02028676|3574306|B4||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Different randomized comparison
3738366|NCT02028676|3574307|B3||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Different randomized comparison
3738367|NCT02028676|3574308|B2||Female|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
3738368|NCT02028676|3574309|B1||Female|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
3738369|NCT02028676|3574300|B10|3 years or older||Age, Customized|Age at trial enrollment (antiretroviral therapy initiation).|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3738370|NCT02028676|3574301|B9|3 years or older||Age, Customized|Age at trial enrollment (antiretroviral therapy initiation).|participants|Number|NA|||||||Different randomized comparison
3738371|NCT02028676|3574302|B8|3 years or older||Age, Customized|Age at trial enrollment (antiretroviral therapy initiation).|participants|Number|NA|||||||Different randomized comparison
3738372|NCT02028676|3574303|B7|3 years or older||Age, Customized|Age at trial enrollment (antiretroviral therapy initiation).|participants|Number|NA|||||||Different randomized comparison
3738373|NCT02028676|3574304|B6|3 years or older||Age, Customized|Age at trial enrollment (antiretroviral therapy initiation).|participants|Number|NA|||||||Different randomized comparison
3738374|NCT02028676|3574305|B5|3 years or older||Age, Customized|Age at trial enrollment (antiretroviral therapy initiation).|participants|Number|NA|||||||Different randomized comparison
3738375|NCT02028676|3574306|B4|3 years or older||Age, Customized|Age at trial enrollment (antiretroviral therapy initiation).|participants|Number|NA|||||||Different randomized comparison
3738376|NCT02028676|3574307|B3|3 years or older||Age, Customized|Age at trial enrollment (antiretroviral therapy initiation).|participants|Number|NA|||||||Different randomized comparison
3738377|NCT02028676|3574308|B2|3 years or older||Age, Customized|Age at trial enrollment (antiretroviral therapy initiation).|participants|Number|427|427.0||||||
3738378|NCT02028676|3574309|B1|3 years or older||Age, Customized|Age at trial enrollment (antiretroviral therapy initiation).|participants|Number|409|409.0||||||
3738379|NCT02028676|3574300|B10|< 3 years||Age, Customized|Age at trial enrollment (antiretroviral therapy initiation).|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3738380|NCT02028676|3574301|B9|< 3 years||Age, Customized|Age at trial enrollment (antiretroviral therapy initiation).|participants|Number|NA|||||||Different randomized comparison
3738381|NCT02028676|3574302|B8|< 3 years||Age, Customized|Age at trial enrollment (antiretroviral therapy initiation).|participants|Number|NA|||||||Different randomized comparison
3738382|NCT02028676|3574303|B7|< 3 years||Age, Customized|Age at trial enrollment (antiretroviral therapy initiation).|participants|Number|NA|||||||Different randomized comparison
3738383|NCT02028676|3574304|B6|< 3 years||Age, Customized|Age at trial enrollment (antiretroviral therapy initiation).|participants|Number|NA|||||||Different randomized comparison
3738384|NCT02028676|3574305|B5|< 3 years||Age, Customized|Age at trial enrollment (antiretroviral therapy initiation).|participants|Number|NA|||||||Different randomized comparison
3738385|NCT02028676|3574306|B4|< 3 years||Age, Customized|Age at trial enrollment (antiretroviral therapy initiation).|participants|Number|NA|||||||Different randomized comparison
3738386|NCT02028676|3574307|B3|< 3 years||Age, Customized|Age at trial enrollment (antiretroviral therapy initiation).|participants|Number|NA|||||||Different randomized comparison
3738387|NCT02028676|3574308|B2|< 3 years||Age, Customized|Age at trial enrollment (antiretroviral therapy initiation).|participants|Number|173|173.0||||||
3738388|NCT02028676|3574309|B1|< 3 years||Age, Customized|Age at trial enrollment (antiretroviral therapy initiation).|participants|Number|197|197.0||||||
3738389|NCT02028676|3574300|B10|||Age|Age at trial enrollment (antiretroviral therapy initiation).|years|Median|6.0|6.0|Inter-Quartile Range|||2.4|9.3|
3738390|NCT02028676|3574301|B9|||Age|Age at trial enrollment (antiretroviral therapy initiation).|years|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738391|NCT02028676|3574302|B8|||Age|Age at trial enrollment (antiretroviral therapy initiation).|years|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738392|NCT02028676|3574303|B7|||Age|Age at trial enrollment (antiretroviral therapy initiation).|years|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738393|NCT02028676|3574304|B6|||Age|Age at trial enrollment (antiretroviral therapy initiation).|years|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738394|NCT02028676|3574305|B5|||Age|Age at trial enrollment (antiretroviral therapy initiation).|years|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738395|NCT02028676|3574306|B4|||Age|Age at trial enrollment (antiretroviral therapy initiation).|years|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738396|NCT02028676|3574307|B3|||Age|Age at trial enrollment (antiretroviral therapy initiation).|years|Median|NA||Inter-Quartile Range|||0.0|0.0|Different randomized comparison
3738397|NCT02028676|3574308|B2|||Age|Age at trial enrollment (antiretroviral therapy initiation).|years|Median|6.0|6.0|Inter-Quartile Range|||2.6|9.4|
3738398|NCT02028676|3574309|B1|||Age|Age at trial enrollment (antiretroviral therapy initiation).|years|Median|5.9|5.9|Inter-Quartile Range|||2.2|9.2|
3738399|NCT02028325|3574490|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3738400|NCT02028325|3574490|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3738401|NCT02028325|3574490|B1||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
3738402|NCT02028325|3574490|B1||Between 18 and 65 years|Age||Participants|Count of Participants|104|104.0||||||
3738403|NCT02028325|3574490|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3738404|NCT02028169|3574494|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3738405|NCT02028169|3574494|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3738406|NCT02028169|3574494|B1|||Age||years|Mean|41.65|41.65|Standard Deviation|11.1|11.1|||
3738407|NCT02028065|3574517|B4||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
3738408|NCT02028065|3574518|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3738409|NCT02028065|3574519|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3738410|NCT02028065|3574520|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3738411|NCT02028065|3574517|B4||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
3738412|NCT02028065|3574518|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3738413|NCT02028065|3574519|B2||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3738414|NCT02028065|3574520|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3738415|NCT02028065|3574517|B4|||Age||years|Mean|38|38.0|Standard Deviation|11|11.0|||
3738416|NCT02028065|3574518|B3|||Age||years|Mean|38|38.0|Standard Deviation|11|11.0|||
3738417|NCT02028065|3574519|B2|||Age||years|Mean|39|39.0|Standard Deviation|11|11.0|||
3738418|NCT02028065|3574520|B1|||Age||years|Mean|38|38.0|Standard Deviation|10|10.0|||
3738419|NCT02027883|3574533|B3|||VF Induction amount of participants|Number of subjects that participated in the VF induction study protocol.|participants|Number|100|100.0||||||
3738420|NCT02027883|3574534|B2|||VF Induction amount of participants|Number of subjects that participated in the VF induction study protocol.|participants|Number|50|50.0||||||
3738421|NCT02027883|3574535|B1|||VF Induction amount of participants|Number of subjects that participated in the VF induction study protocol.|participants|Number|50|50.0||||||
3738422|NCT02027883|3574533|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
3738423|NCT02027883|3574534|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
3738424|NCT02027883|3574535|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3738425|NCT02027883|3574533|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738426|NCT02027883|3574534|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738427|NCT02027883|3574535|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738428|NCT02027883|3574533|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738429|NCT02027883|3574534|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738430|NCT02027883|3574535|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738431|NCT02027883|3574533|B3||White|Race (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3738436|NCT02027883|3574535|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738437|NCT02027883|3574533|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738438|NCT02027883|3574534|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738439|NCT02027883|3574535|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738440|NCT02027883|3574533|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738441|NCT02027883|3574534|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738442|NCT02027883|3574535|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738443|NCT02027883|3574533|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738444|NCT02027883|3574534|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738445|NCT02027883|3574535|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738446|NCT02027883|3574533|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738447|NCT02027883|3574534|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738448|NCT02027883|3574535|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738449|NCT02027883|3574533|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3738450|NCT02027883|3574534|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3738451|NCT02027883|3574535|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3738452|NCT02027883|3574533|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738453|NCT02027883|3574534|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738454|NCT02027883|3574535|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738455|NCT02027883|3574533|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3738456|NCT02027883|3574534|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3738457|NCT02027883|3574535|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3738458|NCT02027883|3574533|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3738459|NCT02027883|3574534|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3738460|NCT02027883|3574535|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3738461|NCT02027883|3574533|B3|||Age||years|Mean|64.25|64.25|Standard Deviation|12.38554|12.38554|||
3738462|NCT02027883|3574534|B2|||Age||years|Mean|66.68|66.68|Standard Deviation|10.51809|10.51809|||
3738463|NCT02027883|3574535|B1|||Age||years|Mean|61.82|61.82|Standard Deviation|13.68403|13.68403|||
3738464|NCT02027883|3574533|B3||>=65 years|Age||Participants|Count of Participants|55|55.0||||||
3738465|NCT02027883|3574534|B2||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
3738466|NCT02027883|3574535|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3738467|NCT02027883|3574533|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3738468|NCT02027883|3574534|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3738469|NCT02027883|3574535|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3738470|NCT02027883|3574533|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3738471|NCT02027883|3574534|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3738472|NCT02027883|3574535|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3738473|NCT02027844|3574546|B4||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3738474|NCT02027844|3574547|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3738475|NCT02027844|3574548|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3738476|NCT02027844|3574549|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3738477|NCT02027844|3574546|B4||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3738478|NCT02027844|3574547|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3738479|NCT02027844|3574548|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3738480|NCT02027844|3574549|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3738481|NCT02027844|3574546|B4|||Age||years|Mean|5.2|5.2|Standard Deviation|1.1|1.1|||
3738482|NCT02027844|3574547|B3|||Age||years|Mean|5.0|5.0|Standard Deviation|1.3|1.3|||
3738483|NCT02027844|3574548|B2|||Age||years|Mean|5.3|5.3|Standard Deviation|1.4|1.4|||
3738484|NCT02027844|3574549|B1|||Age||years|Mean|5.5|5.5|Standard Deviation|1.0|1.0|||
3738485|NCT02027844|3574546|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3738486|NCT02027844|3574547|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3738487|NCT02027844|3574548|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3738488|NCT02027844|3574549|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3738489|NCT02027844|3574546|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3738490|NCT02027844|3574547|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3738491|NCT02027844|3574548|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3738492|NCT02027844|3574549|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3738493|NCT02027844|3574546|B4||<=18 years|Age||Participants|Count of Participants|104|104.0||||||
3738494|NCT02027844|3574547|B3||<=18 years|Age||Participants|Count of Participants|37|37.0||||||
3738495|NCT02027844|3574548|B2||<=18 years|Age||Participants|Count of Participants|33|33.0||||||
3738496|NCT02027844|3574549|B1||<=18 years|Age||Participants|Count of Participants|34|34.0||||||
3738497|NCT02027701|3574568|B1|Spain||Region of Enrollment||participants|Number|10|10.0||||||
3738498|NCT02027701|3574568|B1|Germany||Region of Enrollment||participants|Number|29|29.0||||||
3738499|NCT02027701|3574568|B1|France||Region of Enrollment||participants|Number|1|1.0||||||
3738500|NCT02027701|3574568|B1|Australia||Region of Enrollment||participants|Number|1|1.0||||||
3738501|NCT02027701|3574568|B1|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3738502|NCT02027701|3574568|B1|Italy||Region of Enrollment||participants|Number|8|8.0||||||
3738503|NCT02027701|3574568|B1|Japan||Region of Enrollment||participants|Number|10|10.0||||||
3738504|NCT02027701|3574568|B1|Czechia||Region of Enrollment||participants|Number|2|2.0||||||
3738505|NCT02027701|3574568|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3738506|NCT02027701|3574568|B1|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
3738507|NCT02027701|3574568|B1|Canada||Region of Enrollment||participants|Number|7|7.0||||||
3738508|NCT02027701|3574568|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3738509|NCT02027701|3574568|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738510|NCT02027701|3574568|B1||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3738511|NCT02027701|3574568|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738512|NCT02027701|3574568|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738513|NCT02027701|3574568|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3738514|NCT02027701|3574568|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3738515|NCT02027701|3574568|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3738516|NCT02027701|3574568|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3738517|NCT02027701|3574568|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3738518|NCT02027701|3574568|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3738519|NCT02027701|3574568|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3738520|NCT02027701|3574568|B1|||Age||years|Mean|57.57|57.57|Standard Deviation|13.224|13.224|||
3738521|NCT02027701|3574568|B1||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
3738522|NCT02027701|3574568|B1||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
3738523|NCT02027701|3574568|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3738524|NCT02027428|3574584|B3||Stage IV|Disease Stage at Enrollment|Disease stage = how big the tumor is and how far it has spread. Disease stages range from 0 (not spread) to IV (spread throughout the body). Stage 0: the cancer has not spread beyond the inner lining of the lung. Stage I: the cancer is small and hasn't spread to the lymph nodes (LN). Stage II: the cancer has spread to some LN near the original tumor. Stage III: the cancer has spread to nearby tissue or spread to far away LN. Stage IV: the cancer has spread to other organs such as lung, brain, or liver. BLC are displayed for participants randomized in the maintenance phase.|Participants|Count of Participants|176|176.0||||||
3738525|NCT02027428|3574585|B2||Stage IV|Disease Stage at Enrollment|Disease stage = how big the tumor is and how far it has spread. Disease stages range from 0 (not spread) to IV (spread throughout the body). Stage 0: the cancer has not spread beyond the inner lining of the lung. Stage I: the cancer is small and hasn't spread to the lymph nodes (LN). Stage II: the cancer has spread to some LN near the original tumor. Stage III: the cancer has spread to nearby tissue or spread to far away LN. Stage IV: the cancer has spread to other organs such as lung, brain, or liver. BLC are displayed for participants randomized in the maintenance phase.|Participants|Count of Participants|58|58.0||||||
3738526|NCT02027428|3574586|B1||Stage IV|Disease Stage at Enrollment|Disease stage = how big the tumor is and how far it has spread. Disease stages range from 0 (not spread) to IV (spread throughout the body). Stage 0: the cancer has not spread beyond the inner lining of the lung. Stage I: the cancer is small and hasn't spread to the lymph nodes (LN). Stage II: the cancer has spread to some LN near the original tumor. Stage III: the cancer has spread to nearby tissue or spread to far away LN. Stage IV: the cancer has spread to other organs such as lung, brain, or liver. BLC are displayed for participants randomized in the maintenance phase.|Participants|Count of Participants|118|118.0||||||
3738527|NCT02027428|3574584|B3||Stage IIIB|Disease Stage at Enrollment|Disease stage = how big the tumor is and how far it has spread. Disease stages range from 0 (not spread) to IV (spread throughout the body). Stage 0: the cancer has not spread beyond the inner lining of the lung. Stage I: the cancer is small and hasn't spread to the lymph nodes (LN). Stage II: the cancer has spread to some LN near the original tumor. Stage III: the cancer has spread to nearby tissue or spread to far away LN. Stage IV: the cancer has spread to other organs such as lung, brain, or liver. BLC are displayed for participants randomized in the maintenance phase.|Participants|Count of Participants|26|26.0||||||
3738528|NCT02027428|3574585|B2||Stage IIIB|Disease Stage at Enrollment|Disease stage = how big the tumor is and how far it has spread. Disease stages range from 0 (not spread) to IV (spread throughout the body). Stage 0: the cancer has not spread beyond the inner lining of the lung. Stage I: the cancer is small and hasn't spread to the lymph nodes (LN). Stage II: the cancer has spread to some LN near the original tumor. Stage III: the cancer has spread to nearby tissue or spread to far away LN. Stage IV: the cancer has spread to other organs such as lung, brain, or liver. BLC are displayed for participants randomized in the maintenance phase.|Participants|Count of Participants|8|8.0||||||
3738529|NCT02027428|3574586|B1||Stage IIIB|Disease Stage at Enrollment|Disease stage = how big the tumor is and how far it has spread. Disease stages range from 0 (not spread) to IV (spread throughout the body). Stage 0: the cancer has not spread beyond the inner lining of the lung. Stage I: the cancer is small and hasn't spread to the lymph nodes (LN). Stage II: the cancer has spread to some LN near the original tumor. Stage III: the cancer has spread to nearby tissue or spread to far away LN. Stage IV: the cancer has spread to other organs such as lung, brain, or liver. BLC are displayed for participants randomized in the maintenance phase.|Participants|Count of Participants|18|18.0||||||
3738530|NCT02027428|3574584|B3||Squamous cell carcinoma not confirmed|Confirmed Histology|The histology categories included those with a tumor histology of squamous versus non-squamous types. Baseline characteristics for non-randomized participants is not displayed. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|0|0.0||||||
3738531|NCT02027428|3574585|B2||Squamous cell carcinoma not confirmed|Confirmed Histology|The histology categories included those with a tumor histology of squamous versus non-squamous types. Baseline characteristics for non-randomized participants is not displayed. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|0|0.0||||||
3738532|NCT02027428|3574586|B1||Squamous cell carcinoma not confirmed|Confirmed Histology|The histology categories included those with a tumor histology of squamous versus non-squamous types. Baseline characteristics for non-randomized participants is not displayed. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|0|0.0||||||
3738533|NCT02027428|3574584|B3||Squamous cell carcinoma|Confirmed Histology|The histology categories included those with a tumor histology of squamous versus non-squamous types. Baseline characteristics for non-randomized participants is not displayed. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|202|202.0||||||
3738534|NCT02027428|3574585|B2||Squamous cell carcinoma|Confirmed Histology|The histology categories included those with a tumor histology of squamous versus non-squamous types. Baseline characteristics for non-randomized participants is not displayed. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|66|66.0||||||
3738535|NCT02027428|3574586|B1||Squamous cell carcinoma|Confirmed Histology|The histology categories included those with a tumor histology of squamous versus non-squamous types. Baseline characteristics for non-randomized participants is not displayed. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|136|136.0||||||
3738536|NCT02027428|3574584|B3||Not evaluable|Overall Tumor Response at End of Induction|Tumor response to Induction part chemotherapy for stratification is the response assessed at the last computed tomography (CT) scan before randomization. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|1|1.0||||||
3738537|NCT02027428|3574585|B2||Not evaluable|Overall Tumor Response at End of Induction|Tumor response to Induction part chemotherapy for stratification is the response assessed at the last computed tomography (CT) scan before randomization. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|1|1.0||||||
3738538|NCT02027428|3574586|B1||Not evaluable|Overall Tumor Response at End of Induction|Tumor response to Induction part chemotherapy for stratification is the response assessed at the last computed tomography (CT) scan before randomization. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|0|0.0||||||
3738539|NCT02027428|3574584|B3||Progressive disease|Overall Tumor Response at End of Induction|Tumor response to Induction part chemotherapy for stratification is the response assessed at the last computed tomography (CT) scan before randomization. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|2|2.0||||||
3738540|NCT02027428|3574585|B2||Progressive disease|Overall Tumor Response at End of Induction|Tumor response to Induction part chemotherapy for stratification is the response assessed at the last computed tomography (CT) scan before randomization. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|0|0.0||||||
3738541|NCT02027428|3574586|B1||Progressive disease|Overall Tumor Response at End of Induction|Tumor response to Induction part chemotherapy for stratification is the response assessed at the last computed tomography (CT) scan before randomization. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|2|2.0||||||
3738542|NCT02027428|3574584|B3||Stable disease|Overall Tumor Response at End of Induction|Tumor response to Induction part chemotherapy for stratification is the response assessed at the last computed tomography (CT) scan before randomization. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|62|62.0||||||
3738543|NCT02027428|3574585|B2||Stable disease|Overall Tumor Response at End of Induction|Tumor response to Induction part chemotherapy for stratification is the response assessed at the last computed tomography (CT) scan before randomization. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|21|21.0||||||
3738544|NCT02027428|3574586|B1||Stable disease|Overall Tumor Response at End of Induction|Tumor response to Induction part chemotherapy for stratification is the response assessed at the last computed tomography (CT) scan before randomization. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|41|41.0||||||
3738545|NCT02027428|3574584|B3||Partial response|Overall Tumor Response at End of Induction|Tumor response to Induction part chemotherapy for stratification is the response assessed at the last computed tomography (CT) scan before randomization. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|134|134.0||||||
3738546|NCT02027428|3574585|B2||Partial response|Overall Tumor Response at End of Induction|Tumor response to Induction part chemotherapy for stratification is the response assessed at the last computed tomography (CT) scan before randomization. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|42|42.0||||||
3738632|NCT02027376|3574639|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738547|NCT02027428|3574586|B1||Partial response|Overall Tumor Response at End of Induction|Tumor response to Induction part chemotherapy for stratification is the response assessed at the last computed tomography (CT) scan before randomization. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|92|92.0||||||
3738548|NCT02027428|3574584|B3||Complete response|Overall Tumor Response at End of Induction|Tumor response to Induction part chemotherapy for stratification is the response assessed at the last computed tomography (CT) scan before randomization. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|3|3.0||||||
3738549|NCT02027428|3574585|B2||Complete response|Overall Tumor Response at End of Induction|Tumor response to Induction part chemotherapy for stratification is the response assessed at the last computed tomography (CT) scan before randomization. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|2|2.0||||||
3738550|NCT02027428|3574586|B1||Complete response|Overall Tumor Response at End of Induction|Tumor response to Induction part chemotherapy for stratification is the response assessed at the last computed tomography (CT) scan before randomization. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|1|1.0||||||
3738551|NCT02027428|3574584|B3||>=2=ambulatory/self care; no work or worse|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG PS assesses how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. - 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|0|0.0||||||
3738552|NCT02027428|3574585|B2||>=2=ambulatory/self care; no work or worse|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG PS assesses how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. - 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|0|0.0||||||
3738553|NCT02027428|3574586|B1||>=2=ambulatory/self care; no work or worse|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG PS assesses how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. - 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|0|0.0||||||
3738554|NCT02027428|3574584|B3||1=fully ambulatory; restricted strenuous activity|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG PS assesses how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. - 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|142|142.0||||||
3738555|NCT02027428|3574585|B2||1=fully ambulatory; restricted strenuous activity|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG PS assesses how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. - 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|47|47.0||||||
3738556|NCT02027428|3574586|B1||1=fully ambulatory; restricted strenuous activity|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG PS assesses how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. - 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|95|95.0||||||
3738557|NCT02027428|3574584|B3||0=fully active, no restriction|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG PS assesses how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. - 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|60|60.0||||||
3738558|NCT02027428|3574585|B2||0=fully active, no restriction|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG PS assesses how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. - 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|19|19.0||||||
3738633|NCT02027376|3574639|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3738634|NCT02027376|3574639|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3738635|NCT02027376|3574639|B1|||Age||years|Mean|49.25|49.25|Standard Deviation|13.48|13.48|||
3738559|NCT02027428|3574586|B1||0=fully active, no restriction|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG PS assesses how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. - 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|41|41.0||||||
3738560|NCT02027428|3574584|B3||Other|Race/Ethnicity, Customized|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|2|2.0||||||
3738561|NCT02027428|3574585|B2||Other|Race/Ethnicity, Customized|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|2|2.0||||||
3738562|NCT02027428|3574586|B1||Other|Race/Ethnicity, Customized|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|0|0.0||||||
3738563|NCT02027428|3574584|B3||White|Race/Ethnicity, Customized|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|187|187.0||||||
3738564|NCT02027428|3574585|B2||White|Race/Ethnicity, Customized|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|62|62.0||||||
3738565|NCT02027428|3574586|B1||White|Race/Ethnicity, Customized|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|125|125.0||||||
3738566|NCT02027428|3574584|B3||Black or African American|Race/Ethnicity, Customized|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|11|11.0||||||
3738567|NCT02027428|3574585|B2||Black or African American|Race/Ethnicity, Customized|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|2|2.0||||||
3738568|NCT02027428|3574586|B1||Black or African American|Race/Ethnicity, Customized|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|9|9.0||||||
3738569|NCT02027428|3574584|B3||Asian|Race/Ethnicity, Customized|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|1|1.0||||||
3738570|NCT02027428|3574585|B2||Asian|Race/Ethnicity, Customized|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|0|0.0||||||
3738571|NCT02027428|3574586|B1||Asian|Race/Ethnicity, Customized|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|1|1.0||||||
3738572|NCT02027428|3574584|B3||American Indian or Alaska Native|Race/Ethnicity, Customized|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|1|1.0||||||
3738573|NCT02027428|3574585|B2||American Indian or Alaska Native|Race/Ethnicity, Customized|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|0|0.0||||||
3738574|NCT02027428|3574586|B1||American Indian or Alaska Native|Race/Ethnicity, Customized|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|1|1.0||||||
3738575|NCT02027428|3574584|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|1|1.0||||||
3738576|NCT02027428|3574585|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|0|0.0||||||
3738577|NCT02027428|3574586|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|1|1.0||||||
3738578|NCT02027428|3574584|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|193|193.0||||||
3738579|NCT02027428|3574585|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|61|61.0||||||
3738580|NCT02027428|3574586|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|132|132.0||||||
3738581|NCT02027428|3574584|B3||Hispanic or Latino|Ethnicity (NIH/OMB)|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|8|8.0||||||
3738582|NCT02027428|3574585|B2||Hispanic or Latino|Ethnicity (NIH/OMB)|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|5|5.0||||||
3738583|NCT02027428|3574586|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|3|3.0||||||
3738584|NCT02027428|3574584|B3||Male|Sex: Female, Male|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|130|130.0||||||
3738585|NCT02027428|3574585|B2||Male|Sex: Female, Male|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|43|43.0||||||
3738586|NCT02027428|3574586|B1||Male|Sex: Female, Male|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|87|87.0||||||
3738587|NCT02027428|3574584|B3||Female|Sex: Female, Male|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|72|72.0||||||
3738588|NCT02027428|3574585|B2||Female|Sex: Female, Male|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|23|23.0||||||
3738589|NCT02027428|3574586|B1||Female|Sex: Female, Male|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|49|49.0||||||
3738590|NCT02027428|3574584|B3|>=75 years||Age, Customized|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|37|37.0||||||
3738591|NCT02027428|3574585|B2|>=75 years||Age, Customized|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|11|11.0||||||
3738592|NCT02027428|3574586|B1|>=75 years||Age, Customized|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|26|26.0||||||
3738593|NCT02027428|3574584|B3|<75 years||Age, Customized|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|165|165.0||||||
3738594|NCT02027428|3574585|B2|<75 years||Age, Customized|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|55|55.0||||||
3738595|NCT02027428|3574586|B1|<75 years||Age, Customized|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|110|110.0||||||
3738596|NCT02027428|3574584|B3|>=70 years||Age, Customized|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|82|82.0||||||
3738597|NCT02027428|3574585|B2|>=70 years||Age, Customized|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|25|25.0||||||
3738636|NCT02027311|3574665|B3|||Procedure Time (min)||min|Mean|30.4|30.4|Standard Deviation|14.2|14.2|||
3738598|NCT02027428|3574586|B1|>=70 years||Age, Customized|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|57|57.0||||||
3738599|NCT02027428|3574584|B3|<70 years||Age, Customized|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|120|120.0||||||
3738600|NCT02027428|3574585|B2|<70 years||Age, Customized|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|41|41.0||||||
3738601|NCT02027428|3574586|B1|<70 years||Age, Customized|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|79|79.0||||||
3738602|NCT02027428|3574584|B3|>=65 years||Age, Customized|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|127|127.0||||||
3738603|NCT02027428|3574585|B2|>=65 years||Age, Customized|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|39|39.0||||||
3738604|NCT02027428|3574586|B1|>=65 years||Age, Customized|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|88|88.0||||||
3738605|NCT02027428|3574584|B3|<65 years||Age, Customized|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|75|75.0||||||
3738606|NCT02027428|3574585|B2|<65 years||Age, Customized|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|27|27.0||||||
3738607|NCT02027428|3574586|B1|<65 years||Age, Customized|Induction includes participants who were enrolled and treated in the induction phase. Baseline characteristics are displayed only for participants randomized in the maintenance phase. The total number represents the ITT population in the maintenance phase.|Participants|Count of Participants|48|48.0||||||
3738608|NCT02027428|3574584|B3|||Age|Continuous age values in Total column represent the 202 participants in the Maintenance Period. Induction includes participants who were enrolled and treated however, baseline characteristics for non-randomized participants is not displayed. The total number represents the ITT population in the maintenance phase.|years|Mean|67.0|67.0|Standard Deviation|8.70|8.7|||
3738609|NCT02027428|3574585|B2|||Age|Continuous age values in Total column represent the 202 participants in the Maintenance Period. Induction includes participants who were enrolled and treated however, baseline characteristics for non-randomized participants is not displayed. The total number represents the ITT population in the maintenance phase.|years|Mean|66.8|66.8|Standard Deviation|8.06|8.06|||
3738610|NCT02027428|3574586|B1|||Age|Continuous age values in Total column represent the 202 participants in the Maintenance Period. Induction includes participants who were enrolled and treated however, baseline characteristics for non-randomized participants is not displayed. The total number represents the ITT population in the maintenance phase.|years|Mean|67.1|67.1|Standard Deviation|9.02|9.02|||
3738611|NCT02027402|3574624|B3|Korea, Republic of||Region of Enrollment||participants|Number|198|198.0||||||
3738612|NCT02027402|3574625|B2|Korea, Republic of||Region of Enrollment||participants|Number|100|100.0||||||
3738613|NCT02027402|3574626|B1|Korea, Republic of||Region of Enrollment||participants|Number|98|98.0||||||
3738614|NCT02027402|3574624|B3||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3738615|NCT02027402|3574625|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3738616|NCT02027402|3574626|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3738617|NCT02027402|3574624|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3738618|NCT02027402|3574625|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3738619|NCT02027402|3574626|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3738620|NCT02027402|3574624|B3|||Age||years|Mean|54|54.0|Standard Deviation|16.3|16.3|||
3738621|NCT02027402|3574625|B2|||Age||years|Mean|50|50.0|Standard Deviation|15.9|15.9|||
3738622|NCT02027402|3574626|B1|||Age||years|Mean|58|58.0|Standard Deviation|15.6|15.6|||
3738623|NCT02027376|3574639|B1|Post-menopausal||Menopausal status||participants|Number|7|7.0||||||
3738624|NCT02027376|3574639|B1|Pre-menopausal||Menopausal status||participants|Number|5|5.0||||||
3738625|NCT02027376|3574639|B1|Spain||Region of Enrollment||participants|Number|12|12.0||||||
3738626|NCT02027376|3574639|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738627|NCT02027376|3574639|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738628|NCT02027376|3574639|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3738629|NCT02027376|3574639|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738630|NCT02027376|3574639|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738631|NCT02027376|3574639|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738637|NCT02027311|3574666|B2|||Procedure Time (min)||min|Mean|32.8|32.8|Standard Deviation|13.4|13.4|||
3738638|NCT02027311|3574667|B1|||Procedure Time (min)||min|Mean|27.6|27.6|Standard Deviation|14.9|14.9|||
3738639|NCT02027311|3574665|B3|||Body Mass Index (kg/square of m.)||kg/square of m.|Mean|23.1|23.1|Standard Deviation|3.9|3.9|||
3738640|NCT02027311|3574666|B2|||Body Mass Index (kg/square of m.)||kg/square of m.|Mean|22.6|22.6|Standard Deviation|4.31|4.31|||
3738641|NCT02027311|3574667|B1|||Body Mass Index (kg/square of m.)||kg/square of m.|Mean|23.7|23.7|Standard Deviation|3.5|3.5|||
3738642|NCT02027311|3574665|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3738643|NCT02027311|3574666|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3738644|NCT02027311|3574667|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3738645|NCT02027311|3574665|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3738646|NCT02027311|3574666|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3738647|NCT02027311|3574667|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3738648|NCT02027311|3574665|B3|||Age||years|Mean|70.9|70.9|Standard Deviation|13.8|13.8|||
3738649|NCT02027311|3574666|B2|||Age||years|Mean|71.6|71.6|Standard Deviation|11.5|11.5|||
3738650|NCT02027311|3574667|B1|||Age||years|Mean|70.3|70.3|Standard Deviation|15.7|15.7|||
3738651|NCT02027272|3574676|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3738652|NCT02027272|3574677|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3738653|NCT02027272|3574676|B3|Male||Gender||participants|Number|0|0.0||||||
3738654|NCT02027272|3574677|B2|Male||Gender||participants|Number|0|0.0||||||
3738655|NCT02027272|3574676|B3|Female||Gender||participants|Number|1|1.0||||||
3738656|NCT02027272|3574677|B2|Female||Gender||participants|Number|1|1.0||||||
3738657|NCT02027272|3574676|B3|>=65 years||Age||participants|Number|0|0.0||||||
3738658|NCT02027272|3574677|B2|>=65 years||Age||participants|Number|0|0.0||||||
3738659|NCT02027272|3574676|B3|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
3738660|NCT02027272|3574677|B2|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
3738661|NCT02027272|3574676|B3|<=18 years||Age||participants|Number|0|0.0||||||
3738662|NCT02027272|3574677|B2|<=18 years||Age||participants|Number|0|0.0||||||
3738663|NCT02026453|3574685|B4||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3738664|NCT02026453|3574686|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3738665|NCT02026453|3574687|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3738666|NCT02026453|3574688|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3738667|NCT02026453|3574685|B4||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3738668|NCT02026453|3574686|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3738669|NCT02026453|3574687|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3738670|NCT02026453|3574688|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3738671|NCT02026453|3574685|B4|||Age||years|Mean|72|72.0|Standard Deviation|12|12.0|||
3738672|NCT02026453|3574686|B3|||Age||years|Mean|71|71.0|Standard Deviation|16|16.0|||
3738673|NCT02026453|3574687|B2|||Age||years|Mean|72|72.0|Standard Deviation|16|16.0|||
3738674|NCT02026453|3574688|B1|||Age||years|Mean|71|71.0|Standard Deviation|18|18.0|||
3738675|NCT02026258|3574701|B3|||Little Irrgularity at T0|Little's Irregularity index measures the interproximal contact displacement in mm between the anterior teeth segment from the mesial of the canine on one side to the mesial aspect of the contralateral canine.|millimeters|Mean|7.5|7.5|Standard Deviation|3|3.0|||
3738676|NCT02026258|3574702|B2|||Little Irrgularity at T0|Little's Irregularity index measures the interproximal contact displacement in mm between the anterior teeth segment from the mesial of the canine on one side to the mesial aspect of the contralateral canine.|millimeters|Mean|6.73|6.73|Standard Deviation|1.99|1.99|||
3738677|NCT02026258|3574703|B1|||Little Irrgularity at T0|Little's Irregularity index measures the interproximal contact displacement in mm between the anterior teeth segment from the mesial of the canine on one side to the mesial aspect of the contralateral canine.|millimeters|Mean|8.32|8.32|Standard Deviation|2.29|2.29|||
3738678|NCT02026258|3574701|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
3738679|NCT02026258|3574702|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3738680|NCT02026258|3574703|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3738681|NCT02026258|3574701|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3738682|NCT02026258|3574702|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3738683|NCT02026258|3574703|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3738684|NCT02026258|3574701|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3738685|NCT02026258|3574702|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3738686|NCT02026258|3574703|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3738687|NCT02026258|3574701|B3|||Age||years|Mean|29.7|29.7|Standard Deviation|15.5|15.5|||
3738688|NCT02026258|3574702|B2|||Age||years|Mean|30|30.0|Standard Deviation|12.5|12.5|||
3738689|NCT02026258|3574703|B1|||Age||years|Mean|29.4|29.4|Standard Deviation|9.3|9.3|||
3738690|NCT02026258|3574701|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3738691|NCT02026258|3574702|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3738692|NCT02026258|3574703|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3738693|NCT02026258|3574701|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3738694|NCT02026258|3574702|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3738695|NCT02026258|3574703|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3738696|NCT02026258|3574701|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3738697|NCT02026258|3574702|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3738698|NCT02026258|3574703|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3738699|NCT02026206|3574716|B3|||quality of life as assessed by the EQ-5D|The secondary outcome measures were quality of life as assessed by the EQ-5D (minimun 0.00, maximum 1.00). The EQ-5D descriptive system comprises the following 5 dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 3 levels: no problems, some problems, extreme problems. The subscales combined to compute a total score according to EQ-5D equation formula. The higher values represent a better outcome.All data collected by self-reported sheet.|units on a scale|Mean|0.74|0.74|Standard Deviation|0.24|0.24|||
3738700|NCT02026206|3574717|B2|||quality of life as assessed by the EQ-5D|The secondary outcome measures were quality of life as assessed by the EQ-5D (minimun 0.00, maximum 1.00). The EQ-5D descriptive system comprises the following 5 dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 3 levels: no problems, some problems, extreme problems. The subscales combined to compute a total score according to EQ-5D equation formula. The higher values represent a better outcome.All data collected by self-reported sheet.|units on a scale|Mean|0.74|0.74|Standard Deviation|0.28|0.28|||
3738701|NCT02026206|3574718|B1|||quality of life as assessed by the EQ-5D|The secondary outcome measures were quality of life as assessed by the EQ-5D (minimun 0.00, maximum 1.00). The EQ-5D descriptive system comprises the following 5 dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 3 levels: no problems, some problems, extreme problems. The subscales combined to compute a total score according to EQ-5D equation formula. The higher values represent a better outcome.All data collected by self-reported sheet.|units on a scale|Mean|0.74|0.74|Standard Deviation|0.20|0.2|||
3738702|NCT02026206|3574716|B3|||self-reported visual analog scale (VAS) for menstrual pain intensity|"The primary outcome was menstrual pain intensity described using a 0–10 VAS scale.~The higher values represent a worse outcome. All data collected by self-reported sheet."|units on a scale|Mean|8.28|8.28|Standard Deviation|0.98|0.98|||
3738703|NCT02026206|3574717|B2|||self-reported visual analog scale (VAS) for menstrual pain intensity|"The primary outcome was menstrual pain intensity described using a 0–10 VAS scale.~The higher values represent a worse outcome. All data collected by self-reported sheet."|units on a scale|Mean|8.27|8.27|Standard Deviation|0.92|0.92|||
3738704|NCT02026206|3574718|B1|||self-reported visual analog scale (VAS) for menstrual pain intensity|"The primary outcome was menstrual pain intensity described using a 0–10 VAS scale.~The higher values represent a worse outcome. All data collected by self-reported sheet."|units on a scale|Mean|8.30|8.3|Standard Deviation|1.05|1.05|||
3738705|NCT02026206|3574716|B3|Korea, Republic of||Region of Enrollment||participants|Number|88|88.0||||||
3738706|NCT02026206|3574717|B2|Korea, Republic of||Region of Enrollment||participants|Number|44|44.0||||||
3738707|NCT02026206|3574718|B1|Korea, Republic of||Region of Enrollment||participants|Number|44|44.0||||||
3738708|NCT02026206|3574716|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3738709|NCT02026206|3574717|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3738710|NCT02026206|3574718|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3738711|NCT02026206|3574716|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3738712|NCT02026206|3574717|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3738713|NCT02026206|3574718|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3738714|NCT02026206|3574716|B3|||Age||years|Mean|24.6|24.6|Standard Deviation|4.1|4.1|||
3738715|NCT02026206|3574717|B2|||Age||years|Mean|25.3|25.3|Standard Deviation|4.4|4.4|||
3738716|NCT02026206|3574718|B1|||Age||years|Mean|24.0|24.0|Standard Deviation|3.6|3.6|||
3738717|NCT02026193|3574727|B3|Israel||Region of Enrollment||participants|Number|11|11.0||||||
3738718|NCT02026193|3574728|B2|Israel||Region of Enrollment||participants|Number|8|8.0||||||
3738719|NCT02026193|3574729|B1|Israel||Region of Enrollment||participants|Number|3|3.0||||||
3738720|NCT02026193|3574727|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3738721|NCT02026193|3574728|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3738722|NCT02026193|3574729|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3738723|NCT02026193|3574727|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3738724|NCT02026193|3574728|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3738725|NCT02026193|3574729|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3738726|NCT02026193|3574727|B3|||Age||years|Mean|28.3|28.3|Standard Deviation|5.2|5.2|||
3738727|NCT02026193|3574728|B2|||Age||years|Mean|25|25.0|Standard Deviation|2.6|2.6|||
3738728|NCT02026193|3574729|B1|||Age||years|Mean|29.6|29.6|Standard Deviation|5.5|5.5|||
3738729|NCT02026193|3574727|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3738730|NCT02026193|3574728|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3738731|NCT02026193|3574729|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3738732|NCT02026193|3574727|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3738733|NCT02026193|3574728|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3738734|NCT02026193|3574729|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3738735|NCT02026193|3574727|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3738736|NCT02026193|3574728|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3738737|NCT02026193|3574729|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3738738|NCT02026141|3574736|B3|Canada||Region of Enrollment||participants|Number|40|40.0||||||
3738739|NCT02026141|3574737|B2|Canada||Region of Enrollment||participants|Number|20|20.0||||||
3738740|NCT02026141|3574738|B1|Canada||Region of Enrollment||participants|Number|20|20.0||||||
3738741|NCT02026141|3574736|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3738742|NCT02026141|3574737|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3738743|NCT02026141|3574738|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3738744|NCT02026141|3574736|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3738745|NCT02026141|3574737|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3738746|NCT02026141|3574738|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3738747|NCT02026141|3574736|B3|||Age||years|Mean|66.2|66.2|Standard Deviation|9.2|9.2|||
3738748|NCT02026141|3574737|B2|||Age||years|Mean|66.1|66.1|Standard Deviation|8.2|8.2|||
3738749|NCT02026141|3574738|B1|||Age||years|Mean|66.2|66.2|Standard Deviation|11.4|11.4|||
3738750|NCT02026141|3574736|B3||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3738751|NCT02026141|3574737|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3738752|NCT02026141|3574738|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3738753|NCT02026141|3574736|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3738754|NCT02026141|3574737|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3738755|NCT02026141|3574738|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3738756|NCT02026141|3574736|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3738757|NCT02026141|3574737|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3738758|NCT02026141|3574738|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3738759|NCT02025907|3574745|B3|United States||Region of Enrollment||participants|Number|94|94.0||||||
3738760|NCT02025907|3574746|B2|United States||Region of Enrollment||participants|Number|43|43.0||||||
3738761|NCT02025907|3574747|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
3738762|NCT02025907|3574745|B3|Germany||Region of Enrollment||participants|Number|29|29.0||||||
3738763|NCT02025907|3574746|B2|Germany||Region of Enrollment||participants|Number|13|13.0||||||
3738764|NCT02025907|3574747|B1|Germany||Region of Enrollment||participants|Number|16|16.0||||||
3738765|NCT02025907|3574745|B3|France||Region of Enrollment||participants|Number|16|16.0||||||
3738766|NCT02025907|3574746|B2|France||Region of Enrollment||participants|Number|6|6.0||||||
3738767|NCT02025907|3574747|B1|France||Region of Enrollment||participants|Number|10|10.0||||||
3738768|NCT02025907|3574745|B3|Canada||Region of Enrollment||participants|Number|39|39.0||||||
3738769|NCT02025907|3574746|B2|Canada||Region of Enrollment||participants|Number|23|23.0||||||
3738770|NCT02025907|3574747|B1|Canada||Region of Enrollment||participants|Number|16|16.0||||||
3738771|NCT02025907|3574745|B3|Australia||Region of Enrollment||participants|Number|35|35.0||||||
3738772|NCT02025907|3574746|B2|Australia||Region of Enrollment||participants|Number|22|22.0||||||
3738773|NCT02025907|3574747|B1|Australia||Region of Enrollment||participants|Number|13|13.0||||||
3738774|NCT02025907|3574745|B3||Male|Gender||Participants|Count of Participants|121|121.0||||||
3738775|NCT02025907|3574746|B2||Male|Gender||Participants|Count of Participants|66|66.0||||||
3738776|NCT02025907|3574747|B1||Male|Gender||Participants|Count of Participants|55|55.0||||||
3738777|NCT02025907|3574745|B3||Female|Gender||Participants|Count of Participants|92|92.0||||||
3738778|NCT02025907|3574746|B2||Female|Gender||Participants|Count of Participants|41|41.0||||||
3738779|NCT02025907|3574747|B1||Female|Gender||Participants|Count of Participants|51|51.0||||||
3738780|NCT02025907|3574745|B3|||Age||years|Mean|57.4|57.4|Standard Deviation|9.69|9.69|||
3738781|NCT02025907|3574746|B2|||Age||years|Mean|57.4|57.4|Standard Deviation|9.28|9.28|||
3738782|NCT02025907|3574747|B1|||Age||years|Mean|57.5|57.5|Standard Deviation|10.14|10.14|||
3738783|NCT02025829|3574762|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
3738784|NCT02025829|3574763|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3738785|NCT02025829|3574764|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3738786|NCT02025829|3574762|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3738787|NCT02025829|3574763|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3738788|NCT02025829|3574764|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3738789|NCT02025829|3574762|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3738790|NCT02025829|3574763|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3738791|NCT02025829|3574764|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3738792|NCT02025829|3574762|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3738793|NCT02025829|3574763|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3738794|NCT02025829|3574764|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3738795|NCT02025829|3574762|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3738796|NCT02025829|3574763|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3738797|NCT02025829|3574764|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3738798|NCT02025829|3574762|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3738799|NCT02025829|3574763|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3738800|NCT02025829|3574764|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3738801|NCT02025647|3574774|B1|Without Mental Health Concerns||Those with and w/o mental health concerns as identified by each investigator||participants|Number|104|104.0||||||
3739044|NCT02024971|3574879|B1|Ex-smoker||Smoking Classification||participants|Number|196|196.0||||||
3738802|NCT02025647|3574774|B1|With Mental Health Concerns||Those with and w/o mental health concerns as identified by each investigator||participants|Number|35|35.0||||||
3738803|NCT02025647|3574774|B1|United States||Region of Enrollment||participants|Number|139|139.0||||||
3738804|NCT02025647|3574774|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3738805|NCT02025647|3574774|B1|White||Race/Ethnicity, Customized||participants|Number|117|117.0||||||
3738806|NCT02025647|3574774|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3738807|NCT02025647|3574774|B1|African American||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3738808|NCT02025647|3574774|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3738809|NCT02025647|3574774|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3738810|NCT02025647|3574774|B1|61+ years||Age, Customized||participants|Number|55|55.0||||||
3738811|NCT02025647|3574774|B1|41-60 years||Age, Customized||participants|Number|38|38.0||||||
3738812|NCT02025647|3574774|B1|18-40 years||Age, Customized||participants|Number|46|46.0||||||
3738813|NCT02025621|3574803|B3|United States||Region of Enrollment||participants|Number|690|690.0||||||
3738814|NCT02025621|3574804|B2|United States||Region of Enrollment||participants|Number|333|333.0||||||
3738815|NCT02025621|3574805|B1|United States||Region of Enrollment||participants|Number|357|357.0||||||
3738816|NCT02025621|3574803|B3|Canada||Region of Enrollment||participants|Number|159|159.0||||||
3738817|NCT02025621|3574804|B2|Canada||Region of Enrollment||participants|Number|88|88.0||||||
3738818|NCT02025621|3574805|B1|Canada||Region of Enrollment||participants|Number|71|71.0||||||
3738819|NCT02025621|3574803|B3|Not given||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3738820|NCT02025621|3574804|B2|Not given||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3738821|NCT02025621|3574805|B1|Not given||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3738822|NCT02025621|3574803|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3738823|NCT02025621|3574804|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3738824|NCT02025621|3574805|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3738825|NCT02025621|3574803|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3738826|NCT02025621|3574804|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3738827|NCT02025621|3574805|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3738828|NCT02025621|3574803|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3738829|NCT02025621|3574804|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3738830|NCT02025621|3574805|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3738831|NCT02025621|3574803|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3738832|NCT02025621|3574804|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3738833|NCT02025621|3574805|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3738834|NCT02025621|3574803|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
3738835|NCT02025621|3574804|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3738836|NCT02025621|3574805|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3738837|NCT02025621|3574803|B3|White/Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|760|760.0||||||
3738838|NCT02025621|3574804|B2|White/Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|375|375.0||||||
3738839|NCT02025621|3574805|B1|White/Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|385|385.0||||||
3738840|NCT02025621|3574803|B3||Male|Sex: Female, Male||Participants|Count of Participants|679|679.0||||||
3738841|NCT02025621|3574804|B2||Male|Sex: Female, Male||Participants|Count of Participants|332|332.0||||||
3738842|NCT02025621|3574805|B1||Male|Sex: Female, Male||Participants|Count of Participants|347|347.0||||||
3738843|NCT02025621|3574803|B3||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
3738844|NCT02025621|3574804|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3738845|NCT02025621|3574805|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3738846|NCT02025621|3574803|B3|||Age||years|Median|65|65.0|Full Range|||58.0|72.0|
3738847|NCT02025621|3574804|B2|||Age||years|Median|65|65.0|Full Range|||58.0|72.0|
3738848|NCT02025621|3574805|B1|||Age||years|Median|65|65.0|Full Range|||59.0|73.0|
3738849|NCT02025179|3574824|B4||ASIA D (Motor Incomplete Injury)|American Spinal Injury Association (ASIA) Impairment Scale|"ASIA impairment scale describes a person’s functional impairment as a result of their spinal cord injury.~A = Complete. No motor or sensory function in the lowest sacral spine segment (S4-5).~B = Sensory Incomplete. Sensory function below the neurological level of injury (NLI) and in S4-S5, no motor function below NLI.~C = Motor Incomplete. Motor function is preserved below NLI and more than half of the key muscle groups below NLI have a muscle grade < 3.~D = Motor Incomplete. Motor function is preserved below NLI and at least half of the key muscle groups below NLI have a muscle grade 3."|Participants|Count of Participants|0|0.0||||||
3738893|NCT02025179|3574824|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738894|NCT02025179|3574825|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738895|NCT02025179|3574826|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738896|NCT02025179|3574827|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738897|NCT02025179|3574824|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3738850|NCT02025179|3574825|B3||ASIA D (Motor Incomplete Injury)|American Spinal Injury Association (ASIA) Impairment Scale|"ASIA impairment scale describes a person’s functional impairment as a result of their spinal cord injury.~A = Complete. No motor or sensory function in the lowest sacral spine segment (S4-5).~B = Sensory Incomplete. Sensory function below the neurological level of injury (NLI) and in S4-S5, no motor function below NLI.~C = Motor Incomplete. Motor function is preserved below NLI and more than half of the key muscle groups below NLI have a muscle grade < 3.~D = Motor Incomplete. Motor function is preserved below NLI and at least half of the key muscle groups below NLI have a muscle grade 3."|Participants|Count of Participants|0|0.0||||||
3738851|NCT02025179|3574826|B2||ASIA D (Motor Incomplete Injury)|American Spinal Injury Association (ASIA) Impairment Scale|"ASIA impairment scale describes a person’s functional impairment as a result of their spinal cord injury.~A = Complete. No motor or sensory function in the lowest sacral spine segment (S4-5).~B = Sensory Incomplete. Sensory function below the neurological level of injury (NLI) and in S4-S5, no motor function below NLI.~C = Motor Incomplete. Motor function is preserved below NLI and more than half of the key muscle groups below NLI have a muscle grade < 3.~D = Motor Incomplete. Motor function is preserved below NLI and at least half of the key muscle groups below NLI have a muscle grade 3."|Participants|Count of Participants|0|0.0||||||
3738852|NCT02025179|3574827|B1||ASIA D (Motor Incomplete Injury)|American Spinal Injury Association (ASIA) Impairment Scale|"ASIA impairment scale describes a person’s functional impairment as a result of their spinal cord injury.~A = Complete. No motor or sensory function in the lowest sacral spine segment (S4-5).~B = Sensory Incomplete. Sensory function below the neurological level of injury (NLI) and in S4-S5, no motor function below NLI.~C = Motor Incomplete. Motor function is preserved below NLI and more than half of the key muscle groups below NLI have a muscle grade < 3.~D = Motor Incomplete. Motor function is preserved below NLI and at least half of the key muscle groups below NLI have a muscle grade 3."|Participants|Count of Participants|0|0.0||||||
3738853|NCT02025179|3574824|B4||ASIA C (Motor Incomplete Injury)|American Spinal Injury Association (ASIA) Impairment Scale|"ASIA impairment scale describes a person’s functional impairment as a result of their spinal cord injury.~A = Complete. No motor or sensory function in the lowest sacral spine segment (S4-5).~B = Sensory Incomplete. Sensory function below the neurological level of injury (NLI) and in S4-S5, no motor function below NLI.~C = Motor Incomplete. Motor function is preserved below NLI and more than half of the key muscle groups below NLI have a muscle grade < 3.~D = Motor Incomplete. Motor function is preserved below NLI and at least half of the key muscle groups below NLI have a muscle grade 3."|Participants|Count of Participants|4|4.0||||||
3738854|NCT02025179|3574825|B3||ASIA C (Motor Incomplete Injury)|American Spinal Injury Association (ASIA) Impairment Scale|"ASIA impairment scale describes a person’s functional impairment as a result of their spinal cord injury.~A = Complete. No motor or sensory function in the lowest sacral spine segment (S4-5).~B = Sensory Incomplete. Sensory function below the neurological level of injury (NLI) and in S4-S5, no motor function below NLI.~C = Motor Incomplete. Motor function is preserved below NLI and more than half of the key muscle groups below NLI have a muscle grade < 3.~D = Motor Incomplete. Motor function is preserved below NLI and at least half of the key muscle groups below NLI have a muscle grade 3."|Participants|Count of Participants|0|0.0||||||
3738855|NCT02025179|3574826|B2||ASIA C (Motor Incomplete Injury)|American Spinal Injury Association (ASIA) Impairment Scale|"ASIA impairment scale describes a person’s functional impairment as a result of their spinal cord injury.~A = Complete. No motor or sensory function in the lowest sacral spine segment (S4-5).~B = Sensory Incomplete. Sensory function below the neurological level of injury (NLI) and in S4-S5, no motor function below NLI.~C = Motor Incomplete. Motor function is preserved below NLI and more than half of the key muscle groups below NLI have a muscle grade < 3.~D = Motor Incomplete. Motor function is preserved below NLI and at least half of the key muscle groups below NLI have a muscle grade 3."|Participants|Count of Participants|1|1.0||||||
3738856|NCT02025179|3574827|B1||ASIA C (Motor Incomplete Injury)|American Spinal Injury Association (ASIA) Impairment Scale|"ASIA impairment scale describes a person’s functional impairment as a result of their spinal cord injury.~A = Complete. No motor or sensory function in the lowest sacral spine segment (S4-5).~B = Sensory Incomplete. Sensory function below the neurological level of injury (NLI) and in S4-S5, no motor function below NLI.~C = Motor Incomplete. Motor function is preserved below NLI and more than half of the key muscle groups below NLI have a muscle grade < 3.~D = Motor Incomplete. Motor function is preserved below NLI and at least half of the key muscle groups below NLI have a muscle grade 3."|Participants|Count of Participants|3|3.0||||||
3738857|NCT02025179|3574824|B4||ASIA B (Sensory Incomplete Injury)|American Spinal Injury Association (ASIA) Impairment Scale|"ASIA impairment scale describes a person’s functional impairment as a result of their spinal cord injury.~A = Complete. No motor or sensory function in the lowest sacral spine segment (S4-5).~B = Sensory Incomplete. Sensory function below the neurological level of injury (NLI) and in S4-S5, no motor function below NLI.~C = Motor Incomplete. Motor function is preserved below NLI and more than half of the key muscle groups below NLI have a muscle grade < 3.~D = Motor Incomplete. Motor function is preserved below NLI and at least half of the key muscle groups below NLI have a muscle grade 3."|Participants|Count of Participants|2|2.0||||||
3738858|NCT02025179|3574825|B3||ASIA B (Sensory Incomplete Injury)|American Spinal Injury Association (ASIA) Impairment Scale|"ASIA impairment scale describes a person’s functional impairment as a result of their spinal cord injury.~A = Complete. No motor or sensory function in the lowest sacral spine segment (S4-5).~B = Sensory Incomplete. Sensory function below the neurological level of injury (NLI) and in S4-S5, no motor function below NLI.~C = Motor Incomplete. Motor function is preserved below NLI and more than half of the key muscle groups below NLI have a muscle grade < 3.~D = Motor Incomplete. Motor function is preserved below NLI and at least half of the key muscle groups below NLI have a muscle grade 3."|Participants|Count of Participants|1|1.0||||||
3738859|NCT02025179|3574826|B2||ASIA B (Sensory Incomplete Injury)|American Spinal Injury Association (ASIA) Impairment Scale|"ASIA impairment scale describes a person’s functional impairment as a result of their spinal cord injury.~A = Complete. No motor or sensory function in the lowest sacral spine segment (S4-5).~B = Sensory Incomplete. Sensory function below the neurological level of injury (NLI) and in S4-S5, no motor function below NLI.~C = Motor Incomplete. Motor function is preserved below NLI and more than half of the key muscle groups below NLI have a muscle grade < 3.~D = Motor Incomplete. Motor function is preserved below NLI and at least half of the key muscle groups below NLI have a muscle grade 3."|Participants|Count of Participants|0|0.0||||||
3739045|NCT02024971|3574879|B1|Current smoker||Smoking Classification||participants|Number|155|155.0||||||
3738860|NCT02025179|3574827|B1||ASIA B (Sensory Incomplete Injury)|American Spinal Injury Association (ASIA) Impairment Scale|"ASIA impairment scale describes a person’s functional impairment as a result of their spinal cord injury.~A = Complete. No motor or sensory function in the lowest sacral spine segment (S4-5).~B = Sensory Incomplete. Sensory function below the neurological level of injury (NLI) and in S4-S5, no motor function below NLI.~C = Motor Incomplete. Motor function is preserved below NLI and more than half of the key muscle groups below NLI have a muscle grade < 3.~D = Motor Incomplete. Motor function is preserved below NLI and at least half of the key muscle groups below NLI have a muscle grade 3."|Participants|Count of Participants|1|1.0||||||
3738861|NCT02025179|3574824|B4||ASIA A (Complete Injury)|American Spinal Injury Association (ASIA) Impairment Scale|"ASIA impairment scale describes a person’s functional impairment as a result of their spinal cord injury.~A = Complete. No motor or sensory function in the lowest sacral spine segment (S4-5).~B = Sensory Incomplete. Sensory function below the neurological level of injury (NLI) and in S4-S5, no motor function below NLI.~C = Motor Incomplete. Motor function is preserved below NLI and more than half of the key muscle groups below NLI have a muscle grade < 3.~D = Motor Incomplete. Motor function is preserved below NLI and at least half of the key muscle groups below NLI have a muscle grade 3."|Participants|Count of Participants|19|19.0||||||
3738862|NCT02025179|3574825|B3||ASIA A (Complete Injury)|American Spinal Injury Association (ASIA) Impairment Scale|"ASIA impairment scale describes a person’s functional impairment as a result of their spinal cord injury.~A = Complete. No motor or sensory function in the lowest sacral spine segment (S4-5).~B = Sensory Incomplete. Sensory function below the neurological level of injury (NLI) and in S4-S5, no motor function below NLI.~C = Motor Incomplete. Motor function is preserved below NLI and more than half of the key muscle groups below NLI have a muscle grade < 3.~D = Motor Incomplete. Motor function is preserved below NLI and at least half of the key muscle groups below NLI have a muscle grade 3."|Participants|Count of Participants|7|7.0||||||
3738863|NCT02025179|3574826|B2||ASIA A (Complete Injury)|American Spinal Injury Association (ASIA) Impairment Scale|"ASIA impairment scale describes a person’s functional impairment as a result of their spinal cord injury.~A = Complete. No motor or sensory function in the lowest sacral spine segment (S4-5).~B = Sensory Incomplete. Sensory function below the neurological level of injury (NLI) and in S4-S5, no motor function below NLI.~C = Motor Incomplete. Motor function is preserved below NLI and more than half of the key muscle groups below NLI have a muscle grade < 3.~D = Motor Incomplete. Motor function is preserved below NLI and at least half of the key muscle groups below NLI have a muscle grade 3."|Participants|Count of Participants|8|8.0||||||
3738864|NCT02025179|3574827|B1||ASIA A (Complete Injury)|American Spinal Injury Association (ASIA) Impairment Scale|"ASIA impairment scale describes a person’s functional impairment as a result of their spinal cord injury.~A = Complete. No motor or sensory function in the lowest sacral spine segment (S4-5).~B = Sensory Incomplete. Sensory function below the neurological level of injury (NLI) and in S4-S5, no motor function below NLI.~C = Motor Incomplete. Motor function is preserved below NLI and more than half of the key muscle groups below NLI have a muscle grade < 3.~D = Motor Incomplete. Motor function is preserved below NLI and at least half of the key muscle groups below NLI have a muscle grade 3."|Participants|Count of Participants|4|4.0||||||
3738865|NCT02025179|3574824|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738866|NCT02025179|3574825|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738867|NCT02025179|3574826|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738868|NCT02025179|3574827|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738869|NCT02025179|3574824|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738870|NCT02025179|3574825|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738871|NCT02025179|3574826|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738872|NCT02025179|3574827|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738873|NCT02025179|3574824|B4||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3738874|NCT02025179|3574825|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3738875|NCT02025179|3574826|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3738876|NCT02025179|3574827|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3738877|NCT02025179|3574824|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3738878|NCT02025179|3574825|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3738879|NCT02025179|3574826|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3738880|NCT02025179|3574827|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3738881|NCT02025179|3574824|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3738882|NCT02025179|3574825|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738883|NCT02025179|3574826|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3738884|NCT02025179|3574827|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738885|NCT02025179|3574824|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3738886|NCT02025179|3574825|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738887|NCT02025179|3574826|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3738888|NCT02025179|3574827|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738889|NCT02025179|3574824|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738890|NCT02025179|3574825|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738891|NCT02025179|3574826|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738892|NCT02025179|3574827|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3738898|NCT02025179|3574825|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3738899|NCT02025179|3574826|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3738900|NCT02025179|3574827|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3738901|NCT02025179|3574824|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3738902|NCT02025179|3574825|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3738903|NCT02025179|3574826|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3738904|NCT02025179|3574827|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3738905|NCT02025179|3574824|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3738906|NCT02025179|3574825|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3738907|NCT02025179|3574826|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3738908|NCT02025179|3574827|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3738909|NCT02025179|3574824|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3738910|NCT02025179|3574825|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3738911|NCT02025179|3574826|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3738912|NCT02025179|3574827|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3738913|NCT02025179|3574824|B4|||Age||years|Mean|40.5|40.5|Full Range|||21.1|65.3|
3738914|NCT02025179|3574825|B3|||Age||years|Mean|41.7|41.7|Full Range|||22.8|64.9|
3738915|NCT02025179|3574826|B2|||Age||years|Mean|38.0|38.0|Full Range|||22.2|62.7|
3738916|NCT02025179|3574827|B1|||Age||years|Mean|42.2|42.2|Full Range|||21.1|65.3|
3738917|NCT02025075|3574852|B3|II||ASA Physical Status Classification|ASA I A normal healthy patient ASA II A patient with mild systemic disease|Participants|Count of Participants|32|32.0||||||
3738918|NCT02025075|3574853|B2|II||ASA Physical Status Classification|ASA I A normal healthy patient ASA II A patient with mild systemic disease|Participants|Count of Participants|17|17.0||||||
3738919|NCT02025075|3574854|B1|II||ASA Physical Status Classification|ASA I A normal healthy patient ASA II A patient with mild systemic disease|Participants|Count of Participants|15|15.0||||||
3738920|NCT02025075|3574852|B3|I||ASA Physical Status Classification|ASA I A normal healthy patient ASA II A patient with mild systemic disease|Participants|Count of Participants|3|3.0||||||
3738921|NCT02025075|3574853|B2|I||ASA Physical Status Classification|ASA I A normal healthy patient ASA II A patient with mild systemic disease|Participants|Count of Participants|2|2.0||||||
3738922|NCT02025075|3574854|B1|I||ASA Physical Status Classification|ASA I A normal healthy patient ASA II A patient with mild systemic disease|Participants|Count of Participants|1|1.0||||||
3738923|NCT02025075|3574852|B3|||Body Mass Index||kg/m^2|Mean|28.3|28.3|Standard Deviation|7.7|7.7|||
3738924|NCT02025075|3574853|B2|||Body Mass Index||kg/m^2|Mean|28.0|28.0|Standard Deviation|4.5|4.5|||
3738925|NCT02025075|3574854|B1|||Body Mass Index||kg/m^2|Mean|29.7|29.7|Standard Deviation|8.1|8.1|||
3738926|NCT02025075|3574852|B3|United States||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3738927|NCT02025075|3574853|B2|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3738928|NCT02025075|3574854|B1|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3738929|NCT02025075|3574852|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3738930|NCT02025075|3574853|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3738931|NCT02025075|3574854|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3738932|NCT02025075|3574852|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3738933|NCT02025075|3574853|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3738934|NCT02025075|3574854|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3738935|NCT02025075|3574852|B3|||Age||years|Mean|58.7|58.7|Standard Deviation|10.8|10.8|||
3738936|NCT02025075|3574853|B2|||Age||years|Mean|60.7|60.7|Standard Deviation|9.6|9.6|||
3738937|NCT02025075|3574854|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|11.9|11.9|||
3738938|NCT02024971|3574879|B1|Unknown||Participants with Fasting insulin at the start of treatment with Metact Combination Tablets||participants|Number|971|971.0||||||
3738939|NCT02024971|3574879|B1|≥ 100 μU/dL||Participants with Fasting insulin at the start of treatment with Metact Combination Tablets||participants|Number|0|0.0||||||
3738940|NCT02024971|3574879|B1|≥ 50.0 μU/dL to < 100.0 μU/dL||Participants with Fasting insulin at the start of treatment with Metact Combination Tablets||participants|Number|1|1.0||||||
3738941|NCT02024971|3574879|B1|≥ 10.0 μU/dL to < 50.0 μU/dL||Participants with Fasting insulin at the start of treatment with Metact Combination Tablets||participants|Number|46|46.0||||||
3738942|NCT02024971|3574879|B1|≥ 5.0 μU/dL to < 10.0 μU/dL||Participants with Fasting insulin at the start of treatment with Metact Combination Tablets||participants|Number|25|25.0||||||
3738943|NCT02024971|3574879|B1|≥ 1.0 μU/dL to < 5.0 μU/dL||Participants with Fasting insulin at the start of treatment with Metact Combination Tablets||participants|Number|24|24.0||||||
3738944|NCT02024971|3574879|B1|< 1.0 μU/dL||Participants with Fasting insulin at the start of treatment with Metact Combination Tablets||participants|Number|0|0.0||||||
3738945|NCT02024971|3574879|B1|||Fasting insulin at the start of treatment with Metact Combination Tablets||μU/dL|Mean|10.775|10.775|Standard Deviation|9.0804|9.0804|||
3738946|NCT02024971|3574879|B1|Unknown||Participants with Fasting blood glucose at the start of treatment with Metact Combination Tablets||participants|Number|621|621.0||||||
3738947|NCT02024971|3574879|B1|≥ 160 mg/dL||Participants with Fasting blood glucose at the start of treatment with Metact Combination Tablets||participants|Number|134|134.0||||||
3739046|NCT02024971|3574879|B1|Never smoked||Smoking Classification||participants|Number|499|499.0||||||
3738948|NCT02024971|3574879|B1|≥ 140 to < 160 mg/dL||Participants with Fasting blood glucose at the start of treatment with Metact Combination Tablets||participants|Number|80|80.0||||||
3738949|NCT02024971|3574879|B1|≥ 126 to < 140 mg/dL||Participants with Fasting blood glucose at the start of treatment with Metact Combination Tablets||participants|Number|75|75.0||||||
3738950|NCT02024971|3574879|B1|< 126 mg/dL||Participants with Fasting blood glucose at the start of treatment with Metact Combination Tablets||participants|Number|157|157.0||||||
3738951|NCT02024971|3574879|B1|||Fasting blood glucose at the start of treatment with Metact Combination Tablets||mg/dL|Mean|150.1|150.1|Standard Deviation|56.43|56.43|||
3738952|NCT02024971|3574879|B1|Unknown||Participants with HbA1c (NGSP value) at the start of treatment with Metact Combination Tablets||participants|Number|128|128.0||||||
3738953|NCT02024971|3574879|B1|≥ 8.0%||Participants with HbA1c (NGSP value) at the start of treatment with Metact Combination Tablets||participants|Number|290|290.0||||||
3738954|NCT02024971|3574879|B1|≥ 7.0% to < 8.0%||Participants with HbA1c (NGSP value) at the start of treatment with Metact Combination Tablets||participants|Number|340|340.0||||||
3738955|NCT02024971|3574879|B1|≥ 6.0% to < 7.0%||Participants with HbA1c (NGSP value) at the start of treatment with Metact Combination Tablets||participants|Number|270|270.0||||||
3738956|NCT02024971|3574879|B1|< 6.0%||Participants with HbA1c (NGSP value) at the start of treatment with Metact Combination Tablets||participants|Number|39|39.0||||||
3738957|NCT02024971|3574879|B1|||HbA1c (NGSP value) at the start of treatment with Metact Combination Tablets|HbA1c = glycosylated hemoglobin NGSP = National Glycohemoglobin Standardization Program|percentage of HbA1c|Mean|7.69|7.69|Standard Deviation|1.369|1.369|||
3738958|NCT02024971|3574879|B1|Not assessed or compliance status is unknown||Rate of compliance with exercise regimen at the start of treatment with Metact Combination Tablets||participants|Number|128|128.0||||||
3738959|NCT02024971|3574879|B1|< 50%||Rate of compliance with exercise regimen at the start of treatment with Metact Combination Tablets||participants|Number|135|135.0||||||
3738960|NCT02024971|3574879|B1|≥ 50%||Rate of compliance with exercise regimen at the start of treatment with Metact Combination Tablets||participants|Number|305|305.0||||||
3738961|NCT02024971|3574879|B1|≥ 70%||Rate of compliance with exercise regimen at the start of treatment with Metact Combination Tablets||participants|Number|294|294.0||||||
3738962|NCT02024971|3574879|B1|≥ 90%||Rate of compliance with exercise regimen at the start of treatment with Metact Combination Tablets||participants|Number|205|205.0||||||
3738963|NCT02024971|3574879|B1|Not assessed or compliance status is unknown||Rate of compliance with the diet regimen at the start of treatment with Metact Combination Tablets||participants|Number|95|95.0||||||
3738964|NCT02024971|3574879|B1|< 50%||Rate of compliance with the diet regimen at the start of treatment with Metact Combination Tablets||participants|Number|76|76.0||||||
3738965|NCT02024971|3574879|B1|≥ 50%||Rate of compliance with the diet regimen at the start of treatment with Metact Combination Tablets||participants|Number|259|259.0||||||
3738966|NCT02024971|3574879|B1|≥ 70%||Rate of compliance with the diet regimen at the start of treatment with Metact Combination Tablets||participants|Number|367|367.0||||||
3738967|NCT02024971|3574879|B1|≥ 90%||Rate of compliance with the diet regimen at the start of treatment with Metact Combination Tablets||participants|Number|270|270.0||||||
3738968|NCT02024971|3574879|B1|> 45 mg/day of Pio to Metact HD||Daily dose in Pioglitazone monotherapy prior to switching to Metact Combination Tablets|Participants who responded poorly to pioglitazone treatment were reported. 760 participants did not take pioglitazone in Pioglitazone monotherapy prior to dosing of Metact combination tablet in patients who responded poorly to pioglitazone treatment.|participants|Number|0|0.0||||||
3738969|NCT02024971|3574879|B1|> 45 mg/day of Pio to Metact LD||Daily dose in Pioglitazone monotherapy prior to switching to Metact Combination Tablets|Participants who responded poorly to pioglitazone treatment were reported. 760 participants did not take pioglitazone in Pioglitazone monotherapy prior to dosing of Metact combination tablet in patients who responded poorly to pioglitazone treatment.|participants|Number|0|0.0||||||
3738970|NCT02024971|3574879|B1|> 30 mg/day to ≤ 45 mg/day of Pio to Metact HD||Daily dose in Pioglitazone monotherapy prior to switching to Metact Combination Tablets|Participants who responded poorly to pioglitazone treatment were reported. 760 participants did not take pioglitazone in Pioglitazone monotherapy prior to dosing of Metact combination tablet in patients who responded poorly to pioglitazone treatment.|participants|Number|2|2.0||||||
3738971|NCT02024971|3574879|B1|> 30 mg/day to ≤ 45 mg/day of Pio to Metact LD||Daily dose in Pioglitazone monotherapy prior to switching to Metact Combination Tablets|Participants who responded poorly to pioglitazone treatment were reported. 760 participants did not take pioglitazone in Pioglitazone monotherapy prior to dosing of Metact combination tablet in patients who responded poorly to pioglitazone treatment.|participants|Number|0|0.0||||||
3738972|NCT02024971|3574879|B1|> 15 mg/day to ≤ 30 mg/day of Pio to Metact HD||Daily dose in Pioglitazone monotherapy prior to switching to Metact Combination Tablets|Participants who responded poorly to pioglitazone treatment were reported. 760 participants did not take pioglitazone in Pioglitazone monotherapy prior to dosing of Metact combination tablet in patients who responded poorly to pioglitazone treatment.|participants|Number|93|93.0||||||
3738973|NCT02024971|3574879|B1|> 15 mg/day to ≤ 30 mg/day of Pio to Metact LD||Daily dose in Pioglitazone monotherapy prior to switching to Metact Combination Tablets|Participants who responded poorly to pioglitazone treatment were reported. 760 participants did not take pioglitazone in Pioglitazone monotherapy prior to dosing of Metact combination tablet in patients who responded poorly to pioglitazone treatment.|participants|Number|21|21.0||||||
3738974|NCT02024971|3574879|B1|≤ 15 mg/day of Pio to Metact HD||Daily dose in Pioglitazone monotherapy prior to switching to Metact Combination Tablets|Participants who responded poorly to pioglitazone treatment were reported. 760 participants did not take pioglitazone in Pioglitazone monotherapy prior to dosing of Metact combination tablet in patients who responded poorly to pioglitazone treatment.|participants|Number|13|13.0||||||
3738975|NCT02024971|3574879|B1|≤ 15 mg/day of Pio to Metact LD||Daily dose in Pioglitazone monotherapy prior to switching to Metact Combination Tablets|Participants who responded poorly to pioglitazone treatment were reported. 760 participants did not take pioglitazone in Pioglitazone monotherapy prior to dosing of Metact combination tablet in patients who responded poorly to pioglitazone treatment.|participants|Number|178|178.0||||||
3738976|NCT02024971|3574879|B1|> 45 mg/day||Daily dose in Pioglitazone monotherapy prior to dosing of Metact Combination Tablets|Participants who responded poorly to pioglitazone treatment were reported. 760 participants did not take pioglitazone in Pioglitazone monotherapy prior to dosing of Metact combination tablet in patients who responded poorly to pioglitazone treatment.|participants|Number|0|0.0||||||
3738977|NCT02024971|3574879|B1|> 30 mg/day to ≤ 45 mg/day||Daily dose in Pioglitazone monotherapy prior to dosing of Metact Combination Tablets|Participants who responded poorly to pioglitazone treatment were reported. 760 participants did not take pioglitazone in Pioglitazone monotherapy prior to dosing of Metact combination tablet in patients who responded poorly to pioglitazone treatment.|participants|Number|2|2.0||||||
3738978|NCT02024971|3574879|B1|> 15 mg/day to ≤ 30 mg/day||Daily dose in Pioglitazone monotherapy prior to dosing of Metact Combination Tablets|Participants who responded poorly to pioglitazone treatment were reported. 760 participants did not take pioglitazone in Pioglitazone monotherapy prior to dosing of Metact combination tablet in patients who responded poorly to pioglitazone treatment.|participants|Number|114|114.0||||||
3738979|NCT02024971|3574879|B1|≤ 15 mg/day||Daily dose in Pioglitazone monotherapy prior to dosing of Metact Combination Tablets|Participants who responded poorly to pioglitazone treatment were reported. 760 participants did not take pioglitazone in Pioglitazone monotherapy prior to dosing of Metact combination tablet in patients who responded poorly to pioglitazone treatment.|participants|Number|191|191.0||||||
3738980|NCT02024971|3574879|B1|||Daily dose in Pioglitazone monotherapy prior to dosing of Metact Combination Tablets|Participants who responded poorly to pioglitazone treatment were reported. 760 participants did not take pioglitazone in Pioglitazone monotherapy prior to dosing of Metact combination tablet in patients who responded poorly to pioglitazone treatment.|mg/day|Mean|20.7|20.7|Standard Deviation|7.60|7.6|||
3738981|NCT02024971|3574879|B1|Unknown||Response to pioglitazone in Pioglitazone monotherapy prior to dosing of Metact Combination Tablets|625 participants did not take pioglitazone in pioglitazone monotherapy prior to dosing of Metact combination tablet.|participants|Number|61|61.0||||||
3738982|NCT02024971|3574879|B1|Patients excluding inadequate responders||Response to pioglitazone in Pioglitazone monotherapy prior to dosing of Metact Combination Tablets|625 participants did not take pioglitazone in pioglitazone monotherapy prior to dosing of Metact combination tablet.|participants|Number|74|74.0||||||
3738983|NCT02024971|3574879|B1|Inadequate responders||Response to pioglitazone in Pioglitazone monotherapy prior to dosing of Metact Combination Tablets|625 participants did not take pioglitazone in pioglitazone monotherapy prior to dosing of Metact combination tablet.|participants|Number|307|307.0||7.60|7.6|||
3738984|NCT02024971|3574879|B1|Yes||Switch from metformin (> 500 mg/day) to Metact Combination Tablets||participants|Number|234|234.0||||||
3738985|NCT02024971|3574879|B1|No||Switch from metformin (> 500 mg/day) to Metact Combination Tablets||participants|Number|833|833.0||||||
3738986|NCT02024971|3574879|B1|TID or more||Frequency of daily dosing of Metformin prior to dosing of Metact Combination Tablets|579 participants did not take Metformin prior to dosing of Metact combination tablet. TID = Three times a day.|participants|Number|184|184.0||||||
3738987|NCT02024971|3574879|B1|BID||Frequency of daily dosing of Metformin prior to dosing of Metact Combination Tablets|579 participants did not take Metformin prior to dosing of Metact combination tablet. TID = Three times a day.|participants|Number|246|246.0||||||
3738988|NCT02024971|3574879|B1|Daily||Frequency of daily dosing of Metformin prior to dosing of Metact Combination Tablets|579 participants did not take Metformin prior to dosing of Metact combination tablet. TID = Three times a day.|participants|Number|58|58.0||||||
3738989|NCT02024971|3574879|B1|Unknown||Compliance Status of Metformin (Within 3 Months Before Switching to Metact Combination Tablets)|579 participants did not take Metformin prior to dosing of Metact combination tablet.|participants|Number|3|3.0||||||
3738990|NCT02024971|3574879|B1|< 50%||Compliance Status of Metformin (Within 3 Months Before Switching to Metact Combination Tablets)|579 participants did not take Metformin prior to dosing of Metact combination tablet.|participants|Number|8|8.0||||||
3738991|NCT02024971|3574879|B1|≥ 50%||Compliance Status of Metformin (Within 3 Months Before Switching to Metact Combination Tablets)|579 participants did not take Metformin prior to dosing of Metact combination tablet.|participants|Number|22|22.0||||||
3738992|NCT02024971|3574879|B1|≥ 70%||Compliance Status of Metformin (Within 3 Months Before Switching to Metact Combination Tablets)|579 participants did not take Metformin prior to dosing of Metact combination tablet.|participants|Number|75|75.0||||||
3738993|NCT02024971|3574879|B1|≥ 90%||Compliance Status of Metformin (Within 3 Months Before Switching to Metact Combination Tablets)|579 participants did not take Metformin prior to dosing of Metact combination tablet.|participants|Number|380|380.0||||||
3738994|NCT02024971|3574879|B1|Unknown||Compliance Status of Pioglitazone (Within 3 Months Before Switching to Metact Combination Tablets)|348 participants did not take pioglitazone prior to dosing of Metact combination tablet.|participants|Number|18|18.0||||||
3738995|NCT02024971|3574879|B1|< 50%||Compliance Status of Pioglitazone (Within 3 Months Before Switching to Metact Combination Tablets)|348 participants did not take pioglitazone prior to dosing of Metact combination tablet.|participants|Number|6|6.0||||||
3738996|NCT02024971|3574879|B1|≥ 50%||Compliance Status of Pioglitazone (Within 3 Months Before Switching to Metact Combination Tablets)|348 participants did not take pioglitazone prior to dosing of Metact combination tablet.|participants|Number|19|19.0||||||
3738997|NCT02024971|3574879|B1|≥ 70%||Compliance Status of Pioglitazone (Within 3 Months Before Switching to Metact Combination Tablets)|348 participants did not take pioglitazone prior to dosing of Metact combination tablet.|participants|Number|142|142.0||||||
3738998|NCT02024971|3574879|B1|≥ 90%||Compliance Status of Pioglitazone (Within 3 Months Before Switching to Metact Combination Tablets)|348 participants did not take pioglitazone prior to dosing of Metact combination tablet.|participants|Number|534|534.0||||||
3738999|NCT02024971|3574879|B1|Other||Daily Dose of Metformin Before Switching to Metact Combination Tablets,and Metact Dose Assignment|Metact LD=1 tablet of Metact Combination Tablets low dose. Metact HD=1 tablet Metact Combination Tablets high dose, Pio=Pioglitazone. Participants could be counted in more than 1 category. 579 participants did not take Metformin prior to dosing of Metact combination tablet.|participants|Number|2|2.0||||||
3739016|NCT02024971|3574879|B1|> 500 mg/day||Daily Dose of Metformin Prior to Dosing of Metact Combination Tablets|Participants may be counted in more than 1 category.|participants|Number|234|234.0||||||
3739000|NCT02024971|3574879|B1|>750 mg/day of Met to Metact HD||Daily Dose of Metformin Before Switching to Metact Combination Tablets,and Metact Dose Assignment|Metact LD=1 tablet of Metact Combination Tablets low dose. Metact HD=1 tablet Metact Combination Tablets high dose, Pio=Pioglitazone. Participants could be counted in more than 1 category. 579 participants did not take Metformin prior to dosing of Metact combination tablet.|participants|Number|26|26.0||||||
3739001|NCT02024971|3574879|B1|>750 mg/day of Met to Metact LD||Daily Dose of Metformin Before Switching to Metact Combination Tablets,and Metact Dose Assignment|Metact LD=1 tablet of Metact Combination Tablets low dose. Metact HD=1 tablet Metact Combination Tablets high dose, Pio=Pioglitazone. Participants could be counted in more than 1 category. 579 participants did not take Metformin prior to dosing of Metact combination tablet.|participants|Number|45|45.0||||||
3739002|NCT02024971|3574879|B1|>500 to ≤750 mg/day of Met to Metact HD||Daily Dose of Metformin Before Switching to Metact Combination Tablets,and Metact Dose Assignment|Metact LD=1 tablet of Metact Combination Tablets low dose. Metact HD=1 tablet Metact Combination Tablets high dose, Pio=Pioglitazone. Participants could be counted in more than 1 category. 579 participants did not take Metformin prior to dosing of Metact combination tablet.|participants|Number|37|37.0||||||
3739003|NCT02024971|3574879|B1|>500 to ≤750 mg/day of Met to Metact LD||Daily Dose of Metformin Before Switching to Metact Combination Tablets,and Metact Dose Assignment|Metact LD=1 tablet of Metact Combination Tablets low dose. Metact HD=1 tablet Metact Combination Tablets high dose, Pio=Pioglitazone. Participants could be counted in more than 1 category. 579 participants did not take Metformin prior to dosing of Metact combination tablet.|participants|Number|124|124.0||||||
3739004|NCT02024971|3574879|B1|≤500 mg/day of Met to Metact HD||Daily Dose of Metformin Before Switching to Metact Combination Tablets,and Metact Dose Assignment|Metact LD=1 tablet of Metact Combination Tablets low dose. Metact HD=1 tablet Metact Combination Tablets high dose, Pio=Pioglitazone. Participants could be counted in more than 1 category. 579 participants did not take Metformin prior to dosing of Metact combination tablet.|participants|Number|61|61.0||||||
3739005|NCT02024971|3574879|B1|≤500 mg/day of Met to Metact LD||Daily Dose of Metformin Before Switching to Metact Combination Tablets,and Metact Dose Assignment|Metact LD=1 tablet of Metact Combination Tablets low dose. Metact HD=1 tablet Metact Combination Tablets high dose, Pio=Pioglitazone. Participants could be counted in more than 1 category. 579 participants did not take Metformin prior to dosing of Metact combination tablet.|participants|Number|193|193.0||||||
3739006|NCT02024971|3574879|B1|≥2250 mg/day of Met to Metact HD||Daily Dose of Metformin Before Switching to Metact Combination Tablets,and Metact Dose Assignment|Metact LD=1 tablet of Metact Combination Tablets low dose. Metact HD=1 tablet Metact Combination Tablets high dose, Pio=Pioglitazone. Participants could be counted in more than 1 category. 579 participants did not take Metformin prior to dosing of Metact combination tablet.|participants|Number|4|4.0||||||
3739007|NCT02024971|3574879|B1|≥2250 mg/day of Met to Metact LD||Daily Dose of Metformin Before Switching to Metact Combination Tablets,and Metact Dose Assignment|Metact LD=1 tablet of Metact Combination Tablets low dose. Metact HD=1 tablet Metact Combination Tablets high dose, Pio=Pioglitazone. Participants could be counted in more than 1 category. 579 participants did not take Metformin prior to dosing of Metact combination tablet.|participants|Number|2|2.0||||||
3739008|NCT02024971|3574879|B1|≥1500 to <2250 mg/day of Met to Metact HD||Daily Dose of Metformin Before Switching to Metact Combination Tablets,and Metact Dose Assignment|Metact LD=1 tablet of Metact Combination Tablets low dose. Metact HD=1 tablet Metact Combination Tablets high dose, Pio=Pioglitazone. Participants could be counted in more than 1 category. 579 participants did not take Metformin prior to dosing of Metact combination tablet.|participants|Number|10|10.0||||||
3739009|NCT02024971|3574879|B1|≥1500 to <2250 mg/day of Met to Metact LD||Daily Dose of Metformin Before Switching to Metact Combination Tablets,and Metact Dose Assignment|Metact LD=1 tablet of Metact Combination Tablets low dose. Metact HD=1 tablet Metact Combination Tablets high dose, Pio=Pioglitazone. Participants could be counted in more than 1 category. 579 participants did not take Metformin prior to dosing of Metact combination tablet.|participants|Number|12|12.0||||||
3739010|NCT02024971|3574879|B1|≥750 to <1500 mg/day of Met to Metact HD||Daily Dose of Metformin Before Switching to Metact Combination Tablets,and Metact Dose Assignment|Metact LD=1 tablet of Metact Combination Tablets low dose. Metact HD=1 tablet Metact Combination Tablets high dose, Pio=Pioglitazone. Participants could be counted in more than 1 category. 579 participants did not take Metformin prior to dosing of Metact combination tablet.|participants|Number|49|49.0||||||
3739011|NCT02024971|3574879|B1|≥750 to <1500 mg/day of Met to Metact LD||Daily Dose of Metformin Before Switching to Metact Combination Tablets,and Metact Dose Assignment|Metact LD=1 tablet of Metact Combination Tablets low dose. Metact HD=1 tablet Metact Combination Tablets high dose, Pio=Pioglitazone. Participants could be counted in more than 1 category. 579 participants did not take Metformin prior to dosing of Metact combination tablet.|participants|Number|155|155.0||||||
3739012|NCT02024971|3574879|B1|≥500 to <750 mg/day of Met to Metact HD||Daily Dose of Metformin Before Switching to Metact Combination Tablets,and Metact Dose Assignment|Metact LD=1 tablet of Metact Combination Tablets low dose. Metact HD=1 tablet Metact Combination Tablets high dose, Pio=Pioglitazone. Participants could be counted in more than 1 category. 579 participants did not take Metformin prior to dosing of Metact combination tablet.|participants|Number|55|55.0||||||
3739013|NCT02024971|3574879|B1|≥500 to <750 mg/day of Met to Metact LD||Daily Dose of Metformin Before Switching to Metact Combination Tablets,and Metact Dose Assignment|Metact LD=1 tablet of Metact Combination Tablets low dose. Metact HD=1 tablet Metact Combination Tablets high dose, Pio=Pioglitazone. Participants could be counted in more than 1 category. 579 participants did not take Metformin prior to dosing of Metact combination tablet.|participants|Number|174|174.0||||||
3739014|NCT02024971|3574879|B1|<500 mg/day of Met to Metact HD||Daily Dose of Metformin Before Switching to Metact Combination Tablets,and Metact Dose Assignment|Metact LD=1 tablet of Metact Combination Tablets low dose. Metact HD=1 tablet Metact Combination Tablets high dose, Pio=Pioglitazone. Participants could be counted in more than 1 category. 579 participants did not take Metformin prior to dosing of Metact combination tablet.|participants|Number|6|6.0||||||
3739015|NCT02024971|3574879|B1|<500 mg/day of Met to Metact LD||Daily Dose of Metformin Before Switching to Metact Combination Tablets,and Metact Dose Assignment|Metact LD=1 tablet of Metact Combination Tablets low dose. Metact HD=1 tablet Metact Combination Tablets high dose, Pio=Pioglitazone. Participants could be counted in more than 1 category. 579 participants did not take Metformin prior to dosing of Metact combination tablet.|participants|Number|19|19.0||||||
3739017|NCT02024971|3574879|B1|> 750 mg/day||Daily Dose of Metformin Prior to Dosing of Metact Combination Tablets|Participants may be counted in more than 1 category.|participants|Number|71|71.0||||||
3739018|NCT02024971|3574879|B1|> 500 to ≤ 750 mg/day||Daily Dose of Metformin Prior to Dosing of Metact Combination Tablets|Participants may be counted in more than 1 category.|participants|Number|163|163.0||||||
3739019|NCT02024971|3574879|B1|≤ 500 mg/day||Daily Dose of Metformin Prior to Dosing of Metact Combination Tablets|Participants may be counted in more than 1 category.|participants|Number|254|254.0||||||
3739020|NCT02024971|3574879|B1|≥ 2250 mg/day||Daily Dose of Metformin Prior to Dosing of Metact Combination Tablets|Participants may be counted in more than 1 category.|participants|Number|6|6.0||||||
3739021|NCT02024971|3574879|B1|≥ 1500 to < 2250 mg/day||Daily Dose of Metformin Prior to Dosing of Metact Combination Tablets|Participants may be counted in more than 1 category.|participants|Number|22|22.0||||||
3739022|NCT02024971|3574879|B1|≥ 750 to < 1500 mg/day||Daily Dose of Metformin Prior to Dosing of Metact Combination Tablets|Participants may be counted in more than 1 category.|participants|Number|206|206.0||||||
3739023|NCT02024971|3574879|B1|≥ 500 to < 750 mg/day||Daily Dose of Metformin Prior to Dosing of Metact Combination Tablets|Participants may be counted in more than 1 category.|participants|Number|229|229.0||||||
3739024|NCT02024971|3574879|B1|< 500 mg/day||Daily Dose of Metformin Prior to Dosing of Metact Combination Tablets|Participants may be counted in more than 1 category.|participants|Number|25|25.0||||||
3739025|NCT02024971|3574879|B1|||Daily Dose of Metformin Prior to Dosing of Metact Combination Tablets||mg/day|Mean|681.4|681.4|Standard Deviation|310.08|310.08|||
3739026|NCT02024971|3574879|B1|>45 mg/day of Pio to Metact HD||Daily Dose of Pioglitazone Before Switching to Metact Combination Tablets,and Metact Dose Assignment|Metact LD=1 tablet of Metact Combination Tablets low dose. Metact HD=1 tablet Metact Combination Tablets high dose, Pio=Pioglitazone. 348 participants did not take pioglitazone prior to dosing of Metact combination tablet.|participants|Number|0|0.0||||||
3739027|NCT02024971|3574879|B1|>45 mg/day of Pio to Metact LD||Daily Dose of Pioglitazone Before Switching to Metact Combination Tablets,and Metact Dose Assignment|Metact LD=1 tablet of Metact Combination Tablets low dose. Metact HD=1 tablet Metact Combination Tablets high dose, Pio=Pioglitazone. 348 participants did not take pioglitazone prior to dosing of Metact combination tablet.|participants|Number|0|0.0||||||
3739028|NCT02024971|3574879|B1|>30 to ≤45 mg/day of Pio to Metact HD||Daily Dose of Pioglitazone Before Switching to Metact Combination Tablets,and Metact Dose Assignment|Metact LD=1 tablet of Metact Combination Tablets low dose. Metact HD=1 tablet Metact Combination Tablets high dose, Pio=Pioglitazone. 348 participants did not take pioglitazone prior to dosing of Metact combination tablet.|participants|Number|4|4.0||||||
3739029|NCT02024971|3574879|B1|>30 to ≤45 mg/day of Pio to Metact LD||Daily Dose of Pioglitazone Before Switching to Metact Combination Tablets,and Metact Dose Assignment|Metact LD=1 tablet of Metact Combination Tablets low dose. Metact HD=1 tablet Metact Combination Tablets high dose, Pio=Pioglitazone. 348 participants did not take pioglitazone prior to dosing of Metact combination tablet.|participants|Number|1|1.0||||||
3739030|NCT02024971|3574879|B1|>15 to ≤30 mg/day of Pio to Metact HD||Daily Dose of Pioglitazone Before Switching to Metact Combination Tablets,and Metact Dose Assignment|Metact LD=1 tablet of Metact Combination Tablets low dose. Metact HD=1 tablet Metact Combination Tablets high dose, Pio=Pioglitazone. 348 participants did not take pioglitazone prior to dosing of Metact combination tablet.|participants|Number|212|212.0||||||
3739031|NCT02024971|3574879|B1|>15 to ≤30 mg/day of Pio to Metact LD||Daily Dose of Pioglitazone Before Switching to Metact Combination Tablets,and Metact Dose Assignment|Metact LD=1 tablet of Metact Combination Tablets low dose. Metact HD=1 tablet Metact Combination Tablets high dose, Pio=Pioglitazone. 348 participants did not take pioglitazone prior to dosing of Metact combination tablet.|participants|Number|46|46.0||||||
3739032|NCT02024971|3574879|B1|≤15 mg/day of Pio to Metact HD||Daily Dose of Pioglitazone Before Switching to Metact Combination Tablets,and Metact Dose Assignment|Metact LD=1 tablet of Metact Combination Tablets low dose. Metact HD=1 tablet Metact Combination Tablets high dose, Pio=Pioglitazone. 348 participants did not take pioglitazone prior to dosing of Metact combination tablet.|participants|Number|27|27.0||||||
3739033|NCT02024971|3574879|B1|≤15 mg/day of Pio to Metact LD||Daily Dose of Pioglitazone Before Switching to Metact Combination Tablets,and Metact Dose Assignment|Metact LD=1 tablet of Metact Combination Tablets low dose. Metact HD=1 tablet Metact Combination Tablets high dose, Pio=Pioglitazone. 348 participants did not take pioglitazone prior to dosing of Metact combination tablet.|participants|Number|429|429.0||||||
3739034|NCT02024971|3574879|B1|> 45 mg/day||Daily Dose of Pioglitazone Prior to Dosing of Metact Combination Tablets|348 participants did not take pioglitazone prior to dosing of Metact combination tablet.|participants|Number|0|0.0||||||
3739035|NCT02024971|3574879|B1|> 30 to ≤ 45 mg/day||Daily Dose of Pioglitazone Prior to Dosing of Metact Combination Tablets|348 participants did not take pioglitazone prior to dosing of Metact combination tablet.|participants|Number|5|5.0||||||
3739036|NCT02024971|3574879|B1|> 15 to ≤ 30 mg/day||Daily Dose of Pioglitazone Prior to Dosing of Metact Combination Tablets|348 participants did not take pioglitazone prior to dosing of Metact combination tablet.|participants|Number|258|258.0||||||
3739037|NCT02024971|3574879|B1|≤ 15 mg/day||Daily Dose of Pioglitazone Prior to Dosing of Metact Combination Tablets|348 participants did not take pioglitazone prior to dosing of Metact combination tablet.|participants|Number|456|456.0||||||
3739038|NCT02024971|3574879|B1|||Daily Dose of Pioglitazone Prior to Dosing of Metact Combination Tablets||mg/day|Mean|20.5|20.5|Standard Deviation|7.60|7.6|||
3739039|NCT02024971|3574879|B1|Neither pioglitazone nor metformin prior to dosing||Status of Administration of Pioglitazone and Metformin Prior to Dosing of Metact Combination Tablets||participants|Number|137|137.0||||||
3739040|NCT02024971|3574879|B1|Metformin alone prior to dosing||Status of Administration of Pioglitazone and Metformin Prior to Dosing of Metact Combination Tablets||participants|Number|211|211.0||||||
3739041|NCT02024971|3574879|B1|Pioglitazone alone prior to dosing||Status of Administration of Pioglitazone and Metformin Prior to Dosing of Metact Combination Tablets||participants|Number|442|442.0||||||
3739042|NCT02024971|3574879|B1|Pioglitazone plus metformin prior to dosing||Status of Administration of Pioglitazone and Metformin Prior to Dosing of Metact Combination Tablets||participants|Number|277|277.0||||||
3739043|NCT02024971|3574879|B1|Unknown||Smoking Classification||participants|Number|217|217.0||||||
3739047|NCT02024971|3574879|B1|Unknown||Alcohol History (Drinking Alcohol-Containing Beverages Nearly Every Day)||participants|Number|177|177.0||||||
3739048|NCT02024971|3574879|B1|Yes||Alcohol History (Drinking Alcohol-Containing Beverages Nearly Every Day)||participants|Number|293|293.0||||||
3739049|NCT02024971|3574879|B1|No||Alcohol History (Drinking Alcohol-Containing Beverages Nearly Every Day)||participants|Number|597|597.0||||||
3739050|NCT02024971|3574879|B1|Unknown||Presence of Medical History|Breakdown of medical history was categorized as liver disease, renal disease, heart disease, cerebrovascular disease, malignant tumor and any other disease from those mentioned above. Only participants with medical history are presented.|participants|Number|49|49.0||||||
3739051|NCT02024971|3574879|B1|Yes||Presence of Medical History|Breakdown of medical history was categorized as liver disease, renal disease, heart disease, cerebrovascular disease, malignant tumor and any other disease from those mentioned above. Only participants with medical history are presented.|participants|Number|143|143.0||||||
3739052|NCT02024971|3574879|B1|No||Presence of Medical History|Breakdown of medical history was categorized as liver disease, renal disease, heart disease, cerebrovascular disease, malignant tumor and any other disease from those mentioned above. Only participants with medical history are presented.|participants|Number|875|875.0||||||
3739053|NCT02024971|3574879|B1|Large intestine carcinoma||Complications: Breakdown of Malignant Tumors|Only participants with malignant tumors are reported. Participants may also be counted in more than 1 category.|participants|Number|4|4.0||||||
3739054|NCT02024971|3574879|B1|Gastric cancer||Complications: Breakdown of Malignant Tumors|Only participants with malignant tumors are reported. Participants may also be counted in more than 1 category.|participants|Number|1|1.0||||||
3739055|NCT02024971|3574879|B1|Dermatitis allergic||Complications: Breakdown of Allergic Conditions|Only participants with allergic conditions are reported. Participants may also be counted in more than 1 category.|participants|Number|11|11.0||||||
3739056|NCT02024971|3574879|B1|Rhinitis allergic||Complications: Breakdown of Allergic Conditions|Only participants with allergic conditions are reported. Participants may also be counted in more than 1 category.|participants|Number|38|38.0||||||
3739057|NCT02024971|3574879|B1|Pollinosis||Complications: Breakdown of Allergic Conditions|Only participants with allergic conditions are reported. Participants may also be counted in more than 1 category.|participants|Number|12|12.0||||||
3739058|NCT02024971|3574879|B1|Asthma bronchial||Complications: Breakdown of Allergic Conditions|Only participants with allergic conditions are reported. Participants may also be counted in more than 1 category.|participants|Number|33|33.0||||||
3739059|NCT02024971|3574879|B1|Class IV||Stages of Cardiac Failure (New York Heart Association [NYHA] Classification)|Only participants with cardiac failure are reported. NYHA Class definitions are as follows: Class I - No limitation of physical activity; Class II - Slight limitation of physical activity; Class III - Marked limitation of physical activity; Class IV - Unable to carry on any physical activity without discomfort.|participants|Number|0|0.0||||||
3739060|NCT02024971|3574879|B1|Class III||Stages of Cardiac Failure (New York Heart Association [NYHA] Classification)|Only participants with cardiac failure are reported. NYHA Class definitions are as follows: Class I - No limitation of physical activity; Class II - Slight limitation of physical activity; Class III - Marked limitation of physical activity; Class IV - Unable to carry on any physical activity without discomfort.|participants|Number|0|0.0||||||
3739061|NCT02024971|3574879|B1|Class II||Stages of Cardiac Failure (New York Heart Association [NYHA] Classification)|Only participants with cardiac failure are reported. NYHA Class definitions are as follows: Class I - No limitation of physical activity; Class II - Slight limitation of physical activity; Class III - Marked limitation of physical activity; Class IV - Unable to carry on any physical activity without discomfort.|participants|Number|3|3.0||||||
3739062|NCT02024971|3574879|B1|Class I||Stages of Cardiac Failure (New York Heart Association [NYHA] Classification)|Only participants with cardiac failure are reported. NYHA Class definitions are as follows: Class I - No limitation of physical activity; Class II - Slight limitation of physical activity; Class III - Marked limitation of physical activity; Class IV - Unable to carry on any physical activity without discomfort.|participants|Number|14|14.0||||||
3739063|NCT02024971|3574879|B1|Cerebral infarction (including late effects)||Complications: Breakdown of Heart or Cerebrovascular Diseases|Only participants with heart or cerebrovascular diseases are reported. Participants may also be counted in more than 1 category.|participants|Number|52|52.0||||||
3739064|NCT02024971|3574879|B1|Angina pectoris||Complications: Breakdown of Heart or Cerebrovascular Diseases|Only participants with heart or cerebrovascular diseases are reported. Participants may also be counted in more than 1 category.|participants|Number|55|55.0||||||
3739065|NCT02024971|3574879|B1|Myocardial infarction||Complications: Breakdown of Heart or Cerebrovascular Diseases|Only participants with heart or cerebrovascular diseases are reported. Participants may also be counted in more than 1 category.|participants|Number|9|9.0||||||
3739066|NCT02024971|3574879|B1|Cardiac failure||Complications: Breakdown of Heart or Cerebrovascular Diseases|Only participants with heart or cerebrovascular diseases are reported. Participants may also be counted in more than 1 category.|participants|Number|17|17.0||||||
3739067|NCT02024971|3574879|B1|Renal failure chronic||Complications: Breakdown of Renal Diseases|Only participants with renal diseases are reported. Participants may also be counted in more than 1 category.|participants|Number|4|4.0||||||
3739068|NCT02024971|3574879|B1|Nephrotic syndrome||Complications: Breakdown of Renal Diseases|Only participants with renal diseases are reported. Participants may also be counted in more than 1 category.|participants|Number|2|2.0||||||
3739069|NCT02024971|3574879|B1|Hepatic cirrhosis||Complications: Breakdown of Liver Diseases|Only participants with liver diseases are reported. Participants may also be counted in more than 1 category.|participants|Number|1|1.0||||||
3739070|NCT02024971|3574879|B1|Chronic hepatitis||Complications: Breakdown of Liver Diseases|Only participants with liver diseases are reported. Participants may also be counted in more than 1 category.|participants|Number|17|17.0||||||
3739071|NCT02024971|3574879|B1|Hepatitis alcoholic||Complications: Breakdown of Liver Diseases|Only participants with liver diseases are reported. Participants may also be counted in more than 1 category.|participants|Number|14|14.0||||||
3739072|NCT02024971|3574879|B1|Hepatic steatosis||Complications: Breakdown of Liver Diseases|Only participants with liver diseases are reported. Participants may also be counted in more than 1 category.|participants|Number|107|107.0||||||
3739073|NCT02024971|3574879|B1|Hyperuricaemia||Complications: Breakdown of Lifestyle-Related Diseases (Excluding Diabetes Mellitus)|Participants may be counted in more than 1 category.|participants|Number|79|79.0||||||
3739074|NCT02024971|3574879|B1|Dyslipidaemia||Complications: Breakdown of Lifestyle-Related Diseases (Excluding Diabetes Mellitus)|Participants may be counted in more than 1 category.|participants|Number|634|634.0||||||
3739075|NCT02024971|3574879|B1|Hypertension||Complications: Breakdown of Lifestyle-Related Diseases (Excluding Diabetes Mellitus)|Participants may be counted in more than 1 category.|participants|Number|656|656.0||||||
3739076|NCT02024971|3574879|B1|Diabetic neuropathy||Complications: Breakdown of Diabetic Complications|Only participants with diabetic complications are reported. Participants may also be counted in more than 1 category.|participants|Number|74|74.0||||||
3739077|NCT02024971|3574879|B1|Diabetic retinopathy||Complications: Breakdown of Diabetic Complications|Only participants with diabetic complications are reported. Participants may also be counted in more than 1 category.|participants|Number|56|56.0||||||
3739078|NCT02024971|3574879|B1|Diabetic nephropathy||Complications: Breakdown of Diabetic Complications|Only participants with diabetic complications are reported. Participants may also be counted in more than 1 category.|participants|Number|81|81.0||||||
3739079|NCT02024971|3574879|B1|Other||Breakdown of Complications|Participants may be counted in more than 1 category. DM=diabetes mellitus.|participants|Number|349|349.0||||||
3739080|NCT02024971|3574879|B1|Malignant tumors||Breakdown of Complications|Participants may be counted in more than 1 category. DM=diabetes mellitus.|participants|Number|10|10.0||||||
3739081|NCT02024971|3574879|B1|Allergic conditions||Breakdown of Complications|Participants may be counted in more than 1 category. DM=diabetes mellitus.|participants|Number|84|84.0||||||
3739082|NCT02024971|3574879|B1|Heart or cerebrovascular diseases||Breakdown of Complications|Participants may be counted in more than 1 category. DM=diabetes mellitus.|participants|Number|144|144.0||||||
3739083|NCT02024971|3574879|B1|Renal diseases||Breakdown of Complications|Participants may be counted in more than 1 category. DM=diabetes mellitus.|participants|Number|9|9.0||||||
3739084|NCT02024971|3574879|B1|Liver diseases||Breakdown of Complications|Participants may be counted in more than 1 category. DM=diabetes mellitus.|participants|Number|139|139.0||||||
3739085|NCT02024971|3574879|B1|Lifestyle-related diseases (excluding DM)||Breakdown of Complications|Participants may be counted in more than 1 category. DM=diabetes mellitus.|participants|Number|858|858.0||||||
3739086|NCT02024971|3574879|B1|Diabetic complications||Breakdown of Complications|Participants may be counted in more than 1 category. DM=diabetes mellitus.|participants|Number|169|169.0||||||
3739087|NCT02024971|3574879|B1|Yes||Presence of Complications||participants|Number|935|935.0||||||
3739088|NCT02024971|3574879|B1|No||Presence of Complications||participants|Number|132|132.0||||||
3739089|NCT02024971|3574879|B1|Unknown||History of Allergies||participants|Number|41|41.0||||||
3739090|NCT02024971|3574879|B1|Yes||History of Allergies||participants|Number|95|95.0||||||
3739091|NCT02024971|3574879|B1|No||History of Allergies||participants|Number|931|931.0||||||
3739092|NCT02024971|3574879|B1|Outpatient and Inpatient||Healthcare Category||participants|Number|12|12.0||||||
3739093|NCT02024971|3574879|B1|Inpatient||Healthcare Category||participants|Number|6|6.0||||||
3739094|NCT02024971|3574879|B1|Outpatient||Healthcare Category||participants|Number|1049|1049.0||||||
3739095|NCT02024971|3574879|B1|Unknown||Duration of Type 2 Diabetes, Customized||participants|Number|337|337.0||||||
3739096|NCT02024971|3574879|B1|≥10 years||Duration of Type 2 Diabetes, Customized||participants|Number|216|216.0||||||
3739097|NCT02024971|3574879|B1|≥5 to <10 years||Duration of Type 2 Diabetes, Customized||participants|Number|183|183.0||||||
3739098|NCT02024971|3574879|B1|≥2 to <5 years||Duration of Type 2 Diabetes, Customized||participants|Number|168|168.0||||||
3739099|NCT02024971|3574879|B1|<2 years||Duration of Type 2 Diabetes, Customized||participants|Number|163|163.0||||||
3739100|NCT02024971|3574879|B1|||Duration of Type 2 Diabetes||years|Mean|7.5|7.5|Standard Deviation|6.59|6.59|||
3739101|NCT02024971|3574879|B1|Unknown||Body Mass Index, Customized||participants|Number|391|391.0||||||
3739102|NCT02024971|3574879|B1|≥30 kg/m^2||Body Mass Index, Customized||participants|Number|125|125.0||||||
3739103|NCT02024971|3574879|B1|≥25 to <30 kg/m^2||Body Mass Index, Customized||participants|Number|280|280.0||||||
3739104|NCT02024971|3574879|B1|≥18.5 to <25 kg/m^2||Body Mass Index, Customized||participants|Number|261|261.0||||||
3739105|NCT02024971|3574879|B1|<18.5 kg/m^2||Body Mass Index, Customized||participants|Number|10|10.0||||||
3739106|NCT02024971|3574879|B1|||Body Mass Index (BMI)||kg/m^2|Mean|26.61|26.61|Standard Deviation|4.738|4.738|||
3739107|NCT02024971|3574879|B1|Unmeasured||Weight, Customized||participants|Number|371|371.0||||||
3739108|NCT02024971|3574879|B1|≥70 kg||Weight, Customized||participants|Number|310|310.0||||||
3739109|NCT02024971|3574879|B1|≥60 to <70 kg||Weight, Customized||participants|Number|193|193.0||||||
3739110|NCT02024971|3574879|B1|≥50 to <60 kg||Weight, Customized||participants|Number|138|138.0||||||
3739111|NCT02024971|3574879|B1|≥40 to <50 kg||Weight, Customized||participants|Number|48|48.0||||||
3739112|NCT02024971|3574879|B1|<40 kg||Weight, Customized||participants|Number|7|7.0||||||
3739113|NCT02024971|3574879|B1|||Weight||kg|Mean|69.0|69.0|Standard Deviation|15.36|15.36|||
3739114|NCT02024971|3574879|B1|Pregnant||Pregnancy status (Females)|Female participants only (n=450)|participants|Number|0|0.0||||||
3739115|NCT02024971|3574879|B1|Not pregnant||Pregnancy status (Females)|Female participants only (n=450)|participants|Number|450|450.0||||||
3739116|NCT02024971|3574879|B1||Male|Sex: Female, Male||Participants|Count of Participants|617|617.0||||||
3739117|NCT02024971|3574879|B1||Female|Sex: Female, Male||Participants|Count of Participants|450|450.0||||||
3739118|NCT02024971|3574879|B1|≥80 years||Age, Customized||participants|Number|77|77.0||||||
3739119|NCT02024971|3574879|B1|≥70 to <80 years||Age, Customized||participants|Number|294|294.0||||||
3739120|NCT02024971|3574879|B1|≥60 to <70 years||Age, Customized||participants|Number|347|347.0||||||
3739121|NCT02024971|3574879|B1|≥50 to <60 years||Age, Customized||participants|Number|218|218.0||||||
3739122|NCT02024971|3574879|B1|≥40 to <50 years||Age, Customized||participants|Number|91|91.0||||||
3739123|NCT02024971|3574879|B1|≥30 to <40 years||Age, Customized||participants|Number|33|33.0||||||
3739124|NCT02024971|3574879|B1|≥20 to <30 years||Age, Customized||participants|Number|7|7.0||||||
3739125|NCT02024971|3574879|B1|<20 years||Age, Customized||participants|Number|0|0.0||||||
3739126|NCT02024971|3574879|B1|≥65 years||Age, Customized||participants|Number|533|533.0||||||
3739127|NCT02024971|3574879|B1|<65 years||Age, Customized||participants|Number|534|534.0||||||
3739128|NCT02024971|3574879|B1|||Age||years|Mean|63.7|63.7|Standard Deviation|12.01|12.01|||
3739129|NCT02024932|3574886|B7|Male||Sex/Gender, Customized||Participants|Number|37|37.0||||||
3739130|NCT02024932|3574887|B6|Male||Sex/Gender, Customized||Participants|Number|9|9.0||||||
3739131|NCT02024932|3574888|B5|Male||Sex/Gender, Customized||Participants|Number|18|18.0||||||
3739132|NCT02024932|3574889|B4|Male||Sex/Gender, Customized||Participants|Number|2|2.0||||||
3739133|NCT02024932|3574890|B3|Male||Sex/Gender, Customized||Participants|Number|2|2.0||||||
3739134|NCT02024932|3574891|B2|Male||Sex/Gender, Customized||Participants|Number|4|4.0||||||
3739135|NCT02024932|3574892|B1|Male||Sex/Gender, Customized||Participants|Number|2|2.0||||||
3739136|NCT02024932|3574886|B7|||Age||Years|Mean|56.0|56.0|Standard Deviation|10.33|10.33|||
3739137|NCT02024932|3574887|B6|||Age||Years|Mean|54.0|54.0|Standard Deviation|5.94|5.94|||
3739138|NCT02024932|3574888|B5|||Age||Years|Mean|57.0|57.0|Standard Deviation|55.5|55.5|||
3739139|NCT02024932|3574889|B4|||Age||Years|Mean|41.5|41.5|Standard Deviation|4.95|4.95|||
3739140|NCT02024932|3574890|B3|||Age||Years|Mean|59.5|59.5|Standard Deviation|7.78|7.78|||
3739141|NCT02024932|3574891|B2|||Age||Years|Mean|56.0|56.0|Standard Deviation|12.33|12.33|||
3739142|NCT02024932|3574892|B1|||Age||Years|Mean|67.0|67.0|Standard Deviation|5.66|5.66|||
3739143|NCT02024867|3574954|B3|No Growth||Culture results||participants|Number|4|4.0||||||
3739144|NCT02024867|3574955|B2|No Growth||Culture results||participants|Number|1|1.0||||||
3739145|NCT02024867|3574956|B1|No Growth||Culture results||participants|Number|3|3.0||||||
3739146|NCT02024867|3574954|B3|Other||Culture results||participants|Number|28|28.0||||||
3739147|NCT02024867|3574955|B2|Other||Culture results||participants|Number|14|14.0||||||
3739148|NCT02024867|3574956|B1|Other||Culture results||participants|Number|14|14.0||||||
3739149|NCT02024867|3574954|B3|MSSA||Culture results||participants|Number|79|79.0||||||
3739150|NCT02024867|3574955|B2|MSSA||Culture results||participants|Number|40|40.0||||||
3739151|NCT02024867|3574956|B1|MSSA||Culture results||participants|Number|39|39.0||||||
3739152|NCT02024867|3574954|B3|MRSA||Culture results||participants|Number|138|138.0||||||
3739153|NCT02024867|3574955|B2|MRSA||Culture results||participants|Number|69|69.0||||||
3739154|NCT02024867|3574956|B1|MRSA||Culture results||participants|Number|69|69.0||||||
3739155|NCT02024867|3574954|B3|||Abscess size||cm2|Median|6.25|6.25|Inter-Quartile Range|||4.0|12.0|
3739156|NCT02024867|3574955|B2|||Abscess size||cm2|Median|6.25|6.25|Inter-Quartile Range|||4.0|12.0|
3739157|NCT02024867|3574956|B1|||Abscess size||cm2|Median|6.25|6.25|Inter-Quartile Range|||4.0|12.0|
3739158|NCT02024867|3574954|B3|No||Presence of ≥ 2 Abscesses||participants|Number|231|231.0||||||
3739159|NCT02024867|3574955|B2|No||Presence of ≥ 2 Abscesses||participants|Number|117|117.0||||||
3739160|NCT02024867|3574956|B1|No||Presence of ≥ 2 Abscesses||participants|Number|114|114.0||||||
3739161|NCT02024867|3574954|B3|Yes||Presence of ≥ 2 Abscesses||participants|Number|18|18.0||||||
3739162|NCT02024867|3574955|B2|Yes||Presence of ≥ 2 Abscesses||participants|Number|7|7.0||||||
3739163|NCT02024867|3574956|B1|Yes||Presence of ≥ 2 Abscesses||participants|Number|11|11.0||||||
3739164|NCT02024867|3574954|B3|No||History of household contact with abscess||participants|Number|124|124.0||||||
3739165|NCT02024867|3574955|B2|No||History of household contact with abscess||participants|Number|61|61.0||||||
3739166|NCT02024867|3574956|B1|No||History of household contact with abscess||participants|Number|63|63.0||||||
3739167|NCT02024867|3574954|B3|Yes||History of household contact with abscess||participants|Number|125|125.0||||||
3739168|NCT02024867|3574955|B2|Yes||History of household contact with abscess||participants|Number|63|63.0||||||
3739169|NCT02024867|3574956|B1|Yes||History of household contact with abscess||participants|Number|62|62.0||||||
3739170|NCT02024867|3574954|B3|No||History of abscess||participants|Number|157|157.0||||||
3739171|NCT02024867|3574955|B2|No||History of abscess||participants|Number|82|82.0||||||
3739172|NCT02024867|3574956|B1|No||History of abscess||participants|Number|75|75.0||||||
3739173|NCT02024867|3574954|B3|Yes||History of abscess||participants|Number|92|92.0||||||
3739174|NCT02024867|3574955|B2|Yes||History of abscess||participants|Number|42|42.0||||||
3739175|NCT02024867|3574956|B1|Yes||History of abscess||participants|Number|50|50.0||||||
3739176|NCT02024867|3574954|B3|No||Clindamycin administered in ED||participants|Number|208|208.0||||||
3739177|NCT02024867|3574955|B2|No||Clindamycin administered in ED||participants|Number|95|95.0||||||
3739178|NCT02024867|3574956|B1|No||Clindamycin administered in ED||participants|Number|113|113.0||||||
3739179|NCT02024867|3574954|B3|Yes||Clindamycin administered in ED||participants|Number|41|41.0||||||
3739180|NCT02024867|3574955|B2|Yes||Clindamycin administered in ED||participants|Number|29|29.0||||||
3739181|NCT02024867|3574956|B1|Yes||Clindamycin administered in ED||participants|Number|12|12.0||||||
3739182|NCT02024867|3574954|B3|no cellulitis||presence of cellulitis||participants|Number|189|189.0||||||
3739183|NCT02024867|3574955|B2|no cellulitis||presence of cellulitis||participants|Number|86|86.0||||||
3739184|NCT02024867|3574956|B1|no cellulitis||presence of cellulitis||participants|Number|103|103.0||||||
3739185|NCT02024867|3574954|B3|cellulitis||presence of cellulitis||participants|Number|60|60.0||||||
3739186|NCT02024867|3574955|B2|cellulitis||presence of cellulitis||participants|Number|38|38.0||||||
3739187|NCT02024867|3574956|B1|cellulitis||presence of cellulitis||participants|Number|22|22.0||||||
3739188|NCT02024867|3574954|B3|no fever||presence of fever||participants|Number|227|227.0||||||
3739189|NCT02024867|3574955|B2|no fever||presence of fever||participants|Number|113|113.0||||||
3739190|NCT02024867|3574956|B1|no fever||presence of fever||participants|Number|114|114.0||||||
3739191|NCT02024867|3574954|B3|fever||presence of fever||participants|Number|22|22.0||||||
3739192|NCT02024867|3574955|B2|fever||presence of fever||participants|Number|11|11.0||||||
3739193|NCT02024867|3574956|B1|fever||presence of fever||participants|Number|11|11.0||||||
3739194|NCT02024867|3574954|B3|Abscess both locations||Abscess location||participants|Number|4|4.0||||||
3739195|NCT02024867|3574955|B2|Abscess both locations||Abscess location||participants|Number|3|3.0||||||
3739196|NCT02024867|3574956|B1|Abscess both locations||Abscess location||participants|Number|1|1.0||||||
3739197|NCT02024867|3574954|B3|Abscess above the waist||Abscess location||participants|Number|67|67.0||||||
3739198|NCT02024867|3574955|B2|Abscess above the waist||Abscess location||participants|Number|30|30.0||||||
3739199|NCT02024867|3574956|B1|Abscess above the waist||Abscess location||participants|Number|37|37.0||||||
3739200|NCT02024867|3574954|B3|Abscess below the waist||Abscess location||participants|Number|178|178.0||||||
3739201|NCT02024867|3574955|B2|Abscess below the waist||Abscess location||participants|Number|91|91.0||||||
3739202|NCT02024867|3574956|B1|Abscess below the waist||Abscess location||participants|Number|87|87.0||||||
3739203|NCT02024867|3574954|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3739204|NCT02024867|3574955|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3739205|NCT02024867|3574956|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3739206|NCT02024867|3574954|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3739207|NCT02024867|3574955|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3739208|NCT02024867|3574956|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3739209|NCT02024867|3574954|B3||White|Race (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
3739210|NCT02024867|3574955|B2||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3739211|NCT02024867|3574956|B1||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3739212|NCT02024867|3574954|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
3739213|NCT02024867|3574955|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3739214|NCT02024867|3574956|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3739215|NCT02024867|3574954|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3739216|NCT02024867|3574955|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3739217|NCT02024867|3574956|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3739218|NCT02024867|3574954|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3739219|NCT02024867|3574955|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3739220|NCT02024867|3574956|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3739221|NCT02024867|3574954|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3739222|NCT02024867|3574955|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3739223|NCT02024867|3574956|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3739224|NCT02024867|3574954|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3739225|NCT02024867|3574955|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3739226|NCT02024867|3574956|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3739227|NCT02024867|3574954|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|208|208.0||||||
3739228|NCT02024867|3574955|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
3739229|NCT02024867|3574956|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
3739230|NCT02024867|3574954|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3739231|NCT02024867|3574955|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3739232|NCT02024867|3574956|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3739233|NCT02024867|3574954|B3||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3739234|NCT02024867|3574955|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3739235|NCT02024867|3574956|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3739236|NCT02024867|3574954|B3||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3739237|NCT02024867|3574955|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3739238|NCT02024867|3574956|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3739239|NCT02024867|3574954|B3|||Age||years|Median|4.08|4.08|Full Range|||0.33|17.0|
3739240|NCT02024867|3574955|B2|||Age||years|Median|3.42|3.42|Full Range|||0.33|17.0|
3739241|NCT02024867|3574956|B1|||Age||years|Median|4.5|4.5|Full Range|||0.5|17.0|
3739242|NCT02024724|3574973|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3739243|NCT02024724|3574974|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3739244|NCT02024724|3574975|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3739245|NCT02024724|3574973|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3739559|NCT02023268|3575288|B2|France||Region of Enrollment||participants|Number|31|31.0||||||
3739246|NCT02024724|3574974|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3739247|NCT02024724|3574975|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3739248|NCT02024724|3574973|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3739249|NCT02024724|3574974|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3739250|NCT02024724|3574975|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3739251|NCT02024724|3574973|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
3739252|NCT02024724|3574974|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3739253|NCT02024724|3574975|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3739254|NCT02024724|3574973|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3739255|NCT02024724|3574974|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3739256|NCT02024724|3574975|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3739257|NCT02024724|3574973|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3739258|NCT02024724|3574974|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3739259|NCT02024724|3574975|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3739260|NCT02024724|3574973|B3||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3739261|NCT02024724|3574974|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3739262|NCT02024724|3574975|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3739263|NCT02024724|3574973|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3739264|NCT02024724|3574974|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3739265|NCT02024724|3574975|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3739266|NCT02024724|3574973|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3739267|NCT02024724|3574974|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3739268|NCT02024724|3574975|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3739269|NCT02024698|3574982|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
3739270|NCT02024698|3574982|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3739271|NCT02024698|3574982|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3739272|NCT02024698|3574982|B1|||Age||years|Mean|28.1|28.1|Standard Deviation|5.03|5.03|||
3739273|NCT02024386|3575009|B4|United States||Region of Enrollment||participants|Number|22|22.0||||||
3739274|NCT02024386|3575010|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3739275|NCT02024386|3575011|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3739276|NCT02024386|3575012|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3739277|NCT02024386|3575009|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3739278|NCT02024386|3575010|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3739279|NCT02024386|3575011|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3739280|NCT02024386|3575012|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3739281|NCT02024386|3575009|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3739282|NCT02024386|3575010|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3739283|NCT02024386|3575011|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3739284|NCT02024386|3575012|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3739285|NCT02024386|3575009|B4|||Age||years|Mean|26.4|26.4|Standard Deviation|6.1|6.1|||
3739286|NCT02024386|3575010|B3|||Age||years|Mean|24.8|24.8|Standard Deviation|5.2|5.2|||
3739287|NCT02024386|3575011|B2|||Age||years|Mean|24.3|24.3|Standard Deviation|4.4|4.4|||
3739288|NCT02024386|3575012|B1|||Age||years|Mean|31.5|31.5|Standard Deviation|7.2|7.2|||
3739289|NCT02024165|3575037|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
3739290|NCT02024165|3575037|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3739291|NCT02024165|3575037|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3739292|NCT02024165|3575037|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3739293|NCT02024165|3575037|B1||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
3739294|NCT02024165|3575037|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3739295|NCT02023983|3575042|B3|||Body-mass index||kg/m^2|Mean|28.64|28.64|Standard Deviation|4.3|4.3|||
3739296|NCT02023983|3575043|B2|||Body-mass index||kg/m^2|Mean|27.3|27.3|Standard Deviation|3.5|3.5|||
3739297|NCT02023983|3575044|B1|||Body-mass index||kg/m^2|Mean|29.9|29.9|Standard Deviation|5.1|5.1|||
3739298|NCT02023983|3575042|B3|||Smoking||Participants|Count of Participants|101|101.0||||||
3739299|NCT02023983|3575043|B2|||Smoking||Participants|Count of Participants|45|45.0||||||
3739300|NCT02023983|3575044|B1|||Smoking||Participants|Count of Participants|56|56.0||||||
3739301|NCT02023983|3575042|B3|||Peripheral arterial disease||Participants|Count of Participants|3|3.0||||||
3739302|NCT02023983|3575043|B2|||Peripheral arterial disease||Participants|Count of Participants|1|1.0||||||
3739303|NCT02023983|3575044|B1|||Peripheral arterial disease||Participants|Count of Participants|2|2.0||||||
3739304|NCT02023983|3575042|B3|||Previous stroke / transient ischemic attack||Participants|Count of Participants|4|4.0||||||
3739305|NCT02023983|3575043|B2|||Previous stroke / transient ischemic attack||Participants|Count of Participants|2|2.0||||||
3739560|NCT02023268|3575289|B1|France||Region of Enrollment||participants|Number|31|31.0||||||
3739306|NCT02023983|3575044|B1|||Previous stroke / transient ischemic attack||Participants|Count of Participants|2|2.0||||||
3739307|NCT02023983|3575042|B3|||Previous PCI||Participants|Count of Participants|8|8.0||||||
3739308|NCT02023983|3575043|B2|||Previous PCI||Participants|Count of Participants|6|6.0||||||
3739309|NCT02023983|3575044|B1|||Previous PCI||Participants|Count of Participants|2|2.0||||||
3739310|NCT02023983|3575042|B3|||Previous myocardial infarction||Participants|Count of Participants|9|9.0||||||
3739311|NCT02023983|3575043|B2|||Previous myocardial infarction||Participants|Count of Participants|6|6.0||||||
3739312|NCT02023983|3575044|B1|||Previous myocardial infarction||Participants|Count of Participants|3|3.0||||||
3739313|NCT02023983|3575042|B3|||Hyperliporoteinemia||Participants|Count of Participants|112|112.0||||||
3739314|NCT02023983|3575043|B2|||Hyperliporoteinemia||Participants|Count of Participants|58|58.0||||||
3739315|NCT02023983|3575044|B1|||Hyperliporoteinemia||Participants|Count of Participants|54|54.0||||||
3739316|NCT02023983|3575042|B3|||Impaired glucose tolerance||Participants|Count of Participants|20|20.0||||||
3739317|NCT02023983|3575043|B2|||Impaired glucose tolerance||Participants|Count of Participants|12|12.0||||||
3739318|NCT02023983|3575044|B1|||Impaired glucose tolerance||Participants|Count of Participants|8|8.0||||||
3739319|NCT02023983|3575042|B3|||Diabetes||Participants|Count of Participants|14|14.0||||||
3739320|NCT02023983|3575043|B2|||Diabetes||Participants|Count of Participants|7|7.0||||||
3739321|NCT02023983|3575044|B1|||Diabetes||Participants|Count of Participants|7|7.0||||||
3739322|NCT02023983|3575042|B3|||Hypertension||Participants|Count of Participants|82|82.0||||||
3739323|NCT02023983|3575043|B2|||Hypertension||Participants|Count of Participants|41|41.0||||||
3739324|NCT02023983|3575044|B1|||Hypertension||Participants|Count of Participants|41|41.0||||||
3739325|NCT02023983|3575042|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3739326|NCT02023983|3575042|B3||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3739327|NCT02023983|3575043|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3739328|NCT02023983|3575044|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3739329|NCT02023983|3575042|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3739330|NCT02023983|3575043|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3739331|NCT02023983|3575044|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3739332|NCT02023983|3575042|B3||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
3739333|NCT02023983|3575043|B2||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3739334|NCT02023983|3575044|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3739335|NCT02023983|3575042|B3||Between 18 and 65 years|Age||Participants|Count of Participants|114|114.0||||||
3739336|NCT02023983|3575043|B2||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
3739337|NCT02023983|3575044|B1||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3739338|NCT02023983|3575042|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3739339|NCT02023983|3575043|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3739340|NCT02023983|3575044|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3739341|NCT02023918|3575053|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3739342|NCT02023918|3575053|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3739343|NCT02023918|3575053|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3739344|NCT02023918|3575053|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|3.6|3.6|||
3739345|NCT02023918|3575053|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3739346|NCT02023918|3575053|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3739347|NCT02023918|3575053|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3739348|NCT02023879|3575058|B4|||Calculated LDL-C in mmol/L||mmol/L|Mean|4.089|4.089|Standard Deviation|1.356|1.356|||
3739349|NCT02023879|3575059|B3|||Calculated LDL-C in mmol/L||mmol/L|Mean|4.245|4.245|Standard Deviation|1.789|1.789|||
3739350|NCT02023879|3575060|B2|||Calculated LDL-C in mmol/L||mmol/L|Mean|4.002|4.002|Standard Deviation|1.154|1.154|||
3739351|NCT02023879|3575061|B1|||Calculated LDL-C in mmol/L||mmol/L|Mean|4.106|4.106|Standard Deviation|1.226|1.226|||
3739352|NCT02023879|3575058|B4|||Calculated LDL-C in mg/dL|Calculated LDL-C from Friedewald formula (LDL-C = Total cholesterol [Total-C] - High-Density Lipoprotein Cholesterol [HDL-C] - [Triglyceride/5]).|mg/dL|Mean|157.9|157.9|Standard Deviation|52.4|52.4|||
3739353|NCT02023879|3575059|B3|||Calculated LDL-C in mg/dL|Calculated LDL-C from Friedewald formula (LDL-C = Total cholesterol [Total-C] - High-Density Lipoprotein Cholesterol [HDL-C] - [Triglyceride/5]).|mg/dL|Mean|163.9|163.9|Standard Deviation|69.1|69.1|||
3739354|NCT02023879|3575060|B2|||Calculated LDL-C in mg/dL|Calculated LDL-C from Friedewald formula (LDL-C = Total cholesterol [Total-C] - High-Density Lipoprotein Cholesterol [HDL-C] - [Triglyceride/5]).|mg/dL|Mean|154.5|154.5|Standard Deviation|44.6|44.6|||
3739355|NCT02023879|3575061|B1|||Calculated LDL-C in mg/dL|Calculated LDL-C from Friedewald formula (LDL-C = Total cholesterol [Total-C] - High-Density Lipoprotein Cholesterol [HDL-C] - [Triglyceride/5]).|mg/dL|Mean|158.5|158.5|Standard Deviation|47.3|47.3|||
3739356|NCT02023879|3575058|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3739357|NCT02023879|3575059|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3739358|NCT02023879|3575060|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3739359|NCT02023879|3575061|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3739360|NCT02023879|3575058|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3739361|NCT02023879|3575059|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3739362|NCT02023879|3575060|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3739363|NCT02023879|3575061|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3739364|NCT02023879|3575058|B4||White|Race (NIH/OMB)||Participants|Count of Participants|219|219.0||||||
3739365|NCT02023879|3575059|B3||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3739366|NCT02023879|3575060|B2||White|Race (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
3739367|NCT02023879|3575061|B1||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3739368|NCT02023879|3575058|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3739369|NCT02023879|3575059|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3739370|NCT02023879|3575060|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3739371|NCT02023879|3575061|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3739372|NCT02023879|3575058|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3739373|NCT02023879|3575059|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3739374|NCT02023879|3575060|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3739375|NCT02023879|3575061|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3739376|NCT02023879|3575058|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3739377|NCT02023879|3575059|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3739378|NCT02023879|3575060|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3739379|NCT02023879|3575061|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3739380|NCT02023879|3575058|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3739381|NCT02023879|3575059|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3739382|NCT02023879|3575060|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3739383|NCT02023879|3575061|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3739384|NCT02023879|3575058|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3739385|NCT02023879|3575059|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3739386|NCT02023879|3575060|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3739387|NCT02023879|3575061|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3739388|NCT02023879|3575058|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|220|220.0||||||
3739389|NCT02023879|3575059|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3739390|NCT02023879|3575060|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|109|109.0||||||
3739391|NCT02023879|3575061|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3739392|NCT02023879|3575058|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3739393|NCT02023879|3575059|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3739394|NCT02023879|3575060|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3739395|NCT02023879|3575061|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3739396|NCT02023879|3575058|B4||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3739397|NCT02023879|3575059|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3739398|NCT02023879|3575060|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3739399|NCT02023879|3575061|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3739400|NCT02023879|3575058|B4||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3739401|NCT02023879|3575059|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3739402|NCT02023879|3575060|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3739403|NCT02023879|3575061|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3739404|NCT02023879|3575058|B4|||Age||years|Mean|63.1|63.1|Standard Deviation|10.1|10.1|||
3739405|NCT02023879|3575059|B3|||Age||years|Mean|64.2|64.2|Standard Deviation|10.0|10.0|||
3739406|NCT02023879|3575060|B2|||Age||years|Mean|62.5|62.5|Standard Deviation|9.9|9.9|||
3739407|NCT02023879|3575061|B1|||Age||years|Mean|63.1|63.1|Standard Deviation|10.7|10.7|||
3739408|NCT02023866|3575152|B1||Kearns-Sayre syndrome|Mitochondrial Disease Subtype|LHON = leber hereditary optic neuropathy; MELAS = mitochondrial encephalomyopathy, lactic acidosis, and strokelike syndrome MERFF = myoclonic epilepsy and ragged-red fibers; NUBPL = Nucleotide Binding Protein-Like; POLG = Polymerase (DNA Directed), Gamma.|Participants|Count of Participants|1|1.0||||||
3739409|NCT02023866|3575152|B1||NUBPL Related Encephalopathy|Mitochondrial Disease Subtype|LHON = leber hereditary optic neuropathy; MELAS = mitochondrial encephalomyopathy, lactic acidosis, and strokelike syndrome MERFF = myoclonic epilepsy and ragged-red fibers; NUBPL = Nucleotide Binding Protein-Like; POLG = Polymerase (DNA Directed), Gamma.|Participants|Count of Participants|2|2.0||||||
3739410|NCT02023866|3575152|B1||LHON|Mitochondrial Disease Subtype|LHON = leber hereditary optic neuropathy; MELAS = mitochondrial encephalomyopathy, lactic acidosis, and strokelike syndrome MERFF = myoclonic epilepsy and ragged-red fibers; NUBPL = Nucleotide Binding Protein-Like; POLG = Polymerase (DNA Directed), Gamma.|Participants|Count of Participants|3|3.0||||||
3739452|NCT02023697|3575173|B2|||Time from initial bone metastases diagnosis to randomization||months|Median|29.9|29.9|Full Range|||1.0|170.0|
3739561|NCT02023268|3575287|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3739411|NCT02023866|3575152|B1||Others|Mitochondrial Disease Subtype|LHON = leber hereditary optic neuropathy; MELAS = mitochondrial encephalomyopathy, lactic acidosis, and strokelike syndrome MERFF = myoclonic epilepsy and ragged-red fibers; NUBPL = Nucleotide Binding Protein-Like; POLG = Polymerase (DNA Directed), Gamma.|Participants|Count of Participants|4|4.0||||||
3739412|NCT02023866|3575152|B1||MERFF|Mitochondrial Disease Subtype|LHON = leber hereditary optic neuropathy; MELAS = mitochondrial encephalomyopathy, lactic acidosis, and strokelike syndrome MERFF = myoclonic epilepsy and ragged-red fibers; NUBPL = Nucleotide Binding Protein-Like; POLG = Polymerase (DNA Directed), Gamma.|Participants|Count of Participants|4|4.0||||||
3739413|NCT02023866|3575152|B1||MELAS|Mitochondrial Disease Subtype|LHON = leber hereditary optic neuropathy; MELAS = mitochondrial encephalomyopathy, lactic acidosis, and strokelike syndrome MERFF = myoclonic epilepsy and ragged-red fibers; NUBPL = Nucleotide Binding Protein-Like; POLG = Polymerase (DNA Directed), Gamma.|Participants|Count of Participants|6|6.0||||||
3739414|NCT02023866|3575152|B1||POLG-related disorders|Mitochondrial Disease Subtype|LHON = leber hereditary optic neuropathy; MELAS = mitochondrial encephalomyopathy, lactic acidosis, and strokelike syndrome MERFF = myoclonic epilepsy and ragged-red fibers; NUBPL = Nucleotide Binding Protein-Like; POLG = Polymerase (DNA Directed), Gamma.|Participants|Count of Participants|7|7.0||||||
3739415|NCT02023866|3575152|B1||Leigh Syndrome|Mitochondrial Disease Subtype|LHON = leber hereditary optic neuropathy; MELAS = mitochondrial encephalomyopathy, lactic acidosis, and strokelike syndrome MERFF = myoclonic epilepsy and ragged-red fibers; NUBPL = Nucleotide Binding Protein-Like; POLG = Polymerase (DNA Directed), Gamma.|Participants|Count of Participants|9|9.0||||||
3739416|NCT02023866|3575152|B1||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3739417|NCT02023866|3575152|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3739418|NCT02023866|3575152|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3739419|NCT02023866|3575152|B1||Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3739420|NCT02023866|3575152|B1||Black of African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3739421|NCT02023866|3575152|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3739422|NCT02023866|3575152|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3739423|NCT02023866|3575152|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3739424|NCT02023866|3575152|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3739425|NCT02023866|3575152|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3739426|NCT02023866|3575152|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3739427|NCT02023866|3575152|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3739428|NCT02023866|3575152|B1|||Age||years|Mean|9.3|9.3|Standard Deviation|4.8|4.8|||
3739429|NCT02023801|3575165|B1|||PBLAC Score (assessment of menstrual blood loss)|Pictorial Blood Loss Assessment Chart (PBLAC) is a tool used to assess menstrual blood loss. The PBLAC score takes into account the number of menstrual pads and tampons used as well as amount of saturation. A score of 0 represents no bleeding. Although the PBLAC score does not yield an exact measure of blood loss, it has been found to correlate well with menstrual blood volume. A score greater than 100 is correlated with a blood loss of at least 80 mL.|units on a scale|Mean|438.8|438.8|Standard Deviation|263.6|263.6|||
3739430|NCT02023801|3575165|B1|Mexico||Region of Enrollment||participants|Number|24|24.0||||||
3739431|NCT02023801|3575165|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3739432|NCT02023801|3575165|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3739433|NCT02023801|3575165|B1|||Age||years|Mean|38.5|38.5|Standard Deviation|6|6.0|||
3739434|NCT02023697|3575171|B4|||Time from first bone metastases progression to most recent progression||months|Median|9.5|9.5|Full Range|||0.0|120.0|
3739435|NCT02023697|3575172|B3|||Time from first bone metastases progression to most recent progression||months|Median|13.4|13.4|Full Range|||0.0|120.0|
3739436|NCT02023697|3575173|B2|||Time from first bone metastases progression to most recent progression||months|Median|8.9|8.9|Full Range|||0.0|71.0|
3739437|NCT02023697|3575174|B1|||Time from first bone metastases progression to most recent progression||months|Median|7.9|7.9|Full Range|||0.0|72.0|
3739438|NCT02023697|3575171|B4|||Body Mass Index||kg/m^2|Mean|28.5|28.5|Standard Deviation|5.3|5.3|||
3739439|NCT02023697|3575172|B3|||Body Mass Index||kg/m^2|Mean|29.1|29.1|Standard Deviation|5.4|5.4|||
3739440|NCT02023697|3575173|B2|||Body Mass Index||kg/m^2|Mean|28.0|28.0|Standard Deviation|5.2|5.2|||
3739441|NCT02023697|3575174|B1|||Body Mass Index||kg/m^2|Mean|28.4|28.4|Standard Deviation|5.2|5.2|||
3739442|NCT02023697|3575171|B4|||Time from most recent bone metastases progression to randomization||months|Median|2.4|2.4|Full Range|||0.0|93.0|
3739443|NCT02023697|3575172|B3|||Time from most recent bone metastases progression to randomization||months|Median|1.9|1.9|Full Range|||0.0|41.0|
3739444|NCT02023697|3575173|B2|||Time from most recent bone metastases progression to randomization||months|Median|2.8|2.8|Full Range|||0.0|93.0|
3739445|NCT02023697|3575174|B1|||Time from most recent bone metastases progression to randomization||months|Median|2.3|2.3|Full Range|||0.0|34.0|
3739446|NCT02023697|3575171|B4|||Time from most recent prostate cancer progression to randomization||months|Median|1.3|1.3|Full Range|||0.0|10.0|
3739447|NCT02023697|3575172|B3|||Time from most recent prostate cancer progression to randomization||months|Median|1.3|1.3|Full Range|||0.0|10.0|
3739448|NCT02023697|3575173|B2|||Time from most recent prostate cancer progression to randomization||months|Median|1.4|1.4|Full Range|||0.0|9.0|
3739449|NCT02023697|3575174|B1|||Time from most recent prostate cancer progression to randomization||months|Median|1.4|1.4|Full Range|||0.0|8.0|
3739450|NCT02023697|3575171|B4|||Time from initial bone metastases diagnosis to randomization||months|Median|31.7|31.7|Full Range|||1.0|397.0|
3739451|NCT02023697|3575172|B3|||Time from initial bone metastases diagnosis to randomization||months|Median|37.5|37.5|Full Range|||1.0|397.0|
3739453|NCT02023697|3575174|B1|||Time from initial bone metastases diagnosis to randomization||months|Median|30.8|30.8|Full Range|||2.0|231.0|
3739454|NCT02023697|3575171|B4|||Time from initial prostate cancer diagnosis to randomization||months|Median|66.8|66.8|Full Range|||2.0|396.0|
3739455|NCT02023697|3575172|B3|||Time from initial prostate cancer diagnosis to randomization||months|Median|67.1|67.1|Full Range|||8.0|396.0|
3739456|NCT02023697|3575173|B2|||Time from initial prostate cancer diagnosis to randomization||months|Median|72.9|72.9|Full Range|||7.0|279.0|
3739457|NCT02023697|3575174|B1|||Time from initial prostate cancer diagnosis to randomization||months|Median|58.9|58.9|Full Range|||2.0|285.0|
3739458|NCT02023697|3575171|B4||Superscan|Extent of disease||Participants|Count of Participants|24|24.0||||||
3739459|NCT02023697|3575172|B3||Superscan|Extent of disease||Participants|Count of Participants|6|6.0||||||
3739460|NCT02023697|3575173|B2||Superscan|Extent of disease||Participants|Count of Participants|6|6.0||||||
3739461|NCT02023697|3575174|B1||Superscan|Extent of disease||Participants|Count of Participants|12|12.0||||||
3739462|NCT02023697|3575171|B4||>20 lesions but not a superscan|Extent of disease||Participants|Count of Participants|149|149.0||||||
3739463|NCT02023697|3575172|B3||>20 lesions but not a superscan|Extent of disease||Participants|Count of Participants|54|54.0||||||
3739464|NCT02023697|3575173|B2||>20 lesions but not a superscan|Extent of disease||Participants|Count of Participants|48|48.0||||||
3739465|NCT02023697|3575174|B1||>20 lesions but not a superscan|Extent of disease||Participants|Count of Participants|47|47.0||||||
3739466|NCT02023697|3575171|B4||6-20 metastases|Extent of disease||Participants|Count of Participants|157|157.0||||||
3739467|NCT02023697|3575172|B3||6-20 metastases|Extent of disease||Participants|Count of Participants|52|52.0||||||
3739468|NCT02023697|3575173|B2||6-20 metastases|Extent of disease||Participants|Count of Participants|53|53.0||||||
3739469|NCT02023697|3575174|B1||6-20 metastases|Extent of disease||Participants|Count of Participants|52|52.0||||||
3739470|NCT02023697|3575171|B4||<6 metastases|Extent of disease||Participants|Count of Participants|60|60.0||||||
3739471|NCT02023697|3575172|B3||<6 metastases|Extent of disease||Participants|Count of Participants|19|19.0||||||
3739472|NCT02023697|3575173|B2||<6 metastases|Extent of disease||Participants|Count of Participants|22|22.0||||||
3739473|NCT02023697|3575174|B1||<6 metastases|Extent of disease||Participants|Count of Participants|19|19.0||||||
3739474|NCT02023697|3575171|B4||Normal or abnormal because of benign bone disease|Extent of disease||Participants|Count of Participants|1|1.0||||||
3739475|NCT02023697|3575172|B3||Normal or abnormal because of benign bone disease|Extent of disease||Participants|Count of Participants|0|0.0||||||
3739476|NCT02023697|3575173|B2||Normal or abnormal because of benign bone disease|Extent of disease||Participants|Count of Participants|1|1.0||||||
3739477|NCT02023697|3575174|B1||Normal or abnormal because of benign bone disease|Extent of disease||Participants|Count of Participants|0|0.0||||||
3739478|NCT02023697|3575171|B4|||Average Worst Pain Score (WPS)|Brief Pain Short Form (BPI-SF) encompasses 4 different items to capture the variability of pain over time (pain at its “worst,” “least,” “average,” and “now”). For this study, only the worst pain score (WPS) in the last 24 hours was assessed (a visual analogic scale ranging 0-10, with 0 meaning “no pain” and 10 meaning “pain as bad as you can imagine”), and the mean score of the 7 days prior to the study visit or telephone contact was calculated and this value was recorded in the participant's reported outcome pain data.|scores on a scale|Mean|3.4|3.4|Standard Deviation|2.5|2.5|||
3739479|NCT02023697|3575172|B3|||Average Worst Pain Score (WPS)|Brief Pain Short Form (BPI-SF) encompasses 4 different items to capture the variability of pain over time (pain at its “worst,” “least,” “average,” and “now”). For this study, only the worst pain score (WPS) in the last 24 hours was assessed (a visual analogic scale ranging 0-10, with 0 meaning “no pain” and 10 meaning “pain as bad as you can imagine”), and the mean score of the 7 days prior to the study visit or telephone contact was calculated and this value was recorded in the participant's reported outcome pain data.|scores on a scale|Mean|3.4|3.4|Standard Deviation|2.6|2.6|||
3739480|NCT02023697|3575173|B2|||Average Worst Pain Score (WPS)|Brief Pain Short Form (BPI-SF) encompasses 4 different items to capture the variability of pain over time (pain at its “worst,” “least,” “average,” and “now”). For this study, only the worst pain score (WPS) in the last 24 hours was assessed (a visual analogic scale ranging 0-10, with 0 meaning “no pain” and 10 meaning “pain as bad as you can imagine”), and the mean score of the 7 days prior to the study visit or telephone contact was calculated and this value was recorded in the participant's reported outcome pain data.|scores on a scale|Mean|3.3|3.3|Standard Deviation|2.5|2.5|||
3739481|NCT02023697|3575174|B1|||Average Worst Pain Score (WPS)|Brief Pain Short Form (BPI-SF) encompasses 4 different items to capture the variability of pain over time (pain at its “worst,” “least,” “average,” and “now”). For this study, only the worst pain score (WPS) in the last 24 hours was assessed (a visual analogic scale ranging 0-10, with 0 meaning “no pain” and 10 meaning “pain as bad as you can imagine”), and the mean score of the 7 days prior to the study visit or telephone contact was calculated and this value was recorded in the participant's reported outcome pain data.|scores on a scale|Mean|3.6|3.6|Standard Deviation|2.6|2.6|||
3739482|NCT02023697|3575171|B4||2|ECOG PS|Eastern Cooperative Oncology Group Performance status (ECOG PS): 0-Fully active, able to carry on all pre-diseases performance without restriction, (Karnofsky 90-100); 1- Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature,(Karnofsky 70-80) 2-Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours. (Karnofsky 50-60); 3-Capable of only limited self-care, confined to bed or chair more than 50% of waking hours. (Karnofsky 30-40); 4-Completely disabled.|Participants|Count of Participants|13|13.0||||||
3739495|NCT02023697|3575172|B3||Not reported|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3739496|NCT02023697|3575173|B2||Not reported|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3739497|NCT02023697|3575174|B1||Not reported|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3739498|NCT02023697|3575171|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
3739483|NCT02023697|3575172|B3||2|ECOG PS|Eastern Cooperative Oncology Group Performance status (ECOG PS): 0-Fully active, able to carry on all pre-diseases performance without restriction, (Karnofsky 90-100); 1- Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature,(Karnofsky 70-80) 2-Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours. (Karnofsky 50-60); 3-Capable of only limited self-care, confined to bed or chair more than 50% of waking hours. (Karnofsky 30-40); 4-Completely disabled.|Participants|Count of Participants|5|5.0||||||
3739484|NCT02023697|3575173|B2||2|ECOG PS|Eastern Cooperative Oncology Group Performance status (ECOG PS): 0-Fully active, able to carry on all pre-diseases performance without restriction, (Karnofsky 90-100); 1- Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature,(Karnofsky 70-80) 2-Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours. (Karnofsky 50-60); 3-Capable of only limited self-care, confined to bed or chair more than 50% of waking hours. (Karnofsky 30-40); 4-Completely disabled.|Participants|Count of Participants|4|4.0||||||
3739485|NCT02023697|3575174|B1||2|ECOG PS|Eastern Cooperative Oncology Group Performance status (ECOG PS): 0-Fully active, able to carry on all pre-diseases performance without restriction, (Karnofsky 90-100); 1- Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature,(Karnofsky 70-80) 2-Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours. (Karnofsky 50-60); 3-Capable of only limited self-care, confined to bed or chair more than 50% of waking hours. (Karnofsky 30-40); 4-Completely disabled.|Participants|Count of Participants|4|4.0||||||
3739486|NCT02023697|3575171|B4||1|ECOG PS|Eastern Cooperative Oncology Group Performance status (ECOG PS): 0-Fully active, able to carry on all pre-diseases performance without restriction, (Karnofsky 90-100); 1- Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature,(Karnofsky 70-80) 2-Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours. (Karnofsky 50-60); 3-Capable of only limited self-care, confined to bed or chair more than 50% of waking hours. (Karnofsky 30-40); 4-Completely disabled.|Participants|Count of Participants|222|222.0||||||
3739487|NCT02023697|3575172|B3||1|ECOG PS|Eastern Cooperative Oncology Group Performance status (ECOG PS): 0-Fully active, able to carry on all pre-diseases performance without restriction, (Karnofsky 90-100); 1- Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature,(Karnofsky 70-80) 2-Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours. (Karnofsky 50-60); 3-Capable of only limited self-care, confined to bed or chair more than 50% of waking hours. (Karnofsky 30-40); 4-Completely disabled.|Participants|Count of Participants|77|77.0||||||
3739488|NCT02023697|3575173|B2||1|ECOG PS|Eastern Cooperative Oncology Group Performance status (ECOG PS): 0-Fully active, able to carry on all pre-diseases performance without restriction, (Karnofsky 90-100); 1- Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature,(Karnofsky 70-80) 2-Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours. (Karnofsky 50-60); 3-Capable of only limited self-care, confined to bed or chair more than 50% of waking hours. (Karnofsky 30-40); 4-Completely disabled.|Participants|Count of Participants|67|67.0||||||
3739489|NCT02023697|3575174|B1||1|ECOG PS|Eastern Cooperative Oncology Group Performance status (ECOG PS): 0-Fully active, able to carry on all pre-diseases performance without restriction, (Karnofsky 90-100); 1- Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature,(Karnofsky 70-80) 2-Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours. (Karnofsky 50-60); 3-Capable of only limited self-care, confined to bed or chair more than 50% of waking hours. (Karnofsky 30-40); 4-Completely disabled.|Participants|Count of Participants|78|78.0||||||
3739490|NCT02023697|3575171|B4||0|ECOG PS|Eastern Cooperative Oncology Group Performance status (ECOG PS): 0-Fully active, able to carry on all pre-diseases performance without restriction, (Karnofsky 90-100); 1- Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature,(Karnofsky 70-80) 2-Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours. (Karnofsky 50-60); 3-Capable of only limited self-care, confined to bed or chair more than 50% of waking hours. (Karnofsky 30-40); 4-Completely disabled.|Participants|Count of Participants|156|156.0||||||
3739491|NCT02023697|3575172|B3||0|ECOG PS|Eastern Cooperative Oncology Group Performance status (ECOG PS): 0-Fully active, able to carry on all pre-diseases performance without restriction, (Karnofsky 90-100); 1- Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature,(Karnofsky 70-80) 2-Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours. (Karnofsky 50-60); 3-Capable of only limited self-care, confined to bed or chair more than 50% of waking hours. (Karnofsky 30-40); 4-Completely disabled.|Participants|Count of Participants|49|49.0||||||
3739492|NCT02023697|3575173|B2||0|ECOG PS|Eastern Cooperative Oncology Group Performance status (ECOG PS): 0-Fully active, able to carry on all pre-diseases performance without restriction, (Karnofsky 90-100); 1- Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature,(Karnofsky 70-80) 2-Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours. (Karnofsky 50-60); 3-Capable of only limited self-care, confined to bed or chair more than 50% of waking hours. (Karnofsky 30-40); 4-Completely disabled.|Participants|Count of Participants|59|59.0||||||
3739493|NCT02023697|3575174|B1||0|ECOG PS|Eastern Cooperative Oncology Group Performance status (ECOG PS): 0-Fully active, able to carry on all pre-diseases performance without restriction, (Karnofsky 90-100); 1- Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature,(Karnofsky 70-80) 2-Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours. (Karnofsky 50-60); 3-Capable of only limited self-care, confined to bed or chair more than 50% of waking hours. (Karnofsky 30-40); 4-Completely disabled.|Participants|Count of Participants|48|48.0||||||
3739494|NCT02023697|3575171|B4||Not reported|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3739558|NCT02023268|3575287|B3|France||Region of Enrollment||participants|Number|62|62.0||||||
3739499|NCT02023697|3575172|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3739500|NCT02023697|3575173|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3739501|NCT02023697|3575174|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3739502|NCT02023697|3575171|B4||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3739503|NCT02023697|3575172|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3739504|NCT02023697|3575173|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3739505|NCT02023697|3575174|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3739506|NCT02023697|3575171|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|314|314.0||||||
3739507|NCT02023697|3575172|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|108|108.0||||||
3739508|NCT02023697|3575173|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|102|102.0||||||
3739509|NCT02023697|3575174|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|104|104.0||||||
3739510|NCT02023697|3575171|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3739511|NCT02023697|3575172|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3739512|NCT02023697|3575173|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3739513|NCT02023697|3575174|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3739514|NCT02023697|3575171|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|369|369.0||||||
3739515|NCT02023697|3575172|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
3739516|NCT02023697|3575173|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
3739517|NCT02023697|3575174|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
3739518|NCT02023697|3575171|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3739519|NCT02023697|3575172|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3739520|NCT02023697|3575173|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3739521|NCT02023697|3575174|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3739522|NCT02023697|3575171|B4||Male|Sex: Female, Male||Participants|Count of Participants|391|391.0||||||
3739523|NCT02023697|3575172|B3||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3739524|NCT02023697|3575173|B2||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3739525|NCT02023697|3575174|B1||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3739526|NCT02023697|3575171|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3739527|NCT02023697|3575172|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3739528|NCT02023697|3575173|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3739529|NCT02023697|3575174|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3739530|NCT02023697|3575171|B4|||Age||years|Mean|70.5|70.5|Standard Deviation|8.3|8.3|||
3739531|NCT02023697|3575172|B3|||Age||years|Mean|70.0|70.0|Standard Deviation|8.1|8.1|||
3739532|NCT02023697|3575173|B2|||Age||years|Mean|70.9|70.9|Standard Deviation|8.3|8.3|||
3739533|NCT02023697|3575174|B1|||Age||years|Mean|70.6|70.6|Standard Deviation|8.6|8.6|||
3739534|NCT02023515|3575276|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
3739535|NCT02023515|3575277|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3739536|NCT02023515|3575278|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3739537|NCT02023515|3575276|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3739538|NCT02023515|3575277|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3739539|NCT02023515|3575278|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3739540|NCT02023515|3575276|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3739541|NCT02023515|3575277|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3739542|NCT02023515|3575278|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3739543|NCT02023515|3575276|B3|||Age||years|Mean|45.0|45.0|Standard Deviation|7.9|7.9|||
3739544|NCT02023515|3575277|B2|||Age||years|Mean|44.0|44.0|Standard Deviation|8.8|8.8|||
3739545|NCT02023515|3575278|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|8.0|8.0|||
3739546|NCT02023515|3575276|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3739547|NCT02023515|3575277|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3739548|NCT02023515|3575278|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3739549|NCT02023515|3575276|B3||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3739550|NCT02023515|3575277|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3739551|NCT02023515|3575278|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3739552|NCT02023515|3575276|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3739553|NCT02023515|3575277|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3739554|NCT02023515|3575278|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3739555|NCT02023268|3575287|B3|Tunisia||Region of Enrollment||participants|Number|43|43.0||||||
3739556|NCT02023268|3575288|B2|Tunisia||Region of Enrollment||participants|Number|22|22.0||||||
3739557|NCT02023268|3575289|B1|Tunisia||Region of Enrollment||participants|Number|21|21.0||||||
3739562|NCT02023268|3575288|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3739563|NCT02023268|3575289|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3739564|NCT02023268|3575287|B3||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3739565|NCT02023268|3575288|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3739566|NCT02023268|3575289|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3739567|NCT02023268|3575287|B3|||Age||years|Mean|59.2|59.2|Standard Deviation|12.8|12.8|||
3739568|NCT02023268|3575288|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|13.4|13.4|||
3739569|NCT02023268|3575289|B1|||Age||years|Mean|60|60.0|Standard Deviation|12.2|12.2|||
3739570|NCT02023268|3575287|B3||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
3739571|NCT02023268|3575288|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3739572|NCT02023268|3575289|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3739573|NCT02023268|3575287|B3||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
3739574|NCT02023268|3575288|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3739575|NCT02023268|3575289|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3739576|NCT02023268|3575287|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3739577|NCT02023268|3575288|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3739578|NCT02023268|3575289|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3739579|NCT02023151|3575296|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3739580|NCT02023151|3575296|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3739581|NCT02023151|3575296|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3739582|NCT02023151|3575296|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3739583|NCT02023151|3575296|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3739584|NCT02023151|3575296|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3739585|NCT02023151|3575296|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3739586|NCT02023151|3575296|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3739587|NCT02023151|3575296|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3739588|NCT02023151|3575296|B1|||Age||years|Mean|41|41.0|Standard Deviation|3|3.0|||
3739589|NCT02023125|3575301|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3739590|NCT02023125|3575302|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3739591|NCT02023125|3575303|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3739592|NCT02023125|3575301|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3739593|NCT02023125|3575302|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3739594|NCT02023125|3575303|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3739595|NCT02023125|3575301|B3|||Age||years|Mean|35.4|35.4|Standard Deviation|8.3|8.3|||
3739596|NCT02023125|3575302|B2|||Age||years|Mean|35.4|35.4|Standard Deviation|8.30|8.3|||
3739597|NCT02023125|3575303|B1|||Age||years|Mean|35.3|35.3|Standard Deviation|8.50|8.5|||
3739598|NCT02023112|3575364|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3739599|NCT02023112|3575365|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3739600|NCT02023112|3575366|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3739601|NCT02023112|3575364|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3739602|NCT02023112|3575365|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3739603|NCT02023112|3575366|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3739604|NCT02023112|3575364|B3|≥ 65 years||Age, Customized||participants|Number|53|53.0||||||
3739605|NCT02023112|3575365|B2|≥ 65 years||Age, Customized||participants|Number|24|24.0||||||
3739606|NCT02023112|3575366|B1|≥ 65 years||Age, Customized||participants|Number|29|29.0||||||
3739607|NCT02023112|3575364|B3|< 65 years||Age, Customized||participants|Number|118|118.0||||||
3739608|NCT02023112|3575365|B2|< 65 years||Age, Customized||participants|Number|62|62.0||||||
3739609|NCT02023112|3575366|B1|< 65 years||Age, Customized||participants|Number|56|56.0||||||
3739610|NCT02023099|3575385|B4||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3739611|NCT02023099|3575386|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3739612|NCT02023099|3575387|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3739613|NCT02023099|3575388|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3739614|NCT02023099|3575385|B4||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
3739615|NCT02023099|3575386|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3739616|NCT02023099|3575387|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3739617|NCT02023099|3575388|B1||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3739618|NCT02023099|3575385|B4|≥ 65 years||Age, Customized||participants|Number|154|154.0||||||
3739619|NCT02023099|3575386|B3|≥ 65 years||Age, Customized||participants|Number|21|21.0||||||
3739620|NCT02023099|3575387|B2|≥ 65 years||Age, Customized||participants|Number|47|47.0||||||
3739621|NCT02023099|3575388|B1|≥ 65 years||Age, Customized||participants|Number|86|86.0||||||
3739622|NCT02023099|3575385|B4|< 65 years||Age, Customized||participants|Number|209|209.0||||||
3739623|NCT02023099|3575386|B3|< 65 years||Age, Customized||participants|Number|21|21.0||||||
3739624|NCT02023099|3575387|B2|< 65 years||Age, Customized||participants|Number|59|59.0||||||
3739625|NCT02023099|3575388|B1|< 65 years||Age, Customized||participants|Number|129|129.0||||||
3739626|NCT02022826|3575406|B1|||suspected gastroparesis||Participants|Count of Participants|167|167.0||||||
3739627|NCT02022826|3575406|B1|United States||Region of Enrollment||participants|Number|167|167.0||||||
3739628|NCT02022826|3575406|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3739629|NCT02022826|3575406|B1||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3739630|NCT02022826|3575406|B1|||Age||years|Mean|45|45.0|Full Range|||18.0|72.0|
3739631|NCT02022826|3575406|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3739632|NCT02022826|3575406|B1||Between 18 and 65 years|Age||Participants|Count of Participants|154|154.0||||||
3739633|NCT02022826|3575406|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3739634|NCT02022748|3575411|B3|||BMI||kg/m^2|Mean|28.01|28.01|Standard Deviation|3.91|3.91|||
3739635|NCT02022748|3575412|B2|||BMI||kg/m^2|Mean|28.27|28.27|Standard Deviation|3.75|3.75|||
3739636|NCT02022748|3575413|B1|||BMI||kg/m^2|Mean|27.77|27.77|Standard Deviation|4.18|4.18|||
3739637|NCT02022748|3575411|B3|||Weight||kg|Mean|87.0|87.0|Standard Deviation|17.1|17.1|||
3739638|NCT02022748|3575412|B2|||Weight||kg|Mean|89.0|89.0|Standard Deviation|16.2|16.2|||
3739639|NCT02022748|3575413|B1|||Weight||kg|Mean|85.1|85.1|Standard Deviation|18.3|18.3|||
3739640|NCT02022748|3575411|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3739641|NCT02022748|3575412|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3739642|NCT02022748|3575413|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3739643|NCT02022748|3575411|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3739644|NCT02022748|3575412|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3739645|NCT02022748|3575413|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3739646|NCT02022748|3575411|B3|||Age||years|Mean|47.3|47.3|Standard Deviation|11.8|11.8|||
3739647|NCT02022748|3575412|B2|||Age||years|Mean|43.8|43.8|Standard Deviation|10.4|10.4|||
3739648|NCT02022748|3575413|B1|||Age||years|Mean|50.6|50.6|Standard Deviation|12.5|12.5|||
3739649|NCT02022670|3575438|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3739650|NCT02022670|3575439|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3739651|NCT02022670|3575440|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3739652|NCT02022670|3575441|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3739653|NCT02022670|3575438|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3739654|NCT02022670|3575439|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3739655|NCT02022670|3575440|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3739656|NCT02022670|3575441|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3739657|NCT02022670|3575438|B4|||Age||years|Mean|62|62.0|Standard Deviation|7|7.0|||
3739658|NCT02022670|3575439|B3|||Age||years|Mean|64|64.0|Standard Deviation|6|6.0|||
3739659|NCT02022670|3575440|B2|||Age||years|Mean|60|60.0|Standard Deviation|6|6.0|||
3739660|NCT02022670|3575441|B1|||Age||years|Mean|62|62.0|Standard Deviation|8|8.0|||
3739661|NCT02022085|3575457|B1|Single-sided sensorineural deafness||Type of hearing loss||participants|Number|15|15.0||||||
3739662|NCT02022085|3575457|B1|Conductive hearing loss||Type of hearing loss||participants|Number|39|39.0||||||
3739663|NCT02022085|3575457|B1|United Kingdom||Region of Enrollment||participants|Number|16|16.0||||||
3739664|NCT02022085|3575457|B1|Poland||Region of Enrollment||participants|Number|14|14.0||||||
3739665|NCT02022085|3575457|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3739666|NCT02022085|3575457|B1|Netherlands||Region of Enrollment||participants|Number|23|23.0||||||
3739667|NCT02022085|3575457|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3739668|NCT02022085|3575457|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3739669|NCT02022085|3575457|B1|||Age||years|Mean|42.1|42.1|Standard Deviation|13.6|13.6|||
3739670|NCT02022020|3575483|B1||Male|Gender||Participants|Count of Participants|112|112.0||||||
3739671|NCT02022020|3575483|B1||Female|Gender||Participants|Count of Participants|108|108.0||||||
3739672|NCT02022020|3575483|B1|||Age||Years|Mean|76.1|76.1|Standard Deviation|10.3|10.3|||
3739673|NCT02022007|3575489|B4|United States||Region of Enrollment|All participants were from Baton Rouge and surrounding parishes|Participants|Count of Participants|38|38.0||||||
3739674|NCT02022007|3575490|B3|United States||Region of Enrollment|All participants were from Baton Rouge and surrounding parishes|Participants|Count of Participants|13|13.0||||||
3739675|NCT02022007|3575491|B2|United States||Region of Enrollment|All participants were from Baton Rouge and surrounding parishes|Participants|Count of Participants|12|12.0||||||
3739676|NCT02022007|3575492|B1|United States||Region of Enrollment|All participants were from Baton Rouge and surrounding parishes|Participants|Count of Participants|13|13.0||||||
3739677|NCT02022007|3575489|B4||Unknown or Not Reported|Race (NIH/OMB)|Our patient population is approximately 64% Caucasian and 35% African -American. The remaining ethnicities comprise about 1%.|Participants|Count of Participants|0|0.0||||||
3739678|NCT02022007|3575490|B3||Unknown or Not Reported|Race (NIH/OMB)|Our patient population is approximately 64% Caucasian and 35% African -American. The remaining ethnicities comprise about 1%.|Participants|Count of Participants|0|0.0||||||
3739679|NCT02022007|3575491|B2||Unknown or Not Reported|Race (NIH/OMB)|Our patient population is approximately 64% Caucasian and 35% African -American. The remaining ethnicities comprise about 1%.|Participants|Count of Participants|0|0.0||||||
3739680|NCT02022007|3575492|B1||Unknown or Not Reported|Race (NIH/OMB)|Our patient population is approximately 64% Caucasian and 35% African -American. The remaining ethnicities comprise about 1%.|Participants|Count of Participants|0|0.0||||||
3739681|NCT02022007|3575489|B4||More than one race|Race (NIH/OMB)|Our patient population is approximately 64% Caucasian and 35% African -American. The remaining ethnicities comprise about 1%.|Participants|Count of Participants|0|0.0||||||
3739682|NCT02022007|3575490|B3||More than one race|Race (NIH/OMB)|Our patient population is approximately 64% Caucasian and 35% African -American. The remaining ethnicities comprise about 1%.|Participants|Count of Participants|0|0.0||||||
3739683|NCT02022007|3575491|B2||More than one race|Race (NIH/OMB)|Our patient population is approximately 64% Caucasian and 35% African -American. The remaining ethnicities comprise about 1%.|Participants|Count of Participants|0|0.0||||||
3739684|NCT02022007|3575492|B1||More than one race|Race (NIH/OMB)|Our patient population is approximately 64% Caucasian and 35% African -American. The remaining ethnicities comprise about 1%.|Participants|Count of Participants|0|0.0||||||
3739685|NCT02022007|3575489|B4||White|Race (NIH/OMB)|Our patient population is approximately 64% Caucasian and 35% African -American. The remaining ethnicities comprise about 1%.|Participants|Count of Participants|28|28.0||||||
3739686|NCT02022007|3575490|B3||White|Race (NIH/OMB)|Our patient population is approximately 64% Caucasian and 35% African -American. The remaining ethnicities comprise about 1%.|Participants|Count of Participants|9|9.0||||||
3739687|NCT02022007|3575491|B2||White|Race (NIH/OMB)|Our patient population is approximately 64% Caucasian and 35% African -American. The remaining ethnicities comprise about 1%.|Participants|Count of Participants|9|9.0||||||
3739688|NCT02022007|3575492|B1||White|Race (NIH/OMB)|Our patient population is approximately 64% Caucasian and 35% African -American. The remaining ethnicities comprise about 1%.|Participants|Count of Participants|10|10.0||||||
3739689|NCT02022007|3575489|B4||Black or African American|Race (NIH/OMB)|Our patient population is approximately 64% Caucasian and 35% African -American. The remaining ethnicities comprise about 1%.|Participants|Count of Participants|10|10.0||||||
3739690|NCT02022007|3575490|B3||Black or African American|Race (NIH/OMB)|Our patient population is approximately 64% Caucasian and 35% African -American. The remaining ethnicities comprise about 1%.|Participants|Count of Participants|4|4.0||||||
3739691|NCT02022007|3575491|B2||Black or African American|Race (NIH/OMB)|Our patient population is approximately 64% Caucasian and 35% African -American. The remaining ethnicities comprise about 1%.|Participants|Count of Participants|3|3.0||||||
3739692|NCT02022007|3575492|B1||Black or African American|Race (NIH/OMB)|Our patient population is approximately 64% Caucasian and 35% African -American. The remaining ethnicities comprise about 1%.|Participants|Count of Participants|3|3.0||||||
3739693|NCT02022007|3575489|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Our patient population is approximately 64% Caucasian and 35% African -American. The remaining ethnicities comprise about 1%.|Participants|Count of Participants|0|0.0||||||
3739694|NCT02022007|3575490|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Our patient population is approximately 64% Caucasian and 35% African -American. The remaining ethnicities comprise about 1%.|Participants|Count of Participants|0|0.0||||||
3739695|NCT02022007|3575491|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Our patient population is approximately 64% Caucasian and 35% African -American. The remaining ethnicities comprise about 1%.|Participants|Count of Participants|0|0.0||||||
3739696|NCT02022007|3575492|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Our patient population is approximately 64% Caucasian and 35% African -American. The remaining ethnicities comprise about 1%.|Participants|Count of Participants|0|0.0||||||
3739697|NCT02022007|3575489|B4||Asian|Race (NIH/OMB)|Our patient population is approximately 64% Caucasian and 35% African -American. The remaining ethnicities comprise about 1%.|Participants|Count of Participants|0|0.0||||||
3739698|NCT02022007|3575490|B3||Asian|Race (NIH/OMB)|Our patient population is approximately 64% Caucasian and 35% African -American. The remaining ethnicities comprise about 1%.|Participants|Count of Participants|0|0.0||||||
3739699|NCT02022007|3575491|B2||Asian|Race (NIH/OMB)|Our patient population is approximately 64% Caucasian and 35% African -American. The remaining ethnicities comprise about 1%.|Participants|Count of Participants|0|0.0||||||
3739700|NCT02022007|3575492|B1||Asian|Race (NIH/OMB)|Our patient population is approximately 64% Caucasian and 35% African -American. The remaining ethnicities comprise about 1%.|Participants|Count of Participants|0|0.0||||||
3739701|NCT02022007|3575489|B4||American Indian or Alaska Native|Race (NIH/OMB)|Our patient population is approximately 64% Caucasian and 35% African -American. The remaining ethnicities comprise about 1%.|Participants|Count of Participants|0|0.0||||||
3739702|NCT02022007|3575490|B3||American Indian or Alaska Native|Race (NIH/OMB)|Our patient population is approximately 64% Caucasian and 35% African -American. The remaining ethnicities comprise about 1%.|Participants|Count of Participants|0|0.0||||||
3739703|NCT02022007|3575491|B2||American Indian or Alaska Native|Race (NIH/OMB)|Our patient population is approximately 64% Caucasian and 35% African -American. The remaining ethnicities comprise about 1%.|Participants|Count of Participants|0|0.0||||||
3739704|NCT02022007|3575492|B1||American Indian or Alaska Native|Race (NIH/OMB)|Our patient population is approximately 64% Caucasian and 35% African -American. The remaining ethnicities comprise about 1%.|Participants|Count of Participants|0|0.0||||||
3739705|NCT02022007|3575489|B4||Male|Sex: Female, Male|All participants had to be female to qualify|Participants|Count of Participants|0|0.0||||||
3739706|NCT02022007|3575490|B3||Male|Sex: Female, Male|All participants had to be female to qualify|Participants|Count of Participants|0|0.0||||||
3739707|NCT02022007|3575491|B2||Male|Sex: Female, Male|All participants had to be female to qualify|Participants|Count of Participants|0|0.0||||||
3739708|NCT02022007|3575492|B1||Male|Sex: Female, Male|All participants had to be female to qualify|Participants|Count of Participants|0|0.0||||||
3739709|NCT02022007|3575489|B4||Female|Sex: Female, Male|All participants had to be female to qualify|Participants|Count of Participants|38|38.0||||||
3739710|NCT02022007|3575490|B3||Female|Sex: Female, Male|All participants had to be female to qualify|Participants|Count of Participants|13|13.0||||||
3739711|NCT02022007|3575491|B2||Female|Sex: Female, Male|All participants had to be female to qualify|Participants|Count of Participants|12|12.0||||||
3739712|NCT02022007|3575492|B1||Female|Sex: Female, Male|All participants had to be female to qualify|Participants|Count of Participants|13|13.0||||||
3739713|NCT02022007|3575489|B4||>=65 years|Age|All participants had to be 18 to 42 years to participate|Participants|Count of Participants|0|0.0||||||
3739714|NCT02022007|3575490|B3||>=65 years|Age|All participants had to be 18 to 42 years to participate|Participants|Count of Participants|0|0.0||||||
3739715|NCT02022007|3575491|B2||>=65 years|Age|All participants had to be 18 to 42 years to participate|Participants|Count of Participants|0|0.0||||||
3739716|NCT02022007|3575492|B1||>=65 years|Age|All participants had to be 18 to 42 years to participate|Participants|Count of Participants|0|0.0||||||
3739717|NCT02022007|3575489|B4||Between 18 and 65 years|Age|All participants had to be 18 to 42 years to participate|Participants|Count of Participants|38|38.0||||||
3739718|NCT02022007|3575490|B3||Between 18 and 65 years|Age|All participants had to be 18 to 42 years to participate|Participants|Count of Participants|13|13.0||||||
3739719|NCT02022007|3575491|B2||Between 18 and 65 years|Age|All participants had to be 18 to 42 years to participate|Participants|Count of Participants|12|12.0||||||
3739720|NCT02022007|3575492|B1||Between 18 and 65 years|Age|All participants had to be 18 to 42 years to participate|Participants|Count of Participants|13|13.0||||||
3739721|NCT02022007|3575489|B4||<=18 years|Age|All participants had to be 18 to 42 years to participate|Participants|Count of Participants|0|0.0||||||
3739722|NCT02022007|3575490|B3||<=18 years|Age|All participants had to be 18 to 42 years to participate|Participants|Count of Participants|0|0.0||||||
3739723|NCT02022007|3575491|B2||<=18 years|Age|All participants had to be 18 to 42 years to participate|Participants|Count of Participants|0|0.0||||||
3739724|NCT02022007|3575492|B1||<=18 years|Age|All participants had to be 18 to 42 years to participate|Participants|Count of Participants|0|0.0||||||
3739725|NCT02021942|3575535|B1|Germany||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3739726|NCT02021942|3575535|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3739727|NCT02021942|3575535|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3739728|NCT02021942|3575535|B1|||Age||years|Mean|52.6|52.6|Standard Deviation|12.7|12.7|||
3739729|NCT02021812|3575545|B1|||BMI||kg/(m^2)|Mean|28.7|28.7|Standard Deviation|6.9|6.9|||
3739730|NCT02021812|3575545|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3739731|NCT02021812|3575545|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3739732|NCT02021812|3575545|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3739733|NCT02021812|3575545|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3739734|NCT02021812|3575545|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3739735|NCT02021812|3575545|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3739736|NCT02021812|3575545|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3739737|NCT02021812|3575545|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3739738|NCT02021812|3575545|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3739739|NCT02021812|3575545|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3739740|NCT02021812|3575545|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3739741|NCT02021812|3575545|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3739742|NCT02021812|3575545|B1|||Age||years|Mean|74.1|74.1|Standard Deviation|10.4|10.4|||
3739743|NCT02021656|3575553|B1||TT|IL28B|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|3|3.0||||||
3739744|NCT02021656|3575553|B1||CT|IL28B|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|95|95.0||||||
3739745|NCT02021656|3575553|B1||CC|IL28B|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|286|286.0||||||
3739746|NCT02021656|3575553|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|85|85.0||||||
3739747|NCT02021656|3575553|B1|China||Region of Enrollment||Participants|Count of Participants|206|206.0||||||
3739748|NCT02021656|3575553|B1|South Korea||Region of Enrollment||Participants|Count of Participants|93|93.0||||||
3739749|NCT02021656|3575553|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|384|384.0||||||
3739750|NCT02021656|3575553|B1|Race Subcategory|Other (Taiwanese- Chinese)|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3739751|NCT02021656|3575553|B1|Race Subcategory|Taiwanese|Race/Ethnicity, Customized||Participants|Count of Participants|83|83.0||||||
3739752|NCT02021656|3575553|B1|Race Subcategory|Korean|Race/Ethnicity, Customized||Participants|Count of Participants|93|93.0||||||
3739753|NCT02021656|3575553|B1|Race Subcategory|Chinese|Race/Ethnicity, Customized||Participants|Count of Participants|207|207.0||||||
3739754|NCT02021656|3575553|B1||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3739755|NCT02021656|3575553|B1||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3739756|NCT02021656|3575553|B1|||Age||Years|Mean|51|51.0|Standard Deviation|13.0|13.0|||
3739757|NCT02021643|3575567|B7|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|516|516.0||||||
3739758|NCT02021643|3575568|B6|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|94|94.0||||||
3739759|NCT02021643|3575569|B5|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|193|193.0||||||
3739760|NCT02021643|3575570|B4|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|82|82.0||||||
3739761|NCT02021643|3575571|B3|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|5|5.0||||||
3739762|NCT02021643|3575572|B2|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|8|8.0||||||
3739763|NCT02021643|3575573|B1|≥ 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|134|134.0||||||
3739764|NCT02021643|3575567|B7|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|170|170.0||||||
3739765|NCT02021643|3575568|B6|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|32|32.0||||||
3739766|NCT02021643|3575569|B5|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|87|87.0||||||
3739767|NCT02021643|3575570|B4|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|22|22.0||||||
3739768|NCT02021643|3575571|B3|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|6|6.0||||||
3739769|NCT02021643|3575572|B2|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|2|2.0||||||
3739770|NCT02021643|3575573|B1|< 800,000 IU/mL||HCV RNA Category||Participants|Count of Participants|21|21.0||||||
3739771|NCT02021643|3575567|B7|||HCV RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.84|0.84|||
3739772|NCT02021643|3575568|B6|||HCV RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.71|0.71|||
3739773|NCT02021643|3575569|B5|||HCV RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.96|0.96|||
3739774|NCT02021643|3575570|B4|||HCV RNA||log10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.71|0.71|||
3739775|NCT02021643|3575571|B3|||HCV RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.88|0.88|||
3739776|NCT02021643|3575572|B2|||HCV RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.49|0.49|||
3739777|NCT02021643|3575573|B1|||HCV RNA||log10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.74|0.74|||
3739778|NCT02021643|3575567|B7|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|4|4.0||||||
3739779|NCT02021643|3575568|B6|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|1|1.0||||||
3739780|NCT02021643|3575569|B5|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|1|1.0||||||
3739781|NCT02021643|3575570|B4|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|1|1.0||||||
3739782|NCT02021643|3575571|B3|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|0|0.0||||||
3739783|NCT02021643|3575572|B2|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|0|0.0||||||
3739784|NCT02021643|3575573|B1|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|1|1.0||||||
3739785|NCT02021643|3575567|B7|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|136|136.0||||||
3739786|NCT02021643|3575568|B6|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|23|23.0||||||
3739787|NCT02021643|3575569|B5|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|42|42.0||||||
3739788|NCT02021643|3575570|B4|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|29|29.0||||||
3739789|NCT02021643|3575571|B3|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|0|0.0||||||
3739790|NCT02021643|3575572|B2|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|2|2.0||||||
3739791|NCT02021643|3575573|B1|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|40|40.0||||||
3739792|NCT02021643|3575567|B7|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|546|546.0||||||
3739793|NCT02021643|3575568|B6|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|102|102.0||||||
3739794|NCT02021643|3575569|B5|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|237|237.0||||||
3739795|NCT02021643|3575570|B4|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|74|74.0||||||
3739796|NCT02021643|3575571|B3|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|11|11.0||||||
3739797|NCT02021643|3575572|B2|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|8|8.0||||||
3739798|NCT02021643|3575573|B1|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|114|114.0||||||
3739799|NCT02021643|3575567|B7|Genotype 6||HCV Genotype||Participants|Count of Participants|77|77.0||||||
3739800|NCT02021643|3575568|B6|Genotype 6||HCV Genotype||Participants|Count of Participants|0|0.0||||||
3739801|NCT02021643|3575569|B5|Genotype 6||HCV Genotype||Participants|Count of Participants|0|0.0||||||
3739802|NCT02021643|3575570|B4|Genotype 6||HCV Genotype||Participants|Count of Participants|23|23.0||||||
3739803|NCT02021643|3575571|B3|Genotype 6||HCV Genotype||Participants|Count of Participants|4|4.0||||||
3739804|NCT02021643|3575572|B2|Genotype 6||HCV Genotype||Participants|Count of Participants|3|3.0||||||
3739805|NCT02021643|3575573|B1|Genotype 6||HCV Genotype||Participants|Count of Participants|47|47.0||||||
3739806|NCT02021643|3575567|B7|Genotype 3||HCV Genotype||Participants|Count of Participants|126|126.0||||||
3739807|NCT02021643|3575568|B6|Genotype 3||HCV Genotype||Participants|Count of Participants|126|126.0||||||
3739808|NCT02021643|3575569|B5|Genotype 3||HCV Genotype||Participants|Count of Participants|0|0.0||||||
3739809|NCT02021643|3575570|B4|Genotype 3||HCV Genotype||Participants|Count of Participants|0|0.0||||||
3739810|NCT02021643|3575571|B3|Genotype 3||HCV Genotype||Participants|Count of Participants|0|0.0||||||
3739811|NCT02021643|3575572|B2|Genotype 3||HCV Genotype||Participants|Count of Participants|0|0.0||||||
3739812|NCT02021643|3575573|B1|Genotype 3||HCV Genotype||Participants|Count of Participants|0|0.0||||||
3739813|NCT02021643|3575567|B7|Genotype 2||HCV Genotype||Participants|Count of Participants|280|280.0||||||
3739814|NCT02021643|3575568|B6|Genotype 2||HCV Genotype||Participants|Count of Participants|0|0.0||||||
3739815|NCT02021643|3575569|B5|Genotype 2||HCV Genotype||Participants|Count of Participants|280|280.0||||||
3739816|NCT02021643|3575570|B4|Genotype 2||HCV Genotype||Participants|Count of Participants|0|0.0||||||
3739817|NCT02021643|3575571|B3|Genotype 2||HCV Genotype||Participants|Count of Participants|0|0.0||||||
3739818|NCT02021643|3575572|B2|Genotype 2||HCV Genotype||Participants|Count of Participants|0|0.0||||||
3739819|NCT02021643|3575573|B1|Genotype 2||HCV Genotype||Participants|Count of Participants|0|0.0||||||
3739820|NCT02021643|3575567|B7|Genotype 1||HCV Genotype||Participants|Count of Participants|203|203.0||||||
3739821|NCT02021643|3575568|B6|Genotype 1||HCV Genotype||Participants|Count of Participants|0|0.0||||||
3739822|NCT02021643|3575569|B5|Genotype 1||HCV Genotype||Participants|Count of Participants|0|0.0||||||
3739823|NCT02021643|3575570|B4|Genotype 1||HCV Genotype||Participants|Count of Participants|81|81.0||||||
3739824|NCT02021643|3575571|B3|Genotype 1||HCV Genotype||Participants|Count of Participants|7|7.0||||||
3739825|NCT02021643|3575572|B2|Genotype 1||HCV Genotype||Participants|Count of Participants|7|7.0||||||
3739826|NCT02021643|3575573|B1|Genotype 1||HCV Genotype||Participants|Count of Participants|108|108.0||||||
3739827|NCT02021643|3575567|B7|Vietnam||Region of Enrollment||participants|Number|50|50.0||||||
3739828|NCT02021643|3575568|B6|Vietnam||Region of Enrollment||participants|Number|0|0.0||||||
3739829|NCT02021643|3575569|B5|Vietnam||Region of Enrollment||participants|Number|0|0.0||||||
3739830|NCT02021643|3575570|B4|Vietnam||Region of Enrollment||participants|Number|25|25.0||||||
3739831|NCT02021643|3575571|B3|Vietnam||Region of Enrollment||participants|Number|0|0.0||||||
3739832|NCT02021643|3575572|B2|Vietnam||Region of Enrollment||participants|Number|0|0.0||||||
3739833|NCT02021643|3575573|B1|Vietnam||Region of Enrollment||participants|Number|25|25.0||||||
3739834|NCT02021643|3575567|B7|Taiwan||Region of Enrollment||participants|Number|87|87.0||||||
3739835|NCT02021643|3575568|B6|Taiwan||Region of Enrollment||participants|Number|0|0.0||||||
3739836|NCT02021643|3575569|B5|Taiwan||Region of Enrollment||participants|Number|87|87.0||||||
3739837|NCT02021643|3575570|B4|Taiwan||Region of Enrollment||participants|Number|0|0.0||||||
3739838|NCT02021643|3575571|B3|Taiwan||Region of Enrollment||participants|Number|0|0.0||||||
3739839|NCT02021643|3575572|B2|Taiwan||Region of Enrollment||participants|Number|0|0.0||||||
3739840|NCT02021643|3575573|B1|Taiwan||Region of Enrollment||participants|Number|0|0.0||||||
3739841|NCT02021643|3575567|B7|South Korea||Region of Enrollment||participants|Number|129|129.0||||||
3739842|NCT02021643|3575568|B6|South Korea||Region of Enrollment||participants|Number|0|0.0||||||
3739843|NCT02021643|3575569|B5|South Korea||Region of Enrollment||participants|Number|129|129.0||||||
3739844|NCT02021643|3575570|B4|South Korea||Region of Enrollment||participants|Number|0|0.0||||||
3739845|NCT02021643|3575571|B3|South Korea||Region of Enrollment||participants|Number|0|0.0||||||
3739846|NCT02021643|3575572|B2|South Korea||Region of Enrollment||participants|Number|0|0.0||||||
3739847|NCT02021643|3575573|B1|South Korea||Region of Enrollment||participants|Number|0|0.0||||||
3739848|NCT02021643|3575567|B7|Hong Kong||Region of Enrollment||participants|Number|31|31.0||||||
3739849|NCT02021643|3575568|B6|Hong Kong||Region of Enrollment||participants|Number|0|0.0||||||
3739850|NCT02021643|3575569|B5|Hong Kong||Region of Enrollment||participants|Number|0|0.0||||||
3739851|NCT02021643|3575570|B4|Hong Kong||Region of Enrollment||participants|Number|10|10.0||||||
3739852|NCT02021643|3575571|B3|Hong Kong||Region of Enrollment||participants|Number|11|11.0||||||
3739853|NCT02021643|3575572|B2|Hong Kong||Region of Enrollment||participants|Number|10|10.0||||||
3739854|NCT02021643|3575573|B1|Hong Kong||Region of Enrollment||participants|Number|0|0.0||||||
3739855|NCT02021643|3575567|B7|China||Region of Enrollment||participants|Number|389|389.0||||||
3739856|NCT02021643|3575568|B6|China||Region of Enrollment||participants|Number|126|126.0||||||
3739857|NCT02021643|3575569|B5|China||Region of Enrollment||participants|Number|64|64.0||||||
3739858|NCT02021643|3575570|B4|China||Region of Enrollment||participants|Number|69|69.0||||||
3739859|NCT02021643|3575571|B3|China||Region of Enrollment||participants|Number|0|0.0||||||
3739860|NCT02021643|3575572|B2|China||Region of Enrollment||participants|Number|0|0.0||||||
3739861|NCT02021643|3575573|B1|China||Region of Enrollment||participants|Number|130|130.0||||||
3739862|NCT02021643|3575567|B7|Not Disclosed||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3739863|NCT02021643|3575568|B6|Not Disclosed||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3739864|NCT02021643|3575569|B5|Not Disclosed||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3739865|NCT02021643|3575570|B4|Not Disclosed||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3739866|NCT02021643|3575571|B3|Not Disclosed||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3739867|NCT02021643|3575572|B2|Not Disclosed||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3739868|NCT02021643|3575573|B1|Not Disclosed||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3739869|NCT02021643|3575567|B7|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|676|676.0||||||
3739870|NCT02021643|3575568|B6|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|126|126.0||||||
3739871|NCT02021643|3575569|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|280|280.0||||||
3739872|NCT02021643|3575570|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|98|98.0||||||
3739873|NCT02021643|3575571|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3739874|NCT02021643|3575572|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3739875|NCT02021643|3575573|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|151|151.0||||||
3739876|NCT02021643|3575567|B7|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3739877|NCT02021643|3575568|B6|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3739878|NCT02021643|3575569|B5|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3739879|NCT02021643|3575570|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3739880|NCT02021643|3575571|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3739881|NCT02021643|3575572|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3739882|NCT02021643|3575573|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3739883|NCT02021643|3575567|B7|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|686|686.0||||||
3739884|NCT02021643|3575568|B6|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|126|126.0||||||
3739885|NCT02021643|3575569|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|280|280.0||||||
3739886|NCT02021643|3575570|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|104|104.0||||||
3739887|NCT02021643|3575571|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3739888|NCT02021643|3575572|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3739889|NCT02021643|3575573|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|155|155.0||||||
3739890|NCT02021643|3575567|B7||Male|Sex: Female, Male||Participants|Count of Participants|335|335.0||||||
3739891|NCT02021643|3575568|B6||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3739892|NCT02021643|3575569|B5||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3739893|NCT02021643|3575570|B4||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3739894|NCT02021643|3575571|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3739895|NCT02021643|3575572|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3739896|NCT02021643|3575573|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3739897|NCT02021643|3575567|B7||Female|Sex: Female, Male||Participants|Count of Participants|351|351.0||||||
3739898|NCT02021643|3575568|B6||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3739899|NCT02021643|3575569|B5||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3739900|NCT02021643|3575570|B4||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3739901|NCT02021643|3575571|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3739902|NCT02021643|3575572|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3739903|NCT02021643|3575573|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3739904|NCT02021643|3575567|B7|||Age||years|Mean|47|47.0|Standard Deviation|13.3|13.3|||
3739905|NCT02021643|3575568|B6|||Age||years|Mean|40|40.0|Standard Deviation|8.1|8.1|||
3739906|NCT02021643|3575569|B5|||Age||years|Mean|53|53.0|Standard Deviation|12.3|12.3|||
3739907|NCT02021643|3575570|B4|||Age||years|Mean|49|49.0|Standard Deviation|13.3|13.3|||
3739908|NCT02021643|3575571|B3|||Age||years|Mean|43|43.0|Standard Deviation|17.6|17.6|||
3739909|NCT02021643|3575572|B2|||Age||years|Mean|43|43.0|Standard Deviation|17.2|17.2|||
3739910|NCT02021643|3575573|B1|||Age||years|Mean|41|41.0|Standard Deviation|12.8|12.8|||
3739911|NCT02021565|3575616|B3||Coast Guard|Military Branch|Branch of military in which Veteran care recipient served|Participants|Count of Participants|1|1.0||||||
3739912|NCT02021565|3575617|B2||Coast Guard|Military Branch|Branch of military in which Veteran care recipient served|Participants|Count of Participants|1|1.0||||||
3739913|NCT02021565|3575618|B1||Coast Guard|Military Branch|Branch of military in which Veteran care recipient served|Participants|Count of Participants|0|0.0||||||
3739914|NCT02021565|3575616|B3||Marines|Military Branch|Branch of military in which Veteran care recipient served|Participants|Count of Participants|5|5.0||||||
3739915|NCT02021565|3575617|B2||Marines|Military Branch|Branch of military in which Veteran care recipient served|Participants|Count of Participants|2|2.0||||||
3739916|NCT02021565|3575618|B1||Marines|Military Branch|Branch of military in which Veteran care recipient served|Participants|Count of Participants|3|3.0||||||
3739917|NCT02021565|3575616|B3||Air Force|Military Branch|Branch of military in which Veteran care recipient served|Participants|Count of Participants|13|13.0||||||
3739918|NCT02021565|3575617|B2||Air Force|Military Branch|Branch of military in which Veteran care recipient served|Participants|Count of Participants|5|5.0||||||
3739919|NCT02021565|3575618|B1||Air Force|Military Branch|Branch of military in which Veteran care recipient served|Participants|Count of Participants|8|8.0||||||
3739920|NCT02021565|3575616|B3||Navy|Military Branch|Branch of military in which Veteran care recipient served|Participants|Count of Participants|7|7.0||||||
3739921|NCT02021565|3575617|B2||Navy|Military Branch|Branch of military in which Veteran care recipient served|Participants|Count of Participants|2|2.0||||||
3739922|NCT02021565|3575618|B1||Navy|Military Branch|Branch of military in which Veteran care recipient served|Participants|Count of Participants|5|5.0||||||
3739923|NCT02021565|3575616|B3||Army|Military Branch|Branch of military in which Veteran care recipient served|Participants|Count of Participants|29|29.0||||||
3739924|NCT02021565|3575617|B2||Army|Military Branch|Branch of military in which Veteran care recipient served|Participants|Count of Participants|13|13.0||||||
3739925|NCT02021565|3575618|B1||Army|Military Branch|Branch of military in which Veteran care recipient served|Participants|Count of Participants|16|16.0||||||
3739926|NCT02021565|3575616|B3||Mother|Caregiver Relationship to Veteran||Participants|Count of Participants|1|1.0||||||
3739927|NCT02021565|3575617|B2||Mother|Caregiver Relationship to Veteran||Participants|Count of Participants|0|0.0||||||
3739928|NCT02021565|3575618|B1||Mother|Caregiver Relationship to Veteran||Participants|Count of Participants|1|1.0||||||
3739929|NCT02021565|3575616|B3||Neice|Caregiver Relationship to Veteran||Participants|Count of Participants|1|1.0||||||
3739930|NCT02021565|3575617|B2||Neice|Caregiver Relationship to Veteran||Participants|Count of Participants|1|1.0||||||
3739931|NCT02021565|3575618|B1||Neice|Caregiver Relationship to Veteran||Participants|Count of Participants|0|0.0||||||
3739932|NCT02021565|3575616|B3||Sister|Caregiver Relationship to Veteran||Participants|Count of Participants|2|2.0||||||
3739933|NCT02021565|3575617|B2||Sister|Caregiver Relationship to Veteran||Participants|Count of Participants|1|1.0||||||
3739934|NCT02021565|3575618|B1||Sister|Caregiver Relationship to Veteran||Participants|Count of Participants|1|1.0||||||
3739935|NCT02021565|3575616|B3||Daughter|Caregiver Relationship to Veteran||Participants|Count of Participants|6|6.0||||||
3739936|NCT02021565|3575617|B2||Daughter|Caregiver Relationship to Veteran||Participants|Count of Participants|3|3.0||||||
3739937|NCT02021565|3575618|B1||Daughter|Caregiver Relationship to Veteran||Participants|Count of Participants|3|3.0||||||
3739938|NCT02021565|3575616|B3||Spouse|Caregiver Relationship to Veteran||Participants|Count of Participants|49|49.0||||||
3739939|NCT02021565|3575617|B2||Spouse|Caregiver Relationship to Veteran||Participants|Count of Participants|20|20.0||||||
3739940|NCT02021565|3575618|B1||Spouse|Caregiver Relationship to Veteran||Participants|Count of Participants|29|29.0||||||
3739941|NCT02021565|3575616|B3|Care Recipients|Poor|Health Status|Caregiver and care recipient self-reported health|Participants|Count of Participants|3|3.0||||||
3739942|NCT02021565|3575617|B2|Care Recipients|Poor|Health Status|Caregiver and care recipient self-reported health|Participants|Count of Participants|2|2.0||||||
3739943|NCT02021565|3575618|B1|Care Recipients|Poor|Health Status|Caregiver and care recipient self-reported health|Participants|Count of Participants|1|1.0||||||
3739944|NCT02021565|3575616|B3|Care Recipients|Fair|Health Status|Caregiver and care recipient self-reported health|Participants|Count of Participants|9|9.0||||||
3739945|NCT02021565|3575617|B2|Care Recipients|Fair|Health Status|Caregiver and care recipient self-reported health|Participants|Count of Participants|5|5.0||||||
3739946|NCT02021565|3575618|B1|Care Recipients|Fair|Health Status|Caregiver and care recipient self-reported health|Participants|Count of Participants|4|4.0||||||
3739947|NCT02021565|3575616|B3|Care Recipients|Good|Health Status|Caregiver and care recipient self-reported health|Participants|Count of Participants|10|10.0||||||
3739948|NCT02021565|3575617|B2|Care Recipients|Good|Health Status|Caregiver and care recipient self-reported health|Participants|Count of Participants|0|0.0||||||
3739949|NCT02021565|3575618|B1|Care Recipients|Good|Health Status|Caregiver and care recipient self-reported health|Participants|Count of Participants|10|10.0||||||
3739950|NCT02021565|3575616|B3|Care Recipients|Very Good|Health Status|Caregiver and care recipient self-reported health|Participants|Count of Participants|2|2.0||||||
3739951|NCT02021565|3575617|B2|Care Recipients|Very Good|Health Status|Caregiver and care recipient self-reported health|Participants|Count of Participants|1|1.0||||||
3739952|NCT02021565|3575618|B1|Care Recipients|Very Good|Health Status|Caregiver and care recipient self-reported health|Participants|Count of Participants|1|1.0||||||
3739953|NCT02021565|3575616|B3|Care Recipients|Excellent|Health Status|Caregiver and care recipient self-reported health|Participants|Count of Participants|0|0.0||||||
3739954|NCT02021565|3575617|B2|Care Recipients|Excellent|Health Status|Caregiver and care recipient self-reported health|Participants|Count of Participants|0|0.0||||||
3739955|NCT02021565|3575618|B1|Care Recipients|Excellent|Health Status|Caregiver and care recipient self-reported health|Participants|Count of Participants|0|0.0||||||
3739956|NCT02021565|3575616|B3|Caregivers|Poor|Health Status|Caregiver and care recipient self-reported health|Participants|Count of Participants|1|1.0||||||
3739957|NCT02021565|3575617|B2|Caregivers|Poor|Health Status|Caregiver and care recipient self-reported health|Participants|Count of Participants|1|1.0||||||
3739958|NCT02021565|3575618|B1|Caregivers|Poor|Health Status|Caregiver and care recipient self-reported health|Participants|Count of Participants|0|0.0||||||
3739959|NCT02021565|3575616|B3|Caregivers|Fair|Health Status|Caregiver and care recipient self-reported health|Participants|Count of Participants|4|4.0||||||
3739960|NCT02021565|3575617|B2|Caregivers|Fair|Health Status|Caregiver and care recipient self-reported health|Participants|Count of Participants|2|2.0||||||
3739961|NCT02021565|3575618|B1|Caregivers|Fair|Health Status|Caregiver and care recipient self-reported health|Participants|Count of Participants|2|2.0||||||
3739962|NCT02021565|3575616|B3|Caregivers|Good|Health Status|Caregiver and care recipient self-reported health|Participants|Count of Participants|27|27.0||||||
3739963|NCT02021565|3575617|B2|Caregivers|Good|Health Status|Caregiver and care recipient self-reported health|Participants|Count of Participants|6|6.0||||||
3739964|NCT02021565|3575618|B1|Caregivers|Good|Health Status|Caregiver and care recipient self-reported health|Participants|Count of Participants|21|21.0||||||
3739965|NCT02021565|3575616|B3|Caregivers|Very Good|Health Status|Caregiver and care recipient self-reported health|Participants|Count of Participants|19|19.0||||||
3739966|NCT02021565|3575617|B2|Caregivers|Very Good|Health Status|Caregiver and care recipient self-reported health|Participants|Count of Participants|10|10.0||||||
3739967|NCT02021565|3575618|B1|Caregivers|Very Good|Health Status|Caregiver and care recipient self-reported health|Participants|Count of Participants|9|9.0||||||
3739968|NCT02021565|3575616|B3|Caregivers|Excellent|Health Status|Caregiver and care recipient self-reported health|Participants|Count of Participants|6|6.0||||||
3739969|NCT02021565|3575617|B2|Caregivers|Excellent|Health Status|Caregiver and care recipient self-reported health|Participants|Count of Participants|4|4.0||||||
3739970|NCT02021565|3575618|B1|Caregivers|Excellent|Health Status|Caregiver and care recipient self-reported health|Participants|Count of Participants|2|2.0||||||
3739971|NCT02021565|3575616|B3|||Income|Caregiver reported income (% < 30,000)|Participants|Count of Participants|21|21.0||||||
3739972|NCT02021565|3575617|B2|||Income|Caregiver reported income (% < 30,000)|Participants|Count of Participants|10|10.0||||||
3739973|NCT02021565|3575618|B1|||Income|Caregiver reported income (% < 30,000)|Participants|Count of Participants|11|11.0||||||
3739974|NCT02021565|3575616|B3|Care Recipients|Employed|Employment|"Not employed is disabled or unable to work, unemployed, or never employed outside the home.~Employed is part-time or full-time employment"|Participants|Count of Participants|26|26.0||||||
3739975|NCT02021565|3575617|B2|Care Recipients|Employed|Employment|"Not employed is disabled or unable to work, unemployed, or never employed outside the home.~Employed is part-time or full-time employment"|Participants|Count of Participants|12|12.0||||||
3739976|NCT02021565|3575618|B1|Care Recipients|Employed|Employment|"Not employed is disabled or unable to work, unemployed, or never employed outside the home.~Employed is part-time or full-time employment"|Participants|Count of Participants|14|14.0||||||
3739977|NCT02021565|3575616|B3|Care Recipients|Not Employed|Employment|"Not employed is disabled or unable to work, unemployed, or never employed outside the home.~Employed is part-time or full-time employment"|Participants|Count of Participants|13|13.0||||||
3739978|NCT02021565|3575617|B2|Care Recipients|Not Employed|Employment|"Not employed is disabled or unable to work, unemployed, or never employed outside the home.~Employed is part-time or full-time employment"|Participants|Count of Participants|7|7.0||||||
3739979|NCT02021565|3575618|B1|Care Recipients|Not Employed|Employment|"Not employed is disabled or unable to work, unemployed, or never employed outside the home.~Employed is part-time or full-time employment"|Participants|Count of Participants|6|6.0||||||
3739980|NCT02021565|3575616|B3|Care Recipients|Retired|Employment|"Not employed is disabled or unable to work, unemployed, or never employed outside the home.~Employed is part-time or full-time employment"|Participants|Count of Participants|15|15.0||||||
3739981|NCT02021565|3575617|B2|Care Recipients|Retired|Employment|"Not employed is disabled or unable to work, unemployed, or never employed outside the home.~Employed is part-time or full-time employment"|Participants|Count of Participants|3|3.0||||||
3739982|NCT02021565|3575618|B1|Care Recipients|Retired|Employment|"Not employed is disabled or unable to work, unemployed, or never employed outside the home.~Employed is part-time or full-time employment"|Participants|Count of Participants|12|12.0||||||
3739983|NCT02021565|3575616|B3|Caregivers|Employed|Employment|"Not employed is disabled or unable to work, unemployed, or never employed outside the home.~Employed is part-time or full-time employment"|Participants|Count of Participants|6|6.0||||||
3739984|NCT02021565|3575617|B2|Caregivers|Employed|Employment|"Not employed is disabled or unable to work, unemployed, or never employed outside the home.~Employed is part-time or full-time employment"|Participants|Count of Participants|3|3.0||||||
3739985|NCT02021565|3575618|B1|Caregivers|Employed|Employment|"Not employed is disabled or unable to work, unemployed, or never employed outside the home.~Employed is part-time or full-time employment"|Participants|Count of Participants|3|3.0||||||
3739986|NCT02021565|3575616|B3|Caregivers|Not Employed|Employment|"Not employed is disabled or unable to work, unemployed, or never employed outside the home.~Employed is part-time or full-time employment"|Participants|Count of Participants|19|19.0||||||
3739987|NCT02021565|3575617|B2|Caregivers|Not Employed|Employment|"Not employed is disabled or unable to work, unemployed, or never employed outside the home.~Employed is part-time or full-time employment"|Participants|Count of Participants|8|8.0||||||
3739988|NCT02021565|3575618|B1|Caregivers|Not Employed|Employment|"Not employed is disabled or unable to work, unemployed, or never employed outside the home.~Employed is part-time or full-time employment"|Participants|Count of Participants|11|11.0||||||
3739989|NCT02021565|3575616|B3|Caregivers|Retired|Employment|"Not employed is disabled or unable to work, unemployed, or never employed outside the home.~Employed is part-time or full-time employment"|Participants|Count of Participants|34|34.0||||||
3739990|NCT02021565|3575617|B2|Caregivers|Retired|Employment|"Not employed is disabled or unable to work, unemployed, or never employed outside the home.~Employed is part-time or full-time employment"|Participants|Count of Participants|14|14.0||||||
3739991|NCT02021565|3575618|B1|Caregivers|Retired|Employment|"Not employed is disabled or unable to work, unemployed, or never employed outside the home.~Employed is part-time or full-time employment"|Participants|Count of Participants|20|20.0||||||
3739992|NCT02021565|3575616|B3|Care Recipients||Education|Caregiver education level (% education beyond high school)|Participants|Count of Participants|38|38.0||||||
3739993|NCT02021565|3575617|B2|Care Recipients||Education|Caregiver education level (% education beyond high school)|Participants|Count of Participants|17|17.0||||||
3739994|NCT02021565|3575618|B1|Care Recipients||Education|Caregiver education level (% education beyond high school)|Participants|Count of Participants|21|21.0||||||
3739995|NCT02021565|3575616|B3|Caregivers||Education|Caregiver education level (% education beyond high school)|Participants|Count of Participants|40|40.0||||||
3739996|NCT02021565|3575617|B2|Caregivers||Education|Caregiver education level (% education beyond high school)|Participants|Count of Participants|18|18.0||||||
3739997|NCT02021565|3575618|B1|Caregivers||Education|Caregiver education level (% education beyond high school)|Participants|Count of Participants|22|22.0||||||
3739998|NCT02021565|3575616|B3|||Marital Status|Caregiver marital status (% married)|Participants|Count of Participants|53|53.0||||||
3739999|NCT02021565|3575617|B2|||Marital Status|Caregiver marital status (% married)|Participants|Count of Participants|21|21.0||||||
3740000|NCT02021565|3575618|B1|||Marital Status|Caregiver marital status (% married)|Participants|Count of Participants|32|32.0||||||
3740001|NCT02021565|3575616|B3|||Care Recipient Total Diagnoses||Health Problems|Mean|20.83|20.83|Standard Deviation|11.12|11.12|||
3740002|NCT02021565|3575617|B2|||Care Recipient Total Diagnoses||Health Problems|Mean|23.33|23.33|Standard Deviation|12.17|12.17|||
3740003|NCT02021565|3575618|B1|||Care Recipient Total Diagnoses||Health Problems|Mean|18.94|18.94|Standard Deviation|9.86|9.86|||
3740004|NCT02021565|3575616|B3|||Number of CG Health Problems|Self-reported number of health problems reported by caregivers.|Health problems|Mean|2.37|2.37|Standard Deviation|1.78|1.78|||
3740005|NCT02021565|3575617|B2|||Number of CG Health Problems|Self-reported number of health problems reported by caregivers.|Health problems|Mean|2.24|2.24|Standard Deviation|1.63|1.63|||
3740006|NCT02021565|3575618|B1|||Number of CG Health Problems|Self-reported number of health problems reported by caregivers.|Health problems|Mean|2.47|2.47|Standard Deviation|1.88|1.88|||
3740007|NCT02021565|3575616|B3|United States||Region of Enrollment||Participants|Count of Participants|126|126.0||||||
3740008|NCT02021565|3575617|B2|United States||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
3740009|NCT02021565|3575618|B1|United States||Region of Enrollment||Participants|Count of Participants|72|72.0||||||
3740010|NCT02021565|3575616|B3|Care Recipient|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740011|NCT02021565|3575617|B2|Care Recipient|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740012|NCT02021565|3575618|B1|Care Recipient|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740013|NCT02021565|3575616|B3|Care Recipient|More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740014|NCT02021565|3575617|B2|Care Recipient|More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740015|NCT02021565|3575618|B1|Care Recipient|More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740016|NCT02021565|3575616|B3|Care Recipient|White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3740017|NCT02021565|3575617|B2|Care Recipient|White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3740018|NCT02021565|3575618|B1|Care Recipient|White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3740019|NCT02021565|3575616|B3|Care Recipient|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3740020|NCT02021565|3575617|B2|Care Recipient|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3740021|NCT02021565|3575618|B1|Care Recipient|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3740022|NCT02021565|3575616|B3|Care Recipient|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740023|NCT02021565|3575617|B2|Care Recipient|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740024|NCT02021565|3575618|B1|Care Recipient|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740025|NCT02021565|3575616|B3|Care Recipient|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740026|NCT02021565|3575617|B2|Care Recipient|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740027|NCT02021565|3575618|B1|Care Recipient|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740028|NCT02021565|3575616|B3|Care Recipient|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740029|NCT02021565|3575617|B2|Care Recipient|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740030|NCT02021565|3575618|B1|Care Recipient|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740031|NCT02021565|3575616|B3|Caregiver|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3740032|NCT02021565|3575617|B2|Caregiver|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3740033|NCT02021565|3575618|B1|Caregiver|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740034|NCT02021565|3575616|B3|Caregiver|More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740035|NCT02021565|3575617|B2|Caregiver|More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740036|NCT02021565|3575618|B1|Caregiver|More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740037|NCT02021565|3575616|B3|Caregiver|White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3740038|NCT02021565|3575617|B2|Caregiver|White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3740039|NCT02021565|3575618|B1|Caregiver|White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3740040|NCT02021565|3575616|B3|Caregiver|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3740041|NCT02021565|3575617|B2|Caregiver|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3740042|NCT02021565|3575618|B1|Caregiver|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3740043|NCT02021565|3575616|B3|Caregiver|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740044|NCT02021565|3575617|B2|Caregiver|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740045|NCT02021565|3575618|B1|Caregiver|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740046|NCT02021565|3575616|B3|Caregiver|Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3740047|NCT02021565|3575617|B2|Caregiver|Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3740048|NCT02021565|3575618|B1|Caregiver|Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3740049|NCT02021565|3575616|B3|Caregiver|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740050|NCT02021565|3575617|B2|Caregiver|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740051|NCT02021565|3575618|B1|Caregiver|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740052|NCT02021565|3575616|B3|Male Veterans||Sex/Gender, Customized||Participants|Count of Participants|61|61.0||||||
3740053|NCT02021565|3575617|B2|Male Veterans||Sex/Gender, Customized||Participants|Count of Participants|27|27.0||||||
3740054|NCT02021565|3575618|B1|Male Veterans||Sex/Gender, Customized||Participants|Count of Participants|34|34.0||||||
3740055|NCT02021565|3575616|B3|Female Caregivers||Sex/Gender, Customized||Participants|Count of Participants|56|56.0||||||
3740056|NCT02021565|3575617|B2|Female Caregivers||Sex/Gender, Customized||Participants|Count of Participants|22|22.0||||||
3740057|NCT02021565|3575618|B1|Female Caregivers||Sex/Gender, Customized||Participants|Count of Participants|34|34.0||||||
3740058|NCT02021565|3575616|B3|Care Recipient Age||Age, Customized||years|Mean|75.5|75.5|Standard Deviation|9.8|9.8|||
3740059|NCT02021565|3575617|B2|Care Recipient Age||Age, Customized||years|Mean|77.2|77.2|Standard Deviation|9.3|9.3|||
3740060|NCT02021565|3575618|B1|Care Recipient Age||Age, Customized||years|Mean|74.3|74.3|Standard Deviation|10.1|10.1|||
3740061|NCT02021565|3575616|B3|Caregiver Age||Age, Customized||years|Mean|66|66.0|Standard Deviation|9.4|9.4|||
3740062|NCT02021565|3575617|B2|Caregiver Age||Age, Customized||years|Mean|66|66.0|Standard Deviation|9.1|9.1|||
3740063|NCT02021565|3575618|B1|Caregiver Age||Age, Customized||years|Mean|66|66.0|Standard Deviation|9.5|9.5|||
3740064|NCT02021461|3575631|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740065|NCT02021461|3575631|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740066|NCT02021461|3575631|B1||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3740067|NCT02021461|3575631|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740068|NCT02021461|3575631|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740069|NCT02021461|3575631|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740070|NCT02021461|3575631|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740071|NCT02021461|3575631|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3740072|NCT02021461|3575631|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3740073|NCT02021461|3575631|B1|||Age||years|Mean|6.1|6.1|Standard Deviation|0.8|0.8|||
3740074|NCT02021331|3575637|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3740075|NCT02021331|3575638|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3740076|NCT02021331|3575639|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3740077|NCT02021331|3575637|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3740078|NCT02021331|3575638|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3740079|NCT02021331|3575639|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3740080|NCT02021331|3575637|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3740081|NCT02021331|3575638|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3740082|NCT02021331|3575639|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3740083|NCT02021331|3575637|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3740084|NCT02021331|3575638|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3740085|NCT02021331|3575639|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3740086|NCT02021331|3575637|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3740087|NCT02021331|3575638|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3740088|NCT02021331|3575639|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3740089|NCT02021331|3575637|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3740090|NCT02021331|3575638|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3740091|NCT02021331|3575639|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3740092|NCT02021292|3575650|B3|YES||Use of pulmonary arterial hypertension (PAH) medication||Participants|Count of Participants|49|49.0||||||
3740093|NCT02021292|3575651|B2|YES||Use of pulmonary arterial hypertension (PAH) medication||Participants|Count of Participants|25|25.0||||||
3740094|NCT02021292|3575652|B1|YES||Use of pulmonary arterial hypertension (PAH) medication||Participants|Count of Participants|24|24.0||||||
3740095|NCT02021292|3575650|B3|NO||Use of pulmonary arterial hypertension (PAH) medication||Participants|Count of Participants|31|31.0||||||
3740096|NCT02021292|3575651|B2|NO||Use of pulmonary arterial hypertension (PAH) medication||Participants|Count of Participants|15|15.0||||||
3740097|NCT02021292|3575652|B1|NO||Use of pulmonary arterial hypertension (PAH) medication||Participants|Count of Participants|16|16.0||||||
3740098|NCT02021292|3575650|B3||class IV|WHO functional class|Class I: no symptoms with exercise or at rest. Class II: No symptoms at rest but uncomfortable and short of breath with normal activity such as climbing a flight of stairs, grocery shopping, or making the bed. Class III: May not have symptoms at rest but activities greatly limited by shortness of breath, fatigue, or near fainting (e.g. doing normal chores around the house, have to take breaks while doing activities of daily living). Class IV: Symptoms at rest and severe symptoms with any activity. Most patients also have edema in the feet and ankles as result of right heart failure.|Participants|Count of Participants|1|1.0||||||
3740099|NCT02021292|3575651|B2||class IV|WHO functional class|Class I: no symptoms with exercise or at rest. Class II: No symptoms at rest but uncomfortable and short of breath with normal activity such as climbing a flight of stairs, grocery shopping, or making the bed. Class III: May not have symptoms at rest but activities greatly limited by shortness of breath, fatigue, or near fainting (e.g. doing normal chores around the house, have to take breaks while doing activities of daily living). Class IV: Symptoms at rest and severe symptoms with any activity. Most patients also have edema in the feet and ankles as result of right heart failure.|Participants|Count of Participants|1|1.0||||||
3740100|NCT02021292|3575652|B1||class IV|WHO functional class|Class I: no symptoms with exercise or at rest. Class II: No symptoms at rest but uncomfortable and short of breath with normal activity such as climbing a flight of stairs, grocery shopping, or making the bed. Class III: May not have symptoms at rest but activities greatly limited by shortness of breath, fatigue, or near fainting (e.g. doing normal chores around the house, have to take breaks while doing activities of daily living). Class IV: Symptoms at rest and severe symptoms with any activity. Most patients also have edema in the feet and ankles as result of right heart failure.|Participants|Count of Participants|0|0.0||||||
3740101|NCT02021292|3575650|B3||class III|WHO functional class|Class I: no symptoms with exercise or at rest. Class II: No symptoms at rest but uncomfortable and short of breath with normal activity such as climbing a flight of stairs, grocery shopping, or making the bed. Class III: May not have symptoms at rest but activities greatly limited by shortness of breath, fatigue, or near fainting (e.g. doing normal chores around the house, have to take breaks while doing activities of daily living). Class IV: Symptoms at rest and severe symptoms with any activity. Most patients also have edema in the feet and ankles as result of right heart failure.|Participants|Count of Participants|61|61.0||||||
3740124|NCT02021292|3575652|B1|Western Europe||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3740125|NCT02021292|3575650|B3|Latin America||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3740126|NCT02021292|3575651|B2|Latin America||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3740102|NCT02021292|3575651|B2||class III|WHO functional class|Class I: no symptoms with exercise or at rest. Class II: No symptoms at rest but uncomfortable and short of breath with normal activity such as climbing a flight of stairs, grocery shopping, or making the bed. Class III: May not have symptoms at rest but activities greatly limited by shortness of breath, fatigue, or near fainting (e.g. doing normal chores around the house, have to take breaks while doing activities of daily living). Class IV: Symptoms at rest and severe symptoms with any activity. Most patients also have edema in the feet and ankles as result of right heart failure.|Participants|Count of Participants|33|33.0||||||
3740103|NCT02021292|3575652|B1||class III|WHO functional class|Class I: no symptoms with exercise or at rest. Class II: No symptoms at rest but uncomfortable and short of breath with normal activity such as climbing a flight of stairs, grocery shopping, or making the bed. Class III: May not have symptoms at rest but activities greatly limited by shortness of breath, fatigue, or near fainting (e.g. doing normal chores around the house, have to take breaks while doing activities of daily living). Class IV: Symptoms at rest and severe symptoms with any activity. Most patients also have edema in the feet and ankles as result of right heart failure.|Participants|Count of Participants|28|28.0||||||
3740104|NCT02021292|3575650|B3||class II|WHO functional class|Class I: no symptoms with exercise or at rest. Class II: No symptoms at rest but uncomfortable and short of breath with normal activity such as climbing a flight of stairs, grocery shopping, or making the bed. Class III: May not have symptoms at rest but activities greatly limited by shortness of breath, fatigue, or near fainting (e.g. doing normal chores around the house, have to take breaks while doing activities of daily living). Class IV: Symptoms at rest and severe symptoms with any activity. Most patients also have edema in the feet and ankles as result of right heart failure.|Participants|Count of Participants|18|18.0||||||
3740105|NCT02021292|3575651|B2||class II|WHO functional class|Class I: no symptoms with exercise or at rest. Class II: No symptoms at rest but uncomfortable and short of breath with normal activity such as climbing a flight of stairs, grocery shopping, or making the bed. Class III: May not have symptoms at rest but activities greatly limited by shortness of breath, fatigue, or near fainting (e.g. doing normal chores around the house, have to take breaks while doing activities of daily living). Class IV: Symptoms at rest and severe symptoms with any activity. Most patients also have edema in the feet and ankles as result of right heart failure.|Participants|Count of Participants|6|6.0||||||
3740106|NCT02021292|3575652|B1||class II|WHO functional class|Class I: no symptoms with exercise or at rest. Class II: No symptoms at rest but uncomfortable and short of breath with normal activity such as climbing a flight of stairs, grocery shopping, or making the bed. Class III: May not have symptoms at rest but activities greatly limited by shortness of breath, fatigue, or near fainting (e.g. doing normal chores around the house, have to take breaks while doing activities of daily living). Class IV: Symptoms at rest and severe symptoms with any activity. Most patients also have edema in the feet and ankles as result of right heart failure.|Participants|Count of Participants|12|12.0||||||
3740107|NCT02021292|3575650|B3||class I|WHO functional class|Class I: no symptoms with exercise or at rest. Class II: No symptoms at rest but uncomfortable and short of breath with normal activity such as climbing a flight of stairs, grocery shopping, or making the bed. Class III: May not have symptoms at rest but activities greatly limited by shortness of breath, fatigue, or near fainting (e.g. doing normal chores around the house, have to take breaks while doing activities of daily living). Class IV: Symptoms at rest and severe symptoms with any activity. Most patients also have edema in the feet and ankles as result of right heart failure.|Participants|Count of Participants|0|0.0||||||
3740108|NCT02021292|3575651|B2||class I|WHO functional class|Class I: no symptoms with exercise or at rest. Class II: No symptoms at rest but uncomfortable and short of breath with normal activity such as climbing a flight of stairs, grocery shopping, or making the bed. Class III: May not have symptoms at rest but activities greatly limited by shortness of breath, fatigue, or near fainting (e.g. doing normal chores around the house, have to take breaks while doing activities of daily living). Class IV: Symptoms at rest and severe symptoms with any activity. Most patients also have edema in the feet and ankles as result of right heart failure.|Participants|Count of Participants|0|0.0||||||
3740109|NCT02021292|3575652|B1||class I|WHO functional class|Class I: no symptoms with exercise or at rest. Class II: No symptoms at rest but uncomfortable and short of breath with normal activity such as climbing a flight of stairs, grocery shopping, or making the bed. Class III: May not have symptoms at rest but activities greatly limited by shortness of breath, fatigue, or near fainting (e.g. doing normal chores around the house, have to take breaks while doing activities of daily living). Class IV: Symptoms at rest and severe symptoms with any activity. Most patients also have edema in the feet and ankles as result of right heart failure.|Participants|Count of Participants|0|0.0||||||
3740110|NCT02021292|3575650|B3|||Pulmonary vascular resistance (PVR)||dynes*sec/cm^5|Mean|956.8|956.8|Standard Deviation|434.78|434.78|||
3740111|NCT02021292|3575651|B2|||Pulmonary vascular resistance (PVR)||dynes*sec/cm^5|Mean|984.3|984.3|Standard Deviation|487.06|487.06|||
3740112|NCT02021292|3575652|B1|||Pulmonary vascular resistance (PVR)||dynes*sec/cm^5|Mean|929.2|929.2|Standard Deviation|379.65|379.65|||
3740113|NCT02021292|3575650|B3|||6-minute walk distance (6MWD)||meter|Mean|352.1|352.1|Standard Deviation|80.64|80.64|||
3740114|NCT02021292|3575651|B2|||6-minute walk distance (6MWD)||meter|Mean|351.2|351.2|Standard Deviation|73.79|73.79|||
3740115|NCT02021292|3575652|B1|||6-minute walk distance (6MWD)||meter|Mean|353.0|353.0|Standard Deviation|87.90|87.9|||
3740116|NCT02021292|3575650|B3|||Time since diagnosis of chronic thromboembolic pulmonary hypertension (CTEPH)||years|Mean|1.5|1.5|Standard Deviation|2.16|2.16|||
3740117|NCT02021292|3575651|B2|||Time since diagnosis of chronic thromboembolic pulmonary hypertension (CTEPH)||years|Mean|1.2|1.2|Standard Deviation|1.95|1.95|||
3740118|NCT02021292|3575652|B1|||Time since diagnosis of chronic thromboembolic pulmonary hypertension (CTEPH)||years|Mean|1.7|1.7|Standard Deviation|2.36|2.36|||
3740119|NCT02021292|3575650|B3|||Body Mass Index (BMI)||kg/m^2|Median|25.7|25.7|Full Range|||18.3|47.5|
3740120|NCT02021292|3575651|B2|||Body Mass Index (BMI)||kg/m^2|Median|26.0|26.0|Full Range|||18.3|36.2|
3740121|NCT02021292|3575652|B1|||Body Mass Index (BMI)||kg/m^2|Median|25.7|25.7|Full Range|||19.8|47.5|
3740122|NCT02021292|3575650|B3|Western Europe||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3740123|NCT02021292|3575651|B2|Western Europe||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3740127|NCT02021292|3575652|B1|Latin America||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3740128|NCT02021292|3575650|B3|Eastern Europe||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3740129|NCT02021292|3575651|B2|Eastern Europe||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3740130|NCT02021292|3575652|B1|Eastern Europe||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3740131|NCT02021292|3575650|B3|Asia||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3740132|NCT02021292|3575651|B2|Asia||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3740133|NCT02021292|3575652|B1|Asia||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3740134|NCT02021292|3575650|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3740135|NCT02021292|3575651|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3740136|NCT02021292|3575652|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3740137|NCT02021292|3575650|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3740138|NCT02021292|3575651|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3740139|NCT02021292|3575652|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3740140|NCT02021292|3575650|B3|||Age||years|Median|59.0|59.0|Full Range|||20.0|80.0|
3740141|NCT02021292|3575651|B2|||Age||years|Median|58.0|58.0|Full Range|||23.0|78.0|
3740142|NCT02021292|3575652|B1|||Age||years|Median|60.0|60.0|Full Range|||20.0|80.0|
3740143|NCT02021292|3575650|B3||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
3740144|NCT02021292|3575651|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3740145|NCT02021292|3575652|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3740146|NCT02021292|3575650|B3||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3740147|NCT02021292|3575651|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3740148|NCT02021292|3575652|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3740149|NCT02021292|3575650|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3740150|NCT02021292|3575651|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3740151|NCT02021292|3575652|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3740152|NCT02021071|3575669|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
3740153|NCT02021071|3575670|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3740154|NCT02021071|3575671|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3740155|NCT02021071|3575669|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3740156|NCT02021071|3575670|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3740157|NCT02021071|3575671|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3740158|NCT02021071|3575669|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3740159|NCT02021071|3575670|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3740160|NCT02021071|3575671|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3740161|NCT02021071|3575669|B3|Adult (> 21 years)||Age, Customized||participants|Number|8|8.0||||||
3740162|NCT02021071|3575670|B2|Adult (> 21 years)||Age, Customized||participants|Number|4|4.0||||||
3740163|NCT02021071|3575671|B1|Adult (> 21 years)||Age, Customized||participants|Number|4|4.0||||||
3740164|NCT02021071|3575669|B3|Adolescent (12-21 years)||Age, Customized||participants|Number|12|12.0||||||
3740165|NCT02021071|3575670|B2|Adolescent (12-21 years)||Age, Customized||participants|Number|6|6.0||||||
3740166|NCT02021071|3575671|B1|Adolescent (12-21 years)||Age, Customized||participants|Number|6|6.0||||||
3740167|NCT02021071|3575669|B3|Child (2 - 12 years)||Age, Customized||participants|Number|4|4.0||||||
3740168|NCT02021071|3575670|B2|Child (2 - 12 years)||Age, Customized||participants|Number|2|2.0||||||
3740169|NCT02021071|3575671|B1|Child (2 - 12 years)||Age, Customized||participants|Number|2|2.0||||||
3740170|NCT02021071|3575669|B3|Infant (1st month - 2 years)||Age, Customized||participants|Number|0|0.0||||||
3740171|NCT02021071|3575670|B2|Infant (1st month - 2 years)||Age, Customized||participants|Number|0|0.0||||||
3740172|NCT02021071|3575671|B1|Infant (1st month - 2 years)||Age, Customized||participants|Number|0|0.0||||||
3740173|NCT02021071|3575669|B3|Newborn (birth - 1st month)||Age, Customized||participants|Number|0|0.0||||||
3740174|NCT02021071|3575670|B2|Newborn (birth - 1st month)||Age, Customized||participants|Number|0|0.0||||||
3740175|NCT02021071|3575671|B1|Newborn (birth - 1st month)||Age, Customized||participants|Number|0|0.0||||||
3740176|NCT02020941|3575679|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740177|NCT02020941|3575679|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740178|NCT02020941|3575679|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3740179|NCT02020941|3575679|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740180|NCT02020941|3575679|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740181|NCT02020941|3575679|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740182|NCT02020941|3575679|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740183|NCT02020941|3575679|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3740184|NCT02020941|3575679|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3740185|NCT02020941|3575679|B1|||Age||years|Mean|70.1|70.1|Standard Deviation|6.79|6.79|||
3740186|NCT02020941|3575679|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3740187|NCT02020941|3575679|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3740188|NCT02020941|3575679|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3740189|NCT02020889|3575688|B3|Race customized|Mixed Race|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3740190|NCT02020889|3575689|B2|Race customized|Mixed Race|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3740191|NCT02020889|3575690|B1|Race customized|Mixed Race|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3740192|NCT02020889|3575688|B3|Race customized|White - White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|123|123.0||||||
3740193|NCT02020889|3575689|B2|Race customized|White - White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|62|62.0||||||
3740194|NCT02020889|3575690|B1|Race customized|White - White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|61|61.0||||||
3740195|NCT02020889|3575688|B3|Race customized|White - Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3740196|NCT02020889|3575689|B2|Race customized|White - Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3740197|NCT02020889|3575690|B1|Race customized|White - Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3740198|NCT02020889|3575688|B3|Race customized|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3740199|NCT02020889|3575689|B2|Race customized|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3740200|NCT02020889|3575690|B1|Race customized|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3740201|NCT02020889|3575688|B3|Race customized|Asian - Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3740202|NCT02020889|3575689|B2|Race customized|Asian - Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3740203|NCT02020889|3575690|B1|Race customized|Asian - Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3740204|NCT02020889|3575688|B3|Race customized|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3740205|NCT02020889|3575689|B2|Race customized|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3740206|NCT02020889|3575690|B1|Race customized|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3740207|NCT02020889|3575688|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3740208|NCT02020889|3575689|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3740209|NCT02020889|3575690|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3740210|NCT02020889|3575688|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3740211|NCT02020889|3575689|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3740212|NCT02020889|3575690|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3740213|NCT02020889|3575688|B3|||Age||Years|Mean|48.5|48.5|Standard Deviation|13.34|13.34|||
3740214|NCT02020889|3575689|B2|||Age||Years|Mean|48.7|48.7|Standard Deviation|12.39|12.39|||
3740215|NCT02020889|3575690|B1|||Age||Years|Mean|48.2|48.2|Standard Deviation|14.32|14.32|||
3740216|NCT02020863|3575745|B1|||Stroke Volume Index||ml per meter-squared|Mean|44|44.0|Standard Deviation|10|10.0|||
3740217|NCT02020863|3575745|B1|4||ASA Physical Status patient classification|"ASA II A patient with mild systemic disease Mild diseases only without substantive functional limitations.~ASA III A patient with severe systemic disease Substantive functional limitations; One or more moderate to severe diseases.~ASA IV A patient with severe systemic disease that is a constant threat to life Examples include (but not limited to): recent ( < 3 months) MI, CVA, TIA, or CAD/stents, ongoing cardiac ischemia or severe valve dysfunction, severe reduction of ejection fraction, sepsis, DIC, ARD or ESRD not undergoing regularly scheduled dialysis"|participants|Number|6|6.0||||||
3740218|NCT02020863|3575745|B1|3||ASA Physical Status patient classification|"ASA II A patient with mild systemic disease Mild diseases only without substantive functional limitations.~ASA III A patient with severe systemic disease Substantive functional limitations; One or more moderate to severe diseases.~ASA IV A patient with severe systemic disease that is a constant threat to life Examples include (but not limited to): recent ( < 3 months) MI, CVA, TIA, or CAD/stents, ongoing cardiac ischemia or severe valve dysfunction, severe reduction of ejection fraction, sepsis, DIC, ARD or ESRD not undergoing regularly scheduled dialysis"|participants|Number|28|28.0||||||
3740219|NCT02020863|3575745|B1|2||ASA Physical Status patient classification|"ASA II A patient with mild systemic disease Mild diseases only without substantive functional limitations.~ASA III A patient with severe systemic disease Substantive functional limitations; One or more moderate to severe diseases.~ASA IV A patient with severe systemic disease that is a constant threat to life Examples include (but not limited to): recent ( < 3 months) MI, CVA, TIA, or CAD/stents, ongoing cardiac ischemia or severe valve dysfunction, severe reduction of ejection fraction, sepsis, DIC, ARD or ESRD not undergoing regularly scheduled dialysis"|participants|Number|1|1.0||||||
3740220|NCT02020863|3575745|B1|Complex cholecystectomy||Specific Surgical procedure||participants|Number|3|3.0||||||
3740221|NCT02020863|3575745|B1|Liver resection||Specific Surgical procedure||participants|Number|10|10.0||||||
3740222|NCT02020863|3575745|B1|Distal pancreatectomy||Specific Surgical procedure||participants|Number|5|5.0||||||
3740223|NCT02020863|3575745|B1|Whipple + additional||Specific Surgical procedure||participants|Number|8|8.0||||||
3740224|NCT02020863|3575745|B1|Whipple||Specific Surgical procedure||participants|Number|9|9.0||||||
3740225|NCT02020863|3575745|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3740226|NCT02020863|3575745|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3740227|NCT02020863|3575745|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3740228|NCT02020863|3575745|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|12.8|12.8|||
3740229|NCT02020863|3575745|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3740230|NCT02020863|3575745|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3740231|NCT02020863|3575745|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3740232|NCT02020837|3575749|B1|||Count of Participants|Number of participants|Participants|Count of Participants|2|2.0||||||
3740233|NCT02020837|3575749|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740234|NCT02020837|3575749|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740235|NCT02020837|3575749|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3740236|NCT02020837|3575749|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740237|NCT02020837|3575749|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740238|NCT02020837|3575749|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740239|NCT02020837|3575749|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740240|NCT02020837|3575749|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3740241|NCT02020837|3575749|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3740242|NCT02020837|3575749|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3740243|NCT02020837|3575749|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3740244|NCT02020837|3575749|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3740245|NCT02020616|3575753|B8|||Baseline Fasting Plasma Glucose||milligram/deciliter (mg/dL)|Mean|174.9|174.9|Standard Deviation|46.5|46.5|||
3740246|NCT02020616|3575754|B7|||Baseline Fasting Plasma Glucose||milligram/deciliter (mg/dL)|Mean|150.6|150.6|Standard Deviation|46.8|46.8|||
3740247|NCT02020616|3575755|B6|||Baseline Fasting Plasma Glucose||milligram/deciliter (mg/dL)|Mean|185.9|185.9|Standard Deviation|50.6|50.6|||
3740248|NCT02020616|3575756|B5|||Baseline Fasting Plasma Glucose||milligram/deciliter (mg/dL)|Mean|183.3|183.3|Standard Deviation|46.2|46.2|||
3740249|NCT02020616|3575757|B4|||Baseline Fasting Plasma Glucose||milligram/deciliter (mg/dL)|Mean|173.3|173.3|Standard Deviation|39.6|39.6|||
3740250|NCT02020616|3575758|B3|||Baseline Fasting Plasma Glucose||milligram/deciliter (mg/dL)|Mean|176.6|176.6|Standard Deviation|58.0|58.0|||
3740251|NCT02020616|3575759|B2|||Baseline Fasting Plasma Glucose||milligram/deciliter (mg/dL)|Mean|178.6|178.6|Standard Deviation|44.3|44.3|||
3740252|NCT02020616|3575760|B1|||Baseline Fasting Plasma Glucose||milligram/deciliter (mg/dL)|Mean|180.6|180.6|Standard Deviation|45.3|45.3|||
3740253|NCT02020616|3575753|B8|||Baseline Hemoglobin A1c (HbA1c)||Percent of HbA1c|Mean|8.42|8.42|Standard Deviation|1.02|1.02|||
3740254|NCT02020616|3575754|B7|||Baseline Hemoglobin A1c (HbA1c)||Percent of HbA1c|Mean|8.50|8.5|Standard Deviation|1.03|1.03|||
3740255|NCT02020616|3575755|B6|||Baseline Hemoglobin A1c (HbA1c)||Percent of HbA1c|Mean|8.10|8.1|Standard Deviation|0.63|0.63|||
3740256|NCT02020616|3575756|B5|||Baseline Hemoglobin A1c (HbA1c)||Percent of HbA1c|Mean|9.40|9.4|Standard Deviation|1.43|1.43|||
3740257|NCT02020616|3575757|B4|||Baseline Hemoglobin A1c (HbA1c)||Percent of HbA1c|Mean|8.30|8.3|Standard Deviation|0.74|0.74|||
3740258|NCT02020616|3575758|B3|||Baseline Hemoglobin A1c (HbA1c)||Percent of HbA1c|Mean|7.93|7.93|Standard Deviation|0.81|0.81|||
3740259|NCT02020616|3575759|B2|||Baseline Hemoglobin A1c (HbA1c)||Percent of HbA1c|Mean|8.33|8.33|Standard Deviation|1.17|1.17|||
3740260|NCT02020616|3575760|B1|||Baseline Hemoglobin A1c (HbA1c)||Percent of HbA1c|Mean|8.39|8.39|Standard Deviation|0.80|0.8|||
3740261|NCT02020616|3575753|B8|United States||Region of Enrollment||Participants|Count of Participants|59|59.0||||||
3740262|NCT02020616|3575754|B7|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3740263|NCT02020616|3575755|B6|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3740264|NCT02020616|3575756|B5|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3740265|NCT02020616|3575757|B4|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3740266|NCT02020616|3575758|B3|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3740267|NCT02020616|3575759|B2|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3740268|NCT02020616|3575760|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3740269|NCT02020616|3575753|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740270|NCT02020616|3575754|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740271|NCT02020616|3575755|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740272|NCT02020616|3575756|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740273|NCT02020616|3575757|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740274|NCT02020616|3575758|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740275|NCT02020616|3575759|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740276|NCT02020616|3575760|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740277|NCT02020616|3575753|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3740278|NCT02020616|3575754|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3740279|NCT02020616|3575755|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740280|NCT02020616|3575756|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740281|NCT02020616|3575757|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740282|NCT02020616|3575758|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740283|NCT02020616|3575759|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740284|NCT02020616|3575760|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740285|NCT02020616|3575753|B8||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3740286|NCT02020616|3575754|B7||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3740287|NCT02020616|3575755|B6||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3740288|NCT02020616|3575756|B5||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3740289|NCT02020616|3575757|B4||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3740290|NCT02020616|3575758|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3740291|NCT02020616|3575759|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3740292|NCT02020616|3575760|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3740293|NCT02020616|3575753|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3740294|NCT02020616|3575754|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3740295|NCT02020616|3575755|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740296|NCT02020616|3575756|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3740297|NCT02020616|3575757|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3740298|NCT02020616|3575758|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3740299|NCT02020616|3575759|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740300|NCT02020616|3575760|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740301|NCT02020616|3575753|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740302|NCT02020616|3575754|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740303|NCT02020616|3575755|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740304|NCT02020616|3575756|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740305|NCT02020616|3575757|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740306|NCT02020616|3575758|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740307|NCT02020616|3575759|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740308|NCT02020616|3575760|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740309|NCT02020616|3575753|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3740310|NCT02020616|3575754|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3740311|NCT02020616|3575755|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740312|NCT02020616|3575756|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740313|NCT02020616|3575757|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740314|NCT02020616|3575758|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740315|NCT02020616|3575759|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3740316|NCT02020616|3575760|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740317|NCT02020616|3575753|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740318|NCT02020616|3575754|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740319|NCT02020616|3575755|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740320|NCT02020616|3575756|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740321|NCT02020616|3575757|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740322|NCT02020616|3575758|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740323|NCT02020616|3575759|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740324|NCT02020616|3575760|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740325|NCT02020616|3575753|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740326|NCT02020616|3575754|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740327|NCT02020616|3575755|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740328|NCT02020616|3575756|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740329|NCT02020616|3575757|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740330|NCT02020616|3575758|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740331|NCT02020616|3575759|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740332|NCT02020616|3575760|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740333|NCT02020616|3575753|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3740334|NCT02020616|3575754|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3740335|NCT02020616|3575755|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740336|NCT02020616|3575756|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3740337|NCT02020616|3575757|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3740400|NCT02020369|3575891|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3740338|NCT02020616|3575758|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3740339|NCT02020616|3575759|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3740340|NCT02020616|3575760|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3740341|NCT02020616|3575753|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3740342|NCT02020616|3575754|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3740343|NCT02020616|3575755|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3740344|NCT02020616|3575756|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3740345|NCT02020616|3575757|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3740346|NCT02020616|3575758|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3740347|NCT02020616|3575759|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3740348|NCT02020616|3575760|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3740349|NCT02020616|3575753|B8||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3740350|NCT02020616|3575754|B7||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3740351|NCT02020616|3575755|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3740352|NCT02020616|3575756|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3740353|NCT02020616|3575757|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3740354|NCT02020616|3575758|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3740355|NCT02020616|3575759|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3740356|NCT02020616|3575760|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3740357|NCT02020616|3575753|B8||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3740358|NCT02020616|3575754|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3740359|NCT02020616|3575755|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3740360|NCT02020616|3575756|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3740361|NCT02020616|3575757|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3740362|NCT02020616|3575758|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3740363|NCT02020616|3575759|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3740364|NCT02020616|3575760|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3740365|NCT02020616|3575753|B8|||Age||Years|Mean|55.3|55.3|Standard Deviation|8.5|8.5|||
3740366|NCT02020616|3575754|B7|||Age||Years|Mean|52.8|52.8|Standard Deviation|9.1|9.1|||
3740367|NCT02020616|3575755|B6|||Age||Years|Mean|54.6|54.6|Standard Deviation|8.3|8.3|||
3740368|NCT02020616|3575756|B5|||Age||Years|Mean|50.8|50.8|Standard Deviation|13.0|13.0|||
3740369|NCT02020616|3575757|B4|||Age||Years|Mean|56.3|56.3|Standard Deviation|6.0|6.0|||
3740370|NCT02020616|3575758|B3|||Age||Years|Mean|59.9|59.9|Standard Deviation|5.8|5.8|||
3740371|NCT02020616|3575759|B2|||Age||Years|Mean|57.3|57.3|Standard Deviation|4.9|4.9|||
3740372|NCT02020616|3575760|B1|||Age||Years|Mean|55.9|55.9|Standard Deviation|8.9|8.9|||
3740373|NCT02020577|3575857|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3740374|NCT02020577|3575858|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3740375|NCT02020577|3575859|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3740376|NCT02020577|3575857|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3740377|NCT02020577|3575858|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3740378|NCT02020577|3575859|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3740379|NCT02020577|3575857|B3|||Age||Years|Mean|61.1|61.1|Standard Deviation|11.2|11.2|||
3740380|NCT02020577|3575858|B2|||Age||Years|Mean|61.0|61.0|Standard Deviation|11.4|11.4|||
3740381|NCT02020577|3575859|B1|||Age||Years|Mean|63.3|63.3|Standard Deviation|7.6|7.6|||
3740382|NCT02020512|3575887|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3740383|NCT02020512|3575887|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3740384|NCT02020512|3575887|B1|||Age||Years|Mean|47.3|47.3|Standard Deviation|18.1|18.1|||
3740385|NCT02020369|3575891|B3|Bulgaria||Region of Enrollment||participants|Number|2|2.0||||||
3740386|NCT02020369|3575892|B2|Bulgaria||Region of Enrollment||participants|Number|1|1.0||||||
3740387|NCT02020369|3575893|B1|Bulgaria||Region of Enrollment||participants|Number|1|1.0||||||
3740388|NCT02020369|3575891|B3|Georgia||Region of Enrollment||participants|Number|2|2.0||||||
3740389|NCT02020369|3575892|B2|Georgia||Region of Enrollment||participants|Number|1|1.0||||||
3740390|NCT02020369|3575893|B1|Georgia||Region of Enrollment||participants|Number|1|1.0||||||
3740391|NCT02020369|3575891|B3|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3740392|NCT02020369|3575892|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3740393|NCT02020369|3575893|B1|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3740394|NCT02020369|3575891|B3|Poland||Region of Enrollment||participants|Number|1|1.0||||||
3740395|NCT02020369|3575892|B2|Poland||Region of Enrollment||participants|Number|0|0.0||||||
3740396|NCT02020369|3575893|B1|Poland||Region of Enrollment||participants|Number|1|1.0||||||
3740397|NCT02020369|3575891|B3|Ukraine||Region of Enrollment||participants|Number|12|12.0||||||
3740398|NCT02020369|3575892|B2|Ukraine||Region of Enrollment||participants|Number|6|6.0||||||
3740399|NCT02020369|3575893|B1|Ukraine||Region of Enrollment||participants|Number|6|6.0||||||
3740401|NCT02020369|3575892|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3740402|NCT02020369|3575893|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3740403|NCT02020369|3575891|B3|Russian Federation||Region of Enrollment||participants|Number|5|5.0||||||
3740404|NCT02020369|3575892|B2|Russian Federation||Region of Enrollment||participants|Number|3|3.0||||||
3740405|NCT02020369|3575893|B1|Russian Federation||Region of Enrollment||participants|Number|2|2.0||||||
3740406|NCT02020369|3575891|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740407|NCT02020369|3575892|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740408|NCT02020369|3575893|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740409|NCT02020369|3575891|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740410|NCT02020369|3575892|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740411|NCT02020369|3575893|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740412|NCT02020369|3575891|B3||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3740413|NCT02020369|3575892|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3740414|NCT02020369|3575893|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3740415|NCT02020369|3575891|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3740416|NCT02020369|3575892|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3740417|NCT02020369|3575893|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740418|NCT02020369|3575891|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740419|NCT02020369|3575892|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740420|NCT02020369|3575893|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740421|NCT02020369|3575891|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3740422|NCT02020369|3575892|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740423|NCT02020369|3575893|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3740424|NCT02020369|3575891|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740425|NCT02020369|3575892|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740426|NCT02020369|3575893|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740427|NCT02020369|3575891|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740428|NCT02020369|3575892|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740429|NCT02020369|3575893|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740430|NCT02020369|3575891|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3740431|NCT02020369|3575892|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3740432|NCT02020369|3575893|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3740433|NCT02020369|3575891|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3740434|NCT02020369|3575892|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740435|NCT02020369|3575893|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3740436|NCT02020369|3575891|B3|Male (n)||Sex/Gender, Customized||participants|Number|27|27.0||||||
3740437|NCT02020369|3575892|B2|Male (n)||Sex/Gender, Customized||participants|Number|14|14.0||||||
3740438|NCT02020369|3575893|B1|Male (n)||Sex/Gender, Customized||participants|Number|13|13.0||||||
3740439|NCT02020369|3575891|B3|||Age||years|Mean|31.0|31.0|Standard Deviation|12.35|12.35|||
3740440|NCT02020369|3575892|B2|||Age||years|Mean|30.1|30.1|Standard Deviation|12.98|12.98|||
3740441|NCT02020369|3575893|B1|||Age||years|Mean|31.8|31.8|Standard Deviation|12.10|12.1|||
3740442|NCT02020369|3575891|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3740443|NCT02020369|3575892|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3740444|NCT02020369|3575893|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3740445|NCT02020369|3575891|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3740446|NCT02020369|3575892|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3740447|NCT02020369|3575893|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3740448|NCT02020369|3575891|B3||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3740449|NCT02020369|3575892|B2||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3740450|NCT02020369|3575893|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3740451|NCT02020304|3575908|B3|United States||Region of Enrollment||participants|Number|53|53.0||||||
3740452|NCT02020304|3575909|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
3740453|NCT02020304|3575910|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3740454|NCT02020304|3575908|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3740455|NCT02020304|3575909|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3740456|NCT02020304|3575910|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3740457|NCT02020304|3575908|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3740458|NCT02020304|3575909|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3740459|NCT02020304|3575910|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3740460|NCT02020304|3575908|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3740461|NCT02020304|3575909|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3740462|NCT02020304|3575910|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3740463|NCT02020304|3575908|B3||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
3740464|NCT02020304|3575909|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3740465|NCT02020304|3575910|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3740466|NCT02020304|3575908|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3740467|NCT02020304|3575909|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3740468|NCT02020304|3575910|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3740469|NCT02020135|3575925|B3|||PSA||ug/mL|Median|221.2|221.2|Full Range|||6.0|5781.1|
3740470|NCT02020135|3575926|B2|||PSA||ug/mL|Median|32.1|32.1|Full Range|||6.0|235.8|
3740471|NCT02020135|3575927|B1|||PSA||ug/mL|Median|442.2|442.2|Full Range|||107.9|5781.1|
3740472|NCT02020135|3575925|B3|||Prostate specific antigen (PSA)||ug/mL|Mean|994.6|994.6|Standard Deviation|1874.9|1874.9|||
3740473|NCT02020135|3575926|B2|||Prostate specific antigen (PSA)||ug/mL|Mean|91.3|91.3|Standard Deviation|125.8|125.8|||
3740474|NCT02020135|3575927|B1|||Prostate specific antigen (PSA)||ug/mL|Mean|1446.3|1446.3|Standard Deviation|2209.9|2209.9|||
3740475|NCT02020135|3575925|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3740476|NCT02020135|3575926|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3740477|NCT02020135|3575927|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3740478|NCT02020135|3575925|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3740479|NCT02020135|3575926|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3740480|NCT02020135|3575927|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3740481|NCT02020135|3575925|B3|||Age||years|Mean|74.6|74.6|Full Range|||66.0|84.0|
3740482|NCT02020135|3575926|B2|||Age||years|Mean|77.3|77.3|Full Range|||70.0|84.0|
3740483|NCT02020135|3575927|B1|||Age||years|Mean|73.2|73.2|Full Range|||66.0|81.0|
3740484|NCT02020031|3575937|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3740485|NCT02020031|3575938|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3740486|NCT02020031|3575939|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3740487|NCT02020031|3575937|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3740488|NCT02020031|3575938|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3740489|NCT02020031|3575939|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3740490|NCT02020031|3575937|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3740491|NCT02020031|3575938|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3740492|NCT02020031|3575939|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3740493|NCT02020031|3575937|B3|||Age||years|Mean|68.4|68.4|Full Range|||43.0|83.0|
3740494|NCT02020031|3575938|B2|||Age||years|Mean|67.4|67.4|Full Range|||54.0|82.0|
3740495|NCT02020031|3575939|B1|||Age||years|Mean|69.3|69.3|Full Range|||43.0|83.0|
3740496|NCT02019979|3575948|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3740497|NCT02019979|3575948|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3740498|NCT02019979|3575948|B1|||Age||years|Mean|66.71|66.71|Standard Deviation|6.24|6.24|||
3740499|NCT02019719|3575954|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740500|NCT02019719|3575955|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740501|NCT02019719|3575956|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740502|NCT02019719|3575957|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740503|NCT02019719|3575958|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740504|NCT02019719|3575959|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740505|NCT02019719|3575954|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740506|NCT02019719|3575955|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740507|NCT02019719|3575956|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740508|NCT02019719|3575957|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740509|NCT02019719|3575958|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740510|NCT02019719|3575959|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740511|NCT02019719|3575954|B6||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740512|NCT02019719|3575955|B5||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740513|NCT02019719|3575956|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740514|NCT02019719|3575957|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740515|NCT02019719|3575958|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740516|NCT02019719|3575959|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740517|NCT02019719|3575954|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740518|NCT02019719|3575955|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740519|NCT02019719|3575956|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740520|NCT02019719|3575957|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740521|NCT02019719|3575958|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740522|NCT02019719|3575959|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740523|NCT02019719|3575954|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740524|NCT02019719|3575955|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740525|NCT02019719|3575956|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740526|NCT02019719|3575957|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740527|NCT02019719|3575958|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740528|NCT02019719|3575959|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740529|NCT02019719|3575954|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
3740530|NCT02019719|3575955|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3740531|NCT02019719|3575956|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3740532|NCT02019719|3575957|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3740533|NCT02019719|3575958|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3740534|NCT02019719|3575959|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3740535|NCT02019719|3575954|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740536|NCT02019719|3575955|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740537|NCT02019719|3575956|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740538|NCT02019719|3575957|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740539|NCT02019719|3575958|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740540|NCT02019719|3575959|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740541|NCT02019719|3575954|B6||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3740542|NCT02019719|3575955|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3740543|NCT02019719|3575956|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3740544|NCT02019719|3575957|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3740545|NCT02019719|3575958|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3740546|NCT02019719|3575959|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3740547|NCT02019719|3575954|B6||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3740548|NCT02019719|3575955|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3740549|NCT02019719|3575956|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3740550|NCT02019719|3575957|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3740551|NCT02019719|3575958|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3740552|NCT02019719|3575959|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3740553|NCT02019719|3575954|B6|||Age||Years|Mean|62.4|62.4|Standard Deviation|9.70|9.7|||
3740554|NCT02019719|3575955|B5|||Age||Years|Mean|62.2|62.2|Standard Deviation|11.13|11.13|||
3740555|NCT02019719|3575956|B4|||Age||Years|Mean|66.0|66.0|Standard Deviation|9.23|9.23|||
3740556|NCT02019719|3575957|B3|||Age||Years|Mean|58.9|58.9|Standard Deviation|9.90|9.9|||
3740557|NCT02019719|3575958|B2|||Age||Years|Mean|61.6|61.6|Standard Deviation|8.49|8.49|||
3740558|NCT02019719|3575959|B1|||Age||Years|Mean|63.4|63.4|Standard Deviation|8.98|8.98|||
3740559|NCT02019563|3576060|B3|||Incisors||incisors|Number|172|172.0||||||
3740560|NCT02019563|3576061|B2|||Incisors||incisors|Number|72|72.0||||||
3740561|NCT02019563|3576062|B1|||Incisors||incisors|Number|100|100.0||||||
3740562|NCT02019563|3576060|B3|Canada||Region of Enrollment||participants|Number|70|70.0||||||
3740563|NCT02019563|3576061|B2|Canada||Region of Enrollment||participants|Number|30|30.0||||||
3740564|NCT02019563|3576062|B1|Canada||Region of Enrollment||participants|Number|40|40.0||||||
3740565|NCT02019563|3576060|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3740566|NCT02019563|3576061|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3740567|NCT02019563|3576062|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3740568|NCT02019563|3576060|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3740569|NCT02019563|3576061|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3740570|NCT02019563|3576062|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3740571|NCT02019563|3576060|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3740572|NCT02019563|3576061|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3740573|NCT02019563|3576062|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3740574|NCT02019563|3576060|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3740575|NCT02019563|3576061|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3740576|NCT02019563|3576062|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3740577|NCT02019563|3576060|B3||<=18 years|Age||Participants|Count of Participants|70|70.0||||||
3740578|NCT02019563|3576061|B2||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
3740579|NCT02019563|3576062|B1||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
3740580|NCT02019550|3576077|B3||Male|Gender||Participants|Count of Participants|25|25.0||||||
3740581|NCT02019550|3576078|B2||Male|Gender||Participants|Count of Participants|19|19.0||||||
3740582|NCT02019550|3576079|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
3740583|NCT02019550|3576077|B3||Female|Gender||Participants|Count of Participants|72|72.0||||||
3740584|NCT02019550|3576078|B2||Female|Gender||Participants|Count of Participants|32|32.0||||||
3740585|NCT02019550|3576079|B1||Female|Gender||Participants|Count of Participants|40|40.0||||||
3740586|NCT02019550|3576077|B3|||Age||years|Mean|48.4|48.4|Standard Deviation|10.54|10.54|||
3740587|NCT02019550|3576078|B2|||Age||years|Mean|47.5|47.5|Standard Deviation|11.20|11.2|||
3740588|NCT02019550|3576079|B1|||Age||years|Mean|49.4|49.4|Standard Deviation|9.78|9.78|||
3740589|NCT02019472|3576118|B4|United States||Region of Enrollment||participants|Number|88|88.0||||||
3740590|NCT02019472|3576119|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
3740591|NCT02019472|3576120|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
3740592|NCT02019472|3576121|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3740593|NCT02019472|3576118|B4|Ukraine||Region of Enrollment||participants|Number|118|118.0||||||
3740594|NCT02019472|3576119|B3|Ukraine||Region of Enrollment||participants|Number|39|39.0||||||
3740595|NCT02019472|3576120|B2|Ukraine||Region of Enrollment||participants|Number|37|37.0||||||
3740596|NCT02019472|3576121|B1|Ukraine||Region of Enrollment||participants|Number|42|42.0||||||
3740597|NCT02019472|3576118|B4|Spain||Region of Enrollment||participants|Number|2|2.0||||||
3740598|NCT02019472|3576119|B3|Spain||Region of Enrollment||participants|Number|0|0.0||||||
3740599|NCT02019472|3576120|B2|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3740600|NCT02019472|3576121|B1|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3740601|NCT02019472|3576118|B4|South Africa||Region of Enrollment||participants|Number|24|24.0||||||
3740602|NCT02019472|3576119|B3|South Africa||Region of Enrollment||participants|Number|7|7.0||||||
3740603|NCT02019472|3576120|B2|South Africa||Region of Enrollment||participants|Number|9|9.0||||||
3740604|NCT02019472|3576121|B1|South Africa||Region of Enrollment||participants|Number|8|8.0||||||
3740605|NCT02019472|3576118|B4|Serbia||Region of Enrollment||participants|Number|65|65.0||||||
3740606|NCT02019472|3576119|B3|Serbia||Region of Enrollment||participants|Number|26|26.0||||||
3740607|NCT02019472|3576120|B2|Serbia||Region of Enrollment||participants|Number|19|19.0||||||
3740608|NCT02019472|3576121|B1|Serbia||Region of Enrollment||participants|Number|20|20.0||||||
3740609|NCT02019472|3576118|B4|Russian Federation||Region of Enrollment||participants|Number|92|92.0||||||
3740610|NCT02019472|3576119|B3|Russian Federation||Region of Enrollment||participants|Number|33|33.0||||||
3740611|NCT02019472|3576120|B2|Russian Federation||Region of Enrollment||participants|Number|29|29.0||||||
3740612|NCT02019472|3576121|B1|Russian Federation||Region of Enrollment||participants|Number|30|30.0||||||
3740613|NCT02019472|3576118|B4|Romania||Region of Enrollment||participants|Number|13|13.0||||||
3740614|NCT02019472|3576119|B3|Romania||Region of Enrollment||participants|Number|4|4.0||||||
3740615|NCT02019472|3576120|B2|Romania||Region of Enrollment||participants|Number|5|5.0||||||
3740616|NCT02019472|3576121|B1|Romania||Region of Enrollment||participants|Number|4|4.0||||||
3740617|NCT02019472|3576118|B4|Poland||Region of Enrollment||participants|Number|58|58.0||||||
3740618|NCT02019472|3576119|B3|Poland||Region of Enrollment||participants|Number|20|20.0||||||
3740619|NCT02019472|3576120|B2|Poland||Region of Enrollment||participants|Number|17|17.0||||||
3740620|NCT02019472|3576121|B1|Poland||Region of Enrollment||participants|Number|21|21.0||||||
3740621|NCT02019472|3576118|B4|Moldova||Region of Enrollment||participants|Number|12|12.0||||||
3740622|NCT02019472|3576119|B3|Moldova||Region of Enrollment||participants|Number|4|4.0||||||
3740623|NCT02019472|3576120|B2|Moldova||Region of Enrollment||participants|Number|6|6.0||||||
3740624|NCT02019472|3576121|B1|Moldova||Region of Enrollment||participants|Number|2|2.0||||||
3740625|NCT02019472|3576118|B4|Mexico||Region of Enrollment||participants|Number|11|11.0||||||
3740626|NCT02019472|3576119|B3|Mexico||Region of Enrollment||participants|Number|3|3.0||||||
3740627|NCT02019472|3576120|B2|Mexico||Region of Enrollment||participants|Number|5|5.0||||||
3740628|NCT02019472|3576121|B1|Mexico||Region of Enrollment||participants|Number|3|3.0||||||
3740629|NCT02019472|3576118|B4|Lithuania||Region of Enrollment||participants|Number|36|36.0||||||
3740630|NCT02019472|3576119|B3|Lithuania||Region of Enrollment||participants|Number|9|9.0||||||
3740631|NCT02019472|3576120|B2|Lithuania||Region of Enrollment||participants|Number|15|15.0||||||
3740632|NCT02019472|3576121|B1|Lithuania||Region of Enrollment||participants|Number|12|12.0||||||
3740633|NCT02019472|3576118|B4|Hungary||Region of Enrollment||participants|Number|3|3.0||||||
3740634|NCT02019472|3576119|B3|Hungary||Region of Enrollment||participants|Number|2|2.0||||||
3740635|NCT02019472|3576120|B2|Hungary||Region of Enrollment||participants|Number|1|1.0||||||
3740636|NCT02019472|3576121|B1|Hungary||Region of Enrollment||participants|Number|0|0.0||||||
3740637|NCT02019472|3576118|B4|Germany||Region of Enrollment||participants|Number|11|11.0||||||
3740638|NCT02019472|3576119|B3|Germany||Region of Enrollment||participants|Number|5|5.0||||||
3740639|NCT02019472|3576120|B2|Germany||Region of Enrollment||participants|Number|1|1.0||||||
3740640|NCT02019472|3576121|B1|Germany||Region of Enrollment||participants|Number|5|5.0||||||
3740641|NCT02019472|3576118|B4|Colombia||Region of Enrollment||participants|Number|14|14.0||||||
3740642|NCT02019472|3576119|B3|Colombia||Region of Enrollment||participants|Number|1|1.0||||||
3740643|NCT02019472|3576120|B2|Colombia||Region of Enrollment||participants|Number|6|6.0||||||
3740644|NCT02019472|3576121|B1|Colombia||Region of Enrollment||participants|Number|7|7.0||||||
3740645|NCT02019472|3576118|B4|Chile||Region of Enrollment||participants|Number|10|10.0||||||
3740646|NCT02019472|3576119|B3|Chile||Region of Enrollment||participants|Number|3|3.0||||||
3740647|NCT02019472|3576120|B2|Chile||Region of Enrollment||participants|Number|2|2.0||||||
3740648|NCT02019472|3576121|B1|Chile||Region of Enrollment||participants|Number|5|5.0||||||
3740649|NCT02019472|3576118|B4|Bulgaria||Region of Enrollment||participants|Number|2|2.0||||||
3740650|NCT02019472|3576119|B3|Bulgaria||Region of Enrollment||participants|Number|0|0.0||||||
3740651|NCT02019472|3576120|B2|Bulgaria||Region of Enrollment||participants|Number|1|1.0||||||
3740652|NCT02019472|3576121|B1|Bulgaria||Region of Enrollment||participants|Number|1|1.0||||||
3740653|NCT02019472|3576118|B4||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3740654|NCT02019472|3576119|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3740655|NCT02019472|3576120|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3740656|NCT02019472|3576121|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3740657|NCT02019472|3576118|B4||Female|Sex: Female, Male||Participants|Count of Participants|467|467.0||||||
3740658|NCT02019472|3576119|B3||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3740659|NCT02019472|3576120|B2||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3740660|NCT02019472|3576121|B1||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3740661|NCT02019472|3576118|B4|||Age||years|Mean|51.6|51.6|Standard Deviation|12.36|12.36|||
3740662|NCT02019472|3576119|B3|||Age||years|Mean|49.8|49.8|Standard Deviation|12.31|12.31|||
3740663|NCT02019472|3576120|B2|||Age||years|Mean|52.5|52.5|Standard Deviation|12.46|12.46|||
3740664|NCT02019472|3576121|B1|||Age||years|Mean|52.6|52.6|Standard Deviation|12.15|12.15|||
3740665|NCT02019472|3576118|B4||>=65 years|Age||Participants|Count of Participants|73|73.0||||||
3740666|NCT02019472|3576119|B3||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3740667|NCT02019472|3576120|B2||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
3740668|NCT02019472|3576121|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3740669|NCT02019472|3576118|B4||Between 18 and 65 years|Age||Participants|Count of Participants|486|486.0||||||
3740670|NCT02019472|3576119|B3||Between 18 and 65 years|Age||Participants|Count of Participants|164|164.0||||||
3740671|NCT02019472|3576120|B2||Between 18 and 65 years|Age||Participants|Count of Participants|159|159.0||||||
3740672|NCT02019472|3576121|B1||Between 18 and 65 years|Age||Participants|Count of Participants|163|163.0||||||
3740673|NCT02019472|3576118|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3740674|NCT02019472|3576119|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3740675|NCT02019472|3576120|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3740676|NCT02019472|3576121|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3740677|NCT02019277|3576144|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3740678|NCT02019277|3576144|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3740679|NCT02019277|3576144|B1|||Age||years|Mean|52.9|52.9|Standard Deviation|12.0|12.0|||
3740680|NCT02018822|3576161|B3|United States||Region of Enrollment||participants|Number|85|85.0||||||
3740681|NCT02018822|3576162|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
3740682|NCT02018822|3576163|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3740683|NCT02018822|3576161|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3740684|NCT02018822|3576162|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3740685|NCT02018822|3576163|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740686|NCT02018822|3576161|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740687|NCT02018822|3576162|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740688|NCT02018822|3576163|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740689|NCT02018822|3576161|B3||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3740690|NCT02018822|3576162|B2||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3740691|NCT02018822|3576163|B1||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3740692|NCT02018822|3576161|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3740693|NCT02018822|3576162|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3740694|NCT02018822|3576163|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3740695|NCT02018822|3576161|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740696|NCT02018822|3576162|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740697|NCT02018822|3576163|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740698|NCT02018822|3576161|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3740699|NCT02018822|3576162|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3740700|NCT02018822|3576163|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3740701|NCT02018822|3576161|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740702|NCT02018822|3576162|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740703|NCT02018822|3576163|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740704|NCT02018822|3576161|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3740705|NCT02018822|3576162|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3740706|NCT02018822|3576163|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740707|NCT02018822|3576161|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3740708|NCT02018822|3576162|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3740709|NCT02018822|3576163|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3740710|NCT02018822|3576161|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3740711|NCT02018822|3576162|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3740712|NCT02018822|3576163|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3740713|NCT02018822|3576161|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3740714|NCT02018822|3576162|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3740715|NCT02018822|3576163|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3740716|NCT02018822|3576161|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3740717|NCT02018822|3576162|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3740718|NCT02018822|3576163|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3740719|NCT02018822|3576161|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3740720|NCT02018822|3576162|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3740721|NCT02018822|3576163|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3740722|NCT02018822|3576161|B3||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
3740723|NCT02018822|3576162|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3740724|NCT02018822|3576163|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3740725|NCT02018822|3576161|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3740726|NCT02018822|3576162|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3740727|NCT02018822|3576163|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3740728|NCT02018809|3576188|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740729|NCT02018809|3576189|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740730|NCT02018809|3576190|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740731|NCT02018809|3576191|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740732|NCT02018809|3576192|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740733|NCT02018809|3576188|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3740734|NCT02018809|3576189|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740735|NCT02018809|3576190|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740736|NCT02018809|3576191|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3740737|NCT02018809|3576192|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3740738|NCT02018809|3576188|B5||White|Race (NIH/OMB)||Participants|Count of Participants|174|174.0||||||
3740739|NCT02018809|3576189|B4||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3740740|NCT02018809|3576190|B3||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3740741|NCT02018809|3576191|B2||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3740742|NCT02018809|3576192|B1||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3740743|NCT02018809|3576188|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3740744|NCT02018809|3576189|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3740745|NCT02018809|3576190|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3740746|NCT02018809|3576191|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3740747|NCT02018809|3576192|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740748|NCT02018809|3576188|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3740749|NCT02018809|3576189|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740750|NCT02018809|3576190|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740751|NCT02018809|3576191|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3740752|NCT02018809|3576192|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740753|NCT02018809|3576188|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3740754|NCT02018809|3576189|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3740755|NCT02018809|3576190|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3740756|NCT02018809|3576191|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3740757|NCT02018809|3576192|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740758|NCT02018809|3576188|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3740759|NCT02018809|3576189|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740760|NCT02018809|3576190|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3740761|NCT02018809|3576191|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740762|NCT02018809|3576192|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740763|NCT02018809|3576188|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740764|NCT02018809|3576189|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740765|NCT02018809|3576190|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740766|NCT02018809|3576191|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740767|NCT02018809|3576192|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740768|NCT02018809|3576188|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|188|188.0||||||
3740769|NCT02018809|3576189|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3740770|NCT02018809|3576190|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3740771|NCT02018809|3576191|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3740772|NCT02018809|3576192|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3740773|NCT02018809|3576188|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3740774|NCT02018809|3576189|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3740775|NCT02018809|3576190|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3740776|NCT02018809|3576191|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3740777|NCT02018809|3576192|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3740778|NCT02018809|3576188|B5||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3740779|NCT02018809|3576189|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3740780|NCT02018809|3576190|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3740781|NCT02018809|3576191|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3740782|NCT02018809|3576192|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3740783|NCT02018809|3576188|B5||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3740784|NCT02018809|3576189|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3740785|NCT02018809|3576190|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3740786|NCT02018809|3576191|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3740787|NCT02018809|3576192|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3740788|NCT02018809|3576188|B5|||Age||years|Mean|66|66.0|Standard Deviation|10|10.0|||
3740789|NCT02018809|3576189|B4|||Age||years|Mean|67|67.0|Standard Deviation|10|10.0|||
3740790|NCT02018809|3576190|B3|||Age||years|Mean|65|65.0|Standard Deviation|9|9.0|||
3740791|NCT02018809|3576191|B2|||Age||years|Mean|66|66.0|Standard Deviation|10|10.0|||
3740792|NCT02018809|3576192|B1|||Age||years|Mean|67|67.0|Standard Deviation|10|10.0|||
3740793|NCT02018653|3576209|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3740794|NCT02018653|3576210|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3740795|NCT02018653|3576211|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3740796|NCT02018653|3576209|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3740797|NCT02018653|3576210|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3740798|NCT02018653|3576211|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3740799|NCT02018653|3576209|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3740800|NCT02018653|3576210|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3740801|NCT02018653|3576211|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3740802|NCT02018653|3576209|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3740803|NCT02018653|3576210|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3740804|NCT02018653|3576211|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3740805|NCT02018653|3576209|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3740806|NCT02018653|3576210|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3740807|NCT02018653|3576211|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3740808|NCT02018653|3576209|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3740809|NCT02018653|3576210|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3740810|NCT02018653|3576211|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3740811|NCT02018562|3576218|B3|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3740812|NCT02018562|3576219|B2|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3740813|NCT02018562|3576220|B1|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3740814|NCT02018562|3576218|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3740815|NCT02018562|3576219|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740816|NCT02018562|3576220|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3740817|NCT02018562|3576218|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740818|NCT02018562|3576219|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740819|NCT02018562|3576220|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740820|NCT02018562|3576218|B3||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3740821|NCT02018562|3576219|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3740822|NCT02018562|3576220|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3740823|NCT02018562|3576218|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3740824|NCT02018562|3576219|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3740825|NCT02018562|3576220|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3740826|NCT02018562|3576218|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740827|NCT02018562|3576219|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740828|NCT02018562|3576220|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740829|NCT02018562|3576218|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3740830|NCT02018562|3576219|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740831|NCT02018562|3576220|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3740832|NCT02018562|3576218|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740833|NCT02018562|3576219|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740834|NCT02018562|3576220|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740835|NCT02018562|3576218|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740836|NCT02018562|3576219|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740837|NCT02018562|3576220|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740838|NCT02018562|3576218|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3740839|NCT02018562|3576219|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3740840|NCT02018562|3576220|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3740841|NCT02018562|3576218|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740842|NCT02018562|3576219|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740843|NCT02018562|3576220|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740844|NCT02018562|3576218|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3740845|NCT02018562|3576219|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3740846|NCT02018562|3576220|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3740847|NCT02018562|3576218|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3740848|NCT02018562|3576219|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3740849|NCT02018562|3576220|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3740850|NCT02018562|3576218|B3|||Age||years|Mean|54.32|54.32|Standard Deviation|16.48|16.48|||
3740851|NCT02018562|3576219|B2|||Age||years|Mean|57.92|57.92|Standard Deviation|14.91|14.91|||
3740852|NCT02018562|3576220|B1|||Age||years|Mean|50.72|50.72|Standard Deviation|17.47|17.47|||
3740853|NCT02017574|3576239|B3|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3740854|NCT02017574|3576240|B2|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3740855|NCT02017574|3576241|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3740856|NCT02017574|3576239|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3740857|NCT02017574|3576240|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3740858|NCT02017574|3576241|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3740859|NCT02017574|3576239|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3740860|NCT02017574|3576240|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3740861|NCT02017574|3576241|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3740862|NCT02017574|3576239|B3|||Age||years|Mean|60.7|60.7|Standard Deviation|9.2|9.2|||
3740863|NCT02017574|3576240|B2|||Age||years|Mean|60.7|60.7|Standard Deviation|7.2|7.2|||
3740864|NCT02017574|3576241|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|11.1|11.1|||
3740865|NCT02017574|3576239|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3740866|NCT02017574|3576240|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3740867|NCT02017574|3576241|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3740868|NCT02017574|3576239|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3740869|NCT02017574|3576240|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3740870|NCT02017574|3576241|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3740871|NCT02017574|3576239|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3740872|NCT02017574|3576240|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3740873|NCT02017574|3576241|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3740874|NCT02017522|3576250|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3740875|NCT02017522|3576250|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3740876|NCT02017522|3576250|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3740877|NCT02017522|3576250|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3740878|NCT02017522|3576250|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3740879|NCT02017522|3576250|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3740880|NCT02017093|3576255|B3|||Fugl-Meyer assessment score||units on a scale|Mean|53.7|53.7|Standard Deviation|4.36|4.36|||
3740881|NCT02017093|3576256|B2|||Fugl-Meyer assessment score||units on a scale|Mean|54.3|54.3|Standard Deviation|5.43|5.43|||
3740882|NCT02017093|3576257|B1|||Fugl-Meyer assessment score||units on a scale|Mean|53.2|53.2|Standard Deviation|3.26|3.26|||
3740883|NCT02017093|3576255|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3740884|NCT02017093|3576256|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3740885|NCT02017093|3576257|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3740886|NCT02017093|3576255|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3740887|NCT02017093|3576256|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3740888|NCT02017093|3576257|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3740889|NCT02017093|3576255|B3|||Age||years|Mean|59.14|59.14|Standard Deviation|9.04|9.04|||
3740890|NCT02017093|3576256|B2|||Age||years|Mean|57.33|57.33|Standard Deviation|7.3|7.3|||
3740891|NCT02017093|3576257|B1|||Age||years|Mean|60.5|60.5|Standard Deviation|9.9|9.9|||
3740892|NCT02017093|3576255|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3740893|NCT02017093|3576256|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3740894|NCT02017093|3576257|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3740895|NCT02017093|3576255|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3740896|NCT02017093|3576256|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3740897|NCT02017093|3576257|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3740898|NCT02017093|3576255|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3740899|NCT02017093|3576256|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3740900|NCT02017093|3576257|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3740901|NCT02017015|3576266|B1|>5||Number of Baseline Lesions (Target + Non-Target) by Independent Radiological Review|Target lesions are those measurable at baseline and are generally the largest lesions, most reliably measured and most representative of the participants sites of disease. Non target lesions are all of the sites of disease present at baseline not classified as target lesions. They include bone and cystic lesions and pleural/pericardial effusion/ascites. The Independent Reviewers only evaluated scans for those with baseline and follow-up scans.|participants|Number|43|43.0||||||
3740902|NCT02017015|3576266|B1|5||Number of Baseline Lesions (Target + Non-Target) by Independent Radiological Review|Target lesions are those measurable at baseline and are generally the largest lesions, most reliably measured and most representative of the participants sites of disease. Non target lesions are all of the sites of disease present at baseline not classified as target lesions. They include bone and cystic lesions and pleural/pericardial effusion/ascites. The Independent Reviewers only evaluated scans for those with baseline and follow-up scans.|participants|Number|8|8.0||||||
3740903|NCT02017015|3576266|B1|4||Number of Baseline Lesions (Target + Non-Target) by Independent Radiological Review|Target lesions are those measurable at baseline and are generally the largest lesions, most reliably measured and most representative of the participants sites of disease. Non target lesions are all of the sites of disease present at baseline not classified as target lesions. They include bone and cystic lesions and pleural/pericardial effusion/ascites. The Independent Reviewers only evaluated scans for those with baseline and follow-up scans.|participants|Number|10|10.0||||||
3740904|NCT02017015|3576266|B1|3||Number of Baseline Lesions (Target + Non-Target) by Independent Radiological Review|Target lesions are those measurable at baseline and are generally the largest lesions, most reliably measured and most representative of the participants sites of disease. Non target lesions are all of the sites of disease present at baseline not classified as target lesions. They include bone and cystic lesions and pleural/pericardial effusion/ascites. The Independent Reviewers only evaluated scans for those with baseline and follow-up scans.|participants|Number|13|13.0||||||
3740905|NCT02017015|3576266|B1|2||Number of Baseline Lesions (Target + Non-Target) by Independent Radiological Review|Target lesions are those measurable at baseline and are generally the largest lesions, most reliably measured and most representative of the participants sites of disease. Non target lesions are all of the sites of disease present at baseline not classified as target lesions. They include bone and cystic lesions and pleural/pericardial effusion/ascites. The Independent Reviewers only evaluated scans for those with baseline and follow-up scans.|participants|Number|6|6.0||||||
3740906|NCT02017015|3576266|B1|1||Number of Baseline Lesions (Target + Non-Target) by Independent Radiological Review|Target lesions are those measurable at baseline and are generally the largest lesions, most reliably measured and most representative of the participants sites of disease. Non target lesions are all of the sites of disease present at baseline not classified as target lesions. They include bone and cystic lesions and pleural/pericardial effusion/ascites. The Independent Reviewers only evaluated scans for those with baseline and follow-up scans.|participants|Number|3|3.0||||||
3740907|NCT02017015|3576266|B1|<40% = disabled to severely disabled||Karnofsky Performance Status (KPS)|"The Karnofsky Performance Status Scale (KPS) was designed to measure the level of participant activity and medical care requirements. A general measure of participant independence and has been widely used as a general assessment of participants with cancer. The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a participant's ability to survive chemotherapy for cancer."|participants|Number|0|0.0||||||
3740908|NCT02017015|3576266|B1|50-60% = needs help and needs medical care||Karnofsky Performance Status (KPS)|"The Karnofsky Performance Status Scale (KPS) was designed to measure the level of participant activity and medical care requirements. A general measure of participant independence and has been widely used as a general assessment of participants with cancer. The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a participant's ability to survive chemotherapy for cancer."|participants|Number|0|0.0||||||
3740960|NCT02016885|3576301|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740961|NCT02016885|3576302|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3740962|NCT02016885|3576303|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3740909|NCT02017015|3576266|B1|70-80% = normal activity, symptoms, cannot work||Karnofsky Performance Status (KPS)|"The Karnofsky Performance Status Scale (KPS) was designed to measure the level of participant activity and medical care requirements. A general measure of participant independence and has been widely used as a general assessment of participants with cancer. The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a participant's ability to survive chemotherapy for cancer."|participants|Number|25|25.0||||||
3740910|NCT02017015|3576266|B1|90-100% = normal activity, few symptoms of disease||Karnofsky Performance Status (KPS)|"The Karnofsky Performance Status Scale (KPS) was designed to measure the level of participant activity and medical care requirements. A general measure of participant independence and has been widely used as a general assessment of participants with cancer. The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a participant's ability to survive chemotherapy for cancer."|participants|Number|58|58.0||||||
3740911|NCT02017015|3576266|B1|China||Region of Enrollment||participants|Number|83|83.0||||||
3740912|NCT02017015|3576266|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3740913|NCT02017015|3576266|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3740914|NCT02017015|3576266|B1|||Age||years|Mean|56.2|56.2|Standard Deviation|10.03|10.03|||
3740915|NCT02016963|3576273|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3740916|NCT02016963|3576273|B1|White||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
3740917|NCT02016963|3576273|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3740918|NCT02016963|3576273|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3740919|NCT02016963|3576273|B1|||Age||Years|Mean|40.6|40.6|Standard Deviation|13.3|13.3|||
3740920|NCT02016898|3576289|B3|United States||Region of Enrollment||participants|Number|95|95.0||||||
3740921|NCT02016898|3576290|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
3740922|NCT02016898|3576291|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3740923|NCT02016898|3576289|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3740924|NCT02016898|3576290|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3740925|NCT02016898|3576291|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3740926|NCT02016898|3576289|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740927|NCT02016898|3576290|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740928|NCT02016898|3576291|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740929|NCT02016898|3576289|B3||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3740930|NCT02016898|3576290|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3740931|NCT02016898|3576291|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3740932|NCT02016898|3576289|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3740933|NCT02016898|3576290|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3740934|NCT02016898|3576291|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3740935|NCT02016898|3576289|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3740936|NCT02016898|3576290|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3740937|NCT02016898|3576291|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740938|NCT02016898|3576289|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3740939|NCT02016898|3576290|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3740940|NCT02016898|3576291|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740941|NCT02016898|3576289|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740942|NCT02016898|3576290|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740943|NCT02016898|3576291|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740944|NCT02016898|3576289|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3740945|NCT02016898|3576290|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3740946|NCT02016898|3576291|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3740947|NCT02016898|3576289|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3740948|NCT02016898|3576290|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3740949|NCT02016898|3576291|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3740950|NCT02016898|3576289|B3|||Age||years|Mean|70.4|70.4|Standard Deviation|9.3|9.3|||
3740951|NCT02016898|3576290|B2|||Age||years|Mean|73.1|73.1|Standard Deviation|8.3|8.3|||
3740952|NCT02016898|3576291|B1|||Age||years|Mean|68|68.0|Standard Deviation|9.6|9.6|||
3740953|NCT02016885|3576300|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740954|NCT02016885|3576301|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740955|NCT02016885|3576302|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740956|NCT02016885|3576303|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740957|NCT02016885|3576304|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740958|NCT02016885|3576305|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740959|NCT02016885|3576300|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3740963|NCT02016885|3576304|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3740964|NCT02016885|3576305|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740965|NCT02016885|3576300|B6||White|Race (NIH/OMB)||Participants|Count of Participants|169|169.0||||||
3740966|NCT02016885|3576301|B5||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3740967|NCT02016885|3576302|B4||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3740968|NCT02016885|3576303|B3||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3740969|NCT02016885|3576304|B2||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3740970|NCT02016885|3576305|B1||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3740971|NCT02016885|3576300|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3740972|NCT02016885|3576301|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3740973|NCT02016885|3576302|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3740974|NCT02016885|3576303|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3740975|NCT02016885|3576304|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3740976|NCT02016885|3576305|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3740977|NCT02016885|3576300|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740978|NCT02016885|3576301|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740979|NCT02016885|3576302|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740980|NCT02016885|3576303|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740981|NCT02016885|3576304|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740982|NCT02016885|3576305|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740983|NCT02016885|3576300|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3740984|NCT02016885|3576301|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740985|NCT02016885|3576302|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3740986|NCT02016885|3576303|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3740987|NCT02016885|3576304|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3740988|NCT02016885|3576305|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740989|NCT02016885|3576300|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3740990|NCT02016885|3576301|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740991|NCT02016885|3576302|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740992|NCT02016885|3576303|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3740993|NCT02016885|3576304|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740994|NCT02016885|3576305|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740995|NCT02016885|3576300|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740996|NCT02016885|3576301|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740997|NCT02016885|3576302|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740998|NCT02016885|3576303|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3740999|NCT02016885|3576304|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741000|NCT02016885|3576305|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741001|NCT02016885|3576300|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|177|177.0||||||
3741002|NCT02016885|3576301|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3741003|NCT02016885|3576302|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3741004|NCT02016885|3576303|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3741005|NCT02016885|3576304|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3741006|NCT02016885|3576305|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3741007|NCT02016885|3576300|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3741008|NCT02016885|3576301|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3741009|NCT02016885|3576302|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3741010|NCT02016885|3576303|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3741011|NCT02016885|3576304|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3741012|NCT02016885|3576305|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3741013|NCT02016885|3576300|B6||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3741014|NCT02016885|3576301|B5||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3741015|NCT02016885|3576302|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3741016|NCT02016885|3576303|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3741017|NCT02016885|3576304|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3741018|NCT02016885|3576305|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3741019|NCT02016885|3576300|B6||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3741020|NCT02016885|3576301|B5||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3741021|NCT02016885|3576302|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3741022|NCT02016885|3576303|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3741023|NCT02016885|3576304|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3741024|NCT02016885|3576305|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3741025|NCT02016885|3576300|B6||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3741026|NCT02016885|3576301|B5||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3741027|NCT02016885|3576302|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3741028|NCT02016885|3576303|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3741029|NCT02016885|3576304|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3741030|NCT02016885|3576305|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3741031|NCT02016885|3576300|B6||Between 18 and 65 years|Age||Participants|Count of Participants|189|189.0||||||
3741032|NCT02016885|3576301|B5||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3741033|NCT02016885|3576302|B4||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3741034|NCT02016885|3576303|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3741035|NCT02016885|3576304|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3741036|NCT02016885|3576305|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3741037|NCT02016885|3576300|B6||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3741038|NCT02016885|3576301|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3741039|NCT02016885|3576302|B4||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3741040|NCT02016885|3576303|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3741041|NCT02016885|3576304|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3741042|NCT02016885|3576305|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3741043|NCT02016716|3576346|B4|||Serum Type 1 Collagen C-telopeptide (CTX)||ng/L|Median|426.0|426.0|Inter-Quartile Range|||295.0|590.0|
3741044|NCT02016716|3576347|B3|||Serum Type 1 Collagen C-telopeptide (CTX)||ng/L|Median|402.0|402.0|Inter-Quartile Range|||299.0|530.0|
3741045|NCT02016716|3576348|B2|||Serum Type 1 Collagen C-telopeptide (CTX)||ng/L|Median|440.0|440.0|Inter-Quartile Range|||288.0|613.0|
3741046|NCT02016716|3576349|B1|||Serum Type 1 Collagen C-telopeptide (CTX)||ng/L|Median|426.5|426.5|Inter-Quartile Range|||296.5|560.5|
3741047|NCT02016716|3576346|B4|||Serum Procollagen Type 1 N-telopeptide (P1NP)||μg/L|Median|51.0|51.0|Inter-Quartile Range|||40.0|63.0|
3741048|NCT02016716|3576347|B3|||Serum Procollagen Type 1 N-telopeptide (P1NP)||μg/L|Median|50.0|50.0|Inter-Quartile Range|||40.0|64.0|
3741049|NCT02016716|3576348|B2|||Serum Procollagen Type 1 N-telopeptide (P1NP)||μg/L|Median|53.0|53.0|Inter-Quartile Range|||40.0|61.0|
3741050|NCT02016716|3576349|B1|||Serum Procollagen Type 1 N-telopeptide (P1NP)||μg/L|Median|49.0|49.0|Inter-Quartile Range|||38.0|61.0|
3741051|NCT02016716|3576346|B4|||Femoral Neck BMD T-score||T-score|Mean|-2.118|-2.118|Standard Deviation|0.595|0.595|||
3741052|NCT02016716|3576347|B3|||Femoral Neck BMD T-score||T-score|Mean|-2.018|-2.018|Standard Deviation|0.593|0.593|||
3741053|NCT02016716|3576348|B2|||Femoral Neck BMD T-score||T-score|Mean|-2.139|-2.139|Standard Deviation|0.611|0.611|||
3741054|NCT02016716|3576349|B1|||Femoral Neck BMD T-score||T-score|Mean|-2.304|-2.304|Standard Deviation|0.517|0.517|||
3741055|NCT02016716|3576346|B4|||Total Hip BMD T-score||T-score|Mean|-1.866|-1.866|Standard Deviation|0.660|0.66|||
3741056|NCT02016716|3576347|B3|||Total Hip BMD T-score||T-score|Mean|-1.828|-1.828|Standard Deviation|0.649|0.649|||
3741057|NCT02016716|3576348|B2|||Total Hip BMD T-score||T-score|Mean|-1.819|-1.819|Standard Deviation|0.673|0.673|||
3741058|NCT02016716|3576349|B1|||Total Hip BMD T-score||T-score|Mean|-2.057|-2.057|Standard Deviation|0.634|0.634|||
3741059|NCT02016716|3576346|B4|||Lumbar Spine Bone Mineral Density (BMD) T-score|The T-score is the bone mineral density (BMD) at the site when compared to that of a healthy thirty-year-old. Normal is a T-score of −1.0 or higher; Osteopenia is defined as between −1.0 and −2.5; Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a thirty-year-old man/woman.|T-score|Mean|-2.970|-2.97|Standard Deviation|0.871|0.871|||
3741060|NCT02016716|3576347|B3|||Lumbar Spine Bone Mineral Density (BMD) T-score|The T-score is the bone mineral density (BMD) at the site when compared to that of a healthy thirty-year-old. Normal is a T-score of −1.0 or higher; Osteopenia is defined as between −1.0 and −2.5; Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a thirty-year-old man/woman.|T-score|Mean|-3.029|-3.029|Standard Deviation|0.687|0.687|||
3741061|NCT02016716|3576348|B2|||Lumbar Spine Bone Mineral Density (BMD) T-score|The T-score is the bone mineral density (BMD) at the site when compared to that of a healthy thirty-year-old. Normal is a T-score of −1.0 or higher; Osteopenia is defined as between −1.0 and −2.5; Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a thirty-year-old man/woman.|T-score|Mean|-2.965|-2.965|Standard Deviation|0.960|0.96|||
3741062|NCT02016716|3576349|B1|||Lumbar Spine Bone Mineral Density (BMD) T-score|The T-score is the bone mineral density (BMD) at the site when compared to that of a healthy thirty-year-old. Normal is a T-score of −1.0 or higher; Osteopenia is defined as between −1.0 and −2.5; Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a thirty-year-old man/woman.|T-score|Mean|-2.842|-2.842|Standard Deviation|1.033|1.033|||
3741063|NCT02016716|3576346|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|291|291.0||||||
3741064|NCT02016716|3576347|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|123|123.0||||||
3741065|NCT02016716|3576348|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|115|115.0||||||
3741066|NCT02016716|3576349|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|53|53.0||||||
3741067|NCT02016716|3576346|B4||Black (or African American)|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3741068|NCT02016716|3576347|B3||Black (or African American)|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741069|NCT02016716|3576348|B2||Black (or African American)|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3741070|NCT02016716|3576349|B1||Black (or African American)|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741071|NCT02016716|3576346|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3741072|NCT02016716|3576347|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741073|NCT02016716|3576348|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3741074|NCT02016716|3576349|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741075|NCT02016716|3576346|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741076|NCT02016716|3576347|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741077|NCT02016716|3576348|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741078|NCT02016716|3576349|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741079|NCT02016716|3576346|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|277|277.0||||||
3741080|NCT02016716|3576347|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|114|114.0||||||
3741081|NCT02016716|3576348|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|112|112.0||||||
3741082|NCT02016716|3576349|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3741083|NCT02016716|3576346|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3741084|NCT02016716|3576347|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3741085|NCT02016716|3576348|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3741086|NCT02016716|3576349|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3741087|NCT02016716|3576346|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3741088|NCT02016716|3576347|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3741089|NCT02016716|3576348|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3741090|NCT02016716|3576349|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3741091|NCT02016716|3576346|B4||Female|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
3741092|NCT02016716|3576347|B3||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3741093|NCT02016716|3576348|B2||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3741094|NCT02016716|3576349|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3741095|NCT02016716|3576346|B4||≥ 65 years|Age, Customized||Participants|Count of Participants|179|179.0||||||
3741096|NCT02016716|3576347|B3||≥ 65 years|Age, Customized||Participants|Count of Participants|77|77.0||||||
3741097|NCT02016716|3576348|B2||≥ 65 years|Age, Customized||Participants|Count of Participants|72|72.0||||||
3741098|NCT02016716|3576349|B1||≥ 65 years|Age, Customized||Participants|Count of Participants|30|30.0||||||
3741099|NCT02016716|3576346|B4||< 65 years|Age, Customized||Participants|Count of Participants|115|115.0||||||
3741100|NCT02016716|3576347|B3||< 65 years|Age, Customized||Participants|Count of Participants|46|46.0||||||
3741101|NCT02016716|3576348|B2||< 65 years|Age, Customized||Participants|Count of Participants|46|46.0||||||
3741102|NCT02016716|3576349|B1||< 65 years|Age, Customized||Participants|Count of Participants|23|23.0||||||
3741103|NCT02016716|3576346|B4|||Age||years|Mean|67.7|67.7|Standard Deviation|7.5|7.5|||
3741104|NCT02016716|3576347|B3|||Age||years|Mean|67.7|67.7|Standard Deviation|7.6|7.6|||
3741105|NCT02016716|3576348|B2|||Age||years|Mean|67.4|67.4|Standard Deviation|7.1|7.1|||
3741106|NCT02016716|3576349|B1|||Age||years|Mean|68.4|68.4|Standard Deviation|8.0|8.0|||
3741107|NCT02016690|3576372|B1|5||Lower Respiratory Tract Infection score at the start of treatment|The Lower Respiratory Tract Infection (LRI) Score ranged from 0 (well or baseline); 1(Upper Respiratory tract Infection [URI]), mild; 2 (LRI); 3 (LRI, moderate); 4 (LRI, severe) to 5 (Respiratory Failure). Components of the score included respiratory rate per minute, oxygen saturation, and physical findings. LRI scores were documented on the case report form (CRF).|Participants|Count of Participants|1|1.0||||||
3741108|NCT02016690|3576372|B1|4||Lower Respiratory Tract Infection score at the start of treatment|The Lower Respiratory Tract Infection (LRI) Score ranged from 0 (well or baseline); 1(Upper Respiratory tract Infection [URI]), mild; 2 (LRI); 3 (LRI, moderate); 4 (LRI, severe) to 5 (Respiratory Failure). Components of the score included respiratory rate per minute, oxygen saturation, and physical findings. LRI scores were documented on the case report form (CRF).|Participants|Count of Participants|1|1.0||||||
3741109|NCT02016690|3576372|B1|3||Lower Respiratory Tract Infection score at the start of treatment|The Lower Respiratory Tract Infection (LRI) Score ranged from 0 (well or baseline); 1(Upper Respiratory tract Infection [URI]), mild; 2 (LRI); 3 (LRI, moderate); 4 (LRI, severe) to 5 (Respiratory Failure). Components of the score included respiratory rate per minute, oxygen saturation, and physical findings. LRI scores were documented on the case report form (CRF).|Participants|Count of Participants|4|4.0||||||
3741110|NCT02016690|3576372|B1|2||Lower Respiratory Tract Infection score at the start of treatment|The Lower Respiratory Tract Infection (LRI) Score ranged from 0 (well or baseline); 1(Upper Respiratory tract Infection [URI]), mild; 2 (LRI); 3 (LRI, moderate); 4 (LRI, severe) to 5 (Respiratory Failure). Components of the score included respiratory rate per minute, oxygen saturation, and physical findings. LRI scores were documented on the case report form (CRF).|Participants|Count of Participants|4|4.0||||||
3741111|NCT02016690|3576372|B1|1||Lower Respiratory Tract Infection score at the start of treatment|The Lower Respiratory Tract Infection (LRI) Score ranged from 0 (well or baseline); 1(Upper Respiratory tract Infection [URI]), mild; 2 (LRI); 3 (LRI, moderate); 4 (LRI, severe) to 5 (Respiratory Failure). Components of the score included respiratory rate per minute, oxygen saturation, and physical findings. LRI scores were documented on the case report form (CRF).|Participants|Count of Participants|5|5.0||||||
3741112|NCT02016690|3576372|B1|0||Lower Respiratory Tract Infection score at the start of treatment|The Lower Respiratory Tract Infection (LRI) Score ranged from 0 (well or baseline); 1(Upper Respiratory tract Infection [URI]), mild; 2 (LRI); 3 (LRI, moderate); 4 (LRI, severe) to 5 (Respiratory Failure). Components of the score included respiratory rate per minute, oxygen saturation, and physical findings. LRI scores were documented on the case report form (CRF).|Participants|Count of Participants|289|289.0||||||
3741113|NCT02016690|3576372|B1|Unknown||Comorbidity||Participants|Count of Participants|1|1.0||||||
3741114|NCT02016690|3576372|B1|Yes- others||Comorbidity||Participants|Count of Participants|142|142.0||||||
3741115|NCT02016690|3576372|B1|Yes- cardiovascular disease||Comorbidity||Participants|Count of Participants|45|45.0||||||
3741116|NCT02016690|3576372|B1|Yes- respiratory disease||Comorbidity||Participants|Count of Participants|50|50.0||||||
3741117|NCT02016690|3576372|B1|Yes- hepatic disease||Comorbidity||Participants|Count of Participants|21|21.0||||||
3741118|NCT02016690|3576372|B1|Yes- renal disease||Comorbidity||Participants|Count of Participants|18|18.0||||||
3741119|NCT02016690|3576372|B1|No||Comorbidity||Participants|Count of Participants|120|120.0||||||
3741120|NCT02016690|3576372|B1|Unknown||Participant's predisposition to hypersensitivity||Participants|Count of Participants|28|28.0||||||
3741121|NCT02016690|3576372|B1|Yes- others||Participant's predisposition to hypersensitivity||Participants|Count of Participants|1|1.0||||||
3741122|NCT02016690|3576372|B1|Yes- drug allergy||Participant's predisposition to hypersensitivity||Participants|Count of Participants|3|3.0||||||
3741123|NCT02016690|3576372|B1|Yes- food allergy||Participant's predisposition to hypersensitivity||Participants|Count of Participants|11|11.0||||||
3741124|NCT02016690|3576372|B1|Yes- allergic dermatitis||Participant's predisposition to hypersensitivity||Participants|Count of Participants|4|4.0||||||
3741125|NCT02016690|3576372|B1|Yes- allergic rhinitis||Participant's predisposition to hypersensitivity||Participants|Count of Participants|4|4.0||||||
3741126|NCT02016690|3576372|B1|Yes- allergic bronchitis||Participant's predisposition to hypersensitivity||Participants|Count of Participants|1|1.0||||||
3741127|NCT02016690|3576372|B1|Yes- asthma||Participant's predisposition to hypersensitivity||Participants|Count of Participants|11|11.0||||||
3741128|NCT02016690|3576372|B1|No||Participant's predisposition to hypersensitivity||Participants|Count of Participants|245|245.0||||||
3741129|NCT02016690|3576372|B1|Not specified||Familial predisposition to hypersensitivity||Participants|Count of Participants|6|6.0||||||
3741130|NCT02016690|3576372|B1|Unknown||Familial predisposition to hypersensitivity||Participants|Count of Participants|84|84.0||||||
3741131|NCT02016690|3576372|B1|Yes||Familial predisposition to hypersensitivity||Participants|Count of Participants|34|34.0||||||
3741132|NCT02016690|3576372|B1|No||Familial predisposition to hypersensitivity||Participants|Count of Participants|180|180.0||||||
3741133|NCT02016690|3576372|B1|Not specified||Number of smokers in the household||Participants|Count of Participants|80|80.0||||||
3741134|NCT02016690|3576372|B1|≥ 1 smokers||Number of smokers in the household||Participants|Count of Participants|40|40.0||||||
3741135|NCT02016690|3576372|B1|0 smokers||Number of smokers in the household||Participants|Count of Participants|184|184.0||||||
3741136|NCT02016690|3576372|B1|Not specified||Body weight at birth||Participants|Count of Participants|11|11.0||||||
3741137|NCT02016690|3576372|B1|≥ 4000 grams||Body weight at birth||Participants|Count of Participants|2|2.0||||||
3741138|NCT02016690|3576372|B1|≥ 2500 and ≤ 4000 grams||Body weight at birth||Participants|Count of Participants|207|207.0||||||
3741139|NCT02016690|3576372|B1|≥ 1500 and ≤ 2500 grams||Body weight at birth||Participants|Count of Participants|80|80.0||||||
3741140|NCT02016690|3576372|B1|≥ 1000 and ≤ 1500 grams||Body weight at birth||Participants|Count of Participants|4|4.0||||||
3741141|NCT02016690|3576372|B1|< 1000 grams||Body weight at birth||Participants|Count of Participants|0|0.0||||||
3741142|NCT02016690|3576372|B1|Not specified||Gestational age||Participants|Count of Participants|10|10.0||||||
3741143|NCT02016690|3576372|B1|≥ 42 weeks||Gestational age||Participants|Count of Participants|1|1.0||||||
3741144|NCT02016690|3576372|B1|≥ 37 and < 42 weeks||Gestational age||Participants|Count of Participants|237|237.0||||||
3741145|NCT02016690|3576372|B1|≥ 22 and < 37 weeks||Gestational age||Participants|Count of Participants|56|56.0||||||
3741146|NCT02016690|3576372|B1|< 22 weeks||Gestational age||Participants|Count of Participants|0|0.0||||||
3741147|NCT02016690|3576372|B1|Not specified||Body weight at the start of treatment||Participants|Count of Participants|3|3.0||||||
3741148|NCT02016690|3576372|B1|≥ 15000 grams||Body weight at the start of treatment||Participants|Count of Participants|1|1.0||||||
3741149|NCT02016690|3576372|B1|≥ 10000 and < 15000 grams||Body weight at the start of treatment||Participants|Count of Participants|45|45.0||||||
3741150|NCT02016690|3576372|B1|≥ 5000 and < 10000 grams||Body weight at the start of treatment||Participants|Count of Participants|202|202.0||||||
3741151|NCT02016690|3576372|B1|≥ 2500 and < 5000 grams||Body weight at the start of treatment||Participants|Count of Participants|52|52.0||||||
3741152|NCT02016690|3576372|B1|≥ 1500 and < 2500 grams||Body weight at the start of treatment||Participants|Count of Participants|1|1.0||||||
3741153|NCT02016690|3576372|B1|≥ 1000 and < 1500 grams||Body weight at the start of treatment||Participants|Count of Participants|0|0.0||||||
3741154|NCT02016690|3576372|B1|< 1000 grams||Body weight at the start of treatment||Participants|Count of Participants|0|0.0||||||
3741155|NCT02016690|3576372|B1|> 24 months||Age at the start of treatment||Participants|Count of Participants|0|0.0||||||
3741156|NCT02016690|3576372|B1|> 12 and ≤ 24 months||Age at the start of treatment||Participants|Count of Participants|137|137.0||||||
3741157|NCT02016690|3576372|B1|> 6 and ≤ 12 months||Age at the start of treatment||Participants|Count of Participants|81|81.0||||||
3741158|NCT02016690|3576372|B1|> 3 and ≤ 6 months||Age at the start of treatment||Participants|Count of Participants|31|31.0||||||
3741159|NCT02016690|3576372|B1|> 1 and ≤ 3 months||Age at the start of treatment||Participants|Count of Participants|24|24.0||||||
3741160|NCT02016690|3576372|B1|≤ 1 month||Age at the start of treatment||Participants|Count of Participants|31|31.0||||||
3741161|NCT02016690|3576372|B1|Others||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3741162|NCT02016690|3576372|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3741163|NCT02016690|3576372|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741164|NCT02016690|3576372|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741165|NCT02016690|3576372|B1|Japanese||Race/Ethnicity, Customized||Participants|Count of Participants|297|297.0||||||
3741166|NCT02016690|3576372|B1||Male|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
3741167|NCT02016690|3576372|B1||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3741168|NCT02016690|3576372|B1|||Age||months|Mean|11.9|11.9|Standard Deviation|7.5|7.5|||
3741169|NCT02016625|3576383|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3741170|NCT02016625|3576384|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3741171|NCT02016625|3576385|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3741172|NCT02016625|3576383|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3741173|NCT02016625|3576384|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3741174|NCT02016625|3576385|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3741175|NCT02016625|3576383|B3|||Age||years|Mean|41.3|41.3|Standard Deviation|8.4|8.4|||
3741176|NCT02016625|3576384|B2|||Age||years|Mean|41.5|41.5|Standard Deviation|8.8|8.8|||
3741177|NCT02016625|3576385|B1|||Age||years|Mean|41.2|41.2|Standard Deviation|8.3|8.3|||
3741178|NCT02016612|3576418|B5|United States||Region of Enrollment||Participants|Count of Participants|137|137.0||||||
3741179|NCT02016612|3576419|B4|United States||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
3741180|NCT02016612|3576420|B3|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3741181|NCT02016612|3576421|B2|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3741182|NCT02016612|3576422|B1|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3741183|NCT02016612|3576418|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741184|NCT02016612|3576419|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741185|NCT02016612|3576420|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741186|NCT02016612|3576421|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741187|NCT02016612|3576422|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741188|NCT02016612|3576418|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741189|NCT02016612|3576419|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741190|NCT02016612|3576420|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741191|NCT02016612|3576421|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741192|NCT02016612|3576422|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741193|NCT02016612|3576418|B5||White|Race (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
3741194|NCT02016612|3576419|B4||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3741195|NCT02016612|3576420|B3||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3741196|NCT02016612|3576421|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3741197|NCT02016612|3576422|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3741198|NCT02016612|3576418|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3741199|NCT02016612|3576419|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741200|NCT02016612|3576420|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3741201|NCT02016612|3576421|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741202|NCT02016612|3576422|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3741203|NCT02016612|3576418|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741204|NCT02016612|3576419|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741205|NCT02016612|3576420|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741206|NCT02016612|3576421|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741207|NCT02016612|3576422|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741208|NCT02016612|3576418|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3741209|NCT02016612|3576419|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741210|NCT02016612|3576420|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3741211|NCT02016612|3576421|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3741212|NCT02016612|3576422|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3741213|NCT02016612|3576418|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741214|NCT02016612|3576419|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741215|NCT02016612|3576420|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741216|NCT02016612|3576421|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741217|NCT02016612|3576422|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741218|NCT02016612|3576418|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3741219|NCT02016612|3576419|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3741220|NCT02016612|3576420|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3741221|NCT02016612|3576421|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3741222|NCT02016612|3576422|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3741223|NCT02016612|3576418|B5||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3741224|NCT02016612|3576419|B4||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3741225|NCT02016612|3576420|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3741226|NCT02016612|3576421|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3741227|NCT02016612|3576422|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3741228|NCT02016612|3576418|B5|||Age||years|Mean|42|42.0|Full Range|||20.0|65.0|
3741229|NCT02016612|3576419|B4|||Age||years|Mean|37|37.0|Full Range|||26.0|65.0|
3741230|NCT02016612|3576420|B3|||Age||years|Mean|48|48.0|Full Range|||39.0|65.0|
3741231|NCT02016612|3576421|B2|||Age||years|Mean|38|38.0|Full Range|||20.0|56.0|
3741232|NCT02016612|3576422|B1|||Age||years|Mean|47|47.0|Full Range|||20.0|63.0|
3741233|NCT02016612|3576418|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3741234|NCT02016612|3576419|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3741235|NCT02016612|3576420|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3741236|NCT02016612|3576421|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3741237|NCT02016612|3576422|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3741238|NCT02016612|3576418|B5||Between 18 and 65 years|Age||Participants|Count of Participants|137|137.0||||||
3741239|NCT02016612|3576419|B4||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
3741240|NCT02016612|3576420|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3741241|NCT02016612|3576421|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3741242|NCT02016612|3576422|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3741243|NCT02016612|3576418|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3741244|NCT02016612|3576419|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3741245|NCT02016612|3576420|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3741246|NCT02016612|3576421|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3741247|NCT02016612|3576422|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3741248|NCT02016482|3576439|B3||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3741249|NCT02016482|3576440|B2||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3741250|NCT02016482|3576441|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3741251|NCT02016482|3576439|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3741252|NCT02016482|3576440|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3741253|NCT02016482|3576441|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3741254|NCT02016482|3576439|B3|≥ 65 years||Age, Customized||participants|Number|18|18.0||||||
3741255|NCT02016482|3576440|B2|≥ 65 years||Age, Customized||participants|Number|9|9.0||||||
3741256|NCT02016482|3576441|B1|≥ 65 years||Age, Customized||participants|Number|9|9.0||||||
3741257|NCT02016482|3576439|B3|40 to ≤ 64 years||Age, Customized||participants|Number|135|135.0||||||
3741258|NCT02016482|3576440|B2|40 to ≤ 64 years||Age, Customized||participants|Number|70|70.0||||||
3741259|NCT02016482|3576441|B1|40 to ≤ 64 years||Age, Customized||participants|Number|65|65.0||||||
3741260|NCT02016482|3576439|B3|< 40 years||Age, Customized||participants|Number|64|64.0||||||
3741261|NCT02016482|3576440|B2|< 40 years||Age, Customized||participants|Number|30|30.0||||||
3741262|NCT02016482|3576441|B1|< 40 years||Age, Customized||participants|Number|34|34.0||||||
3741263|NCT02016482|3576439|B3|||Age||years|Mean|46.69|46.69|Standard Deviation|11.980|11.98|||
3741264|NCT02016482|3576440|B2|||Age||years|Mean|47.21|47.21|Standard Deviation|11.858|11.858|||
3741265|NCT02016482|3576441|B1|||Age||years|Mean|46.16|46.16|Standard Deviation|12.134|12.134|||
3741266|NCT02016183|3576530|B1|Had Any Violation||Violation of Inclusion or Exclusion Criteria||Participants|Count of Participants|3|3.0||||||
3741267|NCT02016183|3576530|B1|Had No Violation||Violation of Inclusion or Exclusion Criteria||Participants|Count of Participants|3154|3154.0||||||
3741268|NCT02016183|3576530|B1|Had Used Antihypertensive Drug||Use of Antihypertensive Drug Prior to the Start of the Study Drug||Participants|Count of Participants|2972|2972.0||||||
3741269|NCT02016183|3576530|B1|Had Not Used Antihypertensive Drug||Use of Antihypertensive Drug Prior to the Start of the Study Drug||Participants|Count of Participants|185|185.0||||||
3741270|NCT02016183|3576530|B1|||Duration of Disease||Years|Mean|7.12|7.12|Standard Deviation|7.289|7.289|||
3741271|NCT02016183|3576530|B1|Unknown||Medical History|Medical history defined as a disease or a health condition for each participant before start of the study. Medical history was classified as congenital anomalies, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, GI disorders, hepatic and biliary disorders, renal disease and other medical history. Other medical history included all medical history except for those mentioned above.|Participants|Count of Participants|2|2.0||||||
3741272|NCT02016183|3576530|B1|Had Medical History||Medical History|Medical history defined as a disease or a health condition for each participant before start of the study. Medical history was classified as congenital anomalies, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, GI disorders, hepatic and biliary disorders, renal disease and other medical history. Other medical history included all medical history except for those mentioned above.|Participants|Count of Participants|552|552.0||||||
3741273|NCT02016183|3576530|B1|Had no Medical History||Medical History|Medical history defined as a disease or a health condition for each participant before start of the study. Medical history was classified as congenital anomalies, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, GI disorders, hepatic and biliary disorders, renal disease and other medical history. Other medical history included all medical history except for those mentioned above.|Participants|Count of Participants|2603|2603.0||||||
3741274|NCT02016183|3576530|B1|Had Medical Complications||Medical Complications|Complications defined as a disease or a health condition for each participant at the start of study. Complications were classified as congenital anomalies, endocrine disorders, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, gastrointestinal (GI) disorders, renal disease and other complications. Other complications included all complications except for those mentioned above.|Participants|Count of Participants|2359|2359.0||||||
3741275|NCT02016183|3576530|B1|Had no Medical Complications||Medical Complications|Complications defined as a disease or a health condition for each participant at the start of study. Complications were classified as congenital anomalies, endocrine disorders, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, gastrointestinal (GI) disorders, renal disease and other complications. Other complications included all complications except for those mentioned above.|Participants|Count of Participants|798|798.0||||||
3741276|NCT02016183|3576530|B1|Unknown||Allergy/Predisposition to Hypersensitivity||Participants|Count of Participants|1|1.0||||||
3741277|NCT02016183|3576530|B1|Had Allergy/Predisposition to Hypersensitivity||Allergy/Predisposition to Hypersensitivity||Participants|Count of Participants|345|345.0||||||
3741278|NCT02016183|3576530|B1|Had no Allergy/Predisposition to Hypersensitivity||Allergy/Predisposition to Hypersensitivity||Participants|Count of Participants|2811|2811.0||||||
3741279|NCT02016183|3576530|B1|Unknown||Smoking Classification||Participants|Count of Participants|416|416.0||||||
3741280|NCT02016183|3576530|B1|Current/Ex smoker||Smoking Classification||Participants|Count of Participants|409|409.0||||||
3741281|NCT02016183|3576530|B1|Never smoked||Smoking Classification||Participants|Count of Participants|2332|2332.0||||||
3741282|NCT02016183|3576530|B1|||Waist Circumference||cm|Mean|87.21|87.21|Standard Deviation|10.458|10.458|||
3741283|NCT02016183|3576530|B1|||BMI|Body Mass Index = weight (kg)/[height (m)^2]|kg/m^2|Mean|24.61|24.61|Standard Deviation|3.885|3.885|||
3741284|NCT02016183|3576530|B1|Inpatient and outpatient||Healthcare Category|Participants were categorized as outpatient, inpatient, and outpatient and inpatient (participants who were both outpatient and inpatient during some point at the time and 3 months prior to enrollment).|Participants|Count of Participants|74|74.0||||||
3741285|NCT02016183|3576530|B1|Inpatient||Healthcare Category|Participants were categorized as outpatient, inpatient, and outpatient and inpatient (participants who were both outpatient and inpatient during some point at the time and 3 months prior to enrollment).|Participants|Count of Participants|18|18.0||||||
3741286|NCT02016183|3576530|B1|Outpatient||Healthcare Category|Participants were categorized as outpatient, inpatient, and outpatient and inpatient (participants who were both outpatient and inpatient during some point at the time and 3 months prior to enrollment).|Participants|Count of Participants|3065|3065.0||||||
3741287|NCT02016183|3576530|B1|Japan||Region of Enrollment|All participants were enrolled in Japan.|Participants|Number|3157|3157.0||||||
3741288|NCT02016183|3576530|B1||Male|Sex: Female, Male||Participants|Count of Participants|1411|1411.0||||||
3741289|NCT02016183|3576530|B1||Female|Sex: Female, Male||Participants|Count of Participants|1746|1746.0||||||
3741290|NCT02016183|3576530|B1|||Age||Years|Mean|69.6|69.6|Standard Deviation|12.27|12.27|||
3741291|NCT02016170|3576537|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741292|NCT02016170|3576538|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741293|NCT02016170|3576539|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741294|NCT02016170|3576540|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741295|NCT02016170|3576537|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741296|NCT02016170|3576538|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741297|NCT02016170|3576539|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741298|NCT02016170|3576540|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741299|NCT02016170|3576537|B4||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3741300|NCT02016170|3576538|B3||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3741301|NCT02016170|3576539|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3741302|NCT02016170|3576540|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3741303|NCT02016170|3576537|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3741304|NCT02016170|3576538|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3741305|NCT02016170|3576539|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3741306|NCT02016170|3576540|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3741307|NCT02016170|3576537|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741308|NCT02016170|3576538|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741309|NCT02016170|3576539|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741310|NCT02016170|3576540|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741311|NCT02016170|3576537|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741312|NCT02016170|3576538|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741313|NCT02016170|3576539|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741314|NCT02016170|3576540|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741315|NCT02016170|3576537|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741316|NCT02016170|3576538|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741317|NCT02016170|3576539|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741318|NCT02016170|3576540|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741319|NCT02016170|3576537|B4||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3741320|NCT02016170|3576538|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3741321|NCT02016170|3576539|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3741322|NCT02016170|3576540|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3741323|NCT02016170|3576537|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3741324|NCT02016170|3576538|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3741325|NCT02016170|3576539|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3741326|NCT02016170|3576540|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3741327|NCT02016170|3576537|B4|||Age||years|Mean|57|57.0|Standard Deviation|8|8.0|||
3741328|NCT02016170|3576538|B3|||Age||years|Mean|57|57.0|Standard Deviation|7|7.0|||
3741329|NCT02016170|3576539|B2|||Age||years|Mean|57|57.0|Standard Deviation|7|7.0|||
3741330|NCT02016170|3576540|B1|||Age||years|Mean|55|55.0|Standard Deviation|10|10.0|||
3741331|NCT02016105|3576551|B3|Europe||Region of Enrollment||participants|Number|87|87.0||||||
3741332|NCT02016105|3576552|B2|Europe||Region of Enrollment||participants|Number|44|44.0||||||
3741333|NCT02016105|3576553|B1|Europe||Region of Enrollment||participants|Number|43|43.0||||||
3741334|NCT02016105|3576551|B3|United States||Region of Enrollment||participants|Number|378|378.0||||||
3741335|NCT02016105|3576552|B2|United States||Region of Enrollment||participants|Number|190|190.0||||||
3741336|NCT02016105|3576553|B1|United States||Region of Enrollment||participants|Number|188|188.0||||||
3741337|NCT02016105|3576551|B3||Male|Sex: Female, Male||Participants|Count of Participants|284|284.0||||||
3741338|NCT02016105|3576552|B2||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3741339|NCT02016105|3576553|B1||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3741340|NCT02016105|3576551|B3||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
3741341|NCT02016105|3576552|B2||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3741342|NCT02016105|3576553|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3741343|NCT02016105|3576551|B3|||Age||years|Mean|46.3|46.3|Standard Deviation|14.12|14.12|||
3741344|NCT02016105|3576552|B2|||Age||years|Mean|46.9|46.9|Standard Deviation|14.09|14.09|||
3741345|NCT02016105|3576553|B1|||Age||years|Mean|45.6|45.6|Standard Deviation|14.16|14.16|||
3741346|NCT02016105|3576551|B3||>=65 years|Age||Participants|Count of Participants|52|52.0||||||
3741347|NCT02016105|3576552|B2||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
3741348|NCT02016105|3576553|B1||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
3741349|NCT02016105|3576551|B3||Between 18 and 65 years|Age||Participants|Count of Participants|413|413.0||||||
3741350|NCT02016105|3576552|B2||Between 18 and 65 years|Age||Participants|Count of Participants|208|208.0||||||
3741351|NCT02016105|3576553|B1||Between 18 and 65 years|Age||Participants|Count of Participants|205|205.0||||||
3741352|NCT02016105|3576551|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3741353|NCT02016105|3576552|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3741354|NCT02016105|3576553|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3741355|NCT02015910|3576606|B3||Male|Gender||Participants|Count of Participants|1|1.0||||||
3741356|NCT02015910|3576607|B2||Male|Gender||Participants|Count of Participants|1|1.0||||||
3741357|NCT02015910|3576606|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
3741358|NCT02015910|3576607|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
3741359|NCT02015910|3576606|B3|||Age||years|Mean|68|68.0|Standard Deviation|0|0.0|||
3741360|NCT02015910|3576607|B2|||Age||years|Mean|68|68.0|Standard Deviation|0|0.0|||
3741361|NCT02015910|3576606|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3741362|NCT02015910|3576607|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3741363|NCT02015910|3576606|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3741364|NCT02015910|3576607|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3741365|NCT02015910|3576606|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3741366|NCT02015910|3576607|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3741367|NCT02015793|3576615|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3741368|NCT02015793|3576616|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3741369|NCT02015793|3576617|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3741370|NCT02015793|3576615|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3741371|NCT02015793|3576616|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3741372|NCT02015793|3576617|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3741373|NCT02015793|3576615|B3|||Age||years|Mean|34.5|34.5|Standard Deviation|13.63|13.63|||
3741374|NCT02015793|3576616|B2|||Age||years|Mean|35.6|35.6|Standard Deviation|13.00|13.0|||
3741375|NCT02015793|3576617|B1|||Age||years|Mean|33.5|33.5|Standard Deviation|14.60|14.6|||
3741376|NCT02015754|3576648|B1|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3741377|NCT02015754|3576648|B1|Unknown|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3741378|NCT02015754|3576648|B1|Unknown|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741379|NCT02015754|3576648|B1|Unknown|White|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3741380|NCT02015754|3576648|B1|Non-Hispanic|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741381|NCT02015754|3576648|B1|Non-Hispanic|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3741382|NCT02015754|3576648|B1|Non-Hispanic|White|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3741383|NCT02015754|3576648|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3741384|NCT02015754|3576648|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3741385|NCT02015754|3576648|B1|||Age||years|Median|52.5|52.5|Full Range|||44.0|84.0|
3741386|NCT02015676|3576665|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3741387|NCT02015676|3576666|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3741388|NCT02015676|3576667|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3741389|NCT02015676|3576668|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3741390|NCT02015676|3576665|B4||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3741391|NCT02015676|3576666|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3741392|NCT02015676|3576667|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3741393|NCT02015676|3576668|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3741394|NCT02015676|3576665|B4|||Age||years|Mean|52.61|52.61|Standard Deviation|12.70|12.7|||
3741395|NCT02015676|3576666|B3|||Age||years|Mean|44.33|44.33|Standard Deviation|15.36|15.36|||
3741396|NCT02015676|3576667|B2|||Age||years|Mean|52.98|52.98|Standard Deviation|12.33|12.33|||
3741397|NCT02015676|3576668|B1|||Age||years|Mean|54.73|54.73|Standard Deviation|12.42|12.42|||
3741398|NCT02015663|3576684|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3741399|NCT02015663|3576685|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3741400|NCT02015663|3576686|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3741401|NCT02015663|3576684|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3741402|NCT02015663|3576685|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3741403|NCT02015663|3576686|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3741404|NCT02015663|3576684|B3|||Age||year|Mean|30.7|30.7|Standard Deviation|13.3|13.3|||
3741405|NCT02015663|3576685|B2|||Age||year|Mean|26.5|26.5|Standard Deviation|11.09|11.09|||
3741406|NCT02015663|3576686|B1|||Age||year|Mean|34.9|34.9|Standard Deviation|14.31|14.31|||
3741407|NCT02015637|3576716|B3|||Positive culture for Gonorrhea (GC)|Positive culture for N gonorrhoeae obtained from 1 or more anatomical sites (i.e., urogenital, pharyngeal, rectal) at the Entry Visit, i.e. were part of the Microbiological Intent-to-treat (MITT) population.|Participants|Count of Participants|346|346.0||||||
3741408|NCT02015637|3576717|B2|||Positive culture for Gonorrhea (GC)|Positive culture for N gonorrhoeae obtained from 1 or more anatomical sites (i.e., urogenital, pharyngeal, rectal) at the Entry Visit, i.e. were part of the Microbiological Intent-to-treat (MITT) population.|Participants|Count of Participants|107|107.0||||||
3741409|NCT02015637|3576718|B1|||Positive culture for Gonorrhea (GC)|Positive culture for N gonorrhoeae obtained from 1 or more anatomical sites (i.e., urogenital, pharyngeal, rectal) at the Entry Visit, i.e. were part of the Microbiological Intent-to-treat (MITT) population.|Participants|Count of Participants|239|239.0||||||
3741410|NCT02015637|3576716|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3741411|NCT02015637|3576717|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3741412|NCT02015637|3576718|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3741413|NCT02015637|3576716|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741414|NCT02015637|3576717|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741415|NCT02015637|3576718|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741416|NCT02015637|3576716|B3||White|Race (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
3741417|NCT02015637|3576717|B2||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3741418|NCT02015637|3576718|B1||White|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3741419|NCT02015637|3576716|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|278|278.0||||||
3741420|NCT02015637|3576717|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
3741421|NCT02015637|3576718|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|186|186.0||||||
3741422|NCT02015637|3576716|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741423|NCT02015637|3576717|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741424|NCT02015637|3576718|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741425|NCT02015637|3576716|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3741426|NCT02015637|3576717|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3741427|NCT02015637|3576718|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3741428|NCT02015637|3576716|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3741429|NCT02015637|3576717|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741430|NCT02015637|3576718|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3741431|NCT02015637|3576716|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3741432|NCT02015637|3576717|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3741433|NCT02015637|3576718|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3741434|NCT02015637|3576716|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|399|399.0||||||
3741435|NCT02015637|3576717|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
3741436|NCT02015637|3576718|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|268|268.0||||||
3741437|NCT02015637|3576716|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3741438|NCT02015637|3576717|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3741439|NCT02015637|3576718|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3741440|NCT02015637|3576716|B3||Male|Sex: Female, Male||Participants|Count of Participants|364|364.0||||||
3741441|NCT02015637|3576717|B2||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3741442|NCT02015637|3576718|B1||Male|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
3741443|NCT02015637|3576716|B3||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3741444|NCT02015637|3576717|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3741445|NCT02015637|3576718|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3741446|NCT02015637|3576716|B3|Men who:|Missing|Sex/Gender, Customized||Participants|Count of Participants|1|1.0||||||
3741447|NCT02015637|3576717|B2|Men who:|Missing|Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3741448|NCT02015637|3576718|B1|Men who:|Missing|Sex/Gender, Customized||Participants|Count of Participants|1|1.0||||||
3741449|NCT02015637|3576716|B3|Men who:|Had sex with men or were bisexual|Sex/Gender, Customized||Participants|Count of Participants|172|172.0||||||
3741450|NCT02015637|3576717|B2|Men who:|Had sex with men or were bisexual|Sex/Gender, Customized||Participants|Count of Participants|60|60.0||||||
3741451|NCT02015637|3576718|B1|Men who:|Had sex with men or were bisexual|Sex/Gender, Customized||Participants|Count of Participants|112|112.0||||||
3741452|NCT02015637|3576716|B3|Men who:|Were heterosexul|Sex/Gender, Customized||Participants|Count of Participants|191|191.0||||||
3741453|NCT02015637|3576717|B2|Men who:|Were heterosexul|Sex/Gender, Customized||Participants|Count of Participants|59|59.0||||||
3741454|NCT02015637|3576718|B1|Men who:|Were heterosexul|Sex/Gender, Customized||Participants|Count of Participants|132|132.0||||||
3741455|NCT02015637|3576716|B3|18-70 years||Age, Customized||Participants|Count of Participants|455|455.0||||||
3741456|NCT02015637|3576717|B2|18-70 years||Age, Customized||Participants|Count of Participants|152|152.0||||||
3741457|NCT02015637|3576718|B1|18-70 years||Age, Customized||Participants|Count of Participants|303|303.0||||||
3741458|NCT02015637|3576716|B3|<18 year||Age, Customized||Participants|Count of Participants|3|3.0||||||
3741459|NCT02015637|3576717|B2|<18 year||Age, Customized||Participants|Count of Participants|2|2.0||||||
3741460|NCT02015637|3576718|B1|<18 year||Age, Customized||Participants|Count of Participants|1|1.0||||||
3741461|NCT02015637|3576716|B3|||Age||years|Mean|29.3|29.3|Standard Deviation|9.25|9.25|||
3741462|NCT02015637|3576717|B2|||Age||years|Mean|28.7|28.7|Standard Deviation|10.04|10.04|||
3741463|NCT02015637|3576718|B1|||Age||years|Mean|29.7|29.7|Standard Deviation|8.82|8.82|||
3741464|NCT02015546|3576727|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3741465|NCT02015546|3576728|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3741466|NCT02015546|3576729|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3741467|NCT02015546|3576730|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3741468|NCT02015546|3576727|B4||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3741469|NCT02015546|3576728|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3741470|NCT02015546|3576729|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3741471|NCT02015546|3576730|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3741472|NCT02015546|3576727|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3741473|NCT02015546|3576728|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3741474|NCT02015546|3576729|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3741475|NCT02015546|3576730|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3741476|NCT02015546|3576727|B4||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
3741477|NCT02015546|3576728|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3741478|NCT02015546|3576729|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3741479|NCT02015546|3576730|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3741480|NCT02015546|3576727|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3741481|NCT02015546|3576728|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3741482|NCT02015546|3576729|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3741483|NCT02015546|3576730|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3741484|NCT02015481|3576764|B1|Israel||Region of Enrollment||participants|Number|14|14.0||||||
3741485|NCT02015481|3576764|B1|Canada||Region of Enrollment||participants|Number|11|11.0||||||
3741486|NCT02015481|3576764|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3741487|NCT02015481|3576764|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3741488|NCT02015481|3576764|B1|||Age||years|Mean|59.5|59.5|Standard Deviation|8.34|8.34|||
3741489|NCT02015481|3576764|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3741490|NCT02015481|3576764|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3741491|NCT02015481|3576764|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3741492|NCT02015234|3576771|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3741493|NCT02015234|3576772|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3741494|NCT02015234|3576773|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3741495|NCT02015234|3576771|B3||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3741496|NCT02015234|3576772|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3741497|NCT02015234|3576773|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3741498|NCT02015234|3576771|B3|||Age||Years|Mean|50.9|50.9|Full Range|||19.0|65.0|
3741499|NCT02015234|3576772|B2|||Age||Years|Mean|51.7|51.7|Full Range|||20.0|64.0|
3741500|NCT02015234|3576773|B1|||Age||Years|Mean|50.2|50.2|Full Range|||19.0|65.0|
3741501|NCT02015234|3576771|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3741502|NCT02015234|3576772|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3741503|NCT02015234|3576773|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3741504|NCT02015234|3576771|B3||Between 18 and 65 years|Age||Participants|Count of Participants|154|154.0||||||
3741505|NCT02015234|3576772|B2||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
3741506|NCT02015234|3576773|B1||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
3741507|NCT02015234|3576771|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3741508|NCT02015234|3576772|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3741509|NCT02015234|3576773|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3741510|NCT02015221|3576786|B3|United States||Region of Enrollment||participants|Number|81|81.0||||||
3741511|NCT02015221|3576787|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
3741512|NCT02015221|3576788|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
3741513|NCT02015221|3576786|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3741514|NCT02015221|3576787|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3741515|NCT02015221|3576788|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3741516|NCT02015221|3576786|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3741517|NCT02015221|3576787|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3741518|NCT02015221|3576788|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3741519|NCT02015221|3576786|B3|||Age||years|Mean|62.2|62.2|Standard Deviation|11.2|11.2|||
3741520|NCT02015221|3576787|B2|||Age||years|Mean|61.1|61.1|Standard Deviation|11.7|11.7|||
3741521|NCT02015221|3576788|B1|||Age||years|Mean|63.3|63.3|Standard Deviation|10.5|10.5|||
3741522|NCT02015195|3576795|B8|United States||Region of Enrollment||participants|Number|97|97.0||||||
3741523|NCT02015195|3576796|B7|United States||Region of Enrollment||participants|Number|16|16.0||||||
3741524|NCT02015195|3576797|B6|United States||Region of Enrollment||participants|Number|16|16.0||||||
3741525|NCT02015195|3576798|B5|United States||Region of Enrollment||participants|Number|16|16.0||||||
3741526|NCT02015195|3576799|B4|United States||Region of Enrollment||participants|Number|1|1.0||||||
3741527|NCT02015195|3576800|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
3741528|NCT02015195|3576801|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3741529|NCT02015195|3576802|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3741530|NCT02015195|3576795|B8||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3741531|NCT02015195|3576796|B7||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3741532|NCT02015195|3576797|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3741533|NCT02015195|3576798|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3741534|NCT02015195|3576799|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3741535|NCT02015195|3576800|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3741536|NCT02015195|3576801|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3741537|NCT02015195|3576802|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3741538|NCT02015195|3576795|B8||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3741539|NCT02015195|3576796|B7||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3741540|NCT02015195|3576797|B6||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3741541|NCT02015195|3576798|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3741542|NCT02015195|3576799|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3741543|NCT02015195|3576800|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3741544|NCT02015195|3576801|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3741545|NCT02015195|3576802|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3741546|NCT02015195|3576795|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3741547|NCT02015195|3576796|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3741548|NCT02015195|3576797|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3741549|NCT02015195|3576798|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3741550|NCT02015195|3576799|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3741551|NCT02015195|3576800|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3741552|NCT02015195|3576801|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3741553|NCT02015195|3576802|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3741554|NCT02015195|3576795|B8||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
3741555|NCT02015195|3576796|B7||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3741556|NCT02015195|3576797|B6||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3741557|NCT02015195|3576798|B5||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3741558|NCT02015195|3576799|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3741559|NCT02015195|3576800|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3741560|NCT02015195|3576801|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3741561|NCT02015195|3576802|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3741562|NCT02015195|3576795|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3741563|NCT02015195|3576796|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3741564|NCT02015195|3576797|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3741565|NCT02015195|3576798|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3741566|NCT02015195|3576799|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3741567|NCT02015195|3576800|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3741568|NCT02015195|3576801|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3741569|NCT02015195|3576802|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3741570|NCT02015039|3576829|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3741571|NCT02015039|3576830|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3741572|NCT02015039|3576831|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3741573|NCT02015039|3576829|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3741574|NCT02015039|3576830|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3741575|NCT02015039|3576831|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3741576|NCT02015039|3576829|B3|||Age||years|Mean|62.92|62.92|Full Range|||52.0|74.0|
3741577|NCT02015039|3576830|B2|||Age||years|Mean|63.5|63.5|Full Range|||57.0|72.0|
3741578|NCT02015039|3576831|B1|||Age||years|Mean|62.33|62.33|Full Range|||52.0|74.0|
3741579|NCT02014740|3576850|B3|||HemoglobinA1c (HbA1c)||%|Mean|6.52|6.52|Standard Deviation|0.6|0.6|||
3741580|NCT02014740|3576851|B2|||HemoglobinA1c (HbA1c)||%|Mean|6.4|6.4|Standard Deviation|0.6|0.6|||
3741581|NCT02014740|3576852|B1|||HemoglobinA1c (HbA1c)||%|Mean|6.6|6.6|Standard Deviation|0.8|0.8|||
3741582|NCT02014740|3576850|B3|||Body Mass Index (BMI)||kg/m2|Mean|35.2|35.2|Standard Deviation|6|6.0|||
3741583|NCT02014740|3576851|B2|||Body Mass Index (BMI)||kg/m2|Mean|32.6|32.6|Standard Deviation|6|6.0|||
3741584|NCT02014740|3576852|B1|||Body Mass Index (BMI)||kg/m2|Mean|37.8|37.8|Standard Deviation|7|7.0|||
3741585|NCT02014740|3576850|B3|||Epicardial adipose tissue Thickness (EAT)||mm|Mean|8.75|8.75|Standard Deviation|1.9|1.9|||
3741586|NCT02014740|3576851|B2|||Epicardial adipose tissue Thickness (EAT)||mm|Mean|7.4|7.4|Standard Deviation|1.6|1.6|||
3741587|NCT02014740|3576852|B1|||Epicardial adipose tissue Thickness (EAT)||mm|Mean|9.6|9.6|Standard Deviation|2|2.0|||
3741588|NCT02014740|3576850|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
3741589|NCT02014740|3576851|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
3741590|NCT02014740|3576852|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
3741591|NCT02014740|3576850|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741592|NCT02014740|3576851|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741593|NCT02014740|3576852|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741594|NCT02014740|3576850|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3741595|NCT02014740|3576851|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3741596|NCT02014740|3576852|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3741597|NCT02014740|3576850|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3741598|NCT02014740|3576851|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3741599|NCT02014740|3576852|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3741600|NCT02014740|3576850|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3741601|NCT02014740|3576851|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3741602|NCT02014740|3576852|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3741603|NCT02014740|3576850|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3741604|NCT02014740|3576851|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3741605|NCT02014740|3576852|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3741606|NCT02014740|3576850|B3|||Age||years|Mean|50.8|50.8|Standard Deviation|10|10.0|||
3741607|NCT02014740|3576851|B2|||Age||years|Mean|52|52.0|Standard Deviation|10|10.0|||
3741608|NCT02014740|3576852|B1|||Age||years|Mean|50|50.0|Standard Deviation|10|10.0|||
3741609|NCT02014740|3576850|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3741610|NCT02014740|3576851|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3741611|NCT02014740|3576852|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3741612|NCT02014740|3576850|B3||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
3741613|NCT02014740|3576851|B2||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3741614|NCT02014740|3576852|B1||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
3741615|NCT02014740|3576850|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3741616|NCT02014740|3576851|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3741617|NCT02014740|3576852|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3741618|NCT02014584|3576859|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
3741619|NCT02014584|3576860|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
3741620|NCT02014584|3576861|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3741621|NCT02014584|3576859|B3|Asian - Southeast Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3741622|NCT02014584|3576860|B2|Asian - Southeast Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3741623|NCT02014584|3576861|B1|Asian - Southeast Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3741624|NCT02014584|3576859|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|97|97.0||||||
3741625|NCT02014584|3576860|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|48|48.0||||||
3741626|NCT02014584|3576861|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|49|49.0||||||
3741627|NCT02014584|3576859|B3||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3741628|NCT02014584|3576860|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3741629|NCT02014584|3576861|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3741630|NCT02014584|3576859|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3741631|NCT02014584|3576860|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3741632|NCT02014584|3576861|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3741633|NCT02014584|3576859|B3|||Age||Years|Mean|39.0|39.0|Standard Deviation|6.68|6.68|||
3741634|NCT02014584|3576860|B2|||Age||Years|Mean|39.1|39.1|Standard Deviation|6.65|6.65|||
3741635|NCT02014584|3576861|B1|||Age||Years|Mean|39.0|39.0|Standard Deviation|6.77|6.77|||
3741636|NCT02014519|3576983|B1||Male|Sex: Female, Male||Participants|Count of Participants|787|787.0||||||
3741637|NCT02014519|3576983|B1||Female|Sex: Female, Male||Participants|Count of Participants|1213|1213.0||||||
3741638|NCT02014519|3576983|B1|||Age||years|Mean|47.4|47.4|Standard Deviation|17.7|17.7|||
3741639|NCT02014480|3577040|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|207|207.0||||||
3741640|NCT02014480|3577040|B1||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3741641|NCT02014480|3577040|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3741642|NCT02014480|3577040|B1|||Age||Years|Mean|60.5|60.5|Standard Deviation|7.99|7.99|||
3741643|NCT02014467|3577062|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|484|484.0||||||
3741644|NCT02014467|3577063|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|119|119.0||||||
3741645|NCT02014467|3577064|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|365|365.0||||||
3741646|NCT02014467|3577062|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3741647|NCT02014467|3577063|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3741648|NCT02014467|3577064|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3741649|NCT02014467|3577062|B3||Female|Sex: Female, Male||Participants|Count of Participants|484|484.0||||||
3741650|NCT02014467|3577063|B2||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3741651|NCT02014467|3577064|B1||Female|Sex: Female, Male||Participants|Count of Participants|365|365.0||||||
3741652|NCT02014467|3577062|B3|||Age||Years|Mean|69.0|69.0|Standard Deviation|6.02|6.02|||
3741653|NCT02014467|3577063|B2|||Age||Years|Mean|69.6|69.6|Standard Deviation|5.75|5.75|||
3741654|NCT02014467|3577064|B1|||Age||Years|Mean|68.9|68.9|Standard Deviation|6.10|6.1|||
3741655|NCT02014441|3577125|B1|Unknown||Herpes Simplex Virus Type 1 (HSV-1) Status|HSV-1 status at baseline was determined by HSV-1 iimmunoglobulin G (IgG).|participants|Number|3|3.0||||||
3741656|NCT02014441|3577125|B1|Positive||Herpes Simplex Virus Type 1 (HSV-1) Status|HSV-1 status at baseline was determined by HSV-1 iimmunoglobulin G (IgG).|participants|Number|40|40.0||||||
3741657|NCT02014441|3577125|B1|Negative||Herpes Simplex Virus Type 1 (HSV-1) Status|HSV-1 status at baseline was determined by HSV-1 iimmunoglobulin G (IgG).|participants|Number|17|17.0||||||
3741658|NCT02014441|3577125|B1|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|15|15.0||||||
3741659|NCT02014441|3577125|B1|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|45|45.0||||||
3741660|NCT02014441|3577125|B1|White||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
3741661|NCT02014441|3577125|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3741662|NCT02014441|3577125|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3741663|NCT02014441|3577125|B1|||Age||years|Mean|63.3|63.3|Standard Deviation|16.7|16.7|||
3741664|NCT02014402|3577217|B5|Other|Bovine Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3741665|NCT02014402|3577218|B4|Other|Bovine Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741666|NCT02014402|3577219|B3|Other|Bovine Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741667|NCT02014402|3577220|B2|Other|Bovine Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3741668|NCT02014402|3577221|B1|Other|Bovine Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741669|NCT02014402|3577217|B5|Other|Human Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741670|NCT02014402|3577218|B4|Other|Human Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741671|NCT02014402|3577219|B3|Other|Human Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741672|NCT02014402|3577220|B2|Other|Human Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741673|NCT02014402|3577221|B1|Other|Human Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741674|NCT02014402|3577217|B5|Native Hawaiian or Other Pacific Islander|Bovine Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741675|NCT02014402|3577218|B4|Native Hawaiian or Other Pacific Islander|Bovine Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741676|NCT02014402|3577219|B3|Native Hawaiian or Other Pacific Islander|Bovine Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741677|NCT02014402|3577220|B2|Native Hawaiian or Other Pacific Islander|Bovine Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741678|NCT02014402|3577221|B1|Native Hawaiian or Other Pacific Islander|Bovine Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741679|NCT02014402|3577217|B5|Native Hawaiian or Other Pacific Islander|Human Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3741680|NCT02014402|3577218|B4|Native Hawaiian or Other Pacific Islander|Human Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741681|NCT02014402|3577219|B3|Native Hawaiian or Other Pacific Islander|Human Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741682|NCT02014402|3577220|B2|Native Hawaiian or Other Pacific Islander|Human Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3741683|NCT02014402|3577221|B1|Native Hawaiian or Other Pacific Islander|Human Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741684|NCT02014402|3577217|B5|American Indian or Alaskan Native|Bovine Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3741685|NCT02014402|3577218|B4|American Indian or Alaskan Native|Bovine Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3741686|NCT02014402|3577219|B3|American Indian or Alaskan Native|Bovine Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741687|NCT02014402|3577220|B2|American Indian or Alaskan Native|Bovine Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741688|NCT02014402|3577221|B1|American Indian or Alaskan Native|Bovine Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741689|NCT02014402|3577217|B5|American Indian or Alaskan Native|Human Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3741690|NCT02014402|3577218|B4|American Indian or Alaskan Native|Human Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741691|NCT02014402|3577219|B3|American Indian or Alaskan Native|Human Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741692|NCT02014402|3577220|B2|American Indian or Alaskan Native|Human Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3741693|NCT02014402|3577221|B1|American Indian or Alaskan Native|Human Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741694|NCT02014402|3577217|B5|Asian|Bovine Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3741695|NCT02014402|3577218|B4|Asian|Bovine Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741696|NCT02014402|3577219|B3|Asian|Bovine Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741697|NCT02014402|3577220|B2|Asian|Bovine Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3741698|NCT02014402|3577221|B1|Asian|Bovine Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741699|NCT02014402|3577217|B5|Asian|Human Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3741700|NCT02014402|3577218|B4|Asian|Human Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741701|NCT02014402|3577219|B3|Asian|Human Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3741702|NCT02014402|3577220|B2|Asian|Human Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741703|NCT02014402|3577221|B1|Asian|Human Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741704|NCT02014402|3577217|B5|Black or African American|Bovine Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3741705|NCT02014402|3577218|B4|Black or African American|Bovine Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741706|NCT02014402|3577219|B3|Black or African American|Bovine Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3741707|NCT02014402|3577220|B2|Black or African American|Bovine Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3741708|NCT02014402|3577221|B1|Black or African American|Bovine Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3741709|NCT02014402|3577217|B5|Black or African American|Human Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3741710|NCT02014402|3577218|B4|Black or African American|Human Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3741711|NCT02014402|3577219|B3|Black or African American|Human Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3741712|NCT02014402|3577220|B2|Black or African American|Human Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3741713|NCT02014402|3577221|B1|Black or African American|Human Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3741714|NCT02014402|3577217|B5|White (Caucasian)|Bovine Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
3741715|NCT02014402|3577218|B4|White (Caucasian)|Bovine Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3741716|NCT02014402|3577219|B3|White (Caucasian)|Bovine Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3741717|NCT02014402|3577220|B2|White (Caucasian)|Bovine Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3741718|NCT02014402|3577221|B1|White (Caucasian)|Bovine Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3741719|NCT02014402|3577217|B5|White (Caucasian)|Human Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|97|97.0||||||
3741720|NCT02014402|3577218|B4|White (Caucasian)|Human Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|55|55.0||||||
3741721|NCT02014402|3577219|B3|White (Caucasian)|Human Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3741722|NCT02014402|3577220|B2|White (Caucasian)|Human Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3741723|NCT02014402|3577221|B1|White (Caucasian)|Human Thrombin|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3741724|NCT02014402|3577217|B5|Bovine Thrombin|Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3741725|NCT02014402|3577218|B4|Bovine Thrombin|Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3741726|NCT02014402|3577219|B3|Bovine Thrombin|Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3741727|NCT02014402|3577220|B2|Bovine Thrombin|Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3741728|NCT02014402|3577221|B1|Bovine Thrombin|Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3741729|NCT02014402|3577217|B5|Bovine Thrombin|Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3741730|NCT02014402|3577218|B4|Bovine Thrombin|Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3741731|NCT02014402|3577219|B3|Bovine Thrombin|Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3741732|NCT02014402|3577220|B2|Bovine Thrombin|Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3741733|NCT02014402|3577221|B1|Bovine Thrombin|Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3741734|NCT02014402|3577217|B5|Human Thrombin|Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3741735|NCT02014402|3577218|B4|Human Thrombin|Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3741736|NCT02014402|3577219|B3|Human Thrombin|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3741737|NCT02014402|3577220|B2|Human Thrombin|Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3741738|NCT02014402|3577221|B1|Human Thrombin|Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3741739|NCT02014402|3577217|B5|Human Thrombin|Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3741740|NCT02014402|3577218|B4|Human Thrombin|Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3741741|NCT02014402|3577219|B3|Human Thrombin|Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3741742|NCT02014402|3577220|B2|Human Thrombin|Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3741743|NCT02014402|3577221|B1|Human Thrombin|Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3741744|NCT02014402|3577217|B5|>=65|Bovine Thrombin|Age, Customized||Participants|Count of Participants|19|19.0||||||
3741745|NCT02014402|3577218|B4|>=65|Bovine Thrombin|Age, Customized||Participants|Count of Participants|8|8.0||||||
3741746|NCT02014402|3577219|B3|>=65|Bovine Thrombin|Age, Customized||Participants|Count of Participants|1|1.0||||||
3741747|NCT02014402|3577220|B2|>=65|Bovine Thrombin|Age, Customized||Participants|Count of Participants|2|2.0||||||
3741748|NCT02014402|3577221|B1|>=65|Bovine Thrombin|Age, Customized||Participants|Count of Participants|8|8.0||||||
3741749|NCT02014402|3577217|B5|>=65|Human Thrombin|Age, Customized||Participants|Count of Participants|37|37.0||||||
3741750|NCT02014402|3577218|B4|>=65|Human Thrombin|Age, Customized||Participants|Count of Participants|16|16.0||||||
3741751|NCT02014402|3577219|B3|>=65|Human Thrombin|Age, Customized||Participants|Count of Participants|3|3.0||||||
3741752|NCT02014402|3577220|B2|>=65|Human Thrombin|Age, Customized||Participants|Count of Participants|7|7.0||||||
3741753|NCT02014402|3577221|B1|>=65|Human Thrombin|Age, Customized||Participants|Count of Participants|11|11.0||||||
3741754|NCT02014402|3577217|B5|18-64|Bovine Thrombin|Age, Customized||Participants|Count of Participants|41|41.0||||||
3741755|NCT02014402|3577218|B4|18-64|Bovine Thrombin|Age, Customized||Participants|Count of Participants|19|19.0||||||
3741756|NCT02014402|3577219|B3|18-64|Bovine Thrombin|Age, Customized||Participants|Count of Participants|11|11.0||||||
3741757|NCT02014402|3577220|B2|18-64|Bovine Thrombin|Age, Customized||Participants|Count of Participants|8|8.0||||||
3741758|NCT02014402|3577221|B1|18-64|Bovine Thrombin|Age, Customized||Participants|Count of Participants|3|3.0||||||
3741759|NCT02014402|3577217|B5|18-64|Human Thrombin|Age, Customized||Participants|Count of Participants|82|82.0||||||
3741760|NCT02014402|3577218|B4|18-64|Human Thrombin|Age, Customized||Participants|Count of Participants|40|40.0||||||
3741761|NCT02014402|3577219|B3|18-64|Human Thrombin|Age, Customized||Participants|Count of Participants|20|20.0||||||
3741762|NCT02014402|3577220|B2|18-64|Human Thrombin|Age, Customized||Participants|Count of Participants|13|13.0||||||
3741763|NCT02014402|3577221|B1|18-64|Human Thrombin|Age, Customized||Participants|Count of Participants|9|9.0||||||
3741764|NCT02014402|3577217|B5|12-17|Bovine Thrombin|Age, Customized||Participants|Count of Participants|1|1.0||||||
3741765|NCT02014402|3577218|B4|12-17|Bovine Thrombin|Age, Customized||Participants|Count of Participants|1|1.0||||||
3741766|NCT02014402|3577219|B3|12-17|Bovine Thrombin|Age, Customized||Participants|Count of Participants|0|0.0||||||
3741767|NCT02014402|3577220|B2|12-17|Bovine Thrombin|Age, Customized||Participants|Count of Participants|0|0.0||||||
3741768|NCT02014402|3577221|B1|12-17|Bovine Thrombin|Age, Customized||Participants|Count of Participants|0|0.0||||||
3741769|NCT02014402|3577217|B5|12-17|Human Thrombin|Age, Customized||Participants|Count of Participants|1|1.0||||||
3741770|NCT02014402|3577218|B4|12-17|Human Thrombin|Age, Customized||Participants|Count of Participants|1|1.0||||||
3741771|NCT02014402|3577219|B3|12-17|Human Thrombin|Age, Customized||Participants|Count of Participants|0|0.0||||||
3741772|NCT02014402|3577220|B2|12-17|Human Thrombin|Age, Customized||Participants|Count of Participants|0|0.0||||||
3741773|NCT02014402|3577221|B1|12-17|Human Thrombin|Age, Customized||Participants|Count of Participants|0|0.0||||||
3741774|NCT02014402|3577217|B5|Bovine Thrombin||Age||years|Mean|56.39|56.39|Standard Deviation|16.464|16.464|||
3741775|NCT02014402|3577218|B4|Bovine Thrombin||Age||years|Mean|54.04|54.04|Standard Deviation|17.240|17.24|||
3741776|NCT02014402|3577219|B3|Bovine Thrombin||Age||years|Mean|47.67|47.67|Standard Deviation|12.434|12.434|||
3741777|NCT02014402|3577220|B2|Bovine Thrombin||Age||years|Mean|56.50|56.5|Standard Deviation|14.455|14.455|||
3741778|NCT02014402|3577221|B1|Bovine Thrombin||Age||years|Mean|71.82|71.82|Standard Deviation|9.857|9.857|||
3741779|NCT02014402|3577217|B5|Human Thrombin||Age||years|Mean|55.54|55.54|Standard Deviation|16.017|16.017|||
3741780|NCT02014402|3577218|B4|Human Thrombin||Age||years|Mean|54.32|54.32|Standard Deviation|16.733|16.733|||
3741781|NCT02014402|3577219|B3|Human Thrombin||Age||years|Mean|47.52|47.52|Standard Deviation|13.885|13.885|||
3741782|NCT02014402|3577220|B2|Human Thrombin||Age||years|Mean|57.50|57.5|Standard Deviation|13.987|13.987|||
3741783|NCT02014402|3577221|B1|Human Thrombin||Age||years|Mean|66.30|66.3|Standard Deviation|12.427|12.427|||
3741784|NCT02014363|3577251|B4|United Kingdom||Region of Enrollment||Participants|Count of Participants|164|164.0||||||
3741785|NCT02014363|3577252|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|55|55.0||||||
3741786|NCT02014363|3577253|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
3741787|NCT02014363|3577254|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|55|55.0||||||
3741788|NCT02014363|3577251|B4||Male|Gender||Participants|Count of Participants|115|115.0||||||
3741789|NCT02014363|3577252|B3||Male|Gender||Participants|Count of Participants|36|36.0||||||
3741790|NCT02014363|3577253|B2||Male|Gender||Participants|Count of Participants|40|40.0||||||
3741791|NCT02014363|3577254|B1||Male|Gender||Participants|Count of Participants|39|39.0||||||
3741792|NCT02014363|3577251|B4||Female|Gender||Participants|Count of Participants|49|49.0||||||
3741793|NCT02014363|3577252|B3||Female|Gender||Participants|Count of Participants|19|19.0||||||
3741794|NCT02014363|3577253|B2||Female|Gender||Participants|Count of Participants|14|14.0||||||
3741795|NCT02014363|3577254|B1||Female|Gender||Participants|Count of Participants|16|16.0||||||
3741796|NCT02014363|3577251|B4|||Age||years|Mean|38.8|38.8|Standard Deviation|12.18|12.18|||
3741797|NCT02014363|3577252|B3|||Age||years|Mean|35.6|35.6|Standard Deviation|11.95|11.95|||
3741798|NCT02014363|3577253|B2|||Age||years|Mean|41.1|41.1|Standard Deviation|12.74|12.74|||
3741799|NCT02014363|3577254|B1|||Age||years|Mean|39.8|39.8|Standard Deviation|11.85|11.85|||
3741800|NCT02014363|3577251|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3741801|NCT02014363|3577252|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3741802|NCT02014363|3577253|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3741803|NCT02014363|3577254|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3741804|NCT02014363|3577251|B4||Between 18 and 65 years|Age||Participants|Count of Participants|164|164.0||||||
3741805|NCT02014363|3577252|B3||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
3741806|NCT02014363|3577253|B2||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3741807|NCT02014363|3577254|B1||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
3741808|NCT02014363|3577251|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3741809|NCT02014363|3577252|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3741810|NCT02014363|3577253|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3741811|NCT02014363|3577254|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3741812|NCT02014272|3577264|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3741813|NCT02014272|3577264|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3741814|NCT02014272|3577264|B1|||Age||years|Mean|31.5|31.5|Standard Deviation|7.1|7.1|||
3741815|NCT02014051|3577283|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3741816|NCT02014051|3577283|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3741817|NCT02014051|3577283|B1|80- years||Age, Customized||participants|Number|1|1.0||||||
3741818|NCT02014051|3577283|B1|70-79 years||Age, Customized||participants|Number|4|4.0||||||
3741819|NCT02014051|3577283|B1|60-69 years||Age, Customized||participants|Number|3|3.0||||||
3741820|NCT02014051|3577283|B1|50-59 years||Age, Customized||participants|Number|1|1.0||||||
3741821|NCT02013830|3577297|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3741822|NCT02013830|3577297|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3741823|NCT02013830|3577297|B1|||Age||years|Mean|52|52.0|Standard Deviation|14.91|14.91|||
3741824|NCT02013817|3577308|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3741825|NCT02013817|3577308|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3741826|NCT02013817|3577308|B1|||Age||years|Mean|61.0|61.0|Standard Deviation|10.1|10.1|||
3741827|NCT02013791|3577317|B10|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3741828|NCT02013791|3577318|B9|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3741829|NCT02013791|3577319|B8|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3741830|NCT02013791|3577320|B7|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3741831|NCT02013791|3577321|B6|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3741832|NCT02013791|3577322|B5|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3741833|NCT02013791|3577323|B4|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3741834|NCT02013791|3577324|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3741835|NCT02013791|3577325|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3741836|NCT02013791|3577326|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3741837|NCT02013791|3577317|B10|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3741838|NCT02013791|3577318|B9|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741839|NCT02013791|3577319|B8|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741840|NCT02013791|3577320|B7|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3741841|NCT02013791|3577321|B6|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3741842|NCT02013791|3577322|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3741843|NCT02013791|3577323|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3741844|NCT02013791|3577324|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741845|NCT02013791|3577325|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3741846|NCT02013791|3577326|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741847|NCT02013791|3577317|B10|Black||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3741848|NCT02013791|3577318|B9|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741849|NCT02013791|3577319|B8|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741850|NCT02013791|3577320|B7|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741851|NCT02013791|3577321|B6|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3741852|NCT02013791|3577322|B5|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741853|NCT02013791|3577323|B4|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3741854|NCT02013791|3577324|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3741855|NCT02013791|3577325|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741856|NCT02013791|3577326|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3741857|NCT02013791|3577317|B10|White||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3741858|NCT02013791|3577318|B9|White||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3741859|NCT02013791|3577319|B8|White||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3741860|NCT02013791|3577320|B7|White||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741861|NCT02013791|3577321|B6|White||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3741862|NCT02013791|3577322|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3741863|NCT02013791|3577323|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3741864|NCT02013791|3577324|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3741865|NCT02013791|3577325|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3741866|NCT02013791|3577326|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3741867|NCT02013791|3577317|B10||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3741868|NCT02013791|3577318|B9||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3741869|NCT02013791|3577319|B8||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3741870|NCT02013791|3577320|B7||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3741871|NCT02013791|3577321|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3741872|NCT02013791|3577322|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3741873|NCT02013791|3577323|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3741874|NCT02013791|3577324|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3741875|NCT02013791|3577325|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3741876|NCT02013791|3577326|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3741877|NCT02013791|3577317|B10||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3741878|NCT02013791|3577318|B9||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3741879|NCT02013791|3577319|B8||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3741880|NCT02013791|3577320|B7||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3741881|NCT02013791|3577321|B6||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3741882|NCT02013791|3577322|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3741883|NCT02013791|3577323|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3741884|NCT02013791|3577324|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3741885|NCT02013791|3577325|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3741886|NCT02013791|3577326|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3741887|NCT02013791|3577317|B10|>65 years||Age, Customized||Participants|Count of Participants|9|9.0||||||
3741888|NCT02013791|3577318|B9|>65 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3741889|NCT02013791|3577319|B8|>65 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3741890|NCT02013791|3577320|B7|>65 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3741891|NCT02013791|3577321|B6|>65 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
3741892|NCT02013791|3577322|B5|>65 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3741893|NCT02013791|3577323|B4|>65 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3741894|NCT02013791|3577324|B3|>65 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3741895|NCT02013791|3577325|B2|>65 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3741896|NCT02013791|3577326|B1|>65 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3741897|NCT02013791|3577317|B10|45 to 65 years||Age, Customized||Participants|Count of Participants|36|36.0||||||
3741898|NCT02013791|3577318|B9|45 to 65 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
3741899|NCT02013791|3577319|B8|45 to 65 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
3741900|NCT02013791|3577320|B7|45 to 65 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3741901|NCT02013791|3577321|B6|45 to 65 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
3741902|NCT02013791|3577322|B5|45 to 65 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
3741903|NCT02013791|3577323|B4|45 to 65 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
3741904|NCT02013791|3577324|B3|45 to 65 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
3741905|NCT02013791|3577325|B2|45 to 65 years||Age, Customized||Participants|Count of Participants|7|7.0||||||
3741906|NCT02013791|3577326|B1|45 to 65 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
3741907|NCT02013791|3577317|B10|<45 years||Age, Customized||Participants|Count of Participants|10|10.0||||||
3741908|NCT02013791|3577318|B9|<45 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3741909|NCT02013791|3577319|B8|<45 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
3741910|NCT02013791|3577320|B7|<45 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
3741911|NCT02013791|3577321|B6|<45 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3741912|NCT02013791|3577322|B5|<45 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3741913|NCT02013791|3577323|B4|<45 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
3741914|NCT02013791|3577324|B3|<45 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3741915|NCT02013791|3577325|B2|<45 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3741916|NCT02013791|3577326|B1|<45 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
3741917|NCT02013791|3577317|B10|||Age||years|Mean|54.0|54.0|Standard Deviation|11.19|11.19|||
3741918|NCT02013791|3577318|B9|||Age||years|Mean|56.0|56.0|Standard Deviation|7.55|7.55|||
3741919|NCT02013791|3577319|B8|||Age||years|Mean|53.1|53.1|Standard Deviation|12.19|12.19|||
3741920|NCT02013791|3577320|B7|||Age||years|Mean|52.8|52.8|Standard Deviation|13.45|13.45|||
3741921|NCT02013791|3577321|B6|||Age||years|Mean|57.4|57.4|Standard Deviation|10.69|10.69|||
3741922|NCT02013791|3577322|B5|||Age||years|Mean|52.3|52.3|Standard Deviation|11.64|11.64|||
3741923|NCT02013791|3577323|B4|||Age||years|Mean|50.1|50.1|Standard Deviation|15.06|15.06|||
3741924|NCT02013791|3577324|B3|||Age||years|Mean|58.5|58.5|Standard Deviation|6.95|6.95|||
3741925|NCT02013791|3577325|B2|||Age||years|Mean|55.3|55.3|Standard Deviation|6.58|6.58|||
3741926|NCT02013791|3577326|B1|||Age||years|Mean|52.8|52.8|Standard Deviation|14.47|14.47|||
3741927|NCT02013765|3577355|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3741928|NCT02013765|3577355|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3741929|NCT02013765|3577355|B1|||Age||years|Mean|67.4|67.4|Standard Deviation|8.2|8.2|60.0|81.0|
3741930|NCT02013687|3577365|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741931|NCT02013687|3577366|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741932|NCT02013687|3577367|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741933|NCT02013687|3577368|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741934|NCT02013687|3577369|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741935|NCT02013687|3577365|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741936|NCT02013687|3577366|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741937|NCT02013687|3577367|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741938|NCT02013687|3577368|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741939|NCT02013687|3577369|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741940|NCT02013687|3577365|B5||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3741941|NCT02013687|3577366|B4||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3741942|NCT02013687|3577367|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3741943|NCT02013687|3577368|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3741944|NCT02013687|3577369|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3741945|NCT02013687|3577365|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3741946|NCT02013687|3577366|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3741947|NCT02013687|3577367|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3741948|NCT02013687|3577368|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3741949|NCT02013687|3577369|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3741950|NCT02013687|3577365|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741951|NCT02013687|3577366|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741952|NCT02013687|3577367|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741953|NCT02013687|3577368|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741954|NCT02013687|3577369|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741955|NCT02013687|3577365|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3741956|NCT02013687|3577366|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741957|NCT02013687|3577367|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741958|NCT02013687|3577368|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3741959|NCT02013687|3577369|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741960|NCT02013687|3577365|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741961|NCT02013687|3577366|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741962|NCT02013687|3577367|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741963|NCT02013687|3577368|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741964|NCT02013687|3577369|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741965|NCT02013687|3577365|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3741966|NCT02013687|3577366|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3741967|NCT02013687|3577367|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741968|NCT02013687|3577368|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741969|NCT02013687|3577369|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3741970|NCT02013687|3577365|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3741971|NCT02013687|3577366|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3741972|NCT02013687|3577367|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3741973|NCT02013687|3577368|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3741974|NCT02013687|3577369|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3741975|NCT02013687|3577365|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3741976|NCT02013687|3577366|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3741977|NCT02013687|3577367|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3741978|NCT02013687|3577368|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3741979|NCT02013687|3577369|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3741980|NCT02013687|3577365|B5||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3741981|NCT02013687|3577366|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3741982|NCT02013687|3577367|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3741983|NCT02013687|3577368|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3741984|NCT02013687|3577369|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3741985|NCT02013687|3577365|B5||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3741986|NCT02013687|3577366|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3741987|NCT02013687|3577367|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3741988|NCT02013687|3577368|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3741989|NCT02013687|3577369|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3741990|NCT02013687|3577365|B5|||Age, Customized||years|Mean|34.3|34.3|Standard Deviation|8.82|8.82|||
3741991|NCT02013687|3577366|B4|||Age, Customized||years|Mean|30.6|30.6|Standard Deviation|8.86|8.86|||
3741992|NCT02013687|3577367|B3|||Age, Customized||years|Mean|36.1|36.1|Standard Deviation|8.96|8.96|||
3741993|NCT02013687|3577368|B2|||Age, Customized||years|Mean|36.7|36.7|Standard Deviation|6.59|6.59|||
3741994|NCT02013687|3577369|B1|||Age, Customized||years|Mean|36.8|36.8|Standard Deviation|8.93|8.93|||
3741995|NCT02013622|3577402|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3741996|NCT02013622|3577402|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3741997|NCT02013622|3577402|B1|||Age||Years|Mean|26.1|26.1|Standard Deviation|5.0|5.0|||
3741998|NCT02013609|3577422|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3741999|NCT02013609|3577422|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3742000|NCT02013609|3577422|B1|||Age||Years|Mean|26.6|26.6|Standard Deviation|4.9|4.9|||
3742001|NCT02013544|3577445|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3742002|NCT02013544|3577446|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3742003|NCT02013544|3577447|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3742004|NCT02013544|3577445|B3|Native hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3742005|NCT02013544|3577446|B2|Native hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3742006|NCT02013544|3577447|B1|Native hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3742007|NCT02013544|3577445|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3742008|NCT02013544|3577446|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3742009|NCT02013544|3577447|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3742010|NCT02013544|3577445|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3742011|NCT02013544|3577446|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3742012|NCT02013544|3577447|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3742013|NCT02013544|3577445|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
3742014|NCT02013544|3577446|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3742015|NCT02013544|3577447|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3742016|NCT02013544|3577445|B3|White Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|501|501.0||||||
3742017|NCT02013544|3577446|B2|White Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|338|338.0||||||
3742018|NCT02013544|3577447|B1|White Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|163|163.0||||||
3742019|NCT02013544|3577445|B3|Female||Sex/Gender, Customized||Participants|Count of Participants|554|554.0||||||
3742020|NCT02013544|3577446|B2|Female||Sex/Gender, Customized||Participants|Count of Participants|374|374.0||||||
3742021|NCT02013544|3577447|B1|Female||Sex/Gender, Customized||Participants|Count of Participants|180|180.0||||||
3742022|NCT02013544|3577445|B3|||Age||years|Mean|59.53|59.53|Standard Deviation|6.46|6.46|||
3742023|NCT02013544|3577446|B2|||Age||years|Mean|59.51|59.51|Standard Deviation|6.78|6.78|||
3742024|NCT02013544|3577447|B1|||Age||years|Mean|59.55|59.55|Standard Deviation|5.75|5.75|||
3742025|NCT02013531|3577470|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3742026|NCT02013531|3577470|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3742027|NCT02013531|3577470|B1|||Age||Years|Mean|45.7|45.7|Standard Deviation|15.2|15.2|||
3742028|NCT02013388|3577492|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742029|NCT02013388|3577493|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742030|NCT02013388|3577494|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742031|NCT02013388|3577495|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742032|NCT02013388|3577496|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742033|NCT02013388|3577497|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742034|NCT02013388|3577498|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742035|NCT02013388|3577499|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742036|NCT02013388|3577500|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742037|NCT02013388|3577492|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3742038|NCT02013388|3577493|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742039|NCT02013388|3577494|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742040|NCT02013388|3577495|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742041|NCT02013388|3577496|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742042|NCT02013388|3577497|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742043|NCT02013388|3577498|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742044|NCT02013388|3577499|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742045|NCT02013388|3577500|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3742046|NCT02013388|3577492|B9||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3742047|NCT02013388|3577493|B8||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3742048|NCT02013388|3577494|B7||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3742049|NCT02013388|3577495|B6||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3742050|NCT02013388|3577496|B5||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3742051|NCT02013388|3577497|B4||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3742052|NCT02013388|3577498|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3742053|NCT02013388|3577499|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3742054|NCT02013388|3577500|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3742055|NCT02013388|3577492|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742056|NCT02013388|3577493|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742057|NCT02013388|3577494|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742058|NCT02013388|3577495|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742059|NCT02013388|3577496|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742060|NCT02013388|3577497|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742061|NCT02013388|3577498|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742062|NCT02013388|3577499|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742063|NCT02013388|3577500|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742064|NCT02013388|3577492|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742065|NCT02013388|3577493|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742066|NCT02013388|3577494|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742067|NCT02013388|3577495|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742068|NCT02013388|3577496|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742069|NCT02013388|3577497|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742070|NCT02013388|3577498|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742071|NCT02013388|3577499|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742072|NCT02013388|3577500|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742073|NCT02013388|3577492|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742074|NCT02013388|3577493|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742075|NCT02013388|3577494|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742076|NCT02013388|3577495|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742077|NCT02013388|3577496|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742078|NCT02013388|3577497|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742079|NCT02013388|3577498|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742080|NCT02013388|3577499|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742081|NCT02013388|3577500|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742082|NCT02013388|3577492|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742083|NCT02013388|3577493|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742084|NCT02013388|3577494|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742085|NCT02013388|3577495|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742086|NCT02013388|3577496|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742087|NCT02013388|3577497|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742088|NCT02013388|3577498|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742089|NCT02013388|3577499|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742090|NCT02013388|3577500|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742091|NCT02013388|3577492|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742092|NCT02013388|3577493|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742093|NCT02013388|3577494|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742094|NCT02013388|3577495|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742095|NCT02013388|3577496|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742096|NCT02013388|3577497|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742097|NCT02013388|3577498|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742098|NCT02013388|3577499|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742099|NCT02013388|3577500|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742100|NCT02013388|3577492|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3742101|NCT02013388|3577493|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3742102|NCT02013388|3577494|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3742103|NCT02013388|3577495|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3742104|NCT02013388|3577496|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3742105|NCT02013388|3577497|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3742106|NCT02013388|3577498|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3742107|NCT02013388|3577499|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3742108|NCT02013388|3577500|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3742109|NCT02013388|3577492|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3742110|NCT02013388|3577493|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742111|NCT02013388|3577494|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742112|NCT02013388|3577495|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742113|NCT02013388|3577496|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742114|NCT02013388|3577497|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742115|NCT02013388|3577498|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742116|NCT02013388|3577499|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742117|NCT02013388|3577500|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3742118|NCT02013388|3577492|B9||Male|Gender||Participants|Count of Participants|33|33.0||||||
3742119|NCT02013388|3577493|B8||Male|Gender||Participants|Count of Participants|2|2.0||||||
3742120|NCT02013388|3577494|B7||Male|Gender||Participants|Count of Participants|4|4.0||||||
3742121|NCT02013388|3577495|B6||Male|Gender||Participants|Count of Participants|6|6.0||||||
3742122|NCT02013388|3577496|B5||Male|Gender||Participants|Count of Participants|1|1.0||||||
3742123|NCT02013388|3577497|B4||Male|Gender||Participants|Count of Participants|4|4.0||||||
3742124|NCT02013388|3577498|B3||Male|Gender||Participants|Count of Participants|4|4.0||||||
3742125|NCT02013388|3577499|B2||Male|Gender||Participants|Count of Participants|4|4.0||||||
3742126|NCT02013388|3577500|B1||Male|Gender||Participants|Count of Participants|8|8.0||||||
3742127|NCT02013388|3577492|B9||Female|Gender||Participants|Count of Participants|16|16.0||||||
3742128|NCT02013388|3577493|B8||Female|Gender||Participants|Count of Participants|2|2.0||||||
3742129|NCT02013388|3577494|B7||Female|Gender||Participants|Count of Participants|2|2.0||||||
3742130|NCT02013388|3577495|B6||Female|Gender||Participants|Count of Participants|0|0.0||||||
3742131|NCT02013388|3577496|B5||Female|Gender||Participants|Count of Participants|5|5.0||||||
3742132|NCT02013388|3577497|B4||Female|Gender||Participants|Count of Participants|2|2.0||||||
3742133|NCT02013388|3577498|B3||Female|Gender||Participants|Count of Participants|2|2.0||||||
3742134|NCT02013388|3577499|B2||Female|Gender||Participants|Count of Participants|2|2.0||||||
3742135|NCT02013388|3577500|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
3742136|NCT02013388|3577492|B9|||Age||years|Mean|39.1|39.1|Standard Deviation|11.40|11.4|||
3742137|NCT02013388|3577493|B8|||Age||years|Mean|41.3|41.3|Standard Deviation|11.59|11.59|||
3742138|NCT02013388|3577494|B7|||Age||years|Mean|37.8|37.8|Standard Deviation|11.84|11.84|||
3742139|NCT02013388|3577495|B6|||Age||years|Mean|42.3|42.3|Standard Deviation|9.40|9.4|||
3742140|NCT02013388|3577496|B5|||Age||years|Mean|37.3|37.3|Standard Deviation|10.91|10.91|||
3742141|NCT02013388|3577497|B4|||Age||years|Mean|39.7|39.7|Standard Deviation|10.03|10.03|||
3742142|NCT02013388|3577498|B3|||Age||years|Mean|40.2|40.2|Standard Deviation|14.25|14.25|||
3742143|NCT02013388|3577499|B2|||Age||years|Mean|41.3|41.3|Standard Deviation|14.90|14.9|||
3742144|NCT02013388|3577500|B1|||Age||years|Mean|35.6|35.6|Standard Deviation|12.32|12.32|||
3742145|NCT02013245|3577541|B5|Switzerland||Region of Enrollment||participants|Number|36|36.0||||||
3742146|NCT02013245|3577542|B4|Switzerland||Region of Enrollment||participants|Number|9|9.0||||||
3742147|NCT02013245|3577543|B3|Switzerland||Region of Enrollment||participants|Number|9|9.0||||||
3742148|NCT02013245|3577544|B2|Switzerland||Region of Enrollment||participants|Number|9|9.0||||||
3742149|NCT02013245|3577545|B1|Switzerland||Region of Enrollment||participants|Number|9|9.0||||||
3742150|NCT02013245|3577541|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3742151|NCT02013245|3577542|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3742152|NCT02013245|3577543|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3742153|NCT02013245|3577544|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3742154|NCT02013245|3577545|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3742155|NCT02013245|3577541|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3742156|NCT02013245|3577542|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3742157|NCT02013245|3577543|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3742158|NCT02013245|3577544|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3742159|NCT02013245|3577545|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3742160|NCT02013245|3577541|B5|||Age||years|Mean|27.2|27.2|Standard Deviation|6.0|6.0|||
3742161|NCT02013245|3577542|B4|||Age||years|Mean|25.6|25.6|Standard Deviation|3.4|3.4|||
3742162|NCT02013245|3577543|B3|||Age||years|Mean|27.1|27.1|Standard Deviation|6.1|6.1|||
3742163|NCT02013245|3577544|B2|||Age||years|Mean|28.2|28.2|Standard Deviation|3.2|3.2|||
3742164|NCT02013245|3577545|B1|||Age||years|Mean|28|28.0|Standard Deviation|9.6|9.6|||
3742165|NCT02013245|3577541|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3742166|NCT02013245|3577542|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3742167|NCT02013245|3577543|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3742168|NCT02013245|3577544|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3742169|NCT02013245|3577545|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3742170|NCT02013245|3577541|B5||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3742171|NCT02013245|3577542|B4||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3742172|NCT02013245|3577543|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3742173|NCT02013245|3577544|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3742174|NCT02013245|3577545|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3742175|NCT02013245|3577541|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3742176|NCT02013245|3577542|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3742177|NCT02013245|3577543|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3742178|NCT02013245|3577544|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3742179|NCT02013245|3577545|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3742180|NCT02013206|3577562|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3742181|NCT02013206|3577563|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3742182|NCT02013206|3577564|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3742183|NCT02013206|3577562|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3742184|NCT02013206|3577563|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3742185|NCT02013206|3577564|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3742186|NCT02013206|3577562|B3|||Age||years|Mean|65|65.0|Full Range|||38.0|88.0|
3742187|NCT02013206|3577563|B2|||Age||years|Mean|66|66.0|Full Range|||42.0|88.0|
3742188|NCT02013206|3577564|B1|||Age||years|Mean|64|64.0|Full Range|||38.0|83.0|
3742189|NCT02013167|3577585|B3|HIDAC||Standard of Care Chemotherapy Regimen Received|FLAG = fludarabine, cytarabine arabinoside, and granulocyte colony-stimulating factor (filgrastim); HiDAC = high-dose cytarabine arabinoside|participants|Number|22|22.0||||||
3742190|NCT02013167|3577586|B2|HIDAC||Standard of Care Chemotherapy Regimen Received|FLAG = fludarabine, cytarabine arabinoside, and granulocyte colony-stimulating factor (filgrastim); HiDAC = high-dose cytarabine arabinoside|participants|Number|0|0.0||||||
3742191|NCT02013167|3577587|B1|HIDAC||Standard of Care Chemotherapy Regimen Received|FLAG = fludarabine, cytarabine arabinoside, and granulocyte colony-stimulating factor (filgrastim); HiDAC = high-dose cytarabine arabinoside|participants|Number|22|22.0||||||
3742192|NCT02013167|3577585|B3|Clofarabine||Standard of Care Chemotherapy Regimen Received|FLAG = fludarabine, cytarabine arabinoside, and granulocyte colony-stimulating factor (filgrastim); HiDAC = high-dose cytarabine arabinoside|participants|Number|26|26.0||||||
3742193|NCT02013167|3577586|B2|Clofarabine||Standard of Care Chemotherapy Regimen Received|FLAG = fludarabine, cytarabine arabinoside, and granulocyte colony-stimulating factor (filgrastim); HiDAC = high-dose cytarabine arabinoside|participants|Number|0|0.0||||||
3742194|NCT02013167|3577587|B1|Clofarabine||Standard of Care Chemotherapy Regimen Received|FLAG = fludarabine, cytarabine arabinoside, and granulocyte colony-stimulating factor (filgrastim); HiDAC = high-dose cytarabine arabinoside|participants|Number|26|26.0||||||
3742195|NCT02013167|3577585|B3|High-dose methotrexate||Standard of Care Chemotherapy Regimen Received|FLAG = fludarabine, cytarabine arabinoside, and granulocyte colony-stimulating factor (filgrastim); HiDAC = high-dose cytarabine arabinoside|participants|Number|30|30.0||||||
3742196|NCT02013167|3577586|B2|High-dose methotrexate||Standard of Care Chemotherapy Regimen Received|FLAG = fludarabine, cytarabine arabinoside, and granulocyte colony-stimulating factor (filgrastim); HiDAC = high-dose cytarabine arabinoside|participants|Number|0|0.0||||||
3742197|NCT02013167|3577587|B1|High-dose methotrexate||Standard of Care Chemotherapy Regimen Received|FLAG = fludarabine, cytarabine arabinoside, and granulocyte colony-stimulating factor (filgrastim); HiDAC = high-dose cytarabine arabinoside|participants|Number|30|30.0||||||
3742198|NCT02013167|3577585|B3|FLAG ± anthracycline||Standard of Care Chemotherapy Regimen Received|FLAG = fludarabine, cytarabine arabinoside, and granulocyte colony-stimulating factor (filgrastim); HiDAC = high-dose cytarabine arabinoside|participants|Number|56|56.0||||||
3742199|NCT02013167|3577586|B2|FLAG ± anthracycline||Standard of Care Chemotherapy Regimen Received|FLAG = fludarabine, cytarabine arabinoside, and granulocyte colony-stimulating factor (filgrastim); HiDAC = high-dose cytarabine arabinoside|participants|Number|0|0.0||||||
3742200|NCT02013167|3577587|B1|FLAG ± anthracycline||Standard of Care Chemotherapy Regimen Received|FLAG = fludarabine, cytarabine arabinoside, and granulocyte colony-stimulating factor (filgrastim); HiDAC = high-dose cytarabine arabinoside|participants|Number|56|56.0||||||
3742201|NCT02013167|3577585|B3|No||Prior Allogeneic Hematopoietic Stem Cell Transplant (HCST)||participants|Number|265|265.0||||||
3742202|NCT02013167|3577586|B2|No||Prior Allogeneic Hematopoietic Stem Cell Transplant (HCST)||participants|Number|177|177.0||||||
3742203|NCT02013167|3577587|B1|No||Prior Allogeneic Hematopoietic Stem Cell Transplant (HCST)||participants|Number|88|88.0||||||
3742204|NCT02013167|3577585|B3|Yes||Prior Allogeneic Hematopoietic Stem Cell Transplant (HCST)||participants|Number|140|140.0||||||
3742205|NCT02013167|3577586|B2|Yes||Prior Allogeneic Hematopoietic Stem Cell Transplant (HCST)||participants|Number|94|94.0||||||
3742206|NCT02013167|3577587|B1|Yes||Prior Allogeneic Hematopoietic Stem Cell Transplant (HCST)||participants|Number|46|46.0||||||
3742207|NCT02013167|3577585|B3|No||Prior Salvage Therapy Stratification at Randomization||participants|Number|161|161.0||||||
3742208|NCT02013167|3577586|B2|No||Prior Salvage Therapy Stratification at Randomization||participants|Number|107|107.0||||||
3742267|NCT02013167|3577585|B3|||Age||years|Mean|40.9|40.9|Standard Deviation|17.2|17.2|||
3742209|NCT02013167|3577587|B1|No||Prior Salvage Therapy Stratification at Randomization||participants|Number|54|54.0||||||
3742210|NCT02013167|3577585|B3|Yes||Prior Salvage Therapy Stratification at Randomization||participants|Number|244|244.0||||||
3742211|NCT02013167|3577586|B2|Yes||Prior Salvage Therapy Stratification at Randomization||participants|Number|164|164.0||||||
3742212|NCT02013167|3577587|B1|Yes||Prior Salvage Therapy Stratification at Randomization||participants|Number|80|80.0||||||
3742213|NCT02013167|3577585|B3|≥ 35 years||Age Stratification at Randomization||participants|Number|222|222.0||||||
3742214|NCT02013167|3577586|B2|≥ 35 years||Age Stratification at Randomization||participants|Number|148|148.0||||||
3742215|NCT02013167|3577587|B1|≥ 35 years||Age Stratification at Randomization||participants|Number|74|74.0||||||
3742216|NCT02013167|3577585|B3|< 35 years||Age Stratification at Randomization||participants|Number|183|183.0||||||
3742217|NCT02013167|3577586|B2|< 35 years||Age Stratification at Randomization||participants|Number|123|123.0||||||
3742218|NCT02013167|3577587|B1|< 35 years||Age Stratification at Randomization||participants|Number|60|60.0||||||
3742219|NCT02013167|3577585|B3|Other||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3742220|NCT02013167|3577586|B2|Other||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3742221|NCT02013167|3577587|B1|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3742222|NCT02013167|3577585|B3|Multiple||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3742223|NCT02013167|3577586|B2|Multiple||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3742224|NCT02013167|3577587|B1|Multiple||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3742225|NCT02013167|3577585|B3|White||Race/Ethnicity, Customized||participants|Number|340|340.0||||||
3742226|NCT02013167|3577586|B2|White||Race/Ethnicity, Customized||participants|Number|228|228.0||||||
3742227|NCT02013167|3577587|B1|White||Race/Ethnicity, Customized||participants|Number|112|112.0||||||
3742228|NCT02013167|3577585|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3742229|NCT02013167|3577586|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3742230|NCT02013167|3577587|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3742231|NCT02013167|3577585|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3742232|NCT02013167|3577586|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3742233|NCT02013167|3577587|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3742234|NCT02013167|3577585|B3|Asian||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3742235|NCT02013167|3577586|B2|Asian||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3742236|NCT02013167|3577587|B1|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3742237|NCT02013167|3577585|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3742238|NCT02013167|3577586|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3742239|NCT02013167|3577587|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3742240|NCT02013167|3577585|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3742241|NCT02013167|3577586|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3742242|NCT02013167|3577587|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3742243|NCT02013167|3577585|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|365|365.0||||||
3742244|NCT02013167|3577586|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|243|243.0||||||
3742245|NCT02013167|3577587|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
3742246|NCT02013167|3577585|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3742247|NCT02013167|3577586|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3742248|NCT02013167|3577587|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3742249|NCT02013167|3577585|B3||Male|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
3742250|NCT02013167|3577586|B2||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3742251|NCT02013167|3577587|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3742252|NCT02013167|3577585|B3||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3742253|NCT02013167|3577586|B2||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3742254|NCT02013167|3577587|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3742255|NCT02013167|3577585|B3|≥ 65 years||Age, Customized||participants|Number|48|48.0||||||
3742256|NCT02013167|3577586|B2|≥ 65 years||Age, Customized||participants|Number|33|33.0||||||
3742257|NCT02013167|3577587|B1|≥ 65 years||Age, Customized||participants|Number|15|15.0||||||
3742258|NCT02013167|3577585|B3|55 to 64 years||Age, Customized||participants|Number|60|60.0||||||
3742259|NCT02013167|3577586|B2|55 to 64 years||Age, Customized||participants|Number|34|34.0||||||
3742260|NCT02013167|3577587|B1|55 to 64 years||Age, Customized||participants|Number|26|26.0||||||
3742261|NCT02013167|3577585|B3|35 to 54 years||Age, Customized||participants|Number|113|113.0||||||
3742262|NCT02013167|3577586|B2|35 to 54 years||Age, Customized||participants|Number|80|80.0||||||
3742263|NCT02013167|3577587|B1|35 to 54 years||Age, Customized||participants|Number|33|33.0||||||
3742264|NCT02013167|3577585|B3|< 35 years||Age, Customized||participants|Number|184|184.0||||||
3742265|NCT02013167|3577586|B2|< 35 years||Age, Customized||participants|Number|124|124.0||||||
3742266|NCT02013167|3577587|B1|< 35 years||Age, Customized||participants|Number|60|60.0||||||
3742268|NCT02013167|3577586|B2|||Age||years|Mean|40.8|40.8|Standard Deviation|17.1|17.1|||
3742269|NCT02013167|3577587|B1|||Age||years|Mean|41.1|41.1|Standard Deviation|17.3|17.3|||
3742270|NCT02013050|3577615|B5|United States||Region of Enrollment||participants|Number|109|109.0||||||
3742271|NCT02013050|3577616|B4|United States||Region of Enrollment||participants|Number|23|23.0||||||
3742272|NCT02013050|3577617|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3742273|NCT02013050|3577618|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
3742274|NCT02013050|3577619|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
3742275|NCT02013050|3577615|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742276|NCT02013050|3577616|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742277|NCT02013050|3577617|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742278|NCT02013050|3577618|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742279|NCT02013050|3577619|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742280|NCT02013050|3577615|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742281|NCT02013050|3577616|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742282|NCT02013050|3577617|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742283|NCT02013050|3577618|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742284|NCT02013050|3577619|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742285|NCT02013050|3577615|B5||White|Race (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
3742286|NCT02013050|3577616|B4||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3742287|NCT02013050|3577617|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3742288|NCT02013050|3577618|B2||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3742289|NCT02013050|3577619|B1||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3742290|NCT02013050|3577615|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3742291|NCT02013050|3577616|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3742292|NCT02013050|3577617|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742293|NCT02013050|3577618|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3742294|NCT02013050|3577619|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3742295|NCT02013050|3577615|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3742296|NCT02013050|3577616|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742297|NCT02013050|3577617|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742298|NCT02013050|3577618|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742299|NCT02013050|3577619|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3742300|NCT02013050|3577615|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3742301|NCT02013050|3577616|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3742302|NCT02013050|3577617|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742303|NCT02013050|3577618|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742304|NCT02013050|3577619|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3742305|NCT02013050|3577615|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742306|NCT02013050|3577616|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742307|NCT02013050|3577617|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742308|NCT02013050|3577618|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742309|NCT02013050|3577619|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742310|NCT02013050|3577615|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3742311|NCT02013050|3577616|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742312|NCT02013050|3577617|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742313|NCT02013050|3577618|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3742314|NCT02013050|3577619|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3742315|NCT02013050|3577615|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
3742316|NCT02013050|3577616|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3742317|NCT02013050|3577617|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3742318|NCT02013050|3577618|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3742319|NCT02013050|3577619|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3742320|NCT02013050|3577615|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3742321|NCT02013050|3577616|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3742322|NCT02013050|3577617|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742323|NCT02013050|3577618|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3742324|NCT02013050|3577619|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3742325|NCT02013050|3577615|B5||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3742326|NCT02013050|3577616|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3742327|NCT02013050|3577617|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3742328|NCT02013050|3577618|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3742329|NCT02013050|3577619|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3742330|NCT02013050|3577615|B5||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3742331|NCT02013050|3577616|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3742332|NCT02013050|3577617|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3742333|NCT02013050|3577618|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3742334|NCT02013050|3577619|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3742335|NCT02013050|3577615|B5||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3742336|NCT02013050|3577616|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3742337|NCT02013050|3577617|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3742338|NCT02013050|3577618|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3742339|NCT02013050|3577619|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3742340|NCT02013050|3577615|B5||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
3742341|NCT02013050|3577616|B4||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3742342|NCT02013050|3577617|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3742343|NCT02013050|3577618|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3742344|NCT02013050|3577619|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3742345|NCT02013050|3577615|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3742346|NCT02013050|3577616|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3742347|NCT02013050|3577617|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3742348|NCT02013050|3577618|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3742349|NCT02013050|3577619|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3742350|NCT02012959|3577664|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3742351|NCT02012959|3577664|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3742352|NCT02012959|3577664|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3742353|NCT02012959|3577664|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3742354|NCT02012959|3577664|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3742355|NCT02012959|3577664|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3742356|NCT02012959|3577664|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3742357|NCT02012959|3577664|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3742358|NCT02012959|3577664|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3742359|NCT02012959|3577664|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3742360|NCT02012959|3577664|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3742361|NCT02012959|3577664|B1|||Age||years|Mean|6.1|6.1|Standard Deviation|5.1|5.1|||
3742362|NCT02012686|3577679|B3|||Neck extension time|neck extension time: neck extension position time for thyroidectomy (Just after general anesthesia, the neck of patient was extended. The position was kept before awakening)|minutes|Mean|80|80.0|Standard Deviation|28|28.0|||
3742363|NCT02012686|3577680|B2|||Neck extension time|neck extension time: neck extension position time for thyroidectomy (Just after general anesthesia, the neck of patient was extended. The position was kept before awakening)|minutes|Mean|81|81.0|Standard Deviation|31|31.0|||
3742364|NCT02012686|3577681|B1|||Neck extension time|neck extension time: neck extension position time for thyroidectomy (Just after general anesthesia, the neck of patient was extended. The position was kept before awakening)|minutes|Mean|80|80.0|Standard Deviation|25|25.0|||
3742365|NCT02012686|3577679|B3|||Body mass index||kg/m^2|Mean|23|23.0|Standard Deviation|3|3.0|||
3742366|NCT02012686|3577680|B2|||Body mass index||kg/m^2|Mean|23|23.0|Standard Deviation|3|3.0|||
3742367|NCT02012686|3577681|B1|||Body mass index||kg/m^2|Mean|23|23.0|Standard Deviation|3|3.0|||
3742368|NCT02012686|3577679|B3|Korea, Republic of||Region of Enrollment||participants|Number|98|98.0||||||
3742369|NCT02012686|3577680|B2|Korea, Republic of||Region of Enrollment||participants|Number|48|48.0||||||
3742370|NCT02012686|3577681|B1|Korea, Republic of||Region of Enrollment||participants|Number|50|50.0||||||
3742371|NCT02012686|3577679|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3742372|NCT02012686|3577680|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3742373|NCT02012686|3577681|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3742374|NCT02012686|3577679|B3||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3742375|NCT02012686|3577680|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3742376|NCT02012686|3577681|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3742377|NCT02012686|3577679|B3|||Age||years|Mean|44|44.0|Standard Deviation|10|10.0|||
3742378|NCT02012686|3577680|B2|||Age||years|Mean|44|44.0|Standard Deviation|9|9.0|||
3742379|NCT02012686|3577681|B1|||Age||years|Mean|44|44.0|Standard Deviation|10|10.0|||
3742380|NCT02012582|3577694|B5|Spain||Region of Enrollment||participants|Number|13|13.0||||||
3742381|NCT02012582|3577695|B4|Spain||Region of Enrollment||participants|Number|4|4.0||||||
3742382|NCT02012582|3577696|B3|Spain||Region of Enrollment||participants|Number|3|3.0||||||
3742383|NCT02012582|3577697|B2|Spain||Region of Enrollment||participants|Number|2|2.0||||||
3742384|NCT02012582|3577698|B1|Spain||Region of Enrollment||participants|Number|4|4.0||||||
3742385|NCT02012582|3577694|B5|Switzerland||Region of Enrollment||participants|Number|9|9.0||||||
3742386|NCT02012582|3577695|B4|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
3742387|NCT02012582|3577696|B3|Switzerland||Region of Enrollment||participants|Number|2|2.0||||||
3742388|NCT02012582|3577697|B2|Switzerland||Region of Enrollment||participants|Number|5|5.0||||||
3742389|NCT02012582|3577698|B1|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
3742390|NCT02012582|3577694|B5|France||Region of Enrollment||participants|Number|5|5.0||||||
3742391|NCT02012582|3577695|B4|France||Region of Enrollment||participants|Number|2|2.0||||||
3742392|NCT02012582|3577696|B3|France||Region of Enrollment||participants|Number|1|1.0||||||
3742393|NCT02012582|3577697|B2|France||Region of Enrollment||participants|Number|1|1.0||||||
3742394|NCT02012582|3577698|B1|France||Region of Enrollment||participants|Number|1|1.0||||||
3742395|NCT02012582|3577694|B5|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3742396|NCT02012582|3577695|B4|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3742397|NCT02012582|3577696|B3|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3742398|NCT02012582|3577697|B2|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3742399|NCT02012582|3577698|B1|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
3742400|NCT02012582|3577694|B5|Austria||Region of Enrollment||participants|Number|2|2.0||||||
3742401|NCT02012582|3577695|B4|Austria||Region of Enrollment||participants|Number|1|1.0||||||
3742402|NCT02012582|3577696|B3|Austria||Region of Enrollment||participants|Number|1|1.0||||||
3742403|NCT02012582|3577697|B2|Austria||Region of Enrollment||participants|Number|0|0.0||||||
3742404|NCT02012582|3577698|B1|Austria||Region of Enrollment||participants|Number|0|0.0||||||
3742405|NCT02012582|3577694|B5||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3742406|NCT02012582|3577695|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3742407|NCT02012582|3577696|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3742408|NCT02012582|3577697|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3742409|NCT02012582|3577698|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3742410|NCT02012582|3577694|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3742411|NCT02012582|3577695|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3742412|NCT02012582|3577696|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3742413|NCT02012582|3577697|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3742414|NCT02012582|3577698|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3742415|NCT02012582|3577694|B5|||Age||years|Mean|38.9|38.9|Full Range|||21.0|65.0|
3742416|NCT02012582|3577695|B4|||Age||years|Mean|35.9|35.9|Full Range|||26.0|54.0|
3742417|NCT02012582|3577696|B3|||Age||years|Mean|45.3|45.3|Full Range|||31.0|65.0|
3742418|NCT02012582|3577697|B2|||Age||years|Mean|34.8|34.8|Full Range|||21.0|61.0|
3742419|NCT02012582|3577698|B1|||Age||years|Mean|36.6|36.6|Full Range|||21.0|59.0|
3742420|NCT02012491|3577727|B3|Embryonic of fetal death||Diagnosis||Participants|Count of Participants|223|223.0||||||
3742421|NCT02012491|3577728|B2|Embryonic of fetal death||Diagnosis||Participants|Count of Participants|109|109.0||||||
3742422|NCT02012491|3577729|B1|Embryonic of fetal death||Diagnosis||Participants|Count of Participants|114|114.0||||||
3742423|NCT02012491|3577727|B3|Anembryonic gestation||Diagnosis||Participants|Count of Participants|77|77.0||||||
3742424|NCT02012491|3577728|B2|Anembryonic gestation||Diagnosis||Participants|Count of Participants|40|40.0||||||
3742425|NCT02012491|3577729|B1|Anembryonic gestation||Diagnosis||Participants|Count of Participants|37|37.0||||||
3742426|NCT02012491|3577727|B3|United States||Region of Enrollment||participants|Number|300|300.0||||||
3742427|NCT02012491|3577728|B2|United States||Region of Enrollment||participants|Number|149|149.0||||||
3742428|NCT02012491|3577729|B1|United States||Region of Enrollment||participants|Number|151|151.0||||||
3742429|NCT02012491|3577727|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3742430|NCT02012491|3577728|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3742431|NCT02012491|3577729|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3742432|NCT02012491|3577727|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742433|NCT02012491|3577728|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742434|NCT02012491|3577729|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742435|NCT02012491|3577727|B3||White|Race (NIH/OMB)||Participants|Count of Participants|109|109.0||||||
3742436|NCT02012491|3577728|B2||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3742437|NCT02012491|3577729|B1||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3742438|NCT02012491|3577727|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
3742439|NCT02012491|3577728|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3742440|NCT02012491|3577729|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3742441|NCT02012491|3577727|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742442|NCT02012491|3577728|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742443|NCT02012491|3577729|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742444|NCT02012491|3577727|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3742445|NCT02012491|3577728|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3742446|NCT02012491|3577729|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3742447|NCT02012491|3577727|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742448|NCT02012491|3577728|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742449|NCT02012491|3577729|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742450|NCT02012491|3577727|B3||Male|Sex: Female, Male|Only females where included in this study.|Participants|Count of Participants|0|0.0||||||
3742451|NCT02012491|3577728|B2||Male|Sex: Female, Male|Only females where included in this study.|Participants|Count of Participants|0|0.0||||||
3742452|NCT02012491|3577729|B1||Male|Sex: Female, Male|Only females where included in this study.|Participants|Count of Participants|0|0.0||||||
3742453|NCT02012491|3577727|B3||Female|Sex: Female, Male|Only females where included in this study.|Participants|Count of Participants|300|300.0||||||
3742454|NCT02012491|3577728|B2||Female|Sex: Female, Male|Only females where included in this study.|Participants|Count of Participants|149|149.0||||||
3742455|NCT02012491|3577729|B1||Female|Sex: Female, Male|Only females where included in this study.|Participants|Count of Participants|151|151.0||||||
3742456|NCT02012491|3577727|B3|Participant's age||Age, Customized||years|Mean|30.4|30.4|Full Range|||18.0|46.0|
3742457|NCT02012491|3577728|B2|Participant's age||Age, Customized||years|Mean|30.7|30.7|Full Range|||18.0|46.0|
3742458|NCT02012491|3577729|B1|Participant's age||Age, Customized||years|Mean|30.2|30.2|Full Range|||18.0|46.0|
3742459|NCT02012452|3577746|B3|||Clinical Administered PTSD scale|Scores range from 0-80. Higher scores indicate greater PTSD severity.|units on a scale|Mean|42.89|42.89|Standard Deviation|13.53|13.53|||
3742460|NCT02012452|3577747|B2|||Clinical Administered PTSD scale|Scores range from 0-80. Higher scores indicate greater PTSD severity.|units on a scale|Mean|50.0|50.0|Standard Deviation|8.49|8.49|||
3742461|NCT02012452|3577748|B1|||Clinical Administered PTSD scale|Scores range from 0-80. Higher scores indicate greater PTSD severity.|units on a scale|Mean|40.86|40.86|Standard Deviation|14.51|14.51|||
3742462|NCT02012452|3577746|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
3742463|NCT02012452|3577747|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3742464|NCT02012452|3577748|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3742465|NCT02012452|3577746|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742466|NCT02012452|3577747|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742467|NCT02012452|3577748|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742468|NCT02012452|3577746|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742469|NCT02012452|3577747|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742470|NCT02012452|3577748|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742471|NCT02012452|3577746|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3742472|NCT02012452|3577747|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3742473|NCT02012452|3577748|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3742474|NCT02012452|3577746|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3742475|NCT02012452|3577747|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3742476|NCT02012452|3577748|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3742477|NCT02012452|3577746|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742478|NCT02012452|3577747|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742479|NCT02012452|3577748|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742480|NCT02012452|3577746|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742481|NCT02012452|3577747|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742482|NCT02012452|3577748|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742483|NCT02012452|3577746|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742484|NCT02012452|3577747|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742485|NCT02012452|3577748|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742486|NCT02012452|3577746|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3742487|NCT02012452|3577747|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3742488|NCT02012452|3577748|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3742489|NCT02012452|3577746|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3742490|NCT02012452|3577747|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3742491|NCT02012452|3577748|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3742492|NCT02012452|3577746|B3|||Age||years|Mean|57.12|57.12|Standard Deviation|8.75|8.75|||
3742493|NCT02012452|3577747|B2|||Age||years|Mean|57.05|57.05|Standard Deviation|9.66|9.66|||
3742494|NCT02012452|3577748|B1|||Age||years|Mean|57.35|57.35|Standard Deviation|7.24|7.24|||
3742495|NCT02012218|3577757|B6||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3742496|NCT02012218|3577758|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3742497|NCT02012218|3577759|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3742498|NCT02012218|3577760|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3742499|NCT02012218|3577761|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3742500|NCT02012218|3577762|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3742501|NCT02012218|3577757|B6||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3742502|NCT02012218|3577758|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3742503|NCT02012218|3577759|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3742504|NCT02012218|3577760|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3742505|NCT02012218|3577761|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3742506|NCT02012218|3577762|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3742507|NCT02012218|3577757|B6|||Age||Years|Mean|45.6|45.6|Standard Deviation|12.44|12.44|||
3742508|NCT02012218|3577758|B5|||Age||Years|Mean|41.7|41.7|Standard Deviation|13.59|13.59|||
3742509|NCT02012218|3577759|B4|||Age||Years|Mean|44.1|44.1|Standard Deviation|13.64|13.64|||
3742510|NCT02012218|3577760|B3|||Age||Years|Mean|48.5|48.5|Standard Deviation|12.20|12.2|||
3742511|NCT02012218|3577761|B2|||Age||Years|Mean|41.8|41.8|Standard Deviation|13.57|13.57|||
3742512|NCT02012218|3577762|B1|||Age||Years|Mean|50.2|50.2|Standard Deviation|8.13|8.13|||
3742513|NCT02011893|3577778|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3742514|NCT02011893|3577778|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3742515|NCT02011893|3577778|B1|||Age||years|Mean|59.1|59.1|Standard Deviation|13.5|13.5|||
3742516|NCT02011516|3577796|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
3742517|NCT02011516|3577797|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3742518|NCT02011516|3577798|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3742519|NCT02011516|3577796|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3742520|NCT02011516|3577797|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3742521|NCT02011516|3577798|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3742522|NCT02011516|3577796|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3742523|NCT02011516|3577797|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3742524|NCT02011516|3577798|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3742525|NCT02011516|3577796|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3742526|NCT02011516|3577797|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3742527|NCT02011516|3577798|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3742528|NCT02011516|3577796|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3742529|NCT02011516|3577797|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3742530|NCT02011516|3577798|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3742531|NCT02011516|3577796|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3742532|NCT02011516|3577797|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3742533|NCT02011516|3577798|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3742534|NCT02011490|3577805|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3742535|NCT02011490|3577806|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3742536|NCT02011490|3577807|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3742537|NCT02011490|3577808|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3742538|NCT02011490|3577805|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3742539|NCT02011490|3577806|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3742540|NCT02011490|3577807|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3742541|NCT02011490|3577808|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3742542|NCT02011490|3577805|B4|||Age||Years|Mean|61.5|61.5|Full Range|||47.0|76.0|
3742543|NCT02011490|3577806|B3|||Age||Years|Mean|58.3|58.3|Full Range|||50.0|67.0|
3742544|NCT02011490|3577807|B2|||Age||Years|Mean|64.2|64.2|Full Range|||47.0|76.0|
3742545|NCT02011490|3577808|B1|||Age||Years|Mean|62.3|62.3|Full Range|||47.0|76.0|
3742546|NCT02011464|3577899|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3742547|NCT02011464|3577900|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3742548|NCT02011464|3577901|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3742549|NCT02011464|3577899|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3742550|NCT02011464|3577900|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3742551|NCT02011464|3577901|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3742552|NCT02011464|3577899|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3742553|NCT02011464|3577900|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3742554|NCT02011464|3577901|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3742555|NCT02011464|3577899|B3|||Age|Males and females between the ages 18 and 75 years old|years|Mean|64.1|64.1|Standard Deviation|5.2|5.2|||
3742556|NCT02011464|3577900|B2|||Age|Males and females between the ages 18 and 75 years old|years|Mean|62.8|62.8|Standard Deviation|6.0|6.0|||
3742692|NCT02010567|3577977|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742557|NCT02011464|3577901|B1|||Age|Males and females between the ages 18 and 75 years old|years|Mean|66.1|66.1|Standard Deviation|4.7|4.7|||
3742558|NCT02011113|3577922|B1|Stage III||Durie-Salmon Multiple Myeloma staging at screening|Stages are: Stage I: Hemoglobin > 10 g/dL Serum calcium normal On roentgenogram, normal bone structure or solitary bone plasmacytoma only Low M-component production rates (IgG value < 5 g/dL, IgA value < 3 g/dL, Bence Jones protein < 4 g/24h) Stage II: Overall data as minimally abnormal for stage I, and no single value as abnormal as defined for stage III Stage III: 1 or more of below: Hemoglobin < 8.5 g/dL Serum calcium > 12 mg/dL Advanced lytic bone lesions (scale 3) High-M-component production rates (IgG value > 7 g/dL, IgA value > 5 g/dL, Bence Jones protein > 12 g/24h)|participants|Number|13|13.0||||||
3742559|NCT02011113|3577922|B1|Stage II||Durie-Salmon Multiple Myeloma staging at screening|Stages are: Stage I: Hemoglobin > 10 g/dL Serum calcium normal On roentgenogram, normal bone structure or solitary bone plasmacytoma only Low M-component production rates (IgG value < 5 g/dL, IgA value < 3 g/dL, Bence Jones protein < 4 g/24h) Stage II: Overall data as minimally abnormal for stage I, and no single value as abnormal as defined for stage III Stage III: 1 or more of below: Hemoglobin < 8.5 g/dL Serum calcium > 12 mg/dL Advanced lytic bone lesions (scale 3) High-M-component production rates (IgG value > 7 g/dL, IgA value > 5 g/dL, Bence Jones protein > 12 g/24h)|participants|Number|16|16.0||||||
3742560|NCT02011113|3577922|B1|Stage I||Durie-Salmon Multiple Myeloma staging at screening|Stages are: Stage I: Hemoglobin > 10 g/dL Serum calcium normal On roentgenogram, normal bone structure or solitary bone plasmacytoma only Low M-component production rates (IgG value < 5 g/dL, IgA value < 3 g/dL, Bence Jones protein < 4 g/24h) Stage II: Overall data as minimally abnormal for stage I, and no single value as abnormal as defined for stage III Stage III: 1 or more of below: Hemoglobin < 8.5 g/dL Serum calcium > 12 mg/dL Advanced lytic bone lesions (scale 3) High-M-component production rates (IgG value > 7 g/dL, IgA value > 5 g/dL, Bence Jones protein > 12 g/24h)|participants|Number|7|7.0||||||
3742561|NCT02011113|3577922|B1|No||Prior Stem Cell Transplant for Myeloma||participants|Number|17|17.0||||||
3742562|NCT02011113|3577922|B1|Yes||Prior Stem Cell Transplant for Myeloma||participants|Number|19|19.0||||||
3742563|NCT02011113|3577922|B1|||Prior Chemotherapy Regimens|The number of prior chemotherapy regimens for myeloma|regimens|Median|6.0|6.0|Full Range|||2.0|14.0|
3742564|NCT02011113|3577922|B1|4 = (Completely disabled)||Eastern Cooperative Oncology Group Performance Status] (ECOG)|The ECOG scale is as follows: Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair.|participants|Number|0|0.0||||||
3742565|NCT02011113|3577922|B1|3 = (Limited self-care)||Eastern Cooperative Oncology Group Performance Status] (ECOG)|The ECOG scale is as follows: Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair.|participants|Number|0|0.0||||||
3742566|NCT02011113|3577922|B1|2 = (Ambulatory but unable to work)||Eastern Cooperative Oncology Group Performance Status] (ECOG)|The ECOG scale is as follows: Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair.|participants|Number|3|3.0||||||
3742567|NCT02011113|3577922|B1|1 = (Symptomatic but completely ambulatory)||Eastern Cooperative Oncology Group Performance Status] (ECOG)|The ECOG scale is as follows: Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair.|participants|Number|16|16.0||||||
3742568|NCT02011113|3577922|B1|0 = (Asymptomatic)||Eastern Cooperative Oncology Group Performance Status] (ECOG)|The ECOG scale is as follows: Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair.|participants|Number|17|17.0||||||
3742569|NCT02011113|3577922|B1|Stage III||Durie-Salmon Multiple myeloma staging at screening|Stages are: Stage I: Hemoglobin > 10 g/dL Serum calcium normal On roentgenogram, normal bone structure or solitary bone plasmacytoma only Low M-component production rates (IgG value < 5 g/dL, IgA value < 3 g/dL, Bence Jones protein < 4 g/24h) Stage II: Overall data as minimally abnormal for stage I, and no single value as abnormal as defined for stage III Stage III: 1 or more of below: Hemoglobin < 8.5 g/dL Serum calcium > 12 mg/dL Advanced lytic bone lesions (scale 3) High-M-component production rates (IgG value > 7 g/dL, IgA value > 5 g/dL, Bence Jones protein > 12 g/24h)|participants|Number|13|13.0||||||
3742570|NCT02011113|3577922|B1|Stage II||Durie-Salmon Multiple myeloma staging at screening|Stages are: Stage I: Hemoglobin > 10 g/dL Serum calcium normal On roentgenogram, normal bone structure or solitary bone plasmacytoma only Low M-component production rates (IgG value < 5 g/dL, IgA value < 3 g/dL, Bence Jones protein < 4 g/24h) Stage II: Overall data as minimally abnormal for stage I, and no single value as abnormal as defined for stage III Stage III: 1 or more of below: Hemoglobin < 8.5 g/dL Serum calcium > 12 mg/dL Advanced lytic bone lesions (scale 3) High-M-component production rates (IgG value > 7 g/dL, IgA value > 5 g/dL, Bence Jones protein > 12 g/24h)|participants|Number|16|16.0||||||
3742693|NCT02010567|3577978|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742754|NCT02010567|3577979|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3742571|NCT02011113|3577922|B1|Stage I||Durie-Salmon Multiple myeloma staging at screening|Stages are: Stage I: Hemoglobin > 10 g/dL Serum calcium normal On roentgenogram, normal bone structure or solitary bone plasmacytoma only Low M-component production rates (IgG value < 5 g/dL, IgA value < 3 g/dL, Bence Jones protein < 4 g/24h) Stage II: Overall data as minimally abnormal for stage I, and no single value as abnormal as defined for stage III Stage III: 1 or more of below: Hemoglobin < 8.5 g/dL Serum calcium > 12 mg/dL Advanced lytic bone lesions (scale 3) High-M-component production rates (IgG value > 7 g/dL, IgA value > 5 g/dL, Bence Jones protein > 12 g/24h)|participants|Number|7|7.0||||||
3742572|NCT02011113|3577922|B1|||Time from first diagnosis||years|Median|4.65|4.65|Full Range|||0.6|21.1|
3742573|NCT02011113|3577922|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742574|NCT02011113|3577922|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742575|NCT02011113|3577922|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742576|NCT02011113|3577922|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742577|NCT02011113|3577922|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742578|NCT02011113|3577922|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3742579|NCT02011113|3577922|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742580|NCT02011113|3577922|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3742581|NCT02011113|3577922|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3742582|NCT02011113|3577922|B1|> 75 Years Old||Age, Customized||participants|Number|4|4.0||||||
3742583|NCT02011113|3577922|B1|≤ 75 Years Old||Age, Customized||participants|Number|32|32.0||||||
3742584|NCT02011113|3577922|B1|||Age||years|Median|64.5|64.5|Full Range|||43.0|78.0|
3742585|NCT02010996|3577936|B3|no||glucocorticoid||participants|Number|71|71.0||||||
3742586|NCT02010996|3577937|B2|no||glucocorticoid||participants|Number|36|36.0||||||
3742587|NCT02010996|3577938|B1|no||glucocorticoid||participants|Number|35|35.0||||||
3742588|NCT02010996|3577936|B3|yes||glucocorticoid||participants|Number|1|1.0||||||
3742589|NCT02010996|3577937|B2|yes||glucocorticoid||participants|Number|0|0.0||||||
3742590|NCT02010996|3577938|B1|yes||glucocorticoid||participants|Number|1|1.0||||||
3742591|NCT02010996|3577936|B3|no||obesity||participants|Number|58|58.0||||||
3742592|NCT02010996|3577937|B2|no||obesity||participants|Number|30|30.0||||||
3742593|NCT02010996|3577938|B1|no||obesity||participants|Number|28|28.0||||||
3742594|NCT02010996|3577936|B3|yes||obesity||participants|Number|14|14.0||||||
3742595|NCT02010996|3577937|B2|yes||obesity||participants|Number|6|6.0||||||
3742596|NCT02010996|3577938|B1|yes||obesity||participants|Number|8|8.0||||||
3742597|NCT02010996|3577936|B3|no||smoking||participants|Number|31|31.0||||||
3742598|NCT02010996|3577937|B2|no||smoking||participants|Number|15|15.0||||||
3742599|NCT02010996|3577938|B1|no||smoking||participants|Number|16|16.0||||||
3742600|NCT02010996|3577936|B3|yes||smoking||participants|Number|41|41.0||||||
3742601|NCT02010996|3577937|B2|yes||smoking||participants|Number|21|21.0||||||
3742602|NCT02010996|3577938|B1|yes||smoking||participants|Number|20|20.0||||||
3742603|NCT02010996|3577936|B3|no||carotid artery stenosis||participants|Number|63|63.0||||||
3742604|NCT02010996|3577937|B2|no||carotid artery stenosis||participants|Number|32|32.0||||||
3742605|NCT02010996|3577938|B1|no||carotid artery stenosis||participants|Number|31|31.0||||||
3742606|NCT02010996|3577936|B3|yes||carotid artery stenosis||participants|Number|9|9.0||||||
3742607|NCT02010996|3577937|B2|yes||carotid artery stenosis||participants|Number|4|4.0||||||
3742608|NCT02010996|3577938|B1|yes||carotid artery stenosis||participants|Number|5|5.0||||||
3742609|NCT02010996|3577936|B3|no||diabetes||participants|Number|39|39.0||||||
3742610|NCT02010996|3577937|B2|no||diabetes||participants|Number|20|20.0||||||
3742611|NCT02010996|3577938|B1|no||diabetes||participants|Number|19|19.0||||||
3742612|NCT02010996|3577936|B3|yes||diabetes||participants|Number|33|33.0||||||
3742613|NCT02010996|3577937|B2|yes||diabetes||participants|Number|16|16.0||||||
3742614|NCT02010996|3577938|B1|yes||diabetes||participants|Number|17|17.0||||||
3742615|NCT02010996|3577936|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3742616|NCT02010996|3577937|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3742617|NCT02010996|3577938|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3742618|NCT02010996|3577936|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3742619|NCT02010996|3577937|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3742620|NCT02010996|3577938|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3742621|NCT02010996|3577936|B3|||Age||years|Mean|56.4|56.4|Standard Deviation|11.6|11.6|||
3742622|NCT02010996|3577937|B2|||Age||years|Mean|55.4|55.4|Standard Deviation|12.4|12.4|||
3742623|NCT02010996|3577938|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|10.2|10.2|||
3742624|NCT02010684|3577949|B3|||Body Mass Index||kg/m^2|Mean|31.4|31.4|Standard Deviation|6.4|6.4|||
3742625|NCT02010684|3577950|B2|||Body Mass Index||kg/m^2|Mean|32.6|32.6|Standard Deviation|6.4|6.4|||
3742626|NCT02010684|3577951|B1|||Body Mass Index||kg/m^2|Mean|29.0|29.0|Standard Deviation|5.7|5.7|||
3742627|NCT02010684|3577949|B3|||Self-Efficacy (Diabetes Empowerment Scale)|The Diabetes Empowerment Scale Short Form (DES-SF) measures diabetes-related psychosocial self-efficacy. The questionnaire presents 8 statements on self efficacy where participants rate how strongly they agree. The answers are summed to create a score where higher scores indicate more empowerment. The score range is 0 to 8.|units on a scale|Mean|3.77|3.77|Standard Deviation|2.5|2.5|||
3742694|NCT02010567|3577979|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742628|NCT02010684|3577950|B2|||Self-Efficacy (Diabetes Empowerment Scale)|The Diabetes Empowerment Scale Short Form (DES-SF) measures diabetes-related psychosocial self-efficacy. The questionnaire presents 8 statements on self efficacy where participants rate how strongly they agree. The answers are summed to create a score where higher scores indicate more empowerment. The score range is 0 to 8.|units on a scale|Mean|3.72|3.72|Standard Deviation|2.5|2.5|||
3742629|NCT02010684|3577951|B1|||Self-Efficacy (Diabetes Empowerment Scale)|The Diabetes Empowerment Scale Short Form (DES-SF) measures diabetes-related psychosocial self-efficacy. The questionnaire presents 8 statements on self efficacy where participants rate how strongly they agree. The answers are summed to create a score where higher scores indicate more empowerment. The score range is 0 to 8.|units on a scale|Mean|3.88|3.88|Standard Deviation|2.6|2.6|||
3742630|NCT02010684|3577949|B3|||Yale Physical Activity Scale - Index Summary Score|The Yale Physical Activity Scale measures physical function and activities of daily living. Five activity indices (vigorous activity, leisurely walking, moving, standing and sitting) are calculated by multiplying the frequency of activity with the duration and a weighted factor. The 5 indices are then summed to create an index summary. Higher scores indicate more activity. The minimum and maximum scores are 0 and 142.|units on a scale|Mean|47.5|47.5|Standard Deviation|28|28.0|||
3742631|NCT02010684|3577950|B2|||Yale Physical Activity Scale - Index Summary Score|The Yale Physical Activity Scale measures physical function and activities of daily living. Five activity indices (vigorous activity, leisurely walking, moving, standing and sitting) are calculated by multiplying the frequency of activity with the duration and a weighted factor. The 5 indices are then summed to create an index summary. Higher scores indicate more activity. The minimum and maximum scores are 0 and 142.|units on a scale|Mean|48.3|48.3|Standard Deviation|28|28.0|||
3742632|NCT02010684|3577951|B1|||Yale Physical Activity Scale - Index Summary Score|The Yale Physical Activity Scale measures physical function and activities of daily living. Five activity indices (vigorous activity, leisurely walking, moving, standing and sitting) are calculated by multiplying the frequency of activity with the duration and a weighted factor. The 5 indices are then summed to create an index summary. Higher scores indicate more activity. The minimum and maximum scores are 0 and 142.|units on a scale|Mean|45.8|45.8|Standard Deviation|28|28.0|||
3742633|NCT02010684|3577949|B3|Index Score||EQ-5D|"The EQ-5D measures general quality of life. The index score is based on 5 questions about mobility, self-care, pain, usual activities, and psychological status. The EuroQol Group provides a U.S. preference-weighted algorithm to calculate the index scores. A score of 1 indicates no problems while a score of -0.11 indicates severe problems.~The scale score is based on a visual analog of a thermostat, where 0 represents worst imaginable health and 100 represents best imaginable health. Patients mark a tick for where they feel their health is on that scale."|units on a scale|Mean|0.699|0.699|Standard Deviation|0.21|0.21|||
3742634|NCT02010684|3577950|B2|Index Score||EQ-5D|"The EQ-5D measures general quality of life. The index score is based on 5 questions about mobility, self-care, pain, usual activities, and psychological status. The EuroQol Group provides a U.S. preference-weighted algorithm to calculate the index scores. A score of 1 indicates no problems while a score of -0.11 indicates severe problems.~The scale score is based on a visual analog of a thermostat, where 0 represents worst imaginable health and 100 represents best imaginable health. Patients mark a tick for where they feel their health is on that scale."|units on a scale|Mean|0.795|0.795|Standard Deviation|0.21|0.21|||
3742635|NCT02010684|3577951|B1|Index Score||EQ-5D|"The EQ-5D measures general quality of life. The index score is based on 5 questions about mobility, self-care, pain, usual activities, and psychological status. The EuroQol Group provides a U.S. preference-weighted algorithm to calculate the index scores. A score of 1 indicates no problems while a score of -0.11 indicates severe problems.~The scale score is based on a visual analog of a thermostat, where 0 represents worst imaginable health and 100 represents best imaginable health. Patients mark a tick for where they feel their health is on that scale."|units on a scale|Mean|0.655|0.655|Standard Deviation|0.20|0.2|||
3742636|NCT02010684|3577949|B3|Scale Score||EQ-5D|"The EQ-5D measures general quality of life. The index score is based on 5 questions about mobility, self-care, pain, usual activities, and psychological status. The EuroQol Group provides a U.S. preference-weighted algorithm to calculate the index scores. A score of 1 indicates no problems while a score of -0.11 indicates severe problems.~The scale score is based on a visual analog of a thermostat, where 0 represents worst imaginable health and 100 represents best imaginable health. Patients mark a tick for where they feel their health is on that scale."|units on a scale|Mean|61.3|61.3|Standard Deviation|17|17.0|||
3742637|NCT02010684|3577950|B2|Scale Score||EQ-5D|"The EQ-5D measures general quality of life. The index score is based on 5 questions about mobility, self-care, pain, usual activities, and psychological status. The EuroQol Group provides a U.S. preference-weighted algorithm to calculate the index scores. A score of 1 indicates no problems while a score of -0.11 indicates severe problems.~The scale score is based on a visual analog of a thermostat, where 0 represents worst imaginable health and 100 represents best imaginable health. Patients mark a tick for where they feel their health is on that scale."|units on a scale|Mean|63.6|63.6|Standard Deviation|13|13.0|||
3742638|NCT02010684|3577951|B1|Scale Score||EQ-5D|"The EQ-5D measures general quality of life. The index score is based on 5 questions about mobility, self-care, pain, usual activities, and psychological status. The EuroQol Group provides a U.S. preference-weighted algorithm to calculate the index scores. A score of 1 indicates no problems while a score of -0.11 indicates severe problems.~The scale score is based on a visual analog of a thermostat, where 0 represents worst imaginable health and 100 represents best imaginable health. Patients mark a tick for where they feel their health is on that scale."|units on a scale|Mean|60.2|60.2|Standard Deviation|19|19.0|||
3742639|NCT02010684|3577949|B3|||Patient Health Questionnaire-9 (PHQ-9)|The Patient Health Questionnaire-9 (PHQ-9) measures depression in patients. The questionnaire consists of 9 questions where patients self report how frequently they have depression symptoms over the past two weeks. The scale ranges is 0 to 27 where higher scores indicate greater severity of depression.|units on a scale|Mean|10.5|10.5|Standard Deviation|5.1|5.1|||
3742640|NCT02010684|3577950|B2|||Patient Health Questionnaire-9 (PHQ-9)|The Patient Health Questionnaire-9 (PHQ-9) measures depression in patients. The questionnaire consists of 9 questions where patients self report how frequently they have depression symptoms over the past two weeks. The scale ranges is 0 to 27 where higher scores indicate greater severity of depression.|units on a scale|Mean|11.1|11.1|Standard Deviation|5.1|5.1|||
3742753|NCT02010567|3577978|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3742641|NCT02010684|3577951|B1|||Patient Health Questionnaire-9 (PHQ-9)|The Patient Health Questionnaire-9 (PHQ-9) measures depression in patients. The questionnaire consists of 9 questions where patients self report how frequently they have depression symptoms over the past two weeks. The scale ranges is 0 to 27 where higher scores indicate greater severity of depression.|units on a scale|Mean|6.5|6.5|Standard Deviation|3.6|3.6|||
3742642|NCT02010684|3577949|B3|||Geriatric Depression Scale (GDS)|The Geriatric Depression Scale (GDS) measures depression in older adults. The short form we used consists of 15 yes or no questions. The scale range is 0 to 15, where higher scores indicate greater severity of depression.|units on a scale|Mean|7.1|7.1|Standard Deviation|3.8|3.8|||
3742643|NCT02010684|3577950|B2|||Geriatric Depression Scale (GDS)|The Geriatric Depression Scale (GDS) measures depression in older adults. The short form we used consists of 15 yes or no questions. The scale range is 0 to 15, where higher scores indicate greater severity of depression.|units on a scale|Mean|7.3|7.3|Standard Deviation|3.9|3.9|||
3742644|NCT02010684|3577951|B1|||Geriatric Depression Scale (GDS)|The Geriatric Depression Scale (GDS) measures depression in older adults. The short form we used consists of 15 yes or no questions. The scale range is 0 to 15, where higher scores indicate greater severity of depression.|units on a scale|Mean|6.5|6.5|Standard Deviation|3.6|3.6|||
3742645|NCT02010684|3577949|B3|||Low Density Lipoprotein-C||mg/dL|Mean|109.8|109.8|Standard Deviation|35.5|35.5|||
3742646|NCT02010684|3577950|B2|||Low Density Lipoprotein-C||mg/dL|Mean|109.6|109.6|Standard Deviation|37.0|37.0|||
3742647|NCT02010684|3577951|B1|||Low Density Lipoprotein-C||mg/dL|Mean|110.3|110.3|Standard Deviation|32.4|32.4|||
3742648|NCT02010684|3577949|B3|||Systolic Blood Pressure||mm Hg|Mean|138.5|138.5|Standard Deviation|20|20.0|||
3742649|NCT02010684|3577950|B2|||Systolic Blood Pressure||mm Hg|Mean|138.9|138.9|Standard Deviation|19.4|19.4|||
3742650|NCT02010684|3577951|B1|||Systolic Blood Pressure||mm Hg|Mean|137.7|137.7|Standard Deviation|21.4|21.4|||
3742651|NCT02010684|3577949|B3|||Diastolic Blood Pressure||mm Hg|Mean|79.4|79.4|Standard Deviation|10.7|10.7|||
3742652|NCT02010684|3577950|B2|||Diastolic Blood Pressure||mm Hg|Mean|80.0|80.0|Standard Deviation|10.8|10.8|||
3742653|NCT02010684|3577951|B1|||Diastolic Blood Pressure||mm Hg|Mean|79.0|79.0|Standard Deviation|10.6|10.6|||
3742654|NCT02010684|3577949|B3|||Hemoglobin A1c||%|Mean|9.9|9.9|Standard Deviation|1.7|1.7|||
3742655|NCT02010684|3577950|B2|||Hemoglobin A1c||%|Mean|9.8|9.8|Standard Deviation|1.7|1.7|||
3742656|NCT02010684|3577951|B1|||Hemoglobin A1c||%|Mean|10.1|10.1|Standard Deviation|1.7|1.7|||
3742657|NCT02010684|3577949|B3|Central American||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3742658|NCT02010684|3577950|B2|Central American||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3742659|NCT02010684|3577951|B1|Central American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3742660|NCT02010684|3577949|B3|Mexican||Race/Ethnicity, Customized||participants|Number|89|89.0||||||
3742661|NCT02010684|3577950|B2|Mexican||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
3742662|NCT02010684|3577951|B1|Mexican||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3742663|NCT02010684|3577949|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3742664|NCT02010684|3577950|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3742665|NCT02010684|3577951|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3742666|NCT02010684|3577949|B3||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3742667|NCT02010684|3577950|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3742668|NCT02010684|3577951|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3742669|NCT02010684|3577949|B3|||Age||years|Mean|60|60.0|Standard Deviation|7.9|7.9|||
3742670|NCT02010684|3577950|B2|||Age||years|Mean|60|60.0|Standard Deviation|8.4|8.4|||
3742671|NCT02010684|3577951|B1|||Age||years|Mean|61|61.0|Standard Deviation|7.8|7.8|||
3742672|NCT02010632|3577970|B1|||BMI||kg/m^2|Mean|22.12|22.12|Standard Deviation|2.75|2.75|||
3742673|NCT02010632|3577970|B1|Thailand||Region of Enrollment||participants|Number|31|31.0||||||
3742674|NCT02010632|3577970|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3742675|NCT02010632|3577970|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3742676|NCT02010632|3577970|B1|||Age||years|Mean|29.43|29.43|Standard Deviation|7.21|7.21|||
3742677|NCT02010632|3577970|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3742678|NCT02010632|3577970|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3742679|NCT02010632|3577970|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3742680|NCT02010567|3577977|B6|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3742681|NCT02010567|3577978|B5|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3742682|NCT02010567|3577979|B4|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3742683|NCT02010567|3577980|B3|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3742684|NCT02010567|3577981|B2|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3742685|NCT02010567|3577982|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3742686|NCT02010567|3577977|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3742687|NCT02010567|3577978|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3742688|NCT02010567|3577979|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742689|NCT02010567|3577980|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742690|NCT02010567|3577981|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742691|NCT02010567|3577982|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742695|NCT02010567|3577980|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742696|NCT02010567|3577981|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742697|NCT02010567|3577982|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742698|NCT02010567|3577977|B6||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3742699|NCT02010567|3577978|B5||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3742700|NCT02010567|3577979|B4||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3742701|NCT02010567|3577980|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3742702|NCT02010567|3577981|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3742703|NCT02010567|3577982|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3742704|NCT02010567|3577977|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3742705|NCT02010567|3577978|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3742706|NCT02010567|3577979|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742707|NCT02010567|3577980|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3742708|NCT02010567|3577981|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3742709|NCT02010567|3577982|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742710|NCT02010567|3577977|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742711|NCT02010567|3577978|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742712|NCT02010567|3577979|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742713|NCT02010567|3577980|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742714|NCT02010567|3577981|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742715|NCT02010567|3577982|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742716|NCT02010567|3577977|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742717|NCT02010567|3577978|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742718|NCT02010567|3577979|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742719|NCT02010567|3577980|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742720|NCT02010567|3577981|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742721|NCT02010567|3577982|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742722|NCT02010567|3577977|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742723|NCT02010567|3577978|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742724|NCT02010567|3577979|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742725|NCT02010567|3577980|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742726|NCT02010567|3577981|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742727|NCT02010567|3577982|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3742728|NCT02010567|3577977|B6||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3742729|NCT02010567|3577978|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3742730|NCT02010567|3577979|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3742731|NCT02010567|3577980|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3742732|NCT02010567|3577981|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3742733|NCT02010567|3577982|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3742734|NCT02010567|3577977|B6||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3742735|NCT02010567|3577978|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3742736|NCT02010567|3577979|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3742737|NCT02010567|3577980|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3742738|NCT02010567|3577981|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3742739|NCT02010567|3577982|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3742740|NCT02010567|3577977|B6||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3742741|NCT02010567|3577978|B5||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3742742|NCT02010567|3577979|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3742743|NCT02010567|3577980|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3742744|NCT02010567|3577981|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3742745|NCT02010567|3577982|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3742746|NCT02010567|3577977|B6||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3742747|NCT02010567|3577978|B5||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3742748|NCT02010567|3577979|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3742749|NCT02010567|3577980|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3742750|NCT02010567|3577981|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3742751|NCT02010567|3577982|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3742752|NCT02010567|3577977|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3742755|NCT02010567|3577980|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3742756|NCT02010567|3577981|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3742757|NCT02010567|3577982|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3742758|NCT02010255|3577997|B15|TT||IL28b Status||participants|Number|82|82.0||||||
3742759|NCT02010255|3577998|B14|TT||IL28b Status||participants|Number|0|0.0||||||
3742760|NCT02010255|3577999|B13|TT||IL28b Status||participants|Number|0|0.0||||||
3742761|NCT02010255|3578000|B12|TT||IL28b Status||participants|Number|0|0.0||||||
3742762|NCT02010255|3578001|B11|TT||IL28b Status||participants|Number|1|1.0||||||
3742763|NCT02010255|3578002|B10|TT||IL28b Status||participants|Number|7|7.0||||||
3742764|NCT02010255|3578003|B9|TT||IL28b Status||participants|Number|7|7.0||||||
3742765|NCT02010255|3578004|B8|TT||IL28b Status||participants|Number|5|5.0||||||
3742766|NCT02010255|3578005|B7|TT||IL28b Status||participants|Number|8|8.0||||||
3742767|NCT02010255|3578006|B6|TT||IL28b Status||participants|Number|14|14.0||||||
3742768|NCT02010255|3578007|B5|TT||IL28b Status||participants|Number|12|12.0||||||
3742769|NCT02010255|3578008|B4|TT||IL28b Status||participants|Number|7|7.0||||||
3742770|NCT02010255|3578009|B3|TT||IL28b Status||participants|Number|8|8.0||||||
3742771|NCT02010255|3578010|B2|TT||IL28b Status||participants|Number|9|9.0||||||
3742772|NCT02010255|3578011|B1|TT||IL28b Status||participants|Number|4|4.0||||||
3742773|NCT02010255|3577997|B15|CT||IL28b Status||participants|Number|184|184.0||||||
3742774|NCT02010255|3577998|B14|CT||IL28b Status||participants|Number|1|1.0||||||
3742775|NCT02010255|3577999|B13|CT||IL28b Status||participants|Number|3|3.0||||||
3742776|NCT02010255|3578000|B12|CT||IL28b Status||participants|Number|2|2.0||||||
3742777|NCT02010255|3578001|B11|CT||IL28b Status||participants|Number|2|2.0||||||
3742778|NCT02010255|3578002|B10|CT||IL28b Status||participants|Number|11|11.0||||||
3742779|NCT02010255|3578003|B9|CT||IL28b Status||participants|Number|12|12.0||||||
3742780|NCT02010255|3578004|B8|CT||IL28b Status||participants|Number|21|21.0||||||
3742781|NCT02010255|3578005|B7|CT||IL28b Status||participants|Number|23|23.0||||||
3742782|NCT02010255|3578006|B6|CT||IL28b Status||participants|Number|25|25.0||||||
3742783|NCT02010255|3578007|B5|CT||IL28b Status||participants|Number|31|31.0||||||
3742784|NCT02010255|3578008|B4|CT||IL28b Status||participants|Number|15|15.0||||||
3742785|NCT02010255|3578009|B3|CT||IL28b Status||participants|Number|10|10.0||||||
3742786|NCT02010255|3578010|B2|CT||IL28b Status||participants|Number|10|10.0||||||
3742787|NCT02010255|3578011|B1|CT||IL28b Status||participants|Number|18|18.0||||||
3742788|NCT02010255|3577997|B15|CC||IL28b Status||participants|Number|67|67.0||||||
3742789|NCT02010255|3577998|B14|CC||IL28b Status||participants|Number|1|1.0||||||
3742790|NCT02010255|3577999|B13|CC||IL28b Status||participants|Number|0|0.0||||||
3742791|NCT02010255|3578000|B12|CC||IL28b Status||participants|Number|3|3.0||||||
3742792|NCT02010255|3578001|B11|CC||IL28b Status||participants|Number|0|0.0||||||
3742793|NCT02010255|3578002|B10|CC||IL28b Status||participants|Number|5|5.0||||||
3742794|NCT02010255|3578003|B9|CC||IL28b Status||participants|Number|3|3.0||||||
3742795|NCT02010255|3578004|B8|CC||IL28b Status||participants|Number|7|7.0||||||
3742796|NCT02010255|3578005|B7|CC||IL28b Status||participants|Number|3|3.0||||||
3742797|NCT02010255|3578006|B6|CC||IL28b Status||participants|Number|10|10.0||||||
3742798|NCT02010255|3578007|B5|CC||IL28b Status||participants|Number|9|9.0||||||
3742799|NCT02010255|3578008|B4|CC||IL28b Status||participants|Number|4|4.0||||||
3742800|NCT02010255|3578009|B3|CC||IL28b Status||participants|Number|7|7.0||||||
3742801|NCT02010255|3578010|B2|CC||IL28b Status||participants|Number|9|9.0||||||
3742802|NCT02010255|3578011|B1|CC||IL28b Status||participants|Number|6|6.0||||||
3742803|NCT02010255|3577997|B15|Genotype 4||HCV Genotype||participants|Number|37|37.0||||||
3742804|NCT02010255|3577998|B14|Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3742805|NCT02010255|3577999|B13|Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3742806|NCT02010255|3578000|B12|Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3742807|NCT02010255|3578001|B11|Genotype 4||HCV Genotype||participants|Number|1|1.0||||||
3742808|NCT02010255|3578002|B10|Genotype 4||HCV Genotype||participants|Number|3|3.0||||||
3742809|NCT02010255|3578003|B9|Genotype 4||HCV Genotype||participants|Number|2|2.0||||||
3742810|NCT02010255|3578004|B8|Genotype 4||HCV Genotype||participants|Number|5|5.0||||||
3742811|NCT02010255|3578005|B7|Genotype 4||HCV Genotype||participants|Number|4|4.0||||||
3742812|NCT02010255|3578006|B6|Genotype 4||HCV Genotype||participants|Number|5|5.0||||||
3742813|NCT02010255|3578007|B5|Genotype 4||HCV Genotype||participants|Number|7|7.0||||||
3742814|NCT02010255|3578008|B4|Genotype 4||HCV Genotype||participants|Number|3|3.0||||||
3742815|NCT02010255|3578009|B3|Genotype 4||HCV Genotype||participants|Number|1|1.0||||||
3742816|NCT02010255|3578010|B2|Genotype 4||HCV Genotype||participants|Number|3|3.0||||||
3742817|NCT02010255|3578011|B1|Genotype 4||HCV Genotype||participants|Number|3|3.0||||||
3742818|NCT02010255|3577997|B15|Genotype 1b||HCV Genotype||participants|Number|133|133.0||||||
3742819|NCT02010255|3577998|B14|Genotype 1b||HCV Genotype||participants|Number|0|0.0||||||
3742820|NCT02010255|3577999|B13|Genotype 1b||HCV Genotype||participants|Number|1|1.0||||||
3742821|NCT02010255|3578000|B12|Genotype 1b||HCV Genotype||participants|Number|4|4.0||||||
3742822|NCT02010255|3578001|B11|Genotype 1b||HCV Genotype||participants|Number|1|1.0||||||
3742823|NCT02010255|3578002|B10|Genotype 1b||HCV Genotype||participants|Number|7|7.0||||||
3742824|NCT02010255|3578003|B9|Genotype 1b||HCV Genotype||participants|Number|9|9.0||||||
3742825|NCT02010255|3578004|B8|Genotype 1b||HCV Genotype||participants|Number|15|15.0||||||
3742826|NCT02010255|3578005|B7|Genotype 1b||HCV Genotype||participants|Number|16|16.0||||||
3742827|NCT02010255|3578006|B6|Genotype 1b||HCV Genotype||participants|Number|15|15.0||||||
3742828|NCT02010255|3578007|B5|Genotype 1b||HCV Genotype||participants|Number|18|18.0||||||
3742829|NCT02010255|3578008|B4|Genotype 1b||HCV Genotype||participants|Number|11|11.0||||||
3742830|NCT02010255|3578009|B3|Genotype 1b||HCV Genotype||participants|Number|11|11.0||||||
3742831|NCT02010255|3578010|B2|Genotype 1b||HCV Genotype||participants|Number|13|13.0||||||
3742832|NCT02010255|3578011|B1|Genotype 1b||HCV Genotype||participants|Number|12|12.0||||||
3742833|NCT02010255|3577997|B15|Genotype 1a||HCV Genotype||participants|Number|163|163.0||||||
3742834|NCT02010255|3577998|B14|Genotype 1a||HCV Genotype||participants|Number|2|2.0||||||
3742835|NCT02010255|3577999|B13|Genotype 1a||HCV Genotype||participants|Number|2|2.0||||||
3742836|NCT02010255|3578000|B12|Genotype 1a||HCV Genotype||participants|Number|1|1.0||||||
3742837|NCT02010255|3578001|B11|Genotype 1a||HCV Genotype||participants|Number|1|1.0||||||
3742838|NCT02010255|3578002|B10|Genotype 1a||HCV Genotype||participants|Number|13|13.0||||||
3742839|NCT02010255|3578003|B9|Genotype 1a||HCV Genotype||participants|Number|11|11.0||||||
3742840|NCT02010255|3578004|B8|Genotype 1a||HCV Genotype||participants|Number|13|13.0||||||
3742841|NCT02010255|3578005|B7|Genotype 1a||HCV Genotype||participants|Number|14|14.0||||||
3742842|NCT02010255|3578006|B6|Genotype 1a||HCV Genotype||participants|Number|29|29.0||||||
3742843|NCT02010255|3578007|B5|Genotype 1a||HCV Genotype||participants|Number|27|27.0||||||
3742844|NCT02010255|3578008|B4|Genotype 1a||HCV Genotype||participants|Number|12|12.0||||||
3742845|NCT02010255|3578009|B3|Genotype 1a||HCV Genotype||participants|Number|13|13.0||||||
3742846|NCT02010255|3578010|B2|Genotype 1a||HCV Genotype||participants|Number|12|12.0||||||
3742847|NCT02010255|3578011|B1|Genotype 1a||HCV Genotype||participants|Number|13|13.0||||||
3742848|NCT02010255|3577997|B15|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|227|227.0||||||
3742849|NCT02010255|3577998|B14|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|1|1.0||||||
3742850|NCT02010255|3577999|B13|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|3|3.0||||||
3742851|NCT02010255|3578000|B12|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|5|5.0||||||
3742852|NCT02010255|3578001|B11|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|1|1.0||||||
3742853|NCT02010255|3578002|B10|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|14|14.0||||||
3742854|NCT02010255|3578003|B9|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|17|17.0||||||
3742855|NCT02010255|3578004|B8|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|28|28.0||||||
3742856|NCT02010255|3578005|B7|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|25|25.0||||||
3742857|NCT02010255|3578006|B6|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|44|44.0||||||
3742858|NCT02010255|3578007|B5|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|40|40.0||||||
3742859|NCT02010255|3578008|B4|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|9|9.0||||||
3742860|NCT02010255|3578009|B3|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|9|9.0||||||
3742861|NCT02010255|3578010|B2|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|14|14.0||||||
3742862|NCT02010255|3578011|B1|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|17|17.0||||||
3742863|NCT02010255|3577997|B15|< 800,000 IU/mL||HCV RNA Category||participants|Number|106|106.0||||||
3742864|NCT02010255|3577998|B14|< 800,000 IU/mL||HCV RNA Category||participants|Number|1|1.0||||||
3742865|NCT02010255|3577999|B13|< 800,000 IU/mL||HCV RNA Category||participants|Number|0|0.0||||||
3742866|NCT02010255|3578000|B12|< 800,000 IU/mL||HCV RNA Category||participants|Number|0|0.0||||||
3742867|NCT02010255|3578001|B11|< 800,000 IU/mL||HCV RNA Category||participants|Number|2|2.0||||||
3742868|NCT02010255|3578002|B10|< 800,000 IU/mL||HCV RNA Category||participants|Number|9|9.0||||||
3742869|NCT02010255|3578003|B9|< 800,000 IU/mL||HCV RNA Category||participants|Number|5|5.0||||||
3742870|NCT02010255|3578004|B8|< 800,000 IU/mL||HCV RNA Category||participants|Number|5|5.0||||||
3742871|NCT02010255|3578005|B7|< 800,000 IU/mL||HCV RNA Category||participants|Number|9|9.0||||||
3742872|NCT02010255|3578006|B6|< 800,000 IU/mL||HCV RNA Category||participants|Number|5|5.0||||||
3742873|NCT02010255|3578007|B5|< 800,000 IU/mL||HCV RNA Category||participants|Number|12|12.0||||||
3742874|NCT02010255|3578008|B4|< 800,000 IU/mL||HCV RNA Category||participants|Number|17|17.0||||||
3742875|NCT02010255|3578009|B3|< 800,000 IU/mL||HCV RNA Category||participants|Number|16|16.0||||||
3742876|NCT02010255|3578010|B2|< 800,000 IU/mL||HCV RNA Category||participants|Number|14|14.0||||||
3742877|NCT02010255|3578011|B1|< 800,000 IU/mL||HCV RNA Category||participants|Number|11|11.0||||||
3742878|NCT02010255|3577997|B15|||Hepatitis C Virus (HCV) RNA||log 10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.66|0.66|||
3742879|NCT02010255|3577998|B14|||Hepatitis C Virus (HCV) RNA||log 10 IU/mL|Mean|6.0|6.0|Standard Deviation|0.41|0.41|||
3742880|NCT02010255|3577999|B13|||Hepatitis C Virus (HCV) RNA||log 10 IU/mL|Mean|7.3|7.3|Standard Deviation|0.72|0.72|||
3742881|NCT02010255|3578000|B12|||Hepatitis C Virus (HCV) RNA||log 10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.50|0.5|||
3742882|NCT02010255|3578001|B11|||Hepatitis C Virus (HCV) RNA||log 10 IU/mL|Mean|6.0|6.0|Standard Deviation|0.49|0.49|||
3742883|NCT02010255|3578002|B10|||Hepatitis C Virus (HCV) RNA||log 10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.85|0.85|||
3742884|NCT02010255|3578003|B9|||Hepatitis C Virus (HCV) RNA||log 10 IU/mL|Mean|6.1|6.1|Standard Deviation|0.78|0.78|||
3742885|NCT02010255|3578004|B8|||Hepatitis C Virus (HCV) RNA||log 10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.55|0.55|||
3742886|NCT02010255|3578005|B7|||Hepatitis C Virus (HCV) RNA||log 10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.58|0.58|||
3742887|NCT02010255|3578006|B6|||Hepatitis C Virus (HCV) RNA||log 10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.44|0.44|||
3742888|NCT02010255|3578007|B5|||Hepatitis C Virus (HCV) RNA||log 10 IU/mL|Mean|6.4|6.4|Standard Deviation|0.72|0.72|||
3742889|NCT02010255|3578008|B4|||Hepatitis C Virus (HCV) RNA||log 10 IU/mL|Mean|5.7|5.7|Standard Deviation|0.44|0.44|||
3742890|NCT02010255|3578009|B3|||Hepatitis C Virus (HCV) RNA||log 10 IU/mL|Mean|5.6|5.6|Standard Deviation|0.58|0.58|||
3742891|NCT02010255|3578010|B2|||Hepatitis C Virus (HCV) RNA||log 10 IU/mL|Mean|5.9|5.9|Standard Deviation|0.56|0.56|||
3742892|NCT02010255|3578011|B1|||Hepatitis C Virus (HCV) RNA||log 10 IU/mL|Mean|6.0|6.0|Standard Deviation|0.49|0.49|||
3742893|NCT02010255|3577997|B15|Spain||Region of Enrollment||participants|Number|52|52.0||||||
3742894|NCT02010255|3577998|B14|Spain||Region of Enrollment||participants|Number|0|0.0||||||
3742895|NCT02010255|3577999|B13|Spain||Region of Enrollment||participants|Number|0|0.0||||||
3742896|NCT02010255|3578000|B12|Spain||Region of Enrollment||participants|Number|2|2.0||||||
3742897|NCT02010255|3578001|B11|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3742898|NCT02010255|3578002|B10|Spain||Region of Enrollment||participants|Number|4|4.0||||||
3742899|NCT02010255|3578003|B9|Spain||Region of Enrollment||participants|Number|3|3.0||||||
3742900|NCT02010255|3578004|B8|Spain||Region of Enrollment||participants|Number|5|5.0||||||
3742901|NCT02010255|3578005|B7|Spain||Region of Enrollment||participants|Number|5|5.0||||||
3742902|NCT02010255|3578006|B6|Spain||Region of Enrollment||participants|Number|8|8.0||||||
3742903|NCT02010255|3578007|B5|Spain||Region of Enrollment||participants|Number|4|4.0||||||
3742904|NCT02010255|3578008|B4|Spain||Region of Enrollment||participants|Number|7|7.0||||||
3742905|NCT02010255|3578009|B3|Spain||Region of Enrollment||participants|Number|2|2.0||||||
3742906|NCT02010255|3578010|B2|Spain||Region of Enrollment||participants|Number|5|5.0||||||
3742907|NCT02010255|3578011|B1|Spain||Region of Enrollment||participants|Number|6|6.0||||||
3742908|NCT02010255|3577997|B15|Germany||Region of Enrollment||participants|Number|28|28.0||||||
3742909|NCT02010255|3577998|B14|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3742910|NCT02010255|3577999|B13|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3742911|NCT02010255|3578000|B12|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3742912|NCT02010255|3578001|B11|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3742913|NCT02010255|3578002|B10|Germany||Region of Enrollment||participants|Number|1|1.0||||||
3742914|NCT02010255|3578003|B9|Germany||Region of Enrollment||participants|Number|1|1.0||||||
3742915|NCT02010255|3578004|B8|Germany||Region of Enrollment||participants|Number|3|3.0||||||
3742916|NCT02010255|3578005|B7|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3742917|NCT02010255|3578006|B6|Germany||Region of Enrollment||participants|Number|5|5.0||||||
3742918|NCT02010255|3578007|B5|Germany||Region of Enrollment||participants|Number|6|6.0||||||
3742919|NCT02010255|3578008|B4|Germany||Region of Enrollment||participants|Number|3|3.0||||||
3742920|NCT02010255|3578009|B3|Germany||Region of Enrollment||participants|Number|3|3.0||||||
3742921|NCT02010255|3578010|B2|Germany||Region of Enrollment||participants|Number|4|4.0||||||
3742922|NCT02010255|3578011|B1|Germany||Region of Enrollment||participants|Number|2|2.0||||||
3742923|NCT02010255|3577997|B15|Switzerland||Region of Enrollment||participants|Number|23|23.0||||||
3742924|NCT02010255|3577998|B14|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
3742925|NCT02010255|3577999|B13|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
3742926|NCT02010255|3578000|B12|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
3742927|NCT02010255|3578001|B11|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
3742928|NCT02010255|3578002|B10|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
3742929|NCT02010255|3578003|B9|Switzerland||Region of Enrollment||participants|Number|2|2.0||||||
3742930|NCT02010255|3578004|B8|Switzerland||Region of Enrollment||participants|Number|2|2.0||||||
3742931|NCT02010255|3578005|B7|Switzerland||Region of Enrollment||participants|Number|4|4.0||||||
3742932|NCT02010255|3578006|B6|Switzerland||Region of Enrollment||participants|Number|3|3.0||||||
3742933|NCT02010255|3578007|B5|Switzerland||Region of Enrollment||participants|Number|4|4.0||||||
3742934|NCT02010255|3578008|B4|Switzerland||Region of Enrollment||participants|Number|2|2.0||||||
3742935|NCT02010255|3578009|B3|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
3742936|NCT02010255|3578010|B2|Switzerland||Region of Enrollment||participants|Number|4|4.0||||||
3742937|NCT02010255|3578011|B1|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
3742938|NCT02010255|3577997|B15|France||Region of Enrollment||participants|Number|32|32.0||||||
3742939|NCT02010255|3577998|B14|France||Region of Enrollment||participants|Number|0|0.0||||||
3742940|NCT02010255|3577999|B13|France||Region of Enrollment||participants|Number|1|1.0||||||
3742941|NCT02010255|3578000|B12|France||Region of Enrollment||participants|Number|0|0.0||||||
3742942|NCT02010255|3578001|B11|France||Region of Enrollment||participants|Number|0|0.0||||||
3742943|NCT02010255|3578002|B10|France||Region of Enrollment||participants|Number|3|3.0||||||
3742944|NCT02010255|3578003|B9|France||Region of Enrollment||participants|Number|3|3.0||||||
3742945|NCT02010255|3578004|B8|France||Region of Enrollment||participants|Number|3|3.0||||||
3742946|NCT02010255|3578005|B7|France||Region of Enrollment||participants|Number|6|6.0||||||
3742947|NCT02010255|3578006|B6|France||Region of Enrollment||participants|Number|5|5.0||||||
3742948|NCT02010255|3578007|B5|France||Region of Enrollment||participants|Number|4|4.0||||||
3742949|NCT02010255|3578008|B4|France||Region of Enrollment||participants|Number|4|4.0||||||
3742950|NCT02010255|3578009|B3|France||Region of Enrollment||participants|Number|1|1.0||||||
3742951|NCT02010255|3578010|B2|France||Region of Enrollment||participants|Number|1|1.0||||||
3742952|NCT02010255|3578011|B1|France||Region of Enrollment||participants|Number|1|1.0||||||
3742953|NCT02010255|3577997|B15|Australia||Region of Enrollment||participants|Number|27|27.0||||||
3742954|NCT02010255|3577998|B14|Australia||Region of Enrollment||participants|Number|1|1.0||||||
3742955|NCT02010255|3577999|B13|Australia||Region of Enrollment||participants|Number|0|0.0||||||
3742956|NCT02010255|3578000|B12|Australia||Region of Enrollment||participants|Number|1|1.0||||||
3742957|NCT02010255|3578001|B11|Australia||Region of Enrollment||participants|Number|0|0.0||||||
3742958|NCT02010255|3578002|B10|Australia||Region of Enrollment||participants|Number|2|2.0||||||
3742959|NCT02010255|3578003|B9|Australia||Region of Enrollment||participants|Number|2|2.0||||||
3742960|NCT02010255|3578004|B8|Australia||Region of Enrollment||participants|Number|3|3.0||||||
3742961|NCT02010255|3578005|B7|Australia||Region of Enrollment||participants|Number|3|3.0||||||
3742962|NCT02010255|3578006|B6|Australia||Region of Enrollment||participants|Number|2|2.0||||||
3742963|NCT02010255|3578007|B5|Australia||Region of Enrollment||participants|Number|0|0.0||||||
3742964|NCT02010255|3578008|B4|Australia||Region of Enrollment||participants|Number|4|4.0||||||
3742965|NCT02010255|3578009|B3|Australia||Region of Enrollment||participants|Number|7|7.0||||||
3742966|NCT02010255|3578010|B2|Australia||Region of Enrollment||participants|Number|1|1.0||||||
3742967|NCT02010255|3578011|B1|Australia||Region of Enrollment||participants|Number|1|1.0||||||
3742968|NCT02010255|3577997|B15|United Kingdom||Region of Enrollment||participants|Number|36|36.0||||||
3742969|NCT02010255|3577998|B14|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3742970|NCT02010255|3577999|B13|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3742971|NCT02010255|3578000|B12|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3742972|NCT02010255|3578001|B11|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3742973|NCT02010255|3578002|B10|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3742974|NCT02010255|3578003|B9|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3742975|NCT02010255|3578004|B8|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
3742976|NCT02010255|3578005|B7|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3742977|NCT02010255|3578006|B6|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
3742978|NCT02010255|3578007|B5|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3742979|NCT02010255|3578008|B4|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3742980|NCT02010255|3578009|B3|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3742981|NCT02010255|3578010|B2|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3742982|NCT02010255|3578011|B1|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
3742983|NCT02010255|3577997|B15|Italy||Region of Enrollment||participants|Number|23|23.0||||||
3742984|NCT02010255|3577998|B14|Italy||Region of Enrollment||participants|Number|0|0.0||||||
3742985|NCT02010255|3577999|B13|Italy||Region of Enrollment||participants|Number|0|0.0||||||
3742986|NCT02010255|3578000|B12|Italy||Region of Enrollment||participants|Number|2|2.0||||||
3742987|NCT02010255|3578001|B11|Italy||Region of Enrollment||participants|Number|1|1.0||||||
3742988|NCT02010255|3578002|B10|Italy||Region of Enrollment||participants|Number|3|3.0||||||
3742989|NCT02010255|3578003|B9|Italy||Region of Enrollment||participants|Number|3|3.0||||||
3742990|NCT02010255|3578004|B8|Italy||Region of Enrollment||participants|Number|1|1.0||||||
3742991|NCT02010255|3578005|B7|Italy||Region of Enrollment||participants|Number|3|3.0||||||
3742992|NCT02010255|3578006|B6|Italy||Region of Enrollment||participants|Number|2|2.0||||||
3742993|NCT02010255|3578007|B5|Italy||Region of Enrollment||participants|Number|2|2.0||||||
3742994|NCT02010255|3578008|B4|Italy||Region of Enrollment||participants|Number|1|1.0||||||
3742995|NCT02010255|3578009|B3|Italy||Region of Enrollment||participants|Number|2|2.0||||||
3742996|NCT02010255|3578010|B2|Italy||Region of Enrollment||participants|Number|1|1.0||||||
3742997|NCT02010255|3578011|B1|Italy||Region of Enrollment||participants|Number|2|2.0||||||
3742998|NCT02010255|3577997|B15|Belgium||Region of Enrollment||participants|Number|16|16.0||||||
3742999|NCT02010255|3577998|B14|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
3743000|NCT02010255|3577999|B13|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
3743001|NCT02010255|3578000|B12|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
3743002|NCT02010255|3578001|B11|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
3743003|NCT02010255|3578002|B10|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
3743004|NCT02010255|3578003|B9|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
3743005|NCT02010255|3578004|B8|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
3743006|NCT02010255|3578005|B7|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
3743007|NCT02010255|3578006|B6|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
3743008|NCT02010255|3578007|B5|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
3743009|NCT02010255|3578008|B4|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
3743010|NCT02010255|3578009|B3|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
3743011|NCT02010255|3578010|B2|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
3743012|NCT02010255|3578011|B1|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
3743013|NCT02010255|3577997|B15|Netherlands||Region of Enrollment||participants|Number|8|8.0||||||
3743014|NCT02010255|3577998|B14|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
3743015|NCT02010255|3577999|B13|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
3743016|NCT02010255|3578000|B12|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
3743017|NCT02010255|3578001|B11|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
3743018|NCT02010255|3578002|B10|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
3743019|NCT02010255|3578003|B9|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
3743020|NCT02010255|3578004|B8|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
3743021|NCT02010255|3578005|B7|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
3743022|NCT02010255|3578006|B6|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
3743023|NCT02010255|3578007|B5|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
3743024|NCT02010255|3578008|B4|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
3743025|NCT02010255|3578009|B3|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
3743026|NCT02010255|3578010|B2|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
3743027|NCT02010255|3578011|B1|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
3743028|NCT02010255|3577997|B15|Austria||Region of Enrollment||participants|Number|23|23.0||||||
3743029|NCT02010255|3577998|B14|Austria||Region of Enrollment||participants|Number|0|0.0||||||
3743030|NCT02010255|3577999|B13|Austria||Region of Enrollment||participants|Number|0|0.0||||||
3743031|NCT02010255|3578000|B12|Austria||Region of Enrollment||participants|Number|0|0.0||||||
3743032|NCT02010255|3578001|B11|Austria||Region of Enrollment||participants|Number|0|0.0||||||
3743033|NCT02010255|3578002|B10|Austria||Region of Enrollment||participants|Number|2|2.0||||||
3743034|NCT02010255|3578003|B9|Austria||Region of Enrollment||participants|Number|1|1.0||||||
3743035|NCT02010255|3578004|B8|Austria||Region of Enrollment||participants|Number|3|3.0||||||
3743036|NCT02010255|3578005|B7|Austria||Region of Enrollment||participants|Number|2|2.0||||||
3743037|NCT02010255|3578006|B6|Austria||Region of Enrollment||participants|Number|2|2.0||||||
3743038|NCT02010255|3578007|B5|Austria||Region of Enrollment||participants|Number|8|8.0||||||
3743039|NCT02010255|3578008|B4|Austria||Region of Enrollment||participants|Number|0|0.0||||||
3743040|NCT02010255|3578009|B3|Austria||Region of Enrollment||participants|Number|1|1.0||||||
3743041|NCT02010255|3578010|B2|Austria||Region of Enrollment||participants|Number|2|2.0||||||
3743042|NCT02010255|3578011|B1|Austria||Region of Enrollment||participants|Number|2|2.0||||||
3743043|NCT02010255|3577997|B15|Canada||Region of Enrollment||participants|Number|49|49.0||||||
3743044|NCT02010255|3577998|B14|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3743045|NCT02010255|3577999|B13|Canada||Region of Enrollment||participants|Number|0|0.0||||||
3743046|NCT02010255|3578000|B12|Canada||Region of Enrollment||participants|Number|0|0.0||||||
3743047|NCT02010255|3578001|B11|Canada||Region of Enrollment||participants|Number|0|0.0||||||
3743048|NCT02010255|3578002|B10|Canada||Region of Enrollment||participants|Number|5|5.0||||||
3743049|NCT02010255|3578003|B9|Canada||Region of Enrollment||participants|Number|4|4.0||||||
3743050|NCT02010255|3578004|B8|Canada||Region of Enrollment||participants|Number|5|5.0||||||
3743051|NCT02010255|3578005|B7|Canada||Region of Enrollment||participants|Number|4|4.0||||||
3743052|NCT02010255|3578006|B6|Canada||Region of Enrollment||participants|Number|6|6.0||||||
3743053|NCT02010255|3578007|B5|Canada||Region of Enrollment||participants|Number|8|8.0||||||
3743054|NCT02010255|3578008|B4|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3743055|NCT02010255|3578009|B3|Canada||Region of Enrollment||participants|Number|4|4.0||||||
3743056|NCT02010255|3578010|B2|Canada||Region of Enrollment||participants|Number|5|5.0||||||
3743057|NCT02010255|3578011|B1|Canada||Region of Enrollment||participants|Number|6|6.0||||||
3743058|NCT02010255|3577997|B15|New Zealand||Region of Enrollment||participants|Number|16|16.0||||||
3743059|NCT02010255|3577998|B14|New Zealand||Region of Enrollment||participants|Number|0|0.0||||||
3743060|NCT02010255|3577999|B13|New Zealand||Region of Enrollment||participants|Number|2|2.0||||||
3743061|NCT02010255|3578000|B12|New Zealand||Region of Enrollment||participants|Number|0|0.0||||||
3743062|NCT02010255|3578001|B11|New Zealand||Region of Enrollment||participants|Number|0|0.0||||||
3743063|NCT02010255|3578002|B10|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
3743064|NCT02010255|3578003|B9|New Zealand||Region of Enrollment||participants|Number|2|2.0||||||
3743065|NCT02010255|3578004|B8|New Zealand||Region of Enrollment||participants|Number|2|2.0||||||
3743066|NCT02010255|3578005|B7|New Zealand||Region of Enrollment||participants|Number|2|2.0||||||
3743067|NCT02010255|3578006|B6|New Zealand||Region of Enrollment||participants|Number|0|0.0||||||
3743068|NCT02010255|3578007|B5|New Zealand||Region of Enrollment||participants|Number|2|2.0||||||
3743069|NCT02010255|3578008|B4|New Zealand||Region of Enrollment||participants|Number|3|3.0||||||
3743070|NCT02010255|3578009|B3|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
3743071|NCT02010255|3578010|B2|New Zealand||Region of Enrollment||participants|Number|0|0.0||||||
3743072|NCT02010255|3578011|B1|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
3743073|NCT02010255|3577997|B15|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3743074|NCT02010255|3577998|B14|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743075|NCT02010255|3577999|B13|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743076|NCT02010255|3578000|B12|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743077|NCT02010255|3578001|B11|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743078|NCT02010255|3578002|B10|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743079|NCT02010255|3578003|B9|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3743080|NCT02010255|3578004|B8|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743081|NCT02010255|3578005|B7|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743082|NCT02010255|3578006|B6|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3743083|NCT02010255|3578007|B5|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3743084|NCT02010255|3578008|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743085|NCT02010255|3578009|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3743086|NCT02010255|3578010|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743087|NCT02010255|3578011|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3743088|NCT02010255|3577997|B15|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3743089|NCT02010255|3577998|B14|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743090|NCT02010255|3577999|B13|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743091|NCT02010255|3578000|B12|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743092|NCT02010255|3578001|B11|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743093|NCT02010255|3578002|B10|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743094|NCT02010255|3578003|B9|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743095|NCT02010255|3578004|B8|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743096|NCT02010255|3578005|B7|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3743097|NCT02010255|3578006|B6|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743098|NCT02010255|3578007|B5|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743099|NCT02010255|3578008|B4|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743100|NCT02010255|3578009|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743101|NCT02010255|3578010|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743102|NCT02010255|3578011|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3743103|NCT02010255|3577997|B15|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3743104|NCT02010255|3577998|B14|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3743105|NCT02010255|3577999|B13|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3743106|NCT02010255|3578000|B12|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743107|NCT02010255|3578001|B11|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743108|NCT02010255|3578002|B10|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3743109|NCT02010255|3578003|B9|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743110|NCT02010255|3578004|B8|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3743111|NCT02010255|3578005|B7|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743112|NCT02010255|3578006|B6|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3743113|NCT02010255|3578007|B5|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743114|NCT02010255|3578008|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743115|NCT02010255|3578009|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743116|NCT02010255|3578010|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743117|NCT02010255|3578011|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743118|NCT02010255|3577997|B15|White||Race/Ethnicity, Customized||participants|Number|314|314.0||||||
3743119|NCT02010255|3577998|B14|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3743120|NCT02010255|3577999|B13|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3743121|NCT02010255|3578000|B12|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3743122|NCT02010255|3578001|B11|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3743123|NCT02010255|3578002|B10|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3743124|NCT02010255|3578003|B9|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3743125|NCT02010255|3578004|B8|White||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3743126|NCT02010255|3578005|B7|White||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
3743127|NCT02010255|3578006|B6|White||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
3743128|NCT02010255|3578007|B5|White||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
3743129|NCT02010255|3578008|B4|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3743130|NCT02010255|3578009|B3|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3743131|NCT02010255|3578010|B2|White||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3743132|NCT02010255|3578011|B1|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3743133|NCT02010255|3577997|B15|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3743134|NCT02010255|3577998|B14|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743135|NCT02010255|3577999|B13|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743136|NCT02010255|3578000|B12|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743137|NCT02010255|3578001|B11|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743138|NCT02010255|3578002|B10|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3743139|NCT02010255|3578003|B9|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743140|NCT02010255|3578004|B8|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743141|NCT02010255|3578005|B7|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743142|NCT02010255|3578006|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743143|NCT02010255|3578007|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3743144|NCT02010255|3578008|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3743145|NCT02010255|3578009|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3743146|NCT02010255|3578010|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743147|NCT02010255|3578011|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3743148|NCT02010255|3577997|B15||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3743149|NCT02010255|3577998|B14||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3743150|NCT02010255|3577999|B13||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3743151|NCT02010255|3578000|B12||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3743152|NCT02010255|3578001|B11||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3743153|NCT02010255|3578002|B10||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3743154|NCT02010255|3578003|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3743155|NCT02010255|3578004|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3743156|NCT02010255|3578005|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3743157|NCT02010255|3578006|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3743158|NCT02010255|3578007|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3743159|NCT02010255|3578008|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3743160|NCT02010255|3578009|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3743161|NCT02010255|3578010|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3743162|NCT02010255|3578011|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3743163|NCT02010255|3577997|B15||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|276|276.0||||||
3743164|NCT02010255|3577998|B14||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3743165|NCT02010255|3577999|B13||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3743166|NCT02010255|3578000|B12||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3743167|NCT02010255|3578001|B11||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3743168|NCT02010255|3578002|B10||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3743169|NCT02010255|3578003|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3743170|NCT02010255|3578004|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3743171|NCT02010255|3578005|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3743172|NCT02010255|3578006|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3743173|NCT02010255|3578007|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3743174|NCT02010255|3578008|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3743175|NCT02010255|3578009|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3743176|NCT02010255|3578010|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3743177|NCT02010255|3578011|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3743178|NCT02010255|3577997|B15||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3743179|NCT02010255|3577998|B14||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3743180|NCT02010255|3577999|B13||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3743181|NCT02010255|3578000|B12||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3743182|NCT02010255|3578001|B11||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3743183|NCT02010255|3578002|B10||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3743184|NCT02010255|3578003|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3743185|NCT02010255|3578004|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3743186|NCT02010255|3578005|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3743187|NCT02010255|3578006|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3743188|NCT02010255|3578007|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3743189|NCT02010255|3578008|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3743190|NCT02010255|3578009|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3743191|NCT02010255|3578010|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3743192|NCT02010255|3578011|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3743193|NCT02010255|3577997|B15||Male|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
3743194|NCT02010255|3577998|B14||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3743195|NCT02010255|3577999|B13||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3743196|NCT02010255|3578000|B12||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3743197|NCT02010255|3578001|B11||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3743198|NCT02010255|3578002|B10||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3743199|NCT02010255|3578003|B9||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3743200|NCT02010255|3578004|B8||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3743201|NCT02010255|3578005|B7||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3743202|NCT02010255|3578006|B6||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3743203|NCT02010255|3578007|B5||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3743204|NCT02010255|3578008|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3743205|NCT02010255|3578009|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3743206|NCT02010255|3578010|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3743207|NCT02010255|3578011|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3743208|NCT02010255|3577997|B15||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3743209|NCT02010255|3577998|B14||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3743210|NCT02010255|3577999|B13||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3743211|NCT02010255|3578000|B12||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3743212|NCT02010255|3578001|B11||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3743213|NCT02010255|3578002|B10||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3743214|NCT02010255|3578003|B9||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3743215|NCT02010255|3578004|B8||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3743216|NCT02010255|3578005|B7||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3743217|NCT02010255|3578006|B6||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3743218|NCT02010255|3578007|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3743219|NCT02010255|3578008|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3743220|NCT02010255|3578009|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3743221|NCT02010255|3578010|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3743222|NCT02010255|3578011|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3743223|NCT02010255|3577997|B15|||Age||years|Mean|58|58.0|Standard Deviation|8.4|8.4|||
3743224|NCT02010255|3577998|B14|||Age||years|Mean|56|56.0|Standard Deviation|2.8|2.8|||
3743225|NCT02010255|3577999|B13|||Age||years|Mean|58|58.0|Standard Deviation|2.6|2.6|||
3743226|NCT02010255|3578000|B12|||Age||years|Mean|62|62.0|Standard Deviation|9.2|9.2|||
3743227|NCT02010255|3578001|B11|||Age||years|Mean|62|62.0|Standard Deviation|4.6|4.6|||
3743228|NCT02010255|3578002|B10|||Age||years|Mean|60|60.0|Standard Deviation|10.2|10.2|||
3743229|NCT02010255|3578003|B9|||Age||years|Mean|58|58.0|Standard Deviation|8.0|8.0|||
3743230|NCT02010255|3578004|B8|||Age||years|Mean|62|62.0|Standard Deviation|7.5|7.5|||
3743231|NCT02010255|3578005|B7|||Age||years|Mean|57|57.0|Standard Deviation|7.2|7.2|||
3743232|NCT02010255|3578006|B6|||Age||years|Mean|59|59.0|Standard Deviation|6.9|6.9|||
3743233|NCT02010255|3578007|B5|||Age||years|Mean|58|58.0|Standard Deviation|7.9|7.9|||
3743234|NCT02010255|3578008|B4|||Age||years|Mean|54|54.0|Standard Deviation|10.7|10.7|||
3743235|NCT02010255|3578009|B3|||Age||years|Mean|58|58.0|Standard Deviation|8.1|8.1|||
3743236|NCT02010255|3578010|B2|||Age||years|Mean|56|56.0|Standard Deviation|8.6|8.6|||
3743237|NCT02010255|3578011|B1|||Age||years|Mean|55|55.0|Standard Deviation|9.9|9.9|||
3743238|NCT02010216|3578348|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3743239|NCT02010216|3578348|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3743240|NCT02010216|3578348|B1|||Age||years|Mean|48.3|48.3|Standard Deviation|11.6|11.6|||
3743241|NCT02010021|3578354|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
3743242|NCT02010021|3578355|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3743243|NCT02010021|3578356|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3743244|NCT02010021|3578354|B3|White, not Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3743245|NCT02010021|3578355|B2|White, not Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3743246|NCT02010021|3578356|B1|White, not Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3743247|NCT02010021|3578354|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3743248|NCT02010021|3578355|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3743249|NCT02010021|3578356|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3743250|NCT02010021|3578354|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3743251|NCT02010021|3578355|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3743252|NCT02010021|3578356|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3743253|NCT02010021|3578354|B3|||Age||years|Mean|65.3|65.3|Full Range|||49.0|78.0|
3743254|NCT02010021|3578355|B2|||Age||years|Mean|64.9|64.9|Full Range|||55.0|77.0|
3743255|NCT02010021|3578356|B1|||Age||years|Mean|65.6|65.6|Full Range|||49.0|78.0|
3743256|NCT02009982|3578365|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3743257|NCT02009982|3578366|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3743258|NCT02009982|3578367|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3743259|NCT02009982|3578365|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3743260|NCT02009982|3578366|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3743261|NCT02009982|3578367|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3743262|NCT02009982|3578365|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3743263|NCT02009982|3578366|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3743264|NCT02009982|3578367|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3743265|NCT02009982|3578365|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3743266|NCT02009982|3578366|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3743267|NCT02009982|3578367|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3743268|NCT02009982|3578365|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3743269|NCT02009982|3578366|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3743270|NCT02009982|3578367|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3743271|NCT02009982|3578365|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3743272|NCT02009982|3578366|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3743273|NCT02009982|3578367|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3743274|NCT02009878|3578376|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3743275|NCT02009878|3578377|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3743276|NCT02009878|3578378|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3743277|NCT02009878|3578379|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3743278|NCT02009878|3578376|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3743279|NCT02009878|3578377|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3743280|NCT02009878|3578378|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3743281|NCT02009878|3578379|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3743282|NCT02009878|3578376|B4|||Age||years|Mean|66.34|66.34|Standard Deviation|12.04|12.04|||
3743283|NCT02009878|3578377|B3|||Age||years|Mean|59.67|59.67|Standard Deviation|15.43|15.43|||
3743284|NCT02009878|3578378|B2|||Age||years|Mean|70.20|70.2|Standard Deviation|9.90|9.9|||
3743285|NCT02009878|3578379|B1|||Age||years|Mean|68.50|68.5|Standard Deviation|8.66|8.66|||
3743286|NCT02009865|3578413|B3|No||At least 1 qualifying TG category > 885 mg/dL||Participants|Number|57|57.0||||||
3743287|NCT02009865|3578414|B2|No||At least 1 qualifying TG category > 885 mg/dL||Participants|Number|29|29.0||||||
3743288|NCT02009865|3578415|B1|No||At least 1 qualifying TG category > 885 mg/dL||Participants|Number|28|28.0||||||
3743289|NCT02009865|3578413|B3|Yes||At least 1 qualifying TG category > 885 mg/dL||Participants|Number|105|105.0||||||
3743290|NCT02009865|3578414|B2|Yes||At least 1 qualifying TG category > 885 mg/dL||Participants|Number|52|52.0||||||
3743291|NCT02009865|3578415|B1|Yes||At least 1 qualifying TG category > 885 mg/dL||Participants|Number|53|53.0||||||
3743292|NCT02009865|3578413|B3|No||Lipid-altering drug use||Participants|Number|89|89.0||||||
3743293|NCT02009865|3578414|B2|No||Lipid-altering drug use||Participants|Number|44|44.0||||||
3743294|NCT02009865|3578415|B1|No||Lipid-altering drug use||Participants|Number|45|45.0||||||
3743295|NCT02009865|3578413|B3|Yes||Lipid-altering drug use||Participants|Number|73|73.0||||||
3743296|NCT02009865|3578414|B2|Yes||Lipid-altering drug use||Participants|Number|37|37.0||||||
3743297|NCT02009865|3578415|B1|Yes||Lipid-altering drug use||Participants|Number|36|36.0||||||
3743298|NCT02009865|3578413|B3||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3743299|NCT02009865|3578414|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3743300|NCT02009865|3578415|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3743301|NCT02009865|3578413|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3743302|NCT02009865|3578414|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3743303|NCT02009865|3578415|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3743304|NCT02009865|3578413|B3|||Age||Years|Mean|50.2|50.2|Standard Deviation|10.71|10.71|||
3743305|NCT02009865|3578414|B2|||Age||Years|Mean|50.0|50.0|Standard Deviation|10.88|10.88|||
3743306|NCT02009865|3578415|B1|||Age||Years|Mean|50.3|50.3|Standard Deviation|10.60|10.6|||
3743307|NCT02009722|3578430|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3743308|NCT02009722|3578431|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3743309|NCT02009722|3578432|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3743310|NCT02009722|3578430|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3743311|NCT02009722|3578431|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3743312|NCT02009722|3578432|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3743313|NCT02009722|3578430|B3|||Age||years|Mean|30.5|30.5|Standard Deviation|4.2|4.2|||
3743314|NCT02009722|3578431|B2|||Age||years|Mean|30.6|30.6|Standard Deviation|4.3|4.3|||
3743315|NCT02009722|3578432|B1|||Age||years|Mean|30.3|30.3|Standard Deviation|4.1|4.1|||
3743316|NCT02009696|3578457|B1||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3743317|NCT02009696|3578457|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3743318|NCT02009696|3578457|B1|||Age||years|Mean|68.4|68.4|Standard Deviation|11.9|11.9|||
3743319|NCT02009501|3578465|B3|Tobacco use||Comorbidities||Participants|Count of Participants|10|10.0||||||
3743320|NCT02009501|3578466|B2|Tobacco use||Comorbidities||Participants|Count of Participants|7|7.0||||||
3743321|NCT02009501|3578467|B1|Tobacco use||Comorbidities||Participants|Count of Participants|3|3.0||||||
3743322|NCT02009501|3578465|B3|Hyperlipidemia||Comorbidities||Participants|Count of Participants|13|13.0||||||
3743323|NCT02009501|3578466|B2|Hyperlipidemia||Comorbidities||Participants|Count of Participants|7|7.0||||||
3743324|NCT02009501|3578467|B1|Hyperlipidemia||Comorbidities||Participants|Count of Participants|6|6.0||||||
3743325|NCT02009501|3578465|B3|Chronic Kidney Disease||Comorbidities||Participants|Count of Participants|3|3.0||||||
3743326|NCT02009501|3578466|B2|Chronic Kidney Disease||Comorbidities||Participants|Count of Participants|2|2.0||||||
3743327|NCT02009501|3578467|B1|Chronic Kidney Disease||Comorbidities||Participants|Count of Participants|1|1.0||||||
3743328|NCT02009501|3578465|B3|Morbid Obesity||Comorbidities||Participants|Count of Participants|3|3.0||||||
3743329|NCT02009501|3578466|B2|Morbid Obesity||Comorbidities||Participants|Count of Participants|2|2.0||||||
3743330|NCT02009501|3578467|B1|Morbid Obesity||Comorbidities||Participants|Count of Participants|1|1.0||||||
3743331|NCT02009501|3578465|B3|Diabetes Mellitus||Comorbidities||Participants|Count of Participants|11|11.0||||||
3743332|NCT02009501|3578466|B2|Diabetes Mellitus||Comorbidities||Participants|Count of Participants|5|5.0||||||
3743333|NCT02009501|3578467|B1|Diabetes Mellitus||Comorbidities||Participants|Count of Participants|6|6.0||||||
3743334|NCT02009501|3578465|B3|Hypertension||Comorbidities||Participants|Count of Participants|13|13.0||||||
3743335|NCT02009501|3578466|B2|Hypertension||Comorbidities||Participants|Count of Participants|7|7.0||||||
3743336|NCT02009501|3578467|B1|Hypertension||Comorbidities||Participants|Count of Participants|6|6.0||||||
3743337|NCT02009501|3578465|B3|Mixed||Etiology||Participants|Count of Participants|7|7.0||||||
3743338|NCT02009501|3578466|B2|Mixed||Etiology||Participants|Count of Participants|3|3.0||||||
3743339|NCT02009501|3578467|B1|Mixed||Etiology||Participants|Count of Participants|4|4.0||||||
3743340|NCT02009501|3578465|B3|Diabetic||Etiology||Participants|Count of Participants|1|1.0||||||
3743341|NCT02009501|3578466|B2|Diabetic||Etiology||Participants|Count of Participants|1|1.0||||||
3743342|NCT02009501|3578467|B1|Diabetic||Etiology||Participants|Count of Participants|0|0.0||||||
3743343|NCT02009501|3578465|B3|Venous||Etiology||Participants|Count of Participants|12|12.0||||||
3743344|NCT02009501|3578466|B2|Venous||Etiology||Participants|Count of Participants|7|7.0||||||
3743345|NCT02009501|3578467|B1|Venous||Etiology||Participants|Count of Participants|5|5.0||||||
3743346|NCT02009501|3578465|B3|||Ulcer size||cm^3|Mean|50.48|50.48|Standard Deviation|16.33|16.33|||
3743347|NCT02009501|3578466|B2|||Ulcer size||cm^3|Mean|56.2|56.2|Standard Deviation|17.8|17.8|||
3743348|NCT02009501|3578467|B1|||Ulcer size||cm^3|Mean|43.5|43.5|Standard Deviation|10.8|10.8|||
3743349|NCT02009501|3578465|B3|||Ulcer duration||months|Mean|99.07|99.07|Standard Deviation|43.37|43.37|||
3743350|NCT02009501|3578466|B2|||Ulcer duration||months|Mean|103.3|103.3|Standard Deviation|43.3|43.3|||
3743351|NCT02009501|3578467|B1|||Ulcer duration||months|Mean|93.9|93.9|Standard Deviation|42.9|42.9|||
3743352|NCT02009501|3578465|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3743353|NCT02009501|3578466|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3743354|NCT02009501|3578467|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3743355|NCT02009501|3578465|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3743356|NCT02009501|3578466|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3743357|NCT02009501|3578467|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3743358|NCT02009501|3578465|B3|||Age||years|Mean|63.83|63.83|Standard Deviation|4.89|4.89|||
3743359|NCT02009501|3578466|B2|||Age||years|Mean|62.3|62.3|Standard Deviation|5.8|5.8|||
3743360|NCT02009501|3578467|B1|||Age||years|Mean|65.7|65.7|Standard Deviation|2.4|2.4|||
3743361|NCT02009163|3578474|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3743362|NCT02009163|3578474|B1||Female|Sex: Female, Male||Participants|Count of Participants|358|358.0||||||
3743363|NCT02009163|3578474|B1|>/= 40 years of age||Age, Customized||participants|Number|194|194.0||||||
3743364|NCT02009163|3578474|B1|< 40 years of age||Age, Customized||participants|Number|217|217.0||||||
3743365|NCT02009163|3578474|B1|||Age||years|Mean|38.3|38.3|Standard Deviation|10.40|10.4|||
3743366|NCT02009046|3578509|B3|United States||Region of Enrollment||participants|Number|2881|2881.0||||||
3743367|NCT02009046|3578510|B2|United States||Region of Enrollment||participants|Number|884|884.0||||||
3743368|NCT02009046|3578511|B1|United States||Region of Enrollment||participants|Number|1025|1025.0||||||
3743369|NCT02009046|3578509|B3||Male|Sex: Female, Male||Participants|Count of Participants|943|943.0||||||
3743370|NCT02009046|3578510|B2||Male|Sex: Female, Male||Participants|Count of Participants|436|436.0||||||
3743371|NCT02009046|3578511|B1||Male|Sex: Female, Male||Participants|Count of Participants|507|507.0||||||
3743372|NCT02009046|3578509|B3||Female|Sex: Female, Male||Participants|Count of Participants|966|966.0||||||
3743373|NCT02009046|3578510|B2||Female|Sex: Female, Male||Participants|Count of Participants|448|448.0||||||
3743374|NCT02009046|3578511|B1||Female|Sex: Female, Male||Participants|Count of Participants|518|518.0||||||
3743375|NCT02009046|3578509|B3|||Age||years|Mean|14.15|14.15|Standard Deviation|.60|0.6|||
3743376|NCT02009046|3578510|B2|||Age||years|Mean|14.16|14.16|Standard Deviation|.55|0.55|||
3743377|NCT02009046|3578511|B1|||Age||years|Mean|14.15|14.15|Standard Deviation|.60|0.6|||
3743378|NCT02009046|3578509|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3743379|NCT02009046|3578510|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3743380|NCT02009046|3578511|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3743381|NCT02009046|3578509|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3743382|NCT02009046|3578510|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3743383|NCT02009046|3578511|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3743384|NCT02009046|3578509|B3||<=18 years|Age||Participants|Count of Participants|1909|1909.0||||||
3743385|NCT02009046|3578510|B2||<=18 years|Age||Participants|Count of Participants|884|884.0||||||
3743386|NCT02009046|3578511|B1||<=18 years|Age||Participants|Count of Participants|1025|1025.0||||||
3743387|NCT02008942|3578562|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3743388|NCT02008942|3578562|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3743389|NCT02008942|3578562|B1|||Age||years|Mean|54.8|54.8|Standard Deviation|10.06|10.06|||
3743390|NCT02008916|3578569|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
3743391|NCT02008916|3578570|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3743392|NCT02008916|3578571|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3743393|NCT02008916|3578572|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3743394|NCT02008916|3578569|B4|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3743395|NCT02008916|3578570|B3|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3743396|NCT02008916|3578571|B2|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3743397|NCT02008916|3578572|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3743398|NCT02008916|3578569|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3743399|NCT02008916|3578570|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3743400|NCT02008916|3578571|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3743401|NCT02008916|3578572|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3743402|NCT02008916|3578569|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3743403|NCT02008916|3578570|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3743404|NCT02008916|3578571|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3743405|NCT02008916|3578572|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3743406|NCT02008916|3578569|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3743407|NCT02008916|3578570|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3743408|NCT02008916|3578571|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3743409|NCT02008916|3578572|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3743410|NCT02008916|3578569|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|164|164.0||||||
3743411|NCT02008916|3578570|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|58|58.0||||||
3743412|NCT02008916|3578571|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|52|52.0||||||
3743413|NCT02008916|3578572|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|54|54.0||||||
3743414|NCT02008916|3578569|B4||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3743415|NCT02008916|3578570|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3743416|NCT02008916|3578571|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3743417|NCT02008916|3578572|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3743418|NCT02008916|3578569|B4||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3743419|NCT02008916|3578570|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3743420|NCT02008916|3578571|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3743421|NCT02008916|3578572|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3743422|NCT02008916|3578569|B4|||Age||Years|Mean|42.5|42.5|Standard Deviation|11.41|11.41|||
3743423|NCT02008916|3578570|B3|||Age||Years|Mean|42.7|42.7|Standard Deviation|11.43|11.43|||
3743424|NCT02008916|3578571|B2|||Age||Years|Mean|42.1|42.1|Standard Deviation|11.81|11.81|||
3743425|NCT02008916|3578572|B1|||Age||Years|Mean|42.9|42.9|Standard Deviation|11.11|11.11|||
3743426|NCT02008682|3578607|B3|||Glycosylated haemoglobin A1c (HbA1c)||Percent (%) glycosylated haemoglobin|Mean|8.12|8.12|Standard Deviation|0.806|0.806|||
3743427|NCT02008682|3578608|B2|||Glycosylated haemoglobin A1c (HbA1c)||Percent (%) glycosylated haemoglobin|Mean|8.11|8.11|Standard Deviation|0.780|0.78|||
3743428|NCT02008682|3578609|B1|||Glycosylated haemoglobin A1c (HbA1c)||Percent (%) glycosylated haemoglobin|Mean|8.14|8.14|Standard Deviation|0.833|0.833|||
3743429|NCT02008682|3578607|B3|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.36|9.36|Standard Deviation|2.226|2.226|||
3743430|NCT02008682|3578608|B2|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.46|9.46|Standard Deviation|2.237|2.237|||
3743431|NCT02008682|3578609|B1|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.26|9.26|Standard Deviation|2.216|2.216|||
3743432|NCT02008682|3578607|B3|||Duration of diabetes||years|Mean|5.27|5.27|Standard Deviation|4.92|4.92|||
3743433|NCT02008682|3578608|B2|||Duration of diabetes||years|Mean|5.22|5.22|Standard Deviation|5.40|5.4|||
3743434|NCT02008682|3578609|B1|||Duration of diabetes||years|Mean|5.31|5.31|Standard Deviation|4.39|4.39|||
3743435|NCT02008682|3578607|B3|||Body weight||kg|Mean|75.98|75.98|Standard Deviation|14.330|14.33|||
3743436|NCT02008682|3578608|B2|||Body weight||kg|Mean|75.78|75.78|Standard Deviation|15.089|15.089|||
3743437|NCT02008682|3578609|B1|||Body weight||kg|Mean|76.17|76.17|Standard Deviation|13.562|13.562|||
3743438|NCT02008682|3578607|B3|||Body mass index (BMI)||kg/m^2|Mean|27.24|27.24|Standard Deviation|3.720|3.72|||
3743439|NCT02008682|3578608|B2|||Body mass index (BMI)||kg/m^2|Mean|27.16|27.16|Standard Deviation|4.029|4.029|||
3743440|NCT02008682|3578609|B1|||Body mass index (BMI)||kg/m^2|Mean|27.32|27.32|Standard Deviation|3.389|3.389|||
3743441|NCT02008682|3578607|B3||Male|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
3743442|NCT02008682|3578608|B2||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3743443|NCT02008682|3578609|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3743444|NCT02008682|3578607|B3||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3743445|NCT02008682|3578608|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3743446|NCT02008682|3578609|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3743447|NCT02008682|3578607|B3|||Age||years|Mean|51.5|51.5|Standard Deviation|10.9|10.9|||
3743448|NCT02008682|3578608|B2|||Age||years|Mean|51.4|51.4|Standard Deviation|11.0|11.0|||
3743449|NCT02008682|3578609|B1|||Age||years|Mean|51.7|51.7|Standard Deviation|10.7|10.7|||
3743450|NCT02008617|3578626|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
3743451|NCT02008617|3578627|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3743452|NCT02008617|3578628|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3743453|NCT02008617|3578626|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3743454|NCT02008617|3578627|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3743455|NCT02008617|3578628|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3743456|NCT02008617|3578626|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3743457|NCT02008617|3578627|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3743458|NCT02008617|3578628|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3743459|NCT02008617|3578626|B3|||Age||years|Median|27|27.0|Inter-Quartile Range|||23.0|34.0|
3743460|NCT02008617|3578627|B2|||Age||years|Median|29|29.0|Inter-Quartile Range|||23.0|38.0|
3743461|NCT02008617|3578628|B1|||Age||years|Median|25|25.0|Inter-Quartile Range|||24.0|32.0|
3743462|NCT02008565|3578641|B5||Type 6 (Fluffy pieces with ragged edges, a mushy s|Bristol Stool Index, No. (%)||Participants|Count of Participants|62|62.0||||||
3743463|NCT02008565|3578642|B4||Type 6 (Fluffy pieces with ragged edges, a mushy s|Bristol Stool Index, No. (%)||Participants|Count of Participants|8|8.0||||||
3743464|NCT02008565|3578643|B3||Type 6 (Fluffy pieces with ragged edges, a mushy s|Bristol Stool Index, No. (%)||Participants|Count of Participants|19|19.0||||||
3743465|NCT02008565|3578644|B2||Type 6 (Fluffy pieces with ragged edges, a mushy s|Bristol Stool Index, No. (%)||Participants|Count of Participants|18|18.0||||||
3743466|NCT02008565|3578645|B1||Type 6 (Fluffy pieces with ragged edges, a mushy s|Bristol Stool Index, No. (%)||Participants|Count of Participants|17|17.0||||||
3743467|NCT02008565|3578641|B5||Type 5 (Soft blobs with clear cut edges)|Bristol Stool Index, No. (%)||Participants|Count of Participants|53|53.0||||||
3743468|NCT02008565|3578642|B4||Type 5 (Soft blobs with clear cut edges)|Bristol Stool Index, No. (%)||Participants|Count of Participants|5|5.0||||||
3743469|NCT02008565|3578643|B3||Type 5 (Soft blobs with clear cut edges)|Bristol Stool Index, No. (%)||Participants|Count of Participants|14|14.0||||||
3743470|NCT02008565|3578644|B2||Type 5 (Soft blobs with clear cut edges)|Bristol Stool Index, No. (%)||Participants|Count of Participants|17|17.0||||||
3743471|NCT02008565|3578645|B1||Type 5 (Soft blobs with clear cut edges)|Bristol Stool Index, No. (%)||Participants|Count of Participants|17|17.0||||||
3743472|NCT02008565|3578641|B5||Type 4 (Like a sausage or snake, smooth and soft)|Bristol Stool Index, No. (%)||Participants|Count of Participants|93|93.0||||||
3743473|NCT02008565|3578642|B4||Type 4 (Like a sausage or snake, smooth and soft)|Bristol Stool Index, No. (%)||Participants|Count of Participants|15|15.0||||||
3743474|NCT02008565|3578643|B3||Type 4 (Like a sausage or snake, smooth and soft)|Bristol Stool Index, No. (%)||Participants|Count of Participants|29|29.0||||||
3743475|NCT02008565|3578644|B2||Type 4 (Like a sausage or snake, smooth and soft)|Bristol Stool Index, No. (%)||Participants|Count of Participants|28|28.0||||||
3743476|NCT02008565|3578645|B1||Type 4 (Like a sausage or snake, smooth and soft)|Bristol Stool Index, No. (%)||Participants|Count of Participants|21|21.0||||||
3743477|NCT02008565|3578641|B5||Type 3 (Like a sausage or snake but with cracks on|Bristol Stool Index, No. (%)||Participants|Count of Participants|43|43.0||||||
3743478|NCT02008565|3578642|B4||Type 3 (Like a sausage or snake but with cracks on|Bristol Stool Index, No. (%)||Participants|Count of Participants|3|3.0||||||
3743479|NCT02008565|3578643|B3||Type 3 (Like a sausage or snake but with cracks on|Bristol Stool Index, No. (%)||Participants|Count of Participants|17|17.0||||||
3743480|NCT02008565|3578644|B2||Type 3 (Like a sausage or snake but with cracks on|Bristol Stool Index, No. (%)||Participants|Count of Participants|11|11.0||||||
3743481|NCT02008565|3578645|B1||Type 3 (Like a sausage or snake but with cracks on|Bristol Stool Index, No. (%)||Participants|Count of Participants|12|12.0||||||
3743482|NCT02008565|3578641|B5||Type 2 (Sausage shaped but lumpy)|Bristol Stool Index, No. (%)||Participants|Count of Participants|45|45.0||||||
3743483|NCT02008565|3578642|B4||Type 2 (Sausage shaped but lumpy)|Bristol Stool Index, No. (%)||Participants|Count of Participants|11|11.0||||||
3743484|NCT02008565|3578643|B3||Type 2 (Sausage shaped but lumpy)|Bristol Stool Index, No. (%)||Participants|Count of Participants|7|7.0||||||
3743485|NCT02008565|3578644|B2||Type 2 (Sausage shaped but lumpy)|Bristol Stool Index, No. (%)||Participants|Count of Participants|9|9.0||||||
3743486|NCT02008565|3578645|B1||Type 2 (Sausage shaped but lumpy)|Bristol Stool Index, No. (%)||Participants|Count of Participants|18|18.0||||||
3743487|NCT02008565|3578641|B5|||BMI, mean (SD)||kg/m^2|Mean|30.0|30.0|Standard Deviation|7.8|7.8|||
3743488|NCT02008565|3578642|B4|||BMI, mean (SD)||kg/m^2|Mean|30.5|30.5|Standard Deviation|10.4|10.4|||
3743489|NCT02008565|3578643|B3|||BMI, mean (SD)||kg/m^2|Mean|30.9|30.9|Standard Deviation|6.6|6.6|||
3743490|NCT02008565|3578644|B2|||BMI, mean (SD)||kg/m^2|Mean|28.5|28.5|Standard Deviation|6.7|6.7|||
3743491|NCT02008565|3578645|B1|||BMI, mean (SD)||kg/m^2|Mean|30.1|30.1|Standard Deviation|7.4|7.4|||
3743492|NCT02008565|3578641|B5||No prior pelvic organ prolapse surgery|Prior pelvic organ prolapse surgery, No. (%)||Participants|Count of Participants|226|226.0||||||
3743758|NCT02007512|3578815|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3743493|NCT02008565|3578642|B4||No prior pelvic organ prolapse surgery|Prior pelvic organ prolapse surgery, No. (%)||Participants|Count of Participants|34|34.0||||||
3743494|NCT02008565|3578643|B3||No prior pelvic organ prolapse surgery|Prior pelvic organ prolapse surgery, No. (%)||Participants|Count of Participants|68|68.0||||||
3743495|NCT02008565|3578644|B2||No prior pelvic organ prolapse surgery|Prior pelvic organ prolapse surgery, No. (%)||Participants|Count of Participants|61|61.0||||||
3743496|NCT02008565|3578645|B1||No prior pelvic organ prolapse surgery|Prior pelvic organ prolapse surgery, No. (%)||Participants|Count of Participants|63|63.0||||||
3743497|NCT02008565|3578641|B5||Prior pelvic organ prolapse surgery|Prior pelvic organ prolapse surgery, No. (%)||Participants|Count of Participants|70|70.0||||||
3743498|NCT02008565|3578642|B4||Prior pelvic organ prolapse surgery|Prior pelvic organ prolapse surgery, No. (%)||Participants|Count of Participants|8|8.0||||||
3743499|NCT02008565|3578643|B3||Prior pelvic organ prolapse surgery|Prior pelvic organ prolapse surgery, No. (%)||Participants|Count of Participants|18|18.0||||||
3743500|NCT02008565|3578644|B2||Prior pelvic organ prolapse surgery|Prior pelvic organ prolapse surgery, No. (%)||Participants|Count of Participants|22|22.0||||||
3743501|NCT02008565|3578645|B1||Prior pelvic organ prolapse surgery|Prior pelvic organ prolapse surgery, No. (%)||Participants|Count of Participants|22|22.0||||||
3743502|NCT02008565|3578641|B5||No prior urinary incontinence surgery|Prior urinary incontinence surgery, No. (%)||Participants|Count of Participants|219|219.0||||||
3743503|NCT02008565|3578642|B4||No prior urinary incontinence surgery|Prior urinary incontinence surgery, No. (%)||Participants|Count of Participants|31|31.0||||||
3743504|NCT02008565|3578643|B3||No prior urinary incontinence surgery|Prior urinary incontinence surgery, No. (%)||Participants|Count of Participants|66|66.0||||||
3743505|NCT02008565|3578644|B2||No prior urinary incontinence surgery|Prior urinary incontinence surgery, No. (%)||Participants|Count of Participants|61|61.0||||||
3743506|NCT02008565|3578645|B1||No prior urinary incontinence surgery|Prior urinary incontinence surgery, No. (%)||Participants|Count of Participants|61|61.0||||||
3743507|NCT02008565|3578641|B5||Prior urinary incontinence surgery|Prior urinary incontinence surgery, No. (%)||Participants|Count of Participants|77|77.0||||||
3743508|NCT02008565|3578642|B4||Prior urinary incontinence surgery|Prior urinary incontinence surgery, No. (%)||Participants|Count of Participants|11|11.0||||||
3743509|NCT02008565|3578643|B3||Prior urinary incontinence surgery|Prior urinary incontinence surgery, No. (%)||Participants|Count of Participants|20|20.0||||||
3743510|NCT02008565|3578644|B2||Prior urinary incontinence surgery|Prior urinary incontinence surgery, No. (%)||Participants|Count of Participants|22|22.0||||||
3743511|NCT02008565|3578645|B1||Prior urinary incontinence surgery|Prior urinary incontinence surgery, No. (%)||Participants|Count of Participants|24|24.0||||||
3743512|NCT02008565|3578641|B5||No prior hysterectomy|Prior hysterectomy, No. (%)||Participants|Count of Participants|148|148.0||||||
3743513|NCT02008565|3578642|B4||No prior hysterectomy|Prior hysterectomy, No. (%)||Participants|Count of Participants|24|24.0||||||
3743514|NCT02008565|3578643|B3||No prior hysterectomy|Prior hysterectomy, No. (%)||Participants|Count of Participants|41|41.0||||||
3743515|NCT02008565|3578644|B2||No prior hysterectomy|Prior hysterectomy, No. (%)||Participants|Count of Participants|43|43.0||||||
3743516|NCT02008565|3578645|B1||No prior hysterectomy|Prior hysterectomy, No. (%)||Participants|Count of Participants|40|40.0||||||
3743517|NCT02008565|3578641|B5||Prior hysterectomy|Prior hysterectomy, No. (%)||Participants|Count of Participants|148|148.0||||||
3743518|NCT02008565|3578642|B4||Prior hysterectomy|Prior hysterectomy, No. (%)||Participants|Count of Participants|18|18.0||||||
3743519|NCT02008565|3578643|B3||Prior hysterectomy|Prior hysterectomy, No. (%)||Participants|Count of Participants|45|45.0||||||
3743520|NCT02008565|3578644|B2||Prior hysterectomy|Prior hysterectomy, No. (%)||Participants|Count of Participants|40|40.0||||||
3743521|NCT02008565|3578645|B1||Prior hysterectomy|Prior hysterectomy, No. (%)||Participants|Count of Participants|45|45.0||||||
3743522|NCT02008565|3578641|B5||No prior rectal or anal surgery|Prior rectal or anal surgery, No. (%)||Participants|Count of Participants|256|256.0||||||
3743523|NCT02008565|3578642|B4||No prior rectal or anal surgery|Prior rectal or anal surgery, No. (%)||Participants|Count of Participants|35|35.0||||||
3743524|NCT02008565|3578643|B3||No prior rectal or anal surgery|Prior rectal or anal surgery, No. (%)||Participants|Count of Participants|77|77.0||||||
3743525|NCT02008565|3578644|B2||No prior rectal or anal surgery|Prior rectal or anal surgery, No. (%)||Participants|Count of Participants|72|72.0||||||
3743526|NCT02008565|3578645|B1||No prior rectal or anal surgery|Prior rectal or anal surgery, No. (%)||Participants|Count of Participants|72|72.0||||||
3743527|NCT02008565|3578641|B5||Prior rectal or anal surgery|Prior rectal or anal surgery, No. (%)||Participants|Count of Participants|40|40.0||||||
3743528|NCT02008565|3578642|B4||Prior rectal or anal surgery|Prior rectal or anal surgery, No. (%)||Participants|Count of Participants|7|7.0||||||
3743529|NCT02008565|3578643|B3||Prior rectal or anal surgery|Prior rectal or anal surgery, No. (%)||Participants|Count of Participants|9|9.0||||||
3743530|NCT02008565|3578644|B2||Prior rectal or anal surgery|Prior rectal or anal surgery, No. (%)||Participants|Count of Participants|11|11.0||||||
3743531|NCT02008565|3578645|B1||Prior rectal or anal surgery|Prior rectal or anal surgery, No. (%)||Participants|Count of Participants|13|13.0||||||
3743532|NCT02008565|3578641|B5||No prior accidental bowel leakage surgery|Prior accidental bowel leakage surgery, No. (%)||Participants|Count of Participants|283|283.0||||||
3743533|NCT02008565|3578642|B4||No prior accidental bowel leakage surgery|Prior accidental bowel leakage surgery, No. (%)||Participants|Count of Participants|42|42.0||||||
3743534|NCT02008565|3578643|B3||No prior accidental bowel leakage surgery|Prior accidental bowel leakage surgery, No. (%)||Participants|Count of Participants|82|82.0||||||
3743535|NCT02008565|3578644|B2||No prior accidental bowel leakage surgery|Prior accidental bowel leakage surgery, No. (%)||Participants|Count of Participants|77|77.0||||||
3743536|NCT02008565|3578645|B1||No prior accidental bowel leakage surgery|Prior accidental bowel leakage surgery, No. (%)||Participants|Count of Participants|82|82.0||||||
3743537|NCT02008565|3578641|B5||Prior accidental bowel leakage surgery|Prior accidental bowel leakage surgery, No. (%)||Participants|Count of Participants|13|13.0||||||
3743538|NCT02008565|3578642|B4||Prior accidental bowel leakage surgery|Prior accidental bowel leakage surgery, No. (%)||Participants|Count of Participants|0|0.0||||||
3743539|NCT02008565|3578643|B3||Prior accidental bowel leakage surgery|Prior accidental bowel leakage surgery, No. (%)||Participants|Count of Participants|4|4.0||||||
3743540|NCT02008565|3578644|B2||Prior accidental bowel leakage surgery|Prior accidental bowel leakage surgery, No. (%)||Participants|Count of Participants|6|6.0||||||
3743541|NCT02008565|3578645|B1||Prior accidental bowel leakage surgery|Prior accidental bowel leakage surgery, No. (%)||Participants|Count of Participants|3|3.0||||||
3743542|NCT02008565|3578641|B5||Does not have connective tissue disease|Connective tissue disease, No. (%)||Participants|Count of Participants|284|284.0||||||
3743543|NCT02008565|3578642|B4||Does not have connective tissue disease|Connective tissue disease, No. (%)||Participants|Count of Participants|41|41.0||||||
3743544|NCT02008565|3578643|B3||Does not have connective tissue disease|Connective tissue disease, No. (%)||Participants|Count of Participants|83|83.0||||||
3743545|NCT02008565|3578644|B2||Does not have connective tissue disease|Connective tissue disease, No. (%)||Participants|Count of Participants|78|78.0||||||
3743546|NCT02008565|3578645|B1||Does not have connective tissue disease|Connective tissue disease, No. (%)||Participants|Count of Participants|82|82.0||||||
3743547|NCT02008565|3578641|B5||Connective tissue disease|Connective tissue disease, No. (%)||Participants|Count of Participants|12|12.0||||||
3743548|NCT02008565|3578642|B4||Connective tissue disease|Connective tissue disease, No. (%)||Participants|Count of Participants|1|1.0||||||
3743549|NCT02008565|3578643|B3||Connective tissue disease|Connective tissue disease, No. (%)||Participants|Count of Participants|3|3.0||||||
3743550|NCT02008565|3578644|B2||Connective tissue disease|Connective tissue disease, No. (%)||Participants|Count of Participants|5|5.0||||||
3743551|NCT02008565|3578645|B1||Connective tissue disease|Connective tissue disease, No. (%)||Participants|Count of Participants|3|3.0||||||
3743552|NCT02008565|3578641|B5||Not current smoker|Current smoker, No. (%)||Participants|Count of Participants|275|275.0||||||
3743553|NCT02008565|3578642|B4||Not current smoker|Current smoker, No. (%)||Participants|Count of Participants|40|40.0||||||
3743554|NCT02008565|3578643|B3||Not current smoker|Current smoker, No. (%)||Participants|Count of Participants|78|78.0||||||
3743555|NCT02008565|3578644|B2||Not current smoker|Current smoker, No. (%)||Participants|Count of Participants|75|75.0||||||
3743556|NCT02008565|3578645|B1||Not current smoker|Current smoker, No. (%)||Participants|Count of Participants|82|82.0||||||
3743557|NCT02008565|3578641|B5||Current smoker|Current smoker, No. (%)||Participants|Count of Participants|21|21.0||||||
3743558|NCT02008565|3578642|B4||Current smoker|Current smoker, No. (%)||Participants|Count of Participants|2|2.0||||||
3743559|NCT02008565|3578643|B3||Current smoker|Current smoker, No. (%)||Participants|Count of Participants|8|8.0||||||
3743560|NCT02008565|3578644|B2||Current smoker|Current smoker, No. (%)||Participants|Count of Participants|8|8.0||||||
3743561|NCT02008565|3578645|B1||Current smoker|Current smoker, No. (%)||Participants|Count of Participants|3|3.0||||||
3743562|NCT02008565|3578641|B5||Not currently using estrogen therapy|Currently using estrogen therapy, No. (%)||Participants|Count of Participants|193|193.0||||||
3743563|NCT02008565|3578642|B4||Not currently using estrogen therapy|Currently using estrogen therapy, No. (%)||Participants|Count of Participants|29|29.0||||||
3743564|NCT02008565|3578643|B3||Not currently using estrogen therapy|Currently using estrogen therapy, No. (%)||Participants|Count of Participants|57|57.0||||||
3743565|NCT02008565|3578644|B2||Not currently using estrogen therapy|Currently using estrogen therapy, No. (%)||Participants|Count of Participants|53|53.0||||||
3743566|NCT02008565|3578645|B1||Not currently using estrogen therapy|Currently using estrogen therapy, No. (%)||Participants|Count of Participants|54|54.0||||||
3743567|NCT02008565|3578641|B5||Vaginal|Currently using estrogen therapy, No. (%)||Participants|Count of Participants|75|75.0||||||
3743568|NCT02008565|3578642|B4||Vaginal|Currently using estrogen therapy, No. (%)||Participants|Count of Participants|10|10.0||||||
3743569|NCT02008565|3578643|B3||Vaginal|Currently using estrogen therapy, No. (%)||Participants|Count of Participants|19|19.0||||||
3743570|NCT02008565|3578644|B2||Vaginal|Currently using estrogen therapy, No. (%)||Participants|Count of Participants|22|22.0||||||
3743571|NCT02008565|3578645|B1||Vaginal|Currently using estrogen therapy, No. (%)||Participants|Count of Participants|24|24.0||||||
3743572|NCT02008565|3578641|B5||Oral/Patch|Currently using estrogen therapy, No. (%)||Participants|Count of Participants|28|28.0||||||
3743573|NCT02008565|3578642|B4||Oral/Patch|Currently using estrogen therapy, No. (%)||Participants|Count of Participants|3|3.0||||||
3743574|NCT02008565|3578643|B3||Oral/Patch|Currently using estrogen therapy, No. (%)||Participants|Count of Participants|10|10.0||||||
3743575|NCT02008565|3578644|B2||Oral/Patch|Currently using estrogen therapy, No. (%)||Participants|Count of Participants|8|8.0||||||
3743576|NCT02008565|3578645|B1||Oral/Patch|Currently using estrogen therapy, No. (%)||Participants|Count of Participants|7|7.0||||||
3743577|NCT02008565|3578641|B5||Pre-menopausal|Menstrual status, No. (%)||Participants|Count of Participants|29|29.0||||||
3743578|NCT02008565|3578642|B4||Pre-menopausal|Menstrual status, No. (%)||Participants|Count of Participants|6|6.0||||||
3743579|NCT02008565|3578643|B3||Pre-menopausal|Menstrual status, No. (%)||Participants|Count of Participants|7|7.0||||||
3743580|NCT02008565|3578644|B2||Pre-menopausal|Menstrual status, No. (%)||Participants|Count of Participants|7|7.0||||||
3743581|NCT02008565|3578645|B1||Pre-menopausal|Menstrual status, No. (%)||Participants|Count of Participants|9|9.0||||||
3743582|NCT02008565|3578641|B5||Post-menopausal|Menstrual status, No. (%)||Participants|Count of Participants|251|251.0||||||
3743583|NCT02008565|3578642|B4||Post-menopausal|Menstrual status, No. (%)||Participants|Count of Participants|34|34.0||||||
3743584|NCT02008565|3578643|B3||Post-menopausal|Menstrual status, No. (%)||Participants|Count of Participants|74|74.0||||||
3743585|NCT02008565|3578644|B2||Post-menopausal|Menstrual status, No. (%)||Participants|Count of Participants|69|69.0||||||
3743586|NCT02008565|3578645|B1||Post-menopausal|Menstrual status, No. (%)||Participants|Count of Participants|74|74.0||||||
3743587|NCT02008565|3578641|B5||Not Sure|Menstrual status, No. (%)||Participants|Count of Participants|16|16.0||||||
3743588|NCT02008565|3578642|B4||Not Sure|Menstrual status, No. (%)||Participants|Count of Participants|2|2.0||||||
3743589|NCT02008565|3578643|B3||Not Sure|Menstrual status, No. (%)||Participants|Count of Participants|5|5.0||||||
3743590|NCT02008565|3578644|B2||Not Sure|Menstrual status, No. (%)||Participants|Count of Participants|7|7.0||||||
3743591|NCT02008565|3578645|B1||Not Sure|Menstrual status, No. (%)||Participants|Count of Participants|2|2.0||||||
3743592|NCT02008565|3578641|B5|||Cesarean deliveries, median [min, max]||Cesarean deliveries|Median|0.0|0.0|Full Range|||0.0|5.0|
3743593|NCT02008565|3578642|B4|||Cesarean deliveries, median [min, max]||Cesarean deliveries|Median|0.0|0.0|Full Range|||0.0|2.0|
3743594|NCT02008565|3578643|B3|||Cesarean deliveries, median [min, max]||Cesarean deliveries|Median|0.0|0.0|Full Range|||0.0|2.0|
3743595|NCT02008565|3578644|B2|||Cesarean deliveries, median [min, max]||Cesarean deliveries|Median|0.0|0.0|Full Range|||0.0|5.0|
3743596|NCT02008565|3578645|B1|||Cesarean deliveries, median [min, max]||Cesarean deliveries|Median|0.0|0.0|Full Range|||0.0|4.0|
3743597|NCT02008565|3578641|B5|||Vaginal deliveries, median [min, max]||Vaginal deliveries|Median|2.0|2.0|Full Range|||0.0|7.0|
3743598|NCT02008565|3578642|B4|||Vaginal deliveries, median [min, max]||Vaginal deliveries|Median|2.0|2.0|Full Range|||0.0|7.0|
3743599|NCT02008565|3578643|B3|||Vaginal deliveries, median [min, max]||Vaginal deliveries|Median|2.0|2.0|Full Range|||0.0|6.0|
3743600|NCT02008565|3578644|B2|||Vaginal deliveries, median [min, max]||Vaginal deliveries|Median|2.0|2.0|Full Range|||0.0|6.0|
3743601|NCT02008565|3578645|B1|||Vaginal deliveries, median [min, max]||Vaginal deliveries|Median|2.0|2.0|Full Range|||0.0|7.0|
3743602|NCT02008565|3578641|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|234|234.0||||||
3743603|NCT02008565|3578642|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3743604|NCT02008565|3578643|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|71|71.0||||||
3743605|NCT02008565|3578644|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|67|67.0||||||
3743606|NCT02008565|3578645|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|65|65.0||||||
3743607|NCT02008565|3578641|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3743608|NCT02008565|3578642|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3743609|NCT02008565|3578643|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3743610|NCT02008565|3578644|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3743611|NCT02008565|3578645|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3743612|NCT02008565|3578641|B5|More than one race||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3743613|NCT02008565|3578642|B4|More than one race||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3743614|NCT02008565|3578643|B3|More than one race||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3743615|NCT02008565|3578644|B2|More than one race||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3743616|NCT02008565|3578645|B1|More than one race||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3743617|NCT02008565|3578641|B5|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
3743618|NCT02008565|3578642|B4|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3743619|NCT02008565|3578643|B3|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3743620|NCT02008565|3578644|B2|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3743621|NCT02008565|3578645|B1|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3743622|NCT02008565|3578641|B5|American Indian/Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3743623|NCT02008565|3578642|B4|American Indian/Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3743624|NCT02008565|3578643|B3|American Indian/Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3743625|NCT02008565|3578644|B2|American Indian/Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3743626|NCT02008565|3578645|B1|American Indian/Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3743627|NCT02008565|3578641|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3743628|NCT02008565|3578642|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3743629|NCT02008565|3578643|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3743630|NCT02008565|3578644|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3743631|NCT02008565|3578645|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3743632|NCT02008565|3578641|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|265|265.0||||||
3743633|NCT02008565|3578642|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3743634|NCT02008565|3578643|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3743635|NCT02008565|3578644|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3743636|NCT02008565|3578645|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
3743637|NCT02008565|3578641|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3743638|NCT02008565|3578642|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3743639|NCT02008565|3578643|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3743640|NCT02008565|3578644|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3743641|NCT02008565|3578645|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3743642|NCT02008565|3578641|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3743643|NCT02008565|3578642|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3743644|NCT02008565|3578643|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3743645|NCT02008565|3578644|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3743646|NCT02008565|3578645|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3743647|NCT02008565|3578641|B5||Female|Sex: Female, Male||Participants|Count of Participants|296|296.0||||||
3743648|NCT02008565|3578642|B4||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3743649|NCT02008565|3578643|B3||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3743650|NCT02008565|3578644|B2||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3743651|NCT02008565|3578645|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3743652|NCT02008565|3578641|B5|||Age||years|Mean|63.6|63.6|Standard Deviation|11.1|11.1|||
3743653|NCT02008565|3578642|B4|||Age||years|Mean|62.6|62.6|Standard Deviation|10.6|10.6|||
3743654|NCT02008565|3578643|B3|||Age||years|Mean|63.4|63.4|Standard Deviation|10.6|10.6|||
3743655|NCT02008565|3578644|B2|||Age||years|Mean|63.2|63.2|Standard Deviation|12.2|12.2|||
3743656|NCT02008565|3578645|B1|||Age||years|Mean|65.2|65.2|Standard Deviation|10.9|10.9|||
3743657|NCT02008526|3578706|B4|HIV Positive||HIV Status||Participants|Count of Participants|118|118.0||||||
3743658|NCT02008526|3578707|B3|HIV Positive||HIV Status||Participants|Count of Participants|39|39.0||||||
3743659|NCT02008526|3578708|B2|HIV Positive||HIV Status||Participants|Count of Participants|42|42.0||||||
3743660|NCT02008526|3578709|B1|HIV Positive||HIV Status||Participants|Count of Participants|37|37.0||||||
3743661|NCT02008526|3578706|B4|HIV Negative||HIV Status||Participants|Count of Participants|168|168.0||||||
3743662|NCT02008526|3578707|B3|HIV Negative||HIV Status||Participants|Count of Participants|54|54.0||||||
3743663|NCT02008526|3578708|B2|HIV Negative||HIV Status||Participants|Count of Participants|57|57.0||||||
3743664|NCT02008526|3578709|B1|HIV Negative||HIV Status||Participants|Count of Participants|57|57.0||||||
3743665|NCT02008526|3578706|B4|United States||Region of Enrollment||Participants|Count of Participants|286|286.0||||||
3743666|NCT02008526|3578707|B3|United States||Region of Enrollment||Participants|Count of Participants|93|93.0||||||
3743667|NCT02008526|3578708|B2|United States||Region of Enrollment||Participants|Count of Participants|99|99.0||||||
3743668|NCT02008526|3578709|B1|United States||Region of Enrollment||Participants|Count of Participants|94|94.0||||||
3743669|NCT02008526|3578706|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3743670|NCT02008526|3578707|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3743671|NCT02008526|3578708|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3743672|NCT02008526|3578709|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3743673|NCT02008526|3578706|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3743674|NCT02008526|3578707|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3743675|NCT02008526|3578708|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3743676|NCT02008526|3578709|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3743677|NCT02008526|3578706|B4||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3743678|NCT02008526|3578707|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3743679|NCT02008526|3578708|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3743680|NCT02008526|3578709|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3743681|NCT02008526|3578706|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
3743682|NCT02008526|3578707|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3743683|NCT02008526|3578708|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3743684|NCT02008526|3578709|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3743685|NCT02008526|3578706|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3743686|NCT02008526|3578707|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3743687|NCT02008526|3578708|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3743688|NCT02008526|3578709|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3743689|NCT02008526|3578706|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3743690|NCT02008526|3578707|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3743691|NCT02008526|3578708|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3743692|NCT02008526|3578709|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3743693|NCT02008526|3578706|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3743694|NCT02008526|3578707|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3743695|NCT02008526|3578708|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3743696|NCT02008526|3578709|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3743697|NCT02008526|3578706|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3743698|NCT02008526|3578707|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3743699|NCT02008526|3578708|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3743700|NCT02008526|3578709|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3743701|NCT02008526|3578706|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|214|214.0||||||
3743702|NCT02008526|3578707|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3743703|NCT02008526|3578708|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3743704|NCT02008526|3578709|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3743705|NCT02008526|3578706|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3743706|NCT02008526|3578707|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3743707|NCT02008526|3578708|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3743708|NCT02008526|3578709|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3743709|NCT02008526|3578706|B4||Male|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
3743710|NCT02008526|3578707|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3743711|NCT02008526|3578708|B2||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3743712|NCT02008526|3578709|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3743713|NCT02008526|3578706|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3743714|NCT02008526|3578707|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3743715|NCT02008526|3578708|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3743716|NCT02008526|3578709|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3743717|NCT02008526|3578706|B4|||Age||years|Mean|41.48|41.48|Standard Deviation|10.85|10.85|||
3743718|NCT02008526|3578707|B3|||Age||years|Mean|41.43|41.43|Standard Deviation|10.15|10.15|||
3743719|NCT02008526|3578708|B2|||Age||years|Mean|41.00|41.0|Standard Deviation|11.12|11.12|||
3743720|NCT02008526|3578709|B1|||Age||years|Mean|42.04|42.04|Standard Deviation|11.31|11.31|||
3743721|NCT02008227|3578722|B3||Male|Sex: Female, Male||Participants|Count of Participants|757|757.0||||||
3743722|NCT02008227|3578723|B2||Male|Sex: Female, Male||Participants|Count of Participants|378|378.0||||||
3743723|NCT02008227|3578724|B1||Male|Sex: Female, Male||Participants|Count of Participants|379|379.0||||||
3743724|NCT02008227|3578722|B3||Female|Sex: Female, Male||Participants|Count of Participants|468|468.0||||||
3743725|NCT02008227|3578723|B2||Female|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
3743726|NCT02008227|3578724|B1||Female|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
3743727|NCT02008227|3578722|B3|||Age||Years|Mean|62.8|62.8|Standard Deviation|9.5|9.5|||
3743728|NCT02008227|3578723|B2|||Age||Years|Mean|62.7|62.7|Standard Deviation|9.8|9.8|||
3743729|NCT02008227|3578724|B1|||Age||Years|Mean|62.9|62.9|Standard Deviation|9.2|9.2|||
3743730|NCT02007954|3578786|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3743731|NCT02007954|3578786|B1|Unknown|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3743732|NCT02007954|3578786|B1|Unknown|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3743733|NCT02007954|3578786|B1|Unknown|African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3743734|NCT02007954|3578786|B1|Unknown|White|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3743735|NCT02007954|3578786|B1|Non-Hispanic|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3743736|NCT02007954|3578786|B1|Non-Hispanic|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3743737|NCT02007954|3578786|B1|Non-Hispanic|African American|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3743738|NCT02007954|3578786|B1|Non-Hispanic|White|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3743739|NCT02007954|3578786|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3743740|NCT02007954|3578786|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3743741|NCT02007954|3578786|B1|||Age||years|Median|62.5|62.5|Full Range|||35.0|80.0|
3743742|NCT02007863|3578799|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3743743|NCT02007863|3578799|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3743744|NCT02007863|3578799|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3743745|NCT02007863|3578799|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3743746|NCT02007863|3578799|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3743747|NCT02007863|3578799|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3743748|NCT02007577|3578803|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3743749|NCT02007577|3578804|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3743750|NCT02007577|3578805|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3743751|NCT02007577|3578803|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3743752|NCT02007577|3578804|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3743753|NCT02007577|3578805|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3743754|NCT02007577|3578803|B3|||Age||years|Mean|54|54.0|Standard Deviation|10|10.0|||
3743755|NCT02007577|3578804|B2|||Age||years|Mean|54|54.0|Standard Deviation|10|10.0|||
3743756|NCT02007577|3578805|B1|||Age||years|Mean|54|54.0|Standard Deviation|10|10.0|||
3743757|NCT02007512|3578814|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3743759|NCT02007512|3578816|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3743760|NCT02007512|3578817|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3743761|NCT02007512|3578818|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3743762|NCT02007512|3578814|B5||Female|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
3743763|NCT02007512|3578815|B4||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3743764|NCT02007512|3578816|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3743765|NCT02007512|3578817|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3743766|NCT02007512|3578818|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3743767|NCT02007512|3578814|B5||>=65 years|Age||Participants|Count of Participants|96|96.0||||||
3743768|NCT02007512|3578815|B4||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3743769|NCT02007512|3578816|B3||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3743770|NCT02007512|3578817|B2||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
3743771|NCT02007512|3578818|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3743772|NCT02007512|3578814|B5||Between 18 and 65 years|Age||Participants|Count of Participants|151|151.0||||||
3743773|NCT02007512|3578815|B4||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3743774|NCT02007512|3578816|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3743775|NCT02007512|3578817|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3743776|NCT02007512|3578818|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3743777|NCT02007512|3578814|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3743778|NCT02007512|3578815|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3743779|NCT02007512|3578816|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3743780|NCT02007512|3578817|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3743781|NCT02007512|3578818|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3743782|NCT02007434|3578891|B9|2||Subject Self Rating Scale (SSRS)|The SSRS assesses participant's satisfaction with their appearance in association with the face and chin on a 7-point scale from 0 to 6: where 0 = Extremely dissatisfied, 1 = Dissatisfied, 2 = Slightly dissatisfied, 3 = Neither satisfied nor dissatisfied, 4 = Slightly satisfied, 5 = Satisfied and 6 = Extremely satisfied.|participants|Number|33|33.0||||||
3743783|NCT02007434|3578892|B8|2||Subject Self Rating Scale (SSRS)|The SSRS assesses participant's satisfaction with their appearance in association with the face and chin on a 7-point scale from 0 to 6: where 0 = Extremely dissatisfied, 1 = Dissatisfied, 2 = Slightly dissatisfied, 3 = Neither satisfied nor dissatisfied, 4 = Slightly satisfied, 5 = Satisfied and 6 = Extremely satisfied.|participants|Number|2|2.0||||||
3743784|NCT02007434|3578893|B7|2||Subject Self Rating Scale (SSRS)|The SSRS assesses participant's satisfaction with their appearance in association with the face and chin on a 7-point scale from 0 to 6: where 0 = Extremely dissatisfied, 1 = Dissatisfied, 2 = Slightly dissatisfied, 3 = Neither satisfied nor dissatisfied, 4 = Slightly satisfied, 5 = Satisfied and 6 = Extremely satisfied.|participants|Number|10|10.0||||||
3743785|NCT02007434|3578894|B6|2||Subject Self Rating Scale (SSRS)|The SSRS assesses participant's satisfaction with their appearance in association with the face and chin on a 7-point scale from 0 to 6: where 0 = Extremely dissatisfied, 1 = Dissatisfied, 2 = Slightly dissatisfied, 3 = Neither satisfied nor dissatisfied, 4 = Slightly satisfied, 5 = Satisfied and 6 = Extremely satisfied.|participants|Number|1|1.0||||||
3743786|NCT02007434|3578895|B5|2||Subject Self Rating Scale (SSRS)|The SSRS assesses participant's satisfaction with their appearance in association with the face and chin on a 7-point scale from 0 to 6: where 0 = Extremely dissatisfied, 1 = Dissatisfied, 2 = Slightly dissatisfied, 3 = Neither satisfied nor dissatisfied, 4 = Slightly satisfied, 5 = Satisfied and 6 = Extremely satisfied.|participants|Number|5|5.0||||||
3743787|NCT02007434|3578896|B4|2||Subject Self Rating Scale (SSRS)|The SSRS assesses participant's satisfaction with their appearance in association with the face and chin on a 7-point scale from 0 to 6: where 0 = Extremely dissatisfied, 1 = Dissatisfied, 2 = Slightly dissatisfied, 3 = Neither satisfied nor dissatisfied, 4 = Slightly satisfied, 5 = Satisfied and 6 = Extremely satisfied.|participants|Number|1|1.0||||||
3743788|NCT02007434|3578897|B3|2||Subject Self Rating Scale (SSRS)|The SSRS assesses participant's satisfaction with their appearance in association with the face and chin on a 7-point scale from 0 to 6: where 0 = Extremely dissatisfied, 1 = Dissatisfied, 2 = Slightly dissatisfied, 3 = Neither satisfied nor dissatisfied, 4 = Slightly satisfied, 5 = Satisfied and 6 = Extremely satisfied.|participants|Number|5|5.0||||||
3743789|NCT02007434|3578898|B2|2||Subject Self Rating Scale (SSRS)|The SSRS assesses participant's satisfaction with their appearance in association with the face and chin on a 7-point scale from 0 to 6: where 0 = Extremely dissatisfied, 1 = Dissatisfied, 2 = Slightly dissatisfied, 3 = Neither satisfied nor dissatisfied, 4 = Slightly satisfied, 5 = Satisfied and 6 = Extremely satisfied.|participants|Number|1|1.0||||||
3743790|NCT02007434|3578899|B1|2||Subject Self Rating Scale (SSRS)|The SSRS assesses participant's satisfaction with their appearance in association with the face and chin on a 7-point scale from 0 to 6: where 0 = Extremely dissatisfied, 1 = Dissatisfied, 2 = Slightly dissatisfied, 3 = Neither satisfied nor dissatisfied, 4 = Slightly satisfied, 5 = Satisfied and 6 = Extremely satisfied.|participants|Number|8|8.0||||||
3743791|NCT02007434|3578891|B9|1||Subject Self Rating Scale (SSRS)|The SSRS assesses participant's satisfaction with their appearance in association with the face and chin on a 7-point scale from 0 to 6: where 0 = Extremely dissatisfied, 1 = Dissatisfied, 2 = Slightly dissatisfied, 3 = Neither satisfied nor dissatisfied, 4 = Slightly satisfied, 5 = Satisfied and 6 = Extremely satisfied.|participants|Number|43|43.0||||||
3743792|NCT02007434|3578892|B8|1||Subject Self Rating Scale (SSRS)|The SSRS assesses participant's satisfaction with their appearance in association with the face and chin on a 7-point scale from 0 to 6: where 0 = Extremely dissatisfied, 1 = Dissatisfied, 2 = Slightly dissatisfied, 3 = Neither satisfied nor dissatisfied, 4 = Slightly satisfied, 5 = Satisfied and 6 = Extremely satisfied.|participants|Number|1|1.0||||||
3743905|NCT02007434|3578897|B3|Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743793|NCT02007434|3578893|B7|1||Subject Self Rating Scale (SSRS)|The SSRS assesses participant's satisfaction with their appearance in association with the face and chin on a 7-point scale from 0 to 6: where 0 = Extremely dissatisfied, 1 = Dissatisfied, 2 = Slightly dissatisfied, 3 = Neither satisfied nor dissatisfied, 4 = Slightly satisfied, 5 = Satisfied and 6 = Extremely satisfied.|participants|Number|8|8.0||||||
3743794|NCT02007434|3578894|B6|1||Subject Self Rating Scale (SSRS)|The SSRS assesses participant's satisfaction with their appearance in association with the face and chin on a 7-point scale from 0 to 6: where 0 = Extremely dissatisfied, 1 = Dissatisfied, 2 = Slightly dissatisfied, 3 = Neither satisfied nor dissatisfied, 4 = Slightly satisfied, 5 = Satisfied and 6 = Extremely satisfied.|participants|Number|3|3.0||||||
3743795|NCT02007434|3578895|B5|1||Subject Self Rating Scale (SSRS)|The SSRS assesses participant's satisfaction with their appearance in association with the face and chin on a 7-point scale from 0 to 6: where 0 = Extremely dissatisfied, 1 = Dissatisfied, 2 = Slightly dissatisfied, 3 = Neither satisfied nor dissatisfied, 4 = Slightly satisfied, 5 = Satisfied and 6 = Extremely satisfied.|participants|Number|10|10.0||||||
3743796|NCT02007434|3578896|B4|1||Subject Self Rating Scale (SSRS)|The SSRS assesses participant's satisfaction with their appearance in association with the face and chin on a 7-point scale from 0 to 6: where 0 = Extremely dissatisfied, 1 = Dissatisfied, 2 = Slightly dissatisfied, 3 = Neither satisfied nor dissatisfied, 4 = Slightly satisfied, 5 = Satisfied and 6 = Extremely satisfied.|participants|Number|3|3.0||||||
3743797|NCT02007434|3578897|B3|1||Subject Self Rating Scale (SSRS)|The SSRS assesses participant's satisfaction with their appearance in association with the face and chin on a 7-point scale from 0 to 6: where 0 = Extremely dissatisfied, 1 = Dissatisfied, 2 = Slightly dissatisfied, 3 = Neither satisfied nor dissatisfied, 4 = Slightly satisfied, 5 = Satisfied and 6 = Extremely satisfied.|participants|Number|9|9.0||||||
3743798|NCT02007434|3578898|B2|1||Subject Self Rating Scale (SSRS)|The SSRS assesses participant's satisfaction with their appearance in association with the face and chin on a 7-point scale from 0 to 6: where 0 = Extremely dissatisfied, 1 = Dissatisfied, 2 = Slightly dissatisfied, 3 = Neither satisfied nor dissatisfied, 4 = Slightly satisfied, 5 = Satisfied and 6 = Extremely satisfied.|participants|Number|1|1.0||||||
3743799|NCT02007434|3578899|B1|1||Subject Self Rating Scale (SSRS)|The SSRS assesses participant's satisfaction with their appearance in association with the face and chin on a 7-point scale from 0 to 6: where 0 = Extremely dissatisfied, 1 = Dissatisfied, 2 = Slightly dissatisfied, 3 = Neither satisfied nor dissatisfied, 4 = Slightly satisfied, 5 = Satisfied and 6 = Extremely satisfied.|participants|Number|8|8.0||||||
3743800|NCT02007434|3578891|B9|0||Subject Self Rating Scale (SSRS)|The SSRS assesses participant's satisfaction with their appearance in association with the face and chin on a 7-point scale from 0 to 6: where 0 = Extremely dissatisfied, 1 = Dissatisfied, 2 = Slightly dissatisfied, 3 = Neither satisfied nor dissatisfied, 4 = Slightly satisfied, 5 = Satisfied and 6 = Extremely satisfied.|participants|Number|7|7.0||||||
3743801|NCT02007434|3578892|B8|0||Subject Self Rating Scale (SSRS)|The SSRS assesses participant's satisfaction with their appearance in association with the face and chin on a 7-point scale from 0 to 6: where 0 = Extremely dissatisfied, 1 = Dissatisfied, 2 = Slightly dissatisfied, 3 = Neither satisfied nor dissatisfied, 4 = Slightly satisfied, 5 = Satisfied and 6 = Extremely satisfied.|participants|Number|1|1.0||||||
3743802|NCT02007434|3578893|B7|0||Subject Self Rating Scale (SSRS)|The SSRS assesses participant's satisfaction with their appearance in association with the face and chin on a 7-point scale from 0 to 6: where 0 = Extremely dissatisfied, 1 = Dissatisfied, 2 = Slightly dissatisfied, 3 = Neither satisfied nor dissatisfied, 4 = Slightly satisfied, 5 = Satisfied and 6 = Extremely satisfied.|participants|Number|0|0.0||||||
3743803|NCT02007434|3578894|B6|0||Subject Self Rating Scale (SSRS)|The SSRS assesses participant's satisfaction with their appearance in association with the face and chin on a 7-point scale from 0 to 6: where 0 = Extremely dissatisfied, 1 = Dissatisfied, 2 = Slightly dissatisfied, 3 = Neither satisfied nor dissatisfied, 4 = Slightly satisfied, 5 = Satisfied and 6 = Extremely satisfied.|participants|Number|0|0.0||||||
3743804|NCT02007434|3578895|B5|0||Subject Self Rating Scale (SSRS)|The SSRS assesses participant's satisfaction with their appearance in association with the face and chin on a 7-point scale from 0 to 6: where 0 = Extremely dissatisfied, 1 = Dissatisfied, 2 = Slightly dissatisfied, 3 = Neither satisfied nor dissatisfied, 4 = Slightly satisfied, 5 = Satisfied and 6 = Extremely satisfied.|participants|Number|1|1.0||||||
3743805|NCT02007434|3578896|B4|0||Subject Self Rating Scale (SSRS)|The SSRS assesses participant's satisfaction with their appearance in association with the face and chin on a 7-point scale from 0 to 6: where 0 = Extremely dissatisfied, 1 = Dissatisfied, 2 = Slightly dissatisfied, 3 = Neither satisfied nor dissatisfied, 4 = Slightly satisfied, 5 = Satisfied and 6 = Extremely satisfied.|participants|Number|0|0.0||||||
3743806|NCT02007434|3578897|B3|0||Subject Self Rating Scale (SSRS)|The SSRS assesses participant's satisfaction with their appearance in association with the face and chin on a 7-point scale from 0 to 6: where 0 = Extremely dissatisfied, 1 = Dissatisfied, 2 = Slightly dissatisfied, 3 = Neither satisfied nor dissatisfied, 4 = Slightly satisfied, 5 = Satisfied and 6 = Extremely satisfied.|participants|Number|3|3.0||||||
3743807|NCT02007434|3578898|B2|0||Subject Self Rating Scale (SSRS)|The SSRS assesses participant's satisfaction with their appearance in association with the face and chin on a 7-point scale from 0 to 6: where 0 = Extremely dissatisfied, 1 = Dissatisfied, 2 = Slightly dissatisfied, 3 = Neither satisfied nor dissatisfied, 4 = Slightly satisfied, 5 = Satisfied and 6 = Extremely satisfied.|participants|Number|1|1.0||||||
3743808|NCT02007434|3578899|B1|0||Subject Self Rating Scale (SSRS)|The SSRS assesses participant's satisfaction with their appearance in association with the face and chin on a 7-point scale from 0 to 6: where 0 = Extremely dissatisfied, 1 = Dissatisfied, 2 = Slightly dissatisfied, 3 = Neither satisfied nor dissatisfied, 4 = Slightly satisfied, 5 = Satisfied and 6 = Extremely satisfied.|participants|Number|1|1.0||||||
3743809|NCT02007434|3578891|B9|3||Patient-Reported Submental Fat Rating Scale (PR-SMFRS)|"The PR-SMFRS is based on the participant's response to the question How much fat do you have under your chin right now? answered on a 5-point ordinal scale (0–4) with 0 = no chin fat at all, 1 = a slight amount of chin fat, 2 = a moderate amount of chin fat, 3 = a large amount of chin fat, and 4 = a very large amount of chin fat."|participants|Number|27|27.0||||||
3743906|NCT02007434|3578898|B2|Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743907|NCT02007434|3578899|B1|Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743908|NCT02007434|3578891|B9|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3743810|NCT02007434|3578892|B8|3||Patient-Reported Submental Fat Rating Scale (PR-SMFRS)|"The PR-SMFRS is based on the participant's response to the question How much fat do you have under your chin right now? answered on a 5-point ordinal scale (0–4) with 0 = no chin fat at all, 1 = a slight amount of chin fat, 2 = a moderate amount of chin fat, 3 = a large amount of chin fat, and 4 = a very large amount of chin fat."|participants|Number|1|1.0||||||
3743811|NCT02007434|3578893|B7|3||Patient-Reported Submental Fat Rating Scale (PR-SMFRS)|"The PR-SMFRS is based on the participant's response to the question How much fat do you have under your chin right now? answered on a 5-point ordinal scale (0–4) with 0 = no chin fat at all, 1 = a slight amount of chin fat, 2 = a moderate amount of chin fat, 3 = a large amount of chin fat, and 4 = a very large amount of chin fat."|participants|Number|5|5.0||||||
3743812|NCT02007434|3578894|B6|3||Patient-Reported Submental Fat Rating Scale (PR-SMFRS)|"The PR-SMFRS is based on the participant's response to the question How much fat do you have under your chin right now? answered on a 5-point ordinal scale (0–4) with 0 = no chin fat at all, 1 = a slight amount of chin fat, 2 = a moderate amount of chin fat, 3 = a large amount of chin fat, and 4 = a very large amount of chin fat."|participants|Number|3|3.0||||||
3743813|NCT02007434|3578895|B5|3||Patient-Reported Submental Fat Rating Scale (PR-SMFRS)|"The PR-SMFRS is based on the participant's response to the question How much fat do you have under your chin right now? answered on a 5-point ordinal scale (0–4) with 0 = no chin fat at all, 1 = a slight amount of chin fat, 2 = a moderate amount of chin fat, 3 = a large amount of chin fat, and 4 = a very large amount of chin fat."|participants|Number|4|4.0||||||
3743814|NCT02007434|3578896|B4|3||Patient-Reported Submental Fat Rating Scale (PR-SMFRS)|"The PR-SMFRS is based on the participant's response to the question How much fat do you have under your chin right now? answered on a 5-point ordinal scale (0–4) with 0 = no chin fat at all, 1 = a slight amount of chin fat, 2 = a moderate amount of chin fat, 3 = a large amount of chin fat, and 4 = a very large amount of chin fat."|participants|Number|3|3.0||||||
3743815|NCT02007434|3578897|B3|3||Patient-Reported Submental Fat Rating Scale (PR-SMFRS)|"The PR-SMFRS is based on the participant's response to the question How much fat do you have under your chin right now? answered on a 5-point ordinal scale (0–4) with 0 = no chin fat at all, 1 = a slight amount of chin fat, 2 = a moderate amount of chin fat, 3 = a large amount of chin fat, and 4 = a very large amount of chin fat."|participants|Number|3|3.0||||||
3743816|NCT02007434|3578898|B2|3||Patient-Reported Submental Fat Rating Scale (PR-SMFRS)|"The PR-SMFRS is based on the participant's response to the question How much fat do you have under your chin right now? answered on a 5-point ordinal scale (0–4) with 0 = no chin fat at all, 1 = a slight amount of chin fat, 2 = a moderate amount of chin fat, 3 = a large amount of chin fat, and 4 = a very large amount of chin fat."|participants|Number|1|1.0||||||
3743817|NCT02007434|3578899|B1|3||Patient-Reported Submental Fat Rating Scale (PR-SMFRS)|"The PR-SMFRS is based on the participant's response to the question How much fat do you have under your chin right now? answered on a 5-point ordinal scale (0–4) with 0 = no chin fat at all, 1 = a slight amount of chin fat, 2 = a moderate amount of chin fat, 3 = a large amount of chin fat, and 4 = a very large amount of chin fat."|participants|Number|7|7.0||||||
3743818|NCT02007434|3578891|B9|2||Patient-Reported Submental Fat Rating Scale (PR-SMFRS)|"The PR-SMFRS is based on the participant's response to the question How much fat do you have under your chin right now? answered on a 5-point ordinal scale (0–4) with 0 = no chin fat at all, 1 = a slight amount of chin fat, 2 = a moderate amount of chin fat, 3 = a large amount of chin fat, and 4 = a very large amount of chin fat."|participants|Number|56|56.0||||||
3743819|NCT02007434|3578892|B8|2||Patient-Reported Submental Fat Rating Scale (PR-SMFRS)|"The PR-SMFRS is based on the participant's response to the question How much fat do you have under your chin right now? answered on a 5-point ordinal scale (0–4) with 0 = no chin fat at all, 1 = a slight amount of chin fat, 2 = a moderate amount of chin fat, 3 = a large amount of chin fat, and 4 = a very large amount of chin fat."|participants|Number|3|3.0||||||
3743820|NCT02007434|3578893|B7|2||Patient-Reported Submental Fat Rating Scale (PR-SMFRS)|"The PR-SMFRS is based on the participant's response to the question How much fat do you have under your chin right now? answered on a 5-point ordinal scale (0–4) with 0 = no chin fat at all, 1 = a slight amount of chin fat, 2 = a moderate amount of chin fat, 3 = a large amount of chin fat, and 4 = a very large amount of chin fat."|participants|Number|13|13.0||||||
3743821|NCT02007434|3578894|B6|2||Patient-Reported Submental Fat Rating Scale (PR-SMFRS)|"The PR-SMFRS is based on the participant's response to the question How much fat do you have under your chin right now? answered on a 5-point ordinal scale (0–4) with 0 = no chin fat at all, 1 = a slight amount of chin fat, 2 = a moderate amount of chin fat, 3 = a large amount of chin fat, and 4 = a very large amount of chin fat."|participants|Number|1|1.0||||||
3743822|NCT02007434|3578895|B5|2||Patient-Reported Submental Fat Rating Scale (PR-SMFRS)|"The PR-SMFRS is based on the participant's response to the question How much fat do you have under your chin right now? answered on a 5-point ordinal scale (0–4) with 0 = no chin fat at all, 1 = a slight amount of chin fat, 2 = a moderate amount of chin fat, 3 = a large amount of chin fat, and 4 = a very large amount of chin fat."|participants|Number|12|12.0||||||
3743823|NCT02007434|3578896|B4|2||Patient-Reported Submental Fat Rating Scale (PR-SMFRS)|"The PR-SMFRS is based on the participant's response to the question How much fat do you have under your chin right now? answered on a 5-point ordinal scale (0–4) with 0 = no chin fat at all, 1 = a slight amount of chin fat, 2 = a moderate amount of chin fat, 3 = a large amount of chin fat, and 4 = a very large amount of chin fat."|participants|Number|1|1.0||||||
3743824|NCT02007434|3578897|B3|2||Patient-Reported Submental Fat Rating Scale (PR-SMFRS)|"The PR-SMFRS is based on the participant's response to the question How much fat do you have under your chin right now? answered on a 5-point ordinal scale (0–4) with 0 = no chin fat at all, 1 = a slight amount of chin fat, 2 = a moderate amount of chin fat, 3 = a large amount of chin fat, and 4 = a very large amount of chin fat."|participants|Number|14|14.0||||||
3743825|NCT02007434|3578898|B2|2||Patient-Reported Submental Fat Rating Scale (PR-SMFRS)|"The PR-SMFRS is based on the participant's response to the question How much fat do you have under your chin right now? answered on a 5-point ordinal scale (0–4) with 0 = no chin fat at all, 1 = a slight amount of chin fat, 2 = a moderate amount of chin fat, 3 = a large amount of chin fat, and 4 = a very large amount of chin fat."|participants|Number|2|2.0||||||
3743909|NCT02007434|3578892|B8|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743910|NCT02007434|3578893|B7|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743826|NCT02007434|3578899|B1|2||Patient-Reported Submental Fat Rating Scale (PR-SMFRS)|"The PR-SMFRS is based on the participant's response to the question How much fat do you have under your chin right now? answered on a 5-point ordinal scale (0–4) with 0 = no chin fat at all, 1 = a slight amount of chin fat, 2 = a moderate amount of chin fat, 3 = a large amount of chin fat, and 4 = a very large amount of chin fat."|participants|Number|10|10.0||||||
3743827|NCT02007434|3578891|B9|3||Clinician-Reported Submental Fat Rating Scale (CR-SMFRS)|The CR-SMFRS score is based on the investigator’s clinical evaluation of the participant, where submental fullness is scored on a 5-point ordinal scale (0–4) with 0 = absent, 1 = mild, 2 = moderate, 3 = severe, and 4 = extreme.|participants|Number|25|25.0||||||
3743828|NCT02007434|3578892|B8|3||Clinician-Reported Submental Fat Rating Scale (CR-SMFRS)|The CR-SMFRS score is based on the investigator’s clinical evaluation of the participant, where submental fullness is scored on a 5-point ordinal scale (0–4) with 0 = absent, 1 = mild, 2 = moderate, 3 = severe, and 4 = extreme.|participants|Number|2|2.0||||||
3743829|NCT02007434|3578893|B7|3||Clinician-Reported Submental Fat Rating Scale (CR-SMFRS)|The CR-SMFRS score is based on the investigator’s clinical evaluation of the participant, where submental fullness is scored on a 5-point ordinal scale (0–4) with 0 = absent, 1 = mild, 2 = moderate, 3 = severe, and 4 = extreme.|participants|Number|3|3.0||||||
3743830|NCT02007434|3578894|B6|3||Clinician-Reported Submental Fat Rating Scale (CR-SMFRS)|The CR-SMFRS score is based on the investigator’s clinical evaluation of the participant, where submental fullness is scored on a 5-point ordinal scale (0–4) with 0 = absent, 1 = mild, 2 = moderate, 3 = severe, and 4 = extreme.|participants|Number|0|0.0||||||
3743831|NCT02007434|3578895|B5|3||Clinician-Reported Submental Fat Rating Scale (CR-SMFRS)|The CR-SMFRS score is based on the investigator’s clinical evaluation of the participant, where submental fullness is scored on a 5-point ordinal scale (0–4) with 0 = absent, 1 = mild, 2 = moderate, 3 = severe, and 4 = extreme.|participants|Number|7|7.0||||||
3743832|NCT02007434|3578896|B4|3||Clinician-Reported Submental Fat Rating Scale (CR-SMFRS)|The CR-SMFRS score is based on the investigator’s clinical evaluation of the participant, where submental fullness is scored on a 5-point ordinal scale (0–4) with 0 = absent, 1 = mild, 2 = moderate, 3 = severe, and 4 = extreme.|participants|Number|2|2.0||||||
3743833|NCT02007434|3578897|B3|3||Clinician-Reported Submental Fat Rating Scale (CR-SMFRS)|The CR-SMFRS score is based on the investigator’s clinical evaluation of the participant, where submental fullness is scored on a 5-point ordinal scale (0–4) with 0 = absent, 1 = mild, 2 = moderate, 3 = severe, and 4 = extreme.|participants|Number|5|5.0||||||
3743834|NCT02007434|3578898|B2|3||Clinician-Reported Submental Fat Rating Scale (CR-SMFRS)|The CR-SMFRS score is based on the investigator’s clinical evaluation of the participant, where submental fullness is scored on a 5-point ordinal scale (0–4) with 0 = absent, 1 = mild, 2 = moderate, 3 = severe, and 4 = extreme.|participants|Number|2|2.0||||||
3743835|NCT02007434|3578899|B1|3||Clinician-Reported Submental Fat Rating Scale (CR-SMFRS)|The CR-SMFRS score is based on the investigator’s clinical evaluation of the participant, where submental fullness is scored on a 5-point ordinal scale (0–4) with 0 = absent, 1 = mild, 2 = moderate, 3 = severe, and 4 = extreme.|participants|Number|4|4.0||||||
3743836|NCT02007434|3578891|B9|2||Clinician-Reported Submental Fat Rating Scale (CR-SMFRS)|The CR-SMFRS score is based on the investigator’s clinical evaluation of the participant, where submental fullness is scored on a 5-point ordinal scale (0–4) with 0 = absent, 1 = mild, 2 = moderate, 3 = severe, and 4 = extreme.|participants|Number|58|58.0||||||
3743837|NCT02007434|3578892|B8|2||Clinician-Reported Submental Fat Rating Scale (CR-SMFRS)|The CR-SMFRS score is based on the investigator’s clinical evaluation of the participant, where submental fullness is scored on a 5-point ordinal scale (0–4) with 0 = absent, 1 = mild, 2 = moderate, 3 = severe, and 4 = extreme.|participants|Number|2|2.0||||||
3743838|NCT02007434|3578893|B7|2||Clinician-Reported Submental Fat Rating Scale (CR-SMFRS)|The CR-SMFRS score is based on the investigator’s clinical evaluation of the participant, where submental fullness is scored on a 5-point ordinal scale (0–4) with 0 = absent, 1 = mild, 2 = moderate, 3 = severe, and 4 = extreme.|participants|Number|15|15.0||||||
3743839|NCT02007434|3578894|B6|2||Clinician-Reported Submental Fat Rating Scale (CR-SMFRS)|The CR-SMFRS score is based on the investigator’s clinical evaluation of the participant, where submental fullness is scored on a 5-point ordinal scale (0–4) with 0 = absent, 1 = mild, 2 = moderate, 3 = severe, and 4 = extreme.|participants|Number|4|4.0||||||
3743840|NCT02007434|3578895|B5|2||Clinician-Reported Submental Fat Rating Scale (CR-SMFRS)|The CR-SMFRS score is based on the investigator’s clinical evaluation of the participant, where submental fullness is scored on a 5-point ordinal scale (0–4) with 0 = absent, 1 = mild, 2 = moderate, 3 = severe, and 4 = extreme.|participants|Number|9|9.0||||||
3743841|NCT02007434|3578896|B4|2||Clinician-Reported Submental Fat Rating Scale (CR-SMFRS)|The CR-SMFRS score is based on the investigator’s clinical evaluation of the participant, where submental fullness is scored on a 5-point ordinal scale (0–4) with 0 = absent, 1 = mild, 2 = moderate, 3 = severe, and 4 = extreme.|participants|Number|2|2.0||||||
3743842|NCT02007434|3578897|B3|2||Clinician-Reported Submental Fat Rating Scale (CR-SMFRS)|The CR-SMFRS score is based on the investigator’s clinical evaluation of the participant, where submental fullness is scored on a 5-point ordinal scale (0–4) with 0 = absent, 1 = mild, 2 = moderate, 3 = severe, and 4 = extreme.|participants|Number|12|12.0||||||
3743843|NCT02007434|3578898|B2|2||Clinician-Reported Submental Fat Rating Scale (CR-SMFRS)|The CR-SMFRS score is based on the investigator’s clinical evaluation of the participant, where submental fullness is scored on a 5-point ordinal scale (0–4) with 0 = absent, 1 = mild, 2 = moderate, 3 = severe, and 4 = extreme.|participants|Number|1|1.0||||||
3743844|NCT02007434|3578899|B1|2||Clinician-Reported Submental Fat Rating Scale (CR-SMFRS)|The CR-SMFRS score is based on the investigator’s clinical evaluation of the participant, where submental fullness is scored on a 5-point ordinal scale (0–4) with 0 = absent, 1 = mild, 2 = moderate, 3 = severe, and 4 = extreme.|participants|Number|13|13.0||||||
3743845|NCT02007434|3578891|B9|IV-VI||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|47|47.0||||||
3743846|NCT02007434|3578892|B8|IV-VI||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|3|3.0||||||
3743847|NCT02007434|3578893|B7|IV-VI||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|12|12.0||||||
3743848|NCT02007434|3578894|B6|IV-VI||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|2|2.0||||||
3743849|NCT02007434|3578895|B5|IV-VI||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|10|10.0||||||
3743850|NCT02007434|3578896|B4|IV-VI||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|2|2.0||||||
3743851|NCT02007434|3578897|B3|IV-VI||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|10|10.0||||||
3743852|NCT02007434|3578898|B2|IV-VI||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|3|3.0||||||
3743853|NCT02007434|3578899|B1|IV-VI||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|5|5.0||||||
3743854|NCT02007434|3578891|B9|I-III||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|36|36.0||||||
3743855|NCT02007434|3578892|B8|I-III||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|1|1.0||||||
3743856|NCT02007434|3578893|B7|I-III||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|6|6.0||||||
3743857|NCT02007434|3578894|B6|I-III||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|2|2.0||||||
3743858|NCT02007434|3578895|B5|I-III||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|6|6.0||||||
3743859|NCT02007434|3578896|B4|I-III||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|2|2.0||||||
3743860|NCT02007434|3578897|B3|I-III||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|7|7.0||||||
3743861|NCT02007434|3578898|B2|I-III||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|0|0.0||||||
3743862|NCT02007434|3578899|B1|I-III||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|12|12.0||||||
3743863|NCT02007434|3578891|B9|||Body Mass Index (BMI)||kg/m²|Mean|32.266|32.266|Standard Deviation|4.3474|4.3474|||
3743864|NCT02007434|3578892|B8|||Body Mass Index (BMI)||kg/m²|Mean|31.250|31.25|Standard Deviation|7.7229|7.7229|||
3743865|NCT02007434|3578893|B7|||Body Mass Index (BMI)||kg/m²|Mean|31.706|31.706|Standard Deviation|3.3457|3.3457|||
3743866|NCT02007434|3578894|B6|||Body Mass Index (BMI)||kg/m²|Mean|36.850|36.85|Standard Deviation|2.3587|2.3587|||
3743867|NCT02007434|3578895|B5|||Body Mass Index (BMI)||kg/m²|Mean|32.763|32.763|Standard Deviation|3.7764|3.7764|||
3743868|NCT02007434|3578896|B4|||Body Mass Index (BMI)||kg/m²|Mean|33.350|33.35|Standard Deviation|3.1586|3.1586|||
3743869|NCT02007434|3578897|B3|||Body Mass Index (BMI)||kg/m²|Mean|33.206|33.206|Standard Deviation|4.9806|4.9806|||
3743870|NCT02007434|3578898|B2|||Body Mass Index (BMI)||kg/m²|Mean|28.867|28.867|Standard Deviation|4.9923|4.9923|||
3743871|NCT02007434|3578899|B1|||Body Mass Index (BMI)||kg/m²|Mean|30.959|30.959|Standard Deviation|4.2723|4.2723|||
3743872|NCT02007434|3578891|B9|||Weight||pounds|Mean|202.53|202.53|Standard Deviation|37.514|37.514|||
3743873|NCT02007434|3578892|B8|||Weight||pounds|Mean|185.05|185.05|Standard Deviation|68.356|68.356|||
3743874|NCT02007434|3578893|B7|||Weight||pounds|Mean|200.30|200.3|Standard Deviation|36.592|36.592|||
3743875|NCT02007434|3578894|B6|||Weight||pounds|Mean|217.90|217.9|Standard Deviation|11.485|11.485|||
3743876|NCT02007434|3578895|B5|||Weight||pounds|Mean|205.74|205.74|Standard Deviation|32.847|32.847|||
3743877|NCT02007434|3578896|B4|||Weight||pounds|Mean|223.90|223.9|Standard Deviation|27.534|27.534|||
3743878|NCT02007434|3578897|B3|||Weight||pounds|Mean|205.61|205.61|Standard Deviation|38.716|38.716|||
3743879|NCT02007434|3578898|B2|||Weight||pounds|Mean|221.00|221.0|Standard Deviation|34.492|34.492|||
3743880|NCT02007434|3578899|B1|||Weight||pounds|Mean|191.01|191.01|Standard Deviation|40.086|40.086|||
3743881|NCT02007434|3578891|B9|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3743882|NCT02007434|3578892|B8|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743883|NCT02007434|3578893|B7|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3743884|NCT02007434|3578894|B6|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743885|NCT02007434|3578895|B5|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743886|NCT02007434|3578896|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743887|NCT02007434|3578897|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3743888|NCT02007434|3578898|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743889|NCT02007434|3578899|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743890|NCT02007434|3578891|B9|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3743891|NCT02007434|3578892|B8|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743892|NCT02007434|3578893|B7|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743893|NCT02007434|3578894|B6|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743894|NCT02007434|3578895|B5|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3743895|NCT02007434|3578896|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743896|NCT02007434|3578897|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743897|NCT02007434|3578898|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743898|NCT02007434|3578899|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743899|NCT02007434|3578891|B9|Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3743900|NCT02007434|3578892|B8|Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743901|NCT02007434|3578893|B7|Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743902|NCT02007434|3578894|B6|Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743903|NCT02007434|3578895|B5|Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3743904|NCT02007434|3578896|B4|Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743911|NCT02007434|3578894|B6|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743912|NCT02007434|3578895|B5|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743913|NCT02007434|3578896|B4|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743914|NCT02007434|3578897|B3|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743915|NCT02007434|3578898|B2|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743916|NCT02007434|3578899|B1|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3743917|NCT02007434|3578891|B9|Black or African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3743918|NCT02007434|3578892|B8|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743919|NCT02007434|3578893|B7|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3743920|NCT02007434|3578894|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3743921|NCT02007434|3578895|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3743922|NCT02007434|3578896|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3743923|NCT02007434|3578897|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3743924|NCT02007434|3578898|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3743925|NCT02007434|3578899|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3743926|NCT02007434|3578891|B9|White||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
3743927|NCT02007434|3578892|B8|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3743928|NCT02007434|3578893|B7|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3743929|NCT02007434|3578894|B6|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3743930|NCT02007434|3578895|B5|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3743931|NCT02007434|3578896|B4|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3743932|NCT02007434|3578897|B3|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3743933|NCT02007434|3578898|B2|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3743934|NCT02007434|3578899|B1|White||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3743935|NCT02007434|3578891|B9||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3743936|NCT02007434|3578892|B8||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3743937|NCT02007434|3578893|B7||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3743938|NCT02007434|3578894|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3743939|NCT02007434|3578895|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3743940|NCT02007434|3578896|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3743941|NCT02007434|3578897|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3743942|NCT02007434|3578898|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3743943|NCT02007434|3578899|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3743944|NCT02007434|3578891|B9||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3743945|NCT02007434|3578892|B8||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3743946|NCT02007434|3578893|B7||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3743947|NCT02007434|3578894|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3743948|NCT02007434|3578895|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3743949|NCT02007434|3578896|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3743950|NCT02007434|3578897|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3743951|NCT02007434|3578898|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3743952|NCT02007434|3578899|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3743953|NCT02007434|3578891|B9|||Age||years|Mean|43.5|43.5|Standard Deviation|12.07|12.07|||
3743954|NCT02007434|3578892|B8|||Age||years|Mean|48.0|48.0|Standard Deviation|8.64|8.64|||
3743955|NCT02007434|3578893|B7|||Age||years|Mean|42.3|42.3|Standard Deviation|13.08|13.08|||
3743956|NCT02007434|3578894|B6|||Age||years|Mean|44.8|44.8|Standard Deviation|14.84|14.84|||
3743957|NCT02007434|3578895|B5|||Age||years|Mean|41.3|41.3|Standard Deviation|11.48|11.48|||
3743958|NCT02007434|3578896|B4|||Age||years|Mean|43.8|43.8|Standard Deviation|11.67|11.67|||
3743959|NCT02007434|3578897|B3|||Age||years|Mean|42.4|42.4|Standard Deviation|13.08|13.08|||
3743960|NCT02007434|3578898|B2|||Age||years|Mean|36.3|36.3|Standard Deviation|14.05|14.05|||
3743961|NCT02007434|3578899|B1|||Age||years|Mean|47.8|47.8|Standard Deviation|11.08|11.08|||
3743962|NCT02007369|3579004|B4|China||Region of Enrollment||participants|Number|136|136.0||||||
3743963|NCT02007369|3579005|B3|China||Region of Enrollment||participants|Number|54|54.0||||||
3743964|NCT02007369|3579006|B2|China||Region of Enrollment||participants|Number|40|40.0||||||
3743965|NCT02007369|3579007|B1|China||Region of Enrollment||participants|Number|42|42.0||||||
3743966|NCT02007369|3579004|B4||Male|Gender||Participants|Count of Participants|104|104.0||||||
3743967|NCT02007369|3579005|B3||Male|Gender||Participants|Count of Participants|43|43.0||||||
3743968|NCT02007369|3579006|B2||Male|Gender||Participants|Count of Participants|29|29.0||||||
3743969|NCT02007369|3579007|B1||Male|Gender||Participants|Count of Participants|32|32.0||||||
3743970|NCT02007369|3579004|B4||Female|Gender||Participants|Count of Participants|32|32.0||||||
3743971|NCT02007369|3579005|B3||Female|Gender||Participants|Count of Participants|11|11.0||||||
3743972|NCT02007369|3579006|B2||Female|Gender||Participants|Count of Participants|11|11.0||||||
3743973|NCT02007369|3579007|B1||Female|Gender||Participants|Count of Participants|10|10.0||||||
3743974|NCT02007369|3579004|B4|||Age||years|Mean|40.5|40.5|Standard Deviation|9.9|9.9|||
3743975|NCT02007369|3579005|B3|||Age||years|Mean|42.7|42.7|Standard Deviation|10.4|10.4|||
3743976|NCT02007369|3579006|B2|||Age||years|Mean|37.6|37.6|Standard Deviation|8.0|8.0|||
3743977|NCT02007369|3579007|B1|||Age||years|Mean|40.4|40.4|Standard Deviation|10.4|10.4|||
3743978|NCT02007291|3579026|B1|Brazil||Region of Enrollment||Participants|Count of Participants|71|71.0||||||
3743979|NCT02007291|3579026|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3743980|NCT02007291|3579026|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3743981|NCT02007291|3579026|B1|≥ 80 years old||Age, Customized||Participants|Count of Participants|23|23.0||||||
3743982|NCT02007291|3579026|B1|70-79 years old||Age, Customized||Participants|Count of Participants|36|36.0||||||
3743983|NCT02007291|3579026|B1|≤ 69 years old||Age, Customized||Participants|Count of Participants|12|12.0||||||
3743984|NCT02007278|3579035|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3743985|NCT02007278|3579036|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3743986|NCT02007278|3579037|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3743987|NCT02007278|3579035|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3743988|NCT02007278|3579036|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3743989|NCT02007278|3579037|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3743990|NCT02007278|3579035|B3|||Age||Years|Mean|56.25|56.25|Standard Deviation|10.92|10.92|||
3743991|NCT02007278|3579036|B2|||Age||Years|Mean|55.70|55.7|Standard Deviation|11.51|11.51|||
3743992|NCT02007278|3579037|B1|||Age||Years|Mean|56.74|56.74|Standard Deviation|10.58|10.58|||
3743993|NCT02007252|3579058|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3743994|NCT02007252|3579059|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3743995|NCT02007252|3579060|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3743996|NCT02007252|3579058|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3743997|NCT02007252|3579059|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3743998|NCT02007252|3579060|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3743999|NCT02007252|3579058|B3|||Age||Years|Mean|70.1|70.1|Standard Deviation|6.65|6.65|||
3744000|NCT02007252|3579059|B2|||Age||Years|Mean|70.8|70.8|Standard Deviation|5.84|5.84|||
3744001|NCT02007252|3579060|B1|||Age||Years|Mean|69.4|69.4|Standard Deviation|7.44|7.44|||
3744002|NCT02007200|3579067|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3744003|NCT02007200|3579067|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3744004|NCT02007200|3579067|B1|||Age||Years|Mean|60|60.0|Full Range|||26.0|78.0|
3744005|NCT02007096|3579074|B3|≥2 days||LOS|length of stay|Participants|Count of Participants|29|29.0||||||
3744006|NCT02007096|3579075|B2|≥2 days||LOS|length of stay|Participants|Count of Participants|12|12.0||||||
3744007|NCT02007096|3579076|B1|≥2 days||LOS|length of stay|Participants|Count of Participants|17|17.0||||||
3744008|NCT02007096|3579074|B3|<2 days||LOS|length of stay|Participants|Count of Participants|71|71.0||||||
3744009|NCT02007096|3579075|B2|<2 days||LOS|length of stay|Participants|Count of Participants|36|36.0||||||
3744010|NCT02007096|3579076|B1|<2 days||LOS|length of stay|Participants|Count of Participants|35|35.0||||||
3744011|NCT02007096|3579074|B3|Lateral||Location of hernia defect||Participants|Count of Participants|11|11.0||||||
3744012|NCT02007096|3579075|B2|Lateral||Location of hernia defect||Participants|Count of Participants|3|3.0||||||
3744013|NCT02007096|3579076|B1|Lateral||Location of hernia defect||Participants|Count of Participants|8|8.0||||||
3744014|NCT02007096|3579074|B3|Infraumbilical||Location of hernia defect||Participants|Count of Participants|9|9.0||||||
3744015|NCT02007096|3579075|B2|Infraumbilical||Location of hernia defect||Participants|Count of Participants|7|7.0||||||
3744016|NCT02007096|3579076|B1|Infraumbilical||Location of hernia defect||Participants|Count of Participants|2|2.0||||||
3744017|NCT02007096|3579074|B3|Umbilical||Location of hernia defect||Participants|Count of Participants|39|39.0||||||
3744018|NCT02007096|3579075|B2|Umbilical||Location of hernia defect||Participants|Count of Participants|20|20.0||||||
3744019|NCT02007096|3579076|B1|Umbilical||Location of hernia defect||Participants|Count of Participants|19|19.0||||||
3744020|NCT02007096|3579074|B3|Epigastric||Location of hernia defect||Participants|Count of Participants|41|41.0||||||
3744021|NCT02007096|3579075|B2|Epigastric||Location of hernia defect||Participants|Count of Participants|18|18.0||||||
3744022|NCT02007096|3579076|B1|Epigastric||Location of hernia defect||Participants|Count of Participants|23|23.0||||||
3744023|NCT02007096|3579074|B3|||Hernia defect size||cm^2|Mean|39.12|39.12|Standard Deviation|51.99|51.99|||
3744024|NCT02007096|3579075|B2|||Hernia defect size||cm^2|Mean|39.84|39.84|Standard Deviation|61.27|61.27|||
3744025|NCT02007096|3579076|B1|||Hernia defect size||cm^2|Mean|38.46|38.46|Standard Deviation|42.26|42.26|||
3744026|NCT02007096|3579074|B3|||Previous abdominal surgery||Participants|Count of Participants|72|72.0||||||
3744027|NCT02007096|3579075|B2|||Previous abdominal surgery||Participants|Count of Participants|31|31.0||||||
3744028|NCT02007096|3579076|B1|||Previous abdominal surgery||Participants|Count of Participants|41|41.0||||||
3744029|NCT02007096|3579074|B3|||Smoker||Participants|Count of Participants|32|32.0||||||
3744030|NCT02007096|3579075|B2|||Smoker||Participants|Count of Participants|17|17.0||||||
3744031|NCT02007096|3579076|B1|||Smoker||Participants|Count of Participants|15|15.0||||||
3744121|NCT02006888|3579109|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3744032|NCT02007096|3579074|B3|||GERD|Gastroesophageal reflux disease|Participants|Count of Participants|25|25.0||||||
3744033|NCT02007096|3579075|B2|||GERD|Gastroesophageal reflux disease|Participants|Count of Participants|13|13.0||||||
3744034|NCT02007096|3579076|B1|||GERD|Gastroesophageal reflux disease|Participants|Count of Participants|12|12.0||||||
3744035|NCT02007096|3579074|B3|||Coronary artery disease||Participants|Count of Participants|15|15.0||||||
3744036|NCT02007096|3579075|B2|||Coronary artery disease||Participants|Count of Participants|9|9.0||||||
3744037|NCT02007096|3579076|B1|||Coronary artery disease||Participants|Count of Participants|6|6.0||||||
3744038|NCT02007096|3579074|B3|||Hyperlipidemia||Participants|Count of Participants|34|34.0||||||
3744039|NCT02007096|3579075|B2|||Hyperlipidemia||Participants|Count of Participants|20|20.0||||||
3744040|NCT02007096|3579076|B1|||Hyperlipidemia||Participants|Count of Participants|14|14.0||||||
3744041|NCT02007096|3579074|B3|||Diabetes||Participants|Count of Participants|19|19.0||||||
3744042|NCT02007096|3579075|B2|||Diabetes||Participants|Count of Participants|9|9.0||||||
3744043|NCT02007096|3579076|B1|||Diabetes||Participants|Count of Participants|10|10.0||||||
3744044|NCT02007096|3579074|B3|||Hypertension||Participants|Count of Participants|48|48.0||||||
3744045|NCT02007096|3579075|B2|||Hypertension||Participants|Count of Participants|23|23.0||||||
3744046|NCT02007096|3579076|B1|||Hypertension||Participants|Count of Participants|25|25.0||||||
3744047|NCT02007096|3579074|B3|4||ASA class|"Preoperative American Society of Anesthesia (ASA) scores to evaluate the degree of a patient's sickness or physical state before selecting the anesthetic or before performing surgery, with one being normal to five being severely impaired."|Participants|Count of Participants|3|3.0||||||
3744048|NCT02007096|3579075|B2|4||ASA class|"Preoperative American Society of Anesthesia (ASA) scores to evaluate the degree of a patient's sickness or physical state before selecting the anesthetic or before performing surgery, with one being normal to five being severely impaired."|Participants|Count of Participants|2|2.0||||||
3744049|NCT02007096|3579076|B1|4||ASA class|"Preoperative American Society of Anesthesia (ASA) scores to evaluate the degree of a patient's sickness or physical state before selecting the anesthetic or before performing surgery, with one being normal to five being severely impaired."|Participants|Count of Participants|1|1.0||||||
3744050|NCT02007096|3579074|B3|3||ASA class|"Preoperative American Society of Anesthesia (ASA) scores to evaluate the degree of a patient's sickness or physical state before selecting the anesthetic or before performing surgery, with one being normal to five being severely impaired."|Participants|Count of Participants|36|36.0||||||
3744051|NCT02007096|3579075|B2|3||ASA class|"Preoperative American Society of Anesthesia (ASA) scores to evaluate the degree of a patient's sickness or physical state before selecting the anesthetic or before performing surgery, with one being normal to five being severely impaired."|Participants|Count of Participants|16|16.0||||||
3744052|NCT02007096|3579076|B1|3||ASA class|"Preoperative American Society of Anesthesia (ASA) scores to evaluate the degree of a patient's sickness or physical state before selecting the anesthetic or before performing surgery, with one being normal to five being severely impaired."|Participants|Count of Participants|20|20.0||||||
3744053|NCT02007096|3579074|B3|2||ASA class|"Preoperative American Society of Anesthesia (ASA) scores to evaluate the degree of a patient's sickness or physical state before selecting the anesthetic or before performing surgery, with one being normal to five being severely impaired."|Participants|Count of Participants|48|48.0||||||
3744054|NCT02007096|3579075|B2|2||ASA class|"Preoperative American Society of Anesthesia (ASA) scores to evaluate the degree of a patient's sickness or physical state before selecting the anesthetic or before performing surgery, with one being normal to five being severely impaired."|Participants|Count of Participants|24|24.0||||||
3744055|NCT02007096|3579076|B1|2||ASA class|"Preoperative American Society of Anesthesia (ASA) scores to evaluate the degree of a patient's sickness or physical state before selecting the anesthetic or before performing surgery, with one being normal to five being severely impaired."|Participants|Count of Participants|24|24.0||||||
3744056|NCT02007096|3579074|B3|1||ASA class|"Preoperative American Society of Anesthesia (ASA) scores to evaluate the degree of a patient's sickness or physical state before selecting the anesthetic or before performing surgery, with one being normal to five being severely impaired."|Participants|Count of Participants|13|13.0||||||
3744057|NCT02007096|3579075|B2|1||ASA class|"Preoperative American Society of Anesthesia (ASA) scores to evaluate the degree of a patient's sickness or physical state before selecting the anesthetic or before performing surgery, with one being normal to five being severely impaired."|Participants|Count of Participants|6|6.0||||||
3744058|NCT02007096|3579076|B1|1||ASA class|"Preoperative American Society of Anesthesia (ASA) scores to evaluate the degree of a patient's sickness or physical state before selecting the anesthetic or before performing surgery, with one being normal to five being severely impaired."|Participants|Count of Participants|7|7.0||||||
3744059|NCT02007096|3579074|B3|||BMI|Body Mass Index|kg/m^2|Mean|31.03|31.03|Standard Deviation|6.21|6.21|||
3744060|NCT02007096|3579075|B2|||BMI|Body Mass Index|kg/m^2|Mean|31.16|31.16|Standard Deviation|7.00|7.0|||
3744061|NCT02007096|3579076|B1|||BMI|Body Mass Index|kg/m^2|Mean|30.91|30.91|Standard Deviation|5.45|5.45|||
3744062|NCT02007096|3579074|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3744063|NCT02007096|3579075|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3744064|NCT02007096|3579076|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3744065|NCT02007096|3579074|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3744066|NCT02007096|3579075|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3744067|NCT02007096|3579076|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3744068|NCT02007096|3579074|B3|||Age||years|Mean|53.22|53.22|Standard Deviation|13.11|13.11|||
3744069|NCT02007096|3579075|B2|||Age||years|Mean|53.81|53.81|Standard Deviation|13.45|13.45|||
3744070|NCT02007096|3579076|B1|||Age||years|Mean|52.67|52.67|Standard Deviation|12.89|12.89|||
3744122|NCT02006888|3579110|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3744123|NCT02006888|3579111|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3744071|NCT02007070|3579089|B1|Weakly Positive PD-L1||Programmed Cell Death Ligand 1 (PD-L1) Expression Status|PD-L1 expression was evaluated by immunohistochemistry (IHC) assay with a newly obtained tumor tissue with biopsy. If PD-L1 expression was observed in >1% to ≤50% of tumor cells, regardless of the PD-L1 staining intensity, the participant was defined as weakly positive PD-L1. If PD-L1 expression was observed in >50% of tumor cells, the participant was defined as strongly positive PD-L1.|Participants|Count of Participants|26|26.0||||||
3744072|NCT02007070|3579089|B1|Strongly Positive PD-L1||Programmed Cell Death Ligand 1 (PD-L1) Expression Status|PD-L1 expression was evaluated by immunohistochemistry (IHC) assay with a newly obtained tumor tissue with biopsy. If PD-L1 expression was observed in >1% to ≤50% of tumor cells, regardless of the PD-L1 staining intensity, the participant was defined as weakly positive PD-L1. If PD-L1 expression was observed in >50% of tumor cells, the participant was defined as strongly positive PD-L1.|Participants|Count of Participants|12|12.0||||||
3744073|NCT02007070|3579089|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3744074|NCT02007070|3579089|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3744075|NCT02007070|3579089|B1|||Age||Years|Mean|63.6|63.6|Standard Deviation|8.5|8.5|||
3744076|NCT02006888|3579108|B4|United States||Region of Enrollment||participants|Number|394|394.0||||||
3744077|NCT02006888|3579109|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
3744078|NCT02006888|3579110|B2|United States||Region of Enrollment||participants|Number|156|156.0||||||
3744079|NCT02006888|3579111|B1|United States||Region of Enrollment||participants|Number|158|158.0||||||
3744080|NCT02006888|3579108|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3744081|NCT02006888|3579109|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3744082|NCT02006888|3579110|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3744083|NCT02006888|3579111|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3744084|NCT02006888|3579108|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744085|NCT02006888|3579109|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744086|NCT02006888|3579110|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744087|NCT02006888|3579111|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744088|NCT02006888|3579108|B4||White|Race (NIH/OMB)||Participants|Count of Participants|319|319.0||||||
3744089|NCT02006888|3579109|B3||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3744090|NCT02006888|3579110|B2||White|Race (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
3744091|NCT02006888|3579111|B1||White|Race (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
3744092|NCT02006888|3579108|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3744093|NCT02006888|3579109|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3744094|NCT02006888|3579110|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3744095|NCT02006888|3579111|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3744096|NCT02006888|3579108|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3744097|NCT02006888|3579109|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744098|NCT02006888|3579110|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3744099|NCT02006888|3579111|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3744100|NCT02006888|3579108|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3744101|NCT02006888|3579109|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3744102|NCT02006888|3579110|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3744103|NCT02006888|3579111|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3744104|NCT02006888|3579108|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3744105|NCT02006888|3579109|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744106|NCT02006888|3579110|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3744107|NCT02006888|3579111|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3744108|NCT02006888|3579108|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744109|NCT02006888|3579109|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744110|NCT02006888|3579110|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744111|NCT02006888|3579111|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744112|NCT02006888|3579108|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|338|338.0||||||
3744113|NCT02006888|3579109|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3744114|NCT02006888|3579110|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|133|133.0||||||
3744115|NCT02006888|3579111|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|139|139.0||||||
3744116|NCT02006888|3579108|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3744117|NCT02006888|3579109|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3744118|NCT02006888|3579110|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3744119|NCT02006888|3579111|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3744120|NCT02006888|3579108|B4||Male|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
3744124|NCT02006888|3579108|B4||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3744125|NCT02006888|3579109|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3744126|NCT02006888|3579110|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3744127|NCT02006888|3579111|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3744128|NCT02006888|3579108|B4|||Age||years|Mean|70|70.0|Standard Deviation|9|9.0|||
3744129|NCT02006888|3579109|B3|||Age||years|Mean|71|71.0|Standard Deviation|9|9.0|||
3744130|NCT02006888|3579110|B2|||Age||years|Mean|70|70.0|Standard Deviation|9|9.0|||
3744131|NCT02006888|3579111|B1|||Age||years|Mean|70|70.0|Standard Deviation|9|9.0|||
3744132|NCT02006888|3579108|B4||>=65 years|Age||Participants|Count of Participants|295|295.0||||||
3744133|NCT02006888|3579109|B3||>=65 years|Age||Participants|Count of Participants|63|63.0||||||
3744134|NCT02006888|3579110|B2||>=65 years|Age||Participants|Count of Participants|115|115.0||||||
3744135|NCT02006888|3579111|B1||>=65 years|Age||Participants|Count of Participants|117|117.0||||||
3744136|NCT02006888|3579108|B4||Between 18 and 65 years|Age||Participants|Count of Participants|99|99.0||||||
3744137|NCT02006888|3579109|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3744138|NCT02006888|3579110|B2||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3744139|NCT02006888|3579111|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3744140|NCT02006888|3579108|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3744141|NCT02006888|3579109|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3744142|NCT02006888|3579110|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3744143|NCT02006888|3579111|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3744144|NCT02006836|3579121|B4|||HbA1c||%|Mean|7.60|7.6|Standard Deviation|0.33|0.33|||
3744145|NCT02006836|3579122|B3|||HbA1c||%|Mean|10.06|10.06|Standard Deviation|0.61|0.61|||
3744146|NCT02006836|3579123|B2|||HbA1c||%|Mean|5.57|5.57|Standard Deviation|0.06|0.06|||
3744147|NCT02006836|3579124|B1|||HbA1c||%|Mean|7.53|7.53|Standard Deviation|0.45|0.45|||
3744148|NCT02006836|3579121|B4|||Diastolic blood pressure||mmHg|Mean|78.37|78.37|Standard Deviation|1.16|1.16|||
3744149|NCT02006836|3579122|B3|||Diastolic blood pressure||mmHg|Mean|82.0|82.0|Standard Deviation|1.74|1.74|||
3744150|NCT02006836|3579123|B2|||Diastolic blood pressure||mmHg|Mean|75.25|75.25|Standard Deviation|1.96|1.96|||
3744151|NCT02006836|3579124|B1|||Diastolic blood pressure||mmHg|Mean|78.05|78.05|Standard Deviation|2.11|2.11|||
3744152|NCT02006836|3579121|B4|||Systolic blood pressure||mmHg|Mean|127.58|127.58|Standard Deviation|2.01|2.01|||
3744153|NCT02006836|3579122|B3|||Systolic blood pressure||mmHg|Mean|128.32|128.32|Standard Deviation|3.36|3.36|||
3744154|NCT02006836|3579123|B2|||Systolic blood pressure||mmHg|Mean|124.65|124.65|Standard Deviation|3.66|3.66|||
3744155|NCT02006836|3579124|B1|||Systolic blood pressure||mmHg|Mean|129.8|129.8|Standard Deviation|3.5|3.5|||
3744156|NCT02006836|3579121|B4|||BMI||kg/m2|Mean|24.92|24.92|Standard Deviation|0.45|0.45|||
3744157|NCT02006836|3579122|B3|||BMI||kg/m2|Mean|24.76|24.76|Standard Deviation|0.69|0.69|||
3744158|NCT02006836|3579123|B2|||BMI||kg/m2|Mean|24.49|24.49|Standard Deviation|0.64|0.64|||
3744159|NCT02006836|3579124|B1|||BMI||kg/m2|Mean|25.51|25.51|Standard Deviation|0.97|0.97|||
3744160|NCT02006836|3579121|B4|||Body weight||kg|Mean|67.93|67.93|Standard Deviation|1.52|1.52|||
3744161|NCT02006836|3579122|B3|||Body weight||kg|Mean|68.59|68.59|Standard Deviation|2.64|2.64|||
3744162|NCT02006836|3579123|B2|||Body weight||kg|Mean|66.24|66.24|Standard Deviation|2.43|2.43|||
3744163|NCT02006836|3579124|B1|||Body weight||kg|Mean|69|69.0|Standard Deviation|2.9|2.9|||
3744164|NCT02006836|3579121|B4|China||Region of Enrollment||participants|Number|59|59.0||||||
3744165|NCT02006836|3579122|B3|China||Region of Enrollment||participants|Number|19|19.0||||||
3744166|NCT02006836|3579123|B2|China||Region of Enrollment||participants|Number|20|20.0||||||
3744167|NCT02006836|3579124|B1|China||Region of Enrollment||participants|Number|20|20.0||||||
3744168|NCT02006836|3579121|B4||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3744169|NCT02006836|3579122|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3744170|NCT02006836|3579123|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3744171|NCT02006836|3579124|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3744172|NCT02006836|3579121|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3744173|NCT02006836|3579122|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3744174|NCT02006836|3579123|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3744175|NCT02006836|3579124|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3744176|NCT02006836|3579121|B4|||Age||years|Mean|53.34|53.34|Standard Deviation|1.43|1.43|||
3744177|NCT02006836|3579122|B3|||Age||years|Mean|50.42|50.42|Standard Deviation|2.48|2.48|||
3744178|NCT02006836|3579123|B2|||Age||years|Mean|54.30|54.3|Standard Deviation|2.42|2.42|||
3744179|NCT02006836|3579124|B1|||Age||years|Mean|55.15|55.15|Standard Deviation|2.52|2.52|||
3744180|NCT02006732|3579142|B5||Male|Sex: Female, Male||Participants|Count of Participants|506|506.0||||||
3744181|NCT02006732|3579143|B4||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3744182|NCT02006732|3579144|B3||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3744183|NCT02006732|3579145|B2||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3744184|NCT02006732|3579146|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3744185|NCT02006732|3579142|B5||Female|Sex: Female, Male||Participants|Count of Participants|303|303.0||||||
3744186|NCT02006732|3579143|B4||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3744187|NCT02006732|3579144|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3744188|NCT02006732|3579145|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3744189|NCT02006732|3579146|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3744190|NCT02006732|3579142|B5|||Age||years|Mean|64.6|64.6|Standard Deviation|8.4|8.4|||
3744191|NCT02006732|3579143|B4|||Age||years|Mean|65.2|65.2|Standard Deviation|8.5|8.5|||
3744192|NCT02006732|3579144|B3|||Age||years|Mean|64.4|64.4|Standard Deviation|8.6|8.6|||
3744193|NCT02006732|3579145|B2|||Age||years|Mean|64.7|64.7|Standard Deviation|8.4|8.4|||
3744194|NCT02006732|3579146|B1|||Age||years|Mean|64.0|64.0|Standard Deviation|8.3|8.3|||
3744195|NCT02006719|3579187|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3744196|NCT02006719|3579188|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744197|NCT02006719|3579189|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3744198|NCT02006719|3579187|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3744199|NCT02006719|3579188|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744200|NCT02006719|3579189|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3744201|NCT02006719|3579187|B3||White|Race (NIH/OMB)||Participants|Count of Participants|277|277.0||||||
3744202|NCT02006719|3579188|B2||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3744203|NCT02006719|3579189|B1||White|Race (NIH/OMB)||Participants|Count of Participants|205|205.0||||||
3744204|NCT02006719|3579187|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3744205|NCT02006719|3579188|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3744206|NCT02006719|3579189|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3744207|NCT02006719|3579187|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3744208|NCT02006719|3579188|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744209|NCT02006719|3579189|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3744210|NCT02006719|3579187|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3744211|NCT02006719|3579188|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3744212|NCT02006719|3579189|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3744213|NCT02006719|3579187|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3744214|NCT02006719|3579188|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3744215|NCT02006719|3579189|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744216|NCT02006719|3579187|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744217|NCT02006719|3579188|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744218|NCT02006719|3579189|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744219|NCT02006719|3579187|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|300|300.0||||||
3744220|NCT02006719|3579188|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3744221|NCT02006719|3579189|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|220|220.0||||||
3744222|NCT02006719|3579187|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3744223|NCT02006719|3579188|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3744224|NCT02006719|3579189|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3744225|NCT02006719|3579187|B3||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3744226|NCT02006719|3579188|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3744227|NCT02006719|3579189|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3744228|NCT02006719|3579187|B3||Female|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
3744229|NCT02006719|3579188|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3744230|NCT02006719|3579189|B1||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3744231|NCT02006719|3579187|B3|≥75||Age, Customized||Participants|Count of Participants|1|1.0||||||
3744232|NCT02006719|3579188|B2|≥75||Age, Customized||Participants|Count of Participants|0|0.0||||||
3744233|NCT02006719|3579189|B1|≥75||Age, Customized||Participants|Count of Participants|1|1.0||||||
3744234|NCT02006719|3579187|B3|65-74||Age, Customized||Participants|Count of Participants|20|20.0||||||
3744235|NCT02006719|3579188|B2|65-74||Age, Customized||Participants|Count of Participants|3|3.0||||||
3744236|NCT02006719|3579189|B1|65-74||Age, Customized||Participants|Count of Participants|17|17.0||||||
3744237|NCT02006719|3579187|B3|55-64||Age, Customized||Participants|Count of Participants|98|98.0||||||
3744238|NCT02006719|3579188|B2|55-64||Age, Customized||Participants|Count of Participants|23|23.0||||||
3744239|NCT02006719|3579189|B1|55-64||Age, Customized||Participants|Count of Participants|75|75.0||||||
3744240|NCT02006719|3579187|B3|45-54||Age, Customized||Participants|Count of Participants|158|158.0||||||
3744241|NCT02006719|3579188|B2|45-54||Age, Customized||Participants|Count of Participants|44|44.0||||||
3744242|NCT02006719|3579189|B1|45-54||Age, Customized||Participants|Count of Participants|114|114.0||||||
3744243|NCT02006719|3579187|B3|<45||Age, Customized||Participants|Count of Participants|44|44.0||||||
3744244|NCT02006719|3579188|B2|<45||Age, Customized||Participants|Count of Participants|14|14.0||||||
3744245|NCT02006719|3579189|B1|<45||Age, Customized||Participants|Count of Participants|30|30.0||||||
3744246|NCT02006719|3579187|B3|||Age||years|Median|52.0|52.0|Full Range|||22.0|75.0|
3744247|NCT02006719|3579188|B2|||Age||years|Median|51.0|51.0|Full Range|||22.0|70.0|
3744248|NCT02006719|3579189|B1|||Age||years|Median|53.0|53.0|Full Range|||29.0|75.0|
3744249|NCT02006706|3579220|B1|Serbia||Region of Enrollment||participants|Number|14|14.0||||||
3744250|NCT02006706|3579220|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744251|NCT02006706|3579220|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3744252|NCT02006706|3579220|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744253|NCT02006706|3579220|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744254|NCT02006706|3579220|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744255|NCT02006706|3579220|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3744256|NCT02006706|3579220|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744257|NCT02006706|3579220|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744258|NCT02006706|3579220|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744259|NCT02006706|3579220|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744260|NCT02006706|3579220|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3744261|NCT02006706|3579220|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3744262|NCT02006706|3579220|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3744263|NCT02006706|3579220|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3744264|NCT02006706|3579220|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3744265|NCT02006706|3579220|B1|||Age||years|Mean|52.29|52.29|Standard Deviation|11.89|11.89|||
3744266|NCT02006667|3579225|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3744267|NCT02006667|3579225|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3744268|NCT02006667|3579225|B1|||Age||years|Mean|68.4|68.4|Standard Deviation|8.0|8.0|||
3744269|NCT02006654|3579235|B3|||MMSE total score at screening|Measure Description: The Mini Mental State Examination (MMSE) is an 11-item test to assess the cognitive aspects of mental function. The subtests assess orientation, memory, attention, language, and visual construction. The scores for each item is dichotomous (1 = response is correct, 0 = response is incorrect). Total score of the 11 items ranges from 0 to 30 (higher score indicates lower deficit).|units on a scale|Mean|17.3|17.3|Standard Deviation|2.9|2.9|||
3744270|NCT02006654|3579236|B2|||MMSE total score at screening|Measure Description: The Mini Mental State Examination (MMSE) is an 11-item test to assess the cognitive aspects of mental function. The subtests assess orientation, memory, attention, language, and visual construction. The scores for each item is dichotomous (1 = response is correct, 0 = response is incorrect). Total score of the 11 items ranges from 0 to 30 (higher score indicates lower deficit).|units on a scale|Mean|17.2|17.2|Standard Deviation|2.9|2.9|||
3744271|NCT02006654|3579237|B1|||MMSE total score at screening|Measure Description: The Mini Mental State Examination (MMSE) is an 11-item test to assess the cognitive aspects of mental function. The subtests assess orientation, memory, attention, language, and visual construction. The scores for each item is dichotomous (1 = response is correct, 0 = response is incorrect). Total score of the 11 items ranges from 0 to 30 (higher score indicates lower deficit).|units on a scale|Mean|17.5|17.5|Standard Deviation|3.0|3.0|||
3744272|NCT02006654|3579235|B3|France||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3744273|NCT02006654|3579236|B2|France||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3744274|NCT02006654|3579237|B1|France||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3744275|NCT02006654|3579235|B3|Germany||Region of Enrollment||Participants|Count of Participants|80|80.0||||||
3744276|NCT02006654|3579236|B2|Germany||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
3744277|NCT02006654|3579237|B1|Germany||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3744278|NCT02006654|3579235|B3|Australia||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3744279|NCT02006654|3579236|B2|Australia||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3744280|NCT02006654|3579237|B1|Australia||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3744281|NCT02006654|3579235|B3|Israel||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3744282|NCT02006654|3579236|B2|Israel||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3744283|NCT02006654|3579237|B1|Israel||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3744284|NCT02006654|3579235|B3|Slovakia||Region of Enrollment||Participants|Count of Participants|56|56.0||||||
3744285|NCT02006654|3579236|B2|Slovakia||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3744286|NCT02006654|3579237|B1|Slovakia||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3744287|NCT02006654|3579235|B3|Mexico||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
3744288|NCT02006654|3579236|B2|Mexico||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3744289|NCT02006654|3579237|B1|Mexico||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3744290|NCT02006654|3579235|B3|Brazil||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3744291|NCT02006654|3579236|B2|Brazil||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3744292|NCT02006654|3579237|B1|Brazil||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3744293|NCT02006654|3579235|B3|Turkey||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3744294|NCT02006654|3579236|B2|Turkey||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3744295|NCT02006654|3579237|B1|Turkey||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3744296|NCT02006654|3579235|B3|South Korea||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3744297|NCT02006654|3579236|B2|South Korea||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3744298|NCT02006654|3579237|B1|South Korea||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3744299|NCT02006654|3579235|B3|Spain||Region of Enrollment||Participants|Count of Participants|127|127.0||||||
3744300|NCT02006654|3579236|B2|Spain||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
3744301|NCT02006654|3579237|B1|Spain||Region of Enrollment||Participants|Count of Participants|65|65.0||||||
3744302|NCT02006654|3579235|B3|Switzerland||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3744303|NCT02006654|3579236|B2|Switzerland||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3744304|NCT02006654|3579237|B1|Switzerland||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3744305|NCT02006654|3579235|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3744306|NCT02006654|3579236|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3744307|NCT02006654|3579237|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3744308|NCT02006654|3579235|B3|Czechia||Region of Enrollment||Participants|Count of Participants|79|79.0||||||
3744309|NCT02006654|3579236|B2|Czechia||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3744310|NCT02006654|3579237|B1|Czechia||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3744311|NCT02006654|3579235|B3|United States||Region of Enrollment||Participants|Count of Participants|80|80.0||||||
3744312|NCT02006654|3579236|B2|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3744313|NCT02006654|3579237|B1|United States||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3744314|NCT02006654|3579235|B3|Singapore||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3744315|NCT02006654|3579236|B2|Singapore||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3744316|NCT02006654|3579237|B1|Singapore||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3744317|NCT02006654|3579235|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3744318|NCT02006654|3579236|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3744319|NCT02006654|3579237|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3744320|NCT02006654|3579235|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3744321|NCT02006654|3579236|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Information has not been collected
3744322|NCT02006654|3579237|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Information has not been collected
3744323|NCT02006654|3579235|B3||White|Race (NIH/OMB)||Participants|Count of Participants|591|591.0||||||
3744324|NCT02006654|3579236|B2||White|Race (NIH/OMB)||Participants|Count of Participants|299|299.0||||||
3744325|NCT02006654|3579237|B1||White|Race (NIH/OMB)||Participants|Count of Participants|292|292.0||||||
3744326|NCT02006654|3579235|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3744327|NCT02006654|3579236|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3744328|NCT02006654|3579237|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3744329|NCT02006654|3579235|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744330|NCT02006654|3579236|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744331|NCT02006654|3579237|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744332|NCT02006654|3579235|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3744333|NCT02006654|3579236|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3744334|NCT02006654|3579237|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3744335|NCT02006654|3579235|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3744336|NCT02006654|3579236|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Information has not been collected
3744337|NCT02006654|3579237|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Information has not been collected
3744338|NCT02006654|3579235|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|648|648.0||||||
3744339|NCT02006654|3579236|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|324|324.0||||||
3744340|NCT02006654|3579237|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|324|324.0||||||
3744341|NCT02006654|3579235|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3744342|NCT02006654|3579236|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3744343|NCT02006654|3579237|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3744344|NCT02006654|3579235|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3744345|NCT02006654|3579236|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3744346|NCT02006654|3579237|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3744347|NCT02006654|3579235|B3||Male|Sex: Female, Male||Participants|Count of Participants|462|462.0||||||
3744348|NCT02006654|3579236|B2||Male|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
3744349|NCT02006654|3579237|B1||Male|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
3744350|NCT02006654|3579235|B3||Female|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
3744351|NCT02006654|3579236|B2||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3744352|NCT02006654|3579237|B1||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3744353|NCT02006654|3579235|B3|||Age||years|Mean|73.9|73.9|Standard Deviation|8.3|8.3|||
3744354|NCT02006654|3579236|B2|||Age||years|Mean|73.6|73.6|Standard Deviation|8.6|8.6|||
3744355|NCT02006654|3579237|B1|||Age||years|Mean|74.2|74.2|Standard Deviation|8.0|8.0|||
3744356|NCT02006641|3579264|B4|||MMSE total score at screening|The Mini Mental State Examination (MMSE) is an 11-item test to assess the cognitive aspects of mental function. The subtests assess orientation, memory, attention, language, and visual construction. The scores for each item is dichotomous (1 = response is correct, 0 = response is incorrect). Total score of the 11 items ranges from 0 to 30 (higher score indicates lower deficit).|units on a scale|Mean|17.5|17.5|Standard Deviation|3.0|3.0|||
3744357|NCT02006641|3579265|B3|||MMSE total score at screening|The Mini Mental State Examination (MMSE) is an 11-item test to assess the cognitive aspects of mental function. The subtests assess orientation, memory, attention, language, and visual construction. The scores for each item is dichotomous (1 = response is correct, 0 = response is incorrect). Total score of the 11 items ranges from 0 to 30 (higher score indicates lower deficit).|units on a scale|Mean|17.5|17.5|Standard Deviation|3.0|3.0|||
3744358|NCT02006641|3579266|B2|||MMSE total score at screening|The Mini Mental State Examination (MMSE) is an 11-item test to assess the cognitive aspects of mental function. The subtests assess orientation, memory, attention, language, and visual construction. The scores for each item is dichotomous (1 = response is correct, 0 = response is incorrect). Total score of the 11 items ranges from 0 to 30 (higher score indicates lower deficit).|units on a scale|Mean|17.4|17.4|Standard Deviation|3.0|3.0|||
3744359|NCT02006641|3579267|B1|||MMSE total score at screening|The Mini Mental State Examination (MMSE) is an 11-item test to assess the cognitive aspects of mental function. The subtests assess orientation, memory, attention, language, and visual construction. The scores for each item is dichotomous (1 = response is correct, 0 = response is incorrect). Total score of the 11 items ranges from 0 to 30 (higher score indicates lower deficit).|units on a scale|Mean|17.6|17.6|Standard Deviation|2.9|2.9|||
3744360|NCT02006641|3579264|B4|Croatia||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3744361|NCT02006641|3579265|B3|Croatia||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3744362|NCT02006641|3579266|B2|Croatia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3744363|NCT02006641|3579267|B1|Croatia||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3744364|NCT02006641|3579264|B4|Estonia||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3744365|NCT02006641|3579265|B3|Estonia||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3744366|NCT02006641|3579266|B2|Estonia||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3744367|NCT02006641|3579267|B1|Estonia||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3744368|NCT02006641|3579264|B4|Lithuania||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3744369|NCT02006641|3579265|B3|Lithuania||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3744370|NCT02006641|3579266|B2|Lithuania||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3744371|NCT02006641|3579267|B1|Lithuania||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3744372|NCT02006641|3579264|B4|France||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3744373|NCT02006641|3579265|B3|France||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3744374|NCT02006641|3579266|B2|France||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3744375|NCT02006641|3579267|B1|France||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3744376|NCT02006641|3579264|B4|Israel||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3744377|NCT02006641|3579265|B3|Israel||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3744378|NCT02006641|3579266|B2|Israel||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3744379|NCT02006641|3579267|B1|Israel||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3744380|NCT02006641|3579264|B4|Italy||Region of Enrollment||Participants|Count of Participants|65|65.0||||||
3744381|NCT02006641|3579265|B3|Italy||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3744382|NCT02006641|3579266|B2|Italy||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3744383|NCT02006641|3579267|B1|Italy||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3744384|NCT02006641|3579264|B4|Poland||Region of Enrollment||Participants|Count of Participants|87|87.0||||||
3744385|NCT02006641|3579265|B3|Poland||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3744386|NCT02006641|3579266|B2|Poland||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3744387|NCT02006641|3579267|B1|Poland||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3744388|NCT02006641|3579264|B4|Brazil||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3744389|NCT02006641|3579265|B3|Brazil||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3744390|NCT02006641|3579266|B2|Brazil||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3744391|NCT02006641|3579267|B1|Brazil||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3744392|NCT02006641|3579264|B4|Taiwan||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3744393|NCT02006641|3579265|B3|Taiwan||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3744394|NCT02006641|3579266|B2|Taiwan||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3744395|NCT02006641|3579267|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3744396|NCT02006641|3579264|B4|Finland||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3744397|NCT02006641|3579265|B3|Finland||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3744398|NCT02006641|3579266|B2|Finland||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3744399|NCT02006641|3579267|B1|Finland||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3744400|NCT02006641|3579264|B4|South Korea||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
3744401|NCT02006641|3579265|B3|South Korea||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3744402|NCT02006641|3579266|B2|South Korea||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3744403|NCT02006641|3579267|B1|South Korea||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3744404|NCT02006641|3579264|B4|Canada||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3744405|NCT02006641|3579265|B3|Canada||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3744406|NCT02006641|3579266|B2|Canada||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3744407|NCT02006641|3579267|B1|Canada||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3744408|NCT02006641|3579264|B4|Portugal||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3744409|NCT02006641|3579265|B3|Portugal||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3744410|NCT02006641|3579266|B2|Portugal||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3744411|NCT02006641|3579267|B1|Portugal||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3744412|NCT02006641|3579264|B4|United Kingdom||Region of Enrollment||Participants|Count of Participants|82|82.0||||||
3744413|NCT02006641|3579265|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3744414|NCT02006641|3579266|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3744415|NCT02006641|3579267|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3744416|NCT02006641|3579264|B4|United States||Region of Enrollment||Participants|Count of Participants|164|164.0||||||
3744417|NCT02006641|3579265|B3|United States||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
3744418|NCT02006641|3579266|B2|United States||Region of Enrollment||Participants|Count of Participants|58|58.0||||||
3744419|NCT02006641|3579267|B1|United States||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
3744420|NCT02006641|3579264|B4|Czechia||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
3744421|NCT02006641|3579265|B3|Czechia||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3744422|NCT02006641|3579266|B2|Czechia||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3744423|NCT02006641|3579267|B1|Czechia||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3744424|NCT02006641|3579264|B4|Hungary||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3744425|NCT02006641|3579265|B3|Hungary||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3744426|NCT02006641|3579266|B2|Hungary||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3744427|NCT02006641|3579267|B1|Hungary||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3744428|NCT02006641|3579264|B4|Argentina||Region of Enrollment||Participants|Count of Participants|73|73.0||||||
3744429|NCT02006641|3579265|B3|Argentina||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3744430|NCT02006641|3579266|B2|Argentina||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3744431|NCT02006641|3579267|B1|Argentina||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3744432|NCT02006641|3579264|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3744433|NCT02006641|3579265|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3744434|NCT02006641|3579266|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3744435|NCT02006641|3579267|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3744436|NCT02006641|3579264|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3744437|NCT02006641|3579265|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Information has not been collected
3744438|NCT02006641|3579266|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Information has not been collected
3744439|NCT02006641|3579267|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Information has not been collected
3744440|NCT02006641|3579264|B4||White|Race (NIH/OMB)||Participants|Count of Participants|743|743.0||||||
3744441|NCT02006641|3579265|B3||White|Race (NIH/OMB)||Participants|Count of Participants|244|244.0||||||
3744442|NCT02006641|3579266|B2||White|Race (NIH/OMB)||Participants|Count of Participants|249|249.0||||||
3744443|NCT02006641|3579267|B1||White|Race (NIH/OMB)||Participants|Count of Participants|250|250.0||||||
3744444|NCT02006641|3579264|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3744445|NCT02006641|3579265|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3744446|NCT02006641|3579266|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3744447|NCT02006641|3579267|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3744448|NCT02006641|3579264|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3744449|NCT02006641|3579265|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Information has not been collected
3744450|NCT02006641|3579266|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Information has not been collected
3744451|NCT02006641|3579267|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Information has not been collected
3744452|NCT02006641|3579264|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3744453|NCT02006641|3579265|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3744454|NCT02006641|3579266|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3744455|NCT02006641|3579267|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3744456|NCT02006641|3579264|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3744457|NCT02006641|3579265|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Information has not been collected
3744458|NCT02006641|3579266|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Information has not been collected
3744459|NCT02006641|3579267|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Information has not been collected
3744460|NCT02006641|3579264|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|687|687.0||||||
3744461|NCT02006641|3579265|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|230|230.0||||||
3744462|NCT02006641|3579266|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|227|227.0||||||
3744463|NCT02006641|3579267|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|230|230.0||||||
3744464|NCT02006641|3579264|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
3744465|NCT02006641|3579265|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3744466|NCT02006641|3579266|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3744467|NCT02006641|3579267|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3744468|NCT02006641|3579264|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3744469|NCT02006641|3579265|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3744470|NCT02006641|3579266|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3744471|NCT02006641|3579267|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3744472|NCT02006641|3579264|B4||Male|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
3744473|NCT02006641|3579265|B3||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3744474|NCT02006641|3579266|B2||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3744475|NCT02006641|3579267|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3744476|NCT02006641|3579264|B4||Female|Sex: Female, Male||Participants|Count of Participants|522|522.0||||||
3744477|NCT02006641|3579265|B3||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3744478|NCT02006641|3579266|B2||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3744479|NCT02006641|3579267|B1||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
3744480|NCT02006641|3579264|B4|||Age||years|Mean|74.4|74.4|Standard Deviation|8.1|8.1|||
3744481|NCT02006641|3579265|B3|||Age||years|Mean|75.0|75.0|Standard Deviation|8.0|8.0|||
3744482|NCT02006641|3579266|B2|||Age||years|Mean|74.9|74.9|Standard Deviation|8.1|8.1|||
3744483|NCT02006641|3579267|B1|||Age||years|Mean|73.4|73.4|Standard Deviation|8.3|8.3|||
3744484|NCT02006407|3579307|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
3744485|NCT02006407|3579307|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
3744486|NCT02006407|3579307|B1|||Age||years|Median|14|14.0|Full Range|||8.0|15.0|
3744487|NCT02006342|3579313|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3744488|NCT02006342|3579314|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3744489|NCT02006342|3579315|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3744490|NCT02006342|3579313|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3744491|NCT02006342|3579314|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3744492|NCT02006342|3579315|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3744493|NCT02006342|3579313|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3744494|NCT02006342|3579314|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3744495|NCT02006342|3579315|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3744496|NCT02006342|3579313|B3|||Age||years|Median|41|41.0|Inter-Quartile Range|||29.0|49.5|
3744497|NCT02006342|3579314|B2|||Age||years|Median|41.5|41.5|Inter-Quartile Range|||29.0|50.5|
3744498|NCT02006342|3579315|B1|||Age||years|Median|38.5|38.5|Inter-Quartile Range|||31.5|45.5|
3744499|NCT02006264|3579330|B3|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3744500|NCT02006264|3579331|B2|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3744501|NCT02006264|3579332|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3744502|NCT02006264|3579330|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3744503|NCT02006264|3579331|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3744504|NCT02006264|3579332|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3744505|NCT02006264|3579330|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3744506|NCT02006264|3579331|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3744507|NCT02006264|3579332|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3744508|NCT02006264|3579330|B3|||Age||years|Mean|29.65|29.65|Standard Deviation|6.4|6.4|||
3744509|NCT02006264|3579331|B2|||Age||years|Mean|28.2|28.2|Standard Deviation|5.7|5.7|||
3744510|NCT02006264|3579332|B1|||Age||years|Mean|30|30.0|Standard Deviation|7.1|7.1|||
3744511|NCT02006264|3579330|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3744512|NCT02006264|3579331|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3744513|NCT02006264|3579332|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3744514|NCT02006264|3579330|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3744515|NCT02006264|3579331|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3744516|NCT02006264|3579332|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3744517|NCT02006264|3579330|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3744518|NCT02006264|3579331|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3744519|NCT02006264|3579332|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3744520|NCT02006108|3579351|B1|||Pregnancy||Participants|Count of Participants|0|0.0||||||
3744521|NCT02006108|3579351|B1|Normal||GFR||ml/min/1.73 m2|Mean|90|90.0|Standard Deviation|29|29.0|||
3744522|NCT02006108|3579351|B1|Rejection||GFR||ml/min/1.73 m2|Mean|52|52.0|Standard Deviation|24|24.0|||
3744523|NCT02006108|3579351|B1|||Drug allergies, specifically against iron compounds||Participants|Count of Participants|0|0.0||||||
3744524|NCT02006108|3579351|B1|||MRI Compatibility||Participants|Count of Participants|21|21.0||||||
3744525|NCT02006108|3579351|B1|||Number of Patients with Kidney Transplant||Participants|Count of Participants|21|21.0||||||
3744526|NCT02006108|3579351|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3744527|NCT02006108|3579351|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3744528|NCT02006108|3579351|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744529|NCT02006108|3579351|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3744530|NCT02006108|3579351|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3744531|NCT02006108|3579351|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744532|NCT02006108|3579351|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3744533|NCT02006108|3579351|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744534|NCT02006108|3579351|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744535|NCT02006108|3579351|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3744536|NCT02006108|3579351|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3744537|NCT02006108|3579351|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3744538|NCT02006108|3579351|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3744539|NCT02006108|3579351|B1|||Age||years|Mean|17.8|17.8|Standard Deviation|2.8|2.8|||
3744540|NCT02006108|3579351|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3744541|NCT02006108|3579351|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3744542|NCT02006108|3579351|B1||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
3744543|NCT02006056|3579356|B3||30 Gy in 10 fractions|Radiotherapy dose||Participants|Count of Participants|4|4.0||||||
3744544|NCT02006056|3579357|B2||30 Gy in 10 fractions|Radiotherapy dose||Participants|Count of Participants|0|0.0||||||
3744545|NCT02006056|3579358|B1||30 Gy in 10 fractions|Radiotherapy dose||Participants|Count of Participants|4|4.0||||||
3744546|NCT02006056|3579356|B3||20 Gy in 5 fractions|Radiotherapy dose||Participants|Count of Participants|6|6.0||||||
3744547|NCT02006056|3579357|B2||20 Gy in 5 fractions|Radiotherapy dose||Participants|Count of Participants|0|0.0||||||
3744548|NCT02006056|3579358|B1||20 Gy in 5 fractions|Radiotherapy dose||Participants|Count of Participants|6|6.0||||||
3744549|NCT02006056|3579356|B3||8 Gy in 1 fraction|Radiotherapy dose||Participants|Count of Participants|20|20.0||||||
3744550|NCT02006056|3579357|B2||8 Gy in 1 fraction|Radiotherapy dose||Participants|Count of Participants|4|4.0||||||
3744551|NCT02006056|3579358|B1||8 Gy in 1 fraction|Radiotherapy dose||Participants|Count of Participants|16|16.0||||||
3744552|NCT02006056|3579356|B3||Bisphosphonate only|Systemic treatment||Participants|Count of Participants|2|2.0||||||
3744553|NCT02006056|3579357|B2||Bisphosphonate only|Systemic treatment||Participants|Count of Participants|0|0.0||||||
3744554|NCT02006056|3579358|B1||Bisphosphonate only|Systemic treatment||Participants|Count of Participants|2|2.0||||||
3744555|NCT02006056|3579356|B3||Hormone therapy|Systemic treatment||Participants|Count of Participants|4|4.0||||||
3744556|NCT02006056|3579357|B2||Hormone therapy|Systemic treatment||Participants|Count of Participants|0|0.0||||||
3744557|NCT02006056|3579358|B1||Hormone therapy|Systemic treatment||Participants|Count of Participants|4|4.0||||||
3744558|NCT02006056|3579356|B3||Chemotherapy|Systemic treatment||Participants|Count of Participants|8|8.0||||||
3744559|NCT02006056|3579357|B2||Chemotherapy|Systemic treatment||Participants|Count of Participants|1|1.0||||||
3744560|NCT02006056|3579358|B1||Chemotherapy|Systemic treatment||Participants|Count of Participants|7|7.0||||||
3744561|NCT02006056|3579356|B3||None|Systemic treatment||Participants|Count of Participants|16|16.0||||||
3744562|NCT02006056|3579357|B2||None|Systemic treatment||Participants|Count of Participants|3|3.0||||||
3744563|NCT02006056|3579358|B1||None|Systemic treatment||Participants|Count of Participants|13|13.0||||||
3744564|NCT02006056|3579356|B3||Unknown|Primary cancer site||Participants|Count of Participants|2|2.0||||||
3744565|NCT02006056|3579357|B2||Unknown|Primary cancer site||Participants|Count of Participants|1|1.0||||||
3744566|NCT02006056|3579358|B1||Unknown|Primary cancer site||Participants|Count of Participants|1|1.0||||||
3744567|NCT02006056|3579356|B3||Other|Primary cancer site||Participants|Count of Participants|4|4.0||||||
3744568|NCT02006056|3579357|B2||Other|Primary cancer site||Participants|Count of Participants|1|1.0||||||
3744569|NCT02006056|3579358|B1||Other|Primary cancer site||Participants|Count of Participants|3|3.0||||||
3744570|NCT02006056|3579356|B3||Bladder|Primary cancer site||Participants|Count of Participants|2|2.0||||||
3744571|NCT02006056|3579357|B2||Bladder|Primary cancer site||Participants|Count of Participants|0|0.0||||||
3744572|NCT02006056|3579358|B1||Bladder|Primary cancer site||Participants|Count of Participants|2|2.0||||||
3744573|NCT02006056|3579356|B3||Lung|Primary cancer site||Participants|Count of Participants|3|3.0||||||
3744574|NCT02006056|3579357|B2||Lung|Primary cancer site||Participants|Count of Participants|1|1.0||||||
3744575|NCT02006056|3579358|B1||Lung|Primary cancer site||Participants|Count of Participants|2|2.0||||||
3744576|NCT02006056|3579356|B3||Breast|Primary cancer site||Participants|Count of Participants|8|8.0||||||
3744577|NCT02006056|3579357|B2||Breast|Primary cancer site||Participants|Count of Participants|0|0.0||||||
3744578|NCT02006056|3579358|B1||Breast|Primary cancer site||Participants|Count of Participants|8|8.0||||||
3744579|NCT02006056|3579356|B3||Prostate|Primary cancer site||Participants|Count of Participants|11|11.0||||||
3744580|NCT02006056|3579357|B2||Prostate|Primary cancer site||Participants|Count of Participants|1|1.0||||||
3744581|NCT02006056|3579358|B1||Prostate|Primary cancer site||Participants|Count of Participants|10|10.0||||||
3744582|NCT02006056|3579356|B3|||Score on the KPS|"Karnosky Performance Status Scale: Score from 0-100, with 0 being dead, and 100 being Normal no complaints; no evidence of disease"|units on a scale|Mean|69.3|69.3|Standard Deviation|14.8|14.8|||
3744583|NCT02006056|3579357|B2|||Score on the KPS|"Karnosky Performance Status Scale: Score from 0-100, with 0 being dead, and 100 being Normal no complaints; no evidence of disease"|units on a scale|Mean|70.0|70.0|Standard Deviation|14.1|14.1|||
3744584|NCT02006056|3579358|B1|||Score on the KPS|"Karnosky Performance Status Scale: Score from 0-100, with 0 being dead, and 100 being Normal no complaints; no evidence of disease"|units on a scale|Mean|69.2|69.2|Standard Deviation|15.2|15.2|||
3744585|NCT02006056|3579356|B3||Hospital|Location||Participants|Count of Participants|2|2.0||||||
3744586|NCT02006056|3579357|B2||Hospital|Location||Participants|Count of Participants|0|0.0||||||
3744587|NCT02006056|3579358|B1||Hospital|Location||Participants|Count of Participants|2|2.0||||||
3744588|NCT02006056|3579356|B3||Home|Location||Participants|Count of Participants|28|28.0||||||
3744589|NCT02006056|3579357|B2||Home|Location||Participants|Count of Participants|4|4.0||||||
3744590|NCT02006056|3579358|B1||Home|Location||Participants|Count of Participants|24|24.0||||||
3744591|NCT02006056|3579356|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3744592|NCT02006056|3579357|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3744593|NCT02006056|3579358|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3744594|NCT02006056|3579356|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3744595|NCT02006056|3579357|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3744596|NCT02006056|3579358|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3744597|NCT02006056|3579356|B3|||Age||years|Mean|71.3|71.3|Standard Deviation|11|11.0|||
3744598|NCT02006056|3579357|B2|||Age||years|Mean|69.8|69.8|Standard Deviation|5.7|5.7|||
3744599|NCT02006056|3579358|B1|||Age||years|Mean|71.6|71.6|Standard Deviation|11.7|11.7|||
3744600|NCT02005692|3579368|B1|United States||Region of Enrollment||participants|Number|63|63.0||||||
3744601|NCT02005692|3579368|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744602|NCT02005692|3579368|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3744603|NCT02005692|3579368|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3744604|NCT02005692|3579368|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3744605|NCT02005692|3579368|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744606|NCT02005692|3579368|B1||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3744607|NCT02005692|3579368|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3744608|NCT02005692|3579368|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744609|NCT02005692|3579368|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3744610|NCT02005692|3579368|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3744611|NCT02005692|3579368|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3744612|NCT02005692|3579368|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3744613|NCT02005692|3579368|B1||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
3744614|NCT02005692|3579368|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3744615|NCT02005692|3579368|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3744616|NCT02005692|3579368|B1|||Age||years|Mean|63|63.0|Full Range|||23.0|97.0|
3744617|NCT02005601|3579373|B3|||Knee pain severity with ambulation|Knee pain severity assessed on Numeric Pain Rating scale, which range from 0 (no pain) to 10 (worst pain)|Units on a scale|Mean|5.5|5.5|Standard Deviation|2.6|2.6|||
3744618|NCT02005601|3579374|B2|||Knee pain severity with ambulation|Knee pain severity assessed on Numeric Pain Rating scale, which range from 0 (no pain) to 10 (worst pain)|Units on a scale|Mean|5.2|5.2|Standard Deviation|2.6|2.6|||
3744619|NCT02005601|3579375|B1|||Knee pain severity with ambulation|Knee pain severity assessed on Numeric Pain Rating scale, which range from 0 (no pain) to 10 (worst pain)|Units on a scale|Mean|5.8|5.8|Standard Deviation|2.5|2.5|||
3744620|NCT02005601|3579373|B3|||Body Mass Index||kg/m^2|Median|31|31.0|Inter-Quartile Range|||27.0|35.0|
3744621|NCT02005601|3579374|B2|||Body Mass Index||kg/m^2|Median|31|31.0|Inter-Quartile Range|||27.0|35.0|
3744622|NCT02005601|3579375|B1|||Body Mass Index||kg/m^2|Median|31|31.0|Inter-Quartile Range|||27.0|36.0|
3744623|NCT02005601|3579373|B3|United States||Region of Enrollment||participants|Number|106|106.0||||||
3744624|NCT02005601|3579374|B2|United States||Region of Enrollment||participants|Number|53|53.0||||||
3744625|NCT02005601|3579375|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
3744626|NCT02005601|3579373|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3744627|NCT02005601|3579374|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3744628|NCT02005601|3579375|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3744629|NCT02005601|3579373|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744630|NCT02005601|3579374|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744631|NCT02005601|3579375|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744632|NCT02005601|3579373|B3||White|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3744633|NCT02005601|3579374|B2||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3744634|NCT02005601|3579375|B1||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3744635|NCT02005601|3579373|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3744636|NCT02005601|3579374|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3744637|NCT02005601|3579375|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3744638|NCT02005601|3579373|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744639|NCT02005601|3579374|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744640|NCT02005601|3579375|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744641|NCT02005601|3579373|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3744642|NCT02005601|3579374|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744643|NCT02005601|3579375|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3744644|NCT02005601|3579373|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744645|NCT02005601|3579374|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744646|NCT02005601|3579375|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744647|NCT02005601|3579373|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3744648|NCT02005601|3579374|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3744649|NCT02005601|3579375|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744650|NCT02005601|3579373|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3744651|NCT02005601|3579374|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3744652|NCT02005601|3579375|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3744653|NCT02005601|3579373|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3744654|NCT02005601|3579374|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3744655|NCT02005601|3579375|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3744656|NCT02005601|3579373|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3744657|NCT02005601|3579374|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3744658|NCT02005601|3579375|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3744659|NCT02005601|3579373|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3744660|NCT02005601|3579374|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3744661|NCT02005601|3579375|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3744662|NCT02005601|3579373|B3|||Age||years|Median|64|64.0|Inter-Quartile Range|||59.0|70.0|
3744663|NCT02005601|3579374|B2|||Age||years|Median|63|63.0|Inter-Quartile Range|||57.0|67.0|
3744664|NCT02005601|3579375|B1|||Age||years|Median|67|67.0|Inter-Quartile Range|||61.0|71.0|
3744665|NCT02005562|3579386|B3||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3744666|NCT02005562|3579387|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3744667|NCT02005562|3579388|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3744668|NCT02005562|3579386|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3744669|NCT02005562|3579387|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3744670|NCT02005562|3579388|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3744671|NCT02005562|3579386|B3|||Age||years|Mean|48.5|48.5|Standard Deviation|13.1|13.1|||
3744672|NCT02005562|3579387|B2|||Age||years|Mean|48.5|48.5|Standard Deviation|13.0|13.0|||
3744673|NCT02005562|3579388|B1|||Age||years|Mean|48.4|48.4|Standard Deviation|13.2|13.2|||
3744674|NCT02005549|3579417|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3744675|NCT02005549|3579417|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3744676|NCT02005549|3579417|B1|||Age||years|Median|48|48.0|Full Range|||34.0|69.0|
3744677|NCT02005536|3579423|B1|Japan||Region of Enrollment||Participants|Number|60|60.0||||||
3744678|NCT02005536|3579423|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3744679|NCT02005536|3579423|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3744680|NCT02005536|3579423|B1|||Age||years|Mean|4.0|4.0|Standard Deviation|0.2|0.2|||
3744681|NCT02005536|3579423|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3744682|NCT02005536|3579423|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3744683|NCT02005536|3579423|B1||<=18 years|Age||Participants|Count of Participants|60|60.0||||||
3744684|NCT02005484|3579431|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3744685|NCT02005484|3579431|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3744686|NCT02005484|3579431|B1|||Age||years|Mean|62.49|62.49|Standard Deviation|9.79|9.79|||
3744687|NCT02005471|3579441|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3744688|NCT02005471|3579442|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3744689|NCT02005471|3579443|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3744690|NCT02005471|3579441|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744691|NCT02005471|3579442|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744692|NCT02005471|3579443|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744693|NCT02005471|3579441|B3||White|Race (NIH/OMB)||Participants|Count of Participants|359|359.0||||||
3744694|NCT02005471|3579442|B2||White|Race (NIH/OMB)||Participants|Count of Participants|181|181.0||||||
3744695|NCT02005471|3579443|B1||White|Race (NIH/OMB)||Participants|Count of Participants|178|178.0||||||
3744696|NCT02005471|3579441|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3744697|NCT02005471|3579442|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744698|NCT02005471|3579443|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3744699|NCT02005471|3579441|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744700|NCT02005471|3579442|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744701|NCT02005471|3579443|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744702|NCT02005471|3579441|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3744703|NCT02005471|3579442|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3744704|NCT02005471|3579443|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3744705|NCT02005471|3579441|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744706|NCT02005471|3579442|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744707|NCT02005471|3579443|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744708|NCT02005471|3579441|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3744709|NCT02005471|3579442|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3744710|NCT02005471|3579443|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3744711|NCT02005471|3579441|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|372|372.0||||||
3744712|NCT02005471|3579442|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|186|186.0||||||
3744713|NCT02005471|3579443|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|186|186.0||||||
3744714|NCT02005471|3579441|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3744715|NCT02005471|3579442|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3744716|NCT02005471|3579443|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3744717|NCT02005471|3579441|B3||Male|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
3744718|NCT02005471|3579442|B2||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3744719|NCT02005471|3579443|B1||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3744720|NCT02005471|3579441|B3||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3744721|NCT02005471|3579442|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3744722|NCT02005471|3579443|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3744723|NCT02005471|3579441|B3|||Age||years|Mean|64.1|64.1|Standard Deviation|10.1|10.1|||
3744724|NCT02005471|3579442|B2|||Age||years|Mean|63.9|63.9|Standard Deviation|10.5|10.5|||
3744725|NCT02005471|3579443|B1|||Age||years|Mean|64.4|64.4|Standard Deviation|9.6|9.6|||
3744726|NCT02005393|3579497|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3744727|NCT02005393|3579497|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3744728|NCT02005393|3579497|B1|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3744729|NCT02005393|3579497|B1|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3744730|NCT02005393|3579497|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3744731|NCT02005393|3579497|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3744732|NCT02005393|3579497|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3744733|NCT02005393|3579497|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3744734|NCT02005393|3579497|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744850|NCT02004977|3579582|B2||Male|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
3744735|NCT02005393|3579497|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3744736|NCT02005393|3579497|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744737|NCT02005393|3579497|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3744738|NCT02005393|3579497|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3744739|NCT02005393|3579497|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3744740|NCT02005393|3579497|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3744741|NCT02005393|3579497|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3744742|NCT02005211|3579501|B8|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
3744743|NCT02005211|3579502|B7|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3744744|NCT02005211|3579503|B6|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3744745|NCT02005211|3579504|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3744746|NCT02005211|3579505|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3744747|NCT02005211|3579506|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3744748|NCT02005211|3579507|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3744749|NCT02005211|3579508|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3744750|NCT02005211|3579501|B8|Asian||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
3744751|NCT02005211|3579502|B7|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3744752|NCT02005211|3579503|B6|Asian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3744753|NCT02005211|3579504|B5|Asian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3744754|NCT02005211|3579505|B4|Asian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3744755|NCT02005211|3579506|B3|Asian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3744756|NCT02005211|3579507|B2|Asian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3744757|NCT02005211|3579508|B1|Asian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3744758|NCT02005211|3579501|B8||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3744759|NCT02005211|3579502|B7||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3744760|NCT02005211|3579503|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3744761|NCT02005211|3579504|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3744762|NCT02005211|3579505|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3744763|NCT02005211|3579506|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3744764|NCT02005211|3579507|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3744765|NCT02005211|3579508|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3744766|NCT02005211|3579501|B8||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3744767|NCT02005211|3579502|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3744768|NCT02005211|3579503|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3744769|NCT02005211|3579504|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3744770|NCT02005211|3579505|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3744771|NCT02005211|3579506|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3744772|NCT02005211|3579507|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3744773|NCT02005211|3579508|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3744774|NCT02005211|3579501|B8|Elderly Adults||Age|Age at study enrollment|Years|Mean|63.8|63.8|Standard Deviation|4.8|4.8|||
3744775|NCT02005211|3579502|B7|Elderly Adults||Age|Age at study enrollment|Years|Mean|60.5|60.5|Standard Deviation|5.4|5.4|||
3744776|NCT02005211|3579503|B6|Elderly Adults||Age|Age at study enrollment|Years|Mean|64.2|64.2|Standard Deviation|5.0|5.0|||
3744777|NCT02005211|3579504|B5|Elderly Adults||Age|Age at study enrollment|Years|Mean|65.5|65.5|Standard Deviation|3.8|3.8|59.0|71.0|
3744778|NCT02005211|3579505|B4|Elderly Adults||Age|Age at study enrollment|Years|Mean|NA||Standard Deviation|NA||||Young
3744779|NCT02005211|3579506|B3|Elderly Adults||Age|Age at study enrollment|Years|Mean|NA||Standard Deviation|NA||||Young
3744780|NCT02005211|3579507|B2|Elderly Adults||Age|Age at study enrollment|Years|Mean|NA||Standard Deviation|NA||||Young
3744781|NCT02005211|3579508|B1|Elderly Adults||Age|Age at study enrollment|Years|Mean|NA||Standard Deviation|NA||||Young
3744782|NCT02005211|3579501|B8|Young adult||Age|Age at study enrollment|Years|Mean|26.9|26.9|Standard Deviation|7.8|7.8|56.0|71.0|
3744783|NCT02005211|3579502|B7|Young adult||Age|Age at study enrollment|Years|Mean|NA||Standard Deviation|NA||56.0|68.0|Elderly
3744784|NCT02005211|3579503|B6|Young adult||Age|Age at study enrollment|Years|Mean|NA||Standard Deviation|NA||59.0|70.0|Elderly
3744785|NCT02005211|3579504|B5|Young adult||Age|Age at study enrollment|Years|Mean|NA||Standard Deviation|NA||||Elderly
3744786|NCT02005211|3579505|B4|Young adult||Age|Age at study enrollment|Years|Mean|22.7|22.7|Standard Deviation|3.3|3.3|20.0|29.0|
3744787|NCT02005211|3579506|B3|Young adult||Age|Age at study enrollment|Years|Mean|23.8|23.8|Standard Deviation|5.0|5.0|21.0|34.0|
3744788|NCT02005211|3579507|B2|Young adult||Age|Age at study enrollment|Years|Mean|32.2|32.2|Standard Deviation|9.7|9.7|22.0|46.0|
3744789|NCT02005211|3579508|B1|Young adult||Age|Age at study enrollment|Years|Mean|28.8|28.8|Standard Deviation|9.1|9.1|20.0|42.0|
3744790|NCT02005029|3579547|B3|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3744791|NCT02005029|3579548|B2|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3744792|NCT02005029|3579549|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3744793|NCT02005029|3579547|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744794|NCT02005029|3579548|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744795|NCT02005029|3579549|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744796|NCT02005029|3579547|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744797|NCT02005029|3579548|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744798|NCT02005029|3579549|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744799|NCT02005029|3579547|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3744800|NCT02005029|3579548|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3744801|NCT02005029|3579549|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3744802|NCT02005029|3579547|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744803|NCT02005029|3579548|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744804|NCT02005029|3579549|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744805|NCT02005029|3579547|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744806|NCT02005029|3579548|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744807|NCT02005029|3579549|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744808|NCT02005029|3579547|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744809|NCT02005029|3579548|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744810|NCT02005029|3579549|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744811|NCT02005029|3579547|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744812|NCT02005029|3579548|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744813|NCT02005029|3579549|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3744814|NCT02005029|3579547|B3||Male|Gender||Participants|Count of Participants|8|8.0||||||
3744815|NCT02005029|3579548|B2||Male|Gender||Participants|Count of Participants|4|4.0||||||
3744816|NCT02005029|3579549|B1||Male|Gender||Participants|Count of Participants|4|4.0||||||
3744817|NCT02005029|3579547|B3||Female|Gender||Participants|Count of Participants|2|2.0||||||
3744818|NCT02005029|3579548|B2||Female|Gender||Participants|Count of Participants|1|1.0||||||
3744819|NCT02005029|3579549|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
3744820|NCT02005029|3579547|B3|||Age||years|Mean|64.3|64.3|Full Range|||50.0|77.0|
3744821|NCT02005029|3579548|B2|||Age||years|Mean|64.0|64.0|Full Range|||50.0|76.0|
3744822|NCT02005029|3579549|B1|||Age||years|Mean|64.6|64.6|Full Range|||51.0|77.0|
3744823|NCT02004990|3579576|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3744824|NCT02004990|3579576|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3744825|NCT02004990|3579576|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3744826|NCT02004990|3579576|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3744827|NCT02004990|3579576|B1||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
3744828|NCT02004977|3579581|B3|United States||Region of Enrollment||participants|Number|904|904.0||||||
3744829|NCT02004977|3579582|B2|United States||Region of Enrollment||participants|Number|441|441.0||||||
3744830|NCT02004977|3579583|B1|United States||Region of Enrollment||participants|Number|463|463.0||||||
3744831|NCT02004977|3579581|B3|Mixed race||Race/Ethnicity, Customized||Participants|Count of Participants|182|182.0||||||
3744832|NCT02004977|3579582|B2|Mixed race||Race/Ethnicity, Customized||Participants|Count of Participants|77|77.0||||||
3744833|NCT02004977|3579583|B1|Mixed race||Race/Ethnicity, Customized||Participants|Count of Participants|105|105.0||||||
3744834|NCT02004977|3579581|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
3744835|NCT02004977|3579582|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3744836|NCT02004977|3579583|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3744837|NCT02004977|3579581|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3744838|NCT02004977|3579582|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3744839|NCT02004977|3579583|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3744840|NCT02004977|3579581|B3|Native American or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3744841|NCT02004977|3579582|B2|Native American or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3744842|NCT02004977|3579583|B1|Native American or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3744843|NCT02004977|3579581|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3744844|NCT02004977|3579582|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3744845|NCT02004977|3579583|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3744846|NCT02004977|3579581|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|597|597.0||||||
3744847|NCT02004977|3579582|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|314|314.0||||||
3744848|NCT02004977|3579583|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|283|283.0||||||
3744849|NCT02004977|3579581|B3||Male|Sex: Female, Male||Participants|Count of Participants|413|413.0||||||
3744851|NCT02004977|3579583|B1||Male|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
3744852|NCT02004977|3579581|B3||Female|Sex: Female, Male||Participants|Count of Participants|491|491.0||||||
3744853|NCT02004977|3579582|B2||Female|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
3744854|NCT02004977|3579583|B1||Female|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
3744855|NCT02004977|3579581|B3|||Age||years|Mean|15.2|15.2|Standard Deviation|.8|0.8|||
3744856|NCT02004977|3579582|B2|||Age||years|Mean|15.1|15.1|Standard Deviation|.8|0.8|||
3744857|NCT02004977|3579583|B1|||Age||years|Mean|15.2|15.2|Standard Deviation|.8|0.8|||
3744858|NCT02004977|3579581|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3744859|NCT02004977|3579582|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3744860|NCT02004977|3579583|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3744861|NCT02004977|3579581|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3744862|NCT02004977|3579582|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3744863|NCT02004977|3579583|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3744864|NCT02004977|3579581|B3||<=18 years|Age||Participants|Count of Participants|904|904.0||||||
3744865|NCT02004977|3579582|B2||<=18 years|Age||Participants|Count of Participants|441|441.0||||||
3744866|NCT02004977|3579583|B1||<=18 years|Age||Participants|Count of Participants|463|463.0||||||
3744867|NCT02004886|3579598|B5||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3744868|NCT02004886|3579599|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3744869|NCT02004886|3579600|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3744870|NCT02004886|3579601|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3744871|NCT02004886|3579602|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3744872|NCT02004886|3579598|B5||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3744873|NCT02004886|3579599|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3744874|NCT02004886|3579600|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3744875|NCT02004886|3579601|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3744876|NCT02004886|3579602|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3744877|NCT02004886|3579598|B5|||Age||Years|Mean|54.1|54.1|Standard Deviation|8.0|8.0|||
3744878|NCT02004886|3579599|B4|||Age||Years|Mean|51.5|51.5|Standard Deviation|9.3|9.3|||
3744879|NCT02004886|3579600|B3|||Age||Years|Mean|54.7|54.7|Standard Deviation|8.7|8.7|||
3744880|NCT02004886|3579601|B2|||Age||Years|Mean|55.8|55.8|Standard Deviation|6.8|6.8|||
3744881|NCT02004886|3579602|B1|||Age||Years|Mean|54.5|54.5|Standard Deviation|7.1|7.1|||
3744882|NCT02004873|3579655|B1|Australia||Region of Enrollment||participants|Number|4|4.0||||||
3744883|NCT02004873|3579655|B1|France||Region of Enrollment||participants|Number|38|38.0||||||
3744884|NCT02004873|3579655|B1|Serbia||Region of Enrollment||participants|Number|7|7.0||||||
3744885|NCT02004873|3579655|B1|South Africa||Region of Enrollment||participants|Number|3|3.0||||||
3744886|NCT02004873|3579655|B1|Italy||Region of Enrollment||participants|Number|17|17.0||||||
3744887|NCT02004873|3579655|B1|Denmark||Region of Enrollment||participants|Number|3|3.0||||||
3744888|NCT02004873|3579655|B1|China||Region of Enrollment||participants|Number|7|7.0||||||
3744889|NCT02004873|3579655|B1|Netherlands||Region of Enrollment||participants|Number|37|37.0||||||
3744890|NCT02004873|3579655|B1|Czech Republic||Region of Enrollment||participants|Number|43|43.0||||||
3744891|NCT02004873|3579655|B1|Austria||Region of Enrollment||participants|Number|50|50.0||||||
3744892|NCT02004873|3579655|B1|Canada||Region of Enrollment||participants|Number|15|15.0||||||
3744893|NCT02004873|3579655|B1|Greece||Region of Enrollment||participants|Number|5|5.0||||||
3744894|NCT02004873|3579655|B1|India||Region of Enrollment||participants|Number|19|19.0||||||
3744895|NCT02004873|3579655|B1|Spain||Region of Enrollment||participants|Number|54|54.0||||||
3744896|NCT02004873|3579655|B1|Malaysia||Region of Enrollment||participants|Number|21|21.0||||||
3744897|NCT02004873|3579655|B1|United Kingdom||Region of Enrollment||participants|Number|30|30.0||||||
3744898|NCT02004873|3579655|B1|Japan||Region of Enrollment||participants|Number|38|38.0||||||
3744899|NCT02004873|3579655|B1|United States||Region of Enrollment||participants|Number|297|297.0||||||
3744900|NCT02004873|3579655|B1|Hungary||Region of Enrollment||participants|Number|56|56.0||||||
3744901|NCT02004873|3579655|B1|Missing||Sex/Gender, Customized||participants|Number|1|1.0||||||
3744902|NCT02004873|3579655|B1|Male||Sex/Gender, Customized||participants|Number|434|434.0||||||
3744903|NCT02004873|3579655|B1|Female||Sex/Gender, Customized||participants|Number|309|309.0||||||
3744904|NCT02004873|3579655|B1|||Age||years|Mean|75.7|75.7|Standard Deviation|11.0|11.0|||
3744905|NCT02004847|3579662|B3|Germany||Region of Enrollment||participants|Number|47|47.0||||||
3744906|NCT02004847|3579663|B2|Germany||Region of Enrollment||participants|Number|23|23.0||||||
3744907|NCT02004847|3579664|B1|Germany||Region of Enrollment||participants|Number|24|24.0||||||
3744908|NCT02004847|3579662|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3744909|NCT02004847|3579663|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3744910|NCT02004847|3579664|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3744911|NCT02004847|3579662|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3744912|NCT02004847|3579663|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3744913|NCT02004847|3579664|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3744914|NCT02004847|3579662|B3|||Age||years|Mean|47.79|47.79|Standard Deviation|12.30|12.3|||
3744915|NCT02004847|3579663|B2|||Age||years|Mean|49.09|49.09|Standard Deviation|10.68|10.68|||
3744916|NCT02004847|3579664|B1|||Age||years|Mean|46.54|46.54|Standard Deviation|13.80|13.8|||
3744917|NCT02004847|3579662|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3744918|NCT02004847|3579663|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3744919|NCT02004847|3579664|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3744920|NCT02004847|3579662|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3744921|NCT02004847|3579663|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3744922|NCT02004847|3579664|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3744923|NCT02004847|3579662|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3744924|NCT02004847|3579663|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3744925|NCT02004847|3579664|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3744926|NCT02004366|3579709|B6|United States|Discharged|Region of Enrollment||Participants|Count of Participants|224|224.0||||||
3744927|NCT02004366|3579710|B5|United States|Discharged|Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3744928|NCT02004366|3579711|B4|United States|Discharged|Region of Enrollment||Participants|Count of Participants|93|93.0||||||
3744929|NCT02004366|3579712|B3|United States|Discharged|Region of Enrollment||Participants|Count of Participants|92|92.0||||||
3744930|NCT02004366|3579713|B2|United States|Discharged|Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3744931|NCT02004366|3579714|B1|United States|Discharged|Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3744932|NCT02004366|3579709|B6|United States|In-hospital|Region of Enrollment||Participants|Count of Participants|250|250.0||||||
3744933|NCT02004366|3579710|B5|United States|In-hospital|Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3744934|NCT02004366|3579711|B4|United States|In-hospital|Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3744935|NCT02004366|3579712|B3|United States|In-hospital|Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3744936|NCT02004366|3579713|B2|United States|In-hospital|Region of Enrollment||Participants|Count of Participants|122|122.0||||||
3744937|NCT02004366|3579714|B1|United States|In-hospital|Region of Enrollment||Participants|Count of Participants|128|128.0||||||
3744938|NCT02004366|3579709|B6|Discharge Other||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3744939|NCT02004366|3579710|B5|Discharge Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3744940|NCT02004366|3579711|B4|Discharge Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3744941|NCT02004366|3579712|B3|Discharge Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3744942|NCT02004366|3579713|B2|Discharge Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3744943|NCT02004366|3579714|B1|Discharge Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3744944|NCT02004366|3579709|B6|Discharge Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3744945|NCT02004366|3579710|B5|Discharge Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3744946|NCT02004366|3579711|B4|Discharge Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3744947|NCT02004366|3579712|B3|Discharge Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3744948|NCT02004366|3579713|B2|Discharge Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3744949|NCT02004366|3579714|B1|Discharge Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3744950|NCT02004366|3579709|B6|Discharge White||Race/Ethnicity, Customized||Participants|Count of Participants|75|75.0||||||
3744951|NCT02004366|3579710|B5|Discharge White||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3744952|NCT02004366|3579711|B4|Discharge White||Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3744953|NCT02004366|3579712|B3|Discharge White||Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3744954|NCT02004366|3579713|B2|Discharge White||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3744955|NCT02004366|3579714|B1|Discharge White||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3744956|NCT02004366|3579709|B6|Discharge Black||Race/Ethnicity, Customized||Participants|Count of Participants|111|111.0||||||
3744957|NCT02004366|3579710|B5|Discharge Black||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3744958|NCT02004366|3579711|B4|Discharge Black||Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
3744959|NCT02004366|3579712|B3|Discharge Black||Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3744960|NCT02004366|3579713|B2|Discharge Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3744961|NCT02004366|3579714|B1|Discharge Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3744962|NCT02004366|3579709|B6|In-hospital Other||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3744963|NCT02004366|3579710|B5|In-hospital Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3744964|NCT02004366|3579711|B4|In-hospital Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3744965|NCT02004366|3579712|B3|In-hospital Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3744966|NCT02004366|3579713|B2|In-hospital Other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3744967|NCT02004366|3579714|B1|In-hospital Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3744968|NCT02004366|3579709|B6|In-hospital Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3744969|NCT02004366|3579710|B5|In-hospital Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3744970|NCT02004366|3579711|B4|In-hospital Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3744971|NCT02004366|3579712|B3|In-hospital Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3744972|NCT02004366|3579713|B2|In-hospital Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3744973|NCT02004366|3579714|B1|In-hospital Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3744974|NCT02004366|3579709|B6|In-hospital White||Race/Ethnicity, Customized||Participants|Count of Participants|90|90.0||||||
3744975|NCT02004366|3579710|B5|In-hospital White||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3744976|NCT02004366|3579711|B4|In-hospital White||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3744977|NCT02004366|3579712|B3|In-hospital White||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3744978|NCT02004366|3579713|B2|In-hospital White||Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
3744979|NCT02004366|3579714|B1|In-hospital White||Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
3744980|NCT02004366|3579709|B6|In-hospital Black||Race/Ethnicity, Customized||Participants|Count of Participants|117|117.0||||||
3744981|NCT02004366|3579710|B5|In-hospital Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3744982|NCT02004366|3579711|B4|In-hospital Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3744983|NCT02004366|3579712|B3|In-hospital Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3744984|NCT02004366|3579713|B2|In-hospital Black||Race/Ethnicity, Customized||Participants|Count of Participants|58|58.0||||||
3744985|NCT02004366|3579714|B1|In-hospital Black||Race/Ethnicity, Customized||Participants|Count of Participants|59|59.0||||||
3744986|NCT02004366|3579709|B6|Discharge|Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3744987|NCT02004366|3579710|B5|Discharge|Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3744988|NCT02004366|3579711|B4|Discharge|Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3744989|NCT02004366|3579712|B3|Discharge|Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3744990|NCT02004366|3579713|B2|Discharge|Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Arms are not relevant to the named period
3744991|NCT02004366|3579714|B1|Discharge|Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Arms are not relevant to the named period
3744992|NCT02004366|3579709|B6|Discharge|Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3744993|NCT02004366|3579710|B5|Discharge|Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3744994|NCT02004366|3579711|B4|Discharge|Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3744995|NCT02004366|3579712|B3|Discharge|Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3744996|NCT02004366|3579713|B2|Discharge|Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Arms are not relevant to the named period
3744997|NCT02004366|3579714|B1|Discharge|Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Arms are not relevant to the named period
3744998|NCT02004366|3579709|B6|In-hospital|Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3744999|NCT02004366|3579710|B5|In-hospital|Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Arms are not relevant to the named period
3745000|NCT02004366|3579711|B4|In-hospital|Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Arms are not relevant to the named period
3745001|NCT02004366|3579712|B3|In-hospital|Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Arms are not relevant to the named period
3745002|NCT02004366|3579713|B2|In-hospital|Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3745003|NCT02004366|3579714|B1|In-hospital|Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3745004|NCT02004366|3579709|B6|In-hospital|Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3745005|NCT02004366|3579710|B5|In-hospital|Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Arms are not relevant to the named period
3745006|NCT02004366|3579711|B4|In-hospital|Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Arms are not relevant to the named period
3745007|NCT02004366|3579712|B3|In-hospital|Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Arms are not relevant to the named period
3745008|NCT02004366|3579713|B2|In-hospital|Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3745009|NCT02004366|3579714|B1|In-hospital|Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3745010|NCT02004366|3579709|B6|Discharge||Age||years|Mean|56.7|56.7|Standard Deviation|11.3|11.3|||
3745011|NCT02004366|3579710|B5|Discharge||Age||years|Mean|50.7|50.7|Standard Deviation|11.5|11.5|||
3745012|NCT02004366|3579711|B4|Discharge||Age||years|Mean|57.1|57.1|Standard Deviation|11.7|11.7|||
3745013|NCT02004366|3579712|B3|Discharge||Age||years|Mean|58.8|58.8|Standard Deviation|10.0|10.0|||
3745014|NCT02004366|3579713|B2|Discharge||Age||years|Mean|NA||Standard Deviation|NA||||Arms are not relevant to the named period
3745015|NCT02004366|3579714|B1|Discharge||Age||years|Mean|NA||Standard Deviation|NA||||Arms are not relevant to the named period
3745016|NCT02004366|3579709|B6|In-hospital||Age||years|Mean|57.8|57.8|Standard Deviation|11.3|11.3|||
3745017|NCT02004366|3579710|B5|In-hospital||Age||years|Mean|NA||Standard Deviation|NA||||Arms are not relevant to the named period
3745018|NCT02004366|3579711|B4|In-hospital||Age||years|Mean|NA||Standard Deviation|NA||||Arms are not relevant to the named period
3745019|NCT02004366|3579712|B3|In-hospital||Age||years|Mean|NA||Standard Deviation|NA||||Arms are not relevant to the named period
3745020|NCT02004366|3579713|B2|In-hospital||Age||years|Mean|58|58.0|Standard Deviation|12|12.0|||
3745021|NCT02004366|3579714|B1|In-hospital||Age||years|Mean|58|58.0|Standard Deviation|11|11.0|||
3745022|NCT02004262|3579805|B7||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3745023|NCT02004262|3579806|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3745024|NCT02004262|3579807|B5||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3745025|NCT02004262|3579808|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3745026|NCT02004262|3579809|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3745027|NCT02004262|3579810|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3745028|NCT02004262|3579811|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3745029|NCT02004262|3579805|B7||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3745030|NCT02004262|3579806|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3745031|NCT02004262|3579807|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3745032|NCT02004262|3579808|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3745033|NCT02004262|3579809|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3745034|NCT02004262|3579810|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3745035|NCT02004262|3579811|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3745036|NCT02004262|3579805|B7|||Age||years|Mean|63.7|63.7|Standard Deviation|9.48|9.48|||
3745037|NCT02004262|3579806|B6|||Age||years|Mean|66.6|66.6|Standard Deviation|10.86|10.86|||
3745038|NCT02004262|3579807|B5|||Age||years|Mean|64.1|64.1|Standard Deviation|9.43|9.43|||
3745039|NCT02004262|3579808|B4|||Age||years|Mean|63.9|63.9|Standard Deviation|11.83|11.83|||
3745040|NCT02004262|3579809|B3|||Age||years|Mean|64.0|64.0|Standard Deviation|10.85|10.85|||
3745041|NCT02004262|3579810|B2|||Age||years|Mean|63.2|63.2|Standard Deviation|8.92|8.92|||
3745042|NCT02004262|3579811|B1|||Age||years|Mean|63.3|63.3|Standard Deviation|7.96|7.96|||
3745043|NCT02004236|3579833|B4|Spain||Region of Enrollment||participants|Number|209|209.0||||||
3745044|NCT02004236|3579834|B3|Spain||Region of Enrollment||participants|Number|59|59.0||||||
3745045|NCT02004236|3579835|B2|Spain||Region of Enrollment||participants|Number|75|75.0||||||
3745046|NCT02004236|3579836|B1|Spain||Region of Enrollment||participants|Number|75|75.0||||||
3745047|NCT02004236|3579833|B4||Male|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
3745048|NCT02004236|3579834|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3745049|NCT02004236|3579835|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3745050|NCT02004236|3579836|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3745051|NCT02004236|3579833|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3745052|NCT02004236|3579834|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3745053|NCT02004236|3579835|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3745054|NCT02004236|3579836|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3745055|NCT02004236|3579833|B4|10-12 years||Age, Customized||years|Mean|10.7|10.7|Standard Deviation|0.68|0.68|||
3745056|NCT02004236|3579834|B3|10-12 years||Age, Customized||years|Mean|10.8|10.8|Standard Deviation|0.88|0.88|||
3745057|NCT02004236|3579835|B2|10-12 years||Age, Customized||years|Mean|10.1|10.1|Standard Deviation|0.69|0.69|||
3745058|NCT02004236|3579836|B1|10-12 years||Age, Customized||years|Mean|11.2|11.2|Standard Deviation|0.48|0.48|||
3745059|NCT02004236|3579833|B4|7-9 years||Age, Customized||years|Mean|7.8|7.8|Standard Deviation|0.91|0.91|||
3745060|NCT02004236|3579834|B3|7-9 years||Age, Customized||years|Mean|7.8|7.8|Standard Deviation|1.1|1.1|||
3745061|NCT02004236|3579835|B2|7-9 years||Age, Customized||years|Mean|8.4|8.4|Standard Deviation|0.73|0.73|||
3745062|NCT02004236|3579836|B1|7-9 years||Age, Customized||years|Mean|7.2|7.2|Standard Deviation|0.9|0.9|||
3745063|NCT02004236|3579833|B4|4-6 years||Age, Customized||years|Mean|5.06|5.06|Standard Deviation|0.91|0.91|||
3745064|NCT02004236|3579834|B3|4-6 years||Age, Customized||years|Mean|5.3|5.3|Standard Deviation|0.75|0.75|||
3745065|NCT02004236|3579835|B2|4-6 years||Age, Customized||years|Mean|4.8|4.8|Standard Deviation|1.17|1.17|||
3745066|NCT02004236|3579836|B1|4-6 years||Age, Customized||years|Mean|5.1|5.1|Standard Deviation|0.80|0.8|||
3745067|NCT02004236|3579833|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3745068|NCT02004236|3579834|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3745069|NCT02004236|3579835|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3745070|NCT02004236|3579836|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3745071|NCT02004236|3579833|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3745072|NCT02004236|3579834|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3745073|NCT02004236|3579835|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3745074|NCT02004236|3579836|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3745075|NCT02004236|3579833|B4||<=18 years|Age||Participants|Count of Participants|209|209.0||||||
3745076|NCT02004236|3579834|B3||<=18 years|Age||Participants|Count of Participants|59|59.0||||||
3745077|NCT02004236|3579835|B2||<=18 years|Age||Participants|Count of Participants|75|75.0||||||
3745078|NCT02004236|3579836|B1||<=18 years|Age||Participants|Count of Participants|75|75.0||||||
3745079|NCT02004236|3579833|B4|||Age||years|Mean|7.2|7.2|Standard Deviation|2.12|2.12|||
3745080|NCT02004236|3579834|B3|||Age||years|Mean|7.2|7.2|Standard Deviation|2.3|2.3|||
3745081|NCT02004236|3579835|B2|||Age||years|Mean|6.9|6.9|Standard Deviation|2.1|2.1|||
3745082|NCT02004236|3579836|B1|||Age||years|Mean|7.5|7.5|Standard Deviation|1.98|1.98|||
3745083|NCT02004158|3579882|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3745084|NCT02004158|3579882|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3745085|NCT02004158|3579882|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3745086|NCT02004158|3579882|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3745087|NCT02004158|3579882|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745088|NCT02004158|3579882|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3745089|NCT02004158|3579882|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745090|NCT02004158|3579882|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3745091|NCT02004158|3579882|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3745092|NCT02004158|3579882|B1|||Age||years|Mean|60.4|60.4|Standard Deviation|11.7|11.7|||
3745093|NCT02004132|3579890|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3745094|NCT02004132|3579890|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745095|NCT02004132|3579890|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3745096|NCT02004132|3579890|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3745097|NCT02004132|3579890|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3745098|NCT02004132|3579890|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745099|NCT02004132|3579890|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745100|NCT02004132|3579890|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745101|NCT02004132|3579890|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745102|NCT02004132|3579890|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3745103|NCT02004132|3579890|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3745104|NCT02004132|3579890|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3745105|NCT02004132|3579890|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3745106|NCT02004132|3579890|B1|||Age||years|Mean|38.3|38.3|Standard Deviation|10.6|10.6|||
3745107|NCT02004093|3579896|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3745108|NCT02004093|3579897|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3745109|NCT02004093|3579898|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3745110|NCT02004093|3579896|B3||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3745111|NCT02004093|3579897|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3745112|NCT02004093|3579898|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3745113|NCT02004093|3579896|B3|||Age||years|Mean|56.7|56.7|Standard Deviation|10.86|10.86|||
3745114|NCT02004093|3579897|B2|||Age||years|Mean|55.3|55.3|Standard Deviation|11.41|11.41|||
3745115|NCT02004093|3579898|B1|||Age||years|Mean|58.1|58.1|Standard Deviation|10.16|10.16|||
3745116|NCT02003963|3579929|B3|||Insulin||Micro unit per milliliter|Mean|21.8|21.8|Standard Deviation|12.8|12.8|||
3745117|NCT02003963|3579930|B2|||Insulin||Micro unit per milliliter|Mean|19.4|19.4|Standard Deviation|10.4|10.4|||
3745118|NCT02003963|3579931|B1|||Insulin||Micro unit per milliliter|Mean|24.2|24.2|Standard Deviation|15.2|15.2|||
3745119|NCT02003963|3579929|B3|||Glucose||Milligrams per deciliter|Mean|89.7|89.7|Standard Deviation|28.2|28.2|||
3745120|NCT02003963|3579930|B2|||Glucose||Milligrams per deciliter|Mean|91.8|91.8|Standard Deviation|21.8|21.8|||
3745121|NCT02003963|3579931|B1|||Glucose||Milligrams per deciliter|Mean|87.6|87.6|Standard Deviation|6.4|6.4|||
3745122|NCT02003963|3579929|B3|||Triglycerides||Milligrams per deciliter|Mean|79.5|79.5|Standard Deviation|45.9|45.9|||
3745123|NCT02003963|3579930|B2|||Triglycerides||Milligrams per deciliter|Mean|80.0|80.0|Standard Deviation|42.4|42.4|||
3745124|NCT02003963|3579931|B1|||Triglycerides||Milligrams per deciliter|Mean|78.9|78.9|Standard Deviation|49.4|49.4|||
3745125|NCT02003963|3579929|B3|||Low-density Lipoprotein||Milligrams per deciliter|Mean|90.4|90.4|Standard Deviation|21.1|21.1|||
3745126|NCT02003963|3579930|B2|||Low-density Lipoprotein||Milligrams per deciliter|Mean|94.4|94.4|Standard Deviation|22.9|22.9|||
3745127|NCT02003963|3579931|B1|||Low-density Lipoprotein||Milligrams per deciliter|Mean|86.4|86.4|Standard Deviation|19.2|19.2|||
3745128|NCT02003963|3579929|B3|||High Density Lipoprotein||Milligrams per deciliter|Mean|50.1|50.1|Standard Deviation|8.9|8.9|||
3745129|NCT02003963|3579930|B2|||High Density Lipoprotein||Milligrams per deciliter|Mean|52.7|52.7|Standard Deviation|10.5|10.5|||
3745130|NCT02003963|3579931|B1|||High Density Lipoprotein||Milligrams per deciliter|Mean|47.4|47.4|Standard Deviation|7.3|7.3|||
3745131|NCT02003963|3579929|B3|||Cholesterol||Milligrams per deciliter|Mean|156.6|156.6|Standard Deviation|24.5|24.5|||
3745132|NCT02003963|3579930|B2|||Cholesterol||Milligrams per deciliter|Mean|163.1|163.1|Standard Deviation|27.3|27.3|||
3745133|NCT02003963|3579931|B1|||Cholesterol||Milligrams per deciliter|Mean|149.6|149.6|Standard Deviation|21.6|21.6|||
3745134|NCT02003963|3579929|B3|||Diastolic Blood Pressure Percentile||Percentile|Mean|63.7|63.7|Standard Deviation|21.4|21.4|||
3745135|NCT02003963|3579930|B2|||Diastolic Blood Pressure Percentile||Percentile|Mean|66.4|66.4|Standard Deviation|20.5|20.5|||
3745136|NCT02003963|3579931|B1|||Diastolic Blood Pressure Percentile||Percentile|Mean|60.9|60.9|Standard Deviation|22.3|22.3|||
3745137|NCT02003963|3579929|B3|||Systolic Blood Pressure Percentile||Percentile|Mean|60.1|60.1|Standard Deviation|27.7|27.7|||
3745138|NCT02003963|3579930|B2|||Systolic Blood Pressure Percentile||Percentile|Mean|56.6|56.6|Standard Deviation|30.1|30.1|||
3745139|NCT02003963|3579931|B1|||Systolic Blood Pressure Percentile||Percentile|Mean|63.5|63.5|Standard Deviation|25.2|25.2|||
3745140|NCT02003963|3579929|B3|||MRI Total Adipose Tissue||Kilograms|Mean|13.2|13.2|Standard Deviation|6.1|6.1|||
3745141|NCT02003963|3579930|B2|||MRI Total Adipose Tissue||Kilograms|Mean|13.3|13.3|Standard Deviation|6.3|6.3|||
3745142|NCT02003963|3579931|B1|||MRI Total Adipose Tissue||Kilograms|Mean|13.1|13.1|Standard Deviation|5.9|5.9|||
3745143|NCT02003963|3579929|B3|||MRI Subcutaneous Adipose Tissue||Kilograms|Mean|12.2|12.2|Standard Deviation|5.65|5.65|||
3745144|NCT02003963|3579930|B2|||MRI Subcutaneous Adipose Tissue||Kilograms|Mean|12.3|12.3|Standard Deviation|5.7|5.7|||
3745145|NCT02003963|3579931|B1|||MRI Subcutaneous Adipose Tissue||Kilograms|Mean|12.1|12.1|Standard Deviation|5.6|5.6|||
3745146|NCT02003963|3579929|B3|||MRI Visceral Adipose Tissue||Kilograms|Mean|1.0|1.0|Standard Deviation|0.7|0.7|||
3745147|NCT02003963|3579930|B2|||MRI Visceral Adipose Tissue||Kilograms|Mean|1.0|1.0|Standard Deviation|0.7|0.7|||
3745148|NCT02003963|3579931|B1|||MRI Visceral Adipose Tissue||Kilograms|Mean|1.0|1.0|Standard Deviation|0.7|0.7|||
3745149|NCT02003963|3579929|B3|||DXA BMD Leg||Grams per centimeter squared|Mean|1.3|1.3|Standard Deviation|0.1|0.1|||
3745150|NCT02003963|3579930|B2|||DXA BMD Leg||Grams per centimeter squared|Mean|1.3|1.3|Standard Deviation|0.1|0.1|||
3745151|NCT02003963|3579931|B1|||DXA BMD Leg||Grams per centimeter squared|Mean|1.3|1.3|Standard Deviation|0.1|0.1|||
3745152|NCT02003963|3579929|B3|||DXA BMD Spine||Grams per centimeter squared|Mean|1.15|1.15|Standard Deviation|0.1|0.1|||
3745153|NCT02003963|3579930|B2|||DXA BMD Spine||Grams per centimeter squared|Mean|1.2|1.2|Standard Deviation|0.1|0.1|||
3745154|NCT02003963|3579931|B1|||DXA BMD Spine||Grams per centimeter squared|Mean|1.1|1.1|Standard Deviation|0.1|0.1|||
3745155|NCT02003963|3579929|B3|||DXA BMD Trunk||Grams per centimeter squared|Mean|1.1|1.1|Standard Deviation|0.1|0.1|||
3745156|NCT02003963|3579930|B2|||DXA BMD Trunk||Grams per centimeter squared|Mean|1.1|1.1|Standard Deviation|0.1|0.1|||
3745157|NCT02003963|3579931|B1|||DXA BMD Trunk||Grams per centimeter squared|Mean|1.1|1.1|Standard Deviation|0.1|0.1|||
3745158|NCT02003963|3579929|B3|||DXA Bone Mineral Density (BMD)||Grams per centimeter squared|Mean|1.2|1.2|Standard Deviation|0.1|0.1|||
3745159|NCT02003963|3579930|B2|||DXA Bone Mineral Density (BMD)||Grams per centimeter squared|Mean|1.2|1.2|Standard Deviation|0.1|0.1|||
3745160|NCT02003963|3579931|B1|||DXA Bone Mineral Density (BMD)||Grams per centimeter squared|Mean|1.2|1.2|Standard Deviation|0.1|0.1|||
3745161|NCT02003963|3579929|B3|||DXA Bone Mineral Content (BMC)||Kilograms|Mean|2.65|2.65|Standard Deviation|0.3|0.3|||
3745162|NCT02003963|3579930|B2|||DXA Bone Mineral Content (BMC)||Kilograms|Mean|2.7|2.7|Standard Deviation|0.3|0.3|||
3745163|NCT02003963|3579931|B1|||DXA Bone Mineral Content (BMC)||Kilograms|Mean|2.6|2.6|Standard Deviation|0.3|0.3|||
3745164|NCT02003963|3579929|B3|||DXA Trunk Fat Percentile||Percentile|Mean|50.6|50.6|Standard Deviation|8.8|8.8|||
3745165|NCT02003963|3579930|B2|||DXA Trunk Fat Percentile||Percentile|Mean|50.5|50.5|Standard Deviation|8.1|8.1|||
3745166|NCT02003963|3579931|B1|||DXA Trunk Fat Percentile||Percentile|Mean|50.6|50.6|Standard Deviation|9.5|9.5|||
3745167|NCT02003963|3579929|B3|||DXA Trunk Fat||Kilograms|Mean|25.6|25.6|Standard Deviation|12.9|12.9|||
3745168|NCT02003963|3579930|B2|||DXA Trunk Fat||Kilograms|Mean|26.1|26.1|Standard Deviation|12.1|12.1|||
3745169|NCT02003963|3579931|B1|||DXA Trunk Fat||Kilograms|Mean|25.1|25.1|Standard Deviation|13.6|13.6|||
3745170|NCT02003963|3579929|B3|||DXA Android Fat Percentile||Percentile|Mean|54.1|54.1|Standard Deviation|19.7|19.7|||
3745171|NCT02003963|3579930|B2|||DXA Android Fat Percentile||Percentile|Mean|54.3|54.3|Standard Deviation|9.2|9.2|||
3745172|NCT02003963|3579931|B1|||DXA Android Fat Percentile||Percentile|Mean|53.8|53.8|Standard Deviation|10.5|10.5|||
3745173|NCT02003963|3579929|B3|||DXA Android Fat||Kilograms|Mean|4.3|4.3|Standard Deviation|2.3|2.3|||
3745174|NCT02003963|3579930|B2|||DXA Android Fat||Kilograms|Mean|4.4|4.4|Standard Deviation|2.3|2.3|||
3745175|NCT02003963|3579931|B1|||DXA Android Fat||Kilograms|Mean|4.2|4.2|Standard Deviation|2.2|2.2|||
3745176|NCT02003963|3579929|B3|||DXA Gynoid Fat Percentage||Percentile|Mean|50|50.0|Standard Deviation|5.7|5.7|||
3745177|NCT02003963|3579930|B2|||DXA Gynoid Fat Percentage||Percentile|Mean|50.1|50.1|Standard Deviation|4.9|4.9|||
3745178|NCT02003963|3579931|B1|||DXA Gynoid Fat Percentage||Percentile|Mean|49.8|49.8|Standard Deviation|6.5|6.5|||
3745179|NCT02003963|3579929|B3|||DXA Gynoid Fat||kilograms|Mean|7.9|7.9|Standard Deviation|4.7|4.7|||
3745180|NCT02003963|3579930|B2|||DXA Gynoid Fat||kilograms|Mean|8.1|8.1|Standard Deviation|2.2|2.2|||
3745181|NCT02003963|3579931|B1|||DXA Gynoid Fat||kilograms|Mean|7.6|7.6|Standard Deviation|2.5|2.5|||
3745182|NCT02003963|3579929|B3|||DXA Leg fat percentage||percentile|Mean|48.2|48.2|Standard Deviation|5.4|5.4|||
3745183|NCT02003963|3579930|B2|||DXA Leg fat percentage||percentile|Mean|48.0|48.0|Standard Deviation|5.2|5.2|||
3745184|NCT02003963|3579931|B1|||DXA Leg fat percentage||percentile|Mean|48.3|48.3|Standard Deviation|5.6|5.6|||
3745185|NCT02003963|3579929|B3|||DXA leg fat||kilograms|Mean|16.2|16.2|Standard Deviation|5.2|5.2|||
3745186|NCT02003963|3579930|B2|||DXA leg fat||kilograms|Mean|16.2|16.2|Standard Deviation|4.7|4.7|||
3745187|NCT02003963|3579931|B1|||DXA leg fat||kilograms|Mean|16.2|16.2|Standard Deviation|5.6|5.6|||
3745188|NCT02003963|3579929|B3|||DXA Total body fat percent||percentile|Mean|48.25|48.25|Standard Deviation|13|13.0|||
3745189|NCT02003963|3579930|B2|||DXA Total body fat percent||percentile|Mean|48.2|48.2|Standard Deviation|6.3|6.3|||
3745190|NCT02003963|3579931|B1|||DXA Total body fat percent||percentile|Mean|48.3|48.3|Standard Deviation|19.7|19.7|||
3745191|NCT02003963|3579929|B3|||DXA Total body fat||kilograms|Mean|47.5|47.5|Standard Deviation|18.35|18.35|||
3745192|NCT02003963|3579930|B2|||DXA Total body fat||kilograms|Mean|48.0|48.0|Standard Deviation|17.0|17.0|||
3745193|NCT02003963|3579931|B1|||DXA Total body fat||kilograms|Mean|47.0|47.0|Standard Deviation|19.7|19.7|||
3745194|NCT02003963|3579929|B3|||Waist Circumference||centimeters|Mean|107.5|107.5|Standard Deviation|21.6|21.6|||
3745195|NCT02003963|3579930|B2|||Waist Circumference||centimeters|Mean|107.7|107.7|Standard Deviation|21.1|21.1|||
3745196|NCT02003963|3579931|B1|||Waist Circumference||centimeters|Mean|107.3|107.3|Standard Deviation|22.0|22.0|||
3745197|NCT02003963|3579929|B3|||BMI (percentile)||Percentile|Mean|97.3|97.3|Standard Deviation|3.1|3.1|||
3745198|NCT02003963|3579930|B2|||BMI (percentile)||Percentile|Mean|97.1|97.1|Standard Deviation|3.3|3.3|||
3745199|NCT02003963|3579931|B1|||BMI (percentile)||Percentile|Mean|97.4|97.4|Standard Deviation|2.9|2.9|||
3745200|NCT02003963|3579929|B3|||BMI (z-score)||Z-score|Mean|2.1|2.1|Standard Deviation|0.5|0.5|||
3745201|NCT02003963|3579930|B2|||BMI (z-score)||Z-score|Mean|2.1|2.1|Standard Deviation|0.5|0.5|||
3745202|NCT02003963|3579931|B1|||BMI (z-score)||Z-score|Mean|2.1|2.1|Standard Deviation|0.5|0.5|||
3745203|NCT02003963|3579929|B3|||Height||centimeters|Mean|162.65|162.65|Standard Deviation|5.9|5.9|||
3745204|NCT02003963|3579930|B2|||Height||centimeters|Mean|164.9|164.9|Standard Deviation|5.8|5.8|||
3745205|NCT02003963|3579931|B1|||Height||centimeters|Mean|160.4|160.4|Standard Deviation|5.9|5.9|||
3745206|NCT02003963|3579929|B3|||Weight||kilograms|Mean|99.15|99.15|Standard Deviation|26.7|26.7|||
3745207|NCT02003963|3579930|B2|||Weight||kilograms|Mean|101.1|101.1|Standard Deviation|26.1|26.1|||
3745208|NCT02003963|3579931|B1|||Weight||kilograms|Mean|97.2|97.2|Standard Deviation|27.3|27.3|||
3745209|NCT02003963|3579929|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
3745210|NCT02003963|3579930|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3745211|NCT02003963|3579931|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3745212|NCT02003963|3579929|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745213|NCT02003963|3579930|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745214|NCT02003963|3579931|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745215|NCT02003963|3579929|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745216|NCT02003963|3579930|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745217|NCT02003963|3579931|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745218|NCT02003963|3579929|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3745219|NCT02003963|3579930|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3745220|NCT02003963|3579931|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3745221|NCT02003963|3579929|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3745222|NCT02003963|3579930|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3745223|NCT02003963|3579931|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3745224|NCT02003963|3579929|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745225|NCT02003963|3579930|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745226|NCT02003963|3579931|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745227|NCT02003963|3579929|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745228|NCT02003963|3579930|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745229|NCT02003963|3579931|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745230|NCT02003963|3579929|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745231|NCT02003963|3579930|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745232|NCT02003963|3579931|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745233|NCT02003963|3579929|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3745234|NCT02003963|3579930|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3745235|NCT02003963|3579931|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3745236|NCT02003963|3579929|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3745237|NCT02003963|3579930|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3745238|NCT02003963|3579931|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3745239|NCT02003963|3579929|B3|||Age||years|Mean|15.7|15.7|Standard Deviation|1.3|1.3|||
3745240|NCT02003963|3579930|B2|||Age||years|Mean|16.1|16.1|Standard Deviation|1.4|1.4|||
3745241|NCT02003963|3579931|B1|||Age||years|Mean|15.3|15.3|Standard Deviation|1.2|1.2|||
3745242|NCT02003924|3579952|B3|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|116|116.0||||||
3745243|NCT02003924|3579953|B2|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
3745244|NCT02003924|3579954|B1|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|77|77.0||||||
3745245|NCT02003924|3579952|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3745246|NCT02003924|3579953|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3745247|NCT02003924|3579954|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3745248|NCT02003924|3579952|B3|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3745249|NCT02003924|3579953|B2|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3745250|NCT02003924|3579954|B1|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3745251|NCT02003924|3579952|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|991|991.0||||||
3745252|NCT02003924|3579953|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|320|320.0||||||
3745253|NCT02003924|3579954|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|671|671.0||||||
3745254|NCT02003924|3579952|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3745255|NCT02003924|3579953|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3745256|NCT02003924|3579954|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3745257|NCT02003924|3579952|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3745258|NCT02003924|3579953|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3745259|NCT02003924|3579954|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3745260|NCT02003924|3579952|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|230|230.0||||||
3745261|NCT02003924|3579953|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|88|88.0||||||
3745262|NCT02003924|3579954|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|142|142.0||||||
3745263|NCT02003924|3579952|B3||Male|Sex: Female, Male||Participants|Count of Participants|1401|1401.0||||||
3745264|NCT02003924|3579953|B2||Male|Sex: Female, Male||Participants|Count of Participants|468|468.0||||||
3745265|NCT02003924|3579954|B1||Male|Sex: Female, Male||Participants|Count of Participants|933|933.0||||||
3745266|NCT02003924|3579952|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3745267|NCT02003924|3579953|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3745268|NCT02003924|3579954|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3745269|NCT02003924|3579952|B3|||Age||years|Mean|73.5|73.5|Standard Deviation|7.77|7.77|||
3745270|NCT02003924|3579953|B2|||Age||years|Mean|72.9|72.9|Standard Deviation|7.63|7.63|||
3745271|NCT02003924|3579954|B1|||Age||years|Mean|73.8|73.8|Standard Deviation|7.83|7.83|||
3745272|NCT02003638|3580053|B3|||Coronary artery disease||participants|Number|8|8.0||||||
3745273|NCT02003638|3580054|B2|||Coronary artery disease||participants|Number|3|3.0||||||
3745274|NCT02003638|3580055|B1|||Coronary artery disease||participants|Number|5|5.0||||||
3745275|NCT02003638|3580053|B3|||Body-mass index||kg/m^2|Mean|30.0|30.0|Full Range|||23.7|33.4|
3745276|NCT02003638|3580054|B2|||Body-mass index||kg/m^2|Mean|32|32.0|Full Range|||25.6|33.4|
3745277|NCT02003638|3580055|B1|||Body-mass index||kg/m^2|Mean|28.9|28.9|Full Range|||23.7|33.1|
3745278|NCT02003638|3580053|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3745279|NCT02003638|3580054|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3745280|NCT02003638|3580055|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3745281|NCT02003638|3580053|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3745282|NCT02003638|3580054|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3745283|NCT02003638|3580055|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3745284|NCT02003638|3580053|B3|||Age||years|Mean|64|64.0|Full Range|||56.0|69.0|
3745285|NCT02003638|3580054|B2|||Age||years|Mean|66|66.0|Full Range|||64.0|69.0|
3745286|NCT02003638|3580055|B1|||Age||years|Mean|63|63.0|Full Range|||56.0|67.0|
3745287|NCT02003534|3580062|B1||Male|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
3745288|NCT02003534|3580062|B1||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3745289|NCT02003534|3580062|B1|||Age||Years|Mean|49.8|49.8|Standard Deviation|17.4|17.4|||
3745290|NCT02003404|3580066|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3745291|NCT02003404|3580066|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3745292|NCT02003404|3580066|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3745293|NCT02003404|3580066|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3745294|NCT02003404|3580066|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3745295|NCT02003404|3580066|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3745296|NCT02003391|3580072|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3745297|NCT02003391|3580073|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3745298|NCT02003391|3580074|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3745299|NCT02003391|3580072|B3||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3745300|NCT02003391|3580073|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3745301|NCT02003391|3580074|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3745302|NCT02003391|3580072|B3|||Age||years|Mean|63.3|63.3|Standard Deviation|12.98|12.98|||
3745303|NCT02003391|3580073|B2|||Age||years|Mean|63.8|63.8|Standard Deviation|13.29|13.29|||
3745304|NCT02003391|3580074|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|12.76|12.76|||
3745305|NCT02003365|3580085|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3745306|NCT02003365|3580086|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3745307|NCT02003365|3580087|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3745308|NCT02003365|3580088|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3745309|NCT02003365|3580085|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3745310|NCT02003365|3580086|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3745311|NCT02003365|3580087|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3745312|NCT02003365|3580088|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3745313|NCT02003365|3580085|B4|||Age||years|Mean|62.15|62.15|Full Range|||48.0|78.0|
3745314|NCT02003365|3580086|B3|||Age||years|Mean|61.6|61.6|Full Range|||52.0|75.0|
3745315|NCT02003365|3580087|B2|||Age||years|Mean|62.8|62.8|Full Range|||48.0|78.0|
3745316|NCT02003365|3580088|B1|||Age||years|Mean|61.5|61.5|Full Range|||49.0|69.0|
3745317|NCT02003352|3580101|B1|United States||Region of Enrollment||participants|Number|98|98.0||||||
3745318|NCT02003352|3580101|B1||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3745319|NCT02003352|3580101|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3745320|NCT02003352|3580101|B1|||Age||years|Mean|39|39.0|Full Range|||20.0|60.0|
3745321|NCT02003352|3580101|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3745322|NCT02003352|3580101|B1||Between 18 and 65 years|Age||Participants|Count of Participants|98|98.0||||||
3745323|NCT02003352|3580101|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3745324|NCT02003053|3580105|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
3745325|NCT02003053|3580106|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3745326|NCT02003053|3580107|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3745327|NCT02003053|3580105|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3745328|NCT02003053|3580105|B3||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3745329|NCT02003053|3580106|B2||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||This data was not collected.
3745330|NCT02003053|3580107|B1||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||This data was not collected.
3745331|NCT02003053|3580105|B3||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3745332|NCT02003053|3580106|B2||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||This data was not collected.
3745333|NCT02003053|3580107|B1||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||This data was not collected.
3745334|NCT02003053|3580105|B3|||Age||years|Mean|51.29|51.29|Standard Deviation|11.28|11.28|||
3745335|NCT02003053|3580106|B2|||Age||years|Mean|54.33|54.33|Standard Deviation|3.78|3.78|||
3745336|NCT02003053|3580107|B1|||Age||years|Mean|49.0|49.0|Standard Deviation|16.9|16.9|||
3745337|NCT02003014|3580114|B1|Other||Breakdown of Complications|Breakdown of medical complications was categorized as diabetic retinopathy,diabetic nephropathy,diabetic neuropathy,dyslipidaemia,hypertension,heart disease,liver disease(all types of liver disease),hepatic steatosis,alcoholic liver injury,viral liver injury,other liver disease,renal disease(other than diabetic nephropathy),renal disease(including diabetic nephropathy),malignant tumor,cerebrovascular disease,any other disease from those mentioned above.Baseline characteristic was analyzed only in participants who had medical complications. Participants could be counted in more than 1 category.|participants|Number|234|234.0||||||
3745338|NCT02003014|3580114|B1|Cerebrovascular disease||Breakdown of Complications|Breakdown of medical complications was categorized as diabetic retinopathy,diabetic nephropathy,diabetic neuropathy,dyslipidaemia,hypertension,heart disease,liver disease(all types of liver disease),hepatic steatosis,alcoholic liver injury,viral liver injury,other liver disease,renal disease(other than diabetic nephropathy),renal disease(including diabetic nephropathy),malignant tumor,cerebrovascular disease,any other disease from those mentioned above.Baseline characteristic was analyzed only in participants who had medical complications. Participants could be counted in more than 1 category.|participants|Number|38|38.0||||||
3745339|NCT02003014|3580114|B1|Malignant tumor||Breakdown of Complications|Breakdown of medical complications was categorized as diabetic retinopathy,diabetic nephropathy,diabetic neuropathy,dyslipidaemia,hypertension,heart disease,liver disease(all types of liver disease),hepatic steatosis,alcoholic liver injury,viral liver injury,other liver disease,renal disease(other than diabetic nephropathy),renal disease(including diabetic nephropathy),malignant tumor,cerebrovascular disease,any other disease from those mentioned above.Baseline characteristic was analyzed only in participants who had medical complications. Participants could be counted in more than 1 category.|participants|Number|8|8.0||||||
3745340|NCT02003014|3580114|B1|Renal disease (including diabetic nephropathy)||Breakdown of Complications|Breakdown of medical complications was categorized as diabetic retinopathy,diabetic nephropathy,diabetic neuropathy,dyslipidaemia,hypertension,heart disease,liver disease(all types of liver disease),hepatic steatosis,alcoholic liver injury,viral liver injury,other liver disease,renal disease(other than diabetic nephropathy),renal disease(including diabetic nephropathy),malignant tumor,cerebrovascular disease,any other disease from those mentioned above.Baseline characteristic was analyzed only in participants who had medical complications. Participants could be counted in more than 1 category.|participants|Number|85|85.0||||||
3745341|NCT02003014|3580114|B1|Renal disease (other than diabetic nephropathy)||Breakdown of Complications|Breakdown of medical complications was categorized as diabetic retinopathy,diabetic nephropathy,diabetic neuropathy,dyslipidaemia,hypertension,heart disease,liver disease(all types of liver disease),hepatic steatosis,alcoholic liver injury,viral liver injury,other liver disease,renal disease(other than diabetic nephropathy),renal disease(including diabetic nephropathy),malignant tumor,cerebrovascular disease,any other disease from those mentioned above.Baseline characteristic was analyzed only in participants who had medical complications. Participants could be counted in more than 1 category.|participants|Number|14|14.0||||||
3745342|NCT02003014|3580114|B1|Other liver disease||Breakdown of Complications|Breakdown of medical complications was categorized as diabetic retinopathy,diabetic nephropathy,diabetic neuropathy,dyslipidaemia,hypertension,heart disease,liver disease(all types of liver disease),hepatic steatosis,alcoholic liver injury,viral liver injury,other liver disease,renal disease(other than diabetic nephropathy),renal disease(including diabetic nephropathy),malignant tumor,cerebrovascular disease,any other disease from those mentioned above.Baseline characteristic was analyzed only in participants who had medical complications. Participants could be counted in more than 1 category.|participants|Number|19|19.0||||||
3745393|NCT02003014|3580114|B1|Pregnant||Pregnancy status|The baseline characteristic was analyzed only in female participants.|participants|Number|0|0.0||||||
3745343|NCT02003014|3580114|B1|Viral liver injury||Breakdown of Complications|Breakdown of medical complications was categorized as diabetic retinopathy,diabetic nephropathy,diabetic neuropathy,dyslipidaemia,hypertension,heart disease,liver disease(all types of liver disease),hepatic steatosis,alcoholic liver injury,viral liver injury,other liver disease,renal disease(other than diabetic nephropathy),renal disease(including diabetic nephropathy),malignant tumor,cerebrovascular disease,any other disease from those mentioned above.Baseline characteristic was analyzed only in participants who had medical complications. Participants could be counted in more than 1 category.|participants|Number|1|1.0||||||
3745344|NCT02003014|3580114|B1|Alcoholic liver injury||Breakdown of Complications|Breakdown of medical complications was categorized as diabetic retinopathy,diabetic nephropathy,diabetic neuropathy,dyslipidaemia,hypertension,heart disease,liver disease(all types of liver disease),hepatic steatosis,alcoholic liver injury,viral liver injury,other liver disease,renal disease(other than diabetic nephropathy),renal disease(including diabetic nephropathy),malignant tumor,cerebrovascular disease,any other disease from those mentioned above.Baseline characteristic was analyzed only in participants who had medical complications. Participants could be counted in more than 1 category.|participants|Number|11|11.0||||||
3745345|NCT02003014|3580114|B1|Hepatic steatosis||Breakdown of Complications|Breakdown of medical complications was categorized as diabetic retinopathy,diabetic nephropathy,diabetic neuropathy,dyslipidaemia,hypertension,heart disease,liver disease(all types of liver disease),hepatic steatosis,alcoholic liver injury,viral liver injury,other liver disease,renal disease(other than diabetic nephropathy),renal disease(including diabetic nephropathy),malignant tumor,cerebrovascular disease,any other disease from those mentioned above.Baseline characteristic was analyzed only in participants who had medical complications. Participants could be counted in more than 1 category.|participants|Number|58|58.0||||||
3745346|NCT02003014|3580114|B1|Liver disease (all types of liver disease)||Breakdown of Complications|Breakdown of medical complications was categorized as diabetic retinopathy,diabetic nephropathy,diabetic neuropathy,dyslipidaemia,hypertension,heart disease,liver disease(all types of liver disease),hepatic steatosis,alcoholic liver injury,viral liver injury,other liver disease,renal disease(other than diabetic nephropathy),renal disease(including diabetic nephropathy),malignant tumor,cerebrovascular disease,any other disease from those mentioned above.Baseline characteristic was analyzed only in participants who had medical complications. Participants could be counted in more than 1 category.|participants|Number|79|79.0||||||
3745347|NCT02003014|3580114|B1|Heart disease||Breakdown of Complications|Breakdown of medical complications was categorized as diabetic retinopathy,diabetic nephropathy,diabetic neuropathy,dyslipidaemia,hypertension,heart disease,liver disease(all types of liver disease),hepatic steatosis,alcoholic liver injury,viral liver injury,other liver disease,renal disease(other than diabetic nephropathy),renal disease(including diabetic nephropathy),malignant tumor,cerebrovascular disease,any other disease from those mentioned above.Baseline characteristic was analyzed only in participants who had medical complications. Participants could be counted in more than 1 category.|participants|Number|85|85.0||||||
3745348|NCT02003014|3580114|B1|Hypertension||Breakdown of Complications|Breakdown of medical complications was categorized as diabetic retinopathy,diabetic nephropathy,diabetic neuropathy,dyslipidaemia,hypertension,heart disease,liver disease(all types of liver disease),hepatic steatosis,alcoholic liver injury,viral liver injury,other liver disease,renal disease(other than diabetic nephropathy),renal disease(including diabetic nephropathy),malignant tumor,cerebrovascular disease,any other disease from those mentioned above.Baseline characteristic was analyzed only in participants who had medical complications. Participants could be counted in more than 1 category.|participants|Number|203|203.0||||||
3745349|NCT02003014|3580114|B1|Dyslipidaemia||Breakdown of Complications|Breakdown of medical complications was categorized as diabetic retinopathy,diabetic nephropathy,diabetic neuropathy,dyslipidaemia,hypertension,heart disease,liver disease(all types of liver disease),hepatic steatosis,alcoholic liver injury,viral liver injury,other liver disease,renal disease(other than diabetic nephropathy),renal disease(including diabetic nephropathy),malignant tumor,cerebrovascular disease,any other disease from those mentioned above.Baseline characteristic was analyzed only in participants who had medical complications. Participants could be counted in more than 1 category.|participants|Number|217|217.0||||||
3745350|NCT02003014|3580114|B1|Diabetic neuropathy||Breakdown of Complications|Breakdown of medical complications was categorized as diabetic retinopathy,diabetic nephropathy,diabetic neuropathy,dyslipidaemia,hypertension,heart disease,liver disease(all types of liver disease),hepatic steatosis,alcoholic liver injury,viral liver injury,other liver disease,renal disease(other than diabetic nephropathy),renal disease(including diabetic nephropathy),malignant tumor,cerebrovascular disease,any other disease from those mentioned above.Baseline characteristic was analyzed only in participants who had medical complications. Participants could be counted in more than 1 category.|participants|Number|58|58.0||||||
3745351|NCT02003014|3580114|B1|Diabetic nephropathy||Breakdown of Complications|Breakdown of medical complications was categorized as diabetic retinopathy,diabetic nephropathy,diabetic neuropathy,dyslipidaemia,hypertension,heart disease,liver disease(all types of liver disease),hepatic steatosis,alcoholic liver injury,viral liver injury,other liver disease,renal disease(other than diabetic nephropathy),renal disease(including diabetic nephropathy),malignant tumor,cerebrovascular disease,any other disease from those mentioned above.Baseline characteristic was analyzed only in participants who had medical complications. Participants could be counted in more than 1 category.|participants|Number|75|75.0||||||
3745352|NCT02003014|3580114|B1|Diabetic retinopathy||Breakdown of Complications|Breakdown of medical complications was categorized as diabetic retinopathy,diabetic nephropathy,diabetic neuropathy,dyslipidaemia,hypertension,heart disease,liver disease(all types of liver disease),hepatic steatosis,alcoholic liver injury,viral liver injury,other liver disease,renal disease(other than diabetic nephropathy),renal disease(including diabetic nephropathy),malignant tumor,cerebrovascular disease,any other disease from those mentioned above.Baseline characteristic was analyzed only in participants who had medical complications. Participants could be counted in more than 1 category.|participants|Number|63|63.0||||||
3745353|NCT02003014|3580114|B1|Had presence of medical complications||Medical Complications||participants|Number|780|780.0||||||
3745354|NCT02003014|3580114|B1|Had no presence of medical complications||Medical Complications||participants|Number|100|100.0||||||
3745394|NCT02003014|3580114|B1|Not pregnant||Pregnancy status|The baseline characteristic was analyzed only in female participants.|participants|Number|334|334.0||||||
3745395|NCT02003014|3580114|B1||Male|Sex: Female, Male||Participants|Count of Participants|546|546.0||||||
3745355|NCT02003014|3580114|B1|Other||Breakdown of Medical History|Breakdown of medical history was categorized as liver disease, renal disease, heart disease, cerebrovascular disease, malignant tumor and any other disease from those mentioned above. The baseline characteristic was analyzed only in participants who had medical history. Participants could be counted in more than 1 category (including duplicates).|participants|Number|154|154.0||||||
3745356|NCT02003014|3580114|B1|Malignant tumor||Breakdown of Medical History|Breakdown of medical history was categorized as liver disease, renal disease, heart disease, cerebrovascular disease, malignant tumor and any other disease from those mentioned above. The baseline characteristic was analyzed only in participants who had medical history. Participants could be counted in more than 1 category (including duplicates).|participants|Number|23|23.0||||||
3745357|NCT02003014|3580114|B1|Cerebrovascular disease||Breakdown of Medical History|Breakdown of medical history was categorized as liver disease, renal disease, heart disease, cerebrovascular disease, malignant tumor and any other disease from those mentioned above. The baseline characteristic was analyzed only in participants who had medical history. Participants could be counted in more than 1 category (including duplicates).|participants|Number|21|21.0||||||
3745358|NCT02003014|3580114|B1|Heart disease||Breakdown of Medical History|Breakdown of medical history was categorized as liver disease, renal disease, heart disease, cerebrovascular disease, malignant tumor and any other disease from those mentioned above. The baseline characteristic was analyzed only in participants who had medical history. Participants could be counted in more than 1 category (including duplicates).|participants|Number|20|20.0||||||
3745359|NCT02003014|3580114|B1|Renal disease||Breakdown of Medical History|Breakdown of medical history was categorized as liver disease, renal disease, heart disease, cerebrovascular disease, malignant tumor and any other disease from those mentioned above. The baseline characteristic was analyzed only in participants who had medical history. Participants could be counted in more than 1 category (including duplicates).|participants|Number|4|4.0||||||
3745360|NCT02003014|3580114|B1|Liver disease||Breakdown of Medical History|Breakdown of medical history was categorized as liver disease, renal disease, heart disease, cerebrovascular disease, malignant tumor and any other disease from those mentioned above. The baseline characteristic was analyzed only in participants who had medical history. Participants could be counted in more than 1 category (including duplicates).|participants|Number|6|6.0||||||
3745361|NCT02003014|3580114|B1|Unknown||Medical History||participants|Number|2|2.0||||||
3745362|NCT02003014|3580114|B1|Had presence of medical history||Medical History||participants|Number|206|206.0||||||
3745363|NCT02003014|3580114|B1|Had no presence of medical history||Medical History||participants|Number|672|672.0||||||
3745364|NCT02003014|3580114|B1|Unknown||Body Mass Index||participants|Number|14|14.0||||||
3745365|NCT02003014|3580114|B1|>=30 kg/m^2||Body Mass Index||participants|Number|124|124.0||||||
3745366|NCT02003014|3580114|B1|>=25 to <30 kg/m^2||Body Mass Index||participants|Number|346|346.0||||||
3745367|NCT02003014|3580114|B1|>=18.5 to <25 kg/m^2||Body Mass Index||participants|Number|382|382.0||||||
3745368|NCT02003014|3580114|B1|< 18.5 kilogram per square meter (kg/m^2)||Body Mass Index||participants|Number|14|14.0||||||
3745369|NCT02003014|3580114|B1|Unknown||Weight||participants|Number|8|8.0||||||
3745370|NCT02003014|3580114|B1|>=70 kg||Weight||participants|Number|384|384.0||||||
3745371|NCT02003014|3580114|B1|>=60 to <70 kg||Weight||participants|Number|268|268.0||||||
3745372|NCT02003014|3580114|B1|>=50 to <60 kg||Weight||participants|Number|163|163.0||||||
3745373|NCT02003014|3580114|B1|>=40 to <50 kg||Weight||participants|Number|54|54.0||||||
3745374|NCT02003014|3580114|B1|< 40 kilogram (kg)||Weight||participants|Number|3|3.0||||||
3745375|NCT02003014|3580114|B1|Unknown||Smoking Habits||participants|Number|12|12.0||||||
3745376|NCT02003014|3580114|B1|Current smoker||Smoking Habits||participants|Number|203|203.0||||||
3745377|NCT02003014|3580114|B1|Former smoker||Smoking Habits||participants|Number|145|145.0||||||
3745378|NCT02003014|3580114|B1|None||Smoking Habits||participants|Number|520|520.0||||||
3745379|NCT02003014|3580114|B1|Unknown||Drinking Habits||participants|Number|14|14.0||||||
3745380|NCT02003014|3580114|B1|Current drinker||Drinking Habits||participants|Number|346|346.0||||||
3745381|NCT02003014|3580114|B1|Former drinker||Drinking Habits||participants|Number|46|46.0||||||
3745382|NCT02003014|3580114|B1|None||Drinking Habits||participants|Number|474|474.0||||||
3745383|NCT02003014|3580114|B1|Other||Details Regarding Predisposition to Hypersensitivity|Predisposition to hypersensitivity was categorized as hypersensitivity due to drug, food, or other. The baseline characteristic was analyzed in only participants who had a liability or tendency to suffer from hypersensitivity.|participants|Number|7|7.0||||||
3745384|NCT02003014|3580114|B1|Food||Details Regarding Predisposition to Hypersensitivity|Predisposition to hypersensitivity was categorized as hypersensitivity due to drug, food, or other. The baseline characteristic was analyzed in only participants who had a liability or tendency to suffer from hypersensitivity.|participants|Number|5|5.0||||||
3745385|NCT02003014|3580114|B1|Drug||Details Regarding Predisposition to Hypersensitivity|Predisposition to hypersensitivity was categorized as hypersensitivity due to drug, food, or other. The baseline characteristic was analyzed in only participants who had a liability or tendency to suffer from hypersensitivity.|participants|Number|12|12.0||||||
3745386|NCT02003014|3580114|B1|Had predisposition to hypersensitivity||Predisposition to Hypersensitivity|The baseline characteristic was analyzed in participants who had a liability or tendency to suffer from hypersensitivity.|participants|Number|24|24.0||||||
3745387|NCT02003014|3580114|B1|Had no predisposition to hypersensitivity||Predisposition to Hypersensitivity|The baseline characteristic was analyzed in participants who had a liability or tendency to suffer from hypersensitivity.|participants|Number|856|856.0||||||
3745388|NCT02003014|3580114|B1|Unknown||Time from diagnosis of type 2 diabetes||participants|Number|57|57.0||||||
3745389|NCT02003014|3580114|B1|>=10 years||Time from diagnosis of type 2 diabetes||participants|Number|354|354.0||||||
3745390|NCT02003014|3580114|B1|>=5 to <10 years||Time from diagnosis of type 2 diabetes||participants|Number|239|239.0||||||
3745391|NCT02003014|3580114|B1|Greater than equal to (>=) 1 to <5 years||Time from diagnosis of type 2 diabetes||participants|Number|194|194.0||||||
3745392|NCT02003014|3580114|B1|Less than (<) 1 years||Time from diagnosis of type 2 diabetes||participants|Number|36|36.0||||||
3745396|NCT02003014|3580114|B1||Female|Sex: Female, Male||Participants|Count of Participants|334|334.0||||||
3745397|NCT02003014|3580114|B1|||Age||years|Mean|58.9|58.9|Standard Deviation|11.69|11.69|||
3745398|NCT02002936|3580124|B1||Male|Gender||Participants|Count of Participants|1|1.0||||||
3745399|NCT02002936|3580124|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3745400|NCT02002936|3580124|B1|80-years||Age, Customized||participants|Number|0|0.0||||||
3745401|NCT02002936|3580124|B1|70-79 years||Age, Customized||participants|Number|0|0.0||||||
3745402|NCT02002936|3580124|B1|60-69 years||Age, Customized||participants|Number|0|0.0||||||
3745403|NCT02002936|3580124|B1|50-59 years||Age, Customized||participants|Number|1|1.0||||||
3745404|NCT02002871|3580133|B1|Germany||Region of Enrollment||participants|Number|21|21.0||||||
3745405|NCT02002871|3580133|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3745406|NCT02002871|3580133|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3745407|NCT02002871|3580133|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3745408|NCT02002871|3580133|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3745409|NCT02002871|3580133|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3745410|NCT02002702|3580159|B4||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3745411|NCT02002702|3580160|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3745412|NCT02002702|3580161|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3745413|NCT02002702|3580162|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3745414|NCT02002702|3580159|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3745415|NCT02002702|3580160|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3745416|NCT02002702|3580161|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3745417|NCT02002702|3580162|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3745418|NCT02002702|3580159|B4|≥ 65 years||Age, Customized||participants|Number|36|36.0||||||
3745419|NCT02002702|3580160|B3|≥ 65 years||Age, Customized||participants|Number|12|12.0||||||
3745420|NCT02002702|3580161|B2|≥ 65 years||Age, Customized||participants|Number|14|14.0||||||
3745421|NCT02002702|3580162|B1|≥ 65 years||Age, Customized||participants|Number|10|10.0||||||
3745422|NCT02002702|3580159|B4|< 65 years||Age, Customized||participants|Number|10|10.0||||||
3745423|NCT02002702|3580160|B3|< 65 years||Age, Customized||participants|Number|3|3.0||||||
3745424|NCT02002702|3580161|B2|< 65 years||Age, Customized||participants|Number|1|1.0||||||
3745425|NCT02002702|3580162|B1|< 65 years||Age, Customized||participants|Number|6|6.0||||||
3745426|NCT02002702|3580159|B4|||Age||years|Mean|75.3|75.3|Standard Deviation|11.54|11.54|||
3745427|NCT02002702|3580160|B3|||Age||years|Mean|76.4|76.4|Standard Deviation|12.08|12.08|||
3745428|NCT02002702|3580161|B2|||Age||years|Mean|79.7|79.7|Standard Deviation|9.01|9.01|||
3745429|NCT02002702|3580162|B1|||Age||years|Mean|70.2|70.2|Standard Deviation|11.77|11.77|||
3745430|NCT02002689|3580196|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3745431|NCT02002689|3580196|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3745432|NCT02002689|3580196|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|7.64|7.64|||
3745433|NCT02002689|3580196|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3745434|NCT02002689|3580196|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3745435|NCT02002689|3580196|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3745436|NCT02002650|3580202|B3|||High-risk patients|"met at least one of the major criteria - clinical suspicion of sphincter of Oddi dysfunction, a history of PEP, pancreatic sphincterotomy, precut sphincterotomy, ≥8 cannulation attempts, pneumatic dilatation of an intact biliary sphincter, or ampullectomy.~or met two or more of the minor criteria - age<50 and female gender, a history of recurrent pancreatitis (≥2 episodes), ≥3 injections of contrast into the pancreatic duct with ≥1 injection to the tail of the pancreas, opacification of pancreatic acini, or brush cytology performed on the pancreatic duct."|participants|Number|586|586.0||||||
3745437|NCT02002650|3580203|B2|||High-risk patients|"met at least one of the major criteria - clinical suspicion of sphincter of Oddi dysfunction, a history of PEP, pancreatic sphincterotomy, precut sphincterotomy, ≥8 cannulation attempts, pneumatic dilatation of an intact biliary sphincter, or ampullectomy.~or met two or more of the minor criteria - age<50 and female gender, a history of recurrent pancreatitis (≥2 episodes), ≥3 injections of contrast into the pancreatic duct with ≥1 injection to the tail of the pancreas, opacification of pancreatic acini, or brush cytology performed on the pancreatic duct."|participants|Number|281|281.0||||||
3745438|NCT02002650|3580204|B1|||High-risk patients|"met at least one of the major criteria - clinical suspicion of sphincter of Oddi dysfunction, a history of PEP, pancreatic sphincterotomy, precut sphincterotomy, ≥8 cannulation attempts, pneumatic dilatation of an intact biliary sphincter, or ampullectomy.~or met two or more of the minor criteria - age<50 and female gender, a history of recurrent pancreatitis (≥2 episodes), ≥3 injections of contrast into the pancreatic duct with ≥1 injection to the tail of the pancreas, opacification of pancreatic acini, or brush cytology performed on the pancreatic duct."|participants|Number|305|305.0||||||
3745439|NCT02002650|3580202|B3||Male|Sex: Female, Male||Participants|Count of Participants|1219|1219.0||||||
3745440|NCT02002650|3580203|B2||Male|Sex: Female, Male||Participants|Count of Participants|610|610.0||||||
3745441|NCT02002650|3580204|B1||Male|Sex: Female, Male||Participants|Count of Participants|609|609.0||||||
3745442|NCT02002650|3580202|B3||Female|Sex: Female, Male||Participants|Count of Participants|1381|1381.0||||||
3745443|NCT02002650|3580203|B2||Female|Sex: Female, Male||Participants|Count of Participants|693|693.0||||||
3745444|NCT02002650|3580204|B1||Female|Sex: Female, Male||Participants|Count of Participants|688|688.0||||||
3745445|NCT02002650|3580202|B3|||Age||years|Median|62|62.0|Inter-Quartile Range|||50.0|73.0|
3745446|NCT02002650|3580203|B2|||Age||years|Median|63|63.0|Inter-Quartile Range|||50.0|74.0|
3745447|NCT02002650|3580204|B1|||Age||years|Median|62|62.0|Inter-Quartile Range|||50.0|72.0|
3745448|NCT02002533|3580213|B3|United States||Region of Enrollment||Participants|Count of Participants|71|71.0||||||
3745449|NCT02002533|3580214|B2|United States||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3745450|NCT02002533|3580215|B1|United States||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3745451|NCT02002533|3580213|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745452|NCT02002533|3580214|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745453|NCT02002533|3580215|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745454|NCT02002533|3580213|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745455|NCT02002533|3580214|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745456|NCT02002533|3580215|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745457|NCT02002533|3580213|B3||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3745458|NCT02002533|3580214|B2||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3745459|NCT02002533|3580215|B1||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3745460|NCT02002533|3580213|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3745461|NCT02002533|3580214|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3745462|NCT02002533|3580215|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3745463|NCT02002533|3580213|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745464|NCT02002533|3580214|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745465|NCT02002533|3580215|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745466|NCT02002533|3580213|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3745467|NCT02002533|3580214|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3745468|NCT02002533|3580215|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745469|NCT02002533|3580213|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745470|NCT02002533|3580214|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745471|NCT02002533|3580215|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745472|NCT02002533|3580213|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745473|NCT02002533|3580214|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745474|NCT02002533|3580215|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745475|NCT02002533|3580213|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3745476|NCT02002533|3580214|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3745477|NCT02002533|3580215|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3745478|NCT02002533|3580213|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745479|NCT02002533|3580214|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745480|NCT02002533|3580215|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745481|NCT02002533|3580213|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3745482|NCT02002533|3580214|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3745483|NCT02002533|3580215|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3745484|NCT02002533|3580213|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3745485|NCT02002533|3580214|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3745486|NCT02002533|3580215|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3745487|NCT02002533|3580213|B3|||Age||years|Mean|52.5|52.5|Full Range|||29.0|73.0|
3745488|NCT02002533|3580214|B2|||Age||years|Mean|53.9|53.9|Full Range|||29.0|73.0|
3745489|NCT02002533|3580215|B1|||Age||years|Mean|50.9|50.9|Full Range|||33.0|67.0|
3745490|NCT02002221|3580239|B3||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3745491|NCT02002221|3580240|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3745492|NCT02002221|3580241|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3745493|NCT02002221|3580239|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3745494|NCT02002221|3580240|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3745495|NCT02002221|3580241|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3745496|NCT02002221|3580239|B3|||Age||Years|Mean|59.3|59.3|Standard Deviation|9.34|9.34|||
3745497|NCT02002221|3580240|B2|||Age||Years|Mean|60.1|60.1|Standard Deviation|9.11|9.11|||
3745498|NCT02002221|3580241|B1|||Age||Years|Mean|58.5|58.5|Standard Deviation|9.57|9.57|||
3745499|NCT02002208|3580256|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3745500|NCT02002208|3580257|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3745501|NCT02002208|3580258|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3745502|NCT02002208|3580256|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3745503|NCT02002208|3580257|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3745504|NCT02002208|3580258|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3745505|NCT02002208|3580256|B3|||Age||years|Mean|31.2|31.2|Standard Deviation|8.46|8.46|||
3745506|NCT02002208|3580257|B2|||Age||years|Mean|30.9|30.9|Standard Deviation|8.54|8.54|||
3745507|NCT02002208|3580258|B1|||Age||years|Mean|31.6|31.6|Standard Deviation|8.42|8.42|||
3745508|NCT02002091|3580267|B3|||glycated hemoglobin||%|Mean|9.58|9.58|Standard Deviation|2.29|2.29|||
3745509|NCT02002091|3580268|B2|||glycated hemoglobin||%|Mean|9.48|9.48|Standard Deviation|2.38|2.38|||
3745510|NCT02002091|3580269|B1|||glycated hemoglobin||%|Mean|9.73|9.73|Standard Deviation|2.16|2.16|||
3745511|NCT02002091|3580267|B3|||Glycaemia||g/l|Mean|2.50|2.5|Standard Deviation|1.01|1.01|||
3745512|NCT02002091|3580268|B2|||Glycaemia||g/l|Mean|2.39|2.39|Standard Deviation|0.98|0.98|||
3745513|NCT02002091|3580269|B1|||Glycaemia||g/l|Mean|2.70|2.7|Standard Deviation|1.05|1.05|||
3745514|NCT02002091|3580267|B3|||Diastolic blood pressure||mm Hg|Mean|85.8|85.8|Standard Deviation|11.7|11.7|||
3745515|NCT02002091|3580268|B2|||Diastolic blood pressure||mm Hg|Mean|85.3|85.3|Standard Deviation|10.9|10.9|||
3745516|NCT02002091|3580269|B1|||Diastolic blood pressure||mm Hg|Mean|86.6|86.6|Standard Deviation|13.0|13.0|||
3745517|NCT02002091|3580267|B3|||Systolic blood pressure||mm Hg|Mean|141.2|141.2|Standard Deviation|23.4|23.4|||
3745518|NCT02002091|3580268|B2|||Systolic blood pressure||mm Hg|Mean|141.9|141.9|Standard Deviation|23.9|23.9|||
3745519|NCT02002091|3580269|B1|||Systolic blood pressure||mm Hg|Mean|139.9|139.9|Standard Deviation|22.6|22.6|||
3745520|NCT02002091|3580267|B3|||BMI||kg/m²|Mean|28.0|28.0|Standard Deviation|5.2|5.2|||
3745521|NCT02002091|3580268|B2|||BMI||kg/m²|Mean|28.9|28.9|Standard Deviation|5.1|5.1|||
3745522|NCT02002091|3580269|B1|||BMI||kg/m²|Mean|26.6|26.6|Standard Deviation|4.9|4.9|||
3745523|NCT02002091|3580267|B3|||waist circumference||cm|Mean|98.9|98.9|Standard Deviation|10.7|10.7|||
3745524|NCT02002091|3580268|B2|||waist circumference||cm|Mean|99.3|99.3|Standard Deviation|10.8|10.8|||
3745525|NCT02002091|3580269|B1|||waist circumference||cm|Mean|98.1|98.1|Standard Deviation|10.4|10.4|||
3745526|NCT02002091|3580267|B3|||history of family hypertension||participants|Number|202|202.0||||||
3745527|NCT02002091|3580268|B2|||history of family hypertension||participants|Number|133|133.0||||||
3745528|NCT02002091|3580269|B1|||history of family hypertension||participants|Number|69|69.0||||||
3745529|NCT02002091|3580267|B3|||history of family diabetes||participants|Number|222|222.0||||||
3745530|NCT02002091|3580268|B2|||history of family diabetes||participants|Number|138|138.0||||||
3745531|NCT02002091|3580269|B1|||history of family diabetes||participants|Number|84|84.0||||||
3745532|NCT02002091|3580267|B3|Algeria||Region of Enrollment||participants|Number|327|327.0||||||
3745533|NCT02002091|3580268|B2|Algeria||Region of Enrollment||participants|Number|205|205.0||||||
3745534|NCT02002091|3580269|B1|Algeria||Region of Enrollment||participants|Number|122|122.0||||||
3745535|NCT02002091|3580267|B3||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3745536|NCT02002091|3580268|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3745537|NCT02002091|3580269|B1||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3745538|NCT02002091|3580267|B3||Female|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
3745539|NCT02002091|3580268|B2||Female|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
3745540|NCT02002091|3580269|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3745541|NCT02002091|3580267|B3|||Age||years|Mean|53.5|53.5|Standard Deviation|8.6|8.6|||
3745542|NCT02002091|3580268|B2|||Age||years|Mean|53.7|53.7|Standard Deviation|8.4|8.4|||
3745543|NCT02002091|3580269|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|8.9|8.9|||
3745544|NCT02001987|3580305|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3745545|NCT02001987|3580305|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3745546|NCT02001987|3580305|B1|||Age||years|Mean|57.3|57.3|Standard Deviation|13.8|13.8|||
3745547|NCT02001714|3580379|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3745548|NCT02001714|3580380|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3745549|NCT02001714|3580381|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3745550|NCT02001714|3580379|B3||Female|Sex: Female, Male||Participants|Count of Participants|463|463.0||||||
3745551|NCT02001714|3580380|B2||Female|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
3745552|NCT02001714|3580381|B1||Female|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
3745553|NCT02001714|3580379|B3|||Age||years|Mean|64|64.0|Standard Deviation|7.3|7.3|||
3745554|NCT02001714|3580380|B2|||Age||years|Mean|65|65.0|Standard Deviation|7.7|7.7|||
3745555|NCT02001714|3580381|B1|||Age||years|Mean|64|64.0|Standard Deviation|6.8|6.8|||
3745556|NCT02001558|3580388|B3|United States||Region of Enrollment||participants|Number|65|65.0||||||
3745557|NCT02001558|3580389|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
3745558|NCT02001558|3580390|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
3745559|NCT02001558|3580388|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745560|NCT02001558|3580389|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745561|NCT02001558|3580390|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745562|NCT02001558|3580388|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745563|NCT02001558|3580389|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745564|NCT02001558|3580390|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745565|NCT02001558|3580388|B3||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3745566|NCT02001558|3580389|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3745567|NCT02001558|3580390|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3745568|NCT02001558|3580388|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3745569|NCT02001558|3580389|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3745570|NCT02001558|3580390|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3745571|NCT02001558|3580388|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745572|NCT02001558|3580389|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745573|NCT02001558|3580390|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745574|NCT02001558|3580388|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745575|NCT02001558|3580389|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745576|NCT02001558|3580390|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745577|NCT02001558|3580388|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745578|NCT02001558|3580389|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745579|NCT02001558|3580390|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745580|NCT02001558|3580388|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3745581|NCT02001558|3580389|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3745582|NCT02001558|3580390|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3745583|NCT02001558|3580388|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3745584|NCT02001558|3580389|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3745585|NCT02001558|3580390|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3745586|NCT02001558|3580388|B3|||Age||years|Mean|39.98|39.98|Standard Deviation|12.23|12.23|||
3745587|NCT02001558|3580389|B2|||Age||years|Mean|39.24|39.24|Standard Deviation|11.17|11.17|||
3745588|NCT02001558|3580390|B1|||Age||years|Mean|40.75|40.75|Standard Deviation|13.37|13.37|||
3745589|NCT02001181|3580423|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3745590|NCT02001181|3580424|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3745591|NCT02001181|3580425|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3745592|NCT02001181|3580423|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3745593|NCT02001181|3580424|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3745594|NCT02001181|3580425|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3745595|NCT02001181|3580423|B3|||Age||years|Mean|31.4|31.4|Standard Deviation|10.1|10.1|||
3745596|NCT02001181|3580424|B2|||Age||years|Mean|30.4|30.4|Standard Deviation|10.4|10.4|||
3745597|NCT02001181|3580425|B1|||Age||years|Mean|32.4|32.4|Standard Deviation|9.8|9.8|||
3745598|NCT02001051|3580440|B3|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3745599|NCT02001051|3580441|B2|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3745600|NCT02001051|3580442|B1|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3745601|NCT02001051|3580440|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745602|NCT02001051|3580441|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745603|NCT02001051|3580442|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745604|NCT02001051|3580440|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745605|NCT02001051|3580441|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745606|NCT02001051|3580442|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745607|NCT02001051|3580440|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3745608|NCT02001051|3580441|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3745609|NCT02001051|3580442|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3745610|NCT02001051|3580440|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3745611|NCT02001051|3580441|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3745612|NCT02001051|3580442|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745613|NCT02001051|3580440|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745614|NCT02001051|3580441|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745615|NCT02001051|3580442|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745616|NCT02001051|3580440|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745617|NCT02001051|3580441|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745618|NCT02001051|3580442|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745619|NCT02001051|3580440|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745620|NCT02001051|3580441|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745621|NCT02001051|3580442|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745622|NCT02001051|3580440|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745623|NCT02001051|3580441|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745624|NCT02001051|3580442|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745625|NCT02001051|3580440|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3745626|NCT02001051|3580441|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3745627|NCT02001051|3580442|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3745628|NCT02001051|3580440|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3745629|NCT02001051|3580441|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745630|NCT02001051|3580442|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3745631|NCT02001051|3580440|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3745632|NCT02001051|3580441|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3745633|NCT02001051|3580442|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3745634|NCT02001051|3580440|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3745635|NCT02001051|3580441|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3745636|NCT02001051|3580442|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3745637|NCT02001051|3580440|B3|||Age||years|Mean|45.91|45.91|Standard Deviation|10.18|10.18|||
3745638|NCT02001051|3580441|B2|||Age||years|Mean|43.25|43.25|Standard Deviation|12.09|12.09|||
3745639|NCT02001051|3580442|B1|||Age||years|Mean|48.56|48.56|Standard Deviation|11.68|11.68|||
3745640|NCT02001051|3580440|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3745641|NCT02001051|3580441|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3745642|NCT02001051|3580442|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3745643|NCT02001051|3580440|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3745644|NCT02001051|3580441|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3745645|NCT02001051|3580442|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3745646|NCT02001051|3580440|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3745647|NCT02001051|3580441|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3745648|NCT02001051|3580442|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3745649|NCT02000973|3580463|B5||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3745650|NCT02000973|3580464|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3745651|NCT02000973|3580465|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3745652|NCT02000973|3580466|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3745653|NCT02000973|3580467|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3745654|NCT02000973|3580463|B5||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3745655|NCT02000973|3580464|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3745656|NCT02000973|3580465|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3745657|NCT02000973|3580466|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3745658|NCT02000973|3580467|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3745659|NCT02000973|3580463|B5|||Age||years|Mean|56|56.0|Standard Deviation|6|6.0|||
3745660|NCT02000973|3580464|B4|||Age||years|Mean|58|58.0|Standard Deviation|6|6.0|||
3745661|NCT02000973|3580465|B3|||Age||years|Mean|57|57.0|Standard Deviation|6|6.0|||
3745662|NCT02000973|3580466|B2|||Age||years|Mean|57|57.0|Standard Deviation|6|6.0|||
3745663|NCT02000973|3580467|B1|||Age||years|Mean|54|54.0|Standard Deviation|6|6.0|||
3745664|NCT02000921|3580492|B4|United States||Region of Enrollment||Participants|Count of Participants|136|136.0||||||
3745665|NCT02000921|3580493|B3|United States||Region of Enrollment||Participants|Count of Participants|56|56.0||||||
3745666|NCT02000921|3580494|B2|United States||Region of Enrollment||Participants|Count of Participants|53|53.0||||||
3745667|NCT02000921|3580495|B1|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3745668|NCT02000921|3580492|B4||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3745669|NCT02000921|3580493|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3745670|NCT02000921|3580494|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3745671|NCT02000921|3580495|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3745672|NCT02000921|3580492|B4||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3745673|NCT02000921|3580493|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3745674|NCT02000921|3580494|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3745675|NCT02000921|3580495|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3745676|NCT02000921|3580492|B4|||Age||years|Mean|44|44.0|Standard Deviation|14|14.0|||
3745677|NCT02000921|3580493|B3|||Age||years|Mean|45|45.0|Standard Deviation|15|15.0|||
3745678|NCT02000921|3580494|B2|||Age||years|Mean|44|44.0|Standard Deviation|15|15.0|||
3745679|NCT02000921|3580495|B1|||Age||years|Mean|43|43.0|Standard Deviation|14|14.0|||
3745680|NCT02000921|3580492|B4||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3745681|NCT02000921|3580493|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3745682|NCT02000921|3580494|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3745683|NCT02000921|3580495|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3745684|NCT02000921|3580492|B4||Between 18 and 65 years|Age||Participants|Count of Participants|123|123.0||||||
3745685|NCT02000921|3580493|B3||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3745686|NCT02000921|3580494|B2||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
3745687|NCT02000921|3580495|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3745688|NCT02000921|3580492|B4||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3745689|NCT02000921|3580493|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3745690|NCT02000921|3580494|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3745691|NCT02000921|3580495|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3745692|NCT02000752|3580514|B3|Spain||Region of Enrollment||participants|Number|76|76.0||||||
3745693|NCT02000752|3580515|B2|Spain||Region of Enrollment||participants|Number|29|29.0||||||
3745694|NCT02000752|3580516|B1|Spain||Region of Enrollment||participants|Number|47|47.0||||||
3745695|NCT02000752|3580514|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3745696|NCT02000752|3580515|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3745697|NCT02000752|3580516|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3745698|NCT02000752|3580514|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3745699|NCT02000752|3580515|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3745700|NCT02000752|3580516|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3745701|NCT02000752|3580514|B3|||Age||years|Mean|30.00|30.0|Standard Deviation|4.96|4.96|||
3745702|NCT02000752|3580515|B2|||Age||years|Mean|29.38|29.38|Standard Deviation|4.91|4.91|||
3745703|NCT02000752|3580516|B1|||Age||years|Mean|30.39|30.39|Standard Deviation|4.95|4.95|||
3745704|NCT02000622|3580529|B3||No|Received prior platinum for breast cancer||Participants|Count of Participants|216|216.0||||||
3745705|NCT02000622|3580530|B2||No|Received prior platinum for breast cancer||Participants|Count of Participants|71|71.0||||||
3745706|NCT02000622|3580531|B1||No|Received prior platinum for breast cancer||Participants|Count of Participants|145|145.0||||||
3745707|NCT02000622|3580529|B3||Yes|Received prior platinum for breast cancer||Participants|Count of Participants|86|86.0||||||
3745708|NCT02000622|3580530|B2||Yes|Received prior platinum for breast cancer||Participants|Count of Participants|26|26.0||||||
3745709|NCT02000622|3580531|B1||Yes|Received prior platinum for breast cancer||Participants|Count of Participants|60|60.0||||||
3745710|NCT02000622|3580529|B3||No|Received prior chemotherapy for metastatic breast cancer||Participants|Count of Participants|87|87.0||||||
3745711|NCT02000622|3580530|B2||No|Received prior chemotherapy for metastatic breast cancer||Participants|Count of Participants|28|28.0||||||
3745712|NCT02000622|3580531|B1||No|Received prior chemotherapy for metastatic breast cancer||Participants|Count of Participants|59|59.0||||||
3745713|NCT02000622|3580529|B3||Yes|Received prior chemotherapy for metastatic breast cancer||Participants|Count of Participants|215|215.0||||||
3745714|NCT02000622|3580530|B2||Yes|Received prior chemotherapy for metastatic breast cancer||Participants|Count of Participants|69|69.0||||||
3745715|NCT02000622|3580531|B1||Yes|Received prior chemotherapy for metastatic breast cancer||Participants|Count of Participants|146|146.0||||||
3745716|NCT02000622|3580529|B3||ER and PgR negative|Receptor status|ER = oestrogen receptor; PgR = progesterone receptor; All patients were HER2 negative.|Participants|Count of Participants|150|150.0||||||
3745717|NCT02000622|3580530|B2||ER and PgR negative|Receptor status|ER = oestrogen receptor; PgR = progesterone receptor; All patients were HER2 negative.|Participants|Count of Participants|48|48.0||||||
3745718|NCT02000622|3580531|B1||ER and PgR negative|Receptor status|ER = oestrogen receptor; PgR = progesterone receptor; All patients were HER2 negative.|Participants|Count of Participants|102|102.0||||||
3745719|NCT02000622|3580529|B3||ER and/or PgR positive|Receptor status|ER = oestrogen receptor; PgR = progesterone receptor; All patients were HER2 negative.|Participants|Count of Participants|152|152.0||||||
3745720|NCT02000622|3580530|B2||ER and/or PgR positive|Receptor status|ER = oestrogen receptor; PgR = progesterone receptor; All patients were HER2 negative.|Participants|Count of Participants|49|49.0||||||
3745721|NCT02000622|3580531|B1||ER and/or PgR positive|Receptor status|ER = oestrogen receptor; PgR = progesterone receptor; All patients were HER2 negative.|Participants|Count of Participants|103|103.0||||||
3745722|NCT02000622|3580529|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3745723|NCT02000622|3580530|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3745724|NCT02000622|3580531|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3745725|NCT02000622|3580529|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745726|NCT02000622|3580530|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745727|NCT02000622|3580531|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745728|NCT02000622|3580529|B3||White|Race (NIH/OMB)||Participants|Count of Participants|197|197.0||||||
3745729|NCT02000622|3580530|B2||White|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3745730|NCT02000622|3580531|B1||White|Race (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
3745731|NCT02000622|3580529|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3745732|NCT02000622|3580530|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3745733|NCT02000622|3580531|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3745734|NCT02000622|3580529|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745735|NCT02000622|3580530|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745736|NCT02000622|3580531|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745737|NCT02000622|3580529|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3745738|NCT02000622|3580530|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3745739|NCT02000622|3580531|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3745740|NCT02000622|3580529|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3745741|NCT02000622|3580530|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3745742|NCT02000622|3580531|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3745743|NCT02000622|3580529|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3745744|NCT02000622|3580530|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3745745|NCT02000622|3580531|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3745746|NCT02000622|3580529|B3||Female|Sex: Female, Male||Participants|Count of Participants|295|295.0||||||
3745747|NCT02000622|3580530|B2||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3745748|NCT02000622|3580531|B1||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
3745749|NCT02000622|3580529|B3|Age (years)||Age||Years|Median|44|44.0|Full Range|||22.0|76.0|
3745750|NCT02000622|3580530|B2|Age (years)||Age||Years|Median|45|45.0|Full Range|||24.0|68.0|
3745751|NCT02000622|3580531|B1|Age (years)||Age||Years|Median|44|44.0|Full Range|||22.0|76.0|
3745752|NCT02000531|3580552|B3|China||Region of Enrollment||participants|Number|45|45.0||||||
3745753|NCT02000531|3580553|B2|China||Region of Enrollment||participants|Number|24|24.0||||||
3745754|NCT02000531|3580554|B1|China||Region of Enrollment||participants|Number|21|21.0||||||
3745755|NCT02000531|3580552|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3745756|NCT02000531|3580553|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3745757|NCT02000531|3580554|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3745758|NCT02000531|3580552|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3745759|NCT02000531|3580553|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3745760|NCT02000531|3580554|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3745761|NCT02000531|3580552|B3|||Age||years|Mean|57.3|57.3|Standard Deviation|9.88|9.88|||
3745762|NCT02000531|3580553|B2|||Age||years|Mean|57.0|57.0|Standard Deviation|11.32|11.32|||
3745763|NCT02000531|3580554|B1|||Age||years|Mean|57.8|57.8|Standard Deviation|8.20|8.2|||
3745764|NCT02000531|3580552|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3745765|NCT02000531|3580553|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3745766|NCT02000531|3580554|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3745767|NCT02000531|3580552|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3745768|NCT02000531|3580553|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3745769|NCT02000531|3580554|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3745770|NCT02000531|3580552|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3745771|NCT02000531|3580553|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3745772|NCT02000531|3580554|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3745773|NCT02000440|3580563|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3745774|NCT02000440|3580563|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3745775|NCT02000440|3580563|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3745776|NCT02000440|3580563|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3745777|NCT02000440|3580563|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3745778|NCT02000440|3580563|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3745779|NCT02000440|3580563|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3745780|NCT02000440|3580563|B1|||Age||Years|Mean|40.4|40.4|Standard Deviation|13.68|13.68|||
3745781|NCT02000427|3580583|B1|||Time From Initial Diagnosis||months|Mean|27.3|27.3|Standard Deviation|26.1|26.1|||
3745782|NCT02000427|3580583|B1|No||Prior Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)||participants|Number|25|25.0||||||
3745783|NCT02000427|3580583|B1|Yes||Prior Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)||participants|Number|20|20.0||||||
3745784|NCT02000427|3580583|B1|≥ 3 regimens||Number of Prior Salvage Regimens||participants|Number|8|8.0||||||
3745785|NCT02000427|3580583|B1|2 regimens||Number of Prior Salvage Regimens||participants|Number|11|11.0||||||
3745786|NCT02000427|3580583|B1|1 regimen||Number of Prior Salvage Regimens||participants|Number|12|12.0||||||
3745787|NCT02000427|3580583|B1|0 regimens||Number of Prior Salvage Regimens||participants|Number|14|14.0||||||
3745788|NCT02000427|3580583|B1|≥ 3 relapses||Number of Prior Relapses||participants|Number|4|4.0||||||
3745789|NCT02000427|3580583|B1|2 relapses||Number of Prior Relapses||participants|Number|13|13.0||||||
3745790|NCT02000427|3580583|B1|1 relapse||Number of Prior Relapses||participants|Number|25|25.0||||||
3745791|NCT02000427|3580583|B1|No relapses||Number of Prior Relapses||participants|Number|3|3.0||||||
3745792|NCT02000427|3580583|B1|4 TKIs||Prior Tyrosine Kinase Inhibitor (TKI) Treatment||participants|Number|4|4.0||||||
3745793|NCT02000427|3580583|B1|3 TKIs||Prior Tyrosine Kinase Inhibitor (TKI) Treatment||participants|Number|13|13.0||||||
3745794|NCT02000427|3580583|B1|2 TKIs||Prior Tyrosine Kinase Inhibitor (TKI) Treatment||participants|Number|21|21.0||||||
3745795|NCT02000427|3580583|B1|1 TKI||Prior Tyrosine Kinase Inhibitor (TKI) Treatment||participants|Number|7|7.0||||||
3745796|NCT02000427|3580583|B1|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
3745797|NCT02000427|3580583|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3745798|NCT02000427|3580583|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3745799|NCT02000427|3580583|B1|Black (or African American)||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3745800|NCT02000427|3580583|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3745801|NCT02000427|3580583|B1|White||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
3745802|NCT02000427|3580583|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3745803|NCT02000427|3580583|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3745804|NCT02000427|3580583|B1|≥ 65 years||Age, Customized||participants|Number|12|12.0||||||
3745805|NCT02000427|3580583|B1|55 to < 65 years||Age, Customized||participants|Number|11|11.0||||||
3745806|NCT02000427|3580583|B1|35 to < 55 years||Age, Customized||participants|Number|17|17.0||||||
3745807|NCT02000427|3580583|B1|18 to < 35 years||Age, Customized||participants|Number|5|5.0||||||
3745808|NCT02000427|3580583|B1|||Age||years|Mean|52.8|52.8|Standard Deviation|15.0|15.0|||
3745809|NCT02000180|3580598|B3|Assisted EGDs completed after training||Endoscopic experience||Number of procedures|Mean|1.7|1.7|Standard Deviation|2.9|2.9|||
3745810|NCT02000180|3580599|B2|Assisted EGDs completed after training||Endoscopic experience||Number of procedures|Mean|2|2.0|Standard Deviation|3.5|3.5|||
3745811|NCT02000180|3580600|B1|Assisted EGDs completed after training||Endoscopic experience||Number of procedures|Mean|1.3|1.3|Standard Deviation|2.3|2.3|||
3745812|NCT02000180|3580598|B3|Independent EGDs completed after training||Endoscopic experience||Number of procedures|Mean|0.3|0.3|Standard Deviation|0.8|0.8|||
3745813|NCT02000180|3580599|B2|Independent EGDs completed after training||Endoscopic experience||Number of procedures|Mean|0.2|0.2|Standard Deviation|0.7|0.7|||
3745814|NCT02000180|3580600|B1|Independent EGDs completed after training||Endoscopic experience||Number of procedures|Mean|0.4|0.4|Standard Deviation|1|1.0|||
3745815|NCT02000180|3580598|B3|Assisted colonoscopies completed after training||Endoscopic experience||Number of procedures|Mean|1.7|1.7|Standard Deviation|2.7|2.7|||
3745816|NCT02000180|3580599|B2|Assisted colonoscopies completed after training||Endoscopic experience||Number of procedures|Mean|2|2.0|Standard Deviation|3.6|3.6|||
3745817|NCT02000180|3580600|B1|Assisted colonoscopies completed after training||Endoscopic experience||Number of procedures|Mean|1.5|1.5|Standard Deviation|1.9|1.9|||
3745818|NCT02000180|3580598|B3|Independent colonoscopies completed after training||Endoscopic experience||Number of procedures|Mean|0.1|0.1|Standard Deviation|0.1|0.1|||
3745819|NCT02000180|3580599|B2|Independent colonoscopies completed after training||Endoscopic experience||Number of procedures|Mean|0|0.0|Standard Deviation|0|0.0|||
3745820|NCT02000180|3580600|B1|Independent colonoscopies completed after training||Endoscopic experience||Number of procedures|Mean|0.1|0.1|Standard Deviation|0.3|0.3|||
3745821|NCT02000180|3580598|B3|Assisted EGDs completed before training||Endoscopic experience||Number of procedures|Mean|4.6|4.6|Standard Deviation|9.0|9.0|||
3745822|NCT02000180|3580599|B2|Assisted EGDs completed before training||Endoscopic experience||Number of procedures|Mean|3.2|3.2|Standard Deviation|4.6|4.6|||
3745823|NCT02000180|3580600|B1|Assisted EGDs completed before training||Endoscopic experience||Number of procedures|Mean|6|6.0|Standard Deviation|13.5|13.5|||
3745824|NCT02000180|3580598|B3|Indendent EGDs completed before training||Endoscopic experience||Number of procedures|Mean|1.3|1.3|Standard Deviation|3.6|3.6|||
3745825|NCT02000180|3580599|B2|Indendent EGDs completed before training||Endoscopic experience||Number of procedures|Mean|0.9|0.9|Standard Deviation|1.7|1.7|||
3745826|NCT02000180|3580600|B1|Indendent EGDs completed before training||Endoscopic experience||Number of procedures|Mean|1.8|1.8|Standard Deviation|5.5|5.5|||
3745827|NCT02000180|3580598|B3|Assisted colonoscopies completed before training||Endoscopic experience||Number of procedures|Mean|4.5|4.5|Standard Deviation|8.5|8.5|||
3745828|NCT02000180|3580599|B2|Assisted colonoscopies completed before training||Endoscopic experience||Number of procedures|Mean|3.6|3.6|Standard Deviation|3.4|3.4|||
3745829|NCT02000180|3580600|B1|Assisted colonoscopies completed before training||Endoscopic experience||Number of procedures|Mean|5.5|5.5|Standard Deviation|13.7|13.7|||
3745830|NCT02000180|3580598|B3|Independent colonoscopies completed before trainin||Endoscopic experience||Number of procedures|Mean|0.5|0.5|Standard Deviation|1.8|1.8|||
3745831|NCT02000180|3580599|B2|Independent colonoscopies completed before trainin||Endoscopic experience||Number of procedures|Mean|0.2|0.2|Standard Deviation|0.8|0.8|||
3745832|NCT02000180|3580600|B1|Independent colonoscopies completed before trainin||Endoscopic experience||Number of procedures|Mean|0.8|0.8|Standard Deviation|2.8|2.8|||
3745833|NCT02000180|3580598|B3||Internal medicine|Training program (gastroenterology, general surgery, or internal medicine)||Participants|Count of Participants|2|2.0||||||
3745834|NCT02000180|3580599|B2||Internal medicine|Training program (gastroenterology, general surgery, or internal medicine)||Participants|Count of Participants|1|1.0||||||
3745835|NCT02000180|3580600|B1||Internal medicine|Training program (gastroenterology, general surgery, or internal medicine)||Participants|Count of Participants|1|1.0||||||
3745836|NCT02000180|3580598|B3||General surgery|Training program (gastroenterology, general surgery, or internal medicine)||Participants|Count of Participants|25|25.0||||||
3745837|NCT02000180|3580599|B2||General surgery|Training program (gastroenterology, general surgery, or internal medicine)||Participants|Count of Participants|14|14.0||||||
3745838|NCT02000180|3580600|B1||General surgery|Training program (gastroenterology, general surgery, or internal medicine)||Participants|Count of Participants|11|11.0||||||
3745839|NCT02000180|3580598|B3||Gastroenterology|Training program (gastroenterology, general surgery, or internal medicine)||Participants|Count of Participants|10|10.0||||||
3745840|NCT02000180|3580599|B2||Gastroenterology|Training program (gastroenterology, general surgery, or internal medicine)||Participants|Count of Participants|4|4.0||||||
3745841|NCT02000180|3580600|B1||Gastroenterology|Training program (gastroenterology, general surgery, or internal medicine)||Participants|Count of Participants|6|6.0||||||
3745842|NCT02000180|3580598|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3745843|NCT02000180|3580599|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3745844|NCT02000180|3580600|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3745845|NCT02000180|3580598|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3745846|NCT02000180|3580599|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3745847|NCT02000180|3580600|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3745848|NCT02000180|3580598|B3|||Age||years|Mean|28.1|28.1|Standard Deviation|2.5|2.5|||
3745849|NCT02000180|3580599|B2|||Age||years|Mean|28.1|28.1|Standard Deviation|2|2.0|||
3745850|NCT02000180|3580600|B1|||Age||years|Mean|28.1|28.1|Standard Deviation|3|3.0|||
3745851|NCT02000154|3580613|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3745852|NCT02000154|3580613|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3745853|NCT02000154|3580613|B1|80- years||Age, Customized||participants|Number|0|0.0||||||
3745854|NCT02000154|3580613|B1|70-79 years||Age, Customized||participants|Number|1|1.0||||||
3745855|NCT02000154|3580613|B1|60-69 years||Age, Customized||participants|Number|0|0.0||||||
3745856|NCT01999920|3580621|B3|||Adult Separation Anxiety - 27 Scale|(15 min) Adult Separation Anxiety – 27 Scale 27 items pertaining to adult separation anxiety, each self-rated on a four-point scale, 0=best, 3=worse. Minimum Total Score=0 (better); Maximum Total Score = 81 (worse)|units on a scale|Mean|47.8|47.8|Standard Deviation|14.7|14.7|||
3745857|NCT01999920|3580622|B2|||Adult Separation Anxiety - 27 Scale|(15 min) Adult Separation Anxiety – 27 Scale 27 items pertaining to adult separation anxiety, each self-rated on a four-point scale, 0=best, 3=worse. Minimum Total Score=0 (better); Maximum Total Score = 81 (worse)|units on a scale|Mean|52.0|52.0|Standard Deviation|13.6|13.6|||
3745858|NCT01999920|3580623|B1|||Adult Separation Anxiety - 27 Scale|(15 min) Adult Separation Anxiety – 27 Scale 27 items pertaining to adult separation anxiety, each self-rated on a four-point scale, 0=best, 3=worse. Minimum Total Score=0 (better); Maximum Total Score = 81 (worse)|units on a scale|Mean|44.3|44.3|Standard Deviation|15.1|15.1|||
3745859|NCT01999920|3580621|B3|||Structured Clinical Interview for Separation Anxiety Disorder|Structured Clinical Interview for Separation Anxiety Disorder modified for DSM-5. The eight separation anxiety disorder criteria are each rated on a 0-2 scale for past week time frame. Scores on each of the eight items are summed to produce a total score (range 0 - 16). A higher total score indicates higher symptoms of separation anxiety.|units on a scale|Mean|10.5|10.5|Standard Deviation|2.5|2.5|||
3745860|NCT01999920|3580622|B2|||Structured Clinical Interview for Separation Anxiety Disorder|Structured Clinical Interview for Separation Anxiety Disorder modified for DSM-5. The eight separation anxiety disorder criteria are each rated on a 0-2 scale for past week time frame. Scores on each of the eight items are summed to produce a total score (range 0 - 16). A higher total score indicates higher symptoms of separation anxiety.|units on a scale|Mean|10.2|10.2|Standard Deviation|2.5|2.5|||
3745861|NCT01999920|3580623|B1|||Structured Clinical Interview for Separation Anxiety Disorder|Structured Clinical Interview for Separation Anxiety Disorder modified for DSM-5. The eight separation anxiety disorder criteria are each rated on a 0-2 scale for past week time frame. Scores on each of the eight items are summed to produce a total score (range 0 - 16). A higher total score indicates higher symptoms of separation anxiety.|units on a scale|Mean|10.8|10.8|Standard Deviation|2.6|2.6|||
3745862|NCT01999920|3580621|B3|||Quality of Life Enjoyment & Satisfaction Questionnaire|(10 min) Quality of Life Enjoyment & Satisfaction Questionnaire (Q-LES-Q, Endicott et al, 1993): self-rated assessment of quality of life. 16 items related to life quality, each rated on a score of 1 (very poor) to 5 (very good), with a minimum total score of 16, and a maximum total score of 80.|units on a scale|Mean|50.6|50.6|Standard Deviation|17.7|17.7|||
3745863|NCT01999920|3580622|B2|||Quality of Life Enjoyment & Satisfaction Questionnaire|(10 min) Quality of Life Enjoyment & Satisfaction Questionnaire (Q-LES-Q, Endicott et al, 1993): self-rated assessment of quality of life. 16 items related to life quality, each rated on a score of 1 (very poor) to 5 (very good), with a minimum total score of 16, and a maximum total score of 80.|units on a scale|Mean|55.4|55.4|Standard Deviation|22.2|22.2|||
3745864|NCT01999920|3580623|B1|||Quality of Life Enjoyment & Satisfaction Questionnaire|(10 min) Quality of Life Enjoyment & Satisfaction Questionnaire (Q-LES-Q, Endicott et al, 1993): self-rated assessment of quality of life. 16 items related to life quality, each rated on a score of 1 (very poor) to 5 (very good), with a minimum total score of 16, and a maximum total score of 80.|units on a scale|Mean|46.5|46.5|Standard Deviation|12.1|12.1|||
3745865|NCT01999920|3580621|B3|Preoccupation with Relationships||Attachment Style Questionnaire|(15 min) Attachment Style Questionnaire (Feeney at al., 1994) 40 items relating to quality of adult relationships. Questionnaire includes questions concerning Confidence (8 items, minimum score=8, maximum score=48), Discomfort (10 items, minimum score=10, maximum score=60), Relationships as Secondary (7 items, minimum score=7, maximum score=42), Need for Approval (7 items, minimum score=7, maximum score =42), and Preoccupation with Relationships (8 items, minimum score = 8, maximum score=48), each self-rated on a six-point scale, each self-rated from 1 (totally disagree) to 6 (totally agree)|units on a scale|Mean|34.0|34.0|Standard Deviation|5.6|5.6|||
3745866|NCT01999920|3580622|B2|Preoccupation with Relationships||Attachment Style Questionnaire|(15 min) Attachment Style Questionnaire (Feeney at al., 1994) 40 items relating to quality of adult relationships. Questionnaire includes questions concerning Confidence (8 items, minimum score=8, maximum score=48), Discomfort (10 items, minimum score=10, maximum score=60), Relationships as Secondary (7 items, minimum score=7, maximum score=42), Need for Approval (7 items, minimum score=7, maximum score =42), and Preoccupation with Relationships (8 items, minimum score = 8, maximum score=48), each self-rated on a six-point scale, each self-rated from 1 (totally disagree) to 6 (totally agree)|units on a scale|Mean|33.6|33.6|Standard Deviation|6.3|6.3|||
3745915|NCT01999920|3580623|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3745916|NCT01999920|3580621|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3745917|NCT01999920|3580622|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3745918|NCT01999920|3580623|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3745867|NCT01999920|3580623|B1|Preoccupation with Relationships||Attachment Style Questionnaire|(15 min) Attachment Style Questionnaire (Feeney at al., 1994) 40 items relating to quality of adult relationships. Questionnaire includes questions concerning Confidence (8 items, minimum score=8, maximum score=48), Discomfort (10 items, minimum score=10, maximum score=60), Relationships as Secondary (7 items, minimum score=7, maximum score=42), Need for Approval (7 items, minimum score=7, maximum score =42), and Preoccupation with Relationships (8 items, minimum score = 8, maximum score=48), each self-rated on a six-point scale, each self-rated from 1 (totally disagree) to 6 (totally agree)|units on a scale|Mean|34.4|34.4|Standard Deviation|5.1|5.1|||
3745868|NCT01999920|3580621|B3|Need for Approval||Attachment Style Questionnaire|(15 min) Attachment Style Questionnaire (Feeney at al., 1994) 40 items relating to quality of adult relationships. Questionnaire includes questions concerning Confidence (8 items, minimum score=8, maximum score=48), Discomfort (10 items, minimum score=10, maximum score=60), Relationships as Secondary (7 items, minimum score=7, maximum score=42), Need for Approval (7 items, minimum score=7, maximum score =42), and Preoccupation with Relationships (8 items, minimum score = 8, maximum score=48), each self-rated on a six-point scale, each self-rated from 1 (totally disagree) to 6 (totally agree)|units on a scale|Mean|24.8|24.8|Standard Deviation|6.8|6.8|||
3745869|NCT01999920|3580622|B2|Need for Approval||Attachment Style Questionnaire|(15 min) Attachment Style Questionnaire (Feeney at al., 1994) 40 items relating to quality of adult relationships. Questionnaire includes questions concerning Confidence (8 items, minimum score=8, maximum score=48), Discomfort (10 items, minimum score=10, maximum score=60), Relationships as Secondary (7 items, minimum score=7, maximum score=42), Need for Approval (7 items, minimum score=7, maximum score =42), and Preoccupation with Relationships (8 items, minimum score = 8, maximum score=48), each self-rated on a six-point scale, each self-rated from 1 (totally disagree) to 6 (totally agree)|units on a scale|Mean|26.1|26.1|Standard Deviation|8.8|8.8|||
3745870|NCT01999920|3580623|B1|Need for Approval||Attachment Style Questionnaire|(15 min) Attachment Style Questionnaire (Feeney at al., 1994) 40 items relating to quality of adult relationships. Questionnaire includes questions concerning Confidence (8 items, minimum score=8, maximum score=48), Discomfort (10 items, minimum score=10, maximum score=60), Relationships as Secondary (7 items, minimum score=7, maximum score=42), Need for Approval (7 items, minimum score=7, maximum score =42), and Preoccupation with Relationships (8 items, minimum score = 8, maximum score=48), each self-rated on a six-point scale, each self-rated from 1 (totally disagree) to 6 (totally agree)|units on a scale|Mean|23.8|23.8|Standard Deviation|4.6|4.6|||
3745871|NCT01999920|3580621|B3|Relationships as Secondary||Attachment Style Questionnaire|(15 min) Attachment Style Questionnaire (Feeney at al., 1994) 40 items relating to quality of adult relationships. Questionnaire includes questions concerning Confidence (8 items, minimum score=8, maximum score=48), Discomfort (10 items, minimum score=10, maximum score=60), Relationships as Secondary (7 items, minimum score=7, maximum score=42), Need for Approval (7 items, minimum score=7, maximum score =42), and Preoccupation with Relationships (8 items, minimum score = 8, maximum score=48), each self-rated on a six-point scale, each self-rated from 1 (totally disagree) to 6 (totally agree)|units on a scale|Mean|18.1|18.1|Standard Deviation|5.9|5.9|||
3745872|NCT01999920|3580622|B2|Relationships as Secondary||Attachment Style Questionnaire|(15 min) Attachment Style Questionnaire (Feeney at al., 1994) 40 items relating to quality of adult relationships. Questionnaire includes questions concerning Confidence (8 items, minimum score=8, maximum score=48), Discomfort (10 items, minimum score=10, maximum score=60), Relationships as Secondary (7 items, minimum score=7, maximum score=42), Need for Approval (7 items, minimum score=7, maximum score =42), and Preoccupation with Relationships (8 items, minimum score = 8, maximum score=48), each self-rated on a six-point scale, each self-rated from 1 (totally disagree) to 6 (totally agree)|units on a scale|Mean|19.0|19.0|Standard Deviation|5.9|5.9|||
3745873|NCT01999920|3580623|B1|Relationships as Secondary||Attachment Style Questionnaire|(15 min) Attachment Style Questionnaire (Feeney at al., 1994) 40 items relating to quality of adult relationships. Questionnaire includes questions concerning Confidence (8 items, minimum score=8, maximum score=48), Discomfort (10 items, minimum score=10, maximum score=60), Relationships as Secondary (7 items, minimum score=7, maximum score=42), Need for Approval (7 items, minimum score=7, maximum score =42), and Preoccupation with Relationships (8 items, minimum score = 8, maximum score=48), each self-rated on a six-point scale, each self-rated from 1 (totally disagree) to 6 (totally agree)|units on a scale|Mean|17.4|17.4|Standard Deviation|6.0|6.0|||
3745874|NCT01999920|3580621|B3|Discomfort with Closeness||Attachment Style Questionnaire|(15 min) Attachment Style Questionnaire (Feeney at al., 1994) 40 items relating to quality of adult relationships. Questionnaire includes questions concerning Confidence (8 items, minimum score=8, maximum score=48), Discomfort (10 items, minimum score=10, maximum score=60), Relationships as Secondary (7 items, minimum score=7, maximum score=42), Need for Approval (7 items, minimum score=7, maximum score =42), and Preoccupation with Relationships (8 items, minimum score = 8, maximum score=48), each self-rated on a six-point scale, each self-rated from 1 (totally disagree) to 6 (totally agree)|units on a scale|Mean|42.2|42.2|Standard Deviation|9.3|9.3|||
3745875|NCT01999920|3580622|B2|Discomfort with Closeness||Attachment Style Questionnaire|(15 min) Attachment Style Questionnaire (Feeney at al., 1994) 40 items relating to quality of adult relationships. Questionnaire includes questions concerning Confidence (8 items, minimum score=8, maximum score=48), Discomfort (10 items, minimum score=10, maximum score=60), Relationships as Secondary (7 items, minimum score=7, maximum score=42), Need for Approval (7 items, minimum score=7, maximum score =42), and Preoccupation with Relationships (8 items, minimum score = 8, maximum score=48), each self-rated on a six-point scale, each self-rated from 1 (totally disagree) to 6 (totally agree)|units on a scale|Mean|46.9|46.9|Standard Deviation|7.7|7.7|||
3745876|NCT01999920|3580623|B1|Discomfort with Closeness||Attachment Style Questionnaire|(15 min) Attachment Style Questionnaire (Feeney at al., 1994) 40 items relating to quality of adult relationships. Questionnaire includes questions concerning Confidence (8 items, minimum score=8, maximum score=48), Discomfort (10 items, minimum score=10, maximum score=60), Relationships as Secondary (7 items, minimum score=7, maximum score=42), Need for Approval (7 items, minimum score=7, maximum score =42), and Preoccupation with Relationships (8 items, minimum score = 8, maximum score=48), each self-rated on a six-point scale, each self-rated from 1 (totally disagree) to 6 (totally agree)|units on a scale|Mean|38.2|38.2|Standard Deviation|8.9|8.9|||
3745919|NCT01999920|3580621|B3|||Age||Years|Mean|35.2|35.2|Standard Deviation|14.7|14.7|||
3745920|NCT01999920|3580622|B2|||Age||Years|Mean|32.9|32.9|Standard Deviation|15.6|15.6|||
3745877|NCT01999920|3580621|B3|Confidence||Attachment Style Questionnaire|(15 min) Attachment Style Questionnaire (Feeney at al., 1994) 40 items relating to quality of adult relationships. Questionnaire includes questions concerning Confidence (8 items, minimum score=8, maximum score=48), Discomfort (10 items, minimum score=10, maximum score=60), Relationships as Secondary (7 items, minimum score=7, maximum score=42), Need for Approval (7 items, minimum score=7, maximum score =42), and Preoccupation with Relationships (8 items, minimum score = 8, maximum score=48), each self-rated on a six-point scale, each self-rated from 1 (totally disagree) to 6 (totally agree)|units on a scale|Mean|28.1|28.1|Standard Deviation|7.7|7.7|||
3745878|NCT01999920|3580622|B2|Confidence||Attachment Style Questionnaire|(15 min) Attachment Style Questionnaire (Feeney at al., 1994) 40 items relating to quality of adult relationships. Questionnaire includes questions concerning Confidence (8 items, minimum score=8, maximum score=48), Discomfort (10 items, minimum score=10, maximum score=60), Relationships as Secondary (7 items, minimum score=7, maximum score=42), Need for Approval (7 items, minimum score=7, maximum score =42), and Preoccupation with Relationships (8 items, minimum score = 8, maximum score=48), each self-rated on a six-point scale, each self-rated from 1 (totally disagree) to 6 (totally agree)|units on a scale|Mean|25.3|25.3|Standard Deviation|9.3|9.3|||
3745879|NCT01999920|3580623|B1|Confidence||Attachment Style Questionnaire|(15 min) Attachment Style Questionnaire (Feeney at al., 1994) 40 items relating to quality of adult relationships. Questionnaire includes questions concerning Confidence (8 items, minimum score=8, maximum score=48), Discomfort (10 items, minimum score=10, maximum score=60), Relationships as Secondary (7 items, minimum score=7, maximum score=42), Need for Approval (7 items, minimum score=7, maximum score =42), and Preoccupation with Relationships (8 items, minimum score = 8, maximum score=48), each self-rated on a six-point scale, each self-rated from 1 (totally disagree) to 6 (totally agree)|units on a scale|Mean|30.5|30.5|Standard Deviation|5.3|5.3|||
3745880|NCT01999920|3580621|B3|||Hamilton Depression Rating Scale 17-item|(10 min) Hamilton Rating Scale for Depression (Hamilton, 1960) This standard scale will be used to assess severity of depression, from 0 (least depression) to 50 (greatest depression|units on a scale|Mean|10.5|10.5|Standard Deviation|5.7|5.7|||
3745881|NCT01999920|3580622|B2|||Hamilton Depression Rating Scale 17-item|(10 min) Hamilton Rating Scale for Depression (Hamilton, 1960) This standard scale will be used to assess severity of depression, from 0 (least depression) to 50 (greatest depression|units on a scale|Mean|9.3|9.3|Standard Deviation|5.0|5.0|||
3745882|NCT01999920|3580623|B1|||Hamilton Depression Rating Scale 17-item|(10 min) Hamilton Rating Scale for Depression (Hamilton, 1960) This standard scale will be used to assess severity of depression, from 0 (least depression) to 50 (greatest depression|units on a scale|Mean|11.5|11.5|Standard Deviation|6.3|6.3|||
3745883|NCT01999920|3580621|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3745884|NCT01999920|3580622|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3745885|NCT01999920|3580623|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3745886|NCT01999920|3580621|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745887|NCT01999920|3580622|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745888|NCT01999920|3580623|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745889|NCT01999920|3580621|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3745890|NCT01999920|3580622|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3745891|NCT01999920|3580623|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3745892|NCT01999920|3580621|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3745893|NCT01999920|3580622|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3745894|NCT01999920|3580623|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3745895|NCT01999920|3580621|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745896|NCT01999920|3580622|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745897|NCT01999920|3580623|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745898|NCT01999920|3580621|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3745899|NCT01999920|3580622|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3745900|NCT01999920|3580623|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745901|NCT01999920|3580621|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745902|NCT01999920|3580622|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745903|NCT01999920|3580623|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745904|NCT01999920|3580621|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745905|NCT01999920|3580622|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745906|NCT01999920|3580623|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745907|NCT01999920|3580621|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3745908|NCT01999920|3580622|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3745909|NCT01999920|3580623|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3745910|NCT01999920|3580621|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3745911|NCT01999920|3580622|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745912|NCT01999920|3580623|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3745913|NCT01999920|3580621|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3745914|NCT01999920|3580622|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3745921|NCT01999920|3580623|B1|||Age||Years|Mean|37.3|37.3|Standard Deviation|14.2|14.2|||
3745922|NCT01999894|3580640|B1|United States||Region of Enrollment||participants|Number|102|102.0||||||
3745923|NCT01999894|3580640|B1|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|91|91.0||||||
3745924|NCT01999894|3580640|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3745925|NCT01999894|3580640|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3745926|NCT01999894|3580640|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3745927|NCT01999894|3580640|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3745928|NCT01999894|3580640|B1|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3745929|NCT01999894|3580640|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3745930|NCT01999894|3580640|B1|White||Race/Ethnicity, Customized||participants|Number|86|86.0||||||
3745931|NCT01999894|3580640|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3745932|NCT01999894|3580640|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3745933|NCT01999894|3580640|B1|Years||Age||years|Mean|9.1|9.1|Standard Deviation|2.2|2.2|||
3745934|NCT01999868|3580645|B4|||Dermatology Life Quality Index (DLQI) Score|Dermatology Life Quality Index (DLQI) is a 10-question, participant-reported questionnaire assessing quality of life with respect to skin conditions in the areas of Symptoms and Feelings; Daily Activities; Leisure; Work and School; Personal Relationships; and Treatment. Each question measures the effect the skin condition has on a participant’s quality of life. Responses range from “Not at all” (score = 0) to “Very much” (score = 3). The overall score is the sum for all 10 questions and ranges from 0-30, with higher scores indicating a poor quality of life.|units on a scale|Mean|13.8|13.8|Standard Deviation|7.7|7.7|||
3745935|NCT01999868|3580646|B3|||Dermatology Life Quality Index (DLQI) Score|Dermatology Life Quality Index (DLQI) is a 10-question, participant-reported questionnaire assessing quality of life with respect to skin conditions in the areas of Symptoms and Feelings; Daily Activities; Leisure; Work and School; Personal Relationships; and Treatment. Each question measures the effect the skin condition has on a participant’s quality of life. Responses range from “Not at all” (score = 0) to “Very much” (score = 3). The overall score is the sum for all 10 questions and ranges from 0-30, with higher scores indicating a poor quality of life.|units on a scale|Mean|13.5|13.5|Standard Deviation|8.8|8.8|||
3745936|NCT01999868|3580647|B2|||Dermatology Life Quality Index (DLQI) Score|Dermatology Life Quality Index (DLQI) is a 10-question, participant-reported questionnaire assessing quality of life with respect to skin conditions in the areas of Symptoms and Feelings; Daily Activities; Leisure; Work and School; Personal Relationships; and Treatment. Each question measures the effect the skin condition has on a participant’s quality of life. Responses range from “Not at all” (score = 0) to “Very much” (score = 3). The overall score is the sum for all 10 questions and ranges from 0-30, with higher scores indicating a poor quality of life.|units on a scale|Mean|13.5|13.5|Standard Deviation|7.0|7.0|||
3745937|NCT01999868|3580648|B1|||Dermatology Life Quality Index (DLQI) Score|Dermatology Life Quality Index (DLQI) is a 10-question, participant-reported questionnaire assessing quality of life with respect to skin conditions in the areas of Symptoms and Feelings; Daily Activities; Leisure; Work and School; Personal Relationships; and Treatment. Each question measures the effect the skin condition has on a participant’s quality of life. Responses range from “Not at all” (score = 0) to “Very much” (score = 3). The overall score is the sum for all 10 questions and ranges from 0-30, with higher scores indicating a poor quality of life.|units on a scale|Mean|14.2|14.2|Standard Deviation|8.1|8.1|||
3745938|NCT01999868|3580645|B4|Worse than Minimal (PGA ≥ 1.5)||Physician's Global Assessment (PGA) Score (Categorical)|Number of participants with “cleared or minimal” average Physician's Global Assessment (PGA) scores and those with average PGA scores worse than minimal. The Physician's Global Assessment (PGA) is an overall assessment of psoriasis severity. Duration, erythema and scaling are assessed, averaged, and given a score ranging from 0 to 5 based on the majority of the psoriatic lesions, with higher scores indicating worse disease. A PGA average score < 1.5 was classified as “cleared or minimal.”|Participants|Count of Participants|108|108.0||||||
3745939|NCT01999868|3580646|B3|Worse than Minimal (PGA ≥ 1.5)||Physician's Global Assessment (PGA) Score (Categorical)|Number of participants with “cleared or minimal” average Physician's Global Assessment (PGA) scores and those with average PGA scores worse than minimal. The Physician's Global Assessment (PGA) is an overall assessment of psoriasis severity. Duration, erythema and scaling are assessed, averaged, and given a score ranging from 0 to 5 based on the majority of the psoriatic lesions, with higher scores indicating worse disease. A PGA average score < 1.5 was classified as “cleared or minimal.”|Participants|Count of Participants|17|17.0||||||
3745940|NCT01999868|3580647|B2|Worse than Minimal (PGA ≥ 1.5)||Physician's Global Assessment (PGA) Score (Categorical)|Number of participants with “cleared or minimal” average Physician's Global Assessment (PGA) scores and those with average PGA scores worse than minimal. The Physician's Global Assessment (PGA) is an overall assessment of psoriasis severity. Duration, erythema and scaling are assessed, averaged, and given a score ranging from 0 to 5 based on the majority of the psoriatic lesions, with higher scores indicating worse disease. A PGA average score < 1.5 was classified as “cleared or minimal.”|Participants|Count of Participants|46|46.0||||||
3745941|NCT01999868|3580648|B1|Worse than Minimal (PGA ≥ 1.5)||Physician's Global Assessment (PGA) Score (Categorical)|Number of participants with “cleared or minimal” average Physician's Global Assessment (PGA) scores and those with average PGA scores worse than minimal. The Physician's Global Assessment (PGA) is an overall assessment of psoriasis severity. Duration, erythema and scaling are assessed, averaged, and given a score ranging from 0 to 5 based on the majority of the psoriatic lesions, with higher scores indicating worse disease. A PGA average score < 1.5 was classified as “cleared or minimal.”|Participants|Count of Participants|45|45.0||||||
3745977|NCT01999868|3580648|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3745978|NCT01999868|3580645|B4||White|Race (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3745979|NCT01999868|3580646|B3||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3745980|NCT01999868|3580647|B2||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3745942|NCT01999868|3580645|B4|Cleared or Minimal (PGA <1.5)||Physician's Global Assessment (PGA) Score (Categorical)|Number of participants with “cleared or minimal” average Physician's Global Assessment (PGA) scores and those with average PGA scores worse than minimal. The Physician's Global Assessment (PGA) is an overall assessment of psoriasis severity. Duration, erythema and scaling are assessed, averaged, and given a score ranging from 0 to 5 based on the majority of the psoriatic lesions, with higher scores indicating worse disease. A PGA average score < 1.5 was classified as “cleared or minimal.”|Participants|Count of Participants|0|0.0||||||
3745943|NCT01999868|3580646|B3|Cleared or Minimal (PGA <1.5)||Physician's Global Assessment (PGA) Score (Categorical)|Number of participants with “cleared or minimal” average Physician's Global Assessment (PGA) scores and those with average PGA scores worse than minimal. The Physician's Global Assessment (PGA) is an overall assessment of psoriasis severity. Duration, erythema and scaling are assessed, averaged, and given a score ranging from 0 to 5 based on the majority of the psoriatic lesions, with higher scores indicating worse disease. A PGA average score < 1.5 was classified as “cleared or minimal.”|Participants|Count of Participants|0|0.0||||||
3745944|NCT01999868|3580647|B2|Cleared or Minimal (PGA <1.5)||Physician's Global Assessment (PGA) Score (Categorical)|Number of participants with “cleared or minimal” average Physician's Global Assessment (PGA) scores and those with average PGA scores worse than minimal. The Physician's Global Assessment (PGA) is an overall assessment of psoriasis severity. Duration, erythema and scaling are assessed, averaged, and given a score ranging from 0 to 5 based on the majority of the psoriatic lesions, with higher scores indicating worse disease. A PGA average score < 1.5 was classified as “cleared or minimal.”|Participants|Count of Participants|0|0.0||||||
3745945|NCT01999868|3580648|B1|Cleared or Minimal (PGA <1.5)||Physician's Global Assessment (PGA) Score (Categorical)|Number of participants with “cleared or minimal” average Physician's Global Assessment (PGA) scores and those with average PGA scores worse than minimal. The Physician's Global Assessment (PGA) is an overall assessment of psoriasis severity. Duration, erythema and scaling are assessed, averaged, and given a score ranging from 0 to 5 based on the majority of the psoriatic lesions, with higher scores indicating worse disease. A PGA average score < 1.5 was classified as “cleared or minimal.”|Participants|Count of Participants|0|0.0||||||
3745946|NCT01999868|3580645|B4|||Physician's Global Assessment (PGA) Score|The Physician's Global Assessment (PGA) is an overall assessment of psoriasis severity. Duration, erythema and scaling are assessed, averaged, and given a score ranging from 0 to 5 based on the majority of the psoriatic lesions, with higher scores indicating worse disease. A PGA average score < 1.5 was classified as “cleared or minimal.”|units on a scale|Mean|3.4|3.4|Standard Deviation|0.6|0.6|||
3745947|NCT01999868|3580646|B3|||Physician's Global Assessment (PGA) Score|The Physician's Global Assessment (PGA) is an overall assessment of psoriasis severity. Duration, erythema and scaling are assessed, averaged, and given a score ranging from 0 to 5 based on the majority of the psoriatic lesions, with higher scores indicating worse disease. A PGA average score < 1.5 was classified as “cleared or minimal.”|units on a scale|Mean|3.5|3.5|Standard Deviation|0.6|0.6|||
3745948|NCT01999868|3580647|B2|||Physician's Global Assessment (PGA) Score|The Physician's Global Assessment (PGA) is an overall assessment of psoriasis severity. Duration, erythema and scaling are assessed, averaged, and given a score ranging from 0 to 5 based on the majority of the psoriatic lesions, with higher scores indicating worse disease. A PGA average score < 1.5 was classified as “cleared or minimal.”|units on a scale|Mean|3.3|3.3|Standard Deviation|0.5|0.5|||
3745949|NCT01999868|3580648|B1|||Physician's Global Assessment (PGA) Score|The Physician's Global Assessment (PGA) is an overall assessment of psoriasis severity. Duration, erythema and scaling are assessed, averaged, and given a score ranging from 0 to 5 based on the majority of the psoriatic lesions, with higher scores indicating worse disease. A PGA average score < 1.5 was classified as “cleared or minimal.”|units on a scale|Mean|3.5|3.5|Standard Deviation|0.7|0.7|||
3745950|NCT01999868|3580645|B4|High (>20)||Psoriasis Area Severity Index (PASI) (Randomization Strata)|Number of participants with low and high Psoriasis Area Severity Index (PASI) scores. PASI is an assessment for psoriasis severity based on 4 body areas: Head and Neck, Upper Extremities, Trunk, and Lower Extremities. Psoriasis severity within each body area is assessed for Redness (score 0-4), Thickness (score 0-4) and Scaling (score 0-4). Scores for each body area are summed and weighted by the affected Body Surface Area (score 0-6) to produce the total score. The score ranges from 0 (no psoriasis) to 72 (very severe psoriasis). Scores of 12-20 were considered “low” and scores >20, “high.”|Participants|Count of Participants|37|37.0||||||
3745951|NCT01999868|3580646|B3|High (>20)||Psoriasis Area Severity Index (PASI) (Randomization Strata)|Number of participants with low and high Psoriasis Area Severity Index (PASI) scores. PASI is an assessment for psoriasis severity based on 4 body areas: Head and Neck, Upper Extremities, Trunk, and Lower Extremities. Psoriasis severity within each body area is assessed for Redness (score 0-4), Thickness (score 0-4) and Scaling (score 0-4). Scores for each body area are summed and weighted by the affected Body Surface Area (score 0-6) to produce the total score. The score ranges from 0 (no psoriasis) to 72 (very severe psoriasis). Scores of 12-20 were considered “low” and scores >20, “high.”|Participants|Count of Participants|9|9.0||||||
3745952|NCT01999868|3580647|B2|High (>20)||Psoriasis Area Severity Index (PASI) (Randomization Strata)|Number of participants with low and high Psoriasis Area Severity Index (PASI) scores. PASI is an assessment for psoriasis severity based on 4 body areas: Head and Neck, Upper Extremities, Trunk, and Lower Extremities. Psoriasis severity within each body area is assessed for Redness (score 0-4), Thickness (score 0-4) and Scaling (score 0-4). Scores for each body area are summed and weighted by the affected Body Surface Area (score 0-6) to produce the total score. The score ranges from 0 (no psoriasis) to 72 (very severe psoriasis). Scores of 12-20 were considered “low” and scores >20, “high.”|Participants|Count of Participants|14|14.0||||||
3745953|NCT01999868|3580648|B1|High (>20)||Psoriasis Area Severity Index (PASI) (Randomization Strata)|Number of participants with low and high Psoriasis Area Severity Index (PASI) scores. PASI is an assessment for psoriasis severity based on 4 body areas: Head and Neck, Upper Extremities, Trunk, and Lower Extremities. Psoriasis severity within each body area is assessed for Redness (score 0-4), Thickness (score 0-4) and Scaling (score 0-4). Scores for each body area are summed and weighted by the affected Body Surface Area (score 0-6) to produce the total score. The score ranges from 0 (no psoriasis) to 72 (very severe psoriasis). Scores of 12-20 were considered “low” and scores >20, “high.”|Participants|Count of Participants|14|14.0||||||
3745981|NCT01999868|3580648|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3745954|NCT01999868|3580645|B4|Low (12 – 20)||Psoriasis Area Severity Index (PASI) (Randomization Strata)|Number of participants with low and high Psoriasis Area Severity Index (PASI) scores. PASI is an assessment for psoriasis severity based on 4 body areas: Head and Neck, Upper Extremities, Trunk, and Lower Extremities. Psoriasis severity within each body area is assessed for Redness (score 0-4), Thickness (score 0-4) and Scaling (score 0-4). Scores for each body area are summed and weighted by the affected Body Surface Area (score 0-6) to produce the total score. The score ranges from 0 (no psoriasis) to 72 (very severe psoriasis). Scores of 12-20 were considered “low” and scores >20, “high.”|Participants|Count of Participants|71|71.0||||||
3745955|NCT01999868|3580646|B3|Low (12 – 20)||Psoriasis Area Severity Index (PASI) (Randomization Strata)|Number of participants with low and high Psoriasis Area Severity Index (PASI) scores. PASI is an assessment for psoriasis severity based on 4 body areas: Head and Neck, Upper Extremities, Trunk, and Lower Extremities. Psoriasis severity within each body area is assessed for Redness (score 0-4), Thickness (score 0-4) and Scaling (score 0-4). Scores for each body area are summed and weighted by the affected Body Surface Area (score 0-6) to produce the total score. The score ranges from 0 (no psoriasis) to 72 (very severe psoriasis). Scores of 12-20 were considered “low” and scores >20, “high.”|Participants|Count of Participants|8|8.0||||||
3745956|NCT01999868|3580647|B2|Low (12 – 20)||Psoriasis Area Severity Index (PASI) (Randomization Strata)|Number of participants with low and high Psoriasis Area Severity Index (PASI) scores. PASI is an assessment for psoriasis severity based on 4 body areas: Head and Neck, Upper Extremities, Trunk, and Lower Extremities. Psoriasis severity within each body area is assessed for Redness (score 0-4), Thickness (score 0-4) and Scaling (score 0-4). Scores for each body area are summed and weighted by the affected Body Surface Area (score 0-6) to produce the total score. The score ranges from 0 (no psoriasis) to 72 (very severe psoriasis). Scores of 12-20 were considered “low” and scores >20, “high.”|Participants|Count of Participants|32|32.0||||||
3745957|NCT01999868|3580648|B1|Low (12 – 20)||Psoriasis Area Severity Index (PASI) (Randomization Strata)|Number of participants with low and high Psoriasis Area Severity Index (PASI) scores. PASI is an assessment for psoriasis severity based on 4 body areas: Head and Neck, Upper Extremities, Trunk, and Lower Extremities. Psoriasis severity within each body area is assessed for Redness (score 0-4), Thickness (score 0-4) and Scaling (score 0-4). Scores for each body area are summed and weighted by the affected Body Surface Area (score 0-6) to produce the total score. The score ranges from 0 (no psoriasis) to 72 (very severe psoriasis). Scores of 12-20 were considered “low” and scores >20, “high.”|Participants|Count of Participants|31|31.0||||||
3745958|NCT01999868|3580645|B4|||Psoriasis Area Severity Index (PASI) Score|Baseline Psoriasis Area Severity Index (PASI) score was the score assessed at Week 0. PASI is an assessment for psoriasis severity based on 4 body areas: Head and Neck, Upper Extremities, Trunk, and Lower Extremities. Psoriasis severity within each body area is assessed for Redness (score 0-4), Thickness (score 0-4) and Scaling (score 0-4). Scores for each body area are summed and weighted by the affected Body Surface Area (score 0-6) to produce the total score. The score ranges from 0 (no psoriasis present) to 72 (very severe psoriasis).|units on a scale|Mean|19.9|19.9|Standard Deviation|8.1|8.1|||
3745959|NCT01999868|3580646|B3|||Psoriasis Area Severity Index (PASI) Score|Baseline Psoriasis Area Severity Index (PASI) score was the score assessed at Week 0. PASI is an assessment for psoriasis severity based on 4 body areas: Head and Neck, Upper Extremities, Trunk, and Lower Extremities. Psoriasis severity within each body area is assessed for Redness (score 0-4), Thickness (score 0-4) and Scaling (score 0-4). Scores for each body area are summed and weighted by the affected Body Surface Area (score 0-6) to produce the total score. The score ranges from 0 (no psoriasis present) to 72 (very severe psoriasis).|units on a scale|Mean|21.2|21.2|Standard Deviation|7.7|7.7|||
3745960|NCT01999868|3580647|B2|||Psoriasis Area Severity Index (PASI) Score|Baseline Psoriasis Area Severity Index (PASI) score was the score assessed at Week 0. PASI is an assessment for psoriasis severity based on 4 body areas: Head and Neck, Upper Extremities, Trunk, and Lower Extremities. Psoriasis severity within each body area is assessed for Redness (score 0-4), Thickness (score 0-4) and Scaling (score 0-4). Scores for each body area are summed and weighted by the affected Body Surface Area (score 0-6) to produce the total score. The score ranges from 0 (no psoriasis present) to 72 (very severe psoriasis).|units on a scale|Mean|20.0|20.0|Standard Deviation|8.2|8.2|||
3745961|NCT01999868|3580648|B1|||Psoriasis Area Severity Index (PASI) Score|Baseline Psoriasis Area Severity Index (PASI) score was the score assessed at Week 0. PASI is an assessment for psoriasis severity based on 4 body areas: Head and Neck, Upper Extremities, Trunk, and Lower Extremities. Psoriasis severity within each body area is assessed for Redness (score 0-4), Thickness (score 0-4) and Scaling (score 0-4). Scores for each body area are summed and weighted by the affected Body Surface Area (score 0-6) to produce the total score. The score ranges from 0 (no psoriasis present) to 72 (very severe psoriasis).|units on a scale|Mean|19.2|19.2|Standard Deviation|8.1|8.1|||
3745962|NCT01999868|3580645|B4|United States||Region of Enrollment||participants|Number|73|73.0||||||
3745963|NCT01999868|3580646|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3745964|NCT01999868|3580647|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
3745965|NCT01999868|3580648|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3745966|NCT01999868|3580645|B4|Canada||Region of Enrollment||participants|Number|35|35.0||||||
3745967|NCT01999868|3580646|B3|Canada||Region of Enrollment||participants|Number|6|6.0||||||
3745968|NCT01999868|3580647|B2|Canada||Region of Enrollment||participants|Number|14|14.0||||||
3745969|NCT01999868|3580648|B1|Canada||Region of Enrollment||participants|Number|15|15.0||||||
3745970|NCT01999868|3580645|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745971|NCT01999868|3580646|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745972|NCT01999868|3580647|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745973|NCT01999868|3580648|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745974|NCT01999868|3580645|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3745975|NCT01999868|3580646|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745976|NCT01999868|3580647|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745982|NCT01999868|3580645|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3745983|NCT01999868|3580646|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745984|NCT01999868|3580647|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3745985|NCT01999868|3580648|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3745986|NCT01999868|3580645|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745987|NCT01999868|3580646|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745988|NCT01999868|3580647|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745989|NCT01999868|3580648|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745990|NCT01999868|3580645|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3745991|NCT01999868|3580646|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745992|NCT01999868|3580647|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3745993|NCT01999868|3580648|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3745994|NCT01999868|3580645|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3745995|NCT01999868|3580646|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745996|NCT01999868|3580647|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745997|NCT01999868|3580648|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3745998|NCT01999868|3580645|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3745999|NCT01999868|3580646|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746000|NCT01999868|3580647|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746001|NCT01999868|3580648|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746002|NCT01999868|3580645|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3746003|NCT01999868|3580646|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3746004|NCT01999868|3580647|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3746005|NCT01999868|3580648|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3746006|NCT01999868|3580645|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3746007|NCT01999868|3580646|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3746008|NCT01999868|3580647|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3746009|NCT01999868|3580648|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3746010|NCT01999868|3580645|B4||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3746011|NCT01999868|3580646|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3746012|NCT01999868|3580647|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3746013|NCT01999868|3580648|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3746014|NCT01999868|3580645|B4||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3746015|NCT01999868|3580646|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3746016|NCT01999868|3580647|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3746017|NCT01999868|3580648|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3746018|NCT01999868|3580645|B4|||Age||years|Mean|46.1|46.1|Standard Deviation|12.1|12.1|||
3746019|NCT01999868|3580646|B3|||Age||years|Mean|42.8|42.8|Standard Deviation|15.0|15.0|||
3746020|NCT01999868|3580647|B2|||Age||years|Mean|44.1|44.1|Standard Deviation|11.8|11.8|||
3746021|NCT01999868|3580648|B1|||Age||years|Mean|49.4|49.4|Standard Deviation|10.5|10.5|||
3746022|NCT01999777|3580675|B3|Spain||Region of Enrollment||participants|Number|7|7.0||||||
3746023|NCT01999777|3580676|B2|Spain||Region of Enrollment||participants|Number|4|4.0||||||
3746024|NCT01999777|3580677|B1|Spain||Region of Enrollment||participants|Number|3|3.0||||||
3746025|NCT01999777|3580675|B3|Germany||Region of Enrollment||participants|Number|1|1.0||||||
3746026|NCT01999777|3580676|B2|Germany||Region of Enrollment||participants|Number|1|1.0||||||
3746027|NCT01999777|3580677|B1|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3746028|NCT01999777|3580675|B3|Lithuania||Region of Enrollment||participants|Number|5|5.0||||||
3746029|NCT01999777|3580676|B2|Lithuania||Region of Enrollment||participants|Number|2|2.0||||||
3746030|NCT01999777|3580677|B1|Lithuania||Region of Enrollment||participants|Number|3|3.0||||||
3746031|NCT01999777|3580675|B3|Czechia||Region of Enrollment||participants|Number|4|4.0||||||
3746032|NCT01999777|3580676|B2|Czechia||Region of Enrollment||participants|Number|2|2.0||||||
3746033|NCT01999777|3580677|B1|Czechia||Region of Enrollment||participants|Number|2|2.0||||||
3746034|NCT01999777|3580675|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
3746035|NCT01999777|3580676|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
3746036|NCT01999777|3580677|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3746037|NCT01999777|3580675|B3|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
3746038|NCT01999777|3580676|B2|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
3746039|NCT01999777|3580677|B1|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
3746040|NCT01999777|3580675|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3746041|NCT01999777|3580676|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746042|NCT01999777|3580677|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3746043|NCT01999777|3580675|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746044|NCT01999777|3580676|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746045|NCT01999777|3580677|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746046|NCT01999777|3580675|B3||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3746047|NCT01999777|3580676|B2||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3746048|NCT01999777|3580677|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3746049|NCT01999777|3580675|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3746050|NCT01999777|3580676|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3746051|NCT01999777|3580677|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3746052|NCT01999777|3580675|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746053|NCT01999777|3580676|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746054|NCT01999777|3580677|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746055|NCT01999777|3580675|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3746056|NCT01999777|3580676|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3746057|NCT01999777|3580677|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746058|NCT01999777|3580675|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746059|NCT01999777|3580676|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746060|NCT01999777|3580677|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746061|NCT01999777|3580675|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746062|NCT01999777|3580676|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746063|NCT01999777|3580677|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746064|NCT01999777|3580675|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3746065|NCT01999777|3580676|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3746066|NCT01999777|3580677|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3746067|NCT01999777|3580675|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3746068|NCT01999777|3580676|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3746069|NCT01999777|3580677|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3746070|NCT01999777|3580675|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3746071|NCT01999777|3580676|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3746072|NCT01999777|3580677|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3746073|NCT01999777|3580675|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3746074|NCT01999777|3580676|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3746075|NCT01999777|3580677|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3746076|NCT01999777|3580675|B3|||Age||years|Mean|34.3|34.3|Standard Deviation|13.24|13.24|||
3746077|NCT01999777|3580676|B2|||Age||years|Mean|35.9|35.9|Standard Deviation|13.56|13.56|||
3746078|NCT01999777|3580677|B1|||Age||years|Mean|32.7|32.7|Standard Deviation|12.94|12.94|||
3746079|NCT01999777|3580675|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3746080|NCT01999777|3580676|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3746081|NCT01999777|3580677|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3746082|NCT01999777|3580675|B3||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3746083|NCT01999777|3580676|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3746084|NCT01999777|3580677|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3746085|NCT01999777|3580675|B3||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3746086|NCT01999777|3580676|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3746087|NCT01999777|3580677|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3746088|NCT01999465|3580686|B3||Narakas III-IV|Narakas|"Narakas grade is determined by a single surgeon via either: 1) physical examination and neurological assessment at approximately 1 week of age or at initial clinical appointment, or 2) mother’s or obstetrician’s report of child’s arm/hand movements at birth. The Narakas grade is grouped into Grade I-II versus III-IV in the current study.~Narakas Groups I and II are considered to be less extensive NBPP injury and Groups III and IV are more extensive NBPP injury."|Participants|Count of Participants|4|4.0||||||
3746089|NCT01999465|3580687|B2||Narakas III-IV|Narakas|"Narakas grade is determined by a single surgeon via either: 1) physical examination and neurological assessment at approximately 1 week of age or at initial clinical appointment, or 2) mother’s or obstetrician’s report of child’s arm/hand movements at birth. The Narakas grade is grouped into Grade I-II versus III-IV in the current study.~Narakas Groups I and II are considered to be less extensive NBPP injury and Groups III and IV are more extensive NBPP injury."|Participants|Count of Participants|2|2.0||||||
3746135|NCT01999400|3580697|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3746136|NCT01999400|3580697|B1|||Age||years|Mean|32.9|32.9|Standard Deviation|9.7|9.7|||
3746090|NCT01999465|3580688|B1||Narakas III-IV|Narakas|"Narakas grade is determined by a single surgeon via either: 1) physical examination and neurological assessment at approximately 1 week of age or at initial clinical appointment, or 2) mother’s or obstetrician’s report of child’s arm/hand movements at birth. The Narakas grade is grouped into Grade I-II versus III-IV in the current study.~Narakas Groups I and II are considered to be less extensive NBPP injury and Groups III and IV are more extensive NBPP injury."|Participants|Count of Participants|2|2.0||||||
3746091|NCT01999465|3580686|B3||Narakas I-II|Narakas|"Narakas grade is determined by a single surgeon via either: 1) physical examination and neurological assessment at approximately 1 week of age or at initial clinical appointment, or 2) mother’s or obstetrician’s report of child’s arm/hand movements at birth. The Narakas grade is grouped into Grade I-II versus III-IV in the current study.~Narakas Groups I and II are considered to be less extensive NBPP injury and Groups III and IV are more extensive NBPP injury."|Participants|Count of Participants|13|13.0||||||
3746092|NCT01999465|3580687|B2||Narakas I-II|Narakas|"Narakas grade is determined by a single surgeon via either: 1) physical examination and neurological assessment at approximately 1 week of age or at initial clinical appointment, or 2) mother’s or obstetrician’s report of child’s arm/hand movements at birth. The Narakas grade is grouped into Grade I-II versus III-IV in the current study.~Narakas Groups I and II are considered to be less extensive NBPP injury and Groups III and IV are more extensive NBPP injury."|Participants|Count of Participants|5|5.0||||||
3746093|NCT01999465|3580688|B1||Narakas I-II|Narakas|"Narakas grade is determined by a single surgeon via either: 1) physical examination and neurological assessment at approximately 1 week of age or at initial clinical appointment, or 2) mother’s or obstetrician’s report of child’s arm/hand movements at birth. The Narakas grade is grouped into Grade I-II versus III-IV in the current study.~Narakas Groups I and II are considered to be less extensive NBPP injury and Groups III and IV are more extensive NBPP injury."|Participants|Count of Participants|8|8.0||||||
3746094|NCT01999465|3580686|B3||Right|NBPP-involved side||Participants|Count of Participants|10|10.0||||||
3746095|NCT01999465|3580687|B2||Right|NBPP-involved side||Participants|Count of Participants|5|5.0||||||
3746096|NCT01999465|3580688|B1||Right|NBPP-involved side||Participants|Count of Participants|5|5.0||||||
3746097|NCT01999465|3580686|B3||Left|NBPP-involved side||Participants|Count of Participants|7|7.0||||||
3746098|NCT01999465|3580687|B2||Left|NBPP-involved side||Participants|Count of Participants|2|2.0||||||
3746099|NCT01999465|3580688|B1||Left|NBPP-involved side||Participants|Count of Participants|5|5.0||||||
3746100|NCT01999465|3580686|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
3746101|NCT01999465|3580687|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3746102|NCT01999465|3580688|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3746103|NCT01999465|3580686|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746104|NCT01999465|3580687|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746105|NCT01999465|3580688|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746106|NCT01999465|3580686|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746107|NCT01999465|3580687|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746108|NCT01999465|3580688|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746109|NCT01999465|3580686|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3746110|NCT01999465|3580687|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3746111|NCT01999465|3580688|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3746112|NCT01999465|3580686|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3746113|NCT01999465|3580687|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3746114|NCT01999465|3580688|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746115|NCT01999465|3580686|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746116|NCT01999465|3580687|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746117|NCT01999465|3580688|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746118|NCT01999465|3580686|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3746119|NCT01999465|3580687|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746120|NCT01999465|3580688|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3746121|NCT01999465|3580686|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746122|NCT01999465|3580687|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746123|NCT01999465|3580688|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746124|NCT01999465|3580686|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3746125|NCT01999465|3580687|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3746126|NCT01999465|3580688|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3746127|NCT01999465|3580686|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3746128|NCT01999465|3580687|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3746129|NCT01999465|3580688|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3746130|NCT01999465|3580686|B3|||Age|age is described as months|months|Mean|4|4.0|Standard Deviation|1|1.0|||
3746131|NCT01999465|3580687|B2|||Age|age is described as months|months|Mean|4|4.0|Standard Deviation|1|1.0|||
3746132|NCT01999465|3580688|B1|||Age|age is described as months|months|Mean|4|4.0|Standard Deviation|2|2.0|||
3746133|NCT01999400|3580697|B1|||Body Mass Index||kg per m squared|Mean|26.9|26.9|Standard Deviation|5.6|5.6|||
3746134|NCT01999400|3580697|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3746137|NCT01999348|3580722|B1|Missing data||Sex/Gender, Customized||participants|Number|9|9.0||||||
3746138|NCT01999348|3580722|B1|Male||Sex/Gender, Customized||participants|Number|631|631.0||||||
3746139|NCT01999348|3580722|B1|Female||Sex/Gender, Customized||participants|Number|913|913.0||||||
3746140|NCT01999348|3580722|B1|Missing data||Age, Customized||participants|Number|36|36.0||||||
3746141|NCT01999348|3580722|B1|Greater than or equal to 91||Age, Customized||participants|Number|8|8.0||||||
3746142|NCT01999348|3580722|B1|81 to 90 years||Age, Customized||participants|Number|155|155.0||||||
3746143|NCT01999348|3580722|B1|71 to 80 years||Age, Customized||participants|Number|477|477.0||||||
3746144|NCT01999348|3580722|B1|61 to 70 years||Age, Customized||participants|Number|415|415.0||||||
3746145|NCT01999348|3580722|B1|51 to 60 years||Age, Customized||participants|Number|313|313.0||||||
3746146|NCT01999348|3580722|B1|41 to 50 years||Age, Customized||participants|Number|119|119.0||||||
3746147|NCT01999348|3580722|B1|31 to 40 years||Age, Customized||participants|Number|21|21.0||||||
3746148|NCT01999348|3580722|B1|18 to 30 years||Age, Customized||participants|Number|8|8.0||||||
3746149|NCT01999348|3580722|B1|Less than 18 years||Age, Customized||participants|Number|1|1.0||||||
3746150|NCT01999322|3580732|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3746151|NCT01999322|3580733|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3746152|NCT01999322|3580734|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3746153|NCT01999322|3580732|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3746154|NCT01999322|3580733|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3746155|NCT01999322|3580734|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3746156|NCT01999322|3580732|B3|65-84||Age, Customized||participants|Number|6|6.0||||||
3746157|NCT01999322|3580733|B2|65-84||Age, Customized||participants|Number|0|0.0||||||
3746158|NCT01999322|3580734|B1|65-84||Age, Customized||participants|Number|6|6.0||||||
3746159|NCT01999322|3580732|B3|18-64||Age, Customized||participants|Number|31|31.0||||||
3746160|NCT01999322|3580733|B2|18-64||Age, Customized||participants|Number|12|12.0||||||
3746161|NCT01999322|3580734|B1|18-64||Age, Customized||participants|Number|19|19.0||||||
3746162|NCT01999322|3580732|B3|||Age||years|Mean|44.3|44.3|Standard Deviation|14.6|14.6|||
3746163|NCT01999322|3580733|B2|||Age||years|Mean|34.7|34.7|Standard Deviation|9.1|9.1|||
3746164|NCT01999322|3580734|B1|||Age||years|Mean|48.9|48.9|Standard Deviation|14.6|14.6|||
3746165|NCT01999231|3580747|B5|||height||cm|Mean|166.50|166.5|Standard Deviation|9.45|9.45|||
3746166|NCT01999231|3580748|B4|||height||cm|Mean|164.83|164.83|Standard Deviation|11.11|11.11|||
3746167|NCT01999231|3580749|B3|||height||cm|Mean|163.00|163.0|Standard Deviation|5.06|5.06|||
3746168|NCT01999231|3580750|B2|||height||cm|Mean|169.00|169.0|Standard Deviation|9.67|9.67|||
3746169|NCT01999231|3580751|B1|||height||cm|Mean|169.17|169.17|Standard Deviation|11.97|11.97|||
3746170|NCT01999231|3580747|B5|||Body Mass Index||kg/m^2|Mean|22.58|22.58|Standard Deviation|1.83|1.83|||
3746171|NCT01999231|3580748|B4|||Body Mass Index||kg/m^2|Mean|22.88|22.88|Standard Deviation|2.11|2.11|||
3746172|NCT01999231|3580749|B3|||Body Mass Index||kg/m^2|Mean|22.05|22.05|Standard Deviation|1.13|1.13|||
3746173|NCT01999231|3580750|B2|||Body Mass Index||kg/m^2|Mean|23.07|23.07|Standard Deviation|2.05|2.05|||
3746174|NCT01999231|3580751|B1|||Body Mass Index||kg/m^2|Mean|22.32|22.32|Standard Deviation|2.03|2.03|||
3746175|NCT01999231|3580747|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3746176|NCT01999231|3580748|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3746177|NCT01999231|3580749|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3746178|NCT01999231|3580750|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3746179|NCT01999231|3580751|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3746180|NCT01999231|3580747|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3746181|NCT01999231|3580748|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3746182|NCT01999231|3580749|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3746183|NCT01999231|3580750|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3746184|NCT01999231|3580751|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3746185|NCT01999231|3580747|B5|||Age||years|Mean|27.10|27.1|Standard Deviation|3.96|3.96|||
3746186|NCT01999231|3580748|B4|||Age||years|Mean|27.68|27.68|Standard Deviation|3.79|3.79|||
3746187|NCT01999231|3580749|B3|||Age||years|Mean|30.07|30.07|Standard Deviation|4.00|4.0|||
3746188|NCT01999231|3580750|B2|||Age||years|Mean|25.63|25.63|Standard Deviation|4.13|4.13|||
3746189|NCT01999231|3580751|B1|||Age||years|Mean|25.00|25.0|Standard Deviation|3.93|3.93|||
3746190|NCT01999218|3580784|B4|||Estimated Glomerular Filtration Rate (eGFR)||milliliters/minute/1.73 meters^2|Mean|87.2|87.2|Standard Deviation|18.5|18.5|||
3746191|NCT01999218|3580785|B3|||Estimated Glomerular Filtration Rate (eGFR)||milliliters/minute/1.73 meters^2|Mean|86.6|86.6|Standard Deviation|18.5|18.5|||
3746192|NCT01999218|3580786|B2|||Estimated Glomerular Filtration Rate (eGFR)||milliliters/minute/1.73 meters^2|Mean|86.7|86.7|Standard Deviation|18.3|18.3|||
3746193|NCT01999218|3580787|B1|||Estimated Glomerular Filtration Rate (eGFR)||milliliters/minute/1.73 meters^2|Mean|88.3|88.3|Standard Deviation|18.7|18.7|||
3746194|NCT01999218|3580784|B4||Data not available|Prior Antihyperglycemic (AHA) Medication (Monotherapy or Dual Therapy)||Participants|Count of Participants|1|1.0||||||
3746195|NCT01999218|3580785|B3||Data not available|Prior Antihyperglycemic (AHA) Medication (Monotherapy or Dual Therapy)||Participants|Count of Participants|0|0.0||||||
3746196|NCT01999218|3580786|B2||Data not available|Prior Antihyperglycemic (AHA) Medication (Monotherapy or Dual Therapy)||Participants|Count of Participants|1|1.0||||||
3746197|NCT01999218|3580787|B1||Data not available|Prior Antihyperglycemic (AHA) Medication (Monotherapy or Dual Therapy)||Participants|Count of Participants|0|0.0||||||
3746198|NCT01999218|3580784|B4||No Prior Use & Not on Antihyperglycemic Medication|Prior Antihyperglycemic (AHA) Medication (Monotherapy or Dual Therapy)||Participants|Count of Participants|1|1.0||||||
3746199|NCT01999218|3580785|B3||No Prior Use & Not on Antihyperglycemic Medication|Prior Antihyperglycemic (AHA) Medication (Monotherapy or Dual Therapy)||Participants|Count of Participants|0|0.0||||||
3746200|NCT01999218|3580786|B2||No Prior Use & Not on Antihyperglycemic Medication|Prior Antihyperglycemic (AHA) Medication (Monotherapy or Dual Therapy)||Participants|Count of Participants|1|1.0||||||
3746201|NCT01999218|3580787|B1||No Prior Use & Not on Antihyperglycemic Medication|Prior Antihyperglycemic (AHA) Medication (Monotherapy or Dual Therapy)||Participants|Count of Participants|0|0.0||||||
3746202|NCT01999218|3580784|B4||Prior Antihyperglycemic Medication|Prior Antihyperglycemic (AHA) Medication (Monotherapy or Dual Therapy)||Participants|Count of Participants|1324|1324.0||||||
3746203|NCT01999218|3580785|B3||Prior Antihyperglycemic Medication|Prior Antihyperglycemic (AHA) Medication (Monotherapy or Dual Therapy)||Participants|Count of Participants|437|437.0||||||
3746204|NCT01999218|3580786|B2||Prior Antihyperglycemic Medication|Prior Antihyperglycemic (AHA) Medication (Monotherapy or Dual Therapy)||Participants|Count of Participants|439|439.0||||||
3746205|NCT01999218|3580787|B1||Prior Antihyperglycemic Medication|Prior Antihyperglycemic (AHA) Medication (Monotherapy or Dual Therapy)||Participants|Count of Participants|448|448.0||||||
3746206|NCT01999218|3580784|B4|||Sitting Systolic Blood Pressure||Millimeters of mercury|Mean|130.3|130.3|Standard Deviation|12.4|12.4|||
3746207|NCT01999218|3580785|B3|||Sitting Systolic Blood Pressure||Millimeters of mercury|Mean|129.9|129.9|Standard Deviation|12.0|12.0|||
3746208|NCT01999218|3580786|B2|||Sitting Systolic Blood Pressure||Millimeters of mercury|Mean|130.8|130.8|Standard Deviation|12.4|12.4|||
3746209|NCT01999218|3580787|B1|||Sitting Systolic Blood Pressure||Millimeters of mercury|Mean|130.2|130.2|Standard Deviation|12.8|12.8|||
3746210|NCT01999218|3580784|B4|||Hemoglobin A1C||Percentage|Mean|7.79|7.79|Standard Deviation|0.60|0.6|||
3746211|NCT01999218|3580785|B3|||Hemoglobin A1C||Percentage|Mean|7.76|7.76|Standard Deviation|0.60|0.6|||
3746212|NCT01999218|3580786|B2|||Hemoglobin A1C||Percentage|Mean|7.80|7.8|Standard Deviation|0.60|0.6|||
3746213|NCT01999218|3580787|B1|||Hemoglobin A1C||Percentage|Mean|7.81|7.81|Standard Deviation|0.60|0.6|||
3746214|NCT01999218|3580784|B4|||Body Weight||Kilograms|Mean|86.8|86.8|Standard Deviation|19.6|19.6|||
3746215|NCT01999218|3580785|B3|||Body Weight||Kilograms|Mean|86.8|86.8|Standard Deviation|20.7|20.7|||
3746216|NCT01999218|3580786|B2|||Body Weight||Kilograms|Mean|85.6|85.6|Standard Deviation|19.1|19.1|||
3746217|NCT01999218|3580787|B1|||Body Weight||Kilograms|Mean|87.9|87.9|Standard Deviation|18.9|18.9|||
3746218|NCT01999218|3580784|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746219|NCT01999218|3580785|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746220|NCT01999218|3580786|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746221|NCT01999218|3580787|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746222|NCT01999218|3580784|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3746223|NCT01999218|3580785|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3746224|NCT01999218|3580786|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3746225|NCT01999218|3580787|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3746226|NCT01999218|3580784|B4||White|Race (NIH/OMB)||Participants|Count of Participants|966|966.0||||||
3746227|NCT01999218|3580785|B3||White|Race (NIH/OMB)||Participants|Count of Participants|318|318.0||||||
3746228|NCT01999218|3580786|B2||White|Race (NIH/OMB)||Participants|Count of Participants|316|316.0||||||
3746229|NCT01999218|3580787|B1||White|Race (NIH/OMB)||Participants|Count of Participants|332|332.0||||||
3746230|NCT01999218|3580784|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3746231|NCT01999218|3580785|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3746232|NCT01999218|3580786|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3746233|NCT01999218|3580787|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3746234|NCT01999218|3580784|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746235|NCT01999218|3580785|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746236|NCT01999218|3580786|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746237|NCT01999218|3580787|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746238|NCT01999218|3580784|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|240|240.0||||||
3746239|NCT01999218|3580785|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3746240|NCT01999218|3580786|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
3746241|NCT01999218|3580787|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
3746242|NCT01999218|3580784|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3746243|NCT01999218|3580785|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3746244|NCT01999218|3580786|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3746245|NCT01999218|3580787|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3746246|NCT01999218|3580784|B4||Male|Sex: Female, Male|All randomized participants|Participants|Count of Participants|642|642.0||||||
3746247|NCT01999218|3580785|B3||Male|Sex: Female, Male|All randomized participants|Participants|Count of Participants|224|224.0||||||
3746248|NCT01999218|3580786|B2||Male|Sex: Female, Male|All randomized participants|Participants|Count of Participants|191|191.0||||||
3746249|NCT01999218|3580787|B1||Male|Sex: Female, Male|All randomized participants|Participants|Count of Participants|227|227.0||||||
3746250|NCT01999218|3580784|B4||Female|Sex: Female, Male|All randomized participants|Participants|Count of Participants|684|684.0||||||
3746251|NCT01999218|3580785|B3||Female|Sex: Female, Male|All randomized participants|Participants|Count of Participants|213|213.0||||||
3746252|NCT01999218|3580786|B2||Female|Sex: Female, Male|All randomized participants|Participants|Count of Participants|250|250.0||||||
3746253|NCT01999218|3580787|B1||Female|Sex: Female, Male|All randomized participants|Participants|Count of Participants|221|221.0||||||
3746254|NCT01999218|3580784|B4|||Age||Years|Mean|58.2|58.2|Standard Deviation|9.6|9.6|||
3746255|NCT01999218|3580785|B3|||Age||Years|Mean|57.8|57.8|Standard Deviation|9.2|9.2|||
3746256|NCT01999218|3580786|B2|||Age||Years|Mean|58.0|58.0|Standard Deviation|9.9|9.9|||
3746257|NCT01999218|3580787|B1|||Age||Years|Mean|58.8|58.8|Standard Deviation|9.7|9.7|||
3746258|NCT01999192|3580812|B5||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3746259|NCT01999192|3580813|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3746260|NCT01999192|3580814|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3746261|NCT01999192|3580815|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3746262|NCT01999192|3580816|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3746263|NCT01999192|3580812|B5||Female|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
3746264|NCT01999192|3580813|B4||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3746265|NCT01999192|3580814|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3746266|NCT01999192|3580815|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3746267|NCT01999192|3580816|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3746268|NCT01999192|3580812|B5|>65 years||Age, Customized||years|Number|32|32.0||||||
3746269|NCT01999192|3580813|B4|>65 years||Age, Customized||years|Number|12|12.0||||||
3746270|NCT01999192|3580814|B3|>65 years||Age, Customized||years|Number|8|8.0||||||
3746271|NCT01999192|3580815|B2|>65 years||Age, Customized||years|Number|3|3.0||||||
3746272|NCT01999192|3580816|B1|>65 years||Age, Customized||years|Number|9|9.0||||||
3746273|NCT01999192|3580812|B5|40-<=65 years||Age, Customized||years|Number|231|231.0||||||
3746274|NCT01999192|3580813|B4|40-<=65 years||Age, Customized||years|Number|57|57.0||||||
3746275|NCT01999192|3580814|B3|40-<=65 years||Age, Customized||years|Number|56|56.0||||||
3746276|NCT01999192|3580815|B2|40-<=65 years||Age, Customized||years|Number|56|56.0||||||
3746277|NCT01999192|3580816|B1|40-<=65 years||Age, Customized||years|Number|62|62.0||||||
3746278|NCT01999192|3580812|B5|0-<40 years||Age, Customized||years|Number|50|50.0||||||
3746279|NCT01999192|3580813|B4|0-<40 years||Age, Customized||years|Number|10|10.0||||||
3746280|NCT01999192|3580814|B3|0-<40 years||Age, Customized||years|Number|12|12.0||||||
3746281|NCT01999192|3580815|B2|0-<40 years||Age, Customized||years|Number|19|19.0||||||
3746282|NCT01999192|3580816|B1|0-<40 years||Age, Customized||years|Number|9|9.0||||||
3746283|NCT01999114|3580829|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746284|NCT01999114|3580830|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746285|NCT01999114|3580831|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746286|NCT01999114|3580832|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746287|NCT01999114|3580833|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746288|NCT01999114|3580834|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746289|NCT01999114|3580829|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746290|NCT01999114|3580830|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746291|NCT01999114|3580831|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746292|NCT01999114|3580832|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746293|NCT01999114|3580833|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746294|NCT01999114|3580834|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746295|NCT01999114|3580829|B6||White|Race (NIH/OMB)||Participants|Count of Participants|204|204.0||||||
3746296|NCT01999114|3580830|B5||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3746297|NCT01999114|3580831|B4||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3746298|NCT01999114|3580832|B3||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3746299|NCT01999114|3580833|B2||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3746300|NCT01999114|3580834|B1||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3746301|NCT01999114|3580829|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
3746302|NCT01999114|3580830|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3746303|NCT01999114|3580831|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3746304|NCT01999114|3580832|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3746305|NCT01999114|3580833|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3746306|NCT01999114|3580834|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3746307|NCT01999114|3580829|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3746308|NCT01999114|3580830|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746309|NCT01999114|3580831|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746310|NCT01999114|3580832|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746311|NCT01999114|3580833|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746312|NCT01999114|3580834|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3746313|NCT01999114|3580829|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3746314|NCT01999114|3580830|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3746315|NCT01999114|3580831|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3746316|NCT01999114|3580832|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746317|NCT01999114|3580833|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3746318|NCT01999114|3580834|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3746319|NCT01999114|3580829|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3746320|NCT01999114|3580830|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746321|NCT01999114|3580831|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746322|NCT01999114|3580832|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746323|NCT01999114|3580833|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3746324|NCT01999114|3580834|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3746325|NCT01999114|3580829|B6||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3746326|NCT01999114|3580830|B5||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3746327|NCT01999114|3580831|B4||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3746328|NCT01999114|3580832|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3746329|NCT01999114|3580833|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3746330|NCT01999114|3580834|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3746331|NCT01999114|3580829|B6||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3746332|NCT01999114|3580830|B5||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3746333|NCT01999114|3580831|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3746334|NCT01999114|3580832|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3746335|NCT01999114|3580833|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3746336|NCT01999114|3580834|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3746337|NCT01999114|3580829|B6|||Age||years|Mean|33.4|33.4|Standard Deviation|9.80|9.8|||
3746338|NCT01999114|3580830|B5|||Age||years|Mean|33.0|33.0|Standard Deviation|10.48|10.48|||
3746339|NCT01999114|3580831|B4|||Age||years|Mean|35.0|35.0|Standard Deviation|10.03|10.03|||
3746340|NCT01999114|3580832|B3|||Age||years|Mean|34.0|34.0|Standard Deviation|10.14|10.14|||
3746341|NCT01999114|3580833|B2|||Age||years|Mean|31.6|31.6|Standard Deviation|8.97|8.97|||
3746342|NCT01999114|3580834|B1|||Age||years|Mean|33.3|33.3|Standard Deviation|9.27|9.27|||
3746343|NCT01998984|3580902|B5|Australia||Region of Enrollment||Participants|Count of Participants|132|132.0||||||
3746344|NCT01998984|3580903|B4|Australia||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3746345|NCT01998984|3580904|B3|Australia||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3746346|NCT01998984|3580905|B2|Australia||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3746347|NCT01998984|3580906|B1|Australia||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3746348|NCT01998984|3580902|B5|United States||Region of Enrollment||Participants|Count of Participants|92|92.0||||||
3746349|NCT01998984|3580903|B4|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3746350|NCT01998984|3580904|B3|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3746351|NCT01998984|3580905|B2|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3746352|NCT01998984|3580906|B1|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3746353|NCT01998984|3580902|B5||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3746354|NCT01998984|3580903|B4||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3746355|NCT01998984|3580904|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3746356|NCT01998984|3580905|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3746357|NCT01998984|3580906|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3746358|NCT01998984|3580902|B5||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3746359|NCT01998984|3580903|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3746360|NCT01998984|3580904|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3746361|NCT01998984|3580905|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3746362|NCT01998984|3580906|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3746363|NCT01998984|3580902|B5|||Age||years|Mean|68.3|68.3|Full Range|||39.0|91.0|
3746364|NCT01998984|3580903|B4|||Age||years|Mean|68.6|68.6|Full Range|||42.0|91.0|
3746365|NCT01998984|3580904|B3|||Age||years|Mean|68.8|68.8|Full Range|||44.0|89.0|
3746366|NCT01998984|3580905|B2|||Age||years|Mean|68.1|68.1|Full Range|||42.0|87.0|
3746367|NCT01998984|3580906|B1|||Age||years|Mean|67.7|67.7|Full Range|||39.0|88.0|
3746368|NCT01998919|3580927|B3||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3746369|NCT01998919|3580928|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3746370|NCT01998919|3580929|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3746371|NCT01998919|3580927|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3746372|NCT01998919|3580928|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3746373|NCT01998919|3580929|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3746374|NCT01998919|3580927|B3|||Age||years|Mean|56.45|56.45|Standard Deviation|10.245|10.245|||
3746375|NCT01998919|3580928|B2|||Age||years|Mean|56.4|56.4|Standard Deviation|10.43|10.43|||
3746376|NCT01998919|3580929|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|10.06|10.06|||
3746377|NCT01998906|3580948|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3746378|NCT01998906|3580949|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3746379|NCT01998906|3580950|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3746380|NCT01998906|3580951|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3746381|NCT01998906|3580948|B4||Female|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
3746382|NCT01998906|3580949|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3746383|NCT01998906|3580950|B2||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3746384|NCT01998906|3580951|B1||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3746385|NCT01998906|3580948|B4|||Age||years|Mean|51.0|51.0|Standard Deviation|10.42|10.42|||
3746386|NCT01998906|3580949|B3|||Age||years|Mean|50.6|50.6|Standard Deviation|10.46|10.46|||
3746387|NCT01998906|3580950|B2|||Age||years|Mean|52.3|52.3|Standard Deviation|10.97|10.97|||
3746388|NCT01998906|3580951|B1|||Age||years|Mean|50.2|50.2|Standard Deviation|9.78|9.78|||
3746389|NCT01998893|3580997|B1|3 previous therapies||Number of previous therapies|Number of previous therapies since diagnosis of lymphoma.|participants|Number|13|13.0||||||
3746390|NCT01998893|3580997|B1|2 previous therapies||Number of previous therapies|Number of previous therapies since diagnosis of lymphoma.|participants|Number|11|11.0||||||
3746391|NCT01998893|3580997|B1|1 previous therapy||Number of previous therapies|Number of previous therapies since diagnosis of lymphoma.|participants|Number|14|14.0||||||
3746392|NCT01998893|3580997|B1|No||Other extra-nodal lesions||participants|Number|30|30.0||||||
3746393|NCT01998893|3580997|B1|Yes||Other extra-nodal lesions||participants|Number|8|8.0||||||
3746394|NCT01998893|3580997|B1|Missing||Spleen involvement||participants|Number|1|1.0||||||
3746395|NCT01998893|3580997|B1|No||Spleen involvement||participants|Number|21|21.0||||||
3746396|NCT01998893|3580997|B1|Yes||Spleen involvement||participants|Number|16|16.0||||||
3746397|NCT01998893|3580997|B1|No||Liver involvement||participants|Number|32|32.0||||||
3746398|NCT01998893|3580997|B1|Yes||Liver involvement||participants|Number|6|6.0||||||
3746399|NCT01998893|3580997|B1|No||Bone marrow involvement||participants|Number|10|10.0||||||
3746400|NCT01998893|3580997|B1|Yes||Bone marrow involvement||participants|Number|28|28.0||||||
3746401|NCT01998893|3580997|B1|No||Bulky disease|Bulky disease was defined as at least 1 lesion ≥ 5 centimeters (cm) in diameter.|participants|Number|28|28.0||||||
3746402|NCT01998893|3580997|B1|Yes||Bulky disease|Bulky disease was defined as at least 1 lesion ≥ 5 centimeters (cm) in diameter.|participants|Number|10|10.0||||||
3746403|NCT01998893|3580997|B1|Absent||B-Symptoms|B-Symptoms included high temperatures [greater than (>) 38 degrees Celsius (C)], night sweats, and unintentional weight loss >10 percent (%) over a period of 6 months or less.|participants|Number|24|24.0||||||
3746404|NCT01998893|3580997|B1|Present||B-Symptoms|B-Symptoms included high temperatures [greater than (>) 38 degrees Celsius (C)], night sweats, and unintentional weight loss >10 percent (%) over a period of 6 months or less.|participants|Number|14|14.0||||||
3746405|NCT01998893|3580997|B1|Other||Histological subtype|Histological subtype as confirmed by central pathologic review.|participants|Number|6|6.0||||||
3746406|NCT01998893|3580997|B1|Follicular or centroblastic/centrocytic lymphoma||Histological subtype|Histological subtype as confirmed by central pathologic review.|participants|Number|32|32.0||||||
3746407|NCT01998893|3580997|B1|Stage IV||Ann Arbor stage|"A staging system for lymphomas based on the location of the tumor and on systemic symptoms, ranging from stage I to stage IV.~Stage III indicated that the cancer had spread to both sides of the diaphragm, including 1 organ or area near the lymph nodes or the spleen.~Stage IV indicated diffuse or disseminated involvement of 1 or more extra-lymphatic organs, including any involvement of the liver, bone marrow, or nodular involvement of the lungs."|participants|Number|33|33.0||||||
3746408|NCT01998893|3580997|B1|Stage III||Ann Arbor stage|"A staging system for lymphomas based on the location of the tumor and on systemic symptoms, ranging from stage I to stage IV.~Stage III indicated that the cancer had spread to both sides of the diaphragm, including 1 organ or area near the lymph nodes or the spleen.~Stage IV indicated diffuse or disseminated involvement of 1 or more extra-lymphatic organs, including any involvement of the liver, bone marrow, or nodular involvement of the lungs."|participants|Number|5|5.0||||||
3746409|NCT01998893|3580997|B1|Germany||Region of Enrollment||participants|Number|38|38.0||||||
3746410|NCT01998893|3580997|B1||Unknown or Not Reported|Race (NIH/OMB)|National Institutes of Health (NIH), Office of Management and Budget (OMB)|Participants|Count of Participants|0|0.0||||||
3746411|NCT01998893|3580997|B1||More than one race|Race (NIH/OMB)|National Institutes of Health (NIH), Office of Management and Budget (OMB)|Participants|Count of Participants|0|0.0||||||
3746412|NCT01998893|3580997|B1||White|Race (NIH/OMB)|National Institutes of Health (NIH), Office of Management and Budget (OMB)|Participants|Count of Participants|38|38.0||||||
3746413|NCT01998893|3580997|B1||Black or African American|Race (NIH/OMB)|National Institutes of Health (NIH), Office of Management and Budget (OMB)|Participants|Count of Participants|0|0.0||||||
3746414|NCT01998893|3580997|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|National Institutes of Health (NIH), Office of Management and Budget (OMB)|Participants|Count of Participants|0|0.0||||||
3746415|NCT01998893|3580997|B1||Asian|Race (NIH/OMB)|National Institutes of Health (NIH), Office of Management and Budget (OMB)|Participants|Count of Participants|0|0.0||||||
3746416|NCT01998893|3580997|B1||American Indian or Alaska Native|Race (NIH/OMB)|National Institutes of Health (NIH), Office of Management and Budget (OMB)|Participants|Count of Participants|0|0.0||||||
3746417|NCT01998893|3580997|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3746418|NCT01998893|3580997|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3746419|NCT01998893|3580997|B1|Greater Than or Equal to (≥) 65 Years||Age, Customized||participants|Number|6|6.0||||||
3746420|NCT01998893|3580997|B1|Between 18 and 65 Years||Age, Customized||participants|Number|32|32.0||||||
3746421|NCT01998893|3580997|B1|Less Than or Equal to (≤) 18 Years||Age, Customized||participants|Number|0|0.0||||||
3746422|NCT01998893|3580997|B1|||Age||years|Median|55|55.0|Full Range|||26.0|75.0|
3746423|NCT01998880|3581007|B3||Male|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
3746424|NCT01998880|3581008|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3746425|NCT01998880|3581009|B1||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3746426|NCT01998880|3581007|B3||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3746427|NCT01998880|3581008|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3746428|NCT01998880|3581009|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3746429|NCT01998880|3581007|B3|>=65 years||Age, Customized||participants|Number|278|278.0||||||
3746430|NCT01998880|3581008|B2|>=65 years||Age, Customized||participants|Number|92|92.0||||||
3746431|NCT01998880|3581009|B1|>=65 years||Age, Customized||participants|Number|186|186.0||||||
3746432|NCT01998880|3581007|B3|<65 years||Age, Customized||participants|Number|73|73.0||||||
3746433|NCT01998880|3581008|B2|<65 years||Age, Customized||participants|Number|26|26.0||||||
3746434|NCT01998880|3581009|B1|<65 years||Age, Customized||participants|Number|47|47.0||||||
3746435|NCT01998737|3581040|B3|||Height||cm|Mean|161.5|161.5|Standard Deviation|6.1|6.1|||
3746436|NCT01998737|3581041|B2|||Height||cm|Mean|162.3|162.3|Standard Deviation|6.1|6.1|||
3746437|NCT01998737|3581042|B1|||Height||cm|Mean|161.5|161.5|Standard Deviation|6.1|6.1|||
3746438|NCT01998737|3581040|B3|||Weight||kg|Mean|64.4|64.4|Standard Deviation|9.9|9.9|||
3746439|NCT01998737|3581041|B2|||Weight||kg|Mean|65.5|65.5|Standard Deviation|9.2|9.2|||
3746440|NCT01998737|3581042|B1|||Weight||kg|Mean|64.2|64.2|Standard Deviation|9.9|9.9|||
3746441|NCT01998737|3581040|B3|Finland||Region of Enrollment||participants|Number|988|988.0||||||
3746442|NCT01998737|3581041|B2|Finland||Region of Enrollment||participants|Number|100|100.0||||||
3746443|NCT01998737|3581042|B1|Finland||Region of Enrollment||participants|Number|888|888.0||||||
3746444|NCT01998737|3581040|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|988|988.0||||||
3746445|NCT01998737|3581041|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|100|100.0||||||
3746446|NCT01998737|3581042|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|888|888.0||||||
3746447|NCT01998737|3581040|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3746448|NCT01998737|3581041|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3746449|NCT01998737|3581042|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3746450|NCT01998737|3581040|B3||Female|Sex: Female, Male||Participants|Count of Participants|988|988.0||||||
3746451|NCT01998737|3581041|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3746452|NCT01998737|3581042|B1||Female|Sex: Female, Male||Participants|Count of Participants|888|888.0||||||
3746453|NCT01998737|3581040|B3|||Age||years|Mean|64.9|64.9|Standard Deviation|7.0|7.0|||
3746454|NCT01998737|3581041|B2|||Age||years|Mean|61.6|61.6|Standard Deviation|6.6|6.6|||
3746455|NCT01998737|3581042|B1|||Age||years|Mean|65.3|65.3|Standard Deviation|7|7.0|||
3746456|NCT01998737|3581040|B3||>=65 years|Age||Participants|Count of Participants|461|461.0||||||
3746457|NCT01998737|3581041|B2||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
3746458|NCT01998737|3581042|B1||>=65 years|Age||Participants|Count of Participants|435|435.0||||||
3746459|NCT01998737|3581040|B3||Between 18 and 65 years|Age||Participants|Count of Participants|527|527.0||||||
3746460|NCT01998737|3581041|B2||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
3746461|NCT01998737|3581042|B1||Between 18 and 65 years|Age||Participants|Count of Participants|453|453.0||||||
3746462|NCT01998737|3581040|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3746463|NCT01998737|3581041|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3746464|NCT01998737|3581042|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3746465|NCT01998633|3581053|B3||1 HLA Locus Mismatched Unrelated|Donor Type|HLA matching and relatedness of donor to recipient|Participants|Count of Participants|13|13.0||||||
3746466|NCT01998633|3581054|B2||1 HLA Locus Mismatched Unrelated|Donor Type|HLA matching and relatedness of donor to recipient|Participants|Count of Participants|2|2.0||||||
3746467|NCT01998633|3581055|B1||1 HLA Locus Mismatched Unrelated|Donor Type|HLA matching and relatedness of donor to recipient|Participants|Count of Participants|11|11.0||||||
3746468|NCT01998633|3581053|B3||HLA Matched Unrelated|Donor Type|HLA matching and relatedness of donor to recipient|Participants|Count of Participants|25|25.0||||||
3746469|NCT01998633|3581054|B2||HLA Matched Unrelated|Donor Type|HLA matching and relatedness of donor to recipient|Participants|Count of Participants|9|9.0||||||
3746470|NCT01998633|3581055|B1||HLA Matched Unrelated|Donor Type|HLA matching and relatedness of donor to recipient|Participants|Count of Participants|16|16.0||||||
3746471|NCT01998633|3581053|B3||1 HLA Locus Mismatched Relative|Donor Type|HLA matching and relatedness of donor to recipient|Participants|Count of Participants|1|1.0||||||
3746472|NCT01998633|3581054|B2||1 HLA Locus Mismatched Relative|Donor Type|HLA matching and relatedness of donor to recipient|Participants|Count of Participants|1|1.0||||||
3746473|NCT01998633|3581055|B1||1 HLA Locus Mismatched Relative|Donor Type|HLA matching and relatedness of donor to recipient|Participants|Count of Participants|0|0.0||||||
3746474|NCT01998633|3581053|B3||HLA Matched Sibling|Donor Type|HLA matching and relatedness of donor to recipient|Participants|Count of Participants|7|7.0||||||
3746475|NCT01998633|3581054|B2||HLA Matched Sibling|Donor Type|HLA matching and relatedness of donor to recipient|Participants|Count of Participants|0|0.0||||||
3746476|NCT01998633|3581055|B1||HLA Matched Sibling|Donor Type|HLA matching and relatedness of donor to recipient|Participants|Count of Participants|7|7.0||||||
3746477|NCT01998633|3581053|B3||IPEX|Primary Immune Deficiency Type||Participants|Count of Participants|2|2.0||||||
3746478|NCT01998633|3581054|B2||IPEX|Primary Immune Deficiency Type||Participants|Count of Participants|2|2.0||||||
3746479|NCT01998633|3581053|B3||Hyperimmunoglobulin M Syndrome|Primary Immune Deficiency Type||Participants|Count of Participants|2|2.0||||||
3746480|NCT01998633|3581054|B2||Hyperimmunoglobulin M Syndrome|Primary Immune Deficiency Type||Participants|Count of Participants|2|2.0||||||
3746481|NCT01998633|3581053|B3||Chronic Granulomatous Disease|Primary Immune Deficiency Type||Participants|Count of Participants|5|5.0||||||
3746482|NCT01998633|3581054|B2||Chronic Granulomatous Disease|Primary Immune Deficiency Type||Participants|Count of Participants|5|5.0||||||
3746483|NCT01998633|3581053|B3||Chronic Active Epstein-Barr Virus|Primary Immune Deficiency Type||Participants|Count of Participants|3|3.0||||||
3746484|NCT01998633|3581054|B2||Chronic Active Epstein-Barr Virus|Primary Immune Deficiency Type||Participants|Count of Participants|3|3.0||||||
3746485|NCT01998633|3581053|B3||50|Karnofsky Performance Score (KPS)|"KPS describes patient-perceived global quality of life and functioning on a scale of 0-100.~100: No evidence of disease; 90: Normal activity. Minor signs or symptoms of disease; 80: Normal activity with effort. Some signs or symptoms of disease; 70: Cares for self. Unable to continue normal activity; 60: Needs occasional assistance, but cares for most personal needs; 50: Needs considerable assistance and medical care; 40: Disabled. Needs special care and assistance; 30: Severely disabled. Hospital admission indicated; 20: Very sick. Active supportive therapy needed; 10: Moribund; 0: Dead"|Participants|Count of Participants|1|1.0||||||
3746486|NCT01998633|3581054|B2||50|Karnofsky Performance Score (KPS)|"KPS describes patient-perceived global quality of life and functioning on a scale of 0-100.~100: No evidence of disease; 90: Normal activity. Minor signs or symptoms of disease; 80: Normal activity with effort. Some signs or symptoms of disease; 70: Cares for self. Unable to continue normal activity; 60: Needs occasional assistance, but cares for most personal needs; 50: Needs considerable assistance and medical care; 40: Disabled. Needs special care and assistance; 30: Severely disabled. Hospital admission indicated; 20: Very sick. Active supportive therapy needed; 10: Moribund; 0: Dead"|Participants|Count of Participants|0|0.0||||||
3746487|NCT01998633|3581055|B1||50|Karnofsky Performance Score (KPS)|"KPS describes patient-perceived global quality of life and functioning on a scale of 0-100.~100: No evidence of disease; 90: Normal activity. Minor signs or symptoms of disease; 80: Normal activity with effort. Some signs or symptoms of disease; 70: Cares for self. Unable to continue normal activity; 60: Needs occasional assistance, but cares for most personal needs; 50: Needs considerable assistance and medical care; 40: Disabled. Needs special care and assistance; 30: Severely disabled. Hospital admission indicated; 20: Very sick. Active supportive therapy needed; 10: Moribund; 0: Dead"|Participants|Count of Participants|1|1.0||||||
3746488|NCT01998633|3581053|B3||60|Karnofsky Performance Score (KPS)|"KPS describes patient-perceived global quality of life and functioning on a scale of 0-100.~100: No evidence of disease; 90: Normal activity. Minor signs or symptoms of disease; 80: Normal activity with effort. Some signs or symptoms of disease; 70: Cares for self. Unable to continue normal activity; 60: Needs occasional assistance, but cares for most personal needs; 50: Needs considerable assistance and medical care; 40: Disabled. Needs special care and assistance; 30: Severely disabled. Hospital admission indicated; 20: Very sick. Active supportive therapy needed; 10: Moribund; 0: Dead"|Participants|Count of Participants|1|1.0||||||
3746489|NCT01998633|3581054|B2||60|Karnofsky Performance Score (KPS)|"KPS describes patient-perceived global quality of life and functioning on a scale of 0-100.~100: No evidence of disease; 90: Normal activity. Minor signs or symptoms of disease; 80: Normal activity with effort. Some signs or symptoms of disease; 70: Cares for self. Unable to continue normal activity; 60: Needs occasional assistance, but cares for most personal needs; 50: Needs considerable assistance and medical care; 40: Disabled. Needs special care and assistance; 30: Severely disabled. Hospital admission indicated; 20: Very sick. Active supportive therapy needed; 10: Moribund; 0: Dead"|Participants|Count of Participants|0|0.0||||||
3746490|NCT01998633|3581055|B1||60|Karnofsky Performance Score (KPS)|"KPS describes patient-perceived global quality of life and functioning on a scale of 0-100.~100: No evidence of disease; 90: Normal activity. Minor signs or symptoms of disease; 80: Normal activity with effort. Some signs or symptoms of disease; 70: Cares for self. Unable to continue normal activity; 60: Needs occasional assistance, but cares for most personal needs; 50: Needs considerable assistance and medical care; 40: Disabled. Needs special care and assistance; 30: Severely disabled. Hospital admission indicated; 20: Very sick. Active supportive therapy needed; 10: Moribund; 0: Dead"|Participants|Count of Participants|1|1.0||||||
3746491|NCT01998633|3581053|B3||70|Karnofsky Performance Score (KPS)|"KPS describes patient-perceived global quality of life and functioning on a scale of 0-100.~100: No evidence of disease; 90: Normal activity. Minor signs or symptoms of disease; 80: Normal activity with effort. Some signs or symptoms of disease; 70: Cares for self. Unable to continue normal activity; 60: Needs occasional assistance, but cares for most personal needs; 50: Needs considerable assistance and medical care; 40: Disabled. Needs special care and assistance; 30: Severely disabled. Hospital admission indicated; 20: Very sick. Active supportive therapy needed; 10: Moribund; 0: Dead"|Participants|Count of Participants|2|2.0||||||
3746514|NCT01998633|3581055|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746515|NCT01998633|3581053|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3746516|NCT01998633|3581054|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746492|NCT01998633|3581054|B2||70|Karnofsky Performance Score (KPS)|"KPS describes patient-perceived global quality of life and functioning on a scale of 0-100.~100: No evidence of disease; 90: Normal activity. Minor signs or symptoms of disease; 80: Normal activity with effort. Some signs or symptoms of disease; 70: Cares for self. Unable to continue normal activity; 60: Needs occasional assistance, but cares for most personal needs; 50: Needs considerable assistance and medical care; 40: Disabled. Needs special care and assistance; 30: Severely disabled. Hospital admission indicated; 20: Very sick. Active supportive therapy needed; 10: Moribund; 0: Dead"|Participants|Count of Participants|0|0.0||||||
3746493|NCT01998633|3581055|B1||70|Karnofsky Performance Score (KPS)|"KPS describes patient-perceived global quality of life and functioning on a scale of 0-100.~100: No evidence of disease; 90: Normal activity. Minor signs or symptoms of disease; 80: Normal activity with effort. Some signs or symptoms of disease; 70: Cares for self. Unable to continue normal activity; 60: Needs occasional assistance, but cares for most personal needs; 50: Needs considerable assistance and medical care; 40: Disabled. Needs special care and assistance; 30: Severely disabled. Hospital admission indicated; 20: Very sick. Active supportive therapy needed; 10: Moribund; 0: Dead"|Participants|Count of Participants|2|2.0||||||
3746494|NCT01998633|3581053|B3||80|Karnofsky Performance Score (KPS)|"KPS describes patient-perceived global quality of life and functioning on a scale of 0-100.~100: No evidence of disease; 90: Normal activity. Minor signs or symptoms of disease; 80: Normal activity with effort. Some signs or symptoms of disease; 70: Cares for self. Unable to continue normal activity; 60: Needs occasional assistance, but cares for most personal needs; 50: Needs considerable assistance and medical care; 40: Disabled. Needs special care and assistance; 30: Severely disabled. Hospital admission indicated; 20: Very sick. Active supportive therapy needed; 10: Moribund; 0: Dead"|Participants|Count of Participants|8|8.0||||||
3746495|NCT01998633|3581054|B2||80|Karnofsky Performance Score (KPS)|"KPS describes patient-perceived global quality of life and functioning on a scale of 0-100.~100: No evidence of disease; 90: Normal activity. Minor signs or symptoms of disease; 80: Normal activity with effort. Some signs or symptoms of disease; 70: Cares for self. Unable to continue normal activity; 60: Needs occasional assistance, but cares for most personal needs; 50: Needs considerable assistance and medical care; 40: Disabled. Needs special care and assistance; 30: Severely disabled. Hospital admission indicated; 20: Very sick. Active supportive therapy needed; 10: Moribund; 0: Dead"|Participants|Count of Participants|2|2.0||||||
3746496|NCT01998633|3581055|B1||80|Karnofsky Performance Score (KPS)|"KPS describes patient-perceived global quality of life and functioning on a scale of 0-100.~100: No evidence of disease; 90: Normal activity. Minor signs or symptoms of disease; 80: Normal activity with effort. Some signs or symptoms of disease; 70: Cares for self. Unable to continue normal activity; 60: Needs occasional assistance, but cares for most personal needs; 50: Needs considerable assistance and medical care; 40: Disabled. Needs special care and assistance; 30: Severely disabled. Hospital admission indicated; 20: Very sick. Active supportive therapy needed; 10: Moribund; 0: Dead"|Participants|Count of Participants|6|6.0||||||
3746497|NCT01998633|3581053|B3||90-100|Karnofsky Performance Score (KPS)|"KPS describes patient-perceived global quality of life and functioning on a scale of 0-100.~100: No evidence of disease; 90: Normal activity. Minor signs or symptoms of disease; 80: Normal activity with effort. Some signs or symptoms of disease; 70: Cares for self. Unable to continue normal activity; 60: Needs occasional assistance, but cares for most personal needs; 50: Needs considerable assistance and medical care; 40: Disabled. Needs special care and assistance; 30: Severely disabled. Hospital admission indicated; 20: Very sick. Active supportive therapy needed; 10: Moribund; 0: Dead"|Participants|Count of Participants|34|34.0||||||
3746498|NCT01998633|3581054|B2||90-100|Karnofsky Performance Score (KPS)|"KPS describes patient-perceived global quality of life and functioning on a scale of 0-100.~100: No evidence of disease; 90: Normal activity. Minor signs or symptoms of disease; 80: Normal activity with effort. Some signs or symptoms of disease; 70: Cares for self. Unable to continue normal activity; 60: Needs occasional assistance, but cares for most personal needs; 50: Needs considerable assistance and medical care; 40: Disabled. Needs special care and assistance; 30: Severely disabled. Hospital admission indicated; 20: Very sick. Active supportive therapy needed; 10: Moribund; 0: Dead"|Participants|Count of Participants|10|10.0||||||
3746499|NCT01998633|3581055|B1||90-100|Karnofsky Performance Score (KPS)|"KPS describes patient-perceived global quality of life and functioning on a scale of 0-100.~100: No evidence of disease; 90: Normal activity. Minor signs or symptoms of disease; 80: Normal activity with effort. Some signs or symptoms of disease; 70: Cares for self. Unable to continue normal activity; 60: Needs occasional assistance, but cares for most personal needs; 50: Needs considerable assistance and medical care; 40: Disabled. Needs special care and assistance; 30: Severely disabled. Hospital admission indicated; 20: Very sick. Active supportive therapy needed; 10: Moribund; 0: Dead"|Participants|Count of Participants|24|24.0||||||
3746500|NCT01998633|3581053|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3746501|NCT01998633|3581054|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3746502|NCT01998633|3581055|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3746503|NCT01998633|3581053|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746504|NCT01998633|3581054|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746505|NCT01998633|3581055|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746506|NCT01998633|3581053|B3||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3746507|NCT01998633|3581054|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3746508|NCT01998633|3581055|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3746509|NCT01998633|3581053|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3746510|NCT01998633|3581054|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3746511|NCT01998633|3581055|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3746512|NCT01998633|3581053|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746513|NCT01998633|3581054|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746517|NCT01998633|3581055|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3746518|NCT01998633|3581053|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746519|NCT01998633|3581054|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746520|NCT01998633|3581055|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746521|NCT01998633|3581053|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3746522|NCT01998633|3581054|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3746523|NCT01998633|3581055|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3746524|NCT01998633|3581053|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3746525|NCT01998633|3581054|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3746526|NCT01998633|3581055|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3746527|NCT01998633|3581053|B3||20-29 Years|Age, Customized||Participants|Count of Participants|3|3.0||||||
3746528|NCT01998633|3581054|B2||20-29 Years|Age, Customized||Participants|Count of Participants|2|2.0||||||
3746529|NCT01998633|3581055|B1||20-29 Years|Age, Customized||Participants|Count of Participants|1|1.0||||||
3746530|NCT01998633|3581053|B3||10-19 Years|Age, Customized||Participants|Count of Participants|9|9.0||||||
3746531|NCT01998633|3581054|B2||10-19 Years|Age, Customized||Participants|Count of Participants|2|2.0||||||
3746532|NCT01998633|3581055|B1||10-19 Years|Age, Customized||Participants|Count of Participants|7|7.0||||||
3746533|NCT01998633|3581053|B3||0-9 Years|Age, Customized||Participants|Count of Participants|34|34.0||||||
3746534|NCT01998633|3581054|B2||0-9 Years|Age, Customized||Participants|Count of Participants|8|8.0||||||
3746535|NCT01998633|3581055|B1||0-9 Years|Age, Customized||Participants|Count of Participants|26|26.0||||||
3746536|NCT01998581|3581071|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3746537|NCT01998581|3581072|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3746538|NCT01998581|3581073|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3746539|NCT01998581|3581071|B3||Female|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
3746540|NCT01998581|3581072|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3746541|NCT01998581|3581073|B1||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3746542|NCT01998581|3581071|B3|>65 years||Age, Customized||Participants|Number|21|21.0||||||
3746543|NCT01998581|3581072|B2|>65 years||Age, Customized||Participants|Number|5|5.0||||||
3746544|NCT01998581|3581073|B1|>65 years||Age, Customized||Participants|Number|16|16.0||||||
3746545|NCT01998581|3581071|B3|51 to 65 years||Age, Customized||Participants|Number|121|121.0||||||
3746546|NCT01998581|3581072|B2|51 to 65 years||Age, Customized||Participants|Number|33|33.0||||||
3746547|NCT01998581|3581073|B1|51 to 65 years||Age, Customized||Participants|Number|88|88.0||||||
3746548|NCT01998581|3581071|B3|30 to 50 years||Age, Customized||Participants|Number|74|74.0||||||
3746549|NCT01998581|3581072|B2|30 to 50 years||Age, Customized||Participants|Number|17|17.0||||||
3746550|NCT01998581|3581073|B1|30 to 50 years||Age, Customized||Participants|Number|57|57.0||||||
3746551|NCT01998581|3581071|B3|<30 year||Age, Customized||Participants|Number|8|8.0||||||
3746552|NCT01998581|3581072|B2|<30 year||Age, Customized||Participants|Number|1|1.0||||||
3746553|NCT01998581|3581073|B1|<30 year||Age, Customized||Participants|Number|7|7.0||||||
3746554|NCT01998477|3581084|B3||MALE|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
3746555|NCT01998477|3581085|B2||MALE|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3746556|NCT01998477|3581086|B1||MALE|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3746557|NCT01998477|3581084|B3||FEMALE|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3746558|NCT01998477|3581085|B2||FEMALE|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3746559|NCT01998477|3581086|B1||FEMALE|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3746560|NCT01998477|3581084|B3|||Age||year|Mean|8.8|8.8|Standard Deviation|4.0|4.0|||
3746561|NCT01998477|3581085|B2|||Age||year|Mean|9.0|9.0|Standard Deviation|3.9|3.9|||
3746562|NCT01998477|3581086|B1|||Age||year|Mean|8.7|8.7|Standard Deviation|4.0|4.0|||
3746563|NCT01998438|3581118|B4||Male|Sex: Female, Male||Participants|Count of Participants|542|542.0||||||
3746564|NCT01998438|3581119|B3||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3746565|NCT01998438|3581120|B2||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3746566|NCT01998438|3581121|B1||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3746567|NCT01998438|3581118|B4||Female|Sex: Female, Male||Participants|Count of Participants|413|413.0||||||
3746568|NCT01998438|3581119|B3||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3746569|NCT01998438|3581120|B2||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3746570|NCT01998438|3581121|B1||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3746571|NCT01998438|3581118|B4|||Age||years|Mean|53.1|53.1|Standard Deviation|11.4|11.4|||
3746572|NCT01998438|3581119|B3|||Age||years|Mean|53.1|53.1|Standard Deviation|11.6|11.6|||
3746573|NCT01998438|3581120|B2|||Age||years|Mean|53.2|53.2|Standard Deviation|11.8|11.8|||
3746574|NCT01998438|3581121|B1|||Age||years|Mean|53.1|53.1|Standard Deviation|10.9|10.9|||
3746575|NCT01998399|3581131|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
3746576|NCT01998399|3581132|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3746577|NCT01998399|3581133|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3746578|NCT01998399|3581131|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3746579|NCT01998399|3581132|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3746580|NCT01998399|3581133|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3746581|NCT01998399|3581131|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3746582|NCT01998399|3581132|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3746583|NCT01998399|3581133|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3746584|NCT01998399|3581131|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3746585|NCT01998399|3581132|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3746586|NCT01998399|3581133|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3746587|NCT01998399|3581131|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3746588|NCT01998399|3581132|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3746589|NCT01998399|3581133|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3746590|NCT01998399|3581131|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3746591|NCT01998399|3581132|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3746592|NCT01998399|3581133|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3746593|NCT01998360|3581166|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3746594|NCT01998360|3581167|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3746595|NCT01998360|3581168|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3746596|NCT01998360|3581166|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3746597|NCT01998360|3581167|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3746598|NCT01998360|3581168|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3746599|NCT01998360|3581166|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3746600|NCT01998360|3581167|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3746601|NCT01998360|3581168|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3746602|NCT01998360|3581166|B3||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
3746603|NCT01998360|3581167|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3746604|NCT01998360|3581168|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3746605|NCT01998360|3581166|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3746606|NCT01998360|3581167|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3746607|NCT01998360|3581168|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3746608|NCT01998269|3581183|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3746609|NCT01998269|3581183|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746610|NCT01998269|3581183|B1||White|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3746611|NCT01998269|3581183|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
3746612|NCT01998269|3581183|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746613|NCT01998269|3581183|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746614|NCT01998269|3581183|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746615|NCT01998269|3581183|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3746616|NCT01998269|3581183|B1||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3746617|NCT01998269|3581183|B1|||Age||years|Mean|61.1|61.1|Full Range|||28.0|94.0|
3746618|NCT01997905|3581187|B1|||HAS-BLED Score|A risk score to estimate the one year risk of major bleeding (i.e. intracranial, requiring hospitalization, hemoglobin decrease> 2g/L, and/or transfusion) in patients with atrial fibrillation. HAS-BLED score can range from 0 to 9 points, depending upon the number of risk factors for a given patient. HAS-BLED includes the following factors: Hypertension, Abnormal Kidney and/or Liver Function, Stroke (previous history of stroke, especially deep brain (lacunar) stroke), Bleeding, Labile INR, Elderly (>65 years) and Drugs and/or alcohol. The higher the score, the higher the risk of bleeding.|units on a scale|Mean|3.6|3.6|Standard Deviation|0.70|0.7|||
3746619|NCT01997905|3581187|B1|||CHA2DSVAS Score|CHA2DS2-VASc included additional 'stroke risk modifier' risk factors to the CHADS2. CHA2DS2-VASc score was extended to include: age 65-74, female gender and vascular disease. In the CHA2DS2-VASc score, 'age 75 and above' also has extra weight, with 2 points. The maximum CHA2DS2-VASc score is 9 (for age, either the patient is ≥75 years and gets two points, is between 65-74 and gets one point, or is under 65 and get no point). The higher the CHA2DS2-VASc score, the higher the stroke risk.|units on a scale|Mean|4.6|4.6|Standard Deviation|0.84|0.84|||
3746620|NCT01997905|3581187|B1|||CHADS2 Score|CHADS2 is based on the following: Congestive Heart Failure, Hypertension, Age (75 years or older), Diabetes Mellitus, and Stroke (history of stroke or transient ischemic attack). For each factor that is present, the patient receives one point for a total of 6 points. The higher the CHADS2 score the higher the stroke risk.|units on a scale|Mean|2.9|2.9|Standard Deviation|0.88|0.88|||
3746621|NCT01997905|3581187|B1|Not Reported||NYHA Functional Class|Doctors usually classify patients' heart failure according to the severity of their symptoms. The table below describes the most commonly used classification system, the New York Heart Association (NYHA) Functional Classification. It places patients in one of four categories based on how much they are limited during physical activity(http://www.heart.org/HEARTORG/Conditions/HeartFailure/AboutHeartFailure/Classes-of-Heart-Failure_UCM_306328_Article.jsp#.V8WM3md4epo). The higher the category, the more severe the symptoms.|participants|Number|1|1.0||||||
3746660|NCT01997437|3581235|B1|Russian Federation||Region of Enrollment||participants|Number|5|5.0||||||
3746661|NCT01997437|3581235|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3746662|NCT01997437|3581235|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3746663|NCT01997437|3581235|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3746622|NCT01997905|3581187|B1|No Heart Block||NYHA Functional Class|Doctors usually classify patients' heart failure according to the severity of their symptoms. The table below describes the most commonly used classification system, the New York Heart Association (NYHA) Functional Classification. It places patients in one of four categories based on how much they are limited during physical activity(http://www.heart.org/HEARTORG/Conditions/HeartFailure/AboutHeartFailure/Classes-of-Heart-Failure_UCM_306328_Article.jsp#.V8WM3md4epo). The higher the category, the more severe the symptoms.|participants|Number|1|1.0||||||
3746623|NCT01997905|3581187|B1|IV (Severe limitations)||NYHA Functional Class|Doctors usually classify patients' heart failure according to the severity of their symptoms. The table below describes the most commonly used classification system, the New York Heart Association (NYHA) Functional Classification. It places patients in one of four categories based on how much they are limited during physical activity(http://www.heart.org/HEARTORG/Conditions/HeartFailure/AboutHeartFailure/Classes-of-Heart-Failure_UCM_306328_Article.jsp#.V8WM3md4epo). The higher the category, the more severe the symptoms.|participants|Number|0|0.0||||||
3746624|NCT01997905|3581187|B1|III (Marked limitation)||NYHA Functional Class|Doctors usually classify patients' heart failure according to the severity of their symptoms. The table below describes the most commonly used classification system, the New York Heart Association (NYHA) Functional Classification. It places patients in one of four categories based on how much they are limited during physical activity(http://www.heart.org/HEARTORG/Conditions/HeartFailure/AboutHeartFailure/Classes-of-Heart-Failure_UCM_306328_Article.jsp#.V8WM3md4epo). The higher the category, the more severe the symptoms.|participants|Number|0|0.0||||||
3746625|NCT01997905|3581187|B1|II (Mild symptoms and slight limitation)||NYHA Functional Class|Doctors usually classify patients' heart failure according to the severity of their symptoms. The table below describes the most commonly used classification system, the New York Heart Association (NYHA) Functional Classification. It places patients in one of four categories based on how much they are limited during physical activity(http://www.heart.org/HEARTORG/Conditions/HeartFailure/AboutHeartFailure/Classes-of-Heart-Failure_UCM_306328_Article.jsp#.V8WM3md4epo). The higher the category, the more severe the symptoms.|participants|Number|3|3.0||||||
3746626|NCT01997905|3581187|B1|I (No symptoms and no limitations)||NYHA Functional Class|Doctors usually classify patients' heart failure according to the severity of their symptoms. The table below describes the most commonly used classification system, the New York Heart Association (NYHA) Functional Classification. It places patients in one of four categories based on how much they are limited during physical activity(http://www.heart.org/HEARTORG/Conditions/HeartFailure/AboutHeartFailure/Classes-of-Heart-Failure_UCM_306328_Article.jsp#.V8WM3md4epo). The higher the category, the more severe the symptoms.|participants|Number|6|6.0||||||
3746627|NCT01997905|3581187|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746628|NCT01997905|3581187|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746629|NCT01997905|3581187|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3746630|NCT01997905|3581187|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746631|NCT01997905|3581187|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746632|NCT01997905|3581187|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746633|NCT01997905|3581187|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746634|NCT01997905|3581187|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746635|NCT01997905|3581187|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3746636|NCT01997905|3581187|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3746637|NCT01997905|3581187|B1||Male|Gender||Participants|Count of Participants|7|7.0||||||
3746638|NCT01997905|3581187|B1||Female|Gender||Participants|Count of Participants|4|4.0||||||
3746639|NCT01997905|3581187|B1|||Age||Years|Mean|72|72.0|Standard Deviation|8.85|8.85|||
3746640|NCT01997905|3581187|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3746641|NCT01997905|3581187|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3746642|NCT01997905|3581187|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3746643|NCT01997892|3581196|B1||Male|Sex: Female, Male||Participants|Count of Participants|441|441.0||||||
3746644|NCT01997892|3581196|B1||Female|Sex: Female, Male||Participants|Count of Participants|344|344.0||||||
3746645|NCT01997892|3581196|B1|||Age||years|Mean|68.7|68.7|Standard Deviation|14.3|14.3|||
3746646|NCT01997723|3581208|B1|||Education less than or equal to high school|26/75 had </=high school education and 49/75 had one or more years of college education.|participants|Number|26|26.0||||||
3746647|NCT01997723|3581208|B1|||Household income less than $50,000 per year|57/75 had household income < $50,000 per annum and 18 had household income >/= $50,000 per annum|participants|Number|57|57.0||||||
3746648|NCT01997723|3581208|B1|||employed|36/75 were employed, 39/75 were umemployed.|participants|Number|36|36.0||||||
3746649|NCT01997723|3581208|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746650|NCT01997723|3581208|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746651|NCT01997723|3581208|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746652|NCT01997723|3581208|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3746653|NCT01997723|3581208|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746654|NCT01997723|3581208|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746655|NCT01997723|3581208|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746656|NCT01997723|3581208|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3746657|NCT01997723|3581208|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3746658|NCT01997723|3581208|B1|||Age||years|Mean|44|44.0|Standard Deviation|10.6|10.6|||
3746659|NCT01997437|3581235|B1|Jordan||Region of Enrollment||participants|Number|1|1.0||||||
3746664|NCT01997437|3581235|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3746665|NCT01997437|3581235|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3746666|NCT01997437|3581235|B1|||Age||years|Mean|33|33.0|Full Range|||28.0|41.0|
3746667|NCT01997411|3581242|B6|||Duration of Diabetes||years|Median|3.9|3.9|Inter-Quartile Range|||2.6|6.0|
3746668|NCT01997411|3581243|B5|||Duration of Diabetes||years|Median|5.9|5.9|Inter-Quartile Range|||3.5|8.0|
3746669|NCT01997411|3581244|B4|||Duration of Diabetes||years|Median|4.3|4.3|Inter-Quartile Range|||3.4|6.7|
3746670|NCT01997411|3581245|B3|||Duration of Diabetes||years|Median|5.3|5.3|Inter-Quartile Range|||3.9|6.3|
3746671|NCT01997411|3581246|B2|||Duration of Diabetes||years|Median|2.7|2.7|Inter-Quartile Range|||1.8|3.6|
3746672|NCT01997411|3581247|B1|||Duration of Diabetes||years|Median|3.1|3.1|Inter-Quartile Range|||2.1|3.8|
3746673|NCT01997411|3581242|B6|||Local HbA1c||percent|Mean|8.0|8.0|Standard Deviation|1.0|1.0|||
3746674|NCT01997411|3581243|B5|||Local HbA1c||percent|Mean|8.2|8.2|Standard Deviation|1.5|1.5|||
3746675|NCT01997411|3581244|B4|||Local HbA1c||percent|Mean|8.1|8.1|Standard Deviation|0.7|0.7|||
3746676|NCT01997411|3581245|B3|||Local HbA1c||percent|Mean|7.5|7.5|Standard Deviation|1.1|1.1|||
3746677|NCT01997411|3581246|B2|||Local HbA1c||percent|Mean|8.3|8.3|Standard Deviation|0.8|0.8|||
3746678|NCT01997411|3581247|B1|||Local HbA1c||percent|Mean|7.6|7.6|Standard Deviation|0.5|0.5|||
3746679|NCT01997411|3581242|B6|United States||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
3746680|NCT01997411|3581243|B5|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3746681|NCT01997411|3581244|B4|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3746682|NCT01997411|3581245|B3|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3746683|NCT01997411|3581246|B2|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3746684|NCT01997411|3581247|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3746685|NCT01997411|3581242|B6||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3746686|NCT01997411|3581243|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3746687|NCT01997411|3581244|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3746688|NCT01997411|3581245|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3746689|NCT01997411|3581246|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3746690|NCT01997411|3581247|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3746691|NCT01997411|3581242|B6||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3746692|NCT01997411|3581243|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3746693|NCT01997411|3581244|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3746694|NCT01997411|3581245|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3746695|NCT01997411|3581246|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3746696|NCT01997411|3581247|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3746697|NCT01997411|3581242|B6|||Age||years|Median|10.6|10.6|Inter-Quartile Range|||7.4|12.2|
3746698|NCT01997411|3581243|B5|||Age||years|Median|14.5|14.5|Inter-Quartile Range|||13.2|15.8|
3746699|NCT01997411|3581244|B4|||Age||years|Median|11.1|11.1|Inter-Quartile Range|||10.5|11.8|
3746700|NCT01997411|3581245|B3|||Age||years|Median|11.1|11.1|Inter-Quartile Range|||10.5|11.8|
3746701|NCT01997411|3581246|B2|||Age||years|Median|6.8|6.8|Inter-Quartile Range|||5.7|7.5|
3746702|NCT01997411|3581247|B1|||Age||years|Median|6.8|6.8|Inter-Quartile Range|||5.7|7.5|
3746703|NCT01997398|3581344|B1|||Average duration of Parkinson's disease||years|Mean|10.7|10.7|Standard Deviation|10|10.0|||
3746704|NCT01997398|3581344|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3746705|NCT01997398|3581344|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3746706|NCT01997398|3581344|B1|||Age||years|Mean|61.1|61.1|Standard Deviation|10|10.0|||
3746707|NCT01997229|3581353|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3746708|NCT01997229|3581354|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3746709|NCT01997229|3581355|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3746710|NCT01997229|3581353|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3746711|NCT01997229|3581354|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3746712|NCT01997229|3581355|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3746713|NCT01997229|3581353|B3|||Age||years|Mean|47.2|47.2|Standard Deviation|16.80|16.8|||
3746714|NCT01997229|3581354|B2|||Age||years|Mean|46.9|46.9|Standard Deviation|17.98|17.98|||
3746715|NCT01997229|3581355|B1|||Age||years|Mean|47.5|47.5|Standard Deviation|15.66|15.66|||
3746716|NCT01997216|3581362|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3746717|NCT01997216|3581362|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3746718|NCT01997216|3581362|B1|||Age||years|Mean|52.1|52.1|Standard Deviation|6.0|6.0|||
3746719|NCT01996904|3581373|B3|Korea, Republic of||Region of Enrollment||participants|Number|191|191.0||||||
3746720|NCT01996904|3581374|B2|Korea, Republic of||Region of Enrollment||participants|Number|90|90.0||||||
3746721|NCT01996904|3581375|B1|Korea, Republic of||Region of Enrollment||participants|Number|101|101.0||||||
3746722|NCT01996904|3581373|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3746723|NCT01996904|3581374|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3746724|NCT01996904|3581375|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3746725|NCT01996904|3581373|B3||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3746726|NCT01996904|3581374|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3746727|NCT01996904|3581375|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3746728|NCT01996904|3581373|B3|||Age||years|Mean|61.3|61.3|Standard Deviation|4.9|4.9|||
3746729|NCT01996904|3581374|B2|||Age||years|Mean|61.6|61.6|Standard Deviation|4.6|4.6|||
3746730|NCT01996904|3581375|B1|||Age||years|Mean|61.0|61.0|Standard Deviation|5.3|5.3|||
3746731|NCT01996813|3581382|B3||Laryngeal Mask Airway|Technique used to secure the airway||Participants|Count of Participants|38|38.0||||||
3746732|NCT01996813|3581383|B2||Laryngeal Mask Airway|Technique used to secure the airway||Participants|Count of Participants|17|17.0||||||
3746733|NCT01996813|3581384|B1||Laryngeal Mask Airway|Technique used to secure the airway||Participants|Count of Participants|21|21.0||||||
3746734|NCT01996813|3581382|B3||Endotracheal Tube|Technique used to secure the airway||Participants|Count of Participants|9|9.0||||||
3746735|NCT01996813|3581383|B2||Endotracheal Tube|Technique used to secure the airway||Participants|Count of Participants|6|6.0||||||
3746736|NCT01996813|3581384|B1||Endotracheal Tube|Technique used to secure the airway||Participants|Count of Participants|3|3.0||||||
3746737|NCT01996813|3581382|B3||Yes|Smoker||Participants|Count of Participants|11|11.0||||||
3746738|NCT01996813|3581383|B2||Yes|Smoker||Participants|Count of Participants|2|2.0||||||
3746739|NCT01996813|3581384|B1||Yes|Smoker||Participants|Count of Participants|9|9.0||||||
3746740|NCT01996813|3581382|B3||No|Smoker||Participants|Count of Participants|36|36.0||||||
3746741|NCT01996813|3581383|B2||No|Smoker||Participants|Count of Participants|21|21.0||||||
3746742|NCT01996813|3581384|B1||No|Smoker||Participants|Count of Participants|15|15.0||||||
3746743|NCT01996813|3581382|B3||Yes|Comorbid Chronic Obstructive Pulmonary Disease||Participants|Count of Participants|3|3.0||||||
3746744|NCT01996813|3581383|B2||Yes|Comorbid Chronic Obstructive Pulmonary Disease||Participants|Count of Participants|1|1.0||||||
3746745|NCT01996813|3581384|B1||Yes|Comorbid Chronic Obstructive Pulmonary Disease||Participants|Count of Participants|2|2.0||||||
3746746|NCT01996813|3581382|B3||No|Comorbid Chronic Obstructive Pulmonary Disease||Participants|Count of Participants|44|44.0||||||
3746747|NCT01996813|3581383|B2||No|Comorbid Chronic Obstructive Pulmonary Disease||Participants|Count of Participants|22|22.0||||||
3746748|NCT01996813|3581384|B1||No|Comorbid Chronic Obstructive Pulmonary Disease||Participants|Count of Participants|22|22.0||||||
3746749|NCT01996813|3581382|B3||Yes|Comorbid Coronary Artery Disease||Participants|Count of Participants|4|4.0||||||
3746750|NCT01996813|3581383|B2||Yes|Comorbid Coronary Artery Disease||Participants|Count of Participants|1|1.0||||||
3746751|NCT01996813|3581384|B1||Yes|Comorbid Coronary Artery Disease||Participants|Count of Participants|3|3.0||||||
3746752|NCT01996813|3581382|B3||No|Comorbid Coronary Artery Disease||Participants|Count of Participants|43|43.0||||||
3746753|NCT01996813|3581383|B2||No|Comorbid Coronary Artery Disease||Participants|Count of Participants|22|22.0||||||
3746754|NCT01996813|3581384|B1||No|Comorbid Coronary Artery Disease||Participants|Count of Participants|21|21.0||||||
3746755|NCT01996813|3581382|B3||Yes|Comorbid Obstructive Sleep Apnea||Participants|Count of Participants|14|14.0||||||
3746756|NCT01996813|3581383|B2||Yes|Comorbid Obstructive Sleep Apnea||Participants|Count of Participants|6|6.0||||||
3746757|NCT01996813|3581384|B1||Yes|Comorbid Obstructive Sleep Apnea||Participants|Count of Participants|8|8.0||||||
3746758|NCT01996813|3581382|B3||No|Comorbid Obstructive Sleep Apnea||Participants|Count of Participants|33|33.0||||||
3746759|NCT01996813|3581383|B2||No|Comorbid Obstructive Sleep Apnea||Participants|Count of Participants|17|17.0||||||
3746760|NCT01996813|3581384|B1||No|Comorbid Obstructive Sleep Apnea||Participants|Count of Participants|16|16.0||||||
3746761|NCT01996813|3581382|B3||Yes|Comorbid Hypertension||Participants|Count of Participants|27|27.0||||||
3746762|NCT01996813|3581383|B2||Yes|Comorbid Hypertension||Participants|Count of Participants|13|13.0||||||
3746763|NCT01996813|3581384|B1||Yes|Comorbid Hypertension||Participants|Count of Participants|14|14.0||||||
3746764|NCT01996813|3581382|B3||No|Comorbid Hypertension||Participants|Count of Participants|20|20.0||||||
3746765|NCT01996813|3581383|B2||No|Comorbid Hypertension||Participants|Count of Participants|10|10.0||||||
3746766|NCT01996813|3581384|B1||No|Comorbid Hypertension||Participants|Count of Participants|10|10.0||||||
3746767|NCT01996813|3581382|B3||Yes|Comorbid Peripheral Vascular Disease||Participants|Count of Participants|1|1.0||||||
3746768|NCT01996813|3581383|B2||Yes|Comorbid Peripheral Vascular Disease||Participants|Count of Participants|1|1.0||||||
3746769|NCT01996813|3581384|B1||Yes|Comorbid Peripheral Vascular Disease||Participants|Count of Participants|0|0.0||||||
3746770|NCT01996813|3581382|B3||No|Comorbid Peripheral Vascular Disease||Participants|Count of Participants|46|46.0||||||
3746771|NCT01996813|3581383|B2||No|Comorbid Peripheral Vascular Disease||Participants|Count of Participants|22|22.0||||||
3746772|NCT01996813|3581384|B1||No|Comorbid Peripheral Vascular Disease||Participants|Count of Participants|24|24.0||||||
3746773|NCT01996813|3581382|B3||Yes|Comorbid Diabetes||Participants|Count of Participants|9|9.0||||||
3746774|NCT01996813|3581383|B2||Yes|Comorbid Diabetes||Participants|Count of Participants|4|4.0||||||
3746775|NCT01996813|3581384|B1||Yes|Comorbid Diabetes||Participants|Count of Participants|5|5.0||||||
3746776|NCT01996813|3581382|B3||No|Comorbid Diabetes||Participants|Count of Participants|38|38.0||||||
3746777|NCT01996813|3581383|B2||No|Comorbid Diabetes||Participants|Count of Participants|19|19.0||||||
3746778|NCT01996813|3581384|B1||No|Comorbid Diabetes||Participants|Count of Participants|19|19.0||||||
3746779|NCT01996813|3581382|B3|||Body Mass Index||kg/m^2|Median|34.30|34.3|Inter-Quartile Range|||31.3|37.6|
3746780|NCT01996813|3581383|B2|||Body Mass Index||kg/m^2|Median|33.40|33.4|Inter-Quartile Range|||31.2|36.1|
3746781|NCT01996813|3581384|B1|||Body Mass Index||kg/m^2|Median|35.00|35.0|Inter-Quartile Range|||32.55|37.9|
3746782|NCT01996813|3581382|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
3746783|NCT01996813|3581383|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
3746784|NCT01996813|3581384|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3746785|NCT01996813|3581382|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3746786|NCT01996813|3581383|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3746787|NCT01996813|3581384|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3746788|NCT01996813|3581382|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3746789|NCT01996813|3581383|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3746790|NCT01996813|3581384|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3746791|NCT01996813|3581382|B3|||Age||years|Mean|53.15|53.15|Standard Deviation|11.07|11.07|||
3746792|NCT01996813|3581383|B2|||Age||years|Mean|52.96|52.96|Standard Deviation|10.82|10.82|||
3746793|NCT01996813|3581384|B1|||Age||years|Mean|53.33|53.33|Standard Deviation|11.53|11.53|||
3746794|NCT01996748|3581393|B3|Spain||Region of Enrollment||participants|Number|135|135.0||||||
3746795|NCT01996748|3581394|B2|Spain||Region of Enrollment||participants|Number|69|69.0||||||
3746796|NCT01996748|3581395|B1|Spain||Region of Enrollment||participants|Number|66|66.0||||||
3746797|NCT01996748|3581393|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3746798|NCT01996748|3581394|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3746799|NCT01996748|3581395|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3746800|NCT01996748|3581393|B3||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3746801|NCT01996748|3581394|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3746802|NCT01996748|3581395|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3746803|NCT01996748|3581393|B3|||Age||years|Mean|52.6|52.6|Standard Deviation|12.8|12.8|||
3746804|NCT01996748|3581394|B2|||Age||years|Mean|52.2|52.2|Standard Deviation|11.9|11.9|||
3746805|NCT01996748|3581395|B1|||Age||years|Mean|52.8|52.8|Standard Deviation|12.7|12.7|||
3746806|NCT01996748|3581393|B3||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
3746807|NCT01996748|3581394|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3746808|NCT01996748|3581395|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3746809|NCT01996748|3581393|B3||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
3746810|NCT01996748|3581394|B2||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
3746811|NCT01996748|3581395|B1||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3746812|NCT01996748|3581393|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3746813|NCT01996748|3581394|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3746814|NCT01996748|3581395|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3746815|NCT01996709|3581408|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3746816|NCT01996709|3581409|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3746817|NCT01996709|3581410|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3746818|NCT01996709|3581408|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3746819|NCT01996709|3581409|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3746820|NCT01996709|3581410|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3746821|NCT01996709|3581408|B3|||Age||years|Mean|32.2|32.2|Standard Deviation|9.76|9.76|||
3746822|NCT01996709|3581409|B2|||Age||years|Mean|31.4|31.4|Standard Deviation|7.65|7.65|||
3746823|NCT01996709|3581410|B1|||Age||years|Mean|33.1|33.1|Standard Deviation|11.55|11.55|||
3746824|NCT01996657|3581425|B4|||Elevated D-dimer(n)||participants|Number|91|91.0||||||
3746825|NCT01996657|3581426|B3|||Elevated D-dimer(n)||participants|Number|38|38.0||||||
3746826|NCT01996657|3581427|B2|||Elevated D-dimer(n)||participants|Number|36|36.0||||||
3746827|NCT01996657|3581428|B1|||Elevated D-dimer(n)||participants|Number|17|17.0||||||
3746828|NCT01996657|3581425|B4||Male|Sex: Female, Male||Participants|Count of Participants|399|399.0||||||
3746829|NCT01996657|3581426|B3||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3746830|NCT01996657|3581427|B2||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3746831|NCT01996657|3581428|B1||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3746832|NCT01996657|3581425|B4||Female|Sex: Female, Male||Participants|Count of Participants|311|311.0||||||
3746833|NCT01996657|3581426|B3||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3746834|NCT01996657|3581427|B2||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3746835|NCT01996657|3581428|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3746836|NCT01996657|3581425|B4|||Age||years|Median|49.8|49.8|Standard Deviation|11.3|11.3|||
3746837|NCT01996657|3581426|B3|||Age||years|Median|50.1|50.1|Standard Deviation|10.9|10.9|||
3746838|NCT01996657|3581427|B2|||Age||years|Median|50.4|50.4|Standard Deviation|11.9|11.9|||
3746839|NCT01996657|3581428|B1|||Age||years|Median|48.8|48.8|Standard Deviation|11.5|11.5|||
3746840|NCT01996644|3581444|B3|||BMI||kg/m^2|Mean|20.25|20.25|Standard Deviation|2.09|2.09|||
3746841|NCT01996644|3581445|B2|||BMI||kg/m^2|Mean|20.44|20.44|Standard Deviation|1.91|1.91|||
3746842|NCT01996644|3581446|B1|||BMI||kg/m^2|Mean|20.10|20.1|Standard Deviation|2.13|2.13|||
3746843|NCT01996644|3581444|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
3746844|NCT01996644|3581445|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3746845|NCT01996644|3581446|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3746846|NCT01996644|3581444|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3746847|NCT01996644|3581445|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3746848|NCT01996644|3581446|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3746849|NCT01996644|3581444|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3746850|NCT01996644|3581445|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3746851|NCT01996644|3581446|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3746852|NCT01996644|3581444|B3|||Age||years|Mean|25.44|25.44|Full Range|||14.0|60.0|
3746853|NCT01996644|3581445|B2|||Age||years|Mean|24.63|24.63|Full Range|||14.0|60.0|
3746854|NCT01996644|3581446|B1|||Age||years|Mean|26.10|26.1|Full Range|||15.0|49.0|
3746855|NCT01996644|3581444|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3746856|NCT01996644|3581445|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3746857|NCT01996644|3581446|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3746858|NCT01996644|3581444|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3746859|NCT01996644|3581445|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3746860|NCT01996644|3581446|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3746861|NCT01996644|3581444|B3||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3746862|NCT01996644|3581445|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3746863|NCT01996644|3581446|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3746864|NCT01996592|3581458|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3746865|NCT01996592|3581458|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746866|NCT01996592|3581458|B1||White|Race (NIH/OMB)||Participants|Count of Participants|384|384.0||||||
3746867|NCT01996592|3581458|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
3746868|NCT01996592|3581458|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746869|NCT01996592|3581458|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3746870|NCT01996592|3581458|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746871|NCT01996592|3581458|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3746872|NCT01996592|3581458|B1||Female|Sex: Female, Male||Participants|Count of Participants|530|530.0||||||
3746873|NCT01996592|3581458|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3746874|NCT01996592|3581458|B1||Between 18 and 65 years|Age||Participants|Count of Participants|530|530.0||||||
3746875|NCT01996592|3581458|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3746876|NCT01996410|3581467|B9|United States||Region of Enrollment||participants|Number|10|10.0||||||
3746877|NCT01996410|3581470|B6|United States||Region of Enrollment||participants|Number|2|2.0||||||
3746878|NCT01996410|3581471|B5|United States||Region of Enrollment||participants|Number|2|2.0||||||
3746879|NCT01996410|3581474|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3746880|NCT01996410|3581475|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3746881|NCT01996410|3581467|B9|Male||Gender||participants|Number|0|0.0||||||
3746882|NCT01996410|3581470|B6|Male||Gender||participants|Number|0|0.0||||||
3746883|NCT01996410|3581471|B5|Male||Gender||participants|Number|0|0.0||||||
3746884|NCT01996410|3581474|B2|Male||Gender||participants|Number|0|0.0||||||
3746885|NCT01996410|3581475|B1|Male||Gender||participants|Number|0|0.0||||||
3746886|NCT01996410|3581467|B9|Female||Gender||participants|Number|10|10.0||||||
3746887|NCT01996410|3581470|B6|Female||Gender||participants|Number|2|2.0||||||
3746888|NCT01996410|3581471|B5|Female||Gender||participants|Number|2|2.0||||||
3746889|NCT01996410|3581474|B2|Female||Gender||participants|Number|3|3.0||||||
3746890|NCT01996410|3581475|B1|Female||Gender||participants|Number|3|3.0||||||
3746891|NCT01996410|3581467|B9|||Age||years|Mean|50.1|50.1|Standard Deviation|13.5|13.5|||
3746892|NCT01996410|3581470|B6|||Age||years|Mean|49.0|49.0|Standard Deviation|18.1|18.1|||
3746893|NCT01996410|3581471|B5|||Age||years|Mean|45.0|45.0|Standard Deviation|14.9|14.9|||
3746894|NCT01996410|3581474|B2|||Age||years|Mean|43.2|43.2|Standard Deviation|12.0|12.0|||
3746895|NCT01996410|3581475|B1|||Age||years|Mean|56.9|56.9|Standard Deviation|15.7|15.7|||
3746896|NCT01996410|3581467|B9|>=65 years||Age||participants|Number|2|2.0||||||
3746897|NCT01996410|3581470|B6|>=65 years||Age||participants|Number|0|0.0||||||
3746898|NCT01996410|3581471|B5|>=65 years||Age||participants|Number|0|0.0||||||
3746899|NCT01996410|3581474|B2|>=65 years||Age||participants|Number|0|0.0||||||
3746900|NCT01996410|3581475|B1|>=65 years||Age||participants|Number|2|2.0||||||
3746901|NCT01996410|3581467|B9|Between 18 and 65 years||Age||participants|Number|8|8.0||||||
3746902|NCT01996410|3581470|B6|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
3746903|NCT01996410|3581471|B5|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
3746904|NCT01996410|3581474|B2|Between 18 and 65 years||Age||participants|Number|3|3.0||||||
3746905|NCT01996410|3581475|B1|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
3746906|NCT01996410|3581467|B9|<=18 years||Age||participants|Number|0|0.0||||||
3746907|NCT01996410|3581470|B6|<=18 years||Age||participants|Number|0|0.0||||||
3746908|NCT01996410|3581471|B5|<=18 years||Age||participants|Number|0|0.0||||||
3746909|NCT01996410|3581474|B2|<=18 years||Age||participants|Number|0|0.0||||||
3746910|NCT01996410|3581475|B1|<=18 years||Age||participants|Number|0|0.0||||||
3746911|NCT01996332|3581494|B1||Male|Sex: Female, Male||Participants|Count of Participants|1285|1285.0||||||
3746912|NCT01996332|3581494|B1||Female|Sex: Female, Male||Participants|Count of Participants|520|520.0||||||
3746913|NCT01996332|3581494|B1|||Age||years|Mean|63.55|63.55|Standard Deviation|11.75|11.75|||
3746914|NCT01996319|3581500|B3||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3746915|NCT01996319|3581501|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3746916|NCT01996319|3581502|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3746917|NCT01996319|3581500|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3746918|NCT01996319|3581501|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3746919|NCT01996319|3581502|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3746920|NCT01996319|3581500|B3|||Age||Years|Mean|62.8|62.8|Standard Deviation|7.9|7.9|||
3746921|NCT01996319|3581501|B2|||Age||Years|Mean|61.2|61.2|Standard Deviation|7.7|7.7|||
3746922|NCT01996319|3581502|B1|||Age||Years|Mean|64.3|64.3|Standard Deviation|7.9|7.9|||
3746923|NCT01996033|3581523|B1|||Heart Rate||beats per minute|Mean|71.2|71.2|Standard Deviation|7.1|7.1|||
3746924|NCT01996033|3581523|B1|||Number of Antihypertensive Medications||medications|Mean|4.7|4.7|Standard Deviation|1.1|1.1|||
3746925|NCT01996033|3581523|B1|||Estimated Glomerular Filtration Rate||mL/min per 1.73m2|Mean|72.8|72.8|Standard Deviation|16.1|16.1|||
3746926|NCT01996033|3581523|B1|||Serum Creatinine||micromoles/liter|Mean|88.6|88.6|Standard Deviation|18.7|18.7|||
3746927|NCT01996033|3581523|B1|Diastolic||24Hr Ambulatory Blood Pressure||mmHg|Mean|83.2|83.2|Standard Deviation|15.7|15.7|||
3746928|NCT01996033|3581523|B1|Systolic||24Hr Ambulatory Blood Pressure||mmHg|Mean|157.1|157.1|Standard Deviation|18.6|18.6|||
3746929|NCT01996033|3581523|B1|Diastolic||Office Blood Pressure||mmHg|Mean|87.8|87.8|Standard Deviation|12.6|12.6|||
3746930|NCT01996033|3581523|B1|Systolic||Office Blood Pressure||mmHg|Mean|164.5|164.5|Standard Deviation|20.2|20.2|||
3746931|NCT01996033|3581523|B1|||BMI||kilograms/meter2|Mean|29.9|29.9|Standard Deviation|5.6|5.6|||
3746932|NCT01996033|3581523|B1|||Height||centimeters|Mean|171.2|171.2|Standard Deviation|8.4|8.4|||
3746933|NCT01996033|3581523|B1|||Weight||kilograms|Mean|88.0|88.0|Standard Deviation|18.7|18.7|||
3746934|NCT01996033|3581523|B1|||Smoker||Participants|Count of Participants|8|8.0||||||
3746935|NCT01996033|3581523|B1|||Diabetes (Type II)||Participants|Count of Participants|13|13.0||||||
3746936|NCT01996033|3581523|B1|||Obstructive Sleep Apnea||Participants|Count of Participants|7|7.0||||||
3746937|NCT01996033|3581523|B1|||Cerebrovascular Accident||Participants|Count of Participants|3|3.0||||||
3746938|NCT01996033|3581523|B1|||Percutaneous Coronary Intervention||Participants|Count of Participants|2|2.0||||||
3746939|NCT01996033|3581523|B1|||Coronary Artery Bypass Graft||Participants|Count of Participants|3|3.0||||||
3746940|NCT01996033|3581523|B1|||Coronary Artery Disease||Participants|Count of Participants|7|7.0||||||
3746941|NCT01996033|3581523|B1|||Myocardial Infarction||Participants|Count of Participants|2|2.0||||||
3746942|NCT01996033|3581523|B1|||Years taking anti-HTN medications||years|Mean|15.4|15.4|Standard Deviation|11.3|11.3|||
3746943|NCT01996033|3581523|B1|||Years since HTN diagnosis||years|Mean|19.2|19.2|Standard Deviation|15.5|15.5|||
3746944|NCT01996033|3581523|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3746945|NCT01996033|3581523|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3746946|NCT01996033|3581523|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|10.5|10.5|||
3746947|NCT01995539|3581536|B1|India||Region of Enrollment||participants|Number|181|181.0||||||
3746948|NCT01995539|3581536|B1||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3746949|NCT01995539|3581536|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3746950|NCT01995539|3581536|B1|||Age||Years|Mean|54.1|54.1|Standard Deviation|10.06|10.06|||
3746951|NCT01995526|3581541|B1|Japan||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3746952|NCT01995526|3581541|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746953|NCT01995526|3581541|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746954|NCT01995526|3581541|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746955|NCT01995526|3581541|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746956|NCT01995526|3581541|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746957|NCT01995526|3581541|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3746958|NCT01995526|3581541|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746959|NCT01995526|3581541|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746960|NCT01995526|3581541|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3746961|NCT01995526|3581541|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3746962|NCT01995526|3581541|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3746963|NCT01995526|3581541|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3746964|NCT01995526|3581541|B1|||Age||years|Mean|23.8|23.8|Standard Deviation|3.6|3.6|||
3746965|NCT01995513|3581549|B1||Male|Sex: Female, Male||Participants|Count of Participants|509|509.0||||||
3746966|NCT01995513|3581549|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3746967|NCT01995513|3581549|B1|||Age||years|Mean|72.3|72.3|Standard Deviation|8.31|8.31|||
3746968|NCT01995461|3581594|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
3746969|NCT01995461|3581594|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3746970|NCT01995461|3581594|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3746971|NCT01995461|3581594|B1|||Age||years|Median|74.7|74.7|Full Range|||57.7|88.1|
3746972|NCT01995357|3581600|B1|Denmark||Region of Enrollment||participants|Number|22|22.0||||||
3746973|NCT01995357|3581600|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3746974|NCT01995357|3581600|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3746975|NCT01995357|3581600|B1|||Age||years|Mean|67.0|67.0|Standard Deviation|10.0|10.0|||
3746976|NCT01995201|3581621|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3746977|NCT01995201|3581622|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3746978|NCT01995201|3581623|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3746979|NCT01995201|3581621|B3||Female|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
3746980|NCT01995201|3581622|B2||Female|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
3746981|NCT01995201|3581623|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3746982|NCT01995201|3581621|B3|||Age||years|Mean|53.6|53.6|Standard Deviation|12.3|12.3|||
3746983|NCT01995201|3581622|B2|||Age||years|Mean|53.6|53.6|Standard Deviation|12.2|12.2|||
3746984|NCT01995201|3581623|B1|||Age||years|Mean|53.5|53.5|Standard Deviation|12.7|12.7|||
3746985|NCT01995136|3581738|B1|5:00 PM||Baseline IOP||mmHg|Mean|15.73|15.73|Standard Deviation|2.17|2.17|||
3746986|NCT01995136|3581738|B1|1:00 PM||Baseline IOP||mmHg|Mean|15.72|15.72|Standard Deviation|1.82|1.82|||
3746987|NCT01995136|3581738|B1|9:00 AM||Baseline IOP||mmHg|Mean|16.55|16.55|Standard Deviation|1.43|1.43|||
3746988|NCT01995136|3581738|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3746989|NCT01995136|3581738|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3746990|NCT01995136|3581738|B1|||Age||years|Mean|65.6|65.6|Standard Deviation|11.1|11.1|||
3746991|NCT01995071|3581742|B13||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3746992|NCT01995071|3581744|B11||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3746993|NCT01995071|3581745|B10||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3746994|NCT01995071|3581746|B9||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3746995|NCT01995071|3581747|B8||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3746996|NCT01995071|3581748|B7||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3746997|NCT01995071|3581749|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3746998|NCT01995071|3581750|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3746999|NCT01995071|3581751|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3747000|NCT01995071|3581752|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3747001|NCT01995071|3581753|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3747002|NCT01995071|3581754|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3747003|NCT01995071|3581742|B13||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3747004|NCT01995071|3581744|B11||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3747005|NCT01995071|3581745|B10||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3747006|NCT01995071|3581746|B9||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3747007|NCT01995071|3581747|B8||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3747008|NCT01995071|3581748|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3747009|NCT01995071|3581749|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3747010|NCT01995071|3581750|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3747011|NCT01995071|3581751|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3747012|NCT01995071|3581752|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3747013|NCT01995071|3581753|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3747014|NCT01995071|3581754|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3747015|NCT01995071|3581742|B13|||Age||years|Mean|54.1|54.1|Standard Deviation|9.17|9.17|||
3747016|NCT01995071|3581744|B11|||Age||years|Mean|54.6|54.6|Standard Deviation|5.15|5.15|||
3747017|NCT01995071|3581745|B10|||Age||years|Mean|55.3|55.3|Standard Deviation|9.63|9.63|||
3747018|NCT01995071|3581746|B9|||Age||years|Mean|60.5|60.5|Standard Deviation|5.61|5.61|||
3747019|NCT01995071|3581747|B8|||Age||years|Mean|49.4|49.4|Standard Deviation|15.31|15.31|||
3747020|NCT01995071|3581748|B7|||Age||years|Mean|50.6|50.6|Standard Deviation|12.60|12.6|||
3747021|NCT01995071|3581749|B6|||Age||years|Mean|53.9|53.9|Standard Deviation|9.34|9.34|||
3747022|NCT01995071|3581750|B5|||Age||years|Mean|58.6|58.6|Standard Deviation|6.14|6.14|||
3747023|NCT01995071|3581751|B4|||Age||years|Mean|52.6|52.6|Standard Deviation|6.37|6.37|||
3747024|NCT01995071|3581752|B3|||Age||years|Mean|50.3|50.3|Standard Deviation|9.04|9.04|||
3747025|NCT01995071|3581753|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|9.53|9.53|||
3747026|NCT01995071|3581754|B1|||Age||years|Mean|53.8|53.8|Standard Deviation|5.20|5.2|||
3747027|NCT01995045|3581824|B3|United States||Region of Enrollment||Participants|Count of Participants|57|57.0||||||
3747028|NCT01995045|3581825|B2|United States||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3747029|NCT01995045|3581826|B1|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3747030|NCT01995045|3581824|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3747031|NCT01995045|3581825|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3747032|NCT01995045|3581826|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3747033|NCT01995045|3581824|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3747034|NCT01995045|3581825|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3747035|NCT01995045|3581826|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3747036|NCT01995045|3581824|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3747037|NCT01995045|3581825|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3747038|NCT01995045|3581826|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3747039|NCT01995045|3581824|B3||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
3747040|NCT01995045|3581825|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3747041|NCT01995045|3581826|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3747042|NCT01995045|3581824|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3747043|NCT01995045|3581825|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3747044|NCT01995045|3581826|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3747045|NCT01994993|3581839|B6|United States||Region of Enrollment||count of participants|Number|252|252.0||||||
3747046|NCT01994993|3581840|B5|United States||Region of Enrollment||count of participants|Number|23|23.0||||||
3747047|NCT01994993|3581841|B4|United States||Region of Enrollment||count of participants|Number|55|55.0||||||
3747048|NCT01994993|3581842|B3|United States||Region of Enrollment||count of participants|Number|70|70.0||||||
3747049|NCT01994993|3581843|B2|United States||Region of Enrollment||count of participants|Number|46|46.0||||||
3747050|NCT01994993|3581844|B1|United States||Region of Enrollment||count of participants|Number|58|58.0||||||
3747051|NCT01994993|3581839|B6|Canada||Region of Enrollment||count of participants|Number|5|5.0||||||
3747052|NCT01994993|3581840|B5|Canada||Region of Enrollment||count of participants|Number|1|1.0||||||
3747053|NCT01994993|3581841|B4|Canada||Region of Enrollment||count of participants|Number|0|0.0||||||
3747054|NCT01994993|3581842|B3|Canada||Region of Enrollment||count of participants|Number|0|0.0||||||
3747055|NCT01994993|3581843|B2|Canada||Region of Enrollment||count of participants|Number|0|0.0||||||
3747056|NCT01994993|3581844|B1|Canada||Region of Enrollment||count of participants|Number|4|4.0||||||
3747057|NCT01994993|3581839|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3747058|NCT01994993|3581840|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3747059|NCT01994993|3581841|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3747060|NCT01994993|3581842|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3747061|NCT01994993|3581843|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3747062|NCT01994993|3581844|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3747063|NCT01994993|3581839|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3747064|NCT01994993|3581840|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3747065|NCT01994993|3581841|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3747066|NCT01994993|3581842|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3747067|NCT01994993|3581843|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3747068|NCT01994993|3581844|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3747069|NCT01994993|3581839|B6||White|Race (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
3747070|NCT01994993|3581840|B5||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3747071|NCT01994993|3581841|B4||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3747072|NCT01994993|3581842|B3||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3747073|NCT01994993|3581843|B2||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3747074|NCT01994993|3581844|B1||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3747075|NCT01994993|3581839|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3747076|NCT01994993|3581840|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3747077|NCT01994993|3581841|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3747078|NCT01994993|3581842|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3747079|NCT01994993|3581843|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3747080|NCT01994993|3581844|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3747081|NCT01994993|3581839|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747082|NCT01994993|3581840|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747083|NCT01994993|3581841|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747084|NCT01994993|3581842|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747085|NCT01994993|3581843|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747086|NCT01994993|3581844|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747087|NCT01994993|3581839|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3747088|NCT01994993|3581840|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747089|NCT01994993|3581841|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3747090|NCT01994993|3581842|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3747091|NCT01994993|3581843|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3747092|NCT01994993|3581844|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747093|NCT01994993|3581839|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3747094|NCT01994993|3581840|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747095|NCT01994993|3581841|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3747096|NCT01994993|3581842|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747097|NCT01994993|3581843|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747098|NCT01994993|3581844|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3747099|NCT01994993|3581839|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3747100|NCT01994993|3581840|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3747101|NCT01994993|3581841|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3747102|NCT01994993|3581842|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3747103|NCT01994993|3581843|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3747104|NCT01994993|3581844|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3747105|NCT01994993|3581839|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|190|190.0||||||
3747106|NCT01994993|3581840|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3747107|NCT01994993|3581841|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3747108|NCT01994993|3581842|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3747109|NCT01994993|3581843|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3747110|NCT01994993|3581844|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3747111|NCT01994993|3581839|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3747112|NCT01994993|3581840|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3747113|NCT01994993|3581841|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3747114|NCT01994993|3581842|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3747115|NCT01994993|3581843|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3747116|NCT01994993|3581844|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3747117|NCT01994993|3581839|B6||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3747118|NCT01994993|3581840|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3747119|NCT01994993|3581841|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3747120|NCT01994993|3581842|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3747121|NCT01994993|3581843|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3747122|NCT01994993|3581844|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3747123|NCT01994993|3581839|B6||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3747124|NCT01994993|3581840|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3747125|NCT01994993|3581841|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3747126|NCT01994993|3581842|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3747127|NCT01994993|3581843|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3747128|NCT01994993|3581844|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3747129|NCT01994993|3581839|B6|||Age||Gestational Age (weeks)|Mean|29.5|29.5|Standard Deviation|4.6|4.6|||
3747130|NCT01994993|3581840|B5|||Age||Gestational Age (weeks)|Mean|28.9|28.9|Standard Deviation|4.9|4.9|||
3747131|NCT01994993|3581841|B4|||Age||Gestational Age (weeks)|Mean|36.4|36.4|Standard Deviation|2.1|2.1|||
3747132|NCT01994993|3581842|B3|||Age||Gestational Age (weeks)|Mean|27.5|27.5|Standard Deviation|2.9|2.9|||
3747133|NCT01994993|3581843|B2|||Age||Gestational Age (weeks)|Mean|27.8|27.8|Standard Deviation|3.0|3.0|||
3747134|NCT01994993|3581844|B1|||Age||Gestational Age (weeks)|Mean|27.3|27.3|Standard Deviation|2.6|2.6|||
3747135|NCT01994902|3581900|B1|Male||Gender|one gender registration was missing|participants|Number|49|49.0||||||
3747136|NCT01994902|3581900|B1|Female||Gender|one gender registration was missing|participants|Number|77|77.0||||||
3747137|NCT01994902|3581900|B1|||Age||years|Mean|58.8|58.8|Standard Deviation|14.1|14.1|||
3747138|NCT01994876|3581907|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3747139|NCT01994876|3581907|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3747140|NCT01994876|3581907|B1|||Age||years|Mean|54.4|54.4|Standard Deviation|11.6|11.6|||
3747141|NCT01994863|3581916|B1|France||Region of Enrollment||participants|Number|6|6.0||||||
3747142|NCT01994863|3581916|B1|Netherlands||Region of Enrollment||participants|Number|17|17.0||||||
3747143|NCT01994863|3581916|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3747144|NCT01994863|3581916|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3747145|NCT01994863|3581916|B1|||Age||years|Mean|57.2|57.2|Standard Deviation|12.9|12.9|||
3747146|NCT01994837|3581923|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3747147|NCT01994837|3581923|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3747148|NCT01994837|3581923|B1|||Age||years|Mean|65.9|65.9|Standard Deviation|14.8|14.8|||
3747149|NCT01994785|3581936|B5|United States||Region of Enrollment||participants|Number|440|440.0||||||
3747150|NCT01994785|3581937|B4|United States||Region of Enrollment||participants|Number|114|114.0||||||
3747151|NCT01994785|3581938|B3|United States||Region of Enrollment||participants|Number|117|117.0||||||
3747152|NCT01994785|3581939|B2|United States||Region of Enrollment||participants|Number|108|108.0||||||
3747153|NCT01994785|3581940|B1|United States||Region of Enrollment||participants|Number|101|101.0||||||
3747154|NCT01994785|3581936|B5||Male|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
3747155|NCT01994785|3581937|B4||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3747156|NCT01994785|3581938|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3747157|NCT01994785|3581939|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3747158|NCT01994785|3581940|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3747159|NCT01994785|3581936|B5||Female|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
3747160|NCT01994785|3581937|B4||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3747161|NCT01994785|3581938|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3747162|NCT01994785|3581939|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3747163|NCT01994785|3581940|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3747164|NCT01994785|3581936|B5|||Age||years|Mean|54.6|54.6|Standard Deviation|13.9|13.9|||
3747165|NCT01994785|3581937|B4|||Age||years|Mean|55.3|55.3|Standard Deviation|13.3|13.3|||
3747166|NCT01994785|3581938|B3|||Age||years|Mean|54.1|54.1|Standard Deviation|13.8|13.8|||
3747167|NCT01994785|3581939|B2|||Age||years|Mean|49.8|49.8|Standard Deviation|17.0|17.0|||
3747168|NCT01994785|3581940|B1|||Age||years|Mean|51.8|51.8|Standard Deviation|17.3|17.3|||
3747169|NCT01994746|3581953|B1|United States||Region of Enrollment||Participants|Count of Participants|77|77.0||||||
3747170|NCT01994746|3581953|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3747171|NCT01994746|3581953|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747172|NCT01994746|3581953|B1||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3747173|NCT01994746|3581953|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3747174|NCT01994746|3581953|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747175|NCT01994746|3581953|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747176|NCT01994746|3581953|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747177|NCT01994746|3581953|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3747178|NCT01994746|3581953|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3747179|NCT01994746|3581953|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3747180|NCT01994746|3581953|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3747181|NCT01994746|3581953|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3747182|NCT01994746|3581953|B1|||Age||years|Mean|33|33.0|Standard Deviation|12|12.0|||
3747183|NCT01994746|3581953|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3747184|NCT01994746|3581953|B1||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
3747185|NCT01994746|3581953|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3747186|NCT01994720|3581978|B3|Other||Race/Ethnicity, Customized||Participants|Number|122|122.0||||||
3747187|NCT01994720|3581979|B2|Other||Race/Ethnicity, Customized||Participants|Number|56|56.0||||||
3747188|NCT01994720|3581980|B1|Other||Race/Ethnicity, Customized||Participants|Number|66|66.0||||||
3747189|NCT01994720|3581978|B3|White||Race/Ethnicity, Customized||Participants|Number|8784|8784.0||||||
3747190|NCT01994720|3581979|B2|White||Race/Ethnicity, Customized||Participants|Number|4410|4410.0||||||
3747191|NCT01994720|3581980|B1|White||Race/Ethnicity, Customized||Participants|Number|4374|4374.0||||||
3747192|NCT01994720|3581978|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|239|239.0||||||
3747193|NCT01994720|3581979|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|120|120.0||||||
3747194|NCT01994720|3581980|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|119|119.0||||||
3747195|NCT01994720|3581978|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3747196|NCT01994720|3581979|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3747197|NCT01994720|3581980|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3747198|NCT01994720|3581978|B3|Asian||Race/Ethnicity, Customized||Participants|Number|3906|3906.0||||||
3747199|NCT01994720|3581979|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1949|1949.0||||||
3747200|NCT01994720|3581980|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1957|1957.0||||||
3747201|NCT01994720|3581978|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|143|143.0||||||
3747202|NCT01994720|3581979|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|74|74.0||||||
3747203|NCT01994720|3581980|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|69|69.0||||||
3747204|NCT01994720|3581978|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3747205|NCT01994720|3581979|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3747206|NCT01994720|3581980|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747207|NCT01994720|3581978|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12073|12073.0||||||
3747208|NCT01994720|3581979|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6050|6050.0||||||
3747209|NCT01994720|3581980|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6023|6023.0||||||
3747210|NCT01994720|3581978|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1124|1124.0||||||
3747211|NCT01994720|3581979|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|558|558.0||||||
3747212|NCT01994720|3581980|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|566|566.0||||||
3747213|NCT01994720|3581978|B3||Male|Sex: Female, Male||Participants|Count of Participants|7716|7716.0||||||
3747214|NCT01994720|3581979|B2||Male|Sex: Female, Male||Participants|Count of Participants|3886|3886.0||||||
3747215|NCT01994720|3581980|B1||Male|Sex: Female, Male||Participants|Count of Participants|3830|3830.0||||||
3747216|NCT01994720|3581978|B3||Female|Sex: Female, Male||Participants|Count of Participants|5483|5483.0||||||
3747217|NCT01994720|3581979|B2||Female|Sex: Female, Male||Participants|Count of Participants|2724|2724.0||||||
3747218|NCT01994720|3581980|B1||Female|Sex: Female, Male||Participants|Count of Participants|2759|2759.0||||||
3747219|NCT01994720|3581978|B3|>75 years||Age, Customized||Participants|Number|2995|2995.0||||||
3747220|NCT01994720|3581979|B2|>75 years||Age, Customized||Participants|Number|1491|1491.0||||||
3747221|NCT01994720|3581980|B1|>75 years||Age, Customized||Participants|Number|1504|1504.0||||||
3747222|NCT01994720|3581978|B3|Between 65 and 75 years||Age, Customized||Participants|Number|4176|4176.0||||||
3747223|NCT01994720|3581979|B2|Between 65 and 75 years||Age, Customized||Participants|Number|2112|2112.0||||||
3747224|NCT01994720|3581980|B1|Between 65 and 75 years||Age, Customized||Participants|Number|2064|2064.0||||||
3747225|NCT01994720|3581978|B3|<65 years||Age, Customized||Participants|Number|6028|6028.0||||||
3747226|NCT01994720|3581979|B2|<65 years||Age, Customized||Participants|Number|3007|3007.0||||||
3747227|NCT01994720|3581980|B1|<65 years||Age, Customized||Participants|Number|3021|3021.0||||||
3747228|NCT01994720|3581978|B3|||Age||Years|Mean|65.9|65.9|Standard Deviation|11.30|11.3|||
3747229|NCT01994720|3581979|B2|||Age||Years|Mean|65.9|65.9|Standard Deviation|11.37|11.37|||
3747230|NCT01994720|3581980|B1|||Age||Years|Mean|65.8|65.8|Standard Deviation|11.23|11.23|||
3747231|NCT01994629|3582021|B3|Italy||Region of Enrollment||Subjects|Number|202|202.0||||||
3747232|NCT01994629|3582022|B2|Italy||Region of Enrollment||Subjects|Number|102|102.0||||||
3747233|NCT01994629|3582023|B1|Italy||Region of Enrollment||Subjects|Number|100|100.0||||||
3747234|NCT01994629|3582021|B3||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3747235|NCT01994629|3582022|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3747236|NCT01994629|3582023|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3747237|NCT01994629|3582021|B3||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3747238|NCT01994629|3582022|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3747239|NCT01994629|3582023|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3747240|NCT01994629|3582021|B3|||Age||Months|Mean|12.7|12.7|Standard Deviation|0.9|0.9|||
3747241|NCT01994629|3582022|B2|||Age||Months|Mean|12.7|12.7|Standard Deviation|0.9|0.9|||
3747242|NCT01994629|3582023|B1|||Age||Months|Mean|12.8|12.8|Standard Deviation|1|1.0|||
3747243|NCT01994486|3582048|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3747244|NCT01994486|3582048|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3747245|NCT01994486|3582048|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3747246|NCT01994486|3582048|B1|||Age||years|Mean|51|51.0|Full Range|||20.0|78.0|
3747247|NCT01994486|3582048|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3747248|NCT01994486|3582048|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3747249|NCT01994486|3582048|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3747250|NCT01994395|3582057|B3|||10 Meter Walk Test|Study criteria require initial gait speed of > 0.4 m/s and < 0.8 m/s Participants were asked to walk at their normal self-selected speed 14 meters and the time is measured for the intermediate 10 meters to allow for acceleration and deceleration. This is repeated for three trials and then averaged.|meters per second|Mean|0.68|0.68|Standard Deviation|0.1|0.1|||
3747251|NCT01994395|3582058|B2|||10 Meter Walk Test|Study criteria require initial gait speed of > 0.4 m/s and < 0.8 m/s Participants were asked to walk at their normal self-selected speed 14 meters and the time is measured for the intermediate 10 meters to allow for acceleration and deceleration. This is repeated for three trials and then averaged.|meters per second|Mean|0.65|0.65|Standard Deviation|0.1|0.1|||
3747252|NCT01994395|3582059|B1|||10 Meter Walk Test|Study criteria require initial gait speed of > 0.4 m/s and < 0.8 m/s Participants were asked to walk at their normal self-selected speed 14 meters and the time is measured for the intermediate 10 meters to allow for acceleration and deceleration. This is repeated for three trials and then averaged.|meters per second|Mean|0.7|0.7|Standard Deviation|0.1|0.1|||
3747253|NCT01994395|3582057|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3747254|NCT01994395|3582058|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3747255|NCT01994395|3582059|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3747256|NCT01994395|3582057|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3747257|NCT01994395|3582057|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3747258|NCT01994395|3582058|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3747259|NCT01994395|3582059|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3747260|NCT01994395|3582057|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3747261|NCT01994395|3582058|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3747262|NCT01994395|3582059|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3747263|NCT01994395|3582057|B3|||Age||years|Mean|61|61.0|Standard Deviation|11.5|11.5|||
3747264|NCT01994395|3582058|B2|||Age||years|Mean|62|62.0|Standard Deviation|13|13.0|||
3747265|NCT01994395|3582059|B1|||Age||years|Mean|60|60.0|Standard Deviation|10|10.0|||
3747266|NCT01994395|3582057|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3747267|NCT01994395|3582058|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3747268|NCT01994395|3582059|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3747269|NCT01994395|3582057|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3747270|NCT01994395|3582058|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3747271|NCT01994395|3582059|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3747272|NCT01994395|3582057|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3747273|NCT01994395|3582058|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3747274|NCT01994395|3582059|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3747275|NCT01994291|3582082|B4||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3747276|NCT01994291|3582083|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3747277|NCT01994291|3582084|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3747278|NCT01994291|3582085|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3747279|NCT01994291|3582082|B4||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3747280|NCT01994291|3582083|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3747281|NCT01994291|3582084|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3747282|NCT01994291|3582085|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3747283|NCT01994291|3582082|B4|||Age||years|Mean|62.3|62.3|Standard Deviation|8.4|8.4|||
3747284|NCT01994291|3582083|B3|||Age||years|Mean|63.4|63.4|Standard Deviation|8.4|8.4|||
3747285|NCT01994291|3582084|B2|||Age||years|Mean|60.4|60.4|Standard Deviation|7.5|7.5|||
3747286|NCT01994291|3582085|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|8.8|8.8|||
3747287|NCT01994226|3582141|B3|United Kingdom||Region of Enrollment||participants|Number|399|399.0||||||
3747288|NCT01994226|3582142|B2|United Kingdom||Region of Enrollment||participants|Number|200|200.0||||||
3747289|NCT01994226|3582143|B1|United Kingdom||Region of Enrollment||participants|Number|199|199.0||||||
3747290|NCT01994226|3582141|B3||Male|Sex: Female, Male||Participants|Count of Participants|347|347.0||||||
3747291|NCT01994226|3582142|B2||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
3747292|NCT01994226|3582143|B1||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3747293|NCT01994226|3582141|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3747294|NCT01994226|3582142|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3747295|NCT01994226|3582143|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3747296|NCT01994226|3582141|B3|||Age||years|Mean|59.4|59.4|Standard Deviation|13.9|13.9|||
3747297|NCT01994226|3582142|B2|||Age||years|Mean|58.7|58.7|Standard Deviation|14.4|14.4|||
3747298|NCT01994226|3582143|B1|||Age||years|Mean|60|60.0|Standard Deviation|13.4|13.4|||
3747299|NCT01993940|3582150|B3|||Spontaneous Bowel Movements per Week|A spontaneous bowel movement was defined as a bowel movement that occurred without the use of a rescue laxative therapy during the 24 hours prior to the bowel movement.|spontaneous bowel movements / week|Mean|1.17|1.17|Standard Deviation|0.742|0.742|||
3747300|NCT01993940|3582151|B2|||Spontaneous Bowel Movements per Week|A spontaneous bowel movement was defined as a bowel movement that occurred without the use of a rescue laxative therapy during the 24 hours prior to the bowel movement.|spontaneous bowel movements / week|Mean|1.17|1.17|Standard Deviation|0.730|0.73|||
3747301|NCT01993940|3582152|B1|||Spontaneous Bowel Movements per Week|A spontaneous bowel movement was defined as a bowel movement that occurred without the use of a rescue laxative therapy during the 24 hours prior to the bowel movement.|spontaneous bowel movements / week|Mean|1.16|1.16|Standard Deviation|0.755|0.755|||
3747302|NCT01993940|3582150|B3|> 100 mg||Stratification by Opioid Dose|Dose of opioid was calculated using maintenance and breakthrough morphine equivalent dose. If any participants were treated with < 30 mg, the participants were counted in the '30-100 mg' group.|participants|Number|214|214.0||||||
3747303|NCT01993940|3582151|B2|> 100 mg||Stratification by Opioid Dose|Dose of opioid was calculated using maintenance and breakthrough morphine equivalent dose. If any participants were treated with < 30 mg, the participants were counted in the '30-100 mg' group.|participants|Number|107|107.0||||||
3747304|NCT01993940|3582152|B1|> 100 mg||Stratification by Opioid Dose|Dose of opioid was calculated using maintenance and breakthrough morphine equivalent dose. If any participants were treated with < 30 mg, the participants were counted in the '30-100 mg' group.|participants|Number|107|107.0||||||
3747305|NCT01993940|3582150|B3|30-100 mg||Stratification by Opioid Dose|Dose of opioid was calculated using maintenance and breakthrough morphine equivalent dose. If any participants were treated with < 30 mg, the participants were counted in the '30-100 mg' group.|participants|Number|336|336.0||||||
3747306|NCT01993940|3582151|B2|30-100 mg||Stratification by Opioid Dose|Dose of opioid was calculated using maintenance and breakthrough morphine equivalent dose. If any participants were treated with < 30 mg, the participants were counted in the '30-100 mg' group.|participants|Number|167|167.0||||||
3747360|NCT01993927|3582167|B1|Compliance level of < 70%||Compliance of Dietary Therapy at Treatment Start||Participants|Count of Participants|240|240.0||||||
3747307|NCT01993940|3582152|B1|30-100 mg||Stratification by Opioid Dose|Dose of opioid was calculated using maintenance and breakthrough morphine equivalent dose. If any participants were treated with < 30 mg, the participants were counted in the '30-100 mg' group.|participants|Number|169|169.0||||||
3747308|NCT01993940|3582150|B3|White||Race/Ethnicity, Customized||participants|Number|449|449.0||||||
3747309|NCT01993940|3582151|B2|White||Race/Ethnicity, Customized||participants|Number|227|227.0||||||
3747310|NCT01993940|3582152|B1|White||Race/Ethnicity, Customized||participants|Number|222|222.0||||||
3747311|NCT01993940|3582150|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3747312|NCT01993940|3582151|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3747313|NCT01993940|3582152|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3747314|NCT01993940|3582150|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|88|88.0||||||
3747315|NCT01993940|3582151|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
3747316|NCT01993940|3582152|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
3747317|NCT01993940|3582150|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3747318|NCT01993940|3582151|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3747319|NCT01993940|3582152|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3747320|NCT01993940|3582150|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3747321|NCT01993940|3582151|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3747322|NCT01993940|3582152|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3747323|NCT01993940|3582150|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747324|NCT01993940|3582151|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747325|NCT01993940|3582152|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747326|NCT01993940|3582150|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|497|497.0||||||
3747327|NCT01993940|3582151|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|247|247.0||||||
3747328|NCT01993940|3582152|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|250|250.0||||||
3747329|NCT01993940|3582150|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3747330|NCT01993940|3582151|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3747331|NCT01993940|3582152|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3747332|NCT01993940|3582150|B3||Male|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
3747333|NCT01993940|3582151|B2||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3747334|NCT01993940|3582152|B1||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3747335|NCT01993940|3582150|B3||Female|Sex: Female, Male||Participants|Count of Participants|333|333.0||||||
3747336|NCT01993940|3582151|B2||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3747337|NCT01993940|3582152|B1||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3747338|NCT01993940|3582150|B3|≥ 65 years||Age, Customized||participants|Number|82|82.0||||||
3747339|NCT01993940|3582151|B2|≥ 65 years||Age, Customized||participants|Number|38|38.0||||||
3747340|NCT01993940|3582152|B1|≥ 65 years||Age, Customized||participants|Number|44|44.0||||||
3747341|NCT01993940|3582150|B3|≥ 40 to < 65 years||Age, Customized||participants|Number|406|406.0||||||
3747342|NCT01993940|3582151|B2|≥ 40 to < 65 years||Age, Customized||participants|Number|196|196.0||||||
3747343|NCT01993940|3582152|B1|≥ 40 to < 65 years||Age, Customized||participants|Number|210|210.0||||||
3747344|NCT01993940|3582150|B3|< 40 years||Age, Customized||participants|Number|62|62.0||||||
3747345|NCT01993940|3582151|B2|< 40 years||Age, Customized||participants|Number|40|40.0||||||
3747346|NCT01993940|3582152|B1|< 40 years||Age, Customized||participants|Number|22|22.0||||||
3747347|NCT01993940|3582150|B3|||Age||Years|Mean|53.5|53.5|Standard Deviation|10.96|10.96|||
3747348|NCT01993940|3582151|B2|||Age||Years|Mean|52.9|52.9|Standard Deviation|11.40|11.4|||
3747349|NCT01993940|3582152|B1|||Age||Years|Mean|54.1|54.1|Standard Deviation|10.48|10.48|||
3747350|NCT01993927|3582167|B1|Unknown||Compliance of Exercise Therapy at Treatment Start||Participants|Count of Participants|113|113.0||||||
3747351|NCT01993927|3582167|B1|Compliance level of < 70%||Compliance of Exercise Therapy at Treatment Start||Participants|Count of Participants|269|269.0||||||
3747352|NCT01993927|3582167|B1|Compliance level of ≥ 70%||Compliance of Exercise Therapy at Treatment Start||Participants|Count of Participants|331|331.0||||||
3747353|NCT01993927|3582167|B1|Unknown||Compliance of Exercise Therapy at 3 Months prior to Study Start||Participants|Count of Participants|232|232.0||||||
3747354|NCT01993927|3582167|B1|Compliance level of < 70%||Compliance of Exercise Therapy at 3 Months prior to Study Start||Participants|Count of Participants|221|221.0||||||
3747355|NCT01993927|3582167|B1|Compliance level of ≥ 70%||Compliance of Exercise Therapy at 3 Months prior to Study Start||Participants|Count of Participants|260|260.0||||||
3747356|NCT01993927|3582167|B1|Unknown||Compliance of Exercise Therapy at 6 Months prior to Study Start||Participants|Count of Participants|426|426.0||||||
3747357|NCT01993927|3582167|B1|Compliance level of < 70%||Compliance of Exercise Therapy at 6 Months prior to Study Start||Participants|Count of Participants|120|120.0||||||
3747358|NCT01993927|3582167|B1|Compliance level of ≥ 70%||Compliance of Exercise Therapy at 6 Months prior to Study Start||Participants|Count of Participants|167|167.0||||||
3747359|NCT01993927|3582167|B1|Unknown||Compliance of Dietary Therapy at Treatment Start||Participants|Count of Participants|82|82.0||||||
3747361|NCT01993927|3582167|B1|Compliance level of ≥ 70%||Compliance of Dietary Therapy at Treatment Start||Participants|Count of Participants|391|391.0||||||
3747362|NCT01993927|3582167|B1|Unknown||Compliance of Dietary Therapy at 3 Months prior to Study Start||Participants|Count of Participants|204|204.0||||||
3747363|NCT01993927|3582167|B1|Compliance level of < 70%||Compliance of Dietary Therapy at 3 Months prior to Study Start||Participants|Count of Participants|212|212.0||||||
3747364|NCT01993927|3582167|B1|Compliance level of ≥ 70%||Compliance of Dietary Therapy at 3 Months prior to Study Start||Participants|Count of Participants|297|297.0||||||
3747365|NCT01993927|3582167|B1|Unknown||Compliance of Dietary Therapy at 6 Months prior to Study Start||Participants|Count of Participants|419|419.0||||||
3747366|NCT01993927|3582167|B1|Compliance level of < 70%||Compliance of Dietary Therapy at 6 Months prior to Study Start||Participants|Count of Participants|107|107.0||||||
3747367|NCT01993927|3582167|B1|Compliance level of ≥ 70%||Compliance of Dietary Therapy at 6 Months prior to Study Start||Participants|Count of Participants|187|187.0||||||
3747368|NCT01993927|3582167|B1|Five Factors||Number of Risk Factor|Reporting number of factors of risk which each participant had at study start. Factors included Glucose Intolerance, Complication of Hypertension, Complication of Hyperlipidemia, Obesity, Family History of Diabetes in Second-Degree Relatives|Participants|Count of Participants|19|19.0||||||
3747369|NCT01993927|3582167|B1|Four Factors||Number of Risk Factor|Reporting number of factors of risk which each participant had at study start. Factors included Glucose Intolerance, Complication of Hypertension, Complication of Hyperlipidemia, Obesity, Family History of Diabetes in Second-Degree Relatives|Participants|Count of Participants|178|178.0||||||
3747370|NCT01993927|3582167|B1|Three Factors||Number of Risk Factor|Reporting number of factors of risk which each participant had at study start. Factors included Glucose Intolerance, Complication of Hypertension, Complication of Hyperlipidemia, Obesity, Family History of Diabetes in Second-Degree Relatives|Participants|Count of Participants|278|278.0||||||
3747371|NCT01993927|3582167|B1|Two Factors||Number of Risk Factor|Reporting number of factors of risk which each participant had at study start. Factors included Glucose Intolerance, Complication of Hypertension, Complication of Hyperlipidemia, Obesity, Family History of Diabetes in Second-Degree Relatives|Participants|Count of Participants|238|238.0||||||
3747372|NCT01993927|3582167|B1|One Factor||Number of Risk Factor|Reporting number of factors of risk which each participant had at study start. Factors included Glucose Intolerance, Complication of Hypertension, Complication of Hyperlipidemia, Obesity, Family History of Diabetes in Second-Degree Relatives|Participants|Count of Participants|0|0.0||||||
3747373|NCT01993927|3582167|B1|None||Number of Risk Factor|Reporting number of factors of risk which each participant had at study start. Factors included Glucose Intolerance, Complication of Hypertension, Complication of Hyperlipidemia, Obesity, Family History of Diabetes in Second-Degree Relatives|Participants|Count of Participants|0|0.0||||||
3747374|NCT01993927|3582167|B1|||Insulinogenic Index|Insulinogenic Index measures secretion of insulin, calculated by change from baseline in measured blood insulin at 30min (mcrU/ml), divided by change from baseline in measured blood glucose at 30min (mg/dl).|Score of insulinogenic Index|Mean|0.449|0.449|Standard Deviation|0.3914|0.3914|||
3747375|NCT01993927|3582167|B1|||Homeostasis Model Assessment of Insulin Resistance|Homeostasis Model assessment of insulin resistance measures insulin resistance, calculated by fasting insulin times fasting glucose, divided by a constant (405).|Percent score of insulin resistance|Mean|1.913|1.913|Standard Deviation|1.3331|1.3331|||
3747376|NCT01993927|3582167|B1|||HbA1c (National Glycohemoglobin Standardization Program; NGSP Value)|HbA1c (NGSP) shows a concentration of glucose bound to hemoglobin as a percent of the absolute maximum that can be bound. The 6.5% HbA1c is the JDS value, and is equivalent to the NGSP HbA1c value of 6.9%.|Percent|Mean|6.11|6.11|Standard Deviation|0.406|0.406|||
3747377|NCT01993927|3582167|B1|||HbA1c (Japan DiabetesSociety; JDS Value)|HbA1c (JDS) shows a concentration of glucose bound to hemoglobin as a percent of the absolute maximum that can be bound. The 6.5% HbA1c is the JDS value, and is equivalent to the NGSP HbA1c value of 6.9%.|Percent|Mean|5.72|5.72|Standard Deviation|0.399|0.399|||
3747378|NCT01993927|3582167|B1|||Blood Insulin Level at 2 hr after Dosing||mcU/mL|Mean|69.405|69.405|Standard Deviation|52.2083|52.2083|||
3747379|NCT01993927|3582167|B1|||Blood Insulin Level at 30 min after Dosing||mcU/mL|Mean|38.122|38.122|Standard Deviation|25.7354|25.7354|||
3747380|NCT01993927|3582167|B1|||Fasting Blood Insulin Level||mcU/mL|Mean|7.311|7.311|Standard Deviation|4.8720|4.872|||
3747381|NCT01993927|3582167|B1|||75g OGTT Blood Glucose Level at 2 hr after Dosing||mg/dL|Mean|168.2|168.2|Standard Deviation|17.42|17.42|||
3747382|NCT01993927|3582167|B1|||75g OGTT Blood Glucose Level at 30 min after Dosing||mg/dL|Mean|181.4|181.4|Standard Deviation|28.45|28.45|||
3747383|NCT01993927|3582167|B1|||75g OGTT Fasting Blood Glucose Level|OGTT; Oral glucose tolerance test. 75 g Oral glucose tolerance test measures blood glucose through blood samples drawn at 30, 60, 120 minutes following consumption of a 75 g glucose beverage.|mg/dL|Mean|105.3|105.3|Standard Deviation|11.00|11.0|||
3747384|NCT01993927|3582167|B1|IV (very strong activities in a day)||Daily Activity Intensity Index|Daily Activity Intensity Index is scored time in a day checked by investigators, assessing intensity of daily-life activities including five sub-scales which are Laying, Standing, Walking, Running and Exercising. Score range is from 1 (very mild activities in a day) to 4 (very strong activities in a day). Higher scores reflect stronger activities of participants in a day.|Participants|Count of Participants|7|7.0||||||
3747385|NCT01993927|3582167|B1|III (moderate/optimal)||Daily Activity Intensity Index|Daily Activity Intensity Index is scored time in a day checked by investigators, assessing intensity of daily-life activities including five sub-scales which are Laying, Standing, Walking, Running and Exercising. Score range is from 1 (very mild activities in a day) to 4 (very strong activities in a day). Higher scores reflect stronger activities of participants in a day.|Participants|Count of Participants|245|245.0||||||
3747386|NCT01993927|3582167|B1|II (mild activities)||Daily Activity Intensity Index|Daily Activity Intensity Index is scored time in a day checked by investigators, assessing intensity of daily-life activities including five sub-scales which are Laying, Standing, Walking, Running and Exercising. Score range is from 1 (very mild activities in a day) to 4 (very strong activities in a day). Higher scores reflect stronger activities of participants in a day.|Participants|Count of Participants|302|302.0||||||
3747476|NCT01993888|3582175|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3747387|NCT01993927|3582167|B1|I (very mild activities in a day)||Daily Activity Intensity Index|Daily Activity Intensity Index is scored time in a day checked by investigators, assessing intensity of daily-life activities including five sub-scales which are Laying, Standing, Walking, Running and Exercising. Score range is from 1 (very mild activities in a day) to 4 (very strong activities in a day). Higher scores reflect stronger activities of participants in a day.|Participants|Count of Participants|159|159.0||||||
3747388|NCT01993927|3582167|B1|≥ 1 year||Duration of Dietary and Exercise Therapies prior to the Administration of Voglibose||Participants|Count of Participants|14|14.0||||||
3747389|NCT01993927|3582167|B1|≥ 6 months < 1 year||Duration of Dietary and Exercise Therapies prior to the Administration of Voglibose||Participants|Count of Participants|163|163.0||||||
3747390|NCT01993927|3582167|B1|≥ 3 months < 6 months||Duration of Dietary and Exercise Therapies prior to the Administration of Voglibose||Participants|Count of Participants|176|176.0||||||
3747391|NCT01993927|3582167|B1|< 3 months||Duration of Dietary and Exercise Therapies prior to the Administration of Voglibose||Participants|Count of Participants|304|304.0||||||
3747392|NCT01993927|3582167|B1|Not performed||Duration of Dietary and Exercise Therapies prior to the Administration of Voglibose||Participants|Count of Participants|56|56.0||||||
3747393|NCT01993927|3582167|B1|Unknown||Smoking Classification||Participants|Count of Participants|1|1.0||||||
3747394|NCT01993927|3582167|B1|Current Smoker||Smoking Classification||Participants|Count of Participants|92|92.0||||||
3747395|NCT01993927|3582167|B1|Ex-Smoker||Smoking Classification||Participants|Count of Participants|87|87.0||||||
3747396|NCT01993927|3582167|B1|Never Smoked||Smoking Classification||Participants|Count of Participants|533|533.0||||||
3747397|NCT01993927|3582167|B1|Unknown||Drinking Habits||Participants|Count of Participants|1|1.0||||||
3747398|NCT01993927|3582167|B1|Current Drinker||Drinking Habits||Participants|Count of Participants|261|261.0||||||
3747399|NCT01993927|3582167|B1|Ex-Drinker||Drinking Habits||Participants|Count of Participants|47|47.0||||||
3747400|NCT01993927|3582167|B1|Never Drank||Drinking Habits||Participants|Count of Participants|404|404.0||||||
3747401|NCT01993927|3582167|B1|||BMI|Body Mass Index = weight (kg)/[height (m)^2]|kg/m^2|Mean|24.55|24.55|Standard Deviation|3.873|3.873|||
3747402|NCT01993927|3582167|B1|||Weight||kg|Mean|63.21|63.21|Standard Deviation|13.097|13.097|||
3747403|NCT01993927|3582167|B1|||Height||cm|Mean|160.21|160.21|Standard Deviation|9.619|9.619|||
3747404|NCT01993927|3582167|B1|Unknown||Medical History|Medical history defined as a disease or a health condition for each participant before start of the study. Medical history was classified as congenital anomalies, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, GI disorders, hepatic and biliary disorders, renal disease and other medical history. Other medical history included all medical history except for those mentioned above.|Participants|Count of Participants|3|3.0||||||
3747405|NCT01993927|3582167|B1|Had Presence of Medical History||Medical History|Medical history defined as a disease or a health condition for each participant before start of the study. Medical history was classified as congenital anomalies, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, GI disorders, hepatic and biliary disorders, renal disease and other medical history. Other medical history included all medical history except for those mentioned above.|Participants|Count of Participants|126|126.0||||||
3747406|NCT01993927|3582167|B1|Had No Presence of Medical History||Medical History|Medical history defined as a disease or a health condition for each participant before start of the study. Medical history was classified as congenital anomalies, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, GI disorders, hepatic and biliary disorders, renal disease and other medical history. Other medical history included all medical history except for those mentioned above.|Participants|Count of Participants|584|584.0||||||
3747407|NCT01993927|3582167|B1|Had Presence of Medical Complications||Medical Complications|Complications defined as a disease or a health condition for each participant at the start of study. Complications were classified as congenital anomalies, endocrine disorders, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, gastrointestinal (GI) disorders, renal disease and other complications. Other complications included all complications except for those mentioned above.|Participants|Count of Participants|667|667.0||||||
3747408|NCT01993927|3582167|B1|Had No Presence of Medical Complications||Medical Complications|Complications defined as a disease or a health condition for each participant at the start of study. Complications were classified as congenital anomalies, endocrine disorders, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, gastrointestinal (GI) disorders, renal disease and other complications. Other complications included all complications except for those mentioned above.|Participants|Count of Participants|46|46.0||||||
3747409|NCT01993927|3582167|B1|Had History of Obesity||History of Obesity|Number of Participants with 25 kg/m^2 or more as Body Mass Index were reported.|Participants|Count of Participants|303|303.0||||||
3747410|NCT01993927|3582167|B1|Had No History of Obesity||History of Obesity|Number of Participants with 25 kg/m^2 or more as Body Mass Index were reported.|Participants|Count of Participants|410|410.0||||||
3747411|NCT01993927|3582167|B1|Had Family History of Diabetes||Family History of Diabetes in Second-Degree Relatives||Participants|Count of Participants|146|146.0||||||
3747412|NCT01993927|3582167|B1|Had No Family History of Diabetes||Family History of Diabetes in Second-Degree Relatives||Participants|Count of Participants|567|567.0||||||
3747413|NCT01993927|3582167|B1|Unknown||History of Allergy||Participants|Count of Participants|31|31.0||||||
3747414|NCT01993927|3582167|B1|Had History of Allergy||History of Allergy||Participants|Count of Participants|59|59.0||||||
3747415|NCT01993927|3582167|B1|Had No History of Allergy||History of Allergy||Participants|Count of Participants|623|623.0||||||
3747416|NCT01993927|3582167|B1|Pregnant||Pregnancy Status||Participants|Count of Participants|0|0.0||||||
3747417|NCT01993927|3582167|B1|Not pregnant||Pregnancy Status||Participants|Count of Participants|337|337.0||||||
3747418|NCT01993927|3582167|B1|Inpatient and Outpatient||Healthcare Category|Participants were categorized as outpatient, inpatient, and outpatient and inpatient (participants who were both outpatient and inpatient during some point at the time and 3 months prior to enrollment).|Participants|Count of Participants|5|5.0||||||
3747419|NCT01993927|3582167|B1|Inpatient||Healthcare Category|Participants were categorized as outpatient, inpatient, and outpatient and inpatient (participants who were both outpatient and inpatient during some point at the time and 3 months prior to enrollment).|Participants|Count of Participants|2|2.0||||||
3747420|NCT01993927|3582167|B1|Outpatient||Healthcare Category|Participants were categorized as outpatient, inpatient, and outpatient and inpatient (participants who were both outpatient and inpatient during some point at the time and 3 months prior to enrollment).|Participants|Count of Participants|706|706.0||||||
3747421|NCT01993927|3582167|B1|||Duration of Disease|Mean Duration between start of study and first time of diagnosis of Impaired Glucose Tolerance (IGT) was reported.|Months|Mean|12.51|12.51|Standard Deviation|23.708|23.708|||
3747422|NCT01993927|3582167|B1|Japan||Region of Enrollment|All participants were enrolled in Japan.|Participants|Number|713|713.0||||||
3747423|NCT01993927|3582167|B1||Male|Sex: Female, Male||Participants|Count of Participants|376|376.0||||||
3747424|NCT01993927|3582167|B1||Female|Sex: Female, Male||Participants|Count of Participants|337|337.0||||||
3747425|NCT01993927|3582167|B1|||Age||years|Mean|62.6|62.6|Standard Deviation|11.86|11.86|||
3747426|NCT01993888|3582173|B3|Morbidly Obese||BMI (Grouped)||participants|Number|4|4.0||||||
3747427|NCT01993888|3582174|B2|Morbidly Obese||BMI (Grouped)||participants|Number|2|2.0||||||
3747428|NCT01993888|3582175|B1|Morbidly Obese||BMI (Grouped)||participants|Number|2|2.0||||||
3747429|NCT01993888|3582173|B3|Obese||BMI (Grouped)||participants|Number|32|32.0||||||
3747430|NCT01993888|3582174|B2|Obese||BMI (Grouped)||participants|Number|18|18.0||||||
3747431|NCT01993888|3582175|B1|Obese||BMI (Grouped)||participants|Number|14|14.0||||||
3747432|NCT01993888|3582173|B3|Overweight||BMI (Grouped)||participants|Number|35|35.0||||||
3747433|NCT01993888|3582174|B2|Overweight||BMI (Grouped)||participants|Number|16|16.0||||||
3747434|NCT01993888|3582175|B1|Overweight||BMI (Grouped)||participants|Number|19|19.0||||||
3747435|NCT01993888|3582173|B3|Normal||BMI (Grouped)||participants|Number|27|27.0||||||
3747436|NCT01993888|3582174|B2|Normal||BMI (Grouped)||participants|Number|14|14.0||||||
3747437|NCT01993888|3582175|B1|Normal||BMI (Grouped)||participants|Number|13|13.0||||||
3747438|NCT01993888|3582173|B3|Underweight||BMI (Grouped)||participants|Number|4|4.0||||||
3747439|NCT01993888|3582174|B2|Underweight||BMI (Grouped)||participants|Number|2|2.0||||||
3747440|NCT01993888|3582175|B1|Underweight||BMI (Grouped)||participants|Number|2|2.0||||||
3747441|NCT01993888|3582173|B3|||BMI (kg/m2)||kg/m^2|Median|27.4|27.4|Full Range|||15.2|43.3|
3747442|NCT01993888|3582174|B2|||BMI (kg/m2)||kg/m^2|Median|26.8|26.8|Full Range|||15.2|42.5|
3747443|NCT01993888|3582175|B1|||BMI (kg/m2)||kg/m^2|Median|27.5|27.5|Full Range|||17.5|43.3|
3747444|NCT01993888|3582173|B3|||BMI (kg/m2)||kg/m^2|Mean|28|28.0|Standard Deviation|5.7|5.7|||
3747445|NCT01993888|3582174|B2|||BMI (kg/m2)||kg/m^2|Mean|28.1|28.1|Standard Deviation|5.9|5.9|||
3747446|NCT01993888|3582175|B1|||BMI (kg/m2)||kg/m^2|Mean|28|28.0|Standard Deviation|5.6|5.6|||
3747447|NCT01993888|3582173|B3|Australia||Region of Enrollment||participants|Number|23|23.0||||||
3747448|NCT01993888|3582174|B2|Australia||Region of Enrollment||participants|Number|12|12.0||||||
3747449|NCT01993888|3582175|B1|Australia||Region of Enrollment||participants|Number|11|11.0||||||
3747450|NCT01993888|3582173|B3|United Kingdom||Region of Enrollment||participants|Number|30|30.0||||||
3747451|NCT01993888|3582174|B2|United Kingdom||Region of Enrollment||participants|Number|15|15.0||||||
3747452|NCT01993888|3582175|B1|United Kingdom||Region of Enrollment||participants|Number|15|15.0||||||
3747453|NCT01993888|3582173|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
3747454|NCT01993888|3582174|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
3747455|NCT01993888|3582175|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3747456|NCT01993888|3582173|B3|New Zealand||Region of Enrollment||participants|Number|13|13.0||||||
3747457|NCT01993888|3582174|B2|New Zealand||Region of Enrollment||participants|Number|7|7.0||||||
3747458|NCT01993888|3582175|B1|New Zealand||Region of Enrollment||participants|Number|6|6.0||||||
3747459|NCT01993888|3582173|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3747460|NCT01993888|3582174|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3747461|NCT01993888|3582175|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3747462|NCT01993888|3582173|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747463|NCT01993888|3582174|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747464|NCT01993888|3582175|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747465|NCT01993888|3582173|B3||White|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3747466|NCT01993888|3582174|B2||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3747467|NCT01993888|3582175|B1||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3747468|NCT01993888|3582173|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3747469|NCT01993888|3582174|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3747470|NCT01993888|3582175|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3747471|NCT01993888|3582173|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747472|NCT01993888|3582174|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747473|NCT01993888|3582175|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747474|NCT01993888|3582173|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3747475|NCT01993888|3582174|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3747477|NCT01993888|3582173|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747478|NCT01993888|3582174|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747479|NCT01993888|3582175|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747480|NCT01993888|3582173|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3747481|NCT01993888|3582174|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3747482|NCT01993888|3582175|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3747483|NCT01993888|3582173|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3747484|NCT01993888|3582174|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3747485|NCT01993888|3582175|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3747486|NCT01993888|3582173|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3747487|NCT01993888|3582174|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3747488|NCT01993888|3582175|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3747489|NCT01993888|3582173|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3747490|NCT01993888|3582174|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3747491|NCT01993888|3582175|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3747492|NCT01993888|3582173|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3747493|NCT01993888|3582174|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3747494|NCT01993888|3582175|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3747495|NCT01993888|3582173|B3|||Age||years|Median|63|63.0|Standard Deviation|12.7|12.7|||
3747496|NCT01993888|3582174|B2|||Age||years|Median|63|63.0|Standard Deviation|10.9|10.9|||
3747497|NCT01993888|3582175|B1|||Age||years|Median|64|64.0|Standard Deviation|14.5|14.5|||
3747498|NCT01993888|3582173|B3|||Age||years|Mean|62.2|62.2|Full Range|||23.0|85.0|
3747499|NCT01993888|3582174|B2|||Age||years|Mean|63.2|63.2|Full Range|||36.0|85.0|
3747500|NCT01993888|3582175|B1|||Age||years|Mean|61.3|61.3|Full Range|||23.0|81.0|
3747501|NCT01993888|3582173|B3||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
3747502|NCT01993888|3582174|B2||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3747503|NCT01993888|3582175|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3747504|NCT01993888|3582173|B3||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3747505|NCT01993888|3582174|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3747506|NCT01993888|3582175|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3747507|NCT01993888|3582173|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3747508|NCT01993888|3582174|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3747509|NCT01993888|3582175|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3747510|NCT01993849|3582192|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747511|NCT01993849|3582193|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747512|NCT01993849|3582194|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747513|NCT01993849|3582192|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747514|NCT01993849|3582193|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747515|NCT01993849|3582194|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747516|NCT01993849|3582192|B3||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3747517|NCT01993849|3582193|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3747518|NCT01993849|3582194|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3747519|NCT01993849|3582192|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3747520|NCT01993849|3582193|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3747521|NCT01993849|3582194|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3747522|NCT01993849|3582192|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747523|NCT01993849|3582193|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747524|NCT01993849|3582194|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747525|NCT01993849|3582192|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3747526|NCT01993849|3582193|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747527|NCT01993849|3582194|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3747528|NCT01993849|3582192|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747529|NCT01993849|3582193|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747530|NCT01993849|3582194|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747531|NCT01993849|3582192|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3747532|NCT01993849|3582193|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3747533|NCT01993849|3582194|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3747534|NCT01993849|3582192|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3747535|NCT01993849|3582193|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3747536|NCT01993849|3582194|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3747537|NCT01993849|3582192|B3|||Age||years|Mean|27.0|27.0|Standard Deviation|4.9|4.9|||
3747538|NCT01993849|3582193|B2|||Age||years|Mean|27.4|27.4|Standard Deviation|4.7|4.7|||
3747539|NCT01993849|3582194|B1|||Age||years|Mean|26.7|26.7|Standard Deviation|5.2|5.2|||
3747540|NCT01993823|3582203|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3747541|NCT01993823|3582204|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3747542|NCT01993823|3582205|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3747543|NCT01993823|3582203|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3747544|NCT01993823|3582204|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3747545|NCT01993823|3582205|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3747546|NCT01993823|3582203|B3|||Age||years|Mean|40.8|40.8|Standard Deviation|14.5|14.5|||
3747547|NCT01993823|3582204|B2|||Age||years|Mean|39.8|39.8|Standard Deviation|13.0|13.0|||
3747548|NCT01993823|3582205|B1|||Age||years|Mean|41.8|41.8|Standard Deviation|15.8|15.8|||
3747549|NCT01993238|3582214|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3747550|NCT01993238|3582214|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3747551|NCT01993238|3582214|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3747552|NCT01993238|3582214|B1|||Age||years|Mean|35.9|35.9|Standard Deviation|11.2|11.2|||
3747553|NCT01993108|3582219|B3|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3747554|NCT01993108|3582220|B2|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3747555|NCT01993108|3582221|B1|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3747556|NCT01993108|3582219|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747557|NCT01993108|3582220|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747558|NCT01993108|3582221|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747559|NCT01993108|3582219|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3747560|NCT01993108|3582220|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747561|NCT01993108|3582221|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3747562|NCT01993108|3582219|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3747563|NCT01993108|3582220|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3747564|NCT01993108|3582221|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3747565|NCT01993108|3582219|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3747566|NCT01993108|3582220|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3747567|NCT01993108|3582221|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3747568|NCT01993108|3582219|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747569|NCT01993108|3582220|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747570|NCT01993108|3582221|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747571|NCT01993108|3582219|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3747572|NCT01993108|3582220|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3747573|NCT01993108|3582221|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3747574|NCT01993108|3582219|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747575|NCT01993108|3582220|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747576|NCT01993108|3582221|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747577|NCT01993108|3582219|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3747578|NCT01993108|3582220|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3747579|NCT01993108|3582221|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3747580|NCT01993108|3582219|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3747581|NCT01993108|3582220|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3747582|NCT01993108|3582221|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3747583|NCT01993108|3582219|B3|||Age||years|Mean|23.4|23.4|Standard Deviation|4.4|4.4|||
3747584|NCT01993108|3582220|B2|||Age||years|Mean|22.08|22.08|Standard Deviation|3.4|3.4|||
3747585|NCT01993108|3582221|B1|||Age||years|Mean|24.9|24.9|Standard Deviation|5.0|5.0|||
3747586|NCT01993108|3582219|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3747587|NCT01993108|3582220|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3747588|NCT01993108|3582221|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3747589|NCT01993108|3582219|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3747590|NCT01993108|3582220|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3747591|NCT01993108|3582221|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3747592|NCT01993108|3582219|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3747593|NCT01993108|3582220|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3747594|NCT01993108|3582221|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3747595|NCT01993030|3582251|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3747596|NCT01993030|3582252|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3747597|NCT01993030|3582253|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3747598|NCT01993030|3582251|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3747599|NCT01993030|3582252|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3747600|NCT01993030|3582253|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3747601|NCT01993030|3582251|B3|||Age||years|Mean|37.59|37.59|Standard Deviation|14.41|14.41|||
3747602|NCT01993030|3582252|B2|||Age||years|Mean|37.80|37.8|Standard Deviation|14.73|14.73|||
3747603|NCT01993030|3582253|B1|||Age||years|Mean|37.39|37.39|Standard Deviation|14.29|14.29|||
3747604|NCT01992874|3582268|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3747605|NCT01992874|3582268|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3747606|NCT01992874|3582268|B1|||Age||years|Mean|60.6|60.6|Standard Deviation|11.74|11.74|||
3747607|NCT01992757|3582298|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
3747608|NCT01992757|3582298|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3747609|NCT01992757|3582298|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3747610|NCT01992757|3582298|B1|||Age||years|Mean|63.1|63.1|Full Range|||22.0|84.0|
3747611|NCT01992757|3582298|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3747612|NCT01992757|3582298|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3747613|NCT01992757|3582298|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3747614|NCT01992536|3582303|B11|Male||Sex/Gender, Customized||Participants|Number|91|91.0||||||
3747615|NCT01992536|3582304|B10|Male||Sex/Gender, Customized||Participants|Number|8|8.0||||||
3747616|NCT01992536|3582305|B9|Male||Sex/Gender, Customized||Participants|Number|7|7.0||||||
3747617|NCT01992536|3582306|B8|Male||Sex/Gender, Customized||Participants|Number|9|9.0||||||
3747618|NCT01992536|3582307|B7|Male||Sex/Gender, Customized||Participants|Number|4|4.0||||||
3747619|NCT01992536|3582308|B6|Male||Sex/Gender, Customized||Participants|Number|6|6.0||||||
3747620|NCT01992536|3582309|B5|Male||Sex/Gender, Customized||Participants|Number|9|9.0||||||
3747621|NCT01992536|3582310|B4|Male||Sex/Gender, Customized||Participants|Number|10|10.0||||||
3747622|NCT01992536|3582311|B3|Male||Sex/Gender, Customized||Participants|Number|8|8.0||||||
3747623|NCT01992536|3582312|B2|Male||Sex/Gender, Customized||Participants|Number|12|12.0||||||
3747624|NCT01992536|3582313|B1|Male||Sex/Gender, Customized||Participants|Number|18|18.0||||||
3747625|NCT01992536|3582303|B11|Female||Sex/Gender, Customized||Participants|Number|99|99.0||||||
3747626|NCT01992536|3582304|B10|Female||Sex/Gender, Customized||Participants|Number|11|11.0||||||
3747627|NCT01992536|3582305|B9|Female||Sex/Gender, Customized||Participants|Number|12|12.0||||||
3747628|NCT01992536|3582306|B8|Female||Sex/Gender, Customized||Participants|Number|12|12.0||||||
3747629|NCT01992536|3582307|B7|Female||Sex/Gender, Customized||Participants|Number|3|3.0||||||
3747630|NCT01992536|3582308|B6|Female||Sex/Gender, Customized||Participants|Number|15|15.0||||||
3747631|NCT01992536|3582309|B5|Female||Sex/Gender, Customized||Participants|Number|2|2.0||||||
3747632|NCT01992536|3582310|B4|Female||Sex/Gender, Customized||Participants|Number|14|14.0||||||
3747633|NCT01992536|3582311|B3|Female||Sex/Gender, Customized||Participants|Number|9|9.0||||||
3747634|NCT01992536|3582312|B2|Female||Sex/Gender, Customized||Participants|Number|13|13.0||||||
3747635|NCT01992536|3582313|B1|Female||Sex/Gender, Customized||Participants|Number|8|8.0||||||
3747636|NCT01992536|3582303|B11|||Age||Years|Mean|18.4|18.4|Standard Deviation|5.08|5.08|||
3747637|NCT01992536|3582304|B10|||Age||Years|Mean|17.6|17.6|Standard Deviation|5.19|5.19|||
3747638|NCT01992536|3582305|B9|||Age||Years|Mean|19.2|19.2|Standard Deviation|6.1|6.1|||
3747639|NCT01992536|3582306|B8|||Age||Years|Mean|16.8|16.8|Standard Deviation|4.65|4.65|||
3747640|NCT01992536|3582307|B7|||Age||Years|Mean|17.9|17.9|Standard Deviation|4.67|4.67|||
3747641|NCT01992536|3582308|B6|||Age||Years|Mean|19.7|19.7|Standard Deviation|5.36|5.36|||
3747642|NCT01992536|3582309|B5|||Age||Years|Mean|20.9|20.9|Standard Deviation|3.99|3.99|||
3747643|NCT01992536|3582310|B4|||Age||Years|Mean|19|19.0|Standard Deviation|5.4|5.4|||
3747644|NCT01992536|3582311|B3|||Age||Years|Mean|18|18.0|Standard Deviation|5.05|5.05|||
3747645|NCT01992536|3582312|B2|||Age||Years|Mean|17.1|17.1|Standard Deviation|4.31|4.31|||
3747646|NCT01992536|3582313|B1|||Age||Years|Mean|18.8|18.8|Standard Deviation|5.19|5.19|||
3747647|NCT01992523|3582537|B3|Italy||Region of Enrollment||participants|Number|52|52.0||||||
3747648|NCT01992523|3582538|B2|Italy||Region of Enrollment||participants|Number|26|26.0||||||
3747649|NCT01992523|3582539|B1|Italy||Region of Enrollment||participants|Number|26|26.0||||||
3747650|NCT01992523|3582537|B3|Greece||Region of Enrollment||participants|Number|30|30.0||||||
3747651|NCT01992523|3582538|B2|Greece||Region of Enrollment||participants|Number|15|15.0||||||
3747652|NCT01992523|3582539|B1|Greece||Region of Enrollment||participants|Number|15|15.0||||||
3747653|NCT01992523|3582537|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3747654|NCT01992523|3582538|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3747655|NCT01992523|3582539|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3747656|NCT01992523|3582537|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3747657|NCT01992523|3582538|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3747658|NCT01992523|3582539|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3747659|NCT01992523|3582537|B3|||Age||years|Mean|62|62.0|Standard Deviation|13|13.0|||
3747660|NCT01992523|3582538|B2|||Age||years|Mean|61|61.0|Standard Deviation|14|14.0|||
3747661|NCT01992523|3582539|B1|||Age||years|Mean|64|64.0|Standard Deviation|13|13.0|||
3747662|NCT01992185|3582552|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
3747663|NCT01992185|3582553|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3747664|NCT01992185|3582554|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3747665|NCT01992185|3582552|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3747666|NCT01992185|3582553|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3747667|NCT01992185|3582554|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3747668|NCT01992185|3582552|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3747669|NCT01992185|3582553|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3747670|NCT01992185|3582554|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3747671|NCT01992185|3582552|B3|||Age||years|Mean|36.5|36.5|Standard Deviation|13.9|13.9|||
3747672|NCT01992185|3582553|B2|||Age||years|Mean|35.1|35.1|Standard Deviation|15.2|15.2|||
3747673|NCT01992185|3582554|B1|||Age||years|Mean|38|38.0|Standard Deviation|13.4|13.4|||
3747674|NCT01992172|3582561|B3|United States||Region of Enrollment||Participants|Number|7|7.0||||||
3747675|NCT01992172|3582563|B1|United States||Region of Enrollment||Participants|Number|7|7.0||||||
3747676|NCT01992172|3582561|B3|Male||Gender||Participants|Number|0|0.0||||||
3747677|NCT01992172|3582563|B1|Male||Gender||Participants|Number|0|0.0||||||
3747678|NCT01992172|3582561|B3|Female||Gender||Participants|Number|7|7.0||||||
3747679|NCT01992172|3582563|B1|Female||Gender||Participants|Number|7|7.0||||||
3747680|NCT01992172|3582561|B3|||Age||Years|Mean|32.3|32.3|Standard Deviation|5.29|5.29|||
3747681|NCT01992172|3582563|B1|||Age||Years|Mean|32.3|32.3|Standard Deviation|5.29|5.29|||
3747682|NCT01992172|3582561|B3|>=65 years||Age||Participants|Number|0|0.0||||||
3747683|NCT01992172|3582563|B1|>=65 years||Age||Participants|Number|0|0.0||||||
3747684|NCT01992172|3582561|B3|Between 18 and 65 years||Age||Participants|Number|7|7.0||||||
3747685|NCT01992172|3582563|B1|Between 18 and 65 years||Age||Participants|Number|7|7.0||||||
3747686|NCT01992172|3582561|B3|<=18 years||Age||Participants|Number|0|0.0||||||
3747687|NCT01992172|3582563|B1|<=18 years||Age||Participants|Number|0|0.0||||||
3747688|NCT01992107|3582570|B4||Male|Sex: Female, Male||Participants|Count of Participants|1209|1209.0||||||
3747689|NCT01992107|3582571|B3||Male|Sex: Female, Male||Participants|Count of Participants|297|297.0||||||
3747690|NCT01992107|3582572|B2||Male|Sex: Female, Male||Participants|Count of Participants|309|309.0||||||
3747691|NCT01992107|3582573|B1||Male|Sex: Female, Male||Participants|Count of Participants|603|603.0||||||
3747692|NCT01992107|3582570|B4||Female|Sex: Female, Male||Participants|Count of Participants|1124|1124.0||||||
3747693|NCT01992107|3582571|B3||Female|Sex: Female, Male||Participants|Count of Participants|284|284.0||||||
3747694|NCT01992107|3582572|B2||Female|Sex: Female, Male||Participants|Count of Participants|284|284.0||||||
3747695|NCT01992107|3582573|B1||Female|Sex: Female, Male||Participants|Count of Participants|556|556.0||||||
3747696|NCT01992107|3582570|B4|||Age||year|Mean|9.5|9.5|Standard Deviation|3.8|3.8|||
3747697|NCT01992107|3582571|B3|||Age||year|Mean|9.3|9.3|Standard Deviation|3.7|3.7|||
3747698|NCT01992107|3582572|B2|||Age||year|Mean|9.5|9.5|Standard Deviation|3.8|3.8|||
3747699|NCT01992107|3582573|B1|||Age||year|Mean|9.5|9.5|Standard Deviation|3.8|3.8|||
3747700|NCT01992094|3582628|B4||Male|Sex: Female, Male||Participants|Count of Participants|1164|1164.0||||||
3747701|NCT01992094|3582629|B3||Male|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
3747702|NCT01992094|3582630|B2||Male|Sex: Female, Male||Participants|Count of Participants|284|284.0||||||
3747703|NCT01992094|3582631|B1||Male|Sex: Female, Male||Participants|Count of Participants|603|603.0||||||
3747704|NCT01992094|3582628|B4||Female|Sex: Female, Male||Participants|Count of Participants|1516|1516.0||||||
3747705|NCT01992094|3582629|B3||Female|Sex: Female, Male||Participants|Count of Participants|392|392.0||||||
3747706|NCT01992094|3582630|B2||Female|Sex: Female, Male||Participants|Count of Participants|392|392.0||||||
3747707|NCT01992094|3582631|B1||Female|Sex: Female, Male||Participants|Count of Participants|732|732.0||||||
3747708|NCT01992094|3582628|B4|||Age||year|Mean|57.3|57.3|Standard Deviation|17.9|17.9|||
3747709|NCT01992094|3582629|B3|||Age||year|Mean|57.1|57.1|Standard Deviation|18.1|18.1|||
3747710|NCT01992094|3582630|B2|||Age||year|Mean|57.2|57.2|Standard Deviation|18.0|18.0|||
3747711|NCT01992094|3582631|B1|||Age||year|Mean|57.4|57.4|Standard Deviation|17.8|17.8|||
3747712|NCT01992016|3582689|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3747713|NCT01992016|3582689|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3747714|NCT01992016|3582690|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3747715|NCT01992016|3582691|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3747716|NCT01992016|3582689|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3747717|NCT01992016|3582690|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3747718|NCT01992016|3582691|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3747719|NCT01992016|3582689|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3747720|NCT01992016|3582690|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3747721|NCT01992016|3582691|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3747722|NCT01992016|3582689|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3747723|NCT01992016|3582690|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3747724|NCT01992016|3582691|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3747725|NCT01992016|3582689|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3747726|NCT01992016|3582690|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3747727|NCT01992016|3582691|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3747728|NCT01991990|3582698|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3747729|NCT01991990|3582699|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3747730|NCT01991990|3582700|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3747731|NCT01991990|3582698|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3747732|NCT01991990|3582699|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3747733|NCT01991990|3582700|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3747734|NCT01991990|3582698|B3|||Age||years|Mean|32.7|32.7|Standard Deviation|12.01|12.01|||
3747735|NCT01991990|3582699|B2|||Age||years|Mean|34.5|34.5|Standard Deviation|12.6|12.6|||
3747736|NCT01991990|3582700|B1|||Age||years|Mean|29.5|29.5|Standard Deviation|11.0|11.0|||
3747737|NCT01991860|3582741|B3|United States||Region of Enrollment||participants|Number|342|342.0||||||
3747738|NCT01991860|3582742|B2|United States||Region of Enrollment||participants|Number|166|166.0||||||
3747739|NCT01991860|3582743|B1|United States||Region of Enrollment||participants|Number|176|176.0||||||
3747740|NCT01991860|3582741|B3||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3747741|NCT01991860|3582742|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3747742|NCT01991860|3582743|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3747743|NCT01991860|3582741|B3||Female|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
3747744|NCT01991860|3582742|B2||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3747745|NCT01991860|3582743|B1||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3747746|NCT01991860|3582741|B3|||Age||Years|Mean|53.8|53.8|Standard Deviation|13.9|13.9|||
3747747|NCT01991860|3582742|B2|||Age||Years|Mean|53.0|53.0|Standard Deviation|13.7|13.7|||
3747748|NCT01991860|3582743|B1|||Age||Years|Mean|54.5|54.5|Standard Deviation|14.2|14.2|||
3747749|NCT01991548|3582750|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3747750|NCT01991548|3582750|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3747751|NCT01991548|3582750|B1|||Age||years|Mean|31.7|31.7|Standard Deviation|17.74|17.74|||
3747752|NCT01991548|3582750|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3747753|NCT01991548|3582750|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3747754|NCT01991548|3582750|B1||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
3747755|NCT01991522|3582754|B3|||Number of assisted colonoscopies performed||Colonoscopies|Mean|1.7|1.7|Standard Deviation|4.5|4.5|||
3747756|NCT01991522|3582755|B2|||Number of assisted colonoscopies performed||Colonoscopies|Mean|0.8|0.8|Standard Deviation|1.5|1.5|||
3747757|NCT01991522|3582756|B1|||Number of assisted colonoscopies performed||Colonoscopies|Mean|2.7|2.7|Standard Deviation|7.7|7.7|||
3747758|NCT01991522|3582754|B3|||Number of independent colonoscopies performed||colonoscopies|Mean|0.65|0.65|Standard Deviation|2.7|2.7|||
3747759|NCT01991522|3582755|B2|||Number of independent colonoscopies performed||colonoscopies|Mean|0.7|0.7|Standard Deviation|2.9|2.9|||
3747760|NCT01991522|3582756|B1|||Number of independent colonoscopies performed||colonoscopies|Mean|0.6|0.6|Standard Deviation|2.5|2.5|||
3747761|NCT01991522|3582754|B3||Internal Medicine|Training program (gastroenterology, general surgery, or internal medicine)||Participants|Count of Participants|2|2.0||||||
3747762|NCT01991522|3582755|B2||Internal Medicine|Training program (gastroenterology, general surgery, or internal medicine)||Participants|Count of Participants|2|2.0||||||
3747763|NCT01991522|3582756|B1||Internal Medicine|Training program (gastroenterology, general surgery, or internal medicine)||Participants|Count of Participants|0|0.0||||||
3747764|NCT01991522|3582754|B3||General surgery|Training program (gastroenterology, general surgery, or internal medicine)||Participants|Count of Participants|19|19.0||||||
3747765|NCT01991522|3582755|B2||General surgery|Training program (gastroenterology, general surgery, or internal medicine)||Participants|Count of Participants|11|11.0||||||
3747766|NCT01991522|3582756|B1||General surgery|Training program (gastroenterology, general surgery, or internal medicine)||Participants|Count of Participants|8|8.0||||||
3747767|NCT01991522|3582754|B3||Gastroenterology|Training program (gastroenterology, general surgery, or internal medicine)||Participants|Count of Participants|12|12.0||||||
3747768|NCT01991522|3582755|B2||Gastroenterology|Training program (gastroenterology, general surgery, or internal medicine)||Participants|Count of Participants|4|4.0||||||
3747769|NCT01991522|3582756|B1||Gastroenterology|Training program (gastroenterology, general surgery, or internal medicine)||Participants|Count of Participants|8|8.0||||||
3747770|NCT01991522|3582754|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3747771|NCT01991522|3582754|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3747772|NCT01991522|3582755|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3747773|NCT01991522|3582756|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3747774|NCT01991522|3582754|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3747775|NCT01991522|3582755|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3747776|NCT01991522|3582756|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3747777|NCT01991522|3582754|B3|||Age||years|Mean|29.1|29.1|Standard Deviation|2.9|2.9|||
3747778|NCT01991522|3582755|B2|||Age||years|Mean|29.7|29.7|Standard Deviation|3.8|3.8|||
3747779|NCT01991522|3582756|B1|||Age||years|Mean|28.4|28.4|Standard Deviation|1.3|1.3|||
3747780|NCT01991522|3582754|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3747781|NCT01991522|3582755|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3747782|NCT01991522|3582756|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3747783|NCT01991522|3582754|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3747784|NCT01991522|3582755|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3747785|NCT01991522|3582756|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3747786|NCT01991522|3582754|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3747787|NCT01991522|3582755|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3747788|NCT01991522|3582756|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3747789|NCT01991470|3582765|B1|United States||Region of Enrollment||participants|Number|186|186.0||||||
3747790|NCT01991470|3582765|B1||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3747791|NCT01991470|3582765|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3747792|NCT01991470|3582765|B1|||Age||years|Mean|13.2|13.2|Standard Deviation|3.79|3.79|||
3747793|NCT01991314|3582777|B3|United Kingdom||Region of Enrollment||participants|Number|88|88.0||||||
3747794|NCT01991314|3582778|B2|United Kingdom||Region of Enrollment||participants|Number|43|43.0||||||
3747795|NCT01991314|3582779|B1|United Kingdom||Region of Enrollment||participants|Number|45|45.0||||||
3747796|NCT01991314|3582777|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3747797|NCT01991314|3582778|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3747798|NCT01991314|3582779|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3747799|NCT01991314|3582777|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3747800|NCT01991314|3582778|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3747801|NCT01991314|3582779|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3747802|NCT01991314|3582777|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3747803|NCT01991314|3582778|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3747804|NCT01991314|3582779|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3747805|NCT01991314|3582777|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3747806|NCT01991314|3582778|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3747807|NCT01991314|3582779|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3747808|NCT01991314|3582777|B3||<=18 years|Age||Participants|Count of Participants|45|45.0||||||
3747809|NCT01991314|3582778|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3747810|NCT01991314|3582779|B1||<=18 years|Age||Participants|Count of Participants|45|45.0||||||
3747811|NCT01990898|3582798|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
3747812|NCT01990898|3582798|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3747813|NCT01990898|3582798|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3747814|NCT01990898|3582798|B1|||Age||years|Mean|50|50.0|Full Range|||27.0|74.0|
3747815|NCT01990898|3582798|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3747816|NCT01990898|3582798|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3747817|NCT01990898|3582798|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3747818|NCT01990859|3582802|B1|No||Prior Systemic Anti-Cancer Therapy||participants|Number|4|4.0||||||
3747819|NCT01990859|3582802|B1|Yes||Prior Systemic Anti-Cancer Therapy||participants|Number|16|16.0||||||
3747820|NCT01990859|3582802|B1|Elevated||Baseline LDH Greater than 2 Times Upper Limit of Normal|Elevation in this baseline characteristic was defined as greater than (>) 2 Times the Upper Limit of Normal|participants|Number|7|7.0||||||
3747821|NCT01990859|3582802|B1|Normal||Baseline LDH Greater than 2 Times Upper Limit of Normal|Elevation in this baseline characteristic was defined as greater than (>) 2 Times the Upper Limit of Normal|participants|Number|13|13.0||||||
3747822|NCT01990859|3582802|B1|Elevated||Baseline Lactate Dehydrogenase (LDH)|Elevation defined as greater than (>) Upper Limit of Normal (ULN) limit.|participants|Number|12|12.0||||||
3747823|NCT01990859|3582802|B1|Normal||Baseline Lactate Dehydrogenase (LDH)|Elevation defined as greater than (>) Upper Limit of Normal (ULN) limit.|participants|Number|8|8.0||||||
3747824|NCT01990859|3582802|B1|||Weight in kilograms (kg)||kg|Median|64.0|64.0|Full Range|||40.8|109.0|
3747825|NCT01990859|3582802|B1|||Height in centimeters (cm)||cm|Median|161.7|161.7|Full Range|||144.0|184.6|
3747826|NCT01990859|3582802|B1|ECOG PS 1||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG PS, is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5 with 0=Fully active; 1= restricted in physically strenuous activity; 2= ambulatory; 3=limited self care; 4= completely disabled; 5=dead.|participants|Number|6|6.0||||||
3747827|NCT01990859|3582802|B1|ECOG PS 0||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG PS, is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5 with 0=Fully active; 1= restricted in physically strenuous activity; 2= ambulatory; 3=limited self care; 4= completely disabled; 5=dead.|participants|Number|14|14.0||||||
3747828|NCT01990859|3582802|B1|M1C||M-Stage at Study Entry|Melanoma Tumor Staging: Metastasis (M) classification (M1a versus M1b versus M1c). M1a: Distant skin, subcutaneous tissue, or nodal metastases with normal lactic dehydrogenase (LDH); M1b: Lung metastases with normal LDH; M1c: All other visceral metastases with normal LDH; Any distant metastasis with elevated LDH. Final Version of the American Joint Committee on Cancer Staging System for Cutaneous melanoma. Journal of Clinical Oncology, 2001. (Vol. 19 No.16): p. 3635-3648.|participants|Number|14|14.0||||||
3747829|NCT01990859|3582802|B1|M1B||M-Stage at Study Entry|Melanoma Tumor Staging: Metastasis (M) classification (M1a versus M1b versus M1c). M1a: Distant skin, subcutaneous tissue, or nodal metastases with normal lactic dehydrogenase (LDH); M1b: Lung metastases with normal LDH; M1c: All other visceral metastases with normal LDH; Any distant metastasis with elevated LDH. Final Version of the American Joint Committee on Cancer Staging System for Cutaneous melanoma. Journal of Clinical Oncology, 2001. (Vol. 19 No.16): p. 3635-3648.|participants|Number|4|4.0||||||
3747830|NCT01990859|3582802|B1|M1A||M-Stage at Study Entry|Melanoma Tumor Staging: Metastasis (M) classification (M1a versus M1b versus M1c). M1a: Distant skin, subcutaneous tissue, or nodal metastases with normal lactic dehydrogenase (LDH); M1b: Lung metastases with normal LDH; M1c: All other visceral metastases with normal LDH; Any distant metastasis with elevated LDH. Final Version of the American Joint Committee on Cancer Staging System for Cutaneous melanoma. Journal of Clinical Oncology, 2001. (Vol. 19 No.16): p. 3635-3648.|participants|Number|1|1.0||||||
3747831|NCT01990859|3582802|B1|M0||M-Stage at Study Entry|Melanoma Tumor Staging: Metastasis (M) classification (M1a versus M1b versus M1c). M1a: Distant skin, subcutaneous tissue, or nodal metastases with normal lactic dehydrogenase (LDH); M1b: Lung metastases with normal LDH; M1c: All other visceral metastases with normal LDH; Any distant metastasis with elevated LDH. Final Version of the American Joint Committee on Cancer Staging System for Cutaneous melanoma. Journal of Clinical Oncology, 2001. (Vol. 19 No.16): p. 3635-3648.|participants|Number|1|1.0||||||
3747832|NCT01990859|3582802|B1|Japan||Region of Enrollment||participants|Number|20|20.0||||||
3747833|NCT01990859|3582802|B1|Japanese||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3747834|NCT01990859|3582802|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3747835|NCT01990859|3582802|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3747836|NCT01990859|3582802|B1|Greater than, equal to 65 years||Age, Customized||participants|Number|7|7.0||||||
3747837|NCT01990859|3582802|B1|Less than 65 years||Age, Customized||participants|Number|13|13.0||||||
3747838|NCT01990859|3582802|B1|||Age||years|Median|62.5|62.5|Full Range|||29.0|76.0|
3747839|NCT01990794|3582813|B1|Male weight (n=5)||Weight||pounds (lbs)|Mean|219|219.0|Standard Deviation|53|53.0|||
3747840|NCT01990794|3582813|B1|Female weight (n=5)||Weight||pounds (lbs)|Mean|151|151.0|Standard Deviation|20|20.0|||
3747841|NCT01990794|3582813|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3747842|NCT01990794|3582813|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747843|NCT01990794|3582813|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3747844|NCT01990794|3582813|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3747845|NCT01990794|3582813|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747846|NCT01990794|3582813|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747847|NCT01990794|3582813|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3747848|NCT01990794|3582813|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3747849|NCT01990794|3582813|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3747850|NCT01990794|3582813|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3747851|NCT01990794|3582813|B1|Male Age (n=5)||Age||years|Mean|33|33.0|Standard Deviation|11|11.0|||
3747852|NCT01990794|3582813|B1|Female Age (n=8)||Age||years|Mean|34|34.0|Standard Deviation|10|10.0|||
3747853|NCT01990742|3582925|B3|United States||Region of Enrollment|The nursing home in which each decedent received care serves as the geographic location for this baseline measure.|participants|Number|5830|5830.0||||||
3747854|NCT01990742|3582926|B2|United States||Region of Enrollment|The nursing home in which each decedent received care serves as the geographic location for this baseline measure.|participants|Number|2978|2978.0||||||
3747855|NCT01990742|3582927|B1|United States||Region of Enrollment|The nursing home in which each decedent received care serves as the geographic location for this baseline measure.|participants|Number|2852|2852.0||||||
3747856|NCT01990742|3582925|B3||Unknown or Not Reported|Race (NIH/OMB)|Individual participants were not enrolled; we report here the racial distribution of the nursing home residents who died during the study period in our enrolled facilities, as recorded in the MDS data set used for the outcomes analyses.|Participants|Count of Participants|0|0.0||||||
3747857|NCT01990742|3582926|B2||Unknown or Not Reported|Race (NIH/OMB)|Individual participants were not enrolled; we report here the racial distribution of the nursing home residents who died during the study period in our enrolled facilities, as recorded in the MDS data set used for the outcomes analyses.|Participants|Count of Participants|0|0.0||||||
3747858|NCT01990742|3582927|B1||Unknown or Not Reported|Race (NIH/OMB)|Individual participants were not enrolled; we report here the racial distribution of the nursing home residents who died during the study period in our enrolled facilities, as recorded in the MDS data set used for the outcomes analyses.|Participants|Count of Participants|0|0.0||||||
3747859|NCT01990742|3582925|B3||More than one race|Race (NIH/OMB)|Individual participants were not enrolled; we report here the racial distribution of the nursing home residents who died during the study period in our enrolled facilities, as recorded in the MDS data set used for the outcomes analyses.|Participants|Count of Participants|0|0.0||||||
3747860|NCT01990742|3582926|B2||More than one race|Race (NIH/OMB)|Individual participants were not enrolled; we report here the racial distribution of the nursing home residents who died during the study period in our enrolled facilities, as recorded in the MDS data set used for the outcomes analyses.|Participants|Count of Participants|0|0.0||||||
3747861|NCT01990742|3582927|B1||More than one race|Race (NIH/OMB)|Individual participants were not enrolled; we report here the racial distribution of the nursing home residents who died during the study period in our enrolled facilities, as recorded in the MDS data set used for the outcomes analyses.|Participants|Count of Participants|0|0.0||||||
3747862|NCT01990742|3582925|B3||White|Race (NIH/OMB)|Individual participants were not enrolled; we report here the racial distribution of the nursing home residents who died during the study period in our enrolled facilities, as recorded in the MDS data set used for the outcomes analyses.|Participants|Count of Participants|5503|5503.0||||||
3747863|NCT01990742|3582926|B2||White|Race (NIH/OMB)|Individual participants were not enrolled; we report here the racial distribution of the nursing home residents who died during the study period in our enrolled facilities, as recorded in the MDS data set used for the outcomes analyses.|Participants|Count of Participants|2792|2792.0||||||
3747864|NCT01990742|3582927|B1||White|Race (NIH/OMB)|Individual participants were not enrolled; we report here the racial distribution of the nursing home residents who died during the study period in our enrolled facilities, as recorded in the MDS data set used for the outcomes analyses.|Participants|Count of Participants|2711|2711.0||||||
3747865|NCT01990742|3582925|B3||Black or African American|Race (NIH/OMB)|Individual participants were not enrolled; we report here the racial distribution of the nursing home residents who died during the study period in our enrolled facilities, as recorded in the MDS data set used for the outcomes analyses.|Participants|Count of Participants|261|261.0||||||
3747866|NCT01990742|3582926|B2||Black or African American|Race (NIH/OMB)|Individual participants were not enrolled; we report here the racial distribution of the nursing home residents who died during the study period in our enrolled facilities, as recorded in the MDS data set used for the outcomes analyses.|Participants|Count of Participants|153|153.0||||||
3747867|NCT01990742|3582927|B1||Black or African American|Race (NIH/OMB)|Individual participants were not enrolled; we report here the racial distribution of the nursing home residents who died during the study period in our enrolled facilities, as recorded in the MDS data set used for the outcomes analyses.|Participants|Count of Participants|108|108.0||||||
3747868|NCT01990742|3582925|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Individual participants were not enrolled; we report here the racial distribution of the nursing home residents who died during the study period in our enrolled facilities, as recorded in the MDS data set used for the outcomes analyses.|Participants|Count of Participants|0|0.0||||||
3747869|NCT01990742|3582926|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Individual participants were not enrolled; we report here the racial distribution of the nursing home residents who died during the study period in our enrolled facilities, as recorded in the MDS data set used for the outcomes analyses.|Participants|Count of Participants|0|0.0||||||
3747870|NCT01990742|3582927|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Individual participants were not enrolled; we report here the racial distribution of the nursing home residents who died during the study period in our enrolled facilities, as recorded in the MDS data set used for the outcomes analyses.|Participants|Count of Participants|0|0.0||||||
3747871|NCT01990742|3582925|B3||Asian|Race (NIH/OMB)|Individual participants were not enrolled; we report here the racial distribution of the nursing home residents who died during the study period in our enrolled facilities, as recorded in the MDS data set used for the outcomes analyses.|Participants|Count of Participants|22|22.0||||||
3747872|NCT01990742|3582926|B2||Asian|Race (NIH/OMB)|Individual participants were not enrolled; we report here the racial distribution of the nursing home residents who died during the study period in our enrolled facilities, as recorded in the MDS data set used for the outcomes analyses.|Participants|Count of Participants|11|11.0||||||
3747873|NCT01990742|3582927|B1||Asian|Race (NIH/OMB)|Individual participants were not enrolled; we report here the racial distribution of the nursing home residents who died during the study period in our enrolled facilities, as recorded in the MDS data set used for the outcomes analyses.|Participants|Count of Participants|11|11.0||||||
3747874|NCT01990742|3582925|B3||American Indian or Alaska Native|Race (NIH/OMB)|Individual participants were not enrolled; we report here the racial distribution of the nursing home residents who died during the study period in our enrolled facilities, as recorded in the MDS data set used for the outcomes analyses.|Participants|Count of Participants|44|44.0||||||
3747875|NCT01990742|3582926|B2||American Indian or Alaska Native|Race (NIH/OMB)|Individual participants were not enrolled; we report here the racial distribution of the nursing home residents who died during the study period in our enrolled facilities, as recorded in the MDS data set used for the outcomes analyses.|Participants|Count of Participants|22|22.0||||||
3747876|NCT01990742|3582927|B1||American Indian or Alaska Native|Race (NIH/OMB)|Individual participants were not enrolled; we report here the racial distribution of the nursing home residents who died during the study period in our enrolled facilities, as recorded in the MDS data set used for the outcomes analyses.|Participants|Count of Participants|22|22.0||||||
3747877|NCT01990742|3582925|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)|Individual participants were not enrolled; we report here the ethnicity of the nursing home residents who died during the study period in our enrolled facilities, as recorded in the MDS data set used for the outcomes analyses.|Participants|Count of Participants|0|0.0||||||
3747878|NCT01990742|3582926|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)|Individual participants were not enrolled; we report here the ethnicity of the nursing home residents who died during the study period in our enrolled facilities, as recorded in the MDS data set used for the outcomes analyses.|Participants|Count of Participants|0|0.0||||||
3747879|NCT01990742|3582927|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|Individual participants were not enrolled; we report here the ethnicity of the nursing home residents who died during the study period in our enrolled facilities, as recorded in the MDS data set used for the outcomes analyses.|Participants|Count of Participants|0|0.0||||||
3747880|NCT01990742|3582925|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Individual participants were not enrolled; we report here the ethnicity of the nursing home residents who died during the study period in our enrolled facilities, as recorded in the MDS data set used for the outcomes analyses.|Participants|Count of Participants|5811|5811.0||||||
3747881|NCT01990742|3582926|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Individual participants were not enrolled; we report here the ethnicity of the nursing home residents who died during the study period in our enrolled facilities, as recorded in the MDS data set used for the outcomes analyses.|Participants|Count of Participants|2960|2960.0||||||
3747882|NCT01990742|3582927|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Individual participants were not enrolled; we report here the ethnicity of the nursing home residents who died during the study period in our enrolled facilities, as recorded in the MDS data set used for the outcomes analyses.|Participants|Count of Participants|2851|2851.0||||||
3747883|NCT01990742|3582925|B3||Hispanic or Latino|Ethnicity (NIH/OMB)|Individual participants were not enrolled; we report here the ethnicity of the nursing home residents who died during the study period in our enrolled facilities, as recorded in the MDS data set used for the outcomes analyses.|Participants|Count of Participants|19|19.0||||||
3747884|NCT01990742|3582926|B2||Hispanic or Latino|Ethnicity (NIH/OMB)|Individual participants were not enrolled; we report here the ethnicity of the nursing home residents who died during the study period in our enrolled facilities, as recorded in the MDS data set used for the outcomes analyses.|Participants|Count of Participants|18|18.0||||||
3747885|NCT01990742|3582927|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|Individual participants were not enrolled; we report here the ethnicity of the nursing home residents who died during the study period in our enrolled facilities, as recorded in the MDS data set used for the outcomes analyses.|Participants|Count of Participants|1|1.0||||||
3747886|NCT01990742|3582925|B3||Male|Sex: Female, Male|Individual participants were not enrolled; we report here the gender of the nursing home residents who died during the study period in our enrolled facilities, as recorded in the MDS data set used for the outcomes analyses.|Participants|Count of Participants|2087|2087.0||||||
3747887|NCT01990742|3582926|B2||Male|Sex: Female, Male|Individual participants were not enrolled; we report here the gender of the nursing home residents who died during the study period in our enrolled facilities, as recorded in the MDS data set used for the outcomes analyses.|Participants|Count of Participants|1048|1048.0||||||
3747888|NCT01990742|3582927|B1||Male|Sex: Female, Male|Individual participants were not enrolled; we report here the gender of the nursing home residents who died during the study period in our enrolled facilities, as recorded in the MDS data set used for the outcomes analyses.|Participants|Count of Participants|1039|1039.0||||||
3747889|NCT01990742|3582925|B3||Female|Sex: Female, Male|Individual participants were not enrolled; we report here the gender of the nursing home residents who died during the study period in our enrolled facilities, as recorded in the MDS data set used for the outcomes analyses.|Participants|Count of Participants|3743|3743.0||||||
3747890|NCT01990742|3582926|B2||Female|Sex: Female, Male|Individual participants were not enrolled; we report here the gender of the nursing home residents who died during the study period in our enrolled facilities, as recorded in the MDS data set used for the outcomes analyses.|Participants|Count of Participants|1930|1930.0||||||
3747891|NCT01990742|3582927|B1||Female|Sex: Female, Male|Individual participants were not enrolled; we report here the gender of the nursing home residents who died during the study period in our enrolled facilities, as recorded in the MDS data set used for the outcomes analyses.|Participants|Count of Participants|1813|1813.0||||||
3747892|NCT01990742|3582925|B3|||Age||years|Mean|86.1|86.1|Standard Deviation|9.0|9.0|||
3747893|NCT01990742|3582926|B2|||Age||years|Mean|86.2|86.2|Standard Deviation|9.0|9.0|||
3747894|NCT01990742|3582927|B1|||Age||years|Mean|86.0|86.0|Standard Deviation|8.9|8.9|||
3747895|NCT01990703|3582938|B3|United States||Region of Enrollment||participants|Number|285|285.0||||||
3747896|NCT01990703|3582939|B2|United States||Region of Enrollment||participants|Number|138|138.0||||||
3747897|NCT01990703|3582940|B1|United States||Region of Enrollment||participants|Number|147|147.0||||||
3747898|NCT01990703|3582938|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3747899|NCT01990703|3582939|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3747900|NCT01990703|3582940|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3747901|NCT01990703|3582938|B3||Female|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
3747902|NCT01990703|3582939|B2||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3747903|NCT01990703|3582940|B1||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3747904|NCT01990703|3582938|B3|||Age||Years|Mean|28.4|28.4|Standard Deviation|5.5|5.5|||
3747905|NCT01990703|3582939|B2|||Age||Years|Mean|28.1|28.1|Standard Deviation|5.6|5.6|||
3747906|NCT01990703|3582940|B1|||Age||Years|Mean|28.6|28.6|Standard Deviation|5.4|5.4|||
3747907|NCT01990703|3582938|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3747908|NCT01990703|3582939|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3747909|NCT01990703|3582940|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3747910|NCT01990703|3582938|B3||Between 18 and 65 years|Age||Participants|Count of Participants|285|285.0||||||
3747911|NCT01990703|3582939|B2||Between 18 and 65 years|Age||Participants|Count of Participants|138|138.0||||||
3747912|NCT01990703|3582940|B1||Between 18 and 65 years|Age||Participants|Count of Participants|147|147.0||||||
3747913|NCT01990703|3582938|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3747914|NCT01990703|3582939|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3747915|NCT01990703|3582940|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3747916|NCT01990677|3582949|B3|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3747917|NCT01990677|3582950|B2|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3747918|NCT01990677|3582951|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3747919|NCT01990677|3582949|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3747920|NCT01990677|3582950|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3747921|NCT01990677|3582951|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3747922|NCT01990677|3582949|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3747923|NCT01990677|3582950|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3747924|NCT01990677|3582951|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3747925|NCT01990677|3582949|B3|||Age||years|Mean|54|54.0|Standard Deviation|9.7|9.7|||
3747926|NCT01990677|3582950|B2|||Age||years|Mean|62|62.0|Standard Deviation|5.5|5.5|||
3747927|NCT01990677|3582951|B1|||Age||years|Mean|50|50.0|Standard Deviation|11.8|11.8|||
3747928|NCT01990677|3582949|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3747929|NCT01990677|3582950|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3747930|NCT01990677|3582951|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3747931|NCT01990677|3582949|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3747932|NCT01990677|3582950|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3747933|NCT01990677|3582951|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3747934|NCT01990677|3582949|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3747935|NCT01990677|3582950|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3747936|NCT01990677|3582951|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3747937|NCT01990664|3582962|B3|United States||Region of Enrollment||participants|Number|192|192.0||||||
3747938|NCT01990664|3582963|B2|United States||Region of Enrollment||participants|Number|90|90.0||||||
3747939|NCT01990664|3582964|B1|United States||Region of Enrollment||participants|Number|102|102.0||||||
3747940|NCT01990664|3582962|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3747941|NCT01990664|3582963|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3747942|NCT01990664|3582964|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3747943|NCT01990664|3582962|B3|White||Race/Ethnicity, Customized||participants|Number|143|143.0||||||
3747944|NCT01990664|3582963|B2|White||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
3747945|NCT01990664|3582964|B1|White||Race/Ethnicity, Customized||participants|Number|78|78.0||||||
3747946|NCT01990664|3582962|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3747947|NCT01990664|3582963|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3747948|NCT01990664|3582964|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3747949|NCT01990664|3582962|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
3747950|NCT01990664|3582963|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3747951|NCT01990664|3582964|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3747952|NCT01990664|3582962|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3747953|NCT01990664|3582963|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3747954|NCT01990664|3582964|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3747955|NCT01990664|3582962|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3747956|NCT01990664|3582963|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3747957|NCT01990664|3582964|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3747958|NCT01990664|3582962|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3747959|NCT01990664|3582963|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3747960|NCT01990664|3582964|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3747961|NCT01990664|3582962|B3||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3747962|NCT01990664|3582963|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3747963|NCT01990664|3582964|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3747964|NCT01990664|3582962|B3|||Age||years|Mean|29.57|29.57|Standard Deviation|6.096|6.096|||
3747965|NCT01990664|3582963|B2|||Age||years|Mean|29.22|29.22|Standard Deviation|5.715|5.715|||
3747966|NCT01990664|3582964|B1|||Age||years|Mean|29.80|29.8|Standard Deviation|6.356|6.356|||
3747967|NCT01990560|3582971|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3747968|NCT01990560|3582971|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3747969|NCT01990560|3582971|B1|||Age||years|Mean|65.5|65.5|Standard Deviation|10.6|10.6|||
3747970|NCT01990534|3582985|B1|||Body Mass Index (BMI)|Body Mass Index = weight (kg)/[height (m)^2]|kg/m^2|Mean|23.864|23.864|Standard Deviation|5.4085|5.4085|||
3747971|NCT01990534|3582985|B1|||Baseline Weight||kg|Mean|70.3|70.3|Standard Deviation|19.41|19.41|||
3747972|NCT01990534|3582985|B1|||Baseline Height||cm|Mean|171.0|171.0|Standard Deviation|9.66|9.66|||
3747973|NCT01990534|3582985|B1|Turkey||Region of Enrollment||participants|Number|9|9.0||||||
3747974|NCT01990534|3582985|B1|Thailand||Region of Enrollment||participants|Number|10|10.0||||||
3747975|NCT01990534|3582985|B1|Spain||Region of Enrollment||participants|Number|2|2.0||||||
3747976|NCT01990534|3582985|B1|Poland||Region of Enrollment||participants|Number|26|26.0||||||
3747977|NCT01990534|3582985|B1|Malaysia||Region of Enrollment||participants|Number|8|8.0||||||
3747978|NCT01990534|3582985|B1|Germany||Region of Enrollment||participants|Number|2|2.0||||||
3747979|NCT01990534|3582985|B1|Czech Republic||Region of Enrollment||participants|Number|3|3.0||||||
3747980|NCT01990534|3582985|B1|Asian||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3747981|NCT01990534|3582985|B1|White||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
3747982|NCT01990534|3582985|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
3747983|NCT01990534|3582985|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3747984|NCT01990534|3582985|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3747985|NCT01990534|3582985|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3747986|NCT01990534|3582985|B1|≥65 years||Age, Customized||participants|Number|5|5.0||||||
3747987|NCT01990534|3582985|B1|<65 years||Age, Customized||participants|Number|55|55.0||||||
3747988|NCT01990534|3582985|B1|||Age||years|Mean|35.4|35.4|Standard Deviation|13.83|13.83|||
3747989|NCT01990339|3583001|B1|Unknown||Helicobacter pylori (H. pylori) Infection at the Start of Takepron Treatment||participants|Number|9750|9750.0||||||
3747990|NCT01990339|3583001|B1|Positive||Helicobacter pylori (H. pylori) Infection at the Start of Takepron Treatment||participants|Number|689|689.0||||||
3747991|NCT01990339|3583001|B1|Negative||Helicobacter pylori (H. pylori) Infection at the Start of Takepron Treatment||participants|Number|2214|2214.0||||||
3747992|NCT01990339|3583001|B1|Yes||Marked Kyphosis||participants|Number|505|505.0||||||
3747993|NCT01990339|3583001|B1|No||Marked Kyphosis||participants|Number|12148|12148.0||||||
3747994|NCT01990339|3583001|B1|Unknown||Duration of Dyspeptic Symptoms||participants|Number|1497|1497.0||||||
3747995|NCT01990339|3583001|B1|> 6 months||Duration of Dyspeptic Symptoms||participants|Number|1442|1442.0||||||
3747996|NCT01990339|3583001|B1|> 3 months and ≤ 6 months||Duration of Dyspeptic Symptoms||participants|Number|802|802.0||||||
3747997|NCT01990339|3583001|B1|> 1 month and ≤ 3 months||Duration of Dyspeptic Symptoms||participants|Number|3080|3080.0||||||
3747998|NCT01990339|3583001|B1|< 1 month||Duration of Dyspeptic Symptoms||participants|Number|5832|5832.0||||||
3747999|NCT01990339|3583001|B1|Unknown||History of Gastroesophageal Reflux Disease||participants|Number|3027|3027.0||||||
3748000|NCT01990339|3583001|B1|Recurrence||History of Gastroesophageal Reflux Disease||participants|Number|2498|2498.0||||||
3748001|NCT01990339|3583001|B1|Initial||History of Gastroesophageal Reflux Disease||participants|Number|7128|7128.0||||||
3748002|NCT01990339|3583001|B1|BMI Unknown||Body Mass Index (BMI)||participants|Number|3055|3055.0||||||
3748003|NCT01990339|3583001|B1|BMI ≥ 30 kg/m^2||Body Mass Index (BMI)||participants|Number|472|472.0||||||
3748004|NCT01990339|3583001|B1|BMI ≥ 25 kg/m^2 and < 30 kg/m^2||Body Mass Index (BMI)||participants|Number|3083|3083.0||||||
3748005|NCT01990339|3583001|B1|BMI < 25 kg/m^2||Body Mass Index (BMI)||participants|Number|6043|6043.0||||||
3748006|NCT01990339|3583001|B1|Japan||Region of Enrollment||participants|Number|12653|12653.0||||||
3748007|NCT01990339|3583001|B1|Asian||Race/Ethnicity, Customized||participants|Number|12653|12653.0||||||
3748008|NCT01990339|3583001|B1||Male|Sex: Female, Male||Participants|Count of Participants|5236|5236.0||||||
3748009|NCT01990339|3583001|B1||Female|Sex: Female, Male||Participants|Count of Participants|7417|7417.0||||||
3748010|NCT01990339|3583001|B1|≥ 65 years||Age, Customized||participants|Number|5962|5962.0||||||
3748011|NCT01990339|3583001|B1|< 65 years||Age, Customized||participants|Number|6691|6691.0||||||
3748012|NCT01990313|3583006|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3748013|NCT01990313|3583006|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748014|NCT01990313|3583006|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748015|NCT01990313|3583006|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3748016|NCT01990313|3583006|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748017|NCT01990313|3583006|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748018|NCT01990313|3583006|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3748019|NCT01990313|3583006|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748020|NCT01990313|3583006|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3748021|NCT01990313|3583006|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3748022|NCT01990313|3583006|B1|||Age||years|Mean|62.97|62.97|Standard Deviation|11.36|11.36|||
3748023|NCT01990313|3583006|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3748024|NCT01990313|3583006|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3748025|NCT01990313|3583006|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3748026|NCT01990261|3583011|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3748027|NCT01990261|3583011|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3748028|NCT01990261|3583011|B1|60 years and older||Age, Customized||participants|Number|23|23.0||||||
3748029|NCT01990261|3583011|B1|From 18 to 60 years||Age, Customized||participants|Number|10|10.0||||||
3748030|NCT01989793|3583021|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748031|NCT01989793|3583022|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748032|NCT01989793|3583023|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748033|NCT01989793|3583021|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748034|NCT01989793|3583022|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748035|NCT01989793|3583023|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748036|NCT01989793|3583021|B3||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3748037|NCT01989793|3583022|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3748038|NCT01989793|3583023|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3748039|NCT01989793|3583021|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3748040|NCT01989793|3583022|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3748041|NCT01989793|3583023|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3748042|NCT01989793|3583021|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748043|NCT01989793|3583022|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748044|NCT01989793|3583023|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748045|NCT01989793|3583021|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3748046|NCT01989793|3583022|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3748047|NCT01989793|3583023|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3748048|NCT01989793|3583021|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748049|NCT01989793|3583022|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748050|NCT01989793|3583023|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748051|NCT01989793|3583021|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3748052|NCT01989793|3583022|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3748053|NCT01989793|3583023|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3748054|NCT01989793|3583021|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3748055|NCT01989793|3583022|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3748056|NCT01989793|3583023|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3748057|NCT01989793|3583021|B3||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
3748058|NCT01989793|3583022|B2||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3748059|NCT01989793|3583023|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3748060|NCT01989793|3583021|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3748061|NCT01989793|3583022|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3748062|NCT01989793|3583023|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3748063|NCT01989793|3583021|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3748064|NCT01989793|3583022|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3748065|NCT01989793|3583023|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3748066|NCT01989754|3583046|B3|UNITED STATES||Region of Enrollment||Participants|Count of Participants|673|673.0||||||
3748067|NCT01989754|3583047|B2|UNITED STATES||Region of Enrollment||Participants|Count of Participants|336|336.0||||||
3748068|NCT01989754|3583048|B1|UNITED STATES||Region of Enrollment||Participants|Count of Participants|337|337.0||||||
3748069|NCT01989754|3583046|B3|UNITED KINGDOM||Region of Enrollment||Participants|Count of Participants|151|151.0||||||
3748070|NCT01989754|3583047|B2|UNITED KINGDOM||Region of Enrollment||Participants|Count of Participants|73|73.0||||||
3748071|NCT01989754|3583048|B1|UNITED KINGDOM||Region of Enrollment||Participants|Count of Participants|78|78.0||||||
3748072|NCT01989754|3583046|B3|UKRAINE||Region of Enrollment||Participants|Count of Participants|449|449.0||||||
3748073|NCT01989754|3583047|B2|UKRAINE||Region of Enrollment||Participants|Count of Participants|236|236.0||||||
3748074|NCT01989754|3583048|B1|UKRAINE||Region of Enrollment||Participants|Count of Participants|213|213.0||||||
3748075|NCT01989754|3583046|B3|TAIWAN||Region of Enrollment||Participants|Count of Participants|76|76.0||||||
3748076|NCT01989754|3583047|B2|TAIWAN||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3748077|NCT01989754|3583048|B1|TAIWAN||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3748078|NCT01989754|3583046|B3|SWEDEN||Region of Enrollment||Participants|Count of Participants|221|221.0||||||
3748079|NCT01989754|3583047|B2|SWEDEN||Region of Enrollment||Participants|Count of Participants|103|103.0||||||
3748080|NCT01989754|3583048|B1|SWEDEN||Region of Enrollment||Participants|Count of Participants|118|118.0||||||
3748081|NCT01989754|3583046|B3|SPAIN||Region of Enrollment||Participants|Count of Participants|496|496.0||||||
3748082|NCT01989754|3583047|B2|SPAIN||Region of Enrollment||Participants|Count of Participants|249|249.0||||||
3748083|NCT01989754|3583048|B1|SPAIN||Region of Enrollment||Participants|Count of Participants|247|247.0||||||
3748084|NCT01989754|3583046|B3|SOUTH KOREA||Region of Enrollment||Participants|Count of Participants|167|167.0||||||
3748085|NCT01989754|3583047|B2|SOUTH KOREA||Region of Enrollment||Participants|Count of Participants|94|94.0||||||
3748086|NCT01989754|3583048|B1|SOUTH KOREA||Region of Enrollment||Participants|Count of Participants|73|73.0||||||
3748087|NCT01989754|3583046|B3|RUSSIAN FEDERATION||Region of Enrollment||Participants|Count of Participants|412|412.0||||||
3748088|NCT01989754|3583047|B2|RUSSIAN FEDERATION||Region of Enrollment||Participants|Count of Participants|199|199.0||||||
3748089|NCT01989754|3583048|B1|RUSSIAN FEDERATION||Region of Enrollment||Participants|Count of Participants|213|213.0||||||
3748090|NCT01989754|3583046|B3|POLAND||Region of Enrollment||Participants|Count of Participants|363|363.0||||||
3748091|NCT01989754|3583047|B2|POLAND||Region of Enrollment||Participants|Count of Participants|177|177.0||||||
3748092|NCT01989754|3583048|B1|POLAND||Region of Enrollment||Participants|Count of Participants|186|186.0||||||
3748093|NCT01989754|3583046|B3|NEW ZEALAND||Region of Enrollment||Participants|Count of Participants|105|105.0||||||
3748094|NCT01989754|3583047|B2|NEW ZEALAND||Region of Enrollment||Participants|Count of Participants|56|56.0||||||
3748095|NCT01989754|3583048|B1|NEW ZEALAND||Region of Enrollment||Participants|Count of Participants|49|49.0||||||
3748096|NCT01989754|3583046|B3|NETHERLANDS||Region of Enrollment||Participants|Count of Participants|249|249.0||||||
3748097|NCT01989754|3583047|B2|NETHERLANDS||Region of Enrollment||Participants|Count of Participants|132|132.0||||||
3748098|NCT01989754|3583048|B1|NETHERLANDS||Region of Enrollment||Participants|Count of Participants|117|117.0||||||
3748099|NCT01989754|3583046|B3|MEXICO||Region of Enrollment||Participants|Count of Participants|228|228.0||||||
3748100|NCT01989754|3583047|B2|MEXICO||Region of Enrollment||Participants|Count of Participants|110|110.0||||||
3748101|NCT01989754|3583048|B1|MEXICO||Region of Enrollment||Participants|Count of Participants|118|118.0||||||
3748102|NCT01989754|3583046|B3|MALAYSIA||Region of Enrollment||Participants|Count of Participants|92|92.0||||||
3748103|NCT01989754|3583047|B2|MALAYSIA||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3748104|NCT01989754|3583048|B1|MALAYSIA||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3748105|NCT01989754|3583046|B3|ITALY||Region of Enrollment||Participants|Count of Participants|98|98.0||||||
3748106|NCT01989754|3583047|B2|ITALY||Region of Enrollment||Participants|Count of Participants|49|49.0||||||
3748107|NCT01989754|3583048|B1|ITALY||Region of Enrollment||Participants|Count of Participants|49|49.0||||||
3748108|NCT01989754|3583046|B3|HUNGARY||Region of Enrollment||Participants|Count of Participants|179|179.0||||||
3748109|NCT01989754|3583047|B2|HUNGARY||Region of Enrollment||Participants|Count of Participants|97|97.0||||||
3748110|NCT01989754|3583048|B1|HUNGARY||Region of Enrollment||Participants|Count of Participants|82|82.0||||||
3748111|NCT01989754|3583046|B3|GERMANY||Region of Enrollment||Participants|Count of Participants|101|101.0||||||
3748112|NCT01989754|3583047|B2|GERMANY||Region of Enrollment||Participants|Count of Participants|55|55.0||||||
3748113|NCT01989754|3583048|B1|GERMANY||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
3748114|NCT01989754|3583046|B3|FRANCE||Region of Enrollment||Participants|Count of Participants|124|124.0||||||
3748115|NCT01989754|3583047|B2|FRANCE||Region of Enrollment||Participants|Count of Participants|55|55.0||||||
3748116|NCT01989754|3583048|B1|FRANCE||Region of Enrollment||Participants|Count of Participants|69|69.0||||||
3748117|NCT01989754|3583046|B3|CZECH REPUBLIC||Region of Enrollment||Participants|Count of Participants|139|139.0||||||
3748118|NCT01989754|3583047|B2|CZECH REPUBLIC||Region of Enrollment||Participants|Count of Participants|72|72.0||||||
3748119|NCT01989754|3583048|B1|CZECH REPUBLIC||Region of Enrollment||Participants|Count of Participants|67|67.0||||||
3748120|NCT01989754|3583046|B3|CHINA||Region of Enrollment||Participants|Count of Participants|92|92.0||||||
3748121|NCT01989754|3583047|B2|CHINA||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
3748122|NCT01989754|3583048|B1|CHINA||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
3748123|NCT01989754|3583046|B3|CANADA||Region of Enrollment||Participants|Count of Participants|282|282.0||||||
3748124|NCT01989754|3583047|B2|CANADA||Region of Enrollment||Participants|Count of Participants|146|146.0||||||
3748125|NCT01989754|3583048|B1|CANADA||Region of Enrollment||Participants|Count of Participants|136|136.0||||||
3748126|NCT01989754|3583046|B3|BRAZIL||Region of Enrollment||Participants|Count of Participants|549|549.0||||||
3748127|NCT01989754|3583047|B2|BRAZIL||Region of Enrollment||Participants|Count of Participants|272|272.0||||||
3748128|NCT01989754|3583048|B1|BRAZIL||Region of Enrollment||Participants|Count of Participants|277|277.0||||||
3748129|NCT01989754|3583046|B3|BELGIUM||Region of Enrollment||Participants|Count of Participants|152|152.0||||||
3748130|NCT01989754|3583047|B2|BELGIUM||Region of Enrollment||Participants|Count of Participants|66|66.0||||||
3748131|NCT01989754|3583048|B1|BELGIUM||Region of Enrollment||Participants|Count of Participants|86|86.0||||||
3748132|NCT01989754|3583046|B3|AUSTRALIA||Region of Enrollment||Participants|Count of Participants|109|109.0||||||
3748133|NCT01989754|3583047|B2|AUSTRALIA||Region of Enrollment||Participants|Count of Participants|51|51.0||||||
3748134|NCT01989754|3583048|B1|AUSTRALIA||Region of Enrollment||Participants|Count of Participants|58|58.0||||||
3748135|NCT01989754|3583046|B3|ARGENTINA||Region of Enrollment||Participants|Count of Participants|305|305.0||||||
3748136|NCT01989754|3583047|B2|ARGENTINA||Region of Enrollment||Participants|Count of Participants|159|159.0||||||
3748137|NCT01989754|3583048|B1|ARGENTINA||Region of Enrollment||Participants|Count of Participants|146|146.0||||||
3748138|NCT01989754|3583046|B3|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|3902|3902.0||||||
3748139|NCT01989754|3583047|B2|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1948|1948.0||||||
3748140|NCT01989754|3583048|B1|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1954|1954.0||||||
3748141|NCT01989754|3583046|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|346|346.0||||||
3748142|NCT01989754|3583047|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|172|172.0||||||
3748143|NCT01989754|3583048|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|174|174.0||||||
3748144|NCT01989754|3583046|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|844|844.0||||||
3748145|NCT01989754|3583047|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|437|437.0||||||
3748146|NCT01989754|3583048|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|407|407.0||||||
3748147|NCT01989754|3583046|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|231|231.0||||||
3748148|NCT01989754|3583047|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|106|106.0||||||
3748149|NCT01989754|3583048|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|125|125.0||||||
3748150|NCT01989754|3583046|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|489|489.0||||||
3748151|NCT01989754|3583047|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|244|244.0||||||
3748152|NCT01989754|3583048|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|245|245.0||||||
3748153|NCT01989754|3583046|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|258|258.0||||||
3748154|NCT01989754|3583047|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|133|133.0||||||
3748155|NCT01989754|3583048|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
3748156|NCT01989754|3583046|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3748157|NCT01989754|3583047|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|09|9.0||||||
3748158|NCT01989754|3583048|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3748159|NCT01989754|3583046|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4765|4765.0||||||
3748160|NCT01989754|3583047|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2393|2393.0||||||
3748161|NCT01989754|3583048|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2372|2372.0||||||
3748162|NCT01989754|3583046|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|231|231.0||||||
3748163|NCT01989754|3583047|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
3748164|NCT01989754|3583048|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
3748165|NCT01989754|3583046|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3748166|NCT01989754|3583047|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|08|8.0||||||
3748167|NCT01989754|3583048|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|09|9.0||||||
3748168|NCT01989754|3583046|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|489|489.0||||||
3748169|NCT01989754|3583047|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|244|244.0||||||
3748170|NCT01989754|3583048|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|245|245.0||||||
3748171|NCT01989754|3583046|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3748172|NCT01989754|3583047|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3748173|NCT01989754|3583048|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3748174|NCT01989754|3583046|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3748175|NCT01989754|3583047|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3748176|NCT01989754|3583048|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3748177|NCT01989754|3583046|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4593|4593.0||||||
3748178|NCT01989754|3583047|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2290|2290.0||||||
3748179|NCT01989754|3583048|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2303|2303.0||||||
3748180|NCT01989754|3583046|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1190|1190.0||||||
3748181|NCT01989754|3583047|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|604|604.0||||||
3748182|NCT01989754|3583048|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|586|586.0||||||
3748183|NCT01989754|3583046|B3||Male|Sex: Female, Male||Participants|Count of Participants|3648|3648.0||||||
3748184|NCT01989754|3583047|B2||Male|Sex: Female, Male||Participants|Count of Participants|1854|1854.0||||||
3748185|NCT01989754|3583048|B1||Male|Sex: Female, Male||Participants|Count of Participants|1794|1794.0||||||
3748186|NCT01989754|3583046|B3||Female|Sex: Female, Male||Participants|Count of Participants|2164|2164.0||||||
3748187|NCT01989754|3583047|B2||Female|Sex: Female, Male||Participants|Count of Participants|1053|1053.0||||||
3748188|NCT01989754|3583048|B1||Female|Sex: Female, Male||Participants|Count of Participants|1111|1111.0||||||
3748189|NCT01989754|3583046|B3|||Age||years|Mean|64|64.0|Standard Deviation|8.35|8.35|||
3748190|NCT01989754|3583047|B2|||Age||years|Mean|63.9|63.9|Standard Deviation|8.42|8.42|||
3748191|NCT01989754|3583048|B1|||Age||years|Mean|64|64.0|Standard Deviation|8.28|8.28|||
3748192|NCT01989689|3583059|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3748193|NCT01989689|3583060|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3748194|NCT01989689|3583061|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3748195|NCT01989689|3583059|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3748196|NCT01989689|3583060|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3748197|NCT01989689|3583061|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3748198|NCT01989689|3583059|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3748199|NCT01989689|3583060|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3748200|NCT01989689|3583061|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3748201|NCT01989689|3583059|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3748202|NCT01989689|3583060|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3748203|NCT01989689|3583061|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3748204|NCT01989689|3583059|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3748205|NCT01989689|3583060|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3748206|NCT01989689|3583061|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3748207|NCT01989676|3583072|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3748208|NCT01989676|3583073|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3748209|NCT01989676|3583074|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3748210|NCT01989676|3583072|B3||Female|Sex: Female, Male||Participants|Count of Participants|702|702.0||||||
3748211|NCT01989676|3583073|B2||Female|Sex: Female, Male||Participants|Count of Participants|353|353.0||||||
3748212|NCT01989676|3583074|B1||Female|Sex: Female, Male||Participants|Count of Participants|349|349.0||||||
3748213|NCT01989676|3583072|B3|≥85||Age, Customized||Participants|Number|1|1.0||||||
3748214|NCT01989676|3583073|B2|≥85||Age, Customized||Participants|Number|1|1.0||||||
3748215|NCT01989676|3583074|B1|≥85||Age, Customized||Participants|Number|0|0.0||||||
3748216|NCT01989676|3583072|B3|65 to 84||Age, Customized||Participants|Number|126|126.0||||||
3748217|NCT01989676|3583073|B2|65 to 84||Age, Customized||Participants|Number|60|60.0||||||
3748218|NCT01989676|3583074|B1|65 to 84||Age, Customized||Participants|Number|66|66.0||||||
3748219|NCT01989676|3583072|B3|18 to 64||Age, Customized||Participants|Number|575|575.0||||||
3748220|NCT01989676|3583073|B2|18 to 64||Age, Customized||Participants|Number|292|292.0||||||
3748221|NCT01989676|3583074|B1|18 to 64||Age, Customized||Participants|Number|283|283.0||||||
3748222|NCT01989676|3583072|B3|<18||Age, Customized||Participants|Number|0|0.0||||||
3748223|NCT01989676|3583073|B2|<18||Age, Customized||Participants|Number|0|0.0||||||
3748224|NCT01989676|3583074|B1|<18||Age, Customized||Participants|Number|0|0.0||||||
3748225|NCT01989572|3583095|B7|Male||Gender|One patient on arm V had missing data for gender. Hence, a total of 189 patients on arm V reported gender.|participants|Number|483|483.0||||||
3748226|NCT01989572|3583096|B6|Male||Gender|One patient on arm V had missing data for gender. Hence, a total of 189 patients on arm V reported gender.|participants|Number|112|112.0||||||
3748227|NCT01989572|3583097|B5|Male||Gender|One patient on arm V had missing data for gender. Hence, a total of 189 patients on arm V reported gender.|participants|Number|112|112.0||||||
3748228|NCT01989572|3583098|B4|Male||Gender|One patient on arm V had missing data for gender. Hence, a total of 189 patients on arm V reported gender.|participants|Number|68|68.0||||||
3748229|NCT01989572|3583099|B3|Male||Gender|One patient on arm V had missing data for gender. Hence, a total of 189 patients on arm V reported gender.|participants|Number|64|64.0||||||
3748230|NCT01989572|3583100|B2|Male||Gender|One patient on arm V had missing data for gender. Hence, a total of 189 patients on arm V reported gender.|participants|Number|66|66.0||||||
3748231|NCT01989572|3583101|B1|Male||Gender|One patient on arm V had missing data for gender. Hence, a total of 189 patients on arm V reported gender.|participants|Number|61|61.0||||||
3748232|NCT01989572|3583095|B7|Female||Gender|One patient on arm V had missing data for gender. Hence, a total of 189 patients on arm V reported gender.|participants|Number|331|331.0||||||
3748233|NCT01989572|3583096|B6|Female||Gender|One patient on arm V had missing data for gender. Hence, a total of 189 patients on arm V reported gender.|participants|Number|77|77.0||||||
3748234|NCT01989572|3583097|B5|Female||Gender|One patient on arm V had missing data for gender. Hence, a total of 189 patients on arm V reported gender.|participants|Number|77|77.0||||||
3748235|NCT01989572|3583098|B4|Female||Gender|One patient on arm V had missing data for gender. Hence, a total of 189 patients on arm V reported gender.|participants|Number|39|39.0||||||
3748236|NCT01989572|3583099|B3|Female||Gender|One patient on arm V had missing data for gender. Hence, a total of 189 patients on arm V reported gender.|participants|Number|45|45.0||||||
3748237|NCT01989572|3583100|B2|Female||Gender|One patient on arm V had missing data for gender. Hence, a total of 189 patients on arm V reported gender.|participants|Number|45|45.0||||||
3748238|NCT01989572|3583101|B1|Female||Gender|One patient on arm V had missing data for gender. Hence, a total of 189 patients on arm V reported gender.|participants|Number|48|48.0||||||
3748239|NCT01989572|3583095|B7|||Age||years|Median|58|58.0|Full Range|||19.0|88.0|
3748240|NCT01989572|3583096|B6|||Age||years|Median|57|57.0|Full Range|||19.0|87.0|
3748241|NCT01989572|3583097|B5|||Age||years|Median|60|60.0|Full Range|||19.0|88.0|
3748242|NCT01989572|3583098|B4|||Age||years|Median|58|58.0|Full Range|||23.0|82.0|
3748243|NCT01989572|3583099|B3|||Age||years|Median|57|57.0|Full Range|||23.0|87.0|
3748244|NCT01989572|3583100|B2|||Age||years|Median|56|56.0|Full Range|||22.0|82.0|
3748245|NCT01989572|3583101|B1|||Age||years|Median|60|60.0|Full Range|||27.0|83.0|
3748246|NCT01989455|3583134|B6|Canada||Region of Enrollment||participants|Number|64|64.0||||||
3748247|NCT01989455|3583135|B5|Canada||Region of Enrollment||participants|Number|8|8.0||||||
3748248|NCT01989455|3583136|B4|Canada||Region of Enrollment||participants|Number|14|14.0||||||
3748249|NCT01989455|3583137|B3|Canada||Region of Enrollment||participants|Number|14|14.0||||||
3748250|NCT01989455|3583138|B2|Canada||Region of Enrollment||participants|Number|14|14.0||||||
3748251|NCT01989455|3583139|B1|Canada||Region of Enrollment||participants|Number|14|14.0||||||
3748252|NCT01989455|3583134|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748253|NCT01989455|3583135|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748254|NCT01989455|3583136|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748255|NCT01989455|3583137|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748256|NCT01989455|3583138|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748257|NCT01989455|3583139|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748258|NCT01989455|3583134|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748259|NCT01989455|3583135|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748260|NCT01989455|3583136|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748261|NCT01989455|3583137|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748262|NCT01989455|3583138|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748263|NCT01989455|3583139|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748264|NCT01989455|3583134|B6||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3748265|NCT01989455|3583135|B5||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3748266|NCT01989455|3583136|B4||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3748267|NCT01989455|3583137|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3748268|NCT01989455|3583138|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3748269|NCT01989455|3583139|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3748270|NCT01989455|3583134|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3748271|NCT01989455|3583135|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3748272|NCT01989455|3583136|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3748273|NCT01989455|3583137|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3748274|NCT01989455|3583138|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3748275|NCT01989455|3583139|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3748276|NCT01989455|3583134|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748277|NCT01989455|3583135|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748278|NCT01989455|3583136|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748279|NCT01989455|3583137|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748280|NCT01989455|3583138|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748281|NCT01989455|3583139|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748282|NCT01989455|3583134|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3748283|NCT01989455|3583135|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748284|NCT01989455|3583136|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748285|NCT01989455|3583137|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748286|NCT01989455|3583138|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3748287|NCT01989455|3583139|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3748288|NCT01989455|3583134|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748289|NCT01989455|3583135|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748290|NCT01989455|3583136|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748291|NCT01989455|3583137|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748292|NCT01989455|3583138|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748293|NCT01989455|3583139|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748294|NCT01989455|3583134|B6||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3748295|NCT01989455|3583135|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3748296|NCT01989455|3583136|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3748297|NCT01989455|3583137|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3748298|NCT01989455|3583138|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3748299|NCT01989455|3583139|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3748300|NCT01989455|3583134|B6||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3748301|NCT01989455|3583135|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3748302|NCT01989455|3583136|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3748303|NCT01989455|3583137|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3748304|NCT01989455|3583138|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3748305|NCT01989455|3583139|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3748306|NCT01989455|3583134|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3748307|NCT01989455|3583135|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3748308|NCT01989455|3583136|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3748309|NCT01989455|3583137|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3748310|NCT01989455|3583138|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3748311|NCT01989455|3583139|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3748312|NCT01989455|3583134|B6||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
3748313|NCT01989455|3583135|B5||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3748314|NCT01989455|3583136|B4||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3748315|NCT01989455|3583137|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3748316|NCT01989455|3583138|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3748317|NCT01989455|3583139|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3748318|NCT01989455|3583134|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3748319|NCT01989455|3583135|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3748320|NCT01989455|3583136|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3748321|NCT01989455|3583137|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3748322|NCT01989455|3583138|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3748323|NCT01989455|3583139|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3748324|NCT01989195|3583177|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3748325|NCT01989195|3583177|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
3748326|NCT01989195|3583177|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3748327|NCT01989195|3583177|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3748328|NCT01989195|3583177|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3748329|NCT01989195|3583177|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3748330|NCT01989169|3583185|B3|UNITED STATES||Region of Enrollment||Participants|Number|30|30.0||||||
3748331|NCT01989169|3583186|B2|UNITED STATES||Region of Enrollment||Participants|Number|15|15.0||||||
3748332|NCT01989169|3583187|B1|UNITED STATES||Region of Enrollment||Participants|Number|15|15.0||||||
3748333|NCT01989169|3583185|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3748334|NCT01989169|3583186|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3748335|NCT01989169|3583187|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3748336|NCT01989169|3583185|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3748337|NCT01989169|3583186|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3748338|NCT01989169|3583187|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3748339|NCT01989169|3583185|B3|Between 18 and 65 years||Age, Customized||Participants|Number|29|29.0||||||
3748340|NCT01989169|3583186|B2|Between 18 and 65 years||Age, Customized||Participants|Number|15|15.0||||||
3748341|NCT01989169|3583187|B1|Between 18 and 65 years||Age, Customized||Participants|Number|14|14.0||||||
3748342|NCT01989169|3583185|B3|<=18 years||Age, Customized||Participants|Number|1|1.0||||||
3748343|NCT01989169|3583186|B2|<=18 years||Age, Customized||Participants|Number|0|0.0||||||
3748344|NCT01989169|3583187|B1|<=18 years||Age, Customized||Participants|Number|1|1.0||||||
3748345|NCT01989169|3583185|B3|||Age||Years|Mean|41|41.0|Standard Deviation|11.07|11.07|||
3748346|NCT01989169|3583186|B2|||Age||Years|Mean|44.9|44.9|Standard Deviation|10.53|10.53|||
3748347|NCT01989169|3583187|B1|||Age||Years|Mean|37|37.0|Standard Deviation|10.45|10.45|||
3748348|NCT01989156|3583198|B4|> 19 cig/day||Daily mCC consumption at screening||participants|Number|77|77.0||||||
3748349|NCT01989156|3583199|B3|> 19 cig/day||Daily mCC consumption at screening||participants|Number|21|21.0||||||
3748350|NCT01989156|3583200|B2|> 19 cig/day||Daily mCC consumption at screening||participants|Number|20|20.0||||||
3748351|NCT01989156|3583201|B1|> 19 cig/day||Daily mCC consumption at screening||participants|Number|36|36.0||||||
3748352|NCT01989156|3583198|B4|10 to 19 cig/day||Daily mCC consumption at screening||participants|Number|82|82.0||||||
3748353|NCT01989156|3583199|B3|10 to 19 cig/day||Daily mCC consumption at screening||participants|Number|18|18.0||||||
3748354|NCT01989156|3583200|B2|10 to 19 cig/day||Daily mCC consumption at screening||participants|Number|21|21.0||||||
3748355|NCT01989156|3583201|B1|10 to 19 cig/day||Daily mCC consumption at screening||participants|Number|43|43.0||||||
3748356|NCT01989156|3583198|B4||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3748357|NCT01989156|3583199|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3748358|NCT01989156|3583200|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3748359|NCT01989156|3583201|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3748360|NCT01989156|3583198|B4||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3748361|NCT01989156|3583199|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3748362|NCT01989156|3583200|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3748363|NCT01989156|3583201|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3748364|NCT01989156|3583198|B4|||Age||years|Mean|37.7|37.7|Standard Deviation|11.45|11.45|||
3748365|NCT01989156|3583199|B3|||Age||years|Mean|38.8|38.8|Standard Deviation|11.42|11.42|||
3748366|NCT01989156|3583200|B2|||Age||years|Mean|33.7|33.7|Standard Deviation|10.17|10.17|||
3748367|NCT01989156|3583201|B1|||Age||years|Mean|39.2|39.2|Standard Deviation|11.72|11.72|||
3748368|NCT01989130|3583223|B3|United States||Region of Enrollment||participants|Number|70|70.0||||||
3748369|NCT01989130|3583224|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
3748370|NCT01989130|3583225|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
3748371|NCT01989130|3583223|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3748372|NCT01989130|3583224|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3748373|NCT01989130|3583225|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3748374|NCT01989130|3583223|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3748375|NCT01989130|3583224|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3748376|NCT01989130|3583225|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3748377|NCT01989130|3583223|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3748378|NCT01989130|3583224|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3748379|NCT01989130|3583225|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3748380|NCT01989130|3583223|B3||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
3748381|NCT01989130|3583224|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3748382|NCT01989130|3583225|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3748383|NCT01989130|3583223|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3748384|NCT01989130|3583224|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3748385|NCT01989130|3583225|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3748386|NCT01988922|3583238|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
3748387|NCT01988922|3583239|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3748388|NCT01988922|3583240|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3748389|NCT01988922|3583241|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3748390|NCT01988922|3583238|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3748391|NCT01988922|3583239|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3748392|NCT01988922|3583240|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3748393|NCT01988922|3583241|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3748394|NCT01988922|3583238|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3748395|NCT01988922|3583239|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3748396|NCT01988922|3583240|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3748397|NCT01988922|3583241|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3748398|NCT01988922|3583238|B4|||Age||years|Mean|29|29.0|Standard Deviation|10|10.0|||
3748399|NCT01988922|3583239|B3|||Age||years|Mean|37|37.0|Standard Deviation|13|13.0|||
3748400|NCT01988922|3583240|B2|||Age||years|Mean|27|27.0|Standard Deviation|11|11.0|||
3748401|NCT01988922|3583241|B1|||Age||years|Mean|25|25.0|Standard Deviation|6|6.0|||
3748402|NCT01988922|3583238|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3748403|NCT01988922|3583239|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3748404|NCT01988922|3583240|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3748405|NCT01988922|3583241|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3748406|NCT01988922|3583238|B4||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3748407|NCT01988922|3583239|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3748408|NCT01988922|3583240|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3748409|NCT01988922|3583241|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3748410|NCT01988922|3583238|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3748411|NCT01988922|3583239|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3748412|NCT01988922|3583240|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3748413|NCT01988922|3583241|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3748414|NCT01988857|3583254|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|300|300.0||||||
3748415|NCT01988857|3583254|B1||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3748416|NCT01988857|3583254|B1||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3748417|NCT01988857|3583254|B1|||Age||Years|Mean|7.9|7.9|Standard Deviation|1.38|1.38|||
3748418|NCT01988857|3583254|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3748419|NCT01988857|3583254|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3748420|NCT01988857|3583254|B1||<=18 years|Age||Participants|Count of Participants|300|300.0||||||
3748421|NCT01988662|3583261|B3||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3748422|NCT01988662|3583262|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3748423|NCT01988662|3583263|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3748424|NCT01988662|3583261|B3||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3748425|NCT01988662|3583262|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3748426|NCT01988662|3583263|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3748427|NCT01988662|3583261|B3|||Age||Years|Mean|71.0|71.0|Standard Deviation|8.76|8.76|||
3748428|NCT01988662|3583262|B2|||Age||Years|Mean|72.0|72.0|Standard Deviation|8.43|8.43|||
3748429|NCT01988662|3583263|B1|||Age||Years|Mean|70.1|70.1|Standard Deviation|9.00|9.0|||
3748430|NCT01988415|3583281|B1|Colombia||Region of Enrollment||participants|Number|26|26.0||||||
3748431|NCT01988415|3583281|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3748432|NCT01988415|3583281|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3748433|NCT01988415|3583281|B1|||Age||years|Mean|29|29.0|Standard Deviation|6.6|6.6|||
3748434|NCT01988402|3583289|B3|||Participants with erosions||participants|Number|8|8.0||||||
3748435|NCT01988402|3583290|B2|||Participants with erosions||participants|Number|4|4.0||||||
3748436|NCT01988402|3583291|B1|||Participants with erosions||participants|Number|4|4.0||||||
3748437|NCT01988402|3583289|B3|||participants with tophi||participants|Number|12|12.0||||||
3748438|NCT01988402|3583290|B2|||participants with tophi||participants|Number|6|6.0||||||
3748439|NCT01988402|3583291|B1|||participants with tophi||participants|Number|6|6.0||||||
3748440|NCT01988402|3583289|B3|||participants with history of nephrolithiasis||participants|Number|5|5.0||||||
3748441|NCT01988402|3583290|B2|||participants with history of nephrolithiasis||participants|Number|1|1.0||||||
3748442|NCT01988402|3583291|B1|||participants with history of nephrolithiasis||participants|Number|4|4.0||||||
3748443|NCT01988402|3583289|B3|||number of prior attacks||number|Mean|5.2|5.2|Full Range|||0.0|35.0|
3748444|NCT01988402|3583290|B2|||number of prior attacks||number|Mean|6.58|6.58|Full Range|||1.0|35.0|
3748445|NCT01988402|3583291|B1|||number of prior attacks||number|Mean|3.7|3.7|Full Range|||0.0|12.0|
3748446|NCT01988402|3583289|B3|||Disease duration||years|Mean|5.2|5.2|Full Range|||0.0|20.0|
3748447|NCT01988402|3583290|B2|||Disease duration||years|Mean|4.9|4.9|Full Range|||0.0|17.0|
3748448|NCT01988402|3583291|B1|||Disease duration||years|Mean|5.5|5.5|Full Range|||0.0|20.0|
3748449|NCT01988402|3583289|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3748450|NCT01988402|3583290|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3748451|NCT01988402|3583291|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3748452|NCT01988402|3583289|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3748453|NCT01988402|3583290|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3748454|NCT01988402|3583291|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3748455|NCT01988402|3583289|B3|||Age||Years|Mean|57|57.0|Full Range|||31.0|84.0|
3748456|NCT01988402|3583290|B2|||Age||Years|Mean|53|53.0|Full Range|||31.0|68.0|
3748457|NCT01988402|3583291|B1|||Age||Years|Mean|61|61.0|Full Range|||40.0|84.0|
3748458|NCT01988376|3583304|B3|||Sex/Gender, Customized||participants|Number|258|258.0||||||
3748459|NCT01988376|3583305|B2|||Sex/Gender, Customized||participants|Number|129|129.0||||||
3748460|NCT01988376|3583306|B1|||Sex/Gender, Customized||participants|Number|129|129.0||||||
3748461|NCT01988376|3583304|B3|||Age||years|Mean|57.97|57.97|Standard Deviation|9.79|9.79|||
3748462|NCT01988376|3583305|B2|||Age||years|Mean|58.50|58.5|Standard Deviation|8.13|8.13|||
3748463|NCT01988376|3583306|B1|||Age||years|Mean|57.44|57.44|Standard Deviation|11.44|11.44|||
3748464|NCT01988129|3583313|B3|Biracial||Race/Ethnicity, Customized|The data reflect the categories collected by the fire department|participants|Number|9|9.0||||||
3748465|NCT01988129|3583314|B2|Biracial||Race/Ethnicity, Customized|The data reflect the categories collected by the fire department|participants|Number|2|2.0||||||
3748466|NCT01988129|3583315|B1|Biracial||Race/Ethnicity, Customized|The data reflect the categories collected by the fire department|participants|Number|7|7.0||||||
3748467|NCT01988129|3583313|B3|Native American||Race/Ethnicity, Customized|The data reflect the categories collected by the fire department|participants|Number|4|4.0||||||
3748468|NCT01988129|3583314|B2|Native American||Race/Ethnicity, Customized|The data reflect the categories collected by the fire department|participants|Number|1|1.0||||||
3748469|NCT01988129|3583315|B1|Native American||Race/Ethnicity, Customized|The data reflect the categories collected by the fire department|participants|Number|3|3.0||||||
3748470|NCT01988129|3583313|B3|Asian||Race/Ethnicity, Customized|The data reflect the categories collected by the fire department|participants|Number|4|4.0||||||
3748471|NCT01988129|3583314|B2|Asian||Race/Ethnicity, Customized|The data reflect the categories collected by the fire department|participants|Number|3|3.0||||||
3748472|NCT01988129|3583315|B1|Asian||Race/Ethnicity, Customized|The data reflect the categories collected by the fire department|participants|Number|1|1.0||||||
3748473|NCT01988129|3583313|B3|Hispanic||Race/Ethnicity, Customized|The data reflect the categories collected by the fire department|participants|Number|6|6.0||||||
3748474|NCT01988129|3583314|B2|Hispanic||Race/Ethnicity, Customized|The data reflect the categories collected by the fire department|participants|Number|2|2.0||||||
3748475|NCT01988129|3583315|B1|Hispanic||Race/Ethnicity, Customized|The data reflect the categories collected by the fire department|participants|Number|4|4.0||||||
3748476|NCT01988129|3583313|B3|Black||Race/Ethnicity, Customized|The data reflect the categories collected by the fire department|participants|Number|85|85.0||||||
3748477|NCT01988129|3583314|B2|Black||Race/Ethnicity, Customized|The data reflect the categories collected by the fire department|participants|Number|40|40.0||||||
3748478|NCT01988129|3583315|B1|Black||Race/Ethnicity, Customized|The data reflect the categories collected by the fire department|participants|Number|45|45.0||||||
3748479|NCT01988129|3583313|B3|White||Race/Ethnicity, Customized|The data reflect the categories collected by the fire department|participants|Number|1081|1081.0||||||
3748480|NCT01988129|3583314|B2|White||Race/Ethnicity, Customized|The data reflect the categories collected by the fire department|participants|Number|540|540.0||||||
3748481|NCT01988129|3583315|B1|White||Race/Ethnicity, Customized|The data reflect the categories collected by the fire department|participants|Number|541|541.0||||||
3748482|NCT01988129|3583313|B3||Male|Sex: Female, Male||Participants|Count of Participants|1173|1173.0||||||
3748483|NCT01988129|3583314|B2||Male|Sex: Female, Male||Participants|Count of Participants|583|583.0||||||
3748484|NCT01988129|3583315|B1||Male|Sex: Female, Male||Participants|Count of Participants|590|590.0||||||
3748485|NCT01988129|3583313|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3748486|NCT01988129|3583314|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3748487|NCT01988129|3583315|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3748488|NCT01988129|3583313|B3|||Age||Years|Mean|43.6|43.6|Standard Deviation|7.4|7.4|||
3748489|NCT01988129|3583314|B2|||Age||Years|Mean|44.4|44.4|Standard Deviation|7.4|7.4|||
3748490|NCT01988129|3583315|B1|||Age||Years|Mean|42.7|42.7|Standard Deviation|7.3|7.3|||
3748491|NCT01988012|3583343|B1||Male|Gender||Participants|Count of Participants|20|20.0||||||
3748492|NCT01988012|3583343|B1||Female|Gender||Participants|Count of Participants|80|80.0||||||
3748493|NCT01988012|3583343|B1|||Age||years|Mean|54.3|54.3|Standard Deviation|11.8|11.8|||
3748494|NCT01987986|3583365|B5|United States||Region of Enrollment||participants|Number|150|150.0||||||
3748495|NCT01987986|3583366|B4|United States||Region of Enrollment||participants|Number|24|24.0||||||
3748496|NCT01987986|3583367|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3748497|NCT01987986|3583368|B2|United States||Region of Enrollment||participants|Number|43|43.0||||||
3748498|NCT01987986|3583369|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
3748499|NCT01987986|3583365|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3748500|NCT01987986|3583366|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3748501|NCT01987986|3583367|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3748502|NCT01987986|3583368|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3748503|NCT01987986|3583369|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3748504|NCT01987986|3583365|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|136|136.0||||||
3748505|NCT01987986|3583366|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3748506|NCT01987986|3583367|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3748507|NCT01987986|3583368|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3748508|NCT01987986|3583369|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3748509|NCT01987986|3583365|B5|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3748510|NCT01987986|3583366|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3748511|NCT01987986|3583367|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3748512|NCT01987986|3583368|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3748513|NCT01987986|3583369|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3748514|NCT01987986|3583365|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3748515|NCT01987986|3583366|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3748516|NCT01987986|3583367|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3748517|NCT01987986|3583368|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3748518|NCT01987986|3583369|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3748519|NCT01987986|3583365|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748520|NCT01987986|3583366|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748521|NCT01987986|3583367|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748522|NCT01987986|3583368|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748523|NCT01987986|3583369|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748524|NCT01987986|3583365|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|114|114.0||||||
3748525|NCT01987986|3583366|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3748526|NCT01987986|3583367|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3748527|NCT01987986|3583368|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3748528|NCT01987986|3583369|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3748529|NCT01987986|3583365|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3748530|NCT01987986|3583366|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3748531|NCT01987986|3583367|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3748532|NCT01987986|3583368|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3748533|NCT01987986|3583369|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3748534|NCT01987986|3583365|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3748535|NCT01987986|3583366|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3748536|NCT01987986|3583367|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3748537|NCT01987986|3583368|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3748538|NCT01987986|3583369|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3748539|NCT01987986|3583365|B5||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3748540|NCT01987986|3583366|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3748541|NCT01987986|3583367|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3748542|NCT01987986|3583368|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3748543|NCT01987986|3583369|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3748544|NCT01987986|3583365|B5|>=45||Age, Customized||Participants|Count of Participants|13|13.0||||||
3748545|NCT01987986|3583366|B4|>=45||Age, Customized||Participants|Count of Participants|4|4.0||||||
3748546|NCT01987986|3583367|B3|>=45||Age, Customized||Participants|Count of Participants|1|1.0||||||
3748547|NCT01987986|3583368|B2|>=45||Age, Customized||Participants|Count of Participants|6|6.0||||||
3748548|NCT01987986|3583369|B1|>=45||Age, Customized||Participants|Count of Participants|2|2.0||||||
3748549|NCT01987986|3583365|B5|35-44||Age, Customized||Participants|Count of Participants|94|94.0||||||
3748550|NCT01987986|3583366|B4|35-44||Age, Customized||Participants|Count of Participants|13|13.0||||||
3748551|NCT01987986|3583367|B3|35-44||Age, Customized||Participants|Count of Participants|25|25.0||||||
3748552|NCT01987986|3583368|B2|35-44||Age, Customized||Participants|Count of Participants|23|23.0||||||
3748553|NCT01987986|3583369|B1|35-44||Age, Customized||Participants|Count of Participants|33|33.0||||||
3748554|NCT01987986|3583365|B5|25-34||Age, Customized||Participants|Count of Participants|35|35.0||||||
3748555|NCT01987986|3583366|B4|25-34||Age, Customized||Participants|Count of Participants|6|6.0||||||
3748556|NCT01987986|3583367|B3|25-34||Age, Customized||Participants|Count of Participants|12|12.0||||||
3748557|NCT01987986|3583368|B2|25-34||Age, Customized||Participants|Count of Participants|11|11.0||||||
3748558|NCT01987986|3583369|B1|25-34||Age, Customized||Participants|Count of Participants|6|6.0||||||
3748559|NCT01987986|3583365|B5|<25||Age, Customized||Participants|Count of Participants|8|8.0||||||
3748560|NCT01987986|3583366|B4|<25||Age, Customized||Participants|Count of Participants|1|1.0||||||
3748561|NCT01987986|3583367|B3|<25||Age, Customized||Participants|Count of Participants|2|2.0||||||
3748562|NCT01987986|3583368|B2|<25||Age, Customized||Participants|Count of Participants|3|3.0||||||
3748563|NCT01987986|3583369|B1|<25||Age, Customized||Participants|Count of Participants|2|2.0||||||
3748564|NCT01987986|3583365|B5|||Age||years|Mean|36.9|36.9|Standard Deviation|6.50|6.5|||
3748565|NCT01987986|3583366|B4|||Age||years|Mean|37.3|37.3|Standard Deviation|8.08|8.08|||
3748566|NCT01987986|3583367|B3|||Age||years|Mean|36.1|36.1|Standard Deviation|5.62|5.62|||
3748567|NCT01987986|3583368|B2|||Age||years|Mean|36.8|36.8|Standard Deviation|7.07|7.07|||
3748568|NCT01987986|3583369|B1|||Age||years|Mean|37.7|37.7|Standard Deviation|5.78|5.78|||
3748569|NCT01987960|3583410|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3748570|NCT01987960|3583411|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3748571|NCT01987960|3583412|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3748572|NCT01987960|3583410|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3748573|NCT01987960|3583411|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3748574|NCT01987960|3583412|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3748575|NCT01987960|3583410|B3|||Age||years|Mean|45.6|45.6|Standard Deviation|11.1|11.1|||
3748576|NCT01987960|3583411|B2|||Age||years|Mean|47.6|47.6|Standard Deviation|10.4|10.4|||
3748577|NCT01987960|3583412|B1|||Age||years|Mean|42.9|42.9|Standard Deviation|11.8|11.8|||
3748578|NCT01987908|3583427|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3748579|NCT01987908|3583427|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3748580|NCT01987908|3583427|B1|||Age||Years|Mean|28|28.0|Standard Deviation|7|7.0|||
3748581|NCT01987895|3583510|B3|Unable to determine||CDAD severity at baseline|"CDAD at baseline was considered as severe if the following criteria were met: maximum body temperature > 38.5 C, white blood cell counts > 15.0 x 10*9/L and rise in baseline serum creatinine > 50% compared to the level before CDAD diagnosis. Otherwise, it was considered as mild-moderate. The number of subjects with severe and mild-moderate CDAD at baseline was assessed for each treatment group. If any of the measurements required for derivation of severity was missing, the subjects were classified as unable to determine."|Participants|Count of Participants|40|40.0||||||
3748582|NCT01987895|3583511|B2|Unable to determine||CDAD severity at baseline|"CDAD at baseline was considered as severe if the following criteria were met: maximum body temperature > 38.5 C, white blood cell counts > 15.0 x 10*9/L and rise in baseline serum creatinine > 50% compared to the level before CDAD diagnosis. Otherwise, it was considered as mild-moderate. The number of subjects with severe and mild-moderate CDAD at baseline was assessed for each treatment group. If any of the measurements required for derivation of severity was missing, the subjects were classified as unable to determine."|Participants|Count of Participants|24|24.0||||||
3748583|NCT01987895|3583512|B1|Unable to determine||CDAD severity at baseline|"CDAD at baseline was considered as severe if the following criteria were met: maximum body temperature > 38.5 C, white blood cell counts > 15.0 x 10*9/L and rise in baseline serum creatinine > 50% compared to the level before CDAD diagnosis. Otherwise, it was considered as mild-moderate. The number of subjects with severe and mild-moderate CDAD at baseline was assessed for each treatment group. If any of the measurements required for derivation of severity was missing, the subjects were classified as unable to determine."|Participants|Count of Participants|16|16.0||||||
3748584|NCT01987895|3583510|B3|Severe||CDAD severity at baseline|"CDAD at baseline was considered as severe if the following criteria were met: maximum body temperature > 38.5 C, white blood cell counts > 15.0 x 10*9/L and rise in baseline serum creatinine > 50% compared to the level before CDAD diagnosis. Otherwise, it was considered as mild-moderate. The number of subjects with severe and mild-moderate CDAD at baseline was assessed for each treatment group. If any of the measurements required for derivation of severity was missing, the subjects were classified as unable to determine."|Participants|Count of Participants|110|110.0||||||
3748585|NCT01987895|3583511|B2|Severe||CDAD severity at baseline|"CDAD at baseline was considered as severe if the following criteria were met: maximum body temperature > 38.5 C, white blood cell counts > 15.0 x 10*9/L and rise in baseline serum creatinine > 50% compared to the level before CDAD diagnosis. Otherwise, it was considered as mild-moderate. The number of subjects with severe and mild-moderate CDAD at baseline was assessed for each treatment group. If any of the measurements required for derivation of severity was missing, the subjects were classified as unable to determine."|Participants|Count of Participants|51|51.0||||||
3748586|NCT01987895|3583512|B1|Severe||CDAD severity at baseline|"CDAD at baseline was considered as severe if the following criteria were met: maximum body temperature > 38.5 C, white blood cell counts > 15.0 x 10*9/L and rise in baseline serum creatinine > 50% compared to the level before CDAD diagnosis. Otherwise, it was considered as mild-moderate. The number of subjects with severe and mild-moderate CDAD at baseline was assessed for each treatment group. If any of the measurements required for derivation of severity was missing, the subjects were classified as unable to determine."|Participants|Count of Participants|59|59.0||||||
3748587|NCT01987895|3583510|B3|Mild-Moderate||CDAD severity at baseline|"CDAD at baseline was considered as severe if the following criteria were met: maximum body temperature > 38.5 C, white blood cell counts > 15.0 x 10*9/L and rise in baseline serum creatinine > 50% compared to the level before CDAD diagnosis. Otherwise, it was considered as mild-moderate. The number of subjects with severe and mild-moderate CDAD at baseline was assessed for each treatment group. If any of the measurements required for derivation of severity was missing, the subjects were classified as unable to determine."|Participants|Count of Participants|470|470.0||||||
3748588|NCT01987895|3583511|B2|Mild-Moderate||CDAD severity at baseline|"CDAD at baseline was considered as severe if the following criteria were met: maximum body temperature > 38.5 C, white blood cell counts > 15.0 x 10*9/L and rise in baseline serum creatinine > 50% compared to the level before CDAD diagnosis. Otherwise, it was considered as mild-moderate. The number of subjects with severe and mild-moderate CDAD at baseline was assessed for each treatment group. If any of the measurements required for derivation of severity was missing, the subjects were classified as unable to determine."|Participants|Count of Participants|243|243.0||||||
3748589|NCT01987895|3583512|B1|Mild-Moderate||CDAD severity at baseline|"CDAD at baseline was considered as severe if the following criteria were met: maximum body temperature > 38.5 C, white blood cell counts > 15.0 x 10*9/L and rise in baseline serum creatinine > 50% compared to the level before CDAD diagnosis. Otherwise, it was considered as mild-moderate. The number of subjects with severe and mild-moderate CDAD at baseline was assessed for each treatment group. If any of the measurements required for derivation of severity was missing, the subjects were classified as unable to determine."|Participants|Count of Participants|227|227.0||||||
3748590|NCT01987895|3583510|B3|Unable to determine||Initial strain of Clostridium difficile|"The strain of C. difficile at baseline was identified in the last stool sample collected up to treatment start date and with available C. difficile culture. Identification was done by polymerase chain reaction (PCR). The strains were categorized as hypervirulent strains (PCR ribotype 027, 078 or 244) or non-hypervirulent (other PCR ribotypes). The number of subjects with hypervirulent, non-hypervirulent strains at baseline was assessed for each treatment group. If PCR ribotype at baseline was not available, the subjects were classified as unable to determine."|Participants|Count of Participants|39|39.0||||||
3748655|NCT01987765|3583537|B1|40 to 49 years||Age, Customized||Participants|Number|127|127.0||||||
3748656|NCT01987765|3583537|B1|30 to 39 years||Age, Customized||Participants|Number|139|139.0||||||
3748591|NCT01987895|3583511|B2|Unable to determine||Initial strain of Clostridium difficile|"The strain of C. difficile at baseline was identified in the last stool sample collected up to treatment start date and with available C. difficile culture. Identification was done by polymerase chain reaction (PCR). The strains were categorized as hypervirulent strains (PCR ribotype 027, 078 or 244) or non-hypervirulent (other PCR ribotypes). The number of subjects with hypervirulent, non-hypervirulent strains at baseline was assessed for each treatment group. If PCR ribotype at baseline was not available, the subjects were classified as unable to determine."|Participants|Count of Participants|21|21.0||||||
3748592|NCT01987895|3583512|B1|Unable to determine||Initial strain of Clostridium difficile|"The strain of C. difficile at baseline was identified in the last stool sample collected up to treatment start date and with available C. difficile culture. Identification was done by polymerase chain reaction (PCR). The strains were categorized as hypervirulent strains (PCR ribotype 027, 078 or 244) or non-hypervirulent (other PCR ribotypes). The number of subjects with hypervirulent, non-hypervirulent strains at baseline was assessed for each treatment group. If PCR ribotype at baseline was not available, the subjects were classified as unable to determine."|Participants|Count of Participants|18|18.0||||||
3748593|NCT01987895|3583510|B3|Non-hypervirulent strains||Initial strain of Clostridium difficile|"The strain of C. difficile at baseline was identified in the last stool sample collected up to treatment start date and with available C. difficile culture. Identification was done by polymerase chain reaction (PCR). The strains were categorized as hypervirulent strains (PCR ribotype 027, 078 or 244) or non-hypervirulent (other PCR ribotypes). The number of subjects with hypervirulent, non-hypervirulent strains at baseline was assessed for each treatment group. If PCR ribotype at baseline was not available, the subjects were classified as unable to determine."|Participants|Count of Participants|441|441.0||||||
3748594|NCT01987895|3583511|B2|Non-hypervirulent strains||Initial strain of Clostridium difficile|"The strain of C. difficile at baseline was identified in the last stool sample collected up to treatment start date and with available C. difficile culture. Identification was done by polymerase chain reaction (PCR). The strains were categorized as hypervirulent strains (PCR ribotype 027, 078 or 244) or non-hypervirulent (other PCR ribotypes). The number of subjects with hypervirulent, non-hypervirulent strains at baseline was assessed for each treatment group. If PCR ribotype at baseline was not available, the subjects were classified as unable to determine."|Participants|Count of Participants|215|215.0||||||
3748595|NCT01987895|3583512|B1|Non-hypervirulent strains||Initial strain of Clostridium difficile|"The strain of C. difficile at baseline was identified in the last stool sample collected up to treatment start date and with available C. difficile culture. Identification was done by polymerase chain reaction (PCR). The strains were categorized as hypervirulent strains (PCR ribotype 027, 078 or 244) or non-hypervirulent (other PCR ribotypes). The number of subjects with hypervirulent, non-hypervirulent strains at baseline was assessed for each treatment group. If PCR ribotype at baseline was not available, the subjects were classified as unable to determine."|Participants|Count of Participants|226|226.0||||||
3748596|NCT01987895|3583510|B3|Hypervirulent strains||Initial strain of Clostridium difficile|"The strain of C. difficile at baseline was identified in the last stool sample collected up to treatment start date and with available C. difficile culture. Identification was done by polymerase chain reaction (PCR). The strains were categorized as hypervirulent strains (PCR ribotype 027, 078 or 244) or non-hypervirulent (other PCR ribotypes). The number of subjects with hypervirulent, non-hypervirulent strains at baseline was assessed for each treatment group. If PCR ribotype at baseline was not available, the subjects were classified as unable to determine."|Participants|Count of Participants|140|140.0||||||
3748597|NCT01987895|3583511|B2|Hypervirulent strains||Initial strain of Clostridium difficile|"The strain of C. difficile at baseline was identified in the last stool sample collected up to treatment start date and with available C. difficile culture. Identification was done by polymerase chain reaction (PCR). The strains were categorized as hypervirulent strains (PCR ribotype 027, 078 or 244) or non-hypervirulent (other PCR ribotypes). The number of subjects with hypervirulent, non-hypervirulent strains at baseline was assessed for each treatment group. If PCR ribotype at baseline was not available, the subjects were classified as unable to determine."|Participants|Count of Participants|82|82.0||||||
3748598|NCT01987895|3583512|B1|Hypervirulent strains||Initial strain of Clostridium difficile|"The strain of C. difficile at baseline was identified in the last stool sample collected up to treatment start date and with available C. difficile culture. Identification was done by polymerase chain reaction (PCR). The strains were categorized as hypervirulent strains (PCR ribotype 027, 078 or 244) or non-hypervirulent (other PCR ribotypes). The number of subjects with hypervirulent, non-hypervirulent strains at baseline was assessed for each treatment group. If PCR ribotype at baseline was not available, the subjects were classified as unable to determine."|Participants|Count of Participants|58|58.0||||||
3748599|NCT01987895|3583510|B3|First recurrence||CDAD episode type strata|CDAD episode type strata was defined as baseline stratification factor ‘First occurrence’ or ‘First recurrence’ of CDAD as recorded in the Interactive voice recognition system (IVRS) at the time of subject randomization. Number of subjects with first recurrence or first occurrence at randomization was assessed for each treatment group.|Participants|Count of Participants|129|129.0||||||
3748600|NCT01987895|3583511|B2|First recurrence||CDAD episode type strata|CDAD episode type strata was defined as baseline stratification factor ‘First occurrence’ or ‘First recurrence’ of CDAD as recorded in the Interactive voice recognition system (IVRS) at the time of subject randomization. Number of subjects with first recurrence or first occurrence at randomization was assessed for each treatment group.|Participants|Count of Participants|65|65.0||||||
3748601|NCT01987895|3583512|B1|First recurrence||CDAD episode type strata|CDAD episode type strata was defined as baseline stratification factor ‘First occurrence’ or ‘First recurrence’ of CDAD as recorded in the Interactive voice recognition system (IVRS) at the time of subject randomization. Number of subjects with first recurrence or first occurrence at randomization was assessed for each treatment group.|Participants|Count of Participants|64|64.0||||||
3748602|NCT01987895|3583510|B3|First occurrence||CDAD episode type strata|CDAD episode type strata was defined as baseline stratification factor ‘First occurrence’ or ‘First recurrence’ of CDAD as recorded in the Interactive voice recognition system (IVRS) at the time of subject randomization. Number of subjects with first recurrence or first occurrence at randomization was assessed for each treatment group.|Participants|Count of Participants|491|491.0||||||
3748657|NCT01987765|3583537|B1|20 to 29 years||Age, Customized||Participants|Number|129|129.0||||||
3748603|NCT01987895|3583511|B2|First occurrence||CDAD episode type strata|CDAD episode type strata was defined as baseline stratification factor ‘First occurrence’ or ‘First recurrence’ of CDAD as recorded in the Interactive voice recognition system (IVRS) at the time of subject randomization. Number of subjects with first recurrence or first occurrence at randomization was assessed for each treatment group.|Participants|Count of Participants|253|253.0||||||
3748604|NCT01987895|3583512|B1|First occurrence||CDAD episode type strata|CDAD episode type strata was defined as baseline stratification factor ‘First occurrence’ or ‘First recurrence’ of CDAD as recorded in the Interactive voice recognition system (IVRS) at the time of subject randomization. Number of subjects with first recurrence or first occurrence at randomization was assessed for each treatment group.|Participants|Count of Participants|238|238.0||||||
3748605|NCT01987895|3583510|B3|Other||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3748606|NCT01987895|3583511|B2|Other||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3748607|NCT01987895|3583512|B1|Other||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3748608|NCT01987895|3583510|B3|Europe||Region of Enrollment||Participants|Count of Participants|228|228.0||||||
3748609|NCT01987895|3583511|B2|Europe||Region of Enrollment||Participants|Count of Participants|117|117.0||||||
3748610|NCT01987895|3583512|B1|Europe||Region of Enrollment||Participants|Count of Participants|111|111.0||||||
3748611|NCT01987895|3583510|B3|Canada||Region of Enrollment||Participants|Count of Participants|171|171.0||||||
3748612|NCT01987895|3583511|B2|Canada||Region of Enrollment||Participants|Count of Participants|88|88.0||||||
3748613|NCT01987895|3583512|B1|Canada||Region of Enrollment||Participants|Count of Participants|83|83.0||||||
3748614|NCT01987895|3583510|B3|United States||Region of Enrollment||Participants|Count of Participants|209|209.0||||||
3748615|NCT01987895|3583511|B2|United States||Region of Enrollment||Participants|Count of Participants|108|108.0||||||
3748616|NCT01987895|3583512|B1|United States||Region of Enrollment||Participants|Count of Participants|101|101.0||||||
3748617|NCT01987895|3583510|B3|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3748618|NCT01987895|3583511|B2|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3748619|NCT01987895|3583512|B1|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3748620|NCT01987895|3583510|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3748621|NCT01987895|3583511|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3748622|NCT01987895|3583512|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3748623|NCT01987895|3583510|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|587|587.0||||||
3748624|NCT01987895|3583511|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|299|299.0||||||
3748625|NCT01987895|3583512|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|288|288.0||||||
3748626|NCT01987895|3583510|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3748627|NCT01987895|3583511|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3748628|NCT01987895|3583512|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3748629|NCT01987895|3583510|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3748630|NCT01987895|3583511|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3748631|NCT01987895|3583512|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3748632|NCT01987895|3583510|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3748633|NCT01987895|3583511|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3748634|NCT01987895|3583512|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3748635|NCT01987895|3583510|B3||Male|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
3748636|NCT01987895|3583511|B2||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3748637|NCT01987895|3583512|B1||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3748638|NCT01987895|3583510|B3||Female|Sex: Female, Male||Participants|Count of Participants|378|378.0||||||
3748639|NCT01987895|3583511|B2||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
3748640|NCT01987895|3583512|B1||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3748641|NCT01987895|3583510|B3|75 years and older||Age, Customized||Participants|Count of Participants|94|94.0||||||
3748642|NCT01987895|3583511|B2|75 years and older||Age, Customized||Participants|Count of Participants|45|45.0||||||
3748643|NCT01987895|3583512|B1|75 years and older||Age, Customized||Participants|Count of Participants|49|49.0||||||
3748644|NCT01987895|3583510|B3|65-74 years||Age, Customized||Participants|Count of Participants|143|143.0||||||
3748645|NCT01987895|3583511|B2|65-74 years||Age, Customized||Participants|Count of Participants|70|70.0||||||
3748646|NCT01987895|3583512|B1|65-74 years||Age, Customized||Participants|Count of Participants|73|73.0||||||
3748647|NCT01987895|3583510|B3|18-64 years||Age, Customized||Participants|Count of Participants|383|383.0||||||
3748648|NCT01987895|3583511|B2|18-64 years||Age, Customized||Participants|Count of Participants|203|203.0||||||
3748649|NCT01987895|3583512|B1|18-64 years||Age, Customized||Participants|Count of Participants|180|180.0||||||
3748650|NCT01987765|3583537|B1||Male|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
3748651|NCT01987765|3583537|B1||Female|Sex: Female, Male||Participants|Count of Participants|487|487.0||||||
3748652|NCT01987765|3583537|B1|≥70 years||Age, Customized||Participants|Number|50|50.0||||||
3748653|NCT01987765|3583537|B1|60 to 69 years||Age, Customized||Participants|Number|73|73.0||||||
3748654|NCT01987765|3583537|B1|50 to 59 years||Age, Customized||Participants|Number|84|84.0||||||
3748658|NCT01987765|3583537|B1|<20 years||Age, Customized||Participants|Number|143|143.0||||||
3748659|NCT01987752|3583542|B1|Missing Data||Sex/Gender, Customized||Participants|Number|1|1.0||||||
3748660|NCT01987752|3583542|B1|Male||Sex/Gender, Customized||Participants|Number|384|384.0||||||
3748661|NCT01987752|3583542|B1|Female||Sex/Gender, Customized||Participants|Number|347|347.0||||||
3748662|NCT01987752|3583542|B1|Missing Data||Age, Customized||Participants|Number|4|4.0||||||
3748663|NCT01987752|3583542|B1|≥ 70 years||Age, Customized||Participants|Number|225|225.0||||||
3748664|NCT01987752|3583542|B1|60 - 69 years||Age, Customized||Participants|Number|219|219.0||||||
3748665|NCT01987752|3583542|B1|50 - 59 years||Age, Customized||Participants|Number|144|144.0||||||
3748666|NCT01987752|3583542|B1|< 50 years||Age, Customized||Participants|Number|140|140.0||||||
3748667|NCT01987583|3583547|B3|||Baseline Diastolic Blood Pressure||mmHg|Mean|86|86.0|Standard Deviation|9.3|9.3|||
3748668|NCT01987583|3583548|B2|||Baseline Diastolic Blood Pressure||mmHg|Mean|86|86.0|Standard Deviation|10.7|10.7|||
3748669|NCT01987583|3583549|B1|||Baseline Diastolic Blood Pressure||mmHg|Mean|85|85.0|Standard Deviation|7.9|7.9|||
3748670|NCT01987583|3583547|B3|||Baseline Systolic Blood Pressure||mmHg|Mean|154|154.0|Standard Deviation|11.1|11.1|||
3748671|NCT01987583|3583548|B2|||Baseline Systolic Blood Pressure||mmHg|Mean|156|156.0|Standard Deviation|11.3|11.3|||
3748672|NCT01987583|3583549|B1|||Baseline Systolic Blood Pressure||mmHg|Mean|152|152.0|Standard Deviation|10.7|10.7|||
3748673|NCT01987583|3583547|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3748674|NCT01987583|3583548|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3748675|NCT01987583|3583549|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3748676|NCT01987583|3583547|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3748677|NCT01987583|3583548|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3748678|NCT01987583|3583549|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3748679|NCT01987583|3583547|B3|||Age||years|Mean|53|53.0|Standard Deviation|9.4|9.4|||
3748680|NCT01987583|3583548|B2|||Age||years|Mean|54|54.0|Standard Deviation|9.5|9.5|||
3748681|NCT01987583|3583549|B1|||Age||years|Mean|52|52.0|Standard Deviation|9.4|9.4|||
3748682|NCT01987557|3583558|B4|||Unified Parkinsons Disease Rating Scale-Motor Subsection (UPDRS III)||units on a scale|Mean|22.92|22.92|Standard Deviation|7.73|7.73|||
3748683|NCT01987557|3583559|B3|||Unified Parkinsons Disease Rating Scale-Motor Subsection (UPDRS III)||units on a scale|Mean|22.46|22.46|Standard Deviation|8.64|8.64|||
3748684|NCT01987557|3583560|B2|||Unified Parkinsons Disease Rating Scale-Motor Subsection (UPDRS III)||units on a scale|Mean|22.96|22.96|Standard Deviation|6.93|6.93|||
3748685|NCT01987557|3583561|B1|||Unified Parkinsons Disease Rating Scale-Motor Subsection (UPDRS III)||units on a scale|Mean|23.35|23.35|Standard Deviation|8.13|8.13|||
3748686|NCT01987557|3583558|B4||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3748687|NCT01987557|3583559|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3748688|NCT01987557|3583560|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3748689|NCT01987557|3583561|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3748690|NCT01987557|3583558|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3748691|NCT01987557|3583559|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3748692|NCT01987557|3583560|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3748693|NCT01987557|3583561|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3748694|NCT01987557|3583558|B4|||Age||years|Mean|66.85|66.85|Standard Deviation|8.83|8.83|||
3748695|NCT01987557|3583559|B3|||Age||years|Mean|66.31|66.31|Standard Deviation|9.07|9.07|||
3748696|NCT01987557|3583560|B2|||Age||years|Mean|70.46|70.46|Standard Deviation|9.52|9.52|||
3748697|NCT01987557|3583561|B1|||Age||years|Mean|63.77|63.77|Standard Deviation|7.01|7.01|||
3748698|NCT01987505|3583571|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|139|139.0||||||
3748699|NCT01987505|3583572|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|110|110.0||||||
3748700|NCT01987505|3583573|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3748701|NCT01987505|3583571|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3748702|NCT01987505|3583572|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3748703|NCT01987505|3583573|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3748704|NCT01987505|3583571|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3748705|NCT01987505|3583572|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3748706|NCT01987505|3583573|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3748707|NCT01987505|3583571|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3748708|NCT01987505|3583572|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3748709|NCT01987505|3583573|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3748710|NCT01987505|3583571|B3|||Age||years|Mean|60.2|60.2|Standard Deviation|12.4|12.4|||
3748711|NCT01987505|3583572|B2|||Age||years|Mean|59.6|59.6|Standard Deviation|12.5|12.5|||
3748712|NCT01987505|3583573|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|12.0|12.0|||
3748713|NCT01987479|3583603|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3748714|NCT01987479|3583603|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3748715|NCT01987479|3583603|B1|||Age||years|Mean|55.85|55.85|Standard Deviation|11.20|11.2|||
3748716|NCT01987453|3583628|B4|>= 800,000 IU/mL||HCV RNA Category||Participants|Number|70|70.0||||||
3748717|NCT01987453|3583629|B3|>= 800,000 IU/mL||HCV RNA Category||Participants|Number|2|2.0||||||
3748718|NCT01987453|3583630|B2|>= 800,000 IU/mL||HCV RNA Category||Participants|Number|30|30.0||||||
3748719|NCT01987453|3583631|B1|>= 800,000 IU/mL||HCV RNA Category||Participants|Number|38|38.0||||||
3748720|NCT01987453|3583628|B4|< 800,000 IU/mL||HCV RNA Category||Participants|Number|30|30.0||||||
3748721|NCT01987453|3583629|B3|< 800,000 IU/mL||HCV RNA Category||Participants|Number|6|6.0||||||
3748722|NCT01987453|3583630|B2|< 800,000 IU/mL||HCV RNA Category||Participants|Number|11|11.0||||||
3748723|NCT01987453|3583631|B1|< 800,000 IU/mL||HCV RNA Category||Participants|Number|13|13.0||||||
3748724|NCT01987453|3583628|B4|||HCV RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.61|0.61|||
3748725|NCT01987453|3583629|B3|||HCV RNA||log10 IU/mL|Mean|5.6|5.6|Standard Deviation|0.44|0.44|||
3748726|NCT01987453|3583630|B2|||HCV RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.62|0.62|||
3748727|NCT01987453|3583631|B1|||HCV RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.58|0.58|||
3748728|NCT01987453|3583628|B4|TT||IL28B|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Number|26|26.0||||||
3748729|NCT01987453|3583629|B3|TT||IL28B|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Number|1|1.0||||||
3748730|NCT01987453|3583630|B2|TT||IL28B|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Number|11|11.0||||||
3748731|NCT01987453|3583631|B1|TT||IL28B|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Number|14|14.0||||||
3748732|NCT01987453|3583628|B4|CT||IL28B|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Number|67|67.0||||||
3748733|NCT01987453|3583629|B3|CT||IL28B|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Number|7|7.0||||||
3748734|NCT01987453|3583630|B2|CT||IL28B|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Number|27|27.0||||||
3748735|NCT01987453|3583631|B1|CT||IL28B|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Number|33|33.0||||||
3748736|NCT01987453|3583628|B4|CC||IL28B|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Number|7|7.0||||||
3748737|NCT01987453|3583629|B3|CC||IL28B|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Number|0|0.0||||||
3748738|NCT01987453|3583630|B2|CC||IL28B|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Number|3|3.0||||||
3748739|NCT01987453|3583631|B1|CC||IL28B|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Number|4|4.0||||||
3748740|NCT01987453|3583628|B4|Without SOF||Prior HCV Treatment Experience||Particiapants|Number|6|6.0||||||
3748741|NCT01987453|3583629|B3|Without SOF||Prior HCV Treatment Experience||Particiapants|Number|0|0.0||||||
3748742|NCT01987453|3583630|B2|Without SOF||Prior HCV Treatment Experience||Particiapants|Number|0|0.0||||||
3748743|NCT01987453|3583631|B1|Without SOF||Prior HCV Treatment Experience||Particiapants|Number|6|6.0||||||
3748744|NCT01987453|3583628|B4|LDV/SOF+GS-9669||Prior HCV Treatment Experience||Particiapants|Number|8|8.0||||||
3748745|NCT01987453|3583629|B3|LDV/SOF+GS-9669||Prior HCV Treatment Experience||Particiapants|Number|0|0.0||||||
3748746|NCT01987453|3583630|B2|LDV/SOF+GS-9669||Prior HCV Treatment Experience||Particiapants|Number|8|8.0||||||
3748747|NCT01987453|3583631|B1|LDV/SOF+GS-9669||Prior HCV Treatment Experience||Particiapants|Number|0|0.0||||||
3748748|NCT01987453|3583628|B4|LDV/SOF+RBV||Prior HCV Treatment Experience||Particiapants|Number|15|15.0||||||
3748749|NCT01987453|3583629|B3|LDV/SOF+RBV||Prior HCV Treatment Experience||Particiapants|Number|0|0.0||||||
3748750|NCT01987453|3583630|B2|LDV/SOF+RBV||Prior HCV Treatment Experience||Particiapants|Number|15|15.0||||||
3748751|NCT01987453|3583631|B1|LDV/SOF+RBV||Prior HCV Treatment Experience||Particiapants|Number|0|0.0||||||
3748752|NCT01987453|3583628|B4|LDV/SOF||Prior HCV Treatment Experience||Particiapants|Number|18|18.0||||||
3748753|NCT01987453|3583629|B3|LDV/SOF||Prior HCV Treatment Experience||Particiapants|Number|0|0.0||||||
3748754|NCT01987453|3583630|B2|LDV/SOF||Prior HCV Treatment Experience||Particiapants|Number|18|18.0||||||
3748755|NCT01987453|3583631|B1|LDV/SOF||Prior HCV Treatment Experience||Particiapants|Number|0|0.0||||||
3748756|NCT01987453|3583628|B4|SOF+RBV||Prior HCV Treatment Experience||Particiapants|Number|28|28.0||||||
3748757|NCT01987453|3583629|B3|SOF+RBV||Prior HCV Treatment Experience||Particiapants|Number|8|8.0||||||
3748758|NCT01987453|3583630|B2|SOF+RBV||Prior HCV Treatment Experience||Particiapants|Number|0|0.0||||||
3748759|NCT01987453|3583631|B1|SOF+RBV||Prior HCV Treatment Experience||Particiapants|Number|20|20.0||||||
3748760|NCT01987453|3583628|B4|SOF+PEG+RBV||Prior HCV Treatment Experience||Particiapants|Number|25|25.0||||||
3748761|NCT01987453|3583629|B3|SOF+PEG+RBV||Prior HCV Treatment Experience||Particiapants|Number|0|0.0||||||
3748762|NCT01987453|3583630|B2|SOF+PEG+RBV||Prior HCV Treatment Experience||Particiapants|Number|0|0.0||||||
3748763|NCT01987453|3583631|B1|SOF+PEG+RBV||Prior HCV Treatment Experience||Particiapants|Number|25|25.0||||||
3748764|NCT01987453|3583628|B4|Spain||Region of Enrollment||participants|Number|3|3.0||||||
3748765|NCT01987453|3583629|B3|Spain||Region of Enrollment||participants|Number|3|3.0||||||
3748766|NCT01987453|3583630|B2|Spain||Region of Enrollment||participants|Number|0|0.0||||||
3748767|NCT01987453|3583631|B1|Spain||Region of Enrollment||participants|Number|0|0.0||||||
3748768|NCT01987453|3583628|B4|Australia||Region of Enrollment||participants|Number|1|1.0||||||
3748769|NCT01987453|3583629|B3|Australia||Region of Enrollment||participants|Number|1|1.0||||||
3748770|NCT01987453|3583630|B2|Australia||Region of Enrollment||participants|Number|0|0.0||||||
3748771|NCT01987453|3583631|B1|Australia||Region of Enrollment||participants|Number|0|0.0||||||
3748772|NCT01987453|3583628|B4|United States||Region of Enrollment||participants|Number|96|96.0||||||
3748773|NCT01987453|3583629|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3748774|NCT01987453|3583630|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
3748775|NCT01987453|3583631|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
3748776|NCT01987453|3583628|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|91|91.0||||||
3748777|NCT01987453|3583629|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3748778|NCT01987453|3583630|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|36|36.0||||||
3748779|NCT01987453|3583631|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|47|47.0||||||
3748780|NCT01987453|3583628|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3748781|NCT01987453|3583629|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3748782|NCT01987453|3583630|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3748783|NCT01987453|3583631|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3748784|NCT01987453|3583628|B4|White||Race/Ethnicity, Customized||Participants|Number|81|81.0||||||
3748785|NCT01987453|3583629|B3|White||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3748786|NCT01987453|3583630|B2|White||Race/Ethnicity, Customized||Participants|Number|31|31.0||||||
3748787|NCT01987453|3583631|B1|White||Race/Ethnicity, Customized||Participants|Number|43|43.0||||||
3748788|NCT01987453|3583628|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
3748789|NCT01987453|3583629|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3748790|NCT01987453|3583630|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
3748791|NCT01987453|3583631|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3748792|NCT01987453|3583628|B4||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3748793|NCT01987453|3583629|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3748794|NCT01987453|3583630|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3748795|NCT01987453|3583631|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3748796|NCT01987453|3583628|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3748797|NCT01987453|3583629|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3748798|NCT01987453|3583630|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3748799|NCT01987453|3583631|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3748800|NCT01987453|3583628|B4|||Age||Years|Mean|57|57.0|Standard Deviation|8.2|8.2|||
3748801|NCT01987453|3583629|B3|||Age||Years|Mean|61|61.0|Standard Deviation|6.7|6.7|||
3748802|NCT01987453|3583630|B2|||Age||Years|Mean|58|58.0|Standard Deviation|6.9|6.9|||
3748803|NCT01987453|3583631|B1|||Age||Years|Mean|54|54.0|Standard Deviation|8.7|8.7|||
3748804|NCT01987401|3583656|B4|United States||Region of Enrollment||participants|Number|1242|1242.0||||||
3748805|NCT01987401|3583657|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
3748806|NCT01987401|3583658|B2|United States||Region of Enrollment||participants|Number|591|591.0||||||
3748807|NCT01987401|3583659|B1|United States||Region of Enrollment||participants|Number|591|591.0||||||
3748808|NCT01987401|3583656|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3748809|NCT01987401|3583657|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3748810|NCT01987401|3583658|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3748811|NCT01987401|3583659|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3748812|NCT01987401|3583656|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748813|NCT01987401|3583657|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748814|NCT01987401|3583658|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748815|NCT01987401|3583659|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748816|NCT01987401|3583656|B4||White|Race (NIH/OMB)||Participants|Count of Participants|952|952.0||||||
3748817|NCT01987401|3583657|B3||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3748818|NCT01987401|3583658|B2||White|Race (NIH/OMB)||Participants|Count of Participants|449|449.0||||||
3748819|NCT01987401|3583659|B1||White|Race (NIH/OMB)||Participants|Count of Participants|452|452.0||||||
3748820|NCT01987401|3583656|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|189|189.0||||||
3748821|NCT01987401|3583657|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3748822|NCT01987401|3583658|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
3748823|NCT01987401|3583659|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
3748824|NCT01987401|3583656|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748825|NCT01987401|3583657|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748826|NCT01987401|3583658|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748827|NCT01987401|3583659|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748828|NCT01987401|3583656|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3748829|NCT01987401|3583657|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3748830|NCT01987401|3583658|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3748831|NCT01987401|3583659|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3748832|NCT01987401|3583656|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3748946|NCT01987349|3583677|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3748833|NCT01987401|3583657|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748834|NCT01987401|3583658|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3748835|NCT01987401|3583659|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3748836|NCT01987401|3583656|B4||Male|Sex: Female, Male||Participants|Count of Participants|1054|1054.0||||||
3748837|NCT01987401|3583657|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3748838|NCT01987401|3583658|B2||Male|Sex: Female, Male||Participants|Count of Participants|498|498.0||||||
3748839|NCT01987401|3583659|B1||Male|Sex: Female, Male||Participants|Count of Participants|504|504.0||||||
3748840|NCT01987401|3583656|B4||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3748841|NCT01987401|3583657|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3748842|NCT01987401|3583658|B2||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3748843|NCT01987401|3583659|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3748844|NCT01987401|3583656|B4|||Age||years|Mean|38.7|38.7|Standard Deviation|11.1|11.1|||
3748845|NCT01987401|3583657|B3|||Age||years|Mean|36.7|36.7|Standard Deviation|10.6|10.6|||
3748846|NCT01987401|3583658|B2|||Age||years|Mean|39.4|39.4|Standard Deviation|11.5|11.5|||
3748847|NCT01987401|3583659|B1|||Age||years|Mean|38.2|38.2|Standard Deviation|10.9|10.9|||
3748848|NCT01987349|3583669|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748849|NCT01987349|3583670|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748850|NCT01987349|3583671|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748851|NCT01987349|3583672|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748852|NCT01987349|3583673|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748853|NCT01987349|3583674|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748854|NCT01987349|3583675|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748855|NCT01987349|3583676|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748856|NCT01987349|3583677|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748857|NCT01987349|3583669|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3748858|NCT01987349|3583670|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748859|NCT01987349|3583671|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748860|NCT01987349|3583672|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748861|NCT01987349|3583673|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748862|NCT01987349|3583674|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748863|NCT01987349|3583675|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3748864|NCT01987349|3583676|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748865|NCT01987349|3583677|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748866|NCT01987349|3583669|B9||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3748867|NCT01987349|3583670|B8||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3748868|NCT01987349|3583671|B7||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3748869|NCT01987349|3583672|B6||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3748870|NCT01987349|3583673|B5||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3748871|NCT01987349|3583674|B4||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3748872|NCT01987349|3583675|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3748873|NCT01987349|3583676|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3748874|NCT01987349|3583677|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3748875|NCT01987349|3583669|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3748876|NCT01987349|3583670|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748877|NCT01987349|3583671|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748878|NCT01987349|3583672|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3748879|NCT01987349|3583673|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748880|NCT01987349|3583674|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748881|NCT01987349|3583675|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748882|NCT01987349|3583676|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748883|NCT01987349|3583677|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748884|NCT01987349|3583669|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748885|NCT01987349|3583670|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748886|NCT01987349|3583671|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748887|NCT01987349|3583672|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748888|NCT01987349|3583673|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748889|NCT01987349|3583674|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748890|NCT01987349|3583675|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748891|NCT01987349|3583676|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748892|NCT01987349|3583677|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748893|NCT01987349|3583669|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3748894|NCT01987349|3583670|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3748895|NCT01987349|3583671|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748896|NCT01987349|3583672|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748897|NCT01987349|3583673|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748898|NCT01987349|3583674|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748899|NCT01987349|3583675|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748900|NCT01987349|3583676|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748901|NCT01987349|3583677|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748902|NCT01987349|3583669|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3748903|NCT01987349|3583670|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748904|NCT01987349|3583671|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748905|NCT01987349|3583672|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3748906|NCT01987349|3583673|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748907|NCT01987349|3583674|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748908|NCT01987349|3583675|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748909|NCT01987349|3583676|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748910|NCT01987349|3583677|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748911|NCT01987349|3583669|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748912|NCT01987349|3583670|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748913|NCT01987349|3583671|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748914|NCT01987349|3583672|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748915|NCT01987349|3583673|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748916|NCT01987349|3583674|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748917|NCT01987349|3583675|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748918|NCT01987349|3583676|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748919|NCT01987349|3583677|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748920|NCT01987349|3583669|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3748921|NCT01987349|3583670|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3748922|NCT01987349|3583671|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3748923|NCT01987349|3583672|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3748924|NCT01987349|3583673|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3748925|NCT01987349|3583674|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3748926|NCT01987349|3583675|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3748927|NCT01987349|3583676|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3748928|NCT01987349|3583677|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3748929|NCT01987349|3583669|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3748930|NCT01987349|3583670|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748931|NCT01987349|3583671|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748932|NCT01987349|3583672|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748933|NCT01987349|3583673|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748934|NCT01987349|3583674|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3748935|NCT01987349|3583675|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3748936|NCT01987349|3583676|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748937|NCT01987349|3583677|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3748938|NCT01987349|3583669|B9||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3748939|NCT01987349|3583670|B8||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3748940|NCT01987349|3583671|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3748941|NCT01987349|3583672|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3748942|NCT01987349|3583673|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3748943|NCT01987349|3583674|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3748944|NCT01987349|3583675|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3748945|NCT01987349|3583676|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3748947|NCT01987349|3583669|B9||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3748948|NCT01987349|3583670|B8||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3748949|NCT01987349|3583671|B7||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3748950|NCT01987349|3583672|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3748951|NCT01987349|3583673|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3748952|NCT01987349|3583674|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3748953|NCT01987349|3583675|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3748954|NCT01987349|3583676|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3748955|NCT01987349|3583677|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3748956|NCT01987349|3583669|B9||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
3748957|NCT01987349|3583670|B8||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3748958|NCT01987349|3583671|B7||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3748959|NCT01987349|3583672|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3748960|NCT01987349|3583673|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3748961|NCT01987349|3583674|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3748962|NCT01987349|3583675|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3748963|NCT01987349|3583676|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3748964|NCT01987349|3583677|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3748965|NCT01987349|3583669|B9||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3748966|NCT01987349|3583670|B8||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3748967|NCT01987349|3583671|B7||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3748968|NCT01987349|3583672|B6||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3748969|NCT01987349|3583673|B5||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3748970|NCT01987349|3583674|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3748971|NCT01987349|3583675|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3748972|NCT01987349|3583676|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3748973|NCT01987349|3583677|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3748974|NCT01987349|3583669|B9||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
3748975|NCT01987349|3583670|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3748976|NCT01987349|3583671|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3748977|NCT01987349|3583672|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3748978|NCT01987349|3583673|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3748979|NCT01987349|3583674|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3748980|NCT01987349|3583675|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3748981|NCT01987349|3583676|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3748982|NCT01987349|3583677|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3748983|NCT01987232|3583710|B6||1 (Restrictive but ambulatory)|Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|22|22.0||||||
3748984|NCT01987232|3583711|B5||1 (Restrictive but ambulatory)|Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|4|4.0||||||
3748985|NCT01987232|3583712|B4||1 (Restrictive but ambulatory)|Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|12|12.0||||||
3748986|NCT01987232|3583713|B3||1 (Restrictive but ambulatory)|Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|2|2.0||||||
3748987|NCT01987232|3583714|B2||1 (Restrictive but ambulatory)|Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|3|3.0||||||
3748988|NCT01987232|3583715|B1||1 (Restrictive but ambulatory)|Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|1|1.0||||||
3748989|NCT01987232|3583710|B6||0 (Fully active)|Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|10|10.0||||||
3748990|NCT01987232|3583711|B5||0 (Fully active)|Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|2|2.0||||||
3748991|NCT01987232|3583712|B4||0 (Fully active)|Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|3|3.0||||||
3748992|NCT01987232|3583713|B3||0 (Fully active)|Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|1|1.0||||||
3748993|NCT01987232|3583714|B2||0 (Fully active)|Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|0|0.0||||||
3748994|NCT01987232|3583715|B1||0 (Fully active)|Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|4|4.0||||||
3748995|NCT01987232|3583710|B6||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3748996|NCT01987232|3583711|B5||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3748997|NCT01987232|3583712|B4||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3748998|NCT01987232|3583713|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3748999|NCT01987232|3583714|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3749000|NCT01987232|3583715|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3749001|NCT01987232|3583710|B6||White|Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3749002|NCT01987232|3583711|B5||White|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3749003|NCT01987232|3583712|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3749004|NCT01987232|3583713|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3749005|NCT01987232|3583714|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3749006|NCT01987232|3583715|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3749007|NCT01987232|3583710|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3749008|NCT01987232|3583711|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3749009|NCT01987232|3583712|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749010|NCT01987232|3583713|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749011|NCT01987232|3583714|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749012|NCT01987232|3583715|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749013|NCT01987232|3583710|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3749014|NCT01987232|3583711|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3749015|NCT01987232|3583712|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3749016|NCT01987232|3583713|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3749017|NCT01987232|3583714|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3749018|NCT01987232|3583715|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3749019|NCT01987232|3583710|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3749020|NCT01987232|3583711|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749021|NCT01987232|3583712|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3749022|NCT01987232|3583713|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749023|NCT01987232|3583714|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749024|NCT01987232|3583715|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749025|NCT01987232|3583710|B6||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3749026|NCT01987232|3583711|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3749027|NCT01987232|3583712|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3749028|NCT01987232|3583713|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3749029|NCT01987232|3583714|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3749030|NCT01987232|3583715|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3749031|NCT01987232|3583710|B6||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3749032|NCT01987232|3583711|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3749033|NCT01987232|3583712|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3749034|NCT01987232|3583713|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3749035|NCT01987232|3583714|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3749036|NCT01987232|3583715|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3749037|NCT01987232|3583710|B6||≥ 65 years|Age, Customized||Participants|Count of Participants|7|7.0||||||
3749038|NCT01987232|3583711|B5||≥ 65 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
3749039|NCT01987232|3583712|B4||≥ 65 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
3749040|NCT01987232|3583713|B3||≥ 65 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
3749041|NCT01987232|3583714|B2||≥ 65 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
3749042|NCT01987232|3583715|B1||≥ 65 years|Age, Customized||Participants|Count of Participants|3|3.0||||||
3749043|NCT01987232|3583710|B6||< 65 years|Age, Customized||Participants|Count of Participants|25|25.0||||||
3749044|NCT01987232|3583711|B5||< 65 years|Age, Customized||Participants|Count of Participants|5|5.0||||||
3749045|NCT01987232|3583712|B4||< 65 years|Age, Customized||Participants|Count of Participants|14|14.0||||||
3749046|NCT01987232|3583713|B3||< 65 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
3749047|NCT01987232|3583714|B2||< 65 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
3749048|NCT01987232|3583715|B1||< 65 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
3749049|NCT01987232|3583710|B6|||Age||years|Mean|59.9|59.9|Standard Deviation|10.1|10.1|||
3749050|NCT01987232|3583711|B5|||Age||years|Mean|58.8|58.8|Standard Deviation|7.9|7.9|||
3749051|NCT01987232|3583712|B4|||Age||years|Mean|56.9|56.9|Standard Deviation|9.4|9.4|||
3749052|NCT01987232|3583713|B3|||Age||years|Mean|59.0|59.0|Standard Deviation|7.5|7.5|||
3749053|NCT01987232|3583714|B2|||Age||years|Mean|62.3|62.3|Standard Deviation|8.5|8.5|||
3749054|NCT01987232|3583715|B1|||Age||years|Mean|69.2|69.2|Standard Deviation|13.8|13.8|||
3749055|NCT01987219|3583778|B7|White, not of Hispanic-American Origin||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3749056|NCT01987219|3583779|B6|White, not of Hispanic-American Origin||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3749057|NCT01987219|3583780|B5|White, not of Hispanic-American Origin||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3749058|NCT01987219|3583781|B4|White, not of Hispanic-American Origin||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3749059|NCT01987219|3583782|B3|White, not of Hispanic-American Origin||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3749060|NCT01987219|3583783|B2|White, not of Hispanic-American Origin||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3749061|NCT01987219|3583784|B1|White, not of Hispanic-American Origin||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3749062|NCT01987219|3583778|B7||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3749063|NCT01987219|3583779|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3749064|NCT01987219|3583780|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3749065|NCT01987219|3583781|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3749066|NCT01987219|3583782|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3749067|NCT01987219|3583783|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3749068|NCT01987219|3583784|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3749069|NCT01987219|3583778|B7||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3749070|NCT01987219|3583779|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3749071|NCT01987219|3583780|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3749072|NCT01987219|3583781|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3749073|NCT01987219|3583782|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3749074|NCT01987219|3583783|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3749075|NCT01987219|3583784|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3749076|NCT01987219|3583778|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3749077|NCT01987219|3583779|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3749078|NCT01987219|3583780|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3749079|NCT01987219|3583781|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3749080|NCT01987219|3583782|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3749081|NCT01987219|3583783|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3749082|NCT01987219|3583784|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3749083|NCT01987219|3583778|B7||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3749084|NCT01987219|3583779|B6||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3749085|NCT01987219|3583780|B5||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3749086|NCT01987219|3583781|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3749087|NCT01987219|3583782|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3749088|NCT01987219|3583783|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3749089|NCT01987219|3583784|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3749090|NCT01987219|3583778|B7||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3749091|NCT01987219|3583779|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3749092|NCT01987219|3583780|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3749093|NCT01987219|3583781|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3749094|NCT01987219|3583782|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3749095|NCT01987219|3583783|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3749096|NCT01987219|3583784|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3749097|NCT01986985|3583806|B1|Female||Sex/Gender, Customized||participants|Number|29|29.0||||||
3749098|NCT01986985|3583806|B1|Male||Sex/Gender, Customized||participants|Number|29|29.0||||||
3749099|NCT01986985|3583806|B1|Adult (>=18 years)||Age, Customized||participants|Number|58|58.0||||||
3749100|NCT01986946|3583810|B3||Male|Gender||Participants|Count of Participants|2|2.0||||||
3749101|NCT01986946|3583811|B2||Male|Gender||Participants|Count of Participants|1|1.0||||||
3749102|NCT01986946|3583812|B1||Male|Gender||Participants|Count of Participants|1|1.0||||||
3749103|NCT01986946|3583810|B3||Female|Gender||Participants|Count of Participants|12|12.0||||||
3749104|NCT01986946|3583811|B2||Female|Gender||Participants|Count of Participants|8|8.0||||||
3749105|NCT01986946|3583812|B1||Female|Gender||Participants|Count of Participants|4|4.0||||||
3749106|NCT01986946|3583810|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3749107|NCT01986946|3583811|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3749108|NCT01986946|3583812|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3749109|NCT01986946|3583810|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3749110|NCT01986946|3583811|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3749111|NCT01986946|3583812|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3749112|NCT01986946|3583810|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3749113|NCT01986946|3583811|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3749114|NCT01986946|3583812|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3749115|NCT01986920|3583843|B1|United States||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3749116|NCT01986920|3583843|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749117|NCT01986920|3583843|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749118|NCT01986920|3583843|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3749119|NCT01986920|3583843|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749120|NCT01986920|3583843|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749121|NCT01986920|3583843|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749122|NCT01986920|3583843|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749123|NCT01986920|3583843|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749124|NCT01986920|3583843|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3749125|NCT01986920|3583843|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3749126|NCT01986920|3583843|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3749127|NCT01986920|3583843|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3749128|NCT01986920|3583843|B1|||Age||Years|Mean|69.43|69.43|Standard Deviation|6.52|6.52|||
3749129|NCT01986920|3583843|B1||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
3749130|NCT01986920|3583843|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3749131|NCT01986920|3583843|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3749132|NCT01986855|3583860|B4|Yes||Stratification Factor: Insulin at randomization|Insulin at randomization? (Yes/No)|Participants|Number|264|264.0||||||
3749133|NCT01986855|3583861|B3|Yes||Stratification Factor: Insulin at randomization|Insulin at randomization? (Yes/No)|Participants|Number|88|88.0||||||
3749134|NCT01986855|3583862|B2|Yes||Stratification Factor: Insulin at randomization|Insulin at randomization? (Yes/No)|Participants|Number|87|87.0||||||
3749135|NCT01986855|3583863|B1|Yes||Stratification Factor: Insulin at randomization|Insulin at randomization? (Yes/No)|Participants|Number|89|89.0||||||
3749136|NCT01986855|3583860|B4|No||Stratification Factor: Insulin at randomization|Insulin at randomization? (Yes/No)|Participants|Number|203|203.0||||||
3749137|NCT01986855|3583861|B3|No||Stratification Factor: Insulin at randomization|Insulin at randomization? (Yes/No)|Participants|Number|66|66.0||||||
3749138|NCT01986855|3583862|B2|No||Stratification Factor: Insulin at randomization|Insulin at randomization? (Yes/No)|Participants|Number|68|68.0||||||
3749139|NCT01986855|3583863|B1|No||Stratification Factor: Insulin at randomization|Insulin at randomization? (Yes/No)|Participants|Number|69|69.0||||||
3749140|NCT01986855|3583860|B4|≥45 to <60||Baseline Estimated glomerular filtration rate (eGFR)|Stratification Factor: eGFR (mL/min/1.73m^2)|Participants|Number|308|308.0||||||
3749141|NCT01986855|3583861|B3|≥45 to <60||Baseline Estimated glomerular filtration rate (eGFR)|Stratification Factor: eGFR (mL/min/1.73m^2)|Participants|Number|100|100.0||||||
3749142|NCT01986855|3583862|B2|≥45 to <60||Baseline Estimated glomerular filtration rate (eGFR)|Stratification Factor: eGFR (mL/min/1.73m^2)|Participants|Number|102|102.0||||||
3749143|NCT01986855|3583863|B1|≥45 to <60||Baseline Estimated glomerular filtration rate (eGFR)|Stratification Factor: eGFR (mL/min/1.73m^2)|Participants|Number|106|106.0||||||
3749144|NCT01986855|3583860|B4|≥30 to <45||Baseline Estimated glomerular filtration rate (eGFR)|Stratification Factor: eGFR (mL/min/1.73m^2)|Participants|Number|159|159.0||||||
3749145|NCT01986855|3583861|B3|≥30 to <45||Baseline Estimated glomerular filtration rate (eGFR)|Stratification Factor: eGFR (mL/min/1.73m^2)|Participants|Number|54|54.0||||||
3749146|NCT01986855|3583862|B2|≥30 to <45||Baseline Estimated glomerular filtration rate (eGFR)|Stratification Factor: eGFR (mL/min/1.73m^2)|Participants|Number|53|53.0||||||
3749147|NCT01986855|3583863|B1|≥30 to <45||Baseline Estimated glomerular filtration rate (eGFR)|Stratification Factor: eGFR (mL/min/1.73m^2)|Participants|Number|52|52.0||||||
3749148|NCT01986855|3583860|B4|||Baseline Fasting Plasma Glucose (FPG)||mg/dL|Mean|158.5|158.5|Standard Deviation|53.6|53.6|||
3749149|NCT01986855|3583861|B3|||Baseline Fasting Plasma Glucose (FPG)||mg/dL|Mean|156.9|156.9|Standard Deviation|56.4|56.4|||
3749150|NCT01986855|3583862|B2|||Baseline Fasting Plasma Glucose (FPG)||mg/dL|Mean|157.5|157.5|Standard Deviation|47.8|47.8|||
3749151|NCT01986855|3583863|B1|||Baseline Fasting Plasma Glucose (FPG)||mg/dL|Mean|160.9|160.9|Standard Deviation|56.4|56.4|||
3749152|NCT01986855|3583860|B4|||Baseline Weight||Kilograms|Mean|88.5|88.5|Standard Deviation|19.8|19.8|||
3749153|NCT01986855|3583861|B3|||Baseline Weight||Kilograms|Mean|90.4|90.4|Standard Deviation|18.9|18.9|||
3749154|NCT01986855|3583862|B2|||Baseline Weight||Kilograms|Mean|85.8|85.8|Standard Deviation|17.4|17.4|||
3749155|NCT01986855|3583863|B1|||Baseline Weight||Kilograms|Mean|89.4|89.4|Standard Deviation|22.5|22.5|||
3749156|NCT01986855|3583860|B4|||Baseline Hemoglobin A1C (A1C)||Percentage|Mean|8.15|8.15|Standard Deviation|0.93|0.93|||
3749157|NCT01986855|3583861|B3|||Baseline Hemoglobin A1C (A1C)||Percentage|Mean|8.08|8.08|Standard Deviation|0.89|0.89|||
3749158|NCT01986855|3583862|B2|||Baseline Hemoglobin A1C (A1C)||Percentage|Mean|8.17|8.17|Standard Deviation|0.87|0.87|||
3749159|NCT01986855|3583863|B1|||Baseline Hemoglobin A1C (A1C)||Percentage|Mean|8.20|8.2|Standard Deviation|1.02|1.02|||
3749160|NCT01986855|3583860|B4||Male|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
3749161|NCT01986855|3583861|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3749162|NCT01986855|3583862|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3749163|NCT01986855|3583863|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3749164|NCT01986855|3583860|B4||Female|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
3749165|NCT01986855|3583861|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3749166|NCT01986855|3583862|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3749167|NCT01986855|3583863|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3749168|NCT01986855|3583860|B4|||Age||Years|Mean|67.3|67.3|Standard Deviation|8.6|8.6|||
3749169|NCT01986855|3583861|B3|||Age||Years|Mean|67.5|67.5|Standard Deviation|8.9|8.9|||
3749170|NCT01986855|3583862|B2|||Age||Years|Mean|67.5|67.5|Standard Deviation|8.5|8.5|||
3749171|NCT01986855|3583863|B1|||Age||Years|Mean|66.7|66.7|Standard Deviation|8.3|8.3|||
3749172|NCT01986829|3583894|B1|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3749173|NCT01986829|3583894|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749174|NCT01986829|3583894|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749175|NCT01986829|3583894|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3749176|NCT01986829|3583894|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3749177|NCT01986829|3583894|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749178|NCT01986829|3583894|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749179|NCT01986829|3583894|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749180|NCT01986829|3583894|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3749181|NCT01986829|3583894|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3749182|NCT01986829|3583894|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749183|NCT01986829|3583894|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3749184|NCT01986829|3583894|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3749185|NCT01986829|3583894|B1|||Age||years|Median|56|56.0|Full Range|||39.0|76.0|
3749186|NCT01986790|3583921|B4|||Subjective Numeracy Scale (SNS)|Subjective numeracy was measured using the validated Subjective Numeracy ability subscale. All questions were scored as marked (range 1-6), using the average rating across all 4 questions. A higher value is considered to be a better outcome.|Units on a scale|Mean|4.0|4.0|Standard Deviation|1.1|1.1|||
3749217|NCT01986790|3583924|B1|Other||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3749218|NCT01986790|3583921|B4|White||Race/Ethnicity, Customized||Participants|Number|97|97.0||||||
3749187|NCT01986790|3583922|B3|||Subjective Numeracy Scale (SNS)|Subjective numeracy was measured using the validated Subjective Numeracy ability subscale. All questions were scored as marked (range 1-6), using the average rating across all 4 questions. A higher value is considered to be a better outcome.|Units on a scale|Mean|3.7|3.7|Standard Deviation|1.2|1.2|||
3749188|NCT01986790|3583923|B2|||Subjective Numeracy Scale (SNS)|Subjective numeracy was measured using the validated Subjective Numeracy ability subscale. All questions were scored as marked (range 1-6), using the average rating across all 4 questions. A higher value is considered to be a better outcome.|Units on a scale|Mean|4.2|4.2|Standard Deviation|1.0|1.0|||
3749189|NCT01986790|3583924|B1|||Subjective Numeracy Scale (SNS)|Subjective numeracy was measured using the validated Subjective Numeracy ability subscale. All questions were scored as marked (range 1-6), using the average rating across all 4 questions. A higher value is considered to be a better outcome.|Units on a scale|Mean|4.1|4.1|Standard Deviation|1.1|1.1|||
3749190|NCT01986790|3583921|B4|Not Reported||Rapid Estimate of Adult Literacy in Medicine-SF (REALM-SF)|Health literacy was assessed by the REALM-SF. 9th grade reading level or above=adequate, 7th or 8th grade reading level=marginal, 6th grade reading level or below=inadequate.|Participants|Number|8|8.0||||||
3749191|NCT01986790|3583922|B3|Not Reported||Rapid Estimate of Adult Literacy in Medicine-SF (REALM-SF)|Health literacy was assessed by the REALM-SF. 9th grade reading level or above=adequate, 7th or 8th grade reading level=marginal, 6th grade reading level or below=inadequate.|Participants|Number|4|4.0||||||
3749192|NCT01986790|3583923|B2|Not Reported||Rapid Estimate of Adult Literacy in Medicine-SF (REALM-SF)|Health literacy was assessed by the REALM-SF. 9th grade reading level or above=adequate, 7th or 8th grade reading level=marginal, 6th grade reading level or below=inadequate.|Participants|Number|2|2.0||||||
3749193|NCT01986790|3583924|B1|Not Reported||Rapid Estimate of Adult Literacy in Medicine-SF (REALM-SF)|Health literacy was assessed by the REALM-SF. 9th grade reading level or above=adequate, 7th or 8th grade reading level=marginal, 6th grade reading level or below=inadequate.|Participants|Number|2|2.0||||||
3749194|NCT01986790|3583921|B4|Adequate||Rapid Estimate of Adult Literacy in Medicine-SF (REALM-SF)|Health literacy was assessed by the REALM-SF. 9th grade reading level or above=adequate, 7th or 8th grade reading level=marginal, 6th grade reading level or below=inadequate.|Participants|Number|181|181.0||||||
3749195|NCT01986790|3583922|B3|Adequate||Rapid Estimate of Adult Literacy in Medicine-SF (REALM-SF)|Health literacy was assessed by the REALM-SF. 9th grade reading level or above=adequate, 7th or 8th grade reading level=marginal, 6th grade reading level or below=inadequate.|Participants|Number|44|44.0||||||
3749196|NCT01986790|3583923|B2|Adequate||Rapid Estimate of Adult Literacy in Medicine-SF (REALM-SF)|Health literacy was assessed by the REALM-SF. 9th grade reading level or above=adequate, 7th or 8th grade reading level=marginal, 6th grade reading level or below=inadequate.|Participants|Number|85|85.0||||||
3749197|NCT01986790|3583924|B1|Adequate||Rapid Estimate of Adult Literacy in Medicine-SF (REALM-SF)|Health literacy was assessed by the REALM-SF. 9th grade reading level or above=adequate, 7th or 8th grade reading level=marginal, 6th grade reading level or below=inadequate.|Participants|Number|52|52.0||||||
3749198|NCT01986790|3583921|B4|Marginal||Rapid Estimate of Adult Literacy in Medicine-SF (REALM-SF)|Health literacy was assessed by the REALM-SF. 9th grade reading level or above=adequate, 7th or 8th grade reading level=marginal, 6th grade reading level or below=inadequate.|Participants|Number|129|129.0||||||
3749199|NCT01986790|3583922|B3|Marginal||Rapid Estimate of Adult Literacy in Medicine-SF (REALM-SF)|Health literacy was assessed by the REALM-SF. 9th grade reading level or above=adequate, 7th or 8th grade reading level=marginal, 6th grade reading level or below=inadequate.|Participants|Number|42|42.0||||||
3749200|NCT01986790|3583923|B2|Marginal||Rapid Estimate of Adult Literacy in Medicine-SF (REALM-SF)|Health literacy was assessed by the REALM-SF. 9th grade reading level or above=adequate, 7th or 8th grade reading level=marginal, 6th grade reading level or below=inadequate.|Participants|Number|56|56.0||||||
3749201|NCT01986790|3583924|B1|Marginal||Rapid Estimate of Adult Literacy in Medicine-SF (REALM-SF)|Health literacy was assessed by the REALM-SF. 9th grade reading level or above=adequate, 7th or 8th grade reading level=marginal, 6th grade reading level or below=inadequate.|Participants|Number|31|31.0||||||
3749202|NCT01986790|3583921|B4|Inadequate||Rapid Estimate of Adult Literacy in Medicine-SF (REALM-SF)|Health literacy was assessed by the REALM-SF. 9th grade reading level or above=adequate, 7th or 8th grade reading level=marginal, 6th grade reading level or below=inadequate.|Participants|Number|25|25.0||||||
3749203|NCT01986790|3583922|B3|Inadequate||Rapid Estimate of Adult Literacy in Medicine-SF (REALM-SF)|Health literacy was assessed by the REALM-SF. 9th grade reading level or above=adequate, 7th or 8th grade reading level=marginal, 6th grade reading level or below=inadequate.|Participants|Number|8|8.0||||||
3749204|NCT01986790|3583923|B2|Inadequate||Rapid Estimate of Adult Literacy in Medicine-SF (REALM-SF)|Health literacy was assessed by the REALM-SF. 9th grade reading level or above=adequate, 7th or 8th grade reading level=marginal, 6th grade reading level or below=inadequate.|Participants|Number|11|11.0||||||
3749205|NCT01986790|3583924|B1|Inadequate||Rapid Estimate of Adult Literacy in Medicine-SF (REALM-SF)|Health literacy was assessed by the REALM-SF. 9th grade reading level or above=adequate, 7th or 8th grade reading level=marginal, 6th grade reading level or below=inadequate.|Participants|Number|6|6.0||||||
3749206|NCT01986790|3583921|B4|United States||Region of Enrollment||Participants|Number|343|343.0||||||
3749207|NCT01986790|3583922|B3|United States||Region of Enrollment||Participants|Number|98|98.0||||||
3749208|NCT01986790|3583923|B2|United States||Region of Enrollment||Participants|Number|154|154.0||||||
3749209|NCT01986790|3583924|B1|United States||Region of Enrollment||Participants|Number|91|91.0||||||
3749210|NCT01986790|3583921|B4|Not Reported||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
3749211|NCT01986790|3583922|B3|Not Reported||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3749212|NCT01986790|3583923|B2|Not Reported||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3749213|NCT01986790|3583924|B1|Not Reported||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3749214|NCT01986790|3583921|B4|Other||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
3749215|NCT01986790|3583922|B3|Other||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3749216|NCT01986790|3583923|B2|Other||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3749219|NCT01986790|3583922|B3|White||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
3749220|NCT01986790|3583923|B2|White||Race/Ethnicity, Customized||Participants|Number|42|42.0||||||
3749221|NCT01986790|3583924|B1|White||Race/Ethnicity, Customized||Participants|Number|31|31.0||||||
3749222|NCT01986790|3583921|B4|African American||Race/Ethnicity, Customized||Participants|Number|194|194.0||||||
3749223|NCT01986790|3583922|B3|African American||Race/Ethnicity, Customized||Participants|Number|59|59.0||||||
3749224|NCT01986790|3583923|B2|African American||Race/Ethnicity, Customized||Participants|Number|87|87.0||||||
3749225|NCT01986790|3583924|B1|African American||Race/Ethnicity, Customized||Participants|Number|48|48.0||||||
3749226|NCT01986790|3583921|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3749227|NCT01986790|3583922|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3749228|NCT01986790|3583923|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3749229|NCT01986790|3583924|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3749230|NCT01986790|3583921|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|304|304.0||||||
3749231|NCT01986790|3583922|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3749232|NCT01986790|3583923|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|136|136.0||||||
3749233|NCT01986790|3583924|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3749234|NCT01986790|3583921|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3749235|NCT01986790|3583922|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3749236|NCT01986790|3583923|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3749237|NCT01986790|3583924|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3749238|NCT01986790|3583921|B4||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3749239|NCT01986790|3583922|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3749240|NCT01986790|3583923|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3749241|NCT01986790|3583924|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3749242|NCT01986790|3583921|B4||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
3749243|NCT01986790|3583922|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3749244|NCT01986790|3583923|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3749245|NCT01986790|3583924|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3749246|NCT01986790|3583921|B4|||Age||Years|Mean|38.5|38.5|Standard Deviation|11.8|11.8|||
3749247|NCT01986790|3583922|B3|||Age||Years|Mean|37.8|37.8|Standard Deviation|12.1|12.1|||
3749248|NCT01986790|3583923|B2|||Age||Years|Mean|38.7|38.7|Standard Deviation|11.7|11.7|||
3749249|NCT01986790|3583924|B1|||Age||Years|Mean|38.9|38.9|Standard Deviation|12.0|12.0|||
3749250|NCT01986751|3583940|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
3749251|NCT01986751|3583941|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3749252|NCT01986751|3583942|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3749253|NCT01986751|3583940|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3749254|NCT01986751|3583941|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3749255|NCT01986751|3583942|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3749256|NCT01986751|3583940|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749257|NCT01986751|3583941|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749258|NCT01986751|3583942|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749259|NCT01986751|3583940|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749260|NCT01986751|3583941|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749261|NCT01986751|3583942|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749262|NCT01986751|3583940|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749263|NCT01986751|3583941|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749264|NCT01986751|3583942|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749265|NCT01986751|3583940|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749266|NCT01986751|3583941|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749267|NCT01986751|3583942|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749268|NCT01986751|3583940|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749269|NCT01986751|3583941|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749270|NCT01986751|3583942|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749271|NCT01986751|3583940|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749272|NCT01986751|3583941|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749273|NCT01986751|3583942|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749274|NCT01986751|3583940|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3749275|NCT01986751|3583941|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3749276|NCT01986751|3583942|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3749277|NCT01986751|3583940|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3749278|NCT01986751|3583941|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3749279|NCT01986751|3583942|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3749280|NCT01986751|3583940|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3749281|NCT01986751|3583941|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3749282|NCT01986751|3583942|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3749283|NCT01986751|3583940|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3749284|NCT01986751|3583941|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3749285|NCT01986751|3583942|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3749286|NCT01986751|3583940|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3749287|NCT01986751|3583941|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3749288|NCT01986751|3583942|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3749289|NCT01986686|3583963|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3749290|NCT01986686|3583963|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3749291|NCT01986686|3583964|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3749292|NCT01986686|3583965|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3749293|NCT01986686|3583963|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3749294|NCT01986686|3583964|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3749295|NCT01986686|3583965|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3749296|NCT01986686|3583963|B3|||Age||years|Mean|54.61|54.61|Standard Deviation|13.23|13.23|||
3749297|NCT01986686|3583964|B2|||Age||years|Mean|53.31|53.31|Standard Deviation|13.51|13.51|||
3749298|NCT01986686|3583965|B1|||Age||years|Mean|55.22|55.22|Standard Deviation|13.05|13.05|||
3749299|NCT01986361|3583972|B3|||Sore Throat Pain Intensity Scale (STPIS)|"The participant was instructed to swallow and: Place a line on the Sore Throat Scale that best characterizes the severity of your sore throat now: 0mm=no pain and 100mm=severe pain."|units on a scale|Mean|73.8|73.8|Standard Deviation|9.71|9.71|||
3749300|NCT01986361|3583973|B2|||Sore Throat Pain Intensity Scale (STPIS)|"The participant was instructed to swallow and: Place a line on the Sore Throat Scale that best characterizes the severity of your sore throat now: 0mm=no pain and 100mm=severe pain."|units on a scale|Mean|73.8|73.8|Standard Deviation|9.64|9.64|||
3749301|NCT01986361|3583974|B1|||Sore Throat Pain Intensity Scale (STPIS)|"The participant was instructed to swallow and: Place a line on the Sore Throat Scale that best characterizes the severity of your sore throat now: 0mm=no pain and 100mm=severe pain."|units on a scale|Mean|73.8|73.8|Standard Deviation|9.78|9.78|||
3749302|NCT01986361|3583972|B3|||Sore Throat Scale (STS) Score|"The participant was asked to evaluate his/her sore throat when swallowing using a vertical 0-10 Likert scale, where 0=not sore and 10=very sore. The participant was instructed: Circle the number that shows how sore your throat is now when you swallow."|units on a scale|Mean|7.4|7.4|Standard Deviation|0.98|0.98|||
3749303|NCT01986361|3583973|B2|||Sore Throat Scale (STS) Score|"The participant was asked to evaluate his/her sore throat when swallowing using a vertical 0-10 Likert scale, where 0=not sore and 10=very sore. The participant was instructed: Circle the number that shows how sore your throat is now when you swallow."|units on a scale|Mean|7.3|7.3|Standard Deviation|1.02|1.02|||
3749304|NCT01986361|3583974|B1|||Sore Throat Scale (STS) Score|"The participant was asked to evaluate his/her sore throat when swallowing using a vertical 0-10 Likert scale, where 0=not sore and 10=very sore. The participant was instructed: Circle the number that shows how sore your throat is now when you swallow."|units on a scale|Mean|7.4|7.4|Standard Deviation|0.97|0.97|||
3749305|NCT01986361|3583972|B3|||Height||inches|Mean|67.54|67.54|Standard Deviation|4.103|4.103|||
3749306|NCT01986361|3583973|B2|||Height||inches|Mean|66.90|66.9|Standard Deviation|3.697|3.697|||
3749307|NCT01986361|3583974|B1|||Height||inches|Mean|67.67|67.67|Standard Deviation|4.187|4.187|||
3749308|NCT01986361|3583972|B3|||Weight||pounds|Mean|154.11|154.11|Standard Deviation|31.913|31.913|||
3749309|NCT01986361|3583973|B2|||Weight||pounds|Mean|154.19|154.19|Standard Deviation|35.885|35.885|||
3749310|NCT01986361|3583974|B1|||Weight||pounds|Mean|154.09|154.09|Standard Deviation|31.221|31.221|||
3749311|NCT01986361|3583972|B3||White|Primary Race||Participants|Count of Participants|113|113.0||||||
3749312|NCT01986361|3583973|B2||White|Primary Race||Participants|Count of Participants|19|19.0||||||
3749313|NCT01986361|3583974|B1||White|Primary Race||Participants|Count of Participants|94|94.0||||||
3749314|NCT01986361|3583972|B3||Multi-Racial|Primary Race||Participants|Count of Participants|2|2.0||||||
3749315|NCT01986361|3583973|B2||Multi-Racial|Primary Race||Participants|Count of Participants|0|0.0||||||
3749316|NCT01986361|3583974|B1||Multi-Racial|Primary Race||Participants|Count of Participants|2|2.0||||||
3749317|NCT01986361|3583972|B3||Black or African American|Primary Race||Participants|Count of Participants|5|5.0||||||
3749318|NCT01986361|3583973|B2||Black or African American|Primary Race||Participants|Count of Participants|2|2.0||||||
3749319|NCT01986361|3583974|B1||Black or African American|Primary Race||Participants|Count of Participants|3|3.0||||||
3749320|NCT01986361|3583972|B3||Asian|Primary Race||Participants|Count of Participants|2|2.0||||||
3749321|NCT01986361|3583973|B2||Asian|Primary Race||Participants|Count of Participants|0|0.0||||||
3749322|NCT01986361|3583974|B1||Asian|Primary Race||Participants|Count of Participants|2|2.0||||||
3749323|NCT01986361|3583972|B3||Non-Hispanic or Non-Latino|Race/Ethnicity, Customized||Participants|Count of Participants|112|112.0||||||
3749324|NCT01986361|3583973|B2||Non-Hispanic or Non-Latino|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3749325|NCT01986361|3583974|B1||Non-Hispanic or Non-Latino|Race/Ethnicity, Customized||Participants|Count of Participants|93|93.0||||||
3749326|NCT01986361|3583972|B3||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3749327|NCT01986361|3583973|B2||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3749328|NCT01986361|3583974|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3749329|NCT01986361|3583972|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3749330|NCT01986361|3583973|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3749331|NCT01986361|3583974|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3749332|NCT01986361|3583972|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3749333|NCT01986361|3583973|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3749334|NCT01986361|3583974|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3749335|NCT01986361|3583972|B3|||Age||years|Mean|19.5|19.5|Standard Deviation|1.92|1.92|||
3749336|NCT01986361|3583973|B2|||Age||years|Mean|19.6|19.6|Standard Deviation|1.36|1.36|||
3749337|NCT01986361|3583974|B1|||Age||years|Mean|19.5|19.5|Standard Deviation|2.02|2.02|||
3749338|NCT01986231|3583997|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3749339|NCT01986231|3583997|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3749340|NCT01986231|3583997|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3749341|NCT01986231|3583997|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3749342|NCT01986231|3583997|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3749343|NCT01986140|3584002|B3|United States||Region of Enrollment||participants|Number|236|236.0||||||
3749344|NCT01986140|3584003|B2|United States||Region of Enrollment||participants|Number|79|79.0||||||
3749345|NCT01986140|3584004|B1|United States||Region of Enrollment||participants|Number|157|157.0||||||
3749346|NCT01986140|3584002|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3749347|NCT01986140|3584003|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3749348|NCT01986140|3584004|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3749349|NCT01986140|3584002|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749350|NCT01986140|3584003|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749351|NCT01986140|3584004|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749352|NCT01986140|3584002|B3||White|Race (NIH/OMB)||Participants|Count of Participants|192|192.0||||||
3749353|NCT01986140|3584003|B2||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3749354|NCT01986140|3584004|B1||White|Race (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
3749355|NCT01986140|3584002|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3749356|NCT01986140|3584003|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3749357|NCT01986140|3584004|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3749358|NCT01986140|3584002|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749359|NCT01986140|3584003|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749360|NCT01986140|3584004|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749361|NCT01986140|3584002|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3749362|NCT01986140|3584003|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3749363|NCT01986140|3584004|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3749364|NCT01986140|3584002|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749365|NCT01986140|3584003|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749366|NCT01986140|3584004|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749367|NCT01986140|3584002|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3749368|NCT01986140|3584003|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3749369|NCT01986140|3584004|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3749370|NCT01986140|3584002|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|196|196.0||||||
3749371|NCT01986140|3584003|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3749372|NCT01986140|3584004|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
3749373|NCT01986140|3584002|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3749374|NCT01986140|3584003|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3749375|NCT01986140|3584004|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3749376|NCT01986140|3584002|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3749377|NCT01986140|3584003|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3749378|NCT01986140|3584004|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3749379|NCT01986140|3584002|B3||Female|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
3749380|NCT01986140|3584003|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3749381|NCT01986140|3584004|B1||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3749382|NCT01986140|3584002|B3|||Age||years|Mean|50.4|50.4|Standard Deviation|10.3|10.3|||
3749383|NCT01986140|3584003|B2|||Age||years|Mean|50.6|50.6|Standard Deviation|10.6|10.6|||
3749384|NCT01986140|3584004|B1|||Age||years|Mean|50.4|50.4|Standard Deviation|10.1|10.1|||
3749385|NCT01986062|3584011|B3|United States||Region of Enrollment||participants|Number|97|97.0||||||
3749386|NCT01986062|3584012|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
3749387|NCT01986062|3584013|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
3749388|NCT01986062|3584011|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3749389|NCT01986062|3584012|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3749390|NCT01986062|3584013|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3749391|NCT01986062|3584011|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749392|NCT01986062|3584012|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749393|NCT01986062|3584013|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749394|NCT01986062|3584011|B3||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3749395|NCT01986062|3584012|B2||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3749396|NCT01986062|3584013|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3749397|NCT01986062|3584011|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3749398|NCT01986062|3584012|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3749399|NCT01986062|3584013|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3749400|NCT01986062|3584011|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749401|NCT01986062|3584012|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749402|NCT01986062|3584013|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749403|NCT01986062|3584011|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3749404|NCT01986062|3584012|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749405|NCT01986062|3584013|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3749406|NCT01986062|3584011|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749407|NCT01986062|3584012|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749408|NCT01986062|3584013|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749409|NCT01986062|3584011|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3749410|NCT01986062|3584012|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3749411|NCT01986062|3584013|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3749412|NCT01986062|3584011|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3749413|NCT01986062|3584012|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3749414|NCT01986062|3584013|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3749415|NCT01986062|3584011|B3|||Age||years|Mean|9.6|9.6|Standard Deviation|1.86|1.86|||
3749416|NCT01986062|3584012|B2|||Age||years|Mean|9.6|9.6|Standard Deviation|1.78|1.78|||
3749417|NCT01986062|3584013|B1|||Age||years|Mean|9.6|9.6|Standard Deviation|1.97|1.97|||
3749418|NCT01985685|3584030|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3749419|NCT01985685|3584031|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3749420|NCT01985685|3584032|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3749421|NCT01985685|3584030|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749422|NCT01985685|3584031|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749423|NCT01985685|3584032|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749424|NCT01985685|3584030|B3||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3749425|NCT01985685|3584031|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3749426|NCT01985685|3584032|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3749427|NCT01985685|3584030|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3749428|NCT01985685|3584031|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3749429|NCT01985685|3584032|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3749430|NCT01985685|3584030|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749431|NCT01985685|3584031|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749432|NCT01985685|3584032|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749433|NCT01985685|3584030|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749434|NCT01985685|3584031|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749435|NCT01985685|3584032|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749436|NCT01985685|3584030|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749437|NCT01985685|3584031|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749438|NCT01985685|3584032|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749439|NCT01985685|3584030|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3749440|NCT01985685|3584031|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3749441|NCT01985685|3584032|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3749442|NCT01985685|3584030|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3749443|NCT01985685|3584031|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3749444|NCT01985685|3584032|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3749445|NCT01985685|3584030|B3|||Age||years|Median|67|67.0|Inter-Quartile Range|||53.0|75.0|
3749446|NCT01985685|3584031|B2|||Age||years|Median|66|66.0|Inter-Quartile Range|||49.0|75.0|
3749447|NCT01985685|3584032|B1|||Age||years|Median|70|70.0|Inter-Quartile Range|||61.0|75.0|
3749448|NCT01985581|3584043|B3|Canada||Region of Enrollment||participants|Number|50|50.0||||||
3749449|NCT01985581|3584044|B2|Canada||Region of Enrollment||participants|Number|25|25.0||||||
3749450|NCT01985581|3584045|B1|Canada||Region of Enrollment||participants|Number|25|25.0||||||
3749451|NCT01985581|3584043|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3749452|NCT01985581|3584044|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3749453|NCT01985581|3584045|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3749454|NCT01985581|3584043|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3749455|NCT01985581|3584044|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3749456|NCT01985581|3584045|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3749457|NCT01985581|3584043|B3|||Age||years|Median|9.5|9.5|Full Range|||7.0|12.0|
3749458|NCT01985581|3584044|B2|||Age||years|Median|10|10.0|Full Range|||7.0|12.0|
3749459|NCT01985581|3584045|B1|||Age||years|Median|9.0|9.0|Full Range|||7.0|11.0|
3749460|NCT01985425|3584064|B3|Canada||Region of Enrollment||participants|Number|100|100.0||||||
3749461|NCT01985425|3584065|B2|Canada||Region of Enrollment||participants|Number|51|51.0||||||
3749462|NCT01985425|3584066|B1|Canada||Region of Enrollment||participants|Number|49|49.0||||||
3749463|NCT01985425|3584064|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3749464|NCT01985425|3584065|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3749465|NCT01985425|3584066|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3749466|NCT01985425|3584064|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3749467|NCT01985425|3584065|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3749468|NCT01985425|3584066|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3749469|NCT01985425|3584064|B3|||Age||years|Mean|68.57|68.57|Standard Deviation|7.4|7.4|||
3749470|NCT01985425|3584065|B2|||Age||years|Mean|68.28|68.28|Standard Deviation|7.4|7.4|||
3749471|NCT01985425|3584066|B1|||Age||years|Mean|68.89|68.89|Standard Deviation|7.5|7.5|||
3749472|NCT01985425|3584064|B3||>=65 years|Age||Participants|Count of Participants|65|65.0||||||
3749473|NCT01985425|3584065|B2||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
3749474|NCT01985425|3584066|B1||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
3749475|NCT01985425|3584064|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3749476|NCT01985425|3584065|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3749477|NCT01985425|3584066|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3749478|NCT01985425|3584064|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3749479|NCT01985425|3584065|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3749480|NCT01985425|3584066|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3749481|NCT01985321|3584085|B3|United States||Region of Enrollment||participants|Number|172|172.0||||||
3749482|NCT01985321|3584086|B2|United States||Region of Enrollment||participants|Number|83|83.0||||||
3749483|NCT01985321|3584087|B1|United States||Region of Enrollment||participants|Number|89|89.0||||||
3749484|NCT01985321|3584085|B3|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
3749485|NCT01985321|3584086|B2|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
3749486|NCT01985321|3584087|B1|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
3749487|NCT01985321|3584085|B3|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
3749488|NCT01985321|3584086|B2|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
3749489|NCT01985321|3584087|B1|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
3749490|NCT01985321|3584085|B3|White||Race (NIH/OMB)||participants|Number|139|139.0||||||
3749491|NCT01985321|3584086|B2|White||Race (NIH/OMB)||participants|Number|68|68.0||||||
3749492|NCT01985321|3584087|B1|White||Race (NIH/OMB)||participants|Number|71|71.0||||||
3749493|NCT01985321|3584085|B3|Black or African American||Race (NIH/OMB)||participants|Number|33|33.0||||||
3749494|NCT01985321|3584086|B2|Black or African American||Race (NIH/OMB)||participants|Number|15|15.0||||||
3749495|NCT01985321|3584087|B1|Black or African American||Race (NIH/OMB)||participants|Number|18|18.0||||||
3749496|NCT01985321|3584085|B3|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
3749497|NCT01985321|3584086|B2|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
3749498|NCT01985321|3584087|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
3749499|NCT01985321|3584085|B3|Asian||Race (NIH/OMB)||participants|Number|2|2.0||||||
3749500|NCT01985321|3584086|B2|Asian||Race (NIH/OMB)||participants|Number|2|2.0||||||
3749501|NCT01985321|3584087|B1|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
3749502|NCT01985321|3584085|B3|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|2|2.0||||||
3749503|NCT01985321|3584086|B2|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|2|2.0||||||
3749504|NCT01985321|3584087|B1|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
3749505|NCT01985321|3584085|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749506|NCT01985321|3584086|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749507|NCT01985321|3584087|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749508|NCT01985321|3584085|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|162|162.0||||||
3749509|NCT01985321|3584086|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3749510|NCT01985321|3584087|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3749511|NCT01985321|3584085|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3749512|NCT01985321|3584086|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3749513|NCT01985321|3584087|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3749514|NCT01985321|3584085|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3749515|NCT01985321|3584086|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3749516|NCT01985321|3584087|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3749517|NCT01985321|3584085|B3||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3749518|NCT01985321|3584086|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3749519|NCT01985321|3584087|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3749520|NCT01985321|3584085|B3|||Age||Years|Mean|48.4|48.4|Standard Deviation|19|19.0|||
3749521|NCT01985321|3584086|B2|||Age||Years|Mean|48.6|48.6|Standard Deviation|14.63|14.63|||
3749522|NCT01985321|3584087|B1|||Age||Years|Mean|48.1|48.1|Standard Deviation|15.54|15.54|||
3749523|NCT01985321|3584085|B3||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3749524|NCT01985321|3584086|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3749525|NCT01985321|3584087|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3749526|NCT01985321|3584085|B3||Between 18 and 65 years|Age||Participants|Count of Participants|147|147.0||||||
3749527|NCT01985321|3584086|B2||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
3749528|NCT01985321|3584087|B1||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
3749529|NCT01985321|3584085|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3749530|NCT01985321|3584086|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3749531|NCT01985321|3584087|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3749532|NCT01985126|3584096|B3||None|Refractory to Proteasome Inhibitor (PI)/ Immunomodulatory Drug (IMiD)||Participants|Count of Participants|3|3.0||||||
3749533|NCT01985126|3584097|B2||None|Refractory to Proteasome Inhibitor (PI)/ Immunomodulatory Drug (IMiD)||Participants|Count of Participants|1|1.0||||||
3749534|NCT01985126|3584098|B1||None|Refractory to Proteasome Inhibitor (PI)/ Immunomodulatory Drug (IMiD)||Participants|Count of Participants|2|2.0||||||
3749535|NCT01985126|3584096|B3||IMiD only|Refractory to Proteasome Inhibitor (PI)/ Immunomodulatory Drug (IMiD)||Participants|Count of Participants|1|1.0||||||
3749536|NCT01985126|3584097|B2||IMiD only|Refractory to Proteasome Inhibitor (PI)/ Immunomodulatory Drug (IMiD)||Participants|Count of Participants|1|1.0||||||
3749537|NCT01985126|3584098|B1||IMiD only|Refractory to Proteasome Inhibitor (PI)/ Immunomodulatory Drug (IMiD)||Participants|Count of Participants|0|0.0||||||
3749538|NCT01985126|3584096|B3||PI only|Refractory to Proteasome Inhibitor (PI)/ Immunomodulatory Drug (IMiD)||Participants|Count of Participants|4|4.0||||||
3749539|NCT01985126|3584097|B2||PI only|Refractory to Proteasome Inhibitor (PI)/ Immunomodulatory Drug (IMiD)||Participants|Count of Participants|3|3.0||||||
3749540|NCT01985126|3584098|B1||PI only|Refractory to Proteasome Inhibitor (PI)/ Immunomodulatory Drug (IMiD)||Participants|Count of Participants|1|1.0||||||
3749541|NCT01985126|3584096|B3||Both a PI and IMiD|Refractory to Proteasome Inhibitor (PI)/ Immunomodulatory Drug (IMiD)||Participants|Count of Participants|116|116.0||||||
3749542|NCT01985126|3584097|B2||Both a PI and IMiD|Refractory to Proteasome Inhibitor (PI)/ Immunomodulatory Drug (IMiD)||Participants|Count of Participants|101|101.0||||||
3749543|NCT01985126|3584098|B1||Both a PI and IMiD|Refractory to Proteasome Inhibitor (PI)/ Immunomodulatory Drug (IMiD)||Participants|Count of Participants|15|15.0||||||
3749544|NCT01985126|3584096|B3||> 3 Lines|Number of Prior Lines of Therapy||Participants|Count of Participants|99|99.0||||||
3749545|NCT01985126|3584097|B2||> 3 Lines|Number of Prior Lines of Therapy||Participants|Count of Participants|87|87.0||||||
3749546|NCT01985126|3584098|B1||> 3 Lines|Number of Prior Lines of Therapy||Participants|Count of Participants|12|12.0||||||
3749547|NCT01985126|3584096|B3||<= 3 Lines|Number of Prior Lines of Therapy||Participants|Count of Participants|25|25.0||||||
3749548|NCT01985126|3584097|B2||<= 3 Lines|Number of Prior Lines of Therapy||Participants|Count of Participants|19|19.0||||||
3749549|NCT01985126|3584098|B1||<= 3 Lines|Number of Prior Lines of Therapy||Participants|Count of Participants|6|6.0||||||
3749550|NCT01985126|3584096|B3||III|Stage of Disease (ISS)|The International Staging System (ISS) system consists of stage I: beta2-microglobulin less than (<)3.5 milligram per liter (mg/l) and albumin greater than or equal to (>=) 3.5 gram (g)/100 ml; stage II: neither stage I nor stage III and stage III: beta2-microglobulin >= 5.5 mg/l.|Participants|Count of Participants|48|48.0||||||
3749551|NCT01985126|3584097|B2||III|Stage of Disease (ISS)|The International Staging System (ISS) system consists of stage I: beta2-microglobulin less than (<)3.5 milligram per liter (mg/l) and albumin greater than or equal to (>=) 3.5 gram (g)/100 ml; stage II: neither stage I nor stage III and stage III: beta2-microglobulin >= 5.5 mg/l.|Participants|Count of Participants|40|40.0||||||
3749552|NCT01985126|3584098|B1||III|Stage of Disease (ISS)|The International Staging System (ISS) system consists of stage I: beta2-microglobulin less than (<)3.5 milligram per liter (mg/l) and albumin greater than or equal to (>=) 3.5 gram (g)/100 ml; stage II: neither stage I nor stage III and stage III: beta2-microglobulin >= 5.5 mg/l.|Participants|Count of Participants|8|8.0||||||
3749553|NCT01985126|3584096|B3||II|Stage of Disease (ISS)|The International Staging System (ISS) system consists of stage I: beta2-microglobulin less than (<)3.5 milligram per liter (mg/l) and albumin greater than or equal to (>=) 3.5 gram (g)/100 ml; stage II: neither stage I nor stage III and stage III: beta2-microglobulin >= 5.5 mg/l.|Participants|Count of Participants|48|48.0||||||
3749554|NCT01985126|3584097|B2||II|Stage of Disease (ISS)|The International Staging System (ISS) system consists of stage I: beta2-microglobulin less than (<)3.5 milligram per liter (mg/l) and albumin greater than or equal to (>=) 3.5 gram (g)/100 ml; stage II: neither stage I nor stage III and stage III: beta2-microglobulin >= 5.5 mg/l.|Participants|Count of Participants|40|40.0||||||
3749555|NCT01985126|3584098|B1||II|Stage of Disease (ISS)|The International Staging System (ISS) system consists of stage I: beta2-microglobulin less than (<)3.5 milligram per liter (mg/l) and albumin greater than or equal to (>=) 3.5 gram (g)/100 ml; stage II: neither stage I nor stage III and stage III: beta2-microglobulin >= 5.5 mg/l.|Participants|Count of Participants|8|8.0||||||
3749556|NCT01985126|3584096|B3||I|Stage of Disease (ISS)|The International Staging System (ISS) system consists of stage I: beta2-microglobulin less than (<)3.5 milligram per liter (mg/l) and albumin greater than or equal to (>=) 3.5 gram (g)/100 ml; stage II: neither stage I nor stage III and stage III: beta2-microglobulin >= 5.5 mg/l.|Participants|Count of Participants|28|28.0||||||
3749557|NCT01985126|3584097|B2||I|Stage of Disease (ISS)|The International Staging System (ISS) system consists of stage I: beta2-microglobulin less than (<)3.5 milligram per liter (mg/l) and albumin greater than or equal to (>=) 3.5 gram (g)/100 ml; stage II: neither stage I nor stage III and stage III: beta2-microglobulin >= 5.5 mg/l.|Participants|Count of Participants|26|26.0||||||
3749558|NCT01985126|3584098|B1||I|Stage of Disease (ISS)|The International Staging System (ISS) system consists of stage I: beta2-microglobulin less than (<)3.5 milligram per liter (mg/l) and albumin greater than or equal to (>=) 3.5 gram (g)/100 ml; stage II: neither stage I nor stage III and stage III: beta2-microglobulin >= 5.5 mg/l.|Participants|Count of Participants|2|2.0||||||
3749559|NCT01985126|3584096|B3|United States||Region of Enrollment||Participants|Count of Participants|90|90.0||||||
3749560|NCT01985126|3584097|B2|United States||Region of Enrollment||Participants|Count of Participants|75|75.0||||||
3749561|NCT01985126|3584098|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3749562|NCT01985126|3584096|B3|Spain||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3749563|NCT01985126|3584097|B2|Spain||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3749564|NCT01985126|3584098|B1|Spain||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3749565|NCT01985126|3584096|B3|Canada||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3749566|NCT01985126|3584097|B2|Canada||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3749567|NCT01985126|3584098|B1|Canada||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3749568|NCT01985126|3584096|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3749569|NCT01985126|3584097|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3749570|NCT01985126|3584098|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3749571|NCT01985126|3584096|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3749572|NCT01985126|3584097|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3749573|NCT01985126|3584098|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3749574|NCT01985126|3584096|B3|||Age||years|Mean|63.1|63.1|Standard Deviation|9.68|9.68|||
3749575|NCT01985126|3584097|B2|||Age||years|Mean|62.9|62.9|Standard Deviation|10|10.0|||
3749576|NCT01985126|3584098|B1|||Age||years|Mean|64.2|64.2|Standard Deviation|7.72|7.72|||
3749577|NCT01985126|3584096|B3||>=65 years|Age||Participants|Count of Participants|58|58.0||||||
3749578|NCT01985126|3584097|B2||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
3749579|NCT01985126|3584098|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3749580|NCT01985126|3584096|B3||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
3749581|NCT01985126|3584097|B2||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3749582|NCT01985126|3584098|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3749583|NCT01985126|3584096|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3749584|NCT01985126|3584097|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3749585|NCT01985126|3584098|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3749586|NCT01984892|3584117|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3749587|NCT01984892|3584117|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3749588|NCT01984892|3584117|B1|||Age||years|Median|70|70.0|Full Range|||53.0|87.0|
3749589|NCT01984697|3584123|B6||Male|Sex: Female, Male||Participants|Count of Participants|451|451.0||||||
3749590|NCT01984697|3584124|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3749591|NCT01984697|3584125|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3749592|NCT01984697|3584126|B3||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3749593|NCT01984697|3584127|B2||Male|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
3749594|NCT01984697|3584128|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3749595|NCT01984697|3584123|B6||Female|Sex: Female, Male||Participants|Count of Participants|1067|1067.0||||||
3749596|NCT01984697|3584124|B5||Female|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
3749597|NCT01984697|3584125|B4||Female|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
3749598|NCT01984697|3584126|B3||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3749599|NCT01984697|3584127|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3749600|NCT01984697|3584128|B1||Female|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
3749601|NCT01984697|3584123|B6|Between 16 and 26 years||Age, Customized||Participants|Number|314|314.0||||||
3749602|NCT01984697|3584124|B5|Between 16 and 26 years||Age, Customized||Participants|Number|314|314.0||||||
3749603|NCT01984697|3584125|B4|Between 16 and 26 years||Age, Customized||Participants|Number|0|0.0||||||
3749604|NCT01984697|3584126|B3|Between 16 and 26 years||Age, Customized||Participants|Number|0|0.0||||||
3749605|NCT01984697|3584127|B2|Between 16 and 26 years||Age, Customized||Participants|Number|0|0.0||||||
3749606|NCT01984697|3584128|B1|Between 16 and 26 years||Age, Customized||Participants|Number|0|0.0||||||
3749607|NCT01984697|3584123|B6|Between 13 and 14 years||Age, Customized||Participants|Number|395|395.0||||||
3749608|NCT01984697|3584124|B5|Between 13 and 14 years||Age, Customized||Participants|Number|0|0.0||||||
3749609|NCT01984697|3584125|B4|Between 13 and 14 years||Age, Customized||Participants|Number|100|100.0||||||
3749610|NCT01984697|3584126|B3|Between 13 and 14 years||Age, Customized||Participants|Number|95|95.0||||||
3749611|NCT01984697|3584127|B2|Between 13 and 14 years||Age, Customized||Participants|Number|101|101.0||||||
3749612|NCT01984697|3584128|B1|Between 13 and 14 years||Age, Customized||Participants|Number|99|99.0||||||
3749613|NCT01984697|3584123|B6|Between 11 and 12 years||Age, Customized||Participants|Number|410|410.0||||||
3749614|NCT01984697|3584124|B5|Between 11 and 12 years||Age, Customized||Participants|Number|0|0.0||||||
3749615|NCT01984697|3584125|B4|Between 11 and 12 years||Age, Customized||Participants|Number|100|100.0||||||
3749616|NCT01984697|3584126|B3|Between 11 and 12 years||Age, Customized||Participants|Number|106|106.0||||||
3749617|NCT01984697|3584127|B2|Between 11 and 12 years||Age, Customized||Participants|Number|102|102.0||||||
3749618|NCT01984697|3584128|B1|Between 11 and 12 years||Age, Customized||Participants|Number|102|102.0||||||
3749619|NCT01984697|3584123|B6|Between 9 and 10 years||Age, Customized||Participants|Number|399|399.0||||||
3749620|NCT01984697|3584124|B5|Between 9 and 10 years||Age, Customized||Participants|Number|0|0.0||||||
3749621|NCT01984697|3584125|B4|Between 9 and 10 years||Age, Customized||Participants|Number|101|101.0||||||
3749622|NCT01984697|3584126|B3|Between 9 and 10 years||Age, Customized||Participants|Number|100|100.0||||||
3749623|NCT01984697|3584127|B2|Between 9 and 10 years||Age, Customized||Participants|Number|98|98.0||||||
3749624|NCT01984697|3584128|B1|Between 9 and 10 years||Age, Customized||Participants|Number|100|100.0||||||
3749625|NCT01984697|3584123|B6|||Age||Years|Mean|13.4|13.4|Standard Deviation|4.3|4.3|||
3749626|NCT01984697|3584124|B5|||Age||Years|Mean|21.0|21.0|Standard Deviation|2.7|2.7|||
3749627|NCT01984697|3584125|B4|||Age||Years|Mean|11.4|11.4|Standard Deviation|1.7|1.7|||
3749628|NCT01984697|3584126|B3|||Age||Years|Mean|11.4|11.4|Standard Deviation|1.6|1.6|||
3749629|NCT01984697|3584127|B2|||Age||Years|Mean|11.5|11.5|Standard Deviation|1.7|1.7|||
3749630|NCT01984697|3584128|B1|||Age||Years|Mean|11.4|11.4|Standard Deviation|1.7|1.7|||
3749631|NCT01984684|3584249|B3|||Presence of diabetes||Participants|Count of Participants|107|107.0||||||
3749632|NCT01984684|3584250|B2|||Presence of diabetes||Participants|Count of Participants|54|54.0||||||
3749633|NCT01984684|3584251|B1|||Presence of diabetes||Participants|Count of Participants|53|53.0||||||
3749634|NCT01984684|3584249|B3||>= 30 kg/m2|BMI category||Participants|Count of Participants|425|425.0||||||
3749635|NCT01984684|3584250|B2||>= 30 kg/m2|BMI category||Participants|Count of Participants|214|214.0||||||
3749636|NCT01984684|3584251|B1||>= 30 kg/m2|BMI category||Participants|Count of Participants|211|211.0||||||
3749637|NCT01984684|3584249|B3||< 30 kg/m2|BMI category||Participants|Count of Participants|425|425.0||||||
3749638|NCT01984684|3584250|B2||< 30 kg/m2|BMI category||Participants|Count of Participants|213|213.0||||||
3749639|NCT01984684|3584251|B1||< 30 kg/m2|BMI category||Participants|Count of Participants|212|212.0||||||
3749640|NCT01984684|3584249|B3|||BMI (Body Mass Index)||kg/m2|Mean|30.5|30.5|Standard Deviation|7.49|7.49|||
3749641|NCT01984684|3584250|B2|||BMI (Body Mass Index)||kg/m2|Mean|30.7|30.7|Standard Deviation|7.54|7.54|||
3749642|NCT01984684|3584251|B1|||BMI (Body Mass Index)||kg/m2|Mean|30.4|30.4|Standard Deviation|7.44|7.44|||
3749643|NCT01984684|3584249|B3|Argentina||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3749644|NCT01984684|3584250|B2|Argentina||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3749645|NCT01984684|3584251|B1|Argentina||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3749646|NCT01984684|3584249|B3|Taiwan||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3749647|NCT01984684|3584250|B2|Taiwan||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3749648|NCT01984684|3584251|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3749649|NCT01984684|3584249|B3|South Korea||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3749650|NCT01984684|3584250|B2|South Korea||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3749651|NCT01984684|3584251|B1|South Korea||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3749652|NCT01984684|3584249|B3|Peru||Region of Enrollment||Participants|Count of Participants|63|63.0||||||
3749653|NCT01984684|3584250|B2|Peru||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3749654|NCT01984684|3584251|B1|Peru||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3749655|NCT01984684|3584249|B3|Chile||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3749656|NCT01984684|3584250|B2|Chile||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3749657|NCT01984684|3584251|B1|Chile||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3749658|NCT01984684|3584249|B3|Brazil||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3749659|NCT01984684|3584250|B2|Brazil||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3749660|NCT01984684|3584251|B1|Brazil||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3749661|NCT01984684|3584249|B3|Mexico||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3749662|NCT01984684|3584250|B2|Mexico||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3749663|NCT01984684|3584251|B1|Mexico||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3749664|NCT01984684|3584249|B3|North America||Region of Enrollment||Participants|Count of Participants|398|398.0||||||
3749665|NCT01984684|3584250|B2|North America||Region of Enrollment||Participants|Count of Participants|196|196.0||||||
3749666|NCT01984684|3584251|B1|North America||Region of Enrollment||Participants|Count of Participants|202|202.0||||||
3749667|NCT01984684|3584249|B3|Europe||Region of Enrollment||Participants|Count of Participants|338|338.0||||||
3749668|NCT01984684|3584250|B2|Europe||Region of Enrollment||Participants|Count of Participants|173|173.0||||||
3749669|NCT01984684|3584251|B1|Europe||Region of Enrollment||Participants|Count of Participants|165|165.0||||||
3749670|NCT01984684|3584249|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3749671|NCT01984684|3584250|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3749672|NCT01984684|3584251|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3749673|NCT01984684|3584249|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749674|NCT01984684|3584250|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749675|NCT01984684|3584251|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749676|NCT01984684|3584249|B3||White|Race (NIH/OMB)||Participants|Count of Participants|703|703.0||||||
3749677|NCT01984684|3584250|B2||White|Race (NIH/OMB)||Participants|Count of Participants|355|355.0||||||
3749678|NCT01984684|3584251|B1||White|Race (NIH/OMB)||Participants|Count of Participants|348|348.0||||||
3749679|NCT01984684|3584249|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3749680|NCT01984684|3584250|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3749681|NCT01984684|3584251|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3749682|NCT01984684|3584249|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3749683|NCT01984684|3584250|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3749684|NCT01984684|3584251|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3749685|NCT01984684|3584249|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3749686|NCT01984684|3584250|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3749687|NCT01984684|3584251|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3749688|NCT01984684|3584249|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3749689|NCT01984684|3584250|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3749690|NCT01984684|3584251|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3749691|NCT01984684|3584249|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749692|NCT01984684|3584250|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749693|NCT01984684|3584251|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749694|NCT01984684|3584249|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|619|619.0||||||
3749695|NCT01984684|3584250|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|328|328.0||||||
3749696|NCT01984684|3584251|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|291|291.0||||||
3749697|NCT01984684|3584249|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|231|231.0||||||
3749698|NCT01984684|3584250|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3749699|NCT01984684|3584251|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
3749700|NCT01984684|3584249|B3||Male|Sex: Female, Male||Participants|Count of Participants|538|538.0||||||
3749701|NCT01984684|3584250|B2||Male|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
3749702|NCT01984684|3584251|B1||Male|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
3749703|NCT01984684|3584249|B3||Female|Sex: Female, Male||Participants|Count of Participants|312|312.0||||||
3749704|NCT01984684|3584250|B2||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3749705|NCT01984684|3584251|B1||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3749706|NCT01984684|3584249|B3|> 75 years||Age, Customized||Participants|Count of Participants|66|66.0||||||
3749707|NCT01984684|3584250|B2|> 75 years||Age, Customized||Participants|Count of Participants|31|31.0||||||
3749708|NCT01984684|3584251|B1|> 75 years||Age, Customized||Participants|Count of Participants|35|35.0||||||
3749709|NCT01984684|3584249|B3|> 65 years||Age, Customized||Participants|Count of Participants|154|154.0||||||
3749710|NCT01984684|3584250|B2|> 65 years||Age, Customized||Participants|Count of Participants|75|75.0||||||
3749711|NCT01984684|3584251|B1|> 65 years||Age, Customized||Participants|Count of Participants|79|79.0||||||
3749712|NCT01984684|3584249|B3|<= 65 years||Age, Customized||Participants|Count of Participants|696|696.0||||||
3749713|NCT01984684|3584250|B2|<= 65 years||Age, Customized||Participants|Count of Participants|352|352.0||||||
3749714|NCT01984684|3584251|B1|<= 65 years||Age, Customized||Participants|Count of Participants|344|344.0||||||
3749715|NCT01984684|3584249|B3|||Age||years|Mean|50.7|50.7|Standard Deviation|16.00|16.0|||
3749716|NCT01984684|3584250|B2|||Age||years|Mean|50.2|50.2|Standard Deviation|16.03|16.03|||
3749717|NCT01984684|3584251|B1|||Age||years|Mean|51.2|51.2|Standard Deviation|15.98|15.98|||
3749718|NCT01984515|3584262|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3749719|NCT01984515|3584262|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749720|NCT01984515|3584262|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749721|NCT01984515|3584262|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3749722|NCT01984515|3584262|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3749723|NCT01984515|3584262|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749724|NCT01984515|3584262|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749725|NCT01984515|3584262|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749726|NCT01984515|3584262|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|self-report|Participants|Count of Participants|0|0.0||||||
3749727|NCT01984515|3584262|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|self-report|Participants|Count of Participants|37|37.0||||||
3749728|NCT01984515|3584262|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|self-report|Participants|Count of Participants|3|3.0||||||
3749729|NCT01984515|3584262|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3749730|NCT01984515|3584262|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3749731|NCT01984515|3584262|B1|||Age||years|Mean|47|47.0|Standard Deviation|15|15.0|||
3749732|NCT01984424|3584268|B3|||Lipoprotein(a) Concentration||nmol/L|Median|31.0|31.0|Inter-Quartile Range|||15.0|156.0|
3749733|NCT01984424|3584269|B2|||Lipoprotein(a) Concentration||nmol/L|Median|29.0|29.0|Inter-Quartile Range|||12.5|152.5|
3749734|NCT01984424|3584270|B1|||Lipoprotein(a) Concentration||nmol/L|Median|38.0|38.0|Inter-Quartile Range|||18.0|164.0|
3749735|NCT01984424|3584268|B3|||Triglyceride Concentration||mg/dL|Median|171.3|171.3|Inter-Quartile Range|||127.0|233.0|
3749736|NCT01984424|3584269|B2|||Triglyceride Concentration||mg/dL|Median|176.0|176.0|Inter-Quartile Range|||128.0|233.5|
3749737|NCT01984424|3584270|B1|||Triglyceride Concentration||mg/dL|Median|162.5|162.5|Inter-Quartile Range|||127.0|231.0|
3749738|NCT01984424|3584268|B3|||Apolipoprotein B/Apolipoprotein A1 Ratio||ratio|Mean|1.063|1.063|Standard Deviation|0.366|0.366|||
3749739|NCT01984424|3584269|B2|||Apolipoprotein B/Apolipoprotein A1 Ratio||ratio|Mean|1.063|1.063|Standard Deviation|0.340|0.34|||
3749740|NCT01984424|3584270|B1|||Apolipoprotein B/Apolipoprotein A1 Ratio||ratio|Mean|1.063|1.063|Standard Deviation|0.416|0.416|||
3749741|NCT01984424|3584268|B3|||Total Cholesterol/HDL-C Ratio||ratio|Mean|6.682|6.682|Standard Deviation|2.483|2.483|||
3749742|NCT01984424|3584269|B2|||Total Cholesterol/HDL-C Ratio||ratio|Mean|6.668|6.668|Standard Deviation|2.349|2.349|||
3749743|NCT01984424|3584270|B1|||Total Cholesterol/HDL-C Ratio||ratio|Mean|6.709|6.709|Standard Deviation|2.746|2.746|||
3749744|NCT01984424|3584268|B3|||Apolipoprotein B Concentration||mg/dL|Mean|157.2|157.2|Standard Deviation|41.7|41.7|||
3749745|NCT01984424|3584269|B2|||Apolipoprotein B Concentration||mg/dL|Mean|158.3|158.3|Standard Deviation|41.5|41.5|||
3749746|NCT01984424|3584270|B1|||Apolipoprotein B Concentration||mg/dL|Mean|155.0|155.0|Standard Deviation|42.4|42.4|||
3749747|NCT01984424|3584268|B3|||Non-high-density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|257.2|257.2|Standard Deviation|74.5|74.5|||
3749748|NCT01984424|3584269|B2|||Non-high-density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|256.9|256.9|Standard Deviation|73.8|73.8|||
3749749|NCT01984424|3584270|B1|||Non-high-density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|257.8|257.8|Standard Deviation|76.3|76.3|||
3749750|NCT01984424|3584268|B3|||Very Low-density Lipoprotein Cholesterol (VLDL-C) Concentration||mg/dL|Mean|36.7|36.7|Standard Deviation|15.1|15.1|||
3749751|NCT01984424|3584269|B2|||Very Low-density Lipoprotein Cholesterol (VLDL-C) Concentration||mg/dL|Mean|37.1|37.1|Standard Deviation|15.6|15.6|||
3749752|NCT01984424|3584270|B1|||Very Low-density Lipoprotein Cholesterol (VLDL-C) Concentration||mg/dL|Mean|35.7|35.7|Standard Deviation|14.3|14.3|||
3749753|NCT01984424|3584268|B3|||High-density Lipoprotein Cholesterol (HDL-C)||mg/dL|Mean|49.8|49.8|Standard Deviation|15.4|15.4|||
3749754|NCT01984424|3584269|B2|||High-density Lipoprotein Cholesterol (HDL-C)||mg/dL|Mean|49.7|49.7|Standard Deviation|15.4|15.4|||
3749755|NCT01984424|3584270|B1|||High-density Lipoprotein Cholesterol (HDL-C)||mg/dL|Mean|50.2|50.2|Standard Deviation|15.5|15.5|||
3749756|NCT01984424|3584268|B3|||Total Cholesterol Concentration||mg/dL|Mean|307.0|307.0|Standard Deviation|74.7|74.7|||
3749757|NCT01984424|3584269|B2|||Total Cholesterol Concentration||mg/dL|Mean|306.5|306.5|Standard Deviation|75.4|75.4|||
3749758|NCT01984424|3584270|B1|||Total Cholesterol Concentration||mg/dL|Mean|308.0|308.0|Standard Deviation|73.8|73.8|||
3749759|NCT01984424|3584268|B3|||LDL-C Concentation||mg/dL|Mean|219.9|219.9|Standard Deviation|72.0|72.0|||
3749760|NCT01984424|3584269|B2|||LDL-C Concentation||mg/dL|Mean|218.8|218.8|Standard Deviation|73.1|73.1|||
3749761|NCT01984424|3584270|B1|||LDL-C Concentation||mg/dL|Mean|221.9|221.9|Standard Deviation|70.2|70.2|||
3749762|NCT01984424|3584268|B3||≥ 180 mg/dL|Stratification Factor: Screening Low-density Lipoprotein Cholesterol (LDL-C)||Participants|Count of Participants|157|157.0||||||
3749763|NCT01984424|3584269|B2||≥ 180 mg/dL|Stratification Factor: Screening Low-density Lipoprotein Cholesterol (LDL-C)||Participants|Count of Participants|105|105.0||||||
3749764|NCT01984424|3584270|B1||≥ 180 mg/dL|Stratification Factor: Screening Low-density Lipoprotein Cholesterol (LDL-C)||Participants|Count of Participants|52|52.0||||||
3749765|NCT01984424|3584268|B3||< 180 mg/dL|Stratification Factor: Screening Low-density Lipoprotein Cholesterol (LDL-C)||Participants|Count of Participants|61|61.0||||||
3749766|NCT01984424|3584269|B2||< 180 mg/dL|Stratification Factor: Screening Low-density Lipoprotein Cholesterol (LDL-C)||Participants|Count of Participants|40|40.0||||||
3749767|NCT01984424|3584270|B1||< 180 mg/dL|Stratification Factor: Screening Low-density Lipoprotein Cholesterol (LDL-C)||Participants|Count of Participants|21|21.0||||||
3749768|NCT01984424|3584268|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3749769|NCT01984424|3584269|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3749770|NCT01984424|3584270|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3749771|NCT01984424|3584268|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|207|207.0||||||
3749772|NCT01984424|3584269|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|138|138.0||||||
3749773|NCT01984424|3584270|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|69|69.0||||||
3749774|NCT01984424|3584268|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3749775|NCT01984424|3584269|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3749776|NCT01984424|3584270|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3749777|NCT01984424|3584268|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3749778|NCT01984424|3584269|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3749779|NCT01984424|3584270|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3749780|NCT01984424|3584268|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3749781|NCT01984424|3584269|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3749782|NCT01984424|3584270|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3749783|NCT01984424|3584268|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3749784|NCT01984424|3584269|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3749785|NCT01984424|3584270|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3749786|NCT01984424|3584268|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749787|NCT01984424|3584269|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749788|NCT01984424|3584270|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749789|NCT01984424|3584268|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|216|216.0||||||
3749790|NCT01984424|3584269|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|143|143.0||||||
3749791|NCT01984424|3584270|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3749792|NCT01984424|3584268|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3749793|NCT01984424|3584269|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3749794|NCT01984424|3584270|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749795|NCT01984424|3584268|B3||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3749796|NCT01984424|3584269|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3749797|NCT01984424|3584270|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3749798|NCT01984424|3584268|B3||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3749799|NCT01984424|3584269|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3749800|NCT01984424|3584270|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3749801|NCT01984424|3584268|B3||≥ 65 years|Age, Customized||Participants|Count of Participants|74|74.0||||||
3749802|NCT01984424|3584269|B2||≥ 65 years|Age, Customized||Participants|Count of Participants|53|53.0||||||
3749803|NCT01984424|3584270|B1||≥ 65 years|Age, Customized||Participants|Count of Participants|21|21.0||||||
3749804|NCT01984424|3584268|B3||< 65 years|Age, Customized||Participants|Count of Participants|144|144.0||||||
3749805|NCT01984424|3584269|B2||< 65 years|Age, Customized||Participants|Count of Participants|92|92.0||||||
3749806|NCT01984424|3584270|B1||< 65 years|Age, Customized||Participants|Count of Participants|52|52.0||||||
3749807|NCT01984424|3584268|B3|||Age||years|Mean|58.8|58.8|Standard Deviation|10.5|10.5|||
3749808|NCT01984424|3584269|B2|||Age||years|Mean|59.0|59.0|Standard Deviation|11.1|11.1|||
3749809|NCT01984424|3584270|B1|||Age||years|Mean|58.5|58.5|Standard Deviation|9.4|9.4|||
3749810|NCT01984294|3584323|B4|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|65|65.0||||||
3749811|NCT01984294|3584324|B3|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|21|21.0||||||
3749812|NCT01984294|3584325|B2|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|23|23.0||||||
3749813|NCT01984294|3584326|B1|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|21|21.0||||||
3749814|NCT01984294|3584323|B4|< 800,000 IU/mL||HCV RNA Category||participants|Number|35|35.0||||||
3749815|NCT01984294|3584324|B3|< 800,000 IU/mL||HCV RNA Category||participants|Number|12|12.0||||||
3749816|NCT01984294|3584325|B2|< 800,000 IU/mL||HCV RNA Category||participants|Number|9|9.0||||||
3749817|NCT01984294|3584326|B1|< 800,000 IU/mL||HCV RNA Category||participants|Number|14|14.0||||||
3749818|NCT01984294|3584323|B4|||HCV RNA||log10 IU/mL|Mean|6.0|6.0|Standard Deviation|0.56|0.56|||
3749819|NCT01984294|3584324|B3|||HCV RNA||log10 IU/mL|Mean|6.0|6.0|Standard Deviation|0.57|0.57|||
3749820|NCT01984294|3584325|B2|||HCV RNA||log10 IU/mL|Mean|6.1|6.1|Standard Deviation|0.63|0.63|||
3749821|NCT01984294|3584326|B1|||HCV RNA||log10 IU/mL|Mean|6.0|6.0|Standard Deviation|0.50|0.5|||
3749822|NCT01984294|3584323|B4|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|24|24.0||||||
3749823|NCT01984294|3584324|B3|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|7|7.0||||||
3749824|NCT01984294|3584325|B2|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
3749825|NCT01984294|3584326|B1|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|14|14.0||||||
3749826|NCT01984294|3584323|B4|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|58|58.0||||||
3749827|NCT01984294|3584324|B3|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|19|19.0||||||
3749828|NCT01984294|3584325|B2|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|23|23.0||||||
3749829|NCT01984294|3584326|B1|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|16|16.0||||||
3749830|NCT01984294|3584323|B4|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|18|18.0||||||
3749831|NCT01984294|3584324|B3|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|7|7.0||||||
3749832|NCT01984294|3584325|B2|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|6|6.0||||||
3749833|NCT01984294|3584326|B1|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|5|5.0||||||
3749834|NCT01984294|3584323|B4|Genotype 1b||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|38|38.0||||||
3749835|NCT01984294|3584324|B3|Genotype 1b||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|12|12.0||||||
3749836|NCT01984294|3584325|B2|Genotype 1b||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|12|12.0||||||
3749837|NCT01984294|3584326|B1|Genotype 1b||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|14|14.0||||||
3749838|NCT01984294|3584323|B4|Genotype 1a||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|62|62.0||||||
3749839|NCT01984294|3584324|B3|Genotype 1a||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|21|21.0||||||
3749840|NCT01984294|3584325|B2|Genotype 1a||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|20|20.0||||||
3749841|NCT01984294|3584326|B1|Genotype 1a||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|21|21.0||||||
3749842|NCT01984294|3584323|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
3749843|NCT01984294|3584324|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3749844|NCT01984294|3584325|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3749845|NCT01984294|3584326|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3749846|NCT01984294|3584323|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
3749847|NCT01984294|3584324|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3749848|NCT01984294|3584325|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3749849|NCT01984294|3584326|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3749850|NCT01984294|3584323|B4|American Indian/ Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3749851|NCT01984294|3584324|B3|American Indian/ Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3749852|NCT01984294|3584325|B2|American Indian/ Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3749853|NCT01984294|3584326|B1|American Indian/ Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3749854|NCT01984294|3584323|B4|White||Race/Ethnicity, Customized||participants|Number|92|92.0||||||
3749855|NCT01984294|3584324|B3|White||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3749856|NCT01984294|3584325|B2|White||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3749857|NCT01984294|3584326|B1|White||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3749858|NCT01984294|3584323|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3749859|NCT01984294|3584324|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3749860|NCT01984294|3584325|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3749861|NCT01984294|3584326|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3749862|NCT01984294|3584323|B4||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3749863|NCT01984294|3584324|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3749864|NCT01984294|3584325|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3749865|NCT01984294|3584326|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3749866|NCT01984294|3584323|B4||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3749867|NCT01984294|3584324|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3749868|NCT01984294|3584325|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3749869|NCT01984294|3584326|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3749870|NCT01984294|3584323|B4|||Age||years|Mean|57|57.0|Standard Deviation|8.2|8.2|||
3749871|NCT01984294|3584324|B3|||Age||years|Mean|57|57.0|Standard Deviation|9.3|9.3|||
3749872|NCT01984294|3584325|B2|||Age||years|Mean|57|57.0|Standard Deviation|7.4|7.4|||
3749873|NCT01984294|3584326|B1|||Age||years|Mean|58|58.0|Standard Deviation|7.8|7.8|||
3749874|NCT01984242|3584348|B4||Male|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
3749875|NCT01984242|3584349|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3749876|NCT01984242|3584350|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3749877|NCT01984242|3584351|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3749878|NCT01984242|3584348|B4||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3749879|NCT01984242|3584349|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3749880|NCT01984242|3584350|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3749881|NCT01984242|3584351|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3749882|NCT01984242|3584348|B4|||Age||years|Mean|60.3|60.3|Standard Deviation|10.6|10.6|||
3749883|NCT01984242|3584349|B3|||Age||years|Mean|59.7|59.7|Standard Deviation|10.8|10.8|||
3749884|NCT01984242|3584350|B2|||Age||years|Mean|60.1|60.1|Standard Deviation|10.2|10.2|||
3749885|NCT01984242|3584351|B1|||Age||years|Mean|61.1|61.1|Standard Deviation|10.8|10.8|||
3749886|NCT01984229|3584501|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3749887|NCT01984229|3584502|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3749888|NCT01984229|3584503|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3749889|NCT01984229|3584501|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3749890|NCT01984229|3584502|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3749891|NCT01984229|3584503|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3749892|NCT01984229|3584501|B3|||Age||years|Mean|38.3|38.3|Standard Deviation|8.24|8.24|||
3749893|NCT01984229|3584502|B2|||Age||years|Mean|38.5|38.5|Standard Deviation|8.40|8.4|||
3749894|NCT01984229|3584503|B1|||Age||years|Mean|37.8|37.8|Standard Deviation|8.50|8.5|||
3749895|NCT01983930|3584554|B3|United States||Region of Enrollment||Participants|Count of Participants|79|79.0||||||
3749896|NCT01983930|3584555|B2|United States||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
3749897|NCT01983930|3584556|B1|United States||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3749898|NCT01983930|3584554|B3|Non-Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3749899|NCT01983930|3584555|B2|Non-Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3749900|NCT01983930|3584556|B1|Non-Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3749901|NCT01983930|3584554|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|54|54.0||||||
3749902|NCT01983930|3584555|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3749903|NCT01983930|3584556|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3749904|NCT01983930|3584554|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3749905|NCT01983930|3584555|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3749906|NCT01983930|3584556|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3749907|NCT01983930|3584554|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3749908|NCT01983930|3584555|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3749909|NCT01983930|3584556|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3749910|NCT01983930|3584554|B3|||Age||years|Mean|67.9|67.9|Standard Deviation|8.4|8.4|||
3749911|NCT01983930|3584555|B2|||Age||years|Mean|67.6|67.6|Standard Deviation|8.0|8.0|||
3749912|NCT01983930|3584556|B1|||Age||years|Mean|68.1|68.1|Standard Deviation|8.7|8.7|||
3749913|NCT01983878|3584569|B1|Not Applicable||Histology||Participants|Number|3|3.0||||||
3749914|NCT01983878|3584569|B1|Mixed||Histology||Participants|Number|5|5.0||||||
3749915|NCT01983878|3584569|B1|Diffuse||Histology||Participants|Number|13|13.0||||||
3749916|NCT01983878|3584569|B1|Intestinal||Histology||Participants|Number|15|15.0||||||
3749917|NCT01983878|3584569|B1|Not Applicable||Grade||Participants|Number|1|1.0||||||
3749918|NCT01983878|3584569|B1|Poorly differentiated (High grade)||Grade||Participants|Number|20|20.0||||||
3749919|NCT01983878|3584569|B1|Moderately differentiated (Intermediate grade)||Grade||Participants|Number|11|11.0||||||
3749920|NCT01983878|3584569|B1|Well-differentiated (Low grade)||Grade||Participants|Number|4|4.0||||||
3749921|NCT01983878|3584569|B1|Unknown||Human Epidermal Growth Factor Receptor 2 (HER2) Status||Participants|Number|1|1.0||||||
3749922|NCT01983878|3584569|B1|Not Done||Human Epidermal Growth Factor Receptor 2 (HER2) Status||Participants|Number|3|3.0||||||
3749923|NCT01983878|3584569|B1|Negative||Human Epidermal Growth Factor Receptor 2 (HER2) Status||Participants|Number|26|26.0||||||
3749924|NCT01983878|3584569|B1|Positive||Human Epidermal Growth Factor Receptor 2 (HER2) Status||Participants|Number|6|6.0||||||
3749925|NCT01983878|3584569|B1|Gastric, Antrum||Initial Tumor Location||Participants|Number|14|14.0||||||
3749926|NCT01983878|3584569|B1|Gastric Cardia||Initial Tumor Location||Participants|Number|3|3.0||||||
3749927|NCT01983878|3584569|B1|Body of stomach||Initial Tumor Location||Participants|Number|19|19.0||||||
3749928|NCT01983878|3584569|B1|Adenocarcinoma, Gastric||Pathological Diagnosis||Participants|Number|35|35.0||||||
3749929|NCT01983878|3584569|B1|Adenocarcinoma, Gastroesophageal Junction||Pathological Diagnosis||Participants|Number|1|1.0||||||
3749930|NCT01983878|3584569|B1|Cytological||Basis for Pathological Diagnosis||Participants|Number|0|0.0||||||
3749931|NCT01983878|3584569|B1|Histopathological||Basis for Pathological Diagnosis||Participants|Number|36|36.0||||||
3749932|NCT01983878|3584569|B1|Performance Status = 1||Eastern Cooperative Oncology Group performance status (ECOG PS) 0 vs. 1|0 = Fully active, able to carry on all pre-disease performance without restriction, 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work|Participants|Number|12|12.0||||||
3750013|NCT01983683|3584610|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3749933|NCT01983878|3584569|B1|Performance Status = 0||Eastern Cooperative Oncology Group performance status (ECOG PS) 0 vs. 1|0 = Fully active, able to carry on all pre-disease performance without restriction, 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work|Participants|Number|24|24.0||||||
3749934|NCT01983878|3584569|B1|Japan||Region of Enrollment||Participants|Number|36|36.0||||||
3749935|NCT01983878|3584569|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749936|NCT01983878|3584569|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749937|NCT01983878|3584569|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749938|NCT01983878|3584569|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749939|NCT01983878|3584569|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749940|NCT01983878|3584569|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3749941|NCT01983878|3584569|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749942|NCT01983878|3584569|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749943|NCT01983878|3584569|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3749944|NCT01983878|3584569|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3749945|NCT01983878|3584569|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3749946|NCT01983878|3584569|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3749947|NCT01983878|3584569|B1|||Age||Years|Mean|66.7|66.7|Standard Deviation|9.75|9.75|||
3749948|NCT01983839|3584580|B1|||Body weight||kg|Median|72.6|72.6|Inter-Quartile Range|||64.1|80.6|
3749949|NCT01983839|3584580|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3749950|NCT01983839|3584580|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3749951|NCT01983839|3584580|B1|||Age||years|Median|73|73.0|Inter-Quartile Range|||66.0|83.0|
3749952|NCT01983839|3584580|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3749953|NCT01983839|3584580|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3749954|NCT01983839|3584580|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3749955|NCT01983787|3584585|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3749956|NCT01983787|3584585|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3749957|NCT01983787|3584585|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3749958|NCT01983787|3584585|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3749959|NCT01983787|3584585|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3749960|NCT01983683|3584608|B3||Unable to determine|CDAD severity at baseline|"CDAD at baseline was considered as severe if the following criteria were met: maximum body temperature > 38.5 C, white blood cell counts > 15.0 x 10*9/L and rise in baseline serum creatinine > 50% compared to the level before CDAD diagnosis. Otherwise, it was considered as mild-moderate. The number of subjects with severe and mild-moderate CDAD at baseline was assessed for each treatment group. If any of the measurements required for derivation of severity was missing, the subjects were classified as unable to determine"|Participants|Count of Participants|37|37.0||||||
3749961|NCT01983683|3584609|B2||Unable to determine|CDAD severity at baseline|"CDAD at baseline was considered as severe if the following criteria were met: maximum body temperature > 38.5 C, white blood cell counts > 15.0 x 10*9/L and rise in baseline serum creatinine > 50% compared to the level before CDAD diagnosis. Otherwise, it was considered as mild-moderate. The number of subjects with severe and mild-moderate CDAD at baseline was assessed for each treatment group. If any of the measurements required for derivation of severity was missing, the subjects were classified as unable to determine"|Participants|Count of Participants|17|17.0||||||
3749962|NCT01983683|3584610|B1||Unable to determine|CDAD severity at baseline|"CDAD at baseline was considered as severe if the following criteria were met: maximum body temperature > 38.5 C, white blood cell counts > 15.0 x 10*9/L and rise in baseline serum creatinine > 50% compared to the level before CDAD diagnosis. Otherwise, it was considered as mild-moderate. The number of subjects with severe and mild-moderate CDAD at baseline was assessed for each treatment group. If any of the measurements required for derivation of severity was missing, the subjects were classified as unable to determine"|Participants|Count of Participants|20|20.0||||||
3749963|NCT01983683|3584608|B3||Severe|CDAD severity at baseline|"CDAD at baseline was considered as severe if the following criteria were met: maximum body temperature > 38.5 C, white blood cell counts > 15.0 x 10*9/L and rise in baseline serum creatinine > 50% compared to the level before CDAD diagnosis. Otherwise, it was considered as mild-moderate. The number of subjects with severe and mild-moderate CDAD at baseline was assessed for each treatment group. If any of the measurements required for derivation of severity was missing, the subjects were classified as unable to determine"|Participants|Count of Participants|111|111.0||||||
3749964|NCT01983683|3584609|B2||Severe|CDAD severity at baseline|"CDAD at baseline was considered as severe if the following criteria were met: maximum body temperature > 38.5 C, white blood cell counts > 15.0 x 10*9/L and rise in baseline serum creatinine > 50% compared to the level before CDAD diagnosis. Otherwise, it was considered as mild-moderate. The number of subjects with severe and mild-moderate CDAD at baseline was assessed for each treatment group. If any of the measurements required for derivation of severity was missing, the subjects were classified as unable to determine"|Participants|Count of Participants|57|57.0||||||
3749965|NCT01983683|3584610|B1||Severe|CDAD severity at baseline|"CDAD at baseline was considered as severe if the following criteria were met: maximum body temperature > 38.5 C, white blood cell counts > 15.0 x 10*9/L and rise in baseline serum creatinine > 50% compared to the level before CDAD diagnosis. Otherwise, it was considered as mild-moderate. The number of subjects with severe and mild-moderate CDAD at baseline was assessed for each treatment group. If any of the measurements required for derivation of severity was missing, the subjects were classified as unable to determine"|Participants|Count of Participants|54|54.0||||||
3749966|NCT01983683|3584608|B3||Mild-Moderate|CDAD severity at baseline|"CDAD at baseline was considered as severe if the following criteria were met: maximum body temperature > 38.5 C, white blood cell counts > 15.0 x 10*9/L and rise in baseline serum creatinine > 50% compared to the level before CDAD diagnosis. Otherwise, it was considered as mild-moderate. The number of subjects with severe and mild-moderate CDAD at baseline was assessed for each treatment group. If any of the measurements required for derivation of severity was missing, the subjects were classified as unable to determine"|Participants|Count of Participants|443|443.0||||||
3749967|NCT01983683|3584609|B2||Mild-Moderate|CDAD severity at baseline|"CDAD at baseline was considered as severe if the following criteria were met: maximum body temperature > 38.5 C, white blood cell counts > 15.0 x 10*9/L and rise in baseline serum creatinine > 50% compared to the level before CDAD diagnosis. Otherwise, it was considered as mild-moderate. The number of subjects with severe and mild-moderate CDAD at baseline was assessed for each treatment group. If any of the measurements required for derivation of severity was missing, the subjects were classified as unable to determine"|Participants|Count of Participants|227|227.0||||||
3749968|NCT01983683|3584610|B1||Mild-Moderate|CDAD severity at baseline|"CDAD at baseline was considered as severe if the following criteria were met: maximum body temperature > 38.5 C, white blood cell counts > 15.0 x 10*9/L and rise in baseline serum creatinine > 50% compared to the level before CDAD diagnosis. Otherwise, it was considered as mild-moderate. The number of subjects with severe and mild-moderate CDAD at baseline was assessed for each treatment group. If any of the measurements required for derivation of severity was missing, the subjects were classified as unable to determine"|Participants|Count of Participants|216|216.0||||||
3749969|NCT01983683|3584608|B3||Unable to determine|Initial strain of Clostridium difficile|"The strain of C. difficile at baseline was identified in the last stool sample collected up to treatment start date and with available C. difficile culture. Identification was done by polymerase chain reaction (PCR). The strains were categorized as hypervirulent strains (PCR ribotype 027, 078 or 244) or non-hypervirulent (other PCR ribotypes). The number of subjects with hypervirulent, non-hypervirulent strains at baseline was assessed for each treatment group. If PCR ribotype at baseline was not available, the subjects were classified as unable to determine"|Participants|Count of Participants|64|64.0||||||
3749970|NCT01983683|3584609|B2||Unable to determine|Initial strain of Clostridium difficile|"The strain of C. difficile at baseline was identified in the last stool sample collected up to treatment start date and with available C. difficile culture. Identification was done by polymerase chain reaction (PCR). The strains were categorized as hypervirulent strains (PCR ribotype 027, 078 or 244) or non-hypervirulent (other PCR ribotypes). The number of subjects with hypervirulent, non-hypervirulent strains at baseline was assessed for each treatment group. If PCR ribotype at baseline was not available, the subjects were classified as unable to determine"|Participants|Count of Participants|30|30.0||||||
3749971|NCT01983683|3584610|B1||Unable to determine|Initial strain of Clostridium difficile|"The strain of C. difficile at baseline was identified in the last stool sample collected up to treatment start date and with available C. difficile culture. Identification was done by polymerase chain reaction (PCR). The strains were categorized as hypervirulent strains (PCR ribotype 027, 078 or 244) or non-hypervirulent (other PCR ribotypes). The number of subjects with hypervirulent, non-hypervirulent strains at baseline was assessed for each treatment group. If PCR ribotype at baseline was not available, the subjects were classified as unable to determine"|Participants|Count of Participants|34|34.0||||||
3749972|NCT01983683|3584608|B3||Non-hypervirulent strains|Initial strain of Clostridium difficile|"The strain of C. difficile at baseline was identified in the last stool sample collected up to treatment start date and with available C. difficile culture. Identification was done by polymerase chain reaction (PCR). The strains were categorized as hypervirulent strains (PCR ribotype 027, 078 or 244) or non-hypervirulent (other PCR ribotypes). The number of subjects with hypervirulent, non-hypervirulent strains at baseline was assessed for each treatment group. If PCR ribotype at baseline was not available, the subjects were classified as unable to determine"|Participants|Count of Participants|364|364.0||||||
3749973|NCT01983683|3584609|B2||Non-hypervirulent strains|Initial strain of Clostridium difficile|"The strain of C. difficile at baseline was identified in the last stool sample collected up to treatment start date and with available C. difficile culture. Identification was done by polymerase chain reaction (PCR). The strains were categorized as hypervirulent strains (PCR ribotype 027, 078 or 244) or non-hypervirulent (other PCR ribotypes). The number of subjects with hypervirulent, non-hypervirulent strains at baseline was assessed for each treatment group. If PCR ribotype at baseline was not available, the subjects were classified as unable to determine"|Participants|Count of Participants|183|183.0||||||
3749974|NCT01983683|3584610|B1||Non-hypervirulent strains|Initial strain of Clostridium difficile|"The strain of C. difficile at baseline was identified in the last stool sample collected up to treatment start date and with available C. difficile culture. Identification was done by polymerase chain reaction (PCR). The strains were categorized as hypervirulent strains (PCR ribotype 027, 078 or 244) or non-hypervirulent (other PCR ribotypes). The number of subjects with hypervirulent, non-hypervirulent strains at baseline was assessed for each treatment group. If PCR ribotype at baseline was not available, the subjects were classified as unable to determine"|Participants|Count of Participants|181|181.0||||||
3749975|NCT01983683|3584608|B3||Hypervirulent strains|Initial strain of Clostridium difficile|"The strain of C. difficile at baseline was identified in the last stool sample collected up to treatment start date and with available C. difficile culture. Identification was done by polymerase chain reaction (PCR). The strains were categorized as hypervirulent strains (PCR ribotype 027, 078 or 244) or non-hypervirulent (other PCR ribotypes). The number of subjects with hypervirulent, non-hypervirulent strains at baseline was assessed for each treatment group. If PCR ribotype at baseline was not available, the subjects were classified as unable to determine"|Participants|Count of Participants|163|163.0||||||
3749976|NCT01983683|3584609|B2||Hypervirulent strains|Initial strain of Clostridium difficile|"The strain of C. difficile at baseline was identified in the last stool sample collected up to treatment start date and with available C. difficile culture. Identification was done by polymerase chain reaction (PCR). The strains were categorized as hypervirulent strains (PCR ribotype 027, 078 or 244) or non-hypervirulent (other PCR ribotypes). The number of subjects with hypervirulent, non-hypervirulent strains at baseline was assessed for each treatment group. If PCR ribotype at baseline was not available, the subjects were classified as unable to determine"|Participants|Count of Participants|88|88.0||||||
3750014|NCT01983683|3584608|B3||Male|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
3749977|NCT01983683|3584610|B1||Hypervirulent strains|Initial strain of Clostridium difficile|"The strain of C. difficile at baseline was identified in the last stool sample collected up to treatment start date and with available C. difficile culture. Identification was done by polymerase chain reaction (PCR). The strains were categorized as hypervirulent strains (PCR ribotype 027, 078 or 244) or non-hypervirulent (other PCR ribotypes). The number of subjects with hypervirulent, non-hypervirulent strains at baseline was assessed for each treatment group. If PCR ribotype at baseline was not available, the subjects were classified as unable to determine"|Participants|Count of Participants|75|75.0||||||
3749978|NCT01983683|3584608|B3||First recurrence|CDAD episode type strata|CDAD episode type strata was defined as baseline stratification factor ‘First occurrence’ or ‘First recurrence’ of CDAD as recorded in the Interactive voice recognition system (IVRS) at the time of subject randomization. Number of subjects with first recurrence or first occurrence at randomization was assessed for each treatment group.|Participants|Count of Participants|110|110.0||||||
3749979|NCT01983683|3584609|B2||First recurrence|CDAD episode type strata|CDAD episode type strata was defined as baseline stratification factor ‘First occurrence’ or ‘First recurrence’ of CDAD as recorded in the Interactive voice recognition system (IVRS) at the time of subject randomization. Number of subjects with first recurrence or first occurrence at randomization was assessed for each treatment group.|Participants|Count of Participants|55|55.0||||||
3749980|NCT01983683|3584610|B1||First recurrence|CDAD episode type strata|CDAD episode type strata was defined as baseline stratification factor ‘First occurrence’ or ‘First recurrence’ of CDAD as recorded in the Interactive voice recognition system (IVRS) at the time of subject randomization. Number of subjects with first recurrence or first occurrence at randomization was assessed for each treatment group.|Participants|Count of Participants|55|55.0||||||
3749981|NCT01983683|3584608|B3||First occurrence|CDAD episode type strata|CDAD episode type strata was defined as baseline stratification factor ‘First occurrence’ or ‘First recurrence’ of CDAD as recorded in the Interactive voice recognition system (IVRS) at the time of subject randomization. Number of subjects with first recurrence or first occurrence at randomization was assessed for each treatment group.|Participants|Count of Participants|481|481.0||||||
3749982|NCT01983683|3584609|B2||First occurrence|CDAD episode type strata|CDAD episode type strata was defined as baseline stratification factor ‘First occurrence’ or ‘First recurrence’ of CDAD as recorded in the Interactive voice recognition system (IVRS) at the time of subject randomization. Number of subjects with first recurrence or first occurrence at randomization was assessed for each treatment group.|Participants|Count of Participants|246|246.0||||||
3749983|NCT01983683|3584610|B1||First occurrence|CDAD episode type strata|CDAD episode type strata was defined as baseline stratification factor ‘First occurrence’ or ‘First recurrence’ of CDAD as recorded in the Interactive voice recognition system (IVRS) at the time of subject randomization. Number of subjects with first recurrence or first occurrence at randomization was assessed for each treatment group.|Participants|Count of Participants|235|235.0||||||
3749984|NCT01983683|3584608|B3|Other||Region of Enrollment||Participants|Count of Participants|106|106.0||||||
3749985|NCT01983683|3584609|B2|Other||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
3749986|NCT01983683|3584610|B1|Other||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
3749987|NCT01983683|3584608|B3|Europe||Region of Enrollment||Participants|Count of Participants|245|245.0||||||
3749988|NCT01983683|3584609|B2|Europe||Region of Enrollment||Participants|Count of Participants|124|124.0||||||
3749989|NCT01983683|3584610|B1|Europe||Region of Enrollment||Participants|Count of Participants|121|121.0||||||
3749990|NCT01983683|3584608|B3|Canada||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3749991|NCT01983683|3584609|B2|Canada||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3749992|NCT01983683|3584610|B1|Canada||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3749993|NCT01983683|3584608|B3|United States||Region of Enrollment||Participants|Count of Participants|209|209.0||||||
3749994|NCT01983683|3584609|B2|United States||Region of Enrollment||Participants|Count of Participants|107|107.0||||||
3749995|NCT01983683|3584610|B1|United States||Region of Enrollment||Participants|Count of Participants|102|102.0||||||
3749996|NCT01983683|3584608|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3749997|NCT01983683|3584609|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3749998|NCT01983683|3584610|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3749999|NCT01983683|3584608|B3|Whtie||Race/Ethnicity, Customized||Participants|Count of Participants|537|537.0||||||
3750000|NCT01983683|3584609|B2|Whtie||Race/Ethnicity, Customized||Participants|Count of Participants|271|271.0||||||
3750001|NCT01983683|3584610|B1|Whtie||Race/Ethnicity, Customized||Participants|Count of Participants|266|266.0||||||
3750002|NCT01983683|3584608|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3750003|NCT01983683|3584609|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3750004|NCT01983683|3584610|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3750005|NCT01983683|3584608|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3750006|NCT01983683|3584609|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3750007|NCT01983683|3584610|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3750008|NCT01983683|3584608|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3750009|NCT01983683|3584609|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3750010|NCT01983683|3584610|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3750011|NCT01983683|3584608|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3750012|NCT01983683|3584609|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3750015|NCT01983683|3584609|B2||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3750016|NCT01983683|3584610|B1||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3750017|NCT01983683|3584608|B3||Female|Sex: Female, Male||Participants|Count of Participants|370|370.0||||||
3750018|NCT01983683|3584609|B2||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3750019|NCT01983683|3584610|B1||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
3750020|NCT01983683|3584608|B3|75 years and older||Age, Customized||Participants|Count of Participants|176|176.0||||||
3750021|NCT01983683|3584609|B2|75 years and older||Age, Customized||Participants|Count of Participants|89|89.0||||||
3750022|NCT01983683|3584610|B1|75 years and older||Age, Customized||Participants|Count of Participants|87|87.0||||||
3750023|NCT01983683|3584608|B3|65-74 years||Age, Customized||Participants|Count of Participants|124|124.0||||||
3750024|NCT01983683|3584609|B2|65-74 years||Age, Customized||Participants|Count of Participants|60|60.0||||||
3750025|NCT01983683|3584610|B1|65-74 years||Age, Customized||Participants|Count of Participants|64|64.0||||||
3750026|NCT01983683|3584608|B3|18-64 years||Age, Customized||Participants|Count of Participants|291|291.0||||||
3750027|NCT01983683|3584609|B2|18-64 years||Age, Customized||Participants|Count of Participants|152|152.0||||||
3750028|NCT01983683|3584610|B1|18-64 years||Age, Customized||Participants|Count of Participants|139|139.0||||||
3750029|NCT01983566|3584635|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3750030|NCT01983566|3584636|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3750031|NCT01983566|3584637|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3750032|NCT01983566|3584638|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3750033|NCT01983566|3584639|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3750034|NCT01983566|3584635|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3750035|NCT01983566|3584636|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3750036|NCT01983566|3584637|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3750037|NCT01983566|3584638|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3750038|NCT01983566|3584639|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3750039|NCT01983566|3584635|B5|||Age||years|Mean|28.6|28.6|Standard Deviation|3.5|3.5|||
3750040|NCT01983566|3584636|B4|||Age||years|Mean|27.8|27.8|Standard Deviation|3.0|3.0|||
3750041|NCT01983566|3584637|B3|||Age||years|Mean|32.3|32.3|Standard Deviation|2.9|2.9|||
3750042|NCT01983566|3584638|B2|||Age||years|Mean|25.3|25.3|Standard Deviation|1.0|1.0|||
3750043|NCT01983566|3584639|B1|||Age||years|Mean|29.3|29.3|Standard Deviation|3.0|3.0|||
3750044|NCT01983254|3584661|B3|United States||Region of Enrollment||participants|Number|261|261.0||||||
3750045|NCT01983254|3584662|B2|United States||Region of Enrollment||participants|Number|136|136.0||||||
3750046|NCT01983254|3584663|B1|United States||Region of Enrollment||participants|Number|125|125.0||||||
3750047|NCT01983254|3584661|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3750048|NCT01983254|3584662|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3750049|NCT01983254|3584663|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3750050|NCT01983254|3584661|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3750051|NCT01983254|3584662|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3750052|NCT01983254|3584663|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3750053|NCT01983254|3584661|B3||White|Race (NIH/OMB)||Participants|Count of Participants|197|197.0||||||
3750054|NCT01983254|3584662|B2||White|Race (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
3750055|NCT01983254|3584663|B1||White|Race (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3750056|NCT01983254|3584661|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3750057|NCT01983254|3584662|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3750058|NCT01983254|3584663|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3750059|NCT01983254|3584661|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3750060|NCT01983254|3584662|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750061|NCT01983254|3584663|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3750062|NCT01983254|3584661|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3750063|NCT01983254|3584662|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750064|NCT01983254|3584663|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3750065|NCT01983254|3584661|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3750066|NCT01983254|3584662|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3750067|NCT01983254|3584663|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750068|NCT01983254|3584661|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750069|NCT01983254|3584662|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750070|NCT01983254|3584663|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750071|NCT01983254|3584661|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|258|258.0||||||
3750072|NCT01983254|3584662|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|133|133.0||||||
3750073|NCT01983254|3584663|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
3750074|NCT01983254|3584661|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3750075|NCT01983254|3584662|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3750076|NCT01983254|3584663|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750077|NCT01983254|3584661|B3||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3750078|NCT01983254|3584662|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3750079|NCT01983254|3584663|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3750080|NCT01983254|3584661|B3||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3750081|NCT01983254|3584662|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3750082|NCT01983254|3584663|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3750083|NCT01983254|3584661|B3|Caregivers||Age||years|Mean|51.4|51.4|Standard Deviation|15.0|15.0|||
3750084|NCT01983254|3584662|B2|Caregivers||Age||years|Mean|52.9|52.9|Standard Deviation|15.2|15.2|||
3750085|NCT01983254|3584663|B1|Caregivers||Age||years|Mean|50.0|50.0|Standard Deviation|14.9|14.9|||
3750086|NCT01983254|3584661|B3|Patients||Age||years|Mean|51.7|51.7|Standard Deviation|13.8|13.8|||
3750087|NCT01983254|3584662|B2|Patients||Age||years|Mean|53.7|53.7|Standard Deviation|13.5|13.5|||
3750088|NCT01983254|3584663|B1|Patients||Age||years|Mean|49.7|49.7|Standard Deviation|13.8|13.8|||
3750089|NCT01983254|3584661|B3||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
3750090|NCT01983254|3584662|B2||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
3750091|NCT01983254|3584663|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3750092|NCT01983254|3584661|B3||Between 18 and 65 years|Age||Participants|Count of Participants|215|215.0||||||
3750093|NCT01983254|3584662|B2||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
3750094|NCT01983254|3584663|B1||Between 18 and 65 years|Age||Participants|Count of Participants|105|105.0||||||
3750095|NCT01983254|3584661|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3750096|NCT01983254|3584662|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3750097|NCT01983254|3584663|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3750098|NCT01983111|3584674|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3750099|NCT01983111|3584675|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3750100|NCT01983111|3584676|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3750101|NCT01983111|3584674|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3750102|NCT01983111|3584675|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3750103|NCT01983111|3584676|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3750104|NCT01983111|3584674|B3|||Age||years|Mean|63.02|63.02|Standard Deviation|10.04|10.04|||
3750105|NCT01983111|3584675|B2|||Age||years|Mean|61.54|61.54|Standard Deviation|8.96|8.96|||
3750106|NCT01983111|3584676|B1|||Age||years|Mean|64.42|64.42|Standard Deviation|10.84|10.84|||
3750107|NCT01983111|3584674|B3||>=65 years|Age||Participants|Count of Participants|70|70.0||||||
3750108|NCT01983111|3584675|B2||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
3750109|NCT01983111|3584676|B1||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
3750110|NCT01983111|3584674|B3||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
3750111|NCT01983111|3584675|B2||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3750112|NCT01983111|3584676|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3750113|NCT01983111|3584674|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3750114|NCT01983111|3584675|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3750115|NCT01983111|3584676|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3750116|NCT01983020|3584693|B5|United States||Region of Enrollment||participants|Number|46|46.0||||||
3750117|NCT01983020|3584694|B4|United States||Region of Enrollment||participants|Number|11|11.0||||||
3750118|NCT01983020|3584695|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3750119|NCT01983020|3584696|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3750120|NCT01983020|3584697|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3750121|NCT01983020|3584693|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3750122|NCT01983020|3584694|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3750123|NCT01983020|3584695|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3750124|NCT01983020|3584696|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3750125|NCT01983020|3584697|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3750126|NCT01983020|3584693|B5||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3750127|NCT01983020|3584694|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3750128|NCT01983020|3584695|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3750129|NCT01983020|3584696|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3750130|NCT01983020|3584697|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3750131|NCT01983020|3584693|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3750132|NCT01983020|3584694|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3750133|NCT01983020|3584695|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3750134|NCT01983020|3584696|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3750135|NCT01983020|3584697|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3750136|NCT01983020|3584693|B5||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
3750137|NCT01983020|3584694|B4||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3750138|NCT01983020|3584695|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3750139|NCT01983020|3584696|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3750140|NCT01983020|3584697|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3750141|NCT01983020|3584693|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3750142|NCT01983020|3584694|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3750143|NCT01983020|3584695|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3750144|NCT01983020|3584696|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3750145|NCT01983020|3584697|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3750146|NCT01983020|3584693|B5|||Age||years|Mean|54.39|54.39|Standard Deviation|13.08|13.08|||
3750147|NCT01983020|3584694|B4|||Age||years|Mean|56.3|56.3|Standard Deviation|12.7|12.7|||
3750148|NCT01983020|3584695|B3|||Age||years|Mean|50.3|50.3|Standard Deviation|11.5|11.5|||
3750149|NCT01983020|3584696|B2|||Age||years|Mean|55.16|55.16|Standard Deviation|16.23|16.23|||
3750150|NCT01983020|3584697|B1|||Age||years|Mean|55.8|55.8|Standard Deviation|11.85|11.85|||
3750151|NCT01982812|3584710|B3|retinopathy negative||cerebral malaria retinopathy (present)||participants|Number|16|16.0||||||
3750152|NCT01982812|3584711|B2|retinopathy negative||cerebral malaria retinopathy (present)||participants|Number|9|9.0||||||
3750153|NCT01982812|3584712|B1|retinopathy negative||cerebral malaria retinopathy (present)||participants|Number|7|7.0||||||
3750154|NCT01982812|3584710|B3|retinopathy positive||cerebral malaria retinopathy (present)||participants|Number|28|28.0||||||
3750155|NCT01982812|3584711|B2|retinopathy positive||cerebral malaria retinopathy (present)||participants|Number|12|12.0||||||
3750156|NCT01982812|3584712|B1|retinopathy positive||cerebral malaria retinopathy (present)||participants|Number|16|16.0||||||
3750157|NCT01982812|3584710|B3|African||Race/Ethnicity, Customized|Everyone in this Malawian study population was a black African|participants|Number|44|44.0||||||
3750158|NCT01982812|3584711|B2|African||Race/Ethnicity, Customized|Everyone in this Malawian study population was a black African|participants|Number|21|21.0||||||
3750159|NCT01982812|3584712|B1|African||Race/Ethnicity, Customized|Everyone in this Malawian study population was a black African|participants|Number|23|23.0||||||
3750160|NCT01982812|3584710|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3750161|NCT01982812|3584711|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3750162|NCT01982812|3584712|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3750163|NCT01982812|3584710|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3750164|NCT01982812|3584711|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3750165|NCT01982812|3584712|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3750166|NCT01982812|3584710|B3|||Age||months|Mean|41.6|41.6|Standard Deviation|13.7|13.7|||
3750167|NCT01982812|3584711|B2|||Age||months|Mean|41.8|41.8|Standard Deviation|16.7|16.7|||
3750168|NCT01982812|3584712|B1|||Age||months|Mean|41.4|41.4|Standard Deviation|10.6|10.6|||
3750169|NCT01982812|3584710|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3750170|NCT01982812|3584711|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3750171|NCT01982812|3584712|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3750172|NCT01982812|3584710|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3750173|NCT01982812|3584711|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3750174|NCT01982812|3584712|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3750175|NCT01982812|3584710|B3||<=18 years|Age||Participants|Count of Participants|44|44.0||||||
3750176|NCT01982812|3584711|B2||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
3750177|NCT01982812|3584712|B1||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
3750178|NCT01982773|3584725|B3|United States||Region of Enrollment||Participants|Count of Participants|118|118.0||||||
3750179|NCT01982773|3584726|B2|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3750180|NCT01982773|3584727|B1|United States||Region of Enrollment||Participants|Count of Participants|58|58.0||||||
3750181|NCT01982773|3584725|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750182|NCT01982773|3584726|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750183|NCT01982773|3584727|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750184|NCT01982773|3584725|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3750185|NCT01982773|3584726|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3750186|NCT01982773|3584727|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3750187|NCT01982773|3584725|B3||White|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3750188|NCT01982773|3584726|B2||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3750189|NCT01982773|3584727|B1||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3750190|NCT01982773|3584725|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3750191|NCT01982773|3584726|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3750192|NCT01982773|3584727|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3750369|NCT01981967|3584845|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3750193|NCT01982773|3584725|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750194|NCT01982773|3584726|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750195|NCT01982773|3584727|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750196|NCT01982773|3584725|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3750197|NCT01982773|3584726|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3750198|NCT01982773|3584727|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3750199|NCT01982773|3584725|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3750200|NCT01982773|3584726|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3750201|NCT01982773|3584727|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3750202|NCT01982773|3584725|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3750203|NCT01982773|3584726|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3750204|NCT01982773|3584727|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3750205|NCT01982773|3584725|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
3750206|NCT01982773|3584726|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3750207|NCT01982773|3584727|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3750208|NCT01982773|3584725|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3750209|NCT01982773|3584726|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3750210|NCT01982773|3584727|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3750211|NCT01982773|3584725|B3||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3750212|NCT01982773|3584726|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3750213|NCT01982773|3584727|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3750214|NCT01982773|3584725|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3750215|NCT01982773|3584726|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3750216|NCT01982773|3584727|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3750217|NCT01982773|3584725|B3|||Age||years|Mean|47.6|47.6|Standard Deviation|14.0|14.0|||
3750218|NCT01982773|3584726|B2|||Age||years|Mean|48.7|48.7|Standard Deviation|14.3|14.3|||
3750219|NCT01982773|3584727|B1|||Age||years|Mean|46.5|46.5|Standard Deviation|13.8|13.8|||
3750220|NCT01982773|3584725|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3750221|NCT01982773|3584726|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3750222|NCT01982773|3584727|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3750223|NCT01982773|3584725|B3||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
3750224|NCT01982773|3584726|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3750225|NCT01982773|3584727|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3750226|NCT01982773|3584725|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3750227|NCT01982773|3584726|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3750228|NCT01982773|3584727|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3750229|NCT01982695|3584740|B3|||Ejection Fraction||percentage of blood leaving the heart|Mean|47.6|47.6|Standard Deviation|5.77|5.77|||
3750230|NCT01982695|3584741|B2|||Ejection Fraction||percentage of blood leaving the heart|Mean|47.7|47.7|Standard Deviation|5.49|5.49|||
3750231|NCT01982695|3584742|B1|||Ejection Fraction||percentage of blood leaving the heart|Mean|47.5|47.5|Standard Deviation|6.25|6.25|||
3750232|NCT01982695|3584740|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3750233|NCT01982695|3584741|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3750234|NCT01982695|3584742|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3750235|NCT01982695|3584740|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3750236|NCT01982695|3584741|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3750237|NCT01982695|3584742|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3750238|NCT01982695|3584740|B3|||Age||years|Median|14|14.0|Full Range|||7.0|27.0|
3750239|NCT01982695|3584741|B2|||Age||years|Median|15.5|15.5|Full Range|||7.0|27.0|
3750240|NCT01982695|3584742|B1|||Age||years|Median|12.5|12.5|Full Range|||10.0|21.0|
3750241|NCT01982682|3584749|B1|United States||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3750242|NCT01982682|3584749|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3750243|NCT01982682|3584749|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750244|NCT01982682|3584749|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3750245|NCT01982682|3584749|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3750246|NCT01982682|3584749|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750247|NCT01982682|3584749|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3750248|NCT01982682|3584749|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750249|NCT01982682|3584749|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750370|NCT01981967|3584843|B3||<=18 years|Age||Participants|Count of Participants|10000|10000.0||||||
3750250|NCT01982682|3584749|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3750251|NCT01982682|3584749|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3750252|NCT01982682|3584749|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3750253|NCT01982682|3584749|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3750254|NCT01982682|3584749|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3750255|NCT01982682|3584749|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3750256|NCT01982682|3584749|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3750257|NCT01982539|3584757|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3750258|NCT01982539|3584757|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3750259|NCT01982539|3584757|B1|||Age||years|Mean|14.9|14.9|Standard Deviation|1.38|1.38|||
3750260|NCT01982435|3584761|B3|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3750261|NCT01982435|3584762|B2|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3750262|NCT01982435|3584763|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3750263|NCT01982435|3584761|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3750264|NCT01982435|3584762|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3750265|NCT01982435|3584763|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3750266|NCT01982435|3584761|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3750267|NCT01982435|3584762|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3750268|NCT01982435|3584763|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3750269|NCT01982435|3584761|B3|||Age||years|Mean|63.1|63.1|Standard Deviation|6.1|6.1|||
3750270|NCT01982435|3584762|B2|||Age||years|Mean|63.8|63.8|Standard Deviation|6.4|6.4|||
3750271|NCT01982435|3584763|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|6.0|6.0|||
3750272|NCT01982435|3584761|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3750273|NCT01982435|3584762|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3750274|NCT01982435|3584763|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3750275|NCT01982435|3584761|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3750276|NCT01982435|3584762|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3750277|NCT01982435|3584763|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3750278|NCT01982435|3584761|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3750279|NCT01982435|3584762|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3750280|NCT01982435|3584763|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3750281|NCT01982383|3584792|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3750282|NCT01982383|3584794|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3750283|NCT01982383|3584792|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3750284|NCT01982383|3584794|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3750285|NCT01982383|3584792|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3750286|NCT01982383|3584794|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3750287|NCT01982383|3584792|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3750288|NCT01982383|3584794|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3750289|NCT01982383|3584792|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3750290|NCT01982383|3584794|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3750291|NCT01982292|3584801|B3||Male|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
3750292|NCT01982292|3584802|B2||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3750293|NCT01982292|3584803|B1||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3750294|NCT01982292|3584801|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3750295|NCT01982292|3584802|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3750296|NCT01982292|3584803|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3750297|NCT01982292|3584801|B3|||Age||Years|Mean|66.2|66.2|Standard Deviation|9.79|9.79|||
3750298|NCT01982292|3584802|B2|||Age||Years|Mean|65.2|65.2|Standard Deviation|11.18|11.18|||
3750299|NCT01982292|3584803|B1|||Age||Years|Mean|66.7|66.7|Standard Deviation|8.99|8.99|||
3750300|NCT01982253|3584822|B4|Greater than or equal to (≥) 8.5 percent (%)||Glycosylated Haemoglobin (HbA1c)||participants|Number|3|3.0||||||
3750301|NCT01982253|3584823|B3|Greater than or equal to (≥) 8.5 percent (%)||Glycosylated Haemoglobin (HbA1c)||participants|Number|1|1.0||||||
3750302|NCT01982253|3584824|B2|Greater than or equal to (≥) 8.5 percent (%)||Glycosylated Haemoglobin (HbA1c)||participants|Number|2|2.0||||||
3750303|NCT01982253|3584825|B1|Greater than or equal to (≥) 8.5 percent (%)||Glycosylated Haemoglobin (HbA1c)||participants|Number|0|0.0||||||
3750304|NCT01982253|3584822|B4|Less than (<) 8.5 percent (%)||Glycosylated Haemoglobin (HbA1c)||participants|Number|7|7.0||||||
3750305|NCT01982253|3584823|B3|Less than (<) 8.5 percent (%)||Glycosylated Haemoglobin (HbA1c)||participants|Number|3|3.0||||7.2|8.8|
3750306|NCT01982253|3584824|B2|Less than (<) 8.5 percent (%)||Glycosylated Haemoglobin (HbA1c)||participants|Number|2|2.0||||6.8|9.3|
3750307|NCT01982253|3584825|B1|Less than (<) 8.5 percent (%)||Glycosylated Haemoglobin (HbA1c)||participants|Number|2|2.0||||6.8|8.2|
3750308|NCT01982253|3584822|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3750309|NCT01982253|3584823|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3750310|NCT01982253|3584824|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3750311|NCT01982253|3584825|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3750312|NCT01982253|3584822|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3750313|NCT01982253|3584823|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3750314|NCT01982253|3584824|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3750315|NCT01982253|3584825|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3750316|NCT01982253|3584822|B4|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3750317|NCT01982253|3584823|B3|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3750318|NCT01982253|3584824|B2|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3750319|NCT01982253|3584825|B1|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3750320|NCT01982253|3584822|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3750321|NCT01982253|3584823|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3750322|NCT01982253|3584824|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3750323|NCT01982253|3584825|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3750324|NCT01982253|3584822|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3750325|NCT01982253|3584823|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3750326|NCT01982253|3584824|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3750327|NCT01982253|3584825|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3750328|NCT01982253|3584822|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3750329|NCT01982253|3584823|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3750330|NCT01982253|3584824|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3750331|NCT01982253|3584825|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3750332|NCT01982253|3584822|B4|65 to 84 years||Age, Customized||participants|Number|1|1.0||||||
3750333|NCT01982253|3584823|B3|65 to 84 years||Age, Customized||participants|Number|0|0.0||||||
3750334|NCT01982253|3584824|B2|65 to 84 years||Age, Customized||participants|Number|0|0.0||||||
3750335|NCT01982253|3584825|B1|65 to 84 years||Age, Customized||participants|Number|1|1.0||||||
3750336|NCT01982253|3584822|B4|18 to 64 years||Age, Customized||participants|Number|9|9.0||||||
3750337|NCT01982253|3584823|B3|18 to 64 years||Age, Customized||participants|Number|4|4.0||||||
3750338|NCT01982253|3584824|B2|18 to 64 years||Age, Customized||participants|Number|4|4.0||||||
3750339|NCT01982253|3584825|B1|18 to 64 years||Age, Customized||participants|Number|1|1.0||||||
3750340|NCT01982123|3584838|B1|||Correlation between perfusion and ventilation on SPECT/CT scans pre-RT|Coefficient of determination (R²) between perfusion and ventilation per voxel on SPECT/CT scans prior to radiation treatment|correlation coefficient|Number|0.9|0.9||||||
3750341|NCT01982123|3584838|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3750342|NCT01982123|3584838|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750343|NCT01982123|3584838|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750344|NCT01982123|3584838|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3750345|NCT01982123|3584838|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750346|NCT01982123|3584838|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750347|NCT01982123|3584838|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3750348|NCT01982123|3584838|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750349|NCT01982123|3584838|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3750350|NCT01982123|3584838|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3750351|NCT01982123|3584838|B1|||Age||years|Mean|69.3|69.3|Standard Deviation|8.4|8.4|||
3750352|NCT01981967|3584843|B3|Thailand||Region of Enrollment||Participants|Number|10000|10000.0||||||
3750353|NCT01981967|3584844|B2|Thailand||Region of Enrollment||Participants|Number|3149|3149.0||||||
3750354|NCT01981967|3584845|B1|Thailand||Region of Enrollment||Participants|Number|6851|6851.0||||||
3750355|NCT01981967|3584843|B3||Male|Sex: Female, Male||Participants|Count of Participants|5129|5129.0||||||
3750356|NCT01981967|3584844|B2||Male|Sex: Female, Male||Participants|Count of Participants|1599|1599.0||||||
3750357|NCT01981967|3584845|B1||Male|Sex: Female, Male||Participants|Count of Participants|3530|3530.0||||||
3750358|NCT01981967|3584843|B3||Female|Sex: Female, Male||Participants|Count of Participants|4871|4871.0||||||
3750359|NCT01981967|3584844|B2||Female|Sex: Female, Male||Participants|Count of Participants|1550|1550.0||||||
3750360|NCT01981967|3584845|B1||Female|Sex: Female, Male||Participants|Count of Participants|3321|3321.0||||||
3750361|NCT01981967|3584843|B3|||Age||Years|Mean|1.97|1.97|Standard Deviation|1.28|1.28|||
3750362|NCT01981967|3584844|B2|||Age||Years|Mean|3.60|3.6|Standard Deviation|0.892|0.892|||
3750363|NCT01981967|3584845|B1|||Age||Years|Mean|1.22|1.22|Standard Deviation|0.486|0.486|||
3750364|NCT01981967|3584843|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3750365|NCT01981967|3584844|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3750366|NCT01981967|3584845|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3750367|NCT01981967|3584843|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3750368|NCT01981967|3584844|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3750371|NCT01981967|3584844|B2||<=18 years|Age||Participants|Count of Participants|3149|3149.0||||||
3750372|NCT01981967|3584845|B1||<=18 years|Age||Participants|Count of Participants|6851|6851.0||||||
3750373|NCT01981954|3584856|B1|||Maximum Cystometric Capacity (MCC)||mL|Mean|92.3|92.3|Standard Deviation|38.2|38.2|||
3750374|NCT01981954|3584856|B1|||Duration of NDO Disease||years|Median|1.99|1.99|Full Range|||0.13|4.51|
3750375|NCT01981954|3584856|B1|||Weight||kg|Mean|13.2|13.2|Standard Deviation|2.87|2.87|||
3750376|NCT01981954|3584856|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3750377|NCT01981954|3584856|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3750378|NCT01981954|3584856|B1|||Age||months|Mean|35.3|35.3|Standard Deviation|12.7|12.7|||
3750379|NCT01981954|3584856|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3750380|NCT01981954|3584856|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3750381|NCT01981954|3584856|B1||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
3750382|NCT01981863|3584901|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3750383|NCT01981863|3584902|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3750384|NCT01981863|3584903|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3750385|NCT01981863|3584901|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3750386|NCT01981863|3584902|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3750387|NCT01981863|3584903|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3750388|NCT01981863|3584901|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3750389|NCT01981863|3584902|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3750390|NCT01981863|3584903|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3750391|NCT01981863|3584901|B3|||Age||years|Mean|58|58.0|Standard Deviation|16|16.0|||
3750392|NCT01981863|3584902|B2|||Age||years|Mean|60|60.0|Standard Deviation|15|15.0|||
3750393|NCT01981863|3584903|B1|||Age||years|Mean|57|57.0|Standard Deviation|17|17.0|||
3750394|NCT01981863|3584901|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3750395|NCT01981863|3584902|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3750396|NCT01981863|3584903|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3750397|NCT01981863|3584901|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3750398|NCT01981863|3584902|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3750399|NCT01981863|3584903|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3750400|NCT01981863|3584901|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3750401|NCT01981863|3584902|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3750402|NCT01981863|3584903|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3750403|NCT01981759|3584914|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750404|NCT01981759|3584915|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750405|NCT01981759|3584916|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750406|NCT01981759|3584914|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3750407|NCT01981759|3584915|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3750408|NCT01981759|3584916|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3750409|NCT01981759|3584914|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3750410|NCT01981759|3584915|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3750411|NCT01981759|3584916|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3750412|NCT01981759|3584914|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3750413|NCT01981759|3584915|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3750414|NCT01981759|3584916|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3750415|NCT01981759|3584914|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750416|NCT01981759|3584915|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750417|NCT01981759|3584916|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750418|NCT01981759|3584914|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3750419|NCT01981759|3584915|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3750420|NCT01981759|3584916|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750421|NCT01981759|3584914|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750422|NCT01981759|3584915|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750423|NCT01981759|3584916|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750424|NCT01981759|3584914|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750425|NCT01981759|3584915|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750426|NCT01981759|3584916|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750427|NCT01981759|3584914|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3750428|NCT01981759|3584915|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3750429|NCT01981759|3584916|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3750430|NCT01981759|3584914|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3750431|NCT01981759|3584915|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3750432|NCT01981759|3584916|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3750433|NCT01981759|3584914|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3750434|NCT01981759|3584915|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3750435|NCT01981759|3584916|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3750436|NCT01981759|3584914|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3750437|NCT01981759|3584915|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3750438|NCT01981759|3584916|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3750439|NCT01981759|3584914|B3|||Age||Years|Mean|44.82|44.82|Standard Deviation|12.57|12.57|||
3750440|NCT01981759|3584915|B2|||Age||Years|Mean|44.60|44.6|Standard Deviation|13.26|13.26|||
3750441|NCT01981759|3584916|B1|||Age||Years|Mean|45.55|45.55|Standard Deviation|11.97|11.97|||
3750442|NCT01981616|3584923|B3|||Body Mass Index (BMI)||kg/m^2|Mean|25.1|25.1|Standard Deviation|3.04|3.04|||
3750443|NCT01981616|3584924|B2|||Body Mass Index (BMI)||kg/m^2|Mean|25.4|25.4|Standard Deviation|2.71|2.71|||
3750444|NCT01981616|3584925|B1|||Body Mass Index (BMI)||kg/m^2|Mean|24.8|24.8|Standard Deviation|3.34|3.34|||
3750445|NCT01981616|3584923|B3|||Weight||kg|Mean|75.6|75.6|Standard Deviation|12.51|12.51|||
3750446|NCT01981616|3584924|B2|||Weight||kg|Mean|76.2|76.2|Standard Deviation|11.53|11.53|||
3750447|NCT01981616|3584925|B1|||Weight||kg|Mean|75.0|75.0|Standard Deviation|13.48|13.48|||
3750448|NCT01981616|3584923|B3|||Height||cm|Mean|173.3|173.3|Standard Deviation|8.40|8.4|||
3750449|NCT01981616|3584924|B2|||Height||cm|Mean|173.1|173.1|Standard Deviation|7.94|7.94|||
3750450|NCT01981616|3584925|B1|||Height||cm|Mean|173.4|173.4|Standard Deviation|8.89|8.89|||
3750451|NCT01981616|3584923|B3|United Kingdom||Region of Enrollment||participants|Number|127|127.0||||||
3750452|NCT01981616|3584924|B2|United Kingdom||Region of Enrollment||participants|Number|63|63.0||||||
3750453|NCT01981616|3584925|B1|United Kingdom||Region of Enrollment||participants|Number|64|64.0||||||
3750454|NCT01981616|3584923|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|126|126.0||||||
3750455|NCT01981616|3584924|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
3750456|NCT01981616|3584925|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|64|64.0||||||
3750457|NCT01981616|3584923|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3750458|NCT01981616|3584924|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3750459|NCT01981616|3584925|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3750460|NCT01981616|3584923|B3|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3750461|NCT01981616|3584924|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3750462|NCT01981616|3584925|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3750463|NCT01981616|3584923|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3750464|NCT01981616|3584924|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3750465|NCT01981616|3584925|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3750466|NCT01981616|3584923|B3|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3750467|NCT01981616|3584924|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3750468|NCT01981616|3584925|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3750469|NCT01981616|3584923|B3|White||Race/Ethnicity, Customized||participants|Number|118|118.0||||||
3750470|NCT01981616|3584924|B2|White||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
3750471|NCT01981616|3584925|B1|White||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
3750472|NCT01981616|3584923|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3750473|NCT01981616|3584924|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3750474|NCT01981616|3584925|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3750475|NCT01981616|3584923|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3750476|NCT01981616|3584924|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3750477|NCT01981616|3584925|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3750478|NCT01981616|3584923|B3|||Age||years|Mean|27.5|27.5|Standard Deviation|5.47|5.47|||
3750479|NCT01981616|3584924|B2|||Age||years|Mean|27.3|27.3|Standard Deviation|5.33|5.33|||
3750480|NCT01981616|3584925|B1|||Age||years|Mean|27.7|27.7|Standard Deviation|5.64|5.64|||
3750481|NCT01981564|3584938|B3|||Emergency Department visits over past 3 months||Number of ED visits over past 3 months|Mean|1.26|1.26|Standard Deviation|1.4|1.4|||
3750482|NCT01981564|3584939|B2|||Emergency Department visits over past 3 months||Number of ED visits over past 3 months|Mean|1.48|1.48|Standard Deviation|1.6|1.6|||
3750483|NCT01981564|3584940|B1|||Emergency Department visits over past 3 months||Number of ED visits over past 3 months|Mean|1.02|1.02|Standard Deviation|1.1|1.1|||
3750484|NCT01981564|3584938|B3|||Symptoms days past 14 days||symptom days|Mean|5.88|5.88|Standard Deviation|4.8|4.8|||
3750485|NCT01981564|3584939|B2|||Symptoms days past 14 days||symptom days|Mean|6.17|6.17|Standard Deviation|4.9|4.9|||
3750486|NCT01981564|3584940|B1|||Symptoms days past 14 days||symptom days|Mean|5.55|5.55|Standard Deviation|4.6|4.6|||
3750487|NCT01981564|3584938|B3|United States||Region of Enrollment||participants|Number|222|222.0||||||
3750488|NCT01981564|3584939|B2|United States||Region of Enrollment||participants|Number|115|115.0||||||
3750489|NCT01981564|3584940|B1|United States||Region of Enrollment||participants|Number|107|107.0||||||
3750490|NCT01981564|3584938|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750491|NCT01981564|3584939|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750492|NCT01981564|3584940|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750493|NCT01981564|3584938|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3750494|NCT01981564|3584939|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3750495|NCT01981564|3584940|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3750496|NCT01981564|3584938|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3750497|NCT01981564|3584939|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3750498|NCT01981564|3584940|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3750499|NCT01981564|3584938|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|208|208.0||||||
3750500|NCT01981564|3584939|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
3750501|NCT01981564|3584940|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
3750502|NCT01981564|3584938|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750503|NCT01981564|3584939|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750504|NCT01981564|3584940|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750505|NCT01981564|3584938|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750506|NCT01981564|3584939|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750507|NCT01981564|3584940|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750508|NCT01981564|3584938|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750509|NCT01981564|3584939|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750510|NCT01981564|3584940|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750511|NCT01981564|3584938|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750512|NCT01981564|3584939|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750513|NCT01981564|3584940|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750514|NCT01981564|3584938|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|215|215.0||||||
3750515|NCT01981564|3584939|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|112|112.0||||||
3750516|NCT01981564|3584940|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
3750517|NCT01981564|3584938|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3750518|NCT01981564|3584939|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3750519|NCT01981564|3584940|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3750520|NCT01981564|3584938|B3||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3750521|NCT01981564|3584939|B2||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3750522|NCT01981564|3584940|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3750523|NCT01981564|3584938|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3750524|NCT01981564|3584939|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3750525|NCT01981564|3584940|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3750526|NCT01981564|3584938|B3|||Age||years|Mean|6.3|6.3|Standard Deviation|2.7|2.7|||
3750527|NCT01981564|3584939|B2|||Age||years|Mean|6.5|6.5|Standard Deviation|2.6|2.6|||
3750528|NCT01981564|3584940|B1|||Age||years|Mean|6.2|6.2|Standard Deviation|2.7|2.7|||
3750529|NCT01981564|3584938|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3750530|NCT01981564|3584939|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3750531|NCT01981564|3584940|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3750532|NCT01981564|3584938|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3750533|NCT01981564|3584939|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3750534|NCT01981564|3584940|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3750535|NCT01981564|3584938|B3||<=18 years|Age||Participants|Count of Participants|222|222.0||||||
3750536|NCT01981564|3584939|B2||<=18 years|Age||Participants|Count of Participants|115|115.0||||||
3750537|NCT01981564|3584940|B1||<=18 years|Age||Participants|Count of Participants|107|107.0||||||
3750538|NCT01981473|3584949|B4||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3750539|NCT01981473|3584950|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3750540|NCT01981473|3584951|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3750541|NCT01981473|3584952|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3750542|NCT01981473|3584949|B4||Female|Sex: Female, Male||Participants|Count of Participants|474|474.0||||||
3750543|NCT01981473|3584950|B3||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3750544|NCT01981473|3584951|B2||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3750545|NCT01981473|3584952|B1||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3750546|NCT01981473|3584949|B4|||Age||years|Mean|57.1|57.1|Standard Deviation|13.36|13.36|||
3750547|NCT01981473|3584950|B3|||Age||years|Mean|60.7|60.7|Standard Deviation|13.01|13.01|||
3750548|NCT01981473|3584951|B2|||Age||years|Mean|54.3|54.3|Standard Deviation|12.95|12.95|||
3750549|NCT01981473|3584952|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|13.37|13.37|||
3750550|NCT01981356|3584993|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
3750551|NCT01981356|3584994|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3750552|NCT01981356|3584995|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3750553|NCT01981356|3584993|B3|Not reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3750554|NCT01981356|3584994|B2|Not reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3750555|NCT01981356|3584995|B1|Not reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3750556|NCT01981356|3584993|B3|Asian or Asian American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3750557|NCT01981356|3584994|B2|Asian or Asian American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3750558|NCT01981356|3584995|B1|Asian or Asian American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3750559|NCT01981356|3584993|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3750560|NCT01981356|3584994|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3750561|NCT01981356|3584995|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3750562|NCT01981356|3584993|B3|Hispanic or Latino/a||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3750563|NCT01981356|3584994|B2|Hispanic or Latino/a||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3750564|NCT01981356|3584995|B1|Hispanic or Latino/a||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3750565|NCT01981356|3584993|B3|White/Caucasian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3750566|NCT01981356|3584994|B2|White/Caucasian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3750567|NCT01981356|3584995|B1|White/Caucasian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3750568|NCT01981356|3584993|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3750569|NCT01981356|3584994|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3750570|NCT01981356|3584995|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3750571|NCT01981356|3584993|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3750572|NCT01981356|3584994|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3750573|NCT01981356|3584995|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3750574|NCT01981356|3584993|B3|||Age||years|Mean|53.7|53.7|Standard Deviation|16.3|16.3|||
3750575|NCT01981356|3584994|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|17.7|17.7|||
3750576|NCT01981356|3584995|B1|||Age||years|Mean|52.4|52.4|Standard Deviation|16.2|16.2|||
3750577|NCT01981122|3585021|B3|21-25||Time in Years|Categorical presentation of participants based on time from diagnosis to randomization in this study|years|Number|2|2.0||||||
3750578|NCT01981122|3585022|B2|21-25||Time in Years|Categorical presentation of participants based on time from diagnosis to randomization in this study|years|Number|1|1.0||||||
3750579|NCT01981122|3585023|B1|21-25||Time in Years|Categorical presentation of participants based on time from diagnosis to randomization in this study|years|Number|1|1.0||||||
3750580|NCT01981122|3585021|B3|16-20||Time in Years|Categorical presentation of participants based on time from diagnosis to randomization in this study|years|Number|1|1.0||||||
3750581|NCT01981122|3585022|B2|16-20||Time in Years|Categorical presentation of participants based on time from diagnosis to randomization in this study|years|Number|1|1.0||||||
3750582|NCT01981122|3585023|B1|16-20||Time in Years|Categorical presentation of participants based on time from diagnosis to randomization in this study|years|Number|0|0.0||||||
3750583|NCT01981122|3585021|B3|11-15||Time in Years|Categorical presentation of participants based on time from diagnosis to randomization in this study|years|Number|9|9.0||||||
3750584|NCT01981122|3585022|B2|11-15||Time in Years|Categorical presentation of participants based on time from diagnosis to randomization in this study|years|Number|6|6.0||||||
3750585|NCT01981122|3585023|B1|11-15||Time in Years|Categorical presentation of participants based on time from diagnosis to randomization in this study|years|Number|3|3.0||||||
3750586|NCT01981122|3585021|B3|6-10||Time in Years|Categorical presentation of participants based on time from diagnosis to randomization in this study|years|Number|10|10.0||||||
3750587|NCT01981122|3585022|B2|6-10||Time in Years|Categorical presentation of participants based on time from diagnosis to randomization in this study|years|Number|5|5.0||||||
3750588|NCT01981122|3585023|B1|6-10||Time in Years|Categorical presentation of participants based on time from diagnosis to randomization in this study|years|Number|5|5.0||||||
3750589|NCT01981122|3585021|B3|0-5||Time in Years|Categorical presentation of participants based on time from diagnosis to randomization in this study|years|Number|30|30.0||||||
3750590|NCT01981122|3585022|B2|0-5||Time in Years|Categorical presentation of participants based on time from diagnosis to randomization in this study|years|Number|14|14.0||||||
3750591|NCT01981122|3585023|B1|0-5||Time in Years|Categorical presentation of participants based on time from diagnosis to randomization in this study|years|Number|16|16.0||||||
3750592|NCT01981122|3585021|B3|||Time from Diagnosis to Randomization||Years|Mean|5.8|5.8|Standard Deviation|5.5|5.5|||
3750593|NCT01981122|3585022|B2|||Time from Diagnosis to Randomization||Years|Mean|6.5|6.5|Standard Deviation|5.6|5.6|||
3750594|NCT01981122|3585023|B1|||Time from Diagnosis to Randomization||Years|Mean|5.1|5.1|Standard Deviation|5.3|5.3|||
3750595|NCT01981122|3585021|B3||Missing|Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|2|2.0||||||
3750596|NCT01981122|3585022|B2||Missing|Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|1|1.0||||||
3750597|NCT01981122|3585023|B1||Missing|Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|1|1.0||||||
3750598|NCT01981122|3585021|B3||Gleason Score ≥8|Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|35|35.0||||||
3750599|NCT01981122|3585022|B2||Gleason Score ≥8|Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|16|16.0||||||
3750600|NCT01981122|3585023|B1||Gleason Score ≥8|Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|19|19.0||||||
3750601|NCT01981122|3585021|B3||Gleason Score 7|Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|12|12.0||||||
3750602|NCT01981122|3585022|B2||Gleason Score 7|Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|8|8.0||||||
3750603|NCT01981122|3585023|B1||Gleason Score 7|Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|4|4.0||||||
3750604|NCT01981122|3585021|B3||Gleason Score ≤6|Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|3|3.0||||||
3750605|NCT01981122|3585022|B2||Gleason Score ≤6|Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|2|2.0||||||
3750631|NCT01981122|3585021|B3||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3750632|NCT01981122|3585022|B2||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3750633|NCT01981122|3585023|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3750634|NCT01981122|3585021|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3750635|NCT01981122|3585022|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3750606|NCT01981122|3585023|B1||Gleason Score ≤6|Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|1|1.0||||||
3750607|NCT01981122|3585021|B3||ECOG 1=Restricted Strenuous Activity|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|11|11.0||||||
3750608|NCT01981122|3585022|B2||ECOG 1=Restricted Strenuous Activity|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|8|8.0||||||
3750609|NCT01981122|3585023|B1||ECOG 1=Restricted Strenuous Activity|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|3|3.0||||||
3750610|NCT01981122|3585021|B3||ECOG 0=Fully Active; No restrictions|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|41|41.0||||||
3750611|NCT01981122|3585022|B2||ECOG 0=Fully Active; No restrictions|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|19|19.0||||||
3750612|NCT01981122|3585023|B1||ECOG 0=Fully Active; No restrictions|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|22|22.0||||||
3750613|NCT01981122|3585021|B3|||Body Mass Index||Kg/m^2|Mean|29.6|29.6|Standard Deviation|4.6|4.6|||
3750614|NCT01981122|3585022|B2|||Body Mass Index||Kg/m^2|Mean|29.0|29.0|Standard Deviation|4.2|4.2|||
3750615|NCT01981122|3585023|B1|||Body Mass Index||Kg/m^2|Mean|30.3|30.3|Standard Deviation|5.1|5.1|||
3750616|NCT01981122|3585021|B3|||Weight||Kg|Mean|92.8|92.8|Standard Deviation|16.6|16.6|||
3750617|NCT01981122|3585022|B2|||Weight||Kg|Mean|91.2|91.2|Standard Deviation|13.9|13.9|||
3750618|NCT01981122|3585023|B1|||Weight||Kg|Mean|94.6|94.6|Standard Deviation|19.4|19.4|||
3750619|NCT01981122|3585021|B3|||Height||Centimeters|Mean|177.1|177.1|Standard Deviation|6.9|6.9|||
3750620|NCT01981122|3585022|B2|||Height||Centimeters|Mean|177.2|177.2|Standard Deviation|6.0|6.0|||
3750621|NCT01981122|3585023|B1|||Height||Centimeters|Mean|177.0|177.0|Standard Deviation|8.0|8.0|||
3750622|NCT01981122|3585021|B3|United States||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
3750623|NCT01981122|3585022|B2|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3750624|NCT01981122|3585023|B1|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3750625|NCT01981122|3585021|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750626|NCT01981122|3585022|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750627|NCT01981122|3585023|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750628|NCT01981122|3585021|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750629|NCT01981122|3585022|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750630|NCT01981122|3585023|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750636|NCT01981122|3585023|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750637|NCT01981122|3585021|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750638|NCT01981122|3585022|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750639|NCT01981122|3585023|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750640|NCT01981122|3585021|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750641|NCT01981122|3585022|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750642|NCT01981122|3585023|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750643|NCT01981122|3585021|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750644|NCT01981122|3585022|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750645|NCT01981122|3585023|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750646|NCT01981122|3585021|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3750647|NCT01981122|3585022|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3750648|NCT01981122|3585023|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3750649|NCT01981122|3585021|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3750650|NCT01981122|3585022|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3750651|NCT01981122|3585023|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3750652|NCT01981122|3585021|B3|||Age||Years|Mean|70.0|70.0|Standard Deviation|10.3|10.3|||
3750653|NCT01981122|3585022|B2|||Age||Years|Mean|73.3|73.3|Standard Deviation|9.0|9.0|||
3750654|NCT01981122|3585023|B1|||Age||Years|Mean|66.4|66.4|Standard Deviation|10.6|10.6|||
3750655|NCT01981122|3585021|B3||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
3750656|NCT01981122|3585022|B2||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3750657|NCT01981122|3585023|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3750658|NCT01981122|3585021|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3750659|NCT01981122|3585022|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3750660|NCT01981122|3585023|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3750661|NCT01981122|3585021|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3750662|NCT01981122|3585022|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3750663|NCT01981122|3585023|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3750664|NCT01981096|3585030|B3|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3750665|NCT01981096|3585031|B2|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3750666|NCT01981096|3585032|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3750667|NCT01981096|3585030|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750668|NCT01981096|3585031|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750669|NCT01981096|3585032|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750670|NCT01981096|3585030|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3750671|NCT01981096|3585031|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3750672|NCT01981096|3585032|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750673|NCT01981096|3585030|B3||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3750674|NCT01981096|3585031|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3750675|NCT01981096|3585032|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3750676|NCT01981096|3585030|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750677|NCT01981096|3585031|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750678|NCT01981096|3585032|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750679|NCT01981096|3585030|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750680|NCT01981096|3585031|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750681|NCT01981096|3585032|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750682|NCT01981096|3585030|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750683|NCT01981096|3585031|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750684|NCT01981096|3585032|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750685|NCT01981096|3585030|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3750686|NCT01981096|3585031|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3750687|NCT01981096|3585032|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3750688|NCT01981096|3585030|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750689|NCT01981096|3585031|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750690|NCT01981096|3585032|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750691|NCT01981096|3585030|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3750692|NCT01981096|3585031|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3750693|NCT01981096|3585032|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3750694|NCT01981096|3585030|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750695|NCT01981096|3585031|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750696|NCT01981096|3585032|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750697|NCT01981096|3585030|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3750698|NCT01981096|3585031|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3750699|NCT01981096|3585032|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3750700|NCT01981096|3585030|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3750701|NCT01981096|3585031|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3750702|NCT01981096|3585032|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3750703|NCT01981096|3585030|B3|||Age||years|Mean|15.33|15.33|Standard Deviation|1.53|1.53|||
3750704|NCT01981096|3585031|B2|||Age||years|Mean|15.50|15.5|Standard Deviation|1.36|1.36|||
3750705|NCT01981096|3585032|B1|||Age||years|Mean|15.15|15.15|Standard Deviation|1.69|1.69|||
3750706|NCT01981057|3585043|B3|Austria||Region of Enrollment||participants|Number|100|100.0||||||
3750707|NCT01981057|3585044|B2|Austria||Region of Enrollment||participants|Number|50|50.0||||||
3750708|NCT01981057|3585045|B1|Austria||Region of Enrollment||participants|Number|50|50.0||||||
3750709|NCT01981057|3585043|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3750710|NCT01981057|3585044|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3750711|NCT01981057|3585045|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3750712|NCT01981057|3585043|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3750713|NCT01981057|3585044|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3750714|NCT01981057|3585045|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3750715|NCT01981057|3585043|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3750716|NCT01981057|3585044|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3750717|NCT01981057|3585045|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3750718|NCT01981057|3585043|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3750719|NCT01981057|3585044|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3750720|NCT01981057|3585045|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3750721|NCT01981057|3585043|B3||<=18 years|Age||Participants|Count of Participants|100|100.0||||||
3750722|NCT01981057|3585044|B2||<=18 years|Age||Participants|Count of Participants|50|50.0||||||
3750723|NCT01981057|3585045|B1||<=18 years|Age||Participants|Count of Participants|50|50.0||||||
3750724|NCT01981057|3585043|B3|||Age||days of gestation|Median|233|233.0|Full Range|||189.0|283.0|
3750725|NCT01981057|3585044|B2|||Age||days of gestation|Median|233|233.0|Full Range|||189.0|283.0|
3750726|NCT01981057|3585045|B1|||Age||days of gestation|Median|233|233.0|Full Range|||189.0|283.0|
3750727|NCT01980992|3585052|B3|||Maximum Initial Escalation Day Dose||mg powder|Median|12.0|12.0|Full Range|||3.0|12.0|
3750728|NCT01980992|3585053|B2|||Maximum Initial Escalation Day Dose||mg powder|Median|12.0|12.0|Full Range|||6.0|12.0|
3750729|NCT01980992|3585054|B1|||Maximum Initial Escalation Day Dose||mg powder|Median|12.0|12.0|Full Range|||3.0|12.0|
3750730|NCT01980992|3585052|B3|||Wheat OFC Successfully Consumed Dose||mg protein|Median|43.0|43.0|Inter-Quartile Range|||3.0|143.0|
3750731|NCT01980992|3585053|B2|||Wheat OFC Successfully Consumed Dose||mg protein|Median|43.0|43.0|Inter-Quartile Range|||13.0|143.0|
3750732|NCT01980992|3585054|B1|||Wheat OFC Successfully Consumed Dose||mg protein|Median|43.0|43.0|Inter-Quartile Range|||3.0|143.0|
3750733|NCT01980992|3585052|B3|||Wheat OFC Dose at First Symptom||mg protein|Median|13.0|13.0|Inter-Quartile Range|||3.0|143.0|
3750734|NCT01980992|3585053|B2|||Wheat OFC Dose at First Symptom||mg protein|Median|43.0|43.0|Inter-Quartile Range|||13.0|443.0|
3750735|NCT01980992|3585054|B1|||Wheat OFC Dose at First Symptom||mg protein|Median|13.0|13.0|Inter-Quartile Range|||3.0|43.0|
3750736|NCT01980992|3585052|B3|||Wheat Skin Prick Test|This score is calculated by subtracting the size of the saline wheal (in mm) from the size of the wheat wheal (in mm) observed for a skin prick test. Individuals with a wheat skin prick test score of < 3 mm are considered to have a negative result.|mm|Mean|6.1|6.1|Standard Deviation|3.2|3.2|||
3750737|NCT01980992|3585053|B2|||Wheat Skin Prick Test|This score is calculated by subtracting the size of the saline wheal (in mm) from the size of the wheat wheal (in mm) observed for a skin prick test. Individuals with a wheat skin prick test score of < 3 mm are considered to have a negative result.|mm|Mean|5.3|5.3|Standard Deviation|3.4|3.4|||
3750738|NCT01980992|3585054|B1|||Wheat Skin Prick Test|This score is calculated by subtracting the size of the saline wheal (in mm) from the size of the wheat wheal (in mm) observed for a skin prick test. Individuals with a wheat skin prick test score of < 3 mm are considered to have a negative result.|mm|Mean|6.8|6.8|Standard Deviation|2.8|2.8|||
3750739|NCT01980992|3585052|B3|||Wheat IgG4|Amount of immunoglobulin G4 (IgG4). The limits of detection for the wheat IgG4 assay were 0.1 to 30 mgA/L. Values below the limit of detection were set to 0.05 mgA/L and those above the limit of detection were set to 31 mgA/L for wheat IgG4.|mgA/L|Median|4.2|4.2|Inter-Quartile Range|||2.1|9.9|
3750740|NCT01980992|3585053|B2|||Wheat IgG4|Amount of immunoglobulin G4 (IgG4). The limits of detection for the wheat IgG4 assay were 0.1 to 30 mgA/L. Values below the limit of detection were set to 0.05 mgA/L and those above the limit of detection were set to 31 mgA/L for wheat IgG4.|mgA/L|Median|2.9|2.9|Inter-Quartile Range|||1.7|10.2|
3750741|NCT01980992|3585054|B1|||Wheat IgG4|Amount of immunoglobulin G4 (IgG4). The limits of detection for the wheat IgG4 assay were 0.1 to 30 mgA/L. Values below the limit of detection were set to 0.05 mgA/L and those above the limit of detection were set to 31 mgA/L for wheat IgG4.|mgA/L|Median|4.6|4.6|Inter-Quartile Range|||2.5|8.6|
3750742|NCT01980992|3585052|B3|||Wheat IgE|Amount of serum wheat-specific immunoglobulin E (IgE). Individuals with a wheat IgE of <0.35 kUA/L are considered not to be sensitized to wheat. The limits of detection for the wheat IgE assay were 0.1 to 100 kUA/L. Values below the limit of detection were set to 0.05 kUA/L and those above the limit of detection were set to 101 kUA/L.|kUA/L|Median|88.4|88.4|Inter-Quartile Range|||51.9|101.0|
3750743|NCT01980992|3585053|B2|||Wheat IgE|Amount of serum wheat-specific immunoglobulin E (IgE). Individuals with a wheat IgE of <0.35 kUA/L are considered not to be sensitized to wheat. The limits of detection for the wheat IgE assay were 0.1 to 100 kUA/L. Values below the limit of detection were set to 0.05 kUA/L and those above the limit of detection were set to 101 kUA/L.|kUA/L|Median|94.1|94.1|Inter-Quartile Range|||45.0|101.0|
3750744|NCT01980992|3585054|B1|||Wheat IgE|Amount of serum wheat-specific immunoglobulin E (IgE). Individuals with a wheat IgE of <0.35 kUA/L are considered not to be sensitized to wheat. The limits of detection for the wheat IgE assay were 0.1 to 100 kUA/L. Values below the limit of detection were set to 0.05 kUA/L and those above the limit of detection were set to 101 kUA/L.|kUA/L|Median|86.8|86.8|Inter-Quartile Range|||63.7|101.0|
3750745|NCT01980992|3585052|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750746|NCT01980992|3585053|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750747|NCT01980992|3585054|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750748|NCT01980992|3585052|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3750749|NCT01980992|3585053|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3750750|NCT01980992|3585054|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3750751|NCT01980992|3585052|B3||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3750752|NCT01980992|3585053|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3750753|NCT01980992|3585054|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3750754|NCT01980992|3585052|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3750755|NCT01980992|3585053|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3750756|NCT01980992|3585054|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750757|NCT01980992|3585052|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750758|NCT01980992|3585053|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750759|NCT01980992|3585054|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750760|NCT01980992|3585052|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3750761|NCT01980992|3585053|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3750762|NCT01980992|3585054|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3750763|NCT01980992|3585052|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750764|NCT01980992|3585053|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750765|NCT01980992|3585054|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750766|NCT01980992|3585052|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750767|NCT01980992|3585053|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750768|NCT01980992|3585054|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750769|NCT01980992|3585052|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3750770|NCT01980992|3585053|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3750771|NCT01980992|3585054|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3750772|NCT01980992|3585052|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750773|NCT01980992|3585053|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750774|NCT01980992|3585054|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3750775|NCT01980992|3585052|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3750776|NCT01980992|3585053|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3750777|NCT01980992|3585054|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3750778|NCT01980992|3585052|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3750779|NCT01980992|3585053|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3750780|NCT01980992|3585054|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3750781|NCT01980992|3585052|B3|||Age||years|Median|8.7|8.7|Full Range|||4.2|22.3|
3750782|NCT01980992|3585053|B2|||Age||years|Median|8.6|8.6|Full Range|||4.6|18.4|
3750783|NCT01980992|3585054|B1|||Age||years|Median|8.7|8.7|Full Range|||4.2|22.3|
3750784|NCT01980940|3585072|B9||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3750785|NCT01980940|3585073|B8||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3750786|NCT01980940|3585074|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3750787|NCT01980940|3585075|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3750788|NCT01980940|3585076|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3750789|NCT01980940|3585077|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3750790|NCT01980940|3585078|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3750791|NCT01980940|3585079|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3750792|NCT01980940|3585080|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3750793|NCT01980940|3585072|B9||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3750794|NCT01980940|3585073|B8||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3750795|NCT01980940|3585074|B7||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3750796|NCT01980940|3585075|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3750797|NCT01980940|3585076|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3750798|NCT01980940|3585077|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3750799|NCT01980940|3585078|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3750800|NCT01980940|3585079|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3750801|NCT01980940|3585080|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3750802|NCT01980940|3585072|B9|||Age||years|Mean|61.3|61.3|Standard Deviation|7.8|7.8|||
3750803|NCT01980940|3585073|B8|||Age||years|Mean|61.2|61.2|Standard Deviation|6.7|6.7|||
3750804|NCT01980940|3585074|B7|||Age||years|Mean|61.5|61.5|Standard Deviation|8.2|8.2|||
3750805|NCT01980940|3585075|B6|||Age||years|Mean|60.5|60.5|Standard Deviation|4.9|4.9|||
3750806|NCT01980940|3585076|B5|||Age||years|Mean|55.0|55.0|Standard Deviation|8.5|8.5|||
3750807|NCT01980940|3585077|B4|||Age||years|Mean|62.0|62.0|Standard Deviation|10.0|10.0|||
3750808|NCT01980940|3585078|B3|||Age||years|Mean|63.6|63.6|Standard Deviation|10.6|10.6|||
3750809|NCT01980940|3585079|B2|||Age||years|Mean|61.0|61.0|Standard Deviation|12.3|12.3|||
3750810|NCT01980940|3585080|B1|||Age||years|Mean|61.0|61.0|Standard Deviation|6.6|6.6|||
3750811|NCT01980888|3585139|B3|Missing||17p Deletion in CLL Cells|Participants with CLL who have a 17p deletion lack a portion of the chromosome that acts to suppress cancer growth and is a recognized negative prognostic risk factor.|Participants|Count of Participants|1|1.0||||||
3750812|NCT01980888|3585140|B2|Missing||17p Deletion in CLL Cells|Participants with CLL who have a 17p deletion lack a portion of the chromosome that acts to suppress cancer growth and is a recognized negative prognostic risk factor.|Participants|Count of Participants|0|0.0||||||
3750813|NCT01980888|3585141|B1|Missing||17p Deletion in CLL Cells|Participants with CLL who have a 17p deletion lack a portion of the chromosome that acts to suppress cancer growth and is a recognized negative prognostic risk factor.|Participants|Count of Participants|1|1.0||||||
3750814|NCT01980888|3585139|B3|Present||17p Deletion in CLL Cells|Participants with CLL who have a 17p deletion lack a portion of the chromosome that acts to suppress cancer growth and is a recognized negative prognostic risk factor.|Participants|Count of Participants|19|19.0||||||
3750815|NCT01980888|3585140|B2|Present||17p Deletion in CLL Cells|Participants with CLL who have a 17p deletion lack a portion of the chromosome that acts to suppress cancer growth and is a recognized negative prognostic risk factor.|Participants|Count of Participants|9|9.0||||||
3750816|NCT01980888|3585141|B1|Present||17p Deletion in CLL Cells|Participants with CLL who have a 17p deletion lack a portion of the chromosome that acts to suppress cancer growth and is a recognized negative prognostic risk factor.|Participants|Count of Participants|10|10.0||||||
3750817|NCT01980888|3585139|B3|Absent||17p Deletion in CLL Cells|Participants with CLL who have a 17p deletion lack a portion of the chromosome that acts to suppress cancer growth and is a recognized negative prognostic risk factor.|Participants|Count of Participants|291|291.0||||||
3750818|NCT01980888|3585140|B2|Absent||17p Deletion in CLL Cells|Participants with CLL who have a 17p deletion lack a portion of the chromosome that acts to suppress cancer growth and is a recognized negative prognostic risk factor.|Participants|Count of Participants|145|145.0||||||
3750819|NCT01980888|3585141|B1|Absent||17p Deletion in CLL Cells|Participants with CLL who have a 17p deletion lack a portion of the chromosome that acts to suppress cancer growth and is a recognized negative prognostic risk factor.|Participants|Count of Participants|146|146.0||||||
3750820|NCT01980888|3585139|B3|Missing||IgHV Mutation|The mutation status of the unique immunoglobulin gene (IgHV) rearrangement in the monoclonal proliferation of B-cells in CLL can be used to predict aggressiveness of the disease. Participants with a mutated IgHV gene usually have a less aggressive and more indolent disease, with longer overall survival. Participants with an unmutated IgHV gene usually have a more aggressive disease and shorter overall survival.|Participants|Count of Participants|1|1.0||||||
3750821|NCT01980888|3585140|B2|Missing||IgHV Mutation|The mutation status of the unique immunoglobulin gene (IgHV) rearrangement in the monoclonal proliferation of B-cells in CLL can be used to predict aggressiveness of the disease. Participants with a mutated IgHV gene usually have a less aggressive and more indolent disease, with longer overall survival. Participants with an unmutated IgHV gene usually have a more aggressive disease and shorter overall survival.|Participants|Count of Participants|0|0.0||||||
3750822|NCT01980888|3585141|B1|Missing||IgHV Mutation|The mutation status of the unique immunoglobulin gene (IgHV) rearrangement in the monoclonal proliferation of B-cells in CLL can be used to predict aggressiveness of the disease. Participants with a mutated IgHV gene usually have a less aggressive and more indolent disease, with longer overall survival. Participants with an unmutated IgHV gene usually have a more aggressive disease and shorter overall survival.|Participants|Count of Participants|1|1.0||||||
3750823|NCT01980888|3585139|B3|Unmutated||IgHV Mutation|The mutation status of the unique immunoglobulin gene (IgHV) rearrangement in the monoclonal proliferation of B-cells in CLL can be used to predict aggressiveness of the disease. Participants with a mutated IgHV gene usually have a less aggressive and more indolent disease, with longer overall survival. Participants with an unmutated IgHV gene usually have a more aggressive disease and shorter overall survival.|Participants|Count of Participants|202|202.0||||||
3750824|NCT01980888|3585140|B2|Unmutated||IgHV Mutation|The mutation status of the unique immunoglobulin gene (IgHV) rearrangement in the monoclonal proliferation of B-cells in CLL can be used to predict aggressiveness of the disease. Participants with a mutated IgHV gene usually have a less aggressive and more indolent disease, with longer overall survival. Participants with an unmutated IgHV gene usually have a more aggressive disease and shorter overall survival.|Participants|Count of Participants|100|100.0||||||
3750960|NCT01980875|3585161|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3750825|NCT01980888|3585141|B1|Unmutated||IgHV Mutation|The mutation status of the unique immunoglobulin gene (IgHV) rearrangement in the monoclonal proliferation of B-cells in CLL can be used to predict aggressiveness of the disease. Participants with a mutated IgHV gene usually have a less aggressive and more indolent disease, with longer overall survival. Participants with an unmutated IgHV gene usually have a more aggressive disease and shorter overall survival.|Participants|Count of Participants|102|102.0||||||
3750826|NCT01980888|3585139|B3|Mutated||IgHV Mutation|The mutation status of the unique immunoglobulin gene (IgHV) rearrangement in the monoclonal proliferation of B-cells in CLL can be used to predict aggressiveness of the disease. Participants with a mutated IgHV gene usually have a less aggressive and more indolent disease, with longer overall survival. Participants with an unmutated IgHV gene usually have a more aggressive disease and shorter overall survival.|Participants|Count of Participants|108|108.0||||||
3750827|NCT01980888|3585140|B2|Mutated||IgHV Mutation|The mutation status of the unique immunoglobulin gene (IgHV) rearrangement in the monoclonal proliferation of B-cells in CLL can be used to predict aggressiveness of the disease. Participants with a mutated IgHV gene usually have a less aggressive and more indolent disease, with longer overall survival. Participants with an unmutated IgHV gene usually have a more aggressive disease and shorter overall survival.|Participants|Count of Participants|54|54.0||||||
3750828|NCT01980888|3585141|B1|Mutated||IgHV Mutation|The mutation status of the unique immunoglobulin gene (IgHV) rearrangement in the monoclonal proliferation of B-cells in CLL can be used to predict aggressiveness of the disease. Participants with a mutated IgHV gene usually have a less aggressive and more indolent disease, with longer overall survival. Participants with an unmutated IgHV gene usually have a more aggressive disease and shorter overall survival.|Participants|Count of Participants|54|54.0||||||
3750829|NCT01980888|3585139|B3|Stage IV||Rai Stage at Screening|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL) with higher stages reflecting increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis with lymphadenopathy, Rai Stage II: Lymphocytosis with hepatomegaly or splenomegaly, Rai Stage III: Lymphocytosis with anemia, Rai Stage IV: Lymphocytosis with thrombocytopenia."|Participants|Count of Participants|72|72.0||||||
3750830|NCT01980888|3585140|B2|Stage IV||Rai Stage at Screening|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL) with higher stages reflecting increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis with lymphadenopathy, Rai Stage II: Lymphocytosis with hepatomegaly or splenomegaly, Rai Stage III: Lymphocytosis with anemia, Rai Stage IV: Lymphocytosis with thrombocytopenia."|Participants|Count of Participants|34|34.0||||||
3750831|NCT01980888|3585141|B1|Stage IV||Rai Stage at Screening|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL) with higher stages reflecting increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis with lymphadenopathy, Rai Stage II: Lymphocytosis with hepatomegaly or splenomegaly, Rai Stage III: Lymphocytosis with anemia, Rai Stage IV: Lymphocytosis with thrombocytopenia."|Participants|Count of Participants|38|38.0||||||
3750832|NCT01980888|3585139|B3|Stage III||Rai Stage at Screening|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL) with higher stages reflecting increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis with lymphadenopathy, Rai Stage II: Lymphocytosis with hepatomegaly or splenomegaly, Rai Stage III: Lymphocytosis with anemia, Rai Stage IV: Lymphocytosis with thrombocytopenia."|Participants|Count of Participants|57|57.0||||||
3750833|NCT01980888|3585140|B2|Stage III||Rai Stage at Screening|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL) with higher stages reflecting increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis with lymphadenopathy, Rai Stage II: Lymphocytosis with hepatomegaly or splenomegaly, Rai Stage III: Lymphocytosis with anemia, Rai Stage IV: Lymphocytosis with thrombocytopenia."|Participants|Count of Participants|32|32.0||||||
3750834|NCT01980888|3585141|B1|Stage III||Rai Stage at Screening|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL) with higher stages reflecting increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis with lymphadenopathy, Rai Stage II: Lymphocytosis with hepatomegaly or splenomegaly, Rai Stage III: Lymphocytosis with anemia, Rai Stage IV: Lymphocytosis with thrombocytopenia."|Participants|Count of Participants|25|25.0||||||
3750835|NCT01980888|3585139|B3|Stage II||Rai Stage at Screening|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL) with higher stages reflecting increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis with lymphadenopathy, Rai Stage II: Lymphocytosis with hepatomegaly or splenomegaly, Rai Stage III: Lymphocytosis with anemia, Rai Stage IV: Lymphocytosis with thrombocytopenia."|Participants|Count of Participants|124|124.0||||||
3750836|NCT01980888|3585140|B2|Stage II||Rai Stage at Screening|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL) with higher stages reflecting increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis with lymphadenopathy, Rai Stage II: Lymphocytosis with hepatomegaly or splenomegaly, Rai Stage III: Lymphocytosis with anemia, Rai Stage IV: Lymphocytosis with thrombocytopenia."|Participants|Count of Participants|58|58.0||||||
3750837|NCT01980888|3585141|B1|Stage II||Rai Stage at Screening|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL) with higher stages reflecting increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis with lymphadenopathy, Rai Stage II: Lymphocytosis with hepatomegaly or splenomegaly, Rai Stage III: Lymphocytosis with anemia, Rai Stage IV: Lymphocytosis with thrombocytopenia."|Participants|Count of Participants|66|66.0||||||
3750838|NCT01980888|3585139|B3|Stage I||Rai Stage at Screening|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL) with higher stages reflecting increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis with lymphadenopathy, Rai Stage II: Lymphocytosis with hepatomegaly or splenomegaly, Rai Stage III: Lymphocytosis with anemia, Rai Stage IV: Lymphocytosis with thrombocytopenia."|Participants|Count of Participants|58|58.0||||||
3750839|NCT01980888|3585140|B2|Stage I||Rai Stage at Screening|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL) with higher stages reflecting increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis with lymphadenopathy, Rai Stage II: Lymphocytosis with hepatomegaly or splenomegaly, Rai Stage III: Lymphocytosis with anemia, Rai Stage IV: Lymphocytosis with thrombocytopenia."|Participants|Count of Participants|30|30.0||||||
3750840|NCT01980888|3585141|B1|Stage I||Rai Stage at Screening|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL) with higher stages reflecting increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis with lymphadenopathy, Rai Stage II: Lymphocytosis with hepatomegaly or splenomegaly, Rai Stage III: Lymphocytosis with anemia, Rai Stage IV: Lymphocytosis with thrombocytopenia."|Participants|Count of Participants|28|28.0||||||
3750841|NCT01980888|3585139|B3|Croatia||Region of Enrollment||participants|Number|11|11.0||||||
3750842|NCT01980888|3585140|B2|Croatia||Region of Enrollment||participants|Number|6|6.0||||||
3750843|NCT01980888|3585141|B1|Croatia||Region of Enrollment||participants|Number|5|5.0||||||
3750844|NCT01980888|3585139|B3|France||Region of Enrollment||participants|Number|9|9.0||||||
3750845|NCT01980888|3585140|B2|France||Region of Enrollment||participants|Number|5|5.0||||||
3750846|NCT01980888|3585141|B1|France||Region of Enrollment||participants|Number|4|4.0||||||
3750847|NCT01980888|3585139|B3|Australia||Region of Enrollment||participants|Number|34|34.0||||||
3750848|NCT01980888|3585140|B2|Australia||Region of Enrollment||participants|Number|19|19.0||||||
3750849|NCT01980888|3585141|B1|Australia||Region of Enrollment||participants|Number|15|15.0||||||
3750850|NCT01980888|3585139|B3|Italy||Region of Enrollment||participants|Number|8|8.0||||||
3750851|NCT01980888|3585140|B2|Italy||Region of Enrollment||participants|Number|3|3.0||||||
3750852|NCT01980888|3585141|B1|Italy||Region of Enrollment||participants|Number|5|5.0||||||
3750853|NCT01980888|3585139|B3|Poland||Region of Enrollment||participants|Number|33|33.0||||||
3750854|NCT01980888|3585140|B2|Poland||Region of Enrollment||participants|Number|18|18.0||||||
3750855|NCT01980888|3585141|B1|Poland||Region of Enrollment||participants|Number|15|15.0||||||
3750856|NCT01980888|3585139|B3|Belgium||Region of Enrollment||participants|Number|6|6.0||||||
3750857|NCT01980888|3585140|B2|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
3750858|NCT01980888|3585141|B1|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
3750859|NCT01980888|3585139|B3|Czech Republic||Region of Enrollment||participants|Number|27|27.0||||||
3750860|NCT01980888|3585140|B2|Czech Republic||Region of Enrollment||participants|Number|17|17.0||||||
3750861|NCT01980888|3585141|B1|Czech Republic||Region of Enrollment||participants|Number|10|10.0||||||
3750862|NCT01980888|3585139|B3|Canada||Region of Enrollment||participants|Number|19|19.0||||||
3750863|NCT01980888|3585140|B2|Canada||Region of Enrollment||participants|Number|8|8.0||||||
3750864|NCT01980888|3585141|B1|Canada||Region of Enrollment||participants|Number|11|11.0||||||
3750865|NCT01980888|3585139|B3|Spain||Region of Enrollment||participants|Number|34|34.0||||||
3750866|NCT01980888|3585140|B2|Spain||Region of Enrollment||participants|Number|15|15.0||||||
3750867|NCT01980888|3585141|B1|Spain||Region of Enrollment||participants|Number|19|19.0||||||
3750868|NCT01980888|3585139|B3|United Kingdom||Region of Enrollment||participants|Number|20|20.0||||||
3750869|NCT01980888|3585140|B2|United Kingdom||Region of Enrollment||participants|Number|13|13.0||||||
3750870|NCT01980888|3585141|B1|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
3750871|NCT01980888|3585139|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
3750872|NCT01980888|3585140|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3750873|NCT01980888|3585141|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3750874|NCT01980888|3585139|B3|Hungary||Region of Enrollment||participants|Number|45|45.0||||||
3750875|NCT01980888|3585140|B2|Hungary||Region of Enrollment||participants|Number|21|21.0||||||
3750876|NCT01980888|3585141|B1|Hungary||Region of Enrollment||participants|Number|24|24.0||||||
3750877|NCT01980888|3585139|B3|Romania||Region of Enrollment||participants|Number|5|5.0||||||
3750878|NCT01980888|3585140|B2|Romania||Region of Enrollment||participants|Number|1|1.0||||||
3750879|NCT01980888|3585141|B1|Romania||Region of Enrollment||participants|Number|4|4.0||||||
3750880|NCT01980888|3585139|B3|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3750881|NCT01980888|3585140|B2|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3750882|NCT01980888|3585141|B1|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3750883|NCT01980888|3585139|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|295|295.0||||||
3750884|NCT01980888|3585140|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|149|149.0||||||
3750885|NCT01980888|3585141|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|146|146.0||||||
3750886|NCT01980888|3585139|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3750887|NCT01980888|3585140|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3750888|NCT01980888|3585141|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3750889|NCT01980888|3585139|B3|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3750890|NCT01980888|3585140|B2|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3750891|NCT01980888|3585141|B1|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3750892|NCT01980888|3585139|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3750893|NCT01980888|3585140|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3750894|NCT01980888|3585141|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3750895|NCT01980888|3585139|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|302|302.0||||||
3750896|NCT01980888|3585140|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|150|150.0||||||
3750897|NCT01980888|3585141|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|152|152.0||||||
3750898|NCT01980888|3585139|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3750899|NCT01980888|3585140|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3750900|NCT01980888|3585141|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3750901|NCT01980888|3585139|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3750902|NCT01980888|3585140|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3750903|NCT01980888|3585141|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3750904|NCT01980888|3585139|B3||Male|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
3750905|NCT01980888|3585140|B2||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3750906|NCT01980888|3585141|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3750907|NCT01980888|3585139|B3||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3750908|NCT01980888|3585140|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3750909|NCT01980888|3585141|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3750910|NCT01980888|3585139|B3|||Age||years|Mean|64|64.0|Standard Deviation|9.4|9.4|||
3750911|NCT01980888|3585140|B2|||Age||years|Mean|63|63.0|Standard Deviation|10.0|10.0|||
3750912|NCT01980888|3585141|B1|||Age||years|Mean|64|64.0|Standard Deviation|8.7|8.7|||
3750913|NCT01980875|3585158|B4|Absent||17p Deletion in CLL Cells|Participants with CLL who have deletion of 17p, a portion of the chromosome that acts to suppress cancer growth and is a recognized negative prognostic risk factor.|Participants|Count of Participants|51|51.0||||||
3750914|NCT01980875|3585159|B3|Absent||17p Deletion in CLL Cells|Participants with CLL who have deletion of 17p, a portion of the chromosome that acts to suppress cancer growth and is a recognized negative prognostic risk factor.|Participants|Count of Participants|21|21.0||||||
3750915|NCT01980875|3585160|B2|Absent||17p Deletion in CLL Cells|Participants with CLL who have deletion of 17p, a portion of the chromosome that acts to suppress cancer growth and is a recognized negative prognostic risk factor.|Participants|Count of Participants|22|22.0||||||
3750916|NCT01980875|3585161|B1|Absent||17p Deletion in CLL Cells|Participants with CLL who have deletion of 17p, a portion of the chromosome that acts to suppress cancer growth and is a recognized negative prognostic risk factor.|Participants|Count of Participants|8|8.0||||||
3750917|NCT01980875|3585158|B4|Present||17p Deletion in CLL Cells|Participants with CLL who have deletion of 17p, a portion of the chromosome that acts to suppress cancer growth and is a recognized negative prognostic risk factor.|Participants|Count of Participants|6|6.0||||||
3750918|NCT01980875|3585159|B3|Present||17p Deletion in CLL Cells|Participants with CLL who have deletion of 17p, a portion of the chromosome that acts to suppress cancer growth and is a recognized negative prognostic risk factor.|Participants|Count of Participants|3|3.0||||||
3750919|NCT01980875|3585160|B2|Present||17p Deletion in CLL Cells|Participants with CLL who have deletion of 17p, a portion of the chromosome that acts to suppress cancer growth and is a recognized negative prognostic risk factor.|Participants|Count of Participants|3|3.0||||||
3750920|NCT01980875|3585161|B1|Present||17p Deletion in CLL Cells|Participants with CLL who have deletion of 17p, a portion of the chromosome that acts to suppress cancer growth and is a recognized negative prognostic risk factor.|Participants|Count of Participants|0|0.0||||||
3750921|NCT01980875|3585158|B4|Mutated||IgHV Mutation|The mutation status of the unique immunoglobulin gene (IgHV) rearrangement in the monoclonal proliferation of B-cells in CLL can be used to predict aggressiveness of the disease. Participants with a mutated IgHV gene usually have a less aggressive and more indolent disease, with longer overall survival. Participants with an unmutated IgHV gene usually have a more aggressive disease and shorter overall survival.|Participants|Count of Participants|19|19.0||||||
3750922|NCT01980875|3585159|B3|Mutated||IgHV Mutation|The mutation status of the unique immunoglobulin gene (IgHV) rearrangement in the monoclonal proliferation of B-cells in CLL can be used to predict aggressiveness of the disease. Participants with a mutated IgHV gene usually have a less aggressive and more indolent disease, with longer overall survival. Participants with an unmutated IgHV gene usually have a more aggressive disease and shorter overall survival.|Participants|Count of Participants|7|7.0||||||
3750923|NCT01980875|3585160|B2|Mutated||IgHV Mutation|The mutation status of the unique immunoglobulin gene (IgHV) rearrangement in the monoclonal proliferation of B-cells in CLL can be used to predict aggressiveness of the disease. Participants with a mutated IgHV gene usually have a less aggressive and more indolent disease, with longer overall survival. Participants with an unmutated IgHV gene usually have a more aggressive disease and shorter overall survival.|Participants|Count of Participants|9|9.0||||||
3750924|NCT01980875|3585161|B1|Mutated||IgHV Mutation|The mutation status of the unique immunoglobulin gene (IgHV) rearrangement in the monoclonal proliferation of B-cells in CLL can be used to predict aggressiveness of the disease. Participants with a mutated IgHV gene usually have a less aggressive and more indolent disease, with longer overall survival. Participants with an unmutated IgHV gene usually have a more aggressive disease and shorter overall survival.|Participants|Count of Participants|3|3.0||||||
3750925|NCT01980875|3585158|B4|Unmutated||IgHV Mutation|The mutation status of the unique immunoglobulin gene (IgHV) rearrangement in the monoclonal proliferation of B-cells in CLL can be used to predict aggressiveness of the disease. Participants with a mutated IgHV gene usually have a less aggressive and more indolent disease, with longer overall survival. Participants with an unmutated IgHV gene usually have a more aggressive disease and shorter overall survival.|Participants|Count of Participants|38|38.0||||||
3750926|NCT01980875|3585159|B3|Unmutated||IgHV Mutation|The mutation status of the unique immunoglobulin gene (IgHV) rearrangement in the monoclonal proliferation of B-cells in CLL can be used to predict aggressiveness of the disease. Participants with a mutated IgHV gene usually have a less aggressive and more indolent disease, with longer overall survival. Participants with an unmutated IgHV gene usually have a more aggressive disease and shorter overall survival.|Participants|Count of Participants|17|17.0||||||
3750961|NCT01980875|3585158|B4|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
3750962|NCT01980875|3585159|B3|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
3750927|NCT01980875|3585160|B2|Unmutated||IgHV Mutation|The mutation status of the unique immunoglobulin gene (IgHV) rearrangement in the monoclonal proliferation of B-cells in CLL can be used to predict aggressiveness of the disease. Participants with a mutated IgHV gene usually have a less aggressive and more indolent disease, with longer overall survival. Participants with an unmutated IgHV gene usually have a more aggressive disease and shorter overall survival.|Participants|Count of Participants|16|16.0||||||
3750928|NCT01980875|3585161|B1|Unmutated||IgHV Mutation|The mutation status of the unique immunoglobulin gene (IgHV) rearrangement in the monoclonal proliferation of B-cells in CLL can be used to predict aggressiveness of the disease. Participants with a mutated IgHV gene usually have a less aggressive and more indolent disease, with longer overall survival. Participants with an unmutated IgHV gene usually have a more aggressive disease and shorter overall survival.|Participants|Count of Participants|5|5.0||||||
3750929|NCT01980875|3585158|B4|Stage III-IV||Rai Stage|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL) with higher stages reflecting increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis with lymphadenopathy, Rai Stage II: Lymphocytosis with hepatomegaly or splenomegaly, Rai Stage III: Lymphocytosis with anemia, Rai Stage IV: Lymphocytosis with thrombocytopenia."|Participants|Count of Participants|34|34.0||||||
3750930|NCT01980875|3585159|B3|Stage III-IV||Rai Stage|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL) with higher stages reflecting increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis with lymphadenopathy, Rai Stage II: Lymphocytosis with hepatomegaly or splenomegaly, Rai Stage III: Lymphocytosis with anemia, Rai Stage IV: Lymphocytosis with thrombocytopenia."|Participants|Count of Participants|15|15.0||||||
3750931|NCT01980875|3585160|B2|Stage III-IV||Rai Stage|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL) with higher stages reflecting increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis with lymphadenopathy, Rai Stage II: Lymphocytosis with hepatomegaly or splenomegaly, Rai Stage III: Lymphocytosis with anemia, Rai Stage IV: Lymphocytosis with thrombocytopenia."|Participants|Count of Participants|14|14.0||||||
3750932|NCT01980875|3585161|B1|Stage III-IV||Rai Stage|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL) with higher stages reflecting increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis with lymphadenopathy, Rai Stage II: Lymphocytosis with hepatomegaly or splenomegaly, Rai Stage III: Lymphocytosis with anemia, Rai Stage IV: Lymphocytosis with thrombocytopenia."|Participants|Count of Participants|5|5.0||||||
3750933|NCT01980875|3585158|B4|Stage I-II||Rai Stage|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL) with higher stages reflecting increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis with lymphadenopathy, Rai Stage II: Lymphocytosis with hepatomegaly or splenomegaly, Rai Stage III: Lymphocytosis with anemia, Rai Stage IV: Lymphocytosis with thrombocytopenia."|Participants|Count of Participants|23|23.0||||||
3750934|NCT01980875|3585159|B3|Stage I-II||Rai Stage|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL) with higher stages reflecting increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis with lymphadenopathy, Rai Stage II: Lymphocytosis with hepatomegaly or splenomegaly, Rai Stage III: Lymphocytosis with anemia, Rai Stage IV: Lymphocytosis with thrombocytopenia."|Participants|Count of Participants|9|9.0||||||
3750935|NCT01980875|3585160|B2|Stage I-II||Rai Stage|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL) with higher stages reflecting increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis with lymphadenopathy, Rai Stage II: Lymphocytosis with hepatomegaly or splenomegaly, Rai Stage III: Lymphocytosis with anemia, Rai Stage IV: Lymphocytosis with thrombocytopenia."|Participants|Count of Participants|11|11.0||||||
3750936|NCT01980875|3585161|B1|Stage I-II||Rai Stage|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL) with higher stages reflecting increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis with lymphadenopathy, Rai Stage II: Lymphocytosis with hepatomegaly or splenomegaly, Rai Stage III: Lymphocytosis with anemia, Rai Stage IV: Lymphocytosis with thrombocytopenia."|Participants|Count of Participants|3|3.0||||||
3750937|NCT01980875|3585158|B4|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3750938|NCT01980875|3585159|B3|Spain||Region of Enrollment||participants|Number|0|0.0||||||
3750939|NCT01980875|3585160|B2|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3750940|NCT01980875|3585161|B1|Spain||Region of Enrollment||participants|Number|0|0.0||||||
3750941|NCT01980875|3585158|B4|Australia||Region of Enrollment||participants|Number|4|4.0||||||
3750942|NCT01980875|3585159|B3|Australia||Region of Enrollment||participants|Number|3|3.0||||||
3750943|NCT01980875|3585160|B2|Australia||Region of Enrollment||participants|Number|1|1.0||||||
3750944|NCT01980875|3585161|B1|Australia||Region of Enrollment||participants|Number|0|0.0||||||
3750945|NCT01980875|3585158|B4|France||Region of Enrollment||participants|Number|5|5.0||||||
3750946|NCT01980875|3585159|B3|France||Region of Enrollment||participants|Number|2|2.0||||||
3750947|NCT01980875|3585160|B2|France||Region of Enrollment||participants|Number|3|3.0||||||
3750948|NCT01980875|3585161|B1|France||Region of Enrollment||participants|Number|0|0.0||||||
3750949|NCT01980875|3585158|B4|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3750950|NCT01980875|3585159|B3|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
3750951|NCT01980875|3585160|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3750952|NCT01980875|3585161|B1|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3750953|NCT01980875|3585158|B4|Poland||Region of Enrollment||participants|Number|28|28.0||||||
3750954|NCT01980875|3585159|B3|Poland||Region of Enrollment||participants|Number|12|12.0||||||
3750955|NCT01980875|3585160|B2|Poland||Region of Enrollment||participants|Number|14|14.0||||||
3750956|NCT01980875|3585161|B1|Poland||Region of Enrollment||participants|Number|2|2.0||||||
3750957|NCT01980875|3585158|B4|United States||Region of Enrollment||participants|Number|12|12.0||||||
3750958|NCT01980875|3585159|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3750959|NCT01980875|3585160|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3750963|NCT01980875|3585160|B2|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
3750964|NCT01980875|3585161|B1|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
3750965|NCT01980875|3585158|B4|Canada||Region of Enrollment||participants|Number|2|2.0||||||
3750966|NCT01980875|3585159|B3|Canada||Region of Enrollment||participants|Number|0|0.0||||||
3750967|NCT01980875|3585160|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3750968|NCT01980875|3585161|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3750969|NCT01980875|3585158|B4|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3750970|NCT01980875|3585159|B3|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3750971|NCT01980875|3585160|B2|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3750972|NCT01980875|3585161|B1|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3750973|NCT01980875|3585158|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3750974|NCT01980875|3585159|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3750975|NCT01980875|3585160|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3750976|NCT01980875|3585161|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3750977|NCT01980875|3585158|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
3750978|NCT01980875|3585159|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3750979|NCT01980875|3585160|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3750980|NCT01980875|3585161|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3750981|NCT01980875|3585158|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3750982|NCT01980875|3585159|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3750983|NCT01980875|3585160|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3750984|NCT01980875|3585161|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3750985|NCT01980875|3585158|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3750986|NCT01980875|3585159|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3750987|NCT01980875|3585160|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3750988|NCT01980875|3585161|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3750989|NCT01980875|3585158|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3750990|NCT01980875|3585159|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3750991|NCT01980875|3585160|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3750992|NCT01980875|3585161|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3750993|NCT01980875|3585158|B4|||Age||years|Mean|71.1|71.1|Standard Deviation|7.70|7.7|||
3750994|NCT01980875|3585159|B3|||Age||years|Mean|71.1|71.1|Standard Deviation|6.84|6.84|||
3750995|NCT01980875|3585160|B2|||Age||years|Mean|72.2|72.2|Standard Deviation|8.23|8.23|||
3750996|NCT01980875|3585161|B1|||Age||years|Mean|67.1|67.1|Standard Deviation|8.10|8.1|||
3750997|NCT01980771|3585186|B3|||No condomless sex||Participants|Count of Participants|442|442.0||||||
3750998|NCT01980771|3585187|B2|||No condomless sex||Participants|Count of Participants|205|205.0||||||
3750999|NCT01980771|3585188|B1|||No condomless sex||Participants|Count of Participants|237|237.0||||||
3751000|NCT01980771|3585186|B3|||No incarceration history||Participants|Count of Participants|445|445.0||||||
3751001|NCT01980771|3585187|B2|||No incarceration history||Participants|Count of Participants|248|248.0||||||
3751002|NCT01980771|3585188|B1|||No incarceration history||Participants|Count of Participants|197|197.0||||||
3751003|NCT01980771|3585186|B3|||No alcohol use||Participants|Count of Participants|207|207.0||||||
3751004|NCT01980771|3585187|B2|||No alcohol use||Participants|Count of Participants|95|95.0||||||
3751005|NCT01980771|3585188|B1|||No alcohol use||Participants|Count of Participants|112|112.0||||||
3751006|NCT01980771|3585186|B3|||No substance use (excludes marijuana)||Participants|Count of Participants|743|743.0||||||
3751007|NCT01980771|3585187|B2|||No substance use (excludes marijuana)||Participants|Count of Participants|351|351.0||||||
3751008|NCT01980771|3585188|B1|||No substance use (excludes marijuana)||Participants|Count of Participants|392|392.0||||||
3751009|NCT01980771|3585186|B3|||In stable housing||Participants|Count of Participants|653|653.0||||||
3751010|NCT01980771|3585187|B2|||In stable housing||Participants|Count of Participants|290|290.0||||||
3751011|NCT01980771|3585188|B1|||In stable housing||Participants|Count of Participants|363|363.0||||||
3751012|NCT01980771|3585186|B3|||Born in U.S.||Participants|Count of Participants|557|557.0||||||
3751013|NCT01980771|3585187|B2|||Born in U.S.||Participants|Count of Participants|324|324.0||||||
3751014|NCT01980771|3585188|B1|||Born in U.S.||Participants|Count of Participants|233|233.0||||||
3751015|NCT01980771|3585186|B3|||High school degree or equivalent||Participants|Count of Participants|656|656.0||||||
3751016|NCT01980771|3585187|B2|||High school degree or equivalent||Participants|Count of Participants|321|321.0||||||
3751017|NCT01980771|3585188|B1|||High school degree or equivalent||Participants|Count of Participants|335|335.0||||||
3751018|NCT01980771|3585186|B3|||Currently employed||Participants|Count of Participants|430|430.0||||||
3751019|NCT01980771|3585187|B2|||Currently employed||Participants|Count of Participants|229|229.0||||||
3751020|NCT01980771|3585188|B1|||Currently employed||Participants|Count of Participants|201|201.0||||||
3751021|NCT01980771|3585186|B3|||Current health insurance||Participants|Count of Participants|569|569.0||||||
3751022|NCT01980771|3585187|B2|||Current health insurance||Participants|Count of Participants|300|300.0||||||
3751023|NCT01980771|3585188|B1|||Current health insurance||Participants|Count of Participants|269|269.0||||||
3751024|NCT01980771|3585186|B3|||Living with a sexual partner||Participants|Count of Participants|165|165.0||||||
3751025|NCT01980771|3585187|B2|||Living with a sexual partner||Participants|Count of Participants|85|85.0||||||
3751026|NCT01980771|3585188|B1|||Living with a sexual partner||Participants|Count of Participants|80|80.0||||||
3751027|NCT01980771|3585186|B3|United States||Region of Enrollment||Participants|Count of Participants|860|860.0||||||
3751028|NCT01980771|3585187|B2|United States||Region of Enrollment||Participants|Count of Participants|424|424.0||||||
3751029|NCT01980771|3585188|B1|United States||Region of Enrollment||Participants|Count of Participants|436|436.0||||||
3751030|NCT01980771|3585186|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751031|NCT01980771|3585187|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751032|NCT01980771|3585188|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751033|NCT01980771|3585186|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751034|NCT01980771|3585187|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751035|NCT01980771|3585188|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751036|NCT01980771|3585186|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751037|NCT01980771|3585187|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751038|NCT01980771|3585188|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751039|NCT01980771|3585186|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|860|860.0||||||
3751040|NCT01980771|3585187|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|424|424.0||||||
3751041|NCT01980771|3585188|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|436|436.0||||||
3751042|NCT01980771|3585186|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751043|NCT01980771|3585187|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751044|NCT01980771|3585188|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751045|NCT01980771|3585186|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751046|NCT01980771|3585187|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751047|NCT01980771|3585188|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751048|NCT01980771|3585186|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751049|NCT01980771|3585187|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751050|NCT01980771|3585188|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751051|NCT01980771|3585186|B3||Male|Sex: Female, Male||Participants|Count of Participants|860|860.0||||||
3751052|NCT01980771|3585187|B2||Male|Sex: Female, Male||Participants|Count of Participants|424|424.0||||||
3751053|NCT01980771|3585188|B1||Male|Sex: Female, Male||Participants|Count of Participants|436|436.0||||||
3751054|NCT01980771|3585186|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3751055|NCT01980771|3585187|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3751056|NCT01980771|3585188|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3751057|NCT01980771|3585186|B3|||Age||years|Mean|33.0|33.0|Standard Deviation|11.30|11.3|||
3751058|NCT01980771|3585187|B2|||Age||years|Mean|34.7|34.7|Standard Deviation|11.6|11.6|||
3751059|NCT01980771|3585188|B1|||Age||years|Mean|31.4|31.4|Standard Deviation|10.8|10.8|||
3751060|NCT01980628|3585195|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3751061|NCT01980628|3585195|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3751062|NCT01980628|3585195|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3751063|NCT01980628|3585195|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|53|53.0||||||
3751064|NCT01980628|3585195|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3751065|NCT01980628|3585195|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3751066|NCT01980628|3585195|B1||>=65 years|Age|Participants were required to be of age 18 years or older|Participants|Count of Participants|36|36.0||||||
3751067|NCT01980628|3585195|B1||Between 18 and 65 years|Age|Participants were required to be of age 18 years or older|Participants|Count of Participants|27|27.0||||||
3751068|NCT01980628|3585195|B1||<=18 years|Age|Participants were required to be of age 18 years or older|Participants|Count of Participants|0|0.0||||||
3751069|NCT01980589|3585200|B4|2 (Ambulatory but unable to work)||European Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|1|1.0||||||
3751070|NCT01980589|3585201|B3|2 (Ambulatory but unable to work)||European Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|1|1.0||||||
3751093|NCT01980589|3585200|B4|Asian||Race||participants|Number|2|2.0||||||
3751094|NCT01980589|3585201|B3|Asian||Race||participants|Number|1|1.0||||||
3751071|NCT01980589|3585202|B2|2 (Ambulatory but unable to work)||European Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
3751072|NCT01980589|3585203|B1|2 (Ambulatory but unable to work)||European Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
3751073|NCT01980589|3585200|B4|1 (Restrictive but ambulatory)||European Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|12|12.0||||||
3751074|NCT01980589|3585201|B3|1 (Restrictive but ambulatory)||European Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|8|8.0||||||
3751075|NCT01980589|3585202|B2|1 (Restrictive but ambulatory)||European Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|2|2.0||||||
3751076|NCT01980589|3585203|B1|1 (Restrictive but ambulatory)||European Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|2|2.0||||||
3751077|NCT01980589|3585200|B4|0 (Fully active)||European Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|9|9.0||||||
3751078|NCT01980589|3585201|B3|0 (Fully active)||European Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|7|7.0||||||
3751079|NCT01980589|3585202|B2|0 (Fully active)||European Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|1|1.0||||||
3751080|NCT01980589|3585203|B1|0 (Fully active)||European Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|1|1.0||||||
3751081|NCT01980589|3585200|B4|Other||Race||participants|Number|1|1.0||||||
3751082|NCT01980589|3585201|B3|Other||Race||participants|Number|1|1.0||||||
3751083|NCT01980589|3585202|B2|Other||Race||participants|Number|0|0.0||||||
3751084|NCT01980589|3585203|B1|Other||Race||participants|Number|0|0.0||||||
3751085|NCT01980589|3585200|B4|White||Race||participants|Number|14|14.0||||||
3751086|NCT01980589|3585201|B3|White||Race||participants|Number|11|11.0||||||
3751087|NCT01980589|3585202|B2|White||Race||participants|Number|2|2.0||||||
3751088|NCT01980589|3585203|B1|White||Race||participants|Number|1|1.0||||||
3751089|NCT01980589|3585200|B4|Black or African American||Race||participants|Number|5|5.0||||||
3751090|NCT01980589|3585201|B3|Black or African American||Race||participants|Number|3|3.0||||||
3751091|NCT01980589|3585202|B2|Black or African American||Race||participants|Number|1|1.0||||||
3751092|NCT01980589|3585203|B1|Black or African American||Race||participants|Number|1|1.0||||||
3751096|NCT01980589|3585203|B1|Asian||Race||participants|Number|1|1.0||||||
3751097|NCT01980589|3585200|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3751098|NCT01980589|3585201|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3751099|NCT01980589|3585202|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3751100|NCT01980589|3585203|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3751101|NCT01980589|3585200|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3751102|NCT01980589|3585201|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3751103|NCT01980589|3585202|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3751104|NCT01980589|3585203|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3751105|NCT01980589|3585200|B4|||Age||years|Median|62.5|62.5|Full Range|||49.0|81.0|
3751106|NCT01980589|3585201|B3|||Age||years|Median|65.0|65.0|Full Range|||49.0|81.0|
3751107|NCT01980589|3585202|B2|||Age||years|Median|63.0|63.0|Full Range|||61.0|66.0|
3751108|NCT01980589|3585203|B1|||Age||years|Median|56.0|56.0|Full Range|||53.0|71.0|
3751109|NCT01980524|3585222|B1|Austria||Region of Enrollment||participants|Number|8|8.0||||||
3751110|NCT01980524|3585222|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3751111|NCT01980524|3585222|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3751112|NCT01980524|3585222|B1|||Age||years|Mean|56|56.0|Standard Deviation|11|11.0|||
3751113|NCT01980524|3585222|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3751114|NCT01980524|3585222|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3751115|NCT01980524|3585222|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3751116|NCT01980342|3585233|B1|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3751117|NCT01980342|3585233|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751118|NCT01980342|3585233|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751119|NCT01980342|3585233|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751120|NCT01980342|3585233|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3751121|NCT01980342|3585233|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751122|NCT01980342|3585233|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751123|NCT01980342|3585233|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751124|NCT01980342|3585233|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3751125|NCT01980342|3585233|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3751126|NCT01980342|3585233|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3751127|NCT01980342|3585233|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3751128|NCT01980342|3585233|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3751129|NCT01980095|3585241|B3||Male|Gender||Participants|Count of Participants|74|74.0||||||
3751130|NCT01980095|3585242|B2||Male|Gender||Participants|Count of Participants|25|25.0||||||
3751131|NCT01980095|3585243|B1||Male|Gender||Participants|Count of Participants|49|49.0||||||
3751132|NCT01980095|3585241|B3||Female|Gender||Participants|Count of Participants|44|44.0||||||
3751133|NCT01980095|3585242|B2||Female|Gender||Participants|Count of Participants|16|16.0||||||
3751134|NCT01980095|3585243|B1||Female|Gender||Participants|Count of Participants|28|28.0||||||
3751135|NCT01980095|3585241|B3|||Age||years|Mean|46|46.0|Standard Deviation|10.18|10.18|||
3751136|NCT01980095|3585242|B2|||Age||years|Mean|45.8|45.8|Standard Deviation|9.52|9.52|||
3751137|NCT01980095|3585243|B1|||Age||years|Mean|46.2|46.2|Standard Deviation|10.56|10.56|||
3751138|NCT01980056|3585252|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
3751139|NCT01980056|3585253|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3751140|NCT01980056|3585254|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3751141|NCT01980056|3585255|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3751142|NCT01980056|3585252|B4|Unknown or not reported||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3751143|NCT01980056|3585253|B3|Unknown or not reported||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3751144|NCT01980056|3585254|B2|Unknown or not reported||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3751145|NCT01980056|3585255|B1|Unknown or not reported||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3751146|NCT01980056|3585252|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3751147|NCT01980056|3585253|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3751148|NCT01980056|3585254|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3751149|NCT01980056|3585255|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3751150|NCT01980056|3585252|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3751151|NCT01980056|3585253|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3751152|NCT01980056|3585254|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3751153|NCT01980056|3585255|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3751154|NCT01980056|3585252|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3751155|NCT01980056|3585253|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3751156|NCT01980056|3585254|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3751157|NCT01980056|3585255|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3751158|NCT01980056|3585252|B4||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3751159|NCT01980056|3585253|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3751160|NCT01980056|3585254|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3751161|NCT01980056|3585255|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3751162|NCT01980056|3585252|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3751163|NCT01980056|3585253|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3751164|NCT01980056|3585254|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3751165|NCT01980056|3585255|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3751166|NCT01980056|3585252|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3751167|NCT01980056|3585253|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3751168|NCT01980056|3585254|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3751169|NCT01980056|3585255|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3751170|NCT01979952|3585269|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3751171|NCT01979952|3585270|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3751172|NCT01979952|3585271|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3751173|NCT01979952|3585269|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3751174|NCT01979952|3585270|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3751175|NCT01979952|3585271|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3751176|NCT01979952|3585269|B3|||Age||Years|Mean|67.5|67.5|Standard Deviation|8.6|8.6|||
3751177|NCT01979952|3585270|B2|||Age||Years|Mean|66.2|66.2|Standard Deviation|9.4|9.4|||
3751178|NCT01979952|3585271|B1|||Age||Years|Mean|68.8|68.8|Standard Deviation|7.6|7.6|||
3751179|NCT01979445|3585300|B3|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3751180|NCT01979445|3585301|B2|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3751181|NCT01979445|3585302|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3751182|NCT01979445|3585300|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751183|NCT01979445|3585301|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751184|NCT01979445|3585302|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751185|NCT01979445|3585300|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751186|NCT01979445|3585301|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751187|NCT01979445|3585302|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751188|NCT01979445|3585300|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3751189|NCT01979445|3585301|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3751190|NCT01979445|3585302|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3751191|NCT01979445|3585300|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751192|NCT01979445|3585301|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751193|NCT01979445|3585302|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751194|NCT01979445|3585300|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751195|NCT01979445|3585301|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751196|NCT01979445|3585302|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751197|NCT01979445|3585300|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751198|NCT01979445|3585301|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751199|NCT01979445|3585302|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751200|NCT01979445|3585300|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751201|NCT01979445|3585301|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751202|NCT01979445|3585302|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751203|NCT01979445|3585300|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751204|NCT01979445|3585301|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751205|NCT01979445|3585302|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751206|NCT01979445|3585300|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3751207|NCT01979445|3585301|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3751208|NCT01979445|3585302|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3751209|NCT01979445|3585300|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751210|NCT01979445|3585301|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751211|NCT01979445|3585302|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751212|NCT01979445|3585300|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3751213|NCT01979445|3585301|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3751214|NCT01979445|3585302|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3751215|NCT01979445|3585300|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3751216|NCT01979445|3585301|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3751217|NCT01979445|3585302|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3751218|NCT01979445|3585300|B3|||Age||years|Mean|64.7|64.7|Standard Deviation|6.15|6.15|||
3751219|NCT01979445|3585301|B2|||Age||years|Mean|65.3|65.3|Standard Deviation|6.18|6.18|||
3751220|NCT01979445|3585302|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|6.66|6.66|||
3751221|NCT01979276|3585331|B1|||Lactate Dehydrogenase||U/L|Mean|209.5|209.5|Full Range|||181.0|238.0|
3751222|NCT01979276|3585331|B1|||Beta 2 Microglobulin||mg/L|Mean|2.15|2.15|Full Range|||2.0|2.3|
3751223|NCT01979276|3585331|B1|||Number of Prior lines of therapy||Line of Prior Therapy|Mean|2.5|2.5|Full Range|||2.0|3.0|
3751224|NCT01979276|3585331|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751225|NCT01979276|3585331|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751226|NCT01979276|3585331|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3751227|NCT01979276|3585331|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751228|NCT01979276|3585331|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751229|NCT01979276|3585331|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751230|NCT01979276|3585331|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751231|NCT01979276|3585331|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751232|NCT01979276|3585331|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3751233|NCT01979276|3585331|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751234|NCT01979276|3585331|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3751235|NCT01979276|3585331|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3751236|NCT01979276|3585331|B1|||Age||years|Mean|60.5|60.5|Full Range|||58.0|63.0|
3751237|NCT01979185|3585337|B3|UNITED STATES||Region of Enrollment||Participants|Number|30|30.0||||||
3751238|NCT01979185|3585338|B2|UNITED STATES||Region of Enrollment||Participants|Number|15|15.0||||||
3751239|NCT01979185|3585339|B1|UNITED STATES||Region of Enrollment||Participants|Number|15|15.0||||||
3751240|NCT01979185|3585337|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3751241|NCT01979185|3585338|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3751242|NCT01979185|3585339|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3751243|NCT01979185|3585337|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3751244|NCT01979185|3585338|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3751245|NCT01979185|3585339|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3751246|NCT01979185|3585337|B3|Between 18 and 65 years||Age, Customized||Participants|Number|29|29.0||||||
3751247|NCT01979185|3585338|B2|Between 18 and 65 years||Age, Customized||Participants|Number|14|14.0||||||
3751248|NCT01979185|3585339|B1|Between 18 and 65 years||Age, Customized||Participants|Number|15|15.0||||||
3751249|NCT01979185|3585337|B3|<=18 years||Age, Customized||Participants|Number|1|1.0||||||
3751250|NCT01979185|3585338|B2|<=18 years||Age, Customized||Participants|Number|1|1.0||||||
3751251|NCT01979185|3585339|B1|<=18 years||Age, Customized||Participants|Number|0|0.0||||||
3751252|NCT01979185|3585337|B3|||Age||Years|Mean|39.3|39.3|Standard Deviation|15.17|15.17|||
3751253|NCT01979185|3585338|B2|||Age||Years|Mean|39.6|39.6|Standard Deviation|15.9|15.9|||
3751254|NCT01979185|3585339|B1|||Age||Years|Mean|39.1|39.1|Standard Deviation|14.97|14.97|||
3751255|NCT01979133|3585350|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3751256|NCT01979133|3585350|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751257|NCT01979133|3585350|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751258|NCT01979133|3585350|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3751259|NCT01979133|3585350|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3751260|NCT01979133|3585350|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751261|NCT01979133|3585350|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3751262|NCT01979133|3585350|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751263|NCT01979133|3585350|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3751264|NCT01979133|3585350|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3751265|NCT01979133|3585350|B1|||Age||years|Mean|51.4|51.4|Standard Deviation|7.3|7.3|||
3751266|NCT01979029|3585367|B3|China||Region of Enrollment||participants|Number|57|57.0||||||
3751267|NCT01979029|3585368|B2|China||Region of Enrollment||participants|Number|28|28.0||||||
3751268|NCT01979029|3585369|B1|China||Region of Enrollment||participants|Number|29|29.0||||||
3751269|NCT01979029|3585367|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3751270|NCT01979029|3585368|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3751271|NCT01979029|3585369|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3751272|NCT01979029|3585367|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3751273|NCT01979029|3585368|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3751274|NCT01979029|3585369|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3751275|NCT01979029|3585367|B3|||Age||years|Mean|60.7|60.7|Full Range|||34.0|81.0|
3751276|NCT01979029|3585368|B2|||Age||years|Mean|62.1|62.1|Full Range|||45.0|81.0|
3751277|NCT01979029|3585369|B1|||Age||years|Mean|59.3|59.3|Full Range|||34.0|71.0|
3751278|NCT01979029|3585367|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3751279|NCT01979029|3585368|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3751280|NCT01979029|3585369|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3751281|NCT01979029|3585367|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3751282|NCT01979029|3585368|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3751283|NCT01979029|3585369|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3751284|NCT01979029|3585367|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3751285|NCT01979029|3585368|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3751286|NCT01979029|3585369|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3751287|NCT01978938|3585380|B3||Male|Sex: Female, Male||Participants|Count of Participants|315|315.0||||||
3751288|NCT01978938|3585381|B2||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3751289|NCT01978938|3585382|B1||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3751290|NCT01978938|3585380|B3||Female|Sex: Female, Male||Participants|Count of Participants|593|593.0||||||
3751291|NCT01978938|3585381|B2||Female|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
3751292|NCT01978938|3585382|B1||Female|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
3751293|NCT01978938|3585380|B3|||Age||years|Mean|52.7|52.7|Standard Deviation|19.3|19.3|||
3751294|NCT01978938|3585381|B2|||Age||years|Mean|51.7|51.7|Standard Deviation|19.81|19.81|||
3751295|NCT01978938|3585382|B1|||Age||years|Mean|53.7|53.7|Standard Deviation|18.82|18.82|||
3751296|NCT01978938|3585380|B3||>=65 years|Age||Participants|Count of Participants|316|316.0||||||
3751297|NCT01978938|3585381|B2||>=65 years|Age||Participants|Count of Participants|152|152.0||||||
3751298|NCT01978938|3585382|B1||>=65 years|Age||Participants|Count of Participants|164|164.0||||||
3751299|NCT01978938|3585380|B3||Between 18 and 65 years|Age||Participants|Count of Participants|592|592.0||||||
3751300|NCT01978938|3585381|B2||Between 18 and 65 years|Age||Participants|Count of Participants|301|301.0||||||
3751301|NCT01978938|3585382|B1||Between 18 and 65 years|Age||Participants|Count of Participants|291|291.0||||||
3751302|NCT01978938|3585380|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3751303|NCT01978938|3585381|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3751304|NCT01978938|3585382|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3751305|NCT01978743|3585393|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3751306|NCT01978743|3585393|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3751307|NCT01978743|3585393|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3751308|NCT01978743|3585393|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3751309|NCT01978743|3585393|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3751310|NCT01978743|3585393|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3751311|NCT01978600|3585405|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3751312|NCT01978600|3585406|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3751313|NCT01978600|3585407|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3751314|NCT01978600|3585405|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3751315|NCT01978600|3585406|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3751316|NCT01978600|3585407|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3751317|NCT01978600|3585405|B3|||Age||years|Mean|60.1|60.1|Standard Deviation|10.87|10.87|||
3751318|NCT01978600|3585406|B2|||Age||years|Mean|59.7|59.7|Standard Deviation|11.14|11.14|||
3751319|NCT01978600|3585407|B1|||Age||years|Mean|60.5|60.5|Standard Deviation|10.73|10.73|||
3751320|NCT01978535|3585418|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3751321|NCT01978535|3585419|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3751322|NCT01978535|3585420|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3751323|NCT01978535|3585418|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3751324|NCT01978535|3585418|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3751325|NCT01978535|3585419|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3751326|NCT01978535|3585420|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3751327|NCT01978535|3585418|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3751328|NCT01978535|3585419|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3751329|NCT01978535|3585420|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3751330|NCT01978535|3585418|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3751331|NCT01978535|3585419|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3751332|NCT01978535|3585420|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3751333|NCT01978535|3585418|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3751334|NCT01978535|3585419|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3751335|NCT01978535|3585420|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3751336|NCT01978535|3585418|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3751337|NCT01978535|3585419|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3751338|NCT01978535|3585420|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3751339|NCT01978314|3585427|B6|United States||Region of Enrollment||participants|Number|33|33.0||||||
3751340|NCT01978314|3585428|B5|United States||Region of Enrollment||participants|Number|8|8.0||||||
3751341|NCT01978314|3585429|B4|United States||Region of Enrollment||participants|Number|1|1.0||||||
3751342|NCT01978314|3585430|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3751343|NCT01978314|3585431|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3751344|NCT01978314|3585432|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3751345|NCT01978314|3585427|B6||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3751346|NCT01978314|3585428|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3751347|NCT01978314|3585429|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3751348|NCT01978314|3585430|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3751349|NCT01978314|3585431|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3751350|NCT01978314|3585432|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3751351|NCT01978314|3585427|B6||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3751352|NCT01978314|3585428|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3751353|NCT01978314|3585429|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3751354|NCT01978314|3585430|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3751355|NCT01978314|3585431|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3751356|NCT01978314|3585432|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3751357|NCT01978314|3585427|B6|||Age||years|Mean|46.98|46.98|Standard Deviation|7.78|7.78|||
3751358|NCT01978314|3585428|B5|||Age||years|Mean|31.8|31.8|Standard Deviation|14.10|14.1|||
3751359|NCT01978314|3585429|B4|||Age||years|Mean|63.0|63.0|Standard Deviation|0|0.0|||
3751360|NCT01978314|3585430|B3|||Age||years|Mean|55.6|55.6|Standard Deviation|17.74|17.74|||
3751361|NCT01978314|3585431|B2|||Age||years|Mean|56.6|56.6|Standard Deviation|7.03|7.03|||
3751362|NCT01978314|3585432|B1|||Age||years|Mean|27.9|27.9|Standard Deviation|5.19|5.19|||
3751363|NCT01978314|3585427|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3751364|NCT01978314|3585428|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3751365|NCT01978314|3585429|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3751366|NCT01978314|3585430|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3751367|NCT01978314|3585431|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3751368|NCT01978314|3585432|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3751369|NCT01978314|3585427|B6||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3751370|NCT01978314|3585428|B5||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3751371|NCT01978314|3585429|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3751372|NCT01978314|3585430|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3751373|NCT01978314|3585431|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3751374|NCT01978314|3585432|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3751375|NCT01978314|3585427|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3751376|NCT01978314|3585428|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3751377|NCT01978314|3585429|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3751378|NCT01978314|3585430|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3751379|NCT01978314|3585431|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3751380|NCT01978314|3585432|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3751381|NCT01978262|3585518|B1|United States||Region of Enrollment||participants|Number|92|92.0||||||
3751382|NCT01978262|3585518|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3751383|NCT01978262|3585518|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3751384|NCT01978262|3585518|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3751385|NCT01978262|3585518|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3751386|NCT01978262|3585518|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751387|NCT01978262|3585518|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3751388|NCT01978262|3585518|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3751389|NCT01978262|3585518|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751390|NCT01978262|3585518|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
3751391|NCT01978262|3585518|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3751392|NCT01978262|3585518|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3751393|NCT01978262|3585518|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3751394|NCT01978262|3585518|B1|||Age||years|Median|28|28.0|Full Range|||19.0|39.5|
3751395|NCT01978236|3585523|B1|White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3751396|NCT01978236|3585523|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3751397|NCT01978236|3585523|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3751398|NCT01978236|3585523|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3751399|NCT01978236|3585523|B1|||Age||Years|Mean|56.2|56.2|Standard Deviation|16.52|16.52|||
3751453|NCT01978093|3585585|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3751400|NCT01978145|3585542|B1|Mixed American Indian or Alaskan Native and White||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3751401|NCT01978145|3585542|B1|White||Race/Ethnicity, Customized||Participants|Number|390|390.0||||||
3751402|NCT01978145|3585542|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
3751403|NCT01978145|3585542|B1||Male|Sex: Female, Male||Participants|Count of Participants|339|339.0||||||
3751404|NCT01978145|3585542|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3751405|NCT01978145|3585542|B1|||Age||Years|Mean|62.7|62.7|Standard Deviation|8.43|8.43|||
3751406|NCT01978119|3585559|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|82|82.0||||||
3751407|NCT01978119|3585559|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3751408|NCT01978119|3585559|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3751409|NCT01978119|3585559|B1|||Age||Years|Mean|52.5|52.5|Standard Deviation|14.93|14.93|||
3751410|NCT01978093|3585584|B3|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|68|68.0||||||
3751411|NCT01978093|3585585|B2|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3751412|NCT01978093|3585586|B1|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3751413|NCT01978093|3585584|B3|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|419|419.0||||||
3751414|NCT01978093|3585585|B2|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|218|218.0||||||
3751415|NCT01978093|3585586|B1|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|201|201.0||||||
3751416|NCT01978093|3585584|B3|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3751417|NCT01978093|3585585|B2|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3751418|NCT01978093|3585586|B1|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3751419|NCT01978093|3585584|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3751420|NCT01978093|3585585|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3751421|NCT01978093|3585586|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3751422|NCT01978093|3585584|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3751423|NCT01978093|3585585|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3751424|NCT01978093|3585586|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3751425|NCT01978093|3585584|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3751426|NCT01978093|3585585|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3751427|NCT01978093|3585586|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3751428|NCT01978093|3585584|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3751429|NCT01978093|3585585|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3751430|NCT01978093|3585586|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3751431|NCT01978093|3585584|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3751432|NCT01978093|3585585|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3751433|NCT01978093|3585586|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3751434|NCT01978093|3585584|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3751435|NCT01978093|3585585|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3751436|NCT01978093|3585586|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3751437|NCT01978093|3585584|B3|African Heritage / African American||Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
3751438|NCT01978093|3585585|B2|African Heritage / African American||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3751439|NCT01978093|3585586|B1|African Heritage / African American||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3751440|NCT01978093|3585584|B3||Male|Sex: Female, Male||Participants|Count of Participants|312|312.0||||||
3751441|NCT01978093|3585585|B2||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3751442|NCT01978093|3585586|B1||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3751443|NCT01978093|3585584|B3||Female|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
3751444|NCT01978093|3585585|B2||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3751445|NCT01978093|3585586|B1||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3751446|NCT01978093|3585584|B3|||Age||Weeks|Mean|8.6|8.6|Standard Deviation|1.1|1.1|||
3751447|NCT01978093|3585585|B2|||Age||Weeks|Mean|8.6|8.6|Standard Deviation|1.1|1.1|||
3751448|NCT01978093|3585586|B1|||Age||Weeks|Mean|8.6|8.6|Standard Deviation|1.1|1.1|||
3751449|NCT01978093|3585584|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3751450|NCT01978093|3585585|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3751451|NCT01978093|3585586|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3751452|NCT01978093|3585584|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3751454|NCT01978093|3585586|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3751455|NCT01978093|3585584|B3||<=18 years|Age||Participants|Count of Participants|600|600.0||||||
3751456|NCT01978093|3585585|B2||<=18 years|Age||Participants|Count of Participants|303|303.0||||||
3751457|NCT01978093|3585586|B1||<=18 years|Age||Participants|Count of Participants|297|297.0||||||
3751458|NCT01977820|3585629|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3751459|NCT01977820|3585630|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3751460|NCT01977820|3585631|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3751461|NCT01977820|3585629|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3751462|NCT01977820|3585630|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3751463|NCT01977820|3585631|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3751464|NCT01977820|3585629|B3|>=18 to 29 Years||Age, Customized||Subjects|Number|2|2.0||||||
3751465|NCT01977820|3585630|B2|>=18 to 29 Years||Age, Customized||Subjects|Number|1|1.0||||||
3751466|NCT01977820|3585631|B1|>=18 to 29 Years||Age, Customized||Subjects|Number|1|1.0||||||
3751467|NCT01977794|3585638|B3||Male|Gender||Participants|Count of Participants|47|47.0||||||
3751468|NCT01977794|3585639|B2||Male|Gender||Participants|Count of Participants|27|27.0||||||
3751469|NCT01977794|3585640|B1||Male|Gender||Participants|Count of Participants|20|20.0||||||
3751470|NCT01977794|3585638|B3||Female|Gender||Participants|Count of Participants|149|149.0||||||
3751471|NCT01977794|3585639|B2||Female|Gender||Participants|Count of Participants|72|72.0||||||
3751472|NCT01977794|3585640|B1||Female|Gender||Participants|Count of Participants|77|77.0||||||
3751473|NCT01977794|3585638|B3|||Age||years|Mean|61.5|61.5|Standard Deviation|11.96|11.96|||
3751474|NCT01977794|3585639|B2|||Age||years|Mean|59.6|59.6|Standard Deviation|12.05|12.05|||
3751475|NCT01977794|3585640|B1|||Age||years|Mean|63.4|63.4|Standard Deviation|11.62|11.62|||
3751476|NCT01977781|3585655|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3751477|NCT01977781|3585656|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3751478|NCT01977781|3585657|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3751479|NCT01977781|3585655|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3751480|NCT01977781|3585656|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3751481|NCT01977781|3585657|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3751482|NCT01977781|3585655|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3751483|NCT01977781|3585656|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3751484|NCT01977781|3585657|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3751485|NCT01977781|3585655|B3|||Age||years|Mean|56|56.0|Standard Deviation|11.40|11.4|||
3751486|NCT01977781|3585656|B2|||Age||years|Mean|58|58.0|Standard Deviation|10.98|10.98|||
3751487|NCT01977781|3585657|B1|||Age||years|Mean|54|54.0|Standard Deviation|11.54|11.54|||
3751488|NCT01977729|3585676|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3751489|NCT01977729|3585676|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3751490|NCT01977729|3585676|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3751491|NCT01977729|3585676|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3751492|NCT01977729|3585676|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3751493|NCT01977690|3585686|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3751494|NCT01977690|3585687|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3751495|NCT01977690|3585688|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3751496|NCT01977690|3585686|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3751497|NCT01977690|3585687|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3751498|NCT01977690|3585688|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3751499|NCT01977690|3585686|B3|||Age||years|Mean|56|56.0|Full Range|||41.0|84.0|
3751500|NCT01977690|3585687|B2|||Age||years|Mean|57|57.0|Full Range|||45.0|84.0|
3751501|NCT01977690|3585688|B1|||Age||years|Mean|55|55.0|Full Range|||41.0|79.0|
3751502|NCT01977677|3585695|B4|United States||Region of Enrollment||participants|Number|29|29.0||||||
3751503|NCT01977677|3585696|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3751504|NCT01977677|3585697|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3751505|NCT01977677|3585698|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3751506|NCT01977677|3585695|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751507|NCT01977677|3585696|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751508|NCT01977677|3585697|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751509|NCT01977677|3585698|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751510|NCT01977677|3585695|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751511|NCT01977677|3585696|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751512|NCT01977677|3585697|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751513|NCT01977677|3585698|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751514|NCT01977677|3585695|B4||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3751515|NCT01977677|3585696|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3751516|NCT01977677|3585697|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3751517|NCT01977677|3585698|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3751518|NCT01977677|3585695|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3751519|NCT01977677|3585696|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3751520|NCT01977677|3585697|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751521|NCT01977677|3585698|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751522|NCT01977677|3585695|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751523|NCT01977677|3585696|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751524|NCT01977677|3585697|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751525|NCT01977677|3585698|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751526|NCT01977677|3585695|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3751527|NCT01977677|3585696|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3751528|NCT01977677|3585697|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3751529|NCT01977677|3585698|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751530|NCT01977677|3585695|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751531|NCT01977677|3585696|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751532|NCT01977677|3585697|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751533|NCT01977677|3585698|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751534|NCT01977677|3585695|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751535|NCT01977677|3585696|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751536|NCT01977677|3585697|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751537|NCT01977677|3585698|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751538|NCT01977677|3585695|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3751539|NCT01977677|3585696|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3751540|NCT01977677|3585697|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3751541|NCT01977677|3585698|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3751542|NCT01977677|3585695|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3751543|NCT01977677|3585696|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3751544|NCT01977677|3585697|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751545|NCT01977677|3585698|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751546|NCT01977677|3585695|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3751547|NCT01977677|3585696|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3751548|NCT01977677|3585697|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3751549|NCT01977677|3585698|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3751550|NCT01977677|3585695|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3751551|NCT01977677|3585696|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3751552|NCT01977677|3585697|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3751553|NCT01977677|3585698|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3751554|NCT01977677|3585695|B4|||Age||years|Median|60|60.0|Full Range|||29.0|74.0|
3751555|NCT01977677|3585696|B3|||Age||years|Median|60|60.0|Full Range|||29.0|74.0|
3751556|NCT01977677|3585697|B2|||Age||years|Median|62|62.0|Full Range|||40.0|74.0|
3751557|NCT01977677|3585698|B1|||Age||years|Median|64|64.0|Full Range|||55.0|67.0|
3751558|NCT01977677|3585695|B4||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3751559|NCT01977677|3585696|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3751560|NCT01977677|3585697|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3751561|NCT01977677|3585698|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3751562|NCT01977677|3585695|B4||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3751563|NCT01977677|3585696|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3751564|NCT01977677|3585697|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3751565|NCT01977677|3585698|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3751566|NCT01977677|3585695|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3751567|NCT01977677|3585696|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3751568|NCT01977677|3585697|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3751569|NCT01977677|3585698|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3751570|NCT01977625|3585711|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3751571|NCT01977625|3585711|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751572|NCT01977625|3585711|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3751573|NCT01977625|3585711|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3751574|NCT01977625|3585711|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3751575|NCT01977625|3585711|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751576|NCT01977625|3585711|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751577|NCT01977625|3585711|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3751578|NCT01977625|3585711|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751579|NCT01977625|3585711|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3751580|NCT01977625|3585711|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751581|NCT01977625|3585711|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3751582|NCT01977625|3585711|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3751583|NCT01977625|3585711|B1|||Age||years|Mean|53.5|53.5|Full Range|||49.0|59.0|
3751584|NCT01977625|3585711|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3751585|NCT01977625|3585711|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3751586|NCT01977625|3585711|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3751587|NCT01977612|3585720|B3|Synchronous primary||Indications for surgery||Participants|Count of Participants|6|6.0||||||
3751588|NCT01977612|3585721|B2|Synchronous primary||Indications for surgery||Participants|Count of Participants|3|3.0||||||
3751589|NCT01977612|3585722|B1|Synchronous primary||Indications for surgery||Participants|Count of Participants|3|3.0||||||
3751590|NCT01977612|3585720|B3|Other||Indications for surgery||Participants|Count of Participants|16|16.0||||||
3751591|NCT01977612|3585721|B2|Other||Indications for surgery||Participants|Count of Participants|5|5.0||||||
3751592|NCT01977612|3585722|B1|Other||Indications for surgery||Participants|Count of Participants|11|11.0||||||
3751593|NCT01977612|3585720|B3|Benign||Indications for surgery||Participants|Count of Participants|49|49.0||||||
3751594|NCT01977612|3585721|B2|Benign||Indications for surgery||Participants|Count of Participants|27|27.0||||||
3751595|NCT01977612|3585722|B1|Benign||Indications for surgery||Participants|Count of Participants|22|22.0||||||
3751596|NCT01977612|3585720|B3|Ovarian/fallopian/peritoneal cancer||Indications for surgery||Participants|Count of Participants|45|45.0||||||
3751597|NCT01977612|3585721|B2|Ovarian/fallopian/peritoneal cancer||Indications for surgery||Participants|Count of Participants|21|21.0||||||
3751598|NCT01977612|3585722|B1|Ovarian/fallopian/peritoneal cancer||Indications for surgery||Participants|Count of Participants|24|24.0||||||
3751599|NCT01977612|3585720|B3|Uterine cancer||Indications for surgery||Participants|Count of Participants|47|47.0||||||
3751600|NCT01977612|3585721|B2|Uterine cancer||Indications for surgery||Participants|Count of Participants|23|23.0||||||
3751601|NCT01977612|3585722|B1|Uterine cancer||Indications for surgery||Participants|Count of Participants|24|24.0||||||
3751602|NCT01977612|3585720|B3|3-4||American Society of Anesthesiologists (ASA) class|ASA 1 - Normal healthy patient ASA 2 - A patient with mild systemic disease ASA 3 - A patient with severe systemic disease that is a constant threat to life ASA 4 - A moribund patient who is not expected to survive without the operation|Participants|Count of Participants|77|77.0||||||
3751603|NCT01977612|3585721|B2|3-4||American Society of Anesthesiologists (ASA) class|ASA 1 - Normal healthy patient ASA 2 - A patient with mild systemic disease ASA 3 - A patient with severe systemic disease that is a constant threat to life ASA 4 - A moribund patient who is not expected to survive without the operation|Participants|Count of Participants|32|32.0||||||
3751604|NCT01977612|3585722|B1|3-4||American Society of Anesthesiologists (ASA) class|ASA 1 - Normal healthy patient ASA 2 - A patient with mild systemic disease ASA 3 - A patient with severe systemic disease that is a constant threat to life ASA 4 - A moribund patient who is not expected to survive without the operation|Participants|Count of Participants|45|45.0||||||
3751605|NCT01977612|3585720|B3|1-2||American Society of Anesthesiologists (ASA) class|ASA 1 - Normal healthy patient ASA 2 - A patient with mild systemic disease ASA 3 - A patient with severe systemic disease that is a constant threat to life ASA 4 - A moribund patient who is not expected to survive without the operation|Participants|Count of Participants|86|86.0||||||
3751606|NCT01977612|3585721|B2|1-2||American Society of Anesthesiologists (ASA) class|ASA 1 - Normal healthy patient ASA 2 - A patient with mild systemic disease ASA 3 - A patient with severe systemic disease that is a constant threat to life ASA 4 - A moribund patient who is not expected to survive without the operation|Participants|Count of Participants|47|47.0||||||
3751607|NCT01977612|3585722|B1|1-2||American Society of Anesthesiologists (ASA) class|ASA 1 - Normal healthy patient ASA 2 - A patient with mild systemic disease ASA 3 - A patient with severe systemic disease that is a constant threat to life ASA 4 - A moribund patient who is not expected to survive without the operation|Participants|Count of Participants|39|39.0||||||
3751608|NCT01977612|3585720|B3|||Prior malignancy||Participants|Count of Participants|15|15.0||||||
3751609|NCT01977612|3585721|B2|||Prior malignancy||Participants|Count of Participants|8|8.0||||||
3751610|NCT01977612|3585722|B1|||Prior malignancy||Participants|Count of Participants|7|7.0||||||
3751611|NCT01977612|3585720|B3|||Pulmonary disease||Participants|Count of Participants|47|47.0||||||
3751612|NCT01977612|3585721|B2|||Pulmonary disease||Participants|Count of Participants|27|27.0||||||
3751613|NCT01977612|3585722|B1|||Pulmonary disease||Participants|Count of Participants|20|20.0||||||
3751614|NCT01977612|3585720|B3|||Cardiovascular disease||Participants|Count of Participants|115|115.0||||||
3751615|NCT01977612|3585721|B2|||Cardiovascular disease||Participants|Count of Participants|57|57.0||||||
3751616|NCT01977612|3585722|B1|||Cardiovascular disease||Participants|Count of Participants|58|58.0||||||
3751617|NCT01977612|3585720|B3|||Diabetes mellitus||Participants|Count of Participants|46|46.0||||||
3751618|NCT01977612|3585721|B2|||Diabetes mellitus||Participants|Count of Participants|19|19.0||||||
3751619|NCT01977612|3585722|B1|||Diabetes mellitus||Participants|Count of Participants|27|27.0||||||
3751620|NCT01977612|3585720|B3|Current||Tobacco Use||Participants|Count of Participants|12|12.0||||||
3751621|NCT01977612|3585721|B2|Current||Tobacco Use||Participants|Count of Participants|5|5.0||||||
3751622|NCT01977612|3585722|B1|Current||Tobacco Use||Participants|Count of Participants|7|7.0||||||
3751623|NCT01977612|3585720|B3|Former||Tobacco Use||Participants|Count of Participants|48|48.0||||||
3751624|NCT01977612|3585721|B2|Former||Tobacco Use||Participants|Count of Participants|15|15.0||||||
3751625|NCT01977612|3585722|B1|Former||Tobacco Use||Participants|Count of Participants|33|33.0||||||
3751626|NCT01977612|3585720|B3|Never||Tobacco Use||Participants|Count of Participants|103|103.0||||||
3751627|NCT01977612|3585721|B2|Never||Tobacco Use||Participants|Count of Participants|59|59.0||||||
3751628|NCT01977612|3585722|B1|Never||Tobacco Use||Participants|Count of Participants|44|44.0||||||
3751629|NCT01977612|3585720|B3|||Prior Abdominal Surgery||Participants|Count of Participants|104|104.0||||||
3751630|NCT01977612|3585721|B2|||Prior Abdominal Surgery||Participants|Count of Participants|53|53.0||||||
3751631|NCT01977612|3585722|B1|||Prior Abdominal Surgery||Participants|Count of Participants|51|51.0||||||
3751632|NCT01977612|3585720|B3|50 or greater||Body mass index (BMI)||Participants|Count of Participants|11|11.0||||||
3751633|NCT01977612|3585721|B2|50 or greater||Body mass index (BMI)||Participants|Count of Participants|6|6.0||||||
3751634|NCT01977612|3585722|B1|50 or greater||Body mass index (BMI)||Participants|Count of Participants|5|5.0||||||
3751635|NCT01977612|3585720|B3|40-49.9||Body mass index (BMI)||Participants|Count of Participants|43|43.0||||||
3751636|NCT01977612|3585721|B2|40-49.9||Body mass index (BMI)||Participants|Count of Participants|24|24.0||||||
3751637|NCT01977612|3585722|B1|40-49.9||Body mass index (BMI)||Participants|Count of Participants|19|19.0||||||
3751638|NCT01977612|3585720|B3|30-39.9||Body mass index (BMI)||Participants|Count of Participants|109|109.0||||||
3751639|NCT01977612|3585721|B2|30-39.9||Body mass index (BMI)||Participants|Count of Participants|49|49.0||||||
3751640|NCT01977612|3585722|B1|30-39.9||Body mass index (BMI)||Participants|Count of Participants|60|60.0||||||
3751641|NCT01977612|3585720|B3|United States||Region of Enrollment||participants|Number|163|163.0||||||
3751642|NCT01977612|3585721|B2|United States||Region of Enrollment||participants|Number|79|79.0||||||
3751643|NCT01977612|3585722|B1|United States||Region of Enrollment||participants|Number|84|84.0||||||
3751644|NCT01977612|3585720|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751645|NCT01977612|3585721|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751646|NCT01977612|3585722|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751647|NCT01977612|3585720|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751648|NCT01977612|3585721|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751649|NCT01977612|3585722|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751650|NCT01977612|3585720|B3||White|Race (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
3751651|NCT01977612|3585721|B2||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3751652|NCT01977612|3585722|B1||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3751653|NCT01977612|3585720|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3751654|NCT01977612|3585721|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3751655|NCT01977612|3585722|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3751656|NCT01977612|3585720|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751657|NCT01977612|3585721|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751658|NCT01977612|3585722|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751659|NCT01977612|3585720|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751660|NCT01977612|3585721|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751661|NCT01977612|3585722|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751662|NCT01977612|3585720|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751663|NCT01977612|3585721|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751664|NCT01977612|3585722|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751665|NCT01977612|3585720|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3751666|NCT01977612|3585721|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3751667|NCT01977612|3585722|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3751668|NCT01977612|3585720|B3||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3751669|NCT01977612|3585721|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3751670|NCT01977612|3585722|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3751671|NCT01977612|3585720|B3|||Age||years|Mean|57.4|57.4|Standard Deviation|12.3|12.3|||
3751672|NCT01977612|3585721|B2|||Age||years|Mean|57.1|57.1|Standard Deviation|11.2|11.2|||
3751673|NCT01977612|3585722|B1|||Age||years|Mean|58.5|58.5|Standard Deviation|13.2|13.2|||
3751674|NCT01977573|3585741|B5|White||Race/Ethnicity, Customized|Baseline measurement is provided for the ITT population.|Participants|Number|152|152.0||||||
3751675|NCT01977573|3585742|B4|White||Race/Ethnicity, Customized|Baseline measurement is provided for the ITT population.|Participants|Number|19|19.0||||||
3751676|NCT01977573|3585743|B3|White||Race/Ethnicity, Customized|Baseline measurement is provided for the ITT population.|Participants|Number|22|22.0||||||
3751716|NCT01977482|3585856|B7|Asian||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
3751677|NCT01977573|3585744|B2|White||Race/Ethnicity, Customized|Baseline measurement is provided for the ITT population.|Participants|Number|30|30.0||||||
3751678|NCT01977573|3585745|B1|White||Race/Ethnicity, Customized|Baseline measurement is provided for the ITT population.|Participants|Number|81|81.0||||||
3751679|NCT01977573|3585741|B5|Japanese/East Asian/South East Asian Heritage||Race/Ethnicity, Customized|Baseline measurement is provided for the ITT population.|Participants|Number|60|60.0||||||
3751680|NCT01977573|3585742|B4|Japanese/East Asian/South East Asian Heritage||Race/Ethnicity, Customized|Baseline measurement is provided for the ITT population.|Participants|Number|12|12.0||||||
3751681|NCT01977573|3585743|B3|Japanese/East Asian/South East Asian Heritage||Race/Ethnicity, Customized|Baseline measurement is provided for the ITT population.|Participants|Number|9|9.0||||||
3751682|NCT01977573|3585744|B2|Japanese/East Asian/South East Asian Heritage||Race/Ethnicity, Customized|Baseline measurement is provided for the ITT population.|Participants|Number|11|11.0||||||
3751683|NCT01977573|3585745|B1|Japanese/East Asian/South East Asian Heritage||Race/Ethnicity, Customized|Baseline measurement is provided for the ITT population.|Participants|Number|28|28.0||||||
3751684|NCT01977573|3585741|B5|Central/South Asian Heritage||Race/Ethnicity, Customized|Baseline measurement is provided for the ITT population.|Participants|Number|1|1.0||||||
3751685|NCT01977573|3585742|B4|Central/South Asian Heritage||Race/Ethnicity, Customized|Baseline measurement is provided for the ITT population.|Participants|Number|1|1.0||||||
3751686|NCT01977573|3585743|B3|Central/South Asian Heritage||Race/Ethnicity, Customized|Baseline measurement is provided for the ITT population.|Participants|Number|0|0.0||||||
3751687|NCT01977573|3585744|B2|Central/South Asian Heritage||Race/Ethnicity, Customized|Baseline measurement is provided for the ITT population.|Participants|Number|0|0.0||||||
3751688|NCT01977573|3585745|B1|Central/South Asian Heritage||Race/Ethnicity, Customized|Baseline measurement is provided for the ITT population.|Participants|Number|0|0.0||||||
3751689|NCT01977573|3585741|B5|African American/African Heritage||Race/Ethnicity, Customized|Baseline measurement is provided for the ITT population.|Participants|Number|22|22.0||||||
3751690|NCT01977573|3585742|B4|African American/African Heritage||Race/Ethnicity, Customized|Baseline measurement is provided for the ITT population.|Participants|Number|4|4.0||||||
3751691|NCT01977573|3585743|B3|African American/African Heritage||Race/Ethnicity, Customized|Baseline measurement is provided for the ITT population.|Participants|Number|2|2.0||||||
3751692|NCT01977573|3585744|B2|African American/African Heritage||Race/Ethnicity, Customized|Baseline measurement is provided for the ITT population.|Participants|Number|2|2.0||||||
3751693|NCT01977573|3585745|B1|African American/African Heritage||Race/Ethnicity, Customized|Baseline measurement is provided for the ITT population.|Participants|Number|14|14.0||||||
3751694|NCT01977573|3585741|B5||Male|Sex: Female, Male|Baseline measurement is provided for the ITT population.|Participants|Count of Participants|97|97.0||||||
3751695|NCT01977573|3585742|B4||Male|Sex: Female, Male|Baseline measurement is provided for the ITT population.|Participants|Count of Participants|13|13.0||||||
3751696|NCT01977573|3585743|B3||Male|Sex: Female, Male|Baseline measurement is provided for the ITT population.|Participants|Count of Participants|16|16.0||||||
3751697|NCT01977573|3585744|B2||Male|Sex: Female, Male|Baseline measurement is provided for the ITT population.|Participants|Count of Participants|20|20.0||||||
3751698|NCT01977573|3585745|B1||Male|Sex: Female, Male|Baseline measurement is provided for the ITT population.|Participants|Count of Participants|48|48.0||||||
3751699|NCT01977573|3585741|B5||Female|Sex: Female, Male|Baseline measurement is provided for the ITT population.|Participants|Count of Participants|138|138.0||||||
3751700|NCT01977573|3585742|B4||Female|Sex: Female, Male|Baseline measurement is provided for the ITT population.|Participants|Count of Participants|23|23.0||||||
3751701|NCT01977573|3585743|B3||Female|Sex: Female, Male|Baseline measurement is provided for the ITT population.|Participants|Count of Participants|17|17.0||||||
3751702|NCT01977573|3585744|B2||Female|Sex: Female, Male|Baseline measurement is provided for the ITT population.|Participants|Count of Participants|23|23.0||||||
3751703|NCT01977573|3585745|B1||Female|Sex: Female, Male|Baseline measurement is provided for the ITT population.|Participants|Count of Participants|75|75.0||||||
3751704|NCT01977573|3585741|B5|||Age|The Baseline measurement is provided for the Intent-to-Treat (ITT) population, which consisted of all randomized participants who received at least one dose of study drug, had a Baseline and at least one corresponding on-treatment assessment.|Years|Mean|66.1|66.1|Standard Deviation|13.04|13.04|||
3751705|NCT01977573|3585742|B4|||Age|The Baseline measurement is provided for the Intent-to-Treat (ITT) population, which consisted of all randomized participants who received at least one dose of study drug, had a Baseline and at least one corresponding on-treatment assessment.|Years|Mean|66.7|66.7|Standard Deviation|12.89|12.89|||
3751706|NCT01977573|3585743|B3|||Age|The Baseline measurement is provided for the Intent-to-Treat (ITT) population, which consisted of all randomized participants who received at least one dose of study drug, had a Baseline and at least one corresponding on-treatment assessment.|Years|Mean|62.0|62.0|Standard Deviation|14.06|14.06|||
3751707|NCT01977573|3585744|B2|||Age|The Baseline measurement is provided for the Intent-to-Treat (ITT) population, which consisted of all randomized participants who received at least one dose of study drug, had a Baseline and at least one corresponding on-treatment assessment.|Years|Mean|64.3|64.3|Standard Deviation|14.22|14.22|||
3751708|NCT01977573|3585745|B1|||Age|The Baseline measurement is provided for the Intent-to-Treat (ITT) population, which consisted of all randomized participants who received at least one dose of study drug, had a Baseline and at least one corresponding on-treatment assessment.|Years|Mean|67.6|67.6|Standard Deviation|12.21|12.21|||
3751709|NCT01977482|3585856|B7|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3751710|NCT01977482|3585857|B6|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3751711|NCT01977482|3585858|B5|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3751712|NCT01977482|3585859|B4|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3751713|NCT01977482|3585860|B3|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3751714|NCT01977482|3585861|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3751715|NCT01977482|3585862|B1|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3751717|NCT01977482|3585857|B6|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3751718|NCT01977482|3585858|B5|Asian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3751719|NCT01977482|3585859|B4|Asian||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3751720|NCT01977482|3585860|B3|Asian||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3751721|NCT01977482|3585861|B2|Asian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3751722|NCT01977482|3585862|B1|Asian||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3751723|NCT01977482|3585856|B7|African American||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
3751724|NCT01977482|3585857|B6|African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3751725|NCT01977482|3585858|B5|African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3751726|NCT01977482|3585859|B4|African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3751727|NCT01977482|3585860|B3|African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3751728|NCT01977482|3585861|B2|African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3751729|NCT01977482|3585862|B1|African American||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3751730|NCT01977482|3585856|B7|White||Race/Ethnicity, Customized||Participants|Number|150|150.0||||||
3751731|NCT01977482|3585857|B6|White||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3751732|NCT01977482|3585858|B5|White||Race/Ethnicity, Customized||Participants|Number|31|31.0||||||
3751733|NCT01977482|3585859|B4|White||Race/Ethnicity, Customized||Participants|Number|28|28.0||||||
3751734|NCT01977482|3585860|B3|White||Race/Ethnicity, Customized||Participants|Number|28|28.0||||||
3751735|NCT01977482|3585861|B2|White||Race/Ethnicity, Customized||Participants|Number|28|28.0||||||
3751736|NCT01977482|3585862|B1|White||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
3751737|NCT01977482|3585856|B7||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3751738|NCT01977482|3585857|B6||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3751739|NCT01977482|3585858|B5||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3751740|NCT01977482|3585859|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3751741|NCT01977482|3585860|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3751742|NCT01977482|3585861|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3751743|NCT01977482|3585862|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3751744|NCT01977482|3585856|B7||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3751745|NCT01977482|3585857|B6||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3751746|NCT01977482|3585858|B5||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3751747|NCT01977482|3585859|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3751748|NCT01977482|3585860|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3751749|NCT01977482|3585861|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3751750|NCT01977482|3585862|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3751751|NCT01977482|3585856|B7|Years||Age||Years|Mean|59.5|59.5|Standard Deviation|14.58|14.58|||
3751752|NCT01977482|3585857|B6|Years||Age||Years|Mean|59.9|59.9|Standard Deviation|13.26|13.26|||
3751753|NCT01977482|3585858|B5|Years||Age||Years|Mean|55.4|55.4|Standard Deviation|15.50|15.5|||
3751754|NCT01977482|3585859|B4|Years||Age||Years|Mean|60.1|60.1|Standard Deviation|10.36|10.36|||
3751755|NCT01977482|3585860|B3|Years||Age||Years|Mean|63.5|63.5|Standard Deviation|14.00|14.0|||
3751756|NCT01977482|3585861|B2|Years||Age||Years|Mean|58.7|58.7|Standard Deviation|13.33|13.33|||
3751757|NCT01977482|3585862|B1|Years||Age||Years|Mean|59.7|59.7|Standard Deviation|18.74|18.74|||
3751758|NCT01977456|3585982|B1|||National Institutes of Health Stroke Scale Score (NIHSS)|NIHSS score: A 43 point ordinal scale (0 to 42) measuring severity of stroke. 0 (no measurable effect), 42 (dead)|score|Median|12|12.0|Inter-Quartile Range|||9.0|16.0|
3751759|NCT01977456|3585982|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3751760|NCT01977456|3585982|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3751761|NCT01977456|3585982|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3751762|NCT01977456|3585982|B1|||Age||years|Mean|70.4|70.4|Standard Deviation|12.9|12.9|||
3751763|NCT01977456|3585982|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3751764|NCT01977456|3585982|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3751765|NCT01977456|3585982|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3751766|NCT01977352|3585989|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3751767|NCT01977352|3585990|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3751768|NCT01977352|3585991|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3751769|NCT01977352|3585989|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3751770|NCT01977352|3585990|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3751771|NCT01977352|3585991|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3751772|NCT01977352|3585989|B3|||Age||years|Mean|55.1|55.1|Standard Deviation|9.55|9.55|||
3751773|NCT01977352|3585990|B2|||Age||years|Mean|54.69|54.69|Standard Deviation|9.45|9.45|||
3751774|NCT01977352|3585991|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|9.55|9.55|||
3751775|NCT01977222|3586010|B1|||Peak tidal volume||L|Mean|2.03|2.03|Standard Deviation|0.58|0.58|||
3751776|NCT01977222|3586010|B1|||Peak heart rate||beats per minute|Mean|132.3|132.3|Standard Deviation|31.8|31.8|||
3751777|NCT01977222|3586010|B1|||Peak VE||L/min|Mean|74.3|74.3|Standard Deviation|27.8|27.8|||
3751778|NCT01977222|3586010|B1|||VE/VCO2 slope (ratio)||ratio|Mean|34.1|34.1|Standard Deviation|6.7|6.7|||
3751779|NCT01977222|3586010|B1|||Peak relative VO2||% predicted|Mean|68.1|68.1|Standard Deviation|14.3|14.3|||
3751780|NCT01977222|3586010|B1|||Peak relative VO2||ml/kg/min|Mean|22.2|22.2|Standard Deviation|8.0|8.0|||
3751781|NCT01977222|3586010|B1|||Peak work rate||Watts|Mean|116.5|116.5|Standard Deviation|45.0|45.0|||
3751782|NCT01977222|3586010|B1|||Maximum inspiratory pressure||cmH2O|Mean|87.7|87.7|Standard Deviation|33.0|33.0|||
3751783|NCT01977222|3586010|B1||Atriopulmonary connection|Fontan type||Participants|Count of Participants|3|3.0||||||
3751784|NCT01977222|3586010|B1||Extracardiac conduit|Fontan type||Participants|Count of Participants|1|1.0||||||
3751785|NCT01977222|3586010|B1||Lateral tunnel|Fontan type||Participants|Count of Participants|7|7.0||||||
3751786|NCT01977222|3586010|B1|||Age at Fontan completion||years|Mean|10.7|10.7|Standard Deviation|8.0|8.0|||
3751787|NCT01977222|3586010|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3751788|NCT01977222|3586010|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3751789|NCT01977222|3586010|B1|||Age||years|Mean|34.8|34.8|Standard Deviation|12.6|12.6|||
3751790|NCT01977092|3586021|B3||Parole|Legal status||Participants|Count of Participants|69|69.0||||||
3751791|NCT01977092|3586022|B2||Parole|Legal status||Participants|Count of Participants|49|49.0||||||
3751792|NCT01977092|3586023|B1||Parole|Legal status||Participants|Count of Participants|20|20.0||||||
3751793|NCT01977092|3586021|B3||Probation(including drug court)|Legal status||Participants|Count of Participants|261|261.0||||||
3751794|NCT01977092|3586022|B2||Probation(including drug court)|Legal status||Participants|Count of Participants|132|132.0||||||
3751795|NCT01977092|3586023|B1||Probation(including drug court)|Legal status||Participants|Count of Participants|129|129.0||||||
3751796|NCT01977092|3586021|B3|United States||Region of Enrollment||Participants|Count of Participants|330|330.0||||||
3751797|NCT01977092|3586022|B2|United States||Region of Enrollment||Participants|Count of Participants|181|181.0||||||
3751798|NCT01977092|3586023|B1|United States||Region of Enrollment||Participants|Count of Participants|149|149.0||||||
3751799|NCT01977092|3586021|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751800|NCT01977092|3586022|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751801|NCT01977092|3586023|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751802|NCT01977092|3586021|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3751803|NCT01977092|3586022|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3751804|NCT01977092|3586023|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3751805|NCT01977092|3586021|B3||White|Race (NIH/OMB)||Participants|Count of Participants|217|217.0||||||
3751806|NCT01977092|3586022|B2||White|Race (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
3751807|NCT01977092|3586023|B1||White|Race (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3751808|NCT01977092|3586021|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3751809|NCT01977092|3586022|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3751810|NCT01977092|3586023|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3751811|NCT01977092|3586021|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3751812|NCT01977092|3586022|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3751813|NCT01977092|3586023|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3751814|NCT01977092|3586021|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3751815|NCT01977092|3586022|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3751816|NCT01977092|3586023|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751817|NCT01977092|3586021|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3751818|NCT01977092|3586022|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3751819|NCT01977092|3586023|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3751820|NCT01977092|3586021|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751821|NCT01977092|3586022|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751822|NCT01977092|3586023|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3751823|NCT01977092|3586021|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|263|263.0||||||
3751824|NCT01977092|3586022|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|137|137.0||||||
3751825|NCT01977092|3586023|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
3751826|NCT01977092|3586021|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3751827|NCT01977092|3586022|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3751828|NCT01977092|3586023|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3751829|NCT01977092|3586021|B3||Male|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
3751830|NCT01977092|3586022|B2||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3751831|NCT01977092|3586023|B1||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3751832|NCT01977092|3586021|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3751833|NCT01977092|3586022|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3751834|NCT01977092|3586023|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3751835|NCT01977092|3586021|B3|||Age||years|Mean|38.1|38.1|Standard Deviation|11.7|11.7|||
3751836|NCT01977092|3586022|B2|||Age||years|Mean|39.3|39.3|Standard Deviation|11.6|11.6|||
3751837|NCT01977092|3586023|B1|||Age||years|Mean|38.1|38.1|Standard Deviation|11.9|11.9|||
3751838|NCT01977092|3586021|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3751839|NCT01977092|3586022|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3751840|NCT01977092|3586023|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3751841|NCT01977092|3586021|B3||Between 18 and 65 years|Age||Participants|Count of Participants|326|326.0||||||
3751842|NCT01977092|3586022|B2||Between 18 and 65 years|Age||Participants|Count of Participants|179|179.0||||||
3751843|NCT01977092|3586023|B1||Between 18 and 65 years|Age||Participants|Count of Participants|147|147.0||||||
3751844|NCT01977092|3586021|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3751845|NCT01977092|3586022|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3751846|NCT01977092|3586023|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3751847|NCT01976988|3586034|B3|||Operative Time||minutes|Median|200|200.0|Inter-Quartile Range|||142.0|260.0|
3751848|NCT01976988|3586035|B2|||Operative Time||minutes|Median|200|200.0|Inter-Quartile Range|||142.0|253.0|
3751849|NCT01976988|3586036|B1|||Operative Time||minutes|Median|189|189.0|Inter-Quartile Range|||144.0|260.0|
3751850|NCT01976988|3586034|B3|||Preoperative Platelet Count||1000/uL|Median|266|266.0|Inter-Quartile Range|||201.0|336.0|
3751851|NCT01976988|3586035|B2|||Preoperative Platelet Count||1000/uL|Median|267|267.0|Inter-Quartile Range|||202.0|336.0|
3751852|NCT01976988|3586036|B1|||Preoperative Platelet Count||1000/uL|Median|258|258.0|Inter-Quartile Range|||210.0|339.0|
3751853|NCT01976988|3586034|B3|||Preoperative Hemoglobin g/dL||grams/dL|Mean|12.7|12.7|Standard Deviation|2|2.0|||
3751854|NCT01976988|3586035|B2|||Preoperative Hemoglobin g/dL||grams/dL|Mean|12.6|12.6|Standard Deviation|1.9|1.9|||
3751855|NCT01976988|3586036|B1|||Preoperative Hemoglobin g/dL||grams/dL|Mean|12.7|12.7|Standard Deviation|2|2.0|||
3751856|NCT01976988|3586034|B3|No Conversion to Open||Conversion to Open||participants|Number|354|354.0||||||
3751857|NCT01976988|3586035|B2|No Conversion to Open||Conversion to Open||participants|Number|173|173.0||||||
3751858|NCT01976988|3586036|B1|No Conversion to Open||Conversion to Open||participants|Number|181|181.0||||||
3751859|NCT01976988|3586034|B3|Conversion to Open||Conversion to Open||participants|Number|22|22.0||||||
3751860|NCT01976988|3586035|B2|Conversion to Open||Conversion to Open||participants|Number|11|11.0||||||
3751861|NCT01976988|3586036|B1|Conversion to Open||Conversion to Open||participants|Number|11|11.0||||||
3751862|NCT01976988|3586034|B3|Laparoscopic/Robotic||Surgical Approach||participants|Number|207|207.0||||||
3751863|NCT01976988|3586035|B2|Laparoscopic/Robotic||Surgical Approach||participants|Number|102|102.0||||||
3751864|NCT01976988|3586036|B1|Laparoscopic/Robotic||Surgical Approach||participants|Number|105|105.0||||||
3751865|NCT01976988|3586034|B3|Hand-assisted laparoscopy||Surgical Approach||participants|Number|43|43.0||||||
3751866|NCT01976988|3586035|B2|Hand-assisted laparoscopy||Surgical Approach||participants|Number|29|29.0||||||
3751867|NCT01976988|3586036|B1|Hand-assisted laparoscopy||Surgical Approach||participants|Number|14|14.0||||||
3751868|NCT01976988|3586034|B3|Open||Surgical Approach||participants|Number|126|126.0||||||
3751869|NCT01976988|3586035|B2|Open||Surgical Approach||participants|Number|53|53.0||||||
3751870|NCT01976988|3586036|B1|Open||Surgical Approach||participants|Number|73|73.0||||||
3751871|NCT01976988|3586034|B3|Proctectomy/Proctocolectomy||Type of Resection||participants|Number|41|41.0||||||
3751872|NCT01976988|3586035|B2|Proctectomy/Proctocolectomy||Type of Resection||participants|Number|23|23.0||||||
3751873|NCT01976988|3586036|B1|Proctectomy/Proctocolectomy||Type of Resection||participants|Number|18|18.0||||||
3751874|NCT01976988|3586034|B3|Total Abdominal Colectomy||Type of Resection||participants|Number|79|79.0||||||
3751875|NCT01976988|3586035|B2|Total Abdominal Colectomy||Type of Resection||participants|Number|37|37.0||||||
3751876|NCT01976988|3586036|B1|Total Abdominal Colectomy||Type of Resection||participants|Number|42|42.0||||||
3751877|NCT01976988|3586034|B3|Left Colon||Type of Resection||participants|Number|101|101.0||||||
3751878|NCT01976988|3586035|B2|Left Colon||Type of Resection||participants|Number|49|49.0||||||
3751879|NCT01976988|3586036|B1|Left Colon||Type of Resection||participants|Number|52|52.0||||||
3751880|NCT01976988|3586034|B3|Right Colon||Type of Resection||participants|Number|104|104.0||||||
3751881|NCT01976988|3586035|B2|Right Colon||Type of Resection||participants|Number|53|53.0||||||
3751882|NCT01976988|3586036|B1|Right Colon||Type of Resection||participants|Number|51|51.0||||||
3751883|NCT01976988|3586034|B3|Small Bowel||Type of Resection||participants|Number|51|51.0||||||
3751884|NCT01976988|3586035|B2|Small Bowel||Type of Resection||participants|Number|22|22.0||||||
3751885|NCT01976988|3586036|B1|Small Bowel||Type of Resection||participants|Number|29|29.0||||||
3751886|NCT01976988|3586034|B3|Other||Indication for Surgery||participants|Number|104|104.0||||||
3751887|NCT01976988|3586035|B2|Other||Indication for Surgery||participants|Number|52|52.0||||||
3751888|NCT01976988|3586036|B1|Other||Indication for Surgery||participants|Number|52|52.0||||||
3751889|NCT01976988|3586034|B3|Inflammatory Bowel Disease||Indication for Surgery||participants|Number|138|138.0||||||
3751890|NCT01976988|3586035|B2|Inflammatory Bowel Disease||Indication for Surgery||participants|Number|66|66.0||||||
3751891|NCT01976988|3586036|B1|Inflammatory Bowel Disease||Indication for Surgery||participants|Number|72|72.0||||||
3751892|NCT01976988|3586034|B3|Cancer||Indication for Surgery||participants|Number|134|134.0||||||
3751893|NCT01976988|3586035|B2|Cancer||Indication for Surgery||participants|Number|66|66.0||||||
3751894|NCT01976988|3586036|B1|Cancer||Indication for Surgery||participants|Number|68|68.0||||||
3751895|NCT01976988|3586034|B3|No Prior Hospitalization||Prior Hospitalization||participants|Number|314|314.0||||||
3751896|NCT01976988|3586035|B2|No Prior Hospitalization||Prior Hospitalization||participants|Number|147|147.0||||||
3751897|NCT01976988|3586036|B1|No Prior Hospitalization||Prior Hospitalization||participants|Number|167|167.0||||||
3751898|NCT01976988|3586034|B3|Prior Hosptialization||Prior Hospitalization||participants|Number|62|62.0||||||
3751899|NCT01976988|3586035|B2|Prior Hosptialization||Prior Hospitalization||participants|Number|37|37.0||||||
3751900|NCT01976988|3586036|B1|Prior Hosptialization||Prior Hospitalization||participants|Number|25|25.0||||||
3751901|NCT01976988|3586034|B3|No History VTE||Remote History of Venous Thromboembolism||participants|Number|374|374.0||||||
3751902|NCT01976988|3586035|B2|No History VTE||Remote History of Venous Thromboembolism||participants|Number|183|183.0||||||
3751903|NCT01976988|3586036|B1|No History VTE||Remote History of Venous Thromboembolism||participants|Number|191|191.0||||||
3751904|NCT01976988|3586034|B3|History VTE||Remote History of Venous Thromboembolism||participants|Number|2|2.0||||||
3751905|NCT01976988|3586035|B2|History VTE||Remote History of Venous Thromboembolism||participants|Number|1|1.0||||||
3751906|NCT01976988|3586036|B1|History VTE||Remote History of Venous Thromboembolism||participants|Number|1|1.0||||||
3751907|NCT01976988|3586034|B3|No Antiplatelet||Preoperative Antiplatelet Therapy||participants|Number|327|327.0||||||
3751908|NCT01976988|3586035|B2|No Antiplatelet||Preoperative Antiplatelet Therapy||participants|Number|162|162.0||||||
3751909|NCT01976988|3586036|B1|No Antiplatelet||Preoperative Antiplatelet Therapy||participants|Number|165|165.0||||||
3751910|NCT01976988|3586034|B3|Received Antiplatelet||Preoperative Antiplatelet Therapy||participants|Number|49|49.0||||||
3751911|NCT01976988|3586035|B2|Received Antiplatelet||Preoperative Antiplatelet Therapy||participants|Number|22|22.0||||||
3751912|NCT01976988|3586036|B1|Received Antiplatelet||Preoperative Antiplatelet Therapy||participants|Number|27|27.0||||||
3751913|NCT01976988|3586034|B3|Non-Smoker||Smokers||participants|Number|350|350.0||||||
3751914|NCT01976988|3586035|B2|Non-Smoker||Smokers||participants|Number|172|172.0||||||
3751915|NCT01976988|3586036|B1|Non-Smoker||Smokers||participants|Number|178|178.0||||||
3751916|NCT01976988|3586034|B3|Smoker||Smokers||participants|Number|26|26.0||||||
3751917|NCT01976988|3586035|B2|Smoker||Smokers||participants|Number|12|12.0||||||
3751918|NCT01976988|3586036|B1|Smoker||Smokers||participants|Number|14|14.0||||||
3751919|NCT01976988|3586034|B3|4||ASA Class|"ASA Class 1: Patient is a completely healthy fit patient. ASA Class 2: Patient has mild systemic disease. ASA Class 3: Patient has severe systemic disease that is not incapacitating. ASA Class 4: Patient has incapacitating disease that is a constant threat to life.~ASA Class 5: A moribund patient who is not expected to live 24 hour with or without surgery.~ASA class 1 suggests best outcome and class 5 worst"|participants|Number|2|2.0||||||
3751920|NCT01976988|3586035|B2|4||ASA Class|"ASA Class 1: Patient is a completely healthy fit patient. ASA Class 2: Patient has mild systemic disease. ASA Class 3: Patient has severe systemic disease that is not incapacitating. ASA Class 4: Patient has incapacitating disease that is a constant threat to life.~ASA Class 5: A moribund patient who is not expected to live 24 hour with or without surgery.~ASA class 1 suggests best outcome and class 5 worst"|participants|Number|1|1.0||||||
3751921|NCT01976988|3586036|B1|4||ASA Class|"ASA Class 1: Patient is a completely healthy fit patient. ASA Class 2: Patient has mild systemic disease. ASA Class 3: Patient has severe systemic disease that is not incapacitating. ASA Class 4: Patient has incapacitating disease that is a constant threat to life.~ASA Class 5: A moribund patient who is not expected to live 24 hour with or without surgery.~ASA class 1 suggests best outcome and class 5 worst"|participants|Number|1|1.0||||||
3751922|NCT01976988|3586034|B3|3||ASA Class|"ASA Class 1: Patient is a completely healthy fit patient. ASA Class 2: Patient has mild systemic disease. ASA Class 3: Patient has severe systemic disease that is not incapacitating. ASA Class 4: Patient has incapacitating disease that is a constant threat to life.~ASA Class 5: A moribund patient who is not expected to live 24 hour with or without surgery.~ASA class 1 suggests best outcome and class 5 worst"|participants|Number|127|127.0||||||
3751923|NCT01976988|3586035|B2|3||ASA Class|"ASA Class 1: Patient is a completely healthy fit patient. ASA Class 2: Patient has mild systemic disease. ASA Class 3: Patient has severe systemic disease that is not incapacitating. ASA Class 4: Patient has incapacitating disease that is a constant threat to life.~ASA Class 5: A moribund patient who is not expected to live 24 hour with or without surgery.~ASA class 1 suggests best outcome and class 5 worst"|participants|Number|57|57.0||||||
3751924|NCT01976988|3586036|B1|3||ASA Class|"ASA Class 1: Patient is a completely healthy fit patient. ASA Class 2: Patient has mild systemic disease. ASA Class 3: Patient has severe systemic disease that is not incapacitating. ASA Class 4: Patient has incapacitating disease that is a constant threat to life.~ASA Class 5: A moribund patient who is not expected to live 24 hour with or without surgery.~ASA class 1 suggests best outcome and class 5 worst"|participants|Number|70|70.0||||||
3751925|NCT01976988|3586034|B3|2||ASA Class|"ASA Class 1: Patient is a completely healthy fit patient. ASA Class 2: Patient has mild systemic disease. ASA Class 3: Patient has severe systemic disease that is not incapacitating. ASA Class 4: Patient has incapacitating disease that is a constant threat to life.~ASA Class 5: A moribund patient who is not expected to live 24 hour with or without surgery.~ASA class 1 suggests best outcome and class 5 worst"|participants|Number|231|231.0||||||
3751926|NCT01976988|3586035|B2|2||ASA Class|"ASA Class 1: Patient is a completely healthy fit patient. ASA Class 2: Patient has mild systemic disease. ASA Class 3: Patient has severe systemic disease that is not incapacitating. ASA Class 4: Patient has incapacitating disease that is a constant threat to life.~ASA Class 5: A moribund patient who is not expected to live 24 hour with or without surgery.~ASA class 1 suggests best outcome and class 5 worst"|participants|Number|117|117.0||||||
3751927|NCT01976988|3586036|B1|2||ASA Class|"ASA Class 1: Patient is a completely healthy fit patient. ASA Class 2: Patient has mild systemic disease. ASA Class 3: Patient has severe systemic disease that is not incapacitating. ASA Class 4: Patient has incapacitating disease that is a constant threat to life.~ASA Class 5: A moribund patient who is not expected to live 24 hour with or without surgery.~ASA class 1 suggests best outcome and class 5 worst"|participants|Number|114|114.0||||||
3751982|NCT01976819|3586081|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3751983|NCT01976806|3586090|B3|No Hyperlipidemia||Hyperlipidemia||participants|Number|37|37.0||||||
3751928|NCT01976988|3586034|B3|1||ASA Class|"ASA Class 1: Patient is a completely healthy fit patient. ASA Class 2: Patient has mild systemic disease. ASA Class 3: Patient has severe systemic disease that is not incapacitating. ASA Class 4: Patient has incapacitating disease that is a constant threat to life.~ASA Class 5: A moribund patient who is not expected to live 24 hour with or without surgery.~ASA class 1 suggests best outcome and class 5 worst"|participants|Number|16|16.0||||||
3751929|NCT01976988|3586035|B2|1||ASA Class|"ASA Class 1: Patient is a completely healthy fit patient. ASA Class 2: Patient has mild systemic disease. ASA Class 3: Patient has severe systemic disease that is not incapacitating. ASA Class 4: Patient has incapacitating disease that is a constant threat to life.~ASA Class 5: A moribund patient who is not expected to live 24 hour with or without surgery.~ASA class 1 suggests best outcome and class 5 worst"|participants|Number|9|9.0||||||
3751930|NCT01976988|3586036|B1|1||ASA Class|"ASA Class 1: Patient is a completely healthy fit patient. ASA Class 2: Patient has mild systemic disease. ASA Class 3: Patient has severe systemic disease that is not incapacitating. ASA Class 4: Patient has incapacitating disease that is a constant threat to life.~ASA Class 5: A moribund patient who is not expected to live 24 hour with or without surgery.~ASA class 1 suggests best outcome and class 5 worst"|participants|Number|7|7.0||||||
3751931|NCT01976988|3586034|B3|No Comorbidity||Any Comorbidity||participants|Number|256|256.0||||||
3751932|NCT01976988|3586035|B2|No Comorbidity||Any Comorbidity||participants|Number|130|130.0||||||
3751933|NCT01976988|3586036|B1|No Comorbidity||Any Comorbidity||participants|Number|126|126.0||||||
3751934|NCT01976988|3586034|B3|Any Comorbidity||Any Comorbidity||participants|Number|120|120.0||||||
3751935|NCT01976988|3586035|B2|Any Comorbidity||Any Comorbidity||participants|Number|54|54.0||||||
3751936|NCT01976988|3586036|B1|Any Comorbidity||Any Comorbidity||participants|Number|66|66.0||||||
3751937|NCT01976988|3586034|B3|||Body Mass Index||kg/m^2|Mean|25|25.0|Standard Deviation|6.7|6.7|||
3751938|NCT01976988|3586035|B2|||Body Mass Index||kg/m^2|Mean|24.9|24.9|Standard Deviation|6.1|6.1|||
3751939|NCT01976988|3586036|B1|||Body Mass Index||kg/m^2|Mean|25.8|25.8|Standard Deviation|6.3|6.3|||
3751940|NCT01976988|3586034|B3||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3751941|NCT01976988|3586035|B2||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3751942|NCT01976988|3586036|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3751943|NCT01976988|3586034|B3||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
3751944|NCT01976988|3586035|B2||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3751945|NCT01976988|3586036|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3751946|NCT01976988|3586034|B3|||Age||Years|Mean|52.7|52.7|Standard Deviation|17.6|17.6|||
3751947|NCT01976988|3586035|B2|||Age||Years|Mean|51.7|51.7|Standard Deviation|16.9|16.9|||
3751948|NCT01976988|3586036|B1|||Age||Years|Mean|53.6|53.6|Standard Deviation|18.2|18.2|||
3751949|NCT01976871|3586053|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3751950|NCT01976871|3586053|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3751951|NCT01976871|3586053|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3751952|NCT01976871|3586053|B1|||Age||years|Mean|66.0|66.0|Standard Deviation|12.1|12.1|||
3751953|NCT01976871|3586053|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3751954|NCT01976871|3586053|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3751955|NCT01976871|3586053|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3751956|NCT01976845|3586062|B4|||Body Mass Index (BMI)||kg^m2|Mean|28|28.0|Standard Deviation|5|5.0|||
3751957|NCT01976845|3586063|B3|||Body Mass Index (BMI)||kg^m2|Mean|28|28.0|Standard Deviation|5|5.0|||
3751958|NCT01976845|3586064|B2|||Body Mass Index (BMI)||kg^m2|Mean|28|28.0|Standard Deviation|6|6.0|||
3751959|NCT01976845|3586065|B1|||Body Mass Index (BMI)||kg^m2|Mean|28|28.0|Standard Deviation|5|5.0|||
3751960|NCT01976845|3586062|B4|United States||Region of Enrollment||participants|Number|120|120.0||||||
3751961|NCT01976845|3586063|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3751962|NCT01976845|3586064|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
3751963|NCT01976845|3586065|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3751964|NCT01976845|3586062|B4||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3751965|NCT01976845|3586063|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3751966|NCT01976845|3586064|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3751967|NCT01976845|3586065|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3751968|NCT01976845|3586062|B4||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3751969|NCT01976845|3586063|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3751970|NCT01976845|3586064|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3751971|NCT01976845|3586065|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3751972|NCT01976845|3586062|B4|||Age||years|Mean|51|51.0|Standard Deviation|14|14.0|||
3751973|NCT01976845|3586063|B3|||Age||years|Mean|49|49.0|Standard Deviation|14|14.0|||
3751974|NCT01976845|3586064|B2|||Age||years|Mean|51|51.0|Standard Deviation|15|15.0|||
3751975|NCT01976845|3586065|B1|||Age||years|Mean|52|52.0|Standard Deviation|13|13.0|||
3751976|NCT01976819|3586081|B1|Netherlands||Region of Enrollment||participants|Number|16|16.0||||||
3751977|NCT01976819|3586081|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3751978|NCT01976819|3586081|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3751979|NCT01976819|3586081|B1|||Age||years|Mean|58.50|58.5|Standard Deviation|12.85|12.85|||
3751980|NCT01976819|3586081|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3751981|NCT01976819|3586081|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3751984|NCT01976806|3586091|B2|No Hyperlipidemia||Hyperlipidemia||participants|Number|18|18.0||||||
3751985|NCT01976806|3586092|B1|No Hyperlipidemia||Hyperlipidemia||participants|Number|19|19.0||||||
3751986|NCT01976806|3586090|B3|Hyperlipidemia||Hyperlipidemia||participants|Number|9|9.0||||||
3751987|NCT01976806|3586091|B2|Hyperlipidemia||Hyperlipidemia||participants|Number|4|4.0||||||
3751988|NCT01976806|3586092|B1|Hyperlipidemia||Hyperlipidemia||participants|Number|5|5.0||||||
3751989|NCT01976806|3586090|B3|No Hypertension||Hypertension||participants|Number|36|36.0||||||
3751990|NCT01976806|3586091|B2|No Hypertension||Hypertension||participants|Number|16|16.0||||||
3751991|NCT01976806|3586092|B1|No Hypertension||Hypertension||participants|Number|20|20.0||||||
3751992|NCT01976806|3586090|B3|Hypertension||Hypertension||participants|Number|10|10.0||||||
3751993|NCT01976806|3586091|B2|Hypertension||Hypertension||participants|Number|6|6.0||||||
3751994|NCT01976806|3586092|B1|Hypertension||Hypertension||participants|Number|4|4.0||||||
3751995|NCT01976806|3586090|B3|Obese (>30 kg/m2)||BMI (kg/m2)||participants|Number|18|18.0||||||
3751996|NCT01976806|3586091|B2|Obese (>30 kg/m2)||BMI (kg/m2)||participants|Number|7|7.0||||||
3751997|NCT01976806|3586092|B1|Obese (>30 kg/m2)||BMI (kg/m2)||participants|Number|11|11.0||||||
3751998|NCT01976806|3586090|B3|Overweight (25-30 kg/m2)||BMI (kg/m2)||participants|Number|14|14.0||||||
3751999|NCT01976806|3586091|B2|Overweight (25-30 kg/m2)||BMI (kg/m2)||participants|Number|10|10.0||||||
3752000|NCT01976806|3586092|B1|Overweight (25-30 kg/m2)||BMI (kg/m2)||participants|Number|4|4.0||||||
3752001|NCT01976806|3586090|B3|Normal (18.5-24.9 kg/m2)||BMI (kg/m2)||participants|Number|14|14.0||||||
3752002|NCT01976806|3586091|B2|Normal (18.5-24.9 kg/m2)||BMI (kg/m2)||participants|Number|5|5.0||||||
3752003|NCT01976806|3586092|B1|Normal (18.5-24.9 kg/m2)||BMI (kg/m2)||participants|Number|9|9.0||||||
3752004|NCT01976806|3586090|B3|Never||Smoking Status||participants|Number|31|31.0||||||
3752005|NCT01976806|3586091|B2|Never||Smoking Status||participants|Number|15|15.0||||||
3752006|NCT01976806|3586092|B1|Never||Smoking Status||participants|Number|16|16.0||||||
3752007|NCT01976806|3586090|B3|Former||Smoking Status||participants|Number|13|13.0||||||
3752008|NCT01976806|3586091|B2|Former||Smoking Status||participants|Number|6|6.0||||||
3752009|NCT01976806|3586092|B1|Former||Smoking Status||participants|Number|7|7.0||||||
3752010|NCT01976806|3586090|B3|Current||Smoking Status||participants|Number|2|2.0||||||
3752011|NCT01976806|3586091|B2|Current||Smoking Status||participants|Number|1|1.0||||||
3752012|NCT01976806|3586092|B1|Current||Smoking Status||participants|Number|1|1.0||||||
3752013|NCT01976806|3586090|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3752014|NCT01976806|3586091|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752015|NCT01976806|3586092|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3752016|NCT01976806|3586090|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3752017|NCT01976806|3586091|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3752018|NCT01976806|3586092|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752019|NCT01976806|3586090|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3752020|NCT01976806|3586091|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3752021|NCT01976806|3586092|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3752022|NCT01976806|3586090|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3752023|NCT01976806|3586091|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3752024|NCT01976806|3586092|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3752025|NCT01976806|3586090|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752026|NCT01976806|3586091|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752027|NCT01976806|3586092|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752028|NCT01976806|3586090|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3752029|NCT01976806|3586091|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3752030|NCT01976806|3586092|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3752031|NCT01976806|3586090|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752032|NCT01976806|3586091|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752033|NCT01976806|3586092|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752034|NCT01976806|3586090|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3752035|NCT01976806|3586091|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3752036|NCT01976806|3586092|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3752037|NCT01976806|3586090|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3752038|NCT01976806|3586091|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3752039|NCT01976806|3586092|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3752040|NCT01976806|3586090|B3|||Age||years|Mean|55|55.0|Standard Deviation|8|8.0|||
3752041|NCT01976806|3586091|B2|||Age||years|Mean|57|57.0|Standard Deviation|8|8.0|||
3752042|NCT01976806|3586092|B1|||Age||years|Mean|53|53.0|Standard Deviation|8|8.0|||
3752043|NCT01976663|3586121|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3752044|NCT01976663|3586121|B1||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3752045|NCT01976663|3586121|B1|>65 years||Age, Customized||Participants|Number|15|15.0||||||
3752046|NCT01976663|3586121|B1|51 to 65 years||Age, Customized||Participants|Number|72|72.0||||||
3752047|NCT01976663|3586121|B1|30 to 50 years||Age, Customized||Participants|Number|36|36.0||||||
3752048|NCT01976650|3586135|B1||Male|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
3752049|NCT01976650|3586135|B1||Female|Sex: Female, Male||Participants|Count of Participants|424|424.0||||||
3752050|NCT01976650|3586135|B1|||Age||Years|Mean|62.18|62.18|Standard Deviation|11.14|11.14|||
3752051|NCT01976624|3586140|B1||Male|Sex: Female, Male||Participants|Count of Participants|426|426.0||||||
3752052|NCT01976624|3586140|B1||Female|Sex: Female, Male||Participants|Count of Participants|316|316.0||||||
3752053|NCT01976624|3586140|B1|Data not Available||Age, Customized||participants|Number|1|1.0||||||
3752054|NCT01976624|3586140|B1|≥80 years||Age, Customized||participants|Number|46|46.0||||||
3752055|NCT01976624|3586140|B1|70 to 79 years||Age, Customized||participants|Number|151|151.0||||||
3752056|NCT01976624|3586140|B1|60 to 69 years||Age, Customized||participants|Number|196|196.0||||||
3752057|NCT01976624|3586140|B1|50 to 59 years||Age, Customized||participants|Number|167|167.0||||||
3752058|NCT01976624|3586140|B1|40 to 49 years||Age, Customized||participants|Number|91|91.0||||||
3752059|NCT01976624|3586140|B1|30 to 39 years||Age, Customized||participants|Number|67|67.0||||||
3752060|NCT01976624|3586140|B1|18 to <30 years||Age, Customized||participants|Number|23|23.0||||||
3752061|NCT01976572|3586145|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3752062|NCT01976572|3586145|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3752063|NCT01976572|3586145|B1|||Age||years|Mean|35.1|35.1|Standard Deviation|10.4|10.4|||
3752064|NCT01976572|3586145|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3752065|NCT01976572|3586145|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3752066|NCT01976572|3586145|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3752067|NCT01976507|3586168|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
3752068|NCT01976507|3586168|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3752069|NCT01976507|3586168|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3752070|NCT01976507|3586168|B1|||Age||years|Median|61|61.0|Standard Deviation|12|12.0|||
3752071|NCT01976442|3586175|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
3752072|NCT01976442|3586176|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
3752073|NCT01976442|3586177|B1|United States||Region of Enrollment||participants|Number|69|69.0||||||
3752074|NCT01976442|3586175|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3752075|NCT01976442|3586176|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3752076|NCT01976442|3586177|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3752077|NCT01976442|3586175|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3752078|NCT01976442|3586176|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3752079|NCT01976442|3586177|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3752080|NCT01976442|3586175|B3|||Age||years|Mean|35|35.0|Full Range|||1.0|50.0|
3752081|NCT01976442|3586176|B2|||Age||years|Mean|30|30.0|Full Range|||2.0|49.0|
3752082|NCT01976442|3586177|B1|||Age||years|Mean|40|40.0|Full Range|||1.0|50.0|
3752083|NCT01976416|3586190|B3|Uganda||Region of Enrollment||participants|Number|207|207.0||||||
3752084|NCT01976416|3586191|B2|Uganda||Region of Enrollment||participants|Number|103|103.0||||||
3752085|NCT01976416|3586192|B1|Uganda||Region of Enrollment||participants|Number|104|104.0||||||
3752086|NCT01976416|3586190|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3752087|NCT01976416|3586190|B3||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3752088|NCT01976416|3586191|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3752089|NCT01976416|3586192|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3752090|NCT01976416|3586190|B3||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3752091|NCT01976416|3586191|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3752092|NCT01976416|3586192|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3752093|NCT01976416|3586190|B3|Age 1.00-3.99 years||Age, Customized||Participants|Count of Participants|207|207.0||||||
3752094|NCT01976416|3586191|B2|Age 1.00-3.99 years||Age, Customized||Participants|Count of Participants|103|103.0||||||
3752095|NCT01976416|3586192|B1|Age 1.00-3.99 years||Age, Customized||Participants|Count of Participants|104|104.0||||||
3752096|NCT01976338|3586199|B3||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3752097|NCT01976338|3586200|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3752098|NCT01976338|3586201|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3752099|NCT01976338|3586199|B3||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3752100|NCT01976338|3586200|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3752101|NCT01976338|3586201|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3752102|NCT01976338|3586199|B3|||Age||Years|Mean|56.9|56.9|Standard Deviation|10.09|10.09|||
3752103|NCT01976338|3586200|B2|||Age||Years|Mean|56.8|56.8|Standard Deviation|10.03|10.03|||
3752104|NCT01976338|3586201|B1|||Age||Years|Mean|57.0|57.0|Standard Deviation|10.14|10.14|||
3752105|NCT01976312|3586227|B3||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3752106|NCT01976312|3586228|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3752107|NCT01976312|3586229|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3752108|NCT01976312|3586227|B3||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3752109|NCT01976312|3586228|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3752110|NCT01976312|3586229|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3752111|NCT01976312|3586227|B3|||Age||Years|Mean|54.1|54.1|Standard Deviation|12.77|12.77|||
3752112|NCT01976312|3586228|B2|||Age||Years|Mean|54.1|54.1|Standard Deviation|13.29|13.29|||
3752113|NCT01976312|3586229|B1|||Age||Years|Mean|54.1|54.1|Standard Deviation|12.64|12.64|||
3752114|NCT01976299|3586249|B3||Male|Gender||Participants|Count of Participants|351|351.0||||||
3752115|NCT01976299|3586250|B2||Male|Gender||Participants|Count of Participants|173|173.0||||||
3752116|NCT01976299|3586251|B1||Male|Gender||Participants|Count of Participants|178|178.0||||||
3752117|NCT01976299|3586249|B3||Female|Gender||Participants|Count of Participants|227|227.0||||||
3752118|NCT01976299|3586250|B2||Female|Gender||Participants|Count of Participants|113|113.0||||||
3752119|NCT01976299|3586251|B1||Female|Gender||Participants|Count of Participants|114|114.0||||||
3752120|NCT01976299|3586249|B3|||Age||years|Mean|71.6|71.6|Standard Deviation|9.4|9.4|||
3752121|NCT01976299|3586250|B2|||Age||years|Mean|72.3|72.3|Standard Deviation|9.4|9.4|||
3752122|NCT01976299|3586251|B1|||Age||years|Mean|71|71.0|Standard Deviation|9.3|9.3|||
3752123|NCT01976273|3586266|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3752124|NCT01976273|3586267|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3752125|NCT01976273|3586268|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3752126|NCT01976273|3586266|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752127|NCT01976273|3586267|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752128|NCT01976273|3586268|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752129|NCT01976273|3586266|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3752130|NCT01976273|3586267|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3752131|NCT01976273|3586268|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3752132|NCT01976273|3586266|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3752133|NCT01976273|3586267|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752134|NCT01976273|3586268|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3752135|NCT01976273|3586266|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752136|NCT01976273|3586267|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752137|NCT01976273|3586268|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752138|NCT01976273|3586266|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3752139|NCT01976273|3586267|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752140|NCT01976273|3586268|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3752141|NCT01976273|3586266|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752142|NCT01976273|3586267|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752143|NCT01976273|3586268|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752144|NCT01976273|3586266|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3752145|NCT01976273|3586267|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3752146|NCT01976273|3586268|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3752147|NCT01976273|3586266|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3752148|NCT01976273|3586267|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3752149|NCT01976273|3586268|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3752150|NCT01976273|3586266|B3|||Age||years|Mean|42.94|42.94|Standard Deviation|11.03|11.03|||
3752151|NCT01976273|3586267|B2|||Age||years|Mean|44.11|44.11|Standard Deviation|11.94|11.94|||
3752152|NCT01976273|3586268|B1|||Age||years|Mean|41.78|41.78|Standard Deviation|10.62|10.62|||
3752153|NCT01976104|3586275|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3752154|NCT01976104|3586276|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752155|NCT01976104|3586277|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3752156|NCT01976104|3586278|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752157|NCT01976104|3586279|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752158|NCT01976104|3586275|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3752159|NCT01976104|3586276|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3752160|NCT01976104|3586277|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752161|NCT01976104|3586278|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3752162|NCT01976104|3586279|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3752163|NCT01976104|3586275|B5||White|Race (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
3752164|NCT01976104|3586276|B4||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3752165|NCT01976104|3586277|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3752166|NCT01976104|3586278|B2||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3752167|NCT01976104|3586279|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3752168|NCT01976104|3586275|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3752169|NCT01976104|3586276|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3752170|NCT01976104|3586277|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752171|NCT01976104|3586278|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3752172|NCT01976104|3586279|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3752173|NCT01976104|3586275|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752174|NCT01976104|3586276|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752175|NCT01976104|3586277|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752176|NCT01976104|3586278|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752177|NCT01976104|3586279|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752178|NCT01976104|3586275|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3752179|NCT01976104|3586276|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3752180|NCT01976104|3586277|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3752181|NCT01976104|3586278|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3752182|NCT01976104|3586279|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3752183|NCT01976104|3586275|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752184|NCT01976104|3586276|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752185|NCT01976104|3586277|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752186|NCT01976104|3586278|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752187|NCT01976104|3586279|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752188|NCT01976104|3586275|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3752189|NCT01976104|3586276|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3752190|NCT01976104|3586277|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3752191|NCT01976104|3586278|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3752192|NCT01976104|3586279|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3752193|NCT01976104|3586275|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|152|152.0||||||
3752194|NCT01976104|3586276|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3752195|NCT01976104|3586277|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3752196|NCT01976104|3586278|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3752197|NCT01976104|3586279|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3752198|NCT01976104|3586275|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3752199|NCT01976104|3586276|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3752200|NCT01976104|3586277|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3752201|NCT01976104|3586278|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3752202|NCT01976104|3586279|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3752203|NCT01976104|3586275|B5||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3752204|NCT01976104|3586276|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3752205|NCT01976104|3586277|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3752206|NCT01976104|3586278|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3752207|NCT01976104|3586279|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3752208|NCT01976104|3586275|B5||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3752209|NCT01976104|3586276|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3752210|NCT01976104|3586277|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3752211|NCT01976104|3586278|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3752212|NCT01976104|3586279|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3752213|NCT01976104|3586275|B5|||Age||years|Mean|58.2|58.2|Standard Deviation|12.24|12.24|||
3752214|NCT01976104|3586276|B4|||Age||years|Mean|57.9|57.9|Standard Deviation|11.11|11.11|||
3752215|NCT01976104|3586277|B3|||Age||years|Mean|59.2|59.2|Standard Deviation|10.31|10.31|||
3752216|NCT01976104|3586278|B2|||Age||years|Mean|58.6|58.6|Standard Deviation|14.18|14.18|||
3752217|NCT01976104|3586279|B1|||Age||years|Mean|57.3|57.3|Standard Deviation|11.98|11.98|||
3752218|NCT01975974|3586308|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3752219|NCT01975974|3586308|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3752220|NCT01975974|3586308|B1|||Age||years|Mean|60|60.0|Standard Deviation|16|16.0|||
3752221|NCT01975948|3586312|B5|Patient:Other||Who do you usually live with?|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752222|NCT01975948|3586313|B4|Patient:Other||Who do you usually live with?|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|1|1.0||||||
3752223|NCT01975948|3586314|B3|Patient:Other||Who do you usually live with?|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|6|6.0||||||
3752224|NCT01975948|3586315|B2|Patient:Other||Who do you usually live with?|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752225|NCT01975948|3586316|B1|Patient:Other||Who do you usually live with?|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752226|NCT01975948|3586312|B5|Patient:Alone||Who do you usually live with?|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752227|NCT01975948|3586313|B4|Patient:Alone||Who do you usually live with?|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|6|6.0||||||
3752228|NCT01975948|3586314|B3|Patient:Alone||Who do you usually live with?|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|13|13.0||||||
3752229|NCT01975948|3586315|B2|Patient:Alone||Who do you usually live with?|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752230|NCT01975948|3586316|B1|Patient:Alone||Who do you usually live with?|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752231|NCT01975948|3586312|B5|Patient:Parents||Who do you usually live with?|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752232|NCT01975948|3586313|B4|Patient:Parents||Who do you usually live with?|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|4|4.0||||||
3752233|NCT01975948|3586314|B3|Patient:Parents||Who do you usually live with?|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|4|4.0||||||
3752234|NCT01975948|3586315|B2|Patient:Parents||Who do you usually live with?|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752235|NCT01975948|3586316|B1|Patient:Parents||Who do you usually live with?|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752236|NCT01975948|3586312|B5|Patient:Children (but no spouse/partner)||Who do you usually live with?|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752237|NCT01975948|3586313|B4|Patient:Children (but no spouse/partner)||Who do you usually live with?|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|2|2.0||||||
3752238|NCT01975948|3586314|B3|Patient:Children (but no spouse/partner)||Who do you usually live with?|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|4|4.0||||||
3752239|NCT01975948|3586315|B2|Patient:Children (but no spouse/partner)||Who do you usually live with?|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752240|NCT01975948|3586316|B1|Patient:Children (but no spouse/partner)||Who do you usually live with?|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752241|NCT01975948|3586312|B5|Patient:Spouse partner and children||Who do you usually live with?|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752242|NCT01975948|3586313|B4|Patient:Spouse partner and children||Who do you usually live with?|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|19|19.0||||||
3752243|NCT01975948|3586314|B3|Patient:Spouse partner and children||Who do you usually live with?|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|15|15.0||||||
3752244|NCT01975948|3586315|B2|Patient:Spouse partner and children||Who do you usually live with?|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752245|NCT01975948|3586316|B1|Patient:Spouse partner and children||Who do you usually live with?|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752246|NCT01975948|3586312|B5|Patient: Husband/wife/steady partner||Who do you usually live with?|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752247|NCT01975948|3586313|B4|Patient: Husband/wife/steady partner||Who do you usually live with?|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|17|17.0||||||
3752248|NCT01975948|3586314|B3|Patient: Husband/wife/steady partner||Who do you usually live with?|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|18|18.0||||||
3752249|NCT01975948|3586315|B2|Patient: Husband/wife/steady partner||Who do you usually live with?|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752250|NCT01975948|3586316|B1|Patient: Husband/wife/steady partner||Who do you usually live with?|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752251|NCT01975948|3586312|B5|Patient: Other||Mother tongue|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752252|NCT01975948|3586313|B4|Patient: Other||Mother tongue|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|1|1.0||||||
3752253|NCT01975948|3586314|B3|Patient: Other||Mother tongue|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|2|2.0||||||
3752254|NCT01975948|3586315|B2|Patient: Other||Mother tongue|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752255|NCT01975948|3586316|B1|Patient: Other||Mother tongue|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752256|NCT01975948|3586312|B5|Patient: French||Mother tongue|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752257|NCT01975948|3586313|B4|Patient: French||Mother tongue|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|0|0.0||||||
3752258|NCT01975948|3586314|B3|Patient: French||Mother tongue|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|3|3.0||||||
3752259|NCT01975948|3586315|B2|Patient: French||Mother tongue|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752260|NCT01975948|3586316|B1|Patient: French||Mother tongue|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752261|NCT01975948|3586312|B5|Patient: English||Mother tongue|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752262|NCT01975948|3586313|B4|Patient: English||Mother tongue|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|48|48.0||||||
3752263|NCT01975948|3586314|B3|Patient: English||Mother tongue|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|56|56.0||||||
3752264|NCT01975948|3586315|B2|Patient: English||Mother tongue|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752265|NCT01975948|3586316|B1|Patient: English||Mother tongue|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752266|NCT01975948|3586312|B5|Master’s degree or higher||Education|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752267|NCT01975948|3586313|B4|Master’s degree or higher||Education|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|1|1.0||||||
3752268|NCT01975948|3586314|B3|Master’s degree or higher||Education|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|5|5.0||||||
3752269|NCT01975948|3586315|B2|Master’s degree or higher||Education|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752270|NCT01975948|3586316|B1|Master’s degree or higher||Education|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752271|NCT01975948|3586312|B5|Post-secondary degree||Education|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752272|NCT01975948|3586313|B4|Post-secondary degree||Education|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|13|13.0||||||
3752273|NCT01975948|3586314|B3|Post-secondary degree||Education|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|15|15.0||||||
3752274|NCT01975948|3586315|B2|Post-secondary degree||Education|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752275|NCT01975948|3586316|B1|Post-secondary degree||Education|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752276|NCT01975948|3586312|B5|Post-secondary certificate/diploma||Education|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752277|NCT01975948|3586313|B4|Post-secondary certificate/diploma||Education|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|17|17.0||||||
3752278|NCT01975948|3586314|B3|Post-secondary certificate/diploma||Education|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|14|14.0||||||
3752279|NCT01975948|3586315|B2|Post-secondary certificate/diploma||Education|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752280|NCT01975948|3586316|B1|Post-secondary certificate/diploma||Education|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752281|NCT01975948|3586312|B5|Some post-secondary||Education|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752282|NCT01975948|3586313|B4|Some post-secondary||Education|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|10|10.0||||||
3752283|NCT01975948|3586314|B3|Some post-secondary||Education|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|5|5.0||||||
3752284|NCT01975948|3586315|B2|Some post-secondary||Education|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752285|NCT01975948|3586316|B1|Some post-secondary||Education|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752286|NCT01975948|3586312|B5|High school diploma||Education|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752287|NCT01975948|3586313|B4|High school diploma||Education|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|6|6.0||||||
3752288|NCT01975948|3586314|B3|High school diploma||Education|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|14|14.0||||||
3752289|NCT01975948|3586315|B2|High school diploma||Education|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752290|NCT01975948|3586316|B1|High school diploma||Education|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752291|NCT01975948|3586312|B5|Some elementary or high school||Education|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752292|NCT01975948|3586313|B4|Some elementary or high school||Education|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|2|2.0||||||
3752293|NCT01975948|3586314|B3|Some elementary or high school||Education|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|8|8.0||||||
3752294|NCT01975948|3586315|B2|Some elementary or high school||Education|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752295|NCT01975948|3586316|B1|Some elementary or high school||Education|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752296|NCT01975948|3586312|B5|Patients:Retired/student/at-home/other||Employment status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752297|NCT01975948|3586313|B4|Patients:Retired/student/at-home/other||Employment status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|15|15.0||||||
3752298|NCT01975948|3586314|B3|Patients:Retired/student/at-home/other||Employment status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|5|5.0||||||
3752299|NCT01975948|3586315|B2|Patients:Retired/student/at-home/other||Employment status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752300|NCT01975948|3586316|B1|Patients:Retired/student/at-home/other||Employment status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752301|NCT01975948|3586312|B5|Patients:Unemployed due to illness||Employment status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752302|NCT01975948|3586313|B4|Patients:Unemployed due to illness||Employment status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|3|3.0||||||
3752303|NCT01975948|3586314|B3|Patients:Unemployed due to illness||Employment status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|6|6.0||||||
3752304|NCT01975948|3586315|B2|Patients:Unemployed due to illness||Employment status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752305|NCT01975948|3586316|B1|Patients:Unemployed due to illness||Employment status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752306|NCT01975948|3586312|B5|Patients:Unemployed but available to work||Employment status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752307|NCT01975948|3586313|B4|Patients:Unemployed but available to work||Employment status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|2|2.0||||||
3752308|NCT01975948|3586314|B3|Patients:Unemployed but available to work||Employment status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|5|5.0||||||
3752309|NCT01975948|3586315|B2|Patients:Unemployed but available to work||Employment status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752310|NCT01975948|3586316|B1|Patients:Unemployed but available to work||Employment status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752311|NCT01975948|3586312|B5|Patients:Employed part time||Employment status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752312|NCT01975948|3586313|B4|Patients:Employed part time||Employment status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|13|13.0||||||
3752313|NCT01975948|3586314|B3|Patients:Employed part time||Employment status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|8|8.0||||||
3752314|NCT01975948|3586315|B2|Patients:Employed part time||Employment status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752315|NCT01975948|3586316|B1|Patients:Employed part time||Employment status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752316|NCT01975948|3586312|B5|Patients: Employed full time||Employment status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752317|NCT01975948|3586313|B4|Patients: Employed full time||Employment status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|26|26.0||||||
3752318|NCT01975948|3586314|B3|Patients: Employed full time||Employment status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|27|27.0||||||
3752319|NCT01975948|3586315|B2|Patients: Employed full time||Employment status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752320|NCT01975948|3586316|B1|Patients: Employed full time||Employment status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752321|NCT01975948|3586312|B5|Patients: Widowed||Marital Status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752322|NCT01975948|3586313|B4|Patients: Widowed||Marital Status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|2|2.0||||||
3752323|NCT01975948|3586314|B3|Patients: Widowed||Marital Status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|0|0.0||||||
3752324|NCT01975948|3586315|B2|Patients: Widowed||Marital Status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752325|NCT01975948|3586316|B1|Patients: Widowed||Marital Status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752326|NCT01975948|3586312|B5|Patients: Never married||Marital Status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752327|NCT01975948|3586313|B4|Patients: Never married||Marital Status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|10|10.0||||||
3752328|NCT01975948|3586314|B3|Patients: Never married||Marital Status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|17|17.0||||||
3752329|NCT01975948|3586315|B2|Patients: Never married||Marital Status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752330|NCT01975948|3586316|B1|Patients: Never married||Marital Status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752331|NCT01975948|3586312|B5|Patients: Separated/divorced||Marital Status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752332|NCT01975948|3586313|B4|Patients: Separated/divorced||Marital Status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|5|5.0||||||
3752333|NCT01975948|3586314|B3|Patients: Separated/divorced||Marital Status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|11|11.0||||||
3752334|NCT01975948|3586315|B2|Patients: Separated/divorced||Marital Status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752335|NCT01975948|3586316|B1|Patients: Separated/divorced||Marital Status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752336|NCT01975948|3586312|B5|Patients: Married/common-law||Marital Status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752337|NCT01975948|3586313|B4|Patients: Married/common-law||Marital Status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|32|32.0||||||
3752338|NCT01975948|3586314|B3|Patients: Married/common-law||Marital Status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|33|33.0||||||
3752339|NCT01975948|3586315|B2|Patients: Married/common-law||Marital Status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752340|NCT01975948|3586316|B1|Patients: Married/common-law||Marital Status|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752341|NCT01975948|3586312|B5|Other (hospitalist, locum, etc)||Unique patients/yr|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms
3752342|NCT01975948|3586313|B4|Other (hospitalist, locum, etc)||Unique patients/yr|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|NA|||||||This section applies only to physician group
3752343|NCT01975948|3586314|B3|Other (hospitalist, locum, etc)||Unique patients/yr|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|NA|||||||This section applies only to physician group
3752521|NCT01975935|3586343|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3752344|NCT01975948|3586315|B2|Other (hospitalist, locum, etc)||Unique patients/yr|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|0|0.0||||||
3752345|NCT01975948|3586316|B1|Other (hospitalist, locum, etc)||Unique patients/yr|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|2|2.0||||||
3752346|NCT01975948|3586312|B5|3,000 or more||Unique patients/yr|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms
3752347|NCT01975948|3586313|B4|3,000 or more||Unique patients/yr|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|NA|||||||This section applies only to physician group
3752348|NCT01975948|3586314|B3|3,000 or more||Unique patients/yr|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|NA|||||||This section applies only to physician group
3752349|NCT01975948|3586315|B2|3,000 or more||Unique patients/yr|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|6|6.0||||||
3752350|NCT01975948|3586316|B1|3,000 or more||Unique patients/yr|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|11|11.0||||||
3752351|NCT01975948|3586312|B5|2,000-2,999||Unique patients/yr|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms
3752352|NCT01975948|3586313|B4|2,000-2,999||Unique patients/yr|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|NA|||||||This section applies only to physician group
3752353|NCT01975948|3586314|B3|2,000-2,999||Unique patients/yr|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|NA|||||||This section applies only to physician group
3752354|NCT01975948|3586315|B2|2,000-2,999||Unique patients/yr|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|7|7.0||||||
3752355|NCT01975948|3586316|B1|2,000-2,999||Unique patients/yr|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|2|2.0||||||
3752356|NCT01975948|3586312|B5|1,000-1,999||Unique patients/yr|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms
3752357|NCT01975948|3586313|B4|1,000-1,999||Unique patients/yr|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|NA|||||||This section applies only to physician group
3752358|NCT01975948|3586314|B3|1,000-1,999||Unique patients/yr|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|NA|||||||This section applies only to physician group
3752359|NCT01975948|3586315|B2|1,000-1,999||Unique patients/yr|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|12|12.0||||||
3752360|NCT01975948|3586316|B1|1,000-1,999||Unique patients/yr|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|12|12.0||||||
3752361|NCT01975948|3586312|B5|Fewer than 1,000||Unique patients/yr|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms
3752362|NCT01975948|3586313|B4|Fewer than 1,000||Unique patients/yr|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|NA|||||||This section applies only to physician group
3752363|NCT01975948|3586314|B3|Fewer than 1,000||Unique patients/yr|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|NA|||||||This section applies only to physician group
3752364|NCT01975948|3586315|B2|Fewer than 1,000||Unique patients/yr|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|7|7.0||||||
3752365|NCT01975948|3586316|B1|Fewer than 1,000||Unique patients/yr|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|6|6.0||||||
3752366|NCT01975948|3586312|B5|Large gp practice (5+)||Practice type|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms
3752367|NCT01975948|3586313|B4|Large gp practice (5+)||Practice type|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|NA|||||||This section applies only to physician group
3752368|NCT01975948|3586314|B3|Large gp practice (5+)||Practice type|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|NA|||||||This section applies only to physician group
3752369|NCT01975948|3586315|B2|Large gp practice (5+)||Practice type|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|16|16.0||||||
3752370|NCT01975948|3586316|B1|Large gp practice (5+)||Practice type|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|5|5.0||||||
3752371|NCT01975948|3586312|B5|Small gp practice (<5)||Practice type|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms
3752372|NCT01975948|3586313|B4|Small gp practice (<5)||Practice type|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|NA|||||||This section applies only to physician group
3752373|NCT01975948|3586314|B3|Small gp practice (<5)||Practice type|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|NA|||||||This section applies only to physician group
3752374|NCT01975948|3586315|B2|Small gp practice (<5)||Practice type|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|8|8.0||||||
3752375|NCT01975948|3586316|B1|Small gp practice (<5)||Practice type|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|16|16.0||||||
3752376|NCT01975948|3586312|B5|2-physician practice||Practice type|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms
3752636|NCT01975675|3586389|B2|Japanese||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
3752377|NCT01975948|3586313|B4|2-physician practice||Practice type|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|NA|||||||This section applies only to physician group
3752378|NCT01975948|3586314|B3|2-physician practice||Practice type|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|NA|||||||This section applies only to physician group
3752379|NCT01975948|3586315|B2|2-physician practice||Practice type|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|5|5.0||||||
3752380|NCT01975948|3586316|B1|2-physician practice||Practice type|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|8|8.0||||||
3752381|NCT01975948|3586312|B5|Solo practice||Practice type|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms
3752382|NCT01975948|3586313|B4|Solo practice||Practice type|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|NA|||||||This section applies only to physician group
3752383|NCT01975948|3586314|B3|Solo practice||Practice type|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|NA|||||||This section applies only to physician group
3752384|NCT01975948|3586315|B2|Solo practice||Practice type|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|5|5.0||||||
3752385|NCT01975948|3586316|B1|Solo practice||Practice type|Measures for the physician group are based on pre and post training completers (n=73)|participants|Number|9|9.0||||||
3752386|NCT01975948|3586312|B5|Part time||Pattern of work|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752387|NCT01975948|3586313|B4|Part time||Pattern of work|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||This section applies only to physician group
3752388|NCT01975948|3586314|B3|Part time||Pattern of work|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||This section applies only to physician group
3752389|NCT01975948|3586315|B2|Part time||Pattern of work|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|5|5.0||||||
3752390|NCT01975948|3586316|B1|Part time||Pattern of work|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|5|5.0||||||
3752391|NCT01975948|3586312|B5|Full time||Pattern of work|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752392|NCT01975948|3586313|B4|Full time||Pattern of work|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||This section applies only to physician group
3752393|NCT01975948|3586314|B3|Full time||Pattern of work|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||This section applies only to physician group
3752394|NCT01975948|3586315|B2|Full time||Pattern of work|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|29|29.0||||||
3752395|NCT01975948|3586316|B1|Full time||Pattern of work|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|34|34.0||||||
3752396|NCT01975948|3586312|B5|30 years or more||Years in practice|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752397|NCT01975948|3586313|B4|30 years or more||Years in practice|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||This section applies only to physician group
3752398|NCT01975948|3586314|B3|30 years or more||Years in practice|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||This section applies only to physician group
3752399|NCT01975948|3586315|B2|30 years or more||Years in practice|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|6|6.0||||||
3752400|NCT01975948|3586316|B1|30 years or more||Years in practice|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|5|5.0||||||
3752401|NCT01975948|3586312|B5|25-29years||Years in practice|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752402|NCT01975948|3586313|B4|25-29years||Years in practice|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||This section applies only to physician group
3752403|NCT01975948|3586314|B3|25-29years||Years in practice|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||This section applies only to physician group
3752404|NCT01975948|3586315|B2|25-29years||Years in practice|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|7|7.0||||||
3752405|NCT01975948|3586316|B1|25-29years||Years in practice|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|9|9.0||||||
3752406|NCT01975948|3586312|B5|20-24years||Years in practice|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752407|NCT01975948|3586313|B4|20-24years||Years in practice|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||This section applies only to physician group
3752408|NCT01975948|3586314|B3|20-24years||Years in practice|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||This section applies only to physician group
3752409|NCT01975948|3586315|B2|20-24years||Years in practice|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|3|3.0||||||
3752410|NCT01975948|3586316|B1|20-24years||Years in practice|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|9|9.0||||||
3752411|NCT01975948|3586312|B5|15-19years||Years in practice|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752412|NCT01975948|3586313|B4|15-19years||Years in practice|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||This section applies only to physician group
3752413|NCT01975948|3586314|B3|15-19years||Years in practice|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||This section applies only to physician group
3752414|NCT01975948|3586315|B2|15-19years||Years in practice|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|6|6.0||||||
3752415|NCT01975948|3586316|B1|15-19years||Years in practice|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|1|1.0||||||
3752416|NCT01975948|3586312|B5|10-14years||Years in practice|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752417|NCT01975948|3586313|B4|10-14years||Years in practice|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||This section applies only to physician group
3752418|NCT01975948|3586314|B3|10-14years||Years in practice|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||This section applies only to physician group
3752419|NCT01975948|3586315|B2|10-14years||Years in practice|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|5|5.0||||||
3752420|NCT01975948|3586316|B1|10-14years||Years in practice|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|3|3.0||||||
3752421|NCT01975948|3586312|B5|5-9years||Years in practice|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752422|NCT01975948|3586313|B4|5-9years||Years in practice|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||This section applies only to physician group
3752423|NCT01975948|3586314|B3|5-9years||Years in practice|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||This section applies only to physician group
3752424|NCT01975948|3586315|B2|5-9years||Years in practice|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|3|3.0||||||
3752425|NCT01975948|3586316|B1|5-9years||Years in practice|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|3|3.0||||||
3752426|NCT01975948|3586312|B5|1-4years||Years in practice|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752427|NCT01975948|3586313|B4|1-4years||Years in practice|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||This section applies only to physician group
3752428|NCT01975948|3586314|B3|1-4years||Years in practice|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||This section applies only to physician group
3752429|NCT01975948|3586315|B2|1-4years||Years in practice|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|2|2.0||||||
3752430|NCT01975948|3586316|B1|1-4years||Years in practice|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|7|7.0||||||
3752431|NCT01975948|3586312|B5|Less than 1 year||Years in practice|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752432|NCT01975948|3586313|B4|Less than 1 year||Years in practice|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||This section applies only to physician group
3752433|NCT01975948|3586314|B3|Less than 1 year||Years in practice|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||This section applies only to physician group
3752434|NCT01975948|3586315|B2|Less than 1 year||Years in practice|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|2|2.0||||||
3752435|NCT01975948|3586316|B1|Less than 1 year||Years in practice|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|0|0.0||||||
3752436|NCT01975948|3586312|B5|Canada||Region of Enrollment||participants|Number|189|189.0||||||
3752437|NCT01975948|3586313|B4|Canada||Region of Enrollment||participants|Number|51|51.0||||||
3752438|NCT01975948|3586314|B3|Canada||Region of Enrollment||participants|Number|65|65.0||||||
3752439|NCT01975948|3586315|B2|Canada||Region of Enrollment||participants|Number|34|34.0||||||
3752440|NCT01975948|3586316|B1|Canada||Region of Enrollment||participants|Number|39|39.0||||||
3752441|NCT01975948|3586312|B5||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3752442|NCT01975948|3586313|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3752443|NCT01975948|3586314|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3752444|NCT01975948|3586315|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3752445|NCT01975948|3586316|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3752446|NCT01975948|3586312|B5||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3752447|NCT01975948|3586313|B4||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3752448|NCT01975948|3586314|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3752449|NCT01975948|3586315|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3752450|NCT01975948|3586316|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3752522|NCT01975935|3586344|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3752451|NCT01975948|3586312|B5|Patients >70 years||Age, Customized|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752452|NCT01975948|3586313|B4|Patients >70 years||Age, Customized|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|1|1.0||||||
3752453|NCT01975948|3586314|B3|Patients >70 years||Age, Customized|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|5|5.0||||||
3752454|NCT01975948|3586315|B2|Patients >70 years||Age, Customized|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752455|NCT01975948|3586316|B1|Patients >70 years||Age, Customized|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752456|NCT01975948|3586312|B5|Patients 60-69 years||Age, Customized|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752457|NCT01975948|3586313|B4|Patients 60-69 years||Age, Customized|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|3|3.0||||||
3752458|NCT01975948|3586314|B3|Patients 60-69 years||Age, Customized|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|9|9.0||||||
3752459|NCT01975948|3586315|B2|Patients 60-69 years||Age, Customized|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752460|NCT01975948|3586316|B1|Patients 60-69 years||Age, Customized|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752461|NCT01975948|3586312|B5|Patients 50-59 years||Age, Customized|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752462|NCT01975948|3586313|B4|Patients 50-59 years||Age, Customized|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|7|7.0||||||
3752463|NCT01975948|3586314|B3|Patients 50-59 years||Age, Customized|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|9|9.0||||||
3752464|NCT01975948|3586315|B2|Patients 50-59 years||Age, Customized|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752465|NCT01975948|3586316|B1|Patients 50-59 years||Age, Customized|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752466|NCT01975948|3586312|B5|Patients 40-49 years||Age, Customized|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752467|NCT01975948|3586313|B4|Patients 40-49 years||Age, Customized|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|8|8.0||||||
3752468|NCT01975948|3586314|B3|Patients 40-49 years||Age, Customized|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|14|14.0||||||
3752469|NCT01975948|3586315|B2|Patients 40-49 years||Age, Customized|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752470|NCT01975948|3586316|B1|Patients 40-49 years||Age, Customized|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752471|NCT01975948|3586312|B5|Patients 30-39 years||Age, Customized|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752472|NCT01975948|3586313|B4|Patients 30-39 years||Age, Customized|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|18|18.0||||||
3752473|NCT01975948|3586314|B3|Patients 30-39 years||Age, Customized|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|13|13.0||||||
3752474|NCT01975948|3586315|B2|Patients 30-39 years||Age, Customized|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752475|NCT01975948|3586316|B1|Patients 30-39 years||Age, Customized|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752476|NCT01975948|3586312|B5|Patients 18-29 years||Age, Customized|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752477|NCT01975948|3586313|B4|Patients 18-29 years||Age, Customized|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|12|12.0||||||
3752478|NCT01975948|3586314|B3|Patients 18-29 years||Age, Customized|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|11|11.0||||||
3752479|NCT01975948|3586315|B2|Patients 18-29 years||Age, Customized|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752480|NCT01975948|3586316|B1|Patients 18-29 years||Age, Customized|Patient data is based on those who completed at least one data time point (n=116).|Participants|Count of Participants|NA|||||||This section applies only to patient population
3752481|NCT01975948|3586312|B5|Physician 60-69years||Age, Customized|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752482|NCT01975948|3586313|B4|Physician 60-69years||Age, Customized|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||This section applies only to physician population
3752483|NCT01975948|3586314|B3|Physician 60-69years||Age, Customized|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||This section applies only to physician population
3752484|NCT01975948|3586315|B2|Physician 60-69years||Age, Customized|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|3|3.0||||||
3752485|NCT01975948|3586316|B1|Physician 60-69years||Age, Customized|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|5|5.0||||||
3752486|NCT01975948|3586312|B5|Physician 50-59years||Age, Customized|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752487|NCT01975948|3586313|B4|Physician 50-59years||Age, Customized|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||This section applies only to physician population
3752488|NCT01975948|3586314|B3|Physician 50-59years||Age, Customized|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||This section applies only to physician population
3752489|NCT01975948|3586315|B2|Physician 50-59years||Age, Customized|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|10|10.0||||||
3752490|NCT01975948|3586316|B1|Physician 50-59years||Age, Customized|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|16|16.0||||||
3752491|NCT01975948|3586312|B5|Physician 40-49years||Age, Customized|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752492|NCT01975948|3586313|B4|Physician 40-49years||Age, Customized|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||This section applies only to physician population
3752493|NCT01975948|3586314|B3|Physician 40-49years||Age, Customized|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||This section applies only to physician population
3752494|NCT01975948|3586315|B2|Physician 40-49years||Age, Customized|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|14|14.0||||||
3752495|NCT01975948|3586316|B1|Physician 40-49years||Age, Customized|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|10|10.0||||||
3752496|NCT01975948|3586312|B5|Physician 30-39years||Age, Customized|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752497|NCT01975948|3586313|B4|Physician 30-39years||Age, Customized|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||This section applies only to physician population
3752498|NCT01975948|3586314|B3|Physician 30-39years||Age, Customized|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||This section applies only to physician population
3752499|NCT01975948|3586315|B2|Physician 30-39years||Age, Customized|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|5|5.0||||||
3752500|NCT01975948|3586316|B1|Physician 30-39years||Age, Customized|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|8|8.0||||||
3752501|NCT01975948|3586312|B5|Physician 20-29years||Age, Customized|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752502|NCT01975948|3586313|B4|Physician 20-29years||Age, Customized|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||This section applies only to physician population
3752503|NCT01975948|3586314|B3|Physician 20-29years||Age, Customized|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|NA|||||||This section applies only to physician population
3752504|NCT01975948|3586315|B2|Physician 20-29years||Age, Customized|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|2|2.0||||||
3752505|NCT01975948|3586316|B1|Physician 20-29years||Age, Customized|Measures for the physician group are based on pre and post training completers (n=73).|participants|Number|0|0.0||||||
3752506|NCT01975935|3586343|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
3752507|NCT01975935|3586344|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
3752508|NCT01975935|3586345|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3752509|NCT01975935|3586343|B3|Decline to Answer||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3752510|NCT01975935|3586344|B2|Decline to Answer||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3752511|NCT01975935|3586345|B1|Decline to Answer||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3752512|NCT01975935|3586343|B3|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3752513|NCT01975935|3586344|B2|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3752514|NCT01975935|3586345|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3752515|NCT01975935|3586343|B3|Native American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3752516|NCT01975935|3586344|B2|Native American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3752517|NCT01975935|3586345|B1|Native American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3752518|NCT01975935|3586343|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3752519|NCT01975935|3586344|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3752520|NCT01975935|3586345|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3752523|NCT01975935|3586345|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3752524|NCT01975935|3586343|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
3752525|NCT01975935|3586344|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3752526|NCT01975935|3586345|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3752527|NCT01975935|3586343|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3752528|NCT01975935|3586344|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3752529|NCT01975935|3586345|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3752530|NCT01975935|3586343|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3752531|NCT01975935|3586344|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3752532|NCT01975935|3586345|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3752533|NCT01975935|3586343|B3|||Age||years|Mean|57.52|57.52|Standard Deviation|8.70|8.7|||
3752534|NCT01975935|3586344|B2|||Age||years|Mean|55.81|55.81|Standard Deviation|9.52|9.52|||
3752535|NCT01975935|3586345|B1|||Age||years|Mean|59.24|59.24|Standard Deviation|7.65|7.65|||
3752536|NCT01975935|3586343|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3752537|NCT01975935|3586344|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3752538|NCT01975935|3586345|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3752539|NCT01975935|3586343|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3752540|NCT01975935|3586344|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3752541|NCT01975935|3586345|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3752542|NCT01975935|3586343|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3752543|NCT01975935|3586344|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3752544|NCT01975935|3586345|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3752545|NCT01975922|3586356|B3|United States||Region of Enrollment||participants|Number|97|97.0||||||
3752546|NCT01975922|3586357|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
3752547|NCT01975922|3586358|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
3752548|NCT01975922|3586356|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3752549|NCT01975922|3586357|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3752550|NCT01975922|3586358|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3752551|NCT01975922|3586356|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3752552|NCT01975922|3586357|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3752553|NCT01975922|3586358|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3752554|NCT01975922|3586356|B3|||Age||months|Mean|30.4|30.4|Standard Deviation|5.0|5.0|||
3752555|NCT01975922|3586357|B2|||Age||months|Mean|30.6|30.6|Standard Deviation|5.1|5.1|||
3752556|NCT01975922|3586358|B1|||Age||months|Mean|30.3|30.3|Standard Deviation|5.0|5.0|||
3752557|NCT01975922|3586356|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3752558|NCT01975922|3586357|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3752559|NCT01975922|3586358|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3752560|NCT01975922|3586356|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3752561|NCT01975922|3586357|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3752562|NCT01975922|3586358|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3752563|NCT01975922|3586356|B3||<=18 years|Age||Participants|Count of Participants|97|97.0||||||
3752564|NCT01975922|3586357|B2||<=18 years|Age||Participants|Count of Participants|52|52.0||||||
3752565|NCT01975922|3586358|B1||<=18 years|Age||Participants|Count of Participants|45|45.0||||||
3752566|NCT01975909|3586367|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3752567|NCT01975909|3586368|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3752568|NCT01975909|3586369|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3752569|NCT01975909|3586367|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3752570|NCT01975909|3586368|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3752571|NCT01975909|3586369|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3752572|NCT01975909|3586367|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3752573|NCT01975909|3586368|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3752574|NCT01975909|3586369|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3752575|NCT01975909|3586367|B3|||Age||years|Mean|50.6|50.6|Standard Deviation|7.5|7.5|||
3752576|NCT01975909|3586368|B2|||Age||years|Mean|48.6|48.6|Standard Deviation|4.8|4.8|||
3752577|NCT01975909|3586369|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|10.1|10.1|||
3752578|NCT01975675|3586386|B5|IFN Intolerant||Response to Prior HCV Treatment||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752579|NCT01975675|3586387|B4|IFN Intolerant||Response to Prior HCV Treatment||participants|Number|15|15.0||||||
3752580|NCT01975675|3586388|B3|IFN Intolerant||Response to Prior HCV Treatment||participants|Number|15|15.0||||||
3752581|NCT01975675|3586389|B2|IFN Intolerant||Response to Prior HCV Treatment||participants|Number|NA|||||||Data not available because treatment-naive participants did not receive prior HCV treatment.
3752582|NCT01975675|3586390|B1|IFN Intolerant||Response to Prior HCV Treatment||participants|Number|NA|||||||Data not available because treatment-naive participants did not receive prior HCV treatment.
3752583|NCT01975675|3586386|B5|Relapse/Breakthrough||Response to Prior HCV Treatment||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752584|NCT01975675|3586387|B4|Relapse/Breakthrough||Response to Prior HCV Treatment||participants|Number|44|44.0||||||
3752585|NCT01975675|3586388|B3|Relapse/Breakthrough||Response to Prior HCV Treatment||participants|Number|44|44.0||||||
3752586|NCT01975675|3586389|B2|Relapse/Breakthrough||Response to Prior HCV Treatment||participants|Number|NA|||||||Data not available because treatment-naive participants did not receive prior HCV treatment.
3752587|NCT01975675|3586390|B1|Relapse/Breakthrough||Response to Prior HCV Treatment||participants|Number|NA|||||||Data not available because treatment-naive participants did not receive prior HCV treatment.
3752588|NCT01975675|3586386|B5|Nonresponder||Response to Prior HCV Treatment||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3752589|NCT01975675|3586387|B4|Nonresponder||Response to Prior HCV Treatment||participants|Number|28|28.0||||||
3752590|NCT01975675|3586388|B3|Nonresponder||Response to Prior HCV Treatment||participants|Number|29|29.0||||||
3752591|NCT01975675|3586389|B2|Nonresponder||Response to Prior HCV Treatment||participants|Number|NA|||||||Data not available because treatment-naive participants did not receive prior HCV treatment.
3752592|NCT01975675|3586390|B1|Nonresponder||Response to Prior HCV Treatment||participants|Number|NA|||||||Data not available because treatment-naive participants did not receive prior HCV treatment.
3752593|NCT01975675|3586386|B5|Yes||Cirrhosis Status||participants|Number|76|76.0||||||
3752594|NCT01975675|3586387|B4|Yes||Cirrhosis Status||participants|Number|23|23.0||||||
3752595|NCT01975675|3586388|B3|Yes||Cirrhosis Status||participants|Number|28|28.0||||||
3752596|NCT01975675|3586389|B2|Yes||Cirrhosis Status||participants|Number|12|12.0||||||
3752597|NCT01975675|3586390|B1|Yes||Cirrhosis Status||participants|Number|13|13.0||||||
3752598|NCT01975675|3586386|B5|No||Cirrhosis Status||participants|Number|265|265.0||||||
3752599|NCT01975675|3586387|B4|No||Cirrhosis Status||participants|Number|64|64.0||||||
3752600|NCT01975675|3586388|B3|No||Cirrhosis Status||participants|Number|60|60.0||||||
3752601|NCT01975675|3586389|B2|No||Cirrhosis Status||participants|Number|71|71.0||||||
3752602|NCT01975675|3586390|B1|No||Cirrhosis Status||participants|Number|70|70.0||||||
3752603|NCT01975675|3586386|B5|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|16|16.0||||||
3752604|NCT01975675|3586387|B4|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
3752605|NCT01975675|3586388|B3|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|6|6.0||||||
3752606|NCT01975675|3586389|B2|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|6|6.0||||||
3752607|NCT01975675|3586390|B1|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3752608|NCT01975675|3586386|B5|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|160|160.0||||||
3752609|NCT01975675|3586387|B4|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|51|51.0||||||
3752610|NCT01975675|3586388|B3|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|49|49.0||||||
3752611|NCT01975675|3586389|B2|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|31|31.0||||||
3752612|NCT01975675|3586390|B1|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|29|29.0||||||
3752613|NCT01975675|3586386|B5|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|165|165.0||||||
3752614|NCT01975675|3586387|B4|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|33|33.0||||||
3752615|NCT01975675|3586388|B3|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|33|33.0||||||
3752616|NCT01975675|3586389|B2|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|46|46.0||||||
3752617|NCT01975675|3586390|B1|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|53|53.0||||||
3752618|NCT01975675|3586386|B5|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|304|304.0||||||
3752619|NCT01975675|3586387|B4|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|74|74.0||||||
3752620|NCT01975675|3586388|B3|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|78|78.0||||||
3752621|NCT01975675|3586389|B2|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|75|75.0||||||
3752622|NCT01975675|3586390|B1|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|77|77.0||||||
3752623|NCT01975675|3586386|B5|< 800,000 IU/mL||HCV RNA Category||participants|Number|37|37.0||||||
3752624|NCT01975675|3586387|B4|< 800,000 IU/mL||HCV RNA Category||participants|Number|13|13.0||||||
3752625|NCT01975675|3586388|B3|< 800,000 IU/mL||HCV RNA Category||participants|Number|10|10.0||||||
3752626|NCT01975675|3586389|B2|< 800,000 IU/mL||HCV RNA Category||participants|Number|8|8.0||||||
3752627|NCT01975675|3586390|B1|< 800,000 IU/mL||HCV RNA Category||participants|Number|6|6.0||||||
3752628|NCT01975675|3586386|B5|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.6|6.6|Standard Deviation|0.53|0.53|||
3752629|NCT01975675|3586387|B4|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.54|0.54|||
3752630|NCT01975675|3586388|B3|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.6|6.6|Standard Deviation|0.55|0.55|||
3752631|NCT01975675|3586389|B2|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.6|6.6|Standard Deviation|0.54|0.54|||
3752632|NCT01975675|3586390|B1|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.6|6.6|Standard Deviation|0.48|0.48|||
3752633|NCT01975675|3586386|B5|Japanese||Race/Ethnicity, Customized||participants|Number|341|341.0||||||
3752634|NCT01975675|3586387|B4|Japanese||Race/Ethnicity, Customized||participants|Number|87|87.0||||||
3752635|NCT01975675|3586388|B3|Japanese||Race/Ethnicity, Customized||participants|Number|88|88.0||||||
3752637|NCT01975675|3586390|B1|Japanese||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
3752638|NCT01975675|3586386|B5||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3752639|NCT01975675|3586387|B4||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3752640|NCT01975675|3586388|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3752641|NCT01975675|3586389|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3752642|NCT01975675|3586390|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3752643|NCT01975675|3586386|B5||Female|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
3752644|NCT01975675|3586387|B4||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3752645|NCT01975675|3586388|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3752646|NCT01975675|3586389|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3752647|NCT01975675|3586390|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3752648|NCT01975675|3586386|B5|≥ 65 years||Age, Customized||participants|Number|112|112.0||||||
3752649|NCT01975675|3586387|B4|≥ 65 years||Age, Customized||participants|Number|24|24.0||||||
3752650|NCT01975675|3586388|B3|≥ 65 years||Age, Customized||participants|Number|37|37.0||||||
3752651|NCT01975675|3586389|B2|≥ 65 years||Age, Customized||participants|Number|28|28.0||||||
3752652|NCT01975675|3586390|B1|≥ 65 years||Age, Customized||participants|Number|23|23.0||||||
3752653|NCT01975675|3586386|B5|< 65 years||Age, Customized||participants|Number|229|229.0||||||
3752654|NCT01975675|3586387|B4|< 65 years||Age, Customized||participants|Number|63|63.0||||||
3752655|NCT01975675|3586388|B3|< 65 years||Age, Customized||participants|Number|51|51.0||||||
3752656|NCT01975675|3586389|B2|< 65 years||Age, Customized||participants|Number|55|55.0||||||
3752657|NCT01975675|3586390|B1|< 65 years||Age, Customized||participants|Number|60|60.0||||||
3752658|NCT01975675|3586386|B5|||Age||years|Mean|59|59.0|Standard Deviation|9.4|9.4|||
3752659|NCT01975675|3586387|B4|||Age||years|Mean|59|59.0|Standard Deviation|8.7|8.7|||
3752660|NCT01975675|3586388|B3|||Age||years|Mean|61|61.0|Standard Deviation|8.5|8.5|||
3752661|NCT01975675|3586389|B2|||Age||years|Mean|59|59.0|Standard Deviation|10.3|10.3|||
3752662|NCT01975675|3586390|B1|||Age||years|Mean|59|59.0|Standard Deviation|9.9|9.9|||
3752663|NCT01975467|3586413|B3||Male|Gender||||0|0.0||||||
3752664|NCT01975467|3586413|B3||Female|Gender||||0|0.0||||||
3752665|NCT01975389|3586424|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|283|283.0||||||
3752666|NCT01975389|3586425|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
3752667|NCT01975389|3586426|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|143|143.0||||||
3752668|NCT01975389|3586424|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752669|NCT01975389|3586425|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752670|NCT01975389|3586426|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752671|NCT01975389|3586424|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9560|9560.0||||||
3752672|NCT01975389|3586425|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4784|4784.0||||||
3752673|NCT01975389|3586426|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4776|4776.0||||||
3752674|NCT01975389|3586424|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|498|498.0||||||
3752675|NCT01975389|3586425|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|252|252.0||||||
3752676|NCT01975389|3586426|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|246|246.0||||||
3752677|NCT01975389|3586424|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752678|NCT01975389|3586425|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752679|NCT01975389|3586426|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752680|NCT01975389|3586424|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|223|223.0||||||
3752681|NCT01975389|3586425|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
3752682|NCT01975389|3586426|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|118|118.0||||||
3752683|NCT01975389|3586424|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752684|NCT01975389|3586425|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752685|NCT01975389|3586426|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752686|NCT01975389|3586424|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3752687|NCT01975389|3586425|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3752688|NCT01975389|3586426|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3752689|NCT01975389|3586424|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8817|8817.0||||||
3752690|NCT01975389|3586425|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4387|4387.0||||||
3752691|NCT01975389|3586426|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4430|4430.0||||||
3752692|NCT01975389|3586424|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1744|1744.0||||||
3752693|NCT01975389|3586425|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|892|892.0||||||
3752694|NCT01975389|3586426|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|852|852.0||||||
3752695|NCT01975389|3586424|B3||Male|Sex: Female, Male||Participants|Count of Participants|6923|6923.0||||||
3752696|NCT01975389|3586425|B2||Male|Sex: Female, Male||Participants|Count of Participants|3489|3489.0||||||
3752697|NCT01975389|3586426|B1||Male|Sex: Female, Male||Participants|Count of Participants|3434|3434.0||||||
3752698|NCT01975389|3586424|B3||Female|Sex: Female, Male||Participants|Count of Participants|3641|3641.0||||||
3752699|NCT01975389|3586425|B2||Female|Sex: Female, Male||Participants|Count of Participants|1792|1792.0||||||
3752700|NCT01975389|3586426|B1||Female|Sex: Female, Male||Participants|Count of Participants|1849|1849.0||||||
3752701|NCT01975389|3586424|B3|||Age||Years|Mean|62.4|62.4|Standard Deviation|9.6|9.6|||
3752702|NCT01975389|3586425|B2|||Age||Years|Mean|62.2|62.2|Standard Deviation|9.6|9.6|||
3752703|NCT01975389|3586426|B1|||Age||Years|Mean|62.5|62.5|Standard Deviation|9.5|9.5|||
3752704|NCT01975376|3586485|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|662|662.0||||||
3752705|NCT01975376|3586486|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|333|333.0||||||
3752706|NCT01975376|3586487|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|329|329.0||||||
3752707|NCT01975376|3586485|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752708|NCT01975376|3586486|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752709|NCT01975376|3586487|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752710|NCT01975376|3586485|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14595|14595.0||||||
3752711|NCT01975376|3586486|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7280|7280.0||||||
3752712|NCT01975376|3586487|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7315|7315.0||||||
3752713|NCT01975376|3586485|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|804|804.0||||||
3752714|NCT01975376|3586486|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|412|412.0||||||
3752715|NCT01975376|3586487|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|392|392.0||||||
3752716|NCT01975376|3586485|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752717|NCT01975376|3586486|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752718|NCT01975376|3586487|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752719|NCT01975376|3586485|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|723|723.0||||||
3752720|NCT01975376|3586486|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|369|369.0||||||
3752721|NCT01975376|3586487|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|354|354.0||||||
3752722|NCT01975376|3586485|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752723|NCT01975376|3586486|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752724|NCT01975376|3586487|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752725|NCT01975376|3586485|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3752726|NCT01975376|3586486|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3752727|NCT01975376|3586487|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3752728|NCT01975376|3586485|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13273|13273.0||||||
3752729|NCT01975376|3586486|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6642|6642.0||||||
3752730|NCT01975376|3586487|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6631|6631.0||||||
3752731|NCT01975376|3586485|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3504|3504.0||||||
3752732|NCT01975376|3586486|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1746|1746.0||||||
3752733|NCT01975376|3586487|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1758|1758.0||||||
3752734|NCT01975376|3586485|B3||Male|Sex: Female, Male||Participants|Count of Participants|12354|12354.0||||||
3752735|NCT01975376|3586486|B2||Male|Sex: Female, Male||Participants|Count of Participants|6187|6187.0||||||
3752736|NCT01975376|3586487|B1||Male|Sex: Female, Male||Participants|Count of Participants|6167|6167.0||||||
3752737|NCT01975376|3586485|B3||Female|Sex: Female, Male||Participants|Count of Participants|4430|4430.0||||||
3752738|NCT01975376|3586486|B2||Female|Sex: Female, Male||Participants|Count of Participants|2207|2207.0||||||
3752739|NCT01975376|3586487|B1||Female|Sex: Female, Male||Participants|Count of Participants|2223|2223.0||||||
3752740|NCT01975376|3586485|B3|||Age||Years|Mean|63.3|63.3|Standard Deviation|9.1|9.1|||
3752741|NCT01975376|3586486|B2|||Age||Years|Mean|63.3|63.3|Standard Deviation|9.1|9.1|||
3752742|NCT01975376|3586487|B1|||Age||Years|Mean|63.3|63.3|Standard Deviation|9.2|9.2|||
3752743|NCT01975285|3586546|B3|United States||Region of Enrollment||participants|Number|56|56.0||||||
3752744|NCT01975285|3586547|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
3752745|NCT01975285|3586548|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
3752746|NCT01975285|3586546|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752747|NCT01975285|3586547|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752748|NCT01975285|3586548|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752749|NCT01975285|3586546|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3752750|NCT01975285|3586547|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3752751|NCT01975285|3586548|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752752|NCT01975285|3586546|B3||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3752753|NCT01975285|3586547|B2||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3752754|NCT01975285|3586548|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3752755|NCT01975285|3586546|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3752756|NCT01975285|3586547|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3752757|NCT01975285|3586548|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3752758|NCT01975285|3586546|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752759|NCT01975285|3586547|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752760|NCT01975285|3586548|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752761|NCT01975285|3586546|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3752762|NCT01975285|3586547|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3752763|NCT01975285|3586548|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3752764|NCT01975285|3586546|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752765|NCT01975285|3586547|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752766|NCT01975285|3586548|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752767|NCT01975285|3586546|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3752768|NCT01975285|3586547|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3752769|NCT01975285|3586548|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3752770|NCT01975285|3586546|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3752771|NCT01975285|3586547|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3752772|NCT01975285|3586548|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3752773|NCT01975285|3586546|B3|||Age||years|Mean|55|55.0|Standard Deviation|14|14.0|||
3752774|NCT01975285|3586547|B2|||Age||years|Mean|55|55.0|Standard Deviation|14|14.0|||
3752775|NCT01975285|3586548|B1|||Age||years|Mean|55|55.0|Standard Deviation|15|15.0|||
3752776|NCT01975246|3586563|B3||Male|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
3752777|NCT01975246|3586564|B2||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3752778|NCT01975246|3586565|B1||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3752779|NCT01975246|3586563|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3752780|NCT01975246|3586564|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3752781|NCT01975246|3586565|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3752782|NCT01975246|3586563|B3|||Age||Years|Mean|54.7|54.7|Standard Deviation|9.4|9.4|||
3752783|NCT01975246|3586564|B2|||Age||Years|Mean|55.0|55.0|Standard Deviation|9.7|9.7|||
3752784|NCT01975246|3586565|B1|||Age||Years|Mean|54.4|54.4|Standard Deviation|9.1|9.1|||
3752785|NCT01975220|3586576|B4||Male|Gender||Participants|Count of Participants|41|41.0||||||
3752786|NCT01975220|3586577|B3||Male|Gender||Participants|Count of Participants|14|14.0||||||
3752787|NCT01975220|3586578|B2||Male|Gender||Participants|Count of Participants|14|14.0||||||
3752788|NCT01975220|3586579|B1||Male|Gender||Participants|Count of Participants|13|13.0||||||
3752789|NCT01975220|3586576|B4||Female|Gender||Participants|Count of Participants|30|30.0||||||
3752790|NCT01975220|3586577|B3||Female|Gender||Participants|Count of Participants|10|10.0||||||
3752791|NCT01975220|3586578|B2||Female|Gender||Participants|Count of Participants|10|10.0||||||
3752792|NCT01975220|3586579|B1||Female|Gender||Participants|Count of Participants|10|10.0||||||
3752793|NCT01975220|3586576|B4|||Age||years|Mean|32.5|32.5|Standard Deviation|8.8|8.8|||
3752794|NCT01975220|3586577|B3|||Age||years|Mean|30.8|30.8|Standard Deviation|8.4|8.4|||
3752795|NCT01975220|3586578|B2|||Age||years|Mean|34.2|34.2|Standard Deviation|9.2|9.2|||
3752796|NCT01975220|3586579|B1|||Age||years|Mean|32.4|32.4|Standard Deviation|8.7|8.7|||
3752797|NCT01975090|3586628|B1|Chile||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3752798|NCT01975090|3586628|B1|United States||Region of Enrollment||Participants|Count of Participants|115|115.0||||||
3752799|NCT01975090|3586628|B1|Belgium||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3752800|NCT01975090|3586628|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3752801|NCT01975090|3586628|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3752802|NCT01975090|3586628|B1|||Age||years|Mean|62.6|62.6|Standard Deviation|13.52|13.52|||
3752803|NCT01975090|3586628|B1||>=65 years|Age||Participants|Count of Participants|59|59.0||||||
3752804|NCT01975090|3586628|B1||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
3752805|NCT01975090|3586628|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3752806|NCT01974895|3586638|B3||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3752807|NCT01974895|3586639|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3752808|NCT01974895|3586640|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3752809|NCT01974895|3586638|B3||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3752810|NCT01974895|3586639|B2||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3752811|NCT01974895|3586640|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3752812|NCT01974895|3586638|B3|||Age||Months|Mean|19.7|19.7|Standard Deviation|8.84|8.84|||
3752813|NCT01974895|3586639|B2|||Age||Months|Mean|19.8|19.8|Standard Deviation|8.9|8.9|||
3752814|NCT01974895|3586640|B1|||Age||Months|Mean|19.6|19.6|Standard Deviation|8.8|8.8|||
3752815|NCT01974817|3586671|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3752816|NCT01974817|3586671|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752817|NCT01974817|3586671|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3752818|NCT01974817|3586671|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3752819|NCT01974817|3586671|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3752820|NCT01974817|3586671|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3752821|NCT01974817|3586671|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752822|NCT01974817|3586671|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3752823|NCT01974817|3586671|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3752824|NCT01974817|3586671|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3752825|NCT01974817|3586671|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3752826|NCT01974817|3586671|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3752827|NCT01974817|3586671|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3752828|NCT01974752|3586675|B3|White||Race/Ethnicity, Customized||Participants|Number|127|127.0||||||
3752829|NCT01974752|3586676|B2|White||Race/Ethnicity, Customized||Participants|Number|31|31.0||||||
3752830|NCT01974752|3586677|B1|White||Race/Ethnicity, Customized||Participants|Number|96|96.0||||||
3752831|NCT01974752|3586675|B3|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3752832|NCT01974752|3586676|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3752833|NCT01974752|3586677|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3752834|NCT01974752|3586675|B3||Male|Gender||Participants|Count of Participants|68|68.0||||||
3752835|NCT01974752|3586676|B2||Male|Gender||Participants|Count of Participants|13|13.0||||||
3752836|NCT01974752|3586677|B1||Male|Gender||Participants|Count of Participants|55|55.0||||||
3752837|NCT01974752|3586675|B3||Female|Gender||Participants|Count of Participants|61|61.0||||||
3752838|NCT01974752|3586676|B2||Female|Gender||Participants|Count of Participants|19|19.0||||||
3752839|NCT01974752|3586677|B1||Female|Gender||Participants|Count of Participants|42|42.0||||||
3752840|NCT01974752|3586675|B3|>=65 years||Age, Customized||Participants|Number|58|58.0||||||
3752841|NCT01974752|3586676|B2|>=65 years||Age, Customized||Participants|Number|12|12.0||||||
3752842|NCT01974752|3586677|B1|>=65 years||Age, Customized||Participants|Number|46|46.0||||||
3752843|NCT01974752|3586675|B3|>=55 years To <65 years||Age, Customized||Participants|Number|34|34.0||||||
3752844|NCT01974752|3586676|B2|>=55 years To <65 years||Age, Customized||Participants|Number|9|9.0||||||
3752845|NCT01974752|3586677|B1|>=55 years To <65 years||Age, Customized||Participants|Number|25|25.0||||||
3752846|NCT01974752|3586675|B3|<55 years||Age, Customized||Participants|Number|37|37.0||||||
3752847|NCT01974752|3586676|B2|<55 years||Age, Customized||Participants|Number|11|11.0||||||
3752848|NCT01974752|3586677|B1|<55 years||Age, Customized||Participants|Number|26|26.0||||||
3752849|NCT01974752|3586675|B3|||Age||Years|Mean|60.6|60.6|Standard Deviation|12.01|12.01|22.0|86.0|
3752850|NCT01974752|3586676|B2|||Age||Years|Mean|59.6|59.6|Standard Deviation|11.28|11.28|22.0|86.0|
3752851|NCT01974752|3586677|B1|||Age||Years|Mean|61.0|61.0|Standard Deviation|12.28|12.28|42.0|84.0|
3752852|NCT01974700|3586690|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3752853|NCT01974700|3586691|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3752854|NCT01974700|3586692|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3752855|NCT01974700|3586690|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3752856|NCT01974700|3586691|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3752857|NCT01974700|3586692|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3752858|NCT01974700|3586690|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3752859|NCT01974700|3586691|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3752860|NCT01974700|3586692|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3752861|NCT01974700|3586690|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3752862|NCT01974700|3586691|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3752863|NCT01974700|3586692|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3752864|NCT01974700|3586690|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3752865|NCT01974700|3586691|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3752866|NCT01974700|3586692|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3752867|NCT01974687|3586703|B26||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3752868|NCT01974687|3586704|B25||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3752869|NCT01974687|3586705|B24||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3752870|NCT01974687|3586706|B23||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3752871|NCT01974687|3586707|B22||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3752872|NCT01974687|3586708|B21||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3752873|NCT01974687|3586709|B20||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3752874|NCT01974687|3586710|B19||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3752875|NCT01974687|3586711|B18||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3752876|NCT01974687|3586712|B17||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3752877|NCT01974687|3586713|B16||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3752878|NCT01974687|3586714|B15||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3752879|NCT01974687|3586715|B14||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3752880|NCT01974687|3586716|B13||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3752881|NCT01974687|3586717|B12||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3752882|NCT01974687|3586718|B11||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3752883|NCT01974687|3586719|B10||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3752884|NCT01974687|3586720|B9||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3752885|NCT01974687|3586721|B8||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3752886|NCT01974687|3586722|B7||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3752887|NCT01974687|3586723|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3752888|NCT01974687|3586724|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3752889|NCT01974687|3586725|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3752890|NCT01974687|3586726|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3752891|NCT01974687|3586727|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3752892|NCT01974687|3586728|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3752893|NCT01974687|3586703|B26||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3752894|NCT01974687|3586704|B25||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3752895|NCT01974687|3586705|B24||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3752896|NCT01974687|3586706|B23||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3752897|NCT01974687|3586707|B22||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3752898|NCT01974687|3586708|B21||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3752899|NCT01974687|3586709|B20||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3752900|NCT01974687|3586710|B19||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3752901|NCT01974687|3586711|B18||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3752902|NCT01974687|3586712|B17||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3752903|NCT01974687|3586713|B16||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3752904|NCT01974687|3586714|B15||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3752905|NCT01974687|3586715|B14||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3752906|NCT01974687|3586716|B13||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3752907|NCT01974687|3586717|B12||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3752908|NCT01974687|3586718|B11||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3752909|NCT01974687|3586719|B10||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3752910|NCT01974687|3586720|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3752911|NCT01974687|3586721|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3752912|NCT01974687|3586722|B7||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3752913|NCT01974687|3586723|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3752914|NCT01974687|3586724|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3752915|NCT01974687|3586725|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3752916|NCT01974687|3586726|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3752917|NCT01974687|3586727|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3752918|NCT01974687|3586728|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3752919|NCT01974687|3586703|B26|||Age||Years|Mean|40.47|40.47|Standard Deviation|10.85|10.85|||
3752920|NCT01974687|3586704|B25|||Age||Years|Mean|31.3|31.3|Standard Deviation|11.60|11.6|||
3752921|NCT01974687|3586705|B24|||Age||Years|Mean|43.1|43.1|Standard Deviation|12.54|12.54|||
3752922|NCT01974687|3586706|B23|||Age||Years|Mean|49.1|49.1|Standard Deviation|8.04|8.04|||
3752923|NCT01974687|3586707|B22|||Age||Years|Mean|56.3|56.3|Standard Deviation|3.06|3.06|||
3752924|NCT01974687|3586708|B21|||Age||Years|Mean|57.0|57.0|Standard Deviation|4.36|4.36|||
3752925|NCT01974687|3586709|B20|||Age||Years|Mean|43.7|43.7|Standard Deviation|7.68|7.68|||
3752926|NCT01974687|3586710|B19|||Age||Years|Mean|40.5|40.5|Standard Deviation|8.94|8.94|||
3752927|NCT01974687|3586711|B18|||Age||Years|Mean|40.5|40.5|Standard Deviation|11.70|11.7|||
3752928|NCT01974687|3586712|B17|||Age||Years|Mean|43.3|43.3|Standard Deviation|8.45|8.45|||
3752929|NCT01974687|3586713|B16|||Age||Years|Mean|40.1|40.1|Standard Deviation|11.69|11.69|||
3752930|NCT01974687|3586714|B15|||Age||Years|Mean|44.3|44.3|Standard Deviation|8.63|8.63|||
3752931|NCT01974687|3586715|B14|||Age||Years|Mean|42.7|42.7|Standard Deviation|10.37|10.37|||
3752932|NCT01974687|3586716|B13|||Age||Years|Mean|41.2|41.2|Standard Deviation|10.68|10.68|||
3752933|NCT01974687|3586717|B12|||Age||Years|Mean|41.3|41.3|Standard Deviation|8.96|8.96|||
3752934|NCT01974687|3586718|B11|||Age||Years|Mean|43.3|43.3|Standard Deviation|5.69|5.69|||
3752935|NCT01974687|3586719|B10|||Age||Years|Mean|46.7|46.7|Standard Deviation|4.16|4.16|||
3752936|NCT01974687|3586720|B9|||Age||Years|Mean|42.3|42.3|Standard Deviation|7.23|7.23|||
3752937|NCT01974687|3586721|B8|||Age||Years|Mean|37.0|37.0|Standard Deviation|9.54|9.54|||
3752938|NCT01974687|3586722|B7|||Age||Years|Mean|35.3|35.3|Standard Deviation|12.69|12.69|||
3752939|NCT01974687|3586723|B6|||Age||Years|Mean|36.0|36.0|Standard Deviation|2.83|2.83|||
3752940|NCT01974687|3586724|B5|||Age||Years|Mean|35.2|35.2|Standard Deviation|9.87|9.87|||
3752941|NCT01974687|3586725|B4|||Age||Years|Mean|35.5|35.5|Standard Deviation|11.76|11.76|||
3752942|NCT01974687|3586726|B3|||Age||Years|Mean|33.3|33.3|Standard Deviation|15.06|15.06|||
3752943|NCT01974687|3586727|B2|||Age||Years|Mean|29.2|29.2|Standard Deviation|7.36|7.36|||
3752944|NCT01974687|3586728|B1|||Age||Years|Mean|35.3|35.3|Standard Deviation|7.72|7.72|||
3752945|NCT01974687|3586703|B26||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3752946|NCT01974687|3586704|B25||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3752947|NCT01974687|3586705|B24||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3752948|NCT01974687|3586706|B23||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3752949|NCT01974687|3586707|B22||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3752950|NCT01974687|3586708|B21||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3752951|NCT01974687|3586709|B20||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3752952|NCT01974687|3586710|B19||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3752953|NCT01974687|3586711|B18||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3752954|NCT01974687|3586712|B17||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3752955|NCT01974687|3586713|B16||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3752956|NCT01974687|3586714|B15||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3752957|NCT01974687|3586715|B14||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3752958|NCT01974687|3586716|B13||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3752959|NCT01974687|3586717|B12||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3752960|NCT01974687|3586718|B11||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3752961|NCT01974687|3586719|B10||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3752962|NCT01974687|3586720|B9||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3752963|NCT01974687|3586721|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3752964|NCT01974687|3586722|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3752965|NCT01974687|3586723|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3752966|NCT01974687|3586724|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3752967|NCT01974687|3586725|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3752968|NCT01974687|3586726|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3752969|NCT01974687|3586727|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3752970|NCT01974687|3586728|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3752971|NCT01974687|3586703|B26||Between 18 and 65 years|Age||Participants|Count of Participants|165|165.0||||||
3752972|NCT01974687|3586704|B25||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3752973|NCT01974687|3586705|B24||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3752974|NCT01974687|3586706|B23||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3752975|NCT01974687|3586707|B22||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3752976|NCT01974687|3586708|B21||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3752977|NCT01974687|3586709|B20||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3752978|NCT01974687|3586710|B19||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3752979|NCT01974687|3586711|B18||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3752980|NCT01974687|3586712|B17||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3752981|NCT01974687|3586713|B16||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3752982|NCT01974687|3586714|B15||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3752983|NCT01974687|3586715|B14||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3752984|NCT01974687|3586716|B13||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3752985|NCT01974687|3586717|B12||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3752986|NCT01974687|3586718|B11||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3752987|NCT01974687|3586719|B10||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3752988|NCT01974687|3586720|B9||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3752989|NCT01974687|3586721|B8||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3752990|NCT01974687|3586722|B7||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3752991|NCT01974687|3586723|B6||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3752992|NCT01974687|3586724|B5||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3752993|NCT01974687|3586725|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3752994|NCT01974687|3586726|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3752995|NCT01974687|3586727|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3752996|NCT01974687|3586728|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3752997|NCT01974687|3586703|B26||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3752998|NCT01974687|3586704|B25||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3752999|NCT01974687|3586705|B24||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753000|NCT01974687|3586706|B23||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753001|NCT01974687|3586707|B22||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753002|NCT01974687|3586708|B21||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753003|NCT01974687|3586709|B20||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753004|NCT01974687|3586710|B19||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753005|NCT01974687|3586711|B18||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753006|NCT01974687|3586712|B17||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753007|NCT01974687|3586713|B16||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753008|NCT01974687|3586714|B15||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753009|NCT01974687|3586715|B14||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753010|NCT01974687|3586716|B13||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753011|NCT01974687|3586717|B12||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753012|NCT01974687|3586718|B11||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753013|NCT01974687|3586719|B10||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753014|NCT01974687|3586720|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753015|NCT01974687|3586721|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753016|NCT01974687|3586722|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753017|NCT01974687|3586723|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753018|NCT01974687|3586724|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753019|NCT01974687|3586725|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753020|NCT01974687|3586726|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753021|NCT01974687|3586727|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753022|NCT01974687|3586728|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753023|NCT01974323|3587099|B3||Male|Sex: Female, Male||Participants|Count of Participants|989|989.0||||||
3753024|NCT01974323|3587100|B2||Male|Sex: Female, Male||Participants|Count of Participants|489|489.0||||||
3753025|NCT01974323|3587101|B1||Male|Sex: Female, Male||Participants|Count of Participants|500|500.0||||||
3753026|NCT01974323|3587099|B3||Female|Sex: Female, Male||Participants|Count of Participants|1249|1249.0||||||
3753027|NCT01974323|3587100|B2||Female|Sex: Female, Male||Participants|Count of Participants|631|631.0||||||
3753028|NCT01974323|3587101|B1||Female|Sex: Female, Male||Participants|Count of Participants|618|618.0||||||
3753029|NCT01974323|3587099|B3|||Age||Years|Mean|20.4|20.4|Standard Deviation|7.77|7.77|||
3753030|NCT01974323|3587100|B2|||Age||Years|Mean|20.4|20.4|Standard Deviation|7.38|7.38|||
3753031|NCT01974323|3587101|B1|||Age||Years|Mean|20.5|20.5|Standard Deviation|8.15|8.15|||
3753032|NCT01974245|3587124|B3|Hemodialysis||Dialysis therapy||participants|Number|23|23.0||||||
3753033|NCT01974245|3587125|B2|Hemodialysis||Dialysis therapy||participants|Number|11|11.0||||||
3753034|NCT01974245|3587126|B1|Hemodialysis||Dialysis therapy||participants|Number|12|12.0||||||
3753035|NCT01974245|3587124|B3|Peritoneal dialysis||Dialysis therapy||participants|Number|15|15.0||||||
3753036|NCT01974245|3587125|B2|Peritoneal dialysis||Dialysis therapy||participants|Number|9|9.0||||||
3753037|NCT01974245|3587126|B1|Peritoneal dialysis||Dialysis therapy||participants|Number|6|6.0||||||
3753038|NCT01974245|3587124|B3|Brazil||Region of Enrollment||participants|Number|38|38.0||||||
3753039|NCT01974245|3587125|B2|Brazil||Region of Enrollment||participants|Number|20|20.0||||||
3753040|NCT01974245|3587126|B1|Brazil||Region of Enrollment||participants|Number|18|18.0||||||
3753041|NCT01974245|3587124|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3753042|NCT01974245|3587125|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3753043|NCT01974245|3587126|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3753044|NCT01974245|3587124|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3753045|NCT01974245|3587125|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3753046|NCT01974245|3587126|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3753047|NCT01974245|3587124|B3|||Age||years|Mean|56.0|56.0|Standard Deviation|13.4|13.4|||
3753048|NCT01974245|3587125|B2|||Age||years|Mean|55.5|55.5|Standard Deviation|14.2|14.2|||
3753049|NCT01974245|3587126|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|12.9|12.9|||
3753050|NCT01974141|3587133|B3||Male|Sex: Female, Male||Participants|Count of Participants|929|929.0||||||
3753051|NCT01974141|3587134|B2||Male|Sex: Female, Male||Participants|Count of Participants|476|476.0||||||
3753052|NCT01974141|3587135|B1||Male|Sex: Female, Male||Participants|Count of Participants|453|453.0||||||
3753053|NCT01974141|3587133|B3||Female|Sex: Female, Male||Participants|Count of Participants|1173|1173.0||||||
3753054|NCT01974141|3587134|B2||Female|Sex: Female, Male||Participants|Count of Participants|582|582.0||||||
3753055|NCT01974141|3587135|B1||Female|Sex: Female, Male||Participants|Count of Participants|591|591.0||||||
3753056|NCT01974141|3587133|B3|||Age||Years|Mean|20.0|20.0|Standard Deviation|7.47|7.47|||
3753057|NCT01974141|3587134|B2|||Age||Years|Mean|20.0|20.0|Standard Deviation|7.53|7.53|||
3753058|NCT01974141|3587135|B1|||Age||Years|Mean|20.0|20.0|Standard Deviation|7.41|7.41|||
3753059|NCT01974089|3587158|B3|Denmark||Region of Enrollment||participants|Number|154|154.0||||||
3753060|NCT01974089|3587159|B2|Denmark||Region of Enrollment||participants|Number|101|101.0||||||
3753061|NCT01974089|3587160|B1|Denmark||Region of Enrollment||participants|Number|53|53.0||||||
3753062|NCT01974089|3587158|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3753063|NCT01974089|3587159|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3753064|NCT01974089|3587160|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3753065|NCT01974089|3587158|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3753066|NCT01974089|3587159|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3753067|NCT01974089|3587160|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3753068|NCT01974089|3587158|B3||>=65 years|Age||Participants|Count of Participants|124|124.0||||||
3753069|NCT01974089|3587159|B2||>=65 years|Age||Participants|Count of Participants|78|78.0||||||
3753070|NCT01974089|3587160|B1||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
3753071|NCT01974089|3587158|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3753072|NCT01974089|3587159|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3753073|NCT01974089|3587160|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3753074|NCT01974089|3587158|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753075|NCT01974089|3587159|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753076|NCT01974089|3587160|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753077|NCT01974050|3587171|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3753078|NCT01974050|3587171|B1|Multiracial||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3753079|NCT01974050|3587171|B1|Indigenous Latin American||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3753080|NCT01974050|3587171|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3753081|NCT01974050|3587171|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3753082|NCT01974050|3587171|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|73|73.0||||||
3753083|NCT01974050|3587171|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753084|NCT01974050|3587171|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3753085|NCT01974050|3587171|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3753086|NCT01974050|3587171|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3753087|NCT01974050|3587171|B1||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3753088|NCT01974050|3587171|B1|35-46 years||Age, Customized||Participants|Count of Participants|53|53.0||||||
3753089|NCT01974050|3587171|B1|26-34 years||Age, Customized||Participants|Count of Participants|75|75.0||||||
3753090|NCT01974050|3587171|B1|19-25 years||Age, Customized||Participants|Count of Participants|38|38.0||||||
3753091|NCT01973777|3587178|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3753092|NCT01973777|3587178|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3753093|NCT01973777|3587178|B1|||Age||years|Mean|27|27.0|Full Range|||18.0|39.0|
3753094|NCT01973608|3587184|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3753095|NCT01973608|3587185|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3753096|NCT01973608|3587186|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3753097|NCT01973608|3587187|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3753098|NCT01973608|3587188|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3753099|NCT01973608|3587184|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3753100|NCT01973608|3587185|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3753101|NCT01973608|3587186|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3753102|NCT01973608|3587187|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3753103|NCT01973608|3587188|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3753104|NCT01973608|3587184|B5|||Age||years|Mean|57.91|57.91|Standard Deviation|8.90|8.9|||
3753105|NCT01973608|3587185|B4|||Age||years|Mean|53.78|53.78|Standard Deviation|20.03|20.03|||
3753106|NCT01973608|3587186|B3|||Age||years|Mean|59.67|59.67|Standard Deviation|6.29|6.29|||
3753107|NCT01973608|3587187|B2|||Age||years|Mean|59.55|59.55|Standard Deviation|4.11|4.11|||
3753108|NCT01973608|3587188|B1|||Age||years|Mean|55.12|55.12|Standard Deviation|13.48|13.48|||
3753109|NCT01973595|3587209|B5|United States||Region of Enrollment||participants|Number|58|58.0||||||
3753110|NCT01973595|3587210|B4|United States||Region of Enrollment||participants|Number|14|14.0||||||
3753111|NCT01973595|3587211|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
3753112|NCT01973595|3587212|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3753113|NCT01973595|3587213|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3753114|NCT01973595|3587209|B5||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3753115|NCT01973595|3587210|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3753116|NCT01973595|3587211|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3753117|NCT01973595|3587212|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3753118|NCT01973595|3587213|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3753119|NCT01973595|3587209|B5||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3753120|NCT01973595|3587210|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3753121|NCT01973595|3587211|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3753122|NCT01973595|3587212|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3753123|NCT01973595|3587213|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3753124|NCT01973595|3587209|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3753125|NCT01973595|3587210|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3753126|NCT01973595|3587211|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3753127|NCT01973595|3587212|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3753128|NCT01973595|3587213|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3753129|NCT01973595|3587209|B5||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3753130|NCT01973595|3587210|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3753131|NCT01973595|3587211|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3753132|NCT01973595|3587212|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3753133|NCT01973595|3587213|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3753134|NCT01973595|3587209|B5||<=18 years|Age||Participants|Count of Participants|29|29.0||||||
3753135|NCT01973595|3587210|B4||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
3753136|NCT01973595|3587211|B3||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
3753137|NCT01973595|3587212|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753138|NCT01973595|3587213|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753139|NCT01973491|3587230|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3753140|NCT01973491|3587230|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3753141|NCT01973491|3587230|B1|||Age||years|Mean|27.1|27.1|Standard Deviation|5.45|5.45|||
3753142|NCT01973439|3587246|B1|France||Region of Enrollment||participants|Number|3|3.0||||||
3753143|NCT01973439|3587246|B1|Spain||Region of Enrollment||participants|Number|2|2.0||||||
3753144|NCT01973439|3587246|B1|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
3753145|NCT01973439|3587246|B1|Italy||Region of Enrollment||participants|Number|1|1.0||||||
3753146|NCT01973439|3587246|B1|Germany||Region of Enrollment||participants|Number|3|3.0||||||
3753147|NCT01973439|3587246|B1|Mixed Black/White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3753148|NCT01973439|3587246|B1|Black, African or other||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3753149|NCT01973439|3587246|B1|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3753150|NCT01973439|3587246|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3753151|NCT01973439|3587246|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3753152|NCT01973439|3587246|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3753153|NCT01973439|3587246|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3753154|NCT01973439|3587246|B1||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
3753155|NCT01973413|3587253|B3|||Diabetes Duration|Time since diagnosis of type 1 diabetes|years|Mean|6.4|6.4|Standard Deviation|3.9|3.9|||
3753156|NCT01973413|3587254|B2|||Diabetes Duration|Time since diagnosis of type 1 diabetes|years|Mean|5.6|5.6|Standard Deviation|3.5|3.5|||
3753157|NCT01973413|3587255|B1|||Diabetes Duration|Time since diagnosis of type 1 diabetes|years|Mean|7.6|7.6|Standard Deviation|4.6|4.6|||
3753158|NCT01973413|3587253|B3|||HbA1c|Glycated hemoglobin, estimate of average blood glucose over past 3 months|percent of glycated hemoglobin|Mean|8.4|8.4|Standard Deviation|1.0|1.0|||
3753159|NCT01973413|3587254|B2|||HbA1c|Glycated hemoglobin, estimate of average blood glucose over past 3 months|percent of glycated hemoglobin|Mean|8.1|8.1|Standard Deviation|1.1|1.1|||
3753160|NCT01973413|3587255|B1|||HbA1c|Glycated hemoglobin, estimate of average blood glucose over past 3 months|percent of glycated hemoglobin|Mean|8.7|8.7|Standard Deviation|0.7|0.7|||
3753161|NCT01973413|3587253|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3753162|NCT01973413|3587254|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3753163|NCT01973413|3587255|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3753164|NCT01973413|3587253|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3753165|NCT01973413|3587254|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3753166|NCT01973413|3587255|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3753167|NCT01973413|3587253|B3|||Age||years|Mean|15.3|15.3|Standard Deviation|2.6|2.6|||
3753168|NCT01973413|3587254|B2|||Age||years|Mean|15.3|15.3|Standard Deviation|2.9|2.9|||
3753169|NCT01973413|3587255|B1|||Age||years|Mean|15.3|15.3|Standard Deviation|2.1|2.1|||
3753170|NCT01973387|3587266|B3|Taiwan, Province Of China||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3753171|NCT01973387|3587267|B2|Taiwan, Province Of China||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3753172|NCT01973387|3587268|B1|Taiwan, Province Of China||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3753173|NCT01973387|3587266|B3|Malaysia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3753174|NCT01973387|3587267|B2|Malaysia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3753175|NCT01973387|3587268|B1|Malaysia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3753176|NCT01973387|3587266|B3|China||Region of Enrollment||Participants|Count of Participants|131|131.0||||||
3753177|NCT01973387|3587267|B2|China||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3753178|NCT01973387|3587268|B1|China||Region of Enrollment||Participants|Count of Participants|87|87.0||||||
3753179|NCT01973387|3587266|B3|Australia||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3753180|NCT01973387|3587267|B2|Australia||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3753181|NCT01973387|3587268|B1|Australia||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3753182|NCT01973387|3587266|B3||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3753183|NCT01973387|3587267|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3753184|NCT01973387|3587268|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3753185|NCT01973387|3587266|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3753186|NCT01973387|3587267|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3753187|NCT01973387|3587268|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3753188|NCT01973387|3587266|B3|||Age||years|Mean|63.6|63.6|Standard Deviation|11.3|11.3|||
3753189|NCT01973387|3587267|B2|||Age||years|Mean|63.6|63.6|Standard Deviation|13.04|13.04|||
3753190|NCT01973387|3587268|B1|||Age||years|Mean|63.6|63.6|Standard Deviation|10.36|10.36|||
3753191|NCT01973348|3587283|B5|United States||Region of Enrollment||participants|Number|34|34.0||||||
3753192|NCT01973348|3587286|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3753193|NCT01973348|3587287|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3753194|NCT01973348|3587283|B5||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3753195|NCT01973348|3587286|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3753196|NCT01973348|3587287|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3753197|NCT01973348|3587283|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3753198|NCT01973348|3587286|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3753199|NCT01973348|3587287|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3753200|NCT01973348|3587283|B5|||Age||year old|Mean|5.8|5.8|Standard Deviation|1.2|1.2|||
3753201|NCT01973348|3587286|B2|||Age||year old|Mean|5.9|5.9|Standard Deviation|0.9|0.9|||
3753202|NCT01973348|3587287|B1|||Age||year old|Mean|5.7|5.7|Standard Deviation|1.5|1.5|||
3753203|NCT01973348|3587283|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3753204|NCT01973348|3587286|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3753205|NCT01973348|3587287|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3753206|NCT01973348|3587283|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3753207|NCT01973348|3587286|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3753208|NCT01973348|3587287|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3753209|NCT01973348|3587283|B5||<=18 years|Age||Participants|Count of Participants|34|34.0||||||
3753210|NCT01973348|3587286|B2||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
3753211|NCT01973348|3587287|B1||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
3753212|NCT01973231|3587308|B3|||Body Weight||kg|Mean|101.24|101.24|Standard Deviation|21.696|21.696|||
3753213|NCT01973231|3587309|B2|||Body Weight||kg|Mean|100.58|100.58|Standard Deviation|19.949|19.949|||
3753214|NCT01973231|3587310|B1|||Body Weight||kg|Mean|101.89|101.89|Standard Deviation|23.344|23.344|||
3753215|NCT01973231|3587308|B3|||Fasting plasma glucose (FPG)||mmol/L|Mean|10.36|10.36|Standard Deviation|2.312|2.312|||
3753216|NCT01973231|3587309|B2|||Fasting plasma glucose (FPG)||mmol/L|Mean|10.25|10.25|Standard Deviation|2.254|2.254|||
3753217|NCT01973231|3587310|B1|||Fasting plasma glucose (FPG)||mmol/L|Mean|10.47|10.47|Standard Deviation|2.368|2.368|||
3753218|NCT01973231|3587308|B3|||Glycosylated Haemoglobin (HbA1c)||Percent (%) glycosylated haemoglobin|Mean|8.41|8.41|Standard Deviation|0.754|0.754|||
3753219|NCT01973231|3587309|B2|||Glycosylated Haemoglobin (HbA1c)||Percent (%) glycosylated haemoglobin|Mean|8.43|8.43|Standard Deviation|0.785|0.785|||
3753220|NCT01973231|3587310|B1|||Glycosylated Haemoglobin (HbA1c)||Percent (%) glycosylated haemoglobin|Mean|8.40|8.4|Standard Deviation|0.723|0.723|||
3753221|NCT01973231|3587308|B3||Male|Gender||Participants|Count of Participants|244|244.0||||||
3753222|NCT01973231|3587309|B2||Male|Gender||Participants|Count of Participants|112|112.0||||||
3753223|NCT01973231|3587310|B1||Male|Gender||Participants|Count of Participants|132|132.0||||||
3753224|NCT01973231|3587308|B3||Female|Gender||Participants|Count of Participants|160|160.0||||||
3753225|NCT01973231|3587309|B2||Female|Gender||Participants|Count of Participants|90|90.0||||||
3753226|NCT01973231|3587310|B1||Female|Gender||Participants|Count of Participants|70|70.0||||||
3753227|NCT01973231|3587308|B3|||Age||years|Mean|56.2|56.2|Standard Deviation|10.3|10.3|||
3753228|NCT01973231|3587309|B2|||Age||years|Mean|56.1|56.1|Standard Deviation|10.0|10.0|||
3753229|NCT01973231|3587310|B1|||Age||years|Mean|56.3|56.3|Standard Deviation|10.6|10.6|||
3753230|NCT01973218|3587329|B3||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3753231|NCT01973218|3587330|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3753232|NCT01973218|3587331|B1||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3753233|NCT01973218|3587329|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3753234|NCT01973218|3587330|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3753235|NCT01973218|3587331|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3753236|NCT01973218|3587329|B3|||Age||years|Mean|13.5|13.5|Standard Deviation|1.8|1.8|||
3753237|NCT01973218|3587330|B2|||Age||years|Mean|13.4|13.4|Standard Deviation|1.8|1.8|||
3753238|NCT01973218|3587331|B1|||Age||years|Mean|13.5|13.5|Standard Deviation|1.8|1.8|||
3753239|NCT01973205|3587353|B3|United States||Region of Enrollment||participants|Number|900|900.0||||||
3753240|NCT01973205|3587354|B2|United States||Region of Enrollment||participants|Number|447|447.0||||||
3753241|NCT01973205|3587355|B1|United States||Region of Enrollment||participants|Number|453|453.0||||||
3753242|NCT01973205|3587353|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3753243|NCT01973205|3587354|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3753244|NCT01973205|3587355|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3753245|NCT01973205|3587353|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753246|NCT01973205|3587354|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753247|NCT01973205|3587355|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753248|NCT01973205|3587353|B3||White|Race (NIH/OMB)||Participants|Count of Participants|655|655.0||||||
3753249|NCT01973205|3587354|B2||White|Race (NIH/OMB)||Participants|Count of Participants|318|318.0||||||
3753250|NCT01973205|3587355|B1||White|Race (NIH/OMB)||Participants|Count of Participants|337|337.0||||||
3753251|NCT01973205|3587353|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|201|201.0||||||
3753252|NCT01973205|3587354|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
3753253|NCT01973205|3587355|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3753254|NCT01973205|3587353|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3753255|NCT01973205|3587354|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3753256|NCT01973205|3587355|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3753257|NCT01973205|3587353|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3753258|NCT01973205|3587354|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3753259|NCT01973205|3587355|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3753260|NCT01973205|3587353|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3753261|NCT01973205|3587354|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753262|NCT01973205|3587355|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3753263|NCT01973205|3587353|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753264|NCT01973205|3587354|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753265|NCT01973205|3587355|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753266|NCT01973205|3587353|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|804|804.0||||||
3753267|NCT01973205|3587354|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|399|399.0||||||
3753268|NCT01973205|3587355|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|405|405.0||||||
3753269|NCT01973205|3587353|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3753270|NCT01973205|3587354|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3753271|NCT01973205|3587355|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3753272|NCT01973205|3587353|B3||Male|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
3753273|NCT01973205|3587354|B2||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3753274|NCT01973205|3587355|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3753275|NCT01973205|3587353|B3||Female|Sex: Female, Male||Participants|Count of Participants|701|701.0||||||
3753276|NCT01973205|3587354|B2||Female|Sex: Female, Male||Participants|Count of Participants|350|350.0||||||
3753277|NCT01973205|3587355|B1||Female|Sex: Female, Male||Participants|Count of Participants|351|351.0||||||
3753278|NCT01973205|3587353|B3|||Age||years|Mean|40.1|40.1|Standard Deviation|12.6|12.6|||
3753279|NCT01973205|3587354|B2|||Age||years|Mean|39.7|39.7|Standard Deviation|12.8|12.8|||
3753280|NCT01973205|3587355|B1|||Age||years|Mean|40.6|40.6|Standard Deviation|12.4|12.4|||
3753281|NCT01973062|3587368|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3753282|NCT01973062|3587368|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753283|NCT01973062|3587368|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753284|NCT01973062|3587368|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3753285|NCT01973062|3587368|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753286|NCT01973062|3587368|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753287|NCT01973062|3587368|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753288|NCT01973062|3587368|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753289|NCT01973062|3587368|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753290|NCT01973062|3587368|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3753291|NCT01973062|3587368|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753292|NCT01973062|3587368|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3753293|NCT01973062|3587368|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3753294|NCT01973062|3587368|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3753295|NCT01973062|3587368|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3753296|NCT01973062|3587368|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753297|NCT01973036|3587376|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3753298|NCT01973036|3587377|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3753299|NCT01973036|3587378|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3753300|NCT01973036|3587376|B3||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3753301|NCT01973036|3587377|B2||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3753302|NCT01973036|3587378|B1||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3753303|NCT01973036|3587376|B3|||Age||years|Median|27.25|27.25|Inter-Quartile Range|||23.35|31.9|
3753304|NCT01973036|3587377|B2|||Age||years|Median|27.5|27.5|Inter-Quartile Range|||23.4|32.2|
3753305|NCT01973036|3587378|B1|||Age||years|Median|27|27.0|Inter-Quartile Range|||22.8|31.4|
3753306|NCT01972841|3587419|B7|||Number of pads used/week|The number of pads used was calculated from sum of each record with a new pad checked on valid diary days during the 7-day micturition diary period prior to each visit.|pads|Mean|19.3|19.3|Standard Deviation|19.0|19.0|||
3753307|NCT01972841|3587420|B6|||Number of pads used/week|The number of pads used was calculated from sum of each record with a new pad checked on valid diary days during the 7-day micturition diary period prior to each visit.|pads|Mean|17.7|17.7|Standard Deviation|16.4|16.4|||
3753308|NCT01972841|3587421|B5|||Number of pads used/week|The number of pads used was calculated from sum of each record with a new pad checked on valid diary days during the 7-day micturition diary period prior to each visit.|pads|Mean|17.1|17.1|Standard Deviation|17.7|17.7|||
3753309|NCT01972841|3587422|B4|||Number of pads used/week|The number of pads used was calculated from sum of each record with a new pad checked on valid diary days during the 7-day micturition diary period prior to each visit.|pads|Mean|19.9|19.9|Standard Deviation|21.8|21.8|||
3753310|NCT01972841|3587423|B3|||Number of pads used/week|The number of pads used was calculated from sum of each record with a new pad checked on valid diary days during the 7-day micturition diary period prior to each visit.|pads|Mean|17.9|17.9|Standard Deviation|21.7|21.7|||
3753311|NCT01972841|3587424|B2|||Number of pads used/week|The number of pads used was calculated from sum of each record with a new pad checked on valid diary days during the 7-day micturition diary period prior to each visit.|pads|Mean|19.6|19.6|Standard Deviation|18.7|18.7|||
3753312|NCT01972841|3587425|B1|||Number of pads used/week|The number of pads used was calculated from sum of each record with a new pad checked on valid diary days during the 7-day micturition diary period prior to each visit.|pads|Mean|19.8|19.8|Standard Deviation|20.9|20.9|||
3753313|NCT01972841|3587419|B7|||Mean number of pads used/24 h|The mean number of pads used per 24 hours was calculated from data recorded by the participant per day on valid diary days during the 7-day micturition diary period prior to each visit.|pads|Mean|2.67|2.67|Standard Deviation|2.76|2.76|||
3753314|NCT01972841|3587420|B6|||Mean number of pads used/24 h|The mean number of pads used per 24 hours was calculated from data recorded by the participant per day on valid diary days during the 7-day micturition diary period prior to each visit.|pads|Mean|2.58|2.58|Standard Deviation|2.39|2.39|||
3753315|NCT01972841|3587421|B5|||Mean number of pads used/24 h|The mean number of pads used per 24 hours was calculated from data recorded by the participant per day on valid diary days during the 7-day micturition diary period prior to each visit.|pads|Mean|2.50|2.5|Standard Deviation|2.58|2.58|||
3753316|NCT01972841|3587422|B4|||Mean number of pads used/24 h|The mean number of pads used per 24 hours was calculated from data recorded by the participant per day on valid diary days during the 7-day micturition diary period prior to each visit.|pads|Mean|2.87|2.87|Standard Deviation|3.14|3.14|||
3753317|NCT01972841|3587423|B3|||Mean number of pads used/24 h|The mean number of pads used per 24 hours was calculated from data recorded by the participant per day on valid diary days during the 7-day micturition diary period prior to each visit.|pads|Mean|2.62|2.62|Standard Deviation|3.18|3.18|||
3753318|NCT01972841|3587424|B2|||Mean number of pads used/24 h|The mean number of pads used per 24 hours was calculated from data recorded by the participant per day on valid diary days during the 7-day micturition diary period prior to each visit.|pads|Mean|2.86|2.86|Standard Deviation|2.70|2.7|||
3753319|NCT01972841|3587425|B1|||Mean number of pads used/24 h|The mean number of pads used per 24 hours was calculated from data recorded by the participant per day on valid diary days during the 7-day micturition diary period prior to each visit.|pads|Mean|2.87|2.87|Standard Deviation|2.99|2.99|||
3753320|NCT01972841|3587419|B7|||Number of nocturia episodes/week|The number of nocturia episodes was calculated from sun of each nocturia episodes recorded by the participant per day on valid diary days during the 7-day micturition diary period prior to each visit.|nocturia episode|Mean|10.8|10.8|Standard Deviation|7.2|7.2|||
3753321|NCT01972841|3587420|B6|||Number of nocturia episodes/week|The number of nocturia episodes was calculated from sun of each nocturia episodes recorded by the participant per day on valid diary days during the 7-day micturition diary period prior to each visit.|nocturia episode|Mean|10.5|10.5|Standard Deviation|6.7|6.7|||
3753322|NCT01972841|3587421|B5|||Number of nocturia episodes/week|The number of nocturia episodes was calculated from sun of each nocturia episodes recorded by the participant per day on valid diary days during the 7-day micturition diary period prior to each visit.|nocturia episode|Mean|10.8|10.8|Standard Deviation|7.4|7.4|||
3753323|NCT01972841|3587422|B4|||Number of nocturia episodes/week|The number of nocturia episodes was calculated from sun of each nocturia episodes recorded by the participant per day on valid diary days during the 7-day micturition diary period prior to each visit.|nocturia episode|Mean|11.0|11.0|Standard Deviation|6.6|6.6|||
3753324|NCT01972841|3587423|B3|||Number of nocturia episodes/week|The number of nocturia episodes was calculated from sun of each nocturia episodes recorded by the participant per day on valid diary days during the 7-day micturition diary period prior to each visit.|nocturia episode|Mean|11.0|11.0|Standard Deviation|7.6|7.6|||
3753325|NCT01972841|3587424|B2|||Number of nocturia episodes/week|The number of nocturia episodes was calculated from sun of each nocturia episodes recorded by the participant per day on valid diary days during the 7-day micturition diary period prior to each visit.|nocturia episode|Mean|10.6|10.6|Standard Deviation|7.1|7.1|||
3753326|NCT01972841|3587425|B1|||Number of nocturia episodes/week|The number of nocturia episodes was calculated from sun of each nocturia episodes recorded by the participant per day on valid diary days during the 7-day micturition diary period prior to each visit.|nocturia episode|Mean|10.9|10.9|Standard Deviation|7.4|7.4|||
3753327|NCT01972841|3587419|B7|||Mean number of nocturia episodes/24 h|A nocturia episode was defined as waking at night 1 or more times to void (i.e., any voiding associated with sleep disturbance between the time the participant goes to bed with the intention to sleep until the time the patients gets up in the morning with the intention to stay awake). The mean number of nocturia episodes per 24hr was calculated from data recorded by the participant per day on valid diary days during the 7-day micturition diary period prior to each visit.|nocturia episodes|Mean|1.56|1.56|Standard Deviation|1.03|1.03|||
3753328|NCT01972841|3587420|B6|||Mean number of nocturia episodes/24 h|A nocturia episode was defined as waking at night 1 or more times to void (i.e., any voiding associated with sleep disturbance between the time the participant goes to bed with the intention to sleep until the time the patients gets up in the morning with the intention to stay awake). The mean number of nocturia episodes per 24hr was calculated from data recorded by the participant per day on valid diary days during the 7-day micturition diary period prior to each visit.|nocturia episodes|Mean|1.52|1.52|Standard Deviation|0.97|0.97|||
3753329|NCT01972841|3587421|B5|||Mean number of nocturia episodes/24 h|A nocturia episode was defined as waking at night 1 or more times to void (i.e., any voiding associated with sleep disturbance between the time the participant goes to bed with the intention to sleep until the time the patients gets up in the morning with the intention to stay awake). The mean number of nocturia episodes per 24hr was calculated from data recorded by the participant per day on valid diary days during the 7-day micturition diary period prior to each visit.|nocturia episodes|Mean|1.56|1.56|Standard Deviation|1.07|1.07|||
3753330|NCT01972841|3587422|B4|||Mean number of nocturia episodes/24 h|A nocturia episode was defined as waking at night 1 or more times to void (i.e., any voiding associated with sleep disturbance between the time the participant goes to bed with the intention to sleep until the time the patients gets up in the morning with the intention to stay awake). The mean number of nocturia episodes per 24hr was calculated from data recorded by the participant per day on valid diary days during the 7-day micturition diary period prior to each visit.|nocturia episodes|Mean|1.59|1.59|Standard Deviation|0.96|0.96|||
3753331|NCT01972841|3587423|B3|||Mean number of nocturia episodes/24 h|A nocturia episode was defined as waking at night 1 or more times to void (i.e., any voiding associated with sleep disturbance between the time the participant goes to bed with the intention to sleep until the time the patients gets up in the morning with the intention to stay awake). The mean number of nocturia episodes per 24hr was calculated from data recorded by the participant per day on valid diary days during the 7-day micturition diary period prior to each visit.|nocturia episodes|Mean|1.59|1.59|Standard Deviation|1.09|1.09|||
3753332|NCT01972841|3587424|B2|||Mean number of nocturia episodes/24 h|A nocturia episode was defined as waking at night 1 or more times to void (i.e., any voiding associated with sleep disturbance between the time the participant goes to bed with the intention to sleep until the time the patients gets up in the morning with the intention to stay awake). The mean number of nocturia episodes per 24hr was calculated from data recorded by the participant per day on valid diary days during the 7-day micturition diary period prior to each visit.|nocturia episodes|Mean|1.53|1.53|Standard Deviation|1.02|1.02|||
3753333|NCT01972841|3587425|B1|||Mean number of nocturia episodes/24 h|A nocturia episode was defined as waking at night 1 or more times to void (i.e., any voiding associated with sleep disturbance between the time the participant goes to bed with the intention to sleep until the time the patients gets up in the morning with the intention to stay awake). The mean number of nocturia episodes per 24hr was calculated from data recorded by the participant per day on valid diary days during the 7-day micturition diary period prior to each visit.|nocturia episodes|Mean|1.57|1.57|Standard Deviation|1.06|1.06|||
3753334|NCT01972841|3587419|B7|||Mean number of urgency episodes (Grade 3 or 4)/24 h|An urgency episode (Grade 3 or 4) was defined as a complaint of a sudden, compelling desire to pass urine, which is difficult to defer; it was recorded when a micturition or incontinence episode was recorded and the severity of urinary urgency recorded was 3 (severe urgency) or 4 (urgency incontinence) according to the Patient Perception of Intensity of Urgency Scale (PPIUS). The mean number of urgency episodes per 24 hours was calculated from data recorded by the participant per day on valid diary days during the 7-day micturition diary period prior to each visit.|urgency episodes|Mean|6.32|6.32|Standard Deviation|3.92|3.92|||
3753335|NCT01972841|3587420|B6|||Mean number of urgency episodes (Grade 3 or 4)/24 h|An urgency episode (Grade 3 or 4) was defined as a complaint of a sudden, compelling desire to pass urine, which is difficult to defer; it was recorded when a micturition or incontinence episode was recorded and the severity of urinary urgency recorded was 3 (severe urgency) or 4 (urgency incontinence) according to the Patient Perception of Intensity of Urgency Scale (PPIUS). The mean number of urgency episodes per 24 hours was calculated from data recorded by the participant per day on valid diary days during the 7-day micturition diary period prior to each visit.|urgency episodes|Mean|6.22|6.22|Standard Deviation|3.56|3.56|||
3753336|NCT01972841|3587421|B5|||Mean number of urgency episodes (Grade 3 or 4)/24 h|An urgency episode (Grade 3 or 4) was defined as a complaint of a sudden, compelling desire to pass urine, which is difficult to defer; it was recorded when a micturition or incontinence episode was recorded and the severity of urinary urgency recorded was 3 (severe urgency) or 4 (urgency incontinence) according to the Patient Perception of Intensity of Urgency Scale (PPIUS). The mean number of urgency episodes per 24 hours was calculated from data recorded by the participant per day on valid diary days during the 7-day micturition diary period prior to each visit.|urgency episodes|Mean|6.22|6.22|Standard Deviation|3.70|3.7|||
3753337|NCT01972841|3587422|B4|||Mean number of urgency episodes (Grade 3 or 4)/24 h|An urgency episode (Grade 3 or 4) was defined as a complaint of a sudden, compelling desire to pass urine, which is difficult to defer; it was recorded when a micturition or incontinence episode was recorded and the severity of urinary urgency recorded was 3 (severe urgency) or 4 (urgency incontinence) according to the Patient Perception of Intensity of Urgency Scale (PPIUS). The mean number of urgency episodes per 24 hours was calculated from data recorded by the participant per day on valid diary days during the 7-day micturition diary period prior to each visit.|urgency episodes|Mean|6.48|6.48|Standard Deviation|3.88|3.88|||
3753338|NCT01972841|3587423|B3|||Mean number of urgency episodes (Grade 3 or 4)/24 h|An urgency episode (Grade 3 or 4) was defined as a complaint of a sudden, compelling desire to pass urine, which is difficult to defer; it was recorded when a micturition or incontinence episode was recorded and the severity of urinary urgency recorded was 3 (severe urgency) or 4 (urgency incontinence) according to the Patient Perception of Intensity of Urgency Scale (PPIUS). The mean number of urgency episodes per 24 hours was calculated from data recorded by the participant per day on valid diary days during the 7-day micturition diary period prior to each visit.|urgency episodes|Mean|6.46|6.46|Standard Deviation|4.88|4.88|||
3753374|NCT01972841|3587424|B2|||Mean number of micturitions/24 h|A micturition was defined as any voluntary micturition (excluding incontinence only episodes). The mean number of micturitions per 24 hours was calculated from data recorded by the participant per day on valid diary days during the 7-day micturition diary period.|micturitions|Mean|10.81|10.81|Standard Deviation|2.63|2.63|||
3753339|NCT01972841|3587424|B2|||Mean number of urgency episodes (Grade 3 or 4)/24 h|An urgency episode (Grade 3 or 4) was defined as a complaint of a sudden, compelling desire to pass urine, which is difficult to defer; it was recorded when a micturition or incontinence episode was recorded and the severity of urinary urgency recorded was 3 (severe urgency) or 4 (urgency incontinence) according to the Patient Perception of Intensity of Urgency Scale (PPIUS). The mean number of urgency episodes per 24 hours was calculated from data recorded by the participant per day on valid diary days during the 7-day micturition diary period prior to each visit.|urgency episodes|Mean|6.22|6.22|Standard Deviation|3.89|3.89|||
3753340|NCT01972841|3587425|B1|||Mean number of urgency episodes (Grade 3 or 4)/24 h|An urgency episode (Grade 3 or 4) was defined as a complaint of a sudden, compelling desire to pass urine, which is difficult to defer; it was recorded when a micturition or incontinence episode was recorded and the severity of urinary urgency recorded was 3 (severe urgency) or 4 (urgency incontinence) according to the Patient Perception of Intensity of Urgency Scale (PPIUS). The mean number of urgency episodes per 24 hours was calculated from data recorded by the participant per day on valid diary days during the 7-day micturition diary period prior to each visit.|urgency episodes|Mean|6.52|6.52|Standard Deviation|4.05|4.05|||
3753341|NCT01972841|3587419|B7|||Number of urgency incontinence episodes/week|The number of urgency incontinence episodes was number of times a participant recorded an urgency incontinence episode on valid diary days during the 7-day micturition diary period prior to each visit.|urgency incontinence episodes|Mean|20.3|20.3|Standard Deviation|20.7|20.7|||
3753342|NCT01972841|3587420|B6|||Number of urgency incontinence episodes/week|The number of urgency incontinence episodes was number of times a participant recorded an urgency incontinence episode on valid diary days during the 7-day micturition diary period prior to each visit.|urgency incontinence episodes|Mean|19.2|19.2|Standard Deviation|18.2|18.2|||
3753343|NCT01972841|3587421|B5|||Number of urgency incontinence episodes/week|The number of urgency incontinence episodes was number of times a participant recorded an urgency incontinence episode on valid diary days during the 7-day micturition diary period prior to each visit.|urgency incontinence episodes|Mean|19.5|19.5|Standard Deviation|19.3|19.3|||
3753344|NCT01972841|3587422|B4|||Number of urgency incontinence episodes/week|The number of urgency incontinence episodes was number of times a participant recorded an urgency incontinence episode on valid diary days during the 7-day micturition diary period prior to each visit.|urgency incontinence episodes|Mean|22.4|22.4|Standard Deviation|23.3|23.3|||
3753345|NCT01972841|3587423|B3|||Number of urgency incontinence episodes/week|The number of urgency incontinence episodes was number of times a participant recorded an urgency incontinence episode on valid diary days during the 7-day micturition diary period prior to each visit.|urgency incontinence episodes|Mean|19.8|19.8|Standard Deviation|22.7|22.7|||
3753346|NCT01972841|3587424|B2|||Number of urgency incontinence episodes/week|The number of urgency incontinence episodes was number of times a participant recorded an urgency incontinence episode on valid diary days during the 7-day micturition diary period prior to each visit.|urgency incontinence episodes|Mean|20.6|20.6|Standard Deviation|21.4|21.4|||
3753347|NCT01972841|3587425|B1|||Number of urgency incontinence episodes/week|The number of urgency incontinence episodes was number of times a participant recorded an urgency incontinence episode on valid diary days during the 7-day micturition diary period prior to each visit.|urgency incontinence episodes|Mean|21.7|21.7|Standard Deviation|22.6|22.6|||
3753348|NCT01972841|3587419|B7|||Mean number of urgency incontinence episodes/24 h|An urgency incontinence episode was defined as the involuntary leakage of urine accompanied by or immediately preceded by urgency. The mean number of urgency incontinence episodes per 24 hours was calculated from number of times a participant recorded an urgency incontinence episode per day on valid diary days during the 7-day micturition diary period prior to each visit.|urgency incontinence episodes|Mean|2.94|2.94|Standard Deviation|3.00|3.0|||
3753349|NCT01972841|3587420|B6|||Mean number of urgency incontinence episodes/24 h|An urgency incontinence episode was defined as the involuntary leakage of urine accompanied by or immediately preceded by urgency. The mean number of urgency incontinence episodes per 24 hours was calculated from number of times a participant recorded an urgency incontinence episode per day on valid diary days during the 7-day micturition diary period prior to each visit.|urgency incontinence episodes|Mean|2.80|2.8|Standard Deviation|2.64|2.64|||
3753350|NCT01972841|3587421|B5|||Mean number of urgency incontinence episodes/24 h|An urgency incontinence episode was defined as the involuntary leakage of urine accompanied by or immediately preceded by urgency. The mean number of urgency incontinence episodes per 24 hours was calculated from number of times a participant recorded an urgency incontinence episode per day on valid diary days during the 7-day micturition diary period prior to each visit.|urgency incontinence episodes|Mean|2.85|2.85|Standard Deviation|2.81|2.81|||
3753351|NCT01972841|3587422|B4|||Mean number of urgency incontinence episodes/24 h|An urgency incontinence episode was defined as the involuntary leakage of urine accompanied by or immediately preceded by urgency. The mean number of urgency incontinence episodes per 24 hours was calculated from number of times a participant recorded an urgency incontinence episode per day on valid diary days during the 7-day micturition diary period prior to each visit.|urgency incontinence episodes|Mean|3.23|3.23|Standard Deviation|3.34|3.34|||
3753352|NCT01972841|3587423|B3|||Mean number of urgency incontinence episodes/24 h|An urgency incontinence episode was defined as the involuntary leakage of urine accompanied by or immediately preceded by urgency. The mean number of urgency incontinence episodes per 24 hours was calculated from number of times a participant recorded an urgency incontinence episode per day on valid diary days during the 7-day micturition diary period prior to each visit.|urgency incontinence episodes|Mean|2.89|2.89|Standard Deviation|3.31|3.31|||
3753353|NCT01972841|3587424|B2|||Mean number of urgency incontinence episodes/24 h|An urgency incontinence episode was defined as the involuntary leakage of urine accompanied by or immediately preceded by urgency. The mean number of urgency incontinence episodes per 24 hours was calculated from number of times a participant recorded an urgency incontinence episode per day on valid diary days during the 7-day micturition diary period prior to each visit.|urgency incontinence episodes|Mean|3.00|3.0|Standard Deviation|3.09|3.09|||
3753418|NCT01972776|3587858|B7|||Age||Years|Mean|64|64.0|Standard Deviation|5.3|5.3|||
3753419|NCT01972776|3587859|B6|||Age||Years|Mean|66|66.0|Standard Deviation|5.6|5.6|||
3753420|NCT01972776|3587860|B5|||Age||Years|Mean|64|64.0|Standard Deviation|5.5|5.5|||
3753354|NCT01972841|3587425|B1|||Mean number of urgency incontinence episodes/24 h|An urgency incontinence episode was defined as the involuntary leakage of urine accompanied by or immediately preceded by urgency. The mean number of urgency incontinence episodes per 24 hours was calculated from number of times a participant recorded an urgency incontinence episode per day on valid diary days during the 7-day micturition diary period prior to each visit.|urgency incontinence episodes|Mean|3.14|3.14|Standard Deviation|3.23|3.23|||
3753355|NCT01972841|3587419|B7|||Number of incontinence episodes/week|The number of incontinence episodes was calculated from total number of incontinence episodes recorded by the participant per day on valid diary days during the 7-day micturition diary period.|incontinence episodes|Mean|22.7|22.7|Standard Deviation|22.7|22.7|||
3753356|NCT01972841|3587420|B6|||Number of incontinence episodes/week|The number of incontinence episodes was calculated from total number of incontinence episodes recorded by the participant per day on valid diary days during the 7-day micturition diary period.|incontinence episodes|Mean|21.7|21.7|Standard Deviation|21.3|21.3|||
3753357|NCT01972841|3587421|B5|||Number of incontinence episodes/week|The number of incontinence episodes was calculated from total number of incontinence episodes recorded by the participant per day on valid diary days during the 7-day micturition diary period.|incontinence episodes|Mean|22.1|22.1|Standard Deviation|21.7|21.7|||
3753358|NCT01972841|3587422|B4|||Number of incontinence episodes/week|The number of incontinence episodes was calculated from total number of incontinence episodes recorded by the participant per day on valid diary days during the 7-day micturition diary period.|incontinence episodes|Mean|24.8|24.8|Standard Deviation|24.5|24.5|||
3753359|NCT01972841|3587423|B3|||Number of incontinence episodes/week|The number of incontinence episodes was calculated from total number of incontinence episodes recorded by the participant per day on valid diary days during the 7-day micturition diary period.|incontinence episodes|Mean|21.7|21.7|Standard Deviation|23.8|23.8|||
3753360|NCT01972841|3587424|B2|||Number of incontinence episodes/week|The number of incontinence episodes was calculated from total number of incontinence episodes recorded by the participant per day on valid diary days during the 7-day micturition diary period.|incontinence episodes|Mean|23.5|23.5|Standard Deviation|23.6|23.6|||
3753361|NCT01972841|3587425|B1|||Number of incontinence episodes/week|The number of incontinence episodes was calculated from total number of incontinence episodes recorded by the participant per day on valid diary days during the 7-day micturition diary period.|incontinence episodes|Mean|23.6|23.6|Standard Deviation|23.6|23.6|||
3753362|NCT01972841|3587419|B7|||Mean volume voided per micturition|The mean volume voided per micturition was calculated from the data recorded by the participant during 3 consecutive days with volume measurements during the 7-day micturition diary period.|mL|Least Squares Mean|155.43|155.43|Standard Deviation|59.49|59.49|||
3753363|NCT01972841|3587420|B6|||Mean volume voided per micturition|The mean volume voided per micturition was calculated from the data recorded by the participant during 3 consecutive days with volume measurements during the 7-day micturition diary period.|mL|Least Squares Mean|153.57|153.57|Standard Deviation|59.67|59.67|||
3753364|NCT01972841|3587421|B5|||Mean volume voided per micturition|The mean volume voided per micturition was calculated from the data recorded by the participant during 3 consecutive days with volume measurements during the 7-day micturition diary period.|mL|Least Squares Mean|159.32|159.32|Standard Deviation|58.29|58.29|||
3753365|NCT01972841|3587422|B4|||Mean volume voided per micturition|The mean volume voided per micturition was calculated from the data recorded by the participant during 3 consecutive days with volume measurements during the 7-day micturition diary period.|mL|Least Squares Mean|151.94|151.94|Standard Deviation|59.29|59.29|||
3753366|NCT01972841|3587423|B3|||Mean volume voided per micturition|The mean volume voided per micturition was calculated from the data recorded by the participant during 3 consecutive days with volume measurements during the 7-day micturition diary period.|mL|Least Squares Mean|155.31|155.31|Standard Deviation|60.78|60.78|||
3753367|NCT01972841|3587424|B2|||Mean volume voided per micturition|The mean volume voided per micturition was calculated from the data recorded by the participant during 3 consecutive days with volume measurements during the 7-day micturition diary period.|mL|Least Squares Mean|152.46|152.46|Standard Deviation|60.96|60.96|||
3753368|NCT01972841|3587425|B1|||Mean volume voided per micturition|The mean volume voided per micturition was calculated from the data recorded by the participant during 3 consecutive days with volume measurements during the 7-day micturition diary period.|mL|Least Squares Mean|157.94|157.94|Standard Deviation|58.78|58.78|||
3753369|NCT01972841|3587419|B7|||Mean number of micturitions/24 h|A micturition was defined as any voluntary micturition (excluding incontinence only episodes). The mean number of micturitions per 24 hours was calculated from data recorded by the participant per day on valid diary days during the 7-day micturition diary period.|micturitions|Mean|10.84|10.84|Standard Deviation|2.73|2.73|||
3753370|NCT01972841|3587420|B6|||Mean number of micturitions/24 h|A micturition was defined as any voluntary micturition (excluding incontinence only episodes). The mean number of micturitions per 24 hours was calculated from data recorded by the participant per day on valid diary days during the 7-day micturition diary period.|micturitions|Mean|10.74|10.74|Standard Deviation|2.36|2.36|||
3753371|NCT01972841|3587421|B5|||Mean number of micturitions/24 h|A micturition was defined as any voluntary micturition (excluding incontinence only episodes). The mean number of micturitions per 24 hours was calculated from data recorded by the participant per day on valid diary days during the 7-day micturition diary period.|micturitions|Mean|10.73|10.73|Standard Deviation|2.88|2.88|||
3753372|NCT01972841|3587422|B4|||Mean number of micturitions/24 h|A micturition was defined as any voluntary micturition (excluding incontinence only episodes). The mean number of micturitions per 24 hours was calculated from data recorded by the participant per day on valid diary days during the 7-day micturition diary period.|micturitions|Mean|10.76|10.76|Standard Deviation|2.47|2.47|||
3753373|NCT01972841|3587423|B3|||Mean number of micturitions/24 h|A micturition was defined as any voluntary micturition (excluding incontinence only episodes). The mean number of micturitions per 24 hours was calculated from data recorded by the participant per day on valid diary days during the 7-day micturition diary period.|micturitions|Mean|11.19|11.19|Standard Deviation|3.27|3.27|||
3753421|NCT01972776|3587861|B4|||Age||Years|Mean|61|61.0|Standard Deviation|2.9|2.9|||
3753422|NCT01972776|3587862|B3|||Age||Years|Mean|65|65.0|Standard Deviation|4.5|4.5|||
3753375|NCT01972841|3587425|B1|||Mean number of micturitions/24 h|A micturition was defined as any voluntary micturition (excluding incontinence only episodes). The mean number of micturitions per 24 hours was calculated from data recorded by the participant per day on valid diary days during the 7-day micturition diary period.|micturitions|Mean|10.97|10.97|Standard Deviation|2.86|2.86|||
3753376|NCT01972841|3587419|B7|||Mean number of incontinence episodes/24 h|An incontinence episode was defined as the complaint of any involuntary leakage of urine. The mean number of incontinence episodes per 24 hours was calculated from data recorded by the participant per day on valid diary days during the 7-day micturition diary period.|incontinence episodes|Mean|3.29|3.29|Standard Deviation|3.29|3.29|||
3753377|NCT01972841|3587420|B6|||Mean number of incontinence episodes/24 h|An incontinence episode was defined as the complaint of any involuntary leakage of urine. The mean number of incontinence episodes per 24 hours was calculated from data recorded by the participant per day on valid diary days during the 7-day micturition diary period.|incontinence episodes|Mean|3.16|3.16|Standard Deviation|3.08|3.08|||
3753378|NCT01972841|3587421|B5|||Mean number of incontinence episodes/24 h|An incontinence episode was defined as the complaint of any involuntary leakage of urine. The mean number of incontinence episodes per 24 hours was calculated from data recorded by the participant per day on valid diary days during the 7-day micturition diary period.|incontinence episodes|Mean|3.22|3.22|Standard Deviation|3.17|3.17|||
3753379|NCT01972841|3587422|B4|||Mean number of incontinence episodes/24 h|An incontinence episode was defined as the complaint of any involuntary leakage of urine. The mean number of incontinence episodes per 24 hours was calculated from data recorded by the participant per day on valid diary days during the 7-day micturition diary period.|incontinence episodes|Mean|3.58|3.58|Standard Deviation|3.51|3.51|||
3753380|NCT01972841|3587423|B3|||Mean number of incontinence episodes/24 h|An incontinence episode was defined as the complaint of any involuntary leakage of urine. The mean number of incontinence episodes per 24 hours was calculated from data recorded by the participant per day on valid diary days during the 7-day micturition diary period.|incontinence episodes|Mean|3.18|3.18|Standard Deviation|3.47|3.47|||
3753381|NCT01972841|3587424|B2|||Mean number of incontinence episodes/24 h|An incontinence episode was defined as the complaint of any involuntary leakage of urine. The mean number of incontinence episodes per 24 hours was calculated from data recorded by the participant per day on valid diary days during the 7-day micturition diary period.|incontinence episodes|Mean|3.42|3.42|Standard Deviation|3.40|3.4|||
3753382|NCT01972841|3587425|B1|||Mean number of incontinence episodes/24 h|An incontinence episode was defined as the complaint of any involuntary leakage of urine. The mean number of incontinence episodes per 24 hours was calculated from data recorded by the participant per day on valid diary days during the 7-day micturition diary period.|incontinence episodes|Mean|3.41|3.41|Standard Deviation|3.37|3.37|||
3753383|NCT01972841|3587419|B7||Male|Sex: Female, Male||Participants|Count of Participants|789|789.0||||||
3753384|NCT01972841|3587420|B6||Male|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
3753385|NCT01972841|3587421|B5||Male|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
3753386|NCT01972841|3587422|B4||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3753387|NCT01972841|3587423|B3||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3753388|NCT01972841|3587424|B2||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3753389|NCT01972841|3587425|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3753390|NCT01972841|3587419|B7||Female|Sex: Female, Male||Participants|Count of Participants|2738|2738.0||||||
3753391|NCT01972841|3587420|B6||Female|Sex: Female, Male||Participants|Count of Participants|684|684.0||||||
3753392|NCT01972841|3587421|B5||Female|Sex: Female, Male||Participants|Count of Participants|686|686.0||||||
3753393|NCT01972841|3587422|B4||Female|Sex: Female, Male||Participants|Count of Participants|342|342.0||||||
3753394|NCT01972841|3587423|B3||Female|Sex: Female, Male||Participants|Count of Participants|338|338.0||||||
3753395|NCT01972841|3587424|B2||Female|Sex: Female, Male||Participants|Count of Participants|343|343.0||||||
3753396|NCT01972841|3587425|B1||Female|Sex: Female, Male||Participants|Count of Participants|345|345.0||||||
3753397|NCT01972841|3587419|B7|||Age||Year|Mean|57.16|57.16|Standard Deviation|13.42|13.42|||
3753398|NCT01972841|3587420|B6|||Age||Year|Mean|57.3|57.3|Standard Deviation|13.46|13.46|||
3753399|NCT01972841|3587421|B5|||Age||Year|Mean|56.94|56.94|Standard Deviation|13.78|13.78|||
3753400|NCT01972841|3587422|B4|||Age||Year|Mean|57.88|57.88|Standard Deviation|12.92|12.92|||
3753401|NCT01972841|3587423|B3|||Age||Year|Mean|56.69|56.69|Standard Deviation|13.28|13.28|||
3753402|NCT01972841|3587424|B2|||Age||Year|Mean|56.77|56.77|Standard Deviation|13.46|13.46|||
3753403|NCT01972841|3587425|B1|||Age||Year|Mean|57.46|57.46|Standard Deviation|13.2|13.2|||
3753404|NCT01972776|3587858|B7||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3753405|NCT01972776|3587859|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3753406|NCT01972776|3587860|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3753407|NCT01972776|3587861|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3753408|NCT01972776|3587862|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3753409|NCT01972776|3587863|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3753410|NCT01972776|3587864|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3753411|NCT01972776|3587858|B7||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3753412|NCT01972776|3587859|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3753413|NCT01972776|3587860|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3753414|NCT01972776|3587861|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3753415|NCT01972776|3587862|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3753416|NCT01972776|3587863|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3753417|NCT01972776|3587864|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3753423|NCT01972776|3587863|B2|||Age||Years|Mean|64|64.0|Standard Deviation|7.5|7.5|||
3753424|NCT01972776|3587864|B1|||Age||Years|Mean|63|63.0|Standard Deviation|5.6|5.6|||
3753425|NCT01972724|3587937|B4|||Body Mass Index (BMI)||kg/m^2|Mean|26.52|26.52|Full Range|||19.0|36.7|
3753426|NCT01972724|3587938|B3|||Body Mass Index (BMI)||kg/m^2|Mean|26.25|26.25|Full Range|||19.0|34.6|
3753427|NCT01972724|3587939|B2|||Body Mass Index (BMI)||kg/m^2|Mean|26.46|26.46|Full Range|||20.9|30.8|
3753428|NCT01972724|3587940|B1|||Body Mass Index (BMI)||kg/m^2|Mean|26.86|26.86|Full Range|||22.2|36.7|
3753429|NCT01972724|3587937|B4|||Weight||kg|Mean|70.65|70.65|Full Range|||46.3|101.0|
3753430|NCT01972724|3587938|B3|||Weight||kg|Mean|70.38|70.38|Full Range|||46.3|101.0|
3753431|NCT01972724|3587939|B2|||Weight||kg|Mean|71.20|71.2|Full Range|||47.5|100.0|
3753432|NCT01972724|3587940|B1|||Weight||kg|Mean|70.39|70.39|Full Range|||48.0|97.0|
3753433|NCT01972724|3587937|B4|||Height||cm|Mean|162.89|162.89|Full Range|||145.9|185.0|
3753434|NCT01972724|3587938|B3|||Height||cm|Mean|163.25|163.25|Full Range|9.148|9.148|145.9|182.5|
3753435|NCT01972724|3587939|B2|||Height||cm|Mean|163.50|163.5|Full Range|9.702|9.702|151.0|185.0|
3753436|NCT01972724|3587940|B1|||Height||cm|Mean|161.94|161.94|Full Range|8.392|8.392|147.0|175.0|
3753437|NCT01972724|3587937|B4|Korea, Republic Of||Region of Enrollment||Participants|Count of Participants|111|111.0||||||
3753438|NCT01972724|3587938|B3|Korea, Republic Of||Region of Enrollment||Participants|Count of Participants|77|77.0||||||
3753439|NCT01972724|3587939|B2|Korea, Republic Of||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3753440|NCT01972724|3587940|B1|Korea, Republic Of||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3753441|NCT01972724|3587937|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|111|111.0||||||
3753442|NCT01972724|3587938|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|77|77.0||||||
3753443|NCT01972724|3587939|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3753444|NCT01972724|3587940|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3753445|NCT01972724|3587937|B4||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|111|111.0||||||
3753446|NCT01972724|3587938|B3||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|77|77.0||||||
3753447|NCT01972724|3587939|B2||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3753448|NCT01972724|3587940|B1||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3753449|NCT01972724|3587937|B4||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3753450|NCT01972724|3587938|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3753451|NCT01972724|3587939|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3753452|NCT01972724|3587940|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3753453|NCT01972724|3587937|B4||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3753454|NCT01972724|3587938|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3753455|NCT01972724|3587939|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3753456|NCT01972724|3587940|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3753457|NCT01972724|3587937|B4|||Age||years|Mean|58.6|58.6|Full Range|||31.0|76.0|
3753458|NCT01972724|3587938|B3|||Age||years|Mean|59.2|59.2|Full Range|7.88|7.88|39.0|76.0|
3753459|NCT01972724|3587939|B2|||Age||years|Mean|57.0|57.0|Full Range|12.0|12.0|31.0|74.0|
3753460|NCT01972724|3587940|B1|||Age||years|Mean|59.6|59.6|Full Range|8.73|8.73|44.0|75.0|
3753461|NCT01972659|3587953|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3753462|NCT01972659|3587954|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3753463|NCT01972659|3587955|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3753464|NCT01972659|3587953|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3753465|NCT01972659|3587954|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3753466|NCT01972659|3587955|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3753467|NCT01972659|3587953|B3|||Age||years|Mean|40.1|40.1|Standard Deviation|10.4|10.4|||
3753468|NCT01972659|3587954|B2|||Age||years|Mean|39.4|39.4|Standard Deviation|10.6|10.6|||
3753469|NCT01972659|3587955|B1|||Age||years|Mean|41.3|41.3|Standard Deviation|10.3|10.3|||
3753470|NCT01972568|3587962|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3753471|NCT01972568|3587963|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3753472|NCT01972568|3587964|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3753473|NCT01972568|3587965|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3753474|NCT01972568|3587962|B4||Female|Sex: Female, Male||Participants|Count of Participants|280|280.0||||||
3753475|NCT01972568|3587963|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3753476|NCT01972568|3587964|B2||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3753477|NCT01972568|3587965|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3753478|NCT01972568|3587962|B4|||Age||years|Mean|39|39.0|Standard Deviation|11.9|11.9|||
3753479|NCT01972568|3587963|B3|||Age||years|Mean|40|40.0|Standard Deviation|13.0|13.0|||
3753480|NCT01972568|3587964|B2|||Age||years|Mean|39|39.0|Standard Deviation|11.6|11.6|||
3753481|NCT01972568|3587965|B1|||Age||years|Mean|37|37.0|Standard Deviation|11.2|11.2|||
3753482|NCT01972529|3588002|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3753483|NCT01972529|3588003|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3753484|NCT01972529|3588004|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753485|NCT01972529|3588005|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3753486|NCT01972529|3588006|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3753487|NCT01972529|3588002|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753488|NCT01972529|3588003|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753489|NCT01972529|3588004|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753490|NCT01972529|3588005|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753491|NCT01972529|3588006|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753492|NCT01972529|3588002|B5||White|Race (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
3753493|NCT01972529|3588003|B4||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3753494|NCT01972529|3588004|B3||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3753495|NCT01972529|3588005|B2||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3753496|NCT01972529|3588006|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3753497|NCT01972529|3588002|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3753498|NCT01972529|3588003|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3753499|NCT01972529|3588004|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753500|NCT01972529|3588005|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3753501|NCT01972529|3588006|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753502|NCT01972529|3588002|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753503|NCT01972529|3588003|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753504|NCT01972529|3588004|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753505|NCT01972529|3588005|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753506|NCT01972529|3588006|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753507|NCT01972529|3588002|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
3753508|NCT01972529|3588003|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3753509|NCT01972529|3588004|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3753510|NCT01972529|3588005|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3753511|NCT01972529|3588006|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3753512|NCT01972529|3588002|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753513|NCT01972529|3588003|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753514|NCT01972529|3588004|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753515|NCT01972529|3588005|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753516|NCT01972529|3588006|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753517|NCT01972529|3588002|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3753518|NCT01972529|3588003|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3753519|NCT01972529|3588004|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753520|NCT01972529|3588005|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3753521|NCT01972529|3588006|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3753522|NCT01972529|3588002|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|196|196.0||||||
3753523|NCT01972529|3588003|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3753524|NCT01972529|3588004|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3753525|NCT01972529|3588005|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3753526|NCT01972529|3588006|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3753527|NCT01972529|3588002|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3753528|NCT01972529|3588003|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3753529|NCT01972529|3588004|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3753530|NCT01972529|3588005|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3753531|NCT01972529|3588006|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3753532|NCT01972529|3588002|B5||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3753533|NCT01972529|3588003|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3753534|NCT01972529|3588004|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3753535|NCT01972529|3588005|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3753536|NCT01972529|3588006|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3753537|NCT01972529|3588002|B5||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3753538|NCT01972529|3588003|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3753539|NCT01972529|3588004|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3753540|NCT01972529|3588005|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3753541|NCT01972529|3588006|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3753542|NCT01972529|3588002|B5|||Age||Years|Mean|56.3|56.3|Standard Deviation|10.06|10.06|||
3753543|NCT01972529|3588003|B4|||Age||Years|Mean|57.5|57.5|Standard Deviation|10.06|10.06|||
3753544|NCT01972529|3588004|B3|||Age||Years|Mean|57.8|57.8|Standard Deviation|11.05|11.05|||
3753545|NCT01972529|3588005|B2|||Age||Years|Mean|55.6|55.6|Standard Deviation|9.12|9.12|||
3753546|NCT01972529|3588006|B1|||Age||Years|Mean|55.1|55.1|Standard Deviation|11.02|11.02|||
3753547|NCT01972516|3588035|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3753548|NCT01972516|3588036|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3753549|NCT01972516|3588037|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3753550|NCT01972516|3588035|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3753551|NCT01972516|3588036|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3753552|NCT01972516|3588037|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3753553|NCT01972516|3588035|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3753554|NCT01972516|3588036|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3753555|NCT01972516|3588037|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3753556|NCT01972516|3588035|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3753557|NCT01972516|3588036|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3753558|NCT01972516|3588037|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3753559|NCT01972516|3588035|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753560|NCT01972516|3588036|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753561|NCT01972516|3588037|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753562|NCT01972464|3588052|B3|||Edinburgh Postnatal Depression Scale Score|Scale is scored from 0 to 30. Higher scores indicate more severe symptoms.|units on a scale|Mean|3.4|3.4|Standard Deviation|4.7|4.7|||
3753563|NCT01972464|3588053|B2|||Edinburgh Postnatal Depression Scale Score|Scale is scored from 0 to 30. Higher scores indicate more severe symptoms.|units on a scale|Mean|3.0|3.0|Standard Deviation|4.5|4.5|||
3753564|NCT01972464|3588054|B1|||Edinburgh Postnatal Depression Scale Score|Scale is scored from 0 to 30. Higher scores indicate more severe symptoms.|units on a scale|Mean|3.8|3.8|Standard Deviation|4.9|4.9|||
3753565|NCT01972464|3588052|B3|||Questionnaire on Smoking Urges (QSU)-Brief Score|Scale is scored from 10 to 70. Higher scores indicate more severe symptoms.|units on a scale|Mean|16.9|16.9|Standard Deviation|13.7|13.7|||
3753566|NCT01972464|3588053|B2|||Questionnaire on Smoking Urges (QSU)-Brief Score|Scale is scored from 10 to 70. Higher scores indicate more severe symptoms.|units on a scale|Mean|18.0|18.0|Standard Deviation|12.2|12.2|||
3753567|NCT01972464|3588054|B1|||Questionnaire on Smoking Urges (QSU)-Brief Score|Scale is scored from 10 to 70. Higher scores indicate more severe symptoms.|units on a scale|Mean|15.6|15.6|Standard Deviation|15.4|15.4|||
3753568|NCT01972464|3588052|B3||High dependence|Fagerstrom Test for Nicotine Dependence||Participants|Count of Participants|0|0.0||||||
3753569|NCT01972464|3588053|B2||High dependence|Fagerstrom Test for Nicotine Dependence||Participants|Count of Participants|0|0.0||||||
3753570|NCT01972464|3588054|B1||High dependence|Fagerstrom Test for Nicotine Dependence||Participants|Count of Participants|0|0.0||||||
3753571|NCT01972464|3588052|B3||Moderate dependence|Fagerstrom Test for Nicotine Dependence||Participants|Count of Participants|8|8.0||||||
3753572|NCT01972464|3588053|B2||Moderate dependence|Fagerstrom Test for Nicotine Dependence||Participants|Count of Participants|4|4.0||||||
3753573|NCT01972464|3588054|B1||Moderate dependence|Fagerstrom Test for Nicotine Dependence||Participants|Count of Participants|4|4.0||||||
3753574|NCT01972464|3588052|B3||Low to moderate dependence|Fagerstrom Test for Nicotine Dependence||Participants|Count of Participants|20|20.0||||||
3753575|NCT01972464|3588053|B2||Low to moderate dependence|Fagerstrom Test for Nicotine Dependence||Participants|Count of Participants|11|11.0||||||
3753576|NCT01972464|3588054|B1||Low to moderate dependence|Fagerstrom Test for Nicotine Dependence||Participants|Count of Participants|9|9.0||||||
3753577|NCT01972464|3588052|B3||Low dependence|Fagerstrom Test for Nicotine Dependence||Participants|Count of Participants|13|13.0||||||
3753578|NCT01972464|3588053|B2||Low dependence|Fagerstrom Test for Nicotine Dependence||Participants|Count of Participants|7|7.0||||||
3753579|NCT01972464|3588054|B1||Low dependence|Fagerstrom Test for Nicotine Dependence||Participants|Count of Participants|6|6.0||||||
3753580|NCT01972464|3588052|B3||Missing|Feeding method at week 2 visit||Participants|Count of Participants|6|6.0||||||
3753581|NCT01972464|3588053|B2||Missing|Feeding method at week 2 visit||Participants|Count of Participants|4|4.0||||||
3753582|NCT01972464|3588054|B1||Missing|Feeding method at week 2 visit||Participants|Count of Participants|2|2.0||||||
3753583|NCT01972464|3588052|B3||Formula feed exclusively|Feeding method at week 2 visit||Participants|Count of Participants|21|21.0||||||
3753584|NCT01972464|3588053|B2||Formula feed exclusively|Feeding method at week 2 visit||Participants|Count of Participants|7|7.0||||||
3753585|NCT01972464|3588054|B1||Formula feed exclusively|Feeding method at week 2 visit||Participants|Count of Participants|14|14.0||||||
3753586|NCT01972464|3588052|B3||Breasefeed and formula feed|Feeding method at week 2 visit||Participants|Count of Participants|8|8.0||||||
3753587|NCT01972464|3588053|B2||Breasefeed and formula feed|Feeding method at week 2 visit||Participants|Count of Participants|5|5.0||||||
3753588|NCT01972464|3588054|B1||Breasefeed and formula feed|Feeding method at week 2 visit||Participants|Count of Participants|3|3.0||||||
3753589|NCT01972464|3588052|B3||Breastfeed exclusively|Feeding method at week 2 visit||Participants|Count of Participants|6|6.0||||||
3753590|NCT01972464|3588053|B2||Breastfeed exclusively|Feeding method at week 2 visit||Participants|Count of Participants|6|6.0||||||
3753591|NCT01972464|3588054|B1||Breastfeed exclusively|Feeding method at week 2 visit||Participants|Count of Participants|0|0.0||||||
3753592|NCT01972464|3588052|B3||Unsure|Breastfeeding intentions||Participants|Count of Participants|1|1.0||||||
3753593|NCT01972464|3588053|B2||Unsure|Breastfeeding intentions||Participants|Count of Participants|0|0.0||||||
3753594|NCT01972464|3588054|B1||Unsure|Breastfeeding intentions||Participants|Count of Participants|1|1.0||||||
3753595|NCT01972464|3588052|B3||Formula feed exclusively|Breastfeeding intentions||Participants|Count of Participants|6|6.0||||||
3753596|NCT01972464|3588053|B2||Formula feed exclusively|Breastfeeding intentions||Participants|Count of Participants|2|2.0||||||
3753597|NCT01972464|3588054|B1||Formula feed exclusively|Breastfeeding intentions||Participants|Count of Participants|4|4.0||||||
3753598|NCT01972464|3588052|B3||Breasefeed and formula feed|Breastfeeding intentions||Participants|Count of Participants|21|21.0||||||
3753599|NCT01972464|3588053|B2||Breasefeed and formula feed|Breastfeeding intentions||Participants|Count of Participants|11|11.0||||||
3753600|NCT01972464|3588054|B1||Breasefeed and formula feed|Breastfeeding intentions||Participants|Count of Participants|10|10.0||||||
3753601|NCT01972464|3588052|B3||Breastfeed exclusively|Breastfeeding intentions||Participants|Count of Participants|13|13.0||||||
3753602|NCT01972464|3588053|B2||Breastfeed exclusively|Breastfeeding intentions||Participants|Count of Participants|9|9.0||||||
3753603|NCT01972464|3588054|B1||Breastfeed exclusively|Breastfeeding intentions||Participants|Count of Participants|4|4.0||||||
3753604|NCT01972464|3588052|B3||10 cigarettes/day|Pre-quit smoking level||Participants|Count of Participants|7|7.0||||||
3753605|NCT01972464|3588053|B2||10 cigarettes/day|Pre-quit smoking level||Participants|Count of Participants|5|5.0||||||
3753606|NCT01972464|3588054|B1||10 cigarettes/day|Pre-quit smoking level||Participants|Count of Participants|2|2.0||||||
3753607|NCT01972464|3588052|B3||≤10 cigarettes/day|Pre-quit smoking level||Participants|Count of Participants|34|34.0||||||
3753608|NCT01972464|3588053|B2||≤10 cigarettes/day|Pre-quit smoking level||Participants|Count of Participants|17|17.0||||||
3753609|NCT01972464|3588054|B1||≤10 cigarettes/day|Pre-quit smoking level||Participants|Count of Participants|17|17.0||||||
3753610|NCT01972464|3588052|B3|||Pre-quit number of cigarettes per day||participants|Mean|6.6|6.6|Standard Deviation|3.9|3.9|||
3753611|NCT01972464|3588053|B2|||Pre-quit number of cigarettes per day||participants|Mean|6.2|6.2|Standard Deviation|4.3|4.3|||
3753612|NCT01972464|3588054|B1|||Pre-quit number of cigarettes per day||participants|Mean|7.1|7.1|Standard Deviation|3.3|3.3|||
3753613|NCT01972464|3588052|B3||4+|Parity||Participants|Count of Participants|7|7.0||||||
3753614|NCT01972464|3588053|B2||4+|Parity||Participants|Count of Participants|3|3.0||||||
3753615|NCT01972464|3588054|B1||4+|Parity||Participants|Count of Participants|4|4.0||||||
3753616|NCT01972464|3588052|B3||3|Parity||Participants|Count of Participants|11|11.0||||||
3753617|NCT01972464|3588053|B2||3|Parity||Participants|Count of Participants|7|7.0||||||
3753618|NCT01972464|3588054|B1||3|Parity||Participants|Count of Participants|4|4.0||||||
3753619|NCT01972464|3588052|B3||2|Parity||Participants|Count of Participants|12|12.0||||||
3753620|NCT01972464|3588053|B2||2|Parity||Participants|Count of Participants|4|4.0||||||
3753621|NCT01972464|3588054|B1||2|Parity||Participants|Count of Participants|8|8.0||||||
3753622|NCT01972464|3588052|B3||1|Parity||Participants|Count of Participants|11|11.0||||||
3753623|NCT01972464|3588053|B2||1|Parity||Participants|Count of Participants|8|8.0||||||
3753624|NCT01972464|3588054|B1||1|Parity||Participants|Count of Participants|3|3.0||||||
3753625|NCT01972464|3588052|B3||No|Lives with smoker||Participants|Count of Participants|19|19.0||||||
3753626|NCT01972464|3588053|B2||No|Lives with smoker||Participants|Count of Participants|11|11.0||||||
3753627|NCT01972464|3588054|B1||No|Lives with smoker||Participants|Count of Participants|8|8.0||||||
3753628|NCT01972464|3588052|B3||Yes|Lives with smoker||Participants|Count of Participants|18|18.0||||||
3753629|NCT01972464|3588053|B2||Yes|Lives with smoker||Participants|Count of Participants|10|10.0||||||
3753630|NCT01972464|3588054|B1||Yes|Lives with smoker||Participants|Count of Participants|8|8.0||||||
3753631|NCT01972464|3588052|B3||No|Lives with spouse or partner||Participants|Count of Participants|21|21.0||||||
3753632|NCT01972464|3588053|B2||No|Lives with spouse or partner||Participants|Count of Participants|12|12.0||||||
3753633|NCT01972464|3588054|B1||No|Lives with spouse or partner||Participants|Count of Participants|9|9.0||||||
3753634|NCT01972464|3588052|B3||Yes|Lives with spouse or partner||Participants|Count of Participants|20|20.0||||||
3753635|NCT01972464|3588053|B2||Yes|Lives with spouse or partner||Participants|Count of Participants|10|10.0||||||
3753636|NCT01972464|3588054|B1||Yes|Lives with spouse or partner||Participants|Count of Participants|10|10.0||||||
3753637|NCT01972464|3588052|B3||Some college (no degree)|Education level||Participants|Count of Participants|10|10.0||||||
3753638|NCT01972464|3588053|B2||Some college (no degree)|Education level||Participants|Count of Participants|3|3.0||||||
3753639|NCT01972464|3588054|B1||Some college (no degree)|Education level||Participants|Count of Participants|7|7.0||||||
3753640|NCT01972464|3588052|B3||High school degree|Education level||Participants|Count of Participants|22|22.0||||||
3753641|NCT01972464|3588053|B2||High school degree|Education level||Participants|Count of Participants|13|13.0||||||
3753642|NCT01972464|3588054|B1||High school degree|Education level||Participants|Count of Participants|9|9.0||||||
3753643|NCT01972464|3588052|B3||<High school degree|Education level||Participants|Count of Participants|9|9.0||||||
3753644|NCT01972464|3588053|B2||<High school degree|Education level||Participants|Count of Participants|6|6.0||||||
3753645|NCT01972464|3588054|B1||<High school degree|Education level||Participants|Count of Participants|3|3.0||||||
3753646|NCT01972464|3588052|B3|Race/Ethnicity|More than one race, non-Latina|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3753647|NCT01972464|3588053|B2|Race/Ethnicity|More than one race, non-Latina|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3753648|NCT01972464|3588054|B1|Race/Ethnicity|More than one race, non-Latina|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3753649|NCT01972464|3588052|B3|Race/Ethnicity|White, non-Latina|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3753650|NCT01972464|3588053|B2|Race/Ethnicity|White, non-Latina|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3753651|NCT01972464|3588054|B1|Race/Ethnicity|White, non-Latina|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3753652|NCT01972464|3588052|B3|Race/Ethnicity|Latina|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3753653|NCT01972464|3588053|B2|Race/Ethnicity|Latina|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3753654|NCT01972464|3588054|B1|Race/Ethnicity|Latina|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3753655|NCT01972464|3588052|B3|Race/Ethnicity|Black, non-Latina|Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3753656|NCT01972464|3588053|B2|Race/Ethnicity|Black, non-Latina|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3753657|NCT01972464|3588054|B1|Race/Ethnicity|Black, non-Latina|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3753658|NCT01972464|3588052|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3753659|NCT01972464|3588053|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3753660|NCT01972464|3588054|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3753661|NCT01972464|3588052|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3753662|NCT01972464|3588053|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3753663|NCT01972464|3588054|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3753664|NCT01972464|3588052|B3|||Age||years|Mean|25.8|25.8|Standard Deviation|4.6|4.6|||
3753665|NCT01972464|3588053|B2|||Age||years|Mean|26.2|26.2|Standard Deviation|4.9|4.9|||
3753666|NCT01972464|3588054|B1|||Age||years|Mean|25.3|25.3|Standard Deviation|4.3|4.3|||
3753667|NCT01972438|3588069|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3753668|NCT01972438|3588070|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3753669|NCT01972438|3588071|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753670|NCT01972438|3588069|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753671|NCT01972438|3588070|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753672|NCT01972438|3588071|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753673|NCT01972438|3588069|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3753674|NCT01972438|3588070|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3753675|NCT01972438|3588071|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3753676|NCT01972438|3588069|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3753677|NCT01972438|3588070|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753678|NCT01972438|3588071|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3753679|NCT01972438|3588069|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753680|NCT01972438|3588070|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753681|NCT01972438|3588071|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753682|NCT01972438|3588069|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753683|NCT01972438|3588070|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753684|NCT01972438|3588071|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753685|NCT01972438|3588069|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753686|NCT01972438|3588070|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753687|NCT01972438|3588071|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753688|NCT01972438|3588069|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753689|NCT01972438|3588070|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753690|NCT01972438|3588071|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753691|NCT01972438|3588069|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3753692|NCT01972438|3588070|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3753693|NCT01972438|3588071|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3753694|NCT01972438|3588069|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753695|NCT01972438|3588070|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753696|NCT01972438|3588071|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753697|NCT01972438|3588069|B3||Male|Gender||Participants|Count of Participants|12|12.0||||||
3753698|NCT01972438|3588070|B2||Male|Gender||Participants|Count of Participants|6|6.0||||||
3753699|NCT01972438|3588071|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
3753700|NCT01972438|3588069|B3||Female|Gender||Participants|Count of Participants|6|6.0||||||
3753701|NCT01972438|3588070|B2||Female|Gender||Participants|Count of Participants|3|3.0||||||
3753702|NCT01972438|3588071|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
3753703|NCT01972438|3588069|B3|||Age||years|Mean|49.3|49.3|Standard Deviation|14.38|14.38|||
3753704|NCT01972438|3588070|B2|||Age||years|Mean|53.4|53.4|Standard Deviation|14.77|14.77|||
3753705|NCT01972438|3588071|B1|||Age||years|Mean|45.1|45.1|Standard Deviation|13.49|13.49|||
3753706|NCT01972438|3588069|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3753707|NCT01972438|3588070|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3753708|NCT01972438|3588071|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3753709|NCT01972438|3588069|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3753710|NCT01972438|3588070|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3753711|NCT01972438|3588071|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3753712|NCT01972438|3588069|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753713|NCT01972438|3588070|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753714|NCT01972438|3588071|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753715|NCT01972308|3588124|B3|||asthma control questionnaire|Asthma Control range is 0-6 with lower score better control (0= total control and 6 = extremetly uncontrolled. The minimally important clinical difference is 0.5. A score > 1.5 is considered inadequate control.|units on a scale|Mean|2.4|2.4|Standard Deviation|1.2|1.2|||
3753716|NCT01972308|3588125|B2|||asthma control questionnaire|Asthma Control range is 0-6 with lower score better control (0= total control and 6 = extremetly uncontrolled. The minimally important clinical difference is 0.5. A score > 1.5 is considered inadequate control.|units on a scale|Mean|2.4|2.4|Standard Deviation|1.2|1.2|||
3753717|NCT01972308|3588126|B1|||asthma control questionnaire|Asthma Control range is 0-6 with lower score better control (0= total control and 6 = extremetly uncontrolled. The minimally important clinical difference is 0.5. A score > 1.5 is considered inadequate control.|units on a scale|Mean|2.3|2.3|Standard Deviation|1.1|1.1|||
3753718|NCT01972308|3588124|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3753719|NCT01972308|3588125|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3753720|NCT01972308|3588126|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3753721|NCT01972308|3588124|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3753722|NCT01972308|3588125|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3753723|NCT01972308|3588126|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3753724|NCT01972308|3588124|B3||White|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3753725|NCT01972308|3588125|B2||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3753726|NCT01972308|3588126|B1||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3753727|NCT01972308|3588124|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|206|206.0||||||
3753728|NCT01972308|3588125|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
3753729|NCT01972308|3588126|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3753730|NCT01972308|3588124|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753731|NCT01972308|3588125|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753732|NCT01972308|3588126|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753733|NCT01972308|3588124|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3753734|NCT01972308|3588125|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3753735|NCT01972308|3588126|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3753736|NCT01972308|3588124|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753737|NCT01972308|3588125|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753738|NCT01972308|3588126|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753739|NCT01972308|3588124|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753740|NCT01972308|3588125|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753741|NCT01972308|3588126|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753742|NCT01972308|3588124|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|287|287.0||||||
3753743|NCT01972308|3588125|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|145|145.0||||||
3753744|NCT01972308|3588126|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|142|142.0||||||
3753745|NCT01972308|3588124|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3753746|NCT01972308|3588125|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3753747|NCT01972308|3588126|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3753748|NCT01972308|3588124|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3753749|NCT01972308|3588125|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3753750|NCT01972308|3588126|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3753751|NCT01972308|3588124|B3||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
3753752|NCT01972308|3588125|B2||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3753753|NCT01972308|3588126|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3753754|NCT01972308|3588124|B3|||Age||years|Mean|51.1|51.1|Standard Deviation|14.0|14.0|||
3753755|NCT01972308|3588125|B2|||Age||years|Mean|49.6|49.6|Standard Deviation|13.7|13.7|||
3753756|NCT01972308|3588126|B1|||Age||years|Mean|52.6|52.6|Standard Deviation|14.3|14.3|||
3753757|NCT01972217|3588143|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3753758|NCT01972217|3588144|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3753759|NCT01972217|3588145|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3753760|NCT01972217|3588146|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753761|NCT01972217|3588147|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753762|NCT01972217|3588143|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753763|NCT01972217|3588144|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753764|NCT01972217|3588145|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753765|NCT01972217|3588146|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753766|NCT01972217|3588147|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753767|NCT01972217|3588143|B5||White|Race (NIH/OMB)||Participants|Count of Participants|150|150.0||||||
3753768|NCT01972217|3588144|B4||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3753769|NCT01972217|3588145|B3||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3753770|NCT01972217|3588146|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3753771|NCT01972217|3588147|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3753772|NCT01972217|3588143|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3753773|NCT01972217|3588144|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3753774|NCT01972217|3588145|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3753775|NCT01972217|3588146|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753776|NCT01972217|3588147|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753777|NCT01972217|3588143|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753778|NCT01972217|3588144|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753779|NCT01972217|3588145|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753780|NCT01972217|3588146|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753781|NCT01972217|3588147|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753782|NCT01972217|3588143|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3753783|NCT01972217|3588144|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753784|NCT01972217|3588145|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3753785|NCT01972217|3588146|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753786|NCT01972217|3588147|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753787|NCT01972217|3588143|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753788|NCT01972217|3588144|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753789|NCT01972217|3588145|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753790|NCT01972217|3588146|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753791|NCT01972217|3588147|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753792|NCT01972217|3588143|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3753793|NCT01972217|3588144|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3753794|NCT01972217|3588145|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3753795|NCT01972217|3588146|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753796|NCT01972217|3588147|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753797|NCT01972217|3588143|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|136|136.0||||||
3753798|NCT01972217|3588144|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3753799|NCT01972217|3588145|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3753800|NCT01972217|3588146|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3753801|NCT01972217|3588147|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3753802|NCT01972217|3588143|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3753803|NCT01972217|3588144|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3753804|NCT01972217|3588145|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3753805|NCT01972217|3588146|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753806|NCT01972217|3588147|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3753807|NCT01972217|3588143|B5||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3753808|NCT01972217|3588144|B4||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3753809|NCT01972217|3588145|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3753810|NCT01972217|3588146|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3753811|NCT01972217|3588147|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3753812|NCT01972217|3588143|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3753813|NCT01972217|3588144|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3753814|NCT01972217|3588145|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3753815|NCT01972217|3588146|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3753816|NCT01972217|3588147|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3753817|NCT01972217|3588143|B5||>=65 years|Age||Participants|Count of Participants|116|116.0||||||
3753818|NCT01972217|3588144|B4||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
3753819|NCT01972217|3588145|B3||>=65 years|Age||Participants|Count of Participants|54|54.0||||||
3753820|NCT01972217|3588146|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3753821|NCT01972217|3588147|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3753822|NCT01972217|3588143|B5||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3753823|NCT01972217|3588144|B4||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3753824|NCT01972217|3588145|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3753825|NCT01972217|3588146|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3753826|NCT01972217|3588147|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3753827|NCT01972217|3588143|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753828|NCT01972217|3588144|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753829|NCT01972217|3588145|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753830|NCT01972217|3588146|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753831|NCT01972217|3588147|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753832|NCT01972152|3588196|B1|||Body Mass Index||kg/m^2|Mean|31.2|31.2|Standard Deviation|5.7|5.7|||
3753833|NCT01972152|3588196|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3753834|NCT01972152|3588196|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753835|NCT01972152|3588196|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753836|NCT01972152|3588196|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3753837|NCT01972152|3588196|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3753838|NCT01972152|3588196|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753839|NCT01972152|3588196|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3753840|NCT01972152|3588196|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753841|NCT01972152|3588196|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753842|NCT01972152|3588196|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3753843|NCT01972152|3588196|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3753844|NCT01972152|3588196|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3753845|NCT01972152|3588196|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3753846|NCT01972152|3588196|B1|||Age||years|Mean|38.7|38.7|Standard Deviation|10.8|10.8|||
3753847|NCT01971723|3588236|B3|||Total Strength (kg)|Total strength was calculated by the summation of all one-repetition maxes (squat + bench + deadlift|kg|Mean|375.87|375.87|Standard Deviation|61.97|61.97|||
3753848|NCT01971723|3588237|B2|||Total Strength (kg)|Total strength was calculated by the summation of all one-repetition maxes (squat + bench + deadlift|kg|Mean|375.87|375.87|Standard Deviation|70.07|70.07|||
3753849|NCT01971723|3588238|B1|||Total Strength (kg)|Total strength was calculated by the summation of all one-repetition maxes (squat + bench + deadlift|kg|Mean|379|379.0|Standard Deviation|58.61|58.61|||
3753850|NCT01971723|3588236|B3|||BMI(kg/m^2)||kg/m^2|Mean|25.06|25.06|Standard Deviation|2.90|2.9|||
3753851|NCT01971723|3588237|B2|||BMI(kg/m^2)||kg/m^2|Mean|25.43|25.43|Standard Deviation|3.15|3.15|||
3753852|NCT01971723|3588238|B1|||BMI(kg/m^2)||kg/m^2|Mean|24.73|24.73|Standard Deviation|2.45|2.45|||
3753853|NCT01971723|3588236|B3|||Body Mass (kg)||kg|Mean|77.43|77.43|Standard Deviation|9.85|9.85|||
3753854|NCT01971723|3588237|B2|||Body Mass (kg)||kg|Mean|79.24|79.24|Standard Deviation|9.71|9.71|||
3753855|NCT01971723|3588238|B1|||Body Mass (kg)||kg|Mean|75.89|75.89|Standard Deviation|10.43|10.43|||
3753856|NCT01971723|3588236|B3|||Height (cm)||cm|Mean|178.39|178.39|Standard Deviation|4.51|4.51|||
3753857|NCT01971723|3588237|B2|||Height (cm)||cm|Mean|177.64|177.64|Standard Deviation|4.78|4.78|||
3753858|NCT01971723|3588238|B1|||Height (cm)||cm|Mean|179.13|179.13|Standard Deviation|5.57|5.57|||
3753859|NCT01971723|3588236|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3753860|NCT01971723|3588237|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3753861|NCT01971723|3588238|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3753862|NCT01971723|3588236|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3753863|NCT01971723|3588237|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3753864|NCT01971723|3588238|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3753865|NCT01971723|3588236|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3753866|NCT01971723|3588237|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3753867|NCT01971723|3588238|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3753868|NCT01971723|3588236|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3753869|NCT01971723|3588237|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3753870|NCT01971723|3588238|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3753871|NCT01971723|3588236|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753872|NCT01971723|3588237|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753873|NCT01971723|3588238|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753874|NCT01971645|3588269|B4|United States||Region of Enrollment||Participants|Count of Participants|77|77.0||||||
3753875|NCT01971645|3588270|B3|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3753876|NCT01971645|3588271|B2|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3753877|NCT01971645|3588272|B1|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3753878|NCT01971645|3588269|B4||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3753879|NCT01971645|3588270|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3753880|NCT01971645|3588271|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3753881|NCT01971645|3588272|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3753882|NCT01971645|3588269|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3753883|NCT01971645|3588270|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3753884|NCT01971645|3588271|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3753885|NCT01971645|3588272|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3753886|NCT01971645|3588269|B4|||Age||years|Mean|14.8|14.8|Standard Deviation|2|2.0|||
3753887|NCT01971645|3588270|B3|||Age||years|Mean|14.7|14.7|Standard Deviation|2|2.0|||
3753888|NCT01971645|3588271|B2|||Age||years|Mean|14.6|14.6|Standard Deviation|2|2.0|||
3753889|NCT01971645|3588272|B1|||Age||years|Mean|15.1|15.1|Standard Deviation|2|2.0|||
3753890|NCT01971645|3588269|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3753891|NCT01971645|3588270|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3753892|NCT01971645|3588271|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3753893|NCT01971645|3588272|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3753894|NCT01971645|3588269|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3753895|NCT01971645|3588270|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3753896|NCT01971645|3588271|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3753897|NCT01971645|3588272|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3753898|NCT01971645|3588269|B4||<=18 years|Age||Participants|Count of Participants|74|74.0||||||
3753899|NCT01971645|3588270|B3||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
3753900|NCT01971645|3588271|B2||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
3753901|NCT01971645|3588272|B1||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
3753902|NCT01971593|3588285|B1|||Patients with Transposition of the Great Vessels with a Systemic Right Ventricle (RV)||Participants|Count of Participants|14|14.0||||||
3753903|NCT01971593|3588285|B1|||Tetralogy of Fallot||Participants|Count of Participants|12|12.0||||||
3753904|NCT01971593|3588285|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3753905|NCT01971593|3588285|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3753906|NCT01971593|3588285|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3753907|NCT01971593|3588285|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3753908|NCT01971593|3588285|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753909|NCT01971580|3588295|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3753910|NCT01971580|3588296|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3753911|NCT01971580|3588297|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3753912|NCT01971580|3588295|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3753913|NCT01971580|3588296|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3753914|NCT01971580|3588297|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3753915|NCT01971580|3588295|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3753916|NCT01971580|3588296|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3753917|NCT01971580|3588297|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3753918|NCT01971580|3588295|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3753919|NCT01971580|3588296|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3753920|NCT01971580|3588297|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3753921|NCT01971580|3588295|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753922|NCT01971580|3588296|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753923|NCT01971580|3588297|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3753924|NCT01971567|3588306|B3|||Duration with Sleep Trouble||years|Mean|11.7|11.7|Standard Deviation|11.7|11.7|||
3753925|NCT01971567|3588307|B2|||Duration with Sleep Trouble||years|Mean|12.2|12.2|Standard Deviation|11.3|11.3|||
3753926|NCT01971567|3588308|B1|||Duration with Sleep Trouble||years|Mean|11.1|11.1|Standard Deviation|12.1|12.1|||
3753927|NCT01971567|3588306|B3|Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3753928|NCT01971567|3588307|B2|Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3753929|NCT01971567|3588308|B1|Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3753930|NCT01971567|3588306|B3|Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|89|89.0||||||
3753931|NCT01971567|3588307|B2|Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
3753932|NCT01971567|3588308|B1|Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
3753933|NCT01971567|3588306|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3753934|NCT01971567|3588307|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3753935|NCT01971567|3588308|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3753936|NCT01971567|3588306|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3753937|NCT01971567|3588307|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3753938|NCT01971567|3588308|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3753939|NCT01971567|3588306|B3|||Age||years|Mean|53.5|53.5|Standard Deviation|14.9|14.9|||
3753940|NCT01971567|3588307|B2|||Age||years|Mean|54.7|54.7|Standard Deviation|14.8|14.8|||
3753941|NCT01971567|3588308|B1|||Age||years|Mean|52.4|52.4|Standard Deviation|15.1|15.1|||
3753942|NCT01971554|3588331|B5||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3753943|NCT01971554|3588332|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3753944|NCT01971554|3588333|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3753945|NCT01971554|3588334|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3753946|NCT01971554|3588335|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3753947|NCT01971554|3588331|B5||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3753948|NCT01971554|3588332|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3753949|NCT01971554|3588333|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3753950|NCT01971554|3588334|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3753951|NCT01971554|3588335|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3753952|NCT01971554|3588331|B5|||Age||Years|Mean|55.0|55.0|Full Range|||30.0|65.0|
3753953|NCT01971554|3588332|B4|||Age||Years|Mean|54.7|54.7|Full Range|8.3|8.3|36.0|64.0|
3753954|NCT01971554|3588333|B3|||Age||Years|Mean|55.2|55.2|Full Range|6.9|6.9|37.0|64.0|
3753955|NCT01971554|3588334|B2|||Age||Years|Mean|55.6|55.6|Full Range|6.2|6.2|46.0|65.0|
3753956|NCT01971554|3588335|B1|||Age||Years|Mean|53.9|53.9|Full Range|10.0|10.0|30.0|65.0|
3753957|NCT01971476|3588372|B4|Male (12 to <18 years)||Sex/Gender, Customized||Participants|Number|8|8.0||||||
3753958|NCT01971476|3588373|B3|Male (12 to <18 years)||Sex/Gender, Customized||Participants|Number|0|0.0||||||
3753959|NCT01971476|3588374|B2|Male (12 to <18 years)||Sex/Gender, Customized||Participants|Number|4|4.0||||||
3753960|NCT01971476|3588375|B1|Male (12 to <18 years)||Sex/Gender, Customized||Participants|Number|4|4.0||||||
3753961|NCT01971476|3588372|B4|Female (12 to <18 years)||Sex/Gender, Customized||Participants|Number|2|2.0||||||
3753962|NCT01971476|3588373|B3|Female (12 to <18 years)||Sex/Gender, Customized||Participants|Number|0|0.0||||||
3753963|NCT01971476|3588374|B2|Female (12 to <18 years)||Sex/Gender, Customized||Participants|Number|0|0.0||||||
3753964|NCT01971476|3588375|B1|Female (12 to <18 years)||Sex/Gender, Customized||Participants|Number|2|2.0||||||
3753965|NCT01971476|3588372|B4|Male (2 to <12 years)||Sex/Gender, Customized||Participants|Number|6|6.0||||||
3753966|NCT01971476|3588373|B3|Male (2 to <12 years)||Sex/Gender, Customized||Participants|Number|3|3.0||||||
3753967|NCT01971476|3588374|B2|Male (2 to <12 years)||Sex/Gender, Customized||Participants|Number|1|1.0||||||
3753968|NCT01971476|3588375|B1|Male (2 to <12 years)||Sex/Gender, Customized||Participants|Number|2|2.0||||||
3753969|NCT01971476|3588372|B4|Female (2 to <12 years)||Sex/Gender, Customized||Participants|Number|6|6.0||||||
3753970|NCT01971476|3588373|B3|Female (2 to <12 years)||Sex/Gender, Customized||Participants|Number|3|3.0||||||
3753971|NCT01971476|3588374|B2|Female (2 to <12 years)||Sex/Gender, Customized||Participants|Number|2|2.0||||||
3753972|NCT01971476|3588375|B1|Female (2 to <12 years)||Sex/Gender, Customized||Participants|Number|1|1.0||||||
3753973|NCT01971476|3588372|B4|12 to <18 years||Age||Years|Mean|14.9|14.9|Standard Deviation|2.1|2.1|||
3753974|NCT01971476|3588373|B3|12 to <18 years||Age||Years|Mean|NA||Standard Deviation|NA||||No patients entered.
3753975|NCT01971476|3588374|B2|12 to <18 years||Age||Years|Mean|15.8|15.8|Standard Deviation|1.5|1.5|||
3753976|NCT01971476|3588375|B1|12 to <18 years||Age||Years|Mean|14.3|14.3|Standard Deviation|2.3|2.3|||
3753977|NCT01971476|3588372|B4|2 to <12 years||Age||Years|Mean|6.8|6.8|Standard Deviation|3.0|3.0|||
3753978|NCT01971476|3588373|B3|2 to <12 years||Age||Years|Mean|7.0|7.0|Standard Deviation|3.3|3.3|||
3753979|NCT01971476|3588374|B2|2 to <12 years||Age||Years|Mean|6.3|6.3|Standard Deviation|3.1|3.1|||
3753980|NCT01971476|3588375|B1|2 to <12 years||Age||Years|Mean|7.0|7.0|Standard Deviation|3.6|3.6|||
3753981|NCT01971385|3588454|B4|||Number of Outbreaks a year||frequency per year|Mean|7.68|7.68|Standard Deviation|2.02|2.02|||
3753982|NCT01971385|3588455|B3|||Number of Outbreaks a year||frequency per year|Mean|8.14|8.14|Standard Deviation|2.42|2.42|||
3753983|NCT01971385|3588456|B2|||Number of Outbreaks a year||frequency per year|Mean|7.81|7.81|Standard Deviation|1.81|1.81|||
3753984|NCT01971385|3588457|B1|||Number of Outbreaks a year||frequency per year|Mean|7.06|7.06|Standard Deviation|1.71|1.71|||
3753985|NCT01971385|3588454|B4|United States||Region of Enrollment||participants|Number|54|54.0||||||
3753986|NCT01971385|3588455|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
3753987|NCT01971385|3588456|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
3753988|NCT01971385|3588457|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3753989|NCT01971385|3588454|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3753990|NCT01971385|3588455|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3754050|NCT01971255|3588466|B3||Black|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3753991|NCT01971385|3588456|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3753992|NCT01971385|3588457|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753993|NCT01971385|3588454|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3753994|NCT01971385|3588455|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753995|NCT01971385|3588456|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3753996|NCT01971385|3588457|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3753997|NCT01971385|3588454|B4||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3753998|NCT01971385|3588455|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3753999|NCT01971385|3588456|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3754000|NCT01971385|3588457|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3754001|NCT01971385|3588454|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3754002|NCT01971385|3588455|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754003|NCT01971385|3588456|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754004|NCT01971385|3588457|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3754005|NCT01971385|3588454|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754006|NCT01971385|3588455|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754007|NCT01971385|3588456|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754008|NCT01971385|3588457|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754009|NCT01971385|3588454|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754010|NCT01971385|3588455|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754011|NCT01971385|3588456|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754012|NCT01971385|3588457|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754013|NCT01971385|3588454|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754014|NCT01971385|3588455|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754015|NCT01971385|3588456|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754016|NCT01971385|3588457|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754017|NCT01971385|3588454|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3754018|NCT01971385|3588455|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3754019|NCT01971385|3588456|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3754020|NCT01971385|3588457|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3754021|NCT01971385|3588454|B4||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3754022|NCT01971385|3588455|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3754023|NCT01971385|3588456|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3754024|NCT01971385|3588457|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3754025|NCT01971385|3588454|B4|||Age||years|Mean|44.93|44.93|Standard Deviation|11.88|11.88|||
3754026|NCT01971385|3588455|B3|||Age||years|Mean|44.13|44.13|Standard Deviation|10.88|10.88|||
3754027|NCT01971385|3588456|B2|||Age||years|Mean|47.21|47.21|Standard Deviation|9.37|9.37|||
3754028|NCT01971385|3588457|B1|||Age||years|Mean|44.86|44.86|Standard Deviation|13.68|13.68|||
3754029|NCT01971385|3588454|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3754030|NCT01971385|3588455|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3754031|NCT01971385|3588456|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3754032|NCT01971385|3588457|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3754033|NCT01971385|3588454|B4||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3754034|NCT01971385|3588455|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3754035|NCT01971385|3588456|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3754036|NCT01971385|3588457|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3754037|NCT01971385|3588454|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3754038|NCT01971385|3588455|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3754039|NCT01971385|3588456|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3754040|NCT01971385|3588457|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3754041|NCT01971255|3588466|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754042|NCT01971255|3588467|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754043|NCT01971255|3588468|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754044|NCT01971255|3588466|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754045|NCT01971255|3588467|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754046|NCT01971255|3588468|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754047|NCT01971255|3588466|B3||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3754048|NCT01971255|3588467|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3754049|NCT01971255|3588468|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3754051|NCT01971255|3588467|B2||Black|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3754052|NCT01971255|3588468|B1||Black|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3754053|NCT01971255|3588466|B3||Hawaiian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754054|NCT01971255|3588467|B2||Hawaiian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754055|NCT01971255|3588468|B1||Hawaiian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754056|NCT01971255|3588466|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3754057|NCT01971255|3588467|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3754058|NCT01971255|3588468|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3754059|NCT01971255|3588466|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3754060|NCT01971255|3588467|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754061|NCT01971255|3588468|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3754062|NCT01971255|3588466|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3754063|NCT01971255|3588467|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3754064|NCT01971255|3588468|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3754065|NCT01971255|3588466|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3754066|NCT01971255|3588467|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3754067|NCT01971255|3588468|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3754068|NCT01971255|3588466|B3||Hispanic|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3754069|NCT01971255|3588467|B2||Hispanic|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3754070|NCT01971255|3588468|B1||Hispanic|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3754071|NCT01971255|3588466|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3754072|NCT01971255|3588467|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3754073|NCT01971255|3588468|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3754074|NCT01971255|3588466|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3754075|NCT01971255|3588467|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3754076|NCT01971255|3588468|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3754077|NCT01971255|3588466|B3||GTE65|Age||Participants|Count of Participants|0|0.0||||||
3754078|NCT01971255|3588467|B2||GTE65|Age||Participants|Count of Participants|0|0.0||||||
3754079|NCT01971255|3588468|B1||GTE65|Age||Participants|Count of Participants|0|0.0||||||
3754080|NCT01971255|3588466|B3||BTWN|Age||Participants|Count of Participants|73|73.0||||||
3754081|NCT01971255|3588467|B2||BTWN|Age||Participants|Count of Participants|41|41.0||||||
3754082|NCT01971255|3588468|B1||BTWN|Age||Participants|Count of Participants|32|32.0||||||
3754083|NCT01971255|3588466|B3||LTE18|Age||Participants|Count of Participants|1|1.0||||||
3754084|NCT01971255|3588467|B2||LTE18|Age||Participants|Count of Participants|1|1.0||||||
3754085|NCT01971255|3588468|B1||LTE18|Age||Participants|Count of Participants|0|0.0||||||
3754086|NCT01971203|3588485|B3|Unknown||Education||Participants|Count of Participants|2|2.0||||||
3754087|NCT01971203|3588486|B2|Unknown||Education||Participants|Count of Participants|1|1.0||||||
3754088|NCT01971203|3588487|B1|Unknown||Education||Participants|Count of Participants|1|1.0||||||
3754089|NCT01971203|3588485|B3|Advanced||Education||Participants|Count of Participants|12|12.0||||||
3754090|NCT01971203|3588486|B2|Advanced||Education||Participants|Count of Participants|4|4.0||||||
3754091|NCT01971203|3588487|B1|Advanced||Education||Participants|Count of Participants|8|8.0||||||
3754092|NCT01971203|3588485|B3|College||Education||Participants|Count of Participants|28|28.0||||||
3754093|NCT01971203|3588486|B2|College||Education||Participants|Count of Participants|15|15.0||||||
3754094|NCT01971203|3588487|B1|College||Education||Participants|Count of Participants|13|13.0||||||
3754095|NCT01971203|3588485|B3|Part college||Education||Participants|Count of Participants|13|13.0||||||
3754096|NCT01971203|3588486|B2|Part college||Education||Participants|Count of Participants|10|10.0||||||
3754097|NCT01971203|3588487|B1|Part college||Education||Participants|Count of Participants|3|3.0||||||
3754098|NCT01971203|3588485|B3|HS||Education||Participants|Count of Participants|6|6.0||||||
3754099|NCT01971203|3588486|B2|HS||Education||Participants|Count of Participants|2|2.0||||||
3754100|NCT01971203|3588487|B1|HS||Education||Participants|Count of Participants|4|4.0||||||
3754101|NCT01971203|3588485|B3|Less than HS||Education||Participants|Count of Participants|1|1.0||||||
3754102|NCT01971203|3588486|B2|Less than HS||Education||Participants|Count of Participants|0|0.0||||||
3754103|NCT01971203|3588487|B1|Less than HS||Education||Participants|Count of Participants|1|1.0||||||
3754104|NCT01971203|3588485|B3|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3754105|NCT01971203|3588486|B2|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3754106|NCT01971203|3588487|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754107|NCT01971203|3588485|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3754108|NCT01971203|3588486|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3754109|NCT01971203|3588487|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3754110|NCT01971203|3588485|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3754111|NCT01971203|3588486|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3754112|NCT01971203|3588487|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3754113|NCT01971203|3588485|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3754114|NCT01971203|3588486|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3754115|NCT01971203|3588487|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3754116|NCT01971203|3588485|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3754117|NCT01971203|3588486|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3754118|NCT01971203|3588487|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3754119|NCT01971203|3588485|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
3754120|NCT01971203|3588486|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3754121|NCT01971203|3588487|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3754122|NCT01971203|3588485|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3754123|NCT01971203|3588486|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3754124|NCT01971203|3588487|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3754125|NCT01971203|3588485|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3754126|NCT01971203|3588486|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3754127|NCT01971203|3588487|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3754128|NCT01971203|3588485|B3|||Age||years|Mean|39.90|39.9|Standard Deviation|13.12|13.12|||
3754129|NCT01971203|3588486|B2|||Age||years|Mean|39.88|39.88|Standard Deviation|12.81|12.81|||
3754130|NCT01971203|3588487|B1|||Age||years|Mean|39.93|39.93|Standard Deviation|13.68|13.68|||
3754131|NCT01971086|3588500|B1||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3754132|NCT01971086|3588500|B1||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3754133|NCT01971086|3588500|B1|||Age||years|Mean|27.7|27.7|Standard Deviation|20.0|20.0|||
3754134|NCT01970995|3588512|B4|> 19 cig/day||Daily mCC consumption at Screening||participants|Number|76|76.0||||||
3754135|NCT01970995|3588513|B3|> 19 cig/day||Daily mCC consumption at Screening||participants|Number|19|19.0||||||
3754136|NCT01970995|3588514|B2|> 19 cig/day||Daily mCC consumption at Screening||participants|Number|19|19.0||||||
3754137|NCT01970995|3588515|B1|> 19 cig/day||Daily mCC consumption at Screening||participants|Number|38|38.0||||||
3754138|NCT01970995|3588512|B4|10 to 19 cig/day||Daily mCC consumption at Screening||participants|Number|84|84.0||||||
3754139|NCT01970995|3588513|B3|10 to 19 cig/day||Daily mCC consumption at Screening||participants|Number|21|21.0||||||
3754140|NCT01970995|3588514|B2|10 to 19 cig/day||Daily mCC consumption at Screening||participants|Number|23|23.0||||||
3754141|NCT01970995|3588515|B1|10 to 19 cig/day||Daily mCC consumption at Screening||participants|Number|40|40.0||||||
3754142|NCT01970995|3588512|B4||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3754143|NCT01970995|3588513|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3754144|NCT01970995|3588514|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3754145|NCT01970995|3588515|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3754146|NCT01970995|3588512|B4||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3754147|NCT01970995|3588513|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3754148|NCT01970995|3588514|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3754149|NCT01970995|3588515|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3754150|NCT01970995|3588512|B4|||Age||years|Mean|37.2|37.2|Standard Deviation|10.54|10.54|||
3754151|NCT01970995|3588513|B3|||Age||years|Mean|37.0|37.0|Standard Deviation|9.96|9.96|||
3754152|NCT01970995|3588514|B2|||Age||years|Mean|37.4|37.4|Standard Deviation|11.23|11.23|||
3754153|NCT01970995|3588515|B1|||Age||years|Mean|37.1|37.1|Standard Deviation|10.58|10.58|||
3754154|NCT01970982|3588537|B4|> 19 cig/day||Daily CC consumption at Screening||participants|Number|73|73.0||||||
3754155|NCT01970982|3588538|B3|> 19 cig/day||Daily CC consumption at Screening||participants|Number|19|19.0||||||
3754156|NCT01970982|3588539|B2|> 19 cig/day||Daily CC consumption at Screening||participants|Number|18|18.0||||||
3754157|NCT01970982|3588540|B1|> 19 cig/day||Daily CC consumption at Screening||participants|Number|36|36.0||||||
3754158|NCT01970982|3588537|B4|10 to 19 cig/day||Daily CC consumption at Screening||participants|Number|87|87.0||||||
3754159|NCT01970982|3588538|B3|10 to 19 cig/day||Daily CC consumption at Screening||participants|Number|21|21.0||||||
3754160|NCT01970982|3588539|B2|10 to 19 cig/day||Daily CC consumption at Screening||participants|Number|22|22.0||||||
3754161|NCT01970982|3588540|B1|10 to 19 cig/day||Daily CC consumption at Screening||participants|Number|44|44.0||||||
3754162|NCT01970982|3588537|B4||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3754163|NCT01970982|3588538|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3754164|NCT01970982|3588539|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3754165|NCT01970982|3588540|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3754166|NCT01970982|3588537|B4||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3754167|NCT01970982|3588538|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3754168|NCT01970982|3588539|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3754169|NCT01970982|3588540|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3754170|NCT01970982|3588537|B4|Between 23 and 65 years||Age, Customized||years|Mean|37.1|37.1|Standard Deviation|11.4|11.4|||
3754171|NCT01970982|3588538|B3|Between 23 and 65 years||Age, Customized||years|Mean|35.9|35.9|Standard Deviation|10.6|10.6|||
3754172|NCT01970982|3588539|B2|Between 23 and 65 years||Age, Customized||years|Mean|37.2|37.2|Standard Deviation|11.7|11.7|||
3754173|NCT01970982|3588540|B1|Between 23 and 65 years||Age, Customized||years|Mean|37.6|37.6|Standard Deviation|11.7|11.7|||
3754174|NCT01970878|3588560|B5||Male|Sex: Female, Male||Participants|Count of Participants|1818|1818.0||||||
3754175|NCT01970878|3588561|B4||Male|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
3754176|NCT01970878|3588562|B3||Male|Sex: Female, Male||Participants|Count of Participants|492|492.0||||||
3754177|NCT01970878|3588563|B2||Male|Sex: Female, Male||Participants|Count of Participants|496|496.0||||||
3754178|NCT01970878|3588564|B1||Male|Sex: Female, Male||Participants|Count of Participants|562|562.0||||||
3754179|NCT01970878|3588560|B5||Female|Sex: Female, Male||Participants|Count of Participants|1439|1439.0||||||
3754180|NCT01970878|3588561|B4||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3754181|NCT01970878|3588562|B3||Female|Sex: Female, Male||Participants|Count of Participants|392|392.0||||||
3754182|NCT01970878|3588563|B2||Female|Sex: Female, Male||Participants|Count of Participants|392|392.0||||||
3754183|NCT01970878|3588564|B1||Female|Sex: Female, Male||Participants|Count of Participants|473|473.0||||||
3754184|NCT01970878|3588560|B5|||Age||years|Mean|62.8|62.8|Standard Deviation|8.3|8.3|||
3754185|NCT01970878|3588561|B4|||Age||years|Mean|62.9|62.9|Standard Deviation|8.6|8.6|||
3754186|NCT01970878|3588562|B3|||Age||years|Mean|62.8|62.8|Standard Deviation|8.1|8.1|||
3754187|NCT01970878|3588563|B2|||Age||years|Mean|62.8|62.8|Standard Deviation|8.4|8.4|||
3754188|NCT01970878|3588564|B1|||Age||years|Mean|62.7|62.7|Standard Deviation|8.3|8.3|||
3754189|NCT01970865|3588593|B18|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3754190|NCT01970865|3588594|B17|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754191|NCT01970865|3588595|B16|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3754192|NCT01970865|3588596|B15|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3754193|NCT01970865|3588597|B14|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3754194|NCT01970865|3588598|B13|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3754195|NCT01970865|3588599|B12|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3754196|NCT01970865|3588600|B11|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3754197|NCT01970865|3588601|B10|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3754198|NCT01970865|3588602|B9|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3754199|NCT01970865|3588603|B8|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3754200|NCT01970865|3588604|B7|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754201|NCT01970865|3588605|B6|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754202|NCT01970865|3588606|B5|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3754203|NCT01970865|3588607|B4|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3754204|NCT01970865|3588608|B3|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754205|NCT01970865|3588609|B2|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754206|NCT01970865|3588610|B1|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754207|NCT01970865|3588593|B18|Other||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3754208|NCT01970865|3588594|B17|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754209|NCT01970865|3588595|B16|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3754210|NCT01970865|3588596|B15|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3754211|NCT01970865|3588597|B14|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3754212|NCT01970865|3588598|B13|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3754213|NCT01970865|3588599|B12|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3754214|NCT01970865|3588600|B11|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3754215|NCT01970865|3588601|B10|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754216|NCT01970865|3588602|B9|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754217|NCT01970865|3588603|B8|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754218|NCT01970865|3588604|B7|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754219|NCT01970865|3588605|B6|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754220|NCT01970865|3588606|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3754221|NCT01970865|3588607|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754222|NCT01970865|3588608|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754223|NCT01970865|3588609|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754224|NCT01970865|3588610|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754225|NCT01970865|3588593|B18|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|113|113.0||||||
3754226|NCT01970865|3588594|B17|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3754227|NCT01970865|3588595|B16|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3754228|NCT01970865|3588596|B15|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3754229|NCT01970865|3588597|B14|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3754230|NCT01970865|3588598|B13|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3754231|NCT01970865|3588599|B12|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3754232|NCT01970865|3588600|B11|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3754233|NCT01970865|3588601|B10|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754234|NCT01970865|3588602|B9|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754235|NCT01970865|3588603|B8|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754236|NCT01970865|3588604|B7|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3754237|NCT01970865|3588605|B6|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754238|NCT01970865|3588606|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3754239|NCT01970865|3588607|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3754240|NCT01970865|3588608|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754241|NCT01970865|3588609|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3754242|NCT01970865|3588610|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754243|NCT01970865|3588593|B18|Black||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3754244|NCT01970865|3588594|B17|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754245|NCT01970865|3588595|B16|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3754246|NCT01970865|3588596|B15|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754247|NCT01970865|3588597|B14|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754248|NCT01970865|3588598|B13|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3754249|NCT01970865|3588599|B12|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754250|NCT01970865|3588600|B11|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3754251|NCT01970865|3588601|B10|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754252|NCT01970865|3588602|B9|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754253|NCT01970865|3588603|B8|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3754254|NCT01970865|3588604|B7|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754255|NCT01970865|3588605|B6|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3754256|NCT01970865|3588606|B5|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754257|NCT01970865|3588607|B4|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754258|NCT01970865|3588608|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754259|NCT01970865|3588609|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754260|NCT01970865|3588610|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3754261|NCT01970865|3588593|B18|White||Race/Ethnicity, Customized||Participants|Count of Participants|169|169.0||||||
3754262|NCT01970865|3588594|B17|White||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754263|NCT01970865|3588595|B16|White||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3754264|NCT01970865|3588596|B15|White||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3754265|NCT01970865|3588597|B14|White||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3754266|NCT01970865|3588598|B13|White||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3754267|NCT01970865|3588599|B12|White||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3754268|NCT01970865|3588600|B11|White||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3754269|NCT01970865|3588601|B10|White||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3754270|NCT01970865|3588602|B9|White||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3754271|NCT01970865|3588603|B8|White||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3754272|NCT01970865|3588604|B7|White||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3754273|NCT01970865|3588605|B6|White||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3754274|NCT01970865|3588606|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3754275|NCT01970865|3588607|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3754276|NCT01970865|3588608|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3754277|NCT01970865|3588609|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3754278|NCT01970865|3588610|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3754279|NCT01970865|3588593|B18||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3754280|NCT01970865|3588594|B17||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3754281|NCT01970865|3588595|B16||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3754282|NCT01970865|3588596|B15||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3754283|NCT01970865|3588597|B14||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3754284|NCT01970865|3588598|B13||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3754285|NCT01970865|3588599|B12||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3754286|NCT01970865|3588600|B11||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3754287|NCT01970865|3588601|B10||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3754288|NCT01970865|3588602|B9||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3754289|NCT01970865|3588603|B8||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3754290|NCT01970865|3588604|B7||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3754291|NCT01970865|3588605|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3754292|NCT01970865|3588606|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3754293|NCT01970865|3588607|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3754294|NCT01970865|3588608|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3754295|NCT01970865|3588609|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3754296|NCT01970865|3588610|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3754297|NCT01970865|3588593|B18||Female|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
3754298|NCT01970865|3588594|B17||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3754299|NCT01970865|3588595|B16||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3754300|NCT01970865|3588596|B15||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3754301|NCT01970865|3588597|B14||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3754302|NCT01970865|3588598|B13||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3754303|NCT01970865|3588599|B12||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3754304|NCT01970865|3588600|B11||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3754305|NCT01970865|3588601|B10||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3754306|NCT01970865|3588602|B9||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3754307|NCT01970865|3588603|B8||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3754308|NCT01970865|3588604|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3754309|NCT01970865|3588605|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3754310|NCT01970865|3588606|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3754311|NCT01970865|3588607|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3754312|NCT01970865|3588608|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3754313|NCT01970865|3588609|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3754314|NCT01970865|3588610|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3754315|NCT01970865|3588593|B18|||Age||years|Mean|NA||Standard Deviation|NA||||Demographic data were not summarized for the whole study population.
3754316|NCT01970865|3588594|B17|||Age||years|Mean|44.3|44.3|Standard Deviation|6.1|6.1|||
3754317|NCT01970865|3588595|B16|||Age||years|Mean|52.8|52.8|Standard Deviation|12.9|12.9|||
3754318|NCT01970865|3588596|B15|||Age||years|Mean|51.5|51.5|Standard Deviation|11.2|11.2|||
3754319|NCT01970865|3588597|B14|||Age||years|Mean|52.2|52.2|Standard Deviation|11.8|11.8|||
3754320|NCT01970865|3588598|B13|||Age||years|Mean|54|54.0|Standard Deviation|11.9|11.9|||
3754321|NCT01970865|3588599|B12|||Age||years|Mean|57.1|57.1|Standard Deviation|12.7|12.7|||
3754322|NCT01970865|3588600|B11|||Age||years|Mean|57.4|57.4|Standard Deviation|12.1|12.1|||
3754323|NCT01970865|3588601|B10|||Age||years|Mean|50.8|50.8|Standard Deviation|15.2|15.2|||
3754324|NCT01970865|3588602|B9|||Age||years|Mean|61.3|61.3|Standard Deviation|18.1|18.1|||
3754325|NCT01970865|3588603|B8|||Age||years|Mean|61.3|61.3|Standard Deviation|15.4|15.4|||
3754326|NCT01970865|3588604|B7|||Age||years|Mean|44.7|44.7|Standard Deviation|4.2|4.2|||
3754327|NCT01970865|3588605|B6|||Age||years|Mean|55.3|55.3|Standard Deviation|14.7|14.7|||
3754328|NCT01970865|3588606|B5|||Age||years|Mean|49|49.0|Standard Deviation|11.1|11.1|||
3754329|NCT01970865|3588607|B4|||Age||years|Mean|48.2|48.2|Standard Deviation|13.2|13.2|||
3754330|NCT01970865|3588608|B3|||Age||years|Mean|52.7|52.7|Standard Deviation|10|10.0|||
3754331|NCT01970865|3588609|B2|||Age||years|Mean|53.7|53.7|Standard Deviation|13|13.0|||
3754332|NCT01970865|3588610|B1|||Age||years|Mean|67.3|67.3|Standard Deviation|11.2|11.2|||
3754333|NCT01970787|3589050|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3754334|NCT01970787|3589050|B1||Male|Gender||Participants|Count of Participants|18|18.0||||||
3754335|NCT01970787|3589050|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
3754336|NCT01970787|3589050|B1|||Age||years|Mean|45|45.0|Full Range|||32.0|65.0|
3754337|NCT01970488|3589058|B3|||Body Surface Area (BSA) Affected by Psoriasis|Data are reported for 174 and 173 participants in each reporting group respectively.|percentage of BSA|Mean|26.9|26.9|Standard Deviation|16.00|16.0|||
3754338|NCT01970488|3589059|B2|||Body Surface Area (BSA) Affected by Psoriasis|Data are reported for 174 and 173 participants in each reporting group respectively.|percentage of BSA|Mean|28.5|28.5|Standard Deviation|16.82|16.82|||
3754339|NCT01970488|3589060|B1|||Body Surface Area (BSA) Affected by Psoriasis|Data are reported for 174 and 173 participants in each reporting group respectively.|percentage of BSA|Mean|25.3|25.3|Standard Deviation|15.02|15.02|||
3754340|NCT01970488|3589058|B3|||Psoriasis Area and Severity Index (PASI) Score|"The PASI measures the average redness (erythema), thickness (induration), and scaliness (each graded on a 0 to 4 scale) of psoriasis lesions, weighted by the area of involvement. The total PASI score ranges from 0 to 72. The higher the total score, the more severe the disease.~Data are reported for 174 and 173 participants in each reporting group respectively."|units on a scale|Mean|20.08|20.08|Standard Deviation|7.990|7.99|||
3754370|NCT01970488|3589058|B3|Eastern Europe||Geographic Region||participants|Number|141|141.0||||||
3754371|NCT01970488|3589059|B2|Eastern Europe||Geographic Region||participants|Number|70|70.0||||||
3754341|NCT01970488|3589059|B2|||Psoriasis Area and Severity Index (PASI) Score|"The PASI measures the average redness (erythema), thickness (induration), and scaliness (each graded on a 0 to 4 scale) of psoriasis lesions, weighted by the area of involvement. The total PASI score ranges from 0 to 72. The higher the total score, the more severe the disease.~Data are reported for 174 and 173 participants in each reporting group respectively."|units on a scale|Mean|20.48|20.48|Standard Deviation|7.880|7.88|||
3754342|NCT01970488|3589060|B1|||Psoriasis Area and Severity Index (PASI) Score|"The PASI measures the average redness (erythema), thickness (induration), and scaliness (each graded on a 0 to 4 scale) of psoriasis lesions, weighted by the area of involvement. The total PASI score ranges from 0 to 72. The higher the total score, the more severe the disease.~Data are reported for 174 and 173 participants in each reporting group respectively."|units on a scale|Mean|19.68|19.68|Standard Deviation|8.100|8.1|||
3754343|NCT01970488|3589058|B3|Missing||Static Physician’s Global Assessment (sPGA)|The sPGA is a 6-point scale ranging from 0 (clear) to 5 (very severe) used to measure the severity of disease (induration, scaling, and erythema).|participants|Number|3|3.0||||||
3754344|NCT01970488|3589059|B2|Missing||Static Physician’s Global Assessment (sPGA)|The sPGA is a 6-point scale ranging from 0 (clear) to 5 (very severe) used to measure the severity of disease (induration, scaling, and erythema).|participants|Number|2|2.0||||||
3754345|NCT01970488|3589060|B1|Missing||Static Physician’s Global Assessment (sPGA)|The sPGA is a 6-point scale ranging from 0 (clear) to 5 (very severe) used to measure the severity of disease (induration, scaling, and erythema).|participants|Number|1|1.0||||||
3754346|NCT01970488|3589058|B3|Very Severe||Static Physician’s Global Assessment (sPGA)|The sPGA is a 6-point scale ranging from 0 (clear) to 5 (very severe) used to measure the severity of disease (induration, scaling, and erythema).|participants|Number|17|17.0||||||
3754347|NCT01970488|3589059|B2|Very Severe||Static Physician’s Global Assessment (sPGA)|The sPGA is a 6-point scale ranging from 0 (clear) to 5 (very severe) used to measure the severity of disease (induration, scaling, and erythema).|participants|Number|10|10.0||||||
3754348|NCT01970488|3589060|B1|Very Severe||Static Physician’s Global Assessment (sPGA)|The sPGA is a 6-point scale ranging from 0 (clear) to 5 (very severe) used to measure the severity of disease (induration, scaling, and erythema).|participants|Number|7|7.0||||||
3754349|NCT01970488|3589058|B3|Severe||Static Physician’s Global Assessment (sPGA)|The sPGA is a 6-point scale ranging from 0 (clear) to 5 (very severe) used to measure the severity of disease (induration, scaling, and erythema).|participants|Number|122|122.0||||||
3754350|NCT01970488|3589059|B2|Severe||Static Physician’s Global Assessment (sPGA)|The sPGA is a 6-point scale ranging from 0 (clear) to 5 (very severe) used to measure the severity of disease (induration, scaling, and erythema).|participants|Number|61|61.0||||||
3754351|NCT01970488|3589060|B1|Severe||Static Physician’s Global Assessment (sPGA)|The sPGA is a 6-point scale ranging from 0 (clear) to 5 (very severe) used to measure the severity of disease (induration, scaling, and erythema).|participants|Number|61|61.0||||||
3754352|NCT01970488|3589058|B3|Moderate||Static Physician’s Global Assessment (sPGA)|The sPGA is a 6-point scale ranging from 0 (clear) to 5 (very severe) used to measure the severity of disease (induration, scaling, and erythema).|participants|Number|208|208.0||||||
3754353|NCT01970488|3589059|B2|Moderate||Static Physician’s Global Assessment (sPGA)|The sPGA is a 6-point scale ranging from 0 (clear) to 5 (very severe) used to measure the severity of disease (induration, scaling, and erythema).|participants|Number|102|102.0||||||
3754354|NCT01970488|3589060|B1|Moderate||Static Physician’s Global Assessment (sPGA)|The sPGA is a 6-point scale ranging from 0 (clear) to 5 (very severe) used to measure the severity of disease (induration, scaling, and erythema).|participants|Number|106|106.0||||||
3754355|NCT01970488|3589058|B3|Mild||Static Physician’s Global Assessment (sPGA)|The sPGA is a 6-point scale ranging from 0 (clear) to 5 (very severe) used to measure the severity of disease (induration, scaling, and erythema).|participants|Number|0|0.0||||||
3754356|NCT01970488|3589059|B2|Mild||Static Physician’s Global Assessment (sPGA)|The sPGA is a 6-point scale ranging from 0 (clear) to 5 (very severe) used to measure the severity of disease (induration, scaling, and erythema).|participants|Number|0|0.0||||||
3754357|NCT01970488|3589060|B1|Mild||Static Physician’s Global Assessment (sPGA)|The sPGA is a 6-point scale ranging from 0 (clear) to 5 (very severe) used to measure the severity of disease (induration, scaling, and erythema).|participants|Number|0|0.0||||||
3754358|NCT01970488|3589058|B3|Almost Clear||Static Physician’s Global Assessment (sPGA)|The sPGA is a 6-point scale ranging from 0 (clear) to 5 (very severe) used to measure the severity of disease (induration, scaling, and erythema).|participants|Number|0|0.0||||||
3754359|NCT01970488|3589059|B2|Almost Clear||Static Physician’s Global Assessment (sPGA)|The sPGA is a 6-point scale ranging from 0 (clear) to 5 (very severe) used to measure the severity of disease (induration, scaling, and erythema).|participants|Number|0|0.0||||||
3754360|NCT01970488|3589060|B1|Almost Clear||Static Physician’s Global Assessment (sPGA)|The sPGA is a 6-point scale ranging from 0 (clear) to 5 (very severe) used to measure the severity of disease (induration, scaling, and erythema).|participants|Number|0|0.0||||||
3754361|NCT01970488|3589058|B3|Clear||Static Physician’s Global Assessment (sPGA)|The sPGA is a 6-point scale ranging from 0 (clear) to 5 (very severe) used to measure the severity of disease (induration, scaling, and erythema).|participants|Number|0|0.0||||||
3754362|NCT01970488|3589059|B2|Clear||Static Physician’s Global Assessment (sPGA)|The sPGA is a 6-point scale ranging from 0 (clear) to 5 (very severe) used to measure the severity of disease (induration, scaling, and erythema).|participants|Number|0|0.0||||||
3754363|NCT01970488|3589060|B1|Clear||Static Physician’s Global Assessment (sPGA)|The sPGA is a 6-point scale ranging from 0 (clear) to 5 (very severe) used to measure the severity of disease (induration, scaling, and erythema).|participants|Number|0|0.0||||||
3754364|NCT01970488|3589058|B3|Other||Geographic Region||participants|Number|123|123.0||||||
3754365|NCT01970488|3589059|B2|Other||Geographic Region||participants|Number|62|62.0||||||
3754366|NCT01970488|3589060|B1|Other||Geographic Region||participants|Number|61|61.0||||||
3754367|NCT01970488|3589058|B3|Western Europe||Geographic Region||participants|Number|86|86.0||||||
3754368|NCT01970488|3589059|B2|Western Europe||Geographic Region||participants|Number|43|43.0||||||
3754369|NCT01970488|3589060|B1|Western Europe||Geographic Region||participants|Number|43|43.0||||||
3754372|NCT01970488|3589060|B1|Eastern Europe||Geographic Region||participants|Number|71|71.0||||||
3754373|NCT01970488|3589058|B3|No||Prior Biological Use for Psoriasis||participants|Number|287|287.0||||||
3754374|NCT01970488|3589059|B2|No||Prior Biological Use for Psoriasis||participants|Number|145|145.0||||||
3754375|NCT01970488|3589060|B1|No||Prior Biological Use for Psoriasis||participants|Number|142|142.0||||||
3754376|NCT01970488|3589058|B3|Yes||Prior Biological Use for Psoriasis||participants|Number|63|63.0||||||
3754377|NCT01970488|3589059|B2|Yes||Prior Biological Use for Psoriasis||participants|Number|30|30.0||||||
3754378|NCT01970488|3589060|B1|Yes||Prior Biological Use for Psoriasis||participants|Number|33|33.0||||||
3754379|NCT01970488|3589058|B3|Unknown||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3754380|NCT01970488|3589059|B2|Unknown||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3754381|NCT01970488|3589060|B1|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3754382|NCT01970488|3589058|B3|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3754383|NCT01970488|3589059|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3754384|NCT01970488|3589060|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3754385|NCT01970488|3589058|B3|Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3754386|NCT01970488|3589059|B2|Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3754387|NCT01970488|3589060|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3754388|NCT01970488|3589058|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3754389|NCT01970488|3589059|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3754390|NCT01970488|3589060|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3754391|NCT01970488|3589058|B3|Asian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3754392|NCT01970488|3589059|B2|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3754393|NCT01970488|3589060|B1|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3754394|NCT01970488|3589058|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3754395|NCT01970488|3589059|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3754396|NCT01970488|3589060|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3754397|NCT01970488|3589058|B3|White||Race/Ethnicity, Customized||participants|Number|324|324.0||||||
3754398|NCT01970488|3589059|B2|White||Race/Ethnicity, Customized||participants|Number|157|157.0||||||
3754399|NCT01970488|3589060|B1|White||Race/Ethnicity, Customized||participants|Number|167|167.0||||||
3754400|NCT01970488|3589058|B3||Male|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
3754401|NCT01970488|3589059|B2||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3754402|NCT01970488|3589060|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3754403|NCT01970488|3589058|B3||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3754404|NCT01970488|3589059|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3754405|NCT01970488|3589060|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3754406|NCT01970488|3589058|B3|≥ 65 years||Age, Customized||participants|Number|23|23.0||||||
3754407|NCT01970488|3589059|B2|≥ 65 years||Age, Customized||participants|Number|12|12.0||||||
3754408|NCT01970488|3589060|B1|≥ 65 years||Age, Customized||participants|Number|11|11.0||||||
3754409|NCT01970488|3589058|B3|< 65 years||Age, Customized||participants|Number|327|327.0||||||
3754410|NCT01970488|3589059|B2|< 65 years||Age, Customized||participants|Number|163|163.0||||||
3754411|NCT01970488|3589060|B1|< 65 years||Age, Customized||participants|Number|164|164.0||||||
3754412|NCT01970488|3589058|B3|||Age||years|Mean|44.6|44.6|Standard Deviation|13.31|13.31|||
3754413|NCT01970488|3589059|B2|||Age||years|Mean|44.0|44.0|Standard Deviation|13.68|13.68|||
3754414|NCT01970488|3589060|B1|||Age||years|Mean|45.1|45.1|Standard Deviation|12.95|12.95|||
3754415|NCT01970475|3589129|B3|||Disease Activity Score 28-C-Reactive Protein (DAS28-CRP)|"The DAS28-CRP is a composite score to measure disease activity in patients with RA, derived from the following variables:~The number of swollen and tender joints (28-joint count);~C-reactive protein (CRP);~Patient's global assessment of disease activity assessed on a scale from 0 to 100 transformed from the result measured on a horizontal scale from 0 (no RA activity at all) to 10 (worst RA activity imaginable).~DAS28-CRP scores range from approximately zero to ten. Higher scores indicate higher disease activity.~Data are available for 264 and 261 participants in each group respectively."|units on a scale|Mean|5.67|5.67|Standard Deviation|0.914|0.914|||
3754416|NCT01970475|3589130|B2|||Disease Activity Score 28-C-Reactive Protein (DAS28-CRP)|"The DAS28-CRP is a composite score to measure disease activity in patients with RA, derived from the following variables:~The number of swollen and tender joints (28-joint count);~C-reactive protein (CRP);~Patient's global assessment of disease activity assessed on a scale from 0 to 100 transformed from the result measured on a horizontal scale from 0 (no RA activity at all) to 10 (worst RA activity imaginable).~DAS28-CRP scores range from approximately zero to ten. Higher scores indicate higher disease activity.~Data are available for 264 and 261 participants in each group respectively."|units on a scale|Mean|5.68|5.68|Standard Deviation|0.911|0.911|||
3754417|NCT01970475|3589131|B1|||Disease Activity Score 28-C-Reactive Protein (DAS28-CRP)|"The DAS28-CRP is a composite score to measure disease activity in patients with RA, derived from the following variables:~The number of swollen and tender joints (28-joint count);~C-reactive protein (CRP);~Patient's global assessment of disease activity assessed on a scale from 0 to 100 transformed from the result measured on a horizontal scale from 0 (no RA activity at all) to 10 (worst RA activity imaginable).~DAS28-CRP scores range from approximately zero to ten. Higher scores indicate higher disease activity.~Data are available for 264 and 261 participants in each group respectively."|units on a scale|Mean|5.66|5.66|Standard Deviation|0.918|0.918|||
3754418|NCT01970475|3589129|B3|||C-reactive Protein||mg/L|Mean|14.278|14.278|Standard Deviation|20.0338|20.0338|||
3754419|NCT01970475|3589130|B2|||C-reactive Protein||mg/L|Mean|14.678|14.678|Standard Deviation|19.3848|19.3848|||
3754420|NCT01970475|3589131|B1|||C-reactive Protein||mg/L|Mean|13.881|13.881|Standard Deviation|20.6870|20.687|||
3754421|NCT01970475|3589129|B3|||Health Assessment Questionnaire-Disability Index (HAQ-DI)|"The HAQ-DI questionnaire asks participants to rate their level of difficulty on daily activities as well as their use of aids, devices, or help from another person for these activities and disabilities. Responses are scored from 0 indicating no difficulty to 3 indicating inability to perform a task in that area. The overall score is the average of each of the 8 category scores and ranges from 0 (no disability) to 3 (very severe, high-dependency disability).~Data are available for 263 and 261 participants in each group respectively."|units on a scale|Mean|1.4897|1.4897|Standard Deviation|0.63186|0.63186|||
3754422|NCT01970475|3589130|B2|||Health Assessment Questionnaire-Disability Index (HAQ-DI)|"The HAQ-DI questionnaire asks participants to rate their level of difficulty on daily activities as well as their use of aids, devices, or help from another person for these activities and disabilities. Responses are scored from 0 indicating no difficulty to 3 indicating inability to perform a task in that area. The overall score is the average of each of the 8 category scores and ranges from 0 (no disability) to 3 (very severe, high-dependency disability).~Data are available for 263 and 261 participants in each group respectively."|units on a scale|Mean|1.4976|1.4976|Standard Deviation|0.64743|0.64743|||
3754423|NCT01970475|3589131|B1|||Health Assessment Questionnaire-Disability Index (HAQ-DI)|"The HAQ-DI questionnaire asks participants to rate their level of difficulty on daily activities as well as their use of aids, devices, or help from another person for these activities and disabilities. Responses are scored from 0 indicating no difficulty to 3 indicating inability to perform a task in that area. The overall score is the average of each of the 8 category scores and ranges from 0 (no disability) to 3 (very severe, high-dependency disability).~Data are available for 263 and 261 participants in each group respectively."|units on a scale|Mean|1.4819|1.4819|Standard Deviation|0.61715|0.61715|||
3754424|NCT01970475|3589129|B3|||Subject's Assessment of Disease Related Pain|"The participant's assessment of their current level of pain on a 100 mm horizontal visual analogue scale (VAS). The left-hand extreme of the line was described as no pain at all (score = 0) and the right-hand extreme as worst pain imaginable (score = 100)."|units on a scale|Mean|59.5|59.5|Standard Deviation|22.11|22.11|||
3754425|NCT01970475|3589130|B2|||Subject's Assessment of Disease Related Pain|"The participant's assessment of their current level of pain on a 100 mm horizontal visual analogue scale (VAS). The left-hand extreme of the line was described as no pain at all (score = 0) and the right-hand extreme as worst pain imaginable (score = 100)."|units on a scale|Mean|60.6|60.6|Standard Deviation|22.37|22.37|||
3754426|NCT01970475|3589131|B1|||Subject's Assessment of Disease Related Pain|"The participant's assessment of their current level of pain on a 100 mm horizontal visual analogue scale (VAS). The left-hand extreme of the line was described as no pain at all (score = 0) and the right-hand extreme as worst pain imaginable (score = 100)."|units on a scale|Mean|58.3|58.3|Standard Deviation|21.82|21.82|||
3754427|NCT01970475|3589129|B3|||Investigator Global Health Assessment|"The Investigator's assessment of the participant's current disease activity on a 0 to 10 horizontal scale. The left-hand extreme of the scale was described as no activity at all (symptom-free and no arthritis symptoms; score = 0) and the right-hand extreme as worst activity imaginable (maximum arthritis disease activity; score = 10)."|units on a scale|Mean|6.8|6.8|Standard Deviation|1.45|1.45|||
3754428|NCT01970475|3589130|B2|||Investigator Global Health Assessment|"The Investigator's assessment of the participant's current disease activity on a 0 to 10 horizontal scale. The left-hand extreme of the scale was described as no activity at all (symptom-free and no arthritis symptoms; score = 0) and the right-hand extreme as worst activity imaginable (maximum arthritis disease activity; score = 10)."|units on a scale|Mean|6.7|6.7|Standard Deviation|1.59|1.59|||
3754429|NCT01970475|3589131|B1|||Investigator Global Health Assessment|"The Investigator's assessment of the participant's current disease activity on a 0 to 10 horizontal scale. The left-hand extreme of the scale was described as no activity at all (symptom-free and no arthritis symptoms; score = 0) and the right-hand extreme as worst activity imaginable (maximum arthritis disease activity; score = 10)."|units on a scale|Mean|6.8|6.8|Standard Deviation|1.29|1.29|||
3754430|NCT01970475|3589129|B3|||Subject Global Health Assessment|"The participant's overall assessment of their disease activity in the past week on a 0 to 10 horizontal scale. The left-hand extreme of the scale was described as no RA activity at all (symptom-free and no arthritis symptoms; score = 0) and the right-hand extreme as worst RA activity imaginable (maximum arthritis disease activity; score = 10)."|units on a scale|Mean|6.5|6.5|Standard Deviation|1.89|1.89|||
3754431|NCT01970475|3589130|B2|||Subject Global Health Assessment|"The participant's overall assessment of their disease activity in the past week on a 0 to 10 horizontal scale. The left-hand extreme of the scale was described as no RA activity at all (symptom-free and no arthritis symptoms; score = 0) and the right-hand extreme as worst RA activity imaginable (maximum arthritis disease activity; score = 10)."|units on a scale|Mean|6.6|6.6|Standard Deviation|1.86|1.86|||
3754432|NCT01970475|3589131|B1|||Subject Global Health Assessment|"The participant's overall assessment of their disease activity in the past week on a 0 to 10 horizontal scale. The left-hand extreme of the scale was described as no RA activity at all (symptom-free and no arthritis symptoms; score = 0) and the right-hand extreme as worst RA activity imaginable (maximum arthritis disease activity; score = 10)."|units on a scale|Mean|6.5|6.5|Standard Deviation|1.92|1.92|||
3754433|NCT01970475|3589129|B3|||Tender Joint Count|Sixty-eight joints were assessed and classified as tender/not tender by pressure and joint manipulation on physical examination.|tender joints|Mean|24.1|24.1|Standard Deviation|13.92|13.92|||
3754434|NCT01970475|3589130|B2|||Tender Joint Count|Sixty-eight joints were assessed and classified as tender/not tender by pressure and joint manipulation on physical examination.|tender joints|Mean|23.9|23.9|Standard Deviation|13.49|13.49|||
3754435|NCT01970475|3589131|B1|||Tender Joint Count|Sixty-eight joints were assessed and classified as tender/not tender by pressure and joint manipulation on physical examination.|tender joints|Mean|24.3|24.3|Standard Deviation|14.35|14.35|||
3754436|NCT01970475|3589129|B3|||Swollen Joint Count|Sixty-six joints were assessed and classified as swollen/not swollen by pressure and joint manipulation on physical examination.|swollen joints|Mean|14.4|14.4|Standard Deviation|8.53|8.53|||
3754437|NCT01970475|3589130|B2|||Swollen Joint Count|Sixty-six joints were assessed and classified as swollen/not swollen by pressure and joint manipulation on physical examination.|swollen joints|Mean|14.1|14.1|Standard Deviation|7.98|7.98|||
3754438|NCT01970475|3589131|B1|||Swollen Joint Count|Sixty-six joints were assessed and classified as swollen/not swollen by pressure and joint manipulation on physical examination.|swollen joints|Mean|14.7|14.7|Standard Deviation|9.05|9.05|||
3754439|NCT01970475|3589129|B3|||Duration of RA||years|Mean|9.39|9.39|Standard Deviation|8.054|8.054|||
3754440|NCT01970475|3589130|B2|||Duration of RA||years|Mean|9.37|9.37|Standard Deviation|8.047|8.047|||
3754441|NCT01970475|3589131|B1|||Duration of RA||years|Mean|9.41|9.41|Standard Deviation|8.076|8.076|||
3754442|NCT01970475|3589129|B3|No||Prior Biological Use for Rheumatoid Arthritis (RA)||participants|Number|381|381.0||||||
3754443|NCT01970475|3589130|B2|No||Prior Biological Use for Rheumatoid Arthritis (RA)||participants|Number|188|188.0||||||
3754444|NCT01970475|3589131|B1|No||Prior Biological Use for Rheumatoid Arthritis (RA)||participants|Number|193|193.0||||||
3754445|NCT01970475|3589129|B3|Yes||Prior Biological Use for Rheumatoid Arthritis (RA)||participants|Number|145|145.0||||||
3754446|NCT01970475|3589130|B2|Yes||Prior Biological Use for Rheumatoid Arthritis (RA)||participants|Number|74|74.0||||||
3754447|NCT01970475|3589131|B1|Yes||Prior Biological Use for Rheumatoid Arthritis (RA)||participants|Number|71|71.0||||||
3754448|NCT01970475|3589129|B3|Latin America||Geographic Region||participants|Number|3|3.0||||||
3754449|NCT01970475|3589130|B2|Latin America||Geographic Region||participants|Number|2|2.0||||||
3754450|NCT01970475|3589131|B1|Latin America||Geographic Region||participants|Number|1|1.0||||||
3754451|NCT01970475|3589129|B3|North America||Geographic Region||participants|Number|144|144.0||||||
3754452|NCT01970475|3589130|B2|North America||Geographic Region||participants|Number|72|72.0||||||
3754453|NCT01970475|3589131|B1|North America||Geographic Region||participants|Number|72|72.0||||||
3754454|NCT01970475|3589129|B3|Western Europe||Geographic Region||participants|Number|42|42.0||||||
3754455|NCT01970475|3589130|B2|Western Europe||Geographic Region||participants|Number|20|20.0||||||
3754456|NCT01970475|3589131|B1|Western Europe||Geographic Region||participants|Number|22|22.0||||||
3754457|NCT01970475|3589129|B3|Eastern Europe||Geographic Region||participants|Number|337|337.0||||||
3754458|NCT01970475|3589130|B2|Eastern Europe||Geographic Region||participants|Number|168|168.0||||||
3754459|NCT01970475|3589131|B1|Eastern Europe||Geographic Region||participants|Number|169|169.0||||||
3754460|NCT01970475|3589129|B3|Not Allowed to Collect||Ethnicity||participants|Number|2|2.0||||||
3754461|NCT01970475|3589130|B2|Not Allowed to Collect||Ethnicity||participants|Number|1|1.0||||||
3754462|NCT01970475|3589131|B1|Not Allowed to Collect||Ethnicity||participants|Number|1|1.0||||||
3754463|NCT01970475|3589129|B3|Not Hispanic or Latino||Ethnicity||participants|Number|466|466.0||||||
3754464|NCT01970475|3589130|B2|Not Hispanic or Latino||Ethnicity||participants|Number|236|236.0||||||
3754465|NCT01970475|3589131|B1|Not Hispanic or Latino||Ethnicity||participants|Number|230|230.0||||||
3754466|NCT01970475|3589129|B3|Hispanic or Latino||Ethnicity||participants|Number|58|58.0||||||
3754467|NCT01970475|3589130|B2|Hispanic or Latino||Ethnicity||participants|Number|25|25.0||||||
3754468|NCT01970475|3589131|B1|Hispanic or Latino||Ethnicity||participants|Number|33|33.0||||||
3754469|NCT01970475|3589129|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3754470|NCT01970475|3589130|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3754471|NCT01970475|3589131|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3754472|NCT01970475|3589129|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3754473|NCT01970475|3589130|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3754474|NCT01970475|3589131|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3754475|NCT01970475|3589129|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3754476|NCT01970475|3589130|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3754477|NCT01970475|3589131|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3754478|NCT01970475|3589129|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3754479|NCT01970475|3589130|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3754480|NCT01970475|3589131|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3754481|NCT01970475|3589129|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3754482|NCT01970475|3589130|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3754483|NCT01970475|3589131|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3754484|NCT01970475|3589129|B3|White||Race/Ethnicity, Customized||participants|Number|500|500.0||||||
3754485|NCT01970475|3589130|B2|White||Race/Ethnicity, Customized||participants|Number|249|249.0||||||
3754486|NCT01970475|3589131|B1|White||Race/Ethnicity, Customized||participants|Number|251|251.0||||||
3754487|NCT01970475|3589129|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3754488|NCT01970475|3589130|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3754489|NCT01970475|3589131|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3754490|NCT01970475|3589129|B3||Female|Sex: Female, Male||Participants|Count of Participants|426|426.0||||||
3754491|NCT01970475|3589130|B2||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
3754492|NCT01970475|3589131|B1||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
3754493|NCT01970475|3589129|B3|≥ 65 years||Age, Customized||participants|Number|124|124.0||||||
3754494|NCT01970475|3589130|B2|≥ 65 years||Age, Customized||participants|Number|65|65.0||||||
3754495|NCT01970475|3589131|B1|≥ 65 years||Age, Customized||participants|Number|59|59.0||||||
3754496|NCT01970475|3589129|B3|< 65 years||Age, Customized||participants|Number|402|402.0||||||
3754497|NCT01970475|3589130|B2|< 65 years||Age, Customized||participants|Number|197|197.0||||||
3754498|NCT01970475|3589131|B1|< 65 years||Age, Customized||participants|Number|205|205.0||||||
3754499|NCT01970475|3589129|B3|||Age||years|Mean|55.9|55.9|Standard Deviation|11.67|11.67|||
3754500|NCT01970475|3589130|B2|||Age||years|Mean|56.3|56.3|Standard Deviation|11.47|11.47|||
3754501|NCT01970475|3589131|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|11.88|11.88|||
3754502|NCT01970462|3589150|B3|United States||Region of Enrollment||participants|Number|0|0.0||||||
3754503|NCT01970462|3589151|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3754504|NCT01970462|3589152|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3754505|NCT01970462|3589150|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3754506|NCT01970462|3589151|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3754507|NCT01970462|3589152|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3754508|NCT01970462|3589150|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3754509|NCT01970462|3589151|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3754510|NCT01970462|3589152|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3754511|NCT01970462|3589150|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3754512|NCT01970462|3589151|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3754513|NCT01970462|3589152|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3754514|NCT01970462|3589150|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3754515|NCT01970462|3589151|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3754516|NCT01970462|3589152|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3754517|NCT01970462|3589150|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3754518|NCT01970462|3589151|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3754519|NCT01970462|3589152|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3754520|NCT01970397|3589165|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3754521|NCT01970397|3589166|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3754522|NCT01970397|3589167|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3754523|NCT01970397|3589165|B3||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3754524|NCT01970397|3589166|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3754525|NCT01970397|3589167|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3754526|NCT01970397|3589165|B3|||Age||years|Mean|58.2|58.2|Standard Deviation|8.39|8.39|||
3754527|NCT01970397|3589166|B2|||Age||years|Mean|58.2|58.2|Standard Deviation|9.26|9.26|||
3754528|NCT01970397|3589167|B1|||Age||years|Mean|58.2|58.2|Standard Deviation|7.5|7.5|||
3754529|NCT01970371|3589178|B4|Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3754530|NCT01970371|3589179|B3|Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3754531|NCT01970371|3589180|B2|Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754532|NCT01970371|3589181|B1|Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754533|NCT01970371|3589178|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|60|60.0||||||
3754534|NCT01970371|3589179|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3754535|NCT01970371|3589180|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3754536|NCT01970371|3589181|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3754537|NCT01970371|3589178|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3754538|NCT01970371|3589179|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754539|NCT01970371|3589180|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3754540|NCT01970371|3589181|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3754541|NCT01970371|3589178|B4|Other Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3754542|NCT01970371|3589179|B3|Other Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3754543|NCT01970371|3589180|B2|Other Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3754544|NCT01970371|3589181|B1|Other Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754545|NCT01970371|3589178|B4|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3754546|NCT01970371|3589179|B3|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754547|NCT01970371|3589180|B2|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3754548|NCT01970371|3589181|B1|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754549|NCT01970371|3589178|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3754550|NCT01970371|3589179|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754551|NCT01970371|3589180|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754552|NCT01970371|3589181|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3754553|NCT01970371|3589178|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3754554|NCT01970371|3589179|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3754555|NCT01970371|3589180|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3754556|NCT01970371|3589181|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3754557|NCT01970371|3589178|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|62|62.0||||||
3754558|NCT01970371|3589179|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3754559|NCT01970371|3589180|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3754560|NCT01970371|3589181|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3754561|NCT01970371|3589178|B4||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3754562|NCT01970371|3589179|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3754563|NCT01970371|3589180|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3754564|NCT01970371|3589181|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3754565|NCT01970371|3589178|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3754566|NCT01970371|3589179|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3754567|NCT01970371|3589180|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3754568|NCT01970371|3589181|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3754569|NCT01970371|3589178|B4|||Age||years|Mean|63.51|63.51|Standard Deviation|16.97|16.97|||
3754570|NCT01970371|3589179|B3|||Age||years|Mean|62.8|62.8|Standard Deviation|18.15|18.15|||
3754571|NCT01970371|3589180|B2|||Age||years|Mean|63.29|63.29|Standard Deviation|18.25|18.25|||
3754572|NCT01970371|3589181|B1|||Age||years|Mean|64.94|64.94|Standard Deviation|13.94|13.94|||
3754573|NCT01969799|3589206|B3|Europe||Region of Enrollment||participants|Number|111|111.0||||||
3754574|NCT01969799|3589207|B2|Europe||Region of Enrollment||participants|Number|53|53.0||||||
3754575|NCT01969799|3589208|B1|Europe||Region of Enrollment||participants|Number|58|58.0||||||
3754576|NCT01969799|3589206|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
3754577|NCT01969799|3589207|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3754578|NCT01969799|3589208|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3754579|NCT01969799|3589206|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3754580|NCT01969799|3589207|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3754581|NCT01969799|3589208|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3754582|NCT01969799|3589206|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3754583|NCT01969799|3589207|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3754584|NCT01969799|3589208|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3754585|NCT01969799|3589206|B3||White|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
3754586|NCT01969799|3589207|B2||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3754587|NCT01969799|3589208|B1||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3754588|NCT01969799|3589206|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3754589|NCT01969799|3589207|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3754590|NCT01969799|3589208|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3754591|NCT01969799|3589206|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754592|NCT01969799|3589207|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754593|NCT01969799|3589208|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754594|NCT01969799|3589206|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3754595|NCT01969799|3589207|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3754596|NCT01969799|3589208|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3754597|NCT01969799|3589206|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754598|NCT01969799|3589207|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754599|NCT01969799|3589208|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754600|NCT01969799|3589206|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3754601|NCT01969799|3589207|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3754602|NCT01969799|3589208|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3754603|NCT01969799|3589206|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3754604|NCT01969799|3589207|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3754605|NCT01969799|3589208|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3754606|NCT01969799|3589206|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3754607|NCT01969799|3589207|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3754608|NCT01969799|3589208|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3754609|NCT01969799|3589206|B3||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3754610|NCT01969799|3589207|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3754611|NCT01969799|3589208|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3754612|NCT01969799|3589206|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3754613|NCT01969799|3589207|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3754614|NCT01969799|3589208|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3754615|NCT01969799|3589206|B3||>=65 years|Age||Participants|Count of Participants|78|78.0||||||
3754616|NCT01969799|3589207|B2||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
3754617|NCT01969799|3589208|B1||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
3754618|NCT01969799|3589206|B3||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
3754619|NCT01969799|3589207|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3754620|NCT01969799|3589208|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3754621|NCT01969799|3589206|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3754622|NCT01969799|3589207|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3754623|NCT01969799|3589208|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3754624|NCT01969747|3589229|B5||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3754625|NCT01969747|3589230|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3754626|NCT01969747|3589231|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3754627|NCT01969747|3589232|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3754628|NCT01969747|3589233|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3754629|NCT01969747|3589229|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3754630|NCT01969747|3589230|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3754631|NCT01969747|3589231|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3754632|NCT01969747|3589232|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3754633|NCT01969747|3589233|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3754634|NCT01969747|3589229|B5|||Age||years|Mean|41.0|41.0|Standard Deviation|10.9|10.9|||
3754635|NCT01969747|3589230|B4|||Age||years|Mean|41.9|41.9|Standard Deviation|9.7|9.7|||
3754636|NCT01969747|3589231|B3|||Age||years|Mean|39.6|39.6|Standard Deviation|11.6|11.6|||
3754637|NCT01969747|3589232|B2|||Age||years|Mean|41.9|41.9|Standard Deviation|12.4|12.4|||
3754638|NCT01969747|3589233|B1|||Age||years|Mean|40.5|40.5|Standard Deviation|10.6|10.6|||
3754639|NCT01969721|3589246|B1||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3754640|NCT01969721|3589246|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3754641|NCT01969721|3589246|B1|||Age||Years|Mean|63.6|63.6|Standard Deviation|7.6|7.6|||
3754642|NCT01969708|3589275|B3|||National Eye Institute (NEI) Visual Function Questionnaire (VFQ)-25 overall score|For the National Eye Institute (NEI) Visual Function Questionnaire (VFQ)-25, respondents answer a series of multiple-choice questions about their vision and how it affects daily life. The overall scores range from 0 to 100, with higher scores representing better functioning.|total score|Mean|77|77.0|Standard Deviation|16|16.0|||
3754643|NCT01969708|3589276|B2|||National Eye Institute (NEI) Visual Function Questionnaire (VFQ)-25 overall score|For the National Eye Institute (NEI) Visual Function Questionnaire (VFQ)-25, respondents answer a series of multiple-choice questions about their vision and how it affects daily life. The overall scores range from 0 to 100, with higher scores representing better functioning.|total score|Mean|77|77.0|Standard Deviation|17|17.0|||
3754644|NCT01969708|3589277|B1|||National Eye Institute (NEI) Visual Function Questionnaire (VFQ)-25 overall score|For the National Eye Institute (NEI) Visual Function Questionnaire (VFQ)-25, respondents answer a series of multiple-choice questions about their vision and how it affects daily life. The overall scores range from 0 to 100, with higher scores representing better functioning.|total score|Mean|77|77.0|Standard Deviation|15|15.0|||
3754645|NCT01969708|3589275|B3|||Coronary artery disease||Participants|Count of Participants|56|56.0||||||
3754646|NCT01969708|3589276|B2|||Coronary artery disease||Participants|Count of Participants|30|30.0||||||
3754647|NCT01969708|3589277|B1|||Coronary artery disease||Participants|Count of Participants|26|26.0||||||
3754648|NCT01969708|3589275|B3|||Hypertensive||Participants|Count of Participants|278|278.0||||||
3754649|NCT01969708|3589276|B2|||Hypertensive||Participants|Count of Participants|138|138.0||||||
3754650|NCT01969708|3589277|B1|||Hypertensive||Participants|Count of Participants|140|140.0||||||
3754651|NCT01969708|3589275|B3|||Diabetes mellitus type 2||Participants|Count of Participants|113|113.0||||||
3754652|NCT01969708|3589276|B2|||Diabetes mellitus type 2||Participants|Count of Participants|59|59.0||||||
3754653|NCT01969708|3589277|B1|||Diabetes mellitus type 2||Participants|Count of Participants|54|54.0||||||
3754654|NCT01969708|3589275|B3|||Diabetes mellitus type 1||Participants|Count of Participants|1|1.0||||||
3754655|NCT01969708|3589276|B2|||Diabetes mellitus type 1||Participants|Count of Participants|0|0.0||||||
3754656|NCT01969708|3589277|B1|||Diabetes mellitus type 1||Participants|Count of Participants|1|1.0||||||
3754657|NCT01969708|3589275|B3|||History of cataract||Participants|Count of Participants|203|203.0||||||
3754658|NCT01969708|3589276|B2|||History of cataract||Participants|Count of Participants|95|95.0||||||
3754659|NCT01969708|3589277|B1|||History of cataract||Participants|Count of Participants|108|108.0||||||
3754660|NCT01969708|3589275|B3|||Cataract extraction||Participants|Count of Participants|98|98.0||||||
3754661|NCT01969708|3589276|B2|||Cataract extraction||Participants|Count of Participants|55|55.0||||||
3754662|NCT01969708|3589277|B1|||Cataract extraction||Participants|Count of Participants|43|43.0||||||
3754663|NCT01969708|3589275|B3|||Hemiretinal vein occlusion||Participants|Count of Participants|57|57.0||||||
3754664|NCT01969708|3589276|B2|||Hemiretinal vein occlusion||Participants|Count of Participants|31|31.0||||||
3754665|NCT01969708|3589277|B1|||Hemiretinal vein occlusion||Participants|Count of Participants|26|26.0||||||
3754666|NCT01969708|3589275|B3|||Prior intravitreal steroid use||Participants|Count of Participants|28|28.0||||||
3754667|NCT01969708|3589276|B2|||Prior intravitreal steroid use||Participants|Count of Participants|12|12.0||||||
3754668|NCT01969708|3589277|B1|||Prior intravitreal steroid use||Participants|Count of Participants|16|16.0||||||
3754669|NCT01969708|3589275|B3|||Prior anti-vascular endothelial growth factor (VEGF) treatment||Participants|Count of Participants|121|121.0||||||
3754670|NCT01969708|3589276|B2|||Prior anti-vascular endothelial growth factor (VEGF) treatment||Participants|Count of Participants|56|56.0||||||
3754671|NCT01969708|3589277|B1|||Prior anti-vascular endothelial growth factor (VEGF) treatment||Participants|Count of Participants|65|65.0||||||
3754672|NCT01969708|3589275|B3|||Spectral Domain-Optical Coherence Tomography (SD-OCT) central subfield thickness||um|Mean|665.5|665.5|Standard Deviation|224.4|224.4|||
3754673|NCT01969708|3589276|B2|||Spectral Domain-Optical Coherence Tomography (SD-OCT) central subfield thickness||um|Mean|678.2|678.2|Standard Deviation|233.3|233.3|||
3754674|NCT01969708|3589277|B1|||Spectral Domain-Optical Coherence Tomography (SD-OCT) central subfield thickness||um|Mean|652.4|652.4|Standard Deviation|214.6|214.6|||
3754675|NCT01969708|3589275|B3|||Time between diagnosis of macular edema and randomization||months|Mean|7|7.0|Standard Deviation|14|14.0|||
3754676|NCT01969708|3589276|B2|||Time between diagnosis of macular edema and randomization||months|Mean|5|5.0|Standard Deviation|10|10.0|||
3754677|NCT01969708|3589277|B1|||Time between diagnosis of macular edema and randomization||months|Mean|8|8.0|Standard Deviation|17|17.0|||
3754678|NCT01969708|3589275|B3|||Visual Acuity Letter Score (VALS) of Study Eye|The participant is refracted for best corrected vision, and then reads single letters on an electronic visual acuity tester at a 3 meter distance according to a specific algorithm. A letter score is provided that ranges from 0 (unable to ready any letters) to 100. A visual acuity letter score of 85 corresponds to a visual acuity of 20/20 as a Snellen equivalent.|letters read|Mean|50.3|50.3|Standard Deviation|15.2|15.2|||
3754679|NCT01969708|3589276|B2|||Visual Acuity Letter Score (VALS) of Study Eye|The participant is refracted for best corrected vision, and then reads single letters on an electronic visual acuity tester at a 3 meter distance according to a specific algorithm. A letter score is provided that ranges from 0 (unable to ready any letters) to 100. A visual acuity letter score of 85 corresponds to a visual acuity of 20/20 as a Snellen equivalent.|letters read|Mean|50.4|50.4|Standard Deviation|15.3|15.3|||
3754680|NCT01969708|3589277|B1|||Visual Acuity Letter Score (VALS) of Study Eye|The participant is refracted for best corrected vision, and then reads single letters on an electronic visual acuity tester at a 3 meter distance according to a specific algorithm. A letter score is provided that ranges from 0 (unable to ready any letters) to 100. A visual acuity letter score of 85 corresponds to a visual acuity of 20/20 as a Snellen equivalent.|letters read|Mean|50.3|50.3|Standard Deviation|15.2|15.2|||
3754681|NCT01969708|3589275|B3|United States||Region of Enrollment||participants|Number|362|362.0||||||
3754682|NCT01969708|3589276|B2|United States||Region of Enrollment||participants|Number|182|182.0||||||
3754683|NCT01969708|3589277|B1|United States||Region of Enrollment||participants|Number|180|180.0||||||
3754684|NCT01969708|3589275|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3754685|NCT01969708|3589276|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3754686|NCT01969708|3589277|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3754687|NCT01969708|3589275|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754688|NCT01969708|3589276|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754689|NCT01969708|3589277|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754690|NCT01969708|3589275|B3||White|Race (NIH/OMB)||Participants|Count of Participants|278|278.0||||||
3754691|NCT01969708|3589276|B2||White|Race (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
3754692|NCT01969708|3589277|B1||White|Race (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
3754693|NCT01969708|3589275|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3754694|NCT01969708|3589276|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3754695|NCT01969708|3589277|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3754696|NCT01969708|3589275|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754697|NCT01969708|3589276|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754698|NCT01969708|3589277|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754699|NCT01969708|3589275|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3754700|NCT01969708|3589276|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3754701|NCT01969708|3589277|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3754702|NCT01969708|3589275|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3754703|NCT01969708|3589276|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3754704|NCT01969708|3589277|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3754705|NCT01969708|3589275|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754706|NCT01969708|3589276|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754707|NCT01969708|3589277|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754708|NCT01969708|3589275|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|324|324.0||||||
3754709|NCT01969708|3589276|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|160|160.0||||||
3754770|NCT01969435|3589334|B1|||Age||years|Mean|51|51.0|Full Range|||18.0|73.0|
3754710|NCT01969708|3589277|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|164|164.0||||||
3754711|NCT01969708|3589275|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3754712|NCT01969708|3589276|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3754713|NCT01969708|3589277|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3754714|NCT01969708|3589275|B3||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
3754715|NCT01969708|3589276|B2||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3754716|NCT01969708|3589277|B1||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3754717|NCT01969708|3589275|B3||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3754718|NCT01969708|3589276|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3754719|NCT01969708|3589277|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3754720|NCT01969708|3589275|B3||>=65 years|Age||Participants|Count of Participants|228|228.0||||||
3754721|NCT01969708|3589276|B2||>=65 years|Age||Participants|Count of Participants|115|115.0||||||
3754722|NCT01969708|3589277|B1||>=65 years|Age||Participants|Count of Participants|113|113.0||||||
3754723|NCT01969708|3589275|B3||Between 18 and 65 years|Age||Participants|Count of Participants|134|134.0||||||
3754724|NCT01969708|3589276|B2||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
3754725|NCT01969708|3589277|B1||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
3754726|NCT01969708|3589275|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3754727|NCT01969708|3589276|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3754728|NCT01969708|3589277|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3754729|NCT01969565|3589294|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3754730|NCT01969565|3589294|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754731|NCT01969565|3589294|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754732|NCT01969565|3589294|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754733|NCT01969565|3589294|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754734|NCT01969565|3589294|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754735|NCT01969565|3589294|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3754736|NCT01969565|3589294|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754737|NCT01969565|3589294|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754738|NCT01969565|3589294|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3754739|NCT01969565|3589294|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754740|NCT01969565|3589294|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3754741|NCT01969565|3589294|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3754742|NCT01969565|3589294|B1|||Age||years|Mean|64|64.0|Full Range|||||
3754743|NCT01969539|3589300|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3754744|NCT01969539|3589300|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3754745|NCT01969539|3589300|B1|||Age||Years|Mean|70.4|70.4|Standard Deviation|10.45|10.45|||
3754746|NCT01969448|3589306|B4|United States||Region of Enrollment||participants|Number|79|79.0||||||
3754747|NCT01969448|3589308|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
3754748|NCT01969448|3589309|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
3754749|NCT01969448|3589306|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3754750|NCT01969448|3589307|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3754751|NCT01969448|3589308|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3754752|NCT01969448|3589309|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3754753|NCT01969448|3589306|B4||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3754754|NCT01969448|3589307|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3754755|NCT01969448|3589308|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3754756|NCT01969448|3589309|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3754757|NCT01969448|3589306|B4|||Age||years|Mean|44.2|44.2|Standard Deviation|10.7|10.7|||
3754758|NCT01969448|3589308|B2|||Age||years|Mean|46.6|46.6|Standard Deviation|10.5|10.5|||
3754759|NCT01969448|3589309|B1|||Age||years|Mean|43.2|43.2|Standard Deviation|10.8|10.8|||
3754760|NCT01969435|3589334|B1|Progressive disease||Remission status prior to autologous stem cell transplant||participants|Number|2|2.0||||||
3754761|NCT01969435|3589334|B1|Partial remission||Remission status prior to autologous stem cell transplant||participants|Number|25|25.0||||||
3754762|NCT01969435|3589334|B1|Complete remission||Remission status prior to autologous stem cell transplant||participants|Number|23|23.0||||||
3754763|NCT01969435|3589334|B1|Other Non-Hodgkin Lymphoma||Diagnosis||participants|Number|10|10.0||||||
3754764|NCT01969435|3589334|B1|Mantle cell lymphoma||Diagnosis||participants|Number|8|8.0||||||
3754765|NCT01969435|3589334|B1|Diffuse large B-cell lymphoma||Diagnosis||participants|Number|15|15.0||||||
3754766|NCT01969435|3589334|B1|Hodgkin lymphoma||Diagnosis||participants|Number|17|17.0||||||
3754767|NCT01969435|3589334|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3754768|NCT01969435|3589334|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3754769|NCT01969435|3589334|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3754771|NCT01969240|3589348|B3|United States||Region of Enrollment||participants|Number|898|898.0||||||
3754772|NCT01969240|3589349|B2|United States||Region of Enrollment||participants|Number|447|447.0||||||
3754773|NCT01969240|3589350|B1|United States||Region of Enrollment||participants|Number|451|451.0||||||
3754774|NCT01969240|3589348|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754775|NCT01969240|3589349|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754776|NCT01969240|3589350|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754777|NCT01969240|3589348|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3754778|NCT01969240|3589349|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3754779|NCT01969240|3589350|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3754780|NCT01969240|3589348|B3||White|Race (NIH/OMB)||Participants|Count of Participants|531|531.0||||||
3754781|NCT01969240|3589349|B2||White|Race (NIH/OMB)||Participants|Count of Participants|269|269.0||||||
3754782|NCT01969240|3589350|B1||White|Race (NIH/OMB)||Participants|Count of Participants|262|262.0||||||
3754783|NCT01969240|3589348|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|309|309.0||||||
3754784|NCT01969240|3589349|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|154|154.0||||||
3754785|NCT01969240|3589350|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|155|155.0||||||
3754786|NCT01969240|3589348|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3754787|NCT01969240|3589349|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3754788|NCT01969240|3589350|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3754789|NCT01969240|3589348|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3754790|NCT01969240|3589349|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3754791|NCT01969240|3589350|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3754792|NCT01969240|3589348|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3754793|NCT01969240|3589349|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3754794|NCT01969240|3589350|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3754795|NCT01969240|3589348|B3||Male|Sex: Female, Male||Participants|Count of Participants|364|364.0||||||
3754796|NCT01969240|3589349|B2||Male|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
3754797|NCT01969240|3589350|B1||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
3754798|NCT01969240|3589348|B3||Female|Sex: Female, Male||Participants|Count of Participants|534|534.0||||||
3754799|NCT01969240|3589349|B2||Female|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
3754800|NCT01969240|3589350|B1||Female|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
3754801|NCT01969240|3589348|B3|||Age||years|Mean|50.3|50.3|Standard Deviation|14.6|14.6|||
3754802|NCT01969240|3589349|B2|||Age||years|Mean|50.6|50.6|Standard Deviation|14.1|14.1|||
3754803|NCT01969240|3589350|B1|||Age||years|Mean|50.0|50.0|Standard Deviation|15.0|15.0|||
3754804|NCT01969162|3589369|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3754805|NCT01969162|3589369|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3754806|NCT01969162|3589369|B1|||Age||years|Mean|23.0|23.0|Standard Deviation|4.2|4.2|||
3754807|NCT01969084|3589373|B3|United States||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3754808|NCT01969084|3589374|B2|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3754809|NCT01969084|3589375|B1|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3754810|NCT01969084|3589373|B3||Male|Gender||Participants|Count of Participants|23|23.0||||||
3754811|NCT01969084|3589374|B2||Male|Gender||Participants|Count of Participants|11|11.0||||||
3754812|NCT01969084|3589375|B1||Male|Gender||Participants|Count of Participants|12|12.0||||||
3754813|NCT01969084|3589373|B3||Female|Gender||Participants|Count of Participants|18|18.0||||||
3754814|NCT01969084|3589374|B2||Female|Gender||Participants|Count of Participants|11|11.0||||||
3754815|NCT01969084|3589375|B1||Female|Gender||Participants|Count of Participants|7|7.0||||||
3754816|NCT01969084|3589373|B3|||Age||years|Mean|58.67|58.67|Standard Deviation|6.56|6.56|||
3754817|NCT01969084|3589374|B2|||Age||years|Mean|56.76|56.76|Standard Deviation|6.79|6.79|||
3754818|NCT01969084|3589375|B1|||Age||years|Mean|60.79|60.79|Standard Deviation|5.75|5.75|||
3754819|NCT01969084|3589373|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3754820|NCT01969084|3589374|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3754821|NCT01969084|3589375|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3754822|NCT01969084|3589373|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3754823|NCT01969084|3589374|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3754824|NCT01969084|3589375|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3754825|NCT01969084|3589373|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3754826|NCT01969084|3589374|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3754827|NCT01969084|3589375|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3754878|NCT01968980|3589429|B1||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3754879|NCT01968980|3589427|B3||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3754880|NCT01968980|3589428|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3754828|NCT01969058|3589390|B3|||CD8+ T-cell Activation Percent|"CD8+ T-cell activation percent is the primary endpoint. Level of CD8+ T-cell activation was determined by measuring the percentage of cells that expressed both the activation marker CD38+ and Human leukocyte antigen (HLA)-DR+.~Baseline is defined as the average of pre-entry and entry values"|percentage of cells|Median|13.66|13.66|Inter-Quartile Range|||9.83|19.29|
3754829|NCT01969058|3589391|B2|||CD8+ T-cell Activation Percent|"CD8+ T-cell activation percent is the primary endpoint. Level of CD8+ T-cell activation was determined by measuring the percentage of cells that expressed both the activation marker CD38+ and Human leukocyte antigen (HLA)-DR+.~Baseline is defined as the average of pre-entry and entry values"|percentage of cells|Median|13.40|13.4|Inter-Quartile Range|||8.43|18.56|
3754830|NCT01969058|3589392|B1|||CD8+ T-cell Activation Percent|"CD8+ T-cell activation percent is the primary endpoint. Level of CD8+ T-cell activation was determined by measuring the percentage of cells that expressed both the activation marker CD38+ and Human leukocyte antigen (HLA)-DR+.~Baseline is defined as the average of pre-entry and entry values"|percentage of cells|Median|13.67|13.67|Inter-Quartile Range|||10.35|19.49|
3754831|NCT01969058|3589390|B3|||BMI||kg/m^2|Median|27.1|27.1|Inter-Quartile Range|||22.9|29.2|
3754832|NCT01969058|3589391|B2|||BMI||kg/m^2|Median|26.9|26.9|Inter-Quartile Range|||22.6|27.9|
3754833|NCT01969058|3589392|B1|||BMI||kg/m^2|Median|27.1|27.1|Inter-Quartile Range|||23.1|29.3|
3754834|NCT01969058|3589390|B3|||CD4+ Cell Count||cells/mm^3|Median|552|552.0|Inter-Quartile Range|||310.0|768.0|
3754835|NCT01969058|3589391|B2|||CD4+ Cell Count||cells/mm^3|Median|556|556.0|Inter-Quartile Range|||342.0|781.0|
3754836|NCT01969058|3589392|B1|||CD4+ Cell Count||cells/mm^3|Median|549|549.0|Inter-Quartile Range|||299.0|754.0|
3754837|NCT01969058|3589390|B3|< Assay lower limit (40 copies/mL)||HIV-1 RNA||Participants|Count of Participants|75|75.0||||||
3754838|NCT01969058|3589391|B2|< Assay lower limit (40 copies/mL)||HIV-1 RNA||Participants|Count of Participants|25|25.0||||||
3754839|NCT01969058|3589392|B1|< Assay lower limit (40 copies/mL)||HIV-1 RNA||Participants|Count of Participants|50|50.0||||||
3754840|NCT01969058|3589390|B3|>= Assay lower limit (40 copies/mL)||HIV-1 RNA||Participants|Count of Participants|1|1.0||||||
3754841|NCT01969058|3589391|B2|>= Assay lower limit (40 copies/mL)||HIV-1 RNA||Participants|Count of Participants|1|1.0||||||
3754842|NCT01969058|3589392|B1|>= Assay lower limit (40 copies/mL)||HIV-1 RNA||Participants|Count of Participants|0|0.0||||||
3754843|NCT01969058|3589390|B3|United States||Region of Enrollment||Participants|Count of Participants|75|75.0||||||
3754844|NCT01969058|3589391|B2|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3754845|NCT01969058|3589392|B1|United States||Region of Enrollment||Participants|Count of Participants|49|49.0||||||
3754846|NCT01969058|3589390|B3|Puerto Rico||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3754847|NCT01969058|3589391|B2|Puerto Rico||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3754848|NCT01969058|3589392|B1|Puerto Rico||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3754849|NCT01969058|3589390|B3|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3754850|NCT01969058|3589391|B2|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3754851|NCT01969058|3589392|B1|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3754852|NCT01969058|3589390|B3|Non-Hispanic Black||Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3754853|NCT01969058|3589391|B2|Non-Hispanic Black||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3754854|NCT01969058|3589392|B1|Non-Hispanic Black||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3754855|NCT01969058|3589390|B3|Non-Hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3754856|NCT01969058|3589391|B2|Non-Hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3754857|NCT01969058|3589392|B1|Non-Hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3754858|NCT01969058|3589390|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3754859|NCT01969058|3589391|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3754860|NCT01969058|3589392|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3754861|NCT01969058|3589390|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3754862|NCT01969058|3589391|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3754863|NCT01969058|3589392|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3754864|NCT01969058|3589390|B3|>=60 years||Age, Customized||Participants|Count of Participants|8|8.0||||||
3754865|NCT01969058|3589391|B2|>=60 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
3754866|NCT01969058|3589392|B1|>=60 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
3754867|NCT01969058|3589390|B3|40-59 years||Age, Customized||Participants|Count of Participants|47|47.0||||||
3754868|NCT01969058|3589391|B2|40-59 years||Age, Customized||Participants|Count of Participants|16|16.0||||||
3754869|NCT01969058|3589392|B1|40-59 years||Age, Customized||Participants|Count of Participants|31|31.0||||||
3754870|NCT01969058|3589390|B3|18-39 years||Age, Customized||Participants|Count of Participants|21|21.0||||||
3754871|NCT01969058|3589391|B2|18-39 years||Age, Customized||Participants|Count of Participants|7|7.0||||||
3754872|NCT01969058|3589392|B1|18-39 years||Age, Customized||Participants|Count of Participants|14|14.0||||||
3754873|NCT01969058|3589390|B3|||Age||years|Median|49|49.0|Inter-Quartile Range|||38.0|55.0|
3754874|NCT01969058|3589391|B2|||Age||years|Median|51|51.0|Inter-Quartile Range|||38.0|53.0|
3754875|NCT01969058|3589392|B1|||Age||years|Median|49|49.0|Inter-Quartile Range|||38.0|55.0|
3754876|NCT01968980|3589427|B3||Male|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
3754877|NCT01968980|3589428|B2||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3754881|NCT01968980|3589429|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3754882|NCT01968980|3589427|B3|||Age||years|Mean|56.1|56.1|Standard Deviation|10.8|10.8|||
3754883|NCT01968980|3589428|B2|||Age||years|Mean|56.5|56.5|Standard Deviation|10.5|10.5|||
3754884|NCT01968980|3589429|B1|||Age||years|Mean|55.7|55.7|Standard Deviation|11.2|11.2|||
3754885|NCT01968967|3589490|B3||Male|Sex: Female, Male||Participants|Count of Participants|1271|1271.0||||||
3754886|NCT01968967|3589491|B2||Male|Sex: Female, Male||Participants|Count of Participants|634|634.0||||||
3754887|NCT01968967|3589492|B1||Male|Sex: Female, Male||Participants|Count of Participants|637|637.0||||||
3754888|NCT01968967|3589490|B3||Female|Sex: Female, Male||Participants|Count of Participants|868|868.0||||||
3754889|NCT01968967|3589491|B2||Female|Sex: Female, Male||Participants|Count of Participants|434|434.0||||||
3754890|NCT01968967|3589492|B1||Female|Sex: Female, Male||Participants|Count of Participants|434|434.0||||||
3754891|NCT01968967|3589490|B3|||Age||years|Mean|62|62.0|Standard Deviation|9.6|9.6|||
3754892|NCT01968967|3589491|B2|||Age||years|Mean|61.8|61.8|Standard Deviation|9.3|9.3|||
3754893|NCT01968967|3589492|B1|||Age||years|Mean|62.2|62.2|Standard Deviation|9.8|9.8|||
3754894|NCT01968954|3589563|B3||Male|Sex: Female, Male||Participants|Count of Participants|445|445.0||||||
3754895|NCT01968954|3589564|B2||Male|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
3754896|NCT01968954|3589565|B1||Male|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
3754897|NCT01968954|3589563|B3||Female|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
3754898|NCT01968954|3589564|B2||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3754899|NCT01968954|3589565|B1||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3754900|NCT01968954|3589563|B3|||Age||years|Mean|61.3|61.3|Standard Deviation|10.0|10.0|||
3754901|NCT01968954|3589564|B2|||Age||years|Mean|61.1|61.1|Standard Deviation|10.2|10.2|||
3754902|NCT01968954|3589565|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|9.7|9.7|||
3754903|NCT01968811|3589630|B1|Sweden||Region of Enrollment||participants|Number|10|10.0||||||
3754904|NCT01968811|3589630|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3754905|NCT01968811|3589630|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3754906|NCT01968811|3589630|B1|||Age||years|Mean|74.8|74.8|Standard Deviation|3.7|3.7|||
3754907|NCT01968811|3589630|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3754908|NCT01968811|3589630|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3754909|NCT01968811|3589630|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3754910|NCT01968694|3589635|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
3754911|NCT01968694|3589636|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3754912|NCT01968694|3589637|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3754913|NCT01968694|3589635|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3754914|NCT01968694|3589636|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3754915|NCT01968694|3589637|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3754916|NCT01968694|3589635|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3754917|NCT01968694|3589636|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3754918|NCT01968694|3589637|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3754919|NCT01968694|3589635|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3754920|NCT01968694|3589636|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3754921|NCT01968694|3589637|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3754922|NCT01968694|3589635|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3754923|NCT01968694|3589636|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3754924|NCT01968694|3589637|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3754925|NCT01968694|3589635|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3754926|NCT01968694|3589636|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3754927|NCT01968694|3589637|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3754928|NCT01968551|3589652|B4|≥ 350 cells/µL||CD4 Cell Count Category||participants|Number|124|124.0||||||
3754929|NCT01968551|3589653|B3|≥ 350 cells/µL||CD4 Cell Count Category||participants|Number|38|38.0||||||
3754930|NCT01968551|3589654|B2|≥ 350 cells/µL||CD4 Cell Count Category||participants|Number|69|69.0||||||
3754931|NCT01968551|3589655|B1|≥ 350 cells/µL||CD4 Cell Count Category||participants|Number|17|17.0||||||
3754932|NCT01968551|3589652|B4|≥ 200 to < 350 cells/µL||CD4 Cell Count Category||participants|Number|25|25.0||||||
3754933|NCT01968551|3589653|B3|≥ 200 to < 350 cells/µL||CD4 Cell Count Category||participants|Number|7|7.0||||||
3754934|NCT01968551|3589654|B2|≥ 200 to < 350 cells/µL||CD4 Cell Count Category||participants|Number|15|15.0||||||
3754935|NCT01968551|3589655|B1|≥ 200 to < 350 cells/µL||CD4 Cell Count Category||participants|Number|3|3.0||||||
3754936|NCT01968551|3589652|B4|< 200 cells/µL||CD4 Cell Count Category||participants|Number|7|7.0||||||
3754937|NCT01968551|3589653|B3|< 200 cells/µL||CD4 Cell Count Category||participants|Number|1|1.0||||||
3754938|NCT01968551|3589654|B2|< 200 cells/µL||CD4 Cell Count Category||participants|Number|5|5.0||||||
3754939|NCT01968551|3589655|B1|< 200 cells/µL||CD4 Cell Count Category||participants|Number|1|1.0||||||
3754940|NCT01968551|3589652|B4|||CD4 Cell Count||cells/µL|Mean|583|583.0|Standard Deviation|275.9|275.9|||
3754941|NCT01968551|3589653|B3|||CD4 Cell Count||cells/µL|Mean|571|571.0|Standard Deviation|245.2|245.2|||
3754942|NCT01968551|3589654|B2|||CD4 Cell Count||cells/µL|Mean|562|562.0|Standard Deviation|260.8|260.8|||
3754943|NCT01968551|3589655|B1|||CD4 Cell Count||cells/µL|Mean|700|700.0|Standard Deviation|372.5|372.5|||
3754944|NCT01968551|3589652|B4|≥ 50 copies/mL||HIV-1 RNA Category||participants|Number|4|4.0||||||
3754945|NCT01968551|3589653|B3|≥ 50 copies/mL||HIV-1 RNA Category||participants|Number|0|0.0||||||
3754946|NCT01968551|3589654|B2|≥ 50 copies/mL||HIV-1 RNA Category||participants|Number|2|2.0||||||
3754947|NCT01968551|3589655|B1|≥ 50 copies/mL||HIV-1 RNA Category||participants|Number|2|2.0||||||
3754948|NCT01968551|3589652|B4|< 50 copies/mL||HIV-1 RNA Category||participants|Number|152|152.0||||||
3754949|NCT01968551|3589653|B3|< 50 copies/mL||HIV-1 RNA Category||participants|Number|46|46.0||||||
3754950|NCT01968551|3589654|B2|< 50 copies/mL||HIV-1 RNA Category||participants|Number|87|87.0||||||
3754951|NCT01968551|3589655|B1|< 50 copies/mL||HIV-1 RNA Category||participants|Number|19|19.0||||||
3754952|NCT01968551|3589652|B4|United States||Region of Enrollment||participants|Number|144|144.0||||||
3754953|NCT01968551|3589653|B3|United States||Region of Enrollment||participants|Number|43|43.0||||||
3754954|NCT01968551|3589654|B2|United States||Region of Enrollment||participants|Number|80|80.0||||||
3754955|NCT01968551|3589655|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3754956|NCT01968551|3589652|B4|Canada||Region of Enrollment||participants|Number|12|12.0||||||
3754957|NCT01968551|3589653|B3|Canada||Region of Enrollment||participants|Number|3|3.0||||||
3754958|NCT01968551|3589654|B2|Canada||Region of Enrollment||participants|Number|9|9.0||||||
3754959|NCT01968551|3589655|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
3754960|NCT01968551|3589652|B4|Not Permitted||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3754961|NCT01968551|3589653|B3|Not Permitted||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3754962|NCT01968551|3589654|B2|Not Permitted||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3754963|NCT01968551|3589655|B1|Not Permitted||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3754964|NCT01968551|3589652|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|135|135.0||||||
3754965|NCT01968551|3589653|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
3754966|NCT01968551|3589654|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
3754967|NCT01968551|3589655|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3754968|NCT01968551|3589652|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3754969|NCT01968551|3589653|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3754970|NCT01968551|3589654|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3754971|NCT01968551|3589655|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3754972|NCT01968551|3589652|B4|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3754973|NCT01968551|3589653|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3754974|NCT01968551|3589654|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3754975|NCT01968551|3589655|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3754976|NCT01968551|3589652|B4|Not Permitted||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3754977|NCT01968551|3589653|B3|Not Permitted||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3754978|NCT01968551|3589654|B2|Not Permitted||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3754979|NCT01968551|3589655|B1|Not Permitted||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3754980|NCT01968551|3589652|B4|White||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
3754981|NCT01968551|3589653|B3|White||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3754982|NCT01968551|3589654|B2|White||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
3754983|NCT01968551|3589655|B1|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3754984|NCT01968551|3589652|B4|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3754985|NCT01968551|3589653|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3754986|NCT01968551|3589654|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3754987|NCT01968551|3589655|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3754988|NCT01968551|3589652|B4|Black||Race/Ethnicity, Customized||participants|Number|73|73.0||||||
3754989|NCT01968551|3589653|B3|Black||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3754990|NCT01968551|3589654|B2|Black||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3754991|NCT01968551|3589655|B1|Black||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3754992|NCT01968551|3589652|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3754993|NCT01968551|3589653|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3754994|NCT01968551|3589654|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3754995|NCT01968551|3589655|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3754996|NCT01968551|3589652|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3754997|NCT01968551|3589653|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3754998|NCT01968551|3589654|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3754999|NCT01968551|3589655|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3755000|NCT01968551|3589652|B4||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3755001|NCT01968551|3589653|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3755002|NCT01968551|3589654|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3755003|NCT01968551|3589655|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3755004|NCT01968551|3589652|B4||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3755005|NCT01968551|3589653|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3755006|NCT01968551|3589654|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3755007|NCT01968551|3589655|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3755008|NCT01968551|3589652|B4|||Age||Years|Mean|49|49.0|Standard Deviation|8.4|8.4|||
3755009|NCT01968551|3589653|B3|||Age||Years|Mean|47|47.0|Standard Deviation|9.4|9.4|||
3755010|NCT01968551|3589654|B2|||Age||Years|Mean|49|49.0|Standard Deviation|8.2|8.2|||
3755011|NCT01968551|3589655|B1|||Age||Years|Mean|53|53.0|Standard Deviation|5.7|5.7|||
3755012|NCT01968434|3589671|B3|||Participants coughing since ≥ 3 days at time of enrollment||participants|Number|93|93.0||||||
3755013|NCT01968434|3589672|B2|||Participants coughing since ≥ 3 days at time of enrollment||participants|Number|46|46.0||||||
3755014|NCT01968434|3589673|B1|||Participants coughing since ≥ 3 days at time of enrollment||participants|Number|47|47.0||||||
3755015|NCT01968434|3589671|B3|Israel||Region of Enrollment||participants|Number|150|150.0||||||
3755016|NCT01968434|3589672|B2|Israel||Region of Enrollment||participants|Number|72|72.0||||||
3755017|NCT01968434|3589673|B1|Israel||Region of Enrollment||participants|Number|78|78.0||||||
3755018|NCT01968434|3589671|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3755019|NCT01968434|3589672|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3755020|NCT01968434|3589673|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3755021|NCT01968434|3589671|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3755022|NCT01968434|3589672|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3755023|NCT01968434|3589673|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3755024|NCT01968434|3589671|B3|||Age||months|Mean|42.8|42.8|Standard Deviation|13.7|13.7|||
3755025|NCT01968434|3589672|B2|||Age||months|Mean|43.17|43.17|Standard Deviation|14.57|14.57|||
3755026|NCT01968434|3589673|B1|||Age||months|Mean|42.49|42.49|Standard Deviation|12.96|12.96|||
3755027|NCT01968226|3589684|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755028|NCT01968226|3589684|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755029|NCT01968226|3589684|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3755030|NCT01968226|3589684|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755031|NCT01968226|3589684|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755032|NCT01968226|3589684|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755033|NCT01968226|3589684|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755034|NCT01968226|3589684|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755035|NCT01968226|3589684|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3755036|NCT01968226|3589684|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755037|NCT01968226|3589684|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3755038|NCT01968226|3589684|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3755039|NCT01968226|3589684|B1||>=65 years|Age|No subject data analyzed|Participants|Count of Participants|0|0.0||||||
3755040|NCT01968226|3589684|B1||Between 18 and 65 years|Age|No subject data analyzed|Participants|Count of Participants|0|0.0||||||
3755041|NCT01968226|3589684|B1||<=18 years|Age|No subject data analyzed|Participants|Count of Participants|0|0.0||||||
3755042|NCT01968213|3589688|B3||No|Bulky Lesions (lesion >20 mm) at Baseline||Participants|Count of Participants|464|464.0||||||
3755043|NCT01968213|3589689|B2||No|Bulky Lesions (lesion >20 mm) at Baseline||Participants|Count of Participants|160|160.0||||||
3755044|NCT01968213|3589690|B1||No|Bulky Lesions (lesion >20 mm) at Baseline||Participants|Count of Participants|304|304.0||||||
3755045|NCT01968213|3589688|B3||Yes|Bulky Lesions (lesion >20 mm) at Baseline||Participants|Count of Participants|100|100.0||||||
3755046|NCT01968213|3589689|B2||Yes|Bulky Lesions (lesion >20 mm) at Baseline||Participants|Count of Participants|29|29.0||||||
3755047|NCT01968213|3589690|B1||Yes|Bulky Lesions (lesion >20 mm) at Baseline||Participants|Count of Participants|71|71.0||||||
3755048|NCT01968213|3589688|B3||>12 Months|Penultimate Progression-free (PF) Interval|Progressive disease is defined using Response Evaluation Criteria In Solid Tumors Criteria (RECIST v1.1), as a 20% increase in the sum of the longest diameter of measurable lesions, an unequivocal increase in existing non-measurable lesion(s), or the appearance of unequivocal new lesion(s).|Participants|Count of Participants|337|337.0||||||
3755049|NCT01968213|3589689|B2||>12 Months|Penultimate Progression-free (PF) Interval|Progressive disease is defined using Response Evaluation Criteria In Solid Tumors Criteria (RECIST v1.1), as a 20% increase in the sum of the longest diameter of measurable lesions, an unequivocal increase in existing non-measurable lesion(s), or the appearance of unequivocal new lesion(s).|Participants|Count of Participants|113|113.0||||||
3755050|NCT01968213|3589690|B1||>12 Months|Penultimate Progression-free (PF) Interval|Progressive disease is defined using Response Evaluation Criteria In Solid Tumors Criteria (RECIST v1.1), as a 20% increase in the sum of the longest diameter of measurable lesions, an unequivocal increase in existing non-measurable lesion(s), or the appearance of unequivocal new lesion(s).|Participants|Count of Participants|224|224.0||||||
3755051|NCT01968213|3589688|B3||6-12 Months|Penultimate Progression-free (PF) Interval|Progressive disease is defined using Response Evaluation Criteria In Solid Tumors Criteria (RECIST v1.1), as a 20% increase in the sum of the longest diameter of measurable lesions, an unequivocal increase in existing non-measurable lesion(s), or the appearance of unequivocal new lesion(s).|Participants|Count of Participants|227|227.0||||||
3755078|NCT01968213|3589688|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3755052|NCT01968213|3589689|B2||6-12 Months|Penultimate Progression-free (PF) Interval|Progressive disease is defined using Response Evaluation Criteria In Solid Tumors Criteria (RECIST v1.1), as a 20% increase in the sum of the longest diameter of measurable lesions, an unequivocal increase in existing non-measurable lesion(s), or the appearance of unequivocal new lesion(s).|Participants|Count of Participants|76|76.0||||||
3755053|NCT01968213|3589690|B1||6-12 Months|Penultimate Progression-free (PF) Interval|Progressive disease is defined using Response Evaluation Criteria In Solid Tumors Criteria (RECIST v1.1), as a 20% increase in the sum of the longest diameter of measurable lesions, an unequivocal increase in existing non-measurable lesion(s), or the appearance of unequivocal new lesion(s).|Participants|Count of Participants|151|151.0||||||
3755054|NCT01968213|3589688|B3||RECIST / CA-125 PR|Best Response from Previous Platinum Therapy|Complete and partial responses at baseline must have been reported according to RECIST v1.1, as assessed by CT/MRI, and GCIG CA-125 response criteria, and defined as: Complete Response (CR) i.e. absence of any detectable disease and CA-125<ULN; Partial Response (PR), ≥30% decrease in the sum of the longest diameter of measurable lesions or if non-measurable disease at baseline, a GCIG CA-125 response (least a 50% reduction in CA-125 levels from a pretreatment sample (which must have initially been 2xULN) and confirmed after ≥21 days). CA-125 must have been <ULN for all PRs.|Participants|Count of Participants|374|374.0||||||
3755055|NCT01968213|3589689|B2||RECIST / CA-125 PR|Best Response from Previous Platinum Therapy|Complete and partial responses at baseline must have been reported according to RECIST v1.1, as assessed by CT/MRI, and GCIG CA-125 response criteria, and defined as: Complete Response (CR) i.e. absence of any detectable disease and CA-125<ULN; Partial Response (PR), ≥30% decrease in the sum of the longest diameter of measurable lesions or if non-measurable disease at baseline, a GCIG CA-125 response (least a 50% reduction in CA-125 levels from a pretreatment sample (which must have initially been 2xULN) and confirmed after ≥21 days). CA-125 must have been <ULN for all PRs.|Participants|Count of Participants|125|125.0||||||
3755056|NCT01968213|3589690|B1||RECIST / CA-125 PR|Best Response from Previous Platinum Therapy|Complete and partial responses at baseline must have been reported according to RECIST v1.1, as assessed by CT/MRI, and GCIG CA-125 response criteria, and defined as: Complete Response (CR) i.e. absence of any detectable disease and CA-125<ULN; Partial Response (PR), ≥30% decrease in the sum of the longest diameter of measurable lesions or if non-measurable disease at baseline, a GCIG CA-125 response (least a 50% reduction in CA-125 levels from a pretreatment sample (which must have initially been 2xULN) and confirmed after ≥21 days). CA-125 must have been <ULN for all PRs.|Participants|Count of Participants|249|249.0||||||
3755057|NCT01968213|3589688|B3||RECIST CR|Best Response from Previous Platinum Therapy|Complete and partial responses at baseline must have been reported according to RECIST v1.1, as assessed by CT/MRI, and GCIG CA-125 response criteria, and defined as: Complete Response (CR) i.e. absence of any detectable disease and CA-125<ULN; Partial Response (PR), ≥30% decrease in the sum of the longest diameter of measurable lesions or if non-measurable disease at baseline, a GCIG CA-125 response (least a 50% reduction in CA-125 levels from a pretreatment sample (which must have initially been 2xULN) and confirmed after ≥21 days). CA-125 must have been <ULN for all PRs.|Participants|Count of Participants|190|190.0||||||
3755058|NCT01968213|3589689|B2||RECIST CR|Best Response from Previous Platinum Therapy|Complete and partial responses at baseline must have been reported according to RECIST v1.1, as assessed by CT/MRI, and GCIG CA-125 response criteria, and defined as: Complete Response (CR) i.e. absence of any detectable disease and CA-125<ULN; Partial Response (PR), ≥30% decrease in the sum of the longest diameter of measurable lesions or if non-measurable disease at baseline, a GCIG CA-125 response (least a 50% reduction in CA-125 levels from a pretreatment sample (which must have initially been 2xULN) and confirmed after ≥21 days). CA-125 must have been <ULN for all PRs.|Participants|Count of Participants|64|64.0||||||
3755059|NCT01968213|3589690|B1||RECIST CR|Best Response from Previous Platinum Therapy|Complete and partial responses at baseline must have been reported according to RECIST v1.1, as assessed by CT/MRI, and GCIG CA-125 response criteria, and defined as: Complete Response (CR) i.e. absence of any detectable disease and CA-125<ULN; Partial Response (PR), ≥30% decrease in the sum of the longest diameter of measurable lesions or if non-measurable disease at baseline, a GCIG CA-125 response (least a 50% reduction in CA-125 levels from a pretreatment sample (which must have initially been 2xULN) and confirmed after ≥21 days). CA-125 must have been <ULN for all PRs.|Participants|Count of Participants|126|126.0||||||
3755060|NCT01968213|3589688|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3755061|NCT01968213|3589689|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3755062|NCT01968213|3589690|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3755063|NCT01968213|3589688|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3755064|NCT01968213|3589689|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3755065|NCT01968213|3589690|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3755066|NCT01968213|3589688|B3||White|Race (NIH/OMB)||Participants|Count of Participants|451|451.0||||||
3755067|NCT01968213|3589689|B2||White|Race (NIH/OMB)||Participants|Count of Participants|149|149.0||||||
3755068|NCT01968213|3589690|B1||White|Race (NIH/OMB)||Participants|Count of Participants|302|302.0||||||
3755069|NCT01968213|3589688|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3755070|NCT01968213|3589689|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3755071|NCT01968213|3589690|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3755072|NCT01968213|3589688|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755073|NCT01968213|3589689|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755074|NCT01968213|3589690|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755075|NCT01968213|3589688|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3755076|NCT01968213|3589689|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3755077|NCT01968213|3589690|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3755079|NCT01968213|3589689|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3755080|NCT01968213|3589690|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3755081|NCT01968213|3589688|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3755082|NCT01968213|3589689|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3755083|NCT01968213|3589690|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3755084|NCT01968213|3589688|B3||Female|Sex: Female, Male||Participants|Count of Participants|564|564.0||||||
3755085|NCT01968213|3589689|B2||Female|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
3755086|NCT01968213|3589690|B1||Female|Sex: Female, Male||Participants|Count of Participants|375|375.0||||||
3755087|NCT01968213|3589688|B3|||Age||Years|Median|61|61.0|Full Range|||36.0|85.0|
3755088|NCT01968213|3589689|B2|||Age||Years|Median|62|62.0|Full Range|||36.0|85.0|
3755089|NCT01968213|3589690|B1|||Age||Years|Median|61|61.0|Full Range|||39.0|84.0|
3755090|NCT01968135|3589700|B3|||Total days of current bleeding episode||days|Mean|39.9|39.9|Standard Deviation|41.8|41.8|||
3755091|NCT01968135|3589701|B2|||Total days of current bleeding episode||days|Mean|30.3|30.3|Standard Deviation|37.7|37.7|||
3755092|NCT01968135|3589702|B1|||Total days of current bleeding episode||days|Mean|49.6|49.6|Standard Deviation|44.6|44.6|||
3755093|NCT01968135|3589700|B3|||BMI||kg/m^2|Mean|23.2|23.2|Standard Deviation|3.2|3.2|||
3755094|NCT01968135|3589701|B2|||BMI||kg/m^2|Mean|23.3|23.3|Standard Deviation|3.5|3.5|||
3755095|NCT01968135|3589702|B1|||BMI||kg/m^2|Mean|23.2|23.2|Standard Deviation|2.9|2.9|||
3755096|NCT01968135|3589700|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
3755097|NCT01968135|3589701|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3755098|NCT01968135|3589702|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3755099|NCT01968135|3589700|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755100|NCT01968135|3589701|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755101|NCT01968135|3589702|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755102|NCT01968135|3589700|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3755103|NCT01968135|3589701|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3755104|NCT01968135|3589702|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3755105|NCT01968135|3589700|B3||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3755106|NCT01968135|3589701|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3755107|NCT01968135|3589702|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3755108|NCT01968135|3589700|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3755109|NCT01968135|3589701|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3755110|NCT01968135|3589702|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3755111|NCT01968135|3589700|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755112|NCT01968135|3589701|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755113|NCT01968135|3589702|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755114|NCT01968135|3589700|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3755115|NCT01968135|3589701|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3755116|NCT01968135|3589702|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3755117|NCT01968135|3589700|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755118|NCT01968135|3589701|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755119|NCT01968135|3589702|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755120|NCT01968135|3589700|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755121|NCT01968135|3589701|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755122|NCT01968135|3589702|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755123|NCT01968135|3589700|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3755124|NCT01968135|3589701|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3755125|NCT01968135|3589702|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3755126|NCT01968135|3589700|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3755127|NCT01968135|3589701|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3755128|NCT01968135|3589702|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3755129|NCT01968135|3589700|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3755130|NCT01968135|3589701|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3755131|NCT01968135|3589702|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3755132|NCT01968135|3589700|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3755133|NCT01968135|3589701|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3755134|NCT01968135|3589702|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3755135|NCT01968135|3589700|B3|||Age||years|Mean|21.9|21.9|Standard Deviation|4.0|4.0|||
3755136|NCT01968135|3589701|B2|||Age||years|Mean|21.4|21.4|Standard Deviation|3|3.0|||
3755137|NCT01968135|3589702|B1|||Age||years|Mean|22.4|22.4|Standard Deviation|4.8|4.8|||
3755138|NCT01968057|3589715|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3755139|NCT01968057|3589715|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755140|NCT01968057|3589715|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755141|NCT01968057|3589715|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3755142|NCT01968057|3589715|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755143|NCT01968057|3589715|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755144|NCT01968057|3589715|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755145|NCT01968057|3589715|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755146|NCT01968057|3589715|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755147|NCT01968057|3589715|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3755148|NCT01968057|3589715|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755149|NCT01968057|3589715|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3755150|NCT01968057|3589715|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3755151|NCT01968057|3589715|B1|||Age||years|Mean|38.4|38.4|Standard Deviation|12.7|12.7|||
3755152|NCT01967940|3589725|B4|||CD4 Percentage||percentage|Mean|16.1|16.1|Standard Deviation|10.15|10.15|||
3755153|NCT01967940|3589726|B3|||CD4 Percentage||percentage|Mean|14.3|14.3|Standard Deviation|8.61|8.61|||
3755154|NCT01967940|3589727|B2|||CD4 Percentage||percentage|Mean|16.5|16.5|Standard Deviation|11.09|11.09|||
3755155|NCT01967940|3589728|B1|||CD4 Percentage||percentage|Mean|17.4|17.4|Standard Deviation|10.14|10.14|||
3755156|NCT01967940|3589725|B4|||CD4 Cell Count||cells/µL|Mean|246|246.0|Standard Deviation|213.7|213.7|||
3755157|NCT01967940|3589726|B3|||CD4 Cell Count||cells/µL|Mean|232|232.0|Standard Deviation|162.4|162.4|||
3755158|NCT01967940|3589727|B2|||CD4 Cell Count||cells/µL|Mean|245|245.0|Standard Deviation|244.6|244.6|||
3755159|NCT01967940|3589728|B1|||CD4 Cell Count||cells/µL|Mean|269|269.0|Standard Deviation|207.1|207.1|||
3755160|NCT01967940|3589725|B4||> 100,000 to ≤ 400,000 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|4|4.0||||||
3755161|NCT01967940|3589726|B3||> 100,000 to ≤ 400,000 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|3|3.0||||||
3755162|NCT01967940|3589727|B2||> 100,000 to ≤ 400,000 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|1|1.0||||||
3755163|NCT01967940|3589728|B1||> 100,000 to ≤ 400,000 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|0|0.0||||||
3755164|NCT01967940|3589725|B4||≤ 100,000 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|51|51.0||||||
3755165|NCT01967940|3589726|B3||≤ 100,000 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|12|12.0||||||
3755166|NCT01967940|3589727|B2||≤ 100,000 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|27|27.0||||||
3755167|NCT01967940|3589728|B1||≤ 100,000 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|12|12.0||||||
3755168|NCT01967940|3589725|B4|||HIV-1 RNA||log10 copies/mL|Mean|4.13|4.13|Standard Deviation|0.688|0.688|||
3755169|NCT01967940|3589726|B3|||HIV-1 RNA||log10 copies/mL|Mean|4.03|4.03|Standard Deviation|0.953|0.953|||
3755170|NCT01967940|3589727|B2|||HIV-1 RNA||log10 copies/mL|Mean|4.16|4.16|Standard Deviation|0.544|0.544|||
3755171|NCT01967940|3589728|B1|||HIV-1 RNA||log10 copies/mL|Mean|4.18|4.18|Standard Deviation|0.648|0.648|||
3755172|NCT01967940|3589725|B4|Thailand||Region of Enrollment||participants|Number|10|10.0||||||
3755173|NCT01967940|3589726|B3|Thailand||Region of Enrollment||participants|Number|5|5.0||||||
3755174|NCT01967940|3589727|B2|Thailand||Region of Enrollment||participants|Number|5|5.0||||||
3755175|NCT01967940|3589728|B1|Thailand||Region of Enrollment||participants|Number|0|0.0||||||
3755176|NCT01967940|3589725|B4|Uganda||Region of Enrollment||participants|Number|28|28.0||||||
3755177|NCT01967940|3589726|B3|Uganda||Region of Enrollment||participants|Number|9|9.0||||||
3755178|NCT01967940|3589727|B2|Uganda||Region of Enrollment||participants|Number|19|19.0||||||
3755179|NCT01967940|3589728|B1|Uganda||Region of Enrollment||participants|Number|0|0.0||||||
3755180|NCT01967940|3589725|B4|Dominican Republic||Region of Enrollment||participants|Number|6|6.0||||||
3755181|NCT01967940|3589726|B3|Dominican Republic||Region of Enrollment||participants|Number|1|1.0||||||
3755182|NCT01967940|3589727|B2|Dominican Republic||Region of Enrollment||participants|Number|0|0.0||||||
3755183|NCT01967940|3589728|B1|Dominican Republic||Region of Enrollment||participants|Number|5|5.0||||||
3755184|NCT01967940|3589725|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
3755185|NCT01967940|3589726|B3|United States||Region of Enrollment||participants|Number|0|0.0||||||
3755186|NCT01967940|3589727|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3755187|NCT01967940|3589728|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3755188|NCT01967940|3589725|B4|Russian Federation||Region of Enrollment||participants|Number|3|3.0||||||
3755189|NCT01967940|3589726|B3|Russian Federation||Region of Enrollment||participants|Number|0|0.0||||||
3755190|NCT01967940|3589727|B2|Russian Federation||Region of Enrollment||participants|Number|1|1.0||||||
3755191|NCT01967940|3589728|B1|Russian Federation||Region of Enrollment||participants|Number|2|2.0||||||
3755192|NCT01967940|3589725|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3755193|NCT01967940|3589726|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3755194|NCT01967940|3589727|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3755252|NCT01967732|3589771|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3755195|NCT01967940|3589728|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3755196|NCT01967940|3589725|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3755197|NCT01967940|3589726|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3755198|NCT01967940|3589727|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3755199|NCT01967940|3589728|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3755200|NCT01967940|3589725|B4|Black||Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3755201|NCT01967940|3589726|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3755202|NCT01967940|3589727|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3755203|NCT01967940|3589728|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3755204|NCT01967940|3589725|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3755205|NCT01967940|3589726|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3755206|NCT01967940|3589727|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3755207|NCT01967940|3589728|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3755208|NCT01967940|3589725|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755209|NCT01967940|3589726|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755210|NCT01967940|3589727|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755211|NCT01967940|3589728|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755212|NCT01967940|3589725|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3755213|NCT01967940|3589726|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3755214|NCT01967940|3589727|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3755215|NCT01967940|3589728|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3755216|NCT01967940|3589725|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3755217|NCT01967940|3589726|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3755218|NCT01967940|3589727|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755219|NCT01967940|3589728|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3755220|NCT01967940|3589725|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3755221|NCT01967940|3589726|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3755222|NCT01967940|3589727|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3755223|NCT01967940|3589728|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3755224|NCT01967940|3589725|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3755225|NCT01967940|3589726|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3755226|NCT01967940|3589727|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3755227|NCT01967940|3589728|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3755228|NCT01967940|3589725|B4|||Age||years|Mean|40|40.0|Standard Deviation|8.6|8.6|||
3755229|NCT01967940|3589726|B3|||Age||years|Mean|43|43.0|Standard Deviation|8.2|8.2|||
3755230|NCT01967940|3589727|B2|||Age||years|Mean|40|40.0|Standard Deviation|9.1|9.1|||
3755231|NCT01967940|3589728|B1|||Age||years|Mean|38|38.0|Standard Deviation|7.3|7.3|||
3755232|NCT01967836|3589757|B1|||subjects with central IV catheter in place||participants|Number|20|20.0||||||
3755233|NCT01967836|3589757|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3755234|NCT01967836|3589757|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3755235|NCT01967836|3589757|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3755236|NCT01967836|3589757|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3755237|NCT01967836|3589757|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3755238|NCT01967836|3589757|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3755239|NCT01967784|3589763|B1|Taiwan||Region of Enrollment||Participants|Number|100|100.0||||||
3755240|NCT01967784|3589763|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3755241|NCT01967784|3589763|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3755242|NCT01967784|3589763|B1|Age Continuous||Age||Years|Mean|13.4|13.4|Standard Deviation|2.9|2.9|||
3755243|NCT01967784|3589763|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3755244|NCT01967784|3589763|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3755245|NCT01967784|3589763|B1||<=18 years|Age||Participants|Count of Participants|100|100.0||||||
3755246|NCT01967732|3589771|B3|> 0.6 to ≤ 1 mg||International Organization for Standardization (ISO) nicotine level||participants|Number|35|35.0||||||
3755247|NCT01967732|3589772|B2|> 0.6 to ≤ 1 mg||International Organization for Standardization (ISO) nicotine level||participants|Number|10|10.0||||||
3755248|NCT01967732|3589773|B1|> 0.6 to ≤ 1 mg||International Organization for Standardization (ISO) nicotine level||participants|Number|25|25.0||||||
3755249|NCT01967732|3589771|B3|≤ 0.6 mg||International Organization for Standardization (ISO) nicotine level||participants|Number|25|25.0||||||
3755250|NCT01967732|3589772|B2|≤ 0.6 mg||International Organization for Standardization (ISO) nicotine level||participants|Number|8|8.0||||||
3755251|NCT01967732|3589773|B1|≤ 0.6 mg||International Organization for Standardization (ISO) nicotine level||participants|Number|17|17.0||||||
3755253|NCT01967732|3589772|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3755254|NCT01967732|3589773|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3755255|NCT01967732|3589771|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3755256|NCT01967732|3589772|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3755257|NCT01967732|3589773|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3755258|NCT01967732|3589771|B3|||Age||years|Mean|31.7|31.7|Standard Deviation|8.13|8.13|||
3755259|NCT01967732|3589772|B2|||Age||years|Mean|30.6|30.6|Standard Deviation|5.80|5.8|||
3755260|NCT01967732|3589773|B1|||Age||years|Mean|32.1|32.1|Standard Deviation|8.98|8.98|||
3755261|NCT01967719|3589788|B3|> 1.0 mg||International Organization for Standardization (ISO) nicotine yield||participants|Number|26|26.0||||||
3755262|NCT01967719|3589789|B2|> 1.0 mg||International Organization for Standardization (ISO) nicotine yield||participants|Number|6|6.0||||||
3755263|NCT01967719|3589790|B1|> 1.0 mg||International Organization for Standardization (ISO) nicotine yield||participants|Number|20|20.0||||||
3755264|NCT01967719|3589788|B3|≤ 1.0 mg||International Organization for Standardization (ISO) nicotine yield||participants|Number|32|32.0||||||
3755265|NCT01967719|3589789|B2|≤ 1.0 mg||International Organization for Standardization (ISO) nicotine yield||participants|Number|11|11.0||||||
3755266|NCT01967719|3589790|B1|≤ 1.0 mg||International Organization for Standardization (ISO) nicotine yield||participants|Number|21|21.0||||||
3755267|NCT01967719|3589788|B3||Male|Gender||Participants|Count of Participants|29|29.0||||||
3755268|NCT01967719|3589789|B2||Male|Gender||Participants|Count of Participants|8|8.0||||||
3755269|NCT01967719|3589790|B1||Male|Gender||Participants|Count of Participants|21|21.0||||||
3755270|NCT01967719|3589788|B3||Female|Gender||Participants|Count of Participants|29|29.0||||||
3755271|NCT01967719|3589789|B2||Female|Gender||Participants|Count of Participants|9|9.0||||||
3755272|NCT01967719|3589790|B1||Female|Gender||Participants|Count of Participants|20|20.0||||||
3755273|NCT01967719|3589788|B3|||Age||years|Mean|35.9|35.9|Standard Deviation|9.00|9.0|||
3755274|NCT01967719|3589789|B2|||Age||years|Mean|33.8|33.8|Standard Deviation|6.93|6.93|||
3755275|NCT01967719|3589790|B1|||Age||years|Mean|36.7|36.7|Standard Deviation|9.68|9.68|||
3755276|NCT01967706|3589806|B3|> 0.6 to ≤ 1 mg||International Organization for Standardization (ISO) nicotine level||participants|Number|26|26.0||||||
3755277|NCT01967706|3589807|B2|> 0.6 to ≤ 1 mg||International Organization for Standardization (ISO) nicotine level||participants|Number|8|8.0||||||
3755278|NCT01967706|3589808|B1|> 0.6 to ≤ 1 mg||International Organization for Standardization (ISO) nicotine level||participants|Number|18|18.0||||||
3755279|NCT01967706|3589806|B3|≤ 0.6 mg||International Organization for Standardization (ISO) nicotine level||participants|Number|35|35.0||||||
3755280|NCT01967706|3589807|B2|≤ 0.6 mg||International Organization for Standardization (ISO) nicotine level||participants|Number|10|10.0||||||
3755281|NCT01967706|3589808|B1|≤ 0.6 mg||International Organization for Standardization (ISO) nicotine level||participants|Number|25|25.0||||||
3755282|NCT01967706|3589806|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3755283|NCT01967706|3589807|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3755284|NCT01967706|3589808|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3755285|NCT01967706|3589806|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3755286|NCT01967706|3589807|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3755287|NCT01967706|3589808|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3755288|NCT01967706|3589806|B3|Between 23 and 65 years||Age, Customized||years|Mean|32.6|32.6|Standard Deviation|9.44|9.44|||
3755289|NCT01967706|3589807|B2|Between 23 and 65 years||Age, Customized||years|Mean|30.7|30.7|Standard Deviation|7.80|7.8|||
3755290|NCT01967706|3589808|B1|Between 23 and 65 years||Age, Customized||years|Mean|33.4|33.4|Standard Deviation|10.03|10.03|||
3755291|NCT01967641|3589824|B1|unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3755292|NCT01967641|3589824|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3755293|NCT01967641|3589824|B1|African American||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3755294|NCT01967641|3589824|B1|Caucaisan||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3755295|NCT01967641|3589824|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3755296|NCT01967641|3589824|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3755297|NCT01967641|3589824|B1|||Age||years|Mean|47.5|47.5|Standard Deviation|9.5|9.5|||
3755298|NCT01967628|3589830|B3|||Smokers||Participants|Count of Participants|12|12.0||||||
3755299|NCT01967628|3589831|B2|||Smokers||Participants|Count of Participants|7|7.0||||||
3755300|NCT01967628|3589832|B1|||Smokers||Participants|Count of Participants|5|5.0||||||
3755301|NCT01967628|3589830|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755302|NCT01967628|3589831|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755303|NCT01967628|3589832|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755304|NCT01967628|3589830|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755305|NCT01967628|3589831|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755306|NCT01967628|3589832|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755307|NCT01967628|3589830|B3||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3755308|NCT01967628|3589831|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3755309|NCT01967628|3589832|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3755367|NCT01967550|3589839|B3||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
3755310|NCT01967628|3589830|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3755311|NCT01967628|3589831|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3755312|NCT01967628|3589832|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3755313|NCT01967628|3589830|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755314|NCT01967628|3589831|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755315|NCT01967628|3589832|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755316|NCT01967628|3589830|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755317|NCT01967628|3589831|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755318|NCT01967628|3589832|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755319|NCT01967628|3589830|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755320|NCT01967628|3589831|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755321|NCT01967628|3589832|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755322|NCT01967628|3589830|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3755323|NCT01967628|3589831|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3755324|NCT01967628|3589832|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3755325|NCT01967628|3589830|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3755326|NCT01967628|3589831|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3755327|NCT01967628|3589832|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3755328|NCT01967628|3589830|B3|||Age||years|Mean|26|26.0|Standard Deviation|10|10.0|||
3755329|NCT01967628|3589831|B2|||Age||years|Mean|29.4|29.4|Standard Deviation|13|13.0|||
3755330|NCT01967628|3589832|B1|||Age||years|Mean|25.8|25.8|Standard Deviation|7.6|7.6|||
3755331|NCT01967550|3589839|B3|Germany||Region of Enrollment||participants|Number|304|304.0||||||
3755332|NCT01967550|3589840|B2|Germany||Region of Enrollment||participants|Number|151|151.0||||||
3755333|NCT01967550|3589841|B1|Germany||Region of Enrollment||participants|Number|153|153.0||||||
3755334|NCT01967550|3589839|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755335|NCT01967550|3589840|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755336|NCT01967550|3589841|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755337|NCT01967550|3589839|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755338|NCT01967550|3589840|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755339|NCT01967550|3589841|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755340|NCT01967550|3589839|B3||White|Race (NIH/OMB)||Participants|Count of Participants|303|303.0||||||
3755341|NCT01967550|3589840|B2||White|Race (NIH/OMB)||Participants|Count of Participants|150|150.0||||||
3755342|NCT01967550|3589841|B1||White|Race (NIH/OMB)||Participants|Count of Participants|153|153.0||||||
3755343|NCT01967550|3589839|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3755344|NCT01967550|3589840|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3755345|NCT01967550|3589841|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755346|NCT01967550|3589839|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755347|NCT01967550|3589840|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755348|NCT01967550|3589841|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755349|NCT01967550|3589839|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755350|NCT01967550|3589840|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755351|NCT01967550|3589841|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755352|NCT01967550|3589839|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755353|NCT01967550|3589840|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755354|NCT01967550|3589841|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755355|NCT01967550|3589839|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3755356|NCT01967550|3589840|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3755357|NCT01967550|3589841|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3755358|NCT01967550|3589839|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|258|258.0||||||
3755359|NCT01967550|3589840|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|127|127.0||||||
3755360|NCT01967550|3589841|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
3755361|NCT01967550|3589839|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755362|NCT01967550|3589840|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755363|NCT01967550|3589841|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755364|NCT01967550|3589839|B3||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3755365|NCT01967550|3589840|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3755366|NCT01967550|3589841|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3755368|NCT01967550|3589840|B2||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3755369|NCT01967550|3589841|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3755370|NCT01967550|3589839|B3|||Age||years|Mean|64.6|64.6|Standard Deviation|8.1|8.1|||
3755371|NCT01967550|3589840|B2|||Age||years|Mean|65.1|65.1|Standard Deviation|8.5|8.5|||
3755372|NCT01967550|3589841|B1|||Age||years|Mean|64.2|64.2|Standard Deviation|7.8|7.8|||
3755373|NCT01967342|3589848|B4|||Patient Health Questionnaire-9 items (PHQ-9)|The Patient Health Questionaire-9 (PHQ-9) is a 9-item self-report module. Each item is measured on a scale of 0 (not at all) to 3 (nearly every day). Scores can range from 0 to 27. Higher scores indicate greater severity of depressive symptoms.|units on a scale|Mean|12.1|12.1|Standard Deviation|6.4|6.4|||
3755374|NCT01967342|3589849|B3|||Patient Health Questionnaire-9 items (PHQ-9)|The Patient Health Questionaire-9 (PHQ-9) is a 9-item self-report module. Each item is measured on a scale of 0 (not at all) to 3 (nearly every day). Scores can range from 0 to 27. Higher scores indicate greater severity of depressive symptoms.|units on a scale|Mean|11.9|11.9|Standard Deviation|6.8|6.8|||
3755375|NCT01967342|3589850|B2|||Patient Health Questionnaire-9 items (PHQ-9)|The Patient Health Questionaire-9 (PHQ-9) is a 9-item self-report module. Each item is measured on a scale of 0 (not at all) to 3 (nearly every day). Scores can range from 0 to 27. Higher scores indicate greater severity of depressive symptoms.|units on a scale|Mean|11.7|11.7|Standard Deviation|6.1|6.1|||
3755376|NCT01967342|3589851|B1|||Patient Health Questionnaire-9 items (PHQ-9)|The Patient Health Questionaire-9 (PHQ-9) is a 9-item self-report module. Each item is measured on a scale of 0 (not at all) to 3 (nearly every day). Scores can range from 0 to 27. Higher scores indicate greater severity of depressive symptoms.|units on a scale|Mean|12.8|12.8|Standard Deviation|6.4|6.4|||
3755377|NCT01967342|3589848|B4|||Brief Pain Inventory (BPI) Interference|Pain interference scores were calculated from the mean of 7 items asking participants to rate interference due to pain in various domains on an 11-point Likert scale ranging from 0 (no interference) to 10 (complete interference). Higher scores indicate greater pain interference.|units on a scale|Mean|6.6|6.6|Standard Deviation|2.0|2.0|||
3755378|NCT01967342|3589849|B3|||Brief Pain Inventory (BPI) Interference|Pain interference scores were calculated from the mean of 7 items asking participants to rate interference due to pain in various domains on an 11-point Likert scale ranging from 0 (no interference) to 10 (complete interference). Higher scores indicate greater pain interference.|units on a scale|Mean|6.6|6.6|Standard Deviation|1.9|1.9|||
3755379|NCT01967342|3589850|B2|||Brief Pain Inventory (BPI) Interference|Pain interference scores were calculated from the mean of 7 items asking participants to rate interference due to pain in various domains on an 11-point Likert scale ranging from 0 (no interference) to 10 (complete interference). Higher scores indicate greater pain interference.|units on a scale|Mean|6.7|6.7|Standard Deviation|2.1|2.1|||
3755380|NCT01967342|3589851|B1|||Brief Pain Inventory (BPI) Interference|Pain interference scores were calculated from the mean of 7 items asking participants to rate interference due to pain in various domains on an 11-point Likert scale ranging from 0 (no interference) to 10 (complete interference). Higher scores indicate greater pain interference.|units on a scale|Mean|6.6|6.6|Standard Deviation|2.1|2.1|||
3755381|NCT01967342|3589848|B4|||Brief Pain Inventory (BPI) Severity|Pain severity scores were calculated from the mean of four items asking participants to rate the most severe pain, least severe pain, and average pain over the past 7 days, and current pain on an 11-point Likert Scale ranging from 0 (no pain) to 10 (pain as bad as you can imagine). Higher scores indicate greater pain severity.|units on a scale|Mean|6.5|6.5|Standard Deviation|1.6|1.6|||
3755382|NCT01967342|3589849|B3|||Brief Pain Inventory (BPI) Severity|Pain severity scores were calculated from the mean of four items asking participants to rate the most severe pain, least severe pain, and average pain over the past 7 days, and current pain on an 11-point Likert Scale ranging from 0 (no pain) to 10 (pain as bad as you can imagine). Higher scores indicate greater pain severity.|units on a scale|Mean|6.5|6.5|Standard Deviation|1.5|1.5|||
3755383|NCT01967342|3589850|B2|||Brief Pain Inventory (BPI) Severity|Pain severity scores were calculated from the mean of four items asking participants to rate the most severe pain, least severe pain, and average pain over the past 7 days, and current pain on an 11-point Likert Scale ranging from 0 (no pain) to 10 (pain as bad as you can imagine). Higher scores indicate greater pain severity.|units on a scale|Mean|6.5|6.5|Standard Deviation|1.8|1.8|||
3755384|NCT01967342|3589851|B1|||Brief Pain Inventory (BPI) Severity|Pain severity scores were calculated from the mean of four items asking participants to rate the most severe pain, least severe pain, and average pain over the past 7 days, and current pain on an 11-point Likert Scale ranging from 0 (no pain) to 10 (pain as bad as you can imagine). Higher scores indicate greater pain severity.|units on a scale|Mean|6.5|6.5|Standard Deviation|1.6|1.6|||
3755385|NCT01967342|3589848|B4|White/Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|96|96.0||||||
3755386|NCT01967342|3589849|B3|White/Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
3755387|NCT01967342|3589850|B2|White/Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3755388|NCT01967342|3589851|B1|White/Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
3755389|NCT01967342|3589848|B4|Black/African-American||Race/Ethnicity, Customized||Participants|Count of Participants|194|194.0||||||
3755390|NCT01967342|3589849|B3|Black/African-American||Race/Ethnicity, Customized||Participants|Count of Participants|59|59.0||||||
3755391|NCT01967342|3589850|B2|Black/African-American||Race/Ethnicity, Customized||Participants|Count of Participants|75|75.0||||||
3755392|NCT01967342|3589851|B1|Black/African-American||Race/Ethnicity, Customized||Participants|Count of Participants|60|60.0||||||
3755393|NCT01967342|3589848|B4||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3755394|NCT01967342|3589849|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3755395|NCT01967342|3589850|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3755396|NCT01967342|3589851|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3755397|NCT01967342|3589848|B4||Female|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
3755398|NCT01967342|3589849|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3755399|NCT01967342|3589850|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3755400|NCT01967342|3589851|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3755401|NCT01967342|3589848|B4|||Age||years|Mean|50.6|50.6|Standard Deviation|8.9|8.9|||
3755402|NCT01967342|3589849|B3|||Age||years|Mean|49.9|49.9|Standard Deviation|9.2|9.2|||
3755403|NCT01967342|3589850|B2|||Age||years|Mean|52.2|52.2|Standard Deviation|8.5|8.5|||
3755404|NCT01967342|3589851|B1|||Age||years|Mean|49.7|49.7|Standard Deviation|8.7|8.7|||
3755405|NCT01967342|3589848|B4||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3755406|NCT01967342|3589849|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3755407|NCT01967342|3589850|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3755408|NCT01967342|3589851|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3755409|NCT01967342|3589848|B4||Between 18 and 65 years|Age||Participants|Count of Participants|279|279.0||||||
3755410|NCT01967342|3589849|B3||Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
3755411|NCT01967342|3589850|B2||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
3755412|NCT01967342|3589851|B1||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
3755413|NCT01967342|3589848|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3755414|NCT01967342|3589849|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3755415|NCT01967342|3589850|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3755416|NCT01967342|3589851|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3755417|NCT01967277|3589870|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
3755418|NCT01967277|3589871|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
3755419|NCT01967277|3589872|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3755420|NCT01967277|3589870|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3755421|NCT01967277|3589871|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3755422|NCT01967277|3589872|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3755423|NCT01967277|3589870|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3755424|NCT01967277|3589871|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3755425|NCT01967277|3589872|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3755426|NCT01967277|3589870|B3|||Age||years|Median|49|49.0|Full Range|||28.0|60.0|
3755427|NCT01967277|3589871|B2|||Age||years|Median|49.5|49.5|Full Range|||28.0|58.0|
3755428|NCT01967277|3589872|B1|||Age||years|Median|49|49.0|Full Range|||28.0|60.0|
3755429|NCT01967225|3589881|B5||Bacteremia|Primary diagnosis||Participants|Count of Participants|6|6.0||||||
3755430|NCT01967225|3589882|B4||Bacteremia|Primary diagnosis||Participants|Count of Participants|2|2.0||||||
3755431|NCT01967225|3589883|B3||Bacteremia|Primary diagnosis||Participants|Count of Participants|4|4.0||||||
3755432|NCT01967225|3589884|B2||Bacteremia|Primary diagnosis||Participants|Count of Participants|0|0.0||||||
3755433|NCT01967225|3589885|B1||Bacteremia|Primary diagnosis||Participants|Count of Participants|0|0.0||||||
3755434|NCT01967225|3589881|B5||Infection secondary to ulcer|Primary diagnosis||Participants|Count of Participants|22|22.0||||||
3755435|NCT01967225|3589882|B4||Infection secondary to ulcer|Primary diagnosis||Participants|Count of Participants|0|0.0||||||
3755436|NCT01967225|3589883|B3||Infection secondary to ulcer|Primary diagnosis||Participants|Count of Participants|0|0.0||||||
3755437|NCT01967225|3589884|B2||Infection secondary to ulcer|Primary diagnosis||Participants|Count of Participants|5|5.0||||||
3755438|NCT01967225|3589885|B1||Infection secondary to ulcer|Primary diagnosis||Participants|Count of Participants|17|17.0||||||
3755439|NCT01967225|3589881|B5||Infection secondary to wound, burn, surgical wound|Primary diagnosis||Participants|Count of Participants|25|25.0||||||
3755440|NCT01967225|3589882|B4||Infection secondary to wound, burn, surgical wound|Primary diagnosis||Participants|Count of Participants|0|0.0||||||
3755441|NCT01967225|3589883|B3||Infection secondary to wound, burn, surgical wound|Primary diagnosis||Participants|Count of Participants|0|0.0||||||
3755442|NCT01967225|3589884|B2||Infection secondary to wound, burn, surgical wound|Primary diagnosis||Participants|Count of Participants|10|10.0||||||
3755443|NCT01967225|3589885|B1||Infection secondary to wound, burn, surgical wound|Primary diagnosis||Participants|Count of Participants|15|15.0||||||
3755444|NCT01967225|3589881|B5||Chronic pyoderma|Primary diagnosis||Participants|Count of Participants|5|5.0||||||
3755445|NCT01967225|3589882|B4||Chronic pyoderma|Primary diagnosis||Participants|Count of Participants|0|0.0||||||
3755446|NCT01967225|3589883|B3||Chronic pyoderma|Primary diagnosis||Participants|Count of Participants|0|0.0||||||
3755447|NCT01967225|3589884|B2||Chronic pyoderma|Primary diagnosis||Participants|Count of Participants|2|2.0||||||
3755448|NCT01967225|3589885|B1||Chronic pyoderma|Primary diagnosis||Participants|Count of Participants|3|3.0||||||
3755449|NCT01967225|3589881|B5||Deep SSTI|Primary diagnosis||Participants|Count of Participants|66|66.0||||||
3755450|NCT01967225|3589882|B4||Deep SSTI|Primary diagnosis||Participants|Count of Participants|0|0.0||||||
3755451|NCT01967225|3589883|B3||Deep SSTI|Primary diagnosis||Participants|Count of Participants|0|0.0||||||
3755452|NCT01967225|3589884|B2||Deep SSTI|Primary diagnosis||Participants|Count of Participants|22|22.0||||||
3755453|NCT01967225|3589885|B1||Deep SSTI|Primary diagnosis||Participants|Count of Participants|44|44.0||||||
3755454|NCT01967225|3589881|B5||>75 cm^2|Lesion area||Participants|Count of Participants|79|79.0||||||
3755455|NCT01967225|3589884|B2||>75 cm^2|Lesion area||Participants|Count of Participants|25|25.0||||||
3755456|NCT01967225|3589885|B1||>75 cm^2|Lesion area||Participants|Count of Participants|54|54.0||||||
3755457|NCT01967225|3589881|B5||<=75 cm^2|Lesion area||Participants|Count of Participants|39|39.0||||||
3755458|NCT01967225|3589884|B2||<=75 cm^2|Lesion area||Participants|Count of Participants|14|14.0||||||
3755459|NCT01967225|3589885|B1||<=75 cm^2|Lesion area||Participants|Count of Participants|25|25.0||||||
3755460|NCT01967225|3589881|B5|||Body Mass Index (BMI)||kg/m^2|Mean|25.70|25.7|Standard Deviation|5.34|5.34|||
3755461|NCT01967225|3589882|B4|||Body Mass Index (BMI)||kg/m^2|Mean|22.35|22.35|Standard Deviation|0.64|0.64|||
3755462|NCT01967225|3589883|B3|||Body Mass Index (BMI)||kg/m^2|Mean|30.75|30.75|Standard Deviation|11.19|11.19|||
3755463|NCT01967225|3589884|B2|||Body Mass Index (BMI)||kg/m^2|Mean|25.72|25.72|Standard Deviation|5.80|5.8|||
3755464|NCT01967225|3589885|B1|||Body Mass Index (BMI)||kg/m^2|Mean|25.52|25.52|Standard Deviation|4.70|4.7|||
3755465|NCT01967225|3589881|B5||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3755466|NCT01967225|3589882|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3755467|NCT01967225|3589883|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3755468|NCT01967225|3589884|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3755469|NCT01967225|3589885|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3755470|NCT01967225|3589881|B5||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3755471|NCT01967225|3589882|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3755472|NCT01967225|3589883|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3755473|NCT01967225|3589884|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3755474|NCT01967225|3589885|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3755475|NCT01967225|3589881|B5||> 75 years|Age, Customized||Participants|Count of Participants|27|27.0||||||
3755476|NCT01967225|3589882|B4||> 75 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3755477|NCT01967225|3589883|B3||> 75 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3755478|NCT01967225|3589884|B2||> 75 years|Age, Customized||Participants|Count of Participants|10|10.0||||||
3755479|NCT01967225|3589885|B1||> 75 years|Age, Customized||Participants|Count of Participants|17|17.0||||||
3755480|NCT01967225|3589881|B5||65 - 75 years|Age, Customized||Participants|Count of Participants|43|43.0||||||
3755481|NCT01967225|3589882|B4||65 - 75 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
3755482|NCT01967225|3589883|B3||65 - 75 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
3755483|NCT01967225|3589884|B2||65 - 75 years|Age, Customized||Participants|Count of Participants|9|9.0||||||
3755484|NCT01967225|3589885|B1||65 - 75 years|Age, Customized||Participants|Count of Participants|31|31.0||||||
3755485|NCT01967225|3589881|B5||< 65 years|Age, Customized||Participants|Count of Participants|54|54.0||||||
3755486|NCT01967225|3589882|B4||< 65 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3755487|NCT01967225|3589883|B3||< 65 years|Age, Customized||Participants|Count of Participants|3|3.0||||||
3755488|NCT01967225|3589884|B2||< 65 years|Age, Customized||Participants|Count of Participants|20|20.0||||||
3755489|NCT01967225|3589885|B1||< 65 years|Age, Customized||Participants|Count of Participants|31|31.0||||||
3755490|NCT01967173|3589910|B9|||Childhood Asthma Control Test|Childhood Asthma Control Test is for children 4-11 years of age: The score is calculated as the sum total of a 7-item questionnaire. Four items ranges from 0 (poor control) to 3 (good control) and three items ranges from 0 (poor control) to 5 (good control) so so that the range of the total score is 0 to 27. Scores below 20 indicate that asthma is not well controlled.|units on a scale|Mean|21.4|21.4|Standard Deviation|3.8|3.8|||
3755491|NCT01967173|3589915|B4|||Childhood Asthma Control Test|Childhood Asthma Control Test is for children 4-11 years of age: The score is calculated as the sum total of a 7-item questionnaire. Four items ranges from 0 (poor control) to 3 (good control) and three items ranges from 0 (poor control) to 5 (good control) so so that the range of the total score is 0 to 27. Scores below 20 indicate that asthma is not well controlled.|units on a scale|Mean|22.1|22.1|Standard Deviation|3.6|3.6|||
3755492|NCT01967173|3589916|B3|||Childhood Asthma Control Test|Childhood Asthma Control Test is for children 4-11 years of age: The score is calculated as the sum total of a 7-item questionnaire. Four items ranges from 0 (poor control) to 3 (good control) and three items ranges from 0 (poor control) to 5 (good control) so so that the range of the total score is 0 to 27. Scores below 20 indicate that asthma is not well controlled.|units on a scale|Mean|20.7|20.7|Standard Deviation|4.1|4.1|||
3755493|NCT01967173|3589917|B2|||Childhood Asthma Control Test|Childhood Asthma Control Test is for children 4-11 years of age: The score is calculated as the sum total of a 7-item questionnaire. Four items ranges from 0 (poor control) to 3 (good control) and three items ranges from 0 (poor control) to 5 (good control) so so that the range of the total score is 0 to 27. Scores below 20 indicate that asthma is not well controlled.|units on a scale|Mean|21.2|21.2|Standard Deviation|3.6|3.6|||
3755494|NCT01967173|3589918|B1|||Childhood Asthma Control Test|Childhood Asthma Control Test is for children 4-11 years of age: The score is calculated as the sum total of a 7-item questionnaire. Four items ranges from 0 (poor control) to 3 (good control) and three items ranges from 0 (poor control) to 5 (good control) so so that the range of the total score is 0 to 27. Scores below 20 indicate that asthma is not well controlled.|units on a scale|Mean|21.5|21.5|Standard Deviation|3.7|3.7|||
3755495|NCT01967173|3589910|B9|||Asthma Control Test|Asthma Control Test: The score is calculated as the sum total of a 5-item questionnaire. Each item ranges from 1 (poor control) to 5 (good control) so that the range of the total score is 5 to 25. Scores below 20 indicate that asthma is not well controlled.|units on a scale|Mean|18.9|18.9|Standard Deviation|3.8|3.8|||
3755496|NCT01967173|3589911|B8|||Asthma Control Test|Asthma Control Test: The score is calculated as the sum total of a 5-item questionnaire. Each item ranges from 1 (poor control) to 5 (good control) so that the range of the total score is 5 to 25. Scores below 20 indicate that asthma is not well controlled.|units on a scale|Mean|18.8|18.8|Standard Deviation|3.8|3.8|||
3755541|NCT01967173|3589915|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755497|NCT01967173|3589912|B7|||Asthma Control Test|Asthma Control Test: The score is calculated as the sum total of a 5-item questionnaire. Each item ranges from 1 (poor control) to 5 (good control) so that the range of the total score is 5 to 25. Scores below 20 indicate that asthma is not well controlled.|units on a scale|Mean|19.2|19.2|Standard Deviation|3.7|3.7|||
3755498|NCT01967173|3589913|B6|||Asthma Control Test|Asthma Control Test: The score is calculated as the sum total of a 5-item questionnaire. Each item ranges from 1 (poor control) to 5 (good control) so that the range of the total score is 5 to 25. Scores below 20 indicate that asthma is not well controlled.|units on a scale|Mean|18.6|18.6|Standard Deviation|3.9|3.9|||
3755499|NCT01967173|3589914|B5|||Asthma Control Test|Asthma Control Test: The score is calculated as the sum total of a 5-item questionnaire. Each item ranges from 1 (poor control) to 5 (good control) so that the range of the total score is 5 to 25. Scores below 20 indicate that asthma is not well controlled.|units on a scale|Mean|18.9|18.9|Standard Deviation|3.8|3.8|||
3755500|NCT01967173|3589910|B9|||Forced expiratory volume at one second (FEV1) Percent of Predicted|FEV1, expressed as percent of predicted FEV1 based on age, sex, race, and height.|percent|Mean|89.3|89.3|Standard Deviation|18.1|18.1|||
3755501|NCT01967173|3589911|B8|||Forced expiratory volume at one second (FEV1) Percent of Predicted|FEV1, expressed as percent of predicted FEV1 based on age, sex, race, and height.|percent|Mean|83.4|83.4|Standard Deviation|18|18.0|||
3755502|NCT01967173|3589912|B7|||Forced expiratory volume at one second (FEV1) Percent of Predicted|FEV1, expressed as percent of predicted FEV1 based on age, sex, race, and height.|percent|Mean|83.7|83.7|Standard Deviation|17.3|17.3|||
3755503|NCT01967173|3589913|B6|||Forced expiratory volume at one second (FEV1) Percent of Predicted|FEV1, expressed as percent of predicted FEV1 based on age, sex, race, and height.|percent|Mean|82.9|82.9|Standard Deviation|15.5|15.5|||
3755504|NCT01967173|3589914|B5|||Forced expiratory volume at one second (FEV1) Percent of Predicted|FEV1, expressed as percent of predicted FEV1 based on age, sex, race, and height.|percent|Mean|83.8|83.8|Standard Deviation|19.1|19.1|||
3755505|NCT01967173|3589915|B4|||Forced expiratory volume at one second (FEV1) Percent of Predicted|FEV1, expressed as percent of predicted FEV1 based on age, sex, race, and height.|percent|Mean|96.2|96.2|Standard Deviation|19.1|19.1|||
3755506|NCT01967173|3589916|B3|||Forced expiratory volume at one second (FEV1) Percent of Predicted|FEV1, expressed as percent of predicted FEV1 based on age, sex, race, and height.|percent|Mean|95|95.0|Standard Deviation|13.6|13.6|||
3755507|NCT01967173|3589917|B2|||Forced expiratory volume at one second (FEV1) Percent of Predicted|FEV1, expressed as percent of predicted FEV1 based on age, sex, race, and height.|percent|Mean|92.6|92.6|Standard Deviation|17.9|17.9|||
3755508|NCT01967173|3589918|B1|||Forced expiratory volume at one second (FEV1) Percent of Predicted|FEV1, expressed as percent of predicted FEV1 based on age, sex, race, and height.|percent|Mean|98.1|98.1|Standard Deviation|15.4|15.4|||
3755509|NCT01967173|3589910|B9|United States||Region of Enrollment||participants|Number|574|574.0||||||
3755510|NCT01967173|3589911|B8|United States||Region of Enrollment||participants|Number|74|74.0||||||
3755511|NCT01967173|3589912|B7|United States||Region of Enrollment||participants|Number|75|75.0||||||
3755512|NCT01967173|3589913|B6|United States||Region of Enrollment||participants|Number|72|72.0||||||
3755513|NCT01967173|3589914|B5|United States||Region of Enrollment||participants|Number|73|73.0||||||
3755514|NCT01967173|3589915|B4|United States||Region of Enrollment||participants|Number|71|71.0||||||
3755515|NCT01967173|3589916|B3|United States||Region of Enrollment||participants|Number|71|71.0||||||
3755516|NCT01967173|3589917|B2|United States||Region of Enrollment||participants|Number|69|69.0||||||
3755517|NCT01967173|3589918|B1|United States||Region of Enrollment||participants|Number|69|69.0||||||
3755518|NCT01967173|3589910|B9|Other||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3755519|NCT01967173|3589911|B8|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3755520|NCT01967173|3589912|B7|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3755521|NCT01967173|3589913|B6|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3755522|NCT01967173|3589914|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3755523|NCT01967173|3589915|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3755524|NCT01967173|3589916|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3755525|NCT01967173|3589917|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3755526|NCT01967173|3589918|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3755527|NCT01967173|3589910|B9|Black||Race/Ethnicity, Customized||Participants|Count of Participants|549|549.0||||||
3755528|NCT01967173|3589911|B8|Black||Race/Ethnicity, Customized||Participants|Count of Participants|73|73.0||||||
3755529|NCT01967173|3589912|B7|Black||Race/Ethnicity, Customized||Participants|Count of Participants|74|74.0||||||
3755530|NCT01967173|3589913|B6|Black||Race/Ethnicity, Customized||Participants|Count of Participants|71|71.0||||||
3755531|NCT01967173|3589914|B5|Black||Race/Ethnicity, Customized||Participants|Count of Participants|69|69.0||||||
3755532|NCT01967173|3589915|B4|Black||Race/Ethnicity, Customized||Participants|Count of Participants|66|66.0||||||
3755533|NCT01967173|3589916|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|68|68.0||||||
3755534|NCT01967173|3589917|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|65|65.0||||||
3755535|NCT01967173|3589918|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|63|63.0||||||
3755536|NCT01967173|3589910|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755537|NCT01967173|3589911|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755538|NCT01967173|3589912|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755539|NCT01967173|3589913|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755540|NCT01967173|3589914|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755542|NCT01967173|3589916|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755543|NCT01967173|3589917|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755544|NCT01967173|3589918|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755545|NCT01967173|3589910|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|541|541.0||||||
3755546|NCT01967173|3589911|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3755547|NCT01967173|3589912|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3755548|NCT01967173|3589913|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3755549|NCT01967173|3589914|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3755550|NCT01967173|3589915|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3755551|NCT01967173|3589916|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3755552|NCT01967173|3589917|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3755553|NCT01967173|3589918|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3755554|NCT01967173|3589910|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3755555|NCT01967173|3589911|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3755556|NCT01967173|3589912|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3755557|NCT01967173|3589913|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3755558|NCT01967173|3589914|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3755559|NCT01967173|3589915|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3755560|NCT01967173|3589916|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3755561|NCT01967173|3589917|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3755562|NCT01967173|3589918|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3755563|NCT01967173|3589910|B9||Male|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
3755564|NCT01967173|3589911|B8||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3755565|NCT01967173|3589912|B7||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3755566|NCT01967173|3589913|B6||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3755567|NCT01967173|3589914|B5||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3755568|NCT01967173|3589915|B4||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3755569|NCT01967173|3589916|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3755570|NCT01967173|3589917|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3755571|NCT01967173|3589918|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3755572|NCT01967173|3589910|B9||Female|Sex: Female, Male||Participants|Count of Participants|309|309.0||||||
3755573|NCT01967173|3589911|B8||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3755574|NCT01967173|3589912|B7||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3755575|NCT01967173|3589913|B6||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3755576|NCT01967173|3589914|B5||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3755577|NCT01967173|3589915|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3755578|NCT01967173|3589916|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3755579|NCT01967173|3589917|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3755580|NCT01967173|3589918|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3755581|NCT01967173|3589910|B9|||Age||years|Mean|23.2|23.2|Standard Deviation|18.5|18.5|||
3755582|NCT01967173|3589911|B8|||Age||years|Mean|35.6|35.6|Standard Deviation|16.0|16.0|||
3755583|NCT01967173|3589912|B7|||Age||years|Mean|39.3|39.3|Standard Deviation|16.0|16.0|||
3755584|NCT01967173|3589913|B6|||Age||years|Mean|38.5|38.5|Standard Deviation|15.9|15.9|||
3755585|NCT01967173|3589914|B5|||Age||years|Mean|38.5|38.5|Standard Deviation|16.5|16.5|||
3755586|NCT01967173|3589915|B4|||Age||years|Mean|8.4|8.4|Standard Deviation|1.8|1.8|||
3755587|NCT01967173|3589916|B3|||Age||years|Mean|8.4|8.4|Standard Deviation|1.9|1.9|||
3755588|NCT01967173|3589917|B2|||Age||years|Mean|8.5|8.5|Standard Deviation|1.7|1.7|||
3755589|NCT01967173|3589918|B1|||Age||years|Mean|8.7|8.7|Standard Deviation|2.0|2.0|||
3755590|NCT01967147|3589937|B3|||IDEEL Treatment Inconvenience|The IDEEL is a 10-item questionnaire designed to assess the subject's general satisfaction with treatment use. The subject responded to treatment inconvenience questions (Questions 6, 8-10) using a 0-4 Likert-type scale, where 0=All of the time and 4=None of the time. The IDEEL treatment inconvenience score was calculated as the sum of the responses from Questions 6, 8-10 divided by the number of questions (6, 8-10) answered, multiplied by 25, for a resultant overall score of 0-100.|units on a scale|Mean|75.60|75.6|Standard Deviation|23.40|23.4|||
3755591|NCT01967147|3589938|B2|||IDEEL Treatment Inconvenience|The IDEEL is a 10-item questionnaire designed to assess the subject's general satisfaction with treatment use. The subject responded to treatment inconvenience questions (Questions 6, 8-10) using a 0-4 Likert-type scale, where 0=All of the time and 4=None of the time. The IDEEL treatment inconvenience score was calculated as the sum of the responses from Questions 6, 8-10 divided by the number of questions (6, 8-10) answered, multiplied by 25, for a resultant overall score of 0-100.|units on a scale|Mean|74.48|74.48|Standard Deviation|24.85|24.85|||
3755621|NCT01967121|3589958|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3755592|NCT01967147|3589939|B1|||IDEEL Treatment Inconvenience|The IDEEL is a 10-item questionnaire designed to assess the subject's general satisfaction with treatment use. The subject responded to treatment inconvenience questions (Questions 6, 8-10) using a 0-4 Likert-type scale, where 0=All of the time and 4=None of the time. The IDEEL treatment inconvenience score was calculated as the sum of the responses from Questions 6, 8-10 divided by the number of questions (6, 8-10) answered, multiplied by 25, for a resultant overall score of 0-100.|units on a scale|Mean|76.61|76.61|Standard Deviation|22.08|22.08|||
3755593|NCT01967147|3589937|B3|||Impact of Dry Eye on Everyday Life (IDEEL) Treatment Effectiveness Score|The IDEEL is a 10-item questionnaire designed to assess the subject's general satisfaction with treatment use. The subject responded to treatment effectiveness questions (Questions 2-5) using a 0-4 Likert-type scale, where 0=None of the time and 4=All of the time. The IDEEL treatment effectiveness score was calculated as the sum of the responses from Questions 2-5 divided by the number of questions (2-5) answered, multiplied by 25, for a resultant overall score of 0-100.|units on a scale|Mean|45.35|45.35|Standard Deviation|27.52|27.52|||
3755594|NCT01967147|3589938|B2|||Impact of Dry Eye on Everyday Life (IDEEL) Treatment Effectiveness Score|The IDEEL is a 10-item questionnaire designed to assess the subject's general satisfaction with treatment use. The subject responded to treatment effectiveness questions (Questions 2-5) using a 0-4 Likert-type scale, where 0=None of the time and 4=All of the time. The IDEEL treatment effectiveness score was calculated as the sum of the responses from Questions 2-5 divided by the number of questions (2-5) answered, multiplied by 25, for a resultant overall score of 0-100.|units on a scale|Mean|46.15|46.15|Standard Deviation|27.86|27.86|||
3755595|NCT01967147|3589939|B1|||Impact of Dry Eye on Everyday Life (IDEEL) Treatment Effectiveness Score|The IDEEL is a 10-item questionnaire designed to assess the subject's general satisfaction with treatment use. The subject responded to treatment effectiveness questions (Questions 2-5) using a 0-4 Likert-type scale, where 0=None of the time and 4=All of the time. The IDEEL treatment effectiveness score was calculated as the sum of the responses from Questions 2-5 divided by the number of questions (2-5) answered, multiplied by 25, for a resultant overall score of 0-100.|units on a scale|Mean|44.63|44.63|Standard Deviation|27.32|27.32|||
3755596|NCT01967147|3589937|B3|||Ocular surface disease index (OSDI)|The OSDI is a 12-item quality of life questionnaire designed to assess ocular surface symptoms, their severity, and their impact on the subject's ability to function. Each item was scored by the subject on a 0-4 Likert-type scale (0=None, 4=All of the Time), with a resultant overall score of 0-100 (0=no disability, 100=complete disability).|units on a scale|Mean|39.30|39.3|Standard Deviation|17.42|17.42|||
3755597|NCT01967147|3589938|B2|||Ocular surface disease index (OSDI)|The OSDI is a 12-item quality of life questionnaire designed to assess ocular surface symptoms, their severity, and their impact on the subject's ability to function. Each item was scored by the subject on a 0-4 Likert-type scale (0=None, 4=All of the Time), with a resultant overall score of 0-100 (0=no disability, 100=complete disability).|units on a scale|Mean|38.27|38.27|Standard Deviation|17.39|17.39|||
3755598|NCT01967147|3589939|B1|||Ocular surface disease index (OSDI)|The OSDI is a 12-item quality of life questionnaire designed to assess ocular surface symptoms, their severity, and their impact on the subject's ability to function. Each item was scored by the subject on a 0-4 Likert-type scale (0=None, 4=All of the Time), with a resultant overall score of 0-100 (0=no disability, 100=complete disability).|units on a scale|Mean|40.24|40.24|Standard Deviation|17.48|17.48|||
3755599|NCT01967147|3589937|B3|||Total Ocular Surface Staining (TOSS) Score|The TOSS score (a cumulative cornea and conjunctival staining score) was assessed by the investigator using ophthalmic dye and a biomicroscope. Three areas of the ocular surface were graded for dryness on a 0-5 scale (0=Absent, 5=Severe), with a resultant overall score of 0-15.|units on a scale|Mean|3.40|3.4|Standard Deviation|2.25|2.25|||
3755600|NCT01967147|3589938|B2|||Total Ocular Surface Staining (TOSS) Score|The TOSS score (a cumulative cornea and conjunctival staining score) was assessed by the investigator using ophthalmic dye and a biomicroscope. Three areas of the ocular surface were graded for dryness on a 0-5 scale (0=Absent, 5=Severe), with a resultant overall score of 0-15.|units on a scale|Mean|3.35|3.35|Standard Deviation|2.38|2.38|||
3755601|NCT01967147|3589939|B1|||Total Ocular Surface Staining (TOSS) Score|The TOSS score (a cumulative cornea and conjunctival staining score) was assessed by the investigator using ophthalmic dye and a biomicroscope. Three areas of the ocular surface were graded for dryness on a 0-5 scale (0=Absent, 5=Severe), with a resultant overall score of 0-15.|units on a scale|Mean|3.45|3.45|Standard Deviation|2.14|2.14|||
3755602|NCT01967147|3589937|B3|||Tear Film Break-up Time (TFBUT)||seconds|Mean|3.72|3.72|Standard Deviation|1.48|1.48|||
3755603|NCT01967147|3589938|B2|||Tear Film Break-up Time (TFBUT)||seconds|Mean|3.71|3.71|Standard Deviation|1.59|1.59|||
3755604|NCT01967147|3589939|B1|||Tear Film Break-up Time (TFBUT)||seconds|Mean|3.73|3.73|Standard Deviation|1.37|1.37|||
3755605|NCT01967147|3589937|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3755606|NCT01967147|3589938|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3755607|NCT01967147|3589939|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3755608|NCT01967147|3589937|B3||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3755609|NCT01967147|3589938|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3755610|NCT01967147|3589939|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3755611|NCT01967147|3589937|B3|||Age||years|Mean|59.0|59.0|Standard Deviation|14.7|14.7|||
3755612|NCT01967147|3589938|B2|||Age||years|Mean|58.4|58.4|Standard Deviation|14.0|14.0|||
3755613|NCT01967147|3589939|B1|||Age||years|Mean|59.5|59.5|Standard Deviation|15.5|15.5|||
3755614|NCT01967121|3589955|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3755615|NCT01967121|3589956|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3755616|NCT01967121|3589957|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3755617|NCT01967121|3589958|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3755618|NCT01967121|3589955|B4||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3755619|NCT01967121|3589956|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3755620|NCT01967121|3589957|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3755622|NCT01967121|3589955|B4|||Age||years|Mean|19.64|19.64|Standard Deviation|1.61|1.61|||
3755623|NCT01967121|3589956|B3|||Age||years|Mean|19.78|19.78|Standard Deviation|1.89|1.89|||
3755624|NCT01967121|3589957|B2|||Age||years|Mean|19.61|19.61|Standard Deviation|1.68|1.68|||
3755625|NCT01967121|3589958|B1|||Age||years|Mean|19.43|19.43|Standard Deviation|1.25|1.25|||
3755626|NCT01967069|3589968|B3|||Participants with Moderate Psoriasis According to the Investigator's Global Assessment (IGA)||Participants|Count of Participants|277|277.0||||||
3755627|NCT01967069|3589969|B2|||Participants with Moderate Psoriasis According to the Investigator's Global Assessment (IGA)||Participants|Count of Participants|95|95.0||||||
3755628|NCT01967069|3589970|B1|||Participants with Moderate Psoriasis According to the Investigator's Global Assessment (IGA)||Participants|Count of Participants|182|182.0||||||
3755629|NCT01967069|3589968|B3|||% Body Surface Area||Percent|Mean|13.6|13.6|Standard Deviation|3.64|3.64|||
3755630|NCT01967069|3589969|B2|||% Body Surface Area||Percent|Mean|13.4|13.4|Standard Deviation|3.49|3.49|||
3755631|NCT01967069|3589970|B1|||% Body Surface Area||Percent|Mean|13.7|13.7|Standard Deviation|3.72|3.72|||
3755632|NCT01967069|3589968|B3|United States||Region of Enrollment||participants|Number|277|277.0||||||
3755633|NCT01967069|3589969|B2|United States||Region of Enrollment||participants|Number|95|95.0||||||
3755634|NCT01967069|3589970|B1|United States||Region of Enrollment||participants|Number|182|182.0||||||
3755635|NCT01967069|3589968|B3||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3755636|NCT01967069|3589969|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3755637|NCT01967069|3589970|B1||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3755638|NCT01967069|3589968|B3||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3755639|NCT01967069|3589969|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3755640|NCT01967069|3589970|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3755641|NCT01967069|3589968|B3|||Age||years|Mean|50.2|50.2|Standard Deviation|14.10|14.1|||
3755642|NCT01967069|3589969|B2|||Age||years|Mean|49.9|49.9|Standard Deviation|12.90|12.9|||
3755643|NCT01967069|3589970|B1|||Age||years|Mean|50.3|50.3|Standard Deviation|14.72|14.72|||
3755644|NCT01966926|3589977|B3|||Body Mass Index|Body mass index (BMI) was calculated from height and weight measured by the investigator at baseline.|kg/m^2|Mean|31.04|31.04|Standard Deviation|3.12|3.12|||
3755645|NCT01966926|3589978|B2|||Body Mass Index|Body mass index (BMI) was calculated from height and weight measured by the investigator at baseline.|kg/m^2|Mean|31.08|31.08|Standard Deviation|3.37|3.37|||
3755646|NCT01966926|3589979|B1|||Body Mass Index|Body mass index (BMI) was calculated from height and weight measured by the investigator at baseline.|kg/m^2|Mean|30.99|30.99|Standard Deviation|2.97|2.97|||
3755647|NCT01966926|3589977|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3755648|NCT01966926|3589978|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3755649|NCT01966926|3589979|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3755650|NCT01966926|3589977|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3755651|NCT01966926|3589978|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3755652|NCT01966926|3589979|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3755653|NCT01966926|3589977|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3755654|NCT01966926|3589978|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3755655|NCT01966926|3589979|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3755656|NCT01966926|3589977|B3|||Age||years|Mean|45.7|45.7|Standard Deviation|11.7|11.7|||
3755657|NCT01966926|3589978|B2|||Age||years|Mean|46.4|46.4|Standard Deviation|13.8|13.8|||
3755658|NCT01966926|3589979|B1|||Age||years|Mean|45.0|45.0|Standard Deviation|9.5|9.5|||
3755659|NCT01966926|3589977|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3755660|NCT01966926|3589978|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3755661|NCT01966926|3589979|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3755662|NCT01966926|3589977|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3755663|NCT01966926|3589978|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3755664|NCT01966926|3589979|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3755665|NCT01966926|3589977|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3755666|NCT01966926|3589978|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3755667|NCT01966926|3589979|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3755668|NCT01966770|3589996|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3755669|NCT01966770|3589996|B1|Non-Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3755670|NCT01966770|3589996|B1|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3755671|NCT01966770|3589996|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3755672|NCT01966770|3589996|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3755673|NCT01966770|3589996|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3755674|NCT01966770|3589996|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3755675|NCT01966770|3589996|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3755676|NCT01966718|3590105|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3755677|NCT01966718|3590105|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755678|NCT01966718|3590105|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755679|NCT01966718|3590105|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3755680|NCT01966718|3590105|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3755681|NCT01966718|3590105|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755682|NCT01966718|3590105|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755683|NCT01966718|3590105|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755684|NCT01966718|3590105|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3755685|NCT01966718|3590105|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3755686|NCT01966718|3590105|B1|||Age||years|Mean|64.6|64.6|Full Range|||46.0|80.0|
3755687|NCT01966718|3590105|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3755688|NCT01966718|3590105|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3755689|NCT01966718|3590105|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3755690|NCT01966458|3590113|B3|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3755691|NCT01966458|3590114|B2|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3755692|NCT01966458|3590115|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3755693|NCT01966458|3590113|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|339|339.0||||||
3755694|NCT01966458|3590114|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|118|118.0||||||
3755695|NCT01966458|3590115|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|221|221.0||||||
3755696|NCT01966458|3590113|B3|Race|Native Hawaiian/Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3755697|NCT01966458|3590114|B2|Race|Native Hawaiian/Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3755698|NCT01966458|3590115|B1|Race|Native Hawaiian/Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3755699|NCT01966458|3590113|B3|Race|Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|105|105.0||||||
3755700|NCT01966458|3590114|B2|Race|Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3755701|NCT01966458|3590115|B1|Race|Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|72|72.0||||||
3755702|NCT01966458|3590113|B3|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3755703|NCT01966458|3590114|B2|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3755704|NCT01966458|3590115|B1|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3755705|NCT01966458|3590113|B3|Race|American Indian/Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3755706|NCT01966458|3590114|B2|Race|American Indian/Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3755707|NCT01966458|3590115|B1|Race|American Indian/Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3755708|NCT01966458|3590113|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755709|NCT01966458|3590114|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755710|NCT01966458|3590115|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755711|NCT01966458|3590113|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|442|442.0||||||
3755712|NCT01966458|3590114|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|154|154.0||||||
3755713|NCT01966458|3590115|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|288|288.0||||||
3755714|NCT01966458|3590113|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3755715|NCT01966458|3590114|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3755716|NCT01966458|3590115|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3755717|NCT01966458|3590113|B3||Male|Sex: Female, Male||Participants|Count of Participants|377|377.0||||||
3755718|NCT01966458|3590114|B2||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3755719|NCT01966458|3590115|B1||Male|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
3755720|NCT01966458|3590113|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3755721|NCT01966458|3590114|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3755722|NCT01966458|3590115|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3755723|NCT01966458|3590113|B3|||Age||years|Mean|63.6|63.6|Standard Deviation|11.34|11.34|||
3755724|NCT01966458|3590114|B2|||Age||years|Mean|64.2|64.2|Standard Deviation|11.14|11.14|||
3755725|NCT01966458|3590115|B1|||Age||years|Mean|63.3|63.3|Standard Deviation|11.44|11.44|||
3755726|NCT01966432|3590125|B4|United States||Region of Enrollment||Participants|Count of Participants|98|98.0||||||
3755727|NCT01966432|3590126|B3|United States||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
3755728|NCT01966432|3590127|B2|United States||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3755729|NCT01966432|3590128|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3755730|NCT01966432|3590125|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3755731|NCT01966432|3590126|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3755732|NCT01966432|3590127|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3755733|NCT01966432|3590128|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3755734|NCT01966432|3590125|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755735|NCT01966432|3590126|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755736|NCT01966432|3590127|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755737|NCT01966432|3590128|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755738|NCT01966432|3590125|B4||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3755739|NCT01966432|3590126|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3755740|NCT01966432|3590127|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3755741|NCT01966432|3590128|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3755742|NCT01966432|3590125|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3755743|NCT01966432|3590126|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3755744|NCT01966432|3590127|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3755745|NCT01966432|3590128|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3755746|NCT01966432|3590125|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755747|NCT01966432|3590126|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755748|NCT01966432|3590127|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755749|NCT01966432|3590128|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755750|NCT01966432|3590125|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3755751|NCT01966432|3590126|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3755752|NCT01966432|3590127|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755753|NCT01966432|3590128|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755754|NCT01966432|3590125|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755755|NCT01966432|3590126|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755756|NCT01966432|3590127|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755757|NCT01966432|3590128|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755758|NCT01966432|3590125|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3755759|NCT01966432|3590126|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755760|NCT01966432|3590127|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3755761|NCT01966432|3590128|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755762|NCT01966432|3590125|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
3755763|NCT01966432|3590126|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3755764|NCT01966432|3590127|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3755765|NCT01966432|3590128|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3755766|NCT01966432|3590125|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3755767|NCT01966432|3590126|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3755768|NCT01966432|3590127|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3755769|NCT01966432|3590128|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3755770|NCT01966432|3590125|B4||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3755771|NCT01966432|3590126|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3755772|NCT01966432|3590127|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3755773|NCT01966432|3590128|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3755774|NCT01966432|3590125|B4||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3755775|NCT01966432|3590126|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3755776|NCT01966432|3590127|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3755777|NCT01966432|3590128|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3755778|NCT01966432|3590125|B4|||Age||years|Mean|56|56.0|Standard Deviation|11.0|11.0|||
3755779|NCT01966432|3590126|B3|||Age||years|Mean|60|60.0|Standard Deviation|12.0|12.0|||
3755780|NCT01966432|3590127|B2|||Age||years|Mean|51|51.0|Standard Deviation|9.1|9.1|||
3755781|NCT01966432|3590128|B1|||Age||years|Mean|51|51.0|Standard Deviation|5.8|5.8|||
3755782|NCT01966432|3590125|B4||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3755783|NCT01966432|3590126|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3755784|NCT01966432|3590127|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3755785|NCT01966432|3590128|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3755786|NCT01966432|3590125|B4||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
3755787|NCT01966432|3590126|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3755788|NCT01966432|3590127|B2||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3755789|NCT01966432|3590128|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3755790|NCT01966432|3590125|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3755791|NCT01966432|3590126|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3755792|NCT01966432|3590127|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3755793|NCT01966432|3590128|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3755794|NCT01966380|3590150|B1|Sweden||Region of Enrollment||participants|Number|6|6.0||||||
3755795|NCT01966380|3590150|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3755796|NCT01966380|3590150|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3755797|NCT01966380|3590150|B1|||Age||years|Mean|71|71.0|Inter-Quartile Range|||59.0|87.0|
3755798|NCT01966380|3590150|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3755799|NCT01966380|3590150|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3755800|NCT01966380|3590150|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3755801|NCT01966354|3590157|B4|||Cannulated IJV diameter (cm)||centimeters (cm)|Mean|1.20|1.2|Standard Deviation|0.3|0.3|||
3755802|NCT01966354|3590158|B3|||Cannulated IJV diameter (cm)||centimeters (cm)|Mean|1.10|1.1|Standard Deviation|0.2|0.2|||
3755803|NCT01966354|3590159|B2|||Cannulated IJV diameter (cm)||centimeters (cm)|Mean|1.20|1.2|Standard Deviation|0.3|0.3|||
3755804|NCT01966354|3590160|B1|||Cannulated IJV diameter (cm)||centimeters (cm)|Mean|1.23|1.23|Standard Deviation|0.3|0.3|||
3755805|NCT01966354|3590157|B4|Spain||Region of Enrollment||participants|Number|220|220.0||||||
3755806|NCT01966354|3590158|B3|Spain||Region of Enrollment||participants|Number|72|72.0||||||
3755807|NCT01966354|3590159|B2|Spain||Region of Enrollment||participants|Number|73|73.0||||||
3755808|NCT01966354|3590160|B1|Spain||Region of Enrollment||participants|Number|75|75.0||||||
3755809|NCT01966354|3590157|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755810|NCT01966354|3590158|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755811|NCT01966354|3590159|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755812|NCT01966354|3590160|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755813|NCT01966354|3590157|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755814|NCT01966354|3590158|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755815|NCT01966354|3590159|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755816|NCT01966354|3590160|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755817|NCT01966354|3590157|B4||White|Race (NIH/OMB)||Participants|Count of Participants|220|220.0||||||
3755818|NCT01966354|3590158|B3||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3755819|NCT01966354|3590159|B2||White|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3755820|NCT01966354|3590160|B1||White|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3755821|NCT01966354|3590157|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755822|NCT01966354|3590158|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755823|NCT01966354|3590159|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755824|NCT01966354|3590160|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755825|NCT01966354|3590157|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755826|NCT01966354|3590158|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755827|NCT01966354|3590159|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755828|NCT01966354|3590160|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755829|NCT01966354|3590157|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755830|NCT01966354|3590158|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755831|NCT01966354|3590159|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755832|NCT01966354|3590160|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755833|NCT01966354|3590157|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755834|NCT01966354|3590158|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755835|NCT01966354|3590159|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755836|NCT01966354|3590160|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755837|NCT01966354|3590157|B4||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3755838|NCT01966354|3590158|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3755839|NCT01966354|3590159|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3755840|NCT01966354|3590160|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3755841|NCT01966354|3590157|B4||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3755842|NCT01966354|3590158|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3755843|NCT01966354|3590159|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3755844|NCT01966354|3590160|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3755845|NCT01966354|3590157|B4|||Age||years|Mean|64.7|64.7|Standard Deviation|14.0|14.0|||
3755846|NCT01966354|3590158|B3|||Age||years|Mean|65.2|65.2|Standard Deviation|15.0|15.0|||
3755847|NCT01966354|3590159|B2|||Age||years|Mean|64.9|64.9|Standard Deviation|13.6|13.6|||
3755848|NCT01966354|3590160|B1|||Age||years|Mean|64|64.0|Standard Deviation|13.6|13.6|||
3755849|NCT01966159|3590185|B3|China||Region of Enrollment||participants|Number|412|412.0||||||
3755850|NCT01966159|3590186|B2|China||Region of Enrollment||participants|Number|207|207.0||||||
3755851|NCT01966159|3590187|B1|China||Region of Enrollment||participants|Number|205|205.0||||||
3755852|NCT01966159|3590185|B3||Male|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
3755853|NCT01966159|3590186|B2||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3755854|NCT01966159|3590187|B1||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3755855|NCT01966159|3590185|B3||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3755856|NCT01966159|3590186|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3755857|NCT01966159|3590187|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3755858|NCT01966159|3590185|B3|||Age||years|Mean|58.15|58.15|Standard Deviation|8.97|8.97|||
3755859|NCT01966159|3590186|B2|||Age||years|Mean|57.89|57.89|Standard Deviation|9.19|9.19|||
3755860|NCT01966159|3590187|B1|||Age||years|Mean|58.41|58.41|Standard Deviation|8.76|8.76|||
3755861|NCT01966120|3590198|B3|Germany||Region of Enrollment||participants|Number|87|87.0||||||
3755862|NCT01966120|3590199|B2|Germany||Region of Enrollment||participants|Number|32|32.0||||||
3755863|NCT01966120|3590200|B1|Germany||Region of Enrollment||participants|Number|55|55.0||||||
3755864|NCT01966120|3590198|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755865|NCT01966120|3590199|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755866|NCT01966120|3590200|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755867|NCT01966120|3590198|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755868|NCT01966120|3590199|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755869|NCT01966120|3590200|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755870|NCT01966120|3590198|B3||White|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3755871|NCT01966120|3590199|B2||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3755872|NCT01966120|3590200|B1||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3755873|NCT01966120|3590198|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755874|NCT01966120|3590199|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755875|NCT01966120|3590200|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755876|NCT01966120|3590198|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755877|NCT01966120|3590199|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755878|NCT01966120|3590200|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755879|NCT01966120|3590198|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755880|NCT01966120|3590199|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755881|NCT01966120|3590200|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755882|NCT01966120|3590198|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755883|NCT01966120|3590199|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755884|NCT01966120|3590200|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755885|NCT01966120|3590198|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755886|NCT01966120|3590199|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755887|NCT01966120|3590200|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755888|NCT01966120|3590198|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3755889|NCT01966120|3590199|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3755890|NCT01966120|3590200|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3755891|NCT01966120|3590198|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755892|NCT01966120|3590199|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755893|NCT01966120|3590200|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3755894|NCT01966120|3590198|B3||Male|Gender||Participants|Count of Participants|79|79.0||||||
3755895|NCT01966120|3590199|B2||Male|Gender||Participants|Count of Participants|29|29.0||||||
3755896|NCT01966120|3590200|B1||Male|Gender||Participants|Count of Participants|50|50.0||||||
3755897|NCT01966120|3590198|B3||Female|Gender||Participants|Count of Participants|8|8.0||||||
3755898|NCT01966120|3590199|B2||Female|Gender||Participants|Count of Participants|3|3.0||||||
3755899|NCT01966120|3590200|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
3755900|NCT01966120|3590198|B3||>=65 years|Age||Participants|Count of Participants|74|74.0||||||
3755901|NCT01966120|3590199|B2||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
3755902|NCT01966120|3590200|B1||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
3755903|NCT01966120|3590198|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3755904|NCT01966120|3590199|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3755905|NCT01966120|3590200|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3755906|NCT01966120|3590198|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3755907|NCT01966120|3590199|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3755908|NCT01966120|3590200|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3755909|NCT01966107|3590223|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3755910|NCT01966107|3590224|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3755911|NCT01966107|3590225|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3755912|NCT01966107|3590223|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|3253|3253.0||||||
3755913|NCT01966107|3590224|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|1650|1650.0||||||
3755914|NCT01966107|3590225|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|1603|1603.0||||||
3755915|NCT01966107|3590223|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|303|303.0||||||
3755916|NCT01966107|3590224|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|138|138.0||||||
3755917|NCT01966107|3590225|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|165|165.0||||||
3755918|NCT01966107|3590223|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3755919|NCT01966107|3590224|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3755920|NCT01966107|3590225|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3755921|NCT01966107|3590223|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3755922|NCT01966107|3590224|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3755923|NCT01966107|3590225|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3755924|NCT01966107|3590223|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3755925|NCT01966107|3590224|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3755926|NCT01966107|3590225|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3755927|NCT01966107|3590223|B3||Male|Sex: Female, Male||Participants|Count of Participants|2105|2105.0||||||
3755928|NCT01966107|3590224|B2||Male|Sex: Female, Male||Participants|Count of Participants|1046|1046.0||||||
3755929|NCT01966107|3590225|B1||Male|Sex: Female, Male||Participants|Count of Participants|1059|1059.0||||||
3755930|NCT01966107|3590223|B3||Female|Sex: Female, Male||Participants|Count of Participants|1484|1484.0||||||
3755931|NCT01966107|3590224|B2||Female|Sex: Female, Male||Participants|Count of Participants|752|752.0||||||
3755932|NCT01966107|3590225|B1||Female|Sex: Female, Male||Participants|Count of Participants|732|732.0||||||
3755933|NCT01966107|3590223|B3||>=70 years|Age, Customized||Participants|Count of Participants|1475|1475.0||||||
3755934|NCT01966107|3590224|B2||>=70 years|Age, Customized||Participants|Count of Participants|748|748.0||||||
3755935|NCT01966107|3590225|B1||>=70 years|Age, Customized||Participants|Count of Participants|727|727.0||||||
3755936|NCT01966107|3590223|B3||>=60 - <70 years|Age, Customized||Participants|Count of Participants|1449|1449.0||||||
3755937|NCT01966107|3590224|B2||>=60 - <70 years|Age, Customized||Participants|Count of Participants|725|725.0||||||
3755938|NCT01966107|3590225|B1||>=60 - <70 years|Age, Customized||Participants|Count of Participants|724|724.0||||||
3755939|NCT01966107|3590223|B3||>=40 - <60 years|Age, Customized||Participants|Count of Participants|665|665.0||||||
3755940|NCT01966107|3590224|B2||>=40 - <60 years|Age, Customized||Participants|Count of Participants|325|325.0||||||
3755941|NCT01966107|3590225|B1||>=40 - <60 years|Age, Customized||Participants|Count of Participants|340|340.0||||||
3755942|NCT01966107|3590223|B3|||Age||Years|Mean|67.2|67.2|Standard Deviation|8.4|8.4|||
3755943|NCT01966107|3590224|B2|||Age||Years|Mean|67.2|67.2|Standard Deviation|8.3|8.3|||
3755944|NCT01966107|3590225|B1|||Age||Years|Mean|67.1|67.1|Standard Deviation|8.5|8.5|||
3755945|NCT01966068|3590238|B3|Suburban||Medical Practice Setting||participants|Number|121|121.0||||||
3755946|NCT01966068|3590239|B2|Suburban||Medical Practice Setting||participants|Number|38|38.0||||||
3755947|NCT01966068|3590240|B1|Suburban||Medical Practice Setting||participants|Number|83|83.0||||||
3755948|NCT01966068|3590238|B3|Rural||Medical Practice Setting||participants|Number|52|52.0||||||
3755949|NCT01966068|3590239|B2|Rural||Medical Practice Setting||participants|Number|23|23.0||||||
3755950|NCT01966068|3590240|B1|Rural||Medical Practice Setting||participants|Number|29|29.0||||||
3755951|NCT01966068|3590238|B3|Urban||Medical Practice Setting||participants|Number|64|64.0||||||
3755952|NCT01966068|3590239|B2|Urban||Medical Practice Setting||participants|Number|20|20.0||||||
3755953|NCT01966068|3590240|B1|Urban||Medical Practice Setting||participants|Number|44|44.0||||||
3755954|NCT01966068|3590238|B3|Unknown||Child's Asthma Severity||participants|Number|118|118.0||||||
3755955|NCT01966068|3590239|B2|Unknown||Child's Asthma Severity||participants|Number|55|55.0||||||
3755956|NCT01966068|3590240|B1|Unknown||Child's Asthma Severity||participants|Number|63|63.0||||||
3755957|NCT01966068|3590238|B3|Moderate/Severe Persistent||Child's Asthma Severity||participants|Number|19|19.0||||||
3755958|NCT01966068|3590239|B2|Moderate/Severe Persistent||Child's Asthma Severity||participants|Number|2|2.0||||||
3755959|NCT01966068|3590240|B1|Moderate/Severe Persistent||Child's Asthma Severity||participants|Number|17|17.0||||||
3755960|NCT01966068|3590238|B3|Mild Persistent||Child's Asthma Severity||participants|Number|51|51.0||||||
3755961|NCT01966068|3590239|B2|Mild Persistent||Child's Asthma Severity||participants|Number|12|12.0||||||
3755962|NCT01966068|3590240|B1|Mild Persistent||Child's Asthma Severity||participants|Number|39|39.0||||||
3755963|NCT01966068|3590238|B3|Intermittent||Child's Asthma Severity||participants|Number|49|49.0||||||
3755964|NCT01966068|3590239|B2|Intermittent||Child's Asthma Severity||participants|Number|12|12.0||||||
3755965|NCT01966068|3590240|B1|Intermittent||Child's Asthma Severity||participants|Number|37|37.0||||||
3755966|NCT01966068|3590238|B3|Other||Parent's Relation to Child||participants|Number|9|9.0||||||
3755967|NCT01966068|3590239|B2|Other||Parent's Relation to Child||participants|Number|2|2.0||||||
3755968|NCT01966068|3590240|B1|Other||Parent's Relation to Child||participants|Number|7|7.0||||||
3755969|NCT01966068|3590238|B3|Mother||Parent's Relation to Child||participants|Number|228|228.0||||||
3755970|NCT01966068|3590239|B2|Mother||Parent's Relation to Child||participants|Number|79|79.0||||||
3755971|NCT01966068|3590240|B1|Mother||Parent's Relation to Child||participants|Number|149|149.0||||||
3755972|NCT01966068|3590238|B3|Unemployed||Parent Employment Status||participants|Number|24|24.0||||||
3755973|NCT01966068|3590239|B2|Unemployed||Parent Employment Status||participants|Number|9|9.0||||||
3755974|NCT01966068|3590240|B1|Unemployed||Parent Employment Status||participants|Number|15|15.0||||||
3755975|NCT01966068|3590238|B3|Working Without Pay||Parent Employment Status||participants|Number|43|43.0||||||
3755976|NCT01966068|3590239|B2|Working Without Pay||Parent Employment Status||participants|Number|18|18.0||||||
3755977|NCT01966068|3590240|B1|Working Without Pay||Parent Employment Status||participants|Number|25|25.0||||||
3755978|NCT01966068|3590238|B3|Self-Employed||Parent Employment Status||participants|Number|13|13.0||||||
3755979|NCT01966068|3590239|B2|Self-Employed||Parent Employment Status||participants|Number|8|8.0||||||
3755980|NCT01966068|3590240|B1|Self-Employed||Parent Employment Status||participants|Number|5|5.0||||||
3755981|NCT01966068|3590238|B3|Working Outside the Home||Parent Employment Status||participants|Number|157|157.0||||||
3755982|NCT01966068|3590239|B2|Working Outside the Home||Parent Employment Status||participants|Number|46|46.0||||||
3755983|NCT01966068|3590240|B1|Working Outside the Home||Parent Employment Status||participants|Number|111|111.0||||||
3755984|NCT01966068|3590238|B3|Bachelor's or Higher||Parent Education||participants|Number|122|122.0||||||
3755985|NCT01966068|3590239|B2|Bachelor's or Higher||Parent Education||participants|Number|29|29.0||||||
3755986|NCT01966068|3590240|B1|Bachelor's or Higher||Parent Education||participants|Number|93|93.0||||||
3755987|NCT01966068|3590238|B3|Some College/Associates||Parent Education||participants|Number|81|81.0||||||
3755988|NCT01966068|3590239|B2|Some College/Associates||Parent Education||participants|Number|35|35.0||||||
3755989|NCT01966068|3590240|B1|Some College/Associates||Parent Education||participants|Number|46|46.0||||||
3755990|NCT01966068|3590238|B3|High School or Less||Parent Education||participants|Number|34|34.0||||||
3755991|NCT01966068|3590239|B2|High School or Less||Parent Education||participants|Number|17|17.0||||||
3755992|NCT01966068|3590240|B1|High School or Less||Parent Education||participants|Number|17|17.0||||||
3755993|NCT01966068|3590238|B3|Unkown||Race/Ethnicity, Customized|Child's Race|participants|Number|3|3.0||||||
3755994|NCT01966068|3590239|B2|Unkown||Race/Ethnicity, Customized|Child's Race|participants|Number|1|1.0||||||
3755995|NCT01966068|3590240|B1|Unkown||Race/Ethnicity, Customized|Child's Race|participants|Number|2|2.0||||||
3755996|NCT01966068|3590238|B3|Other||Race/Ethnicity, Customized|Child's Race|participants|Number|11|11.0||||||
3755997|NCT01966068|3590239|B2|Other||Race/Ethnicity, Customized|Child's Race|participants|Number|4|4.0||||||
3755998|NCT01966068|3590240|B1|Other||Race/Ethnicity, Customized|Child's Race|participants|Number|7|7.0||||||
3755999|NCT01966068|3590238|B3|Asian||Race/Ethnicity, Customized|Child's Race|participants|Number|4|4.0||||||
3756000|NCT01966068|3590239|B2|Asian||Race/Ethnicity, Customized|Child's Race|participants|Number|0|0.0||||||
3756001|NCT01966068|3590240|B1|Asian||Race/Ethnicity, Customized|Child's Race|participants|Number|4|4.0||||||
3756002|NCT01966068|3590238|B3|Black/African American||Race/Ethnicity, Customized|Child's Race|participants|Number|75|75.0||||||
3756003|NCT01966068|3590239|B2|Black/African American||Race/Ethnicity, Customized|Child's Race|participants|Number|21|21.0||||||
3756004|NCT01966068|3590240|B1|Black/African American||Race/Ethnicity, Customized|Child's Race|participants|Number|54|54.0||||||
3756005|NCT01966068|3590238|B3|White||Race/Ethnicity, Customized|Child's Race|participants|Number|144|144.0||||||
3756006|NCT01966068|3590239|B2|White||Race/Ethnicity, Customized|Child's Race|participants|Number|55|55.0||||||
3756007|NCT01966068|3590240|B1|White||Race/Ethnicity, Customized|Child's Race|participants|Number|89|89.0||||||
3756008|NCT01966068|3590238|B3|Other||Race/Ethnicity, Customized|Parent's Race|participants|Number|17|17.0||||||
3756009|NCT01966068|3590239|B2|Other||Race/Ethnicity, Customized|Parent's Race|participants|Number|6|6.0||||||
3756010|NCT01966068|3590240|B1|Other||Race/Ethnicity, Customized|Parent's Race|participants|Number|11|11.0||||||
3756011|NCT01966068|3590238|B3|Asian||Race/Ethnicity, Customized|Parent's Race|participants|Number|4|4.0||||||
3756012|NCT01966068|3590239|B2|Asian||Race/Ethnicity, Customized|Parent's Race|participants|Number|0|0.0||||||
3756013|NCT01966068|3590240|B1|Asian||Race/Ethnicity, Customized|Parent's Race|participants|Number|4|4.0||||||
3756014|NCT01966068|3590238|B3|Black/African American||Race/Ethnicity, Customized|Parent's Race|participants|Number|68|68.0||||||
3756015|NCT01966068|3590239|B2|Black/African American||Race/Ethnicity, Customized|Parent's Race|participants|Number|20|20.0||||||
3756016|NCT01966068|3590240|B1|Black/African American||Race/Ethnicity, Customized|Parent's Race|participants|Number|48|48.0||||||
3756017|NCT01966068|3590238|B3|White||Race/Ethnicity, Customized|Parent's Race|participants|Number|148|148.0||||||
3756018|NCT01966068|3590239|B2|White||Race/Ethnicity, Customized|Parent's Race|participants|Number|55|55.0||||||
3756019|NCT01966068|3590240|B1|White||Race/Ethnicity, Customized|Parent's Race|participants|Number|93|93.0||||||
3756020|NCT01966068|3590238|B3||Male|Sex: Female, Male|Child's Gender|Participants|Count of Participants|136|136.0||||||
3756021|NCT01966068|3590239|B2||Male|Sex: Female, Male|Child's Gender|Participants|Count of Participants|51|51.0||||||
3756022|NCT01966068|3590240|B1||Male|Sex: Female, Male|Child's Gender|Participants|Count of Participants|85|85.0||||||
3756023|NCT01966068|3590238|B3||Female|Sex: Female, Male|Child's Gender|Participants|Count of Participants|101|101.0||||||
3756024|NCT01966068|3590239|B2||Female|Sex: Female, Male|Child's Gender|Participants|Count of Participants|30|30.0||||||
3756025|NCT01966068|3590240|B1||Female|Sex: Female, Male|Child's Gender|Participants|Count of Participants|71|71.0||||||
3756026|NCT01966068|3590238|B3|10-12 Years||Age, Customized|Child's Age|participants|Number|62|62.0||||||
3756027|NCT01966068|3590239|B2|10-12 Years||Age, Customized|Child's Age|participants|Number|21|21.0||||||
3756028|NCT01966068|3590240|B1|10-12 Years||Age, Customized|Child's Age|participants|Number|41|41.0||||||
3756029|NCT01966068|3590238|B3|6-9 Years||Age, Customized|Child's Age|participants|Number|175|175.0||||||
3756030|NCT01966068|3590239|B2|6-9 Years||Age, Customized|Child's Age|participants|Number|60|60.0||||||
3756031|NCT01966068|3590240|B1|6-9 Years||Age, Customized|Child's Age|participants|Number|115|115.0||||||
3756032|NCT01966068|3590238|B3|||Age|Parent's Age|years|Mean|37.6|37.6|Standard Deviation|6.0|6.0|||
3756033|NCT01966068|3590239|B2|||Age|Parent's Age|years|Mean|37.1|37.1|Standard Deviation|6.5|6.5|||
3756034|NCT01966068|3590240|B1|||Age|Parent's Age|years|Mean|38.1|38.1|Standard Deviation|5.5|5.5|||
3756035|NCT01966042|3590245|B1|Brazil||Region of Enrollment||participants|Number|13|13.0||||||
3756036|NCT01966042|3590245|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3756037|NCT01966042|3590245|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3756038|NCT01966042|3590245|B1|||Age||years|Mean|64|64.0|Standard Deviation|8|8.0|||
3756039|NCT01966003|3590252|B3|Grade 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|398|398.0||||||
3756040|NCT01966003|3590253|B2|Grade 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|197|197.0||||||
3756041|NCT01966003|3590254|B1|Grade 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|201|201.0||||||
3756042|NCT01966003|3590252|B3|Grade 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|244|244.0||||||
3756043|NCT01966003|3590253|B2|Grade 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|117|117.0||||||
3756044|NCT01966003|3590254|B1|Grade 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|127|127.0||||||
3756045|NCT01966003|3590252|B3|Asia Pacific/Other||Geographic Region||participants|Number|56|56.0||||||
3756046|NCT01966003|3590253|B2|Asia Pacific/Other||Geographic Region||participants|Number|26|26.0||||||
3756047|NCT01966003|3590254|B1|Asia Pacific/Other||Geographic Region||participants|Number|30|30.0||||||
3756048|NCT01966003|3590252|B3|North America||Geographic Region||participants|Number|57|57.0||||||
3756049|NCT01966003|3590253|B2|North America||Geographic Region||participants|Number|26|26.0||||||
3756050|NCT01966003|3590254|B1|North America||Geographic Region||participants|Number|31|31.0||||||
3756051|NCT01966003|3590252|B3|Western Europe||Geographic Region||participants|Number|154|154.0||||||
3756052|NCT01966003|3590253|B2|Western Europe||Geographic Region||participants|Number|76|76.0||||||
3756053|NCT01966003|3590254|B1|Western Europe||Geographic Region||participants|Number|78|78.0||||||
3756054|NCT01966003|3590252|B3|Eastern Europe||Geographic Region||participants|Number|375|375.0||||||
3756055|NCT01966003|3590253|B2|Eastern Europe||Geographic Region||participants|Number|186|186.0||||||
3756056|NCT01966003|3590254|B1|Eastern Europe||Geographic Region||participants|Number|189|189.0||||||
3756057|NCT01966003|3590252|B3|Other||Race/Ethnicity, Customized|Participants were allowed to choose multiple races.|participants|Number|6|6.0||||||
3756058|NCT01966003|3590253|B2|Other||Race/Ethnicity, Customized|Participants were allowed to choose multiple races.|participants|Number|2|2.0||||||
3756059|NCT01966003|3590254|B1|Other||Race/Ethnicity, Customized|Participants were allowed to choose multiple races.|participants|Number|4|4.0||||||
3756060|NCT01966003|3590252|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|Participants were allowed to choose multiple races.|participants|Number|1|1.0||||||
3756061|NCT01966003|3590253|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|Participants were allowed to choose multiple races.|participants|Number|0|0.0||||||
3756062|NCT01966003|3590254|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|Participants were allowed to choose multiple races.|participants|Number|1|1.0||||||
3756063|NCT01966003|3590252|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|Participants were allowed to choose multiple races.|participants|Number|2|2.0||||||
3756064|NCT01966003|3590253|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|Participants were allowed to choose multiple races.|participants|Number|0|0.0||||||
3756065|NCT01966003|3590254|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Participants were allowed to choose multiple races.|participants|Number|2|2.0||||||
3756066|NCT01966003|3590252|B3|Asian||Race/Ethnicity, Customized|Participants were allowed to choose multiple races.|participants|Number|13|13.0||||||
3756067|NCT01966003|3590253|B2|Asian||Race/Ethnicity, Customized|Participants were allowed to choose multiple races.|participants|Number|7|7.0||||||
3756068|NCT01966003|3590254|B1|Asian||Race/Ethnicity, Customized|Participants were allowed to choose multiple races.|participants|Number|6|6.0||||||
3756069|NCT01966003|3590252|B3|Black or African American||Race/Ethnicity, Customized|Participants were allowed to choose multiple races.|participants|Number|7|7.0||||||
3756070|NCT01966003|3590253|B2|Black or African American||Race/Ethnicity, Customized|Participants were allowed to choose multiple races.|participants|Number|5|5.0||||||
3756071|NCT01966003|3590254|B1|Black or African American||Race/Ethnicity, Customized|Participants were allowed to choose multiple races.|participants|Number|2|2.0||||||
3756072|NCT01966003|3590252|B3|White||Race/Ethnicity, Customized|Participants were allowed to choose multiple races.|participants|Number|615|615.0||||||
3756073|NCT01966003|3590253|B2|White||Race/Ethnicity, Customized|Participants were allowed to choose multiple races.|participants|Number|300|300.0||||||
3756074|NCT01966003|3590254|B1|White||Race/Ethnicity, Customized|Participants were allowed to choose multiple races.|participants|Number|315|315.0||||||
3756075|NCT01966003|3590252|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3756076|NCT01966003|3590253|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3756077|NCT01966003|3590254|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3756078|NCT01966003|3590252|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|612|612.0||||||
3756079|NCT01966003|3590253|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|298|298.0||||||
3756080|NCT01966003|3590254|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|314|314.0||||||
3756081|NCT01966003|3590252|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3756082|NCT01966003|3590253|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3756083|NCT01966003|3590254|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3756084|NCT01966003|3590252|B3||Male|Sex: Female, Male||Participants|Count of Participants|384|384.0||||||
3756085|NCT01966003|3590253|B2||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3756086|NCT01966003|3590254|B1||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
3756087|NCT01966003|3590252|B3||Female|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
3756088|NCT01966003|3590253|B2||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3756089|NCT01966003|3590254|B1||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3756090|NCT01966003|3590252|B3|≥ 65 years||Age, Customized||participants|Number|252|252.0||||||
3756091|NCT01966003|3590253|B2|≥ 65 years||Age, Customized||participants|Number|123|123.0||||||
3756092|NCT01966003|3590254|B1|≥ 65 years||Age, Customized||participants|Number|129|129.0||||||
3756093|NCT01966003|3590252|B3|< 65 years||Age, Customized||participants|Number|390|390.0||||||
3756094|NCT01966003|3590253|B2|< 65 years||Age, Customized||participants|Number|191|191.0||||||
3756095|NCT01966003|3590254|B1|< 65 years||Age, Customized||participants|Number|199|199.0||||||
3756096|NCT01966003|3590252|B3|||Age||years|Mean|61.6|61.6|Standard Deviation|8.98|8.98|||
3756097|NCT01966003|3590253|B2|||Age||years|Mean|61.6|61.6|Standard Deviation|8.88|8.88|||
3756098|NCT01966003|3590254|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|9.09|9.09|||
3756099|NCT01965938|3590271|B3|No||Anticipated Difficult airway|Anticipated difficult airway was defined as patients who met one or more of the following criteria: past history of documented difficult intubation, Mallampati Score ≥3, and a body mass index (BMI)≥35.|participants|Number|25|25.0||||||
3756100|NCT01965938|3590272|B2|No||Anticipated Difficult airway|Anticipated difficult airway was defined as patients who met one or more of the following criteria: past history of documented difficult intubation, Mallampati Score ≥3, and a body mass index (BMI)≥35.|participants|Number|14|14.0||||||
3756101|NCT01965938|3590273|B1|No||Anticipated Difficult airway|Anticipated difficult airway was defined as patients who met one or more of the following criteria: past history of documented difficult intubation, Mallampati Score ≥3, and a body mass index (BMI)≥35.|participants|Number|11|11.0||||||
3756102|NCT01965938|3590271|B3|Yes||Anticipated Difficult airway|Anticipated difficult airway was defined as patients who met one or more of the following criteria: past history of documented difficult intubation, Mallampati Score ≥3, and a body mass index (BMI)≥35.|participants|Number|15|15.0||||||
3756103|NCT01965938|3590272|B2|Yes||Anticipated Difficult airway|Anticipated difficult airway was defined as patients who met one or more of the following criteria: past history of documented difficult intubation, Mallampati Score ≥3, and a body mass index (BMI)≥35.|participants|Number|6|6.0||||||
3756104|NCT01965938|3590273|B1|Yes||Anticipated Difficult airway|Anticipated difficult airway was defined as patients who met one or more of the following criteria: past history of documented difficult intubation, Mallampati Score ≥3, and a body mass index (BMI)≥35.|participants|Number|9|9.0||||||
3756186|NCT01965652|3590346|B1|> 100 mg||Stratification by Opioid Dose|Dose of opioid was calculated using maintenance and breakthrough morphine equivalent dose. If any participants were treated with < 30 mg, the participants were counted in the ‘30-100’ group.|participants|Number|225|225.0||||||
3756105|NCT01965938|3590271|B3|Class 4||Mallampati Class (N)|"Mallampati Class~Class I: Soft palate, fauces, uvula, pillars visible Class II: Soft palate, fauces, uvula visible Class III: Soft palate, base of uvula visible Class IV: Soft palate not visible at all~A high Mallampati score (class 3 or 4) is associated with more difficult intubation"|participants|Number|18|18.0||||||
3756106|NCT01965938|3590272|B2|Class 4||Mallampati Class (N)|"Mallampati Class~Class I: Soft palate, fauces, uvula, pillars visible Class II: Soft palate, fauces, uvula visible Class III: Soft palate, base of uvula visible Class IV: Soft palate not visible at all~A high Mallampati score (class 3 or 4) is associated with more difficult intubation"|participants|Number|9|9.0||||||
3756107|NCT01965938|3590273|B1|Class 4||Mallampati Class (N)|"Mallampati Class~Class I: Soft palate, fauces, uvula, pillars visible Class II: Soft palate, fauces, uvula visible Class III: Soft palate, base of uvula visible Class IV: Soft palate not visible at all~A high Mallampati score (class 3 or 4) is associated with more difficult intubation"|participants|Number|9|9.0||||||
3756108|NCT01965938|3590271|B3|Class 3||Mallampati Class (N)|"Mallampati Class~Class I: Soft palate, fauces, uvula, pillars visible Class II: Soft palate, fauces, uvula visible Class III: Soft palate, base of uvula visible Class IV: Soft palate not visible at all~A high Mallampati score (class 3 or 4) is associated with more difficult intubation"|participants|Number|13|13.0||||||
3756109|NCT01965938|3590272|B2|Class 3||Mallampati Class (N)|"Mallampati Class~Class I: Soft palate, fauces, uvula, pillars visible Class II: Soft palate, fauces, uvula visible Class III: Soft palate, base of uvula visible Class IV: Soft palate not visible at all~A high Mallampati score (class 3 or 4) is associated with more difficult intubation"|participants|Number|7|7.0||||||
3756110|NCT01965938|3590273|B1|Class 3||Mallampati Class (N)|"Mallampati Class~Class I: Soft palate, fauces, uvula, pillars visible Class II: Soft palate, fauces, uvula visible Class III: Soft palate, base of uvula visible Class IV: Soft palate not visible at all~A high Mallampati score (class 3 or 4) is associated with more difficult intubation"|participants|Number|6|6.0||||||
3756111|NCT01965938|3590271|B3|Class 2||Mallampati Class (N)|"Mallampati Class~Class I: Soft palate, fauces, uvula, pillars visible Class II: Soft palate, fauces, uvula visible Class III: Soft palate, base of uvula visible Class IV: Soft palate not visible at all~A high Mallampati score (class 3 or 4) is associated with more difficult intubation"|participants|Number|5|5.0||||||
3756112|NCT01965938|3590272|B2|Class 2||Mallampati Class (N)|"Mallampati Class~Class I: Soft palate, fauces, uvula, pillars visible Class II: Soft palate, fauces, uvula visible Class III: Soft palate, base of uvula visible Class IV: Soft palate not visible at all~A high Mallampati score (class 3 or 4) is associated with more difficult intubation"|participants|Number|3|3.0||||||
3756113|NCT01965938|3590273|B1|Class 2||Mallampati Class (N)|"Mallampati Class~Class I: Soft palate, fauces, uvula, pillars visible Class II: Soft palate, fauces, uvula visible Class III: Soft palate, base of uvula visible Class IV: Soft palate not visible at all~A high Mallampati score (class 3 or 4) is associated with more difficult intubation"|participants|Number|2|2.0||||||
3756114|NCT01965938|3590271|B3|Class 1||Mallampati Class (N)|"Mallampati Class~Class I: Soft palate, fauces, uvula, pillars visible Class II: Soft palate, fauces, uvula visible Class III: Soft palate, base of uvula visible Class IV: Soft palate not visible at all~A high Mallampati score (class 3 or 4) is associated with more difficult intubation"|participants|Number|4|4.0||||||
3756115|NCT01965938|3590272|B2|Class 1||Mallampati Class (N)|"Mallampati Class~Class I: Soft palate, fauces, uvula, pillars visible Class II: Soft palate, fauces, uvula visible Class III: Soft palate, base of uvula visible Class IV: Soft palate not visible at all~A high Mallampati score (class 3 or 4) is associated with more difficult intubation"|participants|Number|1|1.0||||||
3756116|NCT01965938|3590273|B1|Class 1||Mallampati Class (N)|"Mallampati Class~Class I: Soft palate, fauces, uvula, pillars visible Class II: Soft palate, fauces, uvula visible Class III: Soft palate, base of uvula visible Class IV: Soft palate not visible at all~A high Mallampati score (class 3 or 4) is associated with more difficult intubation"|participants|Number|3|3.0||||||
3756117|NCT01965938|3590271|B3||Male|Gender||Participants|Count of Participants|17|17.0||||||
3756118|NCT01965938|3590272|B2||Male|Gender||Participants|Count of Participants|7|7.0||||||
3756119|NCT01965938|3590273|B1||Male|Gender||Participants|Count of Participants|10|10.0||||||
3756120|NCT01965938|3590271|B3||Female|Gender||Participants|Count of Participants|23|23.0||||||
3756121|NCT01965938|3590272|B2||Female|Gender||Participants|Count of Participants|13|13.0||||||
3756122|NCT01965938|3590273|B1||Female|Gender||Participants|Count of Participants|10|10.0||||||
3756123|NCT01965938|3590271|B3|||Age||years|Mean|49.5|49.5|Standard Deviation|14|14.0|||
3756124|NCT01965938|3590272|B2|||Age||years|Mean|49|49.0|Standard Deviation|12|12.0|||
3756125|NCT01965938|3590273|B1|||Age||years|Mean|50|50.0|Standard Deviation|15|15.0|||
3756126|NCT01965899|3590294|B1|Australia||Region of Enrollment||participants|Number|33|33.0||||||
3756127|NCT01965899|3590294|B1|Slovakia||Region of Enrollment||participants|Number|25|25.0||||||
3756128|NCT01965899|3590294|B1|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3756129|NCT01965899|3590294|B1|Belgium||Region of Enrollment||participants|Number|10|10.0||||||
3756130|NCT01965899|3590294|B1|Austria||Region of Enrollment||participants|Number|28|28.0||||||
3756131|NCT01965899|3590294|B1|Netherlands||Region of Enrollment||participants|Number|40|40.0||||||
3756132|NCT01965899|3590294|B1|Russian Federation||Region of Enrollment||participants|Number|7|7.0||||||
3756133|NCT01965899|3590294|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3756134|NCT01965899|3590294|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3756135|NCT01965899|3590294|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|12.1|12.1|||
3756136|NCT01965834|3590305|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3756137|NCT01965834|3590305|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3756138|NCT01965834|3590305|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3756139|NCT01965834|3590305|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3756140|NCT01965834|3590305|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3756141|NCT01965834|3590305|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3756142|NCT01965756|3590321|B3|||Clinical Dementia Rating - Global (Composite) Score|The Clinical Dementia Rating (CDR) is a numeric scale used to quantify the severity of symptoms of dementia. A qualified health professional assesses a patient's cognitive and functional performance in six areas: memory, orientation, judgment & problem solving, community affairs, home & hobbies, and personal care. Scores in each of these are combined to obtain a composite score ranging from 0 through 3, with 3 being most severe/impaired. Possible composite rating scores include 0, 0.5, 1, 2, and 3.|units on a scale|Mean|0.658|0.658|Standard Deviation|.579|0.579|||
3756143|NCT01965756|3590322|B2|||Clinical Dementia Rating - Global (Composite) Score|The Clinical Dementia Rating (CDR) is a numeric scale used to quantify the severity of symptoms of dementia. A qualified health professional assesses a patient's cognitive and functional performance in six areas: memory, orientation, judgment & problem solving, community affairs, home & hobbies, and personal care. Scores in each of these are combined to obtain a composite score ranging from 0 through 3, with 3 being most severe/impaired. Possible composite rating scores include 0, 0.5, 1, 2, and 3.|units on a scale|Mean|0.8|0.8|Standard Deviation|0.789|0.789|||
3756144|NCT01965756|3590323|B1|||Clinical Dementia Rating - Global (Composite) Score|The Clinical Dementia Rating (CDR) is a numeric scale used to quantify the severity of symptoms of dementia. A qualified health professional assesses a patient's cognitive and functional performance in six areas: memory, orientation, judgment & problem solving, community affairs, home & hobbies, and personal care. Scores in each of these are combined to obtain a composite score ranging from 0 through 3, with 3 being most severe/impaired. Possible composite rating scores include 0, 0.5, 1, 2, and 3.|units on a scale|Mean|0.5|0.5|Standard Deviation|0|0.0|||
3756145|NCT01965756|3590321|B3|||Plasma Glucose||mg/dL|Mean|90.7|90.7|Standard Deviation|11.4|11.4|||
3756146|NCT01965756|3590322|B2|||Plasma Glucose||mg/dL|Mean|90.9|90.9|Standard Deviation|14.1|14.1|||
3756147|NCT01965756|3590323|B1|||Plasma Glucose||mg/dL|Mean|90.5|90.5|Standard Deviation|8.77|8.77|||
3756148|NCT01965756|3590321|B3|||HbA1c||percentage|Mean|5.44|5.44|Standard Deviation|0.232|0.232|||
3756149|NCT01965756|3590322|B2|||HbA1c||percentage|Mean|5.37|5.37|Standard Deviation|0.236|0.236|||
3756150|NCT01965756|3590323|B1|||HbA1c||percentage|Mean|5.5|5.5|Standard Deviation|0.221|0.221|||
3756151|NCT01965756|3590321|B3|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3756152|NCT01965756|3590322|B2|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3756153|NCT01965756|3590323|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3756154|NCT01965756|3590321|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3756155|NCT01965756|3590322|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3756156|NCT01965756|3590323|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3756157|NCT01965756|3590321|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3756158|NCT01965756|3590322|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3756159|NCT01965756|3590323|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3756160|NCT01965756|3590321|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3756161|NCT01965756|3590322|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3756162|NCT01965756|3590323|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3756163|NCT01965756|3590321|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3756164|NCT01965756|3590322|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3756165|NCT01965756|3590323|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3756166|NCT01965756|3590321|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3756167|NCT01965756|3590322|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3756168|NCT01965756|3590323|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3756169|NCT01965756|3590321|B3|||Age||years|Mean|70.1|70.1|Standard Deviation|6.89|6.89|||
3756170|NCT01965756|3590322|B2|||Age||years|Mean|71.1|71.1|Standard Deviation|6.57|6.57|||
3756171|NCT01965756|3590323|B1|||Age||years|Mean|69.1|69.1|Standard Deviation|7.40|7.4|||
3756172|NCT01965756|3590321|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3756173|NCT01965756|3590322|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3756174|NCT01965756|3590323|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3756175|NCT01965756|3590321|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3756176|NCT01965756|3590322|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3756177|NCT01965756|3590323|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3756178|NCT01965756|3590321|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3756179|NCT01965756|3590322|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3756180|NCT01965756|3590323|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3756181|NCT01965665|3590338|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3756182|NCT01965665|3590338|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3756183|NCT01965665|3590338|B1|||Age||years|Mean|58|58.0|Standard Deviation|9.5|9.5|||
3756184|NCT01965652|3590344|B3|> 100 mg||Stratification by Opioid Dose|Dose of opioid was calculated using maintenance and breakthrough morphine equivalent dose. If any participants were treated with < 30 mg, the participants were counted in the ‘30-100’ group.|participants|Number|452|452.0||||||
3756185|NCT01965652|3590345|B2|> 100 mg||Stratification by Opioid Dose|Dose of opioid was calculated using maintenance and breakthrough morphine equivalent dose. If any participants were treated with < 30 mg, the participants were counted in the ‘30-100’ group.|participants|Number|227|227.0||||||
3756242|NCT01965535|3590435|B3|Genotype 1a||HCV Genotype||participants|Number|98|98.0||||||
3756187|NCT01965652|3590344|B3|30-100 mg||Stratification by Opioid Dose|Dose of opioid was calculated using maintenance and breakthrough morphine equivalent dose. If any participants were treated with < 30 mg, the participants were counted in the ‘30-100’ group.|participants|Number|788|788.0||||||
3756188|NCT01965652|3590345|B2|30-100 mg||Stratification by Opioid Dose|Dose of opioid was calculated using maintenance and breakthrough morphine equivalent dose. If any participants were treated with < 30 mg, the participants were counted in the ‘30-100’ group.|participants|Number|392|392.0||||||
3756189|NCT01965652|3590346|B1|30-100 mg||Stratification by Opioid Dose|Dose of opioid was calculated using maintenance and breakthrough morphine equivalent dose. If any participants were treated with < 30 mg, the participants were counted in the ‘30-100’ group.|participants|Number|396|396.0||||||
3756190|NCT01965652|3590344|B3|White||Race/Ethnicity, Customized||participants|Number|988|988.0||||||
3756191|NCT01965652|3590345|B2|White||Race/Ethnicity, Customized||participants|Number|496|496.0||||||
3756192|NCT01965652|3590346|B1|White||Race/Ethnicity, Customized||participants|Number|492|492.0||||||
3756193|NCT01965652|3590344|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3756194|NCT01965652|3590345|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3756195|NCT01965652|3590346|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3756196|NCT01965652|3590344|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|228|228.0||||||
3756197|NCT01965652|3590345|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|108|108.0||||||
3756198|NCT01965652|3590346|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|120|120.0||||||
3756199|NCT01965652|3590344|B3|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3756200|NCT01965652|3590345|B2|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3756201|NCT01965652|3590346|B1|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3756202|NCT01965652|3590344|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3756203|NCT01965652|3590345|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3756204|NCT01965652|3590346|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3756205|NCT01965652|3590344|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3756206|NCT01965652|3590345|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3756207|NCT01965652|3590346|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3756208|NCT01965652|3590344|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1151|1151.0||||||
3756209|NCT01965652|3590345|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|577|577.0||||||
3756210|NCT01965652|3590346|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|574|574.0||||||
3756211|NCT01965652|3590344|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
3756212|NCT01965652|3590345|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3756213|NCT01965652|3590346|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3756214|NCT01965652|3590344|B3||Male|Sex: Female, Male||Participants|Count of Participants|455|455.0||||||
3756215|NCT01965652|3590345|B2||Male|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
3756216|NCT01965652|3590346|B1||Male|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
3756217|NCT01965652|3590344|B3||Female|Sex: Female, Male||Participants|Count of Participants|785|785.0||||||
3756218|NCT01965652|3590345|B2||Female|Sex: Female, Male||Participants|Count of Participants|402|402.0||||||
3756219|NCT01965652|3590346|B1||Female|Sex: Female, Male||Participants|Count of Participants|383|383.0||||||
3756220|NCT01965652|3590344|B3|≥ 65 years||Age, Customized||participants|Number|177|177.0||||||
3756221|NCT01965652|3590345|B2|≥ 65 years||Age, Customized||participants|Number|76|76.0||||||
3756222|NCT01965652|3590346|B1|≥ 65 years||Age, Customized||participants|Number|101|101.0||||||
3756223|NCT01965652|3590344|B3|≥ 40 to < 65 years||Age, Customized||participants|Number|920|920.0||||||
3756224|NCT01965652|3590345|B2|≥ 40 to < 65 years||Age, Customized||participants|Number|475|475.0||||||
3756225|NCT01965652|3590346|B1|≥ 40 to < 65 years||Age, Customized||participants|Number|445|445.0||||||
3756226|NCT01965652|3590344|B3|< 40 years||Age, Customized||participants|Number|143|143.0||||||
3756227|NCT01965652|3590345|B2|< 40 years||Age, Customized||participants|Number|68|68.0||||||
3756228|NCT01965652|3590346|B1|< 40 years||Age, Customized||participants|Number|75|75.0||||||
3756229|NCT01965652|3590344|B3|||Age||Years|Mean|53.0|53.0|Standard Deviation|11.13|11.13|||
3756230|NCT01965652|3590345|B2|||Age||Years|Mean|52.7|52.7|Standard Deviation|10.55|10.55|||
3756231|NCT01965652|3590346|B1|||Age||Years|Mean|53.4|53.4|Standard Deviation|11.68|11.68|||
3756232|NCT01965600|3590377|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3756233|NCT01965600|3590377|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3756234|NCT01965600|3590377|B1|||Age||years|Mean|32.2|32.2|Standard Deviation|5.3|5.3|||
3756235|NCT01965561|3590424|B1|||Pain|Pain level on Visual Analog Scale (0 mm = no pain, 100 mm = maximum pain)|units on a scale|Mean|0|0.0|Full Range|||0.0|0.0|
3756236|NCT01965561|3590424|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3756237|NCT01965561|3590424|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3756238|NCT01965561|3590424|B1|||Age|Age of healthy human volunteers|years|Mean|51|51.0|Full Range|||42.0|60.0|
3756239|NCT01965535|3590435|B3|Genotype 1b||HCV Genotype||participants|Number|55|55.0||||||
3756240|NCT01965535|3590436|B2|Genotype 1b||HCV Genotype||participants|Number|28|28.0||||||
3756241|NCT01965535|3590437|B1|Genotype 1b||HCV Genotype||participants|Number|27|27.0||||||
3756243|NCT01965535|3590436|B2|Genotype 1a||HCV Genotype||participants|Number|48|48.0||||||
3756244|NCT01965535|3590437|B1|Genotype 1a||HCV Genotype||participants|Number|50|50.0||||||
3756245|NCT01965535|3590435|B3|Genotype 1 (no confirmed subtype)||HCV Genotype||participants|Number|2|2.0||||||
3756246|NCT01965535|3590436|B2|Genotype 1 (no confirmed subtype)||HCV Genotype||participants|Number|1|1.0||||||
3756247|NCT01965535|3590437|B1|Genotype 1 (no confirmed subtype)||HCV Genotype||participants|Number|1|1.0||||||
3756248|NCT01965535|3590435|B3|||Hepatitic C Virus (HCV) RNA||log10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.54|0.54|||
3756249|NCT01965535|3590436|B2|||Hepatitic C Virus (HCV) RNA||log10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.47|0.47|||
3756250|NCT01965535|3590437|B1|||Hepatitic C Virus (HCV) RNA||log10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.59|0.59|||
3756251|NCT01965535|3590435|B3|White||Race/Ethnicity, Customized||participants|Number|151|151.0||||||
3756252|NCT01965535|3590436|B2|White||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
3756253|NCT01965535|3590437|B1|White||Race/Ethnicity, Customized||participants|Number|75|75.0||||||
3756254|NCT01965535|3590435|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3756255|NCT01965535|3590436|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3756256|NCT01965535|3590437|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3756257|NCT01965535|3590435|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3756258|NCT01965535|3590436|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3756259|NCT01965535|3590437|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3756260|NCT01965535|3590435|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|151|151.0||||||
3756261|NCT01965535|3590436|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3756262|NCT01965535|3590437|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
3756263|NCT01965535|3590435|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3756264|NCT01965535|3590436|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3756265|NCT01965535|3590437|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3756266|NCT01965535|3590435|B3||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3756267|NCT01965535|3590436|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3756268|NCT01965535|3590437|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3756269|NCT01965535|3590435|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3756270|NCT01965535|3590436|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3756271|NCT01965535|3590437|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3756272|NCT01965535|3590435|B3|||Age||years|Mean|56|56.0|Standard Deviation|9.2|9.2|||
3756273|NCT01965535|3590436|B2|||Age||years|Mean|56|56.0|Standard Deviation|7.4|7.4|||
3756274|NCT01965535|3590437|B1|||Age||years|Mean|57|57.0|Standard Deviation|10.7|10.7|||
3756275|NCT01965431|3590452|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3756276|NCT01965431|3590452|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3756277|NCT01965431|3590452|B1|||Age||Years|Mean|37.5|37.5|Standard Deviation|8.8|8.8|||
3756278|NCT01965366|3590470|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
3756279|NCT01965366|3590471|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3756280|NCT01965366|3590472|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3756281|NCT01965366|3590470|B3|other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3756282|NCT01965366|3590471|B2|other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3756283|NCT01965366|3590472|B1|other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3756284|NCT01965366|3590470|B3|black||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3756285|NCT01965366|3590471|B2|black||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3756286|NCT01965366|3590472|B1|black||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3756287|NCT01965366|3590470|B3|white||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3756288|NCT01965366|3590471|B2|white||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3756289|NCT01965366|3590472|B1|white||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3756290|NCT01965366|3590470|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3756291|NCT01965366|3590471|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3756292|NCT01965366|3590472|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3756293|NCT01965366|3590470|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3756294|NCT01965366|3590471|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3756295|NCT01965366|3590472|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3756296|NCT01965366|3590470|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3756297|NCT01965366|3590471|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3756298|NCT01965366|3590472|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3756299|NCT01965366|3590470|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3756300|NCT01965366|3590471|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3756301|NCT01965366|3590472|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3756302|NCT01965366|3590470|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3756303|NCT01965366|3590471|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3756304|NCT01965366|3590472|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3756305|NCT01965327|3590481|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3756306|NCT01965327|3590481|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3756307|NCT01965327|3590481|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3756308|NCT01965327|3590481|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3756309|NCT01965327|3590481|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3756310|NCT01965327|3590481|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3756311|NCT01965327|3590481|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3756312|NCT01965327|3590481|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3756313|NCT01965327|3590481|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3756314|NCT01965327|3590481|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3756315|NCT01965327|3590481|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3756316|NCT01965327|3590481|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3756317|NCT01965327|3590481|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3756318|NCT01965327|3590481|B1|||Age||years|Mean|12|12.0|Full Range|||8.0|17.0|
3756319|NCT01965327|3590481|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3756320|NCT01965327|3590481|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3756321|NCT01965327|3590481|B1||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
3756322|NCT01965288|3590486|B3|Spain||Region of Enrollment||participants|Number|60|60.0||||||
3756323|NCT01965288|3590487|B2|Spain||Region of Enrollment||participants|Number|30|30.0||||||
3756324|NCT01965288|3590488|B1|Spain||Region of Enrollment||participants|Number|30|30.0||||||
3756325|NCT01965288|3590486|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3756326|NCT01965288|3590487|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3756327|NCT01965288|3590488|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3756328|NCT01965288|3590486|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3756329|NCT01965288|3590487|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3756330|NCT01965288|3590488|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3756331|NCT01965288|3590486|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3756332|NCT01965288|3590487|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3756333|NCT01965288|3590488|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3756334|NCT01965288|3590486|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3756335|NCT01965288|3590487|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3756336|NCT01965288|3590488|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3756337|NCT01965288|3590486|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3756338|NCT01965288|3590487|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3756339|NCT01965288|3590488|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3756340|NCT01965262|3590695|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3756341|NCT01965262|3590695|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3756342|NCT01965262|3590695|B1|||Age||years|Mean|29.2|29.2|Full Range|||18.0|56.0|
3756343|NCT01965262|3590695|B1|||Age||years|Mean|29.2|29.2|Standard Deviation|11.2|11.2|||
3756344|NCT01965158|3590758|B3|||Spontaneous Bowel Movements per Week||spontaneous bowel movements|Mean|1.31|1.31|Standard Deviation|0.729|0.729|||
3756345|NCT01965158|3590759|B2|||Spontaneous Bowel Movements per Week||spontaneous bowel movements|Mean|1.30|1.3|Standard Deviation|0.713|0.713|||
3756346|NCT01965158|3590760|B1|||Spontaneous Bowel Movements per Week||spontaneous bowel movements|Mean|1.31|1.31|Standard Deviation|0.746|0.746|||
3756347|NCT01965158|3590758|B3|> 100 mg||Stratification by Opioid Dose|Dose of opioid was calculated using maintenance and breakthrough morphine equivalent dose. If any participants were treated with < 30 mg, the participants were counted in ‘30-100 mg’.|participants|Number|237|237.0||||||
3756348|NCT01965158|3590759|B2|> 100 mg||Stratification by Opioid Dose|Dose of opioid was calculated using maintenance and breakthrough morphine equivalent dose. If any participants were treated with < 30 mg, the participants were counted in ‘30-100 mg’.|participants|Number|119|119.0||||||
3756349|NCT01965158|3590760|B1|> 100 mg||Stratification by Opioid Dose|Dose of opioid was calculated using maintenance and breakthrough morphine equivalent dose. If any participants were treated with < 30 mg, the participants were counted in ‘30-100 mg’.|participants|Number|118|118.0||||||
3756350|NCT01965158|3590758|B3|30-100 mg||Stratification by Opioid Dose|Dose of opioid was calculated using maintenance and breakthrough morphine equivalent dose. If any participants were treated with < 30 mg, the participants were counted in ‘30-100 mg’.|participants|Number|308|308.0||||||
3756351|NCT01965158|3590759|B2|30-100 mg||Stratification by Opioid Dose|Dose of opioid was calculated using maintenance and breakthrough morphine equivalent dose. If any participants were treated with < 30 mg, the participants were counted in ‘30-100 mg’.|participants|Number|153|153.0||||||
3756352|NCT01965158|3590760|B1|30-100 mg||Stratification by Opioid Dose|Dose of opioid was calculated using maintenance and breakthrough morphine equivalent dose. If any participants were treated with < 30 mg, the participants were counted in ‘30-100 mg’.|participants|Number|155|155.0||||||
3756353|NCT01965158|3590758|B3|White||Race/Ethnicity, Customized||participants|Number|436|436.0||||||
3756354|NCT01965158|3590759|B2|White||Race/Ethnicity, Customized||participants|Number|220|220.0||||||
3756355|NCT01965158|3590760|B1|White||Race/Ethnicity, Customized||participants|Number|216|216.0||||||
3756356|NCT01965158|3590758|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3756357|NCT01965158|3590759|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3756358|NCT01965158|3590760|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3756359|NCT01965158|3590758|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|101|101.0||||||
3756360|NCT01965158|3590759|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
3756361|NCT01965158|3590760|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
3756362|NCT01965158|3590758|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3756363|NCT01965158|3590759|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3756364|NCT01965158|3590760|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3756365|NCT01965158|3590758|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3756366|NCT01965158|3590759|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3756367|NCT01965158|3590760|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3756368|NCT01965158|3590758|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3756369|NCT01965158|3590759|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3756370|NCT01965158|3590760|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3756371|NCT01965158|3590758|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|492|492.0||||||
3756372|NCT01965158|3590759|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|245|245.0||||||
3756373|NCT01965158|3590760|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|247|247.0||||||
3756374|NCT01965158|3590758|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3756375|NCT01965158|3590759|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3756376|NCT01965158|3590760|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3756377|NCT01965158|3590758|B3||Male|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
3756378|NCT01965158|3590759|B2||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3756379|NCT01965158|3590760|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3756380|NCT01965158|3590758|B3||Female|Sex: Female, Male||Participants|Count of Participants|329|329.0||||||
3756381|NCT01965158|3590759|B2||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3756382|NCT01965158|3590760|B1||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3756383|NCT01965158|3590758|B3|≥ 65 years||Age, Customized||participants|Number|86|86.0||||||
3756384|NCT01965158|3590759|B2|≥ 65 years||Age, Customized||participants|Number|47|47.0||||||
3756385|NCT01965158|3590760|B1|≥ 65 years||Age, Customized||participants|Number|39|39.0||||||
3756386|NCT01965158|3590758|B3|≥ 40 to < 65 years||Age, Customized||participants|Number|408|408.0||||||
3756387|NCT01965158|3590759|B2|≥ 40 to < 65 years||Age, Customized||participants|Number|199|199.0||||||
3756388|NCT01965158|3590760|B1|≥ 40 to < 65 years||Age, Customized||participants|Number|209|209.0||||||
3756389|NCT01965158|3590758|B3|< 40 years||Age, Customized||participants|Number|51|51.0||||||
3756390|NCT01965158|3590759|B2|< 40 years||Age, Customized||participants|Number|26|26.0||||||
3756391|NCT01965158|3590760|B1|< 40 years||Age, Customized||participants|Number|25|25.0||||||
3756392|NCT01965158|3590758|B3|||Age||years|Mean|53.4|53.4|Standard Deviation|10.73|10.73|||
3756393|NCT01965158|3590759|B2|||Age||years|Mean|53.4|53.4|Standard Deviation|11.03|11.03|||
3756394|NCT01965158|3590760|B1|||Age||years|Mean|53.3|53.3|Standard Deviation|10.44|10.44|||
3756395|NCT01965067|3590775|B3|Korea, Republic of||Region of Enrollment||participants|Number|60|60.0||||||
3756396|NCT01965067|3590776|B2|Korea, Republic of||Region of Enrollment||participants|Number|30|30.0||||||
3756397|NCT01965067|3590777|B1|Korea, Republic of||Region of Enrollment||participants|Number|30|30.0||||||
3756398|NCT01965067|3590775|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3756399|NCT01965067|3590776|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3756400|NCT01965067|3590777|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3756401|NCT01965067|3590775|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3756402|NCT01965067|3590776|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3756403|NCT01965067|3590777|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3756404|NCT01965067|3590775|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3756405|NCT01965067|3590776|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3756406|NCT01965067|3590777|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3756407|NCT01965067|3590775|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3756408|NCT01965067|3590776|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3756409|NCT01965067|3590777|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3756410|NCT01965067|3590775|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3756411|NCT01965067|3590776|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3756412|NCT01965067|3590777|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3756413|NCT01965067|3590775|B3|||Age||years|Mean|47.5|47.5|Standard Deviation|9.5|9.5|||
3756414|NCT01965067|3590776|B2|||Age||years|Mean|47.4|47.4|Standard Deviation|9.4|9.4|||
3756415|NCT01965067|3590777|B1|||Age||years|Mean|47.6|47.6|Standard Deviation|9.8|9.8|||
3756416|NCT01965002|3590794|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3756417|NCT01965002|3590794|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3756418|NCT01965002|3590794|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3756419|NCT01965002|3590794|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3756420|NCT01965002|3590794|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3756421|NCT01965002|3590794|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3756422|NCT01965002|3590794|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3756423|NCT01965002|3590794|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3756424|NCT01965002|3590794|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3756425|NCT01965002|3590794|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3756426|NCT01965002|3590794|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3756427|NCT01965002|3590794|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3756428|NCT01965002|3590794|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3756429|NCT01965002|3590794|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3756430|NCT01965002|3590794|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3756431|NCT01964976|3590800|B3|Unknown||Glycosylated Hemoglobin (HbA1c) Level||participants|Number|53|53.0||||||
3756432|NCT01964976|3590801|B2|Unknown||Glycosylated Hemoglobin (HbA1c) Level||participants|Number|10|10.0||||||
3756433|NCT01964976|3590802|B1|Unknown||Glycosylated Hemoglobin (HbA1c) Level||participants|Number|43|43.0||||||
3756434|NCT01964976|3590800|B3|HbA1c >=8.0%||Glycosylated Hemoglobin (HbA1c) Level||participants|Number|376|376.0||||||
3756435|NCT01964976|3590801|B2|HbA1c >=8.0%||Glycosylated Hemoglobin (HbA1c) Level||participants|Number|35|35.0||||||
3756436|NCT01964976|3590802|B1|HbA1c >=8.0%||Glycosylated Hemoglobin (HbA1c) Level||participants|Number|341|341.0||||||
3756437|NCT01964976|3590800|B3|HbA1c >=7.0% to <8.0%||Glycosylated Hemoglobin (HbA1c) Level||participants|Number|424|424.0||||||
3756438|NCT01964976|3590801|B2|HbA1c >=7.0% to <8.0%||Glycosylated Hemoglobin (HbA1c) Level||participants|Number|43|43.0||||||
3756439|NCT01964976|3590802|B1|HbA1c >=7.0% to <8.0%||Glycosylated Hemoglobin (HbA1c) Level||participants|Number|381|381.0||||||
3756440|NCT01964976|3590800|B3|HbA1c >=6.0% to <7.0%||Glycosylated Hemoglobin (HbA1c) Level||participants|Number|193|193.0||||||
3756441|NCT01964976|3590801|B2|HbA1c >=6.0% to <7.0%||Glycosylated Hemoglobin (HbA1c) Level||participants|Number|16|16.0||||||
3756442|NCT01964976|3590802|B1|HbA1c >=6.0% to <7.0%||Glycosylated Hemoglobin (HbA1c) Level||participants|Number|177|177.0||||||
3756443|NCT01964976|3590800|B3|HbA1c <6.0 percent (%)||Glycosylated Hemoglobin (HbA1c) Level||participants|Number|17|17.0||||||
3756444|NCT01964976|3590801|B2|HbA1c <6.0 percent (%)||Glycosylated Hemoglobin (HbA1c) Level||participants|Number|5|5.0||||||
3756445|NCT01964976|3590802|B1|HbA1c <6.0 percent (%)||Glycosylated Hemoglobin (HbA1c) Level||participants|Number|12|12.0||||||
3756446|NCT01964976|3590800|B3|Unknown||Smoking Classification||participants|Number|214|214.0||||||
3756447|NCT01964976|3590801|B2|Unknown||Smoking Classification||participants|Number|31|31.0||||||
3756448|NCT01964976|3590802|B1|Unknown||Smoking Classification||participants|Number|183|183.0||||||
3756449|NCT01964976|3590800|B3|Ex-smoker||Smoking Classification||participants|Number|177|177.0||||||
3756450|NCT01964976|3590801|B2|Ex-smoker||Smoking Classification||participants|Number|15|15.0||||||
3756451|NCT01964976|3590802|B1|Ex-smoker||Smoking Classification||participants|Number|162|162.0||||||
3756452|NCT01964976|3590800|B3|Current Smoker||Smoking Classification||participants|Number|185|185.0||||||
3756453|NCT01964976|3590801|B2|Current Smoker||Smoking Classification||participants|Number|18|18.0||||||
3756454|NCT01964976|3590802|B1|Current Smoker||Smoking Classification||participants|Number|167|167.0||||||
3756455|NCT01964976|3590800|B3|Never Smoked||Smoking Classification||participants|Number|487|487.0||||||
3756456|NCT01964976|3590801|B2|Never Smoked||Smoking Classification||participants|Number|45|45.0||||||
3756457|NCT01964976|3590802|B1|Never Smoked||Smoking Classification||participants|Number|442|442.0||||||
3756458|NCT01964976|3590800|B3|Unknown||History of Alcohol Consumption|In this measure, participants responded whether they consumed alcohol-containing beverages nearly every day or not.|participants|Number|173|173.0||||||
3756459|NCT01964976|3590801|B2|Unknown||History of Alcohol Consumption|In this measure, participants responded whether they consumed alcohol-containing beverages nearly every day or not.|participants|Number|23|23.0||||||
3756460|NCT01964976|3590802|B1|Unknown||History of Alcohol Consumption|In this measure, participants responded whether they consumed alcohol-containing beverages nearly every day or not.|participants|Number|150|150.0||||||
3756461|NCT01964976|3590800|B3|No||History of Alcohol Consumption|In this measure, participants responded whether they consumed alcohol-containing beverages nearly every day or not.|participants|Number|633|633.0||||||
3756462|NCT01964976|3590801|B2|No||History of Alcohol Consumption|In this measure, participants responded whether they consumed alcohol-containing beverages nearly every day or not.|participants|Number|60|60.0||||||
3756463|NCT01964976|3590802|B1|No||History of Alcohol Consumption|In this measure, participants responded whether they consumed alcohol-containing beverages nearly every day or not.|participants|Number|573|573.0||||||
3756464|NCT01964976|3590800|B3|Yes||History of Alcohol Consumption|In this measure, participants responded whether they consumed alcohol-containing beverages nearly every day or not.|participants|Number|257|257.0||||||
3756465|NCT01964976|3590801|B2|Yes||History of Alcohol Consumption|In this measure, participants responded whether they consumed alcohol-containing beverages nearly every day or not.|participants|Number|26|26.0||||||
3756466|NCT01964976|3590802|B1|Yes||History of Alcohol Consumption|In this measure, participants responded whether they consumed alcohol-containing beverages nearly every day or not.|participants|Number|231|231.0||||||
3756467|NCT01964976|3590800|B3|Unknown||Presence of Medical History||participants|Number|121|121.0||||||
3756468|NCT01964976|3590801|B2|Unknown||Presence of Medical History||participants|Number|11|11.0||||||
3756469|NCT01964976|3590802|B1|Unknown||Presence of Medical History||participants|Number|110|110.0||||||
3756470|NCT01964976|3590800|B3|Did not have medical history||Presence of Medical History||participants|Number|762|762.0||||||
3756471|NCT01964976|3590801|B2|Did not have medical history||Presence of Medical History||participants|Number|68|68.0||||||
3756472|NCT01964976|3590802|B1|Did not have medical history||Presence of Medical History||participants|Number|694|694.0||||||
3756473|NCT01964976|3590800|B3|Had medical history||Presence of Medical History||participants|Number|180|180.0||||||
3756474|NCT01964976|3590801|B2|Had medical history||Presence of Medical History||participants|Number|30|30.0||||||
3756475|NCT01964976|3590802|B1|Had medical history||Presence of Medical History||participants|Number|150|150.0||||||
3756476|NCT01964976|3590800|B3|Had no complications||Other Complications|Participants who had complications other than diabetic, hypertension, dyslipidemia, hyperuricemia, liver damage, renal damage, heart disease, heart failure, stroke-related disease, allergic disease, and malignant tumor were analyzed in this measure.|participants|Number|710|710.0||||||
3756477|NCT01964976|3590801|B2|Had no complications||Other Complications|Participants who had complications other than diabetic, hypertension, dyslipidemia, hyperuricemia, liver damage, renal damage, heart disease, heart failure, stroke-related disease, allergic disease, and malignant tumor were analyzed in this measure.|participants|Number|71|71.0||||||
3756478|NCT01964976|3590802|B1|Had no complications||Other Complications|Participants who had complications other than diabetic, hypertension, dyslipidemia, hyperuricemia, liver damage, renal damage, heart disease, heart failure, stroke-related disease, allergic disease, and malignant tumor were analyzed in this measure.|participants|Number|639|639.0||||||
3756479|NCT01964976|3590800|B3|Had complications||Other Complications|Participants who had complications other than diabetic, hypertension, dyslipidemia, hyperuricemia, liver damage, renal damage, heart disease, heart failure, stroke-related disease, allergic disease, and malignant tumor were analyzed in this measure.|participants|Number|353|353.0||||||
3756480|NCT01964976|3590801|B2|Had complications||Other Complications|Participants who had complications other than diabetic, hypertension, dyslipidemia, hyperuricemia, liver damage, renal damage, heart disease, heart failure, stroke-related disease, allergic disease, and malignant tumor were analyzed in this measure.|participants|Number|38|38.0||||||
3756481|NCT01964976|3590802|B1|Had complications||Other Complications|Participants who had complications other than diabetic, hypertension, dyslipidemia, hyperuricemia, liver damage, renal damage, heart disease, heart failure, stroke-related disease, allergic disease, and malignant tumor were analyzed in this measure.|participants|Number|315|315.0||||||
3756482|NCT01964976|3590800|B3|Had no complications||Complications of Malignant Tumor||participants|Number|1039|1039.0||||||
3756483|NCT01964976|3590801|B2|Had no complications||Complications of Malignant Tumor||participants|Number|103|103.0||||||
3756484|NCT01964976|3590802|B1|Had no complications||Complications of Malignant Tumor||participants|Number|936|936.0||||||
3756485|NCT01964976|3590800|B3|Had complications||Complications of Malignant Tumor||participants|Number|24|24.0||||||
3756486|NCT01964976|3590801|B2|Had complications||Complications of Malignant Tumor||participants|Number|6|6.0||||||
3756487|NCT01964976|3590802|B1|Had complications||Complications of Malignant Tumor||participants|Number|18|18.0||||||
3756488|NCT01964976|3590800|B3|Had no complications||Complications of Allergic Disease||participants|Number|990|990.0||||||
3756489|NCT01964976|3590801|B2|Had no complications||Complications of Allergic Disease||participants|Number|102|102.0||||||
3756490|NCT01964976|3590802|B1|Had no complications||Complications of Allergic Disease||participants|Number|888|888.0||||||
3756491|NCT01964976|3590800|B3|Had complications||Complications of Allergic Disease||participants|Number|73|73.0||||||
3756492|NCT01964976|3590801|B2|Had complications||Complications of Allergic Disease||participants|Number|7|7.0||||||
3756493|NCT01964976|3590802|B1|Had complications||Complications of Allergic Disease||participants|Number|66|66.0||||||
3756494|NCT01964976|3590800|B3|Cerebral hemorrhage||Breakdown of Complications of Stroke-related Disease|This baseline characteristic was analyzed only in participants who had complications of stroke-related disease.|participants|Number|1|1.0||||||
3756495|NCT01964976|3590801|B2|Cerebral hemorrhage||Breakdown of Complications of Stroke-related Disease|This baseline characteristic was analyzed only in participants who had complications of stroke-related disease.|participants|Number|0|0.0||||||
3756496|NCT01964976|3590802|B1|Cerebral hemorrhage||Breakdown of Complications of Stroke-related Disease|This baseline characteristic was analyzed only in participants who had complications of stroke-related disease.|participants|Number|1|1.0||||||
3756497|NCT01964976|3590800|B3|Cerebral infarction||Breakdown of Complications of Stroke-related Disease|This baseline characteristic was analyzed only in participants who had complications of stroke-related disease.|participants|Number|62|62.0||||||
3756498|NCT01964976|3590801|B2|Cerebral infarction||Breakdown of Complications of Stroke-related Disease|This baseline characteristic was analyzed only in participants who had complications of stroke-related disease.|participants|Number|5|5.0||||||
3756499|NCT01964976|3590802|B1|Cerebral infarction||Breakdown of Complications of Stroke-related Disease|This baseline characteristic was analyzed only in participants who had complications of stroke-related disease.|participants|Number|57|57.0||||||
3756500|NCT01964976|3590800|B3|Had no complications||Complications of Stroke-related Disease||participants|Number|1000|1000.0||||||
3756501|NCT01964976|3590801|B2|Had no complications||Complications of Stroke-related Disease||participants|Number|104|104.0||||||
3756502|NCT01964976|3590802|B1|Had no complications||Complications of Stroke-related Disease||participants|Number|896|896.0||||||
3756503|NCT01964976|3590800|B3|Had complications||Complications of Stroke-related Disease||participants|Number|63|63.0||||||
3756504|NCT01964976|3590801|B2|Had complications||Complications of Stroke-related Disease||participants|Number|5|5.0||||||
3756505|NCT01964976|3590802|B1|Had complications||Complications of Stroke-related Disease||participants|Number|58|58.0||||||
3756506|NCT01964976|3590800|B3|NYHA Class IV||New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (participants with cardiac disease but without resulting limitations of physical activity), Class II (participants with cardiac disease resulting in slight limitation of physical activity), Class III (participants with cardiac disease resulting in marked limitation of physical activity), Class IV (participants with cardiac disease resulting in inability to carry on any physical activity without discomfort). This baseline measure was analyzed only for participants who had complications of heart failure.|participants|Number|2|2.0||||||
3756507|NCT01964976|3590801|B2|NYHA Class IV||New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (participants with cardiac disease but without resulting limitations of physical activity), Class II (participants with cardiac disease resulting in slight limitation of physical activity), Class III (participants with cardiac disease resulting in marked limitation of physical activity), Class IV (participants with cardiac disease resulting in inability to carry on any physical activity without discomfort). This baseline measure was analyzed only for participants who had complications of heart failure.|participants|Number|1|1.0||||||
3756508|NCT01964976|3590802|B1|NYHA Class IV||New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (participants with cardiac disease but without resulting limitations of physical activity), Class II (participants with cardiac disease resulting in slight limitation of physical activity), Class III (participants with cardiac disease resulting in marked limitation of physical activity), Class IV (participants with cardiac disease resulting in inability to carry on any physical activity without discomfort). This baseline measure was analyzed only for participants who had complications of heart failure.|participants|Number|1|1.0||||||
3756509|NCT01964976|3590800|B3|NYHA Class II||New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (participants with cardiac disease but without resulting limitations of physical activity), Class II (participants with cardiac disease resulting in slight limitation of physical activity), Class III (participants with cardiac disease resulting in marked limitation of physical activity), Class IV (participants with cardiac disease resulting in inability to carry on any physical activity without discomfort). This baseline measure was analyzed only for participants who had complications of heart failure.|participants|Number|5|5.0||||||
3756510|NCT01964976|3590801|B2|NYHA Class II||New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (participants with cardiac disease but without resulting limitations of physical activity), Class II (participants with cardiac disease resulting in slight limitation of physical activity), Class III (participants with cardiac disease resulting in marked limitation of physical activity), Class IV (participants with cardiac disease resulting in inability to carry on any physical activity without discomfort). This baseline measure was analyzed only for participants who had complications of heart failure.|participants|Number|0|0.0||||||
3756511|NCT01964976|3590802|B1|NYHA Class II||New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (participants with cardiac disease but without resulting limitations of physical activity), Class II (participants with cardiac disease resulting in slight limitation of physical activity), Class III (participants with cardiac disease resulting in marked limitation of physical activity), Class IV (participants with cardiac disease resulting in inability to carry on any physical activity without discomfort). This baseline measure was analyzed only for participants who had complications of heart failure.|participants|Number|5|5.0||||||
3756512|NCT01964976|3590800|B3|NYHA Class I||New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (participants with cardiac disease but without resulting limitations of physical activity), Class II (participants with cardiac disease resulting in slight limitation of physical activity), Class III (participants with cardiac disease resulting in marked limitation of physical activity), Class IV (participants with cardiac disease resulting in inability to carry on any physical activity without discomfort). This baseline measure was analyzed only for participants who had complications of heart failure.|participants|Number|13|13.0||||||
3756513|NCT01964976|3590801|B2|NYHA Class I||New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (participants with cardiac disease but without resulting limitations of physical activity), Class II (participants with cardiac disease resulting in slight limitation of physical activity), Class III (participants with cardiac disease resulting in marked limitation of physical activity), Class IV (participants with cardiac disease resulting in inability to carry on any physical activity without discomfort). This baseline measure was analyzed only for participants who had complications of heart failure.|participants|Number|0|0.0||||||
3756514|NCT01964976|3590802|B1|NYHA Class I||New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (participants with cardiac disease but without resulting limitations of physical activity), Class II (participants with cardiac disease resulting in slight limitation of physical activity), Class III (participants with cardiac disease resulting in marked limitation of physical activity), Class IV (participants with cardiac disease resulting in inability to carry on any physical activity without discomfort). This baseline measure was analyzed only for participants who had complications of heart failure.|participants|Number|13|13.0||||||
3756515|NCT01964976|3590800|B3|Had no complications||Complications of Heart Failure||participants|Number|1043|1043.0||||||
3756516|NCT01964976|3590801|B2|Had no complications||Complications of Heart Failure||participants|Number|108|108.0||||||
3756517|NCT01964976|3590802|B1|Had no complications||Complications of Heart Failure||participants|Number|935|935.0||||||
3756518|NCT01964976|3590800|B3|Had complications||Complications of Heart Failure||participants|Number|20|20.0||||||
3756519|NCT01964976|3590801|B2|Had complications||Complications of Heart Failure||participants|Number|1|1.0||||||
3756520|NCT01964976|3590802|B1|Had complications||Complications of Heart Failure||participants|Number|19|19.0||||||
3756611|NCT01964976|3590800|B3|Diabetic retinopathy||Breakdown of diabetic complications|This baseline characteristic was analyzed only in participants who had diabetic complications. Participants may be represented in more than 1 category.|participants|Number|101|101.0||||||
3756521|NCT01964976|3590800|B3|Other||Breakdown of Complications of Heart Disease|Heart disease complications were categorized as cardiac failure, myocardial infarction, angina pectoris, and any other complications related to heart disease. This baseline characteristic was analyzed only in participants who had heart disease complications. Participants may be represented in more than 1 category.|participants|Number|26|26.0||||||
3756522|NCT01964976|3590801|B2|Other||Breakdown of Complications of Heart Disease|Heart disease complications were categorized as cardiac failure, myocardial infarction, angina pectoris, and any other complications related to heart disease. This baseline characteristic was analyzed only in participants who had heart disease complications. Participants may be represented in more than 1 category.|participants|Number|2|2.0||||||
3756523|NCT01964976|3590802|B1|Other||Breakdown of Complications of Heart Disease|Heart disease complications were categorized as cardiac failure, myocardial infarction, angina pectoris, and any other complications related to heart disease. This baseline characteristic was analyzed only in participants who had heart disease complications. Participants may be represented in more than 1 category.|participants|Number|24|24.0||||||
3756524|NCT01964976|3590800|B3|Angina pectoris||Breakdown of Complications of Heart Disease|Heart disease complications were categorized as cardiac failure, myocardial infarction, angina pectoris, and any other complications related to heart disease. This baseline characteristic was analyzed only in participants who had heart disease complications. Participants may be represented in more than 1 category.|participants|Number|52|52.0||||||
3756525|NCT01964976|3590801|B2|Angina pectoris||Breakdown of Complications of Heart Disease|Heart disease complications were categorized as cardiac failure, myocardial infarction, angina pectoris, and any other complications related to heart disease. This baseline characteristic was analyzed only in participants who had heart disease complications. Participants may be represented in more than 1 category.|participants|Number|3|3.0||||||
3756526|NCT01964976|3590802|B1|Angina pectoris||Breakdown of Complications of Heart Disease|Heart disease complications were categorized as cardiac failure, myocardial infarction, angina pectoris, and any other complications related to heart disease. This baseline characteristic was analyzed only in participants who had heart disease complications. Participants may be represented in more than 1 category.|participants|Number|49|49.0||||||
3756527|NCT01964976|3590800|B3|Myocardial infarction||Breakdown of Complications of Heart Disease|Heart disease complications were categorized as cardiac failure, myocardial infarction, angina pectoris, and any other complications related to heart disease. This baseline characteristic was analyzed only in participants who had heart disease complications. Participants may be represented in more than 1 category.|participants|Number|25|25.0||||||
3756528|NCT01964976|3590801|B2|Myocardial infarction||Breakdown of Complications of Heart Disease|Heart disease complications were categorized as cardiac failure, myocardial infarction, angina pectoris, and any other complications related to heart disease. This baseline characteristic was analyzed only in participants who had heart disease complications. Participants may be represented in more than 1 category.|participants|Number|1|1.0||||||
3756529|NCT01964976|3590802|B1|Myocardial infarction||Breakdown of Complications of Heart Disease|Heart disease complications were categorized as cardiac failure, myocardial infarction, angina pectoris, and any other complications related to heart disease. This baseline characteristic was analyzed only in participants who had heart disease complications. Participants may be represented in more than 1 category.|participants|Number|24|24.0||||||
3756530|NCT01964976|3590800|B3|Cardiac failure||Breakdown of Complications of Heart Disease|Heart disease complications were categorized as cardiac failure, myocardial infarction, angina pectoris, and any other complications related to heart disease. This baseline characteristic was analyzed only in participants who had heart disease complications. Participants may be represented in more than 1 category.|participants|Number|20|20.0||||||
3756531|NCT01964976|3590801|B2|Cardiac failure||Breakdown of Complications of Heart Disease|Heart disease complications were categorized as cardiac failure, myocardial infarction, angina pectoris, and any other complications related to heart disease. This baseline characteristic was analyzed only in participants who had heart disease complications. Participants may be represented in more than 1 category.|participants|Number|1|1.0||||||
3756532|NCT01964976|3590802|B1|Cardiac failure||Breakdown of Complications of Heart Disease|Heart disease complications were categorized as cardiac failure, myocardial infarction, angina pectoris, and any other complications related to heart disease. This baseline characteristic was analyzed only in participants who had heart disease complications. Participants may be represented in more than 1 category.|participants|Number|19|19.0||||||
3756533|NCT01964976|3590800|B3|Had no complications||Complications of Heart Disease||participants|Number|953|953.0||||||
3756534|NCT01964976|3590801|B2|Had no complications||Complications of Heart Disease||participants|Number|102|102.0||||||
3756535|NCT01964976|3590802|B1|Had no complications||Complications of Heart Disease||participants|Number|851|851.0||||||
3756536|NCT01964976|3590800|B3|Had complications||Complications of Heart Disease||participants|Number|110|110.0||||||
3756537|NCT01964976|3590801|B2|Had complications||Complications of Heart Disease||participants|Number|7|7.0||||||
3756538|NCT01964976|3590802|B1|Had complications||Complications of Heart Disease||participants|Number|103|103.0||||||
3756539|NCT01964976|3590800|B3|Other||Breakdown of Complications of Renal Damage|Renal damage complications were categorized as nephrotic syndrome, glomerulonephritis, renal failure chronic and any other complications related to renal damage. This baseline characteristic was analyzed only in participants who had renal damage complications. Participants may be represented in more than 1 category.|participants|Number|122|122.0||||||
3756540|NCT01964976|3590801|B2|Other||Breakdown of Complications of Renal Damage|Renal damage complications were categorized as nephrotic syndrome, glomerulonephritis, renal failure chronic and any other complications related to renal damage. This baseline characteristic was analyzed only in participants who had renal damage complications. Participants may be represented in more than 1 category.|participants|Number|12|12.0||||||
3756541|NCT01964976|3590802|B1|Other||Breakdown of Complications of Renal Damage|Renal damage complications were categorized as nephrotic syndrome, glomerulonephritis, renal failure chronic and any other complications related to renal damage. This baseline characteristic was analyzed only in participants who had renal damage complications. Participants may be represented in more than 1 category.|participants|Number|110|110.0||||||
3756706|NCT01964976|3590802|B1|>=2 to <5 years||Time from Diagnosis of Type 2 Diabetes||participants|Number|169|169.0||||||
3756542|NCT01964976|3590800|B3|Renal failure chronic||Breakdown of Complications of Renal Damage|Renal damage complications were categorized as nephrotic syndrome, glomerulonephritis, renal failure chronic and any other complications related to renal damage. This baseline characteristic was analyzed only in participants who had renal damage complications. Participants may be represented in more than 1 category.|participants|Number|2|2.0||||||
3756543|NCT01964976|3590801|B2|Renal failure chronic||Breakdown of Complications of Renal Damage|Renal damage complications were categorized as nephrotic syndrome, glomerulonephritis, renal failure chronic and any other complications related to renal damage. This baseline characteristic was analyzed only in participants who had renal damage complications. Participants may be represented in more than 1 category.|participants|Number|0|0.0||||||
3756544|NCT01964976|3590802|B1|Renal failure chronic||Breakdown of Complications of Renal Damage|Renal damage complications were categorized as nephrotic syndrome, glomerulonephritis, renal failure chronic and any other complications related to renal damage. This baseline characteristic was analyzed only in participants who had renal damage complications. Participants may be represented in more than 1 category.|participants|Number|2|2.0||||||
3756545|NCT01964976|3590800|B3|Glomerulonephritis||Breakdown of Complications of Renal Damage|Renal damage complications were categorized as nephrotic syndrome, glomerulonephritis, renal failure chronic and any other complications related to renal damage. This baseline characteristic was analyzed only in participants who had renal damage complications. Participants may be represented in more than 1 category.|participants|Number|1|1.0||||||
3756546|NCT01964976|3590801|B2|Glomerulonephritis||Breakdown of Complications of Renal Damage|Renal damage complications were categorized as nephrotic syndrome, glomerulonephritis, renal failure chronic and any other complications related to renal damage. This baseline characteristic was analyzed only in participants who had renal damage complications. Participants may be represented in more than 1 category.|participants|Number|0|0.0||||||
3756547|NCT01964976|3590802|B1|Glomerulonephritis||Breakdown of Complications of Renal Damage|Renal damage complications were categorized as nephrotic syndrome, glomerulonephritis, renal failure chronic and any other complications related to renal damage. This baseline characteristic was analyzed only in participants who had renal damage complications. Participants may be represented in more than 1 category.|participants|Number|1|1.0||||||
3756548|NCT01964976|3590800|B3|Nephrotic syndrome||Breakdown of Complications of Renal Damage|Renal damage complications were categorized as nephrotic syndrome, glomerulonephritis, renal failure chronic and any other complications related to renal damage. This baseline characteristic was analyzed only in participants who had renal damage complications. Participants may be represented in more than 1 category.|participants|Number|1|1.0||||||
3756549|NCT01964976|3590801|B2|Nephrotic syndrome||Breakdown of Complications of Renal Damage|Renal damage complications were categorized as nephrotic syndrome, glomerulonephritis, renal failure chronic and any other complications related to renal damage. This baseline characteristic was analyzed only in participants who had renal damage complications. Participants may be represented in more than 1 category.|participants|Number|0|0.0||||||
3756550|NCT01964976|3590802|B1|Nephrotic syndrome||Breakdown of Complications of Renal Damage|Renal damage complications were categorized as nephrotic syndrome, glomerulonephritis, renal failure chronic and any other complications related to renal damage. This baseline characteristic was analyzed only in participants who had renal damage complications. Participants may be represented in more than 1 category.|participants|Number|1|1.0||||||
3756551|NCT01964976|3590800|B3|Had No Complications||Complications of Renal Damage||participants|Number|937|937.0||||||
3756552|NCT01964976|3590801|B2|Had No Complications||Complications of Renal Damage||participants|Number|97|97.0||||||
3756553|NCT01964976|3590802|B1|Had No Complications||Complications of Renal Damage||participants|Number|840|840.0||||||
3756554|NCT01964976|3590800|B3|Had complications||Complications of Renal Damage||participants|Number|126|126.0||||||
3756555|NCT01964976|3590801|B2|Had complications||Complications of Renal Damage||participants|Number|12|12.0||||||
3756556|NCT01964976|3590802|B1|Had complications||Complications of Renal Damage||participants|Number|114|114.0||||||
3756557|NCT01964976|3590800|B3|Unknown||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and a higher severity grade for either AST or ALT serum levels was adopted. Normal: <50 international units per liter (IU/L), Grade 1: >=50 to <100 IU/L, Grade 2: >=100 to <500 IU/L, and Grade 3: >=500 IU/L.|participants|Number|285|285.0||||||
3756558|NCT01964976|3590801|B2|Unknown||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and a higher severity grade for either AST or ALT serum levels was adopted. Normal: <50 international units per liter (IU/L), Grade 1: >=50 to <100 IU/L, Grade 2: >=100 to <500 IU/L, and Grade 3: >=500 IU/L.|participants|Number|30|30.0||||||
3756559|NCT01964976|3590802|B1|Unknown||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and a higher severity grade for either AST or ALT serum levels was adopted. Normal: <50 international units per liter (IU/L), Grade 1: >=50 to <100 IU/L, Grade 2: >=100 to <500 IU/L, and Grade 3: >=500 IU/L.|participants|Number|255|255.0||||||
3756560|NCT01964976|3590800|B3|Grade 2||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and a higher severity grade for either AST or ALT serum levels was adopted. Normal: <50 international units per liter (IU/L), Grade 1: >=50 to <100 IU/L, Grade 2: >=100 to <500 IU/L, and Grade 3: >=500 IU/L.|participants|Number|22|22.0||||||
3756561|NCT01964976|3590801|B2|Grade 2||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and a higher severity grade for either AST or ALT serum levels was adopted. Normal: <50 international units per liter (IU/L), Grade 1: >=50 to <100 IU/L, Grade 2: >=100 to <500 IU/L, and Grade 3: >=500 IU/L.|participants|Number|1|1.0||||||
3756707|NCT01964976|3590800|B3|<2 years||Time from Diagnosis of Type 2 Diabetes||participants|Number|130|130.0||||||
3756562|NCT01964976|3590802|B1|Grade 2||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and a higher severity grade for either AST or ALT serum levels was adopted. Normal: <50 international units per liter (IU/L), Grade 1: >=50 to <100 IU/L, Grade 2: >=100 to <500 IU/L, and Grade 3: >=500 IU/L.|participants|Number|21|21.0||||||
3756563|NCT01964976|3590800|B3|Grade 1||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and a higher severity grade for either AST or ALT serum levels was adopted. Normal: <50 international units per liter (IU/L), Grade 1: >=50 to <100 IU/L, Grade 2: >=100 to <500 IU/L, and Grade 3: >=500 IU/L.|participants|Number|94|94.0||||||
3756564|NCT01964976|3590801|B2|Grade 1||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and a higher severity grade for either AST or ALT serum levels was adopted. Normal: <50 international units per liter (IU/L), Grade 1: >=50 to <100 IU/L, Grade 2: >=100 to <500 IU/L, and Grade 3: >=500 IU/L.|participants|Number|13|13.0||||||
3756565|NCT01964976|3590802|B1|Grade 1||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and a higher severity grade for either AST or ALT serum levels was adopted. Normal: <50 international units per liter (IU/L), Grade 1: >=50 to <100 IU/L, Grade 2: >=100 to <500 IU/L, and Grade 3: >=500 IU/L.|participants|Number|81|81.0||||||
3756566|NCT01964976|3590800|B3|Normal||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and a higher severity grade for either AST or ALT serum levels was adopted. Normal: <50 international units per liter (IU/L), Grade 1: >=50 to <100 IU/L, Grade 2: >=100 to <500 IU/L, and Grade 3: >=500 IU/L.|participants|Number|662|662.0||||||
3756567|NCT01964976|3590801|B2|Normal||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and a higher severity grade for either AST or ALT serum levels was adopted. Normal: <50 international units per liter (IU/L), Grade 1: >=50 to <100 IU/L, Grade 2: >=100 to <500 IU/L, and Grade 3: >=500 IU/L.|participants|Number|65|65.0||||||
3756568|NCT01964976|3590802|B1|Normal||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and a higher severity grade for either AST or ALT serum levels was adopted. Normal: <50 international units per liter (IU/L), Grade 1: >=50 to <100 IU/L, Grade 2: >=100 to <500 IU/L, and Grade 3: >=500 IU/L.|participants|Number|597|597.0||||||
3756569|NCT01964976|3590800|B3|Other||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. This baseline characteristic was analyzed only in participants who had complications of liver damage. Participants may be represented in more than 1 category.|participants|Number|7|7.0||||||
3756570|NCT01964976|3590801|B2|Other||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. This baseline characteristic was analyzed only in participants who had complications of liver damage. Participants may be represented in more than 1 category.|participants|Number|0|0.0||||||
3756571|NCT01964976|3590802|B1|Other||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. This baseline characteristic was analyzed only in participants who had complications of liver damage. Participants may be represented in more than 1 category.|participants|Number|7|7.0||||||
3756572|NCT01964976|3590800|B3|Hepatic cirrhosis||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. This baseline characteristic was analyzed only in participants who had complications of liver damage. Participants may be represented in more than 1 category.|participants|Number|3|3.0||||||
3756573|NCT01964976|3590801|B2|Hepatic cirrhosis||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. This baseline characteristic was analyzed only in participants who had complications of liver damage. Participants may be represented in more than 1 category.|participants|Number|1|1.0||||||
3756574|NCT01964976|3590802|B1|Hepatic cirrhosis||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. This baseline characteristic was analyzed only in participants who had complications of liver damage. Participants may be represented in more than 1 category.|participants|Number|2|2.0||||||
3756575|NCT01964976|3590800|B3|Chronic hepatitis||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. This baseline characteristic was analyzed only in participants who had complications of liver damage. Participants may be represented in more than 1 category.|participants|Number|20|20.0||||||
3756576|NCT01964976|3590801|B2|Chronic hepatitis||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. This baseline characteristic was analyzed only in participants who had complications of liver damage. Participants may be represented in more than 1 category.|participants|Number|5|5.0||||||
3756612|NCT01964976|3590801|B2|Diabetic retinopathy||Breakdown of diabetic complications|This baseline characteristic was analyzed only in participants who had diabetic complications. Participants may be represented in more than 1 category.|participants|Number|10|10.0||||||
3756577|NCT01964976|3590802|B1|Chronic hepatitis||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. This baseline characteristic was analyzed only in participants who had complications of liver damage. Participants may be represented in more than 1 category.|participants|Number|15|15.0||||||
3756578|NCT01964976|3590800|B3|Hepatitis alcoholic||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. This baseline characteristic was analyzed only in participants who had complications of liver damage. Participants may be represented in more than 1 category.|participants|Number|28|28.0||||||
3756579|NCT01964976|3590801|B2|Hepatitis alcoholic||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. This baseline characteristic was analyzed only in participants who had complications of liver damage. Participants may be represented in more than 1 category.|participants|Number|5|5.0||||||
3756580|NCT01964976|3590802|B1|Hepatitis alcoholic||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. This baseline characteristic was analyzed only in participants who had complications of liver damage. Participants may be represented in more than 1 category.|participants|Number|23|23.0||||||
3756581|NCT01964976|3590800|B3|Hepatic steatosis||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. This baseline characteristic was analyzed only in participants who had complications of liver damage. Participants may be represented in more than 1 category.|participants|Number|173|173.0||||||
3756582|NCT01964976|3590801|B2|Hepatic steatosis||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. This baseline characteristic was analyzed only in participants who had complications of liver damage. Participants may be represented in more than 1 category.|participants|Number|15|15.0||||||
3756583|NCT01964976|3590802|B1|Hepatic steatosis||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. This baseline characteristic was analyzed only in participants who had complications of liver damage. Participants may be represented in more than 1 category.|participants|Number|158|158.0||||||
3756584|NCT01964976|3590800|B3|Had no complications||Complications of Liver Damage||participants|Number|840|840.0||||||
3756585|NCT01964976|3590801|B2|Had no complications||Complications of Liver Damage||participants|Number|89|89.0||||||
3756586|NCT01964976|3590802|B1|Had no complications||Complications of Liver Damage||participants|Number|751|751.0||||||
3756587|NCT01964976|3590800|B3|Had complications||Complications of Liver Damage||participants|Number|223|223.0||||||
3756588|NCT01964976|3590801|B2|Had complications||Complications of Liver Damage||participants|Number|20|20.0||||||
3756589|NCT01964976|3590802|B1|Had complications||Complications of Liver Damage||participants|Number|203|203.0||||||
3756590|NCT01964976|3590800|B3|Had no complications||Complications of Hyperuricemia||participants|Number|980|980.0||||||
3756591|NCT01964976|3590801|B2|Had no complications||Complications of Hyperuricemia||participants|Number|95|95.0||||||
3756592|NCT01964976|3590802|B1|Had no complications||Complications of Hyperuricemia||participants|Number|885|885.0||||||
3756593|NCT01964976|3590800|B3|Had complications||Complications of Hyperuricemia||participants|Number|83|83.0||||||
3756594|NCT01964976|3590801|B2|Had complications||Complications of Hyperuricemia||participants|Number|14|14.0||||||
3756595|NCT01964976|3590802|B1|Had complications||Complications of Hyperuricemia||participants|Number|69|69.0||||||
3756596|NCT01964976|3590800|B3|Had no complications||Complications of Dyslipidemia||participants|Number|371|371.0||||||
3756597|NCT01964976|3590801|B2|Had no complications||Complications of Dyslipidemia||participants|Number|40|40.0||||||
3756598|NCT01964976|3590802|B1|Had no complications||Complications of Dyslipidemia||participants|Number|331|331.0||||||
3756599|NCT01964976|3590800|B3|Had complications||Complications of Dyslipidemia||participants|Number|692|692.0||||||
3756600|NCT01964976|3590801|B2|Had complications||Complications of Dyslipidemia||participants|Number|69|69.0||||||
3756601|NCT01964976|3590802|B1|Had complications||Complications of Dyslipidemia||participants|Number|623|623.0||||||
3756602|NCT01964976|3590800|B3|Had no complications||Complications of Hypertension||participants|Number|442|442.0||||||
3756603|NCT01964976|3590801|B2|Had no complications||Complications of Hypertension||participants|Number|55|55.0||||||
3756604|NCT01964976|3590802|B1|Had no complications||Complications of Hypertension||participants|Number|387|387.0||||||
3756605|NCT01964976|3590800|B3|Had complications||Complications of Hypertension||participants|Number|621|621.0||||||
3756606|NCT01964976|3590801|B2|Had complications||Complications of Hypertension||participants|Number|54|54.0||||||
3756607|NCT01964976|3590802|B1|Had complications||Complications of Hypertension||participants|Number|567|567.0||||||
3756608|NCT01964976|3590800|B3|Diabetic neuropathy||Breakdown of diabetic complications|This baseline characteristic was analyzed only in participants who had diabetic complications. Participants may be represented in more than 1 category.|participants|Number|91|91.0||||||
3756609|NCT01964976|3590801|B2|Diabetic neuropathy||Breakdown of diabetic complications|This baseline characteristic was analyzed only in participants who had diabetic complications. Participants may be represented in more than 1 category.|participants|Number|8|8.0||||||
3756610|NCT01964976|3590802|B1|Diabetic neuropathy||Breakdown of diabetic complications|This baseline characteristic was analyzed only in participants who had diabetic complications. Participants may be represented in more than 1 category.|participants|Number|83|83.0||||||
3756708|NCT01964976|3590801|B2|<2 years||Time from Diagnosis of Type 2 Diabetes||participants|Number|16|16.0||||||
3756709|NCT01964976|3590802|B1|<2 years||Time from Diagnosis of Type 2 Diabetes||participants|Number|114|114.0||||||
3756613|NCT01964976|3590802|B1|Diabetic retinopathy||Breakdown of diabetic complications|This baseline characteristic was analyzed only in participants who had diabetic complications. Participants may be represented in more than 1 category.|participants|Number|91|91.0||||||
3756614|NCT01964976|3590800|B3|Diabetic nephropathy||Breakdown of diabetic complications|This baseline characteristic was analyzed only in participants who had diabetic complications. Participants may be represented in more than 1 category.|participants|Number|122|122.0||||||
3756615|NCT01964976|3590801|B2|Diabetic nephropathy||Breakdown of diabetic complications|This baseline characteristic was analyzed only in participants who had diabetic complications. Participants may be represented in more than 1 category.|participants|Number|12|12.0||||||
3756616|NCT01964976|3590802|B1|Diabetic nephropathy||Breakdown of diabetic complications|This baseline characteristic was analyzed only in participants who had diabetic complications. Participants may be represented in more than 1 category.|participants|Number|110|110.0||||||
3756617|NCT01964976|3590800|B3|Had No Complications||Diabetic complications||participants|Number|837|837.0||||||
3756618|NCT01964976|3590801|B2|Had No Complications||Diabetic complications||participants|Number|89|89.0||||||
3756619|NCT01964976|3590802|B1|Had No Complications||Diabetic complications||participants|Number|748|748.0||||||
3756620|NCT01964976|3590800|B3|Had complications||Diabetic complications||participants|Number|226|226.0||||||
3756621|NCT01964976|3590801|B2|Had complications||Diabetic complications||participants|Number|20|20.0||||||
3756622|NCT01964976|3590802|B1|Had complications||Diabetic complications||participants|Number|206|206.0||||||
3756623|NCT01964976|3590800|B3|Had no complications||Health-related Complications||participants|Number|110|110.0||||||
3756624|NCT01964976|3590801|B2|Had no complications||Health-related Complications||participants|Number|18|18.0||||||
3756625|NCT01964976|3590802|B1|Had no complications||Health-related Complications||participants|Number|92|92.0||||||
3756626|NCT01964976|3590800|B3|Had complications||Health-related Complications||participants|Number|953|953.0||||||
3756627|NCT01964976|3590801|B2|Had complications||Health-related Complications||participants|Number|91|91.0||||||
3756628|NCT01964976|3590802|B1|Had complications||Health-related Complications||participants|Number|862|862.0||||||
3756629|NCT01964976|3590800|B3|Unknown||History of Allergy||participants|Number|104|104.0||||||
3756630|NCT01964976|3590801|B2|Unknown||History of Allergy||participants|Number|15|15.0||||||
3756631|NCT01964976|3590802|B1|Unknown||History of Allergy||participants|Number|89|89.0||||||
3756632|NCT01964976|3590800|B3|Did not have allergy||History of Allergy||participants|Number|102|102.0||||||
3756633|NCT01964976|3590801|B2|Did not have allergy||History of Allergy||participants|Number|10|10.0||||||
3756634|NCT01964976|3590802|B1|Did not have allergy||History of Allergy||participants|Number|92|92.0||||||
3756635|NCT01964976|3590800|B3|Had allergy||History of Allergy||participants|Number|857|857.0||||||
3756636|NCT01964976|3590801|B2|Had allergy||History of Allergy||participants|Number|84|84.0||||||
3756637|NCT01964976|3590802|B1|Had allergy||History of Allergy||participants|Number|773|773.0||||||
3756638|NCT01964976|3590800|B3|Unknown||Degree of Renal Dysfunction|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was listed as “unknown.” Normal: >=90 milliliter per minute (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2. eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female), where Cr is serum creatinine.|participants|Number|278|278.0||||||
3756639|NCT01964976|3590801|B2|Unknown||Degree of Renal Dysfunction|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was listed as “unknown.” Normal: >=90 milliliter per minute (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2. eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female), where Cr is serum creatinine.|participants|Number|34|34.0||||||
3756640|NCT01964976|3590802|B1|Unknown||Degree of Renal Dysfunction|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was listed as “unknown.” Normal: >=90 milliliter per minute (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2. eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female), where Cr is serum creatinine.|participants|Number|244|244.0||||||
3756641|NCT01964976|3590800|B3|Severe||Degree of Renal Dysfunction|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was listed as “unknown.” Normal: >=90 milliliter per minute (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2. eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female), where Cr is serum creatinine.|participants|Number|3|3.0||||||
3756642|NCT01964976|3590801|B2|Severe||Degree of Renal Dysfunction|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was listed as “unknown.” Normal: >=90 milliliter per minute (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2. eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female), where Cr is serum creatinine.|participants|Number|0|0.0||||||
3756655|NCT01964976|3590802|B1|Outpatient and inpatient||Healthcare Category|Participants were categorized as outpatient, inpatient, and outpatient and inpatient (participants who were both outpatient and inpatient during some point at the time and 3 months prior to enrollment).|participants|Number|32|32.0||||||
3756710|NCT01964976|3590800|B3||Male|Sex: Female, Male||Participants|Count of Participants|638|638.0||||||
3756643|NCT01964976|3590802|B1|Severe||Degree of Renal Dysfunction|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was listed as “unknown.” Normal: >=90 milliliter per minute (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2. eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female), where Cr is serum creatinine.|participants|Number|3|3.0||||||
3756644|NCT01964976|3590800|B3|Moderate||Degree of Renal Dysfunction|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was listed as “unknown.” Normal: >=90 milliliter per minute (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2. eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female), where Cr is serum creatinine.|participants|Number|148|148.0||||||
3756645|NCT01964976|3590801|B2|Moderate||Degree of Renal Dysfunction|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was listed as “unknown.” Normal: >=90 milliliter per minute (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2. eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female), where Cr is serum creatinine.|participants|Number|13|13.0||||||
3756646|NCT01964976|3590802|B1|Moderate||Degree of Renal Dysfunction|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was listed as “unknown.” Normal: >=90 milliliter per minute (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2. eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female), where Cr is serum creatinine.|participants|Number|135|135.0||||||
3756647|NCT01964976|3590800|B3|Mild||Degree of Renal Dysfunction|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was listed as “unknown.” Normal: >=90 milliliter per minute (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2. eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female), where Cr is serum creatinine.|participants|Number|409|409.0||||||
3756648|NCT01964976|3590801|B2|Mild||Degree of Renal Dysfunction|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was listed as “unknown.” Normal: >=90 milliliter per minute (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2. eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female), where Cr is serum creatinine.|participants|Number|50|50.0||||||
3756649|NCT01964976|3590802|B1|Mild||Degree of Renal Dysfunction|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was listed as “unknown.” Normal: >=90 milliliter per minute (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2. eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female), where Cr is serum creatinine.|participants|Number|359|359.0||||||
3756650|NCT01964976|3590800|B3|Normal||Degree of Renal Dysfunction|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was listed as “unknown.” Normal: >=90 milliliter per minute (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2. eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female), where Cr is serum creatinine.|participants|Number|225|225.0||||||
3756651|NCT01964976|3590801|B2|Normal||Degree of Renal Dysfunction|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was listed as “unknown.” Normal: >=90 milliliter per minute (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2. eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female), where Cr is serum creatinine.|participants|Number|12|12.0||||||
3756652|NCT01964976|3590802|B1|Normal||Degree of Renal Dysfunction|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was listed as “unknown.” Normal: >=90 milliliter per minute (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2. eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female), where Cr is serum creatinine.|participants|Number|213|213.0||||||
3756653|NCT01964976|3590800|B3|Outpatient and inpatient||Healthcare Category|Participants were categorized as outpatient, inpatient, and outpatient and inpatient (participants who were both outpatient and inpatient during some point at the time and 3 months prior to enrollment).|participants|Number|38|38.0||||||
3756654|NCT01964976|3590801|B2|Outpatient and inpatient||Healthcare Category|Participants were categorized as outpatient, inpatient, and outpatient and inpatient (participants who were both outpatient and inpatient during some point at the time and 3 months prior to enrollment).|participants|Number|6|6.0||||||
3756705|NCT01964976|3590801|B2|>=2 to <5 years||Time from Diagnosis of Type 2 Diabetes||participants|Number|20|20.0||||||
3756656|NCT01964976|3590800|B3|Inpatient||Healthcare Category|Participants were categorized as outpatient, inpatient, and outpatient and inpatient (participants who were both outpatient and inpatient during some point at the time and 3 months prior to enrollment).|participants|Number|3|3.0||||||
3756657|NCT01964976|3590801|B2|Inpatient||Healthcare Category|Participants were categorized as outpatient, inpatient, and outpatient and inpatient (participants who were both outpatient and inpatient during some point at the time and 3 months prior to enrollment).|participants|Number|1|1.0||||||
3756658|NCT01964976|3590802|B1|Inpatient||Healthcare Category|Participants were categorized as outpatient, inpatient, and outpatient and inpatient (participants who were both outpatient and inpatient during some point at the time and 3 months prior to enrollment).|participants|Number|2|2.0||||||
3756659|NCT01964976|3590800|B3|Outpatient||Healthcare Category|Participants were categorized as outpatient, inpatient, and outpatient and inpatient (participants who were both outpatient and inpatient during some point at the time and 3 months prior to enrollment).|participants|Number|1022|1022.0||||||
3756660|NCT01964976|3590801|B2|Outpatient||Healthcare Category|Participants were categorized as outpatient, inpatient, and outpatient and inpatient (participants who were both outpatient and inpatient during some point at the time and 3 months prior to enrollment).|participants|Number|102|102.0||||||
3756661|NCT01964976|3590802|B1|Outpatient||Healthcare Category|Participants were categorized as outpatient, inpatient, and outpatient and inpatient (participants who were both outpatient and inpatient during some point at the time and 3 months prior to enrollment).|participants|Number|920|920.0||||||
3756662|NCT01964976|3590800|B3|Pregnant||Pregnancy Status|This baseline characteristic was analyzed only in female participants.|participants|Number|0|0.0||||||
3756663|NCT01964976|3590801|B2|Pregnant||Pregnancy Status|This baseline characteristic was analyzed only in female participants.|participants|Number|0|0.0||||||
3756664|NCT01964976|3590802|B1|Pregnant||Pregnancy Status|This baseline characteristic was analyzed only in female participants.|participants|Number|0|0.0||||||
3756665|NCT01964976|3590800|B3|Not pregnant||Pregnancy Status|This baseline characteristic was analyzed only in female participants.|participants|Number|425|425.0||||||
3756666|NCT01964976|3590801|B2|Not pregnant||Pregnancy Status|This baseline characteristic was analyzed only in female participants.|participants|Number|37|37.0||||||
3756667|NCT01964976|3590802|B1|Not pregnant||Pregnancy Status|This baseline characteristic was analyzed only in female participants.|participants|Number|388|388.0||||||
3756668|NCT01964976|3590800|B3|Unknown (Female)||Waist Circumference||participants|Number|348|348.0||||||
3756669|NCT01964976|3590801|B2|Unknown (Female)||Waist Circumference||participants|Number|30|30.0||||||
3756670|NCT01964976|3590802|B1|Unknown (Female)||Waist Circumference||participants|Number|318|318.0||||||
3756671|NCT01964976|3590800|B3|>=90 cm (Female)||Waist Circumference||participants|Number|36|36.0||||||
3756672|NCT01964976|3590801|B2|>=90 cm (Female)||Waist Circumference||participants|Number|3|3.0||||||
3756673|NCT01964976|3590802|B1|>=90 cm (Female)||Waist Circumference||participants|Number|33|33.0||||||
3756674|NCT01964976|3590800|B3|<90 cm (Female)||Waist Circumference||participants|Number|41|41.0||||||
3756675|NCT01964976|3590801|B2|<90 cm (Female)||Waist Circumference||participants|Number|4|4.0||||||
3756676|NCT01964976|3590802|B1|<90 cm (Female)||Waist Circumference||participants|Number|37|37.0||||||
3756677|NCT01964976|3590800|B3|Unknown (Male)||Waist Circumference||participants|Number|514|514.0||||||
3756678|NCT01964976|3590801|B2|Unknown (Male)||Waist Circumference||participants|Number|63|63.0||||||
3756679|NCT01964976|3590802|B1|Unknown (Male)||Waist Circumference||participants|Number|451|451.0||||||
3756680|NCT01964976|3590800|B3|>=85 cm (Male)||Waist Circumference||participants|Number|94|94.0||||||
3756681|NCT01964976|3590801|B2|>=85 cm (Male)||Waist Circumference||participants|Number|4|4.0||||||
3756682|NCT01964976|3590802|B1|>=85 cm (Male)||Waist Circumference||participants|Number|90|90.0||||||
3756683|NCT01964976|3590800|B3|<85 centimeter (cm) (Male)||Waist Circumference||participants|Number|30|30.0||||||
3756684|NCT01964976|3590801|B2|<85 centimeter (cm) (Male)||Waist Circumference||participants|Number|5|5.0||||||
3756685|NCT01964976|3590802|B1|<85 centimeter (cm) (Male)||Waist Circumference||participants|Number|25|25.0||||||
3756686|NCT01964976|3590800|B3|Unknown||Body Mass Index||participants|Number|228|228.0||||||
3756687|NCT01964976|3590801|B2|Unknown||Body Mass Index||participants|Number|29|29.0||||||
3756688|NCT01964976|3590802|B1|Unknown||Body Mass Index||participants|Number|199|199.0||||||
3756689|NCT01964976|3590800|B3|>=25 kg/m^2||Body Mass Index||participants|Number|455|455.0||||||
3756690|NCT01964976|3590801|B2|>=25 kg/m^2||Body Mass Index||participants|Number|45|45.0||||||
3756691|NCT01964976|3590802|B1|>=25 kg/m^2||Body Mass Index||participants|Number|410|410.0||||||
3756692|NCT01964976|3590800|B3|<25 kilogram per square meter (kg/m^2)||Body Mass Index||participants|Number|380|380.0||||||
3756693|NCT01964976|3590801|B2|<25 kilogram per square meter (kg/m^2)||Body Mass Index||participants|Number|35|35.0||||||
3756694|NCT01964976|3590802|B1|<25 kilogram per square meter (kg/m^2)||Body Mass Index||participants|Number|345|345.0||||||
3756695|NCT01964976|3590800|B3|Unknown||Time from Diagnosis of Type 2 Diabetes||participants|Number|226|226.0||||||
3756696|NCT01964976|3590801|B2|Unknown||Time from Diagnosis of Type 2 Diabetes||participants|Number|27|27.0||||||
3756697|NCT01964976|3590802|B1|Unknown||Time from Diagnosis of Type 2 Diabetes||participants|Number|199|199.0||||||
3756698|NCT01964976|3590800|B3|>=10 years||Time from Diagnosis of Type 2 Diabetes||participants|Number|281|281.0||||||
3756699|NCT01964976|3590801|B2|>=10 years||Time from Diagnosis of Type 2 Diabetes||participants|Number|27|27.0||||||
3756700|NCT01964976|3590802|B1|>=10 years||Time from Diagnosis of Type 2 Diabetes||participants|Number|254|254.0||||||
3756701|NCT01964976|3590800|B3|>=5 to <10 years||Time from Diagnosis of Type 2 Diabetes||participants|Number|237|237.0||||||
3756702|NCT01964976|3590801|B2|>=5 to <10 years||Time from Diagnosis of Type 2 Diabetes||participants|Number|19|19.0||||||
3756703|NCT01964976|3590802|B1|>=5 to <10 years||Time from Diagnosis of Type 2 Diabetes||participants|Number|218|218.0||||||
3756704|NCT01964976|3590800|B3|>=2 to <5 years||Time from Diagnosis of Type 2 Diabetes||participants|Number|189|189.0||||||
3756711|NCT01964976|3590801|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3756712|NCT01964976|3590802|B1||Male|Sex: Female, Male||Participants|Count of Participants|566|566.0||||||
3756713|NCT01964976|3590800|B3||Female|Sex: Female, Male||Participants|Count of Participants|425|425.0||||||
3756714|NCT01964976|3590801|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3756715|NCT01964976|3590802|B1||Female|Sex: Female, Male||Participants|Count of Participants|388|388.0||||||
3756716|NCT01964976|3590800|B3|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|456|456.0||||||
3756717|NCT01964976|3590801|B2|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|41|41.0||||||
3756718|NCT01964976|3590802|B1|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|415|415.0||||||
3756719|NCT01964976|3590800|B3|Less than (<) 65 years||Age, Customized||participants|Number|607|607.0||||||
3756720|NCT01964976|3590801|B2|Less than (<) 65 years||Age, Customized||participants|Number|68|68.0||||||
3756721|NCT01964976|3590802|B1|Less than (<) 65 years||Age, Customized||participants|Number|539|539.0||||||
3756722|NCT01964950|3590814|B3|Unknown||Glycosylated Hemoglobin (HbA1c) Level||participants|Number|76|76.0||||||
3756723|NCT01964950|3590815|B2|Unknown||Glycosylated Hemoglobin (HbA1c) Level||participants|Number|9|9.0||||||
3756724|NCT01964950|3590816|B1|Unknown||Glycosylated Hemoglobin (HbA1c) Level||participants|Number|67|67.0||||||
3756725|NCT01964950|3590814|B3|HbA1c >=8.0%||Glycosylated Hemoglobin (HbA1c) Level||participants|Number|435|435.0||||||
3756726|NCT01964950|3590815|B2|HbA1c >=8.0%||Glycosylated Hemoglobin (HbA1c) Level||participants|Number|61|61.0||||||
3756727|NCT01964950|3590816|B1|HbA1c >=8.0%||Glycosylated Hemoglobin (HbA1c) Level||participants|Number|374|374.0||||||
3756728|NCT01964950|3590814|B3|HbA1c >=7.0% to <8.0%||Glycosylated Hemoglobin (HbA1c) Level||participants|Number|373|373.0||||||
3756729|NCT01964950|3590815|B2|HbA1c >=7.0% to <8.0%||Glycosylated Hemoglobin (HbA1c) Level||participants|Number|61|61.0||||||
3756730|NCT01964950|3590816|B1|HbA1c >=7.0% to <8.0%||Glycosylated Hemoglobin (HbA1c) Level||participants|Number|312|312.0||||||
3756731|NCT01964950|3590814|B3|HbA1c >=6.0% to <7.0%||Glycosylated Hemoglobin (HbA1c) Level||participants|Number|174|174.0||||||
3756732|NCT01964950|3590815|B2|HbA1c >=6.0% to <7.0%||Glycosylated Hemoglobin (HbA1c) Level||participants|Number|25|25.0||||||
3756733|NCT01964950|3590816|B1|HbA1c >=6.0% to <7.0%||Glycosylated Hemoglobin (HbA1c) Level||participants|Number|149|149.0||||||
3756734|NCT01964950|3590814|B3|HbA1c <6.0 percent (%)||Glycosylated Hemoglobin (HbA1c) Level||participants|Number|18|18.0||||||
3756735|NCT01964950|3590815|B2|HbA1c <6.0 percent (%)||Glycosylated Hemoglobin (HbA1c) Level||participants|Number|4|4.0||||||
3756736|NCT01964950|3590816|B1|HbA1c <6.0 percent (%)||Glycosylated Hemoglobin (HbA1c) Level||participants|Number|14|14.0||||||
3756737|NCT01964950|3590814|B3|Unknown||Smoking Classification||participants|Number|250|250.0||||||
3756738|NCT01964950|3590815|B2|Unknown||Smoking Classification||participants|Number|40|40.0||||||
3756739|NCT01964950|3590816|B1|Unknown||Smoking Classification||participants|Number|210|210.0||||||
3756740|NCT01964950|3590814|B3|Ex-smoker||Smoking Classification||participants|Number|228|228.0||||||
3756741|NCT01964950|3590815|B2|Ex-smoker||Smoking Classification||participants|Number|39|39.0||||||
3756742|NCT01964950|3590816|B1|Ex-smoker||Smoking Classification||participants|Number|189|189.0||||||
3756743|NCT01964950|3590814|B3|Current smoker||Smoking Classification||participants|Number|175|175.0||||||
3756744|NCT01964950|3590815|B2|Current smoker||Smoking Classification||participants|Number|30|30.0||||||
3756745|NCT01964950|3590816|B1|Current smoker||Smoking Classification||participants|Number|145|145.0||||||
3756746|NCT01964950|3590814|B3|Never smoked||Smoking Classification||participants|Number|423|423.0||||||
3756747|NCT01964950|3590815|B2|Never smoked||Smoking Classification||participants|Number|51|51.0||||||
3756748|NCT01964950|3590816|B1|Never smoked||Smoking Classification||participants|Number|372|372.0||||||
3756749|NCT01964950|3590814|B3|Unknown||History of Alcohol Consumption|In this measure, participants responded whether they consumed alcohol-containing beverages nearly every day or not.|participants|Number|193|193.0||||||
3756750|NCT01964950|3590815|B2|Unknown||History of Alcohol Consumption|In this measure, participants responded whether they consumed alcohol-containing beverages nearly every day or not.|participants|Number|32|32.0||||||
3756751|NCT01964950|3590816|B1|Unknown||History of Alcohol Consumption|In this measure, participants responded whether they consumed alcohol-containing beverages nearly every day or not.|participants|Number|161|161.0||||||
3756752|NCT01964950|3590814|B3|No||History of Alcohol Consumption|In this measure, participants responded whether they consumed alcohol-containing beverages nearly every day or not.|participants|Number|611|611.0||||||
3756753|NCT01964950|3590815|B2|No||History of Alcohol Consumption|In this measure, participants responded whether they consumed alcohol-containing beverages nearly every day or not.|participants|Number|84|84.0||||||
3756754|NCT01964950|3590816|B1|No||History of Alcohol Consumption|In this measure, participants responded whether they consumed alcohol-containing beverages nearly every day or not.|participants|Number|527|527.0||||||
3756755|NCT01964950|3590814|B3|Yes||History of Alcohol Consumption|In this measure, participants responded whether they consumed alcohol-containing beverages nearly every day or not.|participants|Number|272|272.0||||||
3756756|NCT01964950|3590815|B2|Yes||History of Alcohol Consumption|In this measure, participants responded whether they consumed alcohol-containing beverages nearly every day or not.|participants|Number|44|44.0||||||
3756757|NCT01964950|3590816|B1|Yes||History of Alcohol Consumption|In this measure, participants responded whether they consumed alcohol-containing beverages nearly every day or not.|participants|Number|228|228.0||||||
3756758|NCT01964950|3590814|B3|Unknown||Presence of Medical History||participants|Number|115|115.0||||||
3756759|NCT01964950|3590815|B2|Unknown||Presence of Medical History||participants|Number|16|16.0||||||
3756760|NCT01964950|3590816|B1|Unknown||Presence of Medical History||participants|Number|99|99.0||||||
3756761|NCT01964950|3590814|B3|Did not have medical history||Presence of Medical History||participants|Number|765|765.0||||||
3756762|NCT01964950|3590815|B2|Did not have medical history||Presence of Medical History||participants|Number|113|113.0||||||
3756763|NCT01964950|3590816|B1|Did not have medical history||Presence of Medical History||participants|Number|652|652.0||||||
3756764|NCT01964950|3590814|B3|Had medical history||Presence of Medical History||participants|Number|196|196.0||||||
3756765|NCT01964950|3590815|B2|Had medical history||Presence of Medical History||participants|Number|31|31.0||||||
3756766|NCT01964950|3590816|B1|Had medical history||Presence of Medical History||participants|Number|165|165.0||||||
3756767|NCT01964950|3590814|B3|Had no complications||Complications of Malignant Tumor||participants|Number|1054|1054.0||||||
3756768|NCT01964950|3590815|B2|Had no complications||Complications of Malignant Tumor||participants|Number|157|157.0||||||
3756769|NCT01964950|3590816|B1|Had no complications||Complications of Malignant Tumor||participants|Number|897|897.0||||||
3756770|NCT01964950|3590814|B3|Had complications||Complications of Malignant Tumor||participants|Number|22|22.0||||||
3756771|NCT01964950|3590815|B2|Had complications||Complications of Malignant Tumor||participants|Number|3|3.0||||||
3756772|NCT01964950|3590816|B1|Had complications||Complications of Malignant Tumor||participants|Number|19|19.0||||||
3756773|NCT01964950|3590814|B3|Had no complications||Complications of Allergic Disease||participants|Number|1018|1018.0||||||
3756774|NCT01964950|3590815|B2|Had no complications||Complications of Allergic Disease||participants|Number|153|153.0||||||
3756775|NCT01964950|3590816|B1|Had no complications||Complications of Allergic Disease||participants|Number|865|865.0||||||
3756776|NCT01964950|3590814|B3|Had complications||Complications of Allergic Disease||participants|Number|58|58.0||||||
3756777|NCT01964950|3590815|B2|Had complications||Complications of Allergic Disease||participants|Number|7|7.0||||||
3756778|NCT01964950|3590816|B1|Had complications||Complications of Allergic Disease||participants|Number|51|51.0||||||
3756779|NCT01964950|3590814|B3|Cerebral haemorrhage||Breakdown of Complications of Stroke-related Disease|This baseline characteristic was analyzed only in participants who had complications of stroke-related disease.|participants|Number|1|1.0||||||
3756780|NCT01964950|3590815|B2|Cerebral haemorrhage||Breakdown of Complications of Stroke-related Disease|This baseline characteristic was analyzed only in participants who had complications of stroke-related disease.|participants|Number|0|0.0||||||
3756781|NCT01964950|3590816|B1|Cerebral haemorrhage||Breakdown of Complications of Stroke-related Disease|This baseline characteristic was analyzed only in participants who had complications of stroke-related disease.|participants|Number|1|1.0||||||
3756782|NCT01964950|3590814|B3|Cerebral infarction||Breakdown of Complications of Stroke-related Disease|This baseline characteristic was analyzed only in participants who had complications of stroke-related disease.|participants|Number|71|71.0||||||
3756783|NCT01964950|3590815|B2|Cerebral infarction||Breakdown of Complications of Stroke-related Disease|This baseline characteristic was analyzed only in participants who had complications of stroke-related disease.|participants|Number|7|7.0||||||
3756784|NCT01964950|3590816|B1|Cerebral infarction||Breakdown of Complications of Stroke-related Disease|This baseline characteristic was analyzed only in participants who had complications of stroke-related disease.|participants|Number|64|64.0||||||
3756785|NCT01964950|3590814|B3|Had no complications||Complications of Stroke-related Disease||participants|Number|1004|1004.0||||||
3756786|NCT01964950|3590815|B2|Had no complications||Complications of Stroke-related Disease||participants|Number|153|153.0||||||
3756787|NCT01964950|3590816|B1|Had no complications||Complications of Stroke-related Disease||participants|Number|851|851.0||||||
3756788|NCT01964950|3590814|B3|Had complications||Complications of Stroke-related Disease||participants|Number|72|72.0||||||
3756789|NCT01964950|3590815|B2|Had complications||Complications of Stroke-related Disease||participants|Number|7|7.0||||||
3756790|NCT01964950|3590816|B1|Had complications||Complications of Stroke-related Disease||participants|Number|65|65.0||||||
3756791|NCT01964950|3590814|B3|Unknown||New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (participants with cardiac disease but without resulting limitations of physical activity), Class II (participants with cardiac disease resulting in slight limitation of physical activity), Class III (participants with cardiac disease resulting in marked limitation of physical activity), Class IV (participants with cardiac disease resulting in inability to carry on any physical activity without discomfort). This baseline measure was analyzed only for participants who had complications of heart failure.|participants|Number|3|3.0||||||
3756792|NCT01964950|3590815|B2|Unknown||New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (participants with cardiac disease but without resulting limitations of physical activity), Class II (participants with cardiac disease resulting in slight limitation of physical activity), Class III (participants with cardiac disease resulting in marked limitation of physical activity), Class IV (participants with cardiac disease resulting in inability to carry on any physical activity without discomfort). This baseline measure was analyzed only for participants who had complications of heart failure.|participants|Number|1|1.0||||||
3756793|NCT01964950|3590816|B1|Unknown||New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (participants with cardiac disease but without resulting limitations of physical activity), Class II (participants with cardiac disease resulting in slight limitation of physical activity), Class III (participants with cardiac disease resulting in marked limitation of physical activity), Class IV (participants with cardiac disease resulting in inability to carry on any physical activity without discomfort). This baseline measure was analyzed only for participants who had complications of heart failure.|participants|Number|2|2.0||||||
3756794|NCT01964950|3590814|B3|NYHA Class IV||New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (participants with cardiac disease but without resulting limitations of physical activity), Class II (participants with cardiac disease resulting in slight limitation of physical activity), Class III (participants with cardiac disease resulting in marked limitation of physical activity), Class IV (participants with cardiac disease resulting in inability to carry on any physical activity without discomfort). This baseline measure was analyzed only for participants who had complications of heart failure.|participants|Number|1|1.0||||||
3756806|NCT01964950|3590814|B3|Had no complications||Complications of Heart Failure||participants|Number|1048|1048.0||||||
3756795|NCT01964950|3590815|B2|NYHA Class IV||New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (participants with cardiac disease but without resulting limitations of physical activity), Class II (participants with cardiac disease resulting in slight limitation of physical activity), Class III (participants with cardiac disease resulting in marked limitation of physical activity), Class IV (participants with cardiac disease resulting in inability to carry on any physical activity without discomfort). This baseline measure was analyzed only for participants who had complications of heart failure.|participants|Number|0|0.0||||||
3756796|NCT01964950|3590816|B1|NYHA Class IV||New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (participants with cardiac disease but without resulting limitations of physical activity), Class II (participants with cardiac disease resulting in slight limitation of physical activity), Class III (participants with cardiac disease resulting in marked limitation of physical activity), Class IV (participants with cardiac disease resulting in inability to carry on any physical activity without discomfort). This baseline measure was analyzed only for participants who had complications of heart failure.|participants|Number|1|1.0||||||
3756797|NCT01964950|3590814|B3|NYHA Class III||New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (participants with cardiac disease but without resulting limitations of physical activity), Class II (participants with cardiac disease resulting in slight limitation of physical activity), Class III (participants with cardiac disease resulting in marked limitation of physical activity), Class IV (participants with cardiac disease resulting in inability to carry on any physical activity without discomfort). This baseline measure was analyzed only for participants who had complications of heart failure.|participants|Number|1|1.0||||||
3756798|NCT01964950|3590815|B2|NYHA Class III||New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (participants with cardiac disease but without resulting limitations of physical activity), Class II (participants with cardiac disease resulting in slight limitation of physical activity), Class III (participants with cardiac disease resulting in marked limitation of physical activity), Class IV (participants with cardiac disease resulting in inability to carry on any physical activity without discomfort). This baseline measure was analyzed only for participants who had complications of heart failure.|participants|Number|0|0.0||||||
3756799|NCT01964950|3590816|B1|NYHA Class III||New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (participants with cardiac disease but without resulting limitations of physical activity), Class II (participants with cardiac disease resulting in slight limitation of physical activity), Class III (participants with cardiac disease resulting in marked limitation of physical activity), Class IV (participants with cardiac disease resulting in inability to carry on any physical activity without discomfort). This baseline measure was analyzed only for participants who had complications of heart failure.|participants|Number|1|1.0||||||
3756800|NCT01964950|3590814|B3|NYHA Class II||New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (participants with cardiac disease but without resulting limitations of physical activity), Class II (participants with cardiac disease resulting in slight limitation of physical activity), Class III (participants with cardiac disease resulting in marked limitation of physical activity), Class IV (participants with cardiac disease resulting in inability to carry on any physical activity without discomfort). This baseline measure was analyzed only for participants who had complications of heart failure.|participants|Number|5|5.0||||||
3756801|NCT01964950|3590815|B2|NYHA Class II||New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (participants with cardiac disease but without resulting limitations of physical activity), Class II (participants with cardiac disease resulting in slight limitation of physical activity), Class III (participants with cardiac disease resulting in marked limitation of physical activity), Class IV (participants with cardiac disease resulting in inability to carry on any physical activity without discomfort). This baseline measure was analyzed only for participants who had complications of heart failure.|participants|Number|0|0.0||||||
3756802|NCT01964950|3590816|B1|NYHA Class II||New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (participants with cardiac disease but without resulting limitations of physical activity), Class II (participants with cardiac disease resulting in slight limitation of physical activity), Class III (participants with cardiac disease resulting in marked limitation of physical activity), Class IV (participants with cardiac disease resulting in inability to carry on any physical activity without discomfort). This baseline measure was analyzed only for participants who had complications of heart failure.|participants|Number|5|5.0||||||
3756803|NCT01964950|3590814|B3|NYHA Class I||New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (participants with cardiac disease but without resulting limitations of physical activity), Class II (participants with cardiac disease resulting in slight limitation of physical activity), Class III (participants with cardiac disease resulting in marked limitation of physical activity), Class IV (participants with cardiac disease resulting in inability to carry on any physical activity without discomfort). This baseline measure was analyzed only for participants who had complications of heart failure.|participants|Number|18|18.0||||||
3756804|NCT01964950|3590815|B2|NYHA Class I||New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (participants with cardiac disease but without resulting limitations of physical activity), Class II (participants with cardiac disease resulting in slight limitation of physical activity), Class III (participants with cardiac disease resulting in marked limitation of physical activity), Class IV (participants with cardiac disease resulting in inability to carry on any physical activity without discomfort). This baseline measure was analyzed only for participants who had complications of heart failure.|participants|Number|2|2.0||||||
3756805|NCT01964950|3590816|B1|NYHA Class I||New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (participants with cardiac disease but without resulting limitations of physical activity), Class II (participants with cardiac disease resulting in slight limitation of physical activity), Class III (participants with cardiac disease resulting in marked limitation of physical activity), Class IV (participants with cardiac disease resulting in inability to carry on any physical activity without discomfort). This baseline measure was analyzed only for participants who had complications of heart failure.|participants|Number|16|16.0||||||
3756807|NCT01964950|3590815|B2|Had no complications||Complications of Heart Failure||participants|Number|157|157.0||||||
3756808|NCT01964950|3590816|B1|Had no complications||Complications of Heart Failure||participants|Number|891|891.0||||||
3756809|NCT01964950|3590814|B3|Had complications||Complications of Heart Failure||participants|Number|28|28.0||||||
3756810|NCT01964950|3590815|B2|Had complications||Complications of Heart Failure||participants|Number|3|3.0||||||
3756811|NCT01964950|3590816|B1|Had complications||Complications of Heart Failure||participants|Number|25|25.0||||||
3756812|NCT01964950|3590814|B3|Other||Breakdown of Complications of Heart Disease|Heart disease complications were categorized as cardiac failure, myocardial infarction, angina pectoris, and any other complications related to heart disease. This baseline characteristic was analyzed only in participants who had heart disease complications. Participants may be represented in more than 1 category.|participants|Number|30|30.0||||||
3756813|NCT01964950|3590815|B2|Other||Breakdown of Complications of Heart Disease|Heart disease complications were categorized as cardiac failure, myocardial infarction, angina pectoris, and any other complications related to heart disease. This baseline characteristic was analyzed only in participants who had heart disease complications. Participants may be represented in more than 1 category.|participants|Number|4|4.0||||||
3756814|NCT01964950|3590816|B1|Other||Breakdown of Complications of Heart Disease|Heart disease complications were categorized as cardiac failure, myocardial infarction, angina pectoris, and any other complications related to heart disease. This baseline characteristic was analyzed only in participants who had heart disease complications. Participants may be represented in more than 1 category.|participants|Number|26|26.0||||||
3756815|NCT01964950|3590814|B3|Angina pectoris||Breakdown of Complications of Heart Disease|Heart disease complications were categorized as cardiac failure, myocardial infarction, angina pectoris, and any other complications related to heart disease. This baseline characteristic was analyzed only in participants who had heart disease complications. Participants may be represented in more than 1 category.|participants|Number|77|77.0||||||
3756816|NCT01964950|3590815|B2|Angina pectoris||Breakdown of Complications of Heart Disease|Heart disease complications were categorized as cardiac failure, myocardial infarction, angina pectoris, and any other complications related to heart disease. This baseline characteristic was analyzed only in participants who had heart disease complications. Participants may be represented in more than 1 category.|participants|Number|7|7.0||||||
3756817|NCT01964950|3590816|B1|Angina pectoris||Breakdown of Complications of Heart Disease|Heart disease complications were categorized as cardiac failure, myocardial infarction, angina pectoris, and any other complications related to heart disease. This baseline characteristic was analyzed only in participants who had heart disease complications. Participants may be represented in more than 1 category.|participants|Number|70|70.0||||||
3756818|NCT01964950|3590814|B3|Myocardial infarction||Breakdown of Complications of Heart Disease|Heart disease complications were categorized as cardiac failure, myocardial infarction, angina pectoris, and any other complications related to heart disease. This baseline characteristic was analyzed only in participants who had heart disease complications. Participants may be represented in more than 1 category.|participants|Number|30|30.0||||||
3756819|NCT01964950|3590815|B2|Myocardial infarction||Breakdown of Complications of Heart Disease|Heart disease complications were categorized as cardiac failure, myocardial infarction, angina pectoris, and any other complications related to heart disease. This baseline characteristic was analyzed only in participants who had heart disease complications. Participants may be represented in more than 1 category.|participants|Number|4|4.0||||||
3756820|NCT01964950|3590816|B1|Myocardial infarction||Breakdown of Complications of Heart Disease|Heart disease complications were categorized as cardiac failure, myocardial infarction, angina pectoris, and any other complications related to heart disease. This baseline characteristic was analyzed only in participants who had heart disease complications. Participants may be represented in more than 1 category.|participants|Number|26|26.0||||||
3756821|NCT01964950|3590814|B3|Cardiac failure||Breakdown of Complications of Heart Disease|Heart disease complications were categorized as cardiac failure, myocardial infarction, angina pectoris, and any other complications related to heart disease. This baseline characteristic was analyzed only in participants who had heart disease complications. Participants may be represented in more than 1 category.|participants|Number|28|28.0||||||
3756822|NCT01964950|3590815|B2|Cardiac failure||Breakdown of Complications of Heart Disease|Heart disease complications were categorized as cardiac failure, myocardial infarction, angina pectoris, and any other complications related to heart disease. This baseline characteristic was analyzed only in participants who had heart disease complications. Participants may be represented in more than 1 category.|participants|Number|3|3.0||||||
3756823|NCT01964950|3590816|B1|Cardiac failure||Breakdown of Complications of Heart Disease|Heart disease complications were categorized as cardiac failure, myocardial infarction, angina pectoris, and any other complications related to heart disease. This baseline characteristic was analyzed only in participants who had heart disease complications. Participants may be represented in more than 1 category.|participants|Number|25|25.0||||||
3756824|NCT01964950|3590814|B3|Had no complications||Complications of Heart Disease||participants|Number|929|929.0||||||
3756825|NCT01964950|3590815|B2|Had no complications||Complications of Heart Disease||participants|Number|142|142.0||||||
3756826|NCT01964950|3590816|B1|Had no complications||Complications of Heart Disease||participants|Number|787|787.0||||||
3756827|NCT01964950|3590814|B3|Had complications||Complications of Heart Disease||participants|Number|147|147.0||||||
3756828|NCT01964950|3590815|B2|Had complications||Complications of Heart Disease||participants|Number|18|18.0||||||
3756829|NCT01964950|3590816|B1|Had complications||Complications of Heart Disease||participants|Number|129|129.0||||||
3756830|NCT01964950|3590814|B3|Other||Breakdown of Complications of Renal Damage|Renal damage complications were categorized as nephrotic syndrome, glomerulonephritis, renal failure chronic and any other complications related to renal damage. This baseline characteristic was analyzed only in participants who had renal damage complications. Participants may be represented in more than 1 category.|participants|Number|138|138.0||||||
3756899|NCT01964950|3590814|B3|Diabetic neuropathy||Breakdown of Diabetic Complications|This baseline characteristic was analyzed only in participants who had diabetic complications. Participants may be represented in more than 1 category.|participants|Number|81|81.0||||||
3756831|NCT01964950|3590815|B2|Other||Breakdown of Complications of Renal Damage|Renal damage complications were categorized as nephrotic syndrome, glomerulonephritis, renal failure chronic and any other complications related to renal damage. This baseline characteristic was analyzed only in participants who had renal damage complications. Participants may be represented in more than 1 category.|participants|Number|25|25.0||||||
3756832|NCT01964950|3590816|B1|Other||Breakdown of Complications of Renal Damage|Renal damage complications were categorized as nephrotic syndrome, glomerulonephritis, renal failure chronic and any other complications related to renal damage. This baseline characteristic was analyzed only in participants who had renal damage complications. Participants may be represented in more than 1 category.|participants|Number|113|113.0||||||
3756833|NCT01964950|3590814|B3|Renal failure chronic||Breakdown of Complications of Renal Damage|Renal damage complications were categorized as nephrotic syndrome, glomerulonephritis, renal failure chronic and any other complications related to renal damage. This baseline characteristic was analyzed only in participants who had renal damage complications. Participants may be represented in more than 1 category.|participants|Number|9|9.0||||||
3756834|NCT01964950|3590815|B2|Renal failure chronic||Breakdown of Complications of Renal Damage|Renal damage complications were categorized as nephrotic syndrome, glomerulonephritis, renal failure chronic and any other complications related to renal damage. This baseline characteristic was analyzed only in participants who had renal damage complications. Participants may be represented in more than 1 category.|participants|Number|0|0.0||||||
3756835|NCT01964950|3590816|B1|Renal failure chronic||Breakdown of Complications of Renal Damage|Renal damage complications were categorized as nephrotic syndrome, glomerulonephritis, renal failure chronic and any other complications related to renal damage. This baseline characteristic was analyzed only in participants who had renal damage complications. Participants may be represented in more than 1 category.|participants|Number|9|9.0||||||
3756836|NCT01964950|3590814|B3|Glomerulonephritis||Breakdown of Complications of Renal Damage|Renal damage complications were categorized as nephrotic syndrome, glomerulonephritis, renal failure chronic and any other complications related to renal damage. This baseline characteristic was analyzed only in participants who had renal damage complications. Participants may be represented in more than 1 category.|participants|Number|3|3.0||||||
3756837|NCT01964950|3590815|B2|Glomerulonephritis||Breakdown of Complications of Renal Damage|Renal damage complications were categorized as nephrotic syndrome, glomerulonephritis, renal failure chronic and any other complications related to renal damage. This baseline characteristic was analyzed only in participants who had renal damage complications. Participants may be represented in more than 1 category.|participants|Number|1|1.0||||||
3756838|NCT01964950|3590816|B1|Glomerulonephritis||Breakdown of Complications of Renal Damage|Renal damage complications were categorized as nephrotic syndrome, glomerulonephritis, renal failure chronic and any other complications related to renal damage. This baseline characteristic was analyzed only in participants who had renal damage complications. Participants may be represented in more than 1 category.|participants|Number|2|2.0||||||
3756839|NCT01964950|3590814|B3|Nephrotic syndrome||Breakdown of Complications of Renal Damage|Renal damage complications were categorized as nephrotic syndrome, glomerulonephritis, renal failure chronic and any other complications related to renal damage. This baseline characteristic was analyzed only in participants who had renal damage complications. Participants may be represented in more than 1 category.|participants|Number|4|4.0||||||
3756840|NCT01964950|3590815|B2|Nephrotic syndrome||Breakdown of Complications of Renal Damage|Renal damage complications were categorized as nephrotic syndrome, glomerulonephritis, renal failure chronic and any other complications related to renal damage. This baseline characteristic was analyzed only in participants who had renal damage complications. Participants may be represented in more than 1 category.|participants|Number|1|1.0||||||
3756841|NCT01964950|3590816|B1|Nephrotic syndrome||Breakdown of Complications of Renal Damage|Renal damage complications were categorized as nephrotic syndrome, glomerulonephritis, renal failure chronic and any other complications related to renal damage. This baseline characteristic was analyzed only in participants who had renal damage complications. Participants may be represented in more than 1 category.|participants|Number|3|3.0||||||
3756842|NCT01964950|3590814|B3|Had no complications||Complications of Renal Damage||participants|Number|923|923.0||||||
3756843|NCT01964950|3590815|B2|Had no complications||Complications of Renal Damage||participants|Number|133|133.0||||||
3756844|NCT01964950|3590816|B1|Had no complications||Complications of Renal Damage||participants|Number|790|790.0||||||
3756845|NCT01964950|3590814|B3|Had complications||Complications of Renal Damage||participants|Number|153|153.0||||||
3756846|NCT01964950|3590815|B2|Had complications||Complications of Renal Damage||participants|Number|27|27.0||||||
3756847|NCT01964950|3590816|B1|Had complications||Complications of Renal Damage||participants|Number|126|126.0||||||
3756848|NCT01964950|3590814|B3|Unknown||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and a higher severity grade for either AST or ALT serum levels was adopted. Normal: <50 international units per liter (IU/L), Grade 1: >=50 to <100 IU/L, Grade 2: >=100 to <500 IU/L, and Grade 3: >=500 IU/L.|participants|Number|268|268.0||||||
3756849|NCT01964950|3590815|B2|Unknown||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and a higher severity grade for either AST or ALT serum levels was adopted. Normal: <50 international units per liter (IU/L), Grade 1: >=50 to <100 IU/L, Grade 2: >=100 to <500 IU/L, and Grade 3: >=500 IU/L.|participants|Number|36|36.0||||||
3756850|NCT01964950|3590816|B1|Unknown||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and a higher severity grade for either AST or ALT serum levels was adopted. Normal: <50 international units per liter (IU/L), Grade 1: >=50 to <100 IU/L, Grade 2: >=100 to <500 IU/L, and Grade 3: >=500 IU/L.|participants|Number|232|232.0||||||
3756900|NCT01964950|3590815|B2|Diabetic neuropathy||Breakdown of Diabetic Complications|This baseline characteristic was analyzed only in participants who had diabetic complications. Participants may be represented in more than 1 category.|participants|Number|20|20.0||||||
3756851|NCT01964950|3590814|B3|Grade 2||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and a higher severity grade for either AST or ALT serum levels was adopted. Normal: <50 international units per liter (IU/L), Grade 1: >=50 to <100 IU/L, Grade 2: >=100 to <500 IU/L, and Grade 3: >=500 IU/L.|participants|Number|12|12.0||||||
3756852|NCT01964950|3590815|B2|Grade 2||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and a higher severity grade for either AST or ALT serum levels was adopted. Normal: <50 international units per liter (IU/L), Grade 1: >=50 to <100 IU/L, Grade 2: >=100 to <500 IU/L, and Grade 3: >=500 IU/L.|participants|Number|2|2.0||||||
3756853|NCT01964950|3590816|B1|Grade 2||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and a higher severity grade for either AST or ALT serum levels was adopted. Normal: <50 international units per liter (IU/L), Grade 1: >=50 to <100 IU/L, Grade 2: >=100 to <500 IU/L, and Grade 3: >=500 IU/L.|participants|Number|10|10.0||||||
3756854|NCT01964950|3590814|B3|Grade 1||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and a higher severity grade for either AST or ALT serum levels was adopted. Normal: <50 international units per liter (IU/L), Grade 1: >=50 to <100 IU/L, Grade 2: >=100 to <500 IU/L, and Grade 3: >=500 IU/L.|participants|Number|86|86.0||||||
3756855|NCT01964950|3590815|B2|Grade 1||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and a higher severity grade for either AST or ALT serum levels was adopted. Normal: <50 international units per liter (IU/L), Grade 1: >=50 to <100 IU/L, Grade 2: >=100 to <500 IU/L, and Grade 3: >=500 IU/L.|participants|Number|11|11.0||||||
3756856|NCT01964950|3590816|B1|Grade 1||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and a higher severity grade for either AST or ALT serum levels was adopted. Normal: <50 international units per liter (IU/L), Grade 1: >=50 to <100 IU/L, Grade 2: >=100 to <500 IU/L, and Grade 3: >=500 IU/L.|participants|Number|75|75.0||||||
3756857|NCT01964950|3590814|B3|Normal||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and a higher severity grade for either AST or ALT serum levels was adopted. Normal: <50 international units per liter (IU/L), Grade 1: >=50 to <100 IU/L, Grade 2: >=100 to <500 IU/L, and Grade 3: >=500 IU/L.|participants|Number|710|710.0||||||
3756858|NCT01964950|3590815|B2|Normal||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and a higher severity grade for either AST or ALT serum levels was adopted. Normal: <50 international units per liter (IU/L), Grade 1: >=50 to <100 IU/L, Grade 2: >=100 to <500 IU/L, and Grade 3: >=500 IU/L.|participants|Number|111|111.0||||||
3756859|NCT01964950|3590816|B1|Normal||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and a higher severity grade for either AST or ALT serum levels was adopted. Normal: <50 international units per liter (IU/L), Grade 1: >=50 to <100 IU/L, Grade 2: >=100 to <500 IU/L, and Grade 3: >=500 IU/L.|participants|Number|599|599.0||||||
3756860|NCT01964950|3590814|B3|Other||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. This baseline characteristic was analyzed only in participants who had complications of liver damage. Participants may be represented in more than 1 category.|participants|Number|4|4.0||||||
3756861|NCT01964950|3590815|B2|Other||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. This baseline characteristic was analyzed only in participants who had complications of liver damage. Participants may be represented in more than 1 category.|participants|Number|0|0.0||||||
3756862|NCT01964950|3590816|B1|Other||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. This baseline characteristic was analyzed only in participants who had complications of liver damage. Participants may be represented in more than 1 category.|participants|Number|4|4.0||||||
3756863|NCT01964950|3590814|B3|Hepatic cirrhosis||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. This baseline characteristic was analyzed only in participants who had complications of liver damage. Participants may be represented in more than 1 category.|participants|Number|3|3.0||||||
3756864|NCT01964950|3590815|B2|Hepatic cirrhosis||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. This baseline characteristic was analyzed only in participants who had complications of liver damage. Participants may be represented in more than 1 category.|participants|Number|1|1.0||||||
3756865|NCT01964950|3590816|B1|Hepatic cirrhosis||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. This baseline characteristic was analyzed only in participants who had complications of liver damage. Participants may be represented in more than 1 category.|participants|Number|2|2.0||||||
3756988|NCT01964950|3590816|B1|Unknown||Time From Diagnosis of Type 2 Diabetes||participants|Number|228|228.0||||||
3756866|NCT01964950|3590814|B3|Chronic hepatitis||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. This baseline characteristic was analyzed only in participants who had complications of liver damage. Participants may be represented in more than 1 category.|participants|Number|36|36.0||||||
3756867|NCT01964950|3590815|B2|Chronic hepatitis||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. This baseline characteristic was analyzed only in participants who had complications of liver damage. Participants may be represented in more than 1 category.|participants|Number|5|5.0||||||
3756868|NCT01964950|3590816|B1|Chronic hepatitis||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. This baseline characteristic was analyzed only in participants who had complications of liver damage. Participants may be represented in more than 1 category.|participants|Number|31|31.0||||||
3756869|NCT01964950|3590814|B3|Hepatitis alcoholic||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. This baseline characteristic was analyzed only in participants who had complications of liver damage. Participants may be represented in more than 1 category.|participants|Number|39|39.0||||||
3756870|NCT01964950|3590815|B2|Hepatitis alcoholic||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. This baseline characteristic was analyzed only in participants who had complications of liver damage. Participants may be represented in more than 1 category.|participants|Number|9|9.0||||||
3756871|NCT01964950|3590816|B1|Hepatitis alcoholic||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. This baseline characteristic was analyzed only in participants who had complications of liver damage. Participants may be represented in more than 1 category.|participants|Number|30|30.0||||||
3756872|NCT01964950|3590814|B3|Hepatic steatosis||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. This baseline characteristic was analyzed only in participants who had complications of liver damage. Participants may be represented in more than 1 category.|participants|Number|146|146.0||||||
3756873|NCT01964950|3590815|B2|Hepatic steatosis||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. This baseline characteristic was analyzed only in participants who had complications of liver damage. Participants may be represented in more than 1 category.|participants|Number|24|24.0||||||
3756874|NCT01964950|3590816|B1|Hepatic steatosis||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. This baseline characteristic was analyzed only in participants who had complications of liver damage. Participants may be represented in more than 1 category.|participants|Number|122|122.0||||||
3756875|NCT01964950|3590814|B3|Had no complications||Complications of Liver Damage||participants|Number|860|860.0||||||
3756876|NCT01964950|3590815|B2|Had no complications||Complications of Liver Damage||participants|Number|125|125.0||||||
3756877|NCT01964950|3590816|B1|Had no complications||Complications of Liver Damage||participants|Number|735|735.0||||||
3756878|NCT01964950|3590814|B3|Had complications||Complications of Liver Damage||participants|Number|216|216.0||||||
3756879|NCT01964950|3590815|B2|Had complications||Complications of Liver Damage||participants|Number|35|35.0||||||
3756880|NCT01964950|3590816|B1|Had complications||Complications of Liver Damage||participants|Number|181|181.0||||||
3756881|NCT01964950|3590814|B3|Had no complications||Complications of Hyperuricemia||participants|Number|994|994.0||||||
3756882|NCT01964950|3590815|B2|Had no complications||Complications of Hyperuricemia||participants|Number|152|152.0||||||
3756883|NCT01964950|3590816|B1|Had no complications||Complications of Hyperuricemia||participants|Number|842|842.0||||||
3756884|NCT01964950|3590814|B3|Had complications||Complications of Hyperuricemia||participants|Number|82|82.0||||||
3756885|NCT01964950|3590815|B2|Had complications||Complications of Hyperuricemia||participants|Number|8|8.0||||||
3756886|NCT01964950|3590816|B1|Had complications||Complications of Hyperuricemia||participants|Number|74|74.0||||||
3756887|NCT01964950|3590814|B3|Had no complications||Complications of Dyslipidemia||participants|Number|395|395.0||||||
3756888|NCT01964950|3590815|B2|Had no complications||Complications of Dyslipidemia||participants|Number|61|61.0||||||
3756889|NCT01964950|3590816|B1|Had no complications||Complications of Dyslipidemia||participants|Number|334|334.0||||||
3756890|NCT01964950|3590814|B3|Had complications||Complications of Dyslipidemia||participants|Number|681|681.0||||||
3756891|NCT01964950|3590815|B2|Had complications||Complications of Dyslipidemia||participants|Number|99|99.0||||||
3756892|NCT01964950|3590816|B1|Had complications||Complications of Dyslipidemia||participants|Number|582|582.0||||||
3756893|NCT01964950|3590814|B3|Had no complications||Complications of Hypertension||participants|Number|386|386.0||||||
3756894|NCT01964950|3590815|B2|Had no complications||Complications of Hypertension||participants|Number|63|63.0||||||
3756895|NCT01964950|3590816|B1|Had no complications||Complications of Hypertension||participants|Number|323|323.0||||||
3756896|NCT01964950|3590814|B3|Had complications||Complications of Hypertension||participants|Number|690|690.0||||||
3756897|NCT01964950|3590815|B2|Had complications||Complications of Hypertension||participants|Number|97|97.0||||||
3756898|NCT01964950|3590816|B1|Had complications||Complications of Hypertension||participants|Number|593|593.0||||||
3756989|NCT01964950|3590814|B3|>=10 years||Time From Diagnosis of Type 2 Diabetes||participants|Number|287|287.0||||||
3756901|NCT01964950|3590816|B1|Diabetic neuropathy||Breakdown of Diabetic Complications|This baseline characteristic was analyzed only in participants who had diabetic complications. Participants may be represented in more than 1 category.|participants|Number|61|61.0||||||
3756902|NCT01964950|3590814|B3|Diabetic retinopathy||Breakdown of Diabetic Complications|This baseline characteristic was analyzed only in participants who had diabetic complications. Participants may be represented in more than 1 category.|participants|Number|97|97.0||||||
3756903|NCT01964950|3590815|B2|Diabetic retinopathy||Breakdown of Diabetic Complications|This baseline characteristic was analyzed only in participants who had diabetic complications. Participants may be represented in more than 1 category.|participants|Number|21|21.0||||||
3756904|NCT01964950|3590816|B1|Diabetic retinopathy||Breakdown of Diabetic Complications|This baseline characteristic was analyzed only in participants who had diabetic complications. Participants may be represented in more than 1 category.|participants|Number|76|76.0||||||
3756905|NCT01964950|3590814|B3|Diabetic nephropathy||Breakdown of Diabetic Complications|This baseline characteristic was analyzed only in participants who had diabetic complications. Participants may be represented in more than 1 category.|participants|Number|137|137.0||||||
3756906|NCT01964950|3590815|B2|Diabetic nephropathy||Breakdown of Diabetic Complications|This baseline characteristic was analyzed only in participants who had diabetic complications. Participants may be represented in more than 1 category.|participants|Number|23|23.0||||||
3756907|NCT01964950|3590816|B1|Diabetic nephropathy||Breakdown of Diabetic Complications|This baseline characteristic was analyzed only in participants who had diabetic complications. Participants may be represented in more than 1 category.|participants|Number|114|114.0||||||
3756908|NCT01964950|3590814|B3|Had no complications||Diabetic Complications||participants|Number|846|846.0||||||
3756909|NCT01964950|3590815|B2|Had no complications||Diabetic Complications||participants|Number|117|117.0||||||
3756910|NCT01964950|3590816|B1|Had no complications||Diabetic Complications||participants|Number|729|729.0||||||
3756911|NCT01964950|3590814|B3|Had complications||Diabetic Complications||participants|Number|230|230.0||||||
3756912|NCT01964950|3590815|B2|Had complications||Diabetic Complications||participants|Number|43|43.0||||||
3756913|NCT01964950|3590816|B1|Had complications||Diabetic Complications||participants|Number|187|187.0||||||
3756914|NCT01964950|3590814|B3|Had no complications||Health-related Complications||participants|Number|94|94.0||||||
3756915|NCT01964950|3590815|B2|Had no complications||Health-related Complications||participants|Number|15|15.0||||||
3756916|NCT01964950|3590816|B1|Had no complications||Health-related Complications||participants|Number|79|79.0||||||
3756917|NCT01964950|3590814|B3|Had complications||Health-related Complications||participants|Number|982|982.0||||||
3756918|NCT01964950|3590815|B2|Had complications||Health-related Complications||participants|Number|145|145.0||||||
3756919|NCT01964950|3590816|B1|Had complications||Health-related Complications||participants|Number|837|837.0||||||
3756920|NCT01964950|3590814|B3|Unknown||History of Allergy||participants|Number|117|117.0||||||
3756921|NCT01964950|3590815|B2|Unknown||History of Allergy||participants|Number|21|21.0||||||
3756922|NCT01964950|3590816|B1|Unknown||History of Allergy||participants|Number|96|96.0||||||
3756923|NCT01964950|3590814|B3|Had allergy||History of Allergy||participants|Number|86|86.0||||||
3756924|NCT01964950|3590815|B2|Had allergy||History of Allergy||participants|Number|8|8.0||||||
3756925|NCT01964950|3590816|B1|Had allergy||History of Allergy||participants|Number|78|78.0||||||
3756926|NCT01964950|3590814|B3|Did not have allergy||History of Allergy||participants|Number|873|873.0||||||
3756927|NCT01964950|3590815|B2|Did not have allergy||History of Allergy||participants|Number|131|131.0||||||
3756928|NCT01964950|3590816|B1|Did not have allergy||History of Allergy||participants|Number|742|742.0||||||
3756929|NCT01964950|3590814|B3|Unknown||Degree of Renal Dysfunction|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was listed as “unknown.” Normal: >=90 milliliter per minute (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2. eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female), where Cr is serum creatinine|participants|Number|305|305.0||||||
3756930|NCT01964950|3590815|B2|Unknown||Degree of Renal Dysfunction|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was listed as “unknown.” Normal: >=90 milliliter per minute (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2. eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female), where Cr is serum creatinine|participants|Number|49|49.0||||||
3756931|NCT01964950|3590816|B1|Unknown||Degree of Renal Dysfunction|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was listed as “unknown.” Normal: >=90 milliliter per minute (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2. eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female), where Cr is serum creatinine|participants|Number|256|256.0||||||
3756932|NCT01964950|3590814|B3|Severe||Degree of Renal Dysfunction|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was listed as “unknown.” Normal: >=90 milliliter per minute (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2. eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female), where Cr is serum creatinine|participants|Number|12|12.0||||||
3756990|NCT01964950|3590815|B2|>=10 years||Time From Diagnosis of Type 2 Diabetes||participants|Number|55|55.0||||||
3756991|NCT01964950|3590816|B1|>=10 years||Time From Diagnosis of Type 2 Diabetes||participants|Number|232|232.0||||||
3756933|NCT01964950|3590815|B2|Severe||Degree of Renal Dysfunction|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was listed as “unknown.” Normal: >=90 milliliter per minute (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2. eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female), where Cr is serum creatinine|participants|Number|0|0.0||||||
3756934|NCT01964950|3590816|B1|Severe||Degree of Renal Dysfunction|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was listed as “unknown.” Normal: >=90 milliliter per minute (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2. eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female), where Cr is serum creatinine|participants|Number|12|12.0||||||
3756935|NCT01964950|3590814|B3|Moderate||Degree of Renal Dysfunction|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was listed as “unknown.” Normal: >=90 milliliter per minute (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2. eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female), where Cr is serum creatinine|participants|Number|171|171.0||||||
3756936|NCT01964950|3590815|B2|Moderate||Degree of Renal Dysfunction|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was listed as “unknown.” Normal: >=90 milliliter per minute (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2. eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female), where Cr is serum creatinine|participants|Number|25|25.0||||||
3756937|NCT01964950|3590816|B1|Moderate||Degree of Renal Dysfunction|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was listed as “unknown.” Normal: >=90 milliliter per minute (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2. eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female), where Cr is serum creatinine|participants|Number|146|146.0||||||
3756938|NCT01964950|3590814|B3|Mild||Degree of Renal Dysfunction|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was listed as “unknown.” Normal: >=90 milliliter per minute (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2. eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female), where Cr is serum creatinine|participants|Number|412|412.0||||||
3756939|NCT01964950|3590815|B2|Mild||Degree of Renal Dysfunction|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was listed as “unknown.” Normal: >=90 milliliter per minute (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2. eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female), where Cr is serum creatinine|participants|Number|61|61.0||||||
3756940|NCT01964950|3590816|B1|Mild||Degree of Renal Dysfunction|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was listed as “unknown.” Normal: >=90 milliliter per minute (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2. eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female), where Cr is serum creatinine|participants|Number|351|351.0||||||
3756941|NCT01964950|3590814|B3|Normal||Degree of Renal Dysfunction|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was listed as “unknown.” Normal: >=90 milliliter per minute (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2. eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female), where Cr is serum creatinine|participants|Number|176|176.0||||||
3756942|NCT01964950|3590815|B2|Normal||Degree of Renal Dysfunction|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was listed as “unknown.” Normal: >=90 milliliter per minute (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2. eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female), where Cr is serum creatinine|participants|Number|25|25.0||||||
3756943|NCT01964950|3590816|B1|Normal||Degree of Renal Dysfunction|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was listed as “unknown.” Normal: >=90 milliliter per minute (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2. eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female), where Cr is serum creatinine|participants|Number|151|151.0||||||
3756992|NCT01964950|3590814|B3|>=5 to <10 years||Time From Diagnosis of Type 2 Diabetes||participants|Number|241|241.0||||||
3756944|NCT01964950|3590814|B3|Outpatient and Inpatient||Healthcare Category|Participants were categorized as outpatient, inpatient, and outpatient and inpatient (participants who were both outpatient and inpatient during some point at the time and 3 months prior to enrollment).|participants|Number|25|25.0||||||
3756945|NCT01964950|3590815|B2|Outpatient and Inpatient||Healthcare Category|Participants were categorized as outpatient, inpatient, and outpatient and inpatient (participants who were both outpatient and inpatient during some point at the time and 3 months prior to enrollment).|participants|Number|3|3.0||||||
3756946|NCT01964950|3590816|B1|Outpatient and Inpatient||Healthcare Category|Participants were categorized as outpatient, inpatient, and outpatient and inpatient (participants who were both outpatient and inpatient during some point at the time and 3 months prior to enrollment).|participants|Number|22|22.0||||||
3756947|NCT01964950|3590814|B3|Inpatient||Healthcare Category|Participants were categorized as outpatient, inpatient, and outpatient and inpatient (participants who were both outpatient and inpatient during some point at the time and 3 months prior to enrollment).|participants|Number|4|4.0||||||
3756948|NCT01964950|3590815|B2|Inpatient||Healthcare Category|Participants were categorized as outpatient, inpatient, and outpatient and inpatient (participants who were both outpatient and inpatient during some point at the time and 3 months prior to enrollment).|participants|Number|1|1.0||||||
3756949|NCT01964950|3590816|B1|Inpatient||Healthcare Category|Participants were categorized as outpatient, inpatient, and outpatient and inpatient (participants who were both outpatient and inpatient during some point at the time and 3 months prior to enrollment).|participants|Number|3|3.0||||||
3756950|NCT01964950|3590814|B3|Outpatient||Healthcare Category|Participants were categorized as outpatient, inpatient, and outpatient and inpatient (participants who were both outpatient and inpatient during some point at the time and 3 months prior to enrollment).|participants|Number|1047|1047.0||||||
3756951|NCT01964950|3590815|B2|Outpatient||Healthcare Category|Participants were categorized as outpatient, inpatient, and outpatient and inpatient (participants who were both outpatient and inpatient during some point at the time and 3 months prior to enrollment).|participants|Number|156|156.0||||||
3756952|NCT01964950|3590816|B1|Outpatient||Healthcare Category|Participants were categorized as outpatient, inpatient, and outpatient and inpatient (participants who were both outpatient and inpatient during some point at the time and 3 months prior to enrollment).|participants|Number|891|891.0||||||
3756953|NCT01964950|3590814|B3|Pregnant||Pregnancy Status|This baseline characteristic was analyzed only in female participants.|participants|Number|0|0.0||||||
3756954|NCT01964950|3590815|B2|Pregnant||Pregnancy Status|This baseline characteristic was analyzed only in female participants.|participants|Number|0|0.0||||||
3756955|NCT01964950|3590816|B1|Pregnant||Pregnancy Status|This baseline characteristic was analyzed only in female participants.|participants|Number|0|0.0||||||
3756956|NCT01964950|3590814|B3|Not pregnant||Pregnancy Status|This baseline characteristic was analyzed only in female participants.|participants|Number|430|430.0||||||
3756957|NCT01964950|3590815|B2|Not pregnant||Pregnancy Status|This baseline characteristic was analyzed only in female participants.|participants|Number|52|52.0||||||
3756958|NCT01964950|3590816|B1|Not pregnant||Pregnancy Status|This baseline characteristic was analyzed only in female participants.|participants|Number|378|378.0||||||
3756959|NCT01964950|3590814|B3|Unknown (Female)||Waist circumference||participants|Number|328|328.0||||||
3756960|NCT01964950|3590815|B2|Unknown (Female)||Waist circumference||participants|Number|41|41.0||||||
3756961|NCT01964950|3590816|B1|Unknown (Female)||Waist circumference||participants|Number|287|287.0||||||
3756962|NCT01964950|3590814|B3|>=90 cm (Female)||Waist circumference||participants|Number|43|43.0||||||
3756963|NCT01964950|3590815|B2|>=90 cm (Female)||Waist circumference||participants|Number|4|4.0||||||
3756964|NCT01964950|3590816|B1|>=90 cm (Female)||Waist circumference||participants|Number|39|39.0||||||
3756965|NCT01964950|3590814|B3|<90 cm (Female)||Waist circumference||participants|Number|59|59.0||||||
3756966|NCT01964950|3590815|B2|<90 cm (Female)||Waist circumference||participants|Number|7|7.0||||||
3756967|NCT01964950|3590816|B1|<90 cm (Female)||Waist circumference||participants|Number|52|52.0||||||
3756968|NCT01964950|3590814|B3|Unknown (Male)||Waist circumference||participants|Number|463|463.0||||||
3756969|NCT01964950|3590815|B2|Unknown (Male)||Waist circumference||participants|Number|79|79.0||||||
3756970|NCT01964950|3590816|B1|Unknown (Male)||Waist circumference||participants|Number|384|384.0||||||
3756971|NCT01964950|3590814|B3|>=85 cm (Male)||Waist circumference||participants|Number|124|124.0||||||
3756972|NCT01964950|3590815|B2|>=85 cm (Male)||Waist circumference||participants|Number|22|22.0||||||
3756973|NCT01964950|3590816|B1|>=85 cm (Male)||Waist circumference||participants|Number|102|102.0||||||
3756974|NCT01964950|3590814|B3|<85 centimeter (cm) (Male)||Waist circumference||participants|Number|59|59.0||||||
3756975|NCT01964950|3590815|B2|<85 centimeter (cm) (Male)||Waist circumference||participants|Number|7|7.0||||||
3756976|NCT01964950|3590816|B1|<85 centimeter (cm) (Male)||Waist circumference||participants|Number|52|52.0||||||
3756977|NCT01964950|3590814|B3|Unknown||Body Mass Index (BMI)||participants|Number|309|309.0||||||
3756978|NCT01964950|3590815|B2|Unknown||Body Mass Index (BMI)||participants|Number|37|37.0||||||
3756979|NCT01964950|3590816|B1|Unknown||Body Mass Index (BMI)||participants|Number|272|272.0||||||
3756980|NCT01964950|3590814|B3|>=25 kg/m^2||Body Mass Index (BMI)||participants|Number|378|378.0||||||
3756981|NCT01964950|3590815|B2|>=25 kg/m^2||Body Mass Index (BMI)||participants|Number|60|60.0||||||
3756982|NCT01964950|3590816|B1|>=25 kg/m^2||Body Mass Index (BMI)||participants|Number|318|318.0||||||
3756983|NCT01964950|3590814|B3|<25 kilogram per square meter (kg/m^2)||Body Mass Index (BMI)||participants|Number|389|389.0||||||
3756984|NCT01964950|3590815|B2|<25 kilogram per square meter (kg/m^2)||Body Mass Index (BMI)||participants|Number|63|63.0||||||
3756985|NCT01964950|3590816|B1|<25 kilogram per square meter (kg/m^2)||Body Mass Index (BMI)||participants|Number|326|326.0||||||
3756986|NCT01964950|3590814|B3|Unknown||Time From Diagnosis of Type 2 Diabetes||participants|Number|265|265.0||||||
3756987|NCT01964950|3590815|B2|Unknown||Time From Diagnosis of Type 2 Diabetes||participants|Number|37|37.0||||||
3756993|NCT01964950|3590815|B2|>=5 to <10 years||Time From Diagnosis of Type 2 Diabetes||participants|Number|25|25.0||||||
3756994|NCT01964950|3590816|B1|>=5 to <10 years||Time From Diagnosis of Type 2 Diabetes||participants|Number|216|216.0||||||
3756995|NCT01964950|3590814|B3|Greater than or equal to (>=)2 to <5 years||Time From Diagnosis of Type 2 Diabetes||participants|Number|160|160.0||||||
3756996|NCT01964950|3590815|B2|Greater than or equal to (>=)2 to <5 years||Time From Diagnosis of Type 2 Diabetes||participants|Number|22|22.0||||||
3756997|NCT01964950|3590816|B1|Greater than or equal to (>=)2 to <5 years||Time From Diagnosis of Type 2 Diabetes||participants|Number|138|138.0||||||
3756998|NCT01964950|3590814|B3|Less than (<)2 years||Time From Diagnosis of Type 2 Diabetes||participants|Number|123|123.0||||||
3756999|NCT01964950|3590815|B2|Less than (<)2 years||Time From Diagnosis of Type 2 Diabetes||participants|Number|21|21.0||||||
3757000|NCT01964950|3590816|B1|Less than (<)2 years||Time From Diagnosis of Type 2 Diabetes||participants|Number|102|102.0||||||
3757001|NCT01964950|3590814|B3|Japan||Region of Enrollment||participants|Number|1076|1076.0||||||
3757002|NCT01964950|3590815|B2|Japan||Region of Enrollment||participants|Number|160|160.0||||||
3757003|NCT01964950|3590816|B1|Japan||Region of Enrollment||participants|Number|916|916.0||||||
3757004|NCT01964950|3590814|B3||Male|Sex: Female, Male||Participants|Count of Participants|646|646.0||||||
3757005|NCT01964950|3590815|B2||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3757006|NCT01964950|3590816|B1||Male|Sex: Female, Male||Participants|Count of Participants|538|538.0||||||
3757007|NCT01964950|3590814|B3||Female|Sex: Female, Male||Participants|Count of Participants|430|430.0||||||
3757008|NCT01964950|3590815|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3757009|NCT01964950|3590816|B1||Female|Sex: Female, Male||Participants|Count of Participants|378|378.0||||||
3757010|NCT01964950|3590814|B3|Greater Than or Equal to (>=) 65 Years||Age, Customized||participants|Number|627|627.0||||||
3757011|NCT01964950|3590815|B2|Greater Than or Equal to (>=) 65 Years||Age, Customized||participants|Number|91|91.0||||||
3757012|NCT01964950|3590816|B1|Greater Than or Equal to (>=) 65 Years||Age, Customized||participants|Number|536|536.0||||||
3757013|NCT01964950|3590814|B3|Less Than (<) 65 Years||Age, Customized||participants|Number|449|449.0||||||
3757014|NCT01964950|3590815|B2|Less Than (<) 65 Years||Age, Customized||participants|Number|69|69.0||12.19|12.19|||
3757015|NCT01964950|3590816|B1|Less Than (<) 65 Years||Age, Customized||participants|Number|380|380.0||11.67|11.67|||
3757016|NCT01964898|3590828|B3|United States||Region of Enrollment||participants|Number|59|59.0||||||
3757017|NCT01964898|3590829|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
3757018|NCT01964898|3590830|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
3757019|NCT01964898|3590828|B3||Male|Gender||Participants|Count of Participants|43|43.0||||||
3757020|NCT01964898|3590829|B2||Male|Gender||Participants|Count of Participants|20|20.0||||||
3757021|NCT01964898|3590830|B1||Male|Gender||Participants|Count of Participants|23|23.0||||||
3757022|NCT01964898|3590828|B3||Female|Gender||Participants|Count of Participants|16|16.0||||||
3757023|NCT01964898|3590829|B2||Female|Gender||Participants|Count of Participants|11|11.0||||||
3757024|NCT01964898|3590830|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
3757025|NCT01964898|3590828|B3|||Age||Years|Mean|55.6|55.6|Standard Deviation|10.2|10.2|||
3757026|NCT01964898|3590829|B2|||Age||Years|Mean|57.1|57.1|Standard Deviation|8.3|8.3|||
3757027|NCT01964898|3590830|B1|||Age||Years|Mean|53.9|53.9|Standard Deviation|11.9|11.9|||
3757028|NCT01964716|3590851|B3||Male|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
3757029|NCT01964716|3590852|B2||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3757030|NCT01964716|3590853|B1||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3757031|NCT01964716|3590851|B3||Female|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
3757032|NCT01964716|3590852|B2||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3757033|NCT01964716|3590853|B1||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3757034|NCT01964716|3590851|B3|||Age||days|Mean|57.1|57.1|Standard Deviation|8.7|8.7|||
3757035|NCT01964716|3590852|B2|||Age||days|Mean|56.9|56.9|Standard Deviation|8.8|8.8|||
3757036|NCT01964716|3590853|B1|||Age||days|Mean|57.3|57.3|Standard Deviation|8.6|8.6|||
3757037|NCT01964547|3590890|B3|Czech Republic||Region of Enrollment||participants|Number|121|121.0||||||
3757038|NCT01964547|3590891|B2|Czech Republic||Region of Enrollment||participants|Number|59|59.0||||||
3757039|NCT01964547|3590892|B1|Czech Republic||Region of Enrollment||participants|Number|62|62.0||||||
3757040|NCT01964547|3590890|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3757041|NCT01964547|3590891|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3757042|NCT01964547|3590892|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3757043|NCT01964547|3590890|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3757044|NCT01964547|3590891|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3757045|NCT01964547|3590892|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3757046|NCT01964547|3590890|B3|||Age||years|Mean|48.59|48.59|Standard Deviation|9.642|9.642|||
3757047|NCT01964547|3590891|B2|||Age||years|Mean|48.21|48.21|Standard Deviation|10.381|10.381|||
3757048|NCT01964547|3590892|B1|||Age||years|Mean|48.95|48.95|Standard Deviation|8.954|8.954|||
3757049|NCT01964547|3590890|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3757050|NCT01964547|3590891|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3757051|NCT01964547|3590892|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3757052|NCT01964547|3590890|B3||Between 18 and 65 years|Age||Participants|Count of Participants|119|119.0||||||
3757053|NCT01964547|3590891|B2||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3757054|NCT01964547|3590892|B1||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
3757055|NCT01964547|3590890|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3757056|NCT01964547|3590891|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3757057|NCT01964547|3590892|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3757058|NCT01964521|3590917|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3757059|NCT01964521|3590917|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757060|NCT01964521|3590917|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757061|NCT01964521|3590917|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3757062|NCT01964521|3590917|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757063|NCT01964521|3590917|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757064|NCT01964521|3590917|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3757065|NCT01964521|3590917|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757066|NCT01964521|3590917|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3757067|NCT01964521|3590917|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3757068|NCT01964521|3590917|B1|||Age||years|Mean|61.1|61.1|Standard Deviation|12.6|12.6|||
3757069|NCT01964352|3590922|B5||Male|Sex: Female, Male||Participants|Count of Participants|481|481.0||||||
3757070|NCT01964352|3590923|B4||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3757071|NCT01964352|3590924|B3||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3757072|NCT01964352|3590925|B2||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3757073|NCT01964352|3590926|B1||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3757074|NCT01964352|3590922|B5||Female|Sex: Female, Male||Participants|Count of Participants|331|331.0||||||
3757075|NCT01964352|3590923|B4||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3757076|NCT01964352|3590924|B3||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3757077|NCT01964352|3590925|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3757078|NCT01964352|3590926|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3757079|NCT01964352|3590922|B5|||Age||years|Mean|64.9|64.9|Standard Deviation|8.4|8.4|||
3757080|NCT01964352|3590923|B4|||Age||years|Mean|64.7|64.7|Standard Deviation|8.9|8.9|||
3757081|NCT01964352|3590924|B3|||Age||years|Mean|64.7|64.7|Standard Deviation|8.2|8.2|||
3757082|NCT01964352|3590925|B2|||Age||years|Mean|64.9|64.9|Standard Deviation|8.2|8.2|||
3757083|NCT01964352|3590926|B1|||Age||years|Mean|65.1|65.1|Standard Deviation|8.3|8.3|||
3757084|NCT01964326|3590959|B1||Male|Sex: Female, Male||Participants|Count of Participants|641|641.0||||||
3757085|NCT01964326|3590959|B1||Female|Sex: Female, Male||Participants|Count of Participants|593|593.0||||||
3757086|NCT01964326|3590959|B1|||Age||Years|Mean|57.8|57.8|Standard Deviation|11.5|11.5|||
3757087|NCT01964222|3590966|B3|Adequate||Rapid Estimate of Adult Literacy in Medicine-SF (REALM-SF)|5 participants did not complete this measure due to lack of time during enrollment.|participants|Number|127|127.0||||||
3757088|NCT01964222|3590967|B2|Adequate||Rapid Estimate of Adult Literacy in Medicine-SF (REALM-SF)|5 participants did not complete this measure due to lack of time during enrollment.|participants|Number|66|66.0||||||
3757089|NCT01964222|3590968|B1|Adequate||Rapid Estimate of Adult Literacy in Medicine-SF (REALM-SF)|5 participants did not complete this measure due to lack of time during enrollment.|participants|Number|61|61.0||||||
3757090|NCT01964222|3590966|B3|Marginal||Rapid Estimate of Adult Literacy in Medicine-SF (REALM-SF)|5 participants did not complete this measure due to lack of time during enrollment.|participants|Number|33|33.0||||||
3757091|NCT01964222|3590967|B2|Marginal||Rapid Estimate of Adult Literacy in Medicine-SF (REALM-SF)|5 participants did not complete this measure due to lack of time during enrollment.|participants|Number|13|13.0||||||
3757092|NCT01964222|3590968|B1|Marginal||Rapid Estimate of Adult Literacy in Medicine-SF (REALM-SF)|5 participants did not complete this measure due to lack of time during enrollment.|participants|Number|20|20.0||||||
3757093|NCT01964222|3590966|B3|Inadequate||Rapid Estimate of Adult Literacy in Medicine-SF (REALM-SF)|5 participants did not complete this measure due to lack of time during enrollment.|participants|Number|10|10.0||||||
3757094|NCT01964222|3590967|B2|Inadequate||Rapid Estimate of Adult Literacy in Medicine-SF (REALM-SF)|5 participants did not complete this measure due to lack of time during enrollment.|participants|Number|5|5.0||||||
3757095|NCT01964222|3590968|B1|Inadequate||Rapid Estimate of Adult Literacy in Medicine-SF (REALM-SF)|5 participants did not complete this measure due to lack of time during enrollment.|participants|Number|5|5.0||||||
3757096|NCT01964222|3590966|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757097|NCT01964222|3590967|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757098|NCT01964222|3590968|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757099|NCT01964222|3590966|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3757100|NCT01964222|3590967|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3757101|NCT01964222|3590968|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3757102|NCT01964222|3590966|B3||White|Race (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
3757103|NCT01964222|3590967|B2||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3757104|NCT01964222|3590968|B1||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3757105|NCT01964222|3590966|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3757106|NCT01964222|3590967|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3757107|NCT01964222|3590968|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3757108|NCT01964222|3590966|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757109|NCT01964222|3590967|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757110|NCT01964222|3590968|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757111|NCT01964222|3590966|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3757112|NCT01964222|3590967|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3757113|NCT01964222|3590968|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3757114|NCT01964222|3590966|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3757115|NCT01964222|3590967|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3757116|NCT01964222|3590968|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3757117|NCT01964222|3590966|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757118|NCT01964222|3590967|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757119|NCT01964222|3590968|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757120|NCT01964222|3590966|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|171|171.0||||||
3757121|NCT01964222|3590967|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
3757122|NCT01964222|3590968|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3757123|NCT01964222|3590966|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3757124|NCT01964222|3590967|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3757125|NCT01964222|3590968|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3757126|NCT01964222|3590966|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3757127|NCT01964222|3590967|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3757128|NCT01964222|3590968|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3757129|NCT01964222|3590966|B3||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3757130|NCT01964222|3590967|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3757131|NCT01964222|3590968|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3757132|NCT01964222|3590966|B3|||Age||years|Mean|54.83|54.83|Standard Deviation|12.16|12.16|||
3757133|NCT01964222|3590967|B2|||Age||years|Mean|53.88|53.88|Standard Deviation|12.05|12.05|||
3757134|NCT01964222|3590968|B1|||Age||years|Mean|55.81|55.81|Standard Deviation|12.26|12.26|||
3757135|NCT01964105|3590983|B4|||BREAST-Q|BREAST-Q is a validated measures of patient reported outcomes. For this study we utilized the preoperative and postoperative BREAST -Q designed to analyze outcomes following breast augmentation The BREAST-Q is measured as a Q-score on a scale of 0-100. 0 is a poor score, 100 is an optimal score.|units on a scale|Mean|64.6|64.6|Standard Deviation|19.1|19.1|||
3757136|NCT01964105|3590984|B3|||BREAST-Q|BREAST-Q is a validated measures of patient reported outcomes. For this study we utilized the preoperative and postoperative BREAST -Q designed to analyze outcomes following breast augmentation The BREAST-Q is measured as a Q-score on a scale of 0-100. 0 is a poor score, 100 is an optimal score.|units on a scale|Mean|64.8|64.8|Standard Deviation|19.3|19.3|||
3757137|NCT01964105|3590985|B2|||BREAST-Q|BREAST-Q is a validated measures of patient reported outcomes. For this study we utilized the preoperative and postoperative BREAST -Q designed to analyze outcomes following breast augmentation The BREAST-Q is measured as a Q-score on a scale of 0-100. 0 is a poor score, 100 is an optimal score.|units on a scale|Mean|70.1|70.1|Standard Deviation|21.5|21.5|||
3757138|NCT01964105|3590986|B1|||BREAST-Q|BREAST-Q is a validated measures of patient reported outcomes. For this study we utilized the preoperative and postoperative BREAST -Q designed to analyze outcomes following breast augmentation The BREAST-Q is measured as a Q-score on a scale of 0-100. 0 is a poor score, 100 is an optimal score.|units on a scale|Mean|63.6|63.6|Standard Deviation|18.6|18.6|||
3757139|NCT01964105|3590983|B4|||Volume of Breast||cubic centimeters (cc)|Mean|441|441.0|Standard Deviation|120.5|120.5|||
3757140|NCT01964105|3590984|B3|||Volume of Breast||cubic centimeters (cc)|Mean|420|420.0|Standard Deviation|119.3|119.3|||
3757141|NCT01964105|3590985|B2|||Volume of Breast||cubic centimeters (cc)|Mean|503.4|503.4|Standard Deviation|113.1|113.1|||
3757142|NCT01964105|3590986|B1|||Volume of Breast||cubic centimeters (cc)|Mean|494.5|494.5|Standard Deviation|93|93.0|||
3757143|NCT01964105|3590983|B4|United States||Region of Enrollment||Participants|Count of Participants|85|85.0||||||
3757144|NCT01964105|3590984|B3|United States||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
3757145|NCT01964105|3590985|B2|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3757146|NCT01964105|3590986|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3757147|NCT01964105|3590983|B4|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3757148|NCT01964105|3590983|B4|Female||Sex/Gender, Customized||Participants|Count of Participants|85|85.0||||||
3757149|NCT01964105|3590984|B3|Female||Sex/Gender, Customized||Participants|Count of Participants|62|62.0||||||
3757150|NCT01964105|3590985|B2|Female||Sex/Gender, Customized||Participants|Count of Participants|13|13.0||||||
3757151|NCT01964105|3590986|B1|Female||Sex/Gender, Customized||Participants|Count of Participants|10|10.0||||||
3757152|NCT01964105|3590983|B4|||Age||years|Mean|37.2|37.2|Standard Deviation|8.0|8.0|||
3757153|NCT01964105|3590984|B3|||Age||years|Mean|35.8|35.8|Standard Deviation|8.2|8.2|||
3757154|NCT01964105|3590985|B2|||Age||years|Mean|40.2|40.2|Standard Deviation|11|11.0|||
3757155|NCT01964105|3590986|B1|||Age||years|Mean|38.3|38.3|Standard Deviation|23.1|23.1|||
3757156|NCT01963845|3590996|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3757157|NCT01963845|3590997|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3757158|NCT01963845|3590998|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3757159|NCT01963845|3590996|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3757160|NCT01963845|3590997|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3757161|NCT01963845|3590998|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3757162|NCT01963845|3590996|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3757163|NCT01963845|3590997|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3757164|NCT01963845|3590998|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3757165|NCT01963845|3590996|B3||>=65 years|Age|Subjects recruited from the UCSD hepatology clinic|Participants|Count of Participants|7|7.0||||||
3757166|NCT01963845|3590997|B2||>=65 years|Age|Subjects recruited from the UCSD hepatology clinic|Participants|Count of Participants|4|4.0||||||
3757167|NCT01963845|3590998|B1||>=65 years|Age|Subjects recruited from the UCSD hepatology clinic|Participants|Count of Participants|3|3.0||||||
3757168|NCT01963845|3590996|B3||Between 18 and 65 years|Age|Subjects recruited from the UCSD hepatology clinic|Participants|Count of Participants|43|43.0||||||
3757169|NCT01963845|3590997|B2||Between 18 and 65 years|Age|Subjects recruited from the UCSD hepatology clinic|Participants|Count of Participants|21|21.0||||||
3757170|NCT01963845|3590998|B1||Between 18 and 65 years|Age|Subjects recruited from the UCSD hepatology clinic|Participants|Count of Participants|22|22.0||||||
3757171|NCT01963845|3590996|B3||<=18 years|Age|Subjects recruited from the UCSD hepatology clinic|Participants|Count of Participants|0|0.0||||||
3757172|NCT01963845|3590997|B2||<=18 years|Age|Subjects recruited from the UCSD hepatology clinic|Participants|Count of Participants|0|0.0||||||
3757173|NCT01963845|3590998|B1||<=18 years|Age|Subjects recruited from the UCSD hepatology clinic|Participants|Count of Participants|0|0.0||||||
3757174|NCT01963767|3591013|B3|||Years of Education||years|Mean|15.75|15.75|Standard Deviation|2.67|2.67|||
3757175|NCT01963767|3591014|B2|||Years of Education||years|Mean|15.88|15.88|Standard Deviation|2.41|2.41|||
3757176|NCT01963767|3591015|B1|||Years of Education||years|Mean|15.61|15.61|Standard Deviation|2.93|2.93|||
3757177|NCT01963767|3591013|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3757178|NCT01963767|3591014|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3757179|NCT01963767|3591015|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3757180|NCT01963767|3591013|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3757181|NCT01963767|3591014|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3757182|NCT01963767|3591015|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3757183|NCT01963767|3591013|B3|||Age||years|Mean|73.58|73.58|Standard Deviation|5.51|5.51|||
3757184|NCT01963767|3591014|B2|||Age||years|Mean|72.82|72.82|Standard Deviation|5.54|5.54|||
3757185|NCT01963767|3591015|B1|||Age||years|Mean|74.34|74.34|Standard Deviation|5.48|5.48|||
3757186|NCT01963676|3591024|B3|||Positive and Negative Syndrome Scale|Remission according to PANSS: PANSS score equal to 30. PANSS: standardized, clinician-administered rating scale. 3 subscales; Positive Symptom scale: 7 items, Negative Symptom scale: 7 items, General Symptom scale: 16 items. Each item in each subscale are scored on a 7 point (1 to 7) scale, with 1=none/absent and 7=most severe. Total score for Positive Scale: 7 to 49. Total score for Negative Scale: 7 to 49. Total score for general scale: 16 to 112. Total score for PANSS: 30 to 210; higher score indicates more severe symptoms. The PANSS total score by adding the sums of each subscale.|units on a scale|Mean|70.04|70.04|Standard Deviation|15.21|15.21|||
3757187|NCT01963676|3591025|B2|||Positive and Negative Syndrome Scale|Remission according to PANSS: PANSS score equal to 30. PANSS: standardized, clinician-administered rating scale. 3 subscales; Positive Symptom scale: 7 items, Negative Symptom scale: 7 items, General Symptom scale: 16 items. Each item in each subscale are scored on a 7 point (1 to 7) scale, with 1=none/absent and 7=most severe. Total score for Positive Scale: 7 to 49. Total score for Negative Scale: 7 to 49. Total score for general scale: 16 to 112. Total score for PANSS: 30 to 210; higher score indicates more severe symptoms. The PANSS total score by adding the sums of each subscale.|units on a scale|Mean|66.92|66.92|Standard Deviation|17.17|17.17|||
3757188|NCT01963676|3591026|B1|||Positive and Negative Syndrome Scale|Remission according to PANSS: PANSS score equal to 30. PANSS: standardized, clinician-administered rating scale. 3 subscales; Positive Symptom scale: 7 items, Negative Symptom scale: 7 items, General Symptom scale: 16 items. Each item in each subscale are scored on a 7 point (1 to 7) scale, with 1=none/absent and 7=most severe. Total score for Positive Scale: 7 to 49. Total score for Negative Scale: 7 to 49. Total score for general scale: 16 to 112. Total score for PANSS: 30 to 210; higher score indicates more severe symptoms. The PANSS total score by adding the sums of each subscale.|units on a scale|Mean|73.15|73.15|Standard Deviation|12.90|12.9|||
3757189|NCT01963676|3591024|B3|||Auditory Hallucination Rating Scale|Remission according to AHRS: AHRS score equal to 0. AHRS: standardized, clinician-administered rating scale; assesses 11 aspects characteristically associated with auditory hallucination. Individual items are scored on a 5 point (0 to 4), with 0=none/absent and 4=most severe. Total score: 0 to 44; higher score indicates more severe auditory hallucination symptoms. Scores for each question summed up for total score.|units on a scale|Mean|26.85|26.85|Standard Deviation|6.48|6.48|||
3757190|NCT01963676|3591025|B2|||Auditory Hallucination Rating Scale|Remission according to AHRS: AHRS score equal to 0. AHRS: standardized, clinician-administered rating scale; assesses 11 aspects characteristically associated with auditory hallucination. Individual items are scored on a 5 point (0 to 4), with 0=none/absent and 4=most severe. Total score: 0 to 44; higher score indicates more severe auditory hallucination symptoms. Scores for each question summed up for total score.|units on a scale|Mean|26.69|26.69|Standard Deviation|6.30|6.3|||
3757191|NCT01963676|3591026|B1|||Auditory Hallucination Rating Scale|Remission according to AHRS: AHRS score equal to 0. AHRS: standardized, clinician-administered rating scale; assesses 11 aspects characteristically associated with auditory hallucination. Individual items are scored on a 5 point (0 to 4), with 0=none/absent and 4=most severe. Total score: 0 to 44; higher score indicates more severe auditory hallucination symptoms. Scores for each question summed up for total score.|units on a scale|Mean|27.00|27.0|Standard Deviation|6.90|6.9|||
3757192|NCT01963676|3591024|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
3757193|NCT01963676|3591025|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3757194|NCT01963676|3591026|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3757195|NCT01963676|3591024|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3757196|NCT01963676|3591025|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3757197|NCT01963676|3591026|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3757198|NCT01963676|3591024|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3757199|NCT01963676|3591025|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3757200|NCT01963676|3591026|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3757201|NCT01963676|3591024|B3|||Age||years|Mean|41.69|41.69|Standard Deviation|11.62|11.62|||
3757202|NCT01963676|3591025|B2|||Age||years|Mean|40.00|40.0|Standard Deviation|10.74|10.74|||
3757203|NCT01963676|3591026|B1|||Age||years|Mean|43.38|43.38|Standard Deviation|12.64|12.64|||
3757204|NCT01963676|3591024|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3757205|NCT01963676|3591025|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3757206|NCT01963676|3591026|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3757207|NCT01963676|3591024|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3757208|NCT01963676|3591025|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3757209|NCT01963676|3591026|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3757210|NCT01963676|3591024|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3757211|NCT01963676|3591025|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3757212|NCT01963676|3591026|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3757213|NCT01963611|3591035|B6||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3757214|NCT01963611|3591036|B5||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3757215|NCT01963611|3591037|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3757216|NCT01963611|3591038|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3757217|NCT01963611|3591039|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3757218|NCT01963611|3591040|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3757219|NCT01963611|3591035|B6||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
3757220|NCT01963611|3591036|B5||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3757221|NCT01963611|3591037|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3757222|NCT01963611|3591038|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3757223|NCT01963611|3591039|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3757224|NCT01963611|3591040|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3757225|NCT01963611|3591035|B6|||Age||years|Mean|40.6|40.6|Standard Deviation|10.43|10.43|||
3757226|NCT01963611|3591036|B5|||Age||years|Mean|41.8|41.8|Standard Deviation|11.61|11.61|||
3757227|NCT01963611|3591037|B4|||Age||years|Mean|40.4|40.4|Standard Deviation|9.53|9.53|||
3757228|NCT01963611|3591038|B3|||Age||years|Mean|41.1|41.1|Standard Deviation|10.83|10.83|||
3757229|NCT01963611|3591039|B2|||Age||years|Mean|40.7|40.7|Standard Deviation|9.54|9.54|||
3757230|NCT01963611|3591040|B1|||Age||years|Mean|39.2|39.2|Standard Deviation|10.73|10.73|||
3757231|NCT01963403|3591101|B3||'Some treatment'|intervention requested before enrollment||Participants|Count of Participants|11|11.0||||||
3757232|NCT01963403|3591102|B2||'Some treatment'|intervention requested before enrollment||Participants|Count of Participants|6|6.0||||||
3757233|NCT01963403|3591103|B1||'Some treatment'|intervention requested before enrollment||Participants|Count of Participants|5|5.0||||||
3757234|NCT01963403|3591101|B3||Hormonal treatment|intervention requested before enrollment||Participants|Count of Participants|10|10.0||||||
3757235|NCT01963403|3591102|B2||Hormonal treatment|intervention requested before enrollment||Participants|Count of Participants|4|4.0||||||
3757236|NCT01963403|3591103|B1||Hormonal treatment|intervention requested before enrollment||Participants|Count of Participants|6|6.0||||||
3757237|NCT01963403|3591101|B3||implant removal|intervention requested before enrollment||Participants|Count of Participants|5|5.0||||||
3757238|NCT01963403|3591102|B2||implant removal|intervention requested before enrollment||Participants|Count of Participants|3|3.0||||||
3757239|NCT01963403|3591103|B1||implant removal|intervention requested before enrollment||Participants|Count of Participants|2|2.0||||||
3757240|NCT01963403|3591101|B3|||Duration of implant use||days|Median|144.5|144.5|Full Range|||25.0|764.0|
3757241|NCT01963403|3591102|B2|||Duration of implant use||days|Median|109|109.0|Full Range|||41.0|518.0|
3757242|NCT01963403|3591103|B1|||Duration of implant use||days|Median|343|343.0|Full Range|||25.0|764.0|
3757243|NCT01963403|3591101|B3||Dysmenorrhea|Primary reason for implant||Participants|Count of Participants|1|1.0||||||
3757244|NCT01963403|3591102|B2||Dysmenorrhea|Primary reason for implant||Participants|Count of Participants|0|0.0||||||
3757245|NCT01963403|3591103|B1||Dysmenorrhea|Primary reason for implant||Participants|Count of Participants|1|1.0||||||
3757246|NCT01963403|3591101|B3||Bleeding Problem|Primary reason for implant||Participants|Count of Participants|2|2.0||||||
3757247|NCT01963403|3591102|B2||Bleeding Problem|Primary reason for implant||Participants|Count of Participants|1|1.0||||||
3757248|NCT01963403|3591103|B1||Bleeding Problem|Primary reason for implant||Participants|Count of Participants|1|1.0||||||
3757249|NCT01963403|3591101|B3||Contraception|Primary reason for implant||Participants|Count of Participants|23|23.0||||||
3757250|NCT01963403|3591102|B2||Contraception|Primary reason for implant||Participants|Count of Participants|12|12.0||||||
3757251|NCT01963403|3591103|B1||Contraception|Primary reason for implant||Participants|Count of Participants|11|11.0||||||
3757252|NCT01963403|3591101|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
3757253|NCT01963403|3591102|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3757254|NCT01963403|3591103|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3757255|NCT01963403|3591101|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3757256|NCT01963403|3591102|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3757257|NCT01963403|3591103|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3757258|NCT01963403|3591101|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3757259|NCT01963403|3591102|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3757260|NCT01963403|3591103|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3757261|NCT01963403|3591101|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3757262|NCT01963403|3591102|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3757263|NCT01963403|3591103|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3757264|NCT01963403|3591101|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3757265|NCT01963403|3591102|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3757266|NCT01963403|3591103|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3757267|NCT01963403|3591101|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3757268|NCT01963403|3591102|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3757269|NCT01963403|3591103|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3757270|NCT01963403|3591101|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3757271|NCT01963403|3591102|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3757272|NCT01963403|3591103|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3757273|NCT01963403|3591101|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757274|NCT01963403|3591102|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757275|NCT01963403|3591103|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757276|NCT01963403|3591101|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3757277|NCT01963403|3591102|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757278|NCT01963403|3591103|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3757279|NCT01963403|3591101|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3757280|NCT01963403|3591102|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3757281|NCT01963403|3591103|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3757282|NCT01963403|3591101|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757283|NCT01963403|3591102|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757284|NCT01963403|3591103|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757285|NCT01963403|3591101|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3757286|NCT01963403|3591102|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3757287|NCT01963403|3591103|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3757288|NCT01963403|3591101|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3757289|NCT01963403|3591102|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3757290|NCT01963403|3591103|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3757291|NCT01963403|3591101|B3|||Age||years|Mean|25.6|25.6|Standard Deviation|4.3|4.3|||
3757292|NCT01963403|3591102|B2|||Age||years|Mean|25.8|25.8|Standard Deviation|5.0|5.0|||
3757293|NCT01963403|3591103|B1|||Age||years|Mean|25.4|25.4|Standard Deviation|3.8|3.8|||
3757294|NCT01963260|3591116|B11||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3757295|NCT01963260|3591117|B10||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3757296|NCT01963260|3591118|B9||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3757297|NCT01963260|3591119|B8||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3757298|NCT01963260|3591120|B7||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3757299|NCT01963260|3591121|B6||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3757300|NCT01963260|3591122|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3757301|NCT01963260|3591123|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3757302|NCT01963260|3591124|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3757303|NCT01963260|3591125|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3757304|NCT01963260|3591126|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3757305|NCT01963260|3591116|B11||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3757306|NCT01963260|3591117|B10||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3757307|NCT01963260|3591118|B9||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3757308|NCT01963260|3591119|B8||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3757309|NCT01963260|3591120|B7||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3757310|NCT01963260|3591121|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3757311|NCT01963260|3591122|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3757312|NCT01963260|3591123|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3757313|NCT01963260|3591124|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3757314|NCT01963260|3591125|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3757315|NCT01963260|3591126|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3757316|NCT01963260|3591116|B11|>=65 years||Age, Customized||Participants|Number|1|1.0||||||
3757317|NCT01963260|3591117|B10|>=65 years||Age, Customized||Participants|Number|1|1.0||||||
3757318|NCT01963260|3591118|B9|>=65 years||Age, Customized||Participants|Number|0|0.0||||||
3757319|NCT01963260|3591119|B8|>=65 years||Age, Customized||Participants|Number|0|0.0||||||
3757320|NCT01963260|3591120|B7|>=65 years||Age, Customized||Participants|Number|0|0.0||||||
3757321|NCT01963260|3591121|B6|>=65 years||Age, Customized||Participants|Number|0|0.0||||||
3757322|NCT01963260|3591122|B5|>=65 years||Age, Customized||Participants|Number|0|0.0||||||
3757323|NCT01963260|3591123|B4|>=65 years||Age, Customized||Participants|Number|0|0.0||||||
3757324|NCT01963260|3591124|B3|>=65 years||Age, Customized||Participants|Number|0|0.0||||||
3757325|NCT01963260|3591125|B2|>=65 years||Age, Customized||Participants|Number|0|0.0||||||
3757326|NCT01963260|3591126|B1|>=65 years||Age, Customized||Participants|Number|0|0.0||||||
3757327|NCT01963260|3591116|B11|Between 18 and 65 years||Age, Customized||Participants|Number|51|51.0||||||
3757328|NCT01963260|3591117|B10|Between 18 and 65 years||Age, Customized||Participants|Number|3|3.0||||||
3757329|NCT01963260|3591118|B9|Between 18 and 65 years||Age, Customized||Participants|Number|3|3.0||||||
3757330|NCT01963260|3591119|B8|Between 18 and 65 years||Age, Customized||Participants|Number|2|2.0||||||
3757331|NCT01963260|3591120|B7|Between 18 and 65 years||Age, Customized||Participants|Number|3|3.0||||||
3757332|NCT01963260|3591121|B6|Between 18 and 65 years||Age, Customized||Participants|Number|10|10.0||||||
3757333|NCT01963260|3591122|B5|Between 18 and 65 years||Age, Customized||Participants|Number|6|6.0||||||
3757334|NCT01963260|3591123|B4|Between 18 and 65 years||Age, Customized||Participants|Number|6|6.0||||||
3757335|NCT01963260|3591124|B3|Between 18 and 65 years||Age, Customized||Participants|Number|6|6.0||||||
3757336|NCT01963260|3591125|B2|Between 18 and 65 years||Age, Customized||Participants|Number|6|6.0||||||
3757337|NCT01963260|3591126|B1|Between 18 and 65 years||Age, Customized||Participants|Number|6|6.0||||||
3757338|NCT01963260|3591116|B11|||Age||Years|Mean|33.2|33.2|Standard Deviation|13.0|13.0|||
3757339|NCT01963260|3591117|B10|||Age||Years|Mean|50.3|50.3|Standard Deviation|13.5|13.5|||
3757340|NCT01963260|3591118|B9|||Age||Years|Mean|38.3|38.3|Standard Deviation|22.7|22.7|||
3757341|NCT01963260|3591119|B8|||Age||Years|Mean|53.0|53.0|Standard Deviation|4.2|4.2|||
3757342|NCT01963260|3591120|B7|||Age||Years|Mean|38.7|38.7|Standard Deviation|22.3|22.3|||
3757343|NCT01963260|3591121|B6|||Age||Years|Mean|30.1|30.1|Standard Deviation|9.5|9.5|||
3757344|NCT01963260|3591122|B5|||Age||Years|Mean|32.7|32.7|Standard Deviation|10.5|10.5|||
3757345|NCT01963260|3591123|B4|||Age||Years|Mean|25.7|25.7|Standard Deviation|4.2|4.2|||
3757346|NCT01963260|3591124|B3|||Age||Years|Mean|31.0|31.0|Standard Deviation|12.2|12.2|||
3757347|NCT01963260|3591125|B2|||Age||Years|Mean|32.7|32.7|Standard Deviation|13.0|13.0|||
3757348|NCT01963260|3591126|B1|||Age||Years|Mean|25.7|25.7|Standard Deviation|2.7|2.7|||
3757349|NCT01963234|3591187|B4|||Drug of choice is multiple drugs||Participants|Count of Participants|50|50.0||||||
3757350|NCT01963234|3591188|B3|||Drug of choice is multiple drugs||Participants|Count of Participants|8|8.0||||||
3757351|NCT01963234|3591189|B2|||Drug of choice is multiple drugs||Participants|Count of Participants|20|20.0||||||
3757352|NCT01963234|3591190|B1|||Drug of choice is multiple drugs||Participants|Count of Participants|22|22.0||||||
3757353|NCT01963234|3591187|B4|||Drug of choice is methamphetamine||Participants|Count of Participants|16|16.0||||||
3757354|NCT01963234|3591188|B3|||Drug of choice is methamphetamine||Participants|Count of Participants|1|1.0||||||
3757355|NCT01963234|3591189|B2|||Drug of choice is methamphetamine||Participants|Count of Participants|15|15.0||||||
3757356|NCT01963234|3591190|B1|||Drug of choice is methamphetamine||Participants|Count of Participants|0|0.0||||||
3757357|NCT01963234|3591187|B4|||Drug of choice is marijuana||Participants|Count of Participants|21|21.0||||||
3757358|NCT01963234|3591188|B3|||Drug of choice is marijuana||Participants|Count of Participants|16|16.0||||||
3757359|NCT01963234|3591189|B2|||Drug of choice is marijuana||Participants|Count of Participants|4|4.0||||||
3757360|NCT01963234|3591190|B1|||Drug of choice is marijuana||Participants|Count of Participants|1|1.0||||||
3757361|NCT01963234|3591187|B4|||Drug of choice is crack cocaine||Participants|Count of Participants|23|23.0||||||
3757362|NCT01963234|3591188|B3|||Drug of choice is crack cocaine||Participants|Count of Participants|11|11.0||||||
3757363|NCT01963234|3591189|B2|||Drug of choice is crack cocaine||Participants|Count of Participants|3|3.0||||||
3757364|NCT01963234|3591190|B1|||Drug of choice is crack cocaine||Participants|Count of Participants|9|9.0||||||
3757365|NCT01963234|3591187|B4|||Drug of choice is Opiates||Participants|Count of Participants|53|53.0||||||
3757366|NCT01963234|3591188|B3|||Drug of choice is Opiates||Participants|Count of Participants|8|8.0||||||
3757367|NCT01963234|3591189|B2|||Drug of choice is Opiates||Participants|Count of Participants|14|14.0||||||
3757368|NCT01963234|3591190|B1|||Drug of choice is Opiates||Participants|Count of Participants|31|31.0||||||
3757369|NCT01963234|3591187|B4|||Drug of choice is alcohol||Participants|Count of Participants|105|105.0||||||
3757370|NCT01963234|3591188|B3|||Drug of choice is alcohol||Participants|Count of Participants|27|27.0||||||
3757371|NCT01963234|3591189|B2|||Drug of choice is alcohol||Participants|Count of Participants|44|44.0||||||
3757372|NCT01963234|3591190|B1|||Drug of choice is alcohol||Participants|Count of Participants|34|34.0||||||
3757373|NCT01963234|3591187|B4|||HIV testing|within the past 6 months.|participants|Number|81|81.0||||||
3757374|NCT01963234|3591188|B3|||HIV testing|within the past 6 months.|participants|Number|NA|||||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757375|NCT01963234|3591189|B2|||HIV testing|within the past 6 months.|participants|Number|NA|||||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757376|NCT01963234|3591190|B1|||HIV testing|within the past 6 months.|participants|Number|NA|||||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757377|NCT01963234|3591187|B4|||HIV risky behavior|within the last 6 months.|participants|Number|76|76.0||||||
3757378|NCT01963234|3591188|B3|||HIV risky behavior|within the last 6 months.|participants|Number|NA|||||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757379|NCT01963234|3591189|B2|||HIV risky behavior|within the last 6 months.|participants|Number|NA|||||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757380|NCT01963234|3591190|B1|||HIV risky behavior|within the last 6 months.|participants|Number|NA|||||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757381|NCT01963234|3591187|B4|||Currently receive other addiction treatment|within the last 6 months.|participants|Number|89|89.0||||||
3757382|NCT01963234|3591188|B3|||Currently receive other addiction treatment|within the last 6 months.|participants|Number|NA|||||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757383|NCT01963234|3591189|B2|||Currently receive other addiction treatment|within the last 6 months.|participants|Number|NA|||||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757384|NCT01963234|3591190|B1|||Currently receive other addiction treatment|within the last 6 months.|participants|Number|NA|||||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757385|NCT01963234|3591187|B4|||Any drink or drug|within the last 30 days.|participants|Number|97|97.0||||||
3757386|NCT01963234|3591188|B3|||Any drink or drug|within the last 30 days.|participants|Number|NA|||||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757387|NCT01963234|3591189|B2|||Any drink or drug|within the last 30 days.|participants|Number|NA|||||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757388|NCT01963234|3591190|B1|||Any drink or drug|within the last 30 days.|participants|Number|NA|||||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757389|NCT01963234|3591187|B4|||Illicit drug use|within the last 30 days.|participants|Number|63|63.0||||||
3757390|NCT01963234|3591188|B3|||Illicit drug use|within the last 30 days.|participants|Number|NA|||||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757391|NCT01963234|3591189|B2|||Illicit drug use|within the last 30 days.|participants|Number|NA|||||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757392|NCT01963234|3591190|B1|||Illicit drug use|within the last 30 days.|participants|Number|NA|||||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757393|NCT01963234|3591187|B4|||Any drink|within the last 30 days.|participants|Number|64|64.0||||||
3757394|NCT01963234|3591188|B3|||Any drink|within the last 30 days.|participants|Number|NA|||||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757722|NCT01962961|3591269|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3757395|NCT01963234|3591189|B2|||Any drink|within the last 30 days.|participants|Number|NA|||||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757396|NCT01963234|3591190|B1|||Any drink|within the last 30 days.|participants|Number|NA|||||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757397|NCT01963234|3591187|B4|||Number of ER visits|within the past 6 months.|ER visits|Mean|1.10|1.1|Standard Deviation|2.79|2.79|||
3757398|NCT01963234|3591188|B3|||Number of ER visits|within the past 6 months.|ER visits|Mean|NA||Standard Deviation|NA||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757399|NCT01963234|3591189|B2|||Number of ER visits|within the past 6 months.|ER visits|Mean|NA||Standard Deviation|NA||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757400|NCT01963234|3591190|B1|||Number of ER visits|within the past 6 months.|ER visits|Mean|NA||Standard Deviation|NA||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757401|NCT01963234|3591187|B4|||Number of hospitalizations|Within the last 6 months.|hospitalizations|Mean|0.43|0.43|Standard Deviation|1.03|1.03|||
3757402|NCT01963234|3591188|B3|||Number of hospitalizations|Within the last 6 months.|hospitalizations|Mean|NA||Standard Deviation|NA||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757403|NCT01963234|3591189|B2|||Number of hospitalizations|Within the last 6 months.|hospitalizations|Mean|NA||Standard Deviation|NA||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757404|NCT01963234|3591190|B1|||Number of hospitalizations|Within the last 6 months.|hospitalizations|Mean|NA||Standard Deviation|NA||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757405|NCT01963234|3591187|B4|||Mental subscale Quality of Life|Higher scores on the scale indicate higher quality of life. There are 4 questions that have scales that range from values of 1 to 5. These values are summed to give the score for the mental subscale quality of life. Scale ranges from 4 to 20.|score on a scale|Mean|9.75|9.75|Standard Deviation|2.99|2.99|||
3757406|NCT01963234|3591188|B3|||Mental subscale Quality of Life|Higher scores on the scale indicate higher quality of life. There are 4 questions that have scales that range from values of 1 to 5. These values are summed to give the score for the mental subscale quality of life. Scale ranges from 4 to 20.|score on a scale|Mean|NA||Standard Deviation|NA||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757407|NCT01963234|3591189|B2|||Mental subscale Quality of Life|Higher scores on the scale indicate higher quality of life. There are 4 questions that have scales that range from values of 1 to 5. These values are summed to give the score for the mental subscale quality of life. Scale ranges from 4 to 20.|score on a scale|Mean|NA||Standard Deviation|NA||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757408|NCT01963234|3591190|B1|||Mental subscale Quality of Life|Higher scores on the scale indicate higher quality of life. There are 4 questions that have scales that range from values of 1 to 5. These values are summed to give the score for the mental subscale quality of life. Scale ranges from 4 to 20.|score on a scale|Mean|NA||Standard Deviation|NA||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757409|NCT01963234|3591187|B4|||Physical subscale Quality of Life|Higher scores on the scale indicate higher quality of life. It includes 4 items on overall physical health, physical function, pain, and fatigue that each has a scale ranging from 1 to 5. These values are summed. Scale ranges from 4 to 20.|score on a scale|Mean|13.2|13.2|Standard Deviation|3.01|3.01|||
3757410|NCT01963234|3591188|B3|||Physical subscale Quality of Life|Higher scores on the scale indicate higher quality of life. It includes 4 items on overall physical health, physical function, pain, and fatigue that each has a scale ranging from 1 to 5. These values are summed. Scale ranges from 4 to 20.|score on a scale|Mean|NA||Standard Deviation|NA||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757411|NCT01963234|3591189|B2|||Physical subscale Quality of Life|Higher scores on the scale indicate higher quality of life. It includes 4 items on overall physical health, physical function, pain, and fatigue that each has a scale ranging from 1 to 5. These values are summed. Scale ranges from 4 to 20.|score on a scale|Mean|NA||Standard Deviation|NA||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757434|NCT01963234|3591188|B3|||Patient-centered medical home (PCMH) designation|Three levels of recognition exist, based on practice sites meeting six standards. Level three clinics have the best adherence to the standards. Those standards include team-based care and practice organization, knowing and managing patients, patient-centered access and continuity, care management and support, care coordination and care transitions, and performance measurement and quality improvement.|Level|Number|3|3.0||||||
3757412|NCT01963234|3591190|B1|||Physical subscale Quality of Life|Higher scores on the scale indicate higher quality of life. It includes 4 items on overall physical health, physical function, pain, and fatigue that each has a scale ranging from 1 to 5. These values are summed. Scale ranges from 4 to 20.|score on a scale|Mean|NA||Standard Deviation|NA||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757413|NCT01963234|3591187|B4|||Overall quality of life (QoL)|Higher scores on the scale indicate higher quality of life. Scale ranges from 8 to 40. It includes mental and physical health sub scale values. These values are summed|score on a scale|Mean|28.47|28.47|Standard Deviation|6.46|6.46|||
3757414|NCT01963234|3591188|B3|||Overall quality of life (QoL)|Higher scores on the scale indicate higher quality of life. Scale ranges from 8 to 40. It includes mental and physical health sub scale values. These values are summed|score on a scale|Mean|NA||Standard Deviation|NA||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757415|NCT01963234|3591189|B2|||Overall quality of life (QoL)|Higher scores on the scale indicate higher quality of life. Scale ranges from 8 to 40. It includes mental and physical health sub scale values. These values are summed|score on a scale|Mean|NA||Standard Deviation|NA||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757416|NCT01963234|3591190|B1|||Overall quality of life (QoL)|Higher scores on the scale indicate higher quality of life. Scale ranges from 8 to 40. It includes mental and physical health sub scale values. These values are summed|score on a scale|Mean|NA||Standard Deviation|NA||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757417|NCT01963234|3591187|B4|||Illicit drug-use days|within the last 30 days.|days|Mean|3.22|3.22|Standard Deviation|7.57|7.57|||
3757418|NCT01963234|3591188|B3|||Illicit drug-use days|within the last 30 days.|days|Mean|NA||Standard Deviation|NA||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757419|NCT01963234|3591189|B2|||Illicit drug-use days|within the last 30 days.|days|Mean|NA||Standard Deviation|NA||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757420|NCT01963234|3591190|B1|||Illicit drug-use days|within the last 30 days.|days|Mean|NA||Standard Deviation|NA||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757421|NCT01963234|3591187|B4|||Risky drinking days|within the last 30 days.|days|Mean|1.25|1.25|Standard Deviation|3.78|3.78|||
3757422|NCT01963234|3591188|B3|||Risky drinking days|within the last 30 days.|days|Mean|NA||Standard Deviation|NA||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757423|NCT01963234|3591189|B2|||Risky drinking days|within the last 30 days.|days|Mean|NA||Standard Deviation|NA||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757424|NCT01963234|3591190|B1|||Risky drinking days|within the last 30 days.|days|Mean|NA||Standard Deviation|NA||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757425|NCT01963234|3591187|B4|||Any drinking days|within the last 30 days.|days|Mean|2.53|2.53|Standard Deviation|6.01|6.01|||
3757426|NCT01963234|3591188|B3|||Any drinking days|within the last 30 days.|days|Mean|NA||Standard Deviation|NA||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757427|NCT01963234|3591189|B2|||Any drinking days|within the last 30 days.|days|Mean|NA||Standard Deviation|NA||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757428|NCT01963234|3591190|B1|||Any drinking days|within the last 30 days.|days|Mean|NA||Standard Deviation|NA||||Measure analyzed as a total among all three clinics. We told clinics that we would not report at the site level. We believed that it could reflect poorly on the organization if a site appeared poorly with regard to outcomes in relation to others.
3757429|NCT01963234|3591187|B4|||Patients enrolled in Seva||Participants|Count of Participants|268|268.0||||||
3757430|NCT01963234|3591188|B3|||Patients enrolled in Seva||Participants|Count of Participants|71|71.0||||||
3757431|NCT01963234|3591189|B2|||Patients enrolled in Seva||Participants|Count of Participants|100|100.0||||||
3757432|NCT01963234|3591190|B1|||Patients enrolled in Seva||Participants|Count of Participants|97|97.0||||||
3757433|NCT01963234|3591187|B4|||Patient-centered medical home (PCMH) designation|Three levels of recognition exist, based on practice sites meeting six standards. Level three clinics have the best adherence to the standards. Those standards include team-based care and practice organization, knowing and managing patients, patient-centered access and continuity, care management and support, care coordination and care transitions, and performance measurement and quality improvement.|Level|Number|NA|||||||Site specific.
3757487|NCT01963234|3591189|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757488|NCT01963234|3591190|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757435|NCT01963234|3591189|B2|||Patient-centered medical home (PCMH) designation|Three levels of recognition exist, based on practice sites meeting six standards. Level three clinics have the best adherence to the standards. Those standards include team-based care and practice organization, knowing and managing patients, patient-centered access and continuity, care management and support, care coordination and care transitions, and performance measurement and quality improvement.|Level|Number|3|3.0||||||
3757436|NCT01963234|3591190|B1|||Patient-centered medical home (PCMH) designation|Three levels of recognition exist, based on practice sites meeting six standards. Level three clinics have the best adherence to the standards. Those standards include team-based care and practice organization, knowing and managing patients, patient-centered access and continuity, care management and support, care coordination and care transitions, and performance measurement and quality improvement.|Level|Number|3|3.0||||||
3757437|NCT01963234|3591187|B4|||Not insured||Participants|Count of Participants|72|72.0||||||
3757438|NCT01963234|3591188|B3|||Not insured||Participants|Count of Participants|10|10.0||||||
3757439|NCT01963234|3591189|B2|||Not insured||Participants|Count of Participants|46|46.0||||||
3757440|NCT01963234|3591190|B1|||Not insured||Participants|Count of Participants|16|16.0||||||
3757441|NCT01963234|3591187|B4|||Insured by private/other||Participants|Count of Participants|57|57.0||||||
3757442|NCT01963234|3591188|B3|||Insured by private/other||Participants|Count of Participants|20|20.0||||||
3757443|NCT01963234|3591189|B2|||Insured by private/other||Participants|Count of Participants|19|19.0||||||
3757444|NCT01963234|3591190|B1|||Insured by private/other||Participants|Count of Participants|18|18.0||||||
3757445|NCT01963234|3591187|B4|||Insured by medicaid||Participants|Count of Participants|111|111.0||||||
3757446|NCT01963234|3591188|B3|||Insured by medicaid||Participants|Count of Participants|33|33.0||||||
3757447|NCT01963234|3591189|B2|||Insured by medicaid||Participants|Count of Participants|23|23.0||||||
3757448|NCT01963234|3591190|B1|||Insured by medicaid||Participants|Count of Participants|55|55.0||||||
3757449|NCT01963234|3591187|B4|||Insured by medicare||Participants|Count of Participants|28|28.0||||||
3757450|NCT01963234|3591188|B3|||Insured by medicare||Participants|Count of Participants|8|8.0||||||
3757451|NCT01963234|3591189|B2|||Insured by medicare||Participants|Count of Participants|12|12.0||||||
3757452|NCT01963234|3591190|B1|||Insured by medicare||Participants|Count of Participants|8|8.0||||||
3757453|NCT01963234|3591187|B4|United States||Region of Enrollment||participants|Number|268|268.0||||||
3757454|NCT01963234|3591188|B3|United States||Region of Enrollment||participants|Number|71|71.0||||||
3757455|NCT01963234|3591189|B2|United States||Region of Enrollment||participants|Number|100|100.0||||||
3757456|NCT01963234|3591190|B1|United States||Region of Enrollment||participants|Number|97|97.0||||||
3757457|NCT01963234|3591187|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3757458|NCT01963234|3591188|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3757459|NCT01963234|3591189|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757460|NCT01963234|3591190|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757461|NCT01963234|3591187|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757462|NCT01963234|3591188|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757463|NCT01963234|3591189|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757464|NCT01963234|3591190|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757465|NCT01963234|3591187|B4||White|Race (NIH/OMB)||Participants|Count of Participants|176|176.0||||||
3757466|NCT01963234|3591188|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3757467|NCT01963234|3591189|B2||White|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
3757468|NCT01963234|3591190|B1||White|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3757469|NCT01963234|3591187|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3757470|NCT01963234|3591188|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3757471|NCT01963234|3591189|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3757472|NCT01963234|3591190|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3757473|NCT01963234|3591187|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757474|NCT01963234|3591188|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757475|NCT01963234|3591189|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757476|NCT01963234|3591190|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757477|NCT01963234|3591187|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3757478|NCT01963234|3591188|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757479|NCT01963234|3591189|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3757480|NCT01963234|3591190|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757481|NCT01963234|3591187|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3757482|NCT01963234|3591188|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3757483|NCT01963234|3591189|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3757484|NCT01963234|3591190|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3757485|NCT01963234|3591187|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757486|NCT01963234|3591188|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757489|NCT01963234|3591187|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|230|230.0||||||
3757490|NCT01963234|3591188|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3757491|NCT01963234|3591189|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3757492|NCT01963234|3591190|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3757493|NCT01963234|3591187|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3757494|NCT01963234|3591188|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3757495|NCT01963234|3591189|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3757496|NCT01963234|3591190|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3757497|NCT01963234|3591187|B4||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3757498|NCT01963234|3591188|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3757499|NCT01963234|3591189|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3757500|NCT01963234|3591190|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3757501|NCT01963234|3591187|B4||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3757502|NCT01963234|3591188|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3757503|NCT01963234|3591189|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3757504|NCT01963234|3591190|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3757505|NCT01963234|3591187|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3757506|NCT01963234|3591188|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3757507|NCT01963234|3591189|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3757508|NCT01963234|3591190|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3757509|NCT01963234|3591187|B4||Between 18 and 65 years|Age||Participants|Count of Participants|268|268.0||||||
3757510|NCT01963234|3591188|B3||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
3757511|NCT01963234|3591189|B2||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
3757512|NCT01963234|3591190|B1||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
3757513|NCT01963234|3591187|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3757514|NCT01963234|3591188|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3757515|NCT01963234|3591189|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3757516|NCT01963234|3591190|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3757517|NCT01963143|3591215|B4|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3757518|NCT01963143|3591216|B3|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3757519|NCT01963143|3591217|B2|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3757520|NCT01963143|3591218|B1|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3757521|NCT01963143|3591215|B4|United States||Region of Enrollment||participants|Number|44|44.0||||||
3757522|NCT01963143|3591216|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
3757523|NCT01963143|3591217|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3757524|NCT01963143|3591218|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3757525|NCT01963143|3591215|B4|Hungary||Region of Enrollment||participants|Number|1|1.0||||||
3757526|NCT01963143|3591216|B3|Hungary||Region of Enrollment||participants|Number|1|1.0||||||
3757527|NCT01963143|3591217|B2|Hungary||Region of Enrollment||participants|Number|0|0.0||||||
3757528|NCT01963143|3591218|B1|Hungary||Region of Enrollment||participants|Number|0|0.0||||||
3757529|NCT01963143|3591215|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757530|NCT01963143|3591216|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757531|NCT01963143|3591217|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757532|NCT01963143|3591218|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757533|NCT01963143|3591215|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757534|NCT01963143|3591216|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757535|NCT01963143|3591217|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757536|NCT01963143|3591218|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757537|NCT01963143|3591215|B4||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3757538|NCT01963143|3591216|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3757539|NCT01963143|3591217|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3757540|NCT01963143|3591218|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3757541|NCT01963143|3591215|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757542|NCT01963143|3591216|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757543|NCT01963143|3591217|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757544|NCT01963143|3591218|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757545|NCT01963143|3591215|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757546|NCT01963143|3591216|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757547|NCT01963143|3591217|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757548|NCT01963143|3591218|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757549|NCT01963143|3591215|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757550|NCT01963143|3591216|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757551|NCT01963143|3591217|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757552|NCT01963143|3591218|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757553|NCT01963143|3591215|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757554|NCT01963143|3591216|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757555|NCT01963143|3591217|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757556|NCT01963143|3591218|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757557|NCT01963143|3591215|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757558|NCT01963143|3591216|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757559|NCT01963143|3591217|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757560|NCT01963143|3591218|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757561|NCT01963143|3591215|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3757562|NCT01963143|3591216|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3757563|NCT01963143|3591217|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3757564|NCT01963143|3591218|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3757565|NCT01963143|3591215|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3757566|NCT01963143|3591216|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3757567|NCT01963143|3591217|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3757568|NCT01963143|3591218|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757569|NCT01963143|3591215|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3757570|NCT01963143|3591216|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3757571|NCT01963143|3591217|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3757572|NCT01963143|3591218|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3757573|NCT01963143|3591215|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3757574|NCT01963143|3591216|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3757575|NCT01963143|3591217|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3757576|NCT01963143|3591218|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3757577|NCT01963143|3591215|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3757578|NCT01963143|3591216|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3757579|NCT01963143|3591217|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3757580|NCT01963143|3591218|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3757581|NCT01963143|3591215|B4||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3757582|NCT01963143|3591216|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3757583|NCT01963143|3591217|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3757584|NCT01963143|3591218|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3757585|NCT01963143|3591215|B4||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
3757586|NCT01963143|3591216|B3||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
3757587|NCT01963143|3591217|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3757588|NCT01963143|3591218|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3757589|NCT01963091|3591230|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
3757590|NCT01963091|3591231|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3757591|NCT01963091|3591232|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3757592|NCT01963091|3591230|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3757593|NCT01963091|3591231|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3757594|NCT01963091|3591232|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3757595|NCT01963091|3591230|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3757596|NCT01963091|3591231|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3757597|NCT01963091|3591232|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3757598|NCT01963091|3591230|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3757599|NCT01963091|3591231|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3757600|NCT01963091|3591232|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3757601|NCT01963091|3591230|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3757602|NCT01963091|3591231|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3757603|NCT01963091|3591232|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3757604|NCT01963091|3591230|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3757605|NCT01963091|3591231|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3757606|NCT01963091|3591232|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3757607|NCT01963078|3591243|B5|United States||Region of Enrollment||Count of Participants|Number|38|38.0||||||
3757608|NCT01963078|3591244|B4|United States||Region of Enrollment||Count of Participants|Number|9|9.0||||||
3757609|NCT01963078|3591245|B3|United States||Region of Enrollment||Count of Participants|Number|10|10.0||||||
3757610|NCT01963078|3591246|B2|United States||Region of Enrollment||Count of Participants|Number|10|10.0||||||
3757611|NCT01963078|3591247|B1|United States||Region of Enrollment||Count of Participants|Number|9|9.0||||||
3757612|NCT01963078|3591243|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757613|NCT01963078|3591244|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757614|NCT01963078|3591245|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757615|NCT01963078|3591246|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757616|NCT01963078|3591247|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757617|NCT01963078|3591243|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757618|NCT01963078|3591244|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757619|NCT01963078|3591245|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757620|NCT01963078|3591246|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757621|NCT01963078|3591247|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757622|NCT01963078|3591243|B5||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3757623|NCT01963078|3591244|B4||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3757624|NCT01963078|3591245|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3757625|NCT01963078|3591246|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3757626|NCT01963078|3591247|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3757627|NCT01963078|3591243|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3757628|NCT01963078|3591244|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3757629|NCT01963078|3591245|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3757630|NCT01963078|3591246|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3757631|NCT01963078|3591247|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3757632|NCT01963078|3591243|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757633|NCT01963078|3591244|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757634|NCT01963078|3591245|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757635|NCT01963078|3591246|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757636|NCT01963078|3591247|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757637|NCT01963078|3591243|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3757638|NCT01963078|3591244|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3757639|NCT01963078|3591245|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757640|NCT01963078|3591246|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757641|NCT01963078|3591247|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757642|NCT01963078|3591243|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757643|NCT01963078|3591244|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757644|NCT01963078|3591245|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757645|NCT01963078|3591246|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757646|NCT01963078|3591247|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757647|NCT01963078|3591243|B5||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3757648|NCT01963078|3591244|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3757649|NCT01963078|3591245|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3757650|NCT01963078|3591246|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3757651|NCT01963078|3591247|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3757652|NCT01963078|3591243|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3757653|NCT01963078|3591244|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3757654|NCT01963078|3591245|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3757655|NCT01963078|3591246|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3757656|NCT01963078|3591247|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3757657|NCT01963078|3591243|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3757658|NCT01963078|3591244|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3757659|NCT01963078|3591245|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3757660|NCT01963078|3591246|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3757661|NCT01963078|3591247|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3757662|NCT01963078|3591243|B5||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3757663|NCT01963078|3591244|B4||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3757664|NCT01963078|3591245|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3757665|NCT01963078|3591246|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3757666|NCT01963078|3591247|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3757667|NCT01963078|3591243|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3757668|NCT01963078|3591244|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3757669|NCT01963078|3591245|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3757670|NCT01963078|3591246|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3757671|NCT01963078|3591247|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3757672|NCT01962974|3591260|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3757673|NCT01962974|3591260|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3757674|NCT01962974|3591260|B1|||Age||years|Mean|60.0|60.0|Standard Deviation|11.06|11.06|||
3757675|NCT01962961|3591266|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3757676|NCT01962961|3591267|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757677|NCT01962961|3591268|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757678|NCT01962961|3591269|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3757679|NCT01962961|3591266|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3757680|NCT01962961|3591267|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757681|NCT01962961|3591268|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757682|NCT01962961|3591269|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3757683|NCT01962961|3591266|B4||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3757684|NCT01962961|3591267|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3757685|NCT01962961|3591268|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3757686|NCT01962961|3591269|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3757687|NCT01962961|3591266|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3757688|NCT01962961|3591267|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3757689|NCT01962961|3591268|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3757690|NCT01962961|3591269|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3757691|NCT01962961|3591266|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757692|NCT01962961|3591267|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757693|NCT01962961|3591268|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757694|NCT01962961|3591269|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757695|NCT01962961|3591266|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757696|NCT01962961|3591267|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757697|NCT01962961|3591268|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757698|NCT01962961|3591269|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757699|NCT01962961|3591266|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757700|NCT01962961|3591267|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757701|NCT01962961|3591268|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757702|NCT01962961|3591269|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757703|NCT01962961|3591266|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757704|NCT01962961|3591267|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757705|NCT01962961|3591268|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757706|NCT01962961|3591269|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757707|NCT01962961|3591266|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3757708|NCT01962961|3591267|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3757709|NCT01962961|3591268|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3757710|NCT01962961|3591269|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3757711|NCT01962961|3591266|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3757712|NCT01962961|3591267|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3757713|NCT01962961|3591268|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757714|NCT01962961|3591269|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3757715|NCT01962961|3591266|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3757716|NCT01962961|3591267|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3757717|NCT01962961|3591268|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3757718|NCT01962961|3591269|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3757719|NCT01962961|3591266|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3757720|NCT01962961|3591267|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3757721|NCT01962961|3591268|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3757723|NCT01962961|3591266|B4|||Age||years|Mean|53|53.0|Full Range|||50.0|61.0|
3757724|NCT01962961|3591267|B3|||Age||years|Mean|54|54.0|Full Range|||50.0|57.0|
3757725|NCT01962961|3591268|B2|||Age||years|Mean|53|53.0|Full Range|||51.0|57.0|
3757726|NCT01962961|3591269|B1|||Age||years|Mean|52|52.0|Full Range|||50.0|61.0|
3757727|NCT01962922|3591285|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3757728|NCT01962922|3591286|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
3757729|NCT01962922|3591287|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3757730|NCT01962922|3591285|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3757731|NCT01962922|3591286|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3757732|NCT01962922|3591287|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3757733|NCT01962922|3591285|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3757734|NCT01962922|3591286|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3757735|NCT01962922|3591287|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3757736|NCT01962922|3591285|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3757737|NCT01962922|3591286|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3757738|NCT01962922|3591287|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3757739|NCT01962922|3591285|B3||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
3757740|NCT01962922|3591286|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3757741|NCT01962922|3591287|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3757742|NCT01962922|3591285|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3757743|NCT01962922|3591286|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3757744|NCT01962922|3591287|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3757745|NCT01962688|3591310|B3|no||Diuretic use||participants|Number|4|4.0||||||
3757746|NCT01962688|3591311|B2|no||Diuretic use||participants|Number|3|3.0||||||
3757747|NCT01962688|3591312|B1|no||Diuretic use||participants|Number|1|1.0||||||
3757748|NCT01962688|3591310|B3|yes||Diuretic use||participants|Number|33|33.0||||||
3757749|NCT01962688|3591311|B2|yes||Diuretic use||participants|Number|15|15.0||||||
3757750|NCT01962688|3591312|B1|yes||Diuretic use||participants|Number|18|18.0||||||
3757751|NCT01962688|3591310|B3|||Ejection Fraction||percent|Mean|24.5|24.5|Standard Deviation|8.8|8.8|||
3757752|NCT01962688|3591311|B2|||Ejection Fraction||percent|Mean|24.2|24.2|Standard Deviation|9.5|9.5|||
3757753|NCT01962688|3591312|B1|||Ejection Fraction||percent|Mean|24.8|24.8|Standard Deviation|8.4|8.4|||
3757754|NCT01962688|3591310|B3|no||Ischemic Cardiomyopathy||participants|Number|18|18.0||||||
3757755|NCT01962688|3591311|B2|no||Ischemic Cardiomyopathy||participants|Number|7|7.0||||||
3757756|NCT01962688|3591312|B1|no||Ischemic Cardiomyopathy||participants|Number|11|11.0||||||
3757757|NCT01962688|3591310|B3|yes||Ischemic Cardiomyopathy||participants|Number|19|19.0||||||
3757758|NCT01962688|3591311|B2|yes||Ischemic Cardiomyopathy||participants|Number|11|11.0||||||
3757759|NCT01962688|3591312|B1|yes||Ischemic Cardiomyopathy||participants|Number|8|8.0||||||
3757760|NCT01962688|3591310|B3|||Body Mass Index (BMI)||kg/m^2|Mean|26.4|26.4|Standard Deviation|4.9|4.9|||
3757761|NCT01962688|3591311|B2|||Body Mass Index (BMI)||kg/m^2|Mean|26.4|26.4|Standard Deviation|5.5|5.5|||
3757762|NCT01962688|3591312|B1|||Body Mass Index (BMI)||kg/m^2|Mean|26.3|26.3|Standard Deviation|4.7|4.7|||
3757763|NCT01962688|3591310|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3757764|NCT01962688|3591311|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3757765|NCT01962688|3591312|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3757766|NCT01962688|3591310|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3757767|NCT01962688|3591311|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3757768|NCT01962688|3591312|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3757769|NCT01962688|3591310|B3|||Age||years|Mean|61.2|61.2|Standard Deviation|14.3|14.3|||
3757770|NCT01962688|3591311|B2|||Age||years|Mean|61.5|61.5|Standard Deviation|11.7|11.7|||
3757771|NCT01962688|3591312|B1|||Age||years|Mean|60.9|60.9|Standard Deviation|16.7|16.7|||
3757772|NCT01962558|3591344|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3757773|NCT01962558|3591345|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3757774|NCT01962558|3591346|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3757775|NCT01962558|3591344|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757776|NCT01962558|3591345|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757777|NCT01962558|3591346|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757778|NCT01962558|3591344|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757779|NCT01962558|3591345|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757780|NCT01962558|3591346|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757781|NCT01962558|3591344|B3||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3757782|NCT01962558|3591345|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3757783|NCT01962558|3591346|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3757784|NCT01962558|3591344|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757785|NCT01962558|3591345|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757786|NCT01962558|3591346|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757787|NCT01962558|3591344|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757788|NCT01962558|3591345|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757789|NCT01962558|3591346|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757790|NCT01962558|3591344|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757791|NCT01962558|3591345|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757792|NCT01962558|3591346|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757793|NCT01962558|3591344|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757794|NCT01962558|3591345|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757795|NCT01962558|3591346|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3757796|NCT01962558|3591344|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3757797|NCT01962558|3591345|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3757798|NCT01962558|3591346|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3757799|NCT01962558|3591344|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3757800|NCT01962558|3591345|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3757801|NCT01962558|3591346|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3757802|NCT01962558|3591344|B3|||Age||years|Mean|55.6|55.6|Standard Deviation|8.4|8.4|||
3757803|NCT01962558|3591345|B2|||Age||years|Mean|54.9|54.9|Standard Deviation|9.1|9.1|||
3757804|NCT01962558|3591346|B1|||Age||years|Mean|55.9|55.9|Standard Deviation|7.6|7.6|||
3757805|NCT01962493|3591363|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3757806|NCT01962493|3591364|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3757807|NCT01962493|3591365|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3757808|NCT01962493|3591363|B3||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3757809|NCT01962493|3591364|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3757810|NCT01962493|3591365|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3757811|NCT01962493|3591363|B3|||Age||Years|Mean|39.6|39.6|Standard Deviation|10.94|10.94|||
3757812|NCT01962493|3591364|B2|||Age||Years|Mean|39.5|39.5|Standard Deviation|10.87|10.87|||
3757813|NCT01962493|3591365|B1|||Age||Years|Mean|39.8|39.8|Standard Deviation|11.08|11.08|||
3757814|NCT01962441|3591386|B4|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|400|400.0||||||
3757815|NCT01962441|3591387|B3|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|137|137.0||||||
3757816|NCT01962441|3591388|B2|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|127|127.0||||||
3757817|NCT01962441|3591389|B1|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|136|136.0||||||
3757818|NCT01962441|3591386|B4|< 6 log10 IU/mL||HCV RNA Category||participants|Number|192|192.0||||||
3757819|NCT01962441|3591387|B3|< 6 log10 IU/mL||HCV RNA Category||participants|Number|60|60.0||||||
3757820|NCT01962441|3591388|B2|< 6 log10 IU/mL||HCV RNA Category||participants|Number|72|72.0||||||
3757821|NCT01962441|3591389|B1|< 6 log10 IU/mL||HCV RNA Category||participants|Number|60|60.0||||||
3757822|NCT01962441|3591386|B4|||HCV RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.69|0.69|||
3757823|NCT01962441|3591387|B3|||HCV RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.69|0.69|||
3757824|NCT01962441|3591388|B2|||HCV RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.71|0.71|||
3757825|NCT01962441|3591389|B1|||HCV RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.68|0.68|||
3757826|NCT01962441|3591386|B4|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|79|79.0||||||
3757827|NCT01962441|3591387|B3|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|21|21.0||||||
3757828|NCT01962441|3591388|B2|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|31|31.0||||||
3757829|NCT01962441|3591389|B1|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|27|27.0||||||
3757830|NCT01962441|3591386|B4|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|287|287.0||||||
3757831|NCT01962441|3591387|B3|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|98|98.0||||||
3757832|NCT01962441|3591388|B2|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|95|95.0||||||
3757833|NCT01962441|3591389|B1|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|94|94.0||||||
3757834|NCT01962441|3591386|B4|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|226|226.0||||||
3757835|NCT01962441|3591387|B3|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|78|78.0||||||
3757836|NCT01962441|3591388|B2|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|73|73.0||||||
3757837|NCT01962441|3591389|B1|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|75|75.0||||||
3757838|NCT01962441|3591386|B4|Genotype 3||HCV Genotype||participants|Number|544|544.0||||||
3757839|NCT01962441|3591387|B3|Genotype 3||HCV Genotype||participants|Number|181|181.0||||||
3757840|NCT01962441|3591388|B2|Genotype 3||HCV Genotype||participants|Number|182|182.0||||||
3757841|NCT01962441|3591389|B1|Genotype 3||HCV Genotype||participants|Number|181|181.0||||||
3757842|NCT01962441|3591386|B4|Genotype 2||HCV Genotype||participants|Number|48|48.0||||||
3757843|NCT01962441|3591387|B3|Genotype 2||HCV Genotype||participants|Number|16|16.0||||||
3757844|NCT01962441|3591388|B2|Genotype 2||HCV Genotype||participants|Number|17|17.0||||||
3757845|NCT01962441|3591389|B1|Genotype 2||HCV Genotype||participants|Number|15|15.0||||||
3757846|NCT01962441|3591386|B4|Australia||Region of Enrollment||participants|Number|128|128.0||||||
3757847|NCT01962441|3591387|B3|Australia||Region of Enrollment||participants|Number|44|44.0||||||
3757848|NCT01962441|3591388|B2|Australia||Region of Enrollment||participants|Number|39|39.0||||||
3757849|NCT01962441|3591389|B1|Australia||Region of Enrollment||participants|Number|45|45.0||||||
3757850|NCT01962441|3591386|B4|United Kingdom||Region of Enrollment||participants|Number|248|248.0||||||
3757851|NCT01962441|3591387|B3|United Kingdom||Region of Enrollment||participants|Number|80|80.0||||||
3757852|NCT01962441|3591388|B2|United Kingdom||Region of Enrollment||participants|Number|82|82.0||||||
3757853|NCT01962441|3591389|B1|United Kingdom||Region of Enrollment||participants|Number|86|86.0||||||
3757854|NCT01962441|3591386|B4|United States||Region of Enrollment||participants|Number|93|93.0||||||
3757855|NCT01962441|3591387|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
3757856|NCT01962441|3591388|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
3757857|NCT01962441|3591389|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3757858|NCT01962441|3591386|B4|Canada||Region of Enrollment||participants|Number|83|83.0||||||
3757859|NCT01962441|3591387|B3|Canada||Region of Enrollment||participants|Number|29|29.0||||||
3757860|NCT01962441|3591388|B2|Canada||Region of Enrollment||participants|Number|33|33.0||||||
3757861|NCT01962441|3591389|B1|Canada||Region of Enrollment||participants|Number|21|21.0||||||
3757862|NCT01962441|3591386|B4|New Zealand||Region of Enrollment||participants|Number|40|40.0||||||
3757863|NCT01962441|3591387|B3|New Zealand||Region of Enrollment||participants|Number|13|13.0||||||
3757864|NCT01962441|3591388|B2|New Zealand||Region of Enrollment||participants|Number|12|12.0||||||
3757865|NCT01962441|3591389|B1|New Zealand||Region of Enrollment||participants|Number|15|15.0||||||
3757866|NCT01962441|3591386|B4|Not Disclosed||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3757867|NCT01962441|3591387|B3|Not Disclosed||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3757868|NCT01962441|3591388|B2|Not Disclosed||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3757869|NCT01962441|3591389|B1|Not Disclosed||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3757870|NCT01962441|3591386|B4|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3757871|NCT01962441|3591387|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3757872|NCT01962441|3591388|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3757873|NCT01962441|3591389|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3757874|NCT01962441|3591386|B4|Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3757875|NCT01962441|3591387|B3|Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3757876|NCT01962441|3591388|B2|Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3757877|NCT01962441|3591389|B1|Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3757878|NCT01962441|3591386|B4|American Indian/ Alaska Native/ First Nations||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3757879|NCT01962441|3591387|B3|American Indian/ Alaska Native/ First Nations||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3757880|NCT01962441|3591388|B2|American Indian/ Alaska Native/ First Nations||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3757881|NCT01962441|3591389|B1|American Indian/ Alaska Native/ First Nations||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3757882|NCT01962441|3591386|B4|Asian||Race/Ethnicity, Customized||participants|Number|80|80.0||||||
3757883|NCT01962441|3591387|B3|Asian||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3757884|NCT01962441|3591388|B2|Asian||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3757885|NCT01962441|3591389|B1|Asian||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3757886|NCT01962441|3591386|B4|White||Race/Ethnicity, Customized||participants|Number|495|495.0||||||
3757887|NCT01962441|3591387|B3|White||Race/Ethnicity, Customized||participants|Number|165|165.0||||||
3757888|NCT01962441|3591388|B2|White||Race/Ethnicity, Customized||participants|Number|168|168.0||||||
3757889|NCT01962441|3591389|B1|White||Race/Ethnicity, Customized||participants|Number|162|162.0||||||
3757890|NCT01962441|3591386|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3757891|NCT01962441|3591387|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3757892|NCT01962441|3591388|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3757893|NCT01962441|3591389|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3757894|NCT01962441|3591386|B4|Not Disclosed||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3757895|NCT01962441|3591387|B3|Not Disclosed||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3757896|NCT01962441|3591388|B2|Not Disclosed||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3757897|NCT01962441|3591389|B1|Not Disclosed||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3757898|NCT01962441|3591386|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|567|567.0||||||
3757899|NCT01962441|3591387|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|191|191.0||||||
3757900|NCT01962441|3591388|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|188|188.0||||||
3757901|NCT01962441|3591389|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|188|188.0||||||
3757902|NCT01962441|3591386|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3757903|NCT01962441|3591387|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3757904|NCT01962441|3591388|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3757905|NCT01962441|3591389|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3757906|NCT01962441|3591386|B4||Male|Sex: Female, Male||Participants|Count of Participants|395|395.0||||||
3757907|NCT01962441|3591387|B3||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3757908|NCT01962441|3591388|B2||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3757909|NCT01962441|3591389|B1||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3757910|NCT01962441|3591386|B4||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
3757911|NCT01962441|3591387|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3757912|NCT01962441|3591388|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3757913|NCT01962441|3591389|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3757914|NCT01962441|3591386|B4|||Age||years|Mean|50|50.0|Standard Deviation|9.9|9.9|||
3757915|NCT01962441|3591387|B3|||Age||years|Mean|50|50.0|Standard Deviation|10.2|10.2|||
3757916|NCT01962441|3591388|B2|||Age||years|Mean|49|49.0|Standard Deviation|9.8|9.8|||
3757917|NCT01962441|3591389|B1|||Age||years|Mean|51|51.0|Standard Deviation|9.7|9.7|||
3757918|NCT01962428|3591421|B3|China||Region of Enrollment||participants|Number|262|262.0||||||
3757919|NCT01962428|3591422|B2|China||Region of Enrollment||participants|Number|133|133.0||||||
3757920|NCT01962428|3591423|B1|China||Region of Enrollment||participants|Number|129|129.0||||||
3757921|NCT01962428|3591421|B3||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
3757922|NCT01962428|3591422|B2||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3757923|NCT01962428|3591423|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3757924|NCT01962428|3591421|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3757925|NCT01962428|3591422|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3757926|NCT01962428|3591423|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3757927|NCT01962428|3591421|B3|||Age||years|Mean|59.2|59.2|Standard Deviation|9.46|9.46|||
3757928|NCT01962428|3591422|B2|||Age||years|Mean|58.8|58.8|Standard Deviation|10.26|10.26|||
3757929|NCT01962428|3591423|B1|||Age||years|Mean|59.7|59.7|Standard Deviation|9.47|9.47|||
3757930|NCT01962428|3591421|B3||>=65 years|Age||Participants|Count of Participants|107|107.0||||||
3757931|NCT01962428|3591422|B2||>=65 years|Age||Participants|Count of Participants|53|53.0||||||
3757932|NCT01962428|3591423|B1||>=65 years|Age||Participants|Count of Participants|54|54.0||||||
3757933|NCT01962428|3591421|B3||Between 18 and 65 years|Age||Participants|Count of Participants|155|155.0||||||
3757934|NCT01962428|3591422|B2||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
3757935|NCT01962428|3591423|B1||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
3757936|NCT01962428|3591421|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3757937|NCT01962428|3591422|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3757938|NCT01962428|3591423|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3757939|NCT01962298|3591430|B6|||Body Mass Index||kg/m2|Median|26|26.0|Inter-Quartile Range|||22.0|28.0|
3757940|NCT01962298|3591431|B5|||Body Mass Index||kg/m2|Median|24|24.0|Inter-Quartile Range|||21.0|27.0|
3757941|NCT01962298|3591432|B4|||Body Mass Index||kg/m2|Median|26|26.0|Inter-Quartile Range|||24.0|28.0|
3757942|NCT01962298|3591433|B3|||Body Mass Index||kg/m2|Median|25|25.0|Inter-Quartile Range|||21.0|28.0|
3757943|NCT01962298|3591434|B2|||Body Mass Index||kg/m2|Median|27|27.0|Inter-Quartile Range|||24.0|28.0|
3757944|NCT01962298|3591435|B1|||Body Mass Index||kg/m2|Median|26|26.0|Inter-Quartile Range|||23.0|30.0|
3757945|NCT01962298|3591430|B6||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3757946|NCT01962298|3591431|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3757947|NCT01962298|3591432|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3757948|NCT01962298|3591433|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3757949|NCT01962298|3591434|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3757950|NCT01962298|3591435|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3757951|NCT01962298|3591430|B6||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3757952|NCT01962298|3591431|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3757953|NCT01962298|3591432|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3757954|NCT01962298|3591433|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3757955|NCT01962298|3591434|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3757956|NCT01962298|3591435|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3757957|NCT01962298|3591430|B6|||Age||years|Median|55|55.0|Inter-Quartile Range|||44.0|62.0|
3757958|NCT01962298|3591431|B5|||Age||years|Median|55|55.0|Inter-Quartile Range|||41.0|63.0|
3757959|NCT01962298|3591432|B4|||Age||years|Median|54|54.0|Inter-Quartile Range|||30.0|68.0|
3757960|NCT01962298|3591433|B3|||Age||years|Median|56|56.0|Inter-Quartile Range|||49.0|59.0|
3757961|NCT01962298|3591434|B2|||Age||years|Median|51|51.0|Inter-Quartile Range|||41.0|65.0|
3757962|NCT01962298|3591435|B1|||Age||years|Median|54|54.0|Inter-Quartile Range|||42.0|63.0|
3757963|NCT01962103|3591456|B10|||Number of Prior Systemic Anticancer Regimens Received||systemic anticancer regimens|Mean|2.99|2.99|Standard Deviation|1.552|1.552|||
3757964|NCT01962103|3591457|B9|||Number of Prior Systemic Anticancer Regimens Received||systemic anticancer regimens|Mean|2.21|2.21|Standard Deviation|0.579|0.579|||
3758369|NCT01960855|3591700|B1|||Age||years|Mean|57.5|57.5|Standard Deviation|12.04|12.04|||
3757965|NCT01962103|3591458|B8|||Number of Prior Systemic Anticancer Regimens Received||systemic anticancer regimens|Mean|2.14|2.14|Standard Deviation|0.663|0.663|||
3757966|NCT01962103|3591459|B7|||Number of Prior Systemic Anticancer Regimens Received||systemic anticancer regimens|Mean|2.50|2.5|Standard Deviation|0.519|0.519|||
3757967|NCT01962103|3591460|B6|||Number of Prior Systemic Anticancer Regimens Received||systemic anticancer regimens|Mean|3.00|3.0|Standard Deviation|0.816|0.816|||
3757968|NCT01962103|3591461|B5|||Number of Prior Systemic Anticancer Regimens Received||systemic anticancer regimens|Mean|3.00|3.0|Standard Deviation|1.309|1.309|||
3757969|NCT01962103|3591462|B4|||Number of Prior Systemic Anticancer Regimens Received||systemic anticancer regimens|Mean|3.64|3.64|Standard Deviation|2.461|2.461|||
3757970|NCT01962103|3591463|B3|||Number of Prior Systemic Anticancer Regimens Received||systemic anticancer regimens|Mean|3.64|3.64|Standard Deviation|1.946|1.946|||
3757971|NCT01962103|3591464|B2|||Number of Prior Systemic Anticancer Regimens Received||systemic anticancer regimens|Mean|3.25|3.25|Standard Deviation|1.832|1.832|||
3757972|NCT01962103|3591465|B1|||Number of Prior Systemic Anticancer Regimens Received||systemic anticancer regimens|Mean|3.69|3.69|Standard Deviation|1.815|1.815|||
3757973|NCT01962103|3591456|B10|Other Prior Anticancer Therapies||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|15|15.0||||||
3757974|NCT01962103|3591457|B9|Other Prior Anticancer Therapies||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|0|0.0||||||
3757975|NCT01962103|3591458|B8|Other Prior Anticancer Therapies||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|6|6.0||||||
3757976|NCT01962103|3591459|B7|Other Prior Anticancer Therapies||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|1|1.0||||||
3757977|NCT01962103|3591460|B6|Other Prior Anticancer Therapies||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|0|0.0||||||
3757978|NCT01962103|3591461|B5|Other Prior Anticancer Therapies||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|2|2.0||||||
3757979|NCT01962103|3591462|B4|Other Prior Anticancer Therapies||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|3|3.0||||||
3757980|NCT01962103|3591463|B3|Other Prior Anticancer Therapies||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|1|1.0||||||
3757981|NCT01962103|3591464|B2|Other Prior Anticancer Therapies||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|0|0.0||||||
3757982|NCT01962103|3591465|B1|Other Prior Anticancer Therapies||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|2|2.0||||||
3757983|NCT01962103|3591456|B10|Prior Stem Cell Transplants||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|27|27.0||||||
3757984|NCT01962103|3591457|B9|Prior Stem Cell Transplants||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|0|0.0||||||
3757985|NCT01962103|3591458|B8|Prior Stem Cell Transplants||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|10|10.0||||||
3757986|NCT01962103|3591459|B7|Prior Stem Cell Transplants||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|3|3.0||||||
3757987|NCT01962103|3591460|B6|Prior Stem Cell Transplants||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|2|2.0||||||
3757988|NCT01962103|3591461|B5|Prior Stem Cell Transplants||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|3|3.0||||||
3757989|NCT01962103|3591462|B4|Prior Stem Cell Transplants||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|2|2.0||||||
3757990|NCT01962103|3591463|B3|Prior Stem Cell Transplants||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|3|3.0||||||
3757991|NCT01962103|3591464|B2|Prior Stem Cell Transplants||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|2|2.0||||||
3757992|NCT01962103|3591465|B1|Prior Stem Cell Transplants||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|2|2.0||||||
3757993|NCT01962103|3591456|B10|Prior Systemic Anticancer Regimens||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|106|106.0||||||
3757994|NCT01962103|3591457|B9|Prior Systemic Anticancer Regimens||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|14|14.0||||||
3757995|NCT01962103|3591458|B8|Prior Systemic Anticancer Regimens||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|14|14.0||||||
3757996|NCT01962103|3591459|B7|Prior Systemic Anticancer Regimens||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|14|14.0||||||
3757997|NCT01962103|3591460|B6|Prior Systemic Anticancer Regimens||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|7|7.0||||||
3757998|NCT01962103|3591461|B5|Prior Systemic Anticancer Regimens||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|8|8.0||||||
3757999|NCT01962103|3591462|B4|Prior Systemic Anticancer Regimens||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|11|11.0||||||
3758000|NCT01962103|3591463|B3|Prior Systemic Anticancer Regimens||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|14|14.0||||||
3758001|NCT01962103|3591464|B2|Prior Systemic Anticancer Regimens||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|8|8.0||||||
3758002|NCT01962103|3591465|B1|Prior Systemic Anticancer Regimens||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|16|16.0||||||
3758003|NCT01962103|3591456|B10|Prior Systemic Anticancer Therapy||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|106|106.0||||||
3758004|NCT01962103|3591457|B9|Prior Systemic Anticancer Therapy||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|14|14.0||||||
3758005|NCT01962103|3591458|B8|Prior Systemic Anticancer Therapy||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|14|14.0||||||
3758006|NCT01962103|3591459|B7|Prior Systemic Anticancer Therapy||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|14|14.0||||||
3758007|NCT01962103|3591460|B6|Prior Systemic Anticancer Therapy||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|7|7.0||||||
3758008|NCT01962103|3591461|B5|Prior Systemic Anticancer Therapy||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|8|8.0||||||
3758009|NCT01962103|3591462|B4|Prior Systemic Anticancer Therapy||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|11|11.0||||||
3758010|NCT01962103|3591463|B3|Prior Systemic Anticancer Therapy||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|14|14.0||||||
3758011|NCT01962103|3591464|B2|Prior Systemic Anticancer Therapy||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|8|8.0||||||
3758012|NCT01962103|3591465|B1|Prior Systemic Anticancer Therapy||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|16|16.0||||||
3758013|NCT01962103|3591456|B10|Prior Cancer Surgeries||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|78|78.0||||||
3758014|NCT01962103|3591457|B9|Prior Cancer Surgeries||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|6|6.0||||||
3758015|NCT01962103|3591458|B8|Prior Cancer Surgeries||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|11|11.0||||||
3758016|NCT01962103|3591459|B7|Prior Cancer Surgeries||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|10|10.0||||||
3758017|NCT01962103|3591460|B6|Prior Cancer Surgeries||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|7|7.0||||||
3758018|NCT01962103|3591461|B5|Prior Cancer Surgeries||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|5|5.0||||||
3758019|NCT01962103|3591462|B4|Prior Cancer Surgeries||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|9|9.0||||||
3758020|NCT01962103|3591463|B3|Prior Cancer Surgeries||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|9|9.0||||||
3758021|NCT01962103|3591464|B2|Prior Cancer Surgeries||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|7|7.0||||||
3758022|NCT01962103|3591465|B1|Prior Cancer Surgeries||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|14|14.0||||||
3758023|NCT01962103|3591456|B10|Prior Radiation Therapy||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|75|75.0||||||
3758024|NCT01962103|3591457|B9|Prior Radiation Therapy||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|10|10.0||||||
3758025|NCT01962103|3591458|B8|Prior Radiation Therapy||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|10|10.0||||||
3758026|NCT01962103|3591459|B7|Prior Radiation Therapy||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|12|12.0||||||
3758027|NCT01962103|3591460|B6|Prior Radiation Therapy||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|6|6.0||||||
3758028|NCT01962103|3591461|B5|Prior Radiation Therapy||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|6|6.0||||||
3758029|NCT01962103|3591462|B4|Prior Radiation Therapy||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|7|7.0||||||
3758030|NCT01962103|3591463|B3|Prior Radiation Therapy||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|11|11.0||||||
3758031|NCT01962103|3591464|B2|Prior Radiation Therapy||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|4|4.0||||||
3758032|NCT01962103|3591465|B1|Prior Radiation Therapy||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|9|9.0||||||
3758033|NCT01962103|3591456|B10|Any Prior Cancer Treatment||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|106|106.0||||||
3758034|NCT01962103|3591457|B9|Any Prior Cancer Treatment||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|14|14.0||||||
3758035|NCT01962103|3591458|B8|Any Prior Cancer Treatment||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|14|14.0||||||
3758036|NCT01962103|3591459|B7|Any Prior Cancer Treatment||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|14|14.0||||||
3758037|NCT01962103|3591460|B6|Any Prior Cancer Treatment||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|7|7.0||||||
3758038|NCT01962103|3591461|B5|Any Prior Cancer Treatment||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|8|8.0||||||
3758039|NCT01962103|3591462|B4|Any Prior Cancer Treatment||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|11|11.0||||||
3758040|NCT01962103|3591463|B3|Any Prior Cancer Treatment||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|14|14.0||||||
3758041|NCT01962103|3591464|B2|Any Prior Cancer Treatment||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|8|8.0||||||
3758042|NCT01962103|3591465|B1|Any Prior Cancer Treatment||Participants With Any Prior Cancer Treatment||Participants|Count of Participants|16|16.0||||||
3758043|NCT01962103|3591456|B10|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3758044|NCT01962103|3591457|B9|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3758045|NCT01962103|3591458|B8|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3758046|NCT01962103|3591459|B7|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3758047|NCT01962103|3591460|B6|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3758048|NCT01962103|3591461|B5|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3758049|NCT01962103|3591462|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3758050|NCT01962103|3591463|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3758051|NCT01962103|3591464|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3758052|NCT01962103|3591465|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3758053|NCT01962103|3591456|B10|Other, Not Specified||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3758054|NCT01962103|3591457|B9|Other, Not Specified||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3758055|NCT01962103|3591458|B8|Other, Not Specified||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3758056|NCT01962103|3591459|B7|Other, Not Specified||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3758057|NCT01962103|3591460|B6|Other, Not Specified||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3758058|NCT01962103|3591461|B5|Other, Not Specified||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3758059|NCT01962103|3591462|B4|Other, Not Specified||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3758060|NCT01962103|3591463|B3|Other, Not Specified||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3758061|NCT01962103|3591464|B2|Other, Not Specified||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3758062|NCT01962103|3591465|B1|Other, Not Specified||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3758063|NCT01962103|3591456|B10|Not Collected or Reported||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3758064|NCT01962103|3591457|B9|Not Collected or Reported||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3758065|NCT01962103|3591458|B8|Not Collected or Reported||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3758066|NCT01962103|3591459|B7|Not Collected or Reported||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3758067|NCT01962103|3591460|B6|Not Collected or Reported||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3758068|NCT01962103|3591461|B5|Not Collected or Reported||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3758069|NCT01962103|3591462|B4|Not Collected or Reported||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3758070|NCT01962103|3591463|B3|Not Collected or Reported||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3758071|NCT01962103|3591464|B2|Not Collected or Reported||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3758072|NCT01962103|3591465|B1|Not Collected or Reported||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3758073|NCT01962103|3591456|B10|White||Race/Ethnicity, Customized||Participants|Count of Participants|84|84.0||||||
3758074|NCT01962103|3591457|B9|White||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3758075|NCT01962103|3591458|B8|White||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3758076|NCT01962103|3591459|B7|White||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3758077|NCT01962103|3591460|B6|White||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3758078|NCT01962103|3591461|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3758079|NCT01962103|3591462|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3758080|NCT01962103|3591463|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3758081|NCT01962103|3591464|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3758082|NCT01962103|3591465|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3758083|NCT01962103|3591456|B10||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3758084|NCT01962103|3591457|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3758085|NCT01962103|3591458|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3758086|NCT01962103|3591459|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3758087|NCT01962103|3591460|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3758088|NCT01962103|3591461|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758089|NCT01962103|3591462|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758090|NCT01962103|3591463|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3758091|NCT01962103|3591464|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758092|NCT01962103|3591465|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3758093|NCT01962103|3591456|B10||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3758094|NCT01962103|3591457|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3758095|NCT01962103|3591458|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3758096|NCT01962103|3591459|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3758097|NCT01962103|3591460|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3758098|NCT01962103|3591461|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3758099|NCT01962103|3591462|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3758100|NCT01962103|3591463|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3758101|NCT01962103|3591464|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3758102|NCT01962103|3591465|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3758103|NCT01962103|3591456|B10||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3758104|NCT01962103|3591457|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3758105|NCT01962103|3591458|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3758106|NCT01962103|3591459|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758107|NCT01962103|3591460|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758108|NCT01962103|3591461|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3758109|NCT01962103|3591462|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3758110|NCT01962103|3591463|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3758111|NCT01962103|3591464|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3758112|NCT01962103|3591465|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3758113|NCT01962103|3591456|B10||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3758114|NCT01962103|3591457|B9||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3758115|NCT01962103|3591458|B8||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3758116|NCT01962103|3591459|B7||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3758117|NCT01962103|3591460|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3758118|NCT01962103|3591461|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3758119|NCT01962103|3591462|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3758120|NCT01962103|3591463|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3758121|NCT01962103|3591464|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3758122|NCT01962103|3591465|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3758123|NCT01962103|3591456|B10||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3758124|NCT01962103|3591457|B9||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3758125|NCT01962103|3591458|B8||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3758126|NCT01962103|3591459|B7||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3758127|NCT01962103|3591460|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3758128|NCT01962103|3591461|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3758129|NCT01962103|3591462|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3758130|NCT01962103|3591463|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3758131|NCT01962103|3591464|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3758132|NCT01962103|3591465|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3758133|NCT01962103|3591456|B10|||Age||years|Mean|10.7|10.7|Standard Deviation|4.81|4.81|||
3758134|NCT01962103|3591457|B9|||Age||years|Mean|12.4|12.4|Standard Deviation|6.42|6.42|||
3758135|NCT01962103|3591458|B8|||Age||years|Mean|7.1|7.1|Standard Deviation|3.42|3.42|||
3758136|NCT01962103|3591459|B7|||Age||years|Mean|10.1|10.1|Standard Deviation|4.63|4.63|||
3758137|NCT01962103|3591460|B6|||Age||years|Mean|12.1|12.1|Standard Deviation|2.97|2.97|||
3758138|NCT01962103|3591461|B5|||Age||years|Mean|11.6|11.6|Standard Deviation|4.63|4.63|||
3758139|NCT01962103|3591462|B4|||Age||years|Mean|10.2|10.2|Standard Deviation|5.36|5.36|||
3758140|NCT01962103|3591463|B3|||Age||years|Mean|10.2|10.2|Standard Deviation|4.64|4.64|||
3758141|NCT01962103|3591464|B2|||Age||years|Mean|12.1|12.1|Standard Deviation|5.84|5.84|||
3758142|NCT01962103|3591465|B1|||Age||years|Mean|11.7|11.7|Standard Deviation|3.32|3.32|||
3758143|NCT01961921|3591573|B1|FAP Stage III: Wheelchair-bound or bedridden||Familial Amyloidotic Polyneuropathy (FAP) Stage||Participants|Count of Participants|0|0.0||||||
3758144|NCT01961921|3591573|B1|FAP Stage II: Assistance with ambulation required||Familial Amyloidotic Polyneuropathy (FAP) Stage||Participants|Count of Participants|3|3.0||||||
3758145|NCT01961921|3591573|B1|FAP Stage I: Unimpaired ambulation||Familial Amyloidotic Polyneuropathy (FAP) Stage||Participants|Count of Participants|24|24.0||||||
3758146|NCT01961921|3591573|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3758147|NCT01961921|3591573|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3758148|NCT01961921|3591573|B1|||Age||years|Mean|57.9|57.9|Standard Deviation|15.36|15.36|||
3758149|NCT01961921|3591573|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3758150|NCT01961921|3591573|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3758151|NCT01961921|3591573|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3758152|NCT01961544|3591583|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3758153|NCT01961544|3591583|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3758154|NCT01961544|3591583|B1|||Age||Years|Geometric Mean|50.36|50.36|Standard Deviation|10.71|10.71|||
3758155|NCT01961349|3591588|B4||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3758156|NCT01961349|3591589|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3758157|NCT01961349|3591590|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3758158|NCT01961349|3591591|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3758159|NCT01961349|3591588|B4||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3758160|NCT01961349|3591589|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3758161|NCT01961349|3591590|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3758162|NCT01961349|3591591|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3758163|NCT01961349|3591588|B4|||Age||years|Mean|56.8|56.8|Standard Deviation|14.0|14.0|||
3758164|NCT01961349|3591589|B3|||Age||years|Mean|57.2|57.2|Standard Deviation|14.8|14.8|||
3758165|NCT01961349|3591590|B2|||Age||years|Mean|55.4|55.4|Standard Deviation|12.9|12.9|||
3758166|NCT01961349|3591591|B1|||Age||years|Mean|58.6|58.6|Standard Deviation|14.3|14.3|||
3758167|NCT01961323|3591604|B1|||Diastolic Blood Pressure (DBP)||mmHG|Mean|92.9|92.9|Standard Deviation|10|10.0|||
3758168|NCT01961323|3591604|B1|||Systolic Blood Pressure (SBP)||mmHG|Mean|142|142.0|Standard Deviation|16.6|16.6|||
3758169|NCT01961323|3591604|B1|||Resting Heart Rate||beat/minute|Mean|74.5|74.5|Standard Deviation|14|14.0|||
3758170|NCT01961323|3591604|B1|||B-type Natriuretic Peptide (BNP) Blood Test|B-type natriuretic peptide (BNP) is a hormone produced by the heart. It is released in response to changes in pressure inside the heart. In general, the level of BNP goes up when heart failure develops or gets worse, and it goes down when the condition is stable.|pg/mL|Mean|19.8|19.8|Standard Deviation|13|13.0|||
3758171|NCT01961323|3591604|B1|||Body Mass Index (BMI)||kg/m^2|Mean|31|31.0|Standard Deviation|6.6|6.6|||
3758172|NCT01961323|3591604|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3758173|NCT01961323|3591604|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3758174|NCT01961323|3591604|B1|||Age||years|Mean|50.3|50.3|Standard Deviation|11|11.0|||
3758175|NCT01961297|3591610|B3|||Voice Tremor severity|Only for participants that had voice tremor (VT). VT symptoms were evaluated using a visual analog scale of severity (0 for none, 100 for most severe/profound)|units on a scale|Mean|49.3|49.3|Standard Deviation|24.7|24.7|||
3758176|NCT01961297|3591611|B2|||Voice Tremor severity|Only for participants that had voice tremor (VT). VT symptoms were evaluated using a visual analog scale of severity (0 for none, 100 for most severe/profound)|units on a scale|Mean|49.3|49.3|Standard Deviation|24.7|24.7|||
3758177|NCT01961297|3591610|B3|||Spasmodic dysphonia severity||years|Mean|28.0|28.0|Standard Deviation|16.6|16.6|||
3758178|NCT01961297|3591611|B2|||Spasmodic dysphonia severity||years|Mean|30.3|30.3|Standard Deviation|16.8|16.8|||
3758179|NCT01961297|3591612|B1|||Spasmodic dysphonia severity||years|Mean|25.6|25.6|Standard Deviation|16.3|16.3|||
3758180|NCT01961297|3591610|B3|||Duration of symptom of dysphonia||years|Mean|14.1|14.1|Standard Deviation|12.1|12.1|||
3758181|NCT01961297|3591611|B2|||Duration of symptom of dysphonia||years|Mean|14.7|14.7|Standard Deviation|12.7|12.7|||
3758182|NCT01961297|3591612|B1|||Duration of symptom of dysphonia||years|Mean|13.4|13.4|Standard Deviation|11.5|11.5|||
3758183|NCT01961297|3591610|B3|||Age of onset of dysphonia||years|Mean|40.9|40.9|Standard Deviation|12.6|12.6|||
3758184|NCT01961297|3591611|B2|||Age of onset of dysphonia||years|Mean|44.1|44.1|Standard Deviation|14.2|14.2|||
3758185|NCT01961297|3591612|B1|||Age of onset of dysphonia||years|Mean|37.7|37.7|Standard Deviation|11.0|11.0|||
3758186|NCT01961297|3591610|B3|ABSD/VT||Dystonia subtype|ABSD = abductor spasmodic dysphonia; ADSD = adductor spasmodic dysphonia; VT = voice tremor|Participants|Count of Participants|7|7.0||||||
3758187|NCT01961297|3591611|B2|ABSD/VT||Dystonia subtype|ABSD = abductor spasmodic dysphonia; ADSD = adductor spasmodic dysphonia; VT = voice tremor|Participants|Count of Participants|7|7.0||||||
3758188|NCT01961297|3591612|B1|ABSD/VT||Dystonia subtype|ABSD = abductor spasmodic dysphonia; ADSD = adductor spasmodic dysphonia; VT = voice tremor|Participants|Count of Participants|0|0.0||||||
3758189|NCT01961297|3591610|B3|ADSD/VT||Dystonia subtype|ABSD = abductor spasmodic dysphonia; ADSD = adductor spasmodic dysphonia; VT = voice tremor|Participants|Count of Participants|15|15.0||||||
3758190|NCT01961297|3591611|B2|ADSD/VT||Dystonia subtype|ABSD = abductor spasmodic dysphonia; ADSD = adductor spasmodic dysphonia; VT = voice tremor|Participants|Count of Participants|15|15.0||||||
3758191|NCT01961297|3591612|B1|ADSD/VT||Dystonia subtype|ABSD = abductor spasmodic dysphonia; ADSD = adductor spasmodic dysphonia; VT = voice tremor|Participants|Count of Participants|0|0.0||||||
3758192|NCT01961297|3591610|B3|ABSD||Dystonia subtype|ABSD = abductor spasmodic dysphonia; ADSD = adductor spasmodic dysphonia; VT = voice tremor|Participants|Count of Participants|12|12.0||||||
3758193|NCT01961297|3591611|B2|ABSD||Dystonia subtype|ABSD = abductor spasmodic dysphonia; ADSD = adductor spasmodic dysphonia; VT = voice tremor|Participants|Count of Participants|0|0.0||||||
3758194|NCT01961297|3591612|B1|ABSD||Dystonia subtype|ABSD = abductor spasmodic dysphonia; ADSD = adductor spasmodic dysphonia; VT = voice tremor|Participants|Count of Participants|12|12.0||||||
3758195|NCT01961297|3591610|B3|ADSD||Dystonia subtype|ABSD = abductor spasmodic dysphonia; ADSD = adductor spasmodic dysphonia; VT = voice tremor|Participants|Count of Participants|16|16.0||||||
3758196|NCT01961297|3591611|B2|ADSD||Dystonia subtype|ABSD = abductor spasmodic dysphonia; ADSD = adductor spasmodic dysphonia; VT = voice tremor|Participants|Count of Participants|0|0.0||||||
3758197|NCT01961297|3591612|B1|ADSD||Dystonia subtype|ABSD = abductor spasmodic dysphonia; ADSD = adductor spasmodic dysphonia; VT = voice tremor|Participants|Count of Participants|16|16.0||||||
3758198|NCT01961297|3591610|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758199|NCT01961297|3591611|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758200|NCT01961297|3591612|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758201|NCT01961297|3591610|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758202|NCT01961297|3591611|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758203|NCT01961297|3591612|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758204|NCT01961297|3591610|B3||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3758205|NCT01961297|3591611|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3758206|NCT01961297|3591612|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3758207|NCT01961297|3591610|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3758208|NCT01961297|3591611|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3758209|NCT01961297|3591612|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3758210|NCT01961297|3591610|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758211|NCT01961297|3591611|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758212|NCT01961297|3591612|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758213|NCT01961297|3591610|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758214|NCT01961297|3591611|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758215|NCT01961297|3591612|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758216|NCT01961297|3591610|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758217|NCT01961297|3591611|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758218|NCT01961297|3591612|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758219|NCT01961297|3591610|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3758220|NCT01961297|3591611|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3758221|NCT01961297|3591612|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3758222|NCT01961297|3591610|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3758223|NCT01961297|3591611|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3758224|NCT01961297|3591612|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3758225|NCT01961297|3591610|B3|||Age||years|Mean|54.4|54.4|Standard Deviation|11.8|11.8|||
3758226|NCT01961297|3591611|B2|||Age||years|Mean|58.0|58.0|Standard Deviation|12.2|12.2|||
3758227|NCT01961297|3591612|B1|||Age||years|Mean|50.7|50.7|Standard Deviation|11.3|11.3|||
3758228|NCT01961271|3591627|B1|Korea, Republic of||Region of Enrollment||participants|Number|62|62.0||||||
3758229|NCT01961271|3591627|B1|Philippines||Region of Enrollment||participants|Number|26|26.0||||||
3758230|NCT01961271|3591627|B1|Hong Kong||Region of Enrollment||participants|Number|26|26.0||||||
3758231|NCT01961271|3591627|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3758232|NCT01961271|3591627|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3758233|NCT01961271|3591627|B1|||Age||years|Mean|57|57.0|Standard Deviation|13.4|13.4|||
3758234|NCT01961115|3591636|B4|United States||Region of Enrollment||participants|Number|11|11.0||||||
3758235|NCT01961115|3591637|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
3758236|NCT01961115|3591639|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3758237|NCT01961115|3591636|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3758238|NCT01961115|3591637|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3758239|NCT01961115|3591638|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758240|NCT01961115|3591639|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758241|NCT01961115|3591636|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758242|NCT01961115|3591637|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758243|NCT01961115|3591638|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758244|NCT01961115|3591639|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758245|NCT01961115|3591636|B4||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3758246|NCT01961115|3591637|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3758247|NCT01961115|3591638|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758248|NCT01961115|3591639|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3758249|NCT01961115|3591636|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758250|NCT01961115|3591637|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758251|NCT01961115|3591638|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758252|NCT01961115|3591639|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758253|NCT01961115|3591636|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758254|NCT01961115|3591637|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758255|NCT01961115|3591638|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758256|NCT01961115|3591639|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758257|NCT01961115|3591636|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758258|NCT01961115|3591637|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758259|NCT01961115|3591638|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758260|NCT01961115|3591639|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758261|NCT01961115|3591636|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758262|NCT01961115|3591637|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758263|NCT01961115|3591638|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758264|NCT01961115|3591639|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758265|NCT01961115|3591636|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758266|NCT01961115|3591637|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758267|NCT01961115|3591638|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758268|NCT01961115|3591639|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758269|NCT01961115|3591636|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3758270|NCT01961115|3591637|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3758271|NCT01961115|3591638|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758272|NCT01961115|3591639|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3758273|NCT01961115|3591636|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758274|NCT01961115|3591637|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758275|NCT01961115|3591638|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758276|NCT01961115|3591639|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758277|NCT01961115|3591636|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3758278|NCT01961115|3591637|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3758279|NCT01961115|3591638|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3758280|NCT01961115|3591639|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3758281|NCT01961115|3591636|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3758282|NCT01961115|3591637|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3758283|NCT01961115|3591638|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3758284|NCT01961115|3591639|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3758285|NCT01961115|3591636|B4|||Age||years|Mean|62.2|62.2|Standard Deviation|13.3|13.3|||
3758286|NCT01961115|3591637|B3|||Age||years|Mean|60.3|60.3|Standard Deviation|14.1|14.1|||
3758287|NCT01961115|3591639|B1|||Age||years|Mean|70.5|70.5|Standard Deviation|3.5|3.5|||
3758288|NCT01961115|3591636|B4||>=65 years|Age|Age calculated between time of consent and date of birth.|Participants|Count of Participants|6|6.0||||||
3758289|NCT01961115|3591637|B3||>=65 years|Age|Age calculated between time of consent and date of birth.|Participants|Count of Participants|4|4.0||||||
3758290|NCT01961115|3591638|B2||>=65 years|Age|Age calculated between time of consent and date of birth.|Participants|Count of Participants|0|0.0||||||
3758291|NCT01961115|3591639|B1||>=65 years|Age|Age calculated between time of consent and date of birth.|Participants|Count of Participants|2|2.0||||||
3758292|NCT01961115|3591636|B4||Between 18 and 65 years|Age|Age calculated between time of consent and date of birth.|Participants|Count of Participants|5|5.0||||||
3758293|NCT01961115|3591637|B3||Between 18 and 65 years|Age|Age calculated between time of consent and date of birth.|Participants|Count of Participants|5|5.0||||||
3758294|NCT01961115|3591638|B2||Between 18 and 65 years|Age|Age calculated between time of consent and date of birth.|Participants|Count of Participants|0|0.0||||||
3758295|NCT01961115|3591639|B1||Between 18 and 65 years|Age|Age calculated between time of consent and date of birth.|Participants|Count of Participants|0|0.0||||||
3758296|NCT01961115|3591636|B4||<=18 years|Age|Age calculated between time of consent and date of birth.|Participants|Count of Participants|0|0.0||||||
3758297|NCT01961115|3591637|B3||<=18 years|Age|Age calculated between time of consent and date of birth.|Participants|Count of Participants|0|0.0||||||
3758298|NCT01961115|3591638|B2||<=18 years|Age|Age calculated between time of consent and date of birth.|Participants|Count of Participants|0|0.0||||||
3758299|NCT01961115|3591639|B1||<=18 years|Age|Age calculated between time of consent and date of birth.|Participants|Count of Participants|0|0.0||||||
3758300|NCT01961089|3591676|B1|Switzerland||Region of Enrollment||participants|Number|40|40.0||||||
3758301|NCT01961089|3591676|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3758302|NCT01961089|3591676|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3758303|NCT01961089|3591676|B1|||Age||years|Mean|58.8|58.8|Standard Deviation|18.9|18.9|||
3758304|NCT01961089|3591676|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3758305|NCT01961089|3591676|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3758306|NCT01961089|3591676|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3758307|NCT01960907|3591682|B3|||Patients with one or more hospitalization in the previous year||participants|Number|129|129.0||||||
3758308|NCT01960907|3591683|B2|||Patients with one or more hospitalization in the previous year||participants|Number|64|64.0||||||
3758309|NCT01960907|3591684|B1|||Patients with one or more hospitalization in the previous year||participants|Number|65|65.0||||||
3758310|NCT01960907|3591682|B3|||Patients with two or more COPD exacerbation in the previous year||participants|Number|190|190.0||||||
3758311|NCT01960907|3591683|B2|||Patients with two or more COPD exacerbation in the previous year||participants|Number|91|91.0||||||
3758312|NCT01960907|3591684|B1|||Patients with two or more COPD exacerbation in the previous year||participants|Number|99|99.0||||||
3758313|NCT01960907|3591682|B3|||FEV1/FVC postBD|Ratio between Forced Exhaled Volume in 1 second (FEV1) and the Forced Vital capacity (FVC)|ratio|Median|0.5|0.5|Inter-Quartile Range|||0.4|0.6|
3758314|NCT01960907|3591683|B2|||FEV1/FVC postBD|Ratio between Forced Exhaled Volume in 1 second (FEV1) and the Forced Vital capacity (FVC)|ratio|Median|0.5|0.5|Inter-Quartile Range|||0.4|0.6|
3758315|NCT01960907|3591684|B1|||FEV1/FVC postBD|Ratio between Forced Exhaled Volume in 1 second (FEV1) and the Forced Vital capacity (FVC)|ratio|Median|0.5|0.5|Inter-Quartile Range|||0.4|0.6|
3758316|NCT01960907|3591682|B3|||FVC postBD %pred|Forced Vital Capacity measured after bronchodilation expressed as percentage of its predicted value.|%predicted|Median|75.0|75.0|Inter-Quartile Range|||62.2|89.0|
3758317|NCT01960907|3591683|B2|||FVC postBD %pred|Forced Vital Capacity measured after bronchodilation expressed as percentage of its predicted value.|%predicted|Median|73.8|73.8|Inter-Quartile Range|||61.8|88.0|
3758318|NCT01960907|3591684|B1|||FVC postBD %pred|Forced Vital Capacity measured after bronchodilation expressed as percentage of its predicted value.|%predicted|Median|75.8|75.8|Inter-Quartile Range|||63.0|89.7|
3758370|NCT01960842|3591736|B1|||Duration of Parkinson's Disease Since Initial Diagnosis||years|Mean|12.4|12.4|Standard Deviation|5.08|5.08|||
3758319|NCT01960907|3591682|B3|||FVC postBD|Forced Vital Capacity (FVC) after brochodilation: maximum volume of air exhaled during a full forced exhalation from the maximum to the minimum lung volume achievable by the subject measured after the administration of a maximal dose of a bronchodilator drug.|L|Median|2.5|2.5|Inter-Quartile Range|||2.0|3.1|
3758320|NCT01960907|3591683|B2|||FVC postBD|Forced Vital Capacity (FVC) after brochodilation: maximum volume of air exhaled during a full forced exhalation from the maximum to the minimum lung volume achievable by the subject measured after the administration of a maximal dose of a bronchodilator drug.|L|Median|2.6|2.6|Inter-Quartile Range|||2.0|3.1|
3758321|NCT01960907|3591684|B1|||FVC postBD|Forced Vital Capacity (FVC) after brochodilation: maximum volume of air exhaled during a full forced exhalation from the maximum to the minimum lung volume achievable by the subject measured after the administration of a maximal dose of a bronchodilator drug.|L|Median|2.5|2.5|Inter-Quartile Range|||2.1|3.1|
3758322|NCT01960907|3591682|B3|||FEV1 postBD %pred|Forced Exhaled Volume in 1 second (FEV1) measured after the administration of a maximal dose of bronchodilator expressed as percentage of predicted value.|%predicted|Median|49.8|49.8|Inter-Quartile Range|||37.2|62.1|
3758323|NCT01960907|3591683|B2|||FEV1 postBD %pred|Forced Exhaled Volume in 1 second (FEV1) measured after the administration of a maximal dose of bronchodilator expressed as percentage of predicted value.|%predicted|Median|49.4|49.4|Inter-Quartile Range|||37.1|59.2|
3758324|NCT01960907|3591684|B1|||FEV1 postBD %pred|Forced Exhaled Volume in 1 second (FEV1) measured after the administration of a maximal dose of bronchodilator expressed as percentage of predicted value.|%predicted|Median|50.4|50.4|Inter-Quartile Range|||38.0|63.9|
3758325|NCT01960907|3591682|B3|||FEV1 postBD|Spirometrically measured Forced Exhaled Volume in 1 second (FEV1), measured after a maximal dose of a bronchodilator drug|L|Median|1.3|1.3|Inter-Quartile Range|||1.0|1.7|
3758326|NCT01960907|3591683|B2|||FEV1 postBD|Spirometrically measured Forced Exhaled Volume in 1 second (FEV1), measured after a maximal dose of a bronchodilator drug|L|Median|1.3|1.3|Inter-Quartile Range|||1.0|1.6|
3758327|NCT01960907|3591684|B1|||FEV1 postBD|Spirometrically measured Forced Exhaled Volume in 1 second (FEV1), measured after a maximal dose of a bronchodilator drug|L|Median|1.3|1.3|Inter-Quartile Range|||0.9|1.8|
3758328|NCT01960907|3591682|B3|Spain||Region of Enrollment||participants|Number|61|61.0||||||
3758329|NCT01960907|3591683|B2|Spain||Region of Enrollment||participants|Number|31|31.0||||||
3758330|NCT01960907|3591684|B1|Spain||Region of Enrollment||participants|Number|30|30.0||||||
3758331|NCT01960907|3591682|B3|Estonia||Region of Enrollment||participants|Number|80|80.0||||||
3758332|NCT01960907|3591683|B2|Estonia||Region of Enrollment||participants|Number|41|41.0||||||
3758333|NCT01960907|3591684|B1|Estonia||Region of Enrollment||participants|Number|39|39.0||||||
3758334|NCT01960907|3591682|B3|Slovenia||Region of Enrollment||participants|Number|33|33.0||||||
3758335|NCT01960907|3591683|B2|Slovenia||Region of Enrollment||participants|Number|17|17.0||||||
3758336|NCT01960907|3591684|B1|Slovenia||Region of Enrollment||participants|Number|16|16.0||||||
3758337|NCT01960907|3591682|B3|United Kingdom||Region of Enrollment||participants|Number|75|75.0||||||
3758338|NCT01960907|3591683|B2|United Kingdom||Region of Enrollment||participants|Number|34|34.0||||||
3758339|NCT01960907|3591684|B1|United Kingdom||Region of Enrollment||participants|Number|41|41.0||||||
3758340|NCT01960907|3591682|B3|Sweden||Region of Enrollment||participants|Number|63|63.0||||||
3758341|NCT01960907|3591683|B2|Sweden||Region of Enrollment||participants|Number|31|31.0||||||
3758342|NCT01960907|3591684|B1|Sweden||Region of Enrollment||participants|Number|32|32.0||||||
3758343|NCT01960907|3591682|B3||Male|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
3758344|NCT01960907|3591683|B2||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3758345|NCT01960907|3591684|B1||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3758346|NCT01960907|3591682|B3||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3758347|NCT01960907|3591683|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3758348|NCT01960907|3591684|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3758349|NCT01960907|3591682|B3|||Age||years|Median|71|71.0|Inter-Quartile Range|||66.0|76.0|
3758350|NCT01960907|3591683|B2|||Age||years|Median|71|71.0|Inter-Quartile Range|||66.0|75.8|
3758351|NCT01960907|3591684|B1|||Age||years|Median|71|71.0|Inter-Quartile Range|||65.3|76.0|
3758352|NCT01960855|3591695|B6||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3758353|NCT01960855|3591696|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3758354|NCT01960855|3591697|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3758355|NCT01960855|3591698|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3758356|NCT01960855|3591699|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3758357|NCT01960855|3591700|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3758358|NCT01960855|3591695|B6||Female|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
3758359|NCT01960855|3591696|B5||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3758360|NCT01960855|3591697|B4||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3758361|NCT01960855|3591698|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3758362|NCT01960855|3591699|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3758363|NCT01960855|3591700|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3758364|NCT01960855|3591695|B6|||Age||years|Mean|57.3|57.3|Standard Deviation|12.12|12.12|||
3758365|NCT01960855|3591696|B5|||Age||years|Mean|56.7|56.7|Standard Deviation|12.39|12.39|||
3758366|NCT01960855|3591697|B4|||Age||years|Mean|59.1|59.1|Standard Deviation|11.4|11.4|||
3758367|NCT01960855|3591698|B3|||Age||years|Mean|56.3|56.3|Standard Deviation|11.71|11.71|||
3758368|NCT01960855|3591699|B2|||Age||years|Mean|57|57.0|Standard Deviation|13.06|13.06|||
3758371|NCT01960842|3591736|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3758372|NCT01960842|3591736|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3758373|NCT01960842|3591736|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|10.50|10.5|||
3758374|NCT01960816|3591759|B1|||Nasal Obstruction Symptom Evaluation (NOSE) score|The Nasal Obstruction Symptom Evaluation (NOSE) scale is a validated disease-specific health status outcomes instrument, used to assess severity of nasal obstruction symptoms. Score ranges from 0 to 100. Higher scores indicate increased symptoms/symptom severity.|units on a scale|Mean|58|58.0|Standard Deviation|21.8|21.8|||
3758375|NCT01960816|3591759|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
3758376|NCT01960816|3591759|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3758377|NCT01960816|3591759|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3758378|NCT01960816|3591759|B1|||Age||years|Mean|51|51.0|Standard Deviation|13.1|13.1|||
3758379|NCT01960725|3591765|B3|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
3758380|NCT01960725|3591766|B2|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3758381|NCT01960725|3591767|B1|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3758382|NCT01960725|3591765|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3758383|NCT01960725|3591766|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3758384|NCT01960725|3591767|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3758385|NCT01960725|3591765|B3|African American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3758386|NCT01960725|3591766|B2|African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3758387|NCT01960725|3591767|B1|African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3758388|NCT01960725|3591765|B3|White||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
3758389|NCT01960725|3591766|B2|White||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
3758390|NCT01960725|3591767|B1|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3758391|NCT01960725|3591765|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3758392|NCT01960725|3591766|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3758393|NCT01960725|3591767|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3758394|NCT01960725|3591765|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3758395|NCT01960725|3591766|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3758396|NCT01960725|3591767|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3758397|NCT01960725|3591765|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3758398|NCT01960725|3591766|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3758399|NCT01960725|3591767|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3758400|NCT01960725|3591765|B3|||Age||days|Mean|44.8|44.8|Standard Deviation|19.3|19.3|||
3758401|NCT01960725|3591766|B2|||Age||days|Mean|26.6|26.6|Standard Deviation|7.3|7.3|||
3758402|NCT01960725|3591767|B1|||Age||days|Mean|63|63.0|Standard Deviation|4.6|4.6|||
3758403|NCT01960530|3591790|B1|United Kingdom||Region of Enrollment||participants|Number|14|14.0||||||
3758404|NCT01960530|3591790|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3758405|NCT01960530|3591790|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3758406|NCT01960530|3591790|B1|||Age||years|Mean|32.9|32.9|Standard Deviation|11.66|11.66|||
3758407|NCT01960530|3591790|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3758408|NCT01960530|3591790|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3758409|NCT01960530|3591790|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3758410|NCT01960400|3591823|B3|Canada||Region of Enrollment||participants|Number|22|22.0||||||
3758411|NCT01960400|3591824|B2|Canada||Region of Enrollment||participants|Number|11|11.0||||||
3758412|NCT01960400|3591825|B1|Canada||Region of Enrollment||participants|Number|11|11.0||||||
3758413|NCT01960400|3591823|B3||Male|Gender||Participants|Count of Participants|8|8.0||||||
3758414|NCT01960400|3591824|B2||Male|Gender||Participants|Count of Participants|5|5.0||||||
3758415|NCT01960400|3591825|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
3758416|NCT01960400|3591823|B3||Female|Gender||Participants|Count of Participants|14|14.0||||||
3758417|NCT01960400|3591824|B2||Female|Gender||Participants|Count of Participants|6|6.0||||||
3758418|NCT01960400|3591825|B1||Female|Gender||Participants|Count of Participants|8|8.0||||||
3758419|NCT01960400|3591823|B3|||Age||years|Mean|46.87|46.87|Standard Deviation|13.06|13.06|||
3758420|NCT01960400|3591824|B2|||Age||years|Mean|52.83|52.83|Standard Deviation|12.81|12.81|||
3758421|NCT01960400|3591825|B1|||Age||years|Mean|40.91|40.91|Standard Deviation|10.76|10.76|||
3758422|NCT01960400|3591823|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3758423|NCT01960400|3591824|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3758424|NCT01960400|3591825|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3758425|NCT01960400|3591823|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3758426|NCT01960400|3591824|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3758427|NCT01960400|3591825|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3758428|NCT01960400|3591823|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3758429|NCT01960400|3591824|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3758430|NCT01960400|3591825|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3758431|NCT01960387|3591838|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3758432|NCT01960387|3591838|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3758433|NCT01960387|3591838|B1|||Age||years|Mean|55|55.0|Full Range|||50.0|60.0|
3758434|NCT01960348|3591845|B3|||Baseline mNIS+7|The mNIS+7 is a composite score that quantitates motor, sensory, and autonomic neurologic impairment due to injury of large and small nerves. The minimum and maximum values are 0 and 304, respectively. A higher score indicates a worse outcome.|Points|Mean|78.77|78.77|Standard Deviation|40.064|40.064|||
3758435|NCT01960348|3591846|B2|||Baseline mNIS+7|The mNIS+7 is a composite score that quantitates motor, sensory, and autonomic neurologic impairment due to injury of large and small nerves. The minimum and maximum values are 0 and 304, respectively. A higher score indicates a worse outcome.|Points|Mean|74.61|74.61|Standard Deviation|37.041|37.041|||
3758436|NCT01960348|3591847|B1|||Baseline mNIS+7|The mNIS+7 is a composite score that quantitates motor, sensory, and autonomic neurologic impairment due to injury of large and small nerves. The minimum and maximum values are 0 and 304, respectively. A higher score indicates a worse outcome.|Points|Mean|80.93|80.93|Standard Deviation|41.507|41.507|||
3758437|NCT01960348|3591845|B3||No|Previous Tetramer Stabilizer Use|Prior use of tafamidis meglumine or diflunisal|Participants|Count of Participants|106|106.0||||||
3758438|NCT01960348|3591846|B2||No|Previous Tetramer Stabilizer Use|Prior use of tafamidis meglumine or diflunisal|Participants|Count of Participants|36|36.0||||||
3758439|NCT01960348|3591847|B1||No|Previous Tetramer Stabilizer Use|Prior use of tafamidis meglumine or diflunisal|Participants|Count of Participants|70|70.0||||||
3758440|NCT01960348|3591845|B3||Yes|Previous Tetramer Stabilizer Use|Prior use of tafamidis meglumine or diflunisal|Participants|Count of Participants|119|119.0||||||
3758441|NCT01960348|3591846|B2||Yes|Previous Tetramer Stabilizer Use|Prior use of tafamidis meglumine or diflunisal|Participants|Count of Participants|41|41.0||||||
3758442|NCT01960348|3591847|B1||Yes|Previous Tetramer Stabilizer Use|Prior use of tafamidis meglumine or diflunisal|Participants|Count of Participants|78|78.0||||||
3758443|NCT01960348|3591845|B3||All other mutations (including late onset V30M)|Genotype Class|Transthyretin (TTR) genotype class, collected at baseline|Participants|Count of Participants|202|202.0||||||
3758444|NCT01960348|3591846|B2||All other mutations (including late onset V30M)|Genotype Class|Transthyretin (TTR) genotype class, collected at baseline|Participants|Count of Participants|67|67.0||||||
3758445|NCT01960348|3591847|B1||All other mutations (including late onset V30M)|Genotype Class|Transthyretin (TTR) genotype class, collected at baseline|Participants|Count of Participants|135|135.0||||||
3758446|NCT01960348|3591845|B3||Early onset V30M (<50 years of age at onset)|Genotype Class|Transthyretin (TTR) genotype class, collected at baseline|Participants|Count of Participants|23|23.0||||||
3758447|NCT01960348|3591846|B2||Early onset V30M (<50 years of age at onset)|Genotype Class|Transthyretin (TTR) genotype class, collected at baseline|Participants|Count of Participants|10|10.0||||||
3758448|NCT01960348|3591847|B1||Early onset V30M (<50 years of age at onset)|Genotype Class|Transthyretin (TTR) genotype class, collected at baseline|Participants|Count of Participants|13|13.0||||||
3758449|NCT01960348|3591845|B3||NIS ≥50|Baseline NIS|"The Neuropathy Impairment Score is an assessment of motor weakness (NIS-W), sensation (NIS-S) and reflexes (NIS-R) scored based on physical exam findings.~NIS-W is a measure of motor strength, comprised of cranial nerve and both upper and lower limb motor assessments. The minimum and maximum values are 0 and 192, respectively. A higher score indicates a worse outcome."|Participants|Count of Participants|128|128.0||||||
3758450|NCT01960348|3591846|B2||NIS ≥50|Baseline NIS|"The Neuropathy Impairment Score is an assessment of motor weakness (NIS-W), sensation (NIS-S) and reflexes (NIS-R) scored based on physical exam findings.~NIS-W is a measure of motor strength, comprised of cranial nerve and both upper and lower limb motor assessments. The minimum and maximum values are 0 and 192, respectively. A higher score indicates a worse outcome."|Participants|Count of Participants|42|42.0||||||
3758451|NCT01960348|3591847|B1||NIS ≥50|Baseline NIS|"The Neuropathy Impairment Score is an assessment of motor weakness (NIS-W), sensation (NIS-S) and reflexes (NIS-R) scored based on physical exam findings.~NIS-W is a measure of motor strength, comprised of cranial nerve and both upper and lower limb motor assessments. The minimum and maximum values are 0 and 192, respectively. A higher score indicates a worse outcome."|Participants|Count of Participants|86|86.0||||||
3758452|NCT01960348|3591845|B3||NIS <50|Baseline NIS|"The Neuropathy Impairment Score is an assessment of motor weakness (NIS-W), sensation (NIS-S) and reflexes (NIS-R) scored based on physical exam findings.~NIS-W is a measure of motor strength, comprised of cranial nerve and both upper and lower limb motor assessments. The minimum and maximum values are 0 and 192, respectively. A higher score indicates a worse outcome."|Participants|Count of Participants|97|97.0||||||
3758453|NCT01960348|3591846|B2||NIS <50|Baseline NIS|"The Neuropathy Impairment Score is an assessment of motor weakness (NIS-W), sensation (NIS-S) and reflexes (NIS-R) scored based on physical exam findings.~NIS-W is a measure of motor strength, comprised of cranial nerve and both upper and lower limb motor assessments. The minimum and maximum values are 0 and 192, respectively. A higher score indicates a worse outcome."|Participants|Count of Participants|35|35.0||||||
3758454|NCT01960348|3591847|B1||NIS <50|Baseline NIS|"The Neuropathy Impairment Score is an assessment of motor weakness (NIS-W), sensation (NIS-S) and reflexes (NIS-R) scored based on physical exam findings.~NIS-W is a measure of motor strength, comprised of cranial nerve and both upper and lower limb motor assessments. The minimum and maximum values are 0 and 192, respectively. A higher score indicates a worse outcome."|Participants|Count of Participants|62|62.0||||||
3758455|NCT01960348|3591845|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3758456|NCT01960348|3591846|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3758457|NCT01960348|3591847|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3758458|NCT01960348|3591845|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3758459|NCT01960348|3591846|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758460|NCT01960348|3591847|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3758461|NCT01960348|3591845|B3||White|Race (NIH/OMB)||Participants|Count of Participants|163|163.0||||||
3758462|NCT01960348|3591846|B2||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3758463|NCT01960348|3591847|B1||White|Race (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
3758464|NCT01960348|3591845|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3758465|NCT01960348|3591846|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3758466|NCT01960348|3591847|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3758467|NCT01960348|3591845|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758468|NCT01960348|3591846|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758469|NCT01960348|3591847|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758470|NCT01960348|3591845|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3758471|NCT01960348|3591846|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3758472|NCT01960348|3591847|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3758473|NCT01960348|3591845|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758474|NCT01960348|3591846|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758475|NCT01960348|3591847|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758476|NCT01960348|3591845|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3758477|NCT01960348|3591846|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3758478|NCT01960348|3591847|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3758479|NCT01960348|3591845|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|195|195.0||||||
3758480|NCT01960348|3591846|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3758481|NCT01960348|3591847|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
3758482|NCT01960348|3591845|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3758483|NCT01960348|3591846|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3758484|NCT01960348|3591847|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3758485|NCT01960348|3591845|B3||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3758486|NCT01960348|3591846|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3758487|NCT01960348|3591847|B1||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3758488|NCT01960348|3591845|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3758489|NCT01960348|3591846|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3758490|NCT01960348|3591847|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3758491|NCT01960348|3591845|B3|≥75 years||Age, Customized||Participants|Count of Participants|18|18.0||||||
3758492|NCT01960348|3591846|B2|≥75 years||Age, Customized||Participants|Count of Participants|9|9.0||||||
3758493|NCT01960348|3591847|B1|≥75 years||Age, Customized||Participants|Count of Participants|9|9.0||||||
3758494|NCT01960348|3591845|B3|65-74 years||Age, Customized||Participants|Count of Participants|77|77.0||||||
3758495|NCT01960348|3591846|B2|65-74 years||Age, Customized||Participants|Count of Participants|24|24.0||||||
3758496|NCT01960348|3591847|B1|65-74 years||Age, Customized||Participants|Count of Participants|53|53.0||||||
3758497|NCT01960348|3591845|B3|<65 years||Age, Customized||Participants|Count of Participants|130|130.0||||||
3758498|NCT01960348|3591846|B2|<65 years||Age, Customized||Participants|Count of Participants|44|44.0||||||
3758499|NCT01960348|3591847|B1|<65 years||Age, Customized||Participants|Count of Participants|86|86.0||||||
3758500|NCT01960348|3591845|B3|||Age||years|Mean|60.5|60.5|Standard Deviation|11.61|11.61|||
3758501|NCT01960348|3591846|B2|||Age||years|Mean|62.2|62.2|Standard Deviation|10.76|10.76|||
3758502|NCT01960348|3591847|B1|||Age||years|Mean|59.6|59.6|Standard Deviation|11.96|11.96|||
3758503|NCT01960296|3591866|B3|no||Aspirin Use||participants|Number|11|11.0||||||
3758504|NCT01960296|3591867|B2|no||Aspirin Use||participants|Number|4|4.0||||||
3758505|NCT01960296|3591868|B1|no||Aspirin Use||participants|Number|7|7.0||||||
3758506|NCT01960296|3591866|B3|yes||Aspirin Use||participants|Number|32|32.0||||||
3758507|NCT01960296|3591867|B2|yes||Aspirin Use||participants|Number|18|18.0||||||
3758508|NCT01960296|3591868|B1|yes||Aspirin Use||participants|Number|14|14.0||||||
3758509|NCT01960296|3591866|B3|no||Normal platelet function||participants|Number|12|12.0||||||
3758510|NCT01960296|3591867|B2|no||Normal platelet function||participants|Number|6|6.0||||||
3758511|NCT01960296|3591868|B1|no||Normal platelet function||participants|Number|6|6.0||||||
3758512|NCT01960296|3591866|B3|yes||Normal platelet function||participants|Number|31|31.0||||||
3758513|NCT01960296|3591867|B2|yes||Normal platelet function||participants|Number|16|16.0||||||
3758514|NCT01960296|3591868|B1|yes||Normal platelet function||participants|Number|15|15.0||||||
3758515|NCT01960296|3591866|B3|>2||ASA score|"Preoperative American Society of Anesthesia (ASA) scores to evaluate the degree of a patient's sickness or physical state before selecting the anesthetic or before performing surgery, with one being normal to five being severely impaired."|participants|Number|38|38.0||||||
3758516|NCT01960296|3591867|B2|>2||ASA score|"Preoperative American Society of Anesthesia (ASA) scores to evaluate the degree of a patient's sickness or physical state before selecting the anesthetic or before performing surgery, with one being normal to five being severely impaired."|participants|Number|21|21.0||||||
3758573|NCT01960140|3591889|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758574|NCT01960140|3591889|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3758517|NCT01960296|3591868|B1|>2||ASA score|"Preoperative American Society of Anesthesia (ASA) scores to evaluate the degree of a patient's sickness or physical state before selecting the anesthetic or before performing surgery, with one being normal to five being severely impaired."|participants|Number|17|17.0||||||
3758518|NCT01960296|3591866|B3|2||ASA score|"Preoperative American Society of Anesthesia (ASA) scores to evaluate the degree of a patient's sickness or physical state before selecting the anesthetic or before performing surgery, with one being normal to five being severely impaired."|participants|Number|5|5.0||||||
3758519|NCT01960296|3591867|B2|2||ASA score|"Preoperative American Society of Anesthesia (ASA) scores to evaluate the degree of a patient's sickness or physical state before selecting the anesthetic or before performing surgery, with one being normal to five being severely impaired."|participants|Number|1|1.0||||||
3758520|NCT01960296|3591868|B1|2||ASA score|"Preoperative American Society of Anesthesia (ASA) scores to evaluate the degree of a patient's sickness or physical state before selecting the anesthetic or before performing surgery, with one being normal to five being severely impaired."|participants|Number|4|4.0||||||
3758521|NCT01960296|3591866|B3|no||HL||participants|Number|4|4.0||||||
3758522|NCT01960296|3591867|B2|no||HL||participants|Number|2|2.0||||||
3758523|NCT01960296|3591868|B1|no||HL||participants|Number|2|2.0||||||
3758524|NCT01960296|3591866|B3|yes||HL||participants|Number|39|39.0||||||
3758525|NCT01960296|3591867|B2|yes||HL||participants|Number|20|20.0||||||
3758526|NCT01960296|3591868|B1|yes||HL||participants|Number|19|19.0||||||
3758527|NCT01960296|3591866|B3|no||Diabetes||participants|Number|19|19.0||||||
3758528|NCT01960296|3591867|B2|no||Diabetes||participants|Number|10|10.0||||||
3758529|NCT01960296|3591868|B1|no||Diabetes||participants|Number|9|9.0||||||
3758530|NCT01960296|3591866|B3|yes||Diabetes||participants|Number|24|24.0||||||
3758531|NCT01960296|3591867|B2|yes||Diabetes||participants|Number|12|12.0||||||
3758532|NCT01960296|3591868|B1|yes||Diabetes||participants|Number|12|12.0||||||
3758533|NCT01960296|3591866|B3|no||Hypertension||participants|Number|5|5.0||||||
3758534|NCT01960296|3591867|B2|no||Hypertension||participants|Number|3|3.0||||||
3758535|NCT01960296|3591868|B1|no||Hypertension||participants|Number|2|2.0||||||
3758536|NCT01960296|3591866|B3|yes||Hypertension||participants|Number|38|38.0||||||
3758537|NCT01960296|3591867|B2|yes||Hypertension||participants|Number|19|19.0||||||
3758538|NCT01960296|3591868|B1|yes||Hypertension||participants|Number|19|19.0||||||
3758539|NCT01960296|3591866|B3|no||CAD/CVD/PAD|Coronary Artery Disease(CAD)/Cerebrovascular Disease(CVD)/Peripheral Arterial Disease(PAD)|participants|Number|5|5.0||||||
3758540|NCT01960296|3591867|B2|no||CAD/CVD/PAD|Coronary Artery Disease(CAD)/Cerebrovascular Disease(CVD)/Peripheral Arterial Disease(PAD)|participants|Number|4|4.0||||||
3758541|NCT01960296|3591868|B1|no||CAD/CVD/PAD|Coronary Artery Disease(CAD)/Cerebrovascular Disease(CVD)/Peripheral Arterial Disease(PAD)|participants|Number|1|1.0||||||
3758542|NCT01960296|3591866|B3|yes||CAD/CVD/PAD|Coronary Artery Disease(CAD)/Cerebrovascular Disease(CVD)/Peripheral Arterial Disease(PAD)|participants|Number|38|38.0||||||
3758543|NCT01960296|3591867|B2|yes||CAD/CVD/PAD|Coronary Artery Disease(CAD)/Cerebrovascular Disease(CVD)/Peripheral Arterial Disease(PAD)|participants|Number|18|18.0||||||
3758544|NCT01960296|3591868|B1|yes||CAD/CVD/PAD|Coronary Artery Disease(CAD)/Cerebrovascular Disease(CVD)/Peripheral Arterial Disease(PAD)|participants|Number|20|20.0||||||
3758545|NCT01960296|3591866|B3|Other||Indication||participants|Number|9|9.0||||||
3758546|NCT01960296|3591867|B2|Other||Indication||participants|Number|7|7.0||||||
3758547|NCT01960296|3591868|B1|Other||Indication||participants|Number|2|2.0||||||
3758548|NCT01960296|3591866|B3|CVA||Indication||participants|Number|3|3.0||||||
3758549|NCT01960296|3591867|B2|CVA||Indication||participants|Number|2|2.0||||||
3758550|NCT01960296|3591868|B1|CVA||Indication||participants|Number|1|1.0||||||
3758551|NCT01960296|3591866|B3|Coronary stent||Indication||participants|Number|31|31.0||||||
3758552|NCT01960296|3591867|B2|Coronary stent||Indication||participants|Number|13|13.0||||||
3758553|NCT01960296|3591868|B1|Coronary stent||Indication||participants|Number|18|18.0||||||
3758554|NCT01960296|3591866|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3758555|NCT01960296|3591867|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3758556|NCT01960296|3591868|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3758557|NCT01960296|3591866|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3758558|NCT01960296|3591867|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3758559|NCT01960296|3591868|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3758560|NCT01960296|3591866|B3|||Age||years|Mean|67.9|67.9|Standard Deviation|0|0.0|||
3758561|NCT01960296|3591867|B2|||Age||years|Mean|67.9|67.9|Standard Deviation|0|0.0|||
3758562|NCT01960296|3591868|B1|||Age||years|Mean|67.9|67.9|Standard Deviation|0|0.0|||
3758563|NCT01960140|3591889|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3758564|NCT01960140|3591889|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758565|NCT01960140|3591889|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758566|NCT01960140|3591889|B1||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3758567|NCT01960140|3591889|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3758568|NCT01960140|3591889|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758569|NCT01960140|3591889|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758570|NCT01960140|3591889|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758571|NCT01960140|3591889|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758572|NCT01960140|3591889|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3758575|NCT01960140|3591889|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3758576|NCT01960140|3591889|B1|||Age||years|Mean|40.0|40.0|Standard Deviation|13.0|13.0|||
3758577|NCT01960114|3591898|B3|USA||Region of Enrollment||participants|Number|403|403.0||||||
3758578|NCT01960114|3591899|B2|USA||Region of Enrollment||participants|Number|269|269.0||||||
3758579|NCT01960114|3591900|B1|USA||Region of Enrollment||participants|Number|134|134.0||||||
3758580|NCT01960114|3591898|B3||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3758581|NCT01960114|3591899|B2||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3758582|NCT01960114|3591900|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3758583|NCT01960114|3591898|B3||Female|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
3758584|NCT01960114|3591899|B2||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3758585|NCT01960114|3591900|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3758586|NCT01960114|3591898|B3|||Age||years|Mean|19.6|19.6|Standard Deviation|2.77|2.77|||
3758587|NCT01960114|3591899|B2|||Age||years|Mean|19.5|19.5|Standard Deviation|2.82|2.82|||
3758588|NCT01960114|3591900|B1|||Age||years|Mean|19.6|19.6|Standard Deviation|2.66|2.66|||
3758589|NCT01959945|3591915|B5|United States||Region of Enrollment||participants|Number|217|217.0||||||
3758590|NCT01959945|3591916|B4|United States||Region of Enrollment||participants|Number|31|31.0||||||
3758591|NCT01959945|3591917|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
3758592|NCT01959945|3591918|B2|United States||Region of Enrollment||participants|Number|78|78.0||||||
3758593|NCT01959945|3591919|B1|United States||Region of Enrollment||participants|Number|80|80.0||||||
3758594|NCT01959945|3591915|B5||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3758595|NCT01959945|3591916|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3758596|NCT01959945|3591917|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3758597|NCT01959945|3591918|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3758598|NCT01959945|3591919|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3758599|NCT01959945|3591915|B5||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3758600|NCT01959945|3591916|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3758601|NCT01959945|3591917|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3758602|NCT01959945|3591918|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3758603|NCT01959945|3591919|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3758604|NCT01959945|3591915|B5|6-8 years||Age, Customized||participants|Number|59|59.0||||||
3758605|NCT01959945|3591916|B4|6-8 years||Age, Customized||participants|Number|31|31.0||||||
3758606|NCT01959945|3591917|B3|6-8 years||Age, Customized||participants|Number|28|28.0||||||
3758607|NCT01959945|3591918|B2|6-8 years||Age, Customized||participants|Number|0|0.0||||||
3758608|NCT01959945|3591919|B1|6-8 years||Age, Customized||participants|Number|0|0.0||||||
3758609|NCT01959945|3591915|B5|9-17 years||Age, Customized||participants|Number|158|158.0||||||
3758610|NCT01959945|3591916|B4|9-17 years||Age, Customized||participants|Number|0|0.0||||||
3758611|NCT01959945|3591917|B3|9-17 years||Age, Customized||participants|Number|0|0.0||||||
3758612|NCT01959945|3591918|B2|9-17 years||Age, Customized||participants|Number|78|78.0||||||
3758613|NCT01959945|3591919|B1|9-17 years||Age, Customized||participants|Number|80|80.0||||||
3758614|NCT01959932|3591944|B4|> 19 cig/day||Daily CC consumption at Screening||participants|Number|79|79.0||||||
3758615|NCT01959932|3591945|B3|> 19 cig/day||Daily CC consumption at Screening||participants|Number|20|20.0||||||
3758616|NCT01959932|3591946|B2|> 19 cig/day||Daily CC consumption at Screening||participants|Number|20|20.0||||||
3758617|NCT01959932|3591947|B1|> 19 cig/day||Daily CC consumption at Screening||participants|Number|39|39.0||||||
3758618|NCT01959932|3591944|B4|10 to 19 cig/day||Daily CC consumption at Screening||participants|Number|81|81.0||||||
3758619|NCT01959932|3591945|B3|10 to 19 cig/day||Daily CC consumption at Screening||participants|Number|19|19.0||||||
3758620|NCT01959932|3591946|B2|10 to 19 cig/day||Daily CC consumption at Screening||participants|Number|21|21.0||||||
3758621|NCT01959932|3591947|B1|10 to 19 cig/day||Daily CC consumption at Screening||participants|Number|41|41.0||||||
3758622|NCT01959932|3591944|B4||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3758623|NCT01959932|3591945|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3758624|NCT01959932|3591946|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3758625|NCT01959932|3591947|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3758626|NCT01959932|3591944|B4||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3758627|NCT01959932|3591945|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3758628|NCT01959932|3591946|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3758629|NCT01959932|3591947|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3758630|NCT01959932|3591944|B4|Between 21 and 65 years||Age, Customized||years|Mean|34.3|34.3|Standard Deviation|10.12|10.12|||
3758631|NCT01959932|3591945|B3|Between 21 and 65 years||Age, Customized||years|Mean|33.6|33.6|Standard Deviation|11.51|11.51|||
3758632|NCT01959932|3591946|B2|Between 21 and 65 years||Age, Customized||years|Mean|32.6|32.6|Standard Deviation|10.06|10.06|||
3758633|NCT01959932|3591947|B1|Between 21 and 65 years||Age, Customized||years|Mean|35.4|35.4|Standard Deviation|9.40|9.4|||
3758677|NCT01959880|3591978|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758678|NCT01959880|3591979|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758634|NCT01959919|3591967|B1|||Risk Associated With Clotting Factor Treatment Score|HaemoPREF is 14-item instrument to measure experience of clotting factor treatment. For score for risk associated with clotting factor treatment,3 items were assessed by participants: 1)worried about getting infected with other disease while on treatment,2)worried to infect treatment while preparing for injection and 3)worried to inject treatment by own. Each of 3 items was scored on a scale of 0(most concerned) to 10(not at all concerned),summed up to give total overall score range of 0(most worried) to 30(least worried). Higher scores indicate lower levels of worry associated with treatment.|units on scale|Mean|19.69|19.69|Standard Deviation|7.076|7.076|||
3758635|NCT01959919|3591967|B1|||Impact of Clotting Factor Treatment Score|HaemoPREF is a 14-item instrument to measure experience of clotting factor treatment. For score for impact of clotting factor treatment, 3 items were assessed by participants: 1)difficulty to travel for holidays or works, 2)difficulty to perform daily activities including work or study and 3)difficulty to perform social or leisure activities. Each of 3 items was scored on a scale of 0(most challenging) to 10(least challenging), and summed up to give total overall score range of 0(greatest negative impact) to 30(least negative impact). Higher scores indicate less negative impact on daily life.|units on scale|Mean|17.86|17.86|Standard Deviation|7.117|7.117|||
3758636|NCT01959919|3591967|B1|||Burden of Clotting Factor Treatment Score|HaemoPREF is a participant rated 14-item instrument to measure experience of clotting factor treatment for determining the score for burden of clotting factor treatment, 2 items were assessed by participants: 1) time consumption to treat with treatment and 2) difficulty in finding vein to inject treatment in to. Each of the 2 items was scored on a scale of 0 (most difficult) to 20 (least difficult) and summed up to give a total overall score range of 0 (most burdened) to 40 (least burdened). Higher scores indicate a lower burden of treatment.|units on scale|Mean|11.88|11.88|Standard Deviation|4.652|4.652|||
3758637|NCT01959919|3591967|B1|||Time for Reconstructing the Drug|In this parameter time consumed for performing steps to reconstitute the drug prior to infusion of drug is reported.|minutes|Mean|10.79|10.79|Standard Deviation|7.419|7.419|||
3758638|NCT01959919|3591967|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3758639|NCT01959919|3591967|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3758640|NCT01959919|3591967|B1|||Age||Years|Mean|37.99|37.99|Standard Deviation|11.206|11.206|||
3758641|NCT01959880|3591977|B5|United States||Region of Enrollment||participants|Number|1891|1891.0||||||
3758642|NCT01959880|3591978|B4|United States||Region of Enrollment||participants|Number|181|181.0||||||
3758643|NCT01959880|3591979|B3|United States||Region of Enrollment||participants|Number|209|209.0||||||
3758644|NCT01959880|3591980|B2|United States||Region of Enrollment||participants|Number|369|369.0||||||
3758645|NCT01959880|3591981|B1|United States||Region of Enrollment||participants|Number|1132|1132.0||||||
3758646|NCT01959880|3591977|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|116|116.0||||||
3758647|NCT01959880|3591978|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3758648|NCT01959880|3591979|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3758649|NCT01959880|3591980|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3758650|NCT01959880|3591981|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3758651|NCT01959880|3591977|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758652|NCT01959880|3591978|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758653|NCT01959880|3591979|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758654|NCT01959880|3591980|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758655|NCT01959880|3591981|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758656|NCT01959880|3591977|B5||White|Race (NIH/OMB)||Participants|Count of Participants|1674|1674.0||||||
3758657|NCT01959880|3591978|B4||White|Race (NIH/OMB)||Participants|Count of Participants|162|162.0||||||
3758658|NCT01959880|3591979|B3||White|Race (NIH/OMB)||Participants|Count of Participants|192|192.0||||||
3758659|NCT01959880|3591980|B2||White|Race (NIH/OMB)||Participants|Count of Participants|334|334.0||||||
3758660|NCT01959880|3591981|B1||White|Race (NIH/OMB)||Participants|Count of Participants|986|986.0||||||
3758661|NCT01959880|3591977|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3758662|NCT01959880|3591978|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3758663|NCT01959880|3591979|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758664|NCT01959880|3591980|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3758665|NCT01959880|3591981|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3758666|NCT01959880|3591977|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758667|NCT01959880|3591978|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758668|NCT01959880|3591979|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758669|NCT01959880|3591980|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758670|NCT01959880|3591981|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758671|NCT01959880|3591977|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3758672|NCT01959880|3591978|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3758673|NCT01959880|3591979|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3758674|NCT01959880|3591980|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3758675|NCT01959880|3591981|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3758676|NCT01959880|3591977|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758679|NCT01959880|3591980|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758680|NCT01959880|3591981|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758681|NCT01959880|3591977|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3758682|NCT01959880|3591978|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3758683|NCT01959880|3591979|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3758684|NCT01959880|3591980|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3758685|NCT01959880|3591981|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3758686|NCT01959880|3591977|B5||Female|Sex: Female, Male||Participants|Count of Participants|1891|1891.0||||||
3758687|NCT01959880|3591978|B4||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
3758688|NCT01959880|3591979|B3||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
3758689|NCT01959880|3591980|B2||Female|Sex: Female, Male||Participants|Count of Participants|369|369.0||||||
3758690|NCT01959880|3591981|B1||Female|Sex: Female, Male||Participants|Count of Participants|1132|1132.0||||||
3758691|NCT01959880|3591977|B5|||Age||years|Mean|40.7|40.7|Standard Deviation|12.86|12.86|||
3758692|NCT01959880|3591978|B4|||Age||years|Mean|56.1|56.1|Standard Deviation|9.37|9.37|||
3758693|NCT01959880|3591979|B3|||Age||years|Mean|46.7|46.7|Standard Deviation|10.25|10.25|||
3758694|NCT01959880|3591980|B2|||Age||years|Mean|49.2|49.2|Standard Deviation|10.58|10.58|||
3758695|NCT01959880|3591981|B1|||Age||years|Mean|34.3|34.3|Standard Deviation|9.88|9.88|||
3758696|NCT01959841|3592006|B4||over 48 hours, within 72 hours|Time from onset of rash to the first dose||Participants|Count of Participants|300|300.0||||||
3758697|NCT01959841|3592007|B3||over 48 hours, within 72 hours|Time from onset of rash to the first dose||Participants|Count of Participants|109|109.0||||||
3758698|NCT01959841|3592008|B2||over 48 hours, within 72 hours|Time from onset of rash to the first dose||Participants|Count of Participants|89|89.0||||||
3758699|NCT01959841|3592009|B1||over 48 hours, within 72 hours|Time from onset of rash to the first dose||Participants|Count of Participants|102|102.0||||||
3758700|NCT01959841|3592006|B4||over 24 hours, within 48 hours|Time from onset of rash to the first dose||Participants|Count of Participants|281|281.0||||||
3758701|NCT01959841|3592007|B3||over 24 hours, within 48 hours|Time from onset of rash to the first dose||Participants|Count of Participants|91|91.0||||||
3758702|NCT01959841|3592008|B2||over 24 hours, within 48 hours|Time from onset of rash to the first dose||Participants|Count of Participants|98|98.0||||||
3758703|NCT01959841|3592009|B1||over 24 hours, within 48 hours|Time from onset of rash to the first dose||Participants|Count of Participants|92|92.0||||||
3758704|NCT01959841|3592006|B4||within 24 hours|Time from onset of rash to the first dose||Participants|Count of Participants|154|154.0||||||
3758705|NCT01959841|3592007|B3||within 24 hours|Time from onset of rash to the first dose||Participants|Count of Participants|45|45.0||||||
3758706|NCT01959841|3592008|B2||within 24 hours|Time from onset of rash to the first dose||Participants|Count of Participants|56|56.0||||||
3758707|NCT01959841|3592009|B1||within 24 hours|Time from onset of rash to the first dose||Participants|Count of Participants|53|53.0||||||
3758708|NCT01959841|3592006|B4|Japan||Region of Enrollment||Participants|Count of Participants|735|735.0||||||
3758709|NCT01959841|3592007|B3|Japan||Region of Enrollment||Participants|Count of Participants|245|245.0||||||
3758710|NCT01959841|3592008|B2|Japan||Region of Enrollment||Participants|Count of Participants|243|243.0||||||
3758711|NCT01959841|3592009|B1|Japan||Region of Enrollment||Participants|Count of Participants|247|247.0||||||
3758712|NCT01959841|3592006|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|735|735.0||||||
3758713|NCT01959841|3592007|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|245|245.0||||||
3758714|NCT01959841|3592008|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|243|243.0||||||
3758715|NCT01959841|3592009|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|247|247.0||||||
3758716|NCT01959841|3592006|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758717|NCT01959841|3592007|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758718|NCT01959841|3592008|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758719|NCT01959841|3592009|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758720|NCT01959841|3592006|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758721|NCT01959841|3592007|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758722|NCT01959841|3592008|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758723|NCT01959841|3592009|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758724|NCT01959841|3592006|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758725|NCT01959841|3592007|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758726|NCT01959841|3592008|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758727|NCT01959841|3592009|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758728|NCT01959841|3592006|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758729|NCT01959841|3592007|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758730|NCT01959841|3592008|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758731|NCT01959841|3592009|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758732|NCT01959841|3592006|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758733|NCT01959841|3592007|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758734|NCT01959841|3592008|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758735|NCT01959841|3592009|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758736|NCT01959841|3592006|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758737|NCT01959841|3592007|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758738|NCT01959841|3592008|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758739|NCT01959841|3592009|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758740|NCT01959841|3592006|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|735|735.0||||||
3758741|NCT01959841|3592007|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|245|245.0||||||
3758742|NCT01959841|3592008|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|243|243.0||||||
3758743|NCT01959841|3592009|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|247|247.0||||||
3758744|NCT01959841|3592006|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758745|NCT01959841|3592007|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758746|NCT01959841|3592008|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758747|NCT01959841|3592009|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758748|NCT01959841|3592006|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758749|NCT01959841|3592007|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758750|NCT01959841|3592008|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758751|NCT01959841|3592009|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758752|NCT01959841|3592006|B4||Male|Sex: Female, Male||Participants|Count of Participants|311|311.0||||||
3758753|NCT01959841|3592007|B3||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3758754|NCT01959841|3592008|B2||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3758755|NCT01959841|3592009|B1||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3758756|NCT01959841|3592006|B4||Female|Sex: Female, Male||Participants|Count of Participants|424|424.0||||||
3758757|NCT01959841|3592007|B3||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3758758|NCT01959841|3592008|B2||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3758759|NCT01959841|3592009|B1||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3758760|NCT01959841|3592006|B4|||Age||years|Mean|52.39|52.39|Standard Deviation|16.09|16.09|||
3758761|NCT01959841|3592007|B3|||Age||years|Mean|52.2|52.2|Standard Deviation|15.8|15.8|||
3758762|NCT01959841|3592008|B2|||Age||years|Mean|53.0|53.0|Standard Deviation|16.2|16.2|||
3758763|NCT01959841|3592009|B1|||Age||years|Mean|52.0|52.0|Standard Deviation|16.3|16.3|||
3758764|NCT01959841|3592006|B4||>=65 years|Age||Participants|Count of Participants|205|205.0||||||
3758765|NCT01959841|3592007|B3||>=65 years|Age||Participants|Count of Participants|67|67.0||||||
3758766|NCT01959841|3592008|B2||>=65 years|Age||Participants|Count of Participants|69|69.0||||||
3758767|NCT01959841|3592009|B1||>=65 years|Age||Participants|Count of Participants|69|69.0||||||
3758768|NCT01959841|3592006|B4||Between 18 and 65 years|Age||Participants|Count of Participants|530|530.0||||||
3758769|NCT01959841|3592007|B3||Between 18 and 65 years|Age||Participants|Count of Participants|178|178.0||||||
3758770|NCT01959841|3592008|B2||Between 18 and 65 years|Age||Participants|Count of Participants|174|174.0||||||
3758771|NCT01959841|3592009|B1||Between 18 and 65 years|Age||Participants|Count of Participants|178|178.0||||||
3758772|NCT01959841|3592006|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3758773|NCT01959841|3592007|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3758774|NCT01959841|3592008|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3758775|NCT01959841|3592009|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3758776|NCT01959685|3592034|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3758777|NCT01959685|3592034|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3758778|NCT01959685|3592034|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3758779|NCT01959685|3592034|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3758780|NCT01959685|3592034|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3758781|NCT01959685|3592034|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3758782|NCT01959607|3592039|B3|> 0.6 to ≤ 1 mg||International Organization for Standardization (ISO) nicotine level||participants|Number|28|28.0||||||
3758783|NCT01959607|3592040|B2|> 0.6 to ≤ 1 mg||International Organization for Standardization (ISO) nicotine level||participants|Number|8|8.0||||||
3758784|NCT01959607|3592041|B1|> 0.6 to ≤ 1 mg||International Organization for Standardization (ISO) nicotine level||participants|Number|20|20.0||||||
3758785|NCT01959607|3592039|B3|≤ 0.6 mg||International Organization for Standardization (ISO) nicotine level||participants|Number|32|32.0||||||
3758786|NCT01959607|3592040|B2|≤ 0.6 mg||International Organization for Standardization (ISO) nicotine level||participants|Number|10|10.0||||||
3758787|NCT01959607|3592041|B1|≤ 0.6 mg||International Organization for Standardization (ISO) nicotine level||participants|Number|22|22.0||||||
3758788|NCT01959607|3592039|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3758789|NCT01959607|3592040|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3758790|NCT01959607|3592041|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3758791|NCT01959607|3592039|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3758792|NCT01959607|3592040|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3758793|NCT01959607|3592041|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3758794|NCT01959607|3592039|B3|Between 23 and 65 years||Age, Customized||years|Mean|34.0|34.0|Standard Deviation|9.18|9.18|||
3758795|NCT01959607|3592040|B2|Between 23 and 65 years||Age, Customized||years|Mean|35.8|35.8|Standard Deviation|10.44|10.44|||
3758796|NCT01959607|3592041|B1|Between 23 and 65 years||Age, Customized||years|Mean|33.2|33.2|Standard Deviation|8.61|8.61|||
3758797|NCT01959581|3592057|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3758798|NCT01959581|3592057|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758799|NCT01959581|3592057|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758800|NCT01959581|3592057|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3758801|NCT01959581|3592057|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3758802|NCT01959581|3592057|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758803|NCT01959581|3592057|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3758804|NCT01959581|3592057|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758805|NCT01959581|3592057|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758806|NCT01959581|3592057|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3758807|NCT01959581|3592057|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3758808|NCT01959581|3592057|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3758809|NCT01959581|3592057|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3758810|NCT01959581|3592057|B1|||Age||months|Mean|2.37|2.37|Standard Deviation|1.26|1.26|||
3758811|NCT01959529|3592061|B3|||HbA1c||percentage of HbA1c|Mean|8.43|8.43|Standard Deviation|1.65|1.65|||
3758812|NCT01959529|3592062|B2|||HbA1c||percentage of HbA1c|Mean|8.41|8.41|Standard Deviation|1.67|1.67|||
3758813|NCT01959529|3592063|B1|||HbA1c||percentage of HbA1c|Mean|8.44|8.44|Standard Deviation|1.63|1.63|||
3758814|NCT01959529|3592061|B3||Male|Sex: Female, Male||Participants|Count of Participants|4778|4778.0||||||
3758815|NCT01959529|3592062|B2||Male|Sex: Female, Male||Participants|Count of Participants|2382|2382.0||||||
3758816|NCT01959529|3592063|B1||Male|Sex: Female, Male||Participants|Count of Participants|2396|2396.0||||||
3758817|NCT01959529|3592061|B3||Female|Sex: Female, Male||Participants|Count of Participants|2859|2859.0||||||
3758818|NCT01959529|3592062|B2||Female|Sex: Female, Male||Participants|Count of Participants|1437|1437.0||||||
3758819|NCT01959529|3592063|B1||Female|Sex: Female, Male||Participants|Count of Participants|1422|1422.0||||||
3758820|NCT01959529|3592061|B3|||Age||years|Mean|65.0|65.0|Standard Deviation|7.4|7.4|||
3758821|NCT01959529|3592062|B2|||Age||years|Mean|65.0|65.0|Standard Deviation|7.5|7.5|||
3758822|NCT01959529|3592063|B1|||Age||years|Mean|64.9|64.9|Standard Deviation|7.3|7.3|||
3758823|NCT01959516|3592076|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3758824|NCT01959516|3592076|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3758825|NCT01959516|3592076|B1|||Age||Years|Mean|65.7|65.7|Standard Deviation|8.1|8.1|||
3758826|NCT01959503|3592085|B3|United States||Region of Enrollment||participants|Number|156|156.0||||||
3758827|NCT01959503|3592086|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
3758828|NCT01959503|3592087|B1|United States||Region of Enrollment||participants|Number|106|106.0||||||
3758829|NCT01959503|3592085|B3||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3758830|NCT01959503|3592086|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3758831|NCT01959503|3592087|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3758832|NCT01959503|3592085|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3758833|NCT01959503|3592086|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3758834|NCT01959503|3592087|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3758835|NCT01959503|3592085|B3|||Age||years|Mean|61.8|61.8|Standard Deviation|14.34|14.34|||
3758836|NCT01959503|3592086|B2|||Age||years|Mean|62.4|62.4|Standard Deviation|14.30|14.3|||
3758837|NCT01959503|3592087|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|14.42|14.42|||
3758838|NCT01959412|3592108|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3758839|NCT01959412|3592108|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3758840|NCT01959412|3592108|B1|||Age||Years|Mean|47.4|47.4|Standard Deviation|13.19|13.19|||
3758841|NCT01959035|3592151|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3758842|NCT01959035|3592151|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3758843|NCT01959035|3592151|B1|||Age||years|Mean|43.4|43.4|Standard Deviation|10.9|10.9|||
3758844|NCT01958827|3592177|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3758845|NCT01958827|3592177|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3758846|NCT01958827|3592177|B1|||Age||years|Mean|33.6|33.6|Standard Deviation|10.09|10.09|||
3758847|NCT01958788|3592195|B1|Canada||Region of Enrollment||participants|Number|7|7.0||||||
3758848|NCT01958788|3592195|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758849|NCT01958788|3592195|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758850|NCT01958788|3592195|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3758851|NCT01958788|3592195|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758852|NCT01958788|3592195|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758853|NCT01958788|3592195|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758854|NCT01958788|3592195|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758855|NCT01958788|3592195|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3758856|NCT01958788|3592195|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3758857|NCT01958788|3592195|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3758858|NCT01958788|3592195|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3758859|NCT01958788|3592195|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3758860|NCT01958671|3592205|B4|||Body weight||Kilograms|Mean|92.9|92.9|Standard Deviation|23.2|23.2|||
3758861|NCT01958671|3592206|B3|||Body weight||Kilograms|Mean|94.2|94.2|Standard Deviation|25.2|25.2|||
3758862|NCT01958671|3592207|B2|||Body weight||Kilograms|Mean|90.6|90.6|Standard Deviation|18.3|18.3|||
3758863|NCT01958671|3592208|B1|||Body weight||Kilograms|Mean|94.0|94.0|Standard Deviation|25.4|25.4|||
3758864|NCT01958671|3592205|B4|||Estimated glomerular filtration rate (eGFR)||mL/min/1.75m^2|Mean|87.7|87.7|Standard Deviation|18.6|18.6|||
3758865|NCT01958671|3592206|B3|||Estimated glomerular filtration rate (eGFR)||mL/min/1.75m^2|Mean|86.2|86.2|Standard Deviation|19.4|19.4|||
3758866|NCT01958671|3592207|B2|||Estimated glomerular filtration rate (eGFR)||mL/min/1.75m^2|Mean|88.3|88.3|Standard Deviation|18.0|18.0|||
3758867|NCT01958671|3592208|B1|||Estimated glomerular filtration rate (eGFR)||mL/min/1.75m^2|Mean|88.5|88.5|Standard Deviation|18.4|18.4|||
3758868|NCT01958671|3592205|B4|||Fasting plasma glucose (FPG)||mg/dL|Mean|180.1|180.1|Standard Deviation|47.4|47.4|||
3758869|NCT01958671|3592206|B3|||Fasting plasma glucose (FPG)||mg/dL|Mean|180.2|180.2|Standard Deviation|45.8|45.8|||
3758870|NCT01958671|3592207|B2|||Fasting plasma glucose (FPG)||mg/dL|Mean|179.1|179.1|Standard Deviation|48.2|48.2|||
3758871|NCT01958671|3592208|B1|||Fasting plasma glucose (FPG)||mg/dL|Mean|180.9|180.9|Standard Deviation|48.5|48.5|||
3758872|NCT01958671|3592205|B4|||Hemoglobin A1c (A1C)||Percent|Mean|8.21|8.21|Standard Deviation|0.98|0.98|||
3758873|NCT01958671|3592206|B3|||Hemoglobin A1c (A1C)||Percent|Mean|8.11|8.11|Standard Deviation|0.92|0.92|||
3758874|NCT01958671|3592207|B2|||Hemoglobin A1c (A1C)||Percent|Mean|8.35|8.35|Standard Deviation|1.12|1.12|||
3758875|NCT01958671|3592208|B1|||Hemoglobin A1c (A1C)||Percent|Mean|8.16|8.16|Standard Deviation|0.88|0.88|||
3758876|NCT01958671|3592205|B4||Male|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
3758877|NCT01958671|3592206|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3758878|NCT01958671|3592207|B2||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3758879|NCT01958671|3592208|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3758880|NCT01958671|3592205|B4||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
3758881|NCT01958671|3592206|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3758882|NCT01958671|3592207|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3758883|NCT01958671|3592208|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3758884|NCT01958671|3592205|B4|||Age||Years|Mean|56.4|56.4|Standard Deviation|11.0|11.0|||
3758885|NCT01958671|3592206|B3|||Age||Years|Mean|56.1|56.1|Standard Deviation|10.9|10.9|||
3758886|NCT01958671|3592207|B2|||Age||Years|Mean|56.2|56.2|Standard Deviation|10.8|10.8|||
3758887|NCT01958671|3592208|B1|||Age||Years|Mean|56.8|56.8|Standard Deviation|11.4|11.4|||
3758888|NCT01958645|3592251|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758889|NCT01958645|3592252|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758890|NCT01958645|3592253|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758891|NCT01958645|3592254|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758892|NCT01958645|3592251|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758893|NCT01958645|3592252|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758894|NCT01958645|3592253|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758895|NCT01958645|3592254|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758896|NCT01958645|3592251|B4||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3758897|NCT01958645|3592252|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3758898|NCT01958645|3592253|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3758899|NCT01958645|3592254|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3758900|NCT01958645|3592251|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3758901|NCT01958645|3592252|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758902|NCT01958645|3592253|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3758903|NCT01958645|3592254|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3758904|NCT01958645|3592251|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758905|NCT01958645|3592252|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758906|NCT01958645|3592253|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758907|NCT01958645|3592254|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758908|NCT01958645|3592251|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3758909|NCT01958645|3592252|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3758910|NCT01958645|3592253|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758911|NCT01958645|3592254|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758912|NCT01958645|3592251|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758913|NCT01958645|3592252|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758914|NCT01958645|3592253|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758915|NCT01958645|3592254|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758916|NCT01958645|3592251|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758917|NCT01958645|3592252|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758918|NCT01958645|3592253|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758919|NCT01958645|3592254|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758920|NCT01958645|3592251|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3758921|NCT01958645|3592252|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3758922|NCT01958645|3592253|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3758923|NCT01958645|3592254|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3758924|NCT01958645|3592251|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758925|NCT01958645|3592252|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758926|NCT01958645|3592253|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758927|NCT01958645|3592254|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758928|NCT01958645|3592251|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3758929|NCT01958645|3592252|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3758930|NCT01958645|3592253|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3758931|NCT01958645|3592254|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3758932|NCT01958645|3592251|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3758933|NCT01958645|3592252|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3758934|NCT01958645|3592253|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3758935|NCT01958645|3592254|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3758936|NCT01958645|3592251|B4|||Age||years|Mean|29|29.0|Standard Deviation|7|7.0|||
3758937|NCT01958645|3592252|B3|||Age||years|Mean|30|30.0|Standard Deviation|6|6.0|||
3758938|NCT01958645|3592253|B2|||Age||years|Mean|30|30.0|Standard Deviation|6|6.0|||
3758939|NCT01958645|3592254|B1|||Age||years|Mean|25|25.0|Standard Deviation|9|9.0|||
3758940|NCT01958619|3592280|B5|United Kingdom||Region of Enrollment||participants|Number|55|55.0||||||
3758941|NCT01958619|3592281|B4|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
3758942|NCT01958619|3592282|B3|United Kingdom||Region of Enrollment||participants|Number|14|14.0||||||
3758943|NCT01958619|3592283|B2|United Kingdom||Region of Enrollment||participants|Number|14|14.0||||||
3758944|NCT01958619|3592284|B1|United Kingdom||Region of Enrollment||participants|Number|15|15.0||||||
3758945|NCT01958619|3592280|B5||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3758946|NCT01958619|3592281|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3758947|NCT01958619|3592282|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3758948|NCT01958619|3592283|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3758949|NCT01958619|3592284|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3758950|NCT01958619|3592280|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3758951|NCT01958619|3592281|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3758952|NCT01958619|3592282|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3758953|NCT01958619|3592283|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3758954|NCT01958619|3592284|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3758955|NCT01958619|3592280|B5|||Age||years|Mean|28.5|28.5|Standard Deviation|8.71|8.71|||
3758956|NCT01958619|3592281|B4|||Age||years|Mean|28.6|28.6|Standard Deviation|9.54|9.54|||
3758957|NCT01958619|3592282|B3|||Age||years|Mean|26.9|26.9|Standard Deviation|5.66|5.66|||
3758958|NCT01958619|3592283|B2|||Age||years|Mean|31.8|31.8|Standard Deviation|9.70|9.7|||
3758959|NCT01958619|3592284|B1|||Age||years|Mean|27.0|27.0|Standard Deviation|9.40|9.4|||
3758960|NCT01958606|3592307|B3|||Peak oxygen consumption rate, ml/kg/min||ml/kg/min|Mean|17.7|17.7|Standard Deviation|4.7|4.7|||
3758961|NCT01958606|3592308|B2|||Peak oxygen consumption rate, ml/kg/min||ml/kg/min|Mean|21.6|21.6|Standard Deviation|4.0|4.0|||
3758962|NCT01958606|3592309|B1|||Peak oxygen consumption rate, ml/kg/min||ml/kg/min|Mean|16.0|16.0|Standard Deviation|4.0|4.0|||
3758963|NCT01958606|3592307|B3|||Comfortable gait speed, m/s||m/s|Mean|0.67|0.67|Standard Deviation|0.44|0.44|||
3758964|NCT01958606|3592308|B2|||Comfortable gait speed, m/s||m/s|Mean|0.76|0.76|Standard Deviation|0.36|0.36|||
3758965|NCT01958606|3592309|B1|||Comfortable gait speed, m/s||m/s|Mean|0.63|0.63|Standard Deviation|0.48|0.48|||
3758966|NCT01958606|3592307|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3758967|NCT01958606|3592308|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3758968|NCT01958606|3592309|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3758969|NCT01958606|3592307|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3758970|NCT01958606|3592308|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3758971|NCT01958606|3592309|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3758972|NCT01958606|3592307|B3|||Age||years|Mean|58|58.0|Standard Deviation|10|10.0|||
3758973|NCT01958606|3592308|B2|||Age||years|Mean|57|57.0|Standard Deviation|12|12.0|||
3758974|NCT01958606|3592309|B1|||Age||years|Mean|59|59.0|Standard Deviation|9|9.0|||
3758975|NCT01958489|3592348|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3758976|NCT01958489|3592348|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758977|NCT01958489|3592348|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758978|NCT01958489|3592348|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3758979|NCT01958489|3592348|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3758980|NCT01958489|3592348|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758981|NCT01958489|3592348|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3758982|NCT01958489|3592348|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758983|NCT01958489|3592348|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758984|NCT01958489|3592348|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3758985|NCT01958489|3592348|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758986|NCT01958489|3592348|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3758987|NCT01958489|3592348|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3758988|NCT01958489|3592348|B1|||Age||years|Mean|31.8|31.8|Standard Deviation|9.0|9.0|||
3758989|NCT01958437|3592363|B3|United States||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3758990|NCT01958437|3592364|B2|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3758991|NCT01958437|3592365|B1|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3758992|NCT01958437|3592363|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758993|NCT01958437|3592364|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758994|NCT01958437|3592365|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758995|NCT01958437|3592363|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758996|NCT01958437|3592364|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758997|NCT01958437|3592365|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3758998|NCT01958437|3592363|B3||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3758999|NCT01958437|3592364|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3759000|NCT01958437|3592365|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3759001|NCT01958437|3592363|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3759002|NCT01958437|3592364|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3759003|NCT01958437|3592365|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3759004|NCT01958437|3592363|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759005|NCT01958437|3592364|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759006|NCT01958437|3592365|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759007|NCT01958437|3592363|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759008|NCT01958437|3592364|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759009|NCT01958437|3592365|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759010|NCT01958437|3592363|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759011|NCT01958437|3592364|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759012|NCT01958437|3592365|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759013|NCT01958437|3592363|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3759014|NCT01958437|3592364|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3759015|NCT01958437|3592365|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3759016|NCT01958437|3592363|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3759017|NCT01958437|3592364|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3759018|NCT01958437|3592365|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3759019|NCT01958437|3592363|B3|||Age||years|Mean|70.8|70.8|Standard Deviation|6.89|6.89|||
3759020|NCT01958437|3592364|B2|||Age||years|Mean|69.5|69.5|Standard Deviation|6.55|6.55|||
3759021|NCT01958437|3592365|B1|||Age||years|Mean|72.15|72.15|Standard Deviation|7.14|7.14|||
3759022|NCT01958346|3592390|B3|United States||Region of Enrollment||participants|Number|78|78.0||||||
3759023|NCT01958346|3592391|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
3759024|NCT01958346|3592392|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
3759025|NCT01958346|3592390|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3759026|NCT01958346|3592391|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3759027|NCT01958346|3592392|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3759028|NCT01958346|3592390|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759029|NCT01958346|3592391|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759030|NCT01958346|3592392|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759031|NCT01958346|3592390|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759032|NCT01958346|3592391|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759033|NCT01958346|3592392|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759034|NCT01958346|3592390|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759035|NCT01958346|3592391|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759036|NCT01958346|3592392|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759037|NCT01958346|3592390|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759038|NCT01958346|3592391|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759039|NCT01958346|3592392|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759040|NCT01958346|3592390|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759041|NCT01958346|3592391|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759042|NCT01958346|3592392|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759043|NCT01958346|3592390|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759044|NCT01958346|3592391|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759045|NCT01958346|3592392|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759046|NCT01958346|3592390|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3759047|NCT01958346|3592391|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3759048|NCT01958346|3592392|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3759049|NCT01958346|3592390|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759050|NCT01958346|3592391|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759051|NCT01958346|3592392|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759052|NCT01958346|3592390|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759053|NCT01958346|3592391|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759054|NCT01958346|3592392|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759055|NCT01958346|3592390|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3759056|NCT01958346|3592391|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3759057|NCT01958346|3592392|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3759058|NCT01958346|3592390|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3759059|NCT01958346|3592391|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3759060|NCT01958346|3592392|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3759061|NCT01958346|3592390|B3|||Age||years|Mean|56.2|56.2|Standard Deviation|13.0|13.0|||
3759062|NCT01958346|3592391|B2|||Age||years|Mean|56.7|56.7|Standard Deviation|13.9|13.9|||
3759063|NCT01958346|3592392|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|12.5|12.5|||
3759064|NCT01958320|3592401|B3|||Gestation|weeks of gestation|weeks of gestation|Mean|25.8|25.8|Standard Deviation|1.2|1.2|||
3759065|NCT01958320|3592402|B2|||Gestation|weeks of gestation|weeks of gestation|Mean|25.9|25.9|Standard Deviation|1.1|1.1|||
3759066|NCT01958320|3592403|B1|||Gestation|weeks of gestation|weeks of gestation|Mean|25.7|25.7|Standard Deviation|1.2|1.2|||
3759067|NCT01958320|3592401|B3|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
3759068|NCT01958320|3592402|B2|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3759069|NCT01958320|3592403|B1|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3759070|NCT01958320|3592401|B3|United States||Region of Enrollment||participants|Number|152|152.0||||||
3759071|NCT01958320|3592402|B2|United States||Region of Enrollment||participants|Number|72|72.0||||||
3759072|NCT01958320|3592403|B1|United States||Region of Enrollment||participants|Number|80|80.0||||||
3759073|NCT01958320|3592401|B3|Turkey||Region of Enrollment||participants|Number|29|29.0||||||
3759074|NCT01958320|3592402|B2|Turkey||Region of Enrollment||participants|Number|15|15.0||||||
3759075|NCT01958320|3592403|B1|Turkey||Region of Enrollment||participants|Number|14|14.0||||||
3759076|NCT01958320|3592401|B3|Sweden||Region of Enrollment||participants|Number|14|14.0||||||
3759077|NCT01958320|3592402|B2|Sweden||Region of Enrollment||participants|Number|7|7.0||||||
3759078|NCT01958320|3592403|B1|Sweden||Region of Enrollment||participants|Number|7|7.0||||||
3759079|NCT01958320|3592401|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759080|NCT01958320|3592402|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759081|NCT01958320|3592403|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759082|NCT01958320|3592401|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759083|NCT01958320|3592402|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759084|NCT01958320|3592403|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759085|NCT01958320|3592401|B3||White|Race (NIH/OMB)||Participants|Count of Participants|149|149.0||||||
3759086|NCT01958320|3592402|B2||White|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3759087|NCT01958320|3592403|B1||White|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
3759088|NCT01958320|3592401|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3759089|NCT01958320|3592402|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3759090|NCT01958320|3592403|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3759091|NCT01958320|3592401|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759092|NCT01958320|3592402|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759093|NCT01958320|3592403|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759094|NCT01958320|3592401|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3759095|NCT01958320|3592402|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3759096|NCT01958320|3592403|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3759097|NCT01958320|3592401|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3759098|NCT01958320|3592402|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759099|NCT01958320|3592403|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3759100|NCT01958320|3592401|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759101|NCT01958320|3592402|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759102|NCT01958320|3592403|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759103|NCT01958320|3592401|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|158|158.0||||||
3759104|NCT01958320|3592402|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3759105|NCT01958320|3592403|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3759106|NCT01958320|3592401|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3759107|NCT01958320|3592402|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3759108|NCT01958320|3592403|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3759109|NCT01958320|3592401|B3||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3759110|NCT01958320|3592402|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3759111|NCT01958320|3592403|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3759112|NCT01958320|3592401|B3||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3759113|NCT01958320|3592402|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3759114|NCT01958320|3592403|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3759115|NCT01958320|3592401|B3|||Age|days after birth|days after birth|Mean|8.2|8.2|Standard Deviation|2.2|2.2|||
3759116|NCT01958320|3592402|B2|||Age|days after birth|days after birth|Mean|8.3|8.3|Standard Deviation|2.3|2.3|||
3759117|NCT01958320|3592403|B1|||Age|days after birth|days after birth|Mean|8.1|8.1|Standard Deviation|2.1|2.1|||
3759118|NCT01958320|3592401|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3759119|NCT01958320|3592402|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3759120|NCT01958320|3592403|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3759121|NCT01958320|3592401|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3759122|NCT01958320|3592402|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3759123|NCT01958320|3592403|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3759124|NCT01958320|3592401|B3||<=18 years|Age||Participants|Count of Participants|202|202.0||||||
3759125|NCT01958320|3592402|B2||<=18 years|Age||Participants|Count of Participants|98|98.0||||||
3759126|NCT01958320|3592403|B1||<=18 years|Age||Participants|Count of Participants|104|104.0||||||
3759127|NCT01958281|3592432|B4||TT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|9|9.0||||||
3759128|NCT01958281|3592433|B3||TT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|6|6.0||||||
3759129|NCT01958281|3592434|B2||TT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|1|1.0||||||
3759130|NCT01958281|3592435|B1||TT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|2|2.0||||||
3759131|NCT01958281|3592432|B4||CT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|21|21.0||||||
3759132|NCT01958281|3592433|B3||CT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|11|11.0||||||
3759133|NCT01958281|3592434|B2||CT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|4|4.0||||||
3759134|NCT01958281|3592435|B1||CT|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|6|6.0||||||
3759135|NCT01958281|3592432|B4||CC|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|8|8.0||||||
3759136|NCT01958281|3592433|B3||CC|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|1|1.0||||||
3759137|NCT01958281|3592434|B2||CC|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|5|5.0||||||
3759138|NCT01958281|3592435|B1||CC|IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|2|2.0||||||
3759139|NCT01958281|3592432|B4||Genotype 3a|HCV genotype||Participants|Count of Participants|3|3.0||||||
3759140|NCT01958281|3592433|B3||Genotype 3a|HCV genotype||Participants|Count of Participants|0|0.0||||||
3759141|NCT01958281|3592434|B2||Genotype 3a|HCV genotype||Participants|Count of Participants|2|2.0||||||
3759142|NCT01958281|3592435|B1||Genotype 3a|HCV genotype||Participants|Count of Participants|1|1.0||||||
3759143|NCT01958281|3592432|B4||Genotype 1b|HCV genotype||Participants|Count of Participants|8|8.0||||||
3759144|NCT01958281|3592433|B3||Genotype 1b|HCV genotype||Participants|Count of Participants|4|4.0||||||
3759145|NCT01958281|3592434|B2||Genotype 1b|HCV genotype||Participants|Count of Participants|2|2.0||||||
3759146|NCT01958281|3592435|B1||Genotype 1b|HCV genotype||Participants|Count of Participants|2|2.0||||||
3759147|NCT01958281|3592432|B4||Genotype 1a|HCV genotype||Participants|Count of Participants|27|27.0||||||
3759148|NCT01958281|3592433|B3||Genotype 1a|HCV genotype||Participants|Count of Participants|14|14.0||||||
3759149|NCT01958281|3592434|B2||Genotype 1a|HCV genotype||Participants|Count of Participants|6|6.0||||||
3759150|NCT01958281|3592435|B1||Genotype 1a|HCV genotype||Participants|Count of Participants|7|7.0||||||
3759151|NCT01958281|3592432|B4|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3759152|NCT01958281|3592433|B3|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3759153|NCT01958281|3592434|B2|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3759154|NCT01958281|3592435|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3759155|NCT01958281|3592432|B4|New Zealand||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3759156|NCT01958281|3592433|B3|New Zealand||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3759157|NCT01958281|3592434|B2|New Zealand||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3759158|NCT01958281|3592435|B1|New Zealand||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3759159|NCT01958281|3592432|B4||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3759160|NCT01958281|3592433|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3759161|NCT01958281|3592434|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3759162|NCT01958281|3592435|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3759163|NCT01958281|3592432|B4||Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3759164|NCT01958281|3592433|B3||Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3759165|NCT01958281|3592434|B2||Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3759166|NCT01958281|3592435|B1||Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3759167|NCT01958281|3592432|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3759168|NCT01958281|3592433|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3759169|NCT01958281|3592434|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3759170|NCT01958281|3592435|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3759171|NCT01958281|3592432|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3759172|NCT01958281|3592433|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3759173|NCT01958281|3592434|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3759174|NCT01958281|3592435|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3759175|NCT01958281|3592432|B4||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3759176|NCT01958281|3592433|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3759177|NCT01958281|3592434|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3759178|NCT01958281|3592435|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3759179|NCT01958281|3592432|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759180|NCT01958281|3592433|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759181|NCT01958281|3592434|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759182|NCT01958281|3592435|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759183|NCT01958281|3592432|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3759184|NCT01958281|3592433|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3759185|NCT01958281|3592434|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3759186|NCT01958281|3592435|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3759187|NCT01958281|3592432|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3759188|NCT01958281|3592433|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3759189|NCT01958281|3592434|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3759190|NCT01958281|3592435|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3759191|NCT01958281|3592432|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3759192|NCT01958281|3592433|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3759193|NCT01958281|3592434|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3759194|NCT01958281|3592435|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3759195|NCT01958281|3592432|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3759196|NCT01958281|3592433|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3759197|NCT01958281|3592434|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3759198|NCT01958281|3592435|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3759199|NCT01958281|3592432|B4|||Age||years|Mean|58.9|58.9|Standard Deviation|7.76|7.76|||
3759200|NCT01958281|3592433|B3|||Age||years|Mean|57|57.0|Standard Deviation|7.5|7.5|||
3759201|NCT01958281|3592434|B2|||Age||years|Mean|58|58.0|Standard Deviation|9.0|9.0|||
3759202|NCT01958281|3592435|B1|||Age||years|Mean|62|62.0|Standard Deviation|6.5|6.5|||
3759203|NCT01958164|3592511|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3759204|NCT01958164|3592512|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3759205|NCT01958164|3592513|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3759206|NCT01958164|3592511|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3759207|NCT01958164|3592512|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3759208|NCT01958164|3592513|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3759209|NCT01958164|3592511|B3|||Age||years|Mean|60.9|60.9|Full Range|||26.0|76.0|
3759210|NCT01958164|3592512|B2|||Age||years|Mean|63.9|63.9|Full Range|||35.0|76.0|
3759211|NCT01958164|3592513|B1|||Age||years|Mean|56.0|56.0|Full Range|||26.0|74.0|
3759212|NCT01958060|3592527|B7||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3759213|NCT01958060|3592528|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3759214|NCT01958060|3592529|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3759215|NCT01958060|3592530|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3759216|NCT01958060|3592531|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3759217|NCT01958060|3592532|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3759218|NCT01958060|3592533|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3759219|NCT01958060|3592527|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3759220|NCT01958060|3592528|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3759221|NCT01958060|3592529|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3759222|NCT01958060|3592530|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3759223|NCT01958060|3592531|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3759224|NCT01958060|3592532|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3759225|NCT01958060|3592533|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3759226|NCT01958060|3592527|B7|||Age||Year|Mean|31.0|31.0|Standard Deviation|4.9|4.9|||
3759227|NCT01958060|3592528|B6|||Age||Year|Mean|23.0|23.0|Standard Deviation|NA||||The data of only one patient is available and thus Standard Deviation is not calculable
3759228|NCT01958060|3592529|B5|||Age||Year|Mean|34.3|34.3|Standard Deviation|4.0|4.0|||
3759229|NCT01958060|3592530|B4|||Age||Year|Mean|31.4|31.4|Standard Deviation|4.0|4.0|||
3759230|NCT01958060|3592531|B3|||Age||Year|Mean|33.2|33.2|Standard Deviation|3.4|3.4|||
3759231|NCT01958060|3592532|B2|||Age||Year|Mean|32.5|32.5|Standard Deviation|3.9|3.9|||
3759232|NCT01958060|3592533|B1|||Age||Year|Mean|26.5|26.5|Standard Deviation|4.3|4.3|||
3759233|NCT01958021|3592561|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3759234|NCT01958021|3592562|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3759235|NCT01958021|3592563|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3759236|NCT01958021|3592561|B3||Female|Sex: Female, Male||Participants|Count of Participants|668|668.0||||||
3759237|NCT01958021|3592562|B2||Female|Sex: Female, Male||Participants|Count of Participants|334|334.0||||||
3759238|NCT01958021|3592563|B1||Female|Sex: Female, Male||Participants|Count of Participants|334|334.0||||||
3759239|NCT01958021|3592561|B3|||Age||Years|Mean|61.6|61.6|Standard Deviation|10.75|10.75|||
3759240|NCT01958021|3592562|B2|||Age||Years|Mean|61.9|61.9|Standard Deviation|10.52|10.52|||
3759241|NCT01958021|3592563|B1|||Age||Years|Mean|61.4|61.4|Standard Deviation|10.98|10.98|||
3759242|NCT01958008|3592572|B5||Male|Gender||Participants|Count of Participants|50|50.0||||||
3759243|NCT01958008|3592573|B4||Male|Gender||Participants|Count of Participants|13|13.0||||||
3759244|NCT01958008|3592574|B3||Male|Gender||Participants|Count of Participants|12|12.0||||||
3759245|NCT01958008|3592575|B2||Male|Gender||Participants|Count of Participants|12|12.0||||||
3759246|NCT01958008|3592576|B1||Male|Gender||Participants|Count of Participants|13|13.0||||||
3759247|NCT01958008|3592572|B5||Female|Gender||Participants|Count of Participants|34|34.0||||||
3759248|NCT01958008|3592573|B4||Female|Gender||Participants|Count of Participants|8|8.0||||||
3759249|NCT01958008|3592574|B3||Female|Gender||Participants|Count of Participants|9|9.0||||||
3759250|NCT01958008|3592575|B2||Female|Gender||Participants|Count of Participants|9|9.0||||||
3759251|NCT01958008|3592576|B1||Female|Gender||Participants|Count of Participants|8|8.0||||||
3759252|NCT01958008|3592572|B5|||Age||years|Mean|60.60|60.6|Standard Deviation|6.71|6.71|||
3759253|NCT01958008|3592573|B4|||Age||years|Mean|60.38|60.38|Standard Deviation|6.81|6.81|||
3759254|NCT01958008|3592574|B3|||Age||years|Mean|62.43|62.43|Standard Deviation|7.21|7.21|||
3759255|NCT01958008|3592575|B2|||Age||years|Mean|58.90|58.9|Standard Deviation|6.17|6.17|||
3759256|NCT01958008|3592576|B1|||Age||years|Mean|60.67|60.67|Standard Deviation|6.64|6.64|||
3759257|NCT01957930|3592607|B3|Sweden||Region of Enrollment||participants|Number|72|72.0||||||
3759258|NCT01957930|3592608|B2|Sweden||Region of Enrollment||participants|Number|37|37.0||||||
3759259|NCT01957930|3592609|B1|Sweden||Region of Enrollment||participants|Number|35|35.0||||||
3759260|NCT01957930|3592607|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3759261|NCT01957930|3592608|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3759262|NCT01957930|3592609|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3759263|NCT01957930|3592607|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3759264|NCT01957930|3592608|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3759265|NCT01957930|3592609|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3759266|NCT01957930|3592607|B3|||Age||years|Mean|42|42.0|Full Range|||28.0|63.0|
3759267|NCT01957930|3592608|B2|||Age||years|Mean|42|42.0|Full Range|||31.0|63.0|
3759268|NCT01957930|3592609|B1|||Age||years|Mean|42|42.0|Full Range|||28.0|63.0|
3759269|NCT01957930|3592607|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3759270|NCT01957930|3592608|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3759271|NCT01957930|3592609|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3759272|NCT01957930|3592607|B3||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
3759273|NCT01957930|3592608|B2||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3759274|NCT01957930|3592609|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3759275|NCT01957930|3592607|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3759276|NCT01957930|3592608|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3759277|NCT01957930|3592609|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3759278|NCT01957865|3592616|B4|||Median CD4 count||cells/mm^3|Median|309|309.0|Inter-Quartile Range|||231.0|397.0|
3759279|NCT01957865|3592617|B3|||Median CD4 count||cells/mm^3|Median|382|382.0|Inter-Quartile Range|||249.0|457.0|
3759280|NCT01957865|3592618|B2|||Median CD4 count||cells/mm^3|Median|291|291.0|Inter-Quartile Range|||213.0|350.0|
3759281|NCT01957865|3592619|B1|||Median CD4 count||cells/mm^3|Median|309|309.0|Inter-Quartile Range|||241.0|385.0|
3759282|NCT01957865|3592616|B4|Uganda||Region of Enrollment||participants|Number|63|63.0||||||
3759283|NCT01957865|3592617|B3|Uganda||Region of Enrollment||participants|Number|22|22.0||||||
3759284|NCT01957865|3592618|B2|Uganda||Region of Enrollment||participants|Number|20|20.0||||||
3759285|NCT01957865|3592619|B1|Uganda||Region of Enrollment||participants|Number|21|21.0||||||
3759286|NCT01957865|3592616|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3759287|NCT01957865|3592617|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3759288|NCT01957865|3592618|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3759289|NCT01957865|3592619|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3759290|NCT01957865|3592616|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3759291|NCT01957865|3592617|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3759292|NCT01957865|3592618|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3759293|NCT01957865|3592619|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3759294|NCT01957865|3592616|B4|||Age||years|Median|30|30.0|Inter-Quartile Range|||25.0|35.0|
3759295|NCT01957865|3592617|B3|||Age||years|Median|27|27.0|Inter-Quartile Range|||24.0|32.0|
3759296|NCT01957865|3592618|B2|||Age||years|Median|33|33.0|Inter-Quartile Range|||26.0|35.0|
3759297|NCT01957865|3592619|B1|||Age||years|Median|33|33.0|Inter-Quartile Range|||28.0|40.0|
3759298|NCT01957761|3592632|B1|||Number of cases of BI/NAP1/027||cases|Number|3|3.0||||||
3759299|NCT01957761|3592632|B1|United States||Region of Enrollment||participants|Number|189|189.0||||||
3759300|NCT01957761|3592632|B1||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3759301|NCT01957761|3592632|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3759302|NCT01957761|3592632|B1|||Age||years|Median|9|9.0|Full Range|||1.0|21.0|
3759303|NCT01957761|3592632|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3759304|NCT01957761|3592632|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3759305|NCT01957761|3592632|B1||<=18 years|Age||Participants|Count of Participants|176|176.0||||||
3759306|NCT01957657|3592636|B1|Germany||Region of Enrollment||participants|Number|4|4.0||||||
3759307|NCT01957657|3592636|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3759308|NCT01957657|3592636|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3759309|NCT01957657|3592636|B1|||Age||years|Mean|68.8|68.8|Standard Deviation|10.0|10.0|||
3759310|NCT01957579|3592650|B5|MM||Disease Type|Disease Type (CLL: chronic lymphocytic leukemia, DLBCL: diffuse large B-cell lymphoma, FL: follicular lymphoma, MM: multiple myeloma)|Participants|Number|1|1.0||||||
3759311|NCT01957579|3592651|B4|MM||Disease Type|Disease Type (CLL: chronic lymphocytic leukemia, DLBCL: diffuse large B-cell lymphoma, FL: follicular lymphoma, MM: multiple myeloma)|Participants|Number|0|0.0||||||
3759312|NCT01957579|3592652|B3|MM||Disease Type|Disease Type (CLL: chronic lymphocytic leukemia, DLBCL: diffuse large B-cell lymphoma, FL: follicular lymphoma, MM: multiple myeloma)|Participants|Number|0|0.0||||||
3759313|NCT01957579|3592653|B2|MM||Disease Type|Disease Type (CLL: chronic lymphocytic leukemia, DLBCL: diffuse large B-cell lymphoma, FL: follicular lymphoma, MM: multiple myeloma)|Participants|Number|1|1.0||||||
3759314|NCT01957579|3592654|B1|MM||Disease Type|Disease Type (CLL: chronic lymphocytic leukemia, DLBCL: diffuse large B-cell lymphoma, FL: follicular lymphoma, MM: multiple myeloma)|Participants|Number|0|0.0||||||
3759364|NCT01957384|3592774|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3759315|NCT01957579|3592650|B5|FL||Disease Type|Disease Type (CLL: chronic lymphocytic leukemia, DLBCL: diffuse large B-cell lymphoma, FL: follicular lymphoma, MM: multiple myeloma)|Participants|Number|11|11.0||||||
3759316|NCT01957579|3592651|B4|FL||Disease Type|Disease Type (CLL: chronic lymphocytic leukemia, DLBCL: diffuse large B-cell lymphoma, FL: follicular lymphoma, MM: multiple myeloma)|Participants|Number|3|3.0||||||
3759317|NCT01957579|3592652|B3|FL||Disease Type|Disease Type (CLL: chronic lymphocytic leukemia, DLBCL: diffuse large B-cell lymphoma, FL: follicular lymphoma, MM: multiple myeloma)|Participants|Number|2|2.0||||||
3759318|NCT01957579|3592653|B2|FL||Disease Type|Disease Type (CLL: chronic lymphocytic leukemia, DLBCL: diffuse large B-cell lymphoma, FL: follicular lymphoma, MM: multiple myeloma)|Participants|Number|4|4.0||||||
3759319|NCT01957579|3592654|B1|FL||Disease Type|Disease Type (CLL: chronic lymphocytic leukemia, DLBCL: diffuse large B-cell lymphoma, FL: follicular lymphoma, MM: multiple myeloma)|Participants|Number|2|2.0||||||
3759320|NCT01957579|3592650|B5|DLBCL||Disease Type|Disease Type (CLL: chronic lymphocytic leukemia, DLBCL: diffuse large B-cell lymphoma, FL: follicular lymphoma, MM: multiple myeloma)|Participants|Number|6|6.0||||||
3759321|NCT01957579|3592651|B4|DLBCL||Disease Type|Disease Type (CLL: chronic lymphocytic leukemia, DLBCL: diffuse large B-cell lymphoma, FL: follicular lymphoma, MM: multiple myeloma)|Participants|Number|2|2.0||||||
3759322|NCT01957579|3592652|B3|DLBCL||Disease Type|Disease Type (CLL: chronic lymphocytic leukemia, DLBCL: diffuse large B-cell lymphoma, FL: follicular lymphoma, MM: multiple myeloma)|Participants|Number|2|2.0||||||
3759323|NCT01957579|3592653|B2|DLBCL||Disease Type|Disease Type (CLL: chronic lymphocytic leukemia, DLBCL: diffuse large B-cell lymphoma, FL: follicular lymphoma, MM: multiple myeloma)|Participants|Number|2|2.0||||||
3759324|NCT01957579|3592654|B1|DLBCL||Disease Type|Disease Type (CLL: chronic lymphocytic leukemia, DLBCL: diffuse large B-cell lymphoma, FL: follicular lymphoma, MM: multiple myeloma)|Participants|Number|0|0.0||||||
3759325|NCT01957579|3592650|B5|CLL||Disease Type|Disease Type (CLL: chronic lymphocytic leukemia, DLBCL: diffuse large B-cell lymphoma, FL: follicular lymphoma, MM: multiple myeloma)|Participants|Number|2|2.0||||||
3759326|NCT01957579|3592651|B4|CLL||Disease Type|Disease Type (CLL: chronic lymphocytic leukemia, DLBCL: diffuse large B-cell lymphoma, FL: follicular lymphoma, MM: multiple myeloma)|Participants|Number|1|1.0||||||
3759327|NCT01957579|3592652|B3|CLL||Disease Type|Disease Type (CLL: chronic lymphocytic leukemia, DLBCL: diffuse large B-cell lymphoma, FL: follicular lymphoma, MM: multiple myeloma)|Participants|Number|0|0.0||||||
3759328|NCT01957579|3592653|B2|CLL||Disease Type|Disease Type (CLL: chronic lymphocytic leukemia, DLBCL: diffuse large B-cell lymphoma, FL: follicular lymphoma, MM: multiple myeloma)|Participants|Number|0|0.0||||||
3759329|NCT01957579|3592654|B1|CLL||Disease Type|Disease Type (CLL: chronic lymphocytic leukemia, DLBCL: diffuse large B-cell lymphoma, FL: follicular lymphoma, MM: multiple myeloma)|Participants|Number|1|1.0||||||
3759330|NCT01957579|3592650|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3759331|NCT01957579|3592651|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3759332|NCT01957579|3592652|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3759333|NCT01957579|3592653|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3759334|NCT01957579|3592654|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3759335|NCT01957579|3592650|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3759336|NCT01957579|3592651|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3759337|NCT01957579|3592652|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3759338|NCT01957579|3592653|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3759339|NCT01957579|3592654|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3759340|NCT01957579|3592650|B5|||Age||Years|Mean|61.3|61.3|Standard Deviation|11.4|11.4|41.0|83.0|
3759341|NCT01957579|3592651|B4|||Age||Years|Mean|67.3|67.3|Standard Deviation|11.4|11.4|54.0|83.0|
3759342|NCT01957579|3592652|B3|||Age||Years|Mean|67.0|67.0|Standard Deviation|8.7|8.7|54.0|72.0|
3759343|NCT01957579|3592653|B2|||Age||Years|Mean|57.4|57.4|Standard Deviation|10.5|10.5|41.0|70.0|
3759344|NCT01957579|3592654|B1|||Age||Years|Mean|50.3|50.3|Standard Deviation|8.1|8.1|43.0|59.0|
3759345|NCT01957553|3592724|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3759346|NCT01957553|3592724|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3759347|NCT01957553|3592724|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|12.7|12.7|||
3759348|NCT01957488|3592731|B1||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3759349|NCT01957488|3592731|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3759350|NCT01957488|3592731|B1|||Age||years|Mean|57|57.0|Standard Deviation|11.4|11.4|||
3759351|NCT01957475|3592744|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3759352|NCT01957475|3592744|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3759353|NCT01957475|3592744|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|12.6|12.6|||
3759354|NCT01957462|3592751|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3759355|NCT01957462|3592751|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3759356|NCT01957462|3592751|B1|||Age||years|Mean|61.4|61.4|Standard Deviation|12.7|12.7|||
3759357|NCT01957410|3592758|B1|USA||Region of Enrollment||participants|Number|13|13.0||||||
3759358|NCT01957410|3592758|B1||Male|Gender||Participants|Count of Participants|4|4.0||||||
3759359|NCT01957410|3592758|B1||Female|Gender||Participants|Count of Participants|9|9.0||||||
3759360|NCT01957410|3592758|B1|||Age||years|Mean|40.9|40.9|Standard Deviation|11.45|11.45|||
3759361|NCT01957397|3592763|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3759362|NCT01957397|3592763|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3759363|NCT01957397|3592763|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|10.4|10.4|||
3759365|NCT01957384|3592774|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3759366|NCT01957384|3592774|B1|||Age||years|Mean|28.4|28.4|Standard Deviation|10.9|10.9|||
3759367|NCT01957215|3592787|B3||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3759368|NCT01957215|3592788|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3759369|NCT01957215|3592789|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3759370|NCT01957215|3592787|B3||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3759371|NCT01957215|3592788|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3759372|NCT01957215|3592789|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3759373|NCT01957215|3592787|B3|||Age||Years|Mean|36.6|36.6|Standard Deviation|12.53|12.53|||
3759374|NCT01957215|3592788|B2|||Age||Years|Mean|35.6|35.6|Standard Deviation|12.29|12.29|||
3759375|NCT01957215|3592789|B1|||Age||Years|Mean|37.7|37.7|Standard Deviation|12.73|12.73|||
3759376|NCT01957202|3592818|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|69|69.0||||||
3759377|NCT01957202|3592818|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3759378|NCT01957202|3592818|B1||Male|Gender||Participants|Count of Participants|35|35.0||||||
3759379|NCT01957202|3592818|B1||Female|Gender||Participants|Count of Participants|36|36.0||||||
3759380|NCT01957202|3592818|B1|||Age||Years|Mean|29.4|29.4|Standard Deviation|8.91|8.91|||
3759381|NCT01957163|3592857|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|603|603.0||||||
3759382|NCT01957163|3592858|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|202|202.0||||||
3759383|NCT01957163|3592859|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|201|201.0||||||
3759384|NCT01957163|3592860|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|200|200.0||||||
3759385|NCT01957163|3592857|B4|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3759386|NCT01957163|3592858|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3759387|NCT01957163|3592859|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3759388|NCT01957163|3592860|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3759389|NCT01957163|3592857|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3759390|NCT01957163|3592858|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3759391|NCT01957163|3592859|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3759392|NCT01957163|3592860|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3759393|NCT01957163|3592857|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3759394|NCT01957163|3592858|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3759395|NCT01957163|3592859|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3759396|NCT01957163|3592860|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3759397|NCT01957163|3592857|B4||Male|Sex: Female, Male||Participants|Count of Participants|407|407.0||||||
3759398|NCT01957163|3592858|B3||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3759399|NCT01957163|3592859|B2||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3759400|NCT01957163|3592860|B1||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3759401|NCT01957163|3592857|B4||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
3759402|NCT01957163|3592858|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3759403|NCT01957163|3592859|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3759404|NCT01957163|3592860|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3759405|NCT01957163|3592857|B4|||Age||Years|Mean|64.4|64.4|Standard Deviation|8.10|8.1|||
3759406|NCT01957163|3592858|B3|||Age||Years|Mean|63.8|63.8|Standard Deviation|7.65|7.65|||
3759407|NCT01957163|3592859|B2|||Age||Years|Mean|64.9|64.9|Standard Deviation|8.72|8.72|||
3759408|NCT01957163|3592860|B1|||Age||Years|Mean|64.7|64.7|Standard Deviation|7.90|7.9|||
3759409|NCT01957137|3592873|B1|||Years implanted with InterStim therapy||years|Mean|2.8|2.8|Standard Deviation|3.1|3.1|||
3759410|NCT01957137|3592873|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3759411|NCT01957137|3592873|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3759412|NCT01957137|3592873|B1|||Age|At time of consent|years|Mean|64.0|64.0|Standard Deviation|13.5|13.5|||
3759413|NCT01957111|3592901|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3759414|NCT01957111|3592902|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3759415|NCT01957111|3592903|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3759416|NCT01957111|3592901|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759417|NCT01957111|3592902|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759418|NCT01957111|3592903|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759419|NCT01957111|3592901|B3||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3759420|NCT01957111|3592902|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3759421|NCT01957111|3592903|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3759422|NCT01957111|3592901|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3759423|NCT01957111|3592902|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3759424|NCT01957111|3592903|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3759425|NCT01957111|3592901|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759426|NCT01957111|3592902|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759427|NCT01957111|3592903|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759428|NCT01957111|3592901|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3759429|NCT01957111|3592902|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3759430|NCT01957111|3592903|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3759431|NCT01957111|3592901|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759432|NCT01957111|3592902|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759433|NCT01957111|3592903|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759434|NCT01957111|3592901|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759435|NCT01957111|3592902|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759436|NCT01957111|3592903|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759437|NCT01957111|3592901|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3759438|NCT01957111|3592902|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3759439|NCT01957111|3592903|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3759440|NCT01957111|3592901|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3759441|NCT01957111|3592902|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3759442|NCT01957111|3592903|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3759443|NCT01957111|3592901|B3||Male|Gender||Participants|Count of Participants|10|10.0||||||
3759444|NCT01957111|3592902|B2||Male|Gender||Participants|Count of Participants|5|5.0||||||
3759445|NCT01957111|3592903|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
3759446|NCT01957111|3592901|B3||Female|Gender||Participants|Count of Participants|20|20.0||||||
3759447|NCT01957111|3592902|B2||Female|Gender||Participants|Count of Participants|10|10.0||||||
3759448|NCT01957111|3592903|B1||Female|Gender||Participants|Count of Participants|10|10.0||||||
3759449|NCT01957111|3592901|B3|||Age||years|Mean|36.5|36.5|Standard Deviation|7.7|7.7|||
3759450|NCT01957111|3592902|B2|||Age||years|Mean|36.0|36.0|Standard Deviation|7.5|7.5|||
3759451|NCT01957111|3592903|B1|||Age||years|Mean|37.0|37.0|Standard Deviation|7.9|7.9|||
3759452|NCT01956435|3592912|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3759453|NCT01956435|3592912|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759454|NCT01956435|3592912|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759455|NCT01956435|3592912|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3759456|NCT01956435|3592912|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3759457|NCT01956435|3592912|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759458|NCT01956435|3592912|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759459|NCT01956435|3592912|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759460|NCT01956435|3592912|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3759461|NCT01956435|3592912|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3759462|NCT01956435|3592912|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3759463|NCT01956435|3592912|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3759464|NCT01956435|3592912|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3759465|NCT01956240|3592920|B3|Brazil||Region of Enrollment||participants|Number|97|97.0||||||
3759466|NCT01956240|3592921|B2|Brazil||Region of Enrollment||participants|Number|49|49.0||||||
3759467|NCT01956240|3592922|B1|Brazil||Region of Enrollment||participants|Number|48|48.0||||||
3759468|NCT01956240|3592920|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3759469|NCT01956240|3592921|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3759470|NCT01956240|3592922|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3759471|NCT01956240|3592920|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3759472|NCT01956240|3592921|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3759473|NCT01956240|3592922|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3759474|NCT01956240|3592920|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3759475|NCT01956240|3592921|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3759476|NCT01956240|3592922|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3759477|NCT01956240|3592920|B3||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
3759478|NCT01956240|3592921|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3759479|NCT01956240|3592922|B1||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
3759480|NCT01956240|3592920|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3759481|NCT01956240|3592921|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3759482|NCT01956240|3592922|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3759483|NCT01956123|3592931|B3|COS cycle 3|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3759484|NCT01956123|3592932|B2|COS cycle 3|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3759485|NCT01956123|3592933|B1|COS cycle 3|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3759486|NCT01956123|3592931|B3|COS cycle 3|Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3759487|NCT01956123|3592932|B2|COS cycle 3|Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3759488|NCT01956123|3592933|B1|COS cycle 3|Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3759489|NCT01956123|3592931|B3|COS cycle 2|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3759490|NCT01956123|3592932|B2|COS cycle 2|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3759491|NCT01956123|3592933|B1|COS cycle 2|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3759492|NCT01956123|3592931|B3|COS cycle 2|Female|Sex: Female, Male||Participants|Count of Participants|513|513.0||||||
3759493|NCT01956123|3592932|B2|COS cycle 2|Female|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
3759494|NCT01956123|3592933|B1|COS cycle 2|Female|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
3759495|NCT01956123|3592931|B3|COS cycle 3|>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3759496|NCT01956123|3592932|B2|COS cycle 3|>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3759497|NCT01956123|3592933|B1|COS cycle 3|>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3759498|NCT01956123|3592931|B3|COS cycle 3|Between 18 and 65 years|Age||Participants|Count of Participants|188|188.0||||||
3759499|NCT01956123|3592932|B2|COS cycle 3|Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
3759500|NCT01956123|3592933|B1|COS cycle 3|Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
3759501|NCT01956123|3592931|B3|COS cycle 3|<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3759502|NCT01956123|3592932|B2|COS cycle 3|<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3759503|NCT01956123|3592933|B1|COS cycle 3|<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3759504|NCT01956123|3592931|B3|COS cycle 2|>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3759505|NCT01956123|3592932|B2|COS cycle 2|>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3759506|NCT01956123|3592933|B1|COS cycle 2|>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3759507|NCT01956123|3592931|B3|COS cycle 2|Between 18 and 65 years|Age||Participants|Count of Participants|513|513.0||||||
3759508|NCT01956123|3592932|B2|COS cycle 2|Between 18 and 65 years|Age||Participants|Count of Participants|261|261.0||||||
3759509|NCT01956123|3592933|B1|COS cycle 2|Between 18 and 65 years|Age||Participants|Count of Participants|252|252.0||||||
3759510|NCT01956123|3592931|B3|COS cycle 2|<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3759511|NCT01956123|3592932|B2|COS cycle 2|<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3759512|NCT01956123|3592933|B1|COS cycle 2|<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3759513|NCT01956110|3592986|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3759514|NCT01956110|3592987|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3759515|NCT01956110|3592988|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3759516|NCT01956110|3592986|B3||Female|Sex: Female, Male||Participants|Count of Participants|1326|1326.0||||||
3759517|NCT01956110|3592987|B2||Female|Sex: Female, Male||Participants|Count of Participants|661|661.0||||||
3759518|NCT01956110|3592988|B1||Female|Sex: Female, Male||Participants|Count of Participants|665|665.0||||||
3759519|NCT01956110|3592986|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3759520|NCT01956110|3592987|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3759521|NCT01956110|3592988|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3759522|NCT01956110|3592986|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1326|1326.0||||||
3759523|NCT01956110|3592987|B2||Between 18 and 65 years|Age||Participants|Count of Participants|661|661.0||||||
3759524|NCT01956110|3592988|B1||Between 18 and 65 years|Age||Participants|Count of Participants|665|665.0||||||
3759525|NCT01956110|3592986|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3759526|NCT01956110|3592987|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3759527|NCT01956110|3592988|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3759528|NCT01956097|3593039|B4|Korea, Republic of||Region of Enrollment||participants|Number|75|75.0||||||
3759529|NCT01956097|3593040|B3|Korea, Republic of||Region of Enrollment||participants|Number|15|15.0||||||
3759530|NCT01956097|3593041|B2|Korea, Republic of||Region of Enrollment||participants|Number|30|30.0||||||
3759531|NCT01956097|3593042|B1|Korea, Republic of||Region of Enrollment||participants|Number|30|30.0||||||
3759532|NCT01956097|3593039|B4||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3759533|NCT01956097|3593040|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3759534|NCT01956097|3593041|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3759535|NCT01956097|3593042|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3759536|NCT01956097|3593039|B4||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3759537|NCT01956097|3593040|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3759538|NCT01956097|3593041|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3759539|NCT01956097|3593042|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3759540|NCT01956097|3593039|B4|||Age||years|Mean|40.1|40.1|Standard Deviation|11.7|11.7|||
3759541|NCT01956097|3593040|B3|||Age||years|Mean|40.6|40.6|Standard Deviation|12.7|12.7|||
3759542|NCT01956097|3593041|B2|||Age||years|Mean|42.5|42.5|Standard Deviation|11.2|11.2|||
3759543|NCT01956097|3593042|B1|||Age||years|Mean|37.6|37.6|Standard Deviation|11.7|11.7|||
3759544|NCT01956097|3593039|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3759545|NCT01956097|3593040|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3759546|NCT01956097|3593041|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3759547|NCT01956097|3593042|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3759548|NCT01956097|3593039|B4||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
3759549|NCT01956097|3593040|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3759550|NCT01956097|3593041|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3759551|NCT01956097|3593042|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3759552|NCT01956097|3593039|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3759553|NCT01956097|3593040|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3759554|NCT01956097|3593041|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3759555|NCT01956097|3593042|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3759556|NCT01956032|3593061|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3759557|NCT01956032|3593061|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3759558|NCT01956032|3593061|B1|||Age||Years|Mean|65.5|65.5|Standard Deviation|6.2|6.2|||
3759559|NCT01955954|3593108|B1|United States||Region of Enrollment||participants|Number|69|69.0||||||
3759560|NCT01955954|3593108|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3759561|NCT01955954|3593108|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3759562|NCT01955954|3593108|B1|||Age||years|Mean|36.6|36.6|Standard Deviation|11.0|11.0|||
3759563|NCT01955733|3593117|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3759564|NCT01955733|3593118|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3759565|NCT01955733|3593119|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3759566|NCT01955733|3593120|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3759567|NCT01955733|3593117|B4||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3759568|NCT01955733|3593118|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3759569|NCT01955733|3593119|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3759570|NCT01955733|3593120|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3759571|NCT01955733|3593117|B4|||Age||Years|Mean|55.9|55.9|Standard Deviation|10.38|10.38|||
3759572|NCT01955733|3593118|B3|||Age||Years|Mean|56.8|56.8|Standard Deviation|8.95|8.95|||
3759573|NCT01955733|3593119|B2|||Age||Years|Mean|56.3|56.3|Standard Deviation|11.02|11.02|||
3759574|NCT01955733|3593120|B1|||Age||Years|Mean|54.6|54.6|Standard Deviation|11.23|11.23|||
3759575|NCT01955720|3593142|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3759576|NCT01955720|3593142|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3759577|NCT01955720|3593142|B1|||Age||years|Mean|63.8|63.8|Standard Deviation|9.2|9.2|||
3759578|NCT01955707|3593213|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3759579|NCT01955707|3593214|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3759580|NCT01955707|3593215|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3759581|NCT01955707|3593213|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3759582|NCT01955707|3593214|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3759583|NCT01955707|3593215|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3759584|NCT01955707|3593213|B3|>/= 80 years||Age, Customized||participants|Number|46|46.0||||||
3759585|NCT01955707|3593214|B2|>/= 80 years||Age, Customized||participants|Number|20|20.0||||||
3759586|NCT01955707|3593215|B1|>/= 80 years||Age, Customized||participants|Number|26|26.0||||||
3759587|NCT01955707|3593213|B3|60 to 79 years||Age, Customized||participants|Number|86|86.0||||||
3759588|NCT01955707|3593214|B2|60 to 79 years||Age, Customized||participants|Number|45|45.0||||||
3759589|NCT01955707|3593215|B1|60 to 79 years||Age, Customized||participants|Number|41|41.0||||||
3759590|NCT01955707|3593213|B3|40 to 59 years||Age, Customized||participants|Number|24|24.0||||||
3759591|NCT01955707|3593214|B2|40 to 59 years||Age, Customized||participants|Number|11|11.0||||||
3759592|NCT01955707|3593215|B1|40 to 59 years||Age, Customized||participants|Number|13|13.0||||||
3759593|NCT01955707|3593213|B3|</= 39 years||Age, Customized||participants|Number|5|5.0||||||
3759594|NCT01955707|3593214|B2|</= 39 years||Age, Customized||participants|Number|3|3.0||||||
3759595|NCT01955707|3593215|B1|</= 39 years||Age, Customized||participants|Number|2|2.0||||||
3759596|NCT01955707|3593213|B3|||Age||years|Mean|71.0|71.0|Standard Deviation|12.57|12.57|||
3759597|NCT01955707|3593214|B2|||Age||years|Mean|70.3|70.3|Standard Deviation|13.34|13.34|||
3759598|NCT01955707|3593215|B1|||Age||years|Mean|71.6|71.6|Standard Deviation|11.83|11.83|||
3759599|NCT01955629|3593240|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3759600|NCT01955629|3593240|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3759601|NCT01955629|3593240|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3759602|NCT01955629|3593240|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3759603|NCT01955629|3593240|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3759604|NCT01955564|3593252|B8|United States||Region of Enrollment||participants|Number|54|54.0||||||
3759605|NCT01955564|3593253|B7|United States||Region of Enrollment||participants|Number|6|6.0||||||
3759606|NCT01955564|3593254|B6|United States||Region of Enrollment||participants|Number|6|6.0||||||
3759607|NCT01955564|3593255|B5|United States||Region of Enrollment||participants|Number|6|6.0||||||
3759608|NCT01955564|3593256|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
3759609|NCT01955564|3593257|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3759610|NCT01955564|3593258|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3759611|NCT01955564|3593259|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3759612|NCT01955564|3593252|B8|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3759613|NCT01955564|3593253|B7|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3759614|NCT01955564|3593254|B6|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3759615|NCT01955564|3593255|B5|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3759616|NCT01955564|3593256|B4|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3759617|NCT01955564|3593257|B3|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3759618|NCT01955564|3593258|B2|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3759619|NCT01955564|3593259|B1|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3759620|NCT01955564|3593252|B8|Caucasian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3759621|NCT01955564|3593253|B7|Caucasian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3759622|NCT01955564|3593254|B6|Caucasian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3759623|NCT01955564|3593255|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3759624|NCT01955564|3593256|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3759625|NCT01955564|3593257|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3759626|NCT01955564|3593258|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3759627|NCT01955564|3593259|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3759628|NCT01955564|3593252|B8|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3759629|NCT01955564|3593253|B7|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3759630|NCT01955564|3593254|B6|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3759631|NCT01955564|3593255|B5|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3759632|NCT01955564|3593256|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3759633|NCT01955564|3593257|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3759634|NCT01955564|3593258|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3759635|NCT01955564|3593259|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3759636|NCT01955564|3593252|B8|African American||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3759637|NCT01955564|3593253|B7|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3759638|NCT01955564|3593254|B6|African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3759639|NCT01955564|3593255|B5|African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3759640|NCT01955564|3593256|B4|African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3759641|NCT01955564|3593257|B3|African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3759642|NCT01955564|3593258|B2|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3759643|NCT01955564|3593259|B1|African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3759644|NCT01955564|3593252|B8|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3759645|NCT01955564|3593253|B7|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3759646|NCT01955564|3593254|B6|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3759647|NCT01955564|3593255|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3759648|NCT01955564|3593256|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3759649|NCT01955564|3593257|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3759650|NCT01955564|3593258|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3759651|NCT01955564|3593259|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3759652|NCT01955564|3593252|B8||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3759653|NCT01955564|3593253|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3759654|NCT01955564|3593254|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3759655|NCT01955564|3593255|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3759656|NCT01955564|3593256|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3759657|NCT01955564|3593257|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3759658|NCT01955564|3593258|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3759659|NCT01955564|3593259|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3759660|NCT01955564|3593252|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3759661|NCT01955564|3593253|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3759662|NCT01955564|3593254|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3759663|NCT01955564|3593255|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3759664|NCT01955564|3593256|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3759665|NCT01955564|3593257|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3759666|NCT01955564|3593258|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3759667|NCT01955564|3593259|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3759668|NCT01955564|3593252|B8|18-45||Age, Customized||years|Mean|28.92|28.92|Standard Deviation|3.88|3.88|||
3759669|NCT01955564|3593253|B7|18-45||Age, Customized||years|Mean|24.33|24.33|Standard Deviation|3.56|3.56|||
3759670|NCT01955564|3593254|B6|18-45||Age, Customized||years|Mean|29.50|29.5|Standard Deviation|3.51|3.51|||
3759671|NCT01955564|3593255|B5|18-45||Age, Customized||years|Mean|34.83|34.83|Standard Deviation|5.85|5.85|||
3759672|NCT01955564|3593256|B4|18-45||Age, Customized||years|Mean|30.33|30.33|Standard Deviation|8.12|8.12|||
3759673|NCT01955564|3593257|B3|18-45||Age, Customized||years|Mean|23.83|23.83|Standard Deviation|6.91|6.91|||
3759674|NCT01955564|3593258|B2|18-45||Age, Customized||years|Mean|28.33|28.33|Standard Deviation|6.31|6.31|||
3759675|NCT01955564|3593259|B1|18-45||Age, Customized||years|Mean|31.27|31.27|Standard Deviation|7.71|7.71|||
3759676|NCT01955473|3593293|B6||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3759677|NCT01955473|3593294|B5||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3759678|NCT01955473|3593295|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3759679|NCT01955473|3593296|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3759680|NCT01955473|3593297|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3759681|NCT01955473|3593298|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3759682|NCT01955473|3593293|B6||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3759683|NCT01955473|3593294|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3759684|NCT01955473|3593295|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3759685|NCT01955473|3593296|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3759686|NCT01955473|3593297|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3759687|NCT01955473|3593298|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3759688|NCT01955473|3593293|B6|||Age||years|Mean|61.6|61.6|Standard Deviation|7.03|7.03|||
3759689|NCT01955473|3593294|B5|||Age||years|Mean|61.2|61.2|Standard Deviation|7.20|7.2|||
3759690|NCT01955473|3593295|B4|||Age||years|Mean|59.0|59.0|Standard Deviation|9.32|9.32|||
3759691|NCT01955473|3593296|B3|||Age||years|Mean|66.5|66.5|Standard Deviation|5.96|5.96|||
3759692|NCT01955473|3593297|B2|||Age||years|Mean|62.5|62.5|Standard Deviation|5.09|5.09|||
3759693|NCT01955473|3593298|B1|||Age||years|Mean|59.7|59.7|Standard Deviation|3.51|3.51|||
3759694|NCT01955434|3593456|B1|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3759695|NCT01955434|3593456|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3759696|NCT01955434|3593456|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3759697|NCT01955434|3593456|B1|||Age||years|Median|68.0|68.0|Full Range|||47.0|90.0|
3759698|NCT01955382|3593464|B3|||Parasite density||log10(parasites per microliter)|Mean|4.440|4.44|Standard Deviation|0.2569|0.2569|||
3759699|NCT01955382|3593465|B2|||Parasite density||log10(parasites per microliter)|Mean|4.459|4.459|Standard Deviation|0.2592|0.2592|||
3759700|NCT01955382|3593466|B1|||Parasite density||log10(parasites per microliter)|Mean|4.421|4.421|Standard Deviation|0.2569|0.2569|||
3759701|NCT01955382|3593464|B3|||Temperature||degrees Celsius|Mean|36.41|36.41|Standard Deviation|0.3751|0.3751|||
3759702|NCT01955382|3593465|B2|||Temperature||degrees Celsius|Mean|36.45|36.45|Standard Deviation|0.3988|0.3988|||
3759703|NCT01955382|3593466|B1|||Temperature||degrees Celsius|Mean|36.37|36.37|Standard Deviation|0.3511|0.3511|||
3759704|NCT01955382|3593464|B3|||Hemoglobin concentration||grams per deciliter|Mean|10.54|10.54|Standard Deviation|2.391|2.391|||
3759705|NCT01955382|3593465|B2|||Hemoglobin concentration||grams per deciliter|Mean|10.15|10.15|Standard Deviation|1.047|1.047|||
3759706|NCT01955382|3593466|B1|||Hemoglobin concentration||grams per deciliter|Mean|10.93|10.93|Standard Deviation|3.193|3.193|||
3759707|NCT01955382|3593464|B3|||Weight||Kilograms|Mean|18.59|18.59|Standard Deviation|4.868|4.868|||
3759708|NCT01955382|3593465|B2|||Weight||Kilograms|Mean|17.87|17.87|Standard Deviation|4.568|4.568|||
3759709|NCT01955382|3593466|B1|||Weight||Kilograms|Mean|19.29|19.29|Standard Deviation|5.120|5.12|||
3759710|NCT01955382|3593464|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3759711|NCT01955382|3593465|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3759712|NCT01955382|3593466|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3759713|NCT01955382|3593464|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3759714|NCT01955382|3593465|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3759715|NCT01955382|3593466|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3759716|NCT01955382|3593464|B3|||Age||years|Mean|5.896|5.896|Standard Deviation|2.168|2.168|||
3759717|NCT01955382|3593465|B2|||Age||years|Mean|5.600|5.6|Standard Deviation|2.117|2.117|||
3759718|NCT01955382|3593466|B1|||Age||years|Mean|6.314|6.314|Standard Deviation|2.166|2.166|||
3759719|NCT01955369|3593475|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3759720|NCT01955369|3593475|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3759721|NCT01955369|3593475|B1|||Age||years|Mean|65.8|65.8|Full Range|||23.0|85.0|
3759722|NCT01955161|3593481|B4|||MMSE total score at screening|The Mini Mental State Examination (MMSE) is an 11-item test to assess the cognitive aspects of mental function. The subtests assess orientation, memory, attention, language, and visual construction. The scores for each item is dichotomous (1 = response is correct, 0 = response is incorrect). Total score of the 11 items ranges from 0 to 30 (higher score indicates lower deficit).|units on a scale|Mean|17.4|17.4|Standard Deviation|3.0|3.0|||
3759723|NCT01955161|3593482|B3|||MMSE total score at screening|The Mini Mental State Examination (MMSE) is an 11-item test to assess the cognitive aspects of mental function. The subtests assess orientation, memory, attention, language, and visual construction. The scores for each item is dichotomous (1 = response is correct, 0 = response is incorrect). Total score of the 11 items ranges from 0 to 30 (higher score indicates lower deficit).|units on a scale|Mean|17.4|17.4|Standard Deviation|2.9|2.9|||
3759724|NCT01955161|3593483|B2|||MMSE total score at screening|The Mini Mental State Examination (MMSE) is an 11-item test to assess the cognitive aspects of mental function. The subtests assess orientation, memory, attention, language, and visual construction. The scores for each item is dichotomous (1 = response is correct, 0 = response is incorrect). Total score of the 11 items ranges from 0 to 30 (higher score indicates lower deficit).|units on a scale|Mean|17.2|17.2|Standard Deviation|3.1|3.1|||
3759725|NCT01955161|3593484|B1|||MMSE total score at screening|The Mini Mental State Examination (MMSE) is an 11-item test to assess the cognitive aspects of mental function. The subtests assess orientation, memory, attention, language, and visual construction. The scores for each item is dichotomous (1 = response is correct, 0 = response is incorrect). Total score of the 11 items ranges from 0 to 30 (higher score indicates lower deficit).|units on a scale|Mean|17.4|17.4|Standard Deviation|2.9|2.9|||
3759726|NCT01955161|3593481|B4|Germany||Region of Enrollment||participants|Number|58|58.0||||||
3759727|NCT01955161|3593482|B3|Germany||Region of Enrollment||participants|Number|19|19.0||||||
3759728|NCT01955161|3593483|B2|Germany||Region of Enrollment||participants|Number|22|22.0||||||
3759729|NCT01955161|3593484|B1|Germany||Region of Enrollment||participants|Number|17|17.0||||||
3759730|NCT01955161|3593481|B4|France||Region of Enrollment||participants|Number|46|46.0||||||
3759731|NCT01955161|3593482|B3|France||Region of Enrollment||participants|Number|17|17.0||||||
3759732|NCT01955161|3593483|B2|France||Region of Enrollment||participants|Number|15|15.0||||||
3759733|NCT01955161|3593484|B1|France||Region of Enrollment||participants|Number|14|14.0||||||
3759734|NCT01955161|3593481|B4|Chile||Region of Enrollment||participants|Number|89|89.0||||||
3759735|NCT01955161|3593482|B3|Chile||Region of Enrollment||participants|Number|31|31.0||||||
3759736|NCT01955161|3593483|B2|Chile||Region of Enrollment||participants|Number|30|30.0||||||
3759737|NCT01955161|3593484|B1|Chile||Region of Enrollment||participants|Number|28|28.0||||||
3759738|NCT01955161|3593481|B4|Bulgaria||Region of Enrollment||participants|Number|60|60.0||||||
3759739|NCT01955161|3593482|B3|Bulgaria||Region of Enrollment||participants|Number|19|19.0||||||
3759740|NCT01955161|3593483|B2|Bulgaria||Region of Enrollment||participants|Number|19|19.0||||||
3759741|NCT01955161|3593484|B1|Bulgaria||Region of Enrollment||participants|Number|22|22.0||||||
3759742|NCT01955161|3593481|B4|South Africa||Region of Enrollment||participants|Number|57|57.0||||||
3759743|NCT01955161|3593482|B3|South Africa||Region of Enrollment||participants|Number|20|20.0||||||
3759744|NCT01955161|3593483|B2|South Africa||Region of Enrollment||participants|Number|19|19.0||||||
3759745|NCT01955161|3593484|B1|South Africa||Region of Enrollment||participants|Number|18|18.0||||||
3759746|NCT01955161|3593481|B4|Italy||Region of Enrollment||participants|Number|36|36.0||||||
3759747|NCT01955161|3593482|B3|Italy||Region of Enrollment||participants|Number|11|11.0||||||
3759748|NCT01955161|3593483|B2|Italy||Region of Enrollment||participants|Number|12|12.0||||||
3759749|NCT01955161|3593484|B1|Italy||Region of Enrollment||participants|Number|13|13.0||||||
3759750|NCT01955161|3593481|B4|Poland||Region of Enrollment||participants|Number|73|73.0||||||
3759751|NCT01955161|3593482|B3|Poland||Region of Enrollment||participants|Number|24|24.0||||||
3759752|NCT01955161|3593483|B2|Poland||Region of Enrollment||participants|Number|24|24.0||||||
3759753|NCT01955161|3593484|B1|Poland||Region of Enrollment||participants|Number|25|25.0||||||
3759754|NCT01955161|3593481|B4|Denmark||Region of Enrollment||participants|Number|13|13.0||||||
3759755|NCT01955161|3593482|B3|Denmark||Region of Enrollment||participants|Number|5|5.0||||||
3759756|NCT01955161|3593483|B2|Denmark||Region of Enrollment||participants|Number|4|4.0||||||
3759757|NCT01955161|3593484|B1|Denmark||Region of Enrollment||participants|Number|4|4.0||||||
3759758|NCT01955161|3593481|B4|Belgium||Region of Enrollment||participants|Number|18|18.0||||||
3759759|NCT01955161|3593482|B3|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
3759760|NCT01955161|3593483|B2|Belgium||Region of Enrollment||participants|Number|7|7.0||||||
3759761|NCT01955161|3593484|B1|Belgium||Region of Enrollment||participants|Number|6|6.0||||||
3759762|NCT01955161|3593481|B4|Canada||Region of Enrollment||participants|Number|40|40.0||||||
3759763|NCT01955161|3593482|B3|Canada||Region of Enrollment||participants|Number|13|13.0||||||
3759764|NCT01955161|3593483|B2|Canada||Region of Enrollment||participants|Number|12|12.0||||||
3759765|NCT01955161|3593484|B1|Canada||Region of Enrollment||participants|Number|15|15.0||||||
3759766|NCT01955161|3593481|B4|Spain||Region of Enrollment||participants|Number|60|60.0||||||
3759767|NCT01955161|3593482|B3|Spain||Region of Enrollment||participants|Number|19|19.0||||||
3759768|NCT01955161|3593483|B2|Spain||Region of Enrollment||participants|Number|22|22.0||||||
3759769|NCT01955161|3593484|B1|Spain||Region of Enrollment||participants|Number|19|19.0||||||
3759770|NCT01955161|3593481|B4|Ukraine||Region of Enrollment||participants|Number|61|61.0||||||
3759771|NCT01955161|3593482|B3|Ukraine||Region of Enrollment||participants|Number|20|20.0||||||
3759772|NCT01955161|3593483|B2|Ukraine||Region of Enrollment||participants|Number|20|20.0||||||
3759773|NCT01955161|3593484|B1|Ukraine||Region of Enrollment||participants|Number|21|21.0||||||
3759774|NCT01955161|3593481|B4|United States||Region of Enrollment||participants|Number|130|130.0||||||
3759775|NCT01955161|3593482|B3|United States||Region of Enrollment||participants|Number|43|43.0||||||
3759776|NCT01955161|3593483|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
3759777|NCT01955161|3593484|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
3759778|NCT01955161|3593481|B4|Czech Republic||Region of Enrollment||participants|Number|109|109.0||||||
3759779|NCT01955161|3593482|B3|Czech Republic||Region of Enrollment||participants|Number|38|38.0||||||
3759780|NCT01955161|3593483|B2|Czech Republic||Region of Enrollment||participants|Number|35|35.0||||||
3759781|NCT01955161|3593484|B1|Czech Republic||Region of Enrollment||participants|Number|36|36.0||||||
3759782|NCT01955161|3593481|B4|Romania||Region of Enrollment||participants|Number|10|10.0||||||
3759783|NCT01955161|3593482|B3|Romania||Region of Enrollment||participants|Number|4|4.0||||||
3759784|NCT01955161|3593483|B2|Romania||Region of Enrollment||participants|Number|2|2.0||||||
3759785|NCT01955161|3593484|B1|Romania||Region of Enrollment||participants|Number|4|4.0||||||
3759786|NCT01955161|3593481|B4|Argentina||Region of Enrollment||participants|Number|70|70.0||||||
3759787|NCT01955161|3593482|B3|Argentina||Region of Enrollment||participants|Number|21|21.0||||||
3759788|NCT01955161|3593483|B2|Argentina||Region of Enrollment||participants|Number|25|25.0||||||
3759789|NCT01955161|3593484|B1|Argentina||Region of Enrollment||participants|Number|24|24.0||||||
3759790|NCT01955161|3593481|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3759791|NCT01955161|3593482|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3759792|NCT01955161|3593483|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3759793|NCT01955161|3593484|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3759794|NCT01955161|3593481|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3759795|NCT01955161|3593482|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Information has not been collected
3759796|NCT01955161|3593483|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Information has not been collected
3759797|NCT01955161|3593484|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Information has not been collected
3759798|NCT01955161|3593481|B4||White|Race (NIH/OMB)||Participants|Count of Participants|854|854.0||||||
3759799|NCT01955161|3593482|B3||White|Race (NIH/OMB)||Participants|Count of Participants|284|284.0||||||
3759800|NCT01955161|3593483|B2||White|Race (NIH/OMB)||Participants|Count of Participants|287|287.0||||||
3759801|NCT01955161|3593484|B1||White|Race (NIH/OMB)||Participants|Count of Participants|283|283.0||||||
3759802|NCT01955161|3593481|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3759803|NCT01955161|3593482|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3759804|NCT01955161|3593483|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3759805|NCT01955161|3593484|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3759806|NCT01955161|3593481|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3759807|NCT01955161|3593482|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3759808|NCT01955161|3593483|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3759809|NCT01955161|3593484|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759810|NCT01955161|3593481|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3759811|NCT01955161|3593482|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3759812|NCT01955161|3593483|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3759813|NCT01955161|3593484|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3759814|NCT01955161|3593481|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3759815|NCT01955161|3593482|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Information has not been collected
3759816|NCT01955161|3593483|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Information has not been collected
3759817|NCT01955161|3593484|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Information has not been collected
3759818|NCT01955161|3593481|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|801|801.0||||||
3759819|NCT01955161|3593482|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|267|267.0||||||
3759820|NCT01955161|3593483|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|268|268.0||||||
3759821|NCT01955161|3593484|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|266|266.0||||||
3759822|NCT01955161|3593481|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
3759823|NCT01955161|3593482|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3759824|NCT01955161|3593483|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3759825|NCT01955161|3593484|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3759826|NCT01955161|3593481|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3759827|NCT01955161|3593482|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3759828|NCT01955161|3593483|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3759829|NCT01955161|3593484|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3759830|NCT01955161|3593481|B4||Male|Sex: Female, Male||Participants|Count of Participants|323|323.0||||||
3759831|NCT01955161|3593482|B3||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3759832|NCT01955161|3593483|B2||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3759833|NCT01955161|3593484|B1||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3759834|NCT01955161|3593481|B4||Female|Sex: Female, Male||Participants|Count of Participants|607|607.0||||||
3759835|NCT01955161|3593482|B3||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3759836|NCT01955161|3593483|B2||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
3759837|NCT01955161|3593484|B1||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
3759838|NCT01955161|3593481|B4|||Age||years|Mean|73.8|73.8|Standard Deviation|8.5|8.5|||
3759839|NCT01955161|3593482|B3|||Age||years|Mean|73.7|73.7|Standard Deviation|8.6|8.6|||
3759840|NCT01955161|3593483|B2|||Age||years|Mean|74.0|74.0|Standard Deviation|8.8|8.8|||
3759841|NCT01955161|3593484|B1|||Age||years|Mean|73.8|73.8|Standard Deviation|8.0|8.0|||
3759842|NCT01955122|3593524|B3|Israel||Region of Enrollment||participants|Number|38|38.0||||||
3759843|NCT01955122|3593525|B2|Israel||Region of Enrollment||participants|Number|18|18.0||||||
3759844|NCT01955122|3593526|B1|Israel||Region of Enrollment||participants|Number|20|20.0||||||
3759845|NCT01955122|3593524|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3759846|NCT01955122|3593525|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3759847|NCT01955122|3593526|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3759848|NCT01955122|3593524|B3|Netherlands||Region of Enrollment||participants|Number|70|70.0||||||
3759849|NCT01955122|3593525|B2|Netherlands||Region of Enrollment||participants|Number|36|36.0||||||
3759850|NCT01955122|3593526|B1|Netherlands||Region of Enrollment||participants|Number|34|34.0||||||
3759851|NCT01955122|3593524|B3||Male|Gender||Participants|Count of Participants|71|71.0||||||
3759852|NCT01955122|3593525|B2||Male|Gender||Participants|Count of Participants|41|41.0||||||
3759853|NCT01955122|3593526|B1||Male|Gender||Participants|Count of Participants|30|30.0||||||
3759854|NCT01955122|3593524|B3||Female|Gender||Participants|Count of Participants|45|45.0||||||
3759855|NCT01955122|3593525|B2||Female|Gender||Participants|Count of Participants|16|16.0||||||
3759856|NCT01955122|3593526|B1||Female|Gender||Participants|Count of Participants|29|29.0||||||
3759857|NCT01955122|3593524|B3|||Age||years|Mean|58.7|58.7|Standard Deviation|9.2|9.2|||
3759858|NCT01955122|3593525|B2|||Age||years|Mean|57.9|57.9|Standard Deviation|9.1|9.1|||
3759859|NCT01955122|3593526|B1|||Age||years|Mean|59.6|59.6|Standard Deviation|9.3|9.3|||
3759860|NCT01955122|3593524|B3||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
3759861|NCT01955122|3593525|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3759862|NCT01955122|3593526|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3759863|NCT01955122|3593524|B3||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
3759864|NCT01955122|3593525|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3759865|NCT01955122|3593526|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3759866|NCT01955122|3593524|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3759867|NCT01955122|3593525|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3759868|NCT01955122|3593526|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3759869|NCT01955083|3593545|B3|||B1-Fmean|We calculated the mean sound frequency (Fmean) of the low frequency domain (40 Hz-300 Hz) as 'B1-Fmean'.|Hz|Mean|100.0|100.0|Standard Deviation|26.0|26.0|||
3759870|NCT01955083|3593546|B2|||B1-Fmean|We calculated the mean sound frequency (Fmean) of the low frequency domain (40 Hz-300 Hz) as 'B1-Fmean'.|Hz|Mean|98.0|98.0|Standard Deviation|24.1|24.1|||
3759871|NCT01955083|3593547|B1|||B1-Fmean|We calculated the mean sound frequency (Fmean) of the low frequency domain (40 Hz-300 Hz) as 'B1-Fmean'.|Hz|Mean|101.9|101.9|Standard Deviation|28.4|28.4|||
3759872|NCT01955083|3593545|B3|||B1-Fpeak|We calculated the peak sound frequency (Fpeak) of the low frequency domain (40 Hz-300 Hz) as 'B1-Fpeak'.|Hz|Mean|219.0|219.0|Standard Deviation|46.9|46.9|||
3759873|NCT01955083|3593546|B2|||B1-Fpeak|We calculated the peak sound frequency (Fpeak) of the low frequency domain (40 Hz-300 Hz) as 'B1-Fpeak'.|Hz|Mean|217.3|217.3|Standard Deviation|39.2|39.2|||
3759874|NCT01955083|3593547|B1|||B1-Fpeak|We calculated the peak sound frequency (Fpeak) of the low frequency domain (40 Hz-300 Hz) as 'B1-Fpeak'.|Hz|Mean|220.7|220.7|Standard Deviation|54.8|54.8|||
3759875|NCT01955083|3593545|B3|||B1-Imean|We calculated the mean sound intensity (Imean) of the low frequency domain (40 Hz-300 Hz) as 'B1-Imean'.|dB|Mean|46.0|46.0|Standard Deviation|6.1|6.1|||
3759876|NCT01955083|3593546|B2|||B1-Imean|We calculated the mean sound intensity (Imean) of the low frequency domain (40 Hz-300 Hz) as 'B1-Imean'.|dB|Mean|47.2|47.2|Standard Deviation|4.2|4.2|||
3759877|NCT01955083|3593547|B1|||B1-Imean|We calculated the mean sound intensity (Imean) of the low frequency domain (40 Hz-300 Hz) as 'B1-Imean'.|dB|Mean|44.8|44.8|Standard Deviation|7.5|7.5|||
3759878|NCT01955083|3593545|B3|||B1-Imax|We calculated the maximal sound intensity (Imax) of the low frequency domain (40 Hz-300 Hz) as 'B1-Imax'.|dB|Mean|58.9|58.9|Standard Deviation|10.1|10.1|||
3759879|NCT01955083|3593546|B2|||B1-Imax|We calculated the maximal sound intensity (Imax) of the low frequency domain (40 Hz-300 Hz) as 'B1-Imax'.|dB|Mean|63.8|63.8|Standard Deviation|9.9|9.9|||
3759880|NCT01955083|3593547|B1|||B1-Imax|We calculated the maximal sound intensity (Imax) of the low frequency domain (40 Hz-300 Hz) as 'B1-Imax'.|dB|Mean|53.9|53.9|Standard Deviation|7.8|7.8|||
3759881|NCT01955083|3593545|B3|||B1-SI|We calculated the snoring index (SI) of the low frequency domain (40 Hz-300 Hz) as 'B1-SI'.|event/hour|Mean|113.3|113.3|Standard Deviation|122.2|122.2|||
3759882|NCT01955083|3593546|B2|||B1-SI|We calculated the snoring index (SI) of the low frequency domain (40 Hz-300 Hz) as 'B1-SI'.|event/hour|Mean|113.4|113.4|Standard Deviation|93.5|93.5|||
3759883|NCT01955083|3593547|B1|||B1-SI|We calculated the snoring index (SI) of the low frequency domain (40 Hz-300 Hz) as 'B1-SI'.|event/hour|Mean|113.3|113.3|Standard Deviation|148.9|148.9|||
3759884|NCT01955083|3593545|B3|||Total-Fmean|We calculated the mean sound frequency (Fmean) of the total frequency domain (40 Hz-2,000 Hz) as 'Total-Fmean'.|Hz|Mean|101.9|101.9|Standard Deviation|26.4|26.4|||
3759885|NCT01955083|3593546|B2|||Total-Fmean|We calculated the mean sound frequency (Fmean) of the total frequency domain (40 Hz-2,000 Hz) as 'Total-Fmean'.|Hz|Mean|10.4|10.4|Standard Deviation|22.7|22.7|||
3759886|NCT01955083|3593547|B1|||Total-Fmean|We calculated the mean sound frequency (Fmean) of the total frequency domain (40 Hz-2,000 Hz) as 'Total-Fmean'.|Hz|Mean|102.3|102.3|Standard Deviation|30.4|30.4|||
3759887|NCT01955083|3593545|B3|||Total-Fpeak|We calculated the peak sound frequency (Fpeak) of the total frequency domain (40 Hz-2,000 Hz) as 'Total-Fpeak'.|Hz|Mean|580.3|580.3|Standard Deviation|589.3|589.3|||
3759888|NCT01955083|3593546|B2|||Total-Fpeak|We calculated the peak sound frequency (Fpeak) of the total frequency domain (40 Hz-2,000 Hz) as 'Total-Fpeak'.|Hz|Mean|543.3|543.3|Standard Deviation|593.1|593.1|||
3759889|NCT01955083|3593547|B1|||Total-Fpeak|We calculated the peak sound frequency (Fpeak) of the total frequency domain (40 Hz-2,000 Hz) as 'Total-Fpeak'.|Hz|Mean|617.3|617.3|Standard Deviation|603.8|603.8|||
3759890|NCT01955083|3593545|B3|||Total-Imean|We calculated the mean sound intensity (Imean) of the total frequency domain (40 Hz-2,000 Hz) as 'Total-Imean'.|dB|Mean|49.1|49.1|Standard Deviation|6.6|6.6|||
3759891|NCT01955083|3593546|B2|||Total-Imean|We calculated the mean sound intensity (Imean) of the total frequency domain (40 Hz-2,000 Hz) as 'Total-Imean'.|dB|Mean|50.8|50.8|Standard Deviation|5.0|5.0|||
3759892|NCT01955083|3593547|B1|||Total-Imean|We calculated the mean sound intensity (Imean) of the total frequency domain (40 Hz-2,000 Hz) as 'Total-Imean'.|dB|Mean|47.4|47.4|Standard Deviation|7.6|7.6|||
3759893|NCT01955083|3593545|B3|||Total-Imax|We calculated the maximal sound intensity (Imax) of the total frequency domain (40 Hz-2,000 Hz) as 'Total-Imax'.|dB|Mean|64.3|64.3|Standard Deviation|12.7|12.7|||
3759894|NCT01955083|3593546|B2|||Total-Imax|We calculated the maximal sound intensity (Imax) of the total frequency domain (40 Hz-2,000 Hz) as 'Total-Imax'.|dB|Mean|70.9|70.9|Standard Deviation|13.1|13.1|||
3759895|NCT01955083|3593547|B1|||Total-Imax|We calculated the maximal sound intensity (Imax) of the total frequency domain (40 Hz-2,000 Hz) as 'Total-Imax'.|dB|Mean|57.7|57.7|Standard Deviation|8.2|8.2|||
3759896|NCT01955083|3593545|B3|||Total-SI|We calculated the snoring index (SI) of the total frequency domain (40 Hz-2,000 Hz) as 'Total-SI'.|event/hour|Mean|116.3|116.3|Standard Deviation|122.2|122.2|||
3759897|NCT01955083|3593546|B2|||Total-SI|We calculated the snoring index (SI) of the total frequency domain (40 Hz-2,000 Hz) as 'Total-SI'.|event/hour|Mean|116.3|116.3|Standard Deviation|94.2|94.2|||
3759898|NCT01955083|3593547|B1|||Total-SI|We calculated the snoring index (SI) of the total frequency domain (40 Hz-2,000 Hz) as 'Total-SI'.|event/hour|Mean|116.4|116.4|Standard Deviation|148.6|148.6|||
3759899|NCT01955083|3593545|B3|||SOS|The Mandarin Chinese version of the Snore Outcomes Survey (SOS) questionnaire has been validated and repeatedly used as an outcome measure in obstructive sleep apnea patients. It was comprised of eight Likert-type items to comprehensively evaluate the duration, loudness, and frequency of snoring. The scale of the SOS was normalized from 0 (worst) to 100 (best).|units on a scale|Mean|40.5|40.5|Standard Deviation|8.9|8.9|||
3759900|NCT01955083|3593546|B2|||SOS|The Mandarin Chinese version of the Snore Outcomes Survey (SOS) questionnaire has been validated and repeatedly used as an outcome measure in obstructive sleep apnea patients. It was comprised of eight Likert-type items to comprehensively evaluate the duration, loudness, and frequency of snoring. The scale of the SOS was normalized from 0 (worst) to 100 (best).|units on a scale|Mean|40.4|40.4|Standard Deviation|8.8|8.8|||
3759901|NCT01955083|3593547|B1|||SOS|The Mandarin Chinese version of the Snore Outcomes Survey (SOS) questionnaire has been validated and repeatedly used as an outcome measure in obstructive sleep apnea patients. It was comprised of eight Likert-type items to comprehensively evaluate the duration, loudness, and frequency of snoring. The scale of the SOS was normalized from 0 (worst) to 100 (best).|units on a scale|Mean|40.5|40.5|Standard Deviation|9.4|9.4|||
3759902|NCT01955083|3593545|B3|||VAS|The participants, based on descriptions from their spouse or bed partner, were asked to estimate the severity of their snoring using a 10 cm visual analogue scale (VAS) from 0 (no snoring) to 10 (very severe snoring, bed partner leaves the room).|units on a scale|Mean|7.3|7.3|Standard Deviation|1.9|1.9|||
3759903|NCT01955083|3593546|B2|||VAS|The participants, based on descriptions from their spouse or bed partner, were asked to estimate the severity of their snoring using a 10 cm visual analogue scale (VAS) from 0 (no snoring) to 10 (very severe snoring, bed partner leaves the room).|units on a scale|Mean|7.9|7.9|Standard Deviation|1.7|1.7|||
3759904|NCT01955083|3593547|B1|||VAS|The participants, based on descriptions from their spouse or bed partner, were asked to estimate the severity of their snoring using a 10 cm visual analogue scale (VAS) from 0 (no snoring) to 10 (very severe snoring, bed partner leaves the room).|units on a scale|Mean|6.8|6.8|Standard Deviation|2.0|2.0|||
3759905|NCT01955083|3593545|B3|Taiwan||Region of Enrollment||participants|Number|30|30.0||||||
3759906|NCT01955083|3593546|B2|Taiwan||Region of Enrollment||participants|Number|15|15.0||||||
3759907|NCT01955083|3593547|B1|Taiwan||Region of Enrollment||participants|Number|15|15.0||||||
3759908|NCT01955083|3593545|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3759909|NCT01955083|3593546|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3759910|NCT01955083|3593547|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3759911|NCT01955083|3593545|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3759912|NCT01955083|3593546|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3759913|NCT01955083|3593547|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3759914|NCT01955083|3593545|B3|||Age||years|Mean|36.7|36.7|Standard Deviation|8.6|8.6|||
3759915|NCT01955083|3593546|B2|||Age||years|Mean|38.3|38.3|Standard Deviation|9.7|9.7|||
3759916|NCT01955083|3593547|B1|||Age||years|Mean|35.1|35.1|Standard Deviation|7.3|7.3|||
3759917|NCT01955083|3593545|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3759918|NCT01955083|3593546|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3759919|NCT01955083|3593547|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3759920|NCT01955083|3593545|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3759921|NCT01955083|3593546|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3759922|NCT01955083|3593547|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3759923|NCT01955083|3593545|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3759924|NCT01955083|3593546|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3759925|NCT01955083|3593547|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3759926|NCT01955044|3593578|B4|United States||Region of Enrollment||participants|Number|30|30.0||||||
3759927|NCT01955044|3593579|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3759928|NCT01955044|3593580|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3759929|NCT01955044|3593581|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3759930|NCT01955044|3593578|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3759931|NCT01955044|3593579|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3759932|NCT01955044|3593580|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3759933|NCT01955044|3593581|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3759934|NCT01955044|3593578|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3759935|NCT01955044|3593579|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3759936|NCT01955044|3593580|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3759937|NCT01955044|3593581|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3759938|NCT01955044|3593578|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3759939|NCT01955044|3593579|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3759940|NCT01955044|3593580|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3759941|NCT01955044|3593581|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3759942|NCT01955044|3593578|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3759943|NCT01955044|3593579|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3759944|NCT01955044|3593580|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3759945|NCT01955044|3593581|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3759946|NCT01955044|3593578|B4||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
3759947|NCT01955044|3593579|B3||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
3759948|NCT01955044|3593580|B2||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
3759949|NCT01955044|3593581|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
3759950|NCT01955005|3593594|B3|United States||Region of Enrollment||participants|Number|52|52.0||||||
3759951|NCT01955005|3593595|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3759952|NCT01955005|3593596|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3759953|NCT01955005|3593594|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759954|NCT01955005|3593595|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759955|NCT01955005|3593596|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759956|NCT01955005|3593594|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3759957|NCT01955005|3593595|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759958|NCT01955005|3593596|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3759959|NCT01955005|3593594|B3||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3759960|NCT01955005|3593595|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3759961|NCT01955005|3593596|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3759962|NCT01955005|3593594|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3759963|NCT01955005|3593595|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3759964|NCT01955005|3593596|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759965|NCT01955005|3593594|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759966|NCT01955005|3593595|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759967|NCT01955005|3593596|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759968|NCT01955005|3593594|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759969|NCT01955005|3593595|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759970|NCT01955005|3593596|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759971|NCT01955005|3593594|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759972|NCT01955005|3593595|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759973|NCT01955005|3593596|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3759974|NCT01955005|3593594|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3759975|NCT01955005|3593595|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3759976|NCT01955005|3593596|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3759977|NCT01955005|3593594|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3759978|NCT01955005|3593595|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3759979|NCT01955005|3593596|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3759980|NCT01955005|3593594|B3|||Age||Years|Mean|68.4|68.4|Standard Deviation|6.2|6.2|||
3759981|NCT01955005|3593595|B2|||Age||Years|Mean|68.5|68.5|Standard Deviation|6.4|6.4|||
3759982|NCT01955005|3593596|B1|||Age||Years|Mean|68.4|68.4|Standard Deviation|6.0|6.0|||
3759983|NCT01954771|3593607|B4|||MDRD-eGFR|Modification of Diet in Renal Disease - Estimate glomerular filtration rate (MDRD -eGFR)|ml/min/1.73m²|Median|89.72|89.72|Inter-Quartile Range|||75.54|100.37|
3759984|NCT01954771|3593608|B3|||MDRD-eGFR|Modification of Diet in Renal Disease - Estimate glomerular filtration rate (MDRD -eGFR)|ml/min/1.73m²|Median|93.86|93.86|Inter-Quartile Range|||77.98|110.57|
3759985|NCT01954771|3593609|B2|||MDRD-eGFR|Modification of Diet in Renal Disease - Estimate glomerular filtration rate (MDRD -eGFR)|ml/min/1.73m²|Median|89.66|89.66|Inter-Quartile Range|||75.75|99.8|
3759986|NCT01954771|3593610|B1|||MDRD-eGFR|Modification of Diet in Renal Disease - Estimate glomerular filtration rate (MDRD -eGFR)|ml/min/1.73m²|Median|79.39|79.39|Inter-Quartile Range|||71.6|96.18|
3759987|NCT01954771|3593607|B4|||CKD-EPI -eGFR|Chronic Kidney Disease Epidemiology Collaboration - Estimate glomerular filtration rate (CKD-EPI -eGFR)|ml/min/1.73m²|Median|80.81|80.81|Inter-Quartile Range|||66.88|88.59|
3759988|NCT01954771|3593608|B3|||CKD-EPI -eGFR|Chronic Kidney Disease Epidemiology Collaboration - Estimate glomerular filtration rate (CKD-EPI -eGFR)|ml/min/1.73m²|Median|87.15|87.15|Inter-Quartile Range|||72.93|92.94|
3759989|NCT01954771|3593609|B2|||CKD-EPI -eGFR|Chronic Kidney Disease Epidemiology Collaboration - Estimate glomerular filtration rate (CKD-EPI -eGFR)|ml/min/1.73m²|Median|80.32|80.32|Inter-Quartile Range|||66.73|87.94|
3759990|NCT01954771|3593610|B1|||CKD-EPI -eGFR|Chronic Kidney Disease Epidemiology Collaboration - Estimate glomerular filtration rate (CKD-EPI -eGFR)|ml/min/1.73m²|Median|72.72|72.72|Inter-Quartile Range|||66.81|86.66|
3759991|NCT01954771|3593607|B4|||Urinary albumin ratio(Normal values range from 0-30 mg/g)||mg/g|Median|8.62|8.62|Inter-Quartile Range|||3.84|23.0|
3759992|NCT01954771|3593608|B3|||Urinary albumin ratio(Normal values range from 0-30 mg/g)||mg/g|Median|8.62|8.62|Inter-Quartile Range|||3.34|16.49|
3759993|NCT01954771|3593609|B2|||Urinary albumin ratio(Normal values range from 0-30 mg/g)||mg/g|Median|9.09|9.09|Inter-Quartile Range|||4.4|37.57|
3759994|NCT01954771|3593610|B1|||Urinary albumin ratio(Normal values range from 0-30 mg/g)||mg/g|Median|7.59|7.59|Inter-Quartile Range|||4.4|31.93|
3759995|NCT01954771|3593607|B4|||Creatinine（Normal values range from 59-104 mmol/L for male,45-84 mmol/L for female）||mmol/L|Mean|80.32|80.32|Standard Deviation|16.91|16.91|||
3759996|NCT01954771|3593608|B3|||Creatinine（Normal values range from 59-104 mmol/L for male,45-84 mmol/L for female）||mmol/L|Mean|76.33|76.33|Standard Deviation|18.87|18.87|||
3759997|NCT01954771|3593609|B2|||Creatinine（Normal values range from 59-104 mmol/L for male,45-84 mmol/L for female）||mmol/L|Mean|81.65|81.65|Standard Deviation|16.49|16.49|||
3759998|NCT01954771|3593610|B1|||Creatinine（Normal values range from 59-104 mmol/L for male,45-84 mmol/L for female）||mmol/L|Mean|82.71|82.71|Standard Deviation|15.20|15.2|||
3759999|NCT01954771|3593607|B4|||Blood urea nitrogen（Normal values range from 2.8-7.2 mmol/L）||mmol/L|Mean|5.9|5.9|Standard Deviation|1.4|1.4|||
3760000|NCT01954771|3593608|B3|||Blood urea nitrogen（Normal values range from 2.8-7.2 mmol/L）||mmol/L|Mean|6.0|6.0|Standard Deviation|1.4|1.4|||
3760001|NCT01954771|3593609|B2|||Blood urea nitrogen（Normal values range from 2.8-7.2 mmol/L）||mmol/L|Mean|6.2|6.2|Standard Deviation|1.4|1.4|||
3760002|NCT01954771|3593610|B1|||Blood urea nitrogen（Normal values range from 2.8-7.2 mmol/L）||mmol/L|Mean|5.6|5.6|Standard Deviation|1.4|1.4|||
3760003|NCT01954771|3593607|B4|||LDL-C (1.27-3.12 for normal; ＜2.59 at high risk factors; ＜1.80 at very high risk factors)||mmol/L|Median|2.02|2.02|Inter-Quartile Range|||1.59|2.68|
3760004|NCT01954771|3593608|B3|||LDL-C (1.27-3.12 for normal; ＜2.59 at high risk factors; ＜1.80 at very high risk factors)||mmol/L|Median|1.85|1.85|Inter-Quartile Range|||1.46|2.38|
3760005|NCT01954771|3593609|B2|||LDL-C (1.27-3.12 for normal; ＜2.59 at high risk factors; ＜1.80 at very high risk factors)||mmol/L|Median|2.17|2.17|Inter-Quartile Range|||1.72|2.91|
3760006|NCT01954771|3593610|B1|||LDL-C (1.27-3.12 for normal; ＜2.59 at high risk factors; ＜1.80 at very high risk factors)||mmol/L|Median|2.22|2.22|Inter-Quartile Range|||1.77|2.78|
3760007|NCT01954771|3593607|B4|||High density lipoprotein cholesterol(Normal values range from 1.04-1.55 mmol/L)||mmol/L|Median|1.11|1.11|Inter-Quartile Range|||0.98|1.28|
3760008|NCT01954771|3593608|B3|||High density lipoprotein cholesterol(Normal values range from 1.04-1.55 mmol/L)||mmol/L|Median|1.12|1.12|Inter-Quartile Range|||1.0|1.27|
3760009|NCT01954771|3593609|B2|||High density lipoprotein cholesterol(Normal values range from 1.04-1.55 mmol/L)||mmol/L|Median|1.13|1.13|Inter-Quartile Range|||0.98|1.43|
3760010|NCT01954771|3593610|B1|||High density lipoprotein cholesterol(Normal values range from 1.04-1.55 mmol/L)||mmol/L|Median|1.09|1.09|Inter-Quartile Range|||0.94|1.24|
3760011|NCT01954771|3593607|B4|||Total cholesterol(Normal values range from 3.1-5.2 mmol/L)||mmol/L|Median|3.85|3.85|Inter-Quartile Range|||3.27|4.48|
3760012|NCT01954771|3593608|B3|||Total cholesterol(Normal values range from 3.1-5.2 mmol/L)||mmol/L|Median|3.46|3.46|Inter-Quartile Range|||3.2|4.09|
3760013|NCT01954771|3593609|B2|||Total cholesterol(Normal values range from 3.1-5.2 mmol/L)||mmol/L|Median|4.01|4.01|Inter-Quartile Range|||3.34|4.89|
3760014|NCT01954771|3593610|B1|||Total cholesterol(Normal values range from 3.1-5.2 mmol/L)||mmol/L|Median|3.88|3.88|Inter-Quartile Range|||3.4|4.72|
3760015|NCT01954771|3593607|B4|||Triglyceride(Normal values range from 0-1.7 mmol/L)||mmol/L|Median|1.24|1.24|Inter-Quartile Range|||0.79|1.63|
3760016|NCT01954771|3593608|B3|||Triglyceride(Normal values range from 0-1.7 mmol/L)||mmol/L|Median|1.12|1.12|Inter-Quartile Range|||1.0|1.27|
3760017|NCT01954771|3593609|B2|||Triglyceride(Normal values range from 0-1.7 mmol/L)||mmol/L|Median|1.15|1.15|Inter-Quartile Range|||0.74|1.86|
3760018|NCT01954771|3593610|B1|||Triglyceride(Normal values range from 0-1.7 mmol/L)||mmol/L|Median|1.35|1.35|Inter-Quartile Range|||1.23|1.81|
3760019|NCT01954771|3593607|B4|||Insulin(Normal values range from 2.08-10.9 μU/ml)||μU/ml|Median|9.0|9.0|Inter-Quartile Range|||5.6|13.4|
3760020|NCT01954771|3593608|B3|||Insulin(Normal values range from 2.08-10.9 μU/ml)||μU/ml|Median|8.1|8.1|Inter-Quartile Range|||5.1|15.3|
3760021|NCT01954771|3593609|B2|||Insulin(Normal values range from 2.08-10.9 μU/ml)||μU/ml|Median|9.2|9.2|Inter-Quartile Range|||7.1|12.6|
3760022|NCT01954771|3593610|B1|||Insulin(Normal values range from 2.08-10.9 μU/ml)||μU/ml|Median|8.8|8.8|Inter-Quartile Range|||6.0|13.0|
3760023|NCT01954771|3593607|B4|||C-peptid(Normal values range from 0.78-5.19 ng/ml)||ng/ml|Median|1.97|1.97|Inter-Quartile Range|||1.39|2.56|
3760024|NCT01954771|3593608|B3|||C-peptid(Normal values range from 0.78-5.19 ng/ml)||ng/ml|Median|1.87|1.87|Inter-Quartile Range|||1.17|2.79|
3760025|NCT01954771|3593609|B2|||C-peptid(Normal values range from 0.78-5.19 ng/ml)||ng/ml|Median|2.00|2.0|Inter-Quartile Range|||1.3|2.58|
3760026|NCT01954771|3593610|B1|||C-peptid(Normal values range from 0.78-5.19 ng/ml)||ng/ml|Median|1.94|1.94|Inter-Quartile Range|||1.69|2.5|
3760027|NCT01954771|3593607|B4|||Fasting glucose(Normal values range from 3.9-6.1 mmol/L)||mmol/L|Median|7.4|7.4|Inter-Quartile Range|||6.2|8.4|
3760028|NCT01954771|3593608|B3|||Fasting glucose(Normal values range from 3.9-6.1 mmol/L)||mmol/L|Median|7.5|7.5|Inter-Quartile Range|||6.3|8.2|
3760029|NCT01954771|3593609|B2|||Fasting glucose(Normal values range from 3.9-6.1 mmol/L)||mmol/L|Median|6.5|6.5|Inter-Quartile Range|||5.7|8.4|
3760030|NCT01954771|3593610|B1|||Fasting glucose(Normal values range from 3.9-6.1 mmol/L)||mmol/L|Median|7.6|7.6|Inter-Quartile Range|||6.8|8.7|
3760031|NCT01954771|3593607|B4|||Hemoglobin(Normal values range from 130-175 g/L)||g/L|Median|141.0|141.0|Inter-Quartile Range|||133.0|148.0|
3760032|NCT01954771|3593608|B3|||Hemoglobin(Normal values range from 130-175 g/L)||g/L|Median|143.0|143.0|Inter-Quartile Range|||131.0|147.8|
3760033|NCT01954771|3593609|B2|||Hemoglobin(Normal values range from 130-175 g/L)||g/L|Median|139.5|139.5|Inter-Quartile Range|||121.5|142.3|
3760034|NCT01954771|3593610|B1|||Hemoglobin(Normal values range from 130-175 g/L)||g/L|Median|139.0|139.0|Inter-Quartile Range|||134.0|148.0|
3760035|NCT01954771|3593607|B4|||Glycated hemoglobin(Normal values range from 4-6 percent)||percent|Median|6.8|6.8|Inter-Quartile Range|||6.4|7.5|
3760036|NCT01954771|3593608|B3|||Glycated hemoglobin(Normal values range from 4-6 percent)||percent|Median|6.8|6.8|Inter-Quartile Range|||6.3|7.9|
3760037|NCT01954771|3593609|B2|||Glycated hemoglobin(Normal values range from 4-6 percent)||percent|Median|6.8|6.8|Inter-Quartile Range|||6.5|7.1|
3760038|NCT01954771|3593610|B1|||Glycated hemoglobin(Normal values range from 4-6 percent)||percent|Median|7.0|7.0|Inter-Quartile Range|||6.4|7.9|
3760039|NCT01954771|3593607|B4|||Body mass index||kg/m²|Median|26.1|26.1|Inter-Quartile Range|||23.3|28.4|
3760040|NCT01954771|3593608|B3|||Body mass index||kg/m²|Median|26.3|26.3|Inter-Quartile Range|||23.8|30.2|
3760041|NCT01954771|3593609|B2|||Body mass index||kg/m²|Median|26.1|26.1|Inter-Quartile Range|||23.3|28.6|
3760042|NCT01954771|3593610|B1|||Body mass index||kg/m²|Median|26.1|26.1|Inter-Quartile Range|||23.3|28.5|
3760043|NCT01954771|3593607|B4|||Heart rate||beats per minute|Median|67.0|67.0|Inter-Quartile Range|||62.0|74.0|
3760044|NCT01954771|3593608|B3|||Heart rate||beats per minute|Median|66.0|66.0|Inter-Quartile Range|||60.0|71.8|
3760045|NCT01954771|3593609|B2|||Heart rate||beats per minute|Median|72.0|72.0|Inter-Quartile Range|||64.0|75.0|
3760046|NCT01954771|3593610|B1|||Heart rate||beats per minute|Median|66.0|66.0|Inter-Quartile Range|||59.3|79.0|
3760047|NCT01954771|3593607|B4|||Diastolic blood pressure||mmHg|Median|67.0|67.0|Inter-Quartile Range|||61.3|78.8|
3760048|NCT01954771|3593608|B3|||Diastolic blood pressure||mmHg|Median|68.0|68.0|Inter-Quartile Range|||60.5|80.0|
3760049|NCT01954771|3593609|B2|||Diastolic blood pressure||mmHg|Median|65.5|65.5|Inter-Quartile Range|||60.3|78.8|
3760050|NCT01954771|3593610|B1|||Diastolic blood pressure||mmHg|Median|68.0|68.0|Inter-Quartile Range|||62.0|73.0|
3760051|NCT01954771|3593607|B4|||Systolic blood pressure||mmHg|Median|128.0|128.0|Inter-Quartile Range|||118.5|136.5|
3760052|NCT01954771|3593608|B3|||Systolic blood pressure||mmHg|Median|127.0|127.0|Inter-Quartile Range|||116.0|132.5|
3760053|NCT01954771|3593609|B2|||Systolic blood pressure||mmHg|Median|129.0|129.0|Inter-Quartile Range|||121.5|142.3|
3760054|NCT01954771|3593610|B1|||Systolic blood pressure||mmHg|Median|125.0|125.0|Inter-Quartile Range|||115.0|136.5|
3760055|NCT01954771|3593607|B4|no||β-blocker||participants|Number|35|35.0||||||
3760056|NCT01954771|3593608|B3|no||β-blocker||participants|Number|11|11.0||||||
3760057|NCT01954771|3593609|B2|no||β-blocker||participants|Number|15|15.0||||||
3760058|NCT01954771|3593610|B1|no||β-blocker||participants|Number|9|9.0||||||
3760059|NCT01954771|3593607|B4|yes||β-blocker||participants|Number|54|54.0||||||
3760060|NCT01954771|3593608|B3|yes||β-blocker||participants|Number|17|17.0||||||
3760061|NCT01954771|3593609|B2|yes||β-blocker||participants|Number|17|17.0||||||
3760062|NCT01954771|3593610|B1|yes||β-blocker||participants|Number|20|20.0||||||
3760063|NCT01954771|3593607|B4|no||Statins||participants|Number|11|11.0||||||
3760064|NCT01954771|3593608|B3|no||Statins||participants|Number|3|3.0||||||
3760065|NCT01954771|3593609|B2|no||Statins||participants|Number|6|6.0||||||
3760066|NCT01954771|3593610|B1|no||Statins||participants|Number|2|2.0||||||
3760067|NCT01954771|3593607|B4|yes||Statins||participants|Number|78|78.0||||||
3760068|NCT01954771|3593608|B3|yes||Statins||participants|Number|25|25.0||||||
3760069|NCT01954771|3593609|B2|yes||Statins||participants|Number|26|26.0||||||
3760070|NCT01954771|3593610|B1|yes||Statins||participants|Number|27|27.0||||||
3760071|NCT01954771|3593607|B4|no||Other Oral Anti-diabetic Drugs||participants|Number|13|13.0||||||
3760072|NCT01954771|3593608|B3|no||Other Oral Anti-diabetic Drugs||participants|Number|3|3.0||||||
3760073|NCT01954771|3593609|B2|no||Other Oral Anti-diabetic Drugs||participants|Number|5|5.0||||||
3760074|NCT01954771|3593610|B1|no||Other Oral Anti-diabetic Drugs||participants|Number|5|5.0||||||
3760075|NCT01954771|3593607|B4|yes||Other Oral Anti-diabetic Drugs||participants|Number|76|76.0||||||
3760076|NCT01954771|3593608|B3|yes||Other Oral Anti-diabetic Drugs||participants|Number|25|25.0||||||
3760077|NCT01954771|3593609|B2|yes||Other Oral Anti-diabetic Drugs||participants|Number|27|27.0||||||
3760078|NCT01954771|3593610|B1|yes||Other Oral Anti-diabetic Drugs||participants|Number|24|24.0||||||
3760079|NCT01954771|3593607|B4|no||Insulin secretagogues|include sulfonylureas and glinides|participants|Number|48|48.0||||||
3760080|NCT01954771|3593608|B3|no||Insulin secretagogues|include sulfonylureas and glinides|participants|Number|12|12.0||||||
3760081|NCT01954771|3593609|B2|no||Insulin secretagogues|include sulfonylureas and glinides|participants|Number|19|19.0||||||
3760082|NCT01954771|3593610|B1|no||Insulin secretagogues|include sulfonylureas and glinides|participants|Number|17|17.0||||||
3760083|NCT01954771|3593607|B4|yes||Insulin secretagogues|include sulfonylureas and glinides|participants|Number|41|41.0||||||
3760084|NCT01954771|3593608|B3|yes||Insulin secretagogues|include sulfonylureas and glinides|participants|Number|16|16.0||||||
3760085|NCT01954771|3593609|B2|yes||Insulin secretagogues|include sulfonylureas and glinides|participants|Number|13|13.0||||||
3760086|NCT01954771|3593610|B1|yes||Insulin secretagogues|include sulfonylureas and glinides|participants|Number|12|12.0||||||
3760087|NCT01954771|3593607|B4||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3760088|NCT01954771|3593608|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3760089|NCT01954771|3593609|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3760090|NCT01954771|3593610|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3760091|NCT01954771|3593607|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3760092|NCT01954771|3593608|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3760093|NCT01954771|3593609|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3760094|NCT01954771|3593610|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3760095|NCT01954771|3593607|B4|||Age||years|Median|69.0|69.0|Inter-Quartile Range|||66.0|73.0|
3760096|NCT01954771|3593608|B3|||Age||years|Median|67.0|67.0|Inter-Quartile Range|||65.0|70.0|
3760097|NCT01954771|3593609|B2|||Age||years|Median|70.5|70.5|Inter-Quartile Range|||67.0|74.0|
3760098|NCT01954771|3593610|B1|||Age||years|Median|71.0|71.0|Inter-Quartile Range|||66.0|73.0|
3760099|NCT01954745|3593629|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3760100|NCT01954745|3593629|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
3760101|NCT01954745|3593629|B1||Female|Gender||Participants|Count of Participants|13|13.0||||||
3760102|NCT01954745|3593629|B1|||Age||years|Median|67|67.0|Full Range|||45.0|74.0|
3760103|NCT01954745|3593629|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3760104|NCT01954745|3593629|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3760105|NCT01954745|3593629|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3760106|NCT01954628|3593636|B3|||Post-bronchodilator FEV1% of Predicted||percent predicted|Mean|50.6|50.6|Standard Deviation|13.5|13.5|||
3760107|NCT01954628|3593637|B2|||Post-bronchodilator FEV1% of Predicted||percent predicted|Mean|50.9|50.9|Standard Deviation|13.2|13.2|||
3760108|NCT01954628|3593638|B1|||Post-bronchodilator FEV1% of Predicted||percent predicted|Mean|50.2|50.2|Standard Deviation|13.9|13.9|||
3760109|NCT01954628|3593636|B3|||Post-bronchodilator FEV1/FVC Ratio||ratio|Mean|0.52|0.52|Standard Deviation|0.11|0.11|||
3760110|NCT01954628|3593637|B2|||Post-bronchodilator FEV1/FVC Ratio||ratio|Mean|0.52|0.52|Standard Deviation|0.11|0.11|||
3760111|NCT01954628|3593638|B1|||Post-bronchodilator FEV1/FVC Ratio||ratio|Mean|0.51|0.51|Standard Deviation|0.11|0.11|||
3760112|NCT01954628|3593636|B3|No||Nicotine Replacement Therapy Use||participants|Number|9|9.0||||||
3760113|NCT01954628|3593637|B2|No||Nicotine Replacement Therapy Use||participants|Number|5|5.0||||||
3760114|NCT01954628|3593638|B1|No||Nicotine Replacement Therapy Use||participants|Number|4|4.0||||||
3760115|NCT01954628|3593636|B3|Yes||Nicotine Replacement Therapy Use||participants|Number|391|391.0||||||
3760116|NCT01954628|3593637|B2|Yes||Nicotine Replacement Therapy Use||participants|Number|195|195.0||||||
3760117|NCT01954628|3593638|B1|Yes||Nicotine Replacement Therapy Use||participants|Number|196|196.0||||||
3760118|NCT01954628|3593636|B3|||Smoking Pack Years||pYears|Mean|40.7|40.7|Standard Deviation|21.4|21.4|||
3760119|NCT01954628|3593637|B2|||Smoking Pack Years||pYears|Mean|41.2|41.2|Standard Deviation|20.9|20.9|||
3760120|NCT01954628|3593638|B1|||Smoking Pack Years||pYears|Mean|40.2|40.2|Standard Deviation|22.0|22.0|||
3760121|NCT01954628|3593636|B3|Former Smoker||Smoking Status||participants|Number|228|228.0||||||
3760122|NCT01954628|3593637|B2|Former Smoker||Smoking Status||participants|Number|97|97.0||||||
3760123|NCT01954628|3593638|B1|Former Smoker||Smoking Status||participants|Number|131|131.0||||||
3760124|NCT01954628|3593636|B3|Current Smokers||Smoking Status||participants|Number|172|172.0||||||
3760125|NCT01954628|3593637|B2|Current Smokers||Smoking Status||participants|Number|103|103.0||||||
3760126|NCT01954628|3593638|B1|Current Smokers||Smoking Status||participants|Number|69|69.0||||||
3760127|NCT01954628|3593636|B3|||Years Since COPD Diagnosis||years|Mean|8.0|8.0|Standard Deviation|5.8|5.8|||
3760128|NCT01954628|3593637|B2|||Years Since COPD Diagnosis||years|Mean|7.8|7.8|Standard Deviation|5.9|5.9|||
3760129|NCT01954628|3593638|B1|||Years Since COPD Diagnosis||years|Mean|8.2|8.2|Standard Deviation|5.7|5.7|||
3760130|NCT01954628|3593636|B3|||Number of Previous Hospitalizations for COPD||number of previous hospitlizations|Mean|1.0|1.0|Standard Deviation|2.4|2.4|||
3760131|NCT01954628|3593637|B2|||Number of Previous Hospitalizations for COPD||number of previous hospitlizations|Mean|0.9|0.9|Standard Deviation|1.6|1.6|||
3760132|NCT01954628|3593638|B1|||Number of Previous Hospitalizations for COPD||number of previous hospitlizations|Mean|1.1|1.1|Standard Deviation|3.0|3.0|||
3760133|NCT01954628|3593636|B3|||Number of COPD Exacerbations in Last 18 months||number of exacerbations/18 months|Mean|3.1|3.1|Standard Deviation|1.5|1.5|||
3760134|NCT01954628|3593637|B2|||Number of COPD Exacerbations in Last 18 months||number of exacerbations/18 months|Mean|3.0|3.0|Standard Deviation|1.4|1.4|||
3760135|NCT01954628|3593638|B1|||Number of COPD Exacerbations in Last 18 months||number of exacerbations/18 months|Mean|3.1|3.1|Standard Deviation|1.7|1.7|||
3760136|NCT01954628|3593636|B3|||Body Mass Index||kg/m2|Mean|27.6|27.6|Standard Deviation|6.3|6.3|||
3760137|NCT01954628|3593637|B2|||Body Mass Index||kg/m2|Mean|27.2|27.2|Standard Deviation|6.1|6.1|||
3760138|NCT01954628|3593638|B1|||Body Mass Index||kg/m2|Mean|28.1|28.1|Standard Deviation|6.6|6.6|||
3760139|NCT01954628|3593636|B3|Australia||Region of Enrollment||participants|Number|16|16.0||||||
3760140|NCT01954628|3593637|B2|Australia||Region of Enrollment||participants|Number|9|9.0||||||
3760141|NCT01954628|3593638|B1|Australia||Region of Enrollment||participants|Number|7|7.0||||||
3760142|NCT01954628|3593636|B3|Poland||Region of Enrollment||participants|Number|156|156.0||||||
3760143|NCT01954628|3593637|B2|Poland||Region of Enrollment||participants|Number|75|75.0||||||
3760144|NCT01954628|3593638|B1|Poland||Region of Enrollment||participants|Number|81|81.0||||||
3760145|NCT01954628|3593636|B3|Denmark||Region of Enrollment||participants|Number|26|26.0||||||
3760146|NCT01954628|3593637|B2|Denmark||Region of Enrollment||participants|Number|13|13.0||||||
3760147|NCT01954628|3593638|B1|Denmark||Region of Enrollment||participants|Number|13|13.0||||||
3760148|NCT01954628|3593636|B3|Finland||Region of Enrollment||participants|Number|8|8.0||||||
3760149|NCT01954628|3593637|B2|Finland||Region of Enrollment||participants|Number|3|3.0||||||
3760150|NCT01954628|3593638|B1|Finland||Region of Enrollment||participants|Number|5|5.0||||||
3760151|NCT01954628|3593636|B3|United States||Region of Enrollment||participants|Number|104|104.0||||||
3760152|NCT01954628|3593637|B2|United States||Region of Enrollment||participants|Number|53|53.0||||||
3760153|NCT01954628|3593638|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
3760154|NCT01954628|3593636|B3|Hungary||Region of Enrollment||participants|Number|83|83.0||||||
3760155|NCT01954628|3593637|B2|Hungary||Region of Enrollment||participants|Number|43|43.0||||||
3760156|NCT01954628|3593638|B1|Hungary||Region of Enrollment||participants|Number|40|40.0||||||
3760157|NCT01954628|3593636|B3|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
3760158|NCT01954628|3593637|B2|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
3760159|NCT01954628|3593638|B1|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
3760160|NCT01954628|3593636|B3|New Zealand||Region of Enrollment||participants|Number|6|6.0||||||
3760161|NCT01954628|3593637|B2|New Zealand||Region of Enrollment||participants|Number|3|3.0||||||
3760162|NCT01954628|3593638|B1|New Zealand||Region of Enrollment||participants|Number|3|3.0||||||
3760163|NCT01954628|3593636|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760164|NCT01954628|3593637|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760165|NCT01954628|3593638|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760166|NCT01954628|3593636|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3760167|NCT01954628|3593637|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3760168|NCT01954628|3593638|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3760169|NCT01954628|3593636|B3||White|Race (NIH/OMB)||Participants|Count of Participants|377|377.0||||||
3760170|NCT01954628|3593637|B2||White|Race (NIH/OMB)||Participants|Count of Participants|189|189.0||||||
3760171|NCT01954628|3593638|B1||White|Race (NIH/OMB)||Participants|Count of Participants|188|188.0||||||
3760172|NCT01954628|3593636|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3760173|NCT01954628|3593637|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3760174|NCT01954628|3593638|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3760175|NCT01954628|3593636|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760176|NCT01954628|3593637|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760177|NCT01954628|3593638|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760178|NCT01954628|3593636|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760179|NCT01954628|3593637|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760180|NCT01954628|3593638|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760181|NCT01954628|3593636|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760182|NCT01954628|3593637|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760183|NCT01954628|3593638|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760184|NCT01954628|3593636|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3760185|NCT01954628|3593637|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3760186|NCT01954628|3593638|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3760187|NCT01954628|3593636|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|386|386.0||||||
3760188|NCT01954628|3593637|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|193|193.0||||||
3760189|NCT01954628|3593638|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|193|193.0||||||
3760190|NCT01954628|3593636|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3760191|NCT01954628|3593637|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3760192|NCT01954628|3593638|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3760193|NCT01954628|3593636|B3||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
3760194|NCT01954628|3593637|B2||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3760195|NCT01954628|3593638|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3760196|NCT01954628|3593636|B3||Female|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
3760197|NCT01954628|3593637|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3760198|NCT01954628|3593638|B1||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3760199|NCT01954628|3593636|B3|||Age||years|Mean|65.1|65.1|Standard Deviation|8.4|8.4|||
3760200|NCT01954628|3593637|B2|||Age||years|Mean|64.4|64.4|Standard Deviation|8.5|8.5|||
3760201|NCT01954628|3593638|B1|||Age||years|Mean|65.8|65.8|Standard Deviation|8.2|8.2|||
3760202|NCT01954394|3593658|B3|||Calculated LDL-C in mmol/L|This parameter was evaluated at the baseline in the parent study (EFC12492, R727-CL-1112, EFC12732 or LTS11717).|mmol/L|Mean|3.936|3.936|Standard Deviation|1.379|1.379|||
3760203|NCT01954394|3593659|B2|||Calculated LDL-C in mmol/L|This parameter was evaluated at the baseline in the parent study (EFC12492, R727-CL-1112, EFC12732 or LTS11717).|mmol/L|Mean|3.977|3.977|Standard Deviation|1.432|1.432|||
3760204|NCT01954394|3593660|B1|||Calculated LDL-C in mmol/L|This parameter was evaluated at the baseline in the parent study (EFC12492, R727-CL-1112, EFC12732 or LTS11717).|mmol/L|Mean|3.854|3.854|Standard Deviation|1.265|1.265|||
3760205|NCT01954394|3593658|B3|||Calculated LDL-C in mg/dL|Calculated LDL-C in mg/dL from Friedewald formula (LDL-C = Total cholesterol - High-density lipoprotein cholesterol - [Triglyceride/5]). This parameter was evaluated at the baseline in the parent study (EFC12492, R727-CL-1112, EFC12732 or LTS11717).|mg/dL|Mean|152.0|152.0|Standard Deviation|53.2|53.2|||
3760206|NCT01954394|3593659|B2|||Calculated LDL-C in mg/dL|Calculated LDL-C in mg/dL from Friedewald formula (LDL-C = Total cholesterol - High-density lipoprotein cholesterol - [Triglyceride/5]). This parameter was evaluated at the baseline in the parent study (EFC12492, R727-CL-1112, EFC12732 or LTS11717).|mg/dL|Mean|153.5|153.5|Standard Deviation|55.3|55.3|||
3760207|NCT01954394|3593660|B1|||Calculated LDL-C in mg/dL|Calculated LDL-C in mg/dL from Friedewald formula (LDL-C = Total cholesterol - High-density lipoprotein cholesterol - [Triglyceride/5]). This parameter was evaluated at the baseline in the parent study (EFC12492, R727-CL-1112, EFC12732 or LTS11717).|mg/dL|Mean|148.8|148.8|Standard Deviation|48.8|48.8|||
3760208|NCT01954394|3593658|B3|Black or African American/Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3760209|NCT01954394|3593659|B2|Black or African American/Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3760210|NCT01954394|3593660|B1|Black or African American/Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3760211|NCT01954394|3593658|B3|White/American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3760212|NCT01954394|3593659|B2|White/American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3760213|NCT01954394|3593660|B1|White/American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3760214|NCT01954394|3593658|B3|White/Asian||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3760215|NCT01954394|3593659|B2|White/Asian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3760216|NCT01954394|3593660|B1|White/Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3760217|NCT01954394|3593658|B3|White/Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3760218|NCT01954394|3593659|B2|White/Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3760219|NCT01954394|3593660|B1|White/Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3760220|NCT01954394|3593658|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3760221|NCT01954394|3593659|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3760222|NCT01954394|3593660|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3760223|NCT01954394|3593658|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3760224|NCT01954394|3593659|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3760225|NCT01954394|3593660|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3760226|NCT01954394|3593658|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3760227|NCT01954394|3593659|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3760228|NCT01954394|3593660|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3760229|NCT01954394|3593658|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3760230|NCT01954394|3593659|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3760231|NCT01954394|3593660|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3760232|NCT01954394|3593658|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3760233|NCT01954394|3593659|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3760234|NCT01954394|3593660|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3760235|NCT01954394|3593658|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|938|938.0||||||
3760236|NCT01954394|3593659|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|628|628.0||||||
3760237|NCT01954394|3593660|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|310|310.0||||||
3760238|NCT01954394|3593658|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3760239|NCT01954394|3593659|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3760240|NCT01954394|3593660|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3760241|NCT01954394|3593658|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|940|940.0||||||
3760242|NCT01954394|3593659|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|623|623.0||||||
3760243|NCT01954394|3593660|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|317|317.0||||||
3760244|NCT01954394|3593658|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3760245|NCT01954394|3593659|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3760246|NCT01954394|3593660|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3760247|NCT01954394|3593658|B3||Male|Sex: Female, Male||Participants|Count of Participants|550|550.0||||||
3760248|NCT01954394|3593659|B2||Male|Sex: Female, Male||Participants|Count of Participants|368|368.0||||||
3760249|NCT01954394|3593660|B1||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3760250|NCT01954394|3593658|B3||Female|Sex: Female, Male||Participants|Count of Participants|435|435.0||||||
3760251|NCT01954394|3593659|B2||Female|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
3760252|NCT01954394|3593660|B1||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3760253|NCT01954394|3593658|B3|||Age||years|Mean|54.4|54.4|Standard Deviation|11.9|11.9|||
3760254|NCT01954394|3593659|B2|||Age||years|Mean|54.1|54.1|Standard Deviation|12.1|12.1|||
3760255|NCT01954394|3593660|B1|||Age||years|Mean|54.8|54.8|Standard Deviation|11.4|11.4|||
3760256|NCT01954264|3593711|B1||Male|Sex: Female, Male||Participants|Count of Participants|1266|1266.0||||||
3760257|NCT01954264|3593711|B1||Female|Sex: Female, Male||Participants|Count of Participants|1155|1155.0||||||
3760258|NCT01954264|3593711|B1|||Age||Years|Mean|4.0|4.0|Standard Deviation|2.7|2.7|||
3760259|NCT01954251|3593761|B3||Male|Sex: Female, Male||Participants|Count of Participants|399|399.0||||||
3760260|NCT01954251|3593762|B2||Male|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
3760261|NCT01954251|3593763|B1||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3760262|NCT01954251|3593761|B3||Female|Sex: Female, Male||Participants|Count of Participants|429|429.0||||||
3760263|NCT01954251|3593762|B2||Female|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
3760264|NCT01954251|3593763|B1||Female|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
3760265|NCT01954251|3593761|B3|||Age||Years|Mean|63.4|63.4|Standard Deviation|8.55|8.55|||
3760266|NCT01954251|3593762|B2|||Age||Years|Mean|63.4|63.4|Standard Deviation|8.8|8.8|||
3760267|NCT01954251|3593763|B1|||Age||Years|Mean|63.4|63.4|Standard Deviation|8.3|8.3|||
3760268|NCT01954160|3593798|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3760269|NCT01954160|3593800|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3760270|NCT01954160|3593798|B3|Male||Gender||participants|Number|3|3.0||||||
3760271|NCT01954160|3593800|B1|Male||Gender||participants|Number|3|3.0||||||
3760272|NCT01954160|3593798|B3|Female||Gender||participants|Number|1|1.0||||||
3760273|NCT01954160|3593800|B1|Female||Gender||participants|Number|1|1.0||||||
3760274|NCT01954160|3593798|B3|||Age||years|Mean|52.5|52.5|Standard Deviation|4.4|4.4|||
3760275|NCT01954160|3593800|B1|||Age||years|Mean|52.5|52.5|Standard Deviation|4.4|4.4|||
3760276|NCT01954160|3593798|B3|>=65 years||Age||participants|Number|0|0.0||||||
3760277|NCT01954160|3593800|B1|>=65 years||Age||participants|Number|0|0.0||||||
3760278|NCT01954160|3593798|B3|Between 18 and 65 years||Age||participants|Number|4|4.0||||||
3760279|NCT01954160|3593800|B1|Between 18 and 65 years||Age||participants|Number|4|4.0||||||
3760280|NCT01954160|3593798|B3|<=18 years||Age||participants|Number|0|0.0||||||
3760281|NCT01954160|3593800|B1|<=18 years||Age||participants|Number|0|0.0||||||
3760282|NCT01954121|3593859|B3||Male|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
3760283|NCT01954121|3593860|B2||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3760284|NCT01954121|3593861|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3760285|NCT01954121|3593859|B3||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
3760286|NCT01954121|3593860|B2||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3760287|NCT01954121|3593861|B1||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3760288|NCT01954121|3593859|B3|mean (standard deviation)||Age||years|Mean|35.6|35.6|Standard Deviation|15.4|15.4|||
3760289|NCT01954121|3593860|B2|mean (standard deviation)||Age||years|Mean|33.3|33.3|Standard Deviation|14.3|14.3|||
3760290|NCT01954121|3593861|B1|mean (standard deviation)||Age||years|Mean|37.8|37.8|Standard Deviation|16.2|16.2|||
3760291|NCT01954121|3593859|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3760292|NCT01954121|3593860|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3760293|NCT01954121|3593861|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3760294|NCT01954121|3593859|B3||Between 18 and 65 years|Age||Participants|Count of Participants|370|370.0||||||
3760295|NCT01954121|3593860|B2||Between 18 and 65 years|Age||Participants|Count of Participants|186|186.0||||||
3760296|NCT01954121|3593861|B1||Between 18 and 65 years|Age||Participants|Count of Participants|184|184.0||||||
3760297|NCT01954121|3593859|B3||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
3760298|NCT01954121|3593860|B2||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
3760299|NCT01954121|3593861|B1||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
3760300|NCT01954082|3593876|B3|||APGAR-5 MINUTE|10-point, ordinal scale specifying infant's overall health 5 minutes after birth from 1 (needs immediate medical help) to 10 (in optimal health).|Units on a Scale|Median|6|6.0|Full Range|||0.0|9.0|
3760301|NCT01954082|3593877|B2|||APGAR-5 MINUTE|10-point, ordinal scale specifying infant's overall health 5 minutes after birth from 1 (needs immediate medical help) to 10 (in optimal health).|Units on a Scale|Median|6|6.0|Full Range|||0.0|9.0|
3760302|NCT01954082|3593878|B1|||APGAR-5 MINUTE|10-point, ordinal scale specifying infant's overall health 5 minutes after birth from 1 (needs immediate medical help) to 10 (in optimal health).|Units on a Scale|Median|7|7.0|Full Range|||0.0|9.0|
3760303|NCT01954082|3593876|B3||Test Result Not Available|APGAR-5 MINUTE||Participants|Count of Participants|9|9.0||||||
3760304|NCT01954082|3593877|B2||Test Result Not Available|APGAR-5 MINUTE||Participants|Count of Participants|5|5.0||||||
3760305|NCT01954082|3593878|B1||Test Result Not Available|APGAR-5 MINUTE||Participants|Count of Participants|4|4.0||||||
3760306|NCT01954082|3593876|B3||Test Result Available|APGAR-5 MINUTE||Participants|Count of Participants|629|629.0||||||
3760307|NCT01954082|3593877|B2||Test Result Available|APGAR-5 MINUTE||Participants|Count of Participants|316|316.0||||||
3760308|NCT01954082|3593878|B1||Test Result Available|APGAR-5 MINUTE||Participants|Count of Participants|313|313.0||||||
3760309|NCT01954082|3593876|B3||Yes|EARLY ONSET SEPSIS||Participants|Count of Participants|16|16.0||||||
3760310|NCT01954082|3593877|B2||Yes|EARLY ONSET SEPSIS||Participants|Count of Participants|9|9.0||||||
3760311|NCT01954082|3593878|B1||Yes|EARLY ONSET SEPSIS||Participants|Count of Participants|7|7.0||||||
3760312|NCT01954082|3593876|B3||No|EARLY ONSET SEPSIS||Participants|Count of Participants|622|622.0||||||
3760313|NCT01954082|3593877|B2||No|EARLY ONSET SEPSIS||Participants|Count of Participants|312|312.0||||||
3760314|NCT01954082|3593878|B1||No|EARLY ONSET SEPSIS||Participants|Count of Participants|310|310.0||||||
3760315|NCT01954082|3593876|B3||Unknown/Not Reported|ANTENATAL STEROIDS||Participants|Count of Participants|1|1.0||||||
3760316|NCT01954082|3593877|B2||Unknown/Not Reported|ANTENATAL STEROIDS||Participants|Count of Participants|1|1.0||||||
3760317|NCT01954082|3593878|B1||Unknown/Not Reported|ANTENATAL STEROIDS||Participants|Count of Participants|0|0.0||||||
3760318|NCT01954082|3593876|B3||Yes|ANTENATAL STEROIDS||Participants|Count of Participants|564|564.0||||||
3760319|NCT01954082|3593877|B2||Yes|ANTENATAL STEROIDS||Participants|Count of Participants|283|283.0||||||
3760320|NCT01954082|3593878|B1||Yes|ANTENATAL STEROIDS||Participants|Count of Participants|281|281.0||||||
3760321|NCT01954082|3593876|B3||No|ANTENATAL STEROIDS||Participants|Count of Participants|73|73.0||||||
3760322|NCT01954082|3593877|B2||No|ANTENATAL STEROIDS||Participants|Count of Participants|37|37.0||||||
3760323|NCT01954082|3593878|B1||No|ANTENATAL STEROIDS||Participants|Count of Participants|36|36.0||||||
3760324|NCT01954082|3593876|B3|||BIRTH WEIGHT||Grams|Median|750|750.0|Full Range|||300.0|1589.0|
3760325|NCT01954082|3593877|B2|||BIRTH WEIGHT||Grams|Median|765|765.0|Full Range|||300.0|1589.0|
3760326|NCT01954082|3593878|B1|||BIRTH WEIGHT||Grams|Median|740|740.0|Full Range|||394.0|1390.0|
3760327|NCT01954082|3593876|B3|||BIRTH WEIGHT||Grams|Mean|780.4|780.4|Standard Deviation|196.5|196.5|||
3760328|NCT01954082|3593877|B2|||BIRTH WEIGHT||Grams|Mean|784.6|784.6|Standard Deviation|198.2|198.2|||
3760329|NCT01954082|3593878|B1|||BIRTH WEIGHT||Grams|Mean|776.1|776.1|Standard Deviation|195|195.0|||
3760330|NCT01954082|3593876|B3|United States||Region of Enrollment||Participants|Count of Participants|638|638.0||||||
3760331|NCT01954082|3593877|B2|United States||Region of Enrollment||Participants|Count of Participants|321|321.0||||||
3760332|NCT01954082|3593878|B1|United States||Region of Enrollment||Participants|Count of Participants|317|317.0||||||
3760333|NCT01954082|3593876|B3|Race/Ethnicity|Unknown/Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3760334|NCT01954082|3593877|B2|Race/Ethnicity|Unknown/Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3760335|NCT01954082|3593878|B1|Race/Ethnicity|Unknown/Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3760336|NCT01954082|3593876|B3|Race/Ethnicity|White Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|265|265.0||||||
3760337|NCT01954082|3593877|B2|Race/Ethnicity|White Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|132|132.0||||||
3760338|NCT01954082|3593878|B1|Race/Ethnicity|White Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|133|133.0||||||
3760339|NCT01954082|3593876|B3|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3760340|NCT01954082|3593877|B2|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3760341|NCT01954082|3593878|B1|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3760342|NCT01954082|3593876|B3|Race/Ethnicity|Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|83|83.0||||||
3760343|NCT01954082|3593877|B2|Race/Ethnicity|Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|45|45.0||||||
3760344|NCT01954082|3593878|B1|Race/Ethnicity|Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
3760345|NCT01954082|3593876|B3|Race/Ethnicity|Black Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|232|232.0||||||
3760346|NCT01954082|3593877|B2|Race/Ethnicity|Black Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|113|113.0||||||
3760347|NCT01954082|3593878|B1|Race/Ethnicity|Black Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|119|119.0||||||
3760348|NCT01954082|3593876|B3|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3760349|NCT01954082|3593877|B2|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3760350|NCT01954082|3593878|B1|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3760351|NCT01954082|3593876|B3||Male|Sex: Female, Male||Participants|Count of Participants|321|321.0||||||
3760352|NCT01954082|3593877|B2||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3760353|NCT01954082|3593878|B1||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3760354|NCT01954082|3593876|B3||Female|Sex: Female, Male||Participants|Count of Participants|317|317.0||||||
3760355|NCT01954082|3593877|B2||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3760356|NCT01954082|3593878|B1||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
3760357|NCT01954082|3593876|B3|AGE AT START OF STUDY THERAPY||Age, Customized||Days|Median|3|3.0|Full Range|||1.0|7.0|
3760358|NCT01954082|3593877|B2|AGE AT START OF STUDY THERAPY||Age, Customized||Days|Median|3|3.0|Full Range|||1.0|7.0|
3760359|NCT01954082|3593878|B1|AGE AT START OF STUDY THERAPY||Age, Customized||Days|Median|3|3.0|Full Range|||1.0|5.0|
3760360|NCT01954082|3593876|B3|AGE AT START OF STUDY THERAPY||Age, Customized||Days|Mean|2.8|2.8|Standard Deviation|0.8|0.8|||
3760361|NCT01954082|3593877|B2|AGE AT START OF STUDY THERAPY||Age, Customized||Days|Mean|2.8|2.8|Standard Deviation|0.8|0.8|||
3760362|NCT01954082|3593878|B1|AGE AT START OF STUDY THERAPY||Age, Customized||Days|Mean|2.8|2.8|Standard Deviation|0.8|0.8|||
3760363|NCT01954082|3593876|B3|Gestational Age|>=26 weeks|Age, Customized||Participants|Count of Participants|299|299.0||||||
3760364|NCT01954082|3593877|B2|Gestational Age|>=26 weeks|Age, Customized||Participants|Count of Participants|151|151.0||||||
3760365|NCT01954082|3593878|B1|Gestational Age|>=26 weeks|Age, Customized||Participants|Count of Participants|148|148.0||||||
3760366|NCT01954082|3593876|B3|Gestational Age|<26 weeks|Age, Customized||Participants|Count of Participants|339|339.0||||||
3760367|NCT01954082|3593877|B2|Gestational Age|<26 weeks|Age, Customized||Participants|Count of Participants|170|170.0||||||
3760368|NCT01954082|3593878|B1|Gestational Age|<26 weeks|Age, Customized||Participants|Count of Participants|169|169.0||||||
3760369|NCT01954082|3593876|B3|||Age||weeks|Median|25.9|25.9|Full Range|||22.0|27.9|
3760370|NCT01954082|3593877|B2|||Age||weeks|Median|25.9|25.9|Full Range|||22.7|27.9|
3760371|NCT01954082|3593878|B1|||Age||weeks|Median|25.9|25.9|Full Range|||22.0|27.9|
3760372|NCT01954082|3593876|B3|||Age||weeks|Mean|25.68|25.68|Standard Deviation|1.38|1.38|||
3760373|NCT01954082|3593877|B2|||Age||weeks|Mean|25.72|25.72|Standard Deviation|1.34|1.34|||
3760374|NCT01954082|3593878|B1|||Age||weeks|Mean|25.64|25.64|Standard Deviation|1.42|1.42|||
3760375|NCT01953874|3593897|B3|Loop diuretic||Concomitant medications||participants|Number|111|111.0||||||
3760376|NCT01953874|3593898|B2|Loop diuretic||Concomitant medications||participants|Number|53|53.0||||||
3760377|NCT01953874|3593899|B1|Loop diuretic||Concomitant medications||participants|Number|58|58.0||||||
3760378|NCT01953874|3593897|B3|Aldosterone agonist||Concomitant medications||participants|Number|62|62.0||||||
3760379|NCT01953874|3593898|B2|Aldosterone agonist||Concomitant medications||participants|Number|29|29.0||||||
3760380|NCT01953874|3593899|B1|Aldosterone agonist||Concomitant medications||participants|Number|33|33.0||||||
3760381|NCT01953874|3593897|B3|Beta blocker (HFrEF only)||Concomitant medications||participants|Number|93|93.0||||||
3760382|NCT01953874|3593898|B2|Beta blocker (HFrEF only)||Concomitant medications||participants|Number|46|46.0||||||
3760383|NCT01953874|3593899|B1|Beta blocker (HFrEF only)||Concomitant medications||participants|Number|47|47.0||||||
3760384|NCT01953874|3593897|B3|ACE-I or ARB (HFrEF only)||Concomitant medications||participants|Number|77|77.0||||||
3760385|NCT01953874|3593898|B2|ACE-I or ARB (HFrEF only)||Concomitant medications||participants|Number|38|38.0||||||
3760386|NCT01953874|3593899|B1|ACE-I or ARB (HFrEF only)||Concomitant medications||participants|Number|39|39.0||||||
3760387|NCT01953874|3593897|B3|||6-minute walk distance||meters|Mean|209.2|209.2|Standard Deviation|119|119.0|||
3760388|NCT01953874|3593898|B2|||6-minute walk distance||meters|Mean|196.1|196.1|Standard Deviation|114.6|114.6|||
3760389|NCT01953874|3593899|B1|||6-minute walk distance||meters|Mean|221.4|221.4|Standard Deviation|122.7|122.7|||
3760390|NCT01953874|3593897|B3|||N-terminal pro-brain natriuretic peptide (NT pro-BNP)||pg/mL|Mean|4752.0|4752.0|Standard Deviation|6734.9|6734.9|||
3760391|NCT01953874|3593898|B2|||N-terminal pro-brain natriuretic peptide (NT pro-BNP)||pg/mL|Mean|6056.4|6056.4|Standard Deviation|8401.9|8401.9|||
3760392|NCT01953874|3593899|B1|||N-terminal pro-brain natriuretic peptide (NT pro-BNP)||pg/mL|Mean|3468.5|3468.5|Standard Deviation|4231.6|4231.6|||
3760393|NCT01953874|3593897|B3|ICD||Implanted device||participants|Number|41|41.0||||||
3760394|NCT01953874|3593898|B2|ICD||Implanted device||participants|Number|15|15.0||||||
3760395|NCT01953874|3593899|B1|ICD||Implanted device||participants|Number|26|26.0||||||
3760396|NCT01953874|3593897|B3|Pacemaker||Implanted device||participants|Number|9|9.0||||||
3760397|NCT01953874|3593898|B2|Pacemaker||Implanted device||participants|Number|6|6.0||||||
3760398|NCT01953874|3593899|B1|Pacemaker||Implanted device||participants|Number|3|3.0||||||
3760399|NCT01953874|3593897|B3|||Atrial fibrillation||participants|Number|52|52.0||||||
3760400|NCT01953874|3593898|B2|||Atrial fibrillation||participants|Number|26|26.0||||||
3760401|NCT01953874|3593899|B1|||Atrial fibrillation||participants|Number|26|26.0||||||
3760402|NCT01953874|3593897|B3|||Ischemic HF etiology||participants|Number|44|44.0||||||
3760403|NCT01953874|3593898|B2|||Ischemic HF etiology||participants|Number|18|18.0||||||
3760404|NCT01953874|3593899|B1|||Ischemic HF etiology||participants|Number|26|26.0||||||
3760405|NCT01953874|3593897|B3|COPD||Comorbid Conditions||participants|Number|23|23.0||||||
3760406|NCT01953874|3593898|B2|COPD||Comorbid Conditions||participants|Number|11|11.0||||||
3760407|NCT01953874|3593899|B1|COPD||Comorbid Conditions||participants|Number|12|12.0||||||
3760408|NCT01953874|3593897|B3|Hypertension||Comorbid Conditions||participants|Number|108|108.0||||||
3760409|NCT01953874|3593898|B2|Hypertension||Comorbid Conditions||participants|Number|56|56.0||||||
3760410|NCT01953874|3593899|B1|Hypertension||Comorbid Conditions||participants|Number|52|52.0||||||
3760411|NCT01953874|3593897|B3|Diabetes mellitus||Comorbid Conditions||participants|Number|69|69.0||||||
3760412|NCT01953874|3593898|B2|Diabetes mellitus||Comorbid Conditions||participants|Number|34|34.0||||||
3760413|NCT01953874|3593899|B1|Diabetes mellitus||Comorbid Conditions||participants|Number|35|35.0||||||
3760414|NCT01953874|3593897|B3||Preserved ejection fraction (>45%)|Left ventricular ejection fraction (LVEF)||Participants|Count of Participants|24|24.0||||||
3760415|NCT01953874|3593898|B2||Preserved ejection fraction (>45%)|Left ventricular ejection fraction (LVEF)||Participants|Count of Participants|11|11.0||||||
3760416|NCT01953874|3593899|B1||Preserved ejection fraction (>45%)|Left ventricular ejection fraction (LVEF)||Participants|Count of Participants|13|13.0||||||
3760417|NCT01953874|3593897|B3||Reduced ejection fraction (</=45%)|Left ventricular ejection fraction (LVEF)||Participants|Count of Participants|102|102.0||||||
3760418|NCT01953874|3593898|B2||Reduced ejection fraction (</=45%)|Left ventricular ejection fraction (LVEF)||Participants|Count of Participants|50|50.0||||||
3760419|NCT01953874|3593899|B1||Reduced ejection fraction (</=45%)|Left ventricular ejection fraction (LVEF)||Participants|Count of Participants|52|52.0||||||
3760420|NCT01953874|3593897|B3||Not done|New York Heart Association (NYHA) Class|"NYHA Class I: Cardiac disease, but not symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~NYHA Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~NYHA Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100m). Comfortable only at rest.~NYHA Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bedbound patients."|Participants|Count of Participants|3|3.0||||||
3760421|NCT01953874|3593898|B2||Not done|New York Heart Association (NYHA) Class|"NYHA Class I: Cardiac disease, but not symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~NYHA Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~NYHA Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100m). Comfortable only at rest.~NYHA Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bedbound patients."|Participants|Count of Participants|1|1.0||||||
3760422|NCT01953874|3593899|B1||Not done|New York Heart Association (NYHA) Class|"NYHA Class I: Cardiac disease, but not symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~NYHA Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~NYHA Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100m). Comfortable only at rest.~NYHA Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bedbound patients."|Participants|Count of Participants|2|2.0||||||
3760423|NCT01953874|3593897|B3||NYHA Class IV|New York Heart Association (NYHA) Class|"NYHA Class I: Cardiac disease, but not symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~NYHA Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~NYHA Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100m). Comfortable only at rest.~NYHA Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bedbound patients."|Participants|Count of Participants|12|12.0||||||
3760424|NCT01953874|3593898|B2||NYHA Class IV|New York Heart Association (NYHA) Class|"NYHA Class I: Cardiac disease, but not symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~NYHA Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~NYHA Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100m). Comfortable only at rest.~NYHA Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bedbound patients."|Participants|Count of Participants|3|3.0||||||
3760425|NCT01953874|3593899|B1||NYHA Class IV|New York Heart Association (NYHA) Class|"NYHA Class I: Cardiac disease, but not symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~NYHA Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~NYHA Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100m). Comfortable only at rest.~NYHA Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bedbound patients."|Participants|Count of Participants|9|9.0||||||
3760426|NCT01953874|3593897|B3||NYHA Class III|New York Heart Association (NYHA) Class|"NYHA Class I: Cardiac disease, but not symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~NYHA Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~NYHA Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100m). Comfortable only at rest.~NYHA Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bedbound patients."|Participants|Count of Participants|75|75.0||||||
3760427|NCT01953874|3593898|B2||NYHA Class III|New York Heart Association (NYHA) Class|"NYHA Class I: Cardiac disease, but not symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~NYHA Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~NYHA Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100m). Comfortable only at rest.~NYHA Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bedbound patients."|Participants|Count of Participants|43|43.0||||||
3760428|NCT01953874|3593899|B1||NYHA Class III|New York Heart Association (NYHA) Class|"NYHA Class I: Cardiac disease, but not symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~NYHA Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~NYHA Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100m). Comfortable only at rest.~NYHA Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bedbound patients."|Participants|Count of Participants|32|32.0||||||
3760462|NCT01953874|3593897|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3760463|NCT01953874|3593898|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3760464|NCT01953874|3593899|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760429|NCT01953874|3593897|B3||NYHA Class II|New York Heart Association (NYHA) Class|"NYHA Class I: Cardiac disease, but not symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~NYHA Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~NYHA Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100m). Comfortable only at rest.~NYHA Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bedbound patients."|Participants|Count of Participants|30|30.0||||||
3760430|NCT01953874|3593898|B2||NYHA Class II|New York Heart Association (NYHA) Class|"NYHA Class I: Cardiac disease, but not symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~NYHA Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~NYHA Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100m). Comfortable only at rest.~NYHA Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bedbound patients."|Participants|Count of Participants|11|11.0||||||
3760431|NCT01953874|3593899|B1||NYHA Class II|New York Heart Association (NYHA) Class|"NYHA Class I: Cardiac disease, but not symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~NYHA Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~NYHA Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100m). Comfortable only at rest.~NYHA Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bedbound patients."|Participants|Count of Participants|19|19.0||||||
3760432|NCT01953874|3593897|B3||NYHA Class I|New York Heart Association (NYHA) Class|"NYHA Class I: Cardiac disease, but not symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~NYHA Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~NYHA Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100m). Comfortable only at rest.~NYHA Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bedbound patients."|Participants|Count of Participants|6|6.0||||||
3760433|NCT01953874|3593898|B2||NYHA Class I|New York Heart Association (NYHA) Class|"NYHA Class I: Cardiac disease, but not symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~NYHA Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~NYHA Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100m). Comfortable only at rest.~NYHA Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bedbound patients."|Participants|Count of Participants|3|3.0||||||
3760434|NCT01953874|3593899|B1||NYHA Class I|New York Heart Association (NYHA) Class|"NYHA Class I: Cardiac disease, but not symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~NYHA Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~NYHA Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100m). Comfortable only at rest.~NYHA Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bedbound patients."|Participants|Count of Participants|3|3.0||||||
3760435|NCT01953874|3593897|B3|||Body mass index||kg/m^2|Mean|31.9|31.9|Standard Deviation|8.8|8.8|||
3760436|NCT01953874|3593898|B2|||Body mass index||kg/m^2|Mean|31.4|31.4|Standard Deviation|8.6|8.6|||
3760437|NCT01953874|3593899|B1|||Body mass index||kg/m^2|Mean|32.3|32.3|Standard Deviation|9.0|9.0|||
3760438|NCT01953874|3593897|B3|Germany||Region of Enrollment||participants|Number|35|35.0||||||
3760439|NCT01953874|3593898|B2|Germany||Region of Enrollment||participants|Number|18|18.0||||||
3760440|NCT01953874|3593899|B1|Germany||Region of Enrollment||participants|Number|17|17.0||||||
3760441|NCT01953874|3593897|B3|United States||Region of Enrollment||participants|Number|91|91.0||||||
3760442|NCT01953874|3593898|B2|United States||Region of Enrollment||participants|Number|43|43.0||||||
3760443|NCT01953874|3593899|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
3760444|NCT01953874|3593897|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3760445|NCT01953874|3593898|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760446|NCT01953874|3593899|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3760447|NCT01953874|3593897|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3760448|NCT01953874|3593898|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760449|NCT01953874|3593899|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3760450|NCT01953874|3593897|B3||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3760451|NCT01953874|3593898|B2||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3760452|NCT01953874|3593899|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3760453|NCT01953874|3593897|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3760454|NCT01953874|3593898|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3760455|NCT01953874|3593899|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3760456|NCT01953874|3593897|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760457|NCT01953874|3593898|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760458|NCT01953874|3593899|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760459|NCT01953874|3593897|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3760460|NCT01953874|3593898|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3760461|NCT01953874|3593899|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760465|NCT01953874|3593897|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3760466|NCT01953874|3593898|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3760467|NCT01953874|3593899|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3760468|NCT01953874|3593897|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
3760469|NCT01953874|3593898|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3760470|NCT01953874|3593899|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3760471|NCT01953874|3593897|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3760472|NCT01953874|3593898|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760473|NCT01953874|3593899|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3760474|NCT01953874|3593897|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3760475|NCT01953874|3593898|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3760476|NCT01953874|3593899|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3760477|NCT01953874|3593897|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3760478|NCT01953874|3593898|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3760479|NCT01953874|3593899|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3760480|NCT01953874|3593897|B3|||Age||years|Mean|62.1|62.1|Standard Deviation|13.4|13.4|||
3760481|NCT01953874|3593898|B2|||Age||years|Mean|63.2|63.2|Standard Deviation|13.4|13.4|||
3760482|NCT01953874|3593899|B1|||Age||years|Mean|61.1|61.1|Standard Deviation|13.5|13.5|||
3760483|NCT01953354|3593943|B3|||Mayo Score for Assessment of Ulcerative Colitis Activity|The Mayo Score assesses four areas of ulcerative colitis activity: stool frequency, rectal bleeding, endoscopic findings, and physician’s global assessment. The physician rates each of the four areas on a scale of 0 to 3, with a total possible score of 12. A higher score indicates more disease activity.|Total Mayo Score|Mean|8.3|8.3|Standard Deviation|1.5|1.5|||
3760484|NCT01953354|3593944|B2|||Mayo Score for Assessment of Ulcerative Colitis Activity|The Mayo Score assesses four areas of ulcerative colitis activity: stool frequency, rectal bleeding, endoscopic findings, and physician’s global assessment. The physician rates each of the four areas on a scale of 0 to 3, with a total possible score of 12. A higher score indicates more disease activity.|Total Mayo Score|Mean|7.4|7.4|Standard Deviation|1.3|1.3|||
3760485|NCT01953354|3593945|B1|||Mayo Score for Assessment of Ulcerative Colitis Activity|The Mayo Score assesses four areas of ulcerative colitis activity: stool frequency, rectal bleeding, endoscopic findings, and physician’s global assessment. The physician rates each of the four areas on a scale of 0 to 3, with a total possible score of 12. A higher score indicates more disease activity.|Total Mayo Score|Mean|9.0|9.0|Standard Deviation|1.2|1.2|||
3760486|NCT01953354|3593943|B3|||Percentage of Participants at Baseline Who Were Taking Thiopurine|Percentage of participants at Baseline who were taking Thiopurine prescribed by a physician.|percentage of participants|Number|6.3|6.3||||||
3760487|NCT01953354|3593944|B2|||Percentage of Participants at Baseline Who Were Taking Thiopurine|Percentage of participants at Baseline who were taking Thiopurine prescribed by a physician.|percentage of participants|Number|0.0|0.0||||||
3760488|NCT01953354|3593945|B1|||Percentage of Participants at Baseline Who Were Taking Thiopurine|Percentage of participants at Baseline who were taking Thiopurine prescribed by a physician.|percentage of participants|Number|11.1|11.1||||||
3760489|NCT01953354|3593943|B3|||Percentage of Participants at Baseline Who Were Taking a Corticosteroid|Percentage of participants at Baseline who were taking a corticosteroid prescribed by a physician.|percentage of participants|Number|25.0|25.0||||||
3760490|NCT01953354|3593944|B2|||Percentage of Participants at Baseline Who Were Taking a Corticosteroid|Percentage of participants at Baseline who were taking a corticosteroid prescribed by a physician.|percentage of participants|Number|14.3|14.3||||||
3760491|NCT01953354|3593945|B1|||Percentage of Participants at Baseline Who Were Taking a Corticosteroid|Percentage of participants at Baseline who were taking a corticosteroid prescribed by a physician.|percentage of participants|Number|33.3|33.3||||||
3760492|NCT01953354|3593943|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
3760493|NCT01953354|3593944|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3760494|NCT01953354|3593945|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3760495|NCT01953354|3593943|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760496|NCT01953354|3593944|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760497|NCT01953354|3593945|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760498|NCT01953354|3593943|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760499|NCT01953354|3593944|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760500|NCT01953354|3593945|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760501|NCT01953354|3593943|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3760502|NCT01953354|3593944|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3760503|NCT01953354|3593945|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3760504|NCT01953354|3593943|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760505|NCT01953354|3593944|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760506|NCT01953354|3593945|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760507|NCT01953354|3593943|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760508|NCT01953354|3593944|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760509|NCT01953354|3593945|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760510|NCT01953354|3593943|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3760511|NCT01953354|3593944|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760512|NCT01953354|3593945|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3760513|NCT01953354|3593943|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760514|NCT01953354|3593944|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760515|NCT01953354|3593945|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760516|NCT01953354|3593943|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760517|NCT01953354|3593944|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760518|NCT01953354|3593945|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760519|NCT01953354|3593943|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3760520|NCT01953354|3593944|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3760521|NCT01953354|3593945|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3760522|NCT01953354|3593943|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3760523|NCT01953354|3593944|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3760524|NCT01953354|3593945|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3760525|NCT01953354|3593943|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3760526|NCT01953354|3593944|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3760527|NCT01953354|3593945|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3760528|NCT01953354|3593943|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3760529|NCT01953354|3593944|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3760530|NCT01953354|3593945|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3760531|NCT01953354|3593943|B3|||Age||years|Mean|42.1|42.1|Standard Deviation|10.0|10.0|||
3760532|NCT01953354|3593944|B2|||Age||years|Mean|44.7|44.7|Standard Deviation|11.4|11.4|||
3760533|NCT01953354|3593945|B1|||Age||years|Mean|40.0|40.0|Standard Deviation|9.0|9.0|||
3760534|NCT01953328|3593966|B9|||Very-Low-Density Lipoprotein Cholesterol (VLDL-C) Concentration||mg/dL|Mean|26.6|26.6|Standard Deviation|11.5|11.5|||
3760535|NCT01953328|3593967|B8|||Very-Low-Density Lipoprotein Cholesterol (VLDL-C) Concentration||mg/dL|Mean|24.7|24.7|Standard Deviation|10.3|10.3|||
3760536|NCT01953328|3593968|B7|||Very-Low-Density Lipoprotein Cholesterol (VLDL-C) Concentration||mg/dL|Mean|24.3|24.3|Standard Deviation|10.7|10.7|||
3760537|NCT01953328|3593969|B6|||Very-Low-Density Lipoprotein Cholesterol (VLDL-C) Concentration||mg/dL|Mean|25.1|25.1|Standard Deviation|9.4|9.4|||
3760538|NCT01953328|3593970|B5|||Very-Low-Density Lipoprotein Cholesterol (VLDL-C) Concentration||mg/dL|Mean|27.4|27.4|Standard Deviation|12.0|12.0|||
3760539|NCT01953328|3593971|B4|||Very-Low-Density Lipoprotein Cholesterol (VLDL-C) Concentration||mg/dL|Mean|29.0|29.0|Standard Deviation|12.8|12.8|||
3760540|NCT01953328|3593972|B3|||Very-Low-Density Lipoprotein Cholesterol (VLDL-C) Concentration||mg/dL|Mean|29.2|29.2|Standard Deviation|14.7|14.7|||
3760541|NCT01953328|3593973|B2|||Very-Low-Density Lipoprotein Cholesterol (VLDL-C) Concentration||mg/dL|Mean|26.8|26.8|Standard Deviation|10.2|10.2|||
3760542|NCT01953328|3593974|B1|||Very-Low-Density Lipoprotein Cholesterol (VLDL-C) Concentration||mg/dL|Mean|26.3|26.3|Standard Deviation|11.0|11.0|||
3760543|NCT01953328|3593966|B9|||HDL-C Concentration||mg/dL|Mean|57.1|57.1|Standard Deviation|14.0|14.0|||
3760544|NCT01953328|3593967|B8|||HDL-C Concentration||mg/dL|Mean|56.3|56.3|Standard Deviation|15.7|15.7|||
3760545|NCT01953328|3593968|B7|||HDL-C Concentration||mg/dL|Mean|55.9|55.9|Standard Deviation|14.4|14.4|||
3760546|NCT01953328|3593969|B6|||HDL-C Concentration||mg/dL|Mean|56.0|56.0|Standard Deviation|11.3|11.3|||
3760547|NCT01953328|3593970|B5|||HDL-C Concentration||mg/dL|Mean|59.6|59.6|Standard Deviation|15.4|15.4|||
3760548|NCT01953328|3593971|B4|||HDL-C Concentration||mg/dL|Mean|54.7|54.7|Standard Deviation|13.9|13.9|||
3760549|NCT01953328|3593972|B3|||HDL-C Concentration||mg/dL|Mean|58.6|58.6|Standard Deviation|12.7|12.7|||
3760550|NCT01953328|3593973|B2|||HDL-C Concentration||mg/dL|Mean|58.3|58.3|Standard Deviation|14.6|14.6|||
3760551|NCT01953328|3593974|B1|||HDL-C Concentration||mg/dL|Mean|57.5|57.5|Standard Deviation|13.6|13.6|||
3760552|NCT01953328|3593966|B9|||Triglyceride Concentration||mg/dL|Median|121.5|121.5|Inter-Quartile Range|||92.0|161.5|
3760553|NCT01953328|3593967|B8|||Triglyceride Concentration||mg/dL|Median|113.0|113.0|Inter-Quartile Range|||95.0|137.0|
3760554|NCT01953328|3593968|B7|||Triglyceride Concentration||mg/dL|Median|109.0|109.0|Inter-Quartile Range|||82.0|149.0|
3760555|NCT01953328|3593969|B6|||Triglyceride Concentration||mg/dL|Median|120.0|120.0|Inter-Quartile Range|||87.0|154.0|
3760556|NCT01953328|3593970|B5|||Triglyceride Concentration||mg/dL|Median|120.0|120.0|Inter-Quartile Range|||91.5|187.0|
3760557|NCT01953328|3593971|B4|||Triglyceride Concentration||mg/dL|Median|132.0|132.0|Inter-Quartile Range|||103.0|171.0|
3760558|NCT01953328|3593972|B3|||Triglyceride Concentration||mg/dL|Median|125.0|125.0|Inter-Quartile Range|||97.0|172.0|
3760559|NCT01953328|3593973|B2|||Triglyceride Concentration||mg/dL|Median|128.5|128.5|Inter-Quartile Range|||99.0|164.0|
3760560|NCT01953328|3593974|B1|||Triglyceride Concentration||mg/dL|Median|125.0|125.0|Inter-Quartile Range|||90.0|174.0|
3760561|NCT01953328|3593966|B9|||Lipoprotein(a) Concentration||nmol/L|Median|33.0|33.0|Inter-Quartile Range|||13.0|57.0|
3760562|NCT01953328|3593967|B8|||Lipoprotein(a) Concentration||nmol/L|Median|28.0|28.0|Inter-Quartile Range|||11.0|60.0|
3760563|NCT01953328|3593968|B7|||Lipoprotein(a) Concentration||nmol/L|Median|33.0|33.0|Inter-Quartile Range|||14.0|49.0|
3760564|NCT01953328|3593969|B6|||Lipoprotein(a) Concentration||nmol/L|Median|35.0|35.0|Inter-Quartile Range|||11.0|57.0|
3760565|NCT01953328|3593970|B5|||Lipoprotein(a) Concentration||nmol/L|Median|30.0|30.0|Inter-Quartile Range|||11.0|45.0|
3760566|NCT01953328|3593971|B4|||Lipoprotein(a) Concentration||nmol/L|Median|36.5|36.5|Inter-Quartile Range|||16.0|74.0|
3760567|NCT01953328|3593972|B3|||Lipoprotein(a) Concentration||nmol/L|Median|36.0|36.0|Inter-Quartile Range|||16.0|69.0|
3760568|NCT01953328|3593973|B2|||Lipoprotein(a) Concentration||nmol/L|Median|29.5|29.5|Inter-Quartile Range|||9.0|47.0|
3760569|NCT01953328|3593974|B1|||Lipoprotein(a) Concentration||nmol/L|Median|35.0|35.0|Inter-Quartile Range|||16.5|52.5|
3760570|NCT01953328|3593966|B9|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|0.595|0.595|Standard Deviation|0.179|0.179|||
3760571|NCT01953328|3593967|B8|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|0.576|0.576|Standard Deviation|0.176|0.176|||
3760572|NCT01953328|3593968|B7|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|0.575|0.575|Standard Deviation|0.177|0.177|||
3760573|NCT01953328|3593969|B6|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|0.524|0.524|Standard Deviation|0.108|0.108|||
3760574|NCT01953328|3593970|B5|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|0.529|0.529|Standard Deviation|0.118|0.118|||
3760575|NCT01953328|3593971|B4|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|0.658|0.658|Standard Deviation|0.235|0.235|||
3760576|NCT01953328|3593972|B3|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|0.643|0.643|Standard Deviation|0.223|0.223|||
3760577|NCT01953328|3593973|B2|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|0.628|0.628|Standard Deviation|0.152|0.152|||
3760578|NCT01953328|3593974|B1|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|0.633|0.633|Standard Deviation|0.160|0.16|||
3760579|NCT01953328|3593966|B9|||Total Cholesterol/HDL-C Ratio||ratio|Mean|3.491|3.491|Standard Deviation|1.018|1.018|||
3760580|NCT01953328|3593967|B8|||Total Cholesterol/HDL-C Ratio||ratio|Mean|3.400|3.4|Standard Deviation|1.071|1.071|||
3760581|NCT01953328|3593968|B7|||Total Cholesterol/HDL-C Ratio||ratio|Mean|3.392|3.392|Standard Deviation|1.112|1.112|||
3760582|NCT01953328|3593969|B6|||Total Cholesterol/HDL-C Ratio||ratio|Mean|3.170|3.17|Standard Deviation|0.612|0.612|||
3760583|NCT01953328|3593970|B5|||Total Cholesterol/HDL-C Ratio||ratio|Mean|3.116|3.116|Standard Deviation|0.760|0.76|||
3760584|NCT01953328|3593971|B4|||Total Cholesterol/HDL-C Ratio||ratio|Mean|3.933|3.933|Standard Deviation|1.295|1.295|||
3760585|NCT01953328|3593972|B3|||Total Cholesterol/HDL-C Ratio||ratio|Mean|3.743|3.743|Standard Deviation|1.186|1.186|||
3760586|NCT01953328|3593973|B2|||Total Cholesterol/HDL-C Ratio||ratio|Mean|3.579|3.579|Standard Deviation|0.827|0.827|||
3760587|NCT01953328|3593974|B1|||Total Cholesterol/HDL-C Ratio||ratio|Mean|3.618|3.618|Standard Deviation|0.891|0.891|||
3760588|NCT01953328|3593966|B9|||Total Cholesterol Concentration||mg/dL|Mean|189.8|189.8|Standard Deviation|36.3|36.3|||
3760589|NCT01953328|3593967|B8|||Total Cholesterol Concentration||mg/dL|Mean|179.0|179.0|Standard Deviation|29.4|29.4|||
3760590|NCT01953328|3593968|B7|||Total Cholesterol Concentration||mg/dL|Mean|177.7|177.7|Standard Deviation|26.2|26.2|||
3760591|NCT01953328|3593969|B6|||Total Cholesterol Concentration||mg/dL|Mean|173.6|173.6|Standard Deviation|29.2|29.2|||
3760592|NCT01953328|3593970|B5|||Total Cholesterol Concentration||mg/dL|Mean|177.8|177.8|Standard Deviation|33.0|33.0|||
3760593|NCT01953328|3593971|B4|||Total Cholesterol Concentration||mg/dL|Mean|202.5|202.5|Standard Deviation|38.4|38.4|||
3760594|NCT01953328|3593972|B3|||Total Cholesterol Concentration||mg/dL|Mean|210.4|210.4|Standard Deviation|47.9|47.9|||
3760595|NCT01953328|3593973|B2|||Total Cholesterol Concentration||mg/dL|Mean|199.4|199.4|Standard Deviation|33.2|33.2|||
3760596|NCT01953328|3593974|B1|||Total Cholesterol Concentration||mg/dL|Mean|199.5|199.5|Standard Deviation|30.7|30.7|||
3760597|NCT01953328|3593966|B9|||Apolipoprotein B Concentration||mg/dL|Mean|93.7|93.7|Standard Deviation|22.8|22.8|||
3760598|NCT01953328|3593967|B8|||Apolipoprotein B Concentration||mg/dL|Mean|87.7|87.7|Standard Deviation|19.6|19.6|||
3760599|NCT01953328|3593968|B7|||Apolipoprotein B Concentration||mg/dL|Mean|87.2|87.2|Standard Deviation|19.1|19.1|||
3760600|NCT01953328|3593969|B6|||Apolipoprotein B Concentration||mg/dL|Mean|82.7|82.7|Standard Deviation|14.6|14.6|||
3760601|NCT01953328|3593970|B5|||Apolipoprotein B Concentration||mg/dL|Mean|85.7|85.7|Standard Deviation|18.4|18.4|||
3760602|NCT01953328|3593971|B4|||Apolipoprotein B Concentration||mg/dL|Mean|102.2|102.2|Standard Deviation|24.7|24.7|||
3760603|NCT01953328|3593972|B3|||Apolipoprotein B Concentration||mg/dL|Mean|105.1|105.1|Standard Deviation|31.2|31.2|||
3760604|NCT01953328|3593973|B2|||Apolipoprotein B Concentration||mg/dL|Mean|100.6|100.6|Standard Deviation|20.0|20.0|||
3760605|NCT01953328|3593974|B1|||Apolipoprotein B Concentration||mg/dL|Mean|99.0|99.0|Standard Deviation|20.0|20.0|||
3760606|NCT01953328|3593966|B9|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|132.7|132.7|Standard Deviation|35.9|35.9|||
3760607|NCT01953328|3593967|B8|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|122.7|122.7|Standard Deviation|29.5|29.5|||
3760608|NCT01953328|3593968|B7|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|121.8|121.8|Standard Deviation|29.8|29.8|||
3760609|NCT01953328|3593969|B6|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|117.5|117.5|Standard Deviation|25.1|25.1|||
3760610|NCT01953328|3593970|B5|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|118.2|118.2|Standard Deviation|28.6|28.6|||
3760611|NCT01953328|3593971|B4|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|147.8|147.8|Standard Deviation|39.6|39.6|||
3760612|NCT01953328|3593972|B3|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|151.8|151.8|Standard Deviation|48.8|48.8|||
3760613|NCT01953328|3593973|B2|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|141.2|141.2|Standard Deviation|31.8|31.8|||
3760614|NCT01953328|3593974|B1|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|142.0|142.0|Standard Deviation|30.4|30.4|||
3760615|NCT01953328|3593966|B9|||LDL-C Concentration|Baseline lipid parameters were measured after the lipid-stabilization period and prior to administration of first dose of investigational study drug.|mg/dL|Mean|105.5|105.5|Standard Deviation|32.0|32.0|||
3760616|NCT01953328|3593967|B8|||LDL-C Concentration|Baseline lipid parameters were measured after the lipid-stabilization period and prior to administration of first dose of investigational study drug.|mg/dL|Mean|98.0|98.0|Standard Deviation|25.6|25.6|||
3760617|NCT01953328|3593968|B7|||LDL-C Concentration|Baseline lipid parameters were measured after the lipid-stabilization period and prior to administration of first dose of investigational study drug.|mg/dL|Mean|95.8|95.8|Standard Deviation|23.6|23.6|||
3760618|NCT01953328|3593969|B6|||LDL-C Concentration|Baseline lipid parameters were measured after the lipid-stabilization period and prior to administration of first dose of investigational study drug.|mg/dL|Mean|90.7|90.7|Standard Deviation|20.8|20.8|||
3760619|NCT01953328|3593970|B5|||LDL-C Concentration|Baseline lipid parameters were measured after the lipid-stabilization period and prior to administration of first dose of investigational study drug.|mg/dL|Mean|90.9|90.9|Standard Deviation|25.5|25.5|||
3760620|NCT01953328|3593971|B4|||LDL-C Concentration|Baseline lipid parameters were measured after the lipid-stabilization period and prior to administration of first dose of investigational study drug.|mg/dL|Mean|118.8|118.8|Standard Deviation|36.6|36.6|||
3760621|NCT01953328|3593972|B3|||LDL-C Concentration|Baseline lipid parameters were measured after the lipid-stabilization period and prior to administration of first dose of investigational study drug.|mg/dL|Mean|121.9|121.9|Standard Deviation|44.6|44.6|||
3760622|NCT01953328|3593973|B2|||LDL-C Concentration|Baseline lipid parameters were measured after the lipid-stabilization period and prior to administration of first dose of investigational study drug.|mg/dL|Mean|114.0|114.0|Standard Deviation|29.2|29.2|||
3760623|NCT01953328|3593974|B1|||LDL-C Concentration|Baseline lipid parameters were measured after the lipid-stabilization period and prior to administration of first dose of investigational study drug.|mg/dL|Mean|115.7|115.7|Standard Deviation|26.0|26.0|||
3760624|NCT01953328|3593966|B9|Non-HeFH and Non-Intensive Statin Use||Stratification Factor|Intensive statin use was defined as daily atorvastatin ≥ 10 mg, fluvastatin ≥ 80 mg, lovastatin ≥ 40 mg, pitavastatin ≥ 2 mg, pravastatin ≥ 40 mg, rosuvastatin ≥ 5 mg, simvastatin ≥ 20 mg, or any statin plus ezetimibe. Non-intensive is defined as any dose of a statin at least weekly for the last 4 weeks prior to screening and not included in the above.|participants|Number|298|298.0||||||
3760625|NCT01953328|3593967|B8|Non-HeFH and Non-Intensive Statin Use||Stratification Factor|Intensive statin use was defined as daily atorvastatin ≥ 10 mg, fluvastatin ≥ 80 mg, lovastatin ≥ 40 mg, pitavastatin ≥ 2 mg, pravastatin ≥ 40 mg, rosuvastatin ≥ 5 mg, simvastatin ≥ 20 mg, or any statin plus ezetimibe. Non-intensive is defined as any dose of a statin at least weekly for the last 4 weeks prior to screening and not included in the above.|participants|Number|37|37.0||||||
3760626|NCT01953328|3593968|B7|Non-HeFH and Non-Intensive Statin Use||Stratification Factor|Intensive statin use was defined as daily atorvastatin ≥ 10 mg, fluvastatin ≥ 80 mg, lovastatin ≥ 40 mg, pitavastatin ≥ 2 mg, pravastatin ≥ 40 mg, rosuvastatin ≥ 5 mg, simvastatin ≥ 20 mg, or any statin plus ezetimibe. Non-intensive is defined as any dose of a statin at least weekly for the last 4 weeks prior to screening and not included in the above.|participants|Number|37|37.0||||||
3760627|NCT01953328|3593969|B6|Non-HeFH and Non-Intensive Statin Use||Stratification Factor|Intensive statin use was defined as daily atorvastatin ≥ 10 mg, fluvastatin ≥ 80 mg, lovastatin ≥ 40 mg, pitavastatin ≥ 2 mg, pravastatin ≥ 40 mg, rosuvastatin ≥ 5 mg, simvastatin ≥ 20 mg, or any statin plus ezetimibe. Non-intensive is defined as any dose of a statin at least weekly for the last 4 weeks prior to screening and not included in the above.|participants|Number|38|38.0||||||
3760628|NCT01953328|3593970|B5|Non-HeFH and Non-Intensive Statin Use||Stratification Factor|Intensive statin use was defined as daily atorvastatin ≥ 10 mg, fluvastatin ≥ 80 mg, lovastatin ≥ 40 mg, pitavastatin ≥ 2 mg, pravastatin ≥ 40 mg, rosuvastatin ≥ 5 mg, simvastatin ≥ 20 mg, or any statin plus ezetimibe. Non-intensive is defined as any dose of a statin at least weekly for the last 4 weeks prior to screening and not included in the above.|participants|Number|38|38.0||||||
3760629|NCT01953328|3593971|B4|Non-HeFH and Non-Intensive Statin Use||Stratification Factor|Intensive statin use was defined as daily atorvastatin ≥ 10 mg, fluvastatin ≥ 80 mg, lovastatin ≥ 40 mg, pitavastatin ≥ 2 mg, pravastatin ≥ 40 mg, rosuvastatin ≥ 5 mg, simvastatin ≥ 20 mg, or any statin plus ezetimibe. Non-intensive is defined as any dose of a statin at least weekly for the last 4 weeks prior to screening and not included in the above.|participants|Number|37|37.0||||||
3760630|NCT01953328|3593972|B3|Non-HeFH and Non-Intensive Statin Use||Stratification Factor|Intensive statin use was defined as daily atorvastatin ≥ 10 mg, fluvastatin ≥ 80 mg, lovastatin ≥ 40 mg, pitavastatin ≥ 2 mg, pravastatin ≥ 40 mg, rosuvastatin ≥ 5 mg, simvastatin ≥ 20 mg, or any statin plus ezetimibe. Non-intensive is defined as any dose of a statin at least weekly for the last 4 weeks prior to screening and not included in the above.|participants|Number|37|37.0||||||
3760631|NCT01953328|3593973|B2|Non-HeFH and Non-Intensive Statin Use||Stratification Factor|Intensive statin use was defined as daily atorvastatin ≥ 10 mg, fluvastatin ≥ 80 mg, lovastatin ≥ 40 mg, pitavastatin ≥ 2 mg, pravastatin ≥ 40 mg, rosuvastatin ≥ 5 mg, simvastatin ≥ 20 mg, or any statin plus ezetimibe. Non-intensive is defined as any dose of a statin at least weekly for the last 4 weeks prior to screening and not included in the above.|participants|Number|38|38.0||||||
3760632|NCT01953328|3593974|B1|Non-HeFH and Non-Intensive Statin Use||Stratification Factor|Intensive statin use was defined as daily atorvastatin ≥ 10 mg, fluvastatin ≥ 80 mg, lovastatin ≥ 40 mg, pitavastatin ≥ 2 mg, pravastatin ≥ 40 mg, rosuvastatin ≥ 5 mg, simvastatin ≥ 20 mg, or any statin plus ezetimibe. Non-intensive is defined as any dose of a statin at least weekly for the last 4 weeks prior to screening and not included in the above.|participants|Number|36|36.0||||||
3760633|NCT01953328|3593966|B9|Non-HeFH and Intensive Statin Use||Stratification Factor|Intensive statin use was defined as daily atorvastatin ≥ 10 mg, fluvastatin ≥ 80 mg, lovastatin ≥ 40 mg, pitavastatin ≥ 2 mg, pravastatin ≥ 40 mg, rosuvastatin ≥ 5 mg, simvastatin ≥ 20 mg, or any statin plus ezetimibe. Non-intensive is defined as any dose of a statin at least weekly for the last 4 weeks prior to screening and not included in the above.|participants|Number|85|85.0||||||
3760634|NCT01953328|3593967|B8|Non-HeFH and Intensive Statin Use||Stratification Factor|Intensive statin use was defined as daily atorvastatin ≥ 10 mg, fluvastatin ≥ 80 mg, lovastatin ≥ 40 mg, pitavastatin ≥ 2 mg, pravastatin ≥ 40 mg, rosuvastatin ≥ 5 mg, simvastatin ≥ 20 mg, or any statin plus ezetimibe. Non-intensive is defined as any dose of a statin at least weekly for the last 4 weeks prior to screening and not included in the above.|participants|Number|11|11.0||||||
3760635|NCT01953328|3593968|B7|Non-HeFH and Intensive Statin Use||Stratification Factor|Intensive statin use was defined as daily atorvastatin ≥ 10 mg, fluvastatin ≥ 80 mg, lovastatin ≥ 40 mg, pitavastatin ≥ 2 mg, pravastatin ≥ 40 mg, rosuvastatin ≥ 5 mg, simvastatin ≥ 20 mg, or any statin plus ezetimibe. Non-intensive is defined as any dose of a statin at least weekly for the last 4 weeks prior to screening and not included in the above.|participants|Number|11|11.0||||||
3760636|NCT01953328|3593969|B6|Non-HeFH and Intensive Statin Use||Stratification Factor|Intensive statin use was defined as daily atorvastatin ≥ 10 mg, fluvastatin ≥ 80 mg, lovastatin ≥ 40 mg, pitavastatin ≥ 2 mg, pravastatin ≥ 40 mg, rosuvastatin ≥ 5 mg, simvastatin ≥ 20 mg, or any statin plus ezetimibe. Non-intensive is defined as any dose of a statin at least weekly for the last 4 weeks prior to screening and not included in the above.|participants|Number|11|11.0||||||
3760637|NCT01953328|3593970|B5|Non-HeFH and Intensive Statin Use||Stratification Factor|Intensive statin use was defined as daily atorvastatin ≥ 10 mg, fluvastatin ≥ 80 mg, lovastatin ≥ 40 mg, pitavastatin ≥ 2 mg, pravastatin ≥ 40 mg, rosuvastatin ≥ 5 mg, simvastatin ≥ 20 mg, or any statin plus ezetimibe. Non-intensive is defined as any dose of a statin at least weekly for the last 4 weeks prior to screening and not included in the above.|participants|Number|11|11.0||||||
3760638|NCT01953328|3593971|B4|Non-HeFH and Intensive Statin Use||Stratification Factor|Intensive statin use was defined as daily atorvastatin ≥ 10 mg, fluvastatin ≥ 80 mg, lovastatin ≥ 40 mg, pitavastatin ≥ 2 mg, pravastatin ≥ 40 mg, rosuvastatin ≥ 5 mg, simvastatin ≥ 20 mg, or any statin plus ezetimibe. Non-intensive is defined as any dose of a statin at least weekly for the last 4 weeks prior to screening and not included in the above.|participants|Number|10|10.0||||||
3760639|NCT01953328|3593972|B3|Non-HeFH and Intensive Statin Use||Stratification Factor|Intensive statin use was defined as daily atorvastatin ≥ 10 mg, fluvastatin ≥ 80 mg, lovastatin ≥ 40 mg, pitavastatin ≥ 2 mg, pravastatin ≥ 40 mg, rosuvastatin ≥ 5 mg, simvastatin ≥ 20 mg, or any statin plus ezetimibe. Non-intensive is defined as any dose of a statin at least weekly for the last 4 weeks prior to screening and not included in the above.|participants|Number|11|11.0||||||
3760640|NCT01953328|3593973|B2|Non-HeFH and Intensive Statin Use||Stratification Factor|Intensive statin use was defined as daily atorvastatin ≥ 10 mg, fluvastatin ≥ 80 mg, lovastatin ≥ 40 mg, pitavastatin ≥ 2 mg, pravastatin ≥ 40 mg, rosuvastatin ≥ 5 mg, simvastatin ≥ 20 mg, or any statin plus ezetimibe. Non-intensive is defined as any dose of a statin at least weekly for the last 4 weeks prior to screening and not included in the above.|participants|Number|10|10.0||||||
3760641|NCT01953328|3593974|B1|Non-HeFH and Intensive Statin Use||Stratification Factor|Intensive statin use was defined as daily atorvastatin ≥ 10 mg, fluvastatin ≥ 80 mg, lovastatin ≥ 40 mg, pitavastatin ≥ 2 mg, pravastatin ≥ 40 mg, rosuvastatin ≥ 5 mg, simvastatin ≥ 20 mg, or any statin plus ezetimibe. Non-intensive is defined as any dose of a statin at least weekly for the last 4 weeks prior to screening and not included in the above.|participants|Number|10|10.0||||||
3760642|NCT01953328|3593966|B9|Diagnosis of HeFH||Stratification Factor|Intensive statin use was defined as daily atorvastatin ≥ 10 mg, fluvastatin ≥ 80 mg, lovastatin ≥ 40 mg, pitavastatin ≥ 2 mg, pravastatin ≥ 40 mg, rosuvastatin ≥ 5 mg, simvastatin ≥ 20 mg, or any statin plus ezetimibe. Non-intensive is defined as any dose of a statin at least weekly for the last 4 weeks prior to screening and not included in the above.|participants|Number|21|21.0||||||
3760643|NCT01953328|3593967|B8|Diagnosis of HeFH||Stratification Factor|Intensive statin use was defined as daily atorvastatin ≥ 10 mg, fluvastatin ≥ 80 mg, lovastatin ≥ 40 mg, pitavastatin ≥ 2 mg, pravastatin ≥ 40 mg, rosuvastatin ≥ 5 mg, simvastatin ≥ 20 mg, or any statin plus ezetimibe. Non-intensive is defined as any dose of a statin at least weekly for the last 4 weeks prior to screening and not included in the above.|participants|Number|3|3.0||||||
3760644|NCT01953328|3593968|B7|Diagnosis of HeFH||Stratification Factor|Intensive statin use was defined as daily atorvastatin ≥ 10 mg, fluvastatin ≥ 80 mg, lovastatin ≥ 40 mg, pitavastatin ≥ 2 mg, pravastatin ≥ 40 mg, rosuvastatin ≥ 5 mg, simvastatin ≥ 20 mg, or any statin plus ezetimibe. Non-intensive is defined as any dose of a statin at least weekly for the last 4 weeks prior to screening and not included in the above.|participants|Number|3|3.0||||||
3760645|NCT01953328|3593969|B6|Diagnosis of HeFH||Stratification Factor|Intensive statin use was defined as daily atorvastatin ≥ 10 mg, fluvastatin ≥ 80 mg, lovastatin ≥ 40 mg, pitavastatin ≥ 2 mg, pravastatin ≥ 40 mg, rosuvastatin ≥ 5 mg, simvastatin ≥ 20 mg, or any statin plus ezetimibe. Non-intensive is defined as any dose of a statin at least weekly for the last 4 weeks prior to screening and not included in the above.|participants|Number|2|2.0||||||
3760646|NCT01953328|3593970|B5|Diagnosis of HeFH||Stratification Factor|Intensive statin use was defined as daily atorvastatin ≥ 10 mg, fluvastatin ≥ 80 mg, lovastatin ≥ 40 mg, pitavastatin ≥ 2 mg, pravastatin ≥ 40 mg, rosuvastatin ≥ 5 mg, simvastatin ≥ 20 mg, or any statin plus ezetimibe. Non-intensive is defined as any dose of a statin at least weekly for the last 4 weeks prior to screening and not included in the above.|participants|Number|3|3.0||||||
3760647|NCT01953328|3593971|B4|Diagnosis of HeFH||Stratification Factor|Intensive statin use was defined as daily atorvastatin ≥ 10 mg, fluvastatin ≥ 80 mg, lovastatin ≥ 40 mg, pitavastatin ≥ 2 mg, pravastatin ≥ 40 mg, rosuvastatin ≥ 5 mg, simvastatin ≥ 20 mg, or any statin plus ezetimibe. Non-intensive is defined as any dose of a statin at least weekly for the last 4 weeks prior to screening and not included in the above.|participants|Number|3|3.0||||||
3760648|NCT01953328|3593972|B3|Diagnosis of HeFH||Stratification Factor|Intensive statin use was defined as daily atorvastatin ≥ 10 mg, fluvastatin ≥ 80 mg, lovastatin ≥ 40 mg, pitavastatin ≥ 2 mg, pravastatin ≥ 40 mg, rosuvastatin ≥ 5 mg, simvastatin ≥ 20 mg, or any statin plus ezetimibe. Non-intensive is defined as any dose of a statin at least weekly for the last 4 weeks prior to screening and not included in the above.|participants|Number|2|2.0||||||
3760701|NCT01953328|3593971|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3760702|NCT01953328|3593972|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3760703|NCT01953328|3593973|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3760649|NCT01953328|3593973|B2|Diagnosis of HeFH||Stratification Factor|Intensive statin use was defined as daily atorvastatin ≥ 10 mg, fluvastatin ≥ 80 mg, lovastatin ≥ 40 mg, pitavastatin ≥ 2 mg, pravastatin ≥ 40 mg, rosuvastatin ≥ 5 mg, simvastatin ≥ 20 mg, or any statin plus ezetimibe. Non-intensive is defined as any dose of a statin at least weekly for the last 4 weeks prior to screening and not included in the above.|participants|Number|2|2.0||||||
3760650|NCT01953328|3593974|B1|Diagnosis of HeFH||Stratification Factor|Intensive statin use was defined as daily atorvastatin ≥ 10 mg, fluvastatin ≥ 80 mg, lovastatin ≥ 40 mg, pitavastatin ≥ 2 mg, pravastatin ≥ 40 mg, rosuvastatin ≥ 5 mg, simvastatin ≥ 20 mg, or any statin plus ezetimibe. Non-intensive is defined as any dose of a statin at least weekly for the last 4 weeks prior to screening and not included in the above.|participants|Number|3|3.0||||||
3760651|NCT01953328|3593966|B9|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3760652|NCT01953328|3593967|B8|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3760653|NCT01953328|3593968|B7|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3760654|NCT01953328|3593969|B6|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3760655|NCT01953328|3593970|B5|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3760656|NCT01953328|3593971|B4|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3760657|NCT01953328|3593972|B3|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3760658|NCT01953328|3593973|B2|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3760659|NCT01953328|3593974|B1|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3760660|NCT01953328|3593966|B9|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3760661|NCT01953328|3593967|B8|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3760662|NCT01953328|3593968|B7|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3760663|NCT01953328|3593969|B6|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3760664|NCT01953328|3593970|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3760665|NCT01953328|3593971|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3760666|NCT01953328|3593972|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3760667|NCT01953328|3593973|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3760668|NCT01953328|3593974|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3760669|NCT01953328|3593966|B9|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3760670|NCT01953328|3593967|B8|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3760671|NCT01953328|3593968|B7|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3760672|NCT01953328|3593969|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3760673|NCT01953328|3593970|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3760674|NCT01953328|3593971|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3760675|NCT01953328|3593972|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3760676|NCT01953328|3593973|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3760677|NCT01953328|3593974|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3760678|NCT01953328|3593966|B9|Asian||Race/Ethnicity, Customized||participants|Number|404|404.0||||||
3760679|NCT01953328|3593967|B8|Asian||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
3760680|NCT01953328|3593968|B7|Asian||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
3760681|NCT01953328|3593969|B6|Asian||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
3760682|NCT01953328|3593970|B5|Asian||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
3760683|NCT01953328|3593971|B4|Asian||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
3760684|NCT01953328|3593972|B3|Asian||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
3760685|NCT01953328|3593973|B2|Asian||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
3760686|NCT01953328|3593974|B1|Asian||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
3760687|NCT01953328|3593966|B9|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3760688|NCT01953328|3593967|B8|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3760689|NCT01953328|3593968|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3760690|NCT01953328|3593969|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3760691|NCT01953328|3593970|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3760692|NCT01953328|3593971|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3760693|NCT01953328|3593972|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3760694|NCT01953328|3593973|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3760695|NCT01953328|3593974|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3760696|NCT01953328|3593966|B9||Male|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
3760697|NCT01953328|3593967|B8||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3760698|NCT01953328|3593968|B7||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3760699|NCT01953328|3593969|B6||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3760700|NCT01953328|3593970|B5||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3760704|NCT01953328|3593974|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3760705|NCT01953328|3593966|B9||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3760706|NCT01953328|3593967|B8||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3760707|NCT01953328|3593968|B7||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3760708|NCT01953328|3593969|B6||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3760709|NCT01953328|3593970|B5||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3760710|NCT01953328|3593971|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3760711|NCT01953328|3593972|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3760712|NCT01953328|3593973|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3760713|NCT01953328|3593974|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3760714|NCT01953328|3593966|B9|||Age||years|Mean|61.3|61.3|Standard Deviation|10.3|10.3|||
3760715|NCT01953328|3593967|B8|||Age||years|Mean|61.8|61.8|Standard Deviation|11.9|11.9|||
3760716|NCT01953328|3593968|B7|||Age||years|Mean|60.1|60.1|Standard Deviation|9.9|9.9|||
3760717|NCT01953328|3593969|B6|||Age||years|Mean|60.4|60.4|Standard Deviation|10.5|10.5|||
3760718|NCT01953328|3593970|B5|||Age||years|Mean|60.4|60.4|Standard Deviation|10.4|10.4|||
3760719|NCT01953328|3593971|B4|||Age||years|Mean|60.1|60.1|Standard Deviation|11.6|11.6|||
3760720|NCT01953328|3593972|B3|||Age||years|Mean|65.2|65.2|Standard Deviation|7.8|7.8|||
3760721|NCT01953328|3593973|B2|||Age||years|Mean|60.6|60.6|Standard Deviation|9.9|9.9|||
3760722|NCT01953328|3593974|B1|||Age||years|Mean|62.1|62.1|Standard Deviation|9.9|9.9|||
3760723|NCT01953237|3594183|B3|Race|Multiple races|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3760724|NCT01953237|3594184|B2|Race|Multiple races|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3760725|NCT01953237|3594185|B1|Race|Multiple races|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3760726|NCT01953237|3594183|B3|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3760727|NCT01953237|3594184|B2|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3760728|NCT01953237|3594185|B1|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3760729|NCT01953237|3594183|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3760730|NCT01953237|3594184|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3760731|NCT01953237|3594185|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3760732|NCT01953237|3594183|B3||Male|Gender||Participants|Count of Participants|18|18.0||||||
3760733|NCT01953237|3594184|B2||Male|Gender||Participants|Count of Participants|12|12.0||||||
3760734|NCT01953237|3594185|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
3760735|NCT01953237|3594183|B3||Female|Gender||Participants|Count of Participants|13|13.0||||||
3760736|NCT01953237|3594184|B2||Female|Gender||Participants|Count of Participants|9|9.0||||||
3760737|NCT01953237|3594185|B1||Female|Gender||Participants|Count of Participants|4|4.0||||||
3760738|NCT01953237|3594183|B3|||Age||years|Mean|48.3|48.3|Standard Deviation|11.1|11.1|||
3760739|NCT01953237|3594184|B2|||Age||years|Mean|49.5|49.5|Standard Deviation|10.2|10.2|||
3760740|NCT01953237|3594185|B1|||Age||years|Mean|45.7|45.7|Standard Deviation|12.9|12.9|||
3760741|NCT01953224|3594192|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3760742|NCT01953224|3594193|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3760743|NCT01953224|3594194|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3760744|NCT01953224|3594192|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3760745|NCT01953224|3594193|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760746|NCT01953224|3594194|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3760747|NCT01953224|3594192|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760748|NCT01953224|3594193|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760749|NCT01953224|3594194|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760750|NCT01953224|3594192|B3||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3760751|NCT01953224|3594193|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3760752|NCT01953224|3594194|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3760753|NCT01953224|3594192|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3760754|NCT01953224|3594193|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3760755|NCT01953224|3594194|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3760756|NCT01953224|3594192|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760757|NCT01953224|3594193|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760758|NCT01953224|3594194|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760759|NCT01953224|3594192|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3760760|NCT01953224|3594193|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3760761|NCT01953224|3594194|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760762|NCT01953224|3594192|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760763|NCT01953224|3594193|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760764|NCT01953224|3594194|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760765|NCT01953224|3594192|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760766|NCT01953224|3594193|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760767|NCT01953224|3594194|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760768|NCT01953224|3594192|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3760769|NCT01953224|3594193|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3760770|NCT01953224|3594194|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3760771|NCT01953224|3594192|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3760772|NCT01953224|3594193|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3760773|NCT01953224|3594194|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3760774|NCT01953224|3594192|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3760775|NCT01953224|3594193|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3760776|NCT01953224|3594194|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3760777|NCT01953224|3594192|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3760778|NCT01953224|3594193|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3760779|NCT01953224|3594194|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3760780|NCT01953224|3594192|B3|||Age||years|Mean|48.00|48.0|Standard Deviation|12.63|12.63|||
3760781|NCT01953224|3594193|B2|||Age||years|Mean|49.1|49.1|Standard Deviation|12.01|12.01|||
3760782|NCT01953224|3594194|B1|||Age||years|Mean|46.9|46.9|Standard Deviation|13.44|13.44|||
3760783|NCT01953081|3594211|B3|Australia||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3760784|NCT01953081|3594212|B2|Australia||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3760785|NCT01953081|3594213|B1|Australia||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3760786|NCT01953081|3594211|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760787|NCT01953081|3594212|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760788|NCT01953081|3594213|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760789|NCT01953081|3594211|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760790|NCT01953081|3594212|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760791|NCT01953081|3594213|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760792|NCT01953081|3594211|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3760793|NCT01953081|3594212|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3760794|NCT01953081|3594213|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3760795|NCT01953081|3594211|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760796|NCT01953081|3594212|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760797|NCT01953081|3594213|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760798|NCT01953081|3594211|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760799|NCT01953081|3594212|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760800|NCT01953081|3594213|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760801|NCT01953081|3594211|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760802|NCT01953081|3594212|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760803|NCT01953081|3594213|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760804|NCT01953081|3594211|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760805|NCT01953081|3594212|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760806|NCT01953081|3594213|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760807|NCT01953081|3594211|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3760808|NCT01953081|3594212|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3760809|NCT01953081|3594213|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3760810|NCT01953081|3594211|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3760811|NCT01953081|3594212|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3760812|NCT01953081|3594213|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3760813|NCT01953081|3594211|B3|||Age||years|Mean|54.7|54.7|Standard Deviation|19.9|19.9|||
3760814|NCT01953081|3594212|B2|||Age||years|Mean|55.5|55.5|Standard Deviation|13.37|13.37|||
3760815|NCT01953081|3594213|B1|||Age||years|Mean|54.0|54.0|Standard Deviation|25.29|25.29|||
3760816|NCT01952834|3594230|B1|Non-Hypertensive||History of Hypertension||participants|Number|10|10.0||||||
3760817|NCT01952834|3594230|B1|Hypertensive||History of Hypertension||participants|Number|11|11.0||||||
3760818|NCT01952834|3594230|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3760819|NCT01952834|3594230|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760820|NCT01952834|3594230|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760821|NCT01952834|3594230|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3760822|NCT01952834|3594230|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760823|NCT01952834|3594230|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760824|NCT01952834|3594230|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760825|NCT01952834|3594230|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760826|NCT01952834|3594230|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3760827|NCT01952834|3594230|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3760828|NCT01952834|3594230|B1|||Age||years|Mean|64|64.0|Standard Deviation|7|7.0|||
3760829|NCT01952691|3594237|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3760830|NCT01952691|3594237|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3760831|NCT01952691|3594237|B1|||Age||years|Mean|43.3|43.3|Standard Deviation|13.3|13.3|||
3760832|NCT01952678|3594243|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3760833|NCT01952678|3594244|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760834|NCT01952678|3594245|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3760835|NCT01952678|3594243|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760836|NCT01952678|3594244|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760837|NCT01952678|3594245|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760838|NCT01952678|3594243|B3||White|Race (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
3760839|NCT01952678|3594244|B2||White|Race (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
3760840|NCT01952678|3594245|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760841|NCT01952678|3594243|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3760842|NCT01952678|3594244|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760843|NCT01952678|3594245|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3760844|NCT01952678|3594243|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3760845|NCT01952678|3594244|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760846|NCT01952678|3594245|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3760847|NCT01952678|3594243|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3760848|NCT01952678|3594244|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760849|NCT01952678|3594245|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3760850|NCT01952678|3594243|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3760851|NCT01952678|3594244|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760852|NCT01952678|3594245|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3760853|NCT01952678|3594243|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3760854|NCT01952678|3594244|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3760855|NCT01952678|3594245|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3760856|NCT01952678|3594243|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|187|187.0||||||
3760857|NCT01952678|3594244|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
3760858|NCT01952678|3594245|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3760859|NCT01952678|3594243|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3760860|NCT01952678|3594244|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3760861|NCT01952678|3594245|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3760862|NCT01952678|3594243|B3||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3760863|NCT01952678|3594244|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3760864|NCT01952678|3594245|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3760865|NCT01952678|3594243|B3||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3760866|NCT01952678|3594244|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3760867|NCT01952678|3594245|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3760868|NCT01952678|3594243|B3|||Age||years|Mean|66.4|66.4|Standard Deviation|10.86|10.86|||
3760869|NCT01952678|3594244|B2|||Age||years|Mean|66.4|66.4|Standard Deviation|10.67|10.67|||
3760870|NCT01952678|3594245|B1|||Age||years|Mean|66.4|66.4|Standard Deviation|11.09|11.09|||
3760871|NCT01952665|3594262|B3|United States||Region of Enrollment||participants|Number|63|63.0||||||
3760872|NCT01952665|3594263|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
3760873|NCT01952665|3594264|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
3760874|NCT01952665|3594262|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3760875|NCT01952665|3594263|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3760876|NCT01952665|3594264|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3760877|NCT01952665|3594262|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3760878|NCT01952665|3594263|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3760879|NCT01952665|3594264|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3760880|NCT01952665|3594262|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3760881|NCT01952665|3594263|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3760882|NCT01952665|3594264|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3760883|NCT01952665|3594262|B3||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
3760884|NCT01952665|3594263|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3760885|NCT01952665|3594264|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3760886|NCT01952665|3594262|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3760887|NCT01952665|3594263|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3760888|NCT01952665|3594264|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3760889|NCT01952600|3594403|B4|United States||Region of Enrollment||participants|Number|180|180.0||||||
3760890|NCT01952600|3594404|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
3760891|NCT01952600|3594405|B2|United States||Region of Enrollment||participants|Number|77|77.0||||||
3760892|NCT01952600|3594406|B1|United States||Region of Enrollment||participants|Number|65|65.0||||||
3760893|NCT01952600|3594403|B4||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3760894|NCT01952600|3594404|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3760895|NCT01952600|3594405|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3760896|NCT01952600|3594406|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3760897|NCT01952600|3594403|B4||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3760898|NCT01952600|3594404|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3760899|NCT01952600|3594405|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3760900|NCT01952600|3594406|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3760901|NCT01952600|3594403|B4|||Age||years|Mean|57.54|57.54|Standard Deviation|16.76|16.76|||
3760902|NCT01952600|3594404|B3|||Age||years|Mean|50.37|50.37|Standard Deviation|14.81|14.81|||
3760903|NCT01952600|3594405|B2|||Age||years|Mean|56.14|56.14|Standard Deviation|16.65|16.65|||
3760904|NCT01952600|3594406|B1|||Age||years|Mean|63.40|63.4|Standard Deviation|56.14|56.14|||
3760905|NCT01952600|3594403|B4||>=65 years|Age||Participants|Count of Participants|63|63.0||||||
3760906|NCT01952600|3594404|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3760907|NCT01952600|3594405|B2||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3760908|NCT01952600|3594406|B1||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
3760909|NCT01952600|3594403|B4||Between 18 and 65 years|Age||Participants|Count of Participants|117|117.0||||||
3760910|NCT01952600|3594404|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3760911|NCT01952600|3594405|B2||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
3760912|NCT01952600|3594406|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3760913|NCT01952600|3594403|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3760914|NCT01952600|3594404|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3760915|NCT01952600|3594405|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3760916|NCT01952600|3594406|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3760917|NCT01952574|3594416|B5|||Monthly Migraine Days|A migraine day was any calendar day in which the participant experienced a qualified migraine headache (onset, continuation, or recurrence of the migraine headache). A qualified migraine headache was defined as a migraine without aura or a migraine with aura. Monthly migraine days were calculated as the number of migraine days in the 4-week baseline phase.|migraine days/month|Mean|8.73|8.73|Standard Deviation|2.72|2.72|||
3760918|NCT01952574|3594417|B4|||Monthly Migraine Days|A migraine day was any calendar day in which the participant experienced a qualified migraine headache (onset, continuation, or recurrence of the migraine headache). A qualified migraine headache was defined as a migraine without aura or a migraine with aura. Monthly migraine days were calculated as the number of migraine days in the 4-week baseline phase.|migraine days/month|Mean|8.58|8.58|Standard Deviation|2.49|2.49|||
3760919|NCT01952574|3594418|B3|||Monthly Migraine Days|A migraine day was any calendar day in which the participant experienced a qualified migraine headache (onset, continuation, or recurrence of the migraine headache). A qualified migraine headache was defined as a migraine without aura or a migraine with aura. Monthly migraine days were calculated as the number of migraine days in the 4-week baseline phase.|migraine days/month|Mean|8.93|8.93|Standard Deviation|2.88|2.88|||
3760920|NCT01952574|3594419|B2|||Monthly Migraine Days|A migraine day was any calendar day in which the participant experienced a qualified migraine headache (onset, continuation, or recurrence of the migraine headache). A qualified migraine headache was defined as a migraine without aura or a migraine with aura. Monthly migraine days were calculated as the number of migraine days in the 4-week baseline phase.|migraine days/month|Mean|8.62|8.62|Standard Deviation|2.79|2.79|||
3760921|NCT01952574|3594420|B1|||Monthly Migraine Days|A migraine day was any calendar day in which the participant experienced a qualified migraine headache (onset, continuation, or recurrence of the migraine headache). A qualified migraine headache was defined as a migraine without aura or a migraine with aura. Monthly migraine days were calculated as the number of migraine days in the 4-week baseline phase.|migraine days/month|Mean|8.77|8.77|Standard Deviation|2.72|2.72|||
3760922|NCT01952574|3594416|B5||Other|Region|Region is based on actual data collected at study baseline instead of randomization stratification.|Participants|Count of Participants|224|224.0||||||
3760923|NCT01952574|3594417|B4||Other|Region|Region is based on actual data collected at study baseline instead of randomization stratification.|Participants|Count of Participants|49|49.0||||||
3760924|NCT01952574|3594418|B3||Other|Region|Region is based on actual data collected at study baseline instead of randomization stratification.|Participants|Count of Participants|50|50.0||||||
3760925|NCT01952574|3594419|B2||Other|Region|Region is based on actual data collected at study baseline instead of randomization stratification.|Participants|Count of Participants|50|50.0||||||
3760926|NCT01952574|3594420|B1||Other|Region|Region is based on actual data collected at study baseline instead of randomization stratification.|Participants|Count of Participants|75|75.0||||||
3760927|NCT01952574|3594416|B5||North America|Region|Region is based on actual data collected at study baseline instead of randomization stratification.|Participants|Count of Participants|259|259.0||||||
3760928|NCT01952574|3594417|B4||North America|Region|Region is based on actual data collected at study baseline instead of randomization stratification.|Participants|Count of Participants|58|58.0||||||
3760929|NCT01952574|3594418|B3||North America|Region|Region is based on actual data collected at study baseline instead of randomization stratification.|Participants|Count of Participants|58|58.0||||||
3760930|NCT01952574|3594419|B2||North America|Region|Region is based on actual data collected at study baseline instead of randomization stratification.|Participants|Count of Participants|58|58.0||||||
3760931|NCT01952574|3594420|B1||North America|Region|Region is based on actual data collected at study baseline instead of randomization stratification.|Participants|Count of Participants|85|85.0||||||
3760932|NCT01952574|3594416|B5||Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3760933|NCT01952574|3594417|B4||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3760934|NCT01952574|3594418|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3760935|NCT01952574|3594419|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3760936|NCT01952574|3594420|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3760937|NCT01952574|3594416|B5||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3760938|NCT01952574|3594417|B4||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3760939|NCT01952574|3594418|B3||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3760940|NCT01952574|3594419|B2||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3760941|NCT01952574|3594420|B1||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3760942|NCT01952574|3594416|B5||White|Race/Ethnicity, Customized||Participants|Count of Participants|442|442.0||||||
3760943|NCT01952574|3594417|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|103|103.0||||||
3760944|NCT01952574|3594418|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|100|100.0||||||
3760945|NCT01952574|3594419|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|97|97.0||||||
3760946|NCT01952574|3594420|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|142|142.0||||||
3760947|NCT01952574|3594416|B5||Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3760948|NCT01952574|3594417|B4||Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3760949|NCT01952574|3594418|B3||Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3760950|NCT01952574|3594419|B2||Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3760951|NCT01952574|3594420|B1||Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3760952|NCT01952574|3594416|B5||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3760953|NCT01952574|3594417|B4||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3760954|NCT01952574|3594418|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3760955|NCT01952574|3594419|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3760956|NCT01952574|3594420|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3760957|NCT01952574|3594416|B5||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3760958|NCT01952574|3594417|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3760959|NCT01952574|3594418|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3760960|NCT01952574|3594419|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3760961|NCT01952574|3594420|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3760962|NCT01952574|3594416|B5||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3760963|NCT01952574|3594417|B4||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3760964|NCT01952574|3594418|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3760965|NCT01952574|3594419|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3760966|NCT01952574|3594420|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3760967|NCT01952574|3594416|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760968|NCT01952574|3594417|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760969|NCT01952574|3594418|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760970|NCT01952574|3594419|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760971|NCT01952574|3594420|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3760972|NCT01952574|3594416|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|453|453.0||||||
3760973|NCT01952574|3594417|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
3760974|NCT01952574|3594418|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3760975|NCT01952574|3594419|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3760976|NCT01952574|3594420|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|149|149.0||||||
3760977|NCT01952574|3594416|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3760978|NCT01952574|3594417|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3760979|NCT01952574|3594418|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3760980|NCT01952574|3594419|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3760981|NCT01952574|3594420|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3760982|NCT01952574|3594416|B5||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3760983|NCT01952574|3594417|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3760984|NCT01952574|3594418|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3760985|NCT01952574|3594419|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3760986|NCT01952574|3594420|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3760987|NCT01952574|3594416|B5||Female|Sex: Female, Male||Participants|Count of Participants|389|389.0||||||
3760988|NCT01952574|3594417|B4||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3760989|NCT01952574|3594418|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3760990|NCT01952574|3594419|B2||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3760991|NCT01952574|3594420|B1||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3760992|NCT01952574|3594416|B5|||Age||years|Mean|41.1|41.1|Standard Deviation|10.8|10.8|||
3760993|NCT01952574|3594417|B4|||Age||years|Mean|42.6|42.6|Standard Deviation|9.9|9.9|||
3760994|NCT01952574|3594418|B3|||Age||years|Mean|39.9|39.9|Standard Deviation|12.3|12.3|||
3760995|NCT01952574|3594419|B2|||Age||years|Mean|40.3|40.3|Standard Deviation|10.9|10.9|||
3760996|NCT01952574|3594420|B1|||Age||years|Mean|41.4|41.4|Standard Deviation|10.0|10.0|||
3760997|NCT01952418|3594441|B3|United States||Region of Enrollment||participants|Number|1805|1805.0||||||
3760998|NCT01952418|3594442|B2|United States||Region of Enrollment||participants|Number|895|895.0||||||
3760999|NCT01952418|3594443|B1|United States||Region of Enrollment||participants|Number|910|910.0||||||
3761000|NCT01952418|3594441|B3||Male|Sex: Female, Male||Participants|Count of Participants|786|786.0||||||
3761001|NCT01952418|3594442|B2||Male|Sex: Female, Male||Participants|Count of Participants|397|397.0||||||
3761002|NCT01952418|3594443|B1||Male|Sex: Female, Male||Participants|Count of Participants|389|389.0||||||
3761003|NCT01952418|3594441|B3||Female|Sex: Female, Male||Participants|Count of Participants|1019|1019.0||||||
3761004|NCT01952418|3594442|B2||Female|Sex: Female, Male||Participants|Count of Participants|498|498.0||||||
3761005|NCT01952418|3594443|B1||Female|Sex: Female, Male||Participants|Count of Participants|521|521.0||||||
3761006|NCT01952418|3594441|B3|||Age||years|Mean|55.3|55.3|Standard Deviation|11.7|11.7|||
3761007|NCT01952418|3594442|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|11.5|11.5|||
3761008|NCT01952418|3594443|B1|||Age||years|Mean|54.9|54.9|Standard Deviation|11.8|11.8|||
3761009|NCT01952366|3594456|B1|Norway||Region of Enrollment||participants|Number|169|169.0||||||
3761010|NCT01952366|3594456|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3761011|NCT01952366|3594456|B1||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3761012|NCT01952366|3594456|B1|||Age||years|Mean|76.1|76.1|Standard Deviation|6.8|6.8|||
3761013|NCT01952366|3594456|B1||>=65 years|Age||Participants|Count of Participants|163|163.0||||||
3761014|NCT01952366|3594456|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3761015|NCT01952366|3594456|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3761016|NCT01952301|3594463|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3761017|NCT01952301|3594463|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3761018|NCT01952301|3594463|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3761019|NCT01952301|3594463|B1|||Age||years|Mean|51.9|51.9|Standard Deviation|11.2|11.2|||
3761020|NCT01952301|3594463|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3761021|NCT01952301|3594463|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3761022|NCT01952301|3594463|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3761023|NCT01952145|3594469|B3|||Body weight||Kg|Mean|87.8|87.8|Standard Deviation|16.6|16.6|||
3761024|NCT01952145|3594470|B2|||Body weight||Kg|Mean|87.3|87.3|Standard Deviation|15.8|15.8|||
3761025|NCT01952145|3594471|B1|||Body weight||Kg|Mean|88.3|88.3|Standard Deviation|17.5|17.5|||
3761026|NCT01952145|3594469|B3|||Glycated hemoglobin (HbA1c)||Percentage (%)|Mean|8.3|8.3|Standard Deviation|0.9|0.9|||
3761027|NCT01952145|3594470|B2|||Glycated hemoglobin (HbA1c)||Percentage (%)|Mean|8.2|8.2|Standard Deviation|0.9|0.9|||
3761028|NCT01952145|3594471|B1|||Glycated hemoglobin (HbA1c)||Percentage (%)|Mean|8.4|8.4|Standard Deviation|0.9|0.9|||
3761029|NCT01952145|3594469|B3||Male|Sex: Female, Male||Participants|Count of Participants|280|280.0||||||
3761030|NCT01952145|3594470|B2||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3761031|NCT01952145|3594471|B1||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3761032|NCT01952145|3594469|B3||Female|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
3761033|NCT01952145|3594470|B2||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3761034|NCT01952145|3594471|B1||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3761035|NCT01952145|3594469|B3|||Age||Years|Mean|58.8|58.8|Standard Deviation|9.5|9.5|||
3761036|NCT01952145|3594470|B2|||Age||Years|Mean|59.1|59.1|Standard Deviation|9.3|9.3|||
3761037|NCT01952145|3594471|B1|||Age||Years|Mean|58.4|58.4|Standard Deviation|9.8|9.8|||
3761038|NCT01952080|3594482|B5|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3761039|NCT01952080|3594483|B4|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3761040|NCT01952080|3594484|B3|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3761041|NCT01952080|3594485|B2|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3761042|NCT01952080|3594486|B1|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3761043|NCT01952080|3594482|B5|United States||Region of Enrollment||participants|Number|39|39.0||||||
3761044|NCT01952080|3594483|B4|United States||Region of Enrollment||participants|Number|12|12.0||||||
3761045|NCT01952080|3594484|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
3761046|NCT01952080|3594485|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3761047|NCT01952080|3594486|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3761048|NCT01952080|3594482|B5||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3761049|NCT01952080|3594483|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3761050|NCT01952080|3594484|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3761051|NCT01952080|3594485|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3761052|NCT01952080|3594486|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3761053|NCT01952080|3594482|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3761054|NCT01952080|3594483|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3761055|NCT01952080|3594484|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3761056|NCT01952080|3594485|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3761057|NCT01952080|3594486|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3761058|NCT01952080|3594482|B5|13 to 17 years||Age, Customized||participants|Number|3|3.0||||||
3761059|NCT01952080|3594483|B4|13 to 17 years||Age, Customized||participants|Number|1|1.0||||||
3761060|NCT01952080|3594484|B3|13 to 17 years||Age, Customized||participants|Number|1|1.0||||||
3761061|NCT01952080|3594485|B2|13 to 17 years||Age, Customized||participants|Number|1|1.0||||||
3761062|NCT01952080|3594486|B1|13 to 17 years||Age, Customized||participants|Number|0|0.0||||||
3761063|NCT01952080|3594482|B5|4 to 12 years||Age, Customized||participants|Number|17|17.0||||||
3761064|NCT01952080|3594483|B4|4 to 12 years||Age, Customized||participants|Number|7|7.0||||||
3761065|NCT01952080|3594484|B3|4 to 12 years||Age, Customized||participants|Number|7|7.0||||||
3761066|NCT01952080|3594485|B2|4 to 12 years||Age, Customized||participants|Number|3|3.0||||||
3761067|NCT01952080|3594486|B1|4 to 12 years||Age, Customized||participants|Number|0|0.0||||||
3761068|NCT01952080|3594482|B5|1 to 3 years||Age, Customized||participants|Number|22|22.0||||||
3761069|NCT01952080|3594483|B4|1 to 3 years||Age, Customized||participants|Number|7|7.0||||||
3761070|NCT01952080|3594484|B3|1 to 3 years||Age, Customized||participants|Number|6|6.0||||||
3761071|NCT01952080|3594485|B2|1 to 3 years||Age, Customized||participants|Number|4|4.0||||||
3761072|NCT01952080|3594486|B1|1 to 3 years||Age, Customized||participants|Number|5|5.0||||||
3761073|NCT01952080|3594482|B5|||Age||years|Mean|4.7|4.7|Standard Deviation|3.5|3.5|||
3761074|NCT01952080|3594483|B4|||Age||years|Mean|4.5|4.5|Standard Deviation|3.16|3.16|||
3761075|NCT01952080|3594484|B3|||Age||years|Mean|4.6|4.6|Standard Deviation|3.43|3.43|||
3761076|NCT01952080|3594485|B2|||Age||years|Mean|5.1|5.1|Standard Deviation|4.55|4.55|||
3761077|NCT01952080|3594486|B1|||Age||years|Mean|2.2|2.2|Standard Deviation|0.45|0.45|||
3761078|NCT01951963|3594535|B3|United States||Region of Enrollment||participants|Number|63|63.0||||||
3761079|NCT01951963|3594536|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
3761080|NCT01951963|3594537|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
3761081|NCT01951963|3594535|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3761082|NCT01951963|3594536|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3761083|NCT01951963|3594537|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3761084|NCT01951963|3594535|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3761085|NCT01951963|3594536|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3761086|NCT01951963|3594537|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3761087|NCT01951963|3594535|B3|||Age||years|Mean|13.0|13.0|Standard Deviation|3.7|3.7|||
3761088|NCT01951963|3594536|B2|||Age||years|Mean|12.7|12.7|Standard Deviation|3.7|3.7|||
3761089|NCT01951963|3594537|B1|||Age||years|Mean|13.3|13.3|Standard Deviation|3.6|3.6|||
3761090|NCT01951963|3594535|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3761091|NCT01951963|3594536|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3761092|NCT01951963|3594537|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3761093|NCT01951963|3594535|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3761094|NCT01951963|3594536|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3761095|NCT01951963|3594537|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3761096|NCT01951963|3594535|B3||<=18 years|Age||Participants|Count of Participants|63|63.0||||||
3761097|NCT01951963|3594536|B2||<=18 years|Age||Participants|Count of Participants|32|32.0||||||
3761098|NCT01951963|3594537|B1||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
3761099|NCT01951950|3594548|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3761100|NCT01951950|3594549|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3761101|NCT01951950|3594550|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3761102|NCT01951950|3594548|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3761103|NCT01951950|3594549|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3761104|NCT01951950|3594550|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3761105|NCT01951950|3594548|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3761106|NCT01951950|3594549|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3761107|NCT01951950|3594550|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3761108|NCT01951950|3594548|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3761109|NCT01951950|3594549|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3761110|NCT01951950|3594550|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3761111|NCT01951950|3594548|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3761112|NCT01951950|3594549|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3761113|NCT01951950|3594550|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3761114|NCT01951950|3594548|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3761115|NCT01951950|3594549|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3761116|NCT01951950|3594550|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3761117|NCT01951950|3594548|B3|||Age||years|Mean|56.4|56.4|Standard Deviation|12.7|12.7|||
3761118|NCT01951950|3594549|B2|||Age||years|Mean|55.9|55.9|Standard Deviation|12.6|12.6|||
3761119|NCT01951950|3594550|B1|||Age||years|Mean|56.9|56.9|Standard Deviation|12.7|12.7|||
3761120|NCT01951820|3594557|B3|United States||Region of Enrollment||participants|Number|64|64.0||||||
3761121|NCT01951820|3594558|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3761122|NCT01951820|3594559|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
3761123|NCT01951820|3594557|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3761124|NCT01951820|3594558|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3761125|NCT01951820|3594559|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3761126|NCT01951820|3594557|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3761127|NCT01951820|3594558|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3761128|NCT01951820|3594559|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3761129|NCT01951820|3594557|B3|>18 Years||Age, Customized||participants|Number|64|64.0||||||
3761130|NCT01951820|3594558|B2|>18 Years||Age, Customized||participants|Number|30|30.0||||||
3761131|NCT01951820|3594559|B1|>18 Years||Age, Customized||participants|Number|34|34.0||||||
3761132|NCT01951703|3594566|B3|United States||Region of Enrollment||participants|Number|127|127.0||||||
3761133|NCT01951703|3594567|B2|United States||Region of Enrollment||participants|Number|63|63.0||||||
3761134|NCT01951703|3594568|B1|United States||Region of Enrollment||participants|Number|64|64.0||||||
3761135|NCT01951703|3594566|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761136|NCT01951703|3594567|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761137|NCT01951703|3594568|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761138|NCT01951703|3594566|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761139|NCT01951703|3594567|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761140|NCT01951703|3594568|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761141|NCT01951703|3594566|B3||White|Race (NIH/OMB)||Participants|Count of Participants|117|117.0||||||
3761142|NCT01951703|3594567|B2||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3761143|NCT01951703|3594568|B1||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3761144|NCT01951703|3594566|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3761145|NCT01951703|3594567|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3761146|NCT01951703|3594568|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3761147|NCT01951703|3594566|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3761148|NCT01951703|3594567|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3761149|NCT01951703|3594568|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761150|NCT01951703|3594566|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3761151|NCT01951703|3594567|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3761152|NCT01951703|3594568|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3761153|NCT01951703|3594566|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761154|NCT01951703|3594567|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761155|NCT01951703|3594568|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761156|NCT01951703|3594566|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3761157|NCT01951703|3594567|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3761158|NCT01951703|3594568|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3761159|NCT01951703|3594566|B3||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3761160|NCT01951703|3594567|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3761161|NCT01951703|3594568|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3761162|NCT01951703|3594566|B3|||Age||years|Mean|35.2|35.2|Standard Deviation|9.60|9.6|||
3761163|NCT01951703|3594567|B2|||Age||years|Mean|35.0|35.0|Standard Deviation|9.63|9.63|||
3761164|NCT01951703|3594568|B1|||Age||years|Mean|35.5|35.5|Standard Deviation|9.73|9.73|||
3761165|NCT01951703|3594566|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3761166|NCT01951703|3594567|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3761167|NCT01951703|3594568|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3761168|NCT01951703|3594566|B3||Between 18 and 65 years|Age||Participants|Count of Participants|125|125.0||||||
3761169|NCT01951703|3594567|B2||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
3761170|NCT01951703|3594568|B1||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
3761171|NCT01951703|3594566|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3761172|NCT01951703|3594567|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3761173|NCT01951703|3594568|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3761174|NCT01951651|3594577|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
3761175|NCT01951651|3594578|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3761176|NCT01951651|3594579|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3761177|NCT01951651|3594577|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3761178|NCT01951651|3594578|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3761179|NCT01951651|3594579|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3761180|NCT01951651|3594577|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3761181|NCT01951651|3594578|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3761182|NCT01951651|3594579|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3761183|NCT01951651|3594577|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3761184|NCT01951651|3594578|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3761185|NCT01951651|3594579|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3761186|NCT01951651|3594577|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3761187|NCT01951651|3594578|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3761188|NCT01951651|3594579|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3761189|NCT01951651|3594577|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3761190|NCT01951651|3594578|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3761191|NCT01951651|3594579|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3761192|NCT01951586|3594592|B3|||Time from Initial Diagnosis of NSCLC to Randomization||months|Mean|4.99|4.99|Standard Deviation|14.17|14.17|||
3761193|NCT01951586|3594593|B2|||Time from Initial Diagnosis of NSCLC to Randomization||months|Mean|6.32|6.32|Standard Deviation|16.96|16.96|||
3761194|NCT01951586|3594594|B1|||Time from Initial Diagnosis of NSCLC to Randomization||months|Mean|2.46|2.46|Standard Deviation|5.28|5.28|||
3761195|NCT01951586|3594592|B3|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1~= Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self- Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead."|participants|Number|124|124.0||||||
3761196|NCT01951586|3594593|B2|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1~= Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self- Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead."|participants|Number|79|79.0||||||
3761197|NCT01951586|3594594|B1|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1~= Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self- Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead."|participants|Number|45|45.0||||||
3761198|NCT01951586|3594592|B3|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1~= Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self- Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead."|participants|Number|102|102.0||||||
3761245|NCT01951417|3594630|B1|V||Fitzpatrick Skin Type|"Investigator assessment based on the standard Fitzpatrick Skin Type Scale (I to VI).~TYPE 1: Highly sensitive, always burns, never tans. TYP E 2: Very sun sensitive, burns easily, tans minimally. TYPE 3: Sun sensitive skin, sometimes burns, slowly tans to light brown. TYPE 4: Minimally sun sensitive, burns minimally, always tans to moderate brown.~TYPE 5: Sun insensitive skin, rarely burns, tans well. TYPE 6: Sun insensitive, never burns, deeply pigmented."|participants|Number|13|13.0||||||
3761199|NCT01951586|3594593|B2|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1~= Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self- Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead."|participants|Number|69|69.0||||||
3761200|NCT01951586|3594594|B1|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1~= Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self- Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead."|participants|Number|33|33.0||||||
3761201|NCT01951586|3594592|B3|Rest of World||Geographic region||participants|Number|31|31.0||||||
3761202|NCT01951586|3594593|B2|Rest of World||Geographic region||participants|Number|18|18.0||||||
3761203|NCT01951586|3594594|B1|Rest of World||Geographic region||participants|Number|13|13.0||||||
3761204|NCT01951586|3594592|B3|Western Europe||Geographic region||participants|Number|102|102.0||||||
3761205|NCT01951586|3594593|B2|Western Europe||Geographic region||participants|Number|67|67.0||||||
3761206|NCT01951586|3594594|B1|Western Europe||Geographic region||participants|Number|35|35.0||||||
3761207|NCT01951586|3594592|B3|North America/Australia||Geographic region||participants|Number|93|93.0||||||
3761208|NCT01951586|3594593|B2|North America/Australia||Geographic region||participants|Number|63|63.0||||||
3761209|NCT01951586|3594594|B1|North America/Australia||Geographic region||participants|Number|30|30.0||||||
3761210|NCT01951586|3594592|B3|Non-squamous||Histology|Data are based on randomized strata.|participants|Number|173|173.0||||||
3761211|NCT01951586|3594593|B2|Non-squamous||Histology|Data are based on randomized strata.|participants|Number|113|113.0||||||
3761212|NCT01951586|3594594|B1|Non-squamous||Histology|Data are based on randomized strata.|participants|Number|60|60.0||||||
3761213|NCT01951586|3594592|B3|Squamous||Histology|Data are based on randomized strata.|participants|Number|53|53.0||||||
3761214|NCT01951586|3594593|B2|Squamous||Histology|Data are based on randomized strata.|participants|Number|35|35.0||||||
3761215|NCT01951586|3594594|B1|Squamous||Histology|Data are based on randomized strata.|participants|Number|18|18.0||||||
3761216|NCT01951586|3594592|B3|No||Presence of Bone Metastasis|Data are based on randomized strata.|participants|Number|126|126.0||||||
3761217|NCT01951586|3594593|B2|No||Presence of Bone Metastasis|Data are based on randomized strata.|participants|Number|83|83.0||||||
3761218|NCT01951586|3594594|B1|No||Presence of Bone Metastasis|Data are based on randomized strata.|participants|Number|43|43.0||||||
3761219|NCT01951586|3594592|B3|Yes||Presence of Bone Metastasis|Data are based on randomized strata.|participants|Number|100|100.0||||||
3761220|NCT01951586|3594593|B2|Yes||Presence of Bone Metastasis|Data are based on randomized strata.|participants|Number|65|65.0||||||
3761221|NCT01951586|3594594|B1|Yes||Presence of Bone Metastasis|Data are based on randomized strata.|participants|Number|35|35.0||||||
3761222|NCT01951586|3594592|B3|Others||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3761223|NCT01951586|3594593|B2|Others||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3761224|NCT01951586|3594594|B1|Others||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3761225|NCT01951586|3594592|B3|White or Caucasian||Race/Ethnicity, Customized||participants|Number|206|206.0||||||
3761226|NCT01951586|3594593|B2|White or Caucasian||Race/Ethnicity, Customized||participants|Number|133|133.0||||||
3761227|NCT01951586|3594594|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|73|73.0||||||
3761228|NCT01951586|3594592|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3761229|NCT01951586|3594593|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3761230|NCT01951586|3594594|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3761231|NCT01951586|3594592|B3||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3761232|NCT01951586|3594593|B2||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3761233|NCT01951586|3594594|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3761234|NCT01951586|3594592|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3761235|NCT01951586|3594593|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3761236|NCT01951586|3594594|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3761237|NCT01951586|3594592|B3|||Age||years|Mean|63.8|63.8|Standard Deviation|9.8|9.8|||
3761238|NCT01951586|3594593|B2|||Age||years|Mean|63.8|63.8|Standard Deviation|9.7|9.7|||
3761239|NCT01951586|3594594|B1|||Age||years|Mean|64.0|64.0|Standard Deviation|10.1|10.1|||
3761240|NCT01951573|3594619|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3761241|NCT01951573|3594619|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3761242|NCT01951573|3594619|B1|||Age||years|Mean|59.9|59.9|Standard Deviation|8.2|8.2|||
3761243|NCT01951417|3594630|B1|||History of Acne||years|Mean|4.4|4.4|Standard Deviation|4.7|4.7|||
3761244|NCT01951417|3594630|B1|VI||Fitzpatrick Skin Type|"Investigator assessment based on the standard Fitzpatrick Skin Type Scale (I to VI).~TYPE 1: Highly sensitive, always burns, never tans. TYP E 2: Very sun sensitive, burns easily, tans minimally. TYPE 3: Sun sensitive skin, sometimes burns, slowly tans to light brown. TYPE 4: Minimally sun sensitive, burns minimally, always tans to moderate brown.~TYPE 5: Sun insensitive skin, rarely burns, tans well. TYPE 6: Sun insensitive, never burns, deeply pigmented."|participants|Number|10|10.0||||||
3761289|NCT01951066|3594681|B1|Severe||Baseline Intraretinal Fluid||participants|Number|3|3.0||||||
3761246|NCT01951417|3594630|B1|IV||Fitzpatrick Skin Type|"Investigator assessment based on the standard Fitzpatrick Skin Type Scale (I to VI).~TYPE 1: Highly sensitive, always burns, never tans. TYP E 2: Very sun sensitive, burns easily, tans minimally. TYPE 3: Sun sensitive skin, sometimes burns, slowly tans to light brown. TYPE 4: Minimally sun sensitive, burns minimally, always tans to moderate brown.~TYPE 5: Sun insensitive skin, rarely burns, tans well. TYPE 6: Sun insensitive, never burns, deeply pigmented."|participants|Number|19|19.0||||||
3761247|NCT01951417|3594630|B1|III||Fitzpatrick Skin Type|"Investigator assessment based on the standard Fitzpatrick Skin Type Scale (I to VI).~TYPE 1: Highly sensitive, always burns, never tans. TYP E 2: Very sun sensitive, burns easily, tans minimally. TYPE 3: Sun sensitive skin, sometimes burns, slowly tans to light brown. TYPE 4: Minimally sun sensitive, burns minimally, always tans to moderate brown.~TYPE 5: Sun insensitive skin, rarely burns, tans well. TYPE 6: Sun insensitive, never burns, deeply pigmented."|participants|Number|16|16.0||||||
3761248|NCT01951417|3594630|B1|II||Fitzpatrick Skin Type|"Investigator assessment based on the standard Fitzpatrick Skin Type Scale (I to VI).~TYPE 1: Highly sensitive, always burns, never tans. TYP E 2: Very sun sensitive, burns easily, tans minimally. TYPE 3: Sun sensitive skin, sometimes burns, slowly tans to light brown. TYPE 4: Minimally sun sensitive, burns minimally, always tans to moderate brown.~TYPE 5: Sun insensitive skin, rarely burns, tans well. TYPE 6: Sun insensitive, never burns, deeply pigmented."|participants|Number|20|20.0||||||
3761249|NCT01951417|3594630|B1|I||Fitzpatrick Skin Type|"Investigator assessment based on the standard Fitzpatrick Skin Type Scale (I to VI).~TYPE 1: Highly sensitive, always burns, never tans. TYP E 2: Very sun sensitive, burns easily, tans minimally. TYPE 3: Sun sensitive skin, sometimes burns, slowly tans to light brown. TYPE 4: Minimally sun sensitive, burns minimally, always tans to moderate brown.~TYPE 5: Sun insensitive skin, rarely burns, tans well. TYPE 6: Sun insensitive, never burns, deeply pigmented."|participants|Number|3|3.0||||||
3761250|NCT01951417|3594630|B1|Combination||Skin Type||participants|Number|22|22.0||||||
3761251|NCT01951417|3594630|B1|Oily||Skin Type||participants|Number|32|32.0||||||
3761252|NCT01951417|3594630|B1|Normal||Skin Type||participants|Number|22|22.0||||||
3761253|NCT01951417|3594630|B1|Dry||Skin Type||participants|Number|5|5.0||||||
3761254|NCT01951417|3594630|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761255|NCT01951417|3594630|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3761256|NCT01951417|3594630|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3761257|NCT01951417|3594630|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3761258|NCT01951417|3594630|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761259|NCT01951417|3594630|B1||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3761260|NCT01951417|3594630|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3761261|NCT01951417|3594630|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761262|NCT01951417|3594630|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3761263|NCT01951417|3594630|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3761264|NCT01951417|3594630|B1||Male|Sex: Female, Male|Safety Population|Participants|Count of Participants|41|41.0||||||
3761265|NCT01951417|3594630|B1||Female|Sex: Female, Male|Safety Population|Participants|Count of Participants|40|40.0||||||
3761266|NCT01951417|3594630|B1|||Age||years|Mean|19.0|19.0|Standard Deviation|7.8|7.8|||
3761267|NCT01951170|3594653|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3761268|NCT01951170|3594653|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3761269|NCT01951170|3594653|B1|||Age||years|Mean|56.87|56.87|Standard Deviation|11.525|11.525|||
3761270|NCT01951092|3594676|B1|||Participants with HIV PVL <200 copies/mL|Number of patients with baseline HIV PVL <200 copies/mL|participants|Number|18|18.0||||||
3761271|NCT01951092|3594676|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
3761272|NCT01951092|3594676|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3761273|NCT01951092|3594676|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3761274|NCT01951092|3594676|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3761275|NCT01951092|3594676|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3761276|NCT01951092|3594676|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761277|NCT01951092|3594676|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761278|NCT01951092|3594676|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3761279|NCT01951092|3594676|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3761280|NCT01951092|3594676|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3761281|NCT01951092|3594676|B1|||Age||years|Median|36|36.0|Full Range|||19.0|64.0|
3761282|NCT01951066|3594681|B1|||Baseline Central Subfield Thickness|The Central Subfield Thickness (CST) was measured using Spectralis OCT machine.|Microns|Mean|464.3|464.3|Full Range|||280.0|779.0|
3761283|NCT01951066|3594681|B1|||Baseline Best Corrected Visual Acuity|The Best Corrected Visual Acuity (BCVA) was measured using the Early Treatment of Diabetic Retinopathy Study (ETDRS) Score. Patient can have an ETDRS score ranging from 5 to 100. A higher ETDRS Score represents better visual acuity.|ETDRS Score|Mean|56.1|56.1|Full Range|||30.0|74.0|
3761284|NCT01951066|3594681|B1|Scatter Laser Photocoagulation||Prior Laser||participants|Number|6|6.0||||||
3761285|NCT01951066|3594681|B1|Grid Laser||Prior Laser||participants|Number|6|6.0||||||
3761286|NCT01951066|3594681|B1|||Prior Intraocular Steroids||participants|Number|5|5.0||||||
3761287|NCT01951066|3594681|B1|||Prior Anti-VEGF injections||Injections|Mean|13.3|13.3|Full Range|||0.0|56.0|
3761288|NCT01951066|3594681|B1|||Mean Disease Duration||Months|Mean|48.1|48.1|Full Range|||3.0|132.0|
3761290|NCT01951066|3594681|B1|Moderate||Baseline Intraretinal Fluid||participants|Number|14|14.0||||||
3761291|NCT01951066|3594681|B1|Mild||Baseline Intraretinal Fluid||participants|Number|3|3.0||||||
3761292|NCT01951066|3594681|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3761293|NCT01951066|3594681|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3761294|NCT01951066|3594681|B1|||Age||years|Mean|61.8|61.8|Full Range|||47.0|75.0|
3761295|NCT01950741|3594687|B1|||Visual acuity|Visual acuity was assessed using the Early Treatment Diabetic Retinopathy Study (ETDRS) chart. The ETDRS chart includes 100 letters as the maximum possible score, and 0 letters read as the minimum possible score. Higher scores represents better functioning. ETDRS letters of 85 are equivalent to 20/20 of vision.|letters|Mean|54.4|54.4|Standard Deviation|18.1|18.1|||
3761296|NCT01950741|3594687|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3761297|NCT01950741|3594687|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3761298|NCT01950741|3594687|B1|||Age||years|Mean|68.3|68.3|Full Range|||44.0|84.0|
3761299|NCT01950663|3594696|B1|United States||Region of Enrollment||participants|Number|467|467.0||||||
3761300|NCT01950663|3594696|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3761301|NCT01950663|3594696|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761302|NCT01950663|3594696|B1||White|Race (NIH/OMB)||Participants|Count of Participants|243|243.0||||||
3761303|NCT01950663|3594696|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|184|184.0||||||
3761304|NCT01950663|3594696|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761305|NCT01950663|3594696|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3761306|NCT01950663|3594696|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3761307|NCT01950663|3594696|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761308|NCT01950663|3594696|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|458|458.0||||||
3761309|NCT01950663|3594696|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3761310|NCT01950663|3594696|B1||Male|Sex: Female, Male||Participants|Count of Participants|409|409.0||||||
3761311|NCT01950663|3594696|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3761312|NCT01950663|3594696|B1|||Age||years|Mean|61|61.0|Standard Deviation|11|11.0|||
3761313|NCT01950364|3594700|B3|IV||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|10|10.0||||||
3761314|NCT01950364|3594701|B2|IV||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|4|4.0||||||
3761315|NCT01950364|3594702|B1|IV||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|6|6.0||||||
3761316|NCT01950364|3594700|B3|III||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|1|1.0||||||
3761317|NCT01950364|3594701|B2|III||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|0|0.0||||||
3761318|NCT01950364|3594702|B1|III||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|1|1.0||||||
3761390|NCT01950078|3594826|B1||Female|Sex: Female, Male||Participants|Count of Participants|1005|1005.0||||||
3761391|NCT01950078|3594824|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3761392|NCT01950078|3594825|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3761319|NCT01950364|3594700|B3|II||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|8|8.0||||||
3761320|NCT01950364|3594701|B2|II||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|6|6.0||||||
3761321|NCT01950364|3594702|B1|II||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|2|2.0||||||
3761322|NCT01950364|3594700|B3|I||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|1|1.0||||||
3761323|NCT01950364|3594701|B2|I||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|0|0.0||||||
3761324|NCT01950364|3594702|B1|I||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|1|1.0||||||
3761325|NCT01950364|3594700|B3|||Months from Initial Diagnosis to First Dose||months|Mean|48.3|48.3|Standard Deviation|41.25|41.25|||
3761326|NCT01950364|3594701|B2|||Months from Initial Diagnosis to First Dose||months|Mean|61.9|61.9|Standard Deviation|46.96|46.96|||
3761327|NCT01950364|3594702|B1|||Months from Initial Diagnosis to First Dose||months|Mean|34.7|34.7|Standard Deviation|31.23|31.23|||
3761328|NCT01950364|3594700|B3|sALCL||Disease Type||participants|Number|0|0.0||||||
3761329|NCT01950364|3594701|B2|sALCL||Disease Type||participants|Number|0|0.0||||||
3761330|NCT01950364|3594702|B1|sALCL||Disease Type||participants|Number|0|0.0||||||
3761331|NCT01950364|3594700|B3|Hodgkin lymphoma||Disease Type||participants|Number|20|20.0||||||
3761332|NCT01950364|3594701|B2|Hodgkin lymphoma||Disease Type||participants|Number|10|10.0||||||
3761333|NCT01950364|3594702|B1|Hodgkin lymphoma||Disease Type||participants|Number|10|10.0||||||
3761334|NCT01950364|3594700|B3|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|1|1.0||||||
3761335|NCT01950364|3594701|B2|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|0|0.0||||||
3761336|NCT01950364|3594702|B1|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|1|1.0||||||
3761337|NCT01950364|3594700|B3|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|10|10.0||||||
3761338|NCT01950364|3594701|B2|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|4|4.0||||||
3761393|NCT01950078|3594826|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3761394|NCT01950078|3594824|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1479|1479.0||||||
3761339|NCT01950364|3594702|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|6|6.0||||||
3761340|NCT01950364|3594700|B3|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|9|9.0||||||
3761341|NCT01950364|3594701|B2|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|6|6.0||||||
3761342|NCT01950364|3594702|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|3|3.0||||||
3761343|NCT01950364|3594700|B3|||Height||centimeter (cm)|Mean|169.8|169.8|Standard Deviation|5.15|5.15|||
3761344|NCT01950364|3594701|B2|||Height||centimeter (cm)|Mean|169.7|169.7|Standard Deviation|6.45|6.45|||
3761345|NCT01950364|3594702|B1|||Height||centimeter (cm)|Mean|169.9|169.9|Standard Deviation|3.80|3.8|||
3761346|NCT01950364|3594700|B3|||Weight||kilogram (kg)|Mean|73.98|73.98|Standard Deviation|20.595|20.595|||
3761347|NCT01950364|3594701|B2|||Weight||kilogram (kg)|Mean|76.84|76.84|Standard Deviation|24.213|24.213|||
3761348|NCT01950364|3594702|B1|||Weight||kilogram (kg)|Mean|71.11|71.11|Standard Deviation|17.056|17.056|||
3761349|NCT01950364|3594700|B3|Lithuania||Region of Enrollment||participants|Number|8|8.0||||||
3761350|NCT01950364|3594701|B2|Lithuania||Region of Enrollment||participants|Number|4|4.0||||||
3761351|NCT01950364|3594702|B1|Lithuania||Region of Enrollment||participants|Number|4|4.0||||||
3761352|NCT01950364|3594700|B3|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
3761353|NCT01950364|3594701|B2|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
3761354|NCT01950364|3594702|B1|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
3761355|NCT01950364|3594700|B3|Spain||Region of Enrollment||participants|Number|9|9.0||||||
3761356|NCT01950364|3594701|B2|Spain||Region of Enrollment||participants|Number|5|5.0||||||
3761357|NCT01950364|3594702|B1|Spain||Region of Enrollment||participants|Number|4|4.0||||||
3761358|NCT01950364|3594700|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3761359|NCT01950364|3594701|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3761360|NCT01950364|3594702|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3761361|NCT01950364|3594700|B3|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3761362|NCT01950364|3594701|B2|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3761363|NCT01950364|3594702|B1|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3761364|NCT01950364|3594700|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3761365|NCT01950364|3594701|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3761366|NCT01950364|3594702|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3761367|NCT01950364|3594700|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3761368|NCT01950364|3594701|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3761369|NCT01950364|3594702|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3761370|NCT01950364|3594700|B3|||Age||years|Mean|41.2|41.2|Standard Deviation|10.52|10.52|||
3761371|NCT01950364|3594701|B2|||Age||years|Mean|40.1|40.1|Standard Deviation|9.13|9.13|||
3761372|NCT01950364|3594702|B1|||Age||years|Mean|42.3|42.3|Standard Deviation|12.15|12.15|||
3761373|NCT01950273|3594801|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3761374|NCT01950273|3594802|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3761375|NCT01950273|3594803|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3761376|NCT01950273|3594801|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3761377|NCT01950273|3594802|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3761378|NCT01950273|3594803|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3761379|NCT01950273|3594801|B3|||Age||Years|Mean|59.0|59.0|Standard Deviation|11.93|11.93|||
3761380|NCT01950273|3594802|B2|||Age||Years|Mean|58.4|58.4|Standard Deviation|11.48|11.48|||
3761381|NCT01950273|3594803|B1|||Age||Years|Mean|59.6|59.6|Standard Deviation|12.44|12.44|||
3761382|NCT01950078|3594824|B3|China||Region of Enrollment||participants|Number|1501|1501.0||||||
3761383|NCT01950078|3594825|B2|China||Region of Enrollment||participants|Number|496|496.0||||||
3761384|NCT01950078|3594826|B1|China||Region of Enrollment||participants|Number|1005|1005.0||||||
3761385|NCT01950078|3594824|B3||Male|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
3761386|NCT01950078|3594825|B2||Male|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
3761387|NCT01950078|3594826|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3761388|NCT01950078|3594824|B3||Female|Sex: Female, Male||Participants|Count of Participants|1314|1314.0||||||
3761389|NCT01950078|3594825|B2||Female|Sex: Female, Male||Participants|Count of Participants|309|309.0||||||
3761395|NCT01950078|3594825|B2||Between 18 and 65 years|Age||Participants|Count of Participants|489|489.0||||||
3761396|NCT01950078|3594826|B1||Between 18 and 65 years|Age||Participants|Count of Participants|990|990.0||||||
3761397|NCT01950078|3594824|B3||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
3761398|NCT01950078|3594825|B2||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
3761399|NCT01950078|3594826|B1||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
3761400|NCT01949870|3594835|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3761401|NCT01949870|3594835|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3761402|NCT01949870|3594835|B1|>=65 years||Age, Customized||Participants|Number|3|3.0||||||
3761403|NCT01949870|3594835|B1|>=50 to < 65 years||Age, Customized||Participants|Number|0|0.0||||||
3761404|NCT01949870|3594835|B1|<50 years||Age, Customized||Participants|Number|1|1.0||||||
3761405|NCT01949844|3594839|B1|United States||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3761406|NCT01949844|3594839|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3761407|NCT01949844|3594839|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3761408|NCT01949844|3594839|B1|||Age||years|Mean|65|65.0|Standard Deviation|11|11.0|||
3761409|NCT01949844|3594839|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3761410|NCT01949844|3594839|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3761411|NCT01949844|3594839|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3761412|NCT01949545|3594843|B5|Not reported||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3761413|NCT01949545|3594844|B4|Not reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3761414|NCT01949545|3594845|B3|Not reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3761415|NCT01949545|3594846|B2|Not reported||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3761416|NCT01949545|3594847|B1|Not reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3761417|NCT01949545|3594843|B5|White||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
3761418|NCT01949545|3594844|B4|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3761419|NCT01949545|3594845|B3|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3761420|NCT01949545|3594846|B2|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3761421|NCT01949545|3594847|B1|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3761422|NCT01949545|3594843|B5|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3761423|NCT01949545|3594844|B4|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3761424|NCT01949545|3594845|B3|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3761425|NCT01949545|3594846|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3761426|NCT01949545|3594847|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3761427|NCT01949545|3594843|B5||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3761428|NCT01949545|3594844|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3761429|NCT01949545|3594845|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3761430|NCT01949545|3594846|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3761431|NCT01949545|3594847|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3761432|NCT01949545|3594843|B5||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3761433|NCT01949545|3594844|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3761434|NCT01949545|3594845|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3761435|NCT01949545|3594846|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3761436|NCT01949545|3594847|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3761437|NCT01949545|3594843|B5|≥ 65 years||Age, Customized||participants|Number|20|20.0||||||
3761438|NCT01949545|3594844|B4|≥ 65 years||Age, Customized||participants|Number|1|1.0||||||
3761439|NCT01949545|3594845|B3|≥ 65 years||Age, Customized||participants|Number|6|6.0||||||
3761440|NCT01949545|3594846|B2|≥ 65 years||Age, Customized||participants|Number|5|5.0||||||
3761441|NCT01949545|3594847|B1|≥ 65 years||Age, Customized||participants|Number|8|8.0||||||
3761442|NCT01949545|3594843|B5|< 65 years||Age, Customized||participants|Number|26|26.0||||||
3761443|NCT01949545|3594844|B4|< 65 years||Age, Customized||participants|Number|3|3.0||||||
3761444|NCT01949545|3594845|B3|< 65 years||Age, Customized||participants|Number|8|8.0||||||
3761445|NCT01949545|3594846|B2|< 65 years||Age, Customized||participants|Number|12|12.0||||||
3761446|NCT01949545|3594847|B1|< 65 years||Age, Customized||participants|Number|3|3.0||||||
3761447|NCT01949545|3594843|B5|||Age||years|Mean|61.8|61.8|Standard Deviation|9.3|9.3|||
3761448|NCT01949545|3594844|B4|||Age||years|Mean|56.3|56.3|Standard Deviation|10.9|10.9|||
3761449|NCT01949545|3594845|B3|||Age||years|Mean|61.0|61.0|Standard Deviation|7.9|7.9|||
3761450|NCT01949545|3594846|B2|||Age||years|Mean|59.5|59.5|Standard Deviation|9.1|9.1|||
3761451|NCT01949545|3594847|B1|||Age||years|Mean|68.5|68.5|Standard Deviation|8.2|8.2|||
3761452|NCT01949532|3594996|B3|2 (Ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|1|1.0||||||
3761481|NCT01949532|3594998|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3761453|NCT01949532|3594997|B2|2 (Ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|1|1.0||||||
3761454|NCT01949532|3594998|B1|2 (Ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
3761455|NCT01949532|3594996|B3|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|17|17.0||||||
3761456|NCT01949532|3594997|B2|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|7|7.0||||||
3761457|NCT01949532|3594998|B1|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|10|10.0||||||
3761458|NCT01949532|3594996|B3|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|8|8.0||||||
3761459|NCT01949532|3594997|B2|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|3|3.0||||||
3761460|NCT01949532|3594998|B1|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|5|5.0||||||
3761461|NCT01949532|3594996|B3|Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3761462|NCT01949532|3594997|B2|Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3761463|NCT01949532|3594998|B1|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3761464|NCT01949532|3594996|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3761465|NCT01949532|3594997|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3761466|NCT01949532|3594998|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3761467|NCT01949532|3594996|B3|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3761468|NCT01949532|3594997|B2|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3761469|NCT01949532|3594998|B1|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3761470|NCT01949532|3594996|B3|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3761471|NCT01949532|3594997|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3761472|NCT01949532|3594998|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3761473|NCT01949532|3594996|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3761474|NCT01949532|3594997|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3761475|NCT01949532|3594998|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3761476|NCT01949532|3594996|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3761477|NCT01949532|3594997|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3761478|NCT01949532|3594998|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761479|NCT01949532|3594996|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3761480|NCT01949532|3594997|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3761482|NCT01949532|3594996|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3761483|NCT01949532|3594997|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761484|NCT01949532|3594998|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3761485|NCT01949532|3594996|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3761486|NCT01949532|3594997|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3761487|NCT01949532|3594998|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3761488|NCT01949532|3594996|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3761489|NCT01949532|3594997|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3761490|NCT01949532|3594998|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3761491|NCT01949532|3594996|B3|||Age||years|Mean|64.0|64.0|Standard Deviation|7.9|7.9|||
3761492|NCT01949532|3594997|B2|||Age||years|Mean|62.8|62.8|Standard Deviation|7.9|7.9|||
3761493|NCT01949532|3594998|B1|||Age||years|Mean|64.8|64.8|Standard Deviation|8.1|8.1|||
3761494|NCT01949389|3595067|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
3761495|NCT01949389|3595067|B1|Other Race/Ethnicity||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3761496|NCT01949389|3595067|B1|African American||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3761497|NCT01949389|3595067|B1|White||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
3761498|NCT01949389|3595067|B1||Male|Sex: Female, Male|gender|Participants|Count of Participants|45|45.0||||||
3761499|NCT01949389|3595067|B1||Female|Sex: Female, Male|gender|Participants|Count of Participants|6|6.0||||||
3761500|NCT01949389|3595067|B1|||Age||years|Mean|52.2|52.2|Standard Deviation|10.4|10.4|||
3761501|NCT01949155|3595072|B3||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3761502|NCT01949155|3595073|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3761503|NCT01949155|3595074|B1||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3761504|NCT01949155|3595072|B3||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3761505|NCT01949155|3595073|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3761506|NCT01949155|3595074|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3761507|NCT01949155|3595072|B3|||Age||years|Mean|2.472|2.472|Standard Deviation|2.1677|2.1677|||
3761508|NCT01949155|3595073|B2|||Age||years|Mean|2.863|2.863|Standard Deviation|2.5942|2.5942|||
3761509|NCT01949155|3595074|B1|||Age||years|Mean|2.279|2.279|Standard Deviation|1.9010|1.901|||
3761510|NCT01949155|3595072|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3761511|NCT01949155|3595073|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3761512|NCT01949155|3595074|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3761513|NCT01949155|3595072|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3761514|NCT01949155|3595073|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3761515|NCT01949155|3595074|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3761516|NCT01949155|3595072|B3||<=18 years|Age||Participants|Count of Participants|266|266.0||||||
3761517|NCT01949155|3595073|B2||<=18 years|Age||Participants|Count of Participants|88|88.0||||||
3761518|NCT01949155|3595074|B1||<=18 years|Age||Participants|Count of Participants|178|178.0||||||
3761519|NCT01949142|3595085|B3||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3761520|NCT01949142|3595086|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3761521|NCT01949142|3595087|B1||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3761522|NCT01949142|3595085|B3||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3761523|NCT01949142|3595086|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3761524|NCT01949142|3595087|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3761525|NCT01949142|3595085|B3|||Age||years|Mean|2.416|2.416|Standard Deviation|2.0826|2.0826|||
3761526|NCT01949142|3595086|B2|||Age||years|Mean|2.463|2.463|Standard Deviation|2.1176|2.1176|||
3761527|NCT01949142|3595087|B1|||Age||years|Mean|2.392|2.392|Standard Deviation|2.0710|2.071|||
3761528|NCT01949116|3595098|B3|||Brachial Artery FMD|Flow-mediated vasodilation is defined as the maximum FMD (%) calculated from reactive hyperemia (RH) 60 and RH 90 relative to resting artery diameter.|Percent Dilation|Median|3.45|3.45|Inter-Quartile Range|||2.1|4.91|
3761529|NCT01949116|3595099|B2|||Brachial Artery FMD|Flow-mediated vasodilation is defined as the maximum FMD (%) calculated from reactive hyperemia (RH) 60 and RH 90 relative to resting artery diameter.|Percent Dilation|Median|3.41|3.41|Inter-Quartile Range|||1.98|5.03|
3761530|NCT01949116|3595100|B1|||Brachial Artery FMD|Flow-mediated vasodilation is defined as the maximum FMD (%) calculated from reactive hyperemia (RH) 60 and RH 90 relative to resting artery diameter.|Percent Dilation|Median|3.54|3.54|Inter-Quartile Range|||2.19|4.91|
3761531|NCT01949116|3595098|B3||Missing|HIV-1 RNA||Participants|Count of Participants|2|2.0||||||
3761532|NCT01949116|3595099|B2||Missing|HIV-1 RNA||Participants|Count of Participants|2|2.0||||||
3761533|NCT01949116|3595100|B1||Missing|HIV-1 RNA||Participants|Count of Participants|0|0.0||||||
3761534|NCT01949116|3595098|B3||Below Assay Limit of Detection|HIV-1 RNA||Participants|Count of Participants|168|168.0||||||
3761535|NCT01949116|3595099|B2||Below Assay Limit of Detection|HIV-1 RNA||Participants|Count of Participants|84|84.0||||||
3761536|NCT01949116|3595100|B1||Below Assay Limit of Detection|HIV-1 RNA||Participants|Count of Participants|84|84.0||||||
3761537|NCT01949116|3595098|B3||Detectable|HIV-1 RNA||Participants|Count of Participants|6|6.0||||||
3761538|NCT01949116|3595099|B2||Detectable|HIV-1 RNA||Participants|Count of Participants|4|4.0||||||
3761539|NCT01949116|3595100|B1||Detectable|HIV-1 RNA||Participants|Count of Participants|2|2.0||||||
3761540|NCT01949116|3595098|B3|||CD4+ cell count||cells/mm^3|Median|726|726.0|Inter-Quartile Range|||552.0|940.0|
3761541|NCT01949116|3595099|B2|||CD4+ cell count||cells/mm^3|Median|729|729.0|Inter-Quartile Range|||569.0|947.0|
3761542|NCT01949116|3595100|B1|||CD4+ cell count||cells/mm^3|Median|689|689.0|Inter-Quartile Range|||551.0|910.0|
3761543|NCT01949116|3595098|B3|||10 year ASCVD risk|"Atherosclerotic cardiovascular disease (ASCVD) is defined as coronary death or nonfatal myocardial infarction, or fatal or nonfatal stroke, based on the Pooled Cohort Equations. The 10-year risk was calculated for only those participants who fell in the CVD Risk category, Smoking, hypertension, dyslipidemia, or hsCRP >= 2 mg/L."|Percent risk of ASCVD|Median|8.7|8.7|Inter-Quartile Range|||5.1|13.0|
3761544|NCT01949116|3595099|B2|||10 year ASCVD risk|"Atherosclerotic cardiovascular disease (ASCVD) is defined as coronary death or nonfatal myocardial infarction, or fatal or nonfatal stroke, based on the Pooled Cohort Equations. The 10-year risk was calculated for only those participants who fell in the CVD Risk category, Smoking, hypertension, dyslipidemia, or hsCRP >= 2 mg/L."|Percent risk of ASCVD|Median|7.9|7.9|Inter-Quartile Range|||5.0|12.4|
3761545|NCT01949116|3595100|B1|||10 year ASCVD risk|"Atherosclerotic cardiovascular disease (ASCVD) is defined as coronary death or nonfatal myocardial infarction, or fatal or nonfatal stroke, based on the Pooled Cohort Equations. The 10-year risk was calculated for only those participants who fell in the CVD Risk category, Smoking, hypertension, dyslipidemia, or hsCRP >= 2 mg/L."|Percent risk of ASCVD|Median|10.1|10.1|Inter-Quartile Range|||5.4|14.3|
3761546|NCT01949116|3595098|B3||Smoking/hypertension/dyslipidemia/hsCRP >= 2mg/L|Type of CVD Risk|CVD = cardiovascular disease; CAD = coronary artery disease; PAD = peripheral artery disease; hsCRP = high-sensitivity C-reactive protein.|Participants|Count of Participants|105|105.0||||||
3761547|NCT01949116|3595099|B2||Smoking/hypertension/dyslipidemia/hsCRP >= 2mg/L|Type of CVD Risk|CVD = cardiovascular disease; CAD = coronary artery disease; PAD = peripheral artery disease; hsCRP = high-sensitivity C-reactive protein.|Participants|Count of Participants|58|58.0||||||
3761548|NCT01949116|3595100|B1||Smoking/hypertension/dyslipidemia/hsCRP >= 2mg/L|Type of CVD Risk|CVD = cardiovascular disease; CAD = coronary artery disease; PAD = peripheral artery disease; hsCRP = high-sensitivity C-reactive protein.|Participants|Count of Participants|47|47.0||||||
3761549|NCT01949116|3595098|B3||Controlled type 2 diabetes mellitus|Type of CVD Risk|CVD = cardiovascular disease; CAD = coronary artery disease; PAD = peripheral artery disease; hsCRP = high-sensitivity C-reactive protein.|Participants|Count of Participants|39|39.0||||||
3761550|NCT01949116|3595099|B2||Controlled type 2 diabetes mellitus|Type of CVD Risk|CVD = cardiovascular disease; CAD = coronary artery disease; PAD = peripheral artery disease; hsCRP = high-sensitivity C-reactive protein.|Participants|Count of Participants|20|20.0||||||
3761551|NCT01949116|3595100|B1||Controlled type 2 diabetes mellitus|Type of CVD Risk|CVD = cardiovascular disease; CAD = coronary artery disease; PAD = peripheral artery disease; hsCRP = high-sensitivity C-reactive protein.|Participants|Count of Participants|19|19.0||||||
3761552|NCT01949116|3595098|B3||CAD, CVD, or PAD|Type of CVD Risk|CVD = cardiovascular disease; CAD = coronary artery disease; PAD = peripheral artery disease; hsCRP = high-sensitivity C-reactive protein.|Participants|Count of Participants|32|32.0||||||
3761553|NCT01949116|3595099|B2||CAD, CVD, or PAD|Type of CVD Risk|CVD = cardiovascular disease; CAD = coronary artery disease; PAD = peripheral artery disease; hsCRP = high-sensitivity C-reactive protein.|Participants|Count of Participants|12|12.0||||||
3761554|NCT01949116|3595100|B1||CAD, CVD, or PAD|Type of CVD Risk|CVD = cardiovascular disease; CAD = coronary artery disease; PAD = peripheral artery disease; hsCRP = high-sensitivity C-reactive protein.|Participants|Count of Participants|20|20.0||||||
3761555|NCT01949116|3595098|B3||Current non-smoker|Smoking Status||Participants|Count of Participants|108|108.0||||||
3761556|NCT01949116|3595099|B2||Current non-smoker|Smoking Status||Participants|Count of Participants|50|50.0||||||
3761557|NCT01949116|3595100|B1||Current non-smoker|Smoking Status||Participants|Count of Participants|58|58.0||||||
3761558|NCT01949116|3595098|B3||Current Smoker|Smoking Status||Participants|Count of Participants|68|68.0||||||
3761559|NCT01949116|3595099|B2||Current Smoker|Smoking Status||Participants|Count of Participants|40|40.0||||||
3761560|NCT01949116|3595100|B1||Current Smoker|Smoking Status||Participants|Count of Participants|28|28.0||||||
3761561|NCT01949116|3595098|B3||No Current Statin Use|Current Statin Use|Current Statin Use at Study Entry - this is a stratification factor for the study.|Participants|Count of Participants|73|73.0||||||
3761562|NCT01949116|3595099|B2||No Current Statin Use|Current Statin Use|Current Statin Use at Study Entry - this is a stratification factor for the study.|Participants|Count of Participants|38|38.0||||||
3761563|NCT01949116|3595100|B1||No Current Statin Use|Current Statin Use|Current Statin Use at Study Entry - this is a stratification factor for the study.|Participants|Count of Participants|35|35.0||||||
3761564|NCT01949116|3595098|B3||Current Statin Use|Current Statin Use|Current Statin Use at Study Entry - this is a stratification factor for the study.|Participants|Count of Participants|103|103.0||||||
3761565|NCT01949116|3595099|B2||Current Statin Use|Current Statin Use|Current Statin Use at Study Entry - this is a stratification factor for the study.|Participants|Count of Participants|52|52.0||||||
3761566|NCT01949116|3595100|B1||Current Statin Use|Current Statin Use|Current Statin Use at Study Entry - this is a stratification factor for the study.|Participants|Count of Participants|51|51.0||||||
3761567|NCT01949116|3595098|B3|United States||Region of Enrollment||Participants|Count of Participants|176|176.0||||||
3761568|NCT01949116|3595099|B2|United States||Region of Enrollment||Participants|Count of Participants|90|90.0||||||
3761569|NCT01949116|3595100|B1|United States||Region of Enrollment||Participants|Count of Participants|86|86.0||||||
3761570|NCT01949116|3595098|B3||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
3761571|NCT01949116|3595099|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3761572|NCT01949116|3595100|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3761573|NCT01949116|3595098|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3761574|NCT01949116|3595099|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3761575|NCT01949116|3595100|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3761576|NCT01949116|3595098|B3|||Age||years|Median|54|54.0|Inter-Quartile Range|||49.0|59.0|
3761577|NCT01949116|3595099|B2|||Age||years|Median|53|53.0|Inter-Quartile Range|||49.0|56.0|
3761578|NCT01949116|3595100|B1|||Age||years|Median|55|55.0|Inter-Quartile Range|||51.0|60.0|
3761579|NCT01949090|3595133|B6|Geographic Ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3761580|NCT01949090|3595134|B5|Geographic Ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3761581|NCT01949090|3595135|B4|Geographic Ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3761582|NCT01949090|3595136|B3|Geographic Ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3761583|NCT01949090|3595137|B2|Geographic Ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3761584|NCT01949090|3595138|B1|Geographic Ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3761585|NCT01949090|3595133|B6|Geographic Ancestry|White - Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|340|340.0||||||
3761586|NCT01949090|3595134|B5|Geographic Ancestry|White - Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|116|116.0||||||
3761587|NCT01949090|3595135|B4|Geographic Ancestry|White - Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|57|57.0||||||
3761588|NCT01949090|3595136|B3|Geographic Ancestry|White - Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|52|52.0||||||
3761589|NCT01949090|3595137|B2|Geographic Ancestry|White - Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|59|59.0||||||
3761590|NCT01949090|3595138|B1|Geographic Ancestry|White - Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|56|56.0||||||
3761591|NCT01949090|3595133|B6|Geographic Ancestry|White - Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3761592|NCT01949090|3595134|B5|Geographic Ancestry|White - Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3761593|NCT01949090|3595135|B4|Geographic Ancestry|White - Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3761594|NCT01949090|3595136|B3|Geographic Ancestry|White - Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3761595|NCT01949090|3595137|B2|Geographic Ancestry|White - Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3761596|NCT01949090|3595138|B1|Geographic Ancestry|White - Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3761597|NCT01949090|3595133|B6|Geographic Ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3761598|NCT01949090|3595134|B5|Geographic Ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3761599|NCT01949090|3595135|B4|Geographic Ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3761600|NCT01949090|3595136|B3|Geographic Ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3761601|NCT01949090|3595137|B2|Geographic Ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3761602|NCT01949090|3595138|B1|Geographic Ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3761603|NCT01949090|3595133|B6|Geographic Ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3761604|NCT01949090|3595134|B5|Geographic Ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3761605|NCT01949090|3595135|B4|Geographic Ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3761606|NCT01949090|3595136|B3|Geographic Ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3761607|NCT01949090|3595137|B2|Geographic Ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3761608|NCT01949090|3595138|B1|Geographic Ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3761609|NCT01949090|3595133|B6|Geographic Ancestry|African Heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3761610|NCT01949090|3595134|B5|Geographic Ancestry|African Heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3761611|NCT01949090|3595135|B4|Geographic Ancestry|African Heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3761612|NCT01949090|3595136|B3|Geographic Ancestry|African Heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3761613|NCT01949090|3595137|B2|Geographic Ancestry|African Heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3761614|NCT01949090|3595138|B1|Geographic Ancestry|African Heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3761615|NCT01949090|3595133|B6||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3761616|NCT01949090|3595134|B5||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3761617|NCT01949090|3595135|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3761618|NCT01949090|3595136|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3761619|NCT01949090|3595137|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3761620|NCT01949090|3595138|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3761621|NCT01949090|3595133|B6||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
3761622|NCT01949090|3595134|B5||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3761623|NCT01949090|3595135|B4||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3761624|NCT01949090|3595136|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3761625|NCT01949090|3595137|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3761626|NCT01949090|3595138|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3761627|NCT01949090|3595133|B6|||Age||Years|Mean|73.30|73.3|Standard Deviation|5.75|5.75|||
3761628|NCT01949090|3595134|B5|||Age||Years|Mean|73.0|73.0|Standard Deviation|5.2|5.2|||
3761629|NCT01949090|3595135|B4|||Age||Years|Mean|73.4|73.4|Standard Deviation|5.3|5.3|||
3761630|NCT01949090|3595136|B3|||Age||Years|Mean|73.6|73.6|Standard Deviation|6.5|6.5|||
3761631|NCT01949090|3595137|B2|||Age||Years|Mean|73.9|73.9|Standard Deviation|6.3|6.3|||
3761632|NCT01949090|3595138|B1|||Age||Years|Mean|72.9|72.9|Standard Deviation|6.0|6.0|||
3761633|NCT01949051|3595319|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
3761634|NCT01949051|3595319|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3761635|NCT01949051|3595319|B1|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3761636|NCT01949051|3595319|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3761637|NCT01949051|3595319|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3761638|NCT01949051|3595319|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3761639|NCT01949051|3595319|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|26|26.0||||||
3761640|NCT01949051|3595319|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3761641|NCT01949051|3595319|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3761642|NCT01949051|3595319|B1|||Age||Years|Mean|42.3|42.3|Standard Deviation|11.46|11.46|||
3761643|NCT01948947|3595335|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761644|NCT01948947|3595336|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761645|NCT01948947|3595337|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761646|NCT01948947|3595335|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3761647|NCT01948947|3595336|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3761648|NCT01948947|3595337|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3761649|NCT01948947|3595335|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3761650|NCT01948947|3595336|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3761651|NCT01948947|3595337|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3761652|NCT01948947|3595335|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3761653|NCT01948947|3595336|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3761654|NCT01948947|3595337|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3761655|NCT01948947|3595335|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761656|NCT01948947|3595336|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761657|NCT01948947|3595337|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761658|NCT01948947|3595335|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3761659|NCT01948947|3595336|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761660|NCT01948947|3595337|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3761661|NCT01948947|3595335|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761662|NCT01948947|3595336|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761663|NCT01948947|3595337|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761664|NCT01948947|3595335|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3761665|NCT01948947|3595336|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3761666|NCT01948947|3595337|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3761667|NCT01948947|3595335|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3761668|NCT01948947|3595336|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3761669|NCT01948947|3595337|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3761670|NCT01948947|3595335|B3|||Age||years|Mean|35.28|35.28|Standard Deviation|8.52|8.52|||
3761671|NCT01948947|3595336|B2|||Age||years|Mean|34.43|34.43|Standard Deviation|7.66|7.66|||
3761672|NCT01948947|3595337|B1|||Age||years|Mean|36.13|36.13|Standard Deviation|9.39|9.39|||
3761673|NCT01948908|3595350|B4|Non-Hispanic, Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3761674|NCT01948908|3595351|B3|Non-Hispanic, Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3761675|NCT01948908|3595352|B2|Non-Hispanic, Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3761676|NCT01948908|3595353|B1|Non-Hispanic, Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3761677|NCT01948908|3595350|B4|Non-Hispanic, Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3761678|NCT01948908|3595351|B3|Non-Hispanic, Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3761679|NCT01948908|3595352|B2|Non-Hispanic, Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3761680|NCT01948908|3595353|B1|Non-Hispanic, Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3761681|NCT01948908|3595350|B4|Non-Hispanic, White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3761682|NCT01948908|3595351|B3|Non-Hispanic, White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3761683|NCT01948908|3595352|B2|Non-Hispanic, White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3761684|NCT01948908|3595353|B1|Non-Hispanic, White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3761685|NCT01948908|3595350|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
3761686|NCT01948908|3595351|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3761687|NCT01948908|3595352|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3761688|NCT01948908|3595353|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3761689|NCT01948908|3595350|B4||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3761690|NCT01948908|3595351|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3761691|NCT01948908|3595352|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3761692|NCT01948908|3595353|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3761693|NCT01948908|3595350|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3761694|NCT01948908|3595351|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3761695|NCT01948908|3595352|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3761696|NCT01948908|3595353|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3761697|NCT01948908|3595350|B4|||Age||years|Median|2.9|2.9|Inter-Quartile Range|||2.0|4.0|
3761698|NCT01948908|3595351|B3|||Age||years|Median|2.7|2.7|Inter-Quartile Range|||1.9|3.9|
3761699|NCT01948908|3595352|B2|||Age||years|Median|2.7|2.7|Inter-Quartile Range|||2.1|3.5|
3761700|NCT01948908|3595353|B1|||Age||years|Median|3|3.0|Inter-Quartile Range|||2.4|5.6|
3761701|NCT01948830|3595369|B3||Male|Sex: Female, Male||Participants|Count of Participants|290|290.0||||||
3761702|NCT01948830|3595370|B2||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3761703|NCT01948830|3595371|B1||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3761704|NCT01948830|3595369|B3||Female|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
3761705|NCT01948830|3595370|B2||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
3761706|NCT01948830|3595371|B1||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
3761707|NCT01948830|3595369|B3|||Age||Years|Mean|75.2|75.2|Standard Deviation|8.37|8.37|||
3761708|NCT01948830|3595370|B2|||Age||Years|Mean|75.2|75.2|Standard Deviation|8.13|8.13|||
3761709|NCT01948830|3595371|B1|||Age||Years|Mean|75.3|75.3|Standard Deviation|8.61|8.61|||
3761710|NCT01948791|3595404|B1||Male|Gender||Participants|Count of Participants|64|64.0||||||
3761711|NCT01948791|3595404|B1||Female|Gender||Participants|Count of Participants|101|101.0||||||
3761712|NCT01948791|3595404|B1|||Age||Years|Mean|69.6|69.6|Standard Deviation|8.4|8.4|||
3761713|NCT01948518|3595412|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3761714|NCT01948518|3595412|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3761715|NCT01948518|3595412|B1|||Age||years|Mean|58.6|58.6|Full Range|||45.6|71.6|
3761716|NCT01948375|3595417|B3|no response||Preference of acupuncture||participants|Number|15|15.0||||||
3761717|NCT01948375|3595418|B2|no response||Preference of acupuncture||participants|Number|8|8.0||||||
3761718|NCT01948375|3595419|B1|no response||Preference of acupuncture||participants|Number|7|7.0||||||
3761719|NCT01948375|3595417|B3|Not sure||Preference of acupuncture||participants|Number|1|1.0||||||
3761720|NCT01948375|3595418|B2|Not sure||Preference of acupuncture||participants|Number|1|1.0||||||
3761721|NCT01948375|3595419|B1|Not sure||Preference of acupuncture||participants|Number|0|0.0||||||
3761722|NCT01948375|3595417|B3|Yes||Preference of acupuncture||participants|Number|44|44.0||||||
3761723|NCT01948375|3595418|B2|Yes||Preference of acupuncture||participants|Number|21|21.0||||||
3761724|NCT01948375|3595419|B1|Yes||Preference of acupuncture||participants|Number|23|23.0||||||
3761725|NCT01948375|3595417|B3|no response||Acceptability of acupuncture||participants|Number|15|15.0||||||
3761726|NCT01948375|3595418|B2|no response||Acceptability of acupuncture||participants|Number|8|8.0||||||
3761727|NCT01948375|3595419|B1|no response||Acceptability of acupuncture||participants|Number|7|7.0||||||
3761728|NCT01948375|3595417|B3|Very easy to accept||Acceptability of acupuncture||participants|Number|13|13.0||||||
3761729|NCT01948375|3595418|B2|Very easy to accept||Acceptability of acupuncture||participants|Number|5|5.0||||||
3761730|NCT01948375|3595419|B1|Very easy to accept||Acceptability of acupuncture||participants|Number|8|8.0||||||
3761731|NCT01948375|3595417|B3|Easy to accept||Acceptability of acupuncture||participants|Number|10|10.0||||||
3761732|NCT01948375|3595418|B2|Easy to accept||Acceptability of acupuncture||participants|Number|5|5.0||||||
3761733|NCT01948375|3595419|B1|Easy to accept||Acceptability of acupuncture||participants|Number|5|5.0||||||
3761734|NCT01948375|3595417|B3|Acceptable||Acceptability of acupuncture||participants|Number|20|20.0||||||
3761735|NCT01948375|3595418|B2|Acceptable||Acceptability of acupuncture||participants|Number|10|10.0||||||
3761736|NCT01948375|3595419|B1|Acceptable||Acceptability of acupuncture||participants|Number|10|10.0||||||
3761737|NCT01948375|3595417|B3|A little difficult to accept||Acceptability of acupuncture||participants|Number|1|1.0||||||
3761738|NCT01948375|3595418|B2|A little difficult to accept||Acceptability of acupuncture||participants|Number|1|1.0||||||
3761739|NCT01948375|3595419|B1|A little difficult to accept||Acceptability of acupuncture||participants|Number|0|0.0||||||
3761740|NCT01948375|3595417|B3|Very difficult to accept||Acceptability of acupuncture||participants|Number|1|1.0||||||
3761741|NCT01948375|3595418|B2|Very difficult to accept||Acceptability of acupuncture||participants|Number|1|1.0||||||
3761742|NCT01948375|3595419|B1|Very difficult to accept||Acceptability of acupuncture||participants|Number|0|0.0||||||
3761743|NCT01948375|3595417|B3|Numbness||Type of needle sensation ever experienced||participants|Number|26|26.0||||||
3761744|NCT01948375|3595418|B2|Numbness||Type of needle sensation ever experienced||participants|Number|17|17.0||||||
3761745|NCT01948375|3595419|B1|Numbness||Type of needle sensation ever experienced||participants|Number|9|9.0||||||
3761746|NCT01948375|3595417|B3|Pricking||Type of needle sensation ever experienced||participants|Number|29|29.0||||||
3761747|NCT01948375|3595418|B2|Pricking||Type of needle sensation ever experienced||participants|Number|19|19.0||||||
3761748|NCT01948375|3595419|B1|Pricking||Type of needle sensation ever experienced||participants|Number|10|10.0||||||
3761749|NCT01948375|3595417|B3|Soreness||Type of needle sensation ever experienced||participants|Number|33|33.0||||||
3761750|NCT01948375|3595418|B2|Soreness||Type of needle sensation ever experienced||participants|Number|17|17.0||||||
3761751|NCT01948375|3595419|B1|Soreness||Type of needle sensation ever experienced||participants|Number|16|16.0||||||
3761752|NCT01948375|3595417|B3|Distention||Type of needle sensation ever experienced||participants|Number|38|38.0||||||
3761753|NCT01948375|3595418|B2|Distention||Type of needle sensation ever experienced||participants|Number|20|20.0||||||
3761754|NCT01948375|3595419|B1|Distention||Type of needle sensation ever experienced||participants|Number|18|18.0||||||
3761755|NCT01948375|3595417|B3|no response||Familiarity with needle sensation||participants|Number|15|15.0||||||
3761756|NCT01948375|3595418|B2|no response||Familiarity with needle sensation||participants|Number|8|8.0||||||
3761757|NCT01948375|3595419|B1|no response||Familiarity with needle sensation||participants|Number|7|7.0||||||
3761758|NCT01948375|3595417|B3|no||Familiarity with needle sensation||participants|Number|4|4.0||||||
3761759|NCT01948375|3595418|B2|no||Familiarity with needle sensation||participants|Number|1|1.0||||||
3761760|NCT01948375|3595419|B1|no||Familiarity with needle sensation||participants|Number|3|3.0||||||
3761761|NCT01948375|3595417|B3|yes||Familiarity with needle sensation||participants|Number|41|41.0||||||
3761762|NCT01948375|3595418|B2|yes||Familiarity with needle sensation||participants|Number|21|21.0||||||
3761763|NCT01948375|3595419|B1|yes||Familiarity with needle sensation||participants|Number|20|20.0||||||
3761764|NCT01948375|3595417|B3|||Acupuncture discomfort (vas)|"The discomfort of acupuncture is assessed using visual analogue scale (VAS), where 0 means no discomfort, and 10 means the severest discomfort.~A lower value represented a better outcome, which indicated that needles used induced less pain."|score|Median|0|0.0|Inter-Quartile Range|||0.0|2.0|
3761765|NCT01948375|3595418|B2|||Acupuncture discomfort (vas)|"The discomfort of acupuncture is assessed using visual analogue scale (VAS), where 0 means no discomfort, and 10 means the severest discomfort.~A lower value represented a better outcome, which indicated that needles used induced less pain."|score|Median|0|0.0|Inter-Quartile Range|||0.0|3.5|
3761766|NCT01948375|3595419|B1|||Acupuncture discomfort (vas)|"The discomfort of acupuncture is assessed using visual analogue scale (VAS), where 0 means no discomfort, and 10 means the severest discomfort.~A lower value represented a better outcome, which indicated that needles used induced less pain."|score|Median|0.9|0.9|Inter-Quartile Range|||0.0|2.0|
3761767|NCT01948375|3595417|B3|no report||Nervousness of acupuncture||participants|Number|15|15.0||||||
3761768|NCT01948375|3595418|B2|no report||Nervousness of acupuncture||participants|Number|8|8.0||||||
3761769|NCT01948375|3595419|B1|no report||Nervousness of acupuncture||participants|Number|7|7.0||||||
3761770|NCT01948375|3595417|B3|Very nervous||Nervousness of acupuncture||participants|Number|1|1.0||||||
3761771|NCT01948375|3595418|B2|Very nervous||Nervousness of acupuncture||participants|Number|1|1.0||||||
3761772|NCT01948375|3595419|B1|Very nervous||Nervousness of acupuncture||participants|Number|0|0.0||||||
3761773|NCT01948375|3595417|B3|A little nervous||Nervousness of acupuncture||participants|Number|14|14.0||||||
3761774|NCT01948375|3595418|B2|A little nervous||Nervousness of acupuncture||participants|Number|7|7.0||||||
3761775|NCT01948375|3595419|B1|A little nervous||Nervousness of acupuncture||participants|Number|7|7.0||||||
3761776|NCT01948375|3595417|B3|No nervous||Nervousness of acupuncture||participants|Number|30|30.0||||||
3761777|NCT01948375|3595418|B2|No nervous||Nervousness of acupuncture||participants|Number|14|14.0||||||
3761778|NCT01948375|3595419|B1|No nervous||Nervousness of acupuncture||participants|Number|16|16.0||||||
3761779|NCT01948375|3595417|B3|>10 sessions||Acupuncture experience||participants|Number|23|23.0||||||
3761780|NCT01948375|3595418|B2|>10 sessions||Acupuncture experience||participants|Number|13|13.0||||||
3761781|NCT01948375|3595419|B1|>10 sessions||Acupuncture experience||participants|Number|10|10.0||||||
3761782|NCT01948375|3595417|B3|6-10 sessions||Acupuncture experience||participants|Number|2|2.0||||||
3761783|NCT01948375|3595418|B2|6-10 sessions||Acupuncture experience||participants|Number|2|2.0||||||
3761784|NCT01948375|3595419|B1|6-10 sessions||Acupuncture experience||participants|Number|0|0.0||||||
3761785|NCT01948375|3595417|B3|1-5 sessions||Acupuncture experience||participants|Number|20|20.0||||||
3761786|NCT01948375|3595418|B2|1-5 sessions||Acupuncture experience||participants|Number|7|7.0||||||
3761787|NCT01948375|3595419|B1|1-5 sessions||Acupuncture experience||participants|Number|13|13.0||||||
3761788|NCT01948375|3595417|B3|None||Acupuncture experience||participants|Number|15|15.0||||||
3761789|NCT01948375|3595418|B2|None||Acupuncture experience||participants|Number|8|8.0||||||
3761790|NCT01948375|3595419|B1|None||Acupuncture experience||participants|Number|7|7.0||||||
3761791|NCT01948375|3595417|B3|Tertiary education||Educational level||participants|Number|30|30.0||||||
3761792|NCT01948375|3595418|B2|Tertiary education||Educational level||participants|Number|14|14.0||||||
3761793|NCT01948375|3595419|B1|Tertiary education||Educational level||participants|Number|16|16.0||||||
3761794|NCT01948375|3595417|B3|Secondary education and the below||Educational level||participants|Number|30|30.0||||||
3761795|NCT01948375|3595418|B2|Secondary education and the below||Educational level||participants|Number|16|16.0||||||
3761796|NCT01948375|3595419|B1|Secondary education and the below||Educational level||participants|Number|14|14.0||||||
3761797|NCT01948375|3595417|B3|China||Region of Enrollment||participants|Number|60|60.0||||||
3761798|NCT01948375|3595418|B2|China||Region of Enrollment||participants|Number|30|30.0||||||
3761799|NCT01948375|3595419|B1|China||Region of Enrollment||participants|Number|30|30.0||||||
3761800|NCT01948375|3595417|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3761801|NCT01948375|3595418|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3761802|NCT01948375|3595419|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3761803|NCT01948375|3595417|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3761804|NCT01948375|3595418|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3761805|NCT01948375|3595419|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3761806|NCT01948375|3595417|B3|||Age||years|Mean|49.18|49.18|Standard Deviation|15.55|15.55|||
3761807|NCT01948375|3595418|B2|||Age||years|Mean|48.90|48.9|Standard Deviation|16.74|16.74|||
3761808|NCT01948375|3595419|B1|||Age||years|Mean|49.47|49.47|Standard Deviation|14.54|14.54|||
3761809|NCT01948310|3595434|B3|United States||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3761810|NCT01948310|3595435|B2|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3761811|NCT01948310|3595436|B1|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3761812|NCT01948310|3595434|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761813|NCT01948310|3595435|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761814|NCT01948310|3595436|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761815|NCT01948310|3595434|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761816|NCT01948310|3595435|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761817|NCT01948310|3595436|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761818|NCT01948310|3595434|B3||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3761819|NCT01948310|3595435|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3761820|NCT01948310|3595436|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3761821|NCT01948310|3595434|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3761822|NCT01948310|3595435|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3761823|NCT01948310|3595436|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3761824|NCT01948310|3595434|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761825|NCT01948310|3595435|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761826|NCT01948310|3595436|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761827|NCT01948310|3595434|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761828|NCT01948310|3595435|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761829|NCT01948310|3595436|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761830|NCT01948310|3595434|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761831|NCT01948310|3595435|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761832|NCT01948310|3595436|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761833|NCT01948310|3595434|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3761834|NCT01948310|3595435|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3761835|NCT01948310|3595436|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3761836|NCT01948310|3595434|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3761837|NCT01948310|3595435|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3761838|NCT01948310|3595436|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3761839|NCT01948310|3595434|B3|||Age||years|Mean|68.4|68.4|Standard Deviation|9.6|9.6|||
3761840|NCT01948310|3595435|B2|||Age||years|Mean|67.4|67.4|Standard Deviation|11.2|11.2|||
3761841|NCT01948310|3595436|B1|||Age||years|Mean|69.2|69.2|Standard Deviation|8.3|8.3|||
3761842|NCT01948258|3595447|B1||Other|Occupation||Participants|Count of Participants|12|12.0||||||
3761843|NCT01948258|3595447|B1||Homemaker|Occupation||Participants|Count of Participants|32|32.0||||||
3761844|NCT01948258|3595447|B1||Student|Occupation||Participants|Count of Participants|4|4.0||||||
3761845|NCT01948258|3595447|B1||Support Personnel|Occupation||Participants|Count of Participants|11|11.0||||||
3761846|NCT01948258|3595447|B1||Manufacturing / Driver|Occupation||Participants|Count of Participants|0|0.0||||||
3761847|NCT01948258|3595447|B1||Sales / Customer Services|Occupation||Participants|Count of Participants|29|29.0||||||
3761848|NCT01948258|3595447|B1||Personal Services|Occupation||Participants|Count of Participants|8|8.0||||||
3761849|NCT01948258|3595447|B1||Skilled Trade|Occupation||Participants|Count of Participants|4|4.0||||||
3761850|NCT01948258|3595447|B1||Administrative / Secretarial|Occupation||Participants|Count of Participants|24|24.0||||||
3761851|NCT01948258|3595447|B1||Associate Professional / Technical|Occupation||Participants|Count of Participants|27|27.0||||||
3761852|NCT01948258|3595447|B1||Professional|Occupation||Participants|Count of Participants|59|59.0||||||
3761853|NCT01948258|3595447|B1||Managerial|Occupation||Participants|Count of Participants|23|23.0||||||
3761854|NCT01948258|3595447|B1||No qualifications|Highest qualification||Participants|Count of Participants|5|5.0||||||
3761855|NCT01948258|3595447|B1||Other qualifications|Highest qualification||Participants|Count of Participants|8|8.0||||||
3761856|NCT01948258|3595447|B1||Qualifications at level 1 and below|Highest qualification||Participants|Count of Participants|2|2.0||||||
3761857|NCT01948258|3595447|B1||GCSE (Grade A*-C), vocational level 2 and equivale|Highest qualification||Participants|Count of Participants|41|41.0||||||
3761858|NCT01948258|3595447|B1||A levels, vocational level 3 and equivalents (age|Highest qualification||Participants|Count of Participants|55|55.0||||||
3761859|NCT01948258|3595447|B1||Other higher education below degree level (associa|Highest qualification||Participants|Count of Participants|20|20.0||||||
3761860|NCT01948258|3595447|B1||Degree or equivalent (college degree)|Highest qualification||Participants|Count of Participants|77|77.0||||||
3761861|NCT01948258|3595447|B1||Post-graduate qualifications|Highest qualification||Participants|Count of Participants|25|25.0||||||
3761862|NCT01948258|3595447|B1|Race/Ethnicity|Mixed|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3761863|NCT01948258|3595447|B1|Race/Ethnicity|White: Other White|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3761864|NCT01948258|3595447|B1|Race/Ethnicity|White: Western European|Race/Ethnicity, Customized||Participants|Count of Participants|210|210.0||||||
3761865|NCT01948258|3595447|B1|Race/Ethnicity|White: Mediterranean/Middle Eastern|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3761866|NCT01948258|3595447|B1|Race/Ethnicity|White: Eastern European|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3761867|NCT01948258|3595447|B1|Race/Ethnicity|White: Australian/New Zealander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3761868|NCT01948258|3595447|B1|Race/Ethnicity|White: American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3761869|NCT01948258|3595447|B1|Race/Ethnicity|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3761870|NCT01948258|3595447|B1|Race/Ethnicity|Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3761871|NCT01948258|3595447|B1|Race/Ethnicity|Black: Other Black|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3761872|NCT01948258|3595447|B1|Race/Ethnicity|Black: Caribbean|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3761873|NCT01948258|3595447|B1|Race/Ethnicity|Black: African|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3761874|NCT01948258|3595447|B1|Race/Ethnicity|Asian : Other Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3761875|NCT01948258|3595447|B1|Race/Ethnicity|Asian : South Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3761876|NCT01948258|3595447|B1|Race/Ethnicity|Asian : Pakistani|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3761877|NCT01948258|3595447|B1|Race/Ethnicity|Asian : Indian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3761878|NCT01948258|3595447|B1|Race/Ethnicity|Asian : Chinese|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3761879|NCT01948258|3595447|B1|Race/Ethnicity|Asian : Bangladeshi|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3761880|NCT01948258|3595447|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3761881|NCT01948258|3595447|B1||Female|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
3761882|NCT01948258|3595447|B1|Age of Participants|41-45|Age, Customized|Age of Participants who used the new Clearblue Advanced Fertility Monitor|Participants|Count of Participants|7|7.0||||||
3761883|NCT01948258|3595447|B1|Age of Participants|36-40|Age, Customized|Age of Participants who used the new Clearblue Advanced Fertility Monitor|Participants|Count of Participants|56|56.0||||||
3761884|NCT01948258|3595447|B1|Age of Participants|31-35|Age, Customized|Age of Participants who used the new Clearblue Advanced Fertility Monitor|Participants|Count of Participants|64|64.0||||||
3761885|NCT01948258|3595447|B1|Age of Participants|26-30|Age, Customized|Age of Participants who used the new Clearblue Advanced Fertility Monitor|Participants|Count of Participants|68|68.0||||||
3761886|NCT01948258|3595447|B1|Age of Participants|18-25|Age, Customized|Age of Participants who used the new Clearblue Advanced Fertility Monitor|Participants|Count of Participants|38|38.0||||||
3761887|NCT01948193|3595453|B1|India||Region of Enrollment||Participants|Number|177|177.0||||||
3761888|NCT01948193|3595453|B1||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3761889|NCT01948193|3595453|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3761890|NCT01948193|3595453|B1|||Age||Weeks|Mean|6.9|6.9|Standard Deviation|0.6|0.6|||
3761891|NCT01948193|3595453|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3761892|NCT01948193|3595453|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3761893|NCT01948193|3595453|B1||<=18 years|Age||Participants|Count of Participants|177|177.0||||||
3761894|NCT01948141|3595462|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3761895|NCT01948141|3595462|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3761896|NCT01948141|3595462|B1|||Age||years|Mean|68.5|68.5|Standard Deviation|5.3|5.3|||
3761897|NCT01948076|3595473|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3761898|NCT01948076|3595474|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3761899|NCT01948076|3595475|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3761900|NCT01948076|3595473|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3761901|NCT01948076|3595474|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3761902|NCT01948076|3595475|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3761903|NCT01948076|3595473|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3761904|NCT01948076|3595474|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3761905|NCT01948076|3595475|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3761906|NCT01948076|3595473|B3|||Age||years|Mean|29.4|29.4|Standard Deviation|2.1|2.1|||
3761907|NCT01948076|3595474|B2|||Age||years|Mean|29.5|29.5|Standard Deviation|1.9|1.9|||
3761908|NCT01948076|3595475|B1|||Age||years|Mean|29.3|29.3|Standard Deviation|2.3|2.3|||
3761909|NCT01948076|3595473|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3761910|NCT01948076|3595474|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3761911|NCT01948076|3595475|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3761912|NCT01948076|3595473|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3761913|NCT01948076|3595474|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3761914|NCT01948076|3595475|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3761915|NCT01948076|3595473|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3761916|NCT01948076|3595474|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3761917|NCT01948076|3595475|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3761918|NCT01948063|3595484|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
3761919|NCT01948063|3595485|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3761920|NCT01948063|3595486|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3761921|NCT01948063|3595484|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3761922|NCT01948063|3595485|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3761923|NCT01948063|3595486|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761924|NCT01948063|3595484|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761925|NCT01948063|3595485|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761926|NCT01948063|3595486|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761927|NCT01948063|3595484|B3||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3761928|NCT01948063|3595485|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3761929|NCT01948063|3595486|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3761930|NCT01948063|3595484|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3761931|NCT01948063|3595485|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3761932|NCT01948063|3595486|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3761933|NCT01948063|3595484|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3761934|NCT01948063|3595485|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761935|NCT01948063|3595486|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3761936|NCT01948063|3595484|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3761937|NCT01948063|3595485|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761938|NCT01948063|3595486|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3761939|NCT01948063|3595484|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761940|NCT01948063|3595485|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761941|NCT01948063|3595486|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761942|NCT01948063|3595484|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3761943|NCT01948063|3595485|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3761944|NCT01948063|3595486|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3761945|NCT01948063|3595484|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3761946|NCT01948063|3595485|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3761947|NCT01948063|3595486|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3761948|NCT01948063|3595484|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3761949|NCT01948063|3595485|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3761950|NCT01948063|3595486|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3761951|NCT01948063|3595484|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3761952|NCT01948063|3595485|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3761953|NCT01948063|3595486|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3761954|NCT01948063|3595484|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3761955|NCT01948063|3595485|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3761956|NCT01948063|3595486|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3761957|NCT01948063|3595484|B3|||Age||Years|Mean|62|62.0|Standard Deviation|15|15.0|||
3761958|NCT01948063|3595485|B2|||Age||Years|Mean|60|60.0|Standard Deviation|18|18.0|||
3761959|NCT01948063|3595486|B1|||Age||Years|Mean|64|64.0|Standard Deviation|14|14.0|||
3761960|NCT01948050|3595493|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
3761961|NCT01948050|3595494|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3761962|NCT01948050|3595495|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3761963|NCT01948050|3595493|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3761964|NCT01948050|3595494|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3761965|NCT01948050|3595495|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3761966|NCT01948050|3595493|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3761967|NCT01948050|3595494|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3761968|NCT01948050|3595495|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3761969|NCT01948050|3595493|B3|||Age||years|Mean|54.5|54.5|Standard Deviation|11.2|11.2|||
3761970|NCT01948050|3595494|B2|||Age||years|Mean|49.8|49.8|Standard Deviation|13.4|13.4|||
3761971|NCT01948050|3595495|B1|||Age||years|Mean|56.9|56.9|Standard Deviation|9.4|9.4|||
3761972|NCT01948050|3595493|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3761973|NCT01948050|3595494|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3761974|NCT01948050|3595495|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3761975|NCT01948050|3595493|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3761976|NCT01948050|3595494|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3761977|NCT01948050|3595495|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3761978|NCT01948050|3595493|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3761979|NCT01948050|3595494|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3761980|NCT01948050|3595495|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3761981|NCT01947946|3595502|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3761982|NCT01947946|3595503|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3761983|NCT01947946|3595504|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3761984|NCT01947946|3595505|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3761985|NCT01947946|3595502|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3761986|NCT01947946|3595503|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3761987|NCT01947946|3595504|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3761988|NCT01947946|3595505|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3761989|NCT01947946|3595502|B4|||Age||years|Mean|54.8|54.8|Standard Deviation|9.32|9.32|||
3761990|NCT01947946|3595503|B3|||Age||years|Mean|49.6|49.6|Standard Deviation|6.35|6.35|||
3761991|NCT01947946|3595504|B2|||Age||years|Mean|57.8|57.8|Standard Deviation|6.38|6.38|||
3761992|NCT01947946|3595505|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|15.70|15.7|||
3761993|NCT01947907|3595515|B5|||Screening Peak GH Values||ng/mL|Mean|4.95|4.95|Standard Deviation|2.829|2.829|||
3761994|NCT01947907|3595516|B4|||Screening Peak GH Values||ng/mL|Mean|5.15|5.15|Standard Deviation|3.068|3.068|||
3761995|NCT01947907|3595517|B3|||Screening Peak GH Values||ng/mL|Mean|4.44|4.44|Standard Deviation|2.770|2.77|||
3761996|NCT01947907|3595518|B2|||Screening Peak GH Values||ng/mL|Mean|5.16|5.16|Standard Deviation|2.598|2.598|||
3761997|NCT01947907|3595519|B1|||Screening Peak GH Values||ng/mL|Mean|5.09|5.09|Standard Deviation|3.169|3.169|||
3761998|NCT01947907|3595515|B5|||Baseline Height SDS||Standard Deviation Score|Mean|-3.06|-3.06|Standard Deviation|0.905|0.905|||
3761999|NCT01947907|3595516|B4|||Baseline Height SDS||Standard Deviation Score|Mean|-3.27|-3.27|Standard Deviation|1.077|1.077|||
3762000|NCT01947907|3595517|B3|||Baseline Height SDS||Standard Deviation Score|Mean|-3.17|-3.17|Standard Deviation|1.04|1.04|||
3762001|NCT01947907|3595518|B2|||Baseline Height SDS||Standard Deviation Score|Mean|-2.75|-2.75|Standard Deviation|0.383|0.383|||
3762002|NCT01947907|3595519|B1|||Baseline Height SDS||Standard Deviation Score|Mean|-3.05|-3.05|Standard Deviation|1.127|1.127|||
3762003|NCT01947907|3595515|B5|||Baseline IGF-1 SDS (standard deviation score)||Standard Deviation Score|Mean|-2.19|-2.19|Standard Deviation|0.782|0.782|||
3762004|NCT01947907|3595516|B4|||Baseline IGF-1 SDS (standard deviation score)||Standard Deviation Score|Mean|-2.502|-2.502|Standard Deviation|0.896|0.896|||
3762005|NCT01947907|3595517|B3|||Baseline IGF-1 SDS (standard deviation score)||Standard Deviation Score|Mean|-2.19|-2.19|Standard Deviation|0.7169|0.7169|||
3762006|NCT01947907|3595518|B2|||Baseline IGF-1 SDS (standard deviation score)||Standard Deviation Score|Mean|-2.017|-2.017|Standard Deviation|0.7713|0.7713|||
3762007|NCT01947907|3595519|B1|||Baseline IGF-1 SDS (standard deviation score)||Standard Deviation Score|Mean|-2.034|-2.034|Standard Deviation|0.7429|0.7429|||
3762008|NCT01947907|3595515|B5|Bulgaria||Region of Enrollment||participants|Number|1|1.0||||||
3762009|NCT01947907|3595516|B4|Bulgaria||Region of Enrollment||participants|Number|1|1.0||||||
3762010|NCT01947907|3595517|B3|Bulgaria||Region of Enrollment||participants|Number|0|0.0||||||
3762011|NCT01947907|3595518|B2|Bulgaria||Region of Enrollment||participants|Number|0|0.0||||||
3762012|NCT01947907|3595519|B1|Bulgaria||Region of Enrollment||participants|Number|0|0.0||||||
3762013|NCT01947907|3595515|B5|Poland||Region of Enrollment||participants|Number|1|1.0||||||
3762014|NCT01947907|3595516|B4|Poland||Region of Enrollment||participants|Number|0|0.0||||||
3762015|NCT01947907|3595517|B3|Poland||Region of Enrollment||participants|Number|1|1.0||||||
3762016|NCT01947907|3595518|B2|Poland||Region of Enrollment||participants|Number|0|0.0||||||
3762017|NCT01947907|3595519|B1|Poland||Region of Enrollment||participants|Number|0|0.0||||||
3762018|NCT01947907|3595515|B5|Turkey||Region of Enrollment||participants|Number|3|3.0||||||
3762019|NCT01947907|3595516|B4|Turkey||Region of Enrollment||participants|Number|2|2.0||||||
3762020|NCT01947907|3595517|B3|Turkey||Region of Enrollment||participants|Number|0|0.0||||||
3762021|NCT01947907|3595518|B2|Turkey||Region of Enrollment||participants|Number|0|0.0||||||
3762022|NCT01947907|3595519|B1|Turkey||Region of Enrollment||participants|Number|1|1.0||||||
3762023|NCT01947907|3595515|B5|Greece||Region of Enrollment||participants|Number|3|3.0||||||
3762024|NCT01947907|3595516|B4|Greece||Region of Enrollment||participants|Number|0|0.0||||||
3762025|NCT01947907|3595517|B3|Greece||Region of Enrollment||participants|Number|2|2.0||||||
3762026|NCT01947907|3595518|B2|Greece||Region of Enrollment||participants|Number|0|0.0||||||
3762027|NCT01947907|3595519|B1|Greece||Region of Enrollment||participants|Number|1|1.0||||||
3762028|NCT01947907|3595515|B5|Belarus||Region of Enrollment||participants|Number|7|7.0||||||
3762029|NCT01947907|3595516|B4|Belarus||Region of Enrollment||participants|Number|1|1.0||||||
3762030|NCT01947907|3595517|B3|Belarus||Region of Enrollment||participants|Number|2|2.0||||||
3762031|NCT01947907|3595518|B2|Belarus||Region of Enrollment||participants|Number|2|2.0||||||
3762032|NCT01947907|3595519|B1|Belarus||Region of Enrollment||participants|Number|2|2.0||||||
3762033|NCT01947907|3595515|B5|Ukraine||Region of Enrollment||participants|Number|7|7.0||||||
3762034|NCT01947907|3595516|B4|Ukraine||Region of Enrollment||participants|Number|1|1.0||||||
3762035|NCT01947907|3595517|B3|Ukraine||Region of Enrollment||participants|Number|1|1.0||||||
3762036|NCT01947907|3595518|B2|Ukraine||Region of Enrollment||participants|Number|4|4.0||||||
3762037|NCT01947907|3595519|B1|Ukraine||Region of Enrollment||participants|Number|1|1.0||||||
3762038|NCT01947907|3595515|B5|Egypt||Region of Enrollment||participants|Number|7|7.0||||||
3762039|NCT01947907|3595516|B4|Egypt||Region of Enrollment||participants|Number|1|1.0||||||
3762040|NCT01947907|3595517|B3|Egypt||Region of Enrollment||participants|Number|0|0.0||||||
3762041|NCT01947907|3595518|B2|Egypt||Region of Enrollment||participants|Number|4|4.0||||||
3762042|NCT01947907|3595519|B1|Egypt||Region of Enrollment||participants|Number|2|2.0||||||
3762043|NCT01947907|3595515|B5|Hungary||Region of Enrollment||participants|Number|1|1.0||||||
3762044|NCT01947907|3595516|B4|Hungary||Region of Enrollment||participants|Number|0|0.0||||||
3762045|NCT01947907|3595517|B3|Hungary||Region of Enrollment||participants|Number|1|1.0||||||
3762046|NCT01947907|3595518|B2|Hungary||Region of Enrollment||participants|Number|0|0.0||||||
3762047|NCT01947907|3595519|B1|Hungary||Region of Enrollment||participants|Number|0|0.0||||||
3762048|NCT01947907|3595515|B5|Romania||Region of Enrollment||participants|Number|2|2.0||||||
3762049|NCT01947907|3595516|B4|Romania||Region of Enrollment||participants|Number|1|1.0||||||
3762050|NCT01947907|3595517|B3|Romania||Region of Enrollment||participants|Number|0|0.0||||||
3762051|NCT01947907|3595518|B2|Romania||Region of Enrollment||participants|Number|0|0.0||||||
3762052|NCT01947907|3595519|B1|Romania||Region of Enrollment||participants|Number|1|1.0||||||
3762053|NCT01947907|3595515|B5|Russian Federation||Region of Enrollment||participants|Number|21|21.0||||||
3762054|NCT01947907|3595516|B4|Russian Federation||Region of Enrollment||participants|Number|6|6.0||||||
3762055|NCT01947907|3595517|B3|Russian Federation||Region of Enrollment||participants|Number|7|7.0||||||
3762056|NCT01947907|3595518|B2|Russian Federation||Region of Enrollment||participants|Number|4|4.0||||||
3762057|NCT01947907|3595519|B1|Russian Federation||Region of Enrollment||participants|Number|4|4.0||||||
3762058|NCT01947907|3595515|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762059|NCT01947907|3595516|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762060|NCT01947907|3595517|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762061|NCT01947907|3595518|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762062|NCT01947907|3595519|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762063|NCT01947907|3595515|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762064|NCT01947907|3595516|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762065|NCT01947907|3595517|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762066|NCT01947907|3595518|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762067|NCT01947907|3595519|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762068|NCT01947907|3595515|B5||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3762069|NCT01947907|3595516|B4||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3762070|NCT01947907|3595517|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3762071|NCT01947907|3595518|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3762072|NCT01947907|3595519|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3762073|NCT01947907|3595515|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762074|NCT01947907|3595516|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762075|NCT01947907|3595517|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762076|NCT01947907|3595518|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762077|NCT01947907|3595519|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762078|NCT01947907|3595515|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762079|NCT01947907|3595516|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762080|NCT01947907|3595517|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762081|NCT01947907|3595518|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762082|NCT01947907|3595519|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762083|NCT01947907|3595515|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762084|NCT01947907|3595516|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762085|NCT01947907|3595517|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762086|NCT01947907|3595518|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762087|NCT01947907|3595519|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762088|NCT01947907|3595515|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762089|NCT01947907|3595516|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762090|NCT01947907|3595517|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762091|NCT01947907|3595518|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762092|NCT01947907|3595519|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762093|NCT01947907|3595515|B5||Male|Gender||Participants|Count of Participants|38|38.0||||||
3762094|NCT01947907|3595516|B4||Male|Gender||Participants|Count of Participants|10|10.0||||||
3762095|NCT01947907|3595517|B3||Male|Gender||Participants|Count of Participants|9|9.0||||||
3762096|NCT01947907|3595518|B2||Male|Gender||Participants|Count of Participants|10|10.0||||||
3762097|NCT01947907|3595519|B1||Male|Gender||Participants|Count of Participants|9|9.0||||||
3762098|NCT01947907|3595515|B5||Female|Gender||Participants|Count of Participants|15|15.0||||||
3762099|NCT01947907|3595516|B4||Female|Gender||Participants|Count of Participants|3|3.0||||||
3762100|NCT01947907|3595517|B3||Female|Gender||Participants|Count of Participants|5|5.0||||||
3762101|NCT01947907|3595518|B2||Female|Gender||Participants|Count of Participants|4|4.0||||||
3762102|NCT01947907|3595519|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
3762103|NCT01947907|3595515|B5|||Age||years|Mean|7.77|7.77|Standard Deviation|2.57|2.57|||
3762104|NCT01947907|3595516|B4|||Age||years|Mean|7.53|7.53|Standard Deviation|2.483|2.483|||
3762105|NCT01947907|3595517|B3|||Age||years|Mean|7.32|7.32|Standard Deviation|2.784|2.784|||
3762106|NCT01947907|3595518|B2|||Age||years|Mean|8.24|8.24|Standard Deviation|2.13|2.13|||
3762107|NCT01947907|3595519|B1|||Age||years|Mean|7.98|7.98|Standard Deviation|2.889|2.889|||
3762108|NCT01947907|3595515|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3762109|NCT01947907|3595516|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3762110|NCT01947907|3595517|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3762111|NCT01947907|3595518|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3762112|NCT01947907|3595519|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3762113|NCT01947907|3595515|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3762114|NCT01947907|3595516|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3762115|NCT01947907|3595517|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3762116|NCT01947907|3595518|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3762117|NCT01947907|3595519|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3762118|NCT01947907|3595515|B5||<=18 years|Age||Participants|Count of Participants|53|53.0||||||
3762119|NCT01947907|3595516|B4||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
3762120|NCT01947907|3595517|B3||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
3762121|NCT01947907|3595518|B2||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
3762122|NCT01947907|3595519|B1||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
3762123|NCT01947855|3595561|B4||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3762124|NCT01947855|3595562|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3762125|NCT01947855|3595563|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3762126|NCT01947855|3595564|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3762127|NCT01947855|3595561|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3762128|NCT01947855|3595562|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3762129|NCT01947855|3595563|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3762130|NCT01947855|3595564|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3762131|NCT01947855|3595561|B4|||Age||years|Mean|62.7|62.7|Standard Deviation|8.5|8.5|||
3762132|NCT01947855|3595562|B3|||Age||years|Mean|62.6|62.6|Standard Deviation|7.8|7.8|||
3762133|NCT01947855|3595563|B2|||Age||years|Mean|64.8|64.8|Standard Deviation|5.9|5.9|||
3762134|NCT01947855|3595564|B1|||Age||years|Mean|60.7|60.7|Standard Deviation|10.8|10.8|||
3762135|NCT01947582|3595574|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3762136|NCT01947582|3595574|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762137|NCT01947582|3595574|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762138|NCT01947582|3595574|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762139|NCT01947582|3595574|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3762140|NCT01947582|3595574|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762141|NCT01947582|3595574|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762142|NCT01947582|3595574|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762143|NCT01947582|3595574|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762144|NCT01947582|3595574|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3762145|NCT01947582|3595574|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762146|NCT01947582|3595574|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3762147|NCT01947582|3595574|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3762148|NCT01947582|3595574|B1|||Age||years|Mean|48|48.0|Full Range|||48.0|48.0|
3762149|NCT01947582|3595574|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3762150|NCT01947582|3595574|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3762151|NCT01947582|3595574|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3762152|NCT01947517|3595581|B3|Canada||Region of Enrollment||participants|Number|50|50.0||||||
3762153|NCT01947517|3595582|B2|Canada||Region of Enrollment||participants|Number|25|25.0||||||
3762154|NCT01947517|3595583|B1|Canada||Region of Enrollment||participants|Number|25|25.0||||||
3762155|NCT01947517|3595581|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3762156|NCT01947517|3595582|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3762157|NCT01947517|3595583|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3762158|NCT01947517|3595581|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3762159|NCT01947517|3595582|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3762160|NCT01947517|3595583|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3762161|NCT01947517|3595581|B3|||Age||years|Mean|60.1|60.1|Standard Deviation|15.97|15.97|||
3762162|NCT01947517|3595582|B2|||Age||years|Mean|58.4|58.4|Standard Deviation|16.18|16.18|||
3762163|NCT01947517|3595583|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|17.67|17.67|||
3762164|NCT01947517|3595581|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3762165|NCT01947517|3595582|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3762166|NCT01947517|3595583|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3762167|NCT01947517|3595581|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3762168|NCT01947517|3595582|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3762169|NCT01947517|3595583|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3762170|NCT01947517|3595581|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3762171|NCT01947517|3595582|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3762172|NCT01947517|3595583|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3762173|NCT01947491|3595598|B5|United States||Region of Enrollment||participants|Number|394|394.0||||||
3762174|NCT01947491|3595599|B4|United States||Region of Enrollment||participants|Number|43|43.0||||||
3762175|NCT01947491|3595600|B3|United States||Region of Enrollment||participants|Number|90|90.0||||||
3762176|NCT01947491|3595601|B2|United States||Region of Enrollment||participants|Number|87|87.0||||||
3762177|NCT01947491|3595602|B1|United States||Region of Enrollment||participants|Number|174|174.0||||||
3762178|NCT01947491|3595598|B5||Male|Gender||Participants|Count of Participants|242|242.0||||||
3762179|NCT01947491|3595599|B4||Male|Gender||Participants|Count of Participants|24|24.0||||||
3762180|NCT01947491|3595600|B3||Male|Gender||Participants|Count of Participants|56|56.0||||||
3762181|NCT01947491|3595601|B2||Male|Gender||Participants|Count of Participants|51|51.0||||||
3762182|NCT01947491|3595602|B1||Male|Gender||Participants|Count of Participants|111|111.0||||||
3762183|NCT01947491|3595598|B5||Female|Gender||Participants|Count of Participants|152|152.0||||||
3762184|NCT01947491|3595599|B4||Female|Gender||Participants|Count of Participants|19|19.0||||||
3762185|NCT01947491|3595600|B3||Female|Gender||Participants|Count of Participants|34|34.0||||||
3762186|NCT01947491|3595601|B2||Female|Gender||Participants|Count of Participants|36|36.0||||||
3762187|NCT01947491|3595602|B1||Female|Gender||Participants|Count of Participants|63|63.0||||||
3762188|NCT01947491|3595598|B5|||Age||years|Mean|50.0|50.0|Standard Deviation|13.85|13.85|||
3762189|NCT01947491|3595599|B4|||Age||years|Mean|51.6|51.6|Standard Deviation|12.67|12.67|||
3762190|NCT01947491|3595600|B3|||Age||years|Mean|51.0|51.0|Standard Deviation|12.75|12.75|||
3762191|NCT01947491|3595601|B2|||Age||years|Mean|50.2|50.2|Standard Deviation|14.12|14.12|||
3762192|NCT01947491|3595602|B1|||Age||years|Mean|49.0|49.0|Standard Deviation|14.54|14.54|||
3762193|NCT01947335|3595615|B3|Brazil||Region of Enrollment||participants|Number|83|83.0||||||
3762194|NCT01947335|3595616|B2|Brazil||Region of Enrollment||participants|Number|41|41.0||||||
3762195|NCT01947335|3595617|B1|Brazil||Region of Enrollment||participants|Number|42|42.0||||||
3762196|NCT01947335|3595615|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3762197|NCT01947335|3595616|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3762198|NCT01947335|3595617|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3762199|NCT01947335|3595615|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3762200|NCT01947335|3595616|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3762201|NCT01947335|3595617|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3762202|NCT01947335|3595615|B3|||Age||years|Median|64.6|64.6|Full Range|||57.3|76.5|
3762203|NCT01947335|3595616|B2|||Age||years|Median|67.1|67.1|Full Range|||58.3|76.1|
3762204|NCT01947335|3595617|B1|||Age||years|Median|62.1|62.1|Full Range|||57.3|76.5|
3762205|NCT01947153|3595628|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3762206|NCT01947153|3595628|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3762207|NCT01947153|3595628|B1|||Age||years|Mean|25.0|25.0|Standard Deviation|6.2|6.2|||
3762208|NCT01947127|3595647|B3|Thailand||Region of Enrollment||participants|Number|392|392.0||||||
3762209|NCT01947127|3595648|B2|Thailand||Region of Enrollment||participants|Number|249|249.0||||||
3762210|NCT01947127|3595649|B1|Thailand||Region of Enrollment||participants|Number|143|143.0||||||
3762211|NCT01947127|3595647|B3|Thai and Southeast Asian||Race/Ethnicity, Customized||participants|Number|392|392.0||||||
3762212|NCT01947127|3595648|B2|Thai and Southeast Asian||Race/Ethnicity, Customized||participants|Number|249|249.0||||||
3762213|NCT01947127|3595649|B1|Thai and Southeast Asian||Race/Ethnicity, Customized||participants|Number|143|143.0||||||
3762214|NCT01947127|3595647|B3||Male|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
3762215|NCT01947127|3595648|B2||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3762216|NCT01947127|3595649|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3762217|NCT01947127|3595647|B3||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3762218|NCT01947127|3595648|B2||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3762219|NCT01947127|3595649|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3762220|NCT01947127|3595647|B3|||Age||years|Mean|44.0|44.0|Standard Deviation|14.2|14.2|||
3762221|NCT01947127|3595648|B2|||Age||years|Mean|42.8|42.8|Standard Deviation|14.4|14.4|||
3762222|NCT01947127|3595649|B1|||Age||years|Mean|46.0|46.0|Standard Deviation|13.7|13.7|||
3762223|NCT01947127|3595647|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3762224|NCT01947127|3595648|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3762225|NCT01947127|3595649|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3762226|NCT01947127|3595647|B3||Between 18 and 65 years|Age||Participants|Count of Participants|392|392.0||||||
3762227|NCT01947127|3595648|B2||Between 18 and 65 years|Age||Participants|Count of Participants|249|249.0||||||
3762228|NCT01947127|3595649|B1||Between 18 and 65 years|Age||Participants|Count of Participants|143|143.0||||||
3762229|NCT01947127|3595647|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3762230|NCT01947127|3595648|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3762231|NCT01947127|3595649|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3762232|NCT01946542|3595660|B3|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3762233|NCT01946542|3595661|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3762234|NCT01946542|3595662|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3762235|NCT01946542|3595660|B3|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3762236|NCT01946542|3595661|B2|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3762237|NCT01946542|3595662|B1|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3762238|NCT01946542|3595660|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3762239|NCT01946542|3595661|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3762240|NCT01946542|3595662|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3762241|NCT01946542|3595660|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3762242|NCT01946542|3595661|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3762243|NCT01946542|3595662|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3762244|NCT01946542|3595660|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3762245|NCT01946542|3595661|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3762246|NCT01946542|3595662|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3762247|NCT01946542|3595660|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3762248|NCT01946542|3595661|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3762249|NCT01946542|3595662|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3762250|NCT01946542|3595660|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3762251|NCT01946542|3595661|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3762252|NCT01946542|3595662|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3762253|NCT01946529|3595671|B4|Local||Disease stage||participants|Number|7|7.0||||||
3762254|NCT01946529|3595672|B3|Local||Disease stage||participants|Number|1|1.0||||||
3762255|NCT01946529|3595673|B2|Local||Disease stage||participants|Number|5|5.0||||||
3762256|NCT01946529|3595674|B1|Local||Disease stage||participants|Number|1|1.0||||||
3762257|NCT01946529|3595671|B4|Metastases||Disease stage||participants|Number|16|16.0||||||
3762258|NCT01946529|3595672|B3|Metastases||Disease stage||participants|Number|5|5.0||||||
3762259|NCT01946529|3595673|B2|Metastases||Disease stage||participants|Number|11|11.0||||||
3762260|NCT01946529|3595674|B1|Metastases||Disease stage||participants|Number|0|0.0||||||
3762261|NCT01946529|3595671|B4|Other||Primary disease site||participants|Number|12|12.0||||||
3762262|NCT01946529|3595672|B3|Other||Primary disease site||participants|Number|1|1.0||||||
3762263|NCT01946529|3595673|B2|Other||Primary disease site||participants|Number|10|10.0||||||
3762264|NCT01946529|3595674|B1|Other||Primary disease site||participants|Number|1|1.0||||||
3762265|NCT01946529|3595671|B4|Pelvis||Primary disease site||participants|Number|11|11.0||||||
3762266|NCT01946529|3595672|B3|Pelvis||Primary disease site||participants|Number|5|5.0||||||
3762267|NCT01946529|3595673|B2|Pelvis||Primary disease site||participants|Number|6|6.0||||||
3762268|NCT01946529|3595674|B1|Pelvis||Primary disease site||participants|Number|0|0.0||||||
3762269|NCT01946529|3595671|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3762270|NCT01946529|3595672|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3762271|NCT01946529|3595673|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3762272|NCT01946529|3595674|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762273|NCT01946529|3595671|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762274|NCT01946529|3595672|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762275|NCT01946529|3595673|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762276|NCT01946529|3595674|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762277|NCT01946529|3595671|B4||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3762278|NCT01946529|3595672|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3762279|NCT01946529|3595673|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3762280|NCT01946529|3595674|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3762281|NCT01946529|3595671|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3762282|NCT01946529|3595672|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3762283|NCT01946529|3595673|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762284|NCT01946529|3595674|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762285|NCT01946529|3595671|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762286|NCT01946529|3595672|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762287|NCT01946529|3595673|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762288|NCT01946529|3595674|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762289|NCT01946529|3595671|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3762290|NCT01946529|3595672|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762291|NCT01946529|3595673|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3762292|NCT01946529|3595674|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762293|NCT01946529|3595671|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762294|NCT01946529|3595672|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762295|NCT01946529|3595673|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762296|NCT01946529|3595674|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762297|NCT01946529|3595671|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3762298|NCT01946529|3595672|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3762299|NCT01946529|3595673|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3762300|NCT01946529|3595674|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3762301|NCT01946529|3595671|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3762302|NCT01946529|3595672|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3762303|NCT01946529|3595673|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3762304|NCT01946529|3595674|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3762305|NCT01946529|3595671|B4|||Age||years|Mean|13.4|13.4|Standard Deviation|5.2|5.2|||
3762306|NCT01946529|3595672|B3|||Age||years|Mean|14.7|14.7|Standard Deviation|4.1|4.1|||
3762307|NCT01946529|3595673|B2|||Age||years|Mean|13.0|13.0|Standard Deviation|5.7|5.7|||
3762308|NCT01946529|3595674|B1|||Age||years|Mean|12.0|12.0|Standard Deviation|0|0.0|||
3762309|NCT01946438|3595683|B5|United States||Region of Enrollment||Participants|Number|208|208.0||||||
3762310|NCT01946438|3595684|B4|United States||Region of Enrollment||Participants|Number|52|52.0||||||
3762311|NCT01946438|3595685|B3|United States||Region of Enrollment||Participants|Number|52|52.0||||||
3762312|NCT01946438|3595686|B2|United States||Region of Enrollment||Participants|Number|52|52.0||||||
3762313|NCT01946438|3595687|B1|United States||Region of Enrollment||Participants|Number|52|52.0||||||
3762314|NCT01946438|3595683|B5||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3762315|NCT01946438|3595684|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3762316|NCT01946438|3595685|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3762317|NCT01946438|3595686|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3762318|NCT01946438|3595687|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3762319|NCT01946438|3595683|B5||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3762320|NCT01946438|3595684|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3762321|NCT01946438|3595685|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3762322|NCT01946438|3595686|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3762323|NCT01946438|3595687|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3762324|NCT01946438|3595683|B5|||Age||Years|Mean|58.75|58.75|Standard Deviation|17.3|17.3|||
3762325|NCT01946438|3595684|B4|||Age||Years|Mean|72.6|72.6|Standard Deviation|5.2|5.2|||
3762326|NCT01946438|3595685|B3|||Age||Years|Mean|71.5|71.5|Standard Deviation|4.7|4.7|||
3762327|NCT01946438|3595686|B2|||Age||Years|Mean|46.9|46.9|Standard Deviation|14.7|14.7|||
3762328|NCT01946438|3595687|B1|||Age||Years|Mean|44.2|44.2|Standard Deviation|15.2|15.2|||
3762329|NCT01946438|3595683|B5||>=65 years|Age||Participants|Count of Participants|104|104.0||||||
3762330|NCT01946438|3595684|B4||>=65 years|Age||Participants|Count of Participants|52|52.0||||||
3762331|NCT01946438|3595685|B3||>=65 years|Age||Participants|Count of Participants|52|52.0||||||
3762332|NCT01946438|3595686|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3762333|NCT01946438|3595687|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3762334|NCT01946438|3595683|B5||Between 18 and 65 years|Age||Participants|Count of Participants|104|104.0||||||
3762335|NCT01946438|3595684|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3762336|NCT01946438|3595685|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3762337|NCT01946438|3595686|B2||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3762338|NCT01946438|3595687|B1||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3762339|NCT01946438|3595683|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3762340|NCT01946438|3595684|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3762341|NCT01946438|3595685|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3762342|NCT01946438|3595686|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3762343|NCT01946438|3595687|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3762344|NCT01946425|3595716|B3|United States||Region of Enrollment||Participants|Number|60|60.0||||||
3762345|NCT01946425|3595717|B2|United States||Region of Enrollment||Participants|Number|30|30.0||||||
3762346|NCT01946425|3595718|B1|United States||Region of Enrollment||Participants|Number|30|30.0||||||
3762347|NCT01946425|3595716|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3762348|NCT01946425|3595717|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3762349|NCT01946425|3595718|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3762350|NCT01946425|3595716|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3762351|NCT01946425|3595717|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3762352|NCT01946425|3595718|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3762353|NCT01946425|3595716|B3|Age Continuous||Age||Years|Mean|3.7|3.7|Standard Deviation|2.2|2.2|||
3762354|NCT01946425|3595717|B2|Age Continuous||Age||Years|Mean|5.4|5.4|Standard Deviation|1.8|1.8|||
3762355|NCT01946425|3595718|B1|Age Continuous||Age||Years|Mean|1.9|1.9|Standard Deviation|0.6|0.6|||
3762356|NCT01946425|3595716|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3762357|NCT01946425|3595717|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3762358|NCT01946425|3595718|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3762359|NCT01946425|3595716|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3762360|NCT01946425|3595717|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3762361|NCT01946425|3595718|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3762362|NCT01946425|3595716|B3||<=18 years|Age||Participants|Count of Participants|60|60.0||||||
3762363|NCT01946425|3595717|B2||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
3762364|NCT01946425|3595718|B1||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
3762365|NCT01946412|3595733|B1||Male|Gender||Participants|Count of Participants|27|27.0||||||
3762366|NCT01946412|3595733|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
3762367|NCT01946412|3595733|B1|||Age||years|Mean|3.7|3.7|Standard Deviation|1.04|1.04|||
3762368|NCT01946243|3595755|B1|United States||Region of Enrollment||participants|Number|96|96.0||||||
3762369|NCT01946243|3595755|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3762370|NCT01946243|3595755|B1|White||Race/Ethnicity, Customized||participants|Number|89|89.0||||||
3762371|NCT01946243|3595755|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3762372|NCT01946243|3595755|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3762373|NCT01946243|3595755|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762374|NCT01946243|3595755|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
3762375|NCT01946243|3595755|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3762376|NCT01946243|3595755|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3762377|NCT01946243|3595755|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3762378|NCT01946243|3595755|B1|||Age||years|Mean|76.9|76.9|Standard Deviation|10.23|10.23|||
3762379|NCT01946204|3595776|B3|United States||Region of Enrollment||Participants|Count of Participants|337|337.0||||||
3762380|NCT01946204|3595777|B2|United States||Region of Enrollment||Participants|Count of Participants|224|224.0||||||
3762381|NCT01946204|3595778|B1|United States||Region of Enrollment||Participants|Count of Participants|113|113.0||||||
3762382|NCT01946204|3595776|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|99|99.0||||||
3762383|NCT01946204|3595777|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
3762384|NCT01946204|3595778|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
3762385|NCT01946204|3595776|B3|Taiwan, Province Of China||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3762386|NCT01946204|3595777|B2|Taiwan, Province Of China||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3762387|NCT01946204|3595778|B1|Taiwan, Province Of China||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3762388|NCT01946204|3595776|B3|Sweden||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3762389|NCT01946204|3595777|B2|Sweden||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3762390|NCT01946204|3595778|B1|Sweden||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3762391|NCT01946204|3595776|B3|Spain||Region of Enrollment||Participants|Count of Participants|131|131.0||||||
3762392|NCT01946204|3595777|B2|Spain||Region of Enrollment||Participants|Count of Participants|95|95.0||||||
3762393|NCT01946204|3595778|B1|Spain||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3762394|NCT01946204|3595776|B3|South Africa||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
3762395|NCT01946204|3595777|B2|South Africa||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3762396|NCT01946204|3595778|B1|South Africa||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3762397|NCT01946204|3595776|B3|Slovakia||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3762398|NCT01946204|3595777|B2|Slovakia||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3762399|NCT01946204|3595778|B1|Slovakia||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3762400|NCT01946204|3595776|B3|Russia||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3762401|NCT01946204|3595777|B2|Russia||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3762402|NCT01946204|3595778|B1|Russia||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3762403|NCT01946204|3595776|B3|Romania||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3762404|NCT01946204|3595777|B2|Romania||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3762405|NCT01946204|3595778|B1|Romania||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3762406|NCT01946204|3595776|B3|Poland||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3762407|NCT01946204|3595777|B2|Poland||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3762408|NCT01946204|3595778|B1|Poland||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3762409|NCT01946204|3595776|B3|Norway||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3762410|NCT01946204|3595777|B2|Norway||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3762411|NCT01946204|3595778|B1|Norway||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3762412|NCT01946204|3595776|B3|New Zealand||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3762413|NCT01946204|3595777|B2|New Zealand||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3762414|NCT01946204|3595778|B1|New Zealand||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3762415|NCT01946204|3595776|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3762416|NCT01946204|3595777|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3762417|NCT01946204|3595778|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3762418|NCT01946204|3595776|B3|Japan||Region of Enrollment||Participants|Count of Participants|55|55.0||||||
3762419|NCT01946204|3595777|B2|Japan||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3762420|NCT01946204|3595778|B1|Japan||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3762421|NCT01946204|3595776|B3|Italy||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3762422|NCT01946204|3595777|B2|Italy||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3762423|NCT01946204|3595778|B1|Italy||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3762424|NCT01946204|3595776|B3|Israel||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3762425|NCT01946204|3595777|B2|Israel||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3762426|NCT01946204|3595778|B1|Israel||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3762427|NCT01946204|3595776|B3|Hungary||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3762428|NCT01946204|3595777|B2|Hungary||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3762429|NCT01946204|3595778|B1|Hungary||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3762430|NCT01946204|3595776|B3|Germany||Region of Enrollment||Participants|Count of Participants|51|51.0||||||
3762431|NCT01946204|3595777|B2|Germany||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3762432|NCT01946204|3595778|B1|Germany||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3762433|NCT01946204|3595776|B3|France||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3762434|NCT01946204|3595777|B2|France||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3762435|NCT01946204|3595778|B1|France||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3762436|NCT01946204|3595776|B3|Finland||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3762437|NCT01946204|3595777|B2|Finland||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3762438|NCT01946204|3595778|B1|Finland||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3762439|NCT01946204|3595776|B3|Denmark||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3762440|NCT01946204|3595777|B2|Denmark||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3762441|NCT01946204|3595778|B1|Denmark||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3762442|NCT01946204|3595776|B3|Czech Republic||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3762443|NCT01946204|3595777|B2|Czech Republic||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3762444|NCT01946204|3595778|B1|Czech Republic||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3762445|NCT01946204|3595776|B3|Canada||Region of Enrollment||Participants|Count of Participants|82|82.0||||||
3762446|NCT01946204|3595777|B2|Canada||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
3762447|NCT01946204|3595778|B1|Canada||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3762448|NCT01946204|3595776|B3|Belgium||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3762449|NCT01946204|3595777|B2|Belgium||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3762450|NCT01946204|3595778|B1|Belgium||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3762451|NCT01946204|3595776|B3|Austria||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3762452|NCT01946204|3595777|B2|Austria||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3762453|NCT01946204|3595778|B1|Austria||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3762454|NCT01946204|3595776|B3|Australia||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3762455|NCT01946204|3595777|B2|Australia||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3762456|NCT01946204|3595778|B1|Australia||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3762457|NCT01946204|3595776|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|194|194.0||||||
3762458|NCT01946204|3595777|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|136|136.0||||||
3762459|NCT01946204|3595778|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3762460|NCT01946204|3595776|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3762461|NCT01946204|3595777|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3762462|NCT01946204|3595778|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762463|NCT01946204|3595776|B3||White|Race (NIH/OMB)||Participants|Count of Participants|800|800.0||||||
3762464|NCT01946204|3595777|B2||White|Race (NIH/OMB)||Participants|Count of Participants|524|524.0||||||
3762465|NCT01946204|3595778|B1||White|Race (NIH/OMB)||Participants|Count of Participants|276|276.0||||||
3762466|NCT01946204|3595776|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3762467|NCT01946204|3595777|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3762468|NCT01946204|3595778|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3762469|NCT01946204|3595776|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762470|NCT01946204|3595777|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762471|NCT01946204|3595778|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762472|NCT01946204|3595776|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
3762473|NCT01946204|3595777|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
3762474|NCT01946204|3595778|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3762475|NCT01946204|3595776|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3762476|NCT01946204|3595777|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3762477|NCT01946204|3595778|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762478|NCT01946204|3595776|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|194|194.0||||||
3762479|NCT01946204|3595777|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|136|136.0||||||
3762480|NCT01946204|3595778|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3762481|NCT01946204|3595776|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|997|997.0||||||
3762482|NCT01946204|3595777|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|659|659.0||||||
3762483|NCT01946204|3595778|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|338|338.0||||||
3762484|NCT01946204|3595776|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3762485|NCT01946204|3595777|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3762486|NCT01946204|3595778|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3762487|NCT01946204|3595776|B3||Male|Sex: Female, Male||Participants|Count of Participants|1207|1207.0||||||
3762488|NCT01946204|3595777|B2||Male|Sex: Female, Male||Participants|Count of Participants|806|806.0||||||
3762489|NCT01946204|3595778|B1||Male|Sex: Female, Male||Participants|Count of Participants|401|401.0||||||
3762490|NCT01946204|3595776|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3762491|NCT01946204|3595777|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3762492|NCT01946204|3595778|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3762493|NCT01946204|3595776|B3|||Age||years|Mean|73.9|73.9|Standard Deviation|8.02|8.02|||
3762494|NCT01946204|3595777|B2|||Age||years|Mean|73.7|73.7|Standard Deviation|8.07|8.07|||
3762495|NCT01946204|3595778|B1|||Age||years|Mean|74.1|74.1|Standard Deviation|7.92|7.92|||
3762496|NCT01946178|3595795|B1|Mexico||Region of Enrollment||participants|Number|73|73.0||||||
3762497|NCT01946178|3595795|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3762498|NCT01946178|3595795|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3762499|NCT01946178|3595795|B1|||Age||years|Mean|42.8|42.8|Full Range|||29.0|53.0|
3762500|NCT01946178|3595795|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3762501|NCT01946178|3595795|B1||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
3762502|NCT01946178|3595795|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3762503|NCT01946126|3595803|B3|||Sex/Gender, Customized||Participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3762504|NCT01946126|3595804|B2|||Sex/Gender, Customized||Participants|Number|NA|||||||Gender was not collected in this study.
3762505|NCT01946126|3595805|B1|||Sex/Gender, Customized||Participants|Number|NA|||||||Gender was not collected in this study.
3762506|NCT01946126|3595803|B3|||Age||Years|Mean|45.3|45.3|Standard Deviation|11.58|11.58|||
3762507|NCT01946126|3595804|B2|||Age||Years|Mean|45.44|45.44|Standard Deviation|11.62|11.62|||
3762508|NCT01946126|3595805|B1|||Age||Years|Mean|45.02|45.02|Standard Deviation|11.54|11.54|||
3762509|NCT01945996|3595820|B3|Only Spanish||Language||Participants|Count of Participants|18|18.0||||||
3762510|NCT01945996|3595821|B2|Only Spanish||Language||Participants|Count of Participants|7|7.0||||||
3762511|NCT01945996|3595822|B1|Only Spanish||Language||Participants|Count of Participants|11|11.0||||||
3762512|NCT01945996|3595820|B3|Only English||Language||Participants|Count of Participants|4|4.0||||||
3762513|NCT01945996|3595821|B2|Only English||Language||Participants|Count of Participants|2|2.0||||||
3762514|NCT01945996|3595822|B1|Only English||Language||Participants|Count of Participants|2|2.0||||||
3762515|NCT01945996|3595820|B3|More Spanish than English||Language||Participants|Count of Participants|7|7.0||||||
3762516|NCT01945996|3595821|B2|More Spanish than English||Language||Participants|Count of Participants|3|3.0||||||
3762517|NCT01945996|3595822|B1|More Spanish than English||Language||Participants|Count of Participants|4|4.0||||||
3762518|NCT01945996|3595820|B3|More English than Spanish||Language||Participants|Count of Participants|6|6.0||||||
3762519|NCT01945996|3595821|B2|More English than Spanish||Language||Participants|Count of Participants|4|4.0||||||
3762520|NCT01945996|3595822|B1|More English than Spanish||Language||Participants|Count of Participants|2|2.0||||||
3762521|NCT01945996|3595820|B3|Both Equally||Language||Participants|Count of Participants|2|2.0||||||
3762522|NCT01945996|3595821|B2|Both Equally||Language||Participants|Count of Participants|1|1.0||||||
3762523|NCT01945996|3595822|B1|Both Equally||Language||Participants|Count of Participants|1|1.0||||||
3762524|NCT01945996|3595820|B3|United States||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3762525|NCT01945996|3595821|B2|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3762526|NCT01945996|3595822|B1|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3762527|NCT01945996|3595820|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3762528|NCT01945996|3595821|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3762529|NCT01945996|3595822|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3762530|NCT01945996|3595820|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3762531|NCT01945996|3595821|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3762532|NCT01945996|3595822|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3762533|NCT01945996|3595820|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3762534|NCT01945996|3595821|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3762535|NCT01945996|3595822|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3762536|NCT01945996|3595820|B3|Latino||Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
3762537|NCT01945996|3595821|B2|Latino||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3762538|NCT01945996|3595822|B1|Latino||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3762539|NCT01945996|3595820|B3|Non-hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3762540|NCT01945996|3595821|B2|Non-hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3762541|NCT01945996|3595822|B1|Non-hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3762542|NCT01945996|3595820|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3762543|NCT01945996|3595821|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3762544|NCT01945996|3595822|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3762545|NCT01945996|3595820|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3762546|NCT01945996|3595821|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3762547|NCT01945996|3595822|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3762548|NCT01945996|3595820|B3|||Age||years|Mean|46.05|46.05|Standard Deviation|9.45|9.45|||
3762549|NCT01945996|3595821|B2|||Age||years|Mean|46.04|46.04|Standard Deviation|9.86|9.86|||
3762550|NCT01945996|3595822|B1|||Age||years|Mean|46.05|46.05|Standard Deviation|9.17|9.17|||
3762551|NCT01945970|3595855|B1|||Diastolic blood pressure||mmHg|Mean|74|74.0|Standard Deviation|8|8.0|||
3762552|NCT01945970|3595855|B1|||Systolic blood pressure||mmHg|Mean|118|118.0|Standard Deviation|12|12.0|||
3762553|NCT01945970|3595855|B1|||Body mass index||kg/m^2|Mean|25.0|25.0|Standard Deviation|2.4|2.4|||
3762554|NCT01945970|3595855|B1|Italy||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3762555|NCT01945970|3595855|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3762556|NCT01945970|3595855|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3762557|NCT01945970|3595855|B1|||Age||years|Median|43|43.0|Full Range|||30.0|61.0|
3762558|NCT01945944|3595897|B3|||PEEP (positive end-expiratory pressure)||cm-H20|Median|6|6.0|Inter-Quartile Range|||5.0|7.0|
3762559|NCT01945944|3595898|B2|||PEEP (positive end-expiratory pressure)||cm-H20|Median|7|7.0|Inter-Quartile Range|||6.5|8.0|
3762560|NCT01945944|3595899|B1|||PEEP (positive end-expiratory pressure)||cm-H20|Median|5|5.0|Inter-Quartile Range|||5.0|6.0|
3762561|NCT01945944|3595897|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
3762562|NCT01945944|3595898|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3762563|NCT01945944|3595899|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3762564|NCT01945944|3595897|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3762565|NCT01945944|3595898|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3762566|NCT01945944|3595899|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3762567|NCT01945944|3595897|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3762568|NCT01945944|3595898|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3762569|NCT01945944|3595899|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3762570|NCT01945944|3595897|B3|African-American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3762571|NCT01945944|3595898|B2|African-American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3762572|NCT01945944|3595899|B1|African-American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3762573|NCT01945944|3595897|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3762574|NCT01945944|3595898|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3762575|NCT01945944|3595899|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3762576|NCT01945944|3595897|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3762577|NCT01945944|3595898|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3762578|NCT01945944|3595899|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3762579|NCT01945944|3595897|B3|||Age||weeks|Median|17.9|17.9|Inter-Quartile Range|||5.1|44.0|
3762580|NCT01945944|3595898|B2|||Age||weeks|Median|12.7|12.7|Inter-Quartile Range|||5.6|32.6|
3762581|NCT01945944|3595899|B1|||Age||weeks|Median|26|26.0|Inter-Quartile Range|||3.1|174.2|
3762582|NCT01945866|3595922|B3|||Change in visual acuity letter score from enrollment to randomization|Best-corrected visual acuity letter score as measured by a certified tester using an electronic visual acuity testing machine based on the early treatment diabetic retinopathy study method. Best value on the scale 97, worst 0.|units on a scale|Mean|3|3.0|Standard Deviation|7|7.0|||
3762583|NCT01945866|3595923|B2|||Change in visual acuity letter score from enrollment to randomization|Best-corrected visual acuity letter score as measured by a certified tester using an electronic visual acuity testing machine based on the early treatment diabetic retinopathy study method. Best value on the scale 97, worst 0.|units on a scale|Mean|3|3.0|Standard Deviation|6|6.0|||
3762584|NCT01945866|3595924|B1|||Change in visual acuity letter score from enrollment to randomization|Best-corrected visual acuity letter score as measured by a certified tester using an electronic visual acuity testing machine based on the early treatment diabetic retinopathy study method. Best value on the scale 97, worst 0.|units on a scale|Mean|3|3.0|Standard Deviation|7|7.0|||
3762585|NCT01945866|3595922|B3|PDR and/or prior scatter laser||Randomization diabetic retinopathy severity level on clinical examination|PDR= Proliferative diabetic retinopathy; NPDR= Non-proliferative diabetic retinopathy|Eyes|Number|49|49.0||||||
3762586|NCT01945866|3595923|B2|PDR and/or prior scatter laser||Randomization diabetic retinopathy severity level on clinical examination|PDR= Proliferative diabetic retinopathy; NPDR= Non-proliferative diabetic retinopathy|Eyes|Number|25|25.0||||||
3762587|NCT01945866|3595924|B1|PDR and/or prior scatter laser||Randomization diabetic retinopathy severity level on clinical examination|PDR= Proliferative diabetic retinopathy; NPDR= Non-proliferative diabetic retinopathy|Eyes|Number|24|24.0||||||
3762588|NCT01945866|3595922|B3|Severe NPDR||Randomization diabetic retinopathy severity level on clinical examination|PDR= Proliferative diabetic retinopathy; NPDR= Non-proliferative diabetic retinopathy|Eyes|Number|22|22.0||||||
3762589|NCT01945866|3595923|B2|Severe NPDR||Randomization diabetic retinopathy severity level on clinical examination|PDR= Proliferative diabetic retinopathy; NPDR= Non-proliferative diabetic retinopathy|Eyes|Number|10|10.0||||||
3762590|NCT01945866|3595924|B1|Severe NPDR||Randomization diabetic retinopathy severity level on clinical examination|PDR= Proliferative diabetic retinopathy; NPDR= Non-proliferative diabetic retinopathy|Eyes|Number|12|12.0||||||
3762591|NCT01945866|3595922|B3|Mild/moderate NPDR||Randomization diabetic retinopathy severity level on clinical examination|PDR= Proliferative diabetic retinopathy; NPDR= Non-proliferative diabetic retinopathy|Eyes|Number|58|58.0||||||
3762592|NCT01945866|3595923|B2|Mild/moderate NPDR||Randomization diabetic retinopathy severity level on clinical examination|PDR= Proliferative diabetic retinopathy; NPDR= Non-proliferative diabetic retinopathy|Eyes|Number|30|30.0||||||
3762593|NCT01945866|3595924|B1|Mild/moderate NPDR||Randomization diabetic retinopathy severity level on clinical examination|PDR= Proliferative diabetic retinopathy; NPDR= Non-proliferative diabetic retinopathy|Eyes|Number|28|28.0||||||
3762594|NCT01945866|3595922|B3|||Randomization retinal volume||mm3|Mean|8.5|8.5|Standard Deviation|1.8|1.8|||
3762595|NCT01945866|3595923|B2|||Randomization retinal volume||mm3|Mean|8.3|8.3|Standard Deviation|1.6|1.6|||
3762596|NCT01945866|3595924|B1|||Randomization retinal volume||mm3|Mean|8.6|8.6|Standard Deviation|2.0|2.0|||
3762597|NCT01945866|3595922|B3|VA is improved but OCT CST is not improved||Improvement in visual acuity(VA) and OCT CST thickness during run-in phase|OCT = Optical coherence tomography CST = Central Subfield Thickness|Eyes|Number|26|26.0||||||
3762598|NCT01945866|3595923|B2|VA is improved but OCT CST is not improved||Improvement in visual acuity(VA) and OCT CST thickness during run-in phase|OCT = Optical coherence tomography CST = Central Subfield Thickness|Eyes|Number|12|12.0||||||
3762599|NCT01945866|3595924|B1|VA is improved but OCT CST is not improved||Improvement in visual acuity(VA) and OCT CST thickness during run-in phase|OCT = Optical coherence tomography CST = Central Subfield Thickness|Eyes|Number|14|14.0||||||
3762600|NCT01945866|3595922|B3|VA is not improved but OCT CST is improved||Improvement in visual acuity(VA) and OCT CST thickness during run-in phase|OCT = Optical coherence tomography CST = Central Subfield Thickness|Eyes|Number|32|32.0||||||
3762601|NCT01945866|3595923|B2|VA is not improved but OCT CST is improved||Improvement in visual acuity(VA) and OCT CST thickness during run-in phase|OCT = Optical coherence tomography CST = Central Subfield Thickness|Eyes|Number|16|16.0||||||
3762602|NCT01945866|3595924|B1|VA is not improved but OCT CST is improved||Improvement in visual acuity(VA) and OCT CST thickness during run-in phase|OCT = Optical coherence tomography CST = Central Subfield Thickness|Eyes|Number|16|16.0||||||
3762603|NCT01945866|3595922|B3|VA and OCT CST are both improved||Improvement in visual acuity(VA) and OCT CST thickness during run-in phase|OCT = Optical coherence tomography CST = Central Subfield Thickness|Eyes|Number|44|44.0||||||
3762604|NCT01945866|3595923|B2|VA and OCT CST are both improved||Improvement in visual acuity(VA) and OCT CST thickness during run-in phase|OCT = Optical coherence tomography CST = Central Subfield Thickness|Eyes|Number|22|22.0||||||
3762605|NCT01945866|3595924|B1|VA and OCT CST are both improved||Improvement in visual acuity(VA) and OCT CST thickness during run-in phase|OCT = Optical coherence tomography CST = Central Subfield Thickness|Eyes|Number|22|22.0||||||
3762606|NCT01945866|3595922|B3|Neither VA nor OCT CST is improved||Improvement in visual acuity(VA) and OCT CST thickness during run-in phase|OCT = Optical coherence tomography CST = Central Subfield Thickness|Eyes|Number|27|27.0||||||
3762607|NCT01945866|3595923|B2|Neither VA nor OCT CST is improved||Improvement in visual acuity(VA) and OCT CST thickness during run-in phase|OCT = Optical coherence tomography CST = Central Subfield Thickness|Eyes|Number|15|15.0||||||
3762608|NCT01945866|3595924|B1|Neither VA nor OCT CST is improved||Improvement in visual acuity(VA) and OCT CST thickness during run-in phase|OCT = Optical coherence tomography CST = Central Subfield Thickness|Eyes|Number|12|12.0||||||
3762609|NCT01945866|3595922|B3|||Change in central subfield thickness from enrollment to randomization||Microns|Mean|-54|-54.0|Standard Deviation|93|93.0|||
3762610|NCT01945866|3595923|B2|||Change in central subfield thickness from enrollment to randomization||Microns|Mean|-58|-58.0|Standard Deviation|83|83.0|||
3762611|NCT01945866|3595924|B1|||Change in central subfield thickness from enrollment to randomization||Microns|Mean|-50|-50.0|Standard Deviation|102|102.0|||
3762612|NCT01945866|3595922|B3|||Randomization central subfield thickness|on optical coherence tomography|Microns|Mean|385|385.0|Standard Deviation|110|110.0|||
3762613|NCT01945866|3595923|B2|||Randomization central subfield thickness|on optical coherence tomography|Microns|Mean|375|375.0|Standard Deviation|97|97.0|||
3762614|NCT01945866|3595924|B1|||Randomization central subfield thickness|on optical coherence tomography|Microns|Mean|396|396.0|Standard Deviation|122|122.0|||
3762615|NCT01945866|3595922|B3|||Randomization visual acuity letter score|Best-corrected visual acuity letter score as measured by a certified tester using an electronic visual acuity testing machine based on the early treatment diabetic retinopathy study method . Best value on the scale 97, worst 0.|units on a scale|Mean|63|63.0|Standard Deviation|12|12.0|||
3762616|NCT01945866|3595923|B2|||Randomization visual acuity letter score|Best-corrected visual acuity letter score as measured by a certified tester using an electronic visual acuity testing machine based on the early treatment diabetic retinopathy study method . Best value on the scale 97, worst 0.|units on a scale|Mean|63|63.0|Standard Deviation|12|12.0|||
3762617|NCT01945866|3595924|B1|||Randomization visual acuity letter score|Best-corrected visual acuity letter score as measured by a certified tester using an electronic visual acuity testing machine based on the early treatment diabetic retinopathy study method . Best value on the scale 97, worst 0.|units on a scale|Mean|63|63.0|Standard Deviation|13|13.0|||
3762618|NCT01945866|3595922|B3|||Total anti-VEGF injections for DME within the 20 weeks before run-in phase||Injections|Median|3|3.0|Inter-Quartile Range|||3.0|4.0|
3762619|NCT01945866|3595923|B2|||Total anti-VEGF injections for DME within the 20 weeks before run-in phase||Injections|Median|3|3.0|Inter-Quartile Range|||3.0|4.0|
3762620|NCT01945866|3595924|B1|||Total anti-VEGF injections for DME within the 20 weeks before run-in phase||Injections|Median|3|3.0|Inter-Quartile Range|||3.0|4.0|
3762621|NCT01945866|3595922|B3|Both bevacizumab and ranibizumab||Prior Anti-VEGF for DME||Eyes|Number|3|3.0||||||
3762622|NCT01945866|3595923|B2|Both bevacizumab and ranibizumab||Prior Anti-VEGF for DME||Eyes|Number|2|2.0||||||
3762623|NCT01945866|3595924|B1|Both bevacizumab and ranibizumab||Prior Anti-VEGF for DME||Eyes|Number|1|1.0||||||
3762624|NCT01945866|3595922|B3|Both aflibercept and ranibizumab||Prior Anti-VEGF for DME||Eyes|Number|1|1.0||||||
3762625|NCT01945866|3595923|B2|Both aflibercept and ranibizumab||Prior Anti-VEGF for DME||Eyes|Number|1|1.0||||||
3762626|NCT01945866|3595924|B1|Both aflibercept and ranibizumab||Prior Anti-VEGF for DME||Eyes|Number|0|0.0||||||
3762627|NCT01945866|3595922|B3|Both aflibercept and bevacizumab||Prior Anti-VEGF for DME||Eyes|Number|4|4.0||||||
3762628|NCT01945866|3595923|B2|Both aflibercept and bevacizumab||Prior Anti-VEGF for DME||Eyes|Number|4|4.0||||||
3762629|NCT01945866|3595924|B1|Both aflibercept and bevacizumab||Prior Anti-VEGF for DME||Eyes|Number|0|0.0||||||
3762630|NCT01945866|3595922|B3|Ranibizumab only||Prior Anti-VEGF for DME||Eyes|Number|9|9.0||||||
3762631|NCT01945866|3595923|B2|Ranibizumab only||Prior Anti-VEGF for DME||Eyes|Number|3|3.0||||||
3762632|NCT01945866|3595924|B1|Ranibizumab only||Prior Anti-VEGF for DME||Eyes|Number|6|6.0||||||
3762633|NCT01945866|3595922|B3|Bevacizumab only||Prior Anti-VEGF for DME||Eyes|Number|97|97.0||||||
3762634|NCT01945866|3595923|B2|Bevacizumab only||Prior Anti-VEGF for DME||Eyes|Number|48|48.0||||||
3762635|NCT01945866|3595924|B1|Bevacizumab only||Prior Anti-VEGF for DME||Eyes|Number|49|49.0||||||
3762636|NCT01945866|3595922|B3|Aflibercept only||Prior Anti-VEGF for DME||Eyes|Number|15|15.0||||||
3762637|NCT01945866|3595923|B2|Aflibercept only||Prior Anti-VEGF for DME||Eyes|Number|7|7.0||||||
3762638|NCT01945866|3595924|B1|Aflibercept only||Prior Anti-VEGF for DME||Eyes|Number|8|8.0||||||
3762639|NCT01945866|3595922|B3|||Prior macular laser treatment for DME||Eyes|Number|62|62.0||||||
3762640|NCT01945866|3595923|B2|||Prior macular laser treatment for DME||Eyes|Number|31|31.0||||||
3762641|NCT01945866|3595924|B1|||Prior macular laser treatment for DME||Eyes|Number|31|31.0||||||
3762642|NCT01945866|3595922|B3|||Participants with 2 study eyes||participants|Number|26|26.0||||||
3762643|NCT01945866|3595923|B2|||Participants with 2 study eyes||participants|Number|13|13.0||||||
3762644|NCT01945866|3595924|B1|||Participants with 2 study eyes||participants|Number|13|13.0||||||
3762645|NCT01945866|3595922|B3|||Body Mass Index||kg/m˄2|Median|32|32.0|Inter-Quartile Range|||29.0|37.0|
3762646|NCT01945866|3595923|B2|||Body Mass Index||kg/m˄2|Median|32|32.0|Inter-Quartile Range|||29.0|37.0|
3762647|NCT01945866|3595924|B1|||Body Mass Index||kg/m˄2|Median|33|33.0|Inter-Quartile Range|||29.0|37.0|
3762648|NCT01945866|3595922|B3||Current|Smoking status||Eyes|Count of Units|10|10.0||||||
3762649|NCT01945866|3595923|B2||Current|Smoking status||Eyes|Count of Units|3|3.0||||||
3762650|NCT01945866|3595924|B1||Current|Smoking status||Eyes|Count of Units|7|7.0||||||
3762651|NCT01945866|3595922|B3||Prior|Smoking status||Eyes|Count of Units|32|32.0||||||
3762652|NCT01945866|3595923|B2||Prior|Smoking status||Eyes|Count of Units|18|18.0||||||
3762653|NCT01945866|3595924|B1||Prior|Smoking status||Eyes|Count of Units|14|14.0||||||
3762654|NCT01945866|3595922|B3||Never|Smoking status||Eyes|Count of Units|87|87.0||||||
3762655|NCT01945866|3595923|B2||Never|Smoking status||Eyes|Count of Units|44|44.0||||||
3762656|NCT01945866|3595924|B1||Never|Smoking status||Eyes|Count of Units|43|43.0||||||
3762657|NCT01945866|3595922|B3|||Arterial Blood Pressure||mmHg|Median|97|97.0|Inter-Quartile Range|||87.0|106.0|
3762658|NCT01945866|3595923|B2|||Arterial Blood Pressure||mmHg|Median|97|97.0|Inter-Quartile Range|||87.0|106.0|
3762659|NCT01945866|3595924|B1|||Arterial Blood Pressure||mmHg|Median|98|98.0|Inter-Quartile Range|||87.0|106.0|
3762660|NCT01945866|3595922|B3|||Hemoglobin A1c||Percent Hemoglobin|Median|7.3|7.3|Inter-Quartile Range|||6.5|8.2|
3762661|NCT01945866|3595923|B2|||Hemoglobin A1c||Percent Hemoglobin|Median|7.1|7.1|Inter-Quartile Range|||6.4|8.3|
3762662|NCT01945866|3595924|B1|||Hemoglobin A1c||Percent Hemoglobin|Median|7.4|7.4|Inter-Quartile Range|||6.6|8.2|
3762663|NCT01945866|3595922|B3|||Insulin Used||Participants|Count of Participants|79|79.0||||||
3762664|NCT01945866|3595923|B2|||Insulin Used||Participants|Count of Participants|40|40.0||||||
3762665|NCT01945866|3595924|B1|||Insulin Used||Participants|Count of Participants|39|39.0||||||
3762666|NCT01945866|3595922|B3|||Duration of Diabetes||years|Median|17|17.0|Inter-Quartile Range|||10.0|24.0|
3762667|NCT01945866|3595923|B2|||Duration of Diabetes||years|Median|15|15.0|Inter-Quartile Range|||10.0|21.0|
3762668|NCT01945866|3595924|B1|||Duration of Diabetes||years|Median|19|19.0|Inter-Quartile Range|||10.0|26.0|
3762669|NCT01945866|3595922|B3||Uncertain|Diabetes Type||Eyes|Count of Units|2|2.0||||||
3762670|NCT01945866|3595923|B2||Uncertain|Diabetes Type||Eyes|Count of Units|1|1.0||||||
3762671|NCT01945866|3595924|B1||Uncertain|Diabetes Type||Eyes|Count of Units|1|1.0||||||
3762672|NCT01945866|3595922|B3||Type 2|Diabetes Type||Eyes|Count of Units|123|123.0||||||
3762673|NCT01945866|3595923|B2||Type 2|Diabetes Type||Eyes|Count of Units|62|62.0||||||
3762674|NCT01945866|3595924|B1||Type 2|Diabetes Type||Eyes|Count of Units|61|61.0||||||
3762675|NCT01945866|3595922|B3||Type 1|Diabetes Type||Eyes|Count of Units|4|4.0||||||
3762676|NCT01945866|3595923|B2||Type 1|Diabetes Type||Eyes|Count of Units|2|2.0||||||
3762677|NCT01945866|3595924|B1||Type 1|Diabetes Type||Eyes|Count of Units|2|2.0||||||
3762678|NCT01945866|3595922|B3||Unknown/not reported|Race/Ethnicity, Customized||Eyes|Count of Units|2|2.0||||||
3762679|NCT01945866|3595923|B2||Unknown/not reported|Race/Ethnicity, Customized||Eyes|Count of Units|1|1.0||||||
3762680|NCT01945866|3595924|B1||Unknown/not reported|Race/Ethnicity, Customized||Eyes|Count of Units|1|1.0||||||
3762681|NCT01945866|3595922|B3||Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Eyes|Count of Units|1|1.0||||||
3762682|NCT01945866|3595923|B2||Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Eyes|Count of Units|0|0.0||||||
3762683|NCT01945866|3595924|B1||Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Eyes|Count of Units|1|1.0||||||
3762684|NCT01945866|3595922|B3||Asian|Race/Ethnicity, Customized||Eyes|Count of Units|8|8.0||||||
3762685|NCT01945866|3595923|B2||Asian|Race/Ethnicity, Customized||Eyes|Count of Units|6|6.0||||||
3762686|NCT01945866|3595924|B1||Asian|Race/Ethnicity, Customized||Eyes|Count of Units|2|2.0||||||
3762687|NCT01945866|3595922|B3||Hispanic or Latino|Race/Ethnicity, Customized||Eyes|Count of Units|29|29.0||||||
3762688|NCT01945866|3595923|B2||Hispanic or Latino|Race/Ethnicity, Customized||Eyes|Count of Units|13|13.0||||||
3762689|NCT01945866|3595924|B1||Hispanic or Latino|Race/Ethnicity, Customized||Eyes|Count of Units|16|16.0||||||
3762690|NCT01945866|3595922|B3||Black/African American|Race/Ethnicity, Customized||Eyes|Count of Units|15|15.0||||||
3762691|NCT01945866|3595923|B2||Black/African American|Race/Ethnicity, Customized||Eyes|Count of Units|6|6.0||||||
3762692|NCT01945866|3595924|B1||Black/African American|Race/Ethnicity, Customized||Eyes|Count of Units|9|9.0||||||
3762693|NCT01945866|3595922|B3||White|Race/Ethnicity, Customized||Eyes|Count of Units|74|74.0||||||
3762694|NCT01945866|3595923|B2||White|Race/Ethnicity, Customized||Eyes|Count of Units|39|39.0||||||
3762695|NCT01945866|3595924|B1||White|Race/Ethnicity, Customized||Eyes|Count of Units|35|35.0||||||
3762696|NCT01945866|3595922|B3|Male||Sex/Gender, Customized||Eyes|Count of Units|62|62.0||||||
3762697|NCT01945866|3595923|B2|Male||Sex/Gender, Customized||Eyes|Count of Units|34|34.0||||||
3762698|NCT01945866|3595924|B1|Male||Sex/Gender, Customized||Eyes|Count of Units|28|28.0||||||
3762699|NCT01945866|3595922|B3|Women||Sex/Gender, Customized||Eyes|Count of Units|67|67.0||||||
3762700|NCT01945866|3595923|B2|Women||Sex/Gender, Customized||Eyes|Count of Units|31|31.0||||||
3762701|NCT01945866|3595924|B1|Women||Sex/Gender, Customized||Eyes|Count of Units|36|36.0||||||
3762702|NCT01945866|3595922|B3|Age||Age, Customized||years|Median|65|65.0|Inter-Quartile Range|||59.0|70.0|
3762703|NCT01945866|3595923|B2|Age||Age, Customized||years|Median|64|64.0|Inter-Quartile Range|||59.0|69.0|
3762704|NCT01945866|3595924|B1|Age||Age, Customized||years|Median|66|66.0|Inter-Quartile Range|||59.0|71.0|
3762705|NCT01945775|3595944|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3762706|NCT01945775|3595945|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3762707|NCT01945775|3595946|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3762708|NCT01945775|3595944|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762709|NCT01945775|3595945|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762710|NCT01945775|3595946|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762711|NCT01945775|3595944|B3||White|Race (NIH/OMB)||Participants|Count of Participants|300|300.0||||||
3762712|NCT01945775|3595945|B2||White|Race (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
3762713|NCT01945775|3595946|B1||White|Race (NIH/OMB)||Participants|Count of Participants|192|192.0||||||
3762714|NCT01945775|3595944|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3762715|NCT01945775|3595945|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3762716|NCT01945775|3595946|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3762717|NCT01945775|3595944|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762718|NCT01945775|3595945|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762719|NCT01945775|3595946|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762720|NCT01945775|3595944|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3762721|NCT01945775|3595945|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3762722|NCT01945775|3595946|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3762723|NCT01945775|3595944|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762724|NCT01945775|3595945|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762725|NCT01945775|3595946|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762726|NCT01945775|3595944|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3762727|NCT01945775|3595945|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3762728|NCT01945775|3595946|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3762729|NCT01945775|3595944|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|321|321.0||||||
3762730|NCT01945775|3595945|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
3762731|NCT01945775|3595946|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|210|210.0||||||
3762732|NCT01945775|3595944|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3762733|NCT01945775|3595945|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3762734|NCT01945775|3595946|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3762735|NCT01945775|3595944|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3762736|NCT01945775|3595945|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3762737|NCT01945775|3595946|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3762738|NCT01945775|3595944|B3||Female|Sex: Female, Male||Participants|Count of Participants|424|424.0||||||
3762739|NCT01945775|3595945|B2||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3762740|NCT01945775|3595946|B1||Female|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
3762741|NCT01945775|3595944|B3|||Age||Years|Mean|48.1|48.1|Standard Deviation|11.80|11.8|||
3762742|NCT01945775|3595945|B2|||Age||Years|Mean|49.4|49.4|Standard Deviation|12.12|12.12|||
3762743|NCT01945775|3595946|B1|||Age||Years|Mean|47.5|47.5|Standard Deviation|11.61|11.61|||
3762744|NCT01945489|3595976|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3762745|NCT01945489|3595977|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3762746|NCT01945489|3595978|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3762747|NCT01945489|3595976|B3||Female|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
3762748|NCT01945489|3595977|B2||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3762749|NCT01945489|3595978|B1||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3762750|NCT01945489|3595976|B3|||Age||years|Mean|60.8|60.8|Standard Deviation|12.40|12.4|||
3762751|NCT01945489|3595977|B2|||Age||years|Mean|60.9|60.9|Standard Deviation|12.10|12.1|||
3762752|NCT01945489|3595978|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|12.73|12.73|||
3762753|NCT01945294|3595996|B4||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3762754|NCT01945294|3595997|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3762755|NCT01945294|3595998|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3762756|NCT01945294|3595999|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3762757|NCT01945294|3595996|B4||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3762758|NCT01945294|3595997|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3762759|NCT01945294|3595998|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3762760|NCT01945294|3595999|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3762761|NCT01945294|3595996|B4|||Age||Years|Mean|44.8|44.8|Standard Deviation|11.0|11.0|||
3762762|NCT01945294|3595997|B3|||Age||Years|Mean|46.5|46.5|Standard Deviation|11.8|11.8|||
3762763|NCT01945294|3595998|B2|||Age||Years|Mean|44.6|44.6|Standard Deviation|10.6|10.6|||
3762764|NCT01945294|3595999|B1|||Age||Years|Mean|44.1|44.1|Standard Deviation|11.1|11.1|||
3762765|NCT01945281|3596031|B3|||Weight|Weight at Baseline Measurement|Grams|Mean|2042.9|2042.9|Standard Deviation|1175.5|1175.5|||
3762766|NCT01945281|3596032|B2|||Weight|Weight at Baseline Measurement|Grams|Mean|2160.9|2160.9|Standard Deviation|1513.8|1513.8|||
3762767|NCT01945281|3596033|B1|||Weight|Weight at Baseline Measurement|Grams|Mean|1982.1|1982.1|Standard Deviation|980.6|980.6|||
3762768|NCT01945281|3596031|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762769|NCT01945281|3596032|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762770|NCT01945281|3596033|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762771|NCT01945281|3596031|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3762772|NCT01945281|3596032|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3762773|NCT01945281|3596033|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3762774|NCT01945281|3596031|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3762775|NCT01945281|3596032|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3762776|NCT01945281|3596033|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3762777|NCT01945281|3596031|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3762778|NCT01945281|3596032|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3762779|NCT01945281|3596033|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3762780|NCT01945281|3596031|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762781|NCT01945281|3596032|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762782|NCT01945281|3596033|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762783|NCT01945281|3596031|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762784|NCT01945281|3596032|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762785|NCT01945281|3596033|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3762786|NCT01945281|3596031|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3762787|NCT01945281|3596032|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3762788|NCT01945281|3596033|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3762789|NCT01945281|3596031|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3762790|NCT01945281|3596032|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3762791|NCT01945281|3596033|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3762792|NCT01945281|3596031|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3762793|NCT01945281|3596032|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3762794|NCT01945281|3596033|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3762795|NCT01945281|3596031|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3762796|NCT01945281|3596032|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3762797|NCT01945281|3596033|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3762798|NCT01945281|3596031|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3762799|NCT01945281|3596032|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3762800|NCT01945281|3596033|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3762801|NCT01945281|3596031|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3762802|NCT01945281|3596032|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3762803|NCT01945281|3596033|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3762804|NCT01945281|3596031|B3|||Age||Days|Mean|31.7|31.7|Standard Deviation|21.5|21.5|||
3762805|NCT01945281|3596032|B2|||Age||Days|Mean|32.8|32.8|Standard Deviation|23.3|23.3|||
3762806|NCT01945281|3596033|B1|||Age||Days|Mean|31.1|31.1|Standard Deviation|20.9|20.9|||
3762807|NCT01945242|3596044|B3|Unknown||Glycosylated Hemoglobin A1c (HbA1c)||participants|Number|113|113.0||||||
3762808|NCT01945242|3596045|B2|Unknown||Glycosylated Hemoglobin A1c (HbA1c)||participants|Number|10|10.0||||||
3762809|NCT01945242|3596046|B1|Unknown||Glycosylated Hemoglobin A1c (HbA1c)||participants|Number|103|103.0||||||
3762810|NCT01945242|3596044|B3|HbA1c >=8.0 percent||Glycosylated Hemoglobin A1c (HbA1c)||participants|Number|401|401.0||||||
3762811|NCT01945242|3596045|B2|HbA1c >=8.0 percent||Glycosylated Hemoglobin A1c (HbA1c)||participants|Number|36|36.0||||||
3762812|NCT01945242|3596046|B1|HbA1c >=8.0 percent||Glycosylated Hemoglobin A1c (HbA1c)||participants|Number|365|365.0||||||
3762813|NCT01945242|3596044|B3|HbA1c >=7.0 to <8.0 percent||Glycosylated Hemoglobin A1c (HbA1c)||participants|Number|505|505.0||||||
3762814|NCT01945242|3596045|B2|HbA1c >=7.0 to <8.0 percent||Glycosylated Hemoglobin A1c (HbA1c)||participants|Number|44|44.0||||||
3762815|NCT01945242|3596046|B1|HbA1c >=7.0 to <8.0 percent||Glycosylated Hemoglobin A1c (HbA1c)||participants|Number|461|461.0||||||
3762816|NCT01945242|3596044|B3|HbA1c >=6.0 to <7.0 percent||Glycosylated Hemoglobin A1c (HbA1c)||participants|Number|316|316.0||||||
3762817|NCT01945242|3596045|B2|HbA1c >=6.0 to <7.0 percent||Glycosylated Hemoglobin A1c (HbA1c)||participants|Number|27|27.0||||||
3762818|NCT01945242|3596046|B1|HbA1c >=6.0 to <7.0 percent||Glycosylated Hemoglobin A1c (HbA1c)||participants|Number|289|289.0||||||
3762819|NCT01945242|3596044|B3|HbA1c <6.0 percent||Glycosylated Hemoglobin A1c (HbA1c)||participants|Number|33|33.0||||||
3762820|NCT01945242|3596045|B2|HbA1c <6.0 percent||Glycosylated Hemoglobin A1c (HbA1c)||participants|Number|3|3.0||||||
3762821|NCT01945242|3596046|B1|HbA1c <6.0 percent||Glycosylated Hemoglobin A1c (HbA1c)||participants|Number|30|30.0||||||
3762822|NCT01945242|3596044|B3|Unknown||Time from Diagnosis of Type 2 Diabetes||participants|Number|393|393.0||||||
3762823|NCT01945242|3596045|B2|Unknown||Time from Diagnosis of Type 2 Diabetes||participants|Number|25|25.0||||||
3762824|NCT01945242|3596046|B1|Unknown||Time from Diagnosis of Type 2 Diabetes||participants|Number|368|368.0||||||
3762825|NCT01945242|3596044|B3|>=10 years||Time from Diagnosis of Type 2 Diabetes||participants|Number|310|310.0||||||
3762826|NCT01945242|3596045|B2|>=10 years||Time from Diagnosis of Type 2 Diabetes||participants|Number|22|22.0||||||
3762827|NCT01945242|3596046|B1|>=10 years||Time from Diagnosis of Type 2 Diabetes||participants|Number|288|288.0||||||
3762828|NCT01945242|3596044|B3|>=5 to <10 years||Time from Diagnosis of Type 2 Diabetes||participants|Number|268|268.0||||||
3762829|NCT01945242|3596045|B2|>=5 to <10 years||Time from Diagnosis of Type 2 Diabetes||participants|Number|21|21.0||||||
3762830|NCT01945242|3596046|B1|>=5 to <10 years||Time from Diagnosis of Type 2 Diabetes||participants|Number|247|247.0||||||
3762831|NCT01945242|3596044|B3|>=2 to <5 years||Time from Diagnosis of Type 2 Diabetes||participants|Number|204|204.0||||||
3762832|NCT01945242|3596045|B2|>=2 to <5 years||Time from Diagnosis of Type 2 Diabetes||participants|Number|17|17.0||||||
3762833|NCT01945242|3596046|B1|>=2 to <5 years||Time from Diagnosis of Type 2 Diabetes||participants|Number|187|187.0||||||
3762834|NCT01945242|3596044|B3|<2 years||Time from Diagnosis of Type 2 Diabetes||participants|Number|193|193.0||||||
3762835|NCT01945242|3596045|B2|<2 years||Time from Diagnosis of Type 2 Diabetes||participants|Number|35|35.0||||||
3762836|NCT01945242|3596046|B1|<2 years||Time from Diagnosis of Type 2 Diabetes||participants|Number|158|158.0||||||
3762837|NCT01945242|3596044|B3|Unknown||Smoking Classification||participants|Number|312|312.0||||||
3762838|NCT01945242|3596045|B2|Unknown||Smoking Classification||participants|Number|26|26.0||||||
3762839|NCT01945242|3596046|B1|Unknown||Smoking Classification||participants|Number|286|286.0||||||
3762840|NCT01945242|3596044|B3|Ex-smoker||Smoking Classification||participants|Number|257|257.0||||||
3762841|NCT01945242|3596045|B2|Ex-smoker||Smoking Classification||participants|Number|24|24.0||||||
3762842|NCT01945242|3596046|B1|Ex-smoker||Smoking Classification||participants|Number|233|233.0||||||
3762843|NCT01945242|3596044|B3|Current Smoker||Smoking Classification||participants|Number|229|229.0||||||
3762844|NCT01945242|3596045|B2|Current Smoker||Smoking Classification||participants|Number|25|25.0||||||
3762845|NCT01945242|3596046|B1|Current Smoker||Smoking Classification||participants|Number|204|204.0||||||
3762846|NCT01945242|3596044|B3|Never Smoked||Smoking Classification||participants|Number|570|570.0||||||
3762847|NCT01945242|3596045|B2|Never Smoked||Smoking Classification||participants|Number|45|45.0||||||
3762848|NCT01945242|3596046|B1|Never Smoked||Smoking Classification||participants|Number|525|525.0||||||
3762849|NCT01945242|3596044|B3|Unknown||History of Alcohol Consumption||participants|Number|251|251.0||||||
3762850|NCT01945242|3596045|B2|Unknown||History of Alcohol Consumption||participants|Number|26|26.0||||||
3762851|NCT01945242|3596046|B1|Unknown||History of Alcohol Consumption||participants|Number|225|225.0||||||
3762852|NCT01945242|3596044|B3|Had No Alcohol Consumption||History of Alcohol Consumption||participants|Number|750|750.0||||||
3762853|NCT01945242|3596045|B2|Had No Alcohol Consumption||History of Alcohol Consumption||participants|Number|60|60.0||||||
3762854|NCT01945242|3596046|B1|Had No Alcohol Consumption||History of Alcohol Consumption||participants|Number|690|690.0||||||
3762855|NCT01945242|3596044|B3|Had Alcohol Consumption||History of Alcohol Consumption||participants|Number|367|367.0||||||
3762856|NCT01945242|3596045|B2|Had Alcohol Consumption||History of Alcohol Consumption||participants|Number|34|34.0||||||
3762857|NCT01945242|3596046|B1|Had Alcohol Consumption||History of Alcohol Consumption||participants|Number|333|333.0||||||
3762858|NCT01945242|3596044|B3|Unknown||History of Allergies||participants|Number|122|122.0||||||
3762859|NCT01945242|3596045|B2|Unknown||History of Allergies||participants|Number|18|18.0||||||
3762860|NCT01945242|3596046|B1|Unknown||History of Allergies||participants|Number|104|104.0||||||
3762861|NCT01945242|3596044|B3|Had No History of Allergies||History of Allergies||participants|Number|1161|1161.0||||||
3762862|NCT01945242|3596045|B2|Had No History of Allergies||History of Allergies||participants|Number|95|95.0||||||
3762863|NCT01945242|3596046|B1|Had No History of Allergies||History of Allergies||participants|Number|1066|1066.0||||||
3762864|NCT01945242|3596044|B3|Had History of Allergies||History of Allergies||participants|Number|85|85.0||||||
3762865|NCT01945242|3596045|B2|Had History of Allergies||History of Allergies||participants|Number|7|7.0||||||
3762866|NCT01945242|3596046|B1|Had History of Allergies||History of Allergies||participants|Number|78|78.0||||||
3762867|NCT01945242|3596044|B3|Unknown||Presence of Medical History|The baseline characteristic was analysed in participants who had any illness (medical history of any previous illness) at the start of the study.|participants|Number|139|139.0||||||
3762868|NCT01945242|3596045|B2|Unknown||Presence of Medical History|The baseline characteristic was analysed in participants who had any illness (medical history of any previous illness) at the start of the study.|participants|Number|13|13.0||||||
3762869|NCT01945242|3596046|B1|Unknown||Presence of Medical History|The baseline characteristic was analysed in participants who had any illness (medical history of any previous illness) at the start of the study.|participants|Number|126|126.0||||||
3762870|NCT01945242|3596044|B3|Had No Presence of Medical History||Presence of Medical History|The baseline characteristic was analysed in participants who had any illness (medical history of any previous illness) at the start of the study.|participants|Number|1048|1048.0||||||
3762871|NCT01945242|3596045|B2|Had No Presence of Medical History||Presence of Medical History|The baseline characteristic was analysed in participants who had any illness (medical history of any previous illness) at the start of the study.|participants|Number|88|88.0||||||
3762872|NCT01945242|3596046|B1|Had No Presence of Medical History||Presence of Medical History|The baseline characteristic was analysed in participants who had any illness (medical history of any previous illness) at the start of the study.|participants|Number|960|960.0||||||
3762873|NCT01945242|3596044|B3|Had Presence of Medical History||Presence of Medical History|The baseline characteristic was analysed in participants who had any illness (medical history of any previous illness) at the start of the study.|participants|Number|181|181.0||||||
3762874|NCT01945242|3596045|B2|Had Presence of Medical History||Presence of Medical History|The baseline characteristic was analysed in participants who had any illness (medical history of any previous illness) at the start of the study.|participants|Number|19|19.0||||||
3762875|NCT01945242|3596046|B1|Had Presence of Medical History||Presence of Medical History|The baseline characteristic was analysed in participants who had any illness (medical history of any previous illness) at the start of the study.|participants|Number|162|162.0||||||
3762876|NCT01945242|3596044|B3|Had No Other Complications||Other Complications|Participants who had complications other than diabetic, hypertension, dyslipidemia, hyperuricemia, liver damage, renal damage, heart disease, heart failure, stroke-related disease, allergic disease, and malignant tumor were analyzed.|participants|Number|958|958.0||||||
3762877|NCT01945242|3596045|B2|Had No Other Complications||Other Complications|Participants who had complications other than diabetic, hypertension, dyslipidemia, hyperuricemia, liver damage, renal damage, heart disease, heart failure, stroke-related disease, allergic disease, and malignant tumor were analyzed.|participants|Number|86|86.0||||||
3762878|NCT01945242|3596046|B1|Had No Other Complications||Other Complications|Participants who had complications other than diabetic, hypertension, dyslipidemia, hyperuricemia, liver damage, renal damage, heart disease, heart failure, stroke-related disease, allergic disease, and malignant tumor were analyzed.|participants|Number|872|872.0||||||
3762879|NCT01945242|3596044|B3|Had Other Complications||Other Complications|Participants who had complications other than diabetic, hypertension, dyslipidemia, hyperuricemia, liver damage, renal damage, heart disease, heart failure, stroke-related disease, allergic disease, and malignant tumor were analyzed.|participants|Number|410|410.0||||||
3762880|NCT01945242|3596045|B2|Had Other Complications||Other Complications|Participants who had complications other than diabetic, hypertension, dyslipidemia, hyperuricemia, liver damage, renal damage, heart disease, heart failure, stroke-related disease, allergic disease, and malignant tumor were analyzed.|participants|Number|34|34.0||||||
3762881|NCT01945242|3596046|B1|Had Other Complications||Other Complications|Participants who had complications other than diabetic, hypertension, dyslipidemia, hyperuricemia, liver damage, renal damage, heart disease, heart failure, stroke-related disease, allergic disease, and malignant tumor were analyzed.|participants|Number|376|376.0||||||
3762882|NCT01945242|3596044|B3|Had No Malignant Tumor Complications||Complications of Malignant Tumor (narrow definition)|This baseline measure was analysed for participants who had malignant tumor and/or benign tumor at the start of the study.|participants|Number|1355|1355.0||||||
3762883|NCT01945242|3596045|B2|Had No Malignant Tumor Complications||Complications of Malignant Tumor (narrow definition)|This baseline measure was analysed for participants who had malignant tumor and/or benign tumor at the start of the study.|participants|Number|118|118.0||||||
3762884|NCT01945242|3596046|B1|Had No Malignant Tumor Complications||Complications of Malignant Tumor (narrow definition)|This baseline measure was analysed for participants who had malignant tumor and/or benign tumor at the start of the study.|participants|Number|1237|1237.0||||||
3762885|NCT01945242|3596044|B3|Had Malignant Tumor Complications||Complications of Malignant Tumor (narrow definition)|This baseline measure was analysed for participants who had malignant tumor and/or benign tumor at the start of the study.|participants|Number|13|13.0||||||
3762886|NCT01945242|3596045|B2|Had Malignant Tumor Complications||Complications of Malignant Tumor (narrow definition)|This baseline measure was analysed for participants who had malignant tumor and/or benign tumor at the start of the study.|participants|Number|2|2.0||||||
3762887|NCT01945242|3596046|B1|Had Malignant Tumor Complications||Complications of Malignant Tumor (narrow definition)|This baseline measure was analysed for participants who had malignant tumor and/or benign tumor at the start of the study.|participants|Number|11|11.0||||||
3762888|NCT01945242|3596044|B3|Had No Malignant Tumor Complications||Complications of Malignant Tumor|This baseline measure was analysed for participants who had malignant tumor at the start of the study.|participants|Number|1350|1350.0||||||
3762889|NCT01945242|3596045|B2|Had No Malignant Tumor Complications||Complications of Malignant Tumor|This baseline measure was analysed for participants who had malignant tumor at the start of the study.|participants|Number|115|115.0||||||
3762890|NCT01945242|3596046|B1|Had No Malignant Tumor Complications||Complications of Malignant Tumor|This baseline measure was analysed for participants who had malignant tumor at the start of the study.|participants|Number|1235|1235.0||||||
3762891|NCT01945242|3596044|B3|Had Malignant Tumor Complications||Complications of Malignant Tumor|This baseline measure was analysed for participants who had malignant tumor at the start of the study.|participants|Number|18|18.0||||||
3762892|NCT01945242|3596045|B2|Had Malignant Tumor Complications||Complications of Malignant Tumor|This baseline measure was analysed for participants who had malignant tumor at the start of the study.|participants|Number|5|5.0||||||
3762893|NCT01945242|3596046|B1|Had Malignant Tumor Complications||Complications of Malignant Tumor|This baseline measure was analysed for participants who had malignant tumor at the start of the study.|participants|Number|13|13.0||||||
3762894|NCT01945242|3596044|B3|Dermatitis allergic||Breakdown of Complications of Allergic Disease|The baseline characteristic was analyzed only in participants who had allergic disease complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|2|2.0||||||
3762895|NCT01945242|3596045|B2|Dermatitis allergic||Breakdown of Complications of Allergic Disease|The baseline characteristic was analyzed only in participants who had allergic disease complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|0|0.0||||||
3762896|NCT01945242|3596046|B1|Dermatitis allergic||Breakdown of Complications of Allergic Disease|The baseline characteristic was analyzed only in participants who had allergic disease complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|2|2.0||||||
3762897|NCT01945242|3596044|B3|Rhinitis allergic||Breakdown of Complications of Allergic Disease|The baseline characteristic was analyzed only in participants who had allergic disease complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|29|29.0||||||
3762898|NCT01945242|3596045|B2|Rhinitis allergic||Breakdown of Complications of Allergic Disease|The baseline characteristic was analyzed only in participants who had allergic disease complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|4|4.0||||||
3762899|NCT01945242|3596046|B1|Rhinitis allergic||Breakdown of Complications of Allergic Disease|The baseline characteristic was analyzed only in participants who had allergic disease complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|25|25.0||||||
3762900|NCT01945242|3596044|B3|Pollinosis||Breakdown of Complications of Allergic Disease|The baseline characteristic was analyzed only in participants who had allergic disease complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|12|12.0||||||
3762901|NCT01945242|3596045|B2|Pollinosis||Breakdown of Complications of Allergic Disease|The baseline characteristic was analyzed only in participants who had allergic disease complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|0|0.0||||||
3762902|NCT01945242|3596046|B1|Pollinosis||Breakdown of Complications of Allergic Disease|The baseline characteristic was analyzed only in participants who had allergic disease complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|12|12.0||||||
3762903|NCT01945242|3596044|B3|Asthma bronchial||Breakdown of Complications of Allergic Disease|The baseline characteristic was analyzed only in participants who had allergic disease complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|30|30.0||||||
3762904|NCT01945242|3596045|B2|Asthma bronchial||Breakdown of Complications of Allergic Disease|The baseline characteristic was analyzed only in participants who had allergic disease complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|3|3.0||||||
3762905|NCT01945242|3596046|B1|Asthma bronchial||Breakdown of Complications of Allergic Disease|The baseline characteristic was analyzed only in participants who had allergic disease complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|27|27.0||||||
3762906|NCT01945242|3596044|B3|Had No Allergic Disease Complication||Complications of Allergic Disease||participants|Number|1303|1303.0||||||
3762907|NCT01945242|3596045|B2|Had No Allergic Disease Complication||Complications of Allergic Disease||participants|Number|113|113.0||||||
3762908|NCT01945242|3596046|B1|Had No Allergic Disease Complication||Complications of Allergic Disease||participants|Number|1190|1190.0||||||
3762909|NCT01945242|3596044|B3|Had Allergic Disease Complication||Complications of Allergic Disease||participants|Number|65|65.0||||||
3762910|NCT01945242|3596045|B2|Had Allergic Disease Complication||Complications of Allergic Disease||participants|Number|7|7.0||||||
3762911|NCT01945242|3596046|B1|Had Allergic Disease Complication||Complications of Allergic Disease||participants|Number|58|58.0||||||
3762912|NCT01945242|3596044|B3|Transient ischemic attack||Breakdown of complications of stroke-related disease|The baseline characteristic was analyzed only in participants who had stroke-related disease complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|1|1.0||||||
3762913|NCT01945242|3596045|B2|Transient ischemic attack||Breakdown of complications of stroke-related disease|The baseline characteristic was analyzed only in participants who had stroke-related disease complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|0|0.0||||||
3762914|NCT01945242|3596046|B1|Transient ischemic attack||Breakdown of complications of stroke-related disease|The baseline characteristic was analyzed only in participants who had stroke-related disease complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|1|1.0||||||
3762915|NCT01945242|3596044|B3|Cerebral infarction||Breakdown of complications of stroke-related disease|The baseline characteristic was analyzed only in participants who had stroke-related disease complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|87|87.0||||||
3762916|NCT01945242|3596045|B2|Cerebral infarction||Breakdown of complications of stroke-related disease|The baseline characteristic was analyzed only in participants who had stroke-related disease complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|7|7.0||||||
3762917|NCT01945242|3596046|B1|Cerebral infarction||Breakdown of complications of stroke-related disease|The baseline characteristic was analyzed only in participants who had stroke-related disease complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|80|80.0||||||
3762918|NCT01945242|3596044|B3|Had No Stroke-related Disease Complication||Complications of Stroke-related Disease||participants|Number|1280|1280.0||||||
3762919|NCT01945242|3596045|B2|Had No Stroke-related Disease Complication||Complications of Stroke-related Disease||participants|Number|113|113.0||||||
3762920|NCT01945242|3596046|B1|Had No Stroke-related Disease Complication||Complications of Stroke-related Disease||participants|Number|1167|1167.0||||||
3762921|NCT01945242|3596044|B3|Had Stroke-related Disease Complication||Complications of Stroke-related Disease||participants|Number|88|88.0||||||
3762922|NCT01945242|3596045|B2|Had Stroke-related Disease Complication||Complications of Stroke-related Disease||participants|Number|7|7.0||||||
3762923|NCT01945242|3596046|B1|Had Stroke-related Disease Complication||Complications of Stroke-related Disease||participants|Number|81|81.0||||||
3762924|NCT01945242|3596044|B3|NYHA Class IV||New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (participants with cardiac disease but without resulting limitations of physical activity), Class II (participants with cardiac disease resulting in slight limitation of physical activity), Class III (participants with cardiac disease resulting in marked limitation of physical activity), Class IV (participants with cardiac disease resulting in inability to carry on any physical activity without discomfort). The baseline measure was analyzed only for participants who had complications of heart failure.|participants|Number|0|0.0||||||
3762925|NCT01945242|3596045|B2|NYHA Class IV||New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (participants with cardiac disease but without resulting limitations of physical activity), Class II (participants with cardiac disease resulting in slight limitation of physical activity), Class III (participants with cardiac disease resulting in marked limitation of physical activity), Class IV (participants with cardiac disease resulting in inability to carry on any physical activity without discomfort). The baseline measure was analyzed only for participants who had complications of heart failure.|participants|Number|0|0.0||||||
3762926|NCT01945242|3596046|B1|NYHA Class IV||New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (participants with cardiac disease but without resulting limitations of physical activity), Class II (participants with cardiac disease resulting in slight limitation of physical activity), Class III (participants with cardiac disease resulting in marked limitation of physical activity), Class IV (participants with cardiac disease resulting in inability to carry on any physical activity without discomfort). The baseline measure was analyzed only for participants who had complications of heart failure.|participants|Number|0|0.0||||||
3762927|NCT01945242|3596044|B3|NYHA Class III||New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (participants with cardiac disease but without resulting limitations of physical activity), Class II (participants with cardiac disease resulting in slight limitation of physical activity), Class III (participants with cardiac disease resulting in marked limitation of physical activity), Class IV (participants with cardiac disease resulting in inability to carry on any physical activity without discomfort). The baseline measure was analyzed only for participants who had complications of heart failure.|participants|Number|0|0.0||||||
3762928|NCT01945242|3596045|B2|NYHA Class III||New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (participants with cardiac disease but without resulting limitations of physical activity), Class II (participants with cardiac disease resulting in slight limitation of physical activity), Class III (participants with cardiac disease resulting in marked limitation of physical activity), Class IV (participants with cardiac disease resulting in inability to carry on any physical activity without discomfort). The baseline measure was analyzed only for participants who had complications of heart failure.|participants|Number|0|0.0||||||
3762929|NCT01945242|3596046|B1|NYHA Class III||New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (participants with cardiac disease but without resulting limitations of physical activity), Class II (participants with cardiac disease resulting in slight limitation of physical activity), Class III (participants with cardiac disease resulting in marked limitation of physical activity), Class IV (participants with cardiac disease resulting in inability to carry on any physical activity without discomfort). The baseline measure was analyzed only for participants who had complications of heart failure.|participants|Number|0|0.0||||||
3762930|NCT01945242|3596044|B3|NYHA Class II||New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (participants with cardiac disease but without resulting limitations of physical activity), Class II (participants with cardiac disease resulting in slight limitation of physical activity), Class III (participants with cardiac disease resulting in marked limitation of physical activity), Class IV (participants with cardiac disease resulting in inability to carry on any physical activity without discomfort). The baseline measure was analyzed only for participants who had complications of heart failure.|participants|Number|2|2.0||||||
3762931|NCT01945242|3596045|B2|NYHA Class II||New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (participants with cardiac disease but without resulting limitations of physical activity), Class II (participants with cardiac disease resulting in slight limitation of physical activity), Class III (participants with cardiac disease resulting in marked limitation of physical activity), Class IV (participants with cardiac disease resulting in inability to carry on any physical activity without discomfort). The baseline measure was analyzed only for participants who had complications of heart failure.|participants|Number|1|1.0||||||
3762932|NCT01945242|3596046|B1|NYHA Class II||New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (participants with cardiac disease but without resulting limitations of physical activity), Class II (participants with cardiac disease resulting in slight limitation of physical activity), Class III (participants with cardiac disease resulting in marked limitation of physical activity), Class IV (participants with cardiac disease resulting in inability to carry on any physical activity without discomfort). The baseline measure was analyzed only for participants who had complications of heart failure.|participants|Number|1|1.0||||||
3762933|NCT01945242|3596044|B3|NYHA Class I||New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (participants with cardiac disease but without resulting limitations of physical activity), Class II (participants with cardiac disease resulting in slight limitation of physical activity), Class III (participants with cardiac disease resulting in marked limitation of physical activity), Class IV (participants with cardiac disease resulting in inability to carry on any physical activity without discomfort). The baseline measure was analyzed only for participants who had complications of heart failure.|participants|Number|16|16.0||||||
3762934|NCT01945242|3596045|B2|NYHA Class I||New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (participants with cardiac disease but without resulting limitations of physical activity), Class II (participants with cardiac disease resulting in slight limitation of physical activity), Class III (participants with cardiac disease resulting in marked limitation of physical activity), Class IV (participants with cardiac disease resulting in inability to carry on any physical activity without discomfort). The baseline measure was analyzed only for participants who had complications of heart failure.|participants|Number|1|1.0||||||
3762935|NCT01945242|3596046|B1|NYHA Class I||New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (participants with cardiac disease but without resulting limitations of physical activity), Class II (participants with cardiac disease resulting in slight limitation of physical activity), Class III (participants with cardiac disease resulting in marked limitation of physical activity), Class IV (participants with cardiac disease resulting in inability to carry on any physical activity without discomfort). The baseline measure was analyzed only for participants who had complications of heart failure.|participants|Number|15|15.0||||||
3762936|NCT01945242|3596044|B3|Had No Heart Failure Complications||Complications of Heart Failure||participants|Number|1350|1350.0||||||
3762937|NCT01945242|3596045|B2|Had No Heart Failure Complications||Complications of Heart Failure||participants|Number|118|118.0||||||
3762938|NCT01945242|3596046|B1|Had No Heart Failure Complications||Complications of Heart Failure||participants|Number|1232|1232.0||||||
3762939|NCT01945242|3596044|B3|Had Heart Failure Complications||Complications of Heart Failure||participants|Number|18|18.0||||||
3762940|NCT01945242|3596045|B2|Had Heart Failure Complications||Complications of Heart Failure||participants|Number|2|2.0||||||
3762941|NCT01945242|3596046|B1|Had Heart Failure Complications||Complications of Heart Failure||participants|Number|16|16.0||||||
3762942|NCT01945242|3596044|B3|Other||Breakdown of Complications of Heart Disease|Heart disease complications were categorized as Cardiac failure, Myocardial infarction, Angina pectoris, and any other complications related to heart disease. The baseline characteristic was analyzed only in participants who had heart disease complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|45|45.0||||||
3763442|NCT01945216|3596059|B4|||Height||cm|Mean|160.01|160.01|Standard Deviation|9.691|9.691|||
3762943|NCT01945242|3596045|B2|Other||Breakdown of Complications of Heart Disease|Heart disease complications were categorized as Cardiac failure, Myocardial infarction, Angina pectoris, and any other complications related to heart disease. The baseline characteristic was analyzed only in participants who had heart disease complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|3|3.0||||||
3762944|NCT01945242|3596046|B1|Other||Breakdown of Complications of Heart Disease|Heart disease complications were categorized as Cardiac failure, Myocardial infarction, Angina pectoris, and any other complications related to heart disease. The baseline characteristic was analyzed only in participants who had heart disease complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|42|42.0||||||
3762945|NCT01945242|3596044|B3|Angina pectoris||Breakdown of Complications of Heart Disease|Heart disease complications were categorized as Cardiac failure, Myocardial infarction, Angina pectoris, and any other complications related to heart disease. The baseline characteristic was analyzed only in participants who had heart disease complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|75|75.0||||||
3762946|NCT01945242|3596045|B2|Angina pectoris||Breakdown of Complications of Heart Disease|Heart disease complications were categorized as Cardiac failure, Myocardial infarction, Angina pectoris, and any other complications related to heart disease. The baseline characteristic was analyzed only in participants who had heart disease complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|4|4.0||||||
3762947|NCT01945242|3596046|B1|Angina pectoris||Breakdown of Complications of Heart Disease|Heart disease complications were categorized as Cardiac failure, Myocardial infarction, Angina pectoris, and any other complications related to heart disease. The baseline characteristic was analyzed only in participants who had heart disease complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|71|71.0||||||
3762948|NCT01945242|3596044|B3|Myocardial infarction||Breakdown of Complications of Heart Disease|Heart disease complications were categorized as Cardiac failure, Myocardial infarction, Angina pectoris, and any other complications related to heart disease. The baseline characteristic was analyzed only in participants who had heart disease complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|30|30.0||||||
3762949|NCT01945242|3596045|B2|Myocardial infarction||Breakdown of Complications of Heart Disease|Heart disease complications were categorized as Cardiac failure, Myocardial infarction, Angina pectoris, and any other complications related to heart disease. The baseline characteristic was analyzed only in participants who had heart disease complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|3|3.0||||||
3762950|NCT01945242|3596046|B1|Myocardial infarction||Breakdown of Complications of Heart Disease|Heart disease complications were categorized as Cardiac failure, Myocardial infarction, Angina pectoris, and any other complications related to heart disease. The baseline characteristic was analyzed only in participants who had heart disease complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|27|27.0||||||
3762951|NCT01945242|3596044|B3|Cardiac failure||Breakdown of Complications of Heart Disease|Heart disease complications were categorized as Cardiac failure, Myocardial infarction, Angina pectoris, and any other complications related to heart disease. The baseline characteristic was analyzed only in participants who had heart disease complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|18|18.0||||||
3762952|NCT01945242|3596045|B2|Cardiac failure||Breakdown of Complications of Heart Disease|Heart disease complications were categorized as Cardiac failure, Myocardial infarction, Angina pectoris, and any other complications related to heart disease. The baseline characteristic was analyzed only in participants who had heart disease complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|2|2.0||||||
3762953|NCT01945242|3596046|B1|Cardiac failure||Breakdown of Complications of Heart Disease|Heart disease complications were categorized as Cardiac failure, Myocardial infarction, Angina pectoris, and any other complications related to heart disease. The baseline characteristic was analyzed only in participants who had heart disease complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|16|16.0||||||
3762954|NCT01945242|3596044|B3|Had No Heart Disease Complications||Complications of Heart Disease||participants|Number|1217|1217.0||||||
3762955|NCT01945242|3596045|B2|Had No Heart Disease Complications||Complications of Heart Disease||participants|Number|111|111.0||||||
3762956|NCT01945242|3596046|B1|Had No Heart Disease Complications||Complications of Heart Disease||participants|Number|1106|1106.0||||||
3762957|NCT01945242|3596044|B3|Had Heart Disease Complications||Complications of Heart Disease||participants|Number|151|151.0||||||
3762958|NCT01945242|3596045|B2|Had Heart Disease Complications||Complications of Heart Disease||participants|Number|9|9.0||||||
3762959|NCT01945242|3596046|B1|Had Heart Disease Complications||Complications of Heart Disease||participants|Number|142|142.0||||||
3762960|NCT01945242|3596044|B3|Unknown||Degree of Renal Dysfunction|"Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was reported as “unknown.”~Normal: >=90 milliliter per min (mL/min)/1.73^2 Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2 Severe: <30 mL/min/1.73^2~eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female) where Cr is creatinine clearance."|participants|Number|411|411.0||||||
3762961|NCT01945242|3596045|B2|Unknown||Degree of Renal Dysfunction|"Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was reported as “unknown.”~Normal: >=90 milliliter per min (mL/min)/1.73^2 Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2 Severe: <30 mL/min/1.73^2~eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female) where Cr is creatinine clearance."|participants|Number|33|33.0||||||
3762991|NCT01945242|3596045|B2|Had Renal Damage Complications||Complications of Renal Damage||participants|Number|5|5.0||||||
3762992|NCT01945242|3596046|B1|Had Renal Damage Complications||Complications of Renal Damage||participants|Number|138|138.0||||||
3762962|NCT01945242|3596046|B1|Unknown||Degree of Renal Dysfunction|"Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was reported as “unknown.”~Normal: >=90 milliliter per min (mL/min)/1.73^2 Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2 Severe: <30 mL/min/1.73^2~eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female) where Cr is creatinine clearance."|participants|Number|378|378.0||||||
3762963|NCT01945242|3596044|B3|Severe||Degree of Renal Dysfunction|"Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was reported as “unknown.”~Normal: >=90 milliliter per min (mL/min)/1.73^2 Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2 Severe: <30 mL/min/1.73^2~eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female) where Cr is creatinine clearance."|participants|Number|10|10.0||||||
3762964|NCT01945242|3596045|B2|Severe||Degree of Renal Dysfunction|"Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was reported as “unknown.”~Normal: >=90 milliliter per min (mL/min)/1.73^2 Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2 Severe: <30 mL/min/1.73^2~eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female) where Cr is creatinine clearance."|participants|Number|0|0.0||||||
3762965|NCT01945242|3596046|B1|Severe||Degree of Renal Dysfunction|"Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was reported as “unknown.”~Normal: >=90 milliliter per min (mL/min)/1.73^2 Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2 Severe: <30 mL/min/1.73^2~eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female) where Cr is creatinine clearance."|participants|Number|10|10.0||||||
3762966|NCT01945242|3596044|B3|Moderate||Degree of Renal Dysfunction|"Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was reported as “unknown.”~Normal: >=90 milliliter per min (mL/min)/1.73^2 Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2 Severe: <30 mL/min/1.73^2~eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female) where Cr is creatinine clearance."|participants|Number|189|189.0||||||
3762967|NCT01945242|3596045|B2|Moderate||Degree of Renal Dysfunction|"Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was reported as “unknown.”~Normal: >=90 milliliter per min (mL/min)/1.73^2 Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2 Severe: <30 mL/min/1.73^2~eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female) where Cr is creatinine clearance."|participants|Number|15|15.0||||||
3762968|NCT01945242|3596046|B1|Moderate||Degree of Renal Dysfunction|"Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was reported as “unknown.”~Normal: >=90 milliliter per min (mL/min)/1.73^2 Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2 Severe: <30 mL/min/1.73^2~eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female) where Cr is creatinine clearance."|participants|Number|174|174.0||||||
3762969|NCT01945242|3596044|B3|Mild||Degree of Renal Dysfunction|"Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was reported as “unknown.”~Normal: >=90 milliliter per min (mL/min)/1.73^2 Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2 Severe: <30 mL/min/1.73^2~eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female) where Cr is creatinine clearance."|participants|Number|534|534.0||||||
3762970|NCT01945242|3596045|B2|Mild||Degree of Renal Dysfunction|"Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was reported as “unknown.”~Normal: >=90 milliliter per min (mL/min)/1.73^2 Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2 Severe: <30 mL/min/1.73^2~eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female) where Cr is creatinine clearance."|participants|Number|46|46.0||||||
3762971|NCT01945242|3596046|B1|Mild||Degree of Renal Dysfunction|"Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was reported as “unknown.”~Normal: >=90 milliliter per min (mL/min)/1.73^2 Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2 Severe: <30 mL/min/1.73^2~eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female) where Cr is creatinine clearance."|participants|Number|488|488.0||||||
3762972|NCT01945242|3596044|B3|Normal||Degree of Renal Dysfunction|"Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was reported as “unknown.”~Normal: >=90 milliliter per min (mL/min)/1.73^2 Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2 Severe: <30 mL/min/1.73^2~eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female) where Cr is creatinine clearance."|participants|Number|224|224.0||||||
3763026|NCT01945242|3596044|B3|Had Liver Damage Complications||Complications of Liver Damage||participants|Number|218|218.0||||||
3762973|NCT01945242|3596045|B2|Normal||Degree of Renal Dysfunction|"Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was reported as “unknown.”~Normal: >=90 milliliter per min (mL/min)/1.73^2 Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2 Severe: <30 mL/min/1.73^2~eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female) where Cr is creatinine clearance."|participants|Number|26|26.0||||||
3762974|NCT01945242|3596046|B1|Normal||Degree of Renal Dysfunction|"Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was reported as “unknown.”~Normal: >=90 milliliter per min (mL/min)/1.73^2 Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2 Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2 Severe: <30 mL/min/1.73^2~eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female) where Cr is creatinine clearance."|participants|Number|198|198.0||||||
3762975|NCT01945242|3596044|B3|Other||Breakdown of Complications of Renal Damage|Renal damage complications were categorized as nephrotic syndrome, glomerulonephritis,renal failure chronic and any other complications related to renal damage. The baseline characteristic was analyzed only in participants who had renal damage complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|131|131.0||||||
3762976|NCT01945242|3596045|B2|Other||Breakdown of Complications of Renal Damage|Renal damage complications were categorized as nephrotic syndrome, glomerulonephritis,renal failure chronic and any other complications related to renal damage. The baseline characteristic was analyzed only in participants who had renal damage complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|5|5.0||||||
3762977|NCT01945242|3596046|B1|Other||Breakdown of Complications of Renal Damage|Renal damage complications were categorized as nephrotic syndrome, glomerulonephritis,renal failure chronic and any other complications related to renal damage. The baseline characteristic was analyzed only in participants who had renal damage complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|126|126.0||||||
3762978|NCT01945242|3596044|B3|Renal failure chronic||Breakdown of Complications of Renal Damage|Renal damage complications were categorized as nephrotic syndrome, glomerulonephritis,renal failure chronic and any other complications related to renal damage. The baseline characteristic was analyzed only in participants who had renal damage complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|8|8.0||||||
3762979|NCT01945242|3596045|B2|Renal failure chronic||Breakdown of Complications of Renal Damage|Renal damage complications were categorized as nephrotic syndrome, glomerulonephritis,renal failure chronic and any other complications related to renal damage. The baseline characteristic was analyzed only in participants who had renal damage complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|0|0.0||||||
3762980|NCT01945242|3596046|B1|Renal failure chronic||Breakdown of Complications of Renal Damage|Renal damage complications were categorized as nephrotic syndrome, glomerulonephritis,renal failure chronic and any other complications related to renal damage. The baseline characteristic was analyzed only in participants who had renal damage complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|8|8.0||||||
3762981|NCT01945242|3596044|B3|Glomerulonephritis||Breakdown of Complications of Renal Damage|Renal damage complications were categorized as nephrotic syndrome, glomerulonephritis,renal failure chronic and any other complications related to renal damage. The baseline characteristic was analyzed only in participants who had renal damage complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|3|3.0||||||
3762982|NCT01945242|3596045|B2|Glomerulonephritis||Breakdown of Complications of Renal Damage|Renal damage complications were categorized as nephrotic syndrome, glomerulonephritis,renal failure chronic and any other complications related to renal damage. The baseline characteristic was analyzed only in participants who had renal damage complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|0|0.0||||||
3762983|NCT01945242|3596046|B1|Glomerulonephritis||Breakdown of Complications of Renal Damage|Renal damage complications were categorized as nephrotic syndrome, glomerulonephritis,renal failure chronic and any other complications related to renal damage. The baseline characteristic was analyzed only in participants who had renal damage complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|3|3.0||||||
3762984|NCT01945242|3596044|B3|Nephrotic syndrome||Breakdown of Complications of Renal Damage|Renal damage complications were categorized as nephrotic syndrome, glomerulonephritis,renal failure chronic and any other complications related to renal damage. The baseline characteristic was analyzed only in participants who had renal damage complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|1|1.0||||||
3762985|NCT01945242|3596045|B2|Nephrotic syndrome||Breakdown of Complications of Renal Damage|Renal damage complications were categorized as nephrotic syndrome, glomerulonephritis,renal failure chronic and any other complications related to renal damage. The baseline characteristic was analyzed only in participants who had renal damage complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|0|0.0||||||
3762986|NCT01945242|3596046|B1|Nephrotic syndrome||Breakdown of Complications of Renal Damage|Renal damage complications were categorized as nephrotic syndrome, glomerulonephritis,renal failure chronic and any other complications related to renal damage. The baseline characteristic was analyzed only in participants who had renal damage complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|1|1.0||||||
3762987|NCT01945242|3596044|B3|Had No Renal Damage Complications||Complications of Renal Damage||participants|Number|1225|1225.0||||||
3762988|NCT01945242|3596045|B2|Had No Renal Damage Complications||Complications of Renal Damage||participants|Number|115|115.0||||||
3762989|NCT01945242|3596046|B1|Had No Renal Damage Complications||Complications of Renal Damage||participants|Number|1110|1110.0||||||
3762990|NCT01945242|3596044|B3|Had Renal Damage Complications||Complications of Renal Damage||participants|Number|143|143.0||||||
3763443|NCT01945216|3596060|B3|||Height||cm|Mean|160.18|160.18|Standard Deviation|9.738|9.738|||
3762993|NCT01945242|3596044|B3|Unknown||Degree of Hepatic Dysfunction|"Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and higher grades of serum AST or ALT were adopted.~Normal: <50 international units per liter (IU/L) Grade 1: >=50 to <100 IU/L Grade 2: >=100 to <500 IU/L Grade 3: >=500 IU/L"|participants|Number|415|415.0||||||
3762994|NCT01945242|3596045|B2|Unknown||Degree of Hepatic Dysfunction|"Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and higher grades of serum AST or ALT were adopted.~Normal: <50 international units per liter (IU/L) Grade 1: >=50 to <100 IU/L Grade 2: >=100 to <500 IU/L Grade 3: >=500 IU/L"|participants|Number|36|36.0||||||
3762995|NCT01945242|3596046|B1|Unknown||Degree of Hepatic Dysfunction|"Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and higher grades of serum AST or ALT were adopted.~Normal: <50 international units per liter (IU/L) Grade 1: >=50 to <100 IU/L Grade 2: >=100 to <500 IU/L Grade 3: >=500 IU/L"|participants|Number|379|379.0||||||
3762996|NCT01945242|3596044|B3|Grade 3||Degree of Hepatic Dysfunction|"Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and higher grades of serum AST or ALT were adopted.~Normal: <50 international units per liter (IU/L) Grade 1: >=50 to <100 IU/L Grade 2: >=100 to <500 IU/L Grade 3: >=500 IU/L"|participants|Number|0|0.0||||||
3762997|NCT01945242|3596045|B2|Grade 3||Degree of Hepatic Dysfunction|"Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and higher grades of serum AST or ALT were adopted.~Normal: <50 international units per liter (IU/L) Grade 1: >=50 to <100 IU/L Grade 2: >=100 to <500 IU/L Grade 3: >=500 IU/L"|participants|Number|0|0.0||||||
3762998|NCT01945242|3596046|B1|Grade 3||Degree of Hepatic Dysfunction|"Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and higher grades of serum AST or ALT were adopted.~Normal: <50 international units per liter (IU/L) Grade 1: >=50 to <100 IU/L Grade 2: >=100 to <500 IU/L Grade 3: >=500 IU/L"|participants|Number|0|0.0||||||
3762999|NCT01945242|3596044|B3|Grade 2||Degree of Hepatic Dysfunction|"Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and higher grades of serum AST or ALT were adopted.~Normal: <50 international units per liter (IU/L) Grade 1: >=50 to <100 IU/L Grade 2: >=100 to <500 IU/L Grade 3: >=500 IU/L"|participants|Number|11|11.0||||||
3763000|NCT01945242|3596045|B2|Grade 2||Degree of Hepatic Dysfunction|"Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and higher grades of serum AST or ALT were adopted.~Normal: <50 international units per liter (IU/L) Grade 1: >=50 to <100 IU/L Grade 2: >=100 to <500 IU/L Grade 3: >=500 IU/L"|participants|Number|0|0.0||||||
3763001|NCT01945242|3596046|B1|Grade 2||Degree of Hepatic Dysfunction|"Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and higher grades of serum AST or ALT were adopted.~Normal: <50 international units per liter (IU/L) Grade 1: >=50 to <100 IU/L Grade 2: >=100 to <500 IU/L Grade 3: >=500 IU/L"|participants|Number|11|11.0||||||
3763002|NCT01945242|3596044|B3|Grade 1||Degree of Hepatic Dysfunction|"Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and higher grades of serum AST or ALT were adopted.~Normal: <50 international units per liter (IU/L) Grade 1: >=50 to <100 IU/L Grade 2: >=100 to <500 IU/L Grade 3: >=500 IU/L"|participants|Number|99|99.0||||||
3763003|NCT01945242|3596045|B2|Grade 1||Degree of Hepatic Dysfunction|"Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and higher grades of serum AST or ALT were adopted.~Normal: <50 international units per liter (IU/L) Grade 1: >=50 to <100 IU/L Grade 2: >=100 to <500 IU/L Grade 3: >=500 IU/L"|participants|Number|10|10.0||||||
3763004|NCT01945242|3596046|B1|Grade 1||Degree of Hepatic Dysfunction|"Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and higher grades of serum AST or ALT were adopted.~Normal: <50 international units per liter (IU/L) Grade 1: >=50 to <100 IU/L Grade 2: >=100 to <500 IU/L Grade 3: >=500 IU/L"|participants|Number|89|89.0||||||
3763005|NCT01945242|3596044|B3|Normal||Degree of Hepatic Dysfunction|"Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and higher grades of serum AST or ALT were adopted.~Normal: <50 international units per liter (IU/L) Grade 1: >=50 to <100 IU/L Grade 2: >=100 to <500 IU/L Grade 3: >=500 IU/L"|participants|Number|843|843.0||||||
3763006|NCT01945242|3596045|B2|Normal||Degree of Hepatic Dysfunction|"Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and higher grades of serum AST or ALT were adopted.~Normal: <50 international units per liter (IU/L) Grade 1: >=50 to <100 IU/L Grade 2: >=100 to <500 IU/L Grade 3: >=500 IU/L"|participants|Number|74|74.0||||||
3763007|NCT01945242|3596046|B1|Normal||Degree of Hepatic Dysfunction|"Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and higher grades of serum AST or ALT were adopted.~Normal: <50 international units per liter (IU/L) Grade 1: >=50 to <100 IU/L Grade 2: >=100 to <500 IU/L Grade 3: >=500 IU/L"|participants|Number|769|769.0||||||
3763027|NCT01945242|3596045|B2|Had Liver Damage Complications||Complications of Liver Damage||participants|Number|18|18.0||||||
3763028|NCT01945242|3596046|B1|Had Liver Damage Complications||Complications of Liver Damage||participants|Number|200|200.0||||||
3763008|NCT01945242|3596044|B3|Other||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. The baseline characteristic was analyzed only in participants who had liver damage complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|10|10.0||||||
3763009|NCT01945242|3596045|B2|Other||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. The baseline characteristic was analyzed only in participants who had liver damage complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|2|2.0||||||
3763010|NCT01945242|3596046|B1|Other||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. The baseline characteristic was analyzed only in participants who had liver damage complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|8|8.0||||||
3763011|NCT01945242|3596044|B3|Hepatic cirrhosis||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. The baseline characteristic was analyzed only in participants who had liver damage complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|5|5.0||||||
3763012|NCT01945242|3596045|B2|Hepatic cirrhosis||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. The baseline characteristic was analyzed only in participants who had liver damage complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|0|0.0||||||
3763013|NCT01945242|3596046|B1|Hepatic cirrhosis||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. The baseline characteristic was analyzed only in participants who had liver damage complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|5|5.0||||||
3763014|NCT01945242|3596044|B3|Chronic hepatitis||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. The baseline characteristic was analyzed only in participants who had liver damage complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|19|19.0||||||
3763015|NCT01945242|3596045|B2|Chronic hepatitis||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. The baseline characteristic was analyzed only in participants who had liver damage complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|2|2.0||||||
3763016|NCT01945242|3596046|B1|Chronic hepatitis||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. The baseline characteristic was analyzed only in participants who had liver damage complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|17|17.0||||||
3763017|NCT01945242|3596044|B3|Hepatitis alcoholic||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. The baseline characteristic was analyzed only in participants who had liver damage complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|19|19.0||||||
3763018|NCT01945242|3596045|B2|Hepatitis alcoholic||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. The baseline characteristic was analyzed only in participants who had liver damage complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|1|1.0||||||
3763019|NCT01945242|3596046|B1|Hepatitis alcoholic||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. The baseline characteristic was analyzed only in participants who had liver damage complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|18|18.0||||||
3763020|NCT01945242|3596044|B3|Hepatic steatosis||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. The baseline characteristic was analyzed only in participants who had liver damage complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|172|172.0||||||
3763021|NCT01945242|3596045|B2|Hepatic steatosis||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. The baseline characteristic was analyzed only in participants who had liver damage complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|14|14.0||||||
3763022|NCT01945242|3596046|B1|Hepatic steatosis||Breakdown of Complications of Liver Damage|Liver damage complications were categorized as hepatic steatosis, hepatitis alcoholic, chronic hepatitis, hepatic cirrhosis and any other complications related to liver damage. The baseline characteristic was analyzed only in participants who had liver damage complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|158|158.0||||||
3763023|NCT01945242|3596044|B3|Had No Liver Damage Complications||Complications of Liver Damage||participants|Number|1150|1150.0||||||
3763024|NCT01945242|3596045|B2|Had No Liver Damage Complications||Complications of Liver Damage||participants|Number|102|102.0||||||
3763025|NCT01945242|3596046|B1|Had No Liver Damage Complications||Complications of Liver Damage||participants|Number|1048|1048.0||||||
3763029|NCT01945242|3596044|B3|Had No Hyperuricemia Complications||Complications of Hyperuricemia||participants|Number|1252|1252.0||||||
3763030|NCT01945242|3596045|B2|Had No Hyperuricemia Complications||Complications of Hyperuricemia||participants|Number|110|110.0||||||
3763031|NCT01945242|3596046|B1|Had No Hyperuricemia Complications||Complications of Hyperuricemia||participants|Number|1142|1142.0||||||
3763032|NCT01945242|3596044|B3|Had Hyperuricemia Complications||Complications of Hyperuricemia||participants|Number|116|116.0||||||
3763033|NCT01945242|3596045|B2|Had Hyperuricemia Complications||Complications of Hyperuricemia||participants|Number|10|10.0||||||
3763034|NCT01945242|3596046|B1|Had Hyperuricemia Complications||Complications of Hyperuricemia||participants|Number|106|106.0||||||
3763035|NCT01945242|3596044|B3|Had No Dyslipidemia Complications||Complications of Dyslipidemia||participants|Number|539|539.0||||||
3763036|NCT01945242|3596045|B2|Had No Dyslipidemia Complications||Complications of Dyslipidemia||participants|Number|57|57.0||||||
3763037|NCT01945242|3596046|B1|Had No Dyslipidemia Complications||Complications of Dyslipidemia||participants|Number|482|482.0||||||
3763038|NCT01945242|3596044|B3|Had Dyslipidemia Complications||Complications of Dyslipidemia||participants|Number|829|829.0||||||
3763039|NCT01945242|3596045|B2|Had Dyslipidemia Complications||Complications of Dyslipidemia||participants|Number|63|63.0||||||
3763040|NCT01945242|3596046|B1|Had Dyslipidemia Complications||Complications of Dyslipidemia||participants|Number|766|766.0||||||
3763041|NCT01945242|3596044|B3|Had No Hypertension Complications||Complications of Hypertension||participants|Number|539|539.0||||||
3763042|NCT01945242|3596045|B2|Had No Hypertension Complications||Complications of Hypertension||participants|Number|51|51.0||||||
3763043|NCT01945242|3596046|B1|Had No Hypertension Complications||Complications of Hypertension||participants|Number|488|488.0||||||
3763044|NCT01945242|3596044|B3|Had Hypertension Complications||Complications of Hypertension||participants|Number|829|829.0||||||
3763045|NCT01945242|3596045|B2|Had Hypertension Complications||Complications of Hypertension||participants|Number|69|69.0||||||
3763046|NCT01945242|3596046|B1|Had Hypertension Complications||Complications of Hypertension||participants|Number|760|760.0||||||
3763047|NCT01945242|3596044|B3|Diabetic neuropathy||Breakdown of diabetic complications|The baseline characteristic was analyzed only in participants who had diabetic complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|77|77.0||||||
3763048|NCT01945242|3596045|B2|Diabetic neuropathy||Breakdown of diabetic complications|The baseline characteristic was analyzed only in participants who had diabetic complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|6|6.0||||||
3763049|NCT01945242|3596046|B1|Diabetic neuropathy||Breakdown of diabetic complications|The baseline characteristic was analyzed only in participants who had diabetic complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|71|71.0||||||
3763050|NCT01945242|3596044|B3|Diabetic retinopathy||Breakdown of diabetic complications|The baseline characteristic was analyzed only in participants who had diabetic complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|74|74.0||||||
3763051|NCT01945242|3596045|B2|Diabetic retinopathy||Breakdown of diabetic complications|The baseline characteristic was analyzed only in participants who had diabetic complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|9|9.0||||||
3763052|NCT01945242|3596046|B1|Diabetic retinopathy||Breakdown of diabetic complications|The baseline characteristic was analyzed only in participants who had diabetic complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|65|65.0||||||
3763053|NCT01945242|3596044|B3|Diabetic nephropathy||Breakdown of diabetic complications|The baseline characteristic was analyzed only in participants who had diabetic complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|133|133.0||||||
3763054|NCT01945242|3596045|B2|Diabetic nephropathy||Breakdown of diabetic complications|The baseline characteristic was analyzed only in participants who had diabetic complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|5|5.0||||||
3763055|NCT01945242|3596046|B1|Diabetic nephropathy||Breakdown of diabetic complications|The baseline characteristic was analyzed only in participants who had diabetic complications. Participants could be counted in more than 1 category (including duplicates).|participants|Number|128|128.0||||||
3763056|NCT01945242|3596044|B3|Had No Diabetic Complications||Diabetic complications||participants|Number|1150|1150.0||||||
3763057|NCT01945242|3596045|B2|Had No Diabetic Complications||Diabetic complications||participants|Number|105|105.0||||||
3763058|NCT01945242|3596046|B1|Had No Diabetic Complications||Diabetic complications||participants|Number|1045|1045.0||||||
3763059|NCT01945242|3596044|B3|Had Diabetic Complications||Diabetic complications||participants|Number|218|218.0||||||
3763060|NCT01945242|3596045|B2|Had Diabetic Complications||Diabetic complications||participants|Number|15|15.0||||||
3763061|NCT01945242|3596046|B1|Had Diabetic Complications||Diabetic complications||participants|Number|203|203.0||||||
3763062|NCT01945242|3596044|B3|Had No Complications||Health-related Complications|Participants were asssed on the basis of primary illness (had complications and had no complications) at the start of study.|participants|Number|208|208.0||||||
3763063|NCT01945242|3596045|B2|Had No Complications||Health-related Complications|Participants were asssed on the basis of primary illness (had complications and had no complications) at the start of study.|participants|Number|24|24.0||||||
3763064|NCT01945242|3596046|B1|Had No Complications||Health-related Complications|Participants were asssed on the basis of primary illness (had complications and had no complications) at the start of study.|participants|Number|184|184.0||||||
3763065|NCT01945242|3596044|B3|Had Complications||Health-related Complications|Participants were asssed on the basis of primary illness (had complications and had no complications) at the start of study.|participants|Number|1160|1160.0||||||
3763066|NCT01945242|3596045|B2|Had Complications||Health-related Complications|Participants were asssed on the basis of primary illness (had complications and had no complications) at the start of study.|participants|Number|96|96.0||||||
3763444|NCT01945216|3596061|B2|||Height||cm|Mean|159.34|159.34|Standard Deviation|9.528|9.528|||
3763067|NCT01945242|3596046|B1|Had Complications||Health-related Complications|Participants were asssed on the basis of primary illness (had complications and had no complications) at the start of study.|participants|Number|1064|1064.0||||||
3763068|NCT01945242|3596044|B3|Outpatient and Inpatient||Healthcare category|Participants were categorized as outpatient, inpatient, and outpatient and Inpatient (participants who were both outpatient and inpatient at any time prior to enrollment).|participants|Number|28|28.0||||||
3763069|NCT01945242|3596045|B2|Outpatient and Inpatient||Healthcare category|Participants were categorized as outpatient, inpatient, and outpatient and Inpatient (participants who were both outpatient and inpatient at any time prior to enrollment).|participants|Number|0|0.0||||||
3763070|NCT01945242|3596046|B1|Outpatient and Inpatient||Healthcare category|Participants were categorized as outpatient, inpatient, and outpatient and Inpatient (participants who were both outpatient and inpatient at any time prior to enrollment).|participants|Number|28|28.0||||||
3763071|NCT01945242|3596044|B3|Inpatient||Healthcare category|Participants were categorized as outpatient, inpatient, and outpatient and Inpatient (participants who were both outpatient and inpatient at any time prior to enrollment).|participants|Number|11|11.0||||||
3763072|NCT01945242|3596045|B2|Inpatient||Healthcare category|Participants were categorized as outpatient, inpatient, and outpatient and Inpatient (participants who were both outpatient and inpatient at any time prior to enrollment).|participants|Number|0|0.0||||||
3763073|NCT01945242|3596046|B1|Inpatient||Healthcare category|Participants were categorized as outpatient, inpatient, and outpatient and Inpatient (participants who were both outpatient and inpatient at any time prior to enrollment).|participants|Number|11|11.0||||||
3763074|NCT01945242|3596044|B3|Outpatient||Healthcare category|Participants were categorized as outpatient, inpatient, and outpatient and Inpatient (participants who were both outpatient and inpatient at any time prior to enrollment).|participants|Number|1329|1329.0||||||
3763075|NCT01945242|3596045|B2|Outpatient||Healthcare category|Participants were categorized as outpatient, inpatient, and outpatient and Inpatient (participants who were both outpatient and inpatient at any time prior to enrollment).|participants|Number|120|120.0||||||
3763076|NCT01945242|3596046|B1|Outpatient||Healthcare category|Participants were categorized as outpatient, inpatient, and outpatient and Inpatient (participants who were both outpatient and inpatient at any time prior to enrollment).|participants|Number|1209|1209.0||||||
3763077|NCT01945242|3596044|B3|Pregnant||Pregnancy Status|The baseline characteristic was analyzed only in female participants.|participants|Number|0|0.0||||||
3763078|NCT01945242|3596045|B2|Pregnant||Pregnancy Status|The baseline characteristic was analyzed only in female participants.|participants|Number|0|0.0||||||
3763079|NCT01945242|3596046|B1|Pregnant||Pregnancy Status|The baseline characteristic was analyzed only in female participants.|participants|Number|0|0.0||||||
3763080|NCT01945242|3596044|B3|Not pregnant||Pregnancy Status|The baseline characteristic was analyzed only in female participants.|participants|Number|503|503.0||||||
3763081|NCT01945242|3596045|B2|Not pregnant||Pregnancy Status|The baseline characteristic was analyzed only in female participants.|participants|Number|41|41.0||||||
3763082|NCT01945242|3596046|B1|Not pregnant||Pregnancy Status|The baseline characteristic was analyzed only in female participants.|participants|Number|462|462.0||||||
3763083|NCT01945242|3596044|B3|Unknown (Female)||Waist Circumference||participants|Number|354|354.0||||||
3763084|NCT01945242|3596045|B2|Unknown (Female)||Waist Circumference||participants|Number|33|33.0||||||
3763085|NCT01945242|3596046|B1|Unknown (Female)||Waist Circumference||participants|Number|321|321.0||||||
3763086|NCT01945242|3596044|B3|>=90 cm (Female)||Waist Circumference||participants|Number|53|53.0||||||
3763087|NCT01945242|3596045|B2|>=90 cm (Female)||Waist Circumference||participants|Number|4|4.0||||||
3763088|NCT01945242|3596046|B1|>=90 cm (Female)||Waist Circumference||participants|Number|49|49.0||||||
3763089|NCT01945242|3596044|B3|<90 cm (Female)||Waist Circumference||participants|Number|96|96.0||||||
3763090|NCT01945242|3596045|B2|<90 cm (Female)||Waist Circumference||participants|Number|4|4.0||||||
3763091|NCT01945242|3596046|B1|<90 cm (Female)||Waist Circumference||participants|Number|92|92.0||||||
3763092|NCT01945242|3596044|B3|Unknown (Male)||Waist Circumference||participants|Number|597|597.0||||||
3763093|NCT01945242|3596045|B2|Unknown (Male)||Waist Circumference||participants|Number|55|55.0||||||
3763094|NCT01945242|3596046|B1|Unknown (Male)||Waist Circumference||participants|Number|542|542.0||||||
3763095|NCT01945242|3596044|B3|>=85 cm (Male)||Waist Circumference||participants|Number|201|201.0||||||
3763096|NCT01945242|3596045|B2|>=85 cm (Male)||Waist Circumference||participants|Number|17|17.0||||||
3763097|NCT01945242|3596046|B1|>=85 cm (Male)||Waist Circumference||participants|Number|184|184.0||||||
3763098|NCT01945242|3596044|B3|<85 centimeter (cm) (Male)||Waist Circumference||participants|Number|67|67.0||||||
3763099|NCT01945242|3596045|B2|<85 centimeter (cm) (Male)||Waist Circumference||participants|Number|7|7.0||||||
3763100|NCT01945242|3596046|B1|<85 centimeter (cm) (Male)||Waist Circumference||participants|Number|60|60.0||||||
3763101|NCT01945242|3596044|B3|Unknown||Body Mass Index||participants|Number|474|474.0||||||
3763102|NCT01945242|3596045|B2|Unknown||Body Mass Index||participants|Number|47|47.0||||||
3763103|NCT01945242|3596046|B1|Unknown||Body Mass Index||participants|Number|427|427.0||||||
3763104|NCT01945242|3596044|B3|>=30 kg/m^2||Body Mass Index||participants|Number|150|150.0||||||
3763105|NCT01945242|3596045|B2|>=30 kg/m^2||Body Mass Index||participants|Number|16|16.0||||||
3763106|NCT01945242|3596046|B1|>=30 kg/m^2||Body Mass Index||participants|Number|134|134.0||||||
3763107|NCT01945242|3596044|B3|>=25 to <30 kg/m^2||Body Mass Index||participants|Number|384|384.0||||||
3763108|NCT01945242|3596045|B2|>=25 to <30 kg/m^2||Body Mass Index||participants|Number|31|31.0||||||
3763109|NCT01945242|3596046|B1|>=25 to <30 kg/m^2||Body Mass Index||participants|Number|353|353.0||||||
3763110|NCT01945242|3596044|B3|>=18.5 to <25 kg/m^2||Body Mass Index||participants|Number|344|344.0||||||
3763111|NCT01945242|3596045|B2|>=18.5 to <25 kg/m^2||Body Mass Index||participants|Number|26|26.0||||||
3763112|NCT01945242|3596046|B1|>=18.5 to <25 kg/m^2||Body Mass Index||participants|Number|318|318.0||||||
3763113|NCT01945242|3596044|B3|<18.5 kilogram/square meter (kg/m^2)||Body Mass Index||participants|Number|16|16.0||||||
3763114|NCT01945242|3596045|B2|<18.5 kilogram/square meter (kg/m^2)||Body Mass Index||participants|Number|0|0.0||||||
3763115|NCT01945242|3596046|B1|<18.5 kilogram/square meter (kg/m^2)||Body Mass Index||participants|Number|16|16.0||||||
3763116|NCT01945242|3596044|B3||Male|Sex: Female, Male||Participants|Count of Participants|865|865.0||||||
3763117|NCT01945242|3596045|B2||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3763118|NCT01945242|3596046|B1||Male|Sex: Female, Male||Participants|Count of Participants|786|786.0||||||
3763119|NCT01945242|3596044|B3||Female|Sex: Female, Male||Participants|Count of Participants|503|503.0||||||
3763120|NCT01945242|3596045|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3763121|NCT01945242|3596046|B1||Female|Sex: Female, Male||Participants|Count of Participants|462|462.0||||||
3763122|NCT01945242|3596044|B3|Greater than equal to (>=) 80 years||Age, Customized||participants|Number|138|138.0||||||
3763123|NCT01945242|3596045|B2|Greater than equal to (>=) 80 years||Age, Customized||participants|Number|8|8.0||||||
3763124|NCT01945242|3596046|B1|Greater than equal to (>=) 80 years||Age, Customized||participants|Number|130|130.0||||||
3763125|NCT01945242|3596044|B3|70-79 years||Age, Customized||participants|Number|376|376.0||||||
3763126|NCT01945242|3596045|B2|70-79 years||Age, Customized||participants|Number|39|39.0||||||
3763127|NCT01945242|3596046|B1|70-79 years||Age, Customized||participants|Number|337|337.0||||||
3763128|NCT01945242|3596044|B3|60-69 years||Age, Customized||participants|Number|447|447.0||||||
3763129|NCT01945242|3596045|B2|60-69 years||Age, Customized||participants|Number|35|35.0||||||
3763130|NCT01945242|3596046|B1|60-69 years||Age, Customized||participants|Number|412|412.0||||||
3763131|NCT01945242|3596044|B3|50-59 years||Age, Customized||participants|Number|236|236.0||||||
3763132|NCT01945242|3596045|B2|50-59 years||Age, Customized||participants|Number|22|22.0||||||
3763133|NCT01945242|3596046|B1|50-59 years||Age, Customized||participants|Number|214|214.0||||||
3763134|NCT01945242|3596044|B3|40-49 years||Age, Customized||participants|Number|132|132.0||||||
3763135|NCT01945242|3596045|B2|40-49 years||Age, Customized||participants|Number|12|12.0||||||
3763136|NCT01945242|3596046|B1|40-49 years||Age, Customized||participants|Number|120|120.0||||||
3763137|NCT01945242|3596044|B3|30-39 years||Age, Customized||participants|Number|33|33.0||||||
3763138|NCT01945242|3596045|B2|30-39 years||Age, Customized||participants|Number|4|4.0||||||
3763139|NCT01945242|3596046|B1|30-39 years||Age, Customized||participants|Number|29|29.0||||||
3763140|NCT01945242|3596044|B3|20-29 years||Age, Customized||participants|Number|5|5.0||||||
3763141|NCT01945242|3596045|B2|20-29 years||Age, Customized||participants|Number|0|0.0||||||
3763142|NCT01945242|3596046|B1|20-29 years||Age, Customized||participants|Number|5|5.0||||||
3763143|NCT01945242|3596044|B3|Less than (<) 20 years||Age, Customized||participants|Number|1|1.0||||||
3763144|NCT01945242|3596045|B2|Less than (<) 20 years||Age, Customized||participants|Number|0|0.0||||||
3763145|NCT01945242|3596046|B1|Less than (<) 20 years||Age, Customized||participants|Number|1|1.0||||||
3763146|NCT01945216|3596059|B4|Unknown||Glycosylated Hemoglobin A1c (HbA1c)||Participants|Count of Participants|277|277.0||||||
3763147|NCT01945216|3596060|B3|Unknown||Glycosylated Hemoglobin A1c (HbA1c)||Participants|Count of Participants|96|96.0||||||
3763148|NCT01945216|3596061|B2|Unknown||Glycosylated Hemoglobin A1c (HbA1c)||Participants|Count of Participants|47|47.0||||||
3763149|NCT01945216|3596062|B1|Unknown||Glycosylated Hemoglobin A1c (HbA1c)||Participants|Count of Participants|134|134.0||||||
3763150|NCT01945216|3596059|B4|HbA1c >=8.0 percent||Glycosylated Hemoglobin A1c (HbA1c)||Participants|Count of Participants|891|891.0||||||
3763151|NCT01945216|3596060|B3|HbA1c >=8.0 percent||Glycosylated Hemoglobin A1c (HbA1c)||Participants|Count of Participants|345|345.0||||||
3763152|NCT01945216|3596061|B2|HbA1c >=8.0 percent||Glycosylated Hemoglobin A1c (HbA1c)||Participants|Count of Participants|195|195.0||||||
3763153|NCT01945216|3596062|B1|HbA1c >=8.0 percent||Glycosylated Hemoglobin A1c (HbA1c)||Participants|Count of Participants|351|351.0||||||
3763154|NCT01945216|3596059|B4|HbA1c >=7.0 to <8.0 percent||Glycosylated Hemoglobin A1c (HbA1c)||Participants|Count of Participants|1166|1166.0||||||
3763155|NCT01945216|3596060|B3|HbA1c >=7.0 to <8.0 percent||Glycosylated Hemoglobin A1c (HbA1c)||Participants|Count of Participants|320|320.0||||||
3763156|NCT01945216|3596061|B2|HbA1c >=7.0 to <8.0 percent||Glycosylated Hemoglobin A1c (HbA1c)||Participants|Count of Participants|270|270.0||||||
3763157|NCT01945216|3596062|B1|HbA1c >=7.0 to <8.0 percent||Glycosylated Hemoglobin A1c (HbA1c)||Participants|Count of Participants|576|576.0||||||
3763158|NCT01945216|3596059|B4|HbA1c >=6.0 to <7.0 percent||Glycosylated Hemoglobin A1c (HbA1c)||Participants|Count of Participants|804|804.0||||||
3763159|NCT01945216|3596060|B3|HbA1c >=6.0 to <7.0 percent||Glycosylated Hemoglobin A1c (HbA1c)||Participants|Count of Participants|195|195.0||||||
3763160|NCT01945216|3596061|B2|HbA1c >=6.0 to <7.0 percent||Glycosylated Hemoglobin A1c (HbA1c)||Participants|Count of Participants|134|134.0||||||
3763161|NCT01945216|3596062|B1|HbA1c >=6.0 to <7.0 percent||Glycosylated Hemoglobin A1c (HbA1c)||Participants|Count of Participants|475|475.0||||||
3763162|NCT01945216|3596059|B4|HbA1c <6.0 percent||Glycosylated Hemoglobin A1c (HbA1c)||Participants|Count of Participants|85|85.0||||||
3763163|NCT01945216|3596060|B3|HbA1c <6.0 percent||Glycosylated Hemoglobin A1c (HbA1c)||Participants|Count of Participants|33|33.0||||||
3763164|NCT01945216|3596061|B2|HbA1c <6.0 percent||Glycosylated Hemoglobin A1c (HbA1c)||Participants|Count of Participants|24|24.0||||||
3763165|NCT01945216|3596062|B1|HbA1c <6.0 percent||Glycosylated Hemoglobin A1c (HbA1c)||Participants|Count of Participants|28|28.0||||||
3763166|NCT01945216|3596059|B4|Unknown||Smoking Classification||Participants|Count of Participants|756|756.0||||||
3763167|NCT01945216|3596060|B3|Unknown||Smoking Classification||Participants|Count of Participants|260|260.0||||||
3763168|NCT01945216|3596061|B2|Unknown||Smoking Classification||Participants|Count of Participants|148|148.0||||||
3763445|NCT01945216|3596062|B1|||Height||cm|Mean|160.19|160.19|Standard Deviation|9.725|9.725|||
3763169|NCT01945216|3596062|B1|Unknown||Smoking Classification||Participants|Count of Participants|348|348.0||||||
3763170|NCT01945216|3596059|B4|Ex-Smoker||Smoking Classification||Participants|Count of Participants|562|562.0||||||
3763171|NCT01945216|3596060|B3|Ex-Smoker||Smoking Classification||Participants|Count of Participants|160|160.0||||||
3763172|NCT01945216|3596061|B2|Ex-Smoker||Smoking Classification||Participants|Count of Participants|153|153.0||||||
3763173|NCT01945216|3596062|B1|Ex-Smoker||Smoking Classification||Participants|Count of Participants|249|249.0||||||
3763174|NCT01945216|3596059|B4|Current Smoker||Smoking Classification||Participants|Count of Participants|459|459.0||||||
3763175|NCT01945216|3596060|B3|Current Smoker||Smoking Classification||Participants|Count of Participants|155|155.0||||||
3763176|NCT01945216|3596061|B2|Current Smoker||Smoking Classification||Participants|Count of Participants|77|77.0||||||
3763177|NCT01945216|3596062|B1|Current Smoker||Smoking Classification||Participants|Count of Participants|227|227.0||||||
3763178|NCT01945216|3596059|B4|Never Smoked||Smoking Classification||Participants|Count of Participants|1446|1446.0||||||
3763179|NCT01945216|3596060|B3|Never Smoked||Smoking Classification||Participants|Count of Participants|414|414.0||||||
3763180|NCT01945216|3596061|B2|Never Smoked||Smoking Classification||Participants|Count of Participants|292|292.0||||||
3763181|NCT01945216|3596062|B1|Never Smoked||Smoking Classification||Participants|Count of Participants|740|740.0||||||
3763182|NCT01945216|3596059|B4|Unknown||Alcohol Consumption Classification||Participants|Count of Participants|572|572.0||||||
3763183|NCT01945216|3596060|B3|Unknown||Alcohol Consumption Classification||Participants|Count of Participants|187|187.0||||||
3763184|NCT01945216|3596061|B2|Unknown||Alcohol Consumption Classification||Participants|Count of Participants|128|128.0||||||
3763185|NCT01945216|3596062|B1|Unknown||Alcohol Consumption Classification||Participants|Count of Participants|257|257.0||||||
3763186|NCT01945216|3596059|B4|Not Drinking Almost Everyday||Alcohol Consumption Classification||Participants|Count of Participants|1805|1805.0||||||
3763187|NCT01945216|3596060|B3|Not Drinking Almost Everyday||Alcohol Consumption Classification||Participants|Count of Participants|526|526.0||||||
3763188|NCT01945216|3596061|B2|Not Drinking Almost Everyday||Alcohol Consumption Classification||Participants|Count of Participants|384|384.0||||||
3763189|NCT01945216|3596062|B1|Not Drinking Almost Everyday||Alcohol Consumption Classification||Participants|Count of Participants|895|895.0||||||
3763190|NCT01945216|3596059|B4|Drinking Almost Everyday||Alcohol Consumption Classification||Participants|Count of Participants|846|846.0||||||
3763191|NCT01945216|3596060|B3|Drinking Almost Everyday||Alcohol Consumption Classification||Participants|Count of Participants|276|276.0||||||
3763192|NCT01945216|3596061|B2|Drinking Almost Everyday||Alcohol Consumption Classification||Participants|Count of Participants|158|158.0||||||
3763193|NCT01945216|3596062|B1|Drinking Almost Everyday||Alcohol Consumption Classification||Participants|Count of Participants|412|412.0||||||
3763194|NCT01945216|3596059|B4|Unknown||Medical history|Medical history defined as a disease or a health condition for each participant before start of the study. Medical history was classified as congenital anomalies, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, GI disorders, hepatic and biliary disorders, renal disease and other medical history. Other medical history included all medical history except for those mentioned above.|Participants|Count of Participants|177|177.0||||||
3763195|NCT01945216|3596060|B3|Unknown||Medical history|Medical history defined as a disease or a health condition for each participant before start of the study. Medical history was classified as congenital anomalies, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, GI disorders, hepatic and biliary disorders, renal disease and other medical history. Other medical history included all medical history except for those mentioned above.|Participants|Count of Participants|55|55.0||||||
3763196|NCT01945216|3596061|B2|Unknown||Medical history|Medical history defined as a disease or a health condition for each participant before start of the study. Medical history was classified as congenital anomalies, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, GI disorders, hepatic and biliary disorders, renal disease and other medical history. Other medical history included all medical history except for those mentioned above.|Participants|Count of Participants|42|42.0||||||
3763197|NCT01945216|3596062|B1|Unknown||Medical history|Medical history defined as a disease or a health condition for each participant before start of the study. Medical history was classified as congenital anomalies, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, GI disorders, hepatic and biliary disorders, renal disease and other medical history. Other medical history included all medical history except for those mentioned above.|Participants|Count of Participants|80|80.0||||||
3763198|NCT01945216|3596059|B4|Had Medical History||Medical history|Medical history defined as a disease or a health condition for each participant before start of the study. Medical history was classified as congenital anomalies, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, GI disorders, hepatic and biliary disorders, renal disease and other medical history. Other medical history included all medical history except for those mentioned above.|Participants|Count of Participants|517|517.0||||||
3763199|NCT01945216|3596060|B3|Had Medical History||Medical history|Medical history defined as a disease or a health condition for each participant before start of the study. Medical history was classified as congenital anomalies, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, GI disorders, hepatic and biliary disorders, renal disease and other medical history. Other medical history included all medical history except for those mentioned above.|Participants|Count of Participants|166|166.0||||||
3763200|NCT01945216|3596061|B2|Had Medical History||Medical history|Medical history defined as a disease or a health condition for each participant before start of the study. Medical history was classified as congenital anomalies, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, GI disorders, hepatic and biliary disorders, renal disease and other medical history. Other medical history included all medical history except for those mentioned above.|Participants|Count of Participants|126|126.0||||||
3763364|NCT01945216|3596061|B2|Had Diabetic Complications||Diabetic Complications||Participants|Count of Participants|163|163.0||||||
3763201|NCT01945216|3596062|B1|Had Medical History||Medical history|Medical history defined as a disease or a health condition for each participant before start of the study. Medical history was classified as congenital anomalies, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, GI disorders, hepatic and biliary disorders, renal disease and other medical history. Other medical history included all medical history except for those mentioned above.|Participants|Count of Participants|225|225.0||||||
3763202|NCT01945216|3596059|B4|Had No Medical History||Medical history|Medical history defined as a disease or a health condition for each participant before start of the study. Medical history was classified as congenital anomalies, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, GI disorders, hepatic and biliary disorders, renal disease and other medical history. Other medical history included all medical history except for those mentioned above.|Participants|Count of Participants|2529|2529.0||||||
3763203|NCT01945216|3596060|B3|Had No Medical History||Medical history|Medical history defined as a disease or a health condition for each participant before start of the study. Medical history was classified as congenital anomalies, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, GI disorders, hepatic and biliary disorders, renal disease and other medical history. Other medical history included all medical history except for those mentioned above.|Participants|Count of Participants|768|768.0||||||
3763204|NCT01945216|3596061|B2|Had No Medical History||Medical history|Medical history defined as a disease or a health condition for each participant before start of the study. Medical history was classified as congenital anomalies, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, GI disorders, hepatic and biliary disorders, renal disease and other medical history. Other medical history included all medical history except for those mentioned above.|Participants|Count of Participants|502|502.0||||||
3763205|NCT01945216|3596062|B1|Had No Medical History||Medical history|Medical history defined as a disease or a health condition for each participant before start of the study. Medical history was classified as congenital anomalies, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, GI disorders, hepatic and biliary disorders, renal disease and other medical history. Other medical history included all medical history except for those mentioned above.|Participants|Count of Participants|1259|1259.0||||||
3763206|NCT01945216|3596059|B4|Had Malignancy Complications||Malignancy Complications||Participants|Count of Participants|54|54.0||||||
3763207|NCT01945216|3596060|B3|Had Malignancy Complications||Malignancy Complications||Participants|Count of Participants|29|29.0||||||
3763208|NCT01945216|3596061|B2|Had Malignancy Complications||Malignancy Complications||Participants|Count of Participants|8|8.0||||||
3763209|NCT01945216|3596062|B1|Had Malignancy Complications||Malignancy Complications||Participants|Count of Participants|17|17.0||||||
3763210|NCT01945216|3596059|B4|Had No Malignancy Complications||Malignancy Complications||Participants|Count of Participants|3169|3169.0||||||
3763211|NCT01945216|3596060|B3|Had No Malignancy Complications||Malignancy Complications||Participants|Count of Participants|960|960.0||||||
3763212|NCT01945216|3596061|B2|Had No Malignancy Complications||Malignancy Complications||Participants|Count of Participants|662|662.0||||||
3763213|NCT01945216|3596062|B1|Had No Malignancy Complications||Malignancy Complications||Participants|Count of Participants|1547|1547.0||||||
3763214|NCT01945216|3596059|B4|Had Allergic Disease Complications||Allergic Disease Complications||Participants|Count of Participants|211|211.0||||||
3763215|NCT01945216|3596060|B3|Had Allergic Disease Complications||Allergic Disease Complications||Participants|Count of Participants|75|75.0||||||
3763216|NCT01945216|3596061|B2|Had Allergic Disease Complications||Allergic Disease Complications||Participants|Count of Participants|42|42.0||||||
3763217|NCT01945216|3596062|B1|Had Allergic Disease Complications||Allergic Disease Complications||Participants|Count of Participants|94|94.0||||||
3763218|NCT01945216|3596059|B4|Had No Allergic Disease Complications||Allergic Disease Complications||Participants|Count of Participants|3012|3012.0||||||
3763219|NCT01945216|3596060|B3|Had No Allergic Disease Complications||Allergic Disease Complications||Participants|Count of Participants|914|914.0||||||
3763220|NCT01945216|3596061|B2|Had No Allergic Disease Complications||Allergic Disease Complications||Participants|Count of Participants|628|628.0||||||
3763221|NCT01945216|3596062|B1|Had No Allergic Disease Complications||Allergic Disease Complications||Participants|Count of Participants|1470|1470.0||||||
3763222|NCT01945216|3596059|B4|Had Stroke-Related Disorder Complications||Stroke-Related Disorder Complications||Participants|Count of Participants|178|178.0||||||
3763223|NCT01945216|3596060|B3|Had Stroke-Related Disorder Complications||Stroke-Related Disorder Complications||Participants|Count of Participants|67|67.0||||||
3763224|NCT01945216|3596061|B2|Had Stroke-Related Disorder Complications||Stroke-Related Disorder Complications||Participants|Count of Participants|56|56.0||||||
3763225|NCT01945216|3596062|B1|Had Stroke-Related Disorder Complications||Stroke-Related Disorder Complications||Participants|Count of Participants|55|55.0||||||
3763226|NCT01945216|3596059|B4|Had No Stroke-Related Disorder Complications||Stroke-Related Disorder Complications||Participants|Count of Participants|3045|3045.0||||||
3763227|NCT01945216|3596060|B3|Had No Stroke-Related Disorder Complications||Stroke-Related Disorder Complications||Participants|Count of Participants|922|922.0||||||
3763228|NCT01945216|3596061|B2|Had No Stroke-Related Disorder Complications||Stroke-Related Disorder Complications||Participants|Count of Participants|614|614.0||||||
3763229|NCT01945216|3596062|B1|Had No Stroke-Related Disorder Complications||Stroke-Related Disorder Complications||Participants|Count of Participants|1509|1509.0||||||
3763230|NCT01945216|3596059|B4||Unknown|New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (Participants with cardiac disease but without resulting limitations of physical activity), Class II (Participants with cardiac disease resulting in slight limitation of physical activity), Class III (Participants with cardiac disease resulting in marked limitation of physical activity), Class IV (Participants with cardiac disease resulting in inability to carry on any physical activity without discomfort).|Participants|Count of Participants|3|3.0||||||
3763365|NCT01945216|3596062|B1|Had Diabetic Complications||Diabetic Complications||Participants|Count of Participants|158|158.0||||||
3763231|NCT01945216|3596060|B3||Unknown|New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (Participants with cardiac disease but without resulting limitations of physical activity), Class II (Participants with cardiac disease resulting in slight limitation of physical activity), Class III (Participants with cardiac disease resulting in marked limitation of physical activity), Class IV (Participants with cardiac disease resulting in inability to carry on any physical activity without discomfort).|Participants|Count of Participants|2|2.0||||||
3763232|NCT01945216|3596061|B2||Unknown|New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (Participants with cardiac disease but without resulting limitations of physical activity), Class II (Participants with cardiac disease resulting in slight limitation of physical activity), Class III (Participants with cardiac disease resulting in marked limitation of physical activity), Class IV (Participants with cardiac disease resulting in inability to carry on any physical activity without discomfort).|Participants|Count of Participants|1|1.0||||||
3763233|NCT01945216|3596062|B1||Unknown|New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (Participants with cardiac disease but without resulting limitations of physical activity), Class II (Participants with cardiac disease resulting in slight limitation of physical activity), Class III (Participants with cardiac disease resulting in marked limitation of physical activity), Class IV (Participants with cardiac disease resulting in inability to carry on any physical activity without discomfort).|Participants|Count of Participants|0|0.0||||||
3763234|NCT01945216|3596059|B4||NYHA Class IV|New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (Participants with cardiac disease but without resulting limitations of physical activity), Class II (Participants with cardiac disease resulting in slight limitation of physical activity), Class III (Participants with cardiac disease resulting in marked limitation of physical activity), Class IV (Participants with cardiac disease resulting in inability to carry on any physical activity without discomfort).|Participants|Count of Participants|0|0.0||||||
3763235|NCT01945216|3596060|B3||NYHA Class IV|New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (Participants with cardiac disease but without resulting limitations of physical activity), Class II (Participants with cardiac disease resulting in slight limitation of physical activity), Class III (Participants with cardiac disease resulting in marked limitation of physical activity), Class IV (Participants with cardiac disease resulting in inability to carry on any physical activity without discomfort).|Participants|Count of Participants|0|0.0||||||
3763236|NCT01945216|3596061|B2||NYHA Class IV|New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (Participants with cardiac disease but without resulting limitations of physical activity), Class II (Participants with cardiac disease resulting in slight limitation of physical activity), Class III (Participants with cardiac disease resulting in marked limitation of physical activity), Class IV (Participants with cardiac disease resulting in inability to carry on any physical activity without discomfort).|Participants|Count of Participants|0|0.0||||||
3763237|NCT01945216|3596062|B1||NYHA Class IV|New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (Participants with cardiac disease but without resulting limitations of physical activity), Class II (Participants with cardiac disease resulting in slight limitation of physical activity), Class III (Participants with cardiac disease resulting in marked limitation of physical activity), Class IV (Participants with cardiac disease resulting in inability to carry on any physical activity without discomfort).|Participants|Count of Participants|0|0.0||||||
3763238|NCT01945216|3596059|B4||NYHA Class III|New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (Participants with cardiac disease but without resulting limitations of physical activity), Class II (Participants with cardiac disease resulting in slight limitation of physical activity), Class III (Participants with cardiac disease resulting in marked limitation of physical activity), Class IV (Participants with cardiac disease resulting in inability to carry on any physical activity without discomfort).|Participants|Count of Participants|3|3.0||||||
3763239|NCT01945216|3596060|B3||NYHA Class III|New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (Participants with cardiac disease but without resulting limitations of physical activity), Class II (Participants with cardiac disease resulting in slight limitation of physical activity), Class III (Participants with cardiac disease resulting in marked limitation of physical activity), Class IV (Participants with cardiac disease resulting in inability to carry on any physical activity without discomfort).|Participants|Count of Participants|1|1.0||||||
3763240|NCT01945216|3596061|B2||NYHA Class III|New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (Participants with cardiac disease but without resulting limitations of physical activity), Class II (Participants with cardiac disease resulting in slight limitation of physical activity), Class III (Participants with cardiac disease resulting in marked limitation of physical activity), Class IV (Participants with cardiac disease resulting in inability to carry on any physical activity without discomfort).|Participants|Count of Participants|1|1.0||||||
3763241|NCT01945216|3596062|B1||NYHA Class III|New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (Participants with cardiac disease but without resulting limitations of physical activity), Class II (Participants with cardiac disease resulting in slight limitation of physical activity), Class III (Participants with cardiac disease resulting in marked limitation of physical activity), Class IV (Participants with cardiac disease resulting in inability to carry on any physical activity without discomfort).|Participants|Count of Participants|1|1.0||||||
3763242|NCT01945216|3596059|B4||NYHA Class II|New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (Participants with cardiac disease but without resulting limitations of physical activity), Class II (Participants with cardiac disease resulting in slight limitation of physical activity), Class III (Participants with cardiac disease resulting in marked limitation of physical activity), Class IV (Participants with cardiac disease resulting in inability to carry on any physical activity without discomfort).|Participants|Count of Participants|26|26.0||||||
3763366|NCT01945216|3596059|B4|Had No Diabetic Complications||Diabetic Complications||Participants|Count of Participants|2744|2744.0||||||
3763367|NCT01945216|3596060|B3|Had No Diabetic Complications||Diabetic Complications||Participants|Count of Participants|831|831.0||||||
3763243|NCT01945216|3596060|B3||NYHA Class II|New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (Participants with cardiac disease but without resulting limitations of physical activity), Class II (Participants with cardiac disease resulting in slight limitation of physical activity), Class III (Participants with cardiac disease resulting in marked limitation of physical activity), Class IV (Participants with cardiac disease resulting in inability to carry on any physical activity without discomfort).|Participants|Count of Participants|5|5.0||||||
3763244|NCT01945216|3596061|B2||NYHA Class II|New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (Participants with cardiac disease but without resulting limitations of physical activity), Class II (Participants with cardiac disease resulting in slight limitation of physical activity), Class III (Participants with cardiac disease resulting in marked limitation of physical activity), Class IV (Participants with cardiac disease resulting in inability to carry on any physical activity without discomfort).|Participants|Count of Participants|5|5.0||||||
3763245|NCT01945216|3596062|B1||NYHA Class II|New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (Participants with cardiac disease but without resulting limitations of physical activity), Class II (Participants with cardiac disease resulting in slight limitation of physical activity), Class III (Participants with cardiac disease resulting in marked limitation of physical activity), Class IV (Participants with cardiac disease resulting in inability to carry on any physical activity without discomfort).|Participants|Count of Participants|16|16.0||||||
3763246|NCT01945216|3596059|B4||NYHA Class I|New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (Participants with cardiac disease but without resulting limitations of physical activity), Class II (Participants with cardiac disease resulting in slight limitation of physical activity), Class III (Participants with cardiac disease resulting in marked limitation of physical activity), Class IV (Participants with cardiac disease resulting in inability to carry on any physical activity without discomfort).|Participants|Count of Participants|50|50.0||||||
3763247|NCT01945216|3596060|B3||NYHA Class I|New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (Participants with cardiac disease but without resulting limitations of physical activity), Class II (Participants with cardiac disease resulting in slight limitation of physical activity), Class III (Participants with cardiac disease resulting in marked limitation of physical activity), Class IV (Participants with cardiac disease resulting in inability to carry on any physical activity without discomfort).|Participants|Count of Participants|11|11.0||||||
3763248|NCT01945216|3596061|B2||NYHA Class I|New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (Participants with cardiac disease but without resulting limitations of physical activity), Class II (Participants with cardiac disease resulting in slight limitation of physical activity), Class III (Participants with cardiac disease resulting in marked limitation of physical activity), Class IV (Participants with cardiac disease resulting in inability to carry on any physical activity without discomfort).|Participants|Count of Participants|13|13.0||||||
3763249|NCT01945216|3596062|B1||NYHA Class I|New York Heart Association (NYHA) Heart Failure Classification|NYHA functional classification ranges from Class I (Participants with cardiac disease but without resulting limitations of physical activity), Class II (Participants with cardiac disease resulting in slight limitation of physical activity), Class III (Participants with cardiac disease resulting in marked limitation of physical activity), Class IV (Participants with cardiac disease resulting in inability to carry on any physical activity without discomfort).|Participants|Count of Participants|26|26.0||||||
3763250|NCT01945216|3596059|B4|Had Heart Failure Complications||Heart Failure Complications||Participants|Count of Participants|82|82.0||||||
3763251|NCT01945216|3596060|B3|Had Heart Failure Complications||Heart Failure Complications||Participants|Count of Participants|19|19.0||||||
3763252|NCT01945216|3596061|B2|Had Heart Failure Complications||Heart Failure Complications||Participants|Count of Participants|20|20.0||||||
3763253|NCT01945216|3596062|B1|Had Heart Failure Complications||Heart Failure Complications||Participants|Count of Participants|43|43.0||||||
3763254|NCT01945216|3596059|B4|Had No Heart Failure Complications||Heart Failure Complications||Participants|Count of Participants|3141|3141.0||||||
3763255|NCT01945216|3596060|B3|Had No Heart Failure Complications||Heart Failure Complications||Participants|Count of Participants|970|970.0||||||
3763256|NCT01945216|3596061|B2|Had No Heart Failure Complications||Heart Failure Complications||Participants|Count of Participants|650|650.0||||||
3763257|NCT01945216|3596062|B1|Had No Heart Failure Complications||Heart Failure Complications||Participants|Count of Participants|1521|1521.0||||||
3763258|NCT01945216|3596059|B4|Had Cardiac Disease Complications||Cardiac Disease Complications||Participants|Count of Participants|353|353.0||||||
3763259|NCT01945216|3596060|B3|Had Cardiac Disease Complications||Cardiac Disease Complications||Participants|Count of Participants|119|119.0||||||
3763260|NCT01945216|3596061|B2|Had Cardiac Disease Complications||Cardiac Disease Complications||Participants|Count of Participants|91|91.0||||||
3763261|NCT01945216|3596062|B1|Had Cardiac Disease Complications||Cardiac Disease Complications||Participants|Count of Participants|143|143.0||||||
3763262|NCT01945216|3596059|B4|Had No Cardiac Disease Complications||Cardiac Disease Complications||Participants|Count of Participants|2870|2870.0||||||
3763263|NCT01945216|3596060|B3|Had No Cardiac Disease Complications||Cardiac Disease Complications||Participants|Count of Participants|870|870.0||||||
3763264|NCT01945216|3596061|B2|Had No Cardiac Disease Complications||Cardiac Disease Complications||Participants|Count of Participants|579|579.0||||||
3763265|NCT01945216|3596062|B1|Had No Cardiac Disease Complications||Cardiac Disease Complications||Participants|Count of Participants|1421|1421.0||||||
3763266|NCT01945216|3596059|B4|Unknown||Degree of Renal Dysfunction (Cr)|Normal or Mild: =< 1.4 mg/dL (for male) or =< 1.2 mg/dL (for female), Moderate: >1.4 mg/dL to =< 2.4 mg/dL (for male) or >1.2 mg/dL to =< 2.0 mg/dL (for female), Severe: > 2.4 mg/dL (for male), > 2.0 mg/dL (for female). If the serum creatinine value (Cr) at the start of treatment was not listed, the severity was reported as “unknown.”|Participants|Count of Participants|901|901.0||||||
3763368|NCT01945216|3596061|B2|Had No Diabetic Complications||Diabetic Complications||Participants|Count of Participants|507|507.0||||||
3763502|NCT01945138|3596074|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3763267|NCT01945216|3596060|B3|Unknown||Degree of Renal Dysfunction (Cr)|Normal or Mild: =< 1.4 mg/dL (for male) or =< 1.2 mg/dL (for female), Moderate: >1.4 mg/dL to =< 2.4 mg/dL (for male) or >1.2 mg/dL to =< 2.0 mg/dL (for female), Severe: > 2.4 mg/dL (for male), > 2.0 mg/dL (for female). If the serum creatinine value (Cr) at the start of treatment was not listed, the severity was reported as “unknown.”|Participants|Count of Participants|293|293.0||||||
3763268|NCT01945216|3596061|B2|Unknown||Degree of Renal Dysfunction (Cr)|Normal or Mild: =< 1.4 mg/dL (for male) or =< 1.2 mg/dL (for female), Moderate: >1.4 mg/dL to =< 2.4 mg/dL (for male) or >1.2 mg/dL to =< 2.0 mg/dL (for female), Severe: > 2.4 mg/dL (for male), > 2.0 mg/dL (for female). If the serum creatinine value (Cr) at the start of treatment was not listed, the severity was reported as “unknown.”|Participants|Count of Participants|178|178.0||||||
3763269|NCT01945216|3596062|B1|Unknown||Degree of Renal Dysfunction (Cr)|Normal or Mild: =< 1.4 mg/dL (for male) or =< 1.2 mg/dL (for female), Moderate: >1.4 mg/dL to =< 2.4 mg/dL (for male) or >1.2 mg/dL to =< 2.0 mg/dL (for female), Severe: > 2.4 mg/dL (for male), > 2.0 mg/dL (for female). If the serum creatinine value (Cr) at the start of treatment was not listed, the severity was reported as “unknown.”|Participants|Count of Participants|430|430.0||||||
3763270|NCT01945216|3596059|B4|Severe||Degree of Renal Dysfunction (Cr)|Normal or Mild: =< 1.4 mg/dL (for male) or =< 1.2 mg/dL (for female), Moderate: >1.4 mg/dL to =< 2.4 mg/dL (for male) or >1.2 mg/dL to =< 2.0 mg/dL (for female), Severe: > 2.4 mg/dL (for male), > 2.0 mg/dL (for female). If the serum creatinine value (Cr) at the start of treatment was not listed, the severity was reported as “unknown.”|Participants|Count of Participants|55|55.0||||||
3763271|NCT01945216|3596060|B3|Severe||Degree of Renal Dysfunction (Cr)|Normal or Mild: =< 1.4 mg/dL (for male) or =< 1.2 mg/dL (for female), Moderate: >1.4 mg/dL to =< 2.4 mg/dL (for male) or >1.2 mg/dL to =< 2.0 mg/dL (for female), Severe: > 2.4 mg/dL (for male), > 2.0 mg/dL (for female). If the serum creatinine value (Cr) at the start of treatment was not listed, the severity was reported as “unknown.”|Participants|Count of Participants|15|15.0||||||
3763272|NCT01945216|3596061|B2|Severe||Degree of Renal Dysfunction (Cr)|Normal or Mild: =< 1.4 mg/dL (for male) or =< 1.2 mg/dL (for female), Moderate: >1.4 mg/dL to =< 2.4 mg/dL (for male) or >1.2 mg/dL to =< 2.0 mg/dL (for female), Severe: > 2.4 mg/dL (for male), > 2.0 mg/dL (for female). If the serum creatinine value (Cr) at the start of treatment was not listed, the severity was reported as “unknown.”|Participants|Count of Participants|19|19.0||||||
3763273|NCT01945216|3596062|B1|Severe||Degree of Renal Dysfunction (Cr)|Normal or Mild: =< 1.4 mg/dL (for male) or =< 1.2 mg/dL (for female), Moderate: >1.4 mg/dL to =< 2.4 mg/dL (for male) or >1.2 mg/dL to =< 2.0 mg/dL (for female), Severe: > 2.4 mg/dL (for male), > 2.0 mg/dL (for female). If the serum creatinine value (Cr) at the start of treatment was not listed, the severity was reported as “unknown.”|Participants|Count of Participants|21|21.0||||||
3763274|NCT01945216|3596059|B4|Moderate||Degree of Renal Dysfunction (Cr)|Normal or Mild: =< 1.4 mg/dL (for male) or =< 1.2 mg/dL (for female), Moderate: >1.4 mg/dL to =< 2.4 mg/dL (for male) or >1.2 mg/dL to =< 2.0 mg/dL (for female), Severe: > 2.4 mg/dL (for male), > 2.0 mg/dL (for female). If the serum creatinine value (Cr) at the start of treatment was not listed, the severity was reported as “unknown.”|Participants|Count of Participants|48|48.0||||||
3763275|NCT01945216|3596060|B3|Moderate||Degree of Renal Dysfunction (Cr)|Normal or Mild: =< 1.4 mg/dL (for male) or =< 1.2 mg/dL (for female), Moderate: >1.4 mg/dL to =< 2.4 mg/dL (for male) or >1.2 mg/dL to =< 2.0 mg/dL (for female), Severe: > 2.4 mg/dL (for male), > 2.0 mg/dL (for female). If the serum creatinine value (Cr) at the start of treatment was not listed, the severity was reported as “unknown.”|Participants|Count of Participants|17|17.0||||||
3763276|NCT01945216|3596061|B2|Moderate||Degree of Renal Dysfunction (Cr)|Normal or Mild: =< 1.4 mg/dL (for male) or =< 1.2 mg/dL (for female), Moderate: >1.4 mg/dL to =< 2.4 mg/dL (for male) or >1.2 mg/dL to =< 2.0 mg/dL (for female), Severe: > 2.4 mg/dL (for male), > 2.0 mg/dL (for female). If the serum creatinine value (Cr) at the start of treatment was not listed, the severity was reported as “unknown.”|Participants|Count of Participants|7|7.0||||||
3763277|NCT01945216|3596062|B1|Moderate||Degree of Renal Dysfunction (Cr)|Normal or Mild: =< 1.4 mg/dL (for male) or =< 1.2 mg/dL (for female), Moderate: >1.4 mg/dL to =< 2.4 mg/dL (for male) or >1.2 mg/dL to =< 2.0 mg/dL (for female), Severe: > 2.4 mg/dL (for male), > 2.0 mg/dL (for female). If the serum creatinine value (Cr) at the start of treatment was not listed, the severity was reported as “unknown.”|Participants|Count of Participants|24|24.0||||||
3763278|NCT01945216|3596059|B4|Normal or Mild||Degree of Renal Dysfunction (Cr)|Normal or Mild: =< 1.4 mg/dL (for male) or =< 1.2 mg/dL (for female), Moderate: >1.4 mg/dL to =< 2.4 mg/dL (for male) or >1.2 mg/dL to =< 2.0 mg/dL (for female), Severe: > 2.4 mg/dL (for male), > 2.0 mg/dL (for female). If the serum creatinine value (Cr) at the start of treatment was not listed, the severity was reported as “unknown.”|Participants|Count of Participants|2219|2219.0||||||
3763279|NCT01945216|3596060|B3|Normal or Mild||Degree of Renal Dysfunction (Cr)|Normal or Mild: =< 1.4 mg/dL (for male) or =< 1.2 mg/dL (for female), Moderate: >1.4 mg/dL to =< 2.4 mg/dL (for male) or >1.2 mg/dL to =< 2.0 mg/dL (for female), Severe: > 2.4 mg/dL (for male), > 2.0 mg/dL (for female). If the serum creatinine value (Cr) at the start of treatment was not listed, the severity was reported as “unknown.”|Participants|Count of Participants|664|664.0||||||
3763280|NCT01945216|3596061|B2|Normal or Mild||Degree of Renal Dysfunction (Cr)|Normal or Mild: =< 1.4 mg/dL (for male) or =< 1.2 mg/dL (for female), Moderate: >1.4 mg/dL to =< 2.4 mg/dL (for male) or >1.2 mg/dL to =< 2.0 mg/dL (for female), Severe: > 2.4 mg/dL (for male), > 2.0 mg/dL (for female). If the serum creatinine value (Cr) at the start of treatment was not listed, the severity was reported as “unknown.”|Participants|Count of Participants|466|466.0||||||
3763281|NCT01945216|3596062|B1|Normal or Mild||Degree of Renal Dysfunction (Cr)|Normal or Mild: =< 1.4 mg/dL (for male) or =< 1.2 mg/dL (for female), Moderate: >1.4 mg/dL to =< 2.4 mg/dL (for male) or >1.2 mg/dL to =< 2.0 mg/dL (for female), Severe: > 2.4 mg/dL (for male), > 2.0 mg/dL (for female). If the serum creatinine value (Cr) at the start of treatment was not listed, the severity was reported as “unknown.”|Participants|Count of Participants|1089|1089.0||||||
3763310|NCT01945216|3596059|B4|Unknown||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and higher grades of serum AST or ALT were adopted. Normal: <50 international units per liter (IU/L) Grade 1: >=50 to <100 IU/L Grade 2: >=100 to <500 IU/L Grade 3: >=500 IU/L|Participants|Count of Participants|902|902.0||||||
3763369|NCT01945216|3596062|B1|Had No Diabetic Complications||Diabetic Complications||Participants|Count of Participants|1406|1406.0||||||
3763282|NCT01945216|3596059|B4|Unknown||Degree of Renal Dysfunction (eGFR)|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was reported as “unknown.” Normal: >=90 milliliter per min (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2, Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2 eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female) where Cr is creatinine value.|Participants|Count of Participants|901|901.0||||||
3763283|NCT01945216|3596060|B3|Unknown||Degree of Renal Dysfunction (eGFR)|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was reported as “unknown.” Normal: >=90 milliliter per min (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2, Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2 eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female) where Cr is creatinine value.|Participants|Count of Participants|293|293.0||||||
3763284|NCT01945216|3596061|B2|Unknown||Degree of Renal Dysfunction (eGFR)|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was reported as “unknown.” Normal: >=90 milliliter per min (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2, Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2 eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female) where Cr is creatinine value.|Participants|Count of Participants|178|178.0||||||
3763285|NCT01945216|3596062|B1|Unknown||Degree of Renal Dysfunction (eGFR)|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was reported as “unknown.” Normal: >=90 milliliter per min (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2, Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2 eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female) where Cr is creatinine value.|Participants|Count of Participants|430|430.0||||||
3763286|NCT01945216|3596059|B4|Severe||Degree of Renal Dysfunction (eGFR)|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was reported as “unknown.” Normal: >=90 milliliter per min (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2, Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2 eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female) where Cr is creatinine value.|Participants|Count of Participants|75|75.0||||||
3763287|NCT01945216|3596060|B3|Severe||Degree of Renal Dysfunction (eGFR)|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was reported as “unknown.” Normal: >=90 milliliter per min (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2, Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2 eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female) where Cr is creatinine value.|Participants|Count of Participants|25|25.0||||||
3763288|NCT01945216|3596061|B2|Severe||Degree of Renal Dysfunction (eGFR)|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was reported as “unknown.” Normal: >=90 milliliter per min (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2, Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2 eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female) where Cr is creatinine value.|Participants|Count of Participants|22|22.0||||||
3763289|NCT01945216|3596062|B1|Severe||Degree of Renal Dysfunction (eGFR)|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was reported as “unknown.” Normal: >=90 milliliter per min (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2, Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2 eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female) where Cr is creatinine value.|Participants|Count of Participants|28|28.0||||||
3763290|NCT01945216|3596059|B4|Moderate||Degree of Renal Dysfunction (eGFR)|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was reported as “unknown.” Normal: >=90 milliliter per min (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2, Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2 eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female) where Cr is creatinine value.|Participants|Count of Participants|419|419.0||||||
3763291|NCT01945216|3596060|B3|Moderate||Degree of Renal Dysfunction (eGFR)|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was reported as “unknown.” Normal: >=90 milliliter per min (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2, Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2 eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female) where Cr is creatinine value.|Participants|Count of Participants|121|121.0||||||
3763292|NCT01945216|3596061|B2|Moderate||Degree of Renal Dysfunction (eGFR)|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was reported as “unknown.” Normal: >=90 milliliter per min (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2, Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2 eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female) where Cr is creatinine value.|Participants|Count of Participants|108|108.0||||||
3763293|NCT01945216|3596062|B1|Moderate||Degree of Renal Dysfunction (eGFR)|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was reported as “unknown.” Normal: >=90 milliliter per min (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2, Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2 eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female) where Cr is creatinine value.|Participants|Count of Participants|190|190.0||||||
3763294|NCT01945216|3596059|B4|Mild||Degree of Renal Dysfunction (eGFR)|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was reported as “unknown.” Normal: >=90 milliliter per min (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2, Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2 eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female) where Cr is creatinine value.|Participants|Count of Participants|1282|1282.0||||||
3763295|NCT01945216|3596060|B3|Mild||Degree of Renal Dysfunction (eGFR)|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was reported as “unknown.” Normal: >=90 milliliter per min (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2, Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2 eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female) where Cr is creatinine value.|Participants|Count of Participants|361|361.0||||||
3763296|NCT01945216|3596061|B2|Mild||Degree of Renal Dysfunction (eGFR)|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was reported as “unknown.” Normal: >=90 milliliter per min (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2, Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2 eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female) where Cr is creatinine value.|Participants|Count of Participants|254|254.0||||||
3763297|NCT01945216|3596062|B1|Mild||Degree of Renal Dysfunction (eGFR)|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was reported as “unknown.” Normal: >=90 milliliter per min (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2, Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2 eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female) where Cr is creatinine value.|Participants|Count of Participants|667|667.0||||||
3763298|NCT01945216|3596059|B4|Normal||Degree of Renal Dysfunction (eGFR)|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was reported as “unknown.” Normal: >=90 milliliter per min (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2, Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2 eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female) where Cr is creatinine value.|Participants|Count of Participants|546|546.0||||||
3763299|NCT01945216|3596060|B3|Normal||Degree of Renal Dysfunction (eGFR)|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was reported as “unknown.” Normal: >=90 milliliter per min (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2, Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2 eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female) where Cr is creatinine value.|Participants|Count of Participants|189|189.0||||||
3763300|NCT01945216|3596061|B2|Normal||Degree of Renal Dysfunction (eGFR)|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was reported as “unknown.” Normal: >=90 milliliter per min (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2, Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2 eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female) where Cr is creatinine value.|Participants|Count of Participants|108|108.0||||||
3763301|NCT01945216|3596062|B1|Normal||Degree of Renal Dysfunction (eGFR)|Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was reported as “unknown.” Normal: >=90 milliliter per min (mL/min)/1.73^2, Mild: >=60 mL/min/1.73^2 to <90 mL/min/1.73^2, Moderate: >=30 mL/min/1.73^2 to <60 mL/min/1.73^2, Severe: <30 mL/min/1.73^2 eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female) where Cr is creatinine value.|Participants|Count of Participants|249|249.0||||||
3763302|NCT01945216|3596059|B4|Had Renal Dysfunction Complications||Renal Dysfunction Complications||Participants|Count of Participants|367|367.0||||||
3763303|NCT01945216|3596060|B3|Had Renal Dysfunction Complications||Renal Dysfunction Complications||Participants|Count of Participants|128|128.0||||||
3763304|NCT01945216|3596061|B2|Had Renal Dysfunction Complications||Renal Dysfunction Complications||Participants|Count of Participants|106|106.0||||||
3763305|NCT01945216|3596062|B1|Had Renal Dysfunction Complications||Renal Dysfunction Complications||Participants|Count of Participants|133|133.0||||||
3763306|NCT01945216|3596059|B4|Had No Renal Dysfunction Complications||Renal Dysfunction Complications||Participants|Count of Participants|2856|2856.0||||||
3763307|NCT01945216|3596060|B3|Had No Renal Dysfunction Complications||Renal Dysfunction Complications||Participants|Count of Participants|861|861.0||||||
3763308|NCT01945216|3596061|B2|Had No Renal Dysfunction Complications||Renal Dysfunction Complications||Participants|Count of Participants|564|564.0||||||
3763309|NCT01945216|3596062|B1|Had No Renal Dysfunction Complications||Renal Dysfunction Complications||Participants|Count of Participants|1431|1431.0||||||
3763311|NCT01945216|3596060|B3|Unknown||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and higher grades of serum AST or ALT were adopted. Normal: <50 international units per liter (IU/L) Grade 1: >=50 to <100 IU/L Grade 2: >=100 to <500 IU/L Grade 3: >=500 IU/L|Participants|Count of Participants|287|287.0||||||
3763312|NCT01945216|3596061|B2|Unknown||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and higher grades of serum AST or ALT were adopted. Normal: <50 international units per liter (IU/L) Grade 1: >=50 to <100 IU/L Grade 2: >=100 to <500 IU/L Grade 3: >=500 IU/L|Participants|Count of Participants|181|181.0||||||
3763313|NCT01945216|3596062|B1|Unknown||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and higher grades of serum AST or ALT were adopted. Normal: <50 international units per liter (IU/L) Grade 1: >=50 to <100 IU/L Grade 2: >=100 to <500 IU/L Grade 3: >=500 IU/L|Participants|Count of Participants|434|434.0||||||
3763314|NCT01945216|3596059|B4|Grade 3||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and higher grades of serum AST or ALT were adopted. Normal: <50 international units per liter (IU/L) Grade 1: >=50 to <100 IU/L Grade 2: >=100 to <500 IU/L Grade 3: >=500 IU/L|Participants|Count of Participants|0|0.0||||||
3763315|NCT01945216|3596060|B3|Grade 3||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and higher grades of serum AST or ALT were adopted. Normal: <50 international units per liter (IU/L) Grade 1: >=50 to <100 IU/L Grade 2: >=100 to <500 IU/L Grade 3: >=500 IU/L|Participants|Count of Participants|0|0.0||||||
3763316|NCT01945216|3596061|B2|Grade 3||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and higher grades of serum AST or ALT were adopted. Normal: <50 international units per liter (IU/L) Grade 1: >=50 to <100 IU/L Grade 2: >=100 to <500 IU/L Grade 3: >=500 IU/L|Participants|Count of Participants|0|0.0||||||
3763317|NCT01945216|3596062|B1|Grade 3||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and higher grades of serum AST or ALT were adopted. Normal: <50 international units per liter (IU/L) Grade 1: >=50 to <100 IU/L Grade 2: >=100 to <500 IU/L Grade 3: >=500 IU/L|Participants|Count of Participants|0|0.0||||||
3763318|NCT01945216|3596059|B4|Grade 2||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and higher grades of serum AST or ALT were adopted. Normal: <50 international units per liter (IU/L) Grade 1: >=50 to <100 IU/L Grade 2: >=100 to <500 IU/L Grade 3: >=500 IU/L|Participants|Count of Participants|51|51.0||||||
3763319|NCT01945216|3596060|B3|Grade 2||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and higher grades of serum AST or ALT were adopted. Normal: <50 international units per liter (IU/L) Grade 1: >=50 to <100 IU/L Grade 2: >=100 to <500 IU/L Grade 3: >=500 IU/L|Participants|Count of Participants|19|19.0||||||
3763320|NCT01945216|3596061|B2|Grade 2||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and higher grades of serum AST or ALT were adopted. Normal: <50 international units per liter (IU/L) Grade 1: >=50 to <100 IU/L Grade 2: >=100 to <500 IU/L Grade 3: >=500 IU/L|Participants|Count of Participants|10|10.0||||||
3763321|NCT01945216|3596062|B1|Grade 2||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and higher grades of serum AST or ALT were adopted. Normal: <50 international units per liter (IU/L) Grade 1: >=50 to <100 IU/L Grade 2: >=100 to <500 IU/L Grade 3: >=500 IU/L|Participants|Count of Participants|22|22.0||||||
3763322|NCT01945216|3596059|B4|Grade 1||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and higher grades of serum AST or ALT were adopted. Normal: <50 international units per liter (IU/L) Grade 1: >=50 to <100 IU/L Grade 2: >=100 to <500 IU/L Grade 3: >=500 IU/L|Participants|Count of Participants|245|245.0||||||
3763323|NCT01945216|3596060|B3|Grade 1||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and higher grades of serum AST or ALT were adopted. Normal: <50 international units per liter (IU/L) Grade 1: >=50 to <100 IU/L Grade 2: >=100 to <500 IU/L Grade 3: >=500 IU/L|Participants|Count of Participants|87|87.0||||||
3763324|NCT01945216|3596061|B2|Grade 1||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and higher grades of serum AST or ALT were adopted. Normal: <50 international units per liter (IU/L) Grade 1: >=50 to <100 IU/L Grade 2: >=100 to <500 IU/L Grade 3: >=500 IU/L|Participants|Count of Participants|36|36.0||||||
3763325|NCT01945216|3596062|B1|Grade 1||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and higher grades of serum AST or ALT were adopted. Normal: <50 international units per liter (IU/L) Grade 1: >=50 to <100 IU/L Grade 2: >=100 to <500 IU/L Grade 3: >=500 IU/L|Participants|Count of Participants|122|122.0||||||
3763326|NCT01945216|3596059|B4|Normal||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and higher grades of serum AST or ALT were adopted. Normal: <50 international units per liter (IU/L) Grade 1: >=50 to <100 IU/L Grade 2: >=100 to <500 IU/L Grade 3: >=500 IU/L|Participants|Count of Participants|2025|2025.0||||||
3763327|NCT01945216|3596060|B3|Normal||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and higher grades of serum AST or ALT were adopted. Normal: <50 international units per liter (IU/L) Grade 1: >=50 to <100 IU/L Grade 2: >=100 to <500 IU/L Grade 3: >=500 IU/L|Participants|Count of Participants|596|596.0||||||
3763328|NCT01945216|3596061|B2|Normal||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and higher grades of serum AST or ALT were adopted. Normal: <50 international units per liter (IU/L) Grade 1: >=50 to <100 IU/L Grade 2: >=100 to <500 IU/L Grade 3: >=500 IU/L|Participants|Count of Participants|443|443.0||||||
3763329|NCT01945216|3596062|B1|Normal||Degree of Hepatic Dysfunction|Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and higher grades of serum AST or ALT were adopted. Normal: <50 international units per liter (IU/L) Grade 1: >=50 to <100 IU/L Grade 2: >=100 to <500 IU/L Grade 3: >=500 IU/L|Participants|Count of Participants|986|986.0||||||
3763330|NCT01945216|3596059|B4|Had Hepatic Dysfunction Complications||Hepatic Dysfunction Complications||Participants|Count of Participants|544|544.0||||||
3763331|NCT01945216|3596060|B3|Had Hepatic Dysfunction Complications||Hepatic Dysfunction Complications||Participants|Count of Participants|190|190.0||||||
3763332|NCT01945216|3596061|B2|Had Hepatic Dysfunction Complications||Hepatic Dysfunction Complications||Participants|Count of Participants|116|116.0||||||
3763333|NCT01945216|3596062|B1|Had Hepatic Dysfunction Complications||Hepatic Dysfunction Complications||Participants|Count of Participants|238|238.0||||||
3763334|NCT01945216|3596059|B4|Had No Hepatic Dysfunction Complications||Hepatic Dysfunction Complications||Participants|Count of Participants|2679|2679.0||||||
3763335|NCT01945216|3596060|B3|Had No Hepatic Dysfunction Complications||Hepatic Dysfunction Complications||Participants|Count of Participants|799|799.0||||||
3763336|NCT01945216|3596061|B2|Had No Hepatic Dysfunction Complications||Hepatic Dysfunction Complications||Participants|Count of Participants|554|554.0||||||
3763337|NCT01945216|3596062|B1|Had No Hepatic Dysfunction Complications||Hepatic Dysfunction Complications||Participants|Count of Participants|1326|1326.0||||||
3763338|NCT01945216|3596059|B4|Had Hyperuricemia Complications||Hyperuricemia Complications||Participants|Count of Participants|305|305.0||||||
3763339|NCT01945216|3596060|B3|Had Hyperuricemia Complications||Hyperuricemia Complications||Participants|Count of Participants|98|98.0||||||
3763340|NCT01945216|3596061|B2|Had Hyperuricemia Complications||Hyperuricemia Complications||Participants|Count of Participants|58|58.0||||||
3763341|NCT01945216|3596062|B1|Had Hyperuricemia Complications||Hyperuricemia Complications||Participants|Count of Participants|149|149.0||||||
3763342|NCT01945216|3596059|B4|Had No Hyperuricemia Complications||Hyperuricemia Complications||Participants|Count of Participants|2918|2918.0||||||
3763343|NCT01945216|3596060|B3|Had No Hyperuricemia Complications||Hyperuricemia Complications||Participants|Count of Participants|891|891.0||||||
3763344|NCT01945216|3596061|B2|Had No Hyperuricemia Complications||Hyperuricemia Complications||Participants|Count of Participants|612|612.0||||||
3763345|NCT01945216|3596062|B1|Had No Hyperuricemia Complications||Hyperuricemia Complications||Participants|Count of Participants|1415|1415.0||||||
3763346|NCT01945216|3596059|B4|Had Hyperlipidemia Complications||Hyperlipidemia Complications||Participants|Count of Participants|1882|1882.0||||||
3763347|NCT01945216|3596060|B3|Had Hyperlipidemia Complications||Hyperlipidemia Complications||Participants|Count of Participants|614|614.0||||||
3763348|NCT01945216|3596061|B2|Had Hyperlipidemia Complications||Hyperlipidemia Complications||Participants|Count of Participants|423|423.0||||||
3763349|NCT01945216|3596062|B1|Had Hyperlipidemia Complications||Hyperlipidemia Complications||Participants|Count of Participants|845|845.0||||||
3763350|NCT01945216|3596059|B4|Had No Hyperlipidemia Complications||Hyperlipidemia Complications||Participants|Count of Participants|1341|1341.0||||||
3763351|NCT01945216|3596060|B3|Had No Hyperlipidemia Complications||Hyperlipidemia Complications||Participants|Count of Participants|375|375.0||||||
3763352|NCT01945216|3596061|B2|Had No Hyperlipidemia Complications||Hyperlipidemia Complications||Participants|Count of Participants|247|247.0||||||
3763353|NCT01945216|3596062|B1|Had No Hyperlipidemia Complications||Hyperlipidemia Complications||Participants|Count of Participants|719|719.0||||||
3763354|NCT01945216|3596059|B4|Had Hypertension Complications||Hypertension Complications||Participants|Count of Participants|1912|1912.0||||||
3763355|NCT01945216|3596060|B3|Had Hypertension Complications||Hypertension Complications||Participants|Count of Participants|606|606.0||||||
3763356|NCT01945216|3596061|B2|Had Hypertension Complications||Hypertension Complications||Participants|Count of Participants|421|421.0||||||
3763357|NCT01945216|3596062|B1|Had Hypertension Complications||Hypertension Complications||Participants|Count of Participants|885|885.0||||||
3763358|NCT01945216|3596059|B4|Had No Hypertension Complications||Hypertension Complications||Participants|Count of Participants|1311|1311.0||||||
3763359|NCT01945216|3596060|B3|Had No Hypertension Complications||Hypertension Complications||Participants|Count of Participants|383|383.0||||||
3763360|NCT01945216|3596061|B2|Had No Hypertension Complications||Hypertension Complications||Participants|Count of Participants|249|249.0||||||
3763361|NCT01945216|3596062|B1|Had No Hypertension Complications||Hypertension Complications||Participants|Count of Participants|679|679.0||||||
3763362|NCT01945216|3596059|B4|Had Diabetic Complications||Diabetic Complications||Participants|Count of Participants|479|479.0||||||
3763363|NCT01945216|3596060|B3|Had Diabetic Complications||Diabetic Complications||Participants|Count of Participants|158|158.0||||||
3763370|NCT01945216|3596059|B4|Had Complications||Complications|Complications defined as a disease or a health condition for each participant at the start of study. Complications were classified as congenital anomalies, endocrine disorders, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, gastrointestinal (GI) disorders, renal disease and other complications. Other complications included all complications except for those mentioned above.|Participants|Count of Participants|2742|2742.0||||||
3763371|NCT01945216|3596060|B3|Had Complications||Complications|Complications defined as a disease or a health condition for each participant at the start of study. Complications were classified as congenital anomalies, endocrine disorders, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, gastrointestinal (GI) disorders, renal disease and other complications. Other complications included all complications except for those mentioned above.|Participants|Count of Participants|886|886.0||||||
3763372|NCT01945216|3596061|B2|Had Complications||Complications|Complications defined as a disease or a health condition for each participant at the start of study. Complications were classified as congenital anomalies, endocrine disorders, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, gastrointestinal (GI) disorders, renal disease and other complications. Other complications included all complications except for those mentioned above.|Participants|Count of Participants|609|609.0||||||
3763373|NCT01945216|3596062|B1|Had Complications||Complications|Complications defined as a disease or a health condition for each participant at the start of study. Complications were classified as congenital anomalies, endocrine disorders, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, gastrointestinal (GI) disorders, renal disease and other complications. Other complications included all complications except for those mentioned above.|Participants|Count of Participants|1247|1247.0||||||
3763374|NCT01945216|3596059|B4|Had No Complications||Complications|Complications defined as a disease or a health condition for each participant at the start of study. Complications were classified as congenital anomalies, endocrine disorders, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, gastrointestinal (GI) disorders, renal disease and other complications. Other complications included all complications except for those mentioned above.|Participants|Count of Participants|481|481.0||||||
3763375|NCT01945216|3596060|B3|Had No Complications||Complications|Complications defined as a disease or a health condition for each participant at the start of study. Complications were classified as congenital anomalies, endocrine disorders, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, gastrointestinal (GI) disorders, renal disease and other complications. Other complications included all complications except for those mentioned above.|Participants|Count of Participants|103|103.0||||||
3763376|NCT01945216|3596061|B2|Had No Complications||Complications|Complications defined as a disease or a health condition for each participant at the start of study. Complications were classified as congenital anomalies, endocrine disorders, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, gastrointestinal (GI) disorders, renal disease and other complications. Other complications included all complications except for those mentioned above.|Participants|Count of Participants|61|61.0||||||
3763377|NCT01945216|3596062|B1|Had No Complications||Complications|Complications defined as a disease or a health condition for each participant at the start of study. Complications were classified as congenital anomalies, endocrine disorders, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, gastrointestinal (GI) disorders, renal disease and other complications. Other complications included all complications except for those mentioned above.|Participants|Count of Participants|317|317.0||||||
3763378|NCT01945216|3596059|B4|Unknown||History of Allergy||Participants|Count of Participants|114|114.0||||||
3763379|NCT01945216|3596060|B3|Unknown||History of Allergy||Participants|Count of Participants|29|29.0||||||
3763380|NCT01945216|3596061|B2|Unknown||History of Allergy||Participants|Count of Participants|29|29.0||||||
3763381|NCT01945216|3596062|B1|Unknown||History of Allergy||Participants|Count of Participants|56|56.0||||||
3763382|NCT01945216|3596059|B4|Had history of Allergy||History of Allergy||Participants|Count of Participants|288|288.0||||||
3763383|NCT01945216|3596060|B3|Had history of Allergy||History of Allergy||Participants|Count of Participants|104|104.0||||||
3763384|NCT01945216|3596061|B2|Had history of Allergy||History of Allergy||Participants|Count of Participants|57|57.0||||||
3763385|NCT01945216|3596062|B1|Had history of Allergy||History of Allergy||Participants|Count of Participants|127|127.0||||||
3763386|NCT01945216|3596059|B4|Had no history of Allergy||History of Allergy||Participants|Count of Participants|2821|2821.0||||||
3763387|NCT01945216|3596060|B3|Had no history of Allergy||History of Allergy||Participants|Count of Participants|856|856.0||||||
3763388|NCT01945216|3596061|B2|Had no history of Allergy||History of Allergy||Participants|Count of Participants|584|584.0||||||
3763389|NCT01945216|3596062|B1|Had no history of Allergy||History of Allergy||Participants|Count of Participants|1381|1381.0||||||
3763390|NCT01945216|3596059|B4||Pregnant|Pregnancy Status||Participants|Count of Participants|0|0.0||||||
3763391|NCT01945216|3596060|B3||Pregnant|Pregnancy Status||Participants|Count of Participants|0|0.0||||||
3763392|NCT01945216|3596061|B2||Pregnant|Pregnancy Status||Participants|Count of Participants|0|0.0||||||
3763393|NCT01945216|3596062|B1||Pregnant|Pregnancy Status||Participants|Count of Participants|0|0.0||||||
3763394|NCT01945216|3596059|B4||Not pregnant|Pregnancy Status||Participants|Count of Participants|1367|1367.0||||||
3763395|NCT01945216|3596060|B3||Not pregnant|Pregnancy Status||Participants|Count of Participants|438|438.0||||||
3763396|NCT01945216|3596061|B2||Not pregnant|Pregnancy Status||Participants|Count of Participants|286|286.0||||||
3763397|NCT01945216|3596062|B1||Not pregnant|Pregnancy Status||Participants|Count of Participants|643|643.0||||||
3763398|NCT01945216|3596059|B4|In- to/from out-patient||Healthcare category|Participants were categorized as outpatient, inpatient, and In- to/from out-patient (participants who were both outpatient and inpatient at any time prior to enrollment).|Participants|Count of Participants|90|90.0||||||
3763441|NCT01945216|3596062|B1|||Body Weight||kg|Mean|64.45|64.45|Standard Deviation|13.723|13.723|||
3763399|NCT01945216|3596060|B3|In- to/from out-patient||Healthcare category|Participants were categorized as outpatient, inpatient, and In- to/from out-patient (participants who were both outpatient and inpatient at any time prior to enrollment).|Participants|Count of Participants|36|36.0||||||
3763400|NCT01945216|3596061|B2|In- to/from out-patient||Healthcare category|Participants were categorized as outpatient, inpatient, and In- to/from out-patient (participants who were both outpatient and inpatient at any time prior to enrollment).|Participants|Count of Participants|21|21.0||||||
3763401|NCT01945216|3596062|B1|In- to/from out-patient||Healthcare category|Participants were categorized as outpatient, inpatient, and In- to/from out-patient (participants who were both outpatient and inpatient at any time prior to enrollment).|Participants|Count of Participants|33|33.0||||||
3763402|NCT01945216|3596059|B4|In-patient||Healthcare category|Participants were categorized as outpatient, inpatient, and In- to/from out-patient (participants who were both outpatient and inpatient at any time prior to enrollment).|Participants|Count of Participants|22|22.0||||||
3763403|NCT01945216|3596060|B3|In-patient||Healthcare category|Participants were categorized as outpatient, inpatient, and In- to/from out-patient (participants who were both outpatient and inpatient at any time prior to enrollment).|Participants|Count of Participants|11|11.0||||||
3763404|NCT01945216|3596061|B2|In-patient||Healthcare category|Participants were categorized as outpatient, inpatient, and In- to/from out-patient (participants who were both outpatient and inpatient at any time prior to enrollment).|Participants|Count of Participants|8|8.0||||||
3763405|NCT01945216|3596062|B1|In-patient||Healthcare category|Participants were categorized as outpatient, inpatient, and In- to/from out-patient (participants who were both outpatient and inpatient at any time prior to enrollment).|Participants|Count of Participants|3|3.0||||||
3763406|NCT01945216|3596059|B4|Out-patient||Healthcare category|Participants were categorized as outpatient, inpatient, and In- to/from out-patient (participants who were both outpatient and inpatient at any time prior to enrollment).|Participants|Count of Participants|3111|3111.0||||||
3763407|NCT01945216|3596060|B3|Out-patient||Healthcare category|Participants were categorized as outpatient, inpatient, and In- to/from out-patient (participants who were both outpatient and inpatient at any time prior to enrollment).|Participants|Count of Participants|942|942.0||||||
3763408|NCT01945216|3596061|B2|Out-patient||Healthcare category|Participants were categorized as outpatient, inpatient, and In- to/from out-patient (participants who were both outpatient and inpatient at any time prior to enrollment).|Participants|Count of Participants|641|641.0||||||
3763409|NCT01945216|3596062|B1|Out-patient||Healthcare category|Participants were categorized as outpatient, inpatient, and In- to/from out-patient (participants who were both outpatient and inpatient at any time prior to enrollment).|Participants|Count of Participants|1528|1528.0||||||
3763410|NCT01945216|3596059|B4||Unknown|Waist Circumference (Female)||Participants|Count of Participants|906|906.0||||||
3763411|NCT01945216|3596060|B3||Unknown|Waist Circumference (Female)||Participants|Count of Participants|301|301.0||||||
3763412|NCT01945216|3596061|B2||Unknown|Waist Circumference (Female)||Participants|Count of Participants|184|184.0||||||
3763413|NCT01945216|3596062|B1||Unknown|Waist Circumference (Female)||Participants|Count of Participants|421|421.0||||||
3763414|NCT01945216|3596059|B4||≥ 90cm|Waist Circumference (Female)||Participants|Count of Participants|159|159.0||||||
3763415|NCT01945216|3596060|B3||≥ 90cm|Waist Circumference (Female)||Participants|Count of Participants|52|52.0||||||
3763416|NCT01945216|3596061|B2||≥ 90cm|Waist Circumference (Female)||Participants|Count of Participants|37|37.0||||||
3763417|NCT01945216|3596062|B1||≥ 90cm|Waist Circumference (Female)||Participants|Count of Participants|70|70.0||||||
3763418|NCT01945216|3596059|B4||< 90cm|Waist Circumference (Female)||Participants|Count of Participants|302|302.0||||||
3763419|NCT01945216|3596060|B3||< 90cm|Waist Circumference (Female)||Participants|Count of Participants|85|85.0||||||
3763420|NCT01945216|3596061|B2||< 90cm|Waist Circumference (Female)||Participants|Count of Participants|65|65.0||||||
3763421|NCT01945216|3596062|B1||< 90cm|Waist Circumference (Female)||Participants|Count of Participants|152|152.0||||||
3763422|NCT01945216|3596059|B4||Unknown|Waist Circumference (Male)||Participants|Count of Participants|1233|1233.0||||||
3763423|NCT01945216|3596060|B3||Unknown|Waist Circumference (Male)||Participants|Count of Participants|370|370.0||||||
3763424|NCT01945216|3596061|B2||Unknown|Waist Circumference (Male)||Participants|Count of Participants|249|249.0||||||
3763425|NCT01945216|3596062|B1||Unknown|Waist Circumference (Male)||Participants|Count of Participants|614|614.0||||||
3763426|NCT01945216|3596059|B4||≥ 85cm|Waist Circumference (Male)||Participants|Count of Participants|411|411.0||||||
3763427|NCT01945216|3596060|B3||≥ 85cm|Waist Circumference (Male)||Participants|Count of Participants|120|120.0||||||
3763428|NCT01945216|3596061|B2||≥ 85cm|Waist Circumference (Male)||Participants|Count of Participants|80|80.0||||||
3763429|NCT01945216|3596062|B1||≥ 85cm|Waist Circumference (Male)||Participants|Count of Participants|211|211.0||||||
3763430|NCT01945216|3596059|B4||< 85cm|Waist Circumference (Male)||Participants|Count of Participants|212|212.0||||||
3763431|NCT01945216|3596060|B3||< 85cm|Waist Circumference (Male)||Participants|Count of Participants|61|61.0||||||
3763432|NCT01945216|3596061|B2||< 85cm|Waist Circumference (Male)||Participants|Count of Participants|55|55.0||||||
3763433|NCT01945216|3596062|B1||< 85cm|Waist Circumference (Male)||Participants|Count of Participants|96|96.0||||||
3763434|NCT01945216|3596059|B4|||BMI|Body Mass Index = weight (kg)/[height (m)^2]|kg/m^2|Mean|24.91|24.91|Standard Deviation|4.228|4.228|||
3763435|NCT01945216|3596060|B3|||BMI|Body Mass Index = weight (kg)/[height (m)^2]|kg/m^2|Mean|25.04|25.04|Standard Deviation|4.190|4.19|||
3763436|NCT01945216|3596061|B2|||BMI|Body Mass Index = weight (kg)/[height (m)^2]|kg/m^2|Mean|24.52|24.52|Standard Deviation|4.277|4.277|||
3763437|NCT01945216|3596062|B1|||BMI|Body Mass Index = weight (kg)/[height (m)^2]|kg/m^2|Mean|24.99|24.99|Standard Deviation|4.223|4.223|||
3763438|NCT01945216|3596059|B4|||Body Weight||kg|Mean|64.10|64.1|Standard Deviation|13.691|13.691|||
3763439|NCT01945216|3596060|B3|||Body Weight||kg|Mean|64.51|64.51|Standard Deviation|14.046|14.046|||
3763440|NCT01945216|3596061|B2|||Body Weight||kg|Mean|62.67|62.67|Standard Deviation|13.000|13.0|||
3763446|NCT01945216|3596059|B4|||Time From Diagnosis of Type 2 Diabetes||years|Mean|4.91|4.91|Standard Deviation|5.937|5.937|||
3763447|NCT01945216|3596060|B3|||Time From Diagnosis of Type 2 Diabetes||years|Mean|5.03|5.03|Standard Deviation|5.732|5.732|||
3763448|NCT01945216|3596061|B2|||Time From Diagnosis of Type 2 Diabetes||years|Mean|8.10|8.1|Standard Deviation|7.018|7.018|||
3763449|NCT01945216|3596062|B1|||Time From Diagnosis of Type 2 Diabetes||years|Mean|3.45|3.45|Standard Deviation|4.923|4.923|||
3763450|NCT01945216|3596059|B4|Japan||Region of Enrollment|All participants were enrolled in Japan.|Participants|Number|3223|3223.0||||||
3763451|NCT01945216|3596060|B3|Japan||Region of Enrollment|All participants were enrolled in Japan.|Participants|Number|989|989.0||||||
3763452|NCT01945216|3596061|B2|Japan||Region of Enrollment|All participants were enrolled in Japan.|Participants|Number|670|670.0||||||
3763453|NCT01945216|3596062|B1|Japan||Region of Enrollment|All participants were enrolled in Japan.|Participants|Number|1564|1564.0||||||
3763454|NCT01945216|3596059|B4||Male|Sex: Female, Male||Participants|Count of Participants|1856|1856.0||||||
3763455|NCT01945216|3596060|B3||Male|Sex: Female, Male||Participants|Count of Participants|551|551.0||||||
3763456|NCT01945216|3596061|B2||Male|Sex: Female, Male||Participants|Count of Participants|384|384.0||||||
3763457|NCT01945216|3596062|B1||Male|Sex: Female, Male||Participants|Count of Participants|921|921.0||||||
3763458|NCT01945216|3596059|B4||Female|Sex: Female, Male||Participants|Count of Participants|1367|1367.0||||||
3763459|NCT01945216|3596060|B3||Female|Sex: Female, Male||Participants|Count of Participants|438|438.0||||||
3763460|NCT01945216|3596061|B2||Female|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
3763461|NCT01945216|3596062|B1||Female|Sex: Female, Male||Participants|Count of Participants|643|643.0||||||
3763462|NCT01945216|3596059|B4|||Age||years|Mean|65.1|65.1|Standard Deviation|12.39|12.39|||
3763463|NCT01945216|3596060|B3|||Age||years|Mean|64.0|64.0|Standard Deviation|12.57|12.57|||
3763464|NCT01945216|3596061|B2|||Age||years|Mean|67.2|67.2|Standard Deviation|12.12|12.12|||
3763465|NCT01945216|3596062|B1|||Age||years|Mean|65.0|65.0|Standard Deviation|12.28|12.28|||
3763466|NCT01945138|3596074|B3|Idiopathic Pancreatitis||Etiology of Chronic Pancreatitis (CP)||participants|Number|3|3.0||||||
3763467|NCT01945138|3596075|B2|Idiopathic Pancreatitis||Etiology of Chronic Pancreatitis (CP)||participants|Number|1|1.0||||||
3763468|NCT01945138|3596076|B1|Idiopathic Pancreatitis||Etiology of Chronic Pancreatitis (CP)||participants|Number|2|2.0||||||
3763469|NCT01945138|3596074|B3|Mechanical Dysfunction||Etiology of Chronic Pancreatitis (CP)||participants|Number|7|7.0||||||
3763470|NCT01945138|3596075|B2|Mechanical Dysfunction||Etiology of Chronic Pancreatitis (CP)||participants|Number|3|3.0||||||
3763471|NCT01945138|3596076|B1|Mechanical Dysfunction||Etiology of Chronic Pancreatitis (CP)||participants|Number|4|4.0||||||
3763472|NCT01945138|3596074|B3|Identified Genetic Mutation (PRSS1, SPINK1, CFTR)||Etiology of Chronic Pancreatitis (CP)||participants|Number|4|4.0||||||
3763473|NCT01945138|3596075|B2|Identified Genetic Mutation (PRSS1, SPINK1, CFTR)||Etiology of Chronic Pancreatitis (CP)||participants|Number|3|3.0||||||
3763474|NCT01945138|3596076|B1|Identified Genetic Mutation (PRSS1, SPINK1, CFTR)||Etiology of Chronic Pancreatitis (CP)||participants|Number|1|1.0||||||
3763475|NCT01945138|3596074|B3|||Days on drip||days|Mean|6.0|6.0|Standard Deviation|1.4|1.4|||
3763476|NCT01945138|3596075|B2|||Days on drip||days|Mean|5.1|5.1|Standard Deviation|1.1|1.1|||
3763477|NCT01945138|3596076|B1|||Days on drip||days|Mean|6.9|6.9|Standard Deviation|1.1|1.1|||
3763478|NCT01945138|3596074|B3|||Islet Yield||IEq/kg|Mean|5432|5432.0|Standard Deviation|2983|2983.0|||
3763479|NCT01945138|3596075|B2|||Islet Yield||IEq/kg|Mean|6619|6619.0|Standard Deviation|3357|3357.0|||
3763480|NCT01945138|3596076|B1|||Islet Yield||IEq/kg|Mean|4245|4245.0|Standard Deviation|2174|2174.0|||
3763481|NCT01945138|3596074|B3|||Peak Mixed Meal Tolerance Test (MMTT) C-peptide||ng/mL|Mean|6.1|6.1|Standard Deviation|3.4|3.4|||
3763482|NCT01945138|3596075|B2|||Peak Mixed Meal Tolerance Test (MMTT) C-peptide||ng/mL|Mean|6.4|6.4|Standard Deviation|2.2|2.2|||
3763483|NCT01945138|3596076|B1|||Peak Mixed Meal Tolerance Test (MMTT) C-peptide||ng/mL|Mean|5.8|5.8|Standard Deviation|4.4|4.4|||
3763484|NCT01945138|3596074|B3|||Fasting C-Peptide||ng/mL|Mean|92|92.0|Standard Deviation|10.3|10.3|||
3763485|NCT01945138|3596075|B2|||Fasting C-Peptide||ng/mL|Mean|89|89.0|Standard Deviation|6|6.0|||
3763486|NCT01945138|3596076|B1|||Fasting C-Peptide||ng/mL|Mean|95|95.0|Standard Deviation|13|13.0|||
3763487|NCT01945138|3596074|B3|||Fasting Blood Glucose (BG)||mg/dL|Mean|92|92.0|Standard Deviation|10.3|10.3|||
3763488|NCT01945138|3596075|B2|||Fasting Blood Glucose (BG)||mg/dL|Mean|89|89.0|Standard Deviation|6|6.0|||
3763489|NCT01945138|3596076|B1|||Fasting Blood Glucose (BG)||mg/dL|Mean|95|95.0|Standard Deviation|13|13.0|||
3763490|NCT01945138|3596074|B3|||hemoglobin A1c (A1c)||%|Mean|5.3|5.3|Standard Deviation|0.4|0.4|||
3763491|NCT01945138|3596075|B2|||hemoglobin A1c (A1c)||%|Mean|5.1|5.1|Standard Deviation|0.2|0.2|||
3763492|NCT01945138|3596076|B1|||hemoglobin A1c (A1c)||%|Mean|5.4|5.4|Standard Deviation|0.5|0.5|||
3763493|NCT01945138|3596074|B3|||Body Mass Index (BMI) at Transplant||kg/m2|Mean|25.1|25.1|Standard Deviation|4.9|4.9|||
3763494|NCT01945138|3596075|B2|||Body Mass Index (BMI) at Transplant||kg/m2|Mean|25.3|25.3|Standard Deviation|4.5|4.5|||
3763495|NCT01945138|3596076|B1|||Body Mass Index (BMI) at Transplant||kg/m2|Mean|24.9|24.9|Standard Deviation|5.7|5.7|||
3763496|NCT01945138|3596074|B3|||Weight at Transplant||kg|Mean|71.4|71.4|Standard Deviation|18.4|18.4|||
3763497|NCT01945138|3596075|B2|||Weight at Transplant||kg|Mean|66.1|66.1|Standard Deviation|10.3|10.3|||
3763498|NCT01945138|3596076|B1|||Weight at Transplant||kg|Mean|76.7|76.7|Standard Deviation|23.7|23.7|||
3763499|NCT01945138|3596074|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3763500|NCT01945138|3596075|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3763501|NCT01945138|3596076|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3763503|NCT01945138|3596075|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3763504|NCT01945138|3596076|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3763505|NCT01945138|3596074|B3|||Age||years|Mean|35.9|35.9|Standard Deviation|11.4|11.4|||
3763506|NCT01945138|3596075|B2|||Age||years|Mean|38.6|38.6|Standard Deviation|9.4|9.4|||
3763507|NCT01945138|3596076|B1|||Age||years|Mean|33.1|33.1|Standard Deviation|13.3|13.3|||
3763508|NCT01945112|3596111|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3763509|NCT01945112|3596111|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3763510|NCT01945112|3596111|B1|||Age||years|Mean|39.3|39.3|Full Range|||22.0|63.0|
3763511|NCT01945086|3596117|B4||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3763512|NCT01945086|3596118|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3763513|NCT01945086|3596119|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3763514|NCT01945086|3596120|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3763515|NCT01945086|3596117|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3763516|NCT01945086|3596118|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3763517|NCT01945086|3596119|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3763518|NCT01945086|3596120|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3763519|NCT01945086|3596117|B4|||Age||years|Mean|34.2|34.2|Standard Deviation|9.39|9.39|||
3763520|NCT01945086|3596118|B3|||Age||years|Mean|33.0|33.0|Standard Deviation|8.85|8.85|||
3763521|NCT01945086|3596119|B2|||Age||years|Mean|37.5|37.5|Standard Deviation|8.77|8.77|||
3763522|NCT01945086|3596120|B1|||Age||years|Mean|32.6|32.6|Standard Deviation|10.05|10.05|||
3763523|NCT01945034|3596163|B4|Severe restrict walking(5)||Baseline Participant Assessment of Normal Function/Activity|Participants were asked the following question: “How does your ankle injury affect your walking and normal activity?” The participant’s response was recorded using a 5-point scale: 1=Normal activity and no pain; 2=Normal activity with pain; 3=Mildly restricted walking due to pain and can’t resume normal activities; 4=Moderately restricted walking due to pain and can’t resume normal activities; 5=Severely restricted walking due to pain and can’t resume normal activities. The score ranges from 1-5, with higher scores indicates restricted activity.|participants|Number|43|43.0||||||
3763524|NCT01945034|3596164|B3|Severe restrict walking(5)||Baseline Participant Assessment of Normal Function/Activity|Participants were asked the following question: “How does your ankle injury affect your walking and normal activity?” The participant’s response was recorded using a 5-point scale: 1=Normal activity and no pain; 2=Normal activity with pain; 3=Mildly restricted walking due to pain and can’t resume normal activities; 4=Moderately restricted walking due to pain and can’t resume normal activities; 5=Severely restricted walking due to pain and can’t resume normal activities. The score ranges from 1-5, with higher scores indicates restricted activity.|participants|Number|26|26.0||||||
3763525|NCT01945034|3596165|B2|Severe restrict walking(5)||Baseline Participant Assessment of Normal Function/Activity|Participants were asked the following question: “How does your ankle injury affect your walking and normal activity?” The participant’s response was recorded using a 5-point scale: 1=Normal activity and no pain; 2=Normal activity with pain; 3=Mildly restricted walking due to pain and can’t resume normal activities; 4=Moderately restricted walking due to pain and can’t resume normal activities; 5=Severely restricted walking due to pain and can’t resume normal activities. The score ranges from 1-5, with higher scores indicates restricted activity.|participants|Number|10|10.0||||||
3763526|NCT01945034|3596166|B1|Severe restrict walking(5)||Baseline Participant Assessment of Normal Function/Activity|Participants were asked the following question: “How does your ankle injury affect your walking and normal activity?” The participant’s response was recorded using a 5-point scale: 1=Normal activity and no pain; 2=Normal activity with pain; 3=Mildly restricted walking due to pain and can’t resume normal activities; 4=Moderately restricted walking due to pain and can’t resume normal activities; 5=Severely restricted walking due to pain and can’t resume normal activities. The score ranges from 1-5, with higher scores indicates restricted activity.|participants|Number|7|7.0||||||
3763527|NCT01945034|3596163|B4|Moderate restrict walking(4)||Baseline Participant Assessment of Normal Function/Activity|Participants were asked the following question: “How does your ankle injury affect your walking and normal activity?” The participant’s response was recorded using a 5-point scale: 1=Normal activity and no pain; 2=Normal activity with pain; 3=Mildly restricted walking due to pain and can’t resume normal activities; 4=Moderately restricted walking due to pain and can’t resume normal activities; 5=Severely restricted walking due to pain and can’t resume normal activities. The score ranges from 1-5, with higher scores indicates restricted activity.|participants|Number|179|179.0||||||
3763528|NCT01945034|3596164|B3|Moderate restrict walking(4)||Baseline Participant Assessment of Normal Function/Activity|Participants were asked the following question: “How does your ankle injury affect your walking and normal activity?” The participant’s response was recorded using a 5-point scale: 1=Normal activity and no pain; 2=Normal activity with pain; 3=Mildly restricted walking due to pain and can’t resume normal activities; 4=Moderately restricted walking due to pain and can’t resume normal activities; 5=Severely restricted walking due to pain and can’t resume normal activities. The score ranges from 1-5, with higher scores indicates restricted activity.|participants|Number|91|91.0||||||
3763529|NCT01945034|3596165|B2|Moderate restrict walking(4)||Baseline Participant Assessment of Normal Function/Activity|Participants were asked the following question: “How does your ankle injury affect your walking and normal activity?” The participant’s response was recorded using a 5-point scale: 1=Normal activity and no pain; 2=Normal activity with pain; 3=Mildly restricted walking due to pain and can’t resume normal activities; 4=Moderately restricted walking due to pain and can’t resume normal activities; 5=Severely restricted walking due to pain and can’t resume normal activities. The score ranges from 1-5, with higher scores indicates restricted activity.|participants|Number|45|45.0||||||
3763611|NCT01945034|3596163|B4|||Age||years|Mean|33.3|33.3|Standard Deviation|14.43|14.43|||
3763612|NCT01945034|3596164|B3|||Age||years|Mean|33.0|33.0|Standard Deviation|13.90|13.9|||
3763530|NCT01945034|3596166|B1|Moderate restrict walking(4)||Baseline Participant Assessment of Normal Function/Activity|Participants were asked the following question: “How does your ankle injury affect your walking and normal activity?” The participant’s response was recorded using a 5-point scale: 1=Normal activity and no pain; 2=Normal activity with pain; 3=Mildly restricted walking due to pain and can’t resume normal activities; 4=Moderately restricted walking due to pain and can’t resume normal activities; 5=Severely restricted walking due to pain and can’t resume normal activities. The score ranges from 1-5, with higher scores indicates restricted activity.|participants|Number|43|43.0||||||
3763531|NCT01945034|3596163|B4|Mild restrict walking(3)||Baseline Participant Assessment of Normal Function/Activity|Participants were asked the following question: “How does your ankle injury affect your walking and normal activity?” The participant’s response was recorded using a 5-point scale: 1=Normal activity and no pain; 2=Normal activity with pain; 3=Mildly restricted walking due to pain and can’t resume normal activities; 4=Moderately restricted walking due to pain and can’t resume normal activities; 5=Severely restricted walking due to pain and can’t resume normal activities. The score ranges from 1-5, with higher scores indicates restricted activity.|participants|Number|68|68.0||||||
3763532|NCT01945034|3596164|B3|Mild restrict walking(3)||Baseline Participant Assessment of Normal Function/Activity|Participants were asked the following question: “How does your ankle injury affect your walking and normal activity?” The participant’s response was recorded using a 5-point scale: 1=Normal activity and no pain; 2=Normal activity with pain; 3=Mildly restricted walking due to pain and can’t resume normal activities; 4=Moderately restricted walking due to pain and can’t resume normal activities; 5=Severely restricted walking due to pain and can’t resume normal activities. The score ranges from 1-5, with higher scores indicates restricted activity.|participants|Number|26|26.0||||||
3763533|NCT01945034|3596165|B2|Mild restrict walking(3)||Baseline Participant Assessment of Normal Function/Activity|Participants were asked the following question: “How does your ankle injury affect your walking and normal activity?” The participant’s response was recorded using a 5-point scale: 1=Normal activity and no pain; 2=Normal activity with pain; 3=Mildly restricted walking due to pain and can’t resume normal activities; 4=Moderately restricted walking due to pain and can’t resume normal activities; 5=Severely restricted walking due to pain and can’t resume normal activities. The score ranges from 1-5, with higher scores indicates restricted activity.|participants|Number|26|26.0||||||
3763534|NCT01945034|3596166|B1|Mild restrict walking(3)||Baseline Participant Assessment of Normal Function/Activity|Participants were asked the following question: “How does your ankle injury affect your walking and normal activity?” The participant’s response was recorded using a 5-point scale: 1=Normal activity and no pain; 2=Normal activity with pain; 3=Mildly restricted walking due to pain and can’t resume normal activities; 4=Moderately restricted walking due to pain and can’t resume normal activities; 5=Severely restricted walking due to pain and can’t resume normal activities. The score ranges from 1-5, with higher scores indicates restricted activity.|participants|Number|16|16.0||||||
3763535|NCT01945034|3596163|B4|Normal walking/activity with pain(2)||Baseline Participant Assessment of Normal Function/Activity|Participants were asked the following question: “How does your ankle injury affect your walking and normal activity?” The participant’s response was recorded using a 5-point scale: 1=Normal activity and no pain; 2=Normal activity with pain; 3=Mildly restricted walking due to pain and can’t resume normal activities; 4=Moderately restricted walking due to pain and can’t resume normal activities; 5=Severely restricted walking due to pain and can’t resume normal activities. The score ranges from 1-5, with higher scores indicates restricted activity.|participants|Number|14|14.0||||||
3763536|NCT01945034|3596164|B3|Normal walking/activity with pain(2)||Baseline Participant Assessment of Normal Function/Activity|Participants were asked the following question: “How does your ankle injury affect your walking and normal activity?” The participant’s response was recorded using a 5-point scale: 1=Normal activity and no pain; 2=Normal activity with pain; 3=Mildly restricted walking due to pain and can’t resume normal activities; 4=Moderately restricted walking due to pain and can’t resume normal activities; 5=Severely restricted walking due to pain and can’t resume normal activities. The score ranges from 1-5, with higher scores indicates restricted activity.|participants|Number|9|9.0||||||
3763537|NCT01945034|3596165|B2|Normal walking/activity with pain(2)||Baseline Participant Assessment of Normal Function/Activity|Participants were asked the following question: “How does your ankle injury affect your walking and normal activity?” The participant’s response was recorded using a 5-point scale: 1=Normal activity and no pain; 2=Normal activity with pain; 3=Mildly restricted walking due to pain and can’t resume normal activities; 4=Moderately restricted walking due to pain and can’t resume normal activities; 5=Severely restricted walking due to pain and can’t resume normal activities. The score ranges from 1-5, with higher scores indicates restricted activity.|participants|Number|4|4.0||||||
3763538|NCT01945034|3596166|B1|Normal walking/activity with pain(2)||Baseline Participant Assessment of Normal Function/Activity|Participants were asked the following question: “How does your ankle injury affect your walking and normal activity?” The participant’s response was recorded using a 5-point scale: 1=Normal activity and no pain; 2=Normal activity with pain; 3=Mildly restricted walking due to pain and can’t resume normal activities; 4=Moderately restricted walking due to pain and can’t resume normal activities; 5=Severely restricted walking due to pain and can’t resume normal activities. The score ranges from 1-5, with higher scores indicates restricted activity.|participants|Number|1|1.0||||||
3763539|NCT01945034|3596163|B4|Normal walking/activity and no pain(1)||Baseline Participant Assessment of Normal Function/Activity|Participants were asked the following question: “How does your ankle injury affect your walking and normal activity?” The participant’s response was recorded using a 5-point scale: 1=Normal activity and no pain; 2=Normal activity with pain; 3=Mildly restricted walking due to pain and can’t resume normal activities; 4=Moderately restricted walking due to pain and can’t resume normal activities; 5=Severely restricted walking due to pain and can’t resume normal activities. The score ranges from 1-5, with higher scores indicates restricted activity.|participants|Number|0|0.0||||||
3763602|NCT01945034|3596166|B1|Moderate||Categorical Pain Severity Rating (PSR)|Participants were assessed by 4-Point category pain severity rating scale. Participants rated their pain upon weight bearing using a four-point scale, as follows: 0 = None, 1 = Mild, 2 = Moderate, 3 = Severe. All participants had moderate or severe ankle pain upon weight bearing at baseline.|participants|Number|43|43.0||1.25|1.25|||
3763603|NCT01945034|3596163|B4||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
3763540|NCT01945034|3596164|B3|Normal walking/activity and no pain(1)||Baseline Participant Assessment of Normal Function/Activity|Participants were asked the following question: “How does your ankle injury affect your walking and normal activity?” The participant’s response was recorded using a 5-point scale: 1=Normal activity and no pain; 2=Normal activity with pain; 3=Mildly restricted walking due to pain and can’t resume normal activities; 4=Moderately restricted walking due to pain and can’t resume normal activities; 5=Severely restricted walking due to pain and can’t resume normal activities. The score ranges from 1-5, with higher scores indicates restricted activity.|participants|Number|0|0.0||||||
3763541|NCT01945034|3596165|B2|Normal walking/activity and no pain(1)||Baseline Participant Assessment of Normal Function/Activity|Participants were asked the following question: “How does your ankle injury affect your walking and normal activity?” The participant’s response was recorded using a 5-point scale: 1=Normal activity and no pain; 2=Normal activity with pain; 3=Mildly restricted walking due to pain and can’t resume normal activities; 4=Moderately restricted walking due to pain and can’t resume normal activities; 5=Severely restricted walking due to pain and can’t resume normal activities. The score ranges from 1-5, with higher scores indicates restricted activity.|participants|Number|0|0.0||||||
3763542|NCT01945034|3596166|B1|Normal walking/activity and no pain(1)||Baseline Participant Assessment of Normal Function/Activity|Participants were asked the following question: “How does your ankle injury affect your walking and normal activity?” The participant’s response was recorded using a 5-point scale: 1=Normal activity and no pain; 2=Normal activity with pain; 3=Mildly restricted walking due to pain and can’t resume normal activities; 4=Moderately restricted walking due to pain and can’t resume normal activities; 5=Severely restricted walking due to pain and can’t resume normal activities. The score ranges from 1-5, with higher scores indicates restricted activity.|participants|Number|0|0.0||||||
3763543|NCT01945034|3596163|B4|Very severe(5)||Baseline Physician Global Assessment of Ankle Injury|The physician assessment of the severity of the ankle injury was based on the participant’s individual signs and symptoms which included pain, swelling, tenderness and limitation of range of movement, and graded using the following 6-point scale: 0 = Normal, No signs or symptoms; 1= Very mild, Very mild signs and symptoms; 2 = Mild, Mild signs and symptoms; 3 = Moderate, Moderate signs and symptoms; 4 = Severe, Severe signs and symptoms; 5 = Very severe, Very severe signs and symptoms.|participants|Number|0|0.0||||||
3763544|NCT01945034|3596164|B3|Very severe(5)||Baseline Physician Global Assessment of Ankle Injury|The physician assessment of the severity of the ankle injury was based on the participant’s individual signs and symptoms which included pain, swelling, tenderness and limitation of range of movement, and graded using the following 6-point scale: 0 = Normal, No signs or symptoms; 1= Very mild, Very mild signs and symptoms; 2 = Mild, Mild signs and symptoms; 3 = Moderate, Moderate signs and symptoms; 4 = Severe, Severe signs and symptoms; 5 = Very severe, Very severe signs and symptoms.|participants|Number|0|0.0||||||
3763545|NCT01945034|3596165|B2|Very severe(5)||Baseline Physician Global Assessment of Ankle Injury|The physician assessment of the severity of the ankle injury was based on the participant’s individual signs and symptoms which included pain, swelling, tenderness and limitation of range of movement, and graded using the following 6-point scale: 0 = Normal, No signs or symptoms; 1= Very mild, Very mild signs and symptoms; 2 = Mild, Mild signs and symptoms; 3 = Moderate, Moderate signs and symptoms; 4 = Severe, Severe signs and symptoms; 5 = Very severe, Very severe signs and symptoms.|participants|Number|0|0.0||||||
3763546|NCT01945034|3596166|B1|Very severe(5)||Baseline Physician Global Assessment of Ankle Injury|The physician assessment of the severity of the ankle injury was based on the participant’s individual signs and symptoms which included pain, swelling, tenderness and limitation of range of movement, and graded using the following 6-point scale: 0 = Normal, No signs or symptoms; 1= Very mild, Very mild signs and symptoms; 2 = Mild, Mild signs and symptoms; 3 = Moderate, Moderate signs and symptoms; 4 = Severe, Severe signs and symptoms; 5 = Very severe, Very severe signs and symptoms.|participants|Number|0|0.0||||||
3763547|NCT01945034|3596163|B4|Severe(4)||Baseline Physician Global Assessment of Ankle Injury|The physician assessment of the severity of the ankle injury was based on the participant’s individual signs and symptoms which included pain, swelling, tenderness and limitation of range of movement, and graded using the following 6-point scale: 0 = Normal, No signs or symptoms; 1= Very mild, Very mild signs and symptoms; 2 = Mild, Mild signs and symptoms; 3 = Moderate, Moderate signs and symptoms; 4 = Severe, Severe signs and symptoms; 5 = Very severe, Very severe signs and symptoms.|participants|Number|31|31.0||||||
3763548|NCT01945034|3596164|B3|Severe(4)||Baseline Physician Global Assessment of Ankle Injury|The physician assessment of the severity of the ankle injury was based on the participant’s individual signs and symptoms which included pain, swelling, tenderness and limitation of range of movement, and graded using the following 6-point scale: 0 = Normal, No signs or symptoms; 1= Very mild, Very mild signs and symptoms; 2 = Mild, Mild signs and symptoms; 3 = Moderate, Moderate signs and symptoms; 4 = Severe, Severe signs and symptoms; 5 = Very severe, Very severe signs and symptoms.|participants|Number|20|20.0||||||
3763549|NCT01945034|3596165|B2|Severe(4)||Baseline Physician Global Assessment of Ankle Injury|The physician assessment of the severity of the ankle injury was based on the participant’s individual signs and symptoms which included pain, swelling, tenderness and limitation of range of movement, and graded using the following 6-point scale: 0 = Normal, No signs or symptoms; 1= Very mild, Very mild signs and symptoms; 2 = Mild, Mild signs and symptoms; 3 = Moderate, Moderate signs and symptoms; 4 = Severe, Severe signs and symptoms; 5 = Very severe, Very severe signs and symptoms.|participants|Number|3|3.0||||||
3763550|NCT01945034|3596166|B1|Severe(4)||Baseline Physician Global Assessment of Ankle Injury|The physician assessment of the severity of the ankle injury was based on the participant’s individual signs and symptoms which included pain, swelling, tenderness and limitation of range of movement, and graded using the following 6-point scale: 0 = Normal, No signs or symptoms; 1= Very mild, Very mild signs and symptoms; 2 = Mild, Mild signs and symptoms; 3 = Moderate, Moderate signs and symptoms; 4 = Severe, Severe signs and symptoms; 5 = Very severe, Very severe signs and symptoms.|participants|Number|8|8.0||||||
3763551|NCT01945034|3596163|B4|Moderate(3)||Baseline Physician Global Assessment of Ankle Injury|The physician assessment of the severity of the ankle injury was based on the participant’s individual signs and symptoms which included pain, swelling, tenderness and limitation of range of movement, and graded using the following 6-point scale: 0 = Normal, No signs or symptoms; 1= Very mild, Very mild signs and symptoms; 2 = Mild, Mild signs and symptoms; 3 = Moderate, Moderate signs and symptoms; 4 = Severe, Severe signs and symptoms; 5 = Very severe, Very severe signs and symptoms.|participants|Number|205|205.0||||||
3763552|NCT01945034|3596164|B3|Moderate(3)||Baseline Physician Global Assessment of Ankle Injury|The physician assessment of the severity of the ankle injury was based on the participant’s individual signs and symptoms which included pain, swelling, tenderness and limitation of range of movement, and graded using the following 6-point scale: 0 = Normal, No signs or symptoms; 1= Very mild, Very mild signs and symptoms; 2 = Mild, Mild signs and symptoms; 3 = Moderate, Moderate signs and symptoms; 4 = Severe, Severe signs and symptoms; 5 = Very severe, Very severe signs and symptoms.|participants|Number|101|101.0||||||
3763553|NCT01945034|3596165|B2|Moderate(3)||Baseline Physician Global Assessment of Ankle Injury|The physician assessment of the severity of the ankle injury was based on the participant’s individual signs and symptoms which included pain, swelling, tenderness and limitation of range of movement, and graded using the following 6-point scale: 0 = Normal, No signs or symptoms; 1= Very mild, Very mild signs and symptoms; 2 = Mild, Mild signs and symptoms; 3 = Moderate, Moderate signs and symptoms; 4 = Severe, Severe signs and symptoms; 5 = Very severe, Very severe signs and symptoms.|participants|Number|54|54.0||||||
3763554|NCT01945034|3596166|B1|Moderate(3)||Baseline Physician Global Assessment of Ankle Injury|The physician assessment of the severity of the ankle injury was based on the participant’s individual signs and symptoms which included pain, swelling, tenderness and limitation of range of movement, and graded using the following 6-point scale: 0 = Normal, No signs or symptoms; 1= Very mild, Very mild signs and symptoms; 2 = Mild, Mild signs and symptoms; 3 = Moderate, Moderate signs and symptoms; 4 = Severe, Severe signs and symptoms; 5 = Very severe, Very severe signs and symptoms.|participants|Number|50|50.0||||||
3763555|NCT01945034|3596163|B4|Mild(2)||Baseline Physician Global Assessment of Ankle Injury|The physician assessment of the severity of the ankle injury was based on the participant’s individual signs and symptoms which included pain, swelling, tenderness and limitation of range of movement, and graded using the following 6-point scale: 0 = Normal, No signs or symptoms; 1= Very mild, Very mild signs and symptoms; 2 = Mild, Mild signs and symptoms; 3 = Moderate, Moderate signs and symptoms; 4 = Severe, Severe signs and symptoms; 5 = Very severe, Very severe signs and symptoms.|participants|Number|67|67.0||||||
3763556|NCT01945034|3596164|B3|Mild(2)||Baseline Physician Global Assessment of Ankle Injury|The physician assessment of the severity of the ankle injury was based on the participant’s individual signs and symptoms which included pain, swelling, tenderness and limitation of range of movement, and graded using the following 6-point scale: 0 = Normal, No signs or symptoms; 1= Very mild, Very mild signs and symptoms; 2 = Mild, Mild signs and symptoms; 3 = Moderate, Moderate signs and symptoms; 4 = Severe, Severe signs and symptoms; 5 = Very severe, Very severe signs and symptoms.|participants|Number|30|30.0||||||
3763557|NCT01945034|3596165|B2|Mild(2)||Baseline Physician Global Assessment of Ankle Injury|The physician assessment of the severity of the ankle injury was based on the participant’s individual signs and symptoms which included pain, swelling, tenderness and limitation of range of movement, and graded using the following 6-point scale: 0 = Normal, No signs or symptoms; 1= Very mild, Very mild signs and symptoms; 2 = Mild, Mild signs and symptoms; 3 = Moderate, Moderate signs and symptoms; 4 = Severe, Severe signs and symptoms; 5 = Very severe, Very severe signs and symptoms.|participants|Number|28|28.0||||||
3763558|NCT01945034|3596166|B1|Mild(2)||Baseline Physician Global Assessment of Ankle Injury|The physician assessment of the severity of the ankle injury was based on the participant’s individual signs and symptoms which included pain, swelling, tenderness and limitation of range of movement, and graded using the following 6-point scale: 0 = Normal, No signs or symptoms; 1= Very mild, Very mild signs and symptoms; 2 = Mild, Mild signs and symptoms; 3 = Moderate, Moderate signs and symptoms; 4 = Severe, Severe signs and symptoms; 5 = Very severe, Very severe signs and symptoms.|participants|Number|9|9.0||||||
3763559|NCT01945034|3596163|B4|Very mild(1)||Baseline Physician Global Assessment of Ankle Injury|The physician assessment of the severity of the ankle injury was based on the participant’s individual signs and symptoms which included pain, swelling, tenderness and limitation of range of movement, and graded using the following 6-point scale: 0 = Normal, No signs or symptoms; 1= Very mild, Very mild signs and symptoms; 2 = Mild, Mild signs and symptoms; 3 = Moderate, Moderate signs and symptoms; 4 = Severe, Severe signs and symptoms; 5 = Very severe, Very severe signs and symptoms.|participants|Number|1|1.0||||||
3763560|NCT01945034|3596164|B3|Very mild(1)||Baseline Physician Global Assessment of Ankle Injury|The physician assessment of the severity of the ankle injury was based on the participant’s individual signs and symptoms which included pain, swelling, tenderness and limitation of range of movement, and graded using the following 6-point scale: 0 = Normal, No signs or symptoms; 1= Very mild, Very mild signs and symptoms; 2 = Mild, Mild signs and symptoms; 3 = Moderate, Moderate signs and symptoms; 4 = Severe, Severe signs and symptoms; 5 = Very severe, Very severe signs and symptoms.|participants|Number|1|1.0||||||
3763561|NCT01945034|3596165|B2|Very mild(1)||Baseline Physician Global Assessment of Ankle Injury|The physician assessment of the severity of the ankle injury was based on the participant’s individual signs and symptoms which included pain, swelling, tenderness and limitation of range of movement, and graded using the following 6-point scale: 0 = Normal, No signs or symptoms; 1= Very mild, Very mild signs and symptoms; 2 = Mild, Mild signs and symptoms; 3 = Moderate, Moderate signs and symptoms; 4 = Severe, Severe signs and symptoms; 5 = Very severe, Very severe signs and symptoms.|participants|Number|0|0.0||||||
3763562|NCT01945034|3596166|B1|Very mild(1)||Baseline Physician Global Assessment of Ankle Injury|The physician assessment of the severity of the ankle injury was based on the participant’s individual signs and symptoms which included pain, swelling, tenderness and limitation of range of movement, and graded using the following 6-point scale: 0 = Normal, No signs or symptoms; 1= Very mild, Very mild signs and symptoms; 2 = Mild, Mild signs and symptoms; 3 = Moderate, Moderate signs and symptoms; 4 = Severe, Severe signs and symptoms; 5 = Very severe, Very severe signs and symptoms.|participants|Number|0|0.0||||||
3763563|NCT01945034|3596163|B4|Normal(0)||Baseline Physician Global Assessment of Ankle Injury|The physician assessment of the severity of the ankle injury was based on the participant’s individual signs and symptoms which included pain, swelling, tenderness and limitation of range of movement, and graded using the following 6-point scale: 0 = Normal, No signs or symptoms; 1= Very mild, Very mild signs and symptoms; 2 = Mild, Mild signs and symptoms; 3 = Moderate, Moderate signs and symptoms; 4 = Severe, Severe signs and symptoms; 5 = Very severe, Very severe signs and symptoms.|participants|Number|0|0.0||||||
3763604|NCT01945034|3596164|B3||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3763605|NCT01945034|3596165|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3763564|NCT01945034|3596164|B3|Normal(0)||Baseline Physician Global Assessment of Ankle Injury|The physician assessment of the severity of the ankle injury was based on the participant’s individual signs and symptoms which included pain, swelling, tenderness and limitation of range of movement, and graded using the following 6-point scale: 0 = Normal, No signs or symptoms; 1= Very mild, Very mild signs and symptoms; 2 = Mild, Mild signs and symptoms; 3 = Moderate, Moderate signs and symptoms; 4 = Severe, Severe signs and symptoms; 5 = Very severe, Very severe signs and symptoms.|participants|Number|0|0.0||||||
3763565|NCT01945034|3596165|B2|Normal(0)||Baseline Physician Global Assessment of Ankle Injury|The physician assessment of the severity of the ankle injury was based on the participant’s individual signs and symptoms which included pain, swelling, tenderness and limitation of range of movement, and graded using the following 6-point scale: 0 = Normal, No signs or symptoms; 1= Very mild, Very mild signs and symptoms; 2 = Mild, Mild signs and symptoms; 3 = Moderate, Moderate signs and symptoms; 4 = Severe, Severe signs and symptoms; 5 = Very severe, Very severe signs and symptoms.|participants|Number|0|0.0||||||
3763566|NCT01945034|3596166|B1|Normal(0)||Baseline Physician Global Assessment of Ankle Injury|The physician assessment of the severity of the ankle injury was based on the participant’s individual signs and symptoms which included pain, swelling, tenderness and limitation of range of movement, and graded using the following 6-point scale: 0 = Normal, No signs or symptoms; 1= Very mild, Very mild signs and symptoms; 2 = Mild, Mild signs and symptoms; 3 = Moderate, Moderate signs and symptoms; 4 = Severe, Severe signs and symptoms; 5 = Very severe, Very severe signs and symptoms.|participants|Number|0|0.0||||||
3763567|NCT01945034|3596163|B4|Very Poor(5)||Baseline Participant's Global Assessment of Ankle Injury|Participants were asked the following question: “Considering all the ways your ankle injury affects you, how are you doing today?” The participant’s response was recorded using a 5-point scale: 1 = Very Good, No symptoms and no limitations of normal activities; 2 = Good, Mild symptoms and no limitation of normal activities; 3 = Fair, Moderate symptoms and limitations of some normal activities; 4 = Poor, Severe symptoms and inability to carry out most normal activities; and 5 = Very Poor, Very severe symptoms which are intolerable and inability to carry out all normal activities.|participants|Number|20|20.0||||||
3763568|NCT01945034|3596164|B3|Very Poor(5)||Baseline Participant's Global Assessment of Ankle Injury|Participants were asked the following question: “Considering all the ways your ankle injury affects you, how are you doing today?” The participant’s response was recorded using a 5-point scale: 1 = Very Good, No symptoms and no limitations of normal activities; 2 = Good, Mild symptoms and no limitation of normal activities; 3 = Fair, Moderate symptoms and limitations of some normal activities; 4 = Poor, Severe symptoms and inability to carry out most normal activities; and 5 = Very Poor, Very severe symptoms which are intolerable and inability to carry out all normal activities.|participants|Number|13|13.0||||||
3763569|NCT01945034|3596165|B2|Very Poor(5)||Baseline Participant's Global Assessment of Ankle Injury|Participants were asked the following question: “Considering all the ways your ankle injury affects you, how are you doing today?” The participant’s response was recorded using a 5-point scale: 1 = Very Good, No symptoms and no limitations of normal activities; 2 = Good, Mild symptoms and no limitation of normal activities; 3 = Fair, Moderate symptoms and limitations of some normal activities; 4 = Poor, Severe symptoms and inability to carry out most normal activities; and 5 = Very Poor, Very severe symptoms which are intolerable and inability to carry out all normal activities.|participants|Number|4|4.0||||||
3763570|NCT01945034|3596166|B1|Very Poor(5)||Baseline Participant's Global Assessment of Ankle Injury|Participants were asked the following question: “Considering all the ways your ankle injury affects you, how are you doing today?” The participant’s response was recorded using a 5-point scale: 1 = Very Good, No symptoms and no limitations of normal activities; 2 = Good, Mild symptoms and no limitation of normal activities; 3 = Fair, Moderate symptoms and limitations of some normal activities; 4 = Poor, Severe symptoms and inability to carry out most normal activities; and 5 = Very Poor, Very severe symptoms which are intolerable and inability to carry out all normal activities.|participants|Number|3|3.0||||||
3763571|NCT01945034|3596163|B4|Poor(4)||Baseline Participant's Global Assessment of Ankle Injury|Participants were asked the following question: “Considering all the ways your ankle injury affects you, how are you doing today?” The participant’s response was recorded using a 5-point scale: 1 = Very Good, No symptoms and no limitations of normal activities; 2 = Good, Mild symptoms and no limitation of normal activities; 3 = Fair, Moderate symptoms and limitations of some normal activities; 4 = Poor, Severe symptoms and inability to carry out most normal activities; and 5 = Very Poor, Very severe symptoms which are intolerable and inability to carry out all normal activities.|participants|Number|110|110.0||||||
3763572|NCT01945034|3596164|B3|Poor(4)||Baseline Participant's Global Assessment of Ankle Injury|Participants were asked the following question: “Considering all the ways your ankle injury affects you, how are you doing today?” The participant’s response was recorded using a 5-point scale: 1 = Very Good, No symptoms and no limitations of normal activities; 2 = Good, Mild symptoms and no limitation of normal activities; 3 = Fair, Moderate symptoms and limitations of some normal activities; 4 = Poor, Severe symptoms and inability to carry out most normal activities; and 5 = Very Poor, Very severe symptoms which are intolerable and inability to carry out all normal activities.|participants|Number|55|55.0||||||
3763573|NCT01945034|3596165|B2|Poor(4)||Baseline Participant's Global Assessment of Ankle Injury|Participants were asked the following question: “Considering all the ways your ankle injury affects you, how are you doing today?” The participant’s response was recorded using a 5-point scale: 1 = Very Good, No symptoms and no limitations of normal activities; 2 = Good, Mild symptoms and no limitation of normal activities; 3 = Fair, Moderate symptoms and limitations of some normal activities; 4 = Poor, Severe symptoms and inability to carry out most normal activities; and 5 = Very Poor, Very severe symptoms which are intolerable and inability to carry out all normal activities.|participants|Number|25|25.0||||||
3763574|NCT01945034|3596166|B1|Poor(4)||Baseline Participant's Global Assessment of Ankle Injury|Participants were asked the following question: “Considering all the ways your ankle injury affects you, how are you doing today?” The participant’s response was recorded using a 5-point scale: 1 = Very Good, No symptoms and no limitations of normal activities; 2 = Good, Mild symptoms and no limitation of normal activities; 3 = Fair, Moderate symptoms and limitations of some normal activities; 4 = Poor, Severe symptoms and inability to carry out most normal activities; and 5 = Very Poor, Very severe symptoms which are intolerable and inability to carry out all normal activities.|participants|Number|30|30.0||||||
3763606|NCT01945034|3596166|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3763575|NCT01945034|3596163|B4|Fair(3)||Baseline Participant's Global Assessment of Ankle Injury|Participants were asked the following question: “Considering all the ways your ankle injury affects you, how are you doing today?” The participant’s response was recorded using a 5-point scale: 1 = Very Good, No symptoms and no limitations of normal activities; 2 = Good, Mild symptoms and no limitation of normal activities; 3 = Fair, Moderate symptoms and limitations of some normal activities; 4 = Poor, Severe symptoms and inability to carry out most normal activities; and 5 = Very Poor, Very severe symptoms which are intolerable and inability to carry out all normal activities.|participants|Number|167|167.0||||||
3763576|NCT01945034|3596164|B3|Fair(3)||Baseline Participant's Global Assessment of Ankle Injury|Participants were asked the following question: “Considering all the ways your ankle injury affects you, how are you doing today?” The participant’s response was recorded using a 5-point scale: 1 = Very Good, No symptoms and no limitations of normal activities; 2 = Good, Mild symptoms and no limitation of normal activities; 3 = Fair, Moderate symptoms and limitations of some normal activities; 4 = Poor, Severe symptoms and inability to carry out most normal activities; and 5 = Very Poor, Very severe symptoms which are intolerable and inability to carry out all normal activities.|participants|Number|77|77.0||||||
3763577|NCT01945034|3596165|B2|Fair(3)||Baseline Participant's Global Assessment of Ankle Injury|Participants were asked the following question: “Considering all the ways your ankle injury affects you, how are you doing today?” The participant’s response was recorded using a 5-point scale: 1 = Very Good, No symptoms and no limitations of normal activities; 2 = Good, Mild symptoms and no limitation of normal activities; 3 = Fair, Moderate symptoms and limitations of some normal activities; 4 = Poor, Severe symptoms and inability to carry out most normal activities; and 5 = Very Poor, Very severe symptoms which are intolerable and inability to carry out all normal activities.|participants|Number|56|56.0||||||
3763578|NCT01945034|3596166|B1|Fair(3)||Baseline Participant's Global Assessment of Ankle Injury|Participants were asked the following question: “Considering all the ways your ankle injury affects you, how are you doing today?” The participant’s response was recorded using a 5-point scale: 1 = Very Good, No symptoms and no limitations of normal activities; 2 = Good, Mild symptoms and no limitation of normal activities; 3 = Fair, Moderate symptoms and limitations of some normal activities; 4 = Poor, Severe symptoms and inability to carry out most normal activities; and 5 = Very Poor, Very severe symptoms which are intolerable and inability to carry out all normal activities.|participants|Number|34|34.0||||||
3763579|NCT01945034|3596163|B4|Good(2)||Baseline Participant's Global Assessment of Ankle Injury|Participants were asked the following question: “Considering all the ways your ankle injury affects you, how are you doing today?” The participant’s response was recorded using a 5-point scale: 1 = Very Good, No symptoms and no limitations of normal activities; 2 = Good, Mild symptoms and no limitation of normal activities; 3 = Fair, Moderate symptoms and limitations of some normal activities; 4 = Poor, Severe symptoms and inability to carry out most normal activities; and 5 = Very Poor, Very severe symptoms which are intolerable and inability to carry out all normal activities.|participants|Number|7|7.0||||||
3763580|NCT01945034|3596164|B3|Good(2)||Baseline Participant's Global Assessment of Ankle Injury|Participants were asked the following question: “Considering all the ways your ankle injury affects you, how are you doing today?” The participant’s response was recorded using a 5-point scale: 1 = Very Good, No symptoms and no limitations of normal activities; 2 = Good, Mild symptoms and no limitation of normal activities; 3 = Fair, Moderate symptoms and limitations of some normal activities; 4 = Poor, Severe symptoms and inability to carry out most normal activities; and 5 = Very Poor, Very severe symptoms which are intolerable and inability to carry out all normal activities.|participants|Number|7|7.0||||||
3763581|NCT01945034|3596165|B2|Good(2)||Baseline Participant's Global Assessment of Ankle Injury|Participants were asked the following question: “Considering all the ways your ankle injury affects you, how are you doing today?” The participant’s response was recorded using a 5-point scale: 1 = Very Good, No symptoms and no limitations of normal activities; 2 = Good, Mild symptoms and no limitation of normal activities; 3 = Fair, Moderate symptoms and limitations of some normal activities; 4 = Poor, Severe symptoms and inability to carry out most normal activities; and 5 = Very Poor, Very severe symptoms which are intolerable and inability to carry out all normal activities.|participants|Number|0|0.0||||||
3763582|NCT01945034|3596166|B1|Good(2)||Baseline Participant's Global Assessment of Ankle Injury|Participants were asked the following question: “Considering all the ways your ankle injury affects you, how are you doing today?” The participant’s response was recorded using a 5-point scale: 1 = Very Good, No symptoms and no limitations of normal activities; 2 = Good, Mild symptoms and no limitation of normal activities; 3 = Fair, Moderate symptoms and limitations of some normal activities; 4 = Poor, Severe symptoms and inability to carry out most normal activities; and 5 = Very Poor, Very severe symptoms which are intolerable and inability to carry out all normal activities.|participants|Number|0|0.0||||||
3763583|NCT01945034|3596163|B4|Very Good(1)||Baseline Participant's Global Assessment of Ankle Injury|Participants were asked the following question: “Considering all the ways your ankle injury affects you, how are you doing today?” The participant’s response was recorded using a 5-point scale: 1 = Very Good, No symptoms and no limitations of normal activities; 2 = Good, Mild symptoms and no limitation of normal activities; 3 = Fair, Moderate symptoms and limitations of some normal activities; 4 = Poor, Severe symptoms and inability to carry out most normal activities; and 5 = Very Poor, Very severe symptoms which are intolerable and inability to carry out all normal activities.|participants|Number|0|0.0||||||
3763584|NCT01945034|3596164|B3|Very Good(1)||Baseline Participant's Global Assessment of Ankle Injury|Participants were asked the following question: “Considering all the ways your ankle injury affects you, how are you doing today?” The participant’s response was recorded using a 5-point scale: 1 = Very Good, No symptoms and no limitations of normal activities; 2 = Good, Mild symptoms and no limitation of normal activities; 3 = Fair, Moderate symptoms and limitations of some normal activities; 4 = Poor, Severe symptoms and inability to carry out most normal activities; and 5 = Very Poor, Very severe symptoms which are intolerable and inability to carry out all normal activities.|participants|Number|0|0.0||||||
3763607|NCT01945034|3596163|B4||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3763608|NCT01945034|3596164|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3763609|NCT01945034|3596165|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3763610|NCT01945034|3596166|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3763585|NCT01945034|3596165|B2|Very Good(1)||Baseline Participant's Global Assessment of Ankle Injury|Participants were asked the following question: “Considering all the ways your ankle injury affects you, how are you doing today?” The participant’s response was recorded using a 5-point scale: 1 = Very Good, No symptoms and no limitations of normal activities; 2 = Good, Mild symptoms and no limitation of normal activities; 3 = Fair, Moderate symptoms and limitations of some normal activities; 4 = Poor, Severe symptoms and inability to carry out most normal activities; and 5 = Very Poor, Very severe symptoms which are intolerable and inability to carry out all normal activities.|participants|Number|0|0.0||||||
3763586|NCT01945034|3596166|B1|Very Good(1)||Baseline Participant's Global Assessment of Ankle Injury|Participants were asked the following question: “Considering all the ways your ankle injury affects you, how are you doing today?” The participant’s response was recorded using a 5-point scale: 1 = Very Good, No symptoms and no limitations of normal activities; 2 = Good, Mild symptoms and no limitation of normal activities; 3 = Fair, Moderate symptoms and limitations of some normal activities; 4 = Poor, Severe symptoms and inability to carry out most normal activities; and 5 = Very Poor, Very severe symptoms which are intolerable and inability to carry out all normal activities.|participants|Number|0|0.0||||||
3763587|NCT01945034|3596163|B4|||Baseline Ankle Pain at Rest|Participants rated their pain at rest. PI was assessed on an 11-point numerical rating scale from 0=no pain to 10=most severe pain and this best describes their current pain in the injured ankle.|Units on a scale|Mean|6.4|6.4|Standard Deviation|1.65|1.65|||
3763588|NCT01945034|3596164|B3|||Baseline Ankle Pain at Rest|Participants rated their pain at rest. PI was assessed on an 11-point numerical rating scale from 0=no pain to 10=most severe pain and this best describes their current pain in the injured ankle.|Units on a scale|Mean|6.5|6.5|Standard Deviation|1.70|1.7|||
3763589|NCT01945034|3596165|B2|||Baseline Ankle Pain at Rest|Participants rated their pain at rest. PI was assessed on an 11-point numerical rating scale from 0=no pain to 10=most severe pain and this best describes their current pain in the injured ankle.|Units on a scale|Mean|6.5|6.5|Standard Deviation|1.48|1.48|||
3763590|NCT01945034|3596166|B1|||Baseline Ankle Pain at Rest|Participants rated their pain at rest. PI was assessed on an 11-point numerical rating scale from 0=no pain to 10=most severe pain and this best describes their current pain in the injured ankle.|Units on a scale|Mean|6.2|6.2|Standard Deviation|1.77|1.77|||
3763591|NCT01945034|3596163|B4|||Baseline Ankle Pain upon Weight Bearing|Participants rated their pain on full weight-bearing movement. Pain Intensity (PI) was assessed on an 11-point numerical rating scale from 0=no pain to 10=most severe pain and this best describes their current pain in the injured ankle. At baseline, participants recorded a value of at least 6 (inclusive) to be eligible to participate in the study.|Units on a scale|Mean|8.3|8.3|Standard Deviation|1.18|1.18|||
3763592|NCT01945034|3596164|B3|||Baseline Ankle Pain upon Weight Bearing|Participants rated their pain on full weight-bearing movement. Pain Intensity (PI) was assessed on an 11-point numerical rating scale from 0=no pain to 10=most severe pain and this best describes their current pain in the injured ankle. At baseline, participants recorded a value of at least 6 (inclusive) to be eligible to participate in the study.|Units on a scale|Mean|8.4|8.4|Standard Deviation|1.17|1.17|||
3763593|NCT01945034|3596165|B2|||Baseline Ankle Pain upon Weight Bearing|Participants rated their pain on full weight-bearing movement. Pain Intensity (PI) was assessed on an 11-point numerical rating scale from 0=no pain to 10=most severe pain and this best describes their current pain in the injured ankle. At baseline, participants recorded a value of at least 6 (inclusive) to be eligible to participate in the study.|Units on a scale|Mean|8.1|8.1|Standard Deviation|1.13|1.13|||
3763594|NCT01945034|3596166|B1|||Baseline Ankle Pain upon Weight Bearing|Participants rated their pain on full weight-bearing movement. Pain Intensity (PI) was assessed on an 11-point numerical rating scale from 0=no pain to 10=most severe pain and this best describes their current pain in the injured ankle. At baseline, participants recorded a value of at least 6 (inclusive) to be eligible to participate in the study.|Units on a scale|Mean|8.3|8.3|Standard Deviation|1.25|1.25|||
3763595|NCT01945034|3596163|B4|Severe||Categorical Pain Severity Rating (PSR)|Participants were assessed by 4-Point category pain severity rating scale. Participants rated their pain upon weight bearing using a four-point scale, as follows: 0 = None, 1 = Mild, 2 = Moderate, 3 = Severe. All participants had moderate or severe ankle pain upon weight bearing at baseline.|participants|Number|96|96.0||||||
3763596|NCT01945034|3596164|B3|Severe||Categorical Pain Severity Rating (PSR)|Participants were assessed by 4-Point category pain severity rating scale. Participants rated their pain upon weight bearing using a four-point scale, as follows: 0 = None, 1 = Mild, 2 = Moderate, 3 = Severe. All participants had moderate or severe ankle pain upon weight bearing at baseline.|participants|Number|50|50.0||||||
3763597|NCT01945034|3596165|B2|Severe||Categorical Pain Severity Rating (PSR)|Participants were assessed by 4-Point category pain severity rating scale. Participants rated their pain upon weight bearing using a four-point scale, as follows: 0 = None, 1 = Mild, 2 = Moderate, 3 = Severe. All participants had moderate or severe ankle pain upon weight bearing at baseline.|participants|Number|22|22.0||||||
3763598|NCT01945034|3596166|B1|Severe||Categorical Pain Severity Rating (PSR)|Participants were assessed by 4-Point category pain severity rating scale. Participants rated their pain upon weight bearing using a four-point scale, as follows: 0 = None, 1 = Mild, 2 = Moderate, 3 = Severe. All participants had moderate or severe ankle pain upon weight bearing at baseline.|participants|Number|24|24.0||||||
3763599|NCT01945034|3596163|B4|Moderate||Categorical Pain Severity Rating (PSR)|Participants were assessed by 4-Point category pain severity rating scale. Participants rated their pain upon weight bearing using a four-point scale, as follows: 0 = None, 1 = Mild, 2 = Moderate, 3 = Severe. All participants had moderate or severe ankle pain upon weight bearing at baseline.|participants|Number|208|208.0||||||
3763600|NCT01945034|3596164|B3|Moderate||Categorical Pain Severity Rating (PSR)|Participants were assessed by 4-Point category pain severity rating scale. Participants rated their pain upon weight bearing using a four-point scale, as follows: 0 = None, 1 = Mild, 2 = Moderate, 3 = Severe. All participants had moderate or severe ankle pain upon weight bearing at baseline.|participants|Number|102|102.0||1.17|1.17|||
3763601|NCT01945034|3596165|B2|Moderate||Categorical Pain Severity Rating (PSR)|Participants were assessed by 4-Point category pain severity rating scale. Participants rated their pain upon weight bearing using a four-point scale, as follows: 0 = None, 1 = Mild, 2 = Moderate, 3 = Severe. All participants had moderate or severe ankle pain upon weight bearing at baseline.|participants|Number|63|63.0||1.13|1.13|||
3763613|NCT01945034|3596165|B2|||Age||years|Mean|35.2|35.2|Standard Deviation|14.72|14.72|||
3763614|NCT01945034|3596166|B1|||Age||years|Mean|31.7|31.7|Standard Deviation|15.20|15.2|||
3763615|NCT01945021|3596218|B1|Korea, Republic of||Region of Enrollment||participants|Number|12|12.0||||||
3763616|NCT01945021|3596218|B1|Taiwan||Region of Enrollment||participants|Number|15|15.0||||||
3763617|NCT01945021|3596218|B1|Japan||Region of Enrollment||participants|Number|26|26.0||||||
3763618|NCT01945021|3596218|B1|China||Region of Enrollment||participants|Number|74|74.0||||||
3763619|NCT01945021|3596218|B1|Asian||Race/Ethnicity, Customized||participants|Number|127|127.0||||||
3763620|NCT01945021|3596218|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3763621|NCT01945021|3596218|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3763622|NCT01945021|3596218|B1|> / = 65||Age, Customized||years|Number|21|21.0||||||
3763623|NCT01945021|3596218|B1|< 65||Age, Customized||years|Number|106|106.0||||||
3763624|NCT01944969|3596232|B1|Germany||Region of Enrollment||participants|Number|2|2.0||||||
3763625|NCT01944969|3596232|B1|Finland||Region of Enrollment||participants|Number|2|2.0||||||
3763626|NCT01944969|3596232|B1|Estonia||Region of Enrollment||participants|Number|3|3.0||||||
3763627|NCT01944969|3596232|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3763628|NCT01944969|3596232|B1|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
3763629|NCT01944969|3596232|B1|Slovakia||Region of Enrollment||participants|Number|2|2.0||||||
3763630|NCT01944969|3596232|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3763631|NCT01944969|3596232|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3763632|NCT01944969|3596232|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3763633|NCT01944969|3596232|B1|||Age||years|Mean|66.12|66.12|Standard Deviation|10.03|10.03|||
3763634|NCT01944969|3596232|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3763635|NCT01944969|3596232|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3763636|NCT01944969|3596232|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3763637|NCT01944878|3596243|B3|||alcoholc|The number of alcoholics in each group is described here.|participants|Number|289|289.0||||||
3763638|NCT01944878|3596244|B2|||alcoholc|The number of alcoholics in each group is described here.|participants|Number|233|233.0||||||
3763639|NCT01944878|3596245|B1|||alcoholc|The number of alcoholics in each group is described here.|participants|Number|56|56.0||||||
3763640|NCT01944878|3596243|B3|||smoking|The number of smokers in each group is described here.|participants|Number|203|203.0||||||
3763641|NCT01944878|3596244|B2|||smoking|The number of smokers in each group is described here.|participants|Number|164|164.0||||||
3763642|NCT01944878|3596245|B1|||smoking|The number of smokers in each group is described here.|participants|Number|39|39.0||||||
3763643|NCT01944878|3596243|B3|||Medication (NSAIDs, aspirin, clopidogrel, ticlopidine, steroid)|The number of patients who taking medication in each group is described here.|participants|Number|23|23.0||||||
3763644|NCT01944878|3596244|B2|||Medication (NSAIDs, aspirin, clopidogrel, ticlopidine, steroid)|The number of patients who taking medication in each group is described here.|participants|Number|16|16.0||||||
3763645|NCT01944878|3596245|B1|||Medication (NSAIDs, aspirin, clopidogrel, ticlopidine, steroid)|The number of patients who taking medication in each group is described here.|participants|Number|7|7.0||||||
3763646|NCT01944878|3596243|B3|||PUD|This is the number of peptic ulcer disease patients in the each group (patients with chronic hepatitis vs. patients with liver cirrhosis)|participants|Number|72|72.0||||||
3763647|NCT01944878|3596244|B2|||PUD|This is the number of peptic ulcer disease patients in the each group (patients with chronic hepatitis vs. patients with liver cirrhosis)|participants|Number|59|59.0||||||
3763648|NCT01944878|3596245|B1|||PUD|This is the number of peptic ulcer disease patients in the each group (patients with chronic hepatitis vs. patients with liver cirrhosis)|participants|Number|13|13.0||||||
3763649|NCT01944878|3596243|B3|||HVPG (mmHg)|HVPG (Hepatic vein pressure gradient) was measured in the enrolled population. HVPG reflects portal pressure of patient. To find the relationship between peptic ulcer disease and portal hypertension, the Fisher's exact test was performed.|mmHg|Median|12|12.0|Inter-Quartile Range|||5.0|18.3|
3763650|NCT01944878|3596244|B2|||HVPG (mmHg)|HVPG (Hepatic vein pressure gradient) was measured in the enrolled population. HVPG reflects portal pressure of patient. To find the relationship between peptic ulcer disease and portal hypertension, the Fisher's exact test was performed.|mmHg|Median|15|15.0|Inter-Quartile Range|||10.78|20.0|
3763651|NCT01944878|3596245|B1|||HVPG (mmHg)|HVPG (Hepatic vein pressure gradient) was measured in the enrolled population. HVPG reflects portal pressure of patient. To find the relationship between peptic ulcer disease and portal hypertension, the Fisher's exact test was performed.|mmHg|Median|3.5|3.5|Inter-Quartile Range|||2.0|5.5|
3763652|NCT01944878|3596243|B3||Male|Sex: Female, Male|The number of gender distribution is described in each group here.|Participants|Count of Participants|339|339.0||||||
3763653|NCT01944878|3596244|B2||Male|Sex: Female, Male|The number of gender distribution is described in each group here.|Participants|Count of Participants|258|258.0||||||
3763654|NCT01944878|3596245|B1||Male|Sex: Female, Male|The number of gender distribution is described in each group here.|Participants|Count of Participants|81|81.0||||||
3763655|NCT01944878|3596243|B3||Female|Sex: Female, Male|The number of gender distribution is described in each group here.|Participants|Count of Participants|116|116.0||||||
3763656|NCT01944878|3596244|B2||Female|Sex: Female, Male|The number of gender distribution is described in each group here.|Participants|Count of Participants|70|70.0||||||
3763657|NCT01944878|3596245|B1||Female|Sex: Female, Male|The number of gender distribution is described in each group here.|Participants|Count of Participants|46|46.0||||||
3763658|NCT01944878|3596243|B3|||Age|This is the median age and interquartile range of enrolled patients divided by group (chronic hepatitis vs. liver cirrhosis)|years|Median|50|50.0|Inter-Quartile Range|||44.0|57.0|
3763715|NCT01944839|3596254|B3|||Age||years|Mean|NA||Standard Deviation|NA||||not calculated
3763659|NCT01944878|3596244|B2|||Age|This is the median age and interquartile range of enrolled patients divided by group (chronic hepatitis vs. liver cirrhosis)|years|Median|52|52.0|Inter-Quartile Range|||46.0|59.0|
3763660|NCT01944878|3596245|B1|||Age|This is the median age and interquartile range of enrolled patients divided by group (chronic hepatitis vs. liver cirrhosis)|years|Median|45|45.0|Inter-Quartile Range|||37.0|54.0|
3763661|NCT01944839|3596254|B3|Estonia||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3763662|NCT01944839|3596255|B2|Estonia||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3763663|NCT01944839|3596256|B1|Estonia||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3763664|NCT01944839|3596254|B3|Slovakia||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3763665|NCT01944839|3596255|B2|Slovakia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3763666|NCT01944839|3596256|B1|Slovakia||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3763667|NCT01944839|3596254|B3|Italy||Region of Enrollment||Participants|Count of Participants|118|118.0||||||
3763668|NCT01944839|3596255|B2|Italy||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
3763669|NCT01944839|3596256|B1|Italy||Region of Enrollment||Participants|Count of Participants|56|56.0||||||
3763670|NCT01944839|3596254|B3|Brazil||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3763671|NCT01944839|3596255|B2|Brazil||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3763672|NCT01944839|3596256|B1|Brazil||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3763673|NCT01944839|3596254|B3|Poland||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
3763674|NCT01944839|3596255|B2|Poland||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3763675|NCT01944839|3596256|B1|Poland||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3763676|NCT01944839|3596254|B3|Belgium||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3763677|NCT01944839|3596255|B2|Belgium||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3763678|NCT01944839|3596256|B1|Belgium||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3763679|NCT01944839|3596254|B3|Latvia||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
3763680|NCT01944839|3596255|B2|Latvia||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3763681|NCT01944839|3596256|B1|Latvia||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3763682|NCT01944839|3596254|B3|Austria||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3763683|NCT01944839|3596255|B2|Austria||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3763684|NCT01944839|3596256|B1|Austria||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3763685|NCT01944839|3596254|B3|Canada||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3763686|NCT01944839|3596255|B2|Canada||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3763687|NCT01944839|3596256|B1|Canada||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3763688|NCT01944839|3596254|B3|Switzerland||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3763689|NCT01944839|3596255|B2|Switzerland||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3763690|NCT01944839|3596256|B1|Switzerland||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3763691|NCT01944839|3596254|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3763692|NCT01944839|3596255|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3763693|NCT01944839|3596256|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3763694|NCT01944839|3596254|B3|Czechia||Region of Enrollment||Participants|Count of Participants|84|84.0||||||
3763695|NCT01944839|3596255|B2|Czechia||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3763696|NCT01944839|3596256|B1|Czechia||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3763697|NCT01944839|3596254|B3|United States||Region of Enrollment||Participants|Count of Participants|210|210.0||||||
3763698|NCT01944839|3596255|B2|United States||Region of Enrollment||Participants|Count of Participants|104|104.0||||||
3763699|NCT01944839|3596256|B1|United States||Region of Enrollment||Participants|Count of Participants|106|106.0||||||
3763700|NCT01944839|3596254|B3||Male|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
3763701|NCT01944839|3596255|B2||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3763702|NCT01944839|3596256|B1||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3763703|NCT01944839|3596254|B3||Female|Sex: Female, Male||Participants|Count of Participants|377|377.0||||||
3763704|NCT01944839|3596255|B2||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
3763705|NCT01944839|3596256|B1||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
3763706|NCT01944839|3596254|B3|85 years and over||Age, Customized||Participants|Count of Participants|97|97.0||||||
3763707|NCT01944839|3596255|B2|85 years and over||Age, Customized||Participants|Count of Participants|57|57.0||||||
3763708|NCT01944839|3596256|B1|85 years and over||Age, Customized||Participants|Count of Participants|40|40.0||||||
3763709|NCT01944839|3596254|B3|Adults 65 - 84 years||Age, Customized||Participants|Count of Participants|476|476.0||||||
3763710|NCT01944839|3596255|B2|Adults 65 - 84 years||Age, Customized||Participants|Count of Participants|233|233.0||||||
3763711|NCT01944839|3596256|B1|Adults 65 - 84 years||Age, Customized||Participants|Count of Participants|243|243.0||||||
3763712|NCT01944839|3596254|B3|Adults 18-64 years||Age, Customized||Participants|Count of Participants|46|46.0||||||
3763713|NCT01944839|3596255|B2|Adults 18-64 years||Age, Customized||Participants|Count of Participants|20|20.0||||||
3763714|NCT01944839|3596256|B1|Adults 18-64 years||Age, Customized||Participants|Count of Participants|26|26.0||||||
3763716|NCT01944839|3596255|B2|||Age||years|Mean|76.9|76.9|Standard Deviation|8.04|8.04|||
3763717|NCT01944839|3596256|B1|||Age||years|Mean|76.1|76.1|Standard Deviation|7.98|7.98|||
3763718|NCT01944774|3596263|B4|Current drinker||Drinking status||participants|Number|47|47.0||||||
3763719|NCT01944774|3596264|B3|Current drinker||Drinking status||participants|Number|18|18.0||||||
3763720|NCT01944774|3596265|B2|Current drinker||Drinking status||participants|Number|20|20.0||||||
3763721|NCT01944774|3596266|B1|Current drinker||Drinking status||participants|Number|9|9.0||||||
3763722|NCT01944774|3596263|B4|Former drinker||Drinking status||participants|Number|14|14.0||||||
3763723|NCT01944774|3596264|B3|Former drinker||Drinking status||participants|Number|7|7.0||||||
3763724|NCT01944774|3596265|B2|Former drinker||Drinking status||participants|Number|3|3.0||||||
3763725|NCT01944774|3596266|B1|Former drinker||Drinking status||participants|Number|4|4.0||||||
3763726|NCT01944774|3596263|B4|Lifetime abstainer||Drinking status||participants|Number|134|134.0||||||
3763727|NCT01944774|3596264|B3|Lifetime abstainer||Drinking status||participants|Number|39|39.0||||||
3763728|NCT01944774|3596265|B2|Lifetime abstainer||Drinking status||participants|Number|41|41.0||||||
3763729|NCT01944774|3596266|B1|Lifetime abstainer||Drinking status||participants|Number|54|54.0||||||
3763730|NCT01944774|3596263|B4|Current smoker or smoked within the past 2 years||Smoking status||participants|Number|55|55.0||||||
3763731|NCT01944774|3596264|B3|Current smoker or smoked within the past 2 years||Smoking status||participants|Number|17|17.0||||||
3763732|NCT01944774|3596265|B2|Current smoker or smoked within the past 2 years||Smoking status||participants|Number|24|24.0||||||
3763733|NCT01944774|3596266|B1|Current smoker or smoked within the past 2 years||Smoking status||participants|Number|14|14.0||||||
3763734|NCT01944774|3596263|B4|Former smoker (abstinent for a minimum of 2 years)||Smoking status||participants|Number|20|20.0||||||
3763735|NCT01944774|3596264|B3|Former smoker (abstinent for a minimum of 2 years)||Smoking status||participants|Number|4|4.0||||||
3763736|NCT01944774|3596265|B2|Former smoker (abstinent for a minimum of 2 years)||Smoking status||participants|Number|8|8.0||||||
3763737|NCT01944774|3596266|B1|Former smoker (abstinent for a minimum of 2 years)||Smoking status||participants|Number|8|8.0||||||
3763738|NCT01944774|3596263|B4|Never smoked||Smoking status||participants|Number|120|120.0||||||
3763739|NCT01944774|3596264|B3|Never smoked||Smoking status||participants|Number|43|43.0||||||
3763740|NCT01944774|3596265|B2|Never smoked||Smoking status||participants|Number|32|32.0||||||
3763741|NCT01944774|3596266|B1|Never smoked||Smoking status||participants|Number|45|45.0||||||
3763742|NCT01944774|3596263|B4|Class IV||PORT/PSI score|The pneumonia severity index PSI or PORT Score is a clinical prediction rule that medical practitioners use to calculate the probability of morbidity and mortality among patients with CAP. Point values are given for various parameters of demographics, comorbidity, physical exam fndings, lab and radiographic findings. The total PSI score places a given patient into one of 5 risk classes. Classes I, II, and III are at low risk for death, and may be considered for outpatient treatment. Risk classes IV and V should be hospitalized and even an intensive care should be considered.|participants|Number|10|10.0||||||
3763743|NCT01944774|3596264|B3|Class IV||PORT/PSI score|The pneumonia severity index PSI or PORT Score is a clinical prediction rule that medical practitioners use to calculate the probability of morbidity and mortality among patients with CAP. Point values are given for various parameters of demographics, comorbidity, physical exam fndings, lab and radiographic findings. The total PSI score places a given patient into one of 5 risk classes. Classes I, II, and III are at low risk for death, and may be considered for outpatient treatment. Risk classes IV and V should be hospitalized and even an intensive care should be considered.|participants|Number|5|5.0||||||
3763744|NCT01944774|3596265|B2|Class IV||PORT/PSI score|The pneumonia severity index PSI or PORT Score is a clinical prediction rule that medical practitioners use to calculate the probability of morbidity and mortality among patients with CAP. Point values are given for various parameters of demographics, comorbidity, physical exam fndings, lab and radiographic findings. The total PSI score places a given patient into one of 5 risk classes. Classes I, II, and III are at low risk for death, and may be considered for outpatient treatment. Risk classes IV and V should be hospitalized and even an intensive care should be considered.|participants|Number|3|3.0||||||
3763745|NCT01944774|3596266|B1|Class IV||PORT/PSI score|The pneumonia severity index PSI or PORT Score is a clinical prediction rule that medical practitioners use to calculate the probability of morbidity and mortality among patients with CAP. Point values are given for various parameters of demographics, comorbidity, physical exam fndings, lab and radiographic findings. The total PSI score places a given patient into one of 5 risk classes. Classes I, II, and III are at low risk for death, and may be considered for outpatient treatment. Risk classes IV and V should be hospitalized and even an intensive care should be considered.|participants|Number|2|2.0||||||
3763746|NCT01944774|3596263|B4|Class III||PORT/PSI score|The pneumonia severity index PSI or PORT Score is a clinical prediction rule that medical practitioners use to calculate the probability of morbidity and mortality among patients with CAP. Point values are given for various parameters of demographics, comorbidity, physical exam fndings, lab and radiographic findings. The total PSI score places a given patient into one of 5 risk classes. Classes I, II, and III are at low risk for death, and may be considered for outpatient treatment. Risk classes IV and V should be hospitalized and even an intensive care should be considered.|participants|Number|91|91.0||||||
3763747|NCT01944774|3596264|B3|Class III||PORT/PSI score|The pneumonia severity index PSI or PORT Score is a clinical prediction rule that medical practitioners use to calculate the probability of morbidity and mortality among patients with CAP. Point values are given for various parameters of demographics, comorbidity, physical exam fndings, lab and radiographic findings. The total PSI score places a given patient into one of 5 risk classes. Classes I, II, and III are at low risk for death, and may be considered for outpatient treatment. Risk classes IV and V should be hospitalized and even an intensive care should be considered.|participants|Number|29|29.0||||||
3763785|NCT01944774|3596266|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763786|NCT01944774|3596263|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763787|NCT01944774|3596264|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763748|NCT01944774|3596265|B2|Class III||PORT/PSI score|The pneumonia severity index PSI or PORT Score is a clinical prediction rule that medical practitioners use to calculate the probability of morbidity and mortality among patients with CAP. Point values are given for various parameters of demographics, comorbidity, physical exam fndings, lab and radiographic findings. The total PSI score places a given patient into one of 5 risk classes. Classes I, II, and III are at low risk for death, and may be considered for outpatient treatment. Risk classes IV and V should be hospitalized and even an intensive care should be considered.|participants|Number|28|28.0||||||
3763749|NCT01944774|3596266|B1|Class III||PORT/PSI score|The pneumonia severity index PSI or PORT Score is a clinical prediction rule that medical practitioners use to calculate the probability of morbidity and mortality among patients with CAP. Point values are given for various parameters of demographics, comorbidity, physical exam fndings, lab and radiographic findings. The total PSI score places a given patient into one of 5 risk classes. Classes I, II, and III are at low risk for death, and may be considered for outpatient treatment. Risk classes IV and V should be hospitalized and even an intensive care should be considered.|participants|Number|34|34.0||||||
3763750|NCT01944774|3596263|B4|Class II||PORT/PSI score|The pneumonia severity index PSI or PORT Score is a clinical prediction rule that medical practitioners use to calculate the probability of morbidity and mortality among patients with CAP. Point values are given for various parameters of demographics, comorbidity, physical exam fndings, lab and radiographic findings. The total PSI score places a given patient into one of 5 risk classes. Classes I, II, and III are at low risk for death, and may be considered for outpatient treatment. Risk classes IV and V should be hospitalized and even an intensive care should be considered.|participants|Number|94|94.0||||||
3763751|NCT01944774|3596264|B3|Class II||PORT/PSI score|The pneumonia severity index PSI or PORT Score is a clinical prediction rule that medical practitioners use to calculate the probability of morbidity and mortality among patients with CAP. Point values are given for various parameters of demographics, comorbidity, physical exam fndings, lab and radiographic findings. The total PSI score places a given patient into one of 5 risk classes. Classes I, II, and III are at low risk for death, and may be considered for outpatient treatment. Risk classes IV and V should be hospitalized and even an intensive care should be considered.|participants|Number|30|30.0||||||
3763752|NCT01944774|3596265|B2|Class II||PORT/PSI score|The pneumonia severity index PSI or PORT Score is a clinical prediction rule that medical practitioners use to calculate the probability of morbidity and mortality among patients with CAP. Point values are given for various parameters of demographics, comorbidity, physical exam fndings, lab and radiographic findings. The total PSI score places a given patient into one of 5 risk classes. Classes I, II, and III are at low risk for death, and may be considered for outpatient treatment. Risk classes IV and V should be hospitalized and even an intensive care should be considered.|participants|Number|33|33.0||||||
3763753|NCT01944774|3596266|B1|Class II||PORT/PSI score|The pneumonia severity index PSI or PORT Score is a clinical prediction rule that medical practitioners use to calculate the probability of morbidity and mortality among patients with CAP. Point values are given for various parameters of demographics, comorbidity, physical exam fndings, lab and radiographic findings. The total PSI score places a given patient into one of 5 risk classes. Classes I, II, and III are at low risk for death, and may be considered for outpatient treatment. Risk classes IV and V should be hospitalized and even an intensive care should be considered.|participants|Number|31|31.0||||||
3763754|NCT01944774|3596263|B4|||BMI||kg/m^2|Mean|23.1|23.1|Standard Deviation|3.27|3.27|||
3763755|NCT01944774|3596264|B3|||BMI||kg/m^2|Mean|23.6|23.6|Standard Deviation|3.29|3.29|||
3763756|NCT01944774|3596265|B2|||BMI||kg/m^2|Mean|23.4|23.4|Standard Deviation|3.44|3.44|||
3763757|NCT01944774|3596266|B1|||BMI||kg/m^2|Mean|22.5|22.5|Standard Deviation|3.01|3.01|||
3763758|NCT01944774|3596263|B4|||Weight||kg|Mean|62.5|62.5|Standard Deviation|11.29|11.29|||
3763759|NCT01944774|3596264|B3|||Weight||kg|Mean|64.3|64.3|Standard Deviation|11.81|11.81|||
3763760|NCT01944774|3596265|B2|||Weight||kg|Mean|63.5|63.5|Standard Deviation|12.94|12.94|||
3763761|NCT01944774|3596266|B1|||Weight||kg|Mean|60.0|60.0|Standard Deviation|8.45|8.45|||
3763762|NCT01944774|3596263|B4|||Height||cm|Mean|164.1|164.1|Standard Deviation|8.13|8.13|||
3763763|NCT01944774|3596264|B3|||Height||cm|Mean|164.7|164.7|Standard Deviation|8.68|8.68|||
3763764|NCT01944774|3596265|B2|||Height||cm|Mean|164.2|164.2|Standard Deviation|8.65|8.65|||
3763765|NCT01944774|3596266|B1|||Height||cm|Mean|163.5|163.5|Standard Deviation|7.08|7.08|||
3763766|NCT01944774|3596263|B4|Unknown||Nationality||participants|Number|4|4.0||||||
3763767|NCT01944774|3596264|B3|Unknown||Nationality||participants|Number|1|1.0||||||
3763768|NCT01944774|3596265|B2|Unknown||Nationality||participants|Number|1|1.0||||||
3763769|NCT01944774|3596266|B1|Unknown||Nationality||participants|Number|2|2.0||||||
3763770|NCT01944774|3596263|B4|Taiwan Aborigines||Nationality||participants|Number|1|1.0||||||
3763771|NCT01944774|3596264|B3|Taiwan Aborigines||Nationality||participants|Number|1|1.0||||||
3763772|NCT01944774|3596265|B2|Taiwan Aborigines||Nationality||participants|Number|0|0.0||||||
3763773|NCT01944774|3596266|B1|Taiwan Aborigines||Nationality||participants|Number|0|0.0||||||
3763774|NCT01944774|3596263|B4|Minority ethnic groups||Nationality||participants|Number|6|6.0||||||
3763775|NCT01944774|3596264|B3|Minority ethnic groups||Nationality||participants|Number|1|1.0||||||
3763776|NCT01944774|3596265|B2|Minority ethnic groups||Nationality||participants|Number|2|2.0||||||
3763777|NCT01944774|3596266|B1|Minority ethnic groups||Nationality||participants|Number|3|3.0||||||
3763778|NCT01944774|3596263|B4|Han||Nationality||participants|Number|184|184.0||||||
3763779|NCT01944774|3596264|B3|Han||Nationality||participants|Number|61|61.0||||||
3763780|NCT01944774|3596265|B2|Han||Nationality||participants|Number|61|61.0||||||
3763781|NCT01944774|3596266|B1|Han||Nationality||participants|Number|62|62.0||||||
3763782|NCT01944774|3596263|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763783|NCT01944774|3596264|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763784|NCT01944774|3596265|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763788|NCT01944774|3596265|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763789|NCT01944774|3596266|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763790|NCT01944774|3596263|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763791|NCT01944774|3596264|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763792|NCT01944774|3596265|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763793|NCT01944774|3596266|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763794|NCT01944774|3596263|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763795|NCT01944774|3596264|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763796|NCT01944774|3596265|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763797|NCT01944774|3596266|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763798|NCT01944774|3596263|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763799|NCT01944774|3596264|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763800|NCT01944774|3596265|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763801|NCT01944774|3596266|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763802|NCT01944774|3596263|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|195|195.0||||||
3763803|NCT01944774|3596264|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3763804|NCT01944774|3596265|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3763805|NCT01944774|3596266|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3763806|NCT01944774|3596263|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763807|NCT01944774|3596264|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763808|NCT01944774|3596265|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763809|NCT01944774|3596266|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763810|NCT01944774|3596263|B4||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3763811|NCT01944774|3596264|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3763812|NCT01944774|3596265|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3763813|NCT01944774|3596266|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3763814|NCT01944774|3596263|B4||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3763815|NCT01944774|3596264|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3763816|NCT01944774|3596265|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3763817|NCT01944774|3596266|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3763818|NCT01944774|3596263|B4|≧70 and < 76 years||Age, Customized||participants|Number|27|27.0||||||
3763819|NCT01944774|3596264|B3|≧70 and < 76 years||Age, Customized||participants|Number|9|9.0||||||
3763820|NCT01944774|3596265|B2|≧70 and < 76 years||Age, Customized||participants|Number|8|8.0||||||
3763821|NCT01944774|3596266|B1|≧70 and < 76 years||Age, Customized||participants|Number|10|10.0||||||
3763822|NCT01944774|3596263|B4|≧60 and < 70 years||Age, Customized||participants|Number|50|50.0||||||
3763823|NCT01944774|3596264|B3|≧60 and < 70 years||Age, Customized||participants|Number|17|17.0||||||
3763824|NCT01944774|3596265|B2|≧60 and < 70 years||Age, Customized||participants|Number|17|17.0||||||
3763825|NCT01944774|3596266|B1|≧60 and < 70 years||Age, Customized||participants|Number|16|16.0||||||
3763826|NCT01944774|3596263|B4|≧50 and < 60 years||Age, Customized||participants|Number|42|42.0||||||
3763827|NCT01944774|3596264|B3|≧50 and < 60 years||Age, Customized||participants|Number|11|11.0||||||
3763828|NCT01944774|3596265|B2|≧50 and < 60 years||Age, Customized||participants|Number|15|15.0||||||
3763829|NCT01944774|3596266|B1|≧50 and < 60 years||Age, Customized||participants|Number|16|16.0||||||
3763830|NCT01944774|3596263|B4|≧40 and < 50 years||Age, Customized||participants|Number|30|30.0||||||
3763831|NCT01944774|3596264|B3|≧40 and < 50 years||Age, Customized||participants|Number|8|8.0||||||
3763832|NCT01944774|3596265|B2|≧40 and < 50 years||Age, Customized||participants|Number|12|12.0||||||
3763833|NCT01944774|3596266|B1|≧40 and < 50 years||Age, Customized||participants|Number|10|10.0||||||
3763834|NCT01944774|3596263|B4|≧30 and < 40 years||Age, Customized||participants|Number|26|26.0||||||
3763835|NCT01944774|3596264|B3|≧30 and < 40 years||Age, Customized||participants|Number|9|9.0||||||
3763836|NCT01944774|3596265|B2|≧30 and < 40 years||Age, Customized||participants|Number|8|8.0||||||
3763837|NCT01944774|3596266|B1|≧30 and < 40 years||Age, Customized||participants|Number|9|9.0||||||
3763838|NCT01944774|3596263|B4|≧18 and <30 years||Age, Customized||participants|Number|20|20.0||||||
3763839|NCT01944774|3596264|B3|≧18 and <30 years||Age, Customized||participants|Number|10|10.0||||||
3763840|NCT01944774|3596265|B2|≧18 and <30 years||Age, Customized||participants|Number|4|4.0||||||
3763841|NCT01944774|3596266|B1|≧18 and <30 years||Age, Customized||participants|Number|6|6.0||||||
3763842|NCT01944774|3596263|B4|||Age||years|Mean|52.6|52.6|Standard Deviation|15.14|15.14|||
3763843|NCT01944774|3596264|B3|||Age||years|Mean|51.5|51.5|Standard Deviation|16.00|16.0|||
3763844|NCT01944774|3596265|B2|||Age||years|Mean|53.5|53.5|Standard Deviation|14.21|14.21|||
3763845|NCT01944774|3596266|B1|||Age||years|Mean|52.7|52.7|Standard Deviation|15.33|15.33|||
3763846|NCT01944722|3596309|B3|United States||Region of Enrollment||Participants|Count of Participants|24343|24343.0||||||
3763847|NCT01944722|3596310|B2|United States||Region of Enrollment||Participants|Count of Participants|22383|22383.0||||||
3763848|NCT01944722|3596311|B1|United States||Region of Enrollment||Participants|Count of Participants|1960|1960.0||||||
3763849|NCT01944722|3596309|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|204|204.0||||||
3763850|NCT01944722|3596310|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|180|180.0||||||
3763851|NCT01944722|3596311|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3763852|NCT01944722|3596309|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763853|NCT01944722|3596310|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763854|NCT01944722|3596311|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763855|NCT01944722|3596309|B3||White|Race (NIH/OMB)||Participants|Count of Participants|19434|19434.0||||||
3763856|NCT01944722|3596310|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17988|17988.0||||||
3763857|NCT01944722|3596311|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1446|1446.0||||||
3763858|NCT01944722|3596309|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4181|4181.0||||||
3763859|NCT01944722|3596310|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3722|3722.0||||||
3763860|NCT01944722|3596311|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|459|459.0||||||
3763861|NCT01944722|3596309|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3763862|NCT01944722|3596310|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3763863|NCT01944722|3596311|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3763864|NCT01944722|3596309|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|356|356.0||||||
3763865|NCT01944722|3596310|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|336|336.0||||||
3763866|NCT01944722|3596311|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3763867|NCT01944722|3596309|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
3763868|NCT01944722|3596310|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
3763869|NCT01944722|3596311|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3763870|NCT01944722|3596309|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3763871|NCT01944722|3596310|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3763872|NCT01944722|3596311|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763873|NCT01944722|3596309|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19446|19446.0||||||
3763874|NCT01944722|3596310|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17789|17789.0||||||
3763875|NCT01944722|3596311|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1657|1657.0||||||
3763876|NCT01944722|3596309|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4895|4895.0||||||
3763877|NCT01944722|3596310|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4592|4592.0||||||
3763878|NCT01944722|3596311|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|303|303.0||||||
3763879|NCT01944722|3596309|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3763880|NCT01944722|3596310|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3763881|NCT01944722|3596311|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3763882|NCT01944722|3596309|B3||Female|Sex: Female, Male||Participants|Count of Participants|24343|24343.0||||||
3763883|NCT01944722|3596310|B2||Female|Sex: Female, Male||Participants|Count of Participants|22383|22383.0||||||
3763884|NCT01944722|3596311|B1||Female|Sex: Female, Male||Participants|Count of Participants|1960|1960.0||||||
3763885|NCT01944722|3596309|B3|||Age||years|Mean|43.3|43.3|Standard Deviation|10.0|10.0|||
3763886|NCT01944722|3596310|B2|||Age||years|Mean|43.9|43.9|Standard Deviation|9.6|9.6|||
3763887|NCT01944722|3596311|B1|||Age||years|Mean|36.2|36.2|Standard Deviation|11.5|11.5|||
3763888|NCT01944670|3596345|B1||Dislocated|Subluxed or Dislocated||Participants|Count of Participants|19|19.0||||||
3763889|NCT01944670|3596345|B1||Subluxed|Subluxed or Dislocated||Participants|Count of Participants|7|7.0||||||
3763890|NCT01944670|3596345|B1||Non-dominant Hand|Operative Side||Participants|Count of Participants|17|17.0||||||
3763891|NCT01944670|3596345|B1||Dominant Hand (including ambidextrous patients)|Operative Side||Participants|Count of Participants|9|9.0||||||
3763892|NCT01944670|3596345|B1||Ambidextrous|Side Dominance||Participants|Count of Participants|1|1.0||||||
3763893|NCT01944670|3596345|B1||Left Handed|Side Dominance||Participants|Count of Participants|1|1.0||||||
3763894|NCT01944670|3596345|B1||Right Handed|Side Dominance||Participants|Count of Participants|24|24.0||||||
3763895|NCT01944670|3596345|B1|||Weight (lbs)||lbs|Mean|188.0|188.0|Standard Deviation|41.2|41.2|||
3763896|NCT01944670|3596345|B1|||Height (in)||inches|Mean|65.8|65.8|Standard Deviation|4.0|4.0|||
3763897|NCT01944670|3596345|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3763898|NCT01944670|3596345|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3763899|NCT01944670|3596345|B1|||Age||years|Mean|57.1|57.1|Standard Deviation|18.6|18.6|||
3763927|NCT01944644|3596350|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763928|NCT01944644|3596351|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763929|NCT01944644|3596352|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763900|NCT01944644|3596350|B3|||Positive and Negative Affect Score (PANAS) - Positive Subscale|The Positive and Negative Affect Schedule (PANAS) measures both positive affect and negative affect. Participants in the PANAS are required to respond to two 20-item subscales using 5-point scale that ranges from very slightly or not at all (1) to extremely (5). This positive subscale captures self-rated scale of symptoms of depression ranging from 0-50 (higher score means less depression).|units on a scale|Mean|22.8|22.8|Standard Deviation|8.4|8.4|||
3763901|NCT01944644|3596351|B2|||Positive and Negative Affect Score (PANAS) - Positive Subscale|The Positive and Negative Affect Schedule (PANAS) measures both positive affect and negative affect. Participants in the PANAS are required to respond to two 20-item subscales using 5-point scale that ranges from very slightly or not at all (1) to extremely (5). This positive subscale captures self-rated scale of symptoms of depression ranging from 0-50 (higher score means less depression).|units on a scale|Mean|22.4|22.4|Standard Deviation|8.0|8.0|||
3763902|NCT01944644|3596352|B1|||Positive and Negative Affect Score (PANAS) - Positive Subscale|The Positive and Negative Affect Schedule (PANAS) measures both positive affect and negative affect. Participants in the PANAS are required to respond to two 20-item subscales using 5-point scale that ranges from very slightly or not at all (1) to extremely (5). This positive subscale captures self-rated scale of symptoms of depression ranging from 0-50 (higher score means less depression).|units on a scale|Mean|23.1|23.1|Standard Deviation|8.7|8.7|||
3763903|NCT01944644|3596350|B3|||Positive and Negative Affect Score (PANAS) - Negative Subscale|The Positive and Negative Affect Schedule (PANAS) measures both positive affect and negative affect. Participants in the PANAS are required to respond to two 20-item subscales using 5-point scale that ranges from very slightly or not at all (1) to extremely (5). This negative subscale captures self-rated scale of symptoms of depression ranging from 0-50 (higher score means worse depression).|units on a scale|Mean|25.6|25.6|Standard Deviation|8.25|8.25|||
3763904|NCT01944644|3596351|B2|||Positive and Negative Affect Score (PANAS) - Negative Subscale|The Positive and Negative Affect Schedule (PANAS) measures both positive affect and negative affect. Participants in the PANAS are required to respond to two 20-item subscales using 5-point scale that ranges from very slightly or not at all (1) to extremely (5). This negative subscale captures self-rated scale of symptoms of depression ranging from 0-50 (higher score means worse depression).|units on a scale|Mean|27.5|27.5|Standard Deviation|8.9|8.9|||
3763905|NCT01944644|3596352|B1|||Positive and Negative Affect Score (PANAS) - Negative Subscale|The Positive and Negative Affect Schedule (PANAS) measures both positive affect and negative affect. Participants in the PANAS are required to respond to two 20-item subscales using 5-point scale that ranges from very slightly or not at all (1) to extremely (5). This negative subscale captures self-rated scale of symptoms of depression ranging from 0-50 (higher score means worse depression).|units on a scale|Mean|23.7|23.7|Standard Deviation|7.6|7.6|||
3763906|NCT01944644|3596350|B3|||Visual Analog Scale|A Visual Analog Scale is a measurement of subjective characteristics that cannot be directly measured. Using this self questionnaire, subjects specify their level of depression along a continuous line between two end-points ranging from 0-100 (higher score means better mood).|units on a scale|Mean|52.7|52.7|Standard Deviation|20.1|20.1|||
3763907|NCT01944644|3596351|B2|||Visual Analog Scale|A Visual Analog Scale is a measurement of subjective characteristics that cannot be directly measured. Using this self questionnaire, subjects specify their level of depression along a continuous line between two end-points ranging from 0-100 (higher score means better mood).|units on a scale|Mean|49.9|49.9|Standard Deviation|21.8|21.8|||
3763908|NCT01944644|3596352|B1|||Visual Analog Scale|A Visual Analog Scale is a measurement of subjective characteristics that cannot be directly measured. Using this self questionnaire, subjects specify their level of depression along a continuous line between two end-points ranging from 0-100 (higher score means better mood).|units on a scale|Mean|55.4|55.4|Standard Deviation|19.9|19.9|||
3763909|NCT01944644|3596350|B3|||Hamilton Scale for Depression (HamD) 6 Item|The Hamilton Scale for Depression 6 item subscale scores range from 0-24. Higher scores indicate greater severity of depression. Total scores are reported with no subscales.|units on a scale|Mean|11.6|11.6|Standard Deviation|1.75|1.75|||
3763910|NCT01944644|3596351|B2|||Hamilton Scale for Depression (HamD) 6 Item|The Hamilton Scale for Depression 6 item subscale scores range from 0-24. Higher scores indicate greater severity of depression. Total scores are reported with no subscales.|units on a scale|Mean|11.4|11.4|Standard Deviation|1.8|1.8|||
3763911|NCT01944644|3596352|B1|||Hamilton Scale for Depression (HamD) 6 Item|The Hamilton Scale for Depression 6 item subscale scores range from 0-24. Higher scores indicate greater severity of depression. Total scores are reported with no subscales.|units on a scale|Mean|11.8|11.8|Standard Deviation|1.7|1.7|||
3763912|NCT01944644|3596350|B3|United States||Region of Enrollment||Participants|Count of Participants|66|66.0||||||
3763913|NCT01944644|3596351|B2|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3763914|NCT01944644|3596352|B1|United States||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3763915|NCT01944644|3596350|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763916|NCT01944644|3596351|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763917|NCT01944644|3596352|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763918|NCT01944644|3596350|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3763919|NCT01944644|3596351|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3763920|NCT01944644|3596352|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3763921|NCT01944644|3596350|B3||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3763922|NCT01944644|3596351|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3763923|NCT01944644|3596352|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3763924|NCT01944644|3596350|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3763925|NCT01944644|3596351|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3763926|NCT01944644|3596352|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3763930|NCT01944644|3596350|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3763931|NCT01944644|3596351|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3763932|NCT01944644|3596352|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763933|NCT01944644|3596350|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763934|NCT01944644|3596351|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763935|NCT01944644|3596352|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763936|NCT01944644|3596350|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763937|NCT01944644|3596351|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763938|NCT01944644|3596352|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763939|NCT01944644|3596350|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3763940|NCT01944644|3596351|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3763941|NCT01944644|3596352|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3763942|NCT01944644|3596350|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3763943|NCT01944644|3596351|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3763944|NCT01944644|3596352|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3763945|NCT01944644|3596350|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3763946|NCT01944644|3596351|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3763947|NCT01944644|3596352|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3763948|NCT01944644|3596350|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3763949|NCT01944644|3596351|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3763950|NCT01944644|3596352|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3763951|NCT01944644|3596350|B3|||Age||years|Mean|46.4|46.4|Standard Deviation|13.65|13.65|||
3763952|NCT01944644|3596351|B2|||Age||years|Mean|46.2|46.2|Standard Deviation|12.2|12.2|||
3763953|NCT01944644|3596352|B1|||Age||years|Mean|46.6|46.6|Standard Deviation|15.1|15.1|||
3763954|NCT01944631|3596365|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3763955|NCT01944631|3596366|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3763956|NCT01944631|3596367|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3763957|NCT01944631|3596365|B3||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3763958|NCT01944631|3596366|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3763959|NCT01944631|3596367|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3763960|NCT01944631|3596365|B3|||Age||years|Mean|19.97|19.97|Standard Deviation|2.14|2.14|||
3763961|NCT01944631|3596366|B2|||Age||years|Mean|20.01|20.01|Standard Deviation|2.37|2.37|||
3763962|NCT01944631|3596367|B1|||Age||years|Mean|19.93|19.93|Standard Deviation|1.90|1.9|||
3763963|NCT01944462|3596384|B1|United States||Region of Enrollment||participants|Number|203|203.0||||||
3763964|NCT01944462|3596384|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3763965|NCT01944462|3596384|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763966|NCT01944462|3596384|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3763967|NCT01944462|3596384|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|163|163.0||||||
3763968|NCT01944462|3596384|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763969|NCT01944462|3596384|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763970|NCT01944462|3596384|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3763971|NCT01944462|3596384|B1|Gender, customized|No response / prefer not to answer|Sex/Gender, Customized||Participants|Count of Participants|28|28.0||||||
3763972|NCT01944462|3596384|B1|Gender, customized|Male|Sex/Gender, Customized||Participants|Count of Participants|23|23.0||||||
3763973|NCT01944462|3596384|B1|Gender, customized|Female|Sex/Gender, Customized||Participants|Count of Participants|152|152.0||||||
3763974|NCT01944462|3596384|B1|||Age||years|Mean|74.4|74.4|Standard Deviation|8.955|8.955|||
3763975|NCT01944345|3596393|B1|||BMI < 40kg/m^2||participants|Number|69|69.0||||||
3763976|NCT01944345|3596393|B1|United States||Region of Enrollment||participants|Number|69|69.0||||||
3763977|NCT01944345|3596393|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3763978|NCT01944345|3596393|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3763979|NCT01944345|3596393|B1|||Age||years|Median|60|60.0|Full Range|||27.0|81.0|
3763980|NCT01944345|3596393|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3763981|NCT01944345|3596393|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3763982|NCT01944345|3596393|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3763983|NCT01944319|3596399|B3|China||Region of Enrollment||participants|Number|79|79.0||||||
3763984|NCT01944319|3596400|B2|China||Region of Enrollment||participants|Number|39|39.0||||||
3763985|NCT01944319|3596401|B1|China||Region of Enrollment||participants|Number|40|40.0||||||
3763986|NCT01944319|3596399|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3763987|NCT01944319|3596400|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3763988|NCT01944319|3596401|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3763989|NCT01944319|3596399|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3763990|NCT01944319|3596400|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3763991|NCT01944319|3596401|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3763992|NCT01944319|3596399|B3|||Age||years|Median|79|79.0|Inter-Quartile Range|||76.0|85.0|
3763993|NCT01944319|3596400|B2|||Age||years|Median|78|78.0|Inter-Quartile Range|||76.0|84.0|
3763994|NCT01944319|3596401|B1|||Age||years|Median|79|79.0|Inter-Quartile Range|||74.0|87.0|
3763995|NCT01944098|3596412|B3|||BMI||kg/m^2|Mean|47.5|47.5|Standard Deviation|5.9|5.9|||
3763996|NCT01944098|3596413|B2|||BMI||kg/m^2|Mean|48.3|48.3|Standard Deviation|5.6|5.6|||
3763997|NCT01944098|3596414|B1|||BMI||kg/m^2|Mean|46.4|46.4|Standard Deviation|6.1|6.1|||
3763998|NCT01944098|3596412|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3763999|NCT01944098|3596413|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3764000|NCT01944098|3596414|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3764001|NCT01944098|3596412|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3764002|NCT01944098|3596413|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3764003|NCT01944098|3596414|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3764004|NCT01944098|3596412|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764005|NCT01944098|3596413|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764006|NCT01944098|3596414|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764007|NCT01944098|3596412|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764008|NCT01944098|3596413|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764009|NCT01944098|3596414|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764010|NCT01944098|3596412|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764011|NCT01944098|3596413|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764012|NCT01944098|3596414|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764013|NCT01944098|3596412|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764014|NCT01944098|3596413|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764015|NCT01944098|3596414|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764016|NCT01944098|3596412|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764017|NCT01944098|3596413|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764018|NCT01944098|3596414|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764019|NCT01944098|3596412|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764020|NCT01944098|3596413|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764021|NCT01944098|3596414|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764022|NCT01944098|3596412|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3764023|NCT01944098|3596413|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3764024|NCT01944098|3596414|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3764025|NCT01944098|3596412|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764026|NCT01944098|3596413|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764027|NCT01944098|3596414|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764028|NCT01944098|3596412|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764029|NCT01944098|3596413|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764030|NCT01944098|3596414|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764031|NCT01944098|3596412|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3764032|NCT01944098|3596413|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3764033|NCT01944098|3596414|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3764034|NCT01944098|3596412|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3764035|NCT01944098|3596413|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3764036|NCT01944098|3596414|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3764037|NCT01944098|3596412|B3|Age||Age||years|Mean|47.4|47.4|Standard Deviation|7.8|7.8|||
3764038|NCT01944098|3596413|B2|Age||Age||years|Mean|47.5|47.5|Standard Deviation|7.4|7.4|||
3764039|NCT01944098|3596414|B1|Age||Age||years|Mean|47.3|47.3|Standard Deviation|8.3|8.3|||
3764040|NCT01944059|3596427|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
3764041|NCT01944059|3596427|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764042|NCT01944059|3596427|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3764043|NCT01944059|3596427|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3764044|NCT01944059|3596427|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3764045|NCT01944059|3596427|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764046|NCT01944059|3596427|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764047|NCT01944059|3596427|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764048|NCT01944059|3596427|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764049|NCT01944059|3596427|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3764050|NCT01944059|3596427|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3764051|NCT01944059|3596427|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3764052|NCT01944059|3596427|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3764053|NCT01944059|3596427|B1|||Age||years|Mean|44.8|44.8|Full Range|||22.0|65.0|
3764054|NCT01943864|3596436|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
3764055|NCT01943864|3596436|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3764056|NCT01943864|3596436|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3764057|NCT01943864|3596436|B1|||Age||Years|Mean|62.3|62.3|Standard Deviation|8.16|8.16|||
3764058|NCT01943565|3596464|B4|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3764059|NCT01943565|3596465|B3|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3764060|NCT01943565|3596466|B2|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3764061|NCT01943565|3596467|B1|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3764062|NCT01943565|3596464|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3764063|NCT01943565|3596465|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3764064|NCT01943565|3596466|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3764065|NCT01943565|3596467|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3764066|NCT01943565|3596464|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3764067|NCT01943565|3596465|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3764068|NCT01943565|3596466|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3764069|NCT01943565|3596467|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3764070|NCT01943565|3596464|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3764071|NCT01943565|3596465|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3764072|NCT01943565|3596466|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3764073|NCT01943565|3596467|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3764074|NCT01943565|3596464|B4||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3764075|NCT01943565|3596465|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3764076|NCT01943565|3596466|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3764077|NCT01943565|3596467|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3764078|NCT01943565|3596464|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3764079|NCT01943565|3596465|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3764080|NCT01943565|3596466|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3764081|NCT01943565|3596467|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3764082|NCT01943552|3596498|B3||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3764083|NCT01943552|3596499|B2||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3764084|NCT01943552|3596500|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3764085|NCT01943552|3596498|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3764086|NCT01943552|3596499|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3764087|NCT01943552|3596500|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3764088|NCT01943552|3596498|B3|||Age||Years|Mean|62.9|62.9|Standard Deviation|6.5|6.5|||
3764089|NCT01943552|3596499|B2|||Age||Years|Mean|62.4|62.4|Standard Deviation|6.4|6.4|||
3764090|NCT01943552|3596500|B1|||Age||Years|Mean|63.4|63.4|Standard Deviation|6.5|6.5|||
3764091|NCT01943539|3596517|B1|United States||Region of Enrollment||participants|Number|80|80.0||||||
3764092|NCT01943539|3596517|B1|Neuro-typical|Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3764093|NCT01943539|3596517|B1|Neuro-typical|Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3764094|NCT01943539|3596517|B1|ADHD|Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3764095|NCT01943539|3596517|B1|ADHD|Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3764096|NCT01943539|3596517|B1|Neuro-typical||Age||years|Mean|10.54|10.54|Standard Deviation|1.49|1.49|||
3764097|NCT01943539|3596517|B1|ADHD||Age||years|Mean|10.35|10.35|Standard Deviation|1.24|1.24|||
3764098|NCT01943474|3596527|B3|United States||Region of Enrollment||participants|Number|248|248.0||||||
3764099|NCT01943474|3596528|B2|United States||Region of Enrollment||participants|Number|125|125.0||||||
3764100|NCT01943474|3596529|B1|United States||Region of Enrollment||participants|Number|123|123.0||||||
3764101|NCT01943474|3596527|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764102|NCT01943474|3596528|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764103|NCT01943474|3596529|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764104|NCT01943474|3596527|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|246|246.0||||||
3764105|NCT01943474|3596528|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
3764106|NCT01943474|3596529|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
3764107|NCT01943474|3596527|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3764108|NCT01943474|3596528|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3764109|NCT01943474|3596529|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764110|NCT01943474|3596527|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764111|NCT01943474|3596528|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764112|NCT01943474|3596529|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764113|NCT01943474|3596527|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3764114|NCT01943474|3596528|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3764115|NCT01943474|3596529|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3764116|NCT01943474|3596527|B3||White|Race (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
3764117|NCT01943474|3596528|B2||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3764118|NCT01943474|3596529|B1||White|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3764119|NCT01943474|3596527|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
3764120|NCT01943474|3596528|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3764121|NCT01943474|3596529|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3764122|NCT01943474|3596527|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764123|NCT01943474|3596528|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764124|NCT01943474|3596529|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764125|NCT01943474|3596527|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3764126|NCT01943474|3596528|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3764127|NCT01943474|3596529|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764128|NCT01943474|3596527|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764129|NCT01943474|3596528|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764130|NCT01943474|3596529|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764131|NCT01943474|3596527|B3||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3764132|NCT01943474|3596528|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3764133|NCT01943474|3596529|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3764134|NCT01943474|3596527|B3||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3764135|NCT01943474|3596528|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3764136|NCT01943474|3596529|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3764137|NCT01943474|3596527|B3||>=65 years|Age||Participants|Count of Participants|121|121.0||||||
3764138|NCT01943474|3596528|B2||>=65 years|Age||Participants|Count of Participants|56|56.0||||||
3764139|NCT01943474|3596529|B1||>=65 years|Age||Participants|Count of Participants|65|65.0||||||
3764140|NCT01943474|3596527|B3||Between 18 and 65 years|Age||Participants|Count of Participants|127|127.0||||||
3764141|NCT01943474|3596528|B2||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
3764142|NCT01943474|3596529|B1||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3764143|NCT01943474|3596527|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3764144|NCT01943474|3596528|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3764145|NCT01943474|3596529|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3764146|NCT01943474|3596527|B3|||Age||years|Mean|62.5|62.5|Standard Deviation|15|15.0|||
3764147|NCT01943474|3596528|B2|||Age||years|Mean|62.2|62.2|Standard Deviation|14.5|14.5|||
3764148|NCT01943474|3596529|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|15.5|15.5|||
3764149|NCT01943435|3596551|B4|||Self Paced Walk Test Total Distance||meters|Mean|455.3|455.3|Standard Deviation|480.0|480.0|||
3764150|NCT01943435|3596552|B3|||Self Paced Walk Test Total Distance||meters|Mean|449.2|449.2|Standard Deviation|485.2|485.2|||
3764151|NCT01943435|3596553|B2|||Self Paced Walk Test Total Distance||meters|Mean|433.4|433.4|Standard Deviation|421.2|421.2|||
3764152|NCT01943435|3596554|B1|||Self Paced Walk Test Total Distance||meters|Mean|482.2|482.2|Standard Deviation|529.1|529.1|||
3764153|NCT01943435|3596551|B4|||Swiss Spinal Stenosis Total Score|The SSS is a patient self-reported measure of pain and function related to spinal stenosis. The total score range is 12-55 with increasing values representing worsening disability.|units on a scale|Mean|31.5|31.5|Standard Deviation|6.0|6.0|||
3764154|NCT01943435|3596552|B3|||Swiss Spinal Stenosis Total Score|The SSS is a patient self-reported measure of pain and function related to spinal stenosis. The total score range is 12-55 with increasing values representing worsening disability.|units on a scale|Mean|31.7|31.7|Standard Deviation|6.1|6.1|||
3764155|NCT01943435|3596553|B2|||Swiss Spinal Stenosis Total Score|The SSS is a patient self-reported measure of pain and function related to spinal stenosis. The total score range is 12-55 with increasing values representing worsening disability.|units on a scale|Mean|31.6|31.6|Standard Deviation|6.0|6.0|||
3764156|NCT01943435|3596554|B1|||Swiss Spinal Stenosis Total Score|The SSS is a patient self-reported measure of pain and function related to spinal stenosis. The total score range is 12-55 with increasing values representing worsening disability.|units on a scale|Mean|31.4|31.4|Standard Deviation|5.8|5.8|||
3764157|NCT01943435|3596551|B4|United States||Region of Enrollment||participants|Number|259|259.0||||||
3764158|NCT01943435|3596552|B3|United States||Region of Enrollment||participants|Number|87|87.0||||||
3764159|NCT01943435|3596553|B2|United States||Region of Enrollment||participants|Number|84|84.0||||||
3764160|NCT01943435|3596554|B1|United States||Region of Enrollment||participants|Number|88|88.0||||||
3764161|NCT01943435|3596551|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764162|NCT01943435|3596552|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764163|NCT01943435|3596553|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764164|NCT01943435|3596554|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764165|NCT01943435|3596551|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764166|NCT01943435|3596552|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764167|NCT01943435|3596553|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764168|NCT01943435|3596554|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764169|NCT01943435|3596551|B4||White|Race (NIH/OMB)||Participants|Count of Participants|201|201.0||||||
3764170|NCT01943435|3596552|B3||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3764171|NCT01943435|3596553|B2||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3764172|NCT01943435|3596554|B1||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3764173|NCT01943435|3596551|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3764174|NCT01943435|3596552|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3764175|NCT01943435|3596553|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3764176|NCT01943435|3596554|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3764177|NCT01943435|3596551|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764178|NCT01943435|3596552|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764179|NCT01943435|3596553|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764180|NCT01943435|3596554|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764181|NCT01943435|3596551|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3764182|NCT01943435|3596552|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764183|NCT01943435|3596553|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764184|NCT01943435|3596554|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3764185|NCT01943435|3596551|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3764186|NCT01943435|3596552|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3764187|NCT01943435|3596553|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764188|NCT01943435|3596554|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764189|NCT01943435|3596551|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764190|NCT01943435|3596552|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764191|NCT01943435|3596553|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764192|NCT01943435|3596554|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764193|NCT01943435|3596551|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|259|259.0||||||
3764194|NCT01943435|3596552|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3764195|NCT01943435|3596553|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3764196|NCT01943435|3596554|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3764197|NCT01943435|3596551|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764198|NCT01943435|3596552|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764199|NCT01943435|3596553|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764200|NCT01943435|3596554|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764201|NCT01943435|3596551|B4||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3764202|NCT01943435|3596552|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3764203|NCT01943435|3596553|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3764204|NCT01943435|3596554|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3764205|NCT01943435|3596551|B4||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3764206|NCT01943435|3596552|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3764207|NCT01943435|3596553|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3764208|NCT01943435|3596554|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3764209|NCT01943435|3596551|B4|||Age||years|Mean|72.4|72.4|Standard Deviation|7.8|7.8|||
3764210|NCT01943435|3596552|B3|||Age||years|Mean|72.1|72.1|Standard Deviation|8.1|8.1|||
3764211|NCT01943435|3596553|B2|||Age||years|Mean|72.9|72.9|Standard Deviation|8.1|8.1|||
3764212|NCT01943435|3596554|B1|||Age||years|Mean|72.0|72.0|Standard Deviation|7.4|7.4|||
3764213|NCT01943344|3596570|B1|Ireland||Region of Enrollment||participants|Number|12|12.0||||||
3764214|NCT01943344|3596570|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3764215|NCT01943344|3596570|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3764216|NCT01943344|3596570|B1|||Age||years|Mean|78|78.0|Full Range|||66.0|83.0|
3764217|NCT01943292|3596576|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764218|NCT01943292|3596577|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764219|NCT01943292|3596578|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764220|NCT01943292|3596579|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764221|NCT01943292|3596576|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764222|NCT01943292|3596577|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764223|NCT01943292|3596578|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764224|NCT01943292|3596579|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764225|NCT01943292|3596576|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764226|NCT01943292|3596577|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764227|NCT01943292|3596578|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764228|NCT01943292|3596579|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764229|NCT01943292|3596576|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764230|NCT01943292|3596577|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764231|NCT01943292|3596578|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764232|NCT01943292|3596579|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764233|NCT01943292|3596576|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764234|NCT01943292|3596577|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764235|NCT01943292|3596578|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764236|NCT01943292|3596579|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764237|NCT01943292|3596576|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3764238|NCT01943292|3596577|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3764239|NCT01943292|3596578|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3764240|NCT01943292|3596579|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3764241|NCT01943292|3596576|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764242|NCT01943292|3596577|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764243|NCT01943292|3596578|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764244|NCT01943292|3596579|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764245|NCT01943292|3596576|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3764246|NCT01943292|3596577|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3764247|NCT01943292|3596578|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3764248|NCT01943292|3596579|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3764249|NCT01943292|3596576|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3764250|NCT01943292|3596577|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3764251|NCT01943292|3596578|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3764252|NCT01943292|3596579|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3764253|NCT01943292|3596576|B4|||Age||years|Mean|60.4|60.4|Standard Deviation|11.20|11.2|||
3764254|NCT01943292|3596577|B3|||Age||years|Mean|53.7|53.7|Standard Deviation|16.56|16.56|||
3764255|NCT01943292|3596578|B2|||Age||years|Mean|67.0|67.0|Standard Deviation|7.21|7.21|||
3764256|NCT01943292|3596579|B1|||Age||years|Mean|60.7|60.7|Standard Deviation|6.51|6.51|||
3764257|NCT01943110|3596592|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3764258|NCT01943110|3596592|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3764259|NCT01943110|3596592|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3764260|NCT01943110|3596592|B1|||Age||years|Mean|38|38.0|Full Range|||19.0|55.0|
3764261|NCT01943110|3596592|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3764262|NCT01943110|3596592|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3764263|NCT01943110|3596592|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3764264|NCT01942785|3596608|B1|yes||AAQ anger attacks|The Anger Attacks Questionnaire (AAQ) is a patient-rated scale designed to assess the presence of anger attacks. The AAQ consists of 7 items. Patients are classified as having anger attacks when exhibiting the following 4 criteria: 1) irritability, 2) overreaction to minor annoyances, 3) occurrence of anger attacks (at least one of which occurred within the period), and 4) experienced 4 or more specific symptoms during at least one of the attacks. The overall number of baseline participants was based on the FAS, n=54|participants|Number|17|17.0||||||
3764265|NCT01942785|3596608|B1|no||AAQ anger attacks|The Anger Attacks Questionnaire (AAQ) is a patient-rated scale designed to assess the presence of anger attacks. The AAQ consists of 7 items. Patients are classified as having anger attacks when exhibiting the following 4 criteria: 1) irritability, 2) overreaction to minor annoyances, 3) occurrence of anger attacks (at least one of which occurred within the period), and 4) experienced 4 or more specific symptoms during at least one of the attacks. The overall number of baseline participants was based on the FAS, n=54|participants|Number|37|37.0||||||
3764341|NCT01942590|3596688|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3764342|NCT01942590|3596689|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3764266|NCT01942785|3596608|B1|||KSQ anger-hostility score|The Kellner Symptom Questionnaire (KSQ) is a patient-rated scale designed to assess distress using symptoms of depression, anxiety, anger-hostility, and somatization. The KSQ anger-hostility subscale score ranges from 0 to 23 with higher values indicating worse outcome. The overall number of baseline participants was based on the FAS, n=54|units on a scale|Mean|14.83|14.83|Standard Deviation|4.78|4.78|||
3764267|NCT01942785|3596608|B1|||BIS-11 total score|The Barratt Impulsiveness Scale, Version 11 (BIS-11) is a patient-rated scale designed to assess impulsive personality traits. The BIS-11 consists of 30 items scored on a 4-point scale ranging from 1 (rarely/never) to 4 (almost always/always). The total score ranges from 30 to 120 with higher values indicating worse outcome. The overall number of baseline participants was based on the FAS, n=54|units on a scale|Mean|73.20|73.2|Standard Deviation|12.82|12.82|||
3764268|NCT01942785|3596608|B1|||IDS-C30 item 6 score|The 30-item Inventory of Depressive Symptomatology - Clinician-Rated (IDS-C30) is a clinician-rated scale designed to assess the severity of depressive symptoms. The IDS-C30 item 6 measures mood (irritable) and is rated on a 4-point anchored scale from 0 (least severe) to 3 (most severe) with higher values indicating worse outcome. The overall number of baseline participants was based on the FAS, n=54|units on a scale|Mean|2.20|2.2|Standard Deviation|0.41|0.41|||
3764269|NCT01942785|3596608|B1|||CGI-S score|The Clinical Global Impression severity of illness (CGI-S) provides the clinician's impression of the patient's current state of mental illness. The clinician uses his or her clinical experience of this patient population to rate the severity of the patient's current mental illness on a 7-point scale ranging from 1 (normal - not at all ill) to 7 (among the most extremely ill patients). The overall number of baseline participants was based on the FAS, n=54|units on a scale|Mean|4.09|4.09|Standard Deviation|0.40|0.4|||
3764270|NCT01942785|3596608|B1|||MADRS total score|The Montgomery and Åsberg Depression Rating Scale (MADRS) is a 10-item rating scale designed to assess the severity of the symptoms in depressive illness and to be sensitive to treatment effects. Symptoms are rated on a 7-point scale from 0 (no symptom) to 6 (severe symptom). The total score of the 10 items ranges from 0 to 60, with higher values indicating worse outcome. The overall number of baseline participants was based on the full analysis set (FAS), n=54|units on a scale|Mean|28.52|28.52|Standard Deviation|4.51|4.51|||
3764271|NCT01942785|3596608|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3764272|NCT01942785|3596608|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764273|NCT01942785|3596608|B1||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3764274|NCT01942785|3596608|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3764275|NCT01942785|3596608|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3764276|NCT01942785|3596608|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764277|NCT01942785|3596608|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764278|NCT01942785|3596608|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3764279|NCT01942785|3596608|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3764280|NCT01942785|3596608|B1|||Age||years|Mean|42.41|42.41|Standard Deviation|10.31|10.31|||
3764281|NCT01942733|3596637|B1|||BRIAN total score|The Biological Rhythms Interview of Assessment in Neuropsychiatry (BRIAN) is a clinician-rated scale designed to assess biological rhythms. The BRIAN consists of 18 items divided in 4 subscales: sleep (5 items), activity (5 items), social (4 items), and eating pattern (4 items). Each item is rated on a scale from 1 (no difficulties) to 4 (serious difficulties). The total score of the 18 items ranges from 18 to 72, with higher values indicating worse outcome. The overall number of baseline participants was based on the full analysis set (FAS)(n=44).|units on a scale|Mean|51.7|51.7|Standard Deviation|10.3|10.3|||
3764282|NCT01942733|3596637|B1|||CPFQ total score|The Cognitive and Physical Functioning Questionnaire (CPFQ) is a patient-rated scale designed to assess cognitive and executive dysfunction including symptoms of fatigue in mood and anxiety disorders. The CPFQ consists of 7 items, each rated on a scale from 1 (greater than normal functioning) to 6 (poorer than normal functioning). The total score of the 7 items ranges from 7 to 42, with higher values indicating worse outcome. The overall number of baseline participants was based on the full analysis set (FAS)(n=44).|units on a scale|Mean|27.1|27.1|Standard Deviation|5.3|5.3|||
3764283|NCT01942733|3596637|B1|||ISI total score|The Insomnia Severity Index (ISI) is a patient-rated scale desgined to measure the patient’s perception of his/her insomnia. The ISI comprises 7 items.and each of the 7 items is rated on a 5-point scale from 0 (best situation) to 4 (worst situation). The total score of the 7 items ranges from 0 to 28, with higher values indicating worse outcome. The overall number of baseline participants was based on the full analysis set (FAS)(n=44).|units on a scale|Mean|19.4|19.4|Standard Deviation|3.9|3.9|||
3764284|NCT01942733|3596637|B1|||ESS total score|The Epworth Sleepiness Scale (ESS) is a is a patient-rated scale designed to measure daytime sleepiness. The ESS consists of 8 items describing different situations/activities and the patients rate the chance of them dozing off or falling asleep when they are in these situations. Each item is rated on a 4-point scale from 0 (would never dose) to 3 (high change of dozing). The total score of the 8 items ranges from 0 to 24, with higher values indicating worse outcome. The overall number of baseline participants was based on the full analysis set (FAS)(n=44).|units on a scale|Mean|9.1|9.1|Standard Deviation|4.7|4.7|||
3764285|NCT01942733|3596637|B1|||CGI-S score|The Clinical Global Impression - Severity of Illness (CGI-S) scale assesses the clinician's impression of the patient's current state of mental illness. The clinician uses his or her clinical experience of this patient population to rate the severity of the patient's current mental illness on a 7-point scale ranging from 1 (normal - not at all ill) to 7 (among the most extremely ill patients), with higher values indicating worse outcome. The overall number of baseline participants was based on the full analysis set (FAS)(n=44).|units on a scale|Mean|4.3|4.3|Standard Deviation|0.8|0.8|||
3764343|NCT01942590|3596687|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764344|NCT01942590|3596688|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764345|NCT01942590|3596689|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764286|NCT01942733|3596637|B1|||MADRS total score|The Montgomery and Åsberg Depression Rating Scale (MADRS) is a 10-item rating scale designed to assess the severity of the symptoms in depressive illness and to be sensitive to treatment effects. Symptoms are rated on a 7-point scale from 0 (no symptom) to 6 (severe symptom). The total score of the 10 items ranges from 0 to 60, with higher values indicating worse outcome. The overall number of baseline participants was based on the full analysis set (FAS)(n=54).|units on a scale|Mean|28.3|28.3|Standard Deviation|3.8|3.8|||
3764287|NCT01942733|3596637|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3764288|NCT01942733|3596637|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764289|NCT01942733|3596637|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3764290|NCT01942733|3596637|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3764291|NCT01942733|3596637|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764292|NCT01942733|3596637|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3764293|NCT01942733|3596637|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764294|NCT01942733|3596637|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3764295|NCT01942733|3596637|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3764296|NCT01942733|3596637|B1|||Age||years|Mean|44.4|44.4|Standard Deviation|11.5|11.5|||
3764297|NCT01942720|3596666|B1|United States||Region of Enrollment||Participants|Count of Participants|74|74.0||||||
3764298|NCT01942720|3596666|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3764299|NCT01942720|3596666|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3764300|NCT01942720|3596666|B1|||Age||years|Mean|37.3|37.3|Standard Deviation|13.92|13.92|||
3764301|NCT01942720|3596666|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3764302|NCT01942720|3596666|B1||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
3764303|NCT01942720|3596666|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3764304|NCT01942707|3596674|B3|||BMI||Kg/m2|Mean|27.3|27.3|Standard Deviation|2.6|2.6|||
3764305|NCT01942707|3596675|B2|||BMI||Kg/m2|Mean|28.2|28.2|Standard Deviation|1.9|1.9|||
3764306|NCT01942707|3596676|B1|||BMI||Kg/m2|Mean|26.4|26.4|Standard Deviation|3|3.0|||
3764307|NCT01942707|3596674|B3|Brazil||Region of Enrollment||participants|Number|46|46.0||||||
3764308|NCT01942707|3596675|B2|Brazil||Region of Enrollment||participants|Number|23|23.0||||||
3764309|NCT01942707|3596676|B1|Brazil||Region of Enrollment||participants|Number|23|23.0||||||
3764310|NCT01942707|3596674|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764311|NCT01942707|3596675|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764312|NCT01942707|3596676|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764313|NCT01942707|3596674|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3764314|NCT01942707|3596675|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3764315|NCT01942707|3596676|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3764316|NCT01942707|3596674|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764317|NCT01942707|3596675|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764318|NCT01942707|3596676|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764319|NCT01942707|3596674|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764320|NCT01942707|3596675|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764321|NCT01942707|3596676|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764322|NCT01942707|3596674|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764323|NCT01942707|3596675|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764324|NCT01942707|3596676|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764325|NCT01942707|3596674|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764326|NCT01942707|3596675|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764327|NCT01942707|3596676|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764328|NCT01942707|3596674|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764329|NCT01942707|3596675|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764330|NCT01942707|3596676|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764331|NCT01942707|3596674|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3764332|NCT01942707|3596675|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3764333|NCT01942707|3596676|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3764334|NCT01942707|3596674|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3764335|NCT01942707|3596675|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3764336|NCT01942707|3596676|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3764337|NCT01942707|3596674|B3|||Age|Age as informed by the patient|years|Mean|37.6087|37.6087|Standard Deviation|8.074|8.074|||
3764338|NCT01942707|3596675|B2|||Age|Age as informed by the patient|years|Mean|38.1304|38.1304|Standard Deviation|8.05|8.05|||
3764339|NCT01942707|3596676|B1|||Age|Age as informed by the patient|years|Mean|37.086|37.086|Standard Deviation|8.06|8.06|||
3764340|NCT01942590|3596687|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
3764346|NCT01942590|3596687|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764347|NCT01942590|3596688|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764348|NCT01942590|3596689|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764349|NCT01942590|3596687|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3764350|NCT01942590|3596688|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3764351|NCT01942590|3596689|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3764352|NCT01942590|3596687|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764353|NCT01942590|3596688|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764354|NCT01942590|3596689|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764355|NCT01942590|3596687|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764356|NCT01942590|3596688|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764357|NCT01942590|3596689|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764358|NCT01942590|3596687|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764359|NCT01942590|3596688|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764360|NCT01942590|3596689|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764361|NCT01942590|3596687|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764362|NCT01942590|3596688|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764363|NCT01942590|3596689|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764364|NCT01942590|3596687|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764365|NCT01942590|3596688|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764366|NCT01942590|3596689|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764367|NCT01942590|3596687|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3764368|NCT01942590|3596688|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3764369|NCT01942590|3596689|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3764370|NCT01942590|3596687|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764371|NCT01942590|3596688|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764372|NCT01942590|3596689|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764373|NCT01942590|3596687|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3764374|NCT01942590|3596688|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3764375|NCT01942590|3596689|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3764376|NCT01942590|3596687|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3764377|NCT01942590|3596688|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3764378|NCT01942590|3596689|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3764379|NCT01942590|3596687|B3|||Age||years|Median|51|51.0|Full Range|||19.0|65.0|
3764380|NCT01942590|3596688|B2|||Age||years|Median|32|32.0|Full Range|||19.0|62.0|
3764381|NCT01942590|3596689|B1|||Age||years|Median|52|52.0|Full Range|||37.0|65.0|
3764382|NCT01942161|3596720|B4|Japan||Region of Enrollment||participants|Number|106|106.0||||||
3764383|NCT01942161|3596721|B3|Japan||Region of Enrollment||participants|Number|41|41.0||||||
3764384|NCT01942161|3596722|B2|Japan||Region of Enrollment||participants|Number|30|30.0||||||
3764385|NCT01942161|3596723|B1|Japan||Region of Enrollment||participants|Number|35|35.0||||||
3764386|NCT01942161|3596720|B4||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3764387|NCT01942161|3596721|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3764388|NCT01942161|3596722|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3764389|NCT01942161|3596723|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3764390|NCT01942161|3596720|B4||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3764391|NCT01942161|3596721|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3764392|NCT01942161|3596722|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3764393|NCT01942161|3596723|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3764394|NCT01942161|3596720|B4|||Age||years|Mean|15.0|15.0|Standard Deviation|1.4|1.4|||
3764395|NCT01942161|3596721|B3|||Age||years|Mean|14.7|14.7|Standard Deviation|1.3|1.3|||
3764396|NCT01942161|3596722|B2|||Age||years|Mean|15.4|15.4|Standard Deviation|1.3|1.3|||
3764397|NCT01942161|3596723|B1|||Age||years|Mean|15.1|15.1|Standard Deviation|1.4|1.4|||
3764398|NCT01942161|3596720|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3764399|NCT01942161|3596721|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3764400|NCT01942161|3596722|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3764401|NCT01942161|3596723|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3764402|NCT01942161|3596720|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3764403|NCT01942161|3596721|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3764404|NCT01942161|3596722|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3764405|NCT01942161|3596723|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3764406|NCT01942161|3596720|B4||<=18 years|Age||Participants|Count of Participants|106|106.0||||||
3764407|NCT01942161|3596721|B3||<=18 years|Age||Participants|Count of Participants|41|41.0||||||
3764408|NCT01942161|3596722|B2||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
3764409|NCT01942161|3596723|B1||<=18 years|Age||Participants|Count of Participants|35|35.0||||||
3764410|NCT01942148|3596745|B1|Japan||Region of Enrollment||participants|Number|68|68.0||||||
3764411|NCT01942148|3596745|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3764412|NCT01942148|3596745|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3764413|NCT01942148|3596745|B1|||Age||years|Mean|15.1|15.1|Standard Deviation|1.4|1.4|||
3764414|NCT01942148|3596745|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3764415|NCT01942148|3596745|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3764416|NCT01942148|3596745|B1||<=18 years|Age||Participants|Count of Participants|68|68.0||||||
3764417|NCT01942135|3596751|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3764418|NCT01942135|3596752|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3764419|NCT01942135|3596753|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3764420|NCT01942135|3596751|B3||Female|Sex: Female, Male||Participants|Count of Participants|521|521.0||||||
3764421|NCT01942135|3596752|B2||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3764422|NCT01942135|3596753|B1||Female|Sex: Female, Male||Participants|Count of Participants|347|347.0||||||
3764423|NCT01942135|3596751|B3|||Age||Years|Mean|56.9|56.9|Standard Deviation|11.3|11.3|||
3764424|NCT01942135|3596752|B2|||Age||Years|Mean|56.8|56.8|Standard Deviation|10.4|10.4|||
3764425|NCT01942135|3596753|B1|||Age||Years|Mean|56.9|56.9|Standard Deviation|11.7|11.7|||
3764426|NCT01941940|3596791|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3764427|NCT01941940|3596791|B1||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
3764428|NCT01941940|3596791|B1|||Age||years|Mean|54.7|54.7|Standard Deviation|12.12|12.12|||
3764429|NCT01941615|3596831|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3764430|NCT01941615|3596831|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3764431|NCT01941615|3596831|B1|||Age||years|Mean|26.5|26.5|Standard Deviation|3.7|3.7|||
3764432|NCT01941498|3596840|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3764433|NCT01941498|3596840|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3764434|NCT01941498|3596840|B1|||Age||years|Mean|31.0|31.0|Standard Deviation|6.9|6.9|||
3764435|NCT01941485|3596886|B1||Male|Gender||Participants|Count of Participants|25|25.0||||||
3764436|NCT01941485|3596886|B1||Female|Gender||Participants|Count of Participants|34|34.0||||||
3764437|NCT01941485|3596886|B1|||Age||years|Mean|33.3|33.3|Standard Deviation|9.22|9.22|||
3764438|NCT01941472|3596952|B1|||acute physiology and chronic health evaluation(APACHE) II score|acute physiology and chronic health evaluation(APACHE) II score can range from 0 to 71, with higher scores indicating more severe illness|units on a scale|Mean|27|27.0|Standard Deviation|6|6.0|||
3764439|NCT01941472|3596952|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3764440|NCT01941472|3596952|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3764441|NCT01941472|3596952|B1|||Age||years|Mean|60|60.0|Standard Deviation|15|15.0|||
3764442|NCT01941186|3596956|B3|Never Married||Parent's Marital Status||participants|Number|32|32.0||||||
3764443|NCT01941186|3596957|B2|Never Married||Parent's Marital Status||participants|Number|18|18.0||||||
3764444|NCT01941186|3596958|B1|Never Married||Parent's Marital Status||participants|Number|14|14.0||||||
3764445|NCT01941186|3596956|B3|Divorced/Separated||Parent's Marital Status||participants|Number|6|6.0||||||
3764446|NCT01941186|3596957|B2|Divorced/Separated||Parent's Marital Status||participants|Number|2|2.0||||||
3764447|NCT01941186|3596958|B1|Divorced/Separated||Parent's Marital Status||participants|Number|4|4.0||||||
3764448|NCT01941186|3596956|B3|Married/Living with Partner||Parent's Marital Status||participants|Number|26|26.0||||||
3764449|NCT01941186|3596957|B2|Married/Living with Partner||Parent's Marital Status||participants|Number|13|13.0||||||
3764450|NCT01941186|3596958|B1|Married/Living with Partner||Parent's Marital Status||participants|Number|13|13.0||||||
3764451|NCT01941186|3596956|B3|Unemployed||Parent's Employment Status||participants|Number|27|27.0||||||
3764452|NCT01941186|3596957|B2|Unemployed||Parent's Employment Status||participants|Number|13|13.0||||||
3764453|NCT01941186|3596958|B1|Unemployed||Parent's Employment Status||participants|Number|14|14.0||||||
3764454|NCT01941186|3596956|B3|Employed||Parent's Employment Status||participants|Number|37|37.0||||||
3764455|NCT01941186|3596957|B2|Employed||Parent's Employment Status||participants|Number|20|20.0||||||
3764456|NCT01941186|3596958|B1|Employed||Parent's Employment Status||participants|Number|17|17.0||||||
3764457|NCT01941186|3596956|B3|Post Secondary Education||Parent's Education||participants|Number|9|9.0||||||
3764458|NCT01941186|3596957|B2|Post Secondary Education||Parent's Education||participants|Number|2|2.0||||||
3764459|NCT01941186|3596958|B1|Post Secondary Education||Parent's Education||participants|Number|7|7.0||||||
3764460|NCT01941186|3596956|B3|High School Graduate||Parent's Education||participants|Number|50|50.0||||||
3764461|NCT01941186|3596957|B2|High School Graduate||Parent's Education||participants|Number|27|27.0||||||
3764462|NCT01941186|3596958|B1|High School Graduate||Parent's Education||participants|Number|23|23.0||||||
3764463|NCT01941186|3596956|B3|Less than High School||Parent's Education||participants|Number|5|5.0||||||
3764464|NCT01941186|3596957|B2|Less than High School||Parent's Education||participants|Number|4|4.0||||||
3764465|NCT01941186|3596958|B1|Less than High School||Parent's Education||participants|Number|1|1.0||||||
3764466|NCT01941186|3596956|B3|United States||Region of Enrollment||participants|Number|64|64.0||||||
3764467|NCT01941186|3596957|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
3764468|NCT01941186|3596958|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
3764469|NCT01941186|3596956|B3|Other||Race/Ethnicity, Customized|Parent's Race|participants|Number|8|8.0||||||
3764470|NCT01941186|3596957|B2|Other||Race/Ethnicity, Customized|Parent's Race|participants|Number|1|1.0||||||
3764471|NCT01941186|3596958|B1|Other||Race/Ethnicity, Customized|Parent's Race|participants|Number|7|7.0||||||
3764472|NCT01941186|3596956|B3|Black/African American||Race/Ethnicity, Customized|Parent's Race|participants|Number|56|56.0||||||
3764473|NCT01941186|3596957|B2|Black/African American||Race/Ethnicity, Customized|Parent's Race|participants|Number|32|32.0||||||
3764474|NCT01941186|3596958|B1|Black/African American||Race/Ethnicity, Customized|Parent's Race|participants|Number|24|24.0||||||
3764475|NCT01941186|3596956|B3||Male|Sex: Female, Male|Parent's Gender|Participants|Count of Participants|54|54.0||||||
3764476|NCT01941186|3596957|B2||Male|Sex: Female, Male|Parent's Gender|Participants|Count of Participants|28|28.0||||||
3764477|NCT01941186|3596958|B1||Male|Sex: Female, Male|Parent's Gender|Participants|Count of Participants|26|26.0||||||
3764478|NCT01941186|3596956|B3||Female|Sex: Female, Male|Parent's Gender|Participants|Count of Participants|10|10.0||||||
3764479|NCT01941186|3596957|B2||Female|Sex: Female, Male|Parent's Gender|Participants|Count of Participants|5|5.0||||||
3764480|NCT01941186|3596958|B1||Female|Sex: Female, Male|Parent's Gender|Participants|Count of Participants|5|5.0||||||
3764481|NCT01941186|3596956|B3||Male|Sex: Female, Male|Child's Gender|Participants|Count of Participants|39|39.0||||||
3764482|NCT01941186|3596957|B2||Male|Sex: Female, Male|Child's Gender|Participants|Count of Participants|21|21.0||||||
3764483|NCT01941186|3596958|B1||Male|Sex: Female, Male|Child's Gender|Participants|Count of Participants|18|18.0||||||
3764484|NCT01941186|3596956|B3||Female|Sex: Female, Male|Child's Gender|Participants|Count of Participants|25|25.0||||||
3764485|NCT01941186|3596957|B2||Female|Sex: Female, Male|Child's Gender|Participants|Count of Participants|12|12.0||||||
3764486|NCT01941186|3596958|B1||Female|Sex: Female, Male|Child's Gender|Participants|Count of Participants|13|13.0||||||
3764487|NCT01941186|3596956|B3|Parent: Unknown Age||Age, Customized|Parent's Age|participants|Number|6|6.0||||||
3764488|NCT01941186|3596957|B2|Parent: Unknown Age||Age, Customized|Parent's Age|participants|Number|4|4.0||||||
3764489|NCT01941186|3596958|B1|Parent: Unknown Age||Age, Customized|Parent's Age|participants|Number|2|2.0||||||
3764490|NCT01941186|3596956|B3|Parent: Over 40 Years||Age, Customized|Parent's Age|participants|Number|4|4.0||||||
3764491|NCT01941186|3596957|B2|Parent: Over 40 Years||Age, Customized|Parent's Age|participants|Number|2|2.0||||||
3764492|NCT01941186|3596958|B1|Parent: Over 40 Years||Age, Customized|Parent's Age|participants|Number|2|2.0||||||
3764493|NCT01941186|3596956|B3|Parent: 31-40 Years||Age, Customized|Parent's Age|participants|Number|16|16.0||||||
3764494|NCT01941186|3596957|B2|Parent: 31-40 Years||Age, Customized|Parent's Age|participants|Number|6|6.0||||||
3764495|NCT01941186|3596958|B1|Parent: 31-40 Years||Age, Customized|Parent's Age|participants|Number|10|10.0||||||
3764496|NCT01941186|3596956|B3|Parent: 21-30 Years||Age, Customized|Parent's Age|participants|Number|33|33.0||||||
3764497|NCT01941186|3596957|B2|Parent: 21-30 Years||Age, Customized|Parent's Age|participants|Number|18|18.0||||||
3764498|NCT01941186|3596958|B1|Parent: 21-30 Years||Age, Customized|Parent's Age|participants|Number|15|15.0||||||
3764499|NCT01941186|3596956|B3|Parent: 20 years and Under||Age, Customized|Parent's Age|participants|Number|5|5.0||||||
3764500|NCT01941186|3596957|B2|Parent: 20 years and Under||Age, Customized|Parent's Age|participants|Number|3|3.0||||||
3764501|NCT01941186|3596958|B1|Parent: 20 years and Under||Age, Customized|Parent's Age|participants|Number|2|2.0||||||
3764502|NCT01941186|3596956|B3|Child: Age 25-36 months||Age, Customized|Child's Age|participants|Number|15|15.0||||||
3764503|NCT01941186|3596957|B2|Child: Age 25-36 months||Age, Customized|Child's Age|participants|Number|7|7.0||||||
3764504|NCT01941186|3596958|B1|Child: Age 25-36 months||Age, Customized|Child's Age|participants|Number|8|8.0||||||
3764505|NCT01941186|3596956|B3|Child: Age 13-24 months||Age, Customized|Child's Age|participants|Number|42|42.0||||||
3764506|NCT01941186|3596957|B2|Child: Age 13-24 months||Age, Customized|Child's Age|participants|Number|22|22.0||||||
3764507|NCT01941186|3596958|B1|Child: Age 13-24 months||Age, Customized|Child's Age|participants|Number|20|20.0||||||
3764508|NCT01941186|3596956|B3|Child: Age 1-12 months||Age, Customized|Child's Age|participants|Number|7|7.0||||||
3764509|NCT01941186|3596957|B2|Child: Age 1-12 months||Age, Customized|Child's Age|participants|Number|4|4.0||||||
3764510|NCT01941186|3596958|B1|Child: Age 1-12 months||Age, Customized|Child's Age|participants|Number|3|3.0||||||
3764511|NCT01941095|3596985|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3764512|NCT01941095|3596985|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3764513|NCT01941095|3596985|B1|||Age||years|Mean|56.27|56.27|Standard Deviation|12.77|12.77|||
3764514|NCT01940939|3597008|B3|China||Region of Enrollment||participants|Number|70|70.0||||||
3764515|NCT01940939|3597009|B2|China||Region of Enrollment||participants|Number|35|35.0||||||
3764516|NCT01940939|3597010|B1|China||Region of Enrollment||participants|Number|35|35.0||||||
3764517|NCT01940939|3597008|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764518|NCT01940939|3597009|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764519|NCT01940939|3597010|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764520|NCT01940939|3597008|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764521|NCT01940939|3597009|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764522|NCT01940939|3597010|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764523|NCT01940939|3597008|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764524|NCT01940939|3597009|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764525|NCT01940939|3597010|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764526|NCT01940939|3597008|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764527|NCT01940939|3597009|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764528|NCT01940939|3597010|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764529|NCT01940939|3597008|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764530|NCT01940939|3597009|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764531|NCT01940939|3597010|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764532|NCT01940939|3597008|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3764533|NCT01940939|3597009|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3764534|NCT01940939|3597010|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3764535|NCT01940939|3597008|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764536|NCT01940939|3597009|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764537|NCT01940939|3597010|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764538|NCT01940939|3597008|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3764539|NCT01940939|3597009|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3764540|NCT01940939|3597010|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3764541|NCT01940939|3597008|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3764542|NCT01940939|3597009|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3764543|NCT01940939|3597010|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3764544|NCT01940939|3597008|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3764545|NCT01940939|3597009|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3764546|NCT01940939|3597010|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3764547|NCT01940939|3597008|B3||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
3764548|NCT01940939|3597009|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3764549|NCT01940939|3597010|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3764550|NCT01940939|3597008|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3764551|NCT01940939|3597009|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3764552|NCT01940939|3597010|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3764553|NCT01940900|3597021|B3|Spain||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3764554|NCT01940900|3597022|B2|Spain||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3764555|NCT01940900|3597023|B1|Spain||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3764556|NCT01940900|3597021|B3|Germany||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3764557|NCT01940900|3597022|B2|Germany||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3764558|NCT01940900|3597023|B1|Germany||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3764559|NCT01940900|3597021|B3|France||Region of Enrollment||Participants|Count of Participants|104|104.0||||||
3764560|NCT01940900|3597022|B2|France||Region of Enrollment||Participants|Count of Participants|55|55.0||||||
3764561|NCT01940900|3597023|B1|France||Region of Enrollment||Participants|Count of Participants|49|49.0||||||
3764562|NCT01940900|3597021|B3|Australia||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3764563|NCT01940900|3597022|B2|Australia||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3764564|NCT01940900|3597023|B1|Australia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3764565|NCT01940900|3597021|B3|Israel||Region of Enrollment||Participants|Count of Participants|65|65.0||||||
3764566|NCT01940900|3597022|B2|Israel||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3764567|NCT01940900|3597023|B1|Israel||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3764568|NCT01940900|3597021|B3|Denmark||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3764569|NCT01940900|3597022|B2|Denmark||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3764570|NCT01940900|3597023|B1|Denmark||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3764571|NCT01940900|3597021|B3|United States||Region of Enrollment||Participants|Count of Participants|197|197.0||||||
3764572|NCT01940900|3597022|B2|United States||Region of Enrollment||Participants|Count of Participants|97|97.0||||||
3764573|NCT01940900|3597023|B1|United States||Region of Enrollment||Participants|Count of Participants|100|100.0||||||
3764574|NCT01940900|3597021|B3|Hungary||Region of Enrollment||Participants|Count of Participants|119|119.0||||||
3764575|NCT01940900|3597022|B2|Hungary||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
3764576|NCT01940900|3597023|B1|Hungary||Region of Enrollment||Participants|Count of Participants|58|58.0||||||
3764577|NCT01940900|3597021|B3|Turkey||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3764578|NCT01940900|3597022|B2|Turkey||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3764579|NCT01940900|3597023|B1|Turkey||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3764580|NCT01940900|3597021|B3|Argentina||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3764581|NCT01940900|3597022|B2|Argentina||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3764582|NCT01940900|3597023|B1|Argentina||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3764583|NCT01940900|3597021|B3|Colombia||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3764584|NCT01940900|3597022|B2|Colombia||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3764585|NCT01940900|3597023|B1|Colombia||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3764586|NCT01940900|3597021|B3||Male|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
3764587|NCT01940900|3597022|B2||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3764588|NCT01940900|3597023|B1||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3764589|NCT01940900|3597021|B3||Female|Sex: Female, Male||Participants|Count of Participants|367|367.0||||||
3764590|NCT01940900|3597022|B2||Female|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
3764591|NCT01940900|3597023|B1||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
3764592|NCT01940900|3597021|B3|Age|Adults 85 years and over|Age, Customized||Participants|Count of Participants|120|120.0||||||
3764593|NCT01940900|3597022|B2|Age|Adults 85 years and over|Age, Customized||Participants|Count of Participants|63|63.0||||||
3764594|NCT01940900|3597023|B1|Age|Adults 85 years and over|Age, Customized||Participants|Count of Participants|57|57.0||||||
3764595|NCT01940900|3597021|B3|Age|Adults 65-84 years|Age, Customized||Participants|Count of Participants|445|445.0||||||
3764596|NCT01940900|3597022|B2|Age|Adults 65-84 years|Age, Customized||Participants|Count of Participants|221|221.0||||||
3764597|NCT01940900|3597023|B1|Age|Adults 65-84 years|Age, Customized||Participants|Count of Participants|224|224.0||||||
3764598|NCT01940900|3597021|B3|Age|Adults 18-64 years|Age, Customized||Participants|Count of Participants|61|61.0||||||
3764599|NCT01940900|3597022|B2|Age|Adults 18-64 years|Age, Customized||Participants|Count of Participants|31|31.0||||||
3764600|NCT01940900|3597023|B1|Age|Adults 18-64 years|Age, Customized||Participants|Count of Participants|30|30.0||||||
3764601|NCT01940523|3597030|B3||Male|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
3764602|NCT01940523|3597031|B2||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3764603|NCT01940523|3597032|B1||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3764604|NCT01940523|3597030|B3||Female|Sex: Female, Male||Participants|Count of Participants|380|380.0||||||
3764605|NCT01940523|3597031|B2||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
3764606|NCT01940523|3597032|B1||Female|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
3764607|NCT01940523|3597030|B3|||Age||years|Mean|66.6|66.6|Standard Deviation|9.28|9.28|||
3764608|NCT01940523|3597031|B2|||Age||years|Mean|66.35|66.35|Standard Deviation|9.16|9.16|||
3764609|NCT01940523|3597032|B1|||Age||years|Mean|66.87|66.87|Standard Deviation|9.42|9.42|||
3764610|NCT01940523|3597030|B3||>=65 years|Age||Participants|Count of Participants|343|343.0||||||
3764611|NCT01940523|3597031|B2||>=65 years|Age||Participants|Count of Participants|169|169.0||||||
3764612|NCT01940523|3597032|B1||>=65 years|Age||Participants|Count of Participants|174|174.0||||||
3764613|NCT01940523|3597030|B3||Between 18 and 65 years|Age||Participants|Count of Participants|297|297.0||||||
3764614|NCT01940523|3597031|B2||Between 18 and 65 years|Age||Participants|Count of Participants|151|151.0||||||
3764615|NCT01940523|3597032|B1||Between 18 and 65 years|Age||Participants|Count of Participants|146|146.0||||||
3764616|NCT01940523|3597030|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3764617|NCT01940523|3597031|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3764618|NCT01940523|3597032|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3764619|NCT01940510|3597041|B1||Male|Gender||Participants|Count of Participants|22|22.0||||||
3764620|NCT01940510|3597041|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
3764621|NCT01940510|3597041|B1|||Age||years|Mean|35.3|35.3|Standard Deviation|9.43|9.43|||
3764622|NCT01940497|3597072|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3764623|NCT01940497|3597073|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3764624|NCT01940497|3597074|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3764625|NCT01940497|3597072|B3||Female|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
3764626|NCT01940497|3597073|B2||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3764627|NCT01940497|3597074|B1||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3764628|NCT01940497|3597072|B3|||Age||years|Mean|54.2|54.2|Standard Deviation|10.46|10.46|||
3764629|NCT01940497|3597073|B2|||Age||years|Mean|53.2|53.2|Standard Deviation|10.37|10.37|||
3764630|NCT01940497|3597074|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|10.51|10.51|||
3764631|NCT01940484|3597114|B1|||Methoxy Polyethylene Glycol-Epoetin Beta Dose|The number of participants analyzed for this baseline measure is 97.|micrograms (mcg)|Mean|107.47|107.47|Standard Deviation|41.80|41.8|||
3764632|NCT01940484|3597114|B1|||Mean Hemoglobin Value||g/dL|Mean|11.57|11.57|Standard Deviation|1.47|1.47|||
3764633|NCT01940484|3597114|B1|||Number of Participants With Hemoglobin Level Within the Range of 11-12 Grams Per Deciliter (g/dL)||participants|Number|25|25.0||||||
3764634|NCT01940484|3597114|B1|||Body Weight|The number of participants analyzed for this baseline measure is 97.|kilograms|Mean|75.0|75.0|Standard Deviation|18.5|18.5|||
3764635|NCT01940484|3597114|B1|||Height|The number of participants analyzed for this baseline measure is 86.|centimeters (cm)|Mean|167.5|167.5|Standard Deviation|10.3|10.3|||
3764636|NCT01940484|3597114|B1|||Pulse rate|The number of participants analyzed for this baseline measure is 65.|beats per minute|Mean|73.4|73.4|Standard Deviation|13.1|13.1|||
3764671|NCT01940471|3597132|B3|CC||IL28B Genotype|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|652|652.0||||||
3764637|NCT01940484|3597114|B1|SBP post-dialysis (n=93)||Systolic Blood Pressure (SBP)|"Participant's baseline SBP is reported before undergoing hemodialysis as 'SBP pre-dialysis' and after undergoing hemodialysis as 'SBP post-dialysis' and n represents the number of participants evaluable for the specified baseline measure."|mm Hg|Mean|136.7|136.7|Standard Deviation|19.6|19.6|||
3764638|NCT01940484|3597114|B1|SBP pre-dialysis (n=95)||Systolic Blood Pressure (SBP)|"Participant's baseline SBP is reported before undergoing hemodialysis as 'SBP pre-dialysis' and after undergoing hemodialysis as 'SBP post-dialysis' and n represents the number of participants evaluable for the specified baseline measure."|mm Hg|Mean|145.7|145.7|Standard Deviation|18.8|18.8|||
3764639|NCT01940484|3597114|B1|DBP post-dialysis (n=93)||Diastolic blood pressure (DBP)|"Participant's baseline DBP is reported before undergoing hemodialysis as 'DBP pre-dialysis' and after undergoing hemodialysis as 'DBP post-dialysis' and n represents the number of participants evaluable for the specified baseline measure."|millimeters of Mercury (mm Hg)|Mean|78.8|78.8|Standard Deviation|13.8|13.8|||
3764640|NCT01940484|3597114|B1|DBP pre-dialysis (n=95)||Diastolic blood pressure (DBP)|"Participant's baseline DBP is reported before undergoing hemodialysis as 'DBP pre-dialysis' and after undergoing hemodialysis as 'DBP post-dialysis' and n represents the number of participants evaluable for the specified baseline measure."|millimeters of Mercury (mm Hg)|Mean|82.5|82.5|Standard Deviation|13.6|13.6|||
3764641|NCT01940484|3597114|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3764642|NCT01940484|3597114|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3764643|NCT01940484|3597114|B1|||Age||years|Mean|52.5|52.5|Standard Deviation|15.7|15.7|||
3764644|NCT01940471|3597132|B3|Grade 3||Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|0|0.0||||||
3764645|NCT01940471|3597133|B2|Grade 3||Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|0|0.0||||||
3764646|NCT01940471|3597134|B1|Grade 3||Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|0|0.0||||||
3764647|NCT01940471|3597132|B3|Grade 2||Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|5|5.0||||||
3764648|NCT01940471|3597133|B2|Grade 2||Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|2|2.0||||||
3764649|NCT01940471|3597134|B1|Grade 2||Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|3|3.0||||||
3764650|NCT01940471|3597132|B3|Grade 1||Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|71|71.0||||||
3764651|NCT01940471|3597133|B2|Grade 1||Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|31|31.0||||||
3764652|NCT01940471|3597134|B1|Grade 1||Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|40|40.0||||||
3764653|NCT01940471|3597132|B3|Grade 0||Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|797|797.0||||||
3764654|NCT01940471|3597133|B2|Grade 0||Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|259|259.0||||||
3764655|NCT01940471|3597134|B1|Grade 0||Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|538|538.0||||||
3764656|NCT01940471|3597132|B3|Treatment Naive||Oral Antiviral Treatment Status||Participants|Count of Participants|645|645.0||||||
3764657|NCT01940471|3597133|B2|Treatment Naive||Oral Antiviral Treatment Status||Participants|Count of Participants|215|215.0||||||
3764658|NCT01940471|3597134|B1|Treatment Naive||Oral Antiviral Treatment Status||Participants|Count of Participants|430|430.0||||||
3764659|NCT01940471|3597132|B3|Treatment Experienced||Oral Antiviral Treatment Status||Participants|Count of Participants|228|228.0||||||
3764660|NCT01940471|3597133|B2|Treatment Experienced||Oral Antiviral Treatment Status||Participants|Count of Participants|77|77.0||||||
3764661|NCT01940471|3597134|B1|Treatment Experienced||Oral Antiviral Treatment Status||Participants|Count of Participants|151|151.0||||||
3764662|NCT01940471|3597132|B3|Missing||IL28B Genotype|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|7|7.0||||||
3764663|NCT01940471|3597133|B2|Missing||IL28B Genotype|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|3|3.0||||||
3764664|NCT01940471|3597134|B1|Missing||IL28B Genotype|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|4|4.0||||||
3764665|NCT01940471|3597132|B3|TT||IL28B Genotype|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|33|33.0||||||
3764666|NCT01940471|3597133|B2|TT||IL28B Genotype|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|10|10.0||||||
3764667|NCT01940471|3597134|B1|TT||IL28B Genotype|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|23|23.0||||||
3764668|NCT01940471|3597132|B3|CT||IL28B Genotype|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|181|181.0||||||
3764669|NCT01940471|3597133|B2|CT||IL28B Genotype|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|69|69.0||||||
3764670|NCT01940471|3597134|B1|CT||IL28B Genotype|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|112|112.0||||||
3764672|NCT01940471|3597133|B2|CC||IL28B Genotype|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|210|210.0||||||
3764673|NCT01940471|3597134|B1|CC||IL28B Genotype|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|442|442.0||||||
3764674|NCT01940471|3597132|B3|≥ 8 log10 IU/mL||Plasma HBV DNA Level||Participants|Count of Participants|414|414.0||||||
3764675|NCT01940471|3597133|B2|≥ 8 log10 IU/mL||Plasma HBV DNA Level||Participants|Count of Participants|142|142.0||||||
3764676|NCT01940471|3597134|B1|≥ 8 log10 IU/mL||Plasma HBV DNA Level||Participants|Count of Participants|272|272.0||||||
3764677|NCT01940471|3597132|B3|< 8 log10 IU/mL||Plasma HBV DNA Level||Participants|Count of Participants|459|459.0||||||
3764678|NCT01940471|3597133|B2|< 8 log10 IU/mL||Plasma HBV DNA Level||Participants|Count of Participants|150|150.0||||||
3764679|NCT01940471|3597134|B1|< 8 log10 IU/mL||Plasma HBV DNA Level||Participants|Count of Participants|309|309.0||||||
3764680|NCT01940471|3597132|B3|||HBV DNA||log10 IU/mL|Mean|7.6|7.6|Standard Deviation|1.36|1.36|||
3764681|NCT01940471|3597133|B2|||HBV DNA||log10 IU/mL|Mean|7.6|7.6|Standard Deviation|1.41|1.41|||
3764682|NCT01940471|3597134|B1|||HBV DNA||log10 IU/mL|Mean|7.6|7.6|Standard Deviation|1.34|1.34|||
3764683|NCT01940471|3597132|B3|France||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3764684|NCT01940471|3597133|B2|France||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3764685|NCT01940471|3597134|B1|France||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3764686|NCT01940471|3597132|B3|Bulgaria||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3764687|NCT01940471|3597133|B2|Bulgaria||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3764688|NCT01940471|3597134|B1|Bulgaria||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3764689|NCT01940471|3597132|B3|Australia||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3764690|NCT01940471|3597133|B2|Australia||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3764691|NCT01940471|3597134|B1|Australia||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3764692|NCT01940471|3597132|B3|Italy||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3764693|NCT01940471|3597133|B2|Italy||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3764694|NCT01940471|3597134|B1|Italy||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3764695|NCT01940471|3597132|B3|Poland||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3764696|NCT01940471|3597133|B2|Poland||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3764697|NCT01940471|3597134|B1|Poland||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3764698|NCT01940471|3597132|B3|Korea, Republic of||Region of Enrollment||Participants|Count of Participants|173|173.0||||||
3764699|NCT01940471|3597133|B2|Korea, Republic of||Region of Enrollment||Participants|Count of Participants|53|53.0||||||
3764700|NCT01940471|3597134|B1|Korea, Republic of||Region of Enrollment||Participants|Count of Participants|120|120.0||||||
3764701|NCT01940471|3597132|B3|Taiwan||Region of Enrollment||Participants|Count of Participants|83|83.0||||||
3764702|NCT01940471|3597133|B2|Taiwan||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3764703|NCT01940471|3597134|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
3764704|NCT01940471|3597132|B3|Turkey||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3764705|NCT01940471|3597133|B2|Turkey||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3764706|NCT01940471|3597134|B1|Turkey||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3764707|NCT01940471|3597132|B3|Canada||Region of Enrollment||Participants|Count of Participants|83|83.0||||||
3764708|NCT01940471|3597133|B2|Canada||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3764709|NCT01940471|3597134|B1|Canada||Region of Enrollment||Participants|Count of Participants|55|55.0||||||
3764710|NCT01940471|3597132|B3|New Zealand||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3764711|NCT01940471|3597133|B2|New Zealand||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3764712|NCT01940471|3597134|B1|New Zealand||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3764713|NCT01940471|3597132|B3|Spain||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3764714|NCT01940471|3597133|B2|Spain||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3764715|NCT01940471|3597134|B1|Spain||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3764716|NCT01940471|3597132|B3|India||Region of Enrollment||Participants|Count of Participants|110|110.0||||||
3764717|NCT01940471|3597133|B2|India||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3764718|NCT01940471|3597134|B1|India||Region of Enrollment||Participants|Count of Participants|77|77.0||||||
3764719|NCT01940471|3597132|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3764720|NCT01940471|3597133|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3764721|NCT01940471|3597134|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3764722|NCT01940471|3597132|B3|Japan||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
3764723|NCT01940471|3597133|B2|Japan||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3764724|NCT01940471|3597134|B1|Japan||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3764725|NCT01940471|3597132|B3|United States||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
3764726|NCT01940471|3597133|B2|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3764727|NCT01940471|3597134|B1|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3764728|NCT01940471|3597132|B3|Hong Kong||Region of Enrollment||Participants|Count of Participants|121|121.0||||||
3764729|NCT01940471|3597133|B2|Hong Kong||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3764730|NCT01940471|3597134|B1|Hong Kong||Region of Enrollment||Participants|Count of Participants|71|71.0||||||
3764731|NCT01940471|3597132|B3|Singapore||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3764732|NCT01940471|3597133|B2|Singapore||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3764733|NCT01940471|3597134|B1|Singapore||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3764734|NCT01940471|3597132|B3|Romania||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3764735|NCT01940471|3597133|B2|Romania||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3764736|NCT01940471|3597134|B1|Romania||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3764737|NCT01940471|3597132|B3|Russian Federation||Region of Enrollment||Participants|Count of Participants|49|49.0||||||
3764738|NCT01940471|3597133|B2|Russian Federation||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3764739|NCT01940471|3597134|B1|Russian Federation||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3764740|NCT01940471|3597132|B3|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3764741|NCT01940471|3597133|B2|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3764742|NCT01940471|3597134|B1|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3764743|NCT01940471|3597132|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|862|862.0||||||
3764744|NCT01940471|3597133|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|289|289.0||||||
3764745|NCT01940471|3597134|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|573|573.0||||||
3764746|NCT01940471|3597132|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3764747|NCT01940471|3597133|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3764748|NCT01940471|3597134|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3764749|NCT01940471|3597132|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3764750|NCT01940471|3597133|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3764751|NCT01940471|3597134|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3764752|NCT01940471|3597132|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|149|149.0||||||
3764753|NCT01940471|3597133|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|53|53.0||||||
3764754|NCT01940471|3597134|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|96|96.0||||||
3764755|NCT01940471|3597132|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3764756|NCT01940471|3597133|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3764757|NCT01940471|3597134|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3764758|NCT01940471|3597132|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3764759|NCT01940471|3597133|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3764760|NCT01940471|3597134|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3764761|NCT01940471|3597132|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|714|714.0||||||
3764762|NCT01940471|3597133|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|232|232.0||||||
3764763|NCT01940471|3597134|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|482|482.0||||||
3764764|NCT01940471|3597132|B3||Male|Sex: Female, Male||Participants|Count of Participants|560|560.0||||||
3764765|NCT01940471|3597133|B2||Male|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
3764766|NCT01940471|3597134|B1||Male|Sex: Female, Male||Participants|Count of Participants|371|371.0||||||
3764767|NCT01940471|3597132|B3||Female|Sex: Female, Male||Participants|Count of Participants|313|313.0||||||
3764768|NCT01940471|3597133|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3764769|NCT01940471|3597134|B1||Female|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
3764770|NCT01940471|3597132|B3|||Age||Years|Mean|38|38.0|Standard Deviation|11.3|11.3|||
3764771|NCT01940471|3597133|B2|||Age||Years|Mean|38|38.0|Standard Deviation|11.7|11.7|||
3764772|NCT01940471|3597134|B1|||Age||Years|Mean|38|38.0|Standard Deviation|11.0|11.0|||
3764773|NCT01940354|3597151|B3|United States||Region of Enrollment||participants|Number|220|220.0||||||
3764774|NCT01940354|3597152|B2|United States||Region of Enrollment||participants|Number|110|110.0||||||
3764775|NCT01940354|3597153|B1|United States||Region of Enrollment||participants|Number|110|110.0||||||
3764776|NCT01940354|3597151|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764777|NCT01940354|3597152|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764778|NCT01940354|3597153|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764779|NCT01940354|3597151|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3764780|NCT01940354|3597152|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3764781|NCT01940354|3597153|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3764782|NCT01940354|3597151|B3||White|Race (NIH/OMB)||Participants|Count of Participants|143|143.0||||||
3764783|NCT01940354|3597152|B2||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3764784|NCT01940354|3597153|B1||White|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3764785|NCT01940354|3597151|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3764786|NCT01940354|3597152|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3764787|NCT01940354|3597153|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3764788|NCT01940354|3597151|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764789|NCT01940354|3597152|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764790|NCT01940354|3597153|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764791|NCT01940354|3597151|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3764792|NCT01940354|3597152|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3764793|NCT01940354|3597153|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3764794|NCT01940354|3597151|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764795|NCT01940354|3597152|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764796|NCT01940354|3597153|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3764797|NCT01940354|3597151|B3||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3764798|NCT01940354|3597152|B2||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3764799|NCT01940354|3597153|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3764800|NCT01940354|3597151|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3764801|NCT01940354|3597152|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3764802|NCT01940354|3597153|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3764803|NCT01940354|3597151|B3||>=65 years|Age||Participants|Count of Participants|68|68.0||||||
3764804|NCT01940354|3597152|B2||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
3764805|NCT01940354|3597153|B1||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
3764806|NCT01940354|3597151|B3||Between 18 and 65 years|Age||Participants|Count of Participants|152|152.0||||||
3764807|NCT01940354|3597152|B2||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
3764808|NCT01940354|3597153|B1||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
3764809|NCT01940354|3597151|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3764810|NCT01940354|3597152|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3764811|NCT01940354|3597153|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3764812|NCT01940341|3597164|B3|Grade 3||Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|0|0.0||||||
3764813|NCT01940341|3597165|B2|Grade 3||Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|0|0.0||||||
3764814|NCT01940341|3597166|B1|Grade 3||Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|0|0.0||||||
3764815|NCT01940341|3597164|B3|Grade 2||Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|2|2.0||||||
3764816|NCT01940341|3597165|B2|Grade 2||Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|0|0.0||||||
3764817|NCT01940341|3597166|B1|Grade 2||Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|2|2.0||||||
3764818|NCT01940341|3597164|B3|Grade 1||Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|18|18.0||||||
3764819|NCT01940341|3597165|B2|Grade 1||Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|5|5.0||||||
3764820|NCT01940341|3597166|B1|Grade 1||Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|13|13.0||||||
3764821|NCT01940341|3597164|B3|Grade 0||Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|405|405.0||||||
3764822|NCT01940341|3597165|B2|Grade 0||Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|135|135.0||||||
3764823|NCT01940341|3597166|B1|Grade 0||Proteinuria by Urinalysis (dipstick)|Urine protein was measured using the dipstick method. Grade 0 = Absent; Grade 1 = Mild; Grade 2 = Moderate; Grade 3 = Severe|Participants|Count of Participants|270|270.0||||||
3764824|NCT01940341|3597164|B3|Treatment Naive||Oral antiviral (OAV) treatment status||Participants|Count of Participants|334|334.0||||||
3764825|NCT01940341|3597165|B2|Treatment Naive||Oral antiviral (OAV) treatment status||Participants|Count of Participants|109|109.0||||||
3764826|NCT01940341|3597166|B1|Treatment Naive||Oral antiviral (OAV) treatment status||Participants|Count of Participants|225|225.0||||||
3764827|NCT01940341|3597164|B3|Treatment Experienced||Oral antiviral (OAV) treatment status||Participants|Count of Participants|91|91.0||||||
3764828|NCT01940341|3597165|B2|Treatment Experienced||Oral antiviral (OAV) treatment status||Participants|Count of Participants|31|31.0||||||
3764829|NCT01940341|3597166|B1|Treatment Experienced||Oral antiviral (OAV) treatment status||Participants|Count of Participants|60|60.0||||||
3764830|NCT01940341|3597164|B3|≥ 8 log10 IU/mL||Plasma HBV DNA Level||Participants|Count of Participants|17|17.0||||||
3764831|NCT01940341|3597165|B2|≥ 8 log10 IU/mL||Plasma HBV DNA Level||Participants|Count of Participants|4|4.0||||||
3764832|NCT01940341|3597166|B1|≥ 8 log10 IU/mL||Plasma HBV DNA Level||Participants|Count of Participants|13|13.0||||||
3764833|NCT01940341|3597164|B3|≥ 7 log10 IU/mL - < 8 log10 IU/mL||Plasma HBV DNA Level||Participants|Count of Participants|62|62.0||||||
3764834|NCT01940341|3597165|B2|≥ 7 log10 IU/mL - < 8 log10 IU/mL||Plasma HBV DNA Level||Participants|Count of Participants|20|20.0||||||
3764835|NCT01940341|3597166|B1|≥ 7 log10 IU/mL - < 8 log10 IU/mL||Plasma HBV DNA Level||Participants|Count of Participants|42|42.0||||||
3764836|NCT01940341|3597164|B3|< 7 log10 IU/mL||Plasma HBV DNA Level||Participants|Count of Participants|346|346.0||||||
3764837|NCT01940341|3597165|B2|< 7 log10 IU/mL||Plasma HBV DNA Level||Participants|Count of Participants|116|116.0||||||
3764838|NCT01940341|3597166|B1|< 7 log10 IU/mL||Plasma HBV DNA Level||Participants|Count of Participants|230|230.0||||||
3764839|NCT01940341|3597164|B3|||HBV DNA||log10 IU/mL|Mean|5.8|5.8|Standard Deviation|1.33|1.33|||
3764840|NCT01940341|3597165|B2|||HBV DNA||log10 IU/mL|Mean|5.8|5.8|Standard Deviation|1.32|1.32|||
3764841|NCT01940341|3597166|B1|||HBV DNA||log10 IU/mL|Mean|5.7|5.7|Standard Deviation|1.34|1.34|||
3764842|NCT01940341|3597164|B3|Missing||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|3|3.0||||||
3764843|NCT01940341|3597165|B2|Missing||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|2|2.0||||||
3764844|NCT01940341|3597166|B1|Missing||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|1|1.0||||||
3764845|NCT01940341|3597164|B3|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|19|19.0||||||
3764846|NCT01940341|3597165|B2|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|9|9.0||||||
3764847|NCT01940341|3597166|B1|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|10|10.0||||||
3764848|NCT01940341|3597164|B3|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|88|88.0||||||
3764849|NCT01940341|3597165|B2|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|23|23.0||||||
3764850|NCT01940341|3597166|B1|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|65|65.0||||||
3764851|NCT01940341|3597164|B3|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|315|315.0||||||
3764852|NCT01940341|3597165|B2|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|106|106.0||||||
3764853|NCT01940341|3597166|B1|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|Participants|Count of Participants|209|209.0||||||
3764854|NCT01940341|3597164|B3|Korea, Republic of||Region of Enrollment||participants|Number|45|45.0||||||
3764855|NCT01940341|3597165|B2|Korea, Republic of||Region of Enrollment||participants|Number|15|15.0||||||
3764856|NCT01940341|3597166|B1|Korea, Republic of||Region of Enrollment||participants|Number|30|30.0||||||
3764857|NCT01940341|3597164|B3|France||Region of Enrollment||participants|Number|3|3.0||||||
3764858|NCT01940341|3597165|B2|France||Region of Enrollment||participants|Number|1|1.0||||||
3764859|NCT01940341|3597166|B1|France||Region of Enrollment||participants|Number|2|2.0||||||
3764860|NCT01940341|3597164|B3|Australia||Region of Enrollment||participants|Number|10|10.0||||||
3764861|NCT01940341|3597165|B2|Australia||Region of Enrollment||participants|Number|1|1.0||||||
3764862|NCT01940341|3597166|B1|Australia||Region of Enrollment||participants|Number|9|9.0||||||
3764863|NCT01940341|3597164|B3|Italy||Region of Enrollment||participants|Number|9|9.0||||||
3764864|NCT01940341|3597165|B2|Italy||Region of Enrollment||participants|Number|3|3.0||||||
3764865|NCT01940341|3597166|B1|Italy||Region of Enrollment||participants|Number|6|6.0||||||
3764866|NCT01940341|3597164|B3|Poland||Region of Enrollment||participants|Number|18|18.0||||||
3764867|NCT01940341|3597165|B2|Poland||Region of Enrollment||participants|Number|6|6.0||||||
3764868|NCT01940341|3597166|B1|Poland||Region of Enrollment||participants|Number|12|12.0||||||
3764869|NCT01940341|3597164|B3|Taiwan||Region of Enrollment||participants|Number|37|37.0||||||
3764870|NCT01940341|3597165|B2|Taiwan||Region of Enrollment||participants|Number|15|15.0||||||
3764871|NCT01940341|3597166|B1|Taiwan||Region of Enrollment||participants|Number|22|22.0||||||
3764872|NCT01940341|3597164|B3|Turkey||Region of Enrollment||participants|Number|14|14.0||||||
3764873|NCT01940341|3597165|B2|Turkey||Region of Enrollment||participants|Number|4|4.0||||||
3764874|NCT01940341|3597166|B1|Turkey||Region of Enrollment||participants|Number|10|10.0||||||
3764875|NCT01940341|3597164|B3|Canada||Region of Enrollment||participants|Number|46|46.0||||||
3764876|NCT01940341|3597165|B2|Canada||Region of Enrollment||participants|Number|17|17.0||||||
3764877|NCT01940341|3597166|B1|Canada||Region of Enrollment||participants|Number|29|29.0||||||
3764878|NCT01940341|3597164|B3|New Zealand||Region of Enrollment||participants|Number|12|12.0||||||
3764879|NCT01940341|3597165|B2|New Zealand||Region of Enrollment||participants|Number|2|2.0||||||
3764880|NCT01940341|3597166|B1|New Zealand||Region of Enrollment||participants|Number|10|10.0||||||
3764881|NCT01940341|3597164|B3|Spain||Region of Enrollment||participants|Number|3|3.0||||||
3764882|NCT01940341|3597165|B2|Spain||Region of Enrollment||participants|Number|0|0.0||||||
3764883|NCT01940341|3597166|B1|Spain||Region of Enrollment||participants|Number|3|3.0||||||
3764884|NCT01940341|3597164|B3|India||Region of Enrollment||participants|Number|33|33.0||||||
3764885|NCT01940341|3597165|B2|India||Region of Enrollment||participants|Number|7|7.0||||||
3764886|NCT01940341|3597166|B1|India||Region of Enrollment||participants|Number|26|26.0||||||
3764887|NCT01940341|3597164|B3|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3764888|NCT01940341|3597165|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3764889|NCT01940341|3597166|B1|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
3764890|NCT01940341|3597164|B3|Japan||Region of Enrollment||participants|Number|27|27.0||||||
3764891|NCT01940341|3597165|B2|Japan||Region of Enrollment||participants|Number|6|6.0||||||
3764892|NCT01940341|3597166|B1|Japan||Region of Enrollment||participants|Number|21|21.0||||||
3764893|NCT01940341|3597164|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
3764894|NCT01940341|3597165|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3764895|NCT01940341|3597166|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3764896|NCT01940341|3597164|B3|Hong Kong||Region of Enrollment||participants|Number|69|69.0||||||
3764897|NCT01940341|3597165|B2|Hong Kong||Region of Enrollment||participants|Number|28|28.0||||||
3764898|NCT01940341|3597166|B1|Hong Kong||Region of Enrollment||participants|Number|41|41.0||||||
3764899|NCT01940341|3597164|B3|Romania||Region of Enrollment||participants|Number|21|21.0||||||
3764900|NCT01940341|3597165|B2|Romania||Region of Enrollment||participants|Number|8|8.0||||||
3764901|NCT01940341|3597166|B1|Romania||Region of Enrollment||participants|Number|13|13.0||||||
3764902|NCT01940341|3597164|B3|Russian Federation||Region of Enrollment||participants|Number|35|35.0||||||
3764903|NCT01940341|3597165|B2|Russian Federation||Region of Enrollment||participants|Number|13|13.0||||||
3764904|NCT01940341|3597166|B1|Russian Federation||Region of Enrollment||participants|Number|22|22.0||||||
3764905|NCT01940341|3597164|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3764906|NCT01940341|3597165|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3764907|NCT01940341|3597166|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3764908|NCT01940341|3597164|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|106|106.0||||||
3764909|NCT01940341|3597165|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
3764910|NCT01940341|3597166|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|71|71.0||||||
3764911|NCT01940341|3597164|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3764912|NCT01940341|3597165|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3764913|NCT01940341|3597166|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3764914|NCT01940341|3597164|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3764915|NCT01940341|3597165|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3764916|NCT01940341|3597166|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3764917|NCT01940341|3597164|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|306|306.0||||||
3764918|NCT01940341|3597165|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|101|101.0||||||
3764919|NCT01940341|3597166|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|205|205.0||||||
3764920|NCT01940341|3597164|B3|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3764921|NCT01940341|3597165|B2|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3764922|NCT01940341|3597166|B1|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3764923|NCT01940341|3597164|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|419|419.0||||||
3764924|NCT01940341|3597165|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|140|140.0||||||
3764925|NCT01940341|3597166|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|279|279.0||||||
3764926|NCT01940341|3597164|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3764927|NCT01940341|3597165|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3764928|NCT01940341|3597166|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3764929|NCT01940341|3597164|B3||Male|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
3764930|NCT01940341|3597165|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3764931|NCT01940341|3597166|B1||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
3764932|NCT01940341|3597164|B3||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3764933|NCT01940341|3597165|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3764934|NCT01940341|3597166|B1||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3764935|NCT01940341|3597164|B3|||Age||Years|Mean|46|46.0|Standard Deviation|11.3|11.3|||
3764936|NCT01940341|3597165|B2|||Age||Years|Mean|48|48.0|Standard Deviation|10.4|10.4|||
3764937|NCT01940341|3597166|B1|||Age||Years|Mean|45|45.0|Standard Deviation|11.6|11.6|||
3764938|NCT01940146|3597181|B5||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3764939|NCT01940146|3597182|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3764940|NCT01940146|3597183|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3764941|NCT01940146|3597184|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3764942|NCT01940146|3597185|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3764943|NCT01940146|3597181|B5||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3764944|NCT01940146|3597182|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3764945|NCT01940146|3597183|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3764946|NCT01940146|3597184|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3764947|NCT01940146|3597185|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3764948|NCT01940146|3597181|B5|||Age, Customized||years|Median|37|37.0|Full Range|||18.0|65.0|
3764949|NCT01940146|3597182|B4|||Age, Customized||years|Median|37|37.0|Full Range|||19.0|65.0|
3764950|NCT01940146|3597183|B3|||Age, Customized||years|Median|38|38.0|Full Range|||19.0|63.0|
3764951|NCT01940146|3597184|B2|||Age, Customized||years|Median|36|36.0|Full Range|||24.0|59.0|
3764952|NCT01940146|3597185|B1|||Age, Customized||years|Median|38|38.0|Full Range|||18.0|63.0|
3764953|NCT01940146|3597181|B5|||Age||years|Mean|39|39.0|Standard Deviation|10.4|10.4|||
3764954|NCT01940146|3597182|B4|||Age||years|Mean|38|38.0|Standard Deviation|10.6|10.6|||
3764955|NCT01940146|3597183|B3|||Age||years|Mean|39|39.0|Standard Deviation|10.9|10.9|||
3764956|NCT01940146|3597184|B2|||Age||years|Mean|39|39.0|Standard Deviation|9.5|9.5|||
3764957|NCT01940146|3597185|B1|||Age||years|Mean|39|39.0|Standard Deviation|10.8|10.8|||
3764958|NCT01940120|3597198|B1|||Number of hospitalization days for CHF at 12 months before enrollment||days|Mean|6.0|6.0|Standard Deviation|4.6|4.6|||
3764959|NCT01940120|3597198|B1|||Number of CHF events leading to hospitalizations during 12 months before enrollment||events|Number|51|51.0||||||
3764960|NCT01940120|3597198|B1|Number of patients not hospitalized for CHF||Number of patients hospitalized for CHF during 12 months before enrollment||participants|Number|45|45.0||||||
3764961|NCT01940120|3597198|B1|Number of patients hospitalized for CHF||Number of patients hospitalized for CHF during 12 months before enrollment||participants|Number|33|33.0||||||
3764962|NCT01940120|3597198|B1|NYHA Functional Class IV||NYHA Functional Class|"Class I: Patients with cardiac disease but without resulting limitations of physical activity.~Class II: Patients with cardiac disease resulting in slight limitation of physical activity. Patients are comfortable at rest.~Class III: Patients with cardiac disease resulting in marked limitation of physical activity. They are comfortable at rest.~Class IV: Patients with cardiac disease resulting in inability to carry on any physical activity without discomfort. Symptoms of cardiac insufficiency or anginal syndrome may be present even at rest & discomfort is increased with physical activity."|participants|Number|23|23.0||||||
3764963|NCT01940120|3597198|B1|NYHA Functional Class III||NYHA Functional Class|"Class I: Patients with cardiac disease but without resulting limitations of physical activity.~Class II: Patients with cardiac disease resulting in slight limitation of physical activity. Patients are comfortable at rest.~Class III: Patients with cardiac disease resulting in marked limitation of physical activity. They are comfortable at rest.~Class IV: Patients with cardiac disease resulting in inability to carry on any physical activity without discomfort. Symptoms of cardiac insufficiency or anginal syndrome may be present even at rest & discomfort is increased with physical activity."|participants|Number|47|47.0||||||
3764964|NCT01940120|3597198|B1|NYHA Functional Class II||NYHA Functional Class|"Class I: Patients with cardiac disease but without resulting limitations of physical activity.~Class II: Patients with cardiac disease resulting in slight limitation of physical activity. Patients are comfortable at rest.~Class III: Patients with cardiac disease resulting in marked limitation of physical activity. They are comfortable at rest.~Class IV: Patients with cardiac disease resulting in inability to carry on any physical activity without discomfort. Symptoms of cardiac insufficiency or anginal syndrome may be present even at rest & discomfort is increased with physical activity."|participants|Number|8|8.0||||||
3764965|NCT01940120|3597198|B1|NYHA Functional Class I||NYHA Functional Class|"Class I: Patients with cardiac disease but without resulting limitations of physical activity.~Class II: Patients with cardiac disease resulting in slight limitation of physical activity. Patients are comfortable at rest.~Class III: Patients with cardiac disease resulting in marked limitation of physical activity. They are comfortable at rest.~Class IV: Patients with cardiac disease resulting in inability to carry on any physical activity without discomfort. Symptoms of cardiac insufficiency or anginal syndrome may be present even at rest & discomfort is increased with physical activity."|participants|Number|0|0.0||||||
3764966|NCT01940120|3597198|B1|Mental Health (MCS)||36-Item Short Form Health Survey (SF-36) Quality of Life|The SF-36 is a multidimensional, patient-reported survey containing 36 questions on a 0-100 scale measuring physical (Physical Component Score PCS) & mental health status (Mental Component Score MCS) in relation to 8 health concepts: physical functioning, role limitations due to physical or emotional health, bodily pain, general health perceptions, vitality, social functioning, & general mental health. Higher scores represent better self-perceived health. The PCS & MCS norms for 65-75 year olds are 44 and 52, while the norms for CHF population are 31 and 46, respectively.|scores on a scale|Mean|44.2|44.2|Standard Deviation|12.6|12.6|||
3764967|NCT01940120|3597198|B1|Physical Health (PCS)||36-Item Short Form Health Survey (SF-36) Quality of Life|The SF-36 is a multidimensional, patient-reported survey containing 36 questions on a 0-100 scale measuring physical (Physical Component Score PCS) & mental health status (Mental Component Score MCS) in relation to 8 health concepts: physical functioning, role limitations due to physical or emotional health, bodily pain, general health perceptions, vitality, social functioning, & general mental health. Higher scores represent better self-perceived health. The PCS & MCS norms for 65-75 year olds are 44 and 52, while the norms for CHF population are 31 and 46, respectively.|scores on a scale|Mean|31.6|31.6|Standard Deviation|9.1|9.1|||
3764968|NCT01940120|3597198|B1|Left Ventricular Internal Diameter Systole (LVIDs)||LV Measurement||cm|Mean|3.9|3.9|Standard Deviation|1.1|1.1|||
3764969|NCT01940120|3597198|B1|Left Ventricular Internal Diameter Diastole(LVIDd)||LV Measurement||cm|Mean|5.6|5.6|Standard Deviation|0.7|0.7|||
3764970|NCT01940120|3597198|B1|Left Ventricular End Systolic Volume (LVESV)||LV Measurement||mL|Mean|79.9|79.9|Standard Deviation|42.7|42.7|||
3764971|NCT01940120|3597198|B1|Left Ventricular End Diastolic Volume (LVEDV)||LV Measurement||mL|Mean|166.5|166.5|Standard Deviation|50.7|50.7|||
3765030|NCT01939496|3597476|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3765031|NCT01939405|3597528|B3||missing|parental education||Participants|Count of Participants|1|1.0||||||
3765032|NCT01939405|3597529|B2||missing|parental education||Participants|Count of Participants|0|0.0||||||
3764972|NCT01940120|3597198|B1|||Predicted Surgical Mortality|"The Society of Thoracic Surgeons' risk models predict the risk of operative mortality & morbidity after adult cardiac surgery.~Risk models were developed for nine specific endpoints, including operative mortality.Operative mortality includes both (1) all deaths occurring during the hospitalization, even if after 30 days (2) deaths occurring after discharge, but within 30 days of the procedure.~Therefore, a patient’s mortality risk score is defined as the patient’s predicted risk of operative mortality as calculated by the specific operative mortality statistical model."|Probability percentage|Mean|18.2|18.2|Standard Deviation|8.0|8.0|||
3764973|NCT01940120|3597198|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3764974|NCT01940120|3597198|B1|United States||Region of Enrollment||participants|Number|77|77.0||||||
3764975|NCT01940120|3597198|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3764976|NCT01940120|3597198|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3764977|NCT01940120|3597198|B1|>75 years||Age, Customized||participants|Number|48|48.0||||||
3764978|NCT01940120|3597198|B1|18-75 years||Age, Customized||participants|Number|30|30.0||||||
3764979|NCT01940120|3597198|B1|||Age||years|Mean|76.7|76.7|Standard Deviation|9.8|9.8|||
3764980|NCT01939977|3597352|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3764981|NCT01939977|3597353|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3764982|NCT01939977|3597354|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3764983|NCT01939977|3597352|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3764984|NCT01939977|3597353|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3764985|NCT01939977|3597354|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3764986|NCT01939977|3597352|B3|||Age||years|Mean|57.53|57.53|Standard Deviation|13.79|13.79|||
3764987|NCT01939977|3597353|B2|||Age||years|Mean|56.15|56.15|Standard Deviation|14.48|14.48|||
3764988|NCT01939977|3597354|B1|||Age||years|Mean|58.93|58.93|Standard Deviation|13.05|13.05|||
3764989|NCT01939938|3597391|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3764990|NCT01939938|3597391|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3764991|NCT01939938|3597391|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3764992|NCT01939938|3597391|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3764993|NCT01939938|3597391|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3764994|NCT01939938|3597391|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3764995|NCT01939548|3597397|B4||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3764996|NCT01939548|3597398|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3764997|NCT01939548|3597399|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3764998|NCT01939548|3597400|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3764999|NCT01939548|3597397|B4||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3765000|NCT01939548|3597398|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3765001|NCT01939548|3597399|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3765002|NCT01939548|3597400|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3765003|NCT01939548|3597397|B4|||Age||years|Mean|46.5|46.5|Standard Deviation|9.9|9.9|||
3765004|NCT01939548|3597398|B3|||Age||years|Mean|45.6|45.6|Standard Deviation|9.9|9.9|||
3765005|NCT01939548|3597399|B2|||Age||years|Mean|46.3|46.3|Standard Deviation|9.4|9.4|||
3765006|NCT01939548|3597400|B1|||Age||years|Mean|47.5|47.5|Standard Deviation|10.4|10.4|||
3765007|NCT01939496|3597473|B4||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3765008|NCT01939496|3597474|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3765009|NCT01939496|3597475|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3765010|NCT01939496|3597476|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3765011|NCT01939496|3597473|B4||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3765012|NCT01939496|3597474|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3765013|NCT01939496|3597475|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3765014|NCT01939496|3597476|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3765015|NCT01939496|3597473|B4|||Age||years|Mean|58.6|58.6|Standard Deviation|8.44|8.44|||
3765016|NCT01939496|3597474|B3|||Age||years|Mean|58.3|58.3|Standard Deviation|6.88|6.88|||
3765017|NCT01939496|3597475|B2|||Age||years|Mean|57.8|57.8|Standard Deviation|8.74|8.74|||
3765018|NCT01939496|3597476|B1|||Age||years|Mean|59.6|59.6|Standard Deviation|9.52|9.52|||
3765019|NCT01939496|3597473|B4||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
3765020|NCT01939496|3597474|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3765021|NCT01939496|3597475|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3765022|NCT01939496|3597476|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3765023|NCT01939496|3597473|B4||Between 18 and 65 years|Age||Participants|Count of Participants|129|129.0||||||
3765024|NCT01939496|3597474|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3765025|NCT01939496|3597475|B2||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
3765026|NCT01939496|3597476|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3765027|NCT01939496|3597473|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3765028|NCT01939496|3597474|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3765029|NCT01939496|3597475|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3765033|NCT01939405|3597530|B1||missing|parental education||Participants|Count of Participants|1|1.0||||||
3765034|NCT01939405|3597528|B3||Graduate Education|parental education||Participants|Count of Participants|5|5.0||||||
3765035|NCT01939405|3597529|B2||Graduate Education|parental education||Participants|Count of Participants|1|1.0||||||
3765036|NCT01939405|3597530|B1||Graduate Education|parental education||Participants|Count of Participants|4|4.0||||||
3765037|NCT01939405|3597528|B3||Associates degree or College|parental education||Participants|Count of Participants|34|34.0||||||
3765038|NCT01939405|3597529|B2||Associates degree or College|parental education||Participants|Count of Participants|18|18.0||||||
3765039|NCT01939405|3597530|B1||Associates degree or College|parental education||Participants|Count of Participants|16|16.0||||||
3765040|NCT01939405|3597528|B3||High School or less|parental education||Participants|Count of Participants|20|20.0||||||
3765041|NCT01939405|3597529|B2||High School or less|parental education||Participants|Count of Participants|11|11.0||||||
3765042|NCT01939405|3597530|B1||High School or less|parental education||Participants|Count of Participants|9|9.0||||||
3765043|NCT01939405|3597528|B3|||BMI percentile||BMI percentile|Mean|94|94.0|Standard Deviation|3.9|3.9|||
3765044|NCT01939405|3597529|B2|||BMI percentile||BMI percentile|Mean|94|94.0|Standard Deviation|3.9|3.9|||
3765045|NCT01939405|3597530|B1|||BMI percentile||BMI percentile|Mean|94|94.0|Standard Deviation|3.9|3.9|||
3765046|NCT01939405|3597528|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
3765047|NCT01939405|3597529|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3765048|NCT01939405|3597530|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3765049|NCT01939405|3597528|B3|Race/Ethnicity|Multi/Other|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3765050|NCT01939405|3597529|B2|Race/Ethnicity|Multi/Other|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3765051|NCT01939405|3597530|B1|Race/Ethnicity|Multi/Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3765052|NCT01939405|3597528|B3|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3765053|NCT01939405|3597529|B2|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3765054|NCT01939405|3597530|B1|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3765055|NCT01939405|3597528|B3|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3765056|NCT01939405|3597529|B2|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3765057|NCT01939405|3597530|B1|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3765058|NCT01939405|3597528|B3|Race/Ethnicity|Black|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3765059|NCT01939405|3597529|B2|Race/Ethnicity|Black|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3765060|NCT01939405|3597530|B1|Race/Ethnicity|Black|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3765061|NCT01939405|3597528|B3|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3765062|NCT01939405|3597529|B2|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3765063|NCT01939405|3597530|B1|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3765064|NCT01939405|3597528|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3765065|NCT01939405|3597529|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3765066|NCT01939405|3597530|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3765067|NCT01939405|3597528|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3765068|NCT01939405|3597529|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3765069|NCT01939405|3597530|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3765070|NCT01939405|3597528|B3|||Age||years|Mean|11.9|11.9|Standard Deviation|1.4|1.4|||
3765071|NCT01939405|3597529|B2|||Age||years|Mean|12.2|12.2|Standard Deviation|1.6|1.6|||
3765072|NCT01939405|3597530|B1|||Age||years|Mean|11.6|11.6|Standard Deviation|1.0|1.0|||
3765073|NCT01939405|3597528|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3765074|NCT01939405|3597529|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3765075|NCT01939405|3597530|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3765076|NCT01939405|3597528|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3765077|NCT01939405|3597529|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3765078|NCT01939405|3597530|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3765079|NCT01939405|3597528|B3||<=18 years|Age||Participants|Count of Participants|60|60.0||||||
3765080|NCT01939405|3597529|B2||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
3765081|NCT01939405|3597530|B1||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
3765082|NCT01939314|3597543|B3|||Median Baseline Nausea Score|0mm (No Nausea) to 100mm (Maximum Nausea) on 100mm Visual Analog Scale|units on a scale|Median|20|20.0|Inter-Quartile Range|||0.0|47.0|
3765083|NCT01939314|3597544|B2|||Median Baseline Nausea Score|0mm (No Nausea) to 100mm (Maximum Nausea) on 100mm Visual Analog Scale|units on a scale|Median|0|0.0|Inter-Quartile Range|||0.0|45.5|
3765084|NCT01939314|3597545|B1|||Median Baseline Nausea Score|0mm (No Nausea) to 100mm (Maximum Nausea) on 100mm Visual Analog Scale|units on a scale|Median|29|29.0|Inter-Quartile Range|||0.0|48.0|
3765085|NCT01939314|3597543|B3|||Median Baseline Headache Score|0mm (No Pain) to 100mm (Maximum Pain) on 100mm Visual Analog Scale|units on a scale|Median|79|79.0|Inter-Quartile Range|||64.5|92.5|
3765086|NCT01939314|3597544|B2|||Median Baseline Headache Score|0mm (No Pain) to 100mm (Maximum Pain) on 100mm Visual Analog Scale|units on a scale|Median|79|79.0|Inter-Quartile Range|||64.0|91.75|
3765087|NCT01939314|3597545|B1|||Median Baseline Headache Score|0mm (No Pain) to 100mm (Maximum Pain) on 100mm Visual Analog Scale|units on a scale|Median|80|80.0|Inter-Quartile Range|||66.0|93.0|
3765088|NCT01939314|3597543|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3765089|NCT01939314|3597544|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3765090|NCT01939314|3597545|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3765091|NCT01939314|3597543|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3765092|NCT01939314|3597544|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3765093|NCT01939314|3597545|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3765094|NCT01939314|3597543|B3|||Age||years|Median|39|39.0|Inter-Quartile Range|||28.5|47.5|
3765095|NCT01939314|3597544|B2|||Age||years|Median|41|41.0|Inter-Quartile Range|||29.25|51.0|
3765096|NCT01939314|3597545|B1|||Age||years|Median|33|33.0|Inter-Quartile Range|||23.0|44.0|
3765097|NCT01939301|3597556|B3|United States||Region of Enrollment||Participants|Count of Participants|78|78.0||||||
3765098|NCT01939301|3597557|B2|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3765099|NCT01939301|3597558|B1|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3765100|NCT01939301|3597556|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3765101|NCT01939301|3597557|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3765102|NCT01939301|3597558|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3765103|NCT01939301|3597556|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3765104|NCT01939301|3597557|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3765105|NCT01939301|3597558|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3765106|NCT01939301|3597556|B3|||Age||years|Mean|57|57.0|Standard Deviation|15|15.0|||
3765107|NCT01939301|3597557|B2|||Age||years|Mean|59|59.0|Standard Deviation|16|16.0|||
3765108|NCT01939301|3597558|B1|||Age||years|Mean|55|55.0|Standard Deviation|15|15.0|||
3765109|NCT01939223|3597565|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3765110|NCT01939223|3597566|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3765111|NCT01939223|3597567|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3765112|NCT01939223|3597565|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3765113|NCT01939223|3597566|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3765114|NCT01939223|3597567|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3765115|NCT01939223|3597565|B3|||Age||Years|Mean|58.5|58.5|Standard Deviation|10.50|10.5|||
3765116|NCT01939223|3597566|B2|||Age||Years|Mean|57.0|57.0|Standard Deviation|9.83|9.83|||
3765117|NCT01939223|3597567|B1|||Age||Years|Mean|59.7|59.7|Standard Deviation|11.22|11.22|||
3765118|NCT01939197|3597576|B8||Male|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
3765119|NCT01939197|3597577|B7||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3765120|NCT01939197|3597578|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3765121|NCT01939197|3597579|B5||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3765122|NCT01939197|3597580|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3765123|NCT01939197|3597581|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3765124|NCT01939197|3597582|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3765125|NCT01939197|3597583|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3765126|NCT01939197|3597576|B8||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3765127|NCT01939197|3597577|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3765128|NCT01939197|3597578|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3765129|NCT01939197|3597579|B5||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3765130|NCT01939197|3597580|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3765131|NCT01939197|3597581|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3765132|NCT01939197|3597582|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3765133|NCT01939197|3597583|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3765134|NCT01939197|3597576|B8|Age Group|≥ 55 years|Age, Customized||Participants|Count of Participants|91|91.0||||||
3765135|NCT01939197|3597577|B7|Age Group|≥ 55 years|Age, Customized||Participants|Count of Participants|4|4.0||||||
3765136|NCT01939197|3597578|B6|Age Group|≥ 55 years|Age, Customized||Participants|Count of Participants|3|3.0||||||
3765137|NCT01939197|3597579|B5|Age Group|≥ 55 years|Age, Customized||Participants|Count of Participants|55|55.0||||||
3765138|NCT01939197|3597580|B4|Age Group|≥ 55 years|Age, Customized||Participants|Count of Participants|4|4.0||||||
3765139|NCT01939197|3597581|B3|Age Group|≥ 55 years|Age, Customized||Participants|Count of Participants|5|5.0||||||
3765140|NCT01939197|3597582|B2|Age Group|≥ 55 years|Age, Customized||Participants|Count of Participants|12|12.0||||||
3765141|NCT01939197|3597583|B1|Age Group|≥ 55 years|Age, Customized||Participants|Count of Participants|8|8.0||||||
3765142|NCT01939197|3597576|B8|Age Group|< 55 years|Age, Customized||Participants|Count of Participants|227|227.0||||||
3765143|NCT01939197|3597577|B7|Age Group|< 55 years|Age, Customized||Participants|Count of Participants|24|24.0||||||
3765144|NCT01939197|3597578|B6|Age Group|< 55 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
3765145|NCT01939197|3597579|B5|Age Group|< 55 years|Age, Customized||Participants|Count of Participants|145|145.0||||||
3765322|NCT01938430|3597776|B11|≥ 800 IU/mL||HCV RNA Category||participants|Number|4|4.0||||||
3765146|NCT01939197|3597580|B4|Age Group|< 55 years|Age, Customized||Participants|Count of Participants|8|8.0||||||
3765147|NCT01939197|3597581|B3|Age Group|< 55 years|Age, Customized||Participants|Count of Participants|5|5.0||||||
3765148|NCT01939197|3597582|B2|Age Group|< 55 years|Age, Customized||Participants|Count of Participants|20|20.0||||||
3765149|NCT01939197|3597583|B1|Age Group|< 55 years|Age, Customized||Participants|Count of Participants|23|23.0||||||
3765150|NCT01939145|3597647|B3|Missing/declined||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3765151|NCT01939145|3597648|B2|Missing/declined||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3765152|NCT01939145|3597649|B1|Missing/declined||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3765153|NCT01939145|3597647|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3765154|NCT01939145|3597648|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765155|NCT01939145|3597649|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3765156|NCT01939145|3597647|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3765157|NCT01939145|3597648|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3765158|NCT01939145|3597649|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3765159|NCT01939145|3597647|B3|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3765160|NCT01939145|3597648|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3765161|NCT01939145|3597649|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3765162|NCT01939145|3597647|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
3765163|NCT01939145|3597648|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3765164|NCT01939145|3597649|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3765165|NCT01939145|3597647|B3|African America||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
3765166|NCT01939145|3597648|B2|African America||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3765167|NCT01939145|3597649|B1|African America||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3765168|NCT01939145|3597647|B3||Male|Gender||Participants|Count of Participants|71|71.0||||||
3765169|NCT01939145|3597648|B2||Male|Gender||Participants|Count of Participants|43|43.0||||||
3765170|NCT01939145|3597649|B1||Male|Gender||Participants|Count of Participants|28|28.0||||||
3765171|NCT01939145|3597647|B3||Female|Gender||Participants|Count of Participants|29|29.0||||||
3765172|NCT01939145|3597648|B2||Female|Gender||Participants|Count of Participants|8|8.0||||||
3765173|NCT01939145|3597649|B1||Female|Gender||Participants|Count of Participants|21|21.0||||||
3765174|NCT01939145|3597647|B3|||Age||years|Mean|58.37|58.37|Standard Deviation|14.09|14.09|||
3765175|NCT01939145|3597648|B2|||Age||years|Mean|55.94|55.94|Standard Deviation|13.9|13.9|||
3765176|NCT01939145|3597649|B1|||Age||years|Mean|59.64|59.64|Standard Deviation|15.4|15.4|||
3765177|NCT01939002|3597658|B3||Male|Gender||Participants|Count of Participants|38|38.0||||||
3765178|NCT01939002|3597659|B2||Male|Gender||Participants|Count of Participants|19|19.0||||||
3765179|NCT01939002|3597660|B1||Male|Gender||Participants|Count of Participants|19|19.0||||||
3765180|NCT01939002|3597658|B3||Female|Gender||Participants|Count of Participants|163|163.0||||||
3765181|NCT01939002|3597659|B2||Female|Gender||Participants|Count of Participants|79|79.0||||||
3765182|NCT01939002|3597660|B1||Female|Gender||Participants|Count of Participants|84|84.0||||||
3765183|NCT01939002|3597658|B3|||Age||years|Mean|49.82|49.82|Standard Deviation|9.88|9.88|||
3765184|NCT01939002|3597659|B2|||Age||years|Mean|49.88|49.88|Standard Deviation|9.45|9.45|||
3765185|NCT01939002|3597660|B1|||Age||years|Mean|49.76|49.76|Standard Deviation|10.32|10.32|||
3765186|NCT01938989|3597727|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3765187|NCT01938989|3597727|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3765188|NCT01938989|3597727|B1|||Age||years|Mean|69.9|69.9|Standard Deviation|8.04|8.04|||
3765189|NCT01938833|3597734|B1|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3765190|NCT01938833|3597734|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765191|NCT01938833|3597734|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765192|NCT01938833|3597734|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3765193|NCT01938833|3597734|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765194|NCT01938833|3597734|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765195|NCT01938833|3597734|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765196|NCT01938833|3597734|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765197|NCT01938833|3597734|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765198|NCT01938833|3597734|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3765199|NCT01938833|3597734|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765200|NCT01938833|3597734|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3765201|NCT01938833|3597734|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3765202|NCT01938833|3597734|B1|||Age||Years|Mean|51.6|51.6|Standard Deviation|9.33|9.33|||
3765203|NCT01938625|3597742|B3|Italy||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3765204|NCT01938625|3597743|B2|Italy||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3765205|NCT01938625|3597744|B1|Italy||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3765206|NCT01938625|3597742|B3|Poland||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3765207|NCT01938625|3597743|B2|Poland||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3765208|NCT01938625|3597744|B1|Poland||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3765209|NCT01938625|3597742|B3|Spain||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3765210|NCT01938625|3597743|B2|Spain||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3765211|NCT01938625|3597744|B1|Spain||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3765212|NCT01938625|3597742|B3|Germany||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3765213|NCT01938625|3597743|B2|Germany||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3765214|NCT01938625|3597744|B1|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3765215|NCT01938625|3597742|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3765216|NCT01938625|3597743|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3765217|NCT01938625|3597744|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3765218|NCT01938625|3597742|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3765219|NCT01938625|3597743|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3765220|NCT01938625|3597744|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3765221|NCT01938625|3597742|B3|||Age||years|Median|62|62.0|Full Range|||27.0|69.0|
3765222|NCT01938625|3597743|B2|||Age||years|Median|61|61.0|Full Range|||27.0|69.0|
3765223|NCT01938625|3597744|B1|||Age||years|Median|64.5|64.5|Full Range|||52.0|69.0|
3765224|NCT01938573|3597765|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3765225|NCT01938573|3597765|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3765226|NCT01938573|3597765|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3765227|NCT01938573|3597765|B1|||Age||years|Median|69|69.0|Full Range|||51.0|76.0|
3765228|NCT01938430|3597772|B15|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|82|82.0||||||
3765229|NCT01938430|3597773|B14|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3765230|NCT01938430|3597774|B13|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|2|2.0||||||
3765231|NCT01938430|3597775|B12|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3765232|NCT01938430|3597776|B11|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3765233|NCT01938430|3597777|B10|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|5|5.0||||||
3765234|NCT01938430|3597778|B9|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|9|9.0||||||
3765235|NCT01938430|3597779|B8|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|5|5.0||||||
3765236|NCT01938430|3597780|B7|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|8|8.0||||||
3765237|NCT01938430|3597781|B6|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|19|19.0||||||
3765238|NCT01938430|3597782|B5|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|11|11.0||||||
3765239|NCT01938430|3597783|B4|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|4|4.0||||||
3765240|NCT01938430|3597784|B3|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|4|4.0||||||
3765241|NCT01938430|3597785|B2|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|6|6.0||||||
3765242|NCT01938430|3597786|B1|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|6|6.0||||||
3765243|NCT01938430|3597772|B15|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|193|193.0||||||
3765244|NCT01938430|3597773|B14|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3765245|NCT01938430|3597774|B13|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|2|2.0||||||
3765246|NCT01938430|3597775|B12|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|2|2.0||||||
3765247|NCT01938430|3597776|B11|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|2|2.0||||||
3765248|NCT01938430|3597777|B10|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|16|16.0||||||
3765249|NCT01938430|3597778|B9|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|14|14.0||||||
3765250|NCT01938430|3597779|B8|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|19|19.0||||||
3765251|NCT01938430|3597780|B7|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|11|11.0||||||
3765252|NCT01938430|3597781|B6|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|27|27.0||||||
3765253|NCT01938430|3597782|B5|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|33|33.0||||||
3765254|NCT01938430|3597783|B4|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|15|15.0||||||
3765255|NCT01938430|3597784|B3|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|13|13.0||||||
3765256|NCT01938430|3597785|B2|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|18|18.0||||||
3765257|NCT01938430|3597786|B1|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|20|20.0||||||
3765258|NCT01938430|3597772|B15|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|62|62.0||||||
3765259|NCT01938430|3597773|B14|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3765260|NCT01938430|3597774|B13|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3765261|NCT01938430|3597775|B12|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3765262|NCT01938430|3597776|B11|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|2|2.0||||||
3765263|NCT01938430|3597777|B10|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|5|5.0||||||
3765264|NCT01938430|3597778|B9|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
3765265|NCT01938430|3597779|B8|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3765266|NCT01938430|3597780|B7|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|7|7.0||||||
3765267|NCT01938430|3597781|B6|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|10|10.0||||||
3765268|NCT01938430|3597782|B5|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|11|11.0||||||
3765269|NCT01938430|3597783|B4|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|7|7.0||||||
3765270|NCT01938430|3597784|B3|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|6|6.0||||||
3765271|NCT01938430|3597785|B2|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|5|5.0||||||
3765272|NCT01938430|3597786|B1|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|4|4.0||||||
3765273|NCT01938430|3597772|B15|Genotype 4||HCV Genotype||participants|Number|5|5.0||||||
3765274|NCT01938430|3597773|B14|Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3765275|NCT01938430|3597774|B13|Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3765276|NCT01938430|3597775|B12|Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3765277|NCT01938430|3597776|B11|Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3765278|NCT01938430|3597777|B10|Genotype 4||HCV Genotype||participants|Number|1|1.0||||||
3765279|NCT01938430|3597778|B9|Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3765280|NCT01938430|3597779|B8|Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3765281|NCT01938430|3597780|B7|Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3765282|NCT01938430|3597781|B6|Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3765283|NCT01938430|3597782|B5|Genotype 4||HCV Genotype||participants|Number|1|1.0||||||
3765284|NCT01938430|3597783|B4|Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3765285|NCT01938430|3597784|B3|Genotype 4||HCV Genotype||participants|Number|2|2.0||||||
3765286|NCT01938430|3597785|B2|Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3765287|NCT01938430|3597786|B1|Genotype 4||HCV Genotype||participants|Number|1|1.0||||||
3765288|NCT01938430|3597772|B15|Genotype 1b||HCV Genotype||participants|Number|94|94.0||||||
3765289|NCT01938430|3597773|B14|Genotype 1b||HCV Genotype||participants|Number|0|0.0||||||
3765290|NCT01938430|3597774|B13|Genotype 1b||HCV Genotype||participants|Number|1|1.0||||||
3765291|NCT01938430|3597775|B12|Genotype 1b||HCV Genotype||participants|Number|1|1.0||||||
3765292|NCT01938430|3597776|B11|Genotype 1b||HCV Genotype||participants|Number|1|1.0||||||
3765293|NCT01938430|3597777|B10|Genotype 1b||HCV Genotype||participants|Number|7|7.0||||||
3765294|NCT01938430|3597778|B9|Genotype 1b||HCV Genotype||participants|Number|6|6.0||||||
3765295|NCT01938430|3597779|B8|Genotype 1b||HCV Genotype||participants|Number|8|8.0||||||
3765296|NCT01938430|3597780|B7|Genotype 1b||HCV Genotype||participants|Number|9|9.0||||||
3765297|NCT01938430|3597781|B6|Genotype 1b||HCV Genotype||participants|Number|16|16.0||||||
3765298|NCT01938430|3597782|B5|Genotype 1b||HCV Genotype||participants|Number|14|14.0||||||
3765299|NCT01938430|3597783|B4|Genotype 1b||HCV Genotype||participants|Number|8|8.0||||||
3765300|NCT01938430|3597784|B3|Genotype 1b||HCV Genotype||participants|Number|6|6.0||||||
3765301|NCT01938430|3597785|B2|Genotype 1b||HCV Genotype||participants|Number|7|7.0||||||
3765302|NCT01938430|3597786|B1|Genotype 1b||HCV Genotype||participants|Number|10|10.0||||||
3765303|NCT01938430|3597772|B15|Genotype 1a||HCV Genotype||participants|Number|238|238.0||||||
3765304|NCT01938430|3597773|B14|Genotype 1a||HCV Genotype||participants|Number|2|2.0||||||
3765305|NCT01938430|3597774|B13|Genotype 1a||HCV Genotype||participants|Number|3|3.0||||||
3765306|NCT01938430|3597775|B12|Genotype 1a||HCV Genotype||participants|Number|3|3.0||||||
3765307|NCT01938430|3597776|B11|Genotype 1a||HCV Genotype||participants|Number|4|4.0||||||
3765308|NCT01938430|3597777|B10|Genotype 1a||HCV Genotype||participants|Number|18|18.0||||||
3765309|NCT01938430|3597778|B9|Genotype 1a||HCV Genotype||participants|Number|20|20.0||||||
3765310|NCT01938430|3597779|B8|Genotype 1a||HCV Genotype||participants|Number|17|17.0||||||
3765311|NCT01938430|3597780|B7|Genotype 1a||HCV Genotype||participants|Number|17|17.0||||||
3765312|NCT01938430|3597781|B6|Genotype 1a||HCV Genotype||participants|Number|40|40.0||||||
3765313|NCT01938430|3597782|B5|Genotype 1a||HCV Genotype||participants|Number|40|40.0||||||
3765314|NCT01938430|3597783|B4|Genotype 1a||HCV Genotype||participants|Number|18|18.0||||||
3765315|NCT01938430|3597784|B3|Genotype 1a||HCV Genotype||participants|Number|15|15.0||||||
3765316|NCT01938430|3597785|B2|Genotype 1a||HCV Genotype||participants|Number|22|22.0||||||
3765317|NCT01938430|3597786|B1|Genotype 1a||HCV Genotype||participants|Number|19|19.0||||||
3765318|NCT01938430|3597772|B15|≥ 800 IU/mL||HCV RNA Category||participants|Number|239|239.0||||||
3765319|NCT01938430|3597773|B14|≥ 800 IU/mL||HCV RNA Category||participants|Number|2|2.0||||||
3765320|NCT01938430|3597774|B13|≥ 800 IU/mL||HCV RNA Category||participants|Number|3|3.0||||||
3765321|NCT01938430|3597775|B12|≥ 800 IU/mL||HCV RNA Category||participants|Number|4|4.0||||||
3765323|NCT01938430|3597777|B10|≥ 800 IU/mL||HCV RNA Category||participants|Number|17|17.0||||||
3765324|NCT01938430|3597778|B9|≥ 800 IU/mL||HCV RNA Category||participants|Number|20|20.0||||||
3765325|NCT01938430|3597779|B8|≥ 800 IU/mL||HCV RNA Category||participants|Number|25|25.0||||||
3765326|NCT01938430|3597780|B7|≥ 800 IU/mL||HCV RNA Category||participants|Number|19|19.0||||||
3765327|NCT01938430|3597781|B6|≥ 800 IU/mL||HCV RNA Category||participants|Number|46|46.0||||||
3765328|NCT01938430|3597782|B5|≥ 800 IU/mL||HCV RNA Category||participants|Number|45|45.0||||||
3765329|NCT01938430|3597783|B4|≥ 800 IU/mL||HCV RNA Category||participants|Number|11|11.0||||||
3765330|NCT01938430|3597784|B3|≥ 800 IU/mL||HCV RNA Category||participants|Number|9|9.0||||||
3765331|NCT01938430|3597785|B2|≥ 800 IU/mL||HCV RNA Category||participants|Number|18|18.0||||||
3765332|NCT01938430|3597786|B1|≥ 800 IU/mL||HCV RNA Category||participants|Number|16|16.0||||||
3765333|NCT01938430|3597772|B15|< 800 IU/mL||HCV RNA Category||participants|Number|98|98.0||||||
3765334|NCT01938430|3597773|B14|< 800 IU/mL||HCV RNA Category||participants|Number|0|0.0||||||
3765335|NCT01938430|3597774|B13|< 800 IU/mL||HCV RNA Category||participants|Number|1|1.0||||||
3765336|NCT01938430|3597775|B12|< 800 IU/mL||HCV RNA Category||participants|Number|0|0.0||||||
3765337|NCT01938430|3597776|B11|< 800 IU/mL||HCV RNA Category||participants|Number|1|1.0||||||
3765338|NCT01938430|3597777|B10|< 800 IU/mL||HCV RNA Category||participants|Number|9|9.0||||||
3765339|NCT01938430|3597778|B9|< 800 IU/mL||HCV RNA Category||participants|Number|6|6.0||||||
3765340|NCT01938430|3597779|B8|< 800 IU/mL||HCV RNA Category||participants|Number|0|0.0||||||
3765341|NCT01938430|3597780|B7|< 800 IU/mL||HCV RNA Category||participants|Number|7|7.0||||||
3765342|NCT01938430|3597781|B6|< 800 IU/mL||HCV RNA Category||participants|Number|10|10.0||||||
3765343|NCT01938430|3597782|B5|< 800 IU/mL||HCV RNA Category||participants|Number|10|10.0||||||
3765344|NCT01938430|3597783|B4|< 800 IU/mL||HCV RNA Category||participants|Number|15|15.0||||||
3765345|NCT01938430|3597784|B3|< 800 IU/mL||HCV RNA Category||participants|Number|14|14.0||||||
3765346|NCT01938430|3597785|B2|< 800 IU/mL||HCV RNA Category||participants|Number|11|11.0||||||
3765347|NCT01938430|3597786|B1|< 800 IU/mL||HCV RNA Category||participants|Number|14|14.0||||||
3765348|NCT01938430|3597772|B15|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.77|0.77|||
3765349|NCT01938430|3597773|B14|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|7.1|7.1|Standard Deviation|0.90|0.9|||
3765350|NCT01938430|3597774|B13|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.5|6.5|Standard Deviation|1.24|1.24|||
3765351|NCT01938430|3597775|B12|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.37|0.37|||
3765352|NCT01938430|3597776|B11|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.4|6.4|Standard Deviation|0.42|0.42|||
3765353|NCT01938430|3597777|B10|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.67|0.67|||
3765354|NCT01938430|3597778|B9|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.55|0.55|||
3765355|NCT01938430|3597779|B8|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.7|6.7|Standard Deviation|0.34|0.34|||
3765356|NCT01938430|3597780|B7|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.77|0.77|||
3765357|NCT01938430|3597781|B6|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.4|6.4|Standard Deviation|0.93|0.93|||
3765358|NCT01938430|3597782|B5|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.62|0.62|||
3765359|NCT01938430|3597783|B4|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|5.8|5.8|Standard Deviation|0.71|0.71|||
3765360|NCT01938430|3597784|B3|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|5.6|5.6|Standard Deviation|0.62|0.62|||
3765361|NCT01938430|3597785|B2|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|5.8|5.8|Standard Deviation|0.82|0.82|||
3765362|NCT01938430|3597786|B1|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|5.9|5.9|Standard Deviation|0.68|0.68|||
3765363|NCT01938430|3597772|B15|United States||Region of Enrollment||participants|Number|337|337.0||||||
3765364|NCT01938430|3597773|B14|United States||Region of Enrollment||participants|Number|2|2.0||||||
3765365|NCT01938430|3597774|B13|United States||Region of Enrollment||participants|Number|4|4.0||||||
3765366|NCT01938430|3597775|B12|United States||Region of Enrollment||participants|Number|4|4.0||||||
3765367|NCT01938430|3597776|B11|United States||Region of Enrollment||participants|Number|5|5.0||||||
3765368|NCT01938430|3597777|B10|United States||Region of Enrollment||participants|Number|26|26.0||||||
3765369|NCT01938430|3597778|B9|United States||Region of Enrollment||participants|Number|26|26.0||||||
3765370|NCT01938430|3597779|B8|United States||Region of Enrollment||participants|Number|25|25.0||||||
3765371|NCT01938430|3597780|B7|United States||Region of Enrollment||participants|Number|26|26.0||||||
3765372|NCT01938430|3597781|B6|United States||Region of Enrollment||participants|Number|56|56.0||||||
3765373|NCT01938430|3597782|B5|United States||Region of Enrollment||participants|Number|55|55.0||||||
3765374|NCT01938430|3597783|B4|United States||Region of Enrollment||participants|Number|26|26.0||||||
3765375|NCT01938430|3597784|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
3765376|NCT01938430|3597785|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
3765377|NCT01938430|3597786|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3765378|NCT01938430|3597772|B15|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3765379|NCT01938430|3597773|B14|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765380|NCT01938430|3597774|B13|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765381|NCT01938430|3597775|B12|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765382|NCT01938430|3597776|B11|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765383|NCT01938430|3597777|B10|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765384|NCT01938430|3597778|B9|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765385|NCT01938430|3597779|B8|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765386|NCT01938430|3597780|B7|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3765387|NCT01938430|3597781|B6|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3765388|NCT01938430|3597782|B5|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765389|NCT01938430|3597783|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3765390|NCT01938430|3597784|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765391|NCT01938430|3597785|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765392|NCT01938430|3597786|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765393|NCT01938430|3597772|B15|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3765394|NCT01938430|3597773|B14|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765395|NCT01938430|3597774|B13|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765396|NCT01938430|3597775|B12|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765397|NCT01938430|3597776|B11|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765398|NCT01938430|3597777|B10|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765399|NCT01938430|3597778|B9|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765400|NCT01938430|3597779|B8|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765401|NCT01938430|3597780|B7|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3765402|NCT01938430|3597781|B6|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3765403|NCT01938430|3597782|B5|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3765404|NCT01938430|3597783|B4|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765405|NCT01938430|3597784|B3|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765406|NCT01938430|3597785|B2|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765407|NCT01938430|3597786|B1|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765408|NCT01938430|3597772|B15|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3765409|NCT01938430|3597773|B14|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765410|NCT01938430|3597774|B13|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765411|NCT01938430|3597775|B12|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765412|NCT01938430|3597776|B11|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765413|NCT01938430|3597777|B10|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765414|NCT01938430|3597778|B9|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765415|NCT01938430|3597779|B8|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3765416|NCT01938430|3597780|B7|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765417|NCT01938430|3597781|B6|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765418|NCT01938430|3597782|B5|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765419|NCT01938430|3597783|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765420|NCT01938430|3597784|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765421|NCT01938430|3597785|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765422|NCT01938430|3597786|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765423|NCT01938430|3597772|B15|White||Race/Ethnicity, Customized||participants|Number|299|299.0||||||
3765424|NCT01938430|3597773|B14|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3765425|NCT01938430|3597774|B13|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3765426|NCT01938430|3597775|B12|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3765427|NCT01938430|3597776|B11|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3765428|NCT01938430|3597777|B10|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3765429|NCT01938430|3597778|B9|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3765430|NCT01938430|3597779|B8|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3765431|NCT01938430|3597780|B7|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3765432|NCT01938430|3597781|B6|White||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
3765433|NCT01938430|3597782|B5|White||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
3765434|NCT01938430|3597783|B4|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3765435|NCT01938430|3597784|B3|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3765436|NCT01938430|3597785|B2|White||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3765437|NCT01938430|3597786|B1|White||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3765438|NCT01938430|3597772|B15|Black or African American||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3765439|NCT01938430|3597773|B14|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765440|NCT01938430|3597774|B13|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765441|NCT01938430|3597775|B12|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765442|NCT01938430|3597776|B11|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3765443|NCT01938430|3597777|B10|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3765444|NCT01938430|3597778|B9|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3765445|NCT01938430|3597779|B8|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3765446|NCT01938430|3597780|B7|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3765447|NCT01938430|3597781|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3765448|NCT01938430|3597782|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3765449|NCT01938430|3597783|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3765450|NCT01938430|3597784|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3765451|NCT01938430|3597785|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3765452|NCT01938430|3597786|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3765453|NCT01938430|3597772|B15||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765454|NCT01938430|3597773|B14||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765455|NCT01938430|3597774|B13||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765456|NCT01938430|3597775|B12||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765457|NCT01938430|3597776|B11||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765458|NCT01938430|3597777|B10||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765459|NCT01938430|3597778|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765460|NCT01938430|3597779|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765461|NCT01938430|3597780|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765462|NCT01938430|3597781|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765463|NCT01938430|3597782|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765464|NCT01938430|3597783|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765465|NCT01938430|3597784|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765466|NCT01938430|3597785|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765467|NCT01938430|3597786|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765468|NCT01938430|3597772|B15||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|299|299.0||||||
3765469|NCT01938430|3597773|B14||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3765470|NCT01938430|3597774|B13||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3765471|NCT01938430|3597775|B12||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3765472|NCT01938430|3597776|B11||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3765473|NCT01938430|3597777|B10||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3765474|NCT01938430|3597778|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3765475|NCT01938430|3597779|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3765476|NCT01938430|3597780|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3765477|NCT01938430|3597781|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3765478|NCT01938430|3597782|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3765479|NCT01938430|3597783|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3765480|NCT01938430|3597784|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3765481|NCT01938430|3597785|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3765482|NCT01938430|3597786|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3765483|NCT01938430|3597772|B15||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3765484|NCT01938430|3597773|B14||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765485|NCT01938430|3597774|B13||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765486|NCT01938430|3597775|B12||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765487|NCT01938430|3597776|B11||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3765488|NCT01938430|3597777|B10||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3765489|NCT01938430|3597778|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3765490|NCT01938430|3597779|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3765491|NCT01938430|3597780|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3765492|NCT01938430|3597781|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3765493|NCT01938430|3597782|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3765494|NCT01938430|3597783|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3765495|NCT01938430|3597784|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3765496|NCT01938430|3597785|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3765497|NCT01938430|3597786|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3765498|NCT01938430|3597772|B15||Male|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
3765499|NCT01938430|3597773|B14||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3765500|NCT01938430|3597774|B13||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3765501|NCT01938430|3597775|B12||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3765502|NCT01938430|3597776|B11||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3765503|NCT01938430|3597777|B10||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3765504|NCT01938430|3597778|B9||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3765505|NCT01938430|3597779|B8||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3765506|NCT01938430|3597780|B7||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3765507|NCT01938430|3597781|B6||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3765508|NCT01938430|3597782|B5||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3765509|NCT01938430|3597783|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3765510|NCT01938430|3597784|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3765511|NCT01938430|3597785|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3765512|NCT01938430|3597786|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3765513|NCT01938430|3597772|B15||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3765514|NCT01938430|3597773|B14||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3765515|NCT01938430|3597774|B13||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3765516|NCT01938430|3597775|B12||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3765517|NCT01938430|3597776|B11||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3765518|NCT01938430|3597777|B10||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3765519|NCT01938430|3597778|B9||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3765520|NCT01938430|3597779|B8||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3765521|NCT01938430|3597780|B7||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3765522|NCT01938430|3597781|B6||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3765523|NCT01938430|3597782|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3765524|NCT01938430|3597783|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3765525|NCT01938430|3597784|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3765526|NCT01938430|3597785|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3765527|NCT01938430|3597786|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3765528|NCT01938430|3597772|B15|||Age||years|Mean|59|59.0|Standard Deviation|6.9|6.9|||
3765529|NCT01938430|3597773|B14|||Age||years|Mean|58|58.0|Standard Deviation|8.5|8.5|||
3765530|NCT01938430|3597774|B13|||Age||years|Mean|62|62.0|Standard Deviation|3.2|3.2|||
3765531|NCT01938430|3597775|B12|||Age||years|Mean|61|61.0|Standard Deviation|1.7|1.7|||
3765532|NCT01938430|3597776|B11|||Age||years|Mean|60|60.0|Standard Deviation|3.8|3.8|||
3765533|NCT01938430|3597777|B10|||Age||years|Mean|61|61.0|Standard Deviation|6.6|6.6|||
3765534|NCT01938430|3597778|B9|||Age||years|Mean|59|59.0|Standard Deviation|5.8|5.8|||
3765535|NCT01938430|3597779|B8|||Age||years|Mean|61|61.0|Standard Deviation|10.4|10.4|||
3765536|NCT01938430|3597780|B7|||Age||years|Mean|61|61.0|Standard Deviation|6.2|6.2|||
3765537|NCT01938430|3597781|B6|||Age||years|Mean|58|58.0|Standard Deviation|6.4|6.4|||
3765538|NCT01938430|3597782|B5|||Age||years|Mean|59|59.0|Standard Deviation|6.6|6.6|||
3765539|NCT01938430|3597783|B4|||Age||years|Mean|59|59.0|Standard Deviation|4.6|4.6|||
3765540|NCT01938430|3597784|B3|||Age||years|Mean|57|57.0|Standard Deviation|6.2|6.2|||
3765541|NCT01938430|3597785|B2|||Age||years|Mean|58|58.0|Standard Deviation|6.5|6.5|||
3765542|NCT01938430|3597786|B1|||Age||years|Mean|57|57.0|Standard Deviation|9.1|9.1|||
3765543|NCT01938391|3598124|B1|||Number of treated lesions||lesions|Number|29|29.0||||||
3765544|NCT01938391|3598124|B1|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3765545|NCT01938391|3598124|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765546|NCT01938391|3598124|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765547|NCT01938391|3598124|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3765548|NCT01938391|3598124|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3765549|NCT01938391|3598124|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765550|NCT01938391|3598124|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765551|NCT01938391|3598124|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765552|NCT01938391|3598124|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765553|NCT01938391|3598124|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3765554|NCT01938391|3598124|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3765555|NCT01938391|3598124|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3765556|NCT01938391|3598124|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3765557|NCT01938391|3598124|B1|||Age||years|Mean|70.4|70.4|Standard Deviation|7.8|7.8|||
3765558|NCT01938170|3598134|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3765559|NCT01938170|3598134|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3765560|NCT01938170|3598134|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3765561|NCT01938170|3598134|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3765562|NCT01938170|3598134|B1||<=18 years|Age||Participants|Count of Participants|41|41.0||||||
3765563|NCT01938079|3598139|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3765564|NCT01938079|3598140|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3765565|NCT01938079|3598141|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3765566|NCT01938079|3598139|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3765567|NCT01938079|3598140|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3765568|NCT01938079|3598141|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3765569|NCT01938079|3598139|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3765570|NCT01938079|3598140|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3765571|NCT01938079|3598141|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3765572|NCT01938079|3598139|B3|||Age||years|Mean|44|44.0|Inter-Quartile Range|||29.0|57.0|
3765573|NCT01938079|3598140|B2|||Age||years|Mean|43|43.0|Inter-Quartile Range|||36.0|52.0|
3765574|NCT01938079|3598141|B1|||Age||years|Mean|44|44.0|Inter-Quartile Range|||25.0|58.0|
3765575|NCT01938066|3598148|B3|||Weight||lbs|Mean|210.6|210.6|Standard Deviation|74.3|74.3|||
3765576|NCT01938066|3598149|B2|||Weight||lbs|Mean|202.1|202.1|Standard Deviation|85.1|85.1|||
3765577|NCT01938066|3598150|B1|||Weight||lbs|Mean|215.5|215.5|Standard Deviation|66.2|66.2|||
3765578|NCT01938066|3598148|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
3765579|NCT01938066|3598149|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3765580|NCT01938066|3598150|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3765581|NCT01938066|3598148|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765582|NCT01938066|3598149|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765583|NCT01938066|3598150|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765584|NCT01938066|3598148|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765585|NCT01938066|3598149|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765586|NCT01938066|3598150|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765587|NCT01938066|3598148|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3765588|NCT01938066|3598149|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3765589|NCT01938066|3598150|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3765590|NCT01938066|3598148|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3765591|NCT01938066|3598149|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3765592|NCT01938066|3598150|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3765593|NCT01938066|3598148|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765594|NCT01938066|3598149|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765595|NCT01938066|3598150|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765596|NCT01938066|3598148|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765597|NCT01938066|3598149|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765598|NCT01938066|3598150|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765599|NCT01938066|3598148|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765600|NCT01938066|3598149|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765601|NCT01938066|3598150|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765602|NCT01938066|3598148|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3765603|NCT01938066|3598149|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3765604|NCT01938066|3598150|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3765605|NCT01938066|3598148|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3765606|NCT01938066|3598149|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3765607|NCT01938066|3598150|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3765608|NCT01938066|3598148|B3|||Age||years|Mean|56.8|56.8|Standard Deviation|11|11.0|||
3765609|NCT01938066|3598149|B2|||Age||years|Mean|58.3|58.3|Standard Deviation|12|12.0|||
3765610|NCT01938066|3598150|B1|||Age||years|Mean|54.7|54.7|Standard Deviation|10|10.0|||
3765611|NCT01938066|3598148|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3765612|NCT01938066|3598149|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3765613|NCT01938066|3598150|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3765614|NCT01938066|3598148|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3765615|NCT01938066|3598149|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3765616|NCT01938066|3598150|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3765617|NCT01938066|3598148|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3765618|NCT01938066|3598149|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3765619|NCT01938066|3598150|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3765672|NCT01937871|3598242|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3765620|NCT01938040|3598159|B3|United States||Region of Enrollment|All subjects were from the Northeast section of the United States and all were English speaking. The behavioral questionnaires were copyrighted and validated in English only.|participants|Number|55|55.0||||||
3765621|NCT01938040|3598160|B2|United States||Region of Enrollment|All subjects were from the Northeast section of the United States and all were English speaking. The behavioral questionnaires were copyrighted and validated in English only.|participants|Number|27|27.0||||||
3765622|NCT01938040|3598161|B1|United States||Region of Enrollment|All subjects were from the Northeast section of the United States and all were English speaking. The behavioral questionnaires were copyrighted and validated in English only.|participants|Number|28|28.0||||||
3765623|NCT01938040|3598159|B3||Male|Gender||Participants|Count of Participants|15|15.0||||||
3765624|NCT01938040|3598160|B2||Male|Gender||Participants|Count of Participants|5|5.0||||||
3765625|NCT01938040|3598161|B1||Male|Gender||Participants|Count of Participants|10|10.0||||||
3765626|NCT01938040|3598159|B3||Female|Gender||Participants|Count of Participants|40|40.0||||||
3765627|NCT01938040|3598160|B2||Female|Gender||Participants|Count of Participants|22|22.0||||||
3765628|NCT01938040|3598161|B1||Female|Gender||Participants|Count of Participants|18|18.0||||||
3765629|NCT01938040|3598159|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3765630|NCT01938040|3598160|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3765631|NCT01938040|3598161|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3765632|NCT01938040|3598159|B3||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3765633|NCT01938040|3598160|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3765634|NCT01938040|3598161|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3765635|NCT01938040|3598159|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3765636|NCT01938040|3598160|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3765637|NCT01938040|3598161|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3765638|NCT01937975|3598188|B4|||Estimated Glomerular Filtration Rate|Glomerular Filtration Rate at baseline was based on the Modification of Diet Renal Disease equation. N=6 instead of 8 for Healthy Participants.|mL/min/1.73 m^2|Mean|NA||Full Range|||0.0|0.0|Not determined for the overall population
3765639|NCT01937975|3598189|B3|||Estimated Glomerular Filtration Rate|Glomerular Filtration Rate at baseline was based on the Modification of Diet Renal Disease equation. N=6 instead of 8 for Healthy Participants.|mL/min/1.73 m^2|Mean|93.4|93.4|Full Range|||80.0|124.0|
3765640|NCT01937975|3598190|B2|||Estimated Glomerular Filtration Rate|Glomerular Filtration Rate at baseline was based on the Modification of Diet Renal Disease equation. N=6 instead of 8 for Healthy Participants.|mL/min/1.73 m^2|Mean|18.0|18.0|Full Range|||11.5|23.5|
3765641|NCT01937975|3598191|B1|||Estimated Glomerular Filtration Rate|Glomerular Filtration Rate at baseline was based on the Modification of Diet Renal Disease equation. N=6 instead of 8 for Healthy Participants.|mL/min/1.73 m^2|Mean|NA||Full Range|||0.0|0.0|Not determined for ESRD participants on HD
3765642|NCT01937975|3598188|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3765643|NCT01937975|3598189|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3765644|NCT01937975|3598190|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3765645|NCT01937975|3598191|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3765646|NCT01937975|3598188|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3765647|NCT01937975|3598189|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3765648|NCT01937975|3598190|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3765649|NCT01937975|3598191|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3765650|NCT01937975|3598188|B4|||Age||Years|Mean|56.2|56.2|Full Range|||38.0|75.0|
3765651|NCT01937975|3598189|B3|||Age||Years|Mean|55.1|55.1|Full Range|||47.0|63.0|
3765652|NCT01937975|3598190|B2|||Age||Years|Mean|65.8|65.8|Full Range|||54.0|75.0|
3765653|NCT01937975|3598191|B1|||Age||Years|Mean|47.8|47.8|Full Range|||38.0|61.0|
3765654|NCT01937871|3598240|B4|Taiwan||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3765655|NCT01937871|3598241|B3|Taiwan||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3765656|NCT01937871|3598242|B2|Taiwan||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3765657|NCT01937871|3598243|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3765658|NCT01937871|3598240|B4|Korea, Republic of||Region of Enrollment||Participants|Count of Participants|177|177.0||||||
3765659|NCT01937871|3598241|B3|Korea, Republic of||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3765660|NCT01937871|3598242|B2|Korea, Republic of||Region of Enrollment||Participants|Count of Participants|71|71.0||||||
3765661|NCT01937871|3598243|B1|Korea, Republic of||Region of Enrollment||Participants|Count of Participants|71|71.0||||||
3765662|NCT01937871|3598240|B4|China||Region of Enrollment||Participants|Count of Participants|699|699.0||||||
3765663|NCT01937871|3598241|B3|China||Region of Enrollment||Participants|Count of Participants|143|143.0||||||
3765664|NCT01937871|3598242|B2|China||Region of Enrollment||Participants|Count of Participants|277|277.0||||||
3765665|NCT01937871|3598243|B1|China||Region of Enrollment||Participants|Count of Participants|279|279.0||||||
3765666|NCT01937871|3598240|B4||Male|Sex: Female, Male||Participants|Count of Participants|909|909.0||||||
3765667|NCT01937871|3598241|B3||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
3765668|NCT01937871|3598242|B2||Male|Sex: Female, Male||Participants|Count of Participants|363|363.0||||||
3765669|NCT01937871|3598243|B1||Male|Sex: Female, Male||Participants|Count of Participants|361|361.0||||||
3765670|NCT01937871|3598240|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3765671|NCT01937871|3598241|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3765673|NCT01937871|3598243|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3765674|NCT01937871|3598240|B4|||Age||years|Mean|61.8|61.8|Standard Deviation|7.25|7.25|||
3765675|NCT01937871|3598241|B3|||Age||years|Mean|61.9|61.9|Standard Deviation|7.06|7.06|||
3765676|NCT01937871|3598242|B2|||Age||years|Mean|61.8|61.8|Standard Deviation|7.27|7.27|||
3765677|NCT01937871|3598243|B1|||Age||years|Mean|61.8|61.8|Standard Deviation|7.35|7.35|||
3765678|NCT01937715|3598316|B6||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3765679|NCT01937715|3598317|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3765680|NCT01937715|3598318|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3765681|NCT01937715|3598319|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3765682|NCT01937715|3598320|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3765683|NCT01937715|3598321|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3765684|NCT01937715|3598316|B6||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3765685|NCT01937715|3598317|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3765686|NCT01937715|3598318|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3765687|NCT01937715|3598319|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3765688|NCT01937715|3598320|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3765689|NCT01937715|3598321|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3765690|NCT01937715|3598316|B6|||Age||years|Mean|56.9|56.9|Standard Deviation|12.1|12.1|||
3765691|NCT01937715|3598317|B5|||Age||years|Mean|54.3|54.3|Standard Deviation|5.5|5.5|||
3765692|NCT01937715|3598318|B4|||Age||years|Mean|65.8|65.8|Standard Deviation|9|9.0|||
3765693|NCT01937715|3598319|B3|||Age||years|Mean|63.3|63.3|Standard Deviation|11.6|11.6|||
3765694|NCT01937715|3598320|B2|||Age||years|Mean|54.3|54.3|Standard Deviation|10.1|10.1|||
3765695|NCT01937715|3598321|B1|||Age||years|Mean|41.7|41.7|Standard Deviation|11.7|11.7|||
3765696|NCT01937598|3598447|B1|||BMI||kg/m^2|Mean|31.7|31.7|Standard Deviation|4.4|4.4|||
3765697|NCT01937598|3598447|B1||Male|Gender||Participants|Count of Participants|11|11.0||||||
3765698|NCT01937598|3598447|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
3765699|NCT01937598|3598447|B1|||Age||years|Mean|55|55.0|Standard Deviation|11|11.0|||
3765700|NCT01937520|3598470|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3765701|NCT01937520|3598471|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3765702|NCT01937520|3598472|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3765703|NCT01937520|3598470|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3765704|NCT01937520|3598471|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3765705|NCT01937520|3598472|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3765706|NCT01937520|3598470|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3765707|NCT01937520|3598471|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3765708|NCT01937520|3598472|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3765709|NCT01937520|3598470|B3|45 years or older||Age, Customized||participants|Number|12|12.0||||||
3765710|NCT01937520|3598471|B2|45 years or older||Age, Customized||participants|Number|7|7.0||||||
3765711|NCT01937520|3598472|B1|45 years or older||Age, Customized||participants|Number|5|5.0||||||
3765712|NCT01937520|3598470|B3|<45 years||Age, Customized||participants|Number|8|8.0||||||
3765713|NCT01937520|3598471|B2|<45 years||Age, Customized||participants|Number|2|2.0||||||
3765714|NCT01937520|3598472|B1|<45 years||Age, Customized||participants|Number|6|6.0||||||
3765715|NCT01937390|3598516|B1|Missing||Sex/Gender, Customized||Participants|Number|5|5.0||||||
3765716|NCT01937390|3598516|B1|Male||Sex/Gender, Customized||Participants|Number|465|465.0||||||
3765717|NCT01937390|3598516|B1|Female||Sex/Gender, Customized||Participants|Number|115|115.0||||||
3765718|NCT01937390|3598516|B1|||Age||Years|Mean|57.2|57.2|Standard Deviation|10.1|10.1|||
3765719|NCT01937364|3598524|B3|||Baseline Clinical Institute Withdrawal Assessment of Alcohol Scale, Revised (CIWA-Ar)|Range: 0 to 67; larger values indicate greater severity|units on a scale|Mean|4.2|4.2|Standard Deviation|2.16|2.16|||
3765720|NCT01937364|3598525|B2|||Baseline Clinical Institute Withdrawal Assessment of Alcohol Scale, Revised (CIWA-Ar)|Range: 0 to 67; larger values indicate greater severity|units on a scale|Mean|3.9|3.9|Standard Deviation|2.42|2.42|||
3765721|NCT01937364|3598526|B1|||Baseline Clinical Institute Withdrawal Assessment of Alcohol Scale, Revised (CIWA-Ar)|Range: 0 to 67; larger values indicate greater severity|units on a scale|Mean|4.4|4.4|Standard Deviation|2.01|2.01|||
3765722|NCT01937364|3598524|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
3765723|NCT01937364|3598525|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3765724|NCT01937364|3598526|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3765725|NCT01937364|3598524|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765726|NCT01937364|3598525|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765727|NCT01937364|3598526|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765728|NCT01937364|3598524|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765729|NCT01937364|3598525|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765730|NCT01937364|3598526|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765731|NCT01937364|3598524|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3765732|NCT01937364|3598525|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3765733|NCT01937364|3598526|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3765734|NCT01937364|3598524|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3765735|NCT01937364|3598525|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765736|NCT01937364|3598526|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3765737|NCT01937364|3598524|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765738|NCT01937364|3598525|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765739|NCT01937364|3598526|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765740|NCT01937364|3598524|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765741|NCT01937364|3598525|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765742|NCT01937364|3598526|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765743|NCT01937364|3598524|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3765744|NCT01937364|3598525|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765745|NCT01937364|3598526|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3765746|NCT01937364|3598524|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3765747|NCT01937364|3598525|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3765748|NCT01937364|3598526|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3765749|NCT01937364|3598524|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3765750|NCT01937364|3598525|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3765751|NCT01937364|3598526|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3765752|NCT01937364|3598524|B3|||Age||years|Mean|51.5|51.5|Standard Deviation|11.58|11.58|||
3765753|NCT01937364|3598525|B2|||Age||years|Mean|48.9|48.9|Standard Deviation|11.97|11.97|||
3765754|NCT01937364|3598526|B1|||Age||years|Mean|53.9|53.9|Standard Deviation|11.37|11.37|||
3765755|NCT01937351|3598537|B3|||Height||inches|Mean|66.7|66.7|Standard Deviation|3.8|3.8|||
3765756|NCT01937351|3598538|B2|||Height||inches|Mean|66.5|66.5|Standard Deviation|4.1|4.1|||
3765757|NCT01937351|3598539|B1|||Height||inches|Mean|66.8|66.8|Standard Deviation|3.8|3.8|||
3765758|NCT01937351|3598537|B3|||Weight||pounds|Mean|182.9|182.9|Standard Deviation|44.0|44.0|||
3765759|NCT01937351|3598538|B2|||Weight||pounds|Mean|199.3|199.3|Standard Deviation|45.3|45.3|||
3765760|NCT01937351|3598539|B1|||Weight||pounds|Mean|179.5|179.5|Standard Deviation|43.0|43.0|||
3765761|NCT01937351|3598537|B3|Germany||Region of Enrollment||participants|Number|7|7.0||||||
3765762|NCT01937351|3598538|B2|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3765763|NCT01937351|3598539|B1|Germany||Region of Enrollment||participants|Number|7|7.0||||||
3765764|NCT01937351|3598537|B3|United States||Region of Enrollment||participants|Number|155|155.0||||||
3765765|NCT01937351|3598538|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
3765766|NCT01937351|3598539|B1|United States||Region of Enrollment||participants|Number|127|127.0||||||
3765767|NCT01937351|3598537|B3|Unknown or Unavailable||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3765768|NCT01937351|3598538|B2|Unknown or Unavailable||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765769|NCT01937351|3598539|B1|Unknown or Unavailable||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3765770|NCT01937351|3598537|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3765771|NCT01937351|3598538|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765772|NCT01937351|3598539|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3765773|NCT01937351|3598537|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3765774|NCT01937351|3598538|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765775|NCT01937351|3598539|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3765776|NCT01937351|3598537|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3765777|NCT01937351|3598538|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3765778|NCT01937351|3598539|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3765779|NCT01937351|3598537|B3|African American||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
3765780|NCT01937351|3598538|B2|African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3765781|NCT01937351|3598539|B1|African American||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3765782|NCT01937351|3598537|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|100|100.0||||||
3765783|NCT01937351|3598538|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3765784|NCT01937351|3598539|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|80|80.0||||||
3765785|NCT01937351|3598537|B3||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3765786|NCT01937351|3598538|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3765787|NCT01937351|3598539|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3765788|NCT01937351|3598537|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3765789|NCT01937351|3598538|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3765790|NCT01937351|3598539|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3765791|NCT01937351|3598537|B3|||Age|Subject age in years|years|Mean|67.3|67.3|Standard Deviation|10.5|10.5|||
3765792|NCT01937351|3598538|B2|||Age|Subject age in years|years|Mean|66.7|66.7|Standard Deviation|10.5|10.5|||
3765793|NCT01937351|3598539|B1|||Age|Subject age in years|years|Mean|67.4|67.4|Standard Deviation|10.5|10.5|||
3765794|NCT01937312|3598546|B3|||Mean Diurnal Intraocular Pressure (IOP) at Baseline|Diurnal IOP at Baseline was defined as the average of the four Baseline IOP measurements at timepoints 8 AM, 10 AM, 3 PM, and 5 PM. For each timepoint, the baseline IOP was defined as the average of the timepoint-matched IOP measurements at the Eligibility 1 and Eligibility 2 Visits.|mmHg|Mean|22.53|22.53|Standard Deviation|2.478|2.478|||
3765795|NCT01937312|3598547|B2|||Mean Diurnal Intraocular Pressure (IOP) at Baseline|Diurnal IOP at Baseline was defined as the average of the four Baseline IOP measurements at timepoints 8 AM, 10 AM, 3 PM, and 5 PM. For each timepoint, the baseline IOP was defined as the average of the timepoint-matched IOP measurements at the Eligibility 1 and Eligibility 2 Visits.|mmHg|Mean|22.39|22.39|Standard Deviation|2.774|2.774|||
3765796|NCT01937312|3598548|B1|||Mean Diurnal Intraocular Pressure (IOP) at Baseline|Diurnal IOP at Baseline was defined as the average of the four Baseline IOP measurements at timepoints 8 AM, 10 AM, 3 PM, and 5 PM. For each timepoint, the baseline IOP was defined as the average of the timepoint-matched IOP measurements at the Eligibility 1 and Eligibility 2 Visits.|mmHg|Mean|22.68|22.68|Standard Deviation|2.123|2.123|||
3765797|NCT01937312|3598546|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3765798|NCT01937312|3598547|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3765799|NCT01937312|3598548|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3765800|NCT01937312|3598546|B3||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3765801|NCT01937312|3598547|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3765802|NCT01937312|3598548|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3765803|NCT01937312|3598546|B3|||Age||years|Mean|65.1|65.1|Standard Deviation|9.5|9.5|||
3765804|NCT01937312|3598547|B2|||Age||years|Mean|64.7|64.7|Standard Deviation|9.6|9.6|||
3765805|NCT01937312|3598548|B1|||Age||years|Mean|65.5|65.5|Standard Deviation|9.4|9.4|||
3765806|NCT01937299|3598562|B3|||Mean Diurnal Intraocular Pressure (IOP) at Baseline|Diurnal IOP at Baseline was defined as the average of the four Baseline IOP measurements at timepoints 8 AM, 10 AM, 3 PM, and 5 PM. For each timepoint, the baseline IOP was defined as the average of the timepoint-matched IOP measurements at the Eligibility 1 and Eligibility 2 Visits.|mmHg|Mean|22.57|22.57|Standard Deviation|2.453|2.453|||
3765807|NCT01937299|3598563|B2|||Mean Diurnal Intraocular Pressure (IOP) at Baseline|Diurnal IOP at Baseline was defined as the average of the four Baseline IOP measurements at timepoints 8 AM, 10 AM, 3 PM, and 5 PM. For each timepoint, the baseline IOP was defined as the average of the timepoint-matched IOP measurements at the Eligibility 1 and Eligibility 2 Visits.|mmHg|Mean|22.66|22.66|Standard Deviation|2.407|2.407|||
3765808|NCT01937299|3598564|B1|||Mean Diurnal Intraocular Pressure (IOP) at Baseline|Diurnal IOP at Baseline was defined as the average of the four Baseline IOP measurements at timepoints 8 AM, 10 AM, 3 PM, and 5 PM. For each timepoint, the baseline IOP was defined as the average of the timepoint-matched IOP measurements at the Eligibility 1 and Eligibility 2 Visits.|mmHg|Mean|22.48|22.48|Standard Deviation|2.507|2.507|||
3765809|NCT01937299|3598562|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3765810|NCT01937299|3598563|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3765811|NCT01937299|3598564|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3765812|NCT01937299|3598562|B3||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3765813|NCT01937299|3598563|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3765814|NCT01937299|3598564|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3765815|NCT01937299|3598562|B3|||Age||years|Mean|66.8|66.8|Standard Deviation|10.5|10.5|||
3765816|NCT01937299|3598563|B2|||Age||years|Mean|66.0|66.0|Standard Deviation|10.6|10.6|||
3765817|NCT01937299|3598564|B1|||Age||years|Mean|67.5|67.5|Standard Deviation|10.3|10.3|||
3765818|NCT01937260|3598576|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765819|NCT01937260|3598577|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765820|NCT01937260|3598578|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765821|NCT01937260|3598576|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3765822|NCT01937260|3598577|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765823|NCT01937260|3598578|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3765824|NCT01937260|3598576|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3765825|NCT01937260|3598577|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3765826|NCT01937260|3598578|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3765827|NCT01937260|3598576|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3765828|NCT01937260|3598577|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765829|NCT01937260|3598578|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3765830|NCT01937260|3598576|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3765831|NCT01937260|3598577|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765832|NCT01937260|3598578|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3765833|NCT01937260|3598576|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3765834|NCT01937260|3598577|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3765835|NCT01937260|3598578|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3765836|NCT01937260|3598576|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765837|NCT01937260|3598577|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765838|NCT01937260|3598578|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765839|NCT01937260|3598576|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3765840|NCT01937260|3598577|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3765841|NCT01937260|3598578|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3765842|NCT01937260|3598576|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3765843|NCT01937260|3598577|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3765844|NCT01937260|3598578|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3765845|NCT01937260|3598576|B3|||Age||years|Mean|43|43.0|Standard Deviation|12.6|12.6|||
3765846|NCT01937260|3598577|B2|||Age||years|Mean|46.8|46.8|Standard Deviation|15.6|15.6|||
3765847|NCT01937260|3598578|B1|||Age||years|Mean|41.2|41.2|Standard Deviation|10.9|10.9|||
3765848|NCT01937260|3598576|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3765849|NCT01937260|3598577|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3765850|NCT01937260|3598578|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3765851|NCT01937260|3598576|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3765852|NCT01937260|3598577|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3765853|NCT01937260|3598578|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3765854|NCT01937260|3598576|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3765855|NCT01937260|3598577|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3765856|NCT01937260|3598578|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3765857|NCT01937195|3598586|B1|United States||Region of Enrollment||participants|Number|95|95.0||||||
3765858|NCT01937195|3598586|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765859|NCT01937195|3598586|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765860|NCT01937195|3598586|B1||White|Race (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3765861|NCT01937195|3598586|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765862|NCT01937195|3598586|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765863|NCT01937195|3598586|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765864|NCT01937195|3598586|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765865|NCT01937195|3598586|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3765866|NCT01937195|3598586|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3765867|NCT01937195|3598586|B1||>=65 years|Age||Participants|Count of Participants|64|64.0||||||
3765868|NCT01937195|3598586|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3765869|NCT01937195|3598586|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3765870|NCT01937130|3598596|B5|United Kingdom||Region of Enrollment||participants|Number|16|16.0||||||
3765871|NCT01937130|3598597|B4|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
3765872|NCT01937130|3598598|B3|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3765873|NCT01937130|3598599|B2|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
3765874|NCT01937130|3598600|B1|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
3765875|NCT01937130|3598596|B5|United States||Region of Enrollment||participants|Number|5|5.0||||||
3765876|NCT01937130|3598597|B4|United States||Region of Enrollment||participants|Number|2|2.0||||||
3765877|NCT01937130|3598598|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3765878|NCT01937130|3598599|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3765879|NCT01937130|3598600|B1|United States||Region of Enrollment||participants|Number|0|0.0||||||
3765880|NCT01937130|3598596|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3765881|NCT01937130|3598597|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3765882|NCT01937130|3598598|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3765883|NCT01937130|3598599|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3765884|NCT01937130|3598600|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3765885|NCT01937130|3598596|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3765886|NCT01937130|3598597|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3765887|NCT01937130|3598598|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3765888|NCT01937130|3598599|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3765889|NCT01937130|3598600|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3765890|NCT01937130|3598596|B5|||Age||years|Median|50.0|50.0|Inter-Quartile Range|||30.0|71.0|
3765891|NCT01937130|3598597|B4|||Age||years|Median|53.5|53.5|Inter-Quartile Range|||34.0|59.0|
3765892|NCT01937130|3598598|B3|||Age||years|Median|61.0|61.0|Inter-Quartile Range|||42.0|71.0|
3765893|NCT01937130|3598599|B2|||Age||years|Median|50.0|50.0|Inter-Quartile Range|||30.0|58.0|
3765894|NCT01937130|3598600|B1|||Age||years|Median|49.0|49.0|Inter-Quartile Range|||41.0|60.0|
3765895|NCT01937130|3598596|B5||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3765896|NCT01937130|3598597|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3765897|NCT01937130|3598598|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3765898|NCT01937130|3598599|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3765899|NCT01937130|3598600|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3765900|NCT01937130|3598596|B5||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3765901|NCT01937130|3598597|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3765902|NCT01937130|3598598|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3765903|NCT01937130|3598599|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3765904|NCT01937130|3598600|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3765905|NCT01937130|3598596|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3765906|NCT01937130|3598597|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3765907|NCT01937130|3598598|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3765908|NCT01937130|3598599|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3765909|NCT01937130|3598600|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3765910|NCT01937026|3598630|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3765911|NCT01937026|3598630|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765912|NCT01937026|3598630|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765913|NCT01937026|3598630|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3765914|NCT01937026|3598630|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765915|NCT01937026|3598630|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765916|NCT01937026|3598630|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765917|NCT01937026|3598630|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765918|NCT01937026|3598630|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765919|NCT01937026|3598630|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3765920|NCT01937026|3598630|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3765921|NCT01937026|3598630|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3765922|NCT01937026|3598630|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3765923|NCT01937026|3598630|B1|||Age||years|Mean|37.3|37.3|Standard Deviation|13.3|13.3|||
3765924|NCT01936909|3598648|B4|United States||Region of Enrollment||participants|Number|60|60.0||||||
3765925|NCT01936909|3598649|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3765926|NCT01936909|3598650|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3765927|NCT01936909|3598651|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3765928|NCT01936909|3598648|B4||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3765929|NCT01936909|3598649|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3765930|NCT01936909|3598650|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3765931|NCT01936909|3598651|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3765932|NCT01936909|3598648|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3765933|NCT01936909|3598649|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3765934|NCT01936909|3598650|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3765935|NCT01936909|3598651|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3765936|NCT01936909|3598648|B4|||Age||years|Median|56.5|56.5|Inter-Quartile Range|||50.25|61.0|
3765937|NCT01936909|3598649|B3|||Age||years|Median|59.5|59.5|Inter-Quartile Range|||56.25|66.5|
3765938|NCT01936909|3598650|B2|||Age||years|Median|53.5|53.5|Inter-Quartile Range|||47.25|60.75|
3765939|NCT01936909|3598651|B1|||Age||years|Median|55|55.0|Inter-Quartile Range|||49.75|60.5|
3765940|NCT01936909|3598648|B4||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3765941|NCT01936909|3598649|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3765942|NCT01936909|3598650|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3765943|NCT01936909|3598651|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3765944|NCT01936909|3598648|B4||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
3765945|NCT01936909|3598649|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3765946|NCT01936909|3598650|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3765947|NCT01936909|3598651|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3765948|NCT01936909|3598648|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3765949|NCT01936909|3598649|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3765950|NCT01936909|3598650|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3765951|NCT01936909|3598651|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3765952|NCT01936896|3598667|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3765953|NCT01936896|3598667|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3765954|NCT01936896|3598667|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3765955|NCT01936896|3598667|B1|||Age||years|Median|52.5|52.5|Full Range|||33.0|77.0|
3765956|NCT01936896|3598667|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3765957|NCT01936896|3598667|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3765958|NCT01936896|3598667|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3765959|NCT01936870|3598672|B1||Male|Sex: Female, Male||Participants|Count of Participants|1075|1075.0||||||
3765960|NCT01936870|3598672|B1||Female|Sex: Female, Male||Participants|Count of Participants|1228|1228.0||||||
3765961|NCT01936870|3598672|B1|˃=65 years||Age, Customized||Participants|Number|1773|1773.0||||||
3765962|NCT01936870|3598672|B1|>=15 and <65 years||Age, Customized||Participants|Number|529|529.0||||||
3765963|NCT01936870|3598672|B1|<15 years||Age, Customized||Participants|Number|1|1.0||||||
3765964|NCT01936844|3598685|B3|||C-reactive protein||mg/L|Median|23.8|23.8|Inter-Quartile Range|||10.9|46.9|
3765965|NCT01936844|3598686|B2|||C-reactive protein||mg/L|Median|27.4|27.4|Inter-Quartile Range|||12.0|47.2|
3765966|NCT01936844|3598687|B1|||C-reactive protein||mg/L|Median|22.3|22.3|Inter-Quartile Range|||10.8|95.9|
3765967|NCT01936844|3598685|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3765968|NCT01936844|3598686|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3765969|NCT01936844|3598687|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3765970|NCT01936844|3598685|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3765971|NCT01936844|3598686|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3765972|NCT01936844|3598687|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3765973|NCT01936844|3598685|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3765974|NCT01936844|3598686|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3765975|NCT01936844|3598687|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3765976|NCT01936844|3598685|B3|||Age||years|Median|58|58.0|Inter-Quartile Range|||49.0|64.0|
3765977|NCT01936844|3598686|B2|||Age||years|Median|54|54.0|Inter-Quartile Range|||49.0|66.0|
3765978|NCT01936844|3598687|B1|||Age||years|Median|60|60.0|Inter-Quartile Range|||49.0|64.0|
3765979|NCT01936844|3598685|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3765980|NCT01936844|3598686|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3765981|NCT01936844|3598687|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3765982|NCT01936844|3598685|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3765983|NCT01936844|3598686|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3765984|NCT01936844|3598687|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3765985|NCT01936844|3598685|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3765986|NCT01936844|3598686|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3765987|NCT01936844|3598687|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3765988|NCT01936662|3598698|B3|United States||Region of Enrollment||participants|Number|84|84.0||||||
3765989|NCT01936662|3598699|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
3765990|NCT01936662|3598700|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
3765991|NCT01936662|3598698|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3765992|NCT01936662|3598699|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3765993|NCT01936662|3598700|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3765994|NCT01936662|3598698|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3765995|NCT01936662|3598699|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3765996|NCT01936662|3598700|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3765997|NCT01936662|3598698|B3|||Age||years|Mean|10.2|10.2|Standard Deviation|5.2|5.2|||
3765998|NCT01936662|3598699|B2|||Age||years|Mean|10.1|10.1|Standard Deviation|4.2|4.2|||
3765999|NCT01936662|3598700|B1|||Age||years|Mean|10.4|10.4|Standard Deviation|6.2|6.2|||
3766000|NCT01936662|3598698|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3766001|NCT01936662|3598699|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3766002|NCT01936662|3598700|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3766003|NCT01936662|3598698|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3766004|NCT01936662|3598699|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3766005|NCT01936662|3598700|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3766006|NCT01936662|3598698|B3||<=18 years|Age||Participants|Count of Participants|84|84.0||||||
3766007|NCT01936662|3598699|B2||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
3766008|NCT01936662|3598700|B1||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
3766009|NCT01936649|3598709|B1|||Safety Assessment||participants|Number|51|51.0||||||
3766010|NCT01936649|3598709|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
3766011|NCT01936649|3598709|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3766012|NCT01936649|3598709|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3766013|NCT01936649|3598709|B1|||Age||years|Mean|65.2|65.2|Standard Deviation|12.46|12.46|||
3766014|NCT01936623|3598714|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
3766015|NCT01936623|3598715|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
3766016|NCT01936623|3598716|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3766017|NCT01936623|3598714|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766018|NCT01936623|3598715|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766019|NCT01936623|3598716|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766020|NCT01936623|3598714|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3766021|NCT01936623|3598715|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3766022|NCT01936623|3598716|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3766023|NCT01936623|3598714|B3||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3766024|NCT01936623|3598715|B2||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3766025|NCT01936623|3598716|B1||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3766026|NCT01936623|3598714|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3766027|NCT01936623|3598715|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766028|NCT01936623|3598716|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3766029|NCT01936623|3598714|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766030|NCT01936623|3598715|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766031|NCT01936623|3598716|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766032|NCT01936623|3598714|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766033|NCT01936623|3598715|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766034|NCT01936623|3598716|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766035|NCT01936623|3598714|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3766036|NCT01936623|3598715|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3766037|NCT01936623|3598716|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3766038|NCT01936623|3598714|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766039|NCT01936623|3598715|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766040|NCT01936623|3598716|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766041|NCT01936623|3598714|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3766042|NCT01936623|3598715|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3766043|NCT01936623|3598716|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3766044|NCT01936623|3598714|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3766045|NCT01936623|3598715|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3766046|NCT01936623|3598716|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3766047|NCT01936623|3598714|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3766048|NCT01936623|3598715|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3766049|NCT01936623|3598716|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3766050|NCT01936623|3598714|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3766051|NCT01936623|3598715|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3766052|NCT01936623|3598716|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3766053|NCT01936623|3598714|B3|||Age||years|Mean|35.2|35.2|Standard Deviation|13.0|13.0|||
3766054|NCT01936623|3598715|B2|||Age||years|Mean|36.0|36.0|Standard Deviation|13.8|13.8|||
3766055|NCT01936623|3598716|B1|||Age||years|Mean|34.3|34.3|Standard Deviation|12.4|12.4|||
3766056|NCT01936467|3598729|B3|Plastic stent||Biliary stent present|Number of patients having biliary stent at the time of EUS-FNA|participants|Number|13|13.0||||||
3766057|NCT01936467|3598730|B2|Plastic stent||Biliary stent present|Number of patients having biliary stent at the time of EUS-FNA|participants|Number|6|6.0||||||
3766058|NCT01936467|3598731|B1|Plastic stent||Biliary stent present|Number of patients having biliary stent at the time of EUS-FNA|participants|Number|7|7.0||||||
3766059|NCT01936467|3598729|B3|Metal stent||Biliary stent present|Number of patients having biliary stent at the time of EUS-FNA|participants|Number|6|6.0||||||
3766060|NCT01936467|3598730|B2|Metal stent||Biliary stent present|Number of patients having biliary stent at the time of EUS-FNA|participants|Number|5|5.0||||||
3766061|NCT01936467|3598731|B1|Metal stent||Biliary stent present|Number of patients having biliary stent at the time of EUS-FNA|participants|Number|1|1.0||||||
3766062|NCT01936467|3598729|B3|||EUS features of chronic pancreatitis||participants|Number|18|18.0||||||
3766063|NCT01936467|3598730|B2|||EUS features of chronic pancreatitis||participants|Number|7|7.0||||||
3766064|NCT01936467|3598731|B1|||EUS features of chronic pancreatitis||participants|Number|11|11.0||||||
3766065|NCT01936467|3598729|B3|Arterial and Venous||Vascular involvement||mass|Number|33|33.0||||||
3766066|NCT01936467|3598730|B2|Arterial and Venous||Vascular involvement||mass|Number|14|14.0||||||
3766067|NCT01936467|3598731|B1|Arterial and Venous||Vascular involvement||mass|Number|19|19.0||||||
3766068|NCT01936467|3598729|B3|Venous||Vascular involvement||mass|Number|60|60.0||||||
3766069|NCT01936467|3598730|B2|Venous||Vascular involvement||mass|Number|32|32.0||||||
3766070|NCT01936467|3598731|B1|Venous||Vascular involvement||mass|Number|28|28.0||||||
3766071|NCT01936467|3598729|B3|Arterial||Vascular involvement||mass|Number|49|49.0||||||
3766072|NCT01936467|3598730|B2|Arterial||Vascular involvement||mass|Number|21|21.0||||||
3766073|NCT01936467|3598731|B1|Arterial||Vascular involvement||mass|Number|28|28.0||||||
3766074|NCT01936467|3598729|B3|||Cystic Component||mass|Number|22|22.0||||||
3766075|NCT01936467|3598730|B2|||Cystic Component||mass|Number|10|10.0||||||
3766076|NCT01936467|3598731|B1|||Cystic Component||mass|Number|12|12.0||||||
3766077|NCT01936467|3598729|B3|Hyperecho||Echogeicity of the lesion||participants|Number|1|1.0||||||
3766078|NCT01936467|3598730|B2|Hyperecho||Echogeicity of the lesion||participants|Number|0|0.0||||||
3766079|NCT01936467|3598731|B1|Hyperecho||Echogeicity of the lesion||participants|Number|1|1.0||||||
3766080|NCT01936467|3598729|B3|Isoecho||Echogeicity of the lesion||participants|Number|13|13.0||||||
3766081|NCT01936467|3598730|B2|Isoecho||Echogeicity of the lesion||participants|Number|6|6.0||||||
3766082|NCT01936467|3598731|B1|Isoecho||Echogeicity of the lesion||participants|Number|7|7.0||||||
3766083|NCT01936467|3598729|B3|Hypoecho||Echogeicity of the lesion||participants|Number|107|107.0||||||
3766084|NCT01936467|3598730|B2|Hypoecho||Echogeicity of the lesion||participants|Number|55|55.0||||||
3766085|NCT01936467|3598731|B1|Hypoecho||Echogeicity of the lesion||participants|Number|52|52.0||||||
3766086|NCT01936467|3598729|B3|||Pancreatic mass size||Centimeter|Mean|3.03|3.03|Standard Deviation|1.43|1.43|||
3766087|NCT01936467|3598730|B2|||Pancreatic mass size||Centimeter|Mean|3.2|3.2|Standard Deviation|1.63|1.63|||
3766088|NCT01936467|3598731|B1|||Pancreatic mass size||Centimeter|Mean|2.86|2.86|Standard Deviation|1.23|1.23|||
3766089|NCT01936467|3598729|B3|Tail||Pancreatic mass Location||participants|Number|14|14.0||||||
3766090|NCT01936467|3598730|B2|Tail||Pancreatic mass Location||participants|Number|5|5.0||||||
3766091|NCT01936467|3598731|B1|Tail||Pancreatic mass Location||participants|Number|9|9.0||||||
3766092|NCT01936467|3598729|B3|Body||Pancreatic mass Location||participants|Number|27|27.0||||||
3766093|NCT01936467|3598730|B2|Body||Pancreatic mass Location||participants|Number|13|13.0||||||
3766094|NCT01936467|3598731|B1|Body||Pancreatic mass Location||participants|Number|14|14.0||||||
3766095|NCT01936467|3598729|B3|Neck||Pancreatic mass Location||participants|Number|7|7.0||||||
3766096|NCT01936467|3598730|B2|Neck||Pancreatic mass Location||participants|Number|1|1.0||||||
3766097|NCT01936467|3598731|B1|Neck||Pancreatic mass Location||participants|Number|6|6.0||||||
3766098|NCT01936467|3598729|B3|Uncinate/Head||Pancreatic mass Location||participants|Number|73|73.0||||||
3766099|NCT01936467|3598730|B2|Uncinate/Head||Pancreatic mass Location||participants|Number|42|42.0||||||
3766100|NCT01936467|3598731|B1|Uncinate/Head||Pancreatic mass Location||participants|Number|31|31.0||||||
3766101|NCT01936467|3598729|B3|||Antiplatelet therapy||participants|Number|20|20.0||||||
3766102|NCT01936467|3598730|B2|||Antiplatelet therapy||participants|Number|14|14.0||||||
3766103|NCT01936467|3598731|B1|||Antiplatelet therapy||participants|Number|6|6.0||||||
3766104|NCT01936467|3598729|B3|||Prior non-diagnostic FNA||participants|Number|15|15.0||||||
3766105|NCT01936467|3598730|B2|||Prior non-diagnostic FNA||participants|Number|8|8.0||||||
3766106|NCT01936467|3598731|B1|||Prior non-diagnostic FNA||participants|Number|7|7.0||||||
3766107|NCT01936467|3598729|B3|Radiation therapy||Prior History||participants|Number|6|6.0||||||
3766108|NCT01936467|3598730|B2|Radiation therapy||Prior History||participants|Number|3|3.0||||||
3766109|NCT01936467|3598731|B1|Radiation therapy||Prior History||participants|Number|3|3.0||||||
3766110|NCT01936467|3598729|B3|Chemotherapy||Prior History||participants|Number|4|4.0||||||
3766111|NCT01936467|3598730|B2|Chemotherapy||Prior History||participants|Number|1|1.0||||||
3766112|NCT01936467|3598731|B1|Chemotherapy||Prior History||participants|Number|3|3.0||||||
3766113|NCT01936467|3598729|B3|Chronic Pancreatitis||Prior History||participants|Number|5|5.0||||||
3766114|NCT01936467|3598730|B2|Chronic Pancreatitis||Prior History||participants|Number|2|2.0||||||
3766115|NCT01936467|3598731|B1|Chronic Pancreatitis||Prior History||participants|Number|3|3.0||||||
3766116|NCT01936467|3598729|B3||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3766117|NCT01936467|3598730|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3766118|NCT01936467|3598731|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3766119|NCT01936467|3598729|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3766120|NCT01936467|3598730|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3766121|NCT01936467|3598731|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3766122|NCT01936467|3598729|B3|||Age||years|Mean|64.15|64.15|Standard Deviation|13.8|13.8|||
3766123|NCT01936467|3598730|B2|||Age||years|Mean|64.2|64.2|Standard Deviation|13.8|13.8|||
3766124|NCT01936467|3598731|B1|||Age||years|Mean|64.1|64.1|Standard Deviation|13.8|13.8|||
3766125|NCT01936389|3598750|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3766126|NCT01936389|3598751|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3766127|NCT01936389|3598752|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3766128|NCT01936389|3598750|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3766129|NCT01936389|3598751|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3766130|NCT01936389|3598752|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3766131|NCT01936389|3598750|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3766132|NCT01936389|3598751|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3766133|NCT01936389|3598752|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3766134|NCT01936389|3598750|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3766135|NCT01936389|3598751|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3766136|NCT01936389|3598752|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3766137|NCT01936389|3598750|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3766138|NCT01936389|3598751|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3766139|NCT01936389|3598752|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3766140|NCT01936363|3598759|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3766141|NCT01936363|3598760|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3766142|NCT01936363|3598761|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3766143|NCT01936363|3598759|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3766144|NCT01936363|3598760|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3766145|NCT01936363|3598761|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3766146|NCT01936363|3598759|B3|||Age||years|Mean|49.0|49.0|Standard Deviation|15.26|15.26|||
3766147|NCT01936363|3598760|B2|||Age||years|Mean|50.6|50.6|Standard Deviation|16.39|16.39|||
3766148|NCT01936363|3598761|B1|||Age||years|Mean|47.3|47.3|Standard Deviation|14.07|14.07|||
3766149|NCT01936181|3598786|B3||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3766150|NCT01936181|3598787|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3766151|NCT01936181|3598788|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3766152|NCT01936181|3598786|B3||Female|Sex: Female, Male||Participants|Count of Participants|468|468.0||||||
3766153|NCT01936181|3598787|B2||Female|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
3766154|NCT01936181|3598788|B1||Female|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
3766155|NCT01936181|3598786|B3|||Age||years|Mean|52.1|52.1|Standard Deviation|11.83|11.83|||
3766156|NCT01936181|3598787|B2|||Age||years|Mean|52.6|52.6|Standard Deviation|11.74|11.74|||
3766157|NCT01936181|3598788|B1|||Age||years|Mean|51.6|51.6|Standard Deviation|11.92|11.92|||
3766158|NCT01935947|3598802|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
3766159|NCT01935947|3598803|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3766160|NCT01935947|3598804|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3766161|NCT01935947|3598805|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3766162|NCT01935947|3598802|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766163|NCT01935947|3598803|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766164|NCT01935947|3598804|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766165|NCT01935947|3598805|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766166|NCT01935947|3598802|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766167|NCT01935947|3598803|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766168|NCT01935947|3598804|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766169|NCT01935947|3598805|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766170|NCT01935947|3598802|B4||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3766171|NCT01935947|3598803|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3766172|NCT01935947|3598804|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3766173|NCT01935947|3598805|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3766174|NCT01935947|3598802|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3766175|NCT01935947|3598803|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766176|NCT01935947|3598804|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3766177|NCT01935947|3598805|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3766178|NCT01935947|3598802|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766179|NCT01935947|3598803|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766180|NCT01935947|3598804|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766181|NCT01935947|3598805|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766182|NCT01935947|3598802|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3766183|NCT01935947|3598803|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3766184|NCT01935947|3598804|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3766185|NCT01935947|3598805|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766186|NCT01935947|3598802|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766187|NCT01935947|3598803|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766188|NCT01935947|3598804|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766189|NCT01935947|3598805|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766190|NCT01935947|3598802|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766191|NCT01935947|3598803|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766192|NCT01935947|3598804|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766193|NCT01935947|3598805|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766194|NCT01935947|3598802|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3766195|NCT01935947|3598803|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3766196|NCT01935947|3598804|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3766197|NCT01935947|3598805|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3766198|NCT01935947|3598802|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766199|NCT01935947|3598803|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766200|NCT01935947|3598804|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766201|NCT01935947|3598805|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766202|NCT01935947|3598802|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3766203|NCT01935947|3598803|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3766204|NCT01935947|3598804|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3766205|NCT01935947|3598805|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3766206|NCT01935947|3598802|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3766207|NCT01935947|3598803|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3766208|NCT01935947|3598804|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3766209|NCT01935947|3598805|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3766210|NCT01935947|3598802|B4|||Age||years|Mean|60|60.0|Standard Deviation|4.0|4.0|||
3766211|NCT01935947|3598803|B3|||Age||years|Mean|54|54.0|Standard Deviation|2.0|2.0|||
3766212|NCT01935947|3598804|B2|||Age||years|Mean|62|62.0|Standard Deviation|8.4|8.4|||
3766213|NCT01935947|3598805|B1|||Age||years|Mean|63|63.0|Standard Deviation|12.6|12.6|||
3766214|NCT01935947|3598802|B4||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3766215|NCT01935947|3598803|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3766216|NCT01935947|3598804|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3766217|NCT01935947|3598805|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3766218|NCT01935947|3598802|B4||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3766219|NCT01935947|3598803|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3766220|NCT01935947|3598804|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3766221|NCT01935947|3598805|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3766222|NCT01935947|3598802|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3766223|NCT01935947|3598803|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3766224|NCT01935947|3598804|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3766225|NCT01935947|3598805|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3766226|NCT01935622|3598830|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
3766227|NCT01935622|3598831|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3766228|NCT01935622|3598832|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3766229|NCT01935622|3598833|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3766230|NCT01935622|3598830|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3766231|NCT01935622|3598831|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3766232|NCT01935622|3598832|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3766233|NCT01935622|3598833|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3766234|NCT01935622|3598830|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3766235|NCT01935622|3598831|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3766236|NCT01935622|3598832|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3766237|NCT01935622|3598833|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3766238|NCT01935622|3598830|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3766239|NCT01935622|3598831|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3766240|NCT01935622|3598832|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3766241|NCT01935622|3598833|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3766242|NCT01935622|3598830|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3766243|NCT01935622|3598831|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3766244|NCT01935622|3598832|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3766245|NCT01935622|3598833|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3766246|NCT01935622|3598830|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3766247|NCT01935622|3598831|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3766248|NCT01935622|3598832|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3766249|NCT01935622|3598833|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3766250|NCT01935622|3598830|B4|||Age||years|Median|54|54.0|Full Range|||48.0|60.0|
3766251|NCT01935622|3598831|B3|||Age||years|Median|54|54.0|Full Range|||49.0|60.0|
3766252|NCT01935622|3598832|B2|||Age||years|Median|58|58.0|Full Range|||55.0|59.0|
3766253|NCT01935622|3598833|B1|||Age||years|Median|52|52.0|Full Range|||48.0|55.0|
3766254|NCT01935180|3598843|B3||Colonoscopy performed for symptoms (diagnostic)|Indication||Participants|Count of Participants|191|191.0||||||
3766255|NCT01935180|3598844|B2||Colonoscopy performed for symptoms (diagnostic)|Indication||Participants|Count of Participants|98|98.0||||||
3766256|NCT01935180|3598845|B1||Colonoscopy performed for symptoms (diagnostic)|Indication||Participants|Count of Participants|93|93.0||||||
3766257|NCT01935180|3598843|B3||Colonoscopy performed for polyp surveillance|Indication||Participants|Count of Participants|339|339.0||||||
3766258|NCT01935180|3598844|B2||Colonoscopy performed for polyp surveillance|Indication||Participants|Count of Participants|171|171.0||||||
3766259|NCT01935180|3598845|B1||Colonoscopy performed for polyp surveillance|Indication||Participants|Count of Participants|168|168.0||||||
3766260|NCT01935180|3598843|B3||Colonoscopy performed for cancer screening|Indication||Participants|Count of Participants|583|583.0||||||
3766261|NCT01935180|3598844|B2||Colonoscopy performed for cancer screening|Indication||Participants|Count of Participants|292|292.0||||||
3766262|NCT01935180|3598845|B1||Colonoscopy performed for cancer screening|Indication||Participants|Count of Participants|291|291.0||||||
3766263|NCT01935180|3598843|B3|United States||Region of Enrollment||participants|Number|1113|1113.0||||||
3766264|NCT01935180|3598844|B2|United States||Region of Enrollment||participants|Number|561|561.0||||||
3766265|NCT01935180|3598845|B1|United States||Region of Enrollment||participants|Number|552|552.0||||||
3766266|NCT01935180|3598843|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3766267|NCT01935180|3598843|B3||Male|Sex: Female, Male||Participants|Count of Participants|709|709.0||||||
3766268|NCT01935180|3598844|B2||Male|Sex: Female, Male||Participants|Count of Participants|366|366.0||||||
3766269|NCT01935180|3598845|B1||Male|Sex: Female, Male||Participants|Count of Participants|343|343.0||||||
3766270|NCT01935180|3598843|B3||Female|Sex: Female, Male||Participants|Count of Participants|404|404.0||||||
3766271|NCT01935180|3598844|B2||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
3766272|NCT01935180|3598845|B1||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
3766273|NCT01935180|3598843|B3|||Age||years|Mean|61.8|61.8|Standard Deviation|8.3|8.3|||
3766274|NCT01935180|3598844|B2|||Age||years|Mean|62.5|62.5|Standard Deviation|8.3|8.3|||
3766275|NCT01935180|3598845|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|8.4|8.4|||
3766276|NCT01934894|3598864|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3766277|NCT01934894|3598865|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3766278|NCT01934894|3598866|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3766279|NCT01934894|3598864|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3766280|NCT01934894|3598865|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3766281|NCT01934894|3598866|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3766282|NCT01934894|3598864|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3766283|NCT01934894|3598865|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3766284|NCT01934894|3598866|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3766285|NCT01934894|3598864|B3|||Age||years|Median|58|58.0|Full Range|||40.0|69.0|
3766286|NCT01934894|3598865|B2|||Age||years|Median|60|60.0|Full Range|||40.0|69.0|
3766287|NCT01934894|3598866|B1|||Age||years|Median|58|58.0|Full Range|||46.0|60.0|
3766288|NCT01934790|3598882|B1|||Total alkaline phosphatase (ALP) - median value||Unit per liter|Median|85|85.0|Full Range|||29.0|705.0|
3766289|NCT01934790|3598882|B1|||Prostate specific antigen (PSA) - median value||microgram per liter|Median|67.66|67.66|Full Range|||0.05|2349.04|
3766290|NCT01934790|3598882|B1|||Time since initial treatment with radium-223 dichloride||Months|Median|6.05|6.05|Full Range|||1.2|17.1|
3766291|NCT01934790|3598882|B1|||Time from initial diagnosis||Months|Median|80.34|80.34|Full Range|||11.8|287.9|
3766292|NCT01934790|3598882|B1|||Time from initial diagnosis of bone metastasis||Months|Median|43.12|43.12|Full Range|||7.6|172.4|
3766293|NCT01934790|3598882|B1|||Total alkaline phosphatase (ALP) - mean value||Unit per liter|Mean|122.60|122.6|Standard Deviation|118.49|118.49|||
3766294|NCT01934790|3598882|B1|||Prostate specific antigen (PSA) - mean value||microgram per liter|Mean|211.59|211.59|Standard Deviation|452.84|452.84|||
3766295|NCT01934790|3598882|B1|Superscan||Number of bone lesions||Participants|Number|5|5.0||||||
3766296|NCT01934790|3598882|B1|> 20, not a superscan||Number of bone lesions||Participants|Number|6|6.0||||||
3766297|NCT01934790|3598882|B1|6-20||Number of bone lesions||Participants|Number|15|15.0||||||
3766298|NCT01934790|3598882|B1|1-5||Number of bone lesions||Participants|Number|18|18.0||||||
3766299|NCT01934790|3598882|B1|2||Baseline Eastern Cooperative Oncology Group (ECOG) Performance status (PS) score|Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) is a scale that measures how cancer affects a patient. The scale ranges from 0 (fully active) to 5 (dead).|Participants|Number|3|3.0||||||
3766300|NCT01934790|3598882|B1|1||Baseline Eastern Cooperative Oncology Group (ECOG) Performance status (PS) score|Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) is a scale that measures how cancer affects a patient. The scale ranges from 0 (fully active) to 5 (dead).|Participants|Number|27|27.0||||||
3766301|NCT01934790|3598882|B1|0||Baseline Eastern Cooperative Oncology Group (ECOG) Performance status (PS) score|Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) is a scale that measures how cancer affects a patient. The scale ranges from 0 (fully active) to 5 (dead).|Participants|Number|14|14.0||||||
3766302|NCT01934790|3598882|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3766303|NCT01934790|3598882|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3766304|NCT01934790|3598882|B1|>=65 years||Age, Customized||Participants|Count of Participants|31|31.0||||||
3766305|NCT01934790|3598882|B1|< 65 years||Age, Customized||Participants|Count of Participants|13|13.0||||||
3766306|NCT01934790|3598882|B1|||Age||Years|Median|71|71.0|Full Range|||52.0|91.0|
3766307|NCT01934647|3598910|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3766308|NCT01934647|3598911|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3766309|NCT01934647|3598912|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3766310|NCT01934647|3598913|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3766311|NCT01934647|3598910|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3766312|NCT01934647|3598911|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3766313|NCT01934647|3598912|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3766314|NCT01934647|3598913|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3766315|NCT01934647|3598910|B4|||Age||Years|Mean|51|51.0|Standard Deviation|15.4|15.4|||
3766316|NCT01934647|3598911|B3|||Age||Years|Mean|61.3|61.3|Standard Deviation|11.0|11.0|||
3766317|NCT01934647|3598912|B2|||Age||Years|Mean|52.0|52.0|Standard Deviation|1.4|1.4|||
3766318|NCT01934647|3598913|B1|||Age||Years|Mean|34.5|34.5|Standard Deviation|17.7|17.7|||
3766319|NCT01934582|3598923|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3766320|NCT01934582|3598923|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766321|NCT01934582|3598923|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766322|NCT01934582|3598923|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3766323|NCT01934582|3598923|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3766324|NCT01934582|3598923|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766325|NCT01934582|3598923|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766326|NCT01934582|3598923|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766327|NCT01934582|3598923|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766328|NCT01934582|3598923|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3766329|NCT01934582|3598923|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766330|NCT01934582|3598923|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3766331|NCT01934582|3598923|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3766332|NCT01934582|3598923|B1|||Age||years|Mean|60.6|60.6|Full Range|||38.0|71.0|
3766333|NCT01934582|3598923|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3766334|NCT01934582|3598923|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3766335|NCT01934582|3598923|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3766336|NCT01934517|3598937|B1|Canada||Region of Enrollment||participants|Number|25|25.0||||||
3766337|NCT01934517|3598937|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3766338|NCT01934517|3598937|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3766339|NCT01934517|3598937|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3766340|NCT01934517|3598937|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3766341|NCT01934517|3598937|B1||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
3766342|NCT01934504|3598945|B5|United Kingdom||Region of Enrollment||participants|Number|33|33.0||||||
3766343|NCT01934504|3598946|B4|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3766344|NCT01934504|3598947|B3|United Kingdom||Region of Enrollment||participants|Number|16|16.0||||||
3766345|NCT01934504|3598948|B2|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3766346|NCT01934504|3598949|B1|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3766347|NCT01934504|3598945|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766348|NCT01934504|3598946|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766349|NCT01934504|3598947|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766350|NCT01934504|3598948|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766351|NCT01934504|3598949|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766352|NCT01934504|3598945|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766353|NCT01934504|3598946|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766354|NCT01934504|3598947|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766355|NCT01934504|3598948|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766356|NCT01934504|3598949|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766357|NCT01934504|3598945|B5||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3766358|NCT01934504|3598946|B4||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3766359|NCT01934504|3598947|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3766360|NCT01934504|3598948|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3766361|NCT01934504|3598949|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3766362|NCT01934504|3598945|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3766363|NCT01934504|3598946|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3766364|NCT01934504|3598947|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766365|NCT01934504|3598948|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766366|NCT01934504|3598949|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766367|NCT01934504|3598945|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766368|NCT01934504|3598946|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766369|NCT01934504|3598947|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766370|NCT01934504|3598948|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766371|NCT01934504|3598949|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766372|NCT01934504|3598945|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3766373|NCT01934504|3598946|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766374|NCT01934504|3598947|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3766375|NCT01934504|3598948|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766376|NCT01934504|3598949|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3766377|NCT01934504|3598945|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766378|NCT01934504|3598946|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766379|NCT01934504|3598947|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766380|NCT01934504|3598948|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766381|NCT01934504|3598949|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766382|NCT01934504|3598945|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766383|NCT01934504|3598946|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766384|NCT01934504|3598947|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766385|NCT01934504|3598948|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766386|NCT01934504|3598949|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766387|NCT01934504|3598945|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3766388|NCT01934504|3598946|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3766389|NCT01934504|3598947|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3766390|NCT01934504|3598948|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3766391|NCT01934504|3598949|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3766392|NCT01934504|3598945|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766393|NCT01934504|3598946|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766394|NCT01934504|3598947|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766395|NCT01934504|3598948|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766396|NCT01934504|3598949|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766397|NCT01934504|3598945|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3766398|NCT01934504|3598946|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3766399|NCT01934504|3598947|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3766400|NCT01934504|3598948|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3766401|NCT01934504|3598949|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3766402|NCT01934504|3598945|B5||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3766403|NCT01934504|3598946|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3766404|NCT01934504|3598947|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3766405|NCT01934504|3598948|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3766406|NCT01934504|3598949|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3766407|NCT01934504|3598945|B5|||Age||years|Mean|68.1|68.1|Standard Deviation|9.3|9.3|||
3766408|NCT01934504|3598946|B4|||Age||years|Mean|64.8|64.8|Standard Deviation|7.5|7.5|||
3766409|NCT01934504|3598947|B3|||Age||years|Mean|69.4|69.4|Standard Deviation|7.1|7.1|||
3766410|NCT01934504|3598948|B2|||Age||years|Mean|58.3|58.3|Standard Deviation|7.6|7.6|||
3766411|NCT01934504|3598949|B1|||Age||years|Mean|73.7|73.7|Standard Deviation|13.5|13.5|||
3766412|NCT01934504|3598945|B5||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3766413|NCT01934504|3598946|B4||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3766414|NCT01934504|3598947|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3766415|NCT01934504|3598948|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3766416|NCT01934504|3598949|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3766417|NCT01934504|3598945|B5||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3766418|NCT01934504|3598946|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3766419|NCT01934504|3598947|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3766420|NCT01934504|3598948|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3766421|NCT01934504|3598949|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3766422|NCT01934504|3598945|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3766423|NCT01934504|3598946|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3766424|NCT01934504|3598947|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3766425|NCT01934504|3598948|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3766426|NCT01934504|3598949|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3766427|NCT01934231|3598974|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
3766428|NCT01934231|3598974|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3766429|NCT01934231|3598974|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3766430|NCT01934231|3598974|B1|||Age||Years|Mean|6.6|6.6|Standard Deviation|2.42|2.42|||
3766475|NCT01934218|3598985|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
3766431|NCT01934218|3598983|B3|||50-foot walk test contralateral VAS pain score|Observed VAS pain score of 100 mm; 0 mm meaning no pain; 100 mm meaning extreme contralateral knee pain following 50-foot walk test.|mm|Mean|11.73|11.73|Standard Deviation|7.549|7.549|||
3766432|NCT01934218|3598984|B2|||50-foot walk test contralateral VAS pain score|Observed VAS pain score of 100 mm; 0 mm meaning no pain; 100 mm meaning extreme contralateral knee pain following 50-foot walk test.|mm|Mean|11.95|11.95|Standard Deviation|7.565|7.565|||
3766433|NCT01934218|3598985|B1|||50-foot walk test contralateral VAS pain score|Observed VAS pain score of 100 mm; 0 mm meaning no pain; 100 mm meaning extreme contralateral knee pain following 50-foot walk test.|mm|Mean|11.50|11.5|Standard Deviation|7.536|7.536|||
3766434|NCT01934218|3598983|B3|||50-foot walk test VAS pain score|Observed Visual Analogue Scale (VAS) pain score of 100 mm; 0 mm meaning no pain; 100 mm meaning extreme target knee pain following 50-foot walk test.|mm|Mean|69.31|69.31|Standard Deviation|7.725|7.725|||
3766435|NCT01934218|3598984|B2|||50-foot walk test VAS pain score|Observed Visual Analogue Scale (VAS) pain score of 100 mm; 0 mm meaning no pain; 100 mm meaning extreme target knee pain following 50-foot walk test.|mm|Mean|69.36|69.36|Standard Deviation|7.817|7.817|||
3766436|NCT01934218|3598985|B1|||50-foot walk test VAS pain score|Observed Visual Analogue Scale (VAS) pain score of 100 mm; 0 mm meaning no pain; 100 mm meaning extreme target knee pain following 50-foot walk test.|mm|Mean|69.25|69.25|Standard Deviation|7.640|7.64|||
3766437|NCT01934218|3598983|B3|Left||Study knee||participants|Number|388|388.0||||||
3766438|NCT01934218|3598984|B2|Left||Study knee||participants|Number|195|195.0||||||
3766439|NCT01934218|3598985|B1|Left||Study knee||participants|Number|193|193.0||||||
3766440|NCT01934218|3598983|B3|Right||Study knee||participants|Number|421|421.0||||||
3766441|NCT01934218|3598984|B2|Right||Study knee||participants|Number|212|212.0||||||
3766442|NCT01934218|3598985|B1|Right||Study knee||participants|Number|209|209.0||||||
3766443|NCT01934218|3598983|B3|Post-traumatic||Etiology||participants|Number|91|91.0||||||
3766444|NCT01934218|3598984|B2|Post-traumatic||Etiology||participants|Number|48|48.0||||||
3766445|NCT01934218|3598985|B1|Post-traumatic||Etiology||participants|Number|43|43.0||||||
3766446|NCT01934218|3598983|B3|Idiopathic||Etiology||participants|Number|718|718.0||||||
3766447|NCT01934218|3598984|B2|Idiopathic||Etiology||participants|Number|359|359.0||||||
3766448|NCT01934218|3598985|B1|Idiopathic||Etiology||participants|Number|359|359.0||||||
3766449|NCT01934218|3598983|B3|||osteoarthritis knee disease duration||years|Mean|6.85|6.85|Standard Deviation|7.456|7.456|||
3766450|NCT01934218|3598984|B2|||osteoarthritis knee disease duration||years|Mean|6.90|6.9|Standard Deviation|7.072|7.072|||
3766451|NCT01934218|3598985|B1|||osteoarthritis knee disease duration||years|Mean|6.80|6.8|Standard Deviation|7.835|7.835|||
3766452|NCT01934218|3598983|B3|3||Kellgren-Lawrence score|The Kellgren-Lawrence score is radiological classification of knee osteoarthritis. It progresses from grade 0 to grade IV and classified based on x-rays.|participants|Number|260|260.0||||||
3766453|NCT01934218|3598984|B2|3||Kellgren-Lawrence score|The Kellgren-Lawrence score is radiological classification of knee osteoarthritis. It progresses from grade 0 to grade IV and classified based on x-rays.|participants|Number|132|132.0||||||
3766454|NCT01934218|3598985|B1|3||Kellgren-Lawrence score|The Kellgren-Lawrence score is radiological classification of knee osteoarthritis. It progresses from grade 0 to grade IV and classified based on x-rays.|participants|Number|128|128.0||||||
3766455|NCT01934218|3598983|B3|2||Kellgren-Lawrence score|The Kellgren-Lawrence score is radiological classification of knee osteoarthritis. It progresses from grade 0 to grade IV and classified based on x-rays.|participants|Number|325|325.0||||||
3766456|NCT01934218|3598984|B2|2||Kellgren-Lawrence score|The Kellgren-Lawrence score is radiological classification of knee osteoarthritis. It progresses from grade 0 to grade IV and classified based on x-rays.|participants|Number|164|164.0||||||
3766457|NCT01934218|3598985|B1|2||Kellgren-Lawrence score|The Kellgren-Lawrence score is radiological classification of knee osteoarthritis. It progresses from grade 0 to grade IV and classified based on x-rays.|participants|Number|161|161.0||||||
3766458|NCT01934218|3598983|B3|1||Kellgren-Lawrence score|The Kellgren-Lawrence score is radiological classification of knee osteoarthritis. It progresses from grade 0 to grade IV and classified based on x-rays.|participants|Number|224|224.0||||||
3766459|NCT01934218|3598984|B2|1||Kellgren-Lawrence score|The Kellgren-Lawrence score is radiological classification of knee osteoarthritis. It progresses from grade 0 to grade IV and classified based on x-rays.|participants|Number|111|111.0||||||
3766460|NCT01934218|3598985|B1|1||Kellgren-Lawrence score|The Kellgren-Lawrence score is radiological classification of knee osteoarthritis. It progresses from grade 0 to grade IV and classified based on x-rays.|participants|Number|113|113.0||||||
3766461|NCT01934218|3598983|B3|||Body mass index||kilograms / meter square|Mean|28.698|28.698|Standard Deviation|4.0585|4.0585|||
3766462|NCT01934218|3598984|B2|||Body mass index||kilograms / meter square|Mean|28.797|28.797|Standard Deviation|3.9244|3.9244|||
3766463|NCT01934218|3598985|B1|||Body mass index||kilograms / meter square|Mean|28.597|28.597|Standard Deviation|4.1923|4.1923|||
3766464|NCT01934218|3598983|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3766465|NCT01934218|3598984|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3766466|NCT01934218|3598985|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3766467|NCT01934218|3598983|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766468|NCT01934218|3598984|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766469|NCT01934218|3598985|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766470|NCT01934218|3598983|B3||White|Race (NIH/OMB)||Participants|Count of Participants|524|524.0||||||
3766471|NCT01934218|3598984|B2||White|Race (NIH/OMB)||Participants|Count of Participants|277|277.0||||||
3766472|NCT01934218|3598985|B1||White|Race (NIH/OMB)||Participants|Count of Participants|247|247.0||||||
3766473|NCT01934218|3598983|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|163|163.0||||||
3766474|NCT01934218|3598984|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3766476|NCT01934218|3598983|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3766477|NCT01934218|3598984|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3766478|NCT01934218|3598985|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766479|NCT01934218|3598983|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
3766480|NCT01934218|3598984|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3766481|NCT01934218|3598985|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3766482|NCT01934218|3598983|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766483|NCT01934218|3598984|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766484|NCT01934218|3598985|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766485|NCT01934218|3598983|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766486|NCT01934218|3598984|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766487|NCT01934218|3598985|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766488|NCT01934218|3598983|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|746|746.0||||||
3766489|NCT01934218|3598984|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|379|379.0||||||
3766490|NCT01934218|3598985|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|367|367.0||||||
3766491|NCT01934218|3598983|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3766492|NCT01934218|3598984|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3766493|NCT01934218|3598985|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3766494|NCT01934218|3598983|B3||Male|Sex: Female, Male||Participants|Count of Participants|354|354.0||||||
3766495|NCT01934218|3598984|B2||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
3766496|NCT01934218|3598985|B1||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
3766497|NCT01934218|3598983|B3||Female|Sex: Female, Male||Participants|Count of Participants|455|455.0||||||
3766498|NCT01934218|3598984|B2||Female|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
3766499|NCT01934218|3598985|B1||Female|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
3766500|NCT01934218|3598983|B3|||Age||years|Mean|59.6|59.6|Standard Deviation|9.23|9.23|||
3766501|NCT01934218|3598984|B2|||Age||years|Mean|59.8|59.8|Standard Deviation|9.32|9.32|||
3766502|NCT01934218|3598985|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|9.14|9.14|||
3766503|NCT01934192|3598993|B5|Race, Customized|White - White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|90|90.0||||||
3766504|NCT01934192|3598994|B4|Race, Customized|White - White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3766505|NCT01934192|3598995|B3|Race, Customized|White - White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3766506|NCT01934192|3598996|B2|Race, Customized|White - White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3766507|NCT01934192|3598997|B1|Race, Customized|White - White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3766508|NCT01934192|3598993|B5|Race, Customized|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3766509|NCT01934192|3598994|B4|Race, Customized|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3766510|NCT01934192|3598995|B3|Race, Customized|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3766511|NCT01934192|3598996|B2|Race, Customized|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3766512|NCT01934192|3598997|B1|Race, Customized|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3766513|NCT01934192|3598993|B5|Race, Customized|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3766514|NCT01934192|3598994|B4|Race, Customized|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3766515|NCT01934192|3598995|B3|Race, Customized|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3766516|NCT01934192|3598996|B2|Race, Customized|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3766517|NCT01934192|3598997|B1|Race, Customized|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3766518|NCT01934192|3598993|B5||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3766519|NCT01934192|3598994|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3766520|NCT01934192|3598995|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3766521|NCT01934192|3598996|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3766522|NCT01934192|3598997|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3766523|NCT01934192|3598993|B5||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3766524|NCT01934192|3598994|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3766525|NCT01934192|3598995|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3766526|NCT01934192|3598996|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3766527|NCT01934192|3598997|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3766528|NCT01934192|3598993|B5|||Age||Years|Mean|57.3|57.3|Standard Deviation|16.19|16.19|||
3766529|NCT01934192|3598994|B4|||Age||Years|Mean|45.5|45.5|Standard Deviation|9.68|9.68|||
3766530|NCT01934192|3598995|B3|||Age||Years|Mean|64.3|64.3|Standard Deviation|13.40|13.4|||
3766531|NCT01934192|3598996|B2|||Age||Years|Mean|59.8|59.8|Standard Deviation|16.64|16.64|||
3766532|NCT01934192|3598997|B1|||Age||Years|Mean|55.1|55.1|Standard Deviation|15.93|15.93|||
3766533|NCT01934010|3599134|B4|Turkey||Region of Enrollment||participants|Number|5|5.0||||||
3766534|NCT01934010|3599135|B3|Turkey||Region of Enrollment||participants|Number|0|0.0||||||
3766535|NCT01934010|3599136|B2|Turkey||Region of Enrollment||participants|Number|2|2.0||||||
3766536|NCT01934010|3599137|B1|Turkey||Region of Enrollment||participants|Number|3|3.0||||||
3766537|NCT01934010|3599134|B4|South Korea||Region of Enrollment||participants|Number|16|16.0||||||
3766538|NCT01934010|3599135|B3|South Korea||Region of Enrollment||participants|Number|4|4.0||||||
3766539|NCT01934010|3599136|B2|South Korea||Region of Enrollment||participants|Number|1|1.0||||||
3766540|NCT01934010|3599137|B1|South Korea||Region of Enrollment||participants|Number|11|11.0||||||
3766541|NCT01934010|3599134|B4|Israel||Region of Enrollment||participants|Number|3|3.0||||||
3766542|NCT01934010|3599135|B3|Israel||Region of Enrollment||participants|Number|1|1.0||||||
3766543|NCT01934010|3599136|B2|Israel||Region of Enrollment||participants|Number|1|1.0||||||
3766544|NCT01934010|3599137|B1|Israel||Region of Enrollment||participants|Number|1|1.0||||||
3766545|NCT01934010|3599134|B4|Canada||Region of Enrollment||participants|Number|24|24.0||||||
3766546|NCT01934010|3599135|B3|Canada||Region of Enrollment||participants|Number|9|9.0||||||
3766547|NCT01934010|3599136|B2|Canada||Region of Enrollment||participants|Number|11|11.0||||||
3766548|NCT01934010|3599137|B1|Canada||Region of Enrollment||participants|Number|4|4.0||||||
3766549|NCT01934010|3599134|B4|Czechia||Region of Enrollment||participants|Number|53|53.0||||||
3766550|NCT01934010|3599135|B3|Czechia||Region of Enrollment||participants|Number|22|22.0||||||
3766551|NCT01934010|3599136|B2|Czechia||Region of Enrollment||participants|Number|7|7.0||||||
3766552|NCT01934010|3599137|B1|Czechia||Region of Enrollment||participants|Number|24|24.0||||||
3766553|NCT01934010|3599134|B4|United States||Region of Enrollment||participants|Number|156|156.0||||||
3766554|NCT01934010|3599135|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3766555|NCT01934010|3599136|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
3766556|NCT01934010|3599137|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
3766557|NCT01934010|3599134|B4||Male|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
3766558|NCT01934010|3599135|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3766559|NCT01934010|3599136|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3766560|NCT01934010|3599137|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3766561|NCT01934010|3599134|B4||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3766562|NCT01934010|3599135|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3766563|NCT01934010|3599136|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3766564|NCT01934010|3599137|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3766565|NCT01934010|3599134|B4|||Age||years|Mean|44.8|44.8|Standard Deviation|14.5|14.5|||
3766566|NCT01934010|3599135|B3|||Age||years|Mean|47.6|47.6|Standard Deviation|15.5|15.5|||
3766567|NCT01934010|3599136|B2|||Age||years|Mean|44.7|44.7|Standard Deviation|13.9|13.9|||
3766568|NCT01934010|3599137|B1|||Age||years|Mean|43.1|43.1|Standard Deviation|14.1|14.1|||
3766569|NCT01934010|3599134|B4||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
3766570|NCT01934010|3599135|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3766571|NCT01934010|3599136|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3766572|NCT01934010|3599137|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3766573|NCT01934010|3599134|B4||Between 18 and 65 years|Age||Participants|Count of Participants|231|231.0||||||
3766574|NCT01934010|3599135|B3||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
3766575|NCT01934010|3599136|B2||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
3766576|NCT01934010|3599137|B1||Between 18 and 65 years|Age||Participants|Count of Participants|106|106.0||||||
3766577|NCT01934010|3599134|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3766578|NCT01934010|3599135|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3766579|NCT01934010|3599136|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3766580|NCT01934010|3599137|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3766581|NCT01933932|3599156|B3|Not Hispanic or Latino||Ethnic group||Participants|Number|481|481.0||||||
3766582|NCT01933932|3599157|B2|Not Hispanic or Latino||Ethnic group||Participants|Number|241|241.0||||||
3766583|NCT01933932|3599158|B1|Not Hispanic or Latino||Ethnic group||Participants|Number|240|240.0||||||
3766584|NCT01933932|3599156|B3|Hispanic or Latino||Ethnic group||Participants|Number|29|29.0||||||
3766585|NCT01933932|3599157|B2|Hispanic or Latino||Ethnic group||Participants|Number|15|15.0||||||
3766586|NCT01933932|3599158|B1|Hispanic or Latino||Ethnic group||Participants|Number|14|14.0||||||
3766587|NCT01933932|3599156|B3|Other||Race||Participants|Number|10|10.0||||||
3766588|NCT01933932|3599157|B2|Other||Race||Participants|Number|6|6.0||||||
3766589|NCT01933932|3599158|B1|Other||Race||Participants|Number|4|4.0||||||
3766590|NCT01933932|3599156|B3|American Indian or Alaska Native||Race||Participants|Number|5|5.0||||||
3766591|NCT01933932|3599157|B2|American Indian or Alaska Native||Race||Participants|Number|2|2.0||||||
3766592|NCT01933932|3599158|B1|American Indian or Alaska Native||Race||Participants|Number|3|3.0||||||
3766593|NCT01933932|3599156|B3|Asian||Race||Participants|Number|5|5.0||||||
3766594|NCT01933932|3599157|B2|Asian||Race||Participants|Number|4|4.0||||||
3766595|NCT01933932|3599158|B1|Asian||Race||Participants|Number|1|1.0||||||
3766596|NCT01933932|3599156|B3|Black or African American||Race||Participants|Number|6|6.0||||||
3766597|NCT01933932|3599157|B2|Black or African American||Race||Participants|Number|1|1.0||||||
3766598|NCT01933932|3599158|B1|Black or African American||Race||Participants|Number|5|5.0||||||
3766599|NCT01933932|3599156|B3|White||Race||Participants|Number|484|484.0||||||
3766600|NCT01933932|3599157|B2|White||Race||Participants|Number|243|243.0||||||
3766601|NCT01933932|3599158|B1|White||Race||Participants|Number|241|241.0||||||
3766602|NCT01933932|3599156|B3||Male|Sex: Female, Male||Participants|Count of Participants|303|303.0||||||
3766603|NCT01933932|3599157|B2||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3766604|NCT01933932|3599158|B1||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3766605|NCT01933932|3599156|B3||Female|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
3766606|NCT01933932|3599157|B2||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3766607|NCT01933932|3599158|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3766608|NCT01933932|3599156|B3|<65 years||Age, Customized||Participants|Number|330|330.0||||||
3766609|NCT01933932|3599157|B2|<65 years||Age, Customized||Participants|Number|173|173.0||||||
3766610|NCT01933932|3599158|B1|<65 years||Age, Customized||Participants|Number|157|157.0||||||
3766611|NCT01933932|3599156|B3|>=65 years||Age, Customized||Participants|Number|180|180.0||||||
3766612|NCT01933932|3599157|B2|>=65 years||Age, Customized||Participants|Number|83|83.0||||||
3766613|NCT01933932|3599158|B1|>=65 years||Age, Customized||Participants|Number|97|97.0||||||
3766614|NCT01933932|3599156|B3|||Age||Years|Mean|61.4|61.4|Standard Deviation|8.30|8.3|||
3766615|NCT01933932|3599157|B2|||Age||Years|Mean|60.9|60.9|Standard Deviation|8.08|8.08|||
3766616|NCT01933932|3599158|B1|||Age||Years|Mean|61.9|61.9|Standard Deviation|8.48|8.48|||
3766617|NCT01933919|3599175|B3|||Japanese version of the Children's Yale-Brown Obsessive Total Score|The Japanese version of the Children’s Yale-Brown Obsessive Compulsive Scale (JCY-BOCS) is a 10-item questionnaire assessing the severity of OCD in the past 7 days. Severity of compulsions and obsessions are rated on a scale from 0 (none) to 4 (extreme). The total score is calculated by summing the 10 individual scores and ranges from 0 to 40, where higher scores indicate more extreme symptoms.|units on a scale|Mean|26.2|26.2|Standard Deviation|5.69|5.69|||
3766618|NCT01933919|3599176|B2|||Japanese version of the Children's Yale-Brown Obsessive Total Score|The Japanese version of the Children’s Yale-Brown Obsessive Compulsive Scale (JCY-BOCS) is a 10-item questionnaire assessing the severity of OCD in the past 7 days. Severity of compulsions and obsessions are rated on a scale from 0 (none) to 4 (extreme). The total score is calculated by summing the 10 individual scores and ranges from 0 to 40, where higher scores indicate more extreme symptoms.|units on a scale|Mean|27.1|27.1|Standard Deviation|5.48|5.48|||
3766619|NCT01933919|3599177|B1|||Japanese version of the Children's Yale-Brown Obsessive Total Score|The Japanese version of the Children’s Yale-Brown Obsessive Compulsive Scale (JCY-BOCS) is a 10-item questionnaire assessing the severity of OCD in the past 7 days. Severity of compulsions and obsessions are rated on a scale from 0 (none) to 4 (extreme). The total score is calculated by summing the 10 individual scores and ranges from 0 to 40, where higher scores indicate more extreme symptoms.|units on a scale|Mean|25.4|25.4|Standard Deviation|5.92|5.92|||
3766620|NCT01933919|3599175|B3||No|Prior Treatment with Fluvoxamine||Participants|Count of Participants|36|36.0||||||
3766621|NCT01933919|3599176|B2||No|Prior Treatment with Fluvoxamine||Participants|Count of Participants|17|17.0||||||
3766622|NCT01933919|3599177|B1||No|Prior Treatment with Fluvoxamine||Participants|Count of Participants|19|19.0||||||
3766623|NCT01933919|3599175|B3||Yes|Prior Treatment with Fluvoxamine||Participants|Count of Participants|1|1.0||||||
3766624|NCT01933919|3599176|B2||Yes|Prior Treatment with Fluvoxamine||Participants|Count of Participants|1|1.0||||||
3766625|NCT01933919|3599177|B1||Yes|Prior Treatment with Fluvoxamine||Participants|Count of Participants|0|0.0||||||
3766626|NCT01933919|3599175|B3|Japanese||Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
3766627|NCT01933919|3599176|B2|Japanese||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3766628|NCT01933919|3599177|B1|Japanese||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3766629|NCT01933919|3599175|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3766630|NCT01933919|3599176|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3766631|NCT01933919|3599177|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3766632|NCT01933919|3599175|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3766633|NCT01933919|3599176|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3766634|NCT01933919|3599177|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3766635|NCT01933919|3599175|B3||12-18 years|Age, Customized||Participants|Count of Participants|29|29.0||||||
3766636|NCT01933919|3599176|B2||12-18 years|Age, Customized||Participants|Count of Participants|14|14.0||||||
3766637|NCT01933919|3599177|B1||12-18 years|Age, Customized||Participants|Count of Participants|15|15.0||||||
3766638|NCT01933919|3599175|B3||6-11 years|Age, Customized||Participants|Count of Participants|8|8.0||||||
3766639|NCT01933919|3599176|B2||6-11 years|Age, Customized||Participants|Count of Participants|4|4.0||||||
3766640|NCT01933919|3599177|B1||6-11 years|Age, Customized||Participants|Count of Participants|4|4.0||||||
3766641|NCT01933919|3599175|B3|||Age||years|Mean|13.5|13.5|Standard Deviation|2.74|2.74|||
3766642|NCT01933919|3599176|B2|||Age||years|Mean|13.3|13.3|Standard Deviation|2.72|2.72|||
3766643|NCT01933919|3599177|B1|||Age||years|Mean|13.7|13.7|Standard Deviation|2.83|2.83|||
3766644|NCT01933880|3599212|B3||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3766645|NCT01933880|3599213|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3766646|NCT01933880|3599214|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3766647|NCT01933880|3599212|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3766648|NCT01933880|3599213|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3766649|NCT01933880|3599214|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3766650|NCT01933880|3599212|B3|11 to 12 Years||Age, Customized||participants|Number|39|39.0||||||
3766651|NCT01933880|3599213|B2|11 to 12 Years||Age, Customized||participants|Number|14|14.0||||||
3766652|NCT01933880|3599214|B1|11 to 12 Years||Age, Customized||participants|Number|25|25.0||||||
3766653|NCT01933880|3599212|B3|9 to 10 Years||Age, Customized||participants|Number|71|71.0||||||
3766654|NCT01933880|3599213|B2|9 to 10 Years||Age, Customized||participants|Number|16|16.0||||||
3766655|NCT01933880|3599214|B1|9 to 10 Years||Age, Customized||participants|Number|55|55.0||||||
3766656|NCT01933880|3599212|B3|Less than 7 to 8 Years||Age, Customized||participants|Number|58|58.0||||||
3766657|NCT01933880|3599213|B2|Less than 7 to 8 Years||Age, Customized||participants|Number|10|10.0||1.72|1.72|||
3766658|NCT01933880|3599214|B1|Less than 7 to 8 Years||Age, Customized||participants|Number|48|48.0||1.47|1.47|||
3766659|NCT01933776|3599280|B3|China||Region of Enrollment||Participants|Number|40|40.0||||||
3766660|NCT01933776|3599281|B2|China||Region of Enrollment||Participants|Number|20|20.0||||||
3766661|NCT01933776|3599282|B1|China||Region of Enrollment||Participants|Number|20|20.0||||||
3766662|NCT01933776|3599280|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3766663|NCT01933776|3599281|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3766664|NCT01933776|3599282|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3766665|NCT01933776|3599280|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3766666|NCT01933776|3599281|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3766667|NCT01933776|3599282|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3766668|NCT01933776|3599280|B3|||Age||Years|Mean|25.0|25.0|Standard Deviation|21.9|21.9|||
3766669|NCT01933776|3599281|B2|||Age||Years|Mean|5.8|5.8|Standard Deviation|1.1|1.1|||
3766670|NCT01933776|3599282|B1|||Age||Years|Mean|44.2|44.2|Standard Deviation|14.4|14.4|||
3766671|NCT01933776|3599280|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3766672|NCT01933776|3599281|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3766673|NCT01933776|3599282|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3766674|NCT01933776|3599280|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3766675|NCT01933776|3599281|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3766676|NCT01933776|3599282|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3766677|NCT01933776|3599280|B3||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
3766678|NCT01933776|3599281|B2||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
3766679|NCT01933776|3599282|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3766680|NCT01933672|3599291|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3766681|NCT01933672|3599291|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3766682|NCT01933672|3599291|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|8.3|8.3|||
3766683|NCT01933425|3599343|B1|||Number of patients with 3 pregnancies||participants|Number|3|3.0||||||
3766684|NCT01933425|3599343|B1|||Number of patients with 2 pregnancies||participants|Number|2|2.0||||||
3766685|NCT01933425|3599343|B1|||Number of patients with 1 pregnancy||participants|Number|3|3.0||||||
3766686|NCT01933425|3599343|B1|||Number of patients with 0 pregnancies||participants|Number|6|6.0||||||
3766687|NCT01933425|3599343|B1|||Number of patients with previous abdominal surgery||participants|Number|7|7.0||||||
3766688|NCT01933425|3599343|B1|||BMI||kg/m2|Mean|22.2|22.2|Standard Deviation|2.6|2.6|||
3766689|NCT01933425|3599343|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3766690|NCT01933425|3599343|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3766691|NCT01933425|3599343|B1|||Age||years|Mean|44.2|44.2|Standard Deviation|7.7|7.7|||
3766692|NCT01933399|3599354|B4|United States||Region of Enrollment||participants|Number|98|98.0||||||
3766693|NCT01933399|3599355|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
3766694|NCT01933399|3599356|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
3766695|NCT01933399|3599357|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3766696|NCT01933399|3599354|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766697|NCT01933399|3599355|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766698|NCT01933399|3599356|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766699|NCT01933399|3599357|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766700|NCT01933399|3599354|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766701|NCT01933399|3599355|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766702|NCT01933399|3599356|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766703|NCT01933399|3599357|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766704|NCT01933399|3599354|B4||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3766705|NCT01933399|3599355|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3766706|NCT01933399|3599356|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3766707|NCT01933399|3599357|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3766708|NCT01933399|3599354|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3766709|NCT01933399|3599355|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3766710|NCT01933399|3599356|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3766711|NCT01933399|3599357|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3766712|NCT01933399|3599354|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766713|NCT01933399|3599355|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766714|NCT01933399|3599356|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766715|NCT01933399|3599357|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766716|NCT01933399|3599354|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766717|NCT01933399|3599355|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766718|NCT01933399|3599356|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766719|NCT01933399|3599357|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766720|NCT01933399|3599354|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766721|NCT01933399|3599355|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766722|NCT01933399|3599356|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766723|NCT01933399|3599357|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766724|NCT01933399|3599354|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766725|NCT01933399|3599355|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766726|NCT01933399|3599356|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766727|NCT01933399|3599357|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766728|NCT01933399|3599354|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3766729|NCT01933399|3599355|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3766730|NCT01933399|3599356|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3766731|NCT01933399|3599357|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3766732|NCT01933399|3599354|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766733|NCT01933399|3599355|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766734|NCT01933399|3599356|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766735|NCT01933399|3599357|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766736|NCT01933399|3599354|B4||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3766737|NCT01933399|3599355|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3766738|NCT01933399|3599356|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3766739|NCT01933399|3599357|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3766740|NCT01933399|3599354|B4||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3766741|NCT01933399|3599355|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3766742|NCT01933399|3599356|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3766743|NCT01933399|3599357|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3766744|NCT01933399|3599354|B4|Age||Age, Customized||years|Mean|48.4|48.4|Standard Deviation|15.3|15.3|||
3766745|NCT01933399|3599355|B3|Age||Age, Customized||years|Mean|50.4|50.4|Standard Deviation|14|14.0|||
3766746|NCT01933399|3599356|B2|Age||Age, Customized||years|Mean|48.8|48.8|Standard Deviation|15.6|15.6|||
3766747|NCT01933399|3599357|B1|Age||Age, Customized||years|Mean|45.0|45.0|Standard Deviation|16.6|16.6|||
3766748|NCT01933334|3599370|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3766749|NCT01933334|3599371|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3766750|NCT01933334|3599372|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3766751|NCT01933334|3599370|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3766752|NCT01933334|3599371|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3766753|NCT01933334|3599372|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3766754|NCT01933334|3599370|B3|||Age||years|Mean|50.6|50.6|Standard Deviation|12.27|12.27|||
3766755|NCT01933334|3599371|B2|||Age||years|Mean|51.9|51.9|Standard Deviation|12.52|12.52|||
3766756|NCT01933334|3599372|B1|||Age||years|Mean|49.3|49.3|Standard Deviation|12.08|12.08|||
3766757|NCT01933243|3599383|B3|||BMI||kg/m^2|Mean|19.2|19.2|Standard Deviation|2.1|2.1|||
3766758|NCT01933243|3599384|B2|||BMI||kg/m^2|Mean|18.8|18.8|Standard Deviation|2.1|2.1|||
3766759|NCT01933243|3599385|B1|||BMI||kg/m^2|Mean|19.6|19.6|Standard Deviation|2.0|2.0|||
3766760|NCT01933243|3599383|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766761|NCT01933243|3599384|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766762|NCT01933243|3599385|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766763|NCT01933243|3599383|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766764|NCT01933243|3599384|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766765|NCT01933243|3599385|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766766|NCT01933243|3599383|B3||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3766767|NCT01933243|3599384|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3766768|NCT01933243|3599385|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3766769|NCT01933243|3599383|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3766770|NCT01933243|3599384|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3766771|NCT01933243|3599385|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766772|NCT01933243|3599383|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766773|NCT01933243|3599384|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766774|NCT01933243|3599385|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766775|NCT01933243|3599383|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766776|NCT01933243|3599384|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766777|NCT01933243|3599385|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766778|NCT01933243|3599383|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766779|NCT01933243|3599384|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766780|NCT01933243|3599385|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766781|NCT01933243|3599383|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3766782|NCT01933243|3599384|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3766783|NCT01933243|3599385|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3766784|NCT01933243|3599383|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3766785|NCT01933243|3599384|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3766786|NCT01933243|3599385|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3766787|NCT01933243|3599383|B3|||Age||years|Mean|14.7|14.7|Standard Deviation|1.6|1.6|||
3766788|NCT01933243|3599384|B2|||Age||years|Mean|14.4|14.4|Standard Deviation|1.8|1.8|||
3766789|NCT01933243|3599385|B1|||Age||years|Mean|15.0|15.0|Standard Deviation|1.3|1.3|||
3766790|NCT01933230|3599396|B1|||temperature||degrees celsius|Mean|37.05|37.05|Standard Deviation|0.354|0.354|||
3766791|NCT01933230|3599396|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3766792|NCT01933230|3599396|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3766793|NCT01933230|3599396|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
3766794|NCT01933230|3599396|B1|||Age||years|Mean|62|62.0|Standard Deviation|2.83|2.83|||
3766795|NCT01933230|3599396|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3766796|NCT01933230|3599396|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3766797|NCT01933230|3599396|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3766798|NCT01933048|3599400|B3|United States||Region of Enrollment||participants|Number|1024|1024.0||||||
3766799|NCT01933048|3599401|B2|United States||Region of Enrollment||participants|Number|501|501.0||||||
3766800|NCT01933048|3599402|B1|United States||Region of Enrollment||participants|Number|523|523.0||||||
3766801|NCT01933048|3599400|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|202|202.0||||||
3766802|NCT01933048|3599401|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3766803|NCT01933048|3599402|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
3766804|NCT01933048|3599400|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766805|NCT01933048|3599401|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766806|NCT01933048|3599402|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766807|NCT01933048|3599400|B3||White|Race (NIH/OMB)||Participants|Count of Participants|679|679.0||||||
3766808|NCT01933048|3599401|B2||White|Race (NIH/OMB)||Participants|Count of Participants|347|347.0||||||
3766809|NCT01933048|3599402|B1||White|Race (NIH/OMB)||Participants|Count of Participants|332|332.0||||||
3766810|NCT01933048|3599400|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|143|143.0||||||
3766811|NCT01933048|3599401|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3766812|NCT01933048|3599402|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3766813|NCT01933048|3599400|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766814|NCT01933048|3599401|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766815|NCT01933048|3599402|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766816|NCT01933048|3599400|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766817|NCT01933048|3599401|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766818|NCT01933048|3599402|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766819|NCT01933048|3599400|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766820|NCT01933048|3599401|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766821|NCT01933048|3599402|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766822|NCT01933048|3599400|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766823|NCT01933048|3599401|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766824|NCT01933048|3599402|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766825|NCT01933048|3599400|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|820|820.0||||||
3766826|NCT01933048|3599401|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|400|400.0||||||
3766827|NCT01933048|3599402|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|420|420.0||||||
3766828|NCT01933048|3599400|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|204|204.0||||||
3766829|NCT01933048|3599401|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
3766830|NCT01933048|3599402|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
3766831|NCT01933048|3599400|B3||Male|Sex: Female, Male||Participants|Count of Participants|726|726.0||||||
3766832|NCT01933048|3599401|B2||Male|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
3766833|NCT01933048|3599402|B1||Male|Sex: Female, Male||Participants|Count of Participants|366|366.0||||||
3766834|NCT01933048|3599400|B3||Female|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
3766835|NCT01933048|3599401|B2||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3766836|NCT01933048|3599402|B1||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3766837|NCT01933048|3599400|B3|||Age||years|Median|29|29.0|Inter-Quartile Range|||25.0|37.0|
3766838|NCT01933048|3599401|B2|||Age||years|Median|28|28.0|Inter-Quartile Range|||24.0|36.0|
3766839|NCT01933048|3599402|B1|||Age||years|Median|30|30.0|Inter-Quartile Range|||26.0|38.0|
3766840|NCT01932970|3599416|B1|||Phosphorus|Data available for 135 participants|mg/dL|Mean|5.88|5.88|Standard Deviation|1.71|1.71|||
3766841|NCT01932970|3599416|B1|||Parathyroid Hormone|Data available for 140 participants|pg/mL|Mean|786.3|786.3|Standard Deviation|467.8|467.8|||
3766842|NCT01932970|3599416|B1|||Corrected Calcium|"When albumin was less than 4.0 g/dL, the calcium level was corrected according to the following formula:~Corrected calcium (cCa) (mg/dL) = total Ca (mg/dL) + (4 - albumin [g/dL]) * 0.8."|mg/dL|Mean|9.81|9.81|Standard Deviation|0.75|0.75|||
3766843|NCT01932970|3599416|B1|Not Hispanic/Latino||Ethnicity||participants|Number|108|108.0||||||
3766844|NCT01932970|3599416|B1|Hispanic/Latino||Ethnicity||participants|Number|39|39.0||||||
3766845|NCT01932970|3599416|B1|White||Race||participants|Number|64|64.0||||||
3766846|NCT01932970|3599416|B1|Native Hawaiian or Other Pacific Islander||Race||participants|Number|2|2.0||||||
3766847|NCT01932970|3599416|B1|Black (or African American)||Race||participants|Number|68|68.0||||||
3766848|NCT01932970|3599416|B1|Asian||Race||participants|Number|12|12.0||||||
3766849|NCT01932970|3599416|B1|American Indian or Alaska Native||Race||participants|Number|1|1.0||||||
3766850|NCT01932970|3599416|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3766851|NCT01932970|3599416|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3766852|NCT01932970|3599416|B1|≥ 65 years||Age, Customized||participants|Number|41|41.0||||||
3766853|NCT01932970|3599416|B1|< 65 years||Age, Customized||participants|Number|106|106.0||||||
3766854|NCT01932970|3599416|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|14.0|14.0|||
3766855|NCT01932788|3599424|B3|United States||Region of Enrollment||participants|Number|253|253.0||||||
3766856|NCT01932788|3599425|B2|United States||Region of Enrollment||participants|Number|118|118.0||||||
3766857|NCT01932788|3599426|B1|United States||Region of Enrollment||participants|Number|135|135.0||||||
3766858|NCT01932788|3599424|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766859|NCT01932788|3599425|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766860|NCT01932788|3599426|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766861|NCT01932788|3599424|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|174|174.0||||||
3766862|NCT01932788|3599425|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3766863|NCT01932788|3599426|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3766864|NCT01932788|3599424|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3766865|NCT01932788|3599425|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3766866|NCT01932788|3599426|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3766867|NCT01932788|3599424|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3766868|NCT01932788|3599425|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3766869|NCT01932788|3599426|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3766870|NCT01932788|3599424|B3||Female|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
3766871|NCT01932788|3599425|B2||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3766872|NCT01932788|3599426|B1||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3766873|NCT01932788|3599424|B3|||Age||years|Mean|28.9|28.9|Standard Deviation|4.8|4.8|||
3766874|NCT01932788|3599425|B2|||Age||years|Mean|28.6|28.6|Standard Deviation|5.1|5.1|||
3766875|NCT01932788|3599426|B1|||Age||years|Mean|29.1|29.1|Standard Deviation|4.6|4.6|||
3766876|NCT01932762|3599433|B5||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3766877|NCT01932762|3599434|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3766878|NCT01932762|3599435|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3766879|NCT01932762|3599436|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3766880|NCT01932762|3599437|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3766881|NCT01932762|3599433|B5||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3766882|NCT01932762|3599434|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3766883|NCT01932762|3599435|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3766884|NCT01932762|3599436|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3766885|NCT01932762|3599437|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3766886|NCT01932762|3599433|B5|||Age||years|Mean|49.6|49.6|Standard Deviation|13.0|13.0|||
3766887|NCT01932762|3599434|B4|||Age||years|Mean|52.8|52.8|Standard Deviation|12.3|12.3|||
3766888|NCT01932762|3599435|B3|||Age||years|Mean|52.2|52.2|Standard Deviation|9.3|9.3|||
3766889|NCT01932762|3599436|B2|||Age||years|Mean|48.3|48.3|Standard Deviation|14.6|14.6|||
3766890|NCT01932762|3599437|B1|||Age||years|Mean|47.3|47.3|Standard Deviation|13.6|13.6|||
3766891|NCT01932606|3599474|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
3766892|NCT01932606|3599475|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3766893|NCT01932606|3599476|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3766894|NCT01932606|3599474|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3766895|NCT01932606|3599475|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3766896|NCT01932606|3599476|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3766897|NCT01932606|3599474|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3766898|NCT01932606|3599475|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3766899|NCT01932606|3599476|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3766900|NCT01932606|3599474|B3|||Age||years|Mean|69|69.0|Standard Deviation|8|8.0|||
3766901|NCT01932606|3599475|B2|||Age||years|Mean|70|70.0|Standard Deviation|8|8.0|||
3766902|NCT01932606|3599476|B1|||Age||years|Mean|69|69.0|Standard Deviation|6|6.0|||
3766903|NCT01932294|3599527|B1|United States||Region of Enrollment||participants|Number|171|171.0||||||
3766904|NCT01932294|3599527|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3766905|NCT01932294|3599527|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766906|NCT01932294|3599527|B1||White|Race (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
3766907|NCT01932294|3599527|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3766908|NCT01932294|3599527|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766909|NCT01932294|3599527|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766910|NCT01932294|3599527|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766911|NCT01932294|3599527|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3766912|NCT01932294|3599527|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|160|160.0||||||
3766913|NCT01932294|3599527|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3766914|NCT01932294|3599527|B1||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3766915|NCT01932294|3599527|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3766916|NCT01932294|3599527|B1|||Age||years|Mean|59.03|59.03|Standard Deviation|10.95|10.95|||
3766917|NCT01932294|3599527|B1||>=65 years|Age||Participants|Count of Participants|117|117.0||||||
3766918|NCT01932294|3599527|B1||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
3766919|NCT01932294|3599527|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3766920|NCT01932164|3599533|B1|Brazil||Region of Enrollment||participants|Number|5|5.0||||||
3766921|NCT01932164|3599533|B1||Male|Sex: Female, Male|3 female and 2 male children with cleft lip and palate were submited to bone tissue engineering alveolar bone graft.|Participants|Count of Participants|2|2.0||||||
3766922|NCT01932164|3599533|B1||Female|Sex: Female, Male|3 female and 2 male children with cleft lip and palate were submited to bone tissue engineering alveolar bone graft.|Participants|Count of Participants|3|3.0||||||
3766923|NCT01932164|3599533|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3766924|NCT01932164|3599533|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3766925|NCT01932164|3599533|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3766926|NCT01932112|3599538|B1|Korea, Republic of||Region of Enrollment||participants|Number|378|378.0||||||
3766927|NCT01932112|3599538|B1||Male|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
3766928|NCT01932112|3599538|B1||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3766929|NCT01932112|3599538|B1|||Age||years|Mean|60|60.0|Standard Deviation|11|11.0|||
3766930|NCT01932060|3599542|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
3766931|NCT01932060|3599543|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
3766932|NCT01932060|3599544|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3766933|NCT01932060|3599542|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3766934|NCT01932060|3599543|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3766935|NCT01932060|3599544|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3766936|NCT01932060|3599542|B3||Female|Gender||Participants|Count of Participants|51|51.0||||||
3766937|NCT01932060|3599543|B2||Female|Gender||Participants|Count of Participants|24|24.0||||||
3766938|NCT01932060|3599544|B1||Female|Gender||Participants|Count of Participants|27|27.0||||||
3766939|NCT01932060|3599542|B3|||Age||years|Mean|33|33.0|Standard Deviation|6|6.0|||
3766940|NCT01932060|3599543|B2|||Age||years|Mean|32|32.0|Standard Deviation|5|5.0|||
3766941|NCT01932060|3599544|B1|||Age||years|Mean|34|34.0|Standard Deviation|6|6.0|||
3766942|NCT01931956|3599553|B5|United States||Region of Enrollment||participants|Number|66|66.0||||||
3766943|NCT01931956|3599554|B4|United States||Region of Enrollment||participants|Number|271|271.0||||||
3766944|NCT01931956|3599555|B3|United States||Region of Enrollment||participants|Number|628|628.0||||||
3766945|NCT01931956|3599556|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3766946|NCT01931956|3599557|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
3766947|NCT01931956|3599553|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3766948|NCT01931956|3599554|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3766949|NCT01931956|3599555|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3766950|NCT01931956|3599556|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766951|NCT01931956|3599557|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3766952|NCT01931956|3599553|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766953|NCT01931956|3599554|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766954|NCT01931956|3599555|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766955|NCT01931956|3599556|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766956|NCT01931956|3599557|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766957|NCT01931956|3599553|B5||White|Race (NIH/OMB)||Participants|Count of Participants|869|869.0||||||
3766958|NCT01931956|3599554|B4||White|Race (NIH/OMB)||Participants|Count of Participants|246|246.0||||||
3766959|NCT01931956|3599555|B3||White|Race (NIH/OMB)||Participants|Count of Participants|563|563.0||||||
3766960|NCT01931956|3599556|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3766961|NCT01931956|3599557|B1||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3766962|NCT01931956|3599553|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3766963|NCT01931956|3599554|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3766964|NCT01931956|3599555|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3766965|NCT01931956|3599556|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3766966|NCT01931956|3599557|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3766967|NCT01931956|3599553|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766968|NCT01931956|3599554|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766969|NCT01931956|3599555|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766970|NCT01931956|3599556|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766971|NCT01931956|3599557|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766972|NCT01931956|3599553|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3766973|NCT01931956|3599554|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3766974|NCT01931956|3599555|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3766975|NCT01931956|3599556|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766976|NCT01931956|3599557|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3766977|NCT01931956|3599553|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3766978|NCT01931956|3599554|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3766979|NCT01931956|3599555|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3766980|NCT01931956|3599556|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766981|NCT01931956|3599557|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766982|NCT01931956|3599553|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766983|NCT01931956|3599554|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766984|NCT01931956|3599555|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766985|NCT01931956|3599556|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766986|NCT01931956|3599557|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766987|NCT01931956|3599553|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|919|919.0||||||
3766988|NCT01931956|3599554|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|262|262.0||||||
3766989|NCT01931956|3599555|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|594|594.0||||||
3766990|NCT01931956|3599556|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3766991|NCT01931956|3599557|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3766992|NCT01931956|3599553|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3766993|NCT01931956|3599554|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3766994|NCT01931956|3599555|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3766995|NCT01931956|3599556|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3766996|NCT01931956|3599557|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3766997|NCT01931956|3599553|B5||Male|Sex: Female, Male||Participants|Count of Participants|565|565.0||||||
3766998|NCT01931956|3599554|B4||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3766999|NCT01931956|3599555|B3||Male|Sex: Female, Male||Participants|Count of Participants|375|375.0||||||
3767000|NCT01931956|3599556|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3767001|NCT01931956|3599557|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3767002|NCT01931956|3599553|B5||Female|Sex: Female, Male||Participants|Count of Participants|400|400.0||||||
3767003|NCT01931956|3599554|B4||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3767004|NCT01931956|3599555|B3||Female|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
3767005|NCT01931956|3599556|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3767006|NCT01931956|3599557|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3767007|NCT01931956|3599553|B5|||Age||years|Mean|75.5|75.5|Standard Deviation|9.4|9.4|||
3767008|NCT01931956|3599554|B4|||Age||years|Mean|73.9|73.9|Standard Deviation|11.2|11.2|||
3767009|NCT01931956|3599555|B3|||Age||years|Mean|76.7|76.7|Standard Deviation|10.7|10.7|||
3767010|NCT01931956|3599556|B2|||Age||years|Mean|78.6|78.6|Standard Deviation|11.1|11.1|||
3767011|NCT01931956|3599557|B1|||Age||years|Mean|75.2|75.2|Standard Deviation|9.2|9.2|||
3767012|NCT01931956|3599553|B5||>=65 years|Age||Participants|Count of Participants|840|840.0||||||
3767013|NCT01931956|3599554|B4||>=65 years|Age||Participants|Count of Participants|230|230.0||||||
3767014|NCT01931956|3599555|B3||>=65 years|Age||Participants|Count of Participants|553|553.0||||||
3767015|NCT01931956|3599556|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3767016|NCT01931956|3599557|B1||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
3767017|NCT01931956|3599553|B5||Between 18 and 65 years|Age||Participants|Count of Participants|125|125.0||||||
3767018|NCT01931956|3599554|B4||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3767019|NCT01931956|3599555|B3||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
3767020|NCT01931956|3599556|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3767021|NCT01931956|3599557|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3767022|NCT01931956|3599553|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3767023|NCT01931956|3599554|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3767024|NCT01931956|3599555|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3767025|NCT01931956|3599556|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3767026|NCT01931956|3599557|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3767027|NCT01931878|3599916|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3767028|NCT01931878|3599916|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3767029|NCT01931878|3599916|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3767030|NCT01931878|3599916|B1|||Age||years|Mean|60.71|60.71|Standard Deviation|12.36|12.36|||
3767031|NCT01931878|3599916|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3767032|NCT01931878|3599916|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3767033|NCT01931878|3599916|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3767034|NCT01931865|3599927|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3767035|NCT01931865|3599927|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3767036|NCT01931865|3599927|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3767037|NCT01931865|3599927|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3767038|NCT01931865|3599927|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3767039|NCT01931865|3599927|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3767040|NCT01931839|3599933|B8||Male|Sex: Female, Male||Participants|Count of Participants|590|590.0||||||
3767041|NCT01931839|3599934|B7||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3767042|NCT01931839|3599935|B6||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3767043|NCT01931839|3599936|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3767044|NCT01931839|3599937|B4||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3767045|NCT01931839|3599938|B3||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
3767046|NCT01931839|3599939|B2||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3767047|NCT01931839|3599940|B1||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3767048|NCT01931839|3599933|B8||Female|Sex: Female, Male||Participants|Count of Participants|573|573.0||||||
3767049|NCT01931839|3599934|B7||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3767050|NCT01931839|3599935|B6||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3767051|NCT01931839|3599936|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3767052|NCT01931839|3599937|B4||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3767053|NCT01931839|3599938|B3||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3767054|NCT01931839|3599939|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3767055|NCT01931839|3599940|B1||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3767056|NCT01931839|3599933|B8|Greater than or equal to 18 years||Age, Customized||Participants|Count of Participants|880|880.0||||||
3767057|NCT01931839|3599934|B7|Greater than or equal to 18 years||Age, Customized||Participants|Count of Participants|60|60.0||||||
3767058|NCT01931839|3599935|B6|Greater than or equal to 18 years||Age, Customized||Participants|Count of Participants|55|55.0||||||
3767059|NCT01931839|3599936|B5|Greater than or equal to 18 years||Age, Customized||Participants|Count of Participants|17|17.0||||||
3767060|NCT01931839|3599937|B4|Greater than or equal to 18 years||Age, Customized||Participants|Count of Participants|129|129.0||||||
3767061|NCT01931839|3599938|B3|Greater than or equal to 18 years||Age, Customized||Participants|Count of Participants|246|246.0||||||
3767062|NCT01931839|3599939|B2|Greater than or equal to 18 years||Age, Customized||Participants|Count of Participants|131|131.0||||||
3767063|NCT01931839|3599940|B1|Greater than or equal to 18 years||Age, Customized||Participants|Count of Participants|242|242.0||||||
3767064|NCT01931839|3599933|B8|12 years to less than 18 years||Age, Customized||Participants|Count of Participants|283|283.0||||||
3767065|NCT01931839|3599934|B7|12 years to less than 18 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3767066|NCT01931839|3599935|B6|12 years to less than 18 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3767067|NCT01931839|3599936|B5|12 years to less than 18 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
3767068|NCT01931839|3599937|B4|12 years to less than 18 years||Age, Customized||Participants|Count of Participants|47|47.0||||||
3767069|NCT01931839|3599938|B3|12 years to less than 18 years||Age, Customized||Participants|Count of Participants|94|94.0||||||
3767070|NCT01931839|3599939|B2|12 years to less than 18 years||Age, Customized||Participants|Count of Participants|47|47.0||||||
3767071|NCT01931839|3599940|B1|12 years to less than 18 years||Age, Customized||Participants|Count of Participants|93|93.0||||||
3767072|NCT01931735|3600014|B5|||KOOS Pain Score|Knee injury and Osteoarthritis Outcome Score (KOOS) is a standardized and validated survey used to evaluate the condition of osteoarthritis of the knee. The KOOS Pain scale consists of 9 questions, with each response valued on an ordinal scale of 0-4, and with at total score of 36. Higher numbers indicate more symptoms and physical disabilities. The score is then transformed into a percentage, where 0% is the worst pain and 100% is no pain.|units on a scale|Mean|40.7|40.7|Standard Deviation|14.8|14.8|||
3767073|NCT01931735|3600015|B4|||KOOS Pain Score|Knee injury and Osteoarthritis Outcome Score (KOOS) is a standardized and validated survey used to evaluate the condition of osteoarthritis of the knee. The KOOS Pain scale consists of 9 questions, with each response valued on an ordinal scale of 0-4, and with at total score of 36. Higher numbers indicate more symptoms and physical disabilities. The score is then transformed into a percentage, where 0% is the worst pain and 100% is no pain.|units on a scale|Mean|42.9|42.9|Standard Deviation|17.9|17.9|||
3767074|NCT01931735|3600016|B3|||KOOS Pain Score|Knee injury and Osteoarthritis Outcome Score (KOOS) is a standardized and validated survey used to evaluate the condition of osteoarthritis of the knee. The KOOS Pain scale consists of 9 questions, with each response valued on an ordinal scale of 0-4, and with at total score of 36. Higher numbers indicate more symptoms and physical disabilities. The score is then transformed into a percentage, where 0% is the worst pain and 100% is no pain.|units on a scale|Mean|40.1|40.1|Standard Deviation|12.7|12.7|||
3767075|NCT01931735|3600017|B2|||KOOS Pain Score|Knee injury and Osteoarthritis Outcome Score (KOOS) is a standardized and validated survey used to evaluate the condition of osteoarthritis of the knee. The KOOS Pain scale consists of 9 questions, with each response valued on an ordinal scale of 0-4, and with at total score of 36. Higher numbers indicate more symptoms and physical disabilities. The score is then transformed into a percentage, where 0% is the worst pain and 100% is no pain.|units on a scale|Mean|47.2|47.2|Standard Deviation|11.78|11.78|||
3767076|NCT01931735|3600018|B1|||KOOS Pain Score|Knee injury and Osteoarthritis Outcome Score (KOOS) is a standardized and validated survey used to evaluate the condition of osteoarthritis of the knee. The KOOS Pain scale consists of 9 questions, with each response valued on an ordinal scale of 0-4, and with at total score of 36. Higher numbers indicate more symptoms and physical disabilities. The score is then transformed into a percentage, where 0% is the worst pain and 100% is no pain.|units on a scale|Mean|29.6|29.6|Standard Deviation|8.5|8.5|||
3767077|NCT01931735|3600014|B5|||Total WOMET Score|Western Ontario Meniscal Evaluation Tool (WOMET) is a standardized and validated survey used to evaluate the pain and function of patients with a degenerative meniscal tear. The survey consists of 16 questions regarding physical symptoms, sports/recreation/work/lifestyle, and emotions. Each question is answered via a visual analog scale (VAS) of 0-100mm for a total score of 1600, where higher numbers are worse. The score is then transformed into a percentage, where 0 is the worst pain and functioning and 100% is no pain and fully functioning.|units on a scale|Mean|34.2|34.2|Standard Deviation|20.2|20.2|||
3767078|NCT01931735|3600015|B4|||Total WOMET Score|Western Ontario Meniscal Evaluation Tool (WOMET) is a standardized and validated survey used to evaluate the pain and function of patients with a degenerative meniscal tear. The survey consists of 16 questions regarding physical symptoms, sports/recreation/work/lifestyle, and emotions. Each question is answered via a visual analog scale (VAS) of 0-100mm for a total score of 1600, where higher numbers are worse. The score is then transformed into a percentage, where 0 is the worst pain and functioning and 100% is no pain and fully functioning.|units on a scale|Mean|33.1|33.1|Standard Deviation|22.5|22.5|||
3767079|NCT01931735|3600016|B3|||Total WOMET Score|Western Ontario Meniscal Evaluation Tool (WOMET) is a standardized and validated survey used to evaluate the pain and function of patients with a degenerative meniscal tear. The survey consists of 16 questions regarding physical symptoms, sports/recreation/work/lifestyle, and emotions. Each question is answered via a visual analog scale (VAS) of 0-100mm for a total score of 1600, where higher numbers are worse. The score is then transformed into a percentage, where 0 is the worst pain and functioning and 100% is no pain and fully functioning.|units on a scale|Mean|27.5|27.5|Standard Deviation|12.2|12.2|||
3767080|NCT01931735|3600017|B2|||Total WOMET Score|Western Ontario Meniscal Evaluation Tool (WOMET) is a standardized and validated survey used to evaluate the pain and function of patients with a degenerative meniscal tear. The survey consists of 16 questions regarding physical symptoms, sports/recreation/work/lifestyle, and emotions. Each question is answered via a visual analog scale (VAS) of 0-100mm for a total score of 1600, where higher numbers are worse. The score is then transformed into a percentage, where 0 is the worst pain and functioning and 100% is no pain and fully functioning.|units on a scale|Mean|45.2|45.2|Standard Deviation|9.1|9.1|||
3767081|NCT01931735|3600018|B1|||Total WOMET Score|Western Ontario Meniscal Evaluation Tool (WOMET) is a standardized and validated survey used to evaluate the pain and function of patients with a degenerative meniscal tear. The survey consists of 16 questions regarding physical symptoms, sports/recreation/work/lifestyle, and emotions. Each question is answered via a visual analog scale (VAS) of 0-100mm for a total score of 1600, where higher numbers are worse. The score is then transformed into a percentage, where 0 is the worst pain and functioning and 100% is no pain and fully functioning.|units on a scale|Mean|44.8|44.8|Standard Deviation|31.5|31.5|||
3767082|NCT01931735|3600014|B5|United States||Region of Enrollment||participants|Number|27|27.0||||||
3767083|NCT01931735|3600015|B4|United States||Region of Enrollment||participants|Number|11|11.0||||||
3767084|NCT01931735|3600016|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
3767085|NCT01931735|3600017|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3767086|NCT01931735|3600018|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3767087|NCT01931735|3600014|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3767088|NCT01931735|3600015|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3767089|NCT01931735|3600016|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3767090|NCT01931735|3600017|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3767091|NCT01931735|3600018|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3767092|NCT01931735|3600014|B5|African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3767093|NCT01931735|3600015|B4|African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3767094|NCT01931735|3600016|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3767095|NCT01931735|3600017|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3767096|NCT01931735|3600018|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3767097|NCT01931735|3600014|B5|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3767098|NCT01931735|3600015|B4|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3767099|NCT01931735|3600016|B3|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3767100|NCT01931735|3600017|B2|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3767101|NCT01931735|3600018|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3767102|NCT01931735|3600014|B5|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3767103|NCT01931735|3600015|B4|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3767104|NCT01931735|3600016|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3767105|NCT01931735|3600017|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3767106|NCT01931735|3600018|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3767107|NCT01931735|3600014|B5|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3767108|NCT01931735|3600015|B4|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3767109|NCT01931735|3600016|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3767110|NCT01931735|3600017|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3767111|NCT01931735|3600018|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3767112|NCT01931735|3600014|B5||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3767113|NCT01931735|3600015|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3767114|NCT01931735|3600016|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3767115|NCT01931735|3600017|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3767116|NCT01931735|3600018|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3767117|NCT01931735|3600014|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3767118|NCT01931735|3600015|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3767119|NCT01931735|3600016|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3767120|NCT01931735|3600017|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3767121|NCT01931735|3600018|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3767122|NCT01931735|3600014|B5|||Age||years|Mean|55.3|55.3|Standard Deviation|8.7|8.7|||
3767123|NCT01931735|3600015|B4|||Age||years|Mean|54.5|54.5|Standard Deviation|10.8|10.8|||
3767124|NCT01931735|3600016|B3|||Age||years|Mean|55.6|55.6|Standard Deviation|7.7|7.7|||
3767125|NCT01931735|3600017|B2|||Age||years|Mean|54.3|54.3|Standard Deviation|3.5|3.5|||
3767126|NCT01931735|3600018|B1|||Age||years|Mean|57.8|57.8|Standard Deviation|9.5|9.5|||
3767127|NCT01931709|3600055|B1||IIIC|Clinical stage||Participants|Count of Participants|6|6.0||||||
3767128|NCT01931709|3600055|B1||IIIB|Clinical stage||Participants|Count of Participants|3|3.0||||||
3767129|NCT01931709|3600055|B1||IIIA|Clinical stage||Participants|Count of Participants|9|9.0||||||
3767130|NCT01931709|3600055|B1||IIB|Clinical stage||Participants|Count of Participants|8|8.0||||||
3767131|NCT01931709|3600055|B1||IIA|Clinical stage||Participants|Count of Participants|9|9.0||||||
3767132|NCT01931709|3600055|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767133|NCT01931709|3600055|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767134|NCT01931709|3600055|B1||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3767135|NCT01931709|3600055|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767136|NCT01931709|3600055|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767137|NCT01931709|3600055|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3767138|NCT01931709|3600055|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767139|NCT01931709|3600055|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767140|NCT01931709|3600055|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3767141|NCT01931709|3600055|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3767142|NCT01931709|3600055|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3767143|NCT01931709|3600055|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3767144|NCT01931709|3600055|B1|||Age||years|Median|43|43.0|Full Range|||31.0|66.0|
3767145|NCT01931670|3600065|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3767146|NCT01931670|3600066|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3767147|NCT01931670|3600067|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3767148|NCT01931670|3600068|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3767149|NCT01931670|3600065|B4||Female|Sex: Female, Male||Participants|Count of Participants|815|815.0||||||
3767150|NCT01931670|3600066|B3||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
3767151|NCT01931670|3600067|B2||Female|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
3767152|NCT01931670|3600068|B1||Female|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
3767153|NCT01931670|3600065|B4|||Age||years|Mean|33.2|33.2|Standard Deviation|6.71|6.71|||
3767154|NCT01931670|3600066|B3|||Age||years|Mean|33.4|33.4|Standard Deviation|6.67|6.67|||
3767155|NCT01931670|3600067|B2|||Age||years|Mean|33.1|33.1|Standard Deviation|6.80|6.8|||
3767156|NCT01931670|3600068|B1|||Age||years|Mean|33.1|33.1|Standard Deviation|6.69|6.69|||
3767157|NCT01931527|3600168|B3|||Plasma uric acid concentration||mg/dL|Mean|5.7|5.7|Standard Deviation|1.7|1.7|||
3767158|NCT01931527|3600169|B2|||Plasma uric acid concentration||mg/dL|Mean|7.1|7.1|Standard Deviation|1.6|1.6|||
3767159|NCT01931527|3600170|B1|||Plasma uric acid concentration||mg/dL|Mean|4.5|4.5|Standard Deviation|0.2|0.2|||
3767160|NCT01931527|3600168|B3|||Body mass index||kg/m2|Mean|37.1|37.1|Standard Deviation|4.1|4.1|||
3767161|NCT01931527|3600169|B2|||Body mass index||kg/m2|Mean|38.3|38.3|Standard Deviation|4.8|4.8|||
3767162|NCT01931527|3600170|B1|||Body mass index||kg/m2|Mean|35.9|35.9|Standard Deviation|3.2|3.2|||
3767163|NCT01931527|3600168|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
3767164|NCT01931527|3600169|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3767165|NCT01931527|3600170|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3767166|NCT01931527|3600168|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3767167|NCT01931527|3600169|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3767168|NCT01931527|3600170|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3767169|NCT01931527|3600168|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3767170|NCT01931527|3600169|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3767171|NCT01931527|3600170|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3767172|NCT01931527|3600168|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3767173|NCT01931527|3600169|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3767174|NCT01931527|3600170|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3767175|NCT01931527|3600168|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3767176|NCT01931527|3600169|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3767177|NCT01931527|3600170|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3767178|NCT01931527|3600168|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3767179|NCT01931527|3600169|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3767180|NCT01931527|3600170|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3767181|NCT01931475|3600191|B3|China||Region of Enrollment||participants|Number|407|407.0||||||
3767182|NCT01931475|3600192|B2|China||Region of Enrollment||participants|Number|202|202.0||||||
3767183|NCT01931475|3600193|B1|China||Region of Enrollment||participants|Number|205|205.0||||||
3767184|NCT01931475|3600191|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767185|NCT01931475|3600192|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767186|NCT01931475|3600193|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767187|NCT01931475|3600191|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767188|NCT01931475|3600192|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767189|NCT01931475|3600193|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767190|NCT01931475|3600191|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767191|NCT01931475|3600192|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767192|NCT01931475|3600193|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767193|NCT01931475|3600191|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767194|NCT01931475|3600192|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767195|NCT01931475|3600193|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767196|NCT01931475|3600191|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767197|NCT01931475|3600192|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767198|NCT01931475|3600193|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767199|NCT01931475|3600191|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|407|407.0||||||
3767200|NCT01931475|3600192|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|202|202.0||||||
3767201|NCT01931475|3600193|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|205|205.0||||||
3767202|NCT01931475|3600191|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767203|NCT01931475|3600192|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767204|NCT01931475|3600193|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767205|NCT01931475|3600191|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3767206|NCT01931475|3600192|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3767207|NCT01931475|3600193|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3767208|NCT01931475|3600191|B3||Female|Sex: Female, Male||Participants|Count of Participants|311|311.0||||||
3767209|NCT01931475|3600192|B2||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3767210|NCT01931475|3600193|B1||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3767211|NCT01931475|3600191|B3|||Age||years|Mean|61.14|61.14|Standard Deviation|8.31|8.31|||
3767212|NCT01931475|3600192|B2|||Age||years|Mean|59.83|59.83|Standard Deviation|8.40|8.4|||
3767213|NCT01931475|3600193|B1|||Age||years|Mean|61.17|61.17|Standard Deviation|8.19|8.19|||
3767214|NCT01931462|3600221|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3767215|NCT01931462|3600221|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767216|NCT01931462|3600221|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767217|NCT01931462|3600221|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3767218|NCT01931462|3600221|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767219|NCT01931462|3600221|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767220|NCT01931462|3600221|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767221|NCT01931462|3600221|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767222|NCT01931462|3600221|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3767223|NCT01931462|3600221|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3767224|NCT01931462|3600221|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3767225|NCT01931462|3600221|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3767226|NCT01931462|3600221|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3767227|NCT01931397|3600232|B1|||Number of years post kidney transplantation||years|Mean|5.93|5.93|Standard Deviation|4.57|4.57|||
3767228|NCT01931397|3600232|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3767229|NCT01931397|3600232|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767230|NCT01931397|3600232|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3767231|NCT01931397|3600232|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3767232|NCT01931397|3600232|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3767233|NCT01931397|3600232|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767234|NCT01931397|3600232|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3767235|NCT01931397|3600232|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767236|NCT01931397|3600232|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767237|NCT01931397|3600232|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3767238|NCT01931397|3600232|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3767239|NCT01931397|3600232|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3767240|NCT01931397|3600232|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3767241|NCT01931397|3600232|B1|||Age|Age (years) at time of enrollment|years|Mean|13.6|13.6|Standard Deviation|5.4|5.4|||
3767242|NCT01931150|3600241|B3||Male|Gender||Participants|Count of Participants|9|9.0||||||
3767243|NCT01931150|3600242|B2||Male|Gender||Participants|Count of Participants|4|4.0||||||
3767244|NCT01931150|3600243|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
3767245|NCT01931150|3600241|B3||Female|Gender||Participants|Count of Participants|2|2.0||||||
3767246|NCT01931150|3600242|B2||Female|Gender||Participants|Count of Participants|2|2.0||||||
3767247|NCT01931150|3600243|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3767248|NCT01931150|3600241|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3767249|NCT01931150|3600242|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3767250|NCT01931150|3600243|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3767251|NCT01931150|3600241|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3767252|NCT01931150|3600242|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3767253|NCT01931150|3600243|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3767254|NCT01931150|3600241|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3767255|NCT01931150|3600242|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3767256|NCT01931150|3600243|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3767257|NCT01931059|3600250|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3767258|NCT01931059|3600251|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3767259|NCT01931059|3600252|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3767260|NCT01931059|3600250|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3767261|NCT01931059|3600251|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3767262|NCT01931059|3600252|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3767263|NCT01931059|3600250|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3767264|NCT01931059|3600251|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3767265|NCT01931059|3600252|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3767266|NCT01931059|3600250|B3|||Age||years|Mean|34.0|34.0|Standard Deviation|8.7|8.7|||
3767267|NCT01931059|3600251|B2|||Age||years|Mean|37.5|37.5|Standard Deviation|10.4|10.4|||
3767268|NCT01931059|3600252|B1|||Age||years|Mean|31.7|31.7|Standard Deviation|7.4|7.4|||
3767269|NCT01931059|3600250|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3767270|NCT01931059|3600251|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3767271|NCT01931059|3600252|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3767272|NCT01931059|3600250|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3767273|NCT01931059|3600251|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3767274|NCT01931059|3600252|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3767275|NCT01931059|3600250|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3767276|NCT01931059|3600251|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3767277|NCT01931059|3600252|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3767278|NCT01930890|3600265|B5||Male|Gender||Participants|Count of Participants|12|12.0||||||
3767279|NCT01930890|3600266|B4||Male|Gender||Participants|Count of Participants|2|2.0||||||
3767280|NCT01930890|3600267|B3||Male|Gender||Participants|Count of Participants|3|3.0||||||
3767281|NCT01930890|3600268|B2||Male|Gender||Participants|Count of Participants|4|4.0||||||
3767282|NCT01930890|3600269|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
3767283|NCT01930890|3600265|B5||Female|Gender||Participants|Count of Participants|75|75.0||||||
3767284|NCT01930890|3600266|B4||Female|Gender||Participants|Count of Participants|25|25.0||||||
3767285|NCT01930890|3600267|B3||Female|Gender||Participants|Count of Participants|10|10.0||||||
3767286|NCT01930890|3600268|B2||Female|Gender||Participants|Count of Participants|29|29.0||||||
3767287|NCT01930890|3600269|B1||Female|Gender||Participants|Count of Participants|11|11.0||||||
3767288|NCT01930890|3600265|B5|> 55 years||Age, Customized||participants|Number|1|1.0||||||
3767289|NCT01930890|3600266|B4|> 55 years||Age, Customized||participants|Number|0|0.0||||||
3767290|NCT01930890|3600267|B3|> 55 years||Age, Customized||participants|Number|0|0.0||||||
3767291|NCT01930890|3600268|B2|> 55 years||Age, Customized||participants|Number|1|1.0||||||
3767292|NCT01930890|3600269|B1|> 55 years||Age, Customized||participants|Number|0|0.0||||||
3767293|NCT01930890|3600265|B5|50 to 55 years||Age, Customized||participants|Number|3|3.0||||||
3767294|NCT01930890|3600266|B4|50 to 55 years||Age, Customized||participants|Number|2|2.0||||||
3767295|NCT01930890|3600267|B3|50 to 55 years||Age, Customized||participants|Number|1|1.0||||||
3767296|NCT01930890|3600268|B2|50 to 55 years||Age, Customized||participants|Number|0|0.0||||||
3767297|NCT01930890|3600269|B1|50 to 55 years||Age, Customized||participants|Number|0|0.0||||||
3767298|NCT01930890|3600265|B5|40 to 49 years||Age, Customized||participants|Number|11|11.0||||||
3767299|NCT01930890|3600266|B4|40 to 49 years||Age, Customized||participants|Number|1|1.0||||||
3767300|NCT01930890|3600267|B3|40 to 49 years||Age, Customized||participants|Number|2|2.0||||||
3767301|NCT01930890|3600268|B2|40 to 49 years||Age, Customized||participants|Number|6|6.0||||||
3767302|NCT01930890|3600269|B1|40 to 49 years||Age, Customized||participants|Number|2|2.0||||||
3767303|NCT01930890|3600265|B5|30 to 39 years||Age, Customized||participants|Number|34|34.0||||||
3767304|NCT01930890|3600266|B4|30 to 39 years||Age, Customized||participants|Number|14|14.0||||||
3767305|NCT01930890|3600267|B3|30 to 39 years||Age, Customized||participants|Number|3|3.0||||||
3767306|NCT01930890|3600268|B2|30 to 39 years||Age, Customized||participants|Number|11|11.0||||||
3767307|NCT01930890|3600269|B1|30 to 39 years||Age, Customized||participants|Number|6|6.0||||||
3767308|NCT01930890|3600265|B5|20 to 29 years||Age, Customized||participants|Number|36|36.0||||||
3767309|NCT01930890|3600266|B4|20 to 29 years||Age, Customized||participants|Number|9|9.0||||||
3767310|NCT01930890|3600267|B3|20 to 29 years||Age, Customized||participants|Number|6|6.0||||||
3767311|NCT01930890|3600268|B2|20 to 29 years||Age, Customized||participants|Number|15|15.0||||||
3767312|NCT01930890|3600269|B1|20 to 29 years||Age, Customized||participants|Number|6|6.0||||||
3767313|NCT01930890|3600265|B5|18 to 19 years||Age, Customized||participants|Number|2|2.0||||||
3767314|NCT01930890|3600266|B4|18 to 19 years||Age, Customized||participants|Number|1|1.0||||||
3767315|NCT01930890|3600267|B3|18 to 19 years||Age, Customized||participants|Number|1|1.0||||||
3767316|NCT01930890|3600268|B2|18 to 19 years||Age, Customized||participants|Number|0|0.0||||||
3767317|NCT01930890|3600269|B1|18 to 19 years||Age, Customized||participants|Number|0|0.0||||||
3767318|NCT01930890|3600265|B5|||Age||years|Mean|32.1|32.1|Standard Deviation|8.76|8.76|||
3767319|NCT01930890|3600266|B4|||Age||years|Mean|32.2|32.2|Standard Deviation|8.23|8.23|||
3767320|NCT01930890|3600267|B3|||Age||years|Mean|31.5|31.5|Standard Deviation|10.06|10.06|||
3767321|NCT01930890|3600268|B2|||Age||years|Mean|32.6|32.6|Standard Deviation|8.93|8.93|||
3767322|NCT01930890|3600269|B1|||Age||years|Mean|31.3|31.3|Standard Deviation|8.96|8.96|||
3767323|NCT01930799|3600286|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3767324|NCT01930799|3600286|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3767325|NCT01930799|3600286|B1|||Age||Years|Mean|50.4|50.4|Standard Deviation|11.8|11.8|||
3767326|NCT01930487|3600291|B1|||Duration of OAG||years|Mean|15|15.0|Standard Deviation|8|8.0|||
3767327|NCT01930487|3600291|B1|left||Study Eye||participants|Number|18|18.0||||||
3767328|NCT01930487|3600291|B1|right||Study Eye||participants|Number|24|24.0||||||
3767329|NCT01930487|3600291|B1|no||Hypertension||participants|Number|26|26.0||||||
3767330|NCT01930487|3600291|B1|yes||Hypertension||participants|Number|16|16.0||||||
3767331|NCT01930487|3600291|B1|no||Diabetes (Type 2)||participants|Number|21|21.0||||||
3767332|NCT01930487|3600291|B1|yes||Diabetes (Type 2)||participants|Number|21|21.0||||||
3767333|NCT01930487|3600291|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
3767334|NCT01930487|3600291|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3767335|NCT01930487|3600291|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767336|NCT01930487|3600291|B1||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3767337|NCT01930487|3600291|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3767338|NCT01930487|3600291|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767339|NCT01930487|3600291|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767340|NCT01930487|3600291|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767341|NCT01930487|3600291|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3767342|NCT01930487|3600291|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3767343|NCT01930487|3600291|B1|||Age||years|Mean|67|67.0|Standard Deviation|11|11.0|||
3767344|NCT01930435|3600386|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3767345|NCT01930435|3600386|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3767346|NCT01930435|3600386|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3767347|NCT01930435|3600386|B1|||Age||years|Mean|62.2|62.2|Full Range|||35.0|76.0|
3767348|NCT01930435|3600386|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3767349|NCT01930435|3600386|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3767350|NCT01930435|3600386|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3767351|NCT01930162|3600394|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3767352|NCT01930162|3600394|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3767353|NCT01930162|3600394|B1|||Age||years|Mean|59.0|59.0|Standard Deviation|13.16|13.16|||
3767354|NCT01930058|3600403|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3767355|NCT01930058|3600404|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3767356|NCT01930058|3600405|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3767357|NCT01930058|3600406|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3767358|NCT01930058|3600403|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3767359|NCT01930058|3600404|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3767360|NCT01930058|3600405|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3767361|NCT01930058|3600406|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3767362|NCT01930058|3600403|B4|||Age||Years|Mean|42.2|42.2|Standard Deviation|10.8|10.8|||
3767363|NCT01930058|3600404|B3|||Age||Years|Mean|49.7|49.7|Standard Deviation|7.4|7.4|||
3767364|NCT01930058|3600405|B2|||Age||Years|Mean|45|45.0|Standard Deviation|12.5|12.5|||
3767365|NCT01930058|3600406|B1|||Age||Years|Mean|32|32.0|Standard Deviation|2.6|2.6|||
3767366|NCT01930045|3600430|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3767367|NCT01930045|3600430|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3767368|NCT01930045|3600430|B1|||Age||Years|Mean|48.7|48.7|Standard Deviation|9.0|9.0|||
3767369|NCT01929993|3600460|B3|Female||Sex/Gender, Customized||participants|Number|106|106.0||||||
3767370|NCT01929993|3600461|B2|Female||Sex/Gender, Customized||participants|Number|54|54.0||||||
3767371|NCT01929993|3600462|B1|Female||Sex/Gender, Customized||participants|Number|52|52.0||||||
3767372|NCT01929993|3600460|B3|||Age||years|Mean|43.1|43.1|Standard Deviation|12.0|12.0|||
3767373|NCT01929993|3600461|B2|||Age||years|Mean|42.3|42.3|Standard Deviation|10.7|10.7|||
3767374|NCT01929993|3600462|B1|||Age||years|Mean|44|44.0|Standard Deviation|13.3|13.3|||
3767375|NCT01929980|3600469|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3767376|NCT01929980|3600469|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3767377|NCT01929980|3600469|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3767378|NCT01929980|3600469|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3767379|NCT01929980|3600469|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3767380|NCT01929889|3600473|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3767381|NCT01929889|3600473|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3767382|NCT01929889|3600473|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3767383|NCT01929889|3600473|B1|||Age||years|Mean|28|28.0|Standard Deviation|10.42|10.42|||
3767384|NCT01929889|3600473|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3767385|NCT01929889|3600473|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3767386|NCT01929889|3600473|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3767387|NCT01929876|3600477|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3767388|NCT01929876|3600477|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3767389|NCT01929876|3600477|B1|||Age||years|Mean|38|38.0|Standard Deviation|9.9|9.9|||
3767390|NCT01929863|3600490|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767391|NCT01929863|3600490|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3767392|NCT01929863|3600490|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3767393|NCT01929863|3600490|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3767394|NCT01929863|3600490|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767395|NCT01929863|3600490|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767396|NCT01929863|3600490|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767397|NCT01929863|3600490|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3767398|NCT01929863|3600490|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3767399|NCT01929863|3600490|B1|||Age||Years|Mean|54.9|54.9|Standard Deviation|7.06|7.06|||
3767400|NCT01929759|3600534|B1|Anterior cingulate GABA||Baseline measures for Neurometabolites Based on MRS|The arbitrary units are expressed as the output from MRS software. While similar to concentration (mM) due to assumptions in the software, it is best expressed as arbitrary units for comparison from baseline to the second time point.|arbitrary units|Mean|4.21|4.21|Standard Deviation|1.18|1.18|||
3767401|NCT01929759|3600534|B1|Anterior cingulate glutamate||Baseline measures for Neurometabolites Based on MRS|The arbitrary units are expressed as the output from MRS software. While similar to concentration (mM) due to assumptions in the software, it is best expressed as arbitrary units for comparison from baseline to the second time point.|arbitrary units|Mean|19.16|19.16|Standard Deviation|3.11|3.11|||
3767402|NCT01929759|3600534|B1|Anterior cingulate creatine||Baseline measures for Neurometabolites Based on MRS|The arbitrary units are expressed as the output from MRS software. While similar to concentration (mM) due to assumptions in the software, it is best expressed as arbitrary units for comparison from baseline to the second time point.|arbitrary units|Mean|14.06|14.06|Standard Deviation|2.44|2.44|||
3767403|NCT01929759|3600534|B1|Posterior cingulate GABA||Baseline measures for Neurometabolites Based on MRS|The arbitrary units are expressed as the output from MRS software. While similar to concentration (mM) due to assumptions in the software, it is best expressed as arbitrary units for comparison from baseline to the second time point.|arbitrary units|Mean|4.99|4.99|Standard Deviation|1.29|1.29|||
3767404|NCT01929759|3600534|B1|Posterior cingulate glutamate||Baseline measures for Neurometabolites Based on MRS|The arbitrary units are expressed as the output from MRS software. While similar to concentration (mM) due to assumptions in the software, it is best expressed as arbitrary units for comparison from baseline to the second time point.|arbitrary units|Mean|25.36|25.36|Standard Deviation|3.73|3.73|||
3767405|NCT01929759|3600534|B1|Posterior cingulate creatine||Baseline measures for Neurometabolites Based on MRS|The arbitrary units are expressed as the output from MRS software. While similar to concentration (mM) due to assumptions in the software, it is best expressed as arbitrary units for comparison from baseline to the second time point.|arbitrary units|Mean|19.09|19.09|Standard Deviation|2.27|2.27|||
3767406|NCT01929759|3600534|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3767407|NCT01929759|3600534|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3767408|NCT01929759|3600534|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3767409|NCT01929759|3600534|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3767410|NCT01929759|3600534|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3767411|NCT01929759|3600534|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3767412|NCT01929707|3600546|B1|United States||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
3767413|NCT01929707|3600546|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767414|NCT01929707|3600546|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767415|NCT01929707|3600546|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3767416|NCT01929707|3600546|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3767417|NCT01929707|3600546|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767418|NCT01929707|3600546|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3767419|NCT01929707|3600546|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767420|NCT01929707|3600546|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767421|NCT01929707|3600546|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3767422|NCT01929707|3600546|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3767423|NCT01929707|3600546|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3767424|NCT01929707|3600546|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3767425|NCT01929707|3600546|B1|||Age||years|Mean|49.3|49.3|Standard Deviation|11.7|11.7|||
3767531|NCT01929109|3600718|B4|Yes||Type 2 Diabetes Mellitus (T2DM) status||Participants|Count of Participants|0|0.0||||||
3767532|NCT01929109|3600719|B3|Yes||Type 2 Diabetes Mellitus (T2DM) status||Participants|Count of Participants|0|0.0||||||
3767426|NCT01929681|3600583|B3|||Montgomery-Asberg Depression Rating Scale (MADRS)|The Montgomery-Asberg Depression Rating scale assesses 10 symptom areas of depression during an interview. Each of the 10 items received a score ranging from 0 to 6. The scale has a range of 0-60 for the reported total.|units on a scale|Mean|27.8|27.8|Standard Deviation|5.4|5.4|||
3767427|NCT01929681|3600584|B2|||Montgomery-Asberg Depression Rating Scale (MADRS)|The Montgomery-Asberg Depression Rating scale assesses 10 symptom areas of depression during an interview. Each of the 10 items received a score ranging from 0 to 6. The scale has a range of 0-60 for the reported total.|units on a scale|Mean|27.4|27.4|Standard Deviation|5.0|5.0|||
3767428|NCT01929681|3600585|B1|||Montgomery-Asberg Depression Rating Scale (MADRS)|The Montgomery-Asberg Depression Rating scale assesses 10 symptom areas of depression during an interview. Each of the 10 items received a score ranging from 0 to 6. The scale has a range of 0-60 for the reported total.|units on a scale|Mean|28.2|28.2|Standard Deviation|5.8|5.8|||
3767429|NCT01929681|3600583|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3767430|NCT01929681|3600584|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3767431|NCT01929681|3600585|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3767432|NCT01929681|3600583|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3767433|NCT01929681|3600584|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3767434|NCT01929681|3600585|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3767435|NCT01929681|3600583|B3|||Age||years|Mean|45.1|45.1|Standard Deviation|12.0|12.0|||
3767436|NCT01929681|3600584|B2|||Age||years|Mean|45.7|45.7|Standard Deviation|10.3|10.3|||
3767437|NCT01929681|3600585|B1|||Age||years|Mean|44.5|44.5|Standard Deviation|13.5|13.5|||
3767438|NCT01929473|3600600|B1|Japan||Region of Enrollment||participants|Number|3243|3243.0||||||
3767439|NCT01929473|3600600|B1||Male|Sex: Female, Male||Participants|Count of Participants|1638|1638.0||||||
3767440|NCT01929473|3600600|B1||Female|Sex: Female, Male||Participants|Count of Participants|1605|1605.0||||||
3767441|NCT01929473|3600600|B1|||Age||years|Mean|13.9|13.9|Standard Deviation|1.56|1.56|||
3767442|NCT01929460|3600604|B3|||Number of fine needle aspiration (FNA) passes||passes|Mean|1.42|1.42|Full Range|||1.0|3.0|
3767443|NCT01929460|3600605|B2|||Number of fine needle aspiration (FNA) passes||passes|Mean|1.38|1.38|Full Range|||1.0|3.0|
3767444|NCT01929460|3600606|B1|||Number of fine needle aspiration (FNA) passes||passes|Mean|1.46|1.46|Full Range|||1.0|3.0|
3767445|NCT01929460|3600604|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
3767446|NCT01929460|3600605|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3767447|NCT01929460|3600606|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3767448|NCT01929460|3600604|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3767449|NCT01929460|3600605|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3767450|NCT01929460|3600606|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3767451|NCT01929460|3600604|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3767452|NCT01929460|3600605|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3767453|NCT01929460|3600606|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3767454|NCT01929460|3600604|B3|||Age||years|Mean|68.3|68.3|Full Range|||40.0|85.0|
3767455|NCT01929460|3600605|B2|||Age||years|Mean|68.5|68.5|Full Range|||50.0|82.0|
3767456|NCT01929460|3600606|B1|||Age||years|Mean|68|68.0|Full Range|||40.0|85.0|
3767457|NCT01929317|3600629|B3|Japanese/East Asian Heritage (EAH)/South EAH||Race/Ethnicity, Customized||Participants|Number|81|81.0||||||
3767458|NCT01929317|3600630|B2|Japanese/East Asian Heritage (EAH)/South EAH||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
3767459|NCT01929317|3600631|B1|Japanese/East Asian Heritage (EAH)/South EAH||Race/Ethnicity, Customized||Participants|Number|61|61.0||||||
3767460|NCT01929317|3600629|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3767461|NCT01929317|3600630|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3767462|NCT01929317|3600631|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3767463|NCT01929317|3600629|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3767464|NCT01929317|3600630|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3767465|NCT01929317|3600631|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3767466|NCT01929317|3600629|B3|||Age||Years|Mean|65.0|65.0|Standard Deviation|9.88|9.88|||
3767467|NCT01929317|3600630|B2|||Age||Years|Mean|63.3|63.3|Standard Deviation|12.42|12.42|||
3767468|NCT01929317|3600631|B1|||Age||Years|Mean|65.5|65.5|Standard Deviation|8.95|8.95|||
3767469|NCT01929135|3600699|B3|||Periodontal inflamed surface area (PISA)|Periodontal Inflamed Surface Area (PISA) was calculated using formulas with data of CAL, Gingival Recession and BOP obtaining surface area of bleeding pocket epithelium in square millimetres. A freely downloadable spreadsheet available was used to calculate PISA (http://www.parsprototo.info)|square millimeters|Mean|954|954.0|Standard Deviation|477.67|477.67|||
3767470|NCT01929135|3600700|B2|||Periodontal inflamed surface area (PISA)|Periodontal Inflamed Surface Area (PISA) was calculated using formulas with data of CAL, Gingival Recession and BOP obtaining surface area of bleeding pocket epithelium in square millimetres. A freely downloadable spreadsheet available was used to calculate PISA (http://www.parsprototo.info)|square millimeters|Mean|814.82|814.82|Standard Deviation|488.54|488.54|||
3767471|NCT01929135|3600701|B1|||Periodontal inflamed surface area (PISA)|Periodontal Inflamed Surface Area (PISA) was calculated using formulas with data of CAL, Gingival Recession and BOP obtaining surface area of bleeding pocket epithelium in square millimetres. A freely downloadable spreadsheet available was used to calculate PISA (http://www.parsprototo.info)|square millimeters|Mean|1093.18|1093.18|Standard Deviation|435.96|435.96|||
3767533|NCT01929109|3600720|B2|Yes||Type 2 Diabetes Mellitus (T2DM) status||Participants|Count of Participants|1|1.0||||||
3767472|NCT01929135|3600699|B3|||Gingival index|"Determined as score assigned to each site evaluated respect to clinical criteria as followed:~Score Criteria 0: No inflammation~Mild inflammation, slight change in color, slight edema, no bleeding on probing.~Moderate inflammation, moderate glazing, redness, bleeding on probing.~Severe inflammation, marked redness and hypertrophy, ulceration, tendency to spontaneous bleeding.~Then was calculated a score for each sextant summed the score and divided by the number of examined sites. Later was summed each sextant score and divided by sextant evaluated."|score on a scale|Mean|1.74|1.74|Standard Deviation|0.33|0.33|||
3767473|NCT01929135|3600700|B2|||Gingival index|"Determined as score assigned to each site evaluated respect to clinical criteria as followed:~Score Criteria 0: No inflammation~Mild inflammation, slight change in color, slight edema, no bleeding on probing.~Moderate inflammation, moderate glazing, redness, bleeding on probing.~Severe inflammation, marked redness and hypertrophy, ulceration, tendency to spontaneous bleeding.~Then was calculated a score for each sextant summed the score and divided by the number of examined sites. Later was summed each sextant score and divided by sextant evaluated."|score on a scale|Mean|1.54|1.54|Standard Deviation|0.21|0.21|||
3767474|NCT01929135|3600701|B1|||Gingival index|"Determined as score assigned to each site evaluated respect to clinical criteria as followed:~Score Criteria 0: No inflammation~Mild inflammation, slight change in color, slight edema, no bleeding on probing.~Moderate inflammation, moderate glazing, redness, bleeding on probing.~Severe inflammation, marked redness and hypertrophy, ulceration, tendency to spontaneous bleeding.~Then was calculated a score for each sextant summed the score and divided by the number of examined sites. Later was summed each sextant score and divided by sextant evaluated."|score on a scale|Mean|1.95|1.95|Standard Deviation|0.31|0.31|||
3767475|NCT01929135|3600699|B3|||Oral hygienic index|The Oral hygienic index was evaluated recording the presence and absence of plaque on surfaces examined (mesiobuccal, mediobuccal, distobuccal, mesiolingual/palatal, mediolingual/palatal, distolingual/palatal), then the percentage of surface without plaque was calculated.|percent of surface without plaque|Mean|10.10|10.1|Standard Deviation|17.42|17.42|||
3767476|NCT01929135|3600700|B2|||Oral hygienic index|The Oral hygienic index was evaluated recording the presence and absence of plaque on surfaces examined (mesiobuccal, mediobuccal, distobuccal, mesiolingual/palatal, mediolingual/palatal, distolingual/palatal), then the percentage of surface without plaque was calculated.|percent of surface without plaque|Mean|12.88|12.88|Standard Deviation|18.01|18.01|||
3767477|NCT01929135|3600701|B1|||Oral hygienic index|The Oral hygienic index was evaluated recording the presence and absence of plaque on surfaces examined (mesiobuccal, mediobuccal, distobuccal, mesiolingual/palatal, mediolingual/palatal, distolingual/palatal), then the percentage of surface without plaque was calculated.|percent of surface without plaque|Mean|7.32|7.32|Standard Deviation|16.85|16.85|||
3767478|NCT01929135|3600699|B3|||Recession|Recession was defined as the distance from gingival margin to cemento-enamel junction (CEJ) registered as a negative value when gingival margin extends under CEJ or positive value in case of the gingival margin extends upper CEJ. Each tooth was measured at 6 sites: mesiobuccal, mediobuccal, distobuccal, mesiolingual, mediolingual, distolingual. The mean of all examined sites was calculated in each patient.|millimeters|Mean|0.14|0.14|Standard Deviation|1.04|1.04|||
3767479|NCT01929135|3600700|B2|||Recession|Recession was defined as the distance from gingival margin to cemento-enamel junction (CEJ) registered as a negative value when gingival margin extends under CEJ or positive value in case of the gingival margin extends upper CEJ. Each tooth was measured at 6 sites: mesiobuccal, mediobuccal, distobuccal, mesiolingual, mediolingual, distolingual. The mean of all examined sites was calculated in each patient.|millimeters|Mean|0.28|0.28|Standard Deviation|0.94|0.94|||
3767480|NCT01929135|3600701|B1|||Recession|Recession was defined as the distance from gingival margin to cemento-enamel junction (CEJ) registered as a negative value when gingival margin extends under CEJ or positive value in case of the gingival margin extends upper CEJ. Each tooth was measured at 6 sites: mesiobuccal, mediobuccal, distobuccal, mesiolingual, mediolingual, distolingual. The mean of all examined sites was calculated in each patient.|millimeters|Mean|0.01|0.01|Standard Deviation|1.14|1.14|||
3767481|NCT01929135|3600699|B3|||Bleeding on probing|Bleeding on probing (BOP) was determined by assigning with positive sign (+) when presence of bleeding on probing in buccal and / or palatal of an examined tooth; and with a negative sign (-) when not bleeding. Then the positive signs were summed and divided by the number of examined sites obtaining a percent. Each tooth was probed at 6 sites: mesiobuccal, mediobuccal, distobuccal, mesiolingual, mediolingual, distolingual.|Percentage of probed sites with BOP|Mean|65.67|65.67|Standard Deviation|21.59|21.59|||
3767482|NCT01929135|3600700|B2|||Bleeding on probing|Bleeding on probing (BOP) was determined by assigning with positive sign (+) when presence of bleeding on probing in buccal and / or palatal of an examined tooth; and with a negative sign (-) when not bleeding. Then the positive signs were summed and divided by the number of examined sites obtaining a percent. Each tooth was probed at 6 sites: mesiobuccal, mediobuccal, distobuccal, mesiolingual, mediolingual, distolingual.|Percentage of probed sites with BOP|Mean|53.47|53.47|Standard Deviation|17.77|17.77|||
3767483|NCT01929135|3600701|B1|||Bleeding on probing|Bleeding on probing (BOP) was determined by assigning with positive sign (+) when presence of bleeding on probing in buccal and / or palatal of an examined tooth; and with a negative sign (-) when not bleeding. Then the positive signs were summed and divided by the number of examined sites obtaining a percent. Each tooth was probed at 6 sites: mesiobuccal, mediobuccal, distobuccal, mesiolingual, mediolingual, distolingual.|Percentage of probed sites with BOP|Mean|77.86|77.86|Standard Deviation|18.12|18.12|||
3767484|NCT01929135|3600699|B3|||Clinical attachment level|Clinical attachment level (CAL) was measured as the distance between the base of the clinical pocket and the cement-enamel junction (CEJ) using a University of North Carolina no. 15 color-coded periodontal probe, Hu-Friedy.|millimeters|Mean|3.12|3.12|Standard Deviation|1.38|1.38|||
3767485|NCT01929135|3600700|B2|||Clinical attachment level|Clinical attachment level (CAL) was measured as the distance between the base of the clinical pocket and the cement-enamel junction (CEJ) using a University of North Carolina no. 15 color-coded periodontal probe, Hu-Friedy.|millimeters|Mean|2.52|2.52|Standard Deviation|0.90|0.9|||
3767486|NCT01929135|3600701|B1|||Clinical attachment level|Clinical attachment level (CAL) was measured as the distance between the base of the clinical pocket and the cement-enamel junction (CEJ) using a University of North Carolina no. 15 color-coded periodontal probe, Hu-Friedy.|millimeters|Mean|3.73|3.73|Standard Deviation|1.52|1.52|||
3767487|NCT01929135|3600699|B3|||Probing depth|Probing depth (PD) was defined as the distance from the gingival margin to the base of clinical pocket, was measured as the distance between the base of the clinical pocket and the cement-enamel junction (CEJ) using University of North Carolina no. 15 color-coded periodontal probe, Hu-Friedy.|millimeters|Mean|3.27|3.27|Standard Deviation|0.98|0.98|||
3767488|NCT01929135|3600700|B2|||Probing depth|Probing depth (PD) was defined as the distance from the gingival margin to the base of clinical pocket, was measured as the distance between the base of the clinical pocket and the cement-enamel junction (CEJ) using University of North Carolina no. 15 color-coded periodontal probe, Hu-Friedy.|millimeters|Mean|2.80|2.8|Standard Deviation|0.86|0.86|||
3767489|NCT01929135|3600701|B1|||Probing depth|Probing depth (PD) was defined as the distance from the gingival margin to the base of clinical pocket, was measured as the distance between the base of the clinical pocket and the cement-enamel junction (CEJ) using University of North Carolina no. 15 color-coded periodontal probe, Hu-Friedy.|millimeters|Mean|3.74|3.74|Standard Deviation|0.87|0.87|||
3767490|NCT01929135|3600699|B3|non-smokers patients||Smokers||participants|Number|20|20.0||||||
3767491|NCT01929135|3600700|B2|non-smokers patients||Smokers||participants|Number|7|7.0||||||
3767492|NCT01929135|3600701|B1|non-smokers patients||Smokers||participants|Number|13|13.0||||||
3767493|NCT01929135|3600699|B3|smokers patients||Smokers||participants|Number|16|16.0||||||
3767494|NCT01929135|3600700|B2|smokers patients||Smokers||participants|Number|11|11.0||||||
3767495|NCT01929135|3600701|B1|smokers patients||Smokers||participants|Number|5|5.0||||||
3767496|NCT01929135|3600699|B3|non-diabetic patients||Diabetic||participants|Number|32|32.0||||||
3767497|NCT01929135|3600700|B2|non-diabetic patients||Diabetic||participants|Number|17|17.0||||||
3767498|NCT01929135|3600701|B1|non-diabetic patients||Diabetic||participants|Number|15|15.0||||||
3767499|NCT01929135|3600699|B3|diabetic patients||Diabetic||participants|Number|4|4.0||||||
3767500|NCT01929135|3600700|B2|diabetic patients||Diabetic||participants|Number|1|1.0||||||
3767501|NCT01929135|3600701|B1|diabetic patients||Diabetic||participants|Number|3|3.0||||||
3767502|NCT01929135|3600699|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3767503|NCT01929135|3600700|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3767504|NCT01929135|3600701|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3767505|NCT01929135|3600699|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3767506|NCT01929135|3600700|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3767507|NCT01929135|3600701|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3767508|NCT01929135|3600699|B3|||Age||years|Mean|45.56|45.56|Standard Deviation|8.95|8.95|||
3767509|NCT01929135|3600700|B2|||Age||years|Mean|45.72|45.72|Standard Deviation|9.08|9.08|||
3767510|NCT01929135|3600701|B1|||Age||years|Mean|45.39|45.39|Standard Deviation|9.07|9.07|||
3767511|NCT01929109|3600716|B6|||Estimated Glomerular Filtration Rate (eGRF)|Calculated using Day -1 values for each individual participant.|mL/min/1.73m²|Mean|51.147|51.147|Standard Deviation|35.467|35.467|||
3767512|NCT01929109|3600717|B5|||Estimated Glomerular Filtration Rate (eGRF)|Calculated using Day -1 values for each individual participant.|mL/min/1.73m²|Mean|8.249|8.249|Standard Deviation|1.918|1.918|||
3767513|NCT01929109|3600718|B4|||Estimated Glomerular Filtration Rate (eGRF)|Calculated using Day -1 values for each individual participant.|mL/min/1.73m²|Mean|17.565|17.565|Standard Deviation|7.200|7.2|||
3767514|NCT01929109|3600719|B3|||Estimated Glomerular Filtration Rate (eGRF)|Calculated using Day -1 values for each individual participant.|mL/min/1.73m²|Mean|40.448|40.448|Standard Deviation|12.793|12.793|||
3767515|NCT01929109|3600720|B2|||Estimated Glomerular Filtration Rate (eGRF)|Calculated using Day -1 values for each individual participant.|mL/min/1.73m²|Mean|68.107|68.107|Standard Deviation|15.876|15.876|||
3767516|NCT01929109|3600721|B1|||Estimated Glomerular Filtration Rate (eGRF)|Calculated using Day -1 values for each individual participant.|mL/min/1.73m²|Mean|91.272|91.272|Standard Deviation|17.122|17.122|||
3767517|NCT01929109|3600716|B6|||Creatinine clearance (CLcr)|Calculated using the mean of screening and Day -1 values for each individual participant.|mL/min|Mean|61.149|61.149|Standard Deviation|40.837|40.837|||
3767518|NCT01929109|3600717|B5|||Creatinine clearance (CLcr)|Calculated using the mean of screening and Day -1 values for each individual participant.|mL/min|Mean|13.763|13.763|Standard Deviation|4.159|4.159|||
3767519|NCT01929109|3600718|B4|||Creatinine clearance (CLcr)|Calculated using the mean of screening and Day -1 values for each individual participant.|mL/min|Mean|21.951|21.951|Standard Deviation|3.952|3.952|||
3767520|NCT01929109|3600719|B3|||Creatinine clearance (CLcr)|Calculated using the mean of screening and Day -1 values for each individual participant.|mL/min|Mean|45.844|45.844|Standard Deviation|10.121|10.121|||
3767521|NCT01929109|3600720|B2|||Creatinine clearance (CLcr)|Calculated using the mean of screening and Day -1 values for each individual participant.|mL/min|Mean|72.850|72.85|Standard Deviation|6.512|6.512|||
3767522|NCT01929109|3600721|B1|||Creatinine clearance (CLcr)|Calculated using the mean of screening and Day -1 values for each individual participant.|mL/min|Mean|112.686|112.686|Standard Deviation|16.152|16.152|||
3767523|NCT01929109|3600716|B6|No||Type 2 Diabetes Mellitus (T2DM) status||Participants|Count of Participants|45|45.0||||||
3767524|NCT01929109|3600717|B5|No||Type 2 Diabetes Mellitus (T2DM) status||Participants|Count of Participants|8|8.0||||||
3767525|NCT01929109|3600718|B4|No||Type 2 Diabetes Mellitus (T2DM) status||Participants|Count of Participants|8|8.0||||||
3767526|NCT01929109|3600719|B3|No||Type 2 Diabetes Mellitus (T2DM) status||Participants|Count of Participants|8|8.0||||||
3767527|NCT01929109|3600720|B2|No||Type 2 Diabetes Mellitus (T2DM) status||Participants|Count of Participants|7|7.0||||||
3767528|NCT01929109|3600721|B1|No||Type 2 Diabetes Mellitus (T2DM) status||Participants|Count of Participants|14|14.0||||||
3767529|NCT01929109|3600716|B6|Yes||Type 2 Diabetes Mellitus (T2DM) status||Participants|Count of Participants|1|1.0||||||
3767530|NCT01929109|3600717|B5|Yes||Type 2 Diabetes Mellitus (T2DM) status||Participants|Count of Participants|0|0.0||||||
3767591|NCT01929109|3600718|B4|||Age||years|Mean|63.6|63.6|Standard Deviation|8.4|8.4|||
3767534|NCT01929109|3600721|B1|Yes||Type 2 Diabetes Mellitus (T2DM) status||Participants|Count of Participants|0|0.0||||||
3767535|NCT01929109|3600716|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767536|NCT01929109|3600717|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767537|NCT01929109|3600718|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767538|NCT01929109|3600719|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767539|NCT01929109|3600720|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767540|NCT01929109|3600721|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767541|NCT01929109|3600716|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767542|NCT01929109|3600717|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767543|NCT01929109|3600718|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767544|NCT01929109|3600719|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767545|NCT01929109|3600720|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767546|NCT01929109|3600721|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767547|NCT01929109|3600716|B6||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3767548|NCT01929109|3600717|B5||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3767549|NCT01929109|3600718|B4||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3767550|NCT01929109|3600719|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3767551|NCT01929109|3600720|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3767552|NCT01929109|3600721|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3767553|NCT01929109|3600716|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3767554|NCT01929109|3600717|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3767555|NCT01929109|3600718|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767556|NCT01929109|3600719|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767557|NCT01929109|3600720|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767558|NCT01929109|3600721|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767559|NCT01929109|3600716|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767560|NCT01929109|3600717|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767561|NCT01929109|3600718|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767562|NCT01929109|3600719|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767563|NCT01929109|3600720|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767564|NCT01929109|3600721|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767565|NCT01929109|3600716|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767566|NCT01929109|3600717|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767567|NCT01929109|3600718|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767568|NCT01929109|3600719|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767569|NCT01929109|3600720|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767570|NCT01929109|3600721|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767571|NCT01929109|3600716|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767572|NCT01929109|3600717|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767573|NCT01929109|3600718|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767574|NCT01929109|3600719|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767575|NCT01929109|3600720|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767576|NCT01929109|3600721|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767577|NCT01929109|3600716|B6||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3767578|NCT01929109|3600717|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3767579|NCT01929109|3600718|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3767580|NCT01929109|3600719|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3767581|NCT01929109|3600720|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3767582|NCT01929109|3600721|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3767583|NCT01929109|3600716|B6||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3767584|NCT01929109|3600717|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3767585|NCT01929109|3600718|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3767586|NCT01929109|3600719|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3767587|NCT01929109|3600720|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3767588|NCT01929109|3600721|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3767589|NCT01929109|3600716|B6|||Age||years|Mean|59.2|59.2|Standard Deviation|11.7|11.7|||
3767590|NCT01929109|3600717|B5|||Age||years|Mean|52.0|52.0|Standard Deviation|12.0|12.0|||
3767592|NCT01929109|3600719|B3|||Age||years|Mean|68.6|68.6|Standard Deviation|6.3|6.3|||
3767593|NCT01929109|3600720|B2|||Age||years|Mean|59.8|59.8|Standard Deviation|9.1|9.1|||
3767594|NCT01929109|3600721|B1|||Age||years|Mean|54.9|54.9|Standard Deviation|13.0|13.0|||
3767595|NCT01929083|3600744|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3767596|NCT01929083|3600744|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3767597|NCT01929083|3600744|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3767598|NCT01929083|3600744|B1|||Age||years|Mean|29|29.0|Standard Deviation|5|5.0|||
3767599|NCT01929083|3600744|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3767600|NCT01929083|3600744|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3767601|NCT01929083|3600744|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3767602|NCT01929044|3600769|B3||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3767603|NCT01929044|3600770|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3767604|NCT01929044|3600771|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3767605|NCT01929044|3600769|B3||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3767606|NCT01929044|3600770|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3767607|NCT01929044|3600771|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3767608|NCT01929044|3600769|B3|||Age||Years|Mean|41.1|41.1|Standard Deviation|14.4|14.4|||
3767609|NCT01929044|3600770|B2|||Age||Years|Mean|40.7|40.7|Standard Deviation|14.8|14.8|||
3767610|NCT01929044|3600771|B1|||Age||Years|Mean|41.5|41.5|Standard Deviation|14.2|14.2|||
3767611|NCT01929031|3600790|B5|United States||Region of Enrollment||participants|Number|562|562.0||||||
3767612|NCT01929031|3600791|B4|United States||Region of Enrollment||participants|Number|213|213.0||||||
3767613|NCT01929031|3600792|B3|United States||Region of Enrollment||participants|Number|209|209.0||||||
3767614|NCT01929031|3600793|B2|United States||Region of Enrollment||participants|Number|70|70.0||||||
3767615|NCT01929031|3600794|B1|United States||Region of Enrollment||participants|Number|70|70.0||||||
3767616|NCT01929031|3600790|B5||Male|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
3767617|NCT01929031|3600791|B4||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3767618|NCT01929031|3600792|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3767619|NCT01929031|3600793|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3767620|NCT01929031|3600794|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3767621|NCT01929031|3600790|B5||Female|Sex: Female, Male||Participants|Count of Participants|358|358.0||||||
3767622|NCT01929031|3600791|B4||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3767623|NCT01929031|3600792|B3||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3767624|NCT01929031|3600793|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3767625|NCT01929031|3600794|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3767626|NCT01929031|3600790|B5|||Age||years|Mean|19.5|19.5|Standard Deviation|1.95|1.95|||
3767627|NCT01929031|3600791|B4|||Age||years|Mean|19.5|19.5|Standard Deviation|2.06|2.06|||
3767628|NCT01929031|3600792|B3|||Age||years|Mean|19.6|19.6|Standard Deviation|1.96|1.96|||
3767629|NCT01929031|3600793|B2|||Age||years|Mean|19.2|19.2|Standard Deviation|1.72|1.72|||
3767630|NCT01929031|3600794|B1|||Age||years|Mean|19.3|19.3|Standard Deviation|1.77|1.77|||
3767631|NCT01928940|3600821|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3767632|NCT01928940|3600822|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3767633|NCT01928940|3600823|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3767634|NCT01928940|3600821|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3767635|NCT01928940|3600822|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3767636|NCT01928940|3600823|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3767637|NCT01928940|3600821|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3767638|NCT01928940|3600822|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3767639|NCT01928940|3600823|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3767640|NCT01928940|3600821|B3|||Age||Years|Mean|55.6|55.6|Standard Deviation|15.70|15.7|||
3767641|NCT01928940|3600822|B2|||Age||Years|Mean|59.0|59.0|Standard Deviation|10.99|10.99|||
3767642|NCT01928940|3600823|B1|||Age||Years|Mean|52.2|52.2|Standard Deviation|19.83|19.83|||
3767643|NCT01928927|3600865|B3|||Adipose Tissue Collagen I Deposition||percent area stain positive|Median|2.11|2.11|Inter-Quartile Range|||0.63|3.45|
3767644|NCT01928927|3600866|B2|||Adipose Tissue Collagen I Deposition||percent area stain positive|Median|2.83|2.83|Inter-Quartile Range|||1.36|4.53|
3767645|NCT01928927|3600867|B1|||Adipose Tissue Collagen I Deposition||percent area stain positive|Median|1.51|1.51|Inter-Quartile Range|||0.54|2.69|
3767646|NCT01928927|3600865|B3|||Lymphoid Tissue Collagen I Deposition||percent area stain positive|Median|13.9|13.9|Inter-Quartile Range|||8.4|20.8|
3767647|NCT01928927|3600866|B2|||Lymphoid Tissue Collagen I Deposition||percent area stain positive|Median|12.6|12.6|Inter-Quartile Range|||10.3|19.1|
3767648|NCT01928927|3600867|B1|||Lymphoid Tissue Collagen I Deposition||percent area stain positive|Median|15.3|15.3|Inter-Quartile Range|||6.5|22.1|
3767649|NCT01928927|3600865|B3||>= 200 copies/ml|HIV-1 RNA||Participants|Count of Participants|3|3.0||||||
3767650|NCT01928927|3600866|B2||>= 200 copies/ml|HIV-1 RNA||Participants|Count of Participants|1|1.0||||||
3767651|NCT01928927|3600867|B1||>= 200 copies/ml|HIV-1 RNA||Participants|Count of Participants|2|2.0||||||
3767652|NCT01928927|3600865|B3||40 - <200 copies/ml|HIV-1 RNA||Participants|Count of Participants|6|6.0||||||
3767653|NCT01928927|3600866|B2||40 - <200 copies/ml|HIV-1 RNA||Participants|Count of Participants|3|3.0||||||
3767654|NCT01928927|3600867|B1||40 - <200 copies/ml|HIV-1 RNA||Participants|Count of Participants|3|3.0||||||
3767655|NCT01928927|3600865|B3||<40 copies/ml|HIV-1 RNA||Participants|Count of Participants|35|35.0||||||
3767656|NCT01928927|3600866|B2||<40 copies/ml|HIV-1 RNA||Participants|Count of Participants|11|11.0||||||
3767657|NCT01928927|3600867|B1||<40 copies/ml|HIV-1 RNA||Participants|Count of Participants|24|24.0||||||
3767658|NCT01928927|3600865|B3|||CD4+||cells/mm^3|Median|588|588.0|Inter-Quartile Range|||444.0|841.0|
3767659|NCT01928927|3600866|B2|||CD4+||cells/mm^3|Median|556|556.0|Inter-Quartile Range|||444.0|906.0|
3767660|NCT01928927|3600867|B1|||CD4+||cells/mm^3|Median|604|604.0|Inter-Quartile Range|||438.0|812.0|
3767661|NCT01928927|3600865|B3|||Waist-to-hip ratio||ratio|Median|0.93|0.93|Inter-Quartile Range|||0.89|0.97|
3767662|NCT01928927|3600866|B2|||Waist-to-hip ratio||ratio|Median|0.91|0.91|Inter-Quartile Range|||0.86|0.95|
3767663|NCT01928927|3600867|B1|||Waist-to-hip ratio||ratio|Median|0.94|0.94|Inter-Quartile Range|||0.91|0.98|
3767664|NCT01928927|3600865|B3|||Waist circumference||cm|Median|88|88.0|Inter-Quartile Range|||84.0|99.0|
3767665|NCT01928927|3600866|B2|||Waist circumference||cm|Median|86|86.0|Inter-Quartile Range|||81.0|96.0|
3767666|NCT01928927|3600867|B1|||Waist circumference||cm|Median|92|92.0|Inter-Quartile Range|||85.0|100.0|
3767667|NCT01928927|3600865|B3|||BMI||kg/m^2|Median|25.0|25.0|Inter-Quartile Range|||22.6|28.4|
3767668|NCT01928927|3600866|B2|||BMI||kg/m^2|Median|23.7|23.7|Inter-Quartile Range|||21.4|26.6|
3767669|NCT01928927|3600867|B1|||BMI||kg/m^2|Median|25.4|25.4|Inter-Quartile Range|||23.3|29.8|
3767670|NCT01928927|3600865|B3||Previous History|IV drug history||Participants|Count of Participants|6|6.0||||||
3767671|NCT01928927|3600866|B2||Previous History|IV drug history||Participants|Count of Participants|2|2.0||||||
3767672|NCT01928927|3600867|B1||Previous History|IV drug history||Participants|Count of Participants|4|4.0||||||
3767673|NCT01928927|3600865|B3||No History|IV drug history||Participants|Count of Participants|38|38.0||||||
3767674|NCT01928927|3600866|B2||No History|IV drug history||Participants|Count of Participants|13|13.0||||||
3767675|NCT01928927|3600867|B1||No History|IV drug history||Participants|Count of Participants|25|25.0||||||
3767676|NCT01928927|3600865|B3||More than one race|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3767677|NCT01928927|3600866|B2||More than one race|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3767678|NCT01928927|3600867|B1||More than one race|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3767679|NCT01928927|3600865|B3||Hispanic (Regardless of Race)|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3767680|NCT01928927|3600866|B2||Hispanic (Regardless of Race)|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3767681|NCT01928927|3600867|B1||Hispanic (Regardless of Race)|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3767682|NCT01928927|3600865|B3||Black Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3767683|NCT01928927|3600866|B2||Black Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3767684|NCT01928927|3600867|B1||Black Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3767685|NCT01928927|3600865|B3||White Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3767686|NCT01928927|3600866|B2||White Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3767687|NCT01928927|3600867|B1||White Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3767688|NCT01928927|3600865|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767689|NCT01928927|3600866|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767690|NCT01928927|3600867|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767691|NCT01928927|3600865|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3767692|NCT01928927|3600866|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767693|NCT01928927|3600867|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3767694|NCT01928927|3600865|B3||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3767695|NCT01928927|3600866|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3767696|NCT01928927|3600867|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3767697|NCT01928927|3600865|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3767698|NCT01928927|3600866|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3767699|NCT01928927|3600867|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3767700|NCT01928927|3600865|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767701|NCT01928927|3600866|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767702|NCT01928927|3600867|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767703|NCT01928927|3600865|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767704|NCT01928927|3600866|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767705|NCT01928927|3600867|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767706|NCT01928927|3600865|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767707|NCT01928927|3600866|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767708|NCT01928927|3600867|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767709|NCT01928927|3600865|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767710|NCT01928927|3600866|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767711|NCT01928927|3600867|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767712|NCT01928927|3600865|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3767713|NCT01928927|3600866|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3767714|NCT01928927|3600867|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3767715|NCT01928927|3600865|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3767716|NCT01928927|3600866|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3767717|NCT01928927|3600867|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3767718|NCT01928927|3600865|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3767719|NCT01928927|3600866|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3767720|NCT01928927|3600867|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3767721|NCT01928927|3600865|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3767722|NCT01928927|3600866|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3767723|NCT01928927|3600867|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3767724|NCT01928927|3600865|B3||60-69 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
3767725|NCT01928927|3600866|B2||60-69 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
3767726|NCT01928927|3600867|B1||60-69 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3767727|NCT01928927|3600865|B3||50-59 years|Age, Customized||Participants|Count of Participants|17|17.0||||||
3767728|NCT01928927|3600866|B2||50-59 years|Age, Customized||Participants|Count of Participants|6|6.0||||||
3767729|NCT01928927|3600867|B1||50-59 years|Age, Customized||Participants|Count of Participants|11|11.0||||||
3767730|NCT01928927|3600865|B3||40-49 years|Age, Customized||Participants|Count of Participants|15|15.0||||||
3767731|NCT01928927|3600866|B2||40-49 years|Age, Customized||Participants|Count of Participants|3|3.0||||||
3767732|NCT01928927|3600867|B1||40-49 years|Age, Customized||Participants|Count of Participants|12|12.0||||||
3767733|NCT01928927|3600865|B3||30-39 years|Age, Customized||Participants|Count of Participants|8|8.0||||||
3767734|NCT01928927|3600866|B2||30-39 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
3767735|NCT01928927|3600867|B1||30-39 years|Age, Customized||Participants|Count of Participants|6|6.0||||||
3767736|NCT01928927|3600865|B3||18-29 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
3767737|NCT01928927|3600866|B2||18-29 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
3767738|NCT01928927|3600867|B1||18-29 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3767739|NCT01928927|3600865|B3|||Age||years|Median|48|48.0|Inter-Quartile Range|||41.0|52.0|
3767740|NCT01928927|3600866|B2|||Age||years|Median|50|50.0|Inter-Quartile Range|||39.0|52.0|
3767741|NCT01928927|3600867|B1|||Age||years|Median|47|47.0|Inter-Quartile Range|||41.0|51.0|
3767742|NCT01928862|3600990|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767743|NCT01928862|3600991|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767744|NCT01928862|3600992|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767745|NCT01928862|3600993|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767746|NCT01928862|3600994|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767747|NCT01928862|3600995|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767748|NCT01928862|3600990|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767749|NCT01928862|3600991|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767750|NCT01928862|3600992|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767751|NCT01928862|3600993|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767752|NCT01928862|3600994|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767753|NCT01928862|3600995|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767754|NCT01928862|3600990|B6||White|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3767755|NCT01928862|3600991|B5||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3767756|NCT01928862|3600992|B4||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3767757|NCT01928862|3600993|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3767758|NCT01928862|3600994|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3767759|NCT01928862|3600995|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3767760|NCT01928862|3600990|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3767761|NCT01928862|3600991|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767762|NCT01928862|3600992|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3767763|NCT01928862|3600993|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3767764|NCT01928862|3600994|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767765|NCT01928862|3600995|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767766|NCT01928862|3600990|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3767767|NCT01928862|3600991|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767768|NCT01928862|3600992|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767769|NCT01928862|3600993|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767770|NCT01928862|3600994|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767771|NCT01928862|3600995|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3767772|NCT01928862|3600990|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767773|NCT01928862|3600991|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767774|NCT01928862|3600992|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767775|NCT01928862|3600993|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767776|NCT01928862|3600994|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767777|NCT01928862|3600995|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767778|NCT01928862|3600990|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767779|NCT01928862|3600991|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767780|NCT01928862|3600992|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767781|NCT01928862|3600993|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767782|NCT01928862|3600994|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767783|NCT01928862|3600995|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767784|NCT01928862|3600990|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767785|NCT01928862|3600991|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767786|NCT01928862|3600992|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767787|NCT01928862|3600993|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767788|NCT01928862|3600994|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767789|NCT01928862|3600995|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767790|NCT01928862|3600990|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3767791|NCT01928862|3600991|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3767792|NCT01928862|3600992|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3767793|NCT01928862|3600993|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3767794|NCT01928862|3600994|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3767795|NCT01928862|3600995|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3767796|NCT01928862|3600990|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3767797|NCT01928862|3600991|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767798|NCT01928862|3600992|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3767799|NCT01928862|3600993|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3767800|NCT01928862|3600994|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3767801|NCT01928862|3600995|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767802|NCT01928862|3600990|B6||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3767803|NCT01928862|3600991|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3767804|NCT01928862|3600992|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3767805|NCT01928862|3600993|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3767806|NCT01928862|3600994|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3767807|NCT01928862|3600995|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3767808|NCT01928862|3600990|B6||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3767809|NCT01928862|3600991|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3767810|NCT01928862|3600992|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3767811|NCT01928862|3600993|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3767812|NCT01928862|3600994|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3767813|NCT01928862|3600995|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3767814|NCT01928862|3600990|B6|||Age||years|Mean|12.2|12.2|Standard Deviation|2.41|2.41|||
3767815|NCT01928862|3600991|B5|||Age||years|Mean|14.9|14.9|Standard Deviation|0.92|0.92|||
3767816|NCT01928862|3600992|B4|||Age||years|Mean|15.0|15.0|Standard Deviation|1.03|1.03|||
3767817|NCT01928862|3600993|B3|||Age||years|Mean|10.4|10.4|Standard Deviation|1.20|1.2|||
3767818|NCT01928862|3600994|B2|||Age||years|Mean|10.5|10.5|Standard Deviation|1.21|1.21|||
3767819|NCT01928862|3600995|B1|||Age||years|Mean|10.8|10.8|Standard Deviation|1.00|1.0|||
3767820|NCT01928849|3601036|B3|United States||Region of Enrollment||Participants|Count of Participants|128|128.0||||||
3767821|NCT01928849|3601037|B2|United States||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
3767822|NCT01928849|3601038|B1|United States||Region of Enrollment||Participants|Count of Participants|66|66.0||||||
3767823|NCT01928849|3601036|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3767824|NCT01928849|3601037|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3767825|NCT01928849|3601038|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767826|NCT01928849|3601036|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3767827|NCT01928849|3601037|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767828|NCT01928849|3601038|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3767829|NCT01928849|3601036|B3||White|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3767830|NCT01928849|3601037|B2||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3767831|NCT01928849|3601038|B1||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3767832|NCT01928849|3601036|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3767833|NCT01928849|3601037|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3767834|NCT01928849|3601038|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3767835|NCT01928849|3601036|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767836|NCT01928849|3601037|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767837|NCT01928849|3601038|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767838|NCT01928849|3601036|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3767839|NCT01928849|3601037|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767840|NCT01928849|3601038|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3767841|NCT01928849|3601036|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767842|NCT01928849|3601037|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767843|NCT01928849|3601038|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767844|NCT01928849|3601036|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767845|NCT01928849|3601037|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767846|NCT01928849|3601038|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767847|NCT01928849|3601036|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
3767848|NCT01928849|3601037|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3767849|NCT01928849|3601038|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3767850|NCT01928849|3601036|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3767851|NCT01928849|3601037|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3767852|NCT01928849|3601038|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3767853|NCT01928849|3601036|B3||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3767854|NCT01928849|3601037|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3767855|NCT01928849|3601038|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3767856|NCT01928849|3601036|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3767857|NCT01928849|3601037|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3767858|NCT01928849|3601038|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3767859|NCT01928849|3601036|B3|||Age||years|Mean|50.7|50.7|Standard Deviation|17.3|17.3|||
3767860|NCT01928849|3601037|B2|||Age||years|Mean|51.1|51.1|Standard Deviation|18.2|18.2|||
3767861|NCT01928849|3601038|B1|||Age||years|Mean|50.3|50.3|Standard Deviation|16.6|16.6|||
3767862|NCT01928797|3601057|B3|||Cardiac Output||L/min|Mean|6.4|6.4|Standard Deviation|74|74.0|||
3767863|NCT01928797|3601058|B2|||Cardiac Output||L/min|Mean|6.5|6.5|Standard Deviation|1.3|1.3|||
3767864|NCT01928797|3601059|B1|||Cardiac Output||L/min|Mean|6.3|6.3|Standard Deviation|1.3|1.3|||
3767865|NCT01928797|3601057|B3|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3767866|NCT01928797|3601058|B2|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3767867|NCT01928797|3601059|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3767868|NCT01928797|3601057|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3767869|NCT01928797|3601058|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3767870|NCT01928797|3601059|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3767871|NCT01928797|3601057|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3767872|NCT01928797|3601058|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3767873|NCT01928797|3601059|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3767874|NCT01928797|3601057|B3|||Age||years|Mean|34.2|34.2|Standard Deviation|5.4|5.4|||
3767875|NCT01928797|3601058|B2|||Age||years|Mean|34.3|34.3|Standard Deviation|5.3|5.3|||
3767876|NCT01928797|3601059|B1|||Age||years|Mean|34.1|34.1|Standard Deviation|5.6|5.6|||
3767877|NCT01928797|3601057|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3767878|NCT01928797|3601058|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3767879|NCT01928797|3601059|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3767880|NCT01928797|3601057|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3767881|NCT01928797|3601058|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3767882|NCT01928797|3601059|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3767883|NCT01928797|3601057|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3767884|NCT01928797|3601058|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3767885|NCT01928797|3601059|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3767886|NCT01928771|3601070|B4||Male|Sex: Female, Male||Participants|Count of Participants|408|408.0||||||
3767887|NCT01928771|3601071|B3||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3767888|NCT01928771|3601072|B2||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3767889|NCT01928771|3601073|B1||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3767890|NCT01928771|3601070|B4||Female|Sex: Female, Male||Participants|Count of Participants|796|796.0||||||
3767891|NCT01928771|3601071|B3||Female|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
3767892|NCT01928771|3601072|B2||Female|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
3767893|NCT01928771|3601073|B1||Female|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
3767894|NCT01928771|3601070|B4|||Age||Years|Mean|48.8|48.8|Standard Deviation|14.3|14.3|||
3767895|NCT01928771|3601071|B3|||Age||Years|Mean|48.7|48.7|Standard Deviation|14.9|14.9|||
3767896|NCT01928771|3601072|B2|||Age||Years|Mean|47.6|47.6|Standard Deviation|14.5|14.5|||
3767897|NCT01928771|3601073|B1|||Age||Years|Mean|50.1|50.1|Standard Deviation|13.4|13.4|||
3767898|NCT01928693|3601152|B4|United States||Region of Enrollment||participants|Number|2|2.0||||||
3767899|NCT01928693|3601153|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3767900|NCT01928693|3601154|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3767901|NCT01928693|3601152|B4|Male||Gender||participants|Number|1|1.0||||||
3767902|NCT01928693|3601153|B3|Male||Gender||participants|Number|1|1.0||||||
3767903|NCT01928693|3601154|B2|Male||Gender||participants|Number|0|0.0||||||
3767904|NCT01928693|3601152|B4|Female||Gender||participants|Number|1|1.0||||||
3767905|NCT01928693|3601153|B3|Female||Gender||participants|Number|0|0.0||||||
3767906|NCT01928693|3601154|B2|Female||Gender||participants|Number|1|1.0||||||
3767907|NCT01928693|3601152|B4|>=65 years||Age||participants|Number|1|1.0||||||
3767908|NCT01928693|3601153|B3|>=65 years||Age||participants|Number|0|0.0||||||
3767909|NCT01928693|3601154|B2|>=65 years||Age||participants|Number|1|1.0||||||
3767910|NCT01928693|3601152|B4|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
3767911|NCT01928693|3601153|B3|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
3767912|NCT01928693|3601154|B2|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
3767913|NCT01928693|3601152|B4|<=18 years||Age||participants|Number|0|0.0||||||
3767914|NCT01928693|3601153|B3|<=18 years||Age||participants|Number|0|0.0||||||
3767915|NCT01928693|3601154|B2|<=18 years||Age||participants|Number|0|0.0||||||
3767916|NCT01928680|3601183|B1|China||Region of Enrollment||participants|Number|33|33.0||||||
3767917|NCT01928680|3601183|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3767918|NCT01928680|3601183|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3767919|NCT01928680|3601183|B1|||Age||years|Mean|48|48.0|Standard Deviation|10|10.0|||
3767920|NCT01928680|3601183|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3767921|NCT01928680|3601183|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3767922|NCT01928680|3601183|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3767923|NCT01928615|3601187|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3767924|NCT01928615|3601187|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3767925|NCT01928615|3601187|B1|||Age||years|Mean|38.0|38.0|Standard Deviation|14.1|14.1|||
3767926|NCT01928472|3601202|B5||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3767927|NCT01928472|3601203|B4||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3767928|NCT01928472|3601204|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3767929|NCT01928472|3601205|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3767930|NCT01928472|3601206|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3767931|NCT01928472|3601202|B5||Female|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
3767932|NCT01928472|3601203|B4||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3767933|NCT01928472|3601204|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3767934|NCT01928472|3601205|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3767935|NCT01928472|3601206|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3767936|NCT01928472|3601202|B5|||Age||year|Mean|41.2|41.2|Standard Deviation|13.0|13.0|||
3767937|NCT01928472|3601203|B4|||Age||year|Mean|43.4|43.4|Standard Deviation|12.9|12.9|||
3767938|NCT01928472|3601204|B3|||Age||year|Mean|42.6|42.6|Standard Deviation|13.1|13.1|||
3767939|NCT01928472|3601205|B2|||Age||year|Mean|40.3|40.3|Standard Deviation|12.5|12.5|||
3767940|NCT01928472|3601206|B1|||Age||year|Mean|38.3|38.3|Standard Deviation|13.1|13.1|||
3767941|NCT01928433|3601276|B4|Poland||Region of Enrollment||participants|Number|192|192.0||||||
3767942|NCT01928433|3601277|B3|Poland||Region of Enrollment||participants|Number|65|65.0||||||
3767943|NCT01928433|3601278|B2|Poland||Region of Enrollment||participants|Number|61|61.0||||||
3767944|NCT01928433|3601279|B1|Poland||Region of Enrollment||participants|Number|66|66.0||||||
3767945|NCT01928433|3601276|B4|Germany||Region of Enrollment||participants|Number|31|31.0||||||
3767946|NCT01928433|3601277|B3|Germany||Region of Enrollment||participants|Number|7|7.0||||||
3767947|NCT01928433|3601278|B2|Germany||Region of Enrollment||participants|Number|14|14.0||||||
3767948|NCT01928433|3601279|B1|Germany||Region of Enrollment||participants|Number|10|10.0||||||
3767949|NCT01928433|3601276|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3767950|NCT01928433|3601277|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3767951|NCT01928433|3601278|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3767952|NCT01928433|3601279|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3767953|NCT01928433|3601276|B4||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3767954|NCT01928433|3601277|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3767955|NCT01928433|3601278|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3767956|NCT01928433|3601279|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3767957|NCT01928433|3601276|B4|||Age||years|Mean|54.6|54.6|Standard Deviation|20.08|20.08|||
3767958|NCT01928433|3601277|B3|||Age||years|Mean|51.0|51.0|Standard Deviation|21.01|21.01|||
3767959|NCT01928433|3601278|B2|||Age||years|Mean|58.0|58.0|Standard Deviation|19.28|19.28|||
3767960|NCT01928433|3601279|B1|||Age||years|Mean|54.6|54.6|Standard Deviation|19.63|19.63|||
3767961|NCT01928433|3601276|B4||>=65 years|Age||Participants|Count of Participants|80|80.0||||||
3767962|NCT01928433|3601277|B3||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3767963|NCT01928433|3601278|B2||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
3767964|NCT01928433|3601279|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3767965|NCT01928433|3601276|B4||Between 18 and 65 years|Age||Participants|Count of Participants|143|143.0||||||
3767966|NCT01928433|3601277|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
3767967|NCT01928433|3601278|B2||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
3767968|NCT01928433|3601279|B1||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3767969|NCT01928433|3601276|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3767970|NCT01928433|3601277|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3767971|NCT01928433|3601278|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3767972|NCT01928433|3601279|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3767973|NCT01928381|3601304|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767974|NCT01928381|3601304|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3767975|NCT01928381|3601304|B1||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3767976|NCT01928381|3601304|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3767977|NCT01928381|3601304|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767978|NCT01928381|3601304|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3767979|NCT01928381|3601304|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3767980|NCT01928381|3601304|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767981|NCT01928381|3601304|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3767982|NCT01928381|3601304|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3767983|NCT01928381|3601304|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3767984|NCT01928381|3601304|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3767985|NCT01928381|3601304|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|9.25|9.25|||
3767986|NCT01928186|3601323|B1||Stage IIB|Clinical stage|"Patients presented in early clinical stages of breast cancer, with the extent of disease increasing from the stage I to IIB, as indicated in the NCI TNM staging system (v. 07/11/2014):~Stage I: T1 N0; Stage IIA: T0 N1 or T1 N1 or T2 N0; Stage IIB: T2 N1 or T3 N0. Definitions: No evidence of primary tumor (T0); Primary tumor < or = 20 mm (T1); Primary tumor >20 mm but < or = 50 mm (T2); Primary tumor > 50 mm (T3); No regional lymph node metastases (N0); Metastases to movable ipsilateral level I, II axillary lymph nodes (N1)."|Participants|Count of Participants|4|4.0||||||
3767987|NCT01928186|3601323|B1||Stage IIA|Clinical stage|"Patients presented in early clinical stages of breast cancer, with the extent of disease increasing from the stage I to IIB, as indicated in the NCI TNM staging system (v. 07/11/2014):~Stage I: T1 N0; Stage IIA: T0 N1 or T1 N1 or T2 N0; Stage IIB: T2 N1 or T3 N0. Definitions: No evidence of primary tumor (T0); Primary tumor < or = 20 mm (T1); Primary tumor >20 mm but < or = 50 mm (T2); Primary tumor > 50 mm (T3); No regional lymph node metastases (N0); Metastases to movable ipsilateral level I, II axillary lymph nodes (N1)."|Participants|Count of Participants|14|14.0||||||
3767988|NCT01928186|3601323|B1||Stage I|Clinical stage|"Patients presented in early clinical stages of breast cancer, with the extent of disease increasing from the stage I to IIB, as indicated in the NCI TNM staging system (v. 07/11/2014):~Stage I: T1 N0; Stage IIA: T0 N1 or T1 N1 or T2 N0; Stage IIB: T2 N1 or T3 N0. Definitions: No evidence of primary tumor (T0); Primary tumor < or = 20 mm (T1); Primary tumor >20 mm but < or = 50 mm (T2); Primary tumor > 50 mm (T3); No regional lymph node metastases (N0); Metastases to movable ipsilateral level I, II axillary lymph nodes (N1)."|Participants|Count of Participants|10|10.0||||||
3767989|NCT01928186|3601323|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767990|NCT01928186|3601323|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767991|NCT01928186|3601323|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3767992|NCT01928186|3601323|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3767993|NCT01928186|3601323|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767994|NCT01928186|3601323|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767995|NCT01928186|3601323|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767996|NCT01928186|3601323|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3767997|NCT01928186|3601323|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3767998|NCT01928186|3601323|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3767999|NCT01928186|3601323|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3768000|NCT01928186|3601323|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3768001|NCT01928186|3601323|B1|||Age||years|Median|60.4|60.4|Full Range|||28.2|74.8|
3768002|NCT01928030|3601355|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3768003|NCT01928030|3601355|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768004|NCT01928030|3601355|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768005|NCT01928030|3601355|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3768006|NCT01928030|3601355|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768007|NCT01928030|3601355|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768008|NCT01928030|3601355|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768009|NCT01928030|3601355|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768010|NCT01928030|3601355|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768011|NCT01928030|3601355|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3768012|NCT01928030|3601355|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768013|NCT01928030|3601355|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3768014|NCT01928030|3601355|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3768015|NCT01928030|3601355|B1|||Age||years|Median|56|56.0|Full Range|||56.0|67.0|
3768016|NCT01928030|3601355|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3768017|NCT01928030|3601355|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3768018|NCT01928030|3601355|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3768019|NCT01927887|3601364|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3768020|NCT01927887|3601364|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3768021|NCT01927887|3601364|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3768022|NCT01927887|3601364|B1||>=65 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3768023|NCT01927887|3601364|B1||Between 18 and 65 years|Age, Customized||Participants|Count of Participants|12|12.0||||||
3768024|NCT01927887|3601364|B1||<=18 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3768025|NCT01927887|3601364|B1|||Age||Years|Mean|42|42.0|Standard Deviation|10|10.0|||
3768026|NCT01927757|3601369|B1|Secondary||Adalimumab Response Failure Type|Primary failure: Failure to achieve an American College of Rheumatology 20% improvement (ACR20) or equivalent as judged by the investigator; Secondary failure: Loss of an ACR20 response or equivalent as judged by the investigator.|participants|Number|52|52.0||||||
3768027|NCT01927757|3601369|B1|Primary||Adalimumab Response Failure Type|Primary failure: Failure to achieve an American College of Rheumatology 20% improvement (ACR20) or equivalent as judged by the investigator; Secondary failure: Loss of an ACR20 response or equivalent as judged by the investigator.|participants|Number|33|33.0||||||
3768028|NCT01927757|3601369|B1|Unknown||Anti-adalimumab Antibody Status||participants|Number|5|5.0||||||
3768029|NCT01927757|3601369|B1|Negative||Anti-adalimumab Antibody Status||participants|Number|56|56.0||||||
3768030|NCT01927757|3601369|B1|Positive||Anti-adalimumab Antibody Status||participants|Number|24|24.0||||||
3768031|NCT01927757|3601369|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3768032|NCT01927757|3601369|B1|White||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
3768033|NCT01927757|3601369|B1|Multiple||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3768034|NCT01927757|3601369|B1|Black (or African American)||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3768035|NCT01927757|3601369|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3768036|NCT01927757|3601369|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3768037|NCT01927757|3601369|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3768038|NCT01927757|3601369|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3768039|NCT01927757|3601369|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|11.1|11.1|||
3768040|NCT01927575|3601387|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3768041|NCT01927575|3601387|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3768042|NCT01927575|3601387|B1|||Age||years|Mean|54|54.0|Standard Deviation|NA||||No SD able to be calculated due to only 1 patient enrolled.
3768043|NCT01927575|3601387|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3768044|NCT01927575|3601387|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3768045|NCT01927575|3601387|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3768046|NCT01927419|3601395|B3|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|2|2.0||||||
3768146|NCT01927419|3601396|B2|||Age||Years|Mean|64.5|64.5|Standard Deviation|10.24|10.24|||
3768047|NCT01927419|3601396|B2|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|0|0.0||||||
3768048|NCT01927419|3601397|B1|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|2|2.0||||||
3768049|NCT01927419|3601395|B3|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|24|24.0||||||
3768050|NCT01927419|3601396|B2|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|10|10.0||||||
3768051|NCT01927419|3601397|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|14|14.0||||||
3768052|NCT01927419|3601395|B3|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|116|116.0||||||
3768053|NCT01927419|3601396|B2|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|37|37.0||||||
3768054|NCT01927419|3601397|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|79|79.0||||||
3768055|NCT01927419|3601395|B3|Unknown||Smoking status||Participants|Number|2|2.0||||||
3768056|NCT01927419|3601396|B2|Unknown||Smoking status||Participants|Number|1|1.0||||||
3768057|NCT01927419|3601397|B1|Unknown||Smoking status||Participants|Number|1|1.0||||||
3768058|NCT01927419|3601395|B3|No||Smoking status||Participants|Number|77|77.0||||||
3768059|NCT01927419|3601396|B2|No||Smoking status||Participants|Number|22|22.0||||||
3768060|NCT01927419|3601397|B1|No||Smoking status||Participants|Number|55|55.0||||||
3768061|NCT01927419|3601395|B3|Yes||Smoking status||Participants|Number|63|63.0||||||
3768062|NCT01927419|3601396|B2|Yes||Smoking status||Participants|Number|24|24.0||||||
3768063|NCT01927419|3601397|B1|Yes||Smoking status||Participants|Number|39|39.0||||||
3768064|NCT01927419|3601395|B3|Not reported||History of brain metastases||Participants|Number|1|1.0||||||
3768065|NCT01927419|3601396|B2|Not reported||History of brain metastases||Participants|Number|0|0.0||||||
3768066|NCT01927419|3601397|B1|Not reported||History of brain metastases||Participants|Number|1|1.0||||||
3768067|NCT01927419|3601395|B3|No||History of brain metastases||Participants|Number|137|137.0||||||
3768068|NCT01927419|3601396|B2|No||History of brain metastases||Participants|Number|47|47.0||||||
3768069|NCT01927419|3601397|B1|No||History of brain metastases||Participants|Number|90|90.0||||||
3768070|NCT01927419|3601395|B3|Yes||History of brain metastases||Participants|Number|4|4.0||||||
3768071|NCT01927419|3601396|B2|Yes||History of brain metastases||Participants|Number|0|0.0||||||
3768072|NCT01927419|3601397|B1|Yes||History of brain metastases||Participants|Number|4|4.0||||||
3768073|NCT01927419|3601395|B3|Not reported||Baseline lactate dehydrogenase level||Participants|Number|1|1.0||||||
3768074|NCT01927419|3601396|B2|Not reported||Baseline lactate dehydrogenase level||Participants|Number|0|0.0||||||
3768075|NCT01927419|3601397|B1|Not reported||Baseline lactate dehydrogenase level||Participants|Number|1|1.0||||||
3768076|NCT01927419|3601395|B3|Higher than 2*ULN||Baseline lactate dehydrogenase level||Participants|Number|7|7.0||||||
3768077|NCT01927419|3601396|B2|Higher than 2*ULN||Baseline lactate dehydrogenase level||Participants|Number|1|1.0||||||
3768078|NCT01927419|3601397|B1|Higher than 2*ULN||Baseline lactate dehydrogenase level||Participants|Number|6|6.0||||||
3768079|NCT01927419|3601395|B3|2*ULN or lower||Baseline lactate dehydrogenase level||Participants|Number|134|134.0||||||
3768080|NCT01927419|3601396|B2|2*ULN or lower||Baseline lactate dehydrogenase level||Participants|Number|46|46.0||||||
3768081|NCT01927419|3601397|B1|2*ULN or lower||Baseline lactate dehydrogenase level||Participants|Number|88|88.0||||||
3768082|NCT01927419|3601395|B3|Higher than ULN||Baseline lactate dehydrogenase level||Participants|Number|35|35.0||||||
3768083|NCT01927419|3601396|B2|Higher than ULN||Baseline lactate dehydrogenase level||Participants|Number|11|11.0||||||
3768084|NCT01927419|3601397|B1|Higher than ULN||Baseline lactate dehydrogenase level||Participants|Number|24|24.0||||||
3768085|NCT01927419|3601395|B3|Upper limit of normal (ULN) or lower||Baseline lactate dehydrogenase level||Participants|Number|106|106.0||||||
3768086|NCT01927419|3601396|B2|Upper limit of normal (ULN) or lower||Baseline lactate dehydrogenase level||Participants|Number|36|36.0||||||
3768087|NCT01927419|3601397|B1|Upper limit of normal (ULN) or lower||Baseline lactate dehydrogenase level||Participants|Number|70|70.0||||||
3768088|NCT01927419|3601395|B3|5 years or more||Time from initial diagnosis||Participants|Number|37|37.0||||||
3768089|NCT01927419|3601396|B2|5 years or more||Time from initial diagnosis||Participants|Number|11|11.0||||||
3768090|NCT01927419|3601397|B1|5 years or more||Time from initial diagnosis||Participants|Number|26|26.0||||||
3768091|NCT01927419|3601395|B3|4 to less than 5 years||Time from initial diagnosis||Participants|Number|9|9.0||||||
3768092|NCT01927419|3601396|B2|4 to less than 5 years||Time from initial diagnosis||Participants|Number|5|5.0||||||
3768093|NCT01927419|3601397|B1|4 to less than 5 years||Time from initial diagnosis||Participants|Number|4|4.0||||||
3768094|NCT01927419|3601395|B3|3 to less than 4 years||Time from initial diagnosis||Participants|Number|5|5.0||||||
3768095|NCT01927419|3601396|B2|3 to less than 4 years||Time from initial diagnosis||Participants|Number|1|1.0||||||
3768096|NCT01927419|3601397|B1|3 to less than 4 years||Time from initial diagnosis||Participants|Number|4|4.0||||||
3768097|NCT01927419|3601395|B3|2 to less than 3 years||Time from initial diagnosis||Participants|Number|20|20.0||||||
3768098|NCT01927419|3601396|B2|2 to less than 3 years||Time from initial diagnosis||Participants|Number|3|3.0||||||
3768099|NCT01927419|3601397|B1|2 to less than 3 years||Time from initial diagnosis||Participants|Number|17|17.0||||||
3768100|NCT01927419|3601395|B3|1 to less than 2 years||Time from initial diagnosis||Participants|Number|25|25.0||||||
3768101|NCT01927419|3601396|B2|1 to less than 2 years||Time from initial diagnosis||Participants|Number|9|9.0||||||
3768102|NCT01927419|3601397|B1|1 to less than 2 years||Time from initial diagnosis||Participants|Number|16|16.0||||||
3768103|NCT01927419|3601395|B3|Less than 1 year||Time from initial diagnosis||Participants|Number|46|46.0||||||
3768104|NCT01927419|3601396|B2|Less than 1 year||Time from initial diagnosis||Participants|Number|18|18.0||||||
3768105|NCT01927419|3601397|B1|Less than 1 year||Time from initial diagnosis||Participants|Number|28|28.0||||||
3768106|NCT01927419|3601395|B3|||Time from initial diagnosis||Years|Median|2.01|2.01|Full Range|||0.1|47.4|
3768107|NCT01927419|3601396|B2|||Time from initial diagnosis||Years|Median|1.71|1.71|Full Range|||0.1|20.4|
3768108|NCT01927419|3601397|B1|||Time from initial diagnosis||Years|Median|2.34|2.34|Full Range|||0.1|47.4|
3768109|NCT01927419|3601395|B3|||Weight||Kilograms|Mean|85.28|85.28|Standard Deviation|22.355|22.355|||
3768110|NCT01927419|3601396|B2|||Weight||Kilograms|Mean|83.29|83.29|Standard Deviation|20.248|20.248|||
3768111|NCT01927419|3601397|B1|||Weight||Kilograms|Mean|86.26|86.26|Standard Deviation|23.368|23.368|||
3768112|NCT01927419|3601395|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3768113|NCT01927419|3601396|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3768114|NCT01927419|3601397|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3768115|NCT01927419|3601395|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3768116|NCT01927419|3601396|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3768117|NCT01927419|3601397|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3768118|NCT01927419|3601395|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3768119|NCT01927419|3601396|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3768120|NCT01927419|3601397|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3768121|NCT01927419|3601395|B3|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3768122|NCT01927419|3601396|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3768123|NCT01927419|3601397|B1|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3768124|NCT01927419|3601395|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3768125|NCT01927419|3601396|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3768126|NCT01927419|3601397|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3768127|NCT01927419|3601395|B3|White||Race/Ethnicity, Customized||Participants|Number|139|139.0||||||
3768128|NCT01927419|3601396|B2|White||Race/Ethnicity, Customized||Participants|Number|47|47.0||||||
3768129|NCT01927419|3601397|B1|White||Race/Ethnicity, Customized||Participants|Number|92|92.0||||||
3768130|NCT01927419|3601395|B3||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3768131|NCT01927419|3601396|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3768132|NCT01927419|3601397|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3768133|NCT01927419|3601395|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3768134|NCT01927419|3601396|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3768135|NCT01927419|3601397|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3768136|NCT01927419|3601395|B3|75 years and older||Age, Customized||Participants|Number|17|17.0||||||
3768137|NCT01927419|3601396|B2|75 years and older||Age, Customized||Participants|Number|5|5.0||||||
3768138|NCT01927419|3601397|B1|75 years and older||Age, Customized||Participants|Number|12|12.0||||||
3768139|NCT01927419|3601395|B3|65 years and older to younger than 75 years||Age, Customized||Participants|Number|57|57.0||||||
3768140|NCT01927419|3601396|B2|65 years and older to younger than 75 years||Age, Customized||Participants|Number|22|22.0||||||
3768141|NCT01927419|3601397|B1|65 years and older to younger than 75 years||Age, Customized||Participants|Number|35|35.0||||||
3768142|NCT01927419|3601395|B3|Younger than 65 years||Age, Customized||Participants|Number|68|68.0||||||
3768143|NCT01927419|3601396|B2|Younger than 65 years||Age, Customized||Participants|Number|20|20.0||||||
3768144|NCT01927419|3601397|B1|Younger than 65 years||Age, Customized||Participants|Number|48|48.0||||||
3768145|NCT01927419|3601395|B3|||Age||Years|Mean|63.7|63.7|Standard Deviation|10.74|10.74|||
3768147|NCT01927419|3601397|B1|||Age||Years|Mean|63.3|63.3|Standard Deviation|11.02|11.02|||
3768148|NCT01927120|3601414|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3768149|NCT01927120|3601414|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3768150|NCT01927120|3601414|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3768151|NCT01927120|3601414|B1|||Age||years|Mean|49|49.0|Full Range|||22.0|70.0|
3768152|NCT01927120|3601414|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3768153|NCT01927120|3601414|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3768154|NCT01927120|3601414|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3768155|NCT01927055|3601429|B4|DBH Deficiency||Primary Diagnosis||participants|Number|0|0.0||||||
3768156|NCT01927055|3601430|B3|DBH Deficiency||Primary Diagnosis||participants|Number|0|0.0||||||
3768157|NCT01927055|3601431|B2|DBH Deficiency||Primary Diagnosis||participants|Number|0|0.0||||||
3768158|NCT01927055|3601432|B1|DBH Deficiency||Primary Diagnosis||participants|Number|0|0.0||||||
3768159|NCT01927055|3601429|B4|Multiple System Atrophy||Primary Diagnosis||participants|Number|7|7.0||||||
3768160|NCT01927055|3601430|B3|Multiple System Atrophy||Primary Diagnosis||participants|Number|2|2.0||||||
3768161|NCT01927055|3601431|B2|Multiple System Atrophy||Primary Diagnosis||participants|Number|4|4.0||||||
3768162|NCT01927055|3601432|B1|Multiple System Atrophy||Primary Diagnosis||participants|Number|1|1.0||||||
3768163|NCT01927055|3601429|B4|Pure Autonomic Failure||Primary Diagnosis||participants|Number|7|7.0||||||
3768164|NCT01927055|3601430|B3|Pure Autonomic Failure||Primary Diagnosis||participants|Number|3|3.0||||||
3768165|NCT01927055|3601431|B2|Pure Autonomic Failure||Primary Diagnosis||participants|Number|3|3.0||||||
3768166|NCT01927055|3601432|B1|Pure Autonomic Failure||Primary Diagnosis||participants|Number|1|1.0||||||
3768167|NCT01927055|3601429|B4|Parkinson's Disease||Primary Diagnosis||participants|Number|47|47.0||||||
3768168|NCT01927055|3601430|B3|Parkinson's Disease||Primary Diagnosis||participants|Number|18|18.0||||||
3768169|NCT01927055|3601431|B2|Parkinson's Disease||Primary Diagnosis||participants|Number|15|15.0||||||
3768170|NCT01927055|3601432|B1|Parkinson's Disease||Primary Diagnosis||participants|Number|14|14.0||||||
3768171|NCT01927055|3601429|B4|Canada||Region of Enrollment||participants|Number|8|8.0||||||
3768172|NCT01927055|3601430|B3|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3768173|NCT01927055|3601431|B2|Canada||Region of Enrollment||participants|Number|3|3.0||||||
3768174|NCT01927055|3601432|B1|Canada||Region of Enrollment||participants|Number|4|4.0||||||
3768175|NCT01927055|3601429|B4|United States||Region of Enrollment||participants|Number|53|53.0||||||
3768176|NCT01927055|3601430|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
3768177|NCT01927055|3601431|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3768178|NCT01927055|3601432|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3768179|NCT01927055|3601429|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3768180|NCT01927055|3601430|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768181|NCT01927055|3601431|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768182|NCT01927055|3601432|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3768183|NCT01927055|3601429|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768184|NCT01927055|3601430|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768185|NCT01927055|3601431|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768186|NCT01927055|3601432|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768187|NCT01927055|3601429|B4||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3768188|NCT01927055|3601430|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3768189|NCT01927055|3601431|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3768190|NCT01927055|3601432|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3768191|NCT01927055|3601429|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3768192|NCT01927055|3601430|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3768193|NCT01927055|3601431|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768194|NCT01927055|3601432|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3768195|NCT01927055|3601429|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768196|NCT01927055|3601430|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768197|NCT01927055|3601431|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768198|NCT01927055|3601432|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768199|NCT01927055|3601429|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768200|NCT01927055|3601430|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768201|NCT01927055|3601431|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768202|NCT01927055|3601432|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768203|NCT01927055|3601429|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768204|NCT01927055|3601430|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768205|NCT01927055|3601431|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768206|NCT01927055|3601432|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768207|NCT01927055|3601429|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768208|NCT01927055|3601430|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768209|NCT01927055|3601431|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768210|NCT01927055|3601432|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768211|NCT01927055|3601429|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3768212|NCT01927055|3601430|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3768213|NCT01927055|3601431|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3768214|NCT01927055|3601432|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3768215|NCT01927055|3601429|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3768216|NCT01927055|3601430|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768217|NCT01927055|3601431|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3768218|NCT01927055|3601432|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768219|NCT01927055|3601429|B4||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3768220|NCT01927055|3601430|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3768221|NCT01927055|3601431|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3768222|NCT01927055|3601432|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3768223|NCT01927055|3601429|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3768224|NCT01927055|3601430|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3768225|NCT01927055|3601431|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3768226|NCT01927055|3601432|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3768227|NCT01927055|3601429|B4|||Age||years|Mean|70.5|70.5|Standard Deviation|8.03|8.03|||
3768228|NCT01927055|3601430|B3|||Age||years|Mean|70.8|70.8|Standard Deviation|9.00|9.0|||
3768229|NCT01927055|3601431|B2|||Age||years|Mean|70.2|70.2|Standard Deviation|7.08|7.08|||
3768230|NCT01927055|3601432|B1|||Age||years|Mean|74.3|74.3|Standard Deviation|6.99|6.99|||
3768231|NCT01926977|3601441|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
3768232|NCT01926977|3601442|B2|United States||Region of Enrollment||participants|Number|53|53.0||||||
3768233|NCT01926977|3601443|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
3768234|NCT01926977|3601441|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768235|NCT01926977|3601442|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768236|NCT01926977|3601443|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768237|NCT01926977|3601441|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768238|NCT01926977|3601442|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768239|NCT01926977|3601443|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768240|NCT01926977|3601441|B3||White|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3768241|NCT01926977|3601442|B2||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3768242|NCT01926977|3601443|B1||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3768243|NCT01926977|3601441|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768244|NCT01926977|3601442|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768245|NCT01926977|3601443|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768246|NCT01926977|3601441|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3768247|NCT01926977|3601442|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3768248|NCT01926977|3601443|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768249|NCT01926977|3601441|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3768250|NCT01926977|3601442|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768251|NCT01926977|3601443|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3768252|NCT01926977|3601441|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768253|NCT01926977|3601442|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768254|NCT01926977|3601443|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768255|NCT01926977|3601441|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3768256|NCT01926977|3601442|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3768257|NCT01926977|3601443|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768258|NCT01926977|3601441|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3768259|NCT01926977|3601442|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3768260|NCT01926977|3601443|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3768261|NCT01926977|3601441|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3768262|NCT01926977|3601442|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3768317|NCT01926626|3601612|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
3768263|NCT01926977|3601443|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768264|NCT01926977|3601441|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3768265|NCT01926977|3601442|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3768266|NCT01926977|3601443|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3768267|NCT01926977|3601441|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3768268|NCT01926977|3601442|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3768269|NCT01926977|3601443|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3768270|NCT01926977|3601441|B3|||Age||years|Mean|78.6|78.6|Full Range|||65.0|96.0|
3768271|NCT01926977|3601442|B2|||Age||years|Mean|80.6|80.6|Full Range|||67.0|95.0|
3768272|NCT01926977|3601443|B1|||Age||years|Mean|76.3|76.3|Full Range|||65.0|96.0|
3768273|NCT01926977|3601441|B3||>=65 years|Age||Participants|Count of Participants|100|100.0||||||
3768274|NCT01926977|3601442|B2||>=65 years|Age||Participants|Count of Participants|53|53.0||||||
3768275|NCT01926977|3601443|B1||>=65 years|Age||Participants|Count of Participants|47|47.0||||||
3768276|NCT01926977|3601441|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3768277|NCT01926977|3601442|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3768278|NCT01926977|3601443|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3768279|NCT01926977|3601441|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3768280|NCT01926977|3601442|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3768281|NCT01926977|3601443|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3768282|NCT01926782|3601452|B7|||Calculated LDL-C in mmol/L||mmol/L|Mean|3.162|3.162|Standard Deviation|0.956|0.956|||
3768283|NCT01926782|3601453|B6|||Calculated LDL-C in mmol/L||mmol/L|Mean|3.785|3.785|Standard Deviation|0.868|0.868|||
3768284|NCT01926782|3601454|B5|||Calculated LDL-C in mmol/L||mmol/L|Mean|3.842|3.842|Standard Deviation|0.953|0.953|||
3768285|NCT01926782|3601455|B4|||Calculated LDL-C in mmol/L||mmol/L|Mean|3.392|3.392|Standard Deviation|0.787|0.787|||
3768286|NCT01926782|3601456|B3|||Calculated LDL-C in mmol/L||mmol/L|Mean|2.912|2.912|Standard Deviation|0.85|0.85|||
3768287|NCT01926782|3601457|B2|||Calculated LDL-C in mmol/L||mmol/L|Mean|2.977|2.977|Standard Deviation|0.933|0.933|||
3768288|NCT01926782|3601458|B1|||Calculated LDL-C in mmol/L||mmol/L|Mean|2.903|2.903|Standard Deviation|0.965|0.965|||
3768289|NCT01926782|3601452|B7|||Calculated LDL-C in mg/dL|Calculated LDL-C from Friedewald formula (LDL-C = Total cholesterol - High-density lipoprotein cholesterol - [Triglyceride/5])|mg/dL|Mean|122.1|122.1|Standard Deviation|36.9|36.9|||
3768290|NCT01926782|3601453|B6|||Calculated LDL-C in mg/dL|Calculated LDL-C from Friedewald formula (LDL-C = Total cholesterol - High-density lipoprotein cholesterol - [Triglyceride/5])|mg/dL|Mean|146.1|146.1|Standard Deviation|33.5|33.5|||
3768291|NCT01926782|3601454|B5|||Calculated LDL-C in mg/dL|Calculated LDL-C from Friedewald formula (LDL-C = Total cholesterol - High-density lipoprotein cholesterol - [Triglyceride/5])|mg/dL|Mean|148.4|148.4|Standard Deviation|36.8|36.8|||
3768292|NCT01926782|3601455|B4|||Calculated LDL-C in mg/dL|Calculated LDL-C from Friedewald formula (LDL-C = Total cholesterol - High-density lipoprotein cholesterol - [Triglyceride/5])|mg/dL|Mean|131|131.0|Standard Deviation|30.4|30.4|||
3768293|NCT01926782|3601456|B3|||Calculated LDL-C in mg/dL|Calculated LDL-C from Friedewald formula (LDL-C = Total cholesterol - High-density lipoprotein cholesterol - [Triglyceride/5])|mg/dL|Mean|112.4|112.4|Standard Deviation|32.8|32.8|||
3768294|NCT01926782|3601457|B2|||Calculated LDL-C in mg/dL|Calculated LDL-C from Friedewald formula (LDL-C = Total cholesterol - High-density lipoprotein cholesterol - [Triglyceride/5])|mg/dL|Mean|114.9|114.9|Standard Deviation|36|36.0|||
3768295|NCT01926782|3601458|B1|||Calculated LDL-C in mg/dL|Calculated LDL-C from Friedewald formula (LDL-C = Total cholesterol - High-density lipoprotein cholesterol - [Triglyceride/5])|mg/dL|Mean|112.1|112.1|Standard Deviation|37.3|37.3|||
3768296|NCT01926782|3601452|B7||Male|Sex: Female, Male||Participants|Count of Participants|462|462.0||||||
3768297|NCT01926782|3601453|B6||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3768298|NCT01926782|3601454|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3768299|NCT01926782|3601455|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3768300|NCT01926782|3601456|B3||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
3768301|NCT01926782|3601457|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3768302|NCT01926782|3601458|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3768303|NCT01926782|3601452|B7||Female|Sex: Female, Male||Participants|Count of Participants|341|341.0||||||
3768304|NCT01926782|3601453|B6||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3768305|NCT01926782|3601454|B5||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3768306|NCT01926782|3601455|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3768307|NCT01926782|3601456|B3||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3768308|NCT01926782|3601457|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3768309|NCT01926782|3601458|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3768310|NCT01926782|3601452|B7|||Age||years|Mean|60.8|60.8|Standard Deviation|10.1|10.1|||
3768311|NCT01926782|3601453|B6|||Age||years|Mean|59.2|59.2|Standard Deviation|10.8|10.8|||
3768312|NCT01926782|3601454|B5|||Age||years|Mean|59.3|59.3|Standard Deviation|11.3|11.3|||
3768313|NCT01926782|3601455|B4|||Age||years|Mean|59.4|59.4|Standard Deviation|10.2|10.2|||
3768314|NCT01926782|3601456|B3|||Age||years|Mean|61.6|61.6|Standard Deviation|10|10.0|||
3768315|NCT01926782|3601457|B2|||Age||years|Mean|60.7|60.7|Standard Deviation|9.1|9.1|||
3768316|NCT01926782|3601458|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|9.7|9.7|||
3768318|NCT01926626|3601612|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3768319|NCT01926626|3601612|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3768320|NCT01926626|3601612|B1|||Age||years|Mean|46.53|46.53|Standard Deviation|9.86|9.86|||
3768321|NCT01926626|3601612|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3768322|NCT01926626|3601612|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3768323|NCT01926626|3601612|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3768324|NCT01926509|3601622|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3768325|NCT01926509|3601623|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3768326|NCT01926509|3601624|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3768327|NCT01926509|3601625|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3768328|NCT01926509|3601626|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3768329|NCT01926509|3601622|B5||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3768330|NCT01926509|3601623|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3768331|NCT01926509|3601624|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3768332|NCT01926509|3601625|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3768333|NCT01926509|3601626|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3768334|NCT01926509|3601622|B5||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3768335|NCT01926509|3601623|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3768336|NCT01926509|3601624|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3768337|NCT01926509|3601625|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3768338|NCT01926509|3601626|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3768339|NCT01926509|3601622|B5||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3768340|NCT01926509|3601623|B4||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3768341|NCT01926509|3601624|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3768342|NCT01926509|3601625|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3768343|NCT01926509|3601626|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3768344|NCT01926509|3601622|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3768345|NCT01926509|3601623|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3768346|NCT01926509|3601624|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3768347|NCT01926509|3601625|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3768348|NCT01926509|3601626|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3768349|NCT01926119|3601646|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3768350|NCT01926119|3601646|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3768351|NCT01926119|3601646|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3768352|NCT01926119|3601646|B1|||Age||years|Mean|55.5|55.5|Full Range|||48.0|74.0|
3768353|NCT01926028|3601656|B4|United States||Region of Enrollment||Participants|Count of Participants|188|188.0||||||
3768354|NCT01926028|3601657|B3|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3768355|NCT01926028|3601658|B2|United States||Region of Enrollment||Participants|Count of Participants|89|89.0||||||
3768356|NCT01926028|3601659|B1|United States||Region of Enrollment||Participants|Count of Participants|85|85.0||||||
3768357|NCT01926028|3601656|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3768358|NCT01926028|3601657|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768359|NCT01926028|3601658|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3768360|NCT01926028|3601659|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768361|NCT01926028|3601656|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3768362|NCT01926028|3601657|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768363|NCT01926028|3601658|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3768364|NCT01926028|3601659|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3768365|NCT01926028|3601656|B4||White|Race (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
3768366|NCT01926028|3601657|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3768367|NCT01926028|3601658|B2||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3768368|NCT01926028|3601659|B1||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3768369|NCT01926028|3601656|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3768370|NCT01926028|3601657|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3768371|NCT01926028|3601658|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3768372|NCT01926028|3601659|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3768373|NCT01926028|3601656|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3768374|NCT01926028|3601657|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768375|NCT01926028|3601658|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768376|NCT01926028|3601659|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3768377|NCT01926028|3601656|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768378|NCT01926028|3601657|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768379|NCT01926028|3601658|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768380|NCT01926028|3601659|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768381|NCT01926028|3601656|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3768382|NCT01926028|3601657|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768383|NCT01926028|3601658|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768384|NCT01926028|3601659|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3768385|NCT01926028|3601656|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768386|NCT01926028|3601657|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768387|NCT01926028|3601658|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768388|NCT01926028|3601659|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768389|NCT01926028|3601656|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
3768390|NCT01926028|3601657|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3768391|NCT01926028|3601658|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3768392|NCT01926028|3601659|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3768393|NCT01926028|3601656|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3768394|NCT01926028|3601657|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3768395|NCT01926028|3601658|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3768396|NCT01926028|3601659|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3768397|NCT01926028|3601656|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3768398|NCT01926028|3601657|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3768399|NCT01926028|3601658|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3768400|NCT01926028|3601659|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3768401|NCT01926028|3601656|B4||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3768402|NCT01926028|3601657|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3768403|NCT01926028|3601658|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3768404|NCT01926028|3601659|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3768405|NCT01926028|3601656|B4|||Age||years|Mean|32.5|32.5|Standard Deviation|8.95|8.95|||
3768406|NCT01926028|3601657|B3|||Age||years|Mean|35.4|35.4|Standard Deviation|10.70|10.7|||
3768407|NCT01926028|3601658|B2|||Age||years|Mean|32.1|32.1|Standard Deviation|8.82|8.82|||
3768408|NCT01926028|3601659|B1|||Age||years|Mean|32.4|32.4|Standard Deviation|8.80|8.8|||
3768409|NCT01926015|3601695|B3||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3768410|NCT01926015|3601696|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3768411|NCT01926015|3601697|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3768412|NCT01926015|3601695|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3768413|NCT01926015|3601696|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3768414|NCT01926015|3601697|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3768415|NCT01926015|3601695|B3|||Age||Weeks|Median|9|9.0|Full Range|||6.0|10.0|
3768416|NCT01926015|3601696|B2|||Age||Weeks|Median|9|9.0|Full Range|||6.0|10.0|
3768417|NCT01926015|3601697|B1|||Age||Weeks|Median|8|8.0|Full Range|||6.0|10.0|
3768418|NCT01925950|3601728|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3768419|NCT01925950|3601729|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3768420|NCT01925950|3601730|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3768421|NCT01925950|3601728|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768422|NCT01925950|3601729|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768423|NCT01925950|3601730|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768424|NCT01925950|3601728|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768425|NCT01925950|3601729|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768426|NCT01925950|3601730|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768427|NCT01925950|3601728|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3768428|NCT01925950|3601729|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3768429|NCT01925950|3601730|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3768430|NCT01925950|3601728|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768431|NCT01925950|3601729|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768432|NCT01925950|3601730|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768433|NCT01925950|3601728|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768434|NCT01925950|3601729|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768649|NCT01925612|3601770|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3768435|NCT01925950|3601730|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768436|NCT01925950|3601728|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768437|NCT01925950|3601729|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768438|NCT01925950|3601730|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768439|NCT01925950|3601728|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768440|NCT01925950|3601729|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768441|NCT01925950|3601730|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768442|NCT01925950|3601728|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3768443|NCT01925950|3601729|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3768444|NCT01925950|3601730|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3768445|NCT01925950|3601728|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3768446|NCT01925950|3601729|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3768447|NCT01925950|3601730|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3768448|NCT01925950|3601728|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3768449|NCT01925950|3601729|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3768450|NCT01925950|3601730|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3768451|NCT01925950|3601728|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3768452|NCT01925950|3601729|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3768453|NCT01925950|3601730|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3768454|NCT01925950|3601728|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3768455|NCT01925950|3601729|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3768456|NCT01925950|3601730|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3768457|NCT01925781|3601737|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3768458|NCT01925781|3601738|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3768459|NCT01925781|3601739|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3768460|NCT01925781|3601737|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768461|NCT01925781|3601738|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768462|NCT01925781|3601739|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768463|NCT01925781|3601737|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768464|NCT01925781|3601738|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768465|NCT01925781|3601739|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768466|NCT01925781|3601737|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3768467|NCT01925781|3601738|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3768468|NCT01925781|3601739|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3768469|NCT01925781|3601737|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3768470|NCT01925781|3601738|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768471|NCT01925781|3601739|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3768472|NCT01925781|3601737|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768473|NCT01925781|3601738|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768474|NCT01925781|3601739|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768475|NCT01925781|3601737|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768476|NCT01925781|3601738|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768477|NCT01925781|3601739|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768478|NCT01925781|3601737|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768479|NCT01925781|3601738|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768480|NCT01925781|3601739|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768481|NCT01925781|3601737|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3768482|NCT01925781|3601738|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3768483|NCT01925781|3601739|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3768484|NCT01925781|3601737|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3768485|NCT01925781|3601738|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3768486|NCT01925781|3601739|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3768487|NCT01925781|3601737|B3|||Age||years|Mean|43|43.0|Full Range|||26.0|62.0|
3768488|NCT01925781|3601738|B2|||Age||years|Mean|44|44.0|Full Range|||34.0|61.0|
3768489|NCT01925781|3601739|B1|||Age||years|Mean|42|42.0|Full Range|||26.0|62.0|
3768490|NCT01925768|3601748|B3|||Duration of Psoriatic Arthritis|Duration of Psoriatic Arthritis is reported as the time since diagnosis|years|Mean|3.82|3.82|Standard Deviation|5.007|5.007|||
3768491|NCT01925768|3601749|B2|||Duration of Psoriatic Arthritis|Duration of Psoriatic Arthritis is reported as the time since diagnosis|years|Mean|4.04|4.04|Standard Deviation|4.482|4.482|||
3768590|NCT01925612|3601765|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768492|NCT01925768|3601750|B1|||Duration of Psoriatic Arthritis|Duration of Psoriatic Arthritis is reported as the time since diagnosis|years|Mean|3.59|3.59|Standard Deviation|5.497|5.497|||
3768493|NCT01925768|3601748|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3768494|NCT01925768|3601749|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3768495|NCT01925768|3601750|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3768496|NCT01925768|3601748|B3||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3768497|NCT01925768|3601749|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3768498|NCT01925768|3601750|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3768499|NCT01925768|3601748|B3|||Age||years|Mean|49.3|49.3|Standard Deviation|13.04|13.04|||
3768500|NCT01925768|3601749|B2|||Age||years|Mean|50.7|50.7|Standard Deviation|12.22|12.22|||
3768501|NCT01925768|3601750|B1|||Age||years|Mean|48.0|48.0|Standard Deviation|13.75|13.75|||
3768502|NCT01925703|3601759|B1|||Serum Creatinine Concentration||milligrams per deciliter|Mean|1.2|1.2|Standard Deviation|0.4|0.4|||
3768503|NCT01925703|3601759|B1|||Transferrin Saturation||percentage of transferrin saturation|Mean|11.7|11.7|Standard Deviation|4.6|4.6|||
3768504|NCT01925703|3601759|B1|||Ferritin Concentration||nanograms per milliliter|Mean|86.4|86.4|Standard Deviation|61.4|61.4|||
3768505|NCT01925703|3601759|B1|||Hemoglobin Concentration||grams per deciliter|Mean|10.6|10.6|Standard Deviation|1.4|1.4|||
3768506|NCT01925703|3601759|B1|||Ejection Fraction||percent|Mean|20.2|20.2|Standard Deviation|8.4|8.4|||
3768507|NCT01925703|3601759|B1|Class IV||NYHA Heart Failure Class||participants|Number|6|6.0||||||
3768508|NCT01925703|3601759|B1|Class III||NYHA Heart Failure Class||participants|Number|7|7.0||||||
3768509|NCT01925703|3601759|B1|Class II||NYHA Heart Failure Class||participants|Number|0|0.0||||||
3768510|NCT01925703|3601759|B1|Class I||NYHA Heart Failure Class||participants|Number|0|0.0||||||
3768511|NCT01925703|3601759|B1|||Body Mass Index||kilograms per meter squared|Mean|33.9|33.9|Standard Deviation|9.5|9.5|||
3768512|NCT01925703|3601759|B1|||Weight||kilograms|Mean|94.9|94.9|Standard Deviation|25|25.0|||
3768513|NCT01925703|3601759|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3768514|NCT01925703|3601759|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768515|NCT01925703|3601759|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768516|NCT01925703|3601759|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3768517|NCT01925703|3601759|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3768518|NCT01925703|3601759|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768519|NCT01925703|3601759|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768520|NCT01925703|3601759|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768521|NCT01925703|3601759|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3768522|NCT01925703|3601759|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3768523|NCT01925703|3601759|B1|||Age||years|Mean|58.9|58.9|Standard Deviation|12.8|12.8|||
3768524|NCT01925612|3601765|B6||2|Eastern Cooperative Oncology Group (ECOG) Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed <50% of the time; 3= In bed >50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|28|28.0||||||
3768525|NCT01925612|3601766|B5||2|Eastern Cooperative Oncology Group (ECOG) Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed <50% of the time; 3= In bed >50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|5|5.0||||||
3768526|NCT01925612|3601767|B4||2|Eastern Cooperative Oncology Group (ECOG) Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed <50% of the time; 3= In bed >50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|3|3.0||||||
3768527|NCT01925612|3601768|B3||2|Eastern Cooperative Oncology Group (ECOG) Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed <50% of the time; 3= In bed >50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|6|6.0||||||
3768528|NCT01925612|3601769|B2||2|Eastern Cooperative Oncology Group (ECOG) Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed <50% of the time; 3= In bed >50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|6|6.0||||||
3768529|NCT01925612|3601770|B1||2|Eastern Cooperative Oncology Group (ECOG) Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed <50% of the time; 3= In bed >50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|8|8.0||||||
3768530|NCT01925612|3601765|B6||1|Eastern Cooperative Oncology Group (ECOG) Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed <50% of the time; 3= In bed >50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|39|39.0||||||
3768531|NCT01925612|3601766|B5||1|Eastern Cooperative Oncology Group (ECOG) Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed <50% of the time; 3= In bed >50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|3|3.0||||||
3768532|NCT01925612|3601767|B4||1|Eastern Cooperative Oncology Group (ECOG) Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed <50% of the time; 3= In bed >50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|4|4.0||||||
3768533|NCT01925612|3601768|B3||1|Eastern Cooperative Oncology Group (ECOG) Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed <50% of the time; 3= In bed >50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|4|4.0||||||
3768534|NCT01925612|3601769|B2||1|Eastern Cooperative Oncology Group (ECOG) Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed <50% of the time; 3= In bed >50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|12|12.0||||||
3768535|NCT01925612|3601770|B1||1|Eastern Cooperative Oncology Group (ECOG) Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed <50% of the time; 3= In bed >50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|16|16.0||||||
3768536|NCT01925612|3601765|B6||0|Eastern Cooperative Oncology Group (ECOG) Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed <50% of the time; 3= In bed >50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|18|18.0||||||
3768537|NCT01925612|3601766|B5||0|Eastern Cooperative Oncology Group (ECOG) Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed <50% of the time; 3= In bed >50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|4|4.0||||||
3768538|NCT01925612|3601767|B4||0|Eastern Cooperative Oncology Group (ECOG) Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed <50% of the time; 3= In bed >50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|4|4.0||||||
3768539|NCT01925612|3601768|B3||0|Eastern Cooperative Oncology Group (ECOG) Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed <50% of the time; 3= In bed >50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|1|1.0||||||
3768540|NCT01925612|3601769|B2||0|Eastern Cooperative Oncology Group (ECOG) Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed <50% of the time; 3= In bed >50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|4|4.0||||||
3768541|NCT01925612|3601770|B1||0|Eastern Cooperative Oncology Group (ECOG) Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed <50% of the time; 3= In bed >50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|5|5.0||||||
3768542|NCT01925612|3601765|B6|Italy||Region of Enrollment||participants|Number|1|1.0||||||
3768543|NCT01925612|3601766|B5|Italy||Region of Enrollment||participants|Number|1|1.0||||||
3768544|NCT01925612|3601767|B4|Italy||Region of Enrollment||participants|Number|0|0.0||||||
3768545|NCT01925612|3601768|B3|Italy||Region of Enrollment||participants|Number|0|0.0||||||
3768546|NCT01925612|3601769|B2|Italy||Region of Enrollment||participants|Number|0|0.0||||||
3768547|NCT01925612|3601770|B1|Italy||Region of Enrollment||participants|Number|0|0.0||||||
3768548|NCT01925612|3601765|B6|Poland||Region of Enrollment||participants|Number|2|2.0||||||
3768549|NCT01925612|3601766|B5|Poland||Region of Enrollment||participants|Number|0|0.0||||||
3768550|NCT01925612|3601767|B4|Poland||Region of Enrollment||participants|Number|2|2.0||||||
3768551|NCT01925612|3601768|B3|Poland||Region of Enrollment||participants|Number|0|0.0||||||
3768552|NCT01925612|3601769|B2|Poland||Region of Enrollment||participants|Number|0|0.0||||||
3768553|NCT01925612|3601770|B1|Poland||Region of Enrollment||participants|Number|0|0.0||||||
3768554|NCT01925612|3601765|B6|Czechia||Region of Enrollment||participants|Number|2|2.0||||||
3768555|NCT01925612|3601766|B5|Czechia||Region of Enrollment||participants|Number|1|1.0||||||
3768556|NCT01925612|3601767|B4|Czechia||Region of Enrollment||participants|Number|1|1.0||||||
3768557|NCT01925612|3601768|B3|Czechia||Region of Enrollment||participants|Number|0|0.0||||||
3768558|NCT01925612|3601769|B2|Czechia||Region of Enrollment||participants|Number|0|0.0||||||
3768559|NCT01925612|3601770|B1|Czechia||Region of Enrollment||participants|Number|0|0.0||||||
3768560|NCT01925612|3601765|B6|United States||Region of Enrollment||participants|Number|82|82.0||||||
3768561|NCT01925612|3601766|B5|United States||Region of Enrollment||participants|Number|10|10.0||||||
3768562|NCT01925612|3601767|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
3768563|NCT01925612|3601768|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3768564|NCT01925612|3601769|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
3768565|NCT01925612|3601770|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3768566|NCT01925612|3601765|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3768567|NCT01925612|3601766|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768568|NCT01925612|3601767|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768569|NCT01925612|3601768|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3768570|NCT01925612|3601769|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3768571|NCT01925612|3601770|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3768572|NCT01925612|3601765|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768573|NCT01925612|3601766|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768574|NCT01925612|3601767|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768575|NCT01925612|3601768|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768576|NCT01925612|3601769|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768577|NCT01925612|3601770|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768578|NCT01925612|3601765|B6||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3768579|NCT01925612|3601766|B5||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3768580|NCT01925612|3601767|B4||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3768581|NCT01925612|3601768|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3768582|NCT01925612|3601769|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3768583|NCT01925612|3601770|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3768584|NCT01925612|3601765|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3768585|NCT01925612|3601766|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768586|NCT01925612|3601767|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3768587|NCT01925612|3601768|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3768588|NCT01925612|3601769|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3768589|NCT01925612|3601770|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3768591|NCT01925612|3601766|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768592|NCT01925612|3601767|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768593|NCT01925612|3601768|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768594|NCT01925612|3601769|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768595|NCT01925612|3601770|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768596|NCT01925612|3601765|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3768597|NCT01925612|3601766|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768598|NCT01925612|3601767|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768599|NCT01925612|3601768|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3768600|NCT01925612|3601769|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3768601|NCT01925612|3601770|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768602|NCT01925612|3601765|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768603|NCT01925612|3601766|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768604|NCT01925612|3601767|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768605|NCT01925612|3601768|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768606|NCT01925612|3601769|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768607|NCT01925612|3601770|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768608|NCT01925612|3601765|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3768609|NCT01925612|3601766|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768610|NCT01925612|3601767|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768611|NCT01925612|3601768|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3768612|NCT01925612|3601769|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3768613|NCT01925612|3601770|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768614|NCT01925612|3601765|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3768615|NCT01925612|3601766|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3768616|NCT01925612|3601767|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3768617|NCT01925612|3601768|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3768618|NCT01925612|3601769|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3768619|NCT01925612|3601770|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3768620|NCT01925612|3601765|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3768621|NCT01925612|3601766|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3768622|NCT01925612|3601767|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768623|NCT01925612|3601768|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3768624|NCT01925612|3601769|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3768625|NCT01925612|3601770|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3768626|NCT01925612|3601765|B6||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3768627|NCT01925612|3601766|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3768628|NCT01925612|3601767|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3768629|NCT01925612|3601768|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3768630|NCT01925612|3601769|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3768631|NCT01925612|3601770|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3768632|NCT01925612|3601765|B6||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3768633|NCT01925612|3601766|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3768634|NCT01925612|3601767|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3768635|NCT01925612|3601768|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3768636|NCT01925612|3601769|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3768637|NCT01925612|3601770|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3768638|NCT01925612|3601765|B6|||Age||years|Median|66|66.0|Full Range|||21.0|81.0|
3768639|NCT01925612|3601766|B5|||Age||years|Median|65|65.0|Full Range|||41.0|80.0|
3768640|NCT01925612|3601767|B4|||Age||years|Median|68|68.0|Full Range|||46.0|74.0|
3768641|NCT01925612|3601768|B3|||Age||years|Median|59|59.0|Full Range|||22.0|78.0|
3768642|NCT01925612|3601769|B2|||Age||years|Median|64|64.0|Full Range|||21.0|81.0|
3768643|NCT01925612|3601770|B1|||Age||years|Median|70|70.0|Full Range|||33.0|80.0|
3768644|NCT01925612|3601765|B6||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
3768645|NCT01925612|3601766|B5||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3768646|NCT01925612|3601767|B4||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3768647|NCT01925612|3601768|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3768648|NCT01925612|3601769|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3768650|NCT01925612|3601765|B6||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3768651|NCT01925612|3601766|B5||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3768652|NCT01925612|3601767|B4||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3768653|NCT01925612|3601768|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3768654|NCT01925612|3601769|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3768655|NCT01925612|3601770|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3768656|NCT01925612|3601765|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3768657|NCT01925612|3601766|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3768658|NCT01925612|3601767|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3768659|NCT01925612|3601768|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3768660|NCT01925612|3601769|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3768661|NCT01925612|3601770|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3768662|NCT01925469|3601811|B3|||Unilateral obstruction||participants|Number|7|7.0||||||
3768663|NCT01925469|3601812|B2|||Unilateral obstruction||participants|Number|3|3.0||||||
3768664|NCT01925469|3601813|B1|||Unilateral obstruction||participants|Number|4|4.0||||||
3768665|NCT01925469|3601811|B3|||Bilateral obstruction||participants|Number|3|3.0||||||
3768666|NCT01925469|3601812|B2|||Bilateral obstruction||participants|Number|1|1.0||||||
3768667|NCT01925469|3601813|B1|||Bilateral obstruction||participants|Number|2|2.0||||||
3768668|NCT01925469|3601811|B3|||Pre-medication|"Pre-medication includes ibuprofen or tylenol taken by patient prior to procedure."|participants|Number|28|28.0||||||
3768669|NCT01925469|3601812|B2|||Pre-medication|"Pre-medication includes ibuprofen or tylenol taken by patient prior to procedure."|participants|Number|13|13.0||||||
3768670|NCT01925469|3601813|B1|||Pre-medication|"Pre-medication includes ibuprofen or tylenol taken by patient prior to procedure."|participants|Number|15|15.0||||||
3768671|NCT01925469|3601811|B3|||History of chronic pelvic pain||participants|Number|4|4.0||||||
3768672|NCT01925469|3601812|B2|||History of chronic pelvic pain||participants|Number|2|2.0||||||
3768673|NCT01925469|3601813|B1|||History of chronic pelvic pain||participants|Number|2|2.0||||||
3768674|NCT01925469|3601811|B3|||History of dysmenorrhea||participants|Number|13|13.0||||||
3768675|NCT01925469|3601812|B2|||History of dysmenorrhea||participants|Number|6|6.0||||||
3768676|NCT01925469|3601813|B1|||History of dysmenorrhea||participants|Number|7|7.0||||||
3768677|NCT01925469|3601811|B3|||Nulligravid|A woman who has never been pregnant|participants|Number|17|17.0||||||
3768678|NCT01925469|3601812|B2|||Nulligravid|A woman who has never been pregnant|participants|Number|10|10.0||||||
3768679|NCT01925469|3601813|B1|||Nulligravid|A woman who has never been pregnant|participants|Number|7|7.0||||||
3768680|NCT01925469|3601811|B3|||Nulliparous|A woman who has never had a child.|participants|Number|24|24.0||||||
3768681|NCT01925469|3601812|B2|||Nulliparous|A woman who has never had a child.|participants|Number|12|12.0||||||
3768682|NCT01925469|3601813|B1|||Nulliparous|A woman who has never had a child.|participants|Number|12|12.0||||||
3768683|NCT01925469|3601811|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3768684|NCT01925469|3601812|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3768685|NCT01925469|3601813|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3768686|NCT01925469|3601811|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768687|NCT01925469|3601812|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768688|NCT01925469|3601813|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768689|NCT01925469|3601811|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3768690|NCT01925469|3601812|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768691|NCT01925469|3601813|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3768692|NCT01925469|3601811|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3768693|NCT01925469|3601812|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3768694|NCT01925469|3601813|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3768695|NCT01925469|3601811|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3768696|NCT01925469|3601812|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3768697|NCT01925469|3601813|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3768698|NCT01925469|3601811|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768699|NCT01925469|3601812|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768700|NCT01925469|3601813|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768701|NCT01925469|3601811|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3768702|NCT01925469|3601812|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3768703|NCT01925469|3601813|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3768704|NCT01925469|3601811|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768705|NCT01925469|3601812|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768706|NCT01925469|3601813|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768707|NCT01925469|3601811|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3768708|NCT01925469|3601812|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3768709|NCT01925469|3601813|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3768710|NCT01925469|3601811|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3768711|NCT01925469|3601812|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3768712|NCT01925469|3601813|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3768713|NCT01925469|3601811|B3|||Age||years|Mean|33.9|33.9|Standard Deviation|5.7|5.7|||
3768714|NCT01925469|3601812|B2|||Age||years|Mean|33.3|33.3|Standard Deviation|6.5|6.5|||
3768715|NCT01925469|3601813|B1|||Age||years|Mean|34.3|34.3|Standard Deviation|4.8|4.8|||
3768716|NCT01925417|3601824|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
3768717|NCT01925417|3601824|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768718|NCT01925417|3601824|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3768719|NCT01925417|3601824|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3768720|NCT01925417|3601824|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3768721|NCT01925417|3601824|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3768722|NCT01925417|3601824|B1|||Age||years|Mean|66.8|66.8|Full Range|||26.7|89.6|
3768723|NCT01925417|3601824|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3768724|NCT01925417|3601824|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3768725|NCT01925417|3601824|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3768726|NCT01925404|3601832|B5|||population density||people|Number|2510890|2510890.0||||||
3768727|NCT01925404|3601833|B4|||population density||people|Number|664846|664846.0||||||
3768728|NCT01925404|3601834|B3|||population density||people|Number|603596|603596.0||||||
3768729|NCT01925404|3601835|B2|||population density||people|Number|583346|583346.0||||||
3768730|NCT01925404|3601836|B1|||population density||people|Number|659102|659102.0||||||
3768731|NCT01925404|3601832|B5|||park size,||acres|Mean|8.4|8.4|Full Range|||1.5|25.8|
3768732|NCT01925404|3601833|B4|||park size,||acres|Mean|10.3|10.3|Full Range|||1.5|25.0|
3768733|NCT01925404|3601834|B3|||park size,||acres|Mean|8.0|8.0|Full Range|||1.9|25.8|
3768734|NCT01925404|3601835|B2|||park size,||acres|Mean|9.0|9.0|Full Range|||1.9|19.2|
3768735|NCT01925404|3601836|B1|||park size,||acres|Mean|6.1|6.1|Full Range|||2.6|10.6|
3768736|NCT01925404|3601832|B5||Male|Sex: Female, Male|Gender data are not relevant to parks|parks|Count of Units|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3768737|NCT01925404|3601833|B4||Male|Sex: Female, Male|Gender data are not relevant to parks|parks|Count of Units|NA|||||||Gender is not relevant to parks
3768738|NCT01925404|3601834|B3||Male|Sex: Female, Male|Gender data are not relevant to parks|parks|Count of Units|NA|||||||Gender is not relevant to parks
3768739|NCT01925404|3601835|B2||Male|Sex: Female, Male|Gender data are not relevant to parks|parks|Count of Units|NA|||||||Gender is not relevant to parks
3768740|NCT01925404|3601836|B1||Male|Sex: Female, Male|Gender data are not relevant to parks|parks|Count of Units|NA|||||||Gender is not relevant to parks
3768741|NCT01925404|3601832|B5||Female|Sex: Female, Male|Gender data are not relevant to parks|parks|Count of Units|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3768742|NCT01925404|3601833|B4||Female|Sex: Female, Male|Gender data are not relevant to parks|parks|Count of Units|NA|||||||Gender is not relevant to parks
3768743|NCT01925404|3601834|B3||Female|Sex: Female, Male|Gender data are not relevant to parks|parks|Count of Units|NA|||||||Gender is not relevant to parks
3768744|NCT01925404|3601835|B2||Female|Sex: Female, Male|Gender data are not relevant to parks|parks|Count of Units|NA|||||||Gender is not relevant to parks
3768745|NCT01925404|3601836|B1||Female|Sex: Female, Male|Gender data are not relevant to parks|parks|Count of Units|NA|||||||Gender is not relevant to parks
3768746|NCT01925404|3601832|B5||>=65 years|Age|Age data are not relevant to parks|parks|Count of Units|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3768747|NCT01925404|3601833|B4||>=65 years|Age|Age data are not relevant to parks|parks|Count of Units|NA|||||||Age is not relevant to parks
3768748|NCT01925404|3601834|B3||>=65 years|Age|Age data are not relevant to parks|parks|Count of Units|NA|||||||Age is not relevant to parks
3768749|NCT01925404|3601835|B2||>=65 years|Age|Age data are not relevant to parks|parks|Count of Units|NA|||||||Age is not relevant to parks
3768750|NCT01925404|3601836|B1||>=65 years|Age|Age data are not relevant to parks|parks|Count of Units|NA|||||||Age is not relevant to parks
3768751|NCT01925404|3601832|B5||Between 18 and 65 years|Age|Age data are not relevant to parks|parks|Count of Units|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3768752|NCT01925404|3601833|B4||Between 18 and 65 years|Age|Age data are not relevant to parks|parks|Count of Units|NA|||||||Age is not relevant to parks
3768753|NCT01925404|3601834|B3||Between 18 and 65 years|Age|Age data are not relevant to parks|parks|Count of Units|NA|||||||Age is not relevant to parks
3768754|NCT01925404|3601835|B2||Between 18 and 65 years|Age|Age data are not relevant to parks|parks|Count of Units|NA|||||||Age is not relevant to parks
3768755|NCT01925404|3601836|B1||Between 18 and 65 years|Age|Age data are not relevant to parks|parks|Count of Units|NA|||||||Age is not relevant to parks
3768756|NCT01925404|3601832|B5||<=18 years|Age|Age data are not relevant to parks|parks|Count of Units|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3768757|NCT01925404|3601833|B4||<=18 years|Age|Age data are not relevant to parks|parks|Count of Units|NA|||||||Age is not relevant to parks
3768758|NCT01925404|3601834|B3||<=18 years|Age|Age data are not relevant to parks|parks|Count of Units|NA|||||||Age is not relevant to parks
3768759|NCT01925404|3601835|B2||<=18 years|Age|Age data are not relevant to parks|parks|Count of Units|NA|||||||Age is not relevant to parks
3768760|NCT01925404|3601836|B1||<=18 years|Age|Age data are not relevant to parks|parks|Count of Units|NA|||||||Age is not relevant to parks
3768761|NCT01925274|3601853|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3768762|NCT01925274|3601854|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3768763|NCT01925274|3601855|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3768764|NCT01925274|3601856|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3768765|NCT01925274|3601853|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3768766|NCT01925274|3601854|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3768767|NCT01925274|3601855|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3768768|NCT01925274|3601856|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3768769|NCT01925274|3601853|B4|>=65 years||Age, Customized||participants|Number|6|6.0||||||
3768770|NCT01925274|3601854|B3|>=65 years||Age, Customized||participants|Number|2|2.0||||||
3768771|NCT01925274|3601855|B2|>=65 years||Age, Customized||participants|Number|2|2.0||||||
3768772|NCT01925274|3601856|B1|>=65 years||Age, Customized||participants|Number|2|2.0||||||
3768773|NCT01925274|3601853|B4|18-64 years||Age, Customized||participants|Number|13|13.0||||||
3768774|NCT01925274|3601854|B3|18-64 years||Age, Customized||participants|Number|4|4.0||||||
3768775|NCT01925274|3601855|B2|18-64 years||Age, Customized||participants|Number|4|4.0||||||
3768776|NCT01925274|3601856|B1|18-64 years||Age, Customized||participants|Number|5|5.0||||||
3768777|NCT01925274|3601853|B4|<18 years||Age, Customized||participants|Number|0|0.0||||||
3768778|NCT01925274|3601854|B3|<18 years||Age, Customized||participants|Number|0|0.0||6.7|6.7|||
3768779|NCT01925274|3601855|B2|<18 years||Age, Customized||participants|Number|0|0.0||6.1|6.1|||
3768780|NCT01925274|3601856|B1|<18 years||Age, Customized||participants|Number|0|0.0||7.8|7.8|||
3768781|NCT01925209|3601935|B5||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3768782|NCT01925209|3601936|B4||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3768783|NCT01925209|3601937|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3768784|NCT01925209|3601938|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3768785|NCT01925209|3601939|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3768786|NCT01925209|3601935|B5||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3768787|NCT01925209|3601936|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3768788|NCT01925209|3601937|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3768789|NCT01925209|3601938|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3768790|NCT01925209|3601939|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3768791|NCT01925209|3601935|B5|||Age||Years|Mean|68.1|68.1|Standard Deviation|8.20|8.2|||
3768792|NCT01925209|3601936|B4|||Age||Years|Mean|68.4|68.4|Standard Deviation|8.12|8.12|||
3768793|NCT01925209|3601937|B3|||Age||Years|Mean|69.4|69.4|Standard Deviation|7.91|7.91|||
3768794|NCT01925209|3601938|B2|||Age||Years|Mean|66.5|66.5|Standard Deviation|8.72|8.72|||
3768795|NCT01925209|3601939|B1|||Age||Years|Mean|68.0|68.0|Standard Deviation|7.93|7.93|||
3768796|NCT01925183|3601972|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3768797|NCT01925183|3601973|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3768798|NCT01925183|3601974|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3768799|NCT01925183|3601972|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3768800|NCT01925183|3601973|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3768801|NCT01925183|3601974|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3768802|NCT01925183|3601972|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3768803|NCT01925183|3601973|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3768804|NCT01925183|3601974|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3768805|NCT01925183|3601972|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3768806|NCT01925183|3601973|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3768807|NCT01925183|3601974|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3768808|NCT01925183|3601972|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3768809|NCT01925183|3601973|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3768810|NCT01925183|3601974|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3768811|NCT01925170|3601983|B1|Participants with Prior Mammogram||Breast Density of Participants with No Prior Mammogram||participants|Number|1631|1631.0||||||
3768812|NCT01925170|3601983|B1|Heterogeneously dense breasts||Breast Density of Participants with No Prior Mammogram||participants|Number|5|5.0||||||
3768813|NCT01925170|3601983|B1|Scattered fibroglandular densities||Breast Density of Participants with No Prior Mammogram||participants|Number|2|2.0||||||
3768814|NCT01925170|3601983|B1|None||Molecular Breast Imaging Prior to Study Entry||participants|Number|1459|1459.0||||||
3768815|NCT01925170|3601983|B1|> 730 days||Molecular Breast Imaging Prior to Study Entry||participants|Number|171|171.0||||||
3768816|NCT01925170|3601983|B1|415- 730 days||Molecular Breast Imaging Prior to Study Entry||participants|Number|8|8.0||||||
3768817|NCT01925170|3601983|B1|< 425 days||Molecular Breast Imaging Prior to Study Entry||participants|Number|0|0.0||||||
3768818|NCT01925170|3601983|B1|None||Mammogram Prior to Study Entry|A total of 7 women under the age of 50 with no prior mammogram were enrolled.|participants|Number|7|7.0||||||
3768819|NCT01925170|3601983|B1|>730 days||Mammogram Prior to Study Entry|A total of 7 women under the age of 50 with no prior mammogram were enrolled.|participants|Number|20|20.0||||||
3768884|NCT01924949|3602025|B1|||Age||years|Mean|62|62.0|Standard Deviation|8.7|8.7|||
3768820|NCT01925170|3601983|B1|425-730 days||Mammogram Prior to Study Entry|A total of 7 women under the age of 50 with no prior mammogram were enrolled.|participants|Number|301|301.0||||||
3768821|NCT01925170|3601983|B1|< 425 days||Mammogram Prior to Study Entry|A total of 7 women under the age of 50 with no prior mammogram were enrolled.|participants|Number|1310|1310.0||||||
3768822|NCT01925170|3601983|B1|None of the above risk factors||Risk Factors|"Although participants may have qualified for multiple risk factor categories, they were assigned to only one risk factor category in this table. These risk factors are listed in order of priority. The last two risk factors with respect to first and second-degree relatives with a history of breast cancer refer to subjects who qualified on the basis of family history but did not meet the Gail or Claus model risk threshold levels.~The Gail risk model focuses on nongenetic risk factors, with limited information on family history. The Claus risk model focuses on genetic risk factors."|participants|Number|693|693.0||||||
3768823|NCT01925170|3601983|B1|2 2nd-deg relatives with history of breast cancer||Risk Factors|"Although participants may have qualified for multiple risk factor categories, they were assigned to only one risk factor category in this table. These risk factors are listed in order of priority. The last two risk factors with respect to first and second-degree relatives with a history of breast cancer refer to subjects who qualified on the basis of family history but did not meet the Gail or Claus model risk threshold levels.~The Gail risk model focuses on nongenetic risk factors, with limited information on family history. The Claus risk model focuses on genetic risk factors."|participants|Number|56|56.0||||||
3768824|NCT01925170|3601983|B1|1 first-deg relative with history of breast cancer||Risk Factors|"Although participants may have qualified for multiple risk factor categories, they were assigned to only one risk factor category in this table. These risk factors are listed in order of priority. The last two risk factors with respect to first and second-degree relatives with a history of breast cancer refer to subjects who qualified on the basis of family history but did not meet the Gail or Claus model risk threshold levels.~The Gail risk model focuses on nongenetic risk factors, with limited information on family history. The Claus risk model focuses on genetic risk factors."|participants|Number|53|53.0||||||
3768825|NCT01925170|3601983|B1|Gail model 5 year risk ≥ 1.7%||Risk Factors|"Although participants may have qualified for multiple risk factor categories, they were assigned to only one risk factor category in this table. These risk factors are listed in order of priority. The last two risk factors with respect to first and second-degree relatives with a history of breast cancer refer to subjects who qualified on the basis of family history but did not meet the Gail or Claus model risk threshold levels.~The Gail risk model focuses on nongenetic risk factors, with limited information on family history. The Claus risk model focuses on genetic risk factors."|participants|Number|360|360.0||||||
3768826|NCT01925170|3601983|B1|Gail model 5 year risk ≥ 2.5%||Risk Factors|"Although participants may have qualified for multiple risk factor categories, they were assigned to only one risk factor category in this table. These risk factors are listed in order of priority. The last two risk factors with respect to first and second-degree relatives with a history of breast cancer refer to subjects who qualified on the basis of family history but did not meet the Gail or Claus model risk threshold levels.~The Gail risk model focuses on nongenetic risk factors, with limited information on family history. The Claus risk model focuses on genetic risk factors."|participants|Number|203|203.0||||||
3768827|NCT01925170|3601983|B1|Gail or Claus model lifetime risk ≥ 20%||Risk Factors|"Although participants may have qualified for multiple risk factor categories, they were assigned to only one risk factor category in this table. These risk factors are listed in order of priority. The last two risk factors with respect to first and second-degree relatives with a history of breast cancer refer to subjects who qualified on the basis of family history but did not meet the Gail or Claus model risk threshold levels.~The Gail risk model focuses on nongenetic risk factors, with limited information on family history. The Claus risk model focuses on genetic risk factors."|participants|Number|78|78.0||||||
3768828|NCT01925170|3601983|B1|Prior biopsy showing hyperplasia, etc.||Risk Factors|"Although participants may have qualified for multiple risk factor categories, they were assigned to only one risk factor category in this table. These risk factors are listed in order of priority. The last two risk factors with respect to first and second-degree relatives with a history of breast cancer refer to subjects who qualified on the basis of family history but did not meet the Gail or Claus model risk threshold levels.~The Gail risk model focuses on nongenetic risk factors, with limited information on family history. The Claus risk model focuses on genetic risk factors."|participants|Number|21|21.0||||||
3768829|NCT01925170|3601983|B1|Personal history of breast cancer||Risk Factors|"Although participants may have qualified for multiple risk factor categories, they were assigned to only one risk factor category in this table. These risk factors are listed in order of priority. The last two risk factors with respect to first and second-degree relatives with a history of breast cancer refer to subjects who qualified on the basis of family history but did not meet the Gail or Claus model risk threshold levels.~The Gail risk model focuses on nongenetic risk factors, with limited information on family history. The Claus risk model focuses on genetic risk factors."|participants|Number|166|166.0||||||
3768830|NCT01925170|3601983|B1|Chest, mediastinal, or axillary irradiation||Risk Factors|"Although participants may have qualified for multiple risk factor categories, they were assigned to only one risk factor category in this table. These risk factors are listed in order of priority. The last two risk factors with respect to first and second-degree relatives with a history of breast cancer refer to subjects who qualified on the basis of family history but did not meet the Gail or Claus model risk threshold levels.~The Gail risk model focuses on nongenetic risk factors, with limited information on family history. The Claus risk model focuses on genetic risk factors."|participants|Number|5|5.0||||||
3768831|NCT01925170|3601983|B1|Known mutation in BRCA1 or BRCA2 genes||Risk Factors|"Although participants may have qualified for multiple risk factor categories, they were assigned to only one risk factor category in this table. These risk factors are listed in order of priority. The last two risk factors with respect to first and second-degree relatives with a history of breast cancer refer to subjects who qualified on the basis of family history but did not meet the Gail or Claus model risk threshold levels.~The Gail risk model focuses on nongenetic risk factors, with limited information on family history. The Claus risk model focuses on genetic risk factors."|participants|Number|3|3.0||||||
3768832|NCT01925170|3601983|B1|Extremely dense||Mammographic Breast Density|Eligibility was determined by density assessed on a previous mammogram prior to study entry; mammographic density reported refers to density assessed from the study mammogram.|participants|Number|230|230.0||||||
3768833|NCT01925170|3601983|B1|Heterogeneously dense||Mammographic Breast Density|Eligibility was determined by density assessed on a previous mammogram prior to study entry; mammographic density reported refers to density assessed from the study mammogram.|participants|Number|1259|1259.0||||||
3768834|NCT01925170|3601983|B1|Scattered fibroglandular densities||Mammographic Breast Density|Eligibility was determined by density assessed on a previous mammogram prior to study entry; mammographic density reported refers to density assessed from the study mammogram.|participants|Number|149|149.0||||||
3768835|NCT01925170|3601983|B1|Almost entirely fat||Mammographic Breast Density|Eligibility was determined by density assessed on a previous mammogram prior to study entry; mammographic density reported refers to density assessed from the study mammogram.|participants|Number|0|0.0||||||
3768836|NCT01925170|3601983|B1|Surgical Menopause||Menopausal Status||participants|Number|76|76.0||||||
3768837|NCT01925170|3601983|B1|Postmenopausal||Menopausal Status||participants|Number|1021|1021.0||||||
3768838|NCT01925170|3601983|B1|Peri-menopausal||Menopausal Status||participants|Number|186|186.0||||||
3768839|NCT01925170|3601983|B1|Premenopausal||Menopausal Status||participants|Number|355|355.0||||||
3768840|NCT01925170|3601983|B1|United States||Region of Enrollment||participants|Number|1638|1638.0||||||
3768841|NCT01925170|3601983|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3768842|NCT01925170|3601983|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768843|NCT01925170|3601983|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1605|1605.0||||||
3768844|NCT01925170|3601983|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3768845|NCT01925170|3601983|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768846|NCT01925170|3601983|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3768847|NCT01925170|3601983|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3768848|NCT01925170|3601983|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3768849|NCT01925170|3601983|B1||Female|Sex: Female, Male||Participants|Count of Participants|1638|1638.0||||||
3768850|NCT01925170|3601983|B1|||Age|At the beginning of the study, the protocol inclusion criteria allowed women aged 25 years and older to participate. Between the dates of 5/11/09 and 4/20/10 there were 13 women under age 40 enrolled. On 4/20/2010 a protocol revision was approved by the Institutional Review Board to allow women aged 40 and older. In the final analyzable dataset of 1585 women who completed the study and had reference standard, 6 women were under age 40.|years|Mean|58.1|58.1|Full Range|||31.0|86.0|
3768851|NCT01925144|3602001|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3768852|NCT01925144|3602001|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768853|NCT01925144|3602001|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3768854|NCT01925144|3602001|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3768855|NCT01925144|3602001|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768856|NCT01925144|3602001|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768857|NCT01925144|3602001|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768858|NCT01925144|3602001|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768859|NCT01925144|3602001|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768860|NCT01925144|3602001|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3768861|NCT01925144|3602001|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768862|NCT01925144|3602001|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3768863|NCT01925144|3602001|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3768864|NCT01925144|3602001|B1|||Age||years|Mean|44.1|44.1|Standard Deviation|14.1|14.1|||
3768865|NCT01924975|3602012|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3768866|NCT01924975|3602013|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3768867|NCT01924975|3602014|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3768868|NCT01924975|3602012|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3768869|NCT01924975|3602013|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3768870|NCT01924975|3602014|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3768871|NCT01924975|3602012|B3|||Age||months|Median|11|11.0|Inter-Quartile Range|||5.0|26.0|
3768872|NCT01924975|3602013|B2|||Age||months|Median|8|8.0|Inter-Quartile Range|||4.0|26.0|
3768873|NCT01924975|3602014|B1|||Age||months|Median|12|12.0|Inter-Quartile Range|||6.0|29.0|
3768874|NCT01924949|3602025|B1|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|2|2.0||||||
3768875|NCT01924949|3602025|B1|< 800,000 IU/mL||HCV RNA Category||participants|Number|3|3.0||||||
3768876|NCT01924949|3602025|B1|||HCV RNA||log10 IU/mL|Mean|5.9|5.9|Standard Deviation|0.58|0.58|||
3768877|NCT01924949|3602025|B1|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3768878|NCT01924949|3602025|B1|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
3768879|NCT01924949|3602025|B1|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3768880|NCT01924949|3602025|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3768881|NCT01924949|3602025|B1|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3768882|NCT01924949|3602025|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3768883|NCT01924949|3602025|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3768885|NCT01924871|3602034|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3768886|NCT01924871|3602035|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3768887|NCT01924871|3602036|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3768888|NCT01924871|3602034|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3768889|NCT01924871|3602035|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3768890|NCT01924871|3602036|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3768891|NCT01924871|3602034|B3|||Age||years|Mean|42.17|42.17|Standard Deviation|10.58|10.58|||
3768892|NCT01924871|3602035|B2|||Age||years|Mean|43.24|43.24|Standard Deviation|9.39|9.39|||
3768893|NCT01924871|3602036|B1|||Age||years|Mean|38.76|38.76|Standard Deviation|11.53|11.53|||
3768894|NCT01924845|3602043|B1|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3768895|NCT01924845|3602043|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3768896|NCT01924845|3602043|B1|Germany||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3768897|NCT01924845|3602043|B1|Belgium||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3768898|NCT01924845|3602043|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3768899|NCT01924845|3602043|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3768900|NCT01924845|3602043|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3768901|NCT01924845|3602043|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3768902|NCT01924845|3602043|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3768903|NCT01924845|3602043|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3768904|NCT01924845|3602043|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768905|NCT01924845|3602043|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3768906|NCT01924845|3602043|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3768907|NCT01924845|3602043|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3768908|NCT01924845|3602043|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3768909|NCT01924845|3602043|B1|> 65||Age, Customized||Participants|Count of Participants|2|2.0||||||
3768910|NCT01924845|3602043|B1|18-65||Age, Customized||Participants|Count of Participants|22|22.0||||||
3768911|NCT01924845|3602043|B1|||Age||years|Mean|47.9|47.9|Standard Deviation|13.27|13.27|||
3768912|NCT01924767|3602051|B6||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3768913|NCT01924767|3602052|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3768914|NCT01924767|3602053|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3768915|NCT01924767|3602054|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3768916|NCT01924767|3602055|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3768917|NCT01924767|3602056|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3768918|NCT01924767|3602051|B6||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3768919|NCT01924767|3602052|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3768920|NCT01924767|3602053|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3768921|NCT01924767|3602054|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3768922|NCT01924767|3602055|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3768923|NCT01924767|3602056|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3768924|NCT01924767|3602051|B6|||Age||years|Mean|56.9|56.9|Standard Deviation|8.9|8.9|||
3768925|NCT01924767|3602052|B5|||Age||years|Mean|60.3|60.3|Standard Deviation|5.6|5.6|||
3768926|NCT01924767|3602053|B4|||Age||years|Mean|58.9|58.9|Standard Deviation|8.8|8.8|||
3768927|NCT01924767|3602054|B3|||Age||years|Mean|51.8|51.8|Standard Deviation|10.7|10.7|||
3768928|NCT01924767|3602055|B2|||Age||years|Mean|53.9|53.9|Standard Deviation|10.9|10.9|||
3768929|NCT01924767|3602056|B1|||Age||years|Mean|58.9|58.9|Standard Deviation|6.4|6.4|||
3768930|NCT01924559|3602160|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3768931|NCT01924559|3602160|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3768932|NCT01924559|3602160|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3768933|NCT01924559|3602160|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3768934|NCT01924559|3602160|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3768935|NCT01924533|3602174|B3|None||Gastrectomy Status|ATM Negative Population|Participants|Count of Participants|37|37.0||||||
3768936|NCT01924533|3602175|B2|None||Gastrectomy Status|ATM Negative Population|Participants|Count of Participants|21|21.0||||||
3768937|NCT01924533|3602176|B1|None||Gastrectomy Status|ATM Negative Population|Participants|Count of Participants|16|16.0||||||
3768938|NCT01924533|3602174|B3|Partial||Gastrectomy Status|ATM Negative Population|Participants|Count of Participants|31|31.0||||||
3768939|NCT01924533|3602175|B2|Partial||Gastrectomy Status|ATM Negative Population|Participants|Count of Participants|12|12.0||||||
3768940|NCT01924533|3602176|B1|Partial||Gastrectomy Status|ATM Negative Population|Participants|Count of Participants|19|19.0||||||
3768941|NCT01924533|3602174|B3|Full||Gastrectomy Status|ATM Negative Population|Participants|Count of Participants|26|26.0||||||
3768942|NCT01924533|3602175|B2|Full||Gastrectomy Status|ATM Negative Population|Participants|Count of Participants|13|13.0||||||
3768943|NCT01924533|3602176|B1|Full||Gastrectomy Status|ATM Negative Population|Participants|Count of Participants|13|13.0||||||
3768944|NCT01924533|3602174|B3|Partial||Gastrectomy Status||Participants|Count of Participants|149|149.0||||||
3768945|NCT01924533|3602175|B2|Partial||Gastrectomy Status||Participants|Count of Participants|72|72.0||||||
3768946|NCT01924533|3602176|B1|Partial||Gastrectomy Status||Participants|Count of Participants|77|77.0||||||
3768947|NCT01924533|3602174|B3|None||Gastrectomy Status||Participants|Count of Participants|258|258.0||||||
3768948|NCT01924533|3602175|B2|None||Gastrectomy Status||Participants|Count of Participants|122|122.0||||||
3768949|NCT01924533|3602176|B1|None||Gastrectomy Status||Participants|Count of Participants|136|136.0||||||
3768950|NCT01924533|3602174|B3|Full||Gastrectomy Status||Participants|Count of Participants|118|118.0||||||
3768951|NCT01924533|3602175|B2|Full||Gastrectomy Status||Participants|Count of Participants|68|68.0||||||
3768952|NCT01924533|3602176|B1|Full||Gastrectomy Status||Participants|Count of Participants|50|50.0||||||
3768953|NCT01924533|3602174|B3|Unknown||ATM Status||Participants|Number|35|35.0||||||
3768954|NCT01924533|3602175|B2|Unknown||ATM Status||Participants|Number|20|20.0||||||
3768955|NCT01924533|3602176|B1|Unknown||ATM Status||Participants|Number|15|15.0||||||
3768956|NCT01924533|3602174|B3|Positive||ATM Status||Participants|Number|396|396.0||||||
3768957|NCT01924533|3602175|B2|Positive||ATM Status||Participants|Number|196|196.0||||||
3768958|NCT01924533|3602176|B1|Positive||ATM Status||Participants|Number|200|200.0||||||
3768959|NCT01924533|3602174|B3|Negative||ATM Status||Participants|Number|94|94.0||||||
3768960|NCT01924533|3602175|B2|Negative||ATM Status||Participants|Number|46|46.0||||||
3768961|NCT01924533|3602176|B1|Negative||ATM Status||Participants|Number|48|48.0||||||
3768962|NCT01924533|3602174|B3|Asian||Race/Ethnicity, Customized|ATM Negative Population|Participants|Count of Participants|94|94.0||||||
3768963|NCT01924533|3602175|B2|Asian||Race/Ethnicity, Customized|ATM Negative Population|Participants|Count of Participants|46|46.0||||||
3768964|NCT01924533|3602176|B1|Asian||Race/Ethnicity, Customized|ATM Negative Population|Participants|Count of Participants|48|48.0||||||
3768965|NCT01924533|3602174|B3|Not Hispanic or Latino||Race/Ethnicity, Customized|ATM Negative Population|Participants|Count of Participants|94|94.0||||||
3768966|NCT01924533|3602175|B2|Not Hispanic or Latino||Race/Ethnicity, Customized|ATM Negative Population|Participants|Count of Participants|46|46.0||||||
3768967|NCT01924533|3602176|B1|Not Hispanic or Latino||Race/Ethnicity, Customized|ATM Negative Population|Participants|Count of Participants|48|48.0||||||
3768968|NCT01924533|3602174|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|525|525.0||||||
3768969|NCT01924533|3602175|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|262|262.0||||||
3768970|NCT01924533|3602176|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|263|263.0||||||
3768971|NCT01924533|3602174|B3|Not Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|525|525.0||||||
3768972|NCT01924533|3602175|B2|Not Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|262|262.0||||||
3768973|NCT01924533|3602176|B1|Not Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|263|263.0||||||
3768974|NCT01924533|3602174|B3||Male|Sex: Female, Male||Participants|Count of Participants|359|359.0||||||
3768975|NCT01924533|3602175|B2||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
3768976|NCT01924533|3602176|B1||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3768977|NCT01924533|3602174|B3||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3768978|NCT01924533|3602175|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3768979|NCT01924533|3602176|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3768980|NCT01924533|3602174|B3|>=65||Age, Customized|ATM Negative Population|Participants|Count of Participants|29|29.0||||||
3768981|NCT01924533|3602175|B2|>=65||Age, Customized|ATM Negative Population|Participants|Count of Participants|15|15.0||||||
3768982|NCT01924533|3602176|B1|>=65||Age, Customized|ATM Negative Population|Participants|Count of Participants|14|14.0||||||
3768983|NCT01924533|3602174|B3|>=50 - <65||Age, Customized|ATM Negative Population|Participants|Count of Participants|46|46.0||||||
3768984|NCT01924533|3602175|B2|>=50 - <65||Age, Customized|ATM Negative Population|Participants|Count of Participants|24|24.0||||||
3768985|NCT01924533|3602176|B1|>=50 - <65||Age, Customized|ATM Negative Population|Participants|Count of Participants|22|22.0||||||
3768986|NCT01924533|3602174|B3|>=18 - <50||Age, Customized|ATM Negative Population|Participants|Count of Participants|19|19.0||||||
3768987|NCT01924533|3602175|B2|>=18 - <50||Age, Customized|ATM Negative Population|Participants|Count of Participants|7|7.0||||||
3768988|NCT01924533|3602176|B1|>=18 - <50||Age, Customized|ATM Negative Population|Participants|Count of Participants|12|12.0||||||
3768989|NCT01924533|3602174|B3|>=65||Age, Customized||Participants|Count of Participants|150|150.0||||||
3768990|NCT01924533|3602175|B2|>=65||Age, Customized||Participants|Count of Participants|70|70.0||||||
3768991|NCT01924533|3602176|B1|>=65||Age, Customized||Participants|Count of Participants|80|80.0||||||
3768992|NCT01924533|3602174|B3|>=50 - <65||Age, Customized||Participants|Count of Participants|243|243.0||||||
3768993|NCT01924533|3602175|B2|>=50 - <65||Age, Customized||Participants|Count of Participants|128|128.0||||||
3768994|NCT01924533|3602176|B1|>=50 - <65||Age, Customized||Participants|Count of Participants|115|115.0||||||
3768995|NCT01924533|3602174|B3|>=18 - <50||Age, Customized||Participants|Count of Participants|132|132.0||||||
3768996|NCT01924533|3602175|B2|>=18 - <50||Age, Customized||Participants|Count of Participants|64|64.0||||||
3768997|NCT01924533|3602176|B1|>=18 - <50||Age, Customized||Participants|Count of Participants|68|68.0||||||
3768998|NCT01924533|3602174|B3|||Age|ATM Negative Population|Years|Mean|58.9|58.9|Standard Deviation|11.18|11.18|||
3768999|NCT01924533|3602175|B2|||Age|ATM Negative Population|Years|Mean|60.9|60.9|Standard Deviation|9.90|9.9|||
3769000|NCT01924533|3602176|B1|||Age|ATM Negative Population|Years|Mean|57.0|57.0|Standard Deviation|12.08|12.08|||
3769001|NCT01924533|3602174|B3|||Age||Years|Mean|57.2|57.2|Standard Deviation|11.52|11.52|22.0|83.0|
3769002|NCT01924533|3602175|B2|||Age||Years|Mean|57.3|57.3|Standard Deviation|11.14|11.14|26.0|83.0|
3769003|NCT01924533|3602176|B1|||Age||Years|Mean|57.1|57.1|Standard Deviation|11.90|11.9|22.0|79.0|
3769004|NCT01924429|3602205|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3769005|NCT01924429|3602206|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3769006|NCT01924429|3602207|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3769007|NCT01924429|3602205|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3769008|NCT01924429|3602206|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3769009|NCT01924429|3602207|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3769010|NCT01924429|3602205|B3|||Age||years|Mean|35.84|35.84|Standard Deviation|10.25|10.25|||
3769011|NCT01924429|3602206|B2|||Age||years|Mean|37.27|37.27|Standard Deviation|11.81|11.81|||
3769012|NCT01924429|3602207|B1|||Age||years|Mean|35.46|35.46|Standard Deviation|11.82|11.82|||
3769013|NCT01924390|3602238|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3769014|NCT01924390|3602239|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3769015|NCT01924390|3602240|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3769016|NCT01924390|3602238|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3769017|NCT01924390|3602239|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3769018|NCT01924390|3602240|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3769019|NCT01924390|3602238|B3|||Age||years|Mean|52|52.0|Full Range|||22.0|78.0|
3769020|NCT01924390|3602239|B2|||Age||years|Mean|53|53.0|Full Range|||29.0|72.0|
3769021|NCT01924390|3602240|B1|||Age||years|Mean|51|51.0|Full Range|||22.0|78.0|
3769022|NCT01924364|3602251|B1||Never smoker|Smoker||Participants|Count of Participants|5|5.0||||||
3769023|NCT01924364|3602251|B1||Smoker, former|Smoker||Participants|Count of Participants|0|0.0||||||
3769024|NCT01924364|3602251|B1||Smoker, current|Smoker||Participants|Count of Participants|2|2.0||||||
3769025|NCT01924364|3602251|B1||Retired|Employment|Working full time, part time, unemployed, or retired|Participants|Count of Participants|1|1.0||||||
3769026|NCT01924364|3602251|B1||Unemployed|Employment|Working full time, part time, unemployed, or retired|Participants|Count of Participants|4|4.0||||||
3769027|NCT01924364|3602251|B1||Part time|Employment|Working full time, part time, unemployed, or retired|Participants|Count of Participants|1|1.0||||||
3769028|NCT01924364|3602251|B1||Full time|Employment|Working full time, part time, unemployed, or retired|Participants|Count of Participants|1|1.0||||||
3769029|NCT01924364|3602251|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3769030|NCT01924364|3602251|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769031|NCT01924364|3602251|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3769032|NCT01924364|3602251|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769033|NCT01924364|3602251|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3769034|NCT01924364|3602251|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3769035|NCT01924364|3602251|B1|||Age||years|Mean|53.3|53.3|Standard Deviation|12.3|12.3|||
3769036|NCT01924299|3602266|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3769037|NCT01924299|3602267|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3769038|NCT01924299|3602268|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3769039|NCT01924299|3602266|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769040|NCT01924299|3602267|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769041|NCT01924299|3602268|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769042|NCT01924299|3602266|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3769043|NCT01924299|3602267|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3769044|NCT01924299|3602268|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3769045|NCT01924299|3602266|B3||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3769046|NCT01924299|3602267|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3769047|NCT01924299|3602268|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3769048|NCT01924299|3602266|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3769049|NCT01924299|3602267|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769050|NCT01924299|3602268|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3769051|NCT01924299|3602266|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769052|NCT01924299|3602267|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769053|NCT01924299|3602268|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769054|NCT01924299|3602266|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3769055|NCT01924299|3602267|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3769056|NCT01924299|3602268|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769057|NCT01924299|3602266|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769058|NCT01924299|3602267|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769059|NCT01924299|3602268|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769060|NCT01924299|3602266|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769061|NCT01924299|3602267|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769062|NCT01924299|3602268|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769063|NCT01924299|3602266|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3769064|NCT01924299|3602267|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3769065|NCT01924299|3602268|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3769066|NCT01924299|3602266|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769067|NCT01924299|3602267|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769068|NCT01924299|3602268|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769069|NCT01924299|3602266|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3769070|NCT01924299|3602267|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3769071|NCT01924299|3602268|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3769072|NCT01924299|3602266|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3769073|NCT01924299|3602267|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3769074|NCT01924299|3602268|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3769075|NCT01924299|3602266|B3|||Age||years|Mean|42.5|42.5|Standard Deviation|14.2|14.2|||
3769076|NCT01924299|3602267|B2|||Age||years|Mean|42.7|42.7|Standard Deviation|13.7|13.7|||
3769077|NCT01924299|3602268|B1|||Age||years|Mean|42.3|42.3|Standard Deviation|15.0|15.0|||
3769078|NCT01924182|3602289|B3|||Baseline 23-item toxicity score|A subset of 23 specific items related to opioid side effects from the Common Terminology Criteria for Adverse Events from the National Cancer Institute. The item scores were summed. The range of the total score is 0 (best case) to 90 (worst case).|units on a scale|Mean|8.7|8.7|Standard Deviation|3.8|3.8|||
3769079|NCT01924182|3602291|B1|||Baseline 23-item toxicity score|A subset of 23 specific items related to opioid side effects from the Common Terminology Criteria for Adverse Events from the National Cancer Institute. The item scores were summed. The range of the total score is 0 (best case) to 90 (worst case).|units on a scale|Mean|8.7|8.7|Standard Deviation|3.8|3.8|||
3769080|NCT01924182|3602289|B3|||Baseline patient-reported pain diary score|Average of 5 days of a patient-reported pain diary. The scale ranges from 0 (no pain) to 10 (pain as bad as you can imagine).|units on a scale|Mean|7.0|7.0|Standard Deviation|1.4|1.4|||
3769081|NCT01924182|3602291|B1|||Baseline patient-reported pain diary score|Average of 5 days of a patient-reported pain diary. The scale ranges from 0 (no pain) to 10 (pain as bad as you can imagine).|units on a scale|Mean|7.0|7.0|Standard Deviation|1.4|1.4|||
3769082|NCT01924182|3602289|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3769083|NCT01924182|3602291|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3769084|NCT01924182|3602289|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3769085|NCT01924182|3602291|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3769086|NCT01924182|3602289|B3|||Age||years|Mean|56.2|56.2|Standard Deviation|11.8|11.8|||
3769087|NCT01924182|3602291|B1|||Age||years|Mean|56.2|56.2|Standard Deviation|11.8|11.8|||
3769088|NCT01924169|3602304|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3769089|NCT01924169|3602304|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769090|NCT01924169|3602304|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769091|NCT01924169|3602304|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3769092|NCT01924169|3602304|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769093|NCT01924169|3602304|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769094|NCT01924169|3602304|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769095|NCT01924169|3602304|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769096|NCT01924169|3602304|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769097|NCT01924169|3602304|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3769098|NCT01924169|3602304|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769099|NCT01924169|3602304|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3769100|NCT01924169|3602304|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3769101|NCT01924169|3602304|B1|||Age||years|Median|65|65.0|Full Range|||48.0|68.0|
3769102|NCT01924169|3602304|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3769103|NCT01924169|3602304|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3769104|NCT01924169|3602304|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3769105|NCT01923896|3602309|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3769106|NCT01923896|3602310|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3769107|NCT01923896|3602311|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3769108|NCT01923896|3602309|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3769109|NCT01923896|3602310|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3769110|NCT01923896|3602311|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3769111|NCT01923896|3602309|B3|||Age|Months|Months|Mean|33.1|33.1|Standard Deviation|10.7|10.7|||
3769112|NCT01923896|3602310|B2|||Age|Months|Months|Mean|32.3|32.3|Standard Deviation|11.9|11.9|||
3769113|NCT01923896|3602311|B1|||Age|Months|Months|Mean|33.9|33.9|Standard Deviation|10.1|10.1|||
3769114|NCT01923805|3602324|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3769115|NCT01923805|3602325|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3769116|NCT01923805|3602326|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3769117|NCT01923805|3602324|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3769118|NCT01923805|3602325|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3769119|NCT01923805|3602326|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3769120|NCT01923805|3602324|B3|||Age||years|Mean|60.1|60.1|Full Range|||48.0|69.0|
3769121|NCT01923805|3602325|B2|||Age||years|Mean|57.8|57.8|Full Range|||48.0|66.0|
3769122|NCT01923805|3602326|B1|||Age||years|Mean|64|64.0|Full Range|||59.0|69.0|
3769123|NCT01923740|3602333|B3|China||Region of Enrollment||Participants|Count of Participants|459|459.0||||||
3769124|NCT01923740|3602334|B2|China||Region of Enrollment||Participants|Count of Participants|232|232.0||||||
3769125|NCT01923740|3602335|B1|China||Region of Enrollment||Participants|Count of Participants|227|227.0||||||
3769126|NCT01923740|3602333|B3||Male|Sex: Female, Male||Participants|Count of Participants|332|332.0||||||
3769127|NCT01923740|3602334|B2||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3769128|NCT01923740|3602335|B1||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3769129|NCT01923740|3602333|B3||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3769130|NCT01923740|3602334|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3769131|NCT01923740|3602335|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3769132|NCT01923740|3602333|B3|||Age||years|Mean|57.4|57.4|Standard Deviation|10.5|10.5|||
3769133|NCT01923740|3602334|B2|||Age||years|Mean|57.7|57.7|Standard Deviation|9.6|9.6|||
3769134|NCT01923740|3602335|B1|||Age||years|Mean|57.1|57.1|Standard Deviation|11.4|11.4|||
3769135|NCT01923480|3602550|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3769136|NCT01923480|3602551|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3769137|NCT01923480|3602552|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3769138|NCT01923480|3602553|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3769139|NCT01923480|3602550|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3769140|NCT01923480|3602551|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3769141|NCT01923480|3602552|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3769142|NCT01923480|3602553|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3769143|NCT01923480|3602550|B4|||Age|Age at informed consent.|Years|Mean|63.64|63.64|Standard Deviation|11.00|11.0|||
3769144|NCT01923480|3602551|B3|||Age|Age at informed consent.|Years|Mean|60.50|60.5|Standard Deviation|6.40|6.4|||
3769145|NCT01923480|3602552|B2|||Age|Age at informed consent.|Years|Mean|69.25|69.25|Standard Deviation|14.93|14.93|||
3769146|NCT01923480|3602553|B1|||Age|Age at informed consent.|Years|Mean|60.33|60.33|Standard Deviation|10.50|10.5|||
3769147|NCT01923467|3602713|B1|||Number of cigarettes smoked per day||Cigarettes|Mean|16.0|16.0|Standard Deviation|9.2|9.2|||
3769148|NCT01923467|3602713|B1|United States||Region of Enrollment||participants|Number|767|767.0||||||
3769149|NCT01923467|3602713|B1||Male|Sex: Female, Male||Participants|Count of Participants|369|369.0||||||
3769150|NCT01923467|3602713|B1||Female|Sex: Female, Male||Participants|Count of Participants|398|398.0||||||
3769151|NCT01923467|3602713|B1|||Age||years|Mean|43.1|43.1|Standard Deviation|13.9|13.9|||
3769152|NCT01923389|3602717|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3769153|NCT01923389|3602718|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3769154|NCT01923389|3602719|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3769155|NCT01923389|3602717|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3769156|NCT01923389|3602718|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3769157|NCT01923389|3602719|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3769158|NCT01923389|3602717|B3|||Age||years|Mean|36.5|36.5|Standard Deviation|5.0|5.0|||
3769159|NCT01923389|3602718|B2|||Age||years|Mean|34.0|34.0|Standard Deviation|5.7|5.7|||
3769160|NCT01923389|3602719|B1|||Age||years|Mean|39.0|39.0|Standard Deviation|4.2|4.2|||
3769161|NCT01923363|3602742|B1|Group 4 (Hemodialysis)||Sequential Organ Failure Assessment (SOFA) Score|"Scores can be measured on all patients admitted to the intensive care unit in order to determine level of acuity and mortality risk.~The higher the score, the higher the mortality risk.~Mean SOFA Score Mortality 0-1.0 = 1.2% 1.1-2.0 = 5.4% 2.1-3.0 = 20.0% 3.1-4.0 = 36.1% 4.1-5.0 = 73.1% >5.1 = 84.4%"|units on a scale|Median|9.3|9.3|Full Range|||7.0|11.0|
3769162|NCT01923363|3602742|B1|Group 3 (CrCl < 40 mL/min)||Sequential Organ Failure Assessment (SOFA) Score|"Scores can be measured on all patients admitted to the intensive care unit in order to determine level of acuity and mortality risk.~The higher the score, the higher the mortality risk.~Mean SOFA Score Mortality 0-1.0 = 1.2% 1.1-2.0 = 5.4% 2.1-3.0 = 20.0% 3.1-4.0 = 36.1% 4.1-5.0 = 73.1% >5.1 = 84.4%"|units on a scale|Median|9.4|9.4|Full Range|||6.0|11.0|
3769163|NCT01923363|3602742|B1|Group 2 (CrCl >/= 40 to < 80 mL/min)||Sequential Organ Failure Assessment (SOFA) Score|"Scores can be measured on all patients admitted to the intensive care unit in order to determine level of acuity and mortality risk.~The higher the score, the higher the mortality risk.~Mean SOFA Score Mortality 0-1.0 = 1.2% 1.1-2.0 = 5.4% 2.1-3.0 = 20.0% 3.1-4.0 = 36.1% 4.1-5.0 = 73.1% >5.1 = 84.4%"|units on a scale|Median|7.4|7.4|Full Range|||0.0|14.0|
3769255|NCT01923311|3602749|B3||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3769164|NCT01923363|3602742|B1|Group 1 (CrCl >/= 80 mL/min)||Sequential Organ Failure Assessment (SOFA) Score|"Scores can be measured on all patients admitted to the intensive care unit in order to determine level of acuity and mortality risk.~The higher the score, the higher the mortality risk.~Mean SOFA Score Mortality 0-1.0 = 1.2% 1.1-2.0 = 5.4% 2.1-3.0 = 20.0% 3.1-4.0 = 36.1% 4.1-5.0 = 73.1% >5.1 = 84.4%"|units on a scale|Median|5.8|5.8|Full Range|||5.0|7.0|
3769165|NCT01923363|3602742|B1|Group 4 (Hemodialysis)||Acute Physiologic Assessment and Chronic Health Evaluation (APACHE) II Score|"The APACHE II score is calculated at the beginning of the ICU admission to help determine the patient’s mortality risk for the admission~The higher the score, the higher the risk of mortality.~Approximated Mortality Rate by score~0-4 = 4% 5-9 = 8% 10-14 = 15% 15-19 = 25% 20-24 = 40% 25-29 = 55% 30-34 = 75% >34 = 85%"|units on a scale|Median|26.0|26.0|Full Range|||21.0|29.0|
3769166|NCT01923363|3602742|B1|Group 3 (CrCl < 40 mL/min)||Acute Physiologic Assessment and Chronic Health Evaluation (APACHE) II Score|"The APACHE II score is calculated at the beginning of the ICU admission to help determine the patient’s mortality risk for the admission~The higher the score, the higher the risk of mortality.~Approximated Mortality Rate by score~0-4 = 4% 5-9 = 8% 10-14 = 15% 15-19 = 25% 20-24 = 40% 25-29 = 55% 30-34 = 75% >34 = 85%"|units on a scale|Median|22.8|22.8|Full Range|||16.0|28.0|
3769167|NCT01923363|3602742|B1|Group 2 (CrCl >/= 40 to < 80 mL/min)||Acute Physiologic Assessment and Chronic Health Evaluation (APACHE) II Score|"The APACHE II score is calculated at the beginning of the ICU admission to help determine the patient’s mortality risk for the admission~The higher the score, the higher the risk of mortality.~Approximated Mortality Rate by score~0-4 = 4% 5-9 = 8% 10-14 = 15% 15-19 = 25% 20-24 = 40% 25-29 = 55% 30-34 = 75% >34 = 85%"|units on a scale|Median|16.6|16.6|Full Range|||4.0|42.0|
3769168|NCT01923363|3602742|B1|Group 1 (CrCl >/= 80 mL/min)||Acute Physiologic Assessment and Chronic Health Evaluation (APACHE) II Score|"The APACHE II score is calculated at the beginning of the ICU admission to help determine the patient’s mortality risk for the admission~The higher the score, the higher the risk of mortality.~Approximated Mortality Rate by score~0-4 = 4% 5-9 = 8% 10-14 = 15% 15-19 = 25% 20-24 = 40% 25-29 = 55% 30-34 = 75% >34 = 85%"|units on a scale|Median|15.7|15.7|Full Range|||9.0|26.0|
3769169|NCT01923363|3602742|B1|Group 4 (Hemodialysis)||ICU Status||Participants|Count of Participants|3|3.0||||||
3769170|NCT01923363|3602742|B1|Group 3 (CrCl < 40 mL/min)||ICU Status||Participants|Count of Participants|5|5.0||||||
3769171|NCT01923363|3602742|B1|Group 2 (CrCl >/= 40 to < 80 mL/min)||ICU Status||Participants|Count of Participants|7|7.0||||||
3769172|NCT01923363|3602742|B1|Group 1 (CrCl >/= 80 mL/min)||ICU Status||Participants|Count of Participants|6|6.0||||||
3769173|NCT01923363|3602742|B1|Group 4 (Hemodialysis)||Total Bilirubin||milligrams per deciliter|Median|0.5|0.5|Full Range|||0.3|0.9|
3769174|NCT01923363|3602742|B1|Group 3 (CrCl < 40 mL/min)||Total Bilirubin||milligrams per deciliter|Median|1.3|1.3|Full Range|||0.3|3.0|
3769175|NCT01923363|3602742|B1|Group 2 (CrCl >/= 40 to < 80 mL/min)||Total Bilirubin||milligrams per deciliter|Median|0.8|0.8|Full Range|||0.4|1.9|
3769176|NCT01923363|3602742|B1|Group 1 (CrCl >/= 80 mL/min)||Total Bilirubin||milligrams per deciliter|Median|0.6|0.6|Full Range|||0.2|1.5|
3769177|NCT01923363|3602742|B1|Group 4 (Hemodialysis)||Weight||kilograms|Median|136|136.0|Full Range|||118.0|156.0|
3769178|NCT01923363|3602742|B1|Group 3 (CrCl < 40 mL/min)||Weight||kilograms|Median|121|121.0|Full Range|||109.0|137.0|
3769179|NCT01923363|3602742|B1|Group 2 (CrCl >/= 40 to < 80 mL/min)||Weight||kilograms|Median|142|142.0|Full Range|||118.0|205.0|
3769180|NCT01923363|3602742|B1|Group 1 (CrCl >/= 80 mL/min)||Weight||kilograms|Median|127|127.0|Full Range|||105.0|151.0|
3769181|NCT01923363|3602742|B1|Group 4 (Hemodialysis)||Body Mass Index (BMI)||kilograms per sqare meter|Median|49|49.0|Full Range|||40.0|55.0|
3769182|NCT01923363|3602742|B1|Group 3 (CrCl < 40 mL/min)||Body Mass Index (BMI)||kilograms per sqare meter|Median|38|38.0|Full Range|||33.0|50.0|
3769183|NCT01923363|3602742|B1|Group 2 (CrCl >/= 40 to < 80 mL/min)||Body Mass Index (BMI)||kilograms per sqare meter|Median|47|47.0|Full Range|||34.0|65.0|
3769184|NCT01923363|3602742|B1|Group 1 (CrCl >/= 80 mL/min)||Body Mass Index (BMI)||kilograms per sqare meter|Median|41|41.0|Full Range|||32.0|57.0|
3769185|NCT01923363|3602742|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
3769186|NCT01923363|3602742|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3769187|NCT01923363|3602742|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3769188|NCT01923363|3602742|B1|Group 4 (Hemodialysis)||Age||years|Median|42|42.0|Full Range|||29.0|61.0|
3769189|NCT01923363|3602742|B1|Group 3 (CrCl < 40)||Age||years|Median|60|60.0|Full Range|||48.0|74.0|
3769190|NCT01923363|3602742|B1|Group 2 (CrCl >/= 40 to < 80 mL/min)||Age||years|Median|57|57.0|Full Range|||43.0|79.0|
3769191|NCT01923363|3602742|B1|Group 1 (CrCl >/= 80mL/min)||Age||years|Median|46|46.0|Full Range|||19.0|68.0|
3769192|NCT01923311|3602749|B3||lopinavir|Type of PI in Background Regimen (Excluding Ritonavir)||Participants|Count of Participants|19|19.0||||||
3769193|NCT01923311|3602750|B2||lopinavir|Type of PI in Background Regimen (Excluding Ritonavir)||Participants|Count of Participants|13|13.0||||||
3769194|NCT01923311|3602751|B1||lopinavir|Type of PI in Background Regimen (Excluding Ritonavir)||Participants|Count of Participants|6|6.0||||||
3769195|NCT01923311|3602749|B3||darunavir|Type of PI in Background Regimen (Excluding Ritonavir)||Participants|Count of Participants|3|3.0||||||
3769196|NCT01923311|3602750|B2||darunavir|Type of PI in Background Regimen (Excluding Ritonavir)||Participants|Count of Participants|0|0.0||||||
3769197|NCT01923311|3602751|B1||darunavir|Type of PI in Background Regimen (Excluding Ritonavir)||Participants|Count of Participants|3|3.0||||||
3769198|NCT01923311|3602749|B3||atazanavir|Type of PI in Background Regimen (Excluding Ritonavir)||Participants|Count of Participants|9|9.0||||||
3769199|NCT01923311|3602750|B2||atazanavir|Type of PI in Background Regimen (Excluding Ritonavir)||Participants|Count of Participants|1|1.0||||||
3769200|NCT01923311|3602751|B1||atazanavir|Type of PI in Background Regimen (Excluding Ritonavir)||Participants|Count of Participants|8|8.0||||||
3769201|NCT01923311|3602749|B3|||Cluster of differentiation (CD4) Percentage||percentage (%)|Mean|25.8|25.8|Standard Deviation|12.85|12.85|||
3769202|NCT01923311|3602750|B2|||Cluster of differentiation (CD4) Percentage||percentage (%)|Mean|35.5|35.5|Standard Deviation|9.11|9.11|||
3769203|NCT01923311|3602751|B1|||Cluster of differentiation (CD4) Percentage||percentage (%)|Mean|17.8|17.8|Standard Deviation|9.60|9.6|||
3769204|NCT01923311|3602749|B3||≥ 500 cells/uL|Cluster of differentiation (CD4) Cell Count Category||Participants|Count of Participants|17|17.0||||||
3769205|NCT01923311|3602750|B2||≥ 500 cells/uL|Cluster of differentiation (CD4) Cell Count Category||Participants|Count of Participants|13|13.0||||||
3769206|NCT01923311|3602751|B1||≥ 500 cells/uL|Cluster of differentiation (CD4) Cell Count Category||Participants|Count of Participants|4|4.0||||||
3769207|NCT01923311|3602749|B3||≥ 350 to < 500 cells/uL|Cluster of differentiation (CD4) Cell Count Category||Participants|Count of Participants|4|4.0||||||
3769208|NCT01923311|3602750|B2||≥ 350 to < 500 cells/uL|Cluster of differentiation (CD4) Cell Count Category||Participants|Count of Participants|0|0.0||||||
3769209|NCT01923311|3602751|B1||≥ 350 to < 500 cells/uL|Cluster of differentiation (CD4) Cell Count Category||Participants|Count of Participants|4|4.0||||||
3769210|NCT01923311|3602749|B3||≥ 200 to < 350 cells/uL|Cluster of differentiation (CD4) Cell Count Category||Participants|Count of Participants|3|3.0||||||
3769211|NCT01923311|3602750|B2||≥ 200 to < 350 cells/uL|Cluster of differentiation (CD4) Cell Count Category||Participants|Count of Participants|0|0.0||||||
3769212|NCT01923311|3602751|B1||≥ 200 to < 350 cells/uL|Cluster of differentiation (CD4) Cell Count Category||Participants|Count of Participants|3|3.0||||||
3769213|NCT01923311|3602749|B3||≥ 50 to < 200 cells/uL|Cluster of differentiation (CD4) Cell Count Category||Participants|Count of Participants|7|7.0||||||
3769214|NCT01923311|3602750|B2||≥ 50 to < 200 cells/uL|Cluster of differentiation (CD4) Cell Count Category||Participants|Count of Participants|1|1.0||||||
3769215|NCT01923311|3602751|B1||≥ 50 to < 200 cells/uL|Cluster of differentiation (CD4) Cell Count Category||Participants|Count of Participants|6|6.0||||||
3769216|NCT01923311|3602749|B3||< 50 cells/uL|Cluster of differentiation (CD4) Cell Count Category||Participants|Count of Participants|0|0.0||||||
3769217|NCT01923311|3602750|B2||< 50 cells/uL|Cluster of differentiation (CD4) Cell Count Category||Participants|Count of Participants|0|0.0||||||
3769218|NCT01923311|3602751|B1||< 50 cells/uL|Cluster of differentiation (CD4) Cell Count Category||Participants|Count of Participants|0|0.0||||||
3769219|NCT01923311|3602749|B3|||Cluster of differentiation (CD4) Cell Count||cells/uL|Mean|561.7|561.7|Standard Deviation|354.74|354.74|||
3769220|NCT01923311|3602750|B2|||Cluster of differentiation (CD4) Cell Count||cells/uL|Mean|810.8|810.8|Standard Deviation|303.29|303.29|||
3769221|NCT01923311|3602751|B1|||Cluster of differentiation (CD4) Cell Count||cells/uL|Mean|356.6|356.6|Standard Deviation|249.45|249.45|||
3769222|NCT01923311|3602749|B3||> 100000 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|1|1.0||||||
3769223|NCT01923311|3602750|B2||> 100000 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|0|0.0||||||
3769224|NCT01923311|3602751|B1||> 100000 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|1|1.0||||||
3769225|NCT01923311|3602749|B3||> 1000 to ≤ 100000 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|13|13.0||||||
3769226|NCT01923311|3602750|B2||> 1000 to ≤ 100000 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|0|0.0||||||
3769227|NCT01923311|3602751|B1||> 1000 to ≤ 100000 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|13|13.0||||||
3769228|NCT01923311|3602749|B3||≥ 50 to ≤ 1000 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|4|4.0||||||
3769229|NCT01923311|3602750|B2||≥ 50 to ≤ 1000 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|1|1.0||||||
3769230|NCT01923311|3602751|B1||≥ 50 to ≤ 1000 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|3|3.0||||||
3769231|NCT01923311|3602749|B3||< 50 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|13|13.0||||||
3769232|NCT01923311|3602750|B2||< 50 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|13|13.0||||||
3769233|NCT01923311|3602751|B1||< 50 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|0|0.0||||||
3769234|NCT01923311|3602749|B3|||HIV-1 RNA||log10 copies/mL|Mean|2.91|2.91|Standard Deviation|1.576|1.576|||
3769235|NCT01923311|3602750|B2|||HIV-1 RNA||log10 copies/mL|Mean|1.33|1.33|Standard Deviation|0.204|0.204|||
3769236|NCT01923311|3602751|B1|||HIV-1 RNA||log10 copies/mL|Mean|4.21|4.21|Standard Deviation|0.802|0.802|||
3769237|NCT01923311|3602749|B3|Spain||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3769238|NCT01923311|3602750|B2|Spain||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3769239|NCT01923311|3602751|B1|Spain||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3769240|NCT01923311|3602749|B3|Thailand||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3769241|NCT01923311|3602750|B2|Thailand||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3769242|NCT01923311|3602751|B1|Thailand||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3769243|NCT01923311|3602749|B3|Uganda||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3769244|NCT01923311|3602750|B2|Uganda||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3769245|NCT01923311|3602751|B1|Uganda||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3769246|NCT01923311|3602749|B3|South Africa||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3769247|NCT01923311|3602750|B2|South Africa||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3769248|NCT01923311|3602751|B1|South Africa||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3769249|NCT01923311|3602749|B3|Italy||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3769250|NCT01923311|3602750|B2|Italy||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3769251|NCT01923311|3602751|B1|Italy||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3769252|NCT01923311|3602749|B3|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3769253|NCT01923311|3602750|B2|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3769254|NCT01923311|3602751|B1|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3769256|NCT01923311|3602750|B2||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3769257|NCT01923311|3602751|B1||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3769258|NCT01923311|3602749|B3||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3769259|NCT01923311|3602750|B2||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3769260|NCT01923311|3602751|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3769261|NCT01923311|3602749|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3769262|NCT01923311|3602750|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3769263|NCT01923311|3602751|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3769264|NCT01923311|3602749|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3769265|NCT01923311|3602750|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3769266|NCT01923311|3602751|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3769267|NCT01923311|3602749|B3||Black|Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3769268|NCT01923311|3602750|B2||Black|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3769269|NCT01923311|3602751|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3769270|NCT01923311|3602749|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3769271|NCT01923311|3602750|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3769272|NCT01923311|3602751|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3769273|NCT01923311|3602749|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3769274|NCT01923311|3602750|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3769275|NCT01923311|3602751|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3769276|NCT01923311|3602749|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3769277|NCT01923311|3602750|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3769278|NCT01923311|3602751|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3769279|NCT01923311|3602749|B3|Age 12 to < 18 Years||Age, Customized||Participants|Count of Participants|15|15.0||||||
3769280|NCT01923311|3602750|B2|Age 12 to < 18 Years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3769281|NCT01923311|3602751|B1|Age 12 to < 18 Years||Age, Customized||Participants|Count of Participants|15|15.0||||||
3769282|NCT01923311|3602749|B3|Age 6 to < 12 Years||Age, Customized||Participants|Count of Participants|16|16.0||||||
3769283|NCT01923311|3602750|B2|Age 6 to < 12 Years||Age, Customized||Participants|Count of Participants|14|14.0||||||
3769284|NCT01923311|3602751|B1|Age 6 to < 12 Years||Age, Customized||Participants|Count of Participants|2|2.0||||||
3769285|NCT01923311|3602749|B3|||Age||years|Mean|12|12.0|Standard Deviation|3.8|3.8|||
3769286|NCT01923311|3602750|B2|||Age||years|Mean|9|9.0|Standard Deviation|2.2|2.2|||
3769287|NCT01923311|3602751|B1|||Age||years|Mean|14|14.0|Standard Deviation|2.9|2.9|||
3769288|NCT01923168|3602795|B4|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3769289|NCT01923168|3602796|B3|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3769290|NCT01923168|3602797|B2|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3769291|NCT01923168|3602798|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3769292|NCT01923168|3602795|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3769293|NCT01923168|3602796|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3769294|NCT01923168|3602797|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3769295|NCT01923168|3602798|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3769296|NCT01923168|3602795|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3769297|NCT01923168|3602796|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3769298|NCT01923168|3602797|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3769299|NCT01923168|3602798|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3769300|NCT01923168|3602795|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3769301|NCT01923168|3602796|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3769302|NCT01923168|3602797|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3769303|NCT01923168|3602798|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3769304|NCT01923168|3602795|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|290|290.0||||||
3769305|NCT01923168|3602796|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|105|105.0||||||
3769306|NCT01923168|3602797|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|68|68.0||||||
3769307|NCT01923168|3602798|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|117|117.0||||||
3769308|NCT01923168|3602795|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3769309|NCT01923168|3602796|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3769310|NCT01923168|3602797|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3769311|NCT01923168|3602798|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3769312|NCT01923168|3602795|B4||Female|Sex: Female, Male||Participants|Count of Participants|340|340.0||||||
3769313|NCT01923168|3602796|B3||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3769314|NCT01923168|3602797|B2||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3769315|NCT01923168|3602798|B1||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3769316|NCT01923168|3602795|B4|||Age||Years|Mean|64.1|64.1|Standard Deviation|8.49|8.49|||
3769317|NCT01923168|3602796|B3|||Age||Years|Mean|63.1|63.1|Standard Deviation|8.31|8.31|||
3769318|NCT01923168|3602797|B2|||Age||Years|Mean|65.2|65.2|Standard Deviation|8.61|8.61|||
3769319|NCT01923168|3602798|B1|||Age||Years|Mean|64.3|64.3|Standard Deviation|8.53|8.53|||
3769320|NCT01922986|3602857|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3769321|NCT01922986|3602858|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3769322|NCT01922986|3602859|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3769323|NCT01922986|3602857|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769324|NCT01922986|3602858|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769325|NCT01922986|3602859|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769326|NCT01922986|3602857|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769327|NCT01922986|3602858|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769328|NCT01922986|3602859|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769329|NCT01922986|3602857|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3769330|NCT01922986|3602858|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3769331|NCT01922986|3602859|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3769332|NCT01922986|3602857|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769333|NCT01922986|3602858|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769334|NCT01922986|3602859|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769335|NCT01922986|3602857|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769336|NCT01922986|3602858|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769337|NCT01922986|3602859|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769338|NCT01922986|3602857|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769339|NCT01922986|3602858|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769340|NCT01922986|3602859|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769341|NCT01922986|3602857|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769342|NCT01922986|3602858|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769343|NCT01922986|3602859|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769344|NCT01922986|3602857|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769345|NCT01922986|3602858|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769346|NCT01922986|3602859|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769347|NCT01922986|3602857|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3769348|NCT01922986|3602858|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3769349|NCT01922986|3602859|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3769350|NCT01922986|3602857|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769351|NCT01922986|3602858|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769352|NCT01922986|3602859|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769353|NCT01922986|3602857|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3769354|NCT01922986|3602858|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3769355|NCT01922986|3602859|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3769356|NCT01922986|3602857|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3769357|NCT01922986|3602858|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3769358|NCT01922986|3602859|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3769359|NCT01922986|3602857|B3|||Age||years|Mean|63.0|63.0|Standard Deviation|21.2|21.2|||
3769360|NCT01922986|3602858|B2|||Age||years|Mean|52.5|52.5|Standard Deviation|23.3|23.3|||
3769361|NCT01922986|3602859|B1|||Age||years|Mean|73.5|73.5|Standard Deviation|19.1|19.1|||
3769362|NCT01922986|3602857|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3769363|NCT01922986|3602858|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3769364|NCT01922986|3602859|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3769365|NCT01922986|3602857|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3769366|NCT01922986|3602858|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3769367|NCT01922986|3602859|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3769368|NCT01922986|3602857|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3769369|NCT01922986|3602858|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3769370|NCT01922986|3602859|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3769371|NCT01922934|3602870|B3||No|Coronary artery disease||Participants|Count of Participants|2645|2645.0||||||
3769372|NCT01922934|3602871|B2||No|Coronary artery disease||Participants|Count of Participants|2547|2547.0||||||
3769373|NCT01922934|3602872|B1||No|Coronary artery disease||Participants|Count of Participants|98|98.0||||||
3769374|NCT01922934|3602870|B3||Yes|Coronary artery disease||Participants|Count of Participants|404|404.0||||||
3769375|NCT01922934|3602871|B2||Yes|Coronary artery disease||Participants|Count of Participants|383|383.0||||||
3769376|NCT01922934|3602872|B1||Yes|Coronary artery disease||Participants|Count of Participants|21|21.0||||||
3769377|NCT01922934|3602870|B3||No|Hyperlipidemia||Participants|Count of Participants|1390|1390.0||||||
3769378|NCT01922934|3602871|B2||No|Hyperlipidemia||Participants|Count of Participants|1334|1334.0||||||
3769379|NCT01922934|3602872|B1||No|Hyperlipidemia||Participants|Count of Participants|56|56.0||||||
3769380|NCT01922934|3602870|B3||Yes|Hyperlipidemia||Participants|Count of Participants|1659|1659.0||||||
3769381|NCT01922934|3602871|B2||Yes|Hyperlipidemia||Participants|Count of Participants|1596|1596.0||||||
3769382|NCT01922934|3602872|B1||Yes|Hyperlipidemia||Participants|Count of Participants|63|63.0||||||
3769383|NCT01922934|3602870|B3||No|Hypertension||Participants|Count of Participants|908|908.0||||||
3769384|NCT01922934|3602871|B2||No|Hypertension||Participants|Count of Participants|867|867.0||||||
3769385|NCT01922934|3602872|B1||No|Hypertension||Participants|Count of Participants|41|41.0||||||
3769386|NCT01922934|3602870|B3||Yes|Hypertension||Participants|Count of Participants|2141|2141.0||||||
3769387|NCT01922934|3602871|B2||Yes|Hypertension||Participants|Count of Participants|2063|2063.0||||||
3769388|NCT01922934|3602872|B1||Yes|Hypertension||Participants|Count of Participants|78|78.0||||||
3769389|NCT01922934|3602870|B3||No|Diabetes||Participants|Count of Participants|1641|1641.0||||||
3769390|NCT01922934|3602871|B2||No|Diabetes||Participants|Count of Participants|1580|1580.0||||||
3769391|NCT01922934|3602872|B1||No|Diabetes||Participants|Count of Participants|61|61.0||||||
3769392|NCT01922934|3602870|B3||Yes|Diabetes||Participants|Count of Participants|1408|1408.0||||||
3769393|NCT01922934|3602871|B2||Yes|Diabetes||Participants|Count of Participants|1350|1350.0||||||
3769394|NCT01922934|3602872|B1||Yes|Diabetes||Participants|Count of Participants|58|58.0||||||
3769395|NCT01922934|3602870|B3||Have none|Diabetes, hypertension, or hyperlipidemia||Participants|Count of Participants|574|574.0||||||
3769396|NCT01922934|3602871|B2||Have none|Diabetes, hypertension, or hyperlipidemia||Participants|Count of Participants|554|554.0||||||
3769397|NCT01922934|3602872|B1||Have none|Diabetes, hypertension, or hyperlipidemia||Participants|Count of Participants|20|20.0||||||
3769398|NCT01922934|3602870|B3||Had at least one|Diabetes, hypertension, or hyperlipidemia||Participants|Count of Participants|2475|2475.0||||||
3769399|NCT01922934|3602871|B2||Had at least one|Diabetes, hypertension, or hyperlipidemia||Participants|Count of Participants|2376|2376.0||||||
3769400|NCT01922934|3602872|B1||Had at least one|Diabetes, hypertension, or hyperlipidemia||Participants|Count of Participants|99|99.0||||||
3769401|NCT01922934|3602870|B3||Spanish|Primary Language||Participants|Count of Participants|932|932.0||||||
3769402|NCT01922934|3602871|B2||Spanish|Primary Language||Participants|Count of Participants|897|897.0||||||
3769403|NCT01922934|3602872|B1||Spanish|Primary Language||Participants|Count of Participants|35|35.0||||||
3769404|NCT01922934|3602870|B3||English|Primary Language||Participants|Count of Participants|2117|2117.0||||||
3769405|NCT01922934|3602871|B2||English|Primary Language||Participants|Count of Participants|2033|2033.0||||||
3769406|NCT01922934|3602872|B1||English|Primary Language||Participants|Count of Participants|84|84.0||||||
3769407|NCT01922934|3602870|B3|||Baseline BMI (continuous)||kg/m^2|Median|34.4|34.4|Inter-Quartile Range|||31.9|37.8|
3769408|NCT01922934|3602871|B2|||Baseline BMI (continuous)||kg/m^2|Median|34.3|34.3|Inter-Quartile Range|||31.9|37.7|
3769409|NCT01922934|3602872|B1|||Baseline BMI (continuous)||kg/m^2|Median|34.6|34.6|Inter-Quartile Range|||32.4|39.4|
3769410|NCT01922934|3602870|B3||40-44.9|Baseline BMI||Participants|Count of Participants|442|442.0||||||
3769411|NCT01922934|3602871|B2||40-44.9|Baseline BMI||Participants|Count of Participants|417|417.0||||||
3769412|NCT01922934|3602872|B1||40-44.9|Baseline BMI||Participants|Count of Participants|25|25.0||||||
3769413|NCT01922934|3602870|B3||35-39.9|Baseline BMI||Participants|Count of Participants|933|933.0||||||
3769414|NCT01922934|3602871|B2||35-39.9|Baseline BMI||Participants|Count of Participants|901|901.0||||||
3769415|NCT01922934|3602872|B1||35-39.9|Baseline BMI||Participants|Count of Participants|32|32.0||||||
3769416|NCT01922934|3602870|B3||30-34.9|Baseline BMI||Participants|Count of Participants|1674|1674.0||||||
3769417|NCT01922934|3602871|B2||30-34.9|Baseline BMI||Participants|Count of Participants|1612|1612.0||||||
3769418|NCT01922934|3602872|B1||30-34.9|Baseline BMI||Participants|Count of Participants|62|62.0||||||
3769419|NCT01922934|3602870|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3769420|NCT01922934|3602871|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3769421|NCT01922934|3602872|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769422|NCT01922934|3602870|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769423|NCT01922934|3602871|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769424|NCT01922934|3602872|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769425|NCT01922934|3602870|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2433|2433.0||||||
3769426|NCT01922934|3602871|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2335|2335.0||||||
3769427|NCT01922934|3602872|B1||White|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3769428|NCT01922934|3602870|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|565|565.0||||||
3769429|NCT01922934|3602871|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|545|545.0||||||
3769430|NCT01922934|3602872|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3769522|NCT01922739|3602884|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3769431|NCT01922934|3602870|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769432|NCT01922934|3602871|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769433|NCT01922934|3602872|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769434|NCT01922934|3602870|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3769435|NCT01922934|3602871|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3769436|NCT01922934|3602872|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769437|NCT01922934|3602870|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3769438|NCT01922934|3602871|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769439|NCT01922934|3602872|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3769440|NCT01922934|3602870|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769441|NCT01922934|3602871|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769442|NCT01922934|3602872|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769443|NCT01922934|3602870|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1125|1125.0||||||
3769444|NCT01922934|3602871|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1071|1071.0||||||
3769445|NCT01922934|3602872|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3769446|NCT01922934|3602870|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1924|1924.0||||||
3769447|NCT01922934|3602871|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1859|1859.0||||||
3769448|NCT01922934|3602872|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3769449|NCT01922934|3602870|B3||Male|Sex: Female, Male||Participants|Count of Participants|902|902.0||||||
3769450|NCT01922934|3602871|B2||Male|Sex: Female, Male||Participants|Count of Participants|866|866.0||||||
3769451|NCT01922934|3602872|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3769452|NCT01922934|3602870|B3||Female|Sex: Female, Male||Participants|Count of Participants|2147|2147.0||||||
3769453|NCT01922934|3602871|B2||Female|Sex: Female, Male||Participants|Count of Participants|2064|2064.0||||||
3769454|NCT01922934|3602872|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3769455|NCT01922934|3602870|B3|||Age||years|Median|52|52.0|Inter-Quartile Range|||42.0|61.0|
3769456|NCT01922934|3602871|B2|||Age||years|Median|52|52.0|Inter-Quartile Range|||42.0|61.0|
3769457|NCT01922934|3602872|B1|||Age||years|Median|52|52.0|Inter-Quartile Range|||42.0|60.0|
3769458|NCT01922934|3602870|B3||>=65 years|Age||Participants|Count of Participants|471|471.0||||||
3769459|NCT01922934|3602871|B2||>=65 years|Age||Participants|Count of Participants|455|455.0||||||
3769460|NCT01922934|3602872|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3769461|NCT01922934|3602870|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2578|2578.0||||||
3769462|NCT01922934|3602871|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2475|2475.0||||||
3769463|NCT01922934|3602872|B1||Between 18 and 65 years|Age||Participants|Count of Participants|103|103.0||||||
3769464|NCT01922934|3602870|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3769465|NCT01922934|3602871|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3769466|NCT01922934|3602872|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3769467|NCT01922739|3602883|B3|||Average Pain Intensity (API)|"Measure Description: The API was recorded daily by participants in an electronic diary using an 11-point numerical rating scale (NRS-11), a Likert-type scale in which 0=no pain and 10=the worst pain imaginable. Participants selected the number that best described their average pain intensity over the last 24 hours.~170 representing participants in the Full Analysis Set which includes participants who had at least one post-baseline efficacy assessment. The timeframe for this measurement is the start of the Open-Label Treatment Period. See outcome #8 for change from baseline values."|units on a scale|Mean|2.7|2.7|Standard Deviation|1.57|1.57|||
3769468|NCT01922739|3602884|B2|||Average Pain Intensity (API)|"Measure Description: The API was recorded daily by participants in an electronic diary using an 11-point numerical rating scale (NRS-11), a Likert-type scale in which 0=no pain and 10=the worst pain imaginable. Participants selected the number that best described their average pain intensity over the last 24 hours.~170 representing participants in the Full Analysis Set which includes participants who had at least one post-baseline efficacy assessment. The timeframe for this measurement is the start of the Open-Label Treatment Period. See outcome #8 for change from baseline values."|units on a scale|Mean|3.0|3.0|Standard Deviation|1.78|1.78|||
3769469|NCT01922739|3602885|B1|||Average Pain Intensity (API)|"Measure Description: The API was recorded daily by participants in an electronic diary using an 11-point numerical rating scale (NRS-11), a Likert-type scale in which 0=no pain and 10=the worst pain imaginable. Participants selected the number that best described their average pain intensity over the last 24 hours.~170 representing participants in the Full Analysis Set which includes participants who had at least one post-baseline efficacy assessment. The timeframe for this measurement is the start of the Open-Label Treatment Period. See outcome #8 for change from baseline values."|units on a scale|Mean|2.6|2.6|Standard Deviation|1.41|1.41|||
3769470|NCT01922739|3602883|B3|||Worst Pain Intensity (WPI) Score|"The WPI was recorded daily by participants in an electronic diary using an 11-point numerical rating scale (NRS-11), a Likert-type scale in which 0=no pain and 10=the worst pain imaginable. Participants selected the number that best described their worst pain intensity over the last 24 hours.~170 representing participants in the Full Analysis Set which includes participants who had at least one post-baseline efficacy assessment. The timeframe for this measurement is the start of the Open-Label Treatment Period. See outcome #7 for change from baseline values."|units on a scale|Mean|4.1|4.1|Standard Deviation|1.92|1.92|||
3769523|NCT01922739|3602885|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3769471|NCT01922739|3602884|B2|||Worst Pain Intensity (WPI) Score|"The WPI was recorded daily by participants in an electronic diary using an 11-point numerical rating scale (NRS-11), a Likert-type scale in which 0=no pain and 10=the worst pain imaginable. Participants selected the number that best described their worst pain intensity over the last 24 hours.~170 representing participants in the Full Analysis Set which includes participants who had at least one post-baseline efficacy assessment. The timeframe for this measurement is the start of the Open-Label Treatment Period. See outcome #7 for change from baseline values."|units on a scale|Mean|4.6|4.6|Standard Deviation|2.13|2.13|||
3769472|NCT01922739|3602885|B1|||Worst Pain Intensity (WPI) Score|"The WPI was recorded daily by participants in an electronic diary using an 11-point numerical rating scale (NRS-11), a Likert-type scale in which 0=no pain and 10=the worst pain imaginable. Participants selected the number that best described their worst pain intensity over the last 24 hours.~170 representing participants in the Full Analysis Set which includes participants who had at least one post-baseline efficacy assessment. The timeframe for this measurement is the start of the Open-Label Treatment Period. See outcome #7 for change from baseline values."|units on a scale|Mean|3.7|3.7|Standard Deviation|1.71|1.71|||
3769473|NCT01922739|3602883|B3|||Duration on Opioid Therapy||years|Mean|3.2|3.2|Standard Deviation|4.65|4.65|||
3769474|NCT01922739|3602884|B2|||Duration on Opioid Therapy||years|Mean|4.8|4.8|Standard Deviation|4.06|4.06|||
3769475|NCT01922739|3602885|B1|||Duration on Opioid Therapy||years|Mean|2.1|2.1|Standard Deviation|4.72|4.72|||
3769476|NCT01922739|3602883|B3|||Duration Since Diagnosis of Chronic Low Back Pain|Relative to the start of study 3101|years|Mean|11.6|11.6|Standard Deviation|10.80|10.8|||
3769477|NCT01922739|3602884|B2|||Duration Since Diagnosis of Chronic Low Back Pain|Relative to the start of study 3101|years|Mean|12.8|12.8|Standard Deviation|11.43|11.43|||
3769478|NCT01922739|3602885|B1|||Duration Since Diagnosis of Chronic Low Back Pain|Relative to the start of study 3101|years|Mean|10.7|10.7|Standard Deviation|10.33|10.33|||
3769479|NCT01922739|3602883|B3|||Body Mass Index||kg/m^2|Mean|32.5|32.5|Standard Deviation|8.35|8.35|||
3769480|NCT01922739|3602884|B2|||Body Mass Index||kg/m^2|Mean|31.8|31.8|Standard Deviation|8.27|8.27|||
3769481|NCT01922739|3602885|B1|||Body Mass Index||kg/m^2|Mean|32.9|32.9|Standard Deviation|8.41|8.41|||
3769482|NCT01922739|3602883|B3|||Height||cm|Mean|170.4|170.4|Standard Deviation|10.99|10.99|||
3769483|NCT01922739|3602884|B2|||Height||cm|Mean|172.1|172.1|Standard Deviation|11.18|11.18|||
3769484|NCT01922739|3602885|B1|||Height||cm|Mean|169.3|169.3|Standard Deviation|10.77|10.77|||
3769485|NCT01922739|3602883|B3|||Weight||kg|Mean|94.2|94.2|Standard Deviation|24.69|24.69|||
3769486|NCT01922739|3602884|B2|||Weight||kg|Mean|94.2|94.2|Standard Deviation|25.07|25.07|||
3769487|NCT01922739|3602885|B1|||Weight||kg|Mean|94.2|94.2|Standard Deviation|24.56|24.56|||
3769488|NCT01922739|3602883|B3|Non-Hispanic and non-Latino||Ethnicity||Participants|Count of Participants|154|154.0||||||
3769489|NCT01922739|3602884|B2|Non-Hispanic and non-Latino||Ethnicity||Participants|Count of Participants|69|69.0||||||
3769490|NCT01922739|3602885|B1|Non-Hispanic and non-Latino||Ethnicity||Participants|Count of Participants|85|85.0||||||
3769491|NCT01922739|3602883|B3|Hispanic or Latino||Ethnicity||Participants|Count of Participants|28|28.0||||||
3769492|NCT01922739|3602884|B2|Hispanic or Latino||Ethnicity||Participants|Count of Participants|4|4.0||||||
3769493|NCT01922739|3602885|B1|Hispanic or Latino||Ethnicity||Participants|Count of Participants|24|24.0||||||
3769494|NCT01922739|3602883|B3|Other||Race||Participants|Count of Participants|2|2.0||||||
3769495|NCT01922739|3602884|B2|Other||Race||Participants|Count of Participants|1|1.0||||||
3769496|NCT01922739|3602885|B1|Other||Race||Participants|Count of Participants|1|1.0||||||
3769497|NCT01922739|3602883|B3|Pacific Islander||Race||Participants|Count of Participants|1|1.0||||||
3769498|NCT01922739|3602884|B2|Pacific Islander||Race||Participants|Count of Participants|0|0.0||||||
3769499|NCT01922739|3602885|B1|Pacific Islander||Race||Participants|Count of Participants|1|1.0||||||
3769500|NCT01922739|3602883|B3|American Indian or Alaskan Native||Race||Participants|Count of Participants|3|3.0||||||
3769501|NCT01922739|3602884|B2|American Indian or Alaskan Native||Race||Participants|Count of Participants|1|1.0||||||
3769502|NCT01922739|3602885|B1|American Indian or Alaskan Native||Race||Participants|Count of Participants|2|2.0||||||
3769503|NCT01922739|3602883|B3|Asian||Race||Participants|Count of Participants|10|10.0||||||
3769504|NCT01922739|3602884|B2|Asian||Race||Participants|Count of Participants|1|1.0||||||
3769505|NCT01922739|3602885|B1|Asian||Race||Participants|Count of Participants|9|9.0||||||
3769506|NCT01922739|3602883|B3|Black||Race||Participants|Count of Participants|39|39.0||||||
3769507|NCT01922739|3602884|B2|Black||Race||Participants|Count of Participants|12|12.0||||||
3769508|NCT01922739|3602885|B1|Black||Race||Participants|Count of Participants|27|27.0||||||
3769509|NCT01922739|3602883|B3|White||Race||Participants|Count of Participants|127|127.0||||||
3769510|NCT01922739|3602884|B2|White||Race||Participants|Count of Participants|58|58.0||||||
3769511|NCT01922739|3602885|B1|White||Race||Participants|Count of Participants|69|69.0||||||
3769512|NCT01922739|3602883|B3|>65 years||Age Group||Participants|Count of Participants|35|35.0||||||
3769513|NCT01922739|3602884|B2|>65 years||Age Group||Participants|Count of Participants|20|20.0||||||
3769514|NCT01922739|3602885|B1|>65 years||Age Group||Participants|Count of Participants|15|15.0||||||
3769515|NCT01922739|3602883|B3|<=65 years||Age Group||Participants|Count of Participants|147|147.0||||||
3769516|NCT01922739|3602884|B2|<=65 years||Age Group||Participants|Count of Participants|53|53.0||||||
3769517|NCT01922739|3602885|B1|<=65 years||Age Group||Participants|Count of Participants|94|94.0||||||
3769518|NCT01922739|3602883|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3769519|NCT01922739|3602884|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3769520|NCT01922739|3602885|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3769521|NCT01922739|3602883|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3769524|NCT01922739|3602883|B3|||Age||years|Mean|52.3|52.3|Standard Deviation|13.22|13.22|||
3769525|NCT01922739|3602884|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|12.37|12.37|||
3769526|NCT01922739|3602885|B1|||Age||years|Mean|49.9|49.9|Standard Deviation|13.30|13.3|||
3769527|NCT01922349|3602910|B5||Male|Gender||Participants|Count of Participants|97|97.0||||||
3769528|NCT01922349|3602911|B4||Male|Gender||Participants|Count of Participants|27|27.0||||||
3769529|NCT01922349|3602912|B3||Male|Gender||Participants|Count of Participants|18|18.0||||||
3769530|NCT01922349|3602913|B2||Male|Gender||Participants|Count of Participants|27|27.0||||||
3769531|NCT01922349|3602914|B1||Male|Gender||Participants|Count of Participants|25|25.0||||||
3769532|NCT01922349|3602910|B5||Female|Gender||Participants|Count of Participants|0|0.0||||||
3769533|NCT01922349|3602911|B4||Female|Gender||Participants|Count of Participants|0|0.0||||||
3769534|NCT01922349|3602912|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
3769535|NCT01922349|3602913|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
3769536|NCT01922349|3602914|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3769537|NCT01922349|3602910|B5|||Age||Years|Mean|28.3|28.3|Standard Deviation|5.2|5.2|||
3769538|NCT01922349|3602911|B4|||Age||Years|Mean|28.5|28.5|Standard Deviation|5.2|5.2|||
3769539|NCT01922349|3602912|B3|||Age||Years|Mean|28.3|28.3|Standard Deviation|6.4|6.4|||
3769540|NCT01922349|3602913|B2|||Age||Years|Mean|28.5|28.5|Standard Deviation|4.4|4.4|||
3769541|NCT01922349|3602914|B1|||Age||Years|Mean|27.8|27.8|Standard Deviation|5.1|5.1|||
3769542|NCT01922271|3603022|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3769543|NCT01922271|3603023|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3769544|NCT01922271|3603024|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3769545|NCT01922271|3603022|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3769546|NCT01922271|3603023|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3769547|NCT01922271|3603024|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3769548|NCT01922271|3603022|B3|||Age||years|Mean|61.8|61.8|Standard Deviation|7.7|7.7|||
3769549|NCT01922271|3603023|B2|||Age||years|Mean|61.7|61.7|Standard Deviation|8.2|8.2|||
3769550|NCT01922271|3603024|B1|||Age||years|Mean|61.9|61.9|Standard Deviation|7.2|7.2|||
3769551|NCT01922219|3603043|B1|United States||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3769552|NCT01922219|3603043|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3769553|NCT01922219|3603043|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3769554|NCT01922219|3603043|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3769555|NCT01922219|3603043|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3769556|NCT01922219|3603043|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769557|NCT01922219|3603043|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3769558|NCT01922219|3603043|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769559|NCT01922219|3603043|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3769560|NCT01922219|3603043|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3769561|NCT01922219|3603043|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3769562|NCT01922219|3603043|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3769563|NCT01922219|3603043|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3769564|NCT01922219|3603043|B1|||Age||years|Mean|36|36.0|Standard Deviation|11.1|11.1|||
3769565|NCT01922219|3603043|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3769566|NCT01922219|3603043|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3769567|NCT01922219|3603043|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3769568|NCT01922115|3603049|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3769569|NCT01922115|3603050|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3769570|NCT01922115|3603051|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3769571|NCT01922115|3603049|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3769572|NCT01922115|3603050|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3769573|NCT01922115|3603051|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3769574|NCT01922115|3603049|B3|Black||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3769575|NCT01922115|3603050|B2|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3769576|NCT01922115|3603051|B1|Black||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3769577|NCT01922115|3603049|B3|White||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3769578|NCT01922115|3603050|B2|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3769579|NCT01922115|3603051|B1|White||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3769580|NCT01922115|3603049|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3769581|NCT01922115|3603050|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3769582|NCT01922115|3603051|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3769583|NCT01922115|3603049|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3769584|NCT01922115|3603050|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3769585|NCT01922115|3603051|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3769586|NCT01922115|3603049|B3|||Age||years|Mean|68.56|68.56|Standard Deviation|11.005|11.005|||
3769587|NCT01922115|3603050|B2|||Age||years|Mean|68.71|68.71|Standard Deviation|10.615|10.615|||
3769588|NCT01922115|3603051|B1|||Age||years|Mean|68.39|68.39|Standard Deviation|11.615|11.615|||
3769589|NCT01922089|3603064|B3||Male|Sex: Female, Male||Participants|Count of Participants|392|392.0||||||
3769590|NCT01922089|3603065|B2||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3769591|NCT01922089|3603066|B1||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
3769592|NCT01922089|3603064|B3||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3769593|NCT01922089|3603065|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3769594|NCT01922089|3603066|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3769595|NCT01922089|3603064|B3|||Age||years|Mean|64.0|64.0|Standard Deviation|11.39|11.39|||
3769596|NCT01922089|3603065|B2|||Age||years|Mean|63.8|63.8|Standard Deviation|10.94|10.94|||
3769597|NCT01922089|3603066|B1|||Age||years|Mean|64.2|64.2|Standard Deviation|11.86|11.86|||
3769598|NCT01922037|3603077|B3||Male|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
3769599|NCT01922037|3603078|B2||Male|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
3769600|NCT01922037|3603079|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3769601|NCT01922037|3603077|B3||Female|Sex: Female, Male||Participants|Count of Participants|512|512.0||||||
3769602|NCT01922037|3603078|B2||Female|Sex: Female, Male||Participants|Count of Participants|487|487.0||||||
3769603|NCT01922037|3603079|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3769604|NCT01922037|3603077|B3|||Age||years|Mean|47.3|47.3|Standard Deviation|17.40|17.4|||
3769605|NCT01922037|3603078|B2|||Age||years|Mean|50.4|50.4|Standard Deviation|14.75|14.75|||
3769606|NCT01922037|3603079|B1|||Age||years|Mean|14.0|14.0|Standard Deviation|1.69|1.69|||
3769607|NCT01922011|3603172|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3769608|NCT01922011|3603173|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3769609|NCT01922011|3603174|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3769610|NCT01922011|3603172|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3769611|NCT01922011|3603173|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3769612|NCT01922011|3603174|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3769613|NCT01922011|3603172|B3|||Age||Years|Mean|9.2|9.2|Standard Deviation|4.2|4.2|||
3769614|NCT01922011|3603173|B2|||Age||Years|Mean|9.2|9.2|Standard Deviation|4.1|4.1|||
3769615|NCT01922011|3603174|B1|||Age||Years|Mean|9.1|9.1|Standard Deviation|4.4|4.4|||
3769616|NCT01921894|3603215|B4|United States||Region of Enrollment||participants|Number|24|24.0||||||
3769617|NCT01921894|3603216|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3769618|NCT01921894|3603217|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3769619|NCT01921894|3603218|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3769620|NCT01921894|3603215|B4|Hispanic/Others||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3769621|NCT01921894|3603216|B3|Hispanic/Others||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3769622|NCT01921894|3603217|B2|Hispanic/Others||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3769623|NCT01921894|3603218|B1|Hispanic/Others||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3769624|NCT01921894|3603215|B4|Non-Hispanic Black||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3769625|NCT01921894|3603216|B3|Non-Hispanic Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3769626|NCT01921894|3603217|B2|Non-Hispanic Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3769627|NCT01921894|3603218|B1|Non-Hispanic Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3769628|NCT01921894|3603215|B4|Non-Hispanic white||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3769629|NCT01921894|3603216|B3|Non-Hispanic white||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3769630|NCT01921894|3603217|B2|Non-Hispanic white||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3769631|NCT01921894|3603218|B1|Non-Hispanic white||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3769632|NCT01921894|3603215|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3769633|NCT01921894|3603216|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3769634|NCT01921894|3603217|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3769635|NCT01921894|3603218|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3769636|NCT01921894|3603215|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3769637|NCT01921894|3603216|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3769638|NCT01921894|3603217|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3769639|NCT01921894|3603218|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3769640|NCT01921894|3603215|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3769641|NCT01921894|3603216|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3769642|NCT01921894|3603217|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3769643|NCT01921894|3603218|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3769644|NCT01921894|3603215|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3769645|NCT01921894|3603216|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3769646|NCT01921894|3603217|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3769647|NCT01921894|3603218|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3769648|NCT01921894|3603215|B4||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
3769649|NCT01921894|3603216|B3||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
3769650|NCT01921894|3603217|B2||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
3769651|NCT01921894|3603218|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
3769652|NCT01921829|3603240|B3|||Brain natriuretic peptide||pg/mL|Mean|710.9|710.9|Standard Deviation|578.5|578.5|||
3769653|NCT01921829|3603241|B2|||Brain natriuretic peptide||pg/mL|Mean|530.4|530.4|Standard Deviation|363.7|363.7|||
3769654|NCT01921829|3603242|B1|||Brain natriuretic peptide||pg/mL|Mean|855.3|855.3|Standard Deviation|690.7|690.7|||
3769655|NCT01921829|3603240|B3|||Blood urea nitrogen||mg/dL|Mean|45.6|45.6|Standard Deviation|27.1|27.1|||
3769656|NCT01921829|3603241|B2|||Blood urea nitrogen||mg/dL|Mean|56.3|56.3|Standard Deviation|38.8|38.8|||
3769657|NCT01921829|3603242|B1|||Blood urea nitrogen||mg/dL|Mean|38.2|38.2|Standard Deviation|12.5|12.5|||
3769658|NCT01921829|3603240|B3|||Creatinine||mg/dL|Mean|2.0|2.0|Standard Deviation|0.6|0.6|||
3769659|NCT01921829|3603241|B2|||Creatinine||mg/dL|Mean|2.2|2.2|Standard Deviation|0.8|0.8|||
3769660|NCT01921829|3603242|B1|||Creatinine||mg/dL|Mean|1.9|1.9|Standard Deviation|0.5|0.5|||
3769661|NCT01921829|3603240|B3|||Diuretic dose|(furosemide equivalent)|mg/day|Mean|214.2|214.2|Standard Deviation|99.7|99.7|||
3769662|NCT01921829|3603241|B2|||Diuretic dose|(furosemide equivalent)|mg/day|Mean|166.3|166.3|Standard Deviation|55.5|55.5|||
3769663|NCT01921829|3603242|B1|||Diuretic dose|(furosemide equivalent)|mg/day|Mean|242.5|242.5|Standard Deviation|112.7|112.7|||
3769664|NCT01921829|3603240|B3|||Cardiac resynchronization therapy||Participants|Count of Participants|2|2.0||||||
3769665|NCT01921829|3603241|B2|||Cardiac resynchronization therapy||Participants|Count of Participants|1|1.0||||||
3769666|NCT01921829|3603242|B1|||Cardiac resynchronization therapy||Participants|Count of Participants|1|1.0||||||
3769667|NCT01921829|3603240|B3|||Implantable cardioverter defibrillator||Participants|Count of Participants|7|7.0||||||
3769668|NCT01921829|3603241|B2|||Implantable cardioverter defibrillator||Participants|Count of Participants|2|2.0||||||
3769669|NCT01921829|3603242|B1|||Implantable cardioverter defibrillator||Participants|Count of Participants|5|5.0||||||
3769670|NCT01921829|3603240|B3|||Coronary artery bypass surgery||Participants|Count of Participants|6|6.0||||||
3769671|NCT01921829|3603241|B2|||Coronary artery bypass surgery||Participants|Count of Participants|3|3.0||||||
3769672|NCT01921829|3603242|B1|||Coronary artery bypass surgery||Participants|Count of Participants|3|3.0||||||
3769673|NCT01921829|3603240|B3|||Atrial fibrillation||Participants|Count of Participants|11|11.0||||||
3769674|NCT01921829|3603241|B2|||Atrial fibrillation||Participants|Count of Participants|6|6.0||||||
3769675|NCT01921829|3603242|B1|||Atrial fibrillation||Participants|Count of Participants|5|5.0||||||
3769676|NCT01921829|3603240|B3|||Hyperlipidemia||Participants|Count of Participants|10|10.0||||||
3769677|NCT01921829|3603241|B2|||Hyperlipidemia||Participants|Count of Participants|5|5.0||||||
3769678|NCT01921829|3603242|B1|||Hyperlipidemia||Participants|Count of Participants|5|5.0||||||
3769679|NCT01921829|3603240|B3|||Peripheral vascular disease||Participants|Count of Participants|4|4.0||||||
3769680|NCT01921829|3603241|B2|||Peripheral vascular disease||Participants|Count of Participants|0|0.0||||||
3769681|NCT01921829|3603242|B1|||Peripheral vascular disease||Participants|Count of Participants|4|4.0||||||
3769682|NCT01921829|3603240|B3|||Stroke||Participants|Count of Participants|4|4.0||||||
3769683|NCT01921829|3603241|B2|||Stroke||Participants|Count of Participants|0|0.0||||||
3769684|NCT01921829|3603242|B1|||Stroke||Participants|Count of Participants|4|4.0||||||
3769685|NCT01921829|3603240|B3|||Depression||Participants|Count of Participants|4|4.0||||||
3769686|NCT01921829|3603241|B2|||Depression||Participants|Count of Participants|2|2.0||||||
3769687|NCT01921829|3603242|B1|||Depression||Participants|Count of Participants|2|2.0||||||
3769688|NCT01921829|3603240|B3|||Coronary artery disease||Participants|Count of Participants|11|11.0||||||
3769689|NCT01921829|3603241|B2|||Coronary artery disease||Participants|Count of Participants|6|6.0||||||
3769690|NCT01921829|3603242|B1|||Coronary artery disease||Participants|Count of Participants|5|5.0||||||
3769691|NCT01921829|3603240|B3|||Chronic obstructive pulmonary disease||Participants|Count of Participants|5|5.0||||||
3769692|NCT01921829|3603241|B2|||Chronic obstructive pulmonary disease||Participants|Count of Participants|3|3.0||||||
3769693|NCT01921829|3603242|B1|||Chronic obstructive pulmonary disease||Participants|Count of Participants|2|2.0||||||
3769694|NCT01921829|3603240|B3|||Diabetes mellitus||Participants|Count of Participants|10|10.0||||||
3769695|NCT01921829|3603241|B2|||Diabetes mellitus||Participants|Count of Participants|5|5.0||||||
3769696|NCT01921829|3603242|B1|||Diabetes mellitus||Participants|Count of Participants|5|5.0||||||
3769697|NCT01921829|3603240|B3|||Hypertension||Participants|Count of Participants|16|16.0||||||
3769698|NCT01921829|3603241|B2|||Hypertension||Participants|Count of Participants|7|7.0||||||
3769699|NCT01921829|3603242|B1|||Hypertension||Participants|Count of Participants|9|9.0||||||
3769700|NCT01921829|3603240|B3||Unknown|Edema grade|"Edema grades based on palpation of skin:~- There is a barely detectable 2mm depression. Not easily seen but can be felt. Immediate rebound.~- There is a 4mm deep pit. A few seconds to rebound.~- There is a 6mm deep pit. 10-12 seconds to rebound.~- There is an 8mm deep pit (very deep). >20 seconds to rebound."|Participants|Count of Participants|3|3.0||||||
3769701|NCT01921829|3603241|B2||Unknown|Edema grade|"Edema grades based on palpation of skin:~- There is a barely detectable 2mm depression. Not easily seen but can be felt. Immediate rebound.~- There is a 4mm deep pit. A few seconds to rebound.~- There is a 6mm deep pit. 10-12 seconds to rebound.~- There is an 8mm deep pit (very deep). >20 seconds to rebound."|Participants|Count of Participants|2|2.0||||||
3769762|NCT01921829|3603242|B1|||Alcohol use||Participants|Count of Participants|1|1.0||||||
3769763|NCT01921829|3603240|B3||Never|Smoking||Participants|Count of Participants|7|7.0||||||
3769702|NCT01921829|3603242|B1||Unknown|Edema grade|"Edema grades based on palpation of skin:~- There is a barely detectable 2mm depression. Not easily seen but can be felt. Immediate rebound.~- There is a 4mm deep pit. A few seconds to rebound.~- There is a 6mm deep pit. 10-12 seconds to rebound.~- There is an 8mm deep pit (very deep). >20 seconds to rebound."|Participants|Count of Participants|1|1.0||||||
3769703|NCT01921829|3603240|B3||3+|Edema grade|"Edema grades based on palpation of skin:~- There is a barely detectable 2mm depression. Not easily seen but can be felt. Immediate rebound.~- There is a 4mm deep pit. A few seconds to rebound.~- There is a 6mm deep pit. 10-12 seconds to rebound.~- There is an 8mm deep pit (very deep). >20 seconds to rebound."|Participants|Count of Participants|4|4.0||||||
3769704|NCT01921829|3603241|B2||3+|Edema grade|"Edema grades based on palpation of skin:~- There is a barely detectable 2mm depression. Not easily seen but can be felt. Immediate rebound.~- There is a 4mm deep pit. A few seconds to rebound.~- There is a 6mm deep pit. 10-12 seconds to rebound.~- There is an 8mm deep pit (very deep). >20 seconds to rebound."|Participants|Count of Participants|3|3.0||||||
3769705|NCT01921829|3603242|B1||3+|Edema grade|"Edema grades based on palpation of skin:~- There is a barely detectable 2mm depression. Not easily seen but can be felt. Immediate rebound.~- There is a 4mm deep pit. A few seconds to rebound.~- There is a 6mm deep pit. 10-12 seconds to rebound.~- There is an 8mm deep pit (very deep). >20 seconds to rebound."|Participants|Count of Participants|1|1.0||||||
3769706|NCT01921829|3603240|B3||2+|Edema grade|"Edema grades based on palpation of skin:~- There is a barely detectable 2mm depression. Not easily seen but can be felt. Immediate rebound.~- There is a 4mm deep pit. A few seconds to rebound.~- There is a 6mm deep pit. 10-12 seconds to rebound.~- There is an 8mm deep pit (very deep). >20 seconds to rebound."|Participants|Count of Participants|9|9.0||||||
3769707|NCT01921829|3603241|B2||2+|Edema grade|"Edema grades based on palpation of skin:~- There is a barely detectable 2mm depression. Not easily seen but can be felt. Immediate rebound.~- There is a 4mm deep pit. A few seconds to rebound.~- There is a 6mm deep pit. 10-12 seconds to rebound.~- There is an 8mm deep pit (very deep). >20 seconds to rebound."|Participants|Count of Participants|2|2.0||||||
3769708|NCT01921829|3603242|B1||2+|Edema grade|"Edema grades based on palpation of skin:~- There is a barely detectable 2mm depression. Not easily seen but can be felt. Immediate rebound.~- There is a 4mm deep pit. A few seconds to rebound.~- There is a 6mm deep pit. 10-12 seconds to rebound.~- There is an 8mm deep pit (very deep). >20 seconds to rebound."|Participants|Count of Participants|7|7.0||||||
3769709|NCT01921829|3603240|B3|||Jugular venous pressure elevated||Participants|Count of Participants|13|13.0||||||
3769710|NCT01921829|3603241|B2|||Jugular venous pressure elevated||Participants|Count of Participants|7|7.0||||||
3769711|NCT01921829|3603242|B1|||Jugular venous pressure elevated||Participants|Count of Participants|6|6.0||||||
3769712|NCT01921829|3603240|B3|||Tricuspid regurgitation||Participants|Count of Participants|10|10.0||||||
3769713|NCT01921829|3603241|B2|||Tricuspid regurgitation||Participants|Count of Participants|4|4.0||||||
3769714|NCT01921829|3603242|B1|||Tricuspid regurgitation||Participants|Count of Participants|6|6.0||||||
3769715|NCT01921829|3603240|B3|||Mitral regurgitation||Participants|Count of Participants|7|7.0||||||
3769716|NCT01921829|3603241|B2|||Mitral regurgitation||Participants|Count of Participants|3|3.0||||||
3769717|NCT01921829|3603242|B1|||Mitral regurgitation||Participants|Count of Participants|4|4.0||||||
3769718|NCT01921829|3603240|B3||Reduced|Right ventricular function||Participants|Count of Participants|6|6.0||||||
3769719|NCT01921829|3603241|B2||Reduced|Right ventricular function||Participants|Count of Participants|1|1.0||||||
3769720|NCT01921829|3603242|B1||Reduced|Right ventricular function||Participants|Count of Participants|5|5.0||||||
3769721|NCT01921829|3603240|B3||Normal|Right ventricular function||Participants|Count of Participants|8|8.0||||||
3769722|NCT01921829|3603241|B2||Normal|Right ventricular function||Participants|Count of Participants|5|5.0||||||
3769723|NCT01921829|3603242|B1||Normal|Right ventricular function||Participants|Count of Participants|3|3.0||||||
3769724|NCT01921829|3603240|B3||Unknown|Left ventricular ejection fraction||Participants|Count of Participants|7|7.0||||||
3769725|NCT01921829|3603241|B2||Unknown|Left ventricular ejection fraction||Participants|Count of Participants|3|3.0||||||
3769726|NCT01921829|3603242|B1||Unknown|Left ventricular ejection fraction||Participants|Count of Participants|4|4.0||||||
3769727|NCT01921829|3603240|B3||30-35%|Left ventricular ejection fraction||Participants|Count of Participants|1|1.0||||||
3769728|NCT01921829|3603241|B2||30-35%|Left ventricular ejection fraction||Participants|Count of Participants|0|0.0||||||
3769729|NCT01921829|3603242|B1||30-35%|Left ventricular ejection fraction||Participants|Count of Participants|1|1.0||||||
3769730|NCT01921829|3603240|B3||25-30%|Left ventricular ejection fraction||Participants|Count of Participants|2|2.0||||||
3769731|NCT01921829|3603241|B2||25-30%|Left ventricular ejection fraction||Participants|Count of Participants|2|2.0||||||
3769732|NCT01921829|3603242|B1||25-30%|Left ventricular ejection fraction||Participants|Count of Participants|0|0.0||||||
3769733|NCT01921829|3603240|B3||20-25%|Left ventricular ejection fraction||Participants|Count of Participants|5|5.0||||||
3769734|NCT01921829|3603241|B2||20-25%|Left ventricular ejection fraction||Participants|Count of Participants|2|2.0||||||
3769735|NCT01921829|3603242|B1||20-25%|Left ventricular ejection fraction||Participants|Count of Participants|3|3.0||||||
3769736|NCT01921829|3603240|B3||IV|NYHA Class|"New York Heart Association (NYHA) Functional Classes:~I - No limitation of physical activity. Ordinary physical activity does not cause heart failure (HF) symptoms like undue fatigue, palpitation, dyspnea (shortness of breath).~II - Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in HF symptoms.~III - Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity results in HF symptoms.~IV - Unable to carry on any physical activity without discomfort. HF symptoms occur at rest and increase with any physical activity."|Participants|Count of Participants|2|2.0||||||
3769764|NCT01921829|3603241|B2||Never|Smoking||Participants|Count of Participants|2|2.0||||||
3769765|NCT01921829|3603242|B1||Never|Smoking||Participants|Count of Participants|5|5.0||||||
3769766|NCT01921829|3603240|B3||Past|Smoking||Participants|Count of Participants|11|11.0||||||
3769767|NCT01921829|3603241|B2||Past|Smoking||Participants|Count of Participants|6|6.0||||||
3769737|NCT01921829|3603241|B2||IV|NYHA Class|"New York Heart Association (NYHA) Functional Classes:~I - No limitation of physical activity. Ordinary physical activity does not cause heart failure (HF) symptoms like undue fatigue, palpitation, dyspnea (shortness of breath).~II - Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in HF symptoms.~III - Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity results in HF symptoms.~IV - Unable to carry on any physical activity without discomfort. HF symptoms occur at rest and increase with any physical activity."|Participants|Count of Participants|0|0.0||||||
3769738|NCT01921829|3603242|B1||IV|NYHA Class|"New York Heart Association (NYHA) Functional Classes:~I - No limitation of physical activity. Ordinary physical activity does not cause heart failure (HF) symptoms like undue fatigue, palpitation, dyspnea (shortness of breath).~II - Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in HF symptoms.~III - Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity results in HF symptoms.~IV - Unable to carry on any physical activity without discomfort. HF symptoms occur at rest and increase with any physical activity."|Participants|Count of Participants|2|2.0||||||
3769739|NCT01921829|3603240|B3||III|NYHA Class|"New York Heart Association (NYHA) Functional Classes:~I - No limitation of physical activity. Ordinary physical activity does not cause heart failure (HF) symptoms like undue fatigue, palpitation, dyspnea (shortness of breath).~II - Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in HF symptoms.~III - Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity results in HF symptoms.~IV - Unable to carry on any physical activity without discomfort. HF symptoms occur at rest and increase with any physical activity."|Participants|Count of Participants|9|9.0||||||
3769740|NCT01921829|3603241|B2||III|NYHA Class|"New York Heart Association (NYHA) Functional Classes:~I - No limitation of physical activity. Ordinary physical activity does not cause heart failure (HF) symptoms like undue fatigue, palpitation, dyspnea (shortness of breath).~II - Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in HF symptoms.~III - Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity results in HF symptoms.~IV - Unable to carry on any physical activity without discomfort. HF symptoms occur at rest and increase with any physical activity."|Participants|Count of Participants|4|4.0||||||
3769741|NCT01921829|3603242|B1||III|NYHA Class|"New York Heart Association (NYHA) Functional Classes:~I - No limitation of physical activity. Ordinary physical activity does not cause heart failure (HF) symptoms like undue fatigue, palpitation, dyspnea (shortness of breath).~II - Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in HF symptoms.~III - Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity results in HF symptoms.~IV - Unable to carry on any physical activity without discomfort. HF symptoms occur at rest and increase with any physical activity."|Participants|Count of Participants|5|5.0||||||
3769742|NCT01921829|3603240|B3||II|NYHA Class|"New York Heart Association (NYHA) Functional Classes:~I - No limitation of physical activity. Ordinary physical activity does not cause heart failure (HF) symptoms like undue fatigue, palpitation, dyspnea (shortness of breath).~II - Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in HF symptoms.~III - Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity results in HF symptoms.~IV - Unable to carry on any physical activity without discomfort. HF symptoms occur at rest and increase with any physical activity."|Participants|Count of Participants|4|4.0||||||
3769743|NCT01921829|3603241|B2||II|NYHA Class|"New York Heart Association (NYHA) Functional Classes:~I - No limitation of physical activity. Ordinary physical activity does not cause heart failure (HF) symptoms like undue fatigue, palpitation, dyspnea (shortness of breath).~II - Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in HF symptoms.~III - Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity results in HF symptoms.~IV - Unable to carry on any physical activity without discomfort. HF symptoms occur at rest and increase with any physical activity."|Participants|Count of Participants|2|2.0||||||
3769744|NCT01921829|3603242|B1||II|NYHA Class|"New York Heart Association (NYHA) Functional Classes:~I - No limitation of physical activity. Ordinary physical activity does not cause heart failure (HF) symptoms like undue fatigue, palpitation, dyspnea (shortness of breath).~II - Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in HF symptoms.~III - Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity results in HF symptoms.~IV - Unable to carry on any physical activity without discomfort. HF symptoms occur at rest and increase with any physical activity."|Participants|Count of Participants|2|2.0||||||
3769745|NCT01921829|3603240|B3||Other|Cardiomyopathy type||Participants|Count of Participants|4|4.0||||||
3769746|NCT01921829|3603241|B2||Other|Cardiomyopathy type||Participants|Count of Participants|0|0.0||||||
3769747|NCT01921829|3603242|B1||Other|Cardiomyopathy type||Participants|Count of Participants|4|4.0||||||
3769748|NCT01921829|3603240|B3||Hypertensive|Cardiomyopathy type||Participants|Count of Participants|1|1.0||||||
3769749|NCT01921829|3603241|B2||Hypertensive|Cardiomyopathy type||Participants|Count of Participants|1|1.0||||||
3769750|NCT01921829|3603242|B1||Hypertensive|Cardiomyopathy type||Participants|Count of Participants|0|0.0||||||
3769751|NCT01921829|3603240|B3||Dilated|Cardiomyopathy type||Participants|Count of Participants|3|3.0||||||
3769752|NCT01921829|3603241|B2||Dilated|Cardiomyopathy type||Participants|Count of Participants|2|2.0||||||
3769753|NCT01921829|3603242|B1||Dilated|Cardiomyopathy type||Participants|Count of Participants|1|1.0||||||
3769754|NCT01921829|3603240|B3||Ischemic|Cardiomyopathy type||Participants|Count of Participants|10|10.0||||||
3769755|NCT01921829|3603241|B2||Ischemic|Cardiomyopathy type||Participants|Count of Participants|5|5.0||||||
3769756|NCT01921829|3603242|B1||Ischemic|Cardiomyopathy type||Participants|Count of Participants|5|5.0||||||
3769757|NCT01921829|3603240|B3|||Caffeine use||Participants|Count of Participants|14|14.0||||||
3769758|NCT01921829|3603241|B2|||Caffeine use||Participants|Count of Participants|6|6.0||||||
3769759|NCT01921829|3603242|B1|||Caffeine use||Participants|Count of Participants|8|8.0||||||
3769760|NCT01921829|3603240|B3|||Alcohol use||Participants|Count of Participants|3|3.0||||||
3769761|NCT01921829|3603241|B2|||Alcohol use||Participants|Count of Participants|2|2.0||||||
3769768|NCT01921829|3603242|B1||Past|Smoking||Participants|Count of Participants|5|5.0||||||
3769769|NCT01921829|3603240|B3||Current|Smoking||Participants|Count of Participants|0|0.0||||||
3769770|NCT01921829|3603241|B2||Current|Smoking||Participants|Count of Participants|0|0.0||||||
3769771|NCT01921829|3603242|B1||Current|Smoking||Participants|Count of Participants|0|0.0||||||
3769772|NCT01921829|3603240|B3|||Years of education||years|Mean|13.2|13.2|Standard Deviation|2.3|2.3|||
3769773|NCT01921829|3603241|B2|||Years of education||years|Mean|12.9|12.9|Standard Deviation|2.4|2.4|||
3769774|NCT01921829|3603242|B1|||Years of education||years|Mean|13.5|13.5|Standard Deviation|2.3|2.3|||
3769775|NCT01921829|3603240|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769776|NCT01921829|3603241|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769777|NCT01921829|3603242|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769778|NCT01921829|3603240|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769779|NCT01921829|3603241|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769780|NCT01921829|3603242|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769781|NCT01921829|3603240|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3769782|NCT01921829|3603241|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3769783|NCT01921829|3603242|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3769784|NCT01921829|3603240|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3769785|NCT01921829|3603241|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769786|NCT01921829|3603242|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3769787|NCT01921829|3603240|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769788|NCT01921829|3603241|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769789|NCT01921829|3603242|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769790|NCT01921829|3603240|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3769791|NCT01921829|3603241|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769792|NCT01921829|3603242|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3769793|NCT01921829|3603240|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769794|NCT01921829|3603241|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769795|NCT01921829|3603242|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769796|NCT01921829|3603240|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3769797|NCT01921829|3603241|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3769798|NCT01921829|3603242|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3769799|NCT01921829|3603240|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3769800|NCT01921829|3603241|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3769801|NCT01921829|3603242|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3769802|NCT01921829|3603240|B3|||Age||years|Mean|68.7|68.7|Standard Deviation|7.3|7.3|||
3769803|NCT01921829|3603241|B2|||Age||years|Mean|68.4|68.4|Standard Deviation|6.9|6.9|||
3769804|NCT01921829|3603242|B1|||Age||years|Mean|68.9|68.9|Standard Deviation|8.6|8.6|||
3769805|NCT01921751|3603289|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3769806|NCT01921751|3603290|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3769807|NCT01921751|3603291|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3769808|NCT01921751|3603292|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3769809|NCT01921751|3603289|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3769810|NCT01921751|3603290|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3769811|NCT01921751|3603291|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3769812|NCT01921751|3603292|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3769813|NCT01921751|3603289|B4|||Age||years|Median|66|66.0|Full Range|||59.0|71.0|
3769814|NCT01921751|3603290|B3|||Age||years|Median|66|66.0|Full Range|||60.0|68.0|
3769815|NCT01921751|3603291|B2|||Age||years|Median|69|69.0|Full Range|||59.0|71.0|
3769816|NCT01921751|3603292|B1|||Age||years|Median|63.5|63.5|Full Range|||62.0|69.0|
3769817|NCT01921452|3603312|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3769818|NCT01921452|3603312|B1||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
3769819|NCT01921452|3603312|B1|||Age||Years|Mean|42.99|42.99|Standard Deviation|12.52|12.52|||
3769820|NCT01921387|3603317|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769821|NCT01921387|3603317|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3769822|NCT01921387|3603317|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3769823|NCT01921387|3603317|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769824|NCT01921387|3603317|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769825|NCT01921387|3603317|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769826|NCT01921387|3603317|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769827|NCT01921387|3603317|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769828|NCT01921387|3603317|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3769829|NCT01921387|3603317|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3769830|NCT01921387|3603317|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3769831|NCT01921387|3603317|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3769832|NCT01921387|3603317|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3769833|NCT01921387|3603317|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3769834|NCT01921387|3603317|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3769835|NCT01921348|3603324|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
3769836|NCT01921348|3603325|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3769837|NCT01921348|3603326|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3769838|NCT01921348|3603324|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3769839|NCT01921348|3603325|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3769840|NCT01921348|3603326|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3769841|NCT01921348|3603324|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3769842|NCT01921348|3603325|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3769843|NCT01921348|3603326|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3769844|NCT01921348|3603324|B3|||Age||years|Mean|39.4|39.4|Standard Deviation|12.0|12.0|||
3769845|NCT01921348|3603325|B2|||Age||years|Mean|36.9|36.9|Standard Deviation|12.1|12.1|||
3769846|NCT01921348|3603326|B1|||Age||years|Mean|41.9|41.9|Standard Deviation|12.1|12.1|||
3769847|NCT01921348|3603324|B3||>=65 years|Age|normal individuals with symptomatic allergic rhinitis whose total symptom scores were assessed before and after the intervention|Participants|Count of Participants|0|0.0||||||
3769848|NCT01921348|3603325|B2||>=65 years|Age|normal individuals with symptomatic allergic rhinitis whose total symptom scores were assessed before and after the intervention|Participants|Count of Participants|0|0.0||||||
3769849|NCT01921348|3603326|B1||>=65 years|Age|normal individuals with symptomatic allergic rhinitis whose total symptom scores were assessed before and after the intervention|Participants|Count of Participants|0|0.0||||||
3769850|NCT01921348|3603324|B3||Between 18 and 65 years|Age|normal individuals with symptomatic allergic rhinitis whose total symptom scores were assessed before and after the intervention|Participants|Count of Participants|18|18.0||||||
3769851|NCT01921348|3603325|B2||Between 18 and 65 years|Age|normal individuals with symptomatic allergic rhinitis whose total symptom scores were assessed before and after the intervention|Participants|Count of Participants|9|9.0||||||
3769852|NCT01921348|3603326|B1||Between 18 and 65 years|Age|normal individuals with symptomatic allergic rhinitis whose total symptom scores were assessed before and after the intervention|Participants|Count of Participants|9|9.0||||||
3769853|NCT01921348|3603324|B3||<=18 years|Age|normal individuals with symptomatic allergic rhinitis whose total symptom scores were assessed before and after the intervention|Participants|Count of Participants|0|0.0||||||
3769854|NCT01921348|3603325|B2||<=18 years|Age|normal individuals with symptomatic allergic rhinitis whose total symptom scores were assessed before and after the intervention|Participants|Count of Participants|0|0.0||||||
3769855|NCT01921348|3603326|B1||<=18 years|Age|normal individuals with symptomatic allergic rhinitis whose total symptom scores were assessed before and after the intervention|Participants|Count of Participants|0|0.0||||||
3769856|NCT01921322|3603337|B3|||A1C (%)||%|Mean|10|10.0|Standard Deviation|1.4|1.4|||
3769857|NCT01921322|3603338|B2|||A1C (%)||%|Mean|10|10.0|Standard Deviation|1.2|1.2|||
3769858|NCT01921322|3603339|B1|||A1C (%)||%|Mean|10|10.0|Standard Deviation|1.6|1.6|||
3769859|NCT01921322|3603337|B3|||BMI (kg/m2)||kg/m2|Mean|25|25.0|Standard Deviation|3.1|3.1|||
3769860|NCT01921322|3603338|B2|||BMI (kg/m2)||kg/m2|Mean|25|25.0|Standard Deviation|3.3|3.3|||
3769861|NCT01921322|3603339|B1|||BMI (kg/m2)||kg/m2|Mean|25|25.0|Standard Deviation|3.1|3.1|||
3769862|NCT01921322|3603337|B3|||Weight (kg)||kg|Mean|71|71.0|Standard Deviation|11.2|11.2|||
3769863|NCT01921322|3603338|B2|||Weight (kg)||kg|Mean|72|72.0|Standard Deviation|10.7|10.7|||
3769864|NCT01921322|3603339|B1|||Weight (kg)||kg|Mean|71|71.0|Standard Deviation|11.9|11.9|||
3769865|NCT01921322|3603337|B3|||Height (cm)||cm|Mean|167|167.0|Standard Deviation|7.8|7.8|||
3769866|NCT01921322|3603338|B2|||Height (cm)||cm|Mean|168|168.0|Standard Deviation|7.6|7.6|||
3769867|NCT01921322|3603339|B1|||Height (cm)||cm|Mean|167|167.0|Standard Deviation|8.1|8.1|||
3769868|NCT01921322|3603337|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769869|NCT01921322|3603338|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769870|NCT01921322|3603339|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769871|NCT01921322|3603337|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769872|NCT01921322|3603338|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769873|NCT01921322|3603339|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769874|NCT01921322|3603337|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769875|NCT01921322|3603338|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769876|NCT01921322|3603339|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769877|NCT01921322|3603337|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769878|NCT01921322|3603338|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769879|NCT01921322|3603339|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769880|NCT01921322|3603337|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769881|NCT01921322|3603338|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769882|NCT01921322|3603339|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769883|NCT01921322|3603337|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
3769884|NCT01921322|3603338|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3769885|NCT01921322|3603339|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3769886|NCT01921322|3603337|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769887|NCT01921322|3603338|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769888|NCT01921322|3603339|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769889|NCT01921322|3603337|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3769890|NCT01921322|3603338|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3769891|NCT01921322|3603339|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3769892|NCT01921322|3603337|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3769893|NCT01921322|3603338|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3769894|NCT01921322|3603339|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3769895|NCT01921322|3603337|B3|||Age||years|Mean|50|50.0|Standard Deviation|9.9|9.9|||
3769896|NCT01921322|3603338|B2|||Age||years|Mean|49|49.0|Standard Deviation|9.6|9.6|||
3769897|NCT01921322|3603339|B1|||Age||years|Mean|51|51.0|Standard Deviation|10.2|10.2|||
3769898|NCT01921296|3603348|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3769899|NCT01921296|3603348|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3769900|NCT01921296|3603348|B1|||Age||years|Median|77.5|77.5|Full Range|||77.0|78.0|
3769901|NCT01921270|3603356|B1|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3769902|NCT01921270|3603356|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3769903|NCT01921270|3603356|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3769904|NCT01921270|3603356|B1|||Age||years|Mean|62.83|62.83|Standard Deviation|10.45|10.45|||
3769905|NCT01921257|3603372|B1|Poland||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3769906|NCT01921257|3603372|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769907|NCT01921257|3603372|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769908|NCT01921257|3603372|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3769909|NCT01921257|3603372|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769910|NCT01921257|3603372|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769911|NCT01921257|3603372|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769912|NCT01921257|3603372|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769913|NCT01921257|3603372|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3769914|NCT01921257|3603372|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3769915|NCT01921257|3603372|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3769916|NCT01921257|3603372|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3769917|NCT01921257|3603372|B1||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
3769918|NCT01921205|3603377|B3||Other/Mixed|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3769919|NCT01921205|3603378|B2||Other/Mixed|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3769920|NCT01921205|3603379|B1||Other/Mixed|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3769921|NCT01921205|3603377|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|267|267.0||||||
3769922|NCT01921205|3603378|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|138|138.0||||||
3769923|NCT01921205|3603379|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|129|129.0||||||
3769924|NCT01921205|3603377|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3769925|NCT01921205|3603378|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3769926|NCT01921205|3603379|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3769927|NCT01921205|3603377|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|60|60.0||||||
3769928|NCT01921205|3603378|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3769929|NCT01921205|3603379|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
3769930|NCT01921205|3603377|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3769931|NCT01921205|3603378|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3769932|NCT01921205|3603379|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3769933|NCT01921205|3603377|B3||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
3769934|NCT01921205|3603378|B2||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3769935|NCT01921205|3603379|B1||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3769936|NCT01921205|3603377|B3||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3769937|NCT01921205|3603378|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3769938|NCT01921205|3603379|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3769939|NCT01921205|3603377|B3|||Age||years|Mean|10.7|10.7|Standard Deviation|3.5|3.5|||
3769940|NCT01921205|3603378|B2|||Age||years|Mean|10.5|10.5|Standard Deviation|3.6|3.6|||
3769941|NCT01921205|3603379|B1|||Age||years|Mean|10.9|10.9|Standard Deviation|3.5|3.5|||
3769942|NCT01921205|3603377|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3769943|NCT01921205|3603378|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3769944|NCT01921205|3603379|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3769945|NCT01921205|3603377|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3769946|NCT01921205|3603378|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3769947|NCT01921205|3603379|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3769948|NCT01921205|3603377|B3||<=18 years|Age||Participants|Count of Participants|343|343.0||||||
3769949|NCT01921205|3603378|B2||<=18 years|Age||Participants|Count of Participants|171|171.0||||||
3769950|NCT01921205|3603379|B1||<=18 years|Age||Participants|Count of Participants|172|172.0||||||
3769951|NCT01921166|3603408|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3769952|NCT01921166|3603409|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3769953|NCT01921166|3603410|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3769954|NCT01921166|3603408|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3769955|NCT01921166|3603409|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3769956|NCT01921166|3603410|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3769957|NCT01921166|3603408|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3769958|NCT01921166|3603409|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3769959|NCT01921166|3603410|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3769960|NCT01921166|3603408|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3769961|NCT01921166|3603409|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3769962|NCT01921166|3603410|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3769963|NCT01921166|3603408|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3769964|NCT01921166|3603409|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3769965|NCT01921166|3603410|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3769966|NCT01921101|3603419|B3|||body mass index|Body mass index was calculated based on admission weight (Kg)/ height (m)2; NIH classifications for BMI categories were used ( BMI < 18.5 malnourished; 18.5-24.9 normal weight, 25-29.9 overweight and > 30 obese)|Kg/m2|Mean|30|30.0|Standard Deviation|9.1|9.1|||
3769967|NCT01921101|3603420|B2|||body mass index|Body mass index was calculated based on admission weight (Kg)/ height (m)2; NIH classifications for BMI categories were used ( BMI < 18.5 malnourished; 18.5-24.9 normal weight, 25-29.9 overweight and > 30 obese)|Kg/m2|Mean|30.1|30.1|Standard Deviation|8.9|8.9|||
3769968|NCT01921101|3603421|B1|||body mass index|Body mass index was calculated based on admission weight (Kg)/ height (m)2; NIH classifications for BMI categories were used ( BMI < 18.5 malnourished; 18.5-24.9 normal weight, 25-29.9 overweight and > 30 obese)|Kg/m2|Mean|29.8|29.8|Standard Deviation|9.3|9.3|||
3769969|NCT01921101|3603419|B3|||Sequential Organ Functional Assessment (SOFA)|The sequential organ failure assessment score (SOFA)is a scoring system used in critically ill patients to assess the extent of their organ function. The total score is based on six different scores, one of the respiratory, cardiovascular, hepatic, coagulation, renal and neurological systems. These scores range from 0-24; higher scores indicate more severe organ compromise.|units on a scale|Mean|9.3|9.3|Standard Deviation|3.6|3.6|||
3769970|NCT01921101|3603420|B2|||Sequential Organ Functional Assessment (SOFA)|The sequential organ failure assessment score (SOFA)is a scoring system used in critically ill patients to assess the extent of their organ function. The total score is based on six different scores, one of the respiratory, cardiovascular, hepatic, coagulation, renal and neurological systems. These scores range from 0-24; higher scores indicate more severe organ compromise.|units on a scale|Mean|9.4|9.4|Standard Deviation|3.4|3.4|||
3769971|NCT01921101|3603421|B1|||Sequential Organ Functional Assessment (SOFA)|The sequential organ failure assessment score (SOFA)is a scoring system used in critically ill patients to assess the extent of their organ function. The total score is based on six different scores, one of the respiratory, cardiovascular, hepatic, coagulation, renal and neurological systems. These scores range from 0-24; higher scores indicate more severe organ compromise.|units on a scale|Mean|9.3|9.3|Standard Deviation|3.8|3.8|||
3769972|NCT01921101|3603419|B3|||Acute Physiology and Chronic Health Evaluation II (APACHE II)|The Acute Physiology and Chronic Health Evaluation II (APACHE II) is a severity-of-disease classification. It is applied within 24 hours of admission to the intensive care unit. The scores range from 0-71; higher scores correspond to more severe disease and a higher risk of death|units on a scale|Mean|25.5|25.5|Standard Deviation|8.9|8.9|||
3769973|NCT01921101|3603420|B2|||Acute Physiology and Chronic Health Evaluation II (APACHE II)|The Acute Physiology and Chronic Health Evaluation II (APACHE II) is a severity-of-disease classification. It is applied within 24 hours of admission to the intensive care unit. The scores range from 0-71; higher scores correspond to more severe disease and a higher risk of death|units on a scale|Mean|27.7|27.7|Standard Deviation|7.9|7.9|||
3769974|NCT01921101|3603421|B1|||Acute Physiology and Chronic Health Evaluation II (APACHE II)|The Acute Physiology and Chronic Health Evaluation II (APACHE II) is a severity-of-disease classification. It is applied within 24 hours of admission to the intensive care unit. The scores range from 0-71; higher scores correspond to more severe disease and a higher risk of death|units on a scale|Mean|23.4|23.4|Standard Deviation|9.3|9.3|||
3769975|NCT01921101|3603419|B3|United States||Region of Enrollment||participants|Number|78|78.0||||||
3769976|NCT01921101|3603420|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
3769977|NCT01921101|3603421|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3769978|NCT01921101|3603419|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769979|NCT01921101|3603420|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769980|NCT01921101|3603421|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769981|NCT01921101|3603419|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769982|NCT01921101|3603420|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769983|NCT01921101|3603421|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769984|NCT01921101|3603419|B3||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3769985|NCT01921101|3603420|B2||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3769986|NCT01921101|3603421|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3769987|NCT01921101|3603419|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3769988|NCT01921101|3603420|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3769989|NCT01921101|3603421|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3769990|NCT01921101|3603419|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769991|NCT01921101|3603420|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769992|NCT01921101|3603421|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769993|NCT01921101|3603419|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769994|NCT01921101|3603420|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769995|NCT01921101|3603421|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769996|NCT01921101|3603419|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769997|NCT01921101|3603420|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769998|NCT01921101|3603421|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3769999|NCT01921101|3603419|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3770000|NCT01921101|3603420|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3770001|NCT01921101|3603421|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3770002|NCT01921101|3603419|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3770003|NCT01921101|3603420|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3770004|NCT01921101|3603421|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3770005|NCT01921101|3603419|B3|age||Age||years|Mean|55.4|55.4|Standard Deviation|16.7|16.7|||
3770006|NCT01921101|3603420|B2|age||Age||years|Mean|58.6|58.6|Standard Deviation|16.2|16.2|||
3770007|NCT01921101|3603421|B1|age||Age||years|Mean|52.5|52.5|Standard Deviation|17.1|17.1|||
3770008|NCT01920958|3603430|B1|||Body Mass Index (BMI)|BMI data was available for 216 participants.|kg/m^2|Mean|27.55|27.55|Standard Deviation|5.092|5.092|||
3770009|NCT01920958|3603430|B1|||Weight|Weight data was available for 216 participants.|kg|Mean|79.6|79.6|Standard Deviation|15.84|15.84|||
3770010|NCT01920958|3603430|B1|||Height|Height data was available for 216 participants.|cm|Mean|169.9|169.9|Standard Deviation|9.07|9.07|||
3770011|NCT01920958|3603430|B1|Germany||Region of Enrollment||participants|Number|228|228.0||||||
3770012|NCT01920958|3603430|B1|Missing||Sex/Gender, Customized||participants|Number|7|7.0||||||
3770013|NCT01920958|3603430|B1|Male||Sex/Gender, Customized||participants|Number|111|111.0||||||
3770014|NCT01920958|3603430|B1|Female||Sex/Gender, Customized||participants|Number|110|110.0||||||
3770015|NCT01920958|3603430|B1|||Age|Age data was available for 226 participants.|years|Mean|63.6|63.6|Standard Deviation|10.82|10.82|||
3770016|NCT01920893|3603446|B3||No|Number of participants with asthma|The diagnosis of asthma was based on participant’s history; participants with asthma were required to have a forced expiratory volume in 1 second (FEV1) of more than 60% of predicted use, daily inhaled corticosteroids of no more than 1000 mcg of fluticasone (or equivalent), and could not have had an asthma exacerbation requiring systemic corticosteroids or hospitalization within the prior 3 months.|Participants|Count of Participants|25|25.0||||||
3770017|NCT01920893|3603447|B2||No|Number of participants with asthma|The diagnosis of asthma was based on participant’s history; participants with asthma were required to have a forced expiratory volume in 1 second (FEV1) of more than 60% of predicted use, daily inhaled corticosteroids of no more than 1000 mcg of fluticasone (or equivalent), and could not have had an asthma exacerbation requiring systemic corticosteroids or hospitalization within the prior 3 months.|Participants|Count of Participants|14|14.0||||||
3770018|NCT01920893|3603448|B1||No|Number of participants with asthma|The diagnosis of asthma was based on participant’s history; participants with asthma were required to have a forced expiratory volume in 1 second (FEV1) of more than 60% of predicted use, daily inhaled corticosteroids of no more than 1000 mcg of fluticasone (or equivalent), and could not have had an asthma exacerbation requiring systemic corticosteroids or hospitalization within the prior 3 months.|Participants|Count of Participants|11|11.0||||||
3770019|NCT01920893|3603446|B3||Yes|Number of participants with asthma|The diagnosis of asthma was based on participant’s history; participants with asthma were required to have a forced expiratory volume in 1 second (FEV1) of more than 60% of predicted use, daily inhaled corticosteroids of no more than 1000 mcg of fluticasone (or equivalent), and could not have had an asthma exacerbation requiring systemic corticosteroids or hospitalization within the prior 3 months.|Participants|Count of Participants|35|35.0||||||
3770072|NCT01920854|3603478|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3770073|NCT01920854|3603479|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770074|NCT01920854|3603480|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770020|NCT01920893|3603447|B2||Yes|Number of participants with asthma|The diagnosis of asthma was based on participant’s history; participants with asthma were required to have a forced expiratory volume in 1 second (FEV1) of more than 60% of predicted use, daily inhaled corticosteroids of no more than 1000 mcg of fluticasone (or equivalent), and could not have had an asthma exacerbation requiring systemic corticosteroids or hospitalization within the prior 3 months.|Participants|Count of Participants|16|16.0||||||
3770021|NCT01920893|3603448|B1||Yes|Number of participants with asthma|The diagnosis of asthma was based on participant’s history; participants with asthma were required to have a forced expiratory volume in 1 second (FEV1) of more than 60% of predicted use, daily inhaled corticosteroids of no more than 1000 mcg of fluticasone (or equivalent), and could not have had an asthma exacerbation requiring systemic corticosteroids or hospitalization within the prior 3 months.|Participants|Count of Participants|19|19.0||||||
3770022|NCT01920893|3603446|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770023|NCT01920893|3603447|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770024|NCT01920893|3603448|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770025|NCT01920893|3603446|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770026|NCT01920893|3603447|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770027|NCT01920893|3603448|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770028|NCT01920893|3603446|B3||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3770029|NCT01920893|3603447|B2||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3770030|NCT01920893|3603448|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3770031|NCT01920893|3603446|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3770032|NCT01920893|3603447|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3770033|NCT01920893|3603448|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770034|NCT01920893|3603446|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770035|NCT01920893|3603447|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770036|NCT01920893|3603448|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770037|NCT01920893|3603446|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770038|NCT01920893|3603447|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770039|NCT01920893|3603448|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770040|NCT01920893|3603446|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770041|NCT01920893|3603447|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770042|NCT01920893|3603448|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770043|NCT01920893|3603446|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770044|NCT01920893|3603447|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770045|NCT01920893|3603448|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770046|NCT01920893|3603446|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3770047|NCT01920893|3603447|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3770048|NCT01920893|3603448|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3770049|NCT01920893|3603446|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3770050|NCT01920893|3603447|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3770051|NCT01920893|3603448|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770052|NCT01920893|3603446|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3770053|NCT01920893|3603447|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3770054|NCT01920893|3603448|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3770055|NCT01920893|3603446|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3770056|NCT01920893|3603447|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3770057|NCT01920893|3603448|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3770058|NCT01920893|3603446|B3|||Age||years|Mean|48.4|48.4|Standard Deviation|9.4|9.4|||
3770059|NCT01920893|3603447|B2|||Age||years|Mean|47.4|47.4|Standard Deviation|9.8|9.8|||
3770060|NCT01920893|3603448|B1|||Age||years|Mean|49.3|49.3|Standard Deviation|9.1|9.1|||
3770061|NCT01920854|3603475|B8|United States||Region of Enrollment||participants|Number|48|48.0||||||
3770062|NCT01920854|3603476|B7|United States||Region of Enrollment||participants|Number|6|6.0||||||
3770063|NCT01920854|3603477|B6|United States||Region of Enrollment||participants|Number|6|6.0||||||
3770064|NCT01920854|3603478|B5|United States||Region of Enrollment||participants|Number|6|6.0||||||
3770065|NCT01920854|3603479|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
3770066|NCT01920854|3603480|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3770067|NCT01920854|3603481|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3770068|NCT01920854|3603482|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3770069|NCT01920854|3603475|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3770070|NCT01920854|3603476|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770071|NCT01920854|3603477|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770075|NCT01920854|3603481|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770076|NCT01920854|3603482|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770077|NCT01920854|3603475|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770078|NCT01920854|3603476|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770079|NCT01920854|3603477|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770080|NCT01920854|3603478|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770081|NCT01920854|3603479|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770082|NCT01920854|3603480|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770083|NCT01920854|3603481|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770084|NCT01920854|3603482|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770085|NCT01920854|3603475|B8||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3770086|NCT01920854|3603476|B7||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3770087|NCT01920854|3603477|B6||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3770088|NCT01920854|3603478|B5||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3770089|NCT01920854|3603479|B4||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3770090|NCT01920854|3603480|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3770091|NCT01920854|3603481|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3770092|NCT01920854|3603482|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3770093|NCT01920854|3603475|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3770094|NCT01920854|3603476|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3770095|NCT01920854|3603477|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3770096|NCT01920854|3603478|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3770097|NCT01920854|3603479|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770098|NCT01920854|3603480|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3770099|NCT01920854|3603481|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3770100|NCT01920854|3603482|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3770101|NCT01920854|3603475|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770102|NCT01920854|3603476|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770103|NCT01920854|3603477|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770104|NCT01920854|3603478|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770105|NCT01920854|3603479|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770106|NCT01920854|3603480|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770107|NCT01920854|3603481|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770108|NCT01920854|3603482|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770109|NCT01920854|3603475|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770110|NCT01920854|3603476|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770111|NCT01920854|3603477|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770112|NCT01920854|3603478|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770113|NCT01920854|3603479|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770114|NCT01920854|3603480|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770115|NCT01920854|3603481|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770116|NCT01920854|3603482|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770117|NCT01920854|3603475|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770118|NCT01920854|3603476|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770119|NCT01920854|3603477|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770120|NCT01920854|3603478|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770121|NCT01920854|3603479|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770122|NCT01920854|3603480|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770123|NCT01920854|3603481|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770124|NCT01920854|3603482|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770125|NCT01920854|3603475|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770126|NCT01920854|3603476|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770127|NCT01920854|3603477|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770128|NCT01920854|3603478|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770129|NCT01920854|3603479|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770130|NCT01920854|3603480|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770131|NCT01920854|3603481|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770132|NCT01920854|3603482|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770133|NCT01920854|3603475|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3770134|NCT01920854|3603476|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3770135|NCT01920854|3603477|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3770136|NCT01920854|3603478|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3770137|NCT01920854|3603479|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3770138|NCT01920854|3603480|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3770139|NCT01920854|3603481|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3770140|NCT01920854|3603482|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3770141|NCT01920854|3603475|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3770142|NCT01920854|3603476|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770143|NCT01920854|3603477|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3770144|NCT01920854|3603478|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3770145|NCT01920854|3603479|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770146|NCT01920854|3603480|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770147|NCT01920854|3603481|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770148|NCT01920854|3603482|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770149|NCT01920854|3603475|B8||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3770150|NCT01920854|3603476|B7||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3770151|NCT01920854|3603477|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3770152|NCT01920854|3603478|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3770153|NCT01920854|3603479|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3770154|NCT01920854|3603480|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3770155|NCT01920854|3603481|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3770156|NCT01920854|3603482|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3770157|NCT01920854|3603475|B8||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3770158|NCT01920854|3603476|B7||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3770159|NCT01920854|3603477|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3770160|NCT01920854|3603478|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3770161|NCT01920854|3603479|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3770162|NCT01920854|3603480|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3770163|NCT01920854|3603481|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3770164|NCT01920854|3603482|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3770165|NCT01920854|3603475|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3770166|NCT01920854|3603476|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3770167|NCT01920854|3603477|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3770168|NCT01920854|3603478|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3770169|NCT01920854|3603479|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3770170|NCT01920854|3603480|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3770171|NCT01920854|3603481|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3770172|NCT01920854|3603482|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3770173|NCT01920854|3603475|B8||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
3770174|NCT01920854|3603476|B7||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3770175|NCT01920854|3603477|B6||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3770176|NCT01920854|3603478|B5||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3770177|NCT01920854|3603479|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3770178|NCT01920854|3603480|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3770179|NCT01920854|3603481|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3770180|NCT01920854|3603482|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3770181|NCT01920854|3603475|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770182|NCT01920854|3603476|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770183|NCT01920854|3603477|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770184|NCT01920854|3603478|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770185|NCT01920854|3603479|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770186|NCT01920854|3603480|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770187|NCT01920854|3603481|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770188|NCT01920854|3603482|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770189|NCT01920802|3603612|B4|||Education (years)||years|Mean|15|15.0|Full Range|||12.0|18.0|
3770190|NCT01920802|3603613|B3|||Education (years)||years|Mean|14.9|14.9|Full Range|||13.0|16.0|
3770191|NCT01920802|3603614|B2|||Education (years)||years|Mean|13.6|13.6|Full Range|||12.0|16.0|
3770192|NCT01920802|3603615|B1|||Education (years)||years|Mean|16.4|16.4|Full Range|||14.0|18.0|
3770193|NCT01920802|3603612|B4|||Starting BMI||kg/m^2|Mean|23.0|23.0|Standard Deviation|0.5|0.5|||
3770194|NCT01920802|3603613|B3|||Starting BMI||kg/m^2|Mean|22.7|22.7|Standard Deviation|0.5|0.5|||
3770195|NCT01920802|3603614|B2|||Starting BMI||kg/m^2|Mean|23.6|23.6|Standard Deviation|0.6|0.6|||
3770196|NCT01920802|3603615|B1|||Starting BMI||kg/m^2|Mean|22.7|22.7|Standard Deviation|0.3|0.3|||
3770197|NCT01920802|3603612|B4|United States||Region of Enrollment||participants|Number|24|24.0||||||
3770198|NCT01920802|3603613|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3770199|NCT01920802|3603614|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3770200|NCT01920802|3603615|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3770201|NCT01920802|3603612|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3770202|NCT01920802|3603613|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3770203|NCT01920802|3603614|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770204|NCT01920802|3603615|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770205|NCT01920802|3603612|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3770206|NCT01920802|3603613|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770207|NCT01920802|3603614|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3770208|NCT01920802|3603615|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770209|NCT01920802|3603612|B4||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3770210|NCT01920802|3603613|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3770211|NCT01920802|3603614|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3770212|NCT01920802|3603615|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3770213|NCT01920802|3603612|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3770214|NCT01920802|3603613|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3770215|NCT01920802|3603614|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3770216|NCT01920802|3603615|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3770217|NCT01920802|3603612|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770218|NCT01920802|3603613|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770219|NCT01920802|3603614|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770220|NCT01920802|3603615|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770221|NCT01920802|3603612|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3770222|NCT01920802|3603613|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770223|NCT01920802|3603614|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770224|NCT01920802|3603615|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3770225|NCT01920802|3603612|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3770226|NCT01920802|3603613|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3770227|NCT01920802|3603614|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770228|NCT01920802|3603615|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770229|NCT01920802|3603612|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3770230|NCT01920802|3603613|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3770231|NCT01920802|3603614|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3770232|NCT01920802|3603615|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3770233|NCT01920802|3603612|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3770234|NCT01920802|3603613|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3770235|NCT01920802|3603614|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3770236|NCT01920802|3603615|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3770237|NCT01920802|3603612|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3770238|NCT01920802|3603613|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3770239|NCT01920802|3603614|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3770240|NCT01920802|3603615|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3770241|NCT01920802|3603612|B4||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3770242|NCT01920802|3603613|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3770243|NCT01920802|3603614|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3770244|NCT01920802|3603615|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3770245|NCT01920802|3603612|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770246|NCT01920802|3603613|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770247|NCT01920802|3603614|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770248|NCT01920802|3603615|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770249|NCT01920594|3603646|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770250|NCT01920594|3603647|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770251|NCT01920594|3603648|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770252|NCT01920594|3603646|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770253|NCT01920594|3603647|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770254|NCT01920594|3603648|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770255|NCT01920594|3603646|B3||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3770256|NCT01920594|3603647|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3770257|NCT01920594|3603648|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3770258|NCT01920594|3603646|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3770259|NCT01920594|3603647|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3770260|NCT01920594|3603648|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3770261|NCT01920594|3603646|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770262|NCT01920594|3603647|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770263|NCT01920594|3603648|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770264|NCT01920594|3603646|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3770265|NCT01920594|3603647|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3770266|NCT01920594|3603648|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3770267|NCT01920594|3603646|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770268|NCT01920594|3603647|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770269|NCT01920594|3603648|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770270|NCT01920594|3603646|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3770271|NCT01920594|3603647|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3770272|NCT01920594|3603648|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3770273|NCT01920594|3603646|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3770274|NCT01920594|3603647|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3770275|NCT01920594|3603648|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3770276|NCT01920594|3603646|B3|21 to 88 years||Age, Customized||Participants|Count of Participants|55|55.0||||||
3770277|NCT01920594|3603647|B2|21 to 88 years||Age, Customized||Participants|Count of Participants|28|28.0||||||
3770278|NCT01920594|3603648|B1|21 to 88 years||Age, Customized||Participants|Count of Participants|27|27.0||||||
3770279|NCT01920568|3603697|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
3770280|NCT01920568|3603698|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3770281|NCT01920568|3603699|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3770282|NCT01920568|3603697|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|470|470.0||||||
3770283|NCT01920568|3603698|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|158|158.0||||||
3770284|NCT01920568|3603699|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|312|312.0||||||
3770285|NCT01920568|3603697|B3||Male|Gender||Participants|Count of Participants|158|158.0||||||
3770286|NCT01920568|3603698|B2||Male|Gender||Participants|Count of Participants|54|54.0||||||
3770287|NCT01920568|3603699|B1||Male|Gender||Participants|Count of Participants|104|104.0||||||
3770288|NCT01920568|3603697|B3||Female|Gender||Participants|Count of Participants|327|327.0||||||
3770289|NCT01920568|3603698|B2||Female|Gender||Participants|Count of Participants|105|105.0||||||
3770290|NCT01920568|3603699|B1||Female|Gender||Participants|Count of Participants|222|222.0||||||
3770291|NCT01920568|3603697|B3|||Age||Years|Mean|53.9|53.9|Standard Deviation|11.38|11.38|||
3770292|NCT01920568|3603698|B2|||Age||Years|Mean|53.6|53.6|Standard Deviation|11.45|11.45|||
3770293|NCT01920568|3603699|B1|||Age||Years|Mean|54.0|54.0|Standard Deviation|11.36|11.36|||
3770294|NCT01920555|3603721|B6|Urine Toxicology Screen||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|0|0.0||||||
3770295|NCT01920555|3603722|B5|Urine Toxicology Screen||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|0|0.0||||||
3770296|NCT01920555|3603723|B4|Urine Toxicology Screen||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|0|0.0||||||
3770342|NCT01920555|3603721|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770297|NCT01920555|3603724|B3|Urine Toxicology Screen||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|0|0.0||||||
3770298|NCT01920555|3603725|B2|Urine Toxicology Screen||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|0|0.0||||||
3770299|NCT01920555|3603726|B1|Urine Toxicology Screen||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|0|0.0||||||
3770300|NCT01920555|3603721|B6|Pregnancy Test||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|0|0.0||||||
3770301|NCT01920555|3603722|B5|Pregnancy Test||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|0|0.0||||||
3770302|NCT01920555|3603723|B4|Pregnancy Test||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|0|0.0||||||
3770303|NCT01920555|3603724|B3|Pregnancy Test||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|0|0.0||||||
3770304|NCT01920555|3603725|B2|Pregnancy Test||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|0|0.0||||||
3770305|NCT01920555|3603726|B1|Pregnancy Test||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|0|0.0||||||
3770306|NCT01920555|3603721|B6|Hormonal Measures (remaining tests)||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|0|0.0||||||
3770307|NCT01920555|3603722|B5|Hormonal Measures (remaining tests)||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|0|0.0||||||
3770308|NCT01920555|3603723|B4|Hormonal Measures (remaining tests)||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|0|0.0||||||
3770309|NCT01920555|3603724|B3|Hormonal Measures (remaining tests)||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|0|0.0||||||
3770343|NCT01920555|3603722|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770344|NCT01920555|3603723|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770345|NCT01920555|3603724|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770408|NCT01920282|3603789|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770310|NCT01920555|3603725|B2|Hormonal Measures (remaining tests)||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|0|0.0||||||
3770311|NCT01920555|3603726|B1|Hormonal Measures (remaining tests)||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|0|0.0||||||
3770312|NCT01920555|3603721|B6|Hormonal Measures (DHEA)||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|1|1.0||||||
3770313|NCT01920555|3603722|B5|Hormonal Measures (DHEA)||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|0|0.0||||||
3770314|NCT01920555|3603723|B4|Hormonal Measures (DHEA)||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|1|1.0||||||
3770315|NCT01920555|3603724|B3|Hormonal Measures (DHEA)||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|0|0.0||||||
3770316|NCT01920555|3603725|B2|Hormonal Measures (DHEA)||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|0|0.0||||||
3770317|NCT01920555|3603726|B1|Hormonal Measures (DHEA)||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|0|0.0||||||
3770318|NCT01920555|3603721|B6|Hormonal Measures (testosterone, SHBG, Free T)||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|2|2.0||||||
3770319|NCT01920555|3603722|B5|Hormonal Measures (testosterone, SHBG, Free T)||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|0|0.0||||||
3770320|NCT01920555|3603723|B4|Hormonal Measures (testosterone, SHBG, Free T)||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|0|0.0||||||
3770321|NCT01920555|3603724|B3|Hormonal Measures (testosterone, SHBG, Free T)||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|0|0.0||||||
3770322|NCT01920555|3603725|B2|Hormonal Measures (testosterone, SHBG, Free T)||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|2|2.0||||||
3770346|NCT01920555|3603725|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770347|NCT01920555|3603726|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770409|NCT01920282|3603790|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770323|NCT01920555|3603726|B1|Hormonal Measures (testosterone, SHBG, Free T)||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|0|0.0||||||
3770324|NCT01920555|3603721|B6|Chemistry||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|0|0.0||||||
3770325|NCT01920555|3603722|B5|Chemistry||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|0|0.0||||||
3770326|NCT01920555|3603723|B4|Chemistry||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|0|0.0||||||
3770327|NCT01920555|3603724|B3|Chemistry||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|0|0.0||||||
3770328|NCT01920555|3603725|B2|Chemistry||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|0|0.0||||||
3770329|NCT01920555|3603726|B1|Chemistry||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|0|0.0||||||
3770330|NCT01920555|3603721|B6|CBC||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|0|0.0||||||
3770331|NCT01920555|3603722|B5|CBC||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|0|0.0||||||
3770332|NCT01920555|3603723|B4|CBC||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|0|0.0||||||
3770333|NCT01920555|3603724|B3|CBC||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|0|0.0||||||
3770334|NCT01920555|3603725|B2|CBC||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|0|0.0||||||
3770335|NCT01920555|3603726|B1|CBC||Abnormal and Clinically Significant Labs|Collected at Screening and Day 0 (Day 0 is pre-treatment) CBC, Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid),Hormonal Measures in female subjects: Estradiol, Progesterone, FSH, LH, SHBG, Testosterone; Free testosterone, Hormonal Measures in male subjects: Testosterone, free testosterone, SHBG, DHEA, Progesterone, TSH, Pregnancy Test, Urine Tox Screen|Participants|Count of Participants|0|0.0||||||
3770336|NCT01920555|3603721|B6|||BMI||kg/m^2|Mean|24.96|24.96|Standard Deviation|4.08|4.08|||
3770337|NCT01920555|3603722|B5|||BMI||kg/m^2|Mean|26.3|26.3|Standard Deviation|4.1|4.1|||
3770338|NCT01920555|3603723|B4|||BMI||kg/m^2|Mean|26.1|26.1|Standard Deviation|3.8|3.8|||
3770339|NCT01920555|3603724|B3|||BMI||kg/m^2|Mean|25.3|25.3|Standard Deviation|5.7|5.7|||
3770340|NCT01920555|3603725|B2|||BMI||kg/m^2|Mean|24.9|24.9|Standard Deviation|3.7|3.7|||
3770341|NCT01920555|3603726|B1|||BMI||kg/m^2|Mean|25.2|25.2|Standard Deviation|3.1|3.1|||
3770348|NCT01920555|3603721|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3770349|NCT01920555|3603722|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3770350|NCT01920555|3603723|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3770351|NCT01920555|3603724|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3770352|NCT01920555|3603725|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3770353|NCT01920555|3603726|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3770354|NCT01920555|3603721|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3770355|NCT01920555|3603722|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770356|NCT01920555|3603723|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770357|NCT01920555|3603724|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3770358|NCT01920555|3603725|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770359|NCT01920555|3603726|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3770360|NCT01920555|3603721|B6||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3770361|NCT01920555|3603722|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3770362|NCT01920555|3603723|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3770363|NCT01920555|3603724|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3770364|NCT01920555|3603725|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3770365|NCT01920555|3603726|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3770366|NCT01920555|3603721|B6||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3770367|NCT01920555|3603722|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3770368|NCT01920555|3603723|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3770369|NCT01920555|3603724|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3770370|NCT01920555|3603725|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3770371|NCT01920555|3603726|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3770372|NCT01920555|3603721|B6|||Age||years|Mean|46.04|46.04|Standard Deviation|12.64|12.64|||
3770373|NCT01920555|3603722|B5|||Age||years|Mean|45.6|45.6|Standard Deviation|13.8|13.8|||
3770374|NCT01920555|3603723|B4|||Age||years|Mean|47.4|47.4|Standard Deviation|10.1|10.1|||
3770375|NCT01920555|3603724|B3|||Age||years|Mean|48.6|48.6|Standard Deviation|12.9|12.9|||
3770376|NCT01920555|3603725|B2|||Age||years|Mean|45.5|45.5|Standard Deviation|14.6|14.6|||
3770377|NCT01920555|3603726|B1|||Age||years|Mean|43.1|43.1|Standard Deviation|11.9|11.9|||
3770378|NCT01920282|3603787|B4|||Supine heart rate (bpm)||bpm|Mean|66|66.0|Standard Deviation|2|2.0|||
3770379|NCT01920282|3603788|B3|||Supine heart rate (bpm)||bpm|Mean|66|66.0|Standard Deviation|2|2.0|||
3770380|NCT01920282|3603789|B2|||Supine heart rate (bpm)||bpm|Mean|67|67.0|Standard Deviation|3|3.0|||
3770381|NCT01920282|3603790|B1|||Supine heart rate (bpm)||bpm|Mean|64|64.0|Standard Deviation|1|1.0|||
3770382|NCT01920282|3603787|B4|||Supine blood pressure (mmHg)||mmHg|Mean|142|142.0|Standard Deviation|2.37|2.37|||
3770383|NCT01920282|3603788|B3|||Supine blood pressure (mmHg)||mmHg|Mean|142|142.0|Standard Deviation|2.6|2.6|||
3770384|NCT01920282|3603789|B2|||Supine blood pressure (mmHg)||mmHg|Mean|138|138.0|Standard Deviation|3.1|3.1|||
3770385|NCT01920282|3603790|B1|||Supine blood pressure (mmHg)||mmHg|Mean|146|146.0|Standard Deviation|1.4|1.4|||
3770386|NCT01920282|3603787|B4|United States||Region of Enrollment||participants|Number|45|45.0||||||
3770387|NCT01920282|3603788|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
3770388|NCT01920282|3603789|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3770389|NCT01920282|3603790|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3770390|NCT01920282|3603787|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3770391|NCT01920282|3603788|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3770392|NCT01920282|3603789|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3770393|NCT01920282|3603790|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3770394|NCT01920282|3603787|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3770395|NCT01920282|3603788|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3770396|NCT01920282|3603789|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3770397|NCT01920282|3603790|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3770398|NCT01920282|3603787|B4||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3770399|NCT01920282|3603788|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3770400|NCT01920282|3603789|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3770401|NCT01920282|3603790|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3770402|NCT01920282|3603787|B4||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3770403|NCT01920282|3603788|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3770404|NCT01920282|3603789|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3770405|NCT01920282|3603790|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3770406|NCT01920282|3603787|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770407|NCT01920282|3603788|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770410|NCT01920282|3603787|B4|||Age||yr|Mean|56.3|56.3|Standard Deviation|2.5|2.5|||
3770411|NCT01920282|3603788|B3|||Age||yr|Mean|58.4|58.4|Standard Deviation|2.2|2.2|||
3770412|NCT01920282|3603789|B2|||Age||yr|Mean|52.7|52.7|Standard Deviation|2.2|2.2|||
3770413|NCT01920282|3603790|B1|||Age||yr|Mean|57.7|57.7|Standard Deviation|3.1|3.1|||
3770414|NCT01920178|3603803|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
3770415|NCT01920178|3603804|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3770416|NCT01920178|3603805|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3770417|NCT01920178|3603803|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3770418|NCT01920178|3603804|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3770419|NCT01920178|3603805|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3770420|NCT01920178|3603803|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3770421|NCT01920178|3603804|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3770422|NCT01920178|3603805|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3770423|NCT01920178|3603803|B3|||Age||years|Mean|44.3|44.3|Standard Deviation|11.0|11.0|||
3770424|NCT01920178|3603804|B2|||Age||years|Mean|47.0|47.0|Standard Deviation|2.8|2.8|||
3770425|NCT01920178|3603805|B1|||Age||years|Mean|43.2|43.2|Standard Deviation|13.2|13.2|||
3770426|NCT01920178|3603803|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3770427|NCT01920178|3603804|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3770428|NCT01920178|3603805|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3770429|NCT01920178|3603803|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3770430|NCT01920178|3603804|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3770431|NCT01920178|3603805|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3770432|NCT01920178|3603803|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770433|NCT01920178|3603804|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770434|NCT01920178|3603805|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770435|NCT01919996|3603816|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3770436|NCT01919996|3603816|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3770437|NCT01919996|3603816|B1|||Age||Years|Mean|14.4|14.4|Standard Deviation|2.1|2.1|||
3770438|NCT01919801|3603822|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3770439|NCT01919801|3603823|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3770440|NCT01919801|3603824|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3770441|NCT01919801|3603822|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3770442|NCT01919801|3603823|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3770443|NCT01919801|3603824|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3770444|NCT01919801|3603822|B3|||Age|Age was calculated as the difference between date of birth and date of informed consent, rounded to 1 decimal place.|years|Mean|61.4|61.4|Standard Deviation|12.7|12.7|||
3770445|NCT01919801|3603823|B2|||Age|Age was calculated as the difference between date of birth and date of informed consent, rounded to 1 decimal place.|years|Mean|61.8|61.8|Standard Deviation|13.4|13.4|||
3770446|NCT01919801|3603824|B1|||Age|Age was calculated as the difference between date of birth and date of informed consent, rounded to 1 decimal place.|years|Mean|60.9|60.9|Standard Deviation|12.1|12.1|||
3770447|NCT01919723|3603848|B3|United States||Region of Enrollment||participants|Number|70|70.0||||||
3770448|NCT01919723|3603849|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
3770449|NCT01919723|3603850|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3770450|NCT01919723|3603848|B3||Male|Gender||Participants|Count of Participants|38|38.0||||||
3770451|NCT01919723|3603849|B2||Male|Gender||Participants|Count of Participants|20|20.0||||||
3770452|NCT01919723|3603850|B1||Male|Gender||Participants|Count of Participants|18|18.0||||||
3770453|NCT01919723|3603848|B3||Female|Gender||Participants|Count of Participants|32|32.0||||||
3770454|NCT01919723|3603849|B2||Female|Gender||Participants|Count of Participants|15|15.0||||||
3770455|NCT01919723|3603850|B1||Female|Gender||Participants|Count of Participants|17|17.0||||||
3770456|NCT01919723|3603848|B3|>=19 years||Age, Customized||participants|Number|70|70.0||||||
3770457|NCT01919723|3603849|B2|>=19 years||Age, Customized||participants|Number|35|35.0||||||
3770458|NCT01919723|3603850|B1|>=19 years||Age, Customized||participants|Number|35|35.0||||||
3770459|NCT01919606|3603863|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3770460|NCT01919606|3603865|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3770461|NCT01919606|3603863|B3|Male||Gender||participants|Number|0|0.0||||||
3770462|NCT01919606|3603865|B1|Male||Gender||participants|Number|0|0.0||||||
3770463|NCT01919606|3603863|B3|Female||Gender||participants|Number|1|1.0||||||
3770464|NCT01919606|3603865|B1|Female||Gender||participants|Number|1|1.0||||||
3770465|NCT01919606|3603863|B3|>=65 years||Age||participants|Number|1|1.0||||||
3770466|NCT01919606|3603865|B1|>=65 years||Age||participants|Number|1|1.0||||||
3770467|NCT01919606|3603863|B3|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
3770468|NCT01919606|3603865|B1|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
3770469|NCT01919606|3603863|B3|<=18 years||Age||participants|Number|0|0.0||||||
3770470|NCT01919606|3603865|B1|<=18 years||Age||participants|Number|0|0.0||||||
3770471|NCT01919606|3603863|B3|||Age||years|Mean|67|67.0|Standard Deviation|0|0.0|||
3770472|NCT01919606|3603865|B1|||Age||years|Mean|67|67.0|Standard Deviation|0|0.0|||
3770473|NCT01919450|3603874|B5|United States||Region of Enrollment||participants|Number|80|80.0||||||
3770474|NCT01919450|3603875|B4|United States||Region of Enrollment||participants|Number|20|20.0||||||
3770475|NCT01919450|3603876|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3770476|NCT01919450|3603877|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3770477|NCT01919450|3603878|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3770478|NCT01919450|3603874|B5||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3770479|NCT01919450|3603875|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3770480|NCT01919450|3603876|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3770481|NCT01919450|3603877|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3770482|NCT01919450|3603878|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3770483|NCT01919450|3603874|B5||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3770484|NCT01919450|3603875|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3770485|NCT01919450|3603876|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3770486|NCT01919450|3603877|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3770487|NCT01919450|3603878|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3770488|NCT01919450|3603874|B5|||Age||Years|Mean|51.9|51.9|Standard Deviation|11.0|11.0|||
3770489|NCT01919450|3603875|B4|||Age||Years|Mean|50.6|50.6|Standard Deviation|9.9|9.9|||
3770490|NCT01919450|3603876|B3|||Age||Years|Mean|53.1|53.1|Standard Deviation|9.6|9.6|||
3770491|NCT01919450|3603877|B2|||Age||Years|Mean|51.3|51.3|Standard Deviation|10.4|10.4|||
3770492|NCT01919450|3603878|B1|||Age||Years|Mean|50.5|50.5|Standard Deviation|13.8|13.8|||
3770493|NCT01919307|3603891|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3770494|NCT01919307|3603891|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770495|NCT01919307|3603891|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3770496|NCT01919307|3603891|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3770497|NCT01919307|3603891|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770498|NCT01919307|3603891|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770499|NCT01919307|3603891|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770500|NCT01919307|3603891|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770501|NCT01919307|3603891|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3770502|NCT01919307|3603891|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3770503|NCT01919307|3603891|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3770504|NCT01919307|3603891|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3770505|NCT01919307|3603891|B1|||Age||years|Mean|40|40.0|Standard Deviation|11|11.0|||
3770506|NCT01919229|3603898|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3770507|NCT01919229|3603899|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3770508|NCT01919229|3603900|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3770509|NCT01919229|3603901|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3770510|NCT01919229|3603898|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3770511|NCT01919229|3603899|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3770512|NCT01919229|3603900|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3770513|NCT01919229|3603901|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3770514|NCT01919229|3603898|B4|>=65 years||Age, Customized||Participants|Number|7|7.0||||||
3770515|NCT01919229|3603899|B3|>=65 years||Age, Customized||Participants|Number|4|4.0||||||
3770516|NCT01919229|3603900|B2|>=65 years||Age, Customized||Participants|Number|3|3.0||||||
3770517|NCT01919229|3603901|B1|>=65 years||Age, Customized||Participants|Number|0|0.0||||||
3770518|NCT01919229|3603898|B4|< 65 years||Age, Customized||Participants|Number|7|7.0||||||
3770519|NCT01919229|3603899|B3|< 65 years||Age, Customized||Participants|Number|0|0.0||||||
3770520|NCT01919229|3603900|B2|< 65 years||Age, Customized||Participants|Number|3|3.0||||||
3770521|NCT01919229|3603901|B1|< 65 years||Age, Customized||Participants|Number|4|4.0||||||
3770522|NCT01919229|3603898|B4|||Age||years|Mean|63.8|63.8|Standard Deviation|8.66|8.66|||
3770523|NCT01919229|3603899|B3|||Age||years|Mean|70.0|70.0|Standard Deviation|4.24|4.24|||
3770524|NCT01919229|3603900|B2|||Age||years|Mean|64.2|64.2|Standard Deviation|9.91|9.91|||
3770525|NCT01919229|3603901|B1|||Age||years|Mean|57.0|57.0|Standard Deviation|5.48|5.48|||
3770526|NCT01919216|3603932|B4|||Quick Inventory of Depressive Symptoms—Self Report (QIDS-SR) 16 Item Scale|"The16 item Quick Inventory of Depressive Symptomatology (QIDS) contains 16 questions score from 0 to 3 each.~Qids score 1-5, not depressed; 6-10, Mild depression; 11-15, Moderate depression; 16-20, Severe depression; 21-27, very severe depression"|units on a scale|Mean|19.59|19.59|Standard Deviation|6.27|6.27|||
3770527|NCT01919216|3603933|B3|||Quick Inventory of Depressive Symptoms—Self Report (QIDS-SR) 16 Item Scale|"The16 item Quick Inventory of Depressive Symptomatology (QIDS) contains 16 questions score from 0 to 3 each.~Qids score 1-5, not depressed; 6-10, Mild depression; 11-15, Moderate depression; 16-20, Severe depression; 21-27, very severe depression"|units on a scale|Mean|17.8|17.8|Standard Deviation|7.5|7.5|||
3770664|NCT01918332|3604046|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3770528|NCT01919216|3603934|B2|||Quick Inventory of Depressive Symptoms—Self Report (QIDS-SR) 16 Item Scale|"The16 item Quick Inventory of Depressive Symptomatology (QIDS) contains 16 questions score from 0 to 3 each.~Qids score 1-5, not depressed; 6-10, Mild depression; 11-15, Moderate depression; 16-20, Severe depression; 21-27, very severe depression"|units on a scale|Mean|19.8|19.8|Standard Deviation|7.2|7.2|||
3770529|NCT01919216|3603935|B1|||Quick Inventory of Depressive Symptoms—Self Report (QIDS-SR) 16 Item Scale|"The16 item Quick Inventory of Depressive Symptomatology (QIDS) contains 16 questions score from 0 to 3 each.~Qids score 1-5, not depressed; 6-10, Mild depression; 11-15, Moderate depression; 16-20, Severe depression; 21-27, very severe depression"|units on a scale|Mean|19.7|19.7|Standard Deviation|5.2|5.2|||
3770530|NCT01919216|3603932|B4|||CGI Severity|Clinical Global Impression – Severity scale (CGI-S) is a 7-point scale that requires the clinician to rate the severity of the patient's illness at the time of assessment: 0 normal, not at all ill to 7 Among the most extremely ill patients|units on a scale|Mean|4.35|4.35|Standard Deviation|0.56|0.56|||
3770531|NCT01919216|3603933|B3|||CGI Severity|Clinical Global Impression – Severity scale (CGI-S) is a 7-point scale that requires the clinician to rate the severity of the patient's illness at the time of assessment: 0 normal, not at all ill to 7 Among the most extremely ill patients|units on a scale|Mean|4.3|4.3|Standard Deviation|0.6|0.6|||
3770532|NCT01919216|3603934|B2|||CGI Severity|Clinical Global Impression – Severity scale (CGI-S) is a 7-point scale that requires the clinician to rate the severity of the patient's illness at the time of assessment: 0 normal, not at all ill to 7 Among the most extremely ill patients|units on a scale|Mean|4.3|4.3|Standard Deviation|0.5|0.5|||
3770533|NCT01919216|3603935|B1|||CGI Severity|Clinical Global Impression – Severity scale (CGI-S) is a 7-point scale that requires the clinician to rate the severity of the patient's illness at the time of assessment: 0 normal, not at all ill to 7 Among the most extremely ill patients|units on a scale|Mean|4.4|4.4|Standard Deviation|0.6|0.6|||
3770534|NCT01919216|3603932|B4|||Hamilton Anxiety Rating Scale|HAMA consists of 14 items, each defined by a series of symptoms. Each item is rated on a 5-point scale, ranging from 0 (not present) to 4 (severe). The summation of each of the 14 individually rated items will yield a comprehensive score in the range of 0 to 56. It has been predetermined that the results of the evaluation can be interpreted as follows. A score of 17 or less indicates mild anxiety severity. A score from 18 to 24 indicates mild to moderate anxiety severity. Lastly, a score of 25 to 30 indicates a moderate to severe anxiety severity.|units on a scale|Mean|14.24|14.24|Standard Deviation|5.34|5.34|||
3770535|NCT01919216|3603933|B3|||Hamilton Anxiety Rating Scale|HAMA consists of 14 items, each defined by a series of symptoms. Each item is rated on a 5-point scale, ranging from 0 (not present) to 4 (severe). The summation of each of the 14 individually rated items will yield a comprehensive score in the range of 0 to 56. It has been predetermined that the results of the evaluation can be interpreted as follows. A score of 17 or less indicates mild anxiety severity. A score from 18 to 24 indicates mild to moderate anxiety severity. Lastly, a score of 25 to 30 indicates a moderate to severe anxiety severity.|units on a scale|Mean|16.7|16.7|Standard Deviation|9.2|9.2|||
3770536|NCT01919216|3603934|B2|||Hamilton Anxiety Rating Scale|HAMA consists of 14 items, each defined by a series of symptoms. Each item is rated on a 5-point scale, ranging from 0 (not present) to 4 (severe). The summation of each of the 14 individually rated items will yield a comprehensive score in the range of 0 to 56. It has been predetermined that the results of the evaluation can be interpreted as follows. A score of 17 or less indicates mild anxiety severity. A score from 18 to 24 indicates mild to moderate anxiety severity. Lastly, a score of 25 to 30 indicates a moderate to severe anxiety severity.|units on a scale|Mean|15.1|15.1|Standard Deviation|4.8|4.8|||
3770537|NCT01919216|3603935|B1|||Hamilton Anxiety Rating Scale|HAMA consists of 14 items, each defined by a series of symptoms. Each item is rated on a 5-point scale, ranging from 0 (not present) to 4 (severe). The summation of each of the 14 individually rated items will yield a comprehensive score in the range of 0 to 56. It has been predetermined that the results of the evaluation can be interpreted as follows. A score of 17 or less indicates mild anxiety severity. A score from 18 to 24 indicates mild to moderate anxiety severity. Lastly, a score of 25 to 30 indicates a moderate to severe anxiety severity.|units on a scale|Mean|13.2|13.2|Standard Deviation|4.9|4.9|||
3770538|NCT01919216|3603932|B4|||Hamilton Rating Scale for Depression|The patient is rated by a clinician among 24 dimensions with a score on a 3 or 5 point scale. A score of 0-9 is considered to be normal. Score between 10-18 is considered as mild depression, Scores between 19-26 indicate moderate, scores between 27-34 indicate severe, and score between 35-75 indicate very severe depression.|units on a scale|Mean|25.55|25.55|Standard Deviation|4.8|4.8|||
3770539|NCT01919216|3603933|B3|||Hamilton Rating Scale for Depression|The patient is rated by a clinician among 24 dimensions with a score on a 3 or 5 point scale. A score of 0-9 is considered to be normal. Score between 10-18 is considered as mild depression, Scores between 19-26 indicate moderate, scores between 27-34 indicate severe, and score between 35-75 indicate very severe depression.|units on a scale|Mean|23.8|23.8|Standard Deviation|2.8|2.8|||
3770540|NCT01919216|3603934|B2|||Hamilton Rating Scale for Depression|The patient is rated by a clinician among 24 dimensions with a score on a 3 or 5 point scale. A score of 0-9 is considered to be normal. Score between 10-18 is considered as mild depression, Scores between 19-26 indicate moderate, scores between 27-34 indicate severe, and score between 35-75 indicate very severe depression.|units on a scale|Mean|25.7|25.7|Standard Deviation|4.1|4.1|||
3770541|NCT01919216|3603935|B1|||Hamilton Rating Scale for Depression|The patient is rated by a clinician among 24 dimensions with a score on a 3 or 5 point scale. A score of 0-9 is considered to be normal. Score between 10-18 is considered as mild depression, Scores between 19-26 indicate moderate, scores between 27-34 indicate severe, and score between 35-75 indicate very severe depression.|units on a scale|Mean|25.7|25.7|Standard Deviation|5.5|5.5|||
3770542|NCT01919216|3603932|B4|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3770543|NCT01919216|3603933|B3|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3770544|NCT01919216|3603934|B2|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3770545|NCT01919216|3603935|B1|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3770546|NCT01919216|3603932|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3770547|NCT01919216|3603933|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770548|NCT01919216|3603934|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3770549|NCT01919216|3603935|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3770550|NCT01919216|3603932|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770551|NCT01919216|3603933|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770552|NCT01919216|3603934|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770553|NCT01919216|3603935|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770554|NCT01919216|3603932|B4||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3770555|NCT01919216|3603933|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3770556|NCT01919216|3603934|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3770557|NCT01919216|3603935|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3770558|NCT01919216|3603932|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3770559|NCT01919216|3603933|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3770560|NCT01919216|3603934|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3770561|NCT01919216|3603935|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3770562|NCT01919216|3603932|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770563|NCT01919216|3603933|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770564|NCT01919216|3603934|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770565|NCT01919216|3603935|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770566|NCT01919216|3603932|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3770567|NCT01919216|3603933|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770568|NCT01919216|3603934|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770569|NCT01919216|3603935|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3770570|NCT01919216|3603932|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770571|NCT01919216|3603933|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770572|NCT01919216|3603934|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770573|NCT01919216|3603935|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770574|NCT01919216|3603932|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770575|NCT01919216|3603933|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770576|NCT01919216|3603934|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770577|NCT01919216|3603935|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770578|NCT01919216|3603932|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3770579|NCT01919216|3603933|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3770580|NCT01919216|3603934|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3770581|NCT01919216|3603935|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3770582|NCT01919216|3603932|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3770583|NCT01919216|3603933|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3770584|NCT01919216|3603934|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3770585|NCT01919216|3603935|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3770586|NCT01919216|3603932|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3770587|NCT01919216|3603933|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3770588|NCT01919216|3603934|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3770589|NCT01919216|3603935|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3770590|NCT01919216|3603932|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3770591|NCT01919216|3603933|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3770592|NCT01919216|3603934|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3770593|NCT01919216|3603935|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3770594|NCT01919216|3603932|B4|||Age||years|Mean|41.79|41.79|Standard Deviation|11.36|11.36|||
3770595|NCT01919216|3603933|B3|||Age||years|Mean|34.3|34.3|Standard Deviation|10.2|10.2|||
3770596|NCT01919216|3603934|B2|||Age||years|Mean|43.8|43.8|Standard Deviation|10.7|10.7|||
3770597|NCT01919216|3603935|B1|||Age||years|Mean|41.4|41.4|Standard Deviation|12|12.0|||
3770598|NCT01919216|3603932|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3770599|NCT01919216|3603933|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3770600|NCT01919216|3603934|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3770601|NCT01919216|3603935|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3770602|NCT01919216|3603932|B4||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3770603|NCT01919216|3603933|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3770604|NCT01919216|3603934|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3770605|NCT01919216|3603935|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3770606|NCT01919216|3603932|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770607|NCT01919216|3603933|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770608|NCT01919216|3603934|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770609|NCT01919216|3603935|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770610|NCT01918800|3603945|B3|United States||Region of Enrollment||participants|Number|218|218.0||||||
3770611|NCT01918800|3603946|B2|United States||Region of Enrollment||participants|Number|109|109.0||||||
3770612|NCT01918800|3603947|B1|United States||Region of Enrollment||participants|Number|109|109.0||||||
3770613|NCT01918800|3603945|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770614|NCT01918800|3603946|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770615|NCT01918800|3603947|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770616|NCT01918800|3603945|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3770617|NCT01918800|3603946|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3770618|NCT01918800|3603947|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3770619|NCT01918800|3603945|B3||White|Race (NIH/OMB)||Participants|Count of Participants|165|165.0||||||
3770620|NCT01918800|3603946|B2||White|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3770621|NCT01918800|3603947|B1||White|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3770622|NCT01918800|3603945|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3770623|NCT01918800|3603946|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3770624|NCT01918800|3603947|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3770625|NCT01918800|3603945|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770626|NCT01918800|3603946|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770627|NCT01918800|3603947|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770628|NCT01918800|3603945|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770629|NCT01918800|3603946|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770630|NCT01918800|3603947|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770631|NCT01918800|3603945|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770632|NCT01918800|3603946|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770633|NCT01918800|3603947|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770634|NCT01918800|3603945|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3770635|NCT01918800|3603946|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3770636|NCT01918800|3603947|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3770637|NCT01918800|3603945|B3||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3770638|NCT01918800|3603946|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3770639|NCT01918800|3603947|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3770640|NCT01918800|3603945|B3|||Age||years|Mean|53.7|53.7|Standard Deviation|10.1|10.1|||
3770641|NCT01918800|3603946|B2|||Age||years|Mean|53.6|53.6|Standard Deviation|10.5|10.5|||
3770642|NCT01918800|3603947|B1|||Age||years|Mean|53.9|53.9|Standard Deviation|9.8|9.8|||
3770643|NCT01918800|3603945|B3||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3770644|NCT01918800|3603946|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3770645|NCT01918800|3603947|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3770646|NCT01918800|3603945|B3||Between 18 and 65 years|Age||Participants|Count of Participants|194|194.0||||||
3770647|NCT01918800|3603946|B2||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
3770648|NCT01918800|3603947|B1||Between 18 and 65 years|Age||Participants|Count of Participants|98|98.0||||||
3770649|NCT01918800|3603945|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770650|NCT01918800|3603946|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770651|NCT01918800|3603947|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770652|NCT01918371|3603966|B3||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3770653|NCT01918371|3603967|B2||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3770654|NCT01918371|3603968|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3770655|NCT01918371|3603966|B3||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3770656|NCT01918371|3603967|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3770657|NCT01918371|3603968|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3770658|NCT01918371|3603966|B3|||Age||years|Mean|66.4|66.4|Full Range|NA||26.0|99.0|
3770659|NCT01918371|3603967|B2|||Age||years|Mean|63.4|63.4|Full Range|11.29|11.29|31.0|91.0|
3770660|NCT01918371|3603968|B1|||Age||years|Mean|69.4|69.4|Full Range|13.62|13.62|26.0|99.0|
3770661|NCT01918332|3604043|B5||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3770662|NCT01918332|3604044|B4||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3770663|NCT01918332|3604045|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3770665|NCT01918332|3604047|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3770666|NCT01918332|3604043|B5||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3770667|NCT01918332|3604044|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3770668|NCT01918332|3604045|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3770669|NCT01918332|3604046|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3770670|NCT01918332|3604047|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3770671|NCT01918332|3604043|B5||>=65 years|Age||Participants|Count of Participants|60|60.0||||||
3770672|NCT01918332|3604044|B4||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3770673|NCT01918332|3604045|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3770674|NCT01918332|3604046|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3770675|NCT01918332|3604047|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3770676|NCT01918332|3604043|B5||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
3770677|NCT01918332|3604044|B4||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3770678|NCT01918332|3604045|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3770679|NCT01918332|3604046|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3770680|NCT01918332|3604047|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3770681|NCT01918332|3604043|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770682|NCT01918332|3604044|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770683|NCT01918332|3604045|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770684|NCT01918332|3604046|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770685|NCT01918332|3604047|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770686|NCT01918306|3604060|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3770687|NCT01918306|3604061|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3770688|NCT01918306|3604062|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3770689|NCT01918306|3604060|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3770690|NCT01918306|3604061|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3770691|NCT01918306|3604062|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3770692|NCT01918306|3604060|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3770693|NCT01918306|3604061|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3770694|NCT01918306|3604062|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3770695|NCT01918306|3604060|B3|||Age||years|Mean|53.08|53.08|Standard Deviation|11.081|11.081|||
3770696|NCT01918306|3604061|B2|||Age||years|Mean|51.3|51.3|Standard Deviation|10.1000|10.1|||
3770697|NCT01918306|3604062|B1|||Age||years|Mean|62|62.0|Standard Deviation|15.556|15.556|||
3770698|NCT01918306|3604060|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3770699|NCT01918306|3604061|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3770700|NCT01918306|3604062|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3770701|NCT01918306|3604060|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3770702|NCT01918306|3604061|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3770703|NCT01918306|3604062|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3770704|NCT01918306|3604060|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770705|NCT01918306|3604061|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770706|NCT01918306|3604062|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770707|NCT01918085|3604085|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3770708|NCT01918085|3604086|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3770709|NCT01918085|3604087|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3770710|NCT01918085|3604085|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3770711|NCT01918085|3604086|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3770712|NCT01918085|3604087|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3770713|NCT01918085|3604085|B3|||Age||years|Mean|64.4|64.4|Standard Deviation|7.0|7.0|||
3770714|NCT01918085|3604086|B2|||Age||years|Mean|63.5|63.5|Standard Deviation|7.9|7.9|||
3770715|NCT01918085|3604087|B1|||Age||years|Mean|65.6|65.6|Standard Deviation|5.8|5.8|||
3770716|NCT01918033|3604096|B4||Male|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
3770717|NCT01918033|3604097|B3||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3770718|NCT01918033|3604098|B2||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3770719|NCT01918033|3604099|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3770720|NCT01918033|3604096|B4||Female|Sex: Female, Male||Participants|Count of Participants|342|342.0||||||
3770721|NCT01918033|3604097|B3||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3770722|NCT01918033|3604098|B2||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3770723|NCT01918033|3604099|B1||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3770724|NCT01918033|3604096|B4|||Age||Years|Mean|34.2|34.2|Standard Deviation|12.5|12.5|||
3770725|NCT01918033|3604097|B3|||Age||Years|Mean|34.7|34.7|Standard Deviation|12.6|12.6|||
3770726|NCT01918033|3604098|B2|||Age||Years|Mean|33.7|33.7|Standard Deviation|11.9|11.9|||
3770727|NCT01918033|3604099|B1|||Age||Years|Mean|34.3|34.3|Standard Deviation|13.1|13.1|||
3770728|NCT01917812|3604139|B4|United States||Region of Enrollment||participants|Number|48|48.0||||||
3770729|NCT01917812|3604140|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
3770730|NCT01917812|3604141|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3770731|NCT01917812|3604142|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3770732|NCT01917812|3604139|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3770733|NCT01917812|3604140|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3770734|NCT01917812|3604141|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3770735|NCT01917812|3604142|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3770736|NCT01917812|3604139|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3770737|NCT01917812|3604140|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3770738|NCT01917812|3604141|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3770739|NCT01917812|3604142|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3770740|NCT01917812|3604139|B4|||Age||years|Mean|58|58.0|Standard Deviation|8|8.0|||
3770741|NCT01917812|3604140|B3|||Age||years|Mean|55|55.0|Standard Deviation|8|8.0|||
3770742|NCT01917812|3604141|B2|||Age||years|Mean|58|58.0|Standard Deviation|8|8.0|||
3770743|NCT01917812|3604142|B1|||Age||years|Mean|60|60.0|Standard Deviation|7|7.0|||
3770744|NCT01917773|3604164|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770745|NCT01917773|3604164|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770746|NCT01917773|3604164|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3770747|NCT01917773|3604164|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3770748|NCT01917773|3604164|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770749|NCT01917773|3604164|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770750|NCT01917773|3604164|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770751|NCT01917773|3604164|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3770752|NCT01917773|3604164|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3770753|NCT01917773|3604164|B1|||Age||years|Mean|9.3|9.3|Full Range|||4.6|16.2|
3770754|NCT01917656|3604170|B3||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3770755|NCT01917656|3604171|B2||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3770756|NCT01917656|3604172|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3770757|NCT01917656|3604170|B3||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
3770758|NCT01917656|3604171|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3770759|NCT01917656|3604172|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3770760|NCT01917656|3604170|B3|||Age||years|Mean|54.5|54.5|Standard Deviation|9.30|9.3|||
3770761|NCT01917656|3604171|B2|||Age||years|Mean|54.0|54.0|Standard Deviation|9.33|9.33|||
3770762|NCT01917656|3604172|B1|||Age||years|Mean|54.9|54.9|Standard Deviation|9.27|9.27|||
3770763|NCT01917526|3604197|B3|Thailand||Region of Enrollment||participants|Number|500|500.0||||||
3770764|NCT01917526|3604198|B2|Thailand||Region of Enrollment||participants|Number|250|250.0||||||
3770765|NCT01917526|3604199|B1|Thailand||Region of Enrollment||participants|Number|250|250.0||||||
3770766|NCT01917526|3604197|B3||Male|Gender||Participants|Count of Participants|159|159.0||||||
3770767|NCT01917526|3604198|B2||Male|Gender||Participants|Count of Participants|89|89.0||||||
3770768|NCT01917526|3604199|B1||Male|Gender||Participants|Count of Participants|70|70.0||||||
3770769|NCT01917526|3604197|B3||Female|Gender||Participants|Count of Participants|341|341.0||||||
3770770|NCT01917526|3604198|B2||Female|Gender||Participants|Count of Participants|161|161.0||||||
3770771|NCT01917526|3604199|B1||Female|Gender||Participants|Count of Participants|180|180.0||||||
3770772|NCT01917526|3604197|B3|||Age||years|Mean|48.65|48.65|Standard Deviation|13.9|13.9|||
3770773|NCT01917526|3604198|B2|||Age||years|Mean|48.7|48.7|Standard Deviation|13.8|13.8|||
3770774|NCT01917526|3604199|B1|||Age||years|Mean|48.6|48.6|Standard Deviation|14.0|14.0|||
3770775|NCT01917513|3604208|B3||Male|Sex: Female, Male||Participants|Count of Participants|426|426.0||||||
3770776|NCT01917513|3604209|B2||Male|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
3770777|NCT01917513|3604210|B1||Male|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
3770778|NCT01917513|3604208|B3||Female|Sex: Female, Male||Participants|Count of Participants|377|377.0||||||
3770779|NCT01917513|3604209|B2||Female|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
3770780|NCT01917513|3604210|B1||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
3770781|NCT01917513|3604208|B3|||Age||years|Mean|65.3|65.3|Standard Deviation|8.85|8.85|||
3770782|NCT01917513|3604209|B2|||Age||years|Mean|65.4|65.4|Standard Deviation|8.92|8.92|||
3770783|NCT01917513|3604210|B1|||Age||years|Mean|65.2|65.2|Standard Deviation|8.79|8.79|||
3770784|NCT01917344|3604217|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3770785|NCT01917344|3604217|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3770786|NCT01917344|3604217|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3770787|NCT01917344|3604217|B1|||Age||years|Mean|29|29.0|Standard Deviation|5|5.0|||
3770788|NCT01917344|3604217|B1||>=65 years|Age|Brain and Blood Phenylalanine|Participants|Count of Participants|0|0.0||||||
3770789|NCT01917344|3604217|B1||Between 18 and 65 years|Age|Brain and Blood Phenylalanine|Participants|Count of Participants|10|10.0||||||
3770790|NCT01917344|3604217|B1||<=18 years|Age|Brain and Blood Phenylalanine|Participants|Count of Participants|0|0.0||||||
3770791|NCT01917214|3604221|B1||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||28.21|89.08|
3770792|NCT01917214|3604221|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||30.6|97.26|
3770793|NCT01917214|3604221|B1|||Age|Age data was available for only 211 participants because 1 participant did not have date of diagnosis captured in the database and hence was excluded from the median age calculation.|years|Median|60.73|60.73|Full Range|||28.21|97.26|
3770794|NCT01917006|3604230|B8|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3770795|NCT01917006|3604231|B7|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3770796|NCT01917006|3604232|B6|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3770797|NCT01917006|3604233|B5|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3770798|NCT01917006|3604234|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3770799|NCT01917006|3604235|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3770800|NCT01917006|3604236|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3770801|NCT01917006|3604237|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3770802|NCT01917006|3604230|B8|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3770803|NCT01917006|3604231|B7|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3770804|NCT01917006|3604232|B6|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3770805|NCT01917006|3604233|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3770806|NCT01917006|3604234|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3770807|NCT01917006|3604235|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3770808|NCT01917006|3604236|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3770809|NCT01917006|3604237|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3770810|NCT01917006|3604230|B8|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3770811|NCT01917006|3604231|B7|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3770812|NCT01917006|3604232|B6|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3770813|NCT01917006|3604233|B5|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3770814|NCT01917006|3604234|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3770815|NCT01917006|3604235|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3770816|NCT01917006|3604236|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3770817|NCT01917006|3604237|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3770818|NCT01917006|3604230|B8|Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3770819|NCT01917006|3604231|B7|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3770820|NCT01917006|3604232|B6|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3770821|NCT01917006|3604233|B5|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3770822|NCT01917006|3604234|B4|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3770823|NCT01917006|3604235|B3|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3770824|NCT01917006|3604236|B2|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3770825|NCT01917006|3604237|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3770826|NCT01917006|3604230|B8|Caucasian||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
3770827|NCT01917006|3604231|B7|Caucasian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3770828|NCT01917006|3604232|B6|Caucasian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3770829|NCT01917006|3604233|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3770830|NCT01917006|3604234|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3770831|NCT01917006|3604235|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3770832|NCT01917006|3604236|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3770833|NCT01917006|3604237|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3770834|NCT01917006|3604230|B8||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3770835|NCT01917006|3604231|B7||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3770836|NCT01917006|3604232|B6||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3770837|NCT01917006|3604233|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3770838|NCT01917006|3604234|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3770839|NCT01917006|3604235|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3770840|NCT01917006|3604236|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3770841|NCT01917006|3604237|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3770842|NCT01917006|3604230|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3770843|NCT01917006|3604231|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3770844|NCT01917006|3604232|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3770845|NCT01917006|3604233|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3770846|NCT01917006|3604234|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3770847|NCT01917006|3604235|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3770848|NCT01917006|3604236|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3770849|NCT01917006|3604237|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3770850|NCT01917006|3604230|B8|||Age||years|Mean|40.4|40.4|Standard Deviation|7.41|7.41|||
3770851|NCT01917006|3604231|B7|||Age||years|Mean|41.0|41.0|Standard Deviation|6.08|6.08|||
3770852|NCT01917006|3604232|B6|||Age||years|Mean|39.9|39.9|Standard Deviation|5.96|5.96|||
3770853|NCT01917006|3604233|B5|||Age||years|Mean|40.1|40.1|Standard Deviation|6.53|6.53|||
3770854|NCT01917006|3604234|B4|||Age||years|Mean|39.3|39.3|Standard Deviation|9.05|9.05|||
3770855|NCT01917006|3604235|B3|||Age||years|Mean|39.1|39.1|Standard Deviation|5.62|5.62|||
3770856|NCT01917006|3604236|B2|||Age||years|Mean|41.9|41.9|Standard Deviation|11.65|11.65|||
3770857|NCT01917006|3604237|B1|||Age||years|Mean|41.2|41.2|Standard Deviation|10.83|10.83|||
3770858|NCT01916980|3604275|B3|||Participant-assessed Pruritus Visual Analog Scale (VAS) Score at Baseline|Participants assessed the degree of their pruritus using a 100-mm visual analog scale (VAS; 0mm=No itch, 100mm=Worst imaginable itch) at Baseline. Pruritus VAS scores could range from 0 to 100, with a higher score indicating more severe itching. Baseline was defined as the participant evaluation at the day before the Baseline clinic visit.|Score on a Scale|Mean|60.53|60.53|Standard Deviation|20.66|20.66|||
3770859|NCT01916980|3604276|B2|||Participant-assessed Pruritus Visual Analog Scale (VAS) Score at Baseline|Participants assessed the degree of their pruritus using a 100-mm visual analog scale (VAS; 0mm=No itch, 100mm=Worst imaginable itch) at Baseline. Pruritus VAS scores could range from 0 to 100, with a higher score indicating more severe itching. Baseline was defined as the participant evaluation at the day before the Baseline clinic visit.|Score on a Scale|Mean|60.79|60.79|Standard Deviation|24.45|24.45|||
3770860|NCT01916980|3604277|B1|||Participant-assessed Pruritus Visual Analog Scale (VAS) Score at Baseline|Participants assessed the degree of their pruritus using a 100-mm visual analog scale (VAS; 0mm=No itch, 100mm=Worst imaginable itch) at Baseline. Pruritus VAS scores could range from 0 to 100, with a higher score indicating more severe itching. Baseline was defined as the participant evaluation at the day before the Baseline clinic visit.|Score on a Scale|Mean|60.42|60.42|Standard Deviation|18.94|18.94|||
3770861|NCT01916980|3604275|B3|||Investigator-assessed Sum of Daytime and Nighttime Pruritus/Itch Scores at Baseline|The Investigator assessed the severity of participant pruritus/itch during the daytime (0=Virtually no itching to 4=Cannot relax because of constant itching) and nighttime (0=Virtually no itching to 4=Cannot sleep because of itching) at Baseline. The sum of the daytime and nighttime pruritus/itch scores could range from 0 to 8, with a higher sum score indicating greater severity. Baseline values were assessed based on the participant diary for two days before the Baseline clinic visit and on the participant interview at the Baseline clinic visit.|Score on a Scale|Mean|4.86|4.86|Standard Deviation|1.23|1.23|||
3770862|NCT01916980|3604276|B2|||Investigator-assessed Sum of Daytime and Nighttime Pruritus/Itch Scores at Baseline|The Investigator assessed the severity of participant pruritus/itch during the daytime (0=Virtually no itching to 4=Cannot relax because of constant itching) and nighttime (0=Virtually no itching to 4=Cannot sleep because of itching) at Baseline. The sum of the daytime and nighttime pruritus/itch scores could range from 0 to 8, with a higher sum score indicating greater severity. Baseline values were assessed based on the participant diary for two days before the Baseline clinic visit and on the participant interview at the Baseline clinic visit.|Score on a Scale|Mean|5.10|5.1|Standard Deviation|1.47|1.47|||
3770863|NCT01916980|3604277|B1|||Investigator-assessed Sum of Daytime and Nighttime Pruritus/Itch Scores at Baseline|The Investigator assessed the severity of participant pruritus/itch during the daytime (0=Virtually no itching to 4=Cannot relax because of constant itching) and nighttime (0=Virtually no itching to 4=Cannot sleep because of itching) at Baseline. The sum of the daytime and nighttime pruritus/itch scores could range from 0 to 8, with a higher sum score indicating greater severity. Baseline values were assessed based on the participant diary for two days before the Baseline clinic visit and on the participant interview at the Baseline clinic visit.|Score on a Scale|Mean|4.75|4.75|Standard Deviation|1.10|1.1|||
3770864|NCT01916980|3604275|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3770865|NCT01916980|3604276|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3770866|NCT01916980|3604277|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3770867|NCT01916980|3604275|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3770868|NCT01916980|3604276|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3770869|NCT01916980|3604277|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3770870|NCT01916980|3604275|B3|||Age||Years|Mean|36.4|36.4|Standard Deviation|18.0|18.0|||
3770871|NCT01916980|3604276|B2|||Age||Years|Mean|44.1|44.1|Standard Deviation|21.5|21.5|||
3770872|NCT01916980|3604277|B1|||Age||Years|Mean|33.0|33.0|Standard Deviation|15.2|15.2|||
3770873|NCT01916967|3604294|B4||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3770874|NCT01916967|3604295|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3770875|NCT01916967|3604296|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3770876|NCT01916967|3604297|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3770877|NCT01916967|3604294|B4||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3770878|NCT01916967|3604295|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3770879|NCT01916967|3604296|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3770880|NCT01916967|3604297|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3770881|NCT01916967|3604294|B4|||Age||Years|Mean|39.4|39.4|Standard Deviation|15.7|15.7|||
3770882|NCT01916967|3604295|B3|||Age||Years|Mean|39.3|39.3|Standard Deviation|15.2|15.2|||
3770883|NCT01916967|3604296|B2|||Age||Years|Mean|40.6|40.6|Standard Deviation|15.8|15.8|||
3770884|NCT01916967|3604297|B1|||Age||Years|Mean|38.4|38.4|Standard Deviation|16.3|16.3|||
3770885|NCT01916941|3604340|B3|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3770886|NCT01916941|3604341|B2|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3770887|NCT01916941|3604342|B1|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3770888|NCT01916941|3604340|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3770889|NCT01916941|3604341|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3770890|NCT01916941|3604342|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3770891|NCT01916941|3604340|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3770892|NCT01916941|3604341|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3770893|NCT01916941|3604342|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3770894|NCT01916941|3604340|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3770895|NCT01916941|3604341|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3770896|NCT01916941|3604342|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3770897|NCT01916941|3604340|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3770898|NCT01916941|3604341|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3770899|NCT01916941|3604342|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3770900|NCT01916941|3604340|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770901|NCT01916941|3604341|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770902|NCT01916941|3604342|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770903|NCT01916928|3604349|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3770904|NCT01916928|3604349|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3770905|NCT01916928|3604349|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3770906|NCT01916928|3604349|B1|||Age|Mean age of participants.|years|Mean|31.4|31.4|Standard Deviation|6.1|6.1|||
3770907|NCT01916824|3604353|B3|United States||Region of Enrollment||Participants|Count of Participants|53|53.0||||||
3770908|NCT01916824|3604354|B2|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3770909|NCT01916824|3604355|B1|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3770910|NCT01916824|3604353|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770911|NCT01916824|3604354|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770912|NCT01916824|3604355|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770913|NCT01916824|3604353|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3770914|NCT01916824|3604354|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3770915|NCT01916824|3604355|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3770916|NCT01916824|3604353|B3||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3770917|NCT01916824|3604354|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3770918|NCT01916824|3604355|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3770919|NCT01916824|3604353|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3770920|NCT01916824|3604354|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3770921|NCT01916824|3604355|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3770922|NCT01916824|3604353|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770923|NCT01916824|3604354|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770924|NCT01916824|3604355|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770925|NCT01916824|3604353|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3770926|NCT01916824|3604354|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3770927|NCT01916824|3604355|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3770928|NCT01916824|3604353|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770929|NCT01916824|3604354|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770930|NCT01916824|3604355|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3770931|NCT01916824|3604353|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3770932|NCT01916824|3604354|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3770933|NCT01916824|3604355|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3770934|NCT01916824|3604353|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3770935|NCT01916824|3604354|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3770936|NCT01916824|3604355|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3770937|NCT01916824|3604353|B3|||Age||years|Mean|37.92|37.92|Standard Deviation|12.57|12.57|||
3770938|NCT01916824|3604354|B2|||Age||years|Mean|31.4|31.4|Standard Deviation|9.6|9.6|||
3770939|NCT01916824|3604355|B1|||Age||years|Mean|46.0|46.0|Standard Deviation|11.3|11.3|||
3770940|NCT01916681|3604362|B5|United States||Region of Enrollment||participants|Number|491|491.0||||||
3770941|NCT01916681|3604363|B4|United States||Region of Enrollment||participants|Number|125|125.0||||||
3770942|NCT01916681|3604364|B3|United States||Region of Enrollment||participants|Number|123|123.0||||||
3770943|NCT01916681|3604365|B2|United States||Region of Enrollment||participants|Number|120|120.0||||||
3770944|NCT01916681|3604366|B1|United States||Region of Enrollment||participants|Number|123|123.0||||||
3770945|NCT01916681|3604362|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3770946|NCT01916681|3604363|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3770947|NCT01916681|3604364|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3770948|NCT01916681|3604365|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3770949|NCT01916681|3604366|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3770950|NCT01916681|3604362|B5||Female|Sex: Female, Male||Participants|Count of Participants|491|491.0||||||
3770951|NCT01916681|3604363|B4||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3770952|NCT01916681|3604364|B3||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3770953|NCT01916681|3604365|B2||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3770954|NCT01916681|3604366|B1||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3770955|NCT01916681|3604362|B5|||Age||Years|Median|27|27.0|Inter-Quartile Range|||22.0|32.0|
3770956|NCT01916681|3604363|B4|||Age||Years|Median|26.5|26.5|Inter-Quartile Range|||22.4|31.7|
3770957|NCT01916681|3604364|B3|||Age||Years|Median|27.3|27.3|Inter-Quartile Range|||22.3|32.9|
3770958|NCT01916681|3604365|B2|||Age||Years|Median|26.7|26.7|Inter-Quartile Range|||21.8|31.0|
3770959|NCT01916681|3604366|B1|||Age||Years|Median|28|28.0|Inter-Quartile Range|||22.4|33.1|
3770960|NCT01916681|3604362|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3770961|NCT01916681|3604363|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3770962|NCT01916681|3604364|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3770963|NCT01916681|3604365|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3770964|NCT01916681|3604366|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3770965|NCT01916681|3604362|B5||Between 18 and 65 years|Age||Participants|Count of Participants|491|491.0||||||
3770966|NCT01916681|3604363|B4||Between 18 and 65 years|Age||Participants|Count of Participants|125|125.0||||||
3770967|NCT01916681|3604364|B3||Between 18 and 65 years|Age||Participants|Count of Participants|123|123.0||||||
3770968|NCT01916681|3604365|B2||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
3770969|NCT01916681|3604366|B1||Between 18 and 65 years|Age||Participants|Count of Participants|123|123.0||||||
3770970|NCT01916681|3604362|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770971|NCT01916681|3604363|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770972|NCT01916681|3604364|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770973|NCT01916681|3604365|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770974|NCT01916681|3604366|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3770975|NCT01916629|3604407|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3770976|NCT01916629|3604408|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3770977|NCT01916629|3604409|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3770978|NCT01916629|3604407|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3770979|NCT01916629|3604408|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3770980|NCT01916629|3604409|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3770981|NCT01916629|3604407|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3770982|NCT01916629|3604408|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3770983|NCT01916629|3604409|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3770984|NCT01916629|3604407|B3|||Age||years|Mean|41|41.0|Standard Deviation|12|12.0|||
3770985|NCT01916629|3604408|B2|||Age||years|Mean|35|35.0|Standard Deviation|14|14.0|||
3770986|NCT01916629|3604409|B1|||Age||years|Mean|45|45.0|Standard Deviation|9.7|9.7|||
3770987|NCT01916590|3604416|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
3770988|NCT01916590|3604417|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3770989|NCT01916590|3604418|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3770990|NCT01916590|3604416|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3770991|NCT01916590|3604417|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3770992|NCT01916590|3604418|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3770993|NCT01916590|3604416|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3770994|NCT01916590|3604417|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3770995|NCT01916590|3604418|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3770996|NCT01916590|3604416|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3770997|NCT01916590|3604417|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3770998|NCT01916590|3604418|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3770999|NCT01916590|3604416|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3771000|NCT01916590|3604417|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3771001|NCT01916590|3604418|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3771002|NCT01916590|3604416|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3771003|NCT01916590|3604417|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3771004|NCT01916590|3604418|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3771005|NCT01916304|3604425|B1|||Calculated BMI|Calculated BMI data was available for 96 participants.|kg/m^2|Mean|27.1|27.1|Standard Deviation|6.00|6.0|||
3771006|NCT01916304|3604425|B1|||Investigator Reported Body Mass Index (BMI)|Investigator reported BMI data was available for 93 participants.|kg/m^2|Mean|27.2|27.2|Standard Deviation|5.98|5.98|||
3771007|NCT01916304|3604425|B1|||Height|Height data was available for 96 participants.|cm|Mean|168.4|168.4|Standard Deviation|8.57|8.57|||
3771008|NCT01916304|3604425|B1|||Weight|Weight data is available for 100 participants.|kg|Mean|76.9|76.9|Standard Deviation|18.05|18.05|||
3771009|NCT01916304|3604425|B1|Belgium||Region of Enrollment||participants|Number|101|101.0||||||
3771010|NCT01916304|3604425|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3771011|NCT01916304|3604425|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3771012|NCT01916304|3604425|B1|≥ 65 years||Age, Customized||participants|Number|23|23.0||||||
3771013|NCT01916304|3604425|B1|<65 years||Age, Customized||participants|Number|78|78.0||||||
3771014|NCT01916304|3604425|B1|||Age||years|Mean|54.1|54.1|Standard Deviation|12.17|12.17|||
3771015|NCT01916226|3604433|B5|Not Captured by Study Site||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3771016|NCT01916226|3604434|B4|Not Captured by Study Site||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3771017|NCT01916226|3604435|B3|Not Captured by Study Site||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3771018|NCT01916226|3604436|B2|Not Captured by Study Site||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3771019|NCT01916226|3604437|B1|Not Captured by Study Site||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3771020|NCT01916226|3604433|B5|Mixed Race||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
3771021|NCT01916226|3604434|B4|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3771022|NCT01916226|3604435|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3771023|NCT01916226|3604436|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3771024|NCT01916226|3604437|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3771025|NCT01916226|3604433|B5|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|526|526.0||||||
3771026|NCT01916226|3604434|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|127|127.0||||||
3771027|NCT01916226|3604435|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|128|128.0||||||
3771028|NCT01916226|3604436|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|142|142.0||||||
3771029|NCT01916226|3604437|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|129|129.0||||||
3771030|NCT01916226|3604433|B5|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3771031|NCT01916226|3604434|B4|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3771032|NCT01916226|3604435|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3771033|NCT01916226|3604436|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3771034|NCT01916226|3604437|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3771035|NCT01916226|3604433|B5|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3771036|NCT01916226|3604434|B4|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3771037|NCT01916226|3604435|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3771038|NCT01916226|3604436|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3771039|NCT01916226|3604437|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3771040|NCT01916226|3604433|B5|Asian-East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3771041|NCT01916226|3604434|B4|Asian-East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3771042|NCT01916226|3604435|B3|Asian-East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3771043|NCT01916226|3604436|B2|Asian-East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3771044|NCT01916226|3604437|B1|Asian-East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3771045|NCT01916226|3604433|B5|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3771046|NCT01916226|3604434|B4|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3771047|NCT01916226|3604435|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3771048|NCT01916226|3604436|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3771049|NCT01916226|3604437|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3771050|NCT01916226|3604433|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3771051|NCT01916226|3604434|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3771052|NCT01916226|3604435|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3771053|NCT01916226|3604436|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3771054|NCT01916226|3604437|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3771055|NCT01916226|3604433|B5|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|120|120.0||||||
3771056|NCT01916226|3604434|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
3771057|NCT01916226|3604435|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|31|31.0||||||
3771058|NCT01916226|3604436|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
3771059|NCT01916226|3604437|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|34|34.0||||||
3771060|NCT01916226|3604433|B5||Male|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
3771061|NCT01916226|3604434|B4||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3771062|NCT01916226|3604435|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3771063|NCT01916226|3604436|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3771064|NCT01916226|3604437|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3771065|NCT01916226|3604433|B5||Female|Sex: Female, Male||Participants|Count of Participants|428|428.0||||||
3771066|NCT01916226|3604434|B4||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3771067|NCT01916226|3604435|B3||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3771068|NCT01916226|3604436|B2||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3771069|NCT01916226|3604437|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3771070|NCT01916226|3604433|B5|||Age||Years|Mean|40.3|40.3|Standard Deviation|11.31|11.31|||
3771071|NCT01916226|3604434|B4|||Age||Years|Mean|40.4|40.4|Standard Deviation|11.84|11.84|||
3771072|NCT01916226|3604435|B3|||Age||Years|Mean|41.3|41.3|Standard Deviation|11.29|11.29|||
3771073|NCT01916226|3604436|B2|||Age||Years|Mean|39.2|39.2|Standard Deviation|11.41|11.41|||
3771074|NCT01916226|3604437|B1|||Age||Years|Mean|40.1|40.1|Standard Deviation|10.66|10.66|||
3771075|NCT01916109|3604474|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3771076|NCT01916109|3604474|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3771077|NCT01916109|3604474|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3771078|NCT01916109|3604474|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3771079|NCT01916109|3604474|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3771080|NCT01915940|3604478|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3771081|NCT01915940|3604479|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3771082|NCT01915940|3604480|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3771083|NCT01915940|3604478|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3771084|NCT01915940|3604479|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3771085|NCT01915940|3604480|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3771086|NCT01915940|3604478|B3|||Age||years|Mean|65.6|65.6|Standard Deviation|9.4|9.4|||
3771087|NCT01915940|3604479|B2|||Age||years|Mean|66.3|66.3|Standard Deviation|8.5|8.5|||
3771088|NCT01915940|3604480|B1|||Age||years|Mean|64.9|64.9|Standard Deviation|10.1|10.1|||
3771089|NCT01915914|3604498|B1|Other||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3771090|NCT01915914|3604498|B1|Chinese||Race/Ethnicity, Customized||Participants|Number|118|118.0||||||
3771091|NCT01915914|3604498|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3771092|NCT01915914|3604498|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3771093|NCT01915914|3604498|B1|||Age||Years|Mean|4.8|4.8|Standard Deviation|2.58|2.58|||
3771094|NCT01915849|3604529|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3771095|NCT01915849|3604530|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3771096|NCT01915849|3604531|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3771097|NCT01915849|3604532|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3771098|NCT01915849|3604533|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3771099|NCT01915849|3604529|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3771100|NCT01915849|3604530|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3771101|NCT01915849|3604531|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3771102|NCT01915849|3604532|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3771103|NCT01915849|3604533|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3771104|NCT01915849|3604529|B5|||Age||Years|Mean|56.0|56.0|Standard Deviation|8.26|8.26|||
3771105|NCT01915849|3604530|B4|||Age||Years|Mean|56.0|56.0|Standard Deviation|8.19|8.19|||
3771106|NCT01915849|3604531|B3|||Age||Years|Mean|62.3|62.3|Standard Deviation|3.06|3.06|||
3771107|NCT01915849|3604532|B2|||Age||Years|Mean|54.0|54.0|Standard Deviation|10.54|10.54|||
3771108|NCT01915849|3604533|B1|||Age||Years|Mean|53.4|53.4|Standard Deviation|9.29|9.29|||
3771109|NCT01915823|3604546|B3|United States||Region of Enrollment||participants|Number|348|348.0||||||
3771110|NCT01915823|3604547|B2|United States||Region of Enrollment||participants|Number|175|175.0||||||
3771111|NCT01915823|3604548|B1|United States||Region of Enrollment||participants|Number|173|173.0||||||
3771112|NCT01915823|3604546|B3||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
3771113|NCT01915823|3604547|B2||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3771114|NCT01915823|3604548|B1||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3771115|NCT01915823|3604546|B3||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3771116|NCT01915823|3604547|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3771117|NCT01915823|3604548|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3771118|NCT01915823|3604546|B3|||Age||years|Mean|8.4|8.4|Standard Deviation|2.08|2.08|||
3771119|NCT01915823|3604547|B2|||Age||years|Mean|8.4|8.4|Standard Deviation|2.06|2.06|||
3771120|NCT01915823|3604548|B1|||Age||years|Mean|8.5|8.5|Standard Deviation|2.11|2.11|||
3771121|NCT01915823|3604546|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3771122|NCT01915823|3604547|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3771123|NCT01915823|3604548|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3771124|NCT01915823|3604546|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3771125|NCT01915823|3604547|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3771126|NCT01915823|3604548|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3771127|NCT01915823|3604546|B3||<=18 years|Age||Participants|Count of Participants|348|348.0||||||
3771128|NCT01915823|3604547|B2||<=18 years|Age||Participants|Count of Participants|175|175.0||||||
3771129|NCT01915823|3604548|B1||<=18 years|Age||Participants|Count of Participants|173|173.0||||||
3771130|NCT01915732|3604559|B3|White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3771131|NCT01915732|3604560|B2|White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3771132|NCT01915732|3604561|B1|White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3771133|NCT01915732|3604559|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1015|1015.0||||||
3771134|NCT01915732|3604560|B2|Asian||Race/Ethnicity, Customized||Participants|Number|515|515.0||||||
3771135|NCT01915732|3604561|B1|Asian||Race/Ethnicity, Customized||Participants|Number|500|500.0||||||
3771136|NCT01915732|3604559|B3||Male|Gender||Participants|Count of Participants|251|251.0||||||
3771137|NCT01915732|3604560|B2||Male|Gender||Participants|Count of Participants|133|133.0||||||
3771138|NCT01915732|3604561|B1||Male|Gender||Participants|Count of Participants|118|118.0||||||
3771139|NCT01915732|3604559|B3||Female|Gender||Participants|Count of Participants|765|765.0||||||
3771140|NCT01915732|3604560|B2||Female|Gender||Participants|Count of Participants|383|383.0||||||
3771141|NCT01915732|3604561|B1||Female|Gender||Participants|Count of Participants|382|382.0||||||
3771142|NCT01915732|3604559|B3|||Age||Years|Mean|23.4|23.4|Standard Deviation|4.46|4.46|||
3771143|NCT01915732|3604560|B2|||Age||Years|Mean|23.3|23.3|Standard Deviation|4.29|4.29|||
3771144|NCT01915732|3604561|B1|||Age||Years|Mean|23.4|23.4|Standard Deviation|4.64|4.64|||
3771145|NCT01915173|3604586|B5|||GERD symptom severity|GERD symptom severity was calculated by averaging the severity of GERD symptoms over a 7 day period based on the sum of scores from daily symptom diaries assessing the severity of daytime heartburn, nighttime heartburn, and acid reflux each on a 0-4 point scale (none, mild, moderate, severe, very severe). Higher scores signify worse symptoms (range 0-12).|scores on a scale|Mean|4.3|4.3|Standard Deviation|2.3|2.3|||
3771146|NCT01915173|3604587|B4|||GERD symptom severity|GERD symptom severity was calculated by averaging the severity of GERD symptoms over a 7 day period based on the sum of scores from daily symptom diaries assessing the severity of daytime heartburn, nighttime heartburn, and acid reflux each on a 0-4 point scale (none, mild, moderate, severe, very severe). Higher scores signify worse symptoms (range 0-12).|scores on a scale|Mean|3.8|3.8|Standard Deviation|2.3|2.3|||
3771147|NCT01915173|3604588|B3|||GERD symptom severity|GERD symptom severity was calculated by averaging the severity of GERD symptoms over a 7 day period based on the sum of scores from daily symptom diaries assessing the severity of daytime heartburn, nighttime heartburn, and acid reflux each on a 0-4 point scale (none, mild, moderate, severe, very severe). Higher scores signify worse symptoms (range 0-12).|scores on a scale|Mean|3.6|3.6|Standard Deviation|2.2|2.2|||
3771148|NCT01915173|3604589|B2|||GERD symptom severity|GERD symptom severity was calculated by averaging the severity of GERD symptoms over a 7 day period based on the sum of scores from daily symptom diaries assessing the severity of daytime heartburn, nighttime heartburn, and acid reflux each on a 0-4 point scale (none, mild, moderate, severe, very severe). Higher scores signify worse symptoms (range 0-12).|scores on a scale|Mean|5.6|5.6|Standard Deviation|2.6|2.6|||
3771149|NCT01915173|3604590|B1|||GERD symptom severity|GERD symptom severity was calculated by averaging the severity of GERD symptoms over a 7 day period based on the sum of scores from daily symptom diaries assessing the severity of daytime heartburn, nighttime heartburn, and acid reflux each on a 0-4 point scale (none, mild, moderate, severe, very severe). Higher scores signify worse symptoms (range 0-12).|scores on a scale|Mean|4.2|4.2|Standard Deviation|2.1|2.1|||
3771150|NCT01915173|3604586|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771151|NCT01915173|3604587|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771152|NCT01915173|3604588|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771153|NCT01915173|3604589|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771154|NCT01915173|3604590|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771155|NCT01915173|3604586|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3771156|NCT01915173|3604587|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771157|NCT01915173|3604588|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3771158|NCT01915173|3604589|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771159|NCT01915173|3604590|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771160|NCT01915173|3604586|B5||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3771161|NCT01915173|3604587|B4||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3771162|NCT01915173|3604588|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3771163|NCT01915173|3604589|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3771164|NCT01915173|3604590|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3771165|NCT01915173|3604586|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3771166|NCT01915173|3604587|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3771167|NCT01915173|3604588|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3771168|NCT01915173|3604589|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3771169|NCT01915173|3604590|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3771170|NCT01915173|3604586|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771171|NCT01915173|3604587|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771172|NCT01915173|3604588|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771173|NCT01915173|3604589|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771174|NCT01915173|3604590|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771175|NCT01915173|3604586|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3771176|NCT01915173|3604587|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3771177|NCT01915173|3604588|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771178|NCT01915173|3604589|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3771179|NCT01915173|3604590|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771180|NCT01915173|3604586|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771181|NCT01915173|3604587|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771182|NCT01915173|3604588|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771183|NCT01915173|3604589|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771184|NCT01915173|3604590|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771185|NCT01915173|3604586|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3771186|NCT01915173|3604587|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3771187|NCT01915173|3604588|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771188|NCT01915173|3604589|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771189|NCT01915173|3604590|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771190|NCT01915173|3604586|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3771191|NCT01915173|3604587|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3771192|NCT01915173|3604588|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3771193|NCT01915173|3604589|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3771194|NCT01915173|3604590|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3771195|NCT01915173|3604586|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771196|NCT01915173|3604587|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771197|NCT01915173|3604588|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771198|NCT01915173|3604589|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771199|NCT01915173|3604590|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771200|NCT01915173|3604586|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3771201|NCT01915173|3604587|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3771202|NCT01915173|3604588|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3771203|NCT01915173|3604589|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3771204|NCT01915173|3604590|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3771205|NCT01915173|3604586|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3771206|NCT01915173|3604587|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3771207|NCT01915173|3604588|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3771208|NCT01915173|3604589|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3771209|NCT01915173|3604590|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3771210|NCT01915173|3604586|B5|||Age||years|Mean|58|58.0|Standard Deviation|11|11.0|||
3771211|NCT01915173|3604587|B4|||Age||years|Mean|53|53.0|Standard Deviation|12|12.0|||
3771212|NCT01915173|3604588|B3|||Age||years|Mean|54|54.0|Standard Deviation|9.9|9.9|||
3771213|NCT01915173|3604589|B2|||Age||years|Mean|64|64.0|Standard Deviation|6.3|6.3|||
3771214|NCT01915173|3604590|B1|||Age||years|Mean|60|60.0|Standard Deviation|14|14.0|||
3771215|NCT01915173|3604586|B5||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3771216|NCT01915173|3604587|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3771217|NCT01915173|3604588|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3771218|NCT01915173|3604589|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3771219|NCT01915173|3604590|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3771220|NCT01915173|3604586|B5||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3771221|NCT01915173|3604587|B4||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3771222|NCT01915173|3604588|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3771223|NCT01915173|3604589|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3771224|NCT01915173|3604590|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3771225|NCT01915173|3604586|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3771226|NCT01915173|3604587|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3771227|NCT01915173|3604588|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3771228|NCT01915173|3604589|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3771229|NCT01915173|3604590|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3771230|NCT01915108|3604611|B5||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3771231|NCT01915108|3604612|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3771232|NCT01915108|3604613|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3771233|NCT01915108|3604614|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3771234|NCT01915108|3604615|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3771235|NCT01915108|3604611|B5||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3771236|NCT01915108|3604612|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3771237|NCT01915108|3604613|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3771238|NCT01915108|3604614|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3771239|NCT01915108|3604615|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3771240|NCT01915108|3604611|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3771241|NCT01915108|3604612|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3771242|NCT01915108|3604613|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3771243|NCT01915108|3604614|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3771244|NCT01915108|3604615|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3771245|NCT01915108|3604611|B5||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
3771246|NCT01915108|3604612|B4||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3771247|NCT01915108|3604613|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3771248|NCT01915108|3604614|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3771249|NCT01915108|3604615|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3771250|NCT01915108|3604611|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3771251|NCT01915108|3604612|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3771252|NCT01915108|3604613|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3771253|NCT01915108|3604614|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3771254|NCT01915108|3604615|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3771255|NCT01914926|3604628|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
3771256|NCT01914926|3604629|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3771257|NCT01914926|3604630|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3771258|NCT01914926|3604628|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3771259|NCT01914926|3604629|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3771260|NCT01914926|3604630|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3771261|NCT01914926|3604628|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3771262|NCT01914926|3604629|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3771263|NCT01914926|3604630|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3771264|NCT01914926|3604628|B3|||Age||years|Mean|67.52|67.52|Standard Deviation|14.12|14.12|||
3771265|NCT01914926|3604629|B2|||Age||years|Mean|65.85|65.85|Standard Deviation|13.22|13.22|||
3771266|NCT01914926|3604630|B1|||Age||years|Mean|68.95|68.95|Standard Deviation|14.94|14.94|||
3771267|NCT01914926|3604628|B3||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
3771268|NCT01914926|3604629|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3771269|NCT01914926|3604630|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3771270|NCT01914926|3604628|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3771271|NCT01914926|3604629|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3771272|NCT01914926|3604630|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3771273|NCT01914926|3604628|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3771274|NCT01914926|3604629|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3771275|NCT01914926|3604630|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3771276|NCT01914757|3604637|B4||Male|Gender||Participants|Count of Participants|499|499.0||||||
3771277|NCT01914757|3604638|B3||Male|Gender||Participants|Count of Participants|176|176.0||||||
3771278|NCT01914757|3604639|B2||Male|Gender||Participants|Count of Participants|168|168.0||||||
3771279|NCT01914757|3604640|B1||Male|Gender||Participants|Count of Participants|155|155.0||||||
3771280|NCT01914757|3604637|B4||Female|Gender||Participants|Count of Participants|807|807.0||||||
3771281|NCT01914757|3604638|B3||Female|Gender||Participants|Count of Participants|264|264.0||||||
3771282|NCT01914757|3604639|B2||Female|Gender||Participants|Count of Participants|273|273.0||||||
3771283|NCT01914757|3604640|B1||Female|Gender||Participants|Count of Participants|270|270.0||||||
3771284|NCT01914757|3604637|B4|||Age||Years|Mean|49.2|49.2|Standard Deviation|14.3|14.3|||
3771285|NCT01914757|3604638|B3|||Age||Years|Mean|48.8|48.8|Standard Deviation|15.1|15.1|||
3771286|NCT01914757|3604639|B2|||Age||Years|Mean|49|49.0|Standard Deviation|14.3|14.3|||
3771287|NCT01914757|3604640|B1|||Age||Years|Mean|50.0|50.0|Standard Deviation|13.6|13.6|||
3771288|NCT01914679|3604716|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3771289|NCT01914679|3604716|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3771290|NCT01914679|3604716|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3771291|NCT01914679|3604716|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3771292|NCT01914679|3604716|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3771293|NCT01914666|3604720|B4|Japan||Region of Enrollment||participants|Number|150|150.0||||||
3771294|NCT01914666|3604721|B3|Japan||Region of Enrollment||participants|Number|41|41.0||||||
3771295|NCT01914666|3604722|B2|Japan||Region of Enrollment||participants|Number|42|42.0||||||
3771296|NCT01914666|3604723|B1|Japan||Region of Enrollment||participants|Number|67|67.0||||||
3771297|NCT01914666|3604720|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771298|NCT01914666|3604721|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771299|NCT01914666|3604722|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771300|NCT01914666|3604723|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771301|NCT01914666|3604720|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771302|NCT01914666|3604721|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771303|NCT01914666|3604722|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771304|NCT01914666|3604723|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771305|NCT01914666|3604720|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771306|NCT01914666|3604721|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771307|NCT01914666|3604722|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771308|NCT01914666|3604723|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771309|NCT01914666|3604720|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771310|NCT01914666|3604721|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771311|NCT01914666|3604722|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771312|NCT01914666|3604723|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771313|NCT01914666|3604720|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771314|NCT01914666|3604721|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771315|NCT01914666|3604722|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771316|NCT01914666|3604723|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771317|NCT01914666|3604720|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|150|150.0||||||
3771318|NCT01914666|3604721|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3771319|NCT01914666|3604722|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3771320|NCT01914666|3604723|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3771321|NCT01914666|3604720|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771322|NCT01914666|3604721|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771323|NCT01914666|3604722|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771324|NCT01914666|3604723|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771325|NCT01914666|3604720|B4||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3771326|NCT01914666|3604721|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3771327|NCT01914666|3604722|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3771328|NCT01914666|3604723|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3771329|NCT01914666|3604720|B4||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3771330|NCT01914666|3604721|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3771331|NCT01914666|3604722|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3771332|NCT01914666|3604723|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3771333|NCT01914666|3604720|B4|||Age||years|Mean|56.4|56.4|Standard Deviation|12.8|12.8|||
3771334|NCT01914666|3604721|B3|||Age||years|Mean|58.8|58.8|Standard Deviation|11.1|11.1|||
3771335|NCT01914666|3604722|B2|||Age||years|Mean|57.6|57.6|Standard Deviation|12.0|12.0|||
3771336|NCT01914666|3604723|B1|||Age||years|Mean|54.3|54.3|Standard Deviation|13.9|13.9|||
3771337|NCT01914003|3604758|B3|United States||Region of Enrollment||participants|Number|53|53.0||||||
3771338|NCT01914003|3604759|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
3771339|NCT01914003|3604760|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3771340|NCT01914003|3604758|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3771341|NCT01914003|3604759|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3771342|NCT01914003|3604760|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3771343|NCT01914003|3604758|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3771344|NCT01914003|3604759|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3771345|NCT01914003|3604760|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3771346|NCT01914003|3604758|B3|||Age||years|Median|9|9.0|Inter-Quartile Range|||2.0|15.0|
3771347|NCT01914003|3604759|B2|||Age||years|Median|10.5|10.5|Inter-Quartile Range|||6.25|16.0|
3771348|NCT01914003|3604760|B1|||Age||years|Median|8|8.0|Inter-Quartile Range|||1.0|13.0|
3771349|NCT01914003|3604758|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3771350|NCT01914003|3604759|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3771351|NCT01914003|3604760|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3771352|NCT01914003|3604758|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3771353|NCT01914003|3604759|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3771354|NCT01914003|3604760|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3771355|NCT01914003|3604758|B3||<=18 years|Age||Participants|Count of Participants|53|53.0||||||
3771356|NCT01914003|3604759|B2||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
3771357|NCT01914003|3604760|B1||<=18 years|Age||Participants|Count of Participants|27|27.0||||||
3771358|NCT01913795|3604767|B5|||Forced Vital Capacity (FVC)||Liters|Mean|1.6|1.6|Full Range|||0.8|2.5|
3771359|NCT01913795|3604768|B4|||Forced Vital Capacity (FVC)||Liters|Mean|1.8|1.8|Full Range|||1.2|2.4|
3771360|NCT01913795|3604769|B3|||Forced Vital Capacity (FVC)||Liters|Mean|1.6|1.6|Full Range|||1.1|2.3|
3771361|NCT01913795|3604770|B2|||Forced Vital Capacity (FVC)||Liters|Mean|1.6|1.6|Full Range|||0.8|2.5|
3771362|NCT01913795|3604771|B1|||Forced Vital Capacity (FVC)||Liters|Mean|1.4|1.4|Full Range|||1.2|1.7|
3771363|NCT01913795|3604767|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3771364|NCT01913795|3604768|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3771365|NCT01913795|3604769|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3771366|NCT01913795|3604770|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3771367|NCT01913795|3604771|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3771368|NCT01913795|3604767|B5||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3771369|NCT01913795|3604768|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3771370|NCT01913795|3604769|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3771371|NCT01913795|3604770|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3771372|NCT01913795|3604771|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3771373|NCT01913795|3604767|B5|||Age||years|Mean|9.4|9.4|Full Range|||7.0|12.0|
3771374|NCT01913795|3604768|B4|||Age||years|Mean|9.4|9.4|Full Range|||8.0|12.0|
3771375|NCT01913795|3604769|B3|||Age||years|Mean|9.2|9.2|Full Range|||7.0|11.0|
3771376|NCT01913795|3604770|B2|||Age||years|Mean|10.0|10.0|Full Range|||8.0|12.0|
3771377|NCT01913795|3604771|B1|||Age||years|Mean|8.6|8.6|Full Range|||7.0|10.0|
3771378|NCT01913600|3604788|B1|United States||Region of Enrollment||participants|Number|56|56.0||||||
3771379|NCT01913600|3604788|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3771380|NCT01913600|3604788|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3771381|NCT01913600|3604788|B1|||Age||Years|Mean|60.5|60.5|Standard Deviation|10.7|10.7|||
3771382|NCT01913535|3604805|B6|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3771383|NCT01913535|3604806|B5|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3771384|NCT01913535|3604807|B4|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3771385|NCT01913535|3604808|B3|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3771386|NCT01913535|3604809|B2|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3771387|NCT01913535|3604810|B1|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3771388|NCT01913535|3604805|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771389|NCT01913535|3604806|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771390|NCT01913535|3604807|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771391|NCT01913535|3604808|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771392|NCT01913535|3604809|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771393|NCT01913535|3604810|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771394|NCT01913535|3604805|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771395|NCT01913535|3604806|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771396|NCT01913535|3604807|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771397|NCT01913535|3604808|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771398|NCT01913535|3604809|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771399|NCT01913535|3604810|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771400|NCT01913535|3604805|B6||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3771401|NCT01913535|3604806|B5||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3771402|NCT01913535|3604807|B4||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3771403|NCT01913535|3604808|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3771404|NCT01913535|3604809|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3771405|NCT01913535|3604810|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3771406|NCT01913535|3604805|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771407|NCT01913535|3604806|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771408|NCT01913535|3604807|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771409|NCT01913535|3604808|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771410|NCT01913535|3604809|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771411|NCT01913535|3604810|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771412|NCT01913535|3604805|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771413|NCT01913535|3604806|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771414|NCT01913535|3604807|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771415|NCT01913535|3604808|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771416|NCT01913535|3604809|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771417|NCT01913535|3604810|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771418|NCT01913535|3604805|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771419|NCT01913535|3604806|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771420|NCT01913535|3604807|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771421|NCT01913535|3604808|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771422|NCT01913535|3604809|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771423|NCT01913535|3604810|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771424|NCT01913535|3604805|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771425|NCT01913535|3604806|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771426|NCT01913535|3604807|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771427|NCT01913535|3604808|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771428|NCT01913535|3604809|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771429|NCT01913535|3604810|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771430|NCT01913535|3604805|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771431|NCT01913535|3604806|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771432|NCT01913535|3604807|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771433|NCT01913535|3604808|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771434|NCT01913535|3604809|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771435|NCT01913535|3604810|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771436|NCT01913535|3604805|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3771437|NCT01913535|3604806|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3771438|NCT01913535|3604807|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3771439|NCT01913535|3604808|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3771440|NCT01913535|3604809|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3771441|NCT01913535|3604810|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3771442|NCT01913535|3604805|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771443|NCT01913535|3604806|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771444|NCT01913535|3604807|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771445|NCT01913535|3604808|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771446|NCT01913535|3604809|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771447|NCT01913535|3604810|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771448|NCT01913535|3604805|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3771449|NCT01913535|3604806|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3771450|NCT01913535|3604807|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3771451|NCT01913535|3604808|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3771452|NCT01913535|3604809|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3771453|NCT01913535|3604810|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3771454|NCT01913535|3604805|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3771455|NCT01913535|3604806|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3771456|NCT01913535|3604807|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3771457|NCT01913535|3604808|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3771458|NCT01913535|3604809|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3771459|NCT01913535|3604810|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3771460|NCT01913535|3604805|B6|||Age||years|Median|48.8|48.8|Full Range|||27.2|64.4|
3771461|NCT01913535|3604806|B5|||Age||years|Median|38.8|38.8|Full Range|||38.8|38.8|
3771462|NCT01913535|3604807|B4|||Age||years|Median|36.3|36.3|Full Range|||27.2|45.4|
3771463|NCT01913535|3604808|B3|||Age||years|Median|34.5|34.5|Full Range|||34.5|34.5|
3771464|NCT01913535|3604809|B2|||Age||years|Median|58.3|58.3|Full Range|||58.0|58.5|
3771465|NCT01913535|3604810|B1|||Age||years|Median|58.2|58.2|Full Range|||52.1|64.4|
3771466|NCT01913483|3604845|B3|United States||Region of Enrollment||participants|Number|656|656.0||||||
3771467|NCT01913483|3604846|B2|United States||Region of Enrollment||participants|Number|321|321.0||||||
3771468|NCT01913483|3604847|B1|United States||Region of Enrollment||participants|Number|335|335.0||||||
3771469|NCT01913483|3604845|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771607|NCT01912963|3604952|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3771470|NCT01913483|3604846|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771471|NCT01913483|3604847|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771472|NCT01913483|3604845|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771473|NCT01913483|3604846|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771474|NCT01913483|3604847|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771475|NCT01913483|3604845|B3||White|Race (NIH/OMB)||Participants|Count of Participants|560|560.0||||||
3771476|NCT01913483|3604846|B2||White|Race (NIH/OMB)||Participants|Count of Participants|278|278.0||||||
3771477|NCT01913483|3604847|B1||White|Race (NIH/OMB)||Participants|Count of Participants|282|282.0||||||
3771478|NCT01913483|3604845|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
3771479|NCT01913483|3604846|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3771480|NCT01913483|3604847|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3771481|NCT01913483|3604845|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771482|NCT01913483|3604846|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771483|NCT01913483|3604847|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771484|NCT01913483|3604845|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3771485|NCT01913483|3604846|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3771486|NCT01913483|3604847|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3771487|NCT01913483|3604845|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3771488|NCT01913483|3604846|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3771489|NCT01913483|3604847|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3771490|NCT01913483|3604845|B3||Male|Sex: Female, Male||Participants|Count of Participants|400|400.0||||||
3771491|NCT01913483|3604846|B2||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
3771492|NCT01913483|3604847|B1||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3771493|NCT01913483|3604845|B3||Female|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
3771494|NCT01913483|3604846|B2||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3771495|NCT01913483|3604847|B1||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3771496|NCT01913483|3604845|B3|||Age||Years|Mean|69.0|69.0|Standard Deviation|10.3|10.3|||
3771497|NCT01913483|3604846|B2|||Age||Years|Mean|68.8|68.8|Standard Deviation|10.3|10.3|||
3771498|NCT01913483|3604847|B1|||Age||Years|Mean|69.3|69.3|Standard Deviation|10.3|10.3|||
3771499|NCT01913470|3604858|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3771500|NCT01913470|3604859|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3771501|NCT01913470|3604860|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3771502|NCT01913470|3604858|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771503|NCT01913470|3604859|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771504|NCT01913470|3604860|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771505|NCT01913470|3604858|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3771506|NCT01913470|3604859|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3771507|NCT01913470|3604860|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3771508|NCT01913470|3604858|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3771509|NCT01913470|3604859|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3771510|NCT01913470|3604860|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3771511|NCT01913470|3604858|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3771512|NCT01913470|3604859|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3771513|NCT01913470|3604860|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3771514|NCT01913470|3604858|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3771515|NCT01913470|3604859|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3771516|NCT01913470|3604860|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3771517|NCT01913470|3604858|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3771518|NCT01913470|3604859|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3771519|NCT01913470|3604860|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3771520|NCT01913470|3604858|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3771521|NCT01913470|3604859|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3771522|NCT01913470|3604860|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3771523|NCT01913470|3604858|B3||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
3771524|NCT01913470|3604859|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3771525|NCT01913470|3604860|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3771526|NCT01913405|3604879|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3771527|NCT01913405|3604879|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3771528|NCT01913405|3604879|B1|||Age||Years|Mean|34.8|34.8|Standard Deviation|13.47|13.47|||
3771529|NCT01913314|3604933|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3771530|NCT01913314|3604933|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771531|NCT01913314|3604933|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771532|NCT01913314|3604933|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3771533|NCT01913314|3604933|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771534|NCT01913314|3604933|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771535|NCT01913314|3604933|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771536|NCT01913314|3604933|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771537|NCT01913314|3604933|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771538|NCT01913314|3604933|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3771539|NCT01913314|3604933|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3771540|NCT01913314|3604933|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3771541|NCT01913314|3604933|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3771542|NCT01913314|3604933|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3771543|NCT01913314|3604933|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3771544|NCT01913314|3604933|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3771545|NCT01913041|3604946|B1|China||Region of Enrollment||participants|Number|869|869.0||||||
3771546|NCT01913041|3604946|B1||Male|Sex: Female, Male||Participants|Count of Participants|522|522.0||||||
3771547|NCT01913041|3604946|B1||Female|Sex: Female, Male||Participants|Count of Participants|347|347.0||||||
3771548|NCT01913041|3604946|B1|||Age||years|Median|49.99|49.99|Standard Deviation|16.86|16.86|||
3771549|NCT01912963|3604950|B4|Unknown||ECOG PS|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) ECOG PS 0: Fully active, able to carry on all pre-disease performance without restriction ECOG PS 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature ECOG PS 2: Ambulatory and capable of all self-care but unable to carry out any work activities; Up and about more than 50% of waking hours|count of participants|Number|1|1.0||||||
3771550|NCT01912963|3604951|B3|Unknown||ECOG PS|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) ECOG PS 0: Fully active, able to carry on all pre-disease performance without restriction ECOG PS 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature ECOG PS 2: Ambulatory and capable of all self-care but unable to carry out any work activities; Up and about more than 50% of waking hours|count of participants|Number|0|0.0||||||
3771551|NCT01912963|3604952|B2|Unknown||ECOG PS|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) ECOG PS 0: Fully active, able to carry on all pre-disease performance without restriction ECOG PS 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature ECOG PS 2: Ambulatory and capable of all self-care but unable to carry out any work activities; Up and about more than 50% of waking hours|count of participants|Number|1|1.0||||||
3771552|NCT01912963|3604953|B1|Unknown||ECOG PS|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) ECOG PS 0: Fully active, able to carry on all pre-disease performance without restriction ECOG PS 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature ECOG PS 2: Ambulatory and capable of all self-care but unable to carry out any work activities; Up and about more than 50% of waking hours|count of participants|Number|0|0.0||||||
3771553|NCT01912963|3604950|B4|ECOG PS 1||ECOG PS|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) ECOG PS 0: Fully active, able to carry on all pre-disease performance without restriction ECOG PS 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature ECOG PS 2: Ambulatory and capable of all self-care but unable to carry out any work activities; Up and about more than 50% of waking hours|count of participants|Number|8|8.0||||||
3771554|NCT01912963|3604951|B3|ECOG PS 1||ECOG PS|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) ECOG PS 0: Fully active, able to carry on all pre-disease performance without restriction ECOG PS 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature ECOG PS 2: Ambulatory and capable of all self-care but unable to carry out any work activities; Up and about more than 50% of waking hours|count of participants|Number|3|3.0||||||
3771555|NCT01912963|3604952|B2|ECOG PS 1||ECOG PS|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) ECOG PS 0: Fully active, able to carry on all pre-disease performance without restriction ECOG PS 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature ECOG PS 2: Ambulatory and capable of all self-care but unable to carry out any work activities; Up and about more than 50% of waking hours|count of participants|Number|4|4.0||||||
3771556|NCT01912963|3604953|B1|ECOG PS 1||ECOG PS|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) ECOG PS 0: Fully active, able to carry on all pre-disease performance without restriction ECOG PS 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature ECOG PS 2: Ambulatory and capable of all self-care but unable to carry out any work activities; Up and about more than 50% of waking hours|count of participants|Number|1|1.0||||||
3771557|NCT01912963|3604950|B4|ECOG PS 0||ECOG PS|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) ECOG PS 0: Fully active, able to carry on all pre-disease performance without restriction ECOG PS 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature ECOG PS 2: Ambulatory and capable of all self-care but unable to carry out any work activities; Up and about more than 50% of waking hours|count of participants|Number|23|23.0||||||
3771603|NCT01912963|3604952|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771604|NCT01912963|3604953|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771605|NCT01912963|3604950|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3771558|NCT01912963|3604951|B3|ECOG PS 0||ECOG PS|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) ECOG PS 0: Fully active, able to carry on all pre-disease performance without restriction ECOG PS 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature ECOG PS 2: Ambulatory and capable of all self-care but unable to carry out any work activities; Up and about more than 50% of waking hours|count of participants|Number|4|4.0||||||
3771559|NCT01912963|3604952|B2|ECOG PS 0||ECOG PS|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) ECOG PS 0: Fully active, able to carry on all pre-disease performance without restriction ECOG PS 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature ECOG PS 2: Ambulatory and capable of all self-care but unable to carry out any work activities; Up and about more than 50% of waking hours|count of participants|Number|14|14.0||||||
3771560|NCT01912963|3604953|B1|ECOG PS 0||ECOG PS|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) ECOG PS 0: Fully active, able to carry on all pre-disease performance without restriction ECOG PS 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature ECOG PS 2: Ambulatory and capable of all self-care but unable to carry out any work activities; Up and about more than 50% of waking hours|count of participants|Number|5|5.0||||||
3771561|NCT01912963|3604950|B4|Metastatic diagnosis at primary diagnosis||Time from Primary Diagnosis to metastatic diagnosis||count of participants|Number|10|10.0||||||
3771562|NCT01912963|3604951|B3|Metastatic diagnosis at primary diagnosis||Time from Primary Diagnosis to metastatic diagnosis||count of participants|Number|1|1.0||||||
3771563|NCT01912963|3604952|B2|Metastatic diagnosis at primary diagnosis||Time from Primary Diagnosis to metastatic diagnosis||count of participants|Number|6|6.0||||||
3771564|NCT01912963|3604953|B1|Metastatic diagnosis at primary diagnosis||Time from Primary Diagnosis to metastatic diagnosis||count of participants|Number|3|3.0||||||
3771565|NCT01912963|3604950|B4|> 2 years||Time from Primary Diagnosis to metastatic diagnosis||count of participants|Number|12|12.0||||||
3771566|NCT01912963|3604951|B3|> 2 years||Time from Primary Diagnosis to metastatic diagnosis||count of participants|Number|2|2.0||||||
3771567|NCT01912963|3604952|B2|> 2 years||Time from Primary Diagnosis to metastatic diagnosis||count of participants|Number|8|8.0||||||
3771568|NCT01912963|3604953|B1|> 2 years||Time from Primary Diagnosis to metastatic diagnosis||count of participants|Number|2|2.0||||||
3771569|NCT01912963|3604950|B4|< 2 years||Time from Primary Diagnosis to metastatic diagnosis||count of participants|Number|10|10.0||||||
3771570|NCT01912963|3604951|B3|< 2 years||Time from Primary Diagnosis to metastatic diagnosis||count of participants|Number|4|4.0||||||
3771571|NCT01912963|3604952|B2|< 2 years||Time from Primary Diagnosis to metastatic diagnosis||count of participants|Number|5|5.0||||||
3771572|NCT01912963|3604953|B1|< 2 years||Time from Primary Diagnosis to metastatic diagnosis||count of participants|Number|1|1.0||||||
3771573|NCT01912963|3604950|B4|United States||Region of Enrollment||count of participants|Number|32|32.0||||||
3771574|NCT01912963|3604951|B3|United States||Region of Enrollment||count of participants|Number|7|7.0||||||
3771575|NCT01912963|3604952|B2|United States||Region of Enrollment||count of participants|Number|19|19.0||||||
3771576|NCT01912963|3604953|B1|United States||Region of Enrollment||count of participants|Number|6|6.0||||||
3771577|NCT01912963|3604950|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3771578|NCT01912963|3604951|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771579|NCT01912963|3604952|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3771580|NCT01912963|3604953|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771581|NCT01912963|3604950|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771582|NCT01912963|3604951|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771583|NCT01912963|3604952|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771584|NCT01912963|3604953|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771585|NCT01912963|3604950|B4||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3771586|NCT01912963|3604951|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3771587|NCT01912963|3604952|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3771588|NCT01912963|3604953|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3771589|NCT01912963|3604950|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3771590|NCT01912963|3604951|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771591|NCT01912963|3604952|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3771592|NCT01912963|3604953|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771593|NCT01912963|3604950|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771594|NCT01912963|3604951|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771595|NCT01912963|3604952|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771596|NCT01912963|3604953|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771597|NCT01912963|3604950|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771598|NCT01912963|3604951|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771599|NCT01912963|3604952|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771600|NCT01912963|3604953|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771601|NCT01912963|3604950|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771602|NCT01912963|3604951|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771606|NCT01912963|3604951|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3771608|NCT01912963|3604953|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3771609|NCT01912963|3604950|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3771610|NCT01912963|3604951|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3771611|NCT01912963|3604952|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3771612|NCT01912963|3604953|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3771613|NCT01912963|3604950|B4|||Age||years|Median|53|53.0|Full Range|||33.0|73.0|
3771614|NCT01912963|3604951|B3|||Age||years|Median|47|47.0|Full Range|||40.0|70.0|
3771615|NCT01912963|3604952|B2|||Age||years|Median|53|53.0|Full Range|||33.0|73.0|
3771616|NCT01912963|3604953|B1|||Age||years|Median|55|55.0|Full Range|||38.0|66.0|
3771617|NCT01912781|3604974|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3771618|NCT01912781|3604975|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3771619|NCT01912781|3604976|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3771620|NCT01912781|3604974|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3771621|NCT01912781|3604975|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3771622|NCT01912781|3604976|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3771623|NCT01912781|3604974|B3|||Age||years|Mean|52.1|52.1|Standard Deviation|11.4|11.4|||
3771624|NCT01912781|3604975|B2|||Age||years|Mean|50.5|50.5|Standard Deviation|13.4|13.4|||
3771625|NCT01912781|3604976|B1|||Age||years|Mean|52.9|52.9|Standard Deviation|10.2|10.2|||
3771626|NCT01912768|3605006|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3771627|NCT01912768|3605007|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3771628|NCT01912768|3605008|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3771629|NCT01912768|3605006|B3||Female|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
3771630|NCT01912768|3605007|B2||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3771631|NCT01912768|3605008|B1||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3771632|NCT01912768|3605006|B3|||Age||years|Mean|34.8|34.8|Standard Deviation|11.5|11.5|||
3771633|NCT01912768|3605007|B2|||Age||years|Mean|35.3|35.3|Standard Deviation|10.9|10.9|||
3771634|NCT01912768|3605008|B1|||Age||years|Mean|34.5|34.5|Standard Deviation|11.7|11.7|||
3771635|NCT01912729|3605038|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3771636|NCT01912729|3605039|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3771637|NCT01912729|3605040|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3771638|NCT01912729|3605038|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3771639|NCT01912729|3605039|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3771640|NCT01912729|3605040|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3771641|NCT01912729|3605038|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3771642|NCT01912729|3605039|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3771643|NCT01912729|3605040|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3771644|NCT01912729|3605038|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3771645|NCT01912729|3605039|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3771646|NCT01912729|3605040|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3771647|NCT01912729|3605038|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771648|NCT01912729|3605039|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771649|NCT01912729|3605040|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771650|NCT01912729|3605038|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3771651|NCT01912729|3605039|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3771652|NCT01912729|3605040|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3771653|NCT01912729|3605038|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771654|NCT01912729|3605039|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771655|NCT01912729|3605040|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771656|NCT01912729|3605038|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771657|NCT01912729|3605039|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771658|NCT01912729|3605040|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771659|NCT01912729|3605038|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3771660|NCT01912729|3605039|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3771661|NCT01912729|3605040|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3771662|NCT01912729|3605038|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3771663|NCT01912729|3605039|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3771664|NCT01912729|3605040|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3771665|NCT01912729|3605038|B3|Other||Sex/Gender, Customized||Participants|Count of Participants|1|1.0||||||
3771666|NCT01912729|3605039|B2|Other||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3771667|NCT01912729|3605040|B1|Other||Sex/Gender, Customized||Participants|Count of Participants|1|1.0||||||
3771668|NCT01912729|3605038|B3|Female||Sex/Gender, Customized||Participants|Count of Participants|29|29.0||||||
3771669|NCT01912729|3605039|B2|Female||Sex/Gender, Customized||Participants|Count of Participants|16|16.0||||||
3771670|NCT01912729|3605040|B1|Female||Sex/Gender, Customized||Participants|Count of Participants|13|13.0||||||
3771671|NCT01912729|3605038|B3|Male||Sex/Gender, Customized||Participants|Count of Participants|9|9.0||||||
3771672|NCT01912729|3605039|B2|Male||Sex/Gender, Customized||Participants|Count of Participants|3|3.0||||||
3771673|NCT01912729|3605040|B1|Male||Sex/Gender, Customized||Participants|Count of Participants|6|6.0||||||
3771674|NCT01912729|3605038|B3|||Age||years|Mean|16.23|16.23|Standard Deviation|0.99|0.99|||
3771675|NCT01912729|3605039|B2|||Age||years|Mean|16.0|16.0|Standard Deviation|0.94|0.94|||
3771676|NCT01912729|3605040|B1|||Age||years|Mean|16.45|16.45|Standard Deviation|0.999|0.999|||
3771677|NCT01912599|3605051|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
3771678|NCT01912599|3605052|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3771679|NCT01912599|3605053|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3771680|NCT01912599|3605051|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771681|NCT01912599|3605052|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771682|NCT01912599|3605053|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771683|NCT01912599|3605051|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771684|NCT01912599|3605052|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771685|NCT01912599|3605053|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771686|NCT01912599|3605051|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3771687|NCT01912599|3605052|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3771688|NCT01912599|3605053|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3771689|NCT01912599|3605051|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3771690|NCT01912599|3605052|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3771691|NCT01912599|3605053|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3771692|NCT01912599|3605051|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771693|NCT01912599|3605052|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771694|NCT01912599|3605053|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771695|NCT01912599|3605051|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3771696|NCT01912599|3605052|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3771697|NCT01912599|3605053|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3771698|NCT01912599|3605051|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771699|NCT01912599|3605052|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771700|NCT01912599|3605053|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771701|NCT01912599|3605051|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3771702|NCT01912599|3605052|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3771703|NCT01912599|3605053|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3771704|NCT01912599|3605051|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3771705|NCT01912599|3605052|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3771706|NCT01912599|3605053|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3771707|NCT01912599|3605051|B3|||Age||years|Mean|57.3|57.3|Standard Deviation|14.8|14.8|||
3771708|NCT01912599|3605052|B2|||Age||years|Mean|66.9|66.9|Standard Deviation|11.1|11.1|||
3771709|NCT01912599|3605053|B1|||Age||years|Mean|50.2|50.2|Standard Deviation|13.3|13.3|||
3771710|NCT01912599|3605051|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3771711|NCT01912599|3605052|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3771712|NCT01912599|3605053|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3771713|NCT01912599|3605051|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3771714|NCT01912599|3605052|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3771715|NCT01912599|3605053|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3771716|NCT01912599|3605051|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3771717|NCT01912599|3605052|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3771718|NCT01912599|3605053|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3771719|NCT01912495|3605068|B1|Netherlands||Region of Enrollment||participants|Number|57|57.0||||||
3771720|NCT01912495|3605068|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3771721|NCT01912495|3605068|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3771722|NCT01912495|3605068|B1|||Age||years|Median|40|40.0|Inter-Quartile Range|||34.0|47.0|
3771723|NCT01912404|3605077|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3771724|NCT01912404|3605078|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3771725|NCT01912404|3605079|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3773088|NCT01909141|3605938|B2|||acne||participants|Number|4|4.0||||||
3771726|NCT01912404|3605077|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3771727|NCT01912404|3605078|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3771728|NCT01912404|3605079|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3771729|NCT01912404|3605077|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3771730|NCT01912404|3605078|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3771731|NCT01912404|3605079|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3771732|NCT01912404|3605077|B3|||Age||years|Mean|41.6|41.6|Standard Deviation|10.31|10.31|||
3771733|NCT01912404|3605078|B2|||Age||years|Mean|31|31.0|Standard Deviation|1.41|1.41|||
3771734|NCT01912404|3605079|B1|||Age||years|Mean|48.7|48.7|Standard Deviation|4.93|4.93|||
3771735|NCT01912404|3605077|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3771736|NCT01912404|3605078|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3771737|NCT01912404|3605079|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3771738|NCT01912404|3605077|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3771739|NCT01912404|3605078|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3771740|NCT01912404|3605079|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3771741|NCT01912404|3605077|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3771742|NCT01912404|3605078|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3771743|NCT01912404|3605079|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3771744|NCT01912352|3605086|B1|||Scores on the ADHD Rating Scale-IV|Attendtion-deficit hyperactivity disorder (ADHD) Rating Scale-IV is the sum of 18 questions, ranging from 0 (no symptoms) to 54 (worst possible symptoms).|units on a scale|Mean|26.1|26.1|Standard Deviation|10.5|10.5|||
3771745|NCT01912352|3605086|B1|Korea, Republic of||Region of Enrollment||participants|Number|83|83.0||||||
3771746|NCT01912352|3605086|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3771747|NCT01912352|3605086|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3771748|NCT01912352|3605086|B1|||Age||years|Mean|9.5|9.5|Standard Deviation|2.6|2.6|||
3771749|NCT01912339|3605091|B3|United States||Region of Enrollment||participants|Number|197|197.0||||||
3771750|NCT01912339|3605092|B2|United States||Region of Enrollment||participants|Number|61|61.0||||||
3771751|NCT01912339|3605093|B1|United States||Region of Enrollment||participants|Number|136|136.0||||||
3771752|NCT01912339|3605091|B3||Male|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
3771753|NCT01912339|3605092|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3771754|NCT01912339|3605093|B1||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3771755|NCT01912339|3605091|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3771756|NCT01912339|3605092|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3771757|NCT01912339|3605093|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3771758|NCT01912339|3605091|B3|||Age||years|Mean|62.9|62.9|Standard Deviation|7.0|7.0|||
3771759|NCT01912339|3605092|B2|||Age||years|Mean|62.9|62.9|Standard Deviation|7.0|7.0|||
3771760|NCT01912339|3605093|B1|||Age||years|Mean|63.0|63.0|Standard Deviation|7.1|7.1|||
3771761|NCT01912339|3605091|B3||>=65 years|Age||Participants|Count of Participants|77|77.0||||||
3771762|NCT01912339|3605092|B2||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3771763|NCT01912339|3605093|B1||>=65 years|Age||Participants|Count of Participants|52|52.0||||||
3771764|NCT01912339|3605091|B3||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
3771765|NCT01912339|3605092|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3771766|NCT01912339|3605093|B1||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
3771767|NCT01912339|3605091|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3771768|NCT01912339|3605092|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3771769|NCT01912339|3605093|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3771770|NCT01912222|3605109|B4|||Baseline aspartate aminotransferase (AST)||units per liter (U/L)|Mean|141.09|141.09|Standard Deviation|167.256|167.256|||
3771771|NCT01912222|3605110|B3|||Baseline aspartate aminotransferase (AST)||units per liter (U/L)|Mean|197.48|197.48|Standard Deviation|198.211|198.211|||
3771772|NCT01912222|3605111|B2|||Baseline aspartate aminotransferase (AST)||units per liter (U/L)|Mean|169.97|169.97|Standard Deviation|147.433|147.433|||
3771773|NCT01912222|3605112|B1|||Baseline aspartate aminotransferase (AST)||units per liter (U/L)|Mean|21.04|21.04|Standard Deviation|6.884|6.884|||
3771774|NCT01912222|3605109|B4|||Baseline total bilirubin||micro mole per liter (mcmol/L)|Mean|59.85|59.85|Standard Deviation|66.249|66.249|||
3771775|NCT01912222|3605110|B3|||Baseline total bilirubin||micro mole per liter (mcmol/L)|Mean|108.61|108.61|Standard Deviation|78.372|78.372|||
3771776|NCT01912222|3605111|B2|||Baseline total bilirubin||micro mole per liter (mcmol/L)|Mean|40.25|40.25|Standard Deviation|5.594|5.594|||
3771777|NCT01912222|3605112|B1|||Baseline total bilirubin||micro mole per liter (mcmol/L)|Mean|7.43|7.43|Standard Deviation|3.092|3.092|||
3771778|NCT01912222|3605109|B4|1||Baseline Eastern Cooperative Oncology Group (ECOG) performance status|ECOG assessed participant's performance status on 5 point scale: 0=Fully active/able to carry on all pre-disease activities without restriction; 1=restricted in physically strenuous activity, ambulatory/able to carry out light or sedentary work; 2=ambulatory (>50% of waking hrs), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hrs; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Participants who had a score of 0 or 1 were assessed.|participants|Number|46|46.0||||||
3773089|NCT01909141|3605939|B1|||acne||participants|Number|7|7.0||||||
3771779|NCT01912222|3605110|B3|1||Baseline Eastern Cooperative Oncology Group (ECOG) performance status|ECOG assessed participant's performance status on 5 point scale: 0=Fully active/able to carry on all pre-disease activities without restriction; 1=restricted in physically strenuous activity, ambulatory/able to carry out light or sedentary work; 2=ambulatory (>50% of waking hrs), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hrs; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Participants who had a score of 0 or 1 were assessed.|participants|Number|19|19.0||||||
3771780|NCT01912222|3605111|B2|1||Baseline Eastern Cooperative Oncology Group (ECOG) performance status|ECOG assessed participant's performance status on 5 point scale: 0=Fully active/able to carry on all pre-disease activities without restriction; 1=restricted in physically strenuous activity, ambulatory/able to carry out light or sedentary work; 2=ambulatory (>50% of waking hrs), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hrs; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Participants who had a score of 0 or 1 were assessed.|participants|Number|15|15.0||||||
3771781|NCT01912222|3605112|B1|1||Baseline Eastern Cooperative Oncology Group (ECOG) performance status|ECOG assessed participant's performance status on 5 point scale: 0=Fully active/able to carry on all pre-disease activities without restriction; 1=restricted in physically strenuous activity, ambulatory/able to carry out light or sedentary work; 2=ambulatory (>50% of waking hrs), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hrs; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Participants who had a score of 0 or 1 were assessed.|participants|Number|12|12.0||||||
3771782|NCT01912222|3605109|B4|0||Baseline Eastern Cooperative Oncology Group (ECOG) performance status|ECOG assessed participant's performance status on 5 point scale: 0=Fully active/able to carry on all pre-disease activities without restriction; 1=restricted in physically strenuous activity, ambulatory/able to carry out light or sedentary work; 2=ambulatory (>50% of waking hrs), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hrs; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Participants who had a score of 0 or 1 were assessed.|participants|Number|2|2.0||||||
3771783|NCT01912222|3605110|B3|0||Baseline Eastern Cooperative Oncology Group (ECOG) performance status|ECOG assessed participant's performance status on 5 point scale: 0=Fully active/able to carry on all pre-disease activities without restriction; 1=restricted in physically strenuous activity, ambulatory/able to carry out light or sedentary work; 2=ambulatory (>50% of waking hrs), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hrs; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Participants who had a score of 0 or 1 were assessed.|participants|Number|1|1.0||||||
3771784|NCT01912222|3605111|B2|0||Baseline Eastern Cooperative Oncology Group (ECOG) performance status|ECOG assessed participant's performance status on 5 point scale: 0=Fully active/able to carry on all pre-disease activities without restriction; 1=restricted in physically strenuous activity, ambulatory/able to carry out light or sedentary work; 2=ambulatory (>50% of waking hrs), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hrs; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Participants who had a score of 0 or 1 were assessed.|participants|Number|0|0.0||||||
3771785|NCT01912222|3605112|B1|0||Baseline Eastern Cooperative Oncology Group (ECOG) performance status|ECOG assessed participant's performance status on 5 point scale: 0=Fully active/able to carry on all pre-disease activities without restriction; 1=restricted in physically strenuous activity, ambulatory/able to carry out light or sedentary work; 2=ambulatory (>50% of waking hrs), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hrs; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Participants who had a score of 0 or 1 were assessed.|participants|Number|1|1.0||||||
3771786|NCT01912222|3605109|B4|Had no prior surgery||Participant with prior surgery||participants|Number|4|4.0||||||
3771787|NCT01912222|3605110|B3|Had no prior surgery||Participant with prior surgery||participants|Number|2|2.0||||||
3771788|NCT01912222|3605111|B2|Had no prior surgery||Participant with prior surgery||participants|Number|1|1.0||||||
3771789|NCT01912222|3605112|B1|Had no prior surgery||Participant with prior surgery||participants|Number|1|1.0||||||
3771790|NCT01912222|3605109|B4|Had prior surgery||Participant with prior surgery||participants|Number|44|44.0||||||
3771791|NCT01912222|3605110|B3|Had prior surgery||Participant with prior surgery||participants|Number|18|18.0||||||
3771792|NCT01912222|3605111|B2|Had prior surgery||Participant with prior surgery||participants|Number|14|14.0||||||
3771793|NCT01912222|3605112|B1|Had prior surgery||Participant with prior surgery||participants|Number|12|12.0||||||
3771794|NCT01912222|3605109|B4|Had no prior radiation||Participant with prior radiation||participants|Number|25|25.0||||||
3771795|NCT01912222|3605110|B3|Had no prior radiation||Participant with prior radiation||participants|Number|9|9.0||||||
3771796|NCT01912222|3605111|B2|Had no prior radiation||Participant with prior radiation||participants|Number|9|9.0||||||
3771797|NCT01912222|3605112|B1|Had no prior radiation||Participant with prior radiation||participants|Number|7|7.0||||||
3771798|NCT01912222|3605109|B4|Had prior radiation||Participant with prior radiation||participants|Number|23|23.0||||||
3771799|NCT01912222|3605110|B3|Had prior radiation||Participant with prior radiation||participants|Number|11|11.0||||||
3771800|NCT01912222|3605111|B2|Had prior radiation||Participant with prior radiation||participants|Number|6|6.0||||||
3771801|NCT01912222|3605112|B1|Had prior radiation||Participant with prior radiation||participants|Number|6|6.0||||||
3771802|NCT01912222|3605109|B4|||Participants with prior antineoplastic therapy|All participants had prior antineoplastic therapy.|participants|Number|48|48.0||||||
3771803|NCT01912222|3605110|B3|||Participants with prior antineoplastic therapy|All participants had prior antineoplastic therapy.|participants|Number|20|20.0||||||
3771804|NCT01912222|3605111|B2|||Participants with prior antineoplastic therapy|All participants had prior antineoplastic therapy.|participants|Number|15|15.0||||||
3771805|NCT01912222|3605112|B1|||Participants with prior antineoplastic therapy|All participants had prior antineoplastic therapy.|participants|Number|13|13.0||||||
3771806|NCT01912222|3605109|B4|||Months from initial diagnosis to first dose of ixazomib||months|Mean|37.4|37.4|Standard Deviation|32.56|32.56|||
3771807|NCT01912222|3605110|B3|||Months from initial diagnosis to first dose of ixazomib||months|Mean|35.2|35.2|Standard Deviation|28.73|28.73|||
3771808|NCT01912222|3605111|B2|||Months from initial diagnosis to first dose of ixazomib||months|Mean|23.7|23.7|Standard Deviation|16.59|16.59|||
3771809|NCT01912222|3605112|B1|||Months from initial diagnosis to first dose of ixazomib||months|Mean|56.5|56.5|Standard Deviation|43.40|43.4|||
3771810|NCT01912222|3605109|B4|Other||Disease type at diagnosis|Solid tumor includes colon, colorectal, endometrial, esophageal, gall bladder, head and neck, kidney, liver, melanoma, mesothelioma, non-small cell lung cancer, ovarian, pancreatic, prostate, rectal, and sarcoma. Other tumor includes cholangiocarcinoma, malignant fibrous histiocytoma, metastatic poorly differentiated squamous cell carcinoma of the pelvis, moderately differentiated adenocarcinoma compatible with intrahepatic cholangiocarcinoma, unknown primary with liver metastasis, and peritoneal adenocarcinoma.|participants|Number|6|6.0||||||
3771811|NCT01912222|3605110|B3|Other||Disease type at diagnosis|Solid tumor includes colon, colorectal, endometrial, esophageal, gall bladder, head and neck, kidney, liver, melanoma, mesothelioma, non-small cell lung cancer, ovarian, pancreatic, prostate, rectal, and sarcoma. Other tumor includes cholangiocarcinoma, malignant fibrous histiocytoma, metastatic poorly differentiated squamous cell carcinoma of the pelvis, moderately differentiated adenocarcinoma compatible with intrahepatic cholangiocarcinoma, unknown primary with liver metastasis, and peritoneal adenocarcinoma.|participants|Number|2|2.0||||||
3771812|NCT01912222|3605111|B2|Other||Disease type at diagnosis|Solid tumor includes colon, colorectal, endometrial, esophageal, gall bladder, head and neck, kidney, liver, melanoma, mesothelioma, non-small cell lung cancer, ovarian, pancreatic, prostate, rectal, and sarcoma. Other tumor includes cholangiocarcinoma, malignant fibrous histiocytoma, metastatic poorly differentiated squamous cell carcinoma of the pelvis, moderately differentiated adenocarcinoma compatible with intrahepatic cholangiocarcinoma, unknown primary with liver metastasis, and peritoneal adenocarcinoma.|participants|Number|1|1.0||||||
3771813|NCT01912222|3605112|B1|Other||Disease type at diagnosis|Solid tumor includes colon, colorectal, endometrial, esophageal, gall bladder, head and neck, kidney, liver, melanoma, mesothelioma, non-small cell lung cancer, ovarian, pancreatic, prostate, rectal, and sarcoma. Other tumor includes cholangiocarcinoma, malignant fibrous histiocytoma, metastatic poorly differentiated squamous cell carcinoma of the pelvis, moderately differentiated adenocarcinoma compatible with intrahepatic cholangiocarcinoma, unknown primary with liver metastasis, and peritoneal adenocarcinoma.|participants|Number|3|3.0||||||
3771814|NCT01912222|3605109|B4|Solid tumor||Disease type at diagnosis|Solid tumor includes colon, colorectal, endometrial, esophageal, gall bladder, head and neck, kidney, liver, melanoma, mesothelioma, non-small cell lung cancer, ovarian, pancreatic, prostate, rectal, and sarcoma. Other tumor includes cholangiocarcinoma, malignant fibrous histiocytoma, metastatic poorly differentiated squamous cell carcinoma of the pelvis, moderately differentiated adenocarcinoma compatible with intrahepatic cholangiocarcinoma, unknown primary with liver metastasis, and peritoneal adenocarcinoma.|participants|Number|42|42.0||||||
3771815|NCT01912222|3605110|B3|Solid tumor||Disease type at diagnosis|Solid tumor includes colon, colorectal, endometrial, esophageal, gall bladder, head and neck, kidney, liver, melanoma, mesothelioma, non-small cell lung cancer, ovarian, pancreatic, prostate, rectal, and sarcoma. Other tumor includes cholangiocarcinoma, malignant fibrous histiocytoma, metastatic poorly differentiated squamous cell carcinoma of the pelvis, moderately differentiated adenocarcinoma compatible with intrahepatic cholangiocarcinoma, unknown primary with liver metastasis, and peritoneal adenocarcinoma.|participants|Number|18|18.0||||||
3771816|NCT01912222|3605111|B2|Solid tumor||Disease type at diagnosis|Solid tumor includes colon, colorectal, endometrial, esophageal, gall bladder, head and neck, kidney, liver, melanoma, mesothelioma, non-small cell lung cancer, ovarian, pancreatic, prostate, rectal, and sarcoma. Other tumor includes cholangiocarcinoma, malignant fibrous histiocytoma, metastatic poorly differentiated squamous cell carcinoma of the pelvis, moderately differentiated adenocarcinoma compatible with intrahepatic cholangiocarcinoma, unknown primary with liver metastasis, and peritoneal adenocarcinoma.|participants|Number|14|14.0||||||
3771817|NCT01912222|3605112|B1|Solid tumor||Disease type at diagnosis|Solid tumor includes colon, colorectal, endometrial, esophageal, gall bladder, head and neck, kidney, liver, melanoma, mesothelioma, non-small cell lung cancer, ovarian, pancreatic, prostate, rectal, and sarcoma. Other tumor includes cholangiocarcinoma, malignant fibrous histiocytoma, metastatic poorly differentiated squamous cell carcinoma of the pelvis, moderately differentiated adenocarcinoma compatible with intrahepatic cholangiocarcinoma, unknown primary with liver metastasis, and peritoneal adenocarcinoma.|participants|Number|10|10.0||||||
3771818|NCT01912222|3605109|B4|||Weight||kilogram (kg)|Mean|76.27|76.27|Standard Deviation|18.431|18.431|||
3771819|NCT01912222|3605110|B3|||Weight||kilogram (kg)|Mean|76.94|76.94|Standard Deviation|23.498|23.498|||
3771820|NCT01912222|3605111|B2|||Weight||kilogram (kg)|Mean|76.97|76.97|Standard Deviation|12.050|12.05|||
3771821|NCT01912222|3605112|B1|||Weight||kilogram (kg)|Mean|74.42|74.42|Standard Deviation|16.788|16.788|||
3771822|NCT01912222|3605109|B4|||Height||centimeter (cm)|Mean|169.0|169.0|Standard Deviation|19.01|19.01|||
3771823|NCT01912222|3605110|B3|||Height||centimeter (cm)|Mean|169.6|169.6|Standard Deviation|27.54|27.54|||
3771824|NCT01912222|3605111|B2|||Height||centimeter (cm)|Mean|168.6|168.6|Standard Deviation|12.56|12.56|||
3771825|NCT01912222|3605112|B1|||Height||centimeter (cm)|Mean|168.6|168.6|Standard Deviation|6.79|6.79|||
3771826|NCT01912222|3605109|B4|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3771827|NCT01912222|3605110|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3771828|NCT01912222|3605111|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3771829|NCT01912222|3605112|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3771830|NCT01912222|3605109|B4|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3771831|NCT01912222|3605110|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3771832|NCT01912222|3605111|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3771833|NCT01912222|3605112|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3771834|NCT01912222|3605109|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3771835|NCT01912222|3605110|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3771836|NCT01912222|3605111|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3771837|NCT01912222|3605112|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3771838|NCT01912222|3605109|B4|White||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3771839|NCT01912222|3605110|B3|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3771840|NCT01912222|3605111|B2|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3771841|NCT01912222|3605112|B1|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3771842|NCT01912222|3605109|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3771843|NCT01912222|3605110|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771844|NCT01912222|3605111|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3771845|NCT01912222|3605112|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3771846|NCT01912222|3605109|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3771847|NCT01912222|3605110|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3771848|NCT01912222|3605111|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3771849|NCT01912222|3605112|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3771850|NCT01912222|3605109|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3771851|NCT01912222|3605110|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771852|NCT01912222|3605111|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3771853|NCT01912222|3605112|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771854|NCT01912222|3605109|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3771855|NCT01912222|3605110|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3771856|NCT01912222|3605111|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3771857|NCT01912222|3605112|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3771858|NCT01912222|3605109|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3771859|NCT01912222|3605110|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3771860|NCT01912222|3605111|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3771861|NCT01912222|3605112|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3771862|NCT01912222|3605109|B4|||Age||years|Mean|56.2|56.2|Standard Deviation|14.45|14.45|||
3771863|NCT01912222|3605110|B3|||Age||years|Mean|54.5|54.5|Standard Deviation|13.84|13.84|||
3771864|NCT01912222|3605111|B2|||Age||years|Mean|56.2|56.2|Standard Deviation|15.26|15.26|||
3771865|NCT01912222|3605112|B1|||Age||years|Mean|58.8|58.8|Standard Deviation|15.19|15.19|||
3771866|NCT01911845|3605137|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3771867|NCT01911845|3605137|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3771868|NCT01911845|3605137|B1|||Age||years|Mean|48.2|48.2|Standard Deviation|11.0|11.0|||
3771869|NCT01911819|3605151|B4|United States||Region of Enrollment||participants|Number|21|21.0||||||
3771870|NCT01911819|3605152|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3771871|NCT01911819|3605153|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3771872|NCT01911819|3605154|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3771873|NCT01911819|3605151|B4|Male||Sex/Gender, Customized||participants|Number|10|10.0||||||
3771874|NCT01911819|3605152|B3|Male||Sex/Gender, Customized||participants|Number|5|5.0||||||
3771875|NCT01911819|3605153|B2|Male||Sex/Gender, Customized||participants|Number|6|6.0||||||
3771876|NCT01911819|3605154|B1|Male||Sex/Gender, Customized||participants|Number|4|4.0||||||
3771877|NCT01911819|3605151|B4|Female||Sex/Gender, Customized||participants|Number|11|11.0||||||
3771878|NCT01911819|3605152|B3|Female||Sex/Gender, Customized||participants|Number|5|5.0||||||
3771879|NCT01911819|3605153|B2|Female||Sex/Gender, Customized||participants|Number|3|3.0||||||
3771880|NCT01911819|3605154|B1|Female||Sex/Gender, Customized||participants|Number|5|5.0||||||
3771881|NCT01911819|3605151|B4|>=65 years||Age, Customized||participants|Number|10|10.0||||||
3771882|NCT01911819|3605152|B3|>=65 years||Age, Customized||participants|Number|4|4.0||||||
3771883|NCT01911819|3605153|B2|>=65 years||Age, Customized||participants|Number|5|5.0||||||
3771884|NCT01911819|3605154|B1|>=65 years||Age, Customized||participants|Number|4|4.0||||||
3771885|NCT01911819|3605151|B4|Between 18 and 65 years||Age, Customized||participants|Number|11|11.0||||||
3771886|NCT01911819|3605152|B3|Between 18 and 65 years||Age, Customized||participants|Number|6|6.0||||||
3771887|NCT01911819|3605153|B2|Between 18 and 65 years||Age, Customized||participants|Number|4|4.0||||||
3771888|NCT01911819|3605154|B1|Between 18 and 65 years||Age, Customized||participants|Number|5|5.0||||||
3771889|NCT01911819|3605151|B4|||Age||years|Mean|61.5|61.5|Full Range|||29.0|75.0|
3771890|NCT01911819|3605152|B3|||Age||years|Mean|57.9|57.9|Full Range|||29.0|75.0|
3771891|NCT01911819|3605153|B2|||Age||years|Mean|65.6|65.6|Full Range|||54.0|72.0|
3771892|NCT01911819|3605154|B1|||Age||years|Mean|60.9|60.9|Full Range|||33.0|75.0|
3771893|NCT01911780|3605192|B3||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3771894|NCT01911780|3605193|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3771895|NCT01911780|3605194|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3771896|NCT01911780|3605192|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3771897|NCT01911780|3605193|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3771898|NCT01911780|3605194|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3771899|NCT01911780|3605192|B3|||Age||Years|Mean|55.2|55.2|Standard Deviation|9.2|9.2|||
3771900|NCT01911780|3605193|B2|||Age||Years|Mean|54.4|54.4|Standard Deviation|7.9|7.9|||
3771901|NCT01911780|3605194|B1|||Age||Years|Mean|56.1|56.1|Standard Deviation|10.2|10.2|||
3771902|NCT01911689|3605213|B3|China||Region of Enrollment||participants|Number|168|168.0||||||
3771903|NCT01911689|3605214|B2|China||Region of Enrollment||participants|Number|51|51.0||||||
3771904|NCT01911689|3605215|B1|China||Region of Enrollment||participants|Number|117|117.0||||||
3771905|NCT01911689|3605213|B3||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3771906|NCT01911689|3605214|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3771907|NCT01911689|3605215|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3771908|NCT01911689|3605213|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3771909|NCT01911689|3605214|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3771910|NCT01911689|3605215|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3771911|NCT01911689|3605213|B3|||Age||years|Mean|50.56|50.56|Standard Deviation|16.22|16.22|||
3771912|NCT01911689|3605214|B2|||Age||years|Mean|50.90|50.9|Standard Deviation|17.83|17.83|||
3771913|NCT01911689|3605215|B1|||Age||years|Mean|50.41|50.41|Standard Deviation|15.55|15.55|||
3771914|NCT01911546|3605229|B1||Unknown Etiology|Cause of ESRD||Participants|Count of Participants|5|5.0||||||
3771915|NCT01911546|3605229|B1||Post-Infectious Glomerulonephropathy|Cause of ESRD||Participants|Count of Participants|1|1.0||||||
3771916|NCT01911546|3605229|B1||PCKD|Cause of ESRD||Participants|Count of Participants|2|2.0||||||
3771917|NCT01911546|3605229|B1||Lupus|Cause of ESRD||Participants|Count of Participants|3|3.0||||||
3771918|NCT01911546|3605229|B1||HTN|Cause of ESRD||Participants|Count of Participants|3|3.0||||||
3771919|NCT01911546|3605229|B1||FSGS|Cause of ESRD||Participants|Count of Participants|2|2.0||||||
3771920|NCT01911546|3605229|B1||Congenital|Cause of ESRD||Participants|Count of Participants|3|3.0||||||
3771921|NCT01911546|3605229|B1||Alport Syndrome|Cause of ESRD||Participants|Count of Participants|1|1.0||||||
3771922|NCT01911546|3605229|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3771923|NCT01911546|3605229|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771924|NCT01911546|3605229|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3771925|NCT01911546|3605229|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3771926|NCT01911546|3605229|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3771927|NCT01911546|3605229|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771928|NCT01911546|3605229|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3771929|NCT01911546|3605229|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771930|NCT01911546|3605229|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3771931|NCT01911546|3605229|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3771932|NCT01911546|3605229|B1|||Age||years|Mean|48.65|48.65|Standard Deviation|11.98|11.98|||
3771933|NCT01911546|3605229|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3771934|NCT01911546|3605229|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3771935|NCT01911546|3605229|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3771936|NCT01911442|3605236|B4|United States||Region of Enrollment||participants|Number|149|149.0||||||
3771937|NCT01911442|3605237|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
3771938|NCT01911442|3605238|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
3771939|NCT01911442|3605239|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
3771940|NCT01911442|3605236|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3771941|NCT01911442|3605237|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771942|NCT01911442|3605238|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3771943|NCT01911442|3605239|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3771944|NCT01911442|3605236|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3771945|NCT01911442|3605237|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3771946|NCT01911442|3605238|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3771947|NCT01911442|3605239|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771948|NCT01911442|3605236|B4||White|Race (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
3771949|NCT01911442|3605237|B3||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3771950|NCT01911442|3605238|B2||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3771951|NCT01911442|3605239|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3771952|NCT01911442|3605236|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3771953|NCT01911442|3605237|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3771954|NCT01911442|3605238|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3771955|NCT01911442|3605239|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3771956|NCT01911442|3605236|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771957|NCT01911442|3605237|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771958|NCT01911442|3605238|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771959|NCT01911442|3605239|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771960|NCT01911442|3605236|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3771961|NCT01911442|3605237|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3771962|NCT01911442|3605238|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3771963|NCT01911442|3605239|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771964|NCT01911442|3605236|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3771965|NCT01911442|3605237|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771966|NCT01911442|3605238|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3771967|NCT01911442|3605239|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3771968|NCT01911442|3605236|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771969|NCT01911442|3605237|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771970|NCT01911442|3605238|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771971|NCT01911442|3605239|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3771972|NCT01911442|3605236|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
3771973|NCT01911442|3605237|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3771974|NCT01911442|3605238|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3771975|NCT01911442|3605239|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3771976|NCT01911442|3605236|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3771977|NCT01911442|3605237|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3771978|NCT01911442|3605238|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3771979|NCT01911442|3605239|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3771980|NCT01911442|3605236|B4||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3771981|NCT01911442|3605237|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3771982|NCT01911442|3605238|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3771983|NCT01911442|3605239|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3771984|NCT01911442|3605236|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3771985|NCT01911442|3605237|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3771986|NCT01911442|3605238|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3771987|NCT01911442|3605239|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3771988|NCT01911442|3605236|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3771989|NCT01911442|3605237|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3771990|NCT01911442|3605238|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3771991|NCT01911442|3605239|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3771992|NCT01911442|3605236|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3771993|NCT01911442|3605237|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3771994|NCT01911442|3605238|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3771995|NCT01911442|3605239|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3771996|NCT01911442|3605236|B4||<=18 years|Age||Participants|Count of Participants|149|149.0||||||
3771997|NCT01911442|3605237|B3||<=18 years|Age||Participants|Count of Participants|49|49.0||||||
3771998|NCT01911442|3605238|B2||<=18 years|Age||Participants|Count of Participants|51|51.0||||||
3771999|NCT01911442|3605239|B1||<=18 years|Age||Participants|Count of Participants|49|49.0||||||
3772000|NCT01911429|3605267|B4||295.90 schizophrenia, undifferentiated type|DSM-IV diagnosis of Schizophrenia||Participants|Count of Participants|46|46.0||||||
3772001|NCT01911429|3605268|B3||295.90 schizophrenia, undifferentiated type|DSM-IV diagnosis of Schizophrenia||Participants|Count of Participants|20|20.0||||||
3772002|NCT01911429|3605269|B2||295.90 schizophrenia, undifferentiated type|DSM-IV diagnosis of Schizophrenia||Participants|Count of Participants|17|17.0||||||
3772003|NCT01911429|3605270|B1||295.90 schizophrenia, undifferentiated type|DSM-IV diagnosis of Schizophrenia||Participants|Count of Participants|9|9.0||||||
3772004|NCT01911429|3605267|B4||295.30 schizophrenia, paranoid type|DSM-IV diagnosis of Schizophrenia||Participants|Count of Participants|254|254.0||||||
3772005|NCT01911429|3605268|B3||295.30 schizophrenia, paranoid type|DSM-IV diagnosis of Schizophrenia||Participants|Count of Participants|85|85.0||||||
3772006|NCT01911429|3605269|B2||295.30 schizophrenia, paranoid type|DSM-IV diagnosis of Schizophrenia||Participants|Count of Participants|81|81.0||||||
3772007|NCT01911429|3605270|B1||295.30 schizophrenia, paranoid type|DSM-IV diagnosis of Schizophrenia||Participants|Count of Participants|88|88.0||||||
3772008|NCT01911429|3605267|B4||295.10 schizophrenia, disorganized type|DSM-IV diagnosis of Schizophrenia||Participants|Count of Participants|26|26.0||||||
3772009|NCT01911429|3605268|B3||295.10 schizophrenia, disorganized type|DSM-IV diagnosis of Schizophrenia||Participants|Count of Participants|7|7.0||||||
3772010|NCT01911429|3605269|B2||295.10 schizophrenia, disorganized type|DSM-IV diagnosis of Schizophrenia||Participants|Count of Participants|6|6.0||||||
3772011|NCT01911429|3605270|B1||295.10 schizophrenia, disorganized type|DSM-IV diagnosis of Schizophrenia||Participants|Count of Participants|13|13.0||||||
3772012|NCT01911429|3605267|B4|||Baseline weight||kg|Mean|63.8|63.8|Standard Deviation|12.34|12.34|||
3772013|NCT01911429|3605268|B3|||Baseline weight||kg|Mean|64.0|64.0|Standard Deviation|11.88|11.88|||
3772014|NCT01911429|3605269|B2|||Baseline weight||kg|Mean|63.9|63.9|Standard Deviation|12.88|12.88|||
3772015|NCT01911429|3605270|B1|||Baseline weight||kg|Mean|63.5|63.5|Standard Deviation|12.39|12.39|||
3772016|NCT01911429|3605267|B4|||Baseline BMI||Kg/m^2|Mean|22.48|22.48|Standard Deviation|3.448|3.448|||
3772017|NCT01911429|3605268|B3|||Baseline BMI||Kg/m^2|Mean|22.52|22.52|Standard Deviation|3.606|3.606|||
3772018|NCT01911429|3605269|B2|||Baseline BMI||Kg/m^2|Mean|22.56|22.56|Standard Deviation|3.497|3.497|||
3772019|NCT01911429|3605270|B1|||Baseline BMI||Kg/m^2|Mean|22.38|22.38|Standard Deviation|3.262|3.262|||
3772020|NCT01911429|3605267|B4|>97th percentile||Baseline BMI Percentile||participants|Number|20|20.0||||||
3772021|NCT01911429|3605268|B3|>97th percentile||Baseline BMI Percentile||participants|Number|8|8.0||||||
3772022|NCT01911429|3605269|B2|>97th percentile||Baseline BMI Percentile||participants|Number|6|6.0||||||
3772023|NCT01911429|3605270|B1|>97th percentile||Baseline BMI Percentile||participants|Number|6|6.0||||||
3772024|NCT01911429|3605267|B4|> 3th to 85th percentile||Baseline BMI Percentile||participants|Number|211|211.0||||||
3772025|NCT01911429|3605268|B3|> 3th to 85th percentile||Baseline BMI Percentile||participants|Number|72|72.0||||||
3772026|NCT01911429|3605269|B2|> 3th to 85th percentile||Baseline BMI Percentile||participants|Number|65|65.0||||||
3772027|NCT01911429|3605270|B1|> 3th to 85th percentile||Baseline BMI Percentile||participants|Number|74|74.0||||||
3772028|NCT01911429|3605267|B4|< 3th percentile||Baseline BMI Percentile||participants|Number|2|2.0||||||
3772029|NCT01911429|3605268|B3|< 3th percentile||Baseline BMI Percentile||participants|Number|1|1.0||||||
3772030|NCT01911429|3605269|B2|< 3th percentile||Baseline BMI Percentile||participants|Number|1|1.0||||||
3772031|NCT01911429|3605270|B1|< 3th percentile||Baseline BMI Percentile||participants|Number|0|0.0||||||
3772032|NCT01911429|3605267|B4|East Asia||Region of Enrollment||participants|Number|4|4.0||||||
3772033|NCT01911429|3605268|B3|East Asia||Region of Enrollment||participants|Number|1|1.0||||||
3772034|NCT01911429|3605269|B2|East Asia||Region of Enrollment||participants|Number|1|1.0||||||
3772035|NCT01911429|3605270|B1|East Asia||Region of Enrollment||participants|Number|2|2.0||||||
3772036|NCT01911429|3605267|B4|Southeast Asia||Region of Enrollment||participants|Number|4|4.0||||||
3772037|NCT01911429|3605268|B3|Southeast Asia||Region of Enrollment||participants|Number|1|1.0||||||
3772038|NCT01911429|3605269|B2|Southeast Asia||Region of Enrollment||participants|Number|1|1.0||||||
3772039|NCT01911429|3605270|B1|Southeast Asia||Region of Enrollment||participants|Number|2|2.0||||||
3772040|NCT01911429|3605267|B4|Europe||Region of Enrollment||participants|Number|123|123.0||||||
3772041|NCT01911429|3605268|B3|Europe||Region of Enrollment||participants|Number|61|61.0||||||
3772042|NCT01911429|3605269|B2|Europe||Region of Enrollment||participants|Number|57|57.0||||||
3772043|NCT01911429|3605270|B1|Europe||Region of Enrollment||participants|Number|5|5.0||||||
3772044|NCT01911429|3605267|B4|South America||Region of Enrollment||participants|Number|26|26.0||||||
3772045|NCT01911429|3605268|B3|South America||Region of Enrollment||participants|Number|9|9.0||||||
3772046|NCT01911429|3605269|B2|South America||Region of Enrollment||participants|Number|8|8.0||||||
3772047|NCT01911429|3605270|B1|South America||Region of Enrollment||participants|Number|9|9.0||||||
3772048|NCT01911429|3605267|B4|North America||Region of Enrollment||participants|Number|110|110.0||||||
3772049|NCT01911429|3605268|B3|North America||Region of Enrollment||participants|Number|37|37.0||||||
3772050|NCT01911429|3605269|B2|North America||Region of Enrollment||participants|Number|35|35.0||||||
3772051|NCT01911429|3605270|B1|North America||Region of Enrollment||participants|Number|38|38.0||||||
3772052|NCT01911429|3605267|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772053|NCT01911429|3605268|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772054|NCT01911429|3605269|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772055|NCT01911429|3605270|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772056|NCT01911429|3605267|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3772057|NCT01911429|3605268|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3772058|NCT01911429|3605269|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3772059|NCT01911429|3605270|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3772060|NCT01911429|3605267|B4||White|Race (NIH/OMB)||Participants|Count of Participants|220|220.0||||||
3772061|NCT01911429|3605268|B3||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3772062|NCT01911429|3605269|B2||White|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3772063|NCT01911429|3605270|B1||White|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3772064|NCT01911429|3605267|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3772065|NCT01911429|3605268|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3772066|NCT01911429|3605269|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3772067|NCT01911429|3605270|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3772068|NCT01911429|3605267|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772069|NCT01911429|3605268|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772070|NCT01911429|3605269|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772071|NCT01911429|3605270|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772072|NCT01911429|3605267|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3772073|NCT01911429|3605268|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3772074|NCT01911429|3605269|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3772075|NCT01911429|3605270|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3772076|NCT01911429|3605267|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772077|NCT01911429|3605268|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772078|NCT01911429|3605269|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772079|NCT01911429|3605270|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772080|NCT01911429|3605267|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772081|NCT01911429|3605268|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772082|NCT01911429|3605269|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772083|NCT01911429|3605270|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772084|NCT01911429|3605267|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|282|282.0||||||
3772085|NCT01911429|3605268|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3772086|NCT01911429|3605269|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
3772087|NCT01911429|3605270|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
3772088|NCT01911429|3605267|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3772089|NCT01911429|3605268|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3772090|NCT01911429|3605269|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3772091|NCT01911429|3605270|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3772092|NCT01911429|3605267|B4||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3772093|NCT01911429|3605268|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3772094|NCT01911429|3605269|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3772095|NCT01911429|3605270|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3772096|NCT01911429|3605267|B4||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
3772097|NCT01911429|3605268|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3772098|NCT01911429|3605269|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3772099|NCT01911429|3605270|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3772100|NCT01911429|3605267|B4||16-17 years old|Age, Customized||Participants|Count of Participants|166|166.0||||||
3772101|NCT01911429|3605268|B3||16-17 years old|Age, Customized||Participants|Count of Participants|57|57.0||||||
3772102|NCT01911429|3605269|B2||16-17 years old|Age, Customized||Participants|Count of Participants|49|49.0||||||
3772103|NCT01911429|3605270|B1||16-17 years old|Age, Customized||Participants|Count of Participants|60|60.0||||||
3772104|NCT01911429|3605267|B4||13-15 years old|Age, Customized||Participants|Count of Participants|160|160.0||||||
3772105|NCT01911429|3605268|B3||13-15 years old|Age, Customized||Participants|Count of Participants|55|55.0||||||
3772106|NCT01911429|3605269|B2||13-15 years old|Age, Customized||Participants|Count of Participants|55|55.0||||||
3772107|NCT01911429|3605270|B1||13-15 years old|Age, Customized||Participants|Count of Participants|50|50.0||||||
3772108|NCT01911429|3605267|B4|||Age||years|Mean|15.4|15.4|Standard Deviation|1.35|1.35|||
3772109|NCT01911429|3605268|B3|||Age||years|Mean|15.3|15.3|Standard Deviation|1.37|1.37|||
3772110|NCT01911429|3605269|B2|||Age||years|Mean|15.3|15.3|Standard Deviation|1.35|1.35|||
3772111|NCT01911429|3605270|B1|||Age||years|Mean|15.5|15.5|Standard Deviation|1.33|1.33|||
3772112|NCT01911429|3605267|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3772113|NCT01911429|3605268|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3772114|NCT01911429|3605269|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3772115|NCT01911429|3605270|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3772116|NCT01911429|3605267|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3772117|NCT01911429|3605268|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3772118|NCT01911429|3605269|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3772119|NCT01911429|3605270|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3772120|NCT01911429|3605267|B4||<=18 years|Age||Participants|Count of Participants|326|326.0||||||
3772121|NCT01911429|3605268|B3||<=18 years|Age||Participants|Count of Participants|112|112.0||||||
3772122|NCT01911429|3605269|B2||<=18 years|Age||Participants|Count of Participants|104|104.0||||||
3772123|NCT01911429|3605270|B1||<=18 years|Age||Participants|Count of Participants|110|110.0||||||
3772124|NCT01911403|3605304|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3772125|NCT01911403|3605305|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3772126|NCT01911403|3605306|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3772127|NCT01911403|3605304|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3772128|NCT01911403|3605305|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3772129|NCT01911403|3605306|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3772130|NCT01911403|3605304|B3|||Age||years|Mean|60.84|60.84|Standard Deviation|14.32|14.32|||
3772131|NCT01911403|3605305|B2|||Age||years|Mean|60.92|60.92|Standard Deviation|13.55|13.55|||
3772132|NCT01911403|3605306|B1|||Age||years|Mean|60.77|60.77|Standard Deviation|15.15|15.15|||
3772133|NCT01911390|3605324|B5|United States||Region of Enrollment||participants|Number|38|38.0||||||
3772134|NCT01911390|3605325|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
3772135|NCT01911390|3605326|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
3772136|NCT01911390|3605327|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3772137|NCT01911390|3605328|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3772138|NCT01911390|3605324|B5||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3772139|NCT01911390|3605325|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3772140|NCT01911390|3605326|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3772141|NCT01911390|3605327|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3772142|NCT01911390|3605328|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3772143|NCT01911390|3605324|B5||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3772144|NCT01911390|3605325|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3772145|NCT01911390|3605326|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3772146|NCT01911390|3605327|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3772147|NCT01911390|3605328|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3772148|NCT01911390|3605324|B5|||Age||years|Mean|10|10.0|Standard Deviation|1|1.0|||
3772149|NCT01911390|3605325|B4|||Age||years|Mean|10|10.0|Standard Deviation|1|1.0|||
3772150|NCT01911390|3605326|B3|||Age||years|Mean|10|10.0|Standard Deviation|1|1.0|||
3772151|NCT01911390|3605327|B2|||Age||years|Mean|10|10.0|Standard Deviation|1|1.0|||
3772152|NCT01911390|3605328|B1|||Age||years|Mean|10|10.0|Standard Deviation|1|1.0|||
3772153|NCT01911351|3605345|B3|United States||Region of Enrollment||participants|Number|82|82.0||||||
3772154|NCT01911351|3605346|B2|United States||Region of Enrollment||participants|Number|43|43.0||||||
3772155|NCT01911351|3605347|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
3772156|NCT01911351|3605345|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3772157|NCT01911351|3605346|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3772158|NCT01911351|3605347|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3772159|NCT01911351|3605345|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3772160|NCT01911351|3605346|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3772161|NCT01911351|3605347|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3772162|NCT01911351|3605345|B3|||Age||years|Median|5|5.0|Inter-Quartile Range|||4.0|8.0|
3772163|NCT01911351|3605346|B2|||Age||years|Median|6|6.0|Inter-Quartile Range|||4.0|9.0|
3772164|NCT01911351|3605347|B1|||Age||years|Median|5|5.0|Inter-Quartile Range|||4.0|8.0|
3772165|NCT01911351|3605345|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3772166|NCT01911351|3605346|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3772167|NCT01911351|3605347|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3772168|NCT01911351|3605345|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3772169|NCT01911351|3605346|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3772170|NCT01911351|3605347|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3772171|NCT01911351|3605345|B3||<=18 years|Age||Participants|Count of Participants|82|82.0||||||
3772172|NCT01911351|3605346|B2||<=18 years|Age||Participants|Count of Participants|43|43.0||||||
3772173|NCT01911351|3605347|B1||<=18 years|Age||Participants|Count of Participants|39|39.0||||||
3772174|NCT01911273|3605362|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3772175|NCT01911273|3605363|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3772176|NCT01911273|3605364|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3772177|NCT01911273|3605362|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3772178|NCT01911273|3605363|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3772179|NCT01911273|3605364|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3772180|NCT01911273|3605362|B3|45 to 64 Years||Age, Customized||Participants|Number|2|2.0||||||
3772181|NCT01911273|3605363|B2|45 to 64 Years||Age, Customized||Participants|Number|2|2.0||6.4|6.4|||
3772182|NCT01911273|3605364|B1|45 to 64 Years||Age, Customized||Participants|Number|0|0.0||NA||||
3772183|NCT01911273|3605362|B3|18 to 44 Years||Age, Customized||Participants|Number|1|1.0||||||
3772184|NCT01911273|3605363|B2|18 to 44 Years||Age, Customized||Participants|Number|0|0.0||NA||||
3772185|NCT01911273|3605364|B1|18 to 44 Years||Age, Customized||Participants|Number|1|1.0||0.0|0.0|||
3772186|NCT01911260|3605395|B5|Brazil||Region of Enrollment||participants|Number|199|199.0||||||
3772187|NCT01911260|3605396|B4|Brazil||Region of Enrollment||participants|Number|50|50.0||||||
3772188|NCT01911260|3605397|B3|Brazil||Region of Enrollment||participants|Number|49|49.0||||||
3772189|NCT01911260|3605398|B2|Brazil||Region of Enrollment||participants|Number|50|50.0||||||
3772190|NCT01911260|3605399|B1|Brazil||Region of Enrollment||participants|Number|50|50.0||||||
3772191|NCT01911260|3605395|B5||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3772192|NCT01911260|3605396|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3772193|NCT01911260|3605397|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3772194|NCT01911260|3605398|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3772195|NCT01911260|3605399|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3772196|NCT01911260|3605395|B5||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3772197|NCT01911260|3605396|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3772198|NCT01911260|3605397|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3772199|NCT01911260|3605398|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3772200|NCT01911260|3605399|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3772201|NCT01911260|3605395|B5|||Age||years|Mean|7.63|7.63|Standard Deviation|0.68|0.68|||
3772202|NCT01911260|3605396|B4|||Age||years|Mean|7.64|7.64|Standard Deviation|0.71|0.71|||
3772203|NCT01911260|3605397|B3|||Age||years|Mean|7.63|7.63|Standard Deviation|0.66|0.66|||
3772204|NCT01911260|3605398|B2|||Age||years|Mean|7.64|7.64|Standard Deviation|0.71|0.71|||
3772205|NCT01911260|3605399|B1|||Age||years|Mean|7.63|7.63|Standard Deviation|0.66|0.66|||
3772206|NCT01911260|3605395|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3772207|NCT01911260|3605396|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3772208|NCT01911260|3605397|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3772209|NCT01911260|3605398|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3772210|NCT01911260|3605399|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3772211|NCT01911260|3605395|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3772212|NCT01911260|3605396|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3772213|NCT01911260|3605397|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3772214|NCT01911260|3605398|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3772215|NCT01911260|3605399|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3772216|NCT01911260|3605395|B5||<=18 years|Age||Participants|Count of Participants|199|199.0||||||
3772217|NCT01911260|3605396|B4||<=18 years|Age||Participants|Count of Participants|50|50.0||||||
3772218|NCT01911260|3605397|B3||<=18 years|Age||Participants|Count of Participants|49|49.0||||||
3772219|NCT01911260|3605398|B2||<=18 years|Age||Participants|Count of Participants|50|50.0||||||
3772220|NCT01911260|3605399|B1||<=18 years|Age||Participants|Count of Participants|50|50.0||||||
3772221|NCT01911221|3605412|B1||MALE|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3772222|NCT01911221|3605412|B1||FEMALE|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3772223|NCT01911221|3605412|B1|||Age||year|Mean|38.5|38.5|Standard Deviation|12.2|12.2|||
3772224|NCT01911169|3605426|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772225|NCT01911169|3605427|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772226|NCT01911169|3605428|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772227|NCT01911169|3605426|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772228|NCT01911169|3605427|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772229|NCT01911169|3605428|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772230|NCT01911169|3605426|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3772231|NCT01911169|3605427|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772232|NCT01911169|3605428|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3772233|NCT01911169|3605426|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3772234|NCT01911169|3605427|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3772235|NCT01911169|3605428|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3772236|NCT01911169|3605426|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772237|NCT01911169|3605427|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772238|NCT01911169|3605428|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772239|NCT01911169|3605426|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772240|NCT01911169|3605427|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772241|NCT01911169|3605428|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772242|NCT01911169|3605426|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772243|NCT01911169|3605427|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772244|NCT01911169|3605428|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772245|NCT01911169|3605426|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3772246|NCT01911169|3605427|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3772247|NCT01911169|3605428|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3772248|NCT01911169|3605426|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3772249|NCT01911169|3605427|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3772250|NCT01911169|3605428|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3772251|NCT01911169|3605426|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3772252|NCT01911169|3605427|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3772253|NCT01911169|3605428|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3772254|NCT01911169|3605426|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3772255|NCT01911169|3605427|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3772256|NCT01911169|3605428|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3772257|NCT01911169|3605426|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3772258|NCT01911169|3605427|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3772259|NCT01911169|3605428|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3772260|NCT01911065|3605437|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
3772261|NCT01911065|3605438|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3772262|NCT01911065|3605439|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
3772263|NCT01911065|3605437|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3772264|NCT01911065|3605438|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772265|NCT01911065|3605439|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3772266|NCT01911065|3605437|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772267|NCT01911065|3605438|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772268|NCT01911065|3605439|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772269|NCT01911065|3605437|B3||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3772270|NCT01911065|3605438|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3772271|NCT01911065|3605439|B1||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3772272|NCT01911065|3605437|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772273|NCT01911065|3605438|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772274|NCT01911065|3605439|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772275|NCT01911065|3605437|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772276|NCT01911065|3605438|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772277|NCT01911065|3605439|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772278|NCT01911065|3605437|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3772279|NCT01911065|3605438|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3772280|NCT01911065|3605439|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772281|NCT01911065|3605437|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772282|NCT01911065|3605438|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772283|NCT01911065|3605439|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772284|NCT01911065|3605437|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3772285|NCT01911065|3605438|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772286|NCT01911065|3605439|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3772287|NCT01911065|3605437|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3772288|NCT01911065|3605438|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3772289|NCT01911065|3605439|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3772290|NCT01911065|3605437|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3772291|NCT01911065|3605438|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772292|NCT01911065|3605439|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3772293|NCT01911065|3605437|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3772294|NCT01911065|3605438|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3772295|NCT01911065|3605439|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3772296|NCT01911065|3605437|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3772297|NCT01911065|3605438|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3772298|NCT01911065|3605439|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3772299|NCT01911065|3605437|B3|Age|50 and above|Age, Customized||Participants|Count of Participants|45|45.0||||||
3772300|NCT01911065|3605438|B2|Age|50 and above|Age, Customized||Participants|Count of Participants|0|0.0||||||
3772301|NCT01911065|3605439|B1|Age|50 and above|Age, Customized||Participants|Count of Participants|45|45.0||||||
3772302|NCT01911065|3605437|B3|Age|40-49 Years Old|Age, Customized||Participants|Count of Participants|9|9.0||||||
3772303|NCT01911065|3605438|B2|Age|40-49 Years Old|Age, Customized||Participants|Count of Participants|9|9.0||||||
3772304|NCT01911065|3605439|B1|Age|40-49 Years Old|Age, Customized||Participants|Count of Participants|0|0.0||||||
3772305|NCT01910831|3605448|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3772306|NCT01910831|3605448|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3772307|NCT01910831|3605448|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772308|NCT01910831|3605448|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3772309|NCT01910831|3605448|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772310|NCT01910831|3605448|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772311|NCT01910831|3605448|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772312|NCT01910831|3605448|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772313|NCT01910831|3605448|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772314|NCT01910831|3605448|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3772315|NCT01910831|3605448|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3772316|NCT01910831|3605448|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3772317|NCT01910831|3605448|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3772318|NCT01910831|3605448|B1|||Age||years|Mean|73.60|73.6|Standard Deviation|5.73|5.73|||
3772319|NCT01910831|3605448|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3772320|NCT01910831|3605448|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3772321|NCT01910831|3605448|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3772322|NCT01910792|3605455|B3|||History of Gastric Bypass at least 3 months post-op with no continuing complications||Participants|Count of Participants|9|9.0||||||
3772323|NCT01910792|3605456|B2|||History of Gastric Bypass at least 3 months post-op with no continuing complications||Participants|Count of Participants|0|0.0||||||
3772324|NCT01910792|3605457|B1|||History of Gastric Bypass at least 3 months post-op with no continuing complications||Participants|Count of Participants|9|9.0||||||
3772325|NCT01910792|3605455|B3|||Established diagnosis of Fat Malabsorption Syndromes||Participants|Count of Participants|10|10.0||||||
3772326|NCT01910792|3605456|B2|||Established diagnosis of Fat Malabsorption Syndromes||Participants|Count of Participants|10|10.0||||||
3772327|NCT01910792|3605457|B1|||Established diagnosis of Fat Malabsorption Syndromes||Participants|Count of Participants|0|0.0||||||
3772328|NCT01910792|3605455|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
3772329|NCT01910792|3605456|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3772330|NCT01910792|3605457|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3772331|NCT01910792|3605455|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3772332|NCT01910792|3605455|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3772333|NCT01910792|3605456|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3772334|NCT01910792|3605457|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3772335|NCT01910792|3605455|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3772336|NCT01910792|3605456|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3772337|NCT01910792|3605457|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3772338|NCT01910792|3605455|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3772339|NCT01910792|3605456|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3772340|NCT01910792|3605457|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3772341|NCT01910792|3605455|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3772342|NCT01910792|3605456|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3772343|NCT01910792|3605457|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3772344|NCT01910792|3605455|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3772345|NCT01910792|3605456|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3772346|NCT01910792|3605457|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3772347|NCT01910688|3605464|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3772348|NCT01910688|3605464|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3772349|NCT01910688|3605464|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3772350|NCT01910688|3605464|B1|||Age||years|Mean|45.4|45.4|Standard Deviation|9.08|9.08|||
3772351|NCT01910636|3605471|B3|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|115|115.0||||||
3772352|NCT01910636|3605472|B2|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|51|51.0||||||
3772353|NCT01910636|3605473|B1|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|64|64.0||||||
3772354|NCT01910636|3605471|B3|< 800,000 IU/mL||HCV RNA Category||participants|Number|38|38.0||||||
3772355|NCT01910636|3605472|B2|< 800,000 IU/mL||HCV RNA Category||participants|Number|12|12.0||||||
3772356|NCT01910636|3605473|B1|< 800,000 IU/mL||HCV RNA Category||participants|Number|26|26.0||||||
3772357|NCT01910636|3605471|B3|||HCV RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.84|0.84|||
3772358|NCT01910636|3605472|B2|||HCV RNA||log10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.66|0.66|||
3772359|NCT01910636|3605473|B1|||HCV RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.92|0.92|||
3772360|NCT01910636|3605471|B3|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|4|4.0||||||
3772361|NCT01910636|3605472|B2|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|4|4.0||||||
3772362|NCT01910636|3605473|B1|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3772363|NCT01910636|3605471|B3|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|28|28.0||||||
3772364|NCT01910636|3605472|B2|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|11|11.0||||||
3772365|NCT01910636|3605473|B1|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|17|17.0||||||
3772366|NCT01910636|3605471|B3|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|121|121.0||||||
3772367|NCT01910636|3605472|B2|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|48|48.0||||||
3772368|NCT01910636|3605473|B1|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|73|73.0||||||
3772369|NCT01910636|3605471|B3|Yes||Cirrhosis Status||participants|Number|17|17.0||||||
3772370|NCT01910636|3605472|B2|Yes||Cirrhosis Status||participants|Number|9|9.0||||||
3772371|NCT01910636|3605473|B1|Yes||Cirrhosis Status||participants|Number|8|8.0||||||
3772372|NCT01910636|3605471|B3|No||Cirrhosis Status||participants|Number|136|136.0||||||
3772373|NCT01910636|3605472|B2|No||Cirrhosis Status||participants|Number|54|54.0||||||
3772374|NCT01910636|3605473|B1|No||Cirrhosis Status||participants|Number|82|82.0||||||
3772375|NCT01910636|3605471|B3||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3772376|NCT01910636|3605472|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3772377|NCT01910636|3605473|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3772378|NCT01910636|3605471|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3772379|NCT01910636|3605472|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3772380|NCT01910636|3605473|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3772381|NCT01910636|3605471|B3|||Age||years|Mean|57|57.0|Standard Deviation|10.1|10.1|||
3772382|NCT01910636|3605472|B2|||Age||years|Mean|60|60.0|Standard Deviation|8.8|8.8|||
3772383|NCT01910636|3605473|B1|||Age||years|Mean|55|55.0|Standard Deviation|10.6|10.6|||
3772384|NCT01910441|3605486|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3772385|NCT01910441|3605487|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3772386|NCT01910441|3605488|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3772387|NCT01910441|3605486|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3772388|NCT01910441|3605487|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3772389|NCT01910441|3605488|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3772390|NCT01910441|3605486|B3|||Age||Years|Mean|50.9|50.9|Standard Deviation|10.68|10.68|||
3772391|NCT01910441|3605487|B2|||Age||Years|Mean|52.1|52.1|Standard Deviation|9.29|9.29|||
3772392|NCT01910441|3605488|B1|||Age||Years|Mean|49.7|49.7|Standard Deviation|11.86|11.86|||
3772393|NCT01910402|3605495|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3772394|NCT01910402|3605496|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3772395|NCT01910402|3605497|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3772396|NCT01910402|3605495|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|216|216.0||||||
3772397|NCT01910402|3605496|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|104|104.0||||||
3772398|NCT01910402|3605497|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|112|112.0||||||
3772399|NCT01910402|3605495|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3772400|NCT01910402|3605496|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3772401|NCT01910402|3605497|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3772402|NCT01910402|3605495|B3|Native Hawaiian Or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3772403|NCT01910402|3605496|B2|Native Hawaiian Or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3772404|NCT01910402|3605497|B1|Native Hawaiian Or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3772405|NCT01910402|3605495|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|42|42.0||||||
3772406|NCT01910402|3605496|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
3772407|NCT01910402|3605497|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
3772408|NCT01910402|3605495|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3772409|NCT01910402|3605496|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3772410|NCT01910402|3605497|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3772411|NCT01910402|3605495|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3772412|NCT01910402|3605496|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3772413|NCT01910402|3605497|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3772414|NCT01910402|3605495|B3|American Indian Or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
3772415|NCT01910402|3605496|B2|American Indian Or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3772416|NCT01910402|3605497|B1|American Indian Or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3772417|NCT01910402|3605495|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|210|210.0||||||
3772418|NCT01910402|3605496|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|108|108.0||||||
3772419|NCT01910402|3605497|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|102|102.0||||||
3772420|NCT01910402|3605495|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3772421|NCT01910402|3605496|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3772422|NCT01910402|3605497|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3772423|NCT01910402|3605495|B3||Female|Sex: Female, Male||Participants|Count of Participants|495|495.0||||||
3772424|NCT01910402|3605496|B2||Female|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
3772425|NCT01910402|3605497|B1||Female|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
3772426|NCT01910402|3605495|B3|||Age||Years|Mean|37.9|37.9|Standard Deviation|10.65|10.65|||
3772427|NCT01910402|3605496|B2|||Age||Years|Mean|37.8|37.8|Standard Deviation|10.14|10.14|||
3772428|NCT01910402|3605497|B1|||Age||Years|Mean|38.1|38.1|Standard Deviation|11.15|11.15|||
3772429|NCT01910389|3605566|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3772430|NCT01910389|3605567|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772431|NCT01910389|3605568|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3772432|NCT01910389|3605566|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772433|NCT01910389|3605567|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772434|NCT01910389|3605568|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772435|NCT01910389|3605566|B3||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3772436|NCT01910389|3605567|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3772437|NCT01910389|3605568|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3772438|NCT01910389|3605566|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3772439|NCT01910389|3605567|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3772440|NCT01910389|3605568|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3772441|NCT01910389|3605566|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772442|NCT01910389|3605567|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772443|NCT01910389|3605568|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772444|NCT01910389|3605566|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3772445|NCT01910389|3605567|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772446|NCT01910389|3605568|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3772447|NCT01910389|3605566|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772448|NCT01910389|3605567|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772449|NCT01910389|3605568|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772450|NCT01910389|3605566|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772451|NCT01910389|3605567|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772452|NCT01910389|3605568|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772453|NCT01910389|3605566|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3772454|NCT01910389|3605567|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3772455|NCT01910389|3605568|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3772456|NCT01910389|3605566|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3772457|NCT01910389|3605567|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772458|NCT01910389|3605568|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3772459|NCT01910389|3605566|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3772460|NCT01910389|3605567|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3772461|NCT01910389|3605568|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3772462|NCT01910389|3605566|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3772463|NCT01910389|3605567|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3772464|NCT01910389|3605568|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3772465|NCT01910389|3605566|B3|||Age||years|Median|62.6|62.6|Inter-Quartile Range|||47.7|73.9|
3772466|NCT01910389|3605567|B2|||Age||years|Median|63.3|63.3|Inter-Quartile Range|||51.7|76.8|
3772467|NCT01910389|3605568|B1|||Age||years|Median|62.6|62.6|Inter-Quartile Range|||42.3|72.5|
3772468|NCT01910389|3605566|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3772469|NCT01910389|3605567|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3772470|NCT01910389|3605568|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3772471|NCT01910389|3605566|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3772472|NCT01910389|3605567|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3772473|NCT01910389|3605568|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3772474|NCT01910389|3605566|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3772475|NCT01910389|3605567|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3772476|NCT01910389|3605568|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3772477|NCT01910311|3605599|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3772478|NCT01910311|3605599|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772479|NCT01910311|3605599|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772480|NCT01910311|3605599|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3772481|NCT01910311|3605599|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3772482|NCT01910311|3605599|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772483|NCT01910311|3605599|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3772484|NCT01910311|3605599|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772485|NCT01910311|3605599|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772486|NCT01910311|3605599|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3772487|NCT01910311|3605599|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772488|NCT01910311|3605599|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3772489|NCT01910311|3605599|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3772490|NCT01910311|3605599|B1|||Age||years|Mean|40.9|40.9|Standard Deviation|15.4|15.4|||
3772491|NCT01910181|3605610|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3772492|NCT01910181|3605610|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3772493|NCT01910181|3605610|B1|||Age||years|Mean|42.3|42.3|Standard Deviation|13.6|13.6|||
3772494|NCT01910116|3605635|B3|no||Others|"Number of participants who were taking other OA medications for pain management at baseline.~Others .. medications for OA, not mentioned above."|participants|Number|211|211.0||||||
3772495|NCT01910116|3605636|B2|no||Others|"Number of participants who were taking other OA medications for pain management at baseline.~Others .. medications for OA, not mentioned above."|participants|Number|103|103.0||||||
3772496|NCT01910116|3605637|B1|no||Others|"Number of participants who were taking other OA medications for pain management at baseline.~Others .. medications for OA, not mentioned above."|participants|Number|108|108.0||||||
3772497|NCT01910116|3605635|B3|yes||Others|"Number of participants who were taking other OA medications for pain management at baseline.~Others .. medications for OA, not mentioned above."|participants|Number|4|4.0||||||
3772498|NCT01910116|3605636|B2|yes||Others|"Number of participants who were taking other OA medications for pain management at baseline.~Others .. medications for OA, not mentioned above."|participants|Number|3|3.0||||||
3772499|NCT01910116|3605637|B1|yes||Others|"Number of participants who were taking other OA medications for pain management at baseline.~Others .. medications for OA, not mentioned above."|participants|Number|1|1.0||||||
3772500|NCT01910116|3605635|B3|no||Diacerin|Number of participants who were taking Diacerin for pain management at baseline|participants|Number|207|207.0||||||
3772501|NCT01910116|3605636|B2|no||Diacerin|Number of participants who were taking Diacerin for pain management at baseline|participants|Number|103|103.0||||||
3772502|NCT01910116|3605637|B1|no||Diacerin|Number of participants who were taking Diacerin for pain management at baseline|participants|Number|104|104.0||||||
3772503|NCT01910116|3605635|B3|yes||Diacerin|Number of participants who were taking Diacerin for pain management at baseline|participants|Number|8|8.0||||||
3772504|NCT01910116|3605636|B2|yes||Diacerin|Number of participants who were taking Diacerin for pain management at baseline|participants|Number|3|3.0||||||
3772505|NCT01910116|3605637|B1|yes||Diacerin|Number of participants who were taking Diacerin for pain management at baseline|participants|Number|5|5.0||||||
3772506|NCT01910116|3605635|B3|no||Glucosamine|Number of participants who were taking glucosamine for pain management at baseline|participants|Number|188|188.0||||||
3772507|NCT01910116|3605636|B2|no||Glucosamine|Number of participants who were taking glucosamine for pain management at baseline|participants|Number|93|93.0||||||
3772508|NCT01910116|3605637|B1|no||Glucosamine|Number of participants who were taking glucosamine for pain management at baseline|participants|Number|95|95.0||||||
3772509|NCT01910116|3605635|B3|yes||Glucosamine|Number of participants who were taking glucosamine for pain management at baseline|participants|Number|27|27.0||||||
3772510|NCT01910116|3605636|B2|yes||Glucosamine|Number of participants who were taking glucosamine for pain management at baseline|participants|Number|13|13.0||||||
3772511|NCT01910116|3605637|B1|yes||Glucosamine|Number of participants who were taking glucosamine for pain management at baseline|participants|Number|14|14.0||||||
3772512|NCT01910116|3605635|B3|no||NSAIDs|Number of participants who were taking NSAIDs for pain management at baseline|participants|Number|143|143.0||||||
3772513|NCT01910116|3605636|B2|no||NSAIDs|Number of participants who were taking NSAIDs for pain management at baseline|participants|Number|70|70.0||||||
3772514|NCT01910116|3605637|B1|no||NSAIDs|Number of participants who were taking NSAIDs for pain management at baseline|participants|Number|73|73.0||||||
3772515|NCT01910116|3605635|B3|yes||NSAIDs|Number of participants who were taking NSAIDs for pain management at baseline|participants|Number|72|72.0||||||
3772516|NCT01910116|3605636|B2|yes||NSAIDs|Number of participants who were taking NSAIDs for pain management at baseline|participants|Number|36|36.0||||||
3772517|NCT01910116|3605637|B1|yes||NSAIDs|Number of participants who were taking NSAIDs for pain management at baseline|participants|Number|36|36.0||||||
3772518|NCT01910116|3605635|B3|no||Tramadol|Number of participants who were taking tramadol for pain management at baseline|participants|Number|196|196.0||||||
3772519|NCT01910116|3605636|B2|no||Tramadol|Number of participants who were taking tramadol for pain management at baseline|participants|Number|95|95.0||||||
3772520|NCT01910116|3605637|B1|no||Tramadol|Number of participants who were taking tramadol for pain management at baseline|participants|Number|101|101.0||||||
3772521|NCT01910116|3605635|B3|Yes||Tramadol|Number of participants who were taking tramadol for pain management at baseline|participants|Number|19|19.0||||||
3772522|NCT01910116|3605636|B2|Yes||Tramadol|Number of participants who were taking tramadol for pain management at baseline|participants|Number|11|11.0||||||
3772523|NCT01910116|3605637|B1|Yes||Tramadol|Number of participants who were taking tramadol for pain management at baseline|participants|Number|8|8.0||||||
3772524|NCT01910116|3605635|B3|no||Acetaminophen|Number of participants who were taking acetaminophen for pain management at baseline.|participants|Number|196|196.0||||||
3772525|NCT01910116|3605636|B2|no||Acetaminophen|Number of participants who were taking acetaminophen for pain management at baseline.|participants|Number|96|96.0||||||
3772526|NCT01910116|3605637|B1|no||Acetaminophen|Number of participants who were taking acetaminophen for pain management at baseline.|participants|Number|100|100.0||||||
3772527|NCT01910116|3605635|B3|yes||Acetaminophen|Number of participants who were taking acetaminophen for pain management at baseline.|participants|Number|19|19.0||||||
3772528|NCT01910116|3605636|B2|yes||Acetaminophen|Number of participants who were taking acetaminophen for pain management at baseline.|participants|Number|10|10.0||||||
3772529|NCT01910116|3605637|B1|yes||Acetaminophen|Number of participants who were taking acetaminophen for pain management at baseline.|participants|Number|9|9.0||||||
3772530|NCT01910116|3605635|B3|||C-reactive protein (CRP)|Higher CRP reflects higher systemic inflammation|mg/dL|Mean|0.10|0.1|Standard Deviation|0.20|0.2|||
3772531|NCT01910116|3605636|B2|||C-reactive protein (CRP)|Higher CRP reflects higher systemic inflammation|mg/dL|Mean|0.12|0.12|Standard Deviation|0.26|0.26|||
3772532|NCT01910116|3605637|B1|||C-reactive protein (CRP)|Higher CRP reflects higher systemic inflammation|mg/dL|Mean|0.09|0.09|Standard Deviation|0.11|0.11|||
3772533|NCT01910116|3605635|B3|||Erythrocyte sedimentation rate (ESR)|higher ESR reflects higher degree of systemic inflammation|mm/hr|Mean|13.8|13.8|Standard Deviation|12.5|12.5|||
3772534|NCT01910116|3605636|B2|||Erythrocyte sedimentation rate (ESR)|higher ESR reflects higher degree of systemic inflammation|mm/hr|Mean|13.3|13.3|Standard Deviation|10.0|10.0|||
3772535|NCT01910116|3605637|B1|||Erythrocyte sedimentation rate (ESR)|higher ESR reflects higher degree of systemic inflammation|mm/hr|Mean|14.2|14.2|Standard Deviation|14.6|14.6|||
3772536|NCT01910116|3605635|B3|||Physician global assessment (1–100)|Patient’s general condition rated by physician The Scale ranges from 0 (excellent condition) to 100 (the worst possible condition).|units on a scale|Mean|42.3|42.3|Standard Deviation|12.1|12.1|||
3772537|NCT01910116|3605636|B2|||Physician global assessment (1–100)|Patient’s general condition rated by physician The Scale ranges from 0 (excellent condition) to 100 (the worst possible condition).|units on a scale|Mean|41.5|41.5|Standard Deviation|13.0|13.0|||
3772538|NCT01910116|3605637|B1|||Physician global assessment (1–100)|Patient’s general condition rated by physician The Scale ranges from 0 (excellent condition) to 100 (the worst possible condition).|units on a scale|Mean|43.1|43.1|Standard Deviation|11.1|11.1|||
3772539|NCT01910116|3605635|B3|||Patient global assessment (1–100)|Patient’s general condition rated by patient. The Scale ranges from 0 (excellent condition) to 100 (the worst possible condition).|units on a scale|Mean|49.9|49.9|Standard Deviation|16.3|16.3|||
3772540|NCT01910116|3605636|B2|||Patient global assessment (1–100)|Patient’s general condition rated by patient. The Scale ranges from 0 (excellent condition) to 100 (the worst possible condition).|units on a scale|Mean|50.1|50.1|Standard Deviation|16.3|16.3|||
3772541|NCT01910116|3605637|B1|||Patient global assessment (1–100)|Patient’s general condition rated by patient. The Scale ranges from 0 (excellent condition) to 100 (the worst possible condition).|units on a scale|Mean|49.6|49.6|Standard Deviation|16.5|16.5|||
3772542|NCT01910116|3605635|B3|||Swollen joint count|Number of swollen joints on examination (i.e. number of inflammation joints)|Joint|Mean|0.8|0.8|Standard Deviation|2.1|2.1|||
3772543|NCT01910116|3605636|B2|||Swollen joint count|Number of swollen joints on examination (i.e. number of inflammation joints)|Joint|Mean|0.9|0.9|Standard Deviation|2.4|2.4|||
3772544|NCT01910116|3605637|B1|||Swollen joint count|Number of swollen joints on examination (i.e. number of inflammation joints)|Joint|Mean|0.6|0.6|Standard Deviation|1.8|1.8|||
3772545|NCT01910116|3605635|B3|||Tender joint count|Number of tender joints on examination|Joint|Mean|7.1|7.1|Standard Deviation|5.1|5.1|||
3772546|NCT01910116|3605636|B2|||Tender joint count|Number of tender joints on examination|Joint|Mean|6.5|6.5|Standard Deviation|5.2|5.2|||
3772547|NCT01910116|3605637|B1|||Tender joint count|Number of tender joints on examination|Joint|Mean|7.7|7.7|Standard Deviation|5.2|5.2|||
3772548|NCT01910116|3605635|B3|||AUSCAN function score (0-100)|Scale ranges from 0 (no functional limitation) to 100 (the worst possible functional limitation).|units on a scale|Mean|46.6|46.6|Standard Deviation|22.9|22.9|||
3772549|NCT01910116|3605636|B2|||AUSCAN function score (0-100)|Scale ranges from 0 (no functional limitation) to 100 (the worst possible functional limitation).|units on a scale|Mean|46.2|46.2|Standard Deviation|23.9|23.9|||
3772550|NCT01910116|3605637|B1|||AUSCAN function score (0-100)|Scale ranges from 0 (no functional limitation) to 100 (the worst possible functional limitation).|units on a scale|Mean|47.2|47.2|Standard Deviation|21.8|21.8|||
3772551|NCT01910116|3605635|B3|||AUSCAN stiffness score (0-100)|Scale ranges from 0 (no stiffness) to 100 (the worst possible stiffness).|units on a scale|Mean|57.8|57.8|Standard Deviation|23.4|23.4|||
3772552|NCT01910116|3605636|B2|||AUSCAN stiffness score (0-100)|Scale ranges from 0 (no stiffness) to 100 (the worst possible stiffness).|units on a scale|Mean|60.4|60.4|Standard Deviation|22.8|22.8|||
3772553|NCT01910116|3605637|B1|||AUSCAN stiffness score (0-100)|Scale ranges from 0 (no stiffness) to 100 (the worst possible stiffness).|units on a scale|Mean|55.2|55.2|Standard Deviation|23.8|23.8|||
3772554|NCT01910116|3605635|B3|||AUSCAN pain (0-100)|Scale ranges from 0 (no pain) to 100 (the worst possible pain).|units on a scale|Mean|48.9|48.9|Standard Deviation|18.3|18.3|||
3772555|NCT01910116|3605636|B2|||AUSCAN pain (0-100)|Scale ranges from 0 (no pain) to 100 (the worst possible pain).|units on a scale|Mean|48.2|48.2|Standard Deviation|19.9|19.9|||
3772556|NCT01910116|3605637|B1|||AUSCAN pain (0-100)|Scale ranges from 0 (no pain) to 100 (the worst possible pain).|units on a scale|Mean|49.7|49.7|Standard Deviation|16.7|16.7|||
3772557|NCT01910116|3605635|B3|No||Family history of OA||participants|Number|160|160.0||||||
3772558|NCT01910116|3605636|B2|No||Family history of OA||participants|Number|81|81.0||||||
3772559|NCT01910116|3605637|B1|No||Family history of OA||participants|Number|79|79.0||||||
3772560|NCT01910116|3605635|B3|Yes||Family history of OA||participants|Number|55|55.0||||||
3772561|NCT01910116|3605636|B2|Yes||Family history of OA||participants|Number|25|25.0||||||
3772562|NCT01910116|3605637|B1|Yes||Family history of OA||participants|Number|30|30.0||||||
3772563|NCT01910116|3605635|B3|||Duration of OA||months|Mean|30.1|30.1|Standard Deviation|46.9|46.9|||
3772564|NCT01910116|3605636|B2|||Duration of OA||months|Mean|31.7|31.7|Standard Deviation|47.2|47.2|||
3772565|NCT01910116|3605637|B1|||Duration of OA||months|Mean|28.6|28.6|Standard Deviation|46.8|46.8|||
3772566|NCT01910116|3605635|B3|||Body mass index||kg/m2|Mean|23.9|23.9|Standard Deviation|2.6|2.6|||
3772567|NCT01910116|3605636|B2|||Body mass index||kg/m2|Mean|23.9|23.9|Standard Deviation|2.8|2.8|||
3772568|NCT01910116|3605637|B1|||Body mass index||kg/m2|Mean|23.9|23.9|Standard Deviation|2.5|2.5|||
3772569|NCT01910116|3605635|B3|||Height||cm|Mean|156.8|156.8|Standard Deviation|6.3|6.3|||
3772570|NCT01910116|3605636|B2|||Height||cm|Mean|157.0|157.0|Standard Deviation|6.0|6.0|||
3772571|NCT01910116|3605637|B1|||Height||cm|Mean|156.7|156.7|Standard Deviation|6.7|6.7|||
3772572|NCT01910116|3605635|B3|||Weight||kg|Mean|58.9|58.9|Standard Deviation|7.7|7.7|||
3772573|NCT01910116|3605636|B2|||Weight||kg|Mean|59.0|59.0|Standard Deviation|8.1|8.1|||
3772574|NCT01910116|3605637|B1|||Weight||kg|Mean|58.9|58.9|Standard Deviation|7.4|7.4|||
3772575|NCT01910116|3605635|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3772576|NCT01910116|3605636|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3772577|NCT01910116|3605637|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3772578|NCT01910116|3605635|B3||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
3772579|NCT01910116|3605636|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3772580|NCT01910116|3605637|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3772581|NCT01910116|3605635|B3|||Age||years|Mean|60.1|60.1|Standard Deviation|7.6|7.6|||
3772582|NCT01910116|3605636|B2|||Age||years|Mean|59.4|59.4|Standard Deviation|8.0|8.0|||
3772583|NCT01910116|3605637|B1|||Age||years|Mean|60.7|60.7|Standard Deviation|7.2|7.2|||
3772584|NCT01910064|3605714|B1||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
3772585|NCT01910064|3605714|B1||Female|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
3772586|NCT01910064|3605714|B1|||Age||years|Mean|21.1|21.1|Standard Deviation|6.6|6.6|||
3772587|NCT01909804|3605723|B13|Relapse / Breakthrough||Prior HCV Treatment||participants|Number|230|230.0||||||
3772588|NCT01909804|3605724|B12|Relapse / Breakthrough||Prior HCV Treatment||participants|Number|20|20.0||||||
3772589|NCT01909804|3605725|B11|Relapse / Breakthrough||Prior HCV Treatment||participants|Number|20|20.0||||||
3772590|NCT01909804|3605726|B10|Relapse / Breakthrough||Prior HCV Treatment||participants|Number|16|16.0||||||
3772591|NCT01909804|3605727|B9|Relapse / Breakthrough||Prior HCV Treatment||participants|Number|21|21.0||||||
3772592|NCT01909804|3605728|B8|Relapse / Breakthrough||Prior HCV Treatment||participants|Number|23|23.0||||||
3772593|NCT01909804|3605729|B7|Relapse / Breakthrough||Prior HCV Treatment||participants|Number|16|16.0||||||
3772594|NCT01909804|3605730|B6|Relapse / Breakthrough||Prior HCV Treatment||participants|Number|16|16.0||||||
3772595|NCT01909804|3605731|B5|Relapse / Breakthrough||Prior HCV Treatment||participants|Number|20|20.0||||||
3772596|NCT01909804|3605732|B4|Relapse / Breakthrough||Prior HCV Treatment||participants|Number|21|21.0||||||
3772597|NCT01909804|3605733|B3|Relapse / Breakthrough||Prior HCV Treatment||participants|Number|20|20.0||||||
3772598|NCT01909804|3605734|B2|Relapse / Breakthrough||Prior HCV Treatment||participants|Number|18|18.0||||||
3772599|NCT01909804|3605735|B1|Relapse / Breakthrough||Prior HCV Treatment||participants|Number|19|19.0||||||
3772600|NCT01909804|3605723|B13|Non-responder||Prior HCV Treatment||participants|Number|91|91.0||||||
3772601|NCT01909804|3605724|B12|Non-responder||Prior HCV Treatment||participants|Number|8|8.0||||||
3772602|NCT01909804|3605725|B11|Non-responder||Prior HCV Treatment||participants|Number|7|7.0||||||
3772603|NCT01909804|3605726|B10|Non-responder||Prior HCV Treatment||participants|Number|13|13.0||||||
3772604|NCT01909804|3605727|B9|Non-responder||Prior HCV Treatment||participants|Number|6|6.0||||||
3772605|NCT01909804|3605728|B8|Non-responder||Prior HCV Treatment||participants|Number|3|3.0||||||
3772606|NCT01909804|3605729|B7|Non-responder||Prior HCV Treatment||participants|Number|10|10.0||||||
3772607|NCT01909804|3605730|B6|Non-responder||Prior HCV Treatment||participants|Number|9|9.0||||||
3772608|NCT01909804|3605731|B5|Non-responder||Prior HCV Treatment||participants|Number|6|6.0||||||
3772609|NCT01909804|3605732|B4|Non-responder||Prior HCV Treatment||participants|Number|5|5.0||||||
3772610|NCT01909804|3605733|B3|Non-responder||Prior HCV Treatment||participants|Number|7|7.0||||||
3772611|NCT01909804|3605734|B2|Non-responder||Prior HCV Treatment||participants|Number|10|10.0||||||
3772612|NCT01909804|3605735|B1|Non-responder||Prior HCV Treatment||participants|Number|7|7.0||||||
3772613|NCT01909804|3605723|B13|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|275|275.0||||||
3772614|NCT01909804|3605724|B12|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|25|25.0||||||
3772615|NCT01909804|3605725|B11|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|24|24.0||||||
3772616|NCT01909804|3605726|B10|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|29|29.0||||||
3772617|NCT01909804|3605727|B9|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|21|21.0||||||
3772618|NCT01909804|3605728|B8|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|24|24.0||||||
3772619|NCT01909804|3605729|B7|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|19|19.0||||||
3772620|NCT01909804|3605730|B6|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|18|18.0||||||
3772621|NCT01909804|3605731|B5|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|23|23.0||||||
3772622|NCT01909804|3605732|B4|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|24|24.0||||||
3772623|NCT01909804|3605733|B3|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|25|25.0||||||
3772624|NCT01909804|3605734|B2|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|22|22.0||||||
3772625|NCT01909804|3605735|B1|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|21|21.0||||||
3772626|NCT01909804|3605723|B13|< 800,000 IU/mL||HCV RNA Category||participants|Number|46|46.0||||||
3772627|NCT01909804|3605724|B12|< 800,000 IU/mL||HCV RNA Category||participants|Number|3|3.0||||||
3772628|NCT01909804|3605725|B11|< 800,000 IU/mL||HCV RNA Category||participants|Number|3|3.0||||||
3772629|NCT01909804|3605726|B10|< 800,000 IU/mL||HCV RNA Category||participants|Number|0|0.0||||||
3772630|NCT01909804|3605727|B9|< 800,000 IU/mL||HCV RNA Category||participants|Number|6|6.0||||||
3772631|NCT01909804|3605728|B8|< 800,000 IU/mL||HCV RNA Category||participants|Number|2|2.0||||||
3772632|NCT01909804|3605729|B7|< 800,000 IU/mL||HCV RNA Category||participants|Number|7|7.0||||||
3772633|NCT01909804|3605730|B6|< 800,000 IU/mL||HCV RNA Category||participants|Number|7|7.0||||||
3772634|NCT01909804|3605731|B5|< 800,000 IU/mL||HCV RNA Category||participants|Number|3|3.0||||||
3772635|NCT01909804|3605732|B4|< 800,000 IU/mL||HCV RNA Category||participants|Number|2|2.0||||||
3772636|NCT01909804|3605733|B3|< 800,000 IU/mL||HCV RNA Category||participants|Number|2|2.0||||||
3772637|NCT01909804|3605734|B2|< 800,000 IU/mL||HCV RNA Category||participants|Number|6|6.0||||||
3772638|NCT01909804|3605735|B1|< 800,000 IU/mL||HCV RNA Category||participants|Number|5|5.0||||||
3772639|NCT01909804|3605723|B13|||HCV RNA||log10 IU/mL|Mean|6.6|6.6|Standard Deviation|0.60|0.6|||
3772640|NCT01909804|3605724|B12|||HCV RNA||log10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.43|0.43|||
3772641|NCT01909804|3605725|B11|||HCV RNA||log10 IU/mL|Mean|6.4|6.4|Standard Deviation|0.53|0.53|||
3772642|NCT01909804|3605726|B10|||HCV RNA||log10 IU/mL|Mean|6.8|6.8|Standard Deviation|0.37|0.37|||
3772643|NCT01909804|3605727|B9|||HCV RNA||log10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.59|0.59|||
3772644|NCT01909804|3605728|B8|||HCV RNA||log10 IU/mL|Mean|6.7|6.7|Standard Deviation|0.51|0.51|||
3772645|NCT01909804|3605729|B7|||HCV RNA||log10 IU/mL|Mean|6.4|6.4|Standard Deviation|0.76|0.76|||
3772646|NCT01909804|3605730|B6|||HCV RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.68|0.68|||
3772647|NCT01909804|3605731|B5|||HCV RNA||log10 IU/mL|Mean|6.6|6.6|Standard Deviation|0.46|0.46|||
3772648|NCT01909804|3605732|B4|||HCV RNA||log10 IU/mL|Mean|6.7|6.7|Standard Deviation|0.53|0.53|||
3772649|NCT01909804|3605733|B3|||HCV RNA||log10 IU/mL|Mean|6.6|6.6|Standard Deviation|0.59|0.59|||
3772650|NCT01909804|3605734|B2|||HCV RNA||log10 IU/mL|Mean|6.6|6.6|Standard Deviation|0.70|0.7|||
3772651|NCT01909804|3605735|B1|||HCV RNA||log10 IU/mL|Mean|6.7|6.7|Standard Deviation|0.76|0.76|||
3772652|NCT01909804|3605723|B13|Missing||Cirrhosis Status||participants|Number|8|8.0||||||
3772653|NCT01909804|3605724|B12|Missing||Cirrhosis Status||participants|Number|0|0.0||||||
3772654|NCT01909804|3605725|B11|Missing||Cirrhosis Status||participants|Number|2|2.0||||||
3772655|NCT01909804|3605726|B10|Missing||Cirrhosis Status||participants|Number|0|0.0||||||
3772656|NCT01909804|3605727|B9|Missing||Cirrhosis Status||participants|Number|2|2.0||||||
3772657|NCT01909804|3605728|B8|Missing||Cirrhosis Status||participants|Number|0|0.0||||||
3772658|NCT01909804|3605729|B7|Missing||Cirrhosis Status||participants|Number|0|0.0||||||
3772659|NCT01909804|3605730|B6|Missing||Cirrhosis Status||participants|Number|0|0.0||||||
3772660|NCT01909804|3605731|B5|Missing||Cirrhosis Status||participants|Number|0|0.0||||||
3772661|NCT01909804|3605732|B4|Missing||Cirrhosis Status||participants|Number|2|2.0||||||
3772662|NCT01909804|3605733|B3|Missing||Cirrhosis Status||participants|Number|0|0.0||||||
3772663|NCT01909804|3605734|B2|Missing||Cirrhosis Status||participants|Number|1|1.0||||||
3772664|NCT01909804|3605735|B1|Missing||Cirrhosis Status||participants|Number|1|1.0||||||
3772665|NCT01909804|3605723|B13|Present||Cirrhosis Status||participants|Number|138|138.0||||||
3772666|NCT01909804|3605724|B12|Present||Cirrhosis Status||participants|Number|10|10.0||||||
3772667|NCT01909804|3605725|B11|Present||Cirrhosis Status||participants|Number|7|7.0||||||
3772668|NCT01909804|3605726|B10|Present||Cirrhosis Status||participants|Number|10|10.0||||||
3772669|NCT01909804|3605727|B9|Present||Cirrhosis Status||participants|Number|8|8.0||||||
3772670|NCT01909804|3605728|B8|Present||Cirrhosis Status||participants|Number|26|26.0||||||
3772671|NCT01909804|3605729|B7|Present||Cirrhosis Status||participants|Number|26|26.0||||||
3772672|NCT01909804|3605730|B6|Present||Cirrhosis Status||participants|Number|25|25.0||||||
3772673|NCT01909804|3605731|B5|Present||Cirrhosis Status||participants|Number|26|26.0||||||
3772674|NCT01909804|3605732|B4|Present||Cirrhosis Status||participants|Number|0|0.0||||||
3772675|NCT01909804|3605733|B3|Present||Cirrhosis Status||participants|Number|0|0.0||||||
3772676|NCT01909804|3605734|B2|Present||Cirrhosis Status||participants|Number|0|0.0||||||
3772677|NCT01909804|3605735|B1|Present||Cirrhosis Status||participants|Number|0|0.0||||||
3772678|NCT01909804|3605723|B13|Absent||Cirrhosis Status||participants|Number|175|175.0||||||
3772679|NCT01909804|3605724|B12|Absent||Cirrhosis Status||participants|Number|18|18.0||||||
3772680|NCT01909804|3605725|B11|Absent||Cirrhosis Status||participants|Number|18|18.0||||||
3772681|NCT01909804|3605726|B10|Absent||Cirrhosis Status||participants|Number|19|19.0||||||
3772682|NCT01909804|3605727|B9|Absent||Cirrhosis Status||participants|Number|17|17.0||||||
3772683|NCT01909804|3605728|B8|Absent||Cirrhosis Status||participants|Number|0|0.0||||||
3772684|NCT01909804|3605729|B7|Absent||Cirrhosis Status||participants|Number|0|0.0||||||
3772685|NCT01909804|3605730|B6|Absent||Cirrhosis Status||participants|Number|0|0.0||||||
3772686|NCT01909804|3605731|B5|Absent||Cirrhosis Status||participants|Number|0|0.0||||||
3772687|NCT01909804|3605732|B4|Absent||Cirrhosis Status||participants|Number|24|24.0||||||
3772688|NCT01909804|3605733|B3|Absent||Cirrhosis Status||participants|Number|27|27.0||||||
3772689|NCT01909804|3605734|B2|Absent||Cirrhosis Status||participants|Number|27|27.0||||||
3772690|NCT01909804|3605735|B1|Absent||Cirrhosis Status||participants|Number|25|25.0||||||
3772691|NCT01909804|3605723|B13|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|59|59.0||||||
3772692|NCT01909804|3605724|B12|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|6|6.0||||||
3772693|NCT01909804|3605725|B11|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|8|8.0||||||
3772694|NCT01909804|3605726|B10|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|7|7.0||||||
3772695|NCT01909804|3605727|B9|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|8|8.0||||||
3772696|NCT01909804|3605728|B8|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
3772697|NCT01909804|3605729|B7|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
3772698|NCT01909804|3605730|B6|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|6|6.0||||||
3772699|NCT01909804|3605731|B5|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
3772700|NCT01909804|3605732|B4|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
3772701|NCT01909804|3605733|B3|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|6|6.0||||||
3772702|NCT01909804|3605734|B2|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|4|4.0||||||
3772703|NCT01909804|3605735|B1|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|2|2.0||||||
3772704|NCT01909804|3605723|B13|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|177|177.0||||||
3772705|NCT01909804|3605724|B12|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|19|19.0||||||
3772706|NCT01909804|3605725|B11|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|17|17.0||||||
3772707|NCT01909804|3605726|B10|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|21|21.0||||||
3772708|NCT01909804|3605727|B9|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|19|19.0||||||
3772709|NCT01909804|3605728|B8|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|10|10.0||||||
3772710|NCT01909804|3605729|B7|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|11|11.0||||||
3772711|NCT01909804|3605730|B6|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|14|14.0||||||
3772712|NCT01909804|3605731|B5|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|11|11.0||||||
3772713|NCT01909804|3605732|B4|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|12|12.0||||||
3772714|NCT01909804|3605733|B3|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|13|13.0||||||
3772715|NCT01909804|3605734|B2|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|14|14.0||||||
3772716|NCT01909804|3605735|B1|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|16|16.0||||||
3772717|NCT01909804|3605723|B13|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|85|85.0||||||
3772718|NCT01909804|3605724|B12|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
3772719|NCT01909804|3605725|B11|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|2|2.0||||||
3772720|NCT01909804|3605726|B10|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3772721|NCT01909804|3605727|B9|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3772722|NCT01909804|3605728|B8|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|13|13.0||||||
3772723|NCT01909804|3605729|B7|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|12|12.0||||||
3772724|NCT01909804|3605730|B6|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|5|5.0||||||
3772725|NCT01909804|3605731|B5|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|12|12.0||||||
3772726|NCT01909804|3605732|B4|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|11|11.0||||||
3772727|NCT01909804|3605733|B3|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|8|8.0||||||
3772728|NCT01909804|3605734|B2|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|10|10.0||||||
3772729|NCT01909804|3605735|B1|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|8|8.0||||||
3772730|NCT01909804|3605723|B13|Genotype 3||HCV Genotype||participants|Number|210|210.0||||||
3772731|NCT01909804|3605724|B12|Genotype 3||HCV Genotype||participants|Number|0|0.0||||||
3772732|NCT01909804|3605725|B11|Genotype 3||HCV Genotype||participants|Number|0|0.0||||||
3772733|NCT01909804|3605726|B10|Genotype 3||HCV Genotype||participants|Number|0|0.0||||||
3772734|NCT01909804|3605727|B9|Genotype 3||HCV Genotype||participants|Number|0|0.0||||||
3772735|NCT01909804|3605728|B8|Genotype 3||HCV Genotype||participants|Number|26|26.0||||||
3772736|NCT01909804|3605729|B7|Genotype 3||HCV Genotype||participants|Number|26|26.0||||||
3772737|NCT01909804|3605730|B6|Genotype 3||HCV Genotype||participants|Number|25|25.0||||||
3772738|NCT01909804|3605731|B5|Genotype 3||HCV Genotype||participants|Number|26|26.0||||||
3772739|NCT01909804|3605732|B4|Genotype 3||HCV Genotype||participants|Number|26|26.0||||||
3772740|NCT01909804|3605733|B3|Genotype 3||HCV Genotype||participants|Number|27|27.0||||||
3772741|NCT01909804|3605734|B2|Genotype 3||HCV Genotype||participants|Number|28|28.0||||||
3772742|NCT01909804|3605735|B1|Genotype 3||HCV Genotype||participants|Number|26|26.0||||||
3772743|NCT01909804|3605723|B13|Genotype 1 (no confirmed subtype)||HCV Genotype||participants|Number|1|1.0||||||
3772744|NCT01909804|3605724|B12|Genotype 1 (no confirmed subtype)||HCV Genotype||participants|Number|0|0.0||||||
3772745|NCT01909804|3605725|B11|Genotype 1 (no confirmed subtype)||HCV Genotype||participants|Number|0|0.0||||||
3772746|NCT01909804|3605726|B10|Genotype 1 (no confirmed subtype)||HCV Genotype||participants|Number|0|0.0||||||
3772747|NCT01909804|3605727|B9|Genotype 1 (no confirmed subtype)||HCV Genotype||participants|Number|1|1.0||||||
3772748|NCT01909804|3605728|B8|Genotype 1 (no confirmed subtype)||HCV Genotype||participants|Number|0|0.0||||||
3772749|NCT01909804|3605729|B7|Genotype 1 (no confirmed subtype)||HCV Genotype||participants|Number|0|0.0||||||
3772750|NCT01909804|3605730|B6|Genotype 1 (no confirmed subtype)||HCV Genotype||participants|Number|0|0.0||||||
3772751|NCT01909804|3605731|B5|Genotype 1 (no confirmed subtype)||HCV Genotype||participants|Number|0|0.0||||||
3772752|NCT01909804|3605732|B4|Genotype 1 (no confirmed subtype)||HCV Genotype||participants|Number|0|0.0||||||
3772753|NCT01909804|3605733|B3|Genotype 1 (no confirmed subtype)||HCV Genotype||participants|Number|0|0.0||||||
3772754|NCT01909804|3605734|B2|Genotype 1 (no confirmed subtype)||HCV Genotype||participants|Number|0|0.0||||||
3772755|NCT01909804|3605735|B1|Genotype 1 (no confirmed subtype)||HCV Genotype||participants|Number|0|0.0||||||
3772756|NCT01909804|3605723|B13|Genotype 1b||HCV Genotype||participants|Number|26|26.0||||||
3772757|NCT01909804|3605724|B12|Genotype 1b||HCV Genotype||participants|Number|6|6.0||||||
3772758|NCT01909804|3605725|B11|Genotype 1b||HCV Genotype||participants|Number|6|6.0||||||
3772759|NCT01909804|3605726|B10|Genotype 1b||HCV Genotype||participants|Number|7|7.0||||||
3772760|NCT01909804|3605727|B9|Genotype 1b||HCV Genotype||participants|Number|7|7.0||||||
3772761|NCT01909804|3605728|B8|Genotype 1b||HCV Genotype||participants|Number|0|0.0||||||
3772762|NCT01909804|3605729|B7|Genotype 1b||HCV Genotype||participants|Number|0|0.0||||||
3772763|NCT01909804|3605730|B6|Genotype 1b||HCV Genotype||participants|Number|0|0.0||||||
3772764|NCT01909804|3605731|B5|Genotype 1b||HCV Genotype||participants|Number|0|0.0||||||
3772765|NCT01909804|3605732|B4|Genotype 1b||HCV Genotype||participants|Number|0|0.0||||||
3772766|NCT01909804|3605733|B3|Genotype 1b||HCV Genotype||participants|Number|0|0.0||||||
3772767|NCT01909804|3605734|B2|Genotype 1b||HCV Genotype||participants|Number|0|0.0||||||
3772768|NCT01909804|3605735|B1|Genotype 1b||HCV Genotype||participants|Number|0|0.0||||||
3772769|NCT01909804|3605723|B13|Genotype 1a||HCV Genotype||participants|Number|84|84.0||||||
3772770|NCT01909804|3605724|B12|Genotype 1a||HCV Genotype||participants|Number|22|22.0||||||
3772771|NCT01909804|3605725|B11|Genotype 1a||HCV Genotype||participants|Number|21|21.0||||||
3772772|NCT01909804|3605726|B10|Genotype 1a||HCV Genotype||participants|Number|22|22.0||||||
3772773|NCT01909804|3605727|B9|Genotype 1a||HCV Genotype||participants|Number|19|19.0||||||
3772774|NCT01909804|3605728|B8|Genotype 1a||HCV Genotype||participants|Number|0|0.0||||||
3772775|NCT01909804|3605729|B7|Genotype 1a||HCV Genotype||participants|Number|0|0.0||||||
3772776|NCT01909804|3605730|B6|Genotype 1a||HCV Genotype||participants|Number|0|0.0||||||
3772777|NCT01909804|3605731|B5|Genotype 1a||HCV Genotype||participants|Number|0|0.0||||||
3772778|NCT01909804|3605732|B4|Genotype 1a||HCV Genotype||participants|Number|0|0.0||||||
3772779|NCT01909804|3605733|B3|Genotype 1a||HCV Genotype||participants|Number|0|0.0||||||
3772780|NCT01909804|3605734|B2|Genotype 1a||HCV Genotype||participants|Number|0|0.0||||||
3772781|NCT01909804|3605735|B1|Genotype 1a||HCV Genotype||participants|Number|0|0.0||||||
3772782|NCT01909804|3605723|B13|White||Race/Ethnicity, Customized||participants|Number|288|288.0||||||
3772783|NCT01909804|3605724|B12|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3772784|NCT01909804|3605725|B11|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3772785|NCT01909804|3605726|B10|White||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
3772786|NCT01909804|3605727|B9|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3772787|NCT01909804|3605728|B8|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3772788|NCT01909804|3605729|B7|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3772789|NCT01909804|3605730|B6|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3772790|NCT01909804|3605731|B5|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3772791|NCT01909804|3605732|B4|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3772792|NCT01909804|3605733|B3|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3772793|NCT01909804|3605734|B2|White||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3772794|NCT01909804|3605735|B1|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3772795|NCT01909804|3605723|B13|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3772796|NCT01909804|3605724|B12|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3772797|NCT01909804|3605725|B11|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3772798|NCT01909804|3605726|B10|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3772799|NCT01909804|3605727|B9|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3772800|NCT01909804|3605728|B8|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3772801|NCT01909804|3605729|B7|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3772802|NCT01909804|3605730|B6|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3772803|NCT01909804|3605731|B5|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3772804|NCT01909804|3605732|B4|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3772805|NCT01909804|3605733|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3772806|NCT01909804|3605734|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3772807|NCT01909804|3605735|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3772808|NCT01909804|3605723|B13|Black or African American||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3772809|NCT01909804|3605724|B12|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3772810|NCT01909804|3605725|B11|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3772811|NCT01909804|3605726|B10|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3772812|NCT01909804|3605727|B9|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3772813|NCT01909804|3605728|B8|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3772814|NCT01909804|3605729|B7|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3772815|NCT01909804|3605730|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3772816|NCT01909804|3605731|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3772817|NCT01909804|3605732|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3772818|NCT01909804|3605733|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3772819|NCT01909804|3605734|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3772820|NCT01909804|3605735|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3772821|NCT01909804|3605723|B13|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3772822|NCT01909804|3605724|B12|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3772823|NCT01909804|3605725|B11|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3772824|NCT01909804|3605726|B10|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3772825|NCT01909804|3605727|B9|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3772826|NCT01909804|3605728|B8|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3772827|NCT01909804|3605729|B7|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3772828|NCT01909804|3605730|B6|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3772829|NCT01909804|3605731|B5|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3772830|NCT01909804|3605732|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3772831|NCT01909804|3605733|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3772832|NCT01909804|3605734|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3772833|NCT01909804|3605735|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3772834|NCT01909804|3605723|B13|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3772835|NCT01909804|3605724|B12|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3772836|NCT01909804|3605725|B11|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3772837|NCT01909804|3605726|B10|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3772838|NCT01909804|3605727|B9|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3772839|NCT01909804|3605728|B8|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3772840|NCT01909804|3605729|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3772841|NCT01909804|3605730|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3772842|NCT01909804|3605731|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3772843|NCT01909804|3605732|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3772844|NCT01909804|3605733|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3772845|NCT01909804|3605734|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3772846|NCT01909804|3605735|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3772847|NCT01909804|3605723|B13||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772848|NCT01909804|3605724|B12||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772849|NCT01909804|3605725|B11||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772850|NCT01909804|3605726|B10||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772851|NCT01909804|3605727|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772852|NCT01909804|3605728|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772853|NCT01909804|3605729|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772854|NCT01909804|3605730|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772855|NCT01909804|3605731|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772856|NCT01909804|3605732|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772857|NCT01909804|3605733|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772858|NCT01909804|3605734|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772859|NCT01909804|3605735|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772860|NCT01909804|3605723|B13||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|301|301.0||||||
3772861|NCT01909804|3605724|B12||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3772862|NCT01909804|3605725|B11||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3772863|NCT01909804|3605726|B10||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3772864|NCT01909804|3605727|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3772865|NCT01909804|3605728|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3772866|NCT01909804|3605729|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3772867|NCT01909804|3605730|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3772868|NCT01909804|3605731|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3772869|NCT01909804|3605732|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3772870|NCT01909804|3605733|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3772871|NCT01909804|3605734|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3772872|NCT01909804|3605735|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3772873|NCT01909804|3605723|B13||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3772874|NCT01909804|3605724|B12||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3772875|NCT01909804|3605725|B11||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3772876|NCT01909804|3605726|B10||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3772877|NCT01909804|3605727|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3772878|NCT01909804|3605728|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772879|NCT01909804|3605729|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3772880|NCT01909804|3605730|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3772881|NCT01909804|3605731|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3772882|NCT01909804|3605732|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3772883|NCT01909804|3605733|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3772884|NCT01909804|3605734|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3772885|NCT01909804|3605735|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3772886|NCT01909804|3605723|B13||Male|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
3772887|NCT01909804|3605724|B12||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3772888|NCT01909804|3605725|B11||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3772889|NCT01909804|3605726|B10||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3772890|NCT01909804|3605727|B9||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3772891|NCT01909804|3605728|B8||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3772892|NCT01909804|3605729|B7||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3772893|NCT01909804|3605730|B6||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3772894|NCT01909804|3605731|B5||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3772895|NCT01909804|3605732|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3772896|NCT01909804|3605733|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3772897|NCT01909804|3605734|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3772898|NCT01909804|3605735|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3772899|NCT01909804|3605723|B13||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3772900|NCT01909804|3605724|B12||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3772901|NCT01909804|3605725|B11||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3772902|NCT01909804|3605726|B10||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3772903|NCT01909804|3605727|B9||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3772904|NCT01909804|3605728|B8||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3772905|NCT01909804|3605729|B7||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3772906|NCT01909804|3605730|B6||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3772907|NCT01909804|3605731|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3772908|NCT01909804|3605732|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3772909|NCT01909804|3605733|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3772910|NCT01909804|3605734|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3772911|NCT01909804|3605735|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3772912|NCT01909804|3605723|B13|||Age||years|Mean|55|55.0|Standard Deviation|7.4|7.4|||
3772913|NCT01909804|3605724|B12|||Age||years|Mean|56|56.0|Standard Deviation|6.0|6.0|||
3772914|NCT01909804|3605725|B11|||Age||years|Mean|57|57.0|Standard Deviation|6.4|6.4|||
3772915|NCT01909804|3605726|B10|||Age||years|Mean|57|57.0|Standard Deviation|5.8|5.8|||
3772916|NCT01909804|3605727|B9|||Age||years|Mean|55|55.0|Standard Deviation|8.1|8.1|||
3772917|NCT01909804|3605728|B8|||Age||years|Mean|54|54.0|Standard Deviation|4.7|4.7|||
3772918|NCT01909804|3605729|B7|||Age||years|Mean|56|56.0|Standard Deviation|5.7|5.7|||
3772919|NCT01909804|3605730|B6|||Age||years|Mean|56|56.0|Standard Deviation|5.6|5.6|||
3772920|NCT01909804|3605731|B5|||Age||years|Mean|57|57.0|Standard Deviation|7.0|7.0|||
3772921|NCT01909804|3605732|B4|||Age||years|Mean|56|56.0|Standard Deviation|6.4|6.4|||
3772922|NCT01909804|3605733|B3|||Age||years|Mean|55|55.0|Standard Deviation|6.9|6.9|||
3772923|NCT01909804|3605734|B2|||Age||years|Mean|51|51.0|Standard Deviation|10.4|10.4|||
3772924|NCT01909804|3605735|B1|||Age||years|Mean|54|54.0|Standard Deviation|11.8|11.8|||
3772925|NCT01909778|3605792|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3772926|NCT01909778|3605792|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3772927|NCT01909778|3605792|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3772928|NCT01909778|3605792|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3772929|NCT01909778|3605792|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3772930|NCT01909713|3605816|B1|Mildly Oily||Oiliness Evaluation Score||participants|Number|7|7.0||||||
3772931|NCT01909713|3605816|B1|Not Oily||Oiliness Evaluation Score||participants|Number|28|28.0||||||
3772932|NCT01909713|3605816|B1|MIld||Global Severity of Acne||participants|Number|7|7.0||||||
3772933|NCT01909713|3605816|B1|Almost Clear||Global Severity of Acne||participants|Number|27|27.0||||||
3772934|NCT01909713|3605816|B1|Clear||Global Severity of Acne||participants|Number|1|1.0||||||
3772935|NCT01909713|3605816|B1|VI||Fitzpatrick Skin Type|Fitzpatrick Skin Type Classification I Always burns; never tans II Burns easily; tans minimally III Burns moderately; tans gradually to light brown IV Burns minimally; tans well to moderate brown V Rarely burns; tans profusely to dark brown VI Never burns; tans profusely to black|participants|Number|8|8.0||||||
3772936|NCT01909713|3605816|B1|V||Fitzpatrick Skin Type|Fitzpatrick Skin Type Classification I Always burns; never tans II Burns easily; tans minimally III Burns moderately; tans gradually to light brown IV Burns minimally; tans well to moderate brown V Rarely burns; tans profusely to dark brown VI Never burns; tans profusely to black|participants|Number|12|12.0||||||
3772937|NCT01909713|3605816|B1|IV||Fitzpatrick Skin Type|Fitzpatrick Skin Type Classification I Always burns; never tans II Burns easily; tans minimally III Burns moderately; tans gradually to light brown IV Burns minimally; tans well to moderate brown V Rarely burns; tans profusely to dark brown VI Never burns; tans profusely to black|participants|Number|3|3.0||||||
3772938|NCT01909713|3605816|B1|III||Fitzpatrick Skin Type|Fitzpatrick Skin Type Classification I Always burns; never tans II Burns easily; tans minimally III Burns moderately; tans gradually to light brown IV Burns minimally; tans well to moderate brown V Rarely burns; tans profusely to dark brown VI Never burns; tans profusely to black|participants|Number|5|5.0||||||
3772939|NCT01909713|3605816|B1|II||Fitzpatrick Skin Type|Fitzpatrick Skin Type Classification I Always burns; never tans II Burns easily; tans minimally III Burns moderately; tans gradually to light brown IV Burns minimally; tans well to moderate brown V Rarely burns; tans profusely to dark brown VI Never burns; tans profusely to black|participants|Number|7|7.0||||||
3772940|NCT01909713|3605816|B1|||Normal Skin Type||participants|Number|35|35.0||||||
3772941|NCT01909713|3605816|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772942|NCT01909713|3605816|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3772943|NCT01909713|3605816|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3772944|NCT01909713|3605816|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772945|NCT01909713|3605816|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3772946|NCT01909713|3605816|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3772947|NCT01909713|3605816|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3772948|NCT01909713|3605816|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772949|NCT01909713|3605816|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3772950|NCT01909713|3605816|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772951|NCT01909713|3605816|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3772952|NCT01909713|3605816|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3772953|NCT01909713|3605816|B1|||Age, Customized||years|Median|9.0|9.0|Full Range|||7.0|11.0|
3772954|NCT01909713|3605816|B1|||Age||years|Mean|9.0|9.0|Standard Deviation|1.5|1.5|||
3772955|NCT01909674|3605869|B3|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3772956|NCT01909674|3605870|B2|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3772957|NCT01909674|3605871|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3772958|NCT01909674|3605869|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3772959|NCT01909674|3605869|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3772960|NCT01909674|3605870|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3772961|NCT01909674|3605871|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3772962|NCT01909674|3605869|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3772963|NCT01909674|3605870|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3772964|NCT01909674|3605871|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3772965|NCT01909674|3605869|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3772966|NCT01909674|3605870|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3772967|NCT01909674|3605871|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3772968|NCT01909674|3605869|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3772969|NCT01909674|3605870|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3772970|NCT01909674|3605871|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3772971|NCT01909674|3605869|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3772972|NCT01909674|3605870|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3772973|NCT01909674|3605871|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3772974|NCT01909570|3605878|B3|Spain||Region of Enrollment||participants|Number|175|175.0||||||
3772975|NCT01909570|3605879|B2|Spain||Region of Enrollment||participants|Number|91|91.0||||||
3772976|NCT01909570|3605880|B1|Spain||Region of Enrollment||participants|Number|84|84.0||||||
3772977|NCT01909570|3605878|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772978|NCT01909570|3605879|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772979|NCT01909570|3605880|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772980|NCT01909570|3605878|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772981|NCT01909570|3605879|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772982|NCT01909570|3605880|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772983|NCT01909570|3605878|B3||White|Race (NIH/OMB)||Participants|Count of Participants|175|175.0||||||
3772984|NCT01909570|3605879|B2||White|Race (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3772985|NCT01909570|3605880|B1||White|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3772986|NCT01909570|3605878|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772987|NCT01909570|3605879|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772988|NCT01909570|3605880|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772989|NCT01909570|3605878|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772990|NCT01909570|3605879|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772991|NCT01909570|3605880|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772992|NCT01909570|3605878|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772993|NCT01909570|3605879|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772994|NCT01909570|3605880|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772995|NCT01909570|3605878|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772996|NCT01909570|3605879|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772997|NCT01909570|3605880|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3772998|NCT01909570|3605878|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3772999|NCT01909570|3605879|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3773000|NCT01909570|3605880|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3773001|NCT01909570|3605878|B3||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
3773002|NCT01909570|3605879|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3773003|NCT01909570|3605880|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3773004|NCT01909570|3605878|B3|||Age||years|Mean|32.0|32.0|Standard Deviation|3.7|3.7|||
3773005|NCT01909570|3605879|B2|||Age||years|Mean|31.7|31.7|Standard Deviation|3.8|3.8|||
3773006|NCT01909570|3605880|B1|||Age||years|Mean|32.2|32.2|Standard Deviation|3.6|3.6|||
3773007|NCT01909466|3605891|B1||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3773008|NCT01909466|3605891|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3773009|NCT01909466|3605891|B1|||Age||Years|Mean|43.9|43.9|Standard Deviation|10.2|10.2|||
3773010|NCT01909336|3605912|B4|||Hypernatremic, n|defined as serum sodium > 145 mmol/L.|participants|Number|2|2.0||||||
3773011|NCT01909336|3605913|B3|||Hypernatremic, n|defined as serum sodium > 145 mmol/L.|participants|Number|2|2.0||||||
3773012|NCT01909336|3605914|B2|||Hypernatremic, n|defined as serum sodium > 145 mmol/L.|participants|Number|0|0.0||||||
3773013|NCT01909336|3605915|B1|||Hypernatremic, n|defined as serum sodium > 145 mmol/L.|participants|Number|0|0.0||||||
3773014|NCT01909336|3605912|B4|||Hyponatraemia, n|defined as serum sodium < 135 mmol/L.|participants|Number|51|51.0||||||
3773015|NCT01909336|3605913|B3|||Hyponatraemia, n|defined as serum sodium < 135 mmol/L.|participants|Number|16|16.0||||||
3773016|NCT01909336|3605914|B2|||Hyponatraemia, n|defined as serum sodium < 135 mmol/L.|participants|Number|16|16.0||||||
3773017|NCT01909336|3605915|B1|||Hyponatraemia, n|defined as serum sodium < 135 mmol/L.|participants|Number|19|19.0||||||
3773018|NCT01909336|3605912|B4|||Normonatremic, n|defined as serum sodium 135-145 mmol/L|participants|Number|98|98.0||||||
3773019|NCT01909336|3605913|B3|||Normonatremic, n|defined as serum sodium 135-145 mmol/L|participants|Number|34|34.0||||||
3773020|NCT01909336|3605914|B2|||Normonatremic, n|defined as serum sodium 135-145 mmol/L|participants|Number|34|34.0||||||
3773021|NCT01909336|3605915|B1|||Normonatremic, n|defined as serum sodium 135-145 mmol/L|participants|Number|30|30.0||||||
3773022|NCT01909336|3605912|B4|||Serum osmolarity, mOsm/L||mOsm/L|Mean|279|279.0|Standard Deviation|8.6|8.6|||
3773023|NCT01909336|3605913|B3|||Serum osmolarity, mOsm/L||mOsm/L|Mean|281.4|281.4|Standard Deviation|9.5|9.5|||
3773024|NCT01909336|3605914|B2|||Serum osmolarity, mOsm/L||mOsm/L|Mean|278|278.0|Standard Deviation|16.2|16.2|||
3773025|NCT01909336|3605915|B1|||Serum osmolarity, mOsm/L||mOsm/L|Mean|277.4|277.4|Standard Deviation|10.6|10.6|||
3773026|NCT01909336|3605912|B4|||Serum sodium, mmol/L||mmol/L|Mean|135.5|135.5|Standard Deviation|3|3.0|||
3773027|NCT01909336|3605913|B3|||Serum sodium, mmol/L||mmol/L|Mean|135.8|135.8|Standard Deviation|3.2|3.2|||
3773028|NCT01909336|3605914|B2|||Serum sodium, mmol/L||mmol/L|Mean|135.8|135.8|Standard Deviation|3.1|3.1|||
3773029|NCT01909336|3605915|B1|||Serum sodium, mmol/L||mmol/L|Mean|135|135.0|Standard Deviation|2.8|2.8|||
3773030|NCT01909336|3605912|B4|||Heart rate, bpm||bpm|Mean|126|126.0|Standard Deviation|27|27.0|||
3773031|NCT01909336|3605913|B3|||Heart rate, bpm||bpm|Mean|128|128.0|Standard Deviation|28|28.0|||
3773032|NCT01909336|3605914|B2|||Heart rate, bpm||bpm|Mean|126|126.0|Standard Deviation|29|29.0|||
3773033|NCT01909336|3605915|B1|||Heart rate, bpm||bpm|Mean|124|124.0|Standard Deviation|25|25.0|||
3773034|NCT01909336|3605912|B4|||Systolic blood pressure, mmHg||mmHg|Mean|100.1|100.1|Standard Deviation|10.5|10.5|||
3773035|NCT01909336|3605913|B3|||Systolic blood pressure, mmHg||mmHg|Mean|99.8|99.8|Standard Deviation|11.4|11.4|||
3773036|NCT01909336|3605914|B2|||Systolic blood pressure, mmHg||mmHg|Mean|99.4|99.4|Standard Deviation|9|9.0|||
3773037|NCT01909336|3605915|B1|||Systolic blood pressure, mmHg||mmHg|Mean|101.1|101.1|Standard Deviation|11.2|11.2|||
3773038|NCT01909336|3605912|B4|||Dehydration (mild), n|Dry mucous membranes in association with normal hemodynamic measurements|participants|Number|33|33.0||||||
3773039|NCT01909336|3605913|B3|||Dehydration (mild), n|Dry mucous membranes in association with normal hemodynamic measurements|participants|Number|10|10.0||||||
3773040|NCT01909336|3605914|B2|||Dehydration (mild), n|Dry mucous membranes in association with normal hemodynamic measurements|participants|Number|13|13.0||||||
3773041|NCT01909336|3605915|B1|||Dehydration (mild), n|Dry mucous membranes in association with normal hemodynamic measurements|participants|Number|10|10.0||||||
3773042|NCT01909336|3605912|B4||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3773043|NCT01909336|3605913|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3773044|NCT01909336|3605914|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3773045|NCT01909336|3605915|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3773046|NCT01909336|3605912|B4||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3773047|NCT01909336|3605913|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3773048|NCT01909336|3605914|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3773049|NCT01909336|3605915|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3773050|NCT01909336|3605912|B4|||Age||months|Mean|58.9|58.9|Standard Deviation|56.5|56.5|||
3773051|NCT01909336|3605913|B3|||Age||months|Mean|58.8|58.8|Standard Deviation|57.7|57.7|||
3773052|NCT01909336|3605914|B2|||Age||months|Mean|54.6|54.6|Standard Deviation|55.9|55.9|||
3773053|NCT01909336|3605915|B1|||Age||months|Mean|63.5|63.5|Standard Deviation|56.1|56.1|||
3773054|NCT01909180|3605931|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
3773055|NCT01909180|3605931|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3773056|NCT01909180|3605931|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3773057|NCT01909180|3605931|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3773058|NCT01909180|3605931|B1||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
3773059|NCT01909180|3605931|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3773060|NCT01909141|3605937|B3|||free T4||nmol/L|Mean|13.68|13.68|Standard Deviation|0.68|0.68|||
3773061|NCT01909141|3605938|B2|||free T4||nmol/L|Mean|13.58|13.58|Standard Deviation|0.45|0.45|||
3773062|NCT01909141|3605939|B1|||free T4||nmol/L|Mean|13.78|13.78|Standard Deviation|0.84|0.84|||
3773063|NCT01909141|3605937|B3|||TSH||mIU/L|Mean|3.47|3.47|Standard Deviation|0.53|0.53|||
3773064|NCT01909141|3605938|B2|||TSH||mIU/L|Mean|3.51|3.51|Standard Deviation|0.44|0.44|||
3773065|NCT01909141|3605939|B1|||TSH||mIU/L|Mean|3.42|3.42|Standard Deviation|0.61|0.61|||
3773066|NCT01909141|3605937|B3|||free testosterone||Pmol/dL|Mean|3.99|3.99|Standard Deviation|0.94|0.94|||
3773067|NCT01909141|3605938|B2|||free testosterone||Pmol/dL|Mean|4.12|4.12|Standard Deviation|1.17|1.17|||
3773068|NCT01909141|3605939|B1|||free testosterone||Pmol/dL|Mean|3.87|3.87|Standard Deviation|0.61|0.61|||
3773069|NCT01909141|3605937|B3|||total testosterone||nmol/L|Mean|1.16|1.16|Standard Deviation|0.23|0.23|||
3773070|NCT01909141|3605938|B2|||total testosterone||nmol/L|Mean|1.13|1.13|Standard Deviation|0.2|0.2|||
3773071|NCT01909141|3605939|B1|||total testosterone||nmol/L|Mean|1.19|1.19|Standard Deviation|0.25|0.25|||
3773072|NCT01909141|3605937|B3|||prolactin||ng/ml|Mean|14.9|14.9|Standard Deviation|5.24|5.24|||
3773073|NCT01909141|3605938|B2|||prolactin||ng/ml|Mean|14.3|14.3|Standard Deviation|5.6|5.6|||
3773074|NCT01909141|3605939|B1|||prolactin||ng/ml|Mean|15.52|15.52|Standard Deviation|4.84|4.84|||
3773075|NCT01909141|3605937|B3|||E2||Pmol/dL|Mean|48.24|48.24|Standard Deviation|8.56|8.56|||
3773076|NCT01909141|3605938|B2|||E2||Pmol/dL|Mean|47.75|47.75|Standard Deviation|10.02|10.02|||
3773077|NCT01909141|3605939|B1|||E2||Pmol/dL|Mean|49.83|49.83|Standard Deviation|7.31|7.31|||
3773078|NCT01909141|3605937|B3|||LH||mIU/L|Mean|10.18|10.18|Standard Deviation|3.21|3.21|||
3773079|NCT01909141|3605938|B2|||LH||mIU/L|Mean|10.55|10.55|Standard Deviation|3.25|3.25|||
3773080|NCT01909141|3605939|B1|||LH||mIU/L|Mean|9.81|9.81|Standard Deviation|3.16|3.16|||
3773081|NCT01909141|3605937|B3|||FSH||mIU/L|Mean|5.7|5.7|Standard Deviation|1.35|1.35|||
3773082|NCT01909141|3605938|B2|||FSH||mIU/L|Mean|5.68|5.68|Standard Deviation|1.38|1.38|||
3773083|NCT01909141|3605939|B1|||FSH||mIU/L|Mean|5.71|5.71|Standard Deviation|1.34|1.34|||
3773084|NCT01909141|3605937|B3|||ovarian volume||ml|Mean|14.19|14.19|Standard Deviation|0.98|0.98|||
3773085|NCT01909141|3605938|B2|||ovarian volume||ml|Mean|14.58|14.58|Standard Deviation|1.42|1.42|||
3773086|NCT01909141|3605939|B1|||ovarian volume||ml|Mean|14.17|14.17|Standard Deviation|0.76|0.76|||
3773087|NCT01909141|3605937|B3|||acne||participants|Number|11|11.0||||||
3773090|NCT01909141|3605937|B3|||hirsutism||participants|Number|21|21.0||||||
3773091|NCT01909141|3605938|B2|||hirsutism||participants|Number|10|10.0||||||
3773092|NCT01909141|3605939|B1|||hirsutism||participants|Number|11|11.0||||||
3773093|NCT01909141|3605937|B3|||diastolic blood pressure||mmHg|Mean|69.02|69.02|Standard Deviation|5.61|5.61|||
3773094|NCT01909141|3605938|B2|||diastolic blood pressure||mmHg|Mean|68.44|68.44|Standard Deviation|5.89|5.89|||
3773095|NCT01909141|3605939|B1|||diastolic blood pressure||mmHg|Mean|69.6|69.6|Standard Deviation|5.31|5.31|||
3773096|NCT01909141|3605937|B3|||systolic blood pressure||mmHg|Mean|106.56|106.56|Standard Deviation|8.86|8.86|||
3773097|NCT01909141|3605938|B2|||systolic blood pressure||mmHg|Mean|107.04|107.04|Standard Deviation|8.97|8.97|||
3773098|NCT01909141|3605939|B1|||systolic blood pressure||mmHg|Mean|106.08|106.08|Standard Deviation|8.81|8.81|||
3773099|NCT01909141|3605937|B3|||waist/hip ratio||ratio|Mean|0.837|0.837|Standard Deviation|0.037|0.037|||
3773100|NCT01909141|3605938|B2|||waist/hip ratio||ratio|Mean|0.837|0.837|Standard Deviation|0.04|0.04|||
3773101|NCT01909141|3605939|B1|||waist/hip ratio||ratio|Mean|0.838|0.838|Standard Deviation|0.02|0.02|||
3773102|NCT01909141|3605937|B3|||BMI||kg/m^2|Mean|26.51|26.51|Standard Deviation|2.75|2.75|||
3773103|NCT01909141|3605938|B2|||BMI||kg/m^2|Mean|26.57|26.57|Standard Deviation|2.7|2.7|||
3773104|NCT01909141|3605939|B1|||BMI||kg/m^2|Mean|26.45|26.45|Standard Deviation|2.84|2.84|||
3773105|NCT01909141|3605937|B3|||infertility period||years|Mean|2.87|2.87|Standard Deviation|1.5|1.5|||
3773106|NCT01909141|3605938|B2|||infertility period||years|Mean|3.07|3.07|Standard Deviation|1.46|1.46|||
3773107|NCT01909141|3605939|B1|||infertility period||years|Mean|2.67|2.67|Standard Deviation|1.62|1.62|||
3773108|NCT01909141|3605937|B3|Egypt||Region of Enrollment||participants|Number|100|100.0||||||
3773109|NCT01909141|3605938|B2|Egypt||Region of Enrollment||participants|Number|50|50.0||||||
3773110|NCT01909141|3605939|B1|Egypt||Region of Enrollment||participants|Number|50|50.0||||||
3773111|NCT01909141|3605937|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3773112|NCT01909141|3605938|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3773113|NCT01909141|3605939|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3773114|NCT01909141|3605937|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3773115|NCT01909141|3605938|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3773116|NCT01909141|3605939|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3773117|NCT01909141|3605937|B3|||Age||years|Mean|26.19|26.19|Standard Deviation|3.29|3.29|||
3773118|NCT01909141|3605938|B2|||Age||years|Mean|26.58|26.58|Standard Deviation|2.9|2.9|||
3773119|NCT01909141|3605939|B1|||Age||years|Mean|25.8|25.8|Standard Deviation|3.62|3.62|||
3773120|NCT01909011|3605954|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
3773121|NCT01909011|3605955|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3773122|NCT01909011|3605956|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3773123|NCT01909011|3605954|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3773124|NCT01909011|3605955|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3773125|NCT01909011|3605956|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3773126|NCT01909011|3605954|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3773127|NCT01909011|3605955|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3773128|NCT01909011|3605956|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3773129|NCT01909011|3605954|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3773130|NCT01909011|3605955|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3773131|NCT01909011|3605956|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3773132|NCT01909011|3605954|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3773133|NCT01909011|3605955|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3773134|NCT01909011|3605956|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3773135|NCT01909011|3605954|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3773136|NCT01909011|3605955|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3773137|NCT01909011|3605956|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3773138|NCT01909011|3605954|B3|||Age||years|Mean|47.62|47.62|Standard Deviation|15.88|15.88|||
3773139|NCT01909011|3605955|B2|||Age||years|Mean|43.78|43.78|Standard Deviation|18.26|18.26|||
3773140|NCT01909011|3605956|B1|||Age||years|Mean|52.57|52.57|Standard Deviation|11.43|11.43|||
3773141|NCT01908972|3605967|B3|||Hemangioma volume by MRI||mm^3|Mean|11,737|11.0|Standard Deviation|3348|3348.0|||
3773142|NCT01908972|3605968|B2|||Hemangioma volume by MRI||mm^3|Mean|14,125|14.0|Standard Deviation|18,246|18.0|||
3773143|NCT01908972|3605969|B1|||Hemangioma volume by MRI||mm^3|Mean|9,349|9.0|Standard Deviation|16,015|16.0|||
3773144|NCT01908972|3605967|B3|South Korea||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3773145|NCT01908972|3605968|B2|South Korea||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3773146|NCT01908972|3605969|B1|South Korea||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3773147|NCT01908972|3605967|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3773148|NCT01908972|3605967|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3773149|NCT01908972|3605968|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3773150|NCT01908972|3605969|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3773151|NCT01908972|3605967|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3773152|NCT01908972|3605968|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3773153|NCT01908972|3605969|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3773154|NCT01908972|3605967|B3|||Age||months|Mean|3.3|3.3|Full Range|||0.3|8.2|
3773155|NCT01908972|3605968|B2|||Age||months|Mean|3.6|3.6|Full Range|||0.3|8.2|
3773156|NCT01908972|3605969|B1|||Age||months|Mean|3.0|3.0|Full Range|||0.8|8.0|
3773157|NCT01908972|3605967|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3773158|NCT01908972|3605968|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3773159|NCT01908972|3605969|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3773160|NCT01908972|3605967|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3773161|NCT01908972|3605968|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3773162|NCT01908972|3605969|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3773163|NCT01908972|3605967|B3||<=18 years|Age||Participants|Count of Participants|34|34.0||||||
3773164|NCT01908972|3605968|B2||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
3773165|NCT01908972|3605969|B1||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
3773166|NCT01908907|3606004|B3|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3773167|NCT01908907|3606005|B2|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3773168|NCT01908907|3606006|B1|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3773169|NCT01908907|3606004|B3|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3773170|NCT01908907|3606005|B2|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3773171|NCT01908907|3606006|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3773172|NCT01908907|3606004|B3|Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|53|53.0||||||
3773173|NCT01908907|3606005|B2|Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3773174|NCT01908907|3606006|B1|Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3773175|NCT01908907|3606004|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3773176|NCT01908907|3606005|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3773177|NCT01908907|3606006|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3773178|NCT01908907|3606004|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3773179|NCT01908907|3606005|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3773180|NCT01908907|3606006|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3773181|NCT01908907|3606004|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3773182|NCT01908907|3606005|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3773183|NCT01908907|3606006|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3773184|NCT01908907|3606004|B3|||Age||weeks of GA|Mean|30.52|30.52|Standard Deviation|2.43|2.43|||
3773185|NCT01908907|3606005|B2|||Age||weeks of GA|Mean|30.35|30.35|Standard Deviation|2.46|2.46|||
3773186|NCT01908907|3606006|B1|||Age||weeks of GA|Mean|30.69|30.69|Standard Deviation|2.42|2.42|||
3773187|NCT01908842|3606027|B3|||Duration of opioid use||years|Mean|10.6|10.6|Standard Deviation|9.3|9.3|||
3773188|NCT01908842|3606028|B2|||Duration of opioid use||years|Mean|10.5|10.5|Standard Deviation|9.0|9.0|||
3773189|NCT01908842|3606029|B1|||Duration of opioid use||years|Mean|10.7|10.7|Standard Deviation|9.6|9.6|||
3773190|NCT01908842|3606027|B3|||Body mass index||kg/m2|Mean|26.3|26.3|Standard Deviation|5.8|5.8|||
3773191|NCT01908842|3606028|B2|||Body mass index||kg/m2|Mean|26.3|26.3|Standard Deviation|5.7|5.7|||
3773192|NCT01908842|3606029|B1|||Body mass index||kg/m2|Mean|26.2|26.2|Standard Deviation|5.9|5.9|||
3773193|NCT01908842|3606027|B3|||Weight||kg|Mean|77.7|77.7|Standard Deviation|18.6|18.6|||
3773194|NCT01908842|3606028|B2|||Weight||kg|Mean|78.3|78.3|Standard Deviation|18.4|18.4|||
3773195|NCT01908842|3606029|B1|||Weight||kg|Mean|77.1|77.1|Standard Deviation|18.7|18.7|||
3773196|NCT01908842|3606027|B3|||Height||cm|Mean|171.9|171.9|Standard Deviation|9.4|9.4|||
3773197|NCT01908842|3606028|B2|||Height||cm|Mean|172.3|172.3|Standard Deviation|9.4|9.4|||
3773198|NCT01908842|3606029|B1|||Height||cm|Mean|171.5|171.5|Standard Deviation|9.3|9.3|||
3773199|NCT01908842|3606027|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3773200|NCT01908842|3606028|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3773201|NCT01908842|3606029|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3773202|NCT01908842|3606027|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3773203|NCT01908842|3606028|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3773204|NCT01908842|3606029|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3773205|NCT01908842|3606027|B3||White|Race (NIH/OMB)||Participants|Count of Participants|630|630.0||||||
3773206|NCT01908842|3606028|B2||White|Race (NIH/OMB)||Participants|Count of Participants|312|312.0||||||
3773207|NCT01908842|3606029|B1||White|Race (NIH/OMB)||Participants|Count of Participants|318|318.0||||||
3773208|NCT01908842|3606027|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3773209|NCT01908842|3606028|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3773210|NCT01908842|3606029|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3773211|NCT01908842|3606027|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3773212|NCT01908842|3606028|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773213|NCT01908842|3606029|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3773214|NCT01908842|3606027|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3773215|NCT01908842|3606028|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3773216|NCT01908842|3606029|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3773217|NCT01908842|3606027|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3773218|NCT01908842|3606028|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3773219|NCT01908842|3606029|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3773220|NCT01908842|3606027|B3||Male|Sex: Female, Male||Participants|Count of Participants|452|452.0||||||
3773221|NCT01908842|3606028|B2||Male|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
3773222|NCT01908842|3606029|B1||Male|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
3773223|NCT01908842|3606027|B3||Female|Sex: Female, Male||Participants|Count of Participants|306|306.0||||||
3773224|NCT01908842|3606028|B2||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3773225|NCT01908842|3606029|B1||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3773226|NCT01908842|3606027|B3|||Age||years|Mean|35.6|35.6|Standard Deviation|11.3|11.3|||
3773227|NCT01908842|3606028|B2|||Age||years|Mean|35.7|35.7|Standard Deviation|11.3|11.3|||
3773228|NCT01908842|3606029|B1|||Age||years|Mean|35.6|35.6|Standard Deviation|11.3|11.3|||
3773229|NCT01908829|3606048|B4||Male|Sex: Female, Male||Participants|Count of Participants|366|366.0||||||
3773230|NCT01908829|3606049|B3||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3773231|NCT01908829|3606050|B2||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3773232|NCT01908829|3606051|B1||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3773233|NCT01908829|3606048|B4||Female|Sex: Female, Male||Participants|Count of Participants|1808|1808.0||||||
3773234|NCT01908829|3606049|B3||Female|Sex: Female, Male||Participants|Count of Participants|600|600.0||||||
3773235|NCT01908829|3606050|B2||Female|Sex: Female, Male||Participants|Count of Participants|604|604.0||||||
3773236|NCT01908829|3606051|B1||Female|Sex: Female, Male||Participants|Count of Participants|604|604.0||||||
3773237|NCT01908829|3606048|B4|||Age||Year|Mean|57.5|57.5|Standard Deviation|13.3|13.3|||
3773238|NCT01908829|3606049|B3|||Age||Year|Mean|57.4|57.4|Standard Deviation|13.2|13.2|||
3773239|NCT01908829|3606050|B2|||Age||Year|Mean|56.9|56.9|Standard Deviation|13.5|13.5|||
3773240|NCT01908829|3606051|B1|||Age||Year|Mean|58.2|58.2|Standard Deviation|13.1|13.1|||
3773241|NCT01908803|3606166|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3773242|NCT01908803|3606167|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3773243|NCT01908803|3606168|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3773244|NCT01908803|3606166|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3773245|NCT01908803|3606167|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3773246|NCT01908803|3606168|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3773247|NCT01908803|3606166|B3|||Age||years|Mean|2.7|2.7|Standard Deviation|2.28|2.28|||
3773248|NCT01908803|3606167|B2|||Age||years|Mean|2.4|2.4|Standard Deviation|1.54|1.54|||
3773249|NCT01908803|3606168|B1|||Age||years|Mean|2.9|2.9|Standard Deviation|2.60|2.6|||
3773250|NCT01908582|3606180|B1|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3773251|NCT01908582|3606180|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773252|NCT01908582|3606180|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773253|NCT01908582|3606180|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3773254|NCT01908582|3606180|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3773255|NCT01908582|3606180|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773256|NCT01908582|3606180|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773257|NCT01908582|3606180|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773258|NCT01908582|3606180|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773259|NCT01908582|3606180|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3773260|NCT01908582|3606180|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3773261|NCT01908582|3606180|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3773262|NCT01908582|3606180|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3773263|NCT01908582|3606180|B1|||Age||years|Mean|41.0|41.0|Standard Deviation|11.4|11.4|||
3773264|NCT01908140|3606191|B3|United Kingdom||Region of Enrollment||participants|Number|37|37.0||||||
3773265|NCT01908140|3606192|B2|United Kingdom||Region of Enrollment||participants|Number|21|21.0||||||
3773266|NCT01908140|3606193|B1|United Kingdom||Region of Enrollment||participants|Number|16|16.0||||||
3773267|NCT01908140|3606191|B3|Spain||Region of Enrollment||participants|Number|62|62.0||||||
3773268|NCT01908140|3606192|B2|Spain||Region of Enrollment||participants|Number|34|34.0||||||
3773269|NCT01908140|3606193|B1|Spain||Region of Enrollment||participants|Number|28|28.0||||||
3773270|NCT01908140|3606191|B3|South Africa||Region of Enrollment||participants|Number|134|134.0||||||
3773271|NCT01908140|3606192|B2|South Africa||Region of Enrollment||participants|Number|66|66.0||||||
3773272|NCT01908140|3606193|B1|South Africa||Region of Enrollment||participants|Number|68|68.0||||||
3773273|NCT01908140|3606191|B3|Poland||Region of Enrollment||participants|Number|122|122.0||||||
3773274|NCT01908140|3606192|B2|Poland||Region of Enrollment||participants|Number|55|55.0||||||
3773275|NCT01908140|3606193|B1|Poland||Region of Enrollment||participants|Number|67|67.0||||||
3773276|NCT01908140|3606191|B3|Netherlands||Region of Enrollment||participants|Number|22|22.0||||||
3773277|NCT01908140|3606192|B2|Netherlands||Region of Enrollment||participants|Number|11|11.0||||||
3773278|NCT01908140|3606193|B1|Netherlands||Region of Enrollment||participants|Number|11|11.0||||||
3773279|NCT01908140|3606191|B3|Lithuania||Region of Enrollment||participants|Number|27|27.0||||||
3773280|NCT01908140|3606192|B2|Lithuania||Region of Enrollment||participants|Number|10|10.0||||||
3773281|NCT01908140|3606193|B1|Lithuania||Region of Enrollment||participants|Number|17|17.0||||||
3773282|NCT01908140|3606191|B3|Italy||Region of Enrollment||participants|Number|11|11.0||||||
3773283|NCT01908140|3606192|B2|Italy||Region of Enrollment||participants|Number|5|5.0||||||
3773284|NCT01908140|3606193|B1|Italy||Region of Enrollment||participants|Number|6|6.0||||||
3773285|NCT01908140|3606191|B3|Hungary||Region of Enrollment||participants|Number|98|98.0||||||
3773286|NCT01908140|3606192|B2|Hungary||Region of Enrollment||participants|Number|48|48.0||||||
3773287|NCT01908140|3606193|B1|Hungary||Region of Enrollment||participants|Number|50|50.0||||||
3773288|NCT01908140|3606191|B3|Germany||Region of Enrollment||participants|Number|254|254.0||||||
3773289|NCT01908140|3606192|B2|Germany||Region of Enrollment||participants|Number|136|136.0||||||
3773290|NCT01908140|3606193|B1|Germany||Region of Enrollment||participants|Number|118|118.0||||||
3773291|NCT01908140|3606191|B3|France||Region of Enrollment||participants|Number|14|14.0||||||
3773292|NCT01908140|3606192|B2|France||Region of Enrollment||participants|Number|4|4.0||||||
3773293|NCT01908140|3606193|B1|France||Region of Enrollment||participants|Number|10|10.0||||||
3773294|NCT01908140|3606191|B3|Czech Republic||Region of Enrollment||participants|Number|25|25.0||||||
3773295|NCT01908140|3606192|B2|Czech Republic||Region of Enrollment||participants|Number|14|14.0||||||
3773296|NCT01908140|3606193|B1|Czech Republic||Region of Enrollment||participants|Number|11|11.0||||||
3773297|NCT01908140|3606191|B3|Canada||Region of Enrollment||participants|Number|18|18.0||||||
3773298|NCT01908140|3606192|B2|Canada||Region of Enrollment||participants|Number|6|6.0||||||
3773299|NCT01908140|3606193|B1|Canada||Region of Enrollment||participants|Number|12|12.0||||||
3773300|NCT01908140|3606191|B3|Bulgaria||Region of Enrollment||participants|Number|62|62.0||||||
3773301|NCT01908140|3606192|B2|Bulgaria||Region of Enrollment||participants|Number|32|32.0||||||
3773302|NCT01908140|3606193|B1|Bulgaria||Region of Enrollment||participants|Number|30|30.0||||||
3773303|NCT01908140|3606191|B3|Austria||Region of Enrollment||participants|Number|47|47.0||||||
3773304|NCT01908140|3606192|B2|Austria||Region of Enrollment||participants|Number|24|24.0||||||
3773305|NCT01908140|3606193|B1|Austria||Region of Enrollment||participants|Number|23|23.0||||||
3773306|NCT01908140|3606191|B3||Male|Sex: Female, Male||Participants|Count of Participants|607|607.0||||||
3773307|NCT01908140|3606192|B2||Male|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
3773308|NCT01908140|3606193|B1||Male|Sex: Female, Male||Participants|Count of Participants|307|307.0||||||
3773309|NCT01908140|3606191|B3||Female|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
3773310|NCT01908140|3606192|B2||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3773311|NCT01908140|3606193|B1||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3773312|NCT01908140|3606191|B3|Age (years), mean (SD)||Age, Customized||years|Mean|63.4|63.4|Standard Deviation|7.8|7.8|||
3773313|NCT01908140|3606192|B2|Age (years), mean (SD)||Age, Customized||years|Mean|63.3|63.3|Standard Deviation|7.5|7.5|||
3773314|NCT01908140|3606193|B1|Age (years), mean (SD)||Age, Customized||years|Mean|63.5|63.5|Standard Deviation|8.1|8.1|||
3773315|NCT01908127|3606202|B3|Iran, Islamic Republic of||Region of Enrollment||participants|Number|46|46.0||||||
3773316|NCT01908127|3606203|B2|Iran, Islamic Republic of||Region of Enrollment||participants|Number|23|23.0||||||
3773317|NCT01908127|3606204|B1|Iran, Islamic Republic of||Region of Enrollment||participants|Number|23|23.0||||||
3773318|NCT01908127|3606202|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3773319|NCT01908127|3606203|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3773320|NCT01908127|3606204|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3773321|NCT01908127|3606202|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3773322|NCT01908127|3606203|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3773323|NCT01908127|3606204|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3773324|NCT01908127|3606202|B3|||Age||years|Mean|4.95|4.95|Standard Deviation|1.17|1.17|||
3773325|NCT01908127|3606203|B2|||Age||years|Mean|5|5.0|Standard Deviation|1.17|1.17|||
3773326|NCT01908127|3606204|B1|||Age||years|Mean|4.9|4.9|Standard Deviation|1.17|1.17|||
3773327|NCT01908127|3606202|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3773328|NCT01908127|3606203|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3773329|NCT01908127|3606204|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3773330|NCT01908127|3606202|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3773331|NCT01908127|3606203|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3773332|NCT01908127|3606204|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3773333|NCT01908127|3606202|B3||<=18 years|Age||Participants|Count of Participants|46|46.0||||||
3773334|NCT01908127|3606203|B2||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
3773335|NCT01908127|3606204|B1||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
3773336|NCT01907906|3606213|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
3773337|NCT01907906|3606214|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3773338|NCT01907906|3606215|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3773339|NCT01907906|3606213|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3773340|NCT01907906|3606214|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3773341|NCT01907906|3606215|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773342|NCT01907906|3606213|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773343|NCT01907906|3606214|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773344|NCT01907906|3606215|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773345|NCT01907906|3606213|B3||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3773346|NCT01907906|3606214|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3773347|NCT01907906|3606215|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3773348|NCT01907906|3606213|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773349|NCT01907906|3606214|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773350|NCT01907906|3606215|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773351|NCT01907906|3606213|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773352|NCT01907906|3606214|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773353|NCT01907906|3606215|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773354|NCT01907906|3606213|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3773355|NCT01907906|3606214|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3773356|NCT01907906|3606215|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773357|NCT01907906|3606213|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773358|NCT01907906|3606214|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773359|NCT01907906|3606215|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773360|NCT01907906|3606213|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3773361|NCT01907906|3606214|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3773362|NCT01907906|3606215|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3773363|NCT01907906|3606213|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3773364|NCT01907906|3606214|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3773365|NCT01907906|3606215|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3773366|NCT01907906|3606213|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3773367|NCT01907906|3606214|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3773368|NCT01907906|3606215|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3773369|NCT01907906|3606213|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3773370|NCT01907906|3606214|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3773371|NCT01907906|3606215|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3773372|NCT01907906|3606213|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3773373|NCT01907906|3606214|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3773374|NCT01907906|3606215|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3773375|NCT01907854|3606294|B3|||Fasting Plasma Glucose||mmol/L|Mean|9.9|9.9|Standard Deviation|2.6|2.6|||
3773376|NCT01907854|3606295|B2|||Fasting Plasma Glucose||mmol/L|Mean|9.7|9.7|Standard Deviation|2.5|2.5|||
3773377|NCT01907854|3606296|B1|||Fasting Plasma Glucose||mmol/L|Mean|10.0|10.0|Standard Deviation|2.7|2.7|||
3773378|NCT01907854|3606294|B3|||Body Weight||kg|Mean|90.1|90.1|Standard Deviation|19.7|19.7|||
3773379|NCT01907854|3606295|B2|||Body Weight||kg|Mean|91.2|91.2|Standard Deviation|19.6|19.6|||
3773380|NCT01907854|3606296|B1|||Body Weight||kg|Mean|88.9|88.9|Standard Deviation|19.8|19.8|||
3773381|NCT01907854|3606294|B3|||HbA1c||percentage of glycosylated haemoglobin|Mean|8.3|8.3|Standard Deviation|0.6|0.6|||
3773382|NCT01907854|3606295|B2|||HbA1c||percentage of glycosylated haemoglobin|Mean|8.2|8.2|Standard Deviation|0.6|0.6|||
3773383|NCT01907854|3606296|B1|||HbA1c||percentage of glycosylated haemoglobin|Mean|8.3|8.3|Standard Deviation|0.6|0.6|||
3773384|NCT01907854|3606294|B3||Male|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
3773385|NCT01907854|3606295|B2||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3773386|NCT01907854|3606296|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3773387|NCT01907854|3606294|B3||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3773388|NCT01907854|3606295|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3773389|NCT01907854|3606296|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3773390|NCT01907854|3606294|B3|||Age||years|Mean|56.4|56.4|Standard Deviation|10.2|10.2|||
3773391|NCT01907854|3606295|B2|||Age||years|Mean|56.5|56.5|Standard Deviation|9.7|9.7|||
3773392|NCT01907854|3606296|B1|||Age||years|Mean|56.3|56.3|Standard Deviation|10.6|10.6|||
3773393|NCT01907815|3606315|B3|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3773394|NCT01907815|3606316|B2|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3773395|NCT01907815|3606317|B1|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3773396|NCT01907815|3606315|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3773397|NCT01907815|3606316|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3773398|NCT01907815|3606317|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3773399|NCT01907815|3606315|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3773400|NCT01907815|3606316|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3773401|NCT01907815|3606317|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3773402|NCT01907815|3606315|B3|||Age||years|Median|69|69.0|Full Range|||22.0|80.0|
3773403|NCT01907815|3606316|B2|||Age||years|Median|69|69.0|Full Range|||61.0|80.0|
3773404|NCT01907815|3606317|B1|||Age||years|Median|68|68.0|Full Range|||22.0|80.0|
3773405|NCT01907516|3606332|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
3773406|NCT01907516|3606333|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
3773407|NCT01907516|3606334|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3773408|NCT01907516|3606332|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3773409|NCT01907516|3606333|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3773410|NCT01907516|3606334|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3773411|NCT01907516|3606332|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3773412|NCT01907516|3606333|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3773413|NCT01907516|3606334|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3773414|NCT01907516|3606332|B3|||Age||years|Mean|33.12|33.12|Standard Deviation|5.37|5.37|||
3773415|NCT01907516|3606333|B2|||Age||years|Mean|32.5|32.5|Standard Deviation|5.76|5.76|||
3773416|NCT01907516|3606334|B1|||Age||years|Mean|33.79|33.79|Standard Deviation|4.94|4.94|||
3773417|NCT01907516|3606332|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3773418|NCT01907516|3606333|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3773419|NCT01907516|3606334|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3773420|NCT01907516|3606332|B3||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
3773421|NCT01907516|3606333|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3773422|NCT01907516|3606334|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3773423|NCT01907516|3606332|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3773424|NCT01907516|3606333|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3773425|NCT01907516|3606334|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3773426|NCT01907490|3606342|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3773427|NCT01907490|3606342|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3773428|NCT01907490|3606342|B1|3years-<18 years||Age, Customized||participants|Number|10|10.0||||||
3773429|NCT01907490|3606342|B1|2 years - <3 years||Age, Customized||participants|Number|11|11.0||||||
3773430|NCT01907490|3606342|B1|12 months- <2 years||Age, Customized||participants|Number|9|9.0||||||
3773431|NCT01907490|3606342|B1|6months-<12 months||Age, Customized||participants|Number|8|8.0||||||
3773432|NCT01907334|3606346|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3773433|NCT01907334|3606346|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3773434|NCT01907334|3606346|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3773435|NCT01907334|3606346|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3773436|NCT01907334|3606346|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3773437|NCT01907334|3606346|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
3773438|NCT01907321|3606352|B1|||Penetration-aspiration score|The Penetration-aspiration scale is an 8-point scale in which a score of 1 is best (material does not enter the airway) and a score of 8 is worst.|Penetration-aspiration scale (1 is best)|Median|1|1.0|Full Range|||1.0|8.0|
3773439|NCT01907321|3606352|B1|||Pulmonary function (FEV1/FVC)||ratio (FEV1/FVC)|Mean|.64|0.64|Standard Deviation|.20|0.2|||
3773440|NCT01907321|3606352|B1|||Maximum expiratory pressure||centimeters of water (Cm H2O)|Mean|71.2|71.2|Standard Deviation|28.8|28.8|||
3773441|NCT01907321|3606352|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3773442|NCT01907321|3606352|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773443|NCT01907321|3606352|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773444|NCT01907321|3606352|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3773445|NCT01907321|3606352|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3773446|NCT01907321|3606352|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773447|NCT01907321|3606352|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773448|NCT01907321|3606352|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773449|NCT01907321|3606352|B1||Male|Gender||Participants|Count of Participants|8|8.0||||||
3773450|NCT01907321|3606352|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
3773451|NCT01907321|3606352|B1|||Age||years|Mean|64.5|64.5|Full Range|||52.0|77.0|
3773797|NCT01905540|3606749|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3773452|NCT01907269|3606357|B3|||Number of Participants who Completed the Osteoporosis Treatment History (tailoring)|"Patients in the Video-based intervention arm that didn't rank barriers, did not complete the Patient's Views about Osteoporosis and Use of Therapy Scale, and where readiness to behavior change could not be assessed received an intervention tailored based on their osteoporosis treatment history as assessed by our survey (N=131). The categorization for this variable was dichotomous, those that indicated they had received previous treatment or those that indicated they had not received previous treatment."|Participants|Count of Participants|131|131.0||||||
3773453|NCT01907269|3606358|B2|||Number of Participants who Completed the Osteoporosis Treatment History (tailoring)|"Patients in the Video-based intervention arm that didn't rank barriers, did not complete the Patient's Views about Osteoporosis and Use of Therapy Scale, and where readiness to behavior change could not be assessed received an intervention tailored based on their osteoporosis treatment history as assessed by our survey (N=131). The categorization for this variable was dichotomous, those that indicated they had received previous treatment or those that indicated they had not received previous treatment."|Participants|Count of Participants|0|0.0||||||
3773454|NCT01907269|3606359|B1|||Number of Participants who Completed the Osteoporosis Treatment History (tailoring)|"Patients in the Video-based intervention arm that didn't rank barriers, did not complete the Patient's Views about Osteoporosis and Use of Therapy Scale, and where readiness to behavior change could not be assessed received an intervention tailored based on their osteoporosis treatment history as assessed by our survey (N=131). The categorization for this variable was dichotomous, those that indicated they had received previous treatment or those that indicated they had not received previous treatment."|Participants|Count of Participants|131|131.0||||||
3773455|NCT01907269|3606357|B3|||Number of Participants who Completed Readiness to Behavior Change|"Patients in the Video-based intervention arm that didn't rank barriers,and did not complete the Patient's Views about Osteoporosis and Use of Therapy Scale received a tailored intervention based on their readiness to behavior change (N=300) as assessed by a modified version of Weinstein's Precaution Adoption Process Model. Unfortunately, not all participants completed the Readiness to Behavior Change (i.e., they didn't follow the survey directions); these individuals received an intervention corresponding to the next level of tailoring (e.g., Osteoporosis treatment history)."|Participants|Count of Participants|300|300.0||||||
3773456|NCT01907269|3606358|B2|||Number of Participants who Completed Readiness to Behavior Change|"Patients in the Video-based intervention arm that didn't rank barriers,and did not complete the Patient's Views about Osteoporosis and Use of Therapy Scale received a tailored intervention based on their readiness to behavior change (N=300) as assessed by a modified version of Weinstein's Precaution Adoption Process Model. Unfortunately, not all participants completed the Readiness to Behavior Change (i.e., they didn't follow the survey directions); these individuals received an intervention corresponding to the next level of tailoring (e.g., Osteoporosis treatment history)."|Participants|Count of Participants|0|0.0||||||
3773457|NCT01907269|3606359|B1|||Number of Participants who Completed Readiness to Behavior Change|"Patients in the Video-based intervention arm that didn't rank barriers,and did not complete the Patient's Views about Osteoporosis and Use of Therapy Scale received a tailored intervention based on their readiness to behavior change (N=300) as assessed by a modified version of Weinstein's Precaution Adoption Process Model. Unfortunately, not all participants completed the Readiness to Behavior Change (i.e., they didn't follow the survey directions); these individuals received an intervention corresponding to the next level of tailoring (e.g., Osteoporosis treatment history)."|Participants|Count of Participants|300|300.0||||||
3773458|NCT01907269|3606357|B3|||Number of Participants who completed Patient's Views about Osteoporosis and Use of Therapy Scale|"Patients in the Video-based intervention arm that didn't rank barriers, but who did complete the Patient's Views about Osteoporosis and Use of Therapy Scale (N=429) received a tailored intervention based on responses to this scale. Unfortunately, not all participants completed the Patient's Views about Osteoporosis and Use of Therapy Scale (i.e., they didn't follow the survey directions); these individuals received an intervention corresponding to the next level of tailoring (e.g., Readiness to Behavior Change, or Osteoporosis treatment history)."|Participants|Count of Participants|429|429.0||||||
3773459|NCT01907269|3606358|B2|||Number of Participants who completed Patient's Views about Osteoporosis and Use of Therapy Scale|"Patients in the Video-based intervention arm that didn't rank barriers, but who did complete the Patient's Views about Osteoporosis and Use of Therapy Scale (N=429) received a tailored intervention based on responses to this scale. Unfortunately, not all participants completed the Patient's Views about Osteoporosis and Use of Therapy Scale (i.e., they didn't follow the survey directions); these individuals received an intervention corresponding to the next level of tailoring (e.g., Readiness to Behavior Change, or Osteoporosis treatment history)."|Participants|Count of Participants|0|0.0||||||
3773460|NCT01907269|3606359|B1|||Number of Participants who completed Patient's Views about Osteoporosis and Use of Therapy Scale|"Patients in the Video-based intervention arm that didn't rank barriers, but who did complete the Patient's Views about Osteoporosis and Use of Therapy Scale (N=429) received a tailored intervention based on responses to this scale. Unfortunately, not all participants completed the Patient's Views about Osteoporosis and Use of Therapy Scale (i.e., they didn't follow the survey directions); these individuals received an intervention corresponding to the next level of tailoring (e.g., Readiness to Behavior Change, or Osteoporosis treatment history)."|Participants|Count of Participants|429|429.0||||||
3773461|NCT01907269|3606357|B3|||Number of Participants who Completed Barriers to Osteoporosis Treatment|A list of seven potentially modifiable barriers was presented to patients in the baseline survey. Those that ranked them in the intervention arm (N=482) were allocated a tailored online and video intervention based on their response. Unfortunately, not all participants ranked barriers (i.e., they didn't follow the survey directions). Individuals that did not rank barriers received an intervention corresponding to the next level of tailoring (e.g., Responses on the Patient's Views about Osteoporosis Use and Therapy Scale, Readiness to Behavior Change, or Osteoporosis treatment history).|Participants|Count of Participants|482|482.0||||||
3773510|NCT01907217|3606375|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773511|NCT01907217|3606376|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773512|NCT01907217|3606374|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
3773513|NCT01907217|3606375|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3773462|NCT01907269|3606358|B2|||Number of Participants who Completed Barriers to Osteoporosis Treatment|A list of seven potentially modifiable barriers was presented to patients in the baseline survey. Those that ranked them in the intervention arm (N=482) were allocated a tailored online and video intervention based on their response. Unfortunately, not all participants ranked barriers (i.e., they didn't follow the survey directions). Individuals that did not rank barriers received an intervention corresponding to the next level of tailoring (e.g., Responses on the Patient's Views about Osteoporosis Use and Therapy Scale, Readiness to Behavior Change, or Osteoporosis treatment history).|Participants|Count of Participants|0|0.0||||||
3773463|NCT01907269|3606359|B1|||Number of Participants who Completed Barriers to Osteoporosis Treatment|A list of seven potentially modifiable barriers was presented to patients in the baseline survey. Those that ranked them in the intervention arm (N=482) were allocated a tailored online and video intervention based on their response. Unfortunately, not all participants ranked barriers (i.e., they didn't follow the survey directions). Individuals that did not rank barriers received an intervention corresponding to the next level of tailoring (e.g., Responses on the Patient's Views about Osteoporosis Use and Therapy Scale, Readiness to Behavior Change, or Osteoporosis treatment history).|Participants|Count of Participants|482|482.0||||||
3773464|NCT01907269|3606357|B3|United States||Region of Enrollment||Participants|Count of Participants|2684|2684.0||||||
3773465|NCT01907269|3606358|B2|United States||Region of Enrollment||Participants|Count of Participants|1342|1342.0||||||
3773466|NCT01907269|3606359|B1|United States||Region of Enrollment||Participants|Count of Participants|1342|1342.0||||||
3773467|NCT01907269|3606357|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3773468|NCT01907269|3606358|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3773469|NCT01907269|3606359|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3773470|NCT01907269|3606357|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773471|NCT01907269|3606358|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773472|NCT01907269|3606359|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773473|NCT01907269|3606357|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2486|2486.0||||||
3773474|NCT01907269|3606358|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1239|1239.0||||||
3773475|NCT01907269|3606359|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1247|1247.0||||||
3773476|NCT01907269|3606357|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3773477|NCT01907269|3606358|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3773478|NCT01907269|3606359|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3773479|NCT01907269|3606357|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773480|NCT01907269|3606358|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773481|NCT01907269|3606359|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773482|NCT01907269|3606357|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3773483|NCT01907269|3606358|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3773484|NCT01907269|3606359|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3773485|NCT01907269|3606357|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773486|NCT01907269|3606358|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773487|NCT01907269|3606359|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773488|NCT01907269|3606357|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773489|NCT01907269|3606358|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773490|NCT01907269|3606359|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773491|NCT01907269|3606357|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2638|2638.0||||||
3773492|NCT01907269|3606358|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1321|1321.0||||||
3773493|NCT01907269|3606359|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1317|1317.0||||||
3773494|NCT01907269|3606357|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3773495|NCT01907269|3606358|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3773496|NCT01907269|3606359|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3773497|NCT01907269|3606357|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3773498|NCT01907269|3606358|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3773499|NCT01907269|3606359|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3773500|NCT01907269|3606357|B3||Female|Sex: Female, Male||Participants|Count of Participants|2684|2684.0||||||
3773501|NCT01907269|3606358|B2||Female|Sex: Female, Male||Participants|Count of Participants|1342|1342.0||||||
3773502|NCT01907269|3606359|B1||Female|Sex: Female, Male||Participants|Count of Participants|1342|1342.0||||||
3773503|NCT01907269|3606357|B3|||Age||years|Mean|74.9|74.9|Standard Deviation|7.96|7.96|||
3773504|NCT01907269|3606358|B2|||Age||years|Mean|74.9|74.9|Standard Deviation|7.9|7.9|||
3773505|NCT01907269|3606359|B1|||Age||years|Mean|74.9|74.9|Standard Deviation|8|8.0|||
3773506|NCT01907217|3606374|B3|Ireland||Region of Enrollment||participants|Number|138|138.0||||||
3773507|NCT01907217|3606375|B2|Ireland||Region of Enrollment||participants|Number|69|69.0||||||
3773508|NCT01907217|3606376|B1|Ireland||Region of Enrollment||participants|Number|69|69.0||||||
3773509|NCT01907217|3606374|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773514|NCT01907217|3606376|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3773515|NCT01907217|3606374|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773516|NCT01907217|3606375|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773517|NCT01907217|3606376|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773518|NCT01907217|3606374|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3773519|NCT01907217|3606375|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3773520|NCT01907217|3606376|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3773521|NCT01907217|3606374|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3773522|NCT01907217|3606375|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3773523|NCT01907217|3606376|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3773524|NCT01907217|3606374|B3|||Age||years|Mean|56.7|56.7|Standard Deviation|14.8|14.8|||
3773525|NCT01907217|3606375|B2|||Age||years|Mean|56.6|56.6|Standard Deviation|15.3|15.3|||
3773526|NCT01907217|3606376|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|14.4|14.4|||
3773527|NCT01907113|3606389|B6||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3773528|NCT01907113|3606390|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3773529|NCT01907113|3606391|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3773530|NCT01907113|3606392|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3773531|NCT01907113|3606393|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3773532|NCT01907113|3606394|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3773533|NCT01907113|3606389|B6||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3773534|NCT01907113|3606390|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3773535|NCT01907113|3606391|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3773536|NCT01907113|3606392|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3773537|NCT01907113|3606393|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3773538|NCT01907113|3606394|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3773539|NCT01907113|3606389|B6|||Age||years|Mean|55.8|55.8|Standard Deviation|12.0|12.0|||
3773540|NCT01907113|3606390|B5|||Age||years|Mean|45.8|45.8|Standard Deviation|12.0|12.0|||
3773541|NCT01907113|3606391|B4|||Age||years|Mean|56.0|56.0|Standard Deviation|12.9|12.9|||
3773542|NCT01907113|3606392|B3|||Age||years|Mean|63.1|63.1|Standard Deviation|9.5|9.5|||
3773543|NCT01907113|3606393|B2|||Age||years|Mean|60.0|60.0|Standard Deviation|8.8|8.8|||
3773544|NCT01907113|3606394|B1|||Age||years|Mean|54.5|54.5|Standard Deviation|11.7|11.7|||
3773545|NCT01907087|3606485|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3773546|NCT01907087|3606485|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3773547|NCT01907087|3606485|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3773548|NCT01907087|3606485|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3773549|NCT01907087|3606485|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3773550|NCT01907087|3606485|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3773551|NCT01907087|3606485|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773552|NCT01907087|3606485|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3773553|NCT01907087|3606485|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3773554|NCT01907087|3606485|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3773555|NCT01907087|3606485|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3773556|NCT01907087|3606485|B1|>5 years||Age, Customized||Participants|Count of Participants|4|4.0||||||
3773557|NCT01907087|3606485|B1|<=5 years||Age, Customized||Participants|Count of Participants|20|20.0||||||
3773558|NCT01907087|3606485|B1|||Age||years|Mean|4.3|4.3|Standard Deviation|1.24|1.24|||
3773559|NCT01906866|3606494|B3|France||Region of Enrollment||participants|Number|5|5.0||||||
3773560|NCT01906866|3606495|B2|France||Region of Enrollment||participants|Number|2|2.0||||||
3773561|NCT01906866|3606496|B1|France||Region of Enrollment||participants|Number|3|3.0||||||
3773562|NCT01906866|3606494|B3|United Kingdom||Region of Enrollment||participants|Number|16|16.0||||||
3773563|NCT01906866|3606495|B2|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3773564|NCT01906866|3606496|B1|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3773565|NCT01906866|3606494|B3|Finland||Region of Enrollment||participants|Number|1|1.0||||||
3773566|NCT01906866|3606495|B2|Finland||Region of Enrollment||participants|Number|1|1.0||||||
3773567|NCT01906866|3606496|B1|Finland||Region of Enrollment||participants|Number|0|0.0||||||
3773568|NCT01906866|3606494|B3|United States||Region of Enrollment||participants|Number|91|91.0||||||
3773569|NCT01906866|3606495|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
3773570|NCT01906866|3606496|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
3773571|NCT01906866|3606494|B3|Netherlands||Region of Enrollment||participants|Number|9|9.0||||||
3773572|NCT01906866|3606495|B2|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
3773573|NCT01906866|3606496|B1|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
3773574|NCT01906866|3606494|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773575|NCT01906866|3606495|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773576|NCT01906866|3606496|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773577|NCT01906866|3606494|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3773578|NCT01906866|3606495|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773579|NCT01906866|3606496|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3773580|NCT01906866|3606494|B3||White|Race (NIH/OMB)||Participants|Count of Participants|112|112.0||||||
3773581|NCT01906866|3606495|B2||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3773582|NCT01906866|3606496|B1||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3773583|NCT01906866|3606494|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3773584|NCT01906866|3606495|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3773585|NCT01906866|3606496|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3773586|NCT01906866|3606494|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773587|NCT01906866|3606495|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773588|NCT01906866|3606496|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773589|NCT01906866|3606494|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3773590|NCT01906866|3606495|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3773591|NCT01906866|3606496|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773592|NCT01906866|3606494|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773593|NCT01906866|3606495|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773594|NCT01906866|3606496|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773595|NCT01906866|3606494|B3||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3773596|NCT01906866|3606495|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3773597|NCT01906866|3606496|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3773598|NCT01906866|3606494|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3773599|NCT01906866|3606495|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3773600|NCT01906866|3606496|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3773601|NCT01906866|3606494|B3|||Age||years|Mean|8.7|8.7|Standard Deviation|4.15|4.15|||
3773602|NCT01906866|3606495|B2|||Age||years|Mean|8.4|8.4|Standard Deviation|4.24|4.24|||
3773603|NCT01906866|3606496|B1|||Age||years|Mean|9|9.0|Standard Deviation|4.08|4.08|||
3773604|NCT01906866|3606494|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3773605|NCT01906866|3606495|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3773606|NCT01906866|3606496|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3773607|NCT01906866|3606494|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3773608|NCT01906866|3606495|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3773609|NCT01906866|3606496|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3773610|NCT01906866|3606494|B3||<=18 years|Age||Participants|Count of Participants|125|125.0||||||
3773611|NCT01906866|3606495|B2||<=18 years|Age||Participants|Count of Participants|65|65.0||||||
3773612|NCT01906866|3606496|B1||<=18 years|Age||Participants|Count of Participants|60|60.0||||||
3773613|NCT01906658|3606506|B5|United States||Region of Enrollment||participants|Number|43|43.0||||||
3773614|NCT01906658|3606507|B4|United States||Region of Enrollment||participants|Number|11|11.0||||||
3773615|NCT01906658|3606508|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3773616|NCT01906658|3606509|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3773617|NCT01906658|3606510|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3773618|NCT01906658|3606506|B5||Male|Gender||Participants|Count of Participants|26|26.0||||||
3773619|NCT01906658|3606507|B4||Male|Gender||Participants|Count of Participants|7|7.0||||||
3773620|NCT01906658|3606508|B3||Male|Gender||Participants|Count of Participants|6|6.0||||||
3773621|NCT01906658|3606509|B2||Male|Gender||Participants|Count of Participants|6|6.0||||||
3773622|NCT01906658|3606510|B1||Male|Gender||Participants|Count of Participants|7|7.0||||||
3773623|NCT01906658|3606506|B5||Female|Gender||Participants|Count of Participants|17|17.0||||||
3773624|NCT01906658|3606507|B4||Female|Gender||Participants|Count of Participants|4|4.0||||||
3773625|NCT01906658|3606508|B3||Female|Gender||Participants|Count of Participants|4|4.0||||||
3773626|NCT01906658|3606509|B2||Female|Gender||Participants|Count of Participants|5|5.0||||||
3773627|NCT01906658|3606510|B1||Female|Gender||Participants|Count of Participants|4|4.0||||||
3773628|NCT01906658|3606506|B5||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3773629|NCT01906658|3606507|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3773630|NCT01906658|3606508|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3773631|NCT01906658|3606509|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3773632|NCT01906658|3606510|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3773633|NCT01906658|3606506|B5||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3773634|NCT01906658|3606507|B4||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3773635|NCT01906658|3606508|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3773636|NCT01906658|3606509|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3773637|NCT01906658|3606510|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3773638|NCT01906658|3606506|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3773639|NCT01906658|3606507|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3773640|NCT01906658|3606508|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3773641|NCT01906658|3606509|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3773642|NCT01906658|3606510|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3773643|NCT01906515|3606535|B3|Egypt||Region of Enrollment||participants|Number|106|106.0||||||
3773644|NCT01906515|3606536|B2|Egypt||Region of Enrollment||participants|Number|61|61.0||||||
3773645|NCT01906515|3606537|B1|Egypt||Region of Enrollment||participants|Number|45|45.0||||||
3773646|NCT01906515|3606535|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3773647|NCT01906515|3606536|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3773648|NCT01906515|3606537|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3773649|NCT01906515|3606535|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3773650|NCT01906515|3606536|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3773651|NCT01906515|3606537|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3773652|NCT01906515|3606535|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3773653|NCT01906515|3606536|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3773654|NCT01906515|3606537|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3773655|NCT01906515|3606535|B3||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
3773656|NCT01906515|3606536|B2||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
3773657|NCT01906515|3606537|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3773658|NCT01906515|3606535|B3||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
3773659|NCT01906515|3606536|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3773660|NCT01906515|3606537|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3773661|NCT01906372|3606546|B1|||Autoantibody Status||Participants|Count of Participants|8|8.0||||||
3773662|NCT01906372|3606546|B1|||Disease Duration||years|Mean|2.0|2.0|Standard Deviation|2.0|2.0|||
3773663|NCT01906372|3606546|B1|Polymyositis||Diagnosis||Participants|Count of Participants|5|5.0||||||
3773664|NCT01906372|3606546|B1|Dermatomyositis||Diagnosis||Participants|Count of Participants|6|6.0||||||
3773665|NCT01906372|3606546|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3773666|NCT01906372|3606546|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773667|NCT01906372|3606546|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773668|NCT01906372|3606546|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3773669|NCT01906372|3606546|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3773670|NCT01906372|3606546|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773671|NCT01906372|3606546|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3773672|NCT01906372|3606546|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773673|NCT01906372|3606546|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773674|NCT01906372|3606546|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3773675|NCT01906372|3606546|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3773676|NCT01906372|3606546|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3773677|NCT01906372|3606546|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3773678|NCT01906372|3606546|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3773679|NCT01906372|3606546|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3773680|NCT01906372|3606546|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3773681|NCT01905956|3606551|B3|||Heart Rate||Beats per minute|Mean|70.6|70.6|Standard Deviation|5.4|5.4|||
3773682|NCT01905956|3606552|B2|||Heart Rate||Beats per minute|Mean|70.7|70.7|Standard Deviation|5.5|5.5|||
3773683|NCT01905956|3606553|B1|||Heart Rate||Beats per minute|Mean|70.6|70.6|Standard Deviation|5.3|5.3|||
3773684|NCT01905956|3606551|B3|||Diastolic Blood Pressure||mmHg|Mean|80.5|80.5|Standard Deviation|7.9|7.9|||
3773685|NCT01905956|3606552|B2|||Diastolic Blood Pressure||mmHg|Mean|81.3|81.3|Standard Deviation|9.4|9.4|||
3773686|NCT01905956|3606553|B1|||Diastolic Blood Pressure||mmHg|Mean|79.7|79.7|Standard Deviation|6.2|6.2|||
3773687|NCT01905956|3606551|B3|||Systolic Blood Pressure||mmHg|Mean|125.9|125.9|Standard Deviation|12.9|12.9|||
3773688|NCT01905956|3606552|B2|||Systolic Blood Pressure||mmHg|Mean|128.1|128.1|Standard Deviation|15.7|15.7|||
3773689|NCT01905956|3606553|B1|||Systolic Blood Pressure||mmHg|Mean|123.9|123.9|Standard Deviation|9.2|9.2|||
3773690|NCT01905956|3606551|B3|||Hip Circumference||centimetres (cm)|Mean|109.5|109.5|Standard Deviation|8.1|8.1|||
3773691|NCT01905956|3606552|B2|||Hip Circumference||centimetres (cm)|Mean|108.7|108.7|Standard Deviation|7.8|7.8|||
3773692|NCT01905956|3606553|B1|||Hip Circumference||centimetres (cm)|Mean|110.2|110.2|Standard Deviation|8.3|8.3|||
3773693|NCT01905956|3606551|B3|||Waist Circumference||centimetres (cm)|Mean|100.4|100.4|Standard Deviation|9.2|9.2|||
3773694|NCT01905956|3606552|B2|||Waist Circumference||centimetres (cm)|Mean|98.5|98.5|Standard Deviation|6.9|6.9|||
3773796|NCT01905540|3606748|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3773695|NCT01905956|3606553|B1|||Waist Circumference||centimetres (cm)|Mean|102.1|102.1|Standard Deviation|10.8|10.8|||
3773696|NCT01905956|3606551|B3|||Body Mass Index (BMI)||kilogram per metre square (kg/m^2)|Mean|29.2|29.2|Standard Deviation|2.4|2.4|||
3773697|NCT01905956|3606552|B2|||Body Mass Index (BMI)||kilogram per metre square (kg/m^2)|Mean|29.0|29.0|Standard Deviation|2.1|2.1|||
3773698|NCT01905956|3606553|B1|||Body Mass Index (BMI)||kilogram per metre square (kg/m^2)|Mean|29.3|29.3|Standard Deviation|2.7|2.7|||
3773699|NCT01905956|3606551|B3|||Weight||kilogram (kg)|Mean|81.9|81.9|Standard Deviation|10.8|10.8|||
3773700|NCT01905956|3606552|B2|||Weight||kilogram (kg)|Mean|80.8|80.8|Standard Deviation|8.8|8.8|||
3773701|NCT01905956|3606553|B1|||Weight||kilogram (kg)|Mean|83.0|83.0|Standard Deviation|12.4|12.4|||
3773702|NCT01905956|3606551|B3|||Height||centimetres (cm)|Mean|168.8|168.8|Standard Deviation|9.3|9.3|||
3773703|NCT01905956|3606552|B2|||Height||centimetres (cm)|Mean|168.2|168.2|Standard Deviation|9.0|9.0|||
3773704|NCT01905956|3606553|B1|||Height||centimetres (cm)|Mean|169.3|169.3|Standard Deviation|9.6|9.6|||
3773705|NCT01905956|3606551|B3|Germany||Region of Enrollment||participants|Number|111|111.0||||||
3773706|NCT01905956|3606552|B2|Germany||Region of Enrollment||participants|Number|54|54.0||||||
3773707|NCT01905956|3606553|B1|Germany||Region of Enrollment||participants|Number|57|57.0||||||
3773708|NCT01905956|3606551|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|111|111.0||||||
3773709|NCT01905956|3606552|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
3773710|NCT01905956|3606553|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
3773711|NCT01905956|3606551|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3773712|NCT01905956|3606552|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3773713|NCT01905956|3606553|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3773714|NCT01905956|3606551|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3773715|NCT01905956|3606552|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3773716|NCT01905956|3606553|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3773717|NCT01905956|3606551|B3|||Age||years|Mean|47.4|47.4|Standard Deviation|11.4|11.4|||
3773718|NCT01905956|3606552|B2|||Age||years|Mean|46.3|46.3|Standard Deviation|10.5|10.5|||
3773719|NCT01905956|3606553|B1|||Age||years|Mean|47.9|47.9|Standard Deviation|12.3|12.3|||
3773720|NCT01905956|3606551|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3773721|NCT01905956|3606552|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3773722|NCT01905956|3606553|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3773723|NCT01905956|3606551|B3||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
3773724|NCT01905956|3606552|B2||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3773725|NCT01905956|3606553|B1||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
3773726|NCT01905956|3606551|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3773727|NCT01905956|3606552|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3773728|NCT01905956|3606553|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3773729|NCT01905943|3606576|B1||Male|Sex: Female, Male||Participants|Count of Participants|617|617.0||||||
3773730|NCT01905943|3606576|B1||Female|Sex: Female, Male||Participants|Count of Participants|355|355.0||||||
3773731|NCT01905943|3606576|B1|||Age||years|Mean|65.4|65.4|Standard Deviation|10.94|10.94|||
3773732|NCT01905683|3606693|B1|Russia||Region of Enrollment||participants|Number|33|33.0||||||
3773733|NCT01905683|3606693|B1|Estonia||Region of Enrollment||participants|Number|5|5.0||||||
3773734|NCT01905683|3606693|B1|Germany||Region of Enrollment||participants|Number|1|1.0||||||
3773735|NCT01905683|3606693|B1|Slovakia||Region of Enrollment||participants|Number|5|5.0||||||
3773736|NCT01905683|3606693|B1|Israel||Region of Enrollment||participants|Number|1|1.0||||||
3773737|NCT01905683|3606693|B1|Poland||Region of Enrollment||participants|Number|67|67.0||||||
3773738|NCT01905683|3606693|B1|Ukraine||Region of Enrollment||participants|Number|170|170.0||||||
3773739|NCT01905683|3606693|B1|Czechia||Region of Enrollment||participants|Number|1|1.0||||||
3773740|NCT01905683|3606693|B1|Turkey||Region of Enrollment||participants|Number|5|5.0||||||
3773741|NCT01905683|3606693|B1|Romania||Region of Enrollment||participants|Number|22|22.0||||||
3773742|NCT01905683|3606693|B1|South Korea||Region of Enrollment||participants|Number|59|59.0||||||
3773743|NCT01905683|3606693|B1|Austria||Region of Enrollment||participants|Number|1|1.0||||||
3773744|NCT01905683|3606693|B1||Male|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
3773745|NCT01905683|3606693|B1||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3773746|NCT01905683|3606693|B1|Adolescents (12-17 years)||Age, Customized||Participants|Count of Participants|53|53.0||||||
3773747|NCT01905683|3606693|B1|Children (2-11 years)||Age, Customized||Participants|Count of Participants|317|317.0||||||
3773748|NCT01905683|3606693|B1|||Age||years|Mean|6.2|6.2|Standard Deviation|4.1|4.1|||
3773749|NCT01905657|3606706|B4|Strongly PD-L1 Positive||PD-L1 Tumor Expression Status|PD-L1 expression was evaluated by immunohistochemistry (IHC) assay with a newly obtained tumor tissue with biopsy. If PD-L1 expression was observed in >1%, but ≤49% of tumor cells, a participant was categorized as weakly PD-L1 positive. If PD-L1 expression was observed in ≥50% of tumor cells, a participant was categorized as strongly PD-L1 positive.|Participants|Number|442|442.0||||||
3773750|NCT01905657|3606707|B3|Strongly PD-L1 Positive||PD-L1 Tumor Expression Status|PD-L1 expression was evaluated by immunohistochemistry (IHC) assay with a newly obtained tumor tissue with biopsy. If PD-L1 expression was observed in >1%, but ≤49% of tumor cells, a participant was categorized as weakly PD-L1 positive. If PD-L1 expression was observed in ≥50% of tumor cells, a participant was categorized as strongly PD-L1 positive.|Participants|Number|152|152.0||||||
3773751|NCT01905657|3606708|B2|Strongly PD-L1 Positive||PD-L1 Tumor Expression Status|PD-L1 expression was evaluated by immunohistochemistry (IHC) assay with a newly obtained tumor tissue with biopsy. If PD-L1 expression was observed in >1%, but ≤49% of tumor cells, a participant was categorized as weakly PD-L1 positive. If PD-L1 expression was observed in ≥50% of tumor cells, a participant was categorized as strongly PD-L1 positive.|Participants|Number|151|151.0||||||
3773752|NCT01905657|3606709|B1|Strongly PD-L1 Positive||PD-L1 Tumor Expression Status|PD-L1 expression was evaluated by immunohistochemistry (IHC) assay with a newly obtained tumor tissue with biopsy. If PD-L1 expression was observed in >1%, but ≤49% of tumor cells, a participant was categorized as weakly PD-L1 positive. If PD-L1 expression was observed in ≥50% of tumor cells, a participant was categorized as strongly PD-L1 positive.|Participants|Number|139|139.0||||||
3773753|NCT01905657|3606706|B4|Weakly PD-L1 Positive||PD-L1 Tumor Expression Status|PD-L1 expression was evaluated by immunohistochemistry (IHC) assay with a newly obtained tumor tissue with biopsy. If PD-L1 expression was observed in >1%, but ≤49% of tumor cells, a participant was categorized as weakly PD-L1 positive. If PD-L1 expression was observed in ≥50% of tumor cells, a participant was categorized as strongly PD-L1 positive.|Participants|Number|591|591.0||||||
3773754|NCT01905657|3606707|B3|Weakly PD-L1 Positive||PD-L1 Tumor Expression Status|PD-L1 expression was evaluated by immunohistochemistry (IHC) assay with a newly obtained tumor tissue with biopsy. If PD-L1 expression was observed in >1%, but ≤49% of tumor cells, a participant was categorized as weakly PD-L1 positive. If PD-L1 expression was observed in ≥50% of tumor cells, a participant was categorized as strongly PD-L1 positive.|Participants|Number|191|191.0||||||
3773755|NCT01905657|3606708|B2|Weakly PD-L1 Positive||PD-L1 Tumor Expression Status|PD-L1 expression was evaluated by immunohistochemistry (IHC) assay with a newly obtained tumor tissue with biopsy. If PD-L1 expression was observed in >1%, but ≤49% of tumor cells, a participant was categorized as weakly PD-L1 positive. If PD-L1 expression was observed in ≥50% of tumor cells, a participant was categorized as strongly PD-L1 positive.|Participants|Number|195|195.0||||||
3773756|NCT01905657|3606709|B1|Weakly PD-L1 Positive||PD-L1 Tumor Expression Status|PD-L1 expression was evaluated by immunohistochemistry (IHC) assay with a newly obtained tumor tissue with biopsy. If PD-L1 expression was observed in >1%, but ≤49% of tumor cells, a participant was categorized as weakly PD-L1 positive. If PD-L1 expression was observed in ≥50% of tumor cells, a participant was categorized as strongly PD-L1 positive.|Participants|Number|205|205.0||||||
3773757|NCT01905657|3606706|B4||Male|Sex: Female, Male||Participants|Count of Participants|634|634.0||||||
3773758|NCT01905657|3606707|B3||Male|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
3773759|NCT01905657|3606708|B2||Male|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
3773760|NCT01905657|3606709|B1||Male|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
3773761|NCT01905657|3606706|B4||Female|Sex: Female, Male||Participants|Count of Participants|399|399.0||||||
3773762|NCT01905657|3606707|B3||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3773763|NCT01905657|3606708|B2||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3773764|NCT01905657|3606709|B1||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3773765|NCT01905657|3606706|B4|||Age||Years|Mean|62.0|62.0|Standard Deviation|9.7|9.7|||
3773766|NCT01905657|3606707|B3|||Age||Years|Mean|61.6|61.6|Standard Deviation|9.8|9.8|||
3773767|NCT01905657|3606708|B2|||Age||Years|Mean|62.3|62.3|Standard Deviation|9.7|9.7|||
3773768|NCT01905657|3606709|B1|||Age||Years|Mean|62.1|62.1|Standard Deviation|9.6|9.6|||
3773769|NCT01905553|3606734|B3|UNITED STATES||Region of Enrollment||Participants|Number|9|9.0||||||
3773770|NCT01905553|3606735|B2|UNITED STATES||Region of Enrollment||Participants|Number|4|4.0||||||
3773771|NCT01905553|3606736|B1|UNITED STATES||Region of Enrollment||Participants|Number|5|5.0||||||
3773772|NCT01905553|3606734|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3773773|NCT01905553|3606735|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3773774|NCT01905553|3606736|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3773775|NCT01905553|3606734|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3773776|NCT01905553|3606735|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3773777|NCT01905553|3606736|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3773778|NCT01905553|3606734|B3|||Age||Years|Mean|38.9|38.9|Standard Deviation|9.73|9.73|||
3773779|NCT01905553|3606735|B2|||Age||Years|Mean|35|35.0|Standard Deviation|7.62|7.62|||
3773780|NCT01905553|3606736|B1|||Age||Years|Mean|42|42.0|Standard Deviation|10.89|10.89|||
3773781|NCT01905553|3606734|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3773782|NCT01905553|3606735|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3773783|NCT01905553|3606736|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3773784|NCT01905553|3606734|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3773785|NCT01905553|3606735|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3773786|NCT01905553|3606736|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3773787|NCT01905553|3606734|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3773788|NCT01905553|3606735|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3773789|NCT01905553|3606736|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3773790|NCT01905540|3606747|B5|UNITED STATES||Region of Enrollment||Participants|Number|28|28.0||||||
3773791|NCT01905540|3606748|B4|UNITED STATES||Region of Enrollment||Participants|Number|7|7.0||||||
3773792|NCT01905540|3606749|B3|UNITED STATES||Region of Enrollment||Participants|Number|7|7.0||||||
3773793|NCT01905540|3606750|B2|UNITED STATES||Region of Enrollment||Participants|Number|7|7.0||||||
3773794|NCT01905540|3606751|B1|UNITED STATES||Region of Enrollment||Participants|Number|7|7.0||||||
3773795|NCT01905540|3606747|B5||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3773798|NCT01905540|3606750|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3773799|NCT01905540|3606751|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3773800|NCT01905540|3606747|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3773801|NCT01905540|3606748|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3773802|NCT01905540|3606749|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3773803|NCT01905540|3606750|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3773804|NCT01905540|3606751|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3773805|NCT01905540|3606747|B5|Between 18 and 65 years||Age, Customized||Participants|Number|27|27.0||||||
3773806|NCT01905540|3606748|B4|Between 18 and 65 years||Age, Customized||Participants|Number|7|7.0||||||
3773807|NCT01905540|3606749|B3|Between 18 and 65 years||Age, Customized||Participants|Number|7|7.0||||||
3773808|NCT01905540|3606750|B2|Between 18 and 65 years||Age, Customized||Participants|Number|7|7.0||||||
3773809|NCT01905540|3606751|B1|Between 18 and 65 years||Age, Customized||Participants|Number|6|6.0||||||
3773810|NCT01905540|3606747|B5|>=65 years||Age, Customized||Participants|Number|1|1.0||||||
3773811|NCT01905540|3606748|B4|>=65 years||Age, Customized||Participants|Number|0|0.0||||||
3773812|NCT01905540|3606749|B3|>=65 years||Age, Customized||Participants|Number|0|0.0||||||
3773813|NCT01905540|3606750|B2|>=65 years||Age, Customized||Participants|Number|0|0.0||||||
3773814|NCT01905540|3606751|B1|>=65 years||Age, Customized||Participants|Number|1|1.0||||||
3773815|NCT01905540|3606747|B5|||Age||Years|Mean|43|43.0|Standard Deviation|11.4|11.4|||
3773816|NCT01905540|3606748|B4|||Age||Years|Mean|42.7|42.7|Standard Deviation|13.46|13.46|||
3773817|NCT01905540|3606749|B3|||Age||Years|Mean|41.3|41.3|Standard Deviation|10.27|10.27|||
3773818|NCT01905540|3606750|B2|||Age||Years|Mean|44.4|44.4|Standard Deviation|11.53|11.53|||
3773819|NCT01905540|3606751|B1|||Age||Years|Mean|43.7|43.7|Standard Deviation|12.58|12.58|||
3773820|NCT01905423|3606772|B5|||Prevalence of worm eggs in stool||Participants|Count of Participants|969|969.0||||||
3773821|NCT01905423|3606773|B4|||Prevalence of worm eggs in stool||Participants|Count of Participants|335|335.0||||||
3773822|NCT01905423|3606774|B3|||Prevalence of worm eggs in stool||Participants|Count of Participants|199|199.0||||||
3773823|NCT01905423|3606775|B2|||Prevalence of worm eggs in stool||Participants|Count of Participants|63|63.0||||||
3773824|NCT01905423|3606776|B1|||Prevalence of worm eggs in stool||Participants|Count of Participants|372|372.0||||||
3773825|NCT01905423|3606772|B5|||Lymphatic Filariasis Antigen Prevalence (ICT)||Participants|Count of Participants|554|554.0||||||
3773826|NCT01905423|3606773|B4|||Lymphatic Filariasis Antigen Prevalence (ICT)||Participants|Count of Participants|112|112.0||||||
3773827|NCT01905423|3606774|B3|||Lymphatic Filariasis Antigen Prevalence (ICT)||Participants|Count of Participants|149|149.0||||||
3773828|NCT01905423|3606775|B2|||Lymphatic Filariasis Antigen Prevalence (ICT)||Participants|Count of Participants|232|232.0||||||
3773829|NCT01905423|3606776|B1|||Lymphatic Filariasis Antigen Prevalence (ICT)||Participants|Count of Participants|61|61.0||||||
3773830|NCT01905423|3606772|B5|||LF Microfilaria Prevalence||Participants|Count of Participants|329|329.0||||||
3773831|NCT01905423|3606773|B4|||LF Microfilaria Prevalence||Participants|Count of Participants|45|45.0||||||
3773832|NCT01905423|3606774|B3|||LF Microfilaria Prevalence||Participants|Count of Participants|48|48.0||||||
3773833|NCT01905423|3606775|B2|||LF Microfilaria Prevalence||Participants|Count of Participants|146|146.0||||||
3773834|NCT01905423|3606776|B1|||LF Microfilaria Prevalence||Participants|Count of Participants|90|90.0||||||
3773835|NCT01905423|3606772|B5|Indonesia||Region of Enrollment||participants|Number|6914|6914.0||||||
3773836|NCT01905423|3606773|B4|Indonesia||Region of Enrollment||participants|Number|1634|1634.0||||||
3773837|NCT01905423|3606774|B3|Indonesia||Region of Enrollment||participants|Number|2082|2082.0||||||
3773838|NCT01905423|3606775|B2|Indonesia||Region of Enrollment||participants|Number|1033|1033.0||||||
3773839|NCT01905423|3606776|B1|Indonesia||Region of Enrollment||participants|Number|2165|2165.0||||||
3773840|NCT01905423|3606772|B5|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3773841|NCT01905423|3606772|B5||Male|Sex: Female, Male||Participants|Count of Participants|3001|3001.0||||||
3773842|NCT01905423|3606773|B4||Male|Sex: Female, Male||Participants|Count of Participants|738|738.0||||||
3773843|NCT01905423|3606774|B3||Male|Sex: Female, Male||Participants|Count of Participants|919|919.0||||||
3773844|NCT01905423|3606775|B2||Male|Sex: Female, Male||Participants|Count of Participants|488|488.0||||||
3773845|NCT01905423|3606776|B1||Male|Sex: Female, Male||Participants|Count of Participants|856|856.0||||||
3773846|NCT01905423|3606772|B5||Female|Sex: Female, Male||Participants|Count of Participants|3836|3836.0||||||
3773847|NCT01905423|3606773|B4||Female|Sex: Female, Male||Participants|Count of Participants|896|896.0||||||
3773848|NCT01905423|3606774|B3||Female|Sex: Female, Male||Participants|Count of Participants|1087|1087.0||||||
3773849|NCT01905423|3606775|B2||Female|Sex: Female, Male||Participants|Count of Participants|545|545.0||||||
3773850|NCT01905423|3606776|B1||Female|Sex: Female, Male||Participants|Count of Participants|1308|1308.0||||||
3773851|NCT01905423|3606772|B5|||Age||years|Mean|27.84|27.84|Full Range|||5.0|87.0|
3773852|NCT01905423|3606773|B4|||Age||years|Mean|28.87|28.87|Full Range|||5.0|84.0|
3773853|NCT01905423|3606774|B3|||Age||years|Mean|27.43|27.43|Full Range|||5.0|87.0|
3773854|NCT01905423|3606775|B2|||Age||years|Mean|27.82|27.82|Full Range|||5.0|83.0|
3773855|NCT01905423|3606776|B1|||Age||years|Mean|27.47|27.47|Full Range|||5.0|87.0|
3773856|NCT01905267|3606787|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3773857|NCT01905267|3606788|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3773858|NCT01905267|3606789|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773859|NCT01905267|3606787|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3773860|NCT01905267|3606788|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3773861|NCT01905267|3606789|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3773862|NCT01905267|3606787|B3||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3773863|NCT01905267|3606788|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3773864|NCT01905267|3606789|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3773865|NCT01905267|3606787|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3773866|NCT01905267|3606788|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3773867|NCT01905267|3606789|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3773868|NCT01905267|3606787|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773869|NCT01905267|3606788|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773870|NCT01905267|3606789|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773871|NCT01905267|3606787|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3773872|NCT01905267|3606788|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773873|NCT01905267|3606789|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3773874|NCT01905267|3606787|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773875|NCT01905267|3606788|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773876|NCT01905267|3606789|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773877|NCT01905267|3606787|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3773878|NCT01905267|3606788|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3773879|NCT01905267|3606789|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3773880|NCT01905267|3606787|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3773881|NCT01905267|3606788|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3773882|NCT01905267|3606789|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3773883|NCT01905267|3606787|B3|||Age||years|Mean|15.55|15.55|Standard Deviation|1.91|1.91|||
3773884|NCT01905267|3606788|B2|||Age||years|Mean|15.69|15.69|Standard Deviation|1.89|1.89|||
3773885|NCT01905267|3606789|B1|||Age||years|Mean|15.41|15.41|Standard Deviation|1.97|1.97|||
3773886|NCT01905254|3606798|B1|Germany||Region of Enrollment||participants|Number|34|34.0||||||
3773887|NCT01905254|3606798|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773888|NCT01905254|3606798|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773889|NCT01905254|3606798|B1||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3773890|NCT01905254|3606798|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773891|NCT01905254|3606798|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773892|NCT01905254|3606798|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773893|NCT01905254|3606798|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773894|NCT01905254|3606798|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3773895|NCT01905254|3606798|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3773896|NCT01905254|3606798|B1|||Age||years|Median|53|53.0|Full Range|||21.0|74.0|
3773897|NCT01904864|3606802|B3|United States||Region of Enrollment||Participants|Count of Participants|80|80.0||||||
3773898|NCT01904864|3606803|B2|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3773899|NCT01904864|3606804|B1|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3773900|NCT01904864|3606802|B3|>1 Race/ethnicity||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3773901|NCT01904864|3606803|B2|>1 Race/ethnicity||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3773902|NCT01904864|3606804|B1|>1 Race/ethnicity||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3773903|NCT01904864|3606802|B3|Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3773904|NCT01904864|3606803|B2|Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3773905|NCT01904864|3606804|B1|Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3773906|NCT01904864|3606802|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3773907|NCT01904864|3606803|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3773908|NCT01904864|3606804|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3773909|NCT01904864|3606802|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3773910|NCT01904864|3606803|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3773911|NCT01904864|3606804|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3773912|NCT01904864|3606802|B3|Non-Hispanic white||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3773913|NCT01904864|3606803|B2|Non-Hispanic white||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3773914|NCT01904864|3606804|B1|Non-Hispanic white||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3773915|NCT01904864|3606802|B3|Hispanic white||Race/Ethnicity, Customized||Participants|Count of Participants|49|49.0||||||
3773916|NCT01904864|3606803|B2|Hispanic white||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3773917|NCT01904864|3606804|B1|Hispanic white||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3773918|NCT01904864|3606802|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3773919|NCT01904864|3606803|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3773920|NCT01904864|3606804|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3773921|NCT01904864|3606802|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3773922|NCT01904864|3606803|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3773923|NCT01904864|3606804|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3773924|NCT01904864|3606802|B3|||Age||Months|Median|23|23.0|Full Range|||10.0|37.0|
3773925|NCT01904864|3606803|B2|||Age||Months|Median|22|22.0|Full Range|||10.0|37.0|
3773926|NCT01904864|3606804|B1|||Age||Months|Median|23|23.0|Full Range|||11.0|34.0|
3773927|NCT01904773|3606811|B1|||Tourette's Disorder Duration|Tourette's Disorder Duration in months|months|Median|75|75.0|Full Range|||29.8|159.4|
3773928|NCT01904773|3606811|B1|Past||Nicotine use|Have ever used nicotine, never, past, present response|Participants|Number|0|0.0||||||
3773929|NCT01904773|3606811|B1|Never||Nicotine use|Have ever used nicotine, never, past, present response|Participants|Number|24|24.0||||||
3773930|NCT01904773|3606811|B1|Current||Nicotine use|Have ever used nicotine, never, past, present response|Participants|Number|0|0.0||||||
3773931|NCT01904773|3606811|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773932|NCT01904773|3606811|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773933|NCT01904773|3606811|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3773934|NCT01904773|3606811|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3773935|NCT01904773|3606811|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773936|NCT01904773|3606811|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3773937|NCT01904773|3606811|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773938|NCT01904773|3606811|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3773939|NCT01904773|3606811|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3773940|NCT01904773|3606811|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3773941|NCT01904773|3606811|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3773942|NCT01904773|3606811|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3773943|NCT01904773|3606811|B1|||Age|Adolescent - age 12 to 17|years|Mean|14.6|14.6|Standard Deviation|1.76|1.76|||
3773944|NCT01904760|3606834|B3|China||Region of Enrollment||participants|Number|79|79.0||||||
3773945|NCT01904760|3606835|B2|China||Region of Enrollment||participants|Number|40|40.0||||||
3773946|NCT01904760|3606836|B1|China||Region of Enrollment||participants|Number|39|39.0||||||
3773947|NCT01904760|3606834|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3773948|NCT01904760|3606835|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3773949|NCT01904760|3606836|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3773950|NCT01904760|3606834|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3773951|NCT01904760|3606835|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3773952|NCT01904760|3606836|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3773953|NCT01904760|3606834|B3|||Age||years|Mean|50.5|50.5|Standard Deviation|13.6|13.6|||
3773954|NCT01904760|3606835|B2|||Age||years|Mean|50.6|50.6|Standard Deviation|12.3|12.3|||
3773955|NCT01904760|3606836|B1|||Age||years|Mean|50.3|50.3|Standard Deviation|15.0|15.0|||
3773956|NCT01904721|3606845|B8|Male||Sex/Gender, Customized||Participants|Number|244|244.0||||||
3773957|NCT01904721|3606846|B7|Male||Sex/Gender, Customized||Participants|Number|64|64.0||||||
3773958|NCT01904721|3606847|B6|Male||Sex/Gender, Customized||Participants|Number|65|65.0||||||
3773959|NCT01904721|3606848|B5|Male||Sex/Gender, Customized||Participants|Number|65|65.0||||||
3773960|NCT01904721|3606849|B4|Male||Sex/Gender, Customized||Participants|Number|12|12.0||||||
3773961|NCT01904721|3606850|B3|Male||Sex/Gender, Customized||Participants|Number|12|12.0||||||
3773962|NCT01904721|3606851|B2|Male||Sex/Gender, Customized||Participants|Number|13|13.0||||||
3773963|NCT01904721|3606852|B1|Male||Sex/Gender, Customized||Participants|Number|13|13.0||||||
3773964|NCT01904721|3606845|B8|35 to 49 years||Age, Customized||Participants|Number|178|178.0||||||
3773965|NCT01904721|3606846|B7|35 to 49 years||Age, Customized||Participants|Number|47|47.0||||||
3773966|NCT01904721|3606847|B6|35 to 49 years||Age, Customized||Participants|Number|47|47.0||||||
3773967|NCT01904721|3606848|B5|35 to 49 years||Age, Customized||Participants|Number|48|48.0||||||
3773968|NCT01904721|3606849|B4|35 to 49 years||Age, Customized||Participants|Number|9|9.0||||||
3773969|NCT01904721|3606850|B3|35 to 49 years||Age, Customized||Participants|Number|9|9.0||||||
3773970|NCT01904721|3606851|B2|35 to 49 years||Age, Customized||Participants|Number|13|13.0||||||
3773971|NCT01904721|3606852|B1|35 to 49 years||Age, Customized||Participants|Number|5|5.0||||||
3773972|NCT01904721|3606845|B8|≥18 to <35 years||Age, Customized||Participants|Number|66|66.0||||||
3773973|NCT01904721|3606846|B7|≥18 to <35 years||Age, Customized||Participants|Number|17|17.0||||||
3773974|NCT01904721|3606847|B6|≥18 to <35 years||Age, Customized||Participants|Number|18|18.0||||||
3773975|NCT01904721|3606848|B5|≥18 to <35 years||Age, Customized||Participants|Number|17|17.0||||||
3773976|NCT01904721|3606849|B4|≥18 to <35 years||Age, Customized||Participants|Number|3|3.0||||||
3773977|NCT01904721|3606850|B3|≥18 to <35 years||Age, Customized||Participants|Number|3|3.0||||||
3773978|NCT01904721|3606851|B2|≥18 to <35 years||Age, Customized||Participants|Number|0|0.0||||||
3773979|NCT01904721|3606852|B1|≥18 to <35 years||Age, Customized||Participants|Number|8|8.0||||||
3773980|NCT01904604|3606885|B4|||Age at Initial Peanut Allergic Reaction||years|Mean|2.3|2.3|Standard Deviation|2.3|2.3|||
3773981|NCT01904604|3606886|B3|||Age at Initial Peanut Allergic Reaction||years|Mean|2.1|2.1|Standard Deviation|2.0|2.0|||
3773982|NCT01904604|3606887|B2|||Age at Initial Peanut Allergic Reaction||years|Mean|2.8|2.8|Standard Deviation|3.3|3.3|||
3773983|NCT01904604|3606888|B1|||Age at Initial Peanut Allergic Reaction||years|Mean|1.9|1.9|Standard Deviation|1.2|1.2|||
3773984|NCT01904604|3606885|B4|||Skin Prick Test Score|This score is calculated by subtracting the size of the saline wheal (in mm) from the size of the peanut wheal (in mm) observed for a skin prick test. Individuals with a peanut skin prick test score of < 3 mm are considered to have a negative result.|mm|Mean|13.3|13.3|Standard Deviation|7.0|7.0|||
3773985|NCT01904604|3606886|B3|||Skin Prick Test Score|This score is calculated by subtracting the size of the saline wheal (in mm) from the size of the peanut wheal (in mm) observed for a skin prick test. Individuals with a peanut skin prick test score of < 3 mm are considered to have a negative result.|mm|Mean|12.7|12.7|Standard Deviation|5.2|5.2|||
3773986|NCT01904604|3606887|B2|||Skin Prick Test Score|This score is calculated by subtracting the size of the saline wheal (in mm) from the size of the peanut wheal (in mm) observed for a skin prick test. Individuals with a peanut skin prick test score of < 3 mm are considered to have a negative result.|mm|Mean|12.9|12.9|Standard Deviation|6.8|6.8|||
3773987|NCT01904604|3606888|B1|||Skin Prick Test Score|This score is calculated by subtracting the size of the saline wheal (in mm) from the size of the peanut wheal (in mm) observed for a skin prick test. Individuals with a peanut skin prick test score of < 3 mm are considered to have a negative result.|mm|Mean|14.1|14.1|Standard Deviation|8.6|8.6|||
3773988|NCT01904604|3606885|B4|||Peanut IgE|Amount of serum peanut-specific immunoglobulin E. Individuals with a peanut IgE of <0.35 kUA/L are considered not to be sensitized to peanut.|kUA/L|Mean|84.9|84.9|Standard Deviation|65.7|65.7|||
3773989|NCT01904604|3606886|B3|||Peanut IgE|Amount of serum peanut-specific immunoglobulin E. Individuals with a peanut IgE of <0.35 kUA/L are considered not to be sensitized to peanut.|kUA/L|Mean|89.9|89.9|Standard Deviation|64.3|64.3|||
3773990|NCT01904604|3606887|B2|||Peanut IgE|Amount of serum peanut-specific immunoglobulin E. Individuals with a peanut IgE of <0.35 kUA/L are considered not to be sensitized to peanut.|kUA/L|Mean|87.6|87.6|Standard Deviation|65.3|65.3|||
3773991|NCT01904604|3606888|B1|||Peanut IgE|Amount of serum peanut-specific immunoglobulin E. Individuals with a peanut IgE of <0.35 kUA/L are considered not to be sensitized to peanut.|kUA/L|Mean|77.3|77.3|Standard Deviation|69.4|69.4|||
3773992|NCT01904604|3606885|B4|||Total IgE|Total amount of serum immunoglobulin E.|kU/L|Mean|795.4|795.4|Standard Deviation|884.2|884.2|||
3773993|NCT01904604|3606886|B3|||Total IgE|Total amount of serum immunoglobulin E.|kU/L|Mean|691.5|691.5|Standard Deviation|602.3|602.3|||
3773994|NCT01904604|3606887|B2|||Total IgE|Total amount of serum immunoglobulin E.|kU/L|Mean|949.1|949.1|Standard Deviation|1183.5|1183.5|||
3773995|NCT01904604|3606888|B1|||Total IgE|Total amount of serum immunoglobulin E.|kU/L|Mean|751.8|751.8|Standard Deviation|797.6|797.6|||
3773996|NCT01904604|3606885|B4|||Atopic Dermatitis Total Score|The Atopic Dermatitis Total Score is scored on a 10 point scale of 0 to 9 where a higher score indicates increasing severity of atopic dermatitis. This score is a combination of three scores that range from 0 to 3 in the following areas: body surface area score, disease course, and disease intensity.|Scores on a scale|Mean|1.6|1.6|Standard Deviation|2.4|2.4|||
3773997|NCT01904604|3606886|B3|||Atopic Dermatitis Total Score|The Atopic Dermatitis Total Score is scored on a 10 point scale of 0 to 9 where a higher score indicates increasing severity of atopic dermatitis. This score is a combination of three scores that range from 0 to 3 in the following areas: body surface area score, disease course, and disease intensity.|Scores on a scale|Mean|1.5|1.5|Standard Deviation|2.2|2.2|||
3773998|NCT01904604|3606887|B2|||Atopic Dermatitis Total Score|The Atopic Dermatitis Total Score is scored on a 10 point scale of 0 to 9 where a higher score indicates increasing severity of atopic dermatitis. This score is a combination of three scores that range from 0 to 3 in the following areas: body surface area score, disease course, and disease intensity.|Scores on a scale|Mean|1.4|1.4|Standard Deviation|2.3|2.3|||
3773999|NCT01904604|3606888|B1|||Atopic Dermatitis Total Score|The Atopic Dermatitis Total Score is scored on a 10 point scale of 0 to 9 where a higher score indicates increasing severity of atopic dermatitis. This score is a combination of three scores that range from 0 to 3 in the following areas: body surface area score, disease course, and disease intensity.|Scores on a scale|Mean|1.9|1.9|Standard Deviation|2.6|2.6|||
3774000|NCT01904604|3606885|B4|United States||Region of Enrollment||participants|Number|74|74.0||||||
3774001|NCT01904604|3606886|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
3774002|NCT01904604|3606887|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
3774003|NCT01904604|3606888|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3774004|NCT01904604|3606885|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774005|NCT01904604|3606886|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774006|NCT01904604|3606887|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774007|NCT01904604|3606888|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774008|NCT01904604|3606885|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3774009|NCT01904604|3606886|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3774010|NCT01904604|3606887|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3774011|NCT01904604|3606888|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774012|NCT01904604|3606885|B4||White|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3774013|NCT01904604|3606886|B3||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3774014|NCT01904604|3606887|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3774015|NCT01904604|3606888|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3774016|NCT01904604|3606885|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3774017|NCT01904604|3606886|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774018|NCT01904604|3606887|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3774019|NCT01904604|3606888|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3774020|NCT01904604|3606885|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774021|NCT01904604|3606886|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774022|NCT01904604|3606887|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774023|NCT01904604|3606888|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774024|NCT01904604|3606885|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3774025|NCT01904604|3606886|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774026|NCT01904604|3606887|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3774027|NCT01904604|3606888|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3774028|NCT01904604|3606885|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774029|NCT01904604|3606886|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774030|NCT01904604|3606887|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774031|NCT01904604|3606888|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774032|NCT01904604|3606885|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774033|NCT01904604|3606886|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774034|NCT01904604|3606887|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774035|NCT01904604|3606888|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774036|NCT01904604|3606885|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3774037|NCT01904604|3606886|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3774038|NCT01904604|3606887|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3774039|NCT01904604|3606888|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3774040|NCT01904604|3606885|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3774041|NCT01904604|3606886|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3774042|NCT01904604|3606887|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774043|NCT01904604|3606888|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3774044|NCT01904604|3606885|B4||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3774045|NCT01904604|3606886|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3774046|NCT01904604|3606887|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3774047|NCT01904604|3606888|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3774048|NCT01904604|3606885|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3774049|NCT01904604|3606886|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3774050|NCT01904604|3606887|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3774051|NCT01904604|3606888|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3774052|NCT01904604|3606885|B4|||Age||years|Mean|9.5|9.5|Standard Deviation|3.6|3.6|||
3774053|NCT01904604|3606886|B3|||Age||years|Mean|8.8|8.8|Standard Deviation|3.4|3.4|||
3774054|NCT01904604|3606887|B2|||Age||years|Mean|9.7|9.7|Standard Deviation|3.4|3.4|||
3774055|NCT01904604|3606888|B1|||Age||years|Mean|10.1|10.1|Standard Deviation|3.9|3.9|||
3774056|NCT01904604|3606885|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3774057|NCT01904604|3606886|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3774058|NCT01904604|3606887|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3774059|NCT01904604|3606888|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3774060|NCT01904604|3606885|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3774061|NCT01904604|3606886|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3774062|NCT01904604|3606887|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3774063|NCT01904604|3606888|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3774064|NCT01904604|3606885|B4||<=18 years|Age||Participants|Count of Participants|73|73.0||||||
3774065|NCT01904604|3606886|B3||<=18 years|Age||Participants|Count of Participants|25|25.0||||||
3774066|NCT01904604|3606887|B2||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
3774067|NCT01904604|3606888|B1||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
3774068|NCT01904526|3606906|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3774069|NCT01904526|3606906|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3774070|NCT01904526|3606906|B1|||Age||Years|Mean|45.8|45.8|Standard Deviation|2.49|2.49|||
3774071|NCT01904448|3606920|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3774072|NCT01904448|3606920|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774073|NCT01904448|3606920|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774074|NCT01904448|3606920|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3774075|NCT01904448|3606920|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774076|NCT01904448|3606920|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774077|NCT01904448|3606920|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3774078|NCT01904448|3606920|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774079|NCT01904448|3606920|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3774080|NCT01904448|3606920|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3774081|NCT01904448|3606920|B1|||Age||years|Mean|3.4|3.4|Full Range|||2.1|5.5|
3774082|NCT01904448|3606920|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3774083|NCT01904448|3606920|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3774084|NCT01904448|3606920|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3774085|NCT01904279|3606942|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3774086|NCT01904279|3606943|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3774087|NCT01904279|3606944|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3774088|NCT01904279|3606942|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3774089|NCT01904279|3606943|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3774090|NCT01904279|3606944|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3774091|NCT01904279|3606942|B3|||Age||years|Mean|9.6|9.6|Standard Deviation|4.9|4.9|||
3774092|NCT01904279|3606943|B2|||Age||years|Mean|13.9|13.9|Standard Deviation|2.7|2.7|||
3774093|NCT01904279|3606944|B1|||Age||years|Mean|5.5|5.5|Standard Deviation|2.1|2.1|||
3774094|NCT01904149|3606965|B7|||Height||cm|Mean|164.0|164.0|Standard Deviation|5.94|5.94|||
3774095|NCT01904149|3606966|B6|||Height||cm|Mean|164.4|164.4|Standard Deviation|5.59|5.59|||
3774096|NCT01904149|3606967|B5|||Height||cm|Mean|163.5|163.5|Standard Deviation|5.94|5.94|||
3774097|NCT01904149|3606968|B4|||Height||cm|Mean|164.5|164.5|Standard Deviation|6.17|6.17|||
3774098|NCT01904149|3606969|B3|||Height||cm|Mean|164.1|164.1|Standard Deviation|6.10|6.1|||
3774099|NCT01904149|3606970|B2|||Height||cm|Mean|163.7|163.7|Standard Deviation|6.37|6.37|||
3774100|NCT01904149|3606971|B1|||Height||cm|Mean|163.9|163.9|Standard Deviation|5.40|5.4|||
3774101|NCT01904149|3606965|B7|||Weight||kg|Mean|72.9|72.9|Standard Deviation|13.58|13.58|||
3774102|NCT01904149|3606966|B6|||Weight||kg|Mean|72.6|72.6|Standard Deviation|10.97|10.97|||
3774103|NCT01904149|3606967|B5|||Weight||kg|Mean|72.9|72.9|Standard Deviation|14.60|14.6|||
3774104|NCT01904149|3606968|B4|||Weight||kg|Mean|73.6|73.6|Standard Deviation|13.74|13.74|||
3774105|NCT01904149|3606969|B3|||Weight||kg|Mean|71.3|71.3|Standard Deviation|12.17|12.17|||
3774106|NCT01904149|3606970|B2|||Weight||kg|Mean|72.1|72.1|Standard Deviation|13.54|13.54|||
3774107|NCT01904149|3606971|B1|||Weight||kg|Mean|75.2|75.2|Standard Deviation|15.15|15.15|||
3774108|NCT01904149|3606965|B7|Latvia||Region of Enrollment||participants|Number|72|72.0||||||
3774109|NCT01904149|3606966|B6|Latvia||Region of Enrollment||participants|Number|5|5.0||||||
3774110|NCT01904149|3606967|B5|Latvia||Region of Enrollment||participants|Number|4|4.0||||||
3774111|NCT01904149|3606968|B4|Latvia||Region of Enrollment||participants|Number|7|7.0||||||
3774112|NCT01904149|3606969|B3|Latvia||Region of Enrollment||participants|Number|17|17.0||||||
3774113|NCT01904149|3606970|B2|Latvia||Region of Enrollment||participants|Number|17|17.0||||||
3774114|NCT01904149|3606971|B1|Latvia||Region of Enrollment||participants|Number|22|22.0||||||
3774115|NCT01904149|3606965|B7|Russian Federation||Region of Enrollment||participants|Number|15|15.0||||||
3774116|NCT01904149|3606966|B6|Russian Federation||Region of Enrollment||participants|Number|2|2.0||||||
3774117|NCT01904149|3606967|B5|Russian Federation||Region of Enrollment||participants|Number|2|2.0||||||
3774118|NCT01904149|3606968|B4|Russian Federation||Region of Enrollment||participants|Number|2|2.0||||||
3774119|NCT01904149|3606969|B3|Russian Federation||Region of Enrollment||participants|Number|3|3.0||||||
3774120|NCT01904149|3606970|B2|Russian Federation||Region of Enrollment||participants|Number|3|3.0||||||
3774121|NCT01904149|3606971|B1|Russian Federation||Region of Enrollment||participants|Number|3|3.0||||||
3774122|NCT01904149|3606965|B7|Lithuania||Region of Enrollment||participants|Number|14|14.0||||||
3774123|NCT01904149|3606966|B6|Lithuania||Region of Enrollment||participants|Number|3|3.0||||||
3774124|NCT01904149|3606967|B5|Lithuania||Region of Enrollment||participants|Number|1|1.0||||||
3774125|NCT01904149|3606968|B4|Lithuania||Region of Enrollment||participants|Number|1|1.0||||||
3774126|NCT01904149|3606969|B3|Lithuania||Region of Enrollment||participants|Number|3|3.0||||||
3774127|NCT01904149|3606970|B2|Lithuania||Region of Enrollment||participants|Number|4|4.0||||||
3774128|NCT01904149|3606971|B1|Lithuania||Region of Enrollment||participants|Number|2|2.0||||||
3774129|NCT01904149|3606965|B7|Romania||Region of Enrollment||participants|Number|138|138.0||||||
3774130|NCT01904149|3606966|B6|Romania||Region of Enrollment||participants|Number|12|12.0||||||
3774131|NCT01904149|3606967|B5|Romania||Region of Enrollment||participants|Number|12|12.0||||||
3774132|NCT01904149|3606968|B4|Romania||Region of Enrollment||participants|Number|10|10.0||||||
3774133|NCT01904149|3606969|B3|Romania||Region of Enrollment||participants|Number|32|32.0||||||
3774134|NCT01904149|3606970|B2|Romania||Region of Enrollment||participants|Number|40|40.0||||||
3774135|NCT01904149|3606971|B1|Romania||Region of Enrollment||participants|Number|32|32.0||||||
3774136|NCT01904149|3606965|B7|Poland||Region of Enrollment||participants|Number|234|234.0||||||
3774137|NCT01904149|3606966|B6|Poland||Region of Enrollment||participants|Number|17|17.0||||||
3774138|NCT01904149|3606967|B5|Poland||Region of Enrollment||participants|Number|23|23.0||||||
3774139|NCT01904149|3606968|B4|Poland||Region of Enrollment||participants|Number|18|18.0||||||
3774140|NCT01904149|3606969|B3|Poland||Region of Enrollment||participants|Number|60|60.0||||||
3774141|NCT01904149|3606970|B2|Poland||Region of Enrollment||participants|Number|53|53.0||||||
3774142|NCT01904149|3606971|B1|Poland||Region of Enrollment||participants|Number|63|63.0||||||
3774143|NCT01904149|3606965|B7|Spain||Region of Enrollment||participants|Number|5|5.0||||||
3774144|NCT01904149|3606966|B6|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3774145|NCT01904149|3606967|B5|Spain||Region of Enrollment||participants|Number|0|0.0||||||
3774146|NCT01904149|3606968|B4|Spain||Region of Enrollment||participants|Number|0|0.0||||||
3774147|NCT01904149|3606969|B3|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3774148|NCT01904149|3606970|B2|Spain||Region of Enrollment||participants|Number|2|2.0||||||
3774149|NCT01904149|3606971|B1|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3774150|NCT01904149|3606965|B7|Slovakia||Region of Enrollment||participants|Number|39|39.0||||||
3774151|NCT01904149|3606966|B6|Slovakia||Region of Enrollment||participants|Number|4|4.0||||||
3774152|NCT01904149|3606967|B5|Slovakia||Region of Enrollment||participants|Number|2|2.0||||||
3774153|NCT01904149|3606968|B4|Slovakia||Region of Enrollment||participants|Number|5|5.0||||||
3774154|NCT01904149|3606969|B3|Slovakia||Region of Enrollment||participants|Number|8|8.0||||||
3774155|NCT01904149|3606970|B2|Slovakia||Region of Enrollment||participants|Number|13|13.0||||||
3774156|NCT01904149|3606971|B1|Slovakia||Region of Enrollment||participants|Number|7|7.0||||||
3774157|NCT01904149|3606965|B7|Hungary||Region of Enrollment||participants|Number|89|89.0||||||
3774158|NCT01904149|3606966|B6|Hungary||Region of Enrollment||participants|Number|7|7.0||||||
3774159|NCT01904149|3606967|B5|Hungary||Region of Enrollment||participants|Number|7|7.0||||||
3774160|NCT01904149|3606968|B4|Hungary||Region of Enrollment||participants|Number|8|8.0||||||
3774161|NCT01904149|3606969|B3|Hungary||Region of Enrollment||participants|Number|26|26.0||||||
3774162|NCT01904149|3606970|B2|Hungary||Region of Enrollment||participants|Number|19|19.0||||||
3774163|NCT01904149|3606971|B1|Hungary||Region of Enrollment||participants|Number|22|22.0||||||
3774164|NCT01904149|3606965|B7|White||Race/Ethnicity, Customized||participants|Number|606|606.0||||||
3774165|NCT01904149|3606966|B6|White||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
3774166|NCT01904149|3606967|B5|White||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
3774167|NCT01904149|3606968|B4|White||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
3774168|NCT01904149|3606969|B3|White||Race/Ethnicity, Customized||participants|Number|150|150.0||||||
3774169|NCT01904149|3606970|B2|White||Race/Ethnicity, Customized||participants|Number|151|151.0||||||
3774170|NCT01904149|3606971|B1|White||Race/Ethnicity, Customized||participants|Number|152|152.0||||||
3774171|NCT01904149|3606965|B7|Females||Sex/Gender, Customized||participants|Number|606|606.0||||||
3774172|NCT01904149|3606966|B6|Females||Sex/Gender, Customized||participants|Number|51|51.0||||||
3774173|NCT01904149|3606967|B5|Females||Sex/Gender, Customized||participants|Number|51|51.0||||||
3774174|NCT01904149|3606968|B4|Females||Sex/Gender, Customized||participants|Number|51|51.0||||||
3774175|NCT01904149|3606969|B3|Females||Sex/Gender, Customized||participants|Number|150|150.0||||||
3774176|NCT01904149|3606970|B2|Females||Sex/Gender, Customized||participants|Number|151|151.0||||||
3774177|NCT01904149|3606971|B1|Females||Sex/Gender, Customized||participants|Number|152|152.0||||||
3774178|NCT01904149|3606965|B7|||Age||years|Mean|47.6|47.6|Standard Deviation|6.75|6.75|||
3774179|NCT01904149|3606966|B6|||Age||years|Mean|47.2|47.2|Standard Deviation|4.60|4.6|||
3774180|NCT01904149|3606967|B5|||Age||years|Mean|47.4|47.4|Standard Deviation|7.46|7.46|||
3774181|NCT01904149|3606968|B4|||Age||years|Mean|47.4|47.4|Standard Deviation|6.82|6.82|||
3774182|NCT01904149|3606969|B3|||Age||years|Mean|47.6|47.6|Standard Deviation|6.87|6.87|||
3774183|NCT01904149|3606970|B2|||Age||years|Mean|47.2|47.2|Standard Deviation|7.07|7.07|||
3774184|NCT01904149|3606971|B1|||Age||years|Mean|48.1|48.1|Standard Deviation|6.70|6.7|||
3774185|NCT01904071|3606998|B4|||Pain Score at Triage|Pain Scale: Scores range from 0 (no pain) to 10 (sever pain). A score of 5 is moderate pain.|units on a scale|Mean|5.84|5.84|Standard Deviation|3.23|3.23|||
3774186|NCT01904071|3606999|B3|||Pain Score at Triage|Pain Scale: Scores range from 0 (no pain) to 10 (sever pain). A score of 5 is moderate pain.|units on a scale|Mean|6.98|6.98|Standard Deviation|1.87|1.87|||
3774187|NCT01904071|3607000|B2|||Pain Score at Triage|Pain Scale: Scores range from 0 (no pain) to 10 (sever pain). A score of 5 is moderate pain.|units on a scale|Mean|5.50|5.5|Standard Deviation|3.99|3.99|||
3774188|NCT01904071|3607001|B1|||Pain Score at Triage|Pain Scale: Scores range from 0 (no pain) to 10 (sever pain). A score of 5 is moderate pain.|units on a scale|Mean|5.17|5.17|Standard Deviation|3.29|3.29|||
3774189|NCT01904071|3606998|B4|United States||Region of Enrollment||participants|Number|64|64.0||||||
3774190|NCT01904071|3606999|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3774191|NCT01904071|3607000|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3774192|NCT01904071|3607001|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3774193|NCT01904071|3606998|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3774194|NCT01904071|3606999|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3774195|NCT01904071|3607000|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3774196|NCT01904071|3607001|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3774197|NCT01904071|3606998|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3774198|NCT01904071|3606999|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3774199|NCT01904071|3607000|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3774200|NCT01904071|3607001|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3774201|NCT01904071|3606998|B4|||Age||years|Mean|83|83.0|Standard Deviation|8.64|8.64|||
3774202|NCT01904071|3606999|B3|||Age||years|Mean|85|85.0|Standard Deviation|7.91|7.91|||
3774203|NCT01904071|3607000|B2|||Age||years|Mean|82|82.0|Standard Deviation|7.74|7.74|||
3774204|NCT01904071|3607001|B1|||Age||years|Mean|82|82.0|Standard Deviation|9.96|9.96|||
3774205|NCT01904058|3607023|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3774206|NCT01904058|3607024|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3774207|NCT01904058|3607025|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3774208|NCT01904058|3607026|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3774209|NCT01904058|3607027|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3774210|NCT01904058|3607023|B5||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3774211|NCT01904058|3607024|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3774212|NCT01904058|3607025|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3774213|NCT01904058|3607026|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3774214|NCT01904058|3607027|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3774215|NCT01904058|3607023|B5|||Age||years|Mean|53.3|53.3|Standard Deviation|10.77|10.77|||
3774216|NCT01904058|3607024|B4|||Age||years|Mean|55.8|55.8|Standard Deviation|8.73|8.73|||
3774217|NCT01904058|3607025|B3|||Age||years|Mean|47.5|47.5|Standard Deviation|8.14|8.14|||
3774218|NCT01904058|3607026|B2|||Age||years|Mean|53.5|53.5|Standard Deviation|10.53|10.53|||
3774219|NCT01904058|3607027|B1|||Age||years|Mean|54.7|54.7|Standard Deviation|12.74|12.74|||
3774220|NCT01903993|3607068|B3||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3774221|NCT01903993|3607069|B2||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3774222|NCT01903993|3607070|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3774223|NCT01903993|3607068|B3||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3774224|NCT01903993|3607069|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3774225|NCT01903993|3607070|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3774226|NCT01903993|3607068|B3|||Age||years|Mean|61.6|61.6|Standard Deviation|9.3|9.3|||
3774227|NCT01903993|3607069|B2|||Age||years|Mean|61.5|61.5|Standard Deviation|9.2|9.2|||
3774228|NCT01903993|3607070|B1|||Age||years|Mean|61.8|61.8|Standard Deviation|9.4|9.4|||
3774229|NCT01903876|3607086|B3|||Prosocial intervening|This scale is the Reactions to Offensive Language and Behavior (ROLB) that measures whether or not men confronted inappropriate behaviors of other men. We used the 7-item self-behavior subscale plus an additional 8 items,which directly reflected the content of RealConsent. A series of 15 potential intervening situations were presented and participants were asked to indicate whether they had experienced the situation (yes/no), and whether they had intervened (yes/no). The scale ranges from 0% (did not intervene) to 100% (intervened each time).|percent scores on a scale|Mean|72|72.0|Standard Deviation|24|24.0|||
3774230|NCT01903876|3607087|B2|||Prosocial intervening|This scale is the Reactions to Offensive Language and Behavior (ROLB) that measures whether or not men confronted inappropriate behaviors of other men. We used the 7-item self-behavior subscale plus an additional 8 items,which directly reflected the content of RealConsent. A series of 15 potential intervening situations were presented and participants were asked to indicate whether they had experienced the situation (yes/no), and whether they had intervened (yes/no). The scale ranges from 0% (did not intervene) to 100% (intervened each time).|percent scores on a scale|Mean|72|72.0|Standard Deviation|25|25.0|||
3774231|NCT01903876|3607088|B1|||Prosocial intervening|This scale is the Reactions to Offensive Language and Behavior (ROLB) that measures whether or not men confronted inappropriate behaviors of other men. We used the 7-item self-behavior subscale plus an additional 8 items,which directly reflected the content of RealConsent. A series of 15 potential intervening situations were presented and participants were asked to indicate whether they had experienced the situation (yes/no), and whether they had intervened (yes/no). The scale ranges from 0% (did not intervene) to 100% (intervened each time).|percent scores on a scale|Mean|72|72.0|Standard Deviation|24|24.0|||
3774232|NCT01903876|3607086|B3|||Sexual coercion perpetration|This index is the Revised Conflict Tactics Scale (CTS-2): Sexual Coercion Subscale and assesses 7 sexually coercive-violent behaviors. The index ranges from 0 (no self report of sexually coercive behavior) to 7 (engaged in all of the behaviors).|score on a scale|Mean|.64|0.64|Standard Deviation|1.19|1.19|||
3774233|NCT01903876|3607087|B2|||Sexual coercion perpetration|This index is the Revised Conflict Tactics Scale (CTS-2): Sexual Coercion Subscale and assesses 7 sexually coercive-violent behaviors. The index ranges from 0 (no self report of sexually coercive behavior) to 7 (engaged in all of the behaviors).|score on a scale|Mean|.53|0.53|Standard Deviation|1.07|1.07|||
3774234|NCT01903876|3607088|B1|||Sexual coercion perpetration|This index is the Revised Conflict Tactics Scale (CTS-2): Sexual Coercion Subscale and assesses 7 sexually coercive-violent behaviors. The index ranges from 0 (no self report of sexually coercive behavior) to 7 (engaged in all of the behaviors).|score on a scale|Mean|.76|0.76|Standard Deviation|1.03|1.03|||
3774282|NCT01903876|3607088|B1|Married or has a partner||Relationship status|Some data were missing for this variable; thus, the sum does not equal the overall numbers of baseline participants.|participants|Number|6|6.0||||||
3774235|NCT01903876|3607086|B3|||Hyper-gender ideology|Hypergender Ideology Scale Short Form (HGIS-S) is a continuous scale measure that assesses men's endorsement of masculine gender roles and ranges from 19 (no endorsement) to 95 (high degree of endorsement).|scores on a scale|Mean|46.49|46.49|Standard Deviation|11.28|11.28|||
3774236|NCT01903876|3607087|B2|||Hyper-gender ideology|Hypergender Ideology Scale Short Form (HGIS-S) is a continuous scale measure that assesses men's endorsement of masculine gender roles and ranges from 19 (no endorsement) to 95 (high degree of endorsement).|scores on a scale|Mean|46.59|46.59|Standard Deviation|11.28|11.28|||
3774237|NCT01903876|3607088|B1|||Hyper-gender ideology|Hypergender Ideology Scale Short Form (HGIS-S) is a continuous scale measure that assesses men's endorsement of masculine gender roles and ranges from 19 (no endorsement) to 95 (high degree of endorsement).|scores on a scale|Mean|46.38|46.38|Standard Deviation|11.3|11.3|||
3774238|NCT01903876|3607086|B3|||Date rape attitudes|This is the Rape Attitudes and Beliefs Scale (RABS) that measures positive attitudes toward date rape. This continuous scale ranges from 50 (negative attitudes toward date rape) to 250 (very positive).|scores on a scale|Mean|128.65|128.65|Standard Deviation|24.95|24.95|||
3774239|NCT01903876|3607087|B2|||Date rape attitudes|This is the Rape Attitudes and Beliefs Scale (RABS) that measures positive attitudes toward date rape. This continuous scale ranges from 50 (negative attitudes toward date rape) to 250 (very positive).|scores on a scale|Mean|128.85|128.85|Standard Deviation|24.07|24.07|||
3774240|NCT01903876|3607088|B1|||Date rape attitudes|This is the Rape Attitudes and Beliefs Scale (RABS) that measures positive attitudes toward date rape. This continuous scale ranges from 50 (negative attitudes toward date rape) to 250 (very positive).|scores on a scale|Mean|128.45|128.45|Standard Deviation|25.84|25.84|||
3774241|NCT01903876|3607086|B3|||Hostility towards women|This is the Hostility Toward Women Scale that is a continuous measure that ranges from 0 (no hostility) to 10 (high degree of hostility).|scales on a scale|Mean|3.66|3.66|Standard Deviation|2.49|2.49|||
3774242|NCT01903876|3607087|B2|||Hostility towards women|This is the Hostility Toward Women Scale that is a continuous measure that ranges from 0 (no hostility) to 10 (high degree of hostility).|scales on a scale|Mean|3.42|3.42|Standard Deviation|2.43|2.43|||
3774243|NCT01903876|3607088|B1|||Hostility towards women|This is the Hostility Toward Women Scale that is a continuous measure that ranges from 0 (no hostility) to 10 (high degree of hostility).|scales on a scale|Mean|3.89|3.89|Standard Deviation|2.54|2.54|||
3774244|NCT01903876|3607086|B3|||Empathy for rape victims|This scale is called the Rape Empathy scale and measures the degree of empathy for rape victims. The scale ranges from 19 (no empathy) to 95 (high level of empathy).|scores on a scale|Mean|68.87|68.87|Standard Deviation|9.72|9.72|||
3774245|NCT01903876|3607087|B2|||Empathy for rape victims|This scale is called the Rape Empathy scale and measures the degree of empathy for rape victims. The scale ranges from 19 (no empathy) to 95 (high level of empathy).|scores on a scale|Mean|68.96|68.96|Standard Deviation|9.66|9.66|||
3774246|NCT01903876|3607088|B1|||Empathy for rape victims|This scale is called the Rape Empathy scale and measures the degree of empathy for rape victims. The scale ranges from 19 (no empathy) to 95 (high level of empathy).|scores on a scale|Mean|68.78|68.78|Standard Deviation|9.79|9.79|||
3774247|NCT01903876|3607086|B3|||Outcome expectancies for engaging in rape|This scale measures men's beliefs in positive outcomes for perpetrating sexual violence against a woman. The scale is continuous and ranges from 14 (no agreement with positive outcomes) to 70 (high degree of agreement with positive outcomes).|scores on a scale|Mean|58.37|58.37|Standard Deviation|10.96|10.96|||
3774248|NCT01903876|3607087|B2|||Outcome expectancies for engaging in rape|This scale measures men's beliefs in positive outcomes for perpetrating sexual violence against a woman. The scale is continuous and ranges from 14 (no agreement with positive outcomes) to 70 (high degree of agreement with positive outcomes).|scores on a scale|Mean|58.71|58.71|Standard Deviation|10.76|10.76|||
3774249|NCT01903876|3607088|B1|||Outcome expectancies for engaging in rape|This scale measures men's beliefs in positive outcomes for perpetrating sexual violence against a woman. The scale is continuous and ranges from 14 (no agreement with positive outcomes) to 70 (high degree of agreement with positive outcomes).|scores on a scale|Mean|58.02|58.02|Standard Deviation|11.17|11.17|||
3774250|NCT01903876|3607086|B3|||Rape myth acceptance|The Illinois Rape Myth Acceptance Scale Short Form (IRMA-SF) was used to measure rape myths. This scale is a continuous scale measure with a range of 20 (no endorsement of rape myths) to 100 (high endorsement of rape myths).|scores on a scale|Mean|36.28|36.28|Standard Deviation|10.36|10.36|||
3774251|NCT01903876|3607087|B2|||Rape myth acceptance|The Illinois Rape Myth Acceptance Scale Short Form (IRMA-SF) was used to measure rape myths. This scale is a continuous scale measure with a range of 20 (no endorsement of rape myths) to 100 (high endorsement of rape myths).|scores on a scale|Mean|35.88|35.88|Standard Deviation|10.43|10.43|||
3774252|NCT01903876|3607088|B1|||Rape myth acceptance|The Illinois Rape Myth Acceptance Scale Short Form (IRMA-SF) was used to measure rape myths. This scale is a continuous scale measure with a range of 20 (no endorsement of rape myths) to 100 (high endorsement of rape myths).|scores on a scale|Mean|36.69|36.69|Standard Deviation|10.29|10.29|||
3774253|NCT01903876|3607086|B3|||Self-comfort with men's inappropriate behaviors|This scale measures men's level of comfort with other men's inappropriate behaviors toward women. The continuous scale ranges from 7 (not at all comfortable) to 49 (very comfortable).|scores on a scale|Mean|33.11|33.11|Standard Deviation|10.76|10.76|||
3774254|NCT01903876|3607087|B2|||Self-comfort with men's inappropriate behaviors|This scale measures men's level of comfort with other men's inappropriate behaviors toward women. The continuous scale ranges from 7 (not at all comfortable) to 49 (very comfortable).|scores on a scale|Mean|32.68|32.68|Standard Deviation|10.82|10.82|||
3774255|NCT01903876|3607088|B1|||Self-comfort with men's inappropriate behaviors|This scale measures men's level of comfort with other men's inappropriate behaviors toward women. The continuous scale ranges from 7 (not at all comfortable) to 49 (very comfortable).|scores on a scale|Mean|33.55|33.55|Standard Deviation|10.71|10.71|||
3774256|NCT01903876|3607086|B3|||Outcome expectancies for intervening|This scale measures the positive perceived outcomes that would likely occur if a participant intervened in a situation to prevent women from being sexually victimized. The scale is a continuous scale that ranges from 8 (low positive expectancies) to 40 (very positive expectancies).|scores on a scale|Mean|28.49|28.49|Standard Deviation|4.6|4.6|||
3774257|NCT01903876|3607087|B2|||Outcome expectancies for intervening|This scale measures the positive perceived outcomes that would likely occur if a participant intervened in a situation to prevent women from being sexually victimized. The scale is a continuous scale that ranges from 8 (low positive expectancies) to 40 (very positive expectancies).|scores on a scale|Mean|28.72|28.72|Standard Deviation|4.33|4.33|||
3774258|NCT01903876|3607088|B1|||Outcome expectancies for intervening|This scale measures the positive perceived outcomes that would likely occur if a participant intervened in a situation to prevent women from being sexually victimized. The scale is a continuous scale that ranges from 8 (low positive expectancies) to 40 (very positive expectancies).|scores on a scale|Mean|28.26|28.26|Standard Deviation|4.86|4.86|||
3774259|NCT01903876|3607086|B3|||Intentions to intervene|This scale measures intentions to intervene in situations that place women at risk for sexual victimization. It is a continuous scale measure that ranges from 15 (no intentions to intervene) to 75 (high likelihood to intervene).|score on a scale|Mean|52.39|52.39|Standard Deviation|12.3|12.3|||
3774260|NCT01903876|3607087|B2|||Intentions to intervene|This scale measures intentions to intervene in situations that place women at risk for sexual victimization. It is a continuous scale measure that ranges from 15 (no intentions to intervene) to 75 (high likelihood to intervene).|score on a scale|Mean|52.68|52.68|Standard Deviation|11.85|11.85|||
3774261|NCT01903876|3607088|B1|||Intentions to intervene|This scale measures intentions to intervene in situations that place women at risk for sexual victimization. It is a continuous scale measure that ranges from 15 (no intentions to intervene) to 75 (high likelihood to intervene).|score on a scale|Mean|52.09|52.09|Standard Deviation|12.78|12.78|||
3774262|NCT01903876|3607086|B3|||Self-efficacy to intervene|This scale measures the degree of self-efficacy to intervene in situations that may contribute to a woman being sexually victimized. It is a continuous scale that ranges from 18 (no confidence) to 126 (high degree of confidence).|score on a scale|Mean|88.32|88.32|Standard Deviation|22.27|22.27|||
3774263|NCT01903876|3607087|B2|||Self-efficacy to intervene|This scale measures the degree of self-efficacy to intervene in situations that may contribute to a woman being sexually victimized. It is a continuous scale that ranges from 18 (no confidence) to 126 (high degree of confidence).|score on a scale|Mean|88.74|88.74|Standard Deviation|20.93|20.93|||
3774264|NCT01903876|3607088|B1|||Self-efficacy to intervene|This scale measures the degree of self-efficacy to intervene in situations that may contribute to a woman being sexually victimized. It is a continuous scale that ranges from 18 (no confidence) to 126 (high degree of confidence).|score on a scale|Mean|87.88|87.88|Standard Deviation|23.6|23.6|||
3774265|NCT01903876|3607086|B3|||Knowledge of informed consent to have sex|This index measures the degree of knowledge regarding the elements of informed consent to have sex on a continuous scale with a range from 0 (no knowledge) to 14 (high level of knowledge).|score on a scale|Mean|11.58|11.58|Standard Deviation|2.46|2.46|||
3774266|NCT01903876|3607087|B2|||Knowledge of informed consent to have sex|This index measures the degree of knowledge regarding the elements of informed consent to have sex on a continuous scale with a range from 0 (no knowledge) to 14 (high level of knowledge).|score on a scale|Mean|11.69|11.69|Standard Deviation|2.44|2.44|||
3774267|NCT01903876|3607088|B1|||Knowledge of informed consent to have sex|This index measures the degree of knowledge regarding the elements of informed consent to have sex on a continuous scale with a range from 0 (no knowledge) to 14 (high level of knowledge).|score on a scale|Mean|11.46|11.46|Standard Deviation|2.49|2.49|||
3774268|NCT01903876|3607086|B3|||Legal knowledge of rape/assault|An index that assesses the level of knowledge regarding laws and policies on rape and sexual assault in Georgia and that ranges from 0 (no knowledge) to 9 (high levels of knowledge).|units on a scale|Mean|4.57|4.57|Standard Deviation|1.75|1.75|||
3774269|NCT01903876|3607087|B2|||Legal knowledge of rape/assault|An index that assesses the level of knowledge regarding laws and policies on rape and sexual assault in Georgia and that ranges from 0 (no knowledge) to 9 (high levels of knowledge).|units on a scale|Mean|4.54|4.54|Standard Deviation|1.73|1.73|||
3774270|NCT01903876|3607088|B1|||Legal knowledge of rape/assault|An index that assesses the level of knowledge regarding laws and policies on rape and sexual assault in Georgia and that ranges from 0 (no knowledge) to 9 (high levels of knowledge).|units on a scale|Mean|4.61|4.61|Standard Deviation|1.78|1.78|||
3774271|NCT01903876|3607086|B3|Divorced||Relationship status|Some data were missing for this variable; thus, the sum does not equal the overall numbers of baseline participants.|participants|Number|1|1.0||||||
3774272|NCT01903876|3607087|B2|Divorced||Relationship status|Some data were missing for this variable; thus, the sum does not equal the overall numbers of baseline participants.|participants|Number|0|0.0||||||
3774273|NCT01903876|3607088|B1|Divorced||Relationship status|Some data were missing for this variable; thus, the sum does not equal the overall numbers of baseline participants.|participants|Number|1|1.0||||||
3774274|NCT01903876|3607086|B3|Separated||Relationship status|Some data were missing for this variable; thus, the sum does not equal the overall numbers of baseline participants.|participants|Number|0|0.0||||||
3774275|NCT01903876|3607087|B2|Separated||Relationship status|Some data were missing for this variable; thus, the sum does not equal the overall numbers of baseline participants.|participants|Number|0|0.0||||||
3774276|NCT01903876|3607088|B1|Separated||Relationship status|Some data were missing for this variable; thus, the sum does not equal the overall numbers of baseline participants.|participants|Number|0|0.0||||||
3774277|NCT01903876|3607086|B3|Engaged or committed||Relationship status|Some data were missing for this variable; thus, the sum does not equal the overall numbers of baseline participants.|participants|Number|169|169.0||||||
3774278|NCT01903876|3607087|B2|Engaged or committed||Relationship status|Some data were missing for this variable; thus, the sum does not equal the overall numbers of baseline participants.|participants|Number|82|82.0||||||
3774279|NCT01903876|3607088|B1|Engaged or committed||Relationship status|Some data were missing for this variable; thus, the sum does not equal the overall numbers of baseline participants.|participants|Number|87|87.0||||||
3774280|NCT01903876|3607086|B3|Married or has a partner||Relationship status|Some data were missing for this variable; thus, the sum does not equal the overall numbers of baseline participants.|participants|Number|7|7.0||||||
3774281|NCT01903876|3607087|B2|Married or has a partner||Relationship status|Some data were missing for this variable; thus, the sum does not equal the overall numbers of baseline participants.|participants|Number|1|1.0||||||
3774283|NCT01903876|3607086|B3|Single||Relationship status|Some data were missing for this variable; thus, the sum does not equal the overall numbers of baseline participants.|participants|Number|559|559.0||||||
3774284|NCT01903876|3607087|B2|Single||Relationship status|Some data were missing for this variable; thus, the sum does not equal the overall numbers of baseline participants.|participants|Number|289|289.0||||||
3774285|NCT01903876|3607088|B1|Single||Relationship status|Some data were missing for this variable; thus, the sum does not equal the overall numbers of baseline participants.|participants|Number|270|270.0||||||
3774286|NCT01903876|3607086|B3|||Frequency of vaginal intercourse||vaginal sex acts/60 days|Mean|7.96|7.96|Standard Deviation|12.89|12.89|||
3774287|NCT01903876|3607087|B2|||Frequency of vaginal intercourse||vaginal sex acts/60 days|Mean|7.55|7.55|Standard Deviation|12.75|12.75|||
3774288|NCT01903876|3607088|B1|||Frequency of vaginal intercourse||vaginal sex acts/60 days|Mean|8.38|8.38|Standard Deviation|13.03|13.03|||
3774289|NCT01903876|3607086|B3|United States||Region of Enrollment||participants|Number|743|743.0||||||
3774290|NCT01903876|3607087|B2|United States||Region of Enrollment||participants|Number|376|376.0||||||
3774291|NCT01903876|3607088|B1|United States||Region of Enrollment||participants|Number|367|367.0||||||
3774292|NCT01903876|3607086|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774293|NCT01903876|3607087|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774294|NCT01903876|3607088|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774295|NCT01903876|3607086|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774296|NCT01903876|3607087|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774297|NCT01903876|3607088|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774298|NCT01903876|3607086|B3||White|Race (NIH/OMB)||Participants|Count of Participants|408|408.0||||||
3774299|NCT01903876|3607087|B2||White|Race (NIH/OMB)||Participants|Count of Participants|208|208.0||||||
3774300|NCT01903876|3607088|B1||White|Race (NIH/OMB)||Participants|Count of Participants|200|200.0||||||
3774301|NCT01903876|3607086|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|166|166.0||||||
3774302|NCT01903876|3607087|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3774303|NCT01903876|3607088|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3774304|NCT01903876|3607086|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774305|NCT01903876|3607087|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774306|NCT01903876|3607088|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774307|NCT01903876|3607086|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
3774308|NCT01903876|3607087|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3774309|NCT01903876|3607088|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3774310|NCT01903876|3607086|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3774311|NCT01903876|3607087|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3774312|NCT01903876|3607088|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3774313|NCT01903876|3607086|B3||Male|Sex: Female, Male||Participants|Count of Participants|743|743.0||||||
3774314|NCT01903876|3607087|B2||Male|Sex: Female, Male||Participants|Count of Participants|376|376.0||||||
3774315|NCT01903876|3607088|B1||Male|Sex: Female, Male||Participants|Count of Participants|367|367.0||||||
3774316|NCT01903876|3607086|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3774317|NCT01903876|3607087|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3774318|NCT01903876|3607088|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3774319|NCT01903876|3607086|B3|||Age||years|Mean|20.38|20.38|Standard Deviation|1.67|1.67|||
3774320|NCT01903876|3607087|B2|||Age||years|Mean|20.42|20.42|Standard Deviation|1.69|1.69|||
3774321|NCT01903876|3607088|B1|||Age||years|Mean|20.33|20.33|Standard Deviation|1.66|1.66|||
3774322|NCT01903863|3607097|B3|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3774323|NCT01903863|3607098|B2|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3774324|NCT01903863|3607099|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3774325|NCT01903863|3607097|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3774326|NCT01903863|3607098|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3774327|NCT01903863|3607099|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3774328|NCT01903863|3607097|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3774329|NCT01903863|3607098|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3774330|NCT01903863|3607099|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3774331|NCT01903863|3607097|B3|||Age||years|Median|0.096|0.096|Inter-Quartile Range|||0.008|0.89|
3774332|NCT01903863|3607098|B2|||Age||years|Median|0.063|0.063|Inter-Quartile Range|||0.003|0.42|
3774333|NCT01903863|3607099|B1|||Age||years|Median|0.33|0.33|Inter-Quartile Range|||0.03|1.5|
3774334|NCT01903863|3607097|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3774335|NCT01903863|3607098|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3774336|NCT01903863|3607099|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3774337|NCT01903863|3607097|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3774338|NCT01903863|3607098|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3774339|NCT01903863|3607099|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3774340|NCT01903863|3607097|B3||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
3774341|NCT01903863|3607098|B2||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
3774342|NCT01903863|3607099|B1||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
3774343|NCT01903798|3607120|B5|United States||Region of Enrollment||participants|Number|4|4.0||||||
3774344|NCT01903798|3607121|B4|United States||Region of Enrollment||participants|Number|1|1.0||||||
3774345|NCT01903798|3607122|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3774346|NCT01903798|3607124|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3774347|NCT01903798|3607120|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774348|NCT01903798|3607121|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774349|NCT01903798|3607122|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774350|NCT01903798|3607124|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774351|NCT01903798|3607120|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774352|NCT01903798|3607121|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774353|NCT01903798|3607122|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774354|NCT01903798|3607124|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774355|NCT01903798|3607120|B5||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3774356|NCT01903798|3607121|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774357|NCT01903798|3607122|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3774358|NCT01903798|3607124|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3774359|NCT01903798|3607120|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774360|NCT01903798|3607121|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774361|NCT01903798|3607122|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774362|NCT01903798|3607124|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774363|NCT01903798|3607120|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3774364|NCT01903798|3607121|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3774365|NCT01903798|3607122|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774366|NCT01903798|3607124|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774367|NCT01903798|3607120|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774368|NCT01903798|3607121|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774369|NCT01903798|3607122|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774370|NCT01903798|3607124|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774371|NCT01903798|3607120|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774372|NCT01903798|3607121|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774373|NCT01903798|3607122|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774374|NCT01903798|3607124|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774375|NCT01903798|3607120|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774376|NCT01903798|3607121|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774377|NCT01903798|3607122|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774378|NCT01903798|3607124|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774379|NCT01903798|3607120|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3774380|NCT01903798|3607121|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3774381|NCT01903798|3607122|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3774382|NCT01903798|3607124|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3774383|NCT01903798|3607120|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3774384|NCT01903798|3607121|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774385|NCT01903798|3607122|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774386|NCT01903798|3607124|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3774387|NCT01903798|3607120|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3774388|NCT01903798|3607121|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3774389|NCT01903798|3607122|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3774390|NCT01903798|3607124|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3774391|NCT01903798|3607120|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3774392|NCT01903798|3607121|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3774393|NCT01903798|3607122|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3774394|NCT01903798|3607124|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3774395|NCT01903798|3607120|B5|||Age||years|Mean|52|52.0|Standard Deviation|13.6|13.6|||
3774396|NCT01903798|3607121|B4|||Age||years|Mean|58|58.0|Standard Deviation|0|0.0|||
3774397|NCT01903798|3607122|B3|||Age||years|Mean|71.2|71.2|Standard Deviation|0|0.0|||
3774398|NCT01903798|3607124|B1|||Age||years|Mean|45.6|45.6|Standard Deviation|9.7|9.7|||
3774399|NCT01903798|3607120|B5||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3774400|NCT01903798|3607121|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3774401|NCT01903798|3607122|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3774402|NCT01903798|3607123|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3774403|NCT01903798|3607124|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3774404|NCT01903798|3607120|B5||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3774405|NCT01903798|3607121|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3774406|NCT01903798|3607122|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3774407|NCT01903798|3607123|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3774408|NCT01903798|3607124|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3774409|NCT01903798|3607120|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3774410|NCT01903798|3607121|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3774411|NCT01903798|3607122|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3774412|NCT01903798|3607123|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3774413|NCT01903798|3607124|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3774414|NCT01903720|3607141|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3774415|NCT01903720|3607141|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3774416|NCT01903720|3607141|B1|70 years and over||Age, Customized||participants|Number|7|7.0||||||
3774417|NCT01903720|3607141|B1|60 to 69 years||Age, Customized||participants|Number|22|22.0||||||
3774418|NCT01903720|3607141|B1|50 to 59 years||Age, Customized||participants|Number|29|29.0||||||
3774419|NCT01903720|3607141|B1|40 to 49 years||Age, Customized||participants|Number|12|12.0||||||
3774420|NCT01903720|3607141|B1|30 to 39 years||Age, Customized||participants|Number|1|1.0||||||
3774421|NCT01903720|3607141|B1|||Age||years|Mean|57.46|57.46|Standard Deviation|9.19|9.19|||
3774422|NCT01903564|3607156|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
3774423|NCT01903564|3607157|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
3774424|NCT01903564|3607158|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3774425|NCT01903564|3607156|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3774426|NCT01903564|3607157|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3774427|NCT01903564|3607158|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3774428|NCT01903564|3607156|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3774429|NCT01903564|3607157|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3774430|NCT01903564|3607158|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3774431|NCT01903564|3607156|B3|||Age||years|Mean|31.9|31.9|Full Range|||24.0|42.0|
3774432|NCT01903564|3607157|B2|||Age||years|Mean|32.0|32.0|Full Range|||24.0|42.0|
3774433|NCT01903564|3607158|B1|||Age||years|Mean|31.8|31.8|Full Range|||28.0|35.0|
3774434|NCT01903564|3607156|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3774435|NCT01903564|3607157|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3774436|NCT01903564|3607158|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3774437|NCT01903564|3607156|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3774438|NCT01903564|3607157|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3774439|NCT01903564|3607158|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3774440|NCT01903564|3607156|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3774441|NCT01903564|3607157|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3774442|NCT01903564|3607158|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3774443|NCT01903460|3607175|B5|United Kingdom||Region of Enrollment||participants|Number|20|20.0||||||
3774444|NCT01903460|3607176|B4|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3774445|NCT01903460|3607177|B3|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3774446|NCT01903460|3607178|B2|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3774447|NCT01903460|3607179|B1|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3774448|NCT01903460|3607175|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3774449|NCT01903460|3607176|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3774450|NCT01903460|3607177|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3774451|NCT01903460|3607178|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3774452|NCT01903460|3607179|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3774453|NCT01903460|3607175|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3774454|NCT01903460|3607176|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3774455|NCT01903460|3607177|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3774456|NCT01903460|3607178|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3774457|NCT01903460|3607179|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3774458|NCT01903460|3607175|B5|13 to 18 years||Age, Customized||participants|Number|3|3.0||||||
3774459|NCT01903460|3607176|B4|13 to 18 years||Age, Customized||participants|Number|0|0.0||||||
3774460|NCT01903460|3607177|B3|13 to 18 years||Age, Customized||participants|Number|0|0.0||||||
3774461|NCT01903460|3607178|B2|13 to 18 years||Age, Customized||participants|Number|3|3.0||||||
3774462|NCT01903460|3607179|B1|13 to 18 years||Age, Customized||participants|Number|0|0.0||||||
3774463|NCT01903460|3607175|B5|9 to 12 years||Age, Customized||participants|Number|2|2.0||||||
3774464|NCT01903460|3607176|B4|9 to 12 years||Age, Customized||participants|Number|0|0.0||||||
3774465|NCT01903460|3607177|B3|9 to 12 years||Age, Customized||participants|Number|0|0.0||||||
3774466|NCT01903460|3607178|B2|9 to 12 years||Age, Customized||participants|Number|0|0.0||||||
3774467|NCT01903460|3607179|B1|9 to 12 years||Age, Customized||participants|Number|2|2.0||||||
3774468|NCT01903460|3607175|B5|5 to 8 years||Age, Customized||participants|Number|5|5.0||||||
3774469|NCT01903460|3607176|B4|5 to 8 years||Age, Customized||participants|Number|1|1.0||||||
3774470|NCT01903460|3607177|B3|5 to 8 years||Age, Customized||participants|Number|2|2.0||||||
3774471|NCT01903460|3607178|B2|5 to 8 years||Age, Customized||participants|Number|1|1.0||||||
3774472|NCT01903460|3607179|B1|5 to 8 years||Age, Customized||participants|Number|1|1.0||||||
3774473|NCT01903460|3607175|B5|2 to 4 years||Age, Customized||participants|Number|7|7.0||||||
3774474|NCT01903460|3607176|B4|2 to 4 years||Age, Customized||participants|Number|2|2.0||||||
3774475|NCT01903460|3607177|B3|2 to 4 years||Age, Customized||participants|Number|1|1.0||||||
3774476|NCT01903460|3607178|B2|2 to 4 years||Age, Customized||participants|Number|1|1.0||||||
3774477|NCT01903460|3607179|B1|2 to 4 years||Age, Customized||participants|Number|3|3.0||||||
3774478|NCT01903460|3607175|B5|< 2 years||Age, Customized||participants|Number|3|3.0||||||
3774479|NCT01903460|3607176|B4|< 2 years||Age, Customized||participants|Number|0|0.0||||||
3774480|NCT01903460|3607177|B3|< 2 years||Age, Customized||participants|Number|0|0.0||||||
3774481|NCT01903460|3607178|B2|< 2 years||Age, Customized||participants|Number|3|3.0||||||
3774482|NCT01903460|3607179|B1|< 2 years||Age, Customized||participants|Number|0|0.0||||||
3774483|NCT01903460|3607175|B5|||Age||years|Mean|5.9|5.9|Standard Deviation|4.93|4.93|||
3774484|NCT01903460|3607176|B4|||Age||years|Mean|4.3|4.3|Standard Deviation|3.21|3.21|||
3774485|NCT01903460|3607177|B3|||Age||years|Mean|5.0|5.0|Standard Deviation|2.00|2.0|||
3774486|NCT01903460|3607178|B2|||Age||years|Mean|6.8|6.8|Standard Deviation|6.73|6.73|||
3774487|NCT01903460|3607179|B1|||Age||years|Mean|5.8|5.8|Standard Deviation|4.49|4.49|||
3774488|NCT01903434|3607199|B1|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3774489|NCT01903434|3607199|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774490|NCT01903434|3607199|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3774491|NCT01903434|3607199|B1||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3774492|NCT01903434|3607199|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3774493|NCT01903434|3607199|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774494|NCT01903434|3607199|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774495|NCT01903434|3607199|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3774496|NCT01903434|3607199|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774497|NCT01903434|3607199|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3774498|NCT01903434|3607199|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3774499|NCT01903434|3607199|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3774500|NCT01903434|3607199|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3774501|NCT01903434|3607199|B1|||Age||years|Mean|41.6|41.6|Standard Deviation|13.1|13.1|||
3774502|NCT01903356|3607208|B1|||Hemoglobin A1c (HbA1c) at baseline|HbA1c values measured at baseline in percent. HbA1c is a form of hemoglobin, a blood pigment that carries oxygen, which is bound to glucose. The term HbA1c also refers to glycated hemoglobin. High levels of HbA1c (Normal range is less than 6%) indicate poorer control of diabetes than level in normal range.|Percentage of HbA1c (%)|Mean|7.78|7.78|Standard Deviation|1.35|1.35|||
3774503|NCT01903356|3607208|B1||Male|Sex: Female, Male|Gender distribution of all patients enrolled in the study|Participants|Count of Participants|351|351.0||||||
3774504|NCT01903356|3607208|B1||Female|Sex: Female, Male|Gender distribution of all patients enrolled in the study|Participants|Count of Participants|358|358.0||||||
3774505|NCT01903356|3607208|B1|||Age|Age of all patients enrolled in the study|Years|Mean|62.04|62.04|Standard Deviation|11.56|11.56|||
3774506|NCT01903265|3607216|B3||Male|Gender||Participants|Count of Participants|10|10.0||||||
3774507|NCT01903265|3607217|B2||Male|Gender||Participants|Count of Participants|3|3.0||||||
3774508|NCT01903265|3607218|B1||Male|Gender||Participants|Count of Participants|7|7.0||||||
3774509|NCT01903265|3607216|B3||Female|Gender||Participants|Count of Participants|194|194.0||||||
3774510|NCT01903265|3607217|B2||Female|Gender||Participants|Count of Participants|98|98.0||||||
3774511|NCT01903265|3607218|B1||Female|Gender||Participants|Count of Participants|96|96.0||||||
3774512|NCT01903265|3607216|B3|||Age||years|Mean|50.2|50.2|Full Range|||19.0|65.0|
3774513|NCT01903265|3607217|B2|||Age||years|Mean|49.7|49.7|Full Range|||19.0|65.0|
3774514|NCT01903265|3607218|B1|||Age||years|Mean|50.7|50.7|Full Range|||20.0|64.0|
3774515|NCT01903265|3607216|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3774516|NCT01903265|3607217|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3774517|NCT01903265|3607218|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3774518|NCT01903265|3607216|B3||Between 18 and 65 years|Age||Participants|Count of Participants|199|199.0||||||
3774519|NCT01903265|3607217|B2||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
3774520|NCT01903265|3607218|B1||Between 18 and 65 years|Age||Participants|Count of Participants|103|103.0||||||
3774521|NCT01903265|3607216|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3774522|NCT01903265|3607217|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3774523|NCT01903265|3607218|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3774524|NCT01903252|3607233|B3|||Partial Mayo Clinic Score|Partial Mayo Clinic Score (PMCS) is the sum of the component sub-scores, excluding the endoscopic score. The 3 component sub-scores are: 1) stool frequency, 2) rectal bleeding, and 3) physician's global assessment. The minimum is 0, no pathology and the maximum is 9, severe disease in all sub-scores.|units on a scale|Mean|5.4|5.4|Standard Deviation|1.1|1.1|||
3774525|NCT01903252|3607234|B2|||Partial Mayo Clinic Score|Partial Mayo Clinic Score (PMCS) is the sum of the component sub-scores, excluding the endoscopic score. The 3 component sub-scores are: 1) stool frequency, 2) rectal bleeding, and 3) physician's global assessment. The minimum is 0, no pathology and the maximum is 9, severe disease in all sub-scores.|units on a scale|Mean|5.3|5.3|Standard Deviation|1.1|1.1|||
3774526|NCT01903252|3607235|B1|||Partial Mayo Clinic Score|Partial Mayo Clinic Score (PMCS) is the sum of the component sub-scores, excluding the endoscopic score. The 3 component sub-scores are: 1) stool frequency, 2) rectal bleeding, and 3) physician's global assessment. The minimum is 0, no pathology and the maximum is 9, severe disease in all sub-scores.|units on a scale|Mean|5.5|5.5|Standard Deviation|1.1|1.1|||
3774527|NCT01903252|3607233|B3|||Mayo Score|"Mayo Score and Partial Mayo Clinic Score (PMCS):~The Mayo scoring system is a well-established tool for assessing UC disease activity. The Mayo score is the sum of 4 component sub-scores, each ranging from 0 representing no pathology to 3 for severe disease. The 4 component sub-scores are: 1) stool frequency, 2) rectal bleeding, 3) flexible sigmoidoscopy scores, and 4) physician’s global assessment. The minimum Mayo Score is 0 (no pathology) and the maximum is 12 (severe disease in all sub-scores)."|units on a scale|Mean|7.7|7.7|Standard Deviation|1.3|1.3|||
3774528|NCT01903252|3607234|B2|||Mayo Score|"Mayo Score and Partial Mayo Clinic Score (PMCS):~The Mayo scoring system is a well-established tool for assessing UC disease activity. The Mayo score is the sum of 4 component sub-scores, each ranging from 0 representing no pathology to 3 for severe disease. The 4 component sub-scores are: 1) stool frequency, 2) rectal bleeding, 3) flexible sigmoidoscopy scores, and 4) physician’s global assessment. The minimum Mayo Score is 0 (no pathology) and the maximum is 12 (severe disease in all sub-scores)."|units on a scale|Mean|7.6|7.6|Standard Deviation|1.3|1.3|||
3774529|NCT01903252|3607235|B1|||Mayo Score|"Mayo Score and Partial Mayo Clinic Score (PMCS):~The Mayo scoring system is a well-established tool for assessing UC disease activity. The Mayo score is the sum of 4 component sub-scores, each ranging from 0 representing no pathology to 3 for severe disease. The 4 component sub-scores are: 1) stool frequency, 2) rectal bleeding, 3) flexible sigmoidoscopy scores, and 4) physician’s global assessment. The minimum Mayo Score is 0 (no pathology) and the maximum is 12 (severe disease in all sub-scores)."|units on a scale|Mean|7.7|7.7|Standard Deviation|1.3|1.3|||
3774530|NCT01903252|3607233|B3|United Kingdom||Region of Enrollment||participants|Number|18|18.0||||||
3774531|NCT01903252|3607234|B2|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
3774532|NCT01903252|3607235|B1|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
3774533|NCT01903252|3607233|B3|Ukraine||Region of Enrollment||participants|Number|130|130.0||||||
3774534|NCT01903252|3607234|B2|Ukraine||Region of Enrollment||participants|Number|71|71.0||||||
3774535|NCT01903252|3607235|B1|Ukraine||Region of Enrollment||participants|Number|59|59.0||||||
3774536|NCT01903252|3607233|B3|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
3774537|NCT01903252|3607234|B2|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
3774538|NCT01903252|3607235|B1|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
3774539|NCT01903252|3607233|B3|Spain||Region of Enrollment||participants|Number|2|2.0||||||
3774540|NCT01903252|3607234|B2|Spain||Region of Enrollment||participants|Number|2|2.0||||||
3774541|NCT01903252|3607235|B1|Spain||Region of Enrollment||participants|Number|0|0.0||||||
3774542|NCT01903252|3607233|B3|Slovakia||Region of Enrollment||participants|Number|5|5.0||||||
3774543|NCT01903252|3607234|B2|Slovakia||Region of Enrollment||participants|Number|3|3.0||||||
3774544|NCT01903252|3607235|B1|Slovakia||Region of Enrollment||participants|Number|2|2.0||||||
3774545|NCT01903252|3607233|B3|Serbia||Region of Enrollment||participants|Number|36|36.0||||||
3774546|NCT01903252|3607234|B2|Serbia||Region of Enrollment||participants|Number|18|18.0||||||
3774547|NCT01903252|3607235|B1|Serbia||Region of Enrollment||participants|Number|18|18.0||||||
3774548|NCT01903252|3607233|B3|Russian Federation||Region of Enrollment||participants|Number|101|101.0||||||
3774549|NCT01903252|3607234|B2|Russian Federation||Region of Enrollment||participants|Number|50|50.0||||||
3774550|NCT01903252|3607235|B1|Russian Federation||Region of Enrollment||participants|Number|51|51.0||||||
3774551|NCT01903252|3607233|B3|Romania||Region of Enrollment||participants|Number|3|3.0||||||
3774552|NCT01903252|3607234|B2|Romania||Region of Enrollment||participants|Number|1|1.0||||||
3774553|NCT01903252|3607235|B1|Romania||Region of Enrollment||participants|Number|2|2.0||||||
3774554|NCT01903252|3607233|B3|Poland||Region of Enrollment||participants|Number|92|92.0||||||
3774555|NCT01903252|3607234|B2|Poland||Region of Enrollment||participants|Number|48|48.0||||||
3774556|NCT01903252|3607235|B1|Poland||Region of Enrollment||participants|Number|44|44.0||||||
3774557|NCT01903252|3607233|B3|Norway||Region of Enrollment||participants|Number|9|9.0||||||
3774558|NCT01903252|3607234|B2|Norway||Region of Enrollment||participants|Number|5|5.0||||||
3774559|NCT01903252|3607235|B1|Norway||Region of Enrollment||participants|Number|4|4.0||||||
3774560|NCT01903252|3607233|B3|Lithuania||Region of Enrollment||participants|Number|54|54.0||||||
3774561|NCT01903252|3607234|B2|Lithuania||Region of Enrollment||participants|Number|28|28.0||||||
3774562|NCT01903252|3607235|B1|Lithuania||Region of Enrollment||participants|Number|26|26.0||||||
3774563|NCT01903252|3607233|B3|Latvia||Region of Enrollment||participants|Number|44|44.0||||||
3774564|NCT01903252|3607234|B2|Latvia||Region of Enrollment||participants|Number|22|22.0||||||
3774565|NCT01903252|3607235|B1|Latvia||Region of Enrollment||participants|Number|22|22.0||||||
3774566|NCT01903252|3607233|B3|Ireland||Region of Enrollment||participants|Number|1|1.0||||||
3774567|NCT01903252|3607234|B2|Ireland||Region of Enrollment||participants|Number|0|0.0||||||
3774568|NCT01903252|3607235|B1|Ireland||Region of Enrollment||participants|Number|1|1.0||||||
3774569|NCT01903252|3607233|B3|France||Region of Enrollment||participants|Number|39|39.0||||||
3774570|NCT01903252|3607234|B2|France||Region of Enrollment||participants|Number|16|16.0||||||
3774571|NCT01903252|3607235|B1|France||Region of Enrollment||participants|Number|23|23.0||||||
3774572|NCT01903252|3607233|B3|Hungary||Region of Enrollment||participants|Number|28|28.0||||||
3774573|NCT01903252|3607234|B2|Hungary||Region of Enrollment||participants|Number|11|11.0||||||
3774574|NCT01903252|3607235|B1|Hungary||Region of Enrollment||participants|Number|17|17.0||||||
3774575|NCT01903252|3607233|B3|Finland||Region of Enrollment||participants|Number|3|3.0||||||
3774576|NCT01903252|3607234|B2|Finland||Region of Enrollment||participants|Number|1|1.0||||||
3774577|NCT01903252|3607235|B1|Finland||Region of Enrollment||participants|Number|2|2.0||||||
3774578|NCT01903252|3607233|B3|Denmark||Region of Enrollment||participants|Number|36|36.0||||||
3774579|NCT01903252|3607234|B2|Denmark||Region of Enrollment||participants|Number|16|16.0||||||
3774580|NCT01903252|3607235|B1|Denmark||Region of Enrollment||participants|Number|20|20.0||||||
3774581|NCT01903252|3607233|B3|Czech Republic||Region of Enrollment||participants|Number|38|38.0||||||
3774582|NCT01903252|3607234|B2|Czech Republic||Region of Enrollment||participants|Number|18|18.0||||||
3774583|NCT01903252|3607235|B1|Czech Republic||Region of Enrollment||participants|Number|20|20.0||||||
3774584|NCT01903252|3607233|B3|Canada||Region of Enrollment||participants|Number|32|32.0||||||
3774585|NCT01903252|3607234|B2|Canada||Region of Enrollment||participants|Number|17|17.0||||||
3774586|NCT01903252|3607235|B1|Canada||Region of Enrollment||participants|Number|15|15.0||||||
3774587|NCT01903252|3607233|B3|Bulgaria||Region of Enrollment||participants|Number|30|30.0||||||
3774588|NCT01903252|3607234|B2|Bulgaria||Region of Enrollment||participants|Number|15|15.0||||||
3774589|NCT01903252|3607235|B1|Bulgaria||Region of Enrollment||participants|Number|15|15.0||||||
3774590|NCT01903252|3607233|B3|Belgium||Region of Enrollment||participants|Number|17|17.0||||||
3774591|NCT01903252|3607234|B2|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
3774592|NCT01903252|3607235|B1|Belgium||Region of Enrollment||participants|Number|9|9.0||||||
3774593|NCT01903252|3607233|B3|Belarus||Region of Enrollment||participants|Number|96|96.0||||||
3774594|NCT01903252|3607234|B2|Belarus||Region of Enrollment||participants|Number|49|49.0||||||
3774595|NCT01903252|3607235|B1|Belarus||Region of Enrollment||participants|Number|47|47.0||||||
3774596|NCT01903252|3607233|B3||Not Available|Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3774597|NCT01903252|3607234|B2||Not Available|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3774598|NCT01903252|3607235|B1||Not Available|Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3774599|NCT01903252|3607233|B3||Mixed/Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3774600|NCT01903252|3607234|B2||Mixed/Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3774601|NCT01903252|3607235|B1||Mixed/Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3774602|NCT01903252|3607233|B3||Asian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3774603|NCT01903252|3607234|B2||Asian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3774604|NCT01903252|3607235|B1||Asian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3774605|NCT01903252|3607233|B3||Black|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3774606|NCT01903252|3607234|B2||Black|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3774607|NCT01903252|3607235|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3774608|NCT01903252|3607233|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|764|764.0||||||
3774609|NCT01903252|3607234|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|386|386.0||||||
3774610|NCT01903252|3607235|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|378|378.0||||||
3774611|NCT01903252|3607233|B3||Male|Sex: Female, Male||Participants|Count of Participants|468|468.0||||||
3774612|NCT01903252|3607234|B2||Male|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
3774613|NCT01903252|3607235|B1||Male|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
3774614|NCT01903252|3607233|B3||Female|Sex: Female, Male||Participants|Count of Participants|349|349.0||||||
3774615|NCT01903252|3607234|B2||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
3774616|NCT01903252|3607235|B1||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3774617|NCT01903252|3607233|B3|||Age||years|Mean|43.5|43.5|Standard Deviation|14.32|14.32|||
3774618|NCT01903252|3607234|B2|||Age||years|Mean|43.3|43.3|Standard Deviation|14.11|14.11|||
3774619|NCT01903252|3607235|B1|||Age||years|Mean|43.97|43.97|Standard Deviation|14.54|14.54|||
3774620|NCT01903187|3607317|B3|||Number of Anti-hypertensive medications||number of anti-hypertensive medications|Mean|4.8|4.8|Standard Deviation|1.3|1.3|||
3774621|NCT01903187|3607318|B2|||Number of Anti-hypertensive medications||number of anti-hypertensive medications|Mean|5.5|5.5|Standard Deviation|0.7|0.7|||
3774622|NCT01903187|3607319|B1|||Number of Anti-hypertensive medications||number of anti-hypertensive medications|Mean|4.0|4.0|Standard Deviation|1.4|1.4|||
3774623|NCT01903187|3607317|B3|||Daytime Ambulatory Heart Rate||beats/minute|Mean|65.0|65.0|Standard Deviation|11.7|11.7|||
3774624|NCT01903187|3607318|B2|||Daytime Ambulatory Heart Rate||beats/minute|Mean|60.6|60.6|Standard Deviation|18.3|18.3|||
3774625|NCT01903187|3607319|B1|||Daytime Ambulatory Heart Rate||beats/minute|Mean|69.4|69.4|Standard Deviation|1.6|1.6|||
3774626|NCT01903187|3607317|B3|||Daytime Ambulatory Diastolic BP||mmHg|Mean|87.7|87.7|Standard Deviation|21.2|21.2|||
3774627|NCT01903187|3607318|B2|||Daytime Ambulatory Diastolic BP||mmHg|Mean|75.6|75.6|Standard Deviation|1.8|1.8|||
3774628|NCT01903187|3607319|B1|||Daytime Ambulatory Diastolic BP||mmHg|Mean|99.8|99.8|Standard Deviation|27.6|27.6|||
3774629|NCT01903187|3607317|B3|||Daytime Ambulatory Systolic BP||mmHg|Mean|158.2|158.2|Standard Deviation|16.1|16.1|||
3774630|NCT01903187|3607318|B2|||Daytime Ambulatory Systolic BP||mmHg|Mean|155.0|155.0|Standard Deviation|2.7|2.7|||
3774631|NCT01903187|3607319|B1|||Daytime Ambulatory Systolic BP||mmHg|Mean|161.4|161.4|Standard Deviation|27.0|27.0|||
3774632|NCT01903187|3607317|B3|||24-Hr Ambulatory Heart Rate||beats/minute|Mean|64.3|64.3|Standard Deviation|10.4|10.4|||
3774633|NCT01903187|3607318|B2|||24-Hr Ambulatory Heart Rate||beats/minute|Mean|60.5|60.5|Standard Deviation|16.0|16.0|||
3774634|NCT01903187|3607319|B1|||24-Hr Ambulatory Heart Rate||beats/minute|Mean|68.2|68.2|Standard Deviation|2.9|2.9|||
3774635|NCT01903187|3607317|B3|||24-Hr Ambulatory Diastolic BP||mmHg|Mean|83.9|83.9|Standard Deviation|17.4|17.4|||
3774636|NCT01903187|3607318|B2|||24-Hr Ambulatory Diastolic BP||mmHg|Mean|75.4|75.4|Standard Deviation|1.4|1.4|||
3774637|NCT01903187|3607319|B1|||24-Hr Ambulatory Diastolic BP||mmHg|Mean|92.5|92.5|Standard Deviation|24.7|24.7|||
3774638|NCT01903187|3607317|B3|||24-Hr Ambulatory Systolic BP||mmHg|Mean|153.5|153.5|Standard Deviation|13.6|13.6|||
3774639|NCT01903187|3607318|B2|||24-Hr Ambulatory Systolic BP||mmHg|Mean|155.3|155.3|Standard Deviation|4.3|4.3|||
3774640|NCT01903187|3607319|B1|||24-Hr Ambulatory Systolic BP||mmHg|Mean|151.7|151.7|Standard Deviation|22.9|22.9|||
3774641|NCT01903187|3607317|B3|||Office Heart Rate||beats/minute|Mean|67.5|67.5|Standard Deviation|13.3|13.3|||
3774642|NCT01903187|3607318|B2|||Office Heart Rate||beats/minute|Mean|58.5|58.5|Standard Deviation|7.8|7.8|||
3774643|NCT01903187|3607319|B1|||Office Heart Rate||beats/minute|Mean|76.5|76.5|Standard Deviation|12.0|12.0|||
3774644|NCT01903187|3607317|B3|||Office Diastolic BP||mmHg|Mean|99.8|99.8|Standard Deviation|13.9|13.9|||
3774645|NCT01903187|3607318|B2|||Office Diastolic BP||mmHg|Mean|88.0|88.0|Standard Deviation|1.4|1.4|||
3774646|NCT01903187|3607319|B1|||Office Diastolic BP||mmHg|Mean|111.5|111.5|Standard Deviation|4.9|4.9|||
3774647|NCT01903187|3607317|B3|||Office Systolic BP||mmHg|Mean|188.8|188.8|Standard Deviation|25.5|25.5|||
3774648|NCT01903187|3607318|B2|||Office Systolic BP||mmHg|Mean|199.5|199.5|Standard Deviation|34.6|34.6|||
3774649|NCT01903187|3607319|B1|||Office Systolic BP||mmHg|Mean|178.0|178.0|Standard Deviation|17.0|17.0|||
3774650|NCT01903187|3607317|B3|||Urine Albumin to Creatinine Ratio|Ratio reported as milligrams of albumin per gram of creatinine.|mg/g|Mean|54.3|54.3|Standard Deviation|79.4|79.4|||
3774651|NCT01903187|3607318|B2|||Urine Albumin to Creatinine Ratio|Ratio reported as milligrams of albumin per gram of creatinine.|mg/g|Mean|98.0|98.0|Standard Deviation|106.1|106.1|||
3774652|NCT01903187|3607319|B1|||Urine Albumin to Creatinine Ratio|Ratio reported as milligrams of albumin per gram of creatinine.|mg/g|Mean|10.5|10.5|Standard Deviation|2.1|2.1|||
3774653|NCT01903187|3607317|B3|||Cystatin C||mg/L|Mean|0.87|0.87|Standard Deviation|0.22|0.22|||
3774654|NCT01903187|3607318|B2|||Cystatin C||mg/L|Mean|0.98|0.98|Standard Deviation|0.18|0.18|||
3774655|NCT01903187|3607319|B1|||Cystatin C||mg/L|Mean|0.76|0.76|Standard Deviation|0.25|0.25|||
3774656|NCT01903187|3607317|B3|||Serum Creatinine||umol/L|Mean|76.0|76.0|Standard Deviation|17.5|17.5|||
3774657|NCT01903187|3607318|B2|||Serum Creatinine||umol/L|Mean|83.0|83.0|Standard Deviation|1.4|1.4|||
3774658|NCT01903187|3607319|B1|||Serum Creatinine||umol/L|Mean|69.0|69.0|Standard Deviation|26.9|26.9|||
3774659|NCT01903187|3607317|B3|||eGFR|"Estimated glomular filtration rate use Modified Diet in Renal Disease formula:~For creatinine in µmol/L:~eGFR = 32788 X Serum Creatinine^-1.154 X Age^-0.203 X [1.210 if Black] X [0.742 if Female]"|mL/min/1.73 m2|Mean|81.3|81.3|Standard Deviation|21.0|21.0|||
3774660|NCT01903187|3607318|B2|||eGFR|"Estimated glomular filtration rate use Modified Diet in Renal Disease formula:~For creatinine in µmol/L:~eGFR = 32788 X Serum Creatinine^-1.154 X Age^-0.203 X [1.210 if Black] X [0.742 if Female]"|mL/min/1.73 m2|Mean|71.5|71.5|Standard Deviation|14.8|14.8|||
3774661|NCT01903187|3607319|B1|||eGFR|"Estimated glomular filtration rate use Modified Diet in Renal Disease formula:~For creatinine in µmol/L:~eGFR = 32788 X Serum Creatinine^-1.154 X Age^-0.203 X [1.210 if Black] X [0.742 if Female]"|mL/min/1.73 m2|Mean|91.0|91.0|Standard Deviation|26.9|26.9|||
3774662|NCT01903187|3607317|B3|No||Obstructive Sleep Apnea||participants|Number|3|3.0||||||
3774663|NCT01903187|3607318|B2|No||Obstructive Sleep Apnea||participants|Number|1|1.0||||||
3774664|NCT01903187|3607319|B1|No||Obstructive Sleep Apnea||participants|Number|2|2.0||||||
3774665|NCT01903187|3607317|B3|Yes||Obstructive Sleep Apnea||participants|Number|1|1.0||||||
3774666|NCT01903187|3607318|B2|Yes||Obstructive Sleep Apnea||participants|Number|1|1.0||||||
3774667|NCT01903187|3607319|B1|Yes||Obstructive Sleep Apnea||participants|Number|0|0.0||||||
3774668|NCT01903187|3607317|B3|No||Type II Diabetes||participants|Number|4|4.0||||||
3774669|NCT01903187|3607318|B2|No||Type II Diabetes||participants|Number|2|2.0||||||
3774670|NCT01903187|3607319|B1|No||Type II Diabetes||participants|Number|2|2.0||||||
3774671|NCT01903187|3607317|B3|Yes||Type II Diabetes||participants|Number|0|0.0||||||
3774672|NCT01903187|3607318|B2|Yes||Type II Diabetes||participants|Number|0|0.0||||||
3774673|NCT01903187|3607319|B1|Yes||Type II Diabetes||participants|Number|0|0.0||||||
3774674|NCT01903187|3607317|B3|No||Hyperlipidemia||participants|Number|1|1.0||||||
3774675|NCT01903187|3607318|B2|No||Hyperlipidemia||participants|Number|0|0.0||||||
3774676|NCT01903187|3607319|B1|No||Hyperlipidemia||participants|Number|1|1.0||||||
3774677|NCT01903187|3607317|B3|Yes||Hyperlipidemia||participants|Number|3|3.0||||||
3774678|NCT01903187|3607318|B2|Yes||Hyperlipidemia||participants|Number|2|2.0||||||
3774679|NCT01903187|3607319|B1|Yes||Hyperlipidemia||participants|Number|1|1.0||||||
3774680|NCT01903187|3607317|B3|No||Renal Artery Stenosis||participants|Number|4|4.0||||||
3774681|NCT01903187|3607318|B2|No||Renal Artery Stenosis||participants|Number|2|2.0||||||
3774682|NCT01903187|3607319|B1|No||Renal Artery Stenosis||participants|Number|2|2.0||||||
3774683|NCT01903187|3607317|B3|Yes||Renal Artery Stenosis||participants|Number|0|0.0||||||
3774684|NCT01903187|3607318|B2|Yes||Renal Artery Stenosis||participants|Number|0|0.0||||||
3774685|NCT01903187|3607319|B1|Yes||Renal Artery Stenosis||participants|Number|0|0.0||||||
3774686|NCT01903187|3607317|B3|No||Coronary Artery Disease||participants|Number|3|3.0||||||
3774687|NCT01903187|3607318|B2|No||Coronary Artery Disease||participants|Number|2|2.0||||||
3774688|NCT01903187|3607319|B1|No||Coronary Artery Disease||participants|Number|1|1.0||||||
3774689|NCT01903187|3607317|B3|Yes||Coronary Artery Disease||participants|Number|1|1.0||||||
3774690|NCT01903187|3607318|B2|Yes||Coronary Artery Disease||participants|Number|0|0.0||||||
3774691|NCT01903187|3607319|B1|Yes||Coronary Artery Disease||participants|Number|1|1.0||||||
3774692|NCT01903187|3607317|B3|||Years with hypertension||years|Mean|32.3|32.3|Standard Deviation|3.2|3.2|||
3774693|NCT01903187|3607318|B2|||Years with hypertension||years|Mean|36.0|36.0|Standard Deviation|0|0.0|||
3774694|NCT01903187|3607319|B1|||Years with hypertension||years|Mean|30.5|30.5|Standard Deviation|0.7|0.7|||
3774695|NCT01903187|3607317|B3|||BMI|Body mass index|kg/m^2|Mean|32.2|32.2|Standard Deviation|8.7|8.7|||
3774696|NCT01903187|3607318|B2|||BMI|Body mass index|kg/m^2|Mean|36.5|36.5|Standard Deviation|6.2|6.2|||
3774697|NCT01903187|3607319|B1|||BMI|Body mass index|kg/m^2|Mean|27.9|27.9|Standard Deviation|10.6|10.6|||
3774698|NCT01903187|3607317|B3|||Weight||kilograms|Mean|94.5|94.5|Standard Deviation|23.7|23.7|||
3774699|NCT01903187|3607318|B2|||Weight||kilograms|Mean|108.0|108.0|Standard Deviation|25.0|25.0|||
3774700|NCT01903187|3607319|B1|||Weight||kilograms|Mean|81.0|81.0|Standard Deviation|18.4|18.4|||
3774701|NCT01903187|3607317|B3|||Height||centimeters|Mean|172.2|172.2|Standard Deviation|8.7|8.7|||
3774702|NCT01903187|3607318|B2|||Height||centimeters|Mean|171.5|171.5|Standard Deviation|5.4|5.4|||
3774703|NCT01903187|3607319|B1|||Height||centimeters|Mean|172.9|172.9|Standard Deviation|14.1|14.1|||
3774704|NCT01903187|3607317|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774705|NCT01903187|3607318|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774706|NCT01903187|3607319|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774707|NCT01903187|3607317|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774708|NCT01903187|3607318|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774709|NCT01903187|3607319|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774710|NCT01903187|3607317|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3774711|NCT01903187|3607318|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3774712|NCT01903187|3607319|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3774713|NCT01903187|3607317|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3774714|NCT01903187|3607318|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774715|NCT01903187|3607319|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3774716|NCT01903187|3607317|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774717|NCT01903187|3607318|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774718|NCT01903187|3607319|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774719|NCT01903187|3607317|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774720|NCT01903187|3607318|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774721|NCT01903187|3607319|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774722|NCT01903187|3607317|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774723|NCT01903187|3607318|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774724|NCT01903187|3607319|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774725|NCT01903187|3607317|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774726|NCT01903187|3607318|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774727|NCT01903187|3607319|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774728|NCT01903187|3607317|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3774729|NCT01903187|3607318|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3774730|NCT01903187|3607319|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3774731|NCT01903187|3607317|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774732|NCT01903187|3607318|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774733|NCT01903187|3607319|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774734|NCT01903187|3607317|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3774735|NCT01903187|3607318|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3774736|NCT01903187|3607319|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3774737|NCT01903187|3607317|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3774738|NCT01903187|3607318|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3774739|NCT01903187|3607319|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3774740|NCT01903187|3607317|B3|||Age||years|Mean|57.2|57.2|Standard Deviation|7.4|7.4|||
3774741|NCT01903187|3607318|B2|||Age||years|Mean|60.4|60.4|Standard Deviation|6.7|6.7|||
3774742|NCT01903187|3607319|B1|||Age||years|Mean|54.1|54.1|Standard Deviation|8.9|8.9|||
3774743|NCT01903148|3607332|B3||Male|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
3774744|NCT01903148|3607333|B2||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3774745|NCT01903148|3607334|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3774746|NCT01903148|3607332|B3||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
3774747|NCT01903148|3607333|B2||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3774748|NCT01903148|3607334|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3774749|NCT01903148|3607332|B3|||Age||years|Mean|73.1|73.1|Standard Deviation|13|13.0|||
3774750|NCT01903148|3607333|B2|||Age||years|Mean|72.9|72.9|Standard Deviation|12.5|12.5|||
3774751|NCT01903148|3607334|B1|||Age||years|Mean|73.5|73.5|Standard Deviation|13.9|13.9|||
3774752|NCT01903031|3607350|B4|Peru||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3774753|NCT01903031|3607351|B3|Peru||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3774754|NCT01903031|3607352|B2|Peru||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3774755|NCT01903031|3607353|B1|Peru||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3774756|NCT01903031|3607350|B4|Thailand||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3774757|NCT01903031|3607351|B3|Thailand||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3774758|NCT01903031|3607352|B2|Thailand||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3774759|NCT01903031|3607353|B1|Thailand||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3774760|NCT01903031|3607350|B4|Kenya||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3774761|NCT01903031|3607351|B3|Kenya||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3774762|NCT01903031|3607352|B2|Kenya||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3774763|NCT01903031|3607353|B1|Kenya||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3774764|NCT01903031|3607350|B4|South Africa||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3774765|NCT01903031|3607351|B3|South Africa||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3774766|NCT01903031|3607352|B2|South Africa||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3774767|NCT01903031|3607353|B1|South Africa||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3774768|NCT01903031|3607350|B4|Brazil||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3774769|NCT01903031|3607351|B3|Brazil||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3774770|NCT01903031|3607352|B2|Brazil||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3774771|NCT01903031|3607353|B1|Brazil||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3774772|NCT01903031|3607350|B4|Botswana||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3774773|NCT01903031|3607351|B3|Botswana||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3774774|NCT01903031|3607352|B2|Botswana||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3774775|NCT01903031|3607353|B1|Botswana||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3774776|NCT01903031|3607350|B4|United States||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3774777|NCT01903031|3607351|B3|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3774778|NCT01903031|3607352|B2|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3774779|NCT01903031|3607353|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3774780|NCT01903031|3607350|B4|Puerto Rico||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3774781|NCT01903031|3607351|B3|Puerto Rico||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3774782|NCT01903031|3607352|B2|Puerto Rico||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3774783|NCT01903031|3607353|B1|Puerto Rico||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3774784|NCT01903031|3607350|B4||Asian, Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3774785|NCT01903031|3607351|B3||Asian, Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3774786|NCT01903031|3607352|B2||Asian, Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3774787|NCT01903031|3607353|B1||Asian, Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3774788|NCT01903031|3607350|B4||Hispanic (Regardless of Race)|Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3774789|NCT01903031|3607351|B3||Hispanic (Regardless of Race)|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3774790|NCT01903031|3607352|B2||Hispanic (Regardless of Race)|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3774791|NCT01903031|3607353|B1||Hispanic (Regardless of Race)|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3774792|NCT01903031|3607350|B4||Black Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
3774793|NCT01903031|3607351|B3||Black Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3774794|NCT01903031|3607352|B2||Black Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3774795|NCT01903031|3607353|B1||Black Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3774796|NCT01903031|3607350|B4||White Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3774797|NCT01903031|3607351|B3||White Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3774798|NCT01903031|3607352|B2||White Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3774799|NCT01903031|3607353|B1||White Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3774800|NCT01903031|3607350|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3774801|NCT01903031|3607351|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3774802|NCT01903031|3607352|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3774803|NCT01903031|3607353|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3774804|NCT01903031|3607350|B4||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3774805|NCT01903031|3607351|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3774806|NCT01903031|3607352|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3774807|NCT01903031|3607353|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3774808|NCT01903031|3607350|B4|||Age||years|Median|35|35.0|Full Range|||17.0|55.0|
3774809|NCT01903031|3607351|B3|||Age||years|Median|36|36.0|Full Range|||22.0|50.0|
3774810|NCT01903031|3607352|B2|||Age||years|Median|36|36.0|Full Range|||17.0|55.0|
3774811|NCT01903031|3607353|B1|||Age||years|Median|32|32.0|Full Range|||22.0|48.0|
3774812|NCT01903005|3607395|B3|||Duration of Opioid Use||years|Median|7.95|7.95|Standard Deviation|9.32|9.32|||
3774813|NCT01903005|3607396|B2|||Duration of Opioid Use||years|Median|9.6|9.6|Standard Deviation|8.79|8.79|||
3774814|NCT01903005|3607397|B1|||Duration of Opioid Use||years|Median|7.20|7.2|Standard Deviation|9.50|9.5|||
3774815|NCT01903005|3607395|B3|||Body Mass Index||kg/m^2|Mean|26.41|26.41|Standard Deviation|6.26|6.26|||
3774816|NCT01903005|3607396|B2|||Body Mass Index||kg/m^2|Mean|26.26|26.26|Standard Deviation|6.63|6.63|||
3774817|NCT01903005|3607397|B1|||Body Mass Index||kg/m^2|Mean|26.47|26.47|Standard Deviation|6.11|6.11|||
3774818|NCT01903005|3607395|B3|||Weight||kg|Mean|78.53|78.53|Standard Deviation|19.49|19.49|||
3774819|NCT01903005|3607396|B2|||Weight||kg|Mean|78.98|78.98|Standard Deviation|20.73|20.73|||
3774820|NCT01903005|3607397|B1|||Weight||kg|Mean|78.34|78.34|Standard Deviation|18.99|18.99|||
3774821|NCT01903005|3607395|B3|||Height||cm|Mean|172.38|172.38|Standard Deviation|9.61|9.61|||
3774822|NCT01903005|3607396|B2|||Height||cm|Mean|173.35|173.35|Standard Deviation|10.01|10.01|||
3774823|NCT01903005|3607397|B1|||Height||cm|Mean|171.99|171.99|Standard Deviation|9.43|9.43|||
3774824|NCT01903005|3607395|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3774825|NCT01903005|3607396|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774826|NCT01903005|3607397|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3774827|NCT01903005|3607395|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3774828|NCT01903005|3607396|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3774829|NCT01903005|3607397|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3774830|NCT01903005|3607395|B3||White|Race (NIH/OMB)||Participants|Count of Participants|569|569.0||||||
3774831|NCT01903005|3607396|B2||White|Race (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
3774832|NCT01903005|3607397|B1||White|Race (NIH/OMB)||Participants|Count of Participants|402|402.0||||||
3774833|NCT01903005|3607395|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3774834|NCT01903005|3607396|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3774835|NCT01903005|3607397|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3774836|NCT01903005|3607395|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774837|NCT01903005|3607396|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774838|NCT01903005|3607397|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774839|NCT01903005|3607395|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3774840|NCT01903005|3607396|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774841|NCT01903005|3607397|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3774842|NCT01903005|3607395|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3774843|NCT01903005|3607396|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774844|NCT01903005|3607397|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3774845|NCT01903005|3607395|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774846|NCT01903005|3607396|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774847|NCT01903005|3607397|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3774848|NCT01903005|3607395|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|583|583.0||||||
3774849|NCT01903005|3607396|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|173|173.0||||||
3774850|NCT01903005|3607397|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|410|410.0||||||
3774851|NCT01903005|3607395|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3774852|NCT01903005|3607396|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3774853|NCT01903005|3607397|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3774854|NCT01903005|3607395|B3||Male|Sex: Female, Male||Participants|Count of Participants|406|406.0||||||
3774855|NCT01903005|3607396|B2||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3774856|NCT01903005|3607397|B1||Male|Sex: Female, Male||Participants|Count of Participants|279|279.0||||||
3774857|NCT01903005|3607395|B3||Female|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
3774858|NCT01903005|3607396|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3774859|NCT01903005|3607397|B1||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
3774860|NCT01903005|3607395|B3|||Age||years|Mean|36.8|36.8|Standard Deviation|11.3|11.3|||
3774861|NCT01903005|3607396|B2|||Age||years|Mean|39.0|39.0|Standard Deviation|10.8|10.8|||
3774862|NCT01903005|3607397|B1|||Age||years|Mean|35.9|35.9|Standard Deviation|11.4|11.4|||
3774863|NCT01902888|3607411|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3774864|NCT01902888|3607411|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3774865|NCT01902888|3607411|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3774866|NCT01902888|3607411|B1|||Age||years|Mean|65|65.0|Standard Deviation|12.28|12.28|||
3774867|NCT01902758|3607416|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
3774868|NCT01902758|3607417|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3774869|NCT01902758|3607418|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3774870|NCT01902758|3607416|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3774871|NCT01902758|3607417|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3774872|NCT01902758|3607418|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3774873|NCT01902758|3607416|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3774874|NCT01902758|3607417|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3774875|NCT01902758|3607418|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3774876|NCT01902758|3607416|B3|||Age||years|Mean|23|23.0|Standard Deviation|2|2.0|||
3774877|NCT01902758|3607417|B2|||Age||years|Mean|23|23.0|Standard Deviation|2|2.0|||
3774878|NCT01902758|3607418|B1|||Age||years|Mean|22|22.0|Standard Deviation|2|2.0|||
3774879|NCT01902758|3607416|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3774880|NCT01902758|3607417|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3774881|NCT01902758|3607418|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3774882|NCT01902758|3607416|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3774883|NCT01902758|3607417|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3774884|NCT01902758|3607418|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3774885|NCT01902758|3607416|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3774886|NCT01902758|3607417|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3774887|NCT01902758|3607418|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3774888|NCT01902628|3607425|B1||Male|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
3774889|NCT01902628|3607425|B1||Female|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
3774890|NCT01902628|3607425|B1|||Age||years|Median|76|76.0|Full Range|||23.0|96.0|
3774891|NCT01902459|3607432|B3|Morbidly obese||BMI Category|Underweight: < 18.5 kg/m^2, Normal weight: 18.5 - <25 kg/m^2, Overweight: 25 - <30 kg/m^2, Obese: 30 - <40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participants|Number|19|19.0||||||
3774892|NCT01902459|3607433|B2|Morbidly obese||BMI Category|Underweight: < 18.5 kg/m^2, Normal weight: 18.5 - <25 kg/m^2, Overweight: 25 - <30 kg/m^2, Obese: 30 - <40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participants|Number|8|8.0||||||
3774893|NCT01902459|3607434|B1|Morbidly obese||BMI Category|Underweight: < 18.5 kg/m^2, Normal weight: 18.5 - <25 kg/m^2, Overweight: 25 - <30 kg/m^2, Obese: 30 - <40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participants|Number|11|11.0||||||
3774894|NCT01902459|3607432|B3|Obese||BMI Category|Underweight: < 18.5 kg/m^2, Normal weight: 18.5 - <25 kg/m^2, Overweight: 25 - <30 kg/m^2, Obese: 30 - <40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participants|Number|71|71.0||||||
3774895|NCT01902459|3607433|B2|Obese||BMI Category|Underweight: < 18.5 kg/m^2, Normal weight: 18.5 - <25 kg/m^2, Overweight: 25 - <30 kg/m^2, Obese: 30 - <40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participants|Number|34|34.0||||||
3774896|NCT01902459|3607434|B1|Obese||BMI Category|Underweight: < 18.5 kg/m^2, Normal weight: 18.5 - <25 kg/m^2, Overweight: 25 - <30 kg/m^2, Obese: 30 - <40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participants|Number|37|37.0||||||
3774897|NCT01902459|3607432|B3|Overweight||BMI Category|Underweight: < 18.5 kg/m^2, Normal weight: 18.5 - <25 kg/m^2, Overweight: 25 - <30 kg/m^2, Obese: 30 - <40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participants|Number|37|37.0||||||
3774898|NCT01902459|3607433|B2|Overweight||BMI Category|Underweight: < 18.5 kg/m^2, Normal weight: 18.5 - <25 kg/m^2, Overweight: 25 - <30 kg/m^2, Obese: 30 - <40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participants|Number|22|22.0||||||
3774899|NCT01902459|3607434|B1|Overweight||BMI Category|Underweight: < 18.5 kg/m^2, Normal weight: 18.5 - <25 kg/m^2, Overweight: 25 - <30 kg/m^2, Obese: 30 - <40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participants|Number|15|15.0||||||
3774900|NCT01902459|3607432|B3|Normal||BMI Category|Underweight: < 18.5 kg/m^2, Normal weight: 18.5 - <25 kg/m^2, Overweight: 25 - <30 kg/m^2, Obese: 30 - <40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participants|Number|21|21.0||||||
3774901|NCT01902459|3607433|B2|Normal||BMI Category|Underweight: < 18.5 kg/m^2, Normal weight: 18.5 - <25 kg/m^2, Overweight: 25 - <30 kg/m^2, Obese: 30 - <40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participants|Number|11|11.0||||||
3774902|NCT01902459|3607434|B1|Normal||BMI Category|Underweight: < 18.5 kg/m^2, Normal weight: 18.5 - <25 kg/m^2, Overweight: 25 - <30 kg/m^2, Obese: 30 - <40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participants|Number|10|10.0||||||
3774903|NCT01902459|3607432|B3|Underweight||BMI Category|Underweight: < 18.5 kg/m^2, Normal weight: 18.5 - <25 kg/m^2, Overweight: 25 - <30 kg/m^2, Obese: 30 - <40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participants|Number|2|2.0||||||
3774904|NCT01902459|3607433|B2|Underweight||BMI Category|Underweight: < 18.5 kg/m^2, Normal weight: 18.5 - <25 kg/m^2, Overweight: 25 - <30 kg/m^2, Obese: 30 - <40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participants|Number|0|0.0||||||
3774905|NCT01902459|3607434|B1|Underweight||BMI Category|Underweight: < 18.5 kg/m^2, Normal weight: 18.5 - <25 kg/m^2, Overweight: 25 - <30 kg/m^2, Obese: 30 - <40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participants|Number|2|2.0||||||
3774906|NCT01902459|3607432|B3|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3774907|NCT01902459|3607433|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3774908|NCT01902459|3607434|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3774909|NCT01902459|3607432|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3774910|NCT01902459|3607433|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3774911|NCT01902459|3607434|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3774912|NCT01902459|3607432|B3|White / Caucasian||Race/Ethnicity, Customized||Participants|Number|135|135.0||||||
3774913|NCT01902459|3607433|B2|White / Caucasian||Race/Ethnicity, Customized||Participants|Number|66|66.0||||||
3774914|NCT01902459|3607434|B1|White / Caucasian||Race/Ethnicity, Customized||Participants|Number|69|69.0||||||
3774915|NCT01902459|3607432|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3774916|NCT01902459|3607433|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3774917|NCT01902459|3607434|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3774918|NCT01902459|3607432|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3774919|NCT01902459|3607433|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3774920|NCT01902459|3607434|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3774921|NCT01902459|3607432|B3|>= 75 yeatrs||Age, Customized||Participants|Number|10|10.0||||||
3774922|NCT01902459|3607433|B2|>= 75 yeatrs||Age, Customized||Participants|Number|4|4.0||||||
3774923|NCT01902459|3607434|B1|>= 75 yeatrs||Age, Customized||Participants|Number|6|6.0||||||
3774924|NCT01902459|3607432|B3|65 to < 75 years||Age, Customized||Participants|Number|31|31.0||||||
3774925|NCT01902459|3607433|B2|65 to < 75 years||Age, Customized||Participants|Number|16|16.0||||||
3774926|NCT01902459|3607434|B1|65 to < 75 years||Age, Customized||Participants|Number|15|15.0||||||
3774927|NCT01902459|3607432|B3|50 to < 65 years||Age, Customized||Participants|Number|66|66.0||||||
3774928|NCT01902459|3607433|B2|50 to < 65 years||Age, Customized||Participants|Number|35|35.0||||||
3774929|NCT01902459|3607434|B1|50 to < 65 years||Age, Customized||Participants|Number|31|31.0||||||
3774930|NCT01902459|3607432|B3|18 to < 50 years||Age, Customized||Participants|Number|43|43.0||||||
3774931|NCT01902459|3607433|B2|18 to < 50 years||Age, Customized||Participants|Number|20|20.0||||||
3774932|NCT01902459|3607434|B1|18 to < 50 years||Age, Customized||Participants|Number|23|23.0||||||
3774933|NCT01902303|3607451|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3774934|NCT01902303|3607452|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3774935|NCT01902303|3607453|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3774936|NCT01902303|3607451|B3||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3774937|NCT01902303|3607452|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3774938|NCT01902303|3607453|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3774939|NCT01902303|3607451|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3774940|NCT01902303|3607452|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3774941|NCT01902303|3607453|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3774942|NCT01902303|3607451|B3||Between 18 and 65 years|Age||Participants|Count of Participants|145|145.0||||||
3774943|NCT01902303|3607452|B2||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
3774944|NCT01902303|3607453|B1||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
3774945|NCT01902303|3607451|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3774946|NCT01902303|3607452|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3774947|NCT01902303|3607453|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3774948|NCT01902134|3607462|B7|||Height||cm|Mean|168.5|168.5|Standard Deviation|9.01|9.01|||
3774949|NCT01902134|3607463|B6|||Height||cm|Mean|169.9|169.9|Standard Deviation|7.94|7.94|||
3774950|NCT01902134|3607464|B5|||Height||cm|Mean|168.0|168.0|Standard Deviation|9.49|9.49|||
3774951|NCT01902134|3607465|B4|||Height||cm|Mean|166.1|166.1|Standard Deviation|8.47|8.47|||
3774952|NCT01902134|3607466|B3|||Height||cm|Mean|169.1|169.1|Standard Deviation|9.20|9.2|||
3774953|NCT01902134|3607467|B2|||Height||cm|Mean|167.9|167.9|Standard Deviation|9.14|9.14|||
3774954|NCT01902134|3607468|B1|||Height||cm|Mean|168.8|168.8|Standard Deviation|8.99|8.99|||
3774955|NCT01902134|3607462|B7|||Weight||kg|Mean|82.6|82.6|Standard Deviation|15.80|15.8|||
3774956|NCT01902134|3607463|B6|||Weight||kg|Mean|82.1|82.1|Standard Deviation|15.27|15.27|||
3774957|NCT01902134|3607464|B5|||Weight||kg|Mean|81.7|81.7|Standard Deviation|13.77|13.77|||
3774958|NCT01902134|3607465|B4|||Weight||kg|Mean|82.4|82.4|Standard Deviation|15.91|15.91|||
3774959|NCT01902134|3607466|B3|||Weight||kg|Mean|83.5|83.5|Standard Deviation|17.25|17.25|||
3774960|NCT01902134|3607467|B2|||Weight||kg|Mean|81.4|81.4|Standard Deviation|15.63|15.63|||
3774961|NCT01902134|3607468|B1|||Weight||kg|Mean|83.3|83.3|Standard Deviation|15.37|15.37|||
3774962|NCT01902134|3607462|B7|Latvia||Region of Enrollment||participants|Number|153|153.0||||||
3774963|NCT01902134|3607463|B6|Latvia||Region of Enrollment||participants|Number|16|16.0||||||
3774964|NCT01902134|3607464|B5|Latvia||Region of Enrollment||participants|Number|15|15.0||||||
3774965|NCT01902134|3607465|B4|Latvia||Region of Enrollment||participants|Number|16|16.0||||||
3774966|NCT01902134|3607466|B3|Latvia||Region of Enrollment||participants|Number|36|36.0||||||
3774967|NCT01902134|3607467|B2|Latvia||Region of Enrollment||participants|Number|33|33.0||||||
3774968|NCT01902134|3607468|B1|Latvia||Region of Enrollment||participants|Number|37|37.0||||||
3774969|NCT01902134|3607462|B7|Germany||Region of Enrollment||participants|Number|4|4.0||||||
3774970|NCT01902134|3607463|B6|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3774971|NCT01902134|3607464|B5|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3774972|NCT01902134|3607465|B4|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3774973|NCT01902134|3607466|B3|Germany||Region of Enrollment||participants|Number|2|2.0||||||
3774974|NCT01902134|3607467|B2|Germany||Region of Enrollment||participants|Number|1|1.0||||||
3774975|NCT01902134|3607468|B1|Germany||Region of Enrollment||participants|Number|1|1.0||||||
3774976|NCT01902134|3607462|B7|Lithuania||Region of Enrollment||participants|Number|84|84.0||||||
3774977|NCT01902134|3607463|B6|Lithuania||Region of Enrollment||participants|Number|11|11.0||||||
3774978|NCT01902134|3607464|B5|Lithuania||Region of Enrollment||participants|Number|5|5.0||||||
3774979|NCT01902134|3607465|B4|Lithuania||Region of Enrollment||participants|Number|6|6.0||||||
3774980|NCT01902134|3607466|B3|Lithuania||Region of Enrollment||participants|Number|21|21.0||||||
3774981|NCT01902134|3607467|B2|Lithuania||Region of Enrollment||participants|Number|19|19.0||||||
3774982|NCT01902134|3607468|B1|Lithuania||Region of Enrollment||participants|Number|22|22.0||||||
3774983|NCT01902134|3607462|B7|Ukraine||Region of Enrollment||participants|Number|56|56.0||||||
3774984|NCT01902134|3607463|B6|Ukraine||Region of Enrollment||participants|Number|3|3.0||||||
3774985|NCT01902134|3607464|B5|Ukraine||Region of Enrollment||participants|Number|6|6.0||||||
3774986|NCT01902134|3607465|B4|Ukraine||Region of Enrollment||participants|Number|6|6.0||||||
3774987|NCT01902134|3607466|B3|Ukraine||Region of Enrollment||participants|Number|13|13.0||||||
3774988|NCT01902134|3607467|B2|Ukraine||Region of Enrollment||participants|Number|13|13.0||||||
3774989|NCT01902134|3607468|B1|Ukraine||Region of Enrollment||participants|Number|15|15.0||||||
3774990|NCT01902134|3607462|B7|Poland||Region of Enrollment||participants|Number|33|33.0||||||
3774991|NCT01902134|3607463|B6|Poland||Region of Enrollment||participants|Number|3|3.0||||||
3774992|NCT01902134|3607464|B5|Poland||Region of Enrollment||participants|Number|2|2.0||||||
3774993|NCT01902134|3607465|B4|Poland||Region of Enrollment||participants|Number|2|2.0||||||
3774994|NCT01902134|3607466|B3|Poland||Region of Enrollment||participants|Number|8|8.0||||||
3774995|NCT01902134|3607467|B2|Poland||Region of Enrollment||participants|Number|8|8.0||||||
3774996|NCT01902134|3607468|B1|Poland||Region of Enrollment||participants|Number|10|10.0||||||
3774997|NCT01902134|3607462|B7|Spain||Region of Enrollment||participants|Number|2|2.0||||||
3774998|NCT01902134|3607463|B6|Spain||Region of Enrollment||participants|Number|0|0.0||||||
3774999|NCT01902134|3607464|B5|Spain||Region of Enrollment||participants|Number|0|0.0||||||
3775000|NCT01902134|3607465|B4|Spain||Region of Enrollment||participants|Number|0|0.0||||||
3775001|NCT01902134|3607466|B3|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3775002|NCT01902134|3607467|B2|Spain||Region of Enrollment||participants|Number|0|0.0||||||
3775003|NCT01902134|3607468|B1|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3775004|NCT01902134|3607462|B7|Hungary||Region of Enrollment||participants|Number|204|204.0||||||
3775005|NCT01902134|3607463|B6|Hungary||Region of Enrollment||participants|Number|11|11.0||||||
3775006|NCT01902134|3607464|B5|Hungary||Region of Enrollment||participants|Number|16|16.0||||||
3775007|NCT01902134|3607465|B4|Hungary||Region of Enrollment||participants|Number|17|17.0||||||
3775008|NCT01902134|3607466|B3|Hungary||Region of Enrollment||participants|Number|54|54.0||||||
3775009|NCT01902134|3607467|B2|Hungary||Region of Enrollment||participants|Number|57|57.0||||||
3775010|NCT01902134|3607468|B1|Hungary||Region of Enrollment||participants|Number|49|49.0||||||
3775011|NCT01902134|3607462|B7|Czech Republic||Region of Enrollment||participants|Number|36|36.0||||||
3775012|NCT01902134|3607463|B6|Czech Republic||Region of Enrollment||participants|Number|3|3.0||||||
3775013|NCT01902134|3607464|B5|Czech Republic||Region of Enrollment||participants|Number|4|4.0||||||
3775014|NCT01902134|3607465|B4|Czech Republic||Region of Enrollment||participants|Number|2|2.0||||||
3775015|NCT01902134|3607466|B3|Czech Republic||Region of Enrollment||participants|Number|8|8.0||||||
3775016|NCT01902134|3607467|B2|Czech Republic||Region of Enrollment||participants|Number|10|10.0||||||
3775017|NCT01902134|3607468|B1|Czech Republic||Region of Enrollment||participants|Number|9|9.0||||||
3775018|NCT01902134|3607462|B7|Taiwan||Region of Enrollment||participants|Number|7|7.0||||||
3775019|NCT01902134|3607463|B6|Taiwan||Region of Enrollment||participants|Number|2|2.0||||||
3775020|NCT01902134|3607464|B5|Taiwan||Region of Enrollment||participants|Number|0|0.0||||||
3775021|NCT01902134|3607465|B4|Taiwan||Region of Enrollment||participants|Number|0|0.0||||||
3775022|NCT01902134|3607466|B3|Taiwan||Region of Enrollment||participants|Number|3|3.0||||||
3775023|NCT01902134|3607467|B2|Taiwan||Region of Enrollment||participants|Number|2|2.0||||||
3775024|NCT01902134|3607468|B1|Taiwan||Region of Enrollment||participants|Number|0|0.0||||||
3775025|NCT01902134|3607462|B7|Serbia||Region of Enrollment||participants|Number|62|62.0||||||
3775026|NCT01902134|3607463|B6|Serbia||Region of Enrollment||participants|Number|5|5.0||||||
3775027|NCT01902134|3607464|B5|Serbia||Region of Enrollment||participants|Number|5|5.0||||||
3775028|NCT01902134|3607465|B4|Serbia||Region of Enrollment||participants|Number|5|5.0||||||
3775029|NCT01902134|3607466|B3|Serbia||Region of Enrollment||participants|Number|14|14.0||||||
3775030|NCT01902134|3607467|B2|Serbia||Region of Enrollment||participants|Number|18|18.0||||||
3775031|NCT01902134|3607468|B1|Serbia||Region of Enrollment||participants|Number|15|15.0||||||
3775032|NCT01902134|3607462|B7|White||Race/Ethnicity, Customized||participants|Number|634|634.0||||||
3775033|NCT01902134|3607463|B6|White||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
3775034|NCT01902134|3607464|B5|White||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
3775035|NCT01902134|3607465|B4|White||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
3775036|NCT01902134|3607466|B3|White||Race/Ethnicity, Customized||participants|Number|157|157.0||||||
3775037|NCT01902134|3607467|B2|White||Race/Ethnicity, Customized||participants|Number|159|159.0||||||
3775038|NCT01902134|3607468|B1|White||Race/Ethnicity, Customized||participants|Number|159|159.0||||||
3775039|NCT01902134|3607462|B7|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3775040|NCT01902134|3607463|B6|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3775041|NCT01902134|3607464|B5|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3775042|NCT01902134|3607465|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3775043|NCT01902134|3607466|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3775044|NCT01902134|3607467|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3775045|NCT01902134|3607468|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3775046|NCT01902134|3607462|B7||Male|Sex: Female, Male||Participants|Count of Participants|295|295.0||||||
3775047|NCT01902134|3607463|B6||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3775048|NCT01902134|3607464|B5||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3775049|NCT01902134|3607465|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3775050|NCT01902134|3607466|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3775051|NCT01902134|3607467|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3775052|NCT01902134|3607468|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3775053|NCT01902134|3607462|B7||Female|Sex: Female, Male||Participants|Count of Participants|346|346.0||||||
3775054|NCT01902134|3607463|B6||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3775055|NCT01902134|3607464|B5||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3775056|NCT01902134|3607465|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3775057|NCT01902134|3607466|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3775058|NCT01902134|3607467|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3775059|NCT01902134|3607468|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3775060|NCT01902134|3607462|B7|||Age||years|Mean|61.9|61.9|Standard Deviation|9.96|9.96|||
3775061|NCT01902134|3607463|B6|||Age||years|Mean|59.8|59.8|Standard Deviation|11.30|11.3|||
3775062|NCT01902134|3607464|B5|||Age||years|Mean|61.0|61.0|Standard Deviation|11.10|11.1|||
3775063|NCT01902134|3607465|B4|||Age||years|Mean|63.9|63.9|Standard Deviation|9.0|9.0|||
3775064|NCT01902134|3607466|B3|||Age||years|Mean|61.3|61.3|Standard Deviation|9.68|9.68|||
3775065|NCT01902134|3607467|B2|||Age||years|Mean|63.3|63.3|Standard Deviation|9.01|9.01|||
3775066|NCT01902134|3607468|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|10.43|10.43|||
3775067|NCT01901848|3607495|B3|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3775068|NCT01901848|3607496|B2|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3775069|NCT01901848|3607497|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3775070|NCT01901848|3607495|B3|Multiple Races||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3775071|NCT01901848|3607496|B2|Multiple Races||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3775072|NCT01901848|3607497|B1|Multiple Races||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3775073|NCT01901848|3607495|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3775074|NCT01901848|3607496|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3775075|NCT01901848|3607497|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3775076|NCT01901848|3607495|B3|Caucasian, not Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3775077|NCT01901848|3607496|B2|Caucasian, not Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3775078|NCT01901848|3607497|B1|Caucasian, not Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3775079|NCT01901848|3607495|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3775080|NCT01901848|3607496|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3775081|NCT01901848|3607497|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3775082|NCT01901848|3607495|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3775083|NCT01901848|3607496|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3775084|NCT01901848|3607497|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3775085|NCT01901848|3607495|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3775086|NCT01901848|3607496|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3775087|NCT01901848|3607497|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3775088|NCT01901848|3607495|B3|||Age||years|Mean|49.5|49.5|Standard Deviation|10.8|10.8|||
3775089|NCT01901848|3607496|B2|||Age||years|Mean|53.3|53.3|Standard Deviation|10.8|10.8|||
3775090|NCT01901848|3607497|B1|||Age||years|Mean|43.1|43.1|Standard Deviation|10.8|10.8|||
3775091|NCT01901809|3607506|B5|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3775092|NCT01901809|3607507|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3775093|NCT01901809|3607508|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3775094|NCT01901809|3607509|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3775095|NCT01901809|3607510|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3775096|NCT01901809|3607506|B5|White||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
3775097|NCT01901809|3607507|B4|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3775098|NCT01901809|3607508|B3|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3775099|NCT01901809|3607509|B2|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3775100|NCT01901809|3607510|B1|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3775101|NCT01901809|3607506|B5|Black||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
3775102|NCT01901809|3607507|B4|Black||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3775103|NCT01901809|3607508|B3|Black||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3775104|NCT01901809|3607509|B2|Black||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3775105|NCT01901809|3607510|B1|Black||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3775106|NCT01901809|3607506|B5||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3775107|NCT01901809|3607507|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3775108|NCT01901809|3607508|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3775109|NCT01901809|3607509|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3775110|NCT01901809|3607510|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3775111|NCT01901809|3607506|B5||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3775112|NCT01901809|3607507|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3775113|NCT01901809|3607508|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3775114|NCT01901809|3607509|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3775115|NCT01901809|3607510|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3775116|NCT01901809|3607506|B5|||Age||years|Mean|66|66.0|Standard Deviation|13|13.0|||
3775117|NCT01901809|3607507|B4|||Age||years|Mean|67|67.0|Standard Deviation|13|13.0|||
3775118|NCT01901809|3607508|B3|||Age||years|Mean|66|66.0|Standard Deviation|15|15.0|||
3775119|NCT01901809|3607509|B2|||Age||years|Mean|63|63.0|Standard Deviation|10|10.0|||
3775120|NCT01901809|3607510|B1|||Age||years|Mean|68|68.0|Standard Deviation|13|13.0|||
3775121|NCT01901809|3607506|B5||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
3775122|NCT01901809|3607507|B4||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3775123|NCT01901809|3607508|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3775124|NCT01901809|3607509|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3775125|NCT01901809|3607510|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3775126|NCT01901809|3607506|B5||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3775127|NCT01901809|3607507|B4||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3775128|NCT01901809|3607508|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3775129|NCT01901809|3607509|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3775130|NCT01901809|3607510|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3775131|NCT01901809|3607506|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3775132|NCT01901809|3607507|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3775133|NCT01901809|3607508|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3775134|NCT01901809|3607509|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3775135|NCT01901809|3607510|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3775136|NCT01901653|3607527|B14||2|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|4|4.0||||||
3775137|NCT01901653|3607528|B13||2|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|1|1.0||||||
3775183|NCT01901653|3607532|B9|United States||Region of Enrollment||participants|Number|1|1.0||||||
3775184|NCT01901653|3607533|B8|United States||Region of Enrollment||participants|Number|10|10.0||||||
3775185|NCT01901653|3607534|B7|United States||Region of Enrollment||participants|Number|7|7.0||||||
3775186|NCT01901653|3607535|B6|United States||Region of Enrollment||participants|Number|3|3.0||||||
3775187|NCT01901653|3607536|B5|United States||Region of Enrollment||participants|Number|2|2.0||||||
3775138|NCT01901653|3607529|B12||2|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|0|0.0||||||
3775139|NCT01901653|3607530|B11||2|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|0|0.0||||||
3775140|NCT01901653|3607531|B10||2|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|2|2.0||||||
3775141|NCT01901653|3607532|B9||2|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|0|0.0||||||
3775142|NCT01901653|3607533|B8||2|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|0|0.0||||||
3775143|NCT01901653|3607534|B7||2|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|1|1.0||||||
3775144|NCT01901653|3607535|B6||2|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|0|0.0||||||
3775145|NCT01901653|3607536|B5||2|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|0|0.0||||||
3775146|NCT01901653|3607537|B4||2|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|0|0.0||||||
3775147|NCT01901653|3607538|B3||2|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|0|0.0||||||
3775188|NCT01901653|3607537|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
3775189|NCT01901653|3607538|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3775190|NCT01901653|3607539|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3775191|NCT01901653|3607540|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3775192|NCT01901653|3607527|B14||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3775148|NCT01901653|3607539|B2||2|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|0|0.0||||||
3775149|NCT01901653|3607540|B1||2|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|0|0.0||||||
3775150|NCT01901653|3607527|B14||1|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|55|55.0||||||
3775151|NCT01901653|3607528|B13||1|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|3|3.0||||||
3775152|NCT01901653|3607529|B12||1|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|11|11.0||||||
3775153|NCT01901653|3607530|B11||1|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|1|1.0||||||
3775154|NCT01901653|3607531|B10||1|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|13|13.0||||||
3775155|NCT01901653|3607532|B9||1|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|1|1.0||||||
3775156|NCT01901653|3607533|B8||1|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|7|7.0||||||
3775157|NCT01901653|3607534|B7||1|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|6|6.0||||||
3775193|NCT01901653|3607528|B13||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3775194|NCT01901653|3607529|B12||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775195|NCT01901653|3607530|B11||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775196|NCT01901653|3607531|B10||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3775158|NCT01901653|3607535|B6||1|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|2|2.0||||||
3775159|NCT01901653|3607536|B5||1|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|1|1.0||||||
3775160|NCT01901653|3607537|B4||1|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|1|1.0||||||
3775161|NCT01901653|3607538|B3||1|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|7|7.0||||||
3775162|NCT01901653|3607539|B2||1|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|1|1.0||||||
3775163|NCT01901653|3607540|B1||1|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|1|1.0||||||
3775164|NCT01901653|3607527|B14||0|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|23|23.0||||||
3775165|NCT01901653|3607528|B13||0|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|1|1.0||||||
3775166|NCT01901653|3607529|B12||0|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|5|5.0||||||
3775167|NCT01901653|3607530|B11||0|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|1|1.0||||||
3775197|NCT01901653|3607532|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775198|NCT01901653|3607533|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775199|NCT01901653|3607534|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775200|NCT01901653|3607535|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775168|NCT01901653|3607531|B10||0|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|3|3.0||||||
3775169|NCT01901653|3607532|B9||0|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|0|0.0||||||
3775170|NCT01901653|3607533|B8||0|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|3|3.0||||||
3775171|NCT01901653|3607534|B7||0|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|0|0.0||||||
3775172|NCT01901653|3607535|B6||0|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|1|1.0||||||
3775173|NCT01901653|3607536|B5||0|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|1|1.0||||||
3775174|NCT01901653|3607537|B4||0|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|2|2.0||||||
3775175|NCT01901653|3607538|B3||0|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|4|4.0||||||
3775176|NCT01901653|3607539|B2||0|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|0|0.0||||||
3775177|NCT01901653|3607540|B1||0|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOGScale:Score-Description:0-Normalactivity.Fullyactive,abletocarryonallprediseaseperformancew/orestriction/1-Symptoms,but ambulatory.Restrictedinphysicallystrenuousactivity,butambulatoryandabletocarryoutworkofa light/sedentarynature(eg,light housework,office work)/2-In bed<50%ofthetime.Ambulatoryandcapableofallselfcare,but unabletocarryoutanyworkactivities.Upandabout>50%ofwakinghours/3-In bed>50%ofthetime.Capableofonlylimitedselfcare,confinedtobed/chair>50%ofwakinghours/4-100% bedridden.Completelydisabled.Cannotcarryonanyselfcare.Totallyconfinedtobed/chair/5-Dead.|Participants|Count of Participants|2|2.0||||||
3775178|NCT01901653|3607527|B14|United States||Region of Enrollment||participants|Number|82|82.0||||||
3775179|NCT01901653|3607528|B13|United States||Region of Enrollment||participants|Number|5|5.0||||||
3775180|NCT01901653|3607529|B12|United States||Region of Enrollment||participants|Number|16|16.0||||||
3775181|NCT01901653|3607530|B11|United States||Region of Enrollment||participants|Number|2|2.0||||||
3775182|NCT01901653|3607531|B10|United States||Region of Enrollment||participants|Number|18|18.0||||||
3775201|NCT01901653|3607536|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775202|NCT01901653|3607537|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775203|NCT01901653|3607538|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3775204|NCT01901653|3607539|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775205|NCT01901653|3607540|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775206|NCT01901653|3607527|B14||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3775207|NCT01901653|3607528|B13||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775208|NCT01901653|3607529|B12||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3775209|NCT01901653|3607530|B11||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775210|NCT01901653|3607531|B10||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775211|NCT01901653|3607532|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775212|NCT01901653|3607533|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775213|NCT01901653|3607534|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775214|NCT01901653|3607535|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775215|NCT01901653|3607536|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775216|NCT01901653|3607537|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775217|NCT01901653|3607538|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775218|NCT01901653|3607539|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775219|NCT01901653|3607540|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775220|NCT01901653|3607527|B14||White|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3775221|NCT01901653|3607528|B13||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3775222|NCT01901653|3607529|B12||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3775223|NCT01901653|3607530|B11||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3775224|NCT01901653|3607531|B10||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3775225|NCT01901653|3607532|B9||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3775226|NCT01901653|3607533|B8||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3775227|NCT01901653|3607534|B7||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3775228|NCT01901653|3607535|B6||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3775229|NCT01901653|3607536|B5||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3775230|NCT01901653|3607537|B4||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3775231|NCT01901653|3607538|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3775232|NCT01901653|3607539|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3775233|NCT01901653|3607540|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3775234|NCT01901653|3607527|B14||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3775235|NCT01901653|3607528|B13||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775236|NCT01901653|3607529|B12||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775237|NCT01901653|3607530|B11||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775238|NCT01901653|3607531|B10||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775239|NCT01901653|3607532|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775240|NCT01901653|3607533|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775241|NCT01901653|3607534|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3775242|NCT01901653|3607535|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775243|NCT01901653|3607536|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775244|NCT01901653|3607537|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3775245|NCT01901653|3607538|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775246|NCT01901653|3607539|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775247|NCT01901653|3607540|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775248|NCT01901653|3607527|B14||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775249|NCT01901653|3607528|B13||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775250|NCT01901653|3607529|B12||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775251|NCT01901653|3607530|B11||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775252|NCT01901653|3607531|B10||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775253|NCT01901653|3607532|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775254|NCT01901653|3607533|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775255|NCT01901653|3607534|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775256|NCT01901653|3607535|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775257|NCT01901653|3607536|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775258|NCT01901653|3607537|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775259|NCT01901653|3607538|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775260|NCT01901653|3607539|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775261|NCT01901653|3607540|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775262|NCT01901653|3607527|B14||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3775263|NCT01901653|3607528|B13||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3775264|NCT01901653|3607529|B12||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775265|NCT01901653|3607530|B11||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775266|NCT01901653|3607531|B10||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775267|NCT01901653|3607532|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775268|NCT01901653|3607533|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775269|NCT01901653|3607534|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3775270|NCT01901653|3607535|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3775271|NCT01901653|3607536|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775272|NCT01901653|3607537|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775273|NCT01901653|3607538|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775274|NCT01901653|3607539|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775275|NCT01901653|3607540|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775276|NCT01901653|3607527|B14||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775277|NCT01901653|3607528|B13||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775278|NCT01901653|3607529|B12||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775279|NCT01901653|3607530|B11||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775280|NCT01901653|3607531|B10||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775281|NCT01901653|3607532|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775282|NCT01901653|3607533|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775283|NCT01901653|3607534|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775284|NCT01901653|3607535|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775285|NCT01901653|3607536|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775286|NCT01901653|3607537|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775287|NCT01901653|3607538|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775288|NCT01901653|3607539|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775289|NCT01901653|3607540|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775290|NCT01901653|3607527|B14||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3775291|NCT01901653|3607528|B13||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3775292|NCT01901653|3607529|B12||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3775293|NCT01901653|3607530|B11||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775294|NCT01901653|3607531|B10||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3775295|NCT01901653|3607532|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775296|NCT01901653|3607533|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775297|NCT01901653|3607534|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775298|NCT01901653|3607535|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775299|NCT01901653|3607536|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775300|NCT01901653|3607537|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775301|NCT01901653|3607538|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3775302|NCT01901653|3607539|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775303|NCT01901653|3607540|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775304|NCT01901653|3607527|B14||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3775305|NCT01901653|3607528|B13||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3775306|NCT01901653|3607529|B12||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3775307|NCT01901653|3607530|B11||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3775308|NCT01901653|3607531|B10||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3775309|NCT01901653|3607532|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3775310|NCT01901653|3607533|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3775311|NCT01901653|3607534|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3775312|NCT01901653|3607535|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3775313|NCT01901653|3607536|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3775314|NCT01901653|3607537|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3775315|NCT01901653|3607538|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3775316|NCT01901653|3607539|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3775317|NCT01901653|3607540|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3775318|NCT01901653|3607527|B14||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3775319|NCT01901653|3607528|B13||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775320|NCT01901653|3607529|B12||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775321|NCT01901653|3607530|B11||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775322|NCT01901653|3607531|B10||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3775323|NCT01901653|3607532|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775324|NCT01901653|3607533|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775325|NCT01901653|3607534|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775326|NCT01901653|3607535|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775327|NCT01901653|3607536|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775328|NCT01901653|3607537|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775329|NCT01901653|3607538|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775330|NCT01901653|3607539|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775331|NCT01901653|3607540|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775332|NCT01901653|3607527|B14||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3775333|NCT01901653|3607528|B13||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3775334|NCT01901653|3607529|B12||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3775335|NCT01901653|3607530|B11||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3775336|NCT01901653|3607531|B10||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3775337|NCT01901653|3607532|B9||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3775338|NCT01901653|3607533|B8||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3775339|NCT01901653|3607534|B7||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3775340|NCT01901653|3607535|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3775341|NCT01901653|3607536|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3775342|NCT01901653|3607537|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3775343|NCT01901653|3607538|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3775344|NCT01901653|3607539|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3775345|NCT01901653|3607540|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3775346|NCT01901653|3607527|B14||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3775347|NCT01901653|3607528|B13||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3775348|NCT01901653|3607529|B12||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3775349|NCT01901653|3607530|B11||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3775350|NCT01901653|3607531|B10||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3775351|NCT01901653|3607532|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3775352|NCT01901653|3607533|B8||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3775353|NCT01901653|3607534|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3775354|NCT01901653|3607535|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3775355|NCT01901653|3607536|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3775356|NCT01901653|3607537|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3775357|NCT01901653|3607538|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3775358|NCT01901653|3607539|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3775359|NCT01901653|3607540|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3775360|NCT01901653|3607527|B14||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
3775361|NCT01901653|3607528|B13||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3775362|NCT01901653|3607529|B12||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3775363|NCT01901653|3607530|B11||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3775364|NCT01901653|3607531|B10||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3775365|NCT01901653|3607532|B9||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3775366|NCT01901653|3607533|B8||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3775367|NCT01901653|3607534|B7||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3775368|NCT01901653|3607535|B6||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3775369|NCT01901653|3607536|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3775370|NCT01901653|3607537|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3775371|NCT01901653|3607538|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3775372|NCT01901653|3607539|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3775373|NCT01901653|3607540|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3775374|NCT01901653|3607527|B14||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3775375|NCT01901653|3607528|B13||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3775376|NCT01901653|3607529|B12||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3775377|NCT01901653|3607530|B11||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3775378|NCT01901653|3607531|B10||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3775379|NCT01901653|3607532|B9||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3775380|NCT01901653|3607533|B8||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3775381|NCT01901653|3607534|B7||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3775382|NCT01901653|3607535|B6||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3775383|NCT01901653|3607536|B5||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3775384|NCT01901653|3607537|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3775385|NCT01901653|3607538|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3775386|NCT01901653|3607539|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3775387|NCT01901653|3607540|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3775388|NCT01901653|3607527|B14||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3775389|NCT01901653|3607528|B13||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3775390|NCT01901653|3607529|B12||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3775391|NCT01901653|3607530|B11||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3775392|NCT01901653|3607531|B10||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3775393|NCT01901653|3607532|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3775394|NCT01901653|3607533|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3775395|NCT01901653|3607534|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3775396|NCT01901653|3607535|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3775397|NCT01901653|3607536|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3775398|NCT01901653|3607537|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3775399|NCT01901653|3607538|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3775400|NCT01901653|3607539|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3775401|NCT01901653|3607540|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3775402|NCT01901588|3607594|B3|Other or Unknown||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3775403|NCT01901588|3607595|B2|Other or Unknown||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3775404|NCT01901588|3607596|B1|Other or Unknown||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3775405|NCT01901588|3607594|B3|White, not of Hispanic-American Origin||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
3775406|NCT01901588|3607595|B2|White, not of Hispanic-American Origin||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3775407|NCT01901588|3607596|B1|White, not of Hispanic-American Origin||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3775408|NCT01901588|3607594|B3|Hispanic-American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3775409|NCT01901588|3607595|B2|Hispanic-American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3775410|NCT01901588|3607596|B1|Hispanic-American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3775411|NCT01901588|3607594|B3|Black, Not of Hispanic-American Origin||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3775412|NCT01901588|3607595|B2|Black, Not of Hispanic-American Origin||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3775413|NCT01901588|3607596|B1|Black, Not of Hispanic-American Origin||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3775414|NCT01901588|3607594|B3|Asian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3775415|NCT01901588|3607595|B2|Asian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3775416|NCT01901588|3607596|B1|Asian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3775417|NCT01901588|3607594|B3|American Indian or Alaskan||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3775418|NCT01901588|3607595|B2|American Indian or Alaskan||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3775419|NCT01901588|3607596|B1|American Indian or Alaskan||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3775420|NCT01901588|3607594|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3775421|NCT01901588|3607595|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3775422|NCT01901588|3607596|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3775423|NCT01901588|3607594|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3775424|NCT01901588|3607595|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3775425|NCT01901588|3607596|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3775426|NCT01901588|3607594|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3775427|NCT01901588|3607595|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3775428|NCT01901588|3607596|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3775429|NCT01901588|3607594|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3775430|NCT01901588|3607595|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3775431|NCT01901588|3607596|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3775432|NCT01901588|3607594|B3||<=18 years|Age||Participants|Count of Participants|63|63.0||||||
3775433|NCT01901588|3607595|B2||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
3775434|NCT01901588|3607596|B1||<=18 years|Age||Participants|Count of Participants|32|32.0||||||
3775435|NCT01901575|3607613|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3775436|NCT01901575|3607613|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3775437|NCT01901575|3607613|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775438|NCT01901575|3607613|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3775439|NCT01901575|3607613|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3775440|NCT01901575|3607613|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775441|NCT01901575|3607613|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775442|NCT01901575|3607613|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775443|NCT01901575|3607613|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3775444|NCT01901575|3607613|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3775445|NCT01901575|3607613|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3775446|NCT01901575|3607613|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3775447|NCT01901575|3607613|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3775448|NCT01901393|3607618|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
3775449|NCT01901393|3607619|B2|United States||Region of Enrollment||participants|Number|49|49.0||||||
3775450|NCT01901393|3607620|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
3775451|NCT01901393|3607618|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775452|NCT01901393|3607619|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775453|NCT01901393|3607620|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775454|NCT01901393|3607618|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775455|NCT01901393|3607619|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775456|NCT01901393|3607620|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775457|NCT01901393|3607618|B3||White|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
3775458|NCT01901393|3607619|B2||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3775459|NCT01901393|3607620|B1||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3775460|NCT01901393|3607618|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3775461|NCT01901393|3607619|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3775462|NCT01901393|3607620|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3775463|NCT01901393|3607618|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775464|NCT01901393|3607619|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775465|NCT01901393|3607620|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775466|NCT01901393|3607618|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3775467|NCT01901393|3607619|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775468|NCT01901393|3607620|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3775469|NCT01901393|3607618|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775470|NCT01901393|3607619|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775471|NCT01901393|3607620|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775472|NCT01901393|3607618|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775473|NCT01901393|3607619|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775474|NCT01901393|3607620|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775475|NCT01901393|3607618|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3775476|NCT01901393|3607619|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3775477|NCT01901393|3607620|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3775478|NCT01901393|3607618|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3775479|NCT01901393|3607619|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3775480|NCT01901393|3607620|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3775481|NCT01901393|3607618|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3775482|NCT01901393|3607619|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3775483|NCT01901393|3607620|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3775484|NCT01901393|3607618|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3775485|NCT01901393|3607619|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3775486|NCT01901393|3607620|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3775487|NCT01901393|3607618|B3|||Age||years|Mean|46|46.0|Standard Deviation|14.4|14.4|||
3775488|NCT01901393|3607619|B2|||Age||years|Mean|46|46.0|Standard Deviation|15.5|15.5|||
3775489|NCT01901393|3607620|B1|||Age||years|Mean|45|45.0|Standard Deviation|13.3|13.3|||
3775490|NCT01901341|3607637|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3775491|NCT01901341|3607638|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3775492|NCT01901341|3607639|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3775493|NCT01901341|3607637|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3775494|NCT01901341|3607638|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3775495|NCT01901341|3607639|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3775496|NCT01901341|3607637|B3||GTE65|Age||Participants|Count of Participants|2|2.0||||||
3775497|NCT01901341|3607638|B2||GTE65|Age||Participants|Count of Participants|0|0.0||||||
3775498|NCT01901341|3607639|B1||GTE65|Age||Participants|Count of Participants|2|2.0||||||
3775499|NCT01901341|3607637|B3||BTWN|Age||Participants|Count of Participants|42|42.0||||||
3775500|NCT01901341|3607638|B2||BTWN|Age||Participants|Count of Participants|22|22.0||||||
3775501|NCT01901341|3607639|B1||BTWN|Age||Participants|Count of Participants|20|20.0||||||
3775502|NCT01901341|3607637|B3||LTE18|Age||Participants|Count of Participants|0|0.0||||||
3775503|NCT01901341|3607638|B2||LTE18|Age||Participants|Count of Participants|0|0.0||||||
3775504|NCT01901341|3607639|B1||LTE18|Age||Participants|Count of Participants|0|0.0||||||
3775505|NCT01901328|3607652|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3775506|NCT01901328|3607653|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3775507|NCT01901328|3607654|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3775508|NCT01901328|3607652|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3775509|NCT01901328|3607653|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3775510|NCT01901328|3607654|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3775511|NCT01901328|3607652|B3||GTE65|Age||Participants|Count of Participants|2|2.0||||||
3775512|NCT01901328|3607653|B2||GTE65|Age||Participants|Count of Participants|1|1.0||||||
3775513|NCT01901328|3607654|B1||GTE65|Age||Participants|Count of Participants|1|1.0||||||
3775514|NCT01901328|3607652|B3||BTWN|Age||Participants|Count of Participants|47|47.0||||||
3775515|NCT01901328|3607653|B2||BTWN|Age||Participants|Count of Participants|22|22.0||||||
3775516|NCT01901328|3607654|B1||BTWN|Age||Participants|Count of Participants|25|25.0||||||
3775517|NCT01901328|3607652|B3||LTE18|Age||Participants|Count of Participants|0|0.0||||||
3775518|NCT01901328|3607653|B2||LTE18|Age||Participants|Count of Participants|0|0.0||||||
3775519|NCT01901328|3607654|B1||LTE18|Age||Participants|Count of Participants|0|0.0||||||
3775520|NCT01901302|3607667|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3775521|NCT01901302|3607668|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3775522|NCT01901302|3607669|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3775523|NCT01901302|3607667|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3775524|NCT01901302|3607668|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3775525|NCT01901302|3607669|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3775526|NCT01901302|3607667|B3||GTE65|Age||Participants|Count of Participants|3|3.0||||||
3775527|NCT01901302|3607668|B2||GTE65|Age||Participants|Count of Participants|3|3.0||||||
3775528|NCT01901302|3607669|B1||GTE65|Age||Participants|Count of Participants|0|0.0||||||
3775529|NCT01901302|3607667|B3||BTWN|Age||Participants|Count of Participants|58|58.0||||||
3775530|NCT01901302|3607668|B2||BTWN|Age||Participants|Count of Participants|27|27.0||||||
3775531|NCT01901302|3607669|B1||BTWN|Age||Participants|Count of Participants|31|31.0||||||
3775532|NCT01901302|3607667|B3||LTE18|Age||Participants|Count of Participants|0|0.0||||||
3775533|NCT01901302|3607668|B2||LTE18|Age||Participants|Count of Participants|0|0.0||||||
3775534|NCT01901302|3607669|B1||LTE18|Age||Participants|Count of Participants|0|0.0||||||
3775535|NCT01901289|3607682|B1|||Hypercholesterolemia||Participants|Count of Participants|173|173.0||||||
3775536|NCT01901289|3607682|B1||Still smoking|Smoking Status||Participants|Count of Participants|83|83.0||||||
3775537|NCT01901289|3607682|B1||Quit smoking|Smoking Status||Participants|Count of Participants|86|86.0||||||
3775538|NCT01901289|3607682|B1||Never smoked|Smoking Status||Participants|Count of Participants|31|31.0||||||
3775539|NCT01901289|3607682|B1|||Diabetes||Participants|Count of Participants|92|92.0||||||
3775540|NCT01901289|3607682|B1|United States||Region of Enrollment||participants|Number|200|200.0||||||
3775541|NCT01901289|3607682|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3775542|NCT01901289|3607682|B1||Caucasian or White|Race/Ethnicity, Customized||Participants|Count of Participants|165|165.0||||||
3775543|NCT01901289|3607682|B1||Black/Caucasian or White|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3775544|NCT01901289|3607682|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3775545|NCT01901289|3607682|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3775546|NCT01901289|3607682|B1||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3775547|NCT01901289|3607682|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3775548|NCT01901289|3607682|B1|||Age||years|Mean|67.9|67.9|Standard Deviation|9.5|9.5|||
3775549|NCT01901250|3607686|B3|Severe (6 or more dmfs/DMFS)||Overall Caries Burden at Baseline||participants|Number|141|141.0||||||
3775550|NCT01901250|3607687|B2|Severe (6 or more dmfs/DMFS)||Overall Caries Burden at Baseline||participants|Number|61|61.0||||||
3775551|NCT01901250|3607688|B1|Severe (6 or more dmfs/DMFS)||Overall Caries Burden at Baseline||participants|Number|80|80.0||||||
3775552|NCT01901250|3607686|B3|Moderate (1-5 dmfs/DMFS)||Overall Caries Burden at Baseline||participants|Number|134|134.0||||||
3775553|NCT01901250|3607687|B2|Moderate (1-5 dmfs/DMFS)||Overall Caries Burden at Baseline||participants|Number|66|66.0||||||
3775554|NCT01901250|3607688|B1|Moderate (1-5 dmfs/DMFS)||Overall Caries Burden at Baseline||participants|Number|68|68.0||||||
3775555|NCT01901250|3607686|B3|None (0 dmfs/DMFS)||Overall Caries Burden at Baseline||participants|Number|250|250.0||||||
3775556|NCT01901250|3607687|B2|None (0 dmfs/DMFS)||Overall Caries Burden at Baseline||participants|Number|138|138.0||||||
3775557|NCT01901250|3607688|B1|None (0 dmfs/DMFS)||Overall Caries Burden at Baseline||participants|Number|112|112.0||||||
3775558|NCT01901250|3607686|B3|Unknown or Not reported||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
3775559|NCT01901250|3607687|B2|Unknown or Not reported||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3775560|NCT01901250|3607688|B1|Unknown or Not reported||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
3775561|NCT01901250|3607686|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3775562|NCT01901250|3607687|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3775563|NCT01901250|3607688|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3775564|NCT01901250|3607686|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3775565|NCT01901250|3607687|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3775566|NCT01901250|3607688|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3775567|NCT01901250|3607686|B3|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3775568|NCT01901250|3607687|B2|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3775569|NCT01901250|3607688|B1|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3775570|NCT01901250|3607686|B3|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|461|461.0||||||
3775571|NCT01901250|3607687|B2|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|234|234.0||||||
3775572|NCT01901250|3607688|B1|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|227|227.0||||||
3775573|NCT01901250|3607686|B3||Male|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
3775574|NCT01901250|3607687|B2||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3775575|NCT01901250|3607688|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3775576|NCT01901250|3607686|B3||Female|Sex: Female, Male||Participants|Count of Participants|280|280.0||||||
3775577|NCT01901250|3607687|B2||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3775578|NCT01901250|3607688|B1||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3775579|NCT01901250|3607686|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3775580|NCT01901250|3607687|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3775581|NCT01901250|3607688|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3775582|NCT01901250|3607686|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3775583|NCT01901250|3607687|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3775584|NCT01901250|3607688|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3775585|NCT01901250|3607686|B3||<=18 years|Age||Participants|Count of Participants|525|525.0||||||
3775586|NCT01901250|3607687|B2||<=18 years|Age||Participants|Count of Participants|265|265.0||||||
3775587|NCT01901250|3607688|B1||<=18 years|Age||Participants|Count of Participants|260|260.0||||||
3775588|NCT01901224|3607695|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3775589|NCT01901224|3607695|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775590|NCT01901224|3607695|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775591|NCT01901224|3607695|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3775592|NCT01901224|3607695|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3775593|NCT01901224|3607695|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775594|NCT01901224|3607695|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775595|NCT01901224|3607695|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775596|NCT01901224|3607695|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775597|NCT01901224|3607695|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3775598|NCT01901224|3607695|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775599|NCT01901224|3607695|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3775600|NCT01901224|3607695|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3775601|NCT01901224|3607695|B1|||Age||years|Mean|79.5|79.5|Standard Deviation|4.9|4.9|||
3775602|NCT01901224|3607695|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3775603|NCT01901224|3607695|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3775604|NCT01901224|3607695|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3775605|NCT01901211|3607704|B3|Canada||Region of Enrollment||participants|Number|11|11.0||||||
3775606|NCT01901211|3607705|B2|Canada||Region of Enrollment||participants|Number|5|5.0||||||
3775607|NCT01901211|3607706|B1|Canada||Region of Enrollment||participants|Number|6|6.0||||||
3775608|NCT01901211|3607704|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3775609|NCT01901211|3607704|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3775610|NCT01901211|3607705|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3775611|NCT01901211|3607706|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3775612|NCT01901211|3607704|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3775613|NCT01901211|3607705|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3775614|NCT01901211|3607706|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3775615|NCT01901211|3607704|B3|||Age||years|Mean|15.2|15.2|Standard Deviation|2.0|2.0|||
3775616|NCT01901211|3607705|B2|||Age||years|Mean|16.0|16.0|Standard Deviation|2.4|2.4|||
3775617|NCT01901211|3607706|B1|||Age||years|Mean|14.5|14.5|Standard Deviation|1.3|1.3|||
3775618|NCT01901211|3607704|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3775619|NCT01901211|3607705|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3775620|NCT01901211|3607706|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3775621|NCT01901211|3607704|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3775622|NCT01901211|3607705|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3775623|NCT01901211|3607706|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3775624|NCT01901211|3607704|B3||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
3775625|NCT01901211|3607705|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3775626|NCT01901211|3607706|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3775627|NCT01901185|3607730|B1|Psoriatic arthritis||Disease state||participants|Number|11|11.0||||||
3775628|NCT01901185|3607730|B1|Rheumatoid arthritis||Disease state||participants|Number|66|66.0||||||
3775629|NCT01901185|3607730|B1|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
3775630|NCT01901185|3607730|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3775631|NCT01901185|3607730|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3775632|NCT01901185|3607730|B1|White||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
3775633|NCT01901185|3607730|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3775634|NCT01901185|3607730|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3775635|NCT01901185|3607730|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3775636|NCT01901185|3607730|B1|||Age||years|Mean|53.8|53.8|Standard Deviation|13.7|13.7|||
3775637|NCT01900665|3607737|B3|Spain||Region of Enrollment||Participants|Count of Participants|114|114.0||||||
3775638|NCT01900665|3607738|B2|Spain||Region of Enrollment||Participants|Count of Participants|58|58.0||||||
3775639|NCT01900665|3607739|B1|Spain||Region of Enrollment||Participants|Count of Participants|56|56.0||||||
3775640|NCT01900665|3607737|B3|Germany||Region of Enrollment||Participants|Count of Participants|96|96.0||||||
3775641|NCT01900665|3607738|B2|Germany||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
3775642|NCT01900665|3607739|B1|Germany||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
3775643|NCT01900665|3607737|B3|France||Region of Enrollment||Participants|Count of Participants|173|173.0||||||
3775644|NCT01900665|3607738|B2|France||Region of Enrollment||Participants|Count of Participants|86|86.0||||||
3775645|NCT01900665|3607739|B1|France||Region of Enrollment||Participants|Count of Participants|87|87.0||||||
3775646|NCT01900665|3607737|B3|Australia||Region of Enrollment||Participants|Count of Participants|68|68.0||||||
3775647|NCT01900665|3607738|B2|Australia||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3775648|NCT01900665|3607739|B1|Australia||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3775649|NCT01900665|3607737|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|89|89.0||||||
3775650|NCT01900665|3607738|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3775651|NCT01900665|3607739|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3775652|NCT01900665|3607737|B3|Italy||Region of Enrollment||Participants|Count of Participants|98|98.0||||||
3775653|NCT01900665|3607738|B2|Italy||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
3775654|NCT01900665|3607739|B1|Italy||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
3775655|NCT01900665|3607737|B3|Poland||Region of Enrollment||Participants|Count of Participants|102|102.0||||||
3775656|NCT01900665|3607738|B2|Poland||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3775657|NCT01900665|3607739|B1|Poland||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
3775658|NCT01900665|3607737|B3|Japan||Region of Enrollment||Participants|Count of Participants|132|132.0||||||
3775659|NCT01900665|3607738|B2|Japan||Region of Enrollment||Participants|Count of Participants|65|65.0||||||
3775660|NCT01900665|3607739|B1|Japan||Region of Enrollment||Participants|Count of Participants|67|67.0||||||
3775661|NCT01900665|3607737|B3|United States||Region of Enrollment||Participants|Count of Participants|1078|1078.0||||||
3775662|NCT01900665|3607738|B2|United States||Region of Enrollment||Participants|Count of Participants|541|541.0||||||
3775663|NCT01900665|3607739|B1|United States||Region of Enrollment||Participants|Count of Participants|537|537.0||||||
3775664|NCT01900665|3607737|B3|Sweden||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
3775665|NCT01900665|3607738|B2|Sweden||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3775666|NCT01900665|3607739|B1|Sweden||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3775667|NCT01900665|3607737|B3|Canada||Region of Enrollment||Participants|Count of Participants|127|127.0||||||
3775668|NCT01900665|3607738|B2|Canada||Region of Enrollment||Participants|Count of Participants|66|66.0||||||
3775669|NCT01900665|3607739|B1|Canada||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
3775670|NCT01900665|3607737|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775671|NCT01900665|3607738|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775672|NCT01900665|3607739|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775673|NCT01900665|3607737|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3775674|NCT01900665|3607738|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3775675|NCT01900665|3607739|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3775676|NCT01900665|3607737|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1772|1772.0||||||
3775677|NCT01900665|3607738|B2||White|Race (NIH/OMB)||Participants|Count of Participants|894|894.0||||||
3775678|NCT01900665|3607739|B1||White|Race (NIH/OMB)||Participants|Count of Participants|878|878.0||||||
3775679|NCT01900665|3607737|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3775680|NCT01900665|3607738|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3775681|NCT01900665|3607739|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3775682|NCT01900665|3607737|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3775683|NCT01900665|3607738|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775684|NCT01900665|3607739|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3775685|NCT01900665|3607737|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
3775686|NCT01900665|3607738|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3775687|NCT01900665|3607739|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3775688|NCT01900665|3607737|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775689|NCT01900665|3607738|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775690|NCT01900665|3607739|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775691|NCT01900665|3607737|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775692|NCT01900665|3607738|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775693|NCT01900665|3607739|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775694|NCT01900665|3607737|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1858|1858.0||||||
3775695|NCT01900665|3607738|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|937|937.0||||||
3775696|NCT01900665|3607739|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|921|921.0||||||
3775697|NCT01900665|3607737|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3775698|NCT01900665|3607738|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3775699|NCT01900665|3607739|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3775700|NCT01900665|3607737|B3||Male|Sex: Female, Male||Participants|Count of Participants|898|898.0||||||
3775701|NCT01900665|3607738|B2||Male|Sex: Female, Male||Participants|Count of Participants|441|441.0||||||
3775702|NCT01900665|3607739|B1||Male|Sex: Female, Male||Participants|Count of Participants|457|457.0||||||
3775703|NCT01900665|3607737|B3||Female|Sex: Female, Male||Participants|Count of Participants|1231|1231.0||||||
3775704|NCT01900665|3607738|B2||Female|Sex: Female, Male||Participants|Count of Participants|631|631.0||||||
3775705|NCT01900665|3607739|B1||Female|Sex: Female, Male||Participants|Count of Participants|600|600.0||||||
3775706|NCT01900665|3607737|B3|||Age||years|Mean|72.98|72.98|Standard Deviation|7.894|7.894|||
3775707|NCT01900665|3607738|B2|||Age||years|Mean|73.26|73.26|Standard Deviation|7.966|7.966|||
3775708|NCT01900665|3607739|B1|||Age||years|Mean|72.69|72.69|Standard Deviation|7.814|7.814|||
3775709|NCT01900652|3607781|B3|Other Subtypes of Lung Cancer||Pathological Diagnosis||Participants|Count of Participants|7|7.0||||||
3775710|NCT01900652|3607782|B2|Other Subtypes of Lung Cancer||Pathological Diagnosis||Participants|Count of Participants|4|4.0||||||
3775711|NCT01900652|3607783|B1|Other Subtypes of Lung Cancer||Pathological Diagnosis||Participants|Count of Participants|3|3.0||||||
3775712|NCT01900652|3607781|B3|Large Cell Carcinoma||Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
3775713|NCT01900652|3607782|B2|Large Cell Carcinoma||Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
3775714|NCT01900652|3607783|B1|Large Cell Carcinoma||Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
3775715|NCT01900652|3607781|B3|Squamous Cell Carcinoma||Pathological Diagnosis||Participants|Count of Participants|4|4.0||||||
3775716|NCT01900652|3607782|B2|Squamous Cell Carcinoma||Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
3775717|NCT01900652|3607783|B1|Squamous Cell Carcinoma||Pathological Diagnosis||Participants|Count of Participants|3|3.0||||||
3775718|NCT01900652|3607781|B3|Lung Adenocarcinoma||Pathological Diagnosis||Participants|Count of Participants|99|99.0||||||
3775719|NCT01900652|3607782|B2|Lung Adenocarcinoma||Pathological Diagnosis||Participants|Count of Participants|22|22.0||||||
3775720|NCT01900652|3607783|B1|Lung Adenocarcinoma||Pathological Diagnosis||Participants|Count of Participants|77|77.0||||||
3775721|NCT01900652|3607781|B3|ECOG 2||ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 0 - Fully Active. 1 - Ambulatory, Restricted Strenuous Activity. 2 - Ambulatory, No Work Activities. 3 - Partially Confined to Bed, Limited Self Care. 4 - Completely Disabled. 5 - Death.|Participants|Count of Participants|7|7.0||||||
3775759|NCT01900652|3607783|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3775760|NCT01900652|3607781|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3775722|NCT01900652|3607782|B2|ECOG 2||ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 0 - Fully Active. 1 - Ambulatory, Restricted Strenuous Activity. 2 - Ambulatory, No Work Activities. 3 - Partially Confined to Bed, Limited Self Care. 4 - Completely Disabled. 5 - Death.|Participants|Count of Participants|2|2.0||||||
3775723|NCT01900652|3607783|B1|ECOG 2||ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 0 - Fully Active. 1 - Ambulatory, Restricted Strenuous Activity. 2 - Ambulatory, No Work Activities. 3 - Partially Confined to Bed, Limited Self Care. 4 - Completely Disabled. 5 - Death.|Participants|Count of Participants|5|5.0||||||
3775724|NCT01900652|3607781|B3|ECOG 1||ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 0 - Fully Active. 1 - Ambulatory, Restricted Strenuous Activity. 2 - Ambulatory, No Work Activities. 3 - Partially Confined to Bed, Limited Self Care. 4 - Completely Disabled. 5 - Death.|Participants|Count of Participants|77|77.0||||||
3775725|NCT01900652|3607782|B2|ECOG 1||ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 0 - Fully Active. 1 - Ambulatory, Restricted Strenuous Activity. 2 - Ambulatory, No Work Activities. 3 - Partially Confined to Bed, Limited Self Care. 4 - Completely Disabled. 5 - Death.|Participants|Count of Participants|17|17.0||||||
3775726|NCT01900652|3607783|B1|ECOG 1||ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 0 - Fully Active. 1 - Ambulatory, Restricted Strenuous Activity. 2 - Ambulatory, No Work Activities. 3 - Partially Confined to Bed, Limited Self Care. 4 - Completely Disabled. 5 - Death.|Participants|Count of Participants|60|60.0||||||
3775727|NCT01900652|3607781|B3|ECOG 0||ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 0 - Fully Active. 1 - Ambulatory, Restricted Strenuous Activity. 2 - Ambulatory, No Work Activities. 3 - Partially Confined to Bed, Limited Self Care. 4 - Completely Disabled. 5 - Death.|Participants|Count of Participants|27|27.0||||||
3775728|NCT01900652|3607782|B2|ECOG 0||ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 0 - Fully Active. 1 - Ambulatory, Restricted Strenuous Activity. 2 - Ambulatory, No Work Activities. 3 - Partially Confined to Bed, Limited Self Care. 4 - Completely Disabled. 5 - Death.|Participants|Count of Participants|9|9.0||||||
3775729|NCT01900652|3607783|B1|ECOG 0||ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 0 - Fully Active. 1 - Ambulatory, Restricted Strenuous Activity. 2 - Ambulatory, No Work Activities. 3 - Partially Confined to Bed, Limited Self Care. 4 - Completely Disabled. 5 - Death.|Participants|Count of Participants|18|18.0||||||
3775730|NCT01900652|3607781|B3|Spain||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3775731|NCT01900652|3607782|B2|Spain||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3775732|NCT01900652|3607783|B1|Spain||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3775733|NCT01900652|3607781|B3|Germany||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3775734|NCT01900652|3607782|B2|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3775735|NCT01900652|3607783|B1|Germany||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3775736|NCT01900652|3607781|B3|France||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3775737|NCT01900652|3607782|B2|France||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3775738|NCT01900652|3607783|B1|France||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3775739|NCT01900652|3607781|B3|Israel||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3775740|NCT01900652|3607782|B2|Israel||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3775741|NCT01900652|3607783|B1|Israel||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3775742|NCT01900652|3607781|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3775743|NCT01900652|3607782|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3775744|NCT01900652|3607783|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3775745|NCT01900652|3607781|B3|Italy||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3775746|NCT01900652|3607782|B2|Italy||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3775747|NCT01900652|3607783|B1|Italy||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3775748|NCT01900652|3607781|B3|South Korea||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3775749|NCT01900652|3607782|B2|South Korea||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3775750|NCT01900652|3607783|B1|South Korea||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3775751|NCT01900652|3607781|B3|United States||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3775752|NCT01900652|3607782|B2|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3775753|NCT01900652|3607783|B1|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3775754|NCT01900652|3607781|B3|Belgium||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3775755|NCT01900652|3607782|B2|Belgium||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3775756|NCT01900652|3607783|B1|Belgium||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3775757|NCT01900652|3607781|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3775758|NCT01900652|3607782|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3775761|NCT01900652|3607782|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3775762|NCT01900652|3607783|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3775763|NCT01900652|3607781|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3775764|NCT01900652|3607782|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775765|NCT01900652|3607783|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3775766|NCT01900652|3607781|B3||White|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3775767|NCT01900652|3607782|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3775768|NCT01900652|3607783|B1||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3775769|NCT01900652|3607781|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3775770|NCT01900652|3607782|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775771|NCT01900652|3607783|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3775772|NCT01900652|3607781|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775773|NCT01900652|3607782|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775774|NCT01900652|3607783|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775775|NCT01900652|3607781|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3775776|NCT01900652|3607782|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3775777|NCT01900652|3607783|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3775778|NCT01900652|3607781|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775779|NCT01900652|3607782|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775780|NCT01900652|3607783|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775781|NCT01900652|3607781|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3775782|NCT01900652|3607782|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3775783|NCT01900652|3607783|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3775784|NCT01900652|3607781|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3775785|NCT01900652|3607782|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3775786|NCT01900652|3607783|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3775787|NCT01900652|3607781|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3775788|NCT01900652|3607782|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775789|NCT01900652|3607783|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3775790|NCT01900652|3607781|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3775791|NCT01900652|3607782|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3775792|NCT01900652|3607783|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3775793|NCT01900652|3607781|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3775794|NCT01900652|3607782|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3775795|NCT01900652|3607783|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3775796|NCT01900652|3607781|B3|||Age||years|Mean|63.3|63.3|Standard Deviation|11.2|11.2|||
3775797|NCT01900652|3607782|B2|||Age||years|Mean|60.9|60.9|Standard Deviation|12.0|12.0|||
3775798|NCT01900652|3607783|B1|||Age||years|Mean|64.2|64.2|Standard Deviation|10.8|10.8|||
3775799|NCT01900444|3607818|B1|South Korea||Region of Enrollment||Participants|Number|119|119.0||||||
3775800|NCT01900444|3607818|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3775801|NCT01900444|3607818|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3775802|NCT01900444|3607818|B1|||Age||Years|Mean|2.62|2.62|Standard Deviation|0.391|0.391|||
3775803|NCT01900444|3607818|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3775804|NCT01900444|3607818|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3775805|NCT01900444|3607818|B1||<=18 years|Age||Participants|Count of Participants|119|119.0||||||
3775806|NCT01900431|3607829|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3775807|NCT01900431|3607830|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3775808|NCT01900431|3607831|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3775809|NCT01900431|3607829|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3775810|NCT01900431|3607830|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3775811|NCT01900431|3607831|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3775812|NCT01900431|3607829|B3|||Age||years|Mean|40.0|40.0|Standard Deviation|14.5|14.5|||
3775813|NCT01900431|3607830|B2|||Age||years|Mean|39.3|39.3|Standard Deviation|15.3|15.3|||
3775814|NCT01900431|3607831|B1|||Age||years|Mean|41.5|41.5|Standard Deviation|13.0|13.0|||
3775815|NCT01900392|3607857|B4|Total activity min per week||Physical activity in min per week||Minutes|Median|510|510.0|Inter-Quartile Range|||238.0|1148.0|
3775816|NCT01900392|3607858|B3|Total activity min per week||Physical activity in min per week||Minutes|Median|600|600.0|Inter-Quartile Range|||270.0|925.0|
3775817|NCT01900392|3607859|B2|Total activity min per week||Physical activity in min per week||Minutes|Median|460|460.0|Inter-Quartile Range|||150.0|990.0|
3775818|NCT01900392|3607860|B1|Total activity min per week||Physical activity in min per week||Minutes|Median|533|533.0|Inter-Quartile Range|||283.0|1295.0|
3775819|NCT01900392|3607857|B4|Walking min per week||Physical activity in min per week||Minutes|Median|148|148.0|Inter-Quartile Range|||45.0|428.0|
3775820|NCT01900392|3607858|B3|Walking min per week||Physical activity in min per week||Minutes|Median|150|150.0|Inter-Quartile Range|||90.0|325.0|
3775821|NCT01900392|3607859|B2|Walking min per week||Physical activity in min per week||Minutes|Median|100|100.0|Inter-Quartile Range|||20.0|360.0|
3775822|NCT01900392|3607860|B1|Walking min per week||Physical activity in min per week||Minutes|Median|180|180.0|Inter-Quartile Range|||53.0|537.5|
3775823|NCT01900392|3607857|B4|Moderate-vigorous activity min per week||Physical activity in min per week||Minutes|Median|333|333.0|Inter-Quartile Range|||120.0|700.0|
3775824|NCT01900392|3607858|B3|Moderate-vigorous activity min per week||Physical activity in min per week||Minutes|Median|390|390.0|Inter-Quartile Range|||180.0|630.0|
3775825|NCT01900392|3607859|B2|Moderate-vigorous activity min per week||Physical activity in min per week||Minutes|Median|240|240.0|Inter-Quartile Range|||60.0|585.0|
3775826|NCT01900392|3607860|B1|Moderate-vigorous activity min per week||Physical activity in min per week||Minutes|Median|345|345.0|Inter-Quartile Range|||180.0|885.0|
3775827|NCT01900392|3607857|B4|Emotional eating scale||Eating behaviors by Three-Factor Eating Questionnaire|The raw eating scale scores are transformed to a 0–100 scale [((raw score − lowest possible raw score)/possible raw score range) × 100] Higher scores in the respective scales are indicative of greater cognitive restraint, uncontrolled, or emotional eating|Scores on a scale|Mean|59.9|59.9|Standard Deviation|24.5|24.5|||
3775828|NCT01900392|3607858|B3|Emotional eating scale||Eating behaviors by Three-Factor Eating Questionnaire|The raw eating scale scores are transformed to a 0–100 scale [((raw score − lowest possible raw score)/possible raw score range) × 100] Higher scores in the respective scales are indicative of greater cognitive restraint, uncontrolled, or emotional eating|Scores on a scale|Mean|55.8|55.8|Standard Deviation|27.2|27.2|||
3775829|NCT01900392|3607859|B2|Emotional eating scale||Eating behaviors by Three-Factor Eating Questionnaire|The raw eating scale scores are transformed to a 0–100 scale [((raw score − lowest possible raw score)/possible raw score range) × 100] Higher scores in the respective scales are indicative of greater cognitive restraint, uncontrolled, or emotional eating|Scores on a scale|Mean|63.3|63.3|Standard Deviation|23.5|23.5|||
3775830|NCT01900392|3607860|B1|Emotional eating scale||Eating behaviors by Three-Factor Eating Questionnaire|The raw eating scale scores are transformed to a 0–100 scale [((raw score − lowest possible raw score)/possible raw score range) × 100] Higher scores in the respective scales are indicative of greater cognitive restraint, uncontrolled, or emotional eating|Scores on a scale|Mean|58.7|58.7|Standard Deviation|23.8|23.8|||
3775831|NCT01900392|3607857|B4|Uncontrolled eating scale||Eating behaviors by Three-Factor Eating Questionnaire|The raw eating scale scores are transformed to a 0–100 scale [((raw score − lowest possible raw score)/possible raw score range) × 100] Higher scores in the respective scales are indicative of greater cognitive restraint, uncontrolled, or emotional eating|Scores on a scale|Mean|45.1|45.1|Standard Deviation|16.0|16.0|||
3775832|NCT01900392|3607858|B3|Uncontrolled eating scale||Eating behaviors by Three-Factor Eating Questionnaire|The raw eating scale scores are transformed to a 0–100 scale [((raw score − lowest possible raw score)/possible raw score range) × 100] Higher scores in the respective scales are indicative of greater cognitive restraint, uncontrolled, or emotional eating|Scores on a scale|Mean|41.8|41.8|Standard Deviation|16.1|16.1|||
3775833|NCT01900392|3607859|B2|Uncontrolled eating scale||Eating behaviors by Three-Factor Eating Questionnaire|The raw eating scale scores are transformed to a 0–100 scale [((raw score − lowest possible raw score)/possible raw score range) × 100] Higher scores in the respective scales are indicative of greater cognitive restraint, uncontrolled, or emotional eating|Scores on a scale|Mean|47.6|47.6|Standard Deviation|16.2|16.2|||
3775834|NCT01900392|3607860|B1|Uncontrolled eating scale||Eating behaviors by Three-Factor Eating Questionnaire|The raw eating scale scores are transformed to a 0–100 scale [((raw score − lowest possible raw score)/possible raw score range) × 100] Higher scores in the respective scales are indicative of greater cognitive restraint, uncontrolled, or emotional eating|Scores on a scale|Mean|44.4|44.4|Standard Deviation|15.6|15.6|||
3775835|NCT01900392|3607857|B4|Cognitive restraint scale||Eating behaviors by Three-Factor Eating Questionnaire|The raw eating scale scores are transformed to a 0–100 scale [((raw score − lowest possible raw score)/possible raw score range) × 100] Higher scores in the respective scales are indicative of greater cognitive restraint, uncontrolled, or emotional eating|Scores on a scale|Mean|62.3|62.3|Standard Deviation|14.4|14.4|||
3775836|NCT01900392|3607858|B3|Cognitive restraint scale||Eating behaviors by Three-Factor Eating Questionnaire|The raw eating scale scores are transformed to a 0–100 scale [((raw score − lowest possible raw score)/possible raw score range) × 100] Higher scores in the respective scales are indicative of greater cognitive restraint, uncontrolled, or emotional eating|Scores on a scale|Mean|62.4|62.4|Standard Deviation|12.8|12.8|||
3775837|NCT01900392|3607859|B2|Cognitive restraint scale||Eating behaviors by Three-Factor Eating Questionnaire|The raw eating scale scores are transformed to a 0–100 scale [((raw score − lowest possible raw score)/possible raw score range) × 100] Higher scores in the respective scales are indicative of greater cognitive restraint, uncontrolled, or emotional eating|Scores on a scale|Mean|62.6|62.6|Standard Deviation|14.6|14.6|||
3775838|NCT01900392|3607860|B1|Cognitive restraint scale||Eating behaviors by Three-Factor Eating Questionnaire|The raw eating scale scores are transformed to a 0–100 scale [((raw score − lowest possible raw score)/possible raw score range) × 100] Higher scores in the respective scales are indicative of greater cognitive restraint, uncontrolled, or emotional eating|Scores on a scale|Mean|62.0|62.0|Standard Deviation|15.0|15.0|||
3775839|NCT01900392|3607857|B4|||BMI ≥35 kg/m2 at randomization||Participants|Count of Participants|69|69.0||||||
3775840|NCT01900392|3607858|B3|||BMI ≥35 kg/m2 at randomization||Participants|Count of Participants|14|14.0||||||
3775841|NCT01900392|3607859|B2|||BMI ≥35 kg/m2 at randomization||Participants|Count of Participants|29|29.0||||||
3775842|NCT01900392|3607860|B1|||BMI ≥35 kg/m2 at randomization||Participants|Count of Participants|26|26.0||||||
3775843|NCT01900392|3607857|B4|BMI at randomization||BMI measures||kg/m^2|Mean|32.5|32.5|Standard Deviation|4.1|4.1|||
3775844|NCT01900392|3607858|B3|BMI at randomization||BMI measures||kg/m^2|Mean|32.6|32.6|Standard Deviation|4.1|4.1|||
3775845|NCT01900392|3607859|B2|BMI at randomization||BMI measures||kg/m^2|Mean|32.8|32.8|Standard Deviation|4.3|4.3|||
3775846|NCT01900392|3607860|B1|BMI at randomization||BMI measures||kg/m^2|Mean|32.3|32.3|Standard Deviation|4.1|4.1|||
3775847|NCT01900392|3607857|B4|BMI at start of Weight Watchers||BMI measures||kg/m^2|Mean|36.7|36.7|Standard Deviation|4.3|4.3|||
3775848|NCT01900392|3607858|B3|BMI at start of Weight Watchers||BMI measures||kg/m^2|Mean|36.9|36.9|Standard Deviation|4.5|4.5|||
3775849|NCT01900392|3607859|B2|BMI at start of Weight Watchers||BMI measures||kg/m^2|Mean|36.8|36.8|Standard Deviation|4.1|4.1|||
3775850|NCT01900392|3607860|B1|BMI at start of Weight Watchers||BMI measures||kg/m^2|Mean|36.5|36.5|Standard Deviation|4.4|4.4|||
3775851|NCT01900392|3607857|B4|Weight loss prior to randomization||Weight measures||Kilograms|Mean|11.4|11.4|Standard Deviation|4.7|4.7|||
3775852|NCT01900392|3607858|B3|Weight loss prior to randomization||Weight measures||Kilograms|Mean|11.7|11.7|Standard Deviation|4.3|4.3|||
3775853|NCT01900392|3607859|B2|Weight loss prior to randomization||Weight measures||Kilograms|Mean|10.9|10.9|Standard Deviation|5.1|5.1|||
3775854|NCT01900392|3607860|B1|Weight loss prior to randomization||Weight measures||Kilograms|Mean|11.6|11.6|Standard Deviation|4.4|4.4|||
3775855|NCT01900392|3607857|B4|Weight at randomization||Weight measures||Kilograms|Mean|90.2|90.2|Standard Deviation|14.9|14.9|||
3775856|NCT01900392|3607858|B3|Weight at randomization||Weight measures||Kilograms|Mean|91.2|91.2|Standard Deviation|15.0|15.0|||
3775857|NCT01900392|3607859|B2|Weight at randomization||Weight measures||Kilograms|Mean|90.7|90.7|Standard Deviation|15.7|15.7|||
3775858|NCT01900392|3607860|B1|Weight at randomization||Weight measures||Kilograms|Mean|89.2|89.2|Standard Deviation|14.3|14.3|||
3775859|NCT01900392|3607857|B4|Weight at the start of Weight Watchers||Weight measures||Kilograms|Mean|101.6|101.6|Standard Deviation|15.7|15.7|||
3775860|NCT01900392|3607858|B3|Weight at the start of Weight Watchers||Weight measures||Kilograms|Mean|102.9|102.9|Standard Deviation|15.6|15.6|||
3775861|NCT01900392|3607859|B2|Weight at the start of Weight Watchers||Weight measures||Kilograms|Mean|101.7|101.7|Standard Deviation|16.0|16.0|||
3775862|NCT01900392|3607860|B1|Weight at the start of Weight Watchers||Weight measures||Kilograms|Mean|100.8|100.8|Standard Deviation|15.7|15.7|||
3775863|NCT01900392|3607857|B4|Post-college degree||Education||participants|Number|64|64.0||||||
3775864|NCT01900392|3607858|B3|Post-college degree||Education||participants|Number|12|12.0||||||
3775865|NCT01900392|3607859|B2|Post-college degree||Education||participants|Number|29|29.0||||||
3775866|NCT01900392|3607860|B1|Post-college degree||Education||participants|Number|23|23.0||||||
3775867|NCT01900392|3607857|B4|College graduate||Education||participants|Number|55|55.0||||||
3775868|NCT01900392|3607858|B3|College graduate||Education||participants|Number|16|16.0||||||
3775869|NCT01900392|3607859|B2|College graduate||Education||participants|Number|11|11.0||||||
3775870|NCT01900392|3607860|B1|College graduate||Education||participants|Number|28|28.0||||||
3775871|NCT01900392|3607857|B4|Less than college||Education||participants|Number|72|72.0||||||
3775872|NCT01900392|3607858|B3|Less than college||Education||participants|Number|11|11.0||||||
3775873|NCT01900392|3607859|B2|Less than college||Education||participants|Number|35|35.0||||||
3775874|NCT01900392|3607860|B1|Less than college||Education||participants|Number|26|26.0||||||
3775875|NCT01900392|3607857|B4|||Household size||people per household|Mean|3.1|3.1|Standard Deviation|1.4|1.4|||
3775876|NCT01900392|3607858|B3|||Household size||people per household|Mean|3.0|3.0|Standard Deviation|1.2|1.2|||
3775877|NCT01900392|3607859|B2|||Household size||people per household|Mean|3.0|3.0|Standard Deviation|1.4|1.4|||
3775878|NCT01900392|3607860|B1|||Household size||people per household|Mean|3.2|3.2|Standard Deviation|1.5|1.5|||
3775879|NCT01900392|3607857|B4|≥US $100,000||Household income||Participants|Count of Participants|72|72.0||||||
3775880|NCT01900392|3607858|B3|≥US $100,000||Household income||Participants|Count of Participants|13|13.0||||||
3775881|NCT01900392|3607859|B2|≥US $100,000||Household income||Participants|Count of Participants|30|30.0||||||
3775882|NCT01900392|3607860|B1|≥US $100,000||Household income||Participants|Count of Participants|29|29.0||||||
3775883|NCT01900392|3607857|B4|US $50,000 to <US $100,000||Household income||Participants|Count of Participants|96|96.0||||||
3775884|NCT01900392|3607858|B3|US $50,000 to <US $100,000||Household income||Participants|Count of Participants|20|20.0||||||
3775885|NCT01900392|3607859|B2|US $50,000 to <US $100,000||Household income||Participants|Count of Participants|40|40.0||||||
3775886|NCT01900392|3607860|B1|US $50,000 to <US $100,000||Household income||Participants|Count of Participants|36|36.0||||||
3775887|NCT01900392|3607857|B4|<US $50,000||Household income||Participants|Count of Participants|23|23.0||||||
3775888|NCT01900392|3607858|B3|<US $50,000||Household income||Participants|Count of Participants|6|6.0||||||
3775889|NCT01900392|3607859|B2|<US $50,000||Household income||Participants|Count of Participants|5|5.0||||||
3775890|NCT01900392|3607860|B1|<US $50,000||Household income||Participants|Count of Participants|12|12.0||||||
3775891|NCT01900392|3607857|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3775892|NCT01900392|3607858|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3775893|NCT01900392|3607859|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3775894|NCT01900392|3607860|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3775895|NCT01900392|3607857|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3775896|NCT01900392|3607858|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3775897|NCT01900392|3607859|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3775898|NCT01900392|3607860|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3775899|NCT01900392|3607857|B4||White|Race (NIH/OMB)||Participants|Count of Participants|170|170.0||||||
3775900|NCT01900392|3607858|B3||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3775901|NCT01900392|3607859|B2||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3775902|NCT01900392|3607860|B1||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3775903|NCT01900392|3607857|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3775904|NCT01900392|3607858|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3775905|NCT01900392|3607859|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3775906|NCT01900392|3607860|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3775907|NCT01900392|3607857|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775908|NCT01900392|3607858|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775909|NCT01900392|3607859|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775910|NCT01900392|3607860|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775911|NCT01900392|3607857|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775912|NCT01900392|3607858|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775913|NCT01900392|3607859|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775914|NCT01900392|3607860|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775915|NCT01900392|3607857|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3775916|NCT01900392|3607858|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775917|NCT01900392|3607859|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775918|NCT01900392|3607860|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3775919|NCT01900392|3607857|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775920|NCT01900392|3607858|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775921|NCT01900392|3607859|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775922|NCT01900392|3607860|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775923|NCT01900392|3607857|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|183|183.0||||||
3775924|NCT01900392|3607858|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3775925|NCT01900392|3607859|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3775926|NCT01900392|3607860|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3775927|NCT01900392|3607857|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3775928|NCT01900392|3607858|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3775929|NCT01900392|3607859|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3775930|NCT01900392|3607860|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3775931|NCT01900392|3607857|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3775932|NCT01900392|3607858|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3775933|NCT01900392|3607859|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3775934|NCT01900392|3607860|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3775935|NCT01900392|3607857|B4||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
3775936|NCT01900392|3607858|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3775937|NCT01900392|3607859|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3775938|NCT01900392|3607860|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3775939|NCT01900392|3607857|B4|||Age||years|Mean|49.0|49.0|Standard Deviation|10.5|10.5|||
3775940|NCT01900392|3607858|B3|||Age||years|Mean|50.1|50.1|Standard Deviation|10.0|10.0|||
3775941|NCT01900392|3607859|B2|||Age||years|Mean|48.6|48.6|Standard Deviation|11.0|11.0|||
3775942|NCT01900392|3607860|B1|||Age||years|Mean|48.8|48.8|Standard Deviation|10.3|10.3|||
3775943|NCT01900314|3607873|B3|||Antidepressant Treatment History Form (ATHF-current)|"ATHF is obtained from interview and review of all treatments, with scores obtained based on the type, duration and length of treatment. This figure represents total number of medications and acceptable augmentation strategies, for the current episode.~Range: 0 - infinite~Interpretations: More is worse"|units on a scale|Mean|2.75|2.75|Standard Deviation|1.74|1.74|||
3775944|NCT01900314|3607874|B2|||Antidepressant Treatment History Form (ATHF-current)|"ATHF is obtained from interview and review of all treatments, with scores obtained based on the type, duration and length of treatment. This figure represents total number of medications and acceptable augmentation strategies, for the current episode.~Range: 0 - infinite~Interpretations: More is worse"|units on a scale|Mean|2.94|2.94|Standard Deviation|1.77|1.77|||
3775945|NCT01900314|3607875|B1|||Antidepressant Treatment History Form (ATHF-current)|"ATHF is obtained from interview and review of all treatments, with scores obtained based on the type, duration and length of treatment. This figure represents total number of medications and acceptable augmentation strategies, for the current episode.~Range: 0 - infinite~Interpretations: More is worse"|units on a scale|Mean|2.56|2.56|Standard Deviation|1.75|1.75|||
3775946|NCT01900314|3607873|B3|||Global assessment of Function (GAF)|"Range: 0 - 100~Severely impaired: < 30 moderate impaired: 30-50 mild impaired: 50- 80 No impairment: > 80"|units on a scale|Mean|54.1|54.1|Standard Deviation|4.6|4.6|||
3775997|NCT01899768|3607915|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3775947|NCT01900314|3607874|B2|||Global assessment of Function (GAF)|"Range: 0 - 100~Severely impaired: < 30 moderate impaired: 30-50 mild impaired: 50- 80 No impairment: > 80"|units on a scale|Mean|55.6|55.6|Standard Deviation|4.3|4.3|||
3775948|NCT01900314|3607875|B1|||Global assessment of Function (GAF)|"Range: 0 - 100~Severely impaired: < 30 moderate impaired: 30-50 mild impaired: 50- 80 No impairment: > 80"|units on a scale|Mean|52.6|52.6|Standard Deviation|4.7|4.7|||
3775949|NCT01900314|3607873|B3|||HRSD-17|Depressive symptoms as measured by the 17-item Hamilton Depression Rating Scale (HRSD17) Range: 0-53 Normal: 0-7 Mild: 8 - 13 Moderate 14 - 18 Severe: 19-22 Very severe > 22|units on a scale|Mean|14.2|14.2|Standard Deviation|4.4|4.4|||
3775950|NCT01900314|3607874|B2|||HRSD-17|Depressive symptoms as measured by the 17-item Hamilton Depression Rating Scale (HRSD17) Range: 0-53 Normal: 0-7 Mild: 8 - 13 Moderate 14 - 18 Severe: 19-22 Very severe > 22|units on a scale|Mean|13.1|13.1|Standard Deviation|2.3|2.3|||
3775951|NCT01900314|3607875|B1|||HRSD-17|Depressive symptoms as measured by the 17-item Hamilton Depression Rating Scale (HRSD17) Range: 0-53 Normal: 0-7 Mild: 8 - 13 Moderate 14 - 18 Severe: 19-22 Very severe > 22|units on a scale|Mean|16|16.0|Standard Deviation|3.9|3.9|||
3775952|NCT01900314|3607873|B3|||MADRS|MADRS: Montgomery Asberg Depression Rating Scale Range: 0 - 60 0 to 6 – normal/symptom absent 7 to 19 – mild depression 20 to 34 – moderate depression >34 – severe depression|units on a scale|Mean|23.5|23.5|Standard Deviation|5.1|5.1|||
3775953|NCT01900314|3607874|B2|||MADRS|MADRS: Montgomery Asberg Depression Rating Scale Range: 0 - 60 0 to 6 – normal/symptom absent 7 to 19 – mild depression 20 to 34 – moderate depression >34 – severe depression|units on a scale|Mean|21.9|21.9|Standard Deviation|3.1|3.1|||
3775954|NCT01900314|3607875|B1|||MADRS|MADRS: Montgomery Asberg Depression Rating Scale Range: 0 - 60 0 to 6 – normal/symptom absent 7 to 19 – mild depression 20 to 34 – moderate depression >34 – severe depression|units on a scale|Mean|25.4|25.4|Standard Deviation|5.7|5.7|||
3775955|NCT01900314|3607873|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3775956|NCT01900314|3607874|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3775957|NCT01900314|3607875|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3775958|NCT01900314|3607873|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3775959|NCT01900314|3607874|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3775960|NCT01900314|3607875|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3775961|NCT01900314|3607873|B3|||Age||years|Mean|45.5|45.5|Standard Deviation|10.9|10.9|||
3775962|NCT01900314|3607874|B2|||Age||years|Mean|44.1|44.1|Standard Deviation|11.1|11.1|||
3775963|NCT01900314|3607875|B1|||Age||years|Mean|46.9|46.9|Standard Deviation|10.7|10.7|||
3775964|NCT01900249|3607884|B4||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3775965|NCT01900249|3607885|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3775966|NCT01900249|3607886|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3775967|NCT01900249|3607887|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3775968|NCT01900249|3607884|B4||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3775969|NCT01900249|3607885|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3775970|NCT01900249|3607886|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3775971|NCT01900249|3607887|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3775972|NCT01900249|3607884|B4|||Age||Years|Mean|62.4|62.4|Standard Deviation|12.8|12.8|||
3775973|NCT01900249|3607885|B3|||Age||Years|Mean|61.5|61.5|Standard Deviation|15.2|15.2|||
3775974|NCT01900249|3607886|B2|||Age||Years|Mean|63.3|63.3|Standard Deviation|11.5|11.5|||
3775975|NCT01900249|3607887|B1|||Age||Years|Mean|62.4|62.4|Standard Deviation|11.59|11.59|||
3775976|NCT01900067|3607897|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3775977|NCT01900067|3607898|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3775978|NCT01900067|3607899|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3775979|NCT01900067|3607897|B3||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3775980|NCT01900067|3607898|B2||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3775981|NCT01900067|3607899|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3775982|NCT01900067|3607897|B3|Age||Age, Customized||years|Mean|46.1|46.1|Standard Deviation|15.1|15.1|||
3775983|NCT01900067|3607898|B2|Age||Age, Customized||years|Mean|45.6|45.6|Standard Deviation|14.8|14.8|||
3775984|NCT01900067|3607899|B1|Age||Age, Customized||years|Mean|46.5|46.5|Standard Deviation|15.3|15.3|||
3775985|NCT01900054|3607906|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3775986|NCT01900054|3607906|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3775987|NCT01900054|3607906|B1|||Age||years|Mean|11.2|11.2|Standard Deviation|2.3|2.3|||
3775988|NCT01899911|3607911|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3775989|NCT01899911|3607911|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3775990|NCT01899911|3607911|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3775991|NCT01899911|3607911|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3775992|NCT01899911|3607911|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3775993|NCT01899911|3607911|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3775994|NCT01899911|3607911|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3775995|NCT01899911|3607911|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3775996|NCT01899911|3607911|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3775998|NCT01899768|3607915|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3775999|NCT01899768|3607915|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3776000|NCT01899768|3607915|B1|||Age||Years|Mean|56.7|56.7|Standard Deviation|9.58|9.58|||
3776001|NCT01899742|3607987|B3|White - Mixed Race||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3776002|NCT01899742|3607988|B2|White - Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3776003|NCT01899742|3607989|B1|White - Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3776004|NCT01899742|3607987|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|476|476.0||||||
3776005|NCT01899742|3607988|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|237|237.0||||||
3776006|NCT01899742|3607989|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|239|239.0||||||
3776007|NCT01899742|3607987|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3776008|NCT01899742|3607988|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3776009|NCT01899742|3607989|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3776010|NCT01899742|3607987|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3776011|NCT01899742|3607988|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3776012|NCT01899742|3607989|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3776013|NCT01899742|3607987|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3776014|NCT01899742|3607988|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3776015|NCT01899742|3607989|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3776016|NCT01899742|3607987|B3||Male|Sex: Female, Male||Participants|Count of Participants|323|323.0||||||
3776017|NCT01899742|3607988|B2||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3776018|NCT01899742|3607989|B1||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3776019|NCT01899742|3607987|B3||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3776020|NCT01899742|3607988|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3776021|NCT01899742|3607989|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3776022|NCT01899742|3607987|B3|||Age||Years|Mean|64.4|64.4|Standard Deviation|8.71|8.71|||
3776023|NCT01899742|3607988|B2|||Age||Years|Mean|64.3|64.3|Standard Deviation|8.74|8.74|||
3776024|NCT01899742|3607989|B1|||Age||Years|Mean|64.5|64.5|Standard Deviation|8.71|8.71|||
3776025|NCT01899677|3607998|B3|||birth weight||grams|Mean|1245|1245.0|Standard Deviation|247|247.0|||
3776026|NCT01899677|3607999|B2|||birth weight||grams|Mean|1230|1230.0|Standard Deviation|262|262.0|||
3776027|NCT01899677|3608000|B1|||birth weight||grams|Mean|1266|1266.0|Standard Deviation|228|228.0|||
3776028|NCT01899677|3607998|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3776029|NCT01899677|3607999|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3776030|NCT01899677|3608000|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3776031|NCT01899677|3607998|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3776032|NCT01899677|3607999|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3776033|NCT01899677|3608000|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3776034|NCT01899677|3607998|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3776035|NCT01899677|3607999|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3776036|NCT01899677|3608000|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3776037|NCT01899677|3607998|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3776038|NCT01899677|3607999|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3776039|NCT01899677|3608000|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3776040|NCT01899677|3607998|B3||<=18 years|Age||Participants|Count of Participants|53|53.0||||||
3776041|NCT01899677|3607999|B2||<=18 years|Age||Participants|Count of Participants|28|28.0||||||
3776042|NCT01899677|3608000|B1||<=18 years|Age||Participants|Count of Participants|25|25.0||||||
3776043|NCT01899144|3608029|B1|10 to <15 years||Duration of Previous Metered-Dose Inhaler (MDI) Experience||participants|Number|3|3.0||||||
3776044|NCT01899144|3608029|B1|5 to <10 years||Duration of Previous Metered-Dose Inhaler (MDI) Experience||participants|Number|19|19.0||||||
3776045|NCT01899144|3608029|B1|1 to <5 years||Duration of Previous Metered-Dose Inhaler (MDI) Experience||participants|Number|34|34.0||||||
3776046|NCT01899144|3608029|B1|6 months to <1 year||Duration of Previous Metered-Dose Inhaler (MDI) Experience||participants|Number|3|3.0||||||
3776047|NCT01899144|3608029|B1|3 to <6 months||Duration of Previous Metered-Dose Inhaler (MDI) Experience||participants|Number|0|0.0||||||
3776048|NCT01899144|3608029|B1|<3 months||Duration of Previous Metered-Dose Inhaler (MDI) Experience||participants|Number|1|1.0||||||
3776049|NCT01899144|3608029|B1|None||Duration of Previous Metered-Dose Inhaler (MDI) Experience||participants|Number|1|1.0||||||
3776050|NCT01899144|3608029|B1|10 to <15 years||Duration of Previous Dry-Powder Inhaler (DPI) Experience||participants|Number|0|0.0||||||
3776051|NCT01899144|3608029|B1|5 to <10 years||Duration of Previous Dry-Powder Inhaler (DPI) Experience||participants|Number|0|0.0||||||
3776052|NCT01899144|3608029|B1|1 to <5 years||Duration of Previous Dry-Powder Inhaler (DPI) Experience||participants|Number|9|9.0||||||
3776053|NCT01899144|3608029|B1|6 months to <1 year||Duration of Previous Dry-Powder Inhaler (DPI) Experience||participants|Number|3|3.0||||||
3776054|NCT01899144|3608029|B1|3 to <6 months||Duration of Previous Dry-Powder Inhaler (DPI) Experience||participants|Number|1|1.0||||||
3776055|NCT01899144|3608029|B1|<3 months||Duration of Previous Dry-Powder Inhaler (DPI) Experience||participants|Number|2|2.0||||||
3776056|NCT01899144|3608029|B1|None||Duration of Previous Dry-Powder Inhaler (DPI) Experience||participants|Number|46|46.0||||||
3776057|NCT01899144|3608029|B1|10 to <15 years||Duration of Asthma|Time prior to study start when asthma was first diagnosed.|participants|Number|8|8.0||||||
3776058|NCT01899144|3608029|B1|5 to <10 years||Duration of Asthma|Time prior to study start when asthma was first diagnosed.|participants|Number|30|30.0||||||
3776059|NCT01899144|3608029|B1|1 to <5 years||Duration of Asthma|Time prior to study start when asthma was first diagnosed.|participants|Number|22|22.0||||||
3776060|NCT01899144|3608029|B1|6 months to <1 year||Duration of Asthma|Time prior to study start when asthma was first diagnosed.|participants|Number|1|1.0||||||
3776061|NCT01899144|3608029|B1|3 to <6 months||Duration of Asthma|Time prior to study start when asthma was first diagnosed.|participants|Number|0|0.0||||||
3776062|NCT01899144|3608029|B1|<3 months||Duration of Asthma|Time prior to study start when asthma was first diagnosed.|participants|Number|0|0.0||||||
3776063|NCT01899144|3608029|B1|None||Duration of Asthma|Time prior to study start when asthma was first diagnosed.|participants|Number|0|0.0||||||
3776064|NCT01899144|3608029|B1|||Body Mass Index||kg/m^2|Mean|19.5|19.5|Standard Deviation|4.35|4.35|||
3776065|NCT01899144|3608029|B1|||Height||cm|Mean|138.7|138.7|Standard Deviation|10.2|10.2|||
3776066|NCT01899144|3608029|B1|||Weight||kg|Mean|38.2|38.2|Standard Deviation|12.8|12.8|||
3776067|NCT01899144|3608029|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3776068|NCT01899144|3608029|B1|Black||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3776069|NCT01899144|3608029|B1|White||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3776070|NCT01899144|3608029|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3776071|NCT01899144|3608029|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3776072|NCT01899144|3608029|B1|||Age||years|Mean|9.0|9.0|Standard Deviation|1.6|1.6|||
3776073|NCT01898884|3608051|B6||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3776074|NCT01898884|3608052|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3776075|NCT01898884|3608053|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3776076|NCT01898884|3608054|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3776077|NCT01898884|3608055|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3776078|NCT01898884|3608056|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3776079|NCT01898884|3608051|B6||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3776080|NCT01898884|3608052|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3776081|NCT01898884|3608053|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3776082|NCT01898884|3608054|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3776083|NCT01898884|3608055|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3776084|NCT01898884|3608056|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3776085|NCT01898884|3608051|B6|||Age||years|Mean|26.0|26.0|Standard Deviation|6.27|6.27|||
3776086|NCT01898884|3608052|B5|||Age||years|Mean|26.8|26.8|Standard Deviation|8.86|8.86|||
3776087|NCT01898884|3608053|B4|||Age||years|Mean|28.0|28.0|Standard Deviation|6.90|6.9|||
3776088|NCT01898884|3608054|B3|||Age||years|Mean|27.8|27.8|Standard Deviation|4.45|4.45|||
3776089|NCT01898884|3608055|B2|||Age||years|Mean|22.7|22.7|Standard Deviation|1.97|1.97|||
3776090|NCT01898884|3608056|B1|||Age||years|Mean|25.1|25.1|Standard Deviation|7.04|7.04|||
3776091|NCT01898611|3608214|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
3776092|NCT01898611|3608215|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3776093|NCT01898611|3608216|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3776094|NCT01898611|3608214|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3776095|NCT01898611|3608215|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3776096|NCT01898611|3608216|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3776097|NCT01898611|3608214|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3776098|NCT01898611|3608215|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3776099|NCT01898611|3608216|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3776100|NCT01898611|3608214|B3|||Age||years|Mean|81.5|81.5|Standard Deviation|5|5.0|||
3776101|NCT01898611|3608215|B2|||Age||years|Mean|81.6|81.6|Standard Deviation|5|5.0|||
3776102|NCT01898611|3608216|B1|||Age||years|Mean|81.2|81.2|Standard Deviation|4|4.0|||
3776103|NCT01898611|3608214|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3776104|NCT01898611|3608215|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3776105|NCT01898611|3608216|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3776106|NCT01898611|3608214|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3776107|NCT01898611|3608215|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3776108|NCT01898611|3608216|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3776109|NCT01898611|3608214|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3776110|NCT01898611|3608215|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3776111|NCT01898611|3608216|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3776112|NCT01898598|3608237|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3776113|NCT01898598|3608238|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3776114|NCT01898598|3608239|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3776115|NCT01898598|3608237|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3776116|NCT01898598|3608238|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3776117|NCT01898598|3608239|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3776118|NCT01898598|3608237|B3|||Age||years|Mean|72.2|72.2|Standard Deviation|9.68|9.68|||
3776119|NCT01898598|3608238|B2|||Age||years|Mean|73.6|73.6|Standard Deviation|7.27|7.27|||
3776120|NCT01898598|3608239|B1|||Age||years|Mean|71.5|71.5|Standard Deviation|10.87|10.87|||
3776121|NCT01898442|3608256|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776122|NCT01898442|3608257|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776123|NCT01898442|3608258|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776124|NCT01898442|3608259|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776125|NCT01898442|3608256|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776126|NCT01898442|3608257|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776127|NCT01898442|3608258|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776128|NCT01898442|3608259|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776129|NCT01898442|3608256|B4||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3776130|NCT01898442|3608257|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3776131|NCT01898442|3608258|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3776132|NCT01898442|3608259|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3776133|NCT01898442|3608256|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3776134|NCT01898442|3608257|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3776135|NCT01898442|3608258|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3776136|NCT01898442|3608259|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3776137|NCT01898442|3608256|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776138|NCT01898442|3608257|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776139|NCT01898442|3608258|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776140|NCT01898442|3608259|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776141|NCT01898442|3608256|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776142|NCT01898442|3608257|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776143|NCT01898442|3608258|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776144|NCT01898442|3608259|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776145|NCT01898442|3608256|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776146|NCT01898442|3608257|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776147|NCT01898442|3608258|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776148|NCT01898442|3608259|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776149|NCT01898442|3608256|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3776150|NCT01898442|3608257|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3776151|NCT01898442|3608258|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3776152|NCT01898442|3608259|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3776153|NCT01898442|3608256|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3776154|NCT01898442|3608257|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3776155|NCT01898442|3608258|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3776156|NCT01898442|3608259|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3776157|NCT01898442|3608256|B4|||Age||years|Mean|58|58.0|Standard Deviation|9.5|9.5|||
3776158|NCT01898442|3608257|B3|||Age||years|Mean|57|57.0|Standard Deviation|12.1|12.1|||
3776159|NCT01898442|3608258|B2|||Age||years|Mean|58|58.0|Standard Deviation|8.5|8.5|||
3776160|NCT01898442|3608259|B1|||Age||years|Mean|60|60.0|Standard Deviation|8.6|8.6|||
3776161|NCT01898429|3608284|B1|||HDRS-17||units on a scale|Mean|22.4|22.4|Standard Deviation|2.0|2.0|||
3776162|NCT01898429|3608284|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776163|NCT01898429|3608284|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776164|NCT01898429|3608284|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3776165|NCT01898429|3608284|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776166|NCT01898429|3608284|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776167|NCT01898429|3608284|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776168|NCT01898429|3608284|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776169|NCT01898429|3608284|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776170|NCT01898429|3608284|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3776171|NCT01898429|3608284|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776172|NCT01898429|3608284|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3776173|NCT01898429|3608284|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3776174|NCT01898429|3608284|B1|||Age||years|Mean|45|45.0|Standard Deviation|5.3|5.3|||
3776175|NCT01898403|3608290|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3776176|NCT01898403|3608290|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3776177|NCT01898403|3608290|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776178|NCT01898403|3608290|B1||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3776179|NCT01898403|3608290|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776180|NCT01898403|3608290|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776181|NCT01898403|3608290|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3776182|NCT01898403|3608290|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3776183|NCT01898403|3608290|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776184|NCT01898403|3608290|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3776185|NCT01898403|3608290|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3776186|NCT01898403|3608290|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3776187|NCT01898403|3608290|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3776188|NCT01898403|3608290|B1|||Age||years|Mean|60.7|60.7|Full Range|||18.9|86.7|
3776189|NCT01898403|3608290|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3776190|NCT01898403|3608290|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3776191|NCT01898403|3608290|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3776192|NCT01898286|3608296|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3776193|NCT01898286|3608296|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3776194|NCT01898286|3608296|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3776195|NCT01898286|3608296|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
3776196|NCT01898286|3608296|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3776197|NCT01898286|3608296|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3776198|NCT01898286|3608296|B1|||Age, Customized||years|Median|32.00|32.0|Full Range|||23.0|47.0|
3776199|NCT01898286|3608296|B1|||Age||years|Mean|33.16|33.16|Standard Deviation|7.343|7.343|||
3776200|NCT01898208|3608303|B4|United States||Region of Enrollment||participants|Number|617|617.0||||||
3776201|NCT01898208|3608304|B3|United States||Region of Enrollment||participants|Number|212|212.0||||||
3776202|NCT01898208|3608305|B2|United States||Region of Enrollment||participants|Number|198|198.0||||||
3776203|NCT01898208|3608306|B1|United States||Region of Enrollment||participants|Number|207|207.0||||||
3776204|NCT01898208|3608303|B4||Male|Sex: Female, Male||Participants|Count of Participants|385|385.0||||||
3776205|NCT01898208|3608304|B3||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3776206|NCT01898208|3608305|B2||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3776207|NCT01898208|3608306|B1||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3776208|NCT01898208|3608303|B4||Female|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
3776209|NCT01898208|3608304|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3776210|NCT01898208|3608305|B2||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3776211|NCT01898208|3608306|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3776212|NCT01898208|3608303|B4|||Age||years|Mean|61.4|61.4|Standard Deviation|20.17|20.17|||
3776213|NCT01898208|3608304|B3|||Age||years|Mean|61.2|61.2|Standard Deviation|20.08|20.08|||
3776214|NCT01898208|3608305|B2|||Age||years|Mean|61.4|61.4|Standard Deviation|21.22|21.22|||
3776215|NCT01898208|3608306|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|19.32|19.32|||
3776216|NCT01898195|3608352|B4|United States||Region of Enrollment||participants|Number|158|158.0||||||
3776217|NCT01898195|3608353|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
3776218|NCT01898195|3608354|B2|United States||Region of Enrollment||participants|Number|54|54.0||||||
3776219|NCT01898195|3608355|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
3776220|NCT01898195|3608352|B4||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3776221|NCT01898195|3608353|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3776222|NCT01898195|3608354|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3776223|NCT01898195|3608355|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3776224|NCT01898195|3608352|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3776225|NCT01898195|3608353|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3776226|NCT01898195|3608354|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3776227|NCT01898195|3608355|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3776228|NCT01898195|3608352|B4|||Age||years|Mean|46.84|46.84|Standard Deviation|9.8|9.8|||
3776229|NCT01898195|3608353|B3|||Age||years|Mean|47.88|47.88|Standard Deviation|8.69|8.69|||
3776230|NCT01898195|3608354|B2|||Age||years|Mean|46|46.0|Standard Deviation|9.96|9.96|||
3776231|NCT01898195|3608355|B1|||Age||years|Mean|46.64|46.64|Standard Deviation|10.77|10.77|||
3776232|NCT01898195|3608352|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3776233|NCT01898195|3608353|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3776234|NCT01898195|3608354|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3776235|NCT01898195|3608355|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3776236|NCT01898195|3608352|B4||Between 18 and 65 years|Age||Participants|Count of Participants|158|158.0||||||
3776237|NCT01898195|3608353|B3||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3776238|NCT01898195|3608354|B2||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3776239|NCT01898195|3608355|B1||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
3776240|NCT01898195|3608352|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3776241|NCT01898195|3608353|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3776242|NCT01898195|3608354|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3776243|NCT01898195|3608355|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3776244|NCT01898091|3608368|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
3776245|NCT01898091|3608369|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3776246|NCT01898091|3608370|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
3776247|NCT01898091|3608368|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776248|NCT01898091|3608369|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776249|NCT01898091|3608370|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776250|NCT01898091|3608368|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776251|NCT01898091|3608369|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776252|NCT01898091|3608370|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776253|NCT01898091|3608368|B3||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3776254|NCT01898091|3608369|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3776255|NCT01898091|3608370|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3776256|NCT01898091|3608368|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3776257|NCT01898091|3608369|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3776258|NCT01898091|3608370|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3776259|NCT01898091|3608368|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776260|NCT01898091|3608369|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776261|NCT01898091|3608370|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776262|NCT01898091|3608368|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3776263|NCT01898091|3608369|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776264|NCT01898091|3608370|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3776265|NCT01898091|3608368|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776266|NCT01898091|3608369|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776267|NCT01898091|3608370|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776268|NCT01898091|3608368|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776269|NCT01898091|3608369|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776270|NCT01898091|3608370|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776271|NCT01898091|3608368|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3776272|NCT01898091|3608369|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3776273|NCT01898091|3608370|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3776274|NCT01898091|3608368|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776275|NCT01898091|3608369|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776276|NCT01898091|3608370|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776277|NCT01898091|3608368|B3||Male|Gender||Participants|Count of Participants|31|31.0||||||
3776278|NCT01898091|3608369|B2||Male|Gender||Participants|Count of Participants|15|15.0||||||
3776279|NCT01898091|3608370|B1||Male|Gender||Participants|Count of Participants|16|16.0||||||
3776280|NCT01898091|3608368|B3||Female|Gender||Participants|Count of Participants|11|11.0||||||
3776281|NCT01898091|3608369|B2||Female|Gender||Participants|Count of Participants|4|4.0||||||
3776282|NCT01898091|3608370|B1||Female|Gender||Participants|Count of Participants|7|7.0||||||
3776283|NCT01898091|3608368|B3|||Age||years|Mean|59|59.0|Standard Deviation|11.5|11.5|||
3776284|NCT01898091|3608369|B2|||Age||years|Mean|61|61.0|Standard Deviation|11.5|11.5|||
3776285|NCT01898091|3608370|B1|||Age||years|Mean|57|57.0|Standard Deviation|13.4|13.4|||
3776286|NCT01898013|3608377|B3|United States||Region of Enrollment||participants|Number|94|94.0||||||
3776287|NCT01898013|3608378|B2|United States||Region of Enrollment||participants|Number|49|49.0||||||
3776288|NCT01898013|3608379|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
3776289|NCT01898013|3608377|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3776290|NCT01898013|3608378|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3776291|NCT01898013|3608379|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776292|NCT01898013|3608377|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3776293|NCT01898013|3608378|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776294|NCT01898013|3608379|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3776295|NCT01898013|3608377|B3||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3776296|NCT01898013|3608378|B2||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3776297|NCT01898013|3608379|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3776298|NCT01898013|3608377|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3776299|NCT01898013|3608378|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3776300|NCT01898013|3608379|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3776301|NCT01898013|3608377|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776302|NCT01898013|3608378|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776303|NCT01898013|3608379|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776304|NCT01898013|3608377|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3776305|NCT01898013|3608378|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776306|NCT01898013|3608379|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3776307|NCT01898013|3608377|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776308|NCT01898013|3608378|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776309|NCT01898013|3608379|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776310|NCT01898013|3608377|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3776311|NCT01898013|3608378|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3776312|NCT01898013|3608379|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3776313|NCT01898013|3608377|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3776314|NCT01898013|3608378|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3776315|NCT01898013|3608379|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3776316|NCT01898013|3608377|B3|||Age||years|Mean|37.52|37.52|Standard Deviation|9.84|9.84|||
3776317|NCT01898013|3608378|B2|||Age||years|Mean|37.55|37.55|Standard Deviation|10.25|10.25|||
3776318|NCT01898013|3608379|B1|||Age||years|Mean|37.48|37.48|Standard Deviation|9.47|9.47|||
3776319|NCT01898013|3608377|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3776320|NCT01898013|3608378|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3776321|NCT01898013|3608379|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3776322|NCT01898013|3608377|B3||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
3776323|NCT01898013|3608378|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3776324|NCT01898013|3608379|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3776325|NCT01898013|3608377|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3776326|NCT01898013|3608378|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3776327|NCT01898013|3608379|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3776328|NCT01897792|3608396|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3776329|NCT01897792|3608397|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3776330|NCT01897792|3608398|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3776331|NCT01897792|3608396|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776332|NCT01897792|3608397|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776333|NCT01897792|3608398|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776334|NCT01897792|3608396|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776335|NCT01897792|3608397|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776336|NCT01897792|3608398|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776337|NCT01897792|3608396|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3776338|NCT01897792|3608397|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3776339|NCT01897792|3608398|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3776340|NCT01897792|3608396|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3776341|NCT01897792|3608397|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3776342|NCT01897792|3608398|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776343|NCT01897792|3608396|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776344|NCT01897792|3608397|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776345|NCT01897792|3608398|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776346|NCT01897792|3608396|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776347|NCT01897792|3608397|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776348|NCT01897792|3608398|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776349|NCT01897792|3608396|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776350|NCT01897792|3608397|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776351|NCT01897792|3608398|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776352|NCT01897792|3608396|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3776353|NCT01897792|3608397|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3776354|NCT01897792|3608398|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3776355|NCT01897792|3608396|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3776356|NCT01897792|3608397|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3776357|NCT01897792|3608398|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3776358|NCT01897792|3608396|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3776359|NCT01897792|3608397|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3776360|NCT01897792|3608398|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3776361|NCT01897792|3608396|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3776362|NCT01897792|3608397|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3776363|NCT01897792|3608398|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3776364|NCT01897792|3608396|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3776365|NCT01897792|3608397|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3776366|NCT01897792|3608398|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3776367|NCT01897727|3608423|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
3776368|NCT01897727|3608424|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3776369|NCT01897727|3608425|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3776370|NCT01897727|3608423|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3776371|NCT01897727|3608424|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3776372|NCT01897727|3608425|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3776373|NCT01897727|3608423|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3776374|NCT01897727|3608424|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3776375|NCT01897727|3608425|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3776376|NCT01897727|3608423|B3|||Age||years|Mean|58.4|58.4|Standard Deviation|7.3|7.3|||
3776377|NCT01897727|3608424|B2|||Age||years|Mean|56.8|56.8|Standard Deviation|6.3|6.3|||
3776378|NCT01897727|3608425|B1|||Age||years|Mean|60|60.0|Standard Deviation|8.3|8.3|||
3776379|NCT01897727|3608423|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3776380|NCT01897727|3608424|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3776381|NCT01897727|3608425|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3776382|NCT01897727|3608423|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3776383|NCT01897727|3608424|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3776384|NCT01897727|3608425|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3776385|NCT01897727|3608423|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3776386|NCT01897727|3608424|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3776387|NCT01897727|3608425|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3776388|NCT01897493|3608432|B1|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3776389|NCT01897493|3608432|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776390|NCT01897493|3608432|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776391|NCT01897493|3608432|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3776392|NCT01897493|3608432|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3776393|NCT01897493|3608432|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776394|NCT01897493|3608432|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776395|NCT01897493|3608432|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3776396|NCT01897493|3608432|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776397|NCT01897493|3608432|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3776398|NCT01897493|3608432|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3776399|NCT01897493|3608432|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3776400|NCT01897493|3608432|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3776401|NCT01897493|3608432|B1|||Age||years|Mean|38.6|38.6|Standard Deviation|11.2|11.2|||
3776402|NCT01897402|3608445|B3|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3776403|NCT01897402|3608446|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3776404|NCT01897402|3608447|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3776405|NCT01897402|3608445|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3776406|NCT01897402|3608446|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3776407|NCT01897402|3608447|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3776408|NCT01897402|3608445|B3|Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3776409|NCT01897402|3608446|B2|Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3776410|NCT01897402|3608447|B1|Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3776411|NCT01897402|3608445|B3|Black/ African-American||Race/Ethnicity, Customized||Participants|Number|336|336.0||||||
3776412|NCT01897402|3608446|B2|Black/ African-American||Race/Ethnicity, Customized||Participants|Number|160|160.0||||||
3776413|NCT01897402|3608447|B1|Black/ African-American||Race/Ethnicity, Customized||Participants|Number|176|176.0||||||
3776414|NCT01897402|3608445|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|176|176.0||||||
3776415|NCT01897402|3608446|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|89|89.0||||||
3776416|NCT01897402|3608447|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|87|87.0||||||
3776417|NCT01897402|3608445|B3|American Indian/ Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3776418|NCT01897402|3608446|B2|American Indian/ Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3776419|NCT01897402|3608447|B1|American Indian/ Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3776420|NCT01897402|3608445|B3|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3776421|NCT01897402|3608446|B2|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3776422|NCT01897402|3608447|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3776423|NCT01897402|3608445|B3||Male|Sex: Female, Male||Participants|Count of Participants|299|299.0||||||
3776424|NCT01897402|3608446|B2||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3776425|NCT01897402|3608447|B1||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3776426|NCT01897402|3608445|B3||Female|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
3776427|NCT01897402|3608446|B2||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3776428|NCT01897402|3608447|B1||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3776429|NCT01897402|3608445|B3|||Age||years|Mean|36.6|36.6|Standard Deviation|11.0|11.0|||
3776430|NCT01897402|3608446|B2|||Age||years|Mean|36.0|36.0|Standard Deviation|10.88|10.88|||
3776431|NCT01897402|3608447|B1|||Age||years|Mean|37.1|37.1|Standard Deviation|11.1|11.1|||
3776432|NCT01897285|3608460|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3776433|NCT01897285|3608460|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3776434|NCT01897285|3608460|B1|||Age||years|Mean|37.1|37.1|Standard Deviation|10.46|10.46|||
3776435|NCT01897233|3608468|B1|Part B (n=58): Male||Sex/Gender, Customized|"Data were planned to be reported separately for Part A and Part B of the study. Here n signifies participants who were evaluable for specified part of the study."|participants|Number|27|27.0||||||
3776436|NCT01897233|3608468|B1|Part B (n=58): Female||Sex/Gender, Customized|"Data were planned to be reported separately for Part A and Part B of the study. Here n signifies participants who were evaluable for specified part of the study."|participants|Number|31|31.0||||||
3776437|NCT01897233|3608468|B1|Part A Cohort 2 (n=5): Male||Sex/Gender, Customized|"Data were planned to be reported separately for Part A and Part B of the study. Here n signifies participants who were evaluable for specified part of the study."|participants|Number|4|4.0||||||
3776438|NCT01897233|3608468|B1|Part A Cohort 2 (n=5): Female||Sex/Gender, Customized|"Data were planned to be reported separately for Part A and Part B of the study. Here n signifies participants who were evaluable for specified part of the study."|participants|Number|1|1.0||||||
3776439|NCT01897233|3608468|B1|Part A Cohort 1 (n=5): Male||Sex/Gender, Customized|"Data were planned to be reported separately for Part A and Part B of the study. Here n signifies participants who were evaluable for specified part of the study."|participants|Number|4|4.0||||||
3776440|NCT01897233|3608468|B1|Part A Cohort 1 (n=5): Female||Sex/Gender, Customized|"Data were planned to be reported separately for Part A and Part B of the study. Here n signifies participants who were evaluable for specified part of the study."|participants|Number|1|1.0||||||
3776441|NCT01897233|3608468|B1|Part B (n=58)||Age|Data were planned to be reported separately for Part A and Part B of the study. Here “n” signifies participants who were evaluable for specified part of the study.|years|Mean|9.1|9.1|Standard Deviation|1.53|1.53|||
3776442|NCT01897233|3608468|B1|Part A Cohort 2 (n=5)||Age|Data were planned to be reported separately for Part A and Part B of the study. Here “n” signifies participants who were evaluable for specified part of the study.|years|Mean|9.6|9.6|Standard Deviation|0.89|0.89|||
3776443|NCT01897233|3608468|B1|Part A Cohort 1 (n=5)||Age|Data were planned to be reported separately for Part A and Part B of the study. Here “n” signifies participants who were evaluable for specified part of the study.|years|Mean|6.6|6.6|Standard Deviation|0.89|0.89|||
3776444|NCT01897077|3608490|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3776445|NCT01897077|3608491|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3776446|NCT01897077|3608490|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776447|NCT01897077|3608491|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776448|NCT01897077|3608490|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776449|NCT01897077|3608491|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776450|NCT01897077|3608490|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3776451|NCT01897077|3608491|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3776452|NCT01897077|3608490|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3776453|NCT01897077|3608491|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3776454|NCT01897077|3608490|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776455|NCT01897077|3608491|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776456|NCT01897077|3608490|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3776457|NCT01897077|3608491|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3776458|NCT01897077|3608490|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776459|NCT01897077|3608491|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776460|NCT01897077|3608490|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3776461|NCT01897077|3608491|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3776462|NCT01897077|3608490|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3776463|NCT01897077|3608491|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3776464|NCT01897077|3608490|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3776465|NCT01897077|3608491|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3776466|NCT01897077|3608490|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3776467|NCT01897077|3608491|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3776468|NCT01897077|3608490|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3776469|NCT01897077|3608491|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3776470|NCT01897025|3608509|B3|Singapore||Region of Enrollment||participants|Number|19|19.0||||||
3776471|NCT01897025|3608510|B2|Singapore||Region of Enrollment||participants|Number|9|9.0||||||
3776472|NCT01897025|3608511|B1|Singapore||Region of Enrollment||participants|Number|10|10.0||||||
3776473|NCT01897025|3608509|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3776474|NCT01897025|3608510|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3776475|NCT01897025|3608511|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3776476|NCT01897025|3608509|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3776477|NCT01897025|3608510|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3776478|NCT01897025|3608511|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3776479|NCT01897025|3608509|B3|||Age||years|Mean|54.1|54.1|Standard Deviation|10.6|10.6|||
3776480|NCT01897025|3608510|B2|||Age||years|Mean|56.3|56.3|Standard Deviation|9.5|9.5|||
3776481|NCT01897025|3608511|B1|||Age||years|Mean|52.1|52.1|Standard Deviation|11.7|11.7|||
3776482|NCT01896986|3608518|B3|Australia||Region of Enrollment||participants|Number|37|37.0||||||
3776483|NCT01896986|3608519|B2|Australia||Region of Enrollment||participants|Number|23|23.0||||||
3776484|NCT01896986|3608520|B1|Australia||Region of Enrollment||participants|Number|14|14.0||||||
3776485|NCT01896986|3608518|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3776486|NCT01896986|3608519|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3776487|NCT01896986|3608520|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3776488|NCT01896986|3608518|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3776489|NCT01896986|3608519|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3776490|NCT01896986|3608520|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3776491|NCT01896986|3608518|B3|||Age||years|Mean|21|21.0|Full Range|||12.0|30.0|
3776492|NCT01896986|3608519|B2|||Age||years|Mean|23|23.0|Full Range|||12.0|30.0|
3776493|NCT01896986|3608520|B1|||Age||years|Mean|19|19.0|Full Range|||17.0|24.0|
3776494|NCT01896934|3608527|B1|||Quick Inventory of Depressive Symptoms|Depression rating scale, self-report, Range 0-27, where higher scores indicate more severe depression|units on a scale|Mean|11.94|11.94|Standard Deviation|4.5|4.5|||
3776495|NCT01896934|3608527|B1|||Montgomery-Asberg Depression Rating Scale|Depression rating scale, clinician rated, range 0-60, where higher scores indicate more severe depression|units on a scale|Mean|27.43|27.43|Standard Deviation|4.80|4.8|||
3776496|NCT01896934|3608527|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3776497|NCT01896934|3608527|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776498|NCT01896934|3608527|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3776499|NCT01896934|3608527|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3776500|NCT01896934|3608527|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3776501|NCT01896934|3608527|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776502|NCT01896934|3608527|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776503|NCT01896934|3608527|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776504|NCT01896934|3608527|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776505|NCT01896934|3608527|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3776506|NCT01896934|3608527|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776507|NCT01896934|3608527|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3776508|NCT01896934|3608527|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3776509|NCT01896934|3608527|B1|||Age||years|Mean|68.05|68.05|Standard Deviation|7.15|7.15|||
3776510|NCT01896934|3608527|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3776511|NCT01896934|3608527|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3776512|NCT01896934|3608527|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3776513|NCT01896895|3608533|B4|Malaysia||Region of Enrollment||participants|Number|17|17.0||||||
3776514|NCT01896895|3608534|B3|Malaysia||Region of Enrollment||participants|Number|5|5.0||||||
3776515|NCT01896895|3608535|B2|Malaysia||Region of Enrollment||participants|Number|6|6.0||||||
3776516|NCT01896895|3608536|B1|Malaysia||Region of Enrollment||participants|Number|6|6.0||||||
3776517|NCT01896895|3608533|B4|Sri Lanka||Region of Enrollment||participants|Number|30|30.0||||||
3776518|NCT01896895|3608534|B3|Sri Lanka||Region of Enrollment||participants|Number|10|10.0||||||
3776519|NCT01896895|3608535|B2|Sri Lanka||Region of Enrollment||participants|Number|10|10.0||||||
3776520|NCT01896895|3608536|B1|Sri Lanka||Region of Enrollment||participants|Number|10|10.0||||||
3776521|NCT01896895|3608533|B4|Greece||Region of Enrollment||participants|Number|14|14.0||||||
3776522|NCT01896895|3608534|B3|Greece||Region of Enrollment||participants|Number|4|4.0||||||
3776523|NCT01896895|3608535|B2|Greece||Region of Enrollment||participants|Number|6|6.0||||||
3776524|NCT01896895|3608536|B1|Greece||Region of Enrollment||participants|Number|4|4.0||||||
3776525|NCT01896895|3608533|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3776526|NCT01896895|3608534|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3776527|NCT01896895|3608535|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3776528|NCT01896895|3608536|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3776529|NCT01896895|3608533|B4||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3776530|NCT01896895|3608534|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3776531|NCT01896895|3608535|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3776532|NCT01896895|3608536|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3776533|NCT01896895|3608533|B4|||Age||years|Mean|55.0|55.0|Standard Deviation|13.79|13.79|||
3776534|NCT01896895|3608534|B3|||Age||years|Mean|53.5|53.5|Standard Deviation|13.82|13.82|||
3776535|NCT01896895|3608535|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|15.70|15.7|||
3776536|NCT01896895|3608536|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|12.01|12.01|||
3776537|NCT01896895|3608533|B4||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3776538|NCT01896895|3608534|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3776539|NCT01896895|3608535|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3776540|NCT01896895|3608536|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3776541|NCT01896895|3608533|B4||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3776542|NCT01896895|3608534|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3776543|NCT01896895|3608535|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3776544|NCT01896895|3608536|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3776545|NCT01896895|3608533|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3776546|NCT01896895|3608534|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3776547|NCT01896895|3608535|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3776548|NCT01896895|3608536|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3776549|NCT01896726|3608554|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3776550|NCT01896726|3608554|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776551|NCT01896726|3608554|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776552|NCT01896726|3608554|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3776553|NCT01896726|3608554|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3776554|NCT01896726|3608554|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776555|NCT01896726|3608554|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776556|NCT01896726|3608554|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776557|NCT01896726|3608554|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776558|NCT01896726|3608554|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3776559|NCT01896726|3608554|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776560|NCT01896726|3608554|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3776561|NCT01896726|3608554|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3776562|NCT01896726|3608554|B1|||Age||years|Mean|44.1|44.1|Standard Deviation|12.7|12.7|||
3776563|NCT01896700|3608567|B3|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3776564|NCT01896700|3608568|B2|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3776565|NCT01896700|3608569|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3776566|NCT01896700|3608567|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776567|NCT01896700|3608568|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776568|NCT01896700|3608569|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776569|NCT01896700|3608567|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776570|NCT01896700|3608568|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776571|NCT01896700|3608569|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776572|NCT01896700|3608567|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3776573|NCT01896700|3608568|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3776574|NCT01896700|3608569|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3776575|NCT01896700|3608567|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3776576|NCT01896700|3608568|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3776577|NCT01896700|3608569|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3776578|NCT01896700|3608567|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776579|NCT01896700|3608568|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776580|NCT01896700|3608569|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776581|NCT01896700|3608567|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776582|NCT01896700|3608568|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776583|NCT01896700|3608569|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776584|NCT01896700|3608567|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776585|NCT01896700|3608568|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776586|NCT01896700|3608569|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776587|NCT01896700|3608567|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3776588|NCT01896700|3608568|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3776589|NCT01896700|3608569|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3776590|NCT01896700|3608567|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3776591|NCT01896700|3608568|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3776592|NCT01896700|3608569|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3776593|NCT01896700|3608567|B3|||Age||years|Mean|49.0|49.0|Standard Deviation|8.6|8.6|||
3776594|NCT01896700|3608568|B2|||Age||years|Mean|51.7|51.7|Standard Deviation|8.7|8.7|||
3776595|NCT01896700|3608569|B1|||Age||years|Mean|46.4|46.4|Standard Deviation|7.9|7.9|||
3776596|NCT01896687|3608590|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3776597|NCT01896687|3608591|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3776598|NCT01896687|3608592|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3776599|NCT01896687|3608590|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3776600|NCT01896687|3608591|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3776601|NCT01896687|3608592|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3776602|NCT01896687|3608590|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3776603|NCT01896687|3608591|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3776604|NCT01896687|3608592|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3776605|NCT01896687|3608590|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3776606|NCT01896687|3608591|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3776607|NCT01896687|3608592|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3776608|NCT01896687|3608590|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3776609|NCT01896687|3608591|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3776610|NCT01896687|3608592|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3776611|NCT01896687|3608590|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3776612|NCT01896687|3608591|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3776613|NCT01896687|3608592|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3776614|NCT01896557|3608599|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3776615|NCT01896557|3608600|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3776616|NCT01896557|3608601|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3776617|NCT01896557|3608599|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3776618|NCT01896557|3608600|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3776619|NCT01896557|3608601|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3776620|NCT01896557|3608599|B3|||Age||years|Mean|62.6|62.6|Standard Deviation|9.9|9.9|||
3776621|NCT01896557|3608600|B2|||Age||years|Mean|62.5|62.5|Standard Deviation|8.9|8.9|||
3776622|NCT01896557|3608601|B1|||Age||years|Mean|62.6|62.6|Standard Deviation|10.9|10.9|||
3776623|NCT01896557|3608599|B3||>=65 years|Age|Age according to categories (bellow versus more than or equal to 65 years-old)|Participants|Count of Participants|42|42.0||||||
3776624|NCT01896557|3608600|B2||>=65 years|Age|Age according to categories (bellow versus more than or equal to 65 years-old)|Participants|Count of Participants|22|22.0||||||
3776625|NCT01896557|3608601|B1||>=65 years|Age|Age according to categories (bellow versus more than or equal to 65 years-old)|Participants|Count of Participants|20|20.0||||||
3776626|NCT01896557|3608599|B3||Between 18 and 65 years|Age|Age according to categories (bellow versus more than or equal to 65 years-old)|Participants|Count of Participants|50|50.0||||||
3776627|NCT01896557|3608600|B2||Between 18 and 65 years|Age|Age according to categories (bellow versus more than or equal to 65 years-old)|Participants|Count of Participants|26|26.0||||||
3776628|NCT01896557|3608601|B1||Between 18 and 65 years|Age|Age according to categories (bellow versus more than or equal to 65 years-old)|Participants|Count of Participants|24|24.0||||||
3776629|NCT01896557|3608599|B3||<=18 years|Age|Age according to categories (bellow versus more than or equal to 65 years-old)|Participants|Count of Participants|0|0.0||||||
3776630|NCT01896557|3608600|B2||<=18 years|Age|Age according to categories (bellow versus more than or equal to 65 years-old)|Participants|Count of Participants|0|0.0||||||
3776631|NCT01896557|3608601|B1||<=18 years|Age|Age according to categories (bellow versus more than or equal to 65 years-old)|Participants|Count of Participants|0|0.0||||||
3776632|NCT01896544|3608614|B4|||Day 1: total body fluid balance (TBB)||mL|Median|1,592|1.0|Inter-Quartile Range|||925.0|2.0|
3776633|NCT01896544|3608615|B3|||Day 1: total body fluid balance (TBB)||mL|Median|1,730|1.0|Inter-Quartile Range|||925.0|3075.0|
3776634|NCT01896544|3608616|B2|||Day 1: total body fluid balance (TBB)||mL|Median|1592|1592.0|Inter-Quartile Range|||1.0|2.0|
3776635|NCT01896544|3608617|B1|||Day 1: total body fluid balance (TBB)||mL|Median|1,518|1.0|Inter-Quartile Range|||696.0|2.0|
3776636|NCT01896544|3608614|B4|||Day 1 data: high-sensitivity c-reactive protein (hs-CRP)||mg/L|Median|119|119.0|Inter-Quartile Range|||85.0|267.0|
3776637|NCT01896544|3608615|B3|||Day 1 data: high-sensitivity c-reactive protein (hs-CRP)||mg/L|Median|208|208.0|Inter-Quartile Range|||90.0|359.0|
3776638|NCT01896544|3608616|B2|||Day 1 data: high-sensitivity c-reactive protein (hs-CRP)||mg/L|Median|106|106.0|Inter-Quartile Range|||60.0|267.0|
3776639|NCT01896544|3608617|B1|||Day 1 data: high-sensitivity c-reactive protein (hs-CRP)||mg/L|Median|119|119.0|Inter-Quartile Range|||85.0|247.0|
3776640|NCT01896544|3608614|B4|alive||30 day mortality||participants|Number|22|22.0||||||
3776641|NCT01896544|3608615|B3|alive||30 day mortality||participants|Number|7|7.0||||||
3776642|NCT01896544|3608616|B2|alive||30 day mortality||participants|Number|7|7.0||||||
3776643|NCT01896544|3608617|B1|alive||30 day mortality||participants|Number|8|8.0||||||
3776644|NCT01896544|3608614|B4|dead||30 day mortality||participants|Number|8|8.0||||||
3776645|NCT01896544|3608615|B3|dead||30 day mortality||participants|Number|3|3.0||||||
3776646|NCT01896544|3608616|B2|dead||30 day mortality||participants|Number|3|3.0||||||
3776647|NCT01896544|3608617|B1|dead||30 day mortality||participants|Number|2|2.0||||||
3776648|NCT01896544|3608614|B4|Yes||30 day readmission||participants|Number|2|2.0||||||
3776649|NCT01896544|3608615|B3|Yes||30 day readmission||participants|Number|0|0.0||||||
3776650|NCT01896544|3608616|B2|Yes||30 day readmission||participants|Number|2|2.0||||||
3776651|NCT01896544|3608617|B1|Yes||30 day readmission||participants|Number|0|0.0||||||
3776652|NCT01896544|3608614|B4|No||30 day readmission||participants|Number|28|28.0||||||
3776653|NCT01896544|3608615|B3|No||30 day readmission||participants|Number|10|10.0||||||
3776654|NCT01896544|3608616|B2|No||30 day readmission||participants|Number|8|8.0||||||
3776655|NCT01896544|3608617|B1|No||30 day readmission||participants|Number|10|10.0||||||
3776656|NCT01896544|3608614|B4|Day 1 LL-37 (ng/mL)||Day 1 data: 25 hydroxyvitaminD(25OHD),bioavailable 25 hydroxyvitamin D(B25OHD), cathelicidin (LL-37)||ng/mL|Median|52|52.0|Inter-Quartile Range|||43.0|59.0|
3776657|NCT01896544|3608615|B3|Day 1 LL-37 (ng/mL)||Day 1 data: 25 hydroxyvitaminD(25OHD),bioavailable 25 hydroxyvitamin D(B25OHD), cathelicidin (LL-37)||ng/mL|Median|52|52.0|Inter-Quartile Range|||48.0|59.0|
3776658|NCT01896544|3608616|B2|Day 1 LL-37 (ng/mL)||Day 1 data: 25 hydroxyvitaminD(25OHD),bioavailable 25 hydroxyvitamin D(B25OHD), cathelicidin (LL-37)||ng/mL|Median|53|53.0|Inter-Quartile Range|||43.0|62.0|
3776659|NCT01896544|3608617|B1|Day 1 LL-37 (ng/mL)||Day 1 data: 25 hydroxyvitaminD(25OHD),bioavailable 25 hydroxyvitamin D(B25OHD), cathelicidin (LL-37)||ng/mL|Median|51|51.0|Inter-Quartile Range|||41.0|52.0|
3776660|NCT01896544|3608614|B4|Day 1 B25OHD (ng/mL)||Day 1 data: 25 hydroxyvitaminD(25OHD),bioavailable 25 hydroxyvitamin D(B25OHD), cathelicidin (LL-37)||ng/mL|Median|1.9|1.9|Inter-Quartile Range|||1.2|2.1|
3776661|NCT01896544|3608615|B3|Day 1 B25OHD (ng/mL)||Day 1 data: 25 hydroxyvitaminD(25OHD),bioavailable 25 hydroxyvitamin D(B25OHD), cathelicidin (LL-37)||ng/mL|Median|1.9|1.9|Inter-Quartile Range|||1.2|2.5|
3776662|NCT01896544|3608616|B2|Day 1 B25OHD (ng/mL)||Day 1 data: 25 hydroxyvitaminD(25OHD),bioavailable 25 hydroxyvitamin D(B25OHD), cathelicidin (LL-37)||ng/mL|Median|1.4|1.4|Inter-Quartile Range|||0.8|2.1|
3776663|NCT01896544|3608617|B1|Day 1 B25OHD (ng/mL)||Day 1 data: 25 hydroxyvitaminD(25OHD),bioavailable 25 hydroxyvitamin D(B25OHD), cathelicidin (LL-37)||ng/mL|Median|2.5|2.5|Inter-Quartile Range|||1.7|2.9|
3776664|NCT01896544|3608614|B4|Day 1 25OHD (ng/mL)||Day 1 data: 25 hydroxyvitaminD(25OHD),bioavailable 25 hydroxyvitamin D(B25OHD), cathelicidin (LL-37)||ng/mL|Median|17|17.0|Inter-Quartile Range|||13.0|22.0|
3776665|NCT01896544|3608615|B3|Day 1 25OHD (ng/mL)||Day 1 data: 25 hydroxyvitaminD(25OHD),bioavailable 25 hydroxyvitamin D(B25OHD), cathelicidin (LL-37)||ng/mL|Median|15|15.0|Inter-Quartile Range|||12.0|20.0|
3776666|NCT01896544|3608616|B2|Day 1 25OHD (ng/mL)||Day 1 data: 25 hydroxyvitaminD(25OHD),bioavailable 25 hydroxyvitamin D(B25OHD), cathelicidin (LL-37)||ng/mL|Median|19|19.0|Inter-Quartile Range|||13.0|22.0|
3776667|NCT01896544|3608617|B1|Day 1 25OHD (ng/mL)||Day 1 data: 25 hydroxyvitaminD(25OHD),bioavailable 25 hydroxyvitamin D(B25OHD), cathelicidin (LL-37)||ng/mL|Median|17|17.0|Inter-Quartile Range|||13.0|25.0|
3776668|NCT01896544|3608614|B4|Urinary||Positive culture|Totals do not equal 100% since some patients had more than one location where a positive culture was obtained.|percentage|Number|30|30.0||||||
3776669|NCT01896544|3608615|B3|Urinary||Positive culture|Totals do not equal 100% since some patients had more than one location where a positive culture was obtained.|percentage|Number|10|10.0||||||
3776670|NCT01896544|3608616|B2|Urinary||Positive culture|Totals do not equal 100% since some patients had more than one location where a positive culture was obtained.|percentage|Number|10|10.0||||||
3776671|NCT01896544|3608617|B1|Urinary||Positive culture|Totals do not equal 100% since some patients had more than one location where a positive culture was obtained.|percentage|Number|10|10.0||||||
3776672|NCT01896544|3608614|B4|Blood stream||Positive culture|Totals do not equal 100% since some patients had more than one location where a positive culture was obtained.|percentage|Number|190|190.0||||||
3776673|NCT01896544|3608615|B3|Blood stream||Positive culture|Totals do not equal 100% since some patients had more than one location where a positive culture was obtained.|percentage|Number|60|60.0||||||
3776674|NCT01896544|3608616|B2|Blood stream||Positive culture|Totals do not equal 100% since some patients had more than one location where a positive culture was obtained.|percentage|Number|60|60.0||||||
3776675|NCT01896544|3608617|B1|Blood stream||Positive culture|Totals do not equal 100% since some patients had more than one location where a positive culture was obtained.|percentage|Number|70|70.0||||||
3776676|NCT01896544|3608614|B4|Pulmonary||Positive culture|Totals do not equal 100% since some patients had more than one location where a positive culture was obtained.|percentage|Number|130|130.0||||||
3776721|NCT01896232|3608644|B3|||Corrected Calcium||mg/dL|Mean|9.62|9.62|Standard Deviation|0.69|0.69|||
3776677|NCT01896544|3608615|B3|Pulmonary||Positive culture|Totals do not equal 100% since some patients had more than one location where a positive culture was obtained.|percentage|Number|50|50.0||||||
3776678|NCT01896544|3608616|B2|Pulmonary||Positive culture|Totals do not equal 100% since some patients had more than one location where a positive culture was obtained.|percentage|Number|40|40.0||||||
3776679|NCT01896544|3608617|B1|Pulmonary||Positive culture|Totals do not equal 100% since some patients had more than one location where a positive culture was obtained.|percentage|Number|40|40.0||||||
3776680|NCT01896544|3608614|B4|surgical||Intensive Care Unit (ICU) type||participants|Number|14|14.0||||||
3776681|NCT01896544|3608615|B3|surgical||Intensive Care Unit (ICU) type||participants|Number|5|5.0||||||
3776682|NCT01896544|3608616|B2|surgical||Intensive Care Unit (ICU) type||participants|Number|4|4.0||||||
3776683|NCT01896544|3608617|B1|surgical||Intensive Care Unit (ICU) type||participants|Number|5|5.0||||||
3776684|NCT01896544|3608614|B4|medical||Intensive Care Unit (ICU) type||participants|Number|16|16.0||||||
3776685|NCT01896544|3608615|B3|medical||Intensive Care Unit (ICU) type||participants|Number|5|5.0||||||
3776686|NCT01896544|3608616|B2|medical||Intensive Care Unit (ICU) type||participants|Number|6|6.0||||||
3776687|NCT01896544|3608617|B1|medical||Intensive Care Unit (ICU) type||participants|Number|5|5.0||||||
3776688|NCT01896544|3608614|B4|||Acute Physiology and Chronic Health Evaluation II (APACHE II) score|The APACHE II score is a severity-of-disease classification used in the intensive care unit. The APACHEII score is calculated within within 24 hours of admission. Higher scores correspond with more severe disease and therefore increased risk of death. The score ranges from 0-71 points.|scores on a scale|Median|22|22.0|Inter-Quartile Range|||16.0|28.0|
3776689|NCT01896544|3608615|B3|||Acute Physiology and Chronic Health Evaluation II (APACHE II) score|The APACHE II score is a severity-of-disease classification used in the intensive care unit. The APACHEII score is calculated within within 24 hours of admission. Higher scores correspond with more severe disease and therefore increased risk of death. The score ranges from 0-71 points.|scores on a scale|Median|21|21.0|Inter-Quartile Range|||19.0|32.0|
3776690|NCT01896544|3608616|B2|||Acute Physiology and Chronic Health Evaluation II (APACHE II) score|The APACHE II score is a severity-of-disease classification used in the intensive care unit. The APACHEII score is calculated within within 24 hours of admission. Higher scores correspond with more severe disease and therefore increased risk of death. The score ranges from 0-71 points.|scores on a scale|Median|22|22.0|Inter-Quartile Range|||16.0|28.0|
3776691|NCT01896544|3608617|B1|||Acute Physiology and Chronic Health Evaluation II (APACHE II) score|The APACHE II score is a severity-of-disease classification used in the intensive care unit. The APACHEII score is calculated within within 24 hours of admission. Higher scores correspond with more severe disease and therefore increased risk of death. The score ranges from 0-71 points.|scores on a scale|Median|23|23.0|Inter-Quartile Range|||16.0|25.0|
3776692|NCT01896544|3608614|B4|||Body mass index||kg/m^2|Median|28|28.0|Inter-Quartile Range|||27.0|33.0|
3776693|NCT01896544|3608615|B3|||Body mass index||kg/m^2|Median|28|28.0|Inter-Quartile Range|||27.0|33.0|
3776694|NCT01896544|3608616|B2|||Body mass index||kg/m^2|Median|28|28.0|Inter-Quartile Range|||26.0|35.0|
3776695|NCT01896544|3608617|B1|||Body mass index||kg/m^2|Median|30|30.0|Inter-Quartile Range|||28.0|37.0|
3776696|NCT01896544|3608614|B4|United States||Region of Enrollment||participants|Number|30|30.0||||||
3776697|NCT01896544|3608615|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3776698|NCT01896544|3608616|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3776699|NCT01896544|3608617|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3776700|NCT01896544|3608614|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3776701|NCT01896544|3608615|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3776702|NCT01896544|3608616|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3776703|NCT01896544|3608617|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3776704|NCT01896544|3608614|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3776705|NCT01896544|3608615|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3776706|NCT01896544|3608616|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3776707|NCT01896544|3608617|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3776708|NCT01896544|3608614|B4|||Age||years|Median|64|64.0|Inter-Quartile Range|||58.0|67.0|
3776709|NCT01896544|3608615|B3|||Age||years|Median|64|64.0|Inter-Quartile Range|||55.0|66.0|
3776710|NCT01896544|3608616|B2|||Age||years|Median|65|65.0|Inter-Quartile Range|||58.0|70.0|
3776711|NCT01896544|3608617|B1|||Age||years|Median|62|62.0|Inter-Quartile Range|||59.0|67.0|
3776712|NCT01896297|3608639|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3776713|NCT01896297|3608639|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3776714|NCT01896297|3608639|B1|||Age||Years|Mean|83.35|83.35|Standard Deviation|7.55|7.55|||
3776715|NCT01896232|3608644|B3|||Corrected Calcium Phosphorus Product (cCa x P)|Data available for 341 and 337 participants in each treatment group respectively.|mg²/dL²|Mean|56.00|56.0|Standard Deviation|16.27|16.27|||
3776716|NCT01896232|3608645|B2|||Corrected Calcium Phosphorus Product (cCa x P)|Data available for 341 and 337 participants in each treatment group respectively.|mg²/dL²|Mean|56.36|56.36|Standard Deviation|17.15|17.15|||
3776717|NCT01896232|3608646|B1|||Corrected Calcium Phosphorus Product (cCa x P)|Data available for 341 and 337 participants in each treatment group respectively.|mg²/dL²|Mean|55.65|55.65|Standard Deviation|15.37|15.37|||
3776718|NCT01896232|3608644|B3|||Phosphorus|Data available for 341 and 337 participants in each treatment group respectively.|mg/dL|Mean|5.81|5.81|Standard Deviation|1.63|1.63|||
3776719|NCT01896232|3608645|B2|||Phosphorus|Data available for 341 and 337 participants in each treatment group respectively.|mg/dL|Mean|5.81|5.81|Standard Deviation|1.69|1.69|||
3776720|NCT01896232|3608646|B1|||Phosphorus|Data available for 341 and 337 participants in each treatment group respectively.|mg/dL|Mean|5.82|5.82|Standard Deviation|1.58|1.58|||
3776722|NCT01896232|3608645|B2|||Corrected Calcium||mg/dL|Mean|9.67|9.67|Standard Deviation|0.71|0.71|||
3776723|NCT01896232|3608646|B1|||Corrected Calcium||mg/dL|Mean|9.58|9.58|Standard Deviation|0.67|0.67|||
3776724|NCT01896232|3608644|B3|||Parathyroid Hormone||pg/mL|Mean|1115.52|1115.52|Standard Deviation|666.22|666.22|||
3776725|NCT01896232|3608645|B2|||Parathyroid Hormone||pg/mL|Mean|1092.12|1092.12|Standard Deviation|622.81|622.81|||
3776726|NCT01896232|3608646|B1|||Parathyroid Hormone||pg/mL|Mean|1138.71|1138.71|Standard Deviation|706.77|706.77|||
3776727|NCT01896232|3608644|B3|Non-North America||Stratification Factor: Region||participants|Number|475|475.0||||||
3776728|NCT01896232|3608645|B2|Non-North America||Stratification Factor: Region||participants|Number|237|237.0||||||
3776729|NCT01896232|3608646|B1|Non-North America||Stratification Factor: Region||participants|Number|238|238.0||||||
3776730|NCT01896232|3608644|B3|North America||Stratification Factor: Region||participants|Number|208|208.0||||||
3776731|NCT01896232|3608645|B2|North America||Stratification Factor: Region||participants|Number|103|103.0||||||
3776732|NCT01896232|3608646|B1|North America||Stratification Factor: Region||participants|Number|105|105.0||||||
3776733|NCT01896232|3608644|B3|≥ 900 pg/mL||Stratification Factor: Screening Serum Parathyroid Hormone (PTH)||participants|Number|343|343.0||||||
3776734|NCT01896232|3608645|B2|≥ 900 pg/mL||Stratification Factor: Screening Serum Parathyroid Hormone (PTH)||participants|Number|171|171.0||||||
3776735|NCT01896232|3608646|B1|≥ 900 pg/mL||Stratification Factor: Screening Serum Parathyroid Hormone (PTH)||participants|Number|172|172.0||||||
3776736|NCT01896232|3608644|B3|< 900 pg/mL||Stratification Factor: Screening Serum Parathyroid Hormone (PTH)||participants|Number|340|340.0||||||
3776737|NCT01896232|3608645|B2|< 900 pg/mL||Stratification Factor: Screening Serum Parathyroid Hormone (PTH)||participants|Number|169|169.0||||||
3776738|NCT01896232|3608646|B1|< 900 pg/mL||Stratification Factor: Screening Serum Parathyroid Hormone (PTH)||participants|Number|171|171.0||||||
3776739|NCT01896232|3608644|B3|Not Hispanic/Latino||Ethnicity||participants|Number|604|604.0||||||
3776740|NCT01896232|3608645|B2|Not Hispanic/Latino||Ethnicity||participants|Number|302|302.0||||||
3776741|NCT01896232|3608646|B1|Not Hispanic/Latino||Ethnicity||participants|Number|302|302.0||||||
3776742|NCT01896232|3608644|B3|Hispanic/Latino||Ethnicity||participants|Number|79|79.0||||||
3776743|NCT01896232|3608645|B2|Hispanic/Latino||Ethnicity||participants|Number|38|38.0||||||
3776744|NCT01896232|3608646|B1|Hispanic/Latino||Ethnicity||participants|Number|41|41.0||||||
3776745|NCT01896232|3608644|B3|Other||Race||participants|Number|14|14.0||||||
3776746|NCT01896232|3608645|B2|Other||Race||participants|Number|10|10.0||||||
3776747|NCT01896232|3608646|B1|Other||Race||participants|Number|4|4.0||||||
3776748|NCT01896232|3608644|B3|White||Race||participants|Number|538|538.0||||||
3776749|NCT01896232|3608645|B2|White||Race||participants|Number|261|261.0||||||
3776750|NCT01896232|3608646|B1|White||Race||participants|Number|277|277.0||||||
3776751|NCT01896232|3608644|B3|Native Hawaiian or Other Pacific Islander||Race||participants|Number|9|9.0||||||
3776752|NCT01896232|3608645|B2|Native Hawaiian or Other Pacific Islander||Race||participants|Number|6|6.0||||||
3776753|NCT01896232|3608646|B1|Native Hawaiian or Other Pacific Islander||Race||participants|Number|3|3.0||||||
3776754|NCT01896232|3608644|B3|Black||Race||participants|Number|106|106.0||||||
3776755|NCT01896232|3608645|B2|Black||Race||participants|Number|54|54.0||||||
3776756|NCT01896232|3608646|B1|Black||Race||participants|Number|52|52.0||||||
3776757|NCT01896232|3608644|B3|Asian||Race||participants|Number|16|16.0||||||
3776758|NCT01896232|3608645|B2|Asian||Race||participants|Number|9|9.0||||||
3776759|NCT01896232|3608646|B1|Asian||Race||participants|Number|7|7.0||||||
3776760|NCT01896232|3608644|B3||Male|Sex: Female, Male||Participants|Count of Participants|384|384.0||||||
3776761|NCT01896232|3608645|B2||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
3776762|NCT01896232|3608646|B1||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
3776763|NCT01896232|3608644|B3||Female|Sex: Female, Male||Participants|Count of Participants|299|299.0||||||
3776764|NCT01896232|3608645|B2||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3776765|NCT01896232|3608646|B1||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3776766|NCT01896232|3608644|B3|≥ 65 years||Age, Customized||participants|Number|178|178.0||||||
3776767|NCT01896232|3608645|B2|≥ 65 years||Age, Customized||participants|Number|78|78.0||||||
3776768|NCT01896232|3608646|B1|≥ 65 years||Age, Customized||participants|Number|100|100.0||||||
3776769|NCT01896232|3608644|B3|< 65 years||Age, Customized||participants|Number|505|505.0||||||
3776770|NCT01896232|3608645|B2|< 65 years||Age, Customized||participants|Number|262|262.0||||||
3776771|NCT01896232|3608646|B1|< 65 years||Age, Customized||participants|Number|243|243.0||||||
3776772|NCT01896232|3608644|B3|||Age||years|Mean|54.7|54.7|Standard Deviation|14.1|14.1|||
3776773|NCT01896232|3608645|B2|||Age||years|Mean|54.0|54.0|Standard Deviation|13.8|13.8|||
3776774|NCT01896232|3608646|B1|||Age||years|Mean|55.3|55.3|Standard Deviation|14.4|14.4|||
3776775|NCT01896206|3608667|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3776776|NCT01896206|3608667|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3776777|NCT01896206|3608667|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3776778|NCT01896206|3608667|B1|||Age||years|Mean|17.55|17.55|Standard Deviation|2.53|2.53|||
3776779|NCT01896206|3608667|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3776780|NCT01896206|3608667|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3776781|NCT01896206|3608667|B1||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
3776782|NCT01896193|3608671|B5|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|84|84.0||||||
3776783|NCT01896193|3608672|B4|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|21|21.0||||||
3776784|NCT01896193|3608673|B3|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|20|20.0||||||
3776785|NCT01896193|3608674|B2|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|23|23.0||||||
3776786|NCT01896193|3608675|B1|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|20|20.0||||||
3776787|NCT01896193|3608671|B5|< 800,000 IU/mL||HCV RNA Category||participants|Number|43|43.0||||||
3776788|NCT01896193|3608672|B4|< 800,000 IU/mL||HCV RNA Category||participants|Number|10|10.0||||||
3776789|NCT01896193|3608673|B3|< 800,000 IU/mL||HCV RNA Category||participants|Number|10|10.0||||||
3776790|NCT01896193|3608674|B2|< 800,000 IU/mL||HCV RNA Category||participants|Number|11|11.0||||||
3776791|NCT01896193|3608675|B1|< 800,000 IU/mL||HCV RNA Category||participants|Number|12|12.0||||||
3776792|NCT01896193|3608671|B5|||HCV RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.69|0.69|||
3776793|NCT01896193|3608672|B4|||HCV RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.77|0.77|||
3776794|NCT01896193|3608673|B3|||HCV RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.81|0.81|||
3776795|NCT01896193|3608674|B2|||HCV RNA||log10 IU/mL|Mean|6.1|6.1|Standard Deviation|0.60|0.6|||
3776796|NCT01896193|3608675|B1|||HCV RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.60|0.6|||
3776797|NCT01896193|3608671|B5|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|11|11.0||||||
3776798|NCT01896193|3608672|B4|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3776799|NCT01896193|3608673|B3|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|2|2.0||||||
3776800|NCT01896193|3608674|B2|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|5|5.0||||||
3776801|NCT01896193|3608675|B1|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
3776802|NCT01896193|3608671|B5|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|73|73.0||||||
3776803|NCT01896193|3608672|B4|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|15|15.0||||||
3776804|NCT01896193|3608673|B3|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|16|16.0||||||
3776805|NCT01896193|3608674|B2|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|23|23.0||||||
3776806|NCT01896193|3608675|B1|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|19|19.0||||||
3776807|NCT01896193|3608671|B5|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|43|43.0||||||
3776808|NCT01896193|3608672|B4|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|15|15.0||||||
3776809|NCT01896193|3608673|B3|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|12|12.0||||||
3776810|NCT01896193|3608674|B2|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|6|6.0||||||
3776811|NCT01896193|3608675|B1|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|10|10.0||||||
3776812|NCT01896193|3608671|B5|Missing||Cirrhosis Status||participants|Number|1|1.0||||||
3776813|NCT01896193|3608672|B4|Missing||Cirrhosis Status||participants|Number|0|0.0||||||
3776814|NCT01896193|3608673|B3|Missing||Cirrhosis Status||participants|Number|1|1.0||||||
3776815|NCT01896193|3608674|B2|Missing||Cirrhosis Status||participants|Number|0|0.0||||||
3776816|NCT01896193|3608675|B1|Missing||Cirrhosis Status||participants|Number|0|0.0||||||
3776817|NCT01896193|3608671|B5|Yes||Cirrhosis Status||participants|Number|21|21.0||||||
3776818|NCT01896193|3608672|B4|Yes||Cirrhosis Status||participants|Number|5|5.0||||||
3776819|NCT01896193|3608673|B3|Yes||Cirrhosis Status||participants|Number|6|6.0||||||
3776820|NCT01896193|3608674|B2|Yes||Cirrhosis Status||participants|Number|6|6.0||||||
3776821|NCT01896193|3608675|B1|Yes||Cirrhosis Status||participants|Number|4|4.0||||||
3776822|NCT01896193|3608671|B5|No||Cirrhosis Status||participants|Number|105|105.0||||||
3776823|NCT01896193|3608672|B4|No||Cirrhosis Status||participants|Number|26|26.0||||||
3776824|NCT01896193|3608673|B3|No||Cirrhosis Status||participants|Number|23|23.0||||||
3776825|NCT01896193|3608674|B2|No||Cirrhosis Status||participants|Number|28|28.0||||||
3776826|NCT01896193|3608675|B1|No||Cirrhosis Status||participants|Number|28|28.0||||||
3776827|NCT01896193|3608671|B5|White||Race/Ethnicity, Customized||participants|Number|127|127.0||||||
3776828|NCT01896193|3608672|B4|White||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3776829|NCT01896193|3608673|B3|White||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3776830|NCT01896193|3608674|B2|White||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
3776831|NCT01896193|3608675|B1|White||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3776832|NCT01896193|3608671|B5||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3776833|NCT01896193|3608672|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3776834|NCT01896193|3608673|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3776835|NCT01896193|3608674|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3776836|NCT01896193|3608675|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3776837|NCT01896193|3608671|B5||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3776838|NCT01896193|3608672|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3776839|NCT01896193|3608673|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3776840|NCT01896193|3608674|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3776841|NCT01896193|3608675|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3776842|NCT01896193|3608671|B5|||Age||years|Mean|40|40.0|Standard Deviation|10.3|10.3|||
3776843|NCT01896193|3608672|B4|||Age||years|Mean|40|40.0|Standard Deviation|9.6|9.6|||
3776844|NCT01896193|3608673|B3|||Age||years|Mean|38|38.0|Standard Deviation|8.2|8.2|||
3776845|NCT01896193|3608674|B2|||Age||years|Mean|42|42.0|Standard Deviation|9.8|9.8|||
3776846|NCT01896193|3608675|B1|||Age||years|Mean|41|41.0|Standard Deviation|12.8|12.8|||
3776847|NCT01896115|3608700|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3776848|NCT01896115|3608701|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3776849|NCT01896115|3608702|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3776850|NCT01896115|3608700|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3776851|NCT01896115|3608701|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3776852|NCT01896115|3608702|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3776853|NCT01896115|3608700|B3|||Age||years|Mean|56.5|56.5|Standard Deviation|8.09|8.09|||
3776854|NCT01896115|3608701|B2|||Age||years|Mean|54.0|54.0|Standard Deviation|8.43|8.43|||
3776855|NCT01896115|3608702|B1|||Age||years|Mean|58.9|58.9|Standard Deviation|7.73|7.73|||
3776856|NCT01896050|3608726|B3|||Average pain|Patients reported pain on a 0-10 visual analog scale, with 0 being no pain and 10 being worst pain imaginable.|units on a scale|Mean|2.3|2.3|Standard Deviation|2.1|2.1|||
3776857|NCT01896050|3608727|B2|||Average pain|Patients reported pain on a 0-10 visual analog scale, with 0 being no pain and 10 being worst pain imaginable.|units on a scale|Mean|2.4|2.4|Standard Deviation|1.9|1.9|||
3776858|NCT01896050|3608728|B1|||Average pain|Patients reported pain on a 0-10 visual analog scale, with 0 being no pain and 10 being worst pain imaginable.|units on a scale|Mean|2.3|2.3|Standard Deviation|2.1|2.1|||
3776859|NCT01896050|3608726|B3|||Maximum grip strength, left hand||kPa|Mean|54.6|54.6|Standard Deviation|10.8|10.8|||
3776860|NCT01896050|3608727|B2|||Maximum grip strength, left hand||kPa|Mean|53.7|53.7|Standard Deviation|10.7|10.7|||
3776861|NCT01896050|3608728|B1|||Maximum grip strength, left hand||kPa|Mean|54.8|54.8|Standard Deviation|10.9|10.9|||
3776862|NCT01896050|3608726|B3|||Maximum grip strength, right hand||kPa|Mean|57.3|57.3|Standard Deviation|11.5|11.5|||
3776863|NCT01896050|3608727|B2|||Maximum grip strength, right hand||kPa|Mean|56.4|56.4|Standard Deviation|10.9|10.9|||
3776864|NCT01896050|3608728|B1|||Maximum grip strength, right hand||kPa|Mean|57.5|57.5|Standard Deviation|11.7|11.7|||
3776865|NCT01896050|3608726|B3|||Waist-hip ratio||ratio|Mean|0.91|0.91|Standard Deviation|0.09|0.09|||
3776866|NCT01896050|3608727|B2|||Waist-hip ratio||ratio|Mean|0.92|0.92|Standard Deviation|0.12|0.12|||
3776867|NCT01896050|3608728|B1|||Waist-hip ratio||ratio|Mean|0.91|0.91|Standard Deviation|0.09|0.09|||
3776868|NCT01896050|3608726|B3|||Body-mass index||kg/m^2|Mean|30.1|30.1|Standard Deviation|7.1|7.1|||
3776869|NCT01896050|3608727|B2|||Body-mass index||kg/m^2|Mean|29|29.0|Standard Deviation|7|7.0|||
3776870|NCT01896050|3608728|B1|||Body-mass index||kg/m^2|Mean|30.4|30.4|Standard Deviation|7.1|7.1|||
3776871|NCT01896050|3608726|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3776872|NCT01896050|3608727|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3776873|NCT01896050|3608728|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3776874|NCT01896050|3608726|B3||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3776875|NCT01896050|3608727|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3776876|NCT01896050|3608728|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3776877|NCT01896050|3608726|B3|||Age||years|Median|62|62.0|Full Range|||41.0|79.0|
3776878|NCT01896050|3608727|B2|||Age||years|Median|61.5|61.5|Full Range|||44.0|69.0|
3776879|NCT01896050|3608728|B1|||Age||years|Median|62|62.0|Full Range|||41.0|79.0|
3776880|NCT01895972|3608739|B1|Japan||Region of Enrollment||Participants|Count of Participants|130|130.0||||||
3776881|NCT01895972|3608739|B1|Japanese||Race/Ethnicity, Customized||Participants|Count of Participants|130|130.0||||||
3776882|NCT01895972|3608739|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776883|NCT01895972|3608739|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
3776884|NCT01895972|3608739|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776885|NCT01895972|3608739|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3776886|NCT01895972|3608739|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3776887|NCT01895972|3608739|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|10.87|10.87|||
3776888|NCT01895946|3608744|B3||Male|Sex: Female, Male|Gender, Male/Femelle|Participants|Count of Participants|15|15.0||||||
3776889|NCT01895946|3608745|B2||Male|Sex: Female, Male|Gender, Male/Femelle|Participants|Count of Participants|5|5.0||||||
3776890|NCT01895946|3608746|B1||Male|Sex: Female, Male|Gender, Male/Femelle|Participants|Count of Participants|10|10.0||||||
3776891|NCT01895946|3608744|B3||Female|Sex: Female, Male|Gender, Male/Femelle|Participants|Count of Participants|15|15.0||||||
3776892|NCT01895946|3608745|B2||Female|Sex: Female, Male|Gender, Male/Femelle|Participants|Count of Participants|7|7.0||||||
3776893|NCT01895946|3608746|B1||Female|Sex: Female, Male|Gender, Male/Femelle|Participants|Count of Participants|8|8.0||||||
3776894|NCT01895946|3608744|B3|>=65 years||Age, Customized|Age group, customized|Participants|Number|10|10.0||||||
3776895|NCT01895946|3608745|B2|>=65 years||Age, Customized|Age group, customized|Participants|Number|5|5.0||||||
3776896|NCT01895946|3608746|B1|>=65 years||Age, Customized|Age group, customized|Participants|Number|5|5.0||||||
3776897|NCT01895946|3608744|B3|Between 50 and 65 years||Age, Customized|Age group, customized|Participants|Number|15|15.0||||||
3776898|NCT01895946|3608745|B2|Between 50 and 65 years||Age, Customized|Age group, customized|Participants|Number|6|6.0||||||
3776899|NCT01895946|3608746|B1|Between 50 and 65 years||Age, Customized|Age group, customized|Participants|Number|9|9.0||||||
3776900|NCT01895946|3608744|B3|<50 years||Age, Customized|Age group, customized|Participants|Number|5|5.0||||||
3776901|NCT01895946|3608745|B2|<50 years||Age, Customized|Age group, customized|Participants|Number|1|1.0||||||
3776902|NCT01895946|3608746|B1|<50 years||Age, Customized|Age group, customized|Participants|Number|4|4.0||||||
3776903|NCT01895634|3608765|B1|Japan||Region of Enrollment||participants|Number|49|49.0||||||
3776904|NCT01895634|3608765|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3776905|NCT01895634|3608765|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3776906|NCT01895634|3608765|B1|||Age||years|Mean|70.6|70.6|Standard Deviation|10.7|10.7|||
3776907|NCT01895608|3608773|B5|United States||Region of Enrollment||participants|Number|34|34.0||||||
3776908|NCT01895608|3608774|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
3776909|NCT01895608|3608775|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3776910|NCT01895608|3608776|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3776911|NCT01895608|3608777|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3776912|NCT01895608|3608773|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776913|NCT01895608|3608774|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776914|NCT01895608|3608775|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776915|NCT01895608|3608776|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776916|NCT01895608|3608777|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776917|NCT01895608|3608773|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776918|NCT01895608|3608774|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776919|NCT01895608|3608775|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776920|NCT01895608|3608776|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776921|NCT01895608|3608777|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776922|NCT01895608|3608773|B5||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3776923|NCT01895608|3608774|B4||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3776924|NCT01895608|3608775|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3776925|NCT01895608|3608776|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3776926|NCT01895608|3608777|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3776927|NCT01895608|3608773|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3776928|NCT01895608|3608774|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776929|NCT01895608|3608775|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3776930|NCT01895608|3608776|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3776931|NCT01895608|3608777|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3776932|NCT01895608|3608773|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776933|NCT01895608|3608774|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776934|NCT01895608|3608775|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776935|NCT01895608|3608776|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776936|NCT01895608|3608777|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776937|NCT01895608|3608773|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3776938|NCT01895608|3608774|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3776939|NCT01895608|3608775|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776940|NCT01895608|3608776|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776941|NCT01895608|3608777|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3776942|NCT01895608|3608773|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776943|NCT01895608|3608774|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776944|NCT01895608|3608775|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776945|NCT01895608|3608776|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776946|NCT01895608|3608777|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776947|NCT01895608|3608773|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776948|NCT01895608|3608774|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776949|NCT01895608|3608775|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776950|NCT01895608|3608776|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776951|NCT01895608|3608777|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776952|NCT01895608|3608773|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3776953|NCT01895608|3608774|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3776954|NCT01895608|3608775|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3777016|NCT01895452|3608826|B1|South Korea||Region of Enrollment||participants|Number|0|0.0||||||
3776955|NCT01895608|3608776|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3776956|NCT01895608|3608777|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3776957|NCT01895608|3608773|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776958|NCT01895608|3608774|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776959|NCT01895608|3608775|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776960|NCT01895608|3608776|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776961|NCT01895608|3608777|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776962|NCT01895608|3608773|B5||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3776963|NCT01895608|3608774|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3776964|NCT01895608|3608775|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3776965|NCT01895608|3608776|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3776966|NCT01895608|3608777|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3776967|NCT01895608|3608773|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3776968|NCT01895608|3608774|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3776969|NCT01895608|3608775|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3776970|NCT01895608|3608776|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3776971|NCT01895608|3608777|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3776972|NCT01895608|3608773|B5|||Age||years|Mean|79.0|79.0|Standard Deviation|8.2|8.2|||
3776973|NCT01895608|3608774|B4|||Age||years|Mean|80.7|80.7|Standard Deviation|11.1|11.1|||
3776974|NCT01895608|3608775|B3|||Age||years|Mean|78.1|78.1|Standard Deviation|6.7|6.7|||
3776975|NCT01895608|3608776|B2|||Age||years|Mean|81.9|81.9|Standard Deviation|7.9|7.9|||
3776976|NCT01895608|3608777|B1|||Age||years|Mean|77.0|77.0|Standard Deviation|8.3|8.3|||
3776977|NCT01895543|3608810|B1|||Body Mass Index (BMI)||Kg/m^2|Mean|26.87|26.87|Standard Deviation|4.284|4.284|||
3776978|NCT01895543|3608810|B1|||Weight||Kilogram (Kg)|Mean|73.61|73.61|Standard Deviation|14.159|14.159|||
3776979|NCT01895543|3608810|B1|||Height||Meters (m)|Mean|1.654|1.654|Standard Deviation|0.0834|0.0834|||
3776980|NCT01895543|3608810|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776981|NCT01895543|3608810|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3776982|NCT01895543|3608810|B1||White|Race (NIH/OMB)||Participants|Count of Participants|324|324.0||||||
3776983|NCT01895543|3608810|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3776984|NCT01895543|3608810|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3776985|NCT01895543|3608810|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3776986|NCT01895543|3608810|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3776987|NCT01895543|3608810|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3776988|NCT01895543|3608810|B1||Female|Sex: Female, Male||Participants|Count of Participants|351|351.0||||||
3776989|NCT01895543|3608810|B1|||Age||Years|Mean|48.6|48.6|Standard Deviation|14.13|14.13|||
3776990|NCT01895543|3608810|B1||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
3776991|NCT01895543|3608810|B1||Between 18 and 65 years|Age||Participants|Count of Participants|362|362.0||||||
3776992|NCT01895543|3608810|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3776993|NCT01895452|3608824|B3|Russia||Region of Enrollment||participants|Number|63|63.0||||||
3776994|NCT01895452|3608825|B2|Russia||Region of Enrollment||participants|Number|48|48.0||||||
3776995|NCT01895452|3608826|B1|Russia||Region of Enrollment||participants|Number|15|15.0||||||
3776996|NCT01895452|3608824|B3|Bulgaria||Region of Enrollment||participants|Number|45|45.0||||||
3776997|NCT01895452|3608825|B2|Bulgaria||Region of Enrollment||participants|Number|32|32.0||||||
3776998|NCT01895452|3608826|B1|Bulgaria||Region of Enrollment||participants|Number|13|13.0||||||
3776999|NCT01895452|3608824|B3|Malaysia||Region of Enrollment||participants|Number|18|18.0||||||
3777000|NCT01895452|3608825|B2|Malaysia||Region of Enrollment||participants|Number|17|17.0||||||
3777001|NCT01895452|3608826|B1|Malaysia||Region of Enrollment||participants|Number|1|1.0||||||
3777002|NCT01895452|3608824|B3|Ukraine||Region of Enrollment||participants|Number|79|79.0||||||
3777003|NCT01895452|3608825|B2|Ukraine||Region of Enrollment||participants|Number|64|64.0||||||
3777004|NCT01895452|3608826|B1|Ukraine||Region of Enrollment||participants|Number|15|15.0||||||
3777005|NCT01895452|3608824|B3|Philippines||Region of Enrollment||participants|Number|42|42.0||||||
3777006|NCT01895452|3608825|B2|Philippines||Region of Enrollment||participants|Number|27|27.0||||||
3777007|NCT01895452|3608826|B1|Philippines||Region of Enrollment||participants|Number|15|15.0||||||
3777008|NCT01895452|3608824|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
3777009|NCT01895452|3608825|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
3777010|NCT01895452|3608826|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3777011|NCT01895452|3608824|B3|Romania||Region of Enrollment||participants|Number|3|3.0||||||
3777012|NCT01895452|3608825|B2|Romania||Region of Enrollment||participants|Number|1|1.0||||||
3777013|NCT01895452|3608826|B1|Romania||Region of Enrollment||participants|Number|2|2.0||||||
3777014|NCT01895452|3608824|B3|South Korea||Region of Enrollment||participants|Number|5|5.0||||||
3777015|NCT01895452|3608825|B2|South Korea||Region of Enrollment||participants|Number|5|5.0||||||
3777017|NCT01895452|3608824|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777018|NCT01895452|3608825|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777019|NCT01895452|3608826|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777020|NCT01895452|3608824|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777021|NCT01895452|3608825|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777022|NCT01895452|3608826|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777023|NCT01895452|3608824|B3||White|Race (NIH/OMB)||Participants|Count of Participants|204|204.0||||||
3777024|NCT01895452|3608825|B2||White|Race (NIH/OMB)||Participants|Count of Participants|157|157.0||||||
3777025|NCT01895452|3608826|B1||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3777026|NCT01895452|3608824|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3777027|NCT01895452|3608825|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3777028|NCT01895452|3608826|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3777029|NCT01895452|3608824|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777030|NCT01895452|3608825|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777031|NCT01895452|3608826|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777032|NCT01895452|3608824|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3777033|NCT01895452|3608825|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3777034|NCT01895452|3608826|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3777035|NCT01895452|3608824|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777036|NCT01895452|3608825|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777037|NCT01895452|3608826|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777038|NCT01895452|3608824|B3||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3777039|NCT01895452|3608825|B2||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3777040|NCT01895452|3608826|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3777041|NCT01895452|3608824|B3||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3777042|NCT01895452|3608825|B2||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3777043|NCT01895452|3608826|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3777044|NCT01895452|3608824|B3|||Age||years|Mean|39.6|39.6|Standard Deviation|11.47|11.47|||
3777045|NCT01895452|3608825|B2|||Age||years|Mean|40.1|40.1|Standard Deviation|11.59|11.59|||
3777046|NCT01895452|3608826|B1|||Age||years|Mean|38.0|38.0|Standard Deviation|11.02|11.02|||
3777047|NCT01895335|3608837|B1||Male|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
3777048|NCT01895335|3608837|B1||Female|Sex: Female, Male||Participants|Count of Participants|756|756.0||||||
3777049|NCT01895335|3608837|B1|||Age||years|Mean|47.1|47.1|Standard Deviation|11.0|11.0|||
3777050|NCT01895322|3608854|B1|Japan||Region of Enrollment||participants|Number|20|20.0||||||
3777051|NCT01895322|3608854|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3777052|NCT01895322|3608854|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3777053|NCT01895322|3608854|B1|||Age||years|Mean|65.1|65.1|Standard Deviation|10.9|10.9|||
3777054|NCT01895322|3608854|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3777055|NCT01895322|3608854|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3777056|NCT01895322|3608854|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3777057|NCT01895309|3608861|B3||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3777058|NCT01895309|3608862|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3777059|NCT01895309|3608863|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3777060|NCT01895309|3608861|B3||Female|Sex: Female, Male||Participants|Count of Participants|502|502.0||||||
3777061|NCT01895309|3608862|B2||Female|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
3777062|NCT01895309|3608863|B1||Female|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
3777063|NCT01895309|3608861|B3|||Age||years|Mean|51.8|51.8|Standard Deviation|11.67|11.67|||
3777064|NCT01895309|3608862|B2|||Age||years|Mean|51.6|51.6|Standard Deviation|11.63|11.63|||
3777065|NCT01895309|3608863|B1|||Age||years|Mean|52.1|52.1|Standard Deviation|11.72|11.72|||
3777066|NCT01895270|3608876|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
3777067|NCT01895270|3608877|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3777068|NCT01895270|3608878|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3777069|NCT01895270|3608876|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777070|NCT01895270|3608877|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777071|NCT01895270|3608878|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777072|NCT01895270|3608876|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777073|NCT01895270|3608877|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777074|NCT01895270|3608878|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777075|NCT01895270|3608876|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3777076|NCT01895270|3608877|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3777077|NCT01895270|3608878|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3777078|NCT01895270|3608876|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777079|NCT01895270|3608877|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777080|NCT01895270|3608878|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777081|NCT01895270|3608876|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777082|NCT01895270|3608877|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777083|NCT01895270|3608878|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777084|NCT01895270|3608876|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777085|NCT01895270|3608877|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777086|NCT01895270|3608878|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777087|NCT01895270|3608876|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777088|NCT01895270|3608877|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777089|NCT01895270|3608878|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777090|NCT01895270|3608876|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777091|NCT01895270|3608877|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777092|NCT01895270|3608878|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777093|NCT01895270|3608876|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3777094|NCT01895270|3608877|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3777095|NCT01895270|3608878|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3777096|NCT01895270|3608876|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777097|NCT01895270|3608877|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777098|NCT01895270|3608878|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777099|NCT01895270|3608876|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3777100|NCT01895270|3608877|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3777101|NCT01895270|3608878|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3777102|NCT01895270|3608876|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3777103|NCT01895270|3608877|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3777104|NCT01895270|3608878|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3777105|NCT01895270|3608876|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3777106|NCT01895270|3608877|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3777107|NCT01895270|3608878|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3777108|NCT01895270|3608876|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3777109|NCT01895270|3608877|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3777110|NCT01895270|3608878|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3777111|NCT01895270|3608876|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3777112|NCT01895270|3608877|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3777113|NCT01895270|3608878|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3777114|NCT01895127|3608885|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3777115|NCT01895127|3608886|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3777116|NCT01895127|3608887|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3777117|NCT01895127|3608885|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3777118|NCT01895127|3608886|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3777119|NCT01895127|3608887|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3777120|NCT01895127|3608885|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3777121|NCT01895127|3608886|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3777122|NCT01895127|3608887|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3777123|NCT01895127|3608885|B3|||Age||years|Mean|43.27|43.27|Full Range|||24.0|61.0|
3777124|NCT01895127|3608886|B2|||Age||years|Mean|43.29|43.29|Full Range|||30.0|59.0|
3777125|NCT01895127|3608887|B1|||Age||years|Mean|43.25|43.25|Full Range|||24.0|61.0|
3777126|NCT01895127|3608885|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3777127|NCT01895127|3608886|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3777128|NCT01895127|3608887|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3777129|NCT01895127|3608885|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3777130|NCT01895127|3608886|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3777131|NCT01895127|3608887|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3777132|NCT01895127|3608885|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3777133|NCT01895127|3608886|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3777134|NCT01895127|3608887|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3777135|NCT01895101|3608895|B4|Netherlands||Region of Enrollment||participants|Number|739|739.0||||||
3777136|NCT01895101|3608896|B3|Netherlands||Region of Enrollment||participants|Number|245|245.0||||||
3777137|NCT01895101|3608897|B2|Netherlands||Region of Enrollment||participants|Number|245|245.0||||||
3777138|NCT01895101|3608898|B1|Netherlands||Region of Enrollment||participants|Number|249|249.0||||||
3777139|NCT01895101|3608895|B4||Male|Sex: Female, Male||Participants|Count of Participants|580|580.0||||||
3777140|NCT01895101|3608896|B3||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
3777141|NCT01895101|3608897|B2||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3777142|NCT01895101|3608898|B1||Male|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
3777143|NCT01895101|3608895|B4||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
3777144|NCT01895101|3608896|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3777145|NCT01895101|3608897|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3777146|NCT01895101|3608898|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3777147|NCT01895101|3608895|B4|||Age||years|Median|69|69.0|Inter-Quartile Range|||62.0|75.0|
3777148|NCT01895101|3608896|B3|||Age||years|Median|69|69.0|Inter-Quartile Range|||62.0|75.0|
3777149|NCT01895101|3608897|B2|||Age||years|Median|68|68.0|Inter-Quartile Range|||63.0|76.0|
3777150|NCT01895101|3608898|B1|||Age||years|Median|68|68.0|Inter-Quartile Range|||62.0|75.0|
3777151|NCT01895088|3608914|B1|United States||Region of Enrollment||participants|Number|271|271.0||||||
3777152|NCT01895088|3608914|B1||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3777153|NCT01895088|3608914|B1||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3777154|NCT01895088|3608914|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3777155|NCT01895088|3608914|B1||Between 18 and 65 years|Age||Participants|Count of Participants|271|271.0||||||
3777156|NCT01895088|3608914|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3777157|NCT01895062|3608918|B3|||History of sleep apnea|history of sleep apnea as reported by the study participant|participants|Number|4|4.0||||||
3777158|NCT01895062|3608919|B2|||History of sleep apnea|history of sleep apnea as reported by the study participant|participants|Number|2|2.0||||||
3777159|NCT01895062|3608920|B1|||History of sleep apnea|history of sleep apnea as reported by the study participant|participants|Number|2|2.0||||||
3777160|NCT01895062|3608918|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
3777161|NCT01895062|3608919|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
3777162|NCT01895062|3608920|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3777163|NCT01895062|3608918|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3777164|NCT01895062|3608919|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3777165|NCT01895062|3608920|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3777166|NCT01895062|3608918|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3777167|NCT01895062|3608919|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3777168|NCT01895062|3608920|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3777169|NCT01895062|3608918|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3777170|NCT01895062|3608919|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3777171|NCT01895062|3608920|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3777172|NCT01895062|3608918|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3777173|NCT01895062|3608919|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3777174|NCT01895062|3608920|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3777175|NCT01895062|3608918|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3777176|NCT01895062|3608919|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3777177|NCT01895062|3608920|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3777178|NCT01895062|3608918|B3|||Age||years|Mean|60|60.0|Full Range|||33.0|78.0|
3777179|NCT01895062|3608919|B2|||Age||years|Mean|60|60.0|Full Range|||34.0|77.0|
3777180|NCT01895062|3608920|B1|||Age||years|Mean|60|60.0|Full Range|||33.0|78.0|
3777181|NCT01895036|3608929|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3777182|NCT01895036|3608929|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3777183|NCT01895036|3608929|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3777184|NCT01895036|3608929|B1|||Age||years|Mean|38.2|38.2|Standard Deviation|16.3|16.3|||
3777185|NCT01895036|3608929|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3777186|NCT01895036|3608929|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3777187|NCT01895036|3608929|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3777188|NCT01894984|3608933|B3||Male|Sex: Female, Male||Participants|Count of Participants|313|313.0||||||
3777189|NCT01894984|3608934|B2||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3777190|NCT01894984|3608935|B1||Male|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
3777191|NCT01894984|3608933|B3||Female|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
3777192|NCT01894984|3608934|B2||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3777193|NCT01894984|3608935|B1||Female|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
3777194|NCT01894984|3608933|B3|||Age|Age is provided for 395 participants in Risperidone treatment group because complete date of birth detail is not available for one participant.|Years|Mean|29.2|29.2|Standard Deviation|10.57|10.57|||
3777195|NCT01894984|3608934|B2|||Age|Age is provided for 395 participants in Risperidone treatment group because complete date of birth detail is not available for one participant.|Years|Mean|32.2|32.2|Standard Deviation|11.62|11.62|||
3777196|NCT01894984|3608935|B1|||Age|Age is provided for 395 participants in Risperidone treatment group because complete date of birth detail is not available for one participant.|Years|Mean|27.4|27.4|Standard Deviation|9.44|9.44|||
3777197|NCT01894919|3608952|B14||Male|Sex: Female, Male||Participants|Count of Participants|429|429.0||||||
3777198|NCT01894919|3608953|B13||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3777199|NCT01894919|3608954|B12||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3777200|NCT01894919|3608955|B11||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3777201|NCT01894919|3608956|B10||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3777202|NCT01894919|3608957|B9||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3777203|NCT01894919|3608958|B8||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3777204|NCT01894919|3608959|B7||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3777205|NCT01894919|3608960|B6||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3777206|NCT01894919|3608961|B5||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3777207|NCT01894919|3608962|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3777208|NCT01894919|3608963|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3777209|NCT01894919|3608964|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3777210|NCT01894919|3608965|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3777211|NCT01894919|3608952|B14||Female|Sex: Female, Male||Participants|Count of Participants|422|422.0||||||
3777212|NCT01894919|3608953|B13||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3777213|NCT01894919|3608954|B12||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3777214|NCT01894919|3608955|B11||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3777215|NCT01894919|3608956|B10||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3777216|NCT01894919|3608957|B9||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3777217|NCT01894919|3608958|B8||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3777218|NCT01894919|3608959|B7||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3777219|NCT01894919|3608960|B6||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3777220|NCT01894919|3608961|B5||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3777221|NCT01894919|3608962|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3777222|NCT01894919|3608963|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3777223|NCT01894919|3608964|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3777224|NCT01894919|3608965|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3777225|NCT01894919|3608952|B14|||Age||Years|Mean|5.6|5.6|Standard Deviation|3.20|3.2|||
3777226|NCT01894919|3608953|B13|||Age||Years|Mean|9.7|9.7|Standard Deviation|1.38|1.38|||
3777227|NCT01894919|3608954|B12|||Age||Years|Mean|5.8|5.8|Standard Deviation|1.12|1.12|||
3777228|NCT01894919|3608955|B11|||Age||Years|Mean|3.4|3.4|Standard Deviation|0.29|0.29|||
3777229|NCT01894919|3608956|B10|||Age||Years|Mean|10.4|10.4|Standard Deviation|1.44|1.44|||
3777230|NCT01894919|3608957|B9|||Age||Years|Mean|10.4|10.4|Standard Deviation|1.43|1.43|||
3777231|NCT01894919|3608958|B8|||Age||Years|Mean|6.7|6.7|Standard Deviation|1.16|1.16|||
3777232|NCT01894919|3608959|B7|||Age||Years|Mean|6.5|6.5|Standard Deviation|1.15|1.15|||
3777233|NCT01894919|3608960|B6|||Age||Years|Mean|3.2|3.2|Standard Deviation|0.26|0.26|||
3777234|NCT01894919|3608961|B5|||Age||Years|Mean|3.2|3.2|Standard Deviation|0.29|0.29|||
3777235|NCT01894919|3608962|B4|||Age||Years|Mean|3.1|3.1|Standard Deviation|0.22|0.22|||
3777236|NCT01894919|3608963|B3|||Age||Years|Mean|3.1|3.1|Standard Deviation|0.23|0.23|||
3777237|NCT01894919|3608964|B2|||Age||Years|Mean|3|3.0|Standard Deviation|0.18|0.18|||
3777238|NCT01894919|3608965|B1|||Age||Years|Mean|3.1|3.1|Standard Deviation|0.2|0.2|||
3777239|NCT01894906|3609097|B3|||BMI||kg/m^2|Mean|27.378|27.378|Standard Deviation|6.1888|6.1888|||
3777240|NCT01894906|3609098|B2|||BMI||kg/m^2|Mean|28.332|28.332|Standard Deviation|6.6425|6.6425|||
3777241|NCT01894906|3609099|B1|||BMI||kg/m^2|Mean|26.425|26.425|Standard Deviation|6.1611|6.1611|||
3777242|NCT01894906|3609097|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3777243|NCT01894906|3609098|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3777244|NCT01894906|3609099|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3777245|NCT01894906|3609097|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777246|NCT01894906|3609098|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777247|NCT01894906|3609099|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777248|NCT01894906|3609097|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777249|NCT01894906|3609098|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777250|NCT01894906|3609099|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777251|NCT01894906|3609097|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3777252|NCT01894906|3609098|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777253|NCT01894906|3609099|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3777314|NCT01894607|3609147|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3777254|NCT01894906|3609097|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3777255|NCT01894906|3609098|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3777256|NCT01894906|3609099|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3777257|NCT01894906|3609097|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777258|NCT01894906|3609098|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777259|NCT01894906|3609099|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777260|NCT01894906|3609097|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777261|NCT01894906|3609098|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777262|NCT01894906|3609099|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777263|NCT01894906|3609097|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777264|NCT01894906|3609098|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777265|NCT01894906|3609099|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777266|NCT01894906|3609097|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777267|NCT01894906|3609098|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777268|NCT01894906|3609099|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777269|NCT01894906|3609097|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3777270|NCT01894906|3609098|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3777271|NCT01894906|3609099|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3777272|NCT01894906|3609097|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777273|NCT01894906|3609098|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777274|NCT01894906|3609099|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777275|NCT01894906|3609097|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3777276|NCT01894906|3609098|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3777277|NCT01894906|3609099|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3777278|NCT01894906|3609097|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3777279|NCT01894906|3609098|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3777280|NCT01894906|3609099|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3777281|NCT01894906|3609097|B3|||Age||years|Mean|52.3|52.3|Standard Deviation|11.61|11.61|||
3777282|NCT01894906|3609098|B2|||Age||years|Mean|52.8|52.8|Standard Deviation|8.89|8.89|||
3777283|NCT01894906|3609099|B1|||Age||years|Mean|51.8|51.8|Standard Deviation|14.73|14.73|||
3777284|NCT01894672|3609130|B1|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3777285|NCT01894672|3609130|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3777286|NCT01894672|3609130|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3777287|NCT01894672|3609130|B1|||Age||years|Median|58|58.0|Full Range|||53.0|75.0|
3777288|NCT01894672|3609130|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3777289|NCT01894672|3609130|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3777290|NCT01894672|3609130|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3777291|NCT01894620|3609136|B3|Canada||Region of Enrollment||participants|Number|11|11.0||||||
3777292|NCT01894620|3609137|B2|Canada||Region of Enrollment||participants|Number|5|5.0||||||
3777293|NCT01894620|3609138|B1|Canada||Region of Enrollment||participants|Number|6|6.0||||||
3777294|NCT01894620|3609136|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3777295|NCT01894620|3609137|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3777296|NCT01894620|3609138|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3777297|NCT01894620|3609136|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3777298|NCT01894620|3609137|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3777299|NCT01894620|3609138|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3777300|NCT01894620|3609136|B3|||Age||years|Mean|68.60|68.6|Standard Deviation|9.67|9.67|||
3777301|NCT01894620|3609137|B2|||Age||years|Mean|68.25|68.25|Standard Deviation|9.88|9.88|||
3777302|NCT01894620|3609138|B1|||Age||years|Mean|68.83|68.83|Standard Deviation|10.48|10.48|||
3777303|NCT01894620|3609136|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3777304|NCT01894620|3609137|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3777305|NCT01894620|3609138|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3777306|NCT01894620|3609136|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3777307|NCT01894620|3609137|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3777308|NCT01894620|3609138|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3777309|NCT01894620|3609136|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3777310|NCT01894620|3609137|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3777311|NCT01894620|3609138|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3777312|NCT01894607|3609147|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3777313|NCT01894607|3609147|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3777315|NCT01894607|3609147|B1|||Age||years|Median|52|52.0|Full Range|||29.0|76.0|
3777316|NCT01894581|3609152|B3|||BMI||kg/m^2|Mean|31.6|31.6|Standard Deviation|9.1|9.1|||
3777317|NCT01894581|3609153|B2|||BMI||kg/m^2|Mean|21.8|21.8|Standard Deviation|.5|0.5|||
3777318|NCT01894581|3609154|B1|||BMI||kg/m^2|Mean|37.8|37.8|Standard Deviation|1.5|1.5|||
3777319|NCT01894581|3609152|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
3777320|NCT01894581|3609153|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3777321|NCT01894581|3609154|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3777322|NCT01894581|3609152|B3|Male||Sex/Gender, Customized||participants|Number|0|0.0||||||
3777323|NCT01894581|3609153|B2|Male||Sex/Gender, Customized||participants|Number|0|0.0||||||
3777324|NCT01894581|3609154|B1|Male||Sex/Gender, Customized||participants|Number|0|0.0||||||
3777325|NCT01894581|3609152|B3|Female||Sex/Gender, Customized||participants|Number|27|27.0||||||
3777326|NCT01894581|3609153|B2|Female||Sex/Gender, Customized||participants|Number|12|12.0||||||
3777327|NCT01894581|3609154|B1|Female||Sex/Gender, Customized||participants|Number|15|15.0||||||
3777328|NCT01894581|3609152|B3|||Age||years|Mean|31.6|31.6|Standard Deviation|5.3|5.3|||
3777329|NCT01894581|3609153|B2|||Age||years|Mean|28.4|28.4|Standard Deviation|1.2|1.2|||
3777330|NCT01894581|3609154|B1|||Age||years|Mean|34.8|34.8|Standard Deviation|1.2|1.2|||
3777331|NCT01894555|3609161|B1|Caucasians||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3777332|NCT01894555|3609161|B1|African Americans||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3777333|NCT01894555|3609161|B1||Male|Gender||Participants|Count of Participants|18|18.0||||||
3777334|NCT01894555|3609161|B1||Female|Gender||Participants|Count of Participants|15|15.0||||||
3777335|NCT01894555|3609161|B1|||Age||years|Mean|50.6|50.6|Standard Deviation|8.0|8.0|||
3777336|NCT01894503|3609165|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777337|NCT01894503|3609165|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777338|NCT01894503|3609165|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3777339|NCT01894503|3609165|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777340|NCT01894503|3609165|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777341|NCT01894503|3609165|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777342|NCT01894503|3609165|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777343|NCT01894503|3609165|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777344|NCT01894503|3609165|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3777345|NCT01894503|3609165|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777346|NCT01894503|3609165|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3777347|NCT01894503|3609165|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3777348|NCT01894503|3609165|B1|||Age||years|Mean|46.2|46.2|Full Range|||37.0|58.0|
3777349|NCT01894477|3609170|B3|Samoa||Region of Enrollment||participants|Number|1|1.0||||||
3777350|NCT01894477|3609171|B2|Samoa||Region of Enrollment||participants|Number|1|1.0||||||
3777351|NCT01894477|3609172|B1|Samoa||Region of Enrollment||participants|Number|0|0.0||||||
3777352|NCT01894477|3609170|B3|Indonesia||Region of Enrollment||participants|Number|1|1.0||||||
3777353|NCT01894477|3609171|B2|Indonesia||Region of Enrollment||participants|Number|1|1.0||||||
3777354|NCT01894477|3609172|B1|Indonesia||Region of Enrollment||participants|Number|0|0.0||||||
3777355|NCT01894477|3609170|B3|United States||Region of Enrollment||participants|Number|98|98.0||||||
3777356|NCT01894477|3609171|B2|United States||Region of Enrollment||participants|Number|63|63.0||||||
3777357|NCT01894477|3609172|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3777358|NCT01894477|3609170|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777359|NCT01894477|3609171|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777360|NCT01894477|3609172|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777361|NCT01894477|3609170|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777362|NCT01894477|3609171|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777363|NCT01894477|3609172|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777364|NCT01894477|3609170|B3||White|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3777365|NCT01894477|3609171|B2||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3777366|NCT01894477|3609172|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3777367|NCT01894477|3609170|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777368|NCT01894477|3609171|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777369|NCT01894477|3609172|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777370|NCT01894477|3609170|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3777371|NCT01894477|3609171|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777372|NCT01894477|3609172|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777373|NCT01894477|3609170|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3777374|NCT01894477|3609171|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3777375|NCT01894477|3609172|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3777376|NCT01894477|3609170|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3777377|NCT01894477|3609171|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777378|NCT01894477|3609172|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777379|NCT01894477|3609170|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777380|NCT01894477|3609171|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777381|NCT01894477|3609172|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777382|NCT01894477|3609170|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
3777383|NCT01894477|3609171|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3777384|NCT01894477|3609172|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3777385|NCT01894477|3609170|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3777386|NCT01894477|3609171|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3777387|NCT01894477|3609172|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777388|NCT01894477|3609170|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3777389|NCT01894477|3609171|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3777390|NCT01894477|3609172|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3777391|NCT01894477|3609170|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3777392|NCT01894477|3609171|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3777393|NCT01894477|3609172|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3777394|NCT01894477|3609170|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3777395|NCT01894477|3609171|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3777396|NCT01894477|3609172|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3777397|NCT01894477|3609170|B3||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
3777398|NCT01894477|3609171|B2||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
3777399|NCT01894477|3609172|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3777400|NCT01894477|3609170|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3777401|NCT01894477|3609171|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3777402|NCT01894477|3609172|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3777403|NCT01894256|3609181|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777404|NCT01894256|3609182|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777405|NCT01894256|3609183|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777406|NCT01894256|3609184|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777407|NCT01894256|3609181|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777408|NCT01894256|3609182|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777409|NCT01894256|3609183|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777410|NCT01894256|3609184|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777411|NCT01894256|3609181|B4||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3777412|NCT01894256|3609182|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3777413|NCT01894256|3609183|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3777414|NCT01894256|3609184|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3777415|NCT01894256|3609181|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777416|NCT01894256|3609182|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777417|NCT01894256|3609183|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777418|NCT01894256|3609184|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777419|NCT01894256|3609181|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777420|NCT01894256|3609182|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777421|NCT01894256|3609183|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777422|NCT01894256|3609184|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777423|NCT01894256|3609181|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777424|NCT01894256|3609182|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777425|NCT01894256|3609183|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777426|NCT01894256|3609184|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777427|NCT01894256|3609181|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777428|NCT01894256|3609182|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777429|NCT01894256|3609183|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777430|NCT01894256|3609184|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777431|NCT01894256|3609181|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777432|NCT01894256|3609182|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777433|NCT01894256|3609183|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777434|NCT01894256|3609184|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777435|NCT01894256|3609181|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3777436|NCT01894256|3609182|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3777437|NCT01894256|3609183|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3777438|NCT01894256|3609184|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3777439|NCT01894256|3609181|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777440|NCT01894256|3609182|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777441|NCT01894256|3609183|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777442|NCT01894256|3609184|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777443|NCT01894256|3609181|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3777444|NCT01894256|3609182|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3777445|NCT01894256|3609183|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3777446|NCT01894256|3609184|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3777447|NCT01894256|3609181|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3777448|NCT01894256|3609182|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3777449|NCT01894256|3609183|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3777450|NCT01894256|3609184|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3777451|NCT01894256|3609181|B4|||Age||Years|Mean|61.9|61.9|Standard Deviation|10.52|10.52|||
3777452|NCT01894256|3609182|B3|||Age||Years|Mean|65.4|65.4|Standard Deviation|12.86|12.86|||
3777453|NCT01894256|3609183|B2|||Age||Years|Mean|63.5|63.5|Standard Deviation|6.92|6.92|||
3777454|NCT01894256|3609184|B1|||Age||Years|Mean|57.1|57.1|Standard Deviation|9.90|9.9|||
3777455|NCT01894230|3609230|B3|United States||Region of Enrollment||participants|Number|159|159.0||||||
3777456|NCT01894230|3609231|B2|United States||Region of Enrollment||participants|Number|76|76.0||||||
3777457|NCT01894230|3609232|B1|United States||Region of Enrollment||participants|Number|83|83.0||||||
3777458|NCT01894230|3609230|B3|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3777459|NCT01894230|3609231|B2|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3777460|NCT01894230|3609232|B1|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3777461|NCT01894230|3609230|B3|Race/Ethnicity|Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3777462|NCT01894230|3609231|B2|Race/Ethnicity|Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3777463|NCT01894230|3609232|B1|Race/Ethnicity|Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3777464|NCT01894230|3609230|B3|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|127|127.0||||||
3777465|NCT01894230|3609231|B2|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|61|61.0||||||
3777466|NCT01894230|3609232|B1|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|66|66.0||||||
3777467|NCT01894230|3609230|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3777468|NCT01894230|3609231|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3777469|NCT01894230|3609232|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3777470|NCT01894230|3609230|B3||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3777471|NCT01894230|3609231|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3777472|NCT01894230|3609232|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3777473|NCT01894230|3609230|B3|||Age||years|Mean|62.6|62.6|Standard Deviation|10.8|10.8|||
3777474|NCT01894230|3609231|B2|||Age||years|Mean|62.5|62.5|Standard Deviation|11.5|11.5|||
3777475|NCT01894230|3609232|B1|||Age||years|Mean|62.7|62.7|Standard Deviation|10.2|10.2|||
3777476|NCT01894100|3609257|B3|||single leg stance||seconds|Mean|6.1|6.1|Standard Deviation|3.8|3.8|||
3777477|NCT01894100|3609258|B2|||single leg stance||seconds|Mean|5.4|5.4|Standard Deviation|4.0|4.0|||
3777478|NCT01894100|3609259|B1|||single leg stance||seconds|Mean|6.8|6.8|Standard Deviation|3.7|3.7|||
3777479|NCT01894100|3609257|B3|||5 timed chair stands||seconds|Mean|18.7|18.7|Standard Deviation|9.6|9.6|||
3777480|NCT01894100|3609258|B2|||5 timed chair stands||seconds|Mean|18.4|18.4|Standard Deviation|8.5|8.5|||
3777481|NCT01894100|3609259|B1|||5 timed chair stands||seconds|Mean|18.9|18.9|Standard Deviation|11.0|11.0|||
3777482|NCT01894100|3609257|B3|||8 foot walk||seconds|Mean|3.7|3.7|Standard Deviation|1.0|1.0|||
3777483|NCT01894100|3609258|B2|||8 foot walk||seconds|Mean|3.8|3.8|Standard Deviation|1.1|1.1|||
3777484|NCT01894100|3609259|B1|||8 foot walk||seconds|Mean|3.5|3.5|Standard Deviation|0.9|0.9|||
3777485|NCT01894100|3609257|B3|||WOMAC Function|Possible scores range from 0-68 (no problems to extreme problems with function).|units on a scale|Mean|24.4|24.4|Standard Deviation|8.9|8.9|||
3777486|NCT01894100|3609258|B2|||WOMAC Function|Possible scores range from 0-68 (no problems to extreme problems with function).|units on a scale|Mean|25.1|25.1|Standard Deviation|9.0|9.0|||
3777487|NCT01894100|3609259|B1|||WOMAC Function|Possible scores range from 0-68 (no problems to extreme problems with function).|units on a scale|Mean|23.7|23.7|Standard Deviation|9.1|9.1|||
3777488|NCT01894100|3609257|B3|||WOMAC Stiffness|Possible score range from 0-8 (no stiffness to extreme stiffness)|units on a scale|Mean|3.4|3.4|Standard Deviation|1.3|1.3|||
3777489|NCT01894100|3609258|B2|||WOMAC Stiffness|Possible score range from 0-8 (no stiffness to extreme stiffness)|units on a scale|Mean|3.8|3.8|Standard Deviation|0.8|0.8|||
3777490|NCT01894100|3609259|B1|||WOMAC Stiffness|Possible score range from 0-8 (no stiffness to extreme stiffness)|units on a scale|Mean|3.1|3.1|Standard Deviation|1.6|1.6|||
3777491|NCT01894100|3609257|B3|||WOMAC Pain|Possible scores range from 0-20 (no pain to extreme pain)|units on a scale|Mean|8.4|8.4|Standard Deviation|2.5|2.5|||
3777492|NCT01894100|3609258|B2|||WOMAC Pain|Possible scores range from 0-20 (no pain to extreme pain)|units on a scale|Mean|8.7|8.7|Standard Deviation|2.5|2.5|||
3777493|NCT01894100|3609259|B1|||WOMAC Pain|Possible scores range from 0-20 (no pain to extreme pain)|units on a scale|Mean|8.0|8.0|Standard Deviation|2.5|2.5|||
3777494|NCT01894100|3609257|B3|||Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Total Score|Possible scores range from 0-96 (no problems to extreme problems)|units on a scale|Mean|36.2|36.2|Standard Deviation|8.4|8.4|||
3777495|NCT01894100|3609258|B2|||Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Total Score|Possible scores range from 0-96 (no problems to extreme problems)|units on a scale|Mean|37.7|37.7|Standard Deviation|11.1|11.1|||
3777496|NCT01894100|3609259|B1|||Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Total Score|Possible scores range from 0-96 (no problems to extreme problems)|units on a scale|Mean|34.8|34.8|Standard Deviation|11.4|11.4|||
3777497|NCT01894100|3609257|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3777498|NCT01894100|3609258|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3777499|NCT01894100|3609259|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3777500|NCT01894100|3609257|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777501|NCT01894100|3609258|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777502|NCT01894100|3609259|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777503|NCT01894100|3609257|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777504|NCT01894100|3609258|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777505|NCT01894100|3609259|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777506|NCT01894100|3609257|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3777507|NCT01894100|3609258|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3777508|NCT01894100|3609259|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3777509|NCT01894100|3609257|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3777510|NCT01894100|3609258|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3777511|NCT01894100|3609259|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3777512|NCT01894100|3609257|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777513|NCT01894100|3609258|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777514|NCT01894100|3609259|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777515|NCT01894100|3609257|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777516|NCT01894100|3609258|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777517|NCT01894100|3609259|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777518|NCT01894100|3609257|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777519|NCT01894100|3609258|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777520|NCT01894100|3609259|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777521|NCT01894100|3609257|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3777522|NCT01894100|3609258|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3777523|NCT01894100|3609259|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3777524|NCT01894100|3609257|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3777525|NCT01894100|3609258|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3777526|NCT01894100|3609259|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3777527|NCT01894100|3609257|B3|||Age||years|Mean|73|73.0|Standard Deviation|8|8.0|||
3777528|NCT01894100|3609258|B2|||Age||years|Mean|70|70.0|Standard Deviation|8|8.0|||
3777529|NCT01894100|3609259|B1|||Age||years|Mean|73|73.0|Standard Deviation|8|8.0|||
3777530|NCT01894087|3609268|B3|United States||Region of Enrollment||Participants|Count of Participants|204|204.0||||||
3777531|NCT01894087|3609269|B2|United States||Region of Enrollment||Participants|Count of Participants|102|102.0||||||
3777532|NCT01894087|3609270|B1|United States||Region of Enrollment||Participants|Count of Participants|102|102.0||||||
3777533|NCT01894087|3609268|B3|Other/Missing/More than 1||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3777534|NCT01894087|3609269|B2|Other/Missing/More than 1||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3777535|NCT01894087|3609270|B1|Other/Missing/More than 1||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3777536|NCT01894087|3609268|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
3777537|NCT01894087|3609269|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3777538|NCT01894087|3609270|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3777539|NCT01894087|3609268|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|148|148.0||||||
3777540|NCT01894087|3609269|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|79|79.0||||||
3777541|NCT01894087|3609270|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|69|69.0||||||
3777542|NCT01894087|3609268|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3777543|NCT01894087|3609269|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3777544|NCT01894087|3609270|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3777545|NCT01894087|3609268|B3||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3777546|NCT01894087|3609269|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3777547|NCT01894087|3609270|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3777548|NCT01894087|3609268|B3|||Age||years|Mean|36.8|36.8|Standard Deviation|11.1|11.1|||
3777549|NCT01894087|3609269|B2|||Age||years|Mean|36.1|36.1|Standard Deviation|10.9|10.9|||
3777550|NCT01894087|3609270|B1|||Age||years|Mean|37.5|37.5|Standard Deviation|11.4|11.4|||
3777551|NCT01894022|3609283|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
3777552|NCT01894022|3609284|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3777553|NCT01894022|3609285|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3777554|NCT01894022|3609283|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3777555|NCT01894022|3609284|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3777556|NCT01894022|3609285|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3777557|NCT01894022|3609283|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3777558|NCT01894022|3609284|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3777559|NCT01894022|3609285|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3777560|NCT01894022|3609283|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3777561|NCT01894022|3609284|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3777562|NCT01894022|3609285|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3777563|NCT01894022|3609283|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3777564|NCT01894022|3609284|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3777565|NCT01894022|3609285|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3777566|NCT01894022|3609283|B3|||Age||Years|Median|63.0|63.0|Inter-Quartile Range|10.06|10.06|54.0|69.0|
3777567|NCT01894022|3609284|B2|||Age||Years|Median|61.0|61.0|Inter-Quartile Range|11.71|11.71|47.0|66.0|
3777568|NCT01894022|3609285|B1|||Age||Years|Median|63.0|63.0|Inter-Quartile Range|7.99|7.99|58.0|69.0|
3777569|NCT01893905|3609338|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3777570|NCT01893905|3609339|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3777571|NCT01893905|3609340|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3777572|NCT01893905|3609338|B3||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3777573|NCT01893905|3609339|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3777574|NCT01893905|3609340|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3777575|NCT01893905|3609338|B3|||Age||years|Mean|66.53|66.53|Standard Deviation|8.58|8.58|||
3777576|NCT01893905|3609339|B2|||Age||years|Mean|67.60|67.6|Standard Deviation|8.90|8.9|||
3777577|NCT01893905|3609340|B1|||Age||years|Mean|65.49|65.49|Standard Deviation|8.17|8.17|||
3777578|NCT01893879|3609347|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
3777579|NCT01893879|3609348|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3777580|NCT01893879|3609349|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3777581|NCT01893879|3609347|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3777582|NCT01893879|3609348|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3777583|NCT01893879|3609349|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3777584|NCT01893879|3609347|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3777585|NCT01893879|3609348|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3777586|NCT01893879|3609349|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3777587|NCT01893879|3609347|B3|||Age||years|Mean|45.2|45.2|Standard Deviation|8.3|8.3|||
3777588|NCT01893879|3609348|B2|||Age||years|Mean|45.5|45.5|Standard Deviation|10.1|10.1|||
3777589|NCT01893879|3609349|B1|||Age||years|Mean|44.8|44.8|Standard Deviation|6.0|6.0|||
3777590|NCT01893632|3609356|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777591|NCT01893632|3609357|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777592|NCT01893632|3609358|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777593|NCT01893632|3609356|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777594|NCT01893632|3609357|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777595|NCT01893632|3609358|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777596|NCT01893632|3609356|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777597|NCT01893632|3609357|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777598|NCT01893632|3609358|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777599|NCT01893632|3609356|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777600|NCT01893632|3609357|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777601|NCT01893632|3609358|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777602|NCT01893632|3609356|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777603|NCT01893632|3609357|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777604|NCT01893632|3609358|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777605|NCT01893632|3609356|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777606|NCT01893632|3609357|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777607|NCT01893632|3609358|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777608|NCT01893632|3609356|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777609|NCT01893632|3609357|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777610|NCT01893632|3609358|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777611|NCT01893632|3609356|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777612|NCT01893632|3609357|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777613|NCT01893632|3609358|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777614|NCT01893632|3609356|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777615|NCT01893632|3609357|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777616|NCT01893632|3609358|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777617|NCT01893632|3609356|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777618|NCT01893632|3609357|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777619|NCT01893632|3609358|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777620|NCT01893632|3609356|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3777621|NCT01893632|3609357|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3777622|NCT01893632|3609358|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3777623|NCT01893632|3609356|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3777624|NCT01893632|3609357|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3777625|NCT01893632|3609358|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3777626|NCT01893632|3609356|B3|||Age||years|Mean|59|59.0|Standard Deviation|0|0.0|||
3777627|NCT01893632|3609357|B2|||Age||years|Mean|59|59.0|Standard Deviation|0|0.0|||
3777628|NCT01893632|3609358|B1|||Age||years|Mean|59|59.0|Standard Deviation|0|0.0|||
3777629|NCT01893567|3609365|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
3777630|NCT01893567|3609365|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3777631|NCT01893567|3609365|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3777632|NCT01893567|3609365|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|12.8|12.8|||
3777633|NCT01893411|3609369|B4||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3777634|NCT01893411|3609370|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3777635|NCT01893411|3609371|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3777636|NCT01893411|3609372|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3777637|NCT01893411|3609369|B4||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3777638|NCT01893411|3609370|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3777639|NCT01893411|3609371|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3777640|NCT01893411|3609372|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3777641|NCT01893411|3609369|B4|||Age||years|Mean|6.6|6.6|Standard Deviation|4.1|4.1|||
3777642|NCT01893411|3609370|B3|||Age||years|Mean|7.1|7.1|Standard Deviation|4.6|4.6|||
3777643|NCT01893411|3609371|B2|||Age||years|Mean|6.6|6.6|Standard Deviation|3.8|3.8|||
3777644|NCT01893411|3609372|B1|||Age||years|Mean|6.4|6.4|Standard Deviation|3.9|3.9|||
3777645|NCT01893411|3609369|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3777646|NCT01893411|3609370|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3777647|NCT01893411|3609371|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3777648|NCT01893411|3609372|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3777649|NCT01893411|3609369|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3777650|NCT01893411|3609370|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3777651|NCT01893411|3609371|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3777652|NCT01893411|3609372|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3777653|NCT01893411|3609369|B4||<=18 years|Age||Participants|Count of Participants|311|311.0||||||
3777654|NCT01893411|3609370|B3||<=18 years|Age||Participants|Count of Participants|78|78.0||||||
3777655|NCT01893411|3609371|B2||<=18 years|Age||Participants|Count of Participants|77|77.0||||||
3777656|NCT01893411|3609372|B1||<=18 years|Age||Participants|Count of Participants|156|156.0||||||
3777657|NCT01893359|3609436|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777658|NCT01893359|3609438|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777659|NCT01893359|3609436|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777660|NCT01893359|3609438|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777661|NCT01893359|3609436|B4||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3777662|NCT01893359|3609438|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3777663|NCT01893359|3609436|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777664|NCT01893359|3609438|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777665|NCT01893359|3609436|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777666|NCT01893359|3609438|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777667|NCT01893359|3609436|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777668|NCT01893359|3609438|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777669|NCT01893359|3609436|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777670|NCT01893359|3609438|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777671|NCT01893359|3609436|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3777672|NCT01893359|3609438|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3777673|NCT01893359|3609436|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3777674|NCT01893359|3609438|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3777675|NCT01893359|3609436|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3777676|NCT01893359|3609438|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3777677|NCT01893359|3609436|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3777678|NCT01893359|3609438|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3777679|NCT01893359|3609436|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3777680|NCT01893359|3609438|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3777681|NCT01893346|3609452|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777682|NCT01893346|3609453|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777683|NCT01893346|3609454|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777684|NCT01893346|3609455|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777685|NCT01893346|3609456|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777686|NCT01893346|3609452|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777687|NCT01893346|3609453|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777688|NCT01893346|3609454|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777689|NCT01893346|3609455|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777690|NCT01893346|3609456|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777691|NCT01893346|3609452|B5||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3777692|NCT01893346|3609453|B4||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3777693|NCT01893346|3609454|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3777694|NCT01893346|3609455|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3777695|NCT01893346|3609456|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3777696|NCT01893346|3609452|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3777697|NCT01893346|3609453|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3777698|NCT01893346|3609454|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777699|NCT01893346|3609455|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3777700|NCT01893346|3609456|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777701|NCT01893346|3609452|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777702|NCT01893346|3609453|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777703|NCT01893346|3609454|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777704|NCT01893346|3609455|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777705|NCT01893346|3609456|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777706|NCT01893346|3609452|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777707|NCT01893346|3609453|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777708|NCT01893346|3609454|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777709|NCT01893346|3609455|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777710|NCT01893346|3609456|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777711|NCT01893346|3609452|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777712|NCT01893346|3609453|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777713|NCT01893346|3609454|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777714|NCT01893346|3609455|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777715|NCT01893346|3609456|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777716|NCT01893346|3609452|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777717|NCT01893346|3609453|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777718|NCT01893346|3609454|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777719|NCT01893346|3609455|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777720|NCT01893346|3609456|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777721|NCT01893346|3609452|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3777722|NCT01893346|3609453|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3777723|NCT01893346|3609454|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3777724|NCT01893346|3609455|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3777725|NCT01893346|3609456|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3777726|NCT01893346|3609452|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3777727|NCT01893346|3609453|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777728|NCT01893346|3609454|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3777729|NCT01893346|3609455|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777730|NCT01893346|3609456|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777731|NCT01893346|3609452|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3777732|NCT01893346|3609453|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3777733|NCT01893346|3609454|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3777734|NCT01893346|3609455|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3777735|NCT01893346|3609456|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3777736|NCT01893346|3609452|B5||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3777737|NCT01893346|3609453|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3777738|NCT01893346|3609454|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3777739|NCT01893346|3609455|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3777740|NCT01893346|3609456|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3777741|NCT01893346|3609452|B5|||Age||years|Mean|6.852|6.852|Standard Deviation|5.5200|5.52|||
3777742|NCT01893346|3609453|B4|||Age||years|Mean|0.924|0.924|Standard Deviation|0.5007|0.5007|||
3777743|NCT01893346|3609454|B3|||Age||years|Mean|3.519|3.519|Standard Deviation|1.0044|1.0044|||
3777744|NCT01893346|3609455|B2|||Age||years|Mean|8.020|8.02|Standard Deviation|1.4036|1.4036|||
3777745|NCT01893346|3609456|B1|||Age||years|Mean|14.945|14.945|Standard Deviation|1.5599|1.5599|||
3777746|NCT01893281|3609473|B1|United States||Region of Enrollment||participants|Number|78|78.0||||||
3777747|NCT01893281|3609473|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777748|NCT01893281|3609473|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777749|NCT01893281|3609473|B1||White|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3777750|NCT01893281|3609473|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3777751|NCT01893281|3609473|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777752|NCT01893281|3609473|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777753|NCT01893281|3609473|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777754|NCT01893281|3609473|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777755|NCT01893281|3609473|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3777756|NCT01893281|3609473|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3777757|NCT01893281|3609473|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3777758|NCT01893281|3609473|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3777759|NCT01893281|3609473|B1|||Age||years|Mean|57.3|57.3|Standard Deviation|10.93|10.93|||
3777760|NCT01893203|3609480|B1|||Number of AKs||Number of actinic keratoses (AKs)|Number|177|177.0||||||
3777761|NCT01893203|3609480|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3777762|NCT01893203|3609480|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3777763|NCT01893203|3609480|B1|||Age||years|Mean|79.8|79.8|Full Range|||66.0|88.0|
3777764|NCT01892865|3609487|B3|||Available operative days for randomization||Operative Days|Count of Units|207|207.0||||||
3777765|NCT01892865|3609488|B2|||Available operative days for randomization||Operative Days|Count of Units|100|100.0||||||
3777766|NCT01892865|3609489|B1|||Available operative days for randomization||Operative Days|Count of Units|107|107.0||||||
3777767|NCT01892865|3609487|B3|Sex|Females|Sex/Gender, Customized||Participants|Count of Participants|11|11.0||||||
3777768|NCT01892865|3609488|B2|Sex|Females|Sex/Gender, Customized||Participants|Count of Participants|6|6.0||||||
3777769|NCT01892865|3609489|B1|Sex|Females|Sex/Gender, Customized||Participants|Count of Participants|5|5.0||||||
3777770|NCT01892865|3609487|B3|Sex|Males|Sex/Gender, Customized||Participants|Count of Participants|724|724.0||||||
3777771|NCT01892865|3609488|B2|Sex|Males|Sex/Gender, Customized||Participants|Count of Participants|373|373.0||||||
3777772|NCT01892865|3609489|B1|Sex|Males|Sex/Gender, Customized||Participants|Count of Participants|351|351.0||||||
3777773|NCT01892865|3609487|B3|||Age, Customized||Years|Mean|62.5|62.5|Standard Deviation|10|10.0|||
3777774|NCT01892865|3609488|B2|||Age, Customized||Years|Mean|62.5|62.5|Standard Deviation|10|10.0|||
3777775|NCT01892865|3609489|B1|||Age, Customized||Years|Mean|62|62.0|Standard Deviation|8|8.0|||
3777776|NCT01892722|3609502|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3777777|NCT01892722|3609503|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3777778|NCT01892722|3609504|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3777779|NCT01892722|3609502|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777780|NCT01892722|3609503|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777781|NCT01892722|3609504|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777782|NCT01892722|3609502|B3||White|Race (NIH/OMB)||Participants|Count of Participants|197|197.0||||||
3777783|NCT01892722|3609503|B2||White|Race (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
3777784|NCT01892722|3609504|B1||White|Race (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3777785|NCT01892722|3609502|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3777786|NCT01892722|3609503|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3777787|NCT01892722|3609504|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777788|NCT01892722|3609502|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777789|NCT01892722|3609503|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777790|NCT01892722|3609504|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777791|NCT01892722|3609502|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777792|NCT01892722|3609503|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777793|NCT01892722|3609504|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777794|NCT01892722|3609502|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3777795|NCT01892722|3609503|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3777796|NCT01892722|3609504|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3777797|NCT01892722|3609502|B3||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3777798|NCT01892722|3609503|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3777799|NCT01892722|3609504|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3777800|NCT01892722|3609502|B3||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3777801|NCT01892722|3609503|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3777802|NCT01892722|3609504|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3777803|NCT01892722|3609502|B3|||Age||Years|Mean|15.3|15.3|Standard Deviation|1.81|1.81|||
3777804|NCT01892722|3609503|B2|||Age||Years|Mean|15.4|15.4|Standard Deviation|1.60|1.6|||
3777805|NCT01892722|3609504|B1|||Age||Years|Mean|15.2|15.2|Standard Deviation|2.0|2.0|||
3777806|NCT01892709|3609511|B1|||Nauseated or vomited before receiving first dose of opioid||Participants|Count of Participants|134|134.0||||||
3777807|NCT01892709|3609511|B1|NRS = 10||Initial NRS pain intensity|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable)"|Participants|Count of Participants|118|118.0||||||
3777808|NCT01892709|3609511|B1|NRS = 9||Initial NRS pain intensity|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable)"|Participants|Count of Participants|41|41.0||||||
3777809|NCT01892709|3609511|B1|NRS = 8||Initial NRS pain intensity|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable)"|Participants|Count of Participants|27|27.0||||||
3777810|NCT01892709|3609511|B1|NRS = 5-7||Initial NRS pain intensity|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable)"|Participants|Count of Participants|21|21.0||||||
3777811|NCT01892709|3609511|B1|Other||Location of pain||Participants|Count of Participants|9|9.0||||||
3777812|NCT01892709|3609511|B1|Extremities||Location of pain||Participants|Count of Participants|8|8.0||||||
3777813|NCT01892709|3609511|B1|Back||Location of pain||Participants|Count of Participants|15|15.0||||||
3777814|NCT01892709|3609511|B1|Flank||Location of pain||Participants|Count of Participants|22|22.0||||||
3777815|NCT01892709|3609511|B1|Abdomen/pelvis||Location of pain||Participants|Count of Participants|153|153.0||||||
3777816|NCT01892709|3609511|B1|||Weight||lbs|Mean|177|177.0|Standard Deviation|34|34.0|||
3777817|NCT01892709|3609511|B1|United States||Region of Enrollment||Participants|Count of Participants|207|207.0||||||
3777818|NCT01892709|3609511|B1|White/Other||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3777819|NCT01892709|3609511|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
3777820|NCT01892709|3609511|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|143|143.0||||||
3777821|NCT01892709|3609511|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3777822|NCT01892709|3609511|B1||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3777823|NCT01892709|3609511|B1|||Age||years|Mean|41|41.0|Standard Deviation|12|12.0|||
3777824|NCT01892657|3609521|B1|United States||Region of Enrollment||participants|Number|110|110.0||||||
3777825|NCT01892657|3609521|B1|Caucasian/Hispanic||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3777826|NCT01892657|3609521|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
3777827|NCT01892657|3609521|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|71|71.0||||||
3777828|NCT01892657|3609521|B1|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3777829|NCT01892657|3609521|B1|African American||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
3777830|NCT01892657|3609521|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3777831|NCT01892657|3609521|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3777832|NCT01892657|3609521|B1|||Age||years|Mean|44.0|44.0|Standard Deviation|13.68|13.68|||
3777833|NCT01892657|3609521|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3777834|NCT01892657|3609521|B1||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
3777835|NCT01892657|3609521|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3777836|NCT01892306|3609537|B3|||NEO Five Factor Inventory of Personality, Neuroticism Subscale (NEO-FFI-N)|Neuroticism was assessed at baseline using the NEO Five Factor Personality Inventory Neuroticism Scale (NEO-FFI-N) which is a subscale of the NEO-FFI, a 60-item scale (0-4) calculated by summing scores for each subscale. Only the 12-item Neuroticism subscale is included in this study. Higher scores indicate greater impairment.|units on a scale|Mean|5.79|5.79|Standard Deviation|1.32|1.32|||
3777837|NCT01892306|3609538|B2|||NEO Five Factor Inventory of Personality, Neuroticism Subscale (NEO-FFI-N)|Neuroticism was assessed at baseline using the NEO Five Factor Personality Inventory Neuroticism Scale (NEO-FFI-N) which is a subscale of the NEO-FFI, a 60-item scale (0-4) calculated by summing scores for each subscale. Only the 12-item Neuroticism subscale is included in this study. Higher scores indicate greater impairment.|units on a scale|Mean|5.88|5.88|Standard Deviation|1.54|1.54|||
3777838|NCT01892306|3609539|B1|||NEO Five Factor Inventory of Personality, Neuroticism Subscale (NEO-FFI-N)|Neuroticism was assessed at baseline using the NEO Five Factor Personality Inventory Neuroticism Scale (NEO-FFI-N) which is a subscale of the NEO-FFI, a 60-item scale (0-4) calculated by summing scores for each subscale. Only the 12-item Neuroticism subscale is included in this study. Higher scores indicate greater impairment.|units on a scale|Mean|5.69|5.69|Standard Deviation|1.03|1.03|||
3777839|NCT01892306|3609537|B3|||Anxiety Sensitivity Index (ASI)|Anxiety sensitivity was assessed at baseline using the self-report Anxiety Sensitivity Index questionnaire (ASI) a 16-item likert-type scale (0-4) calculated by summing scores across items (minimum score 0, maximum score 64). Higher scores indicate greater impairment.|units on a scale|Mean|29.45|29.45|Standard Deviation|12.30|12.3|||
3777840|NCT01892306|3609538|B2|||Anxiety Sensitivity Index (ASI)|Anxiety sensitivity was assessed at baseline using the self-report Anxiety Sensitivity Index questionnaire (ASI) a 16-item likert-type scale (0-4) calculated by summing scores across items (minimum score 0, maximum score 64). Higher scores indicate greater impairment.|units on a scale|Mean|26.56|26.56|Standard Deviation|13.47|13.47|||
3777841|NCT01892306|3609539|B1|||Anxiety Sensitivity Index (ASI)|Anxiety sensitivity was assessed at baseline using the self-report Anxiety Sensitivity Index questionnaire (ASI) a 16-item likert-type scale (0-4) calculated by summing scores across items (minimum score 0, maximum score 64). Higher scores indicate greater impairment.|units on a scale|Mean|33|33.0|Standard Deviation|10.07|10.07|||
3777842|NCT01892306|3609537|B3|||Affective Control Scale (ACS)|Perceived controllability of emotions was assessed at baseline using the the self-report Affective Control Scale (ACS) a 42-item Likert-type scale (1-7) calculated by averaging scores across all items (minimum score 1, maximum score 7). Higher scores indicate greater impairment and less perceived control of emotions.|units on a scale|Mean|4.36|4.36|Standard Deviation|0.61|0.61|||
3777843|NCT01892306|3609538|B2|||Affective Control Scale (ACS)|Perceived controllability of emotions was assessed at baseline using the the self-report Affective Control Scale (ACS) a 42-item Likert-type scale (1-7) calculated by averaging scores across all items (minimum score 1, maximum score 7). Higher scores indicate greater impairment and less perceived control of emotions.|units on a scale|Mean|4.24|4.24|Standard Deviation|0.53|0.53|||
3777844|NCT01892306|3609539|B1|||Affective Control Scale (ACS)|Perceived controllability of emotions was assessed at baseline using the the self-report Affective Control Scale (ACS) a 42-item Likert-type scale (1-7) calculated by averaging scores across all items (minimum score 1, maximum score 7). Higher scores indicate greater impairment and less perceived control of emotions.|units on a scale|Mean|4.48|4.48|Standard Deviation|0.70|0.7|||
3777845|NCT01892306|3609537|B3|||Difficulties in Emotion Regulation Scale (DERS)|Emotion regulation skills were assessed at baseline using a self-report questionnaire measure of emotion regulation (Difficulties in Emotion Regulation Scale- DERS), a 36-item Likert-type scale (1-6) calculated by averaging scores across all items (minimum score 1, maximum score 6). Higher scores indicate greater impairment in emotion regulation skills.|units on a scale|Mean|2.92|2.92|Standard Deviation|0.54|0.54|||
3777846|NCT01892306|3609538|B2|||Difficulties in Emotion Regulation Scale (DERS)|Emotion regulation skills were assessed at baseline using a self-report questionnaire measure of emotion regulation (Difficulties in Emotion Regulation Scale- DERS), a 36-item Likert-type scale (1-6) calculated by averaging scores across all items (minimum score 1, maximum score 6). Higher scores indicate greater impairment in emotion regulation skills.|units on a scale|Mean|3.00|3.0|Standard Deviation|0.56|0.56|||
3777847|NCT01892306|3609539|B1|||Difficulties in Emotion Regulation Scale (DERS)|Emotion regulation skills were assessed at baseline using a self-report questionnaire measure of emotion regulation (Difficulties in Emotion Regulation Scale- DERS), a 36-item Likert-type scale (1-6) calculated by averaging scores across all items (minimum score 1, maximum score 6). Higher scores indicate greater impairment in emotion regulation skills.|units on a scale|Mean|2.84|2.84|Standard Deviation|0.53|0.53|||
3777848|NCT01892306|3609537|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3777849|NCT01892306|3609538|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3777850|NCT01892306|3609539|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777851|NCT01892306|3609537|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777852|NCT01892306|3609538|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777853|NCT01892306|3609539|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777854|NCT01892306|3609537|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3777855|NCT01892306|3609538|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3777856|NCT01892306|3609539|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3778153|NCT01891890|3609697|B1||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
3777857|NCT01892306|3609537|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3777858|NCT01892306|3609538|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777859|NCT01892306|3609539|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3777860|NCT01892306|3609537|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777861|NCT01892306|3609538|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777862|NCT01892306|3609539|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777863|NCT01892306|3609537|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777864|NCT01892306|3609538|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777865|NCT01892306|3609539|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777866|NCT01892306|3609537|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777867|NCT01892306|3609538|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777868|NCT01892306|3609539|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777869|NCT01892306|3609537|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3777870|NCT01892306|3609538|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3777871|NCT01892306|3609539|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3777872|NCT01892306|3609537|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3777873|NCT01892306|3609538|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3777874|NCT01892306|3609539|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3777875|NCT01892306|3609537|B3|||Age||years|Mean|43.72|43.72|Standard Deviation|13.84|13.84|||
3777876|NCT01892306|3609538|B2|||Age||years|Mean|44.25|44.25|Standard Deviation|14.27|14.27|||
3777877|NCT01892306|3609539|B1|||Age||years|Mean|43.08|43.08|Standard Deviation|13.84|13.84|||
3777878|NCT01892293|3609560|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777879|NCT01892293|3609560|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777880|NCT01892293|3609560|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3777881|NCT01892293|3609560|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777882|NCT01892293|3609560|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777883|NCT01892293|3609560|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777884|NCT01892293|3609560|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777885|NCT01892293|3609560|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777886|NCT01892293|3609560|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3777887|NCT01892293|3609560|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3777888|NCT01892293|3609560|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3777889|NCT01892293|3609560|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3777890|NCT01892293|3609560|B1|||Age||Years|Mean|64.5|64.5|Full Range|||61.0|68.0|
3777891|NCT01892293|3609560|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3777892|NCT01892293|3609560|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3777893|NCT01892293|3609560|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3777894|NCT01892267|3609566|B3|||Gastrointestinal Quality of Life Index (GIQLI) score|Gastrointestinal Quality of Life Index (GIQLI) score ranging from 0 (worst quality of life possible with severe digestive symptoms) to 144 (optimal quality of life without symptoms|units on a scale|Mean|73.4|73.4|Standard Deviation|20.5|20.5|||
3777895|NCT01892267|3609567|B2|||Gastrointestinal Quality of Life Index (GIQLI) score|Gastrointestinal Quality of Life Index (GIQLI) score ranging from 0 (worst quality of life possible with severe digestive symptoms) to 144 (optimal quality of life without symptoms|units on a scale|Mean|69.1|69.1|Standard Deviation|11.9|11.9|||
3777896|NCT01892267|3609568|B1|||Gastrointestinal Quality of Life Index (GIQLI) score|Gastrointestinal Quality of Life Index (GIQLI) score ranging from 0 (worst quality of life possible with severe digestive symptoms) to 144 (optimal quality of life without symptoms|units on a scale|Mean|78.2|78.2|Standard Deviation|27.1|27.1|||
3777897|NCT01892267|3609566|B3|Male||Sex/Gender, Customized||participants|Number|7|7.0||||||
3777898|NCT01892267|3609567|B2|Male||Sex/Gender, Customized||participants|Number|2|2.0||||||
3777899|NCT01892267|3609568|B1|Male||Sex/Gender, Customized||participants|Number|5|5.0||||||
3777900|NCT01892267|3609566|B3|Female||Sex/Gender, Customized||participants|Number|12|12.0||||||
3777901|NCT01892267|3609567|B2|Female||Sex/Gender, Customized||participants|Number|8|8.0||||||
3777902|NCT01892267|3609568|B1|Female||Sex/Gender, Customized||participants|Number|4|4.0||||||
3777903|NCT01892267|3609566|B3|||Age||years|Mean|56.84|56.84|Standard Deviation|12.77|12.77|||
3777904|NCT01892267|3609567|B2|||Age||years|Mean|52|52.0|Standard Deviation|10.68|10.68|||
3777905|NCT01892267|3609568|B1|||Age||years|Mean|62.22|62.22|Standard Deviation|13.30|13.3|||
3777906|NCT01892189|3609595|B10|Not consumes Caffiene||Caffeine Consumption||participants|Number|3|3.0||||||
3777907|NCT01892189|3609596|B9|Not consumes Caffiene||Caffeine Consumption||participants|Number|0|0.0||||||
3777908|NCT01892189|3609597|B8|Not consumes Caffiene||Caffeine Consumption||participants|Number|0|0.0||||||
3777909|NCT01892189|3609598|B7|Not consumes Caffiene||Caffeine Consumption||participants|Number|0|0.0||||||
3777910|NCT01892189|3609599|B6|Not consumes Caffiene||Caffeine Consumption||participants|Number|1|1.0||||||
3777911|NCT01892189|3609600|B5|Not consumes Caffiene||Caffeine Consumption||participants|Number|1|1.0||||||
3777912|NCT01892189|3609601|B4|Not consumes Caffiene||Caffeine Consumption||participants|Number|0|0.0||||||
3777913|NCT01892189|3609602|B3|Not consumes Caffiene||Caffeine Consumption||participants|Number|0|0.0||||||
3777914|NCT01892189|3609603|B2|Not consumes Caffiene||Caffeine Consumption||participants|Number|0|0.0||||||
3777915|NCT01892189|3609604|B1|Not consumes Caffiene||Caffeine Consumption||participants|Number|1|1.0||||||
3777916|NCT01892189|3609595|B10|Consumes Caffiene||Caffeine Consumption||participants|Number|24|24.0||||||
3777917|NCT01892189|3609596|B9|Consumes Caffiene||Caffeine Consumption||participants|Number|3|3.0||||||
3777918|NCT01892189|3609597|B8|Consumes Caffiene||Caffeine Consumption||participants|Number|3|3.0||||||
3777919|NCT01892189|3609598|B7|Consumes Caffiene||Caffeine Consumption||participants|Number|3|3.0||||||
3777920|NCT01892189|3609599|B6|Consumes Caffiene||Caffeine Consumption||participants|Number|2|2.0||||||
3777921|NCT01892189|3609600|B5|Consumes Caffiene||Caffeine Consumption||participants|Number|2|2.0||||||
3777922|NCT01892189|3609601|B4|Consumes Caffiene||Caffeine Consumption||participants|Number|3|3.0||||||
3777923|NCT01892189|3609602|B3|Consumes Caffiene||Caffeine Consumption||participants|Number|3|3.0||||||
3777924|NCT01892189|3609603|B2|Consumes Caffiene||Caffeine Consumption||participants|Number|3|3.0||||||
3777925|NCT01892189|3609604|B1|Consumes Caffiene||Caffeine Consumption||participants|Number|2|2.0||||||
3777926|NCT01892189|3609595|B10|Ex-smoker||Smoking Classification||participants|Number|4|4.0||||||
3777927|NCT01892189|3609596|B9|Ex-smoker||Smoking Classification||participants|Number|1|1.0||||||
3777928|NCT01892189|3609597|B8|Ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3777929|NCT01892189|3609598|B7|Ex-smoker||Smoking Classification||participants|Number|1|1.0||||||
3777930|NCT01892189|3609599|B6|Ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3777931|NCT01892189|3609600|B5|Ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3777932|NCT01892189|3609601|B4|Ex-smoker||Smoking Classification||participants|Number|1|1.0||||||
3777933|NCT01892189|3609602|B3|Ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3777934|NCT01892189|3609603|B2|Ex-smoker||Smoking Classification||participants|Number|1|1.0||||||
3777935|NCT01892189|3609604|B1|Ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3777936|NCT01892189|3609595|B10|Never smoked||Smoking Classification||participants|Number|23|23.0||||||
3777937|NCT01892189|3609596|B9|Never smoked||Smoking Classification||participants|Number|2|2.0||||||
3777938|NCT01892189|3609597|B8|Never smoked||Smoking Classification||participants|Number|3|3.0||||||
3777939|NCT01892189|3609598|B7|Never smoked||Smoking Classification||participants|Number|2|2.0||||||
3777940|NCT01892189|3609599|B6|Never smoked||Smoking Classification||participants|Number|3|3.0||||||
3777941|NCT01892189|3609600|B5|Never smoked||Smoking Classification||participants|Number|3|3.0||||||
3777942|NCT01892189|3609601|B4|Never smoked||Smoking Classification||participants|Number|2|2.0||||||
3777943|NCT01892189|3609602|B3|Never smoked||Smoking Classification||participants|Number|3|3.0||||||
3777944|NCT01892189|3609603|B2|Never smoked||Smoking Classification||participants|Number|2|2.0||||||
3777945|NCT01892189|3609604|B1|Never smoked||Smoking Classification||participants|Number|3|3.0||||||
3777946|NCT01892189|3609595|B10|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|25.22|25.22|Standard Deviation|2.997|2.997|||
3777947|NCT01892189|3609596|B9|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|23.69|23.69|Standard Deviation|3.269|3.269|||
3777948|NCT01892189|3609597|B8|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|25.71|25.71|Standard Deviation|1.011|1.011|||
3777949|NCT01892189|3609598|B7|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|24.20|24.2|Standard Deviation|2.417|2.417|||
3777950|NCT01892189|3609599|B6|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|23.28|23.28|Standard Deviation|2.611|2.611|||
3777951|NCT01892189|3609600|B5|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|26.99|26.99|Standard Deviation|2.108|2.108|||
3777952|NCT01892189|3609601|B4|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|23.39|23.39|Standard Deviation|3.844|3.844|||
3777953|NCT01892189|3609602|B3|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|25.30|25.3|Standard Deviation|3.190|3.19|||
3777954|NCT01892189|3609603|B2|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|28.38|28.38|Standard Deviation|2.557|2.557|||
3777955|NCT01892189|3609604|B1|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|26.06|26.06|Standard Deviation|4.430|4.43|||
3777956|NCT01892189|3609595|B10|||Weight||kilogram (kg)|Mean|83.40|83.4|Standard Deviation|10.306|10.306|||
3777957|NCT01892189|3609596|B9|||Weight||kilogram (kg)|Mean|79.07|79.07|Standard Deviation|11.716|11.716|||
3777958|NCT01892189|3609597|B8|||Weight||kilogram (kg)|Mean|86.40|86.4|Standard Deviation|4.939|4.939|||
3777959|NCT01892189|3609598|B7|||Weight||kilogram (kg)|Mean|81.10|81.1|Standard Deviation|5.821|5.821|||
3777960|NCT01892189|3609599|B6|||Weight||kilogram (kg)|Mean|77.33|77.33|Standard Deviation|8.107|8.107|||
3777961|NCT01892189|3609600|B5|||Weight||kilogram (kg)|Mean|87.47|87.47|Standard Deviation|13.955|13.955|||
3777962|NCT01892189|3609601|B4|||Weight||kilogram (kg)|Mean|82.3|82.3|Standard Deviation|12.643|12.643|||
3777963|NCT01892189|3609602|B3|||Weight||kilogram (kg)|Mean|79.87|79.87|Standard Deviation|16.910|16.91|||
3777964|NCT01892189|3609603|B2|||Weight||kilogram (kg)|Mean|93.80|93.8|Standard Deviation|4.784|4.784|||
3777965|NCT01892189|3609604|B1|||Weight||kilogram (kg)|Mean|83.23|83.23|Standard Deviation|11.981|11.981|||
3777966|NCT01892189|3609595|B10|||Height||centimeters (cm)|Mean|181.9|181.9|Standard Deviation|6.06|6.06|||
3777967|NCT01892189|3609596|B9|||Height||centimeters (cm)|Mean|182.7|182.7|Standard Deviation|4.51|4.51|||
3777968|NCT01892189|3609597|B8|||Height||centimeters (cm)|Mean|183.3|183.3|Standard Deviation|6.51|6.51|||
3777969|NCT01892189|3609598|B7|||Height||centimeters (cm)|Mean|183.3|183.3|Standard Deviation|8.14|8.14|||
3777970|NCT01892189|3609599|B6|||Height||centimeters (cm)|Mean|182.3|182.3|Standard Deviation|3.06|3.06|||
3777971|NCT01892189|3609600|B5|||Height||centimeters (cm)|Mean|179.7|179.7|Standard Deviation|10.79|10.79|||
3777972|NCT01892189|3609601|B4|||Height||centimeters (cm)|Mean|187.7|187.7|Standard Deviation|3.79|3.79|||
3777973|NCT01892189|3609602|B3|||Height||centimeters (cm)|Mean|177|177.0|Standard Deviation|8.19|8.19|||
3777974|NCT01892189|3609603|B2|||Height||centimeters (cm)|Mean|182|182.0|Standard Deviation|4.58|4.58|||
3777975|NCT01892189|3609604|B1|||Height||centimeters (cm)|Mean|179|179.0|Standard Deviation|2.65|2.65|||
3777976|NCT01892189|3609595|B10|United States||Region of Enrollment||participants|Number|27|27.0||||||
3777977|NCT01892189|3609596|B9|United States||Region of Enrollment||participants|Number|3|3.0||||||
3777978|NCT01892189|3609597|B8|United States||Region of Enrollment||participants|Number|3|3.0||||||
3777979|NCT01892189|3609598|B7|United States||Region of Enrollment||participants|Number|3|3.0||||||
3777980|NCT01892189|3609599|B6|United States||Region of Enrollment||participants|Number|3|3.0||||||
3777981|NCT01892189|3609600|B5|United States||Region of Enrollment||participants|Number|3|3.0||||||
3777982|NCT01892189|3609601|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
3777983|NCT01892189|3609602|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3777984|NCT01892189|3609603|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3777985|NCT01892189|3609604|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3777986|NCT01892189|3609595|B10|Pacific Islander-White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3777987|NCT01892189|3609596|B9|Pacific Islander-White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3777988|NCT01892189|3609597|B8|Pacific Islander-White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3777989|NCT01892189|3609598|B7|Pacific Islander-White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3777990|NCT01892189|3609599|B6|Pacific Islander-White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3777991|NCT01892189|3609600|B5|Pacific Islander-White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3777992|NCT01892189|3609601|B4|Pacific Islander-White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3777993|NCT01892189|3609602|B3|Pacific Islander-White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3777994|NCT01892189|3609603|B2|Pacific Islander-White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3777995|NCT01892189|3609604|B1|Pacific Islander-White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3777996|NCT01892189|3609595|B10|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3777997|NCT01892189|3609596|B9|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3777998|NCT01892189|3609597|B8|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3777999|NCT01892189|3609598|B7|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778000|NCT01892189|3609599|B6|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778001|NCT01892189|3609600|B5|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778002|NCT01892189|3609601|B4|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778003|NCT01892189|3609602|B3|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778004|NCT01892189|3609603|B2|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778005|NCT01892189|3609604|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778006|NCT01892189|3609595|B10|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3778007|NCT01892189|3609596|B9|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778008|NCT01892189|3609597|B8|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778009|NCT01892189|3609598|B7|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3778010|NCT01892189|3609599|B6|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778011|NCT01892189|3609600|B5|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778012|NCT01892189|3609601|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778013|NCT01892189|3609602|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778014|NCT01892189|3609603|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778015|NCT01892189|3609604|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778016|NCT01892189|3609595|B10|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3778017|NCT01892189|3609596|B9|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778018|NCT01892189|3609597|B8|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778019|NCT01892189|3609598|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778020|NCT01892189|3609599|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778021|NCT01892189|3609600|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3778022|NCT01892189|3609601|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778023|NCT01892189|3609602|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778024|NCT01892189|3609603|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778025|NCT01892189|3609604|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778026|NCT01892189|3609595|B10|Non Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3778027|NCT01892189|3609596|B9|Non Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3778028|NCT01892189|3609597|B8|Non Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3778029|NCT01892189|3609598|B7|Non Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3778030|NCT01892189|3609599|B6|Non Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3778031|NCT01892189|3609600|B5|Non Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3778032|NCT01892189|3609601|B4|Non Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3778033|NCT01892189|3609602|B3|Non Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3778034|NCT01892189|3609603|B2|Non Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3778035|NCT01892189|3609604|B1|Non Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3778036|NCT01892189|3609595|B10|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3778037|NCT01892189|3609596|B9|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778038|NCT01892189|3609597|B8|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778039|NCT01892189|3609598|B7|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3778040|NCT01892189|3609599|B6|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778041|NCT01892189|3609600|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778042|NCT01892189|3609601|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778043|NCT01892189|3609602|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778044|NCT01892189|3609603|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778045|NCT01892189|3609604|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778046|NCT01892189|3609595|B10|Male||Sex/Gender, Customized||participants|Number|27|27.0||||||
3778047|NCT01892189|3609596|B9|Male||Sex/Gender, Customized||participants|Number|3|3.0||||||
3778048|NCT01892189|3609597|B8|Male||Sex/Gender, Customized||participants|Number|3|3.0||||||
3778049|NCT01892189|3609598|B7|Male||Sex/Gender, Customized||participants|Number|3|3.0||||||
3778050|NCT01892189|3609599|B6|Male||Sex/Gender, Customized||participants|Number|3|3.0||||||
3778051|NCT01892189|3609600|B5|Male||Sex/Gender, Customized||participants|Number|3|3.0||||||
3778052|NCT01892189|3609601|B4|Male||Sex/Gender, Customized||participants|Number|3|3.0||||||
3778053|NCT01892189|3609602|B3|Male||Sex/Gender, Customized||participants|Number|3|3.0||||||
3778054|NCT01892189|3609603|B2|Male||Sex/Gender, Customized||participants|Number|3|3.0||||||
3778055|NCT01892189|3609604|B1|Male||Sex/Gender, Customized||participants|Number|3|3.0||||||
3778056|NCT01892189|3609595|B10|Female||Sex/Gender, Customized||participants|Number|0|0.0||||||
3778057|NCT01892189|3609596|B9|Female||Sex/Gender, Customized||participants|Number|0|0.0||||||
3778058|NCT01892189|3609597|B8|Female||Sex/Gender, Customized||participants|Number|0|0.0||||||
3778059|NCT01892189|3609598|B7|Female||Sex/Gender, Customized||participants|Number|0|0.0||||||
3778060|NCT01892189|3609599|B6|Female||Sex/Gender, Customized||participants|Number|0|0.0||||||
3778061|NCT01892189|3609600|B5|Female||Sex/Gender, Customized||participants|Number|0|0.0||||||
3778062|NCT01892189|3609601|B4|Female||Sex/Gender, Customized||participants|Number|0|0.0||||||
3778063|NCT01892189|3609602|B3|Female||Sex/Gender, Customized||participants|Number|0|0.0||||||
3778064|NCT01892189|3609603|B2|Female||Sex/Gender, Customized||participants|Number|0|0.0||||||
3778065|NCT01892189|3609604|B1|Female||Sex/Gender, Customized||participants|Number|0|0.0||||||
3778066|NCT01892189|3609595|B10|||Age||years|Mean|25.9|25.9|Standard Deviation|5.60|5.6|||
3778067|NCT01892189|3609596|B9|||Age||years|Mean|23.7|23.7|Standard Deviation|5.69|5.69|||
3778068|NCT01892189|3609597|B8|||Age||years|Mean|24.7|24.7|Standard Deviation|2.08|2.08|||
3778069|NCT01892189|3609598|B7|||Age||years|Mean|27|27.0|Standard Deviation|7.94|7.94|||
3778070|NCT01892189|3609599|B6|||Age||years|Mean|22.3|22.3|Standard Deviation|3.51|3.51|||
3778071|NCT01892189|3609600|B5|||Age||years|Mean|23|23.0|Standard Deviation|5.20|5.2|||
3778072|NCT01892189|3609601|B4|||Age||years|Mean|32.3|32.3|Standard Deviation|5.13|5.13|||
3778073|NCT01892189|3609602|B3|||Age||years|Mean|23.7|23.7|Standard Deviation|6.66|6.66|||
3778074|NCT01892189|3609603|B2|||Age||years|Mean|28.7|28.7|Standard Deviation|7.64|7.64|||
3778075|NCT01892189|3609604|B1|||Age||years|Mean|27.7|27.7|Standard Deviation|3.21|3.21|||
3778076|NCT01892163|3609652|B3|United Kingdom||Region of Enrollment||participants|Number|100|100.0||||||
3778077|NCT01892163|3609653|B2|United Kingdom||Region of Enrollment||participants|Number|50|50.0||||||
3778078|NCT01892163|3609654|B1|United Kingdom||Region of Enrollment||participants|Number|50|50.0||||||
3778079|NCT01892163|3609652|B3||Male|Gender||Participants|Count of Participants|74|74.0||||||
3778080|NCT01892163|3609653|B2||Male|Gender||Participants|Count of Participants|40|40.0||||||
3778081|NCT01892163|3609654|B1||Male|Gender||Participants|Count of Participants|34|34.0||||||
3778082|NCT01892163|3609652|B3||Female|Gender||Participants|Count of Participants|26|26.0||||||
3778083|NCT01892163|3609653|B2||Female|Gender||Participants|Count of Participants|10|10.0||||||
3778084|NCT01892163|3609654|B1||Female|Gender||Participants|Count of Participants|16|16.0||||||
3778085|NCT01892163|3609652|B3|||Age||years|Mean|64.6|64.6|Standard Deviation|10.5|10.5|||
3778086|NCT01892163|3609653|B2|||Age||years|Mean|63.8|63.8|Standard Deviation|11.1|11.1|||
3778087|NCT01892163|3609654|B1|||Age||years|Mean|65.4|65.4|Standard Deviation|9.8|9.8|||
3778088|NCT01892163|3609652|B3||>=65 years|Age||Participants|Count of Participants|55|55.0||||||
3778089|NCT01892163|3609653|B2||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3778090|NCT01892163|3609654|B1||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
3778091|NCT01892163|3609652|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3778092|NCT01892163|3609653|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3778093|NCT01892163|3609654|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3778094|NCT01892163|3609652|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3778095|NCT01892163|3609653|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3778096|NCT01892163|3609654|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3778097|NCT01892020|3609667|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3778098|NCT01892020|3609667|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3778099|NCT01892020|3609667|B1|||Age||years|Mean|59.1|59.1|Standard Deviation|8.5|8.5|||
3778100|NCT01891994|3609686|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3778101|NCT01891994|3609686|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3778102|NCT01891994|3609686|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3778103|NCT01891994|3609686|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3778104|NCT01891994|3609686|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3778105|NCT01891994|3609686|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3778106|NCT01891994|3609686|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778107|NCT01891994|3609686|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778108|NCT01891994|3609686|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3778109|NCT01891994|3609686|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3778110|NCT01891994|3609686|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3778111|NCT01891994|3609686|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3778112|NCT01891994|3609686|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3778113|NCT01891994|3609686|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3778114|NCT01891994|3609686|B1||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
3778115|NCT01891968|3609690|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3778116|NCT01891968|3609690|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3778117|NCT01891968|3609690|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778118|NCT01891968|3609690|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3778119|NCT01891968|3609690|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3778120|NCT01891968|3609690|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778121|NCT01891968|3609690|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778122|NCT01891968|3609690|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778123|NCT01891968|3609690|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3778124|NCT01891968|3609690|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3778125|NCT01891968|3609690|B1|||Age||years|Median|71|71.0|Full Range|||56.0|87.0|
3778126|NCT01891890|3609694|B4|United States||Region of Enrollment||Participants|Count of Participants|72|72.0||||||
3778127|NCT01891890|3609695|B3|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3778128|NCT01891890|3609696|B2|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3778129|NCT01891890|3609697|B1|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3778130|NCT01891890|3609694|B4||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3778131|NCT01891890|3609695|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3778132|NCT01891890|3609696|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3778133|NCT01891890|3609697|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3778134|NCT01891890|3609694|B4||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3778135|NCT01891890|3609695|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3778136|NCT01891890|3609696|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3778137|NCT01891890|3609697|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3778138|NCT01891890|3609694|B4|||Age||years|Mean|8.7|8.7|Standard Deviation|2.8|2.8|||
3778139|NCT01891890|3609695|B3|||Age||years|Mean|9.1|9.1|Standard Deviation|2.1|2.1|||
3778140|NCT01891890|3609696|B2|||Age||years|Mean|8.6|8.6|Standard Deviation|2.4|2.4|||
3778141|NCT01891890|3609697|B1|||Age||years|Mean|8.6|8.6|Standard Deviation|2.0|2.0|||
3778142|NCT01891890|3609694|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3778143|NCT01891890|3609695|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3778144|NCT01891890|3609696|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3778145|NCT01891890|3609697|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3778146|NCT01891890|3609694|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3778147|NCT01891890|3609695|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3778148|NCT01891890|3609696|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3778149|NCT01891890|3609697|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3778150|NCT01891890|3609694|B4||<=18 years|Age||Participants|Count of Participants|72|72.0||||||
3778151|NCT01891890|3609695|B3||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
3778152|NCT01891890|3609696|B2||<=18 years|Age||Participants|Count of Participants|27|27.0||||||
3778154|NCT01891864|3609740|B3|Estonia||Region of Enrollment||participants|Number|81|81.0||||||
3778155|NCT01891864|3609741|B2|Estonia||Region of Enrollment||participants|Number|40|40.0||||||
3778156|NCT01891864|3609742|B1|Estonia||Region of Enrollment||participants|Number|41|41.0||||||
3778157|NCT01891864|3609740|B3|Germany||Region of Enrollment||participants|Number|29|29.0||||||
3778158|NCT01891864|3609741|B2|Germany||Region of Enrollment||participants|Number|17|17.0||||||
3778159|NCT01891864|3609742|B1|Germany||Region of Enrollment||participants|Number|12|12.0||||||
3778160|NCT01891864|3609740|B3|Bulgaria||Region of Enrollment||participants|Number|21|21.0||||||
3778161|NCT01891864|3609741|B2|Bulgaria||Region of Enrollment||participants|Number|8|8.0||||||
3778162|NCT01891864|3609742|B1|Bulgaria||Region of Enrollment||participants|Number|13|13.0||||||
3778163|NCT01891864|3609740|B3|Slovakia||Region of Enrollment||participants|Number|37|37.0||||||
3778164|NCT01891864|3609741|B2|Slovakia||Region of Enrollment||participants|Number|20|20.0||||||
3778165|NCT01891864|3609742|B1|Slovakia||Region of Enrollment||participants|Number|17|17.0||||||
3778166|NCT01891864|3609740|B3|United Kingdom||Region of Enrollment||participants|Number|14|14.0||||||
3778167|NCT01891864|3609741|B2|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3778168|NCT01891864|3609742|B1|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
3778169|NCT01891864|3609740|B3|South Africa||Region of Enrollment||participants|Number|5|5.0||||||
3778170|NCT01891864|3609741|B2|South Africa||Region of Enrollment||participants|Number|1|1.0||||||
3778171|NCT01891864|3609742|B1|South Africa||Region of Enrollment||participants|Number|4|4.0||||||
3778172|NCT01891864|3609740|B3|Poland||Region of Enrollment||participants|Number|190|190.0||||||
3778173|NCT01891864|3609741|B2|Poland||Region of Enrollment||participants|Number|94|94.0||||||
3778174|NCT01891864|3609742|B1|Poland||Region of Enrollment||participants|Number|96|96.0||||||
3778175|NCT01891864|3609740|B3|Ukraine||Region of Enrollment||participants|Number|42|42.0||||||
3778176|NCT01891864|3609741|B2|Ukraine||Region of Enrollment||participants|Number|23|23.0||||||
3778177|NCT01891864|3609742|B1|Ukraine||Region of Enrollment||participants|Number|19|19.0||||||
3778178|NCT01891864|3609740|B3|Hungary||Region of Enrollment||participants|Number|21|21.0||||||
3778179|NCT01891864|3609741|B2|Hungary||Region of Enrollment||participants|Number|12|12.0||||||
3778180|NCT01891864|3609742|B1|Hungary||Region of Enrollment||participants|Number|9|9.0||||||
3778181|NCT01891864|3609740|B3|Romania||Region of Enrollment||participants|Number|33|33.0||||||
3778182|NCT01891864|3609741|B2|Romania||Region of Enrollment||participants|Number|24|24.0||||||
3778183|NCT01891864|3609742|B1|Romania||Region of Enrollment||participants|Number|9|9.0||||||
3778184|NCT01891864|3609740|B3|Russian Federation||Region of Enrollment||participants|Number|17|17.0||||||
3778185|NCT01891864|3609741|B2|Russian Federation||Region of Enrollment||participants|Number|8|8.0||||||
3778186|NCT01891864|3609742|B1|Russian Federation||Region of Enrollment||participants|Number|9|9.0||||||
3778187|NCT01891864|3609740|B3|Czech Republic||Region of Enrollment||participants|Number|41|41.0||||||
3778188|NCT01891864|3609741|B2|Czech Republic||Region of Enrollment||participants|Number|16|16.0||||||
3778189|NCT01891864|3609742|B1|Czech Republic||Region of Enrollment||participants|Number|25|25.0||||||
3778190|NCT01891864|3609740|B3||Male|Sex: Female, Male||Participants|Count of Participants|329|329.0||||||
3778191|NCT01891864|3609741|B2||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3778192|NCT01891864|3609742|B1||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3778193|NCT01891864|3609740|B3||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3778194|NCT01891864|3609741|B2||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3778195|NCT01891864|3609742|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3778196|NCT01891864|3609740|B3|||Age||years|Mean|42.4|42.4|Standard Deviation|12.57|12.57|||
3778197|NCT01891864|3609741|B2|||Age||years|Mean|42.7|42.7|Standard Deviation|12.86|12.86|||
3778198|NCT01891864|3609742|B1|||Age||years|Mean|42.1|42.1|Standard Deviation|12.29|12.29|||
3778199|NCT01891864|3609740|B3||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
3778200|NCT01891864|3609741|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3778201|NCT01891864|3609742|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3778202|NCT01891864|3609740|B3||Between 18 and 65 years|Age||Participants|Count of Participants|503|503.0||||||
3778203|NCT01891864|3609741|B2||Between 18 and 65 years|Age||Participants|Count of Participants|249|249.0||||||
3778204|NCT01891864|3609742|B1||Between 18 and 65 years|Age||Participants|Count of Participants|254|254.0||||||
3778205|NCT01891864|3609740|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3778206|NCT01891864|3609741|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3778207|NCT01891864|3609742|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3778208|NCT01891734|3609767|B3|||Short Form Health Survey-12-Veterans (SF-12 V) Mental Composite Score|The 12-item Short Form Health Survey-12-Veterans (SF-12 V) Mental Composite Score is rated on a 0-100 scale. Higher scores represent better mental health functioning.|units on a scale|Mean|35.94|35.94|Standard Deviation|5.87|5.87|||
3778209|NCT01891734|3609768|B2|||Short Form Health Survey-12-Veterans (SF-12 V) Mental Composite Score|The 12-item Short Form Health Survey-12-Veterans (SF-12 V) Mental Composite Score is rated on a 0-100 scale. Higher scores represent better mental health functioning.|units on a scale|Mean|34.83|34.83|Standard Deviation|6.07|6.07|||
3778210|NCT01891734|3609769|B1|||Short Form Health Survey-12-Veterans (SF-12 V) Mental Composite Score|The 12-item Short Form Health Survey-12-Veterans (SF-12 V) Mental Composite Score is rated on a 0-100 scale. Higher scores represent better mental health functioning.|units on a scale|Mean|36.98|36.98|Standard Deviation|5.65|5.65|||
3778258|NCT01891669|3609786|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3778211|NCT01891734|3609767|B3|||Depression Anxiety and Stress Scale (DASS)-Stress|The 7-item stress subscale on the Depression Anxiety and Stress Scale (DASS) is measured on a 0-42 scale. Higher scores represent worse stress symptoms.|units on a scale|Mean|11.09|11.09|Standard Deviation|4.86|4.86|||
3778212|NCT01891734|3609768|B2|||Depression Anxiety and Stress Scale (DASS)-Stress|The 7-item stress subscale on the Depression Anxiety and Stress Scale (DASS) is measured on a 0-42 scale. Higher scores represent worse stress symptoms.|units on a scale|Mean|11.19|11.19|Standard Deviation|5.75|5.75|||
3778213|NCT01891734|3609769|B1|||Depression Anxiety and Stress Scale (DASS)-Stress|The 7-item stress subscale on the Depression Anxiety and Stress Scale (DASS) is measured on a 0-42 scale. Higher scores represent worse stress symptoms.|units on a scale|Mean|11.00|11.0|Standard Deviation|4.03|4.03|||
3778214|NCT01891734|3609767|B3|||Depression Anxiety and Stress Scale (DASS)-Anxiety|The 7-item anxiety subscale on the Depression Anxiety and Stress Scale (DASS) is measured on a 0-42 scale. Higher scores represent worse anxiety symptoms.|units on a scale|Mean|6.88|6.88|Standard Deviation|5.11|5.11|||
3778215|NCT01891734|3609768|B2|||Depression Anxiety and Stress Scale (DASS)-Anxiety|The 7-item anxiety subscale on the Depression Anxiety and Stress Scale (DASS) is measured on a 0-42 scale. Higher scores represent worse anxiety symptoms.|units on a scale|Mean|7.13|7.13|Standard Deviation|5.83|5.83|||
3778216|NCT01891734|3609769|B1|||Depression Anxiety and Stress Scale (DASS)-Anxiety|The 7-item anxiety subscale on the Depression Anxiety and Stress Scale (DASS) is measured on a 0-42 scale. Higher scores represent worse anxiety symptoms.|units on a scale|Mean|6.65|6.65|Standard Deviation|4.51|4.51|||
3778217|NCT01891734|3609767|B3|||Depression Anxiety and Stress Scale (DASS)-Depression|The 7-item depression subscale on the Depression Anxiety and Stress Scale (DASS) is measured on a 0-42 scale. Higher scores represent worse depression symptoms.|units on a scale|Mean|8.73|8.73|Standard Deviation|5.41|5.41|||
3778218|NCT01891734|3609768|B2|||Depression Anxiety and Stress Scale (DASS)-Depression|The 7-item depression subscale on the Depression Anxiety and Stress Scale (DASS) is measured on a 0-42 scale. Higher scores represent worse depression symptoms.|units on a scale|Mean|9.25|9.25|Standard Deviation|6.05|6.05|||
3778219|NCT01891734|3609769|B1|||Depression Anxiety and Stress Scale (DASS)-Depression|The 7-item depression subscale on the Depression Anxiety and Stress Scale (DASS) is measured on a 0-42 scale. Higher scores represent worse depression symptoms.|units on a scale|Mean|8.24|8.24|Standard Deviation|4.87|4.87|||
3778220|NCT01891734|3609767|B3|Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3778221|NCT01891734|3609768|B2|Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3778222|NCT01891734|3609769|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778223|NCT01891734|3609767|B3|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3778224|NCT01891734|3609768|B2|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778225|NCT01891734|3609769|B1|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3778226|NCT01891734|3609767|B3|Black||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3778227|NCT01891734|3609768|B2|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3778228|NCT01891734|3609769|B1|Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3778229|NCT01891734|3609767|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3778230|NCT01891734|3609768|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3778231|NCT01891734|3609769|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3778232|NCT01891734|3609767|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3778233|NCT01891734|3609768|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3778234|NCT01891734|3609769|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3778235|NCT01891734|3609767|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3778236|NCT01891734|3609768|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3778237|NCT01891734|3609769|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3778238|NCT01891734|3609767|B3|||Age||years|Mean|46.64|46.64|Standard Deviation|12.1|12.1|||
3778239|NCT01891734|3609768|B2|||Age||years|Mean|48.25|48.25|Standard Deviation|12.7|12.7|||
3778240|NCT01891734|3609769|B1|||Age||years|Mean|45.12|45.12|Standard Deviation|11.7|11.7|||
3778241|NCT01891669|3609780|B11||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3778242|NCT01891669|3609781|B10||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3778243|NCT01891669|3609782|B9||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3778244|NCT01891669|3609783|B8||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3778245|NCT01891669|3609784|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3778246|NCT01891669|3609785|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3778247|NCT01891669|3609786|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3778248|NCT01891669|3609787|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3778249|NCT01891669|3609788|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3778250|NCT01891669|3609789|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3778251|NCT01891669|3609790|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3778252|NCT01891669|3609780|B11||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3778253|NCT01891669|3609781|B10||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3778254|NCT01891669|3609782|B9||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3778255|NCT01891669|3609783|B8||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3778256|NCT01891669|3609784|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3778257|NCT01891669|3609785|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3778259|NCT01891669|3609787|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3778260|NCT01891669|3609788|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3778261|NCT01891669|3609789|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3778262|NCT01891669|3609790|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3778263|NCT01891669|3609780|B11|||Age||years|Mean|59.9|59.9|Standard Deviation|12.7|12.7|||
3778264|NCT01891669|3609781|B10|||Age||years|Mean|67.7|67.7|Standard Deviation|5.9|5.9|||
3778265|NCT01891669|3609782|B9|||Age||years|Mean|57.7|57.7|Standard Deviation|5.1|5.1|||
3778266|NCT01891669|3609783|B8|||Age||years|Mean|65.2|65.2|Standard Deviation|9.9|9.9|||
3778267|NCT01891669|3609784|B7|||Age||years|Mean|61.5|61.5|Standard Deviation|7.8|7.8|||
3778268|NCT01891669|3609785|B6|||Age||years|Mean|62|62.0|Standard Deviation|36.8|36.8|||
3778269|NCT01891669|3609786|B5|||Age||years|Mean|53.5|53.5|Standard Deviation|14.8|14.8|||
3778270|NCT01891669|3609787|B4|||Age||years|Mean|60|60.0|Standard Deviation|7.1|7.1|||
3778271|NCT01891669|3609788|B3|||Age||years|Mean|41|41.0|Standard Deviation|22.6|22.6|||
3778272|NCT01891669|3609789|B2|||Age||years|Mean|57|57.0|Standard Deviation|4.2|4.2|||
3778273|NCT01891669|3609790|B1|||Age||years|Mean|60.5|60.5|Standard Deviation|2.1|2.1|||
3778274|NCT01891331|3609950|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3778275|NCT01891331|3609951|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3778276|NCT01891331|3609952|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3778277|NCT01891331|3609953|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3778278|NCT01891331|3609954|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3778279|NCT01891331|3609950|B5||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3778280|NCT01891331|3609951|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3778281|NCT01891331|3609952|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3778282|NCT01891331|3609953|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3778283|NCT01891331|3609954|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3778284|NCT01891331|3609950|B5|||Age||years|Mean|32.7|32.7|Standard Deviation|10.4|10.4|||
3778285|NCT01891331|3609951|B4|||Age||years|Mean|31.3|31.3|Standard Deviation|8.22|8.22|||
3778286|NCT01891331|3609952|B3|||Age||years|Mean|27.6|27.6|Standard Deviation|7.37|7.37|||
3778287|NCT01891331|3609953|B2|||Age||years|Mean|38.2|38.2|Standard Deviation|11.77|11.77|||
3778288|NCT01891331|3609954|B1|||Age||years|Mean|34.4|34.4|Standard Deviation|12.01|12.01|||
3778289|NCT01891305|3609967|B5||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3778290|NCT01891305|3609968|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3778291|NCT01891305|3609969|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3778292|NCT01891305|3609970|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3778293|NCT01891305|3609971|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3778294|NCT01891305|3609967|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3778295|NCT01891305|3609968|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3778296|NCT01891305|3609969|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3778297|NCT01891305|3609970|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3778298|NCT01891305|3609971|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3778299|NCT01891305|3609967|B5|||Age||years|Mean|38.9|38.9|Standard Deviation|12.32|12.32|||
3778300|NCT01891305|3609968|B4|||Age||years|Mean|35.2|35.2|Standard Deviation|10.27|10.27|||
3778301|NCT01891305|3609969|B3|||Age||years|Mean|34.05|34.05|Standard Deviation|12.02|12.02|||
3778302|NCT01891305|3609970|B2|||Age||years|Mean|40.6|40.6|Standard Deviation|11.71|11.71|||
3778303|NCT01891305|3609971|B1|||Age||years|Mean|46|46.0|Standard Deviation|12.84|12.84|||
3778304|NCT01890967|3609984|B7|||Serum LDL Cholesterol Beta Quantification||milligrams per deciliter (mg/dL)|Mean|136.3|136.3|Standard Deviation|45.0|45.0|||
3778305|NCT01890967|3609985|B6|||Serum LDL Cholesterol Beta Quantification||milligrams per deciliter (mg/dL)|Mean|146.0|146.0|Standard Deviation|60.5|60.5|||
3778306|NCT01890967|3609986|B5|||Serum LDL Cholesterol Beta Quantification||milligrams per deciliter (mg/dL)|Mean|135.2|135.2|Standard Deviation|41.2|41.2|||
3778307|NCT01890967|3609987|B4|||Serum LDL Cholesterol Beta Quantification||milligrams per deciliter (mg/dL)|Mean|132.1|132.1|Standard Deviation|42.3|42.3|||
3778308|NCT01890967|3609988|B3|||Serum LDL Cholesterol Beta Quantification||milligrams per deciliter (mg/dL)|Mean|134.0|134.0|Standard Deviation|40.7|40.7|||
3778309|NCT01890967|3609989|B2|||Serum LDL Cholesterol Beta Quantification||milligrams per deciliter (mg/dL)|Mean|134.1|134.1|Standard Deviation|42.4|42.4|||
3778310|NCT01890967|3609990|B1|||Serum LDL Cholesterol Beta Quantification||milligrams per deciliter (mg/dL)|Mean|136.5|136.5|Standard Deviation|39.6|39.6|||
3778311|NCT01890967|3609984|B7|Poland||Region of Enrollment||Participants|Number|31|31.0||||||
3778312|NCT01890967|3609985|B6|Poland||Region of Enrollment||Participants|Number|4|4.0||||||
3778313|NCT01890967|3609986|B5|Poland||Region of Enrollment||Participants|Number|5|5.0||||||
3778314|NCT01890967|3609987|B4|Poland||Region of Enrollment||Participants|Number|6|6.0||||||
3778315|NCT01890967|3609988|B3|Poland||Region of Enrollment||Participants|Number|3|3.0||||||
3778316|NCT01890967|3609989|B2|Poland||Region of Enrollment||Participants|Number|7|7.0||||||
3778317|NCT01890967|3609990|B1|Poland||Region of Enrollment||Participants|Number|6|6.0||||||
3778318|NCT01890967|3609984|B7|Denmark||Region of Enrollment||Participants|Number|29|29.0||||||
3778319|NCT01890967|3609985|B6|Denmark||Region of Enrollment||Participants|Number|5|5.0||||||
3778320|NCT01890967|3609986|B5|Denmark||Region of Enrollment||Participants|Number|6|6.0||||||
3778321|NCT01890967|3609987|B4|Denmark||Region of Enrollment||Participants|Number|6|6.0||||||
3778322|NCT01890967|3609988|B3|Denmark||Region of Enrollment||Participants|Number|5|5.0||||||
3778323|NCT01890967|3609989|B2|Denmark||Region of Enrollment||Participants|Number|4|4.0||||||
3778324|NCT01890967|3609990|B1|Denmark||Region of Enrollment||Participants|Number|3|3.0||||||
3778325|NCT01890967|3609984|B7|Japan||Region of Enrollment||Participants|Number|106|106.0||||||
3778326|NCT01890967|3609985|B6|Japan||Region of Enrollment||Participants|Number|18|18.0||||||
3778327|NCT01890967|3609986|B5|Japan||Region of Enrollment||Participants|Number|18|18.0||||||
3778328|NCT01890967|3609987|B4|Japan||Region of Enrollment||Participants|Number|17|17.0||||||
3778329|NCT01890967|3609988|B3|Japan||Region of Enrollment||Participants|Number|18|18.0||||||
3778330|NCT01890967|3609989|B2|Japan||Region of Enrollment||Participants|Number|18|18.0||||||
3778331|NCT01890967|3609990|B1|Japan||Region of Enrollment||Participants|Number|17|17.0||||||
3778332|NCT01890967|3609984|B7|United States||Region of Enrollment||Participants|Number|143|143.0||||||
3778333|NCT01890967|3609985|B6|United States||Region of Enrollment||Participants|Number|21|21.0||||||
3778334|NCT01890967|3609986|B5|United States||Region of Enrollment||Participants|Number|22|22.0||||||
3778335|NCT01890967|3609987|B4|United States||Region of Enrollment||Participants|Number|26|26.0||||||
3778336|NCT01890967|3609988|B3|United States||Region of Enrollment||Participants|Number|26|26.0||||||
3778337|NCT01890967|3609989|B2|United States||Region of Enrollment||Participants|Number|23|23.0||||||
3778338|NCT01890967|3609990|B1|United States||Region of Enrollment||Participants|Number|25|25.0||||||
3778339|NCT01890967|3609984|B7|Puerto Rico||Region of Enrollment||Participants|Number|5|5.0||||||
3778340|NCT01890967|3609985|B6|Puerto Rico||Region of Enrollment||Participants|Number|1|1.0||||||
3778341|NCT01890967|3609986|B5|Puerto Rico||Region of Enrollment||Participants|Number|0|0.0||||||
3778342|NCT01890967|3609987|B4|Puerto Rico||Region of Enrollment||Participants|Number|1|1.0||||||
3778343|NCT01890967|3609988|B3|Puerto Rico||Region of Enrollment||Participants|Number|1|1.0||||||
3778344|NCT01890967|3609989|B2|Puerto Rico||Region of Enrollment||Participants|Number|0|0.0||||||
3778345|NCT01890967|3609990|B1|Puerto Rico||Region of Enrollment||Participants|Number|2|2.0||||||
3778346|NCT01890967|3609984|B7|Czech Republic||Region of Enrollment||Participants|Number|23|23.0||||||
3778347|NCT01890967|3609985|B6|Czech Republic||Region of Enrollment||Participants|Number|4|4.0||||||
3778348|NCT01890967|3609986|B5|Czech Republic||Region of Enrollment||Participants|Number|5|5.0||||||
3778349|NCT01890967|3609987|B4|Czech Republic||Region of Enrollment||Participants|Number|4|4.0||||||
3778350|NCT01890967|3609988|B3|Czech Republic||Region of Enrollment||Participants|Number|3|3.0||||||
3778351|NCT01890967|3609989|B2|Czech Republic||Region of Enrollment||Participants|Number|2|2.0||||||
3778352|NCT01890967|3609990|B1|Czech Republic||Region of Enrollment||Participants|Number|5|5.0||||||
3778353|NCT01890967|3609984|B7|Netherlands||Region of Enrollment||Participants|Number|88|88.0||||||
3778354|NCT01890967|3609985|B6|Netherlands||Region of Enrollment||Participants|Number|15|15.0||||||
3778355|NCT01890967|3609986|B5|Netherlands||Region of Enrollment||Participants|Number|13|13.0||||||
3778356|NCT01890967|3609987|B4|Netherlands||Region of Enrollment||Participants|Number|11|11.0||||||
3778357|NCT01890967|3609988|B3|Netherlands||Region of Enrollment||Participants|Number|17|17.0||||||
3778358|NCT01890967|3609989|B2|Netherlands||Region of Enrollment||Participants|Number|16|16.0||||||
3778359|NCT01890967|3609990|B1|Netherlands||Region of Enrollment||Participants|Number|16|16.0||||||
3778360|NCT01890967|3609984|B7|Canada||Region of Enrollment||Participants|Number|94|94.0||||||
3778361|NCT01890967|3609985|B6|Canada||Region of Enrollment||Participants|Number|19|19.0||||||
3778362|NCT01890967|3609986|B5|Canada||Region of Enrollment||Participants|Number|17|17.0||||||
3778363|NCT01890967|3609987|B4|Canada||Region of Enrollment||Participants|Number|15|15.0||||||
3778364|NCT01890967|3609988|B3|Canada||Region of Enrollment||Participants|Number|13|13.0||||||
3778365|NCT01890967|3609989|B2|Canada||Region of Enrollment||Participants|Number|17|17.0||||||
3778366|NCT01890967|3609990|B1|Canada||Region of Enrollment||Participants|Number|13|13.0||||||
3778367|NCT01890967|3609984|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778368|NCT01890967|3609985|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778369|NCT01890967|3609986|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778370|NCT01890967|3609987|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778371|NCT01890967|3609988|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778372|NCT01890967|3609989|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778373|NCT01890967|3609990|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778374|NCT01890967|3609984|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3778375|NCT01890967|3609985|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3778376|NCT01890967|3609986|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3778377|NCT01890967|3609987|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778378|NCT01890967|3609988|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778379|NCT01890967|3609989|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778380|NCT01890967|3609990|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3778381|NCT01890967|3609984|B7||White|Race (NIH/OMB)||Participants|Count of Participants|356|356.0||||||
3778382|NCT01890967|3609985|B6||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3778383|NCT01890967|3609986|B5||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3778384|NCT01890967|3609987|B4||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3778385|NCT01890967|3609988|B3||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3778386|NCT01890967|3609989|B2||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3778387|NCT01890967|3609990|B1||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3778388|NCT01890967|3609984|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3778389|NCT01890967|3609985|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3778390|NCT01890967|3609986|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3778391|NCT01890967|3609987|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3778392|NCT01890967|3609988|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3778393|NCT01890967|3609989|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3778394|NCT01890967|3609990|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3778395|NCT01890967|3609984|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778396|NCT01890967|3609985|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778397|NCT01890967|3609986|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778398|NCT01890967|3609987|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778399|NCT01890967|3609988|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778400|NCT01890967|3609989|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778401|NCT01890967|3609990|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778402|NCT01890967|3609984|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|137|137.0||||||
3778403|NCT01890967|3609985|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3778404|NCT01890967|3609986|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3778405|NCT01890967|3609987|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3778406|NCT01890967|3609988|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3778407|NCT01890967|3609989|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3778408|NCT01890967|3609990|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3778409|NCT01890967|3609984|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778410|NCT01890967|3609985|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778411|NCT01890967|3609986|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778412|NCT01890967|3609987|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778413|NCT01890967|3609988|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778414|NCT01890967|3609989|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778415|NCT01890967|3609990|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778416|NCT01890967|3609984|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|191|191.0||||||
3778417|NCT01890967|3609985|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3778418|NCT01890967|3609986|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3778419|NCT01890967|3609987|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3778420|NCT01890967|3609988|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3778421|NCT01890967|3609989|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3778422|NCT01890967|3609990|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3778423|NCT01890967|3609984|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|315|315.0||||||
3778424|NCT01890967|3609985|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3778425|NCT01890967|3609986|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3778426|NCT01890967|3609987|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3778427|NCT01890967|3609988|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3778428|NCT01890967|3609989|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3778429|NCT01890967|3609990|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3778430|NCT01890967|3609984|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3778431|NCT01890967|3609985|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3778432|NCT01890967|3609986|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3778433|NCT01890967|3609987|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3778434|NCT01890967|3609988|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3778435|NCT01890967|3609989|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3778436|NCT01890967|3609990|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3778437|NCT01890967|3609984|B7||Male|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
3778438|NCT01890967|3609985|B6||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3778439|NCT01890967|3609986|B5||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3778440|NCT01890967|3609987|B4||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3778441|NCT01890967|3609988|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3778442|NCT01890967|3609989|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3778443|NCT01890967|3609990|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3778444|NCT01890967|3609984|B7||Female|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
3778445|NCT01890967|3609985|B6||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3778446|NCT01890967|3609986|B5||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3778447|NCT01890967|3609987|B4||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3778448|NCT01890967|3609988|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3778449|NCT01890967|3609989|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3778450|NCT01890967|3609990|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3778451|NCT01890967|3609984|B7|||Age||Years|Mean|58.4|58.4|Standard Deviation|10.2|10.2|||
3778452|NCT01890967|3609985|B6|||Age||Years|Mean|58.7|58.7|Standard Deviation|10.1|10.1|||
3778453|NCT01890967|3609986|B5|||Age||Years|Mean|59.6|59.6|Standard Deviation|8.1|8.1|||
3778454|NCT01890967|3609987|B4|||Age||Years|Mean|59.7|59.7|Standard Deviation|9.4|9.4|||
3778455|NCT01890967|3609988|B3|||Age||Years|Mean|57.1|57.1|Standard Deviation|12.4|12.4|||
3778456|NCT01890967|3609989|B2|||Age||Years|Mean|57.2|57.2|Standard Deviation|9.4|9.4|||
3778457|NCT01890967|3609990|B1|||Age||Years|Mean|57.9|57.9|Standard Deviation|11.2|11.2|||
3778458|NCT01890954|3610062|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
3778459|NCT01890954|3610063|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3778460|NCT01890954|3610064|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3778461|NCT01890954|3610062|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778462|NCT01890954|3610063|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778463|NCT01890954|3610064|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778464|NCT01890954|3610062|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778465|NCT01890954|3610063|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778466|NCT01890954|3610064|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778467|NCT01890954|3610062|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3778468|NCT01890954|3610063|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3778469|NCT01890954|3610064|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3778470|NCT01890954|3610062|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778471|NCT01890954|3610063|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778472|NCT01890954|3610064|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778473|NCT01890954|3610062|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778474|NCT01890954|3610063|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778475|NCT01890954|3610064|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778476|NCT01890954|3610062|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778477|NCT01890954|3610063|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778478|NCT01890954|3610064|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778479|NCT01890954|3610062|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778480|NCT01890954|3610063|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778481|NCT01890954|3610064|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778482|NCT01890954|3610062|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778483|NCT01890954|3610063|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778484|NCT01890954|3610064|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778485|NCT01890954|3610062|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3778486|NCT01890954|3610063|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3778487|NCT01890954|3610064|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3778488|NCT01890954|3610062|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778489|NCT01890954|3610063|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778490|NCT01890954|3610064|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778491|NCT01890954|3610062|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3778492|NCT01890954|3610063|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3778493|NCT01890954|3610064|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3778494|NCT01890954|3610062|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3778495|NCT01890954|3610063|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3778496|NCT01890954|3610064|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3778497|NCT01890954|3610062|B3|||Age||years|Mean|15|15.0|Standard Deviation|2|2.0|||
3778498|NCT01890954|3610063|B2|||Age||years|Mean|15|15.0|Standard Deviation|2|2.0|||
3778499|NCT01890954|3610064|B1|||Age||years|Mean|15|15.0|Standard Deviation|2|2.0|||
3778500|NCT01890954|3610062|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3778501|NCT01890954|3610063|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3778502|NCT01890954|3610064|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3778503|NCT01890954|3610062|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3778504|NCT01890954|3610063|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3778505|NCT01890954|3610064|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3778506|NCT01890954|3610062|B3||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
3778507|NCT01890954|3610063|B2||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
3778508|NCT01890954|3610064|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
3778509|NCT01890915|3610071|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
3778510|NCT01890915|3610072|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3778511|NCT01890915|3610073|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3778512|NCT01890915|3610071|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3778513|NCT01890915|3610072|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3778514|NCT01890915|3610073|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3778515|NCT01890915|3610071|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3778516|NCT01890915|3610072|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3778517|NCT01890915|3610073|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3778518|NCT01890915|3610071|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3778519|NCT01890915|3610072|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3778520|NCT01890915|3610073|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3778521|NCT01890915|3610071|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3778522|NCT01890915|3610072|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3778523|NCT01890915|3610073|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3778524|NCT01890915|3610071|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3778525|NCT01890915|3610072|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3778526|NCT01890915|3610073|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3778527|NCT01890785|3610084|B7|UNITED STATES||Region of Enrollment||Participants|Number|30|30.0||||||
3778528|NCT01890785|3610085|B6|UNITED STATES||Region of Enrollment||Participants|Number|5|5.0||||||
3778529|NCT01890785|3610086|B5|UNITED STATES||Region of Enrollment||Participants|Number|5|5.0||||||
3778530|NCT01890785|3610087|B4|UNITED STATES||Region of Enrollment||Participants|Number|5|5.0||||||
3778531|NCT01890785|3610088|B3|UNITED STATES||Region of Enrollment||Participants|Number|5|5.0||||||
3778532|NCT01890785|3610089|B2|UNITED STATES||Region of Enrollment||Participants|Number|5|5.0||||||
3778533|NCT01890785|3610090|B1|UNITED STATES||Region of Enrollment||Participants|Number|5|5.0||||||
3778534|NCT01890785|3610084|B7||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3778535|NCT01890785|3610085|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3778536|NCT01890785|3610086|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3778537|NCT01890785|3610087|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3778538|NCT01890785|3610088|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3778539|NCT01890785|3610089|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3778540|NCT01890785|3610090|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3778541|NCT01890785|3610084|B7||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3778542|NCT01890785|3610085|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3778543|NCT01890785|3610086|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3778544|NCT01890785|3610087|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3778545|NCT01890785|3610088|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3778546|NCT01890785|3610089|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3778547|NCT01890785|3610090|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3778548|NCT01890785|3610084|B7|Between 18 and 65 years, inclusive||Age, Customized||Participants|Number|30|30.0||||||
3778549|NCT01890785|3610085|B6|Between 18 and 65 years, inclusive||Age, Customized||Participants|Number|5|5.0||||||
3778550|NCT01890785|3610086|B5|Between 18 and 65 years, inclusive||Age, Customized||Participants|Number|5|5.0||||||
3778551|NCT01890785|3610087|B4|Between 18 and 65 years, inclusive||Age, Customized||Participants|Number|5|5.0||||||
3778552|NCT01890785|3610088|B3|Between 18 and 65 years, inclusive||Age, Customized||Participants|Number|5|5.0||||||
3778553|NCT01890785|3610089|B2|Between 18 and 65 years, inclusive||Age, Customized||Participants|Number|5|5.0||||||
3778613|NCT01890694|3610174|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3778554|NCT01890785|3610090|B1|Between 18 and 65 years, inclusive||Age, Customized||Participants|Number|5|5.0||||||
3778555|NCT01890785|3610084|B7|||Age||Years|Mean|37.6|37.6|Standard Deviation|10.07|10.07|||
3778556|NCT01890785|3610085|B6|||Age||Years|Mean|41.8|41.8|Standard Deviation|10.06|10.06|||
3778557|NCT01890785|3610086|B5|||Age||Years|Mean|39.6|39.6|Standard Deviation|9.86|9.86|||
3778558|NCT01890785|3610087|B4|||Age||Years|Mean|34.2|34.2|Standard Deviation|12.42|12.42|||
3778559|NCT01890785|3610088|B3|||Age||Years|Mean|42.2|42.2|Standard Deviation|4.44|4.44|||
3778560|NCT01890785|3610089|B2|||Age||Years|Mean|35.4|35.4|Standard Deviation|12.42|12.42|||
3778561|NCT01890785|3610090|B1|||Age||Years|Mean|32.6|32.6|Standard Deviation|10.16|10.16|||
3778562|NCT01890759|3610112|B3|India||Region of Enrollment||Participants|Number|200|200.0||||||
3778563|NCT01890759|3610113|B2|India||Region of Enrollment||Participants|Number|200|200.0||||||
3778564|NCT01890759|3610114|B1|India||Region of Enrollment||Participants|Number|0|0.0||||||
3778565|NCT01890759|3610112|B3|Russia||Region of Enrollment||Participants|Number|100|100.0||||||
3778566|NCT01890759|3610113|B2|Russia||Region of Enrollment||Participants|Number|0|0.0||||||
3778567|NCT01890759|3610114|B1|Russia||Region of Enrollment||Participants|Number|100|100.0||||||
3778568|NCT01890759|3610112|B3||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3778569|NCT01890759|3610113|B2||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3778570|NCT01890759|3610114|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3778571|NCT01890759|3610112|B3||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3778572|NCT01890759|3610113|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3778573|NCT01890759|3610114|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3778574|NCT01890759|3610112|B3|Age Continuous||Age||Months|Mean|13.1|13.1|Standard Deviation|2.9|2.9|||
3778575|NCT01890759|3610113|B2|Age Continuous||Age||Months|Mean|12.9|12.9|Standard Deviation|3.0|3.0|||
3778576|NCT01890759|3610114|B1|Age Continuous||Age||Months|Mean|13.5|13.5|Standard Deviation|2.7|2.7|||
3778577|NCT01890759|3610112|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3778578|NCT01890759|3610113|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3778579|NCT01890759|3610114|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3778580|NCT01890759|3610112|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3778581|NCT01890759|3610113|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3778582|NCT01890759|3610114|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3778583|NCT01890759|3610112|B3||<=18 years|Age||Participants|Count of Participants|300|300.0||||||
3778584|NCT01890759|3610113|B2||<=18 years|Age||Participants|Count of Participants|200|200.0||||||
3778585|NCT01890759|3610114|B1||<=18 years|Age||Participants|Count of Participants|100|100.0||||||
3778586|NCT01890746|3610147|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|92|92.0||||||
3778587|NCT01890746|3610148|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|50|50.0||||||
3778588|NCT01890746|3610149|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|42|42.0||||||
3778589|NCT01890746|3610147|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3778590|NCT01890746|3610148|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3778591|NCT01890746|3610149|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3778592|NCT01890746|3610147|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3778593|NCT01890746|3610148|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3778594|NCT01890746|3610149|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3778595|NCT01890746|3610147|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|43|43.0||||||
3778596|NCT01890746|3610148|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
3778597|NCT01890746|3610149|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|26|26.0||||||
3778598|NCT01890746|3610147|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3778599|NCT01890746|3610148|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3778600|NCT01890746|3610149|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3778601|NCT01890746|3610147|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3778602|NCT01890746|3610148|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3778603|NCT01890746|3610149|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3778604|NCT01890746|3610147|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3778605|NCT01890746|3610148|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3778606|NCT01890746|3610149|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3778607|NCT01890746|3610147|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3778608|NCT01890746|3610148|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3778609|NCT01890746|3610149|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3778610|NCT01890746|3610147|B3|||Age||Years|Mean|56.7|56.7|Standard Deviation|11.88|11.88|||
3778611|NCT01890746|3610148|B2|||Age||Years|Mean|56.6|56.6|Standard Deviation|11.58|11.58|||
3778612|NCT01890746|3610149|B1|||Age||Years|Mean|56.7|56.7|Standard Deviation|12.25|12.25|||
3778614|NCT01890694|3610175|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3778615|NCT01890694|3610176|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3778616|NCT01890694|3610174|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3778617|NCT01890694|3610175|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3778618|NCT01890694|3610176|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3778619|NCT01890694|3610174|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3778620|NCT01890694|3610175|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3778621|NCT01890694|3610176|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3778622|NCT01890694|3610174|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3778623|NCT01890694|3610175|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3778624|NCT01890694|3610176|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3778625|NCT01890694|3610174|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3778626|NCT01890694|3610175|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3778627|NCT01890694|3610176|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3778628|NCT01890642|3610209|B4|||Previous Venipuncture|Reported Previous Venipuncture Experience. 3 parents stated they did not know if their child had previous venipuncture, accounting for the difference between the number enrolled in the study and the number on which this variable was collected.|participants|Number|202|202.0||||||
3778629|NCT01890642|3610210|B3|||Previous Venipuncture|Reported Previous Venipuncture Experience. 3 parents stated they did not know if their child had previous venipuncture, accounting for the difference between the number enrolled in the study and the number on which this variable was collected.|participants|Number|96|96.0||||||
3778630|NCT01890642|3610211|B2|||Previous Venipuncture|Reported Previous Venipuncture Experience. 3 parents stated they did not know if their child had previous venipuncture, accounting for the difference between the number enrolled in the study and the number on which this variable was collected.|participants|Number|51|51.0||||||
3778631|NCT01890642|3610212|B1|||Previous Venipuncture|Reported Previous Venipuncture Experience. 3 parents stated they did not know if their child had previous venipuncture, accounting for the difference between the number enrolled in the study and the number on which this variable was collected.|participants|Number|55|55.0||||||
3778632|NCT01890642|3610209|B4|United States||Region of Enrollment||participants|Number|205|205.0||||||
3778633|NCT01890642|3610210|B3|United States||Region of Enrollment||participants|Number|96|96.0||||||
3778634|NCT01890642|3610211|B2|United States||Region of Enrollment||participants|Number|53|53.0||||||
3778635|NCT01890642|3610212|B1|United States||Region of Enrollment||participants|Number|56|56.0||||||
3778636|NCT01890642|3610209|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3778637|NCT01890642|3610210|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3778638|NCT01890642|3610211|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3778639|NCT01890642|3610212|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3778640|NCT01890642|3610209|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3778641|NCT01890642|3610210|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3778642|NCT01890642|3610211|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3778643|NCT01890642|3610212|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3778644|NCT01890642|3610209|B4||White|Race (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
3778645|NCT01890642|3610210|B3||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3778646|NCT01890642|3610211|B2||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3778647|NCT01890642|3610212|B1||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3778648|NCT01890642|3610209|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3778649|NCT01890642|3610210|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3778650|NCT01890642|3610211|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3778651|NCT01890642|3610212|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3778652|NCT01890642|3610209|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778653|NCT01890642|3610210|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778654|NCT01890642|3610211|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778655|NCT01890642|3610212|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778656|NCT01890642|3610209|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3778657|NCT01890642|3610210|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778658|NCT01890642|3610211|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3778659|NCT01890642|3610212|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778660|NCT01890642|3610209|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3778661|NCT01890642|3610210|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3778662|NCT01890642|3610211|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778663|NCT01890642|3610212|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778664|NCT01890642|3610209|B4||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3778665|NCT01890642|3610210|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3778666|NCT01890642|3610211|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3778667|NCT01890642|3610212|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3778668|NCT01890642|3610209|B4||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3778669|NCT01890642|3610210|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3778670|NCT01890642|3610211|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3778671|NCT01890642|3610212|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3778672|NCT01890642|3610209|B4|||Age||years|Mean|3.2|3.2|Standard Deviation|1.7|1.7|||
3778673|NCT01890642|3610210|B3|||Age||years|Mean|3.3|3.3|Standard Deviation|1.9|1.9|||
3778674|NCT01890642|3610211|B2|||Age||years|Mean|2.9|2.9|Standard Deviation|1.7|1.7|||
3778675|NCT01890642|3610212|B1|||Age||years|Mean|3.4|3.4|Standard Deviation|1.6|1.6|||
3778676|NCT01890642|3610209|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3778677|NCT01890642|3610210|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3778678|NCT01890642|3610211|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3778679|NCT01890642|3610212|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3778680|NCT01890642|3610209|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3778681|NCT01890642|3610210|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3778682|NCT01890642|3610211|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3778683|NCT01890642|3610212|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3778684|NCT01890642|3610209|B4||<=18 years|Age||Participants|Count of Participants|205|205.0||||||
3778685|NCT01890642|3610210|B3||<=18 years|Age||Participants|Count of Participants|96|96.0||||||
3778686|NCT01890642|3610211|B2||<=18 years|Age||Participants|Count of Participants|53|53.0||||||
3778687|NCT01890642|3610212|B1||<=18 years|Age||Participants|Count of Participants|56|56.0||||||
3778688|NCT01890577|3610234|B1|||Baseline Aranesp Dose||µg/week|Mean|36.6|36.6|Standard Deviation|7.5|7.5|||
3778689|NCT01890577|3610234|B1|Subcutaneous||Baseline Aranesp Route||participants|Number|27|27.0||||||
3778690|NCT01890577|3610234|B1|Intravenous||Baseline Aranesp Route||participants|Number|1|1.0||||||
3778691|NCT01890577|3610234|B1|||Baseline Hemoglobin Concentration|Data were available for 11 participants|g/dL|Mean|9.7|9.7|Standard Deviation|2.0|2.0|||
3778692|NCT01890577|3610234|B1|Colored||Race/Ethnicity, Customized|Race data were available for 27 participants|participants|Number|3|3.0||||||
3778693|NCT01890577|3610234|B1|Asian||Race/Ethnicity, Customized|Race data were available for 27 participants|participants|Number|11|11.0||||||
3778694|NCT01890577|3610234|B1|Black||Race/Ethnicity, Customized|Race data were available for 27 participants|participants|Number|12|12.0||||||
3778695|NCT01890577|3610234|B1|White/caucasian||Race/Ethnicity, Customized|Race data were available for 27 participants|participants|Number|1|1.0||||||
3778696|NCT01890577|3610234|B1|Male||Gender|Gender data were available for 27 participants|participants|Number|14|14.0||||||
3778697|NCT01890577|3610234|B1|Female||Gender|Gender data were available for 27 participants|participants|Number|13|13.0||||||
3778698|NCT01890577|3610234|B1|||Age|Age data were available for 27 participants|years|Mean|55.8|55.8|Standard Deviation|15.1|15.1|||
3778699|NCT01890512|3610247|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3778700|NCT01890512|3610247|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3778701|NCT01890512|3610247|B1|||Age||years|Mean|71.5|71.5|Standard Deviation|11.5|11.5|||
3778702|NCT01890473|3610251|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3778703|NCT01890473|3610252|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3778704|NCT01890473|3610253|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3778705|NCT01890473|3610251|B3||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
3778706|NCT01890473|3610252|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3778707|NCT01890473|3610253|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3778708|NCT01890473|3610251|B3|Greater than, equal to (>=) 65||Age, Customized||participants|Number|59|59.0||||||
3778709|NCT01890473|3610252|B2|Greater than, equal to (>=) 65||Age, Customized||participants|Number|38|38.0||||||
3778710|NCT01890473|3610253|B1|Greater than, equal to (>=) 65||Age, Customized||participants|Number|21|21.0||||||
3778711|NCT01890473|3610251|B3|Less than (<) 65||Age, Customized||participants|Number|165|165.0||||||
3778712|NCT01890473|3610252|B2|Less than (<) 65||Age, Customized||participants|Number|75|75.0||||||
3778713|NCT01890473|3610253|B1|Less than (<) 65||Age, Customized||participants|Number|90|90.0||||||
3778714|NCT01890473|3610251|B3|||Age||years|Mean|54.9|54.9|Standard Deviation|12.97|12.97|||
3778715|NCT01890473|3610252|B2|||Age||years|Mean|56.8|56.8|Standard Deviation|12.36|12.36|||
3778716|NCT01890473|3610253|B1|||Age||years|Mean|53.0|53.0|Standard Deviation|13.34|13.34|||
3778717|NCT01890434|3610280|B1|||Estimated glomerular filtration rate (eGFR)||mL/min/1.73m^2|Mean|82.0|82.0|Standard Deviation|18.73|18.73|||
3778718|NCT01890434|3610280|B1||No|Childbearing potential||Participants|Count of Participants|150|150.0||||||
3778719|NCT01890434|3610280|B1||Yes|Childbearing potential||Participants|Count of Participants|27|27.0||||||
3778720|NCT01890434|3610280|B1|||Body mass index (BMI)||kilogram per square meter (kg/m^2)|Mean|29.4|29.4|Standard Deviation|5.5|5.5|||
3778721|NCT01890434|3610280|B1|||Height||centimeter (cm)|Mean|170.9|170.9|Standard Deviation|9.7|9.7|||
3778722|NCT01890434|3610280|B1|||Body weight||kilogram (kg)|Mean|86.2|86.2|Standard Deviation|18.6|18.6|||
3778723|NCT01890434|3610280|B1|Canada||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3778724|NCT01890434|3610280|B1|Singapore||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3778725|NCT01890434|3610280|B1|Australia||Region of Enrollment||Participants|Count of Participants|71|71.0||||||
3778726|NCT01890434|3610280|B1|United States||Region of Enrollment||Participants|Count of Participants|356|356.0||||||
3778727|NCT01890434|3610280|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3778728|NCT01890434|3610280|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3778729|NCT01890434|3610280|B1||White|Race (NIH/OMB)||Participants|Count of Participants|322|322.0||||||
3778730|NCT01890434|3610280|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
3778731|NCT01890434|3610280|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3778732|NCT01890434|3610280|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3778733|NCT01890434|3610280|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3778734|NCT01890434|3610280|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3778735|NCT01890434|3610280|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|448|448.0||||||
3778736|NCT01890434|3610280|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3778737|NCT01890434|3610280|B1||Male|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
3778738|NCT01890434|3610280|B1||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
3778739|NCT01890434|3610280|B1|||Age||Years|Mean|58.6|58.6|Standard Deviation|10.3|10.3|||
3778740|NCT01890421|3610310|B1|||Estimated glomerular filtration rate (eGFR)|eGFR (based on serum/blood creatinine from local laboratory) was measured/evaluated within 2 weeks before the first gadobutrol injection (at the latest on the day of gadobutrol-enhanced CMRI before the first gadobutrol injection).|mL/min/1.73m^2|Mean|84.2|84.2|Standard Deviation|18.37|18.37|||
3778741|NCT01890421|3610310|B1|>= 65 years||Age||Count of Participants|Number|134|134.0||||||
3778742|NCT01890421|3610310|B1|>= 45 to <= 64 years||Age||Count of Participants|Number|232|232.0||||||
3778743|NCT01890421|3610310|B1|< 45 years||Age||Count of Participants|Number|60|60.0||||||
3778744|NCT01890421|3610310|B1||New Zealand|Country||Participants|Count of Participants|1|1.0||||||
3778745|NCT01890421|3610310|B1||France|Country||Participants|Count of Participants|4|4.0||||||
3778746|NCT01890421|3610310|B1||United Kingdom|Country||Participants|Count of Participants|28|28.0||||||
3778747|NCT01890421|3610310|B1||United States of America|Country||Participants|Count of Participants|31|31.0||||||
3778748|NCT01890421|3610310|B1||Switzerland|Country||Participants|Count of Participants|44|44.0||||||
3778749|NCT01890421|3610310|B1||South Korea|Country||Participants|Count of Participants|108|108.0||||||
3778750|NCT01890421|3610310|B1||Germany|Country||Participants|Count of Participants|210|210.0||||||
3778751|NCT01890421|3610310|B1|||Body Mass Index||Kilogram per square meter (kg/m^2)|Mean|27.160|27.16|Standard Deviation|4.561|4.561|||
3778752|NCT01890421|3610310|B1|||Height||Centimeter|Mean|170.99|170.99|Standard Deviation|9.17|9.17|||
3778753|NCT01890421|3610310|B1|||Body Weight||Kilogram (kg)|Mean|79.75|79.75|Standard Deviation|16.29|16.29|||
3778754|NCT01890421|3610310|B1|No childbearing potential (only males)||Childbearing Potential||Count of Participants|Number|297|297.0||||||
3778755|NCT01890421|3610310|B1|No childbearing potential (only females)||Childbearing Potential||Count of Participants|Number|109|109.0||||||
3778756|NCT01890421|3610310|B1|Of childbearing potential (only females)||Childbearing Potential||Count of Participants|Number|20|20.0||||||
3778757|NCT01890421|3610310|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3778758|NCT01890421|3610310|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778759|NCT01890421|3610310|B1||White|Race (NIH/OMB)||Participants|Count of Participants|310|310.0||||||
3778760|NCT01890421|3610310|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3778761|NCT01890421|3610310|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778762|NCT01890421|3610310|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
3778763|NCT01890421|3610310|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778764|NCT01890421|3610310|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3778765|NCT01890421|3610310|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|414|414.0||||||
3778766|NCT01890421|3610310|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3778767|NCT01890421|3610310|B1||Male|Sex: Female, Male||Participants|Count of Participants|297|297.0||||||
3778768|NCT01890421|3610310|B1||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3778769|NCT01890421|3610310|B1|||Age||Years|Mean|58.4|58.4|Standard Deviation|11.9|11.9|||
3778770|NCT01890343|3610333|B4|United Kingdom||Region of Enrollment||participants|Number|28|28.0||||||
3778771|NCT01890343|3610334|B3|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
3778772|NCT01890343|3610335|B2|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
3778773|NCT01890343|3610336|B1|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3778774|NCT01890343|3610333|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3778775|NCT01890343|3610334|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3778776|NCT01890343|3610335|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3778777|NCT01890343|3610336|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3778778|NCT01890343|3610333|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3778779|NCT01890343|3610334|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3778780|NCT01890343|3610335|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3778781|NCT01890343|3610336|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3778782|NCT01890343|3610333|B4|||Age||years|Mean|62.5|62.5|Standard Deviation|6.22|6.22|||
3778783|NCT01890343|3610334|B3|||Age||years|Mean|62.6|62.6|Standard Deviation|4.35|4.35|||
3778784|NCT01890343|3610335|B2|||Age||years|Mean|62.4|62.4|Standard Deviation|4.99|4.99|||
3778785|NCT01890343|3610336|B1|||Age||years|Mean|62.4|62.4|Standard Deviation|9.62|9.62|||
3778786|NCT01890148|3610349|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3778787|NCT01890148|3610349|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3778788|NCT01890148|3610349|B1|||Age||Years|Mean|46.8|46.8|Standard Deviation|10.3|10.3|||
3778789|NCT01890122|3610365|B5|Taiwan, Province of China||Region of Enrollment||participants|Number|17|17.0||||||
3778790|NCT01890122|3610366|B4|Taiwan, Province of China||Region of Enrollment||participants|Number|4|4.0||||||
3778791|NCT01890122|3610367|B3|Taiwan, Province of China||Region of Enrollment||participants|Number|3|3.0||||||
3778792|NCT01890122|3610368|B2|Taiwan, Province of China||Region of Enrollment||participants|Number|5|5.0||||||
3778793|NCT01890122|3610369|B1|Taiwan, Province of China||Region of Enrollment||participants|Number|5|5.0||||||
3778794|NCT01890122|3610365|B5|Malaysia||Region of Enrollment||participants|Number|75|75.0||||||
3778795|NCT01890122|3610366|B4|Malaysia||Region of Enrollment||participants|Number|19|19.0||||||
3778796|NCT01890122|3610367|B3|Malaysia||Region of Enrollment||participants|Number|18|18.0||||||
3778797|NCT01890122|3610368|B2|Malaysia||Region of Enrollment||participants|Number|19|19.0||||||
3778798|NCT01890122|3610369|B1|Malaysia||Region of Enrollment||participants|Number|19|19.0||||||
3778799|NCT01890122|3610365|B5|Korea, Republic of||Region of Enrollment||participants|Number|39|39.0||||||
3778800|NCT01890122|3610366|B4|Korea, Republic of||Region of Enrollment||participants|Number|10|10.0||||||
3778801|NCT01890122|3610367|B3|Korea, Republic of||Region of Enrollment||participants|Number|10|10.0||||||
3778802|NCT01890122|3610368|B2|Korea, Republic of||Region of Enrollment||participants|Number|10|10.0||||||
3778803|NCT01890122|3610369|B1|Korea, Republic of||Region of Enrollment||participants|Number|9|9.0||||||
3778804|NCT01890122|3610365|B5|China||Region of Enrollment||participants|Number|516|516.0||||||
3778805|NCT01890122|3610366|B4|China||Region of Enrollment||participants|Number|130|130.0||||||
3778806|NCT01890122|3610367|B3|China||Region of Enrollment||participants|Number|128|128.0||||||
3778807|NCT01890122|3610368|B2|China||Region of Enrollment||participants|Number|129|129.0||||||
3778808|NCT01890122|3610369|B1|China||Region of Enrollment||participants|Number|129|129.0||||||
3778809|NCT01890122|3610365|B5|Not Applicable (Participant is Male)||Female Reproductive Status||participants|Number|366|366.0||||||
3778810|NCT01890122|3610366|B4|Not Applicable (Participant is Male)||Female Reproductive Status||participants|Number|95|95.0||||||
3778811|NCT01890122|3610367|B3|Not Applicable (Participant is Male)||Female Reproductive Status||participants|Number|91|91.0||||||
3778812|NCT01890122|3610368|B2|Not Applicable (Participant is Male)||Female Reproductive Status||participants|Number|98|98.0||||||
3778813|NCT01890122|3610369|B1|Not Applicable (Participant is Male)||Female Reproductive Status||participants|Number|82|82.0||||||
3778814|NCT01890122|3610365|B5|Female of Childbearing Potential||Female Reproductive Status||participants|Number|76|76.0||||||
3778815|NCT01890122|3610366|B4|Female of Childbearing Potential||Female Reproductive Status||participants|Number|18|18.0||||||
3778816|NCT01890122|3610367|B3|Female of Childbearing Potential||Female Reproductive Status||participants|Number|21|21.0||||||
3778817|NCT01890122|3610368|B2|Female of Childbearing Potential||Female Reproductive Status||participants|Number|12|12.0||||||
3778818|NCT01890122|3610369|B1|Female of Childbearing Potential||Female Reproductive Status||participants|Number|25|25.0||||||
3778819|NCT01890122|3610365|B5|Surgically Sterile||Female Reproductive Status||participants|Number|31|31.0||||||
3778820|NCT01890122|3610366|B4|Surgically Sterile||Female Reproductive Status||participants|Number|5|5.0||||||
3778821|NCT01890122|3610367|B3|Surgically Sterile||Female Reproductive Status||participants|Number|10|10.0||||||
3778822|NCT01890122|3610368|B2|Surgically Sterile||Female Reproductive Status||participants|Number|8|8.0||||||
3778823|NCT01890122|3610369|B1|Surgically Sterile||Female Reproductive Status||participants|Number|8|8.0||||||
3778824|NCT01890122|3610365|B5|Postmenopausal||Female Reproductive Status||participants|Number|174|174.0||||||
3778825|NCT01890122|3610366|B4|Postmenopausal||Female Reproductive Status||participants|Number|45|45.0||||||
3778826|NCT01890122|3610367|B3|Postmenopausal||Female Reproductive Status||participants|Number|37|37.0||||||
3778827|NCT01890122|3610368|B2|Postmenopausal||Female Reproductive Status||participants|Number|45|45.0||||||
3778828|NCT01890122|3610369|B1|Postmenopausal||Female Reproductive Status||participants|Number|47|47.0||||||
3778829|NCT01890122|3610365|B5|Is an Ex-smoker||Smoking Classification||participants|Number|49|49.0||||||
3778830|NCT01890122|3610366|B4|Is an Ex-smoker||Smoking Classification||participants|Number|15|15.0||||||
3778831|NCT01890122|3610367|B3|Is an Ex-smoker||Smoking Classification||participants|Number|8|8.0||||||
3778832|NCT01890122|3610368|B2|Is an Ex-smoker||Smoking Classification||participants|Number|16|16.0||||||
3778833|NCT01890122|3610369|B1|Is an Ex-smoker||Smoking Classification||participants|Number|10|10.0||||||
3778834|NCT01890122|3610365|B5|Is a Current Smoker||Smoking Classification||participants|Number|136|136.0||||||
3778835|NCT01890122|3610366|B4|Is a Current Smoker||Smoking Classification||participants|Number|36|36.0||||||
3778836|NCT01890122|3610367|B3|Is a Current Smoker||Smoking Classification||participants|Number|38|38.0||||||
3778837|NCT01890122|3610368|B2|Is a Current Smoker||Smoking Classification||participants|Number|35|35.0||||||
3778838|NCT01890122|3610369|B1|Is a Current Smoker||Smoking Classification||participants|Number|27|27.0||||||
3778839|NCT01890122|3610365|B5|Has Never Smoked||Smoking Classification||participants|Number|462|462.0||||||
3778840|NCT01890122|3610366|B4|Has Never Smoked||Smoking Classification||participants|Number|112|112.0||||||
3778841|NCT01890122|3610367|B3|Has Never Smoked||Smoking Classification||participants|Number|113|113.0||||||
3778842|NCT01890122|3610368|B2|Has Never Smoked||Smoking Classification||participants|Number|112|112.0||||||
3778843|NCT01890122|3610369|B1|Has Never Smoked||Smoking Classification||participants|Number|125|125.0||||||
3778844|NCT01890122|3610365|B5|||Body Mass Index (BMI)||kg/m^2|Mean|26.30|26.3|Standard Deviation|3.811|3.811|||
3778845|NCT01890122|3610366|B4|||Body Mass Index (BMI)||kg/m^2|Mean|26.56|26.56|Standard Deviation|4.218|4.218|||
3778846|NCT01890122|3610367|B3|||Body Mass Index (BMI)||kg/m^2|Mean|26.16|26.16|Standard Deviation|3.508|3.508|||
3778847|NCT01890122|3610368|B2|||Body Mass Index (BMI)||kg/m^2|Mean|26.16|26.16|Standard Deviation|3.923|3.923|||
3778848|NCT01890122|3610369|B1|||Body Mass Index (BMI)||kg/m^2|Mean|26.30|26.3|Standard Deviation|3.566|3.566|||
3778849|NCT01890122|3610365|B5|||Weight|Weight data is available for 161, 163, 159 and 163 participants in each treatment arm, respectively.|kg|Mean|71.13|71.13|Standard Deviation|12.388|12.388|||
3778850|NCT01890122|3610366|B4|||Weight|Weight data is available for 161, 163, 159 and 163 participants in each treatment arm, respectively.|kg|Mean|71.79|71.79|Standard Deviation|13.949|13.949|||
3778851|NCT01890122|3610367|B3|||Weight|Weight data is available for 161, 163, 159 and 163 participants in each treatment arm, respectively.|kg|Mean|70.73|70.73|Standard Deviation|11.489|11.489|||
3778852|NCT01890122|3610368|B2|||Weight|Weight data is available for 161, 163, 159 and 163 participants in each treatment arm, respectively.|kg|Mean|71.21|71.21|Standard Deviation|11.669|11.669|||
3778853|NCT01890122|3610369|B1|||Weight|Weight data is available for 161, 163, 159 and 163 participants in each treatment arm, respectively.|kg|Mean|70.79|70.79|Standard Deviation|12.357|12.357|||
3778854|NCT01890122|3610365|B5|||Height||cm|Mean|164.3|164.3|Standard Deviation|8.42|8.42|||
3778855|NCT01890122|3610366|B4|||Height||cm|Mean|164.2|164.2|Standard Deviation|9.19|9.19|||
3778856|NCT01890122|3610367|B3|||Height||cm|Mean|164.3|164.3|Standard Deviation|7.66|7.66|||
3778857|NCT01890122|3610368|B2|||Height||cm|Mean|165.0|165.0|Standard Deviation|8.06|8.06|||
3778858|NCT01890122|3610369|B1|||Height||cm|Mean|163.8|163.8|Standard Deviation|8.72|8.72|||
3778859|NCT01890122|3610365|B5|Hispanic or Latino (No)||Race/Ethnicity, Customized||participants|Number|646|646.0||||||
3778860|NCT01890122|3610366|B4|Hispanic or Latino (No)||Race/Ethnicity, Customized||participants|Number|163|163.0||||||
3778861|NCT01890122|3610367|B3|Hispanic or Latino (No)||Race/Ethnicity, Customized||participants|Number|158|158.0||||||
3778862|NCT01890122|3610368|B2|Hispanic or Latino (No)||Race/Ethnicity, Customized||participants|Number|163|163.0||||||
3778863|NCT01890122|3610369|B1|Hispanic or Latino (No)||Race/Ethnicity, Customized||participants|Number|162|162.0||||||
3778864|NCT01890122|3610365|B5|Hispanic or Latino (Yes)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3778865|NCT01890122|3610366|B4|Hispanic or Latino (Yes)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778866|NCT01890122|3610367|B3|Hispanic or Latino (Yes)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3778867|NCT01890122|3610368|B2|Hispanic or Latino (Yes)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778868|NCT01890122|3610369|B1|Hispanic or Latino (Yes)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778869|NCT01890122|3610365|B5|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3778870|NCT01890122|3610366|B4|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778871|NCT01890122|3610367|B3|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778872|NCT01890122|3610368|B2|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778873|NCT01890122|3610369|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3778874|NCT01890122|3610365|B5|Asian||Race/Ethnicity, Customized||participants|Number|643|643.0||||||
3778875|NCT01890122|3610366|B4|Asian||Race/Ethnicity, Customized||participants|Number|161|161.0||||||
3778876|NCT01890122|3610367|B3|Asian||Race/Ethnicity, Customized||participants|Number|159|159.0||||||
3778877|NCT01890122|3610368|B2|Asian||Race/Ethnicity, Customized||participants|Number|162|162.0||||||
3778878|NCT01890122|3610369|B1|Asian||Race/Ethnicity, Customized||participants|Number|161|161.0||||||
3778879|NCT01890122|3610365|B5|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3778880|NCT01890122|3610366|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3778881|NCT01890122|3610367|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778882|NCT01890122|3610368|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3778883|NCT01890122|3610369|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3778884|NCT01890122|3610365|B5||Male|Sex: Female, Male||Participants|Count of Participants|366|366.0||||||
3778885|NCT01890122|3610366|B4||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3778886|NCT01890122|3610367|B3||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3778887|NCT01890122|3610368|B2||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3778888|NCT01890122|3610369|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3778889|NCT01890122|3610365|B5||Female|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
3778890|NCT01890122|3610366|B4||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3778891|NCT01890122|3610367|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3778892|NCT01890122|3610368|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3778893|NCT01890122|3610369|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3778894|NCT01890122|3610365|B5|||Age||years|Mean|53.6|53.6|Standard Deviation|10.08|10.08|||
3778895|NCT01890122|3610366|B4|||Age||years|Mean|52.2|52.2|Standard Deviation|10.17|10.17|||
3778896|NCT01890122|3610367|B3|||Age||years|Mean|53.4|53.4|Standard Deviation|10.46|10.46|||
3778897|NCT01890122|3610368|B2|||Age||years|Mean|55.4|55.4|Standard Deviation|9.62|9.62|||
3778898|NCT01890122|3610369|B1|||Age||years|Mean|53.6|53.6|Standard Deviation|9.91|9.91|||
3778899|NCT01890031|3610434|B6|||LDL Cholesterol||mg/dL|Mean|125.7|125.7|Standard Deviation|33.4|33.4|||
3778900|NCT01890031|3610435|B5|||LDL Cholesterol||mg/dL|Mean|129.9|129.9|Standard Deviation|38.2|38.2|||
3778901|NCT01890031|3610436|B4|||LDL Cholesterol||mg/dL|Mean|121.2|121.2|Standard Deviation|41.7|41.7|||
3778902|NCT01890031|3610437|B3|||LDL Cholesterol||mg/dL|Mean|130.4|130.4|Standard Deviation|37.8|37.8|||
3778903|NCT01890031|3610438|B2|||LDL Cholesterol||mg/dL|Mean|123.3|123.3|Standard Deviation|32.5|32.5|||
3778904|NCT01890031|3610439|B1|||LDL Cholesterol||mg/dL|Mean|125.5|125.5|Standard Deviation|31.4|31.4|||
3778905|NCT01890031|3610434|B6|United States||Region of Enrollment||participants|Number|131|131.0||||||
3778906|NCT01890031|3610435|B5|United States||Region of Enrollment||participants|Number|8|8.0||||||
3778907|NCT01890031|3610436|B4|United States||Region of Enrollment||participants|Number|11|11.0||||||
3778908|NCT01890031|3610437|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3778909|NCT01890031|3610438|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
3778910|NCT01890031|3610439|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3778911|NCT01890031|3610434|B6||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3778912|NCT01890031|3610435|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3778913|NCT01890031|3610436|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3778914|NCT01890031|3610437|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3778915|NCT01890031|3610438|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3778916|NCT01890031|3610439|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3778917|NCT01890031|3610434|B6||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3778918|NCT01890031|3610435|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3778919|NCT01890031|3610436|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3778920|NCT01890031|3610437|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3778921|NCT01890031|3610438|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3778922|NCT01890031|3610439|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3778923|NCT01890031|3610434|B6|||Age||years|Mean|49.0|49.0|Standard Deviation|12.1|12.1|||
3778924|NCT01890031|3610435|B5|||Age||years|Mean|51.4|51.4|Standard Deviation|13.0|13.0|||
3778925|NCT01890031|3610436|B4|||Age||years|Mean|57.7|57.7|Standard Deviation|8.8|8.8|||
3778926|NCT01890031|3610437|B3|||Age||years|Mean|53.3|53.3|Standard Deviation|9.7|9.7|||
3778927|NCT01890031|3610438|B2|||Age||years|Mean|46.6|46.6|Standard Deviation|13.5|13.5|||
3778928|NCT01890031|3610439|B1|||Age||years|Mean|48.5|48.5|Standard Deviation|11.9|11.9|||
3778929|NCT01889797|3610460|B3|Other||Primary Tumor Type||participants|Number|2|2.0||||||
3778930|NCT01889797|3610461|B2|Other||Primary Tumor Type||participants|Number|0|0.0||||||
3778931|NCT01889797|3610462|B1|Other||Primary Tumor Type||participants|Number|2|2.0||||||
3778932|NCT01889797|3610460|B3|Grade 2 Follicular NHL||Primary Tumor Type||participants|Number|7|7.0||||||
3778933|NCT01889797|3610461|B2|Grade 2 Follicular NHL||Primary Tumor Type||participants|Number|3|3.0||||||
3778934|NCT01889797|3610462|B1|Grade 2 Follicular NHL||Primary Tumor Type||participants|Number|4|4.0||||||
3778935|NCT01889797|3610460|B3|Grade 1 Follicular NHL||Primary Tumor Type||participants|Number|23|23.0||||||
3778936|NCT01889797|3610461|B2|Grade 1 Follicular NHL||Primary Tumor Type||participants|Number|13|13.0||||||
3778937|NCT01889797|3610462|B1|Grade 1 Follicular NHL||Primary Tumor Type||participants|Number|10|10.0||||||
3778938|NCT01889797|3610460|B3|Stage IV||Modified Ann Arbor Staging|The Ann Arbor staging is used to describe the extent of non-Hodgkin lymphoma (NHL) in adults. There are 4 levels of the Ann Arbor staging system. Stage I means the lymphoma is only in 1 lymph node area or lymphoid organ; II indicates 2 or more groups of lymph nodes on the same side of the diaphragm; III indicates disease is present in lymph node areas on both sides of the diaphragm and may have spread to other organs; and IV shows that disease has spread outside the lymph system and also to the bone marrow, liver, brain, spinal cord or lungs. Higher grades are considered as worse.|participants|Number|17|17.0||||||
3778939|NCT01889797|3610461|B2|Stage IV||Modified Ann Arbor Staging|The Ann Arbor staging is used to describe the extent of non-Hodgkin lymphoma (NHL) in adults. There are 4 levels of the Ann Arbor staging system. Stage I means the lymphoma is only in 1 lymph node area or lymphoid organ; II indicates 2 or more groups of lymph nodes on the same side of the diaphragm; III indicates disease is present in lymph node areas on both sides of the diaphragm and may have spread to other organs; and IV shows that disease has spread outside the lymph system and also to the bone marrow, liver, brain, spinal cord or lungs. Higher grades are considered as worse.|participants|Number|7|7.0||||||
3778940|NCT01889797|3610462|B1|Stage IV||Modified Ann Arbor Staging|The Ann Arbor staging is used to describe the extent of non-Hodgkin lymphoma (NHL) in adults. There are 4 levels of the Ann Arbor staging system. Stage I means the lymphoma is only in 1 lymph node area or lymphoid organ; II indicates 2 or more groups of lymph nodes on the same side of the diaphragm; III indicates disease is present in lymph node areas on both sides of the diaphragm and may have spread to other organs; and IV shows that disease has spread outside the lymph system and also to the bone marrow, liver, brain, spinal cord or lungs. Higher grades are considered as worse.|participants|Number|10|10.0||||||
3779006|NCT01889667|3610478|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3779007|NCT01889667|3610475|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3779008|NCT01889667|3610476|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3779009|NCT01889667|3610477|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3778941|NCT01889797|3610460|B3|Stage III (2)||Modified Ann Arbor Staging|The Ann Arbor staging is used to describe the extent of non-Hodgkin lymphoma (NHL) in adults. There are 4 levels of the Ann Arbor staging system. Stage I means the lymphoma is only in 1 lymph node area or lymphoid organ; II indicates 2 or more groups of lymph nodes on the same side of the diaphragm; III indicates disease is present in lymph node areas on both sides of the diaphragm and may have spread to other organs; and IV shows that disease has spread outside the lymph system and also to the bone marrow, liver, brain, spinal cord or lungs. Higher grades are considered as worse.|participants|Number|9|9.0||||||
3778942|NCT01889797|3610461|B2|Stage III (2)||Modified Ann Arbor Staging|The Ann Arbor staging is used to describe the extent of non-Hodgkin lymphoma (NHL) in adults. There are 4 levels of the Ann Arbor staging system. Stage I means the lymphoma is only in 1 lymph node area or lymphoid organ; II indicates 2 or more groups of lymph nodes on the same side of the diaphragm; III indicates disease is present in lymph node areas on both sides of the diaphragm and may have spread to other organs; and IV shows that disease has spread outside the lymph system and also to the bone marrow, liver, brain, spinal cord or lungs. Higher grades are considered as worse.|participants|Number|4|4.0||||||
3778943|NCT01889797|3610462|B1|Stage III (2)||Modified Ann Arbor Staging|The Ann Arbor staging is used to describe the extent of non-Hodgkin lymphoma (NHL) in adults. There are 4 levels of the Ann Arbor staging system. Stage I means the lymphoma is only in 1 lymph node area or lymphoid organ; II indicates 2 or more groups of lymph nodes on the same side of the diaphragm; III indicates disease is present in lymph node areas on both sides of the diaphragm and may have spread to other organs; and IV shows that disease has spread outside the lymph system and also to the bone marrow, liver, brain, spinal cord or lungs. Higher grades are considered as worse.|participants|Number|5|5.0||||||
3778944|NCT01889797|3610460|B3|Stage III (1)||Modified Ann Arbor Staging|The Ann Arbor staging is used to describe the extent of non-Hodgkin lymphoma (NHL) in adults. There are 4 levels of the Ann Arbor staging system. Stage I means the lymphoma is only in 1 lymph node area or lymphoid organ; II indicates 2 or more groups of lymph nodes on the same side of the diaphragm; III indicates disease is present in lymph node areas on both sides of the diaphragm and may have spread to other organs; and IV shows that disease has spread outside the lymph system and also to the bone marrow, liver, brain, spinal cord or lungs. Higher grades are considered as worse.|participants|Number|6|6.0||||||
3778945|NCT01889797|3610461|B2|Stage III (1)||Modified Ann Arbor Staging|The Ann Arbor staging is used to describe the extent of non-Hodgkin lymphoma (NHL) in adults. There are 4 levels of the Ann Arbor staging system. Stage I means the lymphoma is only in 1 lymph node area or lymphoid organ; II indicates 2 or more groups of lymph nodes on the same side of the diaphragm; III indicates disease is present in lymph node areas on both sides of the diaphragm and may have spread to other organs; and IV shows that disease has spread outside the lymph system and also to the bone marrow, liver, brain, spinal cord or lungs. Higher grades are considered as worse.|participants|Number|5|5.0||||||
3778946|NCT01889797|3610462|B1|Stage III (1)||Modified Ann Arbor Staging|The Ann Arbor staging is used to describe the extent of non-Hodgkin lymphoma (NHL) in adults. There are 4 levels of the Ann Arbor staging system. Stage I means the lymphoma is only in 1 lymph node area or lymphoid organ; II indicates 2 or more groups of lymph nodes on the same side of the diaphragm; III indicates disease is present in lymph node areas on both sides of the diaphragm and may have spread to other organs; and IV shows that disease has spread outside the lymph system and also to the bone marrow, liver, brain, spinal cord or lungs. Higher grades are considered as worse.|participants|Number|1|1.0||||||
3778947|NCT01889797|3610460|B3|PS 1||ECOG Performance Status|The ECOG performance status (PS) measures how a disease impacts a patient’s daily living abilities. It describes a patient’s level of functioning in terms of their ability to care for themselves, daily & physical abilities. The PS score ranges from 0 to 5. A PS score of 0 indicates that a patient is fully active & able to carry out all pre-disease performance without restriction; 1 indicates that a patient is restricted in performance; 2 indicates ambulatory; & at the extreme, 5 indicates a patient is deceased. High score indicates the disease has a higher negative impact on living abilities.|participants|Number|8|8.0||||||
3778948|NCT01889797|3610461|B2|PS 1||ECOG Performance Status|The ECOG performance status (PS) measures how a disease impacts a patient’s daily living abilities. It describes a patient’s level of functioning in terms of their ability to care for themselves, daily & physical abilities. The PS score ranges from 0 to 5. A PS score of 0 indicates that a patient is fully active & able to carry out all pre-disease performance without restriction; 1 indicates that a patient is restricted in performance; 2 indicates ambulatory; & at the extreme, 5 indicates a patient is deceased. High score indicates the disease has a higher negative impact on living abilities.|participants|Number|4|4.0||||||
3778949|NCT01889797|3610462|B1|PS 1||ECOG Performance Status|The ECOG performance status (PS) measures how a disease impacts a patient’s daily living abilities. It describes a patient’s level of functioning in terms of their ability to care for themselves, daily & physical abilities. The PS score ranges from 0 to 5. A PS score of 0 indicates that a patient is fully active & able to carry out all pre-disease performance without restriction; 1 indicates that a patient is restricted in performance; 2 indicates ambulatory; & at the extreme, 5 indicates a patient is deceased. High score indicates the disease has a higher negative impact on living abilities.|participants|Number|4|4.0||||||
3778950|NCT01889797|3610460|B3|PS 0||ECOG Performance Status|The ECOG performance status (PS) measures how a disease impacts a patient’s daily living abilities. It describes a patient’s level of functioning in terms of their ability to care for themselves, daily & physical abilities. The PS score ranges from 0 to 5. A PS score of 0 indicates that a patient is fully active & able to carry out all pre-disease performance without restriction; 1 indicates that a patient is restricted in performance; 2 indicates ambulatory; & at the extreme, 5 indicates a patient is deceased. High score indicates the disease has a higher negative impact on living abilities.|participants|Number|24|24.0||||||
3778951|NCT01889797|3610461|B2|PS 0||ECOG Performance Status|The ECOG performance status (PS) measures how a disease impacts a patient’s daily living abilities. It describes a patient’s level of functioning in terms of their ability to care for themselves, daily & physical abilities. The PS score ranges from 0 to 5. A PS score of 0 indicates that a patient is fully active & able to carry out all pre-disease performance without restriction; 1 indicates that a patient is restricted in performance; 2 indicates ambulatory; & at the extreme, 5 indicates a patient is deceased. High score indicates the disease has a higher negative impact on living abilities.|participants|Number|12|12.0||||||
3779010|NCT01889667|3610478|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3778952|NCT01889797|3610462|B1|PS 0||ECOG Performance Status|The ECOG performance status (PS) measures how a disease impacts a patient’s daily living abilities. It describes a patient’s level of functioning in terms of their ability to care for themselves, daily & physical abilities. The PS score ranges from 0 to 5. A PS score of 0 indicates that a patient is fully active & able to carry out all pre-disease performance without restriction; 1 indicates that a patient is restricted in performance; 2 indicates ambulatory; & at the extreme, 5 indicates a patient is deceased. High score indicates the disease has a higher negative impact on living abilities.|participants|Number|12|12.0||||||
3778953|NCT01889797|3610460|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
3778954|NCT01889797|3610461|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3778955|NCT01889797|3610462|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3778956|NCT01889797|3610460|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778957|NCT01889797|3610461|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778958|NCT01889797|3610462|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778959|NCT01889797|3610460|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778960|NCT01889797|3610461|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778961|NCT01889797|3610462|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778962|NCT01889797|3610460|B3||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3778963|NCT01889797|3610461|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3778964|NCT01889797|3610462|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3778965|NCT01889797|3610460|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3778966|NCT01889797|3610461|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778967|NCT01889797|3610462|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3778968|NCT01889797|3610460|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778969|NCT01889797|3610461|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778970|NCT01889797|3610462|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778971|NCT01889797|3610460|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778972|NCT01889797|3610461|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778973|NCT01889797|3610462|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778974|NCT01889797|3610460|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778975|NCT01889797|3610461|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778976|NCT01889797|3610462|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778977|NCT01889797|3610460|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778978|NCT01889797|3610461|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778979|NCT01889797|3610462|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778980|NCT01889797|3610460|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3778981|NCT01889797|3610461|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3778982|NCT01889797|3610462|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3778983|NCT01889797|3610460|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778984|NCT01889797|3610461|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778985|NCT01889797|3610462|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3778986|NCT01889797|3610460|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3778987|NCT01889797|3610461|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3778988|NCT01889797|3610462|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3778989|NCT01889797|3610460|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3778990|NCT01889797|3610461|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3778991|NCT01889797|3610462|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3778992|NCT01889797|3610460|B3|||Age||years|Median|56|56.0|Full Range|||31.0|82.0|
3778993|NCT01889797|3610461|B2|||Age||years|Median|59|59.0|Full Range|||31.0|82.0|
3778994|NCT01889797|3610462|B1|||Age||years|Median|52|52.0|Full Range|||37.0|81.0|
3778995|NCT01889667|3610475|B4|United States||Region of Enrollment||participants|Number|30|30.0||||||
3778996|NCT01889667|3610476|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3778997|NCT01889667|3610477|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3778998|NCT01889667|3610478|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3778999|NCT01889667|3610475|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3779000|NCT01889667|3610476|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3779001|NCT01889667|3610477|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3779002|NCT01889667|3610478|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3779003|NCT01889667|3610475|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3779004|NCT01889667|3610476|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3779005|NCT01889667|3610477|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3779011|NCT01889667|3610475|B4||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3779012|NCT01889667|3610476|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3779013|NCT01889667|3610477|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3779014|NCT01889667|3610478|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3779015|NCT01889667|3610475|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779016|NCT01889667|3610476|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779017|NCT01889667|3610477|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779018|NCT01889667|3610478|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779019|NCT01889667|3610475|B4|||Age||years|Mean|55.3|55.3|Standard Deviation|6.89|6.89|||
3779020|NCT01889667|3610476|B3|||Age||years|Mean|53.6|53.6|Standard Deviation|12.0|12.0|||
3779021|NCT01889667|3610477|B2|||Age||years|Mean|57.4|57.4|Standard Deviation|4.7|4.7|||
3779022|NCT01889667|3610478|B1|||Age||years|Mean|54.1|54.1|Standard Deviation|4.9|4.9|||
3779023|NCT01889563|3610500|B3|Brazil||Region of Enrollment||participants|Number|32|32.0||||||
3779024|NCT01889563|3610501|B2|Brazil||Region of Enrollment||participants|Number|15|15.0||||||
3779025|NCT01889563|3610502|B1|Brazil||Region of Enrollment||participants|Number|17|17.0||||||
3779026|NCT01889563|3610500|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3779027|NCT01889563|3610501|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3779028|NCT01889563|3610502|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3779029|NCT01889563|3610500|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3779030|NCT01889563|3610501|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3779031|NCT01889563|3610502|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3779032|NCT01889563|3610500|B3|||Age||years|Mean|66|66.0|Standard Deviation|8|8.0|||
3779033|NCT01889563|3610501|B2|||Age||years|Mean|66|66.0|Standard Deviation|10|10.0|||
3779034|NCT01889563|3610502|B1|||Age||years|Mean|67|67.0|Standard Deviation|7|7.0|||
3779035|NCT01889563|3610500|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3779036|NCT01889563|3610501|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3779037|NCT01889563|3610502|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3779038|NCT01889563|3610500|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3779039|NCT01889563|3610501|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3779040|NCT01889563|3610502|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3779041|NCT01889563|3610500|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779042|NCT01889563|3610501|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779043|NCT01889563|3610502|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779044|NCT01889420|3610511|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3779045|NCT01889420|3610511|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3779046|NCT01889420|3610511|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3779047|NCT01889420|3610511|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3779048|NCT01889420|3610511|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3779049|NCT01889420|3610511|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779050|NCT01889355|3610517|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779051|NCT01889355|3610517|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779052|NCT01889355|3610517|B1||White|Race (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
3779053|NCT01889355|3610517|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3779054|NCT01889355|3610517|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779055|NCT01889355|3610517|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3779056|NCT01889355|3610517|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779057|NCT01889355|3610517|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3779058|NCT01889355|3610517|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3779059|NCT01889355|3610517|B1||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
3779060|NCT01889355|3610517|B1||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
3779061|NCT01889355|3610517|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779062|NCT01889251|3610521|B3||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3779063|NCT01889251|3610522|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3779064|NCT01889251|3610523|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3779065|NCT01889251|3610521|B3||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3779066|NCT01889251|3610522|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3779067|NCT01889251|3610523|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3779068|NCT01889251|3610521|B3|||Age||years|Mean|68.2|68.2|Standard Deviation|8.0|8.0|||
3779069|NCT01889251|3610522|B2|||Age||years|Mean|68.6|68.6|Standard Deviation|9.2|9.2|||
3779070|NCT01889251|3610523|B1|||Age||years|Mean|68.1|68.1|Standard Deviation|7.3|7.3|||
3779071|NCT01889238|3610530|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3779072|NCT01889238|3610530|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3779073|NCT01889238|3610530|B1|||Age||years|Mean|58.3|58.3|Standard Deviation|12.95|12.95|||
3779074|NCT01888965|3610547|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3779075|NCT01888965|3610547|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3779076|NCT01888965|3610547|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3779077|NCT01888965|3610547|B1|||Age||years|Median|50.9|50.9|Full Range|||39.0|69.0|
3779078|NCT01888965|3610547|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3779079|NCT01888965|3610547|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3779080|NCT01888965|3610547|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779081|NCT01888952|3610553|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3779082|NCT01888952|3610553|B1||Male|Gender||Participants|Count of Participants|4|4.0||||||
3779083|NCT01888952|3610553|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
3779084|NCT01888952|3610553|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3779085|NCT01888952|3610553|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3779086|NCT01888952|3610553|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779087|NCT01888900|3610557|B3|White||Race||participants|Number|19|19.0||||||
3779088|NCT01888900|3610558|B2|White||Race||participants|Number|7|7.0||||||
3779089|NCT01888900|3610559|B1|White||Race||participants|Number|12|12.0||||||
3779090|NCT01888900|3610557|B3|Black||Race||participants|Number|13|13.0||||||
3779091|NCT01888900|3610558|B2|Black||Race||participants|Number|4|4.0||||||
3779092|NCT01888900|3610559|B1|Black||Race||participants|Number|9|9.0||||||
3779093|NCT01888900|3610557|B3|Asian||Race||participants|Number|3|3.0||||||
3779094|NCT01888900|3610558|B2|Asian||Race||participants|Number|2|2.0||||||
3779095|NCT01888900|3610559|B1|Asian||Race||participants|Number|1|1.0||||||
3779096|NCT01888900|3610557|B3|||HCV RNA level|log with base 10 transformed HCV RNA|log10(IU/ml)|Mean|6.69|6.69|Standard Deviation|0.44|0.44|||
3779097|NCT01888900|3610558|B2|||HCV RNA level|log with base 10 transformed HCV RNA|log10(IU/ml)|Mean|6.72|6.72|Standard Deviation|0.37|0.37|||
3779098|NCT01888900|3610559|B1|||HCV RNA level|log with base 10 transformed HCV RNA|log10(IU/ml)|Mean|6.67|6.67|Standard Deviation|0.49|0.49|||
3779099|NCT01888900|3610557|B3|||ALT|alanine aminotransferase|U/L|Mean|91.46|91.46|Standard Deviation|49.68|49.68|||
3779100|NCT01888900|3610558|B2|||ALT|alanine aminotransferase|U/L|Mean|78.08|78.08|Standard Deviation|42.18|42.18|||
3779101|NCT01888900|3610559|B1|||ALT|alanine aminotransferase|U/L|Mean|99.36|99.36|Standard Deviation|52.84|52.84|||
3779102|NCT01888900|3610557|B3||Male|Gender||Participants|Count of Participants|24|24.0||||||
3779103|NCT01888900|3610558|B2||Male|Gender||Participants|Count of Participants|7|7.0||||||
3779104|NCT01888900|3610559|B1||Male|Gender||Participants|Count of Participants|17|17.0||||||
3779105|NCT01888900|3610557|B3||Female|Gender||Participants|Count of Participants|11|11.0||||||
3779106|NCT01888900|3610558|B2||Female|Gender||Participants|Count of Participants|6|6.0||||||
3779107|NCT01888900|3610559|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
3779108|NCT01888900|3610557|B3|||Age||years|Mean|57.54|57.54|Standard Deviation|9.01|9.01|||
3779109|NCT01888900|3610558|B2|||Age||years|Mean|59.31|59.31|Standard Deviation|11.06|11.06|||
3779110|NCT01888900|3610559|B1|||Age||years|Mean|56.50|56.5|Standard Deviation|7.65|7.65|||
3779111|NCT01888432|3610580|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3779112|NCT01888432|3610581|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3779113|NCT01888432|3610582|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3779114|NCT01888432|3610580|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|223|223.0||||||
3779115|NCT01888432|3610581|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|112|112.0||||||
3779116|NCT01888432|3610582|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|111|111.0||||||
3779117|NCT01888432|3610580|B3||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|60|60.0||||||
3779118|NCT01888432|3610581|B2||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3779119|NCT01888432|3610582|B1||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3779120|NCT01888432|3610580|B3||Male|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
3779121|NCT01888432|3610581|B2||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3779122|NCT01888432|3610582|B1||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3779123|NCT01888432|3610580|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3779124|NCT01888432|3610581|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3779125|NCT01888432|3610582|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3779126|NCT01888432|3610580|B3|||Age||Years|Mean|53.5|53.5|Standard Deviation|9.72|9.72|||
3779127|NCT01888432|3610581|B2|||Age||Years|Mean|52.7|52.7|Standard Deviation|10.41|10.41|||
3779128|NCT01888432|3610582|B1|||Age||Years|Mean|54.2|54.2|Standard Deviation|8.95|8.95|||
3779129|NCT01888367|3610615|B4|United States||Region of Enrollment||participants|Number|445|445.0||||||
3779130|NCT01888367|3610616|B3|United States||Region of Enrollment||participants|Number|78|78.0||||||
3779131|NCT01888367|3610617|B2|United States||Region of Enrollment||participants|Number|71|71.0||||||
3779132|NCT01888367|3610618|B1|United States||Region of Enrollment||participants|Number|296|296.0||||||
3779133|NCT01888367|3610615|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3779134|NCT01888367|3610616|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779135|NCT01888367|3610617|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779136|NCT01888367|3610618|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3779137|NCT01888367|3610615|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779138|NCT01888367|3610616|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779139|NCT01888367|3610617|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779140|NCT01888367|3610618|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779141|NCT01888367|3610615|B4||White|Race (NIH/OMB)||Participants|Count of Participants|389|389.0||||||
3779142|NCT01888367|3610616|B3||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3779143|NCT01888367|3610617|B2||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3779144|NCT01888367|3610618|B1||White|Race (NIH/OMB)||Participants|Count of Participants|255|255.0||||||
3779145|NCT01888367|3610615|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3779146|NCT01888367|3610616|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3779147|NCT01888367|3610617|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3779148|NCT01888367|3610618|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3779149|NCT01888367|3610615|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779150|NCT01888367|3610616|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779151|NCT01888367|3610617|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779152|NCT01888367|3610618|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779153|NCT01888367|3610615|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3779154|NCT01888367|3610616|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779155|NCT01888367|3610617|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3779156|NCT01888367|3610618|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3779157|NCT01888367|3610615|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3779158|NCT01888367|3610616|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779159|NCT01888367|3610617|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779160|NCT01888367|3610618|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3779161|NCT01888367|3610615|B4||Male|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
3779162|NCT01888367|3610616|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3779163|NCT01888367|3610617|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3779164|NCT01888367|3610618|B1||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3779165|NCT01888367|3610615|B4||Female|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
3779166|NCT01888367|3610616|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3779167|NCT01888367|3610617|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3779168|NCT01888367|3610618|B1||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3779169|NCT01888367|3610615|B4|||Age||years|Mean|59.8|59.8|Standard Deviation|14.8|14.8|||
3779170|NCT01888367|3610616|B3|||Age||years|Mean|59.6|59.6|Standard Deviation|14.7|14.7|||
3779171|NCT01888367|3610617|B2|||Age||years|Mean|58.8|58.8|Standard Deviation|15.7|15.7|||
3779172|NCT01888367|3610618|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|14.6|14.6|||
3779173|NCT01888003|3610637|B4|United States||Region of Enrollment||participants|Number|51|51.0||||||
3779174|NCT01888003|3610638|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3779175|NCT01888003|3610639|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3779176|NCT01888003|3610640|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3779177|NCT01888003|3610637|B4|Females||Sex/Gender, Customized||participants|Number|22|22.0||||||
3779178|NCT01888003|3610638|B3|Females||Sex/Gender, Customized||participants|Number|15|15.0||||||
3779179|NCT01888003|3610639|B2|Females||Sex/Gender, Customized||participants|Number|6|6.0||||||
3779180|NCT01888003|3610640|B1|Females||Sex/Gender, Customized||participants|Number|1|1.0||||||
3779181|NCT01888003|3610637|B4|Males||Sex/Gender, Customized||participants|Number|29|29.0||||||
3779182|NCT01888003|3610638|B3|Males||Sex/Gender, Customized||participants|Number|25|25.0||||||
3779183|NCT01888003|3610639|B2|Males||Sex/Gender, Customized||participants|Number|0|0.0||||||
3779184|NCT01888003|3610640|B1|Males||Sex/Gender, Customized||participants|Number|4|4.0||||||
3779185|NCT01888003|3610637|B4|||Age||Years|Mean|62|62.0|Full Range|||42.0|79.0|
3779186|NCT01888003|3610638|B3|||Age||Years|Mean|62|62.0|Full Range|||44.0|79.0|
3779187|NCT01888003|3610639|B2|||Age||Years|Mean|62|62.0|Full Range|||42.0|76.0|
3779188|NCT01888003|3610640|B1|||Age||Years|Mean|63|63.0|Full Range|||49.0|71.0|
3779189|NCT01887990|3610659|B5|United States||Region of Enrollment||participants|Number|18|18.0||||||
3779190|NCT01887990|3610660|B4|United States||Region of Enrollment||participants|Number|2|2.0||||||
3779191|NCT01887990|3610661|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3779192|NCT01887990|3610662|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3779193|NCT01887990|3610663|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3779194|NCT01887990|3610659|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3779195|NCT01887990|3610660|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3779196|NCT01887990|3610661|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3779197|NCT01887990|3610662|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3779198|NCT01887990|3610663|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3779199|NCT01887990|3610659|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3779200|NCT01887990|3610660|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3779201|NCT01887990|3610661|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3779202|NCT01887990|3610662|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3779203|NCT01887990|3610663|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3779204|NCT01887990|3610659|B5|||Age||years|Mean|35|35.0|Standard Deviation|9|9.0|||
3779205|NCT01887990|3610660|B4|||Age||years|Mean|31|31.0|Standard Deviation|4|4.0|||
3779206|NCT01887990|3610661|B3|||Age||years|Mean|31|31.0|Standard Deviation|1|1.0|||
3779207|NCT01887990|3610662|B2|||Age||years|Mean|37|37.0|Standard Deviation|11|11.0|||
3779208|NCT01887990|3610663|B1|||Age||years|Mean|37|37.0|Standard Deviation|10|10.0|||
3779209|NCT01887678|3610680|B3|United States||Region of Enrollment||participants|Number|232|232.0||||||
3779210|NCT01887678|3610681|B2|United States||Region of Enrollment||participants|Number|113|113.0||||||
3779211|NCT01887678|3610682|B1|United States||Region of Enrollment||participants|Number|119|119.0||||||
3779212|NCT01887678|3610680|B3||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3779213|NCT01887678|3610681|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3779214|NCT01887678|3610682|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3779215|NCT01887678|3610680|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3779216|NCT01887678|3610681|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3779217|NCT01887678|3610682|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3779218|NCT01887678|3610680|B3|||Age||years|Mean|60.2|60.2|Standard Deviation|8.90|8.9|||
3779219|NCT01887678|3610681|B2|||Age||years|Mean|59.7|59.7|Standard Deviation|8.68|8.68|||
3779220|NCT01887678|3610682|B1|||Age||years|Mean|60.7|60.7|Standard Deviation|9.11|9.11|||
3779221|NCT01887470|3610725|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779222|NCT01887470|3610726|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779223|NCT01887470|3610727|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779224|NCT01887470|3610728|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779225|NCT01887470|3610729|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779226|NCT01887470|3610725|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779227|NCT01887470|3610726|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779228|NCT01887470|3610727|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779229|NCT01887470|3610728|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779230|NCT01887470|3610729|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779231|NCT01887470|3610725|B5||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3779232|NCT01887470|3610726|B4||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3779233|NCT01887470|3610727|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3779234|NCT01887470|3610728|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3779235|NCT01887470|3610729|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3779236|NCT01887470|3610725|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3779237|NCT01887470|3610726|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3779238|NCT01887470|3610727|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779239|NCT01887470|3610728|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779240|NCT01887470|3610729|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779241|NCT01887470|3610725|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779242|NCT01887470|3610726|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779243|NCT01887470|3610727|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779244|NCT01887470|3610728|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779245|NCT01887470|3610729|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779246|NCT01887470|3610725|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779247|NCT01887470|3610726|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779248|NCT01887470|3610727|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779249|NCT01887470|3610728|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779250|NCT01887470|3610729|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779251|NCT01887470|3610725|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779252|NCT01887470|3610726|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779253|NCT01887470|3610727|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779254|NCT01887470|3610728|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779255|NCT01887470|3610729|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779256|NCT01887470|3610725|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779257|NCT01887470|3610726|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779258|NCT01887470|3610727|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779259|NCT01887470|3610728|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779260|NCT01887470|3610729|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779261|NCT01887470|3610725|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3779262|NCT01887470|3610726|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3779263|NCT01887470|3610727|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3779264|NCT01887470|3610728|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3779265|NCT01887470|3610729|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3779266|NCT01887470|3610725|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3779267|NCT01887470|3610726|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3779268|NCT01887470|3610727|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779269|NCT01887470|3610728|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779270|NCT01887470|3610729|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779271|NCT01887470|3610725|B5||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3779272|NCT01887470|3610726|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3779273|NCT01887470|3610727|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3779274|NCT01887470|3610728|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3779275|NCT01887470|3610729|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3779276|NCT01887470|3610725|B5||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3779277|NCT01887470|3610726|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3779278|NCT01887470|3610727|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3779279|NCT01887470|3610728|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3779280|NCT01887470|3610729|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3779281|NCT01887470|3610725|B5||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3779282|NCT01887470|3610726|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3779283|NCT01887470|3610727|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3779284|NCT01887470|3610728|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3779285|NCT01887470|3610729|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3779286|NCT01887470|3610725|B5||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3779287|NCT01887470|3610726|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3779288|NCT01887470|3610727|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3779289|NCT01887470|3610728|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3779290|NCT01887470|3610729|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3779291|NCT01887470|3610725|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779292|NCT01887470|3610726|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779293|NCT01887470|3610727|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779294|NCT01887470|3610728|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779295|NCT01887470|3610729|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779296|NCT01887418|3610748|B4|||Baseline Total Testosterone (TT) (ng/dL)||ng/dL|Mean|343.04|343.04|Standard Deviation|256.67|256.67|||
3779297|NCT01887418|3610749|B3|||Baseline Total Testosterone (TT) (ng/dL)||ng/dL|Mean|735.10|735.1|Standard Deviation|187.96|187.96|||
3779298|NCT01887418|3610750|B2|||Baseline Total Testosterone (TT) (ng/dL)||ng/dL|Mean|214.64|214.64|Standard Deviation|59.05|59.05|||
3779299|NCT01887418|3610751|B1|||Baseline Total Testosterone (TT) (ng/dL)||ng/dL|Mean|201.50|201.5|Standard Deviation|71.53|71.53|||
3779300|NCT01887418|3610748|B4|||Body Mass Index (BMI) at screening (kg/m^2)||kg/m^2|Mean|28.91|28.91|Standard Deviation|2.43|2.43|||
3779301|NCT01887418|3610749|B3|||Body Mass Index (BMI) at screening (kg/m^2)||kg/m^2|Mean|29.05|29.05|Standard Deviation|2.21|2.21|||
3779302|NCT01887418|3610750|B2|||Body Mass Index (BMI) at screening (kg/m^2)||kg/m^2|Mean|28.51|28.51|Standard Deviation|2.17|2.17|||
3779303|NCT01887418|3610751|B1|||Body Mass Index (BMI) at screening (kg/m^2)||kg/m^2|Mean|29.19|29.19|Standard Deviation|2.87|2.87|||
3779304|NCT01887418|3610748|B4|United States||Region of Enrollment||participants|Number|39|39.0||||||
3779305|NCT01887418|3610749|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3779306|NCT01887418|3610750|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3779307|NCT01887418|3610751|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3779308|NCT01887418|3610748|B4|Multiple||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3779309|NCT01887418|3610749|B3|Multiple||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3779310|NCT01887418|3610750|B2|Multiple||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3779311|NCT01887418|3610751|B1|Multiple||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3779312|NCT01887418|3610748|B4|African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3779313|NCT01887418|3610749|B3|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3779314|NCT01887418|3610750|B2|African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3779315|NCT01887418|3610751|B1|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3779316|NCT01887418|3610748|B4|White||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3779317|NCT01887418|3610749|B3|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3779318|NCT01887418|3610750|B2|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3779319|NCT01887418|3610751|B1|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3779320|NCT01887418|3610748|B4||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3779321|NCT01887418|3610749|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3779322|NCT01887418|3610750|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3779323|NCT01887418|3610751|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3779324|NCT01887418|3610748|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3779325|NCT01887418|3610749|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3779326|NCT01887418|3610750|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3779327|NCT01887418|3610751|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3779328|NCT01887418|3610748|B4|||Age||years|Mean|52.9|52.9|Standard Deviation|12.14|12.14|||
3779329|NCT01887418|3610749|B3|||Age||years|Mean|48.9|48.9|Standard Deviation|10.94|10.94|||
3779330|NCT01887418|3610750|B2|||Age||years|Mean|54.0|54.0|Standard Deviation|12.42|12.42|||
3779331|NCT01887418|3610751|B1|||Age||years|Mean|54.7|54.7|Standard Deviation|12.80|12.8|||
3779332|NCT01887353|3610770|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3779333|NCT01887353|3610771|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3779334|NCT01887353|3610772|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3779335|NCT01887353|3610770|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779336|NCT01887353|3610771|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779337|NCT01887353|3610772|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779338|NCT01887353|3610770|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779339|NCT01887353|3610771|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779340|NCT01887353|3610772|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779341|NCT01887353|3610770|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3779342|NCT01887353|3610771|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3779343|NCT01887353|3610772|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3779344|NCT01887353|3610770|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779345|NCT01887353|3610771|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779346|NCT01887353|3610772|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779347|NCT01887353|3610770|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779348|NCT01887353|3610771|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779349|NCT01887353|3610772|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779350|NCT01887353|3610770|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779351|NCT01887353|3610771|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779352|NCT01887353|3610772|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779353|NCT01887353|3610770|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779354|NCT01887353|3610771|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779355|NCT01887353|3610772|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779356|NCT01887353|3610770|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3779357|NCT01887353|3610771|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3779358|NCT01887353|3610772|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3779359|NCT01887353|3610770|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3779360|NCT01887353|3610771|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3779361|NCT01887353|3610772|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3779362|NCT01887353|3610770|B3|||Age||years|Mean|84.3|84.3|Standard Deviation|9.2|9.2|||
3779363|NCT01887353|3610771|B2|||Age||years|Mean|78.9|78.9|Standard Deviation|8.9|8.9|||
3779364|NCT01887353|3610772|B1|||Age||years|Mean|89.7|89.7|Standard Deviation|9.5|9.5|||
3779365|NCT01887210|3610784|B3||Undecided|Sexual Orientation||Participants|Count of Participants|3|3.0||||||
3779366|NCT01887210|3610785|B2||Undecided|Sexual Orientation||Participants|Count of Participants|2|2.0||||||
3779367|NCT01887210|3610786|B1||Undecided|Sexual Orientation||Participants|Count of Participants|1|1.0||||||
3779368|NCT01887210|3610784|B3||Bisexual|Sexual Orientation||Participants|Count of Participants|7|7.0||||||
3779369|NCT01887210|3610785|B2||Bisexual|Sexual Orientation||Participants|Count of Participants|2|2.0||||||
3779370|NCT01887210|3610786|B1||Bisexual|Sexual Orientation||Participants|Count of Participants|5|5.0||||||
3779371|NCT01887210|3610784|B3||Homosexual|Sexual Orientation||Participants|Count of Participants|35|35.0||||||
3779372|NCT01887210|3610785|B2||Homosexual|Sexual Orientation||Participants|Count of Participants|18|18.0||||||
3779373|NCT01887210|3610786|B1||Homosexual|Sexual Orientation||Participants|Count of Participants|17|17.0||||||
3779374|NCT01887210|3610784|B3||Heterosexual|Sexual Orientation||Participants|Count of Participants|16|16.0||||||
3779375|NCT01887210|3610785|B2||Heterosexual|Sexual Orientation||Participants|Count of Participants|7|7.0||||||
3779376|NCT01887210|3610786|B1||Heterosexual|Sexual Orientation||Participants|Count of Participants|9|9.0||||||
3779377|NCT01887210|3610784|B3||Unknown or not reported|Gaming Status|Participants were asked about how often they played video games.|Participants|Count of Participants|1|1.0||||||
3779378|NCT01887210|3610785|B2||Unknown or not reported|Gaming Status|Participants were asked about how often they played video games.|Participants|Count of Participants|0|0.0||||||
3779379|NCT01887210|3610786|B1||Unknown or not reported|Gaming Status|Participants were asked about how often they played video games.|Participants|Count of Participants|1|1.0||||||
3779380|NCT01887210|3610784|B3||Not everyday|Gaming Status|Participants were asked about how often they played video games.|Participants|Count of Participants|38|38.0||||||
3779381|NCT01887210|3610785|B2||Not everyday|Gaming Status|Participants were asked about how often they played video games.|Participants|Count of Participants|17|17.0||||||
3779382|NCT01887210|3610786|B1||Not everyday|Gaming Status|Participants were asked about how often they played video games.|Participants|Count of Participants|21|21.0||||||
3779383|NCT01887210|3610784|B3||Daily or almost daily|Gaming Status|Participants were asked about how often they played video games.|Participants|Count of Participants|22|22.0||||||
3779384|NCT01887210|3610785|B2||Daily or almost daily|Gaming Status|Participants were asked about how often they played video games.|Participants|Count of Participants|12|12.0||||||
3779385|NCT01887210|3610786|B1||Daily or almost daily|Gaming Status|Participants were asked about how often they played video games.|Participants|Count of Participants|10|10.0||||||
3779386|NCT01887210|3610784|B3||No|Started ARV in past 3 months||Participants|Count of Participants|39|39.0||||||
3779387|NCT01887210|3610785|B2||No|Started ARV in past 3 months||Participants|Count of Participants|18|18.0||||||
3779388|NCT01887210|3610786|B1||No|Started ARV in past 3 months||Participants|Count of Participants|21|21.0||||||
3779389|NCT01887210|3610784|B3||Yes|Started ARV in past 3 months||Participants|Count of Participants|22|22.0||||||
3779390|NCT01887210|3610785|B2||Yes|Started ARV in past 3 months||Participants|Count of Participants|11|11.0||||||
3779391|NCT01887210|3610786|B1||Yes|Started ARV in past 3 months||Participants|Count of Participants|11|11.0||||||
3779392|NCT01887210|3610784|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3779393|NCT01887210|3610785|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3779394|NCT01887210|3610786|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3779395|NCT01887210|3610784|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779396|NCT01887210|3610785|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779397|NCT01887210|3610786|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779398|NCT01887210|3610784|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779399|NCT01887210|3610785|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779400|NCT01887210|3610786|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779401|NCT01887210|3610784|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3779402|NCT01887210|3610785|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3779403|NCT01887210|3610786|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3779404|NCT01887210|3610784|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779405|NCT01887210|3610785|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779406|NCT01887210|3610786|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779407|NCT01887210|3610784|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779408|NCT01887210|3610785|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779409|NCT01887210|3610786|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779410|NCT01887210|3610784|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779411|NCT01887210|3610785|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779412|NCT01887210|3610786|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779413|NCT01887210|3610784|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779414|NCT01887210|3610785|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779415|NCT01887210|3610786|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779416|NCT01887210|3610784|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3779417|NCT01887210|3610785|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3779418|NCT01887210|3610786|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3779419|NCT01887210|3610784|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779420|NCT01887210|3610785|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779421|NCT01887210|3610786|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779422|NCT01887210|3610784|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3779423|NCT01887210|3610785|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3779424|NCT01887210|3610786|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3779425|NCT01887210|3610784|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3779426|NCT01887210|3610785|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3779427|NCT01887210|3610786|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3779428|NCT01887210|3610784|B3|||Age||years|Mean|22.4|22.4|Standard Deviation|2.5|2.5|||
3779429|NCT01887210|3610785|B2|||Age||years|Mean|22.3|22.3|Standard Deviation|2.5|2.5|||
3779430|NCT01887210|3610786|B1|||Age||years|Mean|22.5|22.5|Standard Deviation|2.5|2.5|||
3779431|NCT01887171|3610799|B3|Belarus||Region of Enrollment||participants|Number|86|86.0||||||
3779432|NCT01887171|3610800|B2|Belarus||Region of Enrollment||participants|Number|43|43.0||||||
3779433|NCT01887171|3610801|B1|Belarus||Region of Enrollment||participants|Number|43|43.0||||||
3779434|NCT01887171|3610799|B3||Male|Gender||Participants|Count of Participants|47|47.0||||||
3779435|NCT01887171|3610800|B2||Male|Gender||Participants|Count of Participants|22|22.0||||||
3779436|NCT01887171|3610801|B1||Male|Gender||Participants|Count of Participants|25|25.0||||||
3779437|NCT01887171|3610799|B3||Female|Gender||Participants|Count of Participants|39|39.0||||||
3779438|NCT01887171|3610800|B2||Female|Gender||Participants|Count of Participants|21|21.0||||||
3779439|NCT01887171|3610801|B1||Female|Gender||Participants|Count of Participants|18|18.0||||||
3779440|NCT01887171|3610799|B3|||Age||years|Mean|50|50.0|Inter-Quartile Range|||38.0|58.0|
3779441|NCT01887171|3610800|B2|||Age||years|Mean|50|50.0|Inter-Quartile Range|||40.0|58.0|
3779442|NCT01887171|3610801|B1|||Age||years|Mean|50|50.0|Inter-Quartile Range|||38.0|56.0|
3779443|NCT01887171|3610799|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3779444|NCT01887171|3610800|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3779445|NCT01887171|3610801|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3779446|NCT01887171|3610799|B3||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
3779447|NCT01887171|3610800|B2||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3779448|NCT01887171|3610801|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3779449|NCT01887171|3610799|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779450|NCT01887171|3610800|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779451|NCT01887171|3610801|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779452|NCT01887132|3610808|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3779453|NCT01887132|3610808|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779454|NCT01887132|3610808|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779455|NCT01887132|3610808|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3779456|NCT01887132|3610808|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3779457|NCT01887132|3610808|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779458|NCT01887132|3610808|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779459|NCT01887132|3610808|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779460|NCT01887132|3610808|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779461|NCT01887132|3610808|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3779462|NCT01887132|3610808|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779463|NCT01887132|3610808|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3779464|NCT01887132|3610808|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3779465|NCT01887132|3610808|B1|||Age|Mean age of the participants at screening.|years|Mean|3.2|3.2|Full Range|||2.1|3.9|
3779466|NCT01887132|3610808|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3779467|NCT01887132|3610808|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3779468|NCT01887132|3610808|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3779469|NCT01886963|3610813|B3|United States||Region of Enrollment||participants|Number|95|95.0||||||
3779470|NCT01886963|3610814|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
3779471|NCT01886963|3610815|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
3779472|NCT01886963|3610813|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3779473|NCT01886963|3610814|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3779474|NCT01886963|3610815|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3779475|NCT01886963|3610813|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3779476|NCT01886963|3610814|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3779477|NCT01886963|3610815|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3779478|NCT01886963|3610813|B3|||Age||years|Mean|57.6|57.6|Standard Deviation|11.43|11.43|||
3779479|NCT01886963|3610814|B2|||Age||years|Mean|56.7|56.7|Standard Deviation|11.16|11.16|||
3779480|NCT01886963|3610815|B1|||Age||years|Mean|58.3|58.3|Standard Deviation|11.76|11.76|||
3779481|NCT01886963|3610813|B3||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3779482|NCT01886963|3610814|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3779483|NCT01886963|3610815|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3779484|NCT01886963|3610813|B3||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
3779485|NCT01886963|3610814|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3779486|NCT01886963|3610815|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3779487|NCT01886963|3610813|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779488|NCT01886963|3610814|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779489|NCT01886963|3610815|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779490|NCT01886937|3610822|B3|United States||Region of Enrollment||participants|Number|0|0.0||||||
3779491|NCT01886937|3610823|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3779492|NCT01886937|3610824|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3779493|NCT01886937|3610822|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779494|NCT01886937|3610823|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779495|NCT01886937|3610824|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779496|NCT01886937|3610822|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779497|NCT01886937|3610823|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779498|NCT01886937|3610824|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779499|NCT01886937|3610822|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3779500|NCT01886937|3610823|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3779501|NCT01886937|3610824|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3779502|NCT01886937|3610822|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3779503|NCT01886937|3610823|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3779504|NCT01886937|3610824|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3779505|NCT01886937|3610822|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779506|NCT01886937|3610823|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779507|NCT01886937|3610824|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779508|NCT01886937|3610822|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3779509|NCT01886937|3610823|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3779510|NCT01886937|3610824|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3779511|NCT01886937|3610822|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779512|NCT01886937|3610823|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779513|NCT01886937|3610824|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779514|NCT01886937|3610822|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779515|NCT01886937|3610823|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779516|NCT01886937|3610824|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779517|NCT01886937|3610822|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3779518|NCT01886937|3610823|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3779519|NCT01886937|3610824|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3779520|NCT01886937|3610822|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3779521|NCT01886937|3610823|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3779522|NCT01886937|3610824|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3779523|NCT01886937|3610822|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3779524|NCT01886937|3610823|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3779525|NCT01886937|3610824|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3779526|NCT01886937|3610822|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3779527|NCT01886937|3610823|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3779528|NCT01886937|3610824|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3779529|NCT01886937|3610822|B3|||Age||years|Mean|42|42.0|Standard Deviation|14|14.0|||
3779530|NCT01886937|3610823|B2|||Age||years|Mean|37|37.0|Standard Deviation|16|16.0|||
3779531|NCT01886937|3610824|B1|||Age||years|Mean|45|45.0|Standard Deviation|14|14.0|||
3779532|NCT01886937|3610822|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3779533|NCT01886937|3610823|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3779534|NCT01886937|3610824|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3779535|NCT01886937|3610822|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3779536|NCT01886937|3610823|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3779537|NCT01886937|3610824|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3779538|NCT01886937|3610822|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779539|NCT01886937|3610823|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779540|NCT01886937|3610824|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779541|NCT01886833|3610831|B1|Zambia||Region of Enrollment||participants|Number|420|420.0||||||
3779542|NCT01886833|3610831|B1||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3779543|NCT01886833|3610831|B1||Female|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
3779544|NCT01886833|3610831|B1|||Age||months|Mean|27|27.0|Full Range|||18.0|46.0|
3779545|NCT01886807|3610839|B4||Male|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
3779546|NCT01886807|3610840|B3||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3779547|NCT01886807|3610841|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3779548|NCT01886807|3610842|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3779549|NCT01886807|3610839|B4||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
3779550|NCT01886807|3610840|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3779551|NCT01886807|3610841|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3779552|NCT01886807|3610842|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3779553|NCT01886807|3610839|B4|||Age||years|Mean|4.5|4.5|Standard Deviation|2.0|2.0|||
3779554|NCT01886807|3610840|B3|||Age||years|Mean|4.7|4.7|Standard Deviation|2.0|2.0|||
3779555|NCT01886807|3610841|B2|||Age||years|Mean|4.4|4.4|Standard Deviation|2.1|2.1|||
3779556|NCT01886807|3610842|B1|||Age||years|Mean|4.3|4.3|Standard Deviation|1.9|1.9|||
3779557|NCT01886781|3610852|B3|||Duration of IBS (years)||years|Mean|9.74|9.74|Standard Deviation|10|10.0|||
3779558|NCT01886781|3610853|B2|||Duration of IBS (years)||years|Mean|10.05|10.05|Standard Deviation|9.36|9.36|||
3779559|NCT01886781|3610854|B1|||Duration of IBS (years)||years|Mean|9.58|9.58|Standard Deviation|10.32|10.32|||
3779560|NCT01886781|3610852|B3|||Body Mass Index||kg/m^2|Mean|28.85|28.85|Standard Deviation|7.32|7.32|||
3779561|NCT01886781|3610853|B2|||Body Mass Index||kg/m^2|Mean|28.88|28.88|Standard Deviation|7.74|7.74|||
3779562|NCT01886781|3610854|B1|||Body Mass Index||kg/m^2|Mean|28.83|28.83|Standard Deviation|7.12|7.12|||
3779563|NCT01886781|3610852|B3|South Africa||Region of Enrollment||participants|Number|81|81.0||||||
3779564|NCT01886781|3610853|B2|South Africa||Region of Enrollment||participants|Number|27|27.0||||||
3779565|NCT01886781|3610854|B1|South Africa||Region of Enrollment||participants|Number|54|54.0||||||
3779566|NCT01886781|3610852|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3779567|NCT01886781|3610853|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3779568|NCT01886781|3610854|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3779569|NCT01886781|3610852|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3779570|NCT01886781|3610853|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3779571|NCT01886781|3610854|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3779572|NCT01886781|3610852|B3|||Age||years|Mean|47.86|47.86|Standard Deviation|13.03|13.03|||
3779573|NCT01886781|3610853|B2|||Age||years|Mean|47.27|47.27|Standard Deviation|12.15|12.15|||
3779574|NCT01886781|3610854|B1|||Age||years|Mean|48.15|48.15|Standard Deviation|13.48|13.48|||
3779575|NCT01886716|3610861|B5|United States||Region of Enrollment||participants|Number|86|86.0||||||
3779576|NCT01886716|3610862|B4|United States||Region of Enrollment||participants|Number|20|20.0||||||
3779577|NCT01886716|3610863|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
3779578|NCT01886716|3610864|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3779579|NCT01886716|3610865|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3779580|NCT01886716|3610861|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779581|NCT01886716|3610862|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779582|NCT01886716|3610863|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779583|NCT01886716|3610864|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779584|NCT01886716|3610865|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779585|NCT01886716|3610861|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3779586|NCT01886716|3610862|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3779587|NCT01886716|3610863|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3779588|NCT01886716|3610864|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779589|NCT01886716|3610865|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779590|NCT01886716|3610861|B5||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3779591|NCT01886716|3610862|B4||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3779592|NCT01886716|3610863|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3779593|NCT01886716|3610864|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3779594|NCT01886716|3610865|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3779595|NCT01886716|3610861|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3779596|NCT01886716|3610862|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3779597|NCT01886716|3610863|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3779598|NCT01886716|3610864|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3779599|NCT01886716|3610865|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3779600|NCT01886716|3610861|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779601|NCT01886716|3610862|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779602|NCT01886716|3610863|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779603|NCT01886716|3610864|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779604|NCT01886716|3610865|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779605|NCT01886716|3610861|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3779606|NCT01886716|3610862|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779607|NCT01886716|3610863|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779608|NCT01886716|3610864|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3779609|NCT01886716|3610865|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779610|NCT01886716|3610861|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3779611|NCT01886716|3610862|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779612|NCT01886716|3610863|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3779613|NCT01886716|3610864|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779614|NCT01886716|3610865|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779615|NCT01886716|3610861|B5||Male|Gender||Participants|Count of Participants|51|51.0||||||
3779616|NCT01886716|3610862|B4||Male|Gender||Participants|Count of Participants|10|10.0||||||
3779617|NCT01886716|3610863|B3||Male|Gender||Participants|Count of Participants|15|15.0||||||
3779618|NCT01886716|3610864|B2||Male|Gender||Participants|Count of Participants|11|11.0||||||
3779619|NCT01886716|3610865|B1||Male|Gender||Participants|Count of Participants|15|15.0||||||
3779620|NCT01886716|3610861|B5||Female|Gender||Participants|Count of Participants|35|35.0||||||
3779621|NCT01886716|3610862|B4||Female|Gender||Participants|Count of Participants|10|10.0||||||
3779622|NCT01886716|3610863|B3||Female|Gender||Participants|Count of Participants|7|7.0||||||
3779623|NCT01886716|3610864|B2||Female|Gender||Participants|Count of Participants|9|9.0||||||
3779624|NCT01886716|3610865|B1||Female|Gender||Participants|Count of Participants|9|9.0||||||
3779625|NCT01886716|3610861|B5|||Age||years|Mean|44.31|44.31|Standard Deviation|10.93|10.93|||
3779626|NCT01886716|3610862|B4|||Age||years|Mean|39.70|39.7|Standard Deviation|10.62|10.62|||
3779627|NCT01886716|3610863|B3|||Age||years|Mean|47.68|47.68|Standard Deviation|9.83|9.83|||
3779628|NCT01886716|3610864|B2|||Age||years|Mean|47.40|47.4|Standard Deviation|10.94|10.94|||
3779629|NCT01886716|3610865|B1|||Age||years|Mean|42.50|42.5|Standard Deviation|10.95|10.95|||
3779630|NCT01886716|3610861|B5||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3779631|NCT01886716|3610862|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3779632|NCT01886716|3610863|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3779633|NCT01886716|3610864|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3779634|NCT01886716|3610865|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3779635|NCT01886716|3610861|B5||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
3779636|NCT01886716|3610862|B4||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3779637|NCT01886716|3610863|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3779638|NCT01886716|3610864|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3779639|NCT01886716|3610865|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3779640|NCT01886716|3610861|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779641|NCT01886716|3610862|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779642|NCT01886716|3610863|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779643|NCT01886716|3610864|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779644|NCT01886716|3610865|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779645|NCT01886690|3610882|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3779646|NCT01886690|3610883|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3779647|NCT01886690|3610884|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3779648|NCT01886690|3610882|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3779649|NCT01886690|3610883|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3779650|NCT01886690|3610884|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3779651|NCT01886690|3610882|B3|≥ 40 years||Age, Customized||Participants|Number|39|39.0||||||
3779652|NCT01886690|3610883|B2|≥ 40 years||Age, Customized||Participants|Number|22|22.0||||||
3779653|NCT01886690|3610884|B1|≥ 40 years||Age, Customized||Participants|Number|17|17.0||||||
3779654|NCT01886690|3610882|B3|< 40 years||Age, Customized||Participants|Number|109|109.0||||||
3779655|NCT01886690|3610883|B2|< 40 years||Age, Customized||Participants|Number|51|51.0||||||
3779656|NCT01886690|3610884|B1|< 40 years||Age, Customized||Participants|Number|58|58.0||||||
3779657|NCT01886313|3610899|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3779658|NCT01886313|3610900|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3779659|NCT01886313|3610901|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3779660|NCT01886313|3610899|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779661|NCT01886313|3610900|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779662|NCT01886313|3610901|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779663|NCT01886313|3610899|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3779664|NCT01886313|3610900|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779665|NCT01886313|3610901|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3779666|NCT01886313|3610899|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3779667|NCT01886313|3610900|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3779668|NCT01886313|3610901|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3779669|NCT01886313|3610899|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779670|NCT01886313|3610900|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779671|NCT01886313|3610901|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779672|NCT01886313|3610899|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779673|NCT01886313|3610900|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779674|NCT01886313|3610901|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779675|NCT01886313|3610899|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779676|NCT01886313|3610900|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779677|NCT01886313|3610901|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779678|NCT01886313|3610899|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779679|NCT01886313|3610900|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779680|NCT01886313|3610901|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779681|NCT01886313|3610899|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779682|NCT01886313|3610900|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779683|NCT01886313|3610901|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779684|NCT01886313|3610899|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3779685|NCT01886313|3610900|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3779686|NCT01886313|3610901|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3779687|NCT01886313|3610899|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3779688|NCT01886313|3610900|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3779689|NCT01886313|3610901|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3779690|NCT01886313|3610899|B3||Male|Gender||Participants|Count of Participants|4|4.0||||||
3779691|NCT01886313|3610900|B2||Male|Gender||Participants|Count of Participants|1|1.0||||||
3779692|NCT01886313|3610901|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
3779693|NCT01886313|3610899|B3||Female|Gender||Participants|Count of Participants|7|7.0||||||
3779694|NCT01886313|3610900|B2||Female|Gender||Participants|Count of Participants|4|4.0||||||
3779695|NCT01886313|3610901|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
3779696|NCT01886313|3610899|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3779697|NCT01886313|3610900|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3779698|NCT01886313|3610901|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3779699|NCT01886313|3610899|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3779700|NCT01886313|3610900|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3779701|NCT01886313|3610901|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3779702|NCT01886313|3610899|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779703|NCT01886313|3610900|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779704|NCT01886313|3610901|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779705|NCT01886300|3610908|B1||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||As the sample size requirement for the study was not met, the study was terminated; no data for any of the participants was collected.
3779706|NCT01886300|3610908|B1||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||As the sample size requirement for the study was not met, the study was terminated; no data for any of the participants was collected.
3779707|NCT01886300|3610908|B1|||Age||years|Mean|NA||Standard Deviation|NA||||As the sample size requirement for the study was not met, the study was terminated; no data for any of the participants was collected.
3779708|NCT01886287|3610919|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3779709|NCT01886287|3610919|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3779710|NCT01886287|3610919|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3779711|NCT01886287|3610919|B1|||Age||years|Median|63|63.0|Full Range|||53.0|73.0|
3779712|NCT01886287|3610919|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3779713|NCT01886287|3610919|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3779714|NCT01886287|3610919|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779715|NCT01886235|3610924|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779716|NCT01886235|3610924|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779717|NCT01886235|3610924|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3779718|NCT01886235|3610924|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779719|NCT01886235|3610924|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779720|NCT01886235|3610924|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779721|NCT01886235|3610924|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779722|NCT01886235|3610924|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3779723|NCT01886235|3610924|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3779724|NCT01886235|3610924|B1|||Age||years|Mean|58.5|58.5|Standard Deviation|10.6|10.6|||
3779725|NCT01886235|3610924|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3779726|NCT01886235|3610924|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3779727|NCT01886235|3610924|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779728|NCT01885936|3610935|B3|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3779729|NCT01885936|3610936|B2|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3779730|NCT01885936|3610937|B1|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3779731|NCT01885936|3610935|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779732|NCT01885936|3610936|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779733|NCT01885936|3610937|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779734|NCT01885936|3610935|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779735|NCT01885936|3610936|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779736|NCT01885936|3610937|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779737|NCT01885936|3610935|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3779738|NCT01885936|3610936|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3779739|NCT01885936|3610937|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3779740|NCT01885936|3610935|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779741|NCT01885936|3610936|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779742|NCT01885936|3610937|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779743|NCT01885936|3610935|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779744|NCT01885936|3610936|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779745|NCT01885936|3610937|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779746|NCT01885936|3610935|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779747|NCT01885936|3610936|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779748|NCT01885936|3610937|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779749|NCT01885936|3610935|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779750|NCT01885936|3610936|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779751|NCT01885936|3610937|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779752|NCT01885936|3610935|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779753|NCT01885936|3610936|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779754|NCT01885936|3610937|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779755|NCT01885936|3610935|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3779756|NCT01885936|3610936|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3779757|NCT01885936|3610937|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3779758|NCT01885936|3610935|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779759|NCT01885936|3610936|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779760|NCT01885936|3610937|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779761|NCT01885936|3610935|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3779762|NCT01885936|3610936|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3779763|NCT01885936|3610937|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3779764|NCT01885936|3610935|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3779765|NCT01885936|3610936|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3779766|NCT01885936|3610937|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3779767|NCT01885936|3610935|B3|||Age||years|Mean|49.6|49.6|Standard Deviation|9.9|9.9|||
3779768|NCT01885936|3610936|B2|||Age||years|Mean|53.4|53.4|Standard Deviation|9.9|9.9|||
3779769|NCT01885936|3610937|B1|||Age||years|Mean|47.3|47.3|Standard Deviation|9.7|9.7|||
3779770|NCT01885910|3610948|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
3779771|NCT01885910|3610948|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3779772|NCT01885910|3610948|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3779773|NCT01885910|3610948|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3779774|NCT01885910|3610948|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3779775|NCT01885910|3610948|B1||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
3779776|NCT01885910|3610948|B1|||Age||years|Mean|24.8|24.8|Standard Deviation|10.9|10.9|||
3779777|NCT01885871|3610962|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3779778|NCT01885871|3610962|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779779|NCT01885871|3610962|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3779780|NCT01885871|3610962|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3779781|NCT01885871|3610962|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779782|NCT01885871|3610962|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779783|NCT01885871|3610962|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3779784|NCT01885871|3610962|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779785|NCT01885871|3610962|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779786|NCT01885871|3610962|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779787|NCT01885871|3610962|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779788|NCT01885871|3610962|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3779789|NCT01885871|3610962|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3779790|NCT01885871|3610962|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3779791|NCT01885871|3610962|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3779792|NCT01885871|3610962|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779793|NCT01885871|3610962|B1|||Age||years|Mean|52|52.0|Full Range|||41.0|67.0|
3779794|NCT01885559|3610970|B3|||Chronic Kidney Disease Epidemiology Collaboration (CKD EPI) eGFR (ml/min/m^2)||ml/min/m^2|Mean|48.2|48.2|Standard Deviation|11.8|11.8|||
3779795|NCT01885559|3610971|B2|||Chronic Kidney Disease Epidemiology Collaboration (CKD EPI) eGFR (ml/min/m^2)||ml/min/m^2|Mean|48.5|48.5|Standard Deviation|11.5|11.5|||
3779796|NCT01885559|3610972|B1|||Chronic Kidney Disease Epidemiology Collaboration (CKD EPI) eGFR (ml/min/m^2)||ml/min/m^2|Mean|47.9|47.9|Standard Deviation|12.2|12.2|||
3779797|NCT01885559|3610970|B3|||Serum Creatinine (mg/dl)||mg/dl|Mean|1.6|1.6|Standard Deviation|0.4|0.4|||
3779798|NCT01885559|3610971|B2|||Serum Creatinine (mg/dl)||mg/dl|Mean|1.5|1.5|Standard Deviation|0.4|0.4|||
3779799|NCT01885559|3610972|B1|||Serum Creatinine (mg/dl)||mg/dl|Mean|1.6|1.6|Standard Deviation|0.4|0.4|||
3779800|NCT01885559|3610970|B3|||Body Mass Index (kg/m2)||kg/m2|Mean|28.0|28.0|Standard Deviation|5.2|5.2|||
3779801|NCT01885559|3610971|B2|||Body Mass Index (kg/m2)||kg/m2|Mean|28.0|28.0|Standard Deviation|4.9|4.9|||
3779802|NCT01885559|3610972|B1|||Body Mass Index (kg/m2)||kg/m2|Mean|28.0|28.0|Standard Deviation|5.5|5.5|||
3779803|NCT01885559|3610970|B3|||Age at Diagnosis of Autosomal Dominant Polycystic Kidney Disease (yrs)||years|Mean|33.2|33.2|Standard Deviation|12.2|12.2|||
3779804|NCT01885559|3610971|B2|||Age at Diagnosis of Autosomal Dominant Polycystic Kidney Disease (yrs)||years|Mean|33.0|33.0|Standard Deviation|12.0|12.0|||
3779805|NCT01885559|3610972|B1|||Age at Diagnosis of Autosomal Dominant Polycystic Kidney Disease (yrs)||years|Mean|33.5|33.5|Standard Deviation|12.4|12.4|||
3779806|NCT01885559|3610970|B3|No data||PKD Genotype||participants|Number|39|39.0||||||
3779807|NCT01885559|3610971|B2|No data||PKD Genotype||participants|Number|21|21.0||||||
3779808|NCT01885559|3610972|B1|No data||PKD Genotype||participants|Number|18|18.0||||||
3779809|NCT01885559|3610970|B3|No Mutation Detected||PKD Genotype||participants|Number|25|25.0||||||
3779810|NCT01885559|3610971|B2|No Mutation Detected||PKD Genotype||participants|Number|14|14.0||||||
3779811|NCT01885559|3610972|B1|No Mutation Detected||PKD Genotype||participants|Number|11|11.0||||||
3779812|NCT01885559|3610970|B3|PKD2||PKD Genotype||participants|Number|60|60.0||||||
3779813|NCT01885559|3610971|B2|PKD2||PKD Genotype||participants|Number|30|30.0||||||
3779814|NCT01885559|3610972|B1|PKD2||PKD Genotype||participants|Number|30|30.0||||||
3779815|NCT01885559|3610970|B3|PKD1||PKD Genotype||participants|Number|362|362.0||||||
3779816|NCT01885559|3610971|B2|PKD1||PKD Genotype||participants|Number|179|179.0||||||
3779817|NCT01885559|3610972|B1|PKD1||PKD Genotype||participants|Number|183|183.0||||||
3779818|NCT01885559|3610970|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3779819|NCT01885559|3610971|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3779820|NCT01885559|3610972|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779821|NCT01885559|3610970|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3779822|NCT01885559|3610971|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3779823|NCT01885559|3610972|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3779824|NCT01885559|3610970|B3||White|Race (NIH/OMB)||Participants|Count of Participants|454|454.0||||||
3779825|NCT01885559|3610971|B2||White|Race (NIH/OMB)||Participants|Count of Participants|230|230.0||||||
3779826|NCT01885559|3610972|B1||White|Race (NIH/OMB)||Participants|Count of Participants|224|224.0||||||
3779827|NCT01885559|3610970|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3779828|NCT01885559|3610971|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3779829|NCT01885559|3610972|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3779830|NCT01885559|3610970|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779831|NCT01885559|3610971|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779832|NCT01885559|3610972|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779833|NCT01885559|3610970|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3779834|NCT01885559|3610971|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3779835|NCT01885559|3610972|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3779836|NCT01885559|3610970|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3779837|NCT01885559|3610971|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3779838|NCT01885559|3610972|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3779839|NCT01885559|3610970|B3||Male|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
3779840|NCT01885559|3610971|B2||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3779841|NCT01885559|3610972|B1||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3779842|NCT01885559|3610970|B3||Female|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
3779843|NCT01885559|3610971|B2||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3779844|NCT01885559|3610972|B1||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3779845|NCT01885559|3610970|B3|||Age||years|Mean|48.7|48.7|Standard Deviation|8.3|8.3|||
3779846|NCT01885559|3610971|B2|||Age||years|Mean|48.6|48.6|Standard Deviation|8.5|8.5|||
3779847|NCT01885559|3610972|B1|||Age||years|Mean|48.9|48.9|Standard Deviation|8.1|8.1|||
3779848|NCT01885208|3610993|B3|||Patient-reported outcome: Diabetes Treatment Satisfaction Questionnaire (DTSQ)|The DTSQs was used to assess a subject’s treatment satisfaction. This questionnaire contained 8 components and measures the treatment for diabetes (including insulin, tablets and/or diet) in terms of convenience, flexibility and general feelings regarding treatment. The value presented is the 'Treatment Satisfaction' summary score, which is the sum of 6 of the 8 items of the DTSQs questionnaire. Response options range from 6 (best case) to 0 (worst case). Total scores for treatment satisfaction range from 0-36. Higher scores indicate higher satisfaction.|Units on a scale|Mean|27.29|27.29|Standard Deviation|6.58|6.58|||
3779849|NCT01885208|3610994|B2|||Patient-reported outcome: Diabetes Treatment Satisfaction Questionnaire (DTSQ)|The DTSQs was used to assess a subject’s treatment satisfaction. This questionnaire contained 8 components and measures the treatment for diabetes (including insulin, tablets and/or diet) in terms of convenience, flexibility and general feelings regarding treatment. The value presented is the 'Treatment Satisfaction' summary score, which is the sum of 6 of the 8 items of the DTSQs questionnaire. Response options range from 6 (best case) to 0 (worst case). Total scores for treatment satisfaction range from 0-36. Higher scores indicate higher satisfaction.|Units on a scale|Mean|27.23|27.23|Standard Deviation|6.62|6.62|||
3779850|NCT01885208|3610995|B1|||Patient-reported outcome: Diabetes Treatment Satisfaction Questionnaire (DTSQ)|The DTSQs was used to assess a subject’s treatment satisfaction. This questionnaire contained 8 components and measures the treatment for diabetes (including insulin, tablets and/or diet) in terms of convenience, flexibility and general feelings regarding treatment. The value presented is the 'Treatment Satisfaction' summary score, which is the sum of 6 of the 8 items of the DTSQs questionnaire. Response options range from 6 (best case) to 0 (worst case). Total scores for treatment satisfaction range from 0-36. Higher scores indicate higher satisfaction.|Units on a scale|Mean|27.35|27.35|Standard Deviation|6.55|6.55|||
3779851|NCT01885208|3610993|B3|||Diastolic blood pressure||mm Hg|Mean|79.90|79.9|Standard Deviation|8.73|8.73|||
3779852|NCT01885208|3610994|B2|||Diastolic blood pressure||mm Hg|Mean|79.57|79.57|Standard Deviation|8.8|8.8|||
3779853|NCT01885208|3610995|B1|||Diastolic blood pressure||mm Hg|Mean|80.23|80.23|Standard Deviation|8.67|8.67|||
3779854|NCT01885208|3610993|B3|||Systolic blood pressure||mm Hg|Mean|133.51|133.51|Standard Deviation|14.55|14.55|||
3779855|NCT01885208|3610994|B2|||Systolic blood pressure||mm Hg|Mean|133.66|133.66|Standard Deviation|14.25|14.25|||
3779856|NCT01885208|3610995|B1|||Systolic blood pressure||mm Hg|Mean|133.35|133.35|Standard Deviation|14.87|14.87|||
3779857|NCT01885208|3610993|B3|||Fasting Plasma Glucose||mg/ dL|Mean|189.0|189.0|Standard Deviation|48.74|48.74|||
3779858|NCT01885208|3610994|B2|||Fasting Plasma Glucose||mg/ dL|Mean|187.5|187.5|Standard Deviation|49.41|49.41|||
3779859|NCT01885208|3610995|B1|||Fasting Plasma Glucose||mg/ dL|Mean|190.5|190.5|Standard Deviation|48.06|48.06|||
3779860|NCT01885208|3610993|B3|||Body Weight||kilogram (s)|Mean|95.79|95.79|Standard Deviation|21.49|21.49|||
3779861|NCT01885208|3610994|B2|||Body Weight||kilogram (s)|Mean|95.37|95.37|Standard Deviation|20.46|20.46|||
3779862|NCT01885208|3610995|B1|||Body Weight||kilogram (s)|Mean|96.21|96.21|Standard Deviation|22.5|22.5|||
3779863|NCT01885208|3610993|B3|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.35|8.35|Standard Deviation|0.95|0.95|||
3779864|NCT01885208|3610994|B2|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.33|8.33|Standard Deviation|0.96|0.96|||
3779865|NCT01885208|3610995|B1|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.36|8.36|Standard Deviation|0.95|0.95|||
3779866|NCT01885208|3610993|B3||Male|Sex: Female, Male||Participants|Count of Participants|447|447.0||||||
3779867|NCT01885208|3610994|B2||Male|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
3779868|NCT01885208|3610995|B1||Male|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
3779869|NCT01885208|3610993|B3||Female|Sex: Female, Male||Participants|Count of Participants|362|362.0||||||
3779870|NCT01885208|3610994|B2||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
3779871|NCT01885208|3610995|B1||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
3779872|NCT01885208|3610993|B3|||Age||years|Mean|56.6|56.6|Standard Deviation|10.7|10.7|||
3779873|NCT01885208|3610994|B2|||Age||years|Mean|56.7|56.7|Standard Deviation|11.1|11.1|||
3779874|NCT01885208|3610995|B1|||Age||years|Mean|56.4|56.4|Standard Deviation|10.3|10.3|||
3779875|NCT01885117|3611012|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3779876|NCT01885117|3611013|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3779877|NCT01885117|3611014|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3779878|NCT01885117|3611012|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3779879|NCT01885117|3611013|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3779880|NCT01885117|3611014|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3779881|NCT01885117|3611012|B3|||Age||years|Mean|54.1|54.1|Standard Deviation|16.9|16.9|||
3779882|NCT01885117|3611013|B2|||Age||years|Mean|68.2|68.2|Standard Deviation|4.7|4.7|||
3779883|NCT01885117|3611014|B1|||Age||years|Mean|39.2|39.2|Standard Deviation|11.2|11.2|||
3779884|NCT01885104|3611035|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3779885|NCT01885104|3611036|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3779886|NCT01885104|3611037|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3779887|NCT01885104|3611035|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3779888|NCT01885104|3611036|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3779889|NCT01885104|3611037|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3779890|NCT01885104|3611035|B3|||Age||Years|Mean|46.4|46.4|Standard Deviation|14.56|14.56|||
3779891|NCT01885104|3611036|B2|||Age||Years|Mean|48.0|48.0|Standard Deviation|15.17|15.17|||
3779892|NCT01885104|3611037|B1|||Age||Years|Mean|44.5|44.5|Standard Deviation|13.87|13.87|||
3779893|NCT01885000|3611046|B3|Type III||Skin phototype|"Type I: Individuals who never tan and always sunburn if exposed to any appreciable amount of sunlight, primarily red headed individuals and lighty complected blondes.~Type II: Individuals who frequently burn but are able to tan to a small degree after extended sun exposure.~Type III: Individuals who burn infrequently and tan readily."|participants|Number|22|22.0||||||
3779894|NCT01885000|3611047|B2|Type III||Skin phototype|"Type I: Individuals who never tan and always sunburn if exposed to any appreciable amount of sunlight, primarily red headed individuals and lighty complected blondes.~Type II: Individuals who frequently burn but are able to tan to a small degree after extended sun exposure.~Type III: Individuals who burn infrequently and tan readily."|participants|Number|11|11.0||||||
3779895|NCT01885000|3611048|B1|Type III||Skin phototype|"Type I: Individuals who never tan and always sunburn if exposed to any appreciable amount of sunlight, primarily red headed individuals and lighty complected blondes.~Type II: Individuals who frequently burn but are able to tan to a small degree after extended sun exposure.~Type III: Individuals who burn infrequently and tan readily."|participants|Number|11|11.0||||||
3779896|NCT01885000|3611046|B3|Type II||Skin phototype|"Type I: Individuals who never tan and always sunburn if exposed to any appreciable amount of sunlight, primarily red headed individuals and lighty complected blondes.~Type II: Individuals who frequently burn but are able to tan to a small degree after extended sun exposure.~Type III: Individuals who burn infrequently and tan readily."|participants|Number|61|61.0||||||
3779897|NCT01885000|3611047|B2|Type II||Skin phototype|"Type I: Individuals who never tan and always sunburn if exposed to any appreciable amount of sunlight, primarily red headed individuals and lighty complected blondes.~Type II: Individuals who frequently burn but are able to tan to a small degree after extended sun exposure.~Type III: Individuals who burn infrequently and tan readily."|participants|Number|27|27.0||||||
3779898|NCT01885000|3611048|B1|Type II||Skin phototype|"Type I: Individuals who never tan and always sunburn if exposed to any appreciable amount of sunlight, primarily red headed individuals and lighty complected blondes.~Type II: Individuals who frequently burn but are able to tan to a small degree after extended sun exposure.~Type III: Individuals who burn infrequently and tan readily."|participants|Number|34|34.0||||||
3779899|NCT01885000|3611046|B3|Type I||Skin phototype|"Type I: Individuals who never tan and always sunburn if exposed to any appreciable amount of sunlight, primarily red headed individuals and lighty complected blondes.~Type II: Individuals who frequently burn but are able to tan to a small degree after extended sun exposure.~Type III: Individuals who burn infrequently and tan readily."|participants|Number|9|9.0||||||
3779900|NCT01885000|3611047|B2|Type I||Skin phototype|"Type I: Individuals who never tan and always sunburn if exposed to any appreciable amount of sunlight, primarily red headed individuals and lighty complected blondes.~Type II: Individuals who frequently burn but are able to tan to a small degree after extended sun exposure.~Type III: Individuals who burn infrequently and tan readily."|participants|Number|6|6.0||||||
3779901|NCT01885000|3611048|B1|Type I||Skin phototype|"Type I: Individuals who never tan and always sunburn if exposed to any appreciable amount of sunlight, primarily red headed individuals and lighty complected blondes.~Type II: Individuals who frequently burn but are able to tan to a small degree after extended sun exposure.~Type III: Individuals who burn infrequently and tan readily."|participants|Number|3|3.0||||||
3779902|NCT01885000|3611046|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779903|NCT01885000|3611047|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779904|NCT01885000|3611048|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779905|NCT01885000|3611046|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779906|NCT01885000|3611047|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779907|NCT01885000|3611048|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779908|NCT01885000|3611046|B3||White|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
3779909|NCT01885000|3611047|B2||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3779910|NCT01885000|3611048|B1||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3779911|NCT01885000|3611046|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779912|NCT01885000|3611047|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779913|NCT01885000|3611048|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779914|NCT01885000|3611046|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779915|NCT01885000|3611047|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779916|NCT01885000|3611048|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779917|NCT01885000|3611046|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779918|NCT01885000|3611047|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779919|NCT01885000|3611048|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779920|NCT01885000|3611046|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779921|NCT01885000|3611047|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779922|NCT01885000|3611048|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779923|NCT01885000|3611046|B3||Male|Gender||Participants|Count of Participants|36|36.0||||||
3779924|NCT01885000|3611047|B2||Male|Gender||Participants|Count of Participants|18|18.0||||||
3779925|NCT01885000|3611048|B1||Male|Gender||Participants|Count of Participants|18|18.0||||||
3779926|NCT01885000|3611046|B3||Female|Gender||Participants|Count of Participants|56|56.0||||||
3779927|NCT01885000|3611047|B2||Female|Gender||Participants|Count of Participants|26|26.0||||||
3779928|NCT01885000|3611048|B1||Female|Gender||Participants|Count of Participants|30|30.0||||||
3779929|NCT01885000|3611046|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3779930|NCT01885000|3611047|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3779931|NCT01885000|3611048|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3779932|NCT01885000|3611046|B3||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
3779933|NCT01885000|3611047|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3779934|NCT01885000|3611048|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3779935|NCT01885000|3611046|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779936|NCT01885000|3611047|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779937|NCT01885000|3611048|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779938|NCT01884844|3611061|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
3779939|NCT01884844|3611062|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3779940|NCT01884844|3611063|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3779941|NCT01884844|3611061|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779942|NCT01884844|3611062|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779943|NCT01884844|3611063|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779944|NCT01884844|3611061|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3779945|NCT01884844|3611062|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3779946|NCT01884844|3611063|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779947|NCT01884844|3611061|B3||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3779948|NCT01884844|3611062|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3779949|NCT01884844|3611063|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3779950|NCT01884844|3611061|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3779951|NCT01884844|3611062|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3779952|NCT01884844|3611063|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779953|NCT01884844|3611061|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779954|NCT01884844|3611062|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779955|NCT01884844|3611063|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779956|NCT01884844|3611061|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3779957|NCT01884844|3611062|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779958|NCT01884844|3611063|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3779959|NCT01884844|3611061|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779960|NCT01884844|3611062|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779961|NCT01884844|3611063|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779962|NCT01884844|3611061|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3779963|NCT01884844|3611062|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3779964|NCT01884844|3611063|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3779965|NCT01884844|3611061|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3779966|NCT01884844|3611062|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3779967|NCT01884844|3611063|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3779968|NCT01884844|3611061|B3|||Age||years|Mean|44.2|44.2|Standard Deviation|13.1|13.1|||
3779969|NCT01884844|3611062|B2|||Age||years|Mean|43.3|43.3|Standard Deviation|12.9|12.9|||
3779970|NCT01884844|3611063|B1|||Age||years|Mean|45.2|45.2|Standard Deviation|13.3|13.3|||
3779971|NCT01884844|3611061|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3779972|NCT01884844|3611062|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3779973|NCT01884844|3611063|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3779974|NCT01884844|3611061|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3779975|NCT01884844|3611062|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3779976|NCT01884844|3611063|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3779977|NCT01884844|3611061|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779978|NCT01884844|3611062|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779979|NCT01884844|3611063|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779980|NCT01884688|3611070|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779981|NCT01884688|3611070|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779982|NCT01884688|3611070|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3779983|NCT01884688|3611070|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779984|NCT01884688|3611070|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779985|NCT01884688|3611070|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779986|NCT01884688|3611070|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3779987|NCT01884688|3611070|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3779988|NCT01884688|3611070|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3779989|NCT01884688|3611070|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3779990|NCT01884688|3611070|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3779991|NCT01884688|3611070|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3779992|NCT01884675|3611074|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
3779993|NCT01884675|3611075|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3779994|NCT01884675|3611076|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3779995|NCT01884675|3611074|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3779996|NCT01884675|3611075|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3779997|NCT01884675|3611076|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3779998|NCT01884675|3611074|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3779999|NCT01884675|3611075|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3780000|NCT01884675|3611076|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3780001|NCT01884675|3611074|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3780002|NCT01884675|3611075|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3780003|NCT01884675|3611076|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3780004|NCT01884675|3611074|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3780005|NCT01884675|3611075|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3780006|NCT01884675|3611076|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3780007|NCT01884675|3611074|B3|||Age||Years|Median|62.0|62.0|Inter-Quartile Range|11.31|11.31|51.0|68.0|
3780008|NCT01884675|3611075|B2|||Age||Years|Median|63.0|63.0|Inter-Quartile Range|13.38|13.38|51.0|71.0|
3780009|NCT01884675|3611076|B1|||Age||Years|Median|59.0|59.0|Inter-Quartile Range|8.99|8.99|51.0|66.5|
3780010|NCT01884597|3611117|B4|United States||Region of Enrollment||participants|Number|21|21.0||||||
3780011|NCT01884597|3611118|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
3780012|NCT01884597|3611119|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3780013|NCT01884597|3611120|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3780014|NCT01884597|3611117|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780015|NCT01884597|3611118|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780016|NCT01884597|3611119|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780017|NCT01884597|3611120|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780018|NCT01884597|3611117|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3780019|NCT01884597|3611118|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3780020|NCT01884597|3611119|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3780021|NCT01884597|3611120|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3780022|NCT01884597|3611117|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780023|NCT01884597|3611118|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780024|NCT01884597|3611119|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780025|NCT01884597|3611120|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780026|NCT01884597|3611117|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3780027|NCT01884597|3611118|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3780028|NCT01884597|3611119|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3780029|NCT01884597|3611120|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3780030|NCT01884597|3611117|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3780031|NCT01884597|3611118|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3780032|NCT01884597|3611119|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3780033|NCT01884597|3611120|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3780034|NCT01884597|3611117|B4|||Age||years|Mean|77.17|77.17|Standard Deviation|2.2|2.2|||
3780035|NCT01884597|3611118|B3|||Age||years|Mean|77.47|77.47|Standard Deviation|8.37|8.37|||
3780036|NCT01884597|3611119|B2|||Age||years|Mean|71.00|71.0|Standard Deviation|19.80|19.8|||
3780037|NCT01884597|3611120|B1|||Age||years|Mean|75.75|75.75|Standard Deviation|13.72|13.72|||
3780038|NCT01884597|3611117|B4||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3780039|NCT01884597|3611118|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3780040|NCT01884597|3611119|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3780041|NCT01884597|3611120|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3780042|NCT01884597|3611117|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3780043|NCT01884597|3611118|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3780044|NCT01884597|3611119|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3780045|NCT01884597|3611120|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3780046|NCT01884597|3611117|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3780047|NCT01884597|3611118|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3780048|NCT01884597|3611119|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3780049|NCT01884597|3611120|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3780050|NCT01884571|3611151|B1|More than 24 months prior to screening||Timing of Symptom Onset||Participants|Count of Participants|11|11.0||||||
3780051|NCT01884571|3611151|B1|Less than or equal to 24 months prior to screening||Timing of Symptom Onset||Participants|Count of Participants|20|20.0||||||
3780052|NCT01884571|3611151|B1|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3780053|NCT01884571|3611151|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3780054|NCT01884571|3611151|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3780055|NCT01884571|3611151|B1|||Age||years|Mean|53.9|53.9|Standard Deviation|11.2|11.2|||
3780056|NCT01884545|3611162|B5|||Triglycerides||mg/dL|Mean|160.24|160.24|Standard Deviation|90.33|90.33|||
3780057|NCT01884545|3611163|B4|||Triglycerides||mg/dL|Mean|156.60|156.6|Standard Deviation|69.44|69.44|||
3780058|NCT01884545|3611164|B3|||Triglycerides||mg/dL|Mean|157.35|157.35|Standard Deviation|87.76|87.76|||
3780059|NCT01884545|3611165|B2|||Triglycerides||mg/dL|Mean|150.73|150.73|Standard Deviation|70.53|70.53|||
3780060|NCT01884545|3611166|B1|||Triglycerides||mg/dL|Mean|176.19|176.19|Standard Deviation|123.80|123.8|||
3780061|NCT01884545|3611162|B5|||Low-density Lipoprotein (LDL)||mg/dL|Mean|134.05|134.05|Standard Deviation|36.12|36.12|||
3780062|NCT01884545|3611163|B4|||Low-density Lipoprotein (LDL)||mg/dL|Mean|136.95|136.95|Standard Deviation|37.15|37.15|||
3780063|NCT01884545|3611164|B3|||Low-density Lipoprotein (LDL)||mg/dL|Mean|131.94|131.94|Standard Deviation|32.90|32.9|||
3780064|NCT01884545|3611165|B2|||Low-density Lipoprotein (LDL)||mg/dL|Mean|133.51|133.51|Standard Deviation|42.40|42.4|||
3780065|NCT01884545|3611166|B1|||Low-density Lipoprotein (LDL)||mg/dL|Mean|133.63|133.63|Standard Deviation|32.05|32.05|||
3780066|NCT01884545|3611162|B5|||High-density Lipoprotein (HDL)||mg/dL|Mean|52.53|52.53|Standard Deviation|16.62|16.62|||
3780067|NCT01884545|3611163|B4|||High-density Lipoprotein (HDL)||mg/dL|Mean|50.50|50.5|Standard Deviation|16.41|16.41|||
3780068|NCT01884545|3611164|B3|||High-density Lipoprotein (HDL)||mg/dL|Mean|49.59|49.59|Standard Deviation|13.50|13.5|||
3780069|NCT01884545|3611165|B2|||High-density Lipoprotein (HDL)||mg/dL|Mean|56.45|56.45|Standard Deviation|18.62|18.62|||
3780070|NCT01884545|3611166|B1|||High-density Lipoprotein (HDL)||mg/dL|Mean|53.66|53.66|Standard Deviation|17.15|17.15|||
3780071|NCT01884545|3611162|B5|||Diastolic Blood Pressure||mmHg|Mean|80.12|80.12|Standard Deviation|9.63|9.63|||
3780072|NCT01884545|3611163|B4|||Diastolic Blood Pressure||mmHg|Mean|80.62|80.62|Standard Deviation|10.70|10.7|||
3780073|NCT01884545|3611164|B3|||Diastolic Blood Pressure||mmHg|Mean|78.26|78.26|Standard Deviation|8.36|8.36|||
3780074|NCT01884545|3611165|B2|||Diastolic Blood Pressure||mmHg|Mean|80.77|80.77|Standard Deviation|10.38|10.38|||
3780075|NCT01884545|3611166|B1|||Diastolic Blood Pressure||mmHg|Mean|80.78|80.78|Standard Deviation|8.89|8.89|||
3780076|NCT01884545|3611162|B5|||Systolic Blood Pressure||mmHg|Mean|126.77|126.77|Standard Deviation|12.24|12.24|||
3780077|NCT01884545|3611163|B4|||Systolic Blood Pressure||mmHg|Mean|128.68|128.68|Standard Deviation|13.30|13.3|||
3780078|NCT01884545|3611164|B3|||Systolic Blood Pressure||mmHg|Mean|123.24|123.24|Standard Deviation|10.87|10.87|||
3780079|NCT01884545|3611165|B2|||Systolic Blood Pressure||mmHg|Mean|126.41|126.41|Standard Deviation|13.03|13.03|||
3780080|NCT01884545|3611166|B1|||Systolic Blood Pressure||mmHg|Mean|128.60|128.6|Standard Deviation|11.06|11.06|||
3780081|NCT01884545|3611162|B5|||Waist Circumference||cm|Mean|98.30|98.3|Standard Deviation|13.23|13.23|||
3780082|NCT01884545|3611163|B4|||Waist Circumference||cm|Mean|98.56|98.56|Standard Deviation|12.09|12.09|||
3780083|NCT01884545|3611164|B3|||Waist Circumference||cm|Mean|97.23|97.23|Standard Deviation|13.50|13.5|||
3780084|NCT01884545|3611165|B2|||Waist Circumference||cm|Mean|98.51|98.51|Standard Deviation|16.42|16.42|||
3780085|NCT01884545|3611166|B1|||Waist Circumference||cm|Mean|98.86|98.86|Standard Deviation|10.73|10.73|||
3780086|NCT01884545|3611162|B5|||Weight||kg|Mean|85.58|85.58|Standard Deviation|18.15|18.15|||
3780087|NCT01884545|3611163|B4|||Weight||kg|Mean|89.07|89.07|Standard Deviation|17.76|17.76|||
3780088|NCT01884545|3611164|B3|||Weight||kg|Mean|84.96|84.96|Standard Deviation|20.66|20.66|||
3780089|NCT01884545|3611165|B2|||Weight||kg|Mean|82.15|82.15|Standard Deviation|16.75|16.75|||
3780090|NCT01884545|3611166|B1|||Weight||kg|Mean|85.94|85.94|Standard Deviation|17.05|17.05|||
3780130|NCT01884545|3611166|B1||Inactive/light intensity activity|Physical Activity||Participants|Count of Participants|26|26.0||||||
3780091|NCT01884545|3611162|B5|Not applicable (patient not taking medication)||Medication Adherence (Morisky 4)|The Medication Adherence (Morisky 4) data was only collected for patients who were taking medication|Participants|Count of Participants|30|30.0||||||
3780092|NCT01884545|3611163|B4|Not applicable (patient not taking medication)||Medication Adherence (Morisky 4)|The Medication Adherence (Morisky 4) data was only collected for patients who were taking medication|Participants|Count of Participants|8|8.0||||||
3780093|NCT01884545|3611164|B3|Not applicable (patient not taking medication)||Medication Adherence (Morisky 4)|The Medication Adherence (Morisky 4) data was only collected for patients who were taking medication|Participants|Count of Participants|7|7.0||||||
3780094|NCT01884545|3611165|B2|Not applicable (patient not taking medication)||Medication Adherence (Morisky 4)|The Medication Adherence (Morisky 4) data was only collected for patients who were taking medication|Participants|Count of Participants|7|7.0||||||
3780095|NCT01884545|3611166|B1|Not applicable (patient not taking medication)||Medication Adherence (Morisky 4)|The Medication Adherence (Morisky 4) data was only collected for patients who were taking medication|Participants|Count of Participants|8|8.0||||||
3780096|NCT01884545|3611162|B5|High Adherence||Medication Adherence (Morisky 4)|The Medication Adherence (Morisky 4) data was only collected for patients who were taking medication|Participants|Count of Participants|56|56.0||||||
3780097|NCT01884545|3611163|B4|High Adherence||Medication Adherence (Morisky 4)|The Medication Adherence (Morisky 4) data was only collected for patients who were taking medication|Participants|Count of Participants|15|15.0||||||
3780098|NCT01884545|3611164|B3|High Adherence||Medication Adherence (Morisky 4)|The Medication Adherence (Morisky 4) data was only collected for patients who were taking medication|Participants|Count of Participants|11|11.0||||||
3780099|NCT01884545|3611165|B2|High Adherence||Medication Adherence (Morisky 4)|The Medication Adherence (Morisky 4) data was only collected for patients who were taking medication|Participants|Count of Participants|17|17.0||||||
3780100|NCT01884545|3611166|B1|High Adherence||Medication Adherence (Morisky 4)|The Medication Adherence (Morisky 4) data was only collected for patients who were taking medication|Participants|Count of Participants|13|13.0||||||
3780101|NCT01884545|3611162|B5|Medium Adherence||Medication Adherence (Morisky 4)|The Medication Adherence (Morisky 4) data was only collected for patients who were taking medication|Participants|Count of Participants|52|52.0||||||
3780102|NCT01884545|3611163|B4|Medium Adherence||Medication Adherence (Morisky 4)|The Medication Adherence (Morisky 4) data was only collected for patients who were taking medication|Participants|Count of Participants|15|15.0||||||
3780103|NCT01884545|3611164|B3|Medium Adherence||Medication Adherence (Morisky 4)|The Medication Adherence (Morisky 4) data was only collected for patients who were taking medication|Participants|Count of Participants|12|12.0||||||
3780104|NCT01884545|3611165|B2|Medium Adherence||Medication Adherence (Morisky 4)|The Medication Adherence (Morisky 4) data was only collected for patients who were taking medication|Participants|Count of Participants|12|12.0||||||
3780105|NCT01884545|3611166|B1|Medium Adherence||Medication Adherence (Morisky 4)|The Medication Adherence (Morisky 4) data was only collected for patients who were taking medication|Participants|Count of Participants|13|13.0||||||
3780106|NCT01884545|3611162|B5|Low Adherence||Medication Adherence (Morisky 4)|The Medication Adherence (Morisky 4) data was only collected for patients who were taking medication|Participants|Count of Participants|61|61.0||||||
3780107|NCT01884545|3611163|B4|Low Adherence||Medication Adherence (Morisky 4)|The Medication Adherence (Morisky 4) data was only collected for patients who were taking medication|Participants|Count of Participants|14|14.0||||||
3780108|NCT01884545|3611164|B3|Low Adherence||Medication Adherence (Morisky 4)|The Medication Adherence (Morisky 4) data was only collected for patients who were taking medication|Participants|Count of Participants|19|19.0||||||
3780109|NCT01884545|3611165|B2|Low Adherence||Medication Adherence (Morisky 4)|The Medication Adherence (Morisky 4) data was only collected for patients who were taking medication|Participants|Count of Participants|12|12.0||||||
3780110|NCT01884545|3611166|B1|Low Adherence||Medication Adherence (Morisky 4)|The Medication Adherence (Morisky 4) data was only collected for patients who were taking medication|Participants|Count of Participants|16|16.0||||||
3780111|NCT01884545|3611162|B5||Yes|Smoking Status||Participants|Count of Participants|22|22.0||||||
3780112|NCT01884545|3611163|B4||Yes|Smoking Status||Participants|Count of Participants|9|9.0||||||
3780113|NCT01884545|3611164|B3||Yes|Smoking Status||Participants|Count of Participants|5|5.0||||||
3780114|NCT01884545|3611165|B2||Yes|Smoking Status||Participants|Count of Participants|3|3.0||||||
3780115|NCT01884545|3611166|B1||Yes|Smoking Status||Participants|Count of Participants|5|5.0||||||
3780116|NCT01884545|3611162|B5||No|Smoking Status||Participants|Count of Participants|178|178.0||||||
3780117|NCT01884545|3611163|B4||No|Smoking Status||Participants|Count of Participants|43|43.0||||||
3780118|NCT01884545|3611164|B3||No|Smoking Status||Participants|Count of Participants|44|44.0||||||
3780119|NCT01884545|3611165|B2||No|Smoking Status||Participants|Count of Participants|46|46.0||||||
3780120|NCT01884545|3611166|B1||No|Smoking Status||Participants|Count of Participants|45|45.0||||||
3780121|NCT01884545|3611162|B5||Moderate/ hard/very hard intensity activity|Physical Activity||Participants|Count of Participants|104|104.0||||||
3780122|NCT01884545|3611163|B4||Moderate/ hard/very hard intensity activity|Physical Activity||Participants|Count of Participants|27|27.0||||||
3780123|NCT01884545|3611164|B3||Moderate/ hard/very hard intensity activity|Physical Activity||Participants|Count of Participants|24|24.0||||||
3780124|NCT01884545|3611165|B2||Moderate/ hard/very hard intensity activity|Physical Activity||Participants|Count of Participants|29|29.0||||||
3780125|NCT01884545|3611166|B1||Moderate/ hard/very hard intensity activity|Physical Activity||Participants|Count of Participants|24|24.0||||||
3780126|NCT01884545|3611162|B5||Inactive/light intensity activity|Physical Activity||Participants|Count of Participants|96|96.0||||||
3780127|NCT01884545|3611163|B4||Inactive/light intensity activity|Physical Activity||Participants|Count of Participants|25|25.0||||||
3780128|NCT01884545|3611164|B3||Inactive/light intensity activity|Physical Activity||Participants|Count of Participants|25|25.0||||||
3780129|NCT01884545|3611165|B2||Inactive/light intensity activity|Physical Activity||Participants|Count of Participants|20|20.0||||||
3780131|NCT01884545|3611162|B5|||Dietary Intake (Daily grams of fiber)||grams|Mean|16.46|16.46|Standard Deviation|6.73|6.73|||
3780132|NCT01884545|3611163|B4|||Dietary Intake (Daily grams of fiber)||grams|Mean|18.27|18.27|Standard Deviation|8.68|8.68|||
3780133|NCT01884545|3611164|B3|||Dietary Intake (Daily grams of fiber)||grams|Mean|15.75|15.75|Standard Deviation|5.83|5.83|||
3780134|NCT01884545|3611165|B2|||Dietary Intake (Daily grams of fiber)||grams|Mean|14.94|14.94|Standard Deviation|5.57|5.57|||
3780135|NCT01884545|3611166|B1|||Dietary Intake (Daily grams of fiber)||grams|Mean|16.65|16.65|Standard Deviation|5.82|5.82|||
3780136|NCT01884545|3611162|B5|||Dietary Intake (Percent energy from fat)||percent|Mean|34.81|34.81|Standard Deviation|4.14|4.14|||
3780137|NCT01884545|3611163|B4|||Dietary Intake (Percent energy from fat)||percent|Mean|35.66|35.66|Standard Deviation|4.91|4.91|||
3780138|NCT01884545|3611164|B3|||Dietary Intake (Percent energy from fat)||percent|Mean|34.13|34.13|Standard Deviation|4.55|4.55|||
3780139|NCT01884545|3611165|B2|||Dietary Intake (Percent energy from fat)||percent|Mean|34.87|34.87|Standard Deviation|3.17|3.17|||
3780140|NCT01884545|3611166|B1|||Dietary Intake (Percent energy from fat)||percent|Mean|34.50|34.5|Standard Deviation|3.60|3.6|||
3780141|NCT01884545|3611162|B5|United States||Region of Enrollment||Participants|Count of Participants|200|200.0||||||
3780142|NCT01884545|3611163|B4|United States||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
3780143|NCT01884545|3611164|B3|United States||Region of Enrollment||Participants|Count of Participants|49|49.0||||||
3780144|NCT01884545|3611165|B2|United States||Region of Enrollment||Participants|Count of Participants|49|49.0||||||
3780145|NCT01884545|3611166|B1|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3780146|NCT01884545|3611162|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3780147|NCT01884545|3611163|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3780148|NCT01884545|3611164|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3780149|NCT01884545|3611165|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780150|NCT01884545|3611166|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3780151|NCT01884545|3611162|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3780152|NCT01884545|3611163|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3780153|NCT01884545|3611164|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3780154|NCT01884545|3611165|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780155|NCT01884545|3611166|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3780156|NCT01884545|3611162|B5||White|Race (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
3780157|NCT01884545|3611163|B4||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3780158|NCT01884545|3611164|B3||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3780159|NCT01884545|3611165|B2||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3780160|NCT01884545|3611166|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3780161|NCT01884545|3611162|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3780162|NCT01884545|3611163|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3780163|NCT01884545|3611164|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3780164|NCT01884545|3611165|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3780165|NCT01884545|3611166|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3780166|NCT01884545|3611162|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3780167|NCT01884545|3611163|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780168|NCT01884545|3611164|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3780169|NCT01884545|3611165|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780170|NCT01884545|3611166|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3780171|NCT01884545|3611162|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3780172|NCT01884545|3611163|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3780173|NCT01884545|3611164|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3780174|NCT01884545|3611165|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3780175|NCT01884545|3611166|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3780176|NCT01884545|3611162|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3780177|NCT01884545|3611163|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3780178|NCT01884545|3611164|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780179|NCT01884545|3611165|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780180|NCT01884545|3611166|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780181|NCT01884545|3611162|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3780182|NCT01884545|3611163|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780183|NCT01884545|3611164|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780184|NCT01884545|3611165|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3780185|NCT01884545|3611166|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3780186|NCT01884545|3611162|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|179|179.0||||||
3780187|NCT01884545|3611163|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3780188|NCT01884545|3611164|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3780189|NCT01884545|3611165|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3780190|NCT01884545|3611166|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3780191|NCT01884545|3611162|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3780192|NCT01884545|3611163|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3780193|NCT01884545|3611164|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3780194|NCT01884545|3611165|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3780195|NCT01884545|3611166|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3780196|NCT01884545|3611162|B5||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3780197|NCT01884545|3611163|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3780198|NCT01884545|3611164|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3780199|NCT01884545|3611165|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3780200|NCT01884545|3611166|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3780201|NCT01884545|3611162|B5||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3780202|NCT01884545|3611163|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3780203|NCT01884545|3611164|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3780204|NCT01884545|3611165|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3780205|NCT01884545|3611166|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3780206|NCT01884545|3611162|B5|||Age||years|Mean|47.72|47.72|Standard Deviation|11.56|11.56|||
3780207|NCT01884545|3611163|B4|||Age||years|Mean|44.85|44.85|Standard Deviation|11.85|11.85|||
3780208|NCT01884545|3611164|B3|||Age||years|Mean|48.35|48.35|Standard Deviation|10.51|10.51|||
3780209|NCT01884545|3611165|B2|||Age||years|Mean|48.67|48.67|Standard Deviation|12.67|12.67|||
3780210|NCT01884545|3611166|B1|||Age||years|Mean|49.16|49.16|Standard Deviation|10.92|10.92|||
3780211|NCT01884519|3611275|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3780212|NCT01884519|3611276|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3780213|NCT01884519|3611277|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3780214|NCT01884519|3611275|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3780215|NCT01884519|3611276|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3780216|NCT01884519|3611277|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3780217|NCT01884519|3611275|B3|||Age||Years|Mean|55.4|55.4|Standard Deviation|15.68|15.68|||
3780218|NCT01884519|3611276|B2|||Age||Years|Mean|68.2|68.2|Standard Deviation|5.49|5.49|||
3780219|NCT01884519|3611277|B1|||Age||Years|Mean|42.6|42.6|Standard Deviation|11.5|11.5|||
3780220|NCT01884311|3611320|B1|United States||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
3780221|NCT01884311|3611320|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780222|NCT01884311|3611320|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3780223|NCT01884311|3611320|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3780224|NCT01884311|3611320|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780225|NCT01884311|3611320|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780226|NCT01884311|3611320|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3780227|NCT01884311|3611320|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3780228|NCT01884311|3611320|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780229|NCT01884311|3611320|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3780230|NCT01884311|3611320|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3780231|NCT01884311|3611320|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3780232|NCT01884311|3611320|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3780233|NCT01884311|3611320|B1||< 16 years|Age, Customized||Participants|Count of Participants|13|13.0||||||
3780234|NCT01884311|3611320|B1||>=16 years|Age, Customized||Participants|Count of Participants|25|25.0||||||
3780235|NCT01884077|3611328|B3|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3780236|NCT01884077|3611329|B2|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3780237|NCT01884077|3611330|B1|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3780238|NCT01884077|3611328|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3780239|NCT01884077|3611329|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3780240|NCT01884077|3611330|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3780241|NCT01884077|3611328|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3780242|NCT01884077|3611329|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3780243|NCT01884077|3611330|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3780244|NCT01884077|3611328|B3|||Age||years|Median|75.5|75.5|Full Range|||69.0|82.0|
3780245|NCT01884077|3611329|B2|||Age||years|Median|77|77.0|Full Range|||72.0|82.0|
3780246|NCT01884077|3611330|B1|||Age||years|Median|72|72.0|Full Range|||69.0|75.0|
3780247|NCT01884077|3611328|B3||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3780248|NCT01884077|3611329|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3780249|NCT01884077|3611330|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3780250|NCT01884077|3611328|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3780251|NCT01884077|3611329|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3780252|NCT01884077|3611330|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3780253|NCT01884077|3611328|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3780254|NCT01884077|3611329|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3780255|NCT01884077|3611330|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3780256|NCT01884064|3611341|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3780257|NCT01884064|3611342|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3780258|NCT01884064|3611343|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3780259|NCT01884064|3611341|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3780260|NCT01884064|3611342|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3780261|NCT01884064|3611343|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3780262|NCT01884064|3611341|B3|||Age||years|Mean|46.5|46.5|Standard Deviation|12.4|12.4|||
3780263|NCT01884064|3611342|B2|||Age||years|Mean|46.6|46.6|Standard Deviation|14.8|14.8|||
3780264|NCT01884064|3611343|B1|||Age||years|Mean|46.5|46.5|Standard Deviation|12.4|12.4|||
3780265|NCT01884025|3611350|B3|Graduate Degree||Years of Education||participants|Number|2|2.0||||||
3780266|NCT01884025|3611351|B2|Graduate Degree||Years of Education||participants|Number|2|2.0||||||
3780267|NCT01884025|3611352|B1|Graduate Degree||Years of Education||participants|Number|0|0.0||||||
3780268|NCT01884025|3611350|B3|Bachelors Degree||Years of Education||participants|Number|4|4.0||||||
3780269|NCT01884025|3611351|B2|Bachelors Degree||Years of Education||participants|Number|2|2.0||||||
3780270|NCT01884025|3611352|B1|Bachelors Degree||Years of Education||participants|Number|2|2.0||||||
3780271|NCT01884025|3611350|B3|Some COllege||Years of Education||participants|Number|6|6.0||||||
3780272|NCT01884025|3611351|B2|Some COllege||Years of Education||participants|Number|2|2.0||||||
3780273|NCT01884025|3611352|B1|Some COllege||Years of Education||participants|Number|4|4.0||||||
3780274|NCT01884025|3611350|B3|HighSchool/GED||Years of Education||participants|Number|8|8.0||||||
3780275|NCT01884025|3611351|B2|HighSchool/GED||Years of Education||participants|Number|4|4.0||||||
3780276|NCT01884025|3611352|B1|HighSchool/GED||Years of Education||participants|Number|4|4.0||||||
3780277|NCT01884025|3611350|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3780278|NCT01884025|3611351|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3780279|NCT01884025|3611352|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3780280|NCT01884025|3611350|B3|African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3780281|NCT01884025|3611351|B2|African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3780282|NCT01884025|3611352|B1|African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3780283|NCT01884025|3611350|B3|Caucasian (Non-Hispanic)||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3780284|NCT01884025|3611351|B2|Caucasian (Non-Hispanic)||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3780285|NCT01884025|3611352|B1|Caucasian (Non-Hispanic)||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3780286|NCT01884025|3611350|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3780287|NCT01884025|3611351|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3780288|NCT01884025|3611352|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3780289|NCT01884025|3611350|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3780290|NCT01884025|3611351|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3780291|NCT01884025|3611352|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3780292|NCT01884025|3611350|B3|||Age||years|Mean|54.6|54.6|Standard Deviation|7.66|7.66|||
3780293|NCT01884025|3611351|B2|||Age||years|Mean|54.1|54.1|Standard Deviation|8.8|8.8|||
3780294|NCT01884025|3611352|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|6.77|6.77|||
3780295|NCT01884025|3611350|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3780296|NCT01884025|3611351|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3780297|NCT01884025|3611352|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3780298|NCT01884025|3611350|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3780299|NCT01884025|3611351|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3780300|NCT01884025|3611352|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3780301|NCT01884025|3611350|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3780302|NCT01884025|3611351|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3780303|NCT01884025|3611352|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3780304|NCT01883999|3611381|B1|United States||Region of Enrollment||participants|Number|64|64.0||||||
3780305|NCT01883999|3611381|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3780306|NCT01883999|3611381|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3780307|NCT01883999|3611381|B1|||Age||years|Mean|69.6|69.6|Standard Deviation|8.4|8.4|||
3780308|NCT01883986|3611387|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3780309|NCT01883986|3611388|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3780310|NCT01883986|3611389|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3780311|NCT01883986|3611387|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3780312|NCT01883986|3611388|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3780313|NCT01883986|3611389|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3780314|NCT01883986|3611387|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780315|NCT01883986|3611388|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780316|NCT01883986|3611389|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780317|NCT01883986|3611387|B3||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3780318|NCT01883986|3611388|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3780319|NCT01883986|3611389|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3780320|NCT01883986|3611387|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780321|NCT01883986|3611388|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780322|NCT01883986|3611389|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780323|NCT01883986|3611387|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780324|NCT01883986|3611388|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780325|NCT01883986|3611389|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780326|NCT01883986|3611387|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780327|NCT01883986|3611388|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780328|NCT01883986|3611389|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780329|NCT01883986|3611387|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780330|NCT01883986|3611388|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780331|NCT01883986|3611389|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780332|NCT01883986|3611387|B3||Male|Gender||Participants|Count of Participants|38|38.0||||||
3780333|NCT01883986|3611388|B2||Male|Gender||Participants|Count of Participants|19|19.0||||||
3780334|NCT01883986|3611389|B1||Male|Gender||Participants|Count of Participants|19|19.0||||||
3780335|NCT01883986|3611387|B3||Female|Gender||Participants|Count of Participants|2|2.0||||||
3780336|NCT01883986|3611388|B2||Female|Gender||Participants|Count of Participants|1|1.0||||||
3780337|NCT01883986|3611389|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
3780338|NCT01883986|3611387|B3|||Age||years|Mean|66.7|66.7|Standard Deviation|13.1|13.1|||
3780339|NCT01883986|3611388|B2|||Age||years|Mean|64.9|64.9|Standard Deviation|17.6|17.6|||
3780340|NCT01883986|3611389|B1|||Age||years|Mean|68.5|68.5|Standard Deviation|6|6.0|||
3780341|NCT01883908|3611402|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3780342|NCT01883908|3611403|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3780343|NCT01883908|3611404|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3780344|NCT01883908|3611402|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3780345|NCT01883908|3611403|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3780346|NCT01883908|3611404|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3780347|NCT01883908|3611402|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3780348|NCT01883908|3611403|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3780349|NCT01883908|3611404|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3780350|NCT01883908|3611402|B3|||Age, Customized||years|Median|63|63.0|Full Range|||53.0|73.0|
3780351|NCT01883908|3611403|B2|||Age, Customized||years|Median|55|55.0|Full Range|||55.0|55.0|
3780352|NCT01883908|3611404|B1|||Age, Customized||years|Median|63|63.0|Full Range|||53.0|73.0|
3780353|NCT01883895|3611413|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780354|NCT01883895|3611413|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780355|NCT01883895|3611413|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3780356|NCT01883895|3611413|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3780357|NCT01883895|3611413|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3780358|NCT01883895|3611413|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3780359|NCT01883895|3611413|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3780360|NCT01883895|3611413|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780361|NCT01883895|3611413|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3780362|NCT01883895|3611413|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3780363|NCT01883895|3611413|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3780364|NCT01883895|3611413|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3780365|NCT01883895|3611413|B1|||Age||years|Mean|25.4|25.4|Standard Deviation|4.2|4.2|||
3780366|NCT01883895|3611413|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3780367|NCT01883895|3611413|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3780368|NCT01883895|3611413|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3780369|NCT01883804|3611418|B1|||Abnormal Hemoglobin Levels|Hemoglobin < 12 g/dL|Participants|Count of Participants|0|0.0||||||
3780370|NCT01883804|3611418|B1|||Elevated ALT Values||Participants|Count of Participants|0|0.0||||||
3780371|NCT01883804|3611418|B1|||Elevated AST Values||Participants|Count of Participants|0|0.0||||||
3780372|NCT01883804|3611418|B1|||Diastolic Blood Pressure||mmHg|Mean|69.65|69.65|Standard Deviation|8.16|8.16|||
3780373|NCT01883804|3611418|B1|||Systolic Blood Pressure||mmHg|Mean|113.2|113.2|Standard Deviation|10.03|10.03|||
3780374|NCT01883804|3611418|B1|||Positive ZnT8 Autoantibodies||Participants|Count of Participants|11|11.0||||||
3780375|NCT01883804|3611418|B1|||Positive IA-2 Autoantibodies||Participants|Count of Participants|14|14.0||||||
3780376|NCT01883804|3611418|B1|||Positive GAD Autoantibodies||Participants|Count of Participants|15|15.0||||||
3780377|NCT01883804|3611418|B1|||Positive Insulin Autoantibodies (Index)|Only included if measured within 21 days of starting exogenous insulin.|Participants|Count of Participants|1|1.0||||||
3780378|NCT01883804|3611418|B1|||C-Peptide AUC following a 2 Hour Mixed Meal Tolerance Test||nmol/L/Min|Mean|0.64|0.64|Full Range|||0.1|2.67|
3780379|NCT01883804|3611418|B1|||Hemoglobin A1c||Percentage|Mean|7.4|7.4|Full Range|||5.3|12.1|
3780380|NCT01883804|3611418|B1|||Duration of Type 1 Diabetes||Days|Mean|133|133.0|Full Range|||21.0|566.0|
3780381|NCT01883804|3611418|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3780382|NCT01883804|3611418|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780383|NCT01883804|3611418|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780384|NCT01883804|3611418|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3780385|NCT01883804|3611418|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3780386|NCT01883804|3611418|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780387|NCT01883804|3611418|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780388|NCT01883804|3611418|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780389|NCT01883804|3611418|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780390|NCT01883804|3611418|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3780391|NCT01883804|3611418|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3780392|NCT01883804|3611418|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3780393|NCT01883804|3611418|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3780394|NCT01883804|3611418|B1|Mean Age||Age||years|Mean|24.75|24.75|Full Range|||18.0|43.0|
3780395|NCT01883635|3611425|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
3780396|NCT01883635|3611426|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3780397|NCT01883635|3611427|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3780398|NCT01883635|3611425|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780399|NCT01883635|3611426|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780400|NCT01883635|3611427|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780401|NCT01883635|3611425|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780402|NCT01883635|3611426|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780403|NCT01883635|3611427|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780404|NCT01883635|3611425|B3||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3780405|NCT01883635|3611426|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3780406|NCT01883635|3611427|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3780407|NCT01883635|3611425|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780408|NCT01883635|3611426|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780409|NCT01883635|3611427|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780410|NCT01883635|3611425|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780411|NCT01883635|3611426|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780412|NCT01883635|3611427|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780413|NCT01883635|3611425|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780414|NCT01883635|3611426|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780415|NCT01883635|3611427|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780416|NCT01883635|3611425|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780417|NCT01883635|3611426|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780418|NCT01883635|3611427|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780419|NCT01883635|3611425|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780420|NCT01883635|3611426|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780421|NCT01883635|3611427|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780422|NCT01883635|3611425|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3780423|NCT01883635|3611426|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3780424|NCT01883635|3611427|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3780425|NCT01883635|3611425|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3780426|NCT01883635|3611426|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3780427|NCT01883635|3611427|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780428|NCT01883635|3611425|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3780429|NCT01883635|3611426|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3780430|NCT01883635|3611427|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3780431|NCT01883635|3611425|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3780432|NCT01883635|3611426|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3780433|NCT01883635|3611427|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3780434|NCT01883635|3611425|B3|||Age||Years|Mean|55.12|55.12|Standard Deviation|11.71|11.71|||
3780435|NCT01883635|3611426|B2|||Age||Years|Mean|53.90|53.9|Standard Deviation|12.59|12.59|||
3780436|NCT01883635|3611427|B1|||Age||Years|Mean|56.17|56.17|Standard Deviation|11.05|11.05|||
3780437|NCT01883635|3611425|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3780438|NCT01883635|3611426|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3780439|NCT01883635|3611427|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3780440|NCT01883635|3611425|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3780441|NCT01883635|3611426|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3780442|NCT01883635|3611427|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3780443|NCT01883635|3611425|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3780444|NCT01883635|3611426|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3780445|NCT01883635|3611427|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3780446|NCT01883453|3611440|B3|Sweden||Region of Enrollment||participants|Number|98|98.0||||||
3780447|NCT01883453|3611441|B2|Sweden||Region of Enrollment||participants|Number|50|50.0||||||
3780448|NCT01883453|3611442|B1|Sweden||Region of Enrollment||participants|Number|48|48.0||||||
3780449|NCT01883453|3611440|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3780450|NCT01883453|3611441|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3780451|NCT01883453|3611442|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3780452|NCT01883453|3611440|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3780453|NCT01883453|3611441|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3780454|NCT01883453|3611442|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3780455|NCT01883453|3611440|B3|||Age||years|Mean|39|39.0|Full Range|||18.0|72.0|
3780456|NCT01883453|3611441|B2|||Age||years|Mean|40|40.0|Full Range|||18.0|70.0|
3780457|NCT01883453|3611442|B1|||Age||years|Mean|38|38.0|Full Range|||19.0|72.0|
3780458|NCT01883453|3611440|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3780459|NCT01883453|3611441|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3780460|NCT01883453|3611442|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3780461|NCT01883453|3611440|B3||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
3780462|NCT01883453|3611441|B2||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
3780463|NCT01883453|3611442|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3780464|NCT01883453|3611440|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3780465|NCT01883453|3611441|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3780466|NCT01883453|3611442|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3780467|NCT01883440|3611449|B3|Sweden||Region of Enrollment||participants|Number|87|87.0||||||
3780468|NCT01883440|3611450|B2|Sweden||Region of Enrollment||participants|Number|45|45.0||||||
3780469|NCT01883440|3611451|B1|Sweden||Region of Enrollment||participants|Number|42|42.0||||||
3780470|NCT01883440|3611449|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3780471|NCT01883440|3611450|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3780472|NCT01883440|3611451|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3780473|NCT01883440|3611449|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3780474|NCT01883440|3611450|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3780475|NCT01883440|3611451|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3780476|NCT01883440|3611449|B3|||Age||years|Mean|42|42.0|Full Range|||18.0|63.0|
3780477|NCT01883440|3611450|B2|||Age||years|Mean|41|41.0|Full Range|||21.0|61.0|
3780478|NCT01883440|3611451|B1|||Age||years|Mean|44|44.0|Full Range|||18.0|63.0|
3780479|NCT01883440|3611449|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3780480|NCT01883440|3611450|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3780481|NCT01883440|3611451|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3780482|NCT01883440|3611449|B3||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
3780483|NCT01883440|3611450|B2||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3780545|NCT01882907|3611486|B2|||Age||years|Mean|53.9|53.9|Standard Deviation|9.1|9.1|||
3780484|NCT01883440|3611451|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3780485|NCT01883440|3611449|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3780486|NCT01883440|3611450|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3780487|NCT01883440|3611451|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3780488|NCT01883427|3611460|B3|Sweden||Region of Enrollment||participants|Number|40|40.0||||||
3780489|NCT01883427|3611461|B2|Sweden||Region of Enrollment||participants|Number|20|20.0||||||
3780490|NCT01883427|3611462|B1|Sweden||Region of Enrollment||participants|Number|20|20.0||||||
3780491|NCT01883427|3611460|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3780492|NCT01883427|3611461|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3780493|NCT01883427|3611462|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3780494|NCT01883427|3611460|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3780495|NCT01883427|3611461|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3780496|NCT01883427|3611462|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3780497|NCT01883427|3611460|B3|||Age||months|Mean|28|28.0|Full Range|||11.0|44.0|
3780498|NCT01883427|3611461|B2|||Age||months|Mean|27|27.0|Full Range|||11.0|44.0|
3780499|NCT01883427|3611462|B1|||Age||months|Mean|28|28.0|Full Range|||14.0|43.0|
3780500|NCT01883427|3611460|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3780501|NCT01883427|3611461|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3780502|NCT01883427|3611462|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3780503|NCT01883427|3611460|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3780504|NCT01883427|3611461|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3780505|NCT01883427|3611462|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3780506|NCT01883427|3611460|B3||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
3780507|NCT01883427|3611461|B2||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
3780508|NCT01883427|3611462|B1||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
3780509|NCT01883141|3611469|B1|Israel||Region of Enrollment||participants|Number|1|1.0||||||
3780510|NCT01883141|3611469|B1|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3780511|NCT01883141|3611469|B1|Poland||Region of Enrollment||participants|Number|20|20.0||||||
3780512|NCT01883141|3611469|B1|Belgium||Region of Enrollment||participants|Number|6|6.0||||||
3780513|NCT01883141|3611469|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3780514|NCT01883141|3611469|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3780515|NCT01883141|3611469|B1|||Age||Years|Mean|61|61.0|Standard Deviation|13|13.0|||
3780516|NCT01882985|3611478|B1|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3780517|NCT01882985|3611478|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3780518|NCT01882985|3611478|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780519|NCT01882985|3611478|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3780520|NCT01882985|3611478|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780521|NCT01882985|3611478|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780522|NCT01882985|3611478|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3780523|NCT01882985|3611478|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780524|NCT01882985|3611478|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3780525|NCT01882985|3611478|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3780526|NCT01882985|3611478|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3780527|NCT01882985|3611478|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3780528|NCT01882985|3611478|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3780529|NCT01882985|3611478|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3780530|NCT01882985|3611478|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3780531|NCT01882985|3611478|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3780532|NCT01882907|3611485|B3|||Duration of diaebetes||months|Mean|64.3|64.3|Standard Deviation|60.4|60.4|||
3780533|NCT01882907|3611486|B2|||Duration of diaebetes||months|Mean|60.2|60.2|Standard Deviation|58.6|58.6|||
3780534|NCT01882907|3611487|B1|||Duration of diaebetes||months|Mean|68.3|68.3|Standard Deviation|62.0|62.0|||
3780535|NCT01882907|3611485|B3|||Body Mass Index||Kg/m^2|Mean|24.9|24.9|Standard Deviation|3.3|3.3|||
3780536|NCT01882907|3611486|B2|||Body Mass Index||Kg/m^2|Mean|25.0|25.0|Standard Deviation|3.3|3.3|||
3780537|NCT01882907|3611487|B1|||Body Mass Index||Kg/m^2|Mean|24.9|24.9|Standard Deviation|3.2|3.2|||
3780538|NCT01882907|3611485|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3780539|NCT01882907|3611486|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3780540|NCT01882907|3611487|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3780541|NCT01882907|3611485|B3||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3780542|NCT01882907|3611486|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3780543|NCT01882907|3611487|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3780544|NCT01882907|3611485|B3|||Age||years|Mean|54.5|54.5|Standard Deviation|9.5|9.5|||
3780546|NCT01882907|3611487|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|9.8|9.8|||
3780547|NCT01882868|3611494|B1|Did Not Have Prior Treatment||Prior Treatment with Bevacizumab||participants|Number|10|10.0||||||
3780548|NCT01882868|3611494|B1|Had Prior Treatment||Prior Treatment with Bevacizumab||participants|Number|50|50.0||||||
3780549|NCT01882868|3611494|B1|1||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|ECOG PS is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|20|20.0||||||
3780550|NCT01882868|3611494|B1|0||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|ECOG PS is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|40|40.0||||||
3780551|NCT01882868|3611494|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3780552|NCT01882868|3611494|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3780553|NCT01882868|3611494|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|9.8|9.8|||
3780554|NCT01882829|3611524|B1|||Clinical Global Impression - Severity (CGI-S)|a 7-point scale that requires the clinician to rate the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis. Considering total clinical experience, a patient is assessed on severity of mental illness at the time of rating 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|units on a scale|Mean|4.5|4.5|Standard Deviation|0.5|0.5|||
3780555|NCT01882829|3611524|B1|||Montgomery-Asberg Depression Scale (MADRS)|The MADRS-S has 10-items which are based on mood symptoms over the past 7 days. Each items is scored 0 (normal) to 6 (severe depression) with overall score ranges from 0 (normal) to 60 (severe depression).|units on a scale|Mean|32.5|32.5|Standard Deviation|3.9|3.9|||
3780556|NCT01882829|3611524|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3780557|NCT01882829|3611524|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3780558|NCT01882829|3611524|B1|||Age||years|Mean|49.4|49.4|Standard Deviation|7.7|7.7|||
3780559|NCT01882803|3611538|B1|Bulgaria||Region of Enrollment||participants|Number|5|5.0||||||
3780560|NCT01882803|3611538|B1|France||Region of Enrollment||participants|Number|6|6.0||||||
3780561|NCT01882803|3611538|B1|Georgia||Region of Enrollment||participants|Number|1|1.0||||||
3780562|NCT01882803|3611538|B1|Italy||Region of Enrollment||participants|Number|21|21.0||||||
3780563|NCT01882803|3611538|B1|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
3780564|NCT01882803|3611538|B1|Canada||Region of Enrollment||participants|Number|9|9.0||||||
3780565|NCT01882803|3611538|B1|Spain||Region of Enrollment||participants|Number|2|2.0||||||
3780566|NCT01882803|3611538|B1|Belarus||Region of Enrollment||participants|Number|10|10.0||||||
3780567|NCT01882803|3611538|B1|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
3780568|NCT01882803|3611538|B1|Czechia||Region of Enrollment||participants|Number|9|9.0||||||
3780569|NCT01882803|3611538|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
3780570|NCT01882803|3611538|B1|Hungary||Region of Enrollment||participants|Number|7|7.0||||||
3780571|NCT01882803|3611538|B1|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3780572|NCT01882803|3611538|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3780573|NCT01882803|3611538|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3780574|NCT01882803|3611538|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|116|116.0||||||
3780575|NCT01882803|3611538|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3780576|NCT01882803|3611538|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3780577|NCT01882803|3611538|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3780578|NCT01882803|3611538|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3780579|NCT01882803|3611538|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3780580|NCT01882803|3611538|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|118|118.0||||||
3780581|NCT01882803|3611538|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3780582|NCT01882803|3611538|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3780583|NCT01882803|3611538|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3780584|NCT01882803|3611538|B1|||Age||years|Mean|63.6|63.6|Standard Deviation|11.69|11.69|||
3780585|NCT01882803|3611538|B1||>=65 years|Age||Participants|Count of Participants|65|65.0||||||
3780586|NCT01882803|3611538|B1||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
3780587|NCT01882803|3611538|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3780588|NCT01882725|3611549|B1|||Degree of Heel Pain on the Visual Analog Scale (VAS)|"The Visual Analog Pain Scale (VAS) is one of the three most commonly used scales for assessing chronic pain consisting of a 100 millimeter (mm) horizontal line anchored at one end by the label 0: no pain at all and at the other end 100: worst pain imaginable. The subject marks on the line the spot for the overall degree of pain experienced in the study treated heel region upon waking in the morning and taking the first few steps of the day, which is then measured using a ruler."|units on a scale|Mean|69.29|69.29|Standard Deviation|10.67|10.67|||
3780589|NCT01882725|3611549|B1|||Duration of Heel Pain|Duration of heel pain is recorded as number of months of chronic heel pain experienced prior to study enrollment|months|Mean|15.93|15.93|Standard Deviation|15.52|15.52|||
3780590|NCT01882725|3611549|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3780591|NCT01882725|3611549|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780592|NCT01882725|3611549|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3780593|NCT01882725|3611549|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3780594|NCT01882725|3611549|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3780595|NCT01882725|3611549|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3780596|NCT01882725|3611549|B1|||Age||years|Mean|51.79|51.79|Standard Deviation|11.31|11.31|||
3780597|NCT01882647|3611554|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780598|NCT01882647|3611555|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780599|NCT01882647|3611556|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780600|NCT01882647|3611554|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780601|NCT01882647|3611555|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780602|NCT01882647|3611556|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780603|NCT01882647|3611554|B3||White|Race (NIH/OMB)||Participants|Count of Participants|204|204.0||||||
3780604|NCT01882647|3611555|B2||White|Race (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
3780605|NCT01882647|3611556|B1||White|Race (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
3780606|NCT01882647|3611554|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3780607|NCT01882647|3611555|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3780608|NCT01882647|3611556|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3780609|NCT01882647|3611554|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780610|NCT01882647|3611555|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780611|NCT01882647|3611556|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780612|NCT01882647|3611554|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3780613|NCT01882647|3611555|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780614|NCT01882647|3611556|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3780615|NCT01882647|3611554|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3780616|NCT01882647|3611555|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3780617|NCT01882647|3611556|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780618|NCT01882647|3611554|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780619|NCT01882647|3611555|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780620|NCT01882647|3611556|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780621|NCT01882647|3611554|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|182|182.0||||||
3780622|NCT01882647|3611555|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3780623|NCT01882647|3611556|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3780624|NCT01882647|3611554|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3780625|NCT01882647|3611555|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3780626|NCT01882647|3611556|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3780627|NCT01882647|3611554|B3||Male|Gender||Participants|Count of Participants|112|112.0||||||
3780628|NCT01882647|3611555|B2||Male|Gender||Participants|Count of Participants|52|52.0||||||
3780629|NCT01882647|3611556|B1||Male|Gender||Participants|Count of Participants|60|60.0||||||
3780630|NCT01882647|3611554|B3||Female|Gender||Participants|Count of Participants|110|110.0||||||
3780631|NCT01882647|3611555|B2||Female|Gender||Participants|Count of Participants|60|60.0||||||
3780632|NCT01882647|3611556|B1||Female|Gender||Participants|Count of Participants|50|50.0||||||
3780633|NCT01882647|3611554|B3|Mean||Age||years|Mean|50.8|50.8|Standard Deviation|14.79|14.79|||
3780634|NCT01882647|3611555|B2|Mean||Age||years|Mean|50.8|50.8|Standard Deviation|15.15|15.15|||
3780635|NCT01882647|3611556|B1|Mean||Age||years|Mean|50.8|50.8|Standard Deviation|14.49|14.49|||
3780636|NCT01882543|3611573|B3|||Duration of Diagnosis||Months|Mean|69.4|69.4|Standard Deviation|55.73|55.73|||
3780637|NCT01882543|3611574|B2|||Duration of Diagnosis||Months|Mean|76.3|76.3|Standard Deviation|57.28|57.28|||
3780638|NCT01882543|3611575|B1|||Duration of Diagnosis||Months|Mean|63.5|63.5|Standard Deviation|54.43|54.43|||
3780639|NCT01882543|3611573|B3|||BMI||kg/m^2|Mean|27.5|27.5|Standard Deviation|5.31|5.31|||
3780640|NCT01882543|3611574|B2|||BMI||kg/m^2|Mean|29.1|29.1|Standard Deviation|5.62|5.62|||
3780641|NCT01882543|3611575|B1|||BMI||kg/m^2|Mean|26.2|26.2|Standard Deviation|4.71|4.71|||
3780642|NCT01882543|3611573|B3|||Weight||kg|Mean|71.5|71.5|Standard Deviation|14.98|14.98|||
3780643|NCT01882543|3611574|B2|||Weight||kg|Mean|76.5|76.5|Standard Deviation|16.34|16.34|||
3780644|NCT01882543|3611575|B1|||Weight||kg|Mean|67.3|67.3|Standard Deviation|12.40|12.4|||
3780645|NCT01882543|3611573|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
3780646|NCT01882543|3611574|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3780647|NCT01882543|3611575|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3780648|NCT01882543|3611573|B3|Canada||Region of Enrollment||participants|Number|44|44.0||||||
3780649|NCT01882543|3611574|B2|Canada||Region of Enrollment||participants|Number|20|20.0||||||
3780650|NCT01882543|3611575|B1|Canada||Region of Enrollment||participants|Number|24|24.0||||||
3780651|NCT01882543|3611573|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3780652|NCT01882543|3611574|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780653|NCT01882543|3611575|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3780654|NCT01882543|3611573|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780655|NCT01882543|3611574|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780656|NCT01882543|3611575|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780657|NCT01882543|3611573|B3||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3780658|NCT01882543|3611574|B2||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3780659|NCT01882543|3611575|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3780660|NCT01882543|3611573|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3780661|NCT01882543|3611574|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3780662|NCT01882543|3611575|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3780663|NCT01882543|3611573|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780664|NCT01882543|3611574|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780665|NCT01882543|3611575|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780666|NCT01882543|3611573|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3780667|NCT01882543|3611574|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3780668|NCT01882543|3611575|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3780669|NCT01882543|3611573|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780670|NCT01882543|3611574|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780671|NCT01882543|3611575|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780672|NCT01882543|3611573|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780673|NCT01882543|3611574|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780674|NCT01882543|3611575|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780675|NCT01882543|3611573|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3780676|NCT01882543|3611574|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3780677|NCT01882543|3611575|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3780678|NCT01882543|3611573|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780679|NCT01882543|3611574|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780680|NCT01882543|3611575|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780681|NCT01882543|3611573|B3|Female||Sex/Gender, Customized||participants|Number|69|69.0||||||
3780682|NCT01882543|3611574|B2|Female||Sex/Gender, Customized||participants|Number|32|32.0||||||
3780683|NCT01882543|3611575|B1|Female||Sex/Gender, Customized||participants|Number|37|37.0||||||
3780684|NCT01882543|3611573|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3780685|NCT01882543|3611574|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3780686|NCT01882543|3611575|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3780687|NCT01882543|3611573|B3||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
3780688|NCT01882543|3611574|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3780689|NCT01882543|3611575|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3780690|NCT01882543|3611573|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3780691|NCT01882543|3611574|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3780692|NCT01882543|3611575|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3780693|NCT01882465|3611597|B1|Hong Kong||Region of Enrollment||Participants|Number|35|35.0||||||
3780694|NCT01882465|3611597|B1|Asian||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
3780695|NCT01882465|3611597|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3780696|NCT01882465|3611597|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3780697|NCT01882465|3611597|B1|||Age||Years|Mean|22.03|22.03|Standard Deviation|2.885|2.885|||
3780698|NCT01882439|3611611|B5||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
3780699|NCT01882439|3611612|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3780700|NCT01882439|3611613|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3780701|NCT01882439|3611614|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3780702|NCT01882439|3611615|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3780703|NCT01882439|3611611|B5||Female|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
3780704|NCT01882439|3611612|B4||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3780705|NCT01882439|3611613|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3780706|NCT01882439|3611614|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3780707|NCT01882439|3611615|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3780708|NCT01882439|3611611|B5|||Age||Years|Mean|50.0|50.0|Standard Deviation|12.0|12.0|||
3780709|NCT01882439|3611612|B4|||Age||Years|Mean|49.3|49.3|Standard Deviation|14.0|14.0|||
3780710|NCT01882439|3611613|B3|||Age||Years|Mean|48.7|48.7|Standard Deviation|11.2|11.2|||
3780711|NCT01882439|3611614|B2|||Age||Years|Mean|51.3|51.3|Standard Deviation|10.9|10.9|||
3780712|NCT01882439|3611615|B1|||Age||Years|Mean|49.5|49.5|Standard Deviation|12.3|12.3|||
3780713|NCT01882413|3611798|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3780714|NCT01882413|3611798|B1||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3780715|NCT01882413|3611798|B1|||Age||years|Mean|71.8|71.8|Standard Deviation|7.41|7.41|||
3780716|NCT01882257|3611812|B4|United States||Region of Enrollment||participants|Number|74|74.0||||||
3780717|NCT01882257|3611813|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
3780718|NCT01882257|3611814|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
3780719|NCT01882257|3611815|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3780720|NCT01882257|3611812|B4||Male|Gender||Participants|Count of Participants|64|64.0||||||
3780721|NCT01882257|3611813|B3||Male|Gender||Participants|Count of Participants|20|20.0||||||
3780722|NCT01882257|3611814|B2||Male|Gender||Participants|Count of Participants|35|35.0||||||
3780723|NCT01882257|3611815|B1||Male|Gender||Participants|Count of Participants|9|9.0||||||
3780724|NCT01882257|3611812|B4||Female|Gender||Participants|Count of Participants|10|10.0||||||
3780725|NCT01882257|3611813|B3||Female|Gender||Participants|Count of Participants|3|3.0||||||
3780726|NCT01882257|3611814|B2||Female|Gender||Participants|Count of Participants|5|5.0||||||
3780727|NCT01882257|3611815|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
3780728|NCT01882257|3611812|B4|18 to 75 years||Age, Customized||participants|Number|74|74.0||||||
3780729|NCT01882257|3611813|B3|18 to 75 years||Age, Customized||participants|Number|23|23.0||||||
3780730|NCT01882257|3611814|B2|18 to 75 years||Age, Customized||participants|Number|40|40.0||||||
3780731|NCT01882257|3611815|B1|18 to 75 years||Age, Customized||participants|Number|11|11.0||||||
3780732|NCT01882062|3611824|B1|France||Region of Enrollment||participants|Number|10|10.0||||||
3780733|NCT01882062|3611824|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3780734|NCT01882062|3611824|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3780735|NCT01882062|3611824|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3780736|NCT01882062|3611824|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3780737|NCT01882062|3611824|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3780738|NCT01881984|3611828|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3780739|NCT01881984|3611828|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780740|NCT01881984|3611828|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780741|NCT01881984|3611828|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3780742|NCT01881984|3611828|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780743|NCT01881984|3611828|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780744|NCT01881984|3611828|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780745|NCT01881984|3611828|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780746|NCT01881984|3611828|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3780747|NCT01881984|3611828|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3780748|NCT01881984|3611828|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3780749|NCT01881984|3611828|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3780750|NCT01881984|3611828|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3780751|NCT01881932|3611833|B4|United States||Region of Enrollment||participants|Number|19|19.0||||||
3780752|NCT01881932|3611834|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
3780753|NCT01881932|3611835|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3780754|NCT01881932|3611836|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3780755|NCT01881932|3611833|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3780756|NCT01881932|3611834|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3780757|NCT01881932|3611835|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3780758|NCT01881932|3611836|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3780759|NCT01881932|3611833|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3780760|NCT01881932|3611834|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3780761|NCT01881932|3611835|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3780762|NCT01881932|3611836|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3780763|NCT01881932|3611833|B4|||Age, Customized||years|Median|49|49.0|Full Range|||33.0|65.0|
3780764|NCT01881932|3611834|B3|||Age, Customized||years|Median|49|49.0|Full Range|||33.0|65.0|
3780765|NCT01881932|3611835|B2|||Age, Customized||years|Median|50|50.0|Full Range|||44.0|59.0|
3780766|NCT01881932|3611836|B1|||Age, Customized||years|Median|44|44.0|Full Range|||42.0|45.0|
3780767|NCT01881867|3611846|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
3780768|NCT01881867|3611847|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
3780769|NCT01881867|3611848|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
3780770|NCT01881867|3611846|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3780771|NCT01881867|3611847|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3780772|NCT01881867|3611848|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780773|NCT01881867|3611846|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3780774|NCT01881867|3611847|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3780775|NCT01881867|3611848|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3780776|NCT01881867|3611846|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3780777|NCT01881867|3611847|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3780778|NCT01881867|3611848|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3780779|NCT01881867|3611846|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3780780|NCT01881867|3611847|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3780781|NCT01881867|3611848|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3780782|NCT01881867|3611846|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3780783|NCT01881867|3611847|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3780784|NCT01881867|3611848|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3780785|NCT01881867|3611846|B3|||Age||years|Mean|66.9|66.9|Standard Deviation|7.7|7.7|||
3780786|NCT01881867|3611847|B2|||Age||years|Mean|67.6|67.6|Standard Deviation|7.9|7.9|||
3780787|NCT01881867|3611848|B1|||Age||years|Mean|66.1|66.1|Standard Deviation|7.6|7.6|||
3780788|NCT01881828|3611855|B3|||Body Mass Index (BMI) Percentile||percentile|Mean|94|94.0|Standard Deviation|3.9|3.9|||
3780789|NCT01881828|3611856|B2|||Body Mass Index (BMI) Percentile||percentile|Mean|94.3|94.3|Standard Deviation|3.8|3.8|||
3780790|NCT01881828|3611857|B1|||Body Mass Index (BMI) Percentile||percentile|Mean|93.7|93.7|Standard Deviation|4.1|4.1|||
3780791|NCT01881828|3611855|B3|||Total Basal/Long Acting Insulin||unit/kg/day|Mean|0.5|0.5|Standard Deviation|0.1|0.1|||
3780792|NCT01881828|3611856|B2|||Total Basal/Long Acting Insulin||unit/kg/day|Mean|0.5|0.5|Standard Deviation|0.1|0.1|||
3780793|NCT01881828|3611857|B1|||Total Basal/Long Acting Insulin||unit/kg/day|Mean|0.5|0.5|Standard Deviation|0.1|0.1|||
3780794|NCT01881828|3611855|B3|≥ 1.5||Total Daily Insulin Group||participants|Number|9|9.0||||||
3780795|NCT01881828|3611856|B2|≥ 1.5||Total Daily Insulin Group||participants|Number|4|4.0||||||
3780796|NCT01881828|3611857|B1|≥ 1.5||Total Daily Insulin Group||participants|Number|5|5.0||||||
3780797|NCT01881828|3611855|B3|1.0-1.4||Total Daily Insulin Group||participants|Number|72|72.0||||||
3780798|NCT01881828|3611856|B2|1.0-1.4||Total Daily Insulin Group||participants|Number|39|39.0||||||
3780799|NCT01881828|3611857|B1|1.0-1.4||Total Daily Insulin Group||participants|Number|33|33.0||||||
3780800|NCT01881828|3611855|B3|<1.0||Total Daily Insulin Group||participants|Number|59|59.0||||||
3780801|NCT01881828|3611856|B2|<1.0||Total Daily Insulin Group||participants|Number|26|26.0||||||
3780802|NCT01881828|3611857|B1|<1.0||Total Daily Insulin Group||participants|Number|33|33.0||||||
3780803|NCT01881828|3611855|B3|||Total Daily Insulin||unit/kg/day|Mean|1.1|1.1|Standard Deviation|0.2|0.2|||
3780804|NCT01881828|3611856|B2|||Total Daily Insulin||unit/kg/day|Mean|1.1|1.1|Standard Deviation|0.2|0.2|||
3780805|NCT01881828|3611857|B1|||Total Daily Insulin||unit/kg/day|Mean|1.1|1.1|Standard Deviation|0.2|0.2|||
3780806|NCT01881828|3611855|B3|≥ 6||Self-Monitoring of Blood Glucose group||participants|Number|26|26.0||||||
3780807|NCT01881828|3611856|B2|≥ 6||Self-Monitoring of Blood Glucose group||participants|Number|12|12.0||||||
3780808|NCT01881828|3611857|B1|≥ 6||Self-Monitoring of Blood Glucose group||participants|Number|14|14.0||||||
3780809|NCT01881828|3611855|B3|4-5||Self-Monitoring of Blood Glucose group||participants|Number|87|87.0||||||
3780810|NCT01881828|3611856|B2|4-5||Self-Monitoring of Blood Glucose group||participants|Number|43|43.0||||||
3780811|NCT01881828|3611857|B1|4-5||Self-Monitoring of Blood Glucose group||participants|Number|44|44.0||||||
3780812|NCT01881828|3611855|B3|3||Self-Monitoring of Blood Glucose group||participants|Number|27|27.0||||||
3780813|NCT01881828|3611856|B2|3||Self-Monitoring of Blood Glucose group||participants|Number|14|14.0||||||
3780814|NCT01881828|3611857|B1|3||Self-Monitoring of Blood Glucose group||participants|Number|13|13.0||||||
3780815|NCT01881828|3611855|B3|||Self-Monitoring of Blood Glucose per day||number of checks per day|Mean|4.5|4.5|Standard Deviation|1.4|1.4|||
3780816|NCT01881828|3611856|B2|||Self-Monitoring of Blood Glucose per day||number of checks per day|Mean|4.6|4.6|Standard Deviation|1.6|1.6|||
3780817|NCT01881828|3611857|B1|||Self-Monitoring of Blood Glucose per day||number of checks per day|Mean|4.5|4.5|Standard Deviation|1.2|1.2|||
3780818|NCT01881828|3611855|B3|||Continuous Glucose Monitor Use||participants|Number|4|4.0||||||
3780819|NCT01881828|3611856|B2|||Continuous Glucose Monitor Use||participants|Number|2|2.0||||||
3780820|NCT01881828|3611857|B1|||Continuous Glucose Monitor Use||participants|Number|2|2.0||||||
3780821|NCT01881828|3611855|B3|||Insulin Pump Use||participants|Number|99|99.0||||||
3780822|NCT01881828|3611856|B2|||Insulin Pump Use||participants|Number|49|49.0||||||
3780823|NCT01881828|3611857|B1|||Insulin Pump Use||participants|Number|50|50.0||||||
3780824|NCT01881828|3611855|B3|||Mean Sensor Glucose||mg/dL|Mean|207|207.0|Standard Deviation|34.6|34.6|||
3780825|NCT01881828|3611856|B2|||Mean Sensor Glucose||mg/dL|Mean|208|208.0|Standard Deviation|34|34.0|||
3780826|NCT01881828|3611857|B1|||Mean Sensor Glucose||mg/dL|Mean|206|206.0|Standard Deviation|35|35.0|||
3780827|NCT01881828|3611855|B3|≥ 9.5%||HbA1c Group||participants|Number|33|33.0||||||
3780828|NCT01881828|3611856|B2|≥ 9.5%||HbA1c Group||participants|Number|19|19.0||||||
3780829|NCT01881828|3611857|B1|≥ 9.5%||HbA1c Group||participants|Number|14|14.0||||||
3780830|NCT01881828|3611855|B3|8.5%-9.4%||HbA1c Group||participants|Number|58|58.0||||||
3780831|NCT01881828|3611856|B2|8.5%-9.4%||HbA1c Group||participants|Number|26|26.0||||||
3780832|NCT01881828|3611857|B1|8.5%-9.4%||HbA1c Group||participants|Number|32|32.0||||||
3780833|NCT01881828|3611855|B3|< 8.5%||HbA1c Group||participants|Number|49|49.0||||||
3780834|NCT01881828|3611856|B2|< 8.5%||HbA1c Group||participants|Number|24|24.0||||||
3780835|NCT01881828|3611857|B1|< 8.5%||HbA1c Group||participants|Number|25|25.0||||||
3780836|NCT01881828|3611855|B3|||HbA1c Lab||percentage|Mean|8.8|8.8|Standard Deviation|0.7|0.7|||
3780837|NCT01881828|3611856|B2|||HbA1c Lab||percentage|Mean|8.8|8.8|Standard Deviation|0.7|0.7|||
3780838|NCT01881828|3611857|B1|||HbA1c Lab||percentage|Mean|8.8|8.8|Standard Deviation|0.8|0.8|||
3780839|NCT01881828|3611855|B3|≥ 5 episodes||Diabetic Ketoacidosis Events Since T1D Diagnosis||episodes|Number|3|3.0||||||
3780840|NCT01881828|3611856|B2|≥ 5 episodes||Diabetic Ketoacidosis Events Since T1D Diagnosis||episodes|Number|2|2.0||||||
3780841|NCT01881828|3611857|B1|≥ 5 episodes||Diabetic Ketoacidosis Events Since T1D Diagnosis||episodes|Number|1|1.0||||||
3780842|NCT01881828|3611855|B3|3-4 episodes||Diabetic Ketoacidosis Events Since T1D Diagnosis||episodes|Number|8|8.0||||||
3780843|NCT01881828|3611856|B2|3-4 episodes||Diabetic Ketoacidosis Events Since T1D Diagnosis||episodes|Number|6|6.0||||||
3780844|NCT01881828|3611857|B1|3-4 episodes||Diabetic Ketoacidosis Events Since T1D Diagnosis||episodes|Number|2|2.0||||||
3780845|NCT01881828|3611855|B3|1-2 episodes||Diabetic Ketoacidosis Events Since T1D Diagnosis||episodes|Number|28|28.0||||||
3780846|NCT01881828|3611856|B2|1-2 episodes||Diabetic Ketoacidosis Events Since T1D Diagnosis||episodes|Number|13|13.0||||||
3780847|NCT01881828|3611857|B1|1-2 episodes||Diabetic Ketoacidosis Events Since T1D Diagnosis||episodes|Number|15|15.0||||||
3780848|NCT01881828|3611855|B3|None||Diabetic Ketoacidosis Events Since T1D Diagnosis||episodes|Number|101|101.0||||||
3780849|NCT01881828|3611856|B2|None||Diabetic Ketoacidosis Events Since T1D Diagnosis||episodes|Number|48|48.0||||||
3780850|NCT01881828|3611857|B1|None||Diabetic Ketoacidosis Events Since T1D Diagnosis||episodes|Number|53|53.0||||||
3780851|NCT01881828|3611855|B3|≥ 5 episodes||Severe Hypoglycemia Events Since T1D Diagnosis||episodes|Number|7|7.0||||||
3780852|NCT01881828|3611856|B2|≥ 5 episodes||Severe Hypoglycemia Events Since T1D Diagnosis||episodes|Number|5|5.0||||||
3780853|NCT01881828|3611857|B1|≥ 5 episodes||Severe Hypoglycemia Events Since T1D Diagnosis||episodes|Number|2|2.0||||||
3780854|NCT01881828|3611855|B3|3-4 episodes||Severe Hypoglycemia Events Since T1D Diagnosis||episodes|Number|5|5.0||||||
3780855|NCT01881828|3611856|B2|3-4 episodes||Severe Hypoglycemia Events Since T1D Diagnosis||episodes|Number|2|2.0||||||
3780856|NCT01881828|3611857|B1|3-4 episodes||Severe Hypoglycemia Events Since T1D Diagnosis||episodes|Number|3|3.0||||||
3780857|NCT01881828|3611855|B3|1-2 episodes||Severe Hypoglycemia Events Since T1D Diagnosis||episodes|Number|24|24.0||||||
3780858|NCT01881828|3611856|B2|1-2 episodes||Severe Hypoglycemia Events Since T1D Diagnosis||episodes|Number|10|10.0||||||
3780859|NCT01881828|3611857|B1|1-2 episodes||Severe Hypoglycemia Events Since T1D Diagnosis||episodes|Number|14|14.0||||||
3780860|NCT01881828|3611855|B3|None||Severe Hypoglycemia Events Since T1D Diagnosis||episodes|Number|104|104.0||||||
3780861|NCT01881828|3611856|B2|None||Severe Hypoglycemia Events Since T1D Diagnosis||episodes|Number|52|52.0||||||
3780862|NCT01881828|3611857|B1|None||Severe Hypoglycemia Events Since T1D Diagnosis||episodes|Number|52|52.0||||||
3780863|NCT01881828|3611855|B3|Unknown / Do not want to answer||Insurance||participants|Number|8|8.0||||||
3780864|NCT01881828|3611856|B2|Unknown / Do not want to answer||Insurance||participants|Number|4|4.0||||||
3780865|NCT01881828|3611857|B1|Unknown / Do not want to answer||Insurance||participants|Number|4|4.0||||||
3780866|NCT01881828|3611855|B3|None||Insurance||participants|Number|2|2.0||||||
3780867|NCT01881828|3611856|B2|None||Insurance||participants|Number|2|2.0||||||
3780868|NCT01881828|3611857|B1|None||Insurance||participants|Number|0|0.0||||||
3780869|NCT01881828|3611855|B3|Other Insurance||Insurance||participants|Number|29|29.0||||||
3780870|NCT01881828|3611856|B2|Other Insurance||Insurance||participants|Number|15|15.0||||||
3780871|NCT01881828|3611857|B1|Other Insurance||Insurance||participants|Number|14|14.0||||||
3780872|NCT01881828|3611855|B3|Private Insurance||Insurance||participants|Number|101|101.0||||||
3780873|NCT01881828|3611856|B2|Private Insurance||Insurance||participants|Number|48|48.0||||||
3780874|NCT01881828|3611857|B1|Private Insurance||Insurance||participants|Number|53|53.0||||||
3780875|NCT01881828|3611855|B3|Unknown / Do not want to answer||Income Category||participants|Number|41|41.0||||||
3780876|NCT01881828|3611856|B2|Unknown / Do not want to answer||Income Category||participants|Number|18|18.0||||||
3780877|NCT01881828|3611857|B1|Unknown / Do not want to answer||Income Category||participants|Number|23|23.0||||||
3780878|NCT01881828|3611855|B3|$100,000 to less than $200,000||Income Category||participants|Number|11|11.0||||||
3780879|NCT01881828|3611856|B2|$100,000 to less than $200,000||Income Category||participants|Number|6|6.0||||||
3780880|NCT01881828|3611857|B1|$100,000 to less than $200,000||Income Category||participants|Number|5|5.0||||||
3780881|NCT01881828|3611855|B3|$75,000 to less than $100,000||Income Category||participants|Number|26|26.0||||||
3780882|NCT01881828|3611856|B2|$75,000 to less than $100,000||Income Category||participants|Number|12|12.0||||||
3780883|NCT01881828|3611857|B1|$75,000 to less than $100,000||Income Category||participants|Number|14|14.0||||||
3780884|NCT01881828|3611855|B3|$50,000 to less than $75,000||Income Category||participants|Number|23|23.0||||||
3780885|NCT01881828|3611856|B2|$50,000 to less than $75,000||Income Category||participants|Number|13|13.0||||||
3780886|NCT01881828|3611857|B1|$50,000 to less than $75,000||Income Category||participants|Number|10|10.0||||||
3780887|NCT01881828|3611855|B3|$35,000 to less than $50,000||Income Category||participants|Number|10|10.0||||||
3780888|NCT01881828|3611856|B2|$35,000 to less than $50,000||Income Category||participants|Number|7|7.0||||||
3780889|NCT01881828|3611857|B1|$35,000 to less than $50,000||Income Category||participants|Number|3|3.0||||||
3780890|NCT01881828|3611855|B3|Less than $35,000||Income Category||participants|Number|12|12.0||||||
3780891|NCT01881828|3611856|B2|Less than $35,000||Income Category||participants|Number|7|7.0||||||
3780892|NCT01881828|3611857|B1|Less than $35,000||Income Category||participants|Number|5|5.0||||||
3780893|NCT01881828|3611855|B3|Unknown / Do not want to answer||Highest Parent Educaiton Level||participants|Number|6|6.0||||||
3780894|NCT01881828|3611856|B2|Unknown / Do not want to answer||Highest Parent Educaiton Level||participants|Number|2|2.0||||||
3780895|NCT01881828|3611857|B1|Unknown / Do not want to answer||Highest Parent Educaiton Level||participants|Number|4|4.0||||||
3780896|NCT01881828|3611855|B3|Professional||Highest Parent Educaiton Level||participants|Number|12|12.0||||||
3780897|NCT01881828|3611856|B2|Professional||Highest Parent Educaiton Level||participants|Number|7|7.0||||||
3780898|NCT01881828|3611857|B1|Professional||Highest Parent Educaiton Level||participants|Number|5|5.0||||||
3780899|NCT01881828|3611855|B3|Master||Highest Parent Educaiton Level||participants|Number|25|25.0||||||
3780900|NCT01881828|3611856|B2|Master||Highest Parent Educaiton Level||participants|Number|13|13.0||||||
3780901|NCT01881828|3611857|B1|Master||Highest Parent Educaiton Level||participants|Number|12|12.0||||||
3780902|NCT01881828|3611855|B3|Bachelor||Highest Parent Educaiton Level||participants|Number|33|33.0||||||
3780903|NCT01881828|3611856|B2|Bachelor||Highest Parent Educaiton Level||participants|Number|15|15.0||||||
3780904|NCT01881828|3611857|B1|Bachelor||Highest Parent Educaiton Level||participants|Number|18|18.0||||||
3780905|NCT01881828|3611855|B3|Associate||Highest Parent Educaiton Level||participants|Number|22|22.0||||||
3780906|NCT01881828|3611856|B2|Associate||Highest Parent Educaiton Level||participants|Number|12|12.0||||||
3780907|NCT01881828|3611857|B1|Associate||Highest Parent Educaiton Level||participants|Number|10|10.0||||||
3780908|NCT01881828|3611855|B3|High school diploma, GED, or less||Highest Parent Educaiton Level||participants|Number|42|42.0||||||
3780909|NCT01881828|3611856|B2|High school diploma, GED, or less||Highest Parent Educaiton Level||participants|Number|20|20.0||||||
3780910|NCT01881828|3611857|B1|High school diploma, GED, or less||Highest Parent Educaiton Level||participants|Number|22|22.0||||||
3780911|NCT01881828|3611855|B3|Stage 5||Tanner Staging (Breasts/Genitals)|For all three sites of development, Tanner Stage 1 corresponds to the pre-pubertal form with progression to Tanner Stage 5, the final adult form.|participants|Number|104|104.0||||||
3780912|NCT01881828|3611856|B2|Stage 5||Tanner Staging (Breasts/Genitals)|For all three sites of development, Tanner Stage 1 corresponds to the pre-pubertal form with progression to Tanner Stage 5, the final adult form.|participants|Number|51|51.0||||||
3780913|NCT01881828|3611857|B1|Stage 5||Tanner Staging (Breasts/Genitals)|For all three sites of development, Tanner Stage 1 corresponds to the pre-pubertal form with progression to Tanner Stage 5, the final adult form.|participants|Number|53|53.0||||||
3780914|NCT01881828|3611855|B3|Stage 4||Tanner Staging (Breasts/Genitals)|For all three sites of development, Tanner Stage 1 corresponds to the pre-pubertal form with progression to Tanner Stage 5, the final adult form.|participants|Number|21|21.0||||||
3780915|NCT01881828|3611856|B2|Stage 4||Tanner Staging (Breasts/Genitals)|For all three sites of development, Tanner Stage 1 corresponds to the pre-pubertal form with progression to Tanner Stage 5, the final adult form.|participants|Number|9|9.0||||||
3780916|NCT01881828|3611857|B1|Stage 4||Tanner Staging (Breasts/Genitals)|For all three sites of development, Tanner Stage 1 corresponds to the pre-pubertal form with progression to Tanner Stage 5, the final adult form.|participants|Number|12|12.0||||||
3780917|NCT01881828|3611855|B3|Stage 3||Tanner Staging (Breasts/Genitals)|For all three sites of development, Tanner Stage 1 corresponds to the pre-pubertal form with progression to Tanner Stage 5, the final adult form.|participants|Number|11|11.0||||||
3780918|NCT01881828|3611856|B2|Stage 3||Tanner Staging (Breasts/Genitals)|For all three sites of development, Tanner Stage 1 corresponds to the pre-pubertal form with progression to Tanner Stage 5, the final adult form.|participants|Number|6|6.0||||||
3780919|NCT01881828|3611857|B1|Stage 3||Tanner Staging (Breasts/Genitals)|For all three sites of development, Tanner Stage 1 corresponds to the pre-pubertal form with progression to Tanner Stage 5, the final adult form.|participants|Number|5|5.0||||||
3780920|NCT01881828|3611855|B3|Stage 2||Tanner Staging (Breasts/Genitals)|For all three sites of development, Tanner Stage 1 corresponds to the pre-pubertal form with progression to Tanner Stage 5, the final adult form.|participants|Number|2|2.0||||||
3780921|NCT01881828|3611856|B2|Stage 2||Tanner Staging (Breasts/Genitals)|For all three sites of development, Tanner Stage 1 corresponds to the pre-pubertal form with progression to Tanner Stage 5, the final adult form.|participants|Number|2|2.0||||||
3780922|NCT01881828|3611857|B1|Stage 2||Tanner Staging (Breasts/Genitals)|For all three sites of development, Tanner Stage 1 corresponds to the pre-pubertal form with progression to Tanner Stage 5, the final adult form.|participants|Number|0|0.0||||||
3780923|NCT01881828|3611855|B3|Stage 1||Tanner Staging (Breasts/Genitals)|For all three sites of development, Tanner Stage 1 corresponds to the pre-pubertal form with progression to Tanner Stage 5, the final adult form.|participants|Number|2|2.0||||||
3780924|NCT01881828|3611856|B2|Stage 1||Tanner Staging (Breasts/Genitals)|For all three sites of development, Tanner Stage 1 corresponds to the pre-pubertal form with progression to Tanner Stage 5, the final adult form.|participants|Number|1|1.0||||||
3780925|NCT01881828|3611857|B1|Stage 1||Tanner Staging (Breasts/Genitals)|For all three sites of development, Tanner Stage 1 corresponds to the pre-pubertal form with progression to Tanner Stage 5, the final adult form.|participants|Number|1|1.0||||||
3780926|NCT01881828|3611855|B3|Stage 5||Tanner Staging (Pubic Hair)|For all three sites of development, Tanner Stage 1 corresponds to the pre-pubertal form with progression to Tanner Stage 5, the final adult form.|participants|Number|97|97.0||||||
3780927|NCT01881828|3611856|B2|Stage 5||Tanner Staging (Pubic Hair)|For all three sites of development, Tanner Stage 1 corresponds to the pre-pubertal form with progression to Tanner Stage 5, the final adult form.|participants|Number|49|49.0||||||
3780928|NCT01881828|3611857|B1|Stage 5||Tanner Staging (Pubic Hair)|For all three sites of development, Tanner Stage 1 corresponds to the pre-pubertal form with progression to Tanner Stage 5, the final adult form.|participants|Number|48|48.0||||||
3780929|NCT01881828|3611855|B3|Stage 4||Tanner Staging (Pubic Hair)|For all three sites of development, Tanner Stage 1 corresponds to the pre-pubertal form with progression to Tanner Stage 5, the final adult form.|participants|Number|25|25.0||||||
3780930|NCT01881828|3611856|B2|Stage 4||Tanner Staging (Pubic Hair)|For all three sites of development, Tanner Stage 1 corresponds to the pre-pubertal form with progression to Tanner Stage 5, the final adult form.|participants|Number|9|9.0||||||
3780931|NCT01881828|3611857|B1|Stage 4||Tanner Staging (Pubic Hair)|For all three sites of development, Tanner Stage 1 corresponds to the pre-pubertal form with progression to Tanner Stage 5, the final adult form.|participants|Number|16|16.0||||||
3780932|NCT01881828|3611855|B3|Stage 3||Tanner Staging (Pubic Hair)|For all three sites of development, Tanner Stage 1 corresponds to the pre-pubertal form with progression to Tanner Stage 5, the final adult form.|participants|Number|12|12.0||||||
3780933|NCT01881828|3611856|B2|Stage 3||Tanner Staging (Pubic Hair)|For all three sites of development, Tanner Stage 1 corresponds to the pre-pubertal form with progression to Tanner Stage 5, the final adult form.|participants|Number|7|7.0||||||
3780934|NCT01881828|3611857|B1|Stage 3||Tanner Staging (Pubic Hair)|For all three sites of development, Tanner Stage 1 corresponds to the pre-pubertal form with progression to Tanner Stage 5, the final adult form.|participants|Number|5|5.0||||||
3780935|NCT01881828|3611855|B3|Stage 2||Tanner Staging (Pubic Hair)|For all three sites of development, Tanner Stage 1 corresponds to the pre-pubertal form with progression to Tanner Stage 5, the final adult form.|participants|Number|4|4.0||||||
3780936|NCT01881828|3611856|B2|Stage 2||Tanner Staging (Pubic Hair)|For all three sites of development, Tanner Stage 1 corresponds to the pre-pubertal form with progression to Tanner Stage 5, the final adult form.|participants|Number|3|3.0||||||
3780937|NCT01881828|3611857|B1|Stage 2||Tanner Staging (Pubic Hair)|For all three sites of development, Tanner Stage 1 corresponds to the pre-pubertal form with progression to Tanner Stage 5, the final adult form.|participants|Number|1|1.0||||||
3780938|NCT01881828|3611855|B3|Stage 1||Tanner Staging (Pubic Hair)|For all three sites of development, Tanner Stage 1 corresponds to the pre-pubertal form with progression to Tanner Stage 5, the final adult form.|participants|Number|2|2.0||||||
3780939|NCT01881828|3611856|B2|Stage 1||Tanner Staging (Pubic Hair)|For all three sites of development, Tanner Stage 1 corresponds to the pre-pubertal form with progression to Tanner Stage 5, the final adult form.|participants|Number|1|1.0||||||
3780940|NCT01881828|3611857|B1|Stage 1||Tanner Staging (Pubic Hair)|For all three sites of development, Tanner Stage 1 corresponds to the pre-pubertal form with progression to Tanner Stage 5, the final adult form.|participants|Number|1|1.0||||||
3780941|NCT01881828|3611855|B3|Obese: ≥ 95th %||Body Mass Index (BMI) Percentile Group||participants|Number|74|74.0||||||
3780942|NCT01881828|3611856|B2|Obese: ≥ 95th %||Body Mass Index (BMI) Percentile Group||participants|Number|41|41.0||||||
3780943|NCT01881828|3611857|B1|Obese: ≥ 95th %||Body Mass Index (BMI) Percentile Group||participants|Number|33|33.0||||||
3780944|NCT01881828|3611855|B3|Overweight: 85th-<95th%||Body Mass Index (BMI) Percentile Group||participants|Number|62|62.0||||||
3780945|NCT01881828|3611856|B2|Overweight: 85th-<95th%||Body Mass Index (BMI) Percentile Group||participants|Number|26|26.0||||||
3780946|NCT01881828|3611857|B1|Overweight: 85th-<95th%||Body Mass Index (BMI) Percentile Group||participants|Number|36|36.0||||||
3780947|NCT01881828|3611855|B3|||Body Mass Index (BMI) Z Score|Body mass index z-scores are measures of relative weight adjusted for child age and sex. The Z-score indicates the number of standard deviations away from a reference population in the same age range and with the same sex. A Z-score of 0 is equal to the mean. Negative numbers indicate BMI values lower than the mean and positive numbers indicate BMI values higher than the mean.|Z score|Mean|1.6|1.6|Standard Deviation|0.3|0.3|||
3780948|NCT01881828|3611856|B2|||Body Mass Index (BMI) Z Score|Body mass index z-scores are measures of relative weight adjusted for child age and sex. The Z-score indicates the number of standard deviations away from a reference population in the same age range and with the same sex. A Z-score of 0 is equal to the mean. Negative numbers indicate BMI values lower than the mean and positive numbers indicate BMI values higher than the mean.|Z score|Mean|1.7|1.7|Standard Deviation|0.3|0.3|||
3780949|NCT01881828|3611857|B1|||Body Mass Index (BMI) Z Score|Body mass index z-scores are measures of relative weight adjusted for child age and sex. The Z-score indicates the number of standard deviations away from a reference population in the same age range and with the same sex. A Z-score of 0 is equal to the mean. Negative numbers indicate BMI values lower than the mean and positive numbers indicate BMI values higher than the mean.|Z score|Mean|1.6|1.6|Standard Deviation|0.4|0.4|||
3780950|NCT01881828|3611855|B3|≥ 9 years||Duration of Diabetes (group)||years|Number|37|37.0||||||
3780951|NCT01881828|3611856|B2|≥ 9 years||Duration of Diabetes (group)||years|Number|13|13.0||||||
3780952|NCT01881828|3611857|B1|≥ 9 years||Duration of Diabetes (group)||years|Number|24|24.0||||||
3780953|NCT01881828|3611855|B3|6-8 Years||Duration of Diabetes (group)||years|Number|41|41.0||||||
3780954|NCT01881828|3611856|B2|6-8 Years||Duration of Diabetes (group)||years|Number|22|22.0||||||
3780955|NCT01881828|3611857|B1|6-8 Years||Duration of Diabetes (group)||years|Number|19|19.0||||||
3780956|NCT01881828|3611855|B3|3-5 Years||Duration of Diabetes (group)||years|Number|48|48.0||||||
3780957|NCT01881828|3611856|B2|3-5 Years||Duration of Diabetes (group)||years|Number|25|25.0||||||
3780958|NCT01881828|3611857|B1|3-5 Years||Duration of Diabetes (group)||years|Number|23|23.0||||||
3780959|NCT01881828|3611855|B3|1-2 Years||Duration of Diabetes (group)||years|Number|14|14.0||||||
3780960|NCT01881828|3611856|B2|1-2 Years||Duration of Diabetes (group)||years|Number|9|9.0||||||
3780961|NCT01881828|3611857|B1|1-2 Years||Duration of Diabetes (group)||years|Number|5|5.0||||||
3780962|NCT01881828|3611855|B3|||Duration of Diabetes||years|Mean|7.0|7.0|Standard Deviation|3.6|3.6|||
3780963|NCT01881828|3611856|B2|||Duration of Diabetes||years|Mean|6.4|6.4|Standard Deviation|3.0|3.0|||
3780964|NCT01881828|3611857|B1|||Duration of Diabetes||years|Mean|7.5|7.5|Standard Deviation|3.6|3.6|||
3780965|NCT01881828|3611855|B3|More than one race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3780966|NCT01881828|3611856|B2|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3780967|NCT01881828|3611857|B1|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3780968|NCT01881828|3611855|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3780969|NCT01881828|3611856|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3780970|NCT01881828|3611857|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3780971|NCT01881828|3611855|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3780972|NCT01881828|3611856|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3780973|NCT01881828|3611857|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3780974|NCT01881828|3611855|B3|Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3780975|NCT01881828|3611856|B2|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3780976|NCT01881828|3611857|B1|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3780977|NCT01881828|3611855|B3|White||Race/Ethnicity, Customized||participants|Number|103|103.0||||||
3780978|NCT01881828|3611856|B2|White||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
3780979|NCT01881828|3611857|B1|White||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
3780980|NCT01881828|3611855|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3780981|NCT01881828|3611856|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3780982|NCT01881828|3611857|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3780983|NCT01881828|3611855|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3780984|NCT01881828|3611856|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3780985|NCT01881828|3611857|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3780986|NCT01881828|3611855|B3|16-19 years||Age, Customized||years|Number|50|50.0||||||
3780987|NCT01881828|3611856|B2|16-19 years||Age, Customized||years|Number|22|22.0||||||
3780988|NCT01881828|3611857|B1|16-19 years||Age, Customized||years|Number|28|28.0||||||
3780989|NCT01881828|3611855|B3|12-15 years||Age, Customized||years|Number|90|90.0||||||
3780990|NCT01881828|3611856|B2|12-15 years||Age, Customized||years|Number|47|47.0||||||
3780991|NCT01881828|3611857|B1|12-15 years||Age, Customized||years|Number|43|43.0||||||
3780992|NCT01881828|3611855|B3|||Age||years|Mean|15.3|15.3|Standard Deviation|1.7|1.7|||
3780993|NCT01881828|3611856|B2|||Age||years|Mean|15.1|15.1|Standard Deviation|1.8|1.8|||
3780994|NCT01881828|3611857|B1|||Age||years|Mean|15.4|15.4|Standard Deviation|1.7|1.7|||
3780995|NCT01881776|3611878|B4|United States||Region of Enrollment||participants|Number|70|70.0||||||
3780996|NCT01881776|3611879|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
3780997|NCT01881776|3611880|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
3780998|NCT01881776|3611881|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3780999|NCT01881776|3611878|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3781000|NCT01881776|3611879|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3781001|NCT01881776|3611880|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3781002|NCT01881776|3611881|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3781003|NCT01881776|3611878|B4||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3781004|NCT01881776|3611879|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3781005|NCT01881776|3611880|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3781006|NCT01881776|3611881|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3781007|NCT01881776|3611878|B4|||Age||years|Mean|55|55.0|Standard Deviation|11|11.0|||
3781008|NCT01881776|3611879|B3|||Age||years|Mean|52|52.0|Standard Deviation|12|12.0|||
3781009|NCT01881776|3611880|B2|||Age||years|Mean|56|56.0|Standard Deviation|10|10.0|||
3781010|NCT01881776|3611881|B1|||Age||years|Mean|57|57.0|Standard Deviation|9|9.0|||
3781011|NCT01881776|3611878|B4||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3781012|NCT01881776|3611879|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3781013|NCT01881776|3611880|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3781014|NCT01881776|3611881|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3781015|NCT01881776|3611878|B4||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3781016|NCT01881776|3611879|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3781017|NCT01881776|3611880|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3781018|NCT01881776|3611881|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3781019|NCT01881776|3611878|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3781020|NCT01881776|3611879|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3781021|NCT01881776|3611880|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3781022|NCT01881776|3611881|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3781023|NCT01881737|3611909|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3781024|NCT01881737|3611909|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3781025|NCT01881737|3611909|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3781026|NCT01881737|3611909|B1|||Age||years|Mean|22.5|22.5|Standard Deviation|5.8|5.8|||
3781027|NCT01881737|3611909|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3781028|NCT01881737|3611909|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3781029|NCT01881737|3611909|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3781030|NCT01881230|3611918|B4|||Triple-Negative at Latest Diagnosis||Participants|Count of Participants|187|187.0||||||
3781031|NCT01881230|3611919|B3|||Triple-Negative at Latest Diagnosis||Participants|Count of Participants|65|65.0||||||
3781032|NCT01881230|3611920|B2|||Triple-Negative at Latest Diagnosis||Participants|Count of Participants|62|62.0||||||
3781033|NCT01881230|3611921|B1|||Triple-Negative at Latest Diagnosis||Participants|Count of Participants|60|60.0||||||
3781034|NCT01881230|3611918|B4|||Triple-Negative Breast Cancer (TNBC) at Primary Diagnosis|Triple-Negative Breast Cancer defined as estrogen receptor (ER) negative, progesterone receptor (PgR) negative, and human epidermal growth factor receptor 2 (HER2) negative.|Participants|Count of Participants|152|152.0||||||
3781035|NCT01881230|3611919|B3|||Triple-Negative Breast Cancer (TNBC) at Primary Diagnosis|Triple-Negative Breast Cancer defined as estrogen receptor (ER) negative, progesterone receptor (PgR) negative, and human epidermal growth factor receptor 2 (HER2) negative.|Participants|Count of Participants|48|48.0||||||
3781036|NCT01881230|3611920|B2|||Triple-Negative Breast Cancer (TNBC) at Primary Diagnosis|Triple-Negative Breast Cancer defined as estrogen receptor (ER) negative, progesterone receptor (PgR) negative, and human epidermal growth factor receptor 2 (HER2) negative.|Participants|Count of Participants|53|53.0||||||
3781037|NCT01881230|3611921|B1|||Triple-Negative Breast Cancer (TNBC) at Primary Diagnosis|Triple-Negative Breast Cancer defined as estrogen receptor (ER) negative, progesterone receptor (PgR) negative, and human epidermal growth factor receptor 2 (HER2) negative.|Participants|Count of Participants|51|51.0||||||
3781038|NCT01881230|3611918|B4|Stage IV||Stage of Primary Diagnosis|"Invasive breast cancer stages:~Stage 0-Stage 0 = noninvasive ductal carcinoma in situ~Stage Ia-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|Participants|Count of Participants|38|38.0||||||
3781039|NCT01881230|3611919|B3|Stage IV||Stage of Primary Diagnosis|"Invasive breast cancer stages:~Stage 0-Stage 0 = noninvasive ductal carcinoma in situ~Stage Ia-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|Participants|Count of Participants|10|10.0||||||
3781040|NCT01881230|3611920|B2|Stage IV||Stage of Primary Diagnosis|"Invasive breast cancer stages:~Stage 0-Stage 0 = noninvasive ductal carcinoma in situ~Stage Ia-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|Participants|Count of Participants|17|17.0||||||
3781041|NCT01881230|3611921|B1|Stage IV||Stage of Primary Diagnosis|"Invasive breast cancer stages:~Stage 0-Stage 0 = noninvasive ductal carcinoma in situ~Stage Ia-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|Participants|Count of Participants|11|11.0||||||
3781042|NCT01881230|3611918|B4|Stage IIIC||Stage of Primary Diagnosis|"Invasive breast cancer stages:~Stage 0-Stage 0 = noninvasive ductal carcinoma in situ~Stage Ia-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|Participants|Count of Participants|8|8.0||||||
3781043|NCT01881230|3611919|B3|Stage IIIC||Stage of Primary Diagnosis|"Invasive breast cancer stages:~Stage 0-Stage 0 = noninvasive ductal carcinoma in situ~Stage Ia-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|Participants|Count of Participants|2|2.0||||||
3781044|NCT01881230|3611920|B2|Stage IIIC||Stage of Primary Diagnosis|"Invasive breast cancer stages:~Stage 0-Stage 0 = noninvasive ductal carcinoma in situ~Stage Ia-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|Participants|Count of Participants|3|3.0||||||
3781045|NCT01881230|3611921|B1|Stage IIIC||Stage of Primary Diagnosis|"Invasive breast cancer stages:~Stage 0-Stage 0 = noninvasive ductal carcinoma in situ~Stage Ia-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|Participants|Count of Participants|3|3.0||||||
3781102|NCT01881230|3611918|B4|Lymph Nodes(s)||Current Sites of Metastasis||participants|Number|139|139.0||||||
3781103|NCT01881230|3611919|B3|Lymph Nodes(s)||Current Sites of Metastasis||participants|Number|51|51.0||||||
3781046|NCT01881230|3611918|B4|Stage IIIB||Stage of Primary Diagnosis|"Invasive breast cancer stages:~Stage 0-Stage 0 = noninvasive ductal carcinoma in situ~Stage Ia-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|Participants|Count of Participants|11|11.0||||||
3781047|NCT01881230|3611919|B3|Stage IIIB||Stage of Primary Diagnosis|"Invasive breast cancer stages:~Stage 0-Stage 0 = noninvasive ductal carcinoma in situ~Stage Ia-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|Participants|Count of Participants|5|5.0||||||
3781048|NCT01881230|3611920|B2|Stage IIIB||Stage of Primary Diagnosis|"Invasive breast cancer stages:~Stage 0-Stage 0 = noninvasive ductal carcinoma in situ~Stage Ia-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|Participants|Count of Participants|3|3.0||||||
3781049|NCT01881230|3611921|B1|Stage IIIB||Stage of Primary Diagnosis|"Invasive breast cancer stages:~Stage 0-Stage 0 = noninvasive ductal carcinoma in situ~Stage Ia-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|Participants|Count of Participants|3|3.0||||||
3781050|NCT01881230|3611918|B4|Stage IIIA||Stage of Primary Diagnosis|"Invasive breast cancer stages:~Stage 0-Stage 0 = noninvasive ductal carcinoma in situ~Stage Ia-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|Participants|Count of Participants|22|22.0||||||
3781051|NCT01881230|3611919|B3|Stage IIIA||Stage of Primary Diagnosis|"Invasive breast cancer stages:~Stage 0-Stage 0 = noninvasive ductal carcinoma in situ~Stage Ia-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|Participants|Count of Participants|3|3.0||||||
3781052|NCT01881230|3611920|B2|Stage IIIA||Stage of Primary Diagnosis|"Invasive breast cancer stages:~Stage 0-Stage 0 = noninvasive ductal carcinoma in situ~Stage Ia-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|Participants|Count of Participants|10|10.0||||||
3781053|NCT01881230|3611921|B1|Stage IIIA||Stage of Primary Diagnosis|"Invasive breast cancer stages:~Stage 0-Stage 0 = noninvasive ductal carcinoma in situ~Stage Ia-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|Participants|Count of Participants|9|9.0||||||
3781054|NCT01881230|3611918|B4|Stage IIB||Stage of Primary Diagnosis|"Invasive breast cancer stages:~Stage 0-Stage 0 = noninvasive ductal carcinoma in situ~Stage Ia-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|Participants|Count of Participants|24|24.0||||||
3781055|NCT01881230|3611919|B3|Stage IIB||Stage of Primary Diagnosis|"Invasive breast cancer stages:~Stage 0-Stage 0 = noninvasive ductal carcinoma in situ~Stage Ia-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|Participants|Count of Participants|9|9.0||||||
3781056|NCT01881230|3611920|B2|Stage IIB||Stage of Primary Diagnosis|"Invasive breast cancer stages:~Stage 0-Stage 0 = noninvasive ductal carcinoma in situ~Stage Ia-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|Participants|Count of Participants|7|7.0||||||
3781104|NCT01881230|3611920|B2|Lymph Nodes(s)||Current Sites of Metastasis||participants|Number|50|50.0||||||
3781105|NCT01881230|3611921|B1|Lymph Nodes(s)||Current Sites of Metastasis||participants|Number|38|38.0||||||
3781057|NCT01881230|3611921|B1|Stage IIB||Stage of Primary Diagnosis|"Invasive breast cancer stages:~Stage 0-Stage 0 = noninvasive ductal carcinoma in situ~Stage Ia-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|Participants|Count of Participants|8|8.0||||||
3781058|NCT01881230|3611918|B4|Stage IIA||Stage of Primary Diagnosis|"Invasive breast cancer stages:~Stage 0-Stage 0 = noninvasive ductal carcinoma in situ~Stage Ia-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|Participants|Count of Participants|38|38.0||||||
3781059|NCT01881230|3611919|B3|Stage IIA||Stage of Primary Diagnosis|"Invasive breast cancer stages:~Stage 0-Stage 0 = noninvasive ductal carcinoma in situ~Stage Ia-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|Participants|Count of Participants|15|15.0||||||
3781060|NCT01881230|3611920|B2|Stage IIA||Stage of Primary Diagnosis|"Invasive breast cancer stages:~Stage 0-Stage 0 = noninvasive ductal carcinoma in situ~Stage Ia-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|Participants|Count of Participants|9|9.0||||||
3781061|NCT01881230|3611921|B1|Stage IIA||Stage of Primary Diagnosis|"Invasive breast cancer stages:~Stage 0-Stage 0 = noninvasive ductal carcinoma in situ~Stage Ia-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|Participants|Count of Participants|14|14.0||||||
3781062|NCT01881230|3611918|B4|Stage IB||Stage of Primary Diagnosis|"Invasive breast cancer stages:~Stage 0-Stage 0 = noninvasive ductal carcinoma in situ~Stage Ia-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|Participants|Count of Participants|0|0.0||||||
3781063|NCT01881230|3611919|B3|Stage IB||Stage of Primary Diagnosis|"Invasive breast cancer stages:~Stage 0-Stage 0 = noninvasive ductal carcinoma in situ~Stage Ia-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|Participants|Count of Participants|0|0.0||||||
3781064|NCT01881230|3611920|B2|Stage IB||Stage of Primary Diagnosis|"Invasive breast cancer stages:~Stage 0-Stage 0 = noninvasive ductal carcinoma in situ~Stage Ia-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|Participants|Count of Participants|0|0.0||||||
3781065|NCT01881230|3611921|B1|Stage IB||Stage of Primary Diagnosis|"Invasive breast cancer stages:~Stage 0-Stage 0 = noninvasive ductal carcinoma in situ~Stage Ia-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|Participants|Count of Participants|0|0.0||||||
3781066|NCT01881230|3611918|B4|Stage IA||Stage of Primary Diagnosis|"Invasive breast cancer stages:~Stage 0-Stage 0 = noninvasive ductal carcinoma in situ~Stage Ia-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|Participants|Count of Participants|24|24.0||||||
3781067|NCT01881230|3611919|B3|Stage IA||Stage of Primary Diagnosis|"Invasive breast cancer stages:~Stage 0-Stage 0 = noninvasive ductal carcinoma in situ~Stage Ia-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|Participants|Count of Participants|11|11.0||||||
3781106|NCT01881230|3611918|B4|||Time from Primary Diagnosis to Randomization||months|Mean|44.0|44.0|Standard Deviation|53.53|53.53|||
3781266|NCT01880840|3612031|B3|||Age||years|Mean|3.33|3.33|Standard Deviation|1.566|1.566|||
3781068|NCT01881230|3611920|B2|Stage IA||Stage of Primary Diagnosis|"Invasive breast cancer stages:~Stage 0-Stage 0 = noninvasive ductal carcinoma in situ~Stage Ia-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|Participants|Count of Participants|6|6.0||||||
3781069|NCT01881230|3611921|B1|Stage IA||Stage of Primary Diagnosis|"Invasive breast cancer stages:~Stage 0-Stage 0 = noninvasive ductal carcinoma in situ~Stage Ia-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|Participants|Count of Participants|7|7.0||||||
3781070|NCT01881230|3611918|B4|Stage 0||Stage of Primary Diagnosis|"Invasive breast cancer stages:~Stage 0-Stage 0 = noninvasive ductal carcinoma in situ~Stage Ia-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|Participants|Count of Participants|1|1.0||||||
3781071|NCT01881230|3611919|B3|Stage 0||Stage of Primary Diagnosis|"Invasive breast cancer stages:~Stage 0-Stage 0 = noninvasive ductal carcinoma in situ~Stage Ia-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|Participants|Count of Participants|0|0.0||||||
3781072|NCT01881230|3611920|B2|Stage 0||Stage of Primary Diagnosis|"Invasive breast cancer stages:~Stage 0-Stage 0 = noninvasive ductal carcinoma in situ~Stage Ia-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|Participants|Count of Participants|1|1.0||||||
3781073|NCT01881230|3611921|B1|Stage 0||Stage of Primary Diagnosis|"Invasive breast cancer stages:~Stage 0-Stage 0 = noninvasive ductal carcinoma in situ~Stage Ia-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|Participants|Count of Participants|0|0.0||||||
3781074|NCT01881230|3611918|B4|Abdomen/Peritoneal||Current Sites of Metastasis||participants|Number|6|6.0||||||
3781075|NCT01881230|3611919|B3|Abdomen/Peritoneal||Current Sites of Metastasis||participants|Number|3|3.0||||||
3781076|NCT01881230|3611920|B2|Abdomen/Peritoneal||Current Sites of Metastasis||participants|Number|2|2.0||||||
3781077|NCT01881230|3611921|B1|Abdomen/Peritoneal||Current Sites of Metastasis||participants|Number|1|1.0||||||
3781078|NCT01881230|3611918|B4|Other||Current Sites of Metastasis||participants|Number|31|31.0||||||
3781079|NCT01881230|3611919|B3|Other||Current Sites of Metastasis||participants|Number|8|8.0||||||
3781080|NCT01881230|3611920|B2|Other||Current Sites of Metastasis||participants|Number|10|10.0||||||
3781081|NCT01881230|3611921|B1|Other||Current Sites of Metastasis||participants|Number|13|13.0||||||
3781082|NCT01881230|3611918|B4|Skin/Soft Tissue||Current Sites of Metastasis||participants|Number|34|34.0||||||
3781083|NCT01881230|3611919|B3|Skin/Soft Tissue||Current Sites of Metastasis||participants|Number|8|8.0||||||
3781084|NCT01881230|3611920|B2|Skin/Soft Tissue||Current Sites of Metastasis||participants|Number|13|13.0||||||
3781085|NCT01881230|3611921|B1|Skin/Soft Tissue||Current Sites of Metastasis||participants|Number|13|13.0||||||
3781086|NCT01881230|3611918|B4|Right/Left Breast||Current Sites of Metastasis||participants|Number|51|51.0||||||
3781087|NCT01881230|3611919|B3|Right/Left Breast||Current Sites of Metastasis||participants|Number|17|17.0||||||
3781088|NCT01881230|3611920|B2|Right/Left Breast||Current Sites of Metastasis||participants|Number|19|19.0||||||
3781089|NCT01881230|3611921|B1|Right/Left Breast||Current Sites of Metastasis||participants|Number|15|15.0||||||
3781090|NCT01881230|3611918|B4|Liver||Current Sites of Metastasis||participants|Number|56|56.0||||||
3781091|NCT01881230|3611919|B3|Liver||Current Sites of Metastasis||participants|Number|23|23.0||||||
3781092|NCT01881230|3611920|B2|Liver||Current Sites of Metastasis||participants|Number|16|16.0||||||
3781093|NCT01881230|3611921|B1|Liver||Current Sites of Metastasis||participants|Number|17|17.0||||||
3781094|NCT01881230|3611918|B4|Bone||Current Sites of Metastasis||participants|Number|69|69.0||||||
3781095|NCT01881230|3611919|B3|Bone||Current Sites of Metastasis||participants|Number|25|25.0||||||
3781096|NCT01881230|3611920|B2|Bone||Current Sites of Metastasis||participants|Number|21|21.0||||||
3781097|NCT01881230|3611921|B1|Bone||Current Sites of Metastasis||participants|Number|23|23.0||||||
3781098|NCT01881230|3611918|B4|Lung/Thoracic||Current Sites of Metastasis||participants|Number|125|125.0||||||
3781099|NCT01881230|3611919|B3|Lung/Thoracic||Current Sites of Metastasis||participants|Number|41|41.0||||||
3781100|NCT01881230|3611920|B2|Lung/Thoracic||Current Sites of Metastasis||participants|Number|42|42.0||||||
3781101|NCT01881230|3611921|B1|Lung/Thoracic||Current Sites of Metastasis||participants|Number|42|42.0||||||
3781107|NCT01881230|3611919|B3|||Time from Primary Diagnosis to Randomization||months|Mean|52.5|52.5|Standard Deviation|62.37|62.37|||
3781108|NCT01881230|3611920|B2|||Time from Primary Diagnosis to Randomization||months|Mean|35.5|35.5|Standard Deviation|40.51|40.51|||
3781109|NCT01881230|3611921|B1|||Time from Primary Diagnosis to Randomization||months|Mean|43.7|43.7|Standard Deviation|54.60|54.6|||
3781110|NCT01881230|3611918|B4|||Time from First Documented Metastatic Disease/Relapse to Study Randomization||months|Mean|2.6|2.6|Standard Deviation|11.07|11.07|||
3781111|NCT01881230|3611919|B3|||Time from First Documented Metastatic Disease/Relapse to Study Randomization||months|Mean|1.6|1.6|Standard Deviation|1.70|1.7|||
3781112|NCT01881230|3611920|B2|||Time from First Documented Metastatic Disease/Relapse to Study Randomization||months|Mean|4.2|4.2|Standard Deviation|18.39|18.39|||
3781113|NCT01881230|3611921|B1|||Time from First Documented Metastatic Disease/Relapse to Study Randomization||months|Mean|2.1|2.1|Standard Deviation|5.08|5.08|||
3781114|NCT01881230|3611918|B4|||Time from Diagnosis to First Documented Disease/Relapse||months|Mean|40.0|40.0|Standard Deviation|51.46|51.46|||
3781115|NCT01881230|3611919|B3|||Time from Diagnosis to First Documented Disease/Relapse||months|Mean|50.9|50.9|Standard Deviation|62.60|62.6|||
3781116|NCT01881230|3611920|B2|||Time from Diagnosis to First Documented Disease/Relapse||months|Mean|29.9|29.9|Standard Deviation|37.18|37.18|||
3781117|NCT01881230|3611921|B1|||Time from Diagnosis to First Documented Disease/Relapse||months|Mean|38.8|38.8|Standard Deviation|49.46|49.46|||
3781118|NCT01881230|3611918|B4|Missing||Disease Free Interval by Clinical Interpretation|Disease Free Interval is defined as period of being absent of disease less than or equal to one year or free of disease greater than one year.|Years|Number|2|2.0||||||
3781119|NCT01881230|3611919|B3|Missing||Disease Free Interval by Clinical Interpretation|Disease Free Interval is defined as period of being absent of disease less than or equal to one year or free of disease greater than one year.|Years|Number|1|1.0||||||
3781120|NCT01881230|3611920|B2|Missing||Disease Free Interval by Clinical Interpretation|Disease Free Interval is defined as period of being absent of disease less than or equal to one year or free of disease greater than one year.|Years|Number|0|0.0||||||
3781121|NCT01881230|3611921|B1|Missing||Disease Free Interval by Clinical Interpretation|Disease Free Interval is defined as period of being absent of disease less than or equal to one year or free of disease greater than one year.|Years|Number|1|1.0||||||
3781122|NCT01881230|3611918|B4|> 1 year||Disease Free Interval by Clinical Interpretation|Disease Free Interval is defined as period of being absent of disease less than or equal to one year or free of disease greater than one year.|Years|Number|136|136.0||||||
3781123|NCT01881230|3611919|B3|> 1 year||Disease Free Interval by Clinical Interpretation|Disease Free Interval is defined as period of being absent of disease less than or equal to one year or free of disease greater than one year.|Years|Number|45|45.0||||||
3781124|NCT01881230|3611920|B2|> 1 year||Disease Free Interval by Clinical Interpretation|Disease Free Interval is defined as period of being absent of disease less than or equal to one year or free of disease greater than one year.|Years|Number|48|48.0||||||
3781125|NCT01881230|3611921|B1|> 1 year||Disease Free Interval by Clinical Interpretation|Disease Free Interval is defined as period of being absent of disease less than or equal to one year or free of disease greater than one year.|Years|Number|43|43.0||||||
3781126|NCT01881230|3611918|B4|≤ 1 year||Disease Free Interval by Clinical Interpretation|Disease Free Interval is defined as period of being absent of disease less than or equal to one year or free of disease greater than one year.|Years|Number|53|53.0||||||
3781127|NCT01881230|3611919|B3|≤ 1 year||Disease Free Interval by Clinical Interpretation|Disease Free Interval is defined as period of being absent of disease less than or equal to one year or free of disease greater than one year.|Years|Number|20|20.0||||||
3781128|NCT01881230|3611920|B2|≤ 1 year||Disease Free Interval by Clinical Interpretation|Disease Free Interval is defined as period of being absent of disease less than or equal to one year or free of disease greater than one year.|Years|Number|16|16.0||||||
3781129|NCT01881230|3611921|B1|≤ 1 year||Disease Free Interval by Clinical Interpretation|Disease Free Interval is defined as period of being absent of disease less than or equal to one year or free of disease greater than one year.|Years|Number|17|17.0||||||
3781130|NCT01881230|3611918|B4|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|3|3.0||||||
3781131|NCT01881230|3611919|B3|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|2|2.0||||||
3781132|NCT01881230|3611920|B2|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|0|0.0||||||
3781133|NCT01881230|3611921|B1|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|1|1.0||||||
3781134|NCT01881230|3611918|B4|2 = Ambulatory but unable to work||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|1|1.0||||||
3781135|NCT01881230|3611919|B3|2 = Ambulatory but unable to work||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|0|0.0||||||
3781136|NCT01881230|3611920|B2|2 = Ambulatory but unable to work||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|0|0.0||||||
3781137|NCT01881230|3611921|B1|2 = Ambulatory but unable to work||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|1|1.0||||||
3781138|NCT01881230|3611918|B4|1 = Restrictive but ambulatory||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|73|73.0||||||
3781139|NCT01881230|3611919|B3|1 = Restrictive but ambulatory||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|22|22.0||||||
3781140|NCT01881230|3611920|B2|1 = Restrictive but ambulatory||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|26|26.0||||||
3781141|NCT01881230|3611921|B1|1 = Restrictive but ambulatory||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|25|25.0||||||
3781142|NCT01881230|3611918|B4|0 = Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|114|114.0||||||
3781143|NCT01881230|3611919|B3|0 = Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|42|42.0||||||
3781144|NCT01881230|3611920|B2|0 = Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|38|38.0||||||
3781145|NCT01881230|3611921|B1|0 = Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|34|34.0||||||
3781146|NCT01881230|3611918|B4|Unknown or Not Reported||Race||Participants|Count of Participants|9|9.0||||||
3781147|NCT01881230|3611919|B3|Unknown or Not Reported||Race||Participants|Count of Participants|4|4.0||||||
3781148|NCT01881230|3611920|B2|Unknown or Not Reported||Race||Participants|Count of Participants|3|3.0||||||
3781149|NCT01881230|3611921|B1|Unknown or Not Reported||Race||Participants|Count of Participants|2|2.0||||||
3781150|NCT01881230|3611918|B4|White||Race||Participants|Count of Participants|159|159.0||||||
3781151|NCT01881230|3611919|B3|White||Race||Participants|Count of Participants|54|54.0||||||
3781152|NCT01881230|3611920|B2|White||Race||Participants|Count of Participants|55|55.0||||||
3781153|NCT01881230|3611921|B1|White||Race||Participants|Count of Participants|50|50.0||||||
3781154|NCT01881230|3611918|B4|Black or African American||Race||Participants|Count of Participants|23|23.0||||||
3781155|NCT01881230|3611919|B3|Black or African American||Race||Participants|Count of Participants|8|8.0||||||
3781156|NCT01881230|3611920|B2|Black or African American||Race||Participants|Count of Participants|6|6.0||||||
3781157|NCT01881230|3611921|B1|Black or African American||Race||Participants|Count of Participants|9|9.0||||||
3781158|NCT01881230|3611918|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3781159|NCT01881230|3611919|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3781160|NCT01881230|3611920|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3781161|NCT01881230|3611921|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3781162|NCT01881230|3611918|B4||Female|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
3781163|NCT01881230|3611919|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3781164|NCT01881230|3611920|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3781165|NCT01881230|3611921|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3781166|NCT01881230|3611918|B4|||Age||years|Mean|54.9|54.9|Standard Deviation|11.67|11.67|||
3781167|NCT01881230|3611919|B3|||Age||years|Mean|56.7|56.7|Standard Deviation|10.87|10.87|||
3781168|NCT01881230|3611920|B2|||Age||years|Mean|54.3|54.3|Standard Deviation|11.96|11.96|||
3781169|NCT01881230|3611921|B1|||Age||years|Mean|53.7|53.7|Standard Deviation|12.16|12.16|||
3781170|NCT01881126|3611949|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3781171|NCT01881126|3611950|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3781172|NCT01881126|3611951|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3781173|NCT01881126|3611949|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3781174|NCT01881126|3611950|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3781175|NCT01881126|3611951|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3781176|NCT01881126|3611949|B3|||Age||Years|Mean|67.5|67.5|Standard Deviation|8.74|8.74|||
3781177|NCT01881126|3611950|B2|||Age||Years|Mean|67.3|67.3|Standard Deviation|8.19|8.19|||
3781178|NCT01881126|3611951|B1|||Age||Years|Mean|67.8|67.8|Standard Deviation|9.34|9.34|||
3781179|NCT01881113|3611958|B3|United States||Region of Enrollment||participants|Number|101|101.0||||||
3781180|NCT01881113|3611959|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
3781181|NCT01881113|3611960|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
3781182|NCT01881113|3611958|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3781183|NCT01881113|3611959|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3781184|NCT01881113|3611960|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781185|NCT01881113|3611958|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781186|NCT01881113|3611959|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781187|NCT01881113|3611960|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781188|NCT01881113|3611958|B3||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3781189|NCT01881113|3611959|B2||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3781190|NCT01881113|3611960|B1||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3781191|NCT01881113|3611958|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3781192|NCT01881113|3611959|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3781193|NCT01881113|3611960|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3781194|NCT01881113|3611958|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781195|NCT01881113|3611959|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781196|NCT01881113|3611960|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781197|NCT01881113|3611958|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3781198|NCT01881113|3611959|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3781199|NCT01881113|3611960|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781200|NCT01881113|3611958|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781201|NCT01881113|3611959|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781202|NCT01881113|3611960|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781203|NCT01881113|3611958|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781204|NCT01881113|3611959|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781205|NCT01881113|3611960|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781206|NCT01881113|3611958|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3781207|NCT01881113|3611959|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3781208|NCT01881113|3611960|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3781209|NCT01881113|3611958|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3781210|NCT01881113|3611959|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781211|NCT01881113|3611960|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3781212|NCT01881113|3611958|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3781213|NCT01881113|3611959|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3781214|NCT01881113|3611960|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3781215|NCT01881113|3611958|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3781216|NCT01881113|3611959|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3781217|NCT01881113|3611960|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3781218|NCT01881113|3611958|B3|||Age||years|Mean|39.9|39.9|Standard Deviation|11.84|11.84|||
3781219|NCT01881113|3611959|B2|||Age||years|Mean|39.2|39.2|Standard Deviation|10.84|10.84|||
3781220|NCT01881113|3611960|B1|||Age||years|Mean|40.6|40.6|Standard Deviation|12.8|12.8|||
3781221|NCT01881087|3612015|B4|||Height||centimeters|Mean|168|168.0|Standard Deviation|8|8.0|||
3781222|NCT01881087|3612016|B3|||Height||centimeters|Mean|168|168.0|Standard Deviation|9|9.0|||
3781223|NCT01881087|3612017|B2|||Height||centimeters|Mean|167|167.0|Standard Deviation|6|6.0|||
3781224|NCT01881087|3612018|B1|||Height||centimeters|Mean|168|168.0|Standard Deviation|9|9.0|||
3781225|NCT01881087|3612015|B4|||Weight||kilograms|Mean|74.5|74.5|Standard Deviation|12.5|12.5|||
3781226|NCT01881087|3612016|B3|||Weight||kilograms|Mean|75.7|75.7|Standard Deviation|13.9|13.9|||
3781227|NCT01881087|3612017|B2|||Weight||kilograms|Mean|73.3|73.3|Standard Deviation|11.4|11.4|||
3781228|NCT01881087|3612018|B1|||Weight||kilograms|Mean|74.7|74.7|Standard Deviation|12.3|12.3|||
3781229|NCT01881087|3612015|B4|Colombia||Region of Enrollment||participants|Number|180|180.0||||||
3781230|NCT01881087|3612016|B3|Colombia||Region of Enrollment||participants|Number|60|60.0||||||
3781231|NCT01881087|3612017|B2|Colombia||Region of Enrollment||participants|Number|61|61.0||||||
3781232|NCT01881087|3612018|B1|Colombia||Region of Enrollment||participants|Number|59|59.0||||||
3781233|NCT01881087|3612015|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781234|NCT01881087|3612016|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781235|NCT01881087|3612017|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781236|NCT01881087|3612018|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781237|NCT01881087|3612015|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781238|NCT01881087|3612016|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781239|NCT01881087|3612017|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781240|NCT01881087|3612018|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781241|NCT01881087|3612015|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|180|180.0||||||
3781242|NCT01881087|3612016|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3781243|NCT01881087|3612017|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3781244|NCT01881087|3612018|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3781245|NCT01881087|3612015|B4||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3781246|NCT01881087|3612016|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3781247|NCT01881087|3612017|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3781248|NCT01881087|3612018|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3781249|NCT01881087|3612015|B4||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3781250|NCT01881087|3612016|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3781251|NCT01881087|3612017|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3781252|NCT01881087|3612018|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3781253|NCT01881087|3612015|B4|||Age||years|Mean|44.3|44.3|Standard Deviation|12|12.0|||
3781254|NCT01881087|3612016|B3|||Age||years|Mean|44|44.0|Standard Deviation|12|12.0|||
3781255|NCT01881087|3612017|B2|||Age||years|Mean|47|47.0|Standard Deviation|13|13.0|||
3781256|NCT01881087|3612018|B1|||Age||years|Mean|42|42.0|Standard Deviation|13|13.0|||
3781257|NCT01880840|3612031|B3|United States||Region of Enrollment||participants|Number|191|191.0||||||
3781258|NCT01880840|3612032|B2|United States||Region of Enrollment||participants|Number|96|96.0||||||
3781259|NCT01880840|3612033|B1|United States||Region of Enrollment||participants|Number|95|95.0||||||
3781260|NCT01880840|3612031|B3||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3781261|NCT01880840|3612032|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3781262|NCT01880840|3612033|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3781263|NCT01880840|3612031|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3781264|NCT01880840|3612032|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3781265|NCT01880840|3612033|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3781267|NCT01880840|3612032|B2|||Age||years|Mean|3.37|3.37|Standard Deviation|1.595|1.595|||
3781268|NCT01880840|3612033|B1|||Age||years|Mean|3.29|3.29|Standard Deviation|1.538|1.538|||
3781269|NCT01880840|3612031|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3781270|NCT01880840|3612032|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3781271|NCT01880840|3612033|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3781272|NCT01880840|3612031|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3781273|NCT01880840|3612032|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3781274|NCT01880840|3612033|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3781275|NCT01880840|3612031|B3||<=18 years|Age||Participants|Count of Participants|191|191.0||||||
3781276|NCT01880840|3612032|B2||<=18 years|Age||Participants|Count of Participants|96|96.0||||||
3781277|NCT01880840|3612033|B1||<=18 years|Age||Participants|Count of Participants|95|95.0||||||
3781278|NCT01880736|3612040|B5|||Fasting plasma glucose (FPG)||mg/dL|Mean|133.0|133.0|Standard Deviation|35.5|35.5|||
3781279|NCT01880736|3612041|B4|||Fasting plasma glucose (FPG)||mg/dL|Mean|134.5|134.5|Standard Deviation|39.6|39.6|||
3781280|NCT01880736|3612042|B3|||Fasting plasma glucose (FPG)||mg/dL|Mean|131.8|131.8|Standard Deviation|33.5|33.5|||
3781281|NCT01880736|3612043|B2|||Fasting plasma glucose (FPG)||mg/dL|Mean|136.0|136.0|Standard Deviation|38.1|38.1|||
3781282|NCT01880736|3612044|B1|||Fasting plasma glucose (FPG)||mg/dL|Mean|129.8|129.8|Standard Deviation|30.0|30.0|||
3781283|NCT01880736|3612040|B5|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|7.8|7.8|Standard Deviation|0.6|0.6|||
3781284|NCT01880736|3612041|B4|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|7.8|7.8|Standard Deviation|0.6|0.6|||
3781285|NCT01880736|3612042|B3|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|7.8|7.8|Standard Deviation|0.5|0.5|||
3781286|NCT01880736|3612043|B2|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|7.8|7.8|Standard Deviation|0.6|0.6|||
3781287|NCT01880736|3612044|B1|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|7.8|7.8|Standard Deviation|0.6|0.6|||
3781288|NCT01880736|3612040|B5||Male|Gender||Participants|Count of Participants|292|292.0||||||
3781289|NCT01880736|3612041|B4||Male|Gender||Participants|Count of Participants|80|80.0||||||
3781290|NCT01880736|3612042|B3||Male|Gender||Participants|Count of Participants|65|65.0||||||
3781291|NCT01880736|3612043|B2||Male|Gender||Participants|Count of Participants|74|74.0||||||
3781292|NCT01880736|3612044|B1||Male|Gender||Participants|Count of Participants|73|73.0||||||
3781293|NCT01880736|3612040|B5||Female|Gender||Participants|Count of Participants|166|166.0||||||
3781294|NCT01880736|3612041|B4||Female|Gender||Participants|Count of Participants|34|34.0||||||
3781295|NCT01880736|3612042|B3||Female|Gender||Participants|Count of Participants|50|50.0||||||
3781296|NCT01880736|3612043|B2||Female|Gender||Participants|Count of Participants|41|41.0||||||
3781297|NCT01880736|3612044|B1||Female|Gender||Participants|Count of Participants|41|41.0||||||
3781298|NCT01880736|3612040|B5|||Age||years|Mean|60.3|60.3|Standard Deviation|10.7|10.7|||
3781299|NCT01880736|3612041|B4|||Age||years|Mean|60.2|60.2|Standard Deviation|10.8|10.8|||
3781300|NCT01880736|3612042|B3|||Age||years|Mean|60.0|60.0|Standard Deviation|10.8|10.8|||
3781301|NCT01880736|3612043|B2|||Age||years|Mean|60.7|60.7|Standard Deviation|10.5|10.5|||
3781302|NCT01880736|3612044|B1|||Age||years|Mean|60.4|60.4|Standard Deviation|10.6|10.6|||
3781303|NCT01880723|3612089|B3|||VO2 peak (% predicted)||percent predicted|Mean|85|85.0|Standard Deviation|39|39.0|||
3781304|NCT01880723|3612090|B2|||VO2 peak (% predicted)||percent predicted|Mean|54|54.0|Standard Deviation|24|24.0|||
3781305|NCT01880723|3612091|B1|||VO2 peak (% predicted)||percent predicted|Mean|108|108.0|Standard Deviation|35|35.0|||
3781306|NCT01880723|3612089|B3|||BSA (m2)||m2|Mean|1.7|1.7|Standard Deviation|0.1|0.1|||
3781307|NCT01880723|3612090|B2|||BSA (m2)||m2|Mean|1.7|1.7|Standard Deviation|0.2|0.2|||
3781308|NCT01880723|3612091|B1|||BSA (m2)||m2|Mean|1.7|1.7|Standard Deviation|0.1|0.1|||
3781309|NCT01880723|3612089|B3|||BMI (kg/m2)||kg/m2|Mean|22|22.0|Standard Deviation|3|3.0|||
3781310|NCT01880723|3612090|B2|||BMI (kg/m2)||kg/m2|Mean|22|22.0|Standard Deviation|3|3.0|||
3781311|NCT01880723|3612091|B1|||BMI (kg/m2)||kg/m2|Mean|23|23.0|Standard Deviation|3|3.0|||
3781312|NCT01880723|3612089|B3|||Height (cm)||cm|Mean|167|167.0|Standard Deviation|8|8.0|||
3781313|NCT01880723|3612090|B2|||Height (cm)||cm|Mean|166|166.0|Standard Deviation|8|8.0|||
3781314|NCT01880723|3612091|B1|||Height (cm)||cm|Mean|169|169.0|Standard Deviation|8|8.0|||
3781315|NCT01880723|3612089|B3|||Weight (kg)||kg|Mean|62|62.0|Standard Deviation|9|9.0|||
3781316|NCT01880723|3612090|B2|||Weight (kg)||kg|Mean|60|60.0|Standard Deviation|9|9.0|||
3781317|NCT01880723|3612091|B1|||Weight (kg)||kg|Mean|64|64.0|Standard Deviation|9|9.0|||
3781318|NCT01880723|3612089|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3781319|NCT01880723|3612090|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3781320|NCT01880723|3612091|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3781321|NCT01880723|3612089|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3781322|NCT01880723|3612090|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3781323|NCT01880723|3612091|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3781324|NCT01880723|3612089|B3|||Age||years|Mean|24|24.0|Standard Deviation|7|7.0|||
3781325|NCT01880723|3612090|B2|||Age||years|Mean|22|22.0|Standard Deviation|8|8.0|||
3781326|NCT01880723|3612091|B1|||Age||years|Mean|25|25.0|Standard Deviation|6|6.0|||
3781327|NCT01880697|3612106|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3781328|NCT01880697|3612107|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3781329|NCT01880697|3612108|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3781330|NCT01880697|3612106|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3781331|NCT01880697|3612107|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3781332|NCT01880697|3612108|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3781333|NCT01880697|3612106|B3|||Age||years|Mean|53.8|53.8|Standard Deviation|16.7|16.7|||
3781334|NCT01880697|3612107|B2|||Age||years|Mean|68.3|68.3|Standard Deviation|4.8|4.8|||
3781335|NCT01880697|3612108|B1|||Age||years|Mean|39.3|39.3|Standard Deviation|10.7|10.7|||
3781336|NCT01880593|3612129|B3|||CSSRS (lifetime)|The Columbia-Suicide Severity Rating Scale (C-SSRS) - Full range from 0 (low intensity suicidal ideation to 9 (high intensity suicidal ideation).|units on a scale|Mean|2.29|2.29|Standard Deviation|2.28|2.28|||
3781337|NCT01880593|3612130|B2|||CSSRS (lifetime)|The Columbia-Suicide Severity Rating Scale (C-SSRS) - Full range from 0 (low intensity suicidal ideation to 9 (high intensity suicidal ideation).|units on a scale|Mean|2.06|2.06|Standard Deviation|2.02|2.02|||
3781338|NCT01880593|3612131|B1|||CSSRS (lifetime)|The Columbia-Suicide Severity Rating Scale (C-SSRS) - Full range from 0 (low intensity suicidal ideation to 9 (high intensity suicidal ideation).|units on a scale|Mean|2.5|2.5|Standard Deviation|2.7|2.7|||
3781339|NCT01880593|3612129|B3|||HAM-A|Hamilton Anxiety Rating Scale (HAM-A). Each item is scored on a scale of 0 (not present) to 4 (severe), with a total score range of 0–56, where <17 indicates mild severity, 18–24 mild to moderate severity and 25–30 moderate to severe.|units on a scale|Mean|19.5|19.5|Standard Deviation|6.15|6.15|||
3781340|NCT01880593|3612130|B2|||HAM-A|Hamilton Anxiety Rating Scale (HAM-A). Each item is scored on a scale of 0 (not present) to 4 (severe), with a total score range of 0–56, where <17 indicates mild severity, 18–24 mild to moderate severity and 25–30 moderate to severe.|units on a scale|Mean|20.31|20.31|Standard Deviation|5.11|5.11|||
3781341|NCT01880593|3612131|B1|||HAM-A|Hamilton Anxiety Rating Scale (HAM-A). Each item is scored on a scale of 0 (not present) to 4 (severe), with a total score range of 0–56, where <17 indicates mild severity, 18–24 mild to moderate severity and 25–30 moderate to severe.|units on a scale|Mean|18.78|18.78|Standard Deviation|7.02|7.02|||
3781342|NCT01880593|3612129|B3|||BSS|BECK Scale for Suicidal Ideation (BSS) - 0-13 Minimal; 14-19 Mild; 20-28 Moderate; 29-63 Severe|units on a scale|Mean|7.24|7.24|Standard Deviation|8.10|8.1|||
3781343|NCT01880593|3612130|B2|||BSS|BECK Scale for Suicidal Ideation (BSS) - 0-13 Minimal; 14-19 Mild; 20-28 Moderate; 29-63 Severe|units on a scale|Mean|7.56|7.56|Standard Deviation|8.31|8.31|||
3781344|NCT01880593|3612131|B1|||BSS|BECK Scale for Suicidal Ideation (BSS) - 0-13 Minimal; 14-19 Mild; 20-28 Moderate; 29-63 Severe|units on a scale|Mean|5.89|5.89|Standard Deviation|7.71|7.71|||
3781345|NCT01880593|3612129|B3|||CGI-S|The Clinical Global Impression – Severity scale (CGI-S) is a 7-point scale that requires the clinician to rate the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis. Considering total clinical experience, a patient is assessed on severity of mental illness at the time of rating 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|units on a scale|Mean|4.92|4.92|Standard Deviation|.57|0.57|||
3781346|NCT01880593|3612130|B2|||CGI-S|The Clinical Global Impression – Severity scale (CGI-S) is a 7-point scale that requires the clinician to rate the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis. Considering total clinical experience, a patient is assessed on severity of mental illness at the time of rating 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|units on a scale|Mean|5|5.0|Standard Deviation|.52|0.52|||
3781347|NCT01880593|3612131|B1|||CGI-S|The Clinical Global Impression – Severity scale (CGI-S) is a 7-point scale that requires the clinician to rate the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis. Considering total clinical experience, a patient is assessed on severity of mental illness at the time of rating 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|units on a scale|Mean|4.66|4.66|Standard Deviation|.59|0.59|||
3781348|NCT01880593|3612129|B3|||QIDS|Quick Inventory of Depressive Symptomatology, Self-Report (QIDS-SR) score - Each item is rated 0 to 3. The total score ranges from 0 (no depression) - 27 (severe depression).|units on a scale|Mean|17.16|17.16|Standard Deviation|4.32|4.32|||
3781349|NCT01880593|3612130|B2|||QIDS|Quick Inventory of Depressive Symptomatology, Self-Report (QIDS-SR) score - Each item is rated 0 to 3. The total score ranges from 0 (no depression) - 27 (severe depression).|units on a scale|Mean|18.19|18.19|Standard Deviation|3.082|3.082|||
3781350|NCT01880593|3612131|B1|||QIDS|Quick Inventory of Depressive Symptomatology, Self-Report (QIDS-SR) score - Each item is rated 0 to 3. The total score ranges from 0 (no depression) - 27 (severe depression).|units on a scale|Mean|16.22|16.22|Standard Deviation|4.33|4.33|||
3781351|NCT01880593|3612129|B3|||MADRS|The Montgomery-Asberg Depression Rating Scale (MADRS) has 10-items which are based on mood symptoms over the past 7 days. Each items is scored 0 (normal) to 6 (severe depression) with overall score ranges from 0 (normal) to 60 (severe depression).|units on a scale|Mean|32.58|32.58|Standard Deviation|4.69|4.69|||
3781352|NCT01880593|3612130|B2|||MADRS|The Montgomery-Asberg Depression Rating Scale (MADRS) has 10-items which are based on mood symptoms over the past 7 days. Each items is scored 0 (normal) to 6 (severe depression) with overall score ranges from 0 (normal) to 60 (severe depression).|units on a scale|Mean|32.81|32.81|Standard Deviation|5.61|5.61|||
3781353|NCT01880593|3612131|B1|||MADRS|The Montgomery-Asberg Depression Rating Scale (MADRS) has 10-items which are based on mood symptoms over the past 7 days. Each items is scored 0 (normal) to 6 (severe depression) with overall score ranges from 0 (normal) to 60 (severe depression).|units on a scale|Mean|32.39|32.39|Standard Deviation|3.87|3.87|||
3781354|NCT01880593|3612129|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3781355|NCT01880593|3612130|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3781356|NCT01880593|3612131|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3781357|NCT01880593|3612129|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3781358|NCT01880593|3612130|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3781359|NCT01880593|3612131|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3781360|NCT01880593|3612129|B3|||Age||years|Mean|45.41|45.41|Standard Deviation|11.70|11.7|||
3781361|NCT01880593|3612130|B2|||Age||years|Mean|45.87|45.87|Standard Deviation|10.94|10.94|||
3781362|NCT01880593|3612131|B1|||Age||years|Mean|45|45.0|Standard Deviation|12.65|12.65|||
3781363|NCT01880515|3612150|B3|Mexico||Region of Enrollment||participants|Number|90|90.0||||||
3781364|NCT01880515|3612151|B2|Mexico||Region of Enrollment||participants|Number|45|45.0||||||
3781365|NCT01880515|3612152|B1|Mexico||Region of Enrollment||participants|Number|45|45.0||||||
3781366|NCT01880515|3612150|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3781367|NCT01880515|3612151|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3781368|NCT01880515|3612152|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3781369|NCT01880515|3612150|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3781370|NCT01880515|3612151|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3781371|NCT01880515|3612152|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3781372|NCT01880515|3612150|B3|||Age||years|Mean|57.05|57.05|Standard Deviation|14|14.0|||
3781373|NCT01880515|3612151|B2|||Age||years|Mean|56.6|56.6|Standard Deviation|14|14.0|||
3781374|NCT01880515|3612152|B1|||Age||years|Mean|57.5|57.5|Standard Deviation|14|14.0|||
3781375|NCT01880515|3612150|B3||>=65 years|Age||Participants|Count of Participants|66|66.0||||||
3781376|NCT01880515|3612151|B2||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
3781377|NCT01880515|3612152|B1||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
3781378|NCT01880515|3612150|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3781379|NCT01880515|3612151|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3781380|NCT01880515|3612152|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3781381|NCT01880515|3612150|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3781382|NCT01880515|3612151|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3781383|NCT01880515|3612152|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3781384|NCT01880437|3612161|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3781385|NCT01880437|3612162|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3781386|NCT01880437|3612163|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3781387|NCT01880437|3612164|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3781388|NCT01880437|3612161|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3781389|NCT01880437|3612162|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3781390|NCT01880437|3612163|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3781391|NCT01880437|3612164|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3781392|NCT01880437|3612161|B4|||Age||years|Mean|63.1|63.1|Standard Deviation|16.9|16.9|||
3781393|NCT01880437|3612162|B3|||Age||years|Mean|66.2|66.2|Standard Deviation|14.7|14.7|||
3781394|NCT01880437|3612163|B2|||Age||years|Mean|54.5|54.5|Standard Deviation|5.9|5.9|||
3781395|NCT01880437|3612164|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|20.7|20.7|||
3781396|NCT01880424|3612190|B3|United States||countries||Participants|Number|133|133.0||||||
3781397|NCT01880424|3612191|B2|United States||countries||Participants|Number|69|69.0||||||
3781398|NCT01880424|3612192|B1|United States||countries||Participants|Number|64|64.0||||||
3781399|NCT01880424|3612190|B3|New Zealand||countries||Participants|Number|8|8.0||||||
3781400|NCT01880424|3612191|B2|New Zealand||countries||Participants|Number|4|4.0||||||
3781401|NCT01880424|3612192|B1|New Zealand||countries||Participants|Number|4|4.0||||||
3781402|NCT01880424|3612190|B3|Australia||countries||Participants|Number|33|33.0||||||
3781403|NCT01880424|3612191|B2|Australia||countries||Participants|Number|14|14.0||||||
3781404|NCT01880424|3612192|B1|Australia||countries||Participants|Number|19|19.0||||||
3781405|NCT01880424|3612190|B3|Canada||countries||Participants|Number|6|6.0||||||
3781406|NCT01880424|3612191|B2|Canada||countries||Participants|Number|3|3.0||||||
3781407|NCT01880424|3612192|B1|Canada||countries||Participants|Number|3|3.0||||||
3781408|NCT01880424|3612190|B3|China||countries||Participants|Number|659|659.0||||||
3781409|NCT01880424|3612191|B2|China||countries||Participants|Number|332|332.0||||||
3781410|NCT01880424|3612192|B1|China||countries||Participants|Number|327|327.0||||||
3781411|NCT01880424|3612190|B3||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3781412|NCT01880424|3612191|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3781413|NCT01880424|3612192|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3781414|NCT01880424|3612190|B3||Female|Sex: Female, Male||Participants|Count of Participants|688|688.0||||||
3781415|NCT01880424|3612191|B2||Female|Sex: Female, Male||Participants|Count of Participants|355|355.0||||||
3781416|NCT01880424|3612192|B1||Female|Sex: Female, Male||Participants|Count of Participants|333|333.0||||||
3781417|NCT01880424|3612190|B3|>= 65 years||Age, Customized||participants|Number|34|34.0||||||
3781418|NCT01880424|3612191|B2|>= 65 years||Age, Customized||participants|Number|17|17.0||||||
3781419|NCT01880424|3612192|B1|>= 65 years||Age, Customized||participants|Number|17|17.0||||||
3781420|NCT01880424|3612190|B3|between 18 to 65 years||Age, Customized||participants|Number|805|805.0||||||
3781421|NCT01880424|3612191|B2|between 18 to 65 years||Age, Customized||participants|Number|405|405.0||||||
3781422|NCT01880424|3612192|B1|between 18 to 65 years||Age, Customized||participants|Number|400|400.0||||||
3781423|NCT01880424|3612190|B3|||Age||years|Mean|41.1|41.1|Standard Deviation|13.3|13.3|||
3781424|NCT01880424|3612191|B2|||Age||years|Mean|41.3|41.3|Standard Deviation|13.5|13.5|||
3781425|NCT01880424|3612192|B1|||Age||years|Mean|41.0|41.0|Standard Deviation|13.1|13.1|||
3781426|NCT01880320|3612215|B4|Baseline IGA = Severe (4)||Baseline Investigator Global Assessment (IGA)||participants|Number|252|252.0||||||
3781427|NCT01880320|3612216|B3|Baseline IGA = Severe (4)||Baseline Investigator Global Assessment (IGA)||participants|Number|34|34.0||||||
3781428|NCT01880320|3612217|B2|Baseline IGA = Severe (4)||Baseline Investigator Global Assessment (IGA)||participants|Number|112|112.0||||||
3781429|NCT01880320|3612218|B1|Baseline IGA = Severe (4)||Baseline Investigator Global Assessment (IGA)||participants|Number|106|106.0||||||
3781430|NCT01880320|3612215|B4|Baseline IGA = Moderate (3)||Baseline Investigator Global Assessment (IGA)||participants|Number|251|251.0||||||
3781431|NCT01880320|3612216|B3|Baseline IGA = Moderate (3)||Baseline Investigator Global Assessment (IGA)||participants|Number|35|35.0||||||
3781432|NCT01880320|3612217|B2|Baseline IGA = Moderate (3)||Baseline Investigator Global Assessment (IGA)||participants|Number|105|105.0||||||
3781433|NCT01880320|3612218|B1|Baseline IGA = Moderate (3)||Baseline Investigator Global Assessment (IGA)||participants|Number|111|111.0||||||
3781434|NCT01880320|3612215|B4|United States||Region of Enrollment||participants|Number|465|465.0||||||
3781435|NCT01880320|3612216|B3|United States||Region of Enrollment||participants|Number|64|64.0||||||
3781436|NCT01880320|3612217|B2|United States||Region of Enrollment||participants|Number|201|201.0||||||
3781437|NCT01880320|3612218|B1|United States||Region of Enrollment||participants|Number|200|200.0||||||
3781438|NCT01880320|3612215|B4|Canada||Region of Enrollment||participants|Number|38|38.0||||||
3781439|NCT01880320|3612216|B3|Canada||Region of Enrollment||participants|Number|5|5.0||||||
3781440|NCT01880320|3612217|B2|Canada||Region of Enrollment||participants|Number|16|16.0||||||
3781441|NCT01880320|3612218|B1|Canada||Region of Enrollment||participants|Number|17|17.0||||||
3781442|NCT01880320|3612215|B4||Male|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
3781443|NCT01880320|3612216|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3781444|NCT01880320|3612217|B2||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3781445|NCT01880320|3612218|B1||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3781446|NCT01880320|3612215|B4||Female|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
3781447|NCT01880320|3612216|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3781448|NCT01880320|3612217|B2||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3781449|NCT01880320|3612218|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3781450|NCT01880320|3612215|B4|||Age||years|Mean|19.6|19.6|Standard Deviation|7.01|7.01|||
3781451|NCT01880320|3612216|B3|||Age||years|Mean|18.5|18.5|Standard Deviation|5.72|5.72|||
3781452|NCT01880320|3612217|B2|||Age||years|Mean|19.4|19.4|Standard Deviation|6.75|6.75|||
3781453|NCT01880320|3612218|B1|||Age||years|Mean|20.1|20.1|Standard Deviation|7.59|7.59|||
3781454|NCT01880320|3612215|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3781455|NCT01880320|3612216|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3781456|NCT01880320|3612217|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3781457|NCT01880320|3612218|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3781458|NCT01880320|3612215|B4||Between 18 and 65 years|Age||Participants|Count of Participants|200|200.0||||||
3781459|NCT01880320|3612216|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3781460|NCT01880320|3612217|B2||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
3781461|NCT01880320|3612218|B1||Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
3781462|NCT01880320|3612215|B4||<=18 years|Age||Participants|Count of Participants|303|303.0||||||
3781463|NCT01880320|3612216|B3||<=18 years|Age||Participants|Count of Participants|43|43.0||||||
3781464|NCT01880320|3612217|B2||<=18 years|Age||Participants|Count of Participants|136|136.0||||||
3781465|NCT01880320|3612218|B1||<=18 years|Age||Participants|Count of Participants|124|124.0||||||
3781466|NCT01880099|3612234|B4|United States||Region of Enrollment||participants|Number|60|60.0||||||
3781467|NCT01880099|3612235|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
3781468|NCT01880099|3612236|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
3781469|NCT01880099|3612237|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3781470|NCT01880099|3612234|B4||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3781471|NCT01880099|3612235|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3781472|NCT01880099|3612236|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3781473|NCT01880099|3612237|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3781474|NCT01880099|3612234|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3781475|NCT01880099|3612235|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3781476|NCT01880099|3612236|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3781477|NCT01880099|3612237|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3781478|NCT01880099|3612234|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3781479|NCT01880099|3612235|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3781480|NCT01880099|3612236|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3781481|NCT01880099|3612237|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3781482|NCT01880099|3612234|B4||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3781483|NCT01880099|3612235|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3781484|NCT01880099|3612236|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3781485|NCT01880099|3612237|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3781486|NCT01880099|3612234|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3781487|NCT01880099|3612235|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3781488|NCT01880099|3612236|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3781489|NCT01880099|3612237|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3781490|NCT01880086|3612247|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781491|NCT01880086|3612248|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781492|NCT01880086|3612249|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781493|NCT01880086|3612247|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781494|NCT01880086|3612248|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781495|NCT01880086|3612249|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781496|NCT01880086|3612247|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3781497|NCT01880086|3612248|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3781498|NCT01880086|3612249|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3781499|NCT01880086|3612247|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3781500|NCT01880086|3612248|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3781501|NCT01880086|3612249|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3781502|NCT01880086|3612247|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781503|NCT01880086|3612248|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781504|NCT01880086|3612249|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781505|NCT01880086|3612247|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781506|NCT01880086|3612248|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781507|NCT01880086|3612249|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781508|NCT01880086|3612247|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3781509|NCT01880086|3612248|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781510|NCT01880086|3612249|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3781511|NCT01880086|3612247|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3781512|NCT01880086|3612248|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3781513|NCT01880086|3612249|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3781514|NCT01880086|3612247|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3781515|NCT01880086|3612248|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3781516|NCT01880086|3612249|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3781517|NCT01880086|3612247|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3781518|NCT01880086|3612248|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3781519|NCT01880086|3612249|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3781520|NCT01880086|3612247|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3781521|NCT01880086|3612248|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3781522|NCT01880086|3612249|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3781523|NCT01880086|3612247|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3781524|NCT01880086|3612248|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3781525|NCT01880086|3612249|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3781526|NCT01879852|3612268|B3|||Weight||kg|Mean|89.8|89.8|Standard Deviation|26.7|26.7|||
3781527|NCT01879852|3612269|B2|||Weight||kg|Mean|100.9|100.9|Standard Deviation|30.1|30.1|||
3781528|NCT01879852|3612270|B1|||Weight||kg|Mean|78.7|78.7|Standard Deviation|13.2|13.2|||
3781529|NCT01879852|3612268|B3|||Height||cm|Mean|178.5|178.5|Standard Deviation|8.7|8.7|||
3781530|NCT01879852|3612269|B2|||Height||cm|Mean|180.1|180.1|Standard Deviation|8.8|8.8|||
3781531|NCT01879852|3612270|B1|||Height||cm|Mean|176.9|176.9|Standard Deviation|8.5|8.5|||
3781532|NCT01879852|3612268|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781533|NCT01879852|3612269|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781534|NCT01879852|3612270|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781535|NCT01879852|3612268|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3781536|NCT01879852|3612269|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3781537|NCT01879852|3612270|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3781538|NCT01879852|3612268|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3781539|NCT01879852|3612269|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3781540|NCT01879852|3612270|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3781541|NCT01879852|3612268|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781542|NCT01879852|3612269|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781543|NCT01879852|3612270|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781544|NCT01879852|3612268|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781545|NCT01879852|3612269|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781546|NCT01879852|3612270|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781547|NCT01879852|3612268|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3781548|NCT01879852|3612269|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3781549|NCT01879852|3612270|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3781550|NCT01879852|3612268|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3781551|NCT01879852|3612269|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3781552|NCT01879852|3612270|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3781553|NCT01879852|3612268|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781554|NCT01879852|3612269|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781555|NCT01879852|3612270|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781556|NCT01879852|3612268|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3781557|NCT01879852|3612269|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3781558|NCT01879852|3612270|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781559|NCT01879852|3612268|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781560|NCT01879852|3612269|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781561|NCT01879852|3612270|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781562|NCT01879852|3612268|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3781563|NCT01879852|3612269|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3781564|NCT01879852|3612270|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3781565|NCT01879852|3612268|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3781566|NCT01879852|3612269|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3781567|NCT01879852|3612270|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3781568|NCT01879852|3612268|B3|||Age||years|Mean|20.4|20.4|Standard Deviation|4|4.0|||
3781569|NCT01879852|3612269|B2|||Age||years|Mean|18.3|18.3|Standard Deviation|2.8|2.8|||
3781570|NCT01879852|3612270|B1|||Age||years|Mean|22.5|22.5|Standard Deviation|5.2|5.2|||
3781571|NCT01879800|3612283|B3|Not on Antidepressants||On Antidepressant medication||participants|Number|20|20.0||||||
3781572|NCT01879800|3612284|B2|Not on Antidepressants||On Antidepressant medication||participants|Number|15|15.0||||||
3781573|NCT01879800|3612285|B1|Not on Antidepressants||On Antidepressant medication||participants|Number|5|5.0||||||
3781574|NCT01879800|3612283|B3|On Antidepressants||On Antidepressant medication||participants|Number|24|24.0||||||
3781575|NCT01879800|3612284|B2|On Antidepressants||On Antidepressant medication||participants|Number|15|15.0||||||
3781576|NCT01879800|3612285|B1|On Antidepressants||On Antidepressant medication||participants|Number|9|9.0||||||
3781577|NCT01879800|3612283|B3|Unemployed||Employed||Participants|Number|8|8.0||||||
3781578|NCT01879800|3612284|B2|Unemployed||Employed||Participants|Number|4|4.0||||||
3781579|NCT01879800|3612285|B1|Unemployed||Employed||Participants|Number|4|4.0||||||
3781580|NCT01879800|3612283|B3|Employed||Employed||Participants|Number|36|36.0||||||
3781581|NCT01879800|3612284|B2|Employed||Employed||Participants|Number|26|26.0||||||
3781582|NCT01879800|3612285|B1|Employed||Employed||Participants|Number|10|10.0||||||
3781583|NCT01879800|3612283|B3|Did Not Complete College||Completed College||Participants|Number|13|13.0||||||
3781584|NCT01879800|3612284|B2|Did Not Complete College||Completed College||Participants|Number|9|9.0||||||
3781585|NCT01879800|3612285|B1|Did Not Complete College||Completed College||Participants|Number|4|4.0||||||
3781586|NCT01879800|3612283|B3|Completed College||Completed College||Participants|Number|31|31.0||||||
3781587|NCT01879800|3612284|B2|Completed College||Completed College||Participants|Number|21|21.0||||||
3781588|NCT01879800|3612285|B1|Completed College||Completed College||Participants|Number|10|10.0||||||
3781589|NCT01879800|3612283|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
3781590|NCT01879800|3612284|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3781591|NCT01879800|3612285|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3781592|NCT01879800|3612283|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3781593|NCT01879800|3612284|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3781594|NCT01879800|3612285|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3781595|NCT01879800|3612283|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3781596|NCT01879800|3612284|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3781597|NCT01879800|3612285|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3781598|NCT01879800|3612283|B3|||Age||Years|Mean|45|45.0|Full Range|||18.0|64.0|
3781599|NCT01879800|3612284|B2|||Age||Years|Mean|45|45.0|Full Range|||18.0|64.0|
3781600|NCT01879800|3612285|B1|||Age||Years|Mean|45|45.0|Full Range|||18.0|64.0|
3781601|NCT01879800|3612283|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3781602|NCT01879800|3612284|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3781603|NCT01879800|3612285|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3781604|NCT01879800|3612283|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3781605|NCT01879800|3612284|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3781606|NCT01879800|3612285|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3781607|NCT01879800|3612283|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3781608|NCT01879800|3612284|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3781609|NCT01879800|3612285|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3781610|NCT01879735|3612296|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781611|NCT01879735|3612297|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781612|NCT01879735|3612298|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781613|NCT01879735|3612296|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781614|NCT01879735|3612297|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781615|NCT01879735|3612298|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781616|NCT01879735|3612296|B3||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3781617|NCT01879735|3612297|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3781618|NCT01879735|3612298|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3781619|NCT01879735|3612296|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781620|NCT01879735|3612297|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781621|NCT01879735|3612298|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781622|NCT01879735|3612296|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781623|NCT01879735|3612297|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781624|NCT01879735|3612298|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781625|NCT01879735|3612296|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781626|NCT01879735|3612297|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781627|NCT01879735|3612298|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781628|NCT01879735|3612296|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781629|NCT01879735|3612297|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781630|NCT01879735|3612298|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3781631|NCT01879735|3612296|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3781632|NCT01879735|3612297|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3781633|NCT01879735|3612298|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3781634|NCT01879735|3612296|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3781635|NCT01879735|3612297|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3781636|NCT01879735|3612298|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3781637|NCT01879735|3612296|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3781638|NCT01879735|3612297|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3781639|NCT01879735|3612298|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3781640|NCT01879735|3612296|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3781641|NCT01879735|3612297|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3781642|NCT01879735|3612298|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3781643|NCT01879735|3612296|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3781644|NCT01879735|3612297|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3781645|NCT01879735|3612298|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3781646|NCT01879722|3612305|B11|Ex-smoker||Smoking Classification||participants|Number|19|19.0||||||
3781647|NCT01879722|3612306|B10|Ex-smoker||Smoking Classification||participants|Number|4|4.0||||||
3781648|NCT01879722|3612307|B9|Ex-smoker||Smoking Classification||participants|Number|3|3.0||||||
3781649|NCT01879722|3612308|B8|Ex-smoker||Smoking Classification||participants|Number|6|6.0||||||
3781650|NCT01879722|3612309|B7|Ex-smoker||Smoking Classification||participants|Number|1|1.0||||||
3781651|NCT01879722|3612310|B6|Ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3781652|NCT01879722|3612311|B5|Ex-smoker||Smoking Classification||participants|Number|1|1.0||||||
3781653|NCT01879722|3612312|B4|Ex-smoker||Smoking Classification||participants|Number|1|1.0||||||
3781654|NCT01879722|3612313|B3|Ex-smoker||Smoking Classification||participants|Number|1|1.0||||||
3781655|NCT01879722|3612314|B2|Ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3781656|NCT01879722|3612315|B1|Ex-smoker||Smoking Classification||participants|Number|2|2.0||||||
3781657|NCT01879722|3612305|B11|Current smoker||Smoking Classification||participants|Number|38|38.0||||||
3781658|NCT01879722|3612306|B10|Current smoker||Smoking Classification||participants|Number|0|0.0||||||
3781659|NCT01879722|3612307|B9|Current smoker||Smoking Classification||participants|Number|0|0.0||||||
3781660|NCT01879722|3612308|B8|Current smoker||Smoking Classification||participants|Number|0|0.0||||||
3781661|NCT01879722|3612309|B7|Current smoker||Smoking Classification||participants|Number|0|0.0||||||
3781662|NCT01879722|3612310|B6|Current smoker||Smoking Classification||participants|Number|8|8.0||||||
3781663|NCT01879722|3612311|B5|Current smoker||Smoking Classification||participants|Number|7|7.0||||||
3781664|NCT01879722|3612312|B4|Current smoker||Smoking Classification||participants|Number|5|5.0||||||
3781665|NCT01879722|3612313|B3|Current smoker||Smoking Classification||participants|Number|6|6.0||||||
3781666|NCT01879722|3612314|B2|Current smoker||Smoking Classification||participants|Number|7|7.0||||||
3781667|NCT01879722|3612315|B1|Current smoker||Smoking Classification||participants|Number|5|5.0||||||
3781668|NCT01879722|3612305|B11|Never smoked||Smoking Classification||participants|Number|20|20.0||||||
3781669|NCT01879722|3612306|B10|Never smoked||Smoking Classification||participants|Number|2|2.0||||||
3781670|NCT01879722|3612307|B9|Never smoked||Smoking Classification||participants|Number|5|5.0||||||
3781671|NCT01879722|3612308|B8|Never smoked||Smoking Classification||participants|Number|2|2.0||||||
3781672|NCT01879722|3612309|B7|Never smoked||Smoking Classification||participants|Number|7|7.0||||||
3781673|NCT01879722|3612310|B6|Never smoked||Smoking Classification||participants|Number|1|1.0||||||
3781674|NCT01879722|3612311|B5|Never smoked||Smoking Classification||participants|Number|0|0.0||||||
3781675|NCT01879722|3612312|B4|Never smoked||Smoking Classification||participants|Number|2|2.0||||||
3781676|NCT01879722|3612313|B3|Never smoked||Smoking Classification||participants|Number|0|0.0||||||
3781677|NCT01879722|3612314|B2|Never smoked||Smoking Classification||participants|Number|1|1.0||||||
3781678|NCT01879722|3612315|B1|Never smoked||Smoking Classification||participants|Number|0|0.0||||||
3781679|NCT01879722|3612305|B11|No||Caffeine Consumption||participants|Number|30|30.0||||||
3781680|NCT01879722|3612306|B10|No||Caffeine Consumption||participants|Number|3|3.0||||||
3781681|NCT01879722|3612307|B9|No||Caffeine Consumption||participants|Number|2|2.0||||||
3781682|NCT01879722|3612308|B8|No||Caffeine Consumption||participants|Number|4|4.0||||||
3781683|NCT01879722|3612309|B7|No||Caffeine Consumption||participants|Number|5|5.0||||||
3781684|NCT01879722|3612310|B6|No||Caffeine Consumption||participants|Number|1|1.0||||||
3781685|NCT01879722|3612311|B5|No||Caffeine Consumption||participants|Number|6|6.0||||||
3781686|NCT01879722|3612312|B4|No||Caffeine Consumption||participants|Number|3|3.0||||||
3781687|NCT01879722|3612313|B3|No||Caffeine Consumption||participants|Number|2|2.0||||||
3781688|NCT01879722|3612314|B2|No||Caffeine Consumption||participants|Number|0|0.0||||||
3781689|NCT01879722|3612315|B1|No||Caffeine Consumption||participants|Number|4|4.0||||||
3781690|NCT01879722|3612305|B11|Yes||Caffeine Consumption||participants|Number|47|47.0||||||
3781691|NCT01879722|3612306|B10|Yes||Caffeine Consumption||participants|Number|3|3.0||||||
3781692|NCT01879722|3612307|B9|Yes||Caffeine Consumption||participants|Number|6|6.0||||||
3781693|NCT01879722|3612308|B8|Yes||Caffeine Consumption||participants|Number|4|4.0||||||
3781694|NCT01879722|3612309|B7|Yes||Caffeine Consumption||participants|Number|3|3.0||||||
3781695|NCT01879722|3612310|B6|Yes||Caffeine Consumption||participants|Number|8|8.0||||||
3781696|NCT01879722|3612311|B5|Yes||Caffeine Consumption||participants|Number|2|2.0||||||
3781697|NCT01879722|3612312|B4|Yes||Caffeine Consumption||participants|Number|5|5.0||||||
3781698|NCT01879722|3612313|B3|Yes||Caffeine Consumption||participants|Number|5|5.0||||||
3781699|NCT01879722|3612314|B2|Yes||Caffeine Consumption||participants|Number|8|8.0||||||
3781700|NCT01879722|3612315|B1|Yes||Caffeine Consumption||participants|Number|3|3.0||||||
3781701|NCT01879722|3612305|B11|||Body Mass Index (BMI)||kg/m^2|Mean|26.93|26.93|Standard Deviation|4.812|4.812|||
3781702|NCT01879722|3612306|B10|||Body Mass Index (BMI)||kg/m^2|Mean|22.23|22.23|Standard Deviation|2.778|2.778|||
3781703|NCT01879722|3612307|B9|||Body Mass Index (BMI)||kg/m^2|Mean|24.14|24.14|Standard Deviation|1.984|1.984|||
3781704|NCT01879722|3612308|B8|||Body Mass Index (BMI)||kg/m^2|Mean|22.65|22.65|Standard Deviation|2.556|2.556|||
3781705|NCT01879722|3612309|B7|||Body Mass Index (BMI)||kg/m^2|Mean|24.75|24.75|Standard Deviation|1.962|1.962|||
3781706|NCT01879722|3612310|B6|||Body Mass Index (BMI)||kg/m^2|Mean|28.80|28.8|Standard Deviation|5.710|5.71|||
3781707|NCT01879722|3612311|B5|||Body Mass Index (BMI)||kg/m^2|Mean|27.76|27.76|Standard Deviation|4.460|4.46|||
3781708|NCT01879722|3612312|B4|||Body Mass Index (BMI)||kg/m^2|Mean|32.16|32.16|Standard Deviation|4.243|4.243|||
3781709|NCT01879722|3612313|B3|||Body Mass Index (BMI)||kg/m^2|Mean|27.93|27.93|Standard Deviation|5.488|5.488|||
3781710|NCT01879722|3612314|B2|||Body Mass Index (BMI)||kg/m^2|Mean|26.98|26.98|Standard Deviation|3.476|3.476|||
3781711|NCT01879722|3612315|B1|||Body Mass Index (BMI)||kg/m^2|Mean|31.13|31.13|Standard Deviation|3.266|3.266|||
3781712|NCT01879722|3612305|B11|||Weight||kg|Mean|78.70|78.7|Standard Deviation|14.666|14.666|||
3781713|NCT01879722|3612306|B10|||Weight||kg|Mean|63.50|63.5|Standard Deviation|10.037|10.037|||
3781714|NCT01879722|3612307|B9|||Weight||kg|Mean|70.19|70.19|Standard Deviation|6.879|6.879|||
3781715|NCT01879722|3612308|B8|||Weight||kg|Mean|67.45|67.45|Standard Deviation|8.128|8.128|||
3781716|NCT01879722|3612309|B7|||Weight||kg|Mean|73.98|73.98|Standard Deviation|10.503|10.503|||
3781717|NCT01879722|3612310|B6|||Weight||kg|Mean|86.46|86.46|Standard Deviation|17.422|17.422|||
3781718|NCT01879722|3612311|B5|||Weight||kg|Mean|83.51|83.51|Standard Deviation|11.853|11.853|||
3781719|NCT01879722|3612312|B4|||Weight||kg|Mean|88.83|88.83|Standard Deviation|12.805|12.805|||
3781720|NCT01879722|3612313|B3|||Weight||kg|Mean|83.76|83.76|Standard Deviation|19.701|19.701|||
3781721|NCT01879722|3612314|B2|||Weight||kg|Mean|74.75|74.75|Standard Deviation|8.543|8.543|||
3781722|NCT01879722|3612315|B1|||Weight||kg|Mean|92.09|92.09|Standard Deviation|10.138|10.138|||
3781723|NCT01879722|3612305|B11|||Height||cm|Mean|171.0|171.0|Standard Deviation|8.44|8.44|||
3781724|NCT01879722|3612306|B10|||Height||cm|Mean|168.8|168.8|Standard Deviation|6.49|6.49|||
3781725|NCT01879722|3612307|B9|||Height||cm|Mean|171.8|171.8|Standard Deviation|7.46|7.46|||
3781726|NCT01879722|3612308|B8|||Height||cm|Mean|170.5|170.5|Standard Deviation|7.21|7.21|||
3781727|NCT01879722|3612309|B7|||Height||cm|Mean|172.5|172.5|Standard Deviation|10.35|10.35|||
3781728|NCT01879722|3612310|B6|||Height||cm|Mean|173.3|173.3|Standard Deviation|10.95|10.95|||
3781729|NCT01879722|3612311|B5|||Height||cm|Mean|173.9|173.9|Standard Deviation|8.82|8.82|||
3781730|NCT01879722|3612312|B4|||Height||cm|Mean|166.3|166.3|Standard Deviation|7.70|7.7|||
3781731|NCT01879722|3612313|B3|||Height||cm|Mean|172.6|172.6|Standard Deviation|9.61|9.61|||
3781732|NCT01879722|3612314|B2|||Height||cm|Mean|166.8|166.8|Standard Deviation|7.89|7.89|||
3781733|NCT01879722|3612315|B1|||Height||cm|Mean|172.1|172.1|Standard Deviation|9.19|9.19|||
3781734|NCT01879722|3612305|B11|United States||Region of Enrollment||participants|Number|77|77.0||||||
3781735|NCT01879722|3612306|B10|United States||Region of Enrollment||participants|Number|6|6.0||||||
3781736|NCT01879722|3612307|B9|United States||Region of Enrollment||participants|Number|8|8.0||||||
3781737|NCT01879722|3612308|B8|United States||Region of Enrollment||participants|Number|8|8.0||||||
3781738|NCT01879722|3612309|B7|United States||Region of Enrollment||participants|Number|8|8.0||||||
3781739|NCT01879722|3612310|B6|United States||Region of Enrollment||participants|Number|9|9.0||||||
3781740|NCT01879722|3612311|B5|United States||Region of Enrollment||participants|Number|8|8.0||||||
3781741|NCT01879722|3612312|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
3781742|NCT01879722|3612313|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
3781743|NCT01879722|3612314|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3781744|NCT01879722|3612315|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3781745|NCT01879722|3612305|B11|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3781746|NCT01879722|3612306|B10|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3781747|NCT01879722|3612307|B9|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3781748|NCT01879722|3612308|B8|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3781749|NCT01879722|3612309|B7|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3781750|NCT01879722|3612310|B6|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3781751|NCT01879722|3612311|B5|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3781752|NCT01879722|3612312|B4|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3781753|NCT01879722|3612313|B3|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3781754|NCT01879722|3612314|B2|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3781755|NCT01879722|3612315|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3781756|NCT01879722|3612305|B11|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3781757|NCT01879722|3612306|B10|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3781758|NCT01879722|3612307|B9|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3781759|NCT01879722|3612308|B8|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3781760|NCT01879722|3612309|B7|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3781761|NCT01879722|3612310|B6|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3781762|NCT01879722|3612311|B5|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3781763|NCT01879722|3612312|B4|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3781764|NCT01879722|3612313|B3|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3781765|NCT01879722|3612314|B2|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3781766|NCT01879722|3612315|B1|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3781767|NCT01879722|3612305|B11|Black or African American||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
3781768|NCT01879722|3612306|B10|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3781769|NCT01879722|3612307|B9|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3781770|NCT01879722|3612308|B8|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3781771|NCT01879722|3612309|B7|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3781772|NCT01879722|3612310|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3781773|NCT01879722|3612311|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3781774|NCT01879722|3612312|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3781775|NCT01879722|3612313|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3781776|NCT01879722|3612314|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3781777|NCT01879722|3612315|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3781778|NCT01879722|3612305|B11|Asian||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3781779|NCT01879722|3612306|B10|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3781780|NCT01879722|3612307|B9|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3781781|NCT01879722|3612308|B8|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3781782|NCT01879722|3612309|B7|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3781783|NCT01879722|3612310|B6|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3781784|NCT01879722|3612311|B5|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3781785|NCT01879722|3612312|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3781786|NCT01879722|3612313|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3781787|NCT01879722|3612314|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3781788|NCT01879722|3612315|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3781789|NCT01879722|3612305|B11|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|73|73.0||||||
3781790|NCT01879722|3612306|B10|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3781791|NCT01879722|3612307|B9|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3781792|NCT01879722|3612308|B8|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3781793|NCT01879722|3612309|B7|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3781794|NCT01879722|3612310|B6|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3781795|NCT01879722|3612311|B5|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3781796|NCT01879722|3612312|B4|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3781797|NCT01879722|3612313|B3|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3781798|NCT01879722|3612314|B2|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3781799|NCT01879722|3612315|B1|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3781800|NCT01879722|3612305|B11|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3781801|NCT01879722|3612306|B10|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3781802|NCT01879722|3612307|B9|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3781803|NCT01879722|3612308|B8|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3781804|NCT01879722|3612309|B7|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3781805|NCT01879722|3612310|B6|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3781806|NCT01879722|3612311|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3781807|NCT01879722|3612312|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3781808|NCT01879722|3612313|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3781809|NCT01879722|3612314|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3781810|NCT01879722|3612315|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3781811|NCT01879722|3612305|B11||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3781812|NCT01879722|3612306|B10||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3781813|NCT01879722|3612307|B9||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3781814|NCT01879722|3612308|B8||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3781815|NCT01879722|3612309|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3781816|NCT01879722|3612310|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3781817|NCT01879722|3612311|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3781818|NCT01879722|3612312|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3781819|NCT01879722|3612313|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3781820|NCT01879722|3612314|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3781821|NCT01879722|3612315|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3781822|NCT01879722|3612305|B11||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3781823|NCT01879722|3612306|B10||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||11.52|11.52|||
3781824|NCT01879722|3612307|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||10.61|10.61|||
3781825|NCT01879722|3612308|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||9.51|9.51|||
3781826|NCT01879722|3612309|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||9.78|9.78|||
3781827|NCT01879722|3612310|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3781828|NCT01879722|3612311|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||NA||||
3781829|NCT01879722|3612312|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||NA||||
3781830|NCT01879722|3612313|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||NA||||
3781831|NCT01879722|3612314|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||NA||||
3781832|NCT01879722|3612315|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||NA||||
3781833|NCT01879722|3612305|B11|||Age||years|Mean|39.0|39.0|Standard Deviation|10.52|10.52|||
3781834|NCT01879722|3612306|B10|||Age||years|Mean|38.5|38.5|Standard Deviation|11.52|11.52|||
3781835|NCT01879722|3612307|B9|||Age||years|Mean|34.6|34.6|Standard Deviation|10.61|10.61|||
3781836|NCT01879722|3612308|B8|||Age||years|Mean|25.9|25.9|Standard Deviation|9.51|9.51|||
3781837|NCT01879722|3612309|B7|||Age||years|Mean|36.3|36.3|Standard Deviation|9.78|9.78|||
3781838|NCT01879722|3612310|B6|||Age||years|Mean|43.1|43.1|Standard Deviation|11.34|11.34|||
3781839|NCT01879722|3612311|B5|||Age||years|Mean|39.4|39.4|Standard Deviation|8.14|8.14|||
3781840|NCT01879722|3612312|B4|||Age||years|Mean|45.3|45.3|Standard Deviation|8.19|8.19|||
3781841|NCT01879722|3612313|B3|||Age||years|Mean|44.6|44.6|Standard Deviation|9.00|9.0|||
3781842|NCT01879722|3612314|B2|||Age||years|Mean|39.6|39.6|Standard Deviation|9.90|9.9|||
3781843|NCT01879722|3612315|B1|||Age||years|Mean|43.4|43.4|Standard Deviation|4.20|4.2|||
3781844|NCT01879683|3612472|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3781845|NCT01879683|3612472|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3781846|NCT01879683|3612472|B1|||Age||years|Mean|57.2|57.2|Standard Deviation|9.16|9.16|||
3781847|NCT01879618|3612479|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3781848|NCT01879618|3612479|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3781849|NCT01879618|3612479|B1|||Age||Years|Mean|57.1|57.1|Standard Deviation|14.7|14.7|||
3781850|NCT01879579|3612484|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3781851|NCT01879579|3612485|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3781852|NCT01879579|3612486|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3781853|NCT01879579|3612484|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3781854|NCT01879579|3612485|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3781855|NCT01879579|3612486|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3781856|NCT01879579|3612484|B3|||Age||years|Mean|46.70|46.7|Standard Deviation|10.75|10.75|||
3781857|NCT01879579|3612485|B2|||Age||years|Mean|44.61|44.61|Standard Deviation|9.97|9.97|||
3781858|NCT01879579|3612486|B1|||Age||years|Mean|48.48|48.48|Standard Deviation|11.22|11.22|||
3781859|NCT01879553|3612515|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3781860|NCT01879553|3612516|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3781861|NCT01879553|3612517|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3781862|NCT01879553|3612515|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3781863|NCT01879553|3612516|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3781864|NCT01879553|3612517|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3781865|NCT01879553|3612515|B3|||Age||year|Mean|50.9|50.9|Standard Deviation|21.2|21.2|||
3781866|NCT01879553|3612516|B2|||Age||year|Mean|70.2|70.2|Standard Deviation|5.7|5.7|||
3781867|NCT01879553|3612517|B1|||Age||year|Mean|31.6|31.6|Standard Deviation|10.7|10.7|||
3781868|NCT01879540|3612539|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3781869|NCT01879540|3612539|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3781870|NCT01879540|3612539|B1|||Age||year|Mean|71.9|71.9|Standard Deviation|5.0|5.0|||
3781871|NCT01879410|3612550|B3|American Indian or Alaska Native & White||Race/Ethnicity, Customized||Particpants|Number|8|8.0||||||
3781872|NCT01879410|3612551|B2|American Indian or Alaska Native & White||Race/Ethnicity, Customized||Particpants|Number|5|5.0||||||
3781873|NCT01879410|3612552|B1|American Indian or Alaska Native & White||Race/Ethnicity, Customized||Particpants|Number|3|3.0||||||
3781874|NCT01879410|3612550|B3|White||Race/Ethnicity, Customized||Particpants|Number|643|643.0||||||
3781875|NCT01879410|3612551|B2|White||Race/Ethnicity, Customized||Particpants|Number|326|326.0||||||
3781876|NCT01879410|3612552|B1|White||Race/Ethnicity, Customized||Particpants|Number|317|317.0||||||
3781877|NCT01879410|3612550|B3|Asian||Race/Ethnicity, Customized||Particpants|Number|6|6.0||||||
3781878|NCT01879410|3612551|B2|Asian||Race/Ethnicity, Customized||Particpants|Number|2|2.0||||||
3781879|NCT01879410|3612552|B1|Asian||Race/Ethnicity, Customized||Particpants|Number|4|4.0||||||
3781880|NCT01879410|3612550|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Particpants|Number|9|9.0||||||
3781881|NCT01879410|3612551|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Particpants|Number|2|2.0||||||
3781882|NCT01879410|3612552|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Particpants|Number|7|7.0||||||
3781883|NCT01879410|3612550|B3|African American/African Heritage||Race/Ethnicity, Customized||Particpants|Number|31|31.0||||||
3781884|NCT01879410|3612551|B2|African American/African Heritage||Race/Ethnicity, Customized||Particpants|Number|13|13.0||||||
3781885|NCT01879410|3612552|B1|African American/African Heritage||Race/Ethnicity, Customized||Particpants|Number|18|18.0||||||
3781886|NCT01879410|3612550|B3||Male|Sex: Female, Male||Participants|Count of Participants|528|528.0||||||
3781887|NCT01879410|3612551|B2||Male|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
3781888|NCT01879410|3612552|B1||Male|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
3781889|NCT01879410|3612550|B3||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3781890|NCT01879410|3612551|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3781891|NCT01879410|3612552|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3781892|NCT01879410|3612550|B3|||Age||Years|Mean|63.6|63.6|Standard Deviation|8.55|8.55|||
3781893|NCT01879410|3612551|B2|||Age||Years|Mean|64.0|64.0|Standard Deviation|8.53|8.53|||
3781894|NCT01879410|3612552|B1|||Age||Years|Mean|63.2|63.2|Standard Deviation|8.57|8.57|||
3781895|NCT01879371|3612561|B7||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3781896|NCT01879371|3612562|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3781897|NCT01879371|3612563|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3781898|NCT01879371|3612564|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3781899|NCT01879371|3612565|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3781900|NCT01879371|3612566|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3781901|NCT01879371|3612567|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3781902|NCT01879371|3612561|B7||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3781903|NCT01879371|3612562|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3781904|NCT01879371|3612563|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3781905|NCT01879371|3612564|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3781906|NCT01879371|3612565|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3781907|NCT01879371|3612566|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3781908|NCT01879371|3612567|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3781909|NCT01879371|3612561|B7|||Age||years|Mean|39.0|39.0|Standard Deviation|6.2|6.2|||
3781910|NCT01879371|3612562|B6|||Age||years|Mean|38.3|38.3|Standard Deviation|7.1|7.1|||
3781911|NCT01879371|3612563|B5|||Age||years|Mean|37.5|37.5|Standard Deviation|9.2|9.2|||
3781912|NCT01879371|3612564|B4|||Age||years|Mean|40.2|40.2|Standard Deviation|3.8|3.8|||
3781913|NCT01879371|3612565|B3|||Age||years|Mean|42.8|42.8|Standard Deviation|4.5|4.5|||
3781914|NCT01879371|3612566|B2|||Age||years|Mean|36.3|36.3|Standard Deviation|3.3|3.3|||
3781915|NCT01879371|3612567|B1|||Age||years|Mean|38.7|38.7|Standard Deviation|7.6|7.6|||
3781916|NCT01879345|3612586|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3781917|NCT01879345|3612587|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3781918|NCT01879345|3612588|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3781919|NCT01879345|3612589|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3781920|NCT01879345|3612586|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3781921|NCT01879345|3612587|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3781922|NCT01879345|3612588|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3781923|NCT01879345|3612589|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3781924|NCT01879345|3612586|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3781925|NCT01879345|3612587|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3781926|NCT01879345|3612588|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3781927|NCT01879345|3612589|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3781928|NCT01879345|3612586|B4||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3781929|NCT01879345|3612587|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3781930|NCT01879345|3612588|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3781931|NCT01879345|3612589|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3781932|NCT01879345|3612586|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3781933|NCT01879345|3612587|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3781934|NCT01879345|3612588|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3781935|NCT01879345|3612589|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3781936|NCT01879332|3612605|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3781937|NCT01879332|3612606|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3781938|NCT01879332|3612607|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3781939|NCT01879332|3612608|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3781940|NCT01879332|3612605|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3781941|NCT01879332|3612606|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3781942|NCT01879332|3612607|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3781943|NCT01879332|3612608|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3781944|NCT01879332|3612605|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3781945|NCT01879332|3612606|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3781946|NCT01879332|3612607|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3781947|NCT01879332|3612608|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3781948|NCT01879332|3612605|B4||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3781949|NCT01879332|3612606|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3781950|NCT01879332|3612607|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3781951|NCT01879332|3612608|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3781952|NCT01879332|3612605|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3781953|NCT01879332|3612606|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3781954|NCT01879332|3612607|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3781955|NCT01879332|3612608|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3781956|NCT01879319|3612618|B3|||LDL-C Concentration||mg/dL|Mean|116.3|116.3|Standard Deviation|25.4|25.4|||
3781957|NCT01879319|3612619|B2|||LDL-C Concentration||mg/dL|Mean|117.3|117.3|Standard Deviation|23.9|23.9|||
3781958|NCT01879319|3612620|B1|||LDL-C Concentration||mg/dL|Mean|115.3|115.3|Standard Deviation|27.0|27.0|||
3781959|NCT01879319|3612618|B3|≥ 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|45|45.0||||||
3781960|NCT01879319|3612619|B2|≥ 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|23|23.0||||||
3781961|NCT01879319|3612620|B1|≥ 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|22|22.0||||||
3781962|NCT01879319|3612618|B3|< 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|119|119.0||||||
3781963|NCT01879319|3612619|B2|< 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|59|59.0||||||
3781964|NCT01879319|3612620|B1|< 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|60|60.0||||||
3781965|NCT01879319|3612618|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|154|154.0||||||
3781966|NCT01879319|3612619|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
3781967|NCT01879319|3612620|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|78|78.0||||||
3781968|NCT01879319|3612618|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3781969|NCT01879319|3612619|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3781970|NCT01879319|3612620|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3781971|NCT01879319|3612618|B3|Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3781972|NCT01879319|3612619|B2|Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3781973|NCT01879319|3612620|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3781974|NCT01879319|3612618|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3781975|NCT01879319|3612619|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3781976|NCT01879319|3612620|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3781977|NCT01879319|3612618|B3|White||Race/Ethnicity, Customized||participants|Number|144|144.0||||||
3781978|NCT01879319|3612619|B2|White||Race/Ethnicity, Customized||participants|Number|75|75.0||||||
3781979|NCT01879319|3612620|B1|White||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
3781980|NCT01879319|3612618|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3781981|NCT01879319|3612619|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3781982|NCT01879319|3612620|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3781983|NCT01879319|3612618|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3781984|NCT01879319|3612619|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3781985|NCT01879319|3612620|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3781986|NCT01879319|3612618|B3|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3781987|NCT01879319|3612619|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3781988|NCT01879319|3612620|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3781989|NCT01879319|3612618|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3781990|NCT01879319|3612619|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3781991|NCT01879319|3612620|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3781992|NCT01879319|3612618|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3781993|NCT01879319|3612619|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3781994|NCT01879319|3612620|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3781995|NCT01879319|3612618|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3781996|NCT01879319|3612619|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3781997|NCT01879319|3612620|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3781998|NCT01879319|3612618|B3|||Age||years|Mean|59.7|59.7|Standard Deviation|10.2|10.2|||
3781999|NCT01879319|3612619|B2|||Age||years|Mean|59.2|59.2|Standard Deviation|10.0|10.0|||
3782000|NCT01879319|3612620|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|10.5|10.5|||
3782001|NCT01879176|3612629|B3|Austria||Region of Enrollment||participants|Number|37|37.0||||||
3782002|NCT01879176|3612630|B2|Austria||Region of Enrollment||participants|Number|18|18.0||||||
3782003|NCT01879176|3612631|B1|Austria||Region of Enrollment||participants|Number|19|19.0||||||
3782004|NCT01879176|3612629|B3||Male|Gender||Participants|Count of Participants|26|26.0||||||
3782005|NCT01879176|3612630|B2||Male|Gender||Participants|Count of Participants|14|14.0||||||
3782006|NCT01879176|3612631|B1||Male|Gender||Participants|Count of Participants|12|12.0||||||
3782007|NCT01879176|3612629|B3||Female|Gender||Participants|Count of Participants|11|11.0||||||
3782008|NCT01879176|3612630|B2||Female|Gender||Participants|Count of Participants|4|4.0||||||
3782009|NCT01879176|3612631|B1||Female|Gender||Participants|Count of Participants|7|7.0||||||
3782010|NCT01879176|3612629|B3|||Age||years|Mean|67|67.0|Full Range|||30.0|81.0|
3782011|NCT01879176|3612630|B2|||Age||years|Mean|69|69.0|Full Range|||50.0|81.0|
3782012|NCT01879176|3612631|B1|||Age||years|Mean|64|64.0|Full Range|||30.0|81.0|
3782013|NCT01879072|3612638|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3782014|NCT01879072|3612638|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3782015|NCT01879072|3612638|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1370|1370.0||||||
3782016|NCT01879072|3612638|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|203|203.0||||||
3782017|NCT01879072|3612638|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3782018|NCT01879072|3612638|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3782019|NCT01879072|3612638|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3782020|NCT01879072|3612638|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3782021|NCT01879072|3612638|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1552|1552.0||||||
3782022|NCT01879072|3612638|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
3782023|NCT01879072|3612638|B1||Male|Sex: Female, Male||Participants|Count of Participants|1008|1008.0||||||
3782024|NCT01879072|3612638|B1||Female|Sex: Female, Male||Participants|Count of Participants|701|701.0||||||
3782025|NCT01879072|3612638|B1|||Age||years|Median|52.7|52.7|Full Range|||0.5|77.3|
3782026|NCT01879059|3612642|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3782027|NCT01879059|3612642|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3782028|NCT01879059|3612642|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3782029|NCT01879059|3612642|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3782030|NCT01879059|3612642|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3782031|NCT01879059|3612642|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3782032|NCT01879059|3612642|B1|||Age||years|Mean|24|24.0|Standard Deviation|3|3.0|||
3782033|NCT01878825|3612646|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3782034|NCT01878825|3612647|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3782035|NCT01878825|3612648|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3782036|NCT01878825|3612646|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3782037|NCT01878825|3612647|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3782038|NCT01878825|3612648|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3782039|NCT01878825|3612646|B3|||Age||Years|Mean|54.9|54.9|Standard Deviation|16.42|16.42|||
3782040|NCT01878825|3612647|B2|||Age||Years|Mean|68.6|68.6|Standard Deviation|4.92|4.92|||
3782041|NCT01878825|3612648|B1|||Age||Years|Mean|41.1|41.1|Standard Deviation|11.63|11.63|||
3782042|NCT01878812|3612685|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3782043|NCT01878812|3612686|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3782044|NCT01878812|3612687|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3782045|NCT01878812|3612685|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3782046|NCT01878812|3612686|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3782047|NCT01878812|3612687|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3782048|NCT01878812|3612685|B3|||Age||Years|Mean|54.24|54.24|Standard Deviation|18.84|18.84|||
3782049|NCT01878812|3612686|B2|||Age||Years|Mean|70.6|70.6|Standard Deviation|6.81|6.81|||
3782050|NCT01878812|3612687|B1|||Age||Years|Mean|38.7|38.7|Standard Deviation|12.24|12.24|||
3782051|NCT01878799|3612722|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782052|NCT01878799|3612723|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782053|NCT01878799|3612724|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782054|NCT01878799|3612722|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782055|NCT01878799|3612723|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782056|NCT01878799|3612724|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782057|NCT01878799|3612722|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3782058|NCT01878799|3612723|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3782059|NCT01878799|3612724|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3782060|NCT01878799|3612722|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3782061|NCT01878799|3612723|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3782062|NCT01878799|3612724|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3782063|NCT01878799|3612722|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782064|NCT01878799|3612723|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782065|NCT01878799|3612724|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782066|NCT01878799|3612722|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782067|NCT01878799|3612723|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782068|NCT01878799|3612724|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782069|NCT01878799|3612722|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782070|NCT01878799|3612723|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782071|NCT01878799|3612724|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782072|NCT01878799|3612722|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782073|NCT01878799|3612723|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782074|NCT01878799|3612724|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782075|NCT01878799|3612722|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3782076|NCT01878799|3612723|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3782077|NCT01878799|3612724|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3782078|NCT01878799|3612722|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3782079|NCT01878799|3612723|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782080|NCT01878799|3612724|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3782081|NCT01878799|3612722|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3782082|NCT01878799|3612723|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3782083|NCT01878799|3612724|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3782084|NCT01878799|3612722|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3782085|NCT01878799|3612723|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3782086|NCT01878799|3612724|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3782087|NCT01878799|3612722|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3782088|NCT01878799|3612723|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3782089|NCT01878799|3612724|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3782090|NCT01878799|3612722|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3782091|NCT01878799|3612723|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3782092|NCT01878799|3612724|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3782093|NCT01878799|3612722|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3782094|NCT01878799|3612723|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3782095|NCT01878799|3612724|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3782096|NCT01878656|3612731|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3782097|NCT01878656|3612732|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3782098|NCT01878656|3612733|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3782099|NCT01878656|3612731|B3||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3782100|NCT01878656|3612732|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3782101|NCT01878656|3612733|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3782102|NCT01878656|3612731|B3|||Age||years|Median|23|23.0|Inter-Quartile Range|||21.0|27.0|
3782103|NCT01878656|3612732|B2|||Age||years|Median|23|23.0|Inter-Quartile Range|||21.0|27.0|
3782104|NCT01878656|3612733|B1|||Age||years|Median|23|23.0|Inter-Quartile Range|||21.0|27.0|
3782105|NCT01878604|3612740|B1|||plasma LDL cholesterol concentration||mmol/L|Mean|17.55|17.55|Standard Deviation|2.34|2.34|||
3782106|NCT01878604|3612740|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3782107|NCT01878604|3612740|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3782108|NCT01878604|3612740|B1|||Age||year|Mean|5|5.0|Standard Deviation|1|1.0|||
3782109|NCT01878526|3612745|B3|Thailand||Region of Enrollment||participants|Number|75|75.0||||||
3782110|NCT01878526|3612746|B2|Thailand||Region of Enrollment||participants|Number|38|38.0||||||
3782111|NCT01878526|3612747|B1|Thailand||Region of Enrollment||participants|Number|37|37.0||||||
3782112|NCT01878526|3612745|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3782113|NCT01878526|3612746|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3782114|NCT01878526|3612747|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3782115|NCT01878526|3612745|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3782116|NCT01878526|3612746|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3782117|NCT01878526|3612747|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3782118|NCT01878526|3612745|B3|||Age||years|Mean|48.9|48.9|Standard Deviation|10.3|10.3|||
3782119|NCT01878526|3612746|B2|||Age||years|Mean|46.7|46.7|Standard Deviation|12.5|12.5|||
3782120|NCT01878526|3612747|B1|||Age||years|Mean|49.6|49.6|Standard Deviation|9.5|9.5|||
3782121|NCT01878214|3612761|B3|United States||Region of Enrollment||participants|Number|442|442.0||||||
3782122|NCT01878214|3612762|B2|United States||Region of Enrollment||participants|Number|219|219.0||||||
3782123|NCT01878214|3612763|B1|United States||Region of Enrollment||participants|Number|223|223.0||||||
3782124|NCT01878214|3612761|B3||Male|Sex: Female, Male||Participants|Count of Participants|438|438.0||||||
3782125|NCT01878214|3612762|B2||Male|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
3782126|NCT01878214|3612763|B1||Male|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
3782127|NCT01878214|3612761|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3782128|NCT01878214|3612762|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3782129|NCT01878214|3612763|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3782130|NCT01878214|3612761|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3782131|NCT01878214|3612762|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3782132|NCT01878214|3612763|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3782133|NCT01878214|3612761|B3||Between 18 and 65 years|Age||Participants|Count of Participants|439|439.0||||||
3782134|NCT01878214|3612762|B2||Between 18 and 65 years|Age||Participants|Count of Participants|218|218.0||||||
3782135|NCT01878214|3612763|B1||Between 18 and 65 years|Age||Participants|Count of Participants|221|221.0||||||
3782136|NCT01878214|3612761|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3782137|NCT01878214|3612762|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3782138|NCT01878214|3612763|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3782139|NCT01878214|3612761|B3|||Age||years|Mean|35.33|35.33|Standard Deviation|11.44|11.44|||
3782140|NCT01878214|3612762|B2|||Age||years|Mean|35.18|35.18|Standard Deviation|11.54|11.54|||
3782141|NCT01878214|3612763|B1|||Age||years|Mean|35.64|35.64|Standard Deviation|11.54|11.54|||
3782142|NCT01878175|3612778|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3782143|NCT01878175|3612778|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782144|NCT01878175|3612778|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782145|NCT01878175|3612778|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3782146|NCT01878175|3612778|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3782147|NCT01878175|3612778|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782148|NCT01878175|3612778|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782149|NCT01878175|3612778|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782150|NCT01878175|3612778|B1||Male|Gender||Participants|Count of Participants|12|12.0||||||
3782151|NCT01878175|3612778|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
3782152|NCT01878175|3612778|B1|||Age||years|Mean|66.4|66.4|Standard Deviation|6.6|6.6|||
3782153|NCT01878149|3612795|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
3782154|NCT01878149|3612796|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3782155|NCT01878149|3612797|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3782156|NCT01878149|3612795|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3782157|NCT01878149|3612796|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3782158|NCT01878149|3612797|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3782159|NCT01878149|3612795|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3782160|NCT01878149|3612796|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3782161|NCT01878149|3612797|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3782162|NCT01878149|3612795|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3782163|NCT01878149|3612796|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3782164|NCT01878149|3612797|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3782165|NCT01878149|3612795|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3782166|NCT01878149|3612796|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3782167|NCT01878149|3612797|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3782168|NCT01878149|3612795|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3782169|NCT01878149|3612796|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3782170|NCT01878149|3612797|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3782171|NCT01878149|3612795|B3|||Age||years|Mean|62.21|62.21|Standard Deviation|12.36|12.36|||
3782172|NCT01878149|3612796|B2|||Age||years|Mean|63|63.0|Standard Deviation|12.35|12.35|||
3782173|NCT01878149|3612797|B1|||Age||years|Mean|61.63|61.63|Standard Deviation|13.13|13.13|||
3782174|NCT01878097|3612804|B3|Other||Race/Ethnicity, Customized||Percentage of Participants per School|Mean|3.23|3.23|Standard Deviation|2.8|2.8|||
3782175|NCT01878097|3612805|B2|Other||Race/Ethnicity, Customized||Percentage of Participants per School|Mean|2.67|2.67|Standard Deviation|2.21|2.21|||
3782176|NCT01878097|3612806|B1|Other||Race/Ethnicity, Customized||Percentage of Participants per School|Mean|3.78|3.78|Standard Deviation|3.28|3.28|||
3782177|NCT01878097|3612804|B3|White||Race/Ethnicity, Customized||Percentage of Participants per School|Mean|84.86|84.86|Standard Deviation|14.62|14.62|||
3782178|NCT01878097|3612805|B2|White||Race/Ethnicity, Customized||Percentage of Participants per School|Mean|87.22|87.22|Standard Deviation|11.93|11.93|||
3782179|NCT01878097|3612806|B1|White||Race/Ethnicity, Customized||Percentage of Participants per School|Mean|82.51|82.51|Standard Deviation|17.06|17.06|||
3782180|NCT01878097|3612804|B3|Hispanic or Latino/Latina||Race/Ethnicity, Customized||Percentage of Participants per School|Mean|2.23|2.23|Standard Deviation|2.37|2.37|||
3782181|NCT01878097|3612805|B2|Hispanic or Latino/Latina||Race/Ethnicity, Customized||Percentage of Participants per School|Mean|1.31|1.31|Standard Deviation|0.92|0.92|||
3782182|NCT01878097|3612806|B1|Hispanic or Latino/Latina||Race/Ethnicity, Customized||Percentage of Participants per School|Mean|3.16|3.16|Standard Deviation|2.99|2.99|||
3782183|NCT01878097|3612804|B3|Black or African American||Race/Ethnicity, Customized||Percentage of Participants per School|Mean|7.25|7.25|Standard Deviation|9.6|9.6|||
3782184|NCT01878097|3612805|B2|Black or African American||Race/Ethnicity, Customized||Percentage of Participants per School|Mean|6.47|6.47|Standard Deviation|8.65|8.65|||
3782185|NCT01878097|3612806|B1|Black or African American||Race/Ethnicity, Customized||Percentage of Participants per School|Mean|8.03|8.03|Standard Deviation|10.77|10.77|||
3782186|NCT01878097|3612804|B3|Asian||Race/Ethnicity, Customized||Percentage of Participants per School|Mean|1.32|1.32|Standard Deviation|1.33|1.33|||
3782187|NCT01878097|3612805|B2|Asian||Race/Ethnicity, Customized||Percentage of Participants per School|Mean|1.2|1.2|Standard Deviation|1.08|1.08|||
3782188|NCT01878097|3612806|B1|Asian||Race/Ethnicity, Customized||Percentage of Participants per School|Mean|1.44|1.44|Standard Deviation|1.59|1.59|||
3782189|NCT01878097|3612804|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Percentage of Participants per School|Mean|1.11|1.11|Standard Deviation|0.43|0.43|||
3782190|NCT01878097|3612805|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Percentage of Participants per School|Mean|1.13|1.13|Standard Deviation|0.27|0.27|||
3782191|NCT01878097|3612806|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Percentage of Participants per School|Mean|1.08|1.08|Standard Deviation|0.56|0.56|||
3782192|NCT01878097|3612804|B3|Male||Sex/Gender, Customized||Percentage of Participants per School|Mean|45.67|45.67|Standard Deviation|3.04|3.04|||
3782193|NCT01878097|3612805|B2|Male||Sex/Gender, Customized||Percentage of Participants per School|Mean|45.89|45.89|Standard Deviation|2.98|2.98|||
3782194|NCT01878097|3612806|B1|Male||Sex/Gender, Customized||Percentage of Participants per School|Mean|45.44|45.44|Standard Deviation|3.2|3.2|||
3782195|NCT01878097|3612804|B3|Female||Sex/Gender, Customized||Percentage of Participants per School|Mean|54.33|54.33|Standard Deviation|3.04|3.04|||
3782196|NCT01878097|3612805|B2|Female||Sex/Gender, Customized||Percentage of Participants per School|Mean|54.11|54.11|Standard Deviation|2.98|2.98|||
3782197|NCT01878097|3612806|B1|Female||Sex/Gender, Customized||Percentage of Participants per School|Mean|54.56|54.56|Standard Deviation|3.2|3.2|||
3782198|NCT01878097|3612804|B3|Year in School: Senior||Age, Customized||Percentage of Participants per School|Mean|16|16.0|Standard Deviation|8.83|8.83|||
3782199|NCT01878097|3612805|B2|Year in School: Senior||Age, Customized||Percentage of Participants per School|Mean|16.45|16.45|Standard Deviation|7.96|7.96|||
3782200|NCT01878097|3612806|B1|Year in School: Senior||Age, Customized||Percentage of Participants per School|Mean|15.54|15.54|Standard Deviation|9.94|9.94|||
3782201|NCT01878097|3612804|B3|Year in School: Junior||Age, Customized||Percentage of Participants per School|Mean|25.78|25.78|Standard Deviation|5.21|5.21|||
3782202|NCT01878097|3612805|B2|Year in School: Junior||Age, Customized||Percentage of Participants per School|Mean|26.37|26.37|Standard Deviation|4.52|4.52|||
3782203|NCT01878097|3612806|B1|Year in School: Junior||Age, Customized||Percentage of Participants per School|Mean|25.2|25.2|Standard Deviation|5.95|5.95|||
3782204|NCT01878097|3612804|B3|Year in School: Sophomore||Age, Customized||Percentage of Participants per School|Mean|27.35|27.35|Standard Deviation|3.8|3.8|||
3782205|NCT01878097|3612805|B2|Year in School: Sophomore||Age, Customized||Percentage of Participants per School|Mean|26.72|26.72|Standard Deviation|3.69|3.69|||
3782206|NCT01878097|3612806|B1|Year in School: Sophomore||Age, Customized||Percentage of Participants per School|Mean|27.99|27.99|Standard Deviation|3.95|3.95|||
3782207|NCT01878097|3612804|B3|Year in School: First Year||Age, Customized||Percentage of Participants per School|Mean|30.69|30.69|Standard Deviation|4.48|4.48|||
3782208|NCT01878097|3612805|B2|Year in School: First Year||Age, Customized||Percentage of Participants per School|Mean|30.37|30.37|Standard Deviation|3.3|3.3|||
3782209|NCT01878097|3612806|B1|Year in School: First Year||Age, Customized||Percentage of Participants per School|Mean|31.1|31.1|Standard Deviation|5.54|5.54|||
3782210|NCT01878006|3612817|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782211|NCT01878006|3612817|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3782212|NCT01878006|3612817|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3782213|NCT01878006|3612817|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3782214|NCT01878006|3612817|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782215|NCT01878006|3612817|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782216|NCT01878006|3612817|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782217|NCT01878006|3612817|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782218|NCT01878006|3612817|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3782219|NCT01878006|3612817|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782220|NCT01878006|3612817|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3782221|NCT01878006|3612817|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3782222|NCT01878006|3612817|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3782223|NCT01878006|3612817|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3782224|NCT01878006|3612817|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3782225|NCT01877941|3612838|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
3782226|NCT01877941|3612838|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3782227|NCT01877941|3612838|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3782228|NCT01877941|3612838|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3782229|NCT01877941|3612838|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3782230|NCT01877941|3612838|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3782231|NCT01877941|3612838|B1|||Age||years|Mean|65|65.0|Inter-Quartile Range|||55.0|80.0|
3782232|NCT01877720|3612844|B1|||Birth weight||g|Median|790|790.0|Inter-Quartile Range|||675.0|1215.0|
3782233|NCT01877720|3612844|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3782234|NCT01877720|3612844|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3782235|NCT01877720|3612844|B1|Postnatal age at study||Age||day|Median|25|25.0|Inter-Quartile Range|||17.5|32.0|
3782236|NCT01877720|3612844|B1|Gestational age||Age||weeks of gestation|Median|27.1|27.1|Inter-Quartile Range|||26.0|28.2|
3782237|NCT01877668|3612869|B6||Male|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
3782238|NCT01877668|3612870|B5||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3782239|NCT01877668|3612871|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3782240|NCT01877668|3612872|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3782241|NCT01877668|3612873|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3782242|NCT01877668|3612874|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3782243|NCT01877668|3612869|B6||Female|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
3782244|NCT01877668|3612870|B5||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3782245|NCT01877668|3612871|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3782246|NCT01877668|3612872|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3782247|NCT01877668|3612873|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3782248|NCT01877668|3612874|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3782249|NCT01877668|3612869|B6|||Age||Years|Mean|47.9|47.9|Standard Deviation|12.1|12.1|||
3782250|NCT01877668|3612870|B5|||Age||Years|Mean|49.3|49.3|Standard Deviation|13.8|13.8|||
3782251|NCT01877668|3612871|B4|||Age||Years|Mean|46.1|46.1|Standard Deviation|10.4|10.4|||
3782252|NCT01877668|3612872|B3|||Age||Years|Mean|47.4|47.4|Standard Deviation|11.3|11.3|||
3782253|NCT01877668|3612873|B2|||Age||Years|Mean|46.9|46.9|Standard Deviation|12.4|12.4|||
3782254|NCT01877668|3612874|B1|||Age||Years|Mean|49.4|49.4|Standard Deviation|12.6|12.6|||
3782255|NCT01877655|3613107|B3|||Body Mass Index (BMI)||kg/m^2|Mean|26.5|26.5|Standard Deviation|5.06|5.06|||
3782256|NCT01877655|3613108|B2|||Body Mass Index (BMI)||kg/m^2|Mean|26.0|26.0|Standard Deviation|5.05|5.05|||
3782257|NCT01877655|3613109|B1|||Body Mass Index (BMI)||kg/m^2|Mean|27.0|27.0|Standard Deviation|5.02|5.02|||
3782258|NCT01877655|3613107|B3|||Height||Centimeteres|Mean|170.2|170.2|Standard Deviation|9.90|9.9|||
3782259|NCT01877655|3613108|B2|||Height||Centimeteres|Mean|169.7|169.7|Standard Deviation|9.88|9.88|||
3782260|NCT01877655|3613109|B1|||Height||Centimeteres|Mean|170.6|170.6|Standard Deviation|9.91|9.91|||
3782261|NCT01877655|3613107|B3|No||Antithymocyte Globulin (ATG) Use||Participants|Count of Participants|426|426.0||||||
3782262|NCT01877655|3613108|B2|No||Antithymocyte Globulin (ATG) Use||Participants|Count of Participants|208|208.0||||||
3782263|NCT01877655|3613109|B1|No||Antithymocyte Globulin (ATG) Use||Participants|Count of Participants|218|218.0||||||
3782264|NCT01877655|3613107|B3|Yes||Antithymocyte Globulin (ATG) Use||Participants|Count of Participants|88|88.0||||||
3782265|NCT01877655|3613108|B2|Yes||Antithymocyte Globulin (ATG) Use||Participants|Count of Participants|43|43.0||||||
3782266|NCT01877655|3613109|B1|Yes||Antithymocyte Globulin (ATG) Use||Participants|Count of Participants|45|45.0||||||
3782267|NCT01877655|3613107|B3|Missing||Conditioning Regimen||Participants|Count of Participants|17|17.0||||||
3782268|NCT01877655|3613108|B2|Missing||Conditioning Regimen||Participants|Count of Participants|7|7.0||||||
3782269|NCT01877655|3613109|B1|Missing||Conditioning Regimen||Participants|Count of Participants|10|10.0||||||
3782270|NCT01877655|3613107|B3|Non-Myeloablative||Conditioning Regimen||Participants|Count of Participants|255|255.0||||||
3782271|NCT01877655|3613108|B2|Non-Myeloablative||Conditioning Regimen||Participants|Count of Participants|124|124.0||||||
3782272|NCT01877655|3613109|B1|Non-Myeloablative||Conditioning Regimen||Participants|Count of Participants|131|131.0||||||
3782273|NCT01877655|3613107|B3|Myeloablative||Conditioning Regimen||Participants|Count of Participants|242|242.0||||||
3782274|NCT01877655|3613108|B2|Myeloablative||Conditioning Regimen||Participants|Count of Participants|120|120.0||||||
3782275|NCT01877655|3613109|B1|Myeloablative||Conditioning Regimen||Participants|Count of Participants|122|122.0||||||
3782276|NCT01877655|3613107|B3|Missing||Primary Diagnosis||Participants|Count of Participants|1|1.0||||||
3782277|NCT01877655|3613108|B2|Missing||Primary Diagnosis||Participants|Count of Participants|1|1.0||||||
3782278|NCT01877655|3613109|B1|Missing||Primary Diagnosis||Participants|Count of Participants|0|0.0||||||
3782279|NCT01877655|3613107|B3|Lymphoma||Primary Diagnosis||Participants|Count of Participants|64|64.0||||||
3782280|NCT01877655|3613108|B2|Lymphoma||Primary Diagnosis||Participants|Count of Participants|31|31.0||||||
3782281|NCT01877655|3613109|B1|Lymphoma||Primary Diagnosis||Participants|Count of Participants|33|33.0||||||
3782282|NCT01877655|3613107|B3|Primary or Secondary Myelofibrosis||Primary Diagnosis||Participants|Count of Participants|19|19.0||||||
3782283|NCT01877655|3613108|B2|Primary or Secondary Myelofibrosis||Primary Diagnosis||Participants|Count of Participants|11|11.0||||||
3782284|NCT01877655|3613109|B1|Primary or Secondary Myelofibrosis||Primary Diagnosis||Participants|Count of Participants|8|8.0||||||
3782285|NCT01877655|3613107|B3|Myelodysplastic Syndrome||Primary Diagnosis||Participants|Count of Participants|97|97.0||||||
3782286|NCT01877655|3613108|B2|Myelodysplastic Syndrome||Primary Diagnosis||Participants|Count of Participants|51|51.0||||||
3782287|NCT01877655|3613109|B1|Myelodysplastic Syndrome||Primary Diagnosis||Participants|Count of Participants|46|46.0||||||
3782288|NCT01877655|3613107|B3|Chronic Lymphocytic Leukemia (CLL)||Primary Diagnosis||Participants|Count of Participants|17|17.0||||||
3782289|NCT01877655|3613108|B2|Chronic Lymphocytic Leukemia (CLL)||Primary Diagnosis||Participants|Count of Participants|10|10.0||||||
3782290|NCT01877655|3613109|B1|Chronic Lymphocytic Leukemia (CLL)||Primary Diagnosis||Participants|Count of Participants|7|7.0||||||
3782291|NCT01877655|3613107|B3|Chronic Myelogenous Leukemia (CML)||Primary Diagnosis||Participants|Count of Participants|18|18.0||||||
3782292|NCT01877655|3613108|B2|Chronic Myelogenous Leukemia (CML)||Primary Diagnosis||Participants|Count of Participants|12|12.0||||||
3782293|NCT01877655|3613109|B1|Chronic Myelogenous Leukemia (CML)||Primary Diagnosis||Participants|Count of Participants|6|6.0||||||
3782294|NCT01877655|3613107|B3|Acute Biphenotypic Leukemia (ABL)||Primary Diagnosis||Participants|Count of Participants|4|4.0||||||
3782295|NCT01877655|3613108|B2|Acute Biphenotypic Leukemia (ABL)||Primary Diagnosis||Participants|Count of Participants|2|2.0||||||
3782296|NCT01877655|3613109|B1|Acute Biphenotypic Leukemia (ABL)||Primary Diagnosis||Participants|Count of Participants|2|2.0||||||
3782297|NCT01877655|3613107|B3|Acute Undifferentiated Leukemia (AUL)||Primary Diagnosis||Participants|Count of Participants|3|3.0||||||
3782298|NCT01877655|3613108|B2|Acute Undifferentiated Leukemia (AUL)||Primary Diagnosis||Participants|Count of Participants|2|2.0||||||
3782299|NCT01877655|3613109|B1|Acute Undifferentiated Leukemia (AUL)||Primary Diagnosis||Participants|Count of Participants|1|1.0||||||
3782300|NCT01877655|3613107|B3|Acute Lymphoblastic Leukemia (ALL)||Primary Diagnosis||Participants|Count of Participants|68|68.0||||||
3782301|NCT01877655|3613108|B2|Acute Lymphoblastic Leukemia (ALL)||Primary Diagnosis||Participants|Count of Participants|34|34.0||||||
3782302|NCT01877655|3613109|B1|Acute Lymphoblastic Leukemia (ALL)||Primary Diagnosis||Participants|Count of Participants|34|34.0||||||
3782303|NCT01877655|3613107|B3|Acute Myeloid Leukemia (AML)||Primary Diagnosis||Participants|Count of Participants|223|223.0||||||
3782304|NCT01877655|3613108|B2|Acute Myeloid Leukemia (AML)||Primary Diagnosis||Participants|Count of Participants|97|97.0||||||
3782305|NCT01877655|3613109|B1|Acute Myeloid Leukemia (AML)||Primary Diagnosis||Participants|Count of Participants|126|126.0||||||
3782306|NCT01877655|3613107|B3|Non-related Seronegative Donor||Strata||Participants|Count of Participants|151|151.0||||||
3782307|NCT01877655|3613108|B2|Non-related Seronegative Donor||Strata||Participants|Count of Participants|79|79.0||||||
3782308|NCT01877655|3613109|B1|Non-related Seronegative Donor||Strata||Participants|Count of Participants|72|72.0||||||
3782309|NCT01877655|3613107|B3|Non-related Seropositive Donor||Strata||Participants|Count of Participants|169|169.0||||||
3782310|NCT01877655|3613108|B2|Non-related Seropositive Donor||Strata||Participants|Count of Participants|73|73.0||||||
3782311|NCT01877655|3613109|B1|Non-related Seropositive Donor||Strata||Participants|Count of Participants|96|96.0||||||
3782312|NCT01877655|3613107|B3|Related Seronegative Donor||Strata||Participants|Count of Participants|56|56.0||||||
3782313|NCT01877655|3613108|B2|Related Seronegative Donor||Strata||Participants|Count of Participants|26|26.0||||||
3782314|NCT01877655|3613109|B1|Related Seronegative Donor||Strata||Participants|Count of Participants|30|30.0||||||
3782315|NCT01877655|3613107|B3|Related Seropositive Donor||Strata||Participants|Count of Participants|138|138.0||||||
3782316|NCT01877655|3613108|B2|Related Seropositive Donor||Strata||Participants|Count of Participants|73|73.0||||||
3782317|NCT01877655|3613109|B1|Related Seropositive Donor||Strata||Participants|Count of Participants|65|65.0||||||
3782318|NCT01877655|3613107|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3782319|NCT01877655|3613108|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3782320|NCT01877655|3613109|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3782321|NCT01877655|3613107|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782322|NCT01877655|3613108|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782323|NCT01877655|3613109|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782324|NCT01877655|3613107|B3||White|Race (NIH/OMB)||Participants|Count of Participants|366|366.0||||||
3782325|NCT01877655|3613108|B2||White|Race (NIH/OMB)||Participants|Count of Participants|177|177.0||||||
3782326|NCT01877655|3613109|B1||White|Race (NIH/OMB)||Participants|Count of Participants|189|189.0||||||
3782327|NCT01877655|3613107|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3782328|NCT01877655|3613108|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3782329|NCT01877655|3613109|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3782330|NCT01877655|3613107|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782331|NCT01877655|3613108|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782332|NCT01877655|3613109|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782333|NCT01877655|3613107|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
3782334|NCT01877655|3613108|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3782335|NCT01877655|3613109|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3782336|NCT01877655|3613107|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782337|NCT01877655|3613108|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782338|NCT01877655|3613109|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782339|NCT01877655|3613107|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782340|NCT01877655|3613108|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782341|NCT01877655|3613109|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782342|NCT01877655|3613107|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|484|484.0||||||
3782343|NCT01877655|3613108|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|232|232.0||||||
3782344|NCT01877655|3613109|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|252|252.0||||||
3782345|NCT01877655|3613107|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3782346|NCT01877655|3613108|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3782347|NCT01877655|3613109|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3782348|NCT01877655|3613107|B3||Male|Sex: Female, Male||Participants|Count of Participants|299|299.0||||||
3782349|NCT01877655|3613108|B2||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3782350|NCT01877655|3613109|B1||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3782351|NCT01877655|3613107|B3||Female|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
3782352|NCT01877655|3613108|B2||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3782353|NCT01877655|3613109|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3782354|NCT01877655|3613107|B3|||Age||Year|Mean|51.9|51.9|Standard Deviation|12.78|12.78|||
3782355|NCT01877655|3613108|B2|||Age||Year|Mean|51.8|51.8|Standard Deviation|12.41|12.41|||
3782356|NCT01877655|3613109|B1|||Age||Year|Mean|52.0|52.0|Standard Deviation|13.15|13.15|||
3782357|NCT01877642|3613126|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
3782358|NCT01877642|3613127|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
3782359|NCT01877642|3613128|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3782360|NCT01877642|3613126|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3782361|NCT01877642|3613127|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3782362|NCT01877642|3613128|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3782363|NCT01877642|3613126|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3782364|NCT01877642|3613127|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3782365|NCT01877642|3613128|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3782366|NCT01877642|3613126|B3|||Age||years|Mean|30.8|30.8|Standard Deviation|9.30|9.3|||
3782367|NCT01877642|3613127|B2|||Age||years|Mean|30.4|30.4|Standard Deviation|9.46|9.46|||
3782368|NCT01877642|3613128|B1|||Age||years|Mean|32.5|32.5|Standard Deviation|9.68|9.68|||
3782369|NCT01877642|3613126|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3782370|NCT01877642|3613127|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3782371|NCT01877642|3613128|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3782372|NCT01877642|3613126|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3782373|NCT01877642|3613127|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3782374|NCT01877642|3613128|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3782375|NCT01877642|3613126|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3782376|NCT01877642|3613127|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3782377|NCT01877642|3613128|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3782378|NCT01877564|3613155|B3|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3782379|NCT01877564|3613156|B2|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3782380|NCT01877564|3613157|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3782381|NCT01877564|3613155|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3782382|NCT01877564|3613156|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3782383|NCT01877564|3613157|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782384|NCT01877564|3613155|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782385|NCT01877564|3613156|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782386|NCT01877564|3613157|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782387|NCT01877564|3613155|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3782388|NCT01877564|3613156|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3782389|NCT01877564|3613157|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3782390|NCT01877564|3613155|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3782391|NCT01877564|3613156|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782392|NCT01877564|3613157|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3782393|NCT01877564|3613155|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782394|NCT01877564|3613156|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782395|NCT01877564|3613157|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782396|NCT01877564|3613155|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782397|NCT01877564|3613156|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782398|NCT01877564|3613157|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782399|NCT01877564|3613155|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782400|NCT01877564|3613156|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782401|NCT01877564|3613157|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782402|NCT01877564|3613155|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3782403|NCT01877564|3613156|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3782404|NCT01877564|3613157|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3782405|NCT01877564|3613155|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3782406|NCT01877564|3613156|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3782407|NCT01877564|3613157|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3782408|NCT01877564|3613155|B3|||Age||years|Mean|60.8|60.8|Full Range|||42.0|72.0|
3782409|NCT01877564|3613156|B2|||Age||years|Mean|61|61.0|Full Range|||58.0|63.0|
3782410|NCT01877564|3613157|B1|||Age||years|Mean|60.6|60.6|Full Range|||42.0|72.0|
3782411|NCT01877564|3613155|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3782412|NCT01877564|3613156|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3782413|NCT01877564|3613157|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3782414|NCT01877564|3613155|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3782415|NCT01877564|3613156|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3782416|NCT01877564|3613157|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3782417|NCT01877564|3613155|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3782418|NCT01877564|3613156|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3782419|NCT01877564|3613157|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3782420|NCT01877538|3613164|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3782421|NCT01877538|3613164|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3782422|NCT01877538|3613164|B1|||Age||years|Mean|64.7|64.7|Standard Deviation|6.3|6.3|||
3782423|NCT01877421|3613169|B33|United States||Region of Enrollment||participants|Number|135|135.0||||||
3782424|NCT01877421|3613170|B32|United States||Region of Enrollment||participants|Number|3|3.0||||||
3782425|NCT01877421|3613171|B31|United States||Region of Enrollment||participants|Number|7|7.0||||||
3782426|NCT01877421|3613172|B30|United States||Region of Enrollment||participants|Number|3|3.0||||||
3782427|NCT01877421|3613173|B29|United States||Region of Enrollment||participants|Number|7|7.0||||||
3782428|NCT01877421|3613174|B28|United States||Region of Enrollment||participants|Number|3|3.0||||||
3782429|NCT01877421|3613175|B27|United States||Region of Enrollment||participants|Number|7|7.0||||||
3782430|NCT01877421|3613176|B26|United States||Region of Enrollment||participants|Number|3|3.0||||||
3782431|NCT01877421|3613177|B25|United States||Region of Enrollment||participants|Number|6|6.0||||||
3782432|NCT01877421|3613178|B24|United States||Region of Enrollment||participants|Number|2|2.0||||||
3782433|NCT01877421|3613179|B23|United States||Region of Enrollment||participants|Number|7|7.0||||||
3782434|NCT01877421|3613180|B22|United States||Region of Enrollment||participants|Number|3|3.0||||||
3782435|NCT01877421|3613181|B21|United States||Region of Enrollment||participants|Number|7|7.0||||||
3782436|NCT01877421|3613182|B20|United States||Region of Enrollment||participants|Number|2|2.0||||||
3782437|NCT01877421|3613183|B19|United States||Region of Enrollment||participants|Number|4|4.0||||||
3782438|NCT01877421|3613184|B18|United States||Region of Enrollment||participants|Number|3|3.0||||||
3782439|NCT01877421|3613185|B17|United States||Region of Enrollment||participants|Number|7|7.0||||||
3782440|NCT01877421|3613186|B16|United States||Region of Enrollment||participants|Number|3|3.0||||||
3782441|NCT01877421|3613187|B15|United States||Region of Enrollment||participants|Number|7|7.0||||||
3782442|NCT01877421|3613188|B14|United States||Region of Enrollment||participants|Number|3|3.0||||||
3782443|NCT01877421|3613189|B13|United States||Region of Enrollment||participants|Number|7|7.0||||||
3782444|NCT01877421|3613190|B12|United States||Region of Enrollment||participants|Number|3|3.0||||||
3782445|NCT01877421|3613191|B11|United States||Region of Enrollment||participants|Number|7|7.0||||||
3782446|NCT01877421|3613192|B10|United States||Region of Enrollment||participants|Number|3|3.0||||||
3782447|NCT01877421|3613193|B9|United States||Region of Enrollment||participants|Number|7|7.0||||||
3782448|NCT01877421|3613194|B8|United States||Region of Enrollment||participants|Number|2|2.0||||||
3782449|NCT01877421|3613195|B7|United States||Region of Enrollment||participants|Number|4|4.0||||||
3782450|NCT01877421|3613196|B6|United States||Region of Enrollment||participants|Number|2|2.0||||||
3782451|NCT01877421|3613197|B5|United States||Region of Enrollment||participants|Number|4|4.0||||||
3782452|NCT01877421|3613198|B4|United States||Region of Enrollment||participants|Number|2|2.0||||||
3782453|NCT01877421|3613199|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3782454|NCT01877421|3613200|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3782455|NCT01877421|3613201|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3782456|NCT01877421|3613169|B33||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782457|NCT01877421|3613170|B32||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782458|NCT01877421|3613171|B31||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782459|NCT01877421|3613172|B30||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782460|NCT01877421|3613173|B29||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782461|NCT01877421|3613174|B28||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782462|NCT01877421|3613175|B27||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782463|NCT01877421|3613176|B26||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782464|NCT01877421|3613177|B25||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782465|NCT01877421|3613178|B24||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782466|NCT01877421|3613179|B23||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782467|NCT01877421|3613180|B22||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782468|NCT01877421|3613181|B21||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782469|NCT01877421|3613182|B20||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782470|NCT01877421|3613183|B19||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782471|NCT01877421|3613184|B18||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782472|NCT01877421|3613185|B17||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782473|NCT01877421|3613186|B16||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782474|NCT01877421|3613187|B15||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782475|NCT01877421|3613188|B14||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782476|NCT01877421|3613189|B13||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782477|NCT01877421|3613190|B12||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782478|NCT01877421|3613191|B11||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782479|NCT01877421|3613192|B10||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782480|NCT01877421|3613193|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782481|NCT01877421|3613194|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782482|NCT01877421|3613195|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782483|NCT01877421|3613196|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782484|NCT01877421|3613197|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782485|NCT01877421|3613198|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782486|NCT01877421|3613199|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782487|NCT01877421|3613200|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782488|NCT01877421|3613201|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782489|NCT01877421|3613169|B33||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3782490|NCT01877421|3613170|B32||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3782491|NCT01877421|3613171|B31||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782492|NCT01877421|3613172|B30||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782493|NCT01877421|3613173|B29||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782494|NCT01877421|3613174|B28||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782495|NCT01877421|3613175|B27||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3782496|NCT01877421|3613176|B26||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782497|NCT01877421|3613177|B25||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782498|NCT01877421|3613178|B24||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782499|NCT01877421|3613179|B23||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782500|NCT01877421|3613180|B22||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782501|NCT01877421|3613181|B21||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782502|NCT01877421|3613182|B20||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782503|NCT01877421|3613183|B19||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3782504|NCT01877421|3613184|B18||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782505|NCT01877421|3613185|B17||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3782506|NCT01877421|3613186|B16||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782507|NCT01877421|3613187|B15||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782508|NCT01877421|3613188|B14||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782509|NCT01877421|3613189|B13||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782510|NCT01877421|3613190|B12||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782511|NCT01877421|3613191|B11||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782512|NCT01877421|3613192|B10||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782513|NCT01877421|3613193|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782514|NCT01877421|3613194|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782515|NCT01877421|3613195|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782516|NCT01877421|3613196|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782517|NCT01877421|3613197|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782518|NCT01877421|3613198|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782519|NCT01877421|3613199|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782520|NCT01877421|3613200|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782521|NCT01877421|3613201|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782522|NCT01877421|3613169|B33||White|Race (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3782523|NCT01877421|3613170|B32||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3782524|NCT01877421|3613171|B31||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3782525|NCT01877421|3613172|B30||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3782526|NCT01877421|3613173|B29||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3782527|NCT01877421|3613174|B28||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3782528|NCT01877421|3613175|B27||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3782529|NCT01877421|3613176|B26||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3782530|NCT01877421|3613177|B25||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3782531|NCT01877421|3613178|B24||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3782532|NCT01877421|3613179|B23||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3782533|NCT01877421|3613180|B22||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3782534|NCT01877421|3613181|B21||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3782535|NCT01877421|3613182|B20||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3782536|NCT01877421|3613183|B19||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3782537|NCT01877421|3613184|B18||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3782538|NCT01877421|3613185|B17||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3782539|NCT01877421|3613186|B16||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3782540|NCT01877421|3613187|B15||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3782541|NCT01877421|3613188|B14||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3782542|NCT01877421|3613189|B13||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3782543|NCT01877421|3613190|B12||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3782544|NCT01877421|3613191|B11||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3782545|NCT01877421|3613192|B10||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3782546|NCT01877421|3613193|B9||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3782547|NCT01877421|3613194|B8||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3782548|NCT01877421|3613195|B7||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3782549|NCT01877421|3613196|B6||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3782550|NCT01877421|3613197|B5||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3782551|NCT01877421|3613198|B4||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3782552|NCT01877421|3613199|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3782553|NCT01877421|3613200|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3782554|NCT01877421|3613201|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782555|NCT01877421|3613169|B33||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3782556|NCT01877421|3613170|B32||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782557|NCT01877421|3613171|B31||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3782558|NCT01877421|3613172|B30||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3782559|NCT01877421|3613173|B29||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782560|NCT01877421|3613174|B28||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782561|NCT01877421|3613175|B27||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3782562|NCT01877421|3613176|B26||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782563|NCT01877421|3613177|B25||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782564|NCT01877421|3613178|B24||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782565|NCT01877421|3613179|B23||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3782566|NCT01877421|3613180|B22||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3782567|NCT01877421|3613181|B21||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3782568|NCT01877421|3613182|B20||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782569|NCT01877421|3613183|B19||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3782570|NCT01877421|3613184|B18||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782571|NCT01877421|3613185|B17||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3782572|NCT01877421|3613186|B16||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3782573|NCT01877421|3613187|B15||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3782574|NCT01877421|3613188|B14||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782575|NCT01877421|3613189|B13||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3782576|NCT01877421|3613190|B12||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782577|NCT01877421|3613191|B11||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3782578|NCT01877421|3613192|B10||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782579|NCT01877421|3613193|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782580|NCT01877421|3613194|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782581|NCT01877421|3613195|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782582|NCT01877421|3613196|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782583|NCT01877421|3613197|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782584|NCT01877421|3613198|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782585|NCT01877421|3613199|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782586|NCT01877421|3613200|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782587|NCT01877421|3613201|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3782588|NCT01877421|3613169|B33||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782589|NCT01877421|3613170|B32||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782590|NCT01877421|3613171|B31||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782591|NCT01877421|3613172|B30||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782592|NCT01877421|3613173|B29||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782593|NCT01877421|3613174|B28||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782594|NCT01877421|3613175|B27||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782595|NCT01877421|3613176|B26||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782596|NCT01877421|3613177|B25||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782597|NCT01877421|3613178|B24||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782598|NCT01877421|3613179|B23||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782599|NCT01877421|3613180|B22||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782600|NCT01877421|3613181|B21||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782601|NCT01877421|3613182|B20||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782602|NCT01877421|3613183|B19||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782603|NCT01877421|3613184|B18||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782604|NCT01877421|3613185|B17||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782605|NCT01877421|3613186|B16||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782606|NCT01877421|3613187|B15||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782607|NCT01877421|3613188|B14||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782608|NCT01877421|3613189|B13||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782609|NCT01877421|3613190|B12||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782610|NCT01877421|3613191|B11||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782611|NCT01877421|3613192|B10||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782612|NCT01877421|3613193|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782613|NCT01877421|3613194|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782614|NCT01877421|3613195|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782615|NCT01877421|3613196|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782616|NCT01877421|3613197|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782617|NCT01877421|3613198|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782618|NCT01877421|3613199|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782619|NCT01877421|3613200|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782620|NCT01877421|3613201|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782621|NCT01877421|3613169|B33||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3782622|NCT01877421|3613170|B32||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782623|NCT01877421|3613171|B31||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3782624|NCT01877421|3613172|B30||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782625|NCT01877421|3613173|B29||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3782626|NCT01877421|3613174|B28||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3782627|NCT01877421|3613175|B27||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782628|NCT01877421|3613176|B26||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782629|NCT01877421|3613177|B25||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782630|NCT01877421|3613178|B24||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3782631|NCT01877421|3613179|B23||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3782632|NCT01877421|3613180|B22||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782633|NCT01877421|3613181|B21||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782634|NCT01877421|3613182|B20||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782635|NCT01877421|3613183|B19||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782636|NCT01877421|3613184|B18||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3782637|NCT01877421|3613185|B17||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782638|NCT01877421|3613186|B16||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782639|NCT01877421|3613187|B15||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782640|NCT01877421|3613188|B14||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782641|NCT01877421|3613189|B13||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3782642|NCT01877421|3613190|B12||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782643|NCT01877421|3613191|B11||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3782644|NCT01877421|3613192|B10||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3782645|NCT01877421|3613193|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782646|NCT01877421|3613194|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3782647|NCT01877421|3613195|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3782648|NCT01877421|3613196|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782649|NCT01877421|3613197|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782650|NCT01877421|3613198|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782651|NCT01877421|3613199|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3782652|NCT01877421|3613200|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782653|NCT01877421|3613201|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782654|NCT01877421|3613169|B33||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782655|NCT01877421|3613170|B32||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782656|NCT01877421|3613171|B31||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782657|NCT01877421|3613172|B30||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782658|NCT01877421|3613173|B29||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782659|NCT01877421|3613174|B28||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782660|NCT01877421|3613175|B27||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782661|NCT01877421|3613176|B26||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782662|NCT01877421|3613177|B25||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782663|NCT01877421|3613178|B24||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782664|NCT01877421|3613179|B23||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782665|NCT01877421|3613180|B22||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782666|NCT01877421|3613181|B21||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782667|NCT01877421|3613182|B20||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782668|NCT01877421|3613183|B19||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782669|NCT01877421|3613184|B18||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782670|NCT01877421|3613185|B17||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782671|NCT01877421|3613186|B16||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782672|NCT01877421|3613187|B15||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782673|NCT01877421|3613188|B14||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782674|NCT01877421|3613189|B13||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782675|NCT01877421|3613190|B12||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782676|NCT01877421|3613191|B11||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782677|NCT01877421|3613192|B10||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782678|NCT01877421|3613193|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782679|NCT01877421|3613194|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782680|NCT01877421|3613195|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782681|NCT01877421|3613196|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782682|NCT01877421|3613197|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782683|NCT01877421|3613198|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782684|NCT01877421|3613199|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782685|NCT01877421|3613200|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782686|NCT01877421|3613201|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782687|NCT01877421|3613169|B33||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782688|NCT01877421|3613170|B32||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782689|NCT01877421|3613171|B31||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782690|NCT01877421|3613172|B30||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782691|NCT01877421|3613173|B29||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782692|NCT01877421|3613174|B28||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782693|NCT01877421|3613175|B27||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782694|NCT01877421|3613176|B26||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782695|NCT01877421|3613177|B25||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782696|NCT01877421|3613178|B24||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782697|NCT01877421|3613179|B23||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782698|NCT01877421|3613180|B22||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782699|NCT01877421|3613181|B21||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782700|NCT01877421|3613182|B20||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782701|NCT01877421|3613183|B19||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782702|NCT01877421|3613184|B18||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782703|NCT01877421|3613185|B17||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782704|NCT01877421|3613186|B16||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782705|NCT01877421|3613187|B15||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782706|NCT01877421|3613188|B14||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782707|NCT01877421|3613189|B13||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782708|NCT01877421|3613190|B12||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782709|NCT01877421|3613191|B11||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782710|NCT01877421|3613192|B10||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782711|NCT01877421|3613193|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782712|NCT01877421|3613194|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782713|NCT01877421|3613195|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782714|NCT01877421|3613196|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782715|NCT01877421|3613197|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782716|NCT01877421|3613198|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782717|NCT01877421|3613199|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782718|NCT01877421|3613200|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782719|NCT01877421|3613201|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782720|NCT01877421|3613169|B33||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
3782721|NCT01877421|3613170|B32||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3782722|NCT01877421|3613171|B31||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3782723|NCT01877421|3613172|B30||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3782724|NCT01877421|3613173|B29||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3782725|NCT01877421|3613174|B28||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3782726|NCT01877421|3613175|B27||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3782727|NCT01877421|3613176|B26||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3782728|NCT01877421|3613177|B25||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3782729|NCT01877421|3613178|B24||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3782730|NCT01877421|3613179|B23||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3782731|NCT01877421|3613180|B22||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3782732|NCT01877421|3613181|B21||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3782733|NCT01877421|3613182|B20||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3782734|NCT01877421|3613183|B19||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3782735|NCT01877421|3613184|B18||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3782736|NCT01877421|3613185|B17||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3782737|NCT01877421|3613186|B16||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3782738|NCT01877421|3613187|B15||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3782739|NCT01877421|3613188|B14||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3782740|NCT01877421|3613189|B13||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3782741|NCT01877421|3613190|B12||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3782742|NCT01877421|3613191|B11||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3782743|NCT01877421|3613192|B10||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3782744|NCT01877421|3613193|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3782745|NCT01877421|3613194|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3782746|NCT01877421|3613195|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3782747|NCT01877421|3613196|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3782748|NCT01877421|3613197|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3782749|NCT01877421|3613198|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3782750|NCT01877421|3613199|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3782751|NCT01877421|3613200|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3782752|NCT01877421|3613201|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3782753|NCT01877421|3613169|B33||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3782754|NCT01877421|3613170|B32||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782755|NCT01877421|3613171|B31||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3782756|NCT01877421|3613172|B30||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782757|NCT01877421|3613173|B29||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782758|NCT01877421|3613174|B28||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782759|NCT01877421|3613175|B27||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782760|NCT01877421|3613176|B26||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782761|NCT01877421|3613177|B25||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782820|NCT01877421|3613170|B32||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3782762|NCT01877421|3613178|B24||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782763|NCT01877421|3613179|B23||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782764|NCT01877421|3613180|B22||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782765|NCT01877421|3613181|B21||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782766|NCT01877421|3613182|B20||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782767|NCT01877421|3613183|B19||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3782768|NCT01877421|3613184|B18||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3782769|NCT01877421|3613185|B17||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3782770|NCT01877421|3613186|B16||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3782771|NCT01877421|3613187|B15||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782772|NCT01877421|3613188|B14||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782773|NCT01877421|3613189|B13||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782774|NCT01877421|3613190|B12||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782775|NCT01877421|3613191|B11||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3782776|NCT01877421|3613192|B10||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782777|NCT01877421|3613193|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3782778|NCT01877421|3613194|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782779|NCT01877421|3613195|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782780|NCT01877421|3613196|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782781|NCT01877421|3613197|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3782782|NCT01877421|3613198|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782783|NCT01877421|3613199|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782784|NCT01877421|3613200|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782785|NCT01877421|3613201|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782786|NCT01877421|3613169|B33||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3782787|NCT01877421|3613170|B32||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3782788|NCT01877421|3613171|B31||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3782789|NCT01877421|3613172|B30||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3782790|NCT01877421|3613173|B29||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3782791|NCT01877421|3613174|B28||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3782792|NCT01877421|3613175|B27||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3782793|NCT01877421|3613176|B26||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3782794|NCT01877421|3613177|B25||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3782795|NCT01877421|3613178|B24||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3782796|NCT01877421|3613179|B23||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3782797|NCT01877421|3613180|B22||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3782798|NCT01877421|3613181|B21||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3782799|NCT01877421|3613182|B20||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3782800|NCT01877421|3613183|B19||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3782801|NCT01877421|3613184|B18||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3782802|NCT01877421|3613185|B17||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3782803|NCT01877421|3613186|B16||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3782804|NCT01877421|3613187|B15||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3782805|NCT01877421|3613188|B14||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3782806|NCT01877421|3613189|B13||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3782807|NCT01877421|3613190|B12||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3782808|NCT01877421|3613191|B11||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3782809|NCT01877421|3613192|B10||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3782810|NCT01877421|3613193|B9||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3782811|NCT01877421|3613194|B8||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3782812|NCT01877421|3613195|B7||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3782813|NCT01877421|3613196|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3782814|NCT01877421|3613197|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3782815|NCT01877421|3613198|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3782816|NCT01877421|3613199|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3782817|NCT01877421|3613200|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3782818|NCT01877421|3613201|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3782819|NCT01877421|3613169|B33||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3782821|NCT01877421|3613171|B31||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3782822|NCT01877421|3613172|B30||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3782823|NCT01877421|3613173|B29||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3782824|NCT01877421|3613174|B28||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3782825|NCT01877421|3613175|B27||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3782826|NCT01877421|3613176|B26||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3782827|NCT01877421|3613177|B25||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3782828|NCT01877421|3613178|B24||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3782829|NCT01877421|3613179|B23||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3782830|NCT01877421|3613180|B22||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3782831|NCT01877421|3613181|B21||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3782832|NCT01877421|3613182|B20||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3782833|NCT01877421|3613183|B19||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3782834|NCT01877421|3613184|B18||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3782835|NCT01877421|3613185|B17||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3782836|NCT01877421|3613186|B16||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3782837|NCT01877421|3613187|B15||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3782838|NCT01877421|3613188|B14||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3782839|NCT01877421|3613189|B13||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3782840|NCT01877421|3613190|B12||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3782841|NCT01877421|3613191|B11||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3782842|NCT01877421|3613192|B10||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3782843|NCT01877421|3613193|B9||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3782844|NCT01877421|3613194|B8||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3782845|NCT01877421|3613195|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3782846|NCT01877421|3613196|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3782847|NCT01877421|3613197|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3782848|NCT01877421|3613198|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3782849|NCT01877421|3613199|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3782850|NCT01877421|3613200|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3782851|NCT01877421|3613201|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3782852|NCT01877421|3613169|B33|||Age||years|Mean|21.3|21.3|Standard Deviation|0|0.0|||
3782853|NCT01877421|3613170|B32|||Age||years|Mean|21.7|21.7|Standard Deviation|0.6|0.6|||
3782854|NCT01877421|3613171|B31|||Age||years|Mean|26.0|26.0|Standard Deviation|5.0|5.0|||
3782855|NCT01877421|3613172|B30|||Age||years|Mean|26.0|26.0|Standard Deviation|10.4|10.4|||
3782856|NCT01877421|3613173|B29|||Age||years|Mean|37.3|37.3|Standard Deviation|13.9|13.9|||
3782857|NCT01877421|3613174|B28|||Age||years|Mean|24.0|24.0|Standard Deviation|5.0|5.0|||
3782858|NCT01877421|3613175|B27|||Age||years|Mean|21.3|21.3|Standard Deviation|4.8|4.8|||
3782859|NCT01877421|3613176|B26|||Age||years|Mean|34.3|34.3|Standard Deviation|13.6|13.6|||
3782860|NCT01877421|3613177|B25|||Age||years|Mean|30.2|30.2|Standard Deviation|14.3|14.3|||
3782861|NCT01877421|3613178|B24|||Age||years|Mean|33.0|33.0|Standard Deviation|15.6|15.6|||
3782862|NCT01877421|3613179|B23|||Age||years|Mean|25.7|25.7|Standard Deviation|5.8|5.8|||
3782863|NCT01877421|3613180|B22|||Age||years|Mean|22.0|22.0|Standard Deviation|3.6|3.6|||
3782864|NCT01877421|3613181|B21|||Age||years|Mean|38.1|38.1|Standard Deviation|12.2|12.2|||
3782865|NCT01877421|3613182|B20|||Age||years|Mean|36.5|36.5|Standard Deviation|16.3|16.3|||
3782866|NCT01877421|3613183|B19|||Age||years|Mean|31.5|31.5|Standard Deviation|11.4|11.4|||
3782867|NCT01877421|3613184|B18|||Age||years|Mean|33.7|33.7|Standard Deviation|20.6|20.6|||
3782868|NCT01877421|3613185|B17|||Age||years|Mean|26.4|26.4|Standard Deviation|10.4|10.4|||
3782869|NCT01877421|3613186|B16|||Age||years|Mean|44.7|44.7|Standard Deviation|13.6|13.6|||
3782870|NCT01877421|3613187|B15|||Age||years|Mean|29.3|29.3|Standard Deviation|6.7|6.7|||
3782871|NCT01877421|3613188|B14|||Age||years|Mean|35.0|35.0|Standard Deviation|19.1|19.1|||
3782872|NCT01877421|3613189|B13|||Age||years|Mean|27.4|27.4|Standard Deviation|7.5|7.5|||
3782873|NCT01877421|3613190|B12|||Age||years|Mean|36.0|36.0|Standard Deviation|5.6|5.6|||
3782874|NCT01877421|3613191|B11|||Age||years|Mean|36.7|36.7|Standard Deviation|8.9|8.9|||
3782875|NCT01877421|3613192|B10|||Age||years|Mean|49.7|49.7|Standard Deviation|9.5|9.5|||
3782876|NCT01877421|3613193|B9|||Age||years|Mean|38.0|38.0|Standard Deviation|14.3|14.3|||
3782877|NCT01877421|3613194|B8|||Age||years|Mean|44.0|44.0|Standard Deviation|11.3|11.3|||
3782878|NCT01877421|3613195|B7|||Age||years|Mean|44.5|44.5|Standard Deviation|5.0|5.0|||
3782879|NCT01877421|3613196|B6|||Age||years|Mean|40.0|40.0|Standard Deviation|5.7|5.7|||
3782880|NCT01877421|3613197|B5|||Age||years|Mean|29.8|29.8|Standard Deviation|5.1|5.1|||
3782881|NCT01877421|3613198|B4|||Age||years|Mean|41.5|41.5|Standard Deviation|2.1|2.1|||
3782882|NCT01877421|3613199|B3|||Age||years|Mean|31.8|31.8|Standard Deviation|5.5|5.5|||
3782883|NCT01877421|3613200|B2|||Age||years|Mean|49.0|49.0|Standard Deviation|NA||||SD not derived because n=1
3782884|NCT01877421|3613201|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|0.7|0.7|||
3782885|NCT01877408|3613326|B3|South Africa||Region of Enrollment||participants|Number|150|150.0||||||
3782886|NCT01877408|3613327|B2|South Africa||Region of Enrollment||participants|Number|100|100.0||||||
3782887|NCT01877408|3613328|B1|South Africa||Region of Enrollment||participants|Number|50|50.0||||||
3782888|NCT01877408|3613326|B3||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3782889|NCT01877408|3613327|B2||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3782890|NCT01877408|3613328|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3782891|NCT01877408|3613326|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3782892|NCT01877408|3613327|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3782893|NCT01877408|3613328|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3782894|NCT01877408|3613326|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3782895|NCT01877408|3613327|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3782896|NCT01877408|3613328|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3782897|NCT01877408|3613326|B3||Between 18 and 65 years|Age||Participants|Count of Participants|149|149.0||||||
3782898|NCT01877408|3613327|B2||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
3782899|NCT01877408|3613328|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3782900|NCT01877408|3613326|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3782901|NCT01877408|3613327|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3782902|NCT01877408|3613328|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3782903|NCT01877343|3613346|B4|||BMI||kg/m2|Mean|24.4|24.4|Standard Deviation|6.7|6.7|||
3782904|NCT01877343|3613347|B3|||BMI||kg/m2|Mean|20.5|20.5|Standard Deviation|1.7|1.7|||
3782905|NCT01877343|3613348|B2|||BMI||kg/m2|Mean|28.9|28.9|Standard Deviation|8.7|8.7|||
3782906|NCT01877343|3613349|B1|||BMI||kg/m2|Mean|27.4|27.4|Standard Deviation|5.0|5.0|||
3782907|NCT01877343|3613346|B4|||Weight||kg|Mean|67|67.0|Standard Deviation|21|21.0|||
3782908|NCT01877343|3613347|B3|||Weight||kg|Mean|56|56.0|Standard Deviation|11|11.0|||
3782909|NCT01877343|3613348|B2|||Weight||kg|Mean|77|77.0|Standard Deviation|25|25.0|||
3782910|NCT01877343|3613349|B1|||Weight||kg|Mean|83|83.0|Standard Deviation|15|15.0|||
3782911|NCT01877343|3613346|B4|||Height||meters|Mean|1.65|1.65|Standard Deviation|.09|0.09|||
3782912|NCT01877343|3613347|B3|||Height||meters|Mean|1.64|1.64|Standard Deviation|.1|0.1|||
3782913|NCT01877343|3613348|B2|||Height||meters|Mean|1.62|1.62|Standard Deviation|.03|0.03|||
3782914|NCT01877343|3613349|B1|||Height||meters|Mean|1.736|1.736|Standard Deviation|.004|0.004|||
3782915|NCT01877343|3613346|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3782916|NCT01877343|3613347|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3782917|NCT01877343|3613348|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3782918|NCT01877343|3613349|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3782919|NCT01877343|3613346|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3782920|NCT01877343|3613347|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3782921|NCT01877343|3613348|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3782922|NCT01877343|3613349|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3782923|NCT01877343|3613346|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3782924|NCT01877343|3613347|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3782925|NCT01877343|3613348|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3782926|NCT01877343|3613349|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3782927|NCT01877343|3613346|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3782928|NCT01877343|3613347|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3782929|NCT01877343|3613348|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3782930|NCT01877343|3613349|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3782931|NCT01877343|3613346|B4||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
3782932|NCT01877343|3613347|B3||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3782933|NCT01877343|3613348|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3782934|NCT01877343|3613349|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3782935|NCT01877278|3613360|B3|Italy||Region of Enrollment||participants|Number|60|60.0||||||
3782936|NCT01877278|3613361|B2|Italy||Region of Enrollment||participants|Number|30|30.0||||||
3782937|NCT01877278|3613362|B1|Italy||Region of Enrollment||participants|Number|30|30.0||||||
3782938|NCT01877278|3613360|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3782939|NCT01877278|3613361|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3782940|NCT01877278|3613362|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3782941|NCT01877278|3613360|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3782942|NCT01877278|3613361|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3782943|NCT01877278|3613362|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3782944|NCT01877278|3613360|B3|||Age||years|Mean|67.7|67.7|Standard Deviation|10.9|10.9|||
3782945|NCT01877278|3613361|B2|||Age||years|Mean|66.9|66.9|Standard Deviation|10|10.0|||
3782946|NCT01877278|3613362|B1|||Age||years|Mean|68.6|68.6|Standard Deviation|11.9|11.9|||
3782947|NCT01877265|3613371|B1|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3782948|NCT01877265|3613371|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782949|NCT01877265|3613371|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782950|NCT01877265|3613371|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3782951|NCT01877265|3613371|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3782952|NCT01877265|3613371|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782953|NCT01877265|3613371|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3782954|NCT01877265|3613371|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3782955|NCT01877265|3613371|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3782956|NCT01877265|3613371|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3782957|NCT01877265|3613371|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3782958|NCT01877265|3613371|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3782959|NCT01877265|3613371|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3782960|NCT01877265|3613371|B1|||Age||years|Mean|37.6|37.6|Standard Deviation|9.5|9.5|||
3782961|NCT01877239|3613393|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3782962|NCT01877239|3613393|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3782963|NCT01877239|3613393|B1|||Age||years|Mean|54.3|54.3|Standard Deviation|14.9|14.9|||
3782964|NCT01877161|3613399|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3782965|NCT01877161|3613399|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3782966|NCT01877161|3613399|B1|||Age||years|Mean|31.87|31.87|Full Range|||24.0|47.0|
3782967|NCT01877148|3613407|B3|Brazil||Region of Enrollment||participants|Number|10|10.0||||||
3782968|NCT01877148|3613408|B2|Brazil||Region of Enrollment||participants|Number|5|5.0||||||
3782969|NCT01877148|3613409|B1|Brazil||Region of Enrollment||participants|Number|5|5.0||||||
3782970|NCT01877148|3613407|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3782971|NCT01877148|3613408|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3782972|NCT01877148|3613409|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3782973|NCT01877148|3613407|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3782974|NCT01877148|3613408|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3782975|NCT01877148|3613409|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3782976|NCT01877148|3613407|B3|||Age||years|Mean|63.6|63.6|Standard Deviation|10.51|10.51|||
3782977|NCT01877148|3613408|B2|||Age||years|Mean|68.2|68.2|Standard Deviation|11.75|11.75|||
3782978|NCT01877148|3613409|B1|||Age||years|Mean|59|59.0|Standard Deviation|9.27|9.27|||
3782979|NCT01877148|3613407|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3782980|NCT01877148|3613408|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3782981|NCT01877148|3613409|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3782982|NCT01877148|3613407|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3782983|NCT01877148|3613408|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3782984|NCT01877148|3613409|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3782985|NCT01877148|3613407|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3782986|NCT01877148|3613408|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3782987|NCT01877148|3613409|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3782988|NCT01876992|3613422|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3782989|NCT01876992|3613423|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3782990|NCT01876992|3613424|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3782991|NCT01876992|3613422|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3782992|NCT01876992|3613423|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3782993|NCT01876992|3613424|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3782994|NCT01876992|3613422|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3782995|NCT01876992|3613423|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3782996|NCT01876992|3613424|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3782997|NCT01876992|3613422|B3|||Age||years|Mean|34|34.0|Full Range|||19.0|44.0|
3782998|NCT01876992|3613423|B2|||Age||years|Mean|36|36.0|Full Range|||22.0|38.0|
3782999|NCT01876992|3613424|B1|||Age||years|Mean|32|32.0|Full Range|||19.0|44.0|
3783000|NCT01876992|3613422|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3783001|NCT01876992|3613423|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3783002|NCT01876992|3613424|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3783003|NCT01876992|3613422|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3783004|NCT01876992|3613423|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3783005|NCT01876992|3613424|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3783006|NCT01876992|3613422|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3783007|NCT01876992|3613423|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3783008|NCT01876992|3613424|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3783009|NCT01876979|3613437|B3|||Duration to Maxillomandibular Fixation (minutes)||minutes|Mean|28.7|28.7|Full Range|||11.0|50.0|
3783010|NCT01876979|3613438|B2|||Duration to Maxillomandibular Fixation (minutes)||minutes|Mean|40.3|40.3|Full Range|||35.0|50.0|
3783011|NCT01876979|3613439|B1|||Duration to Maxillomandibular Fixation (minutes)||minutes|Mean|17|17.0|Full Range|||11.0|23.0|
3783012|NCT01876979|3613437|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3783013|NCT01876979|3613438|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3783014|NCT01876979|3613439|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3783015|NCT01876979|3613437|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3783016|NCT01876979|3613438|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3783017|NCT01876979|3613439|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3783018|NCT01876979|3613437|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3783019|NCT01876979|3613438|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3783020|NCT01876979|3613439|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3783021|NCT01876979|3613437|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3783022|NCT01876979|3613438|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3783023|NCT01876979|3613439|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3783024|NCT01876979|3613437|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3783025|NCT01876979|3613438|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3783026|NCT01876979|3613439|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3783027|NCT01876823|3613446|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3783028|NCT01876823|3613446|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783029|NCT01876823|3613446|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3783030|NCT01876823|3613446|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3783031|NCT01876823|3613446|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3783032|NCT01876823|3613446|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3783033|NCT01876823|3613446|B1|||Age||years|Mean|65.3|65.3|Standard Deviation|8.9|8.9|||
3783034|NCT01876823|3613446|B1||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
3783035|NCT01876823|3613446|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3783036|NCT01876823|3613446|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3783037|NCT01876810|3613459|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3783038|NCT01876810|3613459|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3783039|NCT01876810|3613459|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3783040|NCT01876810|3613459|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3783041|NCT01876810|3613459|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3783042|NCT01876784|3613470|B3||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3783043|NCT01876784|3613471|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3783044|NCT01876784|3613472|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3783045|NCT01876784|3613470|B3||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3783046|NCT01876784|3613471|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3783047|NCT01876784|3613472|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3783048|NCT01876784|3613470|B3|||Age||years|Mean|63.7|63.7|Standard Deviation|10.36|10.36|||
3783049|NCT01876784|3613471|B2|||Age||years|Mean|63.2|63.2|Standard Deviation|11.02|11.02|||
3783050|NCT01876784|3613472|B1|||Age||years|Mean|64.2|64.2|Standard Deviation|9.69|9.69|||
3783051|NCT01876732|3613479|B1|United States||Region of Enrollment||participants|Number|57|57.0||||||
3783052|NCT01876732|3613479|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3783053|NCT01876732|3613479|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3783054|NCT01876732|3613479|B1|||Age||years|Mean|63.43|63.43|Standard Deviation|14.6|14.6|||
3783055|NCT01876732|3613479|B1||>=65 years|Age|From a single center dialysis unit, patients 18-80 on hemodialysis at least 6 months and taking Epogen were screened for serum Vitamin B12 levels and plasma MMA. Those with an MMA level greater than 800mmol/L had smears of their peripheral blood examined to assess for characteristic findings that are consistent with vitamin B12 deficiency.|Participants|Count of Participants|7|7.0||||||
3783056|NCT01876732|3613479|B1||Between 18 and 65 years|Age|From a single center dialysis unit, patients 18-80 on hemodialysis at least 6 months and taking Epogen were screened for serum Vitamin B12 levels and plasma MMA. Those with an MMA level greater than 800mmol/L had smears of their peripheral blood examined to assess for characteristic findings that are consistent with vitamin B12 deficiency.|Participants|Count of Participants|50|50.0||||||
3783057|NCT01876732|3613479|B1||<=18 years|Age|From a single center dialysis unit, patients 18-80 on hemodialysis at least 6 months and taking Epogen were screened for serum Vitamin B12 levels and plasma MMA. Those with an MMA level greater than 800mmol/L had smears of their peripheral blood examined to assess for characteristic findings that are consistent with vitamin B12 deficiency.|Participants|Count of Participants|0|0.0||||||
3783058|NCT01876706|3613484|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
3783059|NCT01876706|3613484|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783060|NCT01876706|3613484|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783061|NCT01876706|3613484|B1||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3783062|NCT01876706|3613484|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3783063|NCT01876706|3613484|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783064|NCT01876706|3613484|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783065|NCT01876706|3613484|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783066|NCT01876706|3613484|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783067|NCT01876706|3613484|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3783068|NCT01876706|3613484|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3783069|NCT01876706|3613484|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3783070|NCT01876706|3613484|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3783071|NCT01876706|3613484|B1|||Age||years|Mean|65.5|65.5|Standard Deviation|7.6|7.6|||
3783072|NCT01876706|3613484|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3783073|NCT01876706|3613484|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3783074|NCT01876706|3613484|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3783075|NCT01876420|3613501|B1|||Body Surface Area (BSA)||m²|Mean|1.7|1.7|Standard Deviation|0.2|0.2|||
3783076|NCT01876420|3613501|B1|||Logistic EuroScore|The European System for Cardiac Operative Risk Evaluation (EuroSCORE) is a method of calculating predicted operative mortality for patients undergoing cardiac surgery. If a risk factor is present, a weight/number is assigned. The weights are added to give an approximate percent of predicted mortality. A higher score indicates a higher risk. A lower score indicates a lower risk.|percent risk for cardiac surgery|Mean|20.5|20.5|Standard Deviation|12.5|12.5|||
3783077|NCT01876420|3613501|B1|||STS Score|The Society of Thoracic Surgeons (STS) risk model predicts the risk of operative mortality and morbidity after adult cardiac surgery on the basis of patient demographic and clinical variables. After information has been entered on a given case, the online STS risk calculator provides a risk percentage for each of the outcomes. The risk percentage estimates the chance of a specific outcome for a patient with the indicated risk factors. A higher score indicates a higher risk. A lower score indicates a lower risk.|percent of risk for cardiac surgery|Mean|7.0|7.0|Standard Deviation|3.7|3.7|||
3783078|NCT01876420|3613501|B1|NYHA IV||NYHA Class|NEW YORK HEART ASSOCIATION CLASSIFICATION (NYHA) Class I Subject with cardiac disease but without resulting limitations of physical activity. Class II Subjects with cardiac disease resulting in slight limitation of physical activity. Class III Subjects with cardiac disease resulting in marked limitation of physical activity. Class IV Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort.|participants|Number|5|5.0||||||
3783079|NCT01876420|3613501|B1|NYHA III||NYHA Class|NEW YORK HEART ASSOCIATION CLASSIFICATION (NYHA) Class I Subject with cardiac disease but without resulting limitations of physical activity. Class II Subjects with cardiac disease resulting in slight limitation of physical activity. Class III Subjects with cardiac disease resulting in marked limitation of physical activity. Class IV Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort.|participants|Number|36|36.0||||||
3783080|NCT01876420|3613501|B1|NYHA II||NYHA Class|NEW YORK HEART ASSOCIATION CLASSIFICATION (NYHA) Class I Subject with cardiac disease but without resulting limitations of physical activity. Class II Subjects with cardiac disease resulting in slight limitation of physical activity. Class III Subjects with cardiac disease resulting in marked limitation of physical activity. Class IV Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort.|participants|Number|19|19.0||||||
3783081|NCT01876420|3613501|B1|NYHA I||NYHA Class|NEW YORK HEART ASSOCIATION CLASSIFICATION (NYHA) Class I Subject with cardiac disease but without resulting limitations of physical activity. Class II Subjects with cardiac disease resulting in slight limitation of physical activity. Class III Subjects with cardiac disease resulting in marked limitation of physical activity. Class IV Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort.|participants|Number|0|0.0||||||
3783082|NCT01876420|3613501|B1|Australia||Region of Enrollment||participants|Number|25|25.0||||||
3783083|NCT01876420|3613501|B1|United Kingdom||Region of Enrollment||participants|Number|29|29.0||||||
3783084|NCT01876420|3613501|B1|New Zealand||Region of Enrollment||participants|Number|6|6.0||||||
3783085|NCT01876420|3613501|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3783086|NCT01876420|3613501|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3783087|NCT01876420|3613501|B1|||Age||years|Mean|82.8|82.8|Standard Deviation|6.1|6.1|||
3783088|NCT01876381|3613513|B1|Japan||Region of Enrollment||participants|Number|23|23.0||||||
3783089|NCT01876381|3613513|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3783090|NCT01876381|3613513|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3783091|NCT01876381|3613513|B1|||Age||years|Mean|60.4|60.4|Standard Deviation|12.5|12.5|||
3783092|NCT01876381|3613513|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3783093|NCT01876381|3613513|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3783094|NCT01876381|3613513|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3783095|NCT01876368|3613518|B3||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
3783096|NCT01876368|3613519|B2||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3783097|NCT01876368|3613520|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3783098|NCT01876368|3613518|B3||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3783099|NCT01876368|3613519|B2||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3783100|NCT01876368|3613520|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3783101|NCT01876368|3613518|B3|||Age||Years|Mean|57.6|57.6|Standard Deviation|9.65|9.65|||
3783102|NCT01876368|3613519|B2|||Age||Years|Mean|58.0|58.0|Standard Deviation|9.09|9.09|||
3783103|NCT01876368|3613520|B1|||Age||Years|Mean|57.1|57.1|Standard Deviation|10.19|10.19|||
3783104|NCT01876329|3613547|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3783105|NCT01876329|3613548|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3783106|NCT01876329|3613549|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3783107|NCT01876329|3613550|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783108|NCT01876329|3613547|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3783109|NCT01876329|3613548|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783110|NCT01876329|3613549|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3783111|NCT01876329|3613550|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783112|NCT01876329|3613547|B4||White|Race (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3783113|NCT01876329|3613548|B3||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3783114|NCT01876329|3613549|B2||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3783115|NCT01876329|3613550|B1||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3783116|NCT01876329|3613547|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3783117|NCT01876329|3613548|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3783118|NCT01876329|3613549|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3783119|NCT01876329|3613550|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3783120|NCT01876329|3613547|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3783121|NCT01876329|3613548|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783122|NCT01876329|3613549|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783123|NCT01876329|3613550|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3783124|NCT01876329|3613547|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3783125|NCT01876329|3613548|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3783126|NCT01876329|3613549|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3783127|NCT01876329|3613550|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3783128|NCT01876329|3613547|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783129|NCT01876329|3613548|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783130|NCT01876329|3613549|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783131|NCT01876329|3613550|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783132|NCT01876329|3613547|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3783133|NCT01876329|3613548|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3783134|NCT01876329|3613549|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3783135|NCT01876329|3613550|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3783136|NCT01876329|3613547|B4||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3783137|NCT01876329|3613548|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3783138|NCT01876329|3613549|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3783139|NCT01876329|3613550|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3783140|NCT01876329|3613547|B4|||Age||years|Mean|56.8|56.8|Standard Deviation|15.6|15.6|||
3783141|NCT01876329|3613548|B3|||Age||years|Mean|55.8|55.8|Standard Deviation|16.4|16.4|||
3783142|NCT01876329|3613549|B2|||Age||years|Mean|55.1|55.1|Standard Deviation|17.2|17.2|||
3783143|NCT01876329|3613550|B1|||Age||years|Mean|59.6|59.6|Standard Deviation|13.1|13.1|||
3783144|NCT01876329|3613547|B4||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
3783145|NCT01876329|3613548|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3783146|NCT01876329|3613549|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3783147|NCT01876329|3613550|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3783148|NCT01876329|3613547|B4||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
3783149|NCT01876329|3613548|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3783150|NCT01876329|3613549|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3783151|NCT01876329|3613550|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3783152|NCT01876329|3613547|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3783153|NCT01876329|3613548|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3783154|NCT01876329|3613549|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3783155|NCT01876329|3613550|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3783156|NCT01875991|3613563|B3|Plaque Psoriasis||Disease State||participants|Number|60|60.0||||||
3783157|NCT01875991|3613564|B2|Plaque Psoriasis||Disease State||participants|Number|31|31.0||||||
3783158|NCT01875991|3613565|B1|Plaque Psoriasis||Disease State||participants|Number|29|29.0||||||
3783159|NCT01875991|3613563|B3|Rheumatoid Arthritis||Disease State||participants|Number|157|157.0||||||
3783160|NCT01875991|3613564|B2|Rheumatoid Arthritis||Disease State||participants|Number|78|78.0||||||
3783161|NCT01875991|3613565|B1|Rheumatoid Arthritis||Disease State||participants|Number|79|79.0||||||
3783162|NCT01875991|3613563|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|198|198.0||||||
3783163|NCT01875991|3613564|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|99|99.0||||||
3783164|NCT01875991|3613565|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|99|99.0||||||
3783165|NCT01875991|3613563|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3783166|NCT01875991|3613564|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3783167|NCT01875991|3613565|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3783168|NCT01875991|3613563|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3783169|NCT01875991|3613564|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3783170|NCT01875991|3613565|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3783171|NCT01875991|3613563|B3|White||Race/Ethnicity, Customized||participants|Number|202|202.0||||||
3783172|NCT01875991|3613564|B2|White||Race/Ethnicity, Customized||participants|Number|102|102.0||||||
3783173|NCT01875991|3613565|B1|White||Race/Ethnicity, Customized||participants|Number|100|100.0||||||
3783174|NCT01875991|3613563|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3783175|NCT01875991|3613564|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3783176|NCT01875991|3613565|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3783177|NCT01875991|3613563|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3783178|NCT01875991|3613564|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3783179|NCT01875991|3613565|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3783180|NCT01875991|3613563|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3783181|NCT01875991|3613564|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3783182|NCT01875991|3613565|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3783183|NCT01875991|3613563|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3783184|NCT01875991|3613564|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3783185|NCT01875991|3613565|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3783186|NCT01875991|3613563|B3||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3783187|NCT01875991|3613564|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3783188|NCT01875991|3613565|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3783189|NCT01875991|3613563|B3|||Age||years|Mean|54.6|54.6|Standard Deviation|13.7|13.7|||
3783190|NCT01875991|3613564|B2|||Age||years|Mean|53.2|53.2|Standard Deviation|13.6|13.6|||
3783191|NCT01875991|3613565|B1|||Age||years|Mean|55.9|55.9|Standard Deviation|13.8|13.8|||
3783192|NCT01875978|3613587|B3|Taiwan||Region of Enrollment||participants|Number|40|40.0||||||
3783193|NCT01875978|3613588|B2|Taiwan||Region of Enrollment||participants|Number|20|20.0||||||
3783194|NCT01875978|3613589|B1|Taiwan||Region of Enrollment||participants|Number|20|20.0||||||
3783195|NCT01875978|3613587|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3783196|NCT01875978|3613588|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3783197|NCT01875978|3613589|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3783198|NCT01875978|3613587|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3783199|NCT01875978|3613588|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3783200|NCT01875978|3613589|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3783201|NCT01875978|3613587|B3|||Age||years|Mean|51|51.0|Standard Deviation|12|12.0|||
3783202|NCT01875978|3613588|B2|||Age||years|Mean|51|51.0|Standard Deviation|18|18.0|||
3783203|NCT01875978|3613589|B1|||Age||years|Mean|51|51.0|Standard Deviation|12|12.0|||
3783204|NCT01875978|3613587|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3783205|NCT01875978|3613588|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3783206|NCT01875978|3613589|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3783207|NCT01875978|3613587|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3783208|NCT01875978|3613588|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3783209|NCT01875978|3613589|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3783210|NCT01875978|3613587|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3783211|NCT01875978|3613588|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3783212|NCT01875978|3613589|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3783213|NCT01875874|3613602|B1|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3783214|NCT01875874|3613602|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783215|NCT01875874|3613602|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783216|NCT01875874|3613602|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3783217|NCT01875874|3613602|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3783218|NCT01875874|3613602|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783219|NCT01875874|3613602|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3783220|NCT01875874|3613602|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783221|NCT01875874|3613602|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3783222|NCT01875874|3613602|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3783223|NCT01875874|3613602|B1|||Age||years|Mean|38.5|38.5|Standard Deviation|19.99|19.99|||
3783224|NCT01875874|3613602|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3783225|NCT01875874|3613602|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3783226|NCT01875874|3613602|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3783227|NCT01875848|3613607|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
3783228|NCT01875848|3613608|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3783229|NCT01875848|3613609|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3783230|NCT01875848|3613607|B3||Male|Gender||Participants|Count of Participants|7|7.0||||||
3783231|NCT01875848|3613608|B2||Male|Gender||Participants|Count of Participants|4|4.0||||||
3783232|NCT01875848|3613609|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
3783233|NCT01875848|3613607|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
3783234|NCT01875848|3613608|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
3783235|NCT01875848|3613609|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3783236|NCT01875848|3613607|B3|||Age||years|Mean|68.6|68.6|Standard Deviation|7.4|7.4|||
3783237|NCT01875848|3613608|B2|||Age||years|Mean|69.8|69.8|Standard Deviation|9.5|9.5|||
3783238|NCT01875848|3613609|B1|||Age||years|Mean|67.0|67.0|Standard Deviation|4.6|4.6|||
3783239|NCT01875848|3613607|B3||>=65 years|Age|We will measure a range of pre-treatment variables at baseline to ensure that participants meet eligibility criteria. Using validated instruments during treatment and at the end of treatment, we will examine the differential impact of BUP/NX versus opioid dose escalation including outcome assessments related to pain severity, pain interference and patient global assessment of change during treatment.|Participants|Count of Participants|6|6.0||||||
3783240|NCT01875848|3613608|B2||>=65 years|Age|We will measure a range of pre-treatment variables at baseline to ensure that participants meet eligibility criteria. Using validated instruments during treatment and at the end of treatment, we will examine the differential impact of BUP/NX versus opioid dose escalation including outcome assessments related to pain severity, pain interference and patient global assessment of change during treatment.|Participants|Count of Participants|3|3.0||||||
3783241|NCT01875848|3613609|B1||>=65 years|Age|We will measure a range of pre-treatment variables at baseline to ensure that participants meet eligibility criteria. Using validated instruments during treatment and at the end of treatment, we will examine the differential impact of BUP/NX versus opioid dose escalation including outcome assessments related to pain severity, pain interference and patient global assessment of change during treatment.|Participants|Count of Participants|3|3.0||||||
3783242|NCT01875848|3613607|B3||Between 18 and 65 years|Age|We will measure a range of pre-treatment variables at baseline to ensure that participants meet eligibility criteria. Using validated instruments during treatment and at the end of treatment, we will examine the differential impact of BUP/NX versus opioid dose escalation including outcome assessments related to pain severity, pain interference and patient global assessment of change during treatment.|Participants|Count of Participants|1|1.0||||||
3783243|NCT01875848|3613608|B2||Between 18 and 65 years|Age|We will measure a range of pre-treatment variables at baseline to ensure that participants meet eligibility criteria. Using validated instruments during treatment and at the end of treatment, we will examine the differential impact of BUP/NX versus opioid dose escalation including outcome assessments related to pain severity, pain interference and patient global assessment of change during treatment.|Participants|Count of Participants|1|1.0||||||
3783244|NCT01875848|3613609|B1||Between 18 and 65 years|Age|We will measure a range of pre-treatment variables at baseline to ensure that participants meet eligibility criteria. Using validated instruments during treatment and at the end of treatment, we will examine the differential impact of BUP/NX versus opioid dose escalation including outcome assessments related to pain severity, pain interference and patient global assessment of change during treatment.|Participants|Count of Participants|0|0.0||||||
3783245|NCT01875848|3613607|B3||<=18 years|Age|We will measure a range of pre-treatment variables at baseline to ensure that participants meet eligibility criteria. Using validated instruments during treatment and at the end of treatment, we will examine the differential impact of BUP/NX versus opioid dose escalation including outcome assessments related to pain severity, pain interference and patient global assessment of change during treatment.|Participants|Count of Participants|0|0.0||||||
3783246|NCT01875848|3613608|B2||<=18 years|Age|We will measure a range of pre-treatment variables at baseline to ensure that participants meet eligibility criteria. Using validated instruments during treatment and at the end of treatment, we will examine the differential impact of BUP/NX versus opioid dose escalation including outcome assessments related to pain severity, pain interference and patient global assessment of change during treatment.|Participants|Count of Participants|0|0.0||||||
3783247|NCT01875848|3613609|B1||<=18 years|Age|We will measure a range of pre-treatment variables at baseline to ensure that participants meet eligibility criteria. Using validated instruments during treatment and at the end of treatment, we will examine the differential impact of BUP/NX versus opioid dose escalation including outcome assessments related to pain severity, pain interference and patient global assessment of change during treatment.|Participants|Count of Participants|0|0.0||||||
3783248|NCT01875783|3613618|B1|United States||Region of Enrollment||Participants|Count of Participants|385|385.0||||||
3783249|NCT01875783|3613618|B1||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
3783250|NCT01875783|3613618|B1||Female|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
3783251|NCT01875783|3613618|B1|||Age||years|Mean|54.8|54.8|Standard Deviation|14.1|14.1|||
3783252|NCT01875783|3613618|B1||>=65 years|Age||Participants|Count of Participants|91|91.0||||||
3783253|NCT01875783|3613618|B1||Between 18 and 65 years|Age||Participants|Count of Participants|294|294.0||||||
3783254|NCT01875783|3613618|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3783255|NCT01875731|3613625|B3|Argentina||Region of Enrollment||participants|Number|65|65.0||||||
3783256|NCT01875731|3613626|B2|Argentina||Region of Enrollment||participants|Number|32|32.0||||||
3783257|NCT01875731|3613627|B1|Argentina||Region of Enrollment||participants|Number|33|33.0||||||
3783258|NCT01875731|3613625|B3||Male|Gender||Participants|Count of Participants|33|33.0||||||
3783259|NCT01875731|3613626|B2||Male|Gender||Participants|Count of Participants|14|14.0||||||
3783260|NCT01875731|3613627|B1||Male|Gender||Participants|Count of Participants|19|19.0||||||
3783261|NCT01875731|3613625|B3||Female|Gender||Participants|Count of Participants|32|32.0||||||
3783262|NCT01875731|3613626|B2||Female|Gender||Participants|Count of Participants|18|18.0||||||
3783263|NCT01875731|3613627|B1||Female|Gender||Participants|Count of Participants|14|14.0||||||
3783264|NCT01875731|3613625|B3|||Age||months|Mean|17.5|17.5|Standard Deviation|10.8|10.8|||
3783265|NCT01875731|3613626|B2|||Age||months|Mean|17.5|17.5|Standard Deviation|11|11.0|||
3783266|NCT01875731|3613627|B1|||Age||months|Mean|17.2|17.2|Standard Deviation|10.2|10.2|||
3783267|NCT01875510|3613636|B3|Turkey||Region of Enrollment||participants|Number|80|80.0||||||
3783268|NCT01875510|3613637|B2|Turkey||Region of Enrollment||participants|Number|40|40.0||||||
3783269|NCT01875510|3613638|B1|Turkey||Region of Enrollment||participants|Number|40|40.0||||||
3783270|NCT01875510|3613636|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3783271|NCT01875510|3613637|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3783272|NCT01875510|3613638|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3783273|NCT01875510|3613636|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3783274|NCT01875510|3613637|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3783275|NCT01875510|3613638|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3783276|NCT01875510|3613636|B3|gestational age||Age||weeks|Mean|30|30.0|Standard Deviation|2|2.0|||
3783277|NCT01875510|3613637|B2|gestational age||Age||weeks|Mean|30|30.0|Standard Deviation|3|3.0|||
3783278|NCT01875510|3613638|B1|gestational age||Age||weeks|Mean|30|30.0|Standard Deviation|2|2.0|||
3783279|NCT01875510|3613636|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3783280|NCT01875510|3613637|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3783281|NCT01875510|3613638|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3783282|NCT01875510|3613636|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3783283|NCT01875510|3613637|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3783284|NCT01875510|3613638|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3783285|NCT01875510|3613636|B3||<=18 years|Age||Participants|Count of Participants|80|80.0||||||
3783286|NCT01875510|3613637|B2||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
3783287|NCT01875510|3613638|B1||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
3783288|NCT01875471|3613645|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
3783289|NCT01875471|3613646|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
3783290|NCT01875471|3613647|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
3783291|NCT01875471|3613645|B3|United Kingdom||Region of Enrollment||participants|Number|175|175.0||||||
3783292|NCT01875471|3613646|B2|United Kingdom||Region of Enrollment||participants|Number|87|87.0||||||
3783293|NCT01875471|3613647|B1|United Kingdom||Region of Enrollment||participants|Number|88|88.0||||||
3783294|NCT01875471|3613645|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3783295|NCT01875471|3613646|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3783296|NCT01875471|3613647|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3783297|NCT01875471|3613645|B3||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
3783298|NCT01875471|3613646|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3783299|NCT01875471|3613647|B1||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3783300|NCT01875471|3613645|B3|||Age||years|Mean|29.5|29.5|Standard Deviation|7.93|7.93|||
3783301|NCT01875471|3613646|B2|||Age||years|Mean|29.0|29.0|Standard Deviation|7.69|7.69|||
3783302|NCT01875471|3613647|B1|||Age||years|Mean|30.0|30.0|Standard Deviation|8.17|8.17|||
3783303|NCT01875471|3613645|B3||>=65 years|Age|Data was collected on those subjects 18 years and older, there were no pediatric patients enrolled in the study.|Participants|Count of Participants|0|0.0||||||
3783304|NCT01875471|3613646|B2||>=65 years|Age|Data was collected on those subjects 18 years and older, there were no pediatric patients enrolled in the study.|Participants|Count of Participants|0|0.0||||||
3783305|NCT01875471|3613647|B1||>=65 years|Age|Data was collected on those subjects 18 years and older, there were no pediatric patients enrolled in the study.|Participants|Count of Participants|0|0.0||||||
3783306|NCT01875471|3613645|B3||Between 18 and 65 years|Age|Data was collected on those subjects 18 years and older, there were no pediatric patients enrolled in the study.|Participants|Count of Participants|255|255.0||||||
3783307|NCT01875471|3613646|B2||Between 18 and 65 years|Age|Data was collected on those subjects 18 years and older, there were no pediatric patients enrolled in the study.|Participants|Count of Participants|129|129.0||||||
3783308|NCT01875471|3613647|B1||Between 18 and 65 years|Age|Data was collected on those subjects 18 years and older, there were no pediatric patients enrolled in the study.|Participants|Count of Participants|126|126.0||||||
3783309|NCT01875471|3613645|B3||<=18 years|Age|Data was collected on those subjects 18 years and older, there were no pediatric patients enrolled in the study.|Participants|Count of Participants|20|20.0||||||
3783310|NCT01875471|3613646|B2||<=18 years|Age|Data was collected on those subjects 18 years and older, there were no pediatric patients enrolled in the study.|Participants|Count of Participants|9|9.0||||||
3783311|NCT01875471|3613647|B1||<=18 years|Age|Data was collected on those subjects 18 years and older, there were no pediatric patients enrolled in the study.|Participants|Count of Participants|11|11.0||||||
3783312|NCT01875445|3613654|B3|||The Clinical Global Impressions Scale-Severity|A clinician rating of disorder severity with scores ranging from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|4.4|4.4|Standard Deviation|.6|0.6|||
3783313|NCT01875445|3613655|B2|||The Clinical Global Impressions Scale-Severity|A clinician rating of disorder severity with scores ranging from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|4.5|4.5|Standard Deviation|.6|0.6|||
3783314|NCT01875445|3613656|B1|||The Clinical Global Impressions Scale-Severity|A clinician rating of disorder severity with scores ranging from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|4.2|4.2|Standard Deviation|.5|0.5|||
3783315|NCT01875445|3613654|B3|||Massachusetts General Hospital Hairpulling Scale|A standard self-report scale to assess trichotillomania symptom severity. Scale range of 0-28. Higher scores indicate greater severity.|units on a scale|Mean|18.4|18.4|Standard Deviation|3.8|3.8|||
3783316|NCT01875445|3613655|B2|||Massachusetts General Hospital Hairpulling Scale|A standard self-report scale to assess trichotillomania symptom severity. Scale range of 0-28. Higher scores indicate greater severity.|units on a scale|Mean|18.8|18.8|Standard Deviation|4.2|4.2|||
3783317|NCT01875445|3613656|B1|||Massachusetts General Hospital Hairpulling Scale|A standard self-report scale to assess trichotillomania symptom severity. Scale range of 0-28. Higher scores indicate greater severity.|units on a scale|Mean|17.9|17.9|Standard Deviation|3.3|3.3|||
3783318|NCT01875445|3613654|B3|||National Institute of Mental Health Trichotillomania Severity Scale|A standard clinician administered scale to assess trichotillomania symptom severity. Scale range of 0-25. Higher scores indicate greater severity.|units on a scale|Mean|12.3|12.3|Standard Deviation|3.6|3.6|||
3783319|NCT01875445|3613655|B2|||National Institute of Mental Health Trichotillomania Severity Scale|A standard clinician administered scale to assess trichotillomania symptom severity. Scale range of 0-25. Higher scores indicate greater severity.|units on a scale|Mean|12.9|12.9|Standard Deviation|3.7|3.7|||
3783320|NCT01875445|3613656|B1|||National Institute of Mental Health Trichotillomania Severity Scale|A standard clinician administered scale to assess trichotillomania symptom severity. Scale range of 0-25. Higher scores indicate greater severity.|units on a scale|Mean|11.6|11.6|Standard Deviation|3.4|3.4|||
3783321|NCT01875445|3613654|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
3783322|NCT01875445|3613655|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3783323|NCT01875445|3613656|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3783324|NCT01875445|3613654|B3|Race/Ethnicity|Latino/Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3783325|NCT01875445|3613655|B2|Race/Ethnicity|Latino/Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3783326|NCT01875445|3613656|B1|Race/Ethnicity|Latino/Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3783327|NCT01875445|3613654|B3|Race/Ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3783328|NCT01875445|3613655|B2|Race/Ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3783329|NCT01875445|3613656|B1|Race/Ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3783330|NCT01875445|3613654|B3|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
3783331|NCT01875445|3613655|B2|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3783332|NCT01875445|3613656|B1|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3783333|NCT01875445|3613654|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3783334|NCT01875445|3613655|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3783335|NCT01875445|3613656|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3783336|NCT01875445|3613654|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3783337|NCT01875445|3613655|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3783338|NCT01875445|3613656|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3783339|NCT01875445|3613654|B3|||Age||Years|Mean|28.9|28.9|Standard Deviation|11.4|11.4|||
3783340|NCT01875445|3613655|B2|||Age||Years|Mean|28.0|28.0|Standard Deviation|11.4|11.4|||
3783341|NCT01875445|3613656|B1|||Age||Years|Mean|29.8|29.8|Standard Deviation|12.2|12.2|||
3783342|NCT01875185|3613665|B3|United States||Region of Enrollment||Participants|Count of Participants|100|100.0||||||
3783343|NCT01875185|3613666|B2|United States||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
3783344|NCT01875185|3613667|B1|United States||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
3783345|NCT01875185|3613665|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3783346|NCT01875185|3613666|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3783347|NCT01875185|3613667|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3783348|NCT01875185|3613665|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3783349|NCT01875185|3613666|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3783350|NCT01875185|3613667|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3783351|NCT01875185|3613665|B3||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
3783352|NCT01875185|3613666|B2||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
3783353|NCT01875185|3613667|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3783354|NCT01875185|3613665|B3||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3783355|NCT01875185|3613666|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3783356|NCT01875185|3613667|B1||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3783357|NCT01875185|3613665|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3783358|NCT01875185|3613666|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3783359|NCT01875185|3613667|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3783360|NCT01875159|3613680|B3|||Mean birth weight||grams|Mean|1270.1|1270.1|Standard Deviation|267.2|267.2|||
3783361|NCT01875159|3613681|B2|||Mean birth weight||grams|Mean|1274.5|1274.5|Standard Deviation|270.3|270.3|||
3783362|NCT01875159|3613682|B1|||Mean birth weight||grams|Mean|1262.1|1262.1|Standard Deviation|265.6|265.6|||
3783363|NCT01875159|3613680|B3|United States||Region of Enrollment||participants|Number|98|98.0||||||
3783364|NCT01875159|3613681|B2|United States||Region of Enrollment||participants|Number|53|53.0||||||
3783365|NCT01875159|3613682|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
3783366|NCT01875159|3613680|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3783367|NCT01875159|3613681|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3783368|NCT01875159|3613682|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3783369|NCT01875159|3613680|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3783370|NCT01875159|3613681|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783371|NCT01875159|3613682|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3783372|NCT01875159|3613680|B3||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3783373|NCT01875159|3613681|B2||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3783374|NCT01875159|3613682|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3783375|NCT01875159|3613680|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3783376|NCT01875159|3613681|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3783377|NCT01875159|3613682|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3783378|NCT01875159|3613680|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3783379|NCT01875159|3613681|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783380|NCT01875159|3613682|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3783381|NCT01875159|3613680|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783382|NCT01875159|3613681|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783383|NCT01875159|3613682|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783384|NCT01875159|3613680|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783385|NCT01875159|3613681|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783386|NCT01875159|3613682|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783387|NCT01875159|3613680|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3783388|NCT01875159|3613681|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783389|NCT01875159|3613682|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3783390|NCT01875159|3613680|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3783391|NCT01875159|3613681|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3783392|NCT01875159|3613682|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3783393|NCT01875159|3613680|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3783394|NCT01875159|3613681|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3783395|NCT01875159|3613682|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3783396|NCT01875159|3613680|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3783397|NCT01875159|3613681|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3783398|NCT01875159|3613682|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3783399|NCT01875159|3613680|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3783400|NCT01875159|3613681|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3783401|NCT01875159|3613682|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3783402|NCT01875159|3613680|B3|Gestational Age||Age, Customized||Weeks|Mean|28.9|28.9|Standard Deviation|1.7|1.7|||
3783403|NCT01875159|3613681|B2|Gestational Age||Age, Customized||Weeks|Mean|29.1|29.1|Standard Deviation|1.7|1.7|||
3783404|NCT01875159|3613682|B1|Gestational Age||Age, Customized||Weeks|Mean|28.6|28.6|Standard Deviation|1.7|1.7|||
3783405|NCT01874951|3613691|B3|||Clinical Global Improvement-Severity (CGI-S) score|The CGI-S score is a one-item scale that measures severity of depression, scored from 1-7, where 1 = no depression is present, 2 = borderline depression, 3 = mild depression, 4 = moderate depression, 5 = marked depression, 6 = severe depression, and 7 = among the most extremely depressed patient. Thus higher scores indicate greater depressive severity.|units on a scale|Mean|4.3|4.3|Standard Deviation|0.5|0.5|||
3783406|NCT01874951|3613692|B2|||Clinical Global Improvement-Severity (CGI-S) score|The CGI-S score is a one-item scale that measures severity of depression, scored from 1-7, where 1 = no depression is present, 2 = borderline depression, 3 = mild depression, 4 = moderate depression, 5 = marked depression, 6 = severe depression, and 7 = among the most extremely depressed patient. Thus higher scores indicate greater depressive severity.|units on a scale|Mean|4.3|4.3|Standard Deviation|0.5|0.5|||
3783467|NCT01874951|3613693|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3783468|NCT01874951|3613691|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3783469|NCT01874951|3613692|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3783407|NCT01874951|3613693|B1|||Clinical Global Improvement-Severity (CGI-S) score|The CGI-S score is a one-item scale that measures severity of depression, scored from 1-7, where 1 = no depression is present, 2 = borderline depression, 3 = mild depression, 4 = moderate depression, 5 = marked depression, 6 = severe depression, and 7 = among the most extremely depressed patient. Thus higher scores indicate greater depressive severity.|units on a scale|Mean|4.3|4.3|Standard Deviation|0.5|0.5|||
3783408|NCT01874951|3613691|B3|||MADRS-15 score|The MADRS-15 contains 15 items, scored from 0-6, where 0 indicates that the symptom is NOT present and higher scores indicate greater severity. The highest possible score on the instrument is 90 and the lowest 0. The higher the total score, the greater the depressive severity. Items 11-15 characterize additional features of depression including fatigue, psychomotor changes, and hyperphagia and hypersomnia. Overall severity of depression is assessed on the basis of the total score obtained from the first 10 items: None = 0-6, Mild = 7-19, Moderate = 20-34, Severe = 35 or greater.|units on a scale|Mean|36.6|36.6|Standard Deviation|4.9|4.9|||
3783409|NCT01874951|3613692|B2|||MADRS-15 score|The MADRS-15 contains 15 items, scored from 0-6, where 0 indicates that the symptom is NOT present and higher scores indicate greater severity. The highest possible score on the instrument is 90 and the lowest 0. The higher the total score, the greater the depressive severity. Items 11-15 characterize additional features of depression including fatigue, psychomotor changes, and hyperphagia and hypersomnia. Overall severity of depression is assessed on the basis of the total score obtained from the first 10 items: None = 0-6, Mild = 7-19, Moderate = 20-34, Severe = 35 or greater.|units on a scale|Mean|36.6|36.6|Standard Deviation|6.2|6.2|||
3783410|NCT01874951|3613693|B1|||MADRS-15 score|The MADRS-15 contains 15 items, scored from 0-6, where 0 indicates that the symptom is NOT present and higher scores indicate greater severity. The highest possible score on the instrument is 90 and the lowest 0. The higher the total score, the greater the depressive severity. Items 11-15 characterize additional features of depression including fatigue, psychomotor changes, and hyperphagia and hypersomnia. Overall severity of depression is assessed on the basis of the total score obtained from the first 10 items: None = 0-6, Mild = 7-19, Moderate = 20-34, Severe = 35 or greater.|units on a scale|Mean|36.7|36.7|Standard Deviation|4.2|4.2|||
3783411|NCT01874951|3613691|B3|||MADRS-10 score|The MADRS-10 contains 10 items, covering different symptoms of depression. Items are equally weighted and scored from 0-6, where 0 indicates that the symptom is NOT present and higher scores indicate greater severity. Thus the highest possible total score on the instrument is 60 and the lowest possible score is zero. The higher the total score, the greater the depressive severity. As a general guideline, the following total score ranges suggest differing degrees of depression: None = 0-6, Mild = 7-19, Moderate = 20-34, Severe = 35 or greater.|units on a scale|Mean|30.5|30.5|Standard Deviation|4.3|4.3|||
3783412|NCT01874951|3613692|B2|||MADRS-10 score|The MADRS-10 contains 10 items, covering different symptoms of depression. Items are equally weighted and scored from 0-6, where 0 indicates that the symptom is NOT present and higher scores indicate greater severity. Thus the highest possible total score on the instrument is 60 and the lowest possible score is zero. The higher the total score, the greater the depressive severity. As a general guideline, the following total score ranges suggest differing degrees of depression: None = 0-6, Mild = 7-19, Moderate = 20-34, Severe = 35 or greater.|units on a scale|Mean|30.4|30.4|Standard Deviation|4.9|4.9|||
3783413|NCT01874951|3613693|B1|||MADRS-10 score|The MADRS-10 contains 10 items, covering different symptoms of depression. Items are equally weighted and scored from 0-6, where 0 indicates that the symptom is NOT present and higher scores indicate greater severity. Thus the highest possible total score on the instrument is 60 and the lowest possible score is zero. The higher the total score, the greater the depressive severity. As a general guideline, the following total score ranges suggest differing degrees of depression: None = 0-6, Mild = 7-19, Moderate = 20-34, Severe = 35 or greater.|units on a scale|Mean|30.7|30.7|Standard Deviation|4.3|4.3|||
3783414|NCT01874951|3613691|B3|||Hamilton-D-28 score|The HAMD-28 contains 28 items. Items are rated on a 0-4, 0-3, or 0-2 point scale, where 0 means the symptom is NOT present; higher scores indicate greater symptom severity. Twelve items are graded from 0-4, one from 0-3, and fifteen from 0-2. The highest possible score is 81 and the lowest is 0. higher score means greater severity. Items 18-28 characterize additional symptoms--hypersomnia, hyperphagia, depersonalization, paranoia, and obsessive-compulsive. Overall severity is assessedon the basis of the total score from the first 17 items: None:0-7, Mild:8-15, Moderate:16-25, Severe: >=26.|units on a scale|Mean|26.3|26.3|Standard Deviation|3.2|3.2|||
3783415|NCT01874951|3613692|B2|||Hamilton-D-28 score|The HAMD-28 contains 28 items. Items are rated on a 0-4, 0-3, or 0-2 point scale, where 0 means the symptom is NOT present; higher scores indicate greater symptom severity. Twelve items are graded from 0-4, one from 0-3, and fifteen from 0-2. The highest possible score is 81 and the lowest is 0. higher score means greater severity. Items 18-28 characterize additional symptoms--hypersomnia, hyperphagia, depersonalization, paranoia, and obsessive-compulsive. Overall severity is assessedon the basis of the total score from the first 17 items: None:0-7, Mild:8-15, Moderate:16-25, Severe: >=26.|units on a scale|Mean|26.2|26.2|Standard Deviation|4.0|4.0|||
3783416|NCT01874951|3613693|B1|||Hamilton-D-28 score|The HAMD-28 contains 28 items. Items are rated on a 0-4, 0-3, or 0-2 point scale, where 0 means the symptom is NOT present; higher scores indicate greater symptom severity. Twelve items are graded from 0-4, one from 0-3, and fifteen from 0-2. The highest possible score is 81 and the lowest is 0. higher score means greater severity. Items 18-28 characterize additional symptoms--hypersomnia, hyperphagia, depersonalization, paranoia, and obsessive-compulsive. Overall severity is assessedon the basis of the total score from the first 17 items: None:0-7, Mild:8-15, Moderate:16-25, Severe: >=26.|units on a scale|Mean|26.3|26.3|Standard Deviation|2.6|2.6|||
3783417|NCT01874951|3613691|B3|||Hamilton-D-17 score|The HAMD-17 contains 17 items covering different depression symptoms. Items are rated on a 0-4 point or 0-2 point scale, where 0 means the symptom is NOT present; higher scores indicate greater symptom severity. Nine items are graded from 0-4 and eight items are rated from 0-2. The highest possible total score on the instrument is 52 and the lowest score is zero. The higher the total score, the greater the depressive severity. As a general guideline, the following total score ranges suggest differing degrees of depression: None = 0-7, Mild = 8-15, Moderate = 16-25, Severe = 26 or greater.|units on a scale|Mean|22.4|22.4|Standard Deviation|2.4|2.4|||
3783470|NCT01874951|3613693|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3783471|NCT01874665|3613714|B3|||Height||centimeter (cm)|Mean|171.23|171.23|Standard Deviation|7.534|7.534|||
3783418|NCT01874951|3613692|B2|||Hamilton-D-17 score|The HAMD-17 contains 17 items covering different depression symptoms. Items are rated on a 0-4 point or 0-2 point scale, where 0 means the symptom is NOT present; higher scores indicate greater symptom severity. Nine items are graded from 0-4 and eight items are rated from 0-2. The highest possible total score on the instrument is 52 and the lowest score is zero. The higher the total score, the greater the depressive severity. As a general guideline, the following total score ranges suggest differing degrees of depression: None = 0-7, Mild = 8-15, Moderate = 16-25, Severe = 26 or greater.|units on a scale|Mean|21.2|21.2|Standard Deviation|2.0|2.0|||
3783419|NCT01874951|3613693|B1|||Hamilton-D-17 score|The HAMD-17 contains 17 items covering different depression symptoms. Items are rated on a 0-4 point or 0-2 point scale, where 0 means the symptom is NOT present; higher scores indicate greater symptom severity. Nine items are graded from 0-4 and eight items are rated from 0-2. The highest possible total score on the instrument is 52 and the lowest score is zero. The higher the total score, the greater the depressive severity. As a general guideline, the following total score ranges suggest differing degrees of depression: None = 0-7, Mild = 8-15, Moderate = 16-25, Severe = 26 or greater.|units on a scale|Mean|23.7|23.7|Standard Deviation|2.3|2.3|||
3783420|NCT01874951|3613691|B3|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3783421|NCT01874951|3613692|B2|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3783422|NCT01874951|3613693|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3783423|NCT01874951|3613691|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3783424|NCT01874951|3613692|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3783425|NCT01874951|3613693|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783426|NCT01874951|3613691|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3783427|NCT01874951|3613692|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3783428|NCT01874951|3613693|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783429|NCT01874951|3613691|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3783430|NCT01874951|3613692|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3783431|NCT01874951|3613693|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3783432|NCT01874951|3613691|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3783433|NCT01874951|3613692|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783434|NCT01874951|3613693|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3783435|NCT01874951|3613691|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783436|NCT01874951|3613692|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783437|NCT01874951|3613693|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783438|NCT01874951|3613691|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783439|NCT01874951|3613692|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783440|NCT01874951|3613693|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783441|NCT01874951|3613691|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783442|NCT01874951|3613692|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783443|NCT01874951|3613693|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783444|NCT01874951|3613691|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3783445|NCT01874951|3613692|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3783446|NCT01874951|3613693|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3783447|NCT01874951|3613691|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3783448|NCT01874951|3613692|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3783449|NCT01874951|3613693|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3783450|NCT01874951|3613691|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3783451|NCT01874951|3613692|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3783452|NCT01874951|3613693|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783453|NCT01874951|3613691|B3||Male|Gender||Participants|Count of Participants|8|8.0||||||
3783454|NCT01874951|3613692|B2||Male|Gender||Participants|Count of Participants|3|3.0||||||
3783455|NCT01874951|3613693|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
3783456|NCT01874951|3613691|B3||Female|Gender||Participants|Count of Participants|4|4.0||||||
3783457|NCT01874951|3613692|B2||Female|Gender||Participants|Count of Participants|3|3.0||||||
3783458|NCT01874951|3613693|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
3783459|NCT01874951|3613691|B3|||Age||years|Mean|45|45.0|Standard Deviation|12|12.0|||
3783460|NCT01874951|3613692|B2|||Age||years|Mean|47|47.0|Standard Deviation|13|13.0|||
3783461|NCT01874951|3613693|B1|||Age||years|Mean|43|43.0|Standard Deviation|11|11.0|||
3783462|NCT01874951|3613691|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3783463|NCT01874951|3613692|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3783464|NCT01874951|3613693|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3783465|NCT01874951|3613691|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3783466|NCT01874951|3613692|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3783472|NCT01874665|3613715|B2|||Height||centimeter (cm)|Mean|171.28|171.28|Standard Deviation|7.149|7.149|||
3783473|NCT01874665|3613716|B1|||Height||centimeter (cm)|Mean|171.20|171.2|Standard Deviation|7.839|7.839|||
3783474|NCT01874665|3613714|B3|||Weight||kilogram (kg)|Mean|78.45|78.45|Standard Deviation|18.702|18.702|||
3783475|NCT01874665|3613715|B2|||Weight||kilogram (kg)|Mean|75.10|75.1|Standard Deviation|13.917|13.917|||
3783476|NCT01874665|3613716|B1|||Weight||kilogram (kg)|Mean|80.12|80.12|Standard Deviation|20.699|20.699|||
3783477|NCT01874665|3613714|B3|United States||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3783478|NCT01874665|3613715|B2|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3783479|NCT01874665|3613716|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3783480|NCT01874665|3613714|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3783481|NCT01874665|3613715|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783482|NCT01874665|3613716|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3783483|NCT01874665|3613714|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783484|NCT01874665|3613715|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783485|NCT01874665|3613716|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783486|NCT01874665|3613714|B3||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3783487|NCT01874665|3613715|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3783488|NCT01874665|3613716|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3783489|NCT01874665|3613714|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783490|NCT01874665|3613715|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783491|NCT01874665|3613716|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783492|NCT01874665|3613714|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783493|NCT01874665|3613715|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783494|NCT01874665|3613716|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783495|NCT01874665|3613714|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783496|NCT01874665|3613715|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783497|NCT01874665|3613716|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783498|NCT01874665|3613714|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783499|NCT01874665|3613715|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783500|NCT01874665|3613716|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783501|NCT01874665|3613714|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783502|NCT01874665|3613715|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783503|NCT01874665|3613716|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783504|NCT01874665|3613714|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3783505|NCT01874665|3613715|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3783506|NCT01874665|3613716|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3783507|NCT01874665|3613714|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3783508|NCT01874665|3613715|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783509|NCT01874665|3613716|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3783510|NCT01874665|3613714|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3783511|NCT01874665|3613715|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3783512|NCT01874665|3613716|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3783513|NCT01874665|3613714|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3783514|NCT01874665|3613715|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3783515|NCT01874665|3613716|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3783516|NCT01874665|3613714|B3|||Age||years|Mean|57.5|57.5|Standard Deviation|12.63|12.63|||
3783517|NCT01874665|3613715|B2|||Age||years|Mean|53.9|53.9|Standard Deviation|16.06|16.06|||
3783518|NCT01874665|3613716|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|10.37|10.37|||
3783519|NCT01874535|3613743|B3|Taiwan||Region of Enrollment||Participants|Count of Participants|408|408.0||||||
3783520|NCT01874535|3613744|B2|Taiwan||Region of Enrollment||Participants|Count of Participants|201|201.0||||||
3783521|NCT01874535|3613745|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|207|207.0||||||
3783522|NCT01874535|3613743|B3|sex|Male|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
3783523|NCT01874535|3613744|B2|sex|Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3783524|NCT01874535|3613745|B1|sex|Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3783525|NCT01874535|3613743|B3|sex|Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3783526|NCT01874535|3613744|B2|sex|Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3783527|NCT01874535|3613745|B1|sex|Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3783528|NCT01874535|3613743|B3|age||Age||years|Mean|51.1|51.1|Standard Deviation|12.8|12.8|||
3783529|NCT01874535|3613744|B2|age||Age||years|Mean|51.1|51.1|Standard Deviation|12.8|12.8|||
3783530|NCT01874535|3613745|B1|age||Age||years|Mean|51.1|51.1|Standard Deviation|12.8|12.8|||
3783531|NCT01874353|3613752|B3|>12 months||Time to disease progression in the penultimate platinum chemotherapy||Participants|Number|176|176.0||||||
3783532|NCT01874353|3613753|B2|>12 months||Time to disease progression in the penultimate platinum chemotherapy||Participants|Number|59|59.0||||||
3783533|NCT01874353|3613754|B1|>12 months||Time to disease progression in the penultimate platinum chemotherapy||Participants|Number|117|117.0||||||
3783534|NCT01874353|3613752|B3|>6 - 12 months||Time to disease progression in the penultimate platinum chemotherapy||Participants|Number|119|119.0||||||
3783535|NCT01874353|3613753|B2|>6 - 12 months||Time to disease progression in the penultimate platinum chemotherapy||Participants|Number|40|40.0||||||
3783536|NCT01874353|3613754|B1|>6 - 12 months||Time to disease progression in the penultimate platinum chemotherapy||Participants|Number|79|79.0||||||
3783537|NCT01874353|3613752|B3|Partial Response||Response to previous platinum chemotherapy||Participants|Number|157|157.0||||||
3783538|NCT01874353|3613753|B2|Partial Response||Response to previous platinum chemotherapy||Participants|Number|52|52.0||||||
3783539|NCT01874353|3613754|B1|Partial Response||Response to previous platinum chemotherapy||Participants|Number|105|105.0||||||
3783540|NCT01874353|3613752|B3|Complete Response||Response to previous platinum chemotherapy||Participants|Number|138|138.0||||||
3783541|NCT01874353|3613753|B2|Complete Response||Response to previous platinum chemotherapy||Participants|Number|47|47.0||||||
3783542|NCT01874353|3613754|B1|Complete Response||Response to previous platinum chemotherapy||Participants|Number|91|91.0||||||
3783543|NCT01874353|3613752|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3783544|NCT01874353|3613753|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3783545|NCT01874353|3613754|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3783546|NCT01874353|3613752|B3||Female|Sex: Female, Male||Participants|Count of Participants|295|295.0||||||
3783547|NCT01874353|3613753|B2||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3783548|NCT01874353|3613754|B1||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
3783549|NCT01874353|3613752|B3|||Age||Years|Mean|56.9|56.9|Standard Deviation|9.09|9.09|||
3783550|NCT01874353|3613753|B2|||Age||Years|Mean|56.6|56.6|Standard Deviation|8.90|8.9|||
3783551|NCT01874353|3613754|B1|||Age||Years|Mean|57.0|57.0|Standard Deviation|9.20|9.2|||
3783552|NCT01874340|3613778|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3783553|NCT01874340|3613779|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3783554|NCT01874340|3613780|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3783555|NCT01874340|3613781|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3783556|NCT01874340|3613782|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3783557|NCT01874340|3613778|B5||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3783558|NCT01874340|3613779|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3783559|NCT01874340|3613780|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3783560|NCT01874340|3613781|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3783561|NCT01874340|3613782|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3783562|NCT01874340|3613778|B5|||Age||Years|Mean|33.5|33.5|Standard Deviation|8.79|8.79|||
3783563|NCT01874340|3613779|B4|||Age||Years|Mean|34.0|34.0|Standard Deviation|9.30|9.3|||
3783564|NCT01874340|3613780|B3|||Age||Years|Mean|35.5|35.5|Standard Deviation|9.71|9.71|||
3783565|NCT01874340|3613781|B2|||Age||Years|Mean|34.5|34.5|Standard Deviation|8.64|8.64|||
3783566|NCT01874340|3613782|B1|||Age||Years|Mean|28.8|28.8|Standard Deviation|7.73|7.73|||
3783567|NCT01874275|3613811|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3783568|NCT01874275|3613812|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3783569|NCT01874275|3613813|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3783570|NCT01874275|3613811|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3783571|NCT01874275|3613812|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3783572|NCT01874275|3613813|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3783573|NCT01874275|3613811|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3783574|NCT01874275|3613812|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3783575|NCT01874275|3613813|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3783576|NCT01874275|3613811|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3783577|NCT01874275|3613812|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3783578|NCT01874275|3613813|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3783579|NCT01874275|3613811|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3783580|NCT01874275|3613812|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3783581|NCT01874275|3613813|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3783582|NCT01874275|3613811|B3||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3783583|NCT01874275|3613812|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3783584|NCT01874275|3613813|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3783585|NCT01874262|3613826|B3||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3783586|NCT01874262|3613827|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3783587|NCT01874262|3613828|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3783588|NCT01874262|3613826|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3783589|NCT01874262|3613827|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3783590|NCT01874262|3613828|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3783591|NCT01874262|3613826|B3|||Age, Customized||years|Mean|57.5|57.5|Standard Deviation|8.3|8.3|||
3783592|NCT01874262|3613827|B2|||Age, Customized||years|Mean|58.4|58.4|Standard Deviation|8.6|8.6|||
3783593|NCT01874262|3613828|B1|||Age, Customized||years|Mean|56.8|56.8|Standard Deviation|8.0|8.0|||
3783594|NCT01874145|3613835|B3|||Expanded Disability Status Scale (EDSS)|"The Kurtzke Expanded Disability Status Scale (EDSS) is a method of quantifying disability in multiple sclerosis. The EDSS quantifies disability in eight Functional Systems (FS):~pyramidal~cerebellar~brainstem~sensory~bowel and bladder~visual~cerebral~other~The scale is from 0 (normal neurological examination) to 10 (Death due to MS). A grade of 2.5 refers to a mild disability in one functional system or minimal disability in two functional systems."|units on a scale|Mean|2.4|2.4|Standard Deviation|1.37|1.37|||
3783595|NCT01874145|3613836|B2|||Expanded Disability Status Scale (EDSS)|"The Kurtzke Expanded Disability Status Scale (EDSS) is a method of quantifying disability in multiple sclerosis. The EDSS quantifies disability in eight Functional Systems (FS):~pyramidal~cerebellar~brainstem~sensory~bowel and bladder~visual~cerebral~other~The scale is from 0 (normal neurological examination) to 10 (Death due to MS). A grade of 2.5 refers to a mild disability in one functional system or minimal disability in two functional systems."|units on a scale|Mean|2.5|2.5|Standard Deviation|1.36|1.36|||
3783596|NCT01874145|3613837|B1|||Expanded Disability Status Scale (EDSS)|"The Kurtzke Expanded Disability Status Scale (EDSS) is a method of quantifying disability in multiple sclerosis. The EDSS quantifies disability in eight Functional Systems (FS):~pyramidal~cerebellar~brainstem~sensory~bowel and bladder~visual~cerebral~other~The scale is from 0 (normal neurological examination) to 10 (Death due to MS). A grade of 2.5 refers to a mild disability in one functional system or minimal disability in two functional systems."|units on a scale|Mean|2.4|2.4|Standard Deviation|1.38|1.38|||
3783597|NCT01874145|3613835|B3|||Number of Relapses in 2 Years Prior to Screening||relapses|Mean|0.4|0.4|Standard Deviation|0.69|0.69|||
3783598|NCT01874145|3613836|B2|||Number of Relapses in 2 Years Prior to Screening||relapses|Mean|0.4|0.4|Standard Deviation|0.64|0.64|||
3783599|NCT01874145|3613837|B1|||Number of Relapses in 2 Years Prior to Screening||relapses|Mean|0.4|0.4|Standard Deviation|0.74|0.74|||
3783600|NCT01874145|3613835|B3|||Number of Relapses in 1 Year Prior to Screening||relapses|Mean|0.2|0.2|Standard Deviation|0.44|0.44|||
3783601|NCT01874145|3613836|B2|||Number of Relapses in 1 Year Prior to Screening||relapses|Mean|0.2|0.2|Standard Deviation|0.47|0.47|||
3783602|NCT01874145|3613837|B1|||Number of Relapses in 1 Year Prior to Screening||relapses|Mean|0.2|0.2|Standard Deviation|0.41|0.41|||
3783603|NCT01874145|3613835|B3|||Time from MS Diagnosis||years|Mean|11.5|11.5|Standard Deviation|9.30|9.3|||
3783604|NCT01874145|3613836|B2|||Time from MS Diagnosis||years|Mean|10.8|10.8|Standard Deviation|8.55|8.55|||
3783605|NCT01874145|3613837|B1|||Time from MS Diagnosis||years|Mean|12.1|12.1|Standard Deviation|10.04|10.04|||
3783606|NCT01874145|3613835|B3|||Time to First MS Symptom||years|Mean|15.9|15.9|Standard Deviation|11.00|11.0|||
3783607|NCT01874145|3613836|B2|||Time to First MS Symptom||years|Mean|15.7|15.7|Standard Deviation|11.10|11.1|||
3783608|NCT01874145|3613837|B1|||Time to First MS Symptom||years|Mean|16.2|16.2|Standard Deviation|10.95|10.95|||
3783609|NCT01874145|3613835|B3|Never Smoked||Tobacco user||participants|Number|136|136.0||||||
3783610|NCT01874145|3613836|B2|Never Smoked||Tobacco user||participants|Number|71|71.0||||||
3783611|NCT01874145|3613837|B1|Never Smoked||Tobacco user||participants|Number|65|65.0||||||
3783612|NCT01874145|3613835|B3|Former||Tobacco user||participants|Number|50|50.0||||||
3783613|NCT01874145|3613836|B2|Former||Tobacco user||participants|Number|29|29.0||||||
3783614|NCT01874145|3613837|B1|Former||Tobacco user||participants|Number|21|21.0||||||
3783615|NCT01874145|3613835|B3|Current||Tobacco user||participants|Number|23|23.0||||||
3783616|NCT01874145|3613836|B2|Current||Tobacco user||participants|Number|8|8.0||||||
3783617|NCT01874145|3613837|B1|Current||Tobacco user||participants|Number|15|15.0||||||
3783618|NCT01874145|3613835|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3783619|NCT01874145|3613836|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3783620|NCT01874145|3613837|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3783621|NCT01874145|3613835|B3|Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3783622|NCT01874145|3613836|B2|Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3783623|NCT01874145|3613837|B1|Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3783624|NCT01874145|3613835|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3783625|NCT01874145|3613836|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3783626|NCT01874145|3613837|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3783627|NCT01874145|3613835|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3783628|NCT01874145|3613836|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3783629|NCT01874145|3613837|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3783630|NCT01874145|3613835|B3|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3783631|NCT01874145|3613836|B2|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3783632|NCT01874145|3613837|B1|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3783633|NCT01874145|3613835|B3|White||Race/Ethnicity, Customized||participants|Number|196|196.0||||||
3783634|NCT01874145|3613836|B2|White||Race/Ethnicity, Customized||participants|Number|100|100.0||||||
3783635|NCT01874145|3613837|B1|White||Race/Ethnicity, Customized||participants|Number|96|96.0||||||
3783636|NCT01874145|3613835|B3|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3783637|NCT01874145|3613836|B2|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3783638|NCT01874145|3613837|B1|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3783639|NCT01874145|3613835|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3783640|NCT01874145|3613836|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3783641|NCT01874145|3613837|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3783642|NCT01874145|3613835|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|206|206.0||||||
3783643|NCT01874145|3613836|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|107|107.0||||||
3783644|NCT01874145|3613837|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|99|99.0||||||
3783645|NCT01874145|3613835|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3783646|NCT01874145|3613836|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3783647|NCT01874145|3613837|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3783648|NCT01874145|3613835|B3||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3783649|NCT01874145|3613836|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3783650|NCT01874145|3613837|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3783651|NCT01874145|3613835|B3|||Age||years|Mean|50.7|50.7|Standard Deviation|10.22|10.22|||
3783652|NCT01874145|3613836|B2|||Age||years|Mean|50.9|50.9|Standard Deviation|11.01|11.01|||
3783653|NCT01874145|3613837|B1|||Age||years|Mean|50.4|50.4|Standard Deviation|9.34|9.34|||
3783654|NCT01874132|3613874|B4|Portugal||Region of Enrollment||participants|Number|66|66.0||||||
3783655|NCT01874132|3613875|B3|Portugal||Region of Enrollment||participants|Number|22|22.0||||||
3783656|NCT01874132|3613876|B2|Portugal||Region of Enrollment||participants|Number|22|22.0||||||
3783657|NCT01874132|3613877|B1|Portugal||Region of Enrollment||participants|Number|22|22.0||||||
3783658|NCT01874132|3613874|B4||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3783659|NCT01874132|3613875|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3783660|NCT01874132|3613876|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3783661|NCT01874132|3613877|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3783662|NCT01874132|3613874|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3783663|NCT01874132|3613875|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3783664|NCT01874132|3613876|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3783665|NCT01874132|3613877|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3783666|NCT01874132|3613874|B4|||Age||years|Mean|69.5|69.5|Standard Deviation|4.5|4.5|||
3783667|NCT01874132|3613875|B3|||Age||years|Mean|67.2|67.2|Standard Deviation|5.5|5.5|||
3783668|NCT01874132|3613876|B2|||Age||years|Mean|71.3|71.3|Standard Deviation|4.6|4.6|||
3783669|NCT01874132|3613877|B1|||Age||years|Mean|69.0|69.0|Standard Deviation|4.9|4.9|||
3783670|NCT01874132|3613874|B4||>=65 years|Age||Participants|Count of Participants|66|66.0||||||
3783671|NCT01874132|3613875|B3||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3783672|NCT01874132|3613876|B2||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3783673|NCT01874132|3613877|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3783674|NCT01874132|3613874|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3783675|NCT01874132|3613875|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3783676|NCT01874132|3613876|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3783677|NCT01874132|3613877|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3783678|NCT01874132|3613874|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3783679|NCT01874132|3613875|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3783680|NCT01874132|3613876|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3783681|NCT01874132|3613877|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3783682|NCT01874119|3613890|B1|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3783683|NCT01874119|3613890|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3783684|NCT01874119|3613890|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3783685|NCT01874119|3613890|B1|||Age||years|Median|61|61.0|Full Range|||37.0|64.0|
3783686|NCT01874119|3613890|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3783687|NCT01874119|3613890|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3783688|NCT01874119|3613890|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3783689|NCT01874054|3613897|B1||2|Eastern Cooperative Group Oncology Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed <50% of the time; 3= In bed >50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|1|1.0||||||
3783690|NCT01874054|3613897|B1||1|Eastern Cooperative Group Oncology Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed <50% of the time; 3= In bed >50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|18|18.0||||||
3783691|NCT01874054|3613897|B1||0|Eastern Cooperative Group Oncology Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed <50% of the time; 3= In bed >50% of the time; 4=100% bedridden; 5=Dead|Participants|Count of Participants|36|36.0||||||
3783692|NCT01874054|3613897|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
3783693|NCT01874054|3613897|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3783694|NCT01874054|3613897|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783695|NCT01874054|3613897|B1||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3783696|NCT01874054|3613897|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3783697|NCT01874054|3613897|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783698|NCT01874054|3613897|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783699|NCT01874054|3613897|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783700|NCT01874054|3613897|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3783701|NCT01874054|3613897|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3783702|NCT01874054|3613897|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3783703|NCT01874054|3613897|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3783704|NCT01874054|3613897|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3783705|NCT01874054|3613897|B1|||Age||years|Median|36|36.0|Full Range|||19.0|79.0|
3783706|NCT01874054|3613897|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3783707|NCT01874054|3613897|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3783708|NCT01874054|3613897|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3783709|NCT01873989|3613906|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
3783710|NCT01873989|3613907|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3783711|NCT01873989|3613908|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3783712|NCT01873989|3613906|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3783713|NCT01873989|3613907|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3783714|NCT01873989|3613908|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3783715|NCT01873989|3613906|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3783716|NCT01873989|3613907|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3783717|NCT01873989|3613908|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3783718|NCT01873989|3613906|B3|||Age||years|Mean|47|47.0|Standard Deviation|10|10.0|||
3783719|NCT01873989|3613907|B2|||Age||years|Mean|48|48.0|Standard Deviation|11|11.0|||
3783720|NCT01873989|3613908|B1|||Age||years|Mean|46|46.0|Standard Deviation|10|10.0|||
3783721|NCT01873989|3613906|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3783722|NCT01873989|3613907|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3783723|NCT01873989|3613908|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3783724|NCT01873989|3613906|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3783725|NCT01873989|3613907|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3783726|NCT01873989|3613908|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3783727|NCT01873989|3613906|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3783728|NCT01873989|3613907|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3783729|NCT01873989|3613908|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3783730|NCT01873950|3613919|B1|||Ventricular gradient||mV*ms|Mean|111.4|111.4|Standard Deviation|29.5|29.5|||
3783731|NCT01873950|3613919|B1|||Spatial QRS-T angle||degrees|Mean|34.5|34.5|Standard Deviation|9.9|9.9|||
3783732|NCT01873950|3613919|B1|||QTc (Fridericia's heart rate corrected QT interval)||ms|Mean|395.9|395.9|Standard Deviation|17.1|17.1|||
3783733|NCT01873950|3613919|B1|||Tpeak-Tend interval||ms|Mean|73.1|73.1|Standard Deviation|6.4|6.4|||
3783734|NCT01873950|3613919|B1|||J-Tpeakc (heart rate corrected J-Tpeak interval)||ms|Mean|225.6|225.6|Standard Deviation|19.8|19.8|||
3783735|NCT01873950|3613919|B1|||QRS duration||ms|Mean|97.4|97.4|Standard Deviation|6.7|6.7|||
3783736|NCT01873950|3613919|B1|||PR interval||ms|Mean|162.1|162.1|Standard Deviation|21.6|21.6|||
3783737|NCT01873950|3613919|B1|||Heart rate||beats per minute (bpm)|Mean|56.8|56.8|Standard Deviation|6.4|6.4|||
3783738|NCT01873950|3613919|B1|||Diastolic blood pressure||mm Hg|Mean|59.7|59.7|Standard Deviation|7.2|7.2|||
3783739|NCT01873950|3613919|B1|||Systolic blood pressure||mm Hg|Mean|107.1|107.1|Standard Deviation|8.5|8.5|||
3783740|NCT01873950|3613919|B1|||Body mass index||kg/m^2|Mean|23.1|23.1|Standard Deviation|2.6|2.6|||
3783741|NCT01873950|3613919|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3783742|NCT01873950|3613919|B1|Asian / Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3783743|NCT01873950|3613919|B1|African American / Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3783744|NCT01873950|3613919|B1|White / Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3783745|NCT01873950|3613919|B1|White / Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3783746|NCT01873950|3613919|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783747|NCT01873950|3613919|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783748|NCT01873950|3613919|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3783749|NCT01873950|3613919|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3783750|NCT01873950|3613919|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783751|NCT01873950|3613919|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3783752|NCT01873950|3613919|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784016|NCT01872078|3614162|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3783753|NCT01873950|3613919|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783754|NCT01873950|3613919|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3783755|NCT01873950|3613919|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3783756|NCT01873950|3613919|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3783757|NCT01873950|3613919|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3783758|NCT01873950|3613919|B1|||Age||years|Mean|26.9|26.9|Standard Deviation|5.5|5.5|||
3783759|NCT01873859|3613958|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3783760|NCT01873859|3613959|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3783761|NCT01873859|3613960|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3783762|NCT01873859|3613958|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3783763|NCT01873859|3613959|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3783764|NCT01873859|3613960|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3783765|NCT01873859|3613958|B3|||Age||years|Mean|60.9|60.9|Full Range|||41.0|84.0|
3783766|NCT01873859|3613959|B2|||Age||years|Mean|60.1|60.1|Full Range|||41.0|76.0|
3783767|NCT01873859|3613960|B1|||Age||years|Mean|61.57|61.57|Full Range|||41.0|84.0|
3783768|NCT01873729|3613969|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3783769|NCT01873729|3613969|B1||Male|Gender||Participants|Count of Participants|2|2.0||||||
3783770|NCT01873729|3613969|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
3783771|NCT01873729|3613969|B1|||Age||years|Mean|30.7|30.7|Standard Deviation|3.1|3.1|||
3783772|NCT01873729|3613969|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3783773|NCT01873729|3613969|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3783774|NCT01873729|3613969|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3783775|NCT01873417|3613974|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3783776|NCT01873417|3613974|B1||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
3783777|NCT01873417|3613974|B1|||Age||years|Mean|46.9|46.9|Standard Deviation|11.66|11.66|||
3783778|NCT01872910|3613985|B7|||VAS Pain Score at Post-Surgery Pre-Randomization|A100-mm straight line is presented to the participant, with anchors of 0 mm at one end (no pain) and 100 mm at the other end (worst pain imaginable). The participant marks the line at the point that corresponds with his or her perceived intensity of pain.|mm|Mean|72.7|72.7|Standard Deviation|12.7|12.7|||
3783779|NCT01872910|3613986|B6|||VAS Pain Score at Post-Surgery Pre-Randomization|A100-mm straight line is presented to the participant, with anchors of 0 mm at one end (no pain) and 100 mm at the other end (worst pain imaginable). The participant marks the line at the point that corresponds with his or her perceived intensity of pain.|mm|Mean|72.6|72.6|Standard Deviation|12.9|12.9|||
3783780|NCT01872910|3613987|B5|||VAS Pain Score at Post-Surgery Pre-Randomization|A100-mm straight line is presented to the participant, with anchors of 0 mm at one end (no pain) and 100 mm at the other end (worst pain imaginable). The participant marks the line at the point that corresponds with his or her perceived intensity of pain.|mm|Mean|67.0|67.0|Standard Deviation|6.1|6.1|||
3783781|NCT01872910|3613988|B4|||VAS Pain Score at Post-Surgery Pre-Randomization|A100-mm straight line is presented to the participant, with anchors of 0 mm at one end (no pain) and 100 mm at the other end (worst pain imaginable). The participant marks the line at the point that corresponds with his or her perceived intensity of pain.|mm|Mean|75.1|75.1|Standard Deviation|13.0|13.0|||
3783782|NCT01872910|3613989|B3|||VAS Pain Score at Post-Surgery Pre-Randomization|A100-mm straight line is presented to the participant, with anchors of 0 mm at one end (no pain) and 100 mm at the other end (worst pain imaginable). The participant marks the line at the point that corresponds with his or her perceived intensity of pain.|mm|Mean|70.5|70.5|Standard Deviation|10.7|10.7|||
3783783|NCT01872910|3613990|B2|||VAS Pain Score at Post-Surgery Pre-Randomization|A100-mm straight line is presented to the participant, with anchors of 0 mm at one end (no pain) and 100 mm at the other end (worst pain imaginable). The participant marks the line at the point that corresponds with his or her perceived intensity of pain.|mm|Mean|77.0|77.0|Standard Deviation|13.7|13.7|||
3783784|NCT01872910|3613991|B1|||VAS Pain Score at Post-Surgery Pre-Randomization|A100-mm straight line is presented to the participant, with anchors of 0 mm at one end (no pain) and 100 mm at the other end (worst pain imaginable). The participant marks the line at the point that corresponds with his or her perceived intensity of pain.|mm|Mean|69.7|69.7|Standard Deviation|13.1|13.1|||
3783785|NCT01872910|3613985|B7|United States||Region of Enrollment||participants|Number|124|124.0||||||
3783786|NCT01872910|3613986|B6|United States||Region of Enrollment||participants|Number|3|3.0||||||
3783787|NCT01872910|3613987|B5|United States||Region of Enrollment||participants|Number|15|15.0||||||
3783788|NCT01872910|3613988|B4|United States||Region of Enrollment||participants|Number|15|15.0||||||
3783789|NCT01872910|3613989|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3783790|NCT01872910|3613990|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
3783791|NCT01872910|3613991|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3783792|NCT01872910|3613985|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783793|NCT01872910|3613986|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783794|NCT01872910|3613987|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783795|NCT01872910|3613988|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783796|NCT01872910|3613989|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783797|NCT01872910|3613990|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783798|NCT01872910|3613991|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783799|NCT01872910|3613985|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3783800|NCT01872910|3613986|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783801|NCT01872910|3613987|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3783802|NCT01872910|3613988|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3783803|NCT01872910|3613989|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3783804|NCT01872910|3613990|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3783805|NCT01872910|3613991|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3783806|NCT01872910|3613985|B7||White|Race (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
3783807|NCT01872910|3613986|B6||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3783808|NCT01872910|3613987|B5||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3783809|NCT01872910|3613988|B4||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3783810|NCT01872910|3613989|B3||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3783811|NCT01872910|3613990|B2||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3783812|NCT01872910|3613991|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3783813|NCT01872910|3613985|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3783814|NCT01872910|3613986|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783815|NCT01872910|3613987|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783816|NCT01872910|3613988|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783817|NCT01872910|3613989|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3783818|NCT01872910|3613990|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3783819|NCT01872910|3613991|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3783820|NCT01872910|3613985|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783821|NCT01872910|3613986|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783822|NCT01872910|3613987|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783823|NCT01872910|3613988|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783824|NCT01872910|3613989|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783825|NCT01872910|3613990|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783826|NCT01872910|3613991|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783827|NCT01872910|3613985|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3783828|NCT01872910|3613986|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783829|NCT01872910|3613987|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3783830|NCT01872910|3613988|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783831|NCT01872910|3613989|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783832|NCT01872910|3613990|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3783833|NCT01872910|3613991|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3783834|NCT01872910|3613985|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3783835|NCT01872910|3613986|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783836|NCT01872910|3613987|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783837|NCT01872910|3613988|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783838|NCT01872910|3613989|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783839|NCT01872910|3613990|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3783840|NCT01872910|3613991|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783841|NCT01872910|3613985|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783842|NCT01872910|3613986|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783843|NCT01872910|3613987|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783844|NCT01872910|3613988|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783845|NCT01872910|3613989|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783846|NCT01872910|3613990|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783847|NCT01872910|3613991|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783848|NCT01872910|3613985|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3783849|NCT01872910|3613986|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3783850|NCT01872910|3613987|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3783851|NCT01872910|3613988|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3783852|NCT01872910|3613989|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3784017|NCT01872078|3614158|B5||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3783853|NCT01872910|3613990|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3783854|NCT01872910|3613991|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3783855|NCT01872910|3613985|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3783856|NCT01872910|3613986|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3783857|NCT01872910|3613987|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3783858|NCT01872910|3613988|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3783859|NCT01872910|3613989|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3783860|NCT01872910|3613990|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3783861|NCT01872910|3613991|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3783862|NCT01872910|3613985|B7||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3783863|NCT01872910|3613986|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3783864|NCT01872910|3613987|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3783865|NCT01872910|3613988|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3783866|NCT01872910|3613989|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3783867|NCT01872910|3613990|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3783868|NCT01872910|3613991|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3783869|NCT01872910|3613985|B7||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3783870|NCT01872910|3613986|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3783871|NCT01872910|3613987|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3783872|NCT01872910|3613988|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3783873|NCT01872910|3613989|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3783874|NCT01872910|3613990|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3783875|NCT01872910|3613991|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3783876|NCT01872910|3613985|B7|||Age||years|Mean|22.98|22.98|Standard Deviation|3.593|3.593|||
3783877|NCT01872910|3613986|B6|||Age||years|Mean|24.3|24.3|Standard Deviation|2.5|2.5|||
3783878|NCT01872910|3613987|B5|||Age||years|Mean|24.8|24.8|Standard Deviation|2.6|2.6|||
3783879|NCT01872910|3613988|B4|||Age||years|Mean|22.3|22.3|Standard Deviation|3.2|3.2|||
3783880|NCT01872910|3613989|B3|||Age||years|Mean|22.9|22.9|Standard Deviation|3.5|3.5|||
3783881|NCT01872910|3613990|B2|||Age||years|Mean|22.9|22.9|Standard Deviation|4.3|4.3|||
3783882|NCT01872910|3613991|B1|||Age||years|Mean|22.5|22.5|Standard Deviation|3.4|3.4|||
3783883|NCT01872819|3614036|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3783884|NCT01872819|3614036|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783885|NCT01872819|3614036|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783886|NCT01872819|3614036|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3783887|NCT01872819|3614036|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783888|NCT01872819|3614036|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783889|NCT01872819|3614036|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3783890|NCT01872819|3614036|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783891|NCT01872819|3614036|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783892|NCT01872819|3614036|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3783893|NCT01872819|3614036|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783894|NCT01872819|3614036|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3783895|NCT01872819|3614036|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3783896|NCT01872819|3614036|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3783897|NCT01872819|3614036|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3783898|NCT01872819|3614036|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3783899|NCT01872715|3614041|B1|VI||Fistzpatrick Skin Type|Fitzpatrick skin type is a numerical classification scale for the color of skin from Type 1 to Type VI. Skin type 1 = always burns and never tans (light, pale skin) and skin type VI = never burns, tans very easily, and is deeply pigmented (black, very dark brown to black skin).|participants|Number|0|0.0||||||
3783900|NCT01872715|3614041|B1|V||Fistzpatrick Skin Type|Fitzpatrick skin type is a numerical classification scale for the color of skin from Type 1 to Type VI. Skin type 1 = always burns and never tans (light, pale skin) and skin type VI = never burns, tans very easily, and is deeply pigmented (black, very dark brown to black skin).|participants|Number|0|0.0||||||
3783901|NCT01872715|3614041|B1|IV||Fistzpatrick Skin Type|Fitzpatrick skin type is a numerical classification scale for the color of skin from Type 1 to Type VI. Skin type 1 = always burns and never tans (light, pale skin) and skin type VI = never burns, tans very easily, and is deeply pigmented (black, very dark brown to black skin).|participants|Number|2|2.0||||||
3783902|NCT01872715|3614041|B1|III||Fistzpatrick Skin Type|Fitzpatrick skin type is a numerical classification scale for the color of skin from Type 1 to Type VI. Skin type 1 = always burns and never tans (light, pale skin) and skin type VI = never burns, tans very easily, and is deeply pigmented (black, very dark brown to black skin).|participants|Number|5|5.0||||||
3783956|NCT01872689|3614059|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3783903|NCT01872715|3614041|B1|II||Fistzpatrick Skin Type|Fitzpatrick skin type is a numerical classification scale for the color of skin from Type 1 to Type VI. Skin type 1 = always burns and never tans (light, pale skin) and skin type VI = never burns, tans very easily, and is deeply pigmented (black, very dark brown to black skin).|participants|Number|15|15.0||||||
3783904|NCT01872715|3614041|B1|I||Fistzpatrick Skin Type|Fitzpatrick skin type is a numerical classification scale for the color of skin from Type 1 to Type VI. Skin type 1 = always burns and never tans (light, pale skin) and skin type VI = never burns, tans very easily, and is deeply pigmented (black, very dark brown to black skin).|participants|Number|2|2.0||||||
3783905|NCT01872715|3614041|B1|Combination||Skin type||participants|Number|11|11.0||||||
3783906|NCT01872715|3614041|B1|Oily||Skin type||participants|Number|1|1.0||||||
3783907|NCT01872715|3614041|B1|Normal||Skin type||participants|Number|4|4.0||||||
3783908|NCT01872715|3614041|B1|Dry||Skin type||participants|Number|8|8.0||||||
3783909|NCT01872715|3614041|B1|||Years since the first rosacea diagnosis||years|Mean|5.75|5.75|Standard Deviation|8.36|8.36|||
3783910|NCT01872715|3614041|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783911|NCT01872715|3614041|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783912|NCT01872715|3614041|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3783913|NCT01872715|3614041|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783914|NCT01872715|3614041|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783915|NCT01872715|3614041|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783916|NCT01872715|3614041|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783917|NCT01872715|3614041|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783918|NCT01872715|3614041|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3783919|NCT01872715|3614041|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3783920|NCT01872715|3614041|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3783921|NCT01872715|3614041|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3783922|NCT01872715|3614041|B1|||Age||years|Mean|53.04|53.04|Standard Deviation|11.02|11.02|||
3783923|NCT01872689|3614056|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3783924|NCT01872689|3614057|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3783925|NCT01872689|3614058|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3783926|NCT01872689|3614059|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3783927|NCT01872689|3614060|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3783928|NCT01872689|3614056|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3783929|NCT01872689|3614057|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783930|NCT01872689|3614058|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783931|NCT01872689|3614059|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3783932|NCT01872689|3614060|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783933|NCT01872689|3614056|B5||White|Race (NIH/OMB)||Participants|Count of Participants|426|426.0||||||
3783934|NCT01872689|3614057|B4||White|Race (NIH/OMB)||Participants|Count of Participants|151|151.0||||||
3783935|NCT01872689|3614058|B3||White|Race (NIH/OMB)||Participants|Count of Participants|149|149.0||||||
3783936|NCT01872689|3614059|B2||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3783937|NCT01872689|3614060|B1||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3783938|NCT01872689|3614056|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3783939|NCT01872689|3614057|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3783940|NCT01872689|3614058|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3783941|NCT01872689|3614059|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783942|NCT01872689|3614060|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783943|NCT01872689|3614056|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3783944|NCT01872689|3614057|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783945|NCT01872689|3614058|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3783946|NCT01872689|3614059|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783947|NCT01872689|3614060|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3783948|NCT01872689|3614056|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3783949|NCT01872689|3614057|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3783950|NCT01872689|3614058|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3783951|NCT01872689|3614059|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3783952|NCT01872689|3614060|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3783953|NCT01872689|3614056|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3783954|NCT01872689|3614057|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3783955|NCT01872689|3614058|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3783957|NCT01872689|3614060|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3783958|NCT01872689|3614056|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3783959|NCT01872689|3614057|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3783960|NCT01872689|3614058|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3783961|NCT01872689|3614059|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3783962|NCT01872689|3614060|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3783963|NCT01872689|3614056|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|447|447.0||||||
3783964|NCT01872689|3614057|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|155|155.0||||||
3783965|NCT01872689|3614058|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|160|160.0||||||
3783966|NCT01872689|3614059|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3783967|NCT01872689|3614060|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3783968|NCT01872689|3614056|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3783969|NCT01872689|3614057|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3783970|NCT01872689|3614058|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3783971|NCT01872689|3614059|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3783972|NCT01872689|3614060|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3783973|NCT01872689|3614056|B5||Male|Sex: Female, Male||Participants|Count of Participants|412|412.0||||||
3783974|NCT01872689|3614057|B4||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3783975|NCT01872689|3614058|B3||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3783976|NCT01872689|3614059|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3783977|NCT01872689|3614060|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3783978|NCT01872689|3614056|B5||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3783979|NCT01872689|3614057|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3783980|NCT01872689|3614058|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3783981|NCT01872689|3614059|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3783982|NCT01872689|3614060|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3783983|NCT01872689|3614056|B5|>/=75 years||Age, Customized||participants|Number|112|112.0||||||
3783984|NCT01872689|3614057|B4|>/=75 years||Age, Customized||participants|Number|39|39.0||||||
3783985|NCT01872689|3614058|B3|>/=75 years||Age, Customized||participants|Number|32|32.0||||||
3783986|NCT01872689|3614059|B2|>/=75 years||Age, Customized||participants|Number|23|23.0||||||
3783987|NCT01872689|3614060|B1|>/=75 years||Age, Customized||participants|Number|18|18.0||||||
3783988|NCT01872689|3614056|B5|From 65 to <75 years||Age, Customized||participants|Number|273|273.0||||||
3783989|NCT01872689|3614057|B4|From 65 to <75 years||Age, Customized||participants|Number|92|92.0||||||
3783990|NCT01872689|3614058|B3|From 65 to <75 years||Age, Customized||participants|Number|99|99.0||||||
3783991|NCT01872689|3614059|B2|From 65 to <75 years||Age, Customized||participants|Number|44|44.0||||||
3783992|NCT01872689|3614060|B1|From 65 to <75 years||Age, Customized||participants|Number|38|38.0||||||
3783993|NCT01872689|3614056|B5|From 55 to <65 years||Age, Customized||participants|Number|109|109.0||||||
3783994|NCT01872689|3614057|B4|From 55 to <65 years||Age, Customized||participants|Number|41|41.0||||||
3783995|NCT01872689|3614058|B3|From 55 to <65 years||Age, Customized||participants|Number|40|40.0||||||
3783996|NCT01872689|3614059|B2|From 55 to <65 years||Age, Customized||participants|Number|10|10.0||||||
3783997|NCT01872689|3614060|B1|From 55 to <65 years||Age, Customized||participants|Number|18|18.0||||||
3783998|NCT01872689|3614056|B5|From 40 to <55 years||Age, Customized||participants|Number|11|11.0||||||
3783999|NCT01872689|3614057|B4|From 40 to <55 years||Age, Customized||participants|Number|2|2.0||||||
3784000|NCT01872689|3614058|B3|From 40 to <55 years||Age, Customized||participants|Number|6|6.0||||||
3784001|NCT01872689|3614059|B2|From 40 to <55 years||Age, Customized||participants|Number|1|1.0||||||
3784002|NCT01872689|3614060|B1|From 40 to <55 years||Age, Customized||participants|Number|2|2.0||||||
3784003|NCT01872611|3614137|B3||Male|Sex: Female, Male||Participants|Count of Participants|284|284.0||||||
3784004|NCT01872611|3614138|B2||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3784005|NCT01872611|3614139|B1||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3784006|NCT01872611|3614137|B3||Female|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
3784007|NCT01872611|3614138|B2||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3784008|NCT01872611|3614139|B1||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3784009|NCT01872611|3614137|B3|||Age||years|Mean|67.9|67.9|Standard Deviation|8.4|8.4|||
3784010|NCT01872611|3614138|B2|||Age||years|Mean|68.1|68.1|Standard Deviation|8.4|8.4|||
3784011|NCT01872611|3614139|B1|||Age||years|Mean|67.7|67.7|Standard Deviation|8.5|8.5|||
3784012|NCT01872078|3614158|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3784013|NCT01872078|3614159|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3784014|NCT01872078|3614160|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3784015|NCT01872078|3614161|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3784018|NCT01872078|3614159|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3784019|NCT01872078|3614160|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3784020|NCT01872078|3614161|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3784021|NCT01872078|3614162|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3784022|NCT01872078|3614158|B5|||Age||Years|Mean|28|28.0|Standard Deviation|6|6.0|||
3784023|NCT01872078|3614159|B4|||Age||Years|Mean|28|28.0|Standard Deviation|6|6.0|||
3784024|NCT01872078|3614160|B3|||Age||Years|Mean|27|27.0|Standard Deviation|6|6.0|||
3784025|NCT01872078|3614161|B2|||Age||Years|Mean|29|29.0|Standard Deviation|6|6.0|||
3784026|NCT01872078|3614162|B1|||Age||Years|Mean|27|27.0|Standard Deviation|3|3.0|||
3784027|NCT01871870|3614175|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3784028|NCT01871870|3614175|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3784029|NCT01871870|3614175|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3784030|NCT01871870|3614175|B1|||Age||years|Mean|37.4|37.4|Standard Deviation|9.4|9.4|||
3784031|NCT01871870|3614175|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3784032|NCT01871870|3614175|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3784033|NCT01871870|3614175|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3784034|NCT01871805|3614180|B7||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3784035|NCT01871805|3614181|B6||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3784036|NCT01871805|3614182|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3784037|NCT01871805|3614183|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3784038|NCT01871805|3614184|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3784039|NCT01871805|3614185|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3784040|NCT01871805|3614186|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3784041|NCT01871805|3614180|B7||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3784042|NCT01871805|3614181|B6||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3784043|NCT01871805|3614182|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3784044|NCT01871805|3614183|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3784045|NCT01871805|3614184|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3784046|NCT01871805|3614185|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3784047|NCT01871805|3614186|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3784048|NCT01871805|3614180|B7||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3784049|NCT01871805|3614181|B6||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3784050|NCT01871805|3614182|B5||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3784051|NCT01871805|3614183|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3784052|NCT01871805|3614184|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3784053|NCT01871805|3614185|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3784054|NCT01871805|3614186|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3784055|NCT01871805|3614180|B7||Between 18 and 65 years|Age||Participants|Count of Participants|113|113.0||||||
3784056|NCT01871805|3614181|B6||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
3784057|NCT01871805|3614182|B5||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3784058|NCT01871805|3614183|B4||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3784059|NCT01871805|3614184|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3784060|NCT01871805|3614185|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3784061|NCT01871805|3614186|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3784062|NCT01871805|3614180|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3784063|NCT01871805|3614181|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3784064|NCT01871805|3614182|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3784065|NCT01871805|3614183|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3784066|NCT01871805|3614184|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3784067|NCT01871805|3614185|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3784068|NCT01871805|3614186|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3784069|NCT01871558|3614261|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3784070|NCT01871558|3614262|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3784071|NCT01871558|3614263|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3784072|NCT01871558|3614261|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3784073|NCT01871558|3614262|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3784074|NCT01871558|3614263|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3784075|NCT01871558|3614261|B3|||Age||years|Mean|63.7|63.7|Standard Deviation|10.77|10.77|||
3784076|NCT01871558|3614262|B2|||Age||years|Mean|66.8|66.8|Standard Deviation|7.80|7.8|||
3784077|NCT01871558|3614263|B1|||Age||years|Mean|60.6|60.6|Standard Deviation|12.52|12.52|||
3784078|NCT01871532|3614282|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3784079|NCT01871532|3614283|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3784080|NCT01871532|3614284|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3784081|NCT01871532|3614282|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3784082|NCT01871532|3614283|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3784083|NCT01871532|3614284|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3784084|NCT01871532|3614282|B3|||Age||years|Mean|30.1|30.1|Standard Deviation|3.37|3.37|||
3784085|NCT01871532|3614283|B2|||Age||years|Mean|29.5|29.5|Standard Deviation|3.75|3.75|||
3784086|NCT01871532|3614284|B1|||Age||years|Mean|30.8|30.8|Standard Deviation|2.96|2.96|||
3784087|NCT01871519|3614319|B1|Posterior||Estimated pre-fracture vertebral body height||mm|Mean|26.502|26.502|Standard Deviation|4.397|4.397|||
3784088|NCT01871519|3614319|B1|Middle||Estimated pre-fracture vertebral body height||mm|Mean|24.207|24.207|Standard Deviation|4.264|4.264|||
3784089|NCT01871519|3614319|B1|Anterior||Estimated pre-fracture vertebral body height||mm|Mean|24.940|24.94|Standard Deviation|4.811|4.811|||
3784090|NCT01871519|3614319|B1|||BMI||kg/m^2|Mean|26.1|26.1|Standard Deviation|5.5|5.5|||
3784091|NCT01871519|3614319|B1|||Weight||lbs|Mean|153.9|153.9|Standard Deviation|36.9|36.9|||
3784092|NCT01871519|3614319|B1|||Height||inches|Mean|64.3|64.3|Standard Deviation|3.9|3.9|||
3784093|NCT01871519|3614319|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3784094|NCT01871519|3614319|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|330|330.0||||||
3784095|NCT01871519|3614319|B1|Native Hawaiian or other pacific islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3784096|NCT01871519|3614319|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3784097|NCT01871519|3614319|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3784098|NCT01871519|3614319|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3784099|NCT01871519|3614319|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784100|NCT01871519|3614319|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|344|344.0||||||
3784101|NCT01871519|3614319|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3784102|NCT01871519|3614319|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3784103|NCT01871519|3614319|B1||Female|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
3784104|NCT01871519|3614319|B1|||Age||years|Mean|78.9|78.9|Standard Deviation|8.1|8.1|||
3784105|NCT01871441|3614340|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3784106|NCT01871441|3614340|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784107|NCT01871441|3614340|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784108|NCT01871441|3614340|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3784109|NCT01871441|3614340|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3784110|NCT01871441|3614340|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784111|NCT01871441|3614340|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784112|NCT01871441|3614340|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784113|NCT01871441|3614340|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784114|NCT01871441|3614340|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3784115|NCT01871441|3614340|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784116|NCT01871441|3614340|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3784117|NCT01871441|3614340|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3784118|NCT01871441|3614340|B1|||Age||years|Mean|55|55.0|Standard Deviation|11.35|11.35|||
3784119|NCT01871402|3614347|B3|United States||Region of Enrollment||participants|Number|221|221.0||||||
3784120|NCT01871402|3614348|B2|United States||Region of Enrollment||participants|Number|111|111.0||||||
3784121|NCT01871402|3614349|B1|United States||Region of Enrollment||participants|Number|110|110.0||||||
3784122|NCT01871402|3614347|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784123|NCT01871402|3614348|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784124|NCT01871402|3614349|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784125|NCT01871402|3614347|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3784126|NCT01871402|3614348|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3784127|NCT01871402|3614349|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3784128|NCT01871402|3614347|B3||White|Race (NIH/OMB)||Participants|Count of Participants|175|175.0||||||
3784129|NCT01871402|3614348|B2||White|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3784130|NCT01871402|3614349|B1||White|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3784131|NCT01871402|3614347|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3784132|NCT01871402|3614348|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3784133|NCT01871402|3614349|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3784134|NCT01871402|3614347|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3784135|NCT01871402|3614348|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3784136|NCT01871402|3614349|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3784137|NCT01871402|3614347|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3784138|NCT01871402|3614348|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3784139|NCT01871402|3614349|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3784140|NCT01871402|3614347|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3784141|NCT01871402|3614348|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3784142|NCT01871402|3614349|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3784143|NCT01871402|3614347|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784144|NCT01871402|3614348|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784145|NCT01871402|3614349|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784146|NCT01871402|3614347|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|201|201.0||||||
3784147|NCT01871402|3614348|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3784148|NCT01871402|3614349|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
3784149|NCT01871402|3614347|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3784150|NCT01871402|3614348|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3784151|NCT01871402|3614349|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3784152|NCT01871402|3614347|B3||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3784153|NCT01871402|3614348|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3784154|NCT01871402|3614349|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3784155|NCT01871402|3614347|B3||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3784156|NCT01871402|3614348|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3784157|NCT01871402|3614349|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3784158|NCT01871402|3614347|B3|||Age||years|Mean|51.8|51.8|Standard Deviation|13.26|13.26|||
3784159|NCT01871402|3614348|B2|||Age||years|Mean|50.8|50.8|Standard Deviation|14.15|14.15|||
3784160|NCT01871402|3614349|B1|||Age||years|Mean|52.9|52.9|Standard Deviation|12.28|12.28|||
3784161|NCT01871285|3614366|B3||Male|Gender||Participants|Count of Participants|18|18.0||||||
3784162|NCT01871285|3614367|B2||Male|Gender||Participants|Count of Participants|2|2.0||||||
3784163|NCT01871285|3614368|B1||Male|Gender||Participants|Count of Participants|16|16.0||||||
3784164|NCT01871285|3614366|B3||Female|Gender||Participants|Count of Participants|21|21.0||||||
3784165|NCT01871285|3614367|B2||Female|Gender||Participants|Count of Participants|4|4.0||||||
3784166|NCT01871285|3614368|B1||Female|Gender||Participants|Count of Participants|17|17.0||||||
3784167|NCT01871285|3614366|B3|||Age||years|Median|43.0|43.0|Full Range|||26.0|60.0|
3784168|NCT01871285|3614367|B2|||Age||years|Median|44.0|44.0|Full Range|||31.0|60.0|
3784169|NCT01871285|3614368|B1|||Age||years|Median|43.0|43.0|Full Range|||26.0|55.0|
3784170|NCT01871285|3614366|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3784171|NCT01871285|3614367|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3784172|NCT01871285|3614368|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3784173|NCT01871285|3614366|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3784174|NCT01871285|3614367|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3784175|NCT01871285|3614368|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3784176|NCT01871285|3614366|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3784177|NCT01871285|3614367|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3784178|NCT01871285|3614368|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3784179|NCT01871142|3614397|B1|||Maximal respiratory exchange ratio (RERmax)||VCO2/VO2|Mean|1.09|1.09|Standard Deviation|0.02|0.02|||
3784180|NCT01871142|3614397|B1|||Maximal heart rate (HRmax (beats/min))||Beats/minute|Mean|187|187.0|Standard Deviation|4|4.0|||
3784181|NCT01871142|3614397|B1|||VO2max (ml/kg/min)||milliliter/kilogram/minute|Mean|53.2|53.2|Standard Deviation|8|8.0|||
3784182|NCT01871142|3614397|B1|||Maximal oxygen uptake (VO2max (L/min))||Liters/minute|Mean|3.96|3.96|Standard Deviation|0.06|0.06|||
3784183|NCT01871142|3614397|B1|||Waist-to-Hip Ratio||ratio|Mean|79.3|79.3|Standard Deviation|0.04|0.04|||
3784184|NCT01871142|3614397|B1|||Waist Circumference (cm)||centimeters|Mean|79.3|79.3|Standard Deviation|5|5.0|||
3784185|NCT01871142|3614397|B1|||Percent Body Fat||Percentage of body fat|Mean|19|19.0|Standard Deviation|4|4.0|||
3784186|NCT01871142|3614397|B1|||Lean Mass (kg)||kilograms|Mean|56.7|56.7|Standard Deviation|5|5.0|||
3784187|NCT01871142|3614397|B1|||Fat Mass (kg)||kilograms|Mean|14.1|14.1|Standard Deviation|4|4.0|||
3784188|NCT01871142|3614397|B1|||Body Mass Index (BMI)||kg/m^2|Mean|24.3|24.3|Standard Deviation|2|2.0|||
3784189|NCT01871142|3614397|B1|||Body Mass (kg)||Kilograms|Mean|74.8|74.8|Standard Deviation|6|6.0|||
3784190|NCT01871142|3614397|B1|||Height||meters|Mean|1.75|1.75|Standard Deviation|0.03|0.03|||
3784191|NCT01871142|3614397|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3784192|NCT01871142|3614397|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3784193|NCT01871142|3614397|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3784194|NCT01871142|3614397|B1|||Age||years|Mean|27|27.0|Standard Deviation|6|6.0|||
3784195|NCT01871090|3614411|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784196|NCT01871090|3614412|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784197|NCT01871090|3614413|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784198|NCT01871090|3614411|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784199|NCT01871090|3614412|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784200|NCT01871090|3614413|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784201|NCT01871090|3614411|B3||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3784202|NCT01871090|3614412|B2||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3784203|NCT01871090|3614413|B1||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3784204|NCT01871090|3614411|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3784205|NCT01871090|3614412|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3784206|NCT01871090|3614413|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3784207|NCT01871090|3614411|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784208|NCT01871090|3614412|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784209|NCT01871090|3614413|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784210|NCT01871090|3614411|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784211|NCT01871090|3614412|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784212|NCT01871090|3614413|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784213|NCT01871090|3614411|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3784214|NCT01871090|3614412|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3784215|NCT01871090|3614413|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3784216|NCT01871090|3614411|B3||Male|Gender||Participants|Count of Participants|59|59.0||||||
3784217|NCT01871090|3614412|B2||Male|Gender||Participants|Count of Participants|41|41.0||||||
3784218|NCT01871090|3614413|B1||Male|Gender||Participants|Count of Participants|18|18.0||||||
3784219|NCT01871090|3614411|B3||Female|Gender||Participants|Count of Participants|24|24.0||||||
3784220|NCT01871090|3614412|B2||Female|Gender||Participants|Count of Participants|7|7.0||||||
3784221|NCT01871090|3614413|B1||Female|Gender||Participants|Count of Participants|17|17.0||||||
3784222|NCT01871090|3614411|B3|||Age||years|Mean|65.5|65.5|Standard Deviation|16.4|16.4|||
3784223|NCT01871090|3614412|B2|||Age||years|Mean|64.4|64.4|Standard Deviation|14.7|14.7|||
3784224|NCT01871090|3614413|B1|||Age||years|Mean|67.1|67.1|Standard Deviation|18.6|18.6|||
3784225|NCT01870999|3614424|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3784226|NCT01870999|3614425|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3784227|NCT01870999|3614426|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3784228|NCT01870999|3614427|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3784229|NCT01870999|3614424|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3784230|NCT01870999|3614425|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3784231|NCT01870999|3614426|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3784232|NCT01870999|3614427|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3784233|NCT01870999|3614424|B4|||Age||years|Mean|45.2|45.2|Standard Deviation|10.3|10.3|||
3784234|NCT01870999|3614425|B3|||Age||years|Mean|46.0|46.0|Standard Deviation|12.7|12.7|||
3784235|NCT01870999|3614426|B2|||Age||years|Mean|43.3|43.3|Standard Deviation|9.6|9.6|||
3784236|NCT01870999|3614427|B1|||Age||years|Mean|46.8|46.8|Standard Deviation|9.2|9.2|||
3784237|NCT01870973|3614485|B3|United States||Region of Enrollment||participants|Number|95|95.0||||||
3784238|NCT01870973|3614486|B2|United States||Region of Enrollment||participants|Number|49|49.0||||||
3784239|NCT01870973|3614487|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
3784240|NCT01870973|3614485|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3784241|NCT01870973|3614486|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3784242|NCT01870973|3614487|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3784243|NCT01870973|3614485|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3784244|NCT01870973|3614486|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3784245|NCT01870973|3614487|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3784246|NCT01870973|3614485|B3|||Age||years|Mean|37.7|37.7|Standard Deviation|14.1|14.1|||
3784247|NCT01870973|3614486|B2|||Age||years|Mean|39.1|39.1|Standard Deviation|16.1|16.1|||
3784248|NCT01870973|3614487|B1|||Age||years|Mean|36.3|36.3|Standard Deviation|12.1|12.1|||
3784249|NCT01870921|3614494|B1|Other||Race/Ethnicity, Customized|Race|Participants|Number|0|0.0||||||
3784250|NCT01870921|3614494|B1|Asian||Race/Ethnicity, Customized|Race|Participants|Number|2001|2001.0||||||
3784251|NCT01870921|3614494|B1|Not hispanic or latino||Race/Ethnicity, Customized|Ethnic Group|Participants|Number|2001|2001.0||||||
3784252|NCT01870921|3614494|B1|Hispanic or latino||Race/Ethnicity, Customized|Ethnic Group|Participants|Number|0|0.0||||||
3784253|NCT01870921|3614494|B1||Male|Sex: Female, Male||Participants|Count of Participants|1579|1579.0||||||
3784254|NCT01870921|3614494|B1||Female|Sex: Female, Male||Participants|Count of Participants|422|422.0||||||
3784255|NCT01870921|3614494|B1|>= 75 years||Age, Customized||Participants|Number|147|147.0||||||
3784256|NCT01870921|3614494|B1|< 75 years||Age, Customized||Participants|Number|1854|1854.0||||||
3784257|NCT01870921|3614494|B1|||Age||Years|Mean|59.3|59.3|Standard Deviation|10.83|10.83|||
3784258|NCT01870856|3614500|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3784259|NCT01870856|3614501|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3784260|NCT01870856|3614502|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3784261|NCT01870856|3614500|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3784262|NCT01870856|3614501|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3784263|NCT01870856|3614502|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3784264|NCT01870856|3614500|B3|||Age||years|Mean|34.1|34.1|Standard Deviation|10.1|10.1|||
3784265|NCT01870856|3614501|B2|||Age||years|Mean|34.1|34.1|Standard Deviation|9.4|9.4|||
3784266|NCT01870856|3614502|B1|||Age||years|Mean|34.1|34.1|Standard Deviation|10.9|10.9|||
3784267|NCT01870843|3614513|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3784268|NCT01870843|3614513|B1||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3784269|NCT01870843|3614513|B1|||Age|N= 240|Years|Mean|39.0|39.0|Standard Deviation|12.75|12.75|||
3784270|NCT01870778|3614526|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3784271|NCT01870778|3614527|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3784272|NCT01870778|3614528|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3784273|NCT01870778|3614526|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
3784274|NCT01870778|3614527|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3784275|NCT01870778|3614528|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3784276|NCT01870778|3614526|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6016|6016.0||||||
3784277|NCT01870778|3614527|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2999|2999.0||||||
3784278|NCT01870778|3614528|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3017|3017.0||||||
3784279|NCT01870778|3614526|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|334|334.0||||||
3784280|NCT01870778|3614527|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|171|171.0||||||
3784281|NCT01870778|3614528|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|163|163.0||||||
3784282|NCT01870778|3614526|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3784283|NCT01870778|3614527|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3784284|NCT01870778|3614528|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3784285|NCT01870778|3614526|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3784286|NCT01870778|3614527|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3784287|NCT01870778|3614528|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3784288|NCT01870778|3614526|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3784289|NCT01870778|3614527|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3784290|NCT01870778|3614528|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3784291|NCT01870778|3614526|B3||Male|Sex: Female, Male||Participants|Count of Participants|3908|3908.0||||||
3784292|NCT01870778|3614527|B2||Male|Sex: Female, Male||Participants|Count of Participants|1930|1930.0||||||
3784293|NCT01870778|3614528|B1||Male|Sex: Female, Male||Participants|Count of Participants|1978|1978.0||||||
3784294|NCT01870778|3614526|B3||Female|Sex: Female, Male||Participants|Count of Participants|2637|2637.0||||||
3784295|NCT01870778|3614527|B2||Female|Sex: Female, Male||Participants|Count of Participants|1341|1341.0||||||
3784296|NCT01870778|3614528|B1||Female|Sex: Female, Male||Participants|Count of Participants|1296|1296.0||||||
3784297|NCT01870778|3614526|B3|||Age||Years|Mean|73.0|73.0|Standard Deviation|11.20|11.2|||
3784298|NCT01870778|3614527|B2|||Age||Years|Mean|72.8|72.8|Standard Deviation|11.17|11.17|||
3784299|NCT01870778|3614528|B1|||Age||Years|Mean|73.1|73.1|Standard Deviation|11.24|11.24|||
3784300|NCT01870739|3614553|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3784301|NCT01870739|3614554|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3784302|NCT01870739|3614555|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3784303|NCT01870739|3614553|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3784304|NCT01870739|3614554|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3784305|NCT01870739|3614555|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3784306|NCT01870739|3614553|B3|||Age||Years|Mean|59.8|59.8|Standard Deviation|10.7|10.7|||
3784307|NCT01870739|3614554|B2|||Age||Years|Mean|59.2|59.2|Standard Deviation|13.1|13.1|||
3784308|NCT01870739|3614555|B1|||Age||Years|Mean|60.5|60.5|Standard Deviation|7.8|7.8|||
3784309|NCT01870726|3614588|B8||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3784310|NCT01870726|3614589|B7||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3784311|NCT01870726|3614590|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3784312|NCT01870726|3614591|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3784313|NCT01870726|3614592|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3784314|NCT01870726|3614593|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3784315|NCT01870726|3614594|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3784316|NCT01870726|3614595|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3784317|NCT01870726|3614588|B8||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3784318|NCT01870726|3614589|B7||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3784319|NCT01870726|3614590|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3784320|NCT01870726|3614591|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3784321|NCT01870726|3614592|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3784322|NCT01870726|3614593|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3784323|NCT01870726|3614594|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3784324|NCT01870726|3614595|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3784325|NCT01870726|3614588|B8||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3784326|NCT01870726|3614589|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3784327|NCT01870726|3614590|B6||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3784328|NCT01870726|3614591|B5||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3784329|NCT01870726|3614592|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3784330|NCT01870726|3614593|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3784331|NCT01870726|3614594|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3784332|NCT01870726|3614595|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3784333|NCT01870726|3614588|B8||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3784334|NCT01870726|3614589|B7||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3784335|NCT01870726|3614590|B6||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3784336|NCT01870726|3614591|B5||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3784337|NCT01870726|3614592|B4||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3784338|NCT01870726|3614593|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3784339|NCT01870726|3614594|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3784340|NCT01870726|3614595|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3784341|NCT01870726|3614588|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3784342|NCT01870726|3614589|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3784343|NCT01870726|3614590|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3784344|NCT01870726|3614591|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3784345|NCT01870726|3614592|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3784346|NCT01870726|3614593|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3784347|NCT01870726|3614594|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3784348|NCT01870726|3614595|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3784349|NCT01870596|3614684|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
3784350|NCT01870596|3614685|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
3784351|NCT01870596|3614686|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3784352|NCT01870596|3614684|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3784353|NCT01870596|3614685|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3784354|NCT01870596|3614686|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3784355|NCT01870596|3614684|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3784356|NCT01870596|3614685|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3784357|NCT01870596|3614686|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3784358|NCT01870596|3614684|B3|||Age||years|Median|60|60.0|Full Range|||29.0|72.0|
3784359|NCT01870596|3614685|B2|||Age||years|Median|60|60.0|Full Range|||29.0|72.0|
3784360|NCT01870596|3614686|B1|||Age||years|Median|60|60.0|Full Range|||29.0|72.0|
3784361|NCT01870596|3614684|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3784362|NCT01870596|3614685|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3784363|NCT01870596|3614686|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3784364|NCT01870596|3614684|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3784365|NCT01870596|3614685|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3784366|NCT01870596|3614686|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3784367|NCT01870596|3614684|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3784368|NCT01870596|3614685|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3784369|NCT01870596|3614686|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3784370|NCT01870583|3614693|B4|United States||Region of Enrollment||participants|Number|1404|1404.0||||||
3784371|NCT01870583|3614694|B3|United States||Region of Enrollment||participants|Number|463|463.0||||||
3784372|NCT01870583|3614695|B2|United States||Region of Enrollment||participants|Number|474|474.0||||||
3784373|NCT01870583|3614696|B1|United States||Region of Enrollment||participants|Number|467|467.0||||||
3784374|NCT01870583|3614693|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3784375|NCT01870583|3614694|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3784376|NCT01870583|3614695|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3784377|NCT01870583|3614696|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3784378|NCT01870583|3614693|B4||Female|Sex: Female, Male||Participants|Count of Participants|1404|1404.0||||||
3784379|NCT01870583|3614694|B3||Female|Sex: Female, Male||Participants|Count of Participants|463|463.0||||||
3784380|NCT01870583|3614695|B2||Female|Sex: Female, Male||Participants|Count of Participants|474|474.0||||||
3784381|NCT01870583|3614696|B1||Female|Sex: Female, Male||Participants|Count of Participants|467|467.0||||||
3784382|NCT01870583|3614693|B4|||Age||years|Mean|30.2|30.2|Standard Deviation|5.7|5.7|||
3784383|NCT01870583|3614694|B3|||Age||years|Mean|29.9|29.9|Standard Deviation|6.0|6.0|||
3784384|NCT01870583|3614695|B2|||Age||years|Mean|30.3|30.3|Standard Deviation|5.7|5.7|||
3784385|NCT01870583|3614696|B1|||Age||years|Mean|30.1|30.1|Standard Deviation|5.9|5.9|||
3784386|NCT01870388|3614706|B3|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3784387|NCT01870388|3614707|B2|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3784388|NCT01870388|3614708|B1|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3784389|NCT01870388|3614706|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784390|NCT01870388|3614707|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784391|NCT01870388|3614708|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784392|NCT01870388|3614706|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784393|NCT01870388|3614707|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784394|NCT01870388|3614708|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784395|NCT01870388|3614706|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3784396|NCT01870388|3614707|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3784397|NCT01870388|3614708|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3784398|NCT01870388|3614706|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3784399|NCT01870388|3614707|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784400|NCT01870388|3614708|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3784401|NCT01870388|3614706|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784402|NCT01870388|3614707|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784403|NCT01870388|3614708|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784404|NCT01870388|3614706|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784405|NCT01870388|3614707|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784406|NCT01870388|3614708|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784407|NCT01870388|3614706|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784408|NCT01870388|3614707|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784409|NCT01870388|3614708|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784410|NCT01870388|3614706|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784411|NCT01870388|3614707|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784412|NCT01870388|3614708|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784413|NCT01870388|3614706|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3784414|NCT01870388|3614707|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3784415|NCT01870388|3614708|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3784416|NCT01870388|3614706|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3784417|NCT01870388|3614707|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3784418|NCT01870388|3614708|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3784419|NCT01870388|3614706|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3784420|NCT01870388|3614707|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3784421|NCT01870388|3614708|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3784422|NCT01870388|3614706|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3784423|NCT01870388|3614707|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3784424|NCT01870388|3614708|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3784425|NCT01870388|3614706|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3784426|NCT01870388|3614707|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3784427|NCT01870388|3614708|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3784428|NCT01870388|3614706|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3784429|NCT01870388|3614707|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3784430|NCT01870388|3614708|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3784431|NCT01870388|3614706|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3784432|NCT01870388|3614707|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3784433|NCT01870388|3614708|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3784434|NCT01870076|3614717|B5|||Number of Participants with Acuity Level 1|Level 1 is defined as same day surgery and observation (e.g. patients are technically never admitted as inpatient).|Participants|Count of Participants|19|19.0||||||
3784489|NCT01870076|3614717|B5||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3784435|NCT01870076|3614718|B4|||Number of Participants with Acuity Level 1|Level 1 is defined as same day surgery and observation (e.g. patients are technically never admitted as inpatient).|Participants|Count of Participants|4|4.0||||||
3784436|NCT01870076|3614719|B3|||Number of Participants with Acuity Level 1|Level 1 is defined as same day surgery and observation (e.g. patients are technically never admitted as inpatient).|Participants|Count of Participants|5|5.0||||||
3784437|NCT01870076|3614720|B2|||Number of Participants with Acuity Level 1|Level 1 is defined as same day surgery and observation (e.g. patients are technically never admitted as inpatient).|Participants|Count of Participants|7|7.0||||||
3784438|NCT01870076|3614721|B1|||Number of Participants with Acuity Level 1|Level 1 is defined as same day surgery and observation (e.g. patients are technically never admitted as inpatient).|Participants|Count of Participants|3|3.0||||||
3784439|NCT01870076|3614717|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784440|NCT01870076|3614718|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784441|NCT01870076|3614719|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784442|NCT01870076|3614720|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784443|NCT01870076|3614721|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784444|NCT01870076|3614717|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3784445|NCT01870076|3614718|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3784446|NCT01870076|3614719|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3784447|NCT01870076|3614720|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3784448|NCT01870076|3614721|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3784449|NCT01870076|3614717|B5||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3784450|NCT01870076|3614718|B4||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3784451|NCT01870076|3614719|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3784452|NCT01870076|3614720|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3784453|NCT01870076|3614721|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3784454|NCT01870076|3614717|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3784455|NCT01870076|3614718|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3784456|NCT01870076|3614719|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3784457|NCT01870076|3614720|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784458|NCT01870076|3614721|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3784459|NCT01870076|3614717|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784460|NCT01870076|3614718|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784461|NCT01870076|3614719|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784462|NCT01870076|3614720|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784463|NCT01870076|3614721|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784464|NCT01870076|3614717|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3784465|NCT01870076|3614718|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784466|NCT01870076|3614719|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784467|NCT01870076|3614720|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784468|NCT01870076|3614721|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3784469|NCT01870076|3614717|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784470|NCT01870076|3614718|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784471|NCT01870076|3614719|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784472|NCT01870076|3614720|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784473|NCT01870076|3614721|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784474|NCT01870076|3614717|B5||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3784475|NCT01870076|3614718|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3784476|NCT01870076|3614719|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3784477|NCT01870076|3614720|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3784478|NCT01870076|3614721|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3784479|NCT01870076|3614717|B5||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3784480|NCT01870076|3614718|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3784481|NCT01870076|3614719|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3784482|NCT01870076|3614720|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3784483|NCT01870076|3614721|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3784484|NCT01870076|3614717|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3784485|NCT01870076|3614718|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3784486|NCT01870076|3614719|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3784487|NCT01870076|3614720|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3784488|NCT01870076|3614721|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3784490|NCT01870076|3614718|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3784491|NCT01870076|3614719|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3784492|NCT01870076|3614720|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3784493|NCT01870076|3614721|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3784494|NCT01870076|3614717|B5||<=18 years|Age||Participants|Count of Participants|35|35.0||||||
3784495|NCT01870076|3614718|B4||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
3784496|NCT01870076|3614719|B3||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3784497|NCT01870076|3614720|B2||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
3784498|NCT01870076|3614721|B1||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
3784499|NCT01869959|3614738|B5|United States||Region of Enrollment||participants|Number|46|46.0||||||
3784500|NCT01869959|3614739|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
3784501|NCT01869959|3614740|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
3784502|NCT01869959|3614741|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3784503|NCT01869959|3614742|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3784504|NCT01869959|3614738|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784505|NCT01869959|3614739|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784506|NCT01869959|3614740|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784507|NCT01869959|3614741|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784508|NCT01869959|3614742|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784509|NCT01869959|3614738|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784510|NCT01869959|3614739|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784511|NCT01869959|3614740|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784512|NCT01869959|3614741|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784513|NCT01869959|3614742|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784514|NCT01869959|3614738|B5||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3784515|NCT01869959|3614739|B4||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3784516|NCT01869959|3614740|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3784517|NCT01869959|3614741|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3784518|NCT01869959|3614742|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3784519|NCT01869959|3614738|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3784520|NCT01869959|3614739|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784521|NCT01869959|3614740|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3784522|NCT01869959|3614741|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784523|NCT01869959|3614742|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784524|NCT01869959|3614738|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784525|NCT01869959|3614739|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784526|NCT01869959|3614740|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784527|NCT01869959|3614741|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784528|NCT01869959|3614742|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784529|NCT01869959|3614738|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3784530|NCT01869959|3614739|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784531|NCT01869959|3614740|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3784532|NCT01869959|3614741|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784533|NCT01869959|3614742|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784534|NCT01869959|3614738|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784535|NCT01869959|3614739|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784536|NCT01869959|3614740|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784537|NCT01869959|3614741|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784538|NCT01869959|3614742|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784539|NCT01869959|3614738|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784540|NCT01869959|3614739|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784541|NCT01869959|3614740|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784542|NCT01869959|3614741|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784543|NCT01869959|3614742|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784544|NCT01869959|3614738|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3784545|NCT01869959|3614739|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3784546|NCT01869959|3614740|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3784547|NCT01869959|3614741|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3784548|NCT01869959|3614742|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3784549|NCT01869959|3614738|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784550|NCT01869959|3614739|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784551|NCT01869959|3614740|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784552|NCT01869959|3614741|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784553|NCT01869959|3614742|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784554|NCT01869959|3614738|B5||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3784555|NCT01869959|3614739|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3784556|NCT01869959|3614740|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3784557|NCT01869959|3614741|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3784558|NCT01869959|3614742|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3784559|NCT01869959|3614738|B5||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3784560|NCT01869959|3614739|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3784561|NCT01869959|3614740|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3784562|NCT01869959|3614741|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3784563|NCT01869959|3614742|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3784564|NCT01869959|3614738|B5|||Age||Years|Mean|57.7|57.7|Standard Deviation|8.4|8.4|||
3784565|NCT01869959|3614739|B4|||Age||Years|Mean|58.6|58.6|Standard Deviation|6.3|6.3|||
3784566|NCT01869959|3614740|B3|||Age||Years|Mean|56.9|56.9|Standard Deviation|10.2|10.2|||
3784567|NCT01869959|3614741|B2|||Age||Years|Mean|59.6|59.6|Standard Deviation|9.2|9.2|||
3784568|NCT01869959|3614742|B1|||Age||Years|Mean|56.5|56.5|Standard Deviation|7.3|7.3|||
3784569|NCT01869699|3614814|B3|||respiratory rate||breaths per minute|Mean|22|22.0|Standard Deviation|5.5|5.5|||
3784570|NCT01869699|3614815|B2|||respiratory rate||breaths per minute|Mean|20|20.0|Standard Deviation|6|6.0|||
3784571|NCT01869699|3614816|B1|||respiratory rate||breaths per minute|Mean|24|24.0|Standard Deviation|5|5.0|||
3784572|NCT01869699|3614814|B3|||mean arterial pressure||mm Hg|Mean|94.5|94.5|Standard Deviation|18|18.0|||
3784573|NCT01869699|3614815|B2|||mean arterial pressure||mm Hg|Mean|100|100.0|Standard Deviation|20|20.0|||
3784574|NCT01869699|3614816|B1|||mean arterial pressure||mm Hg|Mean|89|89.0|Standard Deviation|16|16.0|||
3784575|NCT01869699|3614814|B3|||diastolic blood pressure||mm Hg|Mean|67.5|67.5|Standard Deviation|14|14.0|||
3784576|NCT01869699|3614815|B2|||diastolic blood pressure||mm Hg|Mean|73|73.0|Standard Deviation|15|15.0|||
3784577|NCT01869699|3614816|B1|||diastolic blood pressure||mm Hg|Mean|64|64.0|Standard Deviation|13|13.0|||
3784578|NCT01869699|3614814|B3|||systolic blood pressure||mm Hg|Mean|143|143.0|Standard Deviation|26|26.0|||
3784579|NCT01869699|3614815|B2|||systolic blood pressure||mm Hg|Mean|151|151.0|Standard Deviation|26|26.0|||
3784580|NCT01869699|3614816|B1|||systolic blood pressure||mm Hg|Mean|135|135.0|Standard Deviation|26|26.0|||
3784581|NCT01869699|3614814|B3|||Heart Rate||beats per minute|Mean|91.5|91.5|Standard Deviation|14.5|14.5|||
3784582|NCT01869699|3614815|B2|||Heart Rate||beats per minute|Mean|90|90.0|Standard Deviation|14|14.0|||
3784583|NCT01869699|3614816|B1|||Heart Rate||beats per minute|Mean|93|93.0|Standard Deviation|15|15.0|||
3784584|NCT01869699|3614814|B3|||Core body temperature||degrees Celsius|Mean|38.5|38.5|Standard Deviation|0.4|0.4|||
3784585|NCT01869699|3614815|B2|||Core body temperature||degrees Celsius|Mean|38.4|38.4|Standard Deviation|0.3|0.3|||
3784586|NCT01869699|3614816|B1|||Core body temperature||degrees Celsius|Mean|38.6|38.6|Standard Deviation|0.5|0.5|||
3784587|NCT01869699|3614814|B3|||Temperature of room||degrees Celsius|Mean|21.4|21.4|Standard Deviation|1.3|1.3|||
3784588|NCT01869699|3614815|B2|||Temperature of room||degrees Celsius|Mean|21.4|21.4|Standard Deviation|1.2|1.2|||
3784589|NCT01869699|3614816|B1|||Temperature of room||degrees Celsius|Mean|21.5|21.5|Standard Deviation|1.4|1.4|||
3784590|NCT01869699|3614814|B3||Number of patients NOT on mechanical ventilation|Mode of ventilation||Participants|Count of Participants|13|13.0||||||
3784591|NCT01869699|3614815|B2||Number of patients NOT on mechanical ventilation|Mode of ventilation||Participants|Count of Participants|8|8.0||||||
3784592|NCT01869699|3614816|B1||Number of patients NOT on mechanical ventilation|Mode of ventilation||Participants|Count of Participants|5|5.0||||||
3784593|NCT01869699|3614814|B3||Number of patients on Assist Control|Mode of ventilation||Participants|Count of Participants|6|6.0||||||
3784594|NCT01869699|3614815|B2||Number of patients on Assist Control|Mode of ventilation||Participants|Count of Participants|2|2.0||||||
3784595|NCT01869699|3614816|B1||Number of patients on Assist Control|Mode of ventilation||Participants|Count of Participants|4|4.0||||||
3784596|NCT01869699|3614814|B3||Number of patients on Pressure Support|Mode of ventilation||Participants|Count of Participants|21|21.0||||||
3784597|NCT01869699|3614815|B2||Number of patients on Pressure Support|Mode of ventilation||Participants|Count of Participants|10|10.0||||||
3784598|NCT01869699|3614816|B1||Number of patients on Pressure Support|Mode of ventilation||Participants|Count of Participants|11|11.0||||||
3784599|NCT01869699|3614814|B3|||Number of patients receiving Mechanical Ventilation||Participants|Count of Participants|27|27.0||||||
3784600|NCT01869699|3614815|B2|||Number of patients receiving Mechanical Ventilation||Participants|Count of Participants|12|12.0||||||
3784601|NCT01869699|3614816|B1|||Number of patients receiving Mechanical Ventilation||Participants|Count of Participants|15|15.0||||||
3784687|NCT01869647|3614848|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3784602|NCT01869699|3614814|B3|||Number of patients with sepsis|Sepsis was defined as new confirmed or suspected infection and 2 or more systemic inflammatory response syndrome (SIRS) criteria. (Dellinger RP, Levy MM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Medicine 2013; 39: 165-228.)|Participants|Count of Participants|27|27.0||||||
3784603|NCT01869699|3614815|B2|||Number of patients with sepsis|Sepsis was defined as new confirmed or suspected infection and 2 or more systemic inflammatory response syndrome (SIRS) criteria. (Dellinger RP, Levy MM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Medicine 2013; 39: 165-228.)|Participants|Count of Participants|13|13.0||||||
3784604|NCT01869699|3614816|B1|||Number of patients with sepsis|Sepsis was defined as new confirmed or suspected infection and 2 or more systemic inflammatory response syndrome (SIRS) criteria. (Dellinger RP, Levy MM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Medicine 2013; 39: 165-228.)|Participants|Count of Participants|14|14.0||||||
3784605|NCT01869699|3614814|B3||Number of patients on no medication infusions|Number of patients receiving types of medication infusions||Participants|Count of Participants|5|5.0||||||
3784606|NCT01869699|3614815|B2||Number of patients on no medication infusions|Number of patients receiving types of medication infusions||Participants|Count of Participants|5|5.0||||||
3784607|NCT01869699|3614816|B1||Number of patients on no medication infusions|Number of patients receiving types of medication infusions||Participants|Count of Participants|0|0.0||||||
3784608|NCT01869699|3614814|B3||Number of patients on analgesic infusions|Number of patients receiving types of medication infusions||Participants|Count of Participants|4|4.0||||||
3784609|NCT01869699|3614815|B2||Number of patients on analgesic infusions|Number of patients receiving types of medication infusions||Participants|Count of Participants|1|1.0||||||
3784610|NCT01869699|3614816|B1||Number of patients on analgesic infusions|Number of patients receiving types of medication infusions||Participants|Count of Participants|3|3.0||||||
3784611|NCT01869699|3614814|B3||Number of patients on sedative infusions|Number of patients receiving types of medication infusions||Participants|Count of Participants|17|17.0||||||
3784612|NCT01869699|3614815|B2||Number of patients on sedative infusions|Number of patients receiving types of medication infusions||Participants|Count of Participants|8|8.0||||||
3784613|NCT01869699|3614816|B1||Number of patients on sedative infusions|Number of patients receiving types of medication infusions||Participants|Count of Participants|9|9.0||||||
3784614|NCT01869699|3614814|B3||Number of patients on vasodilator infusions|Number of patients receiving types of medication infusions||Participants|Count of Participants|4|4.0||||||
3784615|NCT01869699|3614815|B2||Number of patients on vasodilator infusions|Number of patients receiving types of medication infusions||Participants|Count of Participants|2|2.0||||||
3784616|NCT01869699|3614816|B1||Number of patients on vasodilator infusions|Number of patients receiving types of medication infusions||Participants|Count of Participants|2|2.0||||||
3784617|NCT01869699|3614814|B3||Number of patients on vasopressor infusions|Number of patients receiving types of medication infusions||Participants|Count of Participants|10|10.0||||||
3784618|NCT01869699|3614815|B2||Number of patients on vasopressor infusions|Number of patients receiving types of medication infusions||Participants|Count of Participants|4|4.0||||||
3784619|NCT01869699|3614816|B1||Number of patients on vasopressor infusions|Number of patients receiving types of medication infusions||Participants|Count of Participants|6|6.0||||||
3784620|NCT01869699|3614814|B3|Number of patients with Noninfectious etiology||Number of patients with infectious and noninfectious etiology of fever||Participants|Count of Participants|10|10.0||||||
3784621|NCT01869699|3614815|B2|Number of patients with Noninfectious etiology||Number of patients with infectious and noninfectious etiology of fever||Participants|Count of Participants|5|5.0||||||
3784622|NCT01869699|3614816|B1|Number of patients with Noninfectious etiology||Number of patients with infectious and noninfectious etiology of fever||Participants|Count of Participants|5|5.0||||||
3784623|NCT01869699|3614814|B3|Number of patients with Infectious etiology||Number of patients with infectious and noninfectious etiology of fever||Participants|Count of Participants|30|30.0||||||
3784624|NCT01869699|3614815|B2|Number of patients with Infectious etiology||Number of patients with infectious and noninfectious etiology of fever||Participants|Count of Participants|15|15.0||||||
3784625|NCT01869699|3614816|B1|Number of patients with Infectious etiology||Number of patients with infectious and noninfectious etiology of fever||Participants|Count of Participants|15|15.0||||||
3784626|NCT01869699|3614814|B3|||Acute Physiologic and Chronic Health Evaluation (APACHE) II score|Acute Physiologic and Chronic Health Evaluation (APACHE) II is a severity-of-disease classification system (Knaus et al., 1985), one of several ICU scoring systems. It is applied within 24 hours of admission of a patient to an intensive care unit (ICU): an integer score from 0 to 71 is computed based on several measurements; higher scores correspond to more severe disease.|scores on a scale|Mean|24|24.0|Standard Deviation|6|6.0|||
3784627|NCT01869699|3614815|B2|||Acute Physiologic and Chronic Health Evaluation (APACHE) II score|Acute Physiologic and Chronic Health Evaluation (APACHE) II is a severity-of-disease classification system (Knaus et al., 1985), one of several ICU scoring systems. It is applied within 24 hours of admission of a patient to an intensive care unit (ICU): an integer score from 0 to 71 is computed based on several measurements; higher scores correspond to more severe disease.|scores on a scale|Mean|24|24.0|Standard Deviation|6|6.0|||
3784628|NCT01869699|3614816|B1|||Acute Physiologic and Chronic Health Evaluation (APACHE) II score|Acute Physiologic and Chronic Health Evaluation (APACHE) II is a severity-of-disease classification system (Knaus et al., 1985), one of several ICU scoring systems. It is applied within 24 hours of admission of a patient to an intensive care unit (ICU): an integer score from 0 to 71 is computed based on several measurements; higher scores correspond to more severe disease.|scores on a scale|Mean|24|24.0|Standard Deviation|6|6.0|||
3784629|NCT01869699|3614814|B3|Number of patients iwth Neurologic diagnoses||Primary ICU diagnosis||Participants|Count of Participants|22|22.0||||||
3784630|NCT01869699|3614815|B2|Number of patients iwth Neurologic diagnoses||Primary ICU diagnosis||Participants|Count of Participants|12|12.0||||||
3784688|NCT01869647|3614849|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3784631|NCT01869699|3614816|B1|Number of patients iwth Neurologic diagnoses||Primary ICU diagnosis||Participants|Count of Participants|10|10.0||||||
3784632|NCT01869699|3614814|B3|Number of patients with Surgical diagnoses||Primary ICU diagnosis||Participants|Count of Participants|6|6.0||||||
3784633|NCT01869699|3614815|B2|Number of patients with Surgical diagnoses||Primary ICU diagnosis||Participants|Count of Participants|2|2.0||||||
3784634|NCT01869699|3614816|B1|Number of patients with Surgical diagnoses||Primary ICU diagnosis||Participants|Count of Participants|4|4.0||||||
3784635|NCT01869699|3614814|B3|Number of patients with Medical diagnoses||Primary ICU diagnosis||Participants|Count of Participants|12|12.0||||||
3784636|NCT01869699|3614815|B2|Number of patients with Medical diagnoses||Primary ICU diagnosis||Participants|Count of Participants|6|6.0||||||
3784637|NCT01869699|3614816|B1|Number of patients with Medical diagnoses||Primary ICU diagnosis||Participants|Count of Participants|6|6.0||||||
3784638|NCT01869699|3614814|B3|||Body Mass Index (BMI)|Body Mass Index (BMI) units of measure are kilograms per meter squared|kilograms per meter squared|Mean|30|30.0|Standard Deviation|6|6.0|||
3784639|NCT01869699|3614815|B2|||Body Mass Index (BMI)|Body Mass Index (BMI) units of measure are kilograms per meter squared|kilograms per meter squared|Mean|29|29.0|Standard Deviation|5|5.0|||
3784640|NCT01869699|3614816|B1|||Body Mass Index (BMI)|Body Mass Index (BMI) units of measure are kilograms per meter squared|kilograms per meter squared|Mean|31|31.0|Standard Deviation|7|7.0|||
3784641|NCT01869699|3614814|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784642|NCT01869699|3614815|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784643|NCT01869699|3614816|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784644|NCT01869699|3614814|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3784645|NCT01869699|3614815|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3784646|NCT01869699|3614816|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3784647|NCT01869699|3614814|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3784648|NCT01869699|3614815|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3784649|NCT01869699|3614816|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3784650|NCT01869699|3614814|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3784651|NCT01869699|3614815|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3784652|NCT01869699|3614816|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3784653|NCT01869699|3614814|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3784654|NCT01869699|3614815|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3784655|NCT01869699|3614816|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3784656|NCT01869699|3614814|B3|||Age||years|Mean|57.5|57.5|Standard Deviation|14|14.0|||
3784657|NCT01869699|3614815|B2|||Age||years|Mean|58|58.0|Standard Deviation|15|15.0|||
3784658|NCT01869699|3614816|B1|||Age||years|Mean|57|57.0|Standard Deviation|13|13.0|||
3784659|NCT01869686|3614835|B1|||Body Mass Index (BMI)||kg/m^2|Mean|27.73|27.73|Standard Deviation|4.21|4.21|||
3784660|NCT01869686|3614835|B1|Othe||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3784661|NCT01869686|3614835|B1|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3784662|NCT01869686|3614835|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3784663|NCT01869686|3614835|B1|Mixed race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3784664|NCT01869686|3614835|B1|Black (or African American)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3784665|NCT01869686|3614835|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3784666|NCT01869686|3614835|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3784667|NCT01869686|3614835|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3784668|NCT01869686|3614835|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3784669|NCT01869686|3614835|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|7.0|7.0|||
3784670|NCT01869647|3614847|B4|United States||Region of Enrollment||participants|Number|264|264.0||||||
3784671|NCT01869647|3614848|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
3784672|NCT01869647|3614849|B2|United States||Region of Enrollment||participants|Number|136|136.0||||||
3784673|NCT01869647|3614850|B1|United States||Region of Enrollment||participants|Number|66|66.0||||||
3784674|NCT01869647|3614847|B4||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3784675|NCT01869647|3614848|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3784676|NCT01869647|3614849|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3784677|NCT01869647|3614850|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3784678|NCT01869647|3614847|B4||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3784679|NCT01869647|3614848|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3784680|NCT01869647|3614849|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3784681|NCT01869647|3614850|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3784682|NCT01869647|3614847|B4|||Age||years|Mean|44.0|44.0|Standard Deviation|14.0|14.0|||
3784683|NCT01869647|3614848|B3|||Age||years|Mean|46.1|46.1|Standard Deviation|14.7|14.7|||
3784684|NCT01869647|3614849|B2|||Age||years|Mean|44.0|44.0|Standard Deviation|13.7|13.7|||
3784685|NCT01869647|3614850|B1|||Age||years|Mean|42.2|42.2|Standard Deviation|14.1|14.1|||
3784686|NCT01869647|3614847|B4||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3784689|NCT01869647|3614850|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3784690|NCT01869647|3614847|B4||Between 18 and 65 years|Age||Participants|Count of Participants|245|245.0||||||
3784691|NCT01869647|3614848|B3||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3784692|NCT01869647|3614849|B2||Between 18 and 65 years|Age||Participants|Count of Participants|129|129.0||||||
3784693|NCT01869647|3614850|B1||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
3784694|NCT01869647|3614847|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3784695|NCT01869647|3614848|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3784696|NCT01869647|3614849|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3784697|NCT01869647|3614850|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3784698|NCT01869478|3614863|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3784699|NCT01869478|3614864|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3784700|NCT01869478|3614863|B3|Male||Gender||participants|Number|0|0.0||||||
3784701|NCT01869478|3614864|B2|Male||Gender||participants|Number|0|0.0||||||
3784702|NCT01869478|3614863|B3|Female||Gender||participants|Number|1|1.0||||||
3784703|NCT01869478|3614864|B2|Female||Gender||participants|Number|1|1.0||||||
3784704|NCT01869478|3614863|B3|>=65 years||Age||participants|Number|0|0.0||||||
3784705|NCT01869478|3614864|B2|>=65 years||Age||participants|Number|0|0.0||||||
3784706|NCT01869478|3614863|B3|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
3784707|NCT01869478|3614864|B2|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
3784708|NCT01869478|3614863|B3|<=18 years||Age||participants|Number|0|0.0||||||
3784709|NCT01869478|3614864|B2|<=18 years||Age||participants|Number|0|0.0||||||
3784710|NCT01869439|3614874|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3784711|NCT01869439|3614874|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3784712|NCT01869439|3614874|B1|>18 years||Age, Customized||Participants|Count of Participants|40|40.0||||||
3784713|NCT01869348|3614878|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3784714|NCT01869348|3614879|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3784715|NCT01869348|3614880|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3784716|NCT01869348|3614878|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3784717|NCT01869348|3614879|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3784718|NCT01869348|3614880|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3784719|NCT01869348|3614878|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3784720|NCT01869348|3614879|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784721|NCT01869348|3614880|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3784722|NCT01869348|3614878|B3||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3784723|NCT01869348|3614879|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3784724|NCT01869348|3614880|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3784725|NCT01869348|3614878|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3784726|NCT01869348|3614879|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3784727|NCT01869348|3614880|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3784728|NCT01869348|3614878|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784729|NCT01869348|3614879|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784730|NCT01869348|3614880|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784731|NCT01869348|3614878|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784732|NCT01869348|3614879|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784733|NCT01869348|3614880|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784734|NCT01869348|3614878|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3784735|NCT01869348|3614879|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3784736|NCT01869348|3614880|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784737|NCT01869348|3614878|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784738|NCT01869348|3614879|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784739|NCT01869348|3614880|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784740|NCT01869348|3614878|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3784741|NCT01869348|3614879|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3784742|NCT01869348|3614880|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3784743|NCT01869348|3614878|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3784744|NCT01869348|3614879|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3784745|NCT01869348|3614880|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3784746|NCT01869348|3614878|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3784747|NCT01869348|3614879|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3784748|NCT01869348|3614880|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3784749|NCT01869348|3614878|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3784750|NCT01869348|3614879|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3784751|NCT01869348|3614880|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3784752|NCT01869348|3614878|B3|||Age||years|Mean|61.48|61.48|Standard Deviation|5.60|5.6|||
3784753|NCT01869348|3614879|B2|||Age||years|Mean|61.25|61.25|Standard Deviation|5.00|5.0|||
3784754|NCT01869348|3614880|B1|||Age||years|Mean|61.70|61.7|Standard Deviation|6.26|6.26|||
3784755|NCT01869192|3614887|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3784756|NCT01869192|3614888|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3784757|NCT01869192|3614889|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3784758|NCT01869192|3614887|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3784759|NCT01869192|3614888|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3784760|NCT01869192|3614889|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3784761|NCT01869192|3614887|B3|||Age||years|Mean|50|50.0|Full Range|||30.0|73.0|
3784762|NCT01869192|3614888|B2|||Age||years|Mean|50|50.0|Full Range|||33.0|73.0|
3784763|NCT01869192|3614889|B1|||Age||years|Mean|50|50.0|Full Range|||30.0|69.0|
3784764|NCT01869075|3614898|B7||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3784765|NCT01869075|3614899|B6||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Gender of participants was not collected
3784766|NCT01869075|3614901|B4||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Gender of participants was not collected
3784767|NCT01869075|3614903|B2||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Gender of participants was not collected
3784768|NCT01869075|3614898|B7||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3784769|NCT01869075|3614899|B6||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Gender of participants was not collected
3784770|NCT01869075|3614901|B4||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Gender of participants was not collected
3784771|NCT01869075|3614903|B2||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Gender of participants was not collected
3784772|NCT01869075|3614898|B7|18 years and older||Age, Customized||participants|Number|1175|1175.0||||||
3784773|NCT01869075|3614899|B6|18 years and older||Age, Customized||participants|Number|418|418.0||||||
3784774|NCT01869075|3614901|B4|18 years and older||Age, Customized||participants|Number|416|416.0||||||
3784775|NCT01869075|3614903|B2|18 years and older||Age, Customized||participants|Number|341|341.0||||||
3784776|NCT01868997|3614923|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3784777|NCT01868997|3614924|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3784778|NCT01868997|3614925|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3784779|NCT01868997|3614923|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3784780|NCT01868997|3614924|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3784781|NCT01868997|3614925|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3784782|NCT01868997|3614923|B3|||Age||years|Mean|52.9|52.9|Standard Deviation|11.90|11.9|||
3784783|NCT01868997|3614924|B2|||Age||years|Mean|51.7|51.7|Standard Deviation|10.78|10.78|||
3784784|NCT01868997|3614925|B1|||Age||years|Mean|54.1|54.1|Standard Deviation|12.87|12.87|||
3784785|NCT01868893|3614942|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3784786|NCT01868893|3614942|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3784787|NCT01868893|3614942|B1|||Age||years|Mean|67.5|67.5|Standard Deviation|10.33|10.33|||
3784788|NCT01868789|3614949|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
3784789|NCT01868789|3614950|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3784790|NCT01868789|3614951|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3784791|NCT01868789|3614949|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3784792|NCT01868789|3614949|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3784793|NCT01868789|3614950|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3784794|NCT01868789|3614951|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3784795|NCT01868789|3614949|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3784796|NCT01868789|3614950|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3784797|NCT01868789|3614951|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3784798|NCT01868789|3614949|B3|||Age||years|Mean|49.0|49.0|Full Range|||19.6|82.0|
3784799|NCT01868789|3614950|B2|||Age||years|Mean|52.2|52.2|Full Range|||30.6|82.0|
3784800|NCT01868789|3614951|B1|||Age||years|Mean|43.6|43.6|Full Range|||19.6|69.3|
3784801|NCT01868776|3614960|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
3784802|NCT01868776|3614961|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
3784803|NCT01868776|3614962|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3784804|NCT01868776|3614960|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3784805|NCT01868776|3614961|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3784806|NCT01868776|3614962|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3784807|NCT01868776|3614960|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3784808|NCT01868776|3614961|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3784809|NCT01868776|3614962|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3784810|NCT01868776|3614960|B3|||Age||years|Mean|35.1|35.1|Standard Deviation|11|11.0|||
3784811|NCT01868776|3614961|B2|||Age||years|Mean|35.5|35.5|Standard Deviation|10.7|10.7|||
3784812|NCT01868776|3614962|B1|||Age||years|Mean|34.8|34.8|Standard Deviation|11.3|11.3|||
3784813|NCT01868633|3614969|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784814|NCT01868633|3614970|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784815|NCT01868633|3614971|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784816|NCT01868633|3614969|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784817|NCT01868633|3614970|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784818|NCT01868633|3614971|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784819|NCT01868633|3614969|B3||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3784820|NCT01868633|3614970|B2||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3784821|NCT01868633|3614971|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3784822|NCT01868633|3614969|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3784823|NCT01868633|3614970|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3784824|NCT01868633|3614971|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3784825|NCT01868633|3614969|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784826|NCT01868633|3614970|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784827|NCT01868633|3614971|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784828|NCT01868633|3614969|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784829|NCT01868633|3614970|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784830|NCT01868633|3614971|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784831|NCT01868633|3614969|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784832|NCT01868633|3614970|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784833|NCT01868633|3614971|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784834|NCT01868633|3614969|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784835|NCT01868633|3614970|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784836|NCT01868633|3614971|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784837|NCT01868633|3614969|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3784838|NCT01868633|3614970|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3784839|NCT01868633|3614971|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3784840|NCT01868633|3614969|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3784841|NCT01868633|3614970|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3784842|NCT01868633|3614971|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3784843|NCT01868633|3614969|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3784844|NCT01868633|3614970|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3784845|NCT01868633|3614971|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3784846|NCT01868633|3614969|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3784847|NCT01868633|3614970|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3784848|NCT01868633|3614971|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3784849|NCT01868633|3614969|B3|||Age||Years|Mean|31.67|31.67|Standard Deviation|4.95|4.95|||
3784850|NCT01868633|3614970|B2|||Age||Years|Mean|31.65|31.65|Standard Deviation|5.83|5.83|||
3784851|NCT01868633|3614971|B1|||Age||Years|Mean|31.69|31.69|Standard Deviation|4.02|4.02|||
3784852|NCT01868633|3614969|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3784853|NCT01868633|3614970|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3784854|NCT01868633|3614971|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3784855|NCT01868633|3614969|B3||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3784856|NCT01868633|3614970|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3784857|NCT01868633|3614971|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3784858|NCT01868633|3614969|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3784859|NCT01868633|3614970|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3784860|NCT01868633|3614971|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3784861|NCT01868542|3614986|B3||Male|Gender||Participants|Count of Participants|21|21.0||||||
3784862|NCT01868542|3614987|B2||Male|Gender||Participants|Count of Participants|12|12.0||||||
3784863|NCT01868542|3614988|B1||Male|Gender||Participants|Count of Participants|9|9.0||||||
3784864|NCT01868542|3614986|B3||Female|Gender||Participants|Count of Participants|25|25.0||||||
3784865|NCT01868542|3614987|B2||Female|Gender||Participants|Count of Participants|11|11.0||||||
3784866|NCT01868542|3614988|B1||Female|Gender||Participants|Count of Participants|14|14.0||||||
3784867|NCT01868542|3614986|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3784868|NCT01868542|3614987|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3784869|NCT01868542|3614988|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3784870|NCT01868542|3614986|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3784871|NCT01868542|3614987|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3784872|NCT01868542|3614988|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3784873|NCT01868542|3614986|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3784874|NCT01868542|3614987|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3784875|NCT01868542|3614988|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3784876|NCT01868503|3615007|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3784877|NCT01868503|3615007|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3784878|NCT01868503|3615007|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3784879|NCT01868503|3615007|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3784880|NCT01868503|3615007|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3784881|NCT01868503|3615007|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3784882|NCT01868503|3615007|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3784883|NCT01868503|3615007|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3784884|NCT01868503|3615007|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3784885|NCT01868477|3615015|B3|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3784886|NCT01868477|3615016|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3784887|NCT01868477|3615017|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3784888|NCT01868477|3615015|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3784889|NCT01868477|3615016|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3784890|NCT01868477|3615017|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3784891|NCT01868477|3615015|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3784892|NCT01868477|3615016|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3784893|NCT01868477|3615017|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3784894|NCT01868477|3615015|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3784895|NCT01868477|3615016|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3784896|NCT01868477|3615017|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3784897|NCT01868477|3615015|B3|||Age||years|Mean|72.9|72.9|Standard Deviation|6.77|6.77|||
3784898|NCT01868477|3615016|B2|||Age||years|Mean|71.1|71.1|Standard Deviation|7.54|7.54|||
3784899|NCT01868477|3615017|B1|||Age||years|Mean|74.5|74.5|Standard Deviation|5.84|5.84|||
3784900|NCT01868334|3615042|B5|% Caucasians||Race/Ethnicity, Customized||percentage of participants|Number|44.3|44.3||||||
3784901|NCT01868334|3615043|B4|% Caucasians||Race/Ethnicity, Customized||percentage of participants|Number|7.0|7.0||||||
3784902|NCT01868334|3615044|B3|% Caucasians||Race/Ethnicity, Customized||percentage of participants|Number|6.0|6.0||||||
3784903|NCT01868334|3615045|B2|% Caucasians||Race/Ethnicity, Customized||percentage of participants|Number|94.2|94.2||||||
3784904|NCT01868334|3615046|B1|% Caucasians||Race/Ethnicity, Customized||percentage of participants|Number|94.3|94.3||||||
3784905|NCT01868334|3615042|B5|% Female Sex||Sex/Gender, Customized||percentage of participants|Number|65.5|65.5||||||
3784906|NCT01868334|3615043|B4|% Female Sex||Sex/Gender, Customized||percentage of participants|Number|71.0|71.0||||||
3784907|NCT01868334|3615044|B3|% Female Sex||Sex/Gender, Customized||percentage of participants|Number|72.0|72.0||||||
3784908|NCT01868334|3615045|B2|% Female Sex||Sex/Gender, Customized||percentage of participants|Number|57.8|57.8||||||
3784909|NCT01868334|3615046|B1|% Female Sex||Sex/Gender, Customized||percentage of participants|Number|56.7|56.7||||||
3784910|NCT01868334|3615042|B5|||Age||years|Mean|55.1|55.1|Standard Deviation|15.3|15.3|||
3784911|NCT01868334|3615043|B4|||Age||years|Mean|53.0|53.0|Standard Deviation|13.0|13.0|||
3784912|NCT01868334|3615044|B3|||Age||years|Mean|51.0|51.0|Standard Deviation|13.0|13.0|||
3784913|NCT01868334|3615045|B2|||Age||years|Mean|57.8|57.8|Standard Deviation|16.6|16.6|||
3784914|NCT01868334|3615046|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|16.7|16.7|||
3784915|NCT01868243|3615087|B3|Brazil||Region of Enrollment||participants|Number|27|27.0||||||
3784916|NCT01868243|3615088|B2|Brazil||Region of Enrollment||participants|Number|12|12.0||||||
3784917|NCT01868243|3615089|B1|Brazil||Region of Enrollment||participants|Number|15|15.0||||||
3784918|NCT01868243|3615087|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3784919|NCT01868243|3615088|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3784920|NCT01868243|3615089|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3784921|NCT01868243|3615087|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3784922|NCT01868243|3615088|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3784923|NCT01868243|3615089|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3784924|NCT01868243|3615087|B3|||Age||years|Mean|47|47.0|Standard Deviation|8|8.0|||
3784925|NCT01868243|3615088|B2|||Age||years|Mean|46|46.0|Standard Deviation|6|6.0|||
3784926|NCT01868243|3615089|B1|||Age||years|Mean|49|49.0|Standard Deviation|10|10.0|||
3784927|NCT01868074|3615098|B3|||Center of Pressure Excursion Index (3mph)||ratio|Mean|19.9|19.9|Standard Deviation|6.1|6.1|||
3784928|NCT01868074|3615099|B2|||Center of Pressure Excursion Index (3mph)||ratio|Mean|20.8|20.8|Standard Deviation|6.6|6.6|||
3784929|NCT01868074|3615100|B1|||Center of Pressure Excursion Index (3mph)||ratio|Mean|18.1|18.1|Standard Deviation|5.9|5.9|||
3784930|NCT01868074|3615098|B3|||Center of Pressure Excursion Index at self-selected speed|The Center of Pressure Excursion Index is a measurement of the lateral displacement of the center of pressure curve from a reference line drawn from the initial to the final centers of pressure during stance phase of gait, and standardized to the width of the anterior third of the foot during pedobarography.|ratio|Mean|19.95|19.95|Standard Deviation|6.25|6.25|||
3784931|NCT01868074|3615099|B2|||Center of Pressure Excursion Index at self-selected speed|The Center of Pressure Excursion Index is a measurement of the lateral displacement of the center of pressure curve from a reference line drawn from the initial to the final centers of pressure during stance phase of gait, and standardized to the width of the anterior third of the foot during pedobarography.|ratio|Mean|21.3|21.3|Standard Deviation|6.3|6.3|||
3784932|NCT01868074|3615100|B1|||Center of Pressure Excursion Index at self-selected speed|The Center of Pressure Excursion Index is a measurement of the lateral displacement of the center of pressure curve from a reference line drawn from the initial to the final centers of pressure during stance phase of gait, and standardized to the width of the anterior third of the foot during pedobarography.|ratio|Mean|18.6|18.6|Standard Deviation|6.2|6.2|||
3784933|NCT01868074|3615098|B3|||Arch Rigidity|The arch rigidity index, a measure of the ability of the foot to maintain the arch when weight-bearing, was determined by dividing the standing AHI by the seated AHI. A value of 1.0 would indicate a perfectly rigid arch, while smaller values would indicate a more flexible arch.|ratio|Mean|0.94|0.94|Standard Deviation|0.03|0.03|||
3784934|NCT01868074|3615099|B2|||Arch Rigidity|The arch rigidity index, a measure of the ability of the foot to maintain the arch when weight-bearing, was determined by dividing the standing AHI by the seated AHI. A value of 1.0 would indicate a perfectly rigid arch, while smaller values would indicate a more flexible arch.|ratio|Mean|0.94|0.94|Standard Deviation|.02|0.02|||
3784935|NCT01868074|3615100|B1|||Arch Rigidity|The arch rigidity index, a measure of the ability of the foot to maintain the arch when weight-bearing, was determined by dividing the standing AHI by the seated AHI. A value of 1.0 would indicate a perfectly rigid arch, while smaller values would indicate a more flexible arch.|ratio|Mean|0.94|0.94|Standard Deviation|0.03|0.03|||
3784936|NCT01868074|3615098|B3|||Arch Drop|Arch drop was calculated by subtracting the standing arch height from the seated arch height.|mm|Mean|2.9|2.9|Standard Deviation|1.3|1.3|||
3784937|NCT01868074|3615099|B2|||Arch Drop|Arch drop was calculated by subtracting the standing arch height from the seated arch height.|mm|Mean|2.8|2.8|Standard Deviation|1.1|1.1|||
3784938|NCT01868074|3615100|B1|||Arch Drop|Arch drop was calculated by subtracting the standing arch height from the seated arch height.|mm|Mean|3.0|3.0|Standard Deviation|1.4|1.4|||
3784939|NCT01868074|3615098|B3|||AHI Standing|The arch height index (AHI) was calculated as the dorsum height at 50% of total foot length divided by the ipsilateral truncated foot length.|ratio|Mean|0.33|0.33|Standard Deviation|0.02|0.02|||
3784940|NCT01868074|3615099|B2|||AHI Standing|The arch height index (AHI) was calculated as the dorsum height at 50% of total foot length divided by the ipsilateral truncated foot length.|ratio|Mean|0.33|0.33|Standard Deviation|0.02|0.02|||
3784941|NCT01868074|3615100|B1|||AHI Standing|The arch height index (AHI) was calculated as the dorsum height at 50% of total foot length divided by the ipsilateral truncated foot length.|ratio|Mean|0.33|0.33|Standard Deviation|0.02|0.02|||
3784942|NCT01868074|3615098|B3|||AHI Sitting|The arch height index (AHI) was calculated as the dorsum height at 50% of total foot length divided by the ipsilateral truncated foot length.|ratio|Mean|0.35|0.35|Standard Deviation|0.02|0.02|||
3784943|NCT01868074|3615099|B2|||AHI Sitting|The arch height index (AHI) was calculated as the dorsum height at 50% of total foot length divided by the ipsilateral truncated foot length.|ratio|Mean|0.35|0.35|Standard Deviation|0.02|0.02|||
3784944|NCT01868074|3615100|B1|||AHI Sitting|The arch height index (AHI) was calculated as the dorsum height at 50% of total foot length divided by the ipsilateral truncated foot length.|ratio|Mean|0.35|0.35|Standard Deviation|0.02|0.02|||
3784945|NCT01868074|3615098|B3|||Foot Length Standing||mm|Mean|242.9|242.9|Standard Deviation|11.95|11.95|||
3784946|NCT01868074|3615099|B2|||Foot Length Standing||mm|Mean|243.0|243.0|Standard Deviation|13.7|13.7|||
3784947|NCT01868074|3615100|B1|||Foot Length Standing||mm|Mean|242.8|242.8|Standard Deviation|10.2|10.2|||
3784948|NCT01868074|3615098|B3|||Foot Length Sitting||mm|Mean|240.25|240.25|Standard Deviation|11.85|11.85|||
3784949|NCT01868074|3615099|B2|||Foot Length Sitting||mm|Mean|240.1|240.1|Standard Deviation|10.2|10.2|||
3784950|NCT01868074|3615100|B1|||Foot Length Sitting||mm|Mean|240.4|240.4|Standard Deviation|13.5|13.5|||
3784951|NCT01868074|3615098|B3|United States||Region of Enrollment||participants|Number|72|72.0||||||
3784952|NCT01868074|3615099|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
3784953|NCT01868074|3615100|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
3784954|NCT01868074|3615098|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3784955|NCT01868074|3615099|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3784956|NCT01868074|3615100|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3784957|NCT01868074|3615098|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3784958|NCT01868074|3615099|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3784959|NCT01868074|3615100|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3784960|NCT01868074|3615098|B3|||Age||year|Mean|30.3|30.3|Standard Deviation|4.5|4.5|||
3784961|NCT01868074|3615099|B2|||Age||year|Mean|30.4|30.4|Standard Deviation|4.4|4.4|||
3784962|NCT01868074|3615100|B1|||Age||year|Mean|30.2|30.2|Standard Deviation|4.6|4.6|||
3784963|NCT01868074|3615098|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3784964|NCT01868074|3615099|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3784965|NCT01868074|3615100|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3784966|NCT01868074|3615098|B3||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
3784967|NCT01868074|3615099|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3784968|NCT01868074|3615100|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3784969|NCT01868074|3615098|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3784970|NCT01868074|3615099|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3784971|NCT01868074|3615100|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3784972|NCT01868035|3615111|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3784973|NCT01868035|3615111|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3784974|NCT01868035|3615111|B1|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3784975|NCT01868035|3615111|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
3784976|NCT01868035|3615111|B1||Female|Gender||Participants|Count of Participants|9|9.0||||||
3784977|NCT01868035|3615111|B1|||Age||Years|Mean|51.8|51.8|Standard Deviation|13.9|13.9|||
3784978|NCT01868009|3615127|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|270|270.0||||||
3784979|NCT01868009|3615127|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3784980|NCT01868009|3615127|B1||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3784981|NCT01868009|3615127|B1||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3784982|NCT01868009|3615127|B1|||Age||Years|Mean|64.7|64.7|Standard Deviation|9.74|9.74|||
3784983|NCT01867710|3615138|B5|Italy||Region of Enrollment||participants|Number|40|40.0||||||
3784984|NCT01867710|3615139|B4|Italy||Region of Enrollment||participants|Number|10|10.0||||||
3784985|NCT01867710|3615140|B3|Italy||Region of Enrollment||participants|Number|11|11.0||||||
3784986|NCT01867710|3615141|B2|Italy||Region of Enrollment||participants|Number|9|9.0||||||
3784987|NCT01867710|3615142|B1|Italy||Region of Enrollment||participants|Number|10|10.0||||||
3784988|NCT01867710|3615138|B5|Hungary||Region of Enrollment||participants|Number|20|20.0||||||
3784989|NCT01867710|3615139|B4|Hungary||Region of Enrollment||participants|Number|4|4.0||||||
3784990|NCT01867710|3615140|B3|Hungary||Region of Enrollment||participants|Number|6|6.0||||||
3784991|NCT01867710|3615141|B2|Hungary||Region of Enrollment||participants|Number|4|4.0||||||
3784992|NCT01867710|3615142|B1|Hungary||Region of Enrollment||participants|Number|6|6.0||||||
3784993|NCT01867710|3615138|B5|Great Britain||Region of Enrollment||participants|Number|35|35.0||||||
3784994|NCT01867710|3615139|B4|Great Britain||Region of Enrollment||participants|Number|8|8.0||||||
3784995|NCT01867710|3615140|B3|Great Britain||Region of Enrollment||participants|Number|8|8.0||||||
3784996|NCT01867710|3615141|B2|Great Britain||Region of Enrollment||participants|Number|9|9.0||||||
3784997|NCT01867710|3615142|B1|Great Britain||Region of Enrollment||participants|Number|10|10.0||||||
3784998|NCT01867710|3615138|B5|Germany||Region of Enrollment||participants|Number|28|28.0||||||
3784999|NCT01867710|3615139|B4|Germany||Region of Enrollment||participants|Number|6|6.0||||||
3785000|NCT01867710|3615140|B3|Germany||Region of Enrollment||participants|Number|5|5.0||||||
3785001|NCT01867710|3615141|B2|Germany||Region of Enrollment||participants|Number|10|10.0||||||
3785002|NCT01867710|3615142|B1|Germany||Region of Enrollment||participants|Number|7|7.0||||||
3785003|NCT01867710|3615138|B5|Belgium||Region of Enrollment||participants|Number|41|41.0||||||
3785004|NCT01867710|3615139|B4|Belgium||Region of Enrollment||participants|Number|14|14.0||||||
3785005|NCT01867710|3615140|B3|Belgium||Region of Enrollment||participants|Number|10|10.0||||||
3785006|NCT01867710|3615141|B2|Belgium||Region of Enrollment||participants|Number|9|9.0||||||
3785007|NCT01867710|3615142|B1|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
3785008|NCT01867710|3615138|B5||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3785009|NCT01867710|3615139|B4||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3785010|NCT01867710|3615140|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3785011|NCT01867710|3615141|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3785012|NCT01867710|3615142|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3785013|NCT01867710|3615138|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3785014|NCT01867710|3615139|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3785015|NCT01867710|3615140|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3785016|NCT01867710|3615141|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3785017|NCT01867710|3615142|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3785018|NCT01867710|3615138|B5|||Age||years|Mean|69.6|69.6|Standard Deviation|8.35|8.35|||
3785019|NCT01867710|3615139|B4|||Age||years|Mean|71.3|71.3|Standard Deviation|8.12|8.12|||
3785020|NCT01867710|3615140|B3|||Age||years|Mean|69.3|69.3|Standard Deviation|7.51|7.51|||
3785021|NCT01867710|3615141|B2|||Age||years|Mean|69|69.0|Standard Deviation|8.44|8.44|||
3785022|NCT01867710|3615142|B1|||Age||years|Mean|68.9|68.9|Standard Deviation|9.28|9.28|||
3785023|NCT01867658|3615159|B1|United States||Region of Enrollment||participants|Number|112|112.0||||||
3785024|NCT01867658|3615159|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3785025|NCT01867658|3615159|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3785026|NCT01867658|3615159|B1|||Age||years|Mean|67.1|67.1|Standard Deviation|11.21|11.21|||
3785027|NCT01867658|3615159|B1||>=65 years|Age||Participants|Count of Participants|73|73.0||||||
3785028|NCT01867658|3615159|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3785029|NCT01867658|3615159|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3785030|NCT01867632|3615170|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3785031|NCT01867632|3615170|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3785032|NCT01867632|3615171|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3785033|NCT01867632|3615172|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3785034|NCT01867632|3615170|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3785035|NCT01867632|3615171|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3785036|NCT01867632|3615172|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3785037|NCT01867632|3615170|B3|||Age||weeks|Mean|63|63.0|Standard Deviation|26.3|26.3|||
3785038|NCT01867632|3615171|B2|||Age||weeks|Mean|66.6|66.6|Standard Deviation|27.1|27.1|||
3785039|NCT01867632|3615172|B1|||Age||weeks|Mean|59.3|59.3|Standard Deviation|25|25.0|||
3785040|NCT01867580|3615181|B3|United States||Region of Enrollment||Participants|Count of Participants|181|181.0||||||
3785041|NCT01867580|3615182|B2|United States||Region of Enrollment||Participants|Count of Participants|88|88.0||||||
3785042|NCT01867580|3615183|B1|United States||Region of Enrollment||Participants|Count of Participants|93|93.0||||||
3785043|NCT01867580|3615181|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3785044|NCT01867580|3615182|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3785045|NCT01867580|3615183|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785046|NCT01867580|3615181|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785047|NCT01867580|3615182|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785048|NCT01867580|3615183|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785049|NCT01867580|3615181|B3||White|Race (NIH/OMB)||Participants|Count of Participants|112|112.0||||||
3785050|NCT01867580|3615182|B2||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3785051|NCT01867580|3615183|B1||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3785052|NCT01867580|3615181|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3785053|NCT01867580|3615182|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3785054|NCT01867580|3615183|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3785055|NCT01867580|3615181|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785056|NCT01867580|3615182|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785057|NCT01867580|3615183|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785058|NCT01867580|3615181|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785059|NCT01867580|3615182|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785060|NCT01867580|3615183|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785061|NCT01867580|3615181|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785062|NCT01867580|3615182|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785063|NCT01867580|3615183|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785064|NCT01867580|3615181|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785065|NCT01867580|3615182|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785066|NCT01867580|3615183|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785067|NCT01867580|3615181|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|147|147.0||||||
3785068|NCT01867580|3615182|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3785069|NCT01867580|3615183|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3785070|NCT01867580|3615181|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3785071|NCT01867580|3615182|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3785072|NCT01867580|3615183|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3785073|NCT01867580|3615181|B3||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3785074|NCT01867580|3615182|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3785075|NCT01867580|3615183|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3785076|NCT01867580|3615181|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3785077|NCT01867580|3615182|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3785078|NCT01867580|3615183|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3785079|NCT01867580|3615181|B3|||Age||years|Median|53.0|53.0|Standard Deviation|14.04|14.04|||
3785080|NCT01867580|3615182|B2|||Age||years|Median|52.0|52.0|Standard Deviation|14.25|14.25|||
3785081|NCT01867580|3615183|B1|||Age||years|Median|53.0|53.0|Standard Deviation|13.92|13.92|||
3785082|NCT01867515|3615194|B4|United States||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
3785083|NCT01867515|3615195|B3|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3785084|NCT01867515|3615196|B2|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3785085|NCT01867515|3615197|B1|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3785086|NCT01867515|3615194|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3785087|NCT01867515|3615195|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3785088|NCT01867515|3615196|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3785089|NCT01867515|3615197|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3785090|NCT01867515|3615194|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3785091|NCT01867515|3615195|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3785092|NCT01867515|3615196|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3785093|NCT01867515|3615197|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3785094|NCT01867515|3615194|B4|||Age||years|Mean|48.0|48.0|Full Range|||20.0|65.0|
3785095|NCT01867515|3615195|B3|||Age||years|Mean|59.4|59.4|Full Range|||48.0|65.0|
3785096|NCT01867515|3615196|B2|||Age||years|Mean|59.1|59.1|Full Range|||51.0|65.0|
3785097|NCT01867515|3615197|B1|||Age||years|Mean|26.5|26.5|Full Range|||20.0|33.0|
3785098|NCT01867515|3615194|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3785099|NCT01867515|3615195|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3785100|NCT01867515|3615196|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3785101|NCT01867515|3615197|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3785102|NCT01867515|3615194|B4||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3785103|NCT01867515|3615195|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3785104|NCT01867515|3615196|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3785105|NCT01867515|3615197|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3785106|NCT01867515|3615194|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3785107|NCT01867515|3615195|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3785108|NCT01867515|3615196|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3785109|NCT01867515|3615197|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3785110|NCT01867424|3615207|B3|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3785111|NCT01867424|3615208|B2|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3785112|NCT01867424|3615209|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3785113|NCT01867424|3615207|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785114|NCT01867424|3615208|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785115|NCT01867424|3615209|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785116|NCT01867424|3615207|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785117|NCT01867424|3615208|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785118|NCT01867424|3615209|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785119|NCT01867424|3615207|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3785120|NCT01867424|3615208|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3785121|NCT01867424|3615209|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3785122|NCT01867424|3615207|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3785123|NCT01867424|3615208|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3785124|NCT01867424|3615209|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3785125|NCT01867424|3615207|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785126|NCT01867424|3615208|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785127|NCT01867424|3615209|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785128|NCT01867424|3615207|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3785129|NCT01867424|3615208|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3785130|NCT01867424|3615209|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785131|NCT01867424|3615207|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785132|NCT01867424|3615208|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785133|NCT01867424|3615209|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785134|NCT01867424|3615207|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785135|NCT01867424|3615208|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785136|NCT01867424|3615209|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785137|NCT01867424|3615207|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3785138|NCT01867424|3615208|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3785139|NCT01867424|3615209|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3785140|NCT01867424|3615207|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785141|NCT01867424|3615208|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785142|NCT01867424|3615209|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785143|NCT01867424|3615207|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3785144|NCT01867424|3615208|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3785145|NCT01867424|3615209|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3785146|NCT01867424|3615207|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3785147|NCT01867424|3615208|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3785148|NCT01867424|3615209|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3785149|NCT01867424|3615207|B3|||Age||years|Mean|67.91|67.91|Standard Deviation|7.91|7.91|||
3785150|NCT01867424|3615208|B2|||Age||years|Mean|68.67|68.67|Standard Deviation|6.31|6.31|||
3785151|NCT01867424|3615209|B1|||Age||years|Mean|67.16|67.16|Standard Deviation|9.52|9.52|||
3785152|NCT01867424|3615207|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3785153|NCT01867424|3615208|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3785154|NCT01867424|3615209|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3785155|NCT01867424|3615207|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3785156|NCT01867424|3615208|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3785157|NCT01867424|3615209|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3785158|NCT01867424|3615207|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3785159|NCT01867424|3615208|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3785160|NCT01867424|3615209|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3785161|NCT01867307|3615222|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3785162|NCT01867307|3615223|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3785163|NCT01867307|3615224|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3785164|NCT01867307|3615222|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3785165|NCT01867307|3615223|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3785166|NCT01867307|3615224|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3785167|NCT01867307|3615222|B3|||Age||years|Mean|55.9|55.9|Standard Deviation|5.9|5.9|||
3785168|NCT01867307|3615223|B2|||Age||years|Mean|56.7|56.7|Standard Deviation|6.3|6.3|||
3785169|NCT01867307|3615224|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|5.5|5.5|||
3785170|NCT01867216|3615231|B8|||Fasting Blood Glucose||milligrams per deciliter (mg/dL)|Mean|141.05|141.05|Standard Deviation|40.99|40.99|||
3785171|NCT01867216|3615232|B7|||Fasting Blood Glucose||milligrams per deciliter (mg/dL)|Mean|149.56|149.56|Standard Deviation|44.21|44.21|||
3785172|NCT01867216|3615233|B6|||Fasting Blood Glucose||milligrams per deciliter (mg/dL)|Mean|149.50|149.5|Standard Deviation|38.40|38.4|||
3785173|NCT01867216|3615234|B5|||Fasting Blood Glucose||milligrams per deciliter (mg/dL)|Mean|137.11|137.11|Standard Deviation|26.19|26.19|||
3785174|NCT01867216|3615235|B4|||Fasting Blood Glucose||milligrams per deciliter (mg/dL)|Mean|140.19|140.19|Standard Deviation|49.53|49.53|||
3785175|NCT01867216|3615236|B3|||Fasting Blood Glucose||milligrams per deciliter (mg/dL)|Mean|132.39|132.39|Standard Deviation|37.09|37.09|||
3785176|NCT01867216|3615237|B2|||Fasting Blood Glucose||milligrams per deciliter (mg/dL)|Mean|128.45|128.45|Standard Deviation|39.38|39.38|||
3785177|NCT01867216|3615238|B1|||Fasting Blood Glucose||milligrams per deciliter (mg/dL)|Mean|145.92|145.92|Standard Deviation|50.50|50.5|||
3785178|NCT01867216|3615231|B8|||Hemoglobin A1c (HbA1c)|HbA1c is a form of hemoglobin that is primarily measured to identify the average plasma glucose concentration over prolonged periods of time.|percentage of glycosylated hemoglobin|Mean|7.99|7.99|Standard Deviation|1.24|1.24|||
3785179|NCT01867216|3615232|B7|||Hemoglobin A1c (HbA1c)|HbA1c is a form of hemoglobin that is primarily measured to identify the average plasma glucose concentration over prolonged periods of time.|percentage of glycosylated hemoglobin|Mean|7.96|7.96|Standard Deviation|1.21|1.21|||
3785180|NCT01867216|3615233|B6|||Hemoglobin A1c (HbA1c)|HbA1c is a form of hemoglobin that is primarily measured to identify the average plasma glucose concentration over prolonged periods of time.|percentage of glycosylated hemoglobin|Mean|8.09|8.09|Standard Deviation|1.25|1.25|||
3785181|NCT01867216|3615234|B5|||Hemoglobin A1c (HbA1c)|HbA1c is a form of hemoglobin that is primarily measured to identify the average plasma glucose concentration over prolonged periods of time.|percentage of glycosylated hemoglobin|Mean|7.24|7.24|Standard Deviation|0.49|0.49|||
3785182|NCT01867216|3615235|B4|||Hemoglobin A1c (HbA1c)|HbA1c is a form of hemoglobin that is primarily measured to identify the average plasma glucose concentration over prolonged periods of time.|percentage of glycosylated hemoglobin|Mean|7.91|7.91|Standard Deviation|1.69|1.69|||
3785183|NCT01867216|3615236|B3|||Hemoglobin A1c (HbA1c)|HbA1c is a form of hemoglobin that is primarily measured to identify the average plasma glucose concentration over prolonged periods of time.|percentage of glycosylated hemoglobin|Mean|7.74|7.74|Standard Deviation|1.29|1.29|||
3785184|NCT01867216|3615237|B2|||Hemoglobin A1c (HbA1c)|HbA1c is a form of hemoglobin that is primarily measured to identify the average plasma glucose concentration over prolonged periods of time.|percentage of glycosylated hemoglobin|Mean|8.58|8.58|Standard Deviation|1.48|1.48|||
3785185|NCT01867216|3615238|B1|||Hemoglobin A1c (HbA1c)|HbA1c is a form of hemoglobin that is primarily measured to identify the average plasma glucose concentration over prolonged periods of time.|percentage of glycosylated hemoglobin|Mean|8.29|8.29|Standard Deviation|1.08|1.08|||
3785186|NCT01867216|3615231|B8|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m²)|Mean|31.19|31.19|Standard Deviation|4.89|4.89|||
3785187|NCT01867216|3615232|B7|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m²)|Mean|32.90|32.9|Standard Deviation|6.08|6.08|||
3785188|NCT01867216|3615233|B6|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m²)|Mean|34.36|34.36|Standard Deviation|4.04|4.04|||
3785189|NCT01867216|3615234|B5|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m²)|Mean|30.20|30.2|Standard Deviation|6.56|6.56|||
3785243|NCT01867216|3615232|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785190|NCT01867216|3615235|B4|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m²)|Mean|31.08|31.08|Standard Deviation|3.40|3.4|||
3785191|NCT01867216|3615236|B3|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m²)|Mean|30.76|30.76|Standard Deviation|3.74|3.74|||
3785192|NCT01867216|3615237|B2|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m²)|Mean|28.10|28.1|Standard Deviation|3.19|3.19|||
3785193|NCT01867216|3615238|B1|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m²)|Mean|31.00|31.0|Standard Deviation|4.86|4.86|||
3785194|NCT01867216|3615231|B8|United States||Region of Enrollment||Participants|Count of Participants|64|64.0||||||
3785195|NCT01867216|3615232|B7|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3785196|NCT01867216|3615233|B6|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3785197|NCT01867216|3615234|B5|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3785198|NCT01867216|3615235|B4|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3785199|NCT01867216|3615236|B3|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3785200|NCT01867216|3615237|B2|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3785201|NCT01867216|3615238|B1|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3785202|NCT01867216|3615231|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785203|NCT01867216|3615232|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785204|NCT01867216|3615233|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785205|NCT01867216|3615234|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785206|NCT01867216|3615235|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785207|NCT01867216|3615236|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785208|NCT01867216|3615237|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785209|NCT01867216|3615238|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785210|NCT01867216|3615231|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785211|NCT01867216|3615232|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785212|NCT01867216|3615233|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785213|NCT01867216|3615234|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785214|NCT01867216|3615235|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785215|NCT01867216|3615236|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785216|NCT01867216|3615237|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785217|NCT01867216|3615238|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785218|NCT01867216|3615231|B8||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3785219|NCT01867216|3615232|B7||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3785220|NCT01867216|3615233|B6||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3785221|NCT01867216|3615234|B5||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3785222|NCT01867216|3615235|B4||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3785223|NCT01867216|3615236|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3785224|NCT01867216|3615237|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3785225|NCT01867216|3615238|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3785226|NCT01867216|3615231|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3785227|NCT01867216|3615232|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3785228|NCT01867216|3615233|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3785229|NCT01867216|3615234|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3785230|NCT01867216|3615235|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3785231|NCT01867216|3615236|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3785232|NCT01867216|3615237|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3785233|NCT01867216|3615238|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3785234|NCT01867216|3615231|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3785235|NCT01867216|3615232|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3785236|NCT01867216|3615233|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785237|NCT01867216|3615234|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785238|NCT01867216|3615235|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785239|NCT01867216|3615236|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785240|NCT01867216|3615237|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785241|NCT01867216|3615238|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785242|NCT01867216|3615231|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785244|NCT01867216|3615233|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785245|NCT01867216|3615234|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785246|NCT01867216|3615235|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785247|NCT01867216|3615236|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785248|NCT01867216|3615237|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785249|NCT01867216|3615238|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785250|NCT01867216|3615231|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785251|NCT01867216|3615232|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785252|NCT01867216|3615233|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785253|NCT01867216|3615234|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785254|NCT01867216|3615235|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785255|NCT01867216|3615236|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785256|NCT01867216|3615237|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785257|NCT01867216|3615238|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785258|NCT01867216|3615231|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785259|NCT01867216|3615232|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785260|NCT01867216|3615233|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785261|NCT01867216|3615234|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785262|NCT01867216|3615235|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785263|NCT01867216|3615236|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785264|NCT01867216|3615237|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785265|NCT01867216|3615238|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785266|NCT01867216|3615231|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3785267|NCT01867216|3615232|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3785268|NCT01867216|3615233|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3785269|NCT01867216|3615234|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3785270|NCT01867216|3615235|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3785271|NCT01867216|3615236|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3785272|NCT01867216|3615237|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3785273|NCT01867216|3615238|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3785274|NCT01867216|3615231|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3785275|NCT01867216|3615232|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3785276|NCT01867216|3615233|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3785277|NCT01867216|3615234|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3785278|NCT01867216|3615235|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3785279|NCT01867216|3615236|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3785280|NCT01867216|3615237|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3785281|NCT01867216|3615238|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3785282|NCT01867216|3615231|B8||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3785283|NCT01867216|3615232|B7||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3785284|NCT01867216|3615233|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3785285|NCT01867216|3615234|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3785286|NCT01867216|3615235|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3785287|NCT01867216|3615236|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3785288|NCT01867216|3615237|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3785289|NCT01867216|3615238|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3785290|NCT01867216|3615231|B8||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3785291|NCT01867216|3615232|B7||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3785292|NCT01867216|3615233|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3785293|NCT01867216|3615234|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3785294|NCT01867216|3615235|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3785295|NCT01867216|3615236|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3785296|NCT01867216|3615237|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3785297|NCT01867216|3615238|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3785298|NCT01867216|3615231|B8|||Age||years|Mean|54.9|54.9|Standard Deviation|8.7|8.7|||
3785299|NCT01867216|3615232|B7|||Age||years|Mean|50.2|50.2|Standard Deviation|9.3|9.3|||
3785300|NCT01867216|3615233|B6|||Age||years|Mean|54.0|54.0|Standard Deviation|6.4|6.4|||
3785301|NCT01867216|3615234|B5|||Age||years|Mean|59.8|59.8|Standard Deviation|7.6|7.6|||
3785302|NCT01867216|3615235|B4|||Age||years|Mean|58.6|58.6|Standard Deviation|7.8|7.8|||
3785303|NCT01867216|3615236|B3|||Age||years|Mean|52.8|52.8|Standard Deviation|8.0|8.0|||
3785304|NCT01867216|3615237|B2|||Age||years|Mean|59.9|59.9|Standard Deviation|6.6|6.6|||
3785305|NCT01867216|3615238|B1|||Age||years|Mean|51.4|51.4|Standard Deviation|9.9|9.9|||
3785306|NCT01867164|3615299|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3785307|NCT01867164|3615300|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3785308|NCT01867164|3615301|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3785309|NCT01867164|3615299|B3||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3785310|NCT01867164|3615300|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3785311|NCT01867164|3615301|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3785312|NCT01867164|3615299|B3|||Age|Participants who received at least 1 dose of study medication and who were evaluated for efficacy parameters were included in ITT population. A total of 81 participants in Gynoclin V and 78 participants in Vagitrol V were analyzed for this Baseline characteristic.|Years|Mean|30.63|30.63|Standard Deviation|7.33|7.33|||
3785313|NCT01867164|3615300|B2|||Age|Participants who received at least 1 dose of study medication and who were evaluated for efficacy parameters were included in ITT population. A total of 81 participants in Gynoclin V and 78 participants in Vagitrol V were analyzed for this Baseline characteristic.|Years|Mean|30.56|30.56|Standard Deviation|7.50|7.5|||
3785314|NCT01867164|3615301|B1|||Age|Participants who received at least 1 dose of study medication and who were evaluated for efficacy parameters were included in ITT population. A total of 81 participants in Gynoclin V and 78 participants in Vagitrol V were analyzed for this Baseline characteristic.|Years|Mean|30.69|30.69|Standard Deviation|7.17|7.17|||
3785315|NCT01867086|3615316|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785316|NCT01867086|3615316|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785317|NCT01867086|3615316|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3785318|NCT01867086|3615316|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785319|NCT01867086|3615316|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785320|NCT01867086|3615316|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785321|NCT01867086|3615316|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785322|NCT01867086|3615316|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3785323|NCT01867086|3615316|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3785324|NCT01867086|3615316|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3785325|NCT01867086|3615316|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3785326|NCT01867086|3615316|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3785327|NCT01867047|3615323|B3|United States||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
3785328|NCT01867047|3615324|B2|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3785329|NCT01867047|3615325|B1|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3785330|NCT01867047|3615323|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3785331|NCT01867047|3615324|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3785332|NCT01867047|3615325|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3785333|NCT01867047|3615323|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3785334|NCT01867047|3615324|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3785335|NCT01867047|3615325|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3785336|NCT01867047|3615323|B3|||Age||years|Mean|63.5|63.5|Standard Deviation|9.7|9.7|||
3785337|NCT01867047|3615324|B2|||Age||years|Mean|63.7|63.7|Standard Deviation|8.7|8.7|||
3785338|NCT01867047|3615325|B1|||Age||years|Mean|63.3|63.3|Standard Deviation|10.8|10.8|||
3785339|NCT01867047|3615323|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3785340|NCT01867047|3615324|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3785341|NCT01867047|3615325|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3785342|NCT01867047|3615323|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3785343|NCT01867047|3615324|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3785344|NCT01867047|3615325|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3785345|NCT01867047|3615323|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3785346|NCT01867047|3615324|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3785347|NCT01867047|3615325|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3785348|NCT01867021|3615344|B3||Male|Sex: Female, Male||Participants|Count of Participants|1066|1066.0||||||
3785349|NCT01867021|3615345|B2||Male|Sex: Female, Male||Participants|Count of Participants|557|557.0||||||
3785350|NCT01867021|3615346|B1||Male|Sex: Female, Male||Participants|Count of Participants|509|509.0||||||
3785351|NCT01867021|3615344|B3||Female|Sex: Female, Male||Participants|Count of Participants|1836|1836.0||||||
3785352|NCT01867021|3615345|B2||Female|Sex: Female, Male||Participants|Count of Participants|893|893.0||||||
3785353|NCT01867021|3615346|B1||Female|Sex: Female, Male||Participants|Count of Participants|943|943.0||||||
3785354|NCT01867021|3615344|B3|||Age||year|Mean|64.2|64.2|Standard Deviation|8.9|8.9|||
3785355|NCT01867021|3615345|B2|||Age||year|Mean|64.2|64.2|Standard Deviation|8.9|8.9|||
3785356|NCT01867021|3615346|B1|||Age||year|Mean|64.2|64.2|Standard Deviation|8.9|8.9|||
3785357|NCT01866943|3615366|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3785358|NCT01866943|3615366|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3785359|NCT01866943|3615366|B1|||Age||Years|Mean|59.6|59.6|Standard Deviation|9.44|9.44|||
3785360|NCT01866943|3615366|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3785361|NCT01866943|3615366|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3785362|NCT01866943|3615366|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3785363|NCT01866709|3615376|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3785364|NCT01866709|3615377|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3785365|NCT01866709|3615378|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3785366|NCT01866709|3615376|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3785367|NCT01866709|3615377|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3785368|NCT01866709|3615378|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3785369|NCT01866709|3615376|B3|||Age||years|Mean|70.8|70.8|Full Range|||50.0|88.0|
3785370|NCT01866709|3615377|B2|||Age||years|Mean|70.5|70.5|Full Range|||50.0|88.0|
3785371|NCT01866709|3615378|B1|||Age||years|Mean|71.1|71.1|Full Range|||53.0|83.0|
3785372|NCT01866592|3615387|B1|||History of Biologics||Participants|Count of Participants|24|24.0||||||
3785373|NCT01866592|3615387|B1|||History of Oral Systemics||Participants|Count of Participants|28|28.0||||||
3785374|NCT01866592|3615387|B1|||History of Phototherapy||Participants|Count of Participants|23|23.0||||||
3785375|NCT01866592|3615387|B1|||DLQI (Dermatology Quality of Life Index)|The DLQI is calculated by summing the score of 10 questions regarding impact of skin condition on daily life resulting in a maximum of 30 and a minimum of 0. The higher the score, the more quality of life is impaired.|units on a scale|Mean|15.02|15.02|Standard Deviation|6.52|6.52|||
3785376|NCT01866592|3615387|B1|||PGA (Physician's Global Assessment)|The PGA is an average assessment of all psoriatic lesions based on erythema, scale, and induration with scores ranging from 0 (no disease) to 5 (maximal disease).|units on a scale|Mean|3.25|3.25|Standard Deviation|.59|0.59|||
3785377|NCT01866592|3615387|B1|||PASI (Psoriasis Area and Severity Index)|PASI combines the assessment of the severity of lesions and the area affected into a single score in the range of 0 (no disease) to 72 (maximal disease).|units on a scale|Mean|19.12|19.12|Standard Deviation|7.41|7.41|||
3785378|NCT01866592|3615387|B1|||Body Surface Area||kg/m^2|Mean|24.37|24.37|Standard Deviation|14.65|14.65|||
3785379|NCT01866592|3615387|B1|||10 year Framingham Risk|Absolute risk of developing a first cardiovascular disease (CVD) event (coronary death, myocardial infarction, coronary insufficiency, angina, ischemic stroke, hemorrhagic stroke, transient ischemic attack, peripheral artery disease, heart failure) within 10 years. The units are in 10-year risk percentage.|percentage|Mean|7.44|7.44|Standard Deviation|8.3|8.3|||
3785380|NCT01866592|3615387|B1|||History of Statin Use||Participants|Count of Participants|7|7.0||||||
3785381|NCT01866592|3615387|B1|||History of Hyperlipidemia||Participants|Count of Participants|11|11.0||||||
3785382|NCT01866592|3615387|B1|||History of Hypertension||Participants|Count of Participants|14|14.0||||||
3785383|NCT01866592|3615387|B1|||Diabetes||Participants|Count of Participants|3|3.0||||||
3785384|NCT01866592|3615387|B1|||History of Cardiovascular Disease||Participants|Count of Participants|6|6.0||||||
3785385|NCT01866592|3615387|B1|||Psoriatic Arthritis||Participants|Count of Participants|9|9.0||||||
3785386|NCT01866592|3615387|B1|||Psoriasis Duration||years|Mean|16.27|16.27|Standard Deviation|13.78|13.78|||
3785387|NCT01866592|3615387|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3785388|NCT01866592|3615387|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785389|NCT01866592|3615387|B1||White|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3785390|NCT01866592|3615387|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3785391|NCT01866592|3615387|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785392|NCT01866592|3615387|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3785393|NCT01866592|3615387|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3785394|NCT01866592|3615387|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3785395|NCT01866592|3615387|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3785396|NCT01866592|3615387|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3785397|NCT01866592|3615387|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3785398|NCT01866592|3615387|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3785399|NCT01866592|3615387|B1|||Age||years|Mean|42.8642|42.8642|Standard Deviation|14.42|14.42|||
3785400|NCT01866423|3615420|B1|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3785401|NCT01866423|3615420|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3785402|NCT01866423|3615420|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3785403|NCT01866423|3615420|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3785404|NCT01866423|3615420|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3785405|NCT01866423|3615420|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3785406|NCT01866319|3615430|B4||Male|Sex: Female, Male||Participants|Count of Participants|497|497.0||||||
3785407|NCT01866319|3615431|B3||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3785408|NCT01866319|3615432|B2||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3785409|NCT01866319|3615433|B1||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3785410|NCT01866319|3615430|B4||Female|Sex: Female, Male||Participants|Count of Participants|337|337.0||||||
3785411|NCT01866319|3615431|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3785412|NCT01866319|3615432|B2||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3785413|NCT01866319|3615433|B1||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3785414|NCT01866319|3615430|B4|||Age||Years|Mean|60.3|60.3|Standard Deviation|14.1|14.1|||
3785415|NCT01866319|3615431|B3|||Age||Years|Mean|61.2|61.2|Standard Deviation|13.6|13.6|||
3785416|NCT01866319|3615432|B2|||Age||Years|Mean|59.9|59.9|Standard Deviation|14.6|14.6|||
3785417|NCT01866319|3615433|B1|||Age||Years|Mean|59.9|59.9|Standard Deviation|14.2|14.2|||
3785418|NCT01866306|3615449|B8||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3785419|NCT01866306|3615450|B7||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3785420|NCT01866306|3615451|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3785421|NCT01866306|3615452|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3785422|NCT01866306|3615453|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3785423|NCT01866306|3615454|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3785424|NCT01866306|3615455|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3785425|NCT01866306|3615456|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3785426|NCT01866306|3615449|B8||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3785427|NCT01866306|3615450|B7||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3785428|NCT01866306|3615451|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3785429|NCT01866306|3615452|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3785430|NCT01866306|3615453|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3785431|NCT01866306|3615454|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3785432|NCT01866306|3615455|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3785433|NCT01866306|3615456|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3785434|NCT01866306|3615449|B8|||Age||Years|Mean|31.4|31.4|Standard Deviation|9.7|9.7|||
3785435|NCT01866306|3615450|B7|||Age||Years|Mean|28.9|28.9|Standard Deviation|9.3|9.3|||
3785436|NCT01866306|3615451|B6|||Age||Years|Mean|31.7|31.7|Standard Deviation|9.5|9.5|||
3785437|NCT01866306|3615452|B5|||Age||Years|Mean|32.0|32.0|Standard Deviation|10.2|10.2|||
3785438|NCT01866306|3615453|B4|||Age||Years|Mean|31.7|31.7|Standard Deviation|8.9|8.9|||
3785439|NCT01866306|3615454|B3|||Age||Years|Mean|31.7|31.7|Standard Deviation|10.1|10.1|||
3785440|NCT01866306|3615455|B2|||Age||Years|Mean|39.7|39.7|Standard Deviation|11.4|11.4|||
3785441|NCT01866306|3615456|B1|||Age||Years|Mean|31.5|31.5|Standard Deviation|9.6|9.6|||
3785442|NCT01866293|3615534|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3785443|NCT01866293|3615534|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3785444|NCT01866293|3615534|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785445|NCT01866293|3615534|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3785446|NCT01866293|3615534|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3785447|NCT01866293|3615534|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785448|NCT01866293|3615534|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785449|NCT01866293|3615534|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785450|NCT01866293|3615534|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785451|NCT01866293|3615534|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3785452|NCT01866293|3615534|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3785453|NCT01866293|3615534|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3785454|NCT01866293|3615534|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3785455|NCT01866293|3615534|B1|||Age||years|Median|63|63.0|Full Range|||53.0|75.0|
3785456|NCT01866163|3615542|B3||Male|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
3785457|NCT01866163|3615543|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3785458|NCT01866163|3615544|B1||Male|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
3785459|NCT01866163|3615542|B3||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
3785460|NCT01866163|3615543|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3785461|NCT01866163|3615544|B1||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3785462|NCT01866163|3615542|B3|||Age||years|Mean|50.0|50.0|Standard Deviation|13.9|13.9|||
3785463|NCT01866163|3615543|B2|||Age||years|Mean|46.0|46.0|Standard Deviation|13.2|13.2|||
3785464|NCT01866163|3615544|B1|||Age||years|Mean|51.2|51.2|Standard Deviation|13.9|13.9|||
3785465|NCT01866150|3615555|B1||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3785466|NCT01866150|3615555|B1||Female|Sex: Female, Male||Participants|Count of Participants|331|331.0||||||
3785467|NCT01866150|3615555|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|11.53|11.53|||
3785468|NCT01865812|3615576|B1|||HDL Particle Concentration (total) (µmol/L)||µmol/L|Mean|30.08|30.08|Standard Deviation|7.228|7.228|||
3785469|NCT01865812|3615576|B1|||HDL Particle Size (nm)||nm|Mean|10.19|10.19|Standard Deviation|0.734|0.734|||
3785470|NCT01865812|3615576|B1|||HDL Cholesterol Concentration (mmol/L)||mmol/L|Mean|1.86|1.86|Standard Deviation|0.51798|0.51798|||
3785471|NCT01865812|3615576|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
3785472|NCT01865812|3615576|B1|Non-White/Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3785473|NCT01865812|3615576|B1|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3785474|NCT01865812|3615576|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3785475|NCT01865812|3615576|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3785476|NCT01865812|3615576|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|9.15|9.15|||
3785477|NCT01865812|3615576|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3785478|NCT01865812|3615576|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3785479|NCT01865812|3615576|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3785480|NCT01865747|3615582|B3|3-6 adverse factors (poor risk)||Heng Prognostic Criteria||Participants|Count of Participants|106|106.0||||||
3785481|NCT01865747|3615583|B2|3-6 adverse factors (poor risk)||Heng Prognostic Criteria||Participants|Count of Participants|52|52.0||||||
3785482|NCT01865747|3615584|B1|3-6 adverse factors (poor risk)||Heng Prognostic Criteria||Participants|Count of Participants|54|54.0||||||
3785483|NCT01865747|3615582|B3|1-2 adverse factors (intermediate risk)||Heng Prognostic Criteria||Participants|Count of Participants|424|424.0||||||
3785484|NCT01865747|3615583|B2|1-2 adverse factors (intermediate risk)||Heng Prognostic Criteria||Participants|Count of Participants|214|214.0||||||
3785485|NCT01865747|3615584|B1|1-2 adverse factors (intermediate risk)||Heng Prognostic Criteria||Participants|Count of Participants|210|210.0||||||
3785486|NCT01865747|3615582|B3|0 adverse factors (favorable risk)||Heng Prognostic Criteria||Participants|Count of Participants|128|128.0||||||
3785487|NCT01865747|3615583|B2|0 adverse factors (favorable risk)||Heng Prognostic Criteria||Participants|Count of Participants|62|62.0||||||
3785488|NCT01865747|3615584|B1|0 adverse factors (favorable risk)||Heng Prognostic Criteria||Participants|Count of Participants|66|66.0||||||
3785489|NCT01865747|3615582|B3|70 (unable to work, cares for self)||Karnofsky performance status (KPS)||Participants|Count of Participants|51|51.0||||||
3785490|NCT01865747|3615583|B2|70 (unable to work, cares for self)||Karnofsky performance status (KPS)||Participants|Count of Participants|22|22.0||||||
3785491|NCT01865747|3615584|B1|70 (unable to work, cares for self)||Karnofsky performance status (KPS)||Participants|Count of Participants|29|29.0||||||
3785492|NCT01865747|3615582|B3|80 (normal w/effort, minor signs/symptoms)||Karnofsky performance status (KPS)||Participants|Count of Participants|165|165.0||||||
3785493|NCT01865747|3615583|B2|80 (normal w/effort, minor signs/symptoms)||Karnofsky performance status (KPS)||Participants|Count of Participants|90|90.0||||||
3785494|NCT01865747|3615584|B1|80 (normal w/effort, minor signs/symptoms)||Karnofsky performance status (KPS)||Participants|Count of Participants|75|75.0||||||
3785495|NCT01865747|3615582|B3|90 (normal activity, minor signs and symptoms)||Karnofsky performance status (KPS)||Participants|Count of Participants|269|269.0||||||
3785496|NCT01865747|3615583|B2|90 (normal activity, minor signs and symptoms)||Karnofsky performance status (KPS)||Participants|Count of Participants|142|142.0||||||
3785497|NCT01865747|3615584|B1|90 (normal activity, minor signs and symptoms)||Karnofsky performance status (KPS)||Participants|Count of Participants|127|127.0||||||
3785498|NCT01865747|3615582|B3|100 (normal activity)||Karnofsky performance status (KPS)||Participants|Count of Participants|173|173.0||||||
3785499|NCT01865747|3615583|B2|100 (normal activity)||Karnofsky performance status (KPS)||Participants|Count of Participants|74|74.0||||||
3785500|NCT01865747|3615584|B1|100 (normal activity)||Karnofsky performance status (KPS)||Participants|Count of Participants|99|99.0||||||
3785501|NCT01865747|3615582|B3|Prior VEGFR-TKI ≥ 2, MSKCC risk factors = 2 or 3||Randomization Stratification Factors per CRF||Participants|Count of Participants|32|32.0||||||
3785502|NCT01865747|3615583|B2|Prior VEGFR-TKI ≥ 2, MSKCC risk factors = 2 or 3||Randomization Stratification Factors per CRF||Participants|Count of Participants|17|17.0||||||
3785503|NCT01865747|3615584|B1|Prior VEGFR-TKI ≥ 2, MSKCC risk factors = 2 or 3||Randomization Stratification Factors per CRF||Participants|Count of Participants|15|15.0||||||
3785504|NCT01865747|3615582|B3|Prior VEGFR-TKI ≥ 2, MSKCC risk factors = 1||Randomization Stratification Factors per CRF||Participants|Count of Participants|64|64.0||||||
3785505|NCT01865747|3615583|B2|Prior VEGFR-TKI ≥ 2, MSKCC risk factors = 1||Randomization Stratification Factors per CRF||Participants|Count of Participants|32|32.0||||||
3785506|NCT01865747|3615584|B1|Prior VEGFR-TKI ≥ 2, MSKCC risk factors = 1||Randomization Stratification Factors per CRF||Participants|Count of Participants|32|32.0||||||
3785507|NCT01865747|3615582|B3|Prior VEGFR-TKI ≥ 2, MSKCC risk factors =0||Randomization Stratification Factors per CRF||Participants|Count of Participants|98|98.0||||||
3785508|NCT01865747|3615583|B2|Prior VEGFR-TKI ≥ 2, MSKCC risk factors =0||Randomization Stratification Factors per CRF||Participants|Count of Participants|50|50.0||||||
3785509|NCT01865747|3615584|B1|Prior VEGFR-TKI ≥ 2, MSKCC risk factors =0||Randomization Stratification Factors per CRF||Participants|Count of Participants|48|48.0||||||
3785510|NCT01865747|3615582|B3|Prior VEGFR-TKI = 1, MSKCC risk factors = 2 or 3||Randomization Stratification Factors per CRF||Participants|Count of Participants|52|52.0||||||
3785511|NCT01865747|3615583|B2|Prior VEGFR-TKI = 1, MSKCC risk factors = 2 or 3||Randomization Stratification Factors per CRF||Participants|Count of Participants|26|26.0||||||
3785512|NCT01865747|3615584|B1|Prior VEGFR-TKI = 1, MSKCC risk factors = 2 or 3||Randomization Stratification Factors per CRF||Participants|Count of Participants|26|26.0||||||
3785513|NCT01865747|3615582|B3|Prior VEGFR-TKI = 1, MSKCC risk factors = 1||Randomization Stratification Factors per CRF||Participants|Count of Participants|210|210.0||||||
3785514|NCT01865747|3615583|B2|Prior VEGFR-TKI = 1, MSKCC risk factors = 1||Randomization Stratification Factors per CRF||Participants|Count of Participants|103|103.0||||||
3785515|NCT01865747|3615584|B1|Prior VEGFR-TKI = 1, MSKCC risk factors = 1||Randomization Stratification Factors per CRF||Participants|Count of Participants|107|107.0||||||
3785516|NCT01865747|3615582|B3|Prior VEGFR-TKI = 1, MSKCC risk factors = 0||Randomization Stratification Factors per CRF||Participants|Count of Participants|202|202.0||||||
3785517|NCT01865747|3615583|B2|Prior VEGFR-TKI = 1, MSKCC risk factors = 0||Randomization Stratification Factors per CRF||Participants|Count of Participants|100|100.0||||||
3785518|NCT01865747|3615584|B1|Prior VEGFR-TKI = 1, MSKCC risk factors = 0||Randomization Stratification Factors per CRF||Participants|Count of Participants|102|102.0||||||
3785519|NCT01865747|3615582|B3|MSKCC risk factors = 2 or 3||Randomization Stratification Factors per CRF||Participants|Count of Participants|84|84.0||||||
3785520|NCT01865747|3615583|B2|MSKCC risk factors = 2 or 3||Randomization Stratification Factors per CRF||Participants|Count of Participants|43|43.0||||||
3785521|NCT01865747|3615584|B1|MSKCC risk factors = 2 or 3||Randomization Stratification Factors per CRF||Participants|Count of Participants|41|41.0||||||
3785522|NCT01865747|3615582|B3|MSKCC risk factors = 1||Randomization Stratification Factors per CRF||Participants|Count of Participants|274|274.0||||||
3785523|NCT01865747|3615583|B2|MSKCC risk factors = 1||Randomization Stratification Factors per CRF||Participants|Count of Participants|135|135.0||||||
3785524|NCT01865747|3615584|B1|MSKCC risk factors = 1||Randomization Stratification Factors per CRF||Participants|Count of Participants|139|139.0||||||
3785525|NCT01865747|3615582|B3|MSKCC risk factors = 0||Randomization Stratification Factors per CRF||Participants|Count of Participants|300|300.0||||||
3785526|NCT01865747|3615583|B2|MSKCC risk factors = 0||Randomization Stratification Factors per CRF||Participants|Count of Participants|150|150.0||||||
3785527|NCT01865747|3615584|B1|MSKCC risk factors = 0||Randomization Stratification Factors per CRF||Participants|Count of Participants|150|150.0||||||
3785528|NCT01865747|3615582|B3|Prior VEGFR-TKI ≥ 2||Randomization Stratification Factors per CRF||Participants|Count of Participants|194|194.0||||||
3785529|NCT01865747|3615583|B2|Prior VEGFR-TKI ≥ 2||Randomization Stratification Factors per CRF||Participants|Count of Participants|99|99.0||||||
3785530|NCT01865747|3615584|B1|Prior VEGFR-TKI ≥ 2||Randomization Stratification Factors per CRF||Participants|Count of Participants|95|95.0||||||
3785531|NCT01865747|3615582|B3|Prior VEGFR-TKI = 1||Randomization Stratification Factors per CRF||Participants|Count of Participants|464|464.0||||||
3785532|NCT01865747|3615583|B2|Prior VEGFR-TKI = 1||Randomization Stratification Factors per CRF||Participants|Count of Participants|229|229.0||||||
3785533|NCT01865747|3615584|B1|Prior VEGFR-TKI = 1||Randomization Stratification Factors per CRF||Participants|Count of Participants|235|235.0||||||
3785534|NCT01865747|3615582|B3|Latin America||Geographic Region||Participants|Count of Participants|12|12.0||||||
3785535|NCT01865747|3615583|B2|Latin America||Geographic Region||Participants|Count of Participants|6|6.0||||||
3785536|NCT01865747|3615584|B1|Latin America||Geographic Region||Participants|Count of Participants|6|6.0||||||
3785537|NCT01865747|3615582|B3|Asia Pacific||Geographic Region||Participants|Count of Participants|86|86.0||||||
3785538|NCT01865747|3615583|B2|Asia Pacific||Geographic Region||Participants|Count of Participants|47|47.0||||||
3785539|NCT01865747|3615584|B1|Asia Pacific||Geographic Region||Participants|Count of Participants|39|39.0||||||
3785540|NCT01865747|3615582|B3|North America||Geographic Region||Participants|Count of Participants|240|240.0||||||
3785541|NCT01865747|3615583|B2|North America||Geographic Region||Participants|Count of Participants|122|122.0||||||
3785542|NCT01865747|3615584|B1|North America||Geographic Region||Participants|Count of Participants|118|118.0||||||
3785543|NCT01865747|3615582|B3|Europe||Geographic Region||Participants|Count of Participants|320|320.0||||||
3785544|NCT01865747|3615583|B2|Europe||Geographic Region||Participants|Count of Participants|153|153.0||||||
3785545|NCT01865747|3615584|B1|Europe||Geographic Region||Participants|Count of Participants|167|167.0||||||
3785546|NCT01865747|3615582|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3785547|NCT01865747|3615583|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3785548|NCT01865747|3615584|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3785549|NCT01865747|3615582|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785550|NCT01865747|3615583|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785551|NCT01865747|3615584|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785552|NCT01865747|3615582|B3||White|Race (NIH/OMB)||Participants|Count of Participants|532|532.0||||||
3785553|NCT01865747|3615583|B2||White|Race (NIH/OMB)||Participants|Count of Participants|263|263.0||||||
3785554|NCT01865747|3615584|B1||White|Race (NIH/OMB)||Participants|Count of Participants|269|269.0||||||
3785555|NCT01865747|3615582|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3785556|NCT01865747|3615583|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3785557|NCT01865747|3615584|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3785558|NCT01865747|3615582|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785559|NCT01865747|3615583|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785560|NCT01865747|3615584|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785561|NCT01865747|3615582|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3785562|NCT01865747|3615583|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3785563|NCT01865747|3615584|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3785564|NCT01865747|3615582|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785565|NCT01865747|3615583|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785566|NCT01865747|3615584|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785567|NCT01865747|3615582|B3|Ethnicity|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3785568|NCT01865747|3615583|B2|Ethnicity|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3785569|NCT01865747|3615584|B1|Ethnicity|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3785570|NCT01865747|3615582|B3|Ethnicity|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|551|551.0||||||
3785571|NCT01865747|3615583|B2|Ethnicity|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|273|273.0||||||
3785572|NCT01865747|3615584|B1|Ethnicity|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|278|278.0||||||
3785573|NCT01865747|3615582|B3|Ethnicity|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3785574|NCT01865747|3615583|B2|Ethnicity|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3785575|NCT01865747|3615584|B1|Ethnicity|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3785576|NCT01865747|3615582|B3|Missing||Sex/Gender, Customized||participants|Number|1|1.0||||||
3785577|NCT01865747|3615583|B2|Missing||Sex/Gender, Customized||participants|Number|1|1.0||||||
3785578|NCT01865747|3615584|B1|Missing||Sex/Gender, Customized||participants|Number|0|0.0||||||
3785579|NCT01865747|3615582|B3|Female||Sex/Gender, Customized||participants|Number|163|163.0||||||
3785580|NCT01865747|3615583|B2|Female||Sex/Gender, Customized||participants|Number|86|86.0||||||
3785581|NCT01865747|3615584|B1|Female||Sex/Gender, Customized||participants|Number|77|77.0||||||
3785582|NCT01865747|3615582|B3|Male||Sex/Gender, Customized||participants|Number|494|494.0||||||
3785583|NCT01865747|3615583|B2|Male||Sex/Gender, Customized||participants|Number|241|241.0||||||
3785584|NCT01865747|3615584|B1|Male||Sex/Gender, Customized||participants|Number|253|253.0||||||
3785585|NCT01865747|3615582|B3|=>85||Age, Customized||participants|Number|1|1.0||||||
3785586|NCT01865747|3615583|B2|=>85||Age, Customized||participants|Number|0|0.0||||||
3785587|NCT01865747|3615584|B1|=>85||Age, Customized||participants|Number|1|1.0||||||
3785588|NCT01865747|3615582|B3|75 to <85||Age, Customized||participants|Number|62|62.0||||||
3785589|NCT01865747|3615583|B2|75 to <85||Age, Customized||participants|Number|36|36.0||||||
3785590|NCT01865747|3615584|B1|75 to <85||Age, Customized||participants|Number|26|26.0||||||
3785591|NCT01865747|3615582|B3|65 to <75||Age, Customized||participants|Number|201|201.0||||||
3785592|NCT01865747|3615583|B2|65 to <75||Age, Customized||participants|Number|94|94.0||||||
3785593|NCT01865747|3615584|B1|65 to <75||Age, Customized||participants|Number|107|107.0||||||
3785594|NCT01865747|3615582|B3|<65||Age, Customized||participants|Number|394|394.0||||||
3785595|NCT01865747|3615583|B2|<65||Age, Customized||participants|Number|198|198.0||||||
3785596|NCT01865747|3615584|B1|<65||Age, Customized||participants|Number|196|196.0||||||
3785597|NCT01865708|3615595|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3785598|NCT01865708|3615595|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3785599|NCT01865708|3615595|B1|||Age||years|Mean|6.7|6.7|Standard Deviation|4.5|4.5|||
3785600|NCT01865084|3615600|B4|Germany||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3785601|NCT01865084|3615601|B3|Germany||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3785602|NCT01865084|3615602|B2|Germany||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3785603|NCT01865084|3615603|B1|Germany||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3785604|NCT01865084|3615600|B4|France||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3785605|NCT01865084|3615601|B3|France||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3785606|NCT01865084|3615602|B2|France||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3785607|NCT01865084|3615603|B1|France||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3785608|NCT01865084|3615600|B4|Italy||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3785609|NCT01865084|3615601|B3|Italy||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3785610|NCT01865084|3615602|B2|Italy||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3785611|NCT01865084|3615603|B1|Italy||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3785612|NCT01865084|3615600|B4|Korea, Republic of||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3785613|NCT01865084|3615601|B3|Korea, Republic of||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3785614|NCT01865084|3615602|B2|Korea, Republic of||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3785615|NCT01865084|3615603|B1|Korea, Republic of||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3785616|NCT01865084|3615600|B4|Taiwan||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3785617|NCT01865084|3615601|B3|Taiwan||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3785618|NCT01865084|3615602|B2|Taiwan||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3785619|NCT01865084|3615603|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3785620|NCT01865084|3615600|B4|Belgium||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3785621|NCT01865084|3615601|B3|Belgium||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3785622|NCT01865084|3615602|B2|Belgium||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3785623|NCT01865084|3615603|B1|Belgium||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3785624|NCT01865084|3615600|B4|Turkey||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3785625|NCT01865084|3615601|B3|Turkey||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3785626|NCT01865084|3615602|B2|Turkey||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3785627|NCT01865084|3615603|B1|Turkey||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3785628|NCT01865084|3615600|B4|Netherlands||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3785629|NCT01865084|3615601|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3785630|NCT01865084|3615602|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3785631|NCT01865084|3615603|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3785632|NCT01865084|3615600|B4|Canada||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3785633|NCT01865084|3615601|B3|Canada||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3785634|NCT01865084|3615602|B2|Canada||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3785635|NCT01865084|3615603|B1|Canada||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3785636|NCT01865084|3615600|B4|Spain||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3785637|NCT01865084|3615601|B3|Spain||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3785638|NCT01865084|3615602|B2|Spain||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3785639|NCT01865084|3615603|B1|Spain||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3785640|NCT01865084|3615600|B4|Japan||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3785641|NCT01865084|3615601|B3|Japan||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3785642|NCT01865084|3615602|B2|Japan||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3785643|NCT01865084|3615603|B1|Japan||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3785644|NCT01865084|3615600|B4|United States||Region of Enrollment||Participants|Count of Participants|107|107.0||||||
3785645|NCT01865084|3615601|B3|United States||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3785646|NCT01865084|3615602|B2|United States||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3785647|NCT01865084|3615603|B1|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3785648|NCT01865084|3615600|B4|Russian Federation||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3785649|NCT01865084|3615601|B3|Russian Federation||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3785650|NCT01865084|3615602|B2|Russian Federation||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3785651|NCT01865084|3615603|B1|Russian Federation||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3785652|NCT01865084|3615600|B4|Argentina||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3785653|NCT01865084|3615601|B3|Argentina||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3785654|NCT01865084|3615602|B2|Argentina||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3785655|NCT01865084|3615603|B1|Argentina||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3785656|NCT01865084|3615600|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3785657|NCT01865084|3615601|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3785658|NCT01865084|3615602|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785659|NCT01865084|3615603|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785660|NCT01865084|3615600|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3785661|NCT01865084|3615601|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3785662|NCT01865084|3615602|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3785663|NCT01865084|3615603|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3785664|NCT01865084|3615600|B4||White|Race (NIH/OMB)||Participants|Count of Participants|262|262.0||||||
3785665|NCT01865084|3615601|B3||White|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3785666|NCT01865084|3615602|B2||White|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3785667|NCT01865084|3615603|B1||White|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3785668|NCT01865084|3615600|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3785669|NCT01865084|3615601|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3785670|NCT01865084|3615602|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785671|NCT01865084|3615603|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785672|NCT01865084|3615600|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3785673|NCT01865084|3615601|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3785674|NCT01865084|3615602|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3785675|NCT01865084|3615603|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3785676|NCT01865084|3615600|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3785677|NCT01865084|3615601|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3785678|NCT01865084|3615602|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3785679|NCT01865084|3615603|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3785680|NCT01865084|3615600|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3785681|NCT01865084|3615601|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3785682|NCT01865084|3615602|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785683|NCT01865084|3615603|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785684|NCT01865084|3615600|B4||Male|Gender||Participants|Count of Participants|331|331.0||||||
3785685|NCT01865084|3615601|B3||Male|Gender||Participants|Count of Participants|113|113.0||||||
3785686|NCT01865084|3615602|B2||Male|Gender||Participants|Count of Participants|102|102.0||||||
3785687|NCT01865084|3615603|B1||Male|Gender||Participants|Count of Participants|116|116.0||||||
3785688|NCT01865084|3615600|B4||Female|Gender||Participants|Count of Participants|0|0.0||||||
3785689|NCT01865084|3615601|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
3785690|NCT01865084|3615602|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
3785691|NCT01865084|3615603|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3785692|NCT01865084|3615600|B4|||Age||years|Mean|9.6|9.6|Standard Deviation|1.92|1.92|||
3785693|NCT01865084|3615601|B3|||Age||years|Mean|9.5|9.5|Standard Deviation|1.71|1.71|||
3785694|NCT01865084|3615602|B2|||Age||years|Mean|9.9|9.9|Standard Deviation|2.26|2.26|||
3785695|NCT01865084|3615603|B1|||Age||years|Mean|9.4|9.4|Standard Deviation|1.76|1.76|||
3785696|NCT01864538|3615631|B1|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3785697|NCT01864538|3615631|B1|Canada||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3785698|NCT01864538|3615631|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785699|NCT01864538|3615631|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785700|NCT01864538|3615631|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3785701|NCT01864538|3615631|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785702|NCT01864538|3615631|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785703|NCT01864538|3615631|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3785704|NCT01864538|3615631|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785705|NCT01864538|3615631|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3785706|NCT01864538|3615631|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3785707|NCT01864538|3615631|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3785708|NCT01864538|3615631|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3785709|NCT01864538|3615631|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3785710|NCT01864525|3615635|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785711|NCT01864525|3615636|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785712|NCT01864525|3615637|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785713|NCT01864525|3615635|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785714|NCT01864525|3615636|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785715|NCT01864525|3615637|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785716|NCT01864525|3615635|B3||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3785717|NCT01864525|3615636|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3785718|NCT01864525|3615637|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3785719|NCT01864525|3615635|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785720|NCT01864525|3615636|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785721|NCT01864525|3615637|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785722|NCT01864525|3615635|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785723|NCT01864525|3615636|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785724|NCT01864525|3615637|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785725|NCT01864525|3615635|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785726|NCT01864525|3615636|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785727|NCT01864525|3615637|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785728|NCT01864525|3615635|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785729|NCT01864525|3615636|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785730|NCT01864525|3615637|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785731|NCT01864525|3615635|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785732|NCT01864525|3615636|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785733|NCT01864525|3615637|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785734|NCT01864525|3615635|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3785735|NCT01864525|3615636|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3785736|NCT01864525|3615637|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3785737|NCT01864525|3615635|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785738|NCT01864525|3615636|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785739|NCT01864525|3615637|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785740|NCT01864525|3615635|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3785741|NCT01864525|3615636|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3785742|NCT01864525|3615637|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3785743|NCT01864525|3615635|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3785744|NCT01864525|3615636|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3785745|NCT01864525|3615637|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3785746|NCT01864525|3615635|B3|||Age||years|Mean|69.53|69.53|Standard Deviation|9.01|9.01|||
3785747|NCT01864525|3615636|B2|||Age||years|Mean|70.43|70.43|Standard Deviation|11.70|11.7|||
3785748|NCT01864525|3615637|B1|||Age||years|Mean|68.90|68.9|Standard Deviation|7.20|7.2|||
3785749|NCT01864434|3615646|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3785750|NCT01864434|3615647|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3785751|NCT01864434|3615648|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3785752|NCT01864434|3615646|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3785753|NCT01864434|3615647|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3785754|NCT01864434|3615648|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3785755|NCT01864434|3615646|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3785756|NCT01864434|3615647|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3785757|NCT01864434|3615648|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3785758|NCT01864434|3615646|B3|||Age||years|Mean|69.60|69.6|Standard Deviation|8|8.0|||
3785759|NCT01864434|3615647|B2|||Age||years|Mean|70.6|70.6|Standard Deviation|9.4|9.4|||
3785760|NCT01864434|3615648|B1|||Age||years|Mean|68.7|68.7|Standard Deviation|6.4|6.4|||
3785761|NCT01864434|3615646|B3||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
3785762|NCT01864434|3615647|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3785763|NCT01864434|3615648|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3785764|NCT01864434|3615646|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3785765|NCT01864434|3615647|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3785766|NCT01864434|3615648|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3785767|NCT01864434|3615646|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3785768|NCT01864434|3615647|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3785769|NCT01864434|3615648|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3785770|NCT01864200|3615659|B3|United States||Region of Enrollment||Participants|Count of Participants|74|74.0||||||
3785771|NCT01864200|3615660|B2|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3785772|NCT01864200|3615661|B1|United States||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3785773|NCT01864200|3615659|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3785774|NCT01864200|3615660|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3785775|NCT01864200|3615661|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3785776|NCT01864200|3615659|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785777|NCT01864200|3615660|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785778|NCT01864200|3615661|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785779|NCT01864200|3615659|B3||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3785780|NCT01864200|3615660|B2||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3785781|NCT01864200|3615661|B1||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3785782|NCT01864200|3615659|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3785783|NCT01864200|3615660|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3785784|NCT01864200|3615661|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3785785|NCT01864200|3615659|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785786|NCT01864200|3615660|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785787|NCT01864200|3615661|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785788|NCT01864200|3615659|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3785789|NCT01864200|3615660|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785790|NCT01864200|3615661|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3785791|NCT01864200|3615659|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785792|NCT01864200|3615660|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785793|NCT01864200|3615661|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785794|NCT01864200|3615659|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3785795|NCT01864200|3615660|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3785796|NCT01864200|3615661|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3785797|NCT01864200|3615659|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3785798|NCT01864200|3615660|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3785799|NCT01864200|3615661|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3785800|NCT01864200|3615659|B3|||Age||years|Mean|43.04|43.04|Standard Deviation|17.57|17.57|||
3785801|NCT01864200|3615660|B2|||Age||years|Mean|42|42.0|Standard Deviation|17.2|17.2|||
3785802|NCT01864200|3615661|B1|||Age||years|Mean|44|44.0|Standard Deviation|17.9|17.9|||
3785803|NCT01864174|3615668|B3|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3785804|NCT01864174|3615669|B2|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3785805|NCT01864174|3615670|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3785806|NCT01864174|3615668|B3|Asian||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
3785807|NCT01864174|3615669|B2|Asian||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3785808|NCT01864174|3615670|B1|Asian||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3785809|NCT01864174|3615668|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
3785810|NCT01864174|3615669|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3785811|NCT01864174|3615670|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3785812|NCT01864174|3615668|B3|White||Race/Ethnicity, Customized||participants|Number|452|452.0||||||
3785813|NCT01864174|3615669|B2|White||Race/Ethnicity, Customized||participants|Number|225|225.0||||||
3785814|NCT01864174|3615670|B1|White||Race/Ethnicity, Customized||participants|Number|227|227.0||||||
3785815|NCT01864174|3615668|B3||Male|Sex: Female, Male||Participants|Count of Participants|295|295.0||||||
3785816|NCT01864174|3615669|B2||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3785817|NCT01864174|3615670|B1||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3785818|NCT01864174|3615668|B3||Female|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
3785819|NCT01864174|3615669|B2||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3785820|NCT01864174|3615670|B1||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3785821|NCT01864174|3615668|B3|>= 65 years||Age, Customized||participants|Number|115|115.0||||||
3785822|NCT01864174|3615669|B2|>= 65 years||Age, Customized||participants|Number|45|45.0||||||
3785823|NCT01864174|3615670|B1|>= 65 years||Age, Customized||participants|Number|70|70.0||||||
3785824|NCT01864174|3615668|B3|< 65 years||Age, Customized||participants|Number|424|424.0||||||
3785825|NCT01864174|3615669|B2|< 65 years||Age, Customized||participants|Number|226|226.0||||||
3785826|NCT01864174|3615670|B1|< 65 years||Age, Customized||participants|Number|198|198.0||||||
3785827|NCT01864174|3615668|B3|||Age||years|Mean|56.0|56.0|Standard Deviation|10.53|10.53|||
3785828|NCT01864174|3615669|B2|||Age||years|Mean|55.3|55.3|Standard Deviation|10.34|10.34|||
3785829|NCT01864174|3615670|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|10.69|10.69|||
3785830|NCT01864148|3615685|B6||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3785831|NCT01864148|3615686|B5||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3785832|NCT01864148|3615687|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3785833|NCT01864148|3615688|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3785834|NCT01864148|3615689|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3785835|NCT01864148|3615690|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3785836|NCT01864148|3615685|B6||Female|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
3785837|NCT01864148|3615686|B5||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3785838|NCT01864148|3615687|B4||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3785839|NCT01864148|3615688|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3785840|NCT01864148|3615689|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3785841|NCT01864148|3615690|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3785842|NCT01864148|3615685|B6|||Age||years|Mean|39.8|39.8|Standard Deviation|9.51|9.51|||
3785843|NCT01864148|3615686|B5|||Age||years|Mean|39.8|39.8|Standard Deviation|9.10|9.1|||
3785844|NCT01864148|3615687|B4|||Age||years|Mean|40.9|40.9|Standard Deviation|9.70|9.7|||
3785845|NCT01864148|3615688|B3|||Age||years|Mean|40.5|40.5|Standard Deviation|9.78|9.78|||
3785846|NCT01864148|3615689|B2|||Age||years|Mean|36.5|36.5|Standard Deviation|9.47|9.47|||
3785847|NCT01864148|3615690|B1|||Age||years|Mean|39.5|39.5|Standard Deviation|9.29|9.29|||
3785848|NCT01864005|3615721|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785849|NCT01864005|3615722|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785850|NCT01864005|3615723|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785851|NCT01864005|3615721|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785852|NCT01864005|3615722|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785853|NCT01864005|3615723|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785854|NCT01864005|3615721|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785855|NCT01864005|3615722|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785856|NCT01864005|3615723|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785857|NCT01864005|3615721|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785858|NCT01864005|3615722|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785859|NCT01864005|3615723|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785860|NCT01864005|3615721|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785861|NCT01864005|3615722|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785862|NCT01864005|3615723|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785863|NCT01864005|3615721|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3785864|NCT01864005|3615722|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3785865|NCT01864005|3615723|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3785866|NCT01864005|3615721|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785867|NCT01864005|3615722|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785868|NCT01864005|3615723|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785869|NCT01864005|3615721|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3785870|NCT01864005|3615722|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3785871|NCT01864005|3615723|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3785872|NCT01864005|3615721|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3785873|NCT01864005|3615722|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3785874|NCT01864005|3615723|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3785875|NCT01864005|3615721|B3|||Age||years|Mean|58.67|58.67|Standard Deviation|10.291|10.291|||
3785876|NCT01864005|3615722|B2|||Age||years|Mean|58.59|58.59|Standard Deviation|9.789|9.789|||
3785877|NCT01864005|3615723|B1|||Age||years|Mean|58.75|58.75|Standard Deviation|10.967|10.967|||
3785878|NCT01863953|3615738|B4||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3785879|NCT01863953|3615739|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3785880|NCT01863953|3615740|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3785881|NCT01863953|3615741|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3785882|NCT01863953|3615738|B4||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3785883|NCT01863953|3615739|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3785884|NCT01863953|3615740|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3785885|NCT01863953|3615741|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3785886|NCT01863953|3615738|B4|>65 years||Age, Customized||Participants|Number|56|56.0||||||
3785887|NCT01863953|3615739|B3|>65 years||Age, Customized||Participants|Number|18|18.0||||||
3785888|NCT01863953|3615740|B2|>65 years||Age, Customized||Participants|Number|22|22.0||||||
3785889|NCT01863953|3615741|B1|>65 years||Age, Customized||Participants|Number|16|16.0||||||
3785890|NCT01863953|3615738|B4|Between 45 and 65 years||Age, Customized||Participants|Number|55|55.0||||||
3785891|NCT01863953|3615739|B3|Between 45 and 65 years||Age, Customized||Participants|Number|20|20.0||||||
3785892|NCT01863953|3615740|B2|Between 45 and 65 years||Age, Customized||Participants|Number|14|14.0||||||
3785893|NCT01863953|3615741|B1|Between 45 and 65 years||Age, Customized||Participants|Number|21|21.0||||||
3785894|NCT01863953|3615738|B4|<45 years||Age, Customized||Participants|Number|1|1.0||||||
3785895|NCT01863953|3615739|B3|<45 years||Age, Customized||Participants|Number|0|0.0||||||
3785896|NCT01863953|3615740|B2|<45 years||Age, Customized||Participants|Number|0|0.0||||||
3785897|NCT01863953|3615741|B1|<45 years||Age, Customized||Participants|Number|1|1.0||||||
3785898|NCT01863771|3615757|B1|Japan||Region of Enrollment||Participants|Count of Participants|144|144.0||||||
3785899|NCT01863771|3615757|B1||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3785900|NCT01863771|3615757|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3785901|NCT01863771|3615757|B1|||Age||years|Mean|42.4|42.4|Standard Deviation|14.74|14.74|||
3785902|NCT01863758|3615772|B1|||Hemophilia Joint Health Score (HJHS)|The HJHS is determined through a physical examination of the 6 joints most affected by hemophilia; the elbows, knees, and ankles. Knees and ankles are assessed on 11 items: Swelling, duration of swelling, muscle atrophy, axial alignment, crepitus on motion, flexion loss, extension loss, instability, joint pain, strength, and gait. Elbows are assessed on 9 of the 11 items (axial alignment and gait are not assessed). Each item is assessed on a scale that ranges from 0-1 to 0-4. The total score can range from 0 to 148, with a higher score indicating a bigger effect of hemophilia.|Units on a scale|Mean|37.4|37.4|Standard Deviation|25.3|25.3|||
3785903|NCT01863758|3615772|B1|||BMI||kg/m^2|Mean|25.4|25.4|Standard Deviation|5.4|5.4|||
3785904|NCT01863758|3615772|B1|||Weight||kg|Mean|80.5|80.5|Standard Deviation|19.9|19.9|||
3785905|NCT01863758|3615772|B1|||Age||years|Mean|33.6|33.6|Standard Deviation|9.9|9.9|||
3785906|NCT01863758|3615772|B1|Germany||Region of Enrollment||participants|Number|4|4.0||||||
3785907|NCT01863758|3615772|B1|Bulgaria||Region of Enrollment||participants|Number|31|31.0||||||
3785908|NCT01863758|3615772|B1|Slovakia||Region of Enrollment||participants|Number|2|2.0||||||
3785909|NCT01863758|3615772|B1|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3785910|NCT01863758|3615772|B1|Poland||Region of Enrollment||participants|Number|9|9.0||||||
3785911|NCT01863758|3615772|B1|Hungary||Region of Enrollment||participants|Number|4|4.0||||||
3785912|NCT01863758|3615772|B1|Romania||Region of Enrollment||participants|Number|9|9.0||||||
3785913|NCT01863758|3615772|B1|Austria||Region of Enrollment||participants|Number|1|1.0||||||
3785914|NCT01863758|3615772|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785915|NCT01863758|3615772|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785916|NCT01863758|3615772|B1||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3785917|NCT01863758|3615772|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3785918|NCT01863758|3615772|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785919|NCT01863758|3615772|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785920|NCT01863758|3615772|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785921|NCT01863758|3615772|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3785922|NCT01863758|3615772|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3785923|NCT01863758|3615772|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3785924|NCT01863758|3615772|B1||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
3785925|NCT01863758|3615772|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3785926|NCT01863680|3615780|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3785927|NCT01863680|3615780|B1||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3785928|NCT01863680|3615780|B1|||Age||Years|Mean|34.41|34.41|Standard Deviation|3.71|3.71|||
3785929|NCT01863667|3615786|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3785930|NCT01863667|3615787|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3785931|NCT01863667|3615788|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3785932|NCT01863667|3615786|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3785933|NCT01863667|3615787|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3785934|NCT01863667|3615788|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3785935|NCT01863667|3615786|B3|||Age||Years|Mean|57.4|57.4|Standard Deviation|12.1|12.1|||
3785936|NCT01863667|3615787|B2|||Age||Years|Mean|56.8|56.8|Standard Deviation|9.9|9.9|||
3785937|NCT01863667|3615788|B1|||Age||Years|Mean|58.0|58.0|Standard Deviation|14.1|14.1|||
3785938|NCT01863563|3615809|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
3785939|NCT01863563|3615809|B1||Male|Sex: Female, Male|QuickClot sponge will be applied for one minute each site of tonsillectomy and Adenoidectomy|Participants|Count of Participants|52|52.0||||||
3785940|NCT01863563|3615809|B1||Female|Sex: Female, Male|QuickClot sponge will be applied for one minute each site of tonsillectomy and Adenoidectomy|Participants|Count of Participants|48|48.0||||||
3785941|NCT01863563|3615809|B1|||Age||years|Mean|4.8|4.8|Standard Deviation|3.7|3.7|||
3785942|NCT01863563|3615809|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3785943|NCT01863563|3615809|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3785944|NCT01863563|3615809|B1||<=18 years|Age||Participants|Count of Participants|100|100.0||||||
3785945|NCT01863433|3615813|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3785946|NCT01863433|3615813|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3785947|NCT01863433|3615813|B1|||Age, Customized||years|Mean|31.8|31.8|Standard Deviation|10.12|10.12|||
3785948|NCT01863368|3615821|B3|||Mean Total Ocular Surface Staining (TOSS) Score|The TOSS score is a composite score of corneal fluorescein staining, nasal conjunctival lissamine green staining, and temporal conjunctival lissamine green staining, each scored on a 0-5 Likert scale (0=absent, 5=severe). TOSS scores can range from 0 to 15. One eye (study eye) contributed to the analysis. Here, the analysis group includes all randomized subjects with data at visit (46,47 respectively, for a total of 93).|units on a scale|Mean|5.5|5.5|Standard Deviation|1.8|1.8|||
3785949|NCT01863368|3615822|B2|||Mean Total Ocular Surface Staining (TOSS) Score|The TOSS score is a composite score of corneal fluorescein staining, nasal conjunctival lissamine green staining, and temporal conjunctival lissamine green staining, each scored on a 0-5 Likert scale (0=absent, 5=severe). TOSS scores can range from 0 to 15. One eye (study eye) contributed to the analysis. Here, the analysis group includes all randomized subjects with data at visit (46,47 respectively, for a total of 93).|units on a scale|Mean|5.5|5.5|Standard Deviation|1.7|1.7|||
3785950|NCT01863368|3615823|B1|||Mean Total Ocular Surface Staining (TOSS) Score|The TOSS score is a composite score of corneal fluorescein staining, nasal conjunctival lissamine green staining, and temporal conjunctival lissamine green staining, each scored on a 0-5 Likert scale (0=absent, 5=severe). TOSS scores can range from 0 to 15. One eye (study eye) contributed to the analysis. Here, the analysis group includes all randomized subjects with data at visit (46,47 respectively, for a total of 93).|units on a scale|Mean|5.5|5.5|Standard Deviation|1.9|1.9|||
3785951|NCT01863368|3615821|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3785952|NCT01863368|3615822|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3785953|NCT01863368|3615823|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3785954|NCT01863368|3615821|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3785955|NCT01863368|3615822|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3785956|NCT01863368|3615823|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3785957|NCT01863368|3615821|B3|||Age||years|Mean|64.4|64.4|Standard Deviation|13.7|13.7|||
3785958|NCT01863368|3615822|B2|||Age||years|Mean|65.2|65.2|Standard Deviation|14.3|14.3|||
3785959|NCT01863368|3615823|B1|||Age||years|Mean|63.5|63.5|Standard Deviation|13.1|13.1|||
3785960|NCT01863134|3615837|B3|Poland||Region of Enrollment||participants|Number|140|140.0||||||
3785961|NCT01863134|3615838|B2|Poland||Region of Enrollment||participants|Number|72|72.0||||||
3785962|NCT01863134|3615839|B1|Poland||Region of Enrollment||participants|Number|68|68.0||||||
3785963|NCT01863134|3615837|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3785964|NCT01863134|3615838|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3785965|NCT01863134|3615839|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3785966|NCT01863134|3615837|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3785967|NCT01863134|3615838|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3785968|NCT01863134|3615839|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3785969|NCT01863134|3615837|B3|||Age||years|Mean|63.01|63.01|Standard Deviation|9.39|9.39|||
3785970|NCT01863134|3615838|B2|||Age||years|Mean|62.47|62.47|Standard Deviation|10.41|10.41|||
3785971|NCT01863134|3615839|B1|||Age||years|Mean|63.60|63.6|Standard Deviation|8.32|8.32|||
3785972|NCT01863134|3615837|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3785973|NCT01863134|3615838|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3785974|NCT01863134|3615839|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3785975|NCT01863134|3615837|B3||Between 18 and 65 years|Age||Participants|Count of Participants|119|119.0||||||
3785976|NCT01863134|3615838|B2||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
3785977|NCT01863134|3615839|B1||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3785978|NCT01863134|3615837|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3785979|NCT01863134|3615838|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3785980|NCT01863134|3615839|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3785981|NCT01862991|3615846|B4|United States||Region of Enrollment||participants|Number|75|75.0||||||
3785982|NCT01862991|3615847|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
3785983|NCT01862991|3615848|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
3785984|NCT01862991|3615849|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3785985|NCT01862991|3615846|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3785986|NCT01862991|3615847|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3785987|NCT01862991|3615848|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3785988|NCT01862991|3615849|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3785989|NCT01862991|3615846|B4||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3785990|NCT01862991|3615847|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3785991|NCT01862991|3615848|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3785992|NCT01862991|3615849|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3785993|NCT01862991|3615846|B4|||Age||years|Mean|28|28.0|Standard Deviation|6.5|6.5|||
3785994|NCT01862991|3615847|B3|||Age||years|Mean|27|27.0|Standard Deviation|6|6.0|||
3785995|NCT01862991|3615848|B2|||Age||years|Mean|27.5|27.5|Standard Deviation|6|6.0|||
3785996|NCT01862991|3615849|B1|||Age||years|Mean|28|28.0|Standard Deviation|7|7.0|||
3785997|NCT01862874|3615862|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785998|NCT01862874|3615863|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3785999|NCT01862874|3615864|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786000|NCT01862874|3615862|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786001|NCT01862874|3615863|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786002|NCT01862874|3615864|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786003|NCT01862874|3615862|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786004|NCT01862874|3615863|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786005|NCT01862874|3615864|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786006|NCT01862874|3615862|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786007|NCT01862874|3615863|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786008|NCT01862874|3615864|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786009|NCT01862874|3615862|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786010|NCT01862874|3615863|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786011|NCT01862874|3615864|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786012|NCT01862874|3615862|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1124|1124.0||||||
3786013|NCT01862874|3615863|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|562|562.0||||||
3786014|NCT01862874|3615864|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|562|562.0||||||
3786015|NCT01862874|3615862|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786016|NCT01862874|3615863|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786017|NCT01862874|3615864|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786018|NCT01862874|3615862|B3||Male|Sex: Female, Male||Participants|Count of Participants|1124|1124.0||||||
3786019|NCT01862874|3615863|B2||Male|Sex: Female, Male||Participants|Count of Participants|562|562.0||||||
3786020|NCT01862874|3615864|B1||Male|Sex: Female, Male||Participants|Count of Participants|562|562.0||||||
3786021|NCT01862874|3615862|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3786022|NCT01862874|3615863|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3786023|NCT01862874|3615864|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3786024|NCT01862874|3615862|B3|||Age||Years|Mean|22.6|22.6|Standard Deviation|2.0|2.0|||
3786025|NCT01862874|3615863|B2|||Age||Years|Mean|22.6|22.6|Standard Deviation|2.0|2.0|||
3786026|NCT01862874|3615864|B1|||Age||Years|Mean|22.6|22.6|Standard Deviation|2.1|2.1|||
3786027|NCT01862484|3615881|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
3786028|NCT01862484|3615882|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3786029|NCT01862484|3615883|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3786030|NCT01862484|3615881|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3786031|NCT01862484|3615882|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3786032|NCT01862484|3615883|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3786033|NCT01862484|3615881|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3786034|NCT01862484|3615882|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3786035|NCT01862484|3615883|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3786036|NCT01862484|3615881|B3|||Age||years|Mean|10.82|10.82|Standard Deviation|1.49|1.49|||
3786037|NCT01862484|3615882|B2|||Age||years|Mean|10.83|10.83|Standard Deviation|1.25|1.25|||
3786038|NCT01862484|3615883|B1|||Age||years|Mean|10.8|10.8|Standard Deviation|1.73|1.73|||
3786039|NCT01862484|3615881|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786040|NCT01862484|3615882|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786041|NCT01862484|3615883|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786042|NCT01862484|3615881|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3786043|NCT01862484|3615882|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3786044|NCT01862484|3615883|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3786045|NCT01862484|3615881|B3||<=18 years|Age||Participants|Count of Participants|29|29.0||||||
3786046|NCT01862484|3615882|B2||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
3786047|NCT01862484|3615883|B1||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
3786048|NCT01862419|3615890|B3|||Diabetes||participants|Number|722|722.0||||||
3786049|NCT01862419|3615891|B2|||Diabetes||participants|Number|370|370.0||||||
3786050|NCT01862419|3615892|B1|||Diabetes||participants|Number|352|352.0||||||
3786051|NCT01862419|3615890|B3|||Baseline Creatinine||mg/dl|Median|0.90|0.9|Inter-Quartile Range|||0.59|1.37|
3786052|NCT01862419|3615891|B2|||Baseline Creatinine||mg/dl|Median|0.90|0.9|Inter-Quartile Range|||0.56|1.36|
3786053|NCT01862419|3615892|B1|||Baseline Creatinine||mg/dl|Median|0.91|0.91|Inter-Quartile Range|||0.6|1.37|
3786054|NCT01862419|3615890|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|329|329.0||||||
3786055|NCT01862419|3615891|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|159|159.0||||||
3786056|NCT01862419|3615892|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|170|170.0||||||
3786057|NCT01862419|3615890|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3786058|NCT01862419|3615891|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3786059|NCT01862419|3615892|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3786060|NCT01862419|3615890|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1364|1364.0||||||
3786061|NCT01862419|3615891|B2||White|Race (NIH/OMB)||Participants|Count of Participants|675|675.0||||||
3786062|NCT01862419|3615892|B1||White|Race (NIH/OMB)||Participants|Count of Participants|689|689.0||||||
3786063|NCT01862419|3615890|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|647|647.0||||||
3786064|NCT01862419|3615891|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|323|323.0||||||
3786065|NCT01862419|3615892|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|324|324.0||||||
3786066|NCT01862419|3615890|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786067|NCT01862419|3615891|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786068|NCT01862419|3615892|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786069|NCT01862419|3615890|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3786070|NCT01862419|3615891|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3786071|NCT01862419|3615892|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3786072|NCT01862419|3615890|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3786073|NCT01862419|3615891|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3786074|NCT01862419|3615892|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3786075|NCT01862419|3615890|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786076|NCT01862419|3615891|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786077|NCT01862419|3615892|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786078|NCT01862419|3615890|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2322|2322.0||||||
3786079|NCT01862419|3615891|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1154|1154.0||||||
3786080|NCT01862419|3615892|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1168|1168.0||||||
3786081|NCT01862419|3615890|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3786082|NCT01862419|3615891|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3786083|NCT01862419|3615892|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3786084|NCT01862419|3615890|B3||Male|Sex: Female, Male||Participants|Count of Participants|1325|1325.0||||||
3786085|NCT01862419|3615891|B2||Male|Sex: Female, Male||Participants|Count of Participants|655|655.0||||||
3786086|NCT01862419|3615892|B1||Male|Sex: Female, Male||Participants|Count of Participants|670|670.0||||||
3786087|NCT01862419|3615890|B3||Female|Sex: Female, Male||Participants|Count of Participants|1068|1068.0||||||
3786088|NCT01862419|3615891|B2||Female|Sex: Female, Male||Participants|Count of Participants|537|537.0||||||
3786089|NCT01862419|3615892|B1||Female|Sex: Female, Male||Participants|Count of Participants|531|531.0||||||
3786090|NCT01862419|3615890|B3|||Age||years|Mean|60|60.0|Standard Deviation|16|16.0|||
3786091|NCT01862419|3615891|B2|||Age||years|Mean|61|61.0|Standard Deviation|16|16.0|||
3786092|NCT01862419|3615892|B1|||Age||years|Mean|60|60.0|Standard Deviation|17|17.0|||
3786093|NCT01862250|3615903|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3786094|NCT01862250|3615903|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786095|NCT01862250|3615903|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786096|NCT01862250|3615903|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3786097|NCT01862250|3615903|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3786098|NCT01862250|3615903|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786099|NCT01862250|3615903|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786100|NCT01862250|3615903|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786101|NCT01862250|3615903|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3786102|NCT01862250|3615903|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3786103|NCT01862250|3615903|B1|||Age||weeks|Median|38.2|38.2|Full Range|||35.9|39.4|
3786104|NCT01862159|3615910|B1|Sweden||Region of Enrollment||participants|Number|25038|25038.0||||||
3786105|NCT01862159|3615910|B1||Male|Sex: Female, Male||Participants|Count of Participants|6021|6021.0||||||
3786106|NCT01862159|3615910|B1||Female|Sex: Female, Male||Participants|Count of Participants|19017|19017.0||||||
3786107|NCT01862159|3615910|B1|||Age||years|Mean|41.1|41.1|Standard Deviation|10.97|10.97|||
3786108|NCT01862133|3615917|B1|United States||Region of Enrollment||participants|Number|105|105.0||||||
3786109|NCT01862133|3615917|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3786110|NCT01862133|3615917|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3786111|NCT01862133|3615917|B1|||Age||years|Mean|55|55.0|Standard Deviation|13|13.0|||
3786112|NCT01862029|3615924|B1|United States||Region of Enrollment|Subjects resided either within District of Columbia or within the states of Maryland or Virginia.|participants|Number|9|9.0||||||
3786113|NCT01862029|3615924|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3786114|NCT01862029|3615924|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3786115|NCT01862029|3615924|B1|Black or African-American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3786116|NCT01862029|3615924|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3786117|NCT01862029|3615924|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3786118|NCT01862029|3615924|B1|||Age||years|Mean|49.6|49.6|Standard Deviation|6.4|6.4|||
3786119|NCT01861925|3615929|B4|Switzerland||Region of Enrollment||participants|Number|50|50.0||||||
3786120|NCT01861925|3615930|B3|Switzerland||Region of Enrollment||participants|Number|8|8.0||||||
3786121|NCT01861925|3615931|B2|Switzerland||Region of Enrollment||participants|Number|8|8.0||||||
3786122|NCT01861925|3615932|B1|Switzerland||Region of Enrollment||participants|Number|34|34.0||||||
3786123|NCT01861925|3615929|B4||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3786124|NCT01861925|3615930|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3786125|NCT01861925|3615931|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3786126|NCT01861925|3615932|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3786127|NCT01861925|3615929|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3786128|NCT01861925|3615930|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3786129|NCT01861925|3615931|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3786130|NCT01861925|3615932|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3786131|NCT01861925|3615929|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786132|NCT01861925|3615930|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786133|NCT01861925|3615931|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786134|NCT01861925|3615932|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786135|NCT01861925|3615929|B4||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3786136|NCT01861925|3615930|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3786137|NCT01861925|3615931|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3786138|NCT01861925|3615932|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3786139|NCT01861925|3615929|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3786140|NCT01861925|3615930|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3786141|NCT01861925|3615931|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3786142|NCT01861925|3615932|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3786143|NCT01861925|3615929|B4|||Age||years|Mean|37.4|37.4|Standard Deviation|9.5|9.5|||
3786144|NCT01861925|3615930|B3|||Age||years|Mean|32.7|32.7|Standard Deviation|8.2|8.2|||
3786145|NCT01861925|3615931|B2|||Age||years|Mean|36.4|36.4|Standard Deviation|9.0|9.0|||
3786146|NCT01861925|3615932|B1|||Age||years|Mean|38.8|38.8|Standard Deviation|9.8|9.8|||
3786147|NCT01861756|3615955|B3|||HbA1c||%|Mean|8.5|8.5|Standard Deviation|0.8|0.8|||
3786148|NCT01861756|3615956|B2|||HbA1c||%|Mean|8.5|8.5|Standard Deviation|0.8|0.8|||
3786149|NCT01861756|3615957|B1|||HbA1c||%|Mean|8.4|8.4|Standard Deviation|0.8|0.8|||
3786150|NCT01861756|3615955|B3||missing data|Type 2 diabetes duration||Participants|Count of Participants|2|2.0||||||
3786151|NCT01861756|3615956|B2||missing data|Type 2 diabetes duration||Participants|Count of Participants|1|1.0||||||
3786152|NCT01861756|3615957|B1||missing data|Type 2 diabetes duration||Participants|Count of Participants|1|1.0||||||
3786153|NCT01861756|3615955|B3||>10 years|Type 2 diabetes duration||Participants|Count of Participants|106|106.0||||||
3786154|NCT01861756|3615956|B2||>10 years|Type 2 diabetes duration||Participants|Count of Participants|53|53.0||||||
3786155|NCT01861756|3615957|B1||>10 years|Type 2 diabetes duration||Participants|Count of Participants|53|53.0||||||
3786156|NCT01861756|3615955|B3||5 - 10 years|Type 2 diabetes duration||Participants|Count of Participants|47|47.0||||||
3786157|NCT01861756|3615956|B2||5 - 10 years|Type 2 diabetes duration||Participants|Count of Participants|27|27.0||||||
3786158|NCT01861756|3615957|B1||5 - 10 years|Type 2 diabetes duration||Participants|Count of Participants|20|20.0||||||
3786159|NCT01861756|3615955|B3||<5 years|Type 2 diabetes duration||Participants|Count of Participants|49|49.0||||||
3786160|NCT01861756|3615956|B2||<5 years|Type 2 diabetes duration||Participants|Count of Participants|22|22.0||||||
3786161|NCT01861756|3615957|B1||<5 years|Type 2 diabetes duration||Participants|Count of Participants|27|27.0||||||
3786162|NCT01861756|3615955|B3|Greece||Region of Enrollment||participants|Number|204|204.0||||||
3786163|NCT01861756|3615956|B2|Greece||Region of Enrollment||participants|Number|103|103.0||||||
3786164|NCT01861756|3615957|B1|Greece||Region of Enrollment||participants|Number|101|101.0||||||
3786165|NCT01861756|3615955|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3786166|NCT01861756|3615956|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3786167|NCT01861756|3615957|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3786168|NCT01861756|3615955|B3||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3786169|NCT01861756|3615956|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3786170|NCT01861756|3615957|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3786171|NCT01861756|3615955|B3|||Age||years|Mean|65.1|65.1|Standard Deviation|11.1|11.1|||
3786172|NCT01861756|3615956|B2|||Age||years|Mean|64.4|64.4|Standard Deviation|11.3|11.3|||
3786173|NCT01861756|3615957|B1|||Age||years|Mean|65.8|65.8|Standard Deviation|11|11.0|||
3786174|NCT01861704|3615964|B3|United States||Region of Enrollment||participants|Number|177|177.0||||||
3786175|NCT01861704|3615965|B2|United States||Region of Enrollment||participants|Number|107|107.0||||||
3786176|NCT01861704|3615966|B1|United States||Region of Enrollment||participants|Number|70|70.0||||||
3786177|NCT01861704|3615964|B3||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3786178|NCT01861704|3615965|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3786179|NCT01861704|3615966|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3786180|NCT01861704|3615964|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3786181|NCT01861704|3615965|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3786182|NCT01861704|3615966|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3786183|NCT01861704|3615964|B3|>18 years of age||Age, Customized||participants|Number|177|177.0||||||
3786184|NCT01861704|3615965|B2|>18 years of age||Age, Customized||participants|Number|107|107.0||||||
3786185|NCT01861704|3615966|B1|>18 years of age||Age, Customized||participants|Number|70|70.0||||||
3786186|NCT01861704|3615964|B3|<=18 years of age||Age, Customized||participants|Number|0|0.0||||||
3786187|NCT01861704|3615965|B2|<=18 years of age||Age, Customized||participants|Number|0|0.0||||||
3786188|NCT01861704|3615966|B1|<=18 years of age||Age, Customized||participants|Number|0|0.0||||||
3786189|NCT01861665|3615973|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
3786190|NCT01861665|3615974|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3786191|NCT01861665|3615975|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3786192|NCT01861665|3615973|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3786193|NCT01861665|3615973|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3786194|NCT01861665|3615974|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3786195|NCT01861665|3615975|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3786196|NCT01861665|3615973|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3786197|NCT01861665|3615974|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3786198|NCT01861665|3615975|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3786199|NCT01861665|3615973|B3|||Age||years|Mean|32.26|32.26|Standard Deviation|4.83|4.83|||
3786200|NCT01861665|3615974|B2|||Age||years|Mean|30.92|30.92|Standard Deviation|3.87|3.87|||
3786201|NCT01861665|3615975|B1|||Age||years|Mean|33.6|33.6|Standard Deviation|5.79|5.79|||
3786202|NCT01861665|3615973|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786203|NCT01861665|3615974|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786204|NCT01861665|3615975|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786205|NCT01861665|3615973|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3786206|NCT01861665|3615974|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3786207|NCT01861665|3615975|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3786208|NCT01861665|3615973|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3786209|NCT01861665|3615974|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3786210|NCT01861665|3615975|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3786211|NCT01861587|3615982|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
3786212|NCT01861587|3615983|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3786213|NCT01861587|3615984|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3786214|NCT01861587|3615982|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786215|NCT01861587|3615983|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786216|NCT01861587|3615984|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786217|NCT01861587|3615982|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786218|NCT01861587|3615983|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786219|NCT01861587|3615984|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786220|NCT01861587|3615982|B3||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3786221|NCT01861587|3615983|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3786222|NCT01861587|3615984|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3786223|NCT01861587|3615982|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3786224|NCT01861587|3615983|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3786225|NCT01861587|3615984|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3786226|NCT01861587|3615982|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786227|NCT01861587|3615983|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786228|NCT01861587|3615984|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786229|NCT01861587|3615982|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786230|NCT01861587|3615983|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786231|NCT01861587|3615984|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786232|NCT01861587|3615982|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786233|NCT01861587|3615983|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786234|NCT01861587|3615984|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786235|NCT01861587|3615982|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3786236|NCT01861587|3615983|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3786237|NCT01861587|3615984|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3786238|NCT01861587|3615982|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3786239|NCT01861587|3615983|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3786240|NCT01861587|3615984|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3786241|NCT01861587|3615982|B3|||Age||years|Mean|59.4|59.4|Standard Deviation|2.1|2.1|||
3786242|NCT01861587|3615983|B2|||Age||years|Mean|59.4|59.4|Standard Deviation|2.1|2.1|||
3786243|NCT01861587|3615984|B1|||Age||years|Mean|59.4|59.4|Standard Deviation|2.1|2.1|||
3786244|NCT01861574|3615997|B5|United States||Region of Enrollment||participants|Number|108|108.0||||||
3786245|NCT01861574|3615998|B4|United States||Region of Enrollment||participants|Number|28|28.0||||||
3786246|NCT01861574|3615999|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
3786247|NCT01861574|3616000|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3786248|NCT01861574|3616001|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
3786249|NCT01861574|3615997|B5||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3786250|NCT01861574|3615998|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3786251|NCT01861574|3615999|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3786252|NCT01861574|3616000|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3786253|NCT01861574|3616001|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3786254|NCT01861574|3615997|B5||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3786255|NCT01861574|3615998|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3786256|NCT01861574|3615999|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3786257|NCT01861574|3616000|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3786258|NCT01861574|3616001|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3786259|NCT01861574|3615997|B5|||Age||years|Mean|47.04|47.04|Standard Deviation|11.02|11.02|||
3786260|NCT01861574|3615998|B4|||Age||years|Mean|49.89|49.89|Standard Deviation|12.35|12.35|||
3786261|NCT01861574|3615999|B3|||Age||years|Mean|44.33|44.33|Standard Deviation|8.96|8.96|||
3786262|NCT01861574|3616000|B2|||Age||years|Mean|45.44|45.44|Standard Deviation|10.07|10.07|||
3786263|NCT01861574|3616001|B1|||Age||years|Mean|48.21|48.21|Standard Deviation|11.90|11.9|||
3786264|NCT01861574|3615997|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786265|NCT01861574|3615998|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786266|NCT01861574|3615999|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786267|NCT01861574|3616000|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786268|NCT01861574|3616001|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786269|NCT01861574|3615997|B5||Between 18 and 65 years|Age||Participants|Count of Participants|108|108.0||||||
3786270|NCT01861574|3615998|B4||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3786271|NCT01861574|3615999|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3786272|NCT01861574|3616000|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3786273|NCT01861574|3616001|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3786274|NCT01861574|3615997|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3786275|NCT01861574|3615998|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3786276|NCT01861574|3615999|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3786277|NCT01861574|3616000|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3786278|NCT01861574|3616001|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3786279|NCT01861522|3616025|B3||Male|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
3786280|NCT01861522|3616026|B2||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3786281|NCT01861522|3616027|B1||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3786282|NCT01861522|3616025|B3||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
3786283|NCT01861522|3616026|B2||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3786284|NCT01861522|3616027|B1||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3786285|NCT01861522|3616025|B3|||Age||years|Mean|10.4|10.4|Standard Deviation|2.4|2.4|||
3786286|NCT01861522|3616026|B2|||Age||years|Mean|10.4|10.4|Standard Deviation|2.4|2.4|||
3786287|NCT01861522|3616027|B1|||Age||years|Mean|10.3|10.3|Standard Deviation|2.4|2.4|||
3786288|NCT01861457|3616034|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3786289|NCT01861457|3616035|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3786290|NCT01861457|3616036|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3786291|NCT01861457|3616034|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3786292|NCT01861457|3616035|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3786293|NCT01861457|3616036|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3786294|NCT01861457|3616034|B3|||Age||years|Mean|35.1|35.1|Full Range|||26.0|67.0|
3786295|NCT01861457|3616035|B2|||Age||years|Mean|35.4|35.4|Full Range|||26.0|67.0|
3786296|NCT01861457|3616036|B1|||Age||years|Mean|34.5|34.5|Full Range|||26.0|64.0|
3786297|NCT01861301|3616045|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3786298|NCT01861301|3616045|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3786299|NCT01861301|3616045|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3786300|NCT01861301|3616045|B1|||Age||years|Median|66.5|66.5|Full Range|||19.0|81.0|
3786301|NCT01860989|3616052|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3786302|NCT01860989|3616052|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3786303|NCT01860989|3616052|B1|||Age||years|Mean|31.6|31.6|Standard Deviation|7.50|7.5|||
3786304|NCT01860976|3616056|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3786305|NCT01860976|3616057|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3786306|NCT01860976|3616058|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786307|NCT01860976|3616056|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3786308|NCT01860976|3616057|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3786309|NCT01860976|3616058|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3786310|NCT01860976|3616056|B3||White|Race (NIH/OMB)||Participants|Count of Participants|393|393.0||||||
3786311|NCT01860976|3616057|B2||White|Race (NIH/OMB)||Participants|Count of Participants|198|198.0||||||
3786312|NCT01860976|3616058|B1||White|Race (NIH/OMB)||Participants|Count of Participants|195|195.0||||||
3786313|NCT01860976|3616056|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786314|NCT01860976|3616057|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786315|NCT01860976|3616058|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786316|NCT01860976|3616056|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786317|NCT01860976|3616057|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786318|NCT01860976|3616058|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786319|NCT01860976|3616056|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3786320|NCT01860976|3616057|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3786321|NCT01860976|3616058|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786322|NCT01860976|3616056|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786323|NCT01860976|3616057|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786324|NCT01860976|3616058|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786325|NCT01860976|3616056|B3||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
3786326|NCT01860976|3616057|B2||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3786327|NCT01860976|3616058|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3786328|NCT01860976|3616056|B3||Female|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
3786329|NCT01860976|3616057|B2||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3786330|NCT01860976|3616058|B1||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3786331|NCT01860976|3616056|B3|||Age||years|Mean|50.4|50.4|Standard Deviation|10.97|10.97|||
3786332|NCT01860976|3616057|B2|||Age||years|Mean|49.8|49.8|Standard Deviation|11.26|11.26|||
3786333|NCT01860976|3616058|B1|||Age||years|Mean|51.0|51.0|Standard Deviation|10.67|10.67|||
3786334|NCT01860950|3616081|B7|United States||Region of Enrollment||participants|Number|79|79.0||||||
3786335|NCT01860950|3616082|B6|United States||Region of Enrollment||participants|Number|13|13.0||||||
3786336|NCT01860950|3616083|B5|United States||Region of Enrollment||participants|Number|14|14.0||||||
3786337|NCT01860950|3616084|B4|United States||Region of Enrollment||participants|Number|13|13.0||||||
3786338|NCT01860950|3616085|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3786339|NCT01860950|3616086|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3786340|NCT01860950|3616087|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3786341|NCT01860950|3616081|B7||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3786342|NCT01860950|3616082|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3786343|NCT01860950|3616083|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3786344|NCT01860950|3616084|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3786345|NCT01860950|3616085|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3786346|NCT01860950|3616086|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3786347|NCT01860950|3616087|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3786348|NCT01860950|3616081|B7||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3786349|NCT01860950|3616082|B6||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3786350|NCT01860950|3616083|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3786351|NCT01860950|3616084|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3786352|NCT01860950|3616085|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3786353|NCT01860950|3616086|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3786354|NCT01860950|3616087|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3786355|NCT01860950|3616081|B7|||Age||years|Mean|35|35.0|Standard Deviation|11.4|11.4|||
3786356|NCT01860950|3616082|B6|||Age||years|Mean|38.85|38.85|Standard Deviation|12.49|12.49|||
3786357|NCT01860950|3616083|B5|||Age||years|Mean|29.93|29.93|Standard Deviation|8.82|8.82|||
3786358|NCT01860950|3616084|B4|||Age||years|Mean|28.46|28.46|Standard Deviation|7.24|7.24|||
3786359|NCT01860950|3616085|B3|||Age||years|Mean|27.80|27.8|Standard Deviation|6.89|6.89|||
3786360|NCT01860950|3616086|B2|||Age||years|Mean|32.60|32.6|Standard Deviation|11.59|11.59|||
3786361|NCT01860950|3616087|B1|||Age||years|Mean|32.43|32.43|Standard Deviation|9.27|9.27|||
3786362|NCT01860950|3616081|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786363|NCT01860950|3616082|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786364|NCT01860950|3616083|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786365|NCT01860950|3616084|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786366|NCT01860950|3616085|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786367|NCT01860950|3616086|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786368|NCT01860950|3616087|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786369|NCT01860950|3616081|B7||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
3786370|NCT01860950|3616082|B6||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3786371|NCT01860950|3616083|B5||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3786372|NCT01860950|3616084|B4||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3786373|NCT01860950|3616085|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3786374|NCT01860950|3616086|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3786375|NCT01860950|3616087|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3786376|NCT01860950|3616081|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3786377|NCT01860950|3616082|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3786378|NCT01860950|3616083|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3786379|NCT01860950|3616084|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3786380|NCT01860950|3616085|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3786381|NCT01860950|3616086|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3786382|NCT01860950|3616087|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3786383|NCT01860846|3616113|B1||Infliximab|Anti-TNF Treatments||Participants|Count of Participants|23|23.0||||||
3786384|NCT01860846|3616113|B1||Adalimumab|Anti-TNF Treatments||Participants|Count of Participants|78|78.0||||||
3786385|NCT01860846|3616113|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3786386|NCT01860846|3616113|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3786387|NCT01860846|3616113|B1|||Age||years|Mean|36.8|36.8|Standard Deviation|10.9|10.9|||
3786388|NCT01860703|3616124|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3786389|NCT01860703|3616124|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786390|NCT01860703|3616124|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786391|NCT01860703|3616124|B1||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3786392|NCT01860703|3616124|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3786393|NCT01860703|3616124|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786394|NCT01860703|3616124|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786395|NCT01860703|3616124|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786396|NCT01860703|3616124|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786397|NCT01860703|3616124|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3786398|NCT01860703|3616124|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3786399|NCT01860703|3616124|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3786400|NCT01860703|3616124|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3786401|NCT01860703|3616124|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786402|NCT01860703|3616124|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3786403|NCT01860703|3616124|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3786404|NCT01860677|3616159|B1|||Body Mass Index (BMI)||kg/m^2|Mean|24.35|24.35|Standard Deviation|4.76|4.76|||
3786405|NCT01860677|3616159|B1|||Marihuana use (spelling with 'h' used by DEA and FDA)||lifetime uses|Mean|3.5|3.5|Standard Deviation|6.9|6.9|||
3786406|NCT01860677|3616159|B1|||Alcohol consumption||alcoolic drinks/week|Mean|2.1|2.1|Standard Deviation|2.1|2.1|||
3786407|NCT01860677|3616159|B1|||Caffeine consumption||caffeinated beverages/week|Mean|5.2|5.2|Standard Deviation|6.1|6.1|||
3786408|NCT01860677|3616159|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3786409|NCT01860677|3616159|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786410|NCT01860677|3616159|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786411|NCT01860677|3616159|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3786412|NCT01860677|3616159|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3786413|NCT01860677|3616159|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786414|NCT01860677|3616159|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786415|NCT01860677|3616159|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786416|NCT01860677|3616159|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786417|NCT01860677|3616159|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3786418|NCT01860677|3616159|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786419|NCT01860677|3616159|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3786420|NCT01860677|3616159|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3786421|NCT01860677|3616159|B1|||Age||years|Mean|25.4|25.4|Standard Deviation|4.5|4.5|||
3786422|NCT01860586|3616169|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3786423|NCT01860586|3616169|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3786424|NCT01860586|3616169|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786425|NCT01860586|3616169|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3786426|NCT01860586|3616169|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786427|NCT01860586|3616169|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786428|NCT01860586|3616169|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786429|NCT01860586|3616169|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786430|NCT01860586|3616169|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3786431|NCT01860586|3616169|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3786432|NCT01860586|3616169|B1|||Age||years|Mean|59|59.0|Standard Deviation|8|8.0|||
3786433|NCT01860573|3616175|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3786434|NCT01860573|3616176|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3786435|NCT01860573|3616177|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3786436|NCT01860573|3616175|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3786437|NCT01860573|3616176|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3786438|NCT01860573|3616177|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3786439|NCT01860573|3616175|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786440|NCT01860573|3616176|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786441|NCT01860573|3616177|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786442|NCT01860573|3616175|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3786443|NCT01860573|3616176|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3786444|NCT01860573|3616177|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3786445|NCT01860573|3616175|B3||<=18 years|Age||Participants|Count of Participants|168|168.0||||||
3786446|NCT01860573|3616176|B2||<=18 years|Age||Participants|Count of Participants|85|85.0||||||
3786447|NCT01860573|3616177|B1||<=18 years|Age||Participants|Count of Participants|83|83.0||||||
3786448|NCT01860534|3616196|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
3786449|NCT01860534|3616197|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3786450|NCT01860534|3616198|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3786451|NCT01860534|3616196|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3786452|NCT01860534|3616197|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3786453|NCT01860534|3616198|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3786454|NCT01860534|3616196|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3786455|NCT01860534|3616197|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3786456|NCT01860534|3616198|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3786457|NCT01860534|3616196|B3|||Age||years|Mean|0.53|0.53|Standard Deviation|0.04|0.04|||
3786458|NCT01860534|3616197|B2|||Age||years|Mean|0.53|0.53|Standard Deviation|0.04|0.04|||
3786459|NCT01860534|3616198|B1|||Age||years|Mean|0.54|0.54|Standard Deviation|0.04|0.04|||
3786460|NCT01860534|3616196|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786461|NCT01860534|3616197|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786462|NCT01860534|3616198|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786463|NCT01860534|3616196|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3786464|NCT01860534|3616197|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3786465|NCT01860534|3616198|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3786466|NCT01860534|3616196|B3||<=18 years|Age||Participants|Count of Participants|28|28.0||||||
3786467|NCT01860534|3616197|B2||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
3786468|NCT01860534|3616198|B1||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
3786469|NCT01860521|3616211|B3|Italy||Region of Enrollment||participants|Number|104|104.0||||||
3786470|NCT01860521|3616212|B2|Italy||Region of Enrollment||participants|Number|52|52.0||||||
3786471|NCT01860521|3616213|B1|Italy||Region of Enrollment||participants|Number|52|52.0||||||
3786472|NCT01860521|3616211|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3786473|NCT01860521|3616212|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3786474|NCT01860521|3616213|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3786475|NCT01860521|3616211|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3786476|NCT01860521|3616212|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3786477|NCT01860521|3616213|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3786478|NCT01860521|3616211|B3|||Age||years|Mean|32.8|32.8|Standard Deviation|5.0|5.0|||
3786479|NCT01860521|3616212|B2|||Age||years|Mean|32.4|32.4|Standard Deviation|5.3|5.3|||
3786480|NCT01860521|3616213|B1|||Age||years|Mean|33.3|33.3|Standard Deviation|4.7|4.7|||
3786481|NCT01860521|3616211|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786482|NCT01860521|3616212|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786483|NCT01860521|3616213|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786484|NCT01860521|3616211|B3||Between 18 and 65 years|Age||Participants|Count of Participants|104|104.0||||||
3786485|NCT01860521|3616212|B2||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3786486|NCT01860521|3616213|B1||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3786487|NCT01860521|3616211|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3786488|NCT01860521|3616212|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3786489|NCT01860521|3616213|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3786490|NCT01860170|3616226|B4|United States||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3786491|NCT01860170|3616227|B3|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3786492|NCT01860170|3616228|B2|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3786493|NCT01860170|3616229|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3786494|NCT01860170|3616226|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3786495|NCT01860170|3616227|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3786496|NCT01860170|3616228|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3786497|NCT01860170|3616229|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3786498|NCT01860170|3616226|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3786499|NCT01860170|3616227|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3786500|NCT01860170|3616228|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3786501|NCT01860170|3616229|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3786502|NCT01860170|3616226|B4|||Age||years|Mean|56.9|56.9|Full Range|||37.0|70.0|
3786503|NCT01860170|3616227|B3|||Age||years|Mean|56.6|56.6|Full Range|||37.0|70.0|
3786504|NCT01860170|3616228|B2|||Age||years|Mean|56|56.0|Full Range|||47.0|62.0|
3786505|NCT01860170|3616229|B1|||Age||years|Mean|60.3|60.3|Full Range|||56.0|65.0|
3786506|NCT01860170|3616226|B4||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3786507|NCT01860170|3616227|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3786508|NCT01860170|3616228|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786509|NCT01860170|3616229|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3786510|NCT01860170|3616226|B4||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3786511|NCT01860170|3616227|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3786512|NCT01860170|3616228|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3786513|NCT01860170|3616229|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3786514|NCT01860170|3616226|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3786515|NCT01860170|3616227|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3786516|NCT01860170|3616228|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3786517|NCT01860170|3616229|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3786518|NCT01860079|3616245|B3||Male|Sex: Female, Male||Participants|Count of Participants|640|640.0||||||
3786519|NCT01860079|3616246|B2||Male|Sex: Female, Male||Participants|Count of Participants|316|316.0||||||
3786520|NCT01860079|3616247|B1||Male|Sex: Female, Male||Participants|Count of Participants|324|324.0||||||
3786521|NCT01860079|3616245|B3||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3786522|NCT01860079|3616246|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3786523|NCT01860079|3616247|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3786524|NCT01860079|3616245|B3|||Age||years|Mean|54.59|54.59|Standard Deviation|11.05|11.05|||
3786525|NCT01860079|3616246|B2|||Age||years|Mean|54.63|54.63|Standard Deviation|11.82|11.82|||
3786526|NCT01860079|3616247|B1|||Age||years|Mean|54.55|54.55|Standard Deviation|10.25|10.25|||
3786527|NCT01860040|3616254|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3786528|NCT01860040|3616255|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3786529|NCT01860040|3616256|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3786530|NCT01860040|3616254|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3786531|NCT01860040|3616255|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3786532|NCT01860040|3616256|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3786533|NCT01860040|3616254|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786534|NCT01860040|3616255|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786535|NCT01860040|3616256|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786536|NCT01860040|3616254|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3786537|NCT01860040|3616255|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3786538|NCT01860040|3616256|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3786539|NCT01860040|3616254|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3786540|NCT01860040|3616255|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3786541|NCT01860040|3616256|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3786542|NCT01859988|3616262|B7||Male|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
3786543|NCT01859988|3616263|B6||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3786544|NCT01859988|3616264|B5||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3786545|NCT01859988|3616265|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3786546|NCT01859988|3616266|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3786547|NCT01859988|3616267|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3786548|NCT01859988|3616268|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3786549|NCT01859988|3616262|B7||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3786550|NCT01859988|3616263|B6||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3786551|NCT01859988|3616264|B5||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3786552|NCT01859988|3616265|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3786553|NCT01859988|3616266|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3786554|NCT01859988|3616267|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3786555|NCT01859988|3616268|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3786556|NCT01859988|3616262|B7|||Age||years|Mean|37.0|37.0|Standard Deviation|12.06|12.06|||
3786557|NCT01859988|3616263|B6|||Age||years|Mean|37.2|37.2|Standard Deviation|13.10|13.1|||
3786558|NCT01859988|3616264|B5|||Age||years|Mean|36.6|36.6|Standard Deviation|11.55|11.55|||
3786559|NCT01859988|3616265|B4|||Age||years|Mean|36.8|36.8|Standard Deviation|10.77|10.77|||
3786560|NCT01859988|3616266|B3|||Age||years|Mean|35.8|35.8|Standard Deviation|14.90|14.9|||
3786561|NCT01859988|3616267|B2|||Age||years|Mean|39.4|39.4|Standard Deviation|12.06|12.06|||
3786562|NCT01859988|3616268|B1|||Age||years|Mean|36.2|36.2|Standard Deviation|10.74|10.74|||
3786563|NCT01859949|3616365|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3786564|NCT01859949|3616366|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3786565|NCT01859949|3616367|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3786566|NCT01859949|3616365|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3786567|NCT01859949|3616366|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3786568|NCT01859949|3616367|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3786569|NCT01859949|3616365|B3|||Age||years|Mean|5.31|5.31|Standard Deviation|1.45|1.45|||
3786570|NCT01859949|3616366|B2|||Age||years|Mean|5.40|5.4|Standard Deviation|1.27|1.27|||
3786571|NCT01859949|3616367|B1|||Age||years|Mean|5.20|5.2|Standard Deviation|1.64|1.64|||
3786572|NCT01859793|3616384|B3|No||HMG CoA-Reductase||participants|Number|8|8.0||||||
3786573|NCT01859793|3616385|B2|No||HMG CoA-Reductase||participants|Number|3|3.0||||||
3786574|NCT01859793|3616386|B1|No||HMG CoA-Reductase||participants|Number|5|5.0||||||
3786575|NCT01859793|3616384|B3|Yes||HMG CoA-Reductase||participants|Number|22|22.0||||||
3786576|NCT01859793|3616385|B2|Yes||HMG CoA-Reductase||participants|Number|13|13.0||||||
3786577|NCT01859793|3616386|B1|Yes||HMG CoA-Reductase||participants|Number|9|9.0||||||
3786578|NCT01859793|3616384|B3|No||Beta-Blocker||participants|Number|28|28.0||||||
3786579|NCT01859793|3616385|B2|No||Beta-Blocker||participants|Number|15|15.0||||||
3786580|NCT01859793|3616386|B1|No||Beta-Blocker||participants|Number|13|13.0||||||
3786581|NCT01859793|3616384|B3|Yes||Beta-Blocker||participants|Number|2|2.0||||||
3786582|NCT01859793|3616385|B2|Yes||Beta-Blocker||participants|Number|1|1.0||||||
3786583|NCT01859793|3616386|B1|Yes||Beta-Blocker||participants|Number|1|1.0||||||
3786584|NCT01859793|3616384|B3|No||ACE Inhibitor||participants|Number|12|12.0||||||
3786585|NCT01859793|3616385|B2|No||ACE Inhibitor||participants|Number|8|8.0||||||
3786586|NCT01859793|3616386|B1|No||ACE Inhibitor||participants|Number|4|4.0||||||
3786587|NCT01859793|3616384|B3|Yes||ACE Inhibitor||participants|Number|18|18.0||||||
3786588|NCT01859793|3616385|B2|Yes||ACE Inhibitor||participants|Number|8|8.0||||||
3786589|NCT01859793|3616386|B1|Yes||ACE Inhibitor||participants|Number|10|10.0||||||
3786590|NCT01859793|3616384|B3|Past or Current||Smoking Status||participants|Number|8|8.0||||||
3786591|NCT01859793|3616385|B2|Past or Current||Smoking Status||participants|Number|3|3.0||||||
3786592|NCT01859793|3616386|B1|Past or Current||Smoking Status||participants|Number|5|5.0||||||
3786593|NCT01859793|3616384|B3|Never||Smoking Status||participants|Number|22|22.0||||||
3786594|NCT01859793|3616385|B2|Never||Smoking Status||participants|Number|13|13.0||||||
3786595|NCT01859793|3616386|B1|Never||Smoking Status||participants|Number|9|9.0||||||
3786596|NCT01859793|3616384|B3|Without Dyslipidemia||History of High Cholesterol||participants|Number|9|9.0||||||
3786597|NCT01859793|3616385|B2|Without Dyslipidemia||History of High Cholesterol||participants|Number|3|3.0||||||
3786598|NCT01859793|3616386|B1|Without Dyslipidemia||History of High Cholesterol||participants|Number|6|6.0||||||
3786599|NCT01859793|3616384|B3|With Dyslipidemia||History of High Cholesterol||participants|Number|21|21.0||||||
3786600|NCT01859793|3616385|B2|With Dyslipidemia||History of High Cholesterol||participants|Number|13|13.0||||||
3786601|NCT01859793|3616386|B1|With Dyslipidemia||History of High Cholesterol||participants|Number|8|8.0||||||
3786602|NCT01859793|3616384|B3|Without Hypertension||History of Hypertension||participants|Number|10|10.0||||||
3786603|NCT01859793|3616385|B2|Without Hypertension||History of Hypertension||participants|Number|6|6.0||||||
3786604|NCT01859793|3616386|B1|Without Hypertension||History of Hypertension||participants|Number|4|4.0||||||
3786605|NCT01859793|3616384|B3|With Hypertension||History of Hypertension||participants|Number|20|20.0||||||
3786606|NCT01859793|3616385|B2|With Hypertension||History of Hypertension||participants|Number|10|10.0||||||
3786607|NCT01859793|3616386|B1|With Hypertension||History of Hypertension||participants|Number|10|10.0||||||
3786608|NCT01859793|3616384|B3|||Alkaline Phosphatase||mg/dL|Mean|78|78.0|Standard Deviation|16|16.0|||
3786609|NCT01859793|3616385|B2|||Alkaline Phosphatase||mg/dL|Mean|78|78.0|Standard Deviation|20|20.0|||
3786610|NCT01859793|3616386|B1|||Alkaline Phosphatase||mg/dL|Mean|73|73.0|Standard Deviation|10|10.0|||
3786611|NCT01859793|3616384|B3|||Total Bilirubin||mg/dL|Mean|0.5|0.5|Standard Deviation|0.3|0.3|||
3786612|NCT01859793|3616385|B2|||Total Bilirubin||mg/dL|Mean|0.5|0.5|Standard Deviation|0.3|0.3|||
3786613|NCT01859793|3616386|B1|||Total Bilirubin||mg/dL|Mean|0.4|0.4|Standard Deviation|0.2|0.2|||
3786614|NCT01859793|3616384|B3|||Aspartate Aminotransferase (AST)||mg/dL|Mean|25|25.0|Standard Deviation|15|15.0|||
3786615|NCT01859793|3616385|B2|||Aspartate Aminotransferase (AST)||mg/dL|Mean|25|25.0|Standard Deviation|13|13.0|||
3786616|NCT01859793|3616386|B1|||Aspartate Aminotransferase (AST)||mg/dL|Mean|25|25.0|Standard Deviation|17|17.0|||
3786617|NCT01859793|3616384|B3|||Alanine Aminotransferase (ALT)||mg/dL|Mean|29|29.0|Standard Deviation|26|26.0|||
3786618|NCT01859793|3616385|B2|||Alanine Aminotransferase (ALT)||mg/dL|Mean|28|28.0|Standard Deviation|23|23.0|||
3786619|NCT01859793|3616386|B1|||Alanine Aminotransferase (ALT)||mg/dL|Mean|30|30.0|Standard Deviation|30|30.0|||
3786620|NCT01859793|3616384|B3|||Homeostatic Assessment of Insulin Resistance||units on a scale|Mean|4.9|4.9|Standard Deviation|2.5|2.5|||
3786621|NCT01859793|3616385|B2|||Homeostatic Assessment of Insulin Resistance||units on a scale|Mean|5.3|5.3|Standard Deviation|2.9|2.9|||
3786622|NCT01859793|3616386|B1|||Homeostatic Assessment of Insulin Resistance||units on a scale|Mean|4.4|4.4|Standard Deviation|1.9|1.9|||
3786623|NCT01859793|3616384|B3|||Glucose||mg/dL|Mean|126|126.0|Standard Deviation|30|30.0|||
3786624|NCT01859793|3616385|B2|||Glucose||mg/dL|Mean|134|134.0|Standard Deviation|31|31.0|||
3786625|NCT01859793|3616386|B1|||Glucose||mg/dL|Mean|117|117.0|Standard Deviation|26|26.0|||
3786626|NCT01859793|3616384|B3|||Insulin||microU/mL|Mean|15.6|15.6|Standard Deviation|7.4|7.4|||
3786627|NCT01859793|3616385|B2|||Insulin||microU/mL|Mean|16.0|16.0|Standard Deviation|8.9|8.9|||
3786628|NCT01859793|3616386|B1|||Insulin||microU/mL|Mean|15.1|15.1|Standard Deviation|5.6|5.6|||
3786629|NCT01859793|3616384|B3|||Triglycerides||mg/dL|Mean|132|132.0|Standard Deviation|46|46.0|||
3786630|NCT01859793|3616385|B2|||Triglycerides||mg/dL|Mean|138|138.0|Standard Deviation|40|40.0|||
3786631|NCT01859793|3616386|B1|||Triglycerides||mg/dL|Mean|126|126.0|Standard Deviation|53|53.0|||
3786632|NCT01859793|3616384|B3|||Low Density Lipoprotein||mg/dL|Mean|84|84.0|Standard Deviation|27|27.0|||
3786633|NCT01859793|3616385|B2|||Low Density Lipoprotein||mg/dL|Mean|84|84.0|Standard Deviation|26|26.0|||
3786634|NCT01859793|3616386|B1|||Low Density Lipoprotein||mg/dL|Mean|85|85.0|Standard Deviation|29|29.0|||
3786635|NCT01859793|3616384|B3|||High Density Lipoprotein||mg/dL|Mean|55|55.0|Standard Deviation|16|16.0|||
3786636|NCT01859793|3616385|B2|||High Density Lipoprotein||mg/dL|Mean|56|56.0|Standard Deviation|20|20.0|||
3786637|NCT01859793|3616386|B1|||High Density Lipoprotein||mg/dL|Mean|55|55.0|Standard Deviation|12|12.0|||
3786638|NCT01859793|3616384|B3|||Total Cholesterol||mg/dL|Mean|167|167.0|Standard Deviation|30|30.0|||
3786639|NCT01859793|3616385|B2|||Total Cholesterol||mg/dL|Mean|169|169.0|Standard Deviation|29|29.0|||
3786640|NCT01859793|3616386|B1|||Total Cholesterol||mg/dL|Mean|165|165.0|Standard Deviation|31|31.0|||
3786641|NCT01859793|3616384|B3|||Diastolic Blood Pressure||mmHg|Mean|75|75.0|Standard Deviation|8|8.0|||
3786642|NCT01859793|3616385|B2|||Diastolic Blood Pressure||mmHg|Mean|78|78.0|Standard Deviation|20|20.0|||
3786643|NCT01859793|3616386|B1|||Diastolic Blood Pressure||mmHg|Mean|73|73.0|Standard Deviation|11|11.0|||
3786644|NCT01859793|3616384|B3|||Systolic Blood Pressure||mmHg|Mean|134|134.0|Standard Deviation|14|14.0|||
3786645|NCT01859793|3616385|B2|||Systolic Blood Pressure||mmHg|Mean|136|136.0|Standard Deviation|15|15.0|||
3786646|NCT01859793|3616386|B1|||Systolic Blood Pressure||mmHg|Mean|131|131.0|Standard Deviation|13|13.0|||
3786647|NCT01859793|3616384|B3|||Heart Rate||bpm|Mean|74|74.0|Standard Deviation|11|11.0|||
3786648|NCT01859793|3616385|B2|||Heart Rate||bpm|Mean|76|76.0|Standard Deviation|8|8.0|||
3786649|NCT01859793|3616386|B1|||Heart Rate||bpm|Mean|72|72.0|Standard Deviation|10|10.0|||
3786650|NCT01859793|3616384|B3|||HgA1C||percent|Mean|6.8|6.8|Standard Deviation|0.6|0.6|||
3786651|NCT01859793|3616385|B2|||HgA1C||percent|Mean|6.9|6.9|Standard Deviation|0.8|0.8|||
3786652|NCT01859793|3616386|B1|||HgA1C||percent|Mean|6.8|6.8|Standard Deviation|0.2|0.2|||
3786653|NCT01859793|3616384|B3|||Body Mass Index||kg/m^2|Mean|32.4|32.4|Standard Deviation|6.3|6.3|||
3786654|NCT01859793|3616385|B2|||Body Mass Index||kg/m^2|Mean|32.6|32.6|Standard Deviation|6.3|6.3|||
3786655|NCT01859793|3616386|B1|||Body Mass Index||kg/m^2|Mean|32.1|32.1|Standard Deviation|6.6|6.6|||
3786656|NCT01859793|3616384|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3786657|NCT01859793|3616385|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3786658|NCT01859793|3616386|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3786659|NCT01859793|3616384|B3|Non-Caucasian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3786660|NCT01859793|3616385|B2|Non-Caucasian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3786661|NCT01859793|3616386|B1|Non-Caucasian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3786662|NCT01859793|3616384|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3786663|NCT01859793|3616385|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3786664|NCT01859793|3616386|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3786665|NCT01859793|3616384|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3786666|NCT01859793|3616385|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3786667|NCT01859793|3616386|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3786668|NCT01859793|3616384|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3786669|NCT01859793|3616385|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3786670|NCT01859793|3616386|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3786671|NCT01859793|3616384|B3|||Age||years|Mean|63|63.0|Standard Deviation|9|9.0|||
3786672|NCT01859793|3616385|B2|||Age||years|Mean|63|63.0|Standard Deviation|9|9.0|||
3786673|NCT01859793|3616386|B1|||Age||years|Mean|62|62.0|Standard Deviation|10|10.0|||
3786674|NCT01859715|3616397|B4|||Number of CYP2D6 drugs taken||CYP2D6 drug|Median|1|1.0|Full Range|||0.0|6.0|
3786675|NCT01859715|3616398|B3|||Number of CYP2D6 drugs taken||CYP2D6 drug|Median|1|1.0|Full Range|||0.0|6.0|
3786676|NCT01859715|3616399|B2|||Number of CYP2D6 drugs taken||CYP2D6 drug|Median|1|1.0|Full Range|||0.0|5.0|
3786677|NCT01859715|3616400|B1|||Number of CYP2D6 drugs taken||CYP2D6 drug|Median|1|1.0|Full Range|||0.0|6.0|
3786678|NCT01859715|3616397|B4||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3786679|NCT01859715|3616398|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3786680|NCT01859715|3616399|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3786681|NCT01859715|3616400|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3786682|NCT01859715|3616397|B4||Female|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
3786683|NCT01859715|3616398|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3786684|NCT01859715|3616399|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3786685|NCT01859715|3616400|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3786686|NCT01859715|3616397|B4|||Age||years|Mean|40|40.0|Full Range|||18.0|86.0|
3786687|NCT01859715|3616398|B3|||Age||years|Mean|34|34.0|Full Range|||18.0|85.0|
3786688|NCT01859715|3616399|B2|||Age||years|Mean|38|38.0|Full Range|||18.0|84.0|
3786689|NCT01859715|3616400|B1|||Age||years|Mean|40|40.0|Full Range|||18.0|86.0|
3786690|NCT01859702|3616413|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3786691|NCT01859702|3616413|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3786692|NCT01859702|3616413|B1|||Age||years|Mean|71.2|71.2|Standard Deviation|10.4|10.4|||
3786693|NCT01859637|3616417|B1|||Weight||kg|Median|67.0|67.0|Full Range|||55.0|98.0|
3786694|NCT01859637|3616417|B1|||Height||cm|Median|165.0|165.0|Full Range|||159.0|174.0|
3786695|NCT01859637|3616417|B1|No||Granulocyte Colony Stimulating Factor (G-CSF) pretreatment||participants|Number|0|0.0||||||
3786696|NCT01859637|3616417|B1|Yes||Granulocyte Colony Stimulating Factor (G-CSF) pretreatment||participants|Number|6|6.0||||||
3786697|NCT01859637|3616417|B1|Idiopathic neutropenia||Severe Chronic Neutropenia (SCN) diagnosis||participants|Number|4|4.0||||||
3786698|NCT01859637|3616417|B1|Cyclic neutropenia||Severe Chronic Neutropenia (SCN) diagnosis||participants|Number|1|1.0||||||
3786699|NCT01859637|3616417|B1|Congenital neutropenia||Severe Chronic Neutropenia (SCN) diagnosis||participants|Number|1|1.0||||||
3786700|NCT01859637|3616417|B1|Germany||Region of Enrollment||participants|Number|2|2.0||||||
3786701|NCT01859637|3616417|B1|Sweden||Region of Enrollment||participants|Number|4|4.0||||||
3786702|NCT01859637|3616417|B1|Latin American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3786703|NCT01859637|3616417|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3786704|NCT01859637|3616417|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3786705|NCT01859637|3616417|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3786706|NCT01859637|3616417|B1|||Age||years|Median|45.0|45.0|Full Range|||27.0|77.0|
3786707|NCT01859611|3616423|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
3786708|NCT01859611|3616423|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3786709|NCT01859611|3616423|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3786710|NCT01859611|3616423|B1|||Age||years|Mean|45|45.0|Standard Deviation|10|10.0|||
3786711|NCT01859611|3616423|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786712|NCT01859611|3616423|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3786713|NCT01859611|3616423|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3786714|NCT01859598|3616427|B1|||Physical activity||days|Mean|5.4|5.4|Standard Deviation|2.5|2.5|||
3786715|NCT01859598|3616427|B1|||Pre-insulin hypoglycemia||times/person/year|Mean|1.7|1.7|Standard Deviation|10.4|10.4|||
3786716|NCT01859598|3616427|B1|Rural||Current residence of patients||participants|Number|5976|5976.0||||||
3786717|NCT01859598|3616427|B1|Urban||Current residence of patients||participants|Number|13019|13019.0||||||
3786718|NCT01859598|3616427|B1|Tertiary hospitals||Hospital levels||participants|Number|9552|9552.0||||||
3786719|NCT01859598|3616427|B1|Secondary hospitals||Hospital levels||participants|Number|9443|9443.0||||||
3786720|NCT01859598|3616427|B1|In-patient||Recruitment settings||participants|Number|10634|10634.0||||||
3786721|NCT01859598|3616427|B1|Out-patient||Recruitment settings||participants|Number|8361|8361.0||||||
3786722|NCT01859598|3616427|B1|||Body Mass Index (BMI)||kg/m2|Mean|24.7|24.7|Standard Deviation|3.4|3.4|||
3786723|NCT01859598|3616427|B1|||Diastolic Blood Pressure (DBP)||mmHg|Mean|79.5|79.5|Standard Deviation|9.5|9.5|||
3786724|NCT01859598|3616427|B1|||Systolic Blood Pressure (SBP)||mmHg|Mean|130.1|130.1|Standard Deviation|16.0|16.0|||
3786725|NCT01859598|3616427|B1|no||Complication||participants|Number|12251|12251.0||||||
3786726|NCT01859598|3616427|B1|yes||Complication||participants|Number|6744|6744.0||||||
3786727|NCT01859598|3616427|B1|College or higher||Education||participants|Number|3258|3258.0||||||
3786728|NCT01859598|3616427|B1|High school||Education||participants|Number|10583|10583.0||||||
3786729|NCT01859598|3616427|B1|Primary school or illiterate||Education||participants|Number|5154|5154.0||||||
3786730|NCT01859598|3616427|B1|||Duration of Diabetes||years|Mean|6.4|6.4|Standard Deviation|5.3|5.3|||
3786731|NCT01859598|3616427|B1|||Fasting Plasma Glucose (FPG) level||mmol/L|Mean|11.7|11.7|Standard Deviation|4.0|4.0|||
3786732|NCT01859598|3616427|B1|||HbA1c level||%|Mean|9.6|9.6|Standard Deviation|2.0|2.0|||
3786733|NCT01859598|3616427|B1|China||Region of Enrollment||participants|Number|18995|18995.0||||||
3786734|NCT01859598|3616427|B1||Male|Sex: Female, Male||Participants|Count of Participants|9968|9968.0||||||
3786735|NCT01859598|3616427|B1||Female|Sex: Female, Male||Participants|Count of Participants|9027|9027.0||||||
3786736|NCT01859598|3616427|B1|||Age||year|Mean|55.4|55.4|Standard Deviation|10.4|10.4|||
3786737|NCT01859507|3616435|B1|Egypt||Region of Enrollment||participants|Number|28|28.0||||||
3786738|NCT01859507|3616435|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3786739|NCT01859507|3616435|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3786740|NCT01859507|3616435|B1|||Age||years|Mean|29.25|29.25|Standard Deviation|4.85|4.85|||
3786741|NCT01859494|3616440|B1|United States||Region of Enrollment||participants|Number|221|221.0||||||
3786742|NCT01859494|3616440|B1|Unknown or Not Reported||Race/Ethnicity, Customized|Subjects provided more than one choice for Race, therefore the apparent frequency total for Race was different from the number of subjects.|participants|Number|5|5.0||||||
3786743|NCT01859494|3616440|B1|More than one race||Race/Ethnicity, Customized|Subjects provided more than one choice for Race, therefore the apparent frequency total for Race was different from the number of subjects.|participants|Number|3|3.0||||||
3786744|NCT01859494|3616440|B1|White||Race/Ethnicity, Customized|Subjects provided more than one choice for Race, therefore the apparent frequency total for Race was different from the number of subjects.|participants|Number|194|194.0||||||
3786745|NCT01859494|3616440|B1|Black or African American||Race/Ethnicity, Customized|Subjects provided more than one choice for Race, therefore the apparent frequency total for Race was different from the number of subjects.|participants|Number|10|10.0||||||
3786746|NCT01859494|3616440|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Subjects provided more than one choice for Race, therefore the apparent frequency total for Race was different from the number of subjects.|participants|Number|2|2.0||||||
3786747|NCT01859494|3616440|B1|Asian||Race/Ethnicity, Customized|Subjects provided more than one choice for Race, therefore the apparent frequency total for Race was different from the number of subjects.|participants|Number|9|9.0||||||
3786748|NCT01859494|3616440|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Subjects provided more than one choice for Race, therefore the apparent frequency total for Race was different from the number of subjects.|participants|Number|4|4.0||||||
3786749|NCT01859494|3616440|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3786750|NCT01859494|3616440|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|197|197.0||||||
3786751|NCT01859494|3616440|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3786752|NCT01859494|3616440|B1||Male|Gender||Participants|Count of Participants|113|113.0||||||
3786753|NCT01859494|3616440|B1||Female|Gender||Participants|Count of Participants|108|108.0||||||
3786754|NCT01859494|3616440|B1|||Age||years|Mean|51.8|51.8|Full Range|||18.0|95.0|
3786755|NCT01859390|3616449|B3||Not Identified|Cystic Fibrosis (CF) Genotype||Participants|Count of Participants|1|1.0||||||
3786756|NCT01859390|3616450|B2||Not Identified|Cystic Fibrosis (CF) Genotype||Participants|Count of Participants|0|0.0||||||
3786757|NCT01859390|3616451|B1||Not Identified|Cystic Fibrosis (CF) Genotype||Participants|Count of Participants|1|1.0||||||
3786758|NCT01859390|3616449|B3||Other|Cystic Fibrosis (CF) Genotype||Participants|Count of Participants|6|6.0||||||
3786759|NCT01859390|3616450|B2||Other|Cystic Fibrosis (CF) Genotype||Participants|Count of Participants|3|3.0||||||
3786760|NCT01859390|3616451|B1||Other|Cystic Fibrosis (CF) Genotype||Participants|Count of Participants|3|3.0||||||
3786761|NCT01859390|3616449|B3||Delta F508 Heterozygous|Cystic Fibrosis (CF) Genotype||Participants|Count of Participants|27|27.0||||||
3786762|NCT01859390|3616450|B2||Delta F508 Heterozygous|Cystic Fibrosis (CF) Genotype||Participants|Count of Participants|18|18.0||||||
3786763|NCT01859390|3616451|B1||Delta F508 Heterozygous|Cystic Fibrosis (CF) Genotype||Participants|Count of Participants|9|9.0||||||
3786764|NCT01859390|3616449|B3||Delta F508 Homozygous|Cystic Fibrosis (CF) Genotype||Participants|Count of Participants|39|39.0||||||
3786765|NCT01859390|3616450|B2||Delta F508 Homozygous|Cystic Fibrosis (CF) Genotype||Participants|Count of Participants|16|16.0||||||
3786766|NCT01859390|3616451|B1||Delta F508 Homozygous|Cystic Fibrosis (CF) Genotype||Participants|Count of Participants|23|23.0||||||
3786767|NCT01859390|3616449|B3|Race/Ethnicity|Unknown/Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3786768|NCT01859390|3616450|B2|Race/Ethnicity|Unknown/Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3786769|NCT01859390|3616451|B1|Race/Ethnicity|Unknown/Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3786770|NCT01859390|3616449|B3|Race/Ethnicity|African-American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3786771|NCT01859390|3616450|B2|Race/Ethnicity|African-American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3786772|NCT01859390|3616451|B1|Race/Ethnicity|African-American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3786773|NCT01859390|3616449|B3|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3786774|NCT01859390|3616450|B2|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3786775|NCT01859390|3616451|B1|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3786776|NCT01859390|3616449|B3|Race/Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|64|64.0||||||
3786777|NCT01859390|3616450|B2|Race/Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3786778|NCT01859390|3616451|B1|Race/Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3786779|NCT01859390|3616449|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3786780|NCT01859390|3616450|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3786781|NCT01859390|3616451|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3786782|NCT01859390|3616449|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3786783|NCT01859390|3616450|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3786784|NCT01859390|3616451|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3786785|NCT01859390|3616449|B3|Age >30 yrs||Age, Customized|Age Category (10-18 years, 18-30 years, 30+ years)|Participants|Count of Participants|16|16.0||||||
3786786|NCT01859390|3616450|B2|Age >30 yrs||Age, Customized|Age Category (10-18 years, 18-30 years, 30+ years)|Participants|Count of Participants|10|10.0||||||
3786787|NCT01859390|3616451|B1|Age >30 yrs||Age, Customized|Age Category (10-18 years, 18-30 years, 30+ years)|Participants|Count of Participants|6|6.0||||||
3786788|NCT01859390|3616449|B3|Age >=18 - <30 yrs||Age, Customized|Age Category (10-18 years, 18-30 years, 30+ years)|Participants|Count of Participants|28|28.0||||||
3786789|NCT01859390|3616450|B2|Age >=18 - <30 yrs||Age, Customized|Age Category (10-18 years, 18-30 years, 30+ years)|Participants|Count of Participants|11|11.0||||||
3786790|NCT01859390|3616451|B1|Age >=18 - <30 yrs||Age, Customized|Age Category (10-18 years, 18-30 years, 30+ years)|Participants|Count of Participants|17|17.0||||||
3786791|NCT01859390|3616449|B3|Age >=10 - <18 yrs||Age, Customized|Age Category (10-18 years, 18-30 years, 30+ years)|Participants|Count of Participants|29|29.0||||||
3786792|NCT01859390|3616450|B2|Age >=10 - <18 yrs||Age, Customized|Age Category (10-18 years, 18-30 years, 30+ years)|Participants|Count of Participants|16|16.0||||||
3786793|NCT01859390|3616451|B1|Age >=10 - <18 yrs||Age, Customized|Age Category (10-18 years, 18-30 years, 30+ years)|Participants|Count of Participants|13|13.0||||||
3786794|NCT01859390|3616449|B3|||Age||years|Mean|22.6|22.6|Standard Deviation|9.1|9.1|||
3786795|NCT01859390|3616450|B2|||Age||years|Mean|22.9|22.9|Standard Deviation|9.5|9.5|||
3786796|NCT01859390|3616451|B1|||Age||years|Mean|22.3|22.3|Standard Deviation|8.9|8.9|||
3786797|NCT01859325|3616474|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3786798|NCT01859325|3616475|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786799|NCT01859325|3616476|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3786800|NCT01859325|3616474|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3786801|NCT01859325|3616475|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3786802|NCT01859325|3616476|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3786803|NCT01859325|3616474|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3786804|NCT01859325|3616475|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3786805|NCT01859325|3616476|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3786806|NCT01859325|3616474|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3786807|NCT01859325|3616475|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3786808|NCT01859325|3616476|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786809|NCT01859325|3616474|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786810|NCT01859325|3616475|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786811|NCT01859325|3616476|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786812|NCT01859325|3616474|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3786813|NCT01859325|3616475|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3786814|NCT01859325|3616476|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3786815|NCT01859325|3616474|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786816|NCT01859325|3616475|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786817|NCT01859325|3616476|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786818|NCT01859325|3616474|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3786819|NCT01859325|3616475|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786820|NCT01859325|3616476|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3786821|NCT01859325|3616474|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3786822|NCT01859325|3616475|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3786823|NCT01859325|3616476|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3786824|NCT01859325|3616474|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3786825|NCT01859325|3616475|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3786826|NCT01859325|3616476|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3786827|NCT01859325|3616474|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3786828|NCT01859325|3616475|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3786829|NCT01859325|3616476|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3786830|NCT01859325|3616474|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3786831|NCT01859325|3616475|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3786832|NCT01859325|3616476|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3786833|NCT01859325|3616474|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3786834|NCT01859325|3616475|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3786835|NCT01859325|3616476|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786836|NCT01859325|3616474|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3786837|NCT01859325|3616475|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3786838|NCT01859325|3616476|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3786839|NCT01859325|3616474|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3786840|NCT01859325|3616475|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3786841|NCT01859325|3616476|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3786842|NCT01859312|3616486|B1||Salt-wasting (SW)|Phenotype||Participants|Count of Participants|6|6.0||||||
3786843|NCT01859312|3616486|B1||Simple Virilizing (SV)|Phenotype||Participants|Count of Participants|2|2.0||||||
3786844|NCT01859312|3616486|B1|Canada||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3786845|NCT01859312|3616486|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3786846|NCT01859312|3616486|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786847|NCT01859312|3616486|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786848|NCT01859312|3616486|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3786849|NCT01859312|3616486|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786850|NCT01859312|3616486|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786851|NCT01859312|3616486|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786852|NCT01859312|3616486|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786853|NCT01859312|3616486|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786854|NCT01859312|3616486|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3786855|NCT01859312|3616486|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786856|NCT01859312|3616486|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3786857|NCT01859312|3616486|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3786858|NCT01859312|3616486|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786859|NCT01859312|3616486|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3786860|NCT01859312|3616486|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3786861|NCT01859247|3616533|B9|||Cortical Silent Period (CSP)||milliseconds|Mean|105.03|105.03|Full Range|||76.24|169.1|
3786862|NCT01859247|3616534|B8|||Cortical Silent Period (CSP)||milliseconds|Mean|99.76|99.76|Full Range|||99.76|99.76|
3786863|NCT01859247|3616535|B7|||Cortical Silent Period (CSP)||milliseconds|Mean|113.16|113.16|Full Range|||113.16|113.16|
3786864|NCT01859247|3616536|B6|||Cortical Silent Period (CSP)||milliseconds|Mean|76.24|76.24|Full Range|||76.24|76.24|
3786865|NCT01859247|3616537|B5|||Cortical Silent Period (CSP)||milliseconds|Mean|136.92|136.92|Full Range|||136.92|136.92|
3786866|NCT01859247|3616538|B4|||Cortical Silent Period (CSP)||milliseconds|Mean|78.10|78.1|Full Range|||78.1|78.1|
3786867|NCT01859247|3616539|B3|||Cortical Silent Period (CSP)||milliseconds|Mean|133.28|133.28|Full Range|||133.28|133.28|
3786868|NCT01859247|3616540|B2|||Cortical Silent Period (CSP)||milliseconds|Mean|153.70|153.7|Full Range|||153.7|153.7|
3786869|NCT01859247|3616541|B1|||Cortical Silent Period (CSP)||milliseconds|Mean|169.10|169.1|Full Range|||169.1|169.1|
3786870|NCT01859247|3616533|B9|||Dorsal Premotor-Motor Cortical Inhibition (DPMi)||Percentage|Mean|NA||Full Range|||0.0|0.0|Total not calculated because data are not available (NA) in one or more arms.
3786871|NCT01859247|3616534|B8|||Dorsal Premotor-Motor Cortical Inhibition (DPMi)||Percentage|Mean|72.30|72.3|Full Range|||72.3|72.3|
3786872|NCT01859247|3616535|B7|||Dorsal Premotor-Motor Cortical Inhibition (DPMi)||Percentage|Mean|67.80|67.8|Full Range|||67.8|67.8|
3786873|NCT01859247|3616536|B6|||Dorsal Premotor-Motor Cortical Inhibition (DPMi)||Percentage|Mean|NA||Full Range|||0.0|0.0|Pre-DPMI not obtained
3786874|NCT01859247|3616537|B5|||Dorsal Premotor-Motor Cortical Inhibition (DPMi)||Percentage|Mean|NA||Full Range|||0.0|0.0|Pre-DPMI not obtained
3786875|NCT01859247|3616538|B4|||Dorsal Premotor-Motor Cortical Inhibition (DPMi)||Percentage|Mean|71.60|71.6|Full Range|||71.6|71.6|
3786876|NCT01859247|3616539|B3|||Dorsal Premotor-Motor Cortical Inhibition (DPMi)||Percentage|Mean|68.10|68.1|Full Range|||68.1|68.1|
3786877|NCT01859247|3616540|B2|||Dorsal Premotor-Motor Cortical Inhibition (DPMi)||Percentage|Mean|127.50|127.5|Full Range|||127.5|127.5|
3786878|NCT01859247|3616541|B1|||Dorsal Premotor-Motor Cortical Inhibition (DPMi)||Percentage|Mean|213|213.0|Full Range|||213.0|213.0|
3786879|NCT01859247|3616533|B9|||TWSTRS Severity (Toronto Western Spasmodic Torticollis Rating Scale)|Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) was used to assess severity of disease. The score for this section ranges from 0 (absence of severity) to 35 (maximum severity).|units on a scale|Mean|15|15.0|Full Range|||8.0|20.0|
3786880|NCT01859247|3616534|B8|||TWSTRS Severity (Toronto Western Spasmodic Torticollis Rating Scale)|Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) was used to assess severity of disease. The score for this section ranges from 0 (absence of severity) to 35 (maximum severity).|units on a scale|Mean|16|16.0|Full Range|||16.0|16.0|
3786881|NCT01859247|3616535|B7|||TWSTRS Severity (Toronto Western Spasmodic Torticollis Rating Scale)|Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) was used to assess severity of disease. The score for this section ranges from 0 (absence of severity) to 35 (maximum severity).|units on a scale|Mean|12|12.0|Full Range|||12.0|12.0|
3786882|NCT01859247|3616536|B6|||TWSTRS Severity (Toronto Western Spasmodic Torticollis Rating Scale)|Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) was used to assess severity of disease. The score for this section ranges from 0 (absence of severity) to 35 (maximum severity).|units on a scale|Mean|20|20.0|Full Range|||20.0|20.0|
3786883|NCT01859247|3616537|B5|||TWSTRS Severity (Toronto Western Spasmodic Torticollis Rating Scale)|Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) was used to assess severity of disease. The score for this section ranges from 0 (absence of severity) to 35 (maximum severity).|units on a scale|Mean|21|21.0|Full Range|||21.0|21.0|
3786884|NCT01859247|3616538|B4|||TWSTRS Severity (Toronto Western Spasmodic Torticollis Rating Scale)|Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) was used to assess severity of disease. The score for this section ranges from 0 (absence of severity) to 35 (maximum severity).|units on a scale|Mean|14|14.0|Full Range|||14.0|14.0|
3786885|NCT01859247|3616539|B3|||TWSTRS Severity (Toronto Western Spasmodic Torticollis Rating Scale)|Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) was used to assess severity of disease. The score for this section ranges from 0 (absence of severity) to 35 (maximum severity).|units on a scale|Mean|8|8.0|Full Range|||8.0|8.0|
3786886|NCT01859247|3616540|B2|||TWSTRS Severity (Toronto Western Spasmodic Torticollis Rating Scale)|Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) was used to assess severity of disease. The score for this section ranges from 0 (absence of severity) to 35 (maximum severity).|units on a scale|Mean|9|9.0|Full Range|||9.0|9.0|
3786887|NCT01859247|3616541|B1|||TWSTRS Severity (Toronto Western Spasmodic Torticollis Rating Scale)|Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) was used to assess severity of disease. The score for this section ranges from 0 (absence of severity) to 35 (maximum severity).|units on a scale|Mean|20|20.0|Full Range|||20.0|20.0|
3786888|NCT01859247|3616533|B9|United States||Region of Enrollment||participants|Number|8|8.0||||||
3786889|NCT01859247|3616534|B8|United States||Region of Enrollment||participants|Number|1|1.0||||||
3786890|NCT01859247|3616535|B7|United States||Region of Enrollment||participants|Number|1|1.0||||||
3786891|NCT01859247|3616536|B6|United States||Region of Enrollment||participants|Number|1|1.0||||||
3786892|NCT01859247|3616537|B5|United States||Region of Enrollment||participants|Number|1|1.0||||||
3786893|NCT01859247|3616538|B4|United States||Region of Enrollment||participants|Number|1|1.0||||||
3786894|NCT01859247|3616539|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3786895|NCT01859247|3616540|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3786896|NCT01859247|3616541|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3786897|NCT01859247|3616533|B9||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3786898|NCT01859247|3616534|B8||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3786899|NCT01859247|3616535|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3786900|NCT01859247|3616536|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3786901|NCT01859247|3616537|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3786902|NCT01859247|3616538|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3786903|NCT01859247|3616539|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3786904|NCT01859247|3616540|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3786905|NCT01859247|3616541|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3786906|NCT01859247|3616533|B9||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3786907|NCT01859247|3616534|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3786908|NCT01859247|3616535|B7||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3786909|NCT01859247|3616536|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3786910|NCT01859247|3616537|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3786911|NCT01859247|3616538|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3786912|NCT01859247|3616539|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3786913|NCT01859247|3616540|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3786914|NCT01859247|3616541|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3786915|NCT01859247|3616533|B9|||Age||years|Mean|53|53.0|Full Range|||31.0|72.0|
3786916|NCT01859247|3616534|B8|||Age||years|Mean|72|72.0|Full Range|||72.0|72.0|
3786917|NCT01859247|3616535|B7|||Age||years|Mean|65|65.0|Full Range|||65.0|65.0|
3786918|NCT01859247|3616536|B6|||Age||years|Mean|41|41.0|Full Range|||41.0|41.0|
3786919|NCT01859247|3616537|B5|||Age||years|Mean|55|55.0|Full Range|||55.0|55.0|
3786920|NCT01859247|3616538|B4|||Age||years|Mean|31|31.0|Full Range|||31.0|31.0|
3786921|NCT01859247|3616539|B3|||Age||years|Mean|67|67.0|Full Range|||67.0|67.0|
3786922|NCT01859247|3616540|B2|||Age||years|Mean|60|60.0|Full Range|||60.0|60.0|
3786923|NCT01859247|3616541|B1|||Age||years|Mean|33|33.0|Full Range|||33.0|33.0|
3786924|NCT01859195|3616573|B3|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3786925|NCT01859195|3616574|B2|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3786926|NCT01859195|3616575|B1|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3786927|NCT01859195|3616573|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3786928|NCT01859195|3616574|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786929|NCT01859195|3616575|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3786930|NCT01859195|3616573|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3786931|NCT01859195|3616574|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3786932|NCT01859195|3616575|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3786933|NCT01859195|3616573|B3||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3786934|NCT01859195|3616574|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3786935|NCT01859195|3616575|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3786936|NCT01859195|3616573|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3786937|NCT01859195|3616574|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3786938|NCT01859195|3616575|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3786939|NCT01859195|3616573|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786940|NCT01859195|3616574|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786941|NCT01859195|3616575|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786942|NCT01859195|3616573|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786943|NCT01859195|3616574|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786944|NCT01859195|3616575|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786945|NCT01859195|3616573|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786946|NCT01859195|3616574|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786947|NCT01859195|3616575|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786948|NCT01859195|3616573|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786949|NCT01859195|3616574|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786950|NCT01859195|3616575|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786951|NCT01859195|3616573|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3786952|NCT01859195|3616574|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3786953|NCT01859195|3616575|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3786954|NCT01859195|3616573|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3786955|NCT01859195|3616574|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3786956|NCT01859195|3616575|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3786957|NCT01859195|3616573|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3786958|NCT01859195|3616574|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3786959|NCT01859195|3616575|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3786960|NCT01859195|3616573|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3786961|NCT01859195|3616574|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3786962|NCT01859195|3616575|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3786963|NCT01859195|3616573|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786964|NCT01859195|3616574|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786965|NCT01859195|3616575|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3786966|NCT01859195|3616573|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3786967|NCT01859195|3616574|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3786968|NCT01859195|3616575|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3786969|NCT01859195|3616573|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3786970|NCT01859195|3616574|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3786971|NCT01859195|3616575|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3786972|NCT01859143|3616584|B3||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3786973|NCT01859143|3616585|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3786974|NCT01859143|3616586|B1||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3786975|NCT01859143|3616584|B3||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3786976|NCT01859143|3616585|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3786977|NCT01859143|3616586|B1||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3786978|NCT01859143|3616584|B3|||Age||years|Mean|33.2|33.2|Standard Deviation|9.3|9.3|||
3786979|NCT01859143|3616585|B2|||Age||years|Mean|33.6|33.6|Standard Deviation|9.0|9.0|||
3786980|NCT01859143|3616586|B1|||Age||years|Mean|33.1|33.1|Standard Deviation|9.4|9.4|||
3786981|NCT01859078|3616601|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3786982|NCT01859078|3616601|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786983|NCT01859078|3616601|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3786984|NCT01859078|3616601|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3786985|NCT01859078|3616601|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786986|NCT01859078|3616601|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786987|NCT01859078|3616601|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3786988|NCT01859078|3616601|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786989|NCT01859078|3616601|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786990|NCT01859078|3616601|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3786991|NCT01859078|3616601|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3786992|NCT01859078|3616601|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3786993|NCT01859078|3616601|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3786994|NCT01859078|3616601|B1|||Age||years|Mean|33.4|33.4|Standard Deviation|11.3|11.3|||
3786995|NCT01859013|3616615|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3786996|NCT01859013|3616616|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3786997|NCT01859013|3616617|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3786998|NCT01859013|3616615|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3786999|NCT01859013|3616616|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3787000|NCT01859013|3616617|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3787001|NCT01859013|3616615|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3787002|NCT01859013|3616616|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3787003|NCT01859013|3616617|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3787004|NCT01859013|3616615|B3|||Age||years|Mean|15.2|15.2|Standard Deviation|1.7|1.7|||
3787005|NCT01859013|3616616|B2|||Age||years|Mean|15.7|15.7|Standard Deviation|1.8|1.8|||
3787006|NCT01859013|3616617|B1|||Age||years|Mean|14.9|14.9|Standard Deviation|1.6|1.6|||
3787007|NCT01859013|3616615|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3787008|NCT01859013|3616616|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3787009|NCT01859013|3616617|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3787010|NCT01859013|3616615|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3787011|NCT01859013|3616616|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3787012|NCT01859013|3616617|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3787013|NCT01859013|3616615|B3||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
3787014|NCT01859013|3616616|B2||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
3787015|NCT01859013|3616617|B1||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
3787016|NCT01858766|3616624|B20|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|303|303.0||||||
3787017|NCT01858766|3616625|B19|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|24|24.0||||||
3787018|NCT01858766|3616626|B18|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|21|21.0||||||
3787019|NCT01858766|3616627|B17|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|21|21.0||||||
3787020|NCT01858766|3616628|B16|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|20|20.0||||||
3787021|NCT01858766|3616629|B15|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|28|28.0||||||
3787022|NCT01858766|3616630|B14|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|21|21.0||||||
3787023|NCT01858766|3616631|B13|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|25|25.0||||||
3787024|NCT01858766|3616632|B12|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|25|25.0||||||
3787025|NCT01858766|3616633|B11|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|4|4.0||||||
3787026|NCT01858766|3616634|B10|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|3|3.0||||||
3787027|NCT01858766|3616635|B9|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|1|1.0||||||
3787028|NCT01858766|3616636|B8|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|3|3.0||||||
3787029|NCT01858766|3616637|B7|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|5|5.0||||||
3787030|NCT01858766|3616638|B6|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|21|21.0||||||
3787031|NCT01858766|3616639|B5|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|18|18.0||||||
3787032|NCT01858766|3616640|B4|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|9|9.0||||||
3787033|NCT01858766|3616641|B3|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|9|9.0||||||
3787034|NCT01858766|3616642|B2|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|22|22.0||||||
3787035|NCT01858766|3616643|B1|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|23|23.0||||||
3787036|NCT01858766|3616624|B20|< 800,000 IU/mL||HCV RNA Category||participants|Number|74|74.0||||||
3787037|NCT01858766|3616625|B19|< 800,000 IU/mL||HCV RNA Category||participants|Number|2|2.0||||||
3787038|NCT01858766|3616626|B18|< 800,000 IU/mL||HCV RNA Category||participants|Number|5|5.0||||||
3787039|NCT01858766|3616627|B17|< 800,000 IU/mL||HCV RNA Category||participants|Number|4|4.0||||||
3787040|NCT01858766|3616628|B16|< 800,000 IU/mL||HCV RNA Category||participants|Number|6|6.0||||||
3787041|NCT01858766|3616629|B15|< 800,000 IU/mL||HCV RNA Category||participants|Number|3|3.0||||||
3787042|NCT01858766|3616630|B14|< 800,000 IU/mL||HCV RNA Category||participants|Number|8|8.0||||||
3787043|NCT01858766|3616631|B13|< 800,000 IU/mL||HCV RNA Category||participants|Number|5|5.0||||||
3787044|NCT01858766|3616632|B12|< 800,000 IU/mL||HCV RNA Category||participants|Number|5|5.0||||||
3787045|NCT01858766|3616633|B11|< 800,000 IU/mL||HCV RNA Category||participants|Number|1|1.0||||||
3787046|NCT01858766|3616634|B10|< 800,000 IU/mL||HCV RNA Category||participants|Number|1|1.0||||||
3787047|NCT01858766|3616635|B9|< 800,000 IU/mL||HCV RNA Category||participants|Number|0|0.0||||||
3787048|NCT01858766|3616636|B8|< 800,000 IU/mL||HCV RNA Category||participants|Number|4|4.0||||||
3787049|NCT01858766|3616637|B7|< 800,000 IU/mL||HCV RNA Category||participants|Number|2|2.0||||||
3787050|NCT01858766|3616638|B6|< 800,000 IU/mL||HCV RNA Category||participants|Number|6|6.0||||||
3787051|NCT01858766|3616639|B5|< 800,000 IU/mL||HCV RNA Category||participants|Number|9|9.0||||||
3787052|NCT01858766|3616640|B4|< 800,000 IU/mL||HCV RNA Category||participants|Number|1|1.0||||||
3787053|NCT01858766|3616641|B3|< 800,000 IU/mL||HCV RNA Category||participants|Number|2|2.0||||||
3787054|NCT01858766|3616642|B2|< 800,000 IU/mL||HCV RNA Category||participants|Number|6|6.0||||||
3787055|NCT01858766|3616643|B1|< 800,000 IU/mL||HCV RNA Category||participants|Number|4|4.0||||||
3787056|NCT01858766|3616624|B20|||HCV RNA||log10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.75|0.75|||
3787057|NCT01858766|3616625|B19|||HCV RNA||log10 IU/mL|Mean|6.7|6.7|Standard Deviation|0.57|0.57|||
3787058|NCT01858766|3616626|B18|||HCV RNA||log10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.74|0.74|||
3787059|NCT01858766|3616627|B17|||HCV RNA||log10 IU/mL|Mean|6.6|6.6|Standard Deviation|0.80|0.8|||
3787060|NCT01858766|3616628|B16|||HCV RNA||log10 IU/mL|Mean|6.4|6.4|Standard Deviation|0.87|0.87|||
3787061|NCT01858766|3616629|B15|||HCV RNA||log10 IU/mL|Mean|6.6|6.6|Standard Deviation|0.55|0.55|||
3787062|NCT01858766|3616630|B14|||HCV RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.85|0.85|||
3787063|NCT01858766|3616631|B13|||HCV RNA||log10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.63|0.63|||
3787064|NCT01858766|3616632|B12|||HCV RNA||log10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.69|0.69|||
3787065|NCT01858766|3616633|B11|||HCV RNA||log10 IU/mL|Mean|6.7|6.7|Standard Deviation|0.88|0.88|||
3787066|NCT01858766|3616634|B10|||HCV RNA||log10 IU/mL|Mean|6.1|6.1|Standard Deviation|0.89|0.89|||
3787067|NCT01858766|3616635|B9|||HCV RNA||log10 IU/mL|Mean|7.0|7.0|Standard Deviation|NA||||N/A because there is only 1 participant in this group.
3787068|NCT01858766|3616636|B8|||HCV RNA||log10 IU/mL|Mean|5.8|5.8|Standard Deviation|0.55|0.55|||
3787069|NCT01858766|3616637|B7|||HCV RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.58|0.58|||
3787070|NCT01858766|3616638|B6|||HCV RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.74|0.74|||
3787071|NCT01858766|3616639|B5|||HCV RNA||log10 IU/mL|Mean|6.4|6.4|Standard Deviation|1.09|1.09|||
3787072|NCT01858766|3616640|B4|||HCV RNA||log10 IU/mL|Mean|6.7|6.7|Standard Deviation|0.78|0.78|||
3787073|NCT01858766|3616641|B3|||HCV RNA||log10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.74|0.74|||
3787074|NCT01858766|3616642|B2|||HCV RNA||log10 IU/mL|Mean|6.4|6.4|Standard Deviation|0.74|0.74|||
3787075|NCT01858766|3616643|B1|||HCV RNA||log10 IU/mL|Mean|6.4|6.4|Standard Deviation|0.60|0.6|||
3787076|NCT01858766|3616624|B20|Missing||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
3787077|NCT01858766|3616625|B19|Missing||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|2|2.0||||||
3787078|NCT01858766|3616626|B18|Missing||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3787079|NCT01858766|3616627|B17|Missing||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3787080|NCT01858766|3616628|B16|Missing||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3787081|NCT01858766|3616629|B15|Missing||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3787082|NCT01858766|3616630|B14|Missing||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3787083|NCT01858766|3616631|B13|Missing||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3787084|NCT01858766|3616632|B12|Missing||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3787085|NCT01858766|3616633|B11|Missing||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3787190|NCT01858766|3616638|B6|Genotype 5||HCV Genotype||participants|Number|0|0.0||||||
3787086|NCT01858766|3616634|B10|Missing||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3787087|NCT01858766|3616635|B9|Missing||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3787088|NCT01858766|3616636|B8|Missing||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3787089|NCT01858766|3616637|B7|Missing||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3787090|NCT01858766|3616638|B6|Missing||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3787091|NCT01858766|3616639|B5|Missing||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3787092|NCT01858766|3616640|B4|Missing||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3787093|NCT01858766|3616641|B3|Missing||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3787094|NCT01858766|3616642|B2|Missing||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3787095|NCT01858766|3616643|B1|Missing||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3787096|NCT01858766|3616624|B20|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|43|43.0||||||
3787097|NCT01858766|3616625|B19|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
3787098|NCT01858766|3616626|B18|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
3787099|NCT01858766|3616627|B17|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
3787100|NCT01858766|3616628|B16|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
3787101|NCT01858766|3616629|B15|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|4|4.0||||||
3787102|NCT01858766|3616630|B14|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
3787103|NCT01858766|3616631|B13|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|4|4.0||||||
3787104|NCT01858766|3616632|B12|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|7|7.0||||||
3787105|NCT01858766|3616633|B11|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3787106|NCT01858766|3616634|B10|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3787107|NCT01858766|3616635|B9|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3787108|NCT01858766|3616636|B8|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
3787109|NCT01858766|3616637|B7|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3787110|NCT01858766|3616638|B6|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3787111|NCT01858766|3616639|B5|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|2|2.0||||||
3787112|NCT01858766|3616640|B4|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3787113|NCT01858766|3616641|B3|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|2|2.0||||||
3787114|NCT01858766|3616642|B2|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|2|2.0||||||
3787115|NCT01858766|3616643|B1|TT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
3787116|NCT01858766|3616624|B20|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|196|196.0||||||
3787117|NCT01858766|3616625|B19|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|14|14.0||||||
3787118|NCT01858766|3616626|B18|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|14|14.0||||||
3787119|NCT01858766|3616627|B17|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|9|9.0||||||
3787120|NCT01858766|3616628|B16|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|14|14.0||||||
3787121|NCT01858766|3616629|B15|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|18|18.0||||||
3787122|NCT01858766|3616630|B14|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|13|13.0||||||
3787123|NCT01858766|3616631|B13|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|16|16.0||||||
3787124|NCT01858766|3616632|B12|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|14|14.0||||||
3787125|NCT01858766|3616633|B11|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3787126|NCT01858766|3616634|B10|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
3787127|NCT01858766|3616635|B9|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3787128|NCT01858766|3616636|B8|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|2|2.0||||||
3787129|NCT01858766|3616637|B7|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|5|5.0||||||
3787130|NCT01858766|3616638|B6|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|12|12.0||||||
3787131|NCT01858766|3616639|B5|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|13|13.0||||||
3787132|NCT01858766|3616640|B4|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|8|8.0||||||
3787133|NCT01858766|3616641|B3|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|8|8.0||||||
3787134|NCT01858766|3616642|B2|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|17|17.0||||||
3787135|NCT01858766|3616643|B1|CT||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|16|16.0||||||
3787136|NCT01858766|3616624|B20|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|135|135.0||||||
3787137|NCT01858766|3616625|B19|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|7|7.0||||||
3787138|NCT01858766|3616626|B18|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|9|9.0||||||
3787139|NCT01858766|3616627|B17|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|13|13.0||||||
3787140|NCT01858766|3616628|B16|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|9|9.0||||||
3787141|NCT01858766|3616629|B15|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|9|9.0||||||
3787142|NCT01858766|3616630|B14|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|13|13.0||||||
3787143|NCT01858766|3616631|B13|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|10|10.0||||||
3787144|NCT01858766|3616632|B12|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|9|9.0||||||
3787145|NCT01858766|3616633|B11|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|5|5.0||||||
3787146|NCT01858766|3616634|B10|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3787147|NCT01858766|3616635|B9|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3787148|NCT01858766|3616636|B8|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|2|2.0||||||
3787149|NCT01858766|3616637|B7|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|2|2.0||||||
3787150|NCT01858766|3616638|B6|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|13|13.0||||||
3787151|NCT01858766|3616639|B5|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|12|12.0||||||
3787152|NCT01858766|3616640|B4|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|2|2.0||||||
3787153|NCT01858766|3616641|B3|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3787154|NCT01858766|3616642|B2|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|9|9.0||||||
3787155|NCT01858766|3616643|B1|CC||IL28b Status|The CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|8|8.0||||||
3787156|NCT01858766|3616624|B20|Genotype 6||HCV Genotype||participants|Number|9|9.0||||||
3787157|NCT01858766|3616625|B19|Genotype 6||HCV Genotype||participants|Number|0|0.0||||||
3787158|NCT01858766|3616626|B18|Genotype 6||HCV Genotype||participants|Number|0|0.0||||||
3787159|NCT01858766|3616627|B17|Genotype 6||HCV Genotype||participants|Number|0|0.0||||||
3787160|NCT01858766|3616628|B16|Genotype 6||HCV Genotype||participants|Number|0|0.0||||||
3787161|NCT01858766|3616629|B15|Genotype 6||HCV Genotype||participants|Number|0|0.0||||||
3787162|NCT01858766|3616630|B14|Genotype 6||HCV Genotype||participants|Number|0|0.0||||||
3787163|NCT01858766|3616631|B13|Genotype 6||HCV Genotype||participants|Number|0|0.0||||||
3787164|NCT01858766|3616632|B12|Genotype 6||HCV Genotype||participants|Number|0|0.0||||||
3787165|NCT01858766|3616633|B11|Genotype 6||HCV Genotype||participants|Number|5|5.0||||||
3787166|NCT01858766|3616634|B10|Genotype 6||HCV Genotype||participants|Number|4|4.0||||||
3787167|NCT01858766|3616635|B9|Genotype 6||HCV Genotype||participants|Number|0|0.0||||||
3787168|NCT01858766|3616636|B8|Genotype 6||HCV Genotype||participants|Number|0|0.0||||||
3787169|NCT01858766|3616637|B7|Genotype 6||HCV Genotype||participants|Number|0|0.0||||||
3787170|NCT01858766|3616638|B6|Genotype 6||HCV Genotype||participants|Number|0|0.0||||||
3787171|NCT01858766|3616639|B5|Genotype 6||HCV Genotype||participants|Number|0|0.0||||||
3787172|NCT01858766|3616640|B4|Genotype 6||HCV Genotype||participants|Number|0|0.0||||||
3787173|NCT01858766|3616641|B3|Genotype 6||HCV Genotype||participants|Number|0|0.0||||||
3787174|NCT01858766|3616642|B2|Genotype 6||HCV Genotype||participants|Number|0|0.0||||||
3787175|NCT01858766|3616643|B1|Genotype 6||HCV Genotype||participants|Number|0|0.0||||||
3787176|NCT01858766|3616624|B20|Genotype 5||HCV Genotype||participants|Number|1|1.0||||||
3787177|NCT01858766|3616625|B19|Genotype 5||HCV Genotype||participants|Number|0|0.0||||||
3787178|NCT01858766|3616626|B18|Genotype 5||HCV Genotype||participants|Number|0|0.0||||||
3787179|NCT01858766|3616627|B17|Genotype 5||HCV Genotype||participants|Number|0|0.0||||||
3787180|NCT01858766|3616628|B16|Genotype 5||HCV Genotype||participants|Number|0|0.0||||||
3787181|NCT01858766|3616629|B15|Genotype 5||HCV Genotype||participants|Number|0|0.0||||||
3787182|NCT01858766|3616630|B14|Genotype 5||HCV Genotype||participants|Number|0|0.0||||||
3787183|NCT01858766|3616631|B13|Genotype 5||HCV Genotype||participants|Number|0|0.0||||||
3787184|NCT01858766|3616632|B12|Genotype 5||HCV Genotype||participants|Number|0|0.0||||||
3787185|NCT01858766|3616633|B11|Genotype 5||HCV Genotype||participants|Number|0|0.0||||||
3787186|NCT01858766|3616634|B10|Genotype 5||HCV Genotype||participants|Number|0|0.0||||||
3787187|NCT01858766|3616635|B9|Genotype 5||HCV Genotype||participants|Number|1|1.0||||||
3787188|NCT01858766|3616636|B8|Genotype 5||HCV Genotype||participants|Number|0|0.0||||||
3787189|NCT01858766|3616637|B7|Genotype 5||HCV Genotype||participants|Number|0|0.0||||||
3787191|NCT01858766|3616639|B5|Genotype 5||HCV Genotype||participants|Number|0|0.0||||||
3787192|NCT01858766|3616640|B4|Genotype 5||HCV Genotype||participants|Number|0|0.0||||||
3787193|NCT01858766|3616641|B3|Genotype 5||HCV Genotype||participants|Number|0|0.0||||||
3787194|NCT01858766|3616642|B2|Genotype 5||HCV Genotype||participants|Number|0|0.0||||||
3787195|NCT01858766|3616643|B1|Genotype 5||HCV Genotype||participants|Number|0|0.0||||||
3787196|NCT01858766|3616624|B20|Genotype 4||HCV Genotype||participants|Number|14|14.0||||||
3787197|NCT01858766|3616625|B19|Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3787198|NCT01858766|3616626|B18|Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3787199|NCT01858766|3616627|B17|Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3787200|NCT01858766|3616628|B16|Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3787201|NCT01858766|3616629|B15|Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3787202|NCT01858766|3616630|B14|Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3787203|NCT01858766|3616631|B13|Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3787204|NCT01858766|3616632|B12|Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3787205|NCT01858766|3616633|B11|Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3787206|NCT01858766|3616634|B10|Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3787207|NCT01858766|3616635|B9|Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3787208|NCT01858766|3616636|B8|Genotype 4||HCV Genotype||participants|Number|7|7.0||||||
3787209|NCT01858766|3616637|B7|Genotype 4||HCV Genotype||participants|Number|7|7.0||||||
3787210|NCT01858766|3616638|B6|Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3787211|NCT01858766|3616639|B5|Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3787212|NCT01858766|3616640|B4|Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3787213|NCT01858766|3616641|B3|Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3787214|NCT01858766|3616642|B2|Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3787215|NCT01858766|3616643|B1|Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3787216|NCT01858766|3616624|B20|Genotype 3||HCV Genotype||participants|Number|54|54.0||||||
3787217|NCT01858766|3616625|B19|Genotype 3||HCV Genotype||participants|Number|0|0.0||||||
3787218|NCT01858766|3616626|B18|Genotype 3||HCV Genotype||participants|Number|0|0.0||||||
3787219|NCT01858766|3616627|B17|Genotype 3||HCV Genotype||participants|Number|0|0.0||||||
3787220|NCT01858766|3616628|B16|Genotype 3||HCV Genotype||participants|Number|0|0.0||||||
3787221|NCT01858766|3616629|B15|Genotype 3||HCV Genotype||participants|Number|0|0.0||||||
3787222|NCT01858766|3616630|B14|Genotype 3||HCV Genotype||participants|Number|0|0.0||||||
3787223|NCT01858766|3616631|B13|Genotype 3||HCV Genotype||participants|Number|0|0.0||||||
3787224|NCT01858766|3616632|B12|Genotype 3||HCV Genotype||participants|Number|0|0.0||||||
3787225|NCT01858766|3616633|B11|Genotype 3||HCV Genotype||participants|Number|0|0.0||||||
3787226|NCT01858766|3616634|B10|Genotype 3||HCV Genotype||participants|Number|0|0.0||||||
3787227|NCT01858766|3616635|B9|Genotype 3||HCV Genotype||participants|Number|0|0.0||||||
3787228|NCT01858766|3616636|B8|Genotype 3||HCV Genotype||participants|Number|0|0.0||||||
3787229|NCT01858766|3616637|B7|Genotype 3||HCV Genotype||participants|Number|0|0.0||||||
3787230|NCT01858766|3616638|B6|Genotype 3||HCV Genotype||participants|Number|27|27.0||||||
3787231|NCT01858766|3616639|B5|Genotype 3||HCV Genotype||participants|Number|27|27.0||||||
3787232|NCT01858766|3616640|B4|Genotype 3||HCV Genotype||participants|Number|0|0.0||||||
3787233|NCT01858766|3616641|B3|Genotype 3||HCV Genotype||participants|Number|0|0.0||||||
3787234|NCT01858766|3616642|B2|Genotype 3||HCV Genotype||participants|Number|0|0.0||||||
3787235|NCT01858766|3616643|B1|Genotype 3||HCV Genotype||participants|Number|0|0.0||||||
3787236|NCT01858766|3616624|B20|Genotype 2||HCV Genotype||participants|Number|124|124.0||||||
3787237|NCT01858766|3616625|B19|Genotype 2||HCV Genotype||participants|Number|26|26.0||||||
3787238|NCT01858766|3616626|B18|Genotype 2||HCV Genotype||participants|Number|26|26.0||||||
3787239|NCT01858766|3616627|B17|Genotype 2||HCV Genotype||participants|Number|25|25.0||||||
3787240|NCT01858766|3616628|B16|Genotype 2||HCV Genotype||participants|Number|26|26.0||||||
3787241|NCT01858766|3616629|B15|Genotype 2||HCV Genotype||participants|Number|0|0.0||||||
3787242|NCT01858766|3616630|B14|Genotype 2||HCV Genotype||participants|Number|0|0.0||||||
3787243|NCT01858766|3616631|B13|Genotype 2||HCV Genotype||participants|Number|0|0.0||||||
3787244|NCT01858766|3616632|B12|Genotype 2||HCV Genotype||participants|Number|0|0.0||||||
3787245|NCT01858766|3616633|B11|Genotype 2||HCV Genotype||participants|Number|0|0.0||||||
3787246|NCT01858766|3616634|B10|Genotype 2||HCV Genotype||participants|Number|0|0.0||||||
3787247|NCT01858766|3616635|B9|Genotype 2||HCV Genotype||participants|Number|0|0.0||||||
3787248|NCT01858766|3616636|B8|Genotype 2||HCV Genotype||participants|Number|0|0.0||||||
3787249|NCT01858766|3616637|B7|Genotype 2||HCV Genotype||participants|Number|0|0.0||||||
3787250|NCT01858766|3616638|B6|Genotype 2||HCV Genotype||participants|Number|0|0.0||||||
3787251|NCT01858766|3616639|B5|Genotype 2||HCV Genotype||participants|Number|0|0.0||||||
3787252|NCT01858766|3616640|B4|Genotype 2||HCV Genotype||participants|Number|10|10.0||||||
3787253|NCT01858766|3616641|B3|Genotype 2||HCV Genotype||participants|Number|11|11.0||||||
3787254|NCT01858766|3616642|B2|Genotype 2||HCV Genotype||participants|Number|0|0.0||||||
3787255|NCT01858766|3616643|B1|Genotype 2||HCV Genotype||participants|Number|0|0.0||||||
3787256|NCT01858766|3616624|B20|Genotype 1g||HCV Genotype||participants|Number|1|1.0||||||
3787257|NCT01858766|3616625|B19|Genotype 1g||HCV Genotype||participants|Number|0|0.0||||||
3787258|NCT01858766|3616626|B18|Genotype 1g||HCV Genotype||participants|Number|0|0.0||||||
3787259|NCT01858766|3616627|B17|Genotype 1g||HCV Genotype||participants|Number|0|0.0||||||
3787260|NCT01858766|3616628|B16|Genotype 1g||HCV Genotype||participants|Number|0|0.0||||||
3787261|NCT01858766|3616629|B15|Genotype 1g||HCV Genotype||participants|Number|0|0.0||||||
3787262|NCT01858766|3616630|B14|Genotype 1g||HCV Genotype||participants|Number|0|0.0||||||
3787263|NCT01858766|3616631|B13|Genotype 1g||HCV Genotype||participants|Number|0|0.0||||||
3787264|NCT01858766|3616632|B12|Genotype 1g||HCV Genotype||participants|Number|0|0.0||||||
3787265|NCT01858766|3616633|B11|Genotype 1g||HCV Genotype||participants|Number|0|0.0||||||
3787266|NCT01858766|3616634|B10|Genotype 1g||HCV Genotype||participants|Number|0|0.0||||||
3787267|NCT01858766|3616635|B9|Genotype 1g||HCV Genotype||participants|Number|0|0.0||||||
3787268|NCT01858766|3616636|B8|Genotype 1g||HCV Genotype||participants|Number|0|0.0||||||
3787269|NCT01858766|3616637|B7|Genotype 1g||HCV Genotype||participants|Number|0|0.0||||||
3787270|NCT01858766|3616638|B6|Genotype 1g||HCV Genotype||participants|Number|0|0.0||||||
3787271|NCT01858766|3616639|B5|Genotype 1g||HCV Genotype||participants|Number|0|0.0||||||
3787272|NCT01858766|3616640|B4|Genotype 1g||HCV Genotype||participants|Number|0|0.0||||||
3787273|NCT01858766|3616641|B3|Genotype 1g||HCV Genotype||participants|Number|0|0.0||||||
3787274|NCT01858766|3616642|B2|Genotype 1g||HCV Genotype||participants|Number|1|1.0||||||
3787275|NCT01858766|3616643|B1|Genotype 1g||HCV Genotype||participants|Number|0|0.0||||||
3787276|NCT01858766|3616624|B20|Genotype 1b||HCV Genotype||participants|Number|32|32.0||||||
3787277|NCT01858766|3616625|B19|Genotype 1b||HCV Genotype||participants|Number|0|0.0||||||
3787278|NCT01858766|3616626|B18|Genotype 1b||HCV Genotype||participants|Number|0|0.0||||||
3787279|NCT01858766|3616627|B17|Genotype 1b||HCV Genotype||participants|Number|0|0.0||||||
3787280|NCT01858766|3616628|B16|Genotype 1b||HCV Genotype||participants|Number|0|0.0||||||
3787281|NCT01858766|3616629|B15|Genotype 1b||HCV Genotype||participants|Number|6|6.0||||||
3787282|NCT01858766|3616630|B14|Genotype 1b||HCV Genotype||participants|Number|5|5.0||||||
3787283|NCT01858766|3616631|B13|Genotype 1b||HCV Genotype||participants|Number|5|5.0||||||
3787284|NCT01858766|3616632|B12|Genotype 1b||HCV Genotype||participants|Number|5|5.0||||||
3787285|NCT01858766|3616633|B11|Genotype 1b||HCV Genotype||participants|Number|0|0.0||||||
3787286|NCT01858766|3616634|B10|Genotype 1b||HCV Genotype||participants|Number|0|0.0||||||
3787287|NCT01858766|3616635|B9|Genotype 1b||HCV Genotype||participants|Number|0|0.0||||||
3787288|NCT01858766|3616636|B8|Genotype 1b||HCV Genotype||participants|Number|0|0.0||||||
3787289|NCT01858766|3616637|B7|Genotype 1b||HCV Genotype||participants|Number|0|0.0||||||
3787290|NCT01858766|3616638|B6|Genotype 1b||HCV Genotype||participants|Number|0|0.0||||||
3787291|NCT01858766|3616639|B5|Genotype 1b||HCV Genotype||participants|Number|0|0.0||||||
3787292|NCT01858766|3616640|B4|Genotype 1b||HCV Genotype||participants|Number|0|0.0||||||
3787293|NCT01858766|3616641|B3|Genotype 1b||HCV Genotype||participants|Number|0|0.0||||||
3787294|NCT01858766|3616642|B2|Genotype 1b||HCV Genotype||participants|Number|6|6.0||||||
3787295|NCT01858766|3616643|B1|Genotype 1b||HCV Genotype||participants|Number|5|5.0||||||
3787296|NCT01858766|3616624|B20|Genotype 1a||HCV Genotype||participants|Number|142|142.0||||||
3787297|NCT01858766|3616625|B19|Genotype 1a||HCV Genotype||participants|Number|0|0.0||||||
3787298|NCT01858766|3616626|B18|Genotype 1a||HCV Genotype||participants|Number|0|0.0||||||
3787299|NCT01858766|3616627|B17|Genotype 1a||HCV Genotype||participants|Number|0|0.0||||||
3787300|NCT01858766|3616628|B16|Genotype 1a||HCV Genotype||participants|Number|0|0.0||||||
3787301|NCT01858766|3616629|B15|Genotype 1a||HCV Genotype||participants|Number|25|25.0||||||
3787302|NCT01858766|3616630|B14|Genotype 1a||HCV Genotype||participants|Number|24|24.0||||||
3787303|NCT01858766|3616631|B13|Genotype 1a||HCV Genotype||participants|Number|25|25.0||||||
3787304|NCT01858766|3616632|B12|Genotype 1a||HCV Genotype||participants|Number|25|25.0||||||
3787305|NCT01858766|3616633|B11|Genotype 1a||HCV Genotype||participants|Number|0|0.0||||||
3787306|NCT01858766|3616634|B10|Genotype 1a||HCV Genotype||participants|Number|0|0.0||||||
3787307|NCT01858766|3616635|B9|Genotype 1a||HCV Genotype||participants|Number|0|0.0||||||
3787308|NCT01858766|3616636|B8|Genotype 1a||HCV Genotype||participants|Number|0|0.0||||||
3787309|NCT01858766|3616637|B7|Genotype 1a||HCV Genotype||participants|Number|0|0.0||||||
3787310|NCT01858766|3616638|B6|Genotype 1a||HCV Genotype||participants|Number|0|0.0||||||
3787311|NCT01858766|3616639|B5|Genotype 1a||HCV Genotype||participants|Number|0|0.0||||||
3787312|NCT01858766|3616640|B4|Genotype 1a||HCV Genotype||participants|Number|0|0.0||||||
3787313|NCT01858766|3616641|B3|Genotype 1a||HCV Genotype||participants|Number|0|0.0||||||
3787314|NCT01858766|3616642|B2|Genotype 1a||HCV Genotype||participants|Number|21|21.0||||||
3787315|NCT01858766|3616643|B1|Genotype 1a||HCV Genotype||participants|Number|22|22.0||||||
3787316|NCT01858766|3616624|B20|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3787317|NCT01858766|3616625|B19|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787318|NCT01858766|3616626|B18|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787319|NCT01858766|3616627|B17|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787320|NCT01858766|3616628|B16|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787321|NCT01858766|3616629|B15|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3787322|NCT01858766|3616630|B14|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787323|NCT01858766|3616631|B13|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787324|NCT01858766|3616632|B12|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787325|NCT01858766|3616633|B11|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787326|NCT01858766|3616634|B10|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787327|NCT01858766|3616635|B9|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787328|NCT01858766|3616636|B8|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787329|NCT01858766|3616637|B7|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787330|NCT01858766|3616638|B6|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787331|NCT01858766|3616639|B5|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787332|NCT01858766|3616640|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787333|NCT01858766|3616641|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787334|NCT01858766|3616642|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3787335|NCT01858766|3616643|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787336|NCT01858766|3616624|B20|White||Race/Ethnicity, Customized||participants|Number|326|326.0||||||
3787337|NCT01858766|3616625|B19|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3787338|NCT01858766|3616626|B18|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3787339|NCT01858766|3616627|B17|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3787340|NCT01858766|3616628|B16|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3787341|NCT01858766|3616629|B15|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3787342|NCT01858766|3616630|B14|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3787343|NCT01858766|3616631|B13|White||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
3787344|NCT01858766|3616632|B12|White||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3787345|NCT01858766|3616633|B11|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3787346|NCT01858766|3616634|B10|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3787347|NCT01858766|3616635|B9|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3787348|NCT01858766|3616636|B8|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3787349|NCT01858766|3616637|B7|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3787350|NCT01858766|3616638|B6|White||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3787351|NCT01858766|3616639|B5|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3787352|NCT01858766|3616640|B4|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3787353|NCT01858766|3616641|B3|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3787354|NCT01858766|3616642|B2|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3787355|NCT01858766|3616643|B1|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3787356|NCT01858766|3616624|B20|Black or African American||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3787357|NCT01858766|3616625|B19|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787358|NCT01858766|3616626|B18|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3787359|NCT01858766|3616627|B17|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3787360|NCT01858766|3616628|B16|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3787361|NCT01858766|3616629|B15|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3787362|NCT01858766|3616630|B14|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3787363|NCT01858766|3616631|B13|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3787364|NCT01858766|3616632|B12|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3787365|NCT01858766|3616633|B11|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787366|NCT01858766|3616634|B10|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787367|NCT01858766|3616635|B9|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787368|NCT01858766|3616636|B8|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3787369|NCT01858766|3616637|B7|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3787370|NCT01858766|3616638|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787371|NCT01858766|3616639|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3787372|NCT01858766|3616640|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787373|NCT01858766|3616641|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787374|NCT01858766|3616642|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3787375|NCT01858766|3616643|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3787376|NCT01858766|3616624|B20|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3787377|NCT01858766|3616625|B19|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787378|NCT01858766|3616626|B18|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787379|NCT01858766|3616627|B17|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787380|NCT01858766|3616628|B16|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787381|NCT01858766|3616629|B15|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787382|NCT01858766|3616630|B14|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787383|NCT01858766|3616631|B13|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787384|NCT01858766|3616632|B12|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787385|NCT01858766|3616633|B11|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3787386|NCT01858766|3616634|B10|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3787387|NCT01858766|3616635|B9|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787388|NCT01858766|3616636|B8|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787389|NCT01858766|3616637|B7|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787390|NCT01858766|3616638|B6|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787391|NCT01858766|3616639|B5|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787392|NCT01858766|3616640|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787393|NCT01858766|3616641|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787394|NCT01858766|3616642|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3787395|NCT01858766|3616643|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787396|NCT01858766|3616624|B20|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3787397|NCT01858766|3616625|B19|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3787398|NCT01858766|3616626|B18|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787399|NCT01858766|3616627|B17|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787400|NCT01858766|3616628|B16|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3787401|NCT01858766|3616629|B15|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787402|NCT01858766|3616630|B14|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787403|NCT01858766|3616631|B13|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787404|NCT01858766|3616632|B12|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787405|NCT01858766|3616633|B11|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787406|NCT01858766|3616634|B10|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787407|NCT01858766|3616635|B9|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787408|NCT01858766|3616636|B8|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3787409|NCT01858766|3616637|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787410|NCT01858766|3616638|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3787411|NCT01858766|3616639|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3787412|NCT01858766|3616640|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787413|NCT01858766|3616641|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787414|NCT01858766|3616642|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787415|NCT01858766|3616643|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3787416|NCT01858766|3616624|B20||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787417|NCT01858766|3616625|B19||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787418|NCT01858766|3616626|B18||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787419|NCT01858766|3616627|B17||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787420|NCT01858766|3616628|B16||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787421|NCT01858766|3616629|B15||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787422|NCT01858766|3616630|B14||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787423|NCT01858766|3616631|B13||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787424|NCT01858766|3616632|B12||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787425|NCT01858766|3616633|B11||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787426|NCT01858766|3616634|B10||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787427|NCT01858766|3616635|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787428|NCT01858766|3616636|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787429|NCT01858766|3616637|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787430|NCT01858766|3616638|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787431|NCT01858766|3616639|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787432|NCT01858766|3616640|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787433|NCT01858766|3616641|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787434|NCT01858766|3616642|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787435|NCT01858766|3616643|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787436|NCT01858766|3616624|B20||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|338|338.0||||||
3787437|NCT01858766|3616625|B19||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3787438|NCT01858766|3616626|B18||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3787439|NCT01858766|3616627|B17||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3787440|NCT01858766|3616628|B16||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3787441|NCT01858766|3616629|B15||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3787442|NCT01858766|3616630|B14||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3787443|NCT01858766|3616631|B13||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3787444|NCT01858766|3616632|B12||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3787445|NCT01858766|3616633|B11||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3787446|NCT01858766|3616634|B10||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3787447|NCT01858766|3616635|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3787448|NCT01858766|3616636|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3787449|NCT01858766|3616637|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3787450|NCT01858766|3616638|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3787451|NCT01858766|3616639|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3787452|NCT01858766|3616640|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3787453|NCT01858766|3616641|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3787454|NCT01858766|3616642|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3787455|NCT01858766|3616643|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3787456|NCT01858766|3616624|B20||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3787457|NCT01858766|3616625|B19||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3787458|NCT01858766|3616626|B18||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3787459|NCT01858766|3616627|B17||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3787460|NCT01858766|3616628|B16||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3787461|NCT01858766|3616629|B15||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3787462|NCT01858766|3616630|B14||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3787463|NCT01858766|3616631|B13||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3787464|NCT01858766|3616632|B12||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3787465|NCT01858766|3616633|B11||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787466|NCT01858766|3616634|B10||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787467|NCT01858766|3616635|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787468|NCT01858766|3616636|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3787469|NCT01858766|3616637|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787470|NCT01858766|3616638|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3787471|NCT01858766|3616639|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3787472|NCT01858766|3616640|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787473|NCT01858766|3616641|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3787474|NCT01858766|3616642|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3787475|NCT01858766|3616643|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3787476|NCT01858766|3616624|B20||Male|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
3787477|NCT01858766|3616625|B19||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3787478|NCT01858766|3616626|B18||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3787479|NCT01858766|3616627|B17||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3787480|NCT01858766|3616628|B16||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3787481|NCT01858766|3616629|B15||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3787482|NCT01858766|3616630|B14||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3787483|NCT01858766|3616631|B13||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3787484|NCT01858766|3616632|B12||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3787485|NCT01858766|3616633|B11||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3787486|NCT01858766|3616634|B10||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3787487|NCT01858766|3616635|B9||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3787488|NCT01858766|3616636|B8||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3787489|NCT01858766|3616637|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3787490|NCT01858766|3616638|B6||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3787491|NCT01858766|3616639|B5||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3787492|NCT01858766|3616640|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3787493|NCT01858766|3616641|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3787494|NCT01858766|3616642|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3787495|NCT01858766|3616643|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3787496|NCT01858766|3616624|B20||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
3787497|NCT01858766|3616625|B19||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3787498|NCT01858766|3616626|B18||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3787499|NCT01858766|3616627|B17||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3787500|NCT01858766|3616628|B16||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3787501|NCT01858766|3616629|B15||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3787502|NCT01858766|3616630|B14||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3787503|NCT01858766|3616631|B13||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3787504|NCT01858766|3616632|B12||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3787505|NCT01858766|3616633|B11||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3787506|NCT01858766|3616634|B10||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3787507|NCT01858766|3616635|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3787508|NCT01858766|3616636|B8||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3787509|NCT01858766|3616637|B7||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3787510|NCT01858766|3616638|B6||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3787511|NCT01858766|3616639|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3787512|NCT01858766|3616640|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3787513|NCT01858766|3616641|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3787514|NCT01858766|3616642|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3787515|NCT01858766|3616643|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3787516|NCT01858766|3616624|B20|||Age||years|Mean|52|52.0|Standard Deviation|11.3|11.3|||
3787517|NCT01858766|3616625|B19|||Age||years|Mean|51|51.0|Standard Deviation|9.4|9.4|||
3787518|NCT01858766|3616626|B18|||Age||years|Mean|54|54.0|Standard Deviation|10.8|10.8|||
3787519|NCT01858766|3616627|B17|||Age||years|Mean|54|54.0|Standard Deviation|11.5|11.5|||
3787520|NCT01858766|3616628|B16|||Age||years|Mean|52|52.0|Standard Deviation|10.8|10.8|||
3787521|NCT01858766|3616629|B15|||Age||years|Mean|52|52.0|Standard Deviation|13.8|13.8|||
3787522|NCT01858766|3616630|B14|||Age||years|Mean|55|55.0|Standard Deviation|9.6|9.6|||
3787523|NCT01858766|3616631|B13|||Age||years|Mean|53|53.0|Standard Deviation|8.5|8.5|||
3787524|NCT01858766|3616632|B12|||Age||years|Mean|50|50.0|Standard Deviation|10.7|10.7|||
3787525|NCT01858766|3616633|B11|||Age||years|Mean|54|54.0|Standard Deviation|9.3|9.3|||
3787526|NCT01858766|3616634|B10|||Age||years|Mean|57|57.0|Standard Deviation|4.8|4.8|||
3787527|NCT01858766|3616635|B9|||Age||years|Mean|53|53.0|Standard Deviation|NA||||N/A because there is only 1 participant in this group.
3787528|NCT01858766|3616636|B8|||Age||years|Mean|56|56.0|Standard Deviation|5.5|5.5|||
3787529|NCT01858766|3616637|B7|||Age||years|Mean|51|51.0|Standard Deviation|16.1|16.1|||
3787530|NCT01858766|3616638|B6|||Age||years|Mean|50|50.0|Standard Deviation|12.7|12.7|||
3787531|NCT01858766|3616639|B5|||Age||years|Mean|52|52.0|Standard Deviation|10.8|10.8|||
3787532|NCT01858766|3616640|B4|||Age||years|Mean|53|53.0|Standard Deviation|12.6|12.6|||
3787533|NCT01858766|3616641|B3|||Age||years|Mean|42|42.0|Standard Deviation|14.6|14.6|||
3787534|NCT01858766|3616642|B2|||Age||years|Mean|49|49.0|Standard Deviation|12.2|12.2|||
3787535|NCT01858766|3616643|B1|||Age||years|Mean|49|49.0|Standard Deviation|11.4|11.4|||
3787536|NCT01858701|3616732|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3787537|NCT01858701|3616732|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3787538|NCT01858701|3616732|B1|||Age||years|Mean|28|28.0|Standard Deviation|8.2|8.2|||
3787539|NCT01858636|3616739|B1|Netherlands||Region of Enrollment||participants|Number|65|65.0||||||
3787540|NCT01858636|3616739|B1|Germany||Region of Enrollment||participants|Number|146|146.0||||||
3787541|NCT01858636|3616739|B1||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3787542|NCT01858636|3616739|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3787543|NCT01858636|3616739|B1|||Age||years|Mean|66.6|66.6|Standard Deviation|11.1|11.1|||
3787544|NCT01858545|3616744|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3787545|NCT01858545|3616745|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3787546|NCT01858545|3616746|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3787547|NCT01858545|3616744|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3787548|NCT01858545|3616745|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3787549|NCT01858545|3616746|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3787550|NCT01858545|3616744|B3|||Age||Years|Mean|57.6|57.6|Standard Deviation|15.0|15.0|||
3787551|NCT01858545|3616745|B2|||Age||Years|Mean|58.5|58.5|Standard Deviation|11.4|11.4|||
3787552|NCT01858545|3616746|B1|||Age||Years|Mean|57|57.0|Standard Deviation|9.8|9.8|||
3787553|NCT01858428|3616753|B3|Rutherford 4||Rutherford Becker Clinical Category|"Rutherford-Becker Classification is a classification system of Peripheral Arterial Disease, the higher the number the worse the disease.~Category Clinical Description 0-Asymptomatic--no hemodynamically significant occlusive disease~Mild claudication~Moderate claudication~Severe claudication 4*-Ischemic rest pain 5*-Minor tissue loss-nonhealing ulcer, focal gangrene with diffuse pedal ischemia 6*-Major tissue loss-extending above transmetatarsal level, functional foot no longer salvageable *Categories 4, 5, and 6 are also described as critical limb ischemia."|participants|Number|13|13.0||||||
3787554|NCT01858428|3616754|B2|Rutherford 4||Rutherford Becker Clinical Category|"Rutherford-Becker Classification is a classification system of Peripheral Arterial Disease, the higher the number the worse the disease.~Category Clinical Description 0-Asymptomatic--no hemodynamically significant occlusive disease~Mild claudication~Moderate claudication~Severe claudication 4*-Ischemic rest pain 5*-Minor tissue loss-nonhealing ulcer, focal gangrene with diffuse pedal ischemia 6*-Major tissue loss-extending above transmetatarsal level, functional foot no longer salvageable *Categories 4, 5, and 6 are also described as critical limb ischemia."|participants|Number|8|8.0||||||
3787576|NCT01858428|3616755|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|68|68.0||||||
3787555|NCT01858428|3616755|B1|Rutherford 4||Rutherford Becker Clinical Category|"Rutherford-Becker Classification is a classification system of Peripheral Arterial Disease, the higher the number the worse the disease.~Category Clinical Description 0-Asymptomatic--no hemodynamically significant occlusive disease~Mild claudication~Moderate claudication~Severe claudication 4*-Ischemic rest pain 5*-Minor tissue loss-nonhealing ulcer, focal gangrene with diffuse pedal ischemia 6*-Major tissue loss-extending above transmetatarsal level, functional foot no longer salvageable *Categories 4, 5, and 6 are also described as critical limb ischemia."|participants|Number|5|5.0||||||
3787556|NCT01858428|3616753|B3|Rutherford 3||Rutherford Becker Clinical Category|"Rutherford-Becker Classification is a classification system of Peripheral Arterial Disease, the higher the number the worse the disease.~Category Clinical Description 0-Asymptomatic--no hemodynamically significant occlusive disease~Mild claudication~Moderate claudication~Severe claudication 4*-Ischemic rest pain 5*-Minor tissue loss-nonhealing ulcer, focal gangrene with diffuse pedal ischemia 6*-Major tissue loss-extending above transmetatarsal level, functional foot no longer salvageable *Categories 4, 5, and 6 are also described as critical limb ischemia."|participants|Number|189|189.0||||||
3787557|NCT01858428|3616754|B2|Rutherford 3||Rutherford Becker Clinical Category|"Rutherford-Becker Classification is a classification system of Peripheral Arterial Disease, the higher the number the worse the disease.~Category Clinical Description 0-Asymptomatic--no hemodynamically significant occlusive disease~Mild claudication~Moderate claudication~Severe claudication 4*-Ischemic rest pain 5*-Minor tissue loss-nonhealing ulcer, focal gangrene with diffuse pedal ischemia 6*-Major tissue loss-extending above transmetatarsal level, functional foot no longer salvageable *Categories 4, 5, and 6 are also described as critical limb ischemia."|participants|Number|129|129.0||||||
3787558|NCT01858428|3616755|B1|Rutherford 3||Rutherford Becker Clinical Category|"Rutherford-Becker Classification is a classification system of Peripheral Arterial Disease, the higher the number the worse the disease.~Category Clinical Description 0-Asymptomatic--no hemodynamically significant occlusive disease~Mild claudication~Moderate claudication~Severe claudication 4*-Ischemic rest pain 5*-Minor tissue loss-nonhealing ulcer, focal gangrene with diffuse pedal ischemia 6*-Major tissue loss-extending above transmetatarsal level, functional foot no longer salvageable *Categories 4, 5, and 6 are also described as critical limb ischemia."|participants|Number|60|60.0||||||
3787559|NCT01858428|3616753|B3|Rutherford 2||Rutherford Becker Clinical Category|"Rutherford-Becker Classification is a classification system of Peripheral Arterial Disease, the higher the number the worse the disease.~Category Clinical Description 0-Asymptomatic--no hemodynamically significant occlusive disease~Mild claudication~Moderate claudication~Severe claudication 4*-Ischemic rest pain 5*-Minor tissue loss-nonhealing ulcer, focal gangrene with diffuse pedal ischemia 6*-Major tissue loss-extending above transmetatarsal level, functional foot no longer salvageable *Categories 4, 5, and 6 are also described as critical limb ischemia."|participants|Number|98|98.0||||||
3787560|NCT01858428|3616754|B2|Rutherford 2||Rutherford Becker Clinical Category|"Rutherford-Becker Classification is a classification system of Peripheral Arterial Disease, the higher the number the worse the disease.~Category Clinical Description 0-Asymptomatic--no hemodynamically significant occlusive disease~Mild claudication~Moderate claudication~Severe claudication 4*-Ischemic rest pain 5*-Minor tissue loss-nonhealing ulcer, focal gangrene with diffuse pedal ischemia 6*-Major tissue loss-extending above transmetatarsal level, functional foot no longer salvageable *Categories 4, 5, and 6 are also described as critical limb ischemia."|participants|Number|63|63.0||||||
3787561|NCT01858428|3616755|B1|Rutherford 2||Rutherford Becker Clinical Category|"Rutherford-Becker Classification is a classification system of Peripheral Arterial Disease, the higher the number the worse the disease.~Category Clinical Description 0-Asymptomatic--no hemodynamically significant occlusive disease~Mild claudication~Moderate claudication~Severe claudication 4*-Ischemic rest pain 5*-Minor tissue loss-nonhealing ulcer, focal gangrene with diffuse pedal ischemia 6*-Major tissue loss-extending above transmetatarsal level, functional foot no longer salvageable *Categories 4, 5, and 6 are also described as critical limb ischemia."|participants|Number|35|35.0||||||
3787562|NCT01858428|3616753|B3|||Ankle-Brachial Index|The ankle-brachial index (ABI) is the ratio of the blood pressure at the ankle to the blood pressure in the upper arm (brachium). The normal range for the ankle-brachial index is between 0.90 and 1.30. An index under 0.90 means that blood is having a hard time getting to the legs and feet: 0.41 to 0.90 indicates mild to moderate peripheral artery disease; 0.40 and lower indicates severe disease.|ratio|Mean|0.75|0.75|Standard Deviation|0.21|0.21|||
3787563|NCT01858428|3616754|B2|||Ankle-Brachial Index|The ankle-brachial index (ABI) is the ratio of the blood pressure at the ankle to the blood pressure in the upper arm (brachium). The normal range for the ankle-brachial index is between 0.90 and 1.30. An index under 0.90 means that blood is having a hard time getting to the legs and feet: 0.41 to 0.90 indicates mild to moderate peripheral artery disease; 0.40 and lower indicates severe disease.|ratio|Mean|0.75|0.75|Standard Deviation|0.21|0.21|||
3787564|NCT01858428|3616755|B1|||Ankle-Brachial Index|The ankle-brachial index (ABI) is the ratio of the blood pressure at the ankle to the blood pressure in the upper arm (brachium). The normal range for the ankle-brachial index is between 0.90 and 1.30. An index under 0.90 means that blood is having a hard time getting to the legs and feet: 0.41 to 0.90 indicates mild to moderate peripheral artery disease; 0.40 and lower indicates severe disease.|ratio|Mean|0.76|0.76|Standard Deviation|0.20|0.2|||
3787565|NCT01858428|3616753|B3|United States||Region of Enrollment||participants|Number|273|273.0||||||
3787566|NCT01858428|3616754|B2|United States||Region of Enrollment||participants|Number|183|183.0||||||
3787567|NCT01858428|3616755|B1|United States||Region of Enrollment||participants|Number|90|90.0||||||
3787568|NCT01858428|3616753|B3|Austria||Region of Enrollment||participants|Number|27|27.0||||||
3787569|NCT01858428|3616754|B2|Austria||Region of Enrollment||participants|Number|17|17.0||||||
3787570|NCT01858428|3616755|B1|Austria||Region of Enrollment||participants|Number|10|10.0||||||
3787571|NCT01858428|3616753|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3787572|NCT01858428|3616754|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3787573|NCT01858428|3616755|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3787574|NCT01858428|3616753|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|210|210.0||||||
3787575|NCT01858428|3616754|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|142|142.0||||||
3787577|NCT01858428|3616753|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|54|54.0||||||
3787578|NCT01858428|3616754|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
3787579|NCT01858428|3616755|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3787580|NCT01858428|3616753|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3787581|NCT01858428|3616754|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3787582|NCT01858428|3616755|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3787583|NCT01858428|3616753|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3787584|NCT01858428|3616754|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3787585|NCT01858428|3616755|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3787586|NCT01858428|3616753|B3||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
3787587|NCT01858428|3616754|B2||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3787588|NCT01858428|3616755|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3787589|NCT01858428|3616753|B3||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3787590|NCT01858428|3616754|B2||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3787591|NCT01858428|3616755|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3787592|NCT01858428|3616753|B3|Age||Age, Customized||years|Mean|68.8|68.8|Standard Deviation|10.1|10.1|||
3787593|NCT01858428|3616754|B2|Age||Age, Customized||years|Mean|68.3|68.3|Standard Deviation|10.3|10.3|||
3787594|NCT01858428|3616755|B1|Age||Age, Customized||years|Mean|69.8|69.8|Standard Deviation|9.8|9.8|||
3787595|NCT01858389|3616790|B3|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3787596|NCT01858389|3616791|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3787597|NCT01858389|3616792|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3787598|NCT01858389|3616790|B3|Asian||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
3787599|NCT01858389|3616791|B2|Asian||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
3787600|NCT01858389|3616792|B1|Asian||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3787601|NCT01858389|3616790|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3787602|NCT01858389|3616791|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3787603|NCT01858389|3616792|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3787604|NCT01858389|3616790|B3|White||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
3787605|NCT01858389|3616791|B2|White||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3787606|NCT01858389|3616792|B1|White||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3787607|NCT01858389|3616790|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3787608|NCT01858389|3616791|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3787609|NCT01858389|3616792|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3787610|NCT01858389|3616790|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3787611|NCT01858389|3616791|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3787612|NCT01858389|3616792|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3787613|NCT01858389|3616790|B3|65 years and older||Age, Customized||Participants|Number|14|14.0||||||
3787614|NCT01858389|3616791|B2|65 years and older||Age, Customized||Participants|Number|9|9.0||||||
3787615|NCT01858389|3616792|B1|65 years and older||Age, Customized||Participants|Number|5|5.0||||||
3787616|NCT01858389|3616790|B3|Between 45 and 64 years||Age, Customized||Participants|Number|22|22.0||||||
3787617|NCT01858389|3616791|B2|Between 45 and 64 years||Age, Customized||Participants|Number|13|13.0||||||
3787618|NCT01858389|3616792|B1|Between 45 and 64 years||Age, Customized||Participants|Number|9|9.0||||||
3787619|NCT01858389|3616790|B3|Between 18 and 44 years||Age, Customized||Participants|Number|2|2.0||||||
3787620|NCT01858389|3616791|B2|Between 18 and 44 years||Age, Customized||Participants|Number|0|0.0||||||
3787621|NCT01858389|3616792|B1|Between 18 and 44 years||Age, Customized||Participants|Number|2|2.0||||||
3787622|NCT01858389|3616790|B3|Younger than 18 years||Age, Customized||Participants|Number|0|0.0||||||
3787623|NCT01858389|3616791|B2|Younger than 18 years||Age, Customized||Participants|Number|0|0.0||||||
3787624|NCT01858389|3616792|B1|Younger than 18 years||Age, Customized||Participants|Number|0|0.0||||||
3787625|NCT01858376|3616808|B1|||Blood Pressure Diastolic||mm Hg|Mean|76.91|76.91|Standard Deviation|6.92|6.92|||
3787626|NCT01858376|3616808|B1|||Weight||lbs.|Mean|185.19|185.19|Standard Deviation|27.67|27.67|||
3787627|NCT01858376|3616808|B1|||Height||cm|Mean|171|171.0|Standard Deviation|9.38|9.38|||
3787628|NCT01858376|3616808|B1|||Blood Pressure Systolic||mm Hg|Mean|116.87|116.87|Standard Deviation|7.19|7.19|||
3787629|NCT01858376|3616808|B1|||BMI (Body Mass Index)||kg/m^2|Mean|28.57|28.57|Standard Deviation|2.71|2.71|||
3787630|NCT01858376|3616808|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3787631|NCT01858376|3616808|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3787632|NCT01858376|3616808|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3787633|NCT01858376|3616808|B1|||Age||years|Mean|34.5|34.5|Standard Deviation|11.53|11.53|||
3787634|NCT01858376|3616808|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3787635|NCT01858376|3616808|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3787636|NCT01858376|3616808|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3787637|NCT01857986|3616815|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3787638|NCT01857986|3616816|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3787639|NCT01857986|3616817|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3787640|NCT01857986|3616815|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3787641|NCT01857986|3616816|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3787642|NCT01857986|3616817|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3787643|NCT01857986|3616815|B3|||Age||years|Mean|65.8|65.8|Standard Deviation|15.6|15.6|||
3787644|NCT01857986|3616816|B2|||Age||years|Mean|66.7|66.7|Standard Deviation|11.2|11.2|||
3787645|NCT01857986|3616817|B1|||Age||years|Mean|65.0|65.0|Standard Deviation|18.8|18.8|||
3787646|NCT01857882|3616828|B3|||Decisional conflict Scale|"Decisional conflict at baseline. Standard Care n=19, Decision Support Workshop n=20.~The decisional conflict scale measures personal perceptions of uncertainty in choosing options. It is a 16-item 5-response instrument that reports a total score from 0 - 100 with higher scores indicating more conflict (items are summed, divided by 16 and multiplied by 25)."|units on a scale|Mean|49.3|49.3|Standard Deviation|19.0|19.0|||
3787647|NCT01857882|3616829|B2|||Decisional conflict Scale|"Decisional conflict at baseline. Standard Care n=19, Decision Support Workshop n=20.~The decisional conflict scale measures personal perceptions of uncertainty in choosing options. It is a 16-item 5-response instrument that reports a total score from 0 - 100 with higher scores indicating more conflict (items are summed, divided by 16 and multiplied by 25)."|units on a scale|Mean|41.3|41.3|Standard Deviation|17.1|17.1|||
3787648|NCT01857882|3616830|B1|||Decisional conflict Scale|"Decisional conflict at baseline. Standard Care n=19, Decision Support Workshop n=20.~The decisional conflict scale measures personal perceptions of uncertainty in choosing options. It is a 16-item 5-response instrument that reports a total score from 0 - 100 with higher scores indicating more conflict (items are summed, divided by 16 and multiplied by 25)."|units on a scale|Mean|56.8|56.8|Standard Deviation|18.0|18.0|||
3787649|NCT01857882|3616828|B3|Canada||Region of Enrollment||participants|Number|41|41.0||||||
3787650|NCT01857882|3616829|B2|Canada||Region of Enrollment||participants|Number|20|20.0||||||
3787651|NCT01857882|3616830|B1|Canada||Region of Enrollment||participants|Number|21|21.0||||||
3787652|NCT01857882|3616828|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3787653|NCT01857882|3616829|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3787654|NCT01857882|3616830|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3787655|NCT01857882|3616828|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3787656|NCT01857882|3616829|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3787657|NCT01857882|3616830|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3787658|NCT01857882|3616828|B3|||Age||years|Mean|51.2|51.2|Standard Deviation|7.4|7.4|||
3787659|NCT01857882|3616829|B2|||Age||years|Mean|51.5|51.5|Standard Deviation|9.1|9.1|||
3787660|NCT01857882|3616830|B1|||Age||years|Mean|50.9|50.9|Standard Deviation|5.5|5.5|||
3787661|NCT01857869|3616837|B11|Geographic ancestry|Unspecified|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3787662|NCT01857869|3616845|B3|Geographic ancestry|Unspecified|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3787663|NCT01857869|3616846|B2|Geographic ancestry|Unspecified|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3787664|NCT01857869|3616847|B1|Geographic ancestry|Unspecified|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3787665|NCT01857869|3616837|B11|Geographic ancestry|White - Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3787666|NCT01857869|3616845|B3|Geographic ancestry|White - Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3787667|NCT01857869|3616846|B2|Geographic ancestry|White - Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3787668|NCT01857869|3616847|B1|Geographic ancestry|White - Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3787669|NCT01857869|3616837|B11|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3787670|NCT01857869|3616845|B3|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3787671|NCT01857869|3616846|B2|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3787672|NCT01857869|3616847|B1|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3787673|NCT01857869|3616837|B11|Geographic ancestry|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3787674|NCT01857869|3616845|B3|Geographic ancestry|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3787675|NCT01857869|3616846|B2|Geographic ancestry|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3787676|NCT01857869|3616847|B1|Geographic ancestry|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3787677|NCT01857869|3616837|B11|Geographic ancestry|African Heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3787678|NCT01857869|3616845|B3|Geographic ancestry|African Heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3787679|NCT01857869|3616846|B2|Geographic ancestry|African Heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3787680|NCT01857869|3616847|B1|Geographic ancestry|African Heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3787681|NCT01857869|3616837|B11||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3787682|NCT01857869|3616845|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3787683|NCT01857869|3616846|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3787684|NCT01857869|3616847|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3787685|NCT01857869|3616837|B11||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3787686|NCT01857869|3616845|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3787687|NCT01857869|3616846|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3787688|NCT01857869|3616847|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3787689|NCT01857869|3616837|B11|||Age||Years|Mean|33.6|33.6|Standard Deviation|8.6|8.6|||
3787690|NCT01857869|3616845|B3|||Age||Years|Mean|36.4|36.4|Standard Deviation|8.7|8.7|||
3787691|NCT01857869|3616846|B2|||Age||Years|Mean|30.1|30.1|Standard Deviation|7.9|7.9|||
3787692|NCT01857869|3616847|B1|||Age||Years|Mean|34.4|34.4|Standard Deviation|8.6|8.6|||
3787693|NCT01857713|3616936|B1|||BMI||kg/m^2|Mean|25.5|25.5|Standard Deviation|4.2|4.2|||
3787694|NCT01857713|3616936|B1|||Weight||pounds|Mean|160.0|160.0|Standard Deviation|31.3|31.3|||
3787695|NCT01857713|3616936|B1|United States||Region of Enrollment||participants|Number|95|95.0||||||
3787696|NCT01857713|3616936|B1|Not Reported||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3787697|NCT01857713|3616936|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3787698|NCT01857713|3616936|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3787699|NCT01857713|3616936|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3787700|NCT01857713|3616936|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
3787701|NCT01857713|3616936|B1|African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3787702|NCT01857713|3616936|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3787703|NCT01857713|3616936|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3787704|NCT01857713|3616936|B1|||Age||Years|Mean|48.8|48.8|Standard Deviation|13.7|13.7|||
3787705|NCT01857622|3616943|B4|Japan||Region of Enrollment||participants|Number|93|93.0||||||
3787706|NCT01857622|3616944|B3|Japan||Region of Enrollment||participants|Number|21|21.0||||||
3787707|NCT01857622|3616945|B2|Japan||Region of Enrollment||participants|Number|22|22.0||||||
3787708|NCT01857622|3616946|B1|Japan||Region of Enrollment||participants|Number|50|50.0||||||
3787709|NCT01857622|3616943|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787710|NCT01857622|3616944|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787711|NCT01857622|3616945|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787712|NCT01857622|3616946|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787713|NCT01857622|3616943|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787714|NCT01857622|3616944|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787715|NCT01857622|3616945|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787716|NCT01857622|3616946|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787717|NCT01857622|3616943|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787718|NCT01857622|3616944|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787719|NCT01857622|3616945|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787720|NCT01857622|3616946|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787721|NCT01857622|3616943|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787722|NCT01857622|3616944|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787723|NCT01857622|3616945|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787724|NCT01857622|3616946|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787725|NCT01857622|3616943|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787726|NCT01857622|3616944|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787727|NCT01857622|3616945|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787728|NCT01857622|3616946|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787729|NCT01857622|3616943|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
3787730|NCT01857622|3616944|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3787731|NCT01857622|3616945|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3787732|NCT01857622|3616946|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3787733|NCT01857622|3616943|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787734|NCT01857622|3616944|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787735|NCT01857622|3616945|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787736|NCT01857622|3616946|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787737|NCT01857622|3616943|B4||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3787738|NCT01857622|3616944|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3787739|NCT01857622|3616945|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3787740|NCT01857622|3616946|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3787741|NCT01857622|3616943|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3787742|NCT01857622|3616944|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3787743|NCT01857622|3616945|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3787744|NCT01857622|3616946|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3787745|NCT01857622|3616943|B4|||Age||years|Mean|75.9|75.9|Standard Deviation|8.57|8.57|||
3787746|NCT01857622|3616944|B3|||Age||years|Mean|72.2|72.2|Standard Deviation|4.58|4.58|||
3787747|NCT01857622|3616945|B2|||Age||years|Mean|68.0|68.0|Standard Deviation|8.91|8.91|||
3787748|NCT01857622|3616946|B1|||Age||years|Mean|80.9|80.9|Standard Deviation|6.04|6.04|||
3787749|NCT01857583|3616956|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787750|NCT01857583|3616957|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787751|NCT01857583|3616958|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787752|NCT01857583|3616959|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787753|NCT01857583|3616960|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787754|NCT01857583|3616956|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787755|NCT01857583|3616957|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787756|NCT01857583|3616958|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787757|NCT01857583|3616959|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787758|NCT01857583|3616960|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787759|NCT01857583|3616956|B5||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787760|NCT01857583|3616957|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787761|NCT01857583|3616958|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787762|NCT01857583|3616959|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787763|NCT01857583|3616960|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787764|NCT01857583|3616956|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787765|NCT01857583|3616957|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787766|NCT01857583|3616958|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787767|NCT01857583|3616959|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787768|NCT01857583|3616960|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787769|NCT01857583|3616956|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787770|NCT01857583|3616957|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787771|NCT01857583|3616958|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787772|NCT01857583|3616959|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787773|NCT01857583|3616960|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787774|NCT01857583|3616956|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3787775|NCT01857583|3616957|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3787776|NCT01857583|3616958|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3787777|NCT01857583|3616959|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3787778|NCT01857583|3616960|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3787779|NCT01857583|3616956|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787780|NCT01857583|3616957|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787781|NCT01857583|3616958|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787782|NCT01857583|3616959|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787783|NCT01857583|3616960|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787784|NCT01857583|3616956|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3787785|NCT01857583|3616957|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3787786|NCT01857583|3616958|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3787787|NCT01857583|3616959|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3787788|NCT01857583|3616960|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3787789|NCT01857583|3616956|B5||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3787790|NCT01857583|3616957|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3787791|NCT01857583|3616958|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3787792|NCT01857583|3616959|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3787793|NCT01857583|3616960|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3787794|NCT01857583|3616956|B5|||Age||years|Mean|83.5|83.5|Standard Deviation|8.09|8.09|||
3787795|NCT01857583|3616957|B4|||Age||years|Mean|85.7|85.7|Standard Deviation|8.91|8.91|||
3787796|NCT01857583|3616958|B3|||Age||years|Mean|86.5|86.5|Standard Deviation|4.31|4.31|||
3787797|NCT01857583|3616959|B2|||Age||years|Mean|91.7|91.7|Standard Deviation|7.06|7.06|||
3787798|NCT01857583|3616960|B1|||Age||years|Mean|78.1|78.1|Standard Deviation|6.46|6.46|||
3787799|NCT01857531|3616973|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3787800|NCT01857531|3616973|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3787801|NCT01857531|3616973|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3787802|NCT01857531|3616973|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3787803|NCT01857531|3616973|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3787804|NCT01857531|3616973|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3787805|NCT01857531|3616973|B1|||Age||years|Mean|47.44|47.44|Standard Deviation|9.94|9.94|||
3787806|NCT01857362|3616982|B1|Netherlands||Region of Enrollment||participants|Number|12|12.0||||||
3787807|NCT01857362|3616982|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3787808|NCT01857362|3616982|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3787809|NCT01857362|3616982|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3787810|NCT01857362|3616982|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3787811|NCT01857362|3616982|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3787812|NCT01857362|3616982|B1|||Age||years|Mean|31|31.0|Standard Deviation|11|11.0|||
3787813|NCT01857323|3616991|B1|COPD||Disease Type|COPD = Chronic obstructive pulmonary disease|participants|Number|150|150.0||||||
3787814|NCT01857323|3616991|B1|Asthma||Disease Type|COPD = Chronic obstructive pulmonary disease|participants|Number|167|167.0||||||
3787815|NCT01857323|3616991|B1|Non-Hispanic, non-Latino||Race/Ethnicity, Customized||participants|Number|292|292.0||||||
3787816|NCT01857323|3616991|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3787817|NCT01857323|3616991|B1|Other, not specified||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3787818|NCT01857323|3616991|B1|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3787819|NCT01857323|3616991|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3787820|NCT01857323|3616991|B1|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3787821|NCT01857323|3616991|B1|Black||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3787822|NCT01857323|3616991|B1|White||Race/Ethnicity, Customized||participants|Number|268|268.0||||||
3787823|NCT01857323|3616991|B1||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3787824|NCT01857323|3616991|B1||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
3787825|NCT01857323|3616991|B1|65+ years||Age, Customized||participants|Number|129|129.0||||||
3787826|NCT01857323|3616991|B1|12-64 years||Age, Customized||participants|Number|144|144.0||||||
3787827|NCT01857323|3616991|B1|4-11 years||Age, Customized||participants|Number|44|44.0||||||
3787828|NCT01857323|3616991|B1|||Age||years|Mean|51.3|51.3|Standard Deviation|22.7|22.7|||
3787829|NCT01857297|3617000|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3787830|NCT01857297|3617001|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3787831|NCT01857297|3617002|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3787832|NCT01857297|3617000|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3787833|NCT01857297|3617001|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3787834|NCT01857297|3617002|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3787835|NCT01857297|3617000|B3|Years||Age, Customized||years|Mean|51.9|51.9|Standard Deviation|19.65|19.65|||
3787836|NCT01857297|3617001|B2|Years||Age, Customized||years|Mean|69.4|69.4|Standard Deviation|6.02|6.02|||
3787837|NCT01857297|3617002|B1|Years||Age, Customized||years|Mean|34.5|34.5|Standard Deviation|11.17|11.17|||
3787838|NCT01857258|3617017|B1|||Total Cholesterol||mg/dL|Mean|160.5|160.5|Standard Deviation|21.44|21.44|||
3787839|NCT01857258|3617017|B1|||Fasting Glucose||mg/dL|Mean|88.9|88.9|Standard Deviation|5.2|5.2|||
3787840|NCT01857258|3617017|B1|||Body Mass Index||kg/m^2|Mean|22.4|22.4|Standard Deviation|1.8|1.8|||
3787841|NCT01857258|3617017|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3787842|NCT01857258|3617017|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3787843|NCT01857258|3617017|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3787844|NCT01857258|3617017|B1|||Age||years|Mean|25.3|25.3|Standard Deviation|3.9|3.9|||
3787845|NCT01857206|3617038|B3||Male|Sex: Female, Male||Participants|Count of Participants|1003|1003.0||||||
3787846|NCT01857206|3617039|B2||Male|Sex: Female, Male||Participants|Count of Participants|334|334.0||||||
3787847|NCT01857206|3617040|B1||Male|Sex: Female, Male||Participants|Count of Participants|669|669.0||||||
3787848|NCT01857206|3617038|B3||Female|Sex: Female, Male||Participants|Count of Participants|1052|1052.0||||||
3787849|NCT01857206|3617039|B2||Female|Sex: Female, Male||Participants|Count of Participants|349|349.0||||||
3787850|NCT01857206|3617040|B1||Female|Sex: Female, Male||Participants|Count of Participants|703|703.0||||||
3787851|NCT01857206|3617038|B3|||Age||year|Mean|9.1|9.1|Standard Deviation|3.8|3.8|||
3787852|NCT01857206|3617039|B2|||Age||year|Mean|9.3|9.3|Standard Deviation|3.9|3.9|||
3787853|NCT01857206|3617040|B1|||Age||year|Mean|9.1|9.1|Standard Deviation|3.8|3.8|||
3787854|NCT01857102|3617059|B1|United States||Region of Enrollment||participants|Number|114|114.0||||||
3787855|NCT01857102|3617059|B1|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3787856|NCT01857102|3617059|B1|White||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
3787857|NCT01857102|3617059|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3787858|NCT01857102|3617059|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3787859|NCT01857102|3617059|B1|Asian||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
3787860|NCT01857102|3617059|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3787861|NCT01857102|3617059|B1||Male|Sex: Female, Male|All subjects that were dispensed a study lens.|Participants|Count of Participants|39|39.0||||||
3787862|NCT01857102|3617059|B1||Female|Sex: Female, Male|All subjects that were dispensed a study lens.|Participants|Count of Participants|75|75.0||||||
3787863|NCT01857102|3617059|B1|Overall||Age||years|Mean|27.1|27.1|Standard Deviation|4.77|4.77|||
3787864|NCT01857102|3617059|B1|Neophtyes||Age||years|Mean|28.5|28.5|Standard Deviation|2.66|2.66|||
3787865|NCT01857102|3617059|B1|Habitual Users||Age||years|Mean|26.9|26.9|Standard Deviation|4.93|4.93|||
3787866|NCT01857063|3617068|B3||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3787867|NCT01857063|3617069|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3787868|NCT01857063|3617070|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3787869|NCT01857063|3617068|B3||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3787870|NCT01857063|3617069|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3787871|NCT01857063|3617070|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3787872|NCT01857063|3617068|B3|||Age||years|Mean|12.5|12.5|Standard Deviation|1.6|1.6|10.0|15.0|
3787873|NCT01857063|3617069|B2|||Age||years|Mean|12.7|12.7|Standard Deviation|1.5|1.5|10.0|15.0|
3787874|NCT01857063|3617070|B1|||Age||years|Mean|12.3|12.3|Standard Deviation|1.6|1.6|10.0|15.0|
3787875|NCT01856933|3617097|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3787876|NCT01856933|3617097|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3787877|NCT01856933|3617097|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3787878|NCT01856933|3617097|B1|||Age||years|Mean|60.3|60.3|Full Range|||39.0|72.0|
3787879|NCT01856933|3617097|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3787880|NCT01856933|3617097|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3787881|NCT01856933|3617097|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3787882|NCT01856907|3617101|B4|||Hyperglycemia||Participants|Count of Participants|36|36.0||||||
3787883|NCT01856907|3617102|B3|||Hyperglycemia||Participants|Count of Participants|12|12.0||||||
3787884|NCT01856907|3617103|B2|||Hyperglycemia||Participants|Count of Participants|12|12.0||||||
3787885|NCT01856907|3617104|B1|||Hyperglycemia||Participants|Count of Participants|12|12.0||||||
3787886|NCT01856907|3617101|B4|United States||Region of Enrollment||participants|Number|36|36.0||||||
3787887|NCT01856907|3617102|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3787888|NCT01856907|3617103|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3787889|NCT01856907|3617104|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3787890|NCT01856907|3617101|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787891|NCT01856907|3617102|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787892|NCT01856907|3617103|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787893|NCT01856907|3617104|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787894|NCT01856907|3617101|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787895|NCT01856907|3617102|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787896|NCT01856907|3617103|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787897|NCT01856907|3617104|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787898|NCT01856907|3617101|B4||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3787899|NCT01856907|3617102|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3787900|NCT01856907|3617103|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3787901|NCT01856907|3617104|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3787902|NCT01856907|3617101|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3787903|NCT01856907|3617102|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3787904|NCT01856907|3617103|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3787905|NCT01856907|3617104|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3787906|NCT01856907|3617101|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787907|NCT01856907|3617102|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787908|NCT01856907|3617103|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787909|NCT01856907|3617104|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787910|NCT01856907|3617101|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787911|NCT01856907|3617102|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787912|NCT01856907|3617103|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787913|NCT01856907|3617104|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787914|NCT01856907|3617101|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787915|NCT01856907|3617102|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787916|NCT01856907|3617103|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787917|NCT01856907|3617104|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787918|NCT01856907|3617101|B4|Patients||Sex/Gender, Customized|Postpartum previous GDM females|Participants|Count of Participants|36|36.0||||||
3787919|NCT01856907|3617102|B3|Patients||Sex/Gender, Customized|Postpartum previous GDM females|Participants|Count of Participants|12|12.0||||||
3787920|NCT01856907|3617103|B2|Patients||Sex/Gender, Customized|Postpartum previous GDM females|Participants|Count of Participants|12|12.0||||||
3787921|NCT01856907|3617104|B1|Patients||Sex/Gender, Customized|Postpartum previous GDM females|Participants|Count of Participants|12|12.0||||||
3787922|NCT01856907|3617101|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3787923|NCT01856907|3617102|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3787924|NCT01856907|3617103|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3787925|NCT01856907|3617104|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3787926|NCT01856907|3617101|B4||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3787927|NCT01856907|3617102|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3787928|NCT01856907|3617103|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3787929|NCT01856907|3617104|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3787930|NCT01856907|3617101|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3787931|NCT01856907|3617102|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3787932|NCT01856907|3617103|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3787933|NCT01856907|3617104|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3787934|NCT01856764|3617144|B3|||Baseline Participant Assessment of Pruritis||scores on a scale|Mean|5.025|5.025|Full Range|||0.0|10.0|
3787935|NCT01856764|3617145|B2|||Baseline Participant Assessment of Pruritis||scores on a scale|Mean|5.00|5.0|Full Range|||2.0|10.0|
3787936|NCT01856764|3617146|B1|||Baseline Participant Assessment of Pruritis||scores on a scale|Mean|5.05|5.05|Full Range|||0.0|9.0|
3787937|NCT01856764|3617144|B3|||Baseline Transepidermal Water Loss (TEWL) Mean||g/m^2/hr|Mean|41.52|41.52|Full Range|||17.8|69.8|
3787938|NCT01856764|3617145|B2|||Baseline Transepidermal Water Loss (TEWL) Mean||g/m^2/hr|Mean|41.57|41.57|Full Range|||17.8|63.3|
3787939|NCT01856764|3617146|B1|||Baseline Transepidermal Water Loss (TEWL) Mean||g/m^2/hr|Mean|41.47|41.47|Full Range|||17.8|69.8|
3787940|NCT01856764|3617144|B3|||Baseline Modified Local SCORing Atopic Dermatitis (SCORAD)||scores on a scale|Mean|5.725|5.725|Full Range|||4.0|8.0|
3787941|NCT01856764|3617145|B2|||Baseline Modified Local SCORing Atopic Dermatitis (SCORAD)||scores on a scale|Mean|5.85|5.85|Full Range|||4.0|8.0|
3787942|NCT01856764|3617146|B1|||Baseline Modified Local SCORing Atopic Dermatitis (SCORAD)||scores on a scale|Mean|5.60|5.6|Full Range|||4.0|8.0|
3787943|NCT01856764|3617144|B3|N/A (male participant)||Female Reproductive Status||participants|Number|20|20.0||||||
3787944|NCT01856764|3617145|B2|N/A (male participant)||Female Reproductive Status||participants|Number|9|9.0||||||
3787945|NCT01856764|3617146|B1|N/A (male participant)||Female Reproductive Status||participants|Number|11|11.0||||||
3787946|NCT01856764|3617144|B3|Female of childbearing potential||Female Reproductive Status||participants|Number|20|20.0||||||
3787947|NCT01856764|3617145|B2|Female of childbearing potential||Female Reproductive Status||participants|Number|11|11.0||||||
3787948|NCT01856764|3617146|B1|Female of childbearing potential||Female Reproductive Status||participants|Number|9|9.0||||||
3787949|NCT01856764|3617144|B3|Surgically sterile||Female Reproductive Status||participants|Number|0|0.0||||||
3787950|NCT01856764|3617145|B2|Surgically sterile||Female Reproductive Status||participants|Number|0|0.0||||||
3787951|NCT01856764|3617146|B1|Surgically sterile||Female Reproductive Status||participants|Number|0|0.0||||||
3787952|NCT01856764|3617144|B3|Postmenopausal||Female Reproductive Status||participants|Number|0|0.0||||||
3787953|NCT01856764|3617145|B2|Postmenopausal||Female Reproductive Status||participants|Number|0|0.0||||||
3787954|NCT01856764|3617146|B1|Postmenopausal||Female Reproductive Status||participants|Number|0|0.0||||||
3787955|NCT01856764|3617144|B3|Ex-Smoker||Smoking Classificaiton||participants|Number|8|8.0||||||
3787956|NCT01856764|3617145|B2|Ex-Smoker||Smoking Classificaiton||participants|Number|3|3.0||||||
3787957|NCT01856764|3617146|B1|Ex-Smoker||Smoking Classificaiton||participants|Number|5|5.0||||||
3787958|NCT01856764|3617144|B3|Current smoker||Smoking Classificaiton||participants|Number|19|19.0||||||
3787959|NCT01856764|3617145|B2|Current smoker||Smoking Classificaiton||participants|Number|9|9.0||||||
3787960|NCT01856764|3617146|B1|Current smoker||Smoking Classificaiton||participants|Number|10|10.0||||||
3787961|NCT01856764|3617144|B3|Never smoked||Smoking Classificaiton||participants|Number|13|13.0||||||
3787962|NCT01856764|3617145|B2|Never smoked||Smoking Classificaiton||participants|Number|8|8.0||||||
3787963|NCT01856764|3617146|B1|Never smoked||Smoking Classificaiton||participants|Number|5|5.0||||||
3787964|NCT01856764|3617144|B3|||Body Mass Index (BMI)||kg/m^2|Mean|25.62|25.62|Standard Deviation|4.255|4.255|||
3787965|NCT01856764|3617145|B2|||Body Mass Index (BMI)||kg/m^2|Mean|25.59|25.59|Standard Deviation|3.477|3.477|||
3787966|NCT01856764|3617146|B1|||Body Mass Index (BMI)||kg/m^2|Mean|25.65|25.65|Standard Deviation|5.007|5.007|||
3787967|NCT01856764|3617144|B3|||Weight||kilograms|Mean|80.02|80.02|Standard Deviation|17.762|17.762|||
3787968|NCT01856764|3617145|B2|||Weight||kilograms|Mean|78.31|78.31|Standard Deviation|12.965|12.965|||
3787969|NCT01856764|3617146|B1|||Weight||kilograms|Mean|81.72|81.72|Standard Deviation|21.757|21.757|||
3787970|NCT01856764|3617144|B3|||Height||centimeters|Mean|176.1|176.1|Standard Deviation|9.66|9.66|||
3787971|NCT01856764|3617145|B2|||Height||centimeters|Mean|174.9|174.9|Standard Deviation|10.13|10.13|||
3787972|NCT01856764|3617146|B1|||Height||centimeters|Mean|177.3|177.3|Standard Deviation|9.27|9.27|||
3787973|NCT01856764|3617144|B3|Germany||Region of Enrollment||Participants|Number|40|40.0||||||
3787974|NCT01856764|3617145|B2|Germany||Region of Enrollment||Participants|Number|20|20.0||||||
3787975|NCT01856764|3617146|B1|Germany||Region of Enrollment||Participants|Number|20|20.0||||||
3787976|NCT01856764|3617144|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787977|NCT01856764|3617145|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787978|NCT01856764|3617146|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787979|NCT01856764|3617144|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787980|NCT01856764|3617145|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787981|NCT01856764|3617146|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787982|NCT01856764|3617144|B3||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3787983|NCT01856764|3617145|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3787984|NCT01856764|3617146|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3787985|NCT01856764|3617144|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787986|NCT01856764|3617145|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787987|NCT01856764|3617146|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787988|NCT01856764|3617144|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787989|NCT01856764|3617145|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787990|NCT01856764|3617146|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787991|NCT01856764|3617144|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787992|NCT01856764|3617145|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787993|NCT01856764|3617146|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787994|NCT01856764|3617144|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787995|NCT01856764|3617145|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787996|NCT01856764|3617146|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3787997|NCT01856764|3617144|B3||Male|Gender||Participants|Count of Participants|20|20.0||||||
3787998|NCT01856764|3617145|B2||Male|Gender||Participants|Count of Participants|9|9.0||||||
3787999|NCT01856764|3617146|B1||Male|Gender||Participants|Count of Participants|11|11.0||||||
3788000|NCT01856764|3617144|B3||Female|Gender||Participants|Count of Participants|20|20.0||||||
3788001|NCT01856764|3617145|B2||Female|Gender||Participants|Count of Participants|11|11.0||||||
3788002|NCT01856764|3617146|B1||Female|Gender||Participants|Count of Participants|9|9.0||||||
3788003|NCT01856764|3617144|B3|||Age||Years|Mean|34.6|34.6|Standard Deviation|10.66|10.66|||
3788004|NCT01856764|3617145|B2|||Age||Years|Mean|36.5|36.5|Standard Deviation|9.65|9.65|||
3788005|NCT01856764|3617146|B1|||Age||Years|Mean|32.7|32.7|Standard Deviation|11.50|11.5|||
3788006|NCT01856686|3617157|B3|||Behavior (clinical scale)|Behavior assessed by total score of clinical questionnaire (sum of Hyperactivity, Impulsivity and Inattention scores). Range: minimum value: 0 and maximum value: 25. Higher values represent a worse outcome.|units on a scale|Mean|16.19|16.19|Standard Deviation|5.29|5.29|||
3788007|NCT01856686|3617158|B2|||Behavior (clinical scale)|Behavior assessed by total score of clinical questionnaire (sum of Hyperactivity, Impulsivity and Inattention scores). Range: minimum value: 0 and maximum value: 25. Higher values represent a worse outcome.|units on a scale|Mean|16.55|16.55|Standard Deviation|5.76|5.76|||
3788008|NCT01856686|3617159|B1|||Behavior (clinical scale)|Behavior assessed by total score of clinical questionnaire (sum of Hyperactivity, Impulsivity and Inattention scores). Range: minimum value: 0 and maximum value: 25. Higher values represent a worse outcome.|units on a scale|Mean|15.88|15.88|Standard Deviation|4.95|4.95|||
3788009|NCT01856686|3617157|B3|||Inattention score (clinical score)|Inattention score from clinical questionnaire. Range: minimum value: 0 and maximum value: 9. Higher values represent a worse outcome.|units on a scale|Mean|7.79|7.79|Standard Deviation|1.54|1.54|||
3788010|NCT01856686|3617158|B2|||Inattention score (clinical score)|Inattention score from clinical questionnaire. Range: minimum value: 0 and maximum value: 9. Higher values represent a worse outcome.|units on a scale|Mean|7.91|7.91|Standard Deviation|1.60|1.6|||
3788011|NCT01856686|3617159|B1|||Inattention score (clinical score)|Inattention score from clinical questionnaire. Range: minimum value: 0 and maximum value: 9. Higher values represent a worse outcome.|units on a scale|Mean|7.69|7.69|Standard Deviation|1.52|1.52|||
3788012|NCT01856686|3617157|B3|||Impulsivity score (clinical scale)|Impulsivity score from clinical questionnaire. Range: minimum value: 0 and maximum value: 8. Higher values represent a worse outcome.|units on a scale|Mean|4.69|4.69|Standard Deviation|2.54|2.54|||
3788013|NCT01856686|3617158|B2|||Impulsivity score (clinical scale)|Impulsivity score from clinical questionnaire. Range: minimum value: 0 and maximum value: 8. Higher values represent a worse outcome.|units on a scale|Mean|4.82|4.82|Standard Deviation|2.74|2.74|||
3788014|NCT01856686|3617159|B1|||Impulsivity score (clinical scale)|Impulsivity score from clinical questionnaire. Range: minimum value: 0 and maximum value: 8. Higher values represent a worse outcome.|units on a scale|Mean|4.58|4.58|Standard Deviation|2.42|2.42|||
3788015|NCT01856686|3617157|B3|||Hyperactivity score (clinical scale)|Hyperactivity score from clinical questionnaire. Range: minimum value: 0 and maximum value: 8. Higher values represent a worse outcome.|units on a scale|Mean|3.71|3.71|Standard Deviation|2.60|2.6|||
3788016|NCT01856686|3617158|B2|||Hyperactivity score (clinical scale)|Hyperactivity score from clinical questionnaire. Range: minimum value: 0 and maximum value: 8. Higher values represent a worse outcome.|units on a scale|Mean|3.82|3.82|Standard Deviation|2.67|2.67|||
3788017|NCT01856686|3617159|B1|||Hyperactivity score (clinical scale)|Hyperactivity score from clinical questionnaire. Range: minimum value: 0 and maximum value: 8. Higher values represent a worse outcome.|units on a scale|Mean|3.62|3.62|Standard Deviation|2.59|2.59|||
3788018|NCT01856686|3617157|B3|||Body mass index||kg/m2|Mean|17.36|17.36|Standard Deviation|3.48|3.48|||
3788019|NCT01856686|3617158|B2|||Body mass index||kg/m2|Mean|18.77|18.77|Standard Deviation|3.66|3.66|||
3788020|NCT01856686|3617159|B1|||Body mass index||kg/m2|Mean|16.16|16.16|Standard Deviation|2.87|2.87|||
3788021|NCT01856686|3617157|B3|||weight||Kilograms|Mean|33.78|33.78|Standard Deviation|10.26|10.26|||
3788022|NCT01856686|3617158|B2|||weight||Kilograms|Mean|38.15|38.15|Standard Deviation|11.36|11.36|||
3788023|NCT01856686|3617159|B1|||weight||Kilograms|Mean|30.09|30.09|Standard Deviation|7.66|7.66|||
3788024|NCT01856686|3617157|B3|||Monastra ratio|Theta wave/ Beta wave ratio|ratio|Mean|23.52|23.52|Standard Deviation|9.23|9.23|||
3788025|NCT01856686|3617158|B2|||Monastra ratio|Theta wave/ Beta wave ratio|ratio|Mean|25.14|25.14|Standard Deviation|9.72|9.72|||
3788026|NCT01856686|3617159|B1|||Monastra ratio|Theta wave/ Beta wave ratio|ratio|Mean|22.15|22.15|Standard Deviation|8.75|8.75|||
3788027|NCT01856686|3617157|B3|||Frontal midline theta activity- amplitude||microvolts|Mean|9.72|9.72|Standard Deviation|7.17|7.17|||
3788028|NCT01856686|3617158|B2|||Frontal midline theta activity- amplitude||microvolts|Mean|11.66|11.66|Standard Deviation|8.17|8.17|||
3788029|NCT01856686|3617159|B1|||Frontal midline theta activity- amplitude||microvolts|Mean|8.08|8.08|Standard Deviation|5.87|5.87|||
3788030|NCT01856686|3617157|B3|||Frontal midline theta activity- frequency||Hertz|Mean|4.78|4.78|Standard Deviation|1.25|1.25|||
3788031|NCT01856686|3617158|B2|||Frontal midline theta activity- frequency||Hertz|Mean|4.88|4.88|Standard Deviation|1.40|1.4|||
3788032|NCT01856686|3617159|B1|||Frontal midline theta activity- frequency||Hertz|Mean|4.69|4.69|Standard Deviation|1.13|1.13|||
3788033|NCT01856686|3617157|B3|||Mu waves-amplitude|Amplitude of mu waves during visual continuous performance task|microvolts|Mean|7.60|7.6|Standard Deviation|7.33|7.33|||
3788034|NCT01856686|3617158|B2|||Mu waves-amplitude|Amplitude of mu waves during visual continuous performance task|microvolts|Mean|7.87|7.87|Standard Deviation|8.09|8.09|||
3788035|NCT01856686|3617159|B1|||Mu waves-amplitude|Amplitude of mu waves during visual continuous performance task|microvolts|Mean|7.38|7.38|Standard Deviation|6.77|6.77|||
3788036|NCT01856686|3617157|B3|||Mu wave frequency|Frequency mu waves during visual continuous performance task|Hertz|Mean|9.08|9.08|Standard Deviation|1.14|1.14|||
3788037|NCT01856686|3617158|B2|||Mu wave frequency|Frequency mu waves during visual continuous performance task|Hertz|Mean|9.09|9.09|Standard Deviation|1.06|1.06|||
3788038|NCT01856686|3617159|B1|||Mu wave frequency|Frequency mu waves during visual continuous performance task|Hertz|Mean|9.07|9.07|Standard Deviation|1.22|1.22|||
3788039|NCT01856686|3617157|B3|||Parietal alpha waves-frequency|Frequency of Parietal alpha waves during visual continuous performance task|Hertz|Mean|8.91|8.91|Standard Deviation|1.00|1.0|||
3788040|NCT01856686|3617158|B2|||Parietal alpha waves-frequency|Frequency of Parietal alpha waves during visual continuous performance task|Hertz|Mean|9.12|9.12|Standard Deviation|0.94|0.94|||
3788041|NCT01856686|3617159|B1|||Parietal alpha waves-frequency|Frequency of Parietal alpha waves during visual continuous performance task|Hertz|Mean|8.72|8.72|Standard Deviation|1.04|1.04|||
3788042|NCT01856686|3617157|B3|||Occipital alpha waves-amplitude|Amplitude of occipital alpha waves during visual continuous performance task|microvolts|Mean|17.95|17.95|Standard Deviation|13.90|13.9|||
3788043|NCT01856686|3617158|B2|||Occipital alpha waves-amplitude|Amplitude of occipital alpha waves during visual continuous performance task|microvolts|Mean|20.56|20.56|Standard Deviation|17.02|17.02|||
3788044|NCT01856686|3617159|B1|||Occipital alpha waves-amplitude|Amplitude of occipital alpha waves during visual continuous performance task|microvolts|Mean|15.75|15.75|Standard Deviation|10.45|10.45|||
3788045|NCT01856686|3617157|B3|||Occipital alpha waves-frequency|Frequency Occipital alpha waves during visual continuous performance task|Hz|Mean|9.55|9.55|Standard Deviation|1.00|1.0|||
3788046|NCT01856686|3617158|B2|||Occipital alpha waves-frequency|Frequency Occipital alpha waves during visual continuous performance task|Hz|Mean|9.48|9.48|Standard Deviation|0.99|0.99|||
3788047|NCT01856686|3617159|B1|||Occipital alpha waves-frequency|Frequency Occipital alpha waves during visual continuous performance task|Hz|Mean|9.62|9.62|Standard Deviation|1.02|1.02|||
3788048|NCT01856686|3617157|B3|||Comission errors|Comission errors during visual continuous performance task from 19 channels EEG recordings (test duration 22 minutes)|errors|Mean|3.77|3.77|Standard Deviation|5.04|5.04|||
3788049|NCT01856686|3617158|B2|||Comission errors|Comission errors during visual continuous performance task from 19 channels EEG recordings (test duration 22 minutes)|errors|Mean|2.82|2.82|Standard Deviation|2.79|2.79|||
3788050|NCT01856686|3617159|B1|||Comission errors|Comission errors during visual continuous performance task from 19 channels EEG recordings (test duration 22 minutes)|errors|Mean|4.58|4.58|Standard Deviation|6.30|6.3|||
3788051|NCT01856686|3617157|B3|||Omission errors|omission errors during visual continuous performance task from 19 channels EEG recordings (test duration 22 minutes)|errors|Mean|18.71|18.71|Standard Deviation|18.28|18.28|||
3788052|NCT01856686|3617158|B2|||Omission errors|omission errors during visual continuous performance task from 19 channels EEG recordings (test duration 22 minutes)|errors|Mean|18.00|18.0|Standard Deviation|15.39|15.39|||
3788053|NCT01856686|3617159|B1|||Omission errors|omission errors during visual continuous performance task from 19 channels EEG recordings (test duration 22 minutes)|errors|Mean|19.31|19.31|Standard Deviation|20.69|20.69|||
3788054|NCT01856686|3617157|B3|||Reaction time|Reaction time during visual continuous performance task from 19 channels EEG recordings|milliseconds|Mean|514.10|514.1|Standard Deviation|81.28|81.28|||
3788055|NCT01856686|3617158|B2|||Reaction time|Reaction time during visual continuous performance task from 19 channels EEG recordings|milliseconds|Mean|506.59|506.59|Standard Deviation|65.74|65.74|||
3788056|NCT01856686|3617159|B1|||Reaction time|Reaction time during visual continuous performance task from 19 channels EEG recordings|milliseconds|Mean|520.46|520.46|Standard Deviation|93.27|93.27|||
3788057|NCT01856686|3617157|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3788058|NCT01856686|3617158|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3788059|NCT01856686|3617159|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3788060|NCT01856686|3617157|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3788061|NCT01856686|3617158|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3788062|NCT01856686|3617159|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3788063|NCT01856686|3617157|B3|||Age||years|Mean|9.23|9.23|Standard Deviation|1.87|1.87|||
3788064|NCT01856686|3617158|B2|||Age||years|Mean|9.41|9.41|Standard Deviation|1.87|1.87|||
3788065|NCT01856686|3617159|B1|||Age||years|Mean|9.08|9.08|Standard Deviation|1.9|1.9|||
3788066|NCT01856673|3617200|B4|Colombia||Region of Enrollment||participants|Number|521|521.0||||||
3788067|NCT01856673|3617201|B3|Colombia||Region of Enrollment||participants|Number|171|171.0||||||
3788068|NCT01856673|3617202|B2|Colombia||Region of Enrollment||participants|Number|175|175.0||||||
3788069|NCT01856673|3617203|B1|Colombia||Region of Enrollment||participants|Number|175|175.0||||||
3788070|NCT01856673|3617200|B4||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3788071|NCT01856673|3617201|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3788072|NCT01856673|3617202|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3788073|NCT01856673|3617203|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3788074|NCT01856673|3617200|B4||Female|Sex: Female, Male||Participants|Count of Participants|456|456.0||||||
3788075|NCT01856673|3617201|B3||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3788076|NCT01856673|3617202|B2||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3788077|NCT01856673|3617203|B1||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3788078|NCT01856673|3617200|B4|Quibdó||Age||years|Mean|45.39|45.39|Standard Deviation|19.09|19.09|||
3788079|NCT01856673|3617201|B3|Quibdó||Age||years|Mean|44.3|44.3|Standard Deviation|18.9|18.9|||
3788080|NCT01856673|3617202|B2|Quibdó||Age||years|Mean|45.3|45.3|Standard Deviation|29.5|29.5|||
3788081|NCT01856673|3617203|B1|Quibdó||Age||years|Mean|46|46.0|Standard Deviation|19|19.0|||
3788082|NCT01856673|3617200|B4|Buenaventura||Age||years|Mean|40.54|40.54|Standard Deviation|14.08|14.08|||
3788083|NCT01856673|3617201|B3|Buenaventura||Age||years|Mean|41.8|41.8|Standard Deviation|14.8|14.8|||
3788084|NCT01856673|3617202|B2|Buenaventura||Age||years|Mean|39.5|39.5|Standard Deviation|13.3|13.3|||
3788085|NCT01856673|3617203|B1|Buenaventura||Age||years|Mean|40.4|40.4|Standard Deviation|14.1|14.1|||
3788086|NCT01856673|3617200|B4||>=65 years|Age||Participants|Count of Participants|62|62.0||||||
3788087|NCT01856673|3617201|B3||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3788088|NCT01856673|3617202|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3788089|NCT01856673|3617203|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3788090|NCT01856673|3617200|B4||Between 18 and 65 years|Age||Participants|Count of Participants|459|459.0||||||
3788091|NCT01856673|3617201|B3||Between 18 and 65 years|Age||Participants|Count of Participants|149|149.0||||||
3788092|NCT01856673|3617202|B2||Between 18 and 65 years|Age||Participants|Count of Participants|157|157.0||||||
3788093|NCT01856673|3617203|B1||Between 18 and 65 years|Age||Participants|Count of Participants|153|153.0||||||
3788094|NCT01856673|3617200|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3788095|NCT01856673|3617201|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3788096|NCT01856673|3617202|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3788097|NCT01856673|3617203|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3788098|NCT01856595|3617216|B10||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3788099|NCT01856595|3617217|B9||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3788100|NCT01856595|3617218|B8||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3788101|NCT01856595|3617219|B7||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3788102|NCT01856595|3617220|B6||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3788103|NCT01856595|3617221|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3788104|NCT01856595|3617222|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3788105|NCT01856595|3617223|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3788106|NCT01856595|3617224|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3788107|NCT01856595|3617225|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3788108|NCT01856595|3617216|B10||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3788109|NCT01856595|3617217|B9||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3788110|NCT01856595|3617218|B8||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3788111|NCT01856595|3617219|B7||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3788112|NCT01856595|3617220|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3788113|NCT01856595|3617221|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3788114|NCT01856595|3617222|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3788115|NCT01856595|3617223|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3788116|NCT01856595|3617224|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3788117|NCT01856595|3617225|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3788118|NCT01856595|3617216|B10|||Age||years|Mean|56.1|56.1|Standard Deviation|7.7|7.7|||
3788119|NCT01856595|3617217|B9|||Age||years|Mean|55|55.0|Standard Deviation|10|10.0|||
3788120|NCT01856595|3617218|B8|||Age||years|Mean|54.2|54.2|Standard Deviation|8.7|8.7|||
3788121|NCT01856595|3617219|B7|||Age||years|Mean|56.3|56.3|Standard Deviation|7.6|7.6|||
3788122|NCT01856595|3617220|B6|||Age||years|Mean|56.1|56.1|Standard Deviation|6.7|6.7|||
3788123|NCT01856595|3617221|B5|||Age||years|Mean|54|54.0|Standard Deviation|10.8|10.8|||
3788124|NCT01856595|3617222|B4|||Age||years|Mean|56.2|56.2|Standard Deviation|7.7|7.7|||
3788125|NCT01856595|3617223|B3|||Age||years|Mean|53.8|53.8|Standard Deviation|5.9|5.9|||
3788126|NCT01856595|3617224|B2|||Age||years|Mean|58.9|58.9|Standard Deviation|5|5.0|||
3788127|NCT01856595|3617225|B1|||Age||years|Mean|58.9|58.9|Standard Deviation|5.1|5.1|||
3788128|NCT01856569|3617466|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3788129|NCT01856569|3617466|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3788130|NCT01856569|3617466|B1|||Age||years|Mean|41.85|41.85|Standard Deviation|12.46|12.46|||
3788131|NCT01856530|3617475|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
3788132|NCT01856530|3617476|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
3788133|NCT01856530|3617477|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3788134|NCT01856530|3617475|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788135|NCT01856530|3617476|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788136|NCT01856530|3617477|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788137|NCT01856530|3617475|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3788138|NCT01856530|3617476|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3788139|NCT01856530|3617477|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3788140|NCT01856530|3617475|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3788141|NCT01856530|3617476|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3788142|NCT01856530|3617477|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3788143|NCT01856530|3617475|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788144|NCT01856530|3617476|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788145|NCT01856530|3617477|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788146|NCT01856530|3617475|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3788147|NCT01856530|3617476|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3788148|NCT01856530|3617477|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3788149|NCT01856530|3617475|B3||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3788150|NCT01856530|3617476|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3788151|NCT01856530|3617477|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3788152|NCT01856530|3617475|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3788153|NCT01856530|3617476|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3788154|NCT01856530|3617477|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3788155|NCT01856530|3617475|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788156|NCT01856530|3617476|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788157|NCT01856530|3617477|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788158|NCT01856530|3617475|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3788159|NCT01856530|3617476|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3788160|NCT01856530|3617477|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3788161|NCT01856530|3617475|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788162|NCT01856530|3617476|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788163|NCT01856530|3617477|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788164|NCT01856530|3617475|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3788165|NCT01856530|3617476|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3788166|NCT01856530|3617477|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3788167|NCT01856530|3617475|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3788168|NCT01856530|3617476|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3788169|NCT01856530|3617477|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3788170|NCT01856530|3617475|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3788171|NCT01856530|3617476|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3788172|NCT01856530|3617477|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3788173|NCT01856530|3617475|B3||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3788174|NCT01856530|3617476|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3788175|NCT01856530|3617477|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3788176|NCT01856530|3617475|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3788177|NCT01856530|3617476|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3788178|NCT01856530|3617477|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3788234|NCT01856322|3617518|B4|Between 18 and 65 years||Age||participants|Number|3|3.0||||||
3788235|NCT01856322|3617519|B3|Between 18 and 65 years||Age||participants|Number|3|3.0||||||
3788179|NCT01856491|3617494|B1||Unknown or Not Reported|Race (NIH/OMB)|Patient demographic data has been collected during the enrollment visit. No study-specific collection was conducted prior to consent.|Participants|Count of Participants|1|1.0||||||
3788180|NCT01856491|3617494|B1||More than one race|Race (NIH/OMB)|Patient demographic data has been collected during the enrollment visit. No study-specific collection was conducted prior to consent.|Participants|Count of Participants|0|0.0||||||
3788181|NCT01856491|3617494|B1||White|Race (NIH/OMB)|Patient demographic data has been collected during the enrollment visit. No study-specific collection was conducted prior to consent.|Participants|Count of Participants|166|166.0||||||
3788182|NCT01856491|3617494|B1||Black or African American|Race (NIH/OMB)|Patient demographic data has been collected during the enrollment visit. No study-specific collection was conducted prior to consent.|Participants|Count of Participants|0|0.0||||||
3788183|NCT01856491|3617494|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Patient demographic data has been collected during the enrollment visit. No study-specific collection was conducted prior to consent.|Participants|Count of Participants|0|0.0||||||
3788184|NCT01856491|3617494|B1||Asian|Race (NIH/OMB)|Patient demographic data has been collected during the enrollment visit. No study-specific collection was conducted prior to consent.|Participants|Count of Participants|0|0.0||||||
3788185|NCT01856491|3617494|B1||American Indian or Alaska Native|Race (NIH/OMB)|Patient demographic data has been collected during the enrollment visit. No study-specific collection was conducted prior to consent.|Participants|Count of Participants|0|0.0||||||
3788186|NCT01856491|3617494|B1||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3788187|NCT01856491|3617494|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3788188|NCT01856491|3617494|B1|||Age||years|Mean|66.90|66.9|Standard Deviation|10.47|10.47|||
3788189|NCT01856361|3617501|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3788190|NCT01856361|3617502|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3788191|NCT01856361|3617503|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3788192|NCT01856361|3617501|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3788193|NCT01856361|3617502|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3788194|NCT01856361|3617503|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3788195|NCT01856361|3617501|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3788196|NCT01856361|3617502|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3788197|NCT01856361|3617503|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3788198|NCT01856361|3617501|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3788199|NCT01856361|3617502|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3788200|NCT01856361|3617503|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3788201|NCT01856361|3617501|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3788202|NCT01856361|3617502|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3788203|NCT01856361|3617503|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3788204|NCT01856322|3617518|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
3788205|NCT01856322|3617519|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3788206|NCT01856322|3617518|B4|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
3788207|NCT01856322|3617519|B3|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
3788208|NCT01856322|3617518|B4|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
3788209|NCT01856322|3617519|B3|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
3788210|NCT01856322|3617518|B4|White||Race (NIH/OMB)||participants|Number|1|1.0||||||
3788211|NCT01856322|3617519|B3|White||Race (NIH/OMB)||participants|Number|1|1.0||||||
3788212|NCT01856322|3617518|B4|Black or African American||Race (NIH/OMB)||participants|Number|2|2.0||||||
3788213|NCT01856322|3617519|B3|Black or African American||Race (NIH/OMB)||participants|Number|2|2.0||||||
3788214|NCT01856322|3617518|B4|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
3788215|NCT01856322|3617519|B3|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
3788216|NCT01856322|3617518|B4|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
3788217|NCT01856322|3617519|B3|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
3788218|NCT01856322|3617518|B4|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
3788219|NCT01856322|3617519|B3|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
3788220|NCT01856322|3617518|B4|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
3788221|NCT01856322|3617519|B3|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
3788222|NCT01856322|3617518|B4|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|3|3.0||||||
3788223|NCT01856322|3617519|B3|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|3|3.0||||||
3788224|NCT01856322|3617518|B4|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
3788225|NCT01856322|3617519|B3|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
3788226|NCT01856322|3617518|B4|Male||Gender||participants|Number|2|2.0||||||
3788227|NCT01856322|3617519|B3|Male||Gender||participants|Number|2|2.0||||||
3788228|NCT01856322|3617518|B4|Female||Gender||participants|Number|1|1.0||||||
3788229|NCT01856322|3617519|B3|Female||Gender||participants|Number|1|1.0||||||
3788230|NCT01856322|3617518|B4|||Age||years|Mean|72|72.0|Standard Deviation|0|0.0|||
3788231|NCT01856322|3617519|B3|||Age||years|Mean|72|72.0|Standard Deviation|0|0.0|||
3788232|NCT01856322|3617518|B4|>=65 years||Age||participants|Number|0|0.0||||||
3788233|NCT01856322|3617519|B3|>=65 years||Age||participants|Number|0|0.0||||||
3788236|NCT01856322|3617518|B4|<=18 years||Age||participants|Number|0|0.0||||||
3788237|NCT01856322|3617519|B3|<=18 years||Age||participants|Number|0|0.0||||||
3788238|NCT01856270|3617530|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3788239|NCT01856270|3617531|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
3788240|NCT01856270|3617532|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3788241|NCT01856270|3617530|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3788242|NCT01856270|3617531|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3788243|NCT01856270|3617532|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3788244|NCT01856270|3617530|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3788245|NCT01856270|3617531|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3788246|NCT01856270|3617532|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3788247|NCT01856270|3617530|B3|||Age||years|Mean|35.7|35.7|Standard Deviation|12.2|12.2|||
3788248|NCT01856270|3617531|B2|||Age||years|Mean|34.6|34.6|Standard Deviation|12.7|12.7|||
3788249|NCT01856270|3617532|B1|||Age||years|Mean|36.8|36.8|Standard Deviation|11.7|11.7|||
3788250|NCT01856270|3617530|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3788251|NCT01856270|3617531|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3788252|NCT01856270|3617532|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3788253|NCT01856270|3617530|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3788254|NCT01856270|3617531|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3788255|NCT01856270|3617532|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3788256|NCT01856270|3617530|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3788257|NCT01856270|3617531|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3788258|NCT01856270|3617532|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3788259|NCT01856257|3617553|B4|United States||Region of Enrollment||participants|Number|69|69.0||||||
3788260|NCT01856257|3617554|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3788261|NCT01856257|3617555|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
3788262|NCT01856257|3617556|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3788263|NCT01856257|3617553|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3788264|NCT01856257|3617554|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3788265|NCT01856257|3617555|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3788266|NCT01856257|3617556|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3788267|NCT01856257|3617553|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788268|NCT01856257|3617554|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788269|NCT01856257|3617555|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788270|NCT01856257|3617556|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788271|NCT01856257|3617553|B4||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3788272|NCT01856257|3617554|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3788273|NCT01856257|3617555|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3788274|NCT01856257|3617556|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3788275|NCT01856257|3617553|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3788276|NCT01856257|3617554|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3788277|NCT01856257|3617555|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3788278|NCT01856257|3617556|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3788279|NCT01856257|3617553|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788280|NCT01856257|3617554|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788281|NCT01856257|3617555|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788282|NCT01856257|3617556|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788283|NCT01856257|3617553|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3788284|NCT01856257|3617554|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788285|NCT01856257|3617555|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3788286|NCT01856257|3617556|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3788287|NCT01856257|3617553|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788288|NCT01856257|3617554|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788289|NCT01856257|3617555|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788290|NCT01856257|3617556|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788291|NCT01856257|3617553|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3788292|NCT01856257|3617554|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3788293|NCT01856257|3617555|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3788294|NCT01856257|3617556|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3788295|NCT01856257|3617553|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3788296|NCT01856257|3617554|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3788297|NCT01856257|3617555|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3788298|NCT01856257|3617556|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3788299|NCT01856257|3617553|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3788300|NCT01856257|3617554|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3788301|NCT01856257|3617555|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3788302|NCT01856257|3617556|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3788303|NCT01856257|3617553|B4||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3788304|NCT01856257|3617554|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3788305|NCT01856257|3617555|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3788306|NCT01856257|3617556|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3788307|NCT01856257|3617553|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3788308|NCT01856257|3617554|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3788309|NCT01856257|3617555|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3788310|NCT01856257|3617556|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3788311|NCT01856257|3617553|B4|||Age||years|Mean|45.9|45.9|Standard Deviation|8.93|8.93|||
3788312|NCT01856257|3617554|B3|||Age||years|Mean|44.6|44.6|Standard Deviation|9.63|9.63|||
3788313|NCT01856257|3617555|B2|||Age||years|Mean|44.5|44.5|Standard Deviation|10.45|10.45|||
3788314|NCT01856257|3617556|B1|||Age||years|Mean|47.7|47.7|Standard Deviation|6.76|6.76|||
3788315|NCT01856257|3617553|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3788316|NCT01856257|3617554|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3788317|NCT01856257|3617555|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3788318|NCT01856257|3617556|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3788319|NCT01856257|3617553|B4||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
3788320|NCT01856257|3617554|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3788321|NCT01856257|3617555|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3788322|NCT01856257|3617556|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3788323|NCT01856257|3617553|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3788324|NCT01856257|3617554|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3788325|NCT01856257|3617555|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3788326|NCT01856257|3617556|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3788327|NCT01856218|3617658|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3788328|NCT01856218|3617658|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3788329|NCT01856218|3617658|B1|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|1|1.0||||||
3788330|NCT01856218|3617658|B1|Children (2-11 years)||Age, Customized||Participants|Count of Participants|2|2.0||||||
3788331|NCT01855997|3617672|B1|Not Known||HBeAg Status||participants|Number|61|61.0||||||
3788332|NCT01855997|3617672|B1|Negative||HBeAg Status||participants|Number|676|676.0||||||
3788333|NCT01855997|3617672|B1|Positive||HBeAg Status||participants|Number|932|932.0||||||
3788334|NCT01855997|3617672|B1||Male|Sex: Female, Male||Participants|Count of Participants|1198|1198.0||||||
3788335|NCT01855997|3617672|B1||Female|Sex: Female, Male||Participants|Count of Participants|471|471.0||||||
3788336|NCT01855997|3617672|B1|||Age||years|Mean|39.09|39.09|Standard Deviation|0.270|0.27|||
3788337|NCT01855958|3617725|B3|Brazil||Region of Enrollment||participants|Number|26|26.0||||||
3788338|NCT01855958|3617726|B2|Brazil||Region of Enrollment||participants|Number|13|13.0||||||
3788339|NCT01855958|3617727|B1|Brazil||Region of Enrollment||participants|Number|13|13.0||||||
3788340|NCT01855958|3617725|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3788341|NCT01855958|3617726|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3788342|NCT01855958|3617727|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3788343|NCT01855958|3617725|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3788344|NCT01855958|3617726|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3788345|NCT01855958|3617727|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3788346|NCT01855958|3617725|B3|||Age||years|Mean|64.50|64.5|Standard Deviation|7.72|7.72|||
3788347|NCT01855958|3617726|B2|||Age||years|Mean|63.55|63.55|Standard Deviation|7.54|7.54|||
3788348|NCT01855958|3617727|B1|||Age||years|Mean|66.85|66.85|Standard Deviation|7.53|7.53|||
3788349|NCT01855958|3617725|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3788350|NCT01855958|3617726|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3788351|NCT01855958|3617727|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3788352|NCT01855958|3617725|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3788353|NCT01855958|3617726|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3788354|NCT01855958|3617727|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3788355|NCT01855958|3617725|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3788356|NCT01855958|3617726|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3788357|NCT01855958|3617727|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3788358|NCT01855945|3617746|B13||Male|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
3788359|NCT01855945|3617747|B12||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3788360|NCT01855945|3617748|B11||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3788361|NCT01855945|3617749|B10||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3788362|NCT01855945|3617750|B9||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3788363|NCT01855945|3617751|B8||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3788364|NCT01855945|3617752|B7||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3788365|NCT01855945|3617753|B6||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3788366|NCT01855945|3617754|B5||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3788367|NCT01855945|3617755|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3788368|NCT01855945|3617756|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3788369|NCT01855945|3617757|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3788370|NCT01855945|3617758|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3788371|NCT01855945|3617746|B13||Female|Sex: Female, Male||Participants|Count of Participants|336|336.0||||||
3788372|NCT01855945|3617747|B12||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3788373|NCT01855945|3617748|B11||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3788374|NCT01855945|3617749|B10||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3788375|NCT01855945|3617750|B9||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3788376|NCT01855945|3617751|B8||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3788377|NCT01855945|3617752|B7||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3788378|NCT01855945|3617753|B6||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3788379|NCT01855945|3617754|B5||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3788380|NCT01855945|3617755|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3788381|NCT01855945|3617756|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3788382|NCT01855945|3617757|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3788383|NCT01855945|3617758|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3788384|NCT01855945|3617746|B13|||Age||YEARS|Mean|33.2|33.2|Standard Deviation|27.5|27.5|||
3788385|NCT01855945|3617747|B12|||Age||YEARS|Mean|73.8|73.8|Standard Deviation|6.1|6.1|||
3788386|NCT01855945|3617748|B11|||Age||YEARS|Mean|72.9|72.9|Standard Deviation|6.1|6.1|||
3788387|NCT01855945|3617749|B10|||Age||YEARS|Mean|71.3|71.3|Standard Deviation|5.3|5.3|||
3788388|NCT01855945|3617750|B9|||Age||YEARS|Mean|44|44.0|Standard Deviation|14.9|14.9|||
3788389|NCT01855945|3617751|B8|||Age||YEARS|Mean|42.4|42.4|Standard Deviation|13.3|13.3|||
3788390|NCT01855945|3617752|B7|||Age||YEARS|Mean|42.3|42.3|Standard Deviation|12.8|12.8|||
3788391|NCT01855945|3617753|B6|||Age||YEARS|Mean|12.3|12.3|Standard Deviation|2.4|2.4|||
3788392|NCT01855945|3617754|B5|||Age||YEARS|Mean|12.8|12.8|Standard Deviation|2.4|2.4|||
3788393|NCT01855945|3617755|B4|||Age||YEARS|Mean|12.6|12.6|Standard Deviation|2.7|2.7|||
3788394|NCT01855945|3617756|B3|||Age||YEARS|Mean|6.2|6.2|Standard Deviation|1.6|1.6|||
3788395|NCT01855945|3617757|B2|||Age||YEARS|Mean|6|6.0|Standard Deviation|1.6|1.6|||
3788396|NCT01855945|3617758|B1|||Age||YEARS|Mean|6|6.0|Standard Deviation|1.7|1.7|||
3788397|NCT01855919|3617903|B3|Japan||Region of Enrollment||participants|Number|456|456.0||||||
3788398|NCT01855919|3617904|B2|Japan||Region of Enrollment||participants|Number|226|226.0||||||
3788399|NCT01855919|3617905|B1|Japan||Region of Enrollment||participants|Number|230|230.0||||||
3788400|NCT01855919|3617903|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788401|NCT01855919|3617904|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788402|NCT01855919|3617905|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788403|NCT01855919|3617903|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788404|NCT01855919|3617904|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788405|NCT01855919|3617905|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788406|NCT01855919|3617903|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788407|NCT01855919|3617904|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788408|NCT01855919|3617905|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788409|NCT01855919|3617903|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788410|NCT01855919|3617904|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788411|NCT01855919|3617905|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788412|NCT01855919|3617903|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788413|NCT01855919|3617904|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788414|NCT01855919|3617905|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788415|NCT01855919|3617903|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|456|456.0||||||
3788416|NCT01855919|3617904|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|226|226.0||||||
3788417|NCT01855919|3617905|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|230|230.0||||||
3788418|NCT01855919|3617903|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788419|NCT01855919|3617904|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788420|NCT01855919|3617905|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788421|NCT01855919|3617903|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788422|NCT01855919|3617904|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788423|NCT01855919|3617905|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788424|NCT01855919|3617903|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|456|456.0||||||
3788425|NCT01855919|3617904|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|226|226.0||||||
3788426|NCT01855919|3617905|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|230|230.0||||||
3788427|NCT01855919|3617903|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788428|NCT01855919|3617904|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788429|NCT01855919|3617905|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788430|NCT01855919|3617903|B3||Male|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
3788431|NCT01855919|3617904|B2||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3788432|NCT01855919|3617905|B1||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3788433|NCT01855919|3617903|B3||Female|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
3788434|NCT01855919|3617904|B2||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3788435|NCT01855919|3617905|B1||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3788436|NCT01855919|3617903|B3|||Age||years|Mean|58.9|58.9|Standard Deviation|13.4|13.4|||
3788437|NCT01855919|3617904|B2|||Age||years|Mean|57.8|57.8|Standard Deviation|13.7|13.7|||
3788438|NCT01855919|3617905|B1|||Age||years|Mean|60.0|60.0|Standard Deviation|13.2|13.2|||
3788439|NCT01855789|3617938|B1||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3788440|NCT01855789|3617938|B1||Female|Sex: Female, Male||Participants|Count of Participants|556|556.0||||||
3788441|NCT01855789|3617938|B1|||Age||years|Mean|55.8|55.8|Standard Deviation|12.31|12.31|||
3788442|NCT01855425|3617963|B1|France||Region of Enrollment||participants|Number|45|45.0||||||
3788443|NCT01855425|3617963|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3788444|NCT01855425|3617963|B1|Belgium||Region of Enrollment||participants|Number|32|32.0||||||
3788445|NCT01855425|3617963|B1||Male|Sex: Female, Male|gender data was not collected|Participants|Count of Participants|NA|||||||gender data was not collected
3788446|NCT01855425|3617963|B1||Female|Sex: Female, Male|gender data was not collected|Participants|Count of Participants|NA|||||||gender data was not collected
3788447|NCT01855425|3617963|B1|> 18 years - < 80 years||Age, Customized||participants|Number|96|96.0||||||
3788448|NCT01855074|3617967|B1||Male|Sex: Female, Male|Safety set (SS) population (N=79) included all participants who received at least 1 dose of study drug.|Participants|Count of Participants|47|47.0||||||
3788449|NCT01855074|3617967|B1||Female|Sex: Female, Male|Safety set (SS) population (N=79) included all participants who received at least 1 dose of study drug.|Participants|Count of Participants|32|32.0||||||
3788450|NCT01855074|3617967|B1|||Age|Safety set (SS) population (N=79) included all participants who received at least 1 dose of study drug.|Years|Mean|43.0|43.0|Standard Deviation|12.4|12.4|||
3788451|NCT01854944|3617976|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3788452|NCT01854944|3617977|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3788453|NCT01854944|3617978|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3788454|NCT01854944|3617979|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3788455|NCT01854944|3617976|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3788456|NCT01854944|3617977|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3788457|NCT01854944|3617978|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3788458|NCT01854944|3617979|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3788459|NCT01854944|3617976|B4|||Age||Years|Mean|41.3|41.3|Standard Deviation|8.1|8.1|||
3788460|NCT01854944|3617977|B3|||Age||Years|Mean|45|45.0|Standard Deviation|6.9|6.9|||
3788461|NCT01854944|3617978|B2|||Age||Years|Mean|40.8|40.8|Standard Deviation|11.9|11.9|||
3788462|NCT01854944|3617979|B1|||Age||Years|Mean|38.3|38.3|Standard Deviation|4.4|4.4|||
3788463|NCT01854905|3618031|B1||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3788464|NCT01854905|3618031|B1||Female|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
3788465|NCT01854905|3618031|B1|||Age||Years|Mean|29.7|29.7|Standard Deviation|9.97|9.97|||
3788466|NCT01854827|3618035|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3788467|NCT01854827|3618035|B1|Canada||Region of Enrollment||participants|Number|7|7.0||||||
3788468|NCT01854827|3618035|B1|Ethnicity|Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3788469|NCT01854827|3618035|B1|Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3788470|NCT01854827|3618035|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3788471|NCT01854827|3618035|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788472|NCT01854827|3618035|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3788473|NCT01854827|3618035|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3788474|NCT01854827|3618035|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788475|NCT01854827|3618035|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3788476|NCT01854827|3618035|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788477|NCT01854827|3618035|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3788478|NCT01854827|3618035|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3788479|NCT01854827|3618035|B1|||Age||Days|Mean|60.0|60.0|Standard Deviation|18.6|18.6|||
3788480|NCT01854710|3618047|B1|Netherlands||Region of Enrollment||participants|Number|60|60.0||||||
3788481|NCT01854710|3618047|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3788482|NCT01854710|3618047|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3788483|NCT01854710|3618047|B1|||Age||years|Mean|33.8|33.8|Standard Deviation|14.89|14.89|||
3788484|NCT01854710|3618047|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3788485|NCT01854710|3618047|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3788486|NCT01854710|3618047|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3788487|NCT01854697|3618068|B6||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3788488|NCT01854697|3618069|B5||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3788489|NCT01854697|3618070|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3788490|NCT01854697|3618071|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3788491|NCT01854697|3618072|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3788492|NCT01854697|3618073|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3788493|NCT01854697|3618068|B6||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3788494|NCT01854697|3618069|B5||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3788495|NCT01854697|3618070|B4||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3788496|NCT01854697|3618071|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3788497|NCT01854697|3618072|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3788498|NCT01854697|3618073|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3788499|NCT01854697|3618068|B6|>= 55 years||Age, Customized||participants|Number|92|92.0||||||
3788500|NCT01854697|3618069|B5|>= 55 years||Age, Customized||participants|Number|10|10.0||||||
3788501|NCT01854697|3618070|B4|>= 55 years||Age, Customized||participants|Number|23|23.0||||||
3788502|NCT01854697|3618071|B3|>= 55 years||Age, Customized||participants|Number|25|25.0||||||
3788503|NCT01854697|3618072|B2|>= 55 years||Age, Customized||participants|Number|11|11.0||||||
3788504|NCT01854697|3618073|B1|>= 55 years||Age, Customized||participants|Number|23|23.0||||||
3788505|NCT01854697|3618068|B6|< 55 years||Age, Customized||participants|Number|219|219.0||||||
3788506|NCT01854697|3618069|B5|< 55 years||Age, Customized||participants|Number|31|31.0||||||
3788507|NCT01854697|3618070|B4|< 55 years||Age, Customized||participants|Number|60|60.0||||||
3788508|NCT01854697|3618071|B3|< 55 years||Age, Customized||participants|Number|59|59.0||||||
3788509|NCT01854697|3618072|B2|< 55 years||Age, Customized||participants|Number|23|23.0||||||
3788510|NCT01854697|3618073|B1|< 55 years||Age, Customized||participants|Number|46|46.0||||||
3788511|NCT01854697|3618068|B6|||Age||years|Mean|46.2|46.2|Standard Deviation|11.75|11.75|||
3788512|NCT01854697|3618069|B5|||Age||years|Mean|45.9|45.9|Standard Deviation|10.78|10.78|||
3788513|NCT01854697|3618070|B4|||Age||years|Mean|47.1|47.1|Standard Deviation|11.33|11.33|||
3788514|NCT01854697|3618071|B3|||Age||years|Mean|46.2|46.2|Standard Deviation|11.34|11.34|||
3788515|NCT01854697|3618072|B2|||Age||years|Mean|44.5|44.5|Standard Deviation|14.10|14.1|||
3788516|NCT01854697|3618073|B1|||Age||years|Mean|46.1|46.1|Standard Deviation|12.25|12.25|||
3788517|NCT01854658|3618117|B5||Male|Sex: Female, Male||Participants|Count of Participants|886|886.0||||||
3788518|NCT01854658|3618118|B4||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3788519|NCT01854658|3618119|B3||Male|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
3788520|NCT01854658|3618120|B2||Male|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
3788521|NCT01854658|3618121|B1||Male|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
3788522|NCT01854658|3618117|B5||Female|Sex: Female, Male||Participants|Count of Participants|723|723.0||||||
3788523|NCT01854658|3618118|B4||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3788524|NCT01854658|3618119|B3||Female|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
3788525|NCT01854658|3618120|B2||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
3788526|NCT01854658|3618121|B1||Female|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
3788527|NCT01854658|3618117|B5|||Age||Years|Mean|62.9|62.9|Standard Deviation|8.3|8.3|||
3788528|NCT01854658|3618118|B4|||Age||Years|Mean|64.2|64.2|Standard Deviation|8.7|8.7|||
3788529|NCT01854658|3618119|B3|||Age||Years|Mean|62.8|62.8|Standard Deviation|8.2|8.2|||
3788530|NCT01854658|3618120|B2|||Age||Years|Mean|62.8|62.8|Standard Deviation|8.4|8.4|||
3788531|NCT01854658|3618121|B1|||Age||Years|Mean|62.6|62.6|Standard Deviation|7.8|7.8|||
3788532|NCT01854645|3618154|B6||Male|Sex: Female, Male||Participants|Count of Participants|1182|1182.0||||||
3788533|NCT01854645|3618155|B5||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3788534|NCT01854645|3618156|B4||Male|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
3788535|NCT01854645|3618157|B3||Male|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
3788536|NCT01854645|3618158|B2||Male|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
3788537|NCT01854645|3618159|B1||Male|Sex: Female, Male||Participants|Count of Participants|290|290.0||||||
3788538|NCT01854645|3618154|B6||Female|Sex: Female, Male||Participants|Count of Participants|914|914.0||||||
3788539|NCT01854645|3618155|B5||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3788540|NCT01854645|3618156|B4||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3788541|NCT01854645|3618157|B3||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
3788542|NCT01854645|3618158|B2||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
3788543|NCT01854645|3618159|B1||Female|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
3788544|NCT01854645|3618154|B6|||Age||Years|Mean|62.8|62.8|Standard Deviation|8.4|8.4|||
3788545|NCT01854645|3618155|B5|||Age||Years|Mean|62.5|62.5|Standard Deviation|8.3|8.3|||
3788546|NCT01854645|3618156|B4|||Age||Years|Mean|63.0|63.0|Standard Deviation|8.6|8.6|||
3788547|NCT01854645|3618157|B3|||Age||Years|Mean|63.0|63.0|Standard Deviation|8.3|8.3|||
3788548|NCT01854645|3618158|B2|||Age||Years|Mean|62.9|62.9|Standard Deviation|8.4|8.4|||
3788549|NCT01854645|3618159|B1|||Age||Years|Mean|62.6|62.6|Standard Deviation|8.4|8.4|||
3788550|NCT01854632|3618200|B3|Senegal||Region of Enrollment||participants|Number|1761|1761.0||||||
3788551|NCT01854632|3618201|B2|Senegal||Region of Enrollment||participants|Number|587|587.0||||||
3788552|NCT01854632|3618202|B1|Senegal||Region of Enrollment||participants|Number|1174|1174.0||||||
3788553|NCT01854632|3618200|B3||Male|Sex: Female, Male||Participants|Count of Participants|907|907.0||||||
3788554|NCT01854632|3618201|B2||Male|Sex: Female, Male||Participants|Count of Participants|297|297.0||||||
3788555|NCT01854632|3618202|B1||Male|Sex: Female, Male||Participants|Count of Participants|610|610.0||||||
3788556|NCT01854632|3618200|B3||Female|Sex: Female, Male||Participants|Count of Participants|854|854.0||||||
3788557|NCT01854632|3618201|B2||Female|Sex: Female, Male||Participants|Count of Participants|290|290.0||||||
3788558|NCT01854632|3618202|B1||Female|Sex: Female, Male||Participants|Count of Participants|564|564.0||||||
3788559|NCT01854632|3618200|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3788560|NCT01854632|3618201|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3788561|NCT01854632|3618202|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3788562|NCT01854632|3618200|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3788563|NCT01854632|3618201|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3788564|NCT01854632|3618202|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3788565|NCT01854632|3618200|B3||<=18 years|Age||Participants|Count of Participants|1761|1761.0||||||
3788566|NCT01854632|3618201|B2||<=18 years|Age||Participants|Count of Participants|587|587.0||||||
3788567|NCT01854632|3618202|B1||<=18 years|Age||Participants|Count of Participants|1174|1174.0||||||
3788568|NCT01854593|3618209|B3|||preoperative Iris neovascularization or neovascular glaucoma||participants|Number|4|4.0||||||
3788569|NCT01854593|3618210|B2|||preoperative Iris neovascularization or neovascular glaucoma||participants|Number|2|2.0||||||
3788570|NCT01854593|3618211|B1|||preoperative Iris neovascularization or neovascular glaucoma||participants|Number|2|2.0||||||
3788571|NCT01854593|3618209|B3|Incomplete||Previous panretinal photocoagulation||participants|Number|46|46.0||||||
3788572|NCT01854593|3618210|B2|Incomplete||Previous panretinal photocoagulation||participants|Number|23|23.0||||||
3788573|NCT01854593|3618211|B1|Incomplete||Previous panretinal photocoagulation||participants|Number|23|23.0||||||
3788574|NCT01854593|3618209|B3|None||Previous panretinal photocoagulation||participants|Number|20|20.0||||||
3788575|NCT01854593|3618210|B2|None||Previous panretinal photocoagulation||participants|Number|11|11.0||||||
3788576|NCT01854593|3618211|B1|None||Previous panretinal photocoagulation||participants|Number|9|9.0||||||
3788577|NCT01854593|3618209|B3|||Persistent vitreous hemorrhage||participants|Number|59|59.0||||||
3788578|NCT01854593|3618210|B2|||Persistent vitreous hemorrhage||participants|Number|30|30.0||||||
3788579|NCT01854593|3618211|B1|||Persistent vitreous hemorrhage||participants|Number|29|29.0||||||
3788580|NCT01854593|3618209|B3|pseudophakic||Lens status||participants|Number|7|7.0||||||
3788581|NCT01854593|3618210|B2|pseudophakic||Lens status||participants|Number|3|3.0||||||
3788582|NCT01854593|3618211|B1|pseudophakic||Lens status||participants|Number|4|4.0||||||
3788583|NCT01854593|3618209|B3|phakic||Lens status||participants|Number|59|59.0||||||
3788584|NCT01854593|3618210|B2|phakic||Lens status||participants|Number|31|31.0||||||
3788585|NCT01854593|3618211|B1|phakic||Lens status||participants|Number|28|28.0||||||
3788586|NCT01854593|3618209|B3|No||Use of anticoagulants||participants|Number|51|51.0||||||
3788587|NCT01854593|3618210|B2|No||Use of anticoagulants||participants|Number|26|26.0||||||
3788588|NCT01854593|3618211|B1|No||Use of anticoagulants||participants|Number|25|25.0||||||
3788589|NCT01854593|3618209|B3|Yes||Use of anticoagulants||participants|Number|15|15.0||||||
3788590|NCT01854593|3618210|B2|Yes||Use of anticoagulants||participants|Number|8|8.0||||||
3788591|NCT01854593|3618211|B1|Yes||Use of anticoagulants||participants|Number|7|7.0||||||
3788592|NCT01854593|3618209|B3|||HbA1c||%|Mean|7.8|7.8|Standard Deviation|1.6|1.6|||
3788593|NCT01854593|3618210|B2|||HbA1c||%|Mean|7.6|7.6|Standard Deviation|2.0|2.0|||
3788594|NCT01854593|3618211|B1|||HbA1c||%|Mean|8.0|8.0|Standard Deviation|1.7|1.7|||
3788595|NCT01854593|3618209|B3|No||Hyperlipidemia||participants|Number|54|54.0||||||
3788596|NCT01854593|3618210|B2|No||Hyperlipidemia||participants|Number|27|27.0||||||
3788597|NCT01854593|3618211|B1|No||Hyperlipidemia||participants|Number|27|27.0||||||
3788598|NCT01854593|3618209|B3|Yes||Hyperlipidemia||participants|Number|12|12.0||||||
3788599|NCT01854593|3618210|B2|Yes||Hyperlipidemia||participants|Number|7|7.0||||||
3788600|NCT01854593|3618211|B1|Yes||Hyperlipidemia||participants|Number|5|5.0||||||
3788601|NCT01854593|3618209|B3|No||Hypertension||participants|Number|36|36.0||||||
3788602|NCT01854593|3618210|B2|No||Hypertension||participants|Number|18|18.0||||||
3788603|NCT01854593|3618211|B1|No||Hypertension||participants|Number|18|18.0||||||
3788604|NCT01854593|3618209|B3|Yes||Hypertension||participants|Number|30|30.0||||||
3788605|NCT01854593|3618210|B2|Yes||Hypertension||participants|Number|16|16.0||||||
3788606|NCT01854593|3618211|B1|Yes||Hypertension||participants|Number|14|14.0||||||
3788607|NCT01854593|3618209|B3|||Intra Ocular Pressure||mm Hg|Mean|15.0|15.0|Standard Deviation|3.11|3.11|||
3788608|NCT01854593|3618210|B2|||Intra Ocular Pressure||mm Hg|Mean|14.6|14.6|Standard Deviation|3.42|3.42|||
3788609|NCT01854593|3618211|B1|||Intra Ocular Pressure||mm Hg|Mean|15.3|15.3|Standard Deviation|2.69|2.69|||
3788610|NCT01854593|3618209|B3|||Preoperative best corrected visual acuity|Preoperative best corrected visual acuity|LogMAR|Log Mean|1.11|1.11|Standard Deviation|0.59|0.59|||
3788611|NCT01854593|3618210|B2|||Preoperative best corrected visual acuity|Preoperative best corrected visual acuity|LogMAR|Log Mean|1.14|1.14|Standard Deviation|0.58|0.58|||
3788612|NCT01854593|3618211|B1|||Preoperative best corrected visual acuity|Preoperative best corrected visual acuity|LogMAR|Log Mean|1.09|1.09|Standard Deviation|0.60|0.6|||
3788613|NCT01854593|3618209|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3788614|NCT01854593|3618210|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3788615|NCT01854593|3618211|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3788616|NCT01854593|3618209|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3788617|NCT01854593|3618210|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3788618|NCT01854593|3618211|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3788619|NCT01854593|3618209|B3|||Age||years|Mean|59.6|59.6|Standard Deviation|12.4|12.4|||
3788620|NCT01854593|3618210|B2|||Age||years|Mean|59.2|59.2|Standard Deviation|12.9|12.9|||
3788621|NCT01854593|3618211|B1|||Age||years|Mean|59.9|59.9|Standard Deviation|11.8|11.8|||
3788622|NCT01854528|3618242|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3788623|NCT01854528|3618243|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3788624|NCT01854528|3618244|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3788625|NCT01854528|3618242|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3788626|NCT01854528|3618243|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3788627|NCT01854528|3618244|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3788628|NCT01854528|3618242|B3|||Age||years|Median|46.3|46.3|Standard Deviation|11.61|11.61|||
3788629|NCT01854528|3618243|B2|||Age||years|Median|45.0|45.0|Standard Deviation|10.35|10.35|||
3788630|NCT01854528|3618244|B1|||Age||years|Median|46.9|46.9|Standard Deviation|12.15|12.15|||
3788631|NCT01854281|3618261|B5|||history of decompression sickness|number of divers with history of decompression sickness as reported by the divers.|participants|Number|31|31.0||||||
3788632|NCT01854281|3618262|B4|||history of decompression sickness|number of divers with history of decompression sickness as reported by the divers.|participants|Number|3|3.0||||||
3788633|NCT01854281|3618263|B3|||history of decompression sickness|number of divers with history of decompression sickness as reported by the divers.|participants|Number|4|4.0||||||
3788634|NCT01854281|3618264|B2|||history of decompression sickness|number of divers with history of decompression sickness as reported by the divers.|participants|Number|10|10.0||||||
3788635|NCT01854281|3618265|B1|||history of decompression sickness|number of divers with history of decompression sickness as reported by the divers.|participants|Number|14|14.0||||||
3788636|NCT01854281|3618261|B5|||Number of decompression dives|Total number of decompression dives in history reported by the diver.|Dives|Mean|127|127.0|Standard Deviation|228|228.0|||
3788637|NCT01854281|3618262|B4|||Number of decompression dives|Total number of decompression dives in history reported by the diver.|Dives|Mean|44|44.0|Standard Deviation|82|82.0|||
3788638|NCT01854281|3618263|B3|||Number of decompression dives|Total number of decompression dives in history reported by the diver.|Dives|Mean|150|150.0|Standard Deviation|162|162.0|||
3788639|NCT01854281|3618264|B2|||Number of decompression dives|Total number of decompression dives in history reported by the diver.|Dives|Mean|70|70.0|Standard Deviation|180|180.0|||
3788640|NCT01854281|3618265|B1|||Number of decompression dives|Total number of decompression dives in history reported by the diver.|Dives|Mean|251|251.0|Standard Deviation|314|314.0|||
3788641|NCT01854281|3618261|B5|||Number of dives|Total number of dives in history reported by the diver.|Dives|Mean|622|622.0|Standard Deviation|1238|1238.0|||
3788642|NCT01854281|3618262|B4|||Number of dives|Total number of dives in history reported by the diver.|Dives|Mean|191|191.0|Standard Deviation|339|339.0|||
3788643|NCT01854281|3618263|B3|||Number of dives|Total number of dives in history reported by the diver.|Dives|Mean|998|998.0|Standard Deviation|1851|1851.0|||
3788644|NCT01854281|3618264|B2|||Number of dives|Total number of dives in history reported by the diver.|Dives|Mean|412|412.0|Standard Deviation|984|984.0|||
3788645|NCT01854281|3618265|B1|||Number of dives|Total number of dives in history reported by the diver.|Dives|Mean|1237|1237.0|Standard Deviation|1762|1762.0|||
3788646|NCT01854281|3618261|B5|||Body mass index||kg/m2|Mean|26.3|26.3|Standard Deviation|3.9|3.9|||
3788647|NCT01854281|3618262|B4|||Body mass index||kg/m2|Mean|25.2|25.2|Standard Deviation|2.2|2.2|||
3788648|NCT01854281|3618263|B3|||Body mass index||kg/m2|Mean|28.3|28.3|Standard Deviation|5.7|5.7|||
3788649|NCT01854281|3618264|B2|||Body mass index||kg/m2|Mean|25.9|25.9|Standard Deviation|4.2|4.2|||
3788650|NCT01854281|3618265|B1|||Body mass index||kg/m2|Mean|27.3|27.3|Standard Deviation|3.9|3.9|||
3788651|NCT01854281|3618261|B5|Czech Republic||Region of Enrollment||participants|Number|47|47.0||||||
3788652|NCT01854281|3618262|B4|Czech Republic||Region of Enrollment||participants|Number|8|8.0||||||
3788653|NCT01854281|3618263|B3|Czech Republic||Region of Enrollment||participants|Number|5|5.0||||||
3788654|NCT01854281|3618264|B2|Czech Republic||Region of Enrollment||participants|Number|19|19.0||||||
3788655|NCT01854281|3618265|B1|Czech Republic||Region of Enrollment||participants|Number|15|15.0||||||
3788656|NCT01854281|3618261|B5||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3788657|NCT01854281|3618262|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3788658|NCT01854281|3618263|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3788659|NCT01854281|3618264|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3788660|NCT01854281|3618265|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3788661|NCT01854281|3618261|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3788662|NCT01854281|3618262|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3788663|NCT01854281|3618263|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3788664|NCT01854281|3618264|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3788665|NCT01854281|3618265|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3788666|NCT01854281|3618261|B5|||Age||years|Mean|35|35.0|Standard Deviation|8.6|8.6|||
3788667|NCT01854281|3618262|B4|||Age||years|Mean|33|33.0|Standard Deviation|4.8|4.8|||
3788668|NCT01854281|3618263|B3|||Age||years|Mean|33|33.0|Standard Deviation|12.1|12.1|||
3788669|NCT01854281|3618264|B2|||Age||years|Mean|33|33.0|Standard Deviation|7.6|7.6|||
3788670|NCT01854281|3618265|B1|||Age||years|Mean|41|41.0|Standard Deviation|8.5|8.5|||
3788671|NCT01854281|3618261|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3788672|NCT01854281|3618262|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3788673|NCT01854281|3618263|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3788674|NCT01854281|3618264|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3788675|NCT01854281|3618265|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3788676|NCT01854281|3618261|B5||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3788677|NCT01854281|3618262|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3788678|NCT01854281|3618263|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3788679|NCT01854281|3618264|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3788680|NCT01854281|3618265|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3788681|NCT01854281|3618261|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3788682|NCT01854281|3618262|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3788683|NCT01854281|3618263|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3788684|NCT01854281|3618264|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3788685|NCT01854281|3618265|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3788686|NCT01854268|3618278|B1|||Urge-to-cough||units on a scale|Median|7|7.0|Standard Deviation|.32|0.32|||
3788687|NCT01854268|3618278|B1|||Peak expiratory airflow rate||Liters/second|Mean|6.058|6.058|Standard Deviation|.56|0.56|||
3788688|NCT01854268|3618278|B1|||Lung volume initiation||%vital capacity, relative to EEL|Mean|23.3|23.3|Standard Deviation|5.8|5.8|||
3788689|NCT01854268|3618278|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3788690|NCT01854268|3618278|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3788691|NCT01854268|3618278|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3788692|NCT01854268|3618278|B1|||Age||years|Mean|23.3|23.3|Standard Deviation|3.3|3.3|||
3788693|NCT01854268|3618278|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3788694|NCT01854268|3618278|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3788695|NCT01854268|3618278|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3788696|NCT01854242|3618284|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3788697|NCT01854242|3618284|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3788698|NCT01854242|3618284|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3788699|NCT01854242|3618284|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3788700|NCT01854242|3618284|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3788701|NCT01854242|3618284|B1||<=18 years|Age||Participants|Count of Participants|32|32.0||||||
3788702|NCT01854177|3618288|B1|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3788703|NCT01854177|3618288|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3788704|NCT01854177|3618288|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3788705|NCT01854177|3618288|B1|||Age||years|Mean|70.6|70.6|Standard Deviation|6.6|6.6|||
3788706|NCT01854138|3618296|B3||Male|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
3788707|NCT01854138|3618297|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3788708|NCT01854138|3618298|B1||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3788709|NCT01854138|3618296|B3||Female|Sex: Female, Male||Participants|Count of Participants|345|345.0||||||
3788710|NCT01854138|3618297|B2||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3788711|NCT01854138|3618298|B1||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
3788712|NCT01854138|3618296|B3|||Age||years|Mean|66.8|66.8|Standard Deviation|10.6|10.6|||
3788713|NCT01854138|3618297|B2|||Age||years|Mean|66.9|66.9|Standard Deviation|10.2|10.2|||
3788714|NCT01854138|3618298|B1|||Age||years|Mean|66.8|66.8|Standard Deviation|10.8|10.8|||
3788715|NCT01854047|3618311|B6||>=0.3 G/L|Number of Participants According to Blood Eosinophil Count||Participants|Count of Participants|325|325.0||||||
3788716|NCT01854047|3618312|B5||>=0.3 G/L|Number of Participants According to Blood Eosinophil Count||Participants|Count of Participants|62|62.0||||||
3788717|NCT01854047|3618313|B4||>=0.3 G/L|Number of Participants According to Blood Eosinophil Count||Participants|Count of Participants|66|66.0||||||
3788718|NCT01854047|3618314|B3||>=0.3 G/L|Number of Participants According to Blood Eosinophil Count||Participants|Count of Participants|65|65.0||||||
3788719|NCT01854047|3618315|B2||>=0.3 G/L|Number of Participants According to Blood Eosinophil Count||Participants|Count of Participants|64|64.0||||||
3788720|NCT01854047|3618316|B1||>=0.3 G/L|Number of Participants According to Blood Eosinophil Count||Participants|Count of Participants|68|68.0||||||
3788721|NCT01854047|3618311|B6||<0.3 G/L|Number of Participants According to Blood Eosinophil Count||Participants|Count of Participants|451|451.0||||||
3788722|NCT01854047|3618312|B5||<0.3 G/L|Number of Participants According to Blood Eosinophil Count||Participants|Count of Participants|92|92.0||||||
3788723|NCT01854047|3618313|B4||<0.3 G/L|Number of Participants According to Blood Eosinophil Count||Participants|Count of Participants|91|91.0||||||
3788724|NCT01854047|3618314|B3||<0.3 G/L|Number of Participants According to Blood Eosinophil Count||Participants|Count of Participants|85|85.0||||||
3788725|NCT01854047|3618315|B2||<0.3 G/L|Number of Participants According to Blood Eosinophil Count||Participants|Count of Participants|93|93.0||||||
3788726|NCT01854047|3618316|B1||<0.3 G/L|Number of Participants According to Blood Eosinophil Count||Participants|Count of Participants|90|90.0||||||
3788727|NCT01854047|3618311|B6|Not Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|628|628.0||||||
3788728|NCT01854047|3618312|B5|Not Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|128|128.0||||||
3788729|NCT01854047|3618313|B4|Not Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|124|124.0||||||
3788730|NCT01854047|3618314|B3|Not Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|121|121.0||||||
3788731|NCT01854047|3618315|B2|Not Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|128|128.0||||||
3788732|NCT01854047|3618316|B1|Not Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|127|127.0||||||
3788733|NCT01854047|3618311|B6|Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|148|148.0||||||
3788734|NCT01854047|3618312|B5|Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3788735|NCT01854047|3618313|B4|Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3788736|NCT01854047|3618314|B3|Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3788737|NCT01854047|3618315|B2|Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3788738|NCT01854047|3618316|B1|Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3788739|NCT01854047|3618311|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3788740|NCT01854047|3618312|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3788741|NCT01854047|3618313|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3788742|NCT01854047|3618314|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3788743|NCT01854047|3618315|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3788744|NCT01854047|3618316|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3788745|NCT01854047|3618311|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788746|NCT01854047|3618312|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788747|NCT01854047|3618313|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788748|NCT01854047|3618314|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788749|NCT01854047|3618315|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788750|NCT01854047|3618316|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788751|NCT01854047|3618311|B6||White|Race (NIH/OMB)||Participants|Count of Participants|607|607.0||||||
3788752|NCT01854047|3618312|B5||White|Race (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
3788753|NCT01854047|3618313|B4||White|Race (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
3788754|NCT01854047|3618314|B3||White|Race (NIH/OMB)||Participants|Count of Participants|114|114.0||||||
3788755|NCT01854047|3618315|B2||White|Race (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
3788756|NCT01854047|3618316|B1||White|Race (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
3788757|NCT01854047|3618311|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3788758|NCT01854047|3618312|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3788759|NCT01854047|3618313|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3788760|NCT01854047|3618314|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3788761|NCT01854047|3618315|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3788762|NCT01854047|3618316|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3788763|NCT01854047|3618311|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3788764|NCT01854047|3618312|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788765|NCT01854047|3618313|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3788766|NCT01854047|3618314|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788767|NCT01854047|3618315|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788768|NCT01854047|3618316|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788769|NCT01854047|3618311|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
3788770|NCT01854047|3618312|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3788771|NCT01854047|3618313|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3788772|NCT01854047|3618314|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3788773|NCT01854047|3618315|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3788774|NCT01854047|3618316|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3788775|NCT01854047|3618311|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3788776|NCT01854047|3618312|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788777|NCT01854047|3618313|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788778|NCT01854047|3618314|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3788779|NCT01854047|3618315|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788780|NCT01854047|3618316|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788781|NCT01854047|3618311|B6||Male|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
3788782|NCT01854047|3618312|B5||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3788783|NCT01854047|3618313|B4||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3788784|NCT01854047|3618314|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3788785|NCT01854047|3618315|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3788786|NCT01854047|3618316|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3788787|NCT01854047|3618311|B6||Female|Sex: Female, Male||Participants|Count of Participants|490|490.0||||||
3788788|NCT01854047|3618312|B5||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3788789|NCT01854047|3618313|B4||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3788790|NCT01854047|3618314|B3||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3788791|NCT01854047|3618315|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3788792|NCT01854047|3618316|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3788793|NCT01854047|3618311|B6|||Age||years|Mean|48.6|48.6|Standard Deviation|13.0|13.0|||
3788794|NCT01854047|3618312|B5|||Age||years|Mean|47.9|47.9|Standard Deviation|13.1|13.1|||
3788795|NCT01854047|3618313|B4|||Age||years|Mean|47.9|47.9|Standard Deviation|13.1|13.1|||
3788796|NCT01854047|3618314|B3|||Age||years|Mean|51|51.0|Standard Deviation|13.4|13.4|||
3788797|NCT01854047|3618315|B2|||Age||years|Mean|47.5|47.5|Standard Deviation|12.4|12.4|||
3788798|NCT01854047|3618316|B1|||Age||years|Mean|49|49.0|Standard Deviation|12.7|12.7|||
3788799|NCT01854034|3618442|B1|2||Baseline ECOG PS|"The Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)~0: Asymptomatic (Fully active, able to carry on all pre-disease activities without restriction)~1: Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. For example, light housework, office work)~2: Symptomatic, <50% in bed during the day (Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours)"|Participants|Count of Participants|2|2.0||||||
3788800|NCT01854034|3618442|B1|1||Baseline ECOG PS|"The Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)~0: Asymptomatic (Fully active, able to carry on all pre-disease activities without restriction)~1: Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. For example, light housework, office work)~2: Symptomatic, <50% in bed during the day (Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours)"|Participants|Count of Participants|18|18.0||||||
3788801|NCT01854034|3618442|B1|0||Baseline ECOG PS|"The Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)~0: Asymptomatic (Fully active, able to carry on all pre-disease activities without restriction)~1: Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. For example, light housework, office work)~2: Symptomatic, <50% in bed during the day (Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours)"|Participants|Count of Participants|9|9.0||||||
3788802|NCT01854034|3618442|B1|||Number of Participants with prior EGFR TKI|epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)|Participants|Count of Participants|6|6.0||||||
3788803|NCT01854034|3618442|B1|||Median Prior Lines of Therapy||Therapies|Median|1|1.0|Full Range|||1.0|5.0|
3788804|NCT01854034|3618442|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3788805|NCT01854034|3618442|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3788806|NCT01854034|3618442|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3788807|NCT01854034|3618442|B1|||Age||years|Median|60|60.0|Full Range|||31.0|79.0|
3788808|NCT01853982|3618449|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3788809|NCT01853982|3618450|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3788810|NCT01853982|3618451|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3788811|NCT01853982|3618449|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3788812|NCT01853982|3618450|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3788813|NCT01853982|3618451|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3788814|NCT01853982|3618449|B3||GTE65|Age||Participants|Count of Participants|1|1.0||||||
3788815|NCT01853982|3618450|B2||GTE65|Age||Participants|Count of Participants|0|0.0||||||
3788816|NCT01853982|3618451|B1||GTE65|Age||Participants|Count of Participants|1|1.0||||||
3788817|NCT01853982|3618449|B3||BTWN|Age||Participants|Count of Participants|3|3.0||||||
3788818|NCT01853982|3618450|B2||BTWN|Age||Participants|Count of Participants|2|2.0||||||
3788819|NCT01853982|3618451|B1||BTWN|Age||Participants|Count of Participants|1|1.0||||||
3788820|NCT01853982|3618449|B3||LTE18|Age||Participants|Count of Participants|0|0.0||||||
3788821|NCT01853982|3618450|B2||LTE18|Age||Participants|Count of Participants|0|0.0||||||
3788822|NCT01853982|3618451|B1||LTE18|Age||Participants|Count of Participants|0|0.0||||||
3788823|NCT01853839|3618458|B1|Male||Gender|Gender information was only collected for 1969 participants.|participants|Number|1161|1161.0||||||
3788824|NCT01853839|3618458|B1|Female||Gender|Gender information was only collected for 1969 participants.|participants|Number|808|808.0||||||
3788825|NCT01853839|3618458|B1|||Age|Age information was only collected for 1979 participants.|years|Mean|54.78|54.78|Standard Deviation|11.01|11.01|||
3788826|NCT01853696|3618478|B3|United States||Region of Enrollment||participants|Number|167|167.0||||||
3788827|NCT01853696|3618479|B2|United States||Region of Enrollment||participants|Number|83|83.0||||||
3788828|NCT01853696|3618480|B1|United States||Region of Enrollment||participants|Number|84|84.0||||||
3788829|NCT01853696|3618478|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788830|NCT01853696|3618479|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788831|NCT01853696|3618480|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788832|NCT01853696|3618478|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788833|NCT01853696|3618479|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788834|NCT01853696|3618480|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788835|NCT01853696|3618478|B3||White|Race (NIH/OMB)||Participants|Count of Participants|166|166.0||||||
3788836|NCT01853696|3618479|B2||White|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3788837|NCT01853696|3618480|B1||White|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3788838|NCT01853696|3618478|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3788839|NCT01853696|3618479|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3788840|NCT01853696|3618480|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788841|NCT01853696|3618478|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788842|NCT01853696|3618479|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788843|NCT01853696|3618480|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788844|NCT01853696|3618478|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788845|NCT01853696|3618479|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788846|NCT01853696|3618480|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788847|NCT01853696|3618478|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788848|NCT01853696|3618479|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788849|NCT01853696|3618480|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788850|NCT01853696|3618478|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3788851|NCT01853696|3618479|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3788852|NCT01853696|3618480|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3788853|NCT01853696|3618478|B3||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3788854|NCT01853696|3618479|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3788855|NCT01853696|3618480|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3788856|NCT01853696|3618478|B3|||Age||years|Median|69|69.0|Full Range|||22.0|89.0|
3788857|NCT01853696|3618479|B2|||Age||years|Median|69|69.0|Full Range|||22.0|89.0|
3788858|NCT01853696|3618480|B1|||Age||years|Median|69|69.0|Full Range|||22.0|88.0|
3788859|NCT01853605|3618489|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3788860|NCT01853605|3618490|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3788861|NCT01853605|3618491|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3788862|NCT01853605|3618492|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3788863|NCT01853605|3618493|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3788864|NCT01853605|3618489|B5||Female|Sex: Female, Male||Participants|Count of Participants|3811|3811.0||||||
3788865|NCT01853605|3618490|B4||Female|Sex: Female, Male||Participants|Count of Participants|428|428.0||||||
3788866|NCT01853605|3618491|B3||Female|Sex: Female, Male||Participants|Count of Participants|751|751.0||||||
3788867|NCT01853605|3618492|B2||Female|Sex: Female, Male||Participants|Count of Participants|693|693.0||||||
3788868|NCT01853605|3618493|B1||Female|Sex: Female, Male||Participants|Count of Participants|1939|1939.0||||||
3788869|NCT01853605|3618489|B5|||Age||Years|Mean|42.5|42.5|Standard Deviation|11.52|11.52|||
3788870|NCT01853605|3618490|B4|||Age||Years|Mean|53.5|53.5|Standard Deviation|9.11|9.11|||
3788871|NCT01853605|3618491|B3|||Age||Years|Mean|49.8|49.8|Standard Deviation|10.03|10.03|||
3788872|NCT01853605|3618492|B2|||Age||Years|Mean|46.2|46.2|Standard Deviation|9.96|9.96|||
3788873|NCT01853605|3618493|B1|||Age||Years|Mean|36.0|36.0|Standard Deviation|8.65|8.65|||
3788874|NCT01853475|3618514|B4|United Kingdom||Region of Enrollment||participants|Number|24|24.0||||||
3788875|NCT01853475|3618515|B3|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3788876|NCT01853475|3618516|B2|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3788877|NCT01853475|3618517|B1|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3788878|NCT01853475|3618514|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3788879|NCT01853475|3618515|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3788880|NCT01853475|3618516|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3788881|NCT01853475|3618517|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3788882|NCT01853475|3618514|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3788883|NCT01853475|3618515|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3788884|NCT01853475|3618516|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3788885|NCT01853475|3618517|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3788886|NCT01853475|3618514|B4|||Age||years|Mean|31.3|31.3|Standard Deviation|8.77|8.77|||
3788887|NCT01853475|3618515|B3|||Age||years|Mean|30.1|30.1|Standard Deviation|5.79|5.79|||
3788888|NCT01853475|3618516|B2|||Age||years|Mean|30.1|30.1|Standard Deviation|6.33|6.33|||
3788889|NCT01853475|3618517|B1|||Age||years|Mean|33.5|33.5|Standard Deviation|13.06|13.06|||
3788890|NCT01853462|3618536|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3788891|NCT01853462|3618537|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3788892|NCT01853462|3618538|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3788893|NCT01853462|3618536|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3788894|NCT01853462|3618537|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3788895|NCT01853462|3618538|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3788896|NCT01853462|3618536|B3|||Age||years|Mean|21.7|21.7|Standard Deviation|2.9|2.9|||
3788897|NCT01853462|3618537|B2|||Age||years|Mean|21.5|21.5|Standard Deviation|1.8|1.8|||
3788898|NCT01853462|3618538|B1|||Age||years|Mean|21.8|21.8|Standard Deviation|3.8|3.8|||
3788899|NCT01853397|3618605|B5|||Body Mass Index||kg/m^2|Mean|25.5|25.5|Standard Deviation|2.5|2.5|||
3788900|NCT01853397|3618606|B4|||Body Mass Index||kg/m^2|Mean|25.4|25.4|Standard Deviation|2.1|2.1|||
3788901|NCT01853397|3618607|B3|||Body Mass Index||kg/m^2|Mean|25.5|25.5|Standard Deviation|2.8|2.8|||
3788902|NCT01853397|3618608|B2|||Body Mass Index||kg/m^2|Mean|25.2|25.2|Standard Deviation|2.8|2.8|||
3788903|NCT01853397|3618609|B1|||Body Mass Index||kg/m^2|Mean|25.9|25.9|Standard Deviation|2.4|2.4|||
3788904|NCT01853397|3618605|B5|United States||Region of Enrollment||participants|Number|72|72.0||||||
3788905|NCT01853397|3618606|B4|United States||Region of Enrollment||participants|Number|17|17.0||||||
3788906|NCT01853397|3618607|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
3788907|NCT01853397|3618608|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3788908|NCT01853397|3618609|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3788909|NCT01853397|3618605|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3788910|NCT01853397|3618606|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3788911|NCT01853397|3618607|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3788912|NCT01853397|3618608|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3788913|NCT01853397|3618609|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3788914|NCT01853397|3618605|B5||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3788915|NCT01853397|3618606|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3788916|NCT01853397|3618607|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3788917|NCT01853397|3618608|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3788918|NCT01853397|3618609|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3788919|NCT01853397|3618605|B5|||Age||years|Mean|43.0|43.0|Standard Deviation|10.4|10.4|||
3788920|NCT01853397|3618606|B4|||Age||years|Mean|38.8|38.8|Standard Deviation|10.9|10.9|||
3788921|NCT01853397|3618607|B3|||Age||years|Mean|42.4|42.4|Standard Deviation|7.8|7.8|||
3788922|NCT01853397|3618608|B2|||Age||years|Mean|45.9|45.9|Standard Deviation|12.3|12.3|||
3788923|NCT01853397|3618609|B1|||Age||years|Mean|44.4|44.4|Standard Deviation|10.2|10.2|||
3788924|NCT01853384|3618638|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788925|NCT01853384|3618639|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788926|NCT01853384|3618640|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788927|NCT01853384|3618638|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788928|NCT01853384|3618639|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788929|NCT01853384|3618640|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788930|NCT01853384|3618638|B3||White|Race (NIH/OMB)||Participants|Count of Participants|252|252.0||||||
3788931|NCT01853384|3618639|B2||White|Race (NIH/OMB)||Participants|Count of Participants|121|121.0||||||
3788932|NCT01853384|3618640|B1||White|Race (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
3788933|NCT01853384|3618638|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788934|NCT01853384|3618639|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788935|NCT01853384|3618640|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788936|NCT01853384|3618638|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788937|NCT01853384|3618639|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788938|NCT01853384|3618640|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788939|NCT01853384|3618638|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788940|NCT01853384|3618639|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788941|NCT01853384|3618640|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788942|NCT01853384|3618638|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788943|NCT01853384|3618639|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788944|NCT01853384|3618640|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788945|NCT01853384|3618638|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3788946|NCT01853384|3618639|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3788947|NCT01853384|3618640|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3788948|NCT01853384|3618638|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|249|249.0||||||
3788949|NCT01853384|3618639|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
3788950|NCT01853384|3618640|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
3788951|NCT01853384|3618638|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3788952|NCT01853384|3618639|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3788953|NCT01853384|3618640|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3788954|NCT01853384|3618638|B3||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3788955|NCT01853384|3618639|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3788956|NCT01853384|3618640|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3788957|NCT01853384|3618638|B3||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3788958|NCT01853384|3618639|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3788959|NCT01853384|3618640|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3788960|NCT01853384|3618638|B3|70+ years||Age, Customized||participants|Number|108|108.0||||||
3788961|NCT01853384|3618639|B2|70+ years||Age, Customized||participants|Number|55|55.0||||||
3788962|NCT01853384|3618640|B1|70+ years||Age, Customized||participants|Number|53|53.0||||||
3788963|NCT01853384|3618638|B3|60-69 years||Age, Customized||participants|Number|80|80.0||||||
3788964|NCT01853384|3618639|B2|60-69 years||Age, Customized||participants|Number|40|40.0||||||
3788965|NCT01853384|3618640|B1|60-69 years||Age, Customized||participants|Number|40|40.0||||||
3788966|NCT01853384|3618638|B3|50-59 years||Age, Customized||participants|Number|46|46.0||||||
3788967|NCT01853384|3618639|B2|50-59 years||Age, Customized||participants|Number|20|20.0||||||
3788968|NCT01853384|3618640|B1|50-59 years||Age, Customized||participants|Number|26|26.0||||||
3788969|NCT01853384|3618638|B3|40-49 years||Age, Customized||participants|Number|9|9.0||||||
3788970|NCT01853384|3618639|B2|40-49 years||Age, Customized||participants|Number|3|3.0||||||
3788971|NCT01853384|3618640|B1|40-49 years||Age, Customized||participants|Number|6|6.0||||||
3788972|NCT01853384|3618638|B3|18-39 years||Age, Customized||participants|Number|9|9.0||||||
3788973|NCT01853384|3618639|B2|18-39 years||Age, Customized||participants|Number|3|3.0||||||
3788974|NCT01853384|3618640|B1|18-39 years||Age, Customized||participants|Number|6|6.0||||||
3788975|NCT01853384|3618638|B3|||Age||years|Mean|66.8|66.8|Full Range|||28.0|92.0|
3788976|NCT01853384|3618639|B2|||Age||years|Mean|68.1|68.1|Full Range|||28.0|92.0|
3788977|NCT01853384|3618640|B1|||Age||years|Mean|65.6|65.6|Full Range|||28.0|90.0|
3788978|NCT01853371|3618659|B3|||Baseline Diastolic Blood Pressure||mmHg|Mean|91.9|91.9|Standard Deviation|10.2|10.2|||
3788979|NCT01853371|3618660|B2|||Baseline Diastolic Blood Pressure||mmHg|Mean|93.5|93.5|Standard Deviation|10.6|10.6|||
3788980|NCT01853371|3618661|B1|||Baseline Diastolic Blood Pressure||mmHg|Mean|90.6|90.6|Standard Deviation|10.3|10.3|||
3788981|NCT01853371|3618659|B3|||Basline Systolic Blood Pressure||mmHg|Mean|155.3|155.3|Standard Deviation|13.3|13.3|||
3788982|NCT01853371|3618660|B2|||Basline Systolic Blood Pressure||mmHg|Mean|149.4|149.4|Standard Deviation|11.1|11.1|||
3788983|NCT01853371|3618661|B1|||Basline Systolic Blood Pressure||mmHg|Mean|160.1|160.1|Standard Deviation|13.5|13.5|||
3788984|NCT01853371|3618659|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3788985|NCT01853371|3618660|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3788986|NCT01853371|3618661|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3788987|NCT01853371|3618659|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3788988|NCT01853371|3618660|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3788989|NCT01853371|3618661|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3788990|NCT01853371|3618659|B3|||Age||Years|Mean|51.06|51.06|Standard Deviation|8.07|8.07|||
3788991|NCT01853371|3618660|B2|||Age||Years|Mean|49.43|49.43|Standard Deviation|9.50|9.5|||
3788992|NCT01853371|3618661|B1|||Age||Years|Mean|52.20|52.2|Standard Deviation|7.22|7.22|||
3788993|NCT01853332|3618670|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3788994|NCT01853332|3618670|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3788995|NCT01853332|3618670|B1|||Age||years|Mean|45.6|45.6|Standard Deviation|3.5|3.5|||
3789054|NCT01853254|3618688|B1||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3788996|NCT01853280|3618679|B3|United States||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3788997|NCT01853280|3618680|B2|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3788998|NCT01853280|3618681|B1|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3788999|NCT01853280|3618679|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3789000|NCT01853280|3618680|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3789001|NCT01853280|3618681|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3789002|NCT01853280|3618679|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3789003|NCT01853280|3618680|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3789004|NCT01853280|3618681|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3789005|NCT01853280|3618679|B3||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3789006|NCT01853280|3618680|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3789007|NCT01853280|3618681|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3789008|NCT01853280|3618679|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3789009|NCT01853280|3618680|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3789010|NCT01853280|3618681|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3789011|NCT01853280|3618679|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789012|NCT01853280|3618680|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789013|NCT01853280|3618681|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789014|NCT01853280|3618679|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3789015|NCT01853280|3618680|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3789016|NCT01853280|3618681|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789017|NCT01853280|3618679|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789018|NCT01853280|3618680|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789019|NCT01853280|3618681|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789020|NCT01853280|3618679|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789021|NCT01853280|3618680|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789022|NCT01853280|3618681|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789023|NCT01853280|3618679|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3789024|NCT01853280|3618680|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3789025|NCT01853280|3618681|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3789026|NCT01853280|3618679|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3789027|NCT01853280|3618680|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3789028|NCT01853280|3618681|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3789029|NCT01853280|3618679|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3789030|NCT01853280|3618680|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3789031|NCT01853280|3618681|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3789032|NCT01853280|3618679|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3789033|NCT01853280|3618680|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3789034|NCT01853280|3618681|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3789035|NCT01853280|3618679|B3|||Age||years|Mean|39.96|39.96|Standard Deviation|10.14|10.14|||
3789036|NCT01853280|3618680|B2|||Age||years|Mean|37.7|37.7|Standard Deviation|8.9|8.9|||
3789037|NCT01853280|3618681|B1|||Age||years|Mean|41.3|41.3|Standard Deviation|11.4|11.4|||
3789038|NCT01853280|3618679|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3789039|NCT01853280|3618680|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3789040|NCT01853280|3618681|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3789041|NCT01853280|3618679|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3789042|NCT01853280|3618680|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3789043|NCT01853280|3618681|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3789044|NCT01853280|3618679|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3789045|NCT01853280|3618680|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3789046|NCT01853280|3618681|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3789047|NCT01853254|3618688|B1|||Body Mass Index (BMI)||kg/m^2|Mean|28.8|28.8|Standard Deviation|5.89|5.89|||
3789048|NCT01853254|3618688|B1|||Weight||Kilograms (kg)|Mean|85.72|85.72|Standard Deviation|19.803|19.803|||
3789049|NCT01853254|3618688|B1|||Height||Centimeters (cm)|Mean|172.4|172.4|Standard Deviation|10.22|10.22|||
3789050|NCT01853254|3618688|B1|Other||Race/Ethnicity, Customized||Participants|Number|53|53.0||||||
3789051|NCT01853254|3618688|B1|Oriental||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3789052|NCT01853254|3618688|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|189|189.0||||||
3789053|NCT01853254|3618688|B1|Black||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
3789055|NCT01853254|3618688|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3789056|NCT01853254|3618688|B1|||Age||years|Mean|48.3|48.3|Standard Deviation|9.50|9.5|||
3789057|NCT01853215|3618692|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3789058|NCT01853215|3618692|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3789059|NCT01853215|3618692|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3789060|NCT01853215|3618692|B1|||Age||years|Mean|33.4|33.4|Standard Deviation|8.8|8.8|||
3789061|NCT01853215|3618692|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3789062|NCT01853215|3618692|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3789063|NCT01853215|3618692|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3789064|NCT01853176|3618703|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3789065|NCT01853176|3618705|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3789066|NCT01853176|3618703|B3|Male||Gender||participants|Number|0|0.0||||||
3789067|NCT01853176|3618705|B1|Male||Gender||participants|Number|0|0.0||||||
3789068|NCT01853176|3618703|B3|Female||Gender||participants|Number|4|4.0||||||
3789069|NCT01853176|3618705|B1|Female||Gender||participants|Number|4|4.0||||||
3789070|NCT01853176|3618703|B3|>=65 years||Age||participants|Number|0|0.0||||||
3789071|NCT01853176|3618705|B1|>=65 years||Age||participants|Number|0|0.0||||||
3789072|NCT01853176|3618703|B3|Between 18 and 65 years||Age||participants|Number|4|4.0||||||
3789073|NCT01853176|3618705|B1|Between 18 and 65 years||Age||participants|Number|4|4.0||||||
3789074|NCT01853176|3618703|B3|<=18 years||Age||participants|Number|0|0.0||||||
3789075|NCT01853176|3618705|B1|<=18 years||Age||participants|Number|0|0.0||||||
3789076|NCT01853085|3618712|B1|Missing Data||Sex/Gender, Customized||Participants|Number|9|9.0||||||
3789077|NCT01853085|3618712|B1|Male||Sex/Gender, Customized||Participants|Number|723|723.0||||||
3789078|NCT01853085|3618712|B1|Female||Sex/Gender, Customized||Participants|Number|1098|1098.0||||||
3789079|NCT01853085|3618712|B1|Missing Data||Age, Customized||Participants|Number|50|50.0||||||
3789080|NCT01853085|3618712|B1|≥ 91 years||Age, Customized||Participants|Number|16|16.0||||||
3789081|NCT01853085|3618712|B1|81-90 years||Age, Customized||Participants|Number|158|158.0||||||
3789082|NCT01853085|3618712|B1|71-80 years||Age, Customized||Participants|Number|601|601.0||||||
3789083|NCT01853085|3618712|B1|61-70 years||Age, Customized||Participants|Number|509|509.0||||||
3789084|NCT01853085|3618712|B1|51-60 years||Age, Customized||Participants|Number|328|328.0||||||
3789085|NCT01853085|3618712|B1|41-50 years||Age, Customized||Participants|Number|130|130.0||||||
3789086|NCT01853085|3618712|B1|31-40 years||Age, Customized||Participants|Number|28|28.0||||||
3789087|NCT01853085|3618712|B1|18-30 years||Age, Customized||Participants|Number|9|9.0||||||
3789088|NCT01853085|3618712|B1|<18 years||Age, Customized||Participants|Number|1|1.0||||||
3789089|NCT01853072|3618723|B3||Male|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
3789090|NCT01853072|3618724|B2||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3789091|NCT01853072|3618725|B1||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3789092|NCT01853072|3618723|B3||Female|Sex: Female, Male||Participants|Count of Participants|324|324.0||||||
3789093|NCT01853072|3618724|B2||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3789094|NCT01853072|3618725|B1||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3789095|NCT01853072|3618723|B3|||Age||years|Mean|66.8|66.8|Standard Deviation|8.4|8.4|||
3789096|NCT01853072|3618724|B2|||Age||years|Mean|66.8|66.8|Standard Deviation|8.3|8.3|||
3789097|NCT01853072|3618725|B1|||Age||years|Mean|66.8|66.8|Standard Deviation|8.5|8.5|||
3789098|NCT01853046|3618744|B3||Male|Gender||Participants|Count of Participants|11|11.0||||||
3789099|NCT01853046|3618745|B2||Male|Gender||Participants|Count of Participants|2|2.0||||||
3789100|NCT01853046|3618746|B1||Male|Gender||Participants|Count of Participants|9|9.0||||||
3789101|NCT01853046|3618744|B3||Female|Gender||Participants|Count of Participants|13|13.0||||||
3789102|NCT01853046|3618745|B2||Female|Gender||Participants|Count of Participants|4|4.0||||||
3789103|NCT01853046|3618746|B1||Female|Gender||Participants|Count of Participants|9|9.0||||||
3789104|NCT01853046|3618744|B3|||Age||years|Mean|62.5|62.5|Standard Deviation|8.9|8.9|||
3789105|NCT01853046|3618745|B2|||Age||years|Mean|64.2|64.2|Standard Deviation|6.9|6.9|||
3789106|NCT01853046|3618746|B1|||Age||years|Mean|62.0|62.0|Standard Deviation|9.6|9.6|||
3789107|NCT01852955|3618799|B3|United States||Region of Enrollment||participants|Number|65|65.0||||||
3789108|NCT01852955|3618800|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
3789109|NCT01852955|3618801|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
3789110|NCT01852955|3618799|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3789111|NCT01852955|3618800|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3789112|NCT01852955|3618801|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3789113|NCT01852955|3618799|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3789114|NCT01852955|3618800|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3789115|NCT01852955|3618801|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3789116|NCT01852955|3618799|B3|Age||Age, Customized||years|Mean|55|55.0|Full Range|||44.0|68.0|
3789117|NCT01852955|3618800|B2|Age||Age, Customized||years|Mean|52|52.0|Full Range|||44.0|68.0|
3789118|NCT01852955|3618801|B1|Age||Age, Customized||years|Mean|60|60.0|Full Range|||54.0|65.0|
3789119|NCT01852825|3618812|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3789120|NCT01852825|3618813|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3789121|NCT01852825|3618814|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3789122|NCT01852825|3618815|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3789123|NCT01852825|3618812|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3789124|NCT01852825|3618813|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3789125|NCT01852825|3618814|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3789126|NCT01852825|3618815|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3789127|NCT01852825|3618812|B4|||Age||Years|Mean|31.9|31.9|Standard Deviation|9.9|9.9|||
3789128|NCT01852825|3618813|B3|||Age||Years|Mean|25.7|25.7|Standard Deviation|4.0|4.0|||
3789129|NCT01852825|3618814|B2|||Age||Years|Mean|36.1|36.1|Standard Deviation|13.2|13.2|||
3789130|NCT01852825|3618815|B1|||Age||Years|Mean|31.3|31.3|Standard Deviation|8.6|8.6|||
3789131|NCT01852812|3618840|B4||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3789132|NCT01852812|3618841|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3789133|NCT01852812|3618842|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3789134|NCT01852812|3618843|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3789135|NCT01852812|3618840|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3789136|NCT01852812|3618841|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3789137|NCT01852812|3618842|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3789138|NCT01852812|3618843|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3789139|NCT01852812|3618840|B4|||Age||Years|Mean|6.07|6.07|Standard Deviation|3.4|3.4|||
3789140|NCT01852812|3618841|B3|||Age||Years|Mean|11.3|11.3|Standard Deviation|1.0|1.0|||
3789141|NCT01852812|3618842|B2|||Age||Years|Mean|7.78|7.78|Standard Deviation|1.3|1.3|||
3789142|NCT01852812|3618843|B1|||Age||Years|Mean|3.61|3.61|Standard Deviation|1.4|1.4|||
3789143|NCT01852799|3618865|B1|China||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3789144|NCT01852799|3618865|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3789145|NCT01852799|3618865|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3789146|NCT01852799|3618865|B1|||Age||years|Mean|52.1|52.1|Standard Deviation|6.8|6.8|||
3789147|NCT01852799|3618865|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3789148|NCT01852799|3618865|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3789149|NCT01852799|3618865|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3789150|NCT01852669|3618874|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3789151|NCT01852669|3618875|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3789152|NCT01852669|3618876|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3789153|NCT01852669|3618874|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3789154|NCT01852669|3618875|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3789155|NCT01852669|3618876|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3789156|NCT01852669|3618874|B3|||Age||years|Mean|49.63|49.63|Standard Deviation|12.0|12.0|||
3789157|NCT01852669|3618875|B2|||Age||years|Mean|50.9|50.9|Standard Deviation|12.9|12.9|||
3789158|NCT01852669|3618876|B1|||Age||years|Mean|48.3|48.3|Standard Deviation|11.1|11.1|||
3789159|NCT01852591|3618883|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3789160|NCT01852591|3618883|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
3789161|NCT01852591|3618883|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
3789162|NCT01852591|3618883|B1|||Age||years|Mean|61.625|61.625|Full Range|||52.0|68.0|
3789163|NCT01852591|3618883|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3789164|NCT01852591|3618883|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3789165|NCT01852591|3618883|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3789166|NCT01852383|3618890|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3789167|NCT01852383|3618890|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3789168|NCT01852383|3618890|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3789169|NCT01852383|3618890|B1|||Age||years|Mean|70.7|70.7|Standard Deviation|7.6|7.6|||
3789170|NCT01852383|3618890|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3789171|NCT01852383|3618890|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3789172|NCT01852383|3618890|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3789173|NCT01852344|3618897|B5|United States||Region of Enrollment||Participants|Count of Participants|94|94.0||||||
3789174|NCT01852344|3618898|B4|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3789175|NCT01852344|3618899|B3|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3789176|NCT01852344|3618900|B2|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3789177|NCT01852344|3618901|B1|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3789178|NCT01852344|3618897|B5||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3789179|NCT01852344|3618898|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3789180|NCT01852344|3618899|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3789181|NCT01852344|3618900|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3789182|NCT01852344|3618901|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3789183|NCT01852344|3618897|B5||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3789184|NCT01852344|3618898|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3789185|NCT01852344|3618899|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3789186|NCT01852344|3618900|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3789187|NCT01852344|3618901|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3789188|NCT01852344|3618897|B5|||Age||years|Mean|26.9|26.9|Standard Deviation|3.8|3.8|||
3789189|NCT01852344|3618898|B4|||Age||years|Mean|26.6|26.6|Standard Deviation|3.4|3.4|||
3789190|NCT01852344|3618899|B3|||Age||years|Mean|26.9|26.9|Standard Deviation|4.3|4.3|||
3789191|NCT01852344|3618900|B2|||Age||years|Mean|25.8|25.8|Standard Deviation|2.0|2.0|||
3789192|NCT01852344|3618901|B1|||Age||years|Mean|28.2|28.2|Standard Deviation|4.8|4.8|||
3789193|NCT01852344|3618897|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3789194|NCT01852344|3618898|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3789195|NCT01852344|3618899|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3789196|NCT01852344|3618900|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3789197|NCT01852344|3618901|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3789198|NCT01852344|3618897|B5||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
3789199|NCT01852344|3618898|B4||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3789200|NCT01852344|3618899|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3789201|NCT01852344|3618900|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3789202|NCT01852344|3618901|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3789203|NCT01852344|3618897|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3789204|NCT01852344|3618898|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3789205|NCT01852344|3618899|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3789206|NCT01852344|3618900|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3789207|NCT01852344|3618901|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3789208|NCT01852292|3618922|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|64|64.0||||||
3789209|NCT01852292|3618923|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3789210|NCT01852292|3618924|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3789211|NCT01852292|3618922|B3|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3789212|NCT01852292|3618923|B2|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3789213|NCT01852292|3618924|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3789214|NCT01852292|3618922|B3|Not reported||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3789215|NCT01852292|3618923|B2|Not reported||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3789216|NCT01852292|3618924|B1|Not reported||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3789217|NCT01852292|3618922|B3|Mixed ethnicity||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3789218|NCT01852292|3618923|B2|Mixed ethnicity||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3789219|NCT01852292|3618924|B1|Mixed ethnicity||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3789220|NCT01852292|3618922|B3|Russian||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3789221|NCT01852292|3618923|B2|Russian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3789222|NCT01852292|3618924|B1|Russian||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3789223|NCT01852292|3618922|B3|South Asian||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3789224|NCT01852292|3618923|B2|South Asian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3789225|NCT01852292|3618924|B1|South Asian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3789226|NCT01852292|3618922|B3|Southeast Asian||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3789227|NCT01852292|3618923|B2|Southeast Asian||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3789228|NCT01852292|3618924|B1|Southeast Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3789229|NCT01852292|3618922|B3|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3789230|NCT01852292|3618923|B2|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3789231|NCT01852292|3618924|B1|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3789232|NCT01852292|3618922|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3789233|NCT01852292|3618923|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3789234|NCT01852292|3618924|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3789235|NCT01852292|3618922|B3||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3789236|NCT01852292|3618923|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3789237|NCT01852292|3618924|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3789238|NCT01852292|3618922|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3789239|NCT01852292|3618923|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3789240|NCT01852292|3618924|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3789241|NCT01852292|3618922|B3|||Age||Years|Mean|58.1|58.1|Standard Deviation|9.41|9.41|||
3789242|NCT01852292|3618923|B2|||Age||Years|Mean|58.2|58.2|Standard Deviation|9.44|9.44|||
3789243|NCT01852292|3618924|B1|||Age||Years|Mean|58.0|58.0|Standard Deviation|9.44|9.44|||
3789244|NCT01852214|3618949|B1|Non-insulin-dependent||Type of diabetes||participants|Number|20|20.0||||||
3789245|NCT01852214|3618949|B1|Insulin-dependent||Type of diabetes||participants|Number|26|26.0||||||
3789246|NCT01852214|3618949|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789247|NCT01852214|3618949|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789248|NCT01852214|3618949|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3789249|NCT01852214|3618949|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3789250|NCT01852214|3618949|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789251|NCT01852214|3618949|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789252|NCT01852214|3618949|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789253|NCT01852214|3618949|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3789254|NCT01852214|3618949|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3789255|NCT01852214|3618949|B1|||Age||years|Mean|59|59.0|Standard Deviation|8|8.0|||
3789256|NCT01852175|3618962|B3|United States||Region of Enrollment||participants|Number|110|110.0||||||
3789257|NCT01852175|3618963|B2|United States||Region of Enrollment||participants|Number|55|55.0||||||
3789258|NCT01852175|3618964|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
3789259|NCT01852175|3618962|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3789260|NCT01852175|3618963|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3789261|NCT01852175|3618964|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3789262|NCT01852175|3618962|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3789263|NCT01852175|3618963|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3789264|NCT01852175|3618964|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3789265|NCT01852175|3618962|B3||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
3789266|NCT01852175|3618963|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3789267|NCT01852175|3618964|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3789268|NCT01852175|3618962|B3||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
3789269|NCT01852175|3618963|B2||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3789270|NCT01852175|3618964|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3789271|NCT01852175|3618962|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3789272|NCT01852175|3618963|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3789273|NCT01852175|3618964|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3789274|NCT01852162|3618975|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3789275|NCT01852162|3618976|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3789276|NCT01852162|3618977|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3789277|NCT01852162|3618975|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789278|NCT01852162|3618976|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789279|NCT01852162|3618977|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789280|NCT01852162|3618975|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789281|NCT01852162|3618976|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789282|NCT01852162|3618977|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789283|NCT01852162|3618975|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3789284|NCT01852162|3618976|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3789285|NCT01852162|3618977|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3789286|NCT01852162|3618975|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3789287|NCT01852162|3618976|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3789288|NCT01852162|3618977|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3789289|NCT01852162|3618975|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789290|NCT01852162|3618976|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789291|NCT01852162|3618977|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789292|NCT01852162|3618975|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3789293|NCT01852162|3618976|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3789294|NCT01852162|3618977|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789295|NCT01852162|3618975|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789296|NCT01852162|3618976|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789297|NCT01852162|3618977|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789298|NCT01852162|3618975|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3789299|NCT01852162|3618976|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3789300|NCT01852162|3618977|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3789301|NCT01852162|3618975|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3789302|NCT01852162|3618976|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3789303|NCT01852162|3618977|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3789304|NCT01852162|3618975|B3|||Age||years|Mean|63|63.0|Standard Deviation|9|9.0|||
3789305|NCT01852162|3618976|B2|||Age||years|Mean|59|59.0|Standard Deviation|9|9.0|||
3789306|NCT01852162|3618977|B1|||Age||years|Mean|65|65.0|Standard Deviation|8|8.0|||
3789307|NCT01852110|3618992|B3|||Composite Cognition Score-3 Domain (CCS-3D)|CCS-3D is composed of individual cognitive tests, grouped into 3 domains: 1) episodic memory; 2) executive function; and 3) attention/processing speed. For each cognitive test, a z-score (Z) is calculated at each time point [Z = (observed value - study population mean at baseline) / study population standard deviation at baseline]. These individual Zs are first combined into domain-specific Zs, and then into a composite Z, (i.e. CCS-3D). Theoretically, 99.9% of CCS-3D will be ± 3; more positive CCS-3D indicate greater cognitive impairment relative to the total study population at baseline.|z-score|Mean|-0.039|-0.039|Standard Deviation|0.776|0.776|||
3789308|NCT01852110|3618993|B2|||Composite Cognition Score-3 Domain (CCS-3D)|CCS-3D is composed of individual cognitive tests, grouped into 3 domains: 1) episodic memory; 2) executive function; and 3) attention/processing speed. For each cognitive test, a z-score (Z) is calculated at each time point [Z = (observed value - study population mean at baseline) / study population standard deviation at baseline]. These individual Zs are first combined into domain-specific Zs, and then into a composite Z, (i.e. CCS-3D). Theoretically, 99.9% of CCS-3D will be ± 3; more positive CCS-3D indicate greater cognitive impairment relative to the total study population at baseline.|z-score|Mean|0.02|0.02|Standard Deviation|0.816|0.816|||
3789309|NCT01852110|3618994|B1|||Composite Cognition Score-3 Domain (CCS-3D)|CCS-3D is composed of individual cognitive tests, grouped into 3 domains: 1) episodic memory; 2) executive function; and 3) attention/processing speed. For each cognitive test, a z-score (Z) is calculated at each time point [Z = (observed value - study population mean at baseline) / study population standard deviation at baseline]. These individual Zs are first combined into domain-specific Zs, and then into a composite Z, (i.e. CCS-3D). Theoretically, 99.9% of CCS-3D will be ± 3; more positive CCS-3D indicate greater cognitive impairment relative to the total study population at baseline.|z-score|Mean|-0.11|-0.11|Standard Deviation|0.739|0.739|||
3789310|NCT01852110|3618992|B3|||Alzheimer’s Disease Cooperative Study-Activities of Daily Living (ADCS-ADL) Score|The ADCS-ADL score measures the performance of activities of daily living, calculated from a 24-question survey. For each of the 24 questions, scores range from 0 (no independence) to (depending on the question) either 2 (1 question), 3 (17 questions), 4 (5 questions), or 5 (1 question), with higher scores indicating greater independence in activity performance. Scores from individual questions are summed into a total ADCS-ADL score, with potential total scores ranging from 0 to 78. Lower scores indicate less independence in activity performance and, as a result, greater AD severity.|Score on a Scale|Mean|59.9|59.9|Standard Deviation|11.72|11.72|||
3789311|NCT01852110|3618993|B2|||Alzheimer’s Disease Cooperative Study-Activities of Daily Living (ADCS-ADL) Score|The ADCS-ADL score measures the performance of activities of daily living, calculated from a 24-question survey. For each of the 24 questions, scores range from 0 (no independence) to (depending on the question) either 2 (1 question), 3 (17 questions), 4 (5 questions), or 5 (1 question), with higher scores indicating greater independence in activity performance. Scores from individual questions are summed into a total ADCS-ADL score, with potential total scores ranging from 0 to 78. Lower scores indicate less independence in activity performance and, as a result, greater AD severity.|Score on a Scale|Mean|59.4|59.4|Standard Deviation|11.89|11.89|||
3789312|NCT01852110|3618994|B1|||Alzheimer’s Disease Cooperative Study-Activities of Daily Living (ADCS-ADL) Score|The ADCS-ADL score measures the performance of activities of daily living, calculated from a 24-question survey. For each of the 24 questions, scores range from 0 (no independence) to (depending on the question) either 2 (1 question), 3 (17 questions), 4 (5 questions), or 5 (1 question), with higher scores indicating greater independence in activity performance. Scores from individual questions are summed into a total ADCS-ADL score, with potential total scores ranging from 0 to 78. Lower scores indicate less independence in activity performance and, as a result, greater AD severity.|Score on a Scale|Mean|60.7|60.7|Standard Deviation|11.18|11.18|||
3789313|NCT01852110|3618992|B3|||11-item Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog11) Score|ADAS-Cog11 measures cognition by assessing 11 metrics impaired in Alzheimer’s Disease (AD): speech; speech comprehension; word finding; word recall; object/finger naming; orientation; obeying commands; ideational praxis; constructional praxis; word recognition; and remembering instruction. For each metric, scores range from 0 (no impairment) to (depending on the metric) either 5 (8 metrics), 8, 10, or 12 (1 metric each); higher scores indicate more severe impairment. Individual scores sum to a total ADAS-Cog11 score (range: 0-70). Higher total scores indicate greater cognitive impairment.|Score on a Scale|Mean|22.7|22.7|Standard Deviation|7.95|7.95|||
3789314|NCT01852110|3618993|B2|||11-item Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog11) Score|ADAS-Cog11 measures cognition by assessing 11 metrics impaired in Alzheimer’s Disease (AD): speech; speech comprehension; word finding; word recall; object/finger naming; orientation; obeying commands; ideational praxis; constructional praxis; word recognition; and remembering instruction. For each metric, scores range from 0 (no impairment) to (depending on the metric) either 5 (8 metrics), 8, 10, or 12 (1 metric each); higher scores indicate more severe impairment. Individual scores sum to a total ADAS-Cog11 score (range: 0-70). Higher total scores indicate greater cognitive impairment.|Score on a Scale|Mean|23.6|23.6|Standard Deviation|8.73|8.73|||
3789315|NCT01852110|3618994|B1|||11-item Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog11) Score|ADAS-Cog11 measures cognition by assessing 11 metrics impaired in Alzheimer’s Disease (AD): speech; speech comprehension; word finding; word recall; object/finger naming; orientation; obeying commands; ideational praxis; constructional praxis; word recognition; and remembering instruction. For each metric, scores range from 0 (no impairment) to (depending on the metric) either 5 (8 metrics), 8, 10, or 12 (1 metric each); higher scores indicate more severe impairment. Individual scores sum to a total ADAS-Cog11 score (range: 0-70). Higher total scores indicate greater cognitive impairment.|Score on a Scale|Mean|21.8|21.8|Standard Deviation|7.05|7.05|||
3789316|NCT01852110|3618992|B3||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3789317|NCT01852110|3618993|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3789318|NCT01852110|3618994|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3789319|NCT01852110|3618992|B3||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3789320|NCT01852110|3618993|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3789321|NCT01852110|3618994|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3789322|NCT01852110|3618992|B3|||Age||Years|Mean|72.1|72.1|Standard Deviation|7.7|7.7|||
3789323|NCT01852110|3618993|B2|||Age||Years|Mean|71.7|71.7|Standard Deviation|8.3|8.3|||
3789324|NCT01852110|3618994|B1|||Age||Years|Mean|72.5|72.5|Standard Deviation|7.1|7.1|||
3789325|NCT01852032|3619027|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
3789326|NCT01852032|3619027|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3789327|NCT01852032|3619027|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3789328|NCT01852032|3619027|B1|greater than 35 years old||Age, Customized||participants|Number|23|23.0||||||
3789329|NCT01852019|3619035|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3789330|NCT01852019|3619036|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3789331|NCT01852019|3619037|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3789332|NCT01852019|3619035|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789333|NCT01852019|3619036|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789334|NCT01852019|3619037|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789335|NCT01852019|3619035|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3789336|NCT01852019|3619036|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3789337|NCT01852019|3619037|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3789338|NCT01852019|3619035|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789339|NCT01852019|3619036|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789340|NCT01852019|3619037|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789341|NCT01852019|3619035|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789342|NCT01852019|3619036|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789343|NCT01852019|3619037|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789344|NCT01852019|3619035|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789345|NCT01852019|3619036|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789346|NCT01852019|3619037|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789347|NCT01852019|3619035|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3789348|NCT01852019|3619036|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3789349|NCT01852019|3619037|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3789350|NCT01852019|3619035|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789351|NCT01852019|3619036|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789352|NCT01852019|3619037|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789353|NCT01852019|3619035|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789354|NCT01852019|3619036|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789355|NCT01852019|3619037|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789356|NCT01852019|3619035|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789357|NCT01852019|3619036|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789358|NCT01852019|3619037|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789359|NCT01852019|3619035|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789360|NCT01852019|3619036|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789361|NCT01852019|3619037|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789362|NCT01852019|3619035|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3789363|NCT01852019|3619036|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3789364|NCT01852019|3619037|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3789365|NCT01852019|3619035|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3789366|NCT01852019|3619036|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3789367|NCT01852019|3619037|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3789368|NCT01852019|3619035|B3|||Age||years|Mean|64.8|64.8|Standard Deviation|5.87|5.87|||
3789369|NCT01852019|3619036|B2|||Age||years|Mean|67.3|67.3|Standard Deviation|4.37|4.37|||
3789370|NCT01852019|3619037|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|6.47|6.47|||
3789371|NCT01851876|3619060|B3|Turkey||Region of Enrollment||participants|Number|118|118.0||||||
3789372|NCT01851876|3619061|B2|Turkey||Region of Enrollment||participants|Number|62|62.0||||||
3789373|NCT01851876|3619062|B1|Turkey||Region of Enrollment||participants|Number|56|56.0||||||
3789374|NCT01851876|3619060|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3789375|NCT01851876|3619061|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3789376|NCT01851876|3619062|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3789377|NCT01851876|3619060|B3||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3789378|NCT01851876|3619061|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3789379|NCT01851876|3619062|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3789380|NCT01851876|3619060|B3|||Age||years|Mean|31.0|31.0|Standard Deviation|2.92|2.92|||
3789381|NCT01851876|3619061|B2|||Age||years|Mean|31.14|31.14|Standard Deviation|2.95|2.95|||
3789382|NCT01851876|3619062|B1|||Age||years|Mean|30.83|30.83|Standard Deviation|2.90|2.9|||
3789383|NCT01851876|3619060|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3789384|NCT01851876|3619061|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3789385|NCT01851876|3619062|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3789386|NCT01851876|3619060|B3||Between 18 and 65 years|Age||Participants|Count of Participants|118|118.0||||||
3789387|NCT01851876|3619061|B2||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
3789388|NCT01851876|3619062|B1||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
3789389|NCT01851876|3619060|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3789390|NCT01851876|3619061|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3789391|NCT01851876|3619062|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3789392|NCT01851863|3619069|B5|China||Region of Enrollment||participants|Number|262|262.0||||||
3789393|NCT01851863|3619070|B4|China||Region of Enrollment||participants|Number|66|66.0||||||
3789394|NCT01851863|3619071|B3|China||Region of Enrollment||participants|Number|65|65.0||||||
3789395|NCT01851863|3619072|B2|China||Region of Enrollment||participants|Number|66|66.0||||||
3789396|NCT01851863|3619073|B1|China||Region of Enrollment||participants|Number|65|65.0||||||
3789397|NCT01851863|3619069|B5||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3789398|NCT01851863|3619070|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3789399|NCT01851863|3619071|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3789400|NCT01851863|3619072|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3789401|NCT01851863|3619073|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3789402|NCT01851863|3619069|B5||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3789403|NCT01851863|3619070|B4||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3789404|NCT01851863|3619071|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3789405|NCT01851863|3619072|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3789406|NCT01851863|3619073|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3789407|NCT01851863|3619069|B5|||Age||years|Mean|45.91|45.91|Standard Deviation|10.24|10.24|||
3789408|NCT01851863|3619070|B4|||Age||years|Mean|46.81|46.81|Standard Deviation|9.82|9.82|||
3789409|NCT01851863|3619071|B3|||Age||years|Mean|45.72|45.72|Standard Deviation|10.35|10.35|||
3789410|NCT01851863|3619072|B2|||Age||years|Mean|44.16|44.16|Standard Deviation|9.26|9.26|||
3789411|NCT01851863|3619073|B1|||Age||years|Mean|46.69|46.69|Standard Deviation|10.74|10.74|||
3789412|NCT01851772|3619097|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3789413|NCT01851772|3619097|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3789414|NCT01851772|3619097|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3789415|NCT01851772|3619097|B1|||Age||years|Mean|45.67|45.67|Full Range|||34.0|59.0|
3789416|NCT01851772|3619097|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3789417|NCT01851772|3619097|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3789418|NCT01851772|3619097|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3789419|NCT01851720|3619103|B3|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3789420|NCT01851720|3619104|B2|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3789421|NCT01851720|3619103|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3789422|NCT01851720|3619104|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3789423|NCT01851720|3619103|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3789424|NCT01851720|3619104|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3789425|NCT01851720|3619105|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3789426|NCT01851720|3619103|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3789427|NCT01851720|3619104|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3789428|NCT01851720|3619105|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3789429|NCT01851720|3619103|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3789430|NCT01851720|3619104|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3789431|NCT01851720|3619105|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3789432|NCT01851720|3619103|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3789433|NCT01851720|3619104|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3789434|NCT01851720|3619105|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3789435|NCT01851720|3619103|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3789436|NCT01851720|3619104|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3789437|NCT01851720|3619105|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3789438|NCT01851655|3619112|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3789439|NCT01851655|3619113|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3789440|NCT01851655|3619114|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3789441|NCT01851655|3619112|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3789442|NCT01851655|3619113|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3789443|NCT01851655|3619114|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3789444|NCT01851655|3619112|B3|||Age||years|Mean|20.0|20.0|Standard Deviation|4.3|4.3|||
3789445|NCT01851655|3619113|B2|||Age||years|Mean|20.7|20.7|Standard Deviation|4.9|4.9|||
3789446|NCT01851655|3619114|B1|||Age||years|Mean|19.3|19.3|Standard Deviation|3.8|3.8|||
3789447|NCT01851590|3619133|B4|||Plasma γ-glutamyl transferase||U/I|Median|25|25.0|Inter-Quartile Range|||20.0|50.0|
3789448|NCT01851590|3619134|B3|||Plasma γ-glutamyl transferase||U/I|Median|27|27.0|Inter-Quartile Range|||18.0|47.0|
3789449|NCT01851590|3619135|B2|||Plasma γ-glutamyl transferase||U/I|Median|21|21.0|Inter-Quartile Range|||14.0|41.0|
3789450|NCT01851590|3619136|B1|||Plasma γ-glutamyl transferase||U/I|Median|29|29.0|Inter-Quartile Range|||17.0|41.0|
3789451|NCT01851590|3619133|B4|||Plasma creatinine||μmol/l|Mean|78|78.0|Standard Deviation|14|14.0|||
3789452|NCT01851590|3619134|B3|||Plasma creatinine||μmol/l|Mean|79|79.0|Standard Deviation|11|11.0|||
3789453|NCT01851590|3619135|B2|||Plasma creatinine||μmol/l|Mean|78|78.0|Standard Deviation|13|13.0|||
3789454|NCT01851590|3619136|B1|||Plasma creatinine||μmol/l|Mean|76|76.0|Standard Deviation|15|15.0|||
3789455|NCT01851590|3619133|B4|Trichophyton mentagrophytes||Specific dermatophyte species in mycological culture||participants|Number|8|8.0||||||
3789456|NCT01851590|3619134|B3|Trichophyton mentagrophytes||Specific dermatophyte species in mycological culture||participants|Number|4|4.0||||||
3789457|NCT01851590|3619135|B2|Trichophyton mentagrophytes||Specific dermatophyte species in mycological culture||participants|Number|1|1.0||||||
3789458|NCT01851590|3619136|B1|Trichophyton mentagrophytes||Specific dermatophyte species in mycological culture||participants|Number|3|3.0||||||
3789459|NCT01851590|3619133|B4|Trichophyton rubrum||Specific dermatophyte species in mycological culture||participants|Number|65|65.0||||||
3789460|NCT01851590|3619134|B3|Trichophyton rubrum||Specific dermatophyte species in mycological culture||participants|Number|21|21.0||||||
3789461|NCT01851590|3619135|B2|Trichophyton rubrum||Specific dermatophyte species in mycological culture||participants|Number|24|24.0||||||
3789462|NCT01851590|3619136|B1|Trichophyton rubrum||Specific dermatophyte species in mycological culture||participants|Number|20|20.0||||||
3789463|NCT01851590|3619133|B4|||BMI|kg/m2|kg/m^2|Mean|26|26.0|Standard Deviation|4|4.0|||
3789464|NCT01851590|3619134|B3|||BMI|kg/m2|kg/m^2|Mean|27|27.0|Standard Deviation|4|4.0|||
3789465|NCT01851590|3619135|B2|||BMI|kg/m2|kg/m^2|Mean|27|27.0|Standard Deviation|4|4.0|||
3789466|NCT01851590|3619136|B1|||BMI|kg/m2|kg/m^2|Mean|25|25.0|Standard Deviation|3|3.0|||
3789467|NCT01851590|3619133|B4|||Positive mycological culture in toenail samples||participants|Number|73|73.0||||||
3789468|NCT01851590|3619134|B3|||Positive mycological culture in toenail samples||participants|Number|25|25.0||||||
3789469|NCT01851590|3619135|B2|||Positive mycological culture in toenail samples||participants|Number|25|25.0||||||
3789470|NCT01851590|3619136|B1|||Positive mycological culture in toenail samples||participants|Number|23|23.0||||||
3789471|NCT01851590|3619133|B4|Finland||Region of Enrollment||participants|Number|73|73.0||||||
3789472|NCT01851590|3619134|B3|Finland||Region of Enrollment||participants|Number|25|25.0||||||
3789473|NCT01851590|3619135|B2|Finland||Region of Enrollment||participants|Number|25|25.0||||||
3789474|NCT01851590|3619136|B1|Finland||Region of Enrollment||participants|Number|23|23.0||||||
3789475|NCT01851590|3619133|B4||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3789476|NCT01851590|3619134|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3789477|NCT01851590|3619135|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3789478|NCT01851590|3619136|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3789479|NCT01851590|3619133|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3789480|NCT01851590|3619134|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3789481|NCT01851590|3619135|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3789482|NCT01851590|3619136|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3789483|NCT01851590|3619133|B4||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3789484|NCT01851590|3619134|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3789485|NCT01851590|3619135|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3789486|NCT01851590|3619136|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3789487|NCT01851590|3619133|B4||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3789488|NCT01851590|3619134|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3789489|NCT01851590|3619135|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3789490|NCT01851590|3619136|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3789491|NCT01851590|3619133|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3789492|NCT01851590|3619134|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3789493|NCT01851590|3619135|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3789494|NCT01851590|3619136|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3789495|NCT01851330|3619158|B4|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|103|103.0||||||
3789496|NCT01851330|3619159|B3|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|36|36.0||||||
3789497|NCT01851330|3619160|B2|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|28|28.0||||||
3789498|NCT01851330|3619161|B1|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|39|39.0||||||
3789499|NCT01851330|3619158|B4|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|372|372.0||||||
3789500|NCT01851330|3619159|B3|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|124|124.0||||||
3789501|NCT01851330|3619160|B2|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|128|128.0||||||
3789502|NCT01851330|3619161|B1|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|120|120.0||||||
3789503|NCT01851330|3619158|B4|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|172|172.0||||||
3789504|NCT01851330|3619159|B3|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|56|56.0||||||
3789505|NCT01851330|3619160|B2|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|60|60.0||||||
3789506|NCT01851330|3619161|B1|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|56|56.0||||||
3789507|NCT01851330|3619158|B4|Genotype 1b||HCV Genotype||participants|Number|131|131.0||||||
3789508|NCT01851330|3619159|B3|Genotype 1b||HCV Genotype||participants|Number|44|44.0||||||
3789509|NCT01851330|3619160|B2|Genotype 1b||HCV Genotype||participants|Number|44|44.0||||||
3789510|NCT01851330|3619161|B1|Genotype 1b||HCV Genotype||participants|Number|43|43.0||||||
3789511|NCT01851330|3619158|B4|Genotype 1a||HCV Genotype||participants|Number|515|515.0||||||
3789512|NCT01851330|3619159|B3|Genotype 1a||HCV Genotype||participants|Number|172|172.0||||||
3789513|NCT01851330|3619160|B2|Genotype 1a||HCV Genotype||participants|Number|172|172.0||||||
3789514|NCT01851330|3619161|B1|Genotype 1a||HCV Genotype||participants|Number|171|171.0||||||
3789515|NCT01851330|3619158|B4|Genotype 1 (no confirmed subtype)||HCV Genotype||participants|Number|1|1.0||||||
3789516|NCT01851330|3619159|B3|Genotype 1 (no confirmed subtype)||HCV Genotype||participants|Number|0|0.0||||||
3789517|NCT01851330|3619160|B2|Genotype 1 (no confirmed subtype)||HCV Genotype||participants|Number|0|0.0||||||
3789518|NCT01851330|3619161|B1|Genotype 1 (no confirmed subtype)||HCV Genotype||participants|Number|1|1.0||||||
3789519|NCT01851330|3619158|B4|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|524|524.0||||||
3789520|NCT01851330|3619159|B3|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|172|172.0||||||
3789521|NCT01851330|3619160|B2|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|171|171.0||||||
3789522|NCT01851330|3619161|B1|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|181|181.0||||||
3789523|NCT01851330|3619158|B4|< 800,000 IU/mL||HCV RNA Category||participants|Number|123|123.0||||||
3789524|NCT01851330|3619159|B3|< 800,000 IU/mL||HCV RNA Category||participants|Number|44|44.0||||||
3789525|NCT01851330|3619160|B2|< 800,000 IU/mL||HCV RNA Category||participants|Number|45|45.0||||||
3789526|NCT01851330|3619161|B1|< 800,000 IU/mL||HCV RNA Category||participants|Number|34|34.0||||||
3789527|NCT01851330|3619158|B4|||HCV RNA||log10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.74|0.74|||
3789528|NCT01851330|3619159|B3|||HCV RNA||log10 IU/mL|Mean|6.4|6.4|Standard Deviation|0.76|0.76|||
3789529|NCT01851330|3619160|B2|||HCV RNA||log10 IU/mL|Mean|6.4|6.4|Standard Deviation|0.69|0.69|||
3789530|NCT01851330|3619161|B1|||HCV RNA||log10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.76|0.76|||
3789531|NCT01851330|3619158|B4|Not Disclosed||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3789532|NCT01851330|3619159|B3|Not Disclosed||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3789533|NCT01851330|3619160|B2|Not Disclosed||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3789534|NCT01851330|3619161|B1|Not Disclosed||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3789535|NCT01851330|3619158|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|606|606.0||||||
3789536|NCT01851330|3619159|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|202|202.0||||||
3789537|NCT01851330|3619160|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|204|204.0||||||
3789538|NCT01851330|3619161|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|200|200.0||||||
3789539|NCT01851330|3619158|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
3789540|NCT01851330|3619159|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3789541|NCT01851330|3619160|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3789542|NCT01851330|3619161|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3789543|NCT01851330|3619158|B4|Not Disclosed||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3789544|NCT01851330|3619159|B3|Not Disclosed||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3789545|NCT01851330|3619160|B2|Not Disclosed||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3789546|NCT01851330|3619161|B1|Not Disclosed||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3789547|NCT01851330|3619158|B4|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3789548|NCT01851330|3619159|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3789549|NCT01851330|3619160|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3789550|NCT01851330|3619161|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3789551|NCT01851330|3619158|B4|Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3789552|NCT01851330|3619159|B3|Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3789553|NCT01851330|3619160|B2|Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3789554|NCT01851330|3619161|B1|Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3789555|NCT01851330|3619158|B4|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3789556|NCT01851330|3619159|B3|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3789557|NCT01851330|3619160|B2|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3789558|NCT01851330|3619161|B1|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3789559|NCT01851330|3619158|B4|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3789560|NCT01851330|3619159|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3789561|NCT01851330|3619160|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3789562|NCT01851330|3619161|B1|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3789563|NCT01851330|3619158|B4|White||Race/Ethnicity, Customized||participants|Number|507|507.0||||||
3789564|NCT01851330|3619159|B3|White||Race/Ethnicity, Customized||participants|Number|167|167.0||||||
3789565|NCT01851330|3619160|B2|White||Race/Ethnicity, Customized||participants|Number|176|176.0||||||
3789566|NCT01851330|3619161|B1|White||Race/Ethnicity, Customized||participants|Number|164|164.0||||||
3789567|NCT01851330|3619158|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|123|123.0||||||
3789568|NCT01851330|3619159|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
3789569|NCT01851330|3619160|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3789570|NCT01851330|3619161|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
3789571|NCT01851330|3619158|B4||Male|Sex: Female, Male|"Gender was collected as Sex at Birth."|Participants|Count of Participants|375|375.0||||||
3789572|NCT01851330|3619159|B3||Male|Sex: Female, Male|"Gender was collected as Sex at Birth."|Participants|Count of Participants|128|128.0||||||
3789573|NCT01851330|3619160|B2||Male|Sex: Female, Male|"Gender was collected as Sex at Birth."|Participants|Count of Participants|117|117.0||||||
3789574|NCT01851330|3619161|B1||Male|Sex: Female, Male|"Gender was collected as Sex at Birth."|Participants|Count of Participants|130|130.0||||||
3789575|NCT01851330|3619158|B4||Female|Sex: Female, Male|"Gender was collected as Sex at Birth."|Participants|Count of Participants|272|272.0||||||
3789576|NCT01851330|3619159|B3||Female|Sex: Female, Male|"Gender was collected as Sex at Birth."|Participants|Count of Participants|88|88.0||||||
3789577|NCT01851330|3619160|B2||Female|Sex: Female, Male|"Gender was collected as Sex at Birth."|Participants|Count of Participants|99|99.0||||||
3789578|NCT01851330|3619161|B1||Female|Sex: Female, Male|"Gender was collected as Sex at Birth."|Participants|Count of Participants|85|85.0||||||
3789579|NCT01851330|3619158|B4|||Age||years|Mean|52|52.0|Standard Deviation|10.9|10.9|||
3789580|NCT01851330|3619159|B3|||Age||years|Mean|53|53.0|Standard Deviation|10.6|10.6|||
3789581|NCT01851330|3619160|B2|||Age||years|Mean|51|51.0|Standard Deviation|11.7|11.7|||
3789582|NCT01851330|3619161|B1|||Age||years|Mean|53|53.0|Standard Deviation|10.2|10.2|||
3789583|NCT01850745|3619203|B4||Male|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
3789584|NCT01850745|3619204|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3789585|NCT01850745|3619205|B2||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3789586|NCT01850745|3619206|B1||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3789587|NCT01850745|3619203|B4||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3789588|NCT01850745|3619204|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3789589|NCT01850745|3619205|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3789590|NCT01850745|3619206|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3789591|NCT01850745|3619203|B4|||Age||years|Mean|42|42.0|Standard Deviation|1|1.0|||
3789592|NCT01850745|3619204|B3|||Age||years|Mean|42|42.0|Standard Deviation|1|1.0|||
3789593|NCT01850745|3619205|B2|||Age||years|Mean|42|42.0|Standard Deviation|1|1.0|||
3789594|NCT01850745|3619206|B1|||Age||years|Mean|43|43.0|Standard Deviation|1|1.0|||
3789595|NCT01850641|3619216|B1|||Dialysis vintage||months|Mean|111.1|111.1|Standard Deviation|87.5|87.5|||
3789596|NCT01850641|3619216|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789597|NCT01850641|3619216|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789598|NCT01850641|3619216|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789599|NCT01850641|3619216|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789600|NCT01850641|3619216|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789601|NCT01850641|3619216|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3789602|NCT01850641|3619216|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789603|NCT01850641|3619216|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3789604|NCT01850641|3619216|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3789605|NCT01850641|3619216|B1|||Age||years|Mean|63.7|63.7|Standard Deviation|8.0|8.0|||
3789606|NCT01850615|3619228|B3|||Body weight||Kg|Mean|83.7|83.7|Standard Deviation|16.8|16.8|||
3789607|NCT01850615|3619229|B2|||Body weight||Kg|Mean|85.1|85.1|Standard Deviation|17.3|17.3|||
3789608|NCT01850615|3619230|B1|||Body weight||Kg|Mean|82.2|82.2|Standard Deviation|16.2|16.2|||
3789609|NCT01850615|3619228|B3|||Glycosylated haemoglobin (HbA1c)||Percentage of glycosylated haemoglobin|Mean|7.93|7.93|Standard Deviation|0.69|0.69|||
3789610|NCT01850615|3619229|B2|||Glycosylated haemoglobin (HbA1c)||Percentage of glycosylated haemoglobin|Mean|7.92|7.92|Standard Deviation|0.68|0.68|||
3789611|NCT01850615|3619230|B1|||Glycosylated haemoglobin (HbA1c)||Percentage of glycosylated haemoglobin|Mean|7.93|7.93|Standard Deviation|0.69|0.69|||
3789612|NCT01850615|3619228|B3||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3789613|NCT01850615|3619229|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3789614|NCT01850615|3619230|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3789615|NCT01850615|3619228|B3||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3789616|NCT01850615|3619229|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3789617|NCT01850615|3619230|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3789618|NCT01850615|3619228|B3|||Age||years|Mean|57.4|57.4|Standard Deviation|9.2|9.2|||
3789619|NCT01850615|3619229|B2|||Age||years|Mean|57.4|57.4|Standard Deviation|8.5|8.5|||
3789620|NCT01850615|3619230|B1|||Age||years|Mean|57.5|57.5|Standard Deviation|9.9|9.9|||
3789621|NCT01850602|3619247|B3|||Dialysis vintage||months|Mean|103.7|103.7|Standard Deviation|84.8|84.8|||
3789622|NCT01850602|3619248|B2|||Dialysis vintage||months|Mean|102.4|102.4|Standard Deviation|90.6|90.6|||
3789623|NCT01850602|3619249|B1|||Dialysis vintage||months|Mean|104.9|104.9|Standard Deviation|79.7|79.7|||
3789624|NCT01850602|3619247|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789625|NCT01850602|3619248|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789626|NCT01850602|3619249|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789627|NCT01850602|3619247|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789628|NCT01850602|3619248|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789629|NCT01850602|3619249|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789630|NCT01850602|3619247|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789631|NCT01850602|3619248|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789632|NCT01850602|3619249|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789633|NCT01850602|3619247|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789634|NCT01850602|3619248|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789635|NCT01850602|3619249|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789636|NCT01850602|3619247|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789637|NCT01850602|3619248|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789638|NCT01850602|3619249|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789639|NCT01850602|3619247|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|192|192.0||||||
3789640|NCT01850602|3619248|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
3789641|NCT01850602|3619249|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3789642|NCT01850602|3619247|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789643|NCT01850602|3619248|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789644|NCT01850602|3619249|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789645|NCT01850602|3619247|B3||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3789646|NCT01850602|3619248|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3789647|NCT01850602|3619249|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3789648|NCT01850602|3619247|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3789649|NCT01850602|3619248|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3789650|NCT01850602|3619249|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3789651|NCT01850602|3619247|B3|||Age||years|Mean|60.9|60.9|Standard Deviation|11.8|11.8|||
3789652|NCT01850602|3619248|B2|||Age||years|Mean|60.8|60.8|Standard Deviation|12.0|12.0|||
3789653|NCT01850602|3619249|B1|||Age||years|Mean|61.0|61.0|Standard Deviation|11.7|11.7|||
3789654|NCT01850589|3619262|B3|Unspecified Gender||Sex/Gender, Customized|Gender data was not collected in this study.|Participants|Number|36|36.0||||||
3789655|NCT01850589|3619263|B2|Unspecified Gender||Sex/Gender, Customized|Gender data was not collected in this study.|Participants|Number|22|22.0||||||
3789656|NCT01850589|3619264|B1|Unspecified Gender||Sex/Gender, Customized|Gender data was not collected in this study.|Participants|Number|14|14.0||||||
3789657|NCT01850589|3619262|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3789658|NCT01850589|3619263|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3789659|NCT01850589|3619264|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3789660|NCT01850589|3619262|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3789661|NCT01850589|3619263|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3789662|NCT01850589|3619264|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3789663|NCT01850589|3619262|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3789664|NCT01850589|3619263|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3789665|NCT01850589|3619264|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3789666|NCT01850550|3619271|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
3789667|NCT01850550|3619272|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
3789668|NCT01850550|3619273|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3789669|NCT01850550|3619271|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3789670|NCT01850550|3619272|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3789671|NCT01850550|3619273|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3789672|NCT01850550|3619271|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3789673|NCT01850550|3619272|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3789674|NCT01850550|3619273|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3789675|NCT01850550|3619271|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3789676|NCT01850550|3619272|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3789677|NCT01850550|3619273|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3789678|NCT01850550|3619271|B3||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
3789679|NCT01850550|3619272|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3789680|NCT01850550|3619273|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3789681|NCT01850550|3619271|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3789682|NCT01850550|3619272|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3789683|NCT01850550|3619273|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3789684|NCT01850485|3619282|B3|Netherlands||Region of Enrollment||participants|Number|22|22.0||||||
3789685|NCT01850485|3619283|B2|Netherlands||Region of Enrollment||participants|Number|13|13.0||||||
3789686|NCT01850485|3619284|B1|Netherlands||Region of Enrollment||participants|Number|9|9.0||||||
3789687|NCT01850485|3619282|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3789688|NCT01850485|3619283|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3789689|NCT01850485|3619284|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3789690|NCT01850485|3619282|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3789691|NCT01850485|3619283|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3789692|NCT01850485|3619284|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3789693|NCT01850485|3619282|B3|||Age||years|Mean|66.6|66.6|Standard Deviation|9.9|9.9|||
3789694|NCT01850485|3619283|B2|||Age||years|Mean|68.9|68.9|Standard Deviation|9.3|9.3|||
3789695|NCT01850485|3619284|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|12.4|12.4|||
3789696|NCT01850394|3619303|B4|Thailand||Region of Enrollment||participants|Number|135|135.0||||||
3789697|NCT01850394|3619304|B3|Thailand||Region of Enrollment||participants|Number|45|45.0||||||
3789698|NCT01850394|3619305|B2|Thailand||Region of Enrollment||participants|Number|45|45.0||||||
3789699|NCT01850394|3619306|B1|Thailand||Region of Enrollment||participants|Number|45|45.0||||||
3789700|NCT01850394|3619303|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3789701|NCT01850394|3619304|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3789702|NCT01850394|3619305|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3789703|NCT01850394|3619306|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3789704|NCT01850394|3619303|B4||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3789705|NCT01850394|3619304|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3789706|NCT01850394|3619305|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3789707|NCT01850394|3619306|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3789708|NCT01850394|3619303|B4|||Age||years|Mean|67.3|67.3|Standard Deviation|7.5|7.5|||
3789709|NCT01850394|3619304|B3|||Age||years|Mean|68.1|68.1|Standard Deviation|6.2|6.2|||
3789710|NCT01850394|3619305|B2|||Age||years|Mean|67.6|67.6|Standard Deviation|8.7|8.7|||
3789711|NCT01850394|3619306|B1|||Age||years|Mean|66.2|66.2|Standard Deviation|7.3|7.3|||
3789712|NCT01850394|3619303|B4||>=65 years|Age||Participants|Count of Participants|82|82.0||||||
3789713|NCT01850394|3619304|B3||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
3789714|NCT01850394|3619305|B2||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3789715|NCT01850394|3619306|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3789716|NCT01850394|3619303|B4||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
3789717|NCT01850394|3619304|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3789718|NCT01850394|3619305|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3789719|NCT01850394|3619306|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3789720|NCT01850394|3619303|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3789721|NCT01850394|3619304|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3789722|NCT01850394|3619305|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3789723|NCT01850394|3619306|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3789724|NCT01850030|3619328|B3|Spain||Region of Enrollment||participants|Number|109|109.0||||||
3789725|NCT01850030|3619329|B2|Spain||Region of Enrollment||participants|Number|54|54.0||||||
3789726|NCT01850030|3619330|B1|Spain||Region of Enrollment||participants|Number|55|55.0||||||
3789727|NCT01850030|3619328|B3|Germany||Region of Enrollment||participants|Number|122|122.0||||||
3789728|NCT01850030|3619329|B2|Germany||Region of Enrollment||participants|Number|60|60.0||||||
3789729|NCT01850030|3619330|B1|Germany||Region of Enrollment||participants|Number|62|62.0||||||
3789730|NCT01850030|3619328|B3|Israel||Region of Enrollment||participants|Number|135|135.0||||||
3789731|NCT01850030|3619329|B2|Israel||Region of Enrollment||participants|Number|66|66.0||||||
3789732|NCT01850030|3619330|B1|Israel||Region of Enrollment||participants|Number|69|69.0||||||
3789733|NCT01850030|3619328|B3|Finland||Region of Enrollment||participants|Number|9|9.0||||||
3789734|NCT01850030|3619329|B2|Finland||Region of Enrollment||participants|Number|5|5.0||||||
3789735|NCT01850030|3619330|B1|Finland||Region of Enrollment||participants|Number|4|4.0||||||
3789736|NCT01850030|3619328|B3|Belgium||Region of Enrollment||participants|Number|376|376.0||||||
3789737|NCT01850030|3619329|B2|Belgium||Region of Enrollment||participants|Number|182|182.0||||||
3789738|NCT01850030|3619330|B1|Belgium||Region of Enrollment||participants|Number|194|194.0||||||
3789739|NCT01850030|3619328|B3|Russian Federation||Region of Enrollment||participants|Number|209|209.0||||||
3789740|NCT01850030|3619329|B2|Russian Federation||Region of Enrollment||participants|Number|103|103.0||||||
3789741|NCT01850030|3619330|B1|Russian Federation||Region of Enrollment||participants|Number|106|106.0||||||
3789742|NCT01850030|3619328|B3|Austria||Region of Enrollment||participants|Number|14|14.0||||||
3789743|NCT01850030|3619329|B2|Austria||Region of Enrollment||participants|Number|7|7.0||||||
3789744|NCT01850030|3619330|B1|Austria||Region of Enrollment||participants|Number|7|7.0||||||
3789745|NCT01850030|3619328|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3789746|NCT01850030|3619329|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3789747|NCT01850030|3619330|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3789748|NCT01850030|3619328|B3||Female|Sex: Female, Male||Participants|Count of Participants|974|974.0||||||
3789749|NCT01850030|3619329|B2||Female|Sex: Female, Male||Participants|Count of Participants|477|477.0||||||
3789750|NCT01850030|3619330|B1||Female|Sex: Female, Male||Participants|Count of Participants|497|497.0||||||
3789751|NCT01850030|3619328|B3|||Age||years|Mean|32.5|32.5|Standard Deviation|4.4|4.4|||
3789752|NCT01850030|3619329|B2|||Age||years|Mean|32.5|32.5|Standard Deviation|4.4|4.4|||
3789753|NCT01850030|3619330|B1|||Age||years|Mean|32.5|32.5|Standard Deviation|4.5|4.5|||
3789754|NCT01850030|3619328|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3789755|NCT01850030|3619329|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3789756|NCT01850030|3619330|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3789757|NCT01850030|3619328|B3||Between 18 and 65 years|Age||Participants|Count of Participants|974|974.0||||||
3789758|NCT01850030|3619329|B2||Between 18 and 65 years|Age||Participants|Count of Participants|477|477.0||||||
3789759|NCT01850030|3619330|B1||Between 18 and 65 years|Age||Participants|Count of Participants|497|497.0||||||
3789760|NCT01850030|3619328|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3789761|NCT01850030|3619329|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3789762|NCT01850030|3619330|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3789763|NCT01850004|3619343|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3789764|NCT01850004|3619343|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3789765|NCT01850004|3619343|B1|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3789766|NCT01850004|3619343|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|75|75.0||||||
3789767|NCT01850004|3619343|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3789768|NCT01850004|3619343|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3789769|NCT01850004|3619343|B1|||Age||Years|Mean|52.6|52.6|Standard Deviation|14.57|14.57|||
3789770|NCT01849848|3619350|B1|||Body surface area||m^2|Mean|1.576|1.576|Standard Deviation|0.181|0.181|||
3789771|NCT01849848|3619350|B1|||Body weight||kg|Mean|56.86|56.86|Standard Deviation|10.06|10.06|||
3789772|NCT01849848|3619350|B1|||Height||cm|Mean|159.05|159.05|Standard Deviation|9.95|9.95|||
3789773|NCT01849848|3619350|B1|||Serum β2 microglobulin||mg/L|Mean|4.03|4.03|Standard Deviation|1.59|1.59|||
3789774|NCT01849848|3619350|B1|Present||Complication|A complication is a disease or condition that arises as a result of multiple myeloma.|participants|Number|17|17.0||||||
3789775|NCT01849848|3619350|B1|Absent||Complication|A complication is a disease or condition that arises as a result of multiple myeloma.|participants|Number|0|0.0||||||
3789776|NCT01849848|3619350|B1|Present||Accompanying symptoms of the primary disease||participants|Number|16|16.0||||||
3789777|NCT01849848|3619350|B1|Absent||Accompanying symptoms of the primary disease||participants|Number|1|1.0||||||
3789778|NCT01849848|3619350|B1|Present||Medical history||participants|Number|7|7.0||||||
3789779|NCT01849848|3619350|B1|Absent||Medical history||participants|Number|10|10.0||||||
3789780|NCT01849848|3619350|B1|III||Clinical disease stage (International Staging System)|"The criteria of clinical disease stage (International Staging System) are shown below.~stage I: Serum β2-microglobulin < 3.5 mg/L plus serum albumin ≥ 3.5 g/dL, stage II: neither stage I nor III , stage III: Serum β2-microglobulin ≥ 5.5 mg/L"|participants|Number|3|3.0||||||
3789781|NCT01849848|3619350|B1|II||Clinical disease stage (International Staging System)|"The criteria of clinical disease stage (International Staging System) are shown below.~stage I: Serum β2-microglobulin < 3.5 mg/L plus serum albumin ≥ 3.5 g/dL, stage II: neither stage I nor III , stage III: Serum β2-microglobulin ≥ 5.5 mg/L"|participants|Number|11|11.0||||||
3789782|NCT01849848|3619350|B1|I||Clinical disease stage (International Staging System)|"The criteria of clinical disease stage (International Staging System) are shown below.~stage I: Serum β2-microglobulin < 3.5 mg/L plus serum albumin ≥ 3.5 g/dL, stage II: neither stage I nor III , stage III: Serum β2-microglobulin ≥ 5.5 mg/L"|participants|Number|3|3.0||||||
3789821|NCT01849770|3619366|B2|||Baseline Cramps in Previous 30 Days||Number of Cramps|Mean|29.1|29.1|Standard Deviation|43.9|43.9|||
3789822|NCT01849770|3619367|B1|||Baseline Cramps in Previous 30 Days||Number of Cramps|Mean|52.9|52.9|Standard Deviation|91.0|91.0|||
3789823|NCT01849770|3619364|B4|||Baseline Cramps in Previous 24 hours||Number of Cramps|Mean|1.94|1.94|Standard Deviation|2.31|2.31|||
3789783|NCT01849848|3619350|B1|2||Performance status|"The criteria of Eastern Cooperative Oncology Group (ECOG) performance status are shown below.~0: Fully active, able to carry on all pre-disease performance without restriction , 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work , 2: Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours"|participants|Number|2|2.0||||||
3789784|NCT01849848|3619350|B1|1||Performance status|"The criteria of Eastern Cooperative Oncology Group (ECOG) performance status are shown below.~0: Fully active, able to carry on all pre-disease performance without restriction , 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work , 2: Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours"|participants|Number|8|8.0||||||
3789785|NCT01849848|3619350|B1|0||Performance status|"The criteria of Eastern Cooperative Oncology Group (ECOG) performance status are shown below.~0: Fully active, able to carry on all pre-disease performance without restriction , 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work , 2: Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours"|participants|Number|7|7.0||||||
3789786|NCT01849848|3619350|B1|Other||Prior therapy||participants|Number|11|11.0||||||
3789787|NCT01849848|3619350|B1|Alkylating agent||Prior therapy||participants|Number|17|17.0||||||
3789788|NCT01849848|3619350|B1|IMIDs||Prior therapy||participants|Number|16|16.0||||||
3789789|NCT01849848|3619350|B1|Proteasome inhibitor||Prior therapy||participants|Number|17|17.0||||||
3789790|NCT01849848|3619350|B1|Present||Prior therapy||participants|Number|17|17.0||||||
3789791|NCT01849848|3619350|B1|Absent||Prior therapy||participants|Number|0|0.0||||||
3789792|NCT01849848|3619350|B1|λ||Subtype of myeloma|One participant could carry multiple subtypes of myeloma.|participants|Number|4|4.0||||||
3789793|NCT01849848|3619350|B1|κ||Subtype of myeloma|One participant could carry multiple subtypes of myeloma.|participants|Number|13|13.0||||||
3789794|NCT01849848|3619350|B1|Bence Jones type||Subtype of myeloma|One participant could carry multiple subtypes of myeloma.|participants|Number|8|8.0||||||
3789795|NCT01849848|3619350|B1|Immunoglobulin D||Subtype of myeloma|One participant could carry multiple subtypes of myeloma.|participants|Number|0|0.0||||||
3789796|NCT01849848|3619350|B1|Immunoglobulin A||Subtype of myeloma|One participant could carry multiple subtypes of myeloma.|participants|Number|6|6.0||||||
3789797|NCT01849848|3619350|B1|Immunoglobulin G||Subtype of myeloma|One participant could carry multiple subtypes of myeloma.|participants|Number|10|10.0||||||
3789798|NCT01849848|3619350|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3789799|NCT01849848|3619350|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3789800|NCT01849848|3619350|B1|70-79 years||Age, Customized||participants|Number|5|5.0||||||
3789801|NCT01849848|3619350|B1|60-69 years||Age, Customized||participants|Number|7|7.0||||||
3789802|NCT01849848|3619350|B1|50-59 years||Age, Customized||participants|Number|3|3.0||||||
3789803|NCT01849848|3619350|B1|40-49 years||Age, Customized||participants|Number|2|2.0||||||
3789804|NCT01849848|3619350|B1|30-39 years||Age, Customized||participants|Number|0|0.0||||||
3789805|NCT01849848|3619350|B1|20-29 years||Age, Customized||participants|Number|0|0.0||||||
3789806|NCT01849848|3619350|B1|||Age||Years|Mean|63.5|63.5|Standard Deviation|9.8|9.8|||
3789807|NCT01849770|3619364|B4|||ALSFRS-R Total Score|ALS Functional Rating Scale - Revised (ALSFRS-R) Total Score at Baseline. Scale is measured from 0 (worst score) to 48 points (best score).|units on a scale|Mean|35.0|35.0|Standard Deviation|6.7|6.7|||
3789808|NCT01849770|3619365|B3|||ALSFRS-R Total Score|ALS Functional Rating Scale - Revised (ALSFRS-R) Total Score at Baseline. Scale is measured from 0 (worst score) to 48 points (best score).|units on a scale|Mean|34.9|34.9|Standard Deviation|5.5|5.5|||
3789809|NCT01849770|3619366|B2|||ALSFRS-R Total Score|ALS Functional Rating Scale - Revised (ALSFRS-R) Total Score at Baseline. Scale is measured from 0 (worst score) to 48 points (best score).|units on a scale|Mean|33.6|33.6|Standard Deviation|6.7|6.7|||
3789810|NCT01849770|3619367|B1|||ALSFRS-R Total Score|ALS Functional Rating Scale - Revised (ALSFRS-R) Total Score at Baseline. Scale is measured from 0 (worst score) to 48 points (best score).|units on a scale|Mean|36.3|36.3|Standard Deviation|7.8|7.8|||
3789811|NCT01849770|3619364|B4|||Maximum Cramp Pain in Previous 30 Days|Cramp pain measured at 0 no pain and 10 is worst pain.|units on a scale|Mean|3.24|3.24|Standard Deviation|2.45|2.45|||
3789812|NCT01849770|3619365|B3|||Maximum Cramp Pain in Previous 30 Days|Cramp pain measured at 0 no pain and 10 is worst pain.|units on a scale|Mean|3.35|3.35|Standard Deviation|2.70|2.7|||
3789813|NCT01849770|3619366|B2|||Maximum Cramp Pain in Previous 30 Days|Cramp pain measured at 0 no pain and 10 is worst pain.|units on a scale|Mean|3.37|3.37|Standard Deviation|2.36|2.36|||
3789814|NCT01849770|3619367|B1|||Maximum Cramp Pain in Previous 30 Days|Cramp pain measured at 0 no pain and 10 is worst pain.|units on a scale|Mean|3.00|3.0|Standard Deviation|2.38|2.38|||
3789815|NCT01849770|3619364|B4|||Maximum Cramp Pain in Previous 24 hours|Cramp pain measured at 0 no pain and 10 is worst pain.|units on a scale|Mean|2.20|2.2|Standard Deviation|2.38|2.38|||
3789816|NCT01849770|3619365|B3|||Maximum Cramp Pain in Previous 24 hours|Cramp pain measured at 0 no pain and 10 is worst pain.|units on a scale|Mean|2.55|2.55|Standard Deviation|2.78|2.78|||
3789817|NCT01849770|3619366|B2|||Maximum Cramp Pain in Previous 24 hours|Cramp pain measured at 0 no pain and 10 is worst pain.|units on a scale|Mean|2.32|2.32|Standard Deviation|2.11|2.11|||
3789818|NCT01849770|3619367|B1|||Maximum Cramp Pain in Previous 24 hours|Cramp pain measured at 0 no pain and 10 is worst pain.|units on a scale|Mean|1.75|1.75|Standard Deviation|2.24|2.24|||
3789819|NCT01849770|3619364|B4|||Baseline Cramps in Previous 30 Days||Number of Cramps|Mean|42.8|42.8|Standard Deviation|66.1|66.1|||
3789820|NCT01849770|3619365|B3|||Baseline Cramps in Previous 30 Days||Number of Cramps|Mean|46.2|46.2|Standard Deviation|55.9|55.9|||
3789912|NCT01849692|3619410|B3|Cohort 1, Female||Sex/Gender, Customized||participants|Number|4|4.0||||||
3789824|NCT01849770|3619365|B3|||Baseline Cramps in Previous 24 hours||Number of Cramps|Mean|2.15|2.15|Standard Deviation|2.13|2.13|||
3789825|NCT01849770|3619366|B2|||Baseline Cramps in Previous 24 hours||Number of Cramps|Mean|1.68|1.68|Standard Deviation|1.63|1.63|||
3789826|NCT01849770|3619367|B1|||Baseline Cramps in Previous 24 hours||Number of Cramps|Mean|1.97|1.97|Standard Deviation|3.06|3.06|||
3789827|NCT01849770|3619364|B4|||Body Mass Index (BMI) (kg/m^2)||kilograms (kg)/meter squared (m^2)|Mean|27.5|27.5|Standard Deviation|4.2|4.2|||
3789828|NCT01849770|3619365|B3|||Body Mass Index (BMI) (kg/m^2)||kilograms (kg)/meter squared (m^2)|Mean|27.1|27.1|Standard Deviation|3.3|3.3|||
3789829|NCT01849770|3619366|B2|||Body Mass Index (BMI) (kg/m^2)||kilograms (kg)/meter squared (m^2)|Mean|27.3|27.3|Standard Deviation|4.1|4.1|||
3789830|NCT01849770|3619367|B1|||Body Mass Index (BMI) (kg/m^2)||kilograms (kg)/meter squared (m^2)|Mean|28.1|28.1|Standard Deviation|5.1|5.1|||
3789831|NCT01849770|3619364|B4|||Slow Vital Capacity (Max % predicted)||Max %-predicted|Mean|85.6|85.6|Standard Deviation|21.5|21.5|||
3789832|NCT01849770|3619365|B3|||Slow Vital Capacity (Max % predicted)||Max %-predicted|Mean|83.7|83.7|Standard Deviation|22.6|22.6|||
3789833|NCT01849770|3619366|B2|||Slow Vital Capacity (Max % predicted)||Max %-predicted|Mean|86.2|86.2|Standard Deviation|23.7|23.7|||
3789834|NCT01849770|3619367|B1|||Slow Vital Capacity (Max % predicted)||Max %-predicted|Mean|86.7|86.7|Standard Deviation|19.1|19.1|||
3789835|NCT01849770|3619364|B4|||Months Since Diagnosis|Number of months since enrolling into the study that a subject was diagnosed with ALS.|Months|Mean|8.3|8.3|Standard Deviation|7.2|7.2|||
3789836|NCT01849770|3619365|B3|||Months Since Diagnosis|Number of months since enrolling into the study that a subject was diagnosed with ALS.|Months|Mean|7.3|7.3|Standard Deviation|5.9|5.9|||
3789837|NCT01849770|3619366|B2|||Months Since Diagnosis|Number of months since enrolling into the study that a subject was diagnosed with ALS.|Months|Mean|8.9|8.9|Standard Deviation|8.2|8.2|||
3789838|NCT01849770|3619367|B1|||Months Since Diagnosis|Number of months since enrolling into the study that a subject was diagnosed with ALS.|Months|Mean|8.6|8.6|Standard Deviation|7.7|7.7|||
3789839|NCT01849770|3619364|B4|||Months Since Symptom Onset|Number of months since ALS symptom onset prior to enrolling into this study.|Months|Mean|19.0|19.0|Standard Deviation|9.3|9.3|||
3789840|NCT01849770|3619365|B3|||Months Since Symptom Onset|Number of months since ALS symptom onset prior to enrolling into this study.|Months|Mean|17.5|17.5|Standard Deviation|8.3|8.3|||
3789841|NCT01849770|3619366|B2|||Months Since Symptom Onset|Number of months since ALS symptom onset prior to enrolling into this study.|Months|Mean|18.6|18.6|Standard Deviation|9.2|9.2|||
3789842|NCT01849770|3619367|B1|||Months Since Symptom Onset|Number of months since ALS symptom onset prior to enrolling into this study.|Months|Mean|21.0|21.0|Standard Deviation|10.3|10.3|||
3789843|NCT01849770|3619364|B4|United States||Region of Enrollment||participants|Number|59|59.0||||||
3789844|NCT01849770|3619365|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3789845|NCT01849770|3619366|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3789846|NCT01849770|3619367|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3789847|NCT01849770|3619364|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
3789848|NCT01849770|3619365|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3789849|NCT01849770|3619366|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3789850|NCT01849770|3619367|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3789851|NCT01849770|3619364|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3789852|NCT01849770|3619365|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3789853|NCT01849770|3619366|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3789854|NCT01849770|3619367|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3789855|NCT01849770|3619364|B4||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3789856|NCT01849770|3619365|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3789857|NCT01849770|3619366|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3789858|NCT01849770|3619367|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3789859|NCT01849770|3619364|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3789860|NCT01849770|3619365|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3789861|NCT01849770|3619366|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3789862|NCT01849770|3619367|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3789863|NCT01849770|3619364|B4|||Age||years|Mean|58.0|58.0|Standard Deviation|8.3|8.3|||
3789864|NCT01849770|3619365|B3|||Age||years|Mean|57.0|57.0|Standard Deviation|7.0|7.0|||
3789865|NCT01849770|3619366|B2|||Age||years|Mean|58.0|58.0|Standard Deviation|10.7|10.7|||
3789866|NCT01849770|3619367|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|7.1|7.1|||
3789867|NCT01849692|3619410|B3|Cohort 4, n=10, 3||Central subfield thickness (CSFT)||microns|Mean|543.7|543.7|Standard Deviation|126.5|126.5|||
3789868|NCT01849692|3619411|B2|Cohort 4, n=10, 3||Central subfield thickness (CSFT)||microns|Mean|573.3|573.3|Standard Deviation|160.6|160.6|||
3789869|NCT01849692|3619412|B1|Cohort 4, n=10, 3||Central subfield thickness (CSFT)||microns|Mean|534.8|534.8|Standard Deviation|123.4|123.4|||
3789870|NCT01849692|3619410|B3|Cohort 3, n=10, 3||Central subfield thickness (CSFT)||microns|Mean|461.6|461.6|Standard Deviation|91.9|91.9|||
3789871|NCT01849692|3619411|B2|Cohort 3, n=10, 3||Central subfield thickness (CSFT)||microns|Mean|403.3|403.3|Standard Deviation|67.7|67.7|||
3789872|NCT01849692|3619412|B1|Cohort 3, n=10, 3||Central subfield thickness (CSFT)||microns|Mean|479.1|479.1|Standard Deviation|93.7|93.7|||
3789873|NCT01849692|3619410|B3|Cohort 2, n=10, 3||Central subfield thickness (CSFT)||microns|Mean|419.0|419.0|Standard Deviation|83.5|83.5|||
3789913|NCT01849692|3619411|B2|Cohort 1, Female||Sex/Gender, Customized||participants|Number|1|1.0||||||
3789874|NCT01849692|3619411|B2|Cohort 2, n=10, 3||Central subfield thickness (CSFT)||microns|Mean|405.7|405.7|Standard Deviation|19.9|19.9|||
3789875|NCT01849692|3619412|B1|Cohort 2, n=10, 3||Central subfield thickness (CSFT)||microns|Mean|423.0|423.0|Standard Deviation|95.5|95.5|||
3789876|NCT01849692|3619410|B3|Cohort 1, n=10, 3||Central subfield thickness (CSFT)||microns|Mean|522.9|522.9|Standard Deviation|175.5|175.5|||
3789877|NCT01849692|3619411|B2|Cohort 1, n=10, 3||Central subfield thickness (CSFT)||microns|Mean|482.3|482.3|Standard Deviation|104.3|104.3|||
3789878|NCT01849692|3619412|B1|Cohort 1, n=10, 3||Central subfield thickness (CSFT)||microns|Mean|535.1|535.1|Standard Deviation|194.7|194.7|||
3789879|NCT01849692|3619410|B3|Cohort 4, n=10, 3||Best corrected visual acuity (BCVA)|BCVA (with spectacles or other visual corrective devices) using Early Treatment Diabetic Retinopathy Study (ETDRS) testing was reported in letters read correctly out of 70 letters on the chart.|letters|Mean|53.4|53.4|Standard Deviation|14.4|14.4|||
3789880|NCT01849692|3619411|B2|Cohort 4, n=10, 3||Best corrected visual acuity (BCVA)|BCVA (with spectacles or other visual corrective devices) using Early Treatment Diabetic Retinopathy Study (ETDRS) testing was reported in letters read correctly out of 70 letters on the chart.|letters|Mean|48.7|48.7|Standard Deviation|16.9|16.9|||
3789881|NCT01849692|3619412|B1|Cohort 4, n=10, 3||Best corrected visual acuity (BCVA)|BCVA (with spectacles or other visual corrective devices) using Early Treatment Diabetic Retinopathy Study (ETDRS) testing was reported in letters read correctly out of 70 letters on the chart.|letters|Mean|54.8|54.8|Standard Deviation|14.2|14.2|||
3789882|NCT01849692|3619410|B3|Cohort 3, n=10, 3||Best corrected visual acuity (BCVA)|BCVA (with spectacles or other visual corrective devices) using Early Treatment Diabetic Retinopathy Study (ETDRS) testing was reported in letters read correctly out of 70 letters on the chart.|letters|Mean|60.0|60.0|Standard Deviation|12.9|12.9|||
3789883|NCT01849692|3619411|B2|Cohort 3, n=10, 3||Best corrected visual acuity (BCVA)|BCVA (with spectacles or other visual corrective devices) using Early Treatment Diabetic Retinopathy Study (ETDRS) testing was reported in letters read correctly out of 70 letters on the chart.|letters|Mean|59.3|59.3|Standard Deviation|5.1|5.1|||
3789884|NCT01849692|3619412|B1|Cohort 3, n=10, 3||Best corrected visual acuity (BCVA)|BCVA (with spectacles or other visual corrective devices) using Early Treatment Diabetic Retinopathy Study (ETDRS) testing was reported in letters read correctly out of 70 letters on the chart.|letters|Mean|60.2|60.2|Standard Deviation|14.7|14.7|||
3789885|NCT01849692|3619410|B3|Cohort 2, n=10, 3||Best corrected visual acuity (BCVA)|BCVA (with spectacles or other visual corrective devices) using Early Treatment Diabetic Retinopathy Study (ETDRS) testing was reported in letters read correctly out of 70 letters on the chart.|letters|Mean|61.8|61.8|Standard Deviation|10.7|10.7|||
3789886|NCT01849692|3619411|B2|Cohort 2, n=10, 3||Best corrected visual acuity (BCVA)|BCVA (with spectacles or other visual corrective devices) using Early Treatment Diabetic Retinopathy Study (ETDRS) testing was reported in letters read correctly out of 70 letters on the chart.|letters|Mean|64.3|64.3|Standard Deviation|6.8|6.8|||
3789887|NCT01849692|3619412|B1|Cohort 2, n=10, 3||Best corrected visual acuity (BCVA)|BCVA (with spectacles or other visual corrective devices) using Early Treatment Diabetic Retinopathy Study (ETDRS) testing was reported in letters read correctly out of 70 letters on the chart.|letters|Mean|61.0|61.0|Standard Deviation|11.8|11.8|||
3789888|NCT01849692|3619410|B3|Cohort 1, n=10, 3||Best corrected visual acuity (BCVA)|BCVA (with spectacles or other visual corrective devices) using Early Treatment Diabetic Retinopathy Study (ETDRS) testing was reported in letters read correctly out of 70 letters on the chart.|letters|Mean|61.5|61.5|Standard Deviation|7.8|7.8|||
3789889|NCT01849692|3619411|B2|Cohort 1, n=10, 3||Best corrected visual acuity (BCVA)|BCVA (with spectacles or other visual corrective devices) using Early Treatment Diabetic Retinopathy Study (ETDRS) testing was reported in letters read correctly out of 70 letters on the chart.|letters|Mean|55.0|55.0|Standard Deviation|8.7|8.7|||
3789890|NCT01849692|3619412|B1|Cohort 1, n=10, 3||Best corrected visual acuity (BCVA)|BCVA (with spectacles or other visual corrective devices) using Early Treatment Diabetic Retinopathy Study (ETDRS) testing was reported in letters read correctly out of 70 letters on the chart.|letters|Mean|63.4|63.4|Standard Deviation|6.8|6.8|||
3789891|NCT01849692|3619410|B3|Cohort 4, Male||Sex/Gender, Customized||participants|Number|8|8.0||||||
3789892|NCT01849692|3619411|B2|Cohort 4, Male||Sex/Gender, Customized||participants|Number|2|2.0||||||
3789893|NCT01849692|3619412|B1|Cohort 4, Male||Sex/Gender, Customized||participants|Number|6|6.0||||||
3789894|NCT01849692|3619410|B3|Cohort 4, Female||Sex/Gender, Customized||participants|Number|5|5.0||||||
3789895|NCT01849692|3619411|B2|Cohort 4, Female||Sex/Gender, Customized||participants|Number|1|1.0||||||
3789896|NCT01849692|3619412|B1|Cohort 4, Female||Sex/Gender, Customized||participants|Number|4|4.0||||||
3789897|NCT01849692|3619410|B3|Cohort 3, Male||Sex/Gender, Customized||participants|Number|6|6.0||||||
3789898|NCT01849692|3619411|B2|Cohort 3, Male||Sex/Gender, Customized||participants|Number|1|1.0||||||
3789899|NCT01849692|3619412|B1|Cohort 3, Male||Sex/Gender, Customized||participants|Number|5|5.0||||||
3789900|NCT01849692|3619410|B3|Cohort 3, Female||Sex/Gender, Customized||participants|Number|7|7.0||||||
3789901|NCT01849692|3619411|B2|Cohort 3, Female||Sex/Gender, Customized||participants|Number|2|2.0||||||
3789902|NCT01849692|3619412|B1|Cohort 3, Female||Sex/Gender, Customized||participants|Number|5|5.0||||||
3789903|NCT01849692|3619410|B3|Cohort 2, Male||Sex/Gender, Customized||participants|Number|5|5.0||||||
3789904|NCT01849692|3619411|B2|Cohort 2, Male||Sex/Gender, Customized||participants|Number|1|1.0||||||
3789905|NCT01849692|3619412|B1|Cohort 2, Male||Sex/Gender, Customized||participants|Number|4|4.0||||||
3789906|NCT01849692|3619410|B3|Cohort 2, Female||Sex/Gender, Customized||participants|Number|8|8.0||||||
3789907|NCT01849692|3619411|B2|Cohort 2, Female||Sex/Gender, Customized||participants|Number|2|2.0||||||
3789908|NCT01849692|3619412|B1|Cohort 2, Female||Sex/Gender, Customized||participants|Number|6|6.0||||||
3789909|NCT01849692|3619410|B3|Cohort 1, Male||Sex/Gender, Customized||participants|Number|9|9.0||||||
3789910|NCT01849692|3619411|B2|Cohort 1, Male||Sex/Gender, Customized||participants|Number|2|2.0||||||
3789911|NCT01849692|3619412|B1|Cohort 1, Male||Sex/Gender, Customized||participants|Number|7|7.0||||||
3789914|NCT01849692|3619412|B1|Cohort 1, Female||Sex/Gender, Customized||participants|Number|3|3.0||||||
3789915|NCT01849692|3619410|B3|Cohort 4, n=10, 3||Age||years|Mean|80.5|80.5|Standard Deviation|5.9|5.9|||
3789916|NCT01849692|3619411|B2|Cohort 4, n=10, 3||Age||years|Mean|76.7|76.7|Standard Deviation|3.8|3.8|||
3789917|NCT01849692|3619412|B1|Cohort 4, n=10, 3||Age||years|Mean|81.6|81.6|Standard Deviation|6.1|6.1|||
3789918|NCT01849692|3619410|B3|Cohort 3, n=10, 3||Age||years|Mean|77.7|77.7|Standard Deviation|9.8|9.8|||
3789919|NCT01849692|3619411|B2|Cohort 3, n=10, 3||Age||years|Mean|81.7|81.7|Standard Deviation|11.0|11.0|||
3789920|NCT01849692|3619412|B1|Cohort 3, n=10, 3||Age||years|Mean|76.5|76.5|Standard Deviation|9.7|9.7|||
3789921|NCT01849692|3619410|B3|Cohort 2, n=10, 3||Age||years|Mean|75.5|75.5|Standard Deviation|8.7|8.7|||
3789922|NCT01849692|3619411|B2|Cohort 2, n=10, 3||Age||years|Mean|82.0|82.0|Standard Deviation|3.6|3.6|||
3789923|NCT01849692|3619412|B1|Cohort 2, n=10, 3||Age||years|Mean|73.6|73.6|Standard Deviation|8.9|8.9|||
3789924|NCT01849692|3619410|B3|Cohort 1, n=10, 3||Age||years|Mean|77.7|77.7|Standard Deviation|4.3|4.3|||
3789925|NCT01849692|3619411|B2|Cohort 1, n=10, 3||Age||years|Mean|78.3|78.3|Standard Deviation|7.2|7.2|||
3789926|NCT01849692|3619412|B1|Cohort 1, n=10, 3||Age||years|Mean|77.5|77.5|Standard Deviation|3.6|3.6|||
3789927|NCT01849588|3619448|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3789928|NCT01849588|3619448|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789929|NCT01849588|3619448|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789930|NCT01849588|3619448|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3789931|NCT01849588|3619448|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789932|NCT01849588|3619448|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789933|NCT01849588|3619448|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789934|NCT01849588|3619448|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789935|NCT01849588|3619448|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3789936|NCT01849588|3619448|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3789937|NCT01849588|3619448|B1|||Age||years|Median|57.8|57.8|Full Range|||56.9|61.7|
3789938|NCT01849562|3619455|B4|||Height||CM|Mean|171.8|171.8|Standard Deviation|9.66|9.66|||
3789939|NCT01849562|3619456|B3|||Height||CM|Mean|175.6|175.6|Standard Deviation|7.53|7.53|||
3789940|NCT01849562|3619457|B2|||Height||CM|Mean|169.7|169.7|Standard Deviation|9.76|9.76|||
3789941|NCT01849562|3619458|B1|||Height||CM|Mean|170.1|170.1|Standard Deviation|11.14|11.14|||
3789942|NCT01849562|3619455|B4|||Weight||Kg|Mean|80.2|80.2|Standard Deviation|12.1|12.1|||
3789943|NCT01849562|3619456|B3|||Weight||Kg|Mean|81.5|81.5|Standard Deviation|11.9|11.9|||
3789944|NCT01849562|3619457|B2|||Weight||Kg|Mean|81.5|81.5|Standard Deviation|9.88|9.88|||
3789945|NCT01849562|3619458|B1|||Weight||Kg|Mean|78.1|78.1|Standard Deviation|15.02|15.02|||
3789946|NCT01849562|3619455|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789947|NCT01849562|3619456|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789948|NCT01849562|3619457|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789949|NCT01849562|3619458|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789950|NCT01849562|3619455|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789951|NCT01849562|3619456|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789952|NCT01849562|3619457|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789953|NCT01849562|3619458|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789954|NCT01849562|3619455|B4||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3789955|NCT01849562|3619456|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3789956|NCT01849562|3619457|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3789957|NCT01849562|3619458|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3789958|NCT01849562|3619455|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3789959|NCT01849562|3619456|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3789960|NCT01849562|3619457|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3789961|NCT01849562|3619458|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3789962|NCT01849562|3619455|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789963|NCT01849562|3619456|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789964|NCT01849562|3619457|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789965|NCT01849562|3619458|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789966|NCT01849562|3619455|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789967|NCT01849562|3619456|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789968|NCT01849562|3619457|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789969|NCT01849562|3619458|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789970|NCT01849562|3619455|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3789971|NCT01849562|3619456|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789972|NCT01849562|3619457|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3789973|NCT01849562|3619458|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789974|NCT01849562|3619455|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789975|NCT01849562|3619456|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789976|NCT01849562|3619457|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789977|NCT01849562|3619458|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3789978|NCT01849562|3619455|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3789979|NCT01849562|3619456|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3789980|NCT01849562|3619457|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3789981|NCT01849562|3619458|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3789982|NCT01849562|3619455|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3789983|NCT01849562|3619456|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3789984|NCT01849562|3619457|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3789985|NCT01849562|3619458|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3789986|NCT01849562|3619455|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3789987|NCT01849562|3619456|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3789988|NCT01849562|3619457|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3789989|NCT01849562|3619458|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3789990|NCT01849562|3619455|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3789991|NCT01849562|3619456|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3789992|NCT01849562|3619457|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3789993|NCT01849562|3619458|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3789994|NCT01849562|3619455|B4|||Age||Years|Mean|51.7|51.7|Standard Deviation|9.4|9.4|||
3789995|NCT01849562|3619456|B3|||Age||Years|Mean|53.8|53.8|Standard Deviation|8.58|8.58|||
3789996|NCT01849562|3619457|B2|||Age||Years|Mean|50.7|50.7|Standard Deviation|8.51|8.51|||
3789997|NCT01849562|3619458|B1|||Age||Years|Mean|50.5|50.5|Standard Deviation|11.36|11.36|||
3789998|NCT01849562|3619455|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3789999|NCT01849562|3619456|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3790000|NCT01849562|3619457|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3790001|NCT01849562|3619458|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3790002|NCT01849562|3619455|B4||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3790003|NCT01849562|3619456|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3790004|NCT01849562|3619457|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3790005|NCT01849562|3619458|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3790006|NCT01849562|3619455|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3790007|NCT01849562|3619456|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3790008|NCT01849562|3619457|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3790009|NCT01849562|3619458|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3790010|NCT01849497|3619471|B3|||LDL-C Concentration||mg/dL|Mean|117.5|117.5|Standard Deviation|26.8|26.8|||
3790011|NCT01849497|3619472|B2|||LDL-C Concentration||mg/dL|Mean|118.1|118.1|Standard Deviation|28.7|28.7|||
3790012|NCT01849497|3619473|B1|||LDL-C Concentration||mg/dL|Mean|116.9|116.9|Standard Deviation|25.0|25.0|||
3790013|NCT01849497|3619471|B3|≥ 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|37|37.0||||||
3790014|NCT01849497|3619472|B2|≥ 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|18|18.0||||||
3790015|NCT01849497|3619473|B1|≥ 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|19|19.0||||||
3790016|NCT01849497|3619471|B3|< 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|112|112.0||||||
3790017|NCT01849497|3619472|B2|< 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|56|56.0||||||
3790018|NCT01849497|3619473|B1|< 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|56|56.0||||||
3790019|NCT01849497|3619471|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|134|134.0||||||
3790020|NCT01849497|3619472|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
3790021|NCT01849497|3619473|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
3790022|NCT01849497|3619471|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3790023|NCT01849497|3619472|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3790024|NCT01849497|3619473|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3790025|NCT01849497|3619471|B3|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3790026|NCT01849497|3619472|B2|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3790027|NCT01849497|3619473|B1|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3790028|NCT01849497|3619471|B3|White||Race/Ethnicity, Customized||participants|Number|120|120.0||||||
3790029|NCT01849497|3619472|B2|White||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
3790030|NCT01849497|3619473|B1|White||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
3790031|NCT01849497|3619471|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3790032|NCT01849497|3619472|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3790033|NCT01849497|3619473|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3790034|NCT01849497|3619471|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3790035|NCT01849497|3619472|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3790036|NCT01849497|3619473|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3790037|NCT01849497|3619471|B3|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3790038|NCT01849497|3619472|B2|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3790039|NCT01849497|3619473|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3790040|NCT01849497|3619471|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3790041|NCT01849497|3619472|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3790042|NCT01849497|3619473|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3790043|NCT01849497|3619471|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3790044|NCT01849497|3619472|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3790045|NCT01849497|3619473|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3790046|NCT01849497|3619471|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3790047|NCT01849497|3619472|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3790048|NCT01849497|3619473|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3790049|NCT01849497|3619471|B3|||Age||years|Mean|60.9|60.9|Standard Deviation|10.3|10.3|||
3790050|NCT01849497|3619472|B2|||Age||years|Mean|60.6|60.6|Standard Deviation|9.6|9.6|||
3790051|NCT01849497|3619473|B1|||Age||years|Mean|61.2|61.2|Standard Deviation|11.1|11.1|||
3790052|NCT01849458|3619482|B1|||BMI||kg/m^2|Mean|27.9|27.9|Standard Deviation|7|7.0|||
3790053|NCT01849458|3619482|B1|France||Region of Enrollment||participants|Number|11|11.0||||||
3790054|NCT01849458|3619482|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
3790055|NCT01849458|3619482|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3790056|NCT01849458|3619482|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3790057|NCT01849458|3619482|B1|||Age||years|Mean|61.2|61.2|Standard Deviation|6.9|6.9|||
3790058|NCT01849419|3619492|B1|||MDMA use history||lifetime uses|Mean|15.0|15.0|Standard Deviation|11.2|11.2|||
3790059|NCT01849419|3619492|B1|||Education||years|Mean|14.6|14.6|Standard Deviation|1.4|1.4|||
3790060|NCT01849419|3619492|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790061|NCT01849419|3619492|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790062|NCT01849419|3619492|B1||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3790063|NCT01849419|3619492|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790064|NCT01849419|3619492|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790065|NCT01849419|3619492|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790066|NCT01849419|3619492|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790067|NCT01849419|3619492|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790068|NCT01849419|3619492|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3790069|NCT01849419|3619492|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790070|NCT01849419|3619492|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3790071|NCT01849419|3619492|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3790072|NCT01849419|3619492|B1|||Age||years|Mean|23.8|23.8|Standard Deviation|3.9|3.9|||
3790073|NCT01849289|3619519|B3|||Fasting Plasma Glucose (FPG)||mmol/L|Mean|9.4|9.4|Standard Deviation|2.5|2.5|||
3790074|NCT01849289|3619520|B2|||Fasting Plasma Glucose (FPG)||mmol/L|Mean|9.4|9.4|Standard Deviation|2.5|2.5|||
3790075|NCT01849289|3619521|B1|||Fasting Plasma Glucose (FPG)||mmol/L|Mean|9.4|9.4|Standard Deviation|2.4|2.4|||
3790076|NCT01849289|3619519|B3|||HbA1c||percentage of glycosylated haemoglobin|Mean|8.3|8.3|Standard Deviation|0.8|0.8|||
3790077|NCT01849289|3619520|B2|||HbA1c||percentage of glycosylated haemoglobin|Mean|8.3|8.3|Standard Deviation|0.8|0.8|||
3790078|NCT01849289|3619521|B1|||HbA1c||percentage of glycosylated haemoglobin|Mean|8.3|8.3|Standard Deviation|0.9|0.9|||
3790079|NCT01849289|3619519|B3||Male|Sex: Female, Male||Participants|Count of Participants|431|431.0||||||
3790080|NCT01849289|3619520|B2||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3790081|NCT01849289|3619521|B1||Male|Sex: Female, Male||Participants|Count of Participants|299|299.0||||||
3790082|NCT01849289|3619519|B3||Female|Sex: Female, Male||Participants|Count of Participants|402|402.0||||||
3790083|NCT01849289|3619520|B2||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3790084|NCT01849289|3619521|B1||Female|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
3790085|NCT01849289|3619519|B3|||Age||years|Mean|56.2|56.2|Standard Deviation|9.6|9.6|||
3790086|NCT01849289|3619520|B2|||Age||years|Mean|56.6|56.6|Standard Deviation|9.2|9.2|||
3790087|NCT01849289|3619521|B1|||Age||years|Mean|55.9|55.9|Standard Deviation|9.7|9.7|||
3790088|NCT01849276|3619538|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3790089|NCT01849276|3619538|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790090|NCT01849276|3619538|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790091|NCT01849276|3619538|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3790092|NCT01849276|3619538|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3790093|NCT01849276|3619538|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790094|NCT01849276|3619538|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790095|NCT01849276|3619538|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790096|NCT01849276|3619538|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790097|NCT01849276|3619538|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3790098|NCT01849276|3619538|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3790099|NCT01849276|3619538|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3790100|NCT01849276|3619538|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3790101|NCT01849276|3619538|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3790102|NCT01849276|3619538|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3790103|NCT01849276|3619538|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3790104|NCT01849263|3619550|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
3790105|NCT01849263|3619550|B1|Singapore||Region of Enrollment||participants|Number|2|2.0||||||
3790106|NCT01849263|3619550|B1|Canada||Region of Enrollment||participants|Number|5|5.0||||||
3790107|NCT01849263|3619550|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3790108|NCT01849263|3619550|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3790109|NCT01849263|3619550|B1|||Age||years|Median|64|64.0|Full Range|||46.0|82.0|
3790110|NCT01849068|3619560|B3|Canada||Region of Enrollment||participants|Number|20|20.0||||||
3790111|NCT01849068|3619561|B2|Canada||Region of Enrollment||participants|Number|10|10.0||||||
3790112|NCT01849068|3619562|B1|Canada||Region of Enrollment||participants|Number|10|10.0||||||
3790113|NCT01849068|3619560|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3790114|NCT01849068|3619561|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3790115|NCT01849068|3619562|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3790116|NCT01849068|3619560|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3790117|NCT01849068|3619561|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3790118|NCT01849068|3619562|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3790119|NCT01849068|3619560|B3|||Age||years|Mean|39.4|39.4|Standard Deviation|10.8|10.8|||
3790120|NCT01849068|3619561|B2|||Age||years|Mean|39.4|39.4|Standard Deviation|13.6|13.6|||
3790121|NCT01849068|3619562|B1|||Age||years|Mean|39.4|39.4|Standard Deviation|7.9|7.9|||
3790122|NCT01849068|3619560|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3790123|NCT01849068|3619561|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3790124|NCT01849068|3619562|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3790125|NCT01849068|3619560|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3790126|NCT01849068|3619561|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3790127|NCT01849068|3619562|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3790128|NCT01849068|3619560|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3790129|NCT01849068|3619561|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3790130|NCT01849068|3619562|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3790131|NCT01849055|3619575|B7|United States||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
3790132|NCT01849055|3619576|B6|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3790133|NCT01849055|3619577|B5|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3790134|NCT01849055|3619578|B4|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3790135|NCT01849055|3619579|B3|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3790136|NCT01849055|3619580|B2|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3790137|NCT01849055|3619581|B1|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3790138|NCT01849055|3619575|B7||White|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3790139|NCT01849055|3619576|B6||White|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3790140|NCT01849055|3619577|B5||White|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3790141|NCT01849055|3619578|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3790142|NCT01849055|3619579|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3790143|NCT01849055|3619580|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3790144|NCT01849055|3619581|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3790145|NCT01849055|3619575|B7||Native Hawaiian/Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3790146|NCT01849055|3619576|B6||Native Hawaiian/Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3790147|NCT01849055|3619577|B5||Native Hawaiian/Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3790148|NCT01849055|3619578|B4||Native Hawaiian/Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3790149|NCT01849055|3619579|B3||Native Hawaiian/Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3790150|NCT01849055|3619580|B2||Native Hawaiian/Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3790151|NCT01849055|3619581|B1||Native Hawaiian/Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3790152|NCT01849055|3619575|B7||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3790153|NCT01849055|3619576|B6||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3790154|NCT01849055|3619577|B5||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3790155|NCT01849055|3619578|B4||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3790156|NCT01849055|3619579|B3||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3790157|NCT01849055|3619580|B2||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3790158|NCT01849055|3619581|B1||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3790159|NCT01849055|3619575|B7||Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3790160|NCT01849055|3619576|B6||Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3790161|NCT01849055|3619577|B5||Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3790162|NCT01849055|3619578|B4||Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3790163|NCT01849055|3619579|B3||Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3790164|NCT01849055|3619580|B2||Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3790165|NCT01849055|3619581|B1||Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3790166|NCT01849055|3619575|B7||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3790167|NCT01849055|3619576|B6||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3790168|NCT01849055|3619577|B5||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3790169|NCT01849055|3619578|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3790170|NCT01849055|3619579|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3790171|NCT01849055|3619580|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3790172|NCT01849055|3619581|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3790173|NCT01849055|3619575|B7||American Indian/Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3790174|NCT01849055|3619576|B6||American Indian/Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3790175|NCT01849055|3619577|B5||American Indian/Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3790176|NCT01849055|3619578|B4||American Indian/Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3790177|NCT01849055|3619579|B3||American Indian/Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3790178|NCT01849055|3619580|B2||American Indian/Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3790179|NCT01849055|3619581|B1||American Indian/Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3790180|NCT01849055|3619575|B7||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3790181|NCT01849055|3619576|B6||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3790182|NCT01849055|3619577|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3790183|NCT01849055|3619578|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3790184|NCT01849055|3619579|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3790185|NCT01849055|3619580|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3790186|NCT01849055|3619581|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3790187|NCT01849055|3619575|B7||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3790188|NCT01849055|3619576|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3790189|NCT01849055|3619577|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3790190|NCT01849055|3619578|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3790191|NCT01849055|3619579|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3790192|NCT01849055|3619580|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3790193|NCT01849055|3619581|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3790194|NCT01849055|3619575|B7|||Age||Years|Mean|39.7|39.7|Standard Deviation|9.8|9.8|||
3790195|NCT01849055|3619576|B6|||Age||Years|Mean|39.1|39.1|Standard Deviation|6.8|6.8|||
3790196|NCT01849055|3619577|B5|||Age||Years|Mean|39.0|39.0|Standard Deviation|7.7|7.7|||
3790197|NCT01849055|3619578|B4|||Age||Years|Mean|41.4|41.4|Standard Deviation|10.4|10.4|||
3790198|NCT01849055|3619579|B3|||Age||Years|Mean|37.9|37.9|Standard Deviation|12.6|12.6|||
3790199|NCT01849055|3619580|B2|||Age||Years|Mean|43.0|43.0|Standard Deviation|11.7|11.7|||
3790200|NCT01849055|3619581|B1|||Age||Years|Mean|37.8|37.8|Standard Deviation|10.6|10.6|||
3790201|NCT01848990|3619618|B4|United States||Region of Enrollment||participants|Number|455|455.0||||||
3790202|NCT01848990|3619619|B3|United States||Region of Enrollment||participants|Number|113|113.0||||||
3790203|NCT01848990|3619620|B2|United States||Region of Enrollment||participants|Number|115|115.0||||||
3790204|NCT01848990|3619621|B1|United States||Region of Enrollment||participants|Number|227|227.0||||||
3790205|NCT01848990|3619618|B4|Asian Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3790206|NCT01848990|3619619|B3|Asian Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3790207|NCT01848990|3619620|B2|Asian Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3790208|NCT01848990|3619621|B1|Asian Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3790209|NCT01848990|3619618|B4|White||Race/Ethnicity, Customized||participants|Number|435|435.0||||||
3790210|NCT01848990|3619619|B3|White||Race/Ethnicity, Customized||participants|Number|107|107.0||||||
3790211|NCT01848990|3619620|B2|White||Race/Ethnicity, Customized||participants|Number|112|112.0||||||
3790212|NCT01848990|3619621|B1|White||Race/Ethnicity, Customized||participants|Number|216|216.0||||||
3790213|NCT01848990|3619618|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3790214|NCT01848990|3619619|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3790215|NCT01848990|3619620|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3790216|NCT01848990|3619621|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3790217|NCT01848990|3619618|B4|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3790218|NCT01848990|3619619|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3790219|NCT01848990|3619620|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3790220|NCT01848990|3619621|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3790221|NCT01848990|3619618|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3790222|NCT01848990|3619619|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3790223|NCT01848990|3619620|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3790224|NCT01848990|3619621|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3790225|NCT01848990|3619618|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790226|NCT01848990|3619619|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790227|NCT01848990|3619620|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790228|NCT01848990|3619621|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790229|NCT01848990|3619618|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|433|433.0||||||
3790230|NCT01848990|3619619|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
3790231|NCT01848990|3619620|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
3790232|NCT01848990|3619621|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|217|217.0||||||
3790233|NCT01848990|3619618|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3790234|NCT01848990|3619619|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3790235|NCT01848990|3619620|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3790236|NCT01848990|3619621|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3790237|NCT01848990|3619618|B4||Male|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
3790238|NCT01848990|3619619|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3790239|NCT01848990|3619620|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3790240|NCT01848990|3619621|B1||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3790241|NCT01848990|3619618|B4||Female|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
3790242|NCT01848990|3619619|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3790243|NCT01848990|3619620|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3790244|NCT01848990|3619621|B1||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3790245|NCT01848990|3619618|B4|||Age||years|Mean|47.6|47.6|Standard Deviation|13.47|13.47|||
3790246|NCT01848990|3619619|B3|||Age||years|Mean|49.7|49.7|Standard Deviation|14.73|14.73|||
3790247|NCT01848990|3619620|B2|||Age||years|Mean|45.9|45.9|Standard Deviation|13.14|13.14|||
3790248|NCT01848990|3619621|B1|||Age||years|Mean|47.5|47.5|Standard Deviation|12.90|12.9|||
3790249|NCT01848977|3619682|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3790250|NCT01848977|3619682|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3790251|NCT01848977|3619682|B1|||Age||years|Mean|33|33.0|Standard Deviation|5|5.0|||
3790252|NCT01848977|3619682|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3790253|NCT01848977|3619682|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3790254|NCT01848977|3619682|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3790255|NCT01848938|3619691|B3|More than 1 aid a day||Usage of incontinence aids|Usage of incontinence aids during the last 4 weeks.|participants|Number|8|8.0||||||
3790256|NCT01848938|3619692|B2|More than 1 aid a day||Usage of incontinence aids|Usage of incontinence aids during the last 4 weeks.|participants|Number|4|4.0||||||
3790257|NCT01848938|3619693|B1|More than 1 aid a day||Usage of incontinence aids|Usage of incontinence aids during the last 4 weeks.|participants|Number|4|4.0||||||
3790258|NCT01848938|3619691|B3|1 aid a day||Usage of incontinence aids|Usage of incontinence aids during the last 4 weeks.|participants|Number|19|19.0||||||
3790259|NCT01848938|3619692|B2|1 aid a day||Usage of incontinence aids|Usage of incontinence aids during the last 4 weeks.|participants|Number|10|10.0||||||
3790260|NCT01848938|3619693|B1|1 aid a day||Usage of incontinence aids|Usage of incontinence aids during the last 4 weeks.|participants|Number|9|9.0||||||
3790261|NCT01848938|3619691|B3|>3 times/week, but not daily||Usage of incontinence aids|Usage of incontinence aids during the last 4 weeks.|participants|Number|16|16.0||||||
3790262|NCT01848938|3619692|B2|>3 times/week, but not daily||Usage of incontinence aids|Usage of incontinence aids during the last 4 weeks.|participants|Number|5|5.0||||||
3790263|NCT01848938|3619693|B1|>3 times/week, but not daily||Usage of incontinence aids|Usage of incontinence aids during the last 4 weeks.|participants|Number|11|11.0||||||
3790264|NCT01848938|3619691|B3|1-3 times/week||Usage of incontinence aids|Usage of incontinence aids during the last 4 weeks.|participants|Number|37|37.0||||||
3790265|NCT01848938|3619692|B2|1-3 times/week||Usage of incontinence aids|Usage of incontinence aids during the last 4 weeks.|participants|Number|18|18.0||||||
3790266|NCT01848938|3619693|B1|1-3 times/week||Usage of incontinence aids|Usage of incontinence aids during the last 4 weeks.|participants|Number|19|19.0||||||
3790267|NCT01848938|3619691|B3|Less than once a week||Usage of incontinence aids|Usage of incontinence aids during the last 4 weeks.|participants|Number|27|27.0||||||
3790268|NCT01848938|3619692|B2|Less than once a week||Usage of incontinence aids|Usage of incontinence aids during the last 4 weeks.|participants|Number|14|14.0||||||
3790269|NCT01848938|3619693|B1|Less than once a week||Usage of incontinence aids|Usage of incontinence aids during the last 4 weeks.|participants|Number|13|13.0||||||
3790270|NCT01848938|3619691|B3|No use||Usage of incontinence aids|Usage of incontinence aids during the last 4 weeks.|participants|Number|16|16.0||||||
3790271|NCT01848938|3619692|B2|No use||Usage of incontinence aids|Usage of incontinence aids during the last 4 weeks.|participants|Number|10|10.0||||||
3790272|NCT01848938|3619693|B1|No use||Usage of incontinence aids|Usage of incontinence aids during the last 4 weeks.|participants|Number|6|6.0||||||
3790273|NCT01848938|3619691|B3|no regular medication||Regular Medication||participants|Number|71|71.0||||||
3790274|NCT01848938|3619692|B2|no regular medication||Regular Medication||participants|Number|37|37.0||||||
3790275|NCT01848938|3619693|B1|no regular medication||Regular Medication||participants|Number|34|34.0||||||
3790276|NCT01848938|3619691|B3|on regular medication||Regular Medication||participants|Number|52|52.0||||||
3790277|NCT01848938|3619692|B2|on regular medication||Regular Medication||participants|Number|24|24.0||||||
3790278|NCT01848938|3619693|B1|on regular medication||Regular Medication||participants|Number|28|28.0||||||
3790279|NCT01848938|3619691|B3|not nulliparous||Parity||participants|Number|114|114.0||||||
3790280|NCT01848938|3619692|B2|not nulliparous||Parity||participants|Number|57|57.0||||||
3790281|NCT01848938|3619693|B1|not nulliparous||Parity||participants|Number|57|57.0||||||
3790282|NCT01848938|3619691|B3|nulliparous||Parity||participants|Number|9|9.0||||||
3790283|NCT01848938|3619692|B2|nulliparous||Parity||participants|Number|4|4.0||||||
3790284|NCT01848938|3619693|B1|nulliparous||Parity||participants|Number|5|5.0||||||
3790285|NCT01848938|3619691|B3|<3 years at university level||Education||participants|Number|25|25.0||||||
3790286|NCT01848938|3619692|B2|<3 years at university level||Education||participants|Number|15|15.0||||||
3790287|NCT01848938|3619693|B1|<3 years at university level||Education||participants|Number|10|10.0||||||
3790288|NCT01848938|3619691|B3|>=3 years at university level||Education||participants|Number|98|98.0||||||
3790289|NCT01848938|3619692|B2|>=3 years at university level||Education||participants|Number|46|46.0||||||
3790290|NCT01848938|3619693|B1|>=3 years at university level||Education||participants|Number|52|52.0||||||
3790291|NCT01848938|3619691|B3|non-smoker||Smoking||participants|Number|118|118.0||||||
3790292|NCT01848938|3619692|B2|non-smoker||Smoking||participants|Number|58|58.0||||||
3790293|NCT01848938|3619693|B1|non-smoker||Smoking||participants|Number|60|60.0||||||
3790294|NCT01848938|3619691|B3|smoker||Smoking||participants|Number|5|5.0||||||
3790295|NCT01848938|3619692|B2|smoker||Smoking||participants|Number|3|3.0||||||
3790296|NCT01848938|3619693|B1|smoker||Smoking||participants|Number|2|2.0||||||
3790297|NCT01848938|3619691|B3|||Body Mass Index||kg/m^2|Mean|24.2|24.2|Standard Deviation|4.2|4.2|||
3790298|NCT01848938|3619692|B2|||Body Mass Index||kg/m^2|Mean|24.5|24.5|Standard Deviation|4.4|4.4|||
3790299|NCT01848938|3619693|B1|||Body Mass Index||kg/m^2|Mean|24.0|24.0|Standard Deviation|4.1|4.1|||
3790300|NCT01848938|3619691|B3|Sweden||Region of Enrollment||Participants|Count of Participants|123|123.0||||||
3790301|NCT01848938|3619692|B2|Sweden||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
3790302|NCT01848938|3619693|B1|Sweden||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
3790303|NCT01848938|3619691|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3790304|NCT01848938|3619692|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3790305|NCT01848938|3619693|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3790306|NCT01848938|3619691|B3||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3790307|NCT01848938|3619692|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3790308|NCT01848938|3619693|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3790309|NCT01848938|3619691|B3|||Age||years|Mean|44.7|44.7|Standard Deviation|9.4|9.4|||
3790310|NCT01848938|3619692|B2|||Age||years|Mean|44.7|44.7|Standard Deviation|9.1|9.1|||
3790311|NCT01848938|3619693|B1|||Age||years|Mean|44.8|44.8|Standard Deviation|9.7|9.7|||
3790312|NCT01848899|3619710|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3790313|NCT01848899|3619711|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3790314|NCT01848899|3619712|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3790315|NCT01848899|3619710|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3790316|NCT01848899|3619711|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3790317|NCT01848899|3619712|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3790318|NCT01848899|3619710|B3||>=65 years|Age||Participants|Count of Participants|61|61.0||||||
3790319|NCT01848899|3619711|B2||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
3790320|NCT01848899|3619712|B1||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
3790321|NCT01848899|3619710|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3790322|NCT01848899|3619711|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3790323|NCT01848899|3619712|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3790324|NCT01848899|3619710|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3790325|NCT01848899|3619711|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3790326|NCT01848899|3619712|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3790327|NCT01848847|3619727|B3|Turkey||Region of Enrollment||participants|Number|97|97.0||||||
3790328|NCT01848847|3619728|B2|Turkey||Region of Enrollment||participants|Number|48|48.0||||||
3790329|NCT01848847|3619729|B1|Turkey||Region of Enrollment||participants|Number|49|49.0||||||
3790330|NCT01848847|3619727|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3790331|NCT01848847|3619728|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3790332|NCT01848847|3619729|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3790333|NCT01848847|3619727|B3||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3790334|NCT01848847|3619728|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3790335|NCT01848847|3619729|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3790336|NCT01848847|3619727|B3|||Age||years|Mean|40.27|40.27|Standard Deviation|7.36|7.36|||
3790337|NCT01848847|3619728|B2|||Age||years|Mean|41.07|41.07|Standard Deviation|7.68|7.68|||
3790338|NCT01848847|3619729|B1|||Age||years|Mean|39.51|39.51|Standard Deviation|7.04|7.04|||
3790339|NCT01848847|3619727|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3790340|NCT01848847|3619728|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3790341|NCT01848847|3619729|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3790342|NCT01848847|3619727|B3||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
3790343|NCT01848847|3619728|B2||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
3790344|NCT01848847|3619729|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3790345|NCT01848847|3619727|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3790346|NCT01848847|3619728|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3790347|NCT01848847|3619729|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3790348|NCT01848834|3619738|B6||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
3790349|NCT01848834|3619739|B5||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3790350|NCT01848834|3619740|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3790351|NCT01848834|3619741|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3790352|NCT01848834|3619742|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3790353|NCT01848834|3619743|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3790354|NCT01848834|3619738|B6||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3790355|NCT01848834|3619739|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3790356|NCT01848834|3619740|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3790357|NCT01848834|3619741|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3790358|NCT01848834|3619742|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3790359|NCT01848834|3619743|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3790360|NCT01848834|3619738|B6|||Age||Years|Mean|59.6|59.6|Standard Deviation|11.5|11.5|||
3790361|NCT01848834|3619739|B5|||Age||Years|Mean|58.9|58.9|Standard Deviation|9.7|9.7|||
3790362|NCT01848834|3619740|B4|||Age||Years|Mean|58.3|58.3|Standard Deviation|13.2|13.2|||
3790363|NCT01848834|3619741|B3|||Age||Years|Mean|68.5|68.5|Standard Deviation|10.3|10.3|||
3790364|NCT01848834|3619742|B2|||Age||Years|Mean|61.2|61.2|Standard Deviation|11.3|11.3|||
3790365|NCT01848834|3619743|B1|||Age||Years|Mean|51.9|51.9|Standard Deviation|12.1|12.1|||
3790366|NCT01848756|3619782|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790367|NCT01848756|3619782|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3790368|NCT01848756|3619782|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3790369|NCT01848756|3619782|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790370|NCT01848756|3619782|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790371|NCT01848756|3619782|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3790372|NCT01848756|3619782|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790373|NCT01848756|3619782|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
3790374|NCT01848756|3619782|B1||Female|Gender||Participants|Count of Participants|9|9.0||||||
3790375|NCT01848756|3619782|B1|||Age||years|Mean|58|58.0|Standard Deviation|12.9|12.9|||
3790376|NCT01848366|3619792|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3790377|NCT01848366|3619792|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3790378|NCT01848366|3619792|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3790379|NCT01848366|3619792|B1|||Age||years|Mean|56.6|56.6|Full Range|||43.0|79.0|
3790380|NCT01848366|3619792|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3790381|NCT01848366|3619792|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3790382|NCT01848366|3619792|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3790383|NCT01848288|3619796|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3790384|NCT01848288|3619796|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3790385|NCT01848288|3619796|B1|||Age||years|Mean|73.0|73.0|Standard Deviation|7.7|7.7|||
3790386|NCT01848210|3619805|B3|||Body Mass Index (BMI)||kg/cm^2|Mean|29.45|29.45|Full Range|||19.63|39.96|
3790387|NCT01848210|3619806|B2|||Body Mass Index (BMI)||kg/cm^2|Mean|29.14|29.14|Full Range|||19.63|39.86|
3790388|NCT01848210|3619807|B1|||Body Mass Index (BMI)||kg/cm^2|Mean|29.76|29.76|Full Range|||19.91|39.96|
3790389|NCT01848210|3619805|B3|||Weight||kg|Mean|73.89|73.89|Full Range|||45.0|133.0|
3790390|NCT01848210|3619806|B2|||Weight||kg|Mean|73.38|73.38|Full Range|||45.0|114.0|
3790391|NCT01848210|3619807|B1|||Weight||kg|Mean|74.40|74.4|Full Range|||45.0|133.0|
3790392|NCT01848210|3619805|B3|||Height||meters|Mean|1.59|1.59|Full Range|||1.35|1.89|
3790393|NCT01848210|3619806|B2|||Height||meters|Mean|1.59|1.59|Full Range|||1.43|1.89|
3790394|NCT01848210|3619807|B1|||Height||meters|Mean|1.58|1.58|Full Range|||1.35|1.87|
3790395|NCT01848210|3619805|B3|Brazil||Region of Enrollment||participants|Number|771|771.0||||||
3790396|NCT01848210|3619806|B2|Brazil||Region of Enrollment||participants|Number|388|388.0||||||
3790397|NCT01848210|3619807|B1|Brazil||Region of Enrollment||participants|Number|383|383.0||||||
3790398|NCT01848210|3619805|B3|Asian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3790399|NCT01848210|3619806|B2|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3790400|NCT01848210|3619807|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3790401|NCT01848210|3619805|B3|Brown||Race/Ethnicity, Customized||participants|Number|196|196.0||||||
3790402|NCT01848210|3619806|B2|Brown||Race/Ethnicity, Customized||participants|Number|86|86.0||||||
3790403|NCT01848210|3619807|B1|Brown||Race/Ethnicity, Customized||participants|Number|110|110.0||||||
3790404|NCT01848210|3619805|B3|Black||Race/Ethnicity, Customized||participants|Number|103|103.0||||||
3790405|NCT01848210|3619806|B2|Black||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
3790406|NCT01848210|3619807|B1|Black||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
3790407|NCT01848210|3619805|B3|White||Race/Ethnicity, Customized||participants|Number|461|461.0||||||
3790408|NCT01848210|3619806|B2|White||Race/Ethnicity, Customized||participants|Number|240|240.0||||||
3790409|NCT01848210|3619807|B1|White||Race/Ethnicity, Customized||participants|Number|221|221.0||||||
3790410|NCT01848210|3619805|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3790411|NCT01848210|3619806|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3790412|NCT01848210|3619807|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3790413|NCT01848210|3619805|B3||Female|Sex: Female, Male||Participants|Count of Participants|688|688.0||||||
3790414|NCT01848210|3619806|B2||Female|Sex: Female, Male||Participants|Count of Participants|351|351.0||||||
3790415|NCT01848210|3619807|B1||Female|Sex: Female, Male||Participants|Count of Participants|337|337.0||||||
3790416|NCT01848210|3619805|B3|||Age||years|Mean|55.88|55.88|Full Range|||20.0|75.0|
3790417|NCT01848210|3619806|B2|||Age||years|Mean|55.81|55.81|Full Range|||20.0|75.0|
3790418|NCT01848210|3619807|B1|||Age||years|Mean|55.95|55.95|Full Range|||20.0|75.0|
3790419|NCT01848184|3619820|B1|Netherlands||Region of Enrollment||participants|Number|11|11.0||||||
3790420|NCT01848184|3619820|B1|Italy||Region of Enrollment||participants|Number|11|11.0||||||
3790421|NCT01848184|3619820|B1|Denmark||Region of Enrollment||participants|Number|16|16.0||||||
3790422|NCT01848184|3619820|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
3790423|NCT01848184|3619820|B1|Belgium||Region of Enrollment||participants|Number|40|40.0||||||
3790424|NCT01848184|3619820|B1|Sweden||Region of Enrollment||participants|Number|15|15.0||||||
3790425|NCT01848184|3619820|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3790426|NCT01848184|3619820|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3790427|NCT01848184|3619820|B1|||Age||years|Mean|51.2|51.2|Standard Deviation|12.21|12.21|||
3790428|NCT01848184|3619820|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3790429|NCT01848184|3619820|B1||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
3790430|NCT01848184|3619820|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3790431|NCT01848145|3619830|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
3790432|NCT01848145|3619830|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3790433|NCT01848145|3619830|B1|White||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
3790434|NCT01848145|3619830|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3790435|NCT01848145|3619830|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3790436|NCT01848145|3619830|B1|||Age, Customized||years|Median|70|70.0|Full Range|||53.0|89.0|
3790437|NCT01848067|3619839|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3790438|NCT01848067|3619839|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790439|NCT01848067|3619839|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790440|NCT01848067|3619839|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3790441|NCT01848067|3619839|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3790442|NCT01848067|3619839|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790443|NCT01848067|3619839|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3790444|NCT01848067|3619839|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790445|NCT01848067|3619839|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790446|NCT01848067|3619839|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3790447|NCT01848067|3619839|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3790448|NCT01848067|3619839|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3790449|NCT01848067|3619839|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3790450|NCT01848067|3619839|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3790451|NCT01848067|3619839|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3790452|NCT01848067|3619839|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3790453|NCT01848054|3619845|B3|||Duration of opioid dependence||years|Mean|12.4|12.4|Standard Deviation|9.3|9.3|||
3790454|NCT01848054|3619846|B2|||Duration of opioid dependence||years|Mean|11.6|11.6|Standard Deviation|9.2|9.2|||
3790455|NCT01848054|3619847|B1|||Duration of opioid dependence||years|Mean|13.3|13.3|Standard Deviation|9.3|9.3|||
3790456|NCT01848054|3619845|B3|||Body mass index (BMI)||kg/m^2|Mean|25.7|25.7|Standard Deviation|5.9|5.9|||
3790457|NCT01848054|3619846|B2|||Body mass index (BMI)||kg/m^2|Mean|25.3|25.3|Standard Deviation|5.0|5.0|||
3790458|NCT01848054|3619847|B1|||Body mass index (BMI)||kg/m^2|Mean|26.2|26.2|Standard Deviation|6.7|6.7|||
3790459|NCT01848054|3619845|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790460|NCT01848054|3619846|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790461|NCT01848054|3619847|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790462|NCT01848054|3619845|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3790463|NCT01848054|3619846|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3790464|NCT01848054|3619847|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3790465|NCT01848054|3619845|B3||White|Race (NIH/OMB)||Participants|Count of Participants|269|269.0||||||
3790466|NCT01848054|3619846|B2||White|Race (NIH/OMB)||Participants|Count of Participants|135|135.0||||||
3790467|NCT01848054|3619847|B1||White|Race (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
3790468|NCT01848054|3619845|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3790469|NCT01848054|3619846|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3790470|NCT01848054|3619847|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3790471|NCT01848054|3619845|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790472|NCT01848054|3619846|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790473|NCT01848054|3619847|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790474|NCT01848054|3619845|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790475|NCT01848054|3619846|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790476|NCT01848054|3619847|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790477|NCT01848054|3619845|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3790478|NCT01848054|3619846|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790479|NCT01848054|3619847|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3790480|NCT01848054|3619845|B3||Male|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
3790481|NCT01848054|3619846|B2||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3790482|NCT01848054|3619847|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3790483|NCT01848054|3619845|B3||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3790484|NCT01848054|3619846|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3790485|NCT01848054|3619847|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3790486|NCT01848054|3619845|B3|||Age||years|Mean|38.4|38.4|Standard Deviation|10.7|10.7|||
3790487|NCT01848054|3619846|B2|||Age||years|Mean|38.0|38.0|Standard Deviation|10.9|10.9|||
3790488|NCT01848054|3619847|B1|||Age||years|Mean|38.9|38.9|Standard Deviation|10.6|10.6|||
3790489|NCT01847885|3619868|B3|||Beck Depression Inventory score|The Beck Depression Inventory, version II is a survey used to measure depression severity. Scores from 0-13 indicate minimal depression, 14-19 mild depression, 20-28 moderate depression, and 29-63 severe depression. The score range is 0 to 63.|Beck Depression Score|Mean|14.7|14.7|Standard Deviation|10.1|10.1|||
3790490|NCT01847885|3619869|B2|||Beck Depression Inventory score|The Beck Depression Inventory, version II is a survey used to measure depression severity. Scores from 0-13 indicate minimal depression, 14-19 mild depression, 20-28 moderate depression, and 29-63 severe depression. The score range is 0 to 63.|Beck Depression Score|Mean|17.6|17.6|Standard Deviation|11.9|11.9|||
3790491|NCT01847885|3619870|B1|||Beck Depression Inventory score|The Beck Depression Inventory, version II is a survey used to measure depression severity. Scores from 0-13 indicate minimal depression, 14-19 mild depression, 20-28 moderate depression, and 29-63 severe depression. The score range is 0 to 63.|Beck Depression Score|Mean|13.2|13.2|Standard Deviation|9.0|9.0|||
3790492|NCT01847885|3619868|B3|Subluxation absent||Presence of shoulder subluxation||Participants|Count of Participants|7|7.0||||||
3790493|NCT01847885|3619869|B2|Subluxation absent||Presence of shoulder subluxation||Participants|Count of Participants|2|2.0||||||
3790494|NCT01847885|3619870|B1|Subluxation absent||Presence of shoulder subluxation||Participants|Count of Participants|5|5.0||||||
3790495|NCT01847885|3619868|B3|Subluxation present||Presence of shoulder subluxation||Participants|Count of Participants|34|34.0||||||
3790496|NCT01847885|3619869|B2|Subluxation present||Presence of shoulder subluxation||Participants|Count of Participants|11|11.0||||||
3790497|NCT01847885|3619870|B1|Subluxation present||Presence of shoulder subluxation||Participants|Count of Participants|23|23.0||||||
3790498|NCT01847885|3619868|B3|||Time elapsed from stroke, years|Years elapsed from the date of stroke to enrollment in the study|years|Mean|4.5|4.5|Standard Deviation|4.2|4.2|||
3790499|NCT01847885|3619869|B2|||Time elapsed from stroke, years|Years elapsed from the date of stroke to enrollment in the study|years|Mean|3.5|3.5|Standard Deviation|2.8|2.8|||
3790500|NCT01847885|3619870|B1|||Time elapsed from stroke, years|Years elapsed from the date of stroke to enrollment in the study|years|Mean|5.1|5.1|Standard Deviation|4.7|4.7|||
3790501|NCT01847885|3619868|B3|Unknown/not collected||Type of stroke|Medical type of stroke, either hemorrhagic or ischemic|Participants|Count of Participants|1|1.0||||||
3790502|NCT01847885|3619869|B2|Unknown/not collected||Type of stroke|Medical type of stroke, either hemorrhagic or ischemic|Participants|Count of Participants|0|0.0||||||
3790503|NCT01847885|3619870|B1|Unknown/not collected||Type of stroke|Medical type of stroke, either hemorrhagic or ischemic|Participants|Count of Participants|1|1.0||||||
3790504|NCT01847885|3619868|B3|Ischemic||Type of stroke|Medical type of stroke, either hemorrhagic or ischemic|Participants|Count of Participants|26|26.0||||||
3790505|NCT01847885|3619869|B2|Ischemic||Type of stroke|Medical type of stroke, either hemorrhagic or ischemic|Participants|Count of Participants|10|10.0||||||
3790506|NCT01847885|3619870|B1|Ischemic||Type of stroke|Medical type of stroke, either hemorrhagic or ischemic|Participants|Count of Participants|16|16.0||||||
3790507|NCT01847885|3619868|B3|Hemorrhagic||Type of stroke|Medical type of stroke, either hemorrhagic or ischemic|Participants|Count of Participants|16|16.0||||||
3790508|NCT01847885|3619869|B2|Hemorrhagic||Type of stroke|Medical type of stroke, either hemorrhagic or ischemic|Participants|Count of Participants|5|5.0||||||
3790509|NCT01847885|3619870|B1|Hemorrhagic||Type of stroke|Medical type of stroke, either hemorrhagic or ischemic|Participants|Count of Participants|11|11.0||||||
3790510|NCT01847885|3619868|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3790511|NCT01847885|3619869|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790512|NCT01847885|3619870|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3790513|NCT01847885|3619868|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790514|NCT01847885|3619869|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790515|NCT01847885|3619870|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790516|NCT01847885|3619868|B3||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3790517|NCT01847885|3619869|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3790518|NCT01847885|3619870|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3790519|NCT01847885|3619868|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3790520|NCT01847885|3619869|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3790521|NCT01847885|3619870|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3790522|NCT01847885|3619868|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790523|NCT01847885|3619869|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790524|NCT01847885|3619870|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790525|NCT01847885|3619868|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3790526|NCT01847885|3619869|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3790527|NCT01847885|3619870|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3790528|NCT01847885|3619868|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790529|NCT01847885|3619869|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790530|NCT01847885|3619870|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790531|NCT01847885|3619868|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790532|NCT01847885|3619869|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790533|NCT01847885|3619870|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790534|NCT01847885|3619868|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3790535|NCT01847885|3619869|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3790536|NCT01847885|3619870|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3790537|NCT01847885|3619868|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3790538|NCT01847885|3619869|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790539|NCT01847885|3619870|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3790540|NCT01847885|3619868|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3790541|NCT01847885|3619869|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3790542|NCT01847885|3619870|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3790543|NCT01847885|3619868|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3790544|NCT01847885|3619869|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3790545|NCT01847885|3619870|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3790546|NCT01847885|3619868|B3|||Age||years|Mean|57.8|57.8|Standard Deviation|11.1|11.1|||
3790547|NCT01847885|3619869|B2|||Age||years|Mean|58.9|58.9|Standard Deviation|9.8|9.8|||
3790548|NCT01847885|3619870|B1|||Age||years|Mean|57.2|57.2|Standard Deviation|11.8|11.8|||
3790549|NCT01847638|3619904|B3|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3790550|NCT01847638|3619905|B2|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3790551|NCT01847638|3619906|B1|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3790552|NCT01847638|3619904|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790553|NCT01847638|3619905|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790554|NCT01847638|3619906|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790555|NCT01847638|3619904|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790556|NCT01847638|3619905|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790557|NCT01847638|3619906|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790558|NCT01847638|3619904|B3||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3790559|NCT01847638|3619905|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3790560|NCT01847638|3619906|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3790561|NCT01847638|3619904|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3790562|NCT01847638|3619905|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3790563|NCT01847638|3619906|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3790564|NCT01847638|3619904|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790565|NCT01847638|3619905|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790566|NCT01847638|3619906|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790567|NCT01847638|3619904|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790568|NCT01847638|3619905|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790569|NCT01847638|3619906|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790570|NCT01847638|3619904|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790571|NCT01847638|3619905|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790572|NCT01847638|3619906|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790573|NCT01847638|3619904|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790574|NCT01847638|3619905|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790575|NCT01847638|3619906|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790576|NCT01847638|3619904|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3790577|NCT01847638|3619905|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3790578|NCT01847638|3619906|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3790579|NCT01847638|3619904|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3790580|NCT01847638|3619905|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3790581|NCT01847638|3619906|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790582|NCT01847638|3619904|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3790583|NCT01847638|3619905|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3790584|NCT01847638|3619906|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3790585|NCT01847638|3619904|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3790586|NCT01847638|3619905|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3790587|NCT01847638|3619906|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3790588|NCT01847638|3619904|B3|||Age||years|Mean|67.6|67.6|Full Range|||48.0|88.0|
3790589|NCT01847638|3619905|B2|||Age||years|Mean|66.9|66.9|Full Range|||48.0|87.0|
3790590|NCT01847638|3619906|B1|||Age||years|Mean|68.3|68.3|Full Range|||53.0|85.0|
3790591|NCT01847638|3619904|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3790592|NCT01847638|3619905|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3790593|NCT01847638|3619906|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3790594|NCT01847638|3619904|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3790595|NCT01847638|3619905|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3790596|NCT01847638|3619906|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3790597|NCT01847638|3619904|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3790598|NCT01847638|3619905|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3790599|NCT01847638|3619906|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3790600|NCT01847547|3619917|B3||Male|Sex: Female, Male||Participants|Count of Participants|4162|4162.0||||||
3790601|NCT01847547|3619918|B2||Male|Sex: Female, Male||Participants|Count of Participants|2114|2114.0||||||
3790602|NCT01847547|3619919|B1||Male|Sex: Female, Male||Participants|Count of Participants|2048|2048.0||||||
3790603|NCT01847547|3619917|B3||Female|Sex: Female, Male||Participants|Count of Participants|1820|1820.0||||||
3790604|NCT01847547|3619918|B2||Female|Sex: Female, Male||Participants|Count of Participants|877|877.0||||||
3790605|NCT01847547|3619919|B1||Female|Sex: Female, Male||Participants|Count of Participants|943|943.0||||||
3790606|NCT01847547|3619917|B3|||Age||years|Mean|63.60|63.6|Standard Deviation|11.01|11.01|||
3790607|NCT01847547|3619918|B2|||Age||years|Mean|63.26|63.26|Standard Deviation|11.04|11.04|||
3790608|NCT01847547|3619919|B1|||Age||years|Mean|63.86|63.86|Standard Deviation|10.99|10.99|||
3790609|NCT01847443|3619962|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3790610|NCT01847443|3619962|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3790611|NCT01847443|3619962|B1|||Age||Years|Mean|26.8|26.8|Standard Deviation|6.4|6.4|||
3790612|NCT01847430|3619995|B1||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3790613|NCT01847430|3619995|B1||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3790614|NCT01847430|3619995|B1|||Age||Years|Mean|15.3|15.3|Standard Deviation|0.5|0.5|||
3790615|NCT01847196|3620006|B1|Yes||Spleen/Kidney Laceration at Baseline||participants|Number|2|2.0||||||
3790616|NCT01847196|3620006|B1|No||Spleen/Kidney Laceration at Baseline||participants|Number|3|3.0||||||
3790617|NCT01847196|3620006|B1|Yes||Multiple Fractures of Upper and Lower Limbs at Baseline||participants|Number|1|1.0||||||
3790618|NCT01847196|3620006|B1|No||Multiple Fractures of Upper and Lower Limbs at Baseline||participants|Number|4|4.0||||||
3790619|NCT01847196|3620006|B1|Yes||Hepatic Trauma at Baseline||participants|Number|3|3.0||||||
3790620|NCT01847196|3620006|B1|No||Hepatic Trauma at Baseline||participants|Number|2|2.0||||||
3790621|NCT01847196|3620006|B1|Yes||Respiratory Trauma or Distress at Baseline||participants|Number|4|4.0||||||
3790622|NCT01847196|3620006|B1|No||Respiratory Trauma or Distress at Baseline||participants|Number|1|1.0||||||
3790623|NCT01847196|3620006|B1|Yes||Spinal Injury at Baseline||participants|Number|1|1.0||||||
3790624|NCT01847196|3620006|B1|No||Spinal Injury at Baseline||participants|Number|4|4.0||||||
3790625|NCT01847196|3620006|B1|Yes||Musculoskeletal Fractures at Baseline||participants|Number|4|4.0||||||
3790626|NCT01847196|3620006|B1|No||Musculoskeletal Fractures at Baseline||participants|Number|1|1.0||||||
3790627|NCT01847196|3620006|B1|Yes||Subarachnoid and/or Subdural Bleeding at Baseline||participants|Number|2|2.0||||||
3790628|NCT01847196|3620006|B1|No||Subarachnoid and/or Subdural Bleeding at Baseline||participants|Number|3|3.0||||||
3790629|NCT01847196|3620006|B1|Yes||Traumatic Brain Injury at Baseline||participants|Number|3|3.0||||||
3790630|NCT01847196|3620006|B1|No||Traumatic Brain Injury at Baseline||participants|Number|2|2.0||||||
3790631|NCT01847196|3620006|B1|Yes||Subject on Dialysis at Baseline||participants|Number|0|0.0||||||
3790632|NCT01847196|3620006|B1|No||Subject on Dialysis at Baseline||participants|Number|5|5.0||||||
3790633|NCT01847196|3620006|B1|Yes||Subject on Vasopressors at Baseline||participants|Number|0|0.0||||||
3790634|NCT01847196|3620006|B1|No||Subject on Vasopressors at Baseline||participants|Number|5|5.0||||||
3790635|NCT01847196|3620006|B1|Yes||Subject on Mechanical Ventilation at Baseline||participants|Number|2|2.0||||||
3790636|NCT01847196|3620006|B1|No||Subject on Mechanical Ventilation at Baseline||participants|Number|3|3.0||||||
3790637|NCT01847196|3620006|B1|Yes||Baseline Central Venous Catheter in Place||participants|Number|2|2.0||||||
3790638|NCT01847196|3620006|B1|No||Baseline Central Venous Catheter in Place||participants|Number|3|3.0||||||
3790639|NCT01847196|3620006|B1|Yes||Baseline Venous Thromboembolism||participants|Number|0|0.0||||||
3790640|NCT01847196|3620006|B1|No||Baseline Venous Thromboembolism||participants|Number|5|5.0||||||
3790641|NCT01847196|3620006|B1|||Trauma as Primary Reason for Hospital Admission||participants|Number|5|5.0||||||
3790642|NCT01847196|3620006|B1|||Body Mass Index||kg/m^2|Mean|25.8|25.8|Standard Deviation|4.5|4.5|||
3790643|NCT01847196|3620006|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3790644|NCT01847196|3620006|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3790645|NCT01847196|3620006|B1|||Age||years|Mean|33.2|33.2|Standard Deviation|10.4|10.4|||
3790646|NCT01847131|3620011|B3|||nasal congestion scores|The severity of nasal congestion was recorded on a 0 to 3 scale (0 = no symptom, 1= mild symptom, 2 = moderate symptom and 3 = severe symptom).|units on a scale|Geometric Mean|1.76|1.76|Standard Deviation|0.59|0.59|||
3790647|NCT01847131|3620012|B2|||nasal congestion scores|The severity of nasal congestion was recorded on a 0 to 3 scale (0 = no symptom, 1= mild symptom, 2 = moderate symptom and 3 = severe symptom).|units on a scale|Geometric Mean|1.78|1.78|Standard Deviation|0.64|0.64|||
3790648|NCT01847131|3620013|B1|||nasal congestion scores|The severity of nasal congestion was recorded on a 0 to 3 scale (0 = no symptom, 1= mild symptom, 2 = moderate symptom and 3 = severe symptom).|units on a scale|Geometric Mean|1.73|1.73|Standard Deviation|0.54|0.54|||
3790649|NCT01847131|3620011|B3|Thailand||Region of Enrollment||participants|Number|50|50.0||||||
3790650|NCT01847131|3620012|B2|Thailand||Region of Enrollment||participants|Number|25|25.0||||||
3790651|NCT01847131|3620013|B1|Thailand||Region of Enrollment||participants|Number|25|25.0||||||
3790652|NCT01847131|3620011|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3790653|NCT01847131|3620012|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3790654|NCT01847131|3620013|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3790655|NCT01847131|3620011|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3790656|NCT01847131|3620012|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3790657|NCT01847131|3620013|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3790658|NCT01847131|3620011|B3||>=65 years|Age|Age, gender, allergy skin prick testing for aeroallergens and baseline nasal congestion scores were measured.|Participants|Count of Participants|2|2.0||||||
3790659|NCT01847131|3620012|B2||>=65 years|Age|Age, gender, allergy skin prick testing for aeroallergens and baseline nasal congestion scores were measured.|Participants|Count of Participants|1|1.0||||||
3790660|NCT01847131|3620013|B1||>=65 years|Age|Age, gender, allergy skin prick testing for aeroallergens and baseline nasal congestion scores were measured.|Participants|Count of Participants|1|1.0||||||
3790661|NCT01847131|3620011|B3||Between 18 and 65 years|Age|Age, gender, allergy skin prick testing for aeroallergens and baseline nasal congestion scores were measured.|Participants|Count of Participants|48|48.0||||||
3790662|NCT01847131|3620012|B2||Between 18 and 65 years|Age|Age, gender, allergy skin prick testing for aeroallergens and baseline nasal congestion scores were measured.|Participants|Count of Participants|24|24.0||||||
3790663|NCT01847131|3620013|B1||Between 18 and 65 years|Age|Age, gender, allergy skin prick testing for aeroallergens and baseline nasal congestion scores were measured.|Participants|Count of Participants|24|24.0||||||
3790664|NCT01847131|3620011|B3||<=18 years|Age|Age, gender, allergy skin prick testing for aeroallergens and baseline nasal congestion scores were measured.|Participants|Count of Participants|0|0.0||||||
3790665|NCT01847131|3620012|B2||<=18 years|Age|Age, gender, allergy skin prick testing for aeroallergens and baseline nasal congestion scores were measured.|Participants|Count of Participants|0|0.0||||||
3790666|NCT01847131|3620013|B1||<=18 years|Age|Age, gender, allergy skin prick testing for aeroallergens and baseline nasal congestion scores were measured.|Participants|Count of Participants|0|0.0||||||
3790667|NCT01847014|3620022|B1||Unknown or Not Reported|Race (NIH/OMB)|Patient population is the Extension Analysis Set (EAS), a total of 4 participants.|Participants|Count of Participants|0|0.0||||||
3790668|NCT01847014|3620022|B1||More than one race|Race (NIH/OMB)|Patient population is the Extension Analysis Set (EAS), a total of 4 participants.|Participants|Count of Participants|0|0.0||||||
3790669|NCT01847014|3620022|B1||White|Race (NIH/OMB)|Patient population is the Extension Analysis Set (EAS), a total of 4 participants.|Participants|Count of Participants|3|3.0||||||
3790670|NCT01847014|3620022|B1||Black or African American|Race (NIH/OMB)|Patient population is the Extension Analysis Set (EAS), a total of 4 participants.|Participants|Count of Participants|1|1.0||||||
3790671|NCT01847014|3620022|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Patient population is the Extension Analysis Set (EAS), a total of 4 participants.|Participants|Count of Participants|0|0.0||||||
3790672|NCT01847014|3620022|B1||Asian|Race (NIH/OMB)|Patient population is the Extension Analysis Set (EAS), a total of 4 participants.|Participants|Count of Participants|0|0.0||||||
3790673|NCT01847014|3620022|B1||American Indian or Alaska Native|Race (NIH/OMB)|Patient population is the Extension Analysis Set (EAS), a total of 4 participants.|Participants|Count of Participants|0|0.0||||||
3790674|NCT01847014|3620022|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|Participant population is Extension Analysis Set, a total of four participants.|Participants|Count of Participants|0|0.0||||||
3790675|NCT01847014|3620022|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Participant population is Extension Analysis Set, a total of four participants.|Participants|Count of Participants|4|4.0||||||
3790676|NCT01847014|3620022|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|Participant population is Extension Analysis Set, a total of four participants.|Participants|Count of Participants|0|0.0||||||
3790677|NCT01847014|3620022|B1||Male|Sex: Female, Male|Participant population is Extension Analysis Set, a total of four patients. Subject's sex was captured in the SYMPHONY AC-055-401 Screening visit.|Participants|Count of Participants|0|0.0||||||
3790678|NCT01847014|3620022|B1||Female|Sex: Female, Male|Participant population is Extension Analysis Set, a total of four patients. Subject's sex was captured in the SYMPHONY AC-055-401 Screening visit.|Participants|Count of Participants|4|4.0||||||
3790679|NCT01847014|3620022|B1|||Age|Participant population is Extension Analysis Set, a total of four patients. Subject's age was captured in the SYMPHONY AC-055-401 Screening visit.|Years|Mean|60.8|60.8|Full Range|||55.0|66.5|
3790680|NCT01847014|3620022|B1||>=65 years|Age|Participant population is Extension Analysis Set, a total of four patients. Age of patients recorded.|Participants|Count of Participants|1|1.0||||||
3790681|NCT01847014|3620022|B1||Between 18 and 65 years|Age|Participant population is Extension Analysis Set, a total of four patients. Age of patients recorded.|Participants|Count of Participants|3|3.0||||||
3790682|NCT01847014|3620022|B1||<=18 years|Age|Participant population is Extension Analysis Set, a total of four patients. Age of patients recorded.|Participants|Count of Participants|0|0.0||||||
3790683|NCT01846741|3620026|B1|Yes||Seizures with auras in past 2 months||participants|Number|13|13.0||||||
3790684|NCT01846741|3620026|B1|No||Seizures with auras in past 2 months||participants|Number|7|7.0||||||
3790685|NCT01846741|3620026|B1|Yes||Family history of seizures||participants|Number|8|8.0||||||
3790686|NCT01846741|3620026|B1|No||Family history of seizures||participants|Number|12|12.0||||||
3790687|NCT01846741|3620026|B1|Cryptogenic||Etiology||participants|Number|2|2.0||||||
3790688|NCT01846741|3620026|B1|Symptomatic Partial||Etiology||participants|Number|10|10.0||||||
3790689|NCT01846741|3620026|B1|Idiopathic Partial||Etiology||participants|Number|8|8.0||||||
3790690|NCT01846741|3620026|B1|Yes||Previous brain or Epilepsy surgery||participants|Number|8|8.0||||||
3790691|NCT01846741|3620026|B1|No||Previous brain or Epilepsy surgery||participants|Number|12|12.0||||||
3790692|NCT01846741|3620026|B1|||Time from diagnosis to VNS therapy||years|Median|17|17.0|Full Range|||1.0|52.0|
3790693|NCT01846741|3620026|B1|||Time from diagnosis to VNS therapy||years|Mean|21.2|21.2|Standard Deviation|15.3|15.3|||
3790694|NCT01846741|3620026|B1|Minimal Impairment||Cognitive Status||participants|Number|6|6.0||||||
3790695|NCT01846741|3620026|B1|Normal||Cognitive Status||participants|Number|14|14.0||||||
3790696|NCT01846741|3620026|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3790697|NCT01846741|3620026|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3790698|NCT01846741|3620026|B1|White||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3790699|NCT01846741|3620026|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3790700|NCT01846741|3620026|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3790701|NCT01846741|3620026|B1|60 years or older||Age, Customized||years|Number|2|2.0||||||
3790702|NCT01846741|3620026|B1|50-59 years||Age, Customized||years|Number|2|2.0||||||
3790703|NCT01846741|3620026|B1|40-49 years||Age, Customized||years|Number|2|2.0||||||
3790704|NCT01846741|3620026|B1|30-39 years||Age, Customized||years|Number|5|5.0||||||
3790705|NCT01846741|3620026|B1|18-29 years||Age, Customized||years|Number|9|9.0||||||
3790706|NCT01846741|3620026|B1|||Age, Customized||years|Median|31|31.0|Full Range|||21.0|69.0|
3790707|NCT01846741|3620026|B1|||Age||Years|Mean|35.6|35.6|Standard Deviation|14.1|14.1|||
3790708|NCT01846702|3620082|B8|Singapore||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3790709|NCT01846702|3620083|B7|Singapore||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3790710|NCT01846702|3620084|B6|Singapore||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3790711|NCT01846702|3620085|B5|Singapore||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3790712|NCT01846702|3620086|B4|Singapore||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3790713|NCT01846702|3620087|B3|Singapore||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3790714|NCT01846702|3620088|B2|Singapore||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3790715|NCT01846702|3620089|B1|Singapore||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3790716|NCT01846702|3620082|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790717|NCT01846702|3620083|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790718|NCT01846702|3620084|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790719|NCT01846702|3620085|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790720|NCT01846702|3620086|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790721|NCT01846702|3620087|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790722|NCT01846702|3620088|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790723|NCT01846702|3620089|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790724|NCT01846702|3620082|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790725|NCT01846702|3620083|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790726|NCT01846702|3620084|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790727|NCT01846702|3620085|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790728|NCT01846702|3620086|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790729|NCT01846702|3620087|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790730|NCT01846702|3620088|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790731|NCT01846702|3620089|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790732|NCT01846702|3620082|B8||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3790733|NCT01846702|3620083|B7||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790734|NCT01846702|3620084|B6||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790735|NCT01846702|3620085|B5||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790736|NCT01846702|3620086|B4||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3790737|NCT01846702|3620087|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790738|NCT01846702|3620088|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790739|NCT01846702|3620089|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790740|NCT01846702|3620082|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790741|NCT01846702|3620083|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790742|NCT01846702|3620084|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790743|NCT01846702|3620085|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790744|NCT01846702|3620086|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790745|NCT01846702|3620087|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790746|NCT01846702|3620088|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790747|NCT01846702|3620089|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790748|NCT01846702|3620082|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790749|NCT01846702|3620083|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790750|NCT01846702|3620084|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790751|NCT01846702|3620085|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790752|NCT01846702|3620086|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790753|NCT01846702|3620087|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790754|NCT01846702|3620088|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790755|NCT01846702|3620089|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790756|NCT01846702|3620082|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3790757|NCT01846702|3620083|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3790758|NCT01846702|3620084|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3790759|NCT01846702|3620085|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3790760|NCT01846702|3620086|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3790761|NCT01846702|3620087|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3790762|NCT01846702|3620088|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3790763|NCT01846702|3620089|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3790764|NCT01846702|3620082|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790765|NCT01846702|3620083|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790766|NCT01846702|3620084|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790767|NCT01846702|3620085|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790768|NCT01846702|3620086|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790769|NCT01846702|3620087|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790770|NCT01846702|3620088|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790771|NCT01846702|3620089|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790772|NCT01846702|3620082|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790773|NCT01846702|3620083|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790774|NCT01846702|3620084|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790775|NCT01846702|3620085|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790776|NCT01846702|3620086|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790777|NCT01846702|3620087|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790778|NCT01846702|3620088|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790779|NCT01846702|3620089|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790780|NCT01846702|3620082|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3790781|NCT01846702|3620083|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3790782|NCT01846702|3620084|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3790783|NCT01846702|3620085|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3790784|NCT01846702|3620086|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3790785|NCT01846702|3620087|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3790786|NCT01846702|3620088|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3790787|NCT01846702|3620089|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3790788|NCT01846702|3620082|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790789|NCT01846702|3620083|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790790|NCT01846702|3620084|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790791|NCT01846702|3620085|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790792|NCT01846702|3620086|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790793|NCT01846702|3620087|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790794|NCT01846702|3620088|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790795|NCT01846702|3620089|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790796|NCT01846702|3620082|B8||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3790797|NCT01846702|3620083|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3790798|NCT01846702|3620084|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3790799|NCT01846702|3620085|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3790800|NCT01846702|3620086|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3790801|NCT01846702|3620087|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3790802|NCT01846702|3620088|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3790803|NCT01846702|3620089|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3790804|NCT01846702|3620082|B8||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3790805|NCT01846702|3620083|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3790806|NCT01846702|3620084|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3790807|NCT01846702|3620085|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3790808|NCT01846702|3620086|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3790809|NCT01846702|3620087|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3790810|NCT01846702|3620088|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3790811|NCT01846702|3620089|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3790812|NCT01846702|3620082|B8|||Age||years|Mean|34.4|34.4|Standard Deviation|10.2|10.2|||
3790813|NCT01846702|3620083|B7|||Age||years|Mean|36.3|36.3|Standard Deviation|4.8|4.8|||
3790814|NCT01846702|3620084|B6|||Age||years|Mean|30.5|30.5|Standard Deviation|5.0|5.0|||
3790815|NCT01846702|3620085|B5|||Age||years|Mean|40.7|40.7|Standard Deviation|12.6|12.6|||
3790816|NCT01846702|3620086|B4|||Age||years|Mean|32.7|32.7|Standard Deviation|7.4|7.4|||
3790817|NCT01846702|3620087|B3|||Age||years|Mean|34.5|34.5|Standard Deviation|11.2|11.2|||
3790818|NCT01846702|3620088|B2|||Age||years|Mean|30.7|30.7|Standard Deviation|13.2|13.2|||
3790819|NCT01846702|3620089|B1|||Age||years|Mean|35.7|35.7|Standard Deviation|14|14.0|||
3790820|NCT01846624|3620174|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3790821|NCT01846624|3620174|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3790822|NCT01846624|3620174|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790823|NCT01846624|3620174|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3790824|NCT01846624|3620174|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790825|NCT01846624|3620174|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790826|NCT01846624|3620174|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3790827|NCT01846624|3620174|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790828|NCT01846624|3620174|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790829|NCT01846624|3620174|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3790830|NCT01846624|3620174|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3790831|NCT01846624|3620174|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3790832|NCT01846624|3620174|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3790833|NCT01846624|3620174|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3790834|NCT01846624|3620174|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3790835|NCT01846624|3620174|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3790836|NCT01846507|3620182|B1|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3790837|NCT01846507|3620182|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790838|NCT01846507|3620182|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3790839|NCT01846507|3620182|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3790840|NCT01846507|3620182|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3790841|NCT01846507|3620182|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790842|NCT01846507|3620182|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3790843|NCT01846507|3620182|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790844|NCT01846507|3620182|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790845|NCT01846507|3620182|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3790846|NCT01846507|3620182|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3790847|NCT01846507|3620182|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3790848|NCT01846507|3620182|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3790849|NCT01846507|3620182|B1|||Age||years|Mean|14.7|14.7|Full Range|||11.0|18.0|
3790850|NCT01846455|3620199|B6|||Body Mass Index||kg/m^2|Mean|27.1|27.1|Full Range|||18.7|32.9|
3790851|NCT01846455|3620200|B5|||Body Mass Index||kg/m^2|Mean|29.3|29.3|Full Range|||22.1|32.2|
3790852|NCT01846455|3620201|B4|||Body Mass Index||kg/m^2|Mean|26.2|26.2|Full Range|||20.6|32.9|
3790853|NCT01846455|3620202|B3|||Body Mass Index||kg/m^2|Mean|27.9|27.9|Full Range|||23.2|32.8|
3790854|NCT01846455|3620203|B2|||Body Mass Index||kg/m^2|Mean|27.0|27.0|Full Range|||20.3|32.3|
3790855|NCT01846455|3620204|B1|||Body Mass Index||kg/m^2|Mean|25.5|25.5|Full Range|||18.7|32.8|
3790856|NCT01846455|3620199|B6|||Weight||kg|Mean|76.5|76.5|Full Range|||54.0|109.0|
3790857|NCT01846455|3620200|B5|||Weight||kg|Mean|76.6|76.6|Full Range|||69.2|83.6|
3790858|NCT01846455|3620201|B4|||Weight||kg|Mean|74.7|74.7|Full Range|||60.2|109.0|
3790859|NCT01846455|3620202|B3|||Weight||kg|Mean|82.2|82.2|Full Range|||64.8|103.0|
3790860|NCT01846455|3620203|B2|||Weight||kg|Mean|75.4|75.4|Full Range|||56.0|95.0|
3790861|NCT01846455|3620204|B1|||Weight||kg|Mean|74.2|74.2|Full Range|||54.0|92.5|
3790862|NCT01846455|3620199|B6|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3790863|NCT01846455|3620200|B5|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3790864|NCT01846455|3620201|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3790865|NCT01846455|3620202|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3790866|NCT01846455|3620203|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3790867|NCT01846455|3620204|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3790868|NCT01846455|3620199|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3790869|NCT01846455|3620200|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3790870|NCT01846455|3620201|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3790871|NCT01846455|3620202|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3790872|NCT01846455|3620203|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3790873|NCT01846455|3620204|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3790874|NCT01846455|3620199|B6|White||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3790875|NCT01846455|3620200|B5|White||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3790876|NCT01846455|3620201|B4|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3790877|NCT01846455|3620202|B3|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3790878|NCT01846455|3620203|B2|White||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3790879|NCT01846455|3620204|B1|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3790880|NCT01846455|3620199|B6||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3790881|NCT01846455|3620200|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3790882|NCT01846455|3620201|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3790883|NCT01846455|3620202|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3790884|NCT01846455|3620203|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3790885|NCT01846455|3620204|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3790886|NCT01846455|3620199|B6||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3790887|NCT01846455|3620200|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3790888|NCT01846455|3620201|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3790889|NCT01846455|3620202|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3790890|NCT01846455|3620203|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3790891|NCT01846455|3620204|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3790892|NCT01846455|3620199|B6|||Age||years|Mean|56.0|56.0|Full Range|||42.0|65.0|
3790893|NCT01846455|3620200|B5|||Age||years|Mean|57.1|57.1|Full Range|||49.0|62.0|
3790894|NCT01846455|3620201|B4|||Age||years|Mean|53.0|53.0|Full Range|||43.0|59.0|
3790895|NCT01846455|3620202|B3|||Age||years|Mean|53.9|53.9|Full Range|||42.0|65.0|
3790896|NCT01846455|3620203|B2|||Age||years|Mean|58.6|58.6|Full Range|||52.0|63.0|
3790897|NCT01846455|3620204|B1|||Age||years|Mean|58.0|58.0|Full Range|||51.0|62.0|
3790898|NCT01846442|3620265|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3790899|NCT01846442|3620266|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3790900|NCT01846442|3620267|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3790901|NCT01846442|3620268|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3790902|NCT01846442|3620269|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3790903|NCT01846442|3620265|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3790904|NCT01846442|3620266|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3790905|NCT01846442|3620267|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3790906|NCT01846442|3620268|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3790907|NCT01846442|3620269|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3790908|NCT01846442|3620265|B5|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3790909|NCT01846442|3620266|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3790910|NCT01846442|3620267|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3790911|NCT01846442|3620268|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3790912|NCT01846442|3620269|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3790913|NCT01846442|3620265|B5|White Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|208|208.0||||||
3790914|NCT01846442|3620266|B4|White Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|53|53.0||||||
3790915|NCT01846442|3620267|B3|White Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|54|54.0||||||
3790916|NCT01846442|3620268|B2|White Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
3790917|NCT01846442|3620269|B1|White Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
3790918|NCT01846442|3620265|B5|Female||Sex/Gender, Customized||Participants|Count of Participants|217|217.0||||||
3790919|NCT01846442|3620266|B4|Female||Sex/Gender, Customized||Participants|Count of Participants|54|54.0||||||
3790920|NCT01846442|3620267|B3|Female||Sex/Gender, Customized||Participants|Count of Participants|56|56.0||||||
3790921|NCT01846442|3620268|B2|Female||Sex/Gender, Customized||Participants|Count of Participants|53|53.0||||||
3790922|NCT01846442|3620269|B1|Female||Sex/Gender, Customized||Participants|Count of Participants|54|54.0||||||
3790923|NCT01846442|3620265|B5|||Age||years|Mean|58.65|58.65|Standard Deviation|5.50|5.5|||
3790924|NCT01846442|3620266|B4|||Age||years|Mean|59.44|59.44|Standard Deviation|4.63|4.63|||
3790925|NCT01846442|3620267|B3|||Age||years|Mean|58.45|58.45|Standard Deviation|5.55|5.55|||
3790926|NCT01846442|3620268|B2|||Age||years|Mean|57.68|57.68|Standard Deviation|6.31|6.31|||
3790927|NCT01846442|3620269|B1|||Age||years|Mean|59.00|59.0|Standard Deviation|5.40|5.4|||
3790928|NCT01846416|3620310|B4||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3790929|NCT01846416|3620311|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3790930|NCT01846416|3620312|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3790931|NCT01846416|3620313|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3790932|NCT01846416|3620310|B4||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3790933|NCT01846416|3620311|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3790934|NCT01846416|3620312|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3790935|NCT01846416|3620313|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3790936|NCT01846416|3620310|B4|||Age||years|Mean|65.7|65.7|Standard Deviation|9.6|9.6|||
3790937|NCT01846416|3620311|B3|||Age||years|Mean|63.8|63.8|Standard Deviation|7.7|7.7|||
3790938|NCT01846416|3620312|B2|||Age||years|Mean|65.2|65.2|Standard Deviation|9.3|9.3|||
3790939|NCT01846416|3620313|B1|||Age||years|Mean|68|68.0|Standard Deviation|10.8|10.8|||
3790940|NCT01846299|3620358|B3||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3790941|NCT01846299|3620359|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3790942|NCT01846299|3620360|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3790943|NCT01846299|3620358|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3790944|NCT01846299|3620359|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3790945|NCT01846299|3620360|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3790946|NCT01846299|3620358|B3|||Age||Years|Mean|62.9|62.9|Standard Deviation|14.50|14.5|||
3790947|NCT01846299|3620359|B2|||Age||Years|Mean|61.8|61.8|Standard Deviation|15.55|15.55|||
3790948|NCT01846299|3620360|B1|||Age||Years|Mean|63.5|63.5|Standard Deviation|13.97|13.97|||
3790949|NCT01846221|3620397|B3|United States||Region of Enrollment||participants|Number|98|98.0||||||
3790950|NCT01846221|3620398|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
3790951|NCT01846221|3620399|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
3790952|NCT01846221|3620397|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3790953|NCT01846221|3620398|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3790954|NCT01846221|3620399|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3790955|NCT01846221|3620397|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790956|NCT01846221|3620398|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790957|NCT01846221|3620399|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790958|NCT01846221|3620397|B3||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3790959|NCT01846221|3620398|B2||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3790960|NCT01846221|3620399|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3790961|NCT01846221|3620397|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3790962|NCT01846221|3620398|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3790963|NCT01846221|3620399|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3790964|NCT01846221|3620397|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790965|NCT01846221|3620398|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790966|NCT01846221|3620399|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790967|NCT01846221|3620397|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3790968|NCT01846221|3620398|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3790969|NCT01846221|3620399|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3790970|NCT01846221|3620397|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790971|NCT01846221|3620398|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790972|NCT01846221|3620399|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3790973|NCT01846221|3620397|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3790974|NCT01846221|3620398|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3790975|NCT01846221|3620399|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3790976|NCT01846221|3620397|B3||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3790977|NCT01846221|3620398|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3790978|NCT01846221|3620399|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3790979|NCT01846221|3620397|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3790980|NCT01846221|3620398|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3790981|NCT01846221|3620399|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3790982|NCT01846221|3620397|B3||Between 18 and 65 years|Age||Participants|Count of Participants|98|98.0||||||
3790983|NCT01846221|3620398|B2||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3790984|NCT01846221|3620399|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3790985|NCT01846221|3620397|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3790986|NCT01846221|3620398|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3790987|NCT01846221|3620399|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3790988|NCT01846208|3620414|B4|||Baseline Cockroach SPT||mms|Median|0.00|0.0|Inter-Quartile Range|||0.0|2.5|
3790989|NCT01846208|3620415|B3|||Baseline Cockroach SPT||mms|Median|0.00|0.0|Inter-Quartile Range|||0.0|2.5|
3790990|NCT01846208|3620416|B2|||Baseline Cockroach SPT||mms|Median|0.00|0.0|Inter-Quartile Range|||0.0|3.0|
3790991|NCT01846208|3620417|B1|||Baseline Cockroach SPT||mms|Median|0.00|0.0|Inter-Quartile Range|||0.0|1.5|
3790992|NCT01846208|3620414|B4|||Baseline Mold SPT||mms|Median|0.00|0.0|Inter-Quartile Range|||0.0|3.5|
3790993|NCT01846208|3620415|B3|||Baseline Mold SPT||mms|Median|0.00|0.0|Inter-Quartile Range|||0.0|3.5|
3790994|NCT01846208|3620416|B2|||Baseline Mold SPT||mms|Median|1.00|1.0|Inter-Quartile Range|||0.0|4.5|
3790995|NCT01846208|3620417|B1|||Baseline Mold SPT||mms|Median|0.50|0.5|Inter-Quartile Range|||0.0|4.0|
3790996|NCT01846208|3620414|B4|||Baseline Weed SPT||mms|Median|0.00|0.0|Inter-Quartile Range|||0.0|4.0|
3790997|NCT01846208|3620415|B3|||Baseline Weed SPT||mms|Median|0.00|0.0|Inter-Quartile Range|||0.0|3.5|
3790998|NCT01846208|3620416|B2|||Baseline Weed SPT||mms|Median|0.00|0.0|Inter-Quartile Range|||0.0|3.5|
3790999|NCT01846208|3620417|B1|||Baseline Weed SPT||mms|Median|1.50|1.5|Inter-Quartile Range|||0.0|5.5|
3791000|NCT01846208|3620414|B4|||Baseline Grass SPT||mms|Median|2.50|2.5|Inter-Quartile Range|||0.0|6.5|
3791001|NCT01846208|3620415|B3|||Baseline Grass SPT||mms|Median|2.50|2.5|Inter-Quartile Range|||0.0|6.5|
3791002|NCT01846208|3620416|B2|||Baseline Grass SPT||mms|Median|0.00|0.0|Inter-Quartile Range|||0.0|6.5|
3791003|NCT01846208|3620417|B1|||Baseline Grass SPT||mms|Median|4.50|4.5|Inter-Quartile Range|||0.0|7.0|
3791004|NCT01846208|3620414|B4|||Baseline Tree SPT||mms|Median|3.50|3.5|Inter-Quartile Range|||0.0|7.0|
3791005|NCT01846208|3620415|B3|||Baseline Tree SPT||mms|Median|3.00|3.0|Inter-Quartile Range|||0.0|6.5|
3791006|NCT01846208|3620416|B2|||Baseline Tree SPT||mms|Median|4.50|4.5|Inter-Quartile Range|||0.0|8.5|
3791007|NCT01846208|3620417|B1|||Baseline Tree SPT||mms|Median|2.50|2.5|Inter-Quartile Range|||0.0|7.0|
3791008|NCT01846208|3620414|B4|||Baseline Peanut SPT||mms|Median|11.00|11.0|Inter-Quartile Range|||3.25|17.5|
3791009|NCT01846208|3620415|B3|||Baseline Peanut SPT||mms|Median|10.50|10.5|Inter-Quartile Range|||1.75|21.0|
3791010|NCT01846208|3620416|B2|||Baseline Peanut SPT||mms|Median|11.00|11.0|Inter-Quartile Range|||8.5|17.5|
3791011|NCT01846208|3620417|B1|||Baseline Peanut SPT||mms|Median|10.50|10.5|Inter-Quartile Range|||3.5|17.0|
3791012|NCT01846208|3620414|B4|||Baseline Milk SPT||mms|Median|2.50|2.5|Inter-Quartile Range|||0.0|44.0|
3791013|NCT01846208|3620415|B3|||Baseline Milk SPT||mms|Median|3.50|3.5|Inter-Quartile Range|||0.0|44.0|
3791014|NCT01846208|3620416|B2|||Baseline Milk SPT||mms|Median|3.00|3.0|Inter-Quartile Range|||0.0|8.5|
3791015|NCT01846208|3620417|B1|||Baseline Milk SPT||mms|Median|1.00|1.0|Inter-Quartile Range|||0.0|10.0|
3791016|NCT01846208|3620414|B4|||Baseline Egg Skin Prick Test (SPT)|Skin prick tests performed using study approved procedures for food and environmental allergens. A skin test probe is pressed through a commercial extract of an allergen into the epidermis.|mms|Median|11.00|11.0|Inter-Quartile Range|||6.5|15.0|
3791017|NCT01846208|3620415|B3|||Baseline Egg Skin Prick Test (SPT)|Skin prick tests performed using study approved procedures for food and environmental allergens. A skin test probe is pressed through a commercial extract of an allergen into the epidermis.|mms|Median|12.00|12.0|Inter-Quartile Range|||7.5|16.5|
3791018|NCT01846208|3620416|B2|||Baseline Egg Skin Prick Test (SPT)|Skin prick tests performed using study approved procedures for food and environmental allergens. A skin test probe is pressed through a commercial extract of an allergen into the epidermis.|mms|Median|11.00|11.0|Inter-Quartile Range|||6.5|15.0|
3791019|NCT01846208|3620417|B1|||Baseline Egg Skin Prick Test (SPT)|Skin prick tests performed using study approved procedures for food and environmental allergens. A skin test probe is pressed through a commercial extract of an allergen into the epidermis.|mms|Median|7.50|7.5|Inter-Quartile Range|||5.5|13.5|
3791020|NCT01846208|3620414|B4|||Baseline Ovomucoid IgG4|Assay limits of detection ranges: 0.07 to 30 mgA/L, Values outside of range were truncated (lower and upper values): 0.035 and 31 mgA/L|mgA/L|Median|0.11|0.11|Inter-Quartile Range|||0.04|0.6|
3791021|NCT01846208|3620415|B3|||Baseline Ovomucoid IgG4|Assay limits of detection ranges: 0.07 to 30 mgA/L, Values outside of range were truncated (lower and upper values): 0.035 and 31 mgA/L|mgA/L|Median|0.09|0.09|Inter-Quartile Range|||0.04|0.26|
3791022|NCT01846208|3620416|B2|||Baseline Ovomucoid IgG4|Assay limits of detection ranges: 0.07 to 30 mgA/L, Values outside of range were truncated (lower and upper values): 0.035 and 31 mgA/L|mgA/L|Median|0.15|0.15|Inter-Quartile Range|||0.04|2.49|
3791023|NCT01846208|3620417|B1|||Baseline Ovomucoid IgG4|Assay limits of detection ranges: 0.07 to 30 mgA/L, Values outside of range were truncated (lower and upper values): 0.035 and 31 mgA/L|mgA/L|Median|0.25|0.25|Inter-Quartile Range|||0.04|1.34|
3791024|NCT01846208|3620414|B4|||Baseline Ovalbumin IgG4|Assay limits of detection ranges: 0.07 to 30 mgA/L, Values outside of range were truncated (lower and upper values): 0.035 and 31 mgA/L|mgA/L|Median|0.49|0.49|Inter-Quartile Range|||0.14|1.93|
3791025|NCT01846208|3620415|B3|||Baseline Ovalbumin IgG4|Assay limits of detection ranges: 0.07 to 30 mgA/L, Values outside of range were truncated (lower and upper values): 0.035 and 31 mgA/L|mgA/L|Median|0.33|0.33|Inter-Quartile Range|||0.16|1.04|
3791026|NCT01846208|3620416|B2|||Baseline Ovalbumin IgG4|Assay limits of detection ranges: 0.07 to 30 mgA/L, Values outside of range were truncated (lower and upper values): 0.035 and 31 mgA/L|mgA/L|Median|0.53|0.53|Inter-Quartile Range|||0.09|1.93|
3791027|NCT01846208|3620417|B1|||Baseline Ovalbumin IgG4|Assay limits of detection ranges: 0.07 to 30 mgA/L, Values outside of range were truncated (lower and upper values): 0.035 and 31 mgA/L|mgA/L|Median|0.64|0.64|Inter-Quartile Range|||0.14|5.23|
3791028|NCT01846208|3620414|B4|||Baseline Ovomucoid IgE|Assay limits of detection ranges: 0.01 to 100 kUA/L, Values outside of range were truncated (lower and upper values): 0.05 and 101 kUA/L|kUA/L|Median|9.76|9.76|Inter-Quartile Range|||3.48|18.95|
3791029|NCT01846208|3620415|B3|||Baseline Ovomucoid IgE|Assay limits of detection ranges: 0.01 to 100 kUA/L, Values outside of range were truncated (lower and upper values): 0.05 and 101 kUA/L|kUA/L|Median|16.40|16.4|Inter-Quartile Range|||6.11|35.5|
3791030|NCT01846208|3620416|B2|||Baseline Ovomucoid IgE|Assay limits of detection ranges: 0.01 to 100 kUA/L, Values outside of range were truncated (lower and upper values): 0.05 and 101 kUA/L|kUA/L|Median|6.93|6.93|Inter-Quartile Range|||3.27|13.2|
3791031|NCT01846208|3620417|B1|||Baseline Ovomucoid IgE|Assay limits of detection ranges: 0.01 to 100 kUA/L, Values outside of range were truncated (lower and upper values): 0.05 and 101 kUA/L|kUA/L|Median|6.94|6.94|Inter-Quartile Range|||1.52|13.4|
3791032|NCT01846208|3620414|B4|||Baseline Ovalbumin IgE|Assay limits of detection ranges: 0.01 to 100 kUA/L, Values outside of range were truncated (lower and upper values): 0.05 and 101 kUA/L|kUA/L|Median|8.88|8.88|Inter-Quartile Range|||4.11|20.2|
3791033|NCT01846208|3620415|B3|||Baseline Ovalbumin IgE|Assay limits of detection ranges: 0.01 to 100 kUA/L, Values outside of range were truncated (lower and upper values): 0.05 and 101 kUA/L|kUA/L|Median|16.10|16.1|Inter-Quartile Range|||7.3|29.7|
3791034|NCT01846208|3620416|B2|||Baseline Ovalbumin IgE|Assay limits of detection ranges: 0.01 to 100 kUA/L, Values outside of range were truncated (lower and upper values): 0.05 and 101 kUA/L|kUA/L|Median|5.85|5.85|Inter-Quartile Range|||3.41|10.4|
3791035|NCT01846208|3620417|B1|||Baseline Ovalbumin IgE|Assay limits of detection ranges: 0.01 to 100 kUA/L, Values outside of range were truncated (lower and upper values): 0.05 and 101 kUA/L|kUA/L|Median|5.53|5.53|Inter-Quartile Range|||3.2|20.2|
3791036|NCT01846208|3620414|B4|||Baseline Ratio IgG4/IgE||ratio|Median|11.18|11.18|Inter-Quartile Range|||3.86|42.25|
3791037|NCT01846208|3620415|B3|||Baseline Ratio IgG4/IgE||ratio|Median|5.01|5.01|Inter-Quartile Range|||2.79|11.24|
3791038|NCT01846208|3620416|B2|||Baseline Ratio IgG4/IgE||ratio|Median|25.75|25.75|Inter-Quartile Range|||11.13|86.55|
3791039|NCT01846208|3620417|B1|||Baseline Ratio IgG4/IgE||ratio|Median|24.94|24.94|Inter-Quartile Range|||2.23|119.64|
3791040|NCT01846208|3620414|B4|||Baseline Egg %IgE||% IgE|Median|2.13|2.13|Inter-Quartile Range|||1.03|4.29|
3791041|NCT01846208|3620415|B3|||Baseline Egg %IgE||% IgE|Median|3.06|3.06|Inter-Quartile Range|||1.21|5.86|
3791042|NCT01846208|3620416|B2|||Baseline Egg %IgE||% IgE|Median|1.80|1.8|Inter-Quartile Range|||0.97|5.29|
3791043|NCT01846208|3620417|B1|||Baseline Egg %IgE||% IgE|Median|1.86|1.86|Inter-Quartile Range|||0.89|3.62|
3791044|NCT01846208|3620414|B4|||Baseline Egg IgG4|Assay limits of detection ranges: 0.07 to 30 mgA/L, Values outside of range were truncated (lower and upper values): 0.035 and 31 mgA/L|mgA/L|Median|0.64|0.64|Inter-Quartile Range|||0.17|1.84|
3791045|NCT01846208|3620415|B3|||Baseline Egg IgG4|Assay limits of detection ranges: 0.07 to 30 mgA/L, Values outside of range were truncated (lower and upper values): 0.035 and 31 mgA/L|mgA/L|Median|0.28|0.28|Inter-Quartile Range|||0.13|1.02|
3791046|NCT01846208|3620416|B2|||Baseline Egg IgG4|Assay limits of detection ranges: 0.07 to 30 mgA/L, Values outside of range were truncated (lower and upper values): 0.035 and 31 mgA/L|mgA/L|Median|0.81|0.81|Inter-Quartile Range|||0.26|3.71|
3791047|NCT01846208|3620417|B1|||Baseline Egg IgG4|Assay limits of detection ranges: 0.07 to 30 mgA/L, Values outside of range were truncated (lower and upper values): 0.035 and 31 mgA/L|mgA/L|Median|0.84|0.84|Inter-Quartile Range|||0.08|7.31|
3791048|NCT01846208|3620414|B4|||Baseline Total IgE|Assay limits of detection ranges: Total IgE: 5000 kU/L upper limit, Values above range were truncated: 5001 kU/L|kUA/L|Median|885.50|885.5|Inter-Quartile Range|||366.5|1699.0|
3791049|NCT01846208|3620415|B3|||Baseline Total IgE|Assay limits of detection ranges: Total IgE: 5000 kU/L upper limit, Values above range were truncated: 5001 kU/L|kUA/L|Median|960.00|960.0|Inter-Quartile Range|||390.0|1659.0|
3791050|NCT01846208|3620416|B2|||Baseline Total IgE|Assay limits of detection ranges: Total IgE: 5000 kU/L upper limit, Values above range were truncated: 5001 kU/L|kUA/L|Median|873.00|873.0|Inter-Quartile Range|||269.0|1671.0|
3791051|NCT01846208|3620417|B1|||Baseline Total IgE|Assay limits of detection ranges: Total IgE: 5000 kU/L upper limit, Values above range were truncated: 5001 kU/L|kUA/L|Median|809.00|809.0|Inter-Quartile Range|||389.0|1870.0|
3791052|NCT01846208|3620414|B4|||Baseline Egg IgE|Assay limits of detection Ranges: 0.01 to 100 kUA/L, Values outside of range were truncated (lower and upper values): 0.05 and 101 kUA/L|kUA/L|Median|15.60|15.6|Inter-Quartile Range|||8.22|37.65|
3791053|NCT01846208|3620415|B3|||Baseline Egg IgE|Assay limits of detection Ranges: 0.01 to 100 kUA/L, Values outside of range were truncated (lower and upper values): 0.05 and 101 kUA/L|kUA/L|Median|26.25|26.25|Inter-Quartile Range|||11.7|68.8|
3791054|NCT01846208|3620416|B2|||Baseline Egg IgE|Assay limits of detection Ranges: 0.01 to 100 kUA/L, Values outside of range were truncated (lower and upper values): 0.05 and 101 kUA/L|kUA/L|Median|12.30|12.3|Inter-Quartile Range|||9.09|31.1|
3791055|NCT01846208|3620417|B1|||Baseline Egg IgE|Assay limits of detection Ranges: 0.01 to 100 kUA/L, Values outside of range were truncated (lower and upper values): 0.05 and 101 kUA/L|kUA/L|Median|9.77|9.77|Inter-Quartile Range|||6.54|27.1|
3791056|NCT01846208|3620414|B4|||Atopic Dermatitis Score|The Atopic Dermatitis Total Score is scored on a 10 point scale of 0 to 9 where a higher score indicates increasing severity of atopic dermatitis. This score is a combination of three scores that range from 0 to 3 in the following areas: body surface area score, disease course, and disease intensity.|units on a scale|Median|0.0|0.0|Inter-Quartile Range|||0.0|5.0|
3791057|NCT01846208|3620415|B3|||Atopic Dermatitis Score|The Atopic Dermatitis Total Score is scored on a 10 point scale of 0 to 9 where a higher score indicates increasing severity of atopic dermatitis. This score is a combination of three scores that range from 0 to 3 in the following areas: body surface area score, disease course, and disease intensity.|units on a scale|Median|0.0|0.0|Inter-Quartile Range|||0.0|4.0|
3791058|NCT01846208|3620416|B2|||Atopic Dermatitis Score|The Atopic Dermatitis Total Score is scored on a 10 point scale of 0 to 9 where a higher score indicates increasing severity of atopic dermatitis. This score is a combination of three scores that range from 0 to 3 in the following areas: body surface area score, disease course, and disease intensity.|units on a scale|Median|0.0|0.0|Inter-Quartile Range|||0.0|5.0|
3791059|NCT01846208|3620417|B1|||Atopic Dermatitis Score|The Atopic Dermatitis Total Score is scored on a 10 point scale of 0 to 9 where a higher score indicates increasing severity of atopic dermatitis. This score is a combination of three scores that range from 0 to 3 in the following areas: body surface area score, disease course, and disease intensity.|units on a scale|Median|0.0|0.0|Inter-Quartile Range|||0.0|5.0|
3791060|NCT01846208|3620414|B4|||Atopic Dermatitis History||Participants|Count of Participants|55|55.0||||||
3791061|NCT01846208|3620415|B3|||Atopic Dermatitis History||Participants|Count of Participants|24|24.0||||||
3791062|NCT01846208|3620416|B2|||Atopic Dermatitis History||Participants|Count of Participants|13|13.0||||||
3791063|NCT01846208|3620417|B1|||Atopic Dermatitis History||Participants|Count of Participants|18|18.0||||||
3791064|NCT01846208|3620414|B4|||Allergic Rhinitis||Participants|Count of Participants|73|73.0||||||
3791065|NCT01846208|3620415|B3|||Allergic Rhinitis||Participants|Count of Participants|31|31.0||||||
3791066|NCT01846208|3620416|B2|||Allergic Rhinitis||Participants|Count of Participants|18|18.0||||||
3791067|NCT01846208|3620417|B1|||Allergic Rhinitis||Participants|Count of Participants|24|24.0||||||
3791068|NCT01846208|3620414|B4|||Allergic GI Disease||Participants|Count of Participants|0|0.0||||||
3791069|NCT01846208|3620415|B3|||Allergic GI Disease||Participants|Count of Participants|0|0.0||||||
3791070|NCT01846208|3620416|B2|||Allergic GI Disease||Participants|Count of Participants|0|0.0||||||
3791071|NCT01846208|3620417|B1|||Allergic GI Disease||Participants|Count of Participants|0|0.0||||||
3791072|NCT01846208|3620414|B4|Moderate persistent||Asthma Severity History||Participants|Count of Participants|2|2.0||||||
3791073|NCT01846208|3620415|B3|Moderate persistent||Asthma Severity History||Participants|Count of Participants|0|0.0||||||
3791074|NCT01846208|3620416|B2|Moderate persistent||Asthma Severity History||Participants|Count of Participants|1|1.0||||||
3791075|NCT01846208|3620417|B1|Moderate persistent||Asthma Severity History||Participants|Count of Participants|1|1.0||||||
3791076|NCT01846208|3620414|B4|Mild persistent||Asthma Severity History||Participants|Count of Participants|5|5.0||||||
3791077|NCT01846208|3620415|B3|Mild persistent||Asthma Severity History||Participants|Count of Participants|2|2.0||||||
3791078|NCT01846208|3620416|B2|Mild persistent||Asthma Severity History||Participants|Count of Participants|2|2.0||||||
3791079|NCT01846208|3620417|B1|Mild persistent||Asthma Severity History||Participants|Count of Participants|1|1.0||||||
3791080|NCT01846208|3620414|B4|Mild intermittent||Asthma Severity History||Participants|Count of Participants|50|50.0||||||
3791081|NCT01846208|3620415|B3|Mild intermittent||Asthma Severity History||Participants|Count of Participants|24|24.0||||||
3791082|NCT01846208|3620416|B2|Mild intermittent||Asthma Severity History||Participants|Count of Participants|10|10.0||||||
3791083|NCT01846208|3620417|B1|Mild intermittent||Asthma Severity History||Participants|Count of Participants|16|16.0||||||
3791084|NCT01846208|3620414|B4|No History||Asthma Severity History||Participants|Count of Participants|32|32.0||||||
3791085|NCT01846208|3620415|B3|No History||Asthma Severity History||Participants|Count of Participants|13|13.0||||||
3791086|NCT01846208|3620416|B2|No History||Asthma Severity History||Participants|Count of Participants|10|10.0||||||
3791087|NCT01846208|3620417|B1|No History||Asthma Severity History||Participants|Count of Participants|9|9.0||||||
3791088|NCT01846208|3620414|B4|Yes||Other Food Allergy History||Participants|Count of Participants|77|77.0||||||
3791089|NCT01846208|3620415|B3|Yes||Other Food Allergy History||Participants|Count of Participants|31|31.0||||||
3791090|NCT01846208|3620416|B2|Yes||Other Food Allergy History||Participants|Count of Participants|20|20.0||||||
3791091|NCT01846208|3620417|B1|Yes||Other Food Allergy History||Participants|Count of Participants|26|26.0||||||
3791092|NCT01846208|3620414|B4|No/Unknown||Other Food Allergy History||Participants|Count of Participants|12|12.0||||||
3791093|NCT01846208|3620415|B3|No/Unknown||Other Food Allergy History||Participants|Count of Participants|8|8.0||||||
3791094|NCT01846208|3620416|B2|No/Unknown||Other Food Allergy History||Participants|Count of Participants|3|3.0||||||
3791095|NCT01846208|3620417|B1|No/Unknown||Other Food Allergy History||Participants|Count of Participants|1|1.0||||||
3791096|NCT01846208|3620414|B4||Hispanic or Latino origin|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3791097|NCT01846208|3620415|B3||Hispanic or Latino origin|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3791098|NCT01846208|3620416|B2||Hispanic or Latino origin|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3791099|NCT01846208|3620417|B1||Hispanic or Latino origin|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3791100|NCT01846208|3620414|B4||Non-Hispanic or Non-Latino origin|Race/Ethnicity, Customized||Participants|Count of Participants|87|87.0||||||
3791101|NCT01846208|3620415|B3||Non-Hispanic or Non-Latino origin|Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
3791102|NCT01846208|3620416|B2||Non-Hispanic or Non-Latino origin|Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3791103|NCT01846208|3620417|B1||Non-Hispanic or Non-Latino origin|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3791104|NCT01846208|3620414|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791105|NCT01846208|3620415|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791106|NCT01846208|3620416|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791107|NCT01846208|3620417|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791108|NCT01846208|3620414|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3791109|NCT01846208|3620415|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3791110|NCT01846208|3620416|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3791111|NCT01846208|3620417|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3791112|NCT01846208|3620414|B4||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3791113|NCT01846208|3620415|B3||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3791114|NCT01846208|3620416|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3791115|NCT01846208|3620417|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3791116|NCT01846208|3620414|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3791117|NCT01846208|3620415|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791118|NCT01846208|3620416|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3791119|NCT01846208|3620417|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3791120|NCT01846208|3620414|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791121|NCT01846208|3620415|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791122|NCT01846208|3620416|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791123|NCT01846208|3620417|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791124|NCT01846208|3620414|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3791125|NCT01846208|3620415|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3791126|NCT01846208|3620416|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3791127|NCT01846208|3620417|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3791128|NCT01846208|3620414|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791129|NCT01846208|3620415|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791130|NCT01846208|3620416|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791131|NCT01846208|3620417|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791132|NCT01846208|3620414|B4||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3791133|NCT01846208|3620415|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3791134|NCT01846208|3620416|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3791135|NCT01846208|3620417|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3791136|NCT01846208|3620414|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3791137|NCT01846208|3620415|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3791138|NCT01846208|3620416|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3791139|NCT01846208|3620417|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3791140|NCT01846208|3620414|B4|||Age||years|Mean|8.4|8.4|Standard Deviation|2.8|2.8|||
3791141|NCT01846208|3620415|B3|||Age||years|Mean|8.8|8.8|Standard Deviation|2.4|2.4|||
3791142|NCT01846208|3620416|B2|||Age||years|Mean|9.1|9.1|Standard Deviation|3.1|3.1|||
3791143|NCT01846208|3620417|B1|||Age||years|Mean|7.2|7.2|Standard Deviation|3.0|3.0|||
3791144|NCT01846104|3620436|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791145|NCT01846104|3620436|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791146|NCT01846104|3620436|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3791147|NCT01846104|3620436|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791148|NCT01846104|3620436|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791149|NCT01846104|3620436|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791150|NCT01846104|3620436|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791151|NCT01846104|3620436|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3791152|NCT01846104|3620436|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3791153|NCT01846104|3620436|B1|||Age||years|Mean|39|39.0|Standard Deviation|10.03|10.03|||
3791154|NCT01846039|3620442|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3791155|NCT01846039|3620442|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3791156|NCT01846039|3620442|B1|||Age||years|Mean|40.2|40.2|Standard Deviation|11.78|11.78|||
3791157|NCT01845974|3620452|B3|ammiodarone and dronedarone||Prior Antiarrhythmia drug failure||Participants|Count of Participants|1|1.0||||||
3791158|NCT01845974|3620453|B2|ammiodarone and dronedarone||Prior Antiarrhythmia drug failure||Participants|Count of Participants|1|1.0||||||
3791159|NCT01845974|3620454|B1|ammiodarone and dronedarone||Prior Antiarrhythmia drug failure||Participants|Count of Participants|0|0.0||||||
3791160|NCT01845974|3620452|B3|ammiodarone and fleccainide||Prior Antiarrhythmia drug failure||Participants|Count of Participants|1|1.0||||||
3791161|NCT01845974|3620453|B2|ammiodarone and fleccainide||Prior Antiarrhythmia drug failure||Participants|Count of Participants|0|0.0||||||
3791162|NCT01845974|3620454|B1|ammiodarone and fleccainide||Prior Antiarrhythmia drug failure||Participants|Count of Participants|1|1.0||||||
3791163|NCT01845974|3620452|B3|dronedarone||Prior Antiarrhythmia drug failure||Participants|Count of Participants|4|4.0||||||
3791164|NCT01845974|3620453|B2|dronedarone||Prior Antiarrhythmia drug failure||Participants|Count of Participants|3|3.0||||||
3791165|NCT01845974|3620454|B1|dronedarone||Prior Antiarrhythmia drug failure||Participants|Count of Participants|1|1.0||||||
3791166|NCT01845974|3620452|B3|fleccainide||Prior Antiarrhythmia drug failure||Participants|Count of Participants|2|2.0||||||
3791167|NCT01845974|3620453|B2|fleccainide||Prior Antiarrhythmia drug failure||Participants|Count of Participants|2|2.0||||||
3791168|NCT01845974|3620454|B1|fleccainide||Prior Antiarrhythmia drug failure||Participants|Count of Participants|0|0.0||||||
3791169|NCT01845974|3620452|B3|dofetilide||Prior Antiarrhythmia drug failure||Participants|Count of Participants|1|1.0||||||
3791170|NCT01845974|3620453|B2|dofetilide||Prior Antiarrhythmia drug failure||Participants|Count of Participants|1|1.0||||||
3791171|NCT01845974|3620454|B1|dofetilide||Prior Antiarrhythmia drug failure||Participants|Count of Participants|0|0.0||||||
3791172|NCT01845974|3620452|B3|sotolol||Prior Antiarrhythmia drug failure||Participants|Count of Participants|2|2.0||||||
3791173|NCT01845974|3620453|B2|sotolol||Prior Antiarrhythmia drug failure||Participants|Count of Participants|1|1.0||||||
3791174|NCT01845974|3620454|B1|sotolol||Prior Antiarrhythmia drug failure||Participants|Count of Participants|1|1.0||||||
3791175|NCT01845974|3620452|B3|none||Prior Antiarrhythmia drug failure||Participants|Count of Participants|1|1.0||||||
3791176|NCT01845974|3620453|B2|none||Prior Antiarrhythmia drug failure||Participants|Count of Participants|1|1.0||||||
3791177|NCT01845974|3620454|B1|none||Prior Antiarrhythmia drug failure||Participants|Count of Participants|0|0.0||||||
3791178|NCT01845974|3620452|B3|prior catheter Radiofrequency ablation for Afib||prior cardiac surgery||Participants|Count of Participants|3|3.0||||||
3791179|NCT01845974|3620453|B2|prior catheter Radiofrequency ablation for Afib||prior cardiac surgery||Participants|Count of Participants|2|2.0||||||
3791180|NCT01845974|3620454|B1|prior catheter Radiofrequency ablation for Afib||prior cardiac surgery||Participants|Count of Participants|1|1.0||||||
3791181|NCT01845974|3620452|B3|right atrial flutter ablation||prior cardiac surgery||Participants|Count of Participants|2|2.0||||||
3791182|NCT01845974|3620453|B2|right atrial flutter ablation||prior cardiac surgery||Participants|Count of Participants|2|2.0||||||
3791183|NCT01845974|3620454|B1|right atrial flutter ablation||prior cardiac surgery||Participants|Count of Participants|0|0.0||||||
3791184|NCT01845974|3620452|B3|surgical maze||prior cardiac surgery||Participants|Count of Participants|0|0.0||||||
3791185|NCT01845974|3620453|B2|surgical maze||prior cardiac surgery||Participants|Count of Participants|0|0.0||||||
3791186|NCT01845974|3620454|B1|surgical maze||prior cardiac surgery||Participants|Count of Participants|0|0.0||||||
3791187|NCT01845974|3620452|B3|coronary artery bypass grafting||prior cardiac surgery||Participants|Count of Participants|1|1.0||||||
3791188|NCT01845974|3620453|B2|coronary artery bypass grafting||prior cardiac surgery||Participants|Count of Participants|1|1.0||||||
3791189|NCT01845974|3620454|B1|coronary artery bypass grafting||prior cardiac surgery||Participants|Count of Participants|0|0.0||||||
3791190|NCT01845974|3620452|B3|pacemaker||prior cardiac surgery||Participants|Count of Participants|1|1.0||||||
3791191|NCT01845974|3620453|B2|pacemaker||prior cardiac surgery||Participants|Count of Participants|1|1.0||||||
3791192|NCT01845974|3620454|B1|pacemaker||prior cardiac surgery||Participants|Count of Participants|0|0.0||||||
3791193|NCT01845974|3620452|B3|||CHADsVasc 2 score= 2+|"Congestive heart failure = 1 Hypertension: blood pressure consistently above 140/90 mmHg (or treated hypertension on medication) =1; Age ≥75 years=2 Diabetes Mellitus =1; Prior Stroke or TIA or thromboembolism =2 ;Vascular disease (e.g. peripheral artery disease, myocardial infarction, aortic plaque) =1; Age 65–74 years =1; Sex category female =+1-items are summed to arrive at a score ranging from 0 to 9, with scores >=2 indicating moderate-high stroke risk.)"|Participants|Count of Participants|12|12.0||||||
3791194|NCT01845974|3620453|B2|||CHADsVasc 2 score= 2+|"Congestive heart failure = 1 Hypertension: blood pressure consistently above 140/90 mmHg (or treated hypertension on medication) =1; Age ≥75 years=2 Diabetes Mellitus =1; Prior Stroke or TIA or thromboembolism =2 ;Vascular disease (e.g. peripheral artery disease, myocardial infarction, aortic plaque) =1; Age 65–74 years =1; Sex category female =+1-items are summed to arrive at a score ranging from 0 to 9, with scores >=2 indicating moderate-high stroke risk.)"|Participants|Count of Participants|9|9.0||||||
3791195|NCT01845974|3620454|B1|||CHADsVasc 2 score= 2+|"Congestive heart failure = 1 Hypertension: blood pressure consistently above 140/90 mmHg (or treated hypertension on medication) =1; Age ≥75 years=2 Diabetes Mellitus =1; Prior Stroke or TIA or thromboembolism =2 ;Vascular disease (e.g. peripheral artery disease, myocardial infarction, aortic plaque) =1; Age 65–74 years =1; Sex category female =+1-items are summed to arrive at a score ranging from 0 to 9, with scores >=2 indicating moderate-high stroke risk.)"|Participants|Count of Participants|3|3.0||||||
3791196|NCT01845974|3620452|B3|diuretic||Previous therapies||Participants|Count of Participants|1|1.0||||||
3791197|NCT01845974|3620453|B2|diuretic||Previous therapies||Participants|Count of Participants|0|0.0||||||
3791198|NCT01845974|3620454|B1|diuretic||Previous therapies||Participants|Count of Participants|1|1.0||||||
3791199|NCT01845974|3620452|B3|spiranolactone||Previous therapies||Participants|Count of Participants|0|0.0||||||
3791200|NCT01845974|3620453|B2|spiranolactone||Previous therapies||Participants|Count of Participants|0|0.0||||||
3791201|NCT01845974|3620454|B1|spiranolactone||Previous therapies||Participants|Count of Participants|0|0.0||||||
3791202|NCT01845974|3620452|B3|digoxin||Previous therapies||Participants|Count of Participants|2|2.0||||||
3791203|NCT01845974|3620453|B2|digoxin||Previous therapies||Participants|Count of Participants|2|2.0||||||
3791204|NCT01845974|3620454|B1|digoxin||Previous therapies||Participants|Count of Participants|0|0.0||||||
3791205|NCT01845974|3620452|B3|beta blockers||Previous therapies||Participants|Count of Participants|9|9.0||||||
3791206|NCT01845974|3620453|B2|beta blockers||Previous therapies||Participants|Count of Participants|7|7.0||||||
3791207|NCT01845974|3620454|B1|beta blockers||Previous therapies||Participants|Count of Participants|2|2.0||||||
3791208|NCT01845974|3620452|B3|angiotensin converting enzymes||Previous therapies||Participants|Count of Participants|3|3.0||||||
3791209|NCT01845974|3620453|B2|angiotensin converting enzymes||Previous therapies||Participants|Count of Participants|3|3.0||||||
3791210|NCT01845974|3620454|B1|angiotensin converting enzymes||Previous therapies||Participants|Count of Participants|0|0.0||||||
3791211|NCT01845974|3620452|B3|angiotensin 2 receptor blockers||Previous therapies||Participants|Count of Participants|3|3.0||||||
3791212|NCT01845974|3620453|B2|angiotensin 2 receptor blockers||Previous therapies||Participants|Count of Participants|2|2.0||||||
3791213|NCT01845974|3620454|B1|angiotensin 2 receptor blockers||Previous therapies||Participants|Count of Participants|1|1.0||||||
3791214|NCT01845974|3620452|B3|statin||Previous therapies||Participants|Count of Participants|6|6.0||||||
3791215|NCT01845974|3620453|B2|statin||Previous therapies||Participants|Count of Participants|4|4.0||||||
3791216|NCT01845974|3620454|B1|statin||Previous therapies||Participants|Count of Participants|2|2.0||||||
3791217|NCT01845974|3620452|B3|||Tobacco history||Participants|Count of Participants|5|5.0||||||
3791218|NCT01845974|3620453|B2|||Tobacco history||Participants|Count of Participants|5|5.0||||||
3791219|NCT01845974|3620454|B1|||Tobacco history||Participants|Count of Participants|0|0.0||||||
3791220|NCT01845974|3620452|B3|Coronary artery disease||Comorbidities||Participants|Count of Participants|4|4.0||||||
3791221|NCT01845974|3620453|B2|Coronary artery disease||Comorbidities||Participants|Count of Participants|2|2.0||||||
3791222|NCT01845974|3620454|B1|Coronary artery disease||Comorbidities||Participants|Count of Participants|2|2.0||||||
3791223|NCT01845974|3620452|B3|Obstructive sleep apnea||Comorbidities||Participants|Count of Participants|4|4.0||||||
3791224|NCT01845974|3620453|B2|Obstructive sleep apnea||Comorbidities||Participants|Count of Participants|1|1.0||||||
3791225|NCT01845974|3620454|B1|Obstructive sleep apnea||Comorbidities||Participants|Count of Participants|3|3.0||||||
3791226|NCT01845974|3620452|B3|Diabetes||Comorbidities||Participants|Count of Participants|3|3.0||||||
3791227|NCT01845974|3620453|B2|Diabetes||Comorbidities||Participants|Count of Participants|2|2.0||||||
3791228|NCT01845974|3620454|B1|Diabetes||Comorbidities||Participants|Count of Participants|1|1.0||||||
3791229|NCT01845974|3620452|B3|Heart Failure||Comorbidities||Participants|Count of Participants|2|2.0||||||
3791230|NCT01845974|3620453|B2|Heart Failure||Comorbidities||Participants|Count of Participants|0|0.0||||||
3791231|NCT01845974|3620454|B1|Heart Failure||Comorbidities||Participants|Count of Participants|2|2.0||||||
3791232|NCT01845974|3620452|B3|Hypertension||Comorbidities||Participants|Count of Participants|7|7.0||||||
3791233|NCT01845974|3620453|B2|Hypertension||Comorbidities||Participants|Count of Participants|5|5.0||||||
3791234|NCT01845974|3620454|B1|Hypertension||Comorbidities||Participants|Count of Participants|2|2.0||||||
3791235|NCT01845974|3620452|B3|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3791236|NCT01845974|3620453|B2|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3791237|NCT01845974|3620454|B1|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3791238|NCT01845974|3620452|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3791239|NCT01845974|3620453|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3791240|NCT01845974|3620454|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3791241|NCT01845974|3620452|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3791242|NCT01845974|3620453|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3791243|NCT01845974|3620454|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3791244|NCT01845974|3620452|B3|||Age||years|Mean|61.23|61.23|Standard Deviation|11.08|11.08|||
3791245|NCT01845974|3620453|B2|||Age||years|Mean|61.3|61.3|Standard Deviation|9|9.0|||
3791246|NCT01845974|3620454|B1|||Age||years|Mean|61|61.0|Standard Deviation|16.5|16.5|||
3791247|NCT01845831|3620461|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3791248|NCT01845831|3620462|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3791249|NCT01845831|3620463|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3791250|NCT01845831|3620461|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|159|159.0||||||
3791251|NCT01845831|3620462|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|78|78.0||||||
3791252|NCT01845831|3620463|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|81|81.0||||||
3791253|NCT01845831|3620461|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|89|89.0||||||
3791254|NCT01845831|3620462|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
3791255|NCT01845831|3620463|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|45|45.0||||||
3791256|NCT01845831|3620461|B3||Male|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3791257|NCT01845831|3620462|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3791258|NCT01845831|3620463|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3791259|NCT01845831|3620461|B3||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3791260|NCT01845831|3620462|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3791261|NCT01845831|3620463|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3791262|NCT01845831|3620461|B3|||Age||years|Mean|56.9|56.9|Standard Deviation|10.9|10.9|||
3791263|NCT01845831|3620462|B2|||Age||years|Mean|57.1|57.1|Standard Deviation|10.4|10.4|||
3791264|NCT01845831|3620463|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|11.4|11.4|||
3791265|NCT01845792|3620494|B3|||Prior Docetaxel AND Abiraterone||Participants|Count of Participants|7|7.0||||||
3791266|NCT01845792|3620495|B2|||Prior Docetaxel AND Abiraterone||Participants|Count of Participants|2|2.0||||||
3791267|NCT01845792|3620496|B1|||Prior Docetaxel AND Abiraterone||Participants|Count of Participants|5|5.0||||||
3791268|NCT01845792|3620494|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
3791269|NCT01845792|3620495|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3791270|NCT01845792|3620496|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3791271|NCT01845792|3620494|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791272|NCT01845792|3620495|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791273|NCT01845792|3620496|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791274|NCT01845792|3620494|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791275|NCT01845792|3620495|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791276|NCT01845792|3620496|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791277|NCT01845792|3620494|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3791278|NCT01845792|3620495|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3791279|NCT01845792|3620496|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3791280|NCT01845792|3620494|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3791281|NCT01845792|3620495|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791282|NCT01845792|3620496|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3791283|NCT01845792|3620494|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791284|NCT01845792|3620495|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791285|NCT01845792|3620496|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791286|NCT01845792|3620494|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791287|NCT01845792|3620495|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791288|NCT01845792|3620496|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791289|NCT01845792|3620494|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791290|NCT01845792|3620495|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791291|NCT01845792|3620496|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791292|NCT01845792|3620494|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3791293|NCT01845792|3620495|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3791294|NCT01845792|3620496|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3791295|NCT01845792|3620494|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3791296|NCT01845792|3620495|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3791297|NCT01845792|3620496|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3791298|NCT01845792|3620494|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3791299|NCT01845792|3620495|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3791300|NCT01845792|3620496|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3791301|NCT01845792|3620494|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3791302|NCT01845792|3620495|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3791303|NCT01845792|3620496|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3791304|NCT01845792|3620494|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3791305|NCT01845792|3620495|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3791306|NCT01845792|3620496|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3791307|NCT01845636|3620505|B1|||Selective Reminding Test Total Recall Score|The Selective Reminding Test (SRT) is a 12-item test of verbal learning and memory. To administer, the researcher will read aloud a list of 12 words. The participant repeats each word aloud to ensure that the word was heard correctly. Immediately following the reading of all 12 words, the participant is asked to recall as many words as possible within the one minute time limit. The participant is then reminded of the words they did not say and asked to recall the list again. This process is repeated for 6 trials. The total immediate recall for all 6 trials is the number that is reported.|Words|Mean|33.61|33.61|Standard Deviation|8.15|8.15|||
3791308|NCT01845636|3620505|B1|United States||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3791309|NCT01845636|3620505|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3791310|NCT01845636|3620505|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3791311|NCT01845636|3620505|B1|||Age||years|Mean|70.4|70.4|Standard Deviation|9.8|9.8|||
3791312|NCT01845636|3620505|B1||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
3791313|NCT01845636|3620505|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3791314|NCT01845636|3620505|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3791315|NCT01845220|3620513|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3791316|NCT01845220|3620513|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791317|NCT01845220|3620513|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791318|NCT01845220|3620513|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791319|NCT01845220|3620513|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791320|NCT01845220|3620513|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791321|NCT01845220|3620513|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3791322|NCT01845220|3620513|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791323|NCT01845220|3620513|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3791324|NCT01845220|3620513|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3791325|NCT01845220|3620513|B1|||Age||years|Mean|34|34.0|Full Range|||25.0|43.0|
3791326|NCT01845155|3620520|B3|||Tinnitus Pitch||Hz|Mean|5834|5834.0|Standard Deviation|2622|2622.0|||
3791327|NCT01845155|3620521|B2|||Tinnitus Pitch||Hz|Mean|5851|5851.0|Standard Deviation|2678|2678.0|||
3791328|NCT01845155|3620522|B1|||Tinnitus Pitch||Hz|Mean|5805|5805.0|Standard Deviation|2594|2594.0|||
3791329|NCT01845155|3620520|B3|||TQ-score||units on a scale|Mean|32.9|32.9|Standard Deviation|15.0|15.0|||
3791330|NCT01845155|3620521|B2|||TQ-score||units on a scale|Mean|32.9|32.9|Standard Deviation|13.4|13.4|||
3791331|NCT01845155|3620522|B1|||TQ-score||units on a scale|Mean|33.0|33.0|Standard Deviation|14.8|14.8|||
3791332|NCT01845155|3620520|B3|Germany||Region of Enrollment||participants|Number|290|290.0||||||
3791333|NCT01845155|3620521|B2|Germany||Region of Enrollment||participants|Number|144|144.0||||||
3791334|NCT01845155|3620522|B1|Germany||Region of Enrollment||participants|Number|146|146.0||||||
3791335|NCT01845155|3620520|B3||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3791336|NCT01845155|3620521|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3791337|NCT01845155|3620522|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3791338|NCT01845155|3620520|B3||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
3791339|NCT01845155|3620521|B2||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3791340|NCT01845155|3620522|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3791341|NCT01845155|3620520|B3|||Age||years|Mean|52.5|52.5|Standard Deviation|11.9|11.9|||
3791342|NCT01845155|3620521|B2|||Age||years|Mean|53.2|53.2|Standard Deviation|11.9|11.9|||
3791343|NCT01845155|3620522|B1|||Age||years|Mean|52.0|52.0|Standard Deviation|11.6|11.6|||
3791344|NCT01845155|3620520|B3||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
3791345|NCT01845155|3620521|B2||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3791346|NCT01845155|3620522|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3791347|NCT01845155|3620520|B3||Between 18 and 65 years|Age||Participants|Count of Participants|244|244.0||||||
3791348|NCT01845155|3620521|B2||Between 18 and 65 years|Age||Participants|Count of Participants|119|119.0||||||
3791349|NCT01845155|3620522|B1||Between 18 and 65 years|Age||Participants|Count of Participants|125|125.0||||||
3791350|NCT01845155|3620520|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3791351|NCT01845155|3620521|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3791352|NCT01845155|3620522|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3791353|NCT01845103|3620531|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3791354|NCT01845103|3620531|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3791355|NCT01845103|3620531|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3791356|NCT01845103|3620531|B1|||Age||years|Mean|75|75.0|Standard Deviation|||||
3791357|NCT01845103|3620531|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3791358|NCT01845103|3620531|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3791359|NCT01845103|3620531|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3791360|NCT01845077|3620536|B4||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3791361|NCT01845077|3620537|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3791362|NCT01845077|3620538|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3791363|NCT01845077|3620539|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3791364|NCT01845077|3620536|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3791365|NCT01845077|3620537|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3791366|NCT01845077|3620538|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3791367|NCT01845077|3620539|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3791368|NCT01845077|3620536|B4|||Age||years|Mean|31.3|31.3|Standard Deviation|8.8|8.8|||
3791369|NCT01845077|3620537|B3|||Age||years|Mean|28.4|28.4|Standard Deviation|7.1|7.1|||
3791370|NCT01845077|3620538|B2|||Age||years|Mean|30.6|30.6|Standard Deviation|9.0|9.0|||
3791371|NCT01845077|3620539|B1|||Age||years|Mean|34.8|34.8|Standard Deviation|9.3|9.3|||
3791372|NCT01845025|3620588|B3||Male|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
3791373|NCT01845025|3620589|B2||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3791374|NCT01845025|3620590|B1||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3791375|NCT01845025|3620588|B3||Female|Sex: Female, Male||Participants|Count of Participants|556|556.0||||||
3791376|NCT01845025|3620589|B2||Female|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
3791377|NCT01845025|3620590|B1||Female|Sex: Female, Male||Participants|Count of Participants|284|284.0||||||
3791378|NCT01845025|3620588|B3|||Age||years|Mean|45.2|45.2|Standard Deviation|16.84|16.84|||
3791379|NCT01845025|3620589|B2|||Age||years|Mean|45.6|45.6|Standard Deviation|17.02|17.02|||
3791380|NCT01845025|3620590|B1|||Age||years|Mean|44.7|44.7|Standard Deviation|16.67|16.67|||
3791381|NCT01844895|3620613|B1|||Methotrexate (MTX) Dose at SubStudy Baseline|Substudy baseline=Day 1 of Substudy. MTX dose is measured in milligrams per week (mg/wk).|mg/wk|Mean|17.0|17.0|Standard Deviation|6.0|6.0|||
3791382|NCT01844895|3620613|B1|||Duration of Disease||years|Median|6.0|6.0|Full Range|||0.0|41.0|
3791383|NCT01844895|3620613|B1|>100 kg||Body Weight||participants|Number|6|6.0||||||
3791384|NCT01844895|3620613|B1|60 - 100 kg||Body Weight||participants|Number|83|83.0||||||
3791385|NCT01844895|3620613|B1|<60 kilogram (kg)||Body Weight||participants|Number|28|28.0||||||
3791386|NCT01844895|3620613|B1|North America||Region of Enrollment||participants|Number|17|17.0||||||
3791387|NCT01844895|3620613|B1|South America||Region of Enrollment||participants|Number|100|100.0||||||
3791388|NCT01844895|3620613|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3791389|NCT01844895|3620613|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3791390|NCT01844895|3620613|B1|||Age||years|Mean|53.9|53.9|Standard Deviation|11.8|11.8|||
3791391|NCT01844856|3620629|B3|Estonia||Region of Enrollment||participants|Number|66|66.0||||||
3791392|NCT01844856|3620630|B2|Estonia||Region of Enrollment||participants|Number|34|34.0||||||
3791393|NCT01844856|3620631|B1|Estonia||Region of Enrollment||participants|Number|32|32.0||||||
3791394|NCT01844856|3620629|B3|Germany||Region of Enrollment||participants|Number|4|4.0||||||
3791395|NCT01844856|3620630|B2|Germany||Region of Enrollment||participants|Number|2|2.0||||||
3791396|NCT01844856|3620631|B1|Germany||Region of Enrollment||participants|Number|2|2.0||||||
3791397|NCT01844856|3620629|B3|Lithuania||Region of Enrollment||participants|Number|52|52.0||||||
3791398|NCT01844856|3620630|B2|Lithuania||Region of Enrollment||participants|Number|26|26.0||||||
3791399|NCT01844856|3620631|B1|Lithuania||Region of Enrollment||participants|Number|26|26.0||||||
3791400|NCT01844856|3620629|B3|Bulgaria||Region of Enrollment||participants|Number|89|89.0||||||
3791401|NCT01844856|3620630|B2|Bulgaria||Region of Enrollment||participants|Number|44|44.0||||||
3791402|NCT01844856|3620631|B1|Bulgaria||Region of Enrollment||participants|Number|45|45.0||||||
3791403|NCT01844856|3620629|B3|South Africa||Region of Enrollment||participants|Number|1|1.0||||||
3791404|NCT01844856|3620630|B2|South Africa||Region of Enrollment||participants|Number|1|1.0||||||
3791405|NCT01844856|3620631|B1|South Africa||Region of Enrollment||participants|Number|0|0.0||||||
3791406|NCT01844856|3620629|B3|Latvia||Region of Enrollment||participants|Number|48|48.0||||||
3791407|NCT01844856|3620630|B2|Latvia||Region of Enrollment||participants|Number|23|23.0||||||
3791408|NCT01844856|3620631|B1|Latvia||Region of Enrollment||participants|Number|25|25.0||||||
3791409|NCT01844856|3620629|B3|Czech Republic||Region of Enrollment||participants|Number|31|31.0||||||
3791410|NCT01844856|3620630|B2|Czech Republic||Region of Enrollment||participants|Number|17|17.0||||||
3791411|NCT01844856|3620631|B1|Czech Republic||Region of Enrollment||participants|Number|14|14.0||||||
3791412|NCT01844856|3620629|B3|Ukraine||Region of Enrollment||participants|Number|76|76.0||||||
3791413|NCT01844856|3620630|B2|Ukraine||Region of Enrollment||participants|Number|38|38.0||||||
3791414|NCT01844856|3620631|B1|Ukraine||Region of Enrollment||participants|Number|38|38.0||||||
3791415|NCT01844856|3620629|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
3791416|NCT01844856|3620630|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3791417|NCT01844856|3620631|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3791418|NCT01844856|3620629|B3|Romania||Region of Enrollment||participants|Number|84|84.0||||||
3791419|NCT01844856|3620630|B2|Romania||Region of Enrollment||participants|Number|42|42.0||||||
3791420|NCT01844856|3620631|B1|Romania||Region of Enrollment||participants|Number|42|42.0||||||
3791421|NCT01844856|3620629|B3|Russian Federation||Region of Enrollment||participants|Number|52|52.0||||||
3791422|NCT01844856|3620630|B2|Russian Federation||Region of Enrollment||participants|Number|24|24.0||||||
3791423|NCT01844856|3620631|B1|Russian Federation||Region of Enrollment||participants|Number|28|28.0||||||
3791424|NCT01844856|3620629|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3791425|NCT01844856|3620630|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3791426|NCT01844856|3620631|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3791427|NCT01844856|3620629|B3|Other Race||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3791428|NCT01844856|3620630|B2|Other Race||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3791429|NCT01844856|3620631|B1|Other Race||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3791430|NCT01844856|3620629|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3791431|NCT01844856|3620630|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3791432|NCT01844856|3620631|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3791433|NCT01844856|3620629|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3791434|NCT01844856|3620630|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3791435|NCT01844856|3620631|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3791436|NCT01844856|3620629|B3|White||Race/Ethnicity, Customized||participants|Number|523|523.0||||||
3791437|NCT01844856|3620630|B2|White||Race/Ethnicity, Customized||participants|Number|260|260.0||||||
3791438|NCT01844856|3620631|B1|White||Race/Ethnicity, Customized||participants|Number|263|263.0||||||
3791439|NCT01844856|3620629|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3791440|NCT01844856|3620630|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791441|NCT01844856|3620631|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3791442|NCT01844856|3620629|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|523|523.0||||||
3791443|NCT01844856|3620630|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|262|262.0||||||
3791444|NCT01844856|3620631|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|261|261.0||||||
3791445|NCT01844856|3620629|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3791446|NCT01844856|3620630|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3791447|NCT01844856|3620631|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3791448|NCT01844856|3620629|B3||Male|Sex: Female, Male||Participants|Count of Participants|319|319.0||||||
3791449|NCT01844856|3620630|B2||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3791450|NCT01844856|3620631|B1||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3791451|NCT01844856|3620629|B3||Female|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
3791452|NCT01844856|3620630|B2||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3791453|NCT01844856|3620631|B1||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3791454|NCT01844856|3620629|B3|||Age|Mean/standard deviation of age for the combined eravacycline and ertapenem treatment groups was calculated by hand.|years|Mean|54.8|54.8|Standard Deviation|16.49|16.49|||
3791455|NCT01844856|3620630|B2|||Age|Mean/standard deviation of age for the combined eravacycline and ertapenem treatment groups was calculated by hand.|years|Mean|54.8|54.8|Standard Deviation|16.09|16.09|||
3791456|NCT01844856|3620631|B1|||Age|Mean/standard deviation of age for the combined eravacycline and ertapenem treatment groups was calculated by hand.|years|Mean|54.8|54.8|Standard Deviation|16.92|16.92|||
3791457|NCT01844830|3620642|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3791458|NCT01844830|3620643|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3791459|NCT01844830|3620644|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3791460|NCT01844830|3620642|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791461|NCT01844830|3620643|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791462|NCT01844830|3620644|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791463|NCT01844830|3620642|B3||White|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3791464|NCT01844830|3620643|B2||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3791465|NCT01844830|3620644|B1||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3791466|NCT01844830|3620642|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3791467|NCT01844830|3620643|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3791468|NCT01844830|3620644|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3791469|NCT01844830|3620642|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3791470|NCT01844830|3620643|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3791471|NCT01844830|3620644|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791472|NCT01844830|3620642|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3791473|NCT01844830|3620643|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791474|NCT01844830|3620644|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3791475|NCT01844830|3620642|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3791476|NCT01844830|3620643|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3791477|NCT01844830|3620644|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791478|NCT01844830|3620642|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791479|NCT01844830|3620643|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791480|NCT01844830|3620644|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791481|NCT01844830|3620642|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3791482|NCT01844830|3620643|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3791483|NCT01844830|3620644|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3791484|NCT01844830|3620642|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3791485|NCT01844830|3620643|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3791486|NCT01844830|3620644|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3791487|NCT01844830|3620642|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3791488|NCT01844830|3620643|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3791489|NCT01844830|3620644|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3791490|NCT01844830|3620642|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3791491|NCT01844830|3620643|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3791492|NCT01844830|3620644|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3791493|NCT01844830|3620642|B3|||Age||years|Mean|8.2|8.2|Standard Deviation|4.1|4.1|||
3791494|NCT01844830|3620643|B2|||Age||years|Mean|8.1|8.1|Standard Deviation|3.8|3.8|||
3791495|NCT01844830|3620644|B1|||Age||years|Mean|8.3|8.3|Standard Deviation|4.2|4.2|||
3791496|NCT01844817|3620673|B3|United States||Region of Enrollment||participants|Number|132|132.0||||||
3791497|NCT01844817|3620674|B2|United States||Region of Enrollment||participants|Number|66|66.0||||||
3791498|NCT01844817|3620675|B1|United States||Region of Enrollment||participants|Number|66|66.0||||||
3791499|NCT01844817|3620673|B3|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3791500|NCT01844817|3620674|B2|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3791501|NCT01844817|3620675|B1|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3791502|NCT01844817|3620673|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|117|117.0||||||
3791503|NCT01844817|3620674|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|61|61.0||||||
3791504|NCT01844817|3620675|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|56|56.0||||||
3791505|NCT01844817|3620673|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3791506|NCT01844817|3620674|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3791507|NCT01844817|3620675|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3791508|NCT01844817|3620673|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3791509|NCT01844817|3620674|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3791510|NCT01844817|3620675|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3791511|NCT01844817|3620673|B3|||Age||years|Median|66|66.0|Full Range|||39.0|83.0|
3791512|NCT01844817|3620674|B2|||Age||years|Median|65.5|65.5|Full Range|||47.0|83.0|
3791513|NCT01844817|3620675|B1|||Age||years|Median|66.5|66.5|Full Range|||39.0|82.0|
3791514|NCT01844778|3620686|B4||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3791515|NCT01844778|3620687|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3791516|NCT01844778|3620688|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3791517|NCT01844778|3620689|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3791518|NCT01844778|3620686|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3791519|NCT01844778|3620687|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3791520|NCT01844778|3620688|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3791521|NCT01844778|3620689|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3791522|NCT01844778|3620686|B4|||Age||Years|Mean|27.6|27.6|Standard Deviation|8.40|8.4|||
3791523|NCT01844778|3620687|B3|||Age||Years|Mean|26.6|26.6|Standard Deviation|7.25|7.25|||
3791524|NCT01844778|3620688|B2|||Age||Years|Mean|28.4|28.4|Standard Deviation|9.86|9.86|||
3791525|NCT01844778|3620689|B1|||Age||Years|Mean|27.4|27.4|Standard Deviation|6.82|6.82|||
3791526|NCT01844765|3620715|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3791527|NCT01844765|3620716|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3791528|NCT01844765|3620717|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3791529|NCT01844765|3620715|B3|Native American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3791530|NCT01844765|3620716|B2|Native American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3791531|NCT01844765|3620717|B1|Native American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3791532|NCT01844765|3620715|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3791533|NCT01844765|3620716|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3791534|NCT01844765|3620717|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3791535|NCT01844765|3620715|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3791536|NCT01844765|3620716|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3791537|NCT01844765|3620717|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3791538|NCT01844765|3620715|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3791539|NCT01844765|3620716|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3791540|NCT01844765|3620717|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3791541|NCT01844765|3620715|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3791542|NCT01844765|3620716|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3791543|NCT01844765|3620717|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3791544|NCT01844765|3620715|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3791545|NCT01844765|3620716|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3791546|NCT01844765|3620717|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3791547|NCT01844765|3620715|B3|12 to < 18 years||Age, Customized||Participants|Count of Participants|40|40.0||||||
3791548|NCT01844765|3620716|B2|12 to < 18 years||Age, Customized||Participants|Count of Participants|19|19.0||||||
3791549|NCT01844765|3620717|B1|12 to < 18 years||Age, Customized||Participants|Count of Participants|21|21.0||||||
3791550|NCT01844765|3620715|B3|1 to < 12 years||Age, Customized||Participants|Count of Participants|18|18.0||||||
3791551|NCT01844765|3620716|B2|1 to < 12 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
3791552|NCT01844765|3620717|B1|1 to < 12 years||Age, Customized||Participants|Count of Participants|12|12.0||||||
3791553|NCT01844700|3620736|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
3791554|NCT01844700|3620737|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3791555|NCT01844700|3620738|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3791556|NCT01844700|3620736|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3791557|NCT01844700|3620737|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3791558|NCT01844700|3620738|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3791559|NCT01844700|3620736|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3791560|NCT01844700|3620737|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3791561|NCT01844700|3620738|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3791562|NCT01844700|3620736|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3791563|NCT01844700|3620737|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3791564|NCT01844700|3620738|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3791565|NCT01844700|3620736|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3791566|NCT01844700|3620737|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3791567|NCT01844700|3620738|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3791568|NCT01844700|3620736|B3||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
3791569|NCT01844700|3620737|B2||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3791570|NCT01844700|3620738|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3791571|NCT01844687|3620751|B1|||alcohol drinkers||participants|Number|14|14.0||||||
3791572|NCT01844687|3620751|B1|||tobacco cigarette smokers||participants|Number|18|18.0||||||
3791573|NCT01844687|3620751|B1|||cannabis cigarettes per day||cannabis cigarettes used per day|Mean|5.1|5.1|Standard Deviation|5.3|5.3|||
3791574|NCT01844687|3620751|B1|||cannabis use (number of days per week)||days per week|Mean|6.5|6.5|Standard Deviation|1.0|1.0|||
3791575|NCT01844687|3620751|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
3791576|NCT01844687|3620751|B1|mixed||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3791577|NCT01844687|3620751|B1|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3791578|NCT01844687|3620751|B1|Black||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3791579|NCT01844687|3620751|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3791580|NCT01844687|3620751|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3791581|NCT01844687|3620751|B1|||Age||years|Mean|29.1|29.1|Standard Deviation|9.1|9.1|||
3791582|NCT01844531|3620810|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3791583|NCT01844531|3620811|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3791584|NCT01844531|3620812|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3791585|NCT01844531|3620813|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3791586|NCT01844531|3620814|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3791587|NCT01844531|3620810|B5||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3791588|NCT01844531|3620811|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3791589|NCT01844531|3620812|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3791590|NCT01844531|3620813|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3791591|NCT01844531|3620814|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3791592|NCT01844531|3620810|B5|||Age||years|Mean|35.6|35.6|Standard Deviation|8.9|8.9|||
3791593|NCT01844531|3620811|B4|||Age||years|Mean|37.5|37.5|Standard Deviation|9.0|9.0|||
3791594|NCT01844531|3620812|B3|||Age||years|Mean|35.8|35.8|Standard Deviation|10.5|10.5|||
3791595|NCT01844531|3620813|B2|||Age||years|Mean|30.8|30.8|Standard Deviation|7.6|7.6|||
3791596|NCT01844531|3620814|B1|||Age||years|Mean|38.2|38.2|Standard Deviation|8.6|8.6|||
3791597|NCT01844518|3620847|B1|>=50 kg||Weight||participants|Number|81|81.0||||||
3791598|NCT01844518|3620847|B1|25 to 50 kg||Weight||participants|Number|74|74.0||||||
3791599|NCT01844518|3620847|B1|<25 kg||Weight||participants|Number|18|18.0||||||
3791600|NCT01844518|3620847|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3791601|NCT01844518|3620847|B1||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3791602|NCT01844518|3620847|B1|||Age||years|Median|13.0|13.0|Full Range|||6.0|17.0|
3791603|NCT01844505|3620861|B4|NOT REPORTED||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3791604|NCT01844505|3620862|B3|NOT REPORTED||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3791605|NCT01844505|3620863|B2|NOT REPORTED||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3791606|NCT01844505|3620864|B1|NOT REPORTED||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3791607|NCT01844505|3620861|B4|OTHER||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3791608|NCT01844505|3620862|B3|OTHER||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3791609|NCT01844505|3620863|B2|OTHER||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3791610|NCT01844505|3620864|B1|OTHER||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3791611|NCT01844505|3620861|B4|NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3791612|NCT01844505|3620862|B3|NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3791613|NCT01844505|3620863|B2|NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3791614|NCT01844505|3620864|B1|NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3791615|NCT01844505|3620861|B4|AMERICAN INDIAN OR ALASKA NATIVE||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3791616|NCT01844505|3620862|B3|AMERICAN INDIAN OR ALASKA NATIVE||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3791617|NCT01844505|3620863|B2|AMERICAN INDIAN OR ALASKA NATIVE||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3791618|NCT01844505|3620864|B1|AMERICAN INDIAN OR ALASKA NATIVE||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3791619|NCT01844505|3620861|B4|ASIAN||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3791620|NCT01844505|3620862|B3|ASIAN||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3791621|NCT01844505|3620863|B2|ASIAN||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3791622|NCT01844505|3620864|B1|ASIAN||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3791623|NCT01844505|3620861|B4|BLACK OR AFRICAN AMERICAN||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3791624|NCT01844505|3620862|B3|BLACK OR AFRICAN AMERICAN||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3791625|NCT01844505|3620863|B2|BLACK OR AFRICAN AMERICAN||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3791626|NCT01844505|3620864|B1|BLACK OR AFRICAN AMERICAN||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3791627|NCT01844505|3620861|B4|WHITE||Race/Ethnicity, Customized||Participants|Count of Participants|921|921.0||||||
3791628|NCT01844505|3620862|B3|WHITE||Race/Ethnicity, Customized||Participants|Count of Participants|303|303.0||||||
3791629|NCT01844505|3620863|B2|WHITE||Race/Ethnicity, Customized||Participants|Count of Participants|310|310.0||||||
3791630|NCT01844505|3620864|B1|WHITE||Race/Ethnicity, Customized||Participants|Count of Participants|308|308.0||||||
3791631|NCT01844505|3620861|B4||Male|Sex: Female, Male||Participants|Count of Participants|610|610.0||||||
3791632|NCT01844505|3620862|B3||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3791633|NCT01844505|3620863|B2||Male|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
3791634|NCT01844505|3620864|B1||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3791635|NCT01844505|3620861|B4||Female|Sex: Female, Male||Participants|Count of Participants|335|335.0||||||
3791636|NCT01844505|3620862|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3791637|NCT01844505|3620863|B2||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3791638|NCT01844505|3620864|B1||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3791639|NCT01844505|3620861|B4|>=75 years||Age, Customized||Participants|Count of Participants|118|118.0||||||
3791640|NCT01844505|3620862|B3|>=75 years||Age, Customized||Participants|Count of Participants|44|44.0||||||
3791641|NCT01844505|3620863|B2|>=75 years||Age, Customized||Participants|Count of Participants|35|35.0||||||
3791642|NCT01844505|3620864|B1|>=75 years||Age, Customized||Participants|Count of Participants|39|39.0||||||
3791643|NCT01844505|3620861|B4|>= 65 and < 75 years||Age, Customized||Participants|Count of Participants|262|262.0||||||
3791644|NCT01844505|3620862|B3|>= 65 and < 75 years||Age, Customized||Participants|Count of Participants|89|89.0||||||
3791645|NCT01844505|3620863|B2|>= 65 and < 75 years||Age, Customized||Participants|Count of Participants|94|94.0||||||
3791646|NCT01844505|3620864|B1|>= 65 and < 75 years||Age, Customized||Participants|Count of Participants|79|79.0||||||
3791647|NCT01844505|3620861|B4|< 65 years||Age, Customized||Participants|Count of Participants|565|565.0||||||
3791648|NCT01844505|3620862|B3|< 65 years||Age, Customized||Participants|Count of Participants|182|182.0||||||
3791649|NCT01844505|3620863|B2|< 65 years||Age, Customized||Participants|Count of Participants|185|185.0||||||
3791650|NCT01844505|3620864|B1|< 65 years||Age, Customized||Participants|Count of Participants|198|198.0||||||
3791651|NCT01844505|3620861|B4|||Age||years|Mean|59.6|59.6|Standard Deviation|13.69|13.69|||
3791652|NCT01844505|3620862|B3|||Age||years|Mean|60.8|60.8|Standard Deviation|13.23|13.23|||
3791653|NCT01844505|3620863|B2|||Age||years|Mean|59.3|59.3|Standard Deviation|13.86|13.86|||
3791654|NCT01844505|3620864|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|13.92|13.92|||
3791655|NCT01844479|3620916|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3791656|NCT01844479|3620916|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3791657|NCT01844479|3620916|B1|||Age||years|Mean|65.1|65.1|Full Range|||38.0|79.0|
3791658|NCT01844388|3620945|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3791659|NCT01844388|3620946|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3791660|NCT01844388|3620947|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3791661|NCT01844388|3620945|B3||Female|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
3791662|NCT01844388|3620946|B2||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3791663|NCT01844388|3620947|B1||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3791664|NCT01844388|3620945|B3|≥40 years||Age, Customized||participants|Number|105|105.0||||||
3791665|NCT01844388|3620946|B2|≥40 years||Age, Customized||participants|Number|31|31.0||||||
3791666|NCT01844388|3620947|B1|≥40 years||Age, Customized||participants|Number|74|74.0||||||
3791667|NCT01844388|3620945|B3|<40 years||Age, Customized||participants|Number|260|260.0||||||
3791668|NCT01844388|3620946|B2|<40 years||Age, Customized||participants|Number|90|90.0||||||
3791669|NCT01844388|3620947|B1|<40 years||Age, Customized||participants|Number|170|170.0||||||
3791670|NCT01844206|3620958|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3791671|NCT01844206|3620959|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3791672|NCT01844206|3620960|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3791673|NCT01844206|3620958|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3791674|NCT01844206|3620959|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3791675|NCT01844206|3620960|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3791676|NCT01844206|3620958|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791677|NCT01844206|3620959|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791678|NCT01844206|3620960|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791679|NCT01844206|3620958|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791680|NCT01844206|3620959|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791681|NCT01844206|3620960|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791682|NCT01844206|3620958|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3791683|NCT01844206|3620959|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3791684|NCT01844206|3620960|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3791685|NCT01844206|3620958|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3791686|NCT01844206|3620959|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3791687|NCT01844206|3620960|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3791688|NCT01844206|3620958|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3791689|NCT01844206|3620959|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3791690|NCT01844206|3620960|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3791691|NCT01844206|3620958|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3791692|NCT01844206|3620959|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3791693|NCT01844206|3620960|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3791694|NCT01844206|3620958|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3791695|NCT01844206|3620959|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3791696|NCT01844206|3620960|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3791697|NCT01843972|3620967|B11||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3791698|NCT01843972|3620968|B10||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3791699|NCT01843972|3620969|B9||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3791700|NCT01843972|3620970|B8||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3791701|NCT01843972|3620971|B7||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3791702|NCT01843972|3620972|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3791703|NCT01843972|3620973|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3791704|NCT01843972|3620974|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3791705|NCT01843972|3620975|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3791706|NCT01843972|3620976|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3791707|NCT01843972|3620977|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3791708|NCT01843972|3620967|B11||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3791709|NCT01843972|3620968|B10||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3791710|NCT01843972|3620969|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3791711|NCT01843972|3620970|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3791712|NCT01843972|3620971|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3791713|NCT01843972|3620972|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3791714|NCT01843972|3620973|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3791715|NCT01843972|3620974|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3791716|NCT01843972|3620975|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3791717|NCT01843972|3620976|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3791718|NCT01843972|3620977|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3791719|NCT01843972|3620967|B11|||Age||years|Mean|31.8|31.8|Standard Deviation|8.3|8.3|||
3791720|NCT01843972|3620968|B10|||Age||years|Mean|35.8|35.8|Standard Deviation|10.2|10.2|||
3791721|NCT01843972|3620969|B9|||Age||years|Mean|32.2|32.2|Standard Deviation|9.3|9.3|||
3791722|NCT01843972|3620970|B8|||Age||years|Mean|30.2|30.2|Standard Deviation|8.0|8.0|||
3791723|NCT01843972|3620971|B7|||Age||years|Mean|29.2|29.2|Standard Deviation|2.6|2.6|||
3791724|NCT01843972|3620972|B6|||Age||years|Mean|37.5|37.5|Standard Deviation|6.0|6.0|||
3791725|NCT01843972|3620973|B5|||Age||years|Mean|26.5|26.5|Standard Deviation|5.2|5.2|||
3791726|NCT01843972|3620974|B4|||Age||years|Mean|34.5|34.5|Standard Deviation|6.8|6.8|||
3791727|NCT01843972|3620975|B3|||Age||years|Mean|32.0|32.0|Standard Deviation|8.4|8.4|||
3791728|NCT01843972|3620976|B2|||Age||years|Mean|31.2|31.2|Standard Deviation|8.0|8.0|||
3791729|NCT01843972|3620977|B1|||Age||years|Mean|28.3|28.3|Standard Deviation|8.2|8.2|||
3791730|NCT01843933|3621054|B3|Other||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
3791731|NCT01843933|3621055|B2|Other||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3791732|NCT01843933|3621056|B1|Other||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3791733|NCT01843933|3621054|B3|Black||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
3791734|NCT01843933|3621055|B2|Black||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3791735|NCT01843933|3621056|B1|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3791736|NCT01843933|3621054|B3|White||Race/Ethnicity, Customized||participants|Number|125|125.0||||||
3791737|NCT01843933|3621055|B2|White||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
3791738|NCT01843933|3621056|B1|White||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
3791739|NCT01843933|3621054|B3||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3791740|NCT01843933|3621055|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3791741|NCT01843933|3621056|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3791742|NCT01843933|3621054|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3791743|NCT01843933|3621055|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3791744|NCT01843933|3621056|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3791745|NCT01843933|3621054|B3|||Age||years|Mean|10.2|10.2|Standard Deviation|5.3|5.3|||
3791746|NCT01843933|3621055|B2|||Age||years|Mean|10.1|10.1|Standard Deviation|5.4|5.4|||
3791747|NCT01843933|3621056|B1|||Age||years|Mean|10.4|10.4|Standard Deviation|5.1|5.1|||
3791748|NCT01843920|3621063|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
3791749|NCT01843920|3621064|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3791750|NCT01843920|3621065|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3791751|NCT01843920|3621063|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3791752|NCT01843920|3621064|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3791753|NCT01843920|3621065|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3791754|NCT01843920|3621063|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3791755|NCT01843920|3621064|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3791756|NCT01843920|3621065|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3791757|NCT01843920|3621063|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3791758|NCT01843920|3621064|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3791759|NCT01843920|3621065|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3791760|NCT01843920|3621063|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3791761|NCT01843920|3621064|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3791762|NCT01843920|3621065|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3791763|NCT01843920|3621063|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3791764|NCT01843920|3621064|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3791765|NCT01843920|3621065|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3791766|NCT01843842|3621074|B3|Russia||Region of Enrollment||Participants|Count of Participants|306|306.0||||||
3791767|NCT01843842|3621075|B2|Russia||Region of Enrollment||Participants|Count of Participants|152|152.0||||||
3791768|NCT01843842|3621076|B1|Russia||Region of Enrollment||Participants|Count of Participants|154|154.0||||||
3791769|NCT01843842|3621074|B3||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
3791770|NCT01843842|3621075|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3791771|NCT01843842|3621076|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3791772|NCT01843842|3621074|B3||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3791773|NCT01843842|3621075|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3791774|NCT01843842|3621076|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3791775|NCT01843842|3621074|B3|||Age||years|Mean|10.0|10.0|Standard Deviation|4.1|4.1|||
3791776|NCT01843842|3621075|B2|||Age||years|Mean|10.2|10.2|Standard Deviation|4.2|4.2|||
3791777|NCT01843842|3621076|B1|||Age||years|Mean|9.8|9.8|Standard Deviation|4.1|4.1|||
3791778|NCT01843777|3621097|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3791779|NCT01843777|3621098|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3791780|NCT01843777|3621099|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3791781|NCT01843777|3621097|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3791782|NCT01843777|3621098|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3791783|NCT01843777|3621099|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3791784|NCT01843777|3621097|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3791785|NCT01843777|3621098|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3791786|NCT01843777|3621099|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3791787|NCT01843777|3621097|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3791788|NCT01843777|3621098|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3791789|NCT01843777|3621099|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3791790|NCT01843777|3621097|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3791791|NCT01843777|3621098|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3791792|NCT01843777|3621099|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3791793|NCT01843777|3621097|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3791794|NCT01843777|3621098|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3791795|NCT01843777|3621099|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3791796|NCT01843673|3621108|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3791797|NCT01843673|3621108|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3791798|NCT01843673|3621108|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791799|NCT01843673|3621108|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3791800|NCT01843673|3621108|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3791801|NCT01843673|3621108|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791802|NCT01843673|3621108|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791803|NCT01843673|3621108|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791804|NCT01843673|3621108|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791805|NCT01843673|3621108|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3791806|NCT01843673|3621108|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791807|NCT01843673|3621108|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3791808|NCT01843673|3621108|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3791809|NCT01843673|3621108|B1|||Age||years|Mean|63|63.0|Standard Deviation|10|10.0|||
3791810|NCT01843673|3621108|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3791811|NCT01843673|3621108|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3791812|NCT01843673|3621108|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3791813|NCT01843660|3621120|B1||Male|Sex: Female, Male||Participants|Count of Participants|542|542.0||||||
3791814|NCT01843660|3621120|B1||Female|Sex: Female, Male||Participants|Count of Participants|493|493.0||||||
3791815|NCT01843660|3621120|B1|||Age||Years|Mean|42.43|42.43|Standard Deviation|12.34|12.34|||
3791816|NCT01843621|3621138|B1|Thailand||Region of Enrollment||participants|Number|7|7.0||||||
3791817|NCT01843621|3621138|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3791818|NCT01843621|3621138|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3791819|NCT01843621|3621138|B1|||Age||years|Mean|8.3|8.3|Standard Deviation|0.49|0.49|||
3791820|NCT01843465|3621155|B1|France||Region of Enrollment||participants|Number|34|34.0||||||
3791821|NCT01843465|3621155|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3791822|NCT01843465|3621155|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3791823|NCT01843465|3621155|B1|||Age||years|Mean|59.5|59.5|Standard Deviation|12.5|12.5|||
3791824|NCT01843465|3621155|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3791825|NCT01843465|3621155|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3791826|NCT01843465|3621155|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3791827|NCT01843374|3621159|B3||Male|Sex: Female, Male||Participants|Count of Participants|434|434.0||||||
3791828|NCT01843374|3621160|B2||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3791829|NCT01843374|3621161|B1||Male|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
3791830|NCT01843374|3621159|B3||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3791831|NCT01843374|3621160|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3791832|NCT01843374|3621161|B1||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3791833|NCT01843374|3621159|B3||>= 65 years|Age, Customized||Participants|Count of Participants|334|334.0||||||
3791834|NCT01843374|3621160|B2||>= 65 years|Age, Customized||Participants|Count of Participants|114|114.0||||||
3791835|NCT01843374|3621161|B1||>= 65 years|Age, Customized||Participants|Count of Participants|220|220.0||||||
3791836|NCT01843374|3621159|B3||< 65 years|Age, Customized||Participants|Count of Participants|237|237.0||||||
3791837|NCT01843374|3621160|B2||< 65 years|Age, Customized||Participants|Count of Participants|75|75.0||||||
3791838|NCT01843374|3621161|B1||< 65 years|Age, Customized||Participants|Count of Participants|162|162.0||||||
3791839|NCT01843374|3621159|B3|||Age||Years|Mean|65.6|65.6|Standard Deviation|9.10|9.1|28.0|87.0|
3791840|NCT01843374|3621160|B2|||Age||Years|Mean|66.3|66.3|Standard Deviation|8.8|8.8|||
3791841|NCT01843374|3621161|B1|||Age||Years|Mean|65.2|65.2|Standard Deviation|9.24|9.24|28.0|87.0|
3791842|NCT01843348|3621186|B4||Male|Sex: Female, Male||Participants|Count of Participants|411|411.0||||||
3791843|NCT01843348|3621187|B3||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3791844|NCT01843348|3621188|B2||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3791845|NCT01843348|3621189|B1||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3791846|NCT01843348|3621186|B4||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3791847|NCT01843348|3621187|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3791848|NCT01843348|3621188|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3791849|NCT01843348|3621189|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3791850|NCT01843348|3621186|B4|||Age||years|Mean|54.9|54.9|Standard Deviation|12.74|12.74|||
3791851|NCT01843348|3621187|B3|||Age||years|Mean|55.1|55.1|Standard Deviation|12.61|12.61|||
3791852|NCT01843348|3621188|B2|||Age||years|Mean|54.3|54.3|Standard Deviation|13.50|13.5|||
3791853|NCT01843348|3621189|B1|||Age||years|Mean|55.3|55.3|Standard Deviation|12.09|12.09|||
3791854|NCT01843205|3621231|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3791855|NCT01843205|3621231|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791856|NCT01843205|3621231|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3791857|NCT01843205|3621231|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3791858|NCT01843205|3621231|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3791859|NCT01843205|3621231|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791860|NCT01843205|3621231|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791861|NCT01843205|3621231|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791862|NCT01843205|3621231|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791863|NCT01843205|3621231|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3791864|NCT01843205|3621231|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3791865|NCT01843205|3621231|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3791866|NCT01843205|3621231|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3791867|NCT01843205|3621231|B1|||Age||years|Mean|40.5|40.5|Standard Deviation|5.7|5.7|||
3791868|NCT01843192|3621290|B4|United States||Region of Enrollment||participants|Number|61|61.0||||||
3791869|NCT01843192|3621291|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
3791870|NCT01843192|3621292|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
3791871|NCT01843192|3621293|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3791872|NCT01843192|3621290|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791873|NCT01843192|3621291|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791874|NCT01843192|3621292|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791875|NCT01843192|3621293|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791876|NCT01843192|3621290|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791877|NCT01843192|3621291|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791878|NCT01843192|3621292|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791879|NCT01843192|3621293|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791880|NCT01843192|3621290|B4||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3791881|NCT01843192|3621291|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3791882|NCT01843192|3621292|B2||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3791883|NCT01843192|3621293|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3791884|NCT01843192|3621290|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3791885|NCT01843192|3621291|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791886|NCT01843192|3621292|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791887|NCT01843192|3621293|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3791888|NCT01843192|3621290|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791889|NCT01843192|3621291|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791890|NCT01843192|3621292|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791891|NCT01843192|3621293|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791892|NCT01843192|3621290|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3791893|NCT01843192|3621291|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791894|NCT01843192|3621292|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3791895|NCT01843192|3621293|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791896|NCT01843192|3621290|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791897|NCT01843192|3621291|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791898|NCT01843192|3621292|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791899|NCT01843192|3621293|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791900|NCT01843192|3621290|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791901|NCT01843192|3621291|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791902|NCT01843192|3621292|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791903|NCT01843192|3621293|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791904|NCT01843192|3621290|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3791905|NCT01843192|3621291|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3791906|NCT01843192|3621292|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3791907|NCT01843192|3621293|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3791908|NCT01843192|3621290|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791909|NCT01843192|3621291|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791910|NCT01843192|3621292|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791911|NCT01843192|3621293|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791912|NCT01843192|3621290|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3791913|NCT01843192|3621291|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3791914|NCT01843192|3621292|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3791915|NCT01843192|3621293|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3791916|NCT01843192|3621290|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3791917|NCT01843192|3621291|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3791918|NCT01843192|3621292|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3791919|NCT01843192|3621293|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3791920|NCT01843192|3621290|B4|||Age||years|Mean|66.3|66.3|Standard Deviation|8.51|8.51|||
3791921|NCT01843192|3621291|B3|||Age||years|Mean|68.7|68.7|Standard Deviation|5.72|5.72|||
3791922|NCT01843192|3621292|B2|||Age||years|Mean|68.1|68.1|Standard Deviation|7.26|7.26|||
3791923|NCT01843192|3621293|B1|||Age||years|Mean|63.3|63.3|Standard Deviation|10.02|10.02|||
3791924|NCT01842958|3621324|B3|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3791925|NCT01842958|3621325|B2|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3791926|NCT01842958|3621326|B1|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3791927|NCT01842958|3621324|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3791928|NCT01842958|3621325|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791929|NCT01842958|3621326|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3791930|NCT01842958|3621324|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791931|NCT01842958|3621325|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791932|NCT01842958|3621326|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791933|NCT01842958|3621324|B3||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3791934|NCT01842958|3621325|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3791935|NCT01842958|3621326|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3791936|NCT01842958|3621324|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3791937|NCT01842958|3621325|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3791938|NCT01842958|3621326|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3792055|NCT01842607|3621468|B1|||Age||Years|Mean|51.1|51.1|Standard Deviation|13.87|13.87|||
3791939|NCT01842958|3621324|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791940|NCT01842958|3621325|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791941|NCT01842958|3621326|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791942|NCT01842958|3621324|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3791943|NCT01842958|3621325|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3791944|NCT01842958|3621326|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3791945|NCT01842958|3621324|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791946|NCT01842958|3621325|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791947|NCT01842958|3621326|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791948|NCT01842958|3621324|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791949|NCT01842958|3621325|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791950|NCT01842958|3621326|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791951|NCT01842958|3621324|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3791952|NCT01842958|3621325|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3791953|NCT01842958|3621326|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3791954|NCT01842958|3621324|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3791955|NCT01842958|3621325|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3791956|NCT01842958|3621326|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3791957|NCT01842958|3621324|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3791958|NCT01842958|3621325|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3791959|NCT01842958|3621326|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3791960|NCT01842958|3621324|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3791961|NCT01842958|3621325|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3791962|NCT01842958|3621326|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3791963|NCT01842958|3621324|B3|||Age||years|Mean|51.2|51.2|Standard Deviation|14.04|14.04|||
3791964|NCT01842958|3621325|B2|||Age||years|Mean|49.6|49.6|Standard Deviation|14.20|14.2|||
3791965|NCT01842958|3621326|B1|||Age||years|Mean|52.9|52.9|Standard Deviation|13.96|13.96|||
3791966|NCT01842906|3621345|B3|Nepal||Region of Enrollment||participants|Number|219|219.0||||||
3791967|NCT01842906|3621346|B2|Nepal||Region of Enrollment||participants|Number|104|104.0||||||
3791968|NCT01842906|3621347|B1|Nepal||Region of Enrollment||participants|Number|115|115.0||||||
3791969|NCT01842906|3621345|B3||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3791970|NCT01842906|3621346|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3791971|NCT01842906|3621347|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3791972|NCT01842906|3621345|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3791973|NCT01842906|3621346|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3791974|NCT01842906|3621347|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3791975|NCT01842906|3621345|B3|||Age||years|Mean|38|38.0|Standard Deviation|7|7.0|||
3791976|NCT01842906|3621346|B2|||Age||years|Mean|37|37.0|Standard Deviation|8|8.0|||
3791977|NCT01842906|3621347|B1|||Age||years|Mean|39|39.0|Standard Deviation|6|6.0|||
3791978|NCT01842841|3621360|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3791979|NCT01842841|3621360|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3791980|NCT01842841|3621360|B1|||Age|Age at the time of first dose in the current study (Week 53)|years|Mean|22.20|22.2|Standard Deviation|11.946|11.946|||
3791981|NCT01842789|3621379|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3791982|NCT01842789|3621380|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3791983|NCT01842789|3621381|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3791984|NCT01842789|3621379|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3791985|NCT01842789|3621380|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3791986|NCT01842789|3621381|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3791987|NCT01842789|3621379|B3|||Age||Years|Mean|42.7|42.7|Full Range|||28.5|52.9|
3791988|NCT01842789|3621380|B2|||Age||Years|Mean|43.9|43.9|Full Range|||31.2|52.9|
3791989|NCT01842789|3621381|B1|||Age||Years|Mean|41.8|41.8|Full Range|||28.5|49.6|
3791990|NCT01842646|3621391|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3791991|NCT01842646|3621391|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3791992|NCT01842646|3621391|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3791993|NCT01842646|3621391|B1|||Age||years|Median|75|75.0|Full Range|||55.0|88.0|
3791994|NCT01842646|3621391|B1||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
3791995|NCT01842646|3621391|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3791996|NCT01842646|3621391|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3791997|NCT01842633|3621399|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792056|NCT01842594|3621487|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3791998|NCT01842633|3621400|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3791999|NCT01842633|3621401|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792000|NCT01842633|3621402|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792001|NCT01842633|3621399|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3792002|NCT01842633|3621400|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792003|NCT01842633|3621401|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3792004|NCT01842633|3621402|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3792005|NCT01842633|3621399|B4||White|Race (NIH/OMB)||Participants|Count of Participants|139|139.0||||||
3792006|NCT01842633|3621400|B3||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3792007|NCT01842633|3621401|B2||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3792008|NCT01842633|3621402|B1||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3792009|NCT01842633|3621399|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3792010|NCT01842633|3621400|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3792011|NCT01842633|3621401|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3792012|NCT01842633|3621402|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3792013|NCT01842633|3621399|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792014|NCT01842633|3621400|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792015|NCT01842633|3621401|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792016|NCT01842633|3621402|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792017|NCT01842633|3621399|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3792018|NCT01842633|3621400|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3792019|NCT01842633|3621401|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792020|NCT01842633|3621402|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3792021|NCT01842633|3621399|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792022|NCT01842633|3621400|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792023|NCT01842633|3621401|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792024|NCT01842633|3621402|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792025|NCT01842633|3621399|B4||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3792026|NCT01842633|3621400|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3792027|NCT01842633|3621401|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3792028|NCT01842633|3621402|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3792029|NCT01842633|3621399|B4||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3792030|NCT01842633|3621400|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3792031|NCT01842633|3621401|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3792032|NCT01842633|3621402|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3792033|NCT01842633|3621399|B4|||Age||Years|Mean|38.9|38.9|Standard Deviation|12.32|12.32|||
3792034|NCT01842633|3621400|B3|||Age||Years|Mean|38.5|38.5|Standard Deviation|12.65|12.65|||
3792035|NCT01842633|3621401|B2|||Age||Years|Mean|38.1|38.1|Standard Deviation|13.13|13.13|||
3792036|NCT01842633|3621402|B1|||Age||Years|Mean|39.9|39.9|Standard Deviation|11.39|11.39|||
3792037|NCT01842620|3621451|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792038|NCT01842620|3621451|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792039|NCT01842620|3621451|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3792040|NCT01842620|3621451|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3792041|NCT01842620|3621451|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3792042|NCT01842620|3621451|B1|||Age||Years|Mean|27.8|27.8|Standard Deviation|7.7|7.7|||
3792043|NCT01842607|3621468|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3792044|NCT01842607|3621468|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|517|517.0||||||
3792045|NCT01842607|3621468|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
3792046|NCT01842607|3621468|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3792047|NCT01842607|3621468|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3792048|NCT01842607|3621468|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|45|45.0||||||
3792049|NCT01842607|3621468|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|44|44.0||||||
3792050|NCT01842607|3621468|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3792051|NCT01842607|3621468|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3792052|NCT01842607|3621468|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3792053|NCT01842607|3621468|B1||Male|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
3792054|NCT01842607|3621468|B1||Female|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
3792057|NCT01842594|3621487|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3792058|NCT01842594|3621487|B1|||Age||years|Median|63|63.0|Full Range|||17.0|80.0|
3792059|NCT01842464|3621492|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3792060|NCT01842464|3621492|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3792061|NCT01842464|3621492|B1|||Age||years|Mean|62.4|62.4|Standard Deviation|7.75|7.75|||
3792062|NCT01842464|3621492|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3792063|NCT01842464|3621492|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3792064|NCT01842464|3621492|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3792065|NCT01842438|3621498|B3|||EPIC sexual bother subscale (prostate-specific quality of life)|Higher scores indicate better outcomes (better functioning; less bother). This measure was only completed by patients (all of whom were male).|units on a scale|Mean|22.28|22.28|Full Range|||0.0|62.5|
3792066|NCT01842438|3621499|B2|||EPIC sexual bother subscale (prostate-specific quality of life)|Higher scores indicate better outcomes (better functioning; less bother). This measure was only completed by patients (all of whom were male).|units on a scale|Mean|20.45|20.45|Full Range|||0.0|62.5|
3792067|NCT01842438|3621500|B1|||EPIC sexual bother subscale (prostate-specific quality of life)|Higher scores indicate better outcomes (better functioning; less bother). This measure was only completed by patients (all of whom were male).|units on a scale|Mean|24.11|24.11|Full Range|||0.0|62.5|
3792068|NCT01842438|3621498|B3|United Kingdom||Region of Enrollment||participants|Number|86|86.0||||||
3792069|NCT01842438|3621499|B2|United Kingdom||Region of Enrollment||participants|Number|44|44.0||||||
3792070|NCT01842438|3621500|B1|United Kingdom||Region of Enrollment||participants|Number|42|42.0||||||
3792071|NCT01842438|3621498|B3|Female||Sex/Gender, Customized||participants|Number|42|42.0||||||
3792072|NCT01842438|3621499|B2|Female||Sex/Gender, Customized||participants|Number|22|22.0||||||
3792073|NCT01842438|3621500|B1|Female||Sex/Gender, Customized||participants|Number|20|20.0||||||
3792074|NCT01842438|3621498|B3|Male||Sex/Gender, Customized||participants|Number|44|44.0||||||
3792075|NCT01842438|3621499|B2|Male||Sex/Gender, Customized||participants|Number|22|22.0||||||
3792076|NCT01842438|3621500|B1|Male||Sex/Gender, Customized||participants|Number|22|22.0||||||
3792077|NCT01842438|3621498|B3|||Age|Data was collected only for patient participants (all of whom were male)|years|Mean|63.72|63.72|Standard Deviation|7.772|7.772|||
3792078|NCT01842438|3621499|B2|||Age|Data was collected only for patient participants (all of whom were male)|years|Mean|63.27|63.27|Standard Deviation|8.800|8.8|||
3792079|NCT01842438|3621500|B1|||Age|Data was collected only for patient participants (all of whom were male)|years|Mean|64.15|64.15|Standard Deviation|6.885|6.885|||
3792080|NCT01842334|3621513|B3|||Baseline Cigs/Day||cigarettes/day|Mean|13.04|13.04|Standard Deviation|1.97|1.97|||
3792081|NCT01842334|3621514|B2|||Baseline Cigs/Day||cigarettes/day|Mean|12.87|12.87|Standard Deviation|2.01|2.01|||
3792082|NCT01842334|3621515|B1|||Baseline Cigs/Day||cigarettes/day|Mean|13.34|13.34|Standard Deviation|2.18|2.18|||
3792083|NCT01842334|3621513|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792084|NCT01842334|3621514|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792085|NCT01842334|3621515|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792086|NCT01842334|3621513|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792087|NCT01842334|3621514|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792088|NCT01842334|3621515|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792089|NCT01842334|3621513|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3792090|NCT01842334|3621514|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3792091|NCT01842334|3621515|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3792092|NCT01842334|3621513|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3792093|NCT01842334|3621514|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3792094|NCT01842334|3621515|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3792095|NCT01842334|3621513|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792096|NCT01842334|3621514|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792097|NCT01842334|3621515|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792098|NCT01842334|3621513|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792099|NCT01842334|3621514|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792100|NCT01842334|3621515|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792101|NCT01842334|3621513|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792102|NCT01842334|3621514|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792103|NCT01842334|3621515|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792104|NCT01842334|3621513|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3792105|NCT01842334|3621514|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3792106|NCT01842334|3621515|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3792107|NCT01842334|3621513|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3792108|NCT01842334|3621514|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3792109|NCT01842334|3621515|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3792110|NCT01842334|3621513|B3|||Age||years|Mean|35.58|35.58|Standard Deviation|13.34|13.34|||
3792111|NCT01842334|3621514|B2|||Age||years|Mean|39.57|39.57|Standard Deviation|15.79|15.79|||
3792112|NCT01842334|3621515|B1|||Age||years|Mean|30|30.0|Standard Deviation|6.96|6.96|||
3792113|NCT01841970|3621522|B1|Previous Treatment No||Previous Treatment Received (Y/N)||participants|Number|0|0.0||||||
3792114|NCT01841970|3621522|B1|Previous Treatment Yes||Previous Treatment Received (Y/N)||participants|Number|20|20.0||||||
3792115|NCT01841970|3621522|B1|Bleeding No||Bleeding (Y/N)||participants|Number|0|0.0||||||
3792116|NCT01841970|3621522|B1|Bleeding Yes||Bleeding (Y/N)||participants|Number|20|20.0||||||
3792117|NCT01841970|3621522|B1|Pain No||Pain (Y/N)||participants|Number|7|7.0||||||
3792118|NCT01841970|3621522|B1|Pain Yes||Pain (Y/N)||participants|Number|13|13.0||||||
3792119|NCT01841970|3621522|B1|Grade II||Hemorrhoid grade|Hemorrhoids as graded on a scale of I-IV, with I being least symptomatic. Grade I: Bleeding hemorrhoids which do not prolapse outside the anal canal • Grade II: Hemorrhoids which prolapse, usually with defecation, but retract spontaneously|participants|Number|13|13.0||||||
3792120|NCT01841970|3621522|B1|Grade I||Hemorrhoid grade|Hemorrhoids as graded on a scale of I-IV, with I being least symptomatic. Grade I: Bleeding hemorrhoids which do not prolapse outside the anal canal • Grade II: Hemorrhoids which prolapse, usually with defecation, but retract spontaneously|participants|Number|7|7.0||||||
3792121|NCT01841970|3621522|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3792122|NCT01841970|3621522|B1||Male|Gender||Participants|Count of Participants|9|9.0||||||
3792123|NCT01841970|3621522|B1||Female|Gender||Participants|Count of Participants|11|11.0||||||
3792124|NCT01841970|3621522|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|18.1|18.1|||
3792125|NCT01841931|3621538|B1|||Pain severity|Pain Severity measured with a numeric scale (0 to 10) - Brief Pain Inventory (BPI)|units on a scale|Mean|7|7.0|Full Range|||4.0|10.0|
3792126|NCT01841931|3621538|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3792127|NCT01841931|3621538|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3792128|NCT01841931|3621538|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3792129|NCT01841931|3621538|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3792130|NCT01841931|3621538|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3792131|NCT01841931|3621538|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3792132|NCT01841762|3621546|B1||Unknown or Not Reported|Race (NIH/OMB)|A total of 284 participants analyzed.|Participants|Count of Participants|0|0.0||||||
3792133|NCT01841762|3621546|B1||More than one race|Race (NIH/OMB)|A total of 284 participants analyzed.|Participants|Count of Participants|10|10.0||||||
3792134|NCT01841762|3621546|B1||White|Race (NIH/OMB)|A total of 284 participants analyzed.|Participants|Count of Participants|228|228.0||||||
3792135|NCT01841762|3621546|B1||Black or African American|Race (NIH/OMB)|A total of 284 participants analyzed.|Participants|Count of Participants|35|35.0||||||
3792136|NCT01841762|3621546|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|A total of 284 participants analyzed.|Participants|Count of Participants|1|1.0||||||
3792137|NCT01841762|3621546|B1||Asian|Race (NIH/OMB)|A total of 284 participants analyzed.|Participants|Count of Participants|8|8.0||||||
3792138|NCT01841762|3621546|B1||American Indian or Alaska Native|Race (NIH/OMB)|A total of 284 participants analyzed.|Participants|Count of Participants|2|2.0||||||
3792139|NCT01841762|3621546|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|A total of 284 participants analyzed.|Participants|Count of Participants|0|0.0||||||
3792140|NCT01841762|3621546|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|A total of 284 participants analyzed.|Participants|Count of Participants|257|257.0||||||
3792141|NCT01841762|3621546|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|A total of 284 participants analyzed.|Participants|Count of Participants|27|27.0||||||
3792142|NCT01841762|3621546|B1||Male|Sex: Female, Male|A total of 284 participants analyzed.|Participants|Count of Participants|61|61.0||||||
3792143|NCT01841762|3621546|B1||Female|Sex: Female, Male|A total of 284 participants analyzed.|Participants|Count of Participants|223|223.0||||||
3792144|NCT01841762|3621546|B1|||Age|Full Analysis Set of 284 patients.|Years|Mean|59.7|59.7|Inter-Quartile Range|||52.0|69.0|
3792145|NCT01841762|3621546|B1||>=65 years|Age|Age of patients reported.|Participants|Count of Participants|117|117.0||||||
3792146|NCT01841762|3621546|B1||Between 18 and 65 years|Age|Age of patients reported.|Participants|Count of Participants|167|167.0||||||
3792147|NCT01841762|3621546|B1||<=18 years|Age|Age of patients reported.|Participants|Count of Participants|0|0.0||||||
3792148|NCT01841697|3621554|B3|||Fasting plasma glucose (FPG)||mg/dL|Mean|157.0|157.0|Standard Deviation|34.4|34.4|||
3792149|NCT01841697|3621555|B2|||Fasting plasma glucose (FPG)||mg/dL|Mean|153.9|153.9|Standard Deviation|32.8|32.8|||
3792150|NCT01841697|3621556|B1|||Fasting plasma glucose (FPG)||mg/dL|Mean|160.1|160.1|Standard Deviation|35.7|35.7|||
3792151|NCT01841697|3621554|B3|||Hemoglobin A1c (A1C)||Percent|Mean|7.50|7.5|Standard Deviation|0.76|0.76|||
3792152|NCT01841697|3621555|B2|||Hemoglobin A1c (A1C)||Percent|Mean|7.49|7.49|Standard Deviation|0.74|0.74|||
3792153|NCT01841697|3621556|B1|||Hemoglobin A1c (A1C)||Percent|Mean|7.52|7.52|Standard Deviation|0.77|0.77|||
3792154|NCT01841697|3621554|B3||Male|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
3792155|NCT01841697|3621555|B2||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
3792156|NCT01841697|3621556|B1||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3792157|NCT01841697|3621554|B3||Female|Sex: Female, Male||Participants|Count of Participants|316|316.0||||||
3792158|NCT01841697|3621555|B2||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3792159|NCT01841697|3621556|B1||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3792160|NCT01841697|3621554|B3|||Age||Years|Mean|57.3|57.3|Standard Deviation|9.8|9.8|||
3792161|NCT01841697|3621555|B2|||Age||Years|Mean|57.6|57.6|Standard Deviation|9.8|9.8|||
3792162|NCT01841697|3621556|B1|||Age||Years|Mean|57.0|57.0|Standard Deviation|9.8|9.8|||
3792163|NCT01841632|3621573|B1|Germany||Region of Enrollment||participants|Number|3|3.0||||||
3792164|NCT01841632|3621573|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3792165|NCT01841632|3621573|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3792166|NCT01841632|3621573|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3792167|NCT01841632|3621573|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3792168|NCT01841632|3621573|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3792169|NCT01841619|3621578|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3792170|NCT01841619|3621578|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3792171|NCT01841619|3621578|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3792172|NCT01841619|3621578|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3792173|NCT01841619|3621578|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3792174|NCT01841606|3621586|B3|Canada||Region of Enrollment||participants|Number|52|52.0||||||
3792175|NCT01841606|3621587|B2|Canada||Region of Enrollment||participants|Number|27|27.0||||||
3792176|NCT01841606|3621588|B1|Canada||Region of Enrollment||participants|Number|25|25.0||||||
3792177|NCT01841606|3621586|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3792178|NCT01841606|3621587|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3792179|NCT01841606|3621588|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3792180|NCT01841606|3621586|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3792181|NCT01841606|3621587|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3792182|NCT01841606|3621588|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3792183|NCT01841606|3621586|B3|||Age||years|Mean|34.5|34.5|Standard Deviation|4.27|4.27|||
3792184|NCT01841606|3621587|B2|||Age||years|Mean|34.7|34.7|Standard Deviation|4.76|4.76|||
3792185|NCT01841606|3621588|B1|||Age||years|Mean|34.32|34.32|Standard Deviation|3.86|3.86|||
3792186|NCT01841593|3621595|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3792187|NCT01841593|3621596|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3792188|NCT01841593|3621597|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3792189|NCT01841593|3621595|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3792190|NCT01841593|3621596|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3792191|NCT01841593|3621597|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3792192|NCT01841593|3621595|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3792193|NCT01841593|3621596|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3792194|NCT01841593|3621597|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3792195|NCT01841593|3621595|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3792196|NCT01841593|3621596|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3792197|NCT01841593|3621597|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3792198|NCT01841593|3621595|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3792199|NCT01841593|3621596|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3792200|NCT01841593|3621597|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3792201|NCT01841567|3621614|B1|Germany||Region of Enrollment||participants|Number|60|60.0||||||
3792202|NCT01841567|3621614|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3792203|NCT01841567|3621614|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3792204|NCT01841567|3621614|B1|||Age||years|Mean|65.2|65.2|Standard Deviation|11.1|11.1|||
3792205|NCT01841216|3621619|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3792206|NCT01841216|3621620|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3792207|NCT01841216|3621621|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3792208|NCT01841216|3621619|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3792209|NCT01841216|3621620|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3792210|NCT01841216|3621621|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3792211|NCT01841216|3621619|B3|African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3792212|NCT01841216|3621620|B2|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3792213|NCT01841216|3621621|B1|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3792214|NCT01841216|3621619|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3792215|NCT01841216|3621620|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3792216|NCT01841216|3621621|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3792217|NCT01841216|3621619|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3792218|NCT01841216|3621620|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3792219|NCT01841216|3621621|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3792220|NCT01841216|3621619|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3792221|NCT01841216|3621620|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3792222|NCT01841216|3621621|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3792223|NCT01841216|3621619|B3|||Age||years|Mean|32.6|32.6|Full Range|||18.0|61.0|
3792224|NCT01841216|3621620|B2|||Age||years|Mean|29|29.0|Full Range|||18.0|47.0|
3792225|NCT01841216|3621621|B1|||Age||years|Mean|36.2|36.2|Full Range|||23.0|61.0|
3792226|NCT01841216|3621619|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3792227|NCT01841216|3621620|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3792228|NCT01841216|3621621|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3792229|NCT01841216|3621619|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3792230|NCT01841216|3621620|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3792231|NCT01841216|3621621|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3792232|NCT01841216|3621619|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3792233|NCT01841216|3621620|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3792234|NCT01841216|3621621|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3792235|NCT01841021|3621630|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3792236|NCT01841021|3621630|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3792237|NCT01841021|3621630|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
3792238|NCT01841021|3621630|B1|||Age||68|Mean|68|68.0|Full Range|||68.0|68.0|
3792239|NCT01841021|3621630|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3792240|NCT01841021|3621630|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3792241|NCT01841021|3621630|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3792242|NCT01840943|3621640|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3792243|NCT01840943|3621641|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3792244|NCT01840943|3621642|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3792245|NCT01840943|3621640|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3792246|NCT01840943|3621641|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3792247|NCT01840943|3621642|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3792248|NCT01840943|3621640|B3|||Age||years|Mean|54.0|54.0|Standard Deviation|6.96|6.96|||
3792249|NCT01840943|3621641|B2|||Age||years|Mean|51.6|51.6|Standard Deviation|8.32|8.32|||
3792250|NCT01840943|3621642|B1|||Age||years|Mean|56.1|56.1|Standard Deviation|4.97|4.97|||
3792251|NCT01840605|3621677|B3||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3792252|NCT01840605|3621678|B2||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3792253|NCT01840605|3621679|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3792254|NCT01840605|3621677|B3||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3792255|NCT01840605|3621678|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3792256|NCT01840605|3621679|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3792257|NCT01840605|3621677|B3|||Age||years|Mean|10.3|10.3|Standard Deviation|2.4|2.4|||
3792258|NCT01840605|3621678|B2|||Age||years|Mean|10.4|10.4|Standard Deviation|2.5|2.5|||
3792259|NCT01840605|3621679|B1|||Age||years|Mean|10.2|10.2|Standard Deviation|2.3|2.3|||
3792260|NCT01840410|3621692|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3792261|NCT01840410|3621693|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3792262|NCT01840410|3621694|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3792263|NCT01840410|3621692|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3792264|NCT01840410|3621693|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3792265|NCT01840410|3621694|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3792266|NCT01840410|3621692|B3|||Age||Years|Mean|53.7|53.7|Standard Deviation|15.85|15.85|||
3792267|NCT01840410|3621693|B2|||Age||Years|Mean|51.9|51.9|Standard Deviation|17.29|17.29|||
3792268|NCT01840410|3621694|B1|||Age||Years|Mean|54.6|54.6|Standard Deviation|15.07|15.07|||
3792269|NCT01840345|3621731|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792270|NCT01840345|3621731|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792271|NCT01840345|3621731|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3792272|NCT01840345|3621731|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3792273|NCT01840345|3621731|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792274|NCT01840345|3621731|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792275|NCT01840345|3621731|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792276|NCT01840345|3621731|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3792277|NCT01840345|3621731|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3792278|NCT01840345|3621731|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3792279|NCT01840345|3621731|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3792280|NCT01840345|3621731|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3792281|NCT01840319|3621738|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3792282|NCT01840319|3621738|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3792283|NCT01840319|3621738|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|15.4|15.4|||
3792284|NCT01840163|3621742|B3|||Number of participants leaning towards a treatment option and felt sure about choice||Participants|Count of Participants|353|353.0||||||
3792285|NCT01840163|3621743|B2|||Number of participants leaning towards a treatment option and felt sure about choice||Participants|Count of Participants|175|175.0||||||
3792286|NCT01840163|3621744|B1|||Number of participants leaning towards a treatment option and felt sure about choice||Participants|Count of Participants|178|178.0||||||
3792287|NCT01840163|3621742|B3|United States||Region of Enrollment||participants|Number|537|537.0||||||
3792288|NCT01840163|3621743|B2|United States||Region of Enrollment||participants|Number|270|270.0||||||
3792289|NCT01840163|3621744|B1|United States||Region of Enrollment||participants|Number|267|267.0||||||
3792290|NCT01840163|3621742|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3792291|NCT01840163|3621743|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3792292|NCT01840163|3621744|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3792293|NCT01840163|3621742|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3792294|NCT01840163|3621743|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3792295|NCT01840163|3621744|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792296|NCT01840163|3621742|B3||White|Race (NIH/OMB)||Participants|Count of Participants|425|425.0||||||
3792297|NCT01840163|3621743|B2||White|Race (NIH/OMB)||Participants|Count of Participants|214|214.0||||||
3792298|NCT01840163|3621744|B1||White|Race (NIH/OMB)||Participants|Count of Participants|211|211.0||||||
3792299|NCT01840163|3621742|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
3792300|NCT01840163|3621743|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3792301|NCT01840163|3621744|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3792302|NCT01840163|3621742|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792303|NCT01840163|3621743|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792304|NCT01840163|3621744|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792305|NCT01840163|3621742|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3792306|NCT01840163|3621743|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3792307|NCT01840163|3621744|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3792308|NCT01840163|3621742|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3792309|NCT01840163|3621743|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792310|NCT01840163|3621744|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3792311|NCT01840163|3621742|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792312|NCT01840163|3621743|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792313|NCT01840163|3621744|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792314|NCT01840163|3621742|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|529|529.0||||||
3792315|NCT01840163|3621743|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|265|265.0||||||
3792316|NCT01840163|3621744|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|264|264.0||||||
3792317|NCT01840163|3621742|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3792318|NCT01840163|3621743|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3792319|NCT01840163|3621744|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3792320|NCT01840163|3621742|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3792321|NCT01840163|3621743|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3792322|NCT01840163|3621744|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3792323|NCT01840163|3621742|B3||Female|Sex: Female, Male||Participants|Count of Participants|537|537.0||||||
3792324|NCT01840163|3621743|B2||Female|Sex: Female, Male||Participants|Count of Participants|270|270.0||||||
3792325|NCT01840163|3621744|B1||Female|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
3792326|NCT01840163|3621742|B3||>=65 years|Age||Participants|Count of Participants|121|121.0||||||
3792327|NCT01840163|3621743|B2||>=65 years|Age||Participants|Count of Participants|62|62.0||||||
3792328|NCT01840163|3621744|B1||>=65 years|Age||Participants|Count of Participants|59|59.0||||||
3792329|NCT01840163|3621742|B3||Between 18 and 65 years|Age||Participants|Count of Participants|416|416.0||||||
3792330|NCT01840163|3621743|B2||Between 18 and 65 years|Age||Participants|Count of Participants|208|208.0||||||
3792331|NCT01840163|3621744|B1||Between 18 and 65 years|Age||Participants|Count of Participants|208|208.0||||||
3792332|NCT01840163|3621742|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3792333|NCT01840163|3621743|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3792334|NCT01840163|3621744|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3792335|NCT01840072|3621765|B3|China||Region of Enrollment||participants|Number|4071|4071.0||||||
3792336|NCT01840072|3621766|B2|China||Region of Enrollment||participants|Number|2033|2033.0||||||
3792337|NCT01840072|3621767|B1|China||Region of Enrollment||participants|Number|2038|2038.0||||||
3792338|NCT01840072|3621765|B3|Asian||Race/Ethnicity, Customized||participants|Number|4071|4071.0||||||
3792339|NCT01840072|3621766|B2|Asian||Race/Ethnicity, Customized||participants|Number|2033|2033.0||||||
3792340|NCT01840072|3621767|B1|Asian||Race/Ethnicity, Customized||participants|Number|2038|2038.0||||||
3792341|NCT01840072|3621765|B3||Male|Sex: Female, Male||Participants|Count of Participants|1467|1467.0||||||
3792342|NCT01840072|3621766|B2||Male|Sex: Female, Male||Participants|Count of Participants|746|746.0||||||
3792343|NCT01840072|3621767|B1||Male|Sex: Female, Male||Participants|Count of Participants|721|721.0||||||
3792344|NCT01840072|3621765|B3||Female|Sex: Female, Male||Participants|Count of Participants|2604|2604.0||||||
3792345|NCT01840072|3621766|B2||Female|Sex: Female, Male||Participants|Count of Participants|1287|1287.0||||||
3792346|NCT01840072|3621767|B1||Female|Sex: Female, Male||Participants|Count of Participants|1317|1317.0||||||
3792347|NCT01840072|3621765|B3|||Age||years|Mean|62.0|62.0|Standard Deviation|10.9|10.9|||
3792348|NCT01840072|3621766|B2|||Age||years|Mean|61.8|61.8|Standard Deviation|11.0|11.0|||
3792349|NCT01840072|3621767|B1|||Age||years|Mean|62.1|62.1|Standard Deviation|10.8|10.8|||
3792350|NCT01839708|3621790|B3|United States||Region of Enrollment||participants|Number|569|569.0||||||
3792351|NCT01839708|3621791|B2|United States||Region of Enrollment||participants|Number|182|182.0||||||
3792352|NCT01839708|3621792|B1|United States||Region of Enrollment||participants|Number|387|387.0||||||
3792353|NCT01839708|3621790|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3792354|NCT01839708|3621791|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3792355|NCT01839708|3621792|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3792356|NCT01839708|3621790|B3||Female|Sex: Female, Male||Participants|Count of Participants|569|569.0||||||
3792357|NCT01839708|3621791|B2||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3792358|NCT01839708|3621792|B1||Female|Sex: Female, Male||Participants|Count of Participants|387|387.0||||||
3792359|NCT01839708|3621790|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3792360|NCT01839708|3621791|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3792361|NCT01839708|3621792|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3792362|NCT01839708|3621790|B3||Between 18 and 65 years|Age||Participants|Count of Participants|569|569.0||||||
3792363|NCT01839708|3621791|B2||Between 18 and 65 years|Age||Participants|Count of Participants|182|182.0||||||
3792364|NCT01839708|3621792|B1||Between 18 and 65 years|Age||Participants|Count of Participants|387|387.0||||||
3792365|NCT01839708|3621790|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3792366|NCT01839708|3621791|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3792367|NCT01839708|3621792|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3792368|NCT01839695|3621825|B1|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
3792369|NCT01839695|3621825|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3792370|NCT01839695|3621825|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3792371|NCT01839695|3621825|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792372|NCT01839695|3621825|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3792373|NCT01839695|3621825|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3792374|NCT01839695|3621825|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792375|NCT01839695|3621825|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792376|NCT01839695|3621825|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792377|NCT01839695|3621825|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3792378|NCT01839695|3621825|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3792379|NCT01839695|3621825|B1|||Age||years|Mean|72.89|72.89|Standard Deviation|7.61|7.61|||
3792380|NCT01839656|3621830|B3|||Mean CMAP Amplitude of the Ulnar Nerve at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|mV|Mean|0.501|0.501|Standard Deviation|0.786|0.786|||
3792381|NCT01839656|3621831|B2|||Mean CMAP Amplitude of the Ulnar Nerve at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|mV|Mean|0.532|0.532|Standard Deviation|0.878|0.878|||
3792382|NCT01839656|3621832|B1|||Mean CMAP Amplitude of the Ulnar Nerve at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|mV|Mean|0.372|0.372|Standard Deviation|0.177|0.177|||
3792383|NCT01839656|3621830|B3|||Mean Compound Muscle Action Potential (CMAP) Amplitude of the Peroneal Nerve at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|millivolts (mV)|Mean|0.549|0.549|Standard Deviation|0.626|0.626|||
3792384|NCT01839656|3621831|B2|||Mean Compound Muscle Action Potential (CMAP) Amplitude of the Peroneal Nerve at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|millivolts (mV)|Mean|0.518|0.518|Standard Deviation|0.664|0.664|||
3792385|NCT01839656|3621832|B1|||Mean Compound Muscle Action Potential (CMAP) Amplitude of the Peroneal Nerve at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|millivolts (mV)|Mean|0.673|0.673|Standard Deviation|0.501|0.501|||
3792386|NCT01839656|3621830|B3|||Mean CHOP INTEND Total Scores at Baseline|The CHOP-INTEND test includes 16 items structured to move from easiest to hardest with the grading including gravity eliminated (lower scores) to antigravity movements (higher scores). All item scores range from 0 (worst) to 4 (best). Total scores range from 0 to 64, with higher scores indicating better movement functioning. Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Units on a scale|Mean|30|30.0|Standard Deviation|11|11.0|||
3792387|NCT01839656|3621831|B2|||Mean CHOP INTEND Total Scores at Baseline|The CHOP-INTEND test includes 16 items structured to move from easiest to hardest with the grading including gravity eliminated (lower scores) to antigravity movements (higher scores). All item scores range from 0 (worst) to 4 (best). Total scores range from 0 to 64, with higher scores indicating better movement functioning. Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Units on a scale|Mean|30|30.0|Standard Deviation|12|12.0|||
3792415|NCT01839656|3621832|B1||Cruising (walks holding on)|HINE Walking Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792563|NCT01839604|3621858|B3||Female|Gender||Participants|Count of Participants|2|2.0||||||
3792388|NCT01839656|3621832|B1|||Mean CHOP INTEND Total Scores at Baseline|The CHOP-INTEND test includes 16 items structured to move from easiest to hardest with the grading including gravity eliminated (lower scores) to antigravity movements (higher scores). All item scores range from 0 (worst) to 4 (best). Total scores range from 0 to 64, with higher scores indicating better movement functioning. Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Units on a scale|Mean|27|27.0|Standard Deviation|5|5.0|||
3792389|NCT01839656|3621830|B3||60 to 64|Distribution of Total Scores of the CHOP-INTEND Scale at Baseline|The Children's Hospital of Philadelphia Infant Test for Neuromuscular Disease (CHOP-INTEND) test includes 16 items structured to move from easiest to hardest with the grading including gravity eliminated (lower scores) to antigravity movements (higher scores). All item scores range from 0 (worst) to 4 (best). Total scores range from 0 to 64, with higher scores indicating better movement functioning. Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|1|1.0||||||
3792390|NCT01839656|3621831|B2||60 to 64|Distribution of Total Scores of the CHOP-INTEND Scale at Baseline|The Children's Hospital of Philadelphia Infant Test for Neuromuscular Disease (CHOP-INTEND) test includes 16 items structured to move from easiest to hardest with the grading including gravity eliminated (lower scores) to antigravity movements (higher scores). All item scores range from 0 (worst) to 4 (best). Total scores range from 0 to 64, with higher scores indicating better movement functioning. Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|1|1.0||||||
3792391|NCT01839656|3621832|B1||60 to 64|Distribution of Total Scores of the CHOP-INTEND Scale at Baseline|The Children's Hospital of Philadelphia Infant Test for Neuromuscular Disease (CHOP-INTEND) test includes 16 items structured to move from easiest to hardest with the grading including gravity eliminated (lower scores) to antigravity movements (higher scores). All item scores range from 0 (worst) to 4 (best). Total scores range from 0 to 64, with higher scores indicating better movement functioning. Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792392|NCT01839656|3621830|B3||50 to 59|Distribution of Total Scores of the CHOP-INTEND Scale at Baseline|The Children's Hospital of Philadelphia Infant Test for Neuromuscular Disease (CHOP-INTEND) test includes 16 items structured to move from easiest to hardest with the grading including gravity eliminated (lower scores) to antigravity movements (higher scores). All item scores range from 0 (worst) to 4 (best). Total scores range from 0 to 64, with higher scores indicating better movement functioning. Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792393|NCT01839656|3621831|B2||50 to 59|Distribution of Total Scores of the CHOP-INTEND Scale at Baseline|The Children's Hospital of Philadelphia Infant Test for Neuromuscular Disease (CHOP-INTEND) test includes 16 items structured to move from easiest to hardest with the grading including gravity eliminated (lower scores) to antigravity movements (higher scores). All item scores range from 0 (worst) to 4 (best). Total scores range from 0 to 64, with higher scores indicating better movement functioning. Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792394|NCT01839656|3621832|B1||50 to 59|Distribution of Total Scores of the CHOP-INTEND Scale at Baseline|The Children's Hospital of Philadelphia Infant Test for Neuromuscular Disease (CHOP-INTEND) test includes 16 items structured to move from easiest to hardest with the grading including gravity eliminated (lower scores) to antigravity movements (higher scores). All item scores range from 0 (worst) to 4 (best). Total scores range from 0 to 64, with higher scores indicating better movement functioning. Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792395|NCT01839656|3621830|B3||40 to 49|Distribution of Total Scores of the CHOP-INTEND Scale at Baseline|The Children's Hospital of Philadelphia Infant Test for Neuromuscular Disease (CHOP-INTEND) test includes 16 items structured to move from easiest to hardest with the grading including gravity eliminated (lower scores) to antigravity movements (higher scores). All item scores range from 0 (worst) to 4 (best). Total scores range from 0 to 64, with higher scores indicating better movement functioning. Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|1|1.0||||||
3792396|NCT01839656|3621831|B2||40 to 49|Distribution of Total Scores of the CHOP-INTEND Scale at Baseline|The Children's Hospital of Philadelphia Infant Test for Neuromuscular Disease (CHOP-INTEND) test includes 16 items structured to move from easiest to hardest with the grading including gravity eliminated (lower scores) to antigravity movements (higher scores). All item scores range from 0 (worst) to 4 (best). Total scores range from 0 to 64, with higher scores indicating better movement functioning. Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|1|1.0||||||
3792397|NCT01839656|3621832|B1||40 to 49|Distribution of Total Scores of the CHOP-INTEND Scale at Baseline|The Children's Hospital of Philadelphia Infant Test for Neuromuscular Disease (CHOP-INTEND) test includes 16 items structured to move from easiest to hardest with the grading including gravity eliminated (lower scores) to antigravity movements (higher scores). All item scores range from 0 (worst) to 4 (best). Total scores range from 0 to 64, with higher scores indicating better movement functioning. Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792398|NCT01839656|3621830|B3||30 to 39|Distribution of Total Scores of the CHOP-INTEND Scale at Baseline|The Children's Hospital of Philadelphia Infant Test for Neuromuscular Disease (CHOP-INTEND) test includes 16 items structured to move from easiest to hardest with the grading including gravity eliminated (lower scores) to antigravity movements (higher scores). All item scores range from 0 (worst) to 4 (best). Total scores range from 0 to 64, with higher scores indicating better movement functioning. Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|7|7.0||||||
3792399|NCT01839656|3621831|B2||30 to 39|Distribution of Total Scores of the CHOP-INTEND Scale at Baseline|The Children's Hospital of Philadelphia Infant Test for Neuromuscular Disease (CHOP-INTEND) test includes 16 items structured to move from easiest to hardest with the grading including gravity eliminated (lower scores) to antigravity movements (higher scores). All item scores range from 0 (worst) to 4 (best). Total scores range from 0 to 64, with higher scores indicating better movement functioning. Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|6|6.0||||||
3792561|NCT01839604|3621856|B5||Female|Gender||Participants|Count of Participants|0|0.0||||||
3792400|NCT01839656|3621832|B1||30 to 39|Distribution of Total Scores of the CHOP-INTEND Scale at Baseline|The Children's Hospital of Philadelphia Infant Test for Neuromuscular Disease (CHOP-INTEND) test includes 16 items structured to move from easiest to hardest with the grading including gravity eliminated (lower scores) to antigravity movements (higher scores). All item scores range from 0 (worst) to 4 (best). Total scores range from 0 to 64, with higher scores indicating better movement functioning. Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|1|1.0||||||
3792401|NCT01839656|3621830|B3||20 to 29|Distribution of Total Scores of the CHOP-INTEND Scale at Baseline|The Children's Hospital of Philadelphia Infant Test for Neuromuscular Disease (CHOP-INTEND) test includes 16 items structured to move from easiest to hardest with the grading including gravity eliminated (lower scores) to antigravity movements (higher scores). All item scores range from 0 (worst) to 4 (best). Total scores range from 0 to 64, with higher scores indicating better movement functioning. Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|9|9.0||||||
3792402|NCT01839656|3621831|B2||20 to 29|Distribution of Total Scores of the CHOP-INTEND Scale at Baseline|The Children's Hospital of Philadelphia Infant Test for Neuromuscular Disease (CHOP-INTEND) test includes 16 items structured to move from easiest to hardest with the grading including gravity eliminated (lower scores) to antigravity movements (higher scores). All item scores range from 0 (worst) to 4 (best). Total scores range from 0 to 64, with higher scores indicating better movement functioning. Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|6|6.0||||||
3792403|NCT01839656|3621832|B1||20 to 29|Distribution of Total Scores of the CHOP-INTEND Scale at Baseline|The Children's Hospital of Philadelphia Infant Test for Neuromuscular Disease (CHOP-INTEND) test includes 16 items structured to move from easiest to hardest with the grading including gravity eliminated (lower scores) to antigravity movements (higher scores). All item scores range from 0 (worst) to 4 (best). Total scores range from 0 to 64, with higher scores indicating better movement functioning. Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|3|3.0||||||
3792404|NCT01839656|3621830|B3||10 to 19|Distribution of Total Scores of the CHOP-INTEND Scale at Baseline|The Children's Hospital of Philadelphia Infant Test for Neuromuscular Disease (CHOP-INTEND) test includes 16 items structured to move from easiest to hardest with the grading including gravity eliminated (lower scores) to antigravity movements (higher scores). All item scores range from 0 (worst) to 4 (best). Total scores range from 0 to 64, with higher scores indicating better movement functioning. Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|2|2.0||||||
3792405|NCT01839656|3621831|B2||10 to 19|Distribution of Total Scores of the CHOP-INTEND Scale at Baseline|The Children's Hospital of Philadelphia Infant Test for Neuromuscular Disease (CHOP-INTEND) test includes 16 items structured to move from easiest to hardest with the grading including gravity eliminated (lower scores) to antigravity movements (higher scores). All item scores range from 0 (worst) to 4 (best). Total scores range from 0 to 64, with higher scores indicating better movement functioning. Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|2|2.0||||||
3792406|NCT01839656|3621832|B1||10 to 19|Distribution of Total Scores of the CHOP-INTEND Scale at Baseline|The Children's Hospital of Philadelphia Infant Test for Neuromuscular Disease (CHOP-INTEND) test includes 16 items structured to move from easiest to hardest with the grading including gravity eliminated (lower scores) to antigravity movements (higher scores). All item scores range from 0 (worst) to 4 (best). Total scores range from 0 to 64, with higher scores indicating better movement functioning. Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792407|NCT01839656|3621830|B3||0 to 9|Distribution of Total Scores of the CHOP-INTEND Scale at Baseline|The Children's Hospital of Philadelphia Infant Test for Neuromuscular Disease (CHOP-INTEND) test includes 16 items structured to move from easiest to hardest with the grading including gravity eliminated (lower scores) to antigravity movements (higher scores). All item scores range from 0 (worst) to 4 (best). Total scores range from 0 to 64, with higher scores indicating better movement functioning. Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792408|NCT01839656|3621831|B2||0 to 9|Distribution of Total Scores of the CHOP-INTEND Scale at Baseline|The Children's Hospital of Philadelphia Infant Test for Neuromuscular Disease (CHOP-INTEND) test includes 16 items structured to move from easiest to hardest with the grading including gravity eliminated (lower scores) to antigravity movements (higher scores). All item scores range from 0 (worst) to 4 (best). Total scores range from 0 to 64, with higher scores indicating better movement functioning. Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792409|NCT01839656|3621832|B1||0 to 9|Distribution of Total Scores of the CHOP-INTEND Scale at Baseline|The Children's Hospital of Philadelphia Infant Test for Neuromuscular Disease (CHOP-INTEND) test includes 16 items structured to move from easiest to hardest with the grading including gravity eliminated (lower scores) to antigravity movements (higher scores). All item scores range from 0 (worst) to 4 (best). Total scores range from 0 to 64, with higher scores indicating better movement functioning. Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792410|NCT01839656|3621830|B3||Walking independently|HINE Walking Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792411|NCT01839656|3621831|B2||Walking independently|HINE Walking Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792412|NCT01839656|3621832|B1||Walking independently|HINE Walking Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792413|NCT01839656|3621830|B3||Cruising (walks holding on)|HINE Walking Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792414|NCT01839656|3621831|B2||Cruising (walks holding on)|HINE Walking Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792416|NCT01839656|3621830|B3||Bouncing|HINE Walking Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|1|1.0||||||
3792417|NCT01839656|3621831|B2||Bouncing|HINE Walking Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|1|1.0||||||
3792418|NCT01839656|3621832|B1||Bouncing|HINE Walking Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792419|NCT01839656|3621830|B3||No walking|HINE Walking Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|19|19.0||||||
3792420|NCT01839656|3621831|B2||No walking|HINE Walking Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|15|15.0||||||
3792421|NCT01839656|3621832|B1||No walking|HINE Walking Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|4|4.0||||||
3792422|NCT01839656|3621830|B3||Stands unaided|HINE Standing Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792423|NCT01839656|3621831|B2||Stands unaided|HINE Standing Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792424|NCT01839656|3621832|B1||Stands unaided|HINE Standing Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792425|NCT01839656|3621830|B3||Stands with support|HINE Standing Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792426|NCT01839656|3621831|B2||Stands with support|HINE Standing Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792427|NCT01839656|3621832|B1||Stands with support|HINE Standing Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792428|NCT01839656|3621830|B3||Supports weight|HINE Standing Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|1|1.0||||||
3792429|NCT01839656|3621831|B2||Supports weight|HINE Standing Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|1|1.0||||||
3792430|NCT01839656|3621832|B1||Supports weight|HINE Standing Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792431|NCT01839656|3621830|B3||Does not support weight|HINE Standing Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|19|19.0||||||
3792432|NCT01839656|3621831|B2||Does not support weight|HINE Standing Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|15|15.0||||||
3792433|NCT01839656|3621832|B1||Does not support weight|HINE Standing Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|4|4.0||||||
3792434|NCT01839656|3621830|B3||Crawling on hands and knees|HINE Crawling Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792435|NCT01839656|3621831|B2||Crawling on hands and knees|HINE Crawling Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792436|NCT01839656|3621832|B1||Crawling on hands and knees|HINE Crawling Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792437|NCT01839656|3621830|B3||Crawling flat on abdomen|HINE Crawling Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792438|NCT01839656|3621831|B2||Crawling flat on abdomen|HINE Crawling Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792439|NCT01839656|3621832|B1||Crawling flat on abdomen|HINE Crawling Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792440|NCT01839656|3621830|B3||On outstretched hand|HINE Crawling Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|1|1.0||||||
3792441|NCT01839656|3621831|B2||On outstretched hand|HINE Crawling Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|1|1.0||||||
3792442|NCT01839656|3621832|B1||On outstretched hand|HINE Crawling Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792443|NCT01839656|3621830|B3||On elbow|HINE Crawling Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|1|1.0||||||
3792444|NCT01839656|3621831|B2||On elbow|HINE Crawling Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|1|1.0||||||
3792445|NCT01839656|3621832|B1||On elbow|HINE Crawling Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792446|NCT01839656|3621830|B3||Does not lift head|HINE Crawling Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|18|18.0||||||
3792562|NCT01839604|3621857|B4||Female|Gender||Participants|Count of Participants|2|2.0||||||
3792447|NCT01839656|3621831|B2||Does not lift head|HINE Crawling Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|14|14.0||||||
3792448|NCT01839656|3621832|B1||Does not lift head|HINE Crawling Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|4|4.0||||||
3792449|NCT01839656|3621830|B3||Supine to prone|HINE Rolling Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792450|NCT01839656|3621831|B2||Supine to prone|HINE Rolling Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792451|NCT01839656|3621832|B1||Supine to prone|HINE Rolling Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792452|NCT01839656|3621830|B3||Prone to supine|HINE Rolling Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|1|1.0||||||
3792453|NCT01839656|3621831|B2||Prone to supine|HINE Rolling Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|1|1.0||||||
3792454|NCT01839656|3621832|B1||Prone to supine|HINE Rolling Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792455|NCT01839656|3621830|B3||Rolling side to side|HINE Rolling Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792456|NCT01839656|3621831|B2||Rolling side to side|HINE Rolling Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792457|NCT01839656|3621832|B1||Rolling side to side|HINE Rolling Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792458|NCT01839656|3621830|B3||No rolling|HINE Rolling Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|19|19.0||||||
3792459|NCT01839656|3621831|B2||No rolling|HINE Rolling Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|15|15.0||||||
3792460|NCT01839656|3621832|B1||No rolling|HINE Rolling Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|4|4.0||||||
3792461|NCT01839656|3621830|B3||Touches toes|HINE Ability to Kick Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792462|NCT01839656|3621831|B2||Touches toes|HINE Ability to Kick Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792463|NCT01839656|3621832|B1||Touches toes|HINE Ability to Kick Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792464|NCT01839656|3621830|B3||Touches leg|HINE Ability to Kick Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792465|NCT01839656|3621831|B2||Touches leg|HINE Ability to Kick Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792466|NCT01839656|3621832|B1||Touches leg|HINE Ability to Kick Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792467|NCT01839656|3621830|B3||Upward (vertically)|HINE Ability to Kick Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|1|1.0||||||
3792468|NCT01839656|3621831|B2||Upward (vertically)|HINE Ability to Kick Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|1|1.0||||||
3792469|NCT01839656|3621832|B1||Upward (vertically)|HINE Ability to Kick Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792470|NCT01839656|3621830|B3||Kick horizontally, legs do not lift|HINE Ability to Kick Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|13|13.0||||||
3792471|NCT01839656|3621831|B2||Kick horizontally, legs do not lift|HINE Ability to Kick Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|10|10.0||||||
3792472|NCT01839656|3621832|B1||Kick horizontally, legs do not lift|HINE Ability to Kick Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|3|3.0||||||
3792473|NCT01839656|3621830|B3||No kicking|HINE Ability to Kick Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|6|6.0||||||
3792474|NCT01839656|3621831|B2||No kicking|HINE Ability to Kick Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|5|5.0||||||
3792475|NCT01839656|3621832|B1||No kicking|HINE Ability to Kick Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|1|1.0||||||
3792476|NCT01839656|3621830|B3||Pincer grasp|HINE Voluntary Grasp Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792477|NCT01839656|3621831|B2||Pincer grasp|HINE Voluntary Grasp Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792478|NCT01839656|3621832|B1||Pincer grasp|HINE Voluntary Grasp Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792479|NCT01839656|3621830|B3||Index finger and thumb but immature grasp|HINE Voluntary Grasp Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792480|NCT01839656|3621831|B2||Index finger and thumb but immature grasp|HINE Voluntary Grasp Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792481|NCT01839656|3621832|B1||Index finger and thumb but immature grasp|HINE Voluntary Grasp Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792482|NCT01839656|3621830|B3||Uses whole hand|HINE Voluntary Grasp Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|17|17.0||||||
3792483|NCT01839656|3621831|B2||Uses whole hand|HINE Voluntary Grasp Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|13|13.0||||||
3792484|NCT01839656|3621832|B1||Uses whole hand|HINE Voluntary Grasp Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|4|4.0||||||
3792485|NCT01839656|3621830|B3||No grasp|HINE Voluntary Grasp Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|3|3.0||||||
3792486|NCT01839656|3621831|B2||No grasp|HINE Voluntary Grasp Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|3|3.0||||||
3792487|NCT01839656|3621832|B1||No grasp|HINE Voluntary Grasp Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792488|NCT01839656|3621830|B3||Pivots (rotates)|HINE Sitting Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792489|NCT01839656|3621831|B2||Pivots (rotates)|HINE Sitting Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792490|NCT01839656|3621832|B1||Pivots (rotates)|HINE Sitting Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792491|NCT01839656|3621830|B3||Stable sit|HINE Sitting Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792492|NCT01839656|3621831|B2||Stable sit|HINE Sitting Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792493|NCT01839656|3621832|B1||Stable sit|HINE Sitting Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792494|NCT01839656|3621830|B3||Props|HINE Sitting Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792495|NCT01839656|3621831|B2||Props|HINE Sitting Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792496|NCT01839656|3621832|B1||Props|HINE Sitting Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792497|NCT01839656|3621830|B3||Sits with support at hips|HINE Sitting Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|1|1.0||||||
3792498|NCT01839656|3621831|B2||Sits with support at hips|HINE Sitting Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|1|1.0||||||
3792499|NCT01839656|3621832|B1||Sits with support at hips|HINE Sitting Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792500|NCT01839656|3621830|B3||Cannot sit|HINE Sitting Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|19|19.0||||||
3792501|NCT01839656|3621831|B2||Cannot sit|HINE Sitting Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|15|15.0||||||
3792502|NCT01839656|3621832|B1||Cannot sit|HINE Sitting Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|4|4.0||||||
3792503|NCT01839656|3621830|B3||All the time maintained upright|Hammersmith Infant Neurological Examination (HINE) Head Control Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|1|1.0||||||
3792504|NCT01839656|3621831|B2||All the time maintained upright|Hammersmith Infant Neurological Examination (HINE) Head Control Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|1|1.0||||||
3792505|NCT01839656|3621832|B1||All the time maintained upright|Hammersmith Infant Neurological Examination (HINE) Head Control Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|0|0.0||||||
3792506|NCT01839656|3621830|B3||Wobbles|Hammersmith Infant Neurological Examination (HINE) Head Control Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|3|3.0||||||
3792507|NCT01839656|3621831|B2||Wobbles|Hammersmith Infant Neurological Examination (HINE) Head Control Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|2|2.0||||||
3792508|NCT01839656|3621832|B1||Wobbles|Hammersmith Infant Neurological Examination (HINE) Head Control Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|1|1.0||||||
3792509|NCT01839656|3621830|B3||Unable to maintain head upright|Hammersmith Infant Neurological Examination (HINE) Head Control Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|16|16.0||||||
3792510|NCT01839656|3621831|B2||Unable to maintain head upright|Hammersmith Infant Neurological Examination (HINE) Head Control Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|13|13.0||||||
3792511|NCT01839656|3621832|B1||Unable to maintain head upright|Hammersmith Infant Neurological Examination (HINE) Head Control Motor Milestones at Baseline|Baseline was defined as the last non-missing value prior to the first dose of nusinersen.|Participants|Count of Participants|3|3.0||||||
3792512|NCT01839656|3621830|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3792513|NCT01839656|3621831|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3792514|NCT01839656|3621832|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3792515|NCT01839656|3621830|B3||Multiple Race|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3792516|NCT01839656|3621831|B2||Multiple Race|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3792517|NCT01839656|3621832|B1||Multiple Race|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3792518|NCT01839656|3621830|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3792519|NCT01839656|3621831|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3792520|NCT01839656|3621832|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3792521|NCT01839656|3621830|B3||American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3792522|NCT01839656|3621831|B2||American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3792523|NCT01839656|3621832|B1||American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3792524|NCT01839656|3621830|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3792525|NCT01839656|3621831|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3792526|NCT01839656|3621832|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3792527|NCT01839656|3621830|B3||Black|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3792528|NCT01839656|3621831|B2||Black|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3792529|NCT01839656|3621832|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3792530|NCT01839656|3621830|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3792531|NCT01839656|3621831|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3792532|NCT01839656|3621832|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3792533|NCT01839656|3621830|B3||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3792534|NCT01839656|3621831|B2||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3792535|NCT01839656|3621832|B1||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3792536|NCT01839656|3621830|B3||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3792537|NCT01839656|3621831|B2||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3792538|NCT01839656|3621832|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3792539|NCT01839656|3621830|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3792540|NCT01839656|3621831|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3792541|NCT01839656|3621832|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3792542|NCT01839656|3621830|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3792543|NCT01839656|3621831|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3792544|NCT01839656|3621832|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3792545|NCT01839656|3621830|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3792546|NCT01839656|3621831|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3792547|NCT01839656|3621832|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3792548|NCT01839656|3621830|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3792549|NCT01839656|3621831|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3792550|NCT01839656|3621832|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3792551|NCT01839656|3621830|B3||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
3792552|NCT01839656|3621831|B2||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
3792553|NCT01839656|3621832|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3792554|NCT01839604|3621855|B6||Male|Gender||Participants|Count of Participants|34|34.0||||||
3792555|NCT01839604|3621856|B5||Male|Gender||Participants|Count of Participants|15|15.0||||||
3792556|NCT01839604|3621857|B4||Male|Gender||Participants|Count of Participants|3|3.0||||||
3792557|NCT01839604|3621858|B3||Male|Gender||Participants|Count of Participants|5|5.0||||||
3792558|NCT01839604|3621859|B2||Male|Gender||Participants|Count of Participants|5|5.0||||||
3792559|NCT01839604|3621860|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
3792560|NCT01839604|3621855|B6||Female|Gender||Participants|Count of Participants|5|5.0||||||
3792564|NCT01839604|3621859|B2||Female|Gender||Participants|Count of Participants|1|1.0||||||
3792565|NCT01839604|3621860|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3792566|NCT01839604|3621855|B6|||Age||years|Mean|59.2|59.2|Standard Deviation|10.4|10.4|||
3792567|NCT01839604|3621856|B5|||Age||years|Mean|57.5|57.5|Standard Deviation|8.9|8.9|||
3792568|NCT01839604|3621857|B4|||Age||years|Mean|58.0|58.0|Standard Deviation|11.0|11.0|||
3792569|NCT01839604|3621858|B3|||Age||years|Mean|64.1|64.1|Standard Deviation|10.4|10.4|||
3792570|NCT01839604|3621859|B2|||Age||years|Mean|58.3|58.3|Standard Deviation|12.9|12.9|||
3792571|NCT01839604|3621860|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|13.0|13.0|||
3792572|NCT01839396|3621891|B3||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3792573|NCT01839396|3621892|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3792574|NCT01839396|3621893|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3792575|NCT01839396|3621891|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3792576|NCT01839396|3621892|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3792577|NCT01839396|3621893|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3792578|NCT01839396|3621891|B3|Age||Age|Mean age is reported at time of enrollment|years|Mean|59.9|59.9|Standard Deviation|7.9|7.9|||
3792579|NCT01839396|3621892|B2|Age||Age|Mean age is reported at time of enrollment|years|Mean|57.5|57.5|Standard Deviation|7.66|7.66|||
3792580|NCT01839396|3621893|B1|Age||Age|Mean age is reported at time of enrollment|years|Mean|60.7|60.7|Standard Deviation|7.9|7.9|||
3792581|NCT01839318|3621902|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3792582|NCT01839318|3621902|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3792583|NCT01839318|3621902|B1|||Age||years|Mean|24.96|24.96|Standard Deviation|3.54|3.54|||
3792584|NCT01839279|3621918|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792585|NCT01839279|3621919|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792586|NCT01839279|3621920|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792587|NCT01839279|3621921|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792588|NCT01839279|3621918|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3792589|NCT01839279|3621919|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3792590|NCT01839279|3621920|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3792591|NCT01839279|3621921|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3792592|NCT01839279|3621918|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3792593|NCT01839279|3621919|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3792594|NCT01839279|3621920|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3792595|NCT01839279|3621921|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3792596|NCT01839279|3621918|B4||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3792597|NCT01839279|3621919|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3792598|NCT01839279|3621920|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3792599|NCT01839279|3621921|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3792600|NCT01839279|3621918|B4||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3792601|NCT01839279|3621919|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3792602|NCT01839279|3621920|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3792603|NCT01839279|3621921|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3792604|NCT01839279|3621918|B4|||Age||years|Mean|34.0|34.0|Standard Deviation|7.03|7.03|||
3792605|NCT01839279|3621919|B3|||Age||years|Mean|35.3|35.3|Standard Deviation|7.21|7.21|||
3792606|NCT01839279|3621920|B2|||Age||years|Mean|34.1|34.1|Standard Deviation|7.51|7.51|||
3792607|NCT01839279|3621921|B1|||Age||years|Mean|33.4|33.4|Standard Deviation|6.75|6.75|||
3792608|NCT01839110|3621942|B4|United States||Region of Enrollment||participants|Number|22|22.0||||||
3792609|NCT01839110|3621943|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
3792610|NCT01839110|3621944|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3792611|NCT01839110|3621945|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3792612|NCT01839110|3621942|B4|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3792613|NCT01839110|3621942|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3792614|NCT01839110|3621943|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3792615|NCT01839110|3621944|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3792616|NCT01839110|3621945|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3792617|NCT01839110|3621942|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3792618|NCT01839110|3621943|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3792619|NCT01839110|3621944|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3792620|NCT01839110|3621945|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3792621|NCT01839110|3621942|B4|||Age||years|Mean|54.4|54.4|Standard Deviation|15.9|15.9|||
3792622|NCT01839110|3621943|B3|||Age||years|Mean|53.2|53.2|Standard Deviation|17.9|17.9|||
3792623|NCT01839110|3621944|B2|||Age||years|Mean|57.7|57.7|Standard Deviation|6.8|6.8|||
3792624|NCT01839110|3621945|B1|||Age||years|Mean|53.0|53.0|Standard Deviation|19.7|19.7|||
3792625|NCT01839058|3621955|B3|Canada||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3792626|NCT01839058|3621956|B2|Canada||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3792627|NCT01839058|3621957|B1|Canada||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3792628|NCT01839058|3621955|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3792629|NCT01839058|3621956|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3792630|NCT01839058|3621957|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3792631|NCT01839058|3621955|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3792632|NCT01839058|3621956|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3792633|NCT01839058|3621957|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3792634|NCT01839058|3621955|B3|||Age||years|Mean|50.9|50.9|Standard Deviation|14.5|14.5|||
3792635|NCT01839058|3621956|B2|||Age||years|Mean|49.4|49.4|Standard Deviation|18.3|18.3|||
3792636|NCT01839058|3621957|B1|||Age||years|Mean|52.4|52.4|Standard Deviation|10.1|10.1|||
3792637|NCT01838980|3621970|B1||Male|Gender||Participants|Count of Participants|7|7.0||||||
3792638|NCT01838980|3621970|B1||Female|Gender||Participants|Count of Participants|8|8.0||||||
3792639|NCT01838980|3621970|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3792640|NCT01838980|3621970|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3792641|NCT01838980|3621970|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3792642|NCT01838941|3621974|B1|PEX1 G843D/null mutations||Mutation status|Homozygous (mild form of PBD) or hemizygous for PEX1 G843D mutation (intermediate form of PBD)|participants|Number|10|10.0||||||
3792643|NCT01838941|3621974|B1|PEX1 G843D homozygous mutation||Mutation status|Homozygous (mild form of PBD) or hemizygous for PEX1 G843D mutation (intermediate form of PBD)|participants|Number|2|2.0||||||
3792644|NCT01838941|3621974|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3792645|NCT01838941|3621974|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
3792646|NCT01838941|3621974|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3792647|NCT01838941|3621974|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3792648|NCT01838941|3621974|B1|||Age||years|Median|4.75|4.75|Full Range|||0.92|31.17|
3792649|NCT01838941|3621974|B1||>=65 years|Age|"Participants (n = 12) were seen at the research site at the beginning (baseline visit) and at the end of the study (6-month visit).~Physical examination was done at baseline and final visits. Medical history was collected and updated at that time.~Hematology, laboratory, and biochemical parameters were measured at baseline and 6 months."|Participants|Count of Participants|0|0.0||||||
3792650|NCT01838941|3621974|B1||Between 18 and 65 years|Age|"Participants (n = 12) were seen at the research site at the beginning (baseline visit) and at the end of the study (6-month visit).~Physical examination was done at baseline and final visits. Medical history was collected and updated at that time.~Hematology, laboratory, and biochemical parameters were measured at baseline and 6 months."|Participants|Count of Participants|1|1.0||||||
3792651|NCT01838941|3621974|B1||<=18 years|Age|"Participants (n = 12) were seen at the research site at the beginning (baseline visit) and at the end of the study (6-month visit).~Physical examination was done at baseline and final visits. Medical history was collected and updated at that time.~Hematology, laboratory, and biochemical parameters were measured at baseline and 6 months."|Participants|Count of Participants|11|11.0||||||
3792652|NCT01838863|3621979|B3|||Partial thromboplastin time (PTT) in the field||seconds|Median|27.1|27.1|Inter-Quartile Range|||24.7|30.4|
3792653|NCT01838863|3621980|B2|||Partial thromboplastin time (PTT) in the field||seconds|Median|26.9|26.9|Inter-Quartile Range|||24.6|30.4|
3792654|NCT01838863|3621981|B1|||Partial thromboplastin time (PTT) in the field||seconds|Median|27.1|27.1|Inter-Quartile Range|||25.0|30.0|
3792655|NCT01838863|3621979|B3|||International normalized ratio (INR) in the field >=1.3||Participants|Count of Participants|4|4.0||||||
3792656|NCT01838863|3621980|B2|||International normalized ratio (INR) in the field >=1.3||Participants|Count of Participants|2|2.0||||||
3792657|NCT01838863|3621981|B1|||International normalized ratio (INR) in the field >=1.3||Participants|Count of Participants|2|2.0||||||
3792658|NCT01838863|3621979|B3|||International normalized ratio (INR) in the field||ratio|Median|1.1|1.1|Inter-Quartile Range|||1.0|1.2|
3792659|NCT01838863|3621980|B2|||International normalized ratio (INR) in the field||ratio|Median|1.1|1.1|Inter-Quartile Range|||1.0|1.1|
3792660|NCT01838863|3621981|B1|||International normalized ratio (INR) in the field||ratio|Median|1.1|1.1|Inter-Quartile Range|||1.0|1.2|
3792661|NCT01838863|3621979|B3|||Fibrinogen in the field||mg/dL|Median|268|268.0|Inter-Quartile Range|||228.5|322.5|
3792662|NCT01838863|3621980|B2|||Fibrinogen in the field||mg/dL|Median|278|278.0|Inter-Quartile Range|||250.0|331.0|
3792663|NCT01838863|3621981|B1|||Fibrinogen in the field||mg/dL|Median|253|253.0|Inter-Quartile Range|||226.0|308.0|
3792664|NCT01838863|3621979|B3|||Platelet count in the field||1000 cells/microL|Median|287.5|287.5|Inter-Quartile Range|||245.5|345.8|
3792665|NCT01838863|3621980|B2|||Platelet count in the field||1000 cells/microL|Median|273.5|273.5|Inter-Quartile Range|||219.0|331.0|
3792666|NCT01838863|3621981|B1|||Platelet count in the field||1000 cells/microL|Median|300.5|300.5|Inter-Quartile Range|||251.8|353.2|
3792667|NCT01838863|3621979|B3|||Haemoglobin (Hb) in the field||g/dL|Median|14.6|14.6|Inter-Quartile Range|||13.2|15.7|
3792668|NCT01838863|3621980|B2|||Haemoglobin (Hb) in the field||g/dL|Median|14.2|14.2|Inter-Quartile Range|||13.2|15.9|
3792669|NCT01838863|3621981|B1|||Haemoglobin (Hb) in the field||g/dL|Median|15.1|15.1|Inter-Quartile Range|||13.6|15.7|
3792742|NCT01838694|3622074|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
3792743|NCT01838694|3622075|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3792744|NCT01838694|3622073|B3||Male|Gender||Participants|Count of Participants|2|2.0||||||
3792670|NCT01838863|3621979|B3|||Glasgow Coma Scale (GCS) in the field|Glasgow Coma Scale (GCS) is a neurological scale which aims to give a reliable and objective way of recording the conscious state of a person for initial as well as subsequent assessment. The GCS is the summation of scores for eye, verbal, and motor responses. The minimum score is a 3 which indicates deep coma or a brain-dead state. The maximum is 15 which indicates a fully awake patient.|units on a scale|Median|14|14.0|Inter-Quartile Range|||8.0|15.0|
3792671|NCT01838863|3621980|B2|||Glasgow Coma Scale (GCS) in the field|Glasgow Coma Scale (GCS) is a neurological scale which aims to give a reliable and objective way of recording the conscious state of a person for initial as well as subsequent assessment. The GCS is the summation of scores for eye, verbal, and motor responses. The minimum score is a 3 which indicates deep coma or a brain-dead state. The maximum is 15 which indicates a fully awake patient.|units on a scale|Median|14|14.0|Inter-Quartile Range|||8.0|15.0|
3792672|NCT01838863|3621981|B1|||Glasgow Coma Scale (GCS) in the field|Glasgow Coma Scale (GCS) is a neurological scale which aims to give a reliable and objective way of recording the conscious state of a person for initial as well as subsequent assessment. The GCS is the summation of scores for eye, verbal, and motor responses. The minimum score is a 3 which indicates deep coma or a brain-dead state. The maximum is 15 which indicates a fully awake patient.|units on a scale|Median|14|14.0|Inter-Quartile Range|||7.0|15.0|
3792673|NCT01838863|3621979|B3|||Body temperature in the field||degrees Celsius|Median|36|36.0|Inter-Quartile Range|||34.9|36.9|
3792674|NCT01838863|3621980|B2|||Body temperature in the field||degrees Celsius|Median|36|36.0|Inter-Quartile Range|||35.1|37.0|
3792675|NCT01838863|3621981|B1|||Body temperature in the field||degrees Celsius|Median|36|36.0|Inter-Quartile Range|||34.8|36.6|
3792676|NCT01838863|3621979|B3|||Severe shock defined as systolic blood pressure (SBP) in the field <=70mmHg||Participants|Count of Participants|77|77.0||||||
3792677|NCT01838863|3621980|B2|||Severe shock defined as systolic blood pressure (SBP) in the field <=70mmHg||Participants|Count of Participants|33|33.0||||||
3792678|NCT01838863|3621981|B1|||Severe shock defined as systolic blood pressure (SBP) in the field <=70mmHg||Participants|Count of Participants|44|44.0||||||
3792679|NCT01838863|3621979|B3|||Systolic blood pressure (SBP) in the field||mmHg|Median|68|68.0|Inter-Quartile Range|||50.0|80.0|
3792680|NCT01838863|3621980|B2|||Systolic blood pressure (SBP) in the field||mmHg|Median|70|70.0|Inter-Quartile Range|||58.0|80.0|
3792681|NCT01838863|3621981|B1|||Systolic blood pressure (SBP) in the field||mmHg|Median|64|64.0|Inter-Quartile Range|||50.0|80.0|
3792682|NCT01838863|3621979|B3|||Heart rate (HR) in the field||beats per minute (BPM)|Median|110|110.0|Inter-Quartile Range|||100.0|120.0|
3792683|NCT01838863|3621980|B2|||Heart rate (HR) in the field||beats per minute (BPM)|Median|112|112.0|Inter-Quartile Range|||100.0|120.0|
3792684|NCT01838863|3621981|B1|||Heart rate (HR) in the field||beats per minute (BPM)|Median|110|110.0|Inter-Quartile Range|||98.0|120.0|
3792685|NCT01838863|3621979|B3|||Maximal Abbreviated Injury Score (AIS) extremities|Abbreviated Injury Score is an anatomical-based coding system on a scale of one to six, one being a minor injury and six being maximal.|units on a scale|Median|0|0.0|Inter-Quartile Range|||0.0|2.0|
3792686|NCT01838863|3621980|B2|||Maximal Abbreviated Injury Score (AIS) extremities|Abbreviated Injury Score is an anatomical-based coding system on a scale of one to six, one being a minor injury and six being maximal.|units on a scale|Median|0|0.0|Inter-Quartile Range|||0.0|2.0|
3792687|NCT01838863|3621981|B1|||Maximal Abbreviated Injury Score (AIS) extremities|Abbreviated Injury Score is an anatomical-based coding system on a scale of one to six, one being a minor injury and six being maximal.|units on a scale|Median|1|1.0|Inter-Quartile Range|||0.0|3.0|
3792688|NCT01838863|3621979|B3|||Maximal Abbreviated Injury Score (AIS) abdomen and pelvis|Abbreviated Injury Score is an anatomical-based coding system on a scale of one to six, one being a minor injury and six being maximal.|units on a scale|Median|0|0.0|Inter-Quartile Range|||0.0|3.0|
3792689|NCT01838863|3621980|B2|||Maximal Abbreviated Injury Score (AIS) abdomen and pelvis|Abbreviated Injury Score is an anatomical-based coding system on a scale of one to six, one being a minor injury and six being maximal.|units on a scale|Median|0|0.0|Inter-Quartile Range|||0.0|3.0|
3792690|NCT01838863|3621981|B1|||Maximal Abbreviated Injury Score (AIS) abdomen and pelvis|Abbreviated Injury Score is an anatomical-based coding system on a scale of one to six, one being a minor injury and six being maximal.|units on a scale|Median|0|0.0|Inter-Quartile Range|||0.0|3.0|
3792691|NCT01838863|3621979|B3|||Maximal Abbreviated Injury Score (AIS) chest|Abbreviated Injury Score is an anatomical-based coding system on a scale of one to six, one being a minor injury and six being maximal.|units on a scale|Median|2|2.0|Inter-Quartile Range|||0.0|3.0|
3792692|NCT01838863|3621980|B2|||Maximal Abbreviated Injury Score (AIS) chest|Abbreviated Injury Score is an anatomical-based coding system on a scale of one to six, one being a minor injury and six being maximal.|units on a scale|Median|3|3.0|Inter-Quartile Range|||0.0|3.0|
3792693|NCT01838863|3621981|B1|||Maximal Abbreviated Injury Score (AIS) chest|Abbreviated Injury Score is an anatomical-based coding system on a scale of one to six, one being a minor injury and six being maximal.|units on a scale|Median|1|1.0|Inter-Quartile Range|||0.0|3.0|
3792694|NCT01838863|3621979|B3|||Traumatic Brain Injury (TBI) defined as AIS head >=3||Participants|Count of Participants|28|28.0||||||
3792695|NCT01838863|3621980|B2|||Traumatic Brain Injury (TBI) defined as AIS head >=3||Participants|Count of Participants|13|13.0||||||
3792696|NCT01838863|3621981|B1|||Traumatic Brain Injury (TBI) defined as AIS head >=3||Participants|Count of Participants|15|15.0||||||
3792697|NCT01838863|3621979|B3|||Maximal Abbreviated Injury Score (AIS) for head and neck|Abbreviated Injury Score is an anatomical-based coding system on a scale of one to six, one being a minor injury and six being maximal.|units on a scale|Median|0|0.0|Inter-Quartile Range|||0.0|2.0|
3792698|NCT01838863|3621980|B2|||Maximal Abbreviated Injury Score (AIS) for head and neck|Abbreviated Injury Score is an anatomical-based coding system on a scale of one to six, one being a minor injury and six being maximal.|units on a scale|Median|0|0.0|Inter-Quartile Range|||0.0|2.3|
3792699|NCT01838863|3621981|B1|||Maximal Abbreviated Injury Score (AIS) for head and neck|Abbreviated Injury Score is an anatomical-based coding system on a scale of one to six, one being a minor injury and six being maximal.|units on a scale|Median|0|0.0|Inter-Quartile Range|||0.0|2.0|
3792700|NCT01838863|3621979|B3|||New Injury Severity Scale (NISS)|The New Injury Severity Score (NISS) is an anatomical scoring system that provides an overall score for patients with multiple injuries. This is calculated as the sum of the squares of the top three Abbreviated Injury Scores (AIS) regardless of body region. AIS is an anatomical-based coding system on a scale of one to six, one being a minor injury and six being maximal. The NISS score takes values from 0 to 75. This score is virtually the only anatomical scoring system in use and correlates linearly with mortality, morbidity, hospital stay and other measures of severity.|units on a scale|Median|27|27.0|Inter-Quartile Range|||10.0|38.0|
3792701|NCT01838863|3621980|B2|||New Injury Severity Scale (NISS)|The New Injury Severity Score (NISS) is an anatomical scoring system that provides an overall score for patients with multiple injuries. This is calculated as the sum of the squares of the top three Abbreviated Injury Scores (AIS) regardless of body region. AIS is an anatomical-based coding system on a scale of one to six, one being a minor injury and six being maximal. The NISS score takes values from 0 to 75. This score is virtually the only anatomical scoring system in use and correlates linearly with mortality, morbidity, hospital stay and other measures of severity.|units on a scale|Median|27|27.0|Inter-Quartile Range|||11.8|35.0|
3792702|NCT01838863|3621981|B1|||New Injury Severity Scale (NISS)|The New Injury Severity Score (NISS) is an anatomical scoring system that provides an overall score for patients with multiple injuries. This is calculated as the sum of the squares of the top three Abbreviated Injury Scores (AIS) regardless of body region. AIS is an anatomical-based coding system on a scale of one to six, one being a minor injury and six being maximal. The NISS score takes values from 0 to 75. This score is virtually the only anatomical scoring system in use and correlates linearly with mortality, morbidity, hospital stay and other measures of severity.|units on a scale|Median|27|27.0|Inter-Quartile Range|||10.0|41.0|
3792703|NCT01838863|3621979|B3|||Blunt injury mechanism|Blunt force trauma is an injury that occurs when an object hits or strikes a part of the body.|Participants|Count of Participants|62|62.0||||||
3792704|NCT01838863|3621980|B2|||Blunt injury mechanism|Blunt force trauma is an injury that occurs when an object hits or strikes a part of the body.|Participants|Count of Participants|32|32.0||||||
3792705|NCT01838863|3621981|B1|||Blunt injury mechanism|Blunt force trauma is an injury that occurs when an object hits or strikes a part of the body.|Participants|Count of Participants|30|30.0||||||
3792706|NCT01838863|3621979|B3|||Comorbidities|Presence of one or more additional diseases or disorders co-occurring in trauma patient.|Participants|Count of Participants|18|18.0||||||
3792707|NCT01838863|3621980|B2|||Comorbidities|Presence of one or more additional diseases or disorders co-occurring in trauma patient.|Participants|Count of Participants|8|8.0||||||
3792708|NCT01838863|3621981|B1|||Comorbidities|Presence of one or more additional diseases or disorders co-occurring in trauma patient.|Participants|Count of Participants|10|10.0||||||
3792709|NCT01838863|3621979|B3|||Body Mass Index (BMI)||kg/m^2|Median|26.7|26.7|Inter-Quartile Range|||23.4|30.5|
3792710|NCT01838863|3621980|B2|||Body Mass Index (BMI)||kg/m^2|Median|26.1|26.1|Inter-Quartile Range|||23.2|29.4|
3792711|NCT01838863|3621981|B1|||Body Mass Index (BMI)||kg/m^2|Median|27.1|27.1|Inter-Quartile Range|||23.9|30.5|
3792712|NCT01838863|3621979|B3|United States||Region of Enrollment||participants|Number|125|125.0||||||
3792713|NCT01838863|3621980|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
3792714|NCT01838863|3621981|B1|United States||Region of Enrollment||participants|Number|65|65.0||||||
3792715|NCT01838863|3621979|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792716|NCT01838863|3621980|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792717|NCT01838863|3621981|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792718|NCT01838863|3621979|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3792719|NCT01838863|3621980|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3792720|NCT01838863|3621981|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3792721|NCT01838863|3621979|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3792722|NCT01838863|3621980|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3792723|NCT01838863|3621981|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3792724|NCT01838863|3621979|B3||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3792725|NCT01838863|3621980|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3792726|NCT01838863|3621981|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3792727|NCT01838863|3621979|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3792728|NCT01838863|3621980|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3792729|NCT01838863|3621981|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3792730|NCT01838863|3621979|B3|||Age||years|Median|33|33.0|Inter-Quartile Range|||25.0|47.0|
3792731|NCT01838863|3621980|B2|||Age||years|Median|32.5|32.5|Inter-Quartile Range|||25.8|42.0|
3792732|NCT01838863|3621981|B1|||Age||years|Median|33|33.0|Inter-Quartile Range|||25.0|51.0|
3792733|NCT01838785|3622068|B1|Taiwan||Region of Enrollment||participants|Number|25|25.0||||||
3792734|NCT01838785|3622068|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3792735|NCT01838785|3622068|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3792736|NCT01838785|3622068|B1|>60 years||Age, Customized||participants|Number|3|3.0||||||
3792737|NCT01838785|3622068|B1|50-59 years||Age, Customized||participants|Number|4|4.0||||||
3792738|NCT01838785|3622068|B1|40-49 years||Age, Customized||participants|Number|7|7.0||||||
3792739|NCT01838785|3622068|B1|30-39 years||Age, Customized||participants|Number|6|6.0||||||
3792740|NCT01838785|3622068|B1|20-29 years||Age, Customized||participants|Number|5|5.0||||||
3792741|NCT01838694|3622073|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3792745|NCT01838694|3622074|B2||Male|Gender||Participants|Count of Participants|1|1.0||||||
3792746|NCT01838694|3622075|B1||Male|Gender||Participants|Count of Participants|1|1.0||||||
3792747|NCT01838694|3622073|B3||Female|Gender||Participants|Count of Participants|28|28.0||||||
3792748|NCT01838694|3622074|B2||Female|Gender||Participants|Count of Participants|21|21.0||||||
3792749|NCT01838694|3622075|B1||Female|Gender||Participants|Count of Participants|7|7.0||||||
3792750|NCT01838694|3622073|B3|||Age||years|Mean|45|45.0|Standard Deviation|15|15.0|||
3792751|NCT01838694|3622074|B2|||Age||years|Mean|43|43.0|Standard Deviation|15|15.0|||
3792752|NCT01838694|3622075|B1|||Age||years|Mean|50|50.0|Standard Deviation|18|18.0|||
3792753|NCT01838694|3622073|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3792754|NCT01838694|3622074|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3792755|NCT01838694|3622075|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3792756|NCT01838694|3622073|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3792757|NCT01838694|3622074|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3792758|NCT01838694|3622075|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3792759|NCT01838694|3622073|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3792760|NCT01838694|3622074|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3792761|NCT01838694|3622075|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3792762|NCT01838681|3622085|B1|Korea, Republic of||Region of Enrollment||participants|Number|2|2.0||||||
3792763|NCT01838681|3622085|B1|Estonia||Region of Enrollment||participants|Number|161|161.0||||||
3792764|NCT01838681|3622085|B1|Germany||Region of Enrollment||participants|Number|325|325.0||||||
3792765|NCT01838681|3622085|B1|Lithuania||Region of Enrollment||participants|Number|76|76.0||||||
3792766|NCT01838681|3622085|B1|Bulgaria||Region of Enrollment||participants|Number|119|119.0||||||
3792767|NCT01838681|3622085|B1|Mexico||Region of Enrollment||participants|Number|72|72.0||||||
3792768|NCT01838681|3622085|B1|Poland||Region of Enrollment||participants|Number|325|325.0||||||
3792769|NCT01838681|3622085|B1|Finland||Region of Enrollment||participants|Number|136|136.0||||||
3792770|NCT01838681|3622085|B1|Sweden||Region of Enrollment||participants|Number|85|85.0||||||
3792771|NCT01838681|3622085|B1|Latvia||Region of Enrollment||participants|Number|84|84.0||||||
3792772|NCT01838681|3622085|B1|Canada||Region of Enrollment||participants|Number|30|30.0||||||
3792773|NCT01838681|3622085|B1|United Kingdom||Region of Enrollment||participants|Number|168|168.0||||||
3792774|NCT01838681|3622085|B1|Ukraine||Region of Enrollment||participants|Number|189|189.0||||||
3792775|NCT01838681|3622085|B1|United States||Region of Enrollment||participants|Number|78|78.0||||||
3792776|NCT01838681|3622085|B1|Romania||Region of Enrollment||participants|Number|15|15.0||||||
3792777|NCT01838681|3622085|B1|Russian Federation||Region of Enrollment||participants|Number|121|121.0||||||
3792778|NCT01838681|3622085|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3792779|NCT01838681|3622085|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792780|NCT01838681|3622085|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1918|1918.0||||||
3792781|NCT01838681|3622085|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3792782|NCT01838681|3622085|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792783|NCT01838681|3622085|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3792784|NCT01838681|3622085|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792785|NCT01838681|3622085|B1||Male|Sex: Female, Male||Participants|Count of Participants|584|584.0||||||
3792786|NCT01838681|3622085|B1||Female|Sex: Female, Male||Participants|Count of Participants|1402|1402.0||||||
3792787|NCT01838681|3622085|B1|||Age||years|Mean|47.3|47.3|Standard Deviation|12.0|12.0|||
3792788|NCT01838655|3622128|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3792789|NCT01838655|3622128|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792790|NCT01838655|3622128|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3792791|NCT01838655|3622128|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792792|NCT01838655|3622128|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792793|NCT01838655|3622128|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792794|NCT01838655|3622128|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792795|NCT01838655|3622128|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3792796|NCT01838655|3622128|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3792797|NCT01838655|3622128|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792798|NCT01838655|3622128|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3792799|NCT01838655|3622128|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3792800|NCT01838655|3622128|B1|||Age||years|Mean|38.8|38.8|Full Range|||24.0|52.0|
3792801|NCT01838655|3622128|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3792802|NCT01838655|3622128|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3792803|NCT01838655|3622128|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3792804|NCT01838642|3622196|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3792805|NCT01838642|3622196|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792806|NCT01838642|3622196|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792807|NCT01838642|3622196|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3792808|NCT01838642|3622196|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792809|NCT01838642|3622196|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792810|NCT01838642|3622196|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792811|NCT01838642|3622196|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792812|NCT01838642|3622196|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792813|NCT01838642|3622196|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3792814|NCT01838642|3622196|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792815|NCT01838642|3622196|B1||Male|Gender||Participants|Count of Participants|1|1.0||||||
3792816|NCT01838642|3622196|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
3792817|NCT01838642|3622196|B1|||Age||years|Mean|59.13|59.13|Standard Deviation|5.83|5.83|||
3792818|NCT01838642|3622196|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3792819|NCT01838642|3622196|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3792820|NCT01838642|3622196|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3792821|NCT01838616|3622207|B3|painDETECT negative||painDETECT|"The painDETECT questionnaire was used to determine the possibility of the presence of a neuropathic pain component. It is a participant completed questionnaire. A total score is calculated. Participants with a score between 0 and 12 are scored as being negative (no neuropathic pain component). Value between 19 and 38 as being positive (presence of neuropathic component). Values from 13 to 18 are scored as being unclear. Participants being treated with a stable regimen of centrally acting co-analgesics at baseline were permitted if the score was at least 9."|participants|Number|5|5.0||||||
3792822|NCT01838616|3622208|B2|painDETECT negative||painDETECT|"The painDETECT questionnaire was used to determine the possibility of the presence of a neuropathic pain component. It is a participant completed questionnaire. A total score is calculated. Participants with a score between 0 and 12 are scored as being negative (no neuropathic pain component). Value between 19 and 38 as being positive (presence of neuropathic component). Values from 13 to 18 are scored as being unclear. Participants being treated with a stable regimen of centrally acting co-analgesics at baseline were permitted if the score was at least 9."|participants|Number|4|4.0||||||
3792823|NCT01838616|3622209|B1|painDETECT negative||painDETECT|"The painDETECT questionnaire was used to determine the possibility of the presence of a neuropathic pain component. It is a participant completed questionnaire. A total score is calculated. Participants with a score between 0 and 12 are scored as being negative (no neuropathic pain component). Value between 19 and 38 as being positive (presence of neuropathic component). Values from 13 to 18 are scored as being unclear. Participants being treated with a stable regimen of centrally acting co-analgesics at baseline were permitted if the score was at least 9."|participants|Number|1|1.0||||||
3792824|NCT01838616|3622207|B3|painDETECT unclear||painDETECT|"The painDETECT questionnaire was used to determine the possibility of the presence of a neuropathic pain component. It is a participant completed questionnaire. A total score is calculated. Participants with a score between 0 and 12 are scored as being negative (no neuropathic pain component). Value between 19 and 38 as being positive (presence of neuropathic component). Values from 13 to 18 are scored as being unclear. Participants being treated with a stable regimen of centrally acting co-analgesics at baseline were permitted if the score was at least 9."|participants|Number|60|60.0||||||
3792825|NCT01838616|3622208|B2|painDETECT unclear||painDETECT|"The painDETECT questionnaire was used to determine the possibility of the presence of a neuropathic pain component. It is a participant completed questionnaire. A total score is calculated. Participants with a score between 0 and 12 are scored as being negative (no neuropathic pain component). Value between 19 and 38 as being positive (presence of neuropathic component). Values from 13 to 18 are scored as being unclear. Participants being treated with a stable regimen of centrally acting co-analgesics at baseline were permitted if the score was at least 9."|participants|Number|27|27.0||||||
3792826|NCT01838616|3622209|B1|painDETECT unclear||painDETECT|"The painDETECT questionnaire was used to determine the possibility of the presence of a neuropathic pain component. It is a participant completed questionnaire. A total score is calculated. Participants with a score between 0 and 12 are scored as being negative (no neuropathic pain component). Value between 19 and 38 as being positive (presence of neuropathic component). Values from 13 to 18 are scored as being unclear. Participants being treated with a stable regimen of centrally acting co-analgesics at baseline were permitted if the score was at least 9."|participants|Number|33|33.0||||||
3792827|NCT01838616|3622207|B3|painDETECT positive||painDETECT|"The painDETECT questionnaire was used to determine the possibility of the presence of a neuropathic pain component. It is a participant completed questionnaire. A total score is calculated. Participants with a score between 0 and 12 are scored as being negative (no neuropathic pain component). Value between 19 and 38 as being positive (presence of neuropathic component). Values from 13 to 18 are scored as being unclear. Participants being treated with a stable regimen of centrally acting co-analgesics at baseline were permitted if the score was at least 9."|participants|Number|193|193.0||||||
3792828|NCT01838616|3622208|B2|painDETECT positive||painDETECT|"The painDETECT questionnaire was used to determine the possibility of the presence of a neuropathic pain component. It is a participant completed questionnaire. A total score is calculated. Participants with a score between 0 and 12 are scored as being negative (no neuropathic pain component). Value between 19 and 38 as being positive (presence of neuropathic component). Values from 13 to 18 are scored as being unclear. Participants being treated with a stable regimen of centrally acting co-analgesics at baseline were permitted if the score was at least 9."|participants|Number|97|97.0||||||
3792885|NCT01838590|3622278|B4|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|19|19.0||||||
3792886|NCT01838590|3622279|B3|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|9|9.0||||||
3792887|NCT01838590|3622280|B2|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|16|16.0||||||
3792829|NCT01838616|3622209|B1|painDETECT positive||painDETECT|"The painDETECT questionnaire was used to determine the possibility of the presence of a neuropathic pain component. It is a participant completed questionnaire. A total score is calculated. Participants with a score between 0 and 12 are scored as being negative (no neuropathic pain component). Value between 19 and 38 as being positive (presence of neuropathic component). Values from 13 to 18 are scored as being unclear. Participants being treated with a stable regimen of centrally acting co-analgesics at baseline were permitted if the score was at least 9."|participants|Number|96|96.0||||||
3792830|NCT01838616|3622207|B3|||Weight||kilogram|Mean|83.5|83.5|Standard Deviation|18.39|18.39|||
3792831|NCT01838616|3622208|B2|||Weight||kilogram|Mean|81.6|81.6|Standard Deviation|18.43|18.43|||
3792832|NCT01838616|3622209|B1|||Weight||kilogram|Mean|85.3|85.3|Standard Deviation|18.23|18.23|||
3792833|NCT01838616|3622207|B3|||Height||centimeters|Mean|168.3|168.3|Standard Deviation|10.38|10.38|||
3792834|NCT01838616|3622208|B2|||Height||centimeters|Mean|167.7|167.7|Standard Deviation|9.71|9.71|||
3792835|NCT01838616|3622209|B1|||Height||centimeters|Mean|168.9|168.9|Standard Deviation|11.00|11.0|||
3792836|NCT01838616|3622207|B3|||Duration of pain [months]||months|Median|70.5|70.5|Full Range|||3.0|552.0|
3792837|NCT01838616|3622208|B2|||Duration of pain [months]||months|Median|72|72.0|Full Range|||3.0|504.0|
3792838|NCT01838616|3622209|B1|||Duration of pain [months]||months|Median|61.5|61.5|Full Range|||4.0|552.0|
3792839|NCT01838616|3622207|B3|||Lumbar radiculopathy||participants|Number|151|151.0||||||
3792840|NCT01838616|3622208|B2|||Lumbar radiculopathy||participants|Number|75|75.0||||||
3792841|NCT01838616|3622209|B1|||Lumbar radiculopathy||participants|Number|76|76.0||||||
3792842|NCT01838616|3622207|B3|||Dermatol pain present||participants|Number|232|232.0||||||
3792843|NCT01838616|3622208|B2|||Dermatol pain present||participants|Number|111|111.0||||||
3792844|NCT01838616|3622209|B1|||Dermatol pain present||participants|Number|121|121.0||||||
3792845|NCT01838616|3622207|B3|Germany||Region of Enrollment||participants|Number|202|202.0||||||
3792846|NCT01838616|3622208|B2|Germany||Region of Enrollment||participants|Number|100|100.0||||||
3792847|NCT01838616|3622209|B1|Germany||Region of Enrollment||participants|Number|102|102.0||||||
3792848|NCT01838616|3622207|B3|Austria||Region of Enrollment||participants|Number|17|17.0||||||
3792849|NCT01838616|3622208|B2|Austria||Region of Enrollment||participants|Number|9|9.0||||||
3792850|NCT01838616|3622209|B1|Austria||Region of Enrollment||participants|Number|8|8.0||||||
3792851|NCT01838616|3622207|B3|Spain||Region of Enrollment||participants|Number|39|39.0||||||
3792852|NCT01838616|3622208|B2|Spain||Region of Enrollment||participants|Number|19|19.0||||||
3792853|NCT01838616|3622209|B1|Spain||Region of Enrollment||participants|Number|20|20.0||||||
3792854|NCT01838616|3622207|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792855|NCT01838616|3622208|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792856|NCT01838616|3622209|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792857|NCT01838616|3622207|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792858|NCT01838616|3622208|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792859|NCT01838616|3622209|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792860|NCT01838616|3622207|B3||White|Race (NIH/OMB)||Participants|Count of Participants|258|258.0||||||
3792861|NCT01838616|3622208|B2||White|Race (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
3792862|NCT01838616|3622209|B1||White|Race (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
3792863|NCT01838616|3622207|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792864|NCT01838616|3622208|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792865|NCT01838616|3622209|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792866|NCT01838616|3622207|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792867|NCT01838616|3622208|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792868|NCT01838616|3622209|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792869|NCT01838616|3622207|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792870|NCT01838616|3622208|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792871|NCT01838616|3622209|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792872|NCT01838616|3622207|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792873|NCT01838616|3622208|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792874|NCT01838616|3622209|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3792875|NCT01838616|3622207|B3||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3792876|NCT01838616|3622208|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3792877|NCT01838616|3622209|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3792878|NCT01838616|3622207|B3||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3792879|NCT01838616|3622208|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3792880|NCT01838616|3622209|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3792881|NCT01838616|3622207|B3|||Age||years|Mean|58.2|58.2|Standard Deviation|11.84|11.84|||
3792882|NCT01838616|3622208|B2|||Age||years|Mean|58.4|58.4|Standard Deviation|12.23|12.23|||
3792883|NCT01838616|3622209|B1|||Age||years|Mean|58.1|58.1|Standard Deviation|11.48|11.48|||
3792884|NCT01838590|3622277|B5|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|54|54.0||||||
3792888|NCT01838590|3622281|B1|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|10|10.0||||||
3792889|NCT01838590|3622277|B5|< 800,000 IU/mL||HCV RNA Category||participants|Number|49|49.0||||||
3792890|NCT01838590|3622278|B4|< 800,000 IU/mL||HCV RNA Category||participants|Number|8|8.0||||||
3792891|NCT01838590|3622279|B3|< 800,000 IU/mL||HCV RNA Category||participants|Number|15|15.0||||||
3792892|NCT01838590|3622280|B2|< 800,000 IU/mL||HCV RNA Category||participants|Number|11|11.0||||||
3792893|NCT01838590|3622281|B1|< 800,000 IU/mL||HCV RNA Category||participants|Number|15|15.0||||||
3792894|NCT01838590|3622277|B5|||HCV RNA||log10 IU/mL|Mean|5.8|5.8|Standard Deviation|0.70|0.7|||
3792895|NCT01838590|3622278|B4|||HCV RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.49|0.49|||
3792896|NCT01838590|3622279|B3|||HCV RNA||log10 IU/mL|Mean|5.5|5.5|Standard Deviation|0.75|0.75|||
3792897|NCT01838590|3622280|B2|||HCV RNA||log10 IU/mL|Mean|5.9|5.9|Standard Deviation|0.57|0.57|||
3792898|NCT01838590|3622281|B1|||HCV RNA||log10 IU/mL|Mean|5.6|5.6|Standard Deviation|0.73|0.73|||
3792899|NCT01838590|3622277|B5|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|20|20.0||||||
3792900|NCT01838590|3622278|B4|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3792901|NCT01838590|3622279|B3|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|6|6.0||||||
3792902|NCT01838590|3622280|B2|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|8|8.0||||||
3792903|NCT01838590|3622281|B1|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|5|5.0||||||
3792904|NCT01838590|3622277|B5|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|63|63.0||||||
3792905|NCT01838590|3622278|B4|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|21|21.0||||||
3792906|NCT01838590|3622279|B3|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|12|12.0||||||
3792907|NCT01838590|3622280|B2|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|18|18.0||||||
3792908|NCT01838590|3622281|B1|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|12|12.0||||||
3792909|NCT01838590|3622277|B5|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|20|20.0||||||
3792910|NCT01838590|3622278|B4|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|5|5.0||||||
3792911|NCT01838590|3622279|B3|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|6|6.0||||||
3792912|NCT01838590|3622280|B2|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3792913|NCT01838590|3622281|B1|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|8|8.0||||||
3792914|NCT01838590|3622277|B5|Yes||Cirrhosis Status||participants|Number|17|17.0||||||
3792915|NCT01838590|3622278|B4|Yes||Cirrhosis Status||participants|Number|6|6.0||||||
3792916|NCT01838590|3622279|B3|Yes||Cirrhosis Status||participants|Number|3|3.0||||||
3792917|NCT01838590|3622280|B2|Yes||Cirrhosis Status||participants|Number|5|5.0||||||
3792918|NCT01838590|3622281|B1|Yes||Cirrhosis Status||participants|Number|3|3.0||||||
3792919|NCT01838590|3622277|B5|No||Cirrhosis Status||participants|Number|86|86.0||||||
3792920|NCT01838590|3622278|B4|No||Cirrhosis Status||participants|Number|21|21.0||||||
3792921|NCT01838590|3622279|B3|No||Cirrhosis Status||participants|Number|21|21.0||||||
3792922|NCT01838590|3622280|B2|No||Cirrhosis Status||participants|Number|22|22.0||||||
3792923|NCT01838590|3622281|B1|No||Cirrhosis Status||participants|Number|22|22.0||||||
3792924|NCT01838590|3622277|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|103|103.0||||||
3792925|NCT01838590|3622278|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
3792926|NCT01838590|3622279|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3792927|NCT01838590|3622280|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
3792928|NCT01838590|3622281|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3792929|NCT01838590|3622277|B5|White||Race/Ethnicity, Customized||participants|Number|103|103.0||||||
3792930|NCT01838590|3622278|B4|White||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
3792931|NCT01838590|3622279|B3|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3792932|NCT01838590|3622280|B2|White||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
3792933|NCT01838590|3622281|B1|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3792934|NCT01838590|3622277|B5||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3792935|NCT01838590|3622278|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3792936|NCT01838590|3622279|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3792937|NCT01838590|3622280|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3792938|NCT01838590|3622281|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3792939|NCT01838590|3622277|B5||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3792940|NCT01838590|3622278|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3792941|NCT01838590|3622279|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3792942|NCT01838590|3622280|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3792943|NCT01838590|3622281|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3792944|NCT01838590|3622277|B5|||Age||years|Mean|47|47.0|Standard Deviation|11.9|11.9|||
3792945|NCT01838590|3622278|B4|||Age||years|Mean|51|51.0|Standard Deviation|8.3|8.3|||
3792946|NCT01838590|3622279|B3|||Age||years|Mean|46|46.0|Standard Deviation|14.5|14.5|||
3792947|NCT01838590|3622280|B2|||Age||years|Mean|46|46.0|Standard Deviation|11.5|11.5|||
3792948|NCT01838590|3622281|B1|||Age||years|Mean|43|43.0|Standard Deviation|12.3|12.3|||
3792949|NCT01838499|3622304|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3792950|NCT01838499|3622305|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3792951|NCT01838499|3622306|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3792952|NCT01838499|3622304|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3792953|NCT01838499|3622305|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3792954|NCT01838499|3622306|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3792955|NCT01838499|3622304|B3|||Age||Years|Mean|36.9|36.9|Standard Deviation|11.72|11.72|||
3792956|NCT01838499|3622305|B2|||Age||Years|Mean|36.4|36.4|Standard Deviation|12.42|12.42|||
3792957|NCT01838499|3622306|B1|||Age||Years|Mean|37.5|37.5|Standard Deviation|11.08|11.08|||
3792958|NCT01838304|3622317|B3|||Weight||kg|Mean|82.22|82.22|Standard Deviation|25.4|25.4|||
3792959|NCT01838304|3622318|B2|||Weight||kg|Mean|82.1|82.1|Standard Deviation|23.9|23.9|||
3792960|NCT01838304|3622319|B1|||Weight||kg|Mean|82.3|82.3|Standard Deviation|27.4|27.4|||
3792961|NCT01838304|3622317|B3|||ASA 3|American Society of Anesthesia physical status rating. ASA 1 = Healthy ASA 2 = Minor illness (i.e. hypertension) ASA 3 = Major illness (i.e. S/P myocardial infarction)|Participants|Count of Participants|15|15.0||||||
3792962|NCT01838304|3622318|B2|||ASA 3|American Society of Anesthesia physical status rating. ASA 1 = Healthy ASA 2 = Minor illness (i.e. hypertension) ASA 3 = Major illness (i.e. S/P myocardial infarction)|Participants|Count of Participants|8|8.0||||||
3792963|NCT01838304|3622319|B1|||ASA 3|American Society of Anesthesia physical status rating. ASA 1 = Healthy ASA 2 = Minor illness (i.e. hypertension) ASA 3 = Major illness (i.e. S/P myocardial infarction)|Participants|Count of Participants|7|7.0||||||
3792964|NCT01838304|3622317|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3792965|NCT01838304|3622318|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3792966|NCT01838304|3622319|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3792967|NCT01838304|3622317|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3792968|NCT01838304|3622318|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3792969|NCT01838304|3622319|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3792970|NCT01838304|3622317|B3|||Age||years|Mean|50.625|50.625|Standard Deviation|15.345|15.345|||
3792971|NCT01838304|3622318|B2|||Age||years|Mean|52.8|52.8|Standard Deviation|16.5|16.5|||
3792972|NCT01838304|3622319|B1|||Age||years|Mean|48.5|48.5|Standard Deviation|14.2|14.2|||
3792973|NCT01838213|3622332|B3|Norway||Region of Enrollment||participants|Number|343|343.0||||||
3792974|NCT01838213|3622333|B2|Norway||Region of Enrollment||participants|Number|262|262.0||||||
3792975|NCT01838213|3622334|B1|Norway||Region of Enrollment||participants|Number|81|81.0||||||
3792976|NCT01838213|3622332|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3792977|NCT01838213|3622333|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3792978|NCT01838213|3622334|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3792979|NCT01838213|3622332|B3||Female|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
3792980|NCT01838213|3622333|B2||Female|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
3792981|NCT01838213|3622334|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3792982|NCT01838213|3622332|B3|||Age||years|Mean|59|59.0|Full Range|||18.0|93.0|
3792983|NCT01838213|3622333|B2|||Age||years|Mean|61|61.0|Full Range|||19.0|93.0|
3792984|NCT01838213|3622334|B1|||Age||years|Mean|54|54.0|Full Range|||18.0|92.0|
3792985|NCT01838044|3622341|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3792986|NCT01838044|3622342|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3792987|NCT01838044|3622343|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3792988|NCT01838044|3622341|B3||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3792989|NCT01838044|3622342|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3792990|NCT01838044|3622343|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3792991|NCT01838044|3622341|B3|||Age||Years|Mean|49.5|49.5|Standard Deviation|11.9|11.9|||
3792992|NCT01838044|3622342|B2|||Age||Years|Mean|49.2|49.2|Standard Deviation|12.2|12.2|||
3792993|NCT01838044|3622343|B1|||Age||Years|Mean|49.7|49.7|Standard Deviation|11.7|11.7|||
3792994|NCT01837966|3622375|B3|ASA III||American Society of Anesthesiologists (ASA) Physical Status Classification|"ASA Physical Status I, II, III~ASA I: Normal healthy patient (excludes the very young/very old) ASA II - Patients w/ mild systemic disease (No functional limitations; well-controlled disease of one body system; i.e. controlled HTN or diabetes w/o systemic effects, cigarette smoking w/o COPD) ASA III - Patients w/ severe systemic disease (Some functional limitation; controlled disease of more than one body system/or one major system; no immediate danger of death; i.e controlled Congestive Heart Failure, stable angina, old heart attack, poorly controlled HTN)"|participants|Number|2|2.0||||||
3792995|NCT01837966|3622376|B2|ASA III||American Society of Anesthesiologists (ASA) Physical Status Classification|"ASA Physical Status I, II, III~ASA I: Normal healthy patient (excludes the very young/very old) ASA II - Patients w/ mild systemic disease (No functional limitations; well-controlled disease of one body system; i.e. controlled HTN or diabetes w/o systemic effects, cigarette smoking w/o COPD) ASA III - Patients w/ severe systemic disease (Some functional limitation; controlled disease of more than one body system/or one major system; no immediate danger of death; i.e controlled Congestive Heart Failure, stable angina, old heart attack, poorly controlled HTN)"|participants|Number|1|1.0||||||
3792996|NCT01837966|3622377|B1|ASA III||American Society of Anesthesiologists (ASA) Physical Status Classification|"ASA Physical Status I, II, III~ASA I: Normal healthy patient (excludes the very young/very old) ASA II - Patients w/ mild systemic disease (No functional limitations; well-controlled disease of one body system; i.e. controlled HTN or diabetes w/o systemic effects, cigarette smoking w/o COPD) ASA III - Patients w/ severe systemic disease (Some functional limitation; controlled disease of more than one body system/or one major system; no immediate danger of death; i.e controlled Congestive Heart Failure, stable angina, old heart attack, poorly controlled HTN)"|participants|Number|1|1.0||||||
3792997|NCT01837966|3622375|B3|ASA II||American Society of Anesthesiologists (ASA) Physical Status Classification|"ASA Physical Status I, II, III~ASA I: Normal healthy patient (excludes the very young/very old) ASA II - Patients w/ mild systemic disease (No functional limitations; well-controlled disease of one body system; i.e. controlled HTN or diabetes w/o systemic effects, cigarette smoking w/o COPD) ASA III - Patients w/ severe systemic disease (Some functional limitation; controlled disease of more than one body system/or one major system; no immediate danger of death; i.e controlled Congestive Heart Failure, stable angina, old heart attack, poorly controlled HTN)"|participants|Number|56|56.0||||||
3792998|NCT01837966|3622376|B2|ASA II||American Society of Anesthesiologists (ASA) Physical Status Classification|"ASA Physical Status I, II, III~ASA I: Normal healthy patient (excludes the very young/very old) ASA II - Patients w/ mild systemic disease (No functional limitations; well-controlled disease of one body system; i.e. controlled HTN or diabetes w/o systemic effects, cigarette smoking w/o COPD) ASA III - Patients w/ severe systemic disease (Some functional limitation; controlled disease of more than one body system/or one major system; no immediate danger of death; i.e controlled Congestive Heart Failure, stable angina, old heart attack, poorly controlled HTN)"|participants|Number|29|29.0||||||
3792999|NCT01837966|3622377|B1|ASA II||American Society of Anesthesiologists (ASA) Physical Status Classification|"ASA Physical Status I, II, III~ASA I: Normal healthy patient (excludes the very young/very old) ASA II - Patients w/ mild systemic disease (No functional limitations; well-controlled disease of one body system; i.e. controlled HTN or diabetes w/o systemic effects, cigarette smoking w/o COPD) ASA III - Patients w/ severe systemic disease (Some functional limitation; controlled disease of more than one body system/or one major system; no immediate danger of death; i.e controlled Congestive Heart Failure, stable angina, old heart attack, poorly controlled HTN)"|participants|Number|27|27.0||||||
3793000|NCT01837966|3622375|B3|ASA I||American Society of Anesthesiologists (ASA) Physical Status Classification|"ASA Physical Status I, II, III~ASA I: Normal healthy patient (excludes the very young/very old) ASA II - Patients w/ mild systemic disease (No functional limitations; well-controlled disease of one body system; i.e. controlled HTN or diabetes w/o systemic effects, cigarette smoking w/o COPD) ASA III - Patients w/ severe systemic disease (Some functional limitation; controlled disease of more than one body system/or one major system; no immediate danger of death; i.e controlled Congestive Heart Failure, stable angina, old heart attack, poorly controlled HTN)"|participants|Number|30|30.0||||||
3793001|NCT01837966|3622376|B2|ASA I||American Society of Anesthesiologists (ASA) Physical Status Classification|"ASA Physical Status I, II, III~ASA I: Normal healthy patient (excludes the very young/very old) ASA II - Patients w/ mild systemic disease (No functional limitations; well-controlled disease of one body system; i.e. controlled HTN or diabetes w/o systemic effects, cigarette smoking w/o COPD) ASA III - Patients w/ severe systemic disease (Some functional limitation; controlled disease of more than one body system/or one major system; no immediate danger of death; i.e controlled Congestive Heart Failure, stable angina, old heart attack, poorly controlled HTN)"|participants|Number|15|15.0||||||
3793002|NCT01837966|3622377|B1|ASA I||American Society of Anesthesiologists (ASA) Physical Status Classification|"ASA Physical Status I, II, III~ASA I: Normal healthy patient (excludes the very young/very old) ASA II - Patients w/ mild systemic disease (No functional limitations; well-controlled disease of one body system; i.e. controlled HTN or diabetes w/o systemic effects, cigarette smoking w/o COPD) ASA III - Patients w/ severe systemic disease (Some functional limitation; controlled disease of more than one body system/or one major system; no immediate danger of death; i.e controlled Congestive Heart Failure, stable angina, old heart attack, poorly controlled HTN)"|participants|Number|15|15.0||||||
3793003|NCT01837966|3622375|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3793004|NCT01837966|3622376|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3793005|NCT01837966|3622377|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3793006|NCT01837966|3622375|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793007|NCT01837966|3622376|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793008|NCT01837966|3622377|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793009|NCT01837966|3622375|B3||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3793010|NCT01837966|3622376|B2||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3793011|NCT01837966|3622377|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3793012|NCT01837966|3622375|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3793013|NCT01837966|3622376|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3793014|NCT01837966|3622377|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3793015|NCT01837966|3622375|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793016|NCT01837966|3622376|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793017|NCT01837966|3622377|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793018|NCT01837966|3622375|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3793019|NCT01837966|3622376|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3793020|NCT01837966|3622377|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3793021|NCT01837966|3622375|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793022|NCT01837966|3622376|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793023|NCT01837966|3622377|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793024|NCT01837966|3622375|B3|Female||Sex/Gender, Customized||participants|Number|88|88.0||||||
3793025|NCT01837966|3622376|B2|Female||Sex/Gender, Customized||participants|Number|45|45.0||||||
3793026|NCT01837966|3622377|B1|Female||Sex/Gender, Customized||participants|Number|43|43.0||||||
3793027|NCT01837966|3622375|B3|Male||Sex/Gender, Customized||participants|Number|0|0.0||||||
3793028|NCT01837966|3622376|B2|Male||Sex/Gender, Customized||participants|Number|0|0.0||||||
3793029|NCT01837966|3622377|B1|Male||Sex/Gender, Customized||participants|Number|0|0.0||||||
3793030|NCT01837966|3622375|B3|||Age||years|Mean|49|49.0|Full Range|||22.0|86.0|
3793031|NCT01837966|3622376|B2|||Age||years|Mean|48|48.0|Full Range|||22.0|82.0|
3793032|NCT01837966|3622377|B1|||Age||years|Mean|50|50.0|Full Range|||24.0|86.0|
3793033|NCT01837823|3622384|B1||the right coronary artery (RCA)|Location of coronary artery disease||Participants|Count of Participants|26|26.0||||||
3793034|NCT01837823|3622384|B1||left circumflex artery (LCX)|Location of coronary artery disease||Participants|Count of Participants|23|23.0||||||
3793035|NCT01837823|3622384|B1||the left anterior descending artery (LAD)|Location of coronary artery disease||Participants|Count of Participants|36|36.0||||||
3793036|NCT01837823|3622384|B1||none|Statin use||Participants|Count of Participants|16|16.0||||||
3793037|NCT01837823|3622384|B1||fluvastatin|Statin use||Participants|Count of Participants|1|1.0||||||
3793038|NCT01837823|3622384|B1||pravastatin|Statin use||Participants|Count of Participants|4|4.0||||||
3793039|NCT01837823|3622384|B1||rosuvastatin|Statin use||Participants|Count of Participants|12|12.0||||||
3793040|NCT01837823|3622384|B1||simvastatin|Statin use||Participants|Count of Participants|23|23.0||||||
3793041|NCT01837823|3622384|B1||atorvastatin|Statin use||Participants|Count of Participants|29|29.0||||||
3793042|NCT01837823|3622384|B1|||Prior percutaneous coronary intervention (PCI)||Participants|Count of Participants|24|24.0||||||
3793043|NCT01837823|3622384|B1|||Prior myocardial infarction (MI)||Participants|Count of Participants|12|12.0||||||
3793044|NCT01837823|3622384|B1|||History of smoking||Participants|Count of Participants|26|26.0||||||
3793045|NCT01837823|3622384|B1|||Current smoking||Participants|Count of Participants|12|12.0||||||
3793046|NCT01837823|3622384|B1|||Body mass index (BMI)||kg/m^2|Mean|29.6|29.6|Standard Deviation|5.2|5.2|||
3793047|NCT01837823|3622384|B1|||Diabetes mellitus||Participants|Count of Participants|37|37.0||||||
3793048|NCT01837823|3622384|B1|||Hypercholesterolemia||Participants|Count of Participants|75|75.0||||||
3793049|NCT01837823|3622384|B1|||Hypertension||Participants|Count of Participants|76|76.0||||||
3793050|NCT01837823|3622384|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3793051|NCT01837823|3622384|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3793052|NCT01837823|3622384|B1|||Age||years|Mean|62.4|62.4|Standard Deviation|11.2|11.2|||
3793053|NCT01837797|3622412|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3793054|NCT01837797|3622413|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3793055|NCT01837797|3622414|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3793056|NCT01837797|3622415|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3793057|NCT01837797|3622412|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3793058|NCT01837797|3622413|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3793059|NCT01837797|3622414|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3793060|NCT01837797|3622415|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3793061|NCT01837797|3622412|B4||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3793062|NCT01837797|3622413|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3793063|NCT01837797|3622414|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3793064|NCT01837797|3622415|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3793065|NCT01837797|3622412|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3793066|NCT01837797|3622413|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3793067|NCT01837797|3622414|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3793068|NCT01837797|3622415|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3793069|NCT01837797|3622412|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3793070|NCT01837797|3622413|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3793071|NCT01837797|3622414|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3793072|NCT01837797|3622415|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3793073|NCT01837719|3622454|B1|||Body mass index||kg/m^2|Mean|26.5|26.5|Standard Deviation|2.9|2.9|||
3793074|NCT01837719|3622454|B1|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3793075|NCT01837719|3622454|B1|Black||Race/Ethnicity, Customized||Participants|Number|33|33.0||||||
3793076|NCT01837719|3622454|B1|White||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
3793077|NCT01837719|3622454|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3793078|NCT01837719|3622454|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3793079|NCT01837719|3622454|B1|||Age||Years|Mean|32.5|32.5|Standard Deviation|7.4|7.4|||
3793080|NCT01837680|3622521|B3|||Time between visits||weeks|Median|1.5|1.5|Inter-Quartile Range|||1.3|1.9|
3793081|NCT01837680|3622522|B2|||Time between visits||weeks|Median|1.5|1.5|Inter-Quartile Range|||1.3|1.8|
3793082|NCT01837680|3622523|B1|||Time between visits||weeks|Median|1.5|1.5|Inter-Quartile Range|||1.3|2.0|
3793083|NCT01837680|3622521|B3|||Gestational age insulin started||weeks|Median|30.0|30.0|Inter-Quartile Range|||27.3|31.4|
3793084|NCT01837680|3622522|B2|||Gestational age insulin started||weeks|Median|30.0|30.0|Inter-Quartile Range|||25.1|31.5|
3793085|NCT01837680|3622523|B1|||Gestational age insulin started||weeks|Median|29.6|29.6|Inter-Quartile Range|||27.5|31.4|
3793086|NCT01837680|3622521|B3|||Gestational age at entry to DIPP||weeks|Median|27.5|27.5|Inter-Quartile Range|||24.1|29.0|
3793087|NCT01837680|3622522|B2|||Gestational age at entry to DIPP||weeks|Median|28.1|28.1|Inter-Quartile Range|||25.1|29.3|
3793088|NCT01837680|3622523|B1|||Gestational age at entry to DIPP||weeks|Median|27.3|27.3|Inter-Quartile Range|||23.3|28.5|
3793089|NCT01837680|3622521|B3|Other type of insulin||Previous management||Participants|Count of Participants|1|1.0||||||
3793090|NCT01837680|3622522|B2|Other type of insulin||Previous management||Participants|Count of Participants|1|1.0||||||
3793091|NCT01837680|3622523|B1|Other type of insulin||Previous management||Participants|Count of Participants|0|0.0||||||
3793092|NCT01837680|3622521|B3|Metformin and glyburide||Previous management||Participants|Count of Participants|1|1.0||||||
3793093|NCT01837680|3622522|B2|Metformin and glyburide||Previous management||Participants|Count of Participants|0|0.0||||||
3793094|NCT01837680|3622523|B1|Metformin and glyburide||Previous management||Participants|Count of Participants|1|1.0||||||
3793095|NCT01837680|3622521|B3|Metformin||Previous management||Participants|Count of Participants|5|5.0||||||
3793096|NCT01837680|3622522|B2|Metformin||Previous management||Participants|Count of Participants|2|2.0||||||
3793097|NCT01837680|3622523|B1|Metformin||Previous management||Participants|Count of Participants|3|3.0||||||
3793098|NCT01837680|3622521|B3|Glyburide||Previous management||Participants|Count of Participants|5|5.0||||||
3793099|NCT01837680|3622522|B2|Glyburide||Previous management||Participants|Count of Participants|2|2.0||||||
3793100|NCT01837680|3622523|B1|Glyburide||Previous management||Participants|Count of Participants|3|3.0||||||
3793101|NCT01837680|3622521|B3|Diet, Metformin||Previous management||Participants|Count of Participants|1|1.0||||||
3793102|NCT01837680|3622522|B2|Diet, Metformin||Previous management||Participants|Count of Participants|1|1.0||||||
3793103|NCT01837680|3622523|B1|Diet, Metformin||Previous management||Participants|Count of Participants|0|0.0||||||
3793104|NCT01837680|3622521|B3|Diet||Previous management||Participants|Count of Participants|74|74.0||||||
3793105|NCT01837680|3622522|B2|Diet||Previous management||Participants|Count of Participants|39|39.0||||||
3793106|NCT01837680|3622523|B1|Diet||Previous management||Participants|Count of Participants|35|35.0||||||
3793107|NCT01837680|3622521|B3|||Gestational age diagnosed||weeks|Median|26.3|26.3|Inter-Quartile Range|||25.2|27.4|
3793108|NCT01837680|3622522|B2|||Gestational age diagnosed||weeks|Median|26.6|26.6|Inter-Quartile Range|||25.4|28.2|
3793109|NCT01837680|3622523|B1|||Gestational age diagnosed||weeks|Median|26.1|26.1|Inter-Quartile Range|||24.8|27.1|
3793110|NCT01837680|3622521|B3|Morbidly obese||Prepregnancy body status||Participants|Count of Participants|7|7.0||||||
3793111|NCT01837680|3622522|B2|Morbidly obese||Prepregnancy body status||Participants|Count of Participants|3|3.0||||||
3793112|NCT01837680|3622523|B1|Morbidly obese||Prepregnancy body status||Participants|Count of Participants|4|4.0||||||
3793113|NCT01837680|3622521|B3|Overweight||Prepregnancy body status||Participants|Count of Participants|28|28.0||||||
3793114|NCT01837680|3622522|B2|Overweight||Prepregnancy body status||Participants|Count of Participants|16|16.0||||||
3793115|NCT01837680|3622523|B1|Overweight||Prepregnancy body status||Participants|Count of Participants|12|12.0||||||
3793116|NCT01837680|3622521|B3|Obese||Prepregnancy body status||Participants|Count of Participants|26|26.0||||||
3793117|NCT01837680|3622522|B2|Obese||Prepregnancy body status||Participants|Count of Participants|12|12.0||||||
3793118|NCT01837680|3622523|B1|Obese||Prepregnancy body status||Participants|Count of Participants|14|14.0||||||
3793119|NCT01837680|3622521|B3|Normal||Prepregnancy body status||Participants|Count of Participants|25|25.0||||||
3793120|NCT01837680|3622522|B2|Normal||Prepregnancy body status||Participants|Count of Participants|14|14.0||||||
3793121|NCT01837680|3622523|B1|Normal||Prepregnancy body status||Participants|Count of Participants|11|11.0||||||
3793122|NCT01837680|3622521|B3|||Prepregnancy body mass index||kg/m^2|Median|28.4|28.4|Inter-Quartile Range|||24.5|32.3|
3793123|NCT01837680|3622522|B2|||Prepregnancy body mass index||kg/m^2|Median|28.6|28.6|Inter-Quartile Range|||24.4|31.1|
3793124|NCT01837680|3622523|B1|||Prepregnancy body mass index||kg/m^2|Median|28.3|28.3|Inter-Quartile Range|||24.9|33.8|
3793125|NCT01837680|3622521|B3|||Thyroid disease||Participants|Count of Participants|14|14.0||||||
3793126|NCT01837680|3622522|B2|||Thyroid disease||Participants|Count of Participants|8|8.0||||||
3793127|NCT01837680|3622523|B1|||Thyroid disease||Participants|Count of Participants|6|6.0||||||
3793128|NCT01837680|3622521|B3|||Renal disease||Participants|Count of Participants|6|6.0||||||
3793129|NCT01837680|3622522|B2|||Renal disease||Participants|Count of Participants|5|5.0||||||
3793130|NCT01837680|3622523|B1|||Renal disease||Participants|Count of Participants|1|1.0||||||
3793131|NCT01837680|3622521|B3|||Chronic hypertension||Participants|Count of Participants|11|11.0||||||
3793132|NCT01837680|3622522|B2|||Chronic hypertension||Participants|Count of Participants|6|6.0||||||
3793133|NCT01837680|3622523|B1|||Chronic hypertension||Participants|Count of Participants|5|5.0||||||
3793134|NCT01837680|3622521|B3|||Polycystic ovary syndrome||Participants|Count of Participants|17|17.0||||||
3793135|NCT01837680|3622522|B2|||Polycystic ovary syndrome||Participants|Count of Participants|12|12.0||||||
3793136|NCT01837680|3622523|B1|||Polycystic ovary syndrome||Participants|Count of Participants|5|5.0||||||
3793137|NCT01837680|3622521|B3|||Multiple gestation||Participants|Count of Participants|5|5.0||||||
3793138|NCT01837680|3622522|B2|||Multiple gestation||Participants|Count of Participants|3|3.0||||||
3793139|NCT01837680|3622523|B1|||Multiple gestation||Participants|Count of Participants|2|2.0||||||
3793140|NCT01837680|3622521|B3|||GDM in previous pregnancies||Participants|Count of Participants|17|17.0||||||
3793141|NCT01837680|3622522|B2|||GDM in previous pregnancies||Participants|Count of Participants|9|9.0||||||
3793142|NCT01837680|3622523|B1|||GDM in previous pregnancies||Participants|Count of Participants|8|8.0||||||
3793143|NCT01837680|3622521|B3|||T2DM|Type 2 Diabetes Mellitus|Participants|Count of Participants|14|14.0||||||
3793144|NCT01837680|3622522|B2|||T2DM|Type 2 Diabetes Mellitus|Participants|Count of Participants|7|7.0||||||
3793145|NCT01837680|3622523|B1|||T2DM|Type 2 Diabetes Mellitus|Participants|Count of Participants|7|7.0||||||
3793146|NCT01837680|3622521|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3793147|NCT01837680|3622522|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3793148|NCT01837680|3622523|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3793149|NCT01837680|3622521|B3|Biracial/Multiracial||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3793150|NCT01837680|3622522|B2|Biracial/Multiracial||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3793151|NCT01837680|3622523|B1|Biracial/Multiracial||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3793152|NCT01837680|3622521|B3|Native American/Alaskan||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3793153|NCT01837680|3622522|B2|Native American/Alaskan||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3793154|NCT01837680|3622523|B1|Native American/Alaskan||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3793155|NCT01837680|3622521|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3793156|NCT01837680|3622522|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3793157|NCT01837680|3622523|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3793158|NCT01837680|3622521|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3793159|NCT01837680|3622522|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3793160|NCT01837680|3622523|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3793161|NCT01837680|3622521|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3793162|NCT01837680|3622522|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3793163|NCT01837680|3622523|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3793164|NCT01837680|3622521|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3793165|NCT01837680|3622522|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3793166|NCT01837680|3622523|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3793167|NCT01837680|3622521|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3793168|NCT01837680|3622522|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3793169|NCT01837680|3622523|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3793170|NCT01837680|3622521|B3|||Age||years|Mean|35|35.0|Full Range|||31.0|38.0|
3793171|NCT01837680|3622522|B2|||Age||years|Mean|35|35.0|Full Range|||32.0|38.0|
3793172|NCT01837680|3622523|B1|||Age||years|Mean|35|35.0|Full Range|||31.0|38.0|
3793173|NCT01837550|3622560|B3|||Use of hearing aid||years|Mean|7.5|7.5|Standard Deviation|8.0|8.0|||
3793174|NCT01837550|3622561|B2|||Use of hearing aid||years|Mean|7.4|7.4|Standard Deviation|6.3|6.3|||
3793175|NCT01837550|3622562|B1|||Use of hearing aid||years|Mean|7.5|7.5|Standard Deviation|9.6|9.6|||
3793176|NCT01837550|3622560|B3|Monaurally||Number of Hearing Aids||numbers|Number|15|15.0||||||
3793177|NCT01837550|3622561|B2|Monaurally||Number of Hearing Aids||numbers|Number|6|6.0||||||
3793178|NCT01837550|3622562|B1|Monaurally||Number of Hearing Aids||numbers|Number|9|9.0||||||
3793179|NCT01837550|3622560|B3|Binaurally||Number of Hearing Aids||numbers|Number|59|59.0||||||
3793180|NCT01837550|3622561|B2|Binaurally||Number of Hearing Aids||numbers|Number|31|31.0||||||
3793181|NCT01837550|3622562|B1|Binaurally||Number of Hearing Aids||numbers|Number|28|28.0||||||
3793182|NCT01837550|3622560|B3|Left ear||Pure-tone average|Measuring the presence of conductive or sensorineural hearing loss of a mild to moderate degree, i.e., 20–60 dB HL. Pure-tone average (PTA) measured across 500-, 1000-, and 2000 Hz.|decibel Hearing Level|Mean|37.1|37.1|Standard Deviation|9.5|9.5|||
3793183|NCT01837550|3622561|B2|Left ear||Pure-tone average|Measuring the presence of conductive or sensorineural hearing loss of a mild to moderate degree, i.e., 20–60 dB HL. Pure-tone average (PTA) measured across 500-, 1000-, and 2000 Hz.|decibel Hearing Level|Mean|36.5|36.5|Standard Deviation|8.5|8.5|||
3793184|NCT01837550|3622562|B1|Left ear||Pure-tone average|Measuring the presence of conductive or sensorineural hearing loss of a mild to moderate degree, i.e., 20–60 dB HL. Pure-tone average (PTA) measured across 500-, 1000-, and 2000 Hz.|decibel Hearing Level|Mean|37.8|37.8|Standard Deviation|10.5|10.5|||
3793185|NCT01837550|3622560|B3|Right ear||Pure-tone average|Measuring the presence of conductive or sensorineural hearing loss of a mild to moderate degree, i.e., 20–60 dB HL. Pure-tone average (PTA) measured across 500-, 1000-, and 2000 Hz.|decibel Hearing Level|Mean|37.8|37.8|Standard Deviation|10.0|10.0|||
3793186|NCT01837550|3622561|B2|Right ear||Pure-tone average|Measuring the presence of conductive or sensorineural hearing loss of a mild to moderate degree, i.e., 20–60 dB HL. Pure-tone average (PTA) measured across 500-, 1000-, and 2000 Hz.|decibel Hearing Level|Mean|38.0|38.0|Standard Deviation|8.6|8.6|||
3793187|NCT01837550|3622562|B1|Right ear||Pure-tone average|Measuring the presence of conductive or sensorineural hearing loss of a mild to moderate degree, i.e., 20–60 dB HL. Pure-tone average (PTA) measured across 500-, 1000-, and 2000 Hz.|decibel Hearing Level|Mean|37.5|37.5|Standard Deviation|11.3|11.3|||
3793188|NCT01837550|3622560|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3793189|NCT01837550|3622561|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3793190|NCT01837550|3622562|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3793191|NCT01837550|3622560|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3793192|NCT01837550|3622561|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3793193|NCT01837550|3622562|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3793194|NCT01837550|3622560|B3|||Age||years|Mean|62.0|62.0|Standard Deviation|11.6|11.6|||
3793195|NCT01837550|3622561|B2|||Age||years|Mean|62.1|62.1|Standard Deviation|11.4|11.4|||
3793196|NCT01837550|3622562|B1|||Age||years|Mean|61.8|61.8|Standard Deviation|11.9|11.9|||
3793197|NCT01837537|3622575|B1|United States||Region of Enrollment||participants|Number|90|90.0||||||
3793198|NCT01837537|3622575|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793199|NCT01837537|3622575|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793200|NCT01837537|3622575|B1||White|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
3793201|NCT01837537|3622575|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3793202|NCT01837537|3622575|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793203|NCT01837537|3622575|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793204|NCT01837537|3622575|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3793205|NCT01837537|3622575|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3793206|NCT01837537|3622575|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3793207|NCT01837537|3622575|B1|||Age||years|Mean|54.2|54.2|Full Range|||18.0|91.0|
3793208|NCT01837524|3622580|B3|||Body Mass Index (BMI)||kg/m^2|Mean|34.8|34.8|Standard Deviation|5.0|5.0|||
3793209|NCT01837524|3622581|B2|||Body Mass Index (BMI)||kg/m^2|Mean|34.1|34.1|Standard Deviation|5.3|5.3|||
3793210|NCT01837524|3622582|B1|||Body Mass Index (BMI)||kg/m^2|Mean|35.6|35.6|Standard Deviation|4.7|4.7|||
3793211|NCT01837524|3622580|B3|United States||Region of Enrollment||participants|Number|55|55.0||||||
3793212|NCT01837524|3622581|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
3793213|NCT01837524|3622582|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
3793214|NCT01837524|3622580|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793215|NCT01837524|3622581|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793216|NCT01837524|3622582|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793217|NCT01837524|3622580|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793218|NCT01837524|3622581|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793219|NCT01837524|3622582|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793220|NCT01837524|3622580|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3793221|NCT01837524|3622581|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3793222|NCT01837524|3622582|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3793223|NCT01837524|3622580|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3793224|NCT01837524|3622581|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3793225|NCT01837524|3622582|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3793226|NCT01837524|3622580|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793227|NCT01837524|3622581|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793228|NCT01837524|3622582|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793229|NCT01837524|3622580|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793230|NCT01837524|3622581|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793231|NCT01837524|3622582|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793232|NCT01837524|3622580|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793233|NCT01837524|3622581|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793234|NCT01837524|3622582|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793235|NCT01837524|3622580|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3793236|NCT01837524|3622581|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3793237|NCT01837524|3622582|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3793238|NCT01837524|3622580|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3793239|NCT01837524|3622581|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3793240|NCT01837524|3622582|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3793241|NCT01837524|3622580|B3|||Age||years|Mean|44.3|44.3|Standard Deviation|9.2|9.2|||
3793242|NCT01837524|3622581|B2|||Age||years|Mean|43.4|43.4|Standard Deviation|8.2|8.2|||
3793243|NCT01837524|3622582|B1|||Age||years|Mean|45.1|45.1|Standard Deviation|10|10.0|||
3793244|NCT01836809|3622589|B5|United States||Region of Enrollment||participants|Number|2|2.0||||||
3793245|NCT01836809|3622590|B4|United States||Region of Enrollment||participants|Number|2|2.0||||||
3793246|NCT01836809|3622589|B5|Male||Gender||participants|Number|1|1.0||||||
3793247|NCT01836809|3622590|B4|Male||Gender||participants|Number|1|1.0||||||
3793248|NCT01836809|3622589|B5|Female||Gender||participants|Number|1|1.0||||||
3793249|NCT01836809|3622590|B4|Female||Gender||participants|Number|1|1.0||||||
3793250|NCT01836809|3622589|B5|>=65 years||Age||participants|Number|0|0.0||||||
3793251|NCT01836809|3622590|B4|>=65 years||Age||participants|Number|0|0.0||||||
3793252|NCT01836809|3622589|B5|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
3793253|NCT01836809|3622590|B4|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
3793254|NCT01836809|3622589|B5|<=18 years||Age||participants|Number|0|0.0||||||
3793255|NCT01836809|3622590|B4|<=18 years||Age||participants|Number|0|0.0||||||
3793256|NCT01836809|3622589|B5|||Age||years|Median|59.5|59.5|Full Range|||58.0|61.0|
3793257|NCT01836809|3622590|B4|||Age||years|Median|59.5|59.5|Full Range|||58.0|61.0|
3793258|NCT01836549|3622626|B7||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3793259|NCT01836549|3622627|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3793260|NCT01836549|3622628|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3793261|NCT01836549|3622629|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3793262|NCT01836549|3622630|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3793263|NCT01836549|3622631|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3793264|NCT01836549|3622632|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3793265|NCT01836549|3622626|B7||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3793266|NCT01836549|3622627|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3793267|NCT01836549|3622628|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3793268|NCT01836549|3622629|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3793269|NCT01836549|3622630|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3793270|NCT01836549|3622631|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3793271|NCT01836549|3622632|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3793272|NCT01836549|3622626|B7|||Age||Years|Mean|10.62|10.62|Standard Deviation|4.40|4.4|||
3793273|NCT01836549|3622627|B6|||Age||Years|Mean|10.45|10.45|Standard Deviation|2.14|2.14|||
3793274|NCT01836549|3622628|B5|||Age||Years|Mean|11.51|11.51|Standard Deviation|3.84|3.84|||
3793275|NCT01836549|3622629|B4|||Age||Years|Mean|11.66|11.66|Standard Deviation|5.24|5.24|||
3793276|NCT01836549|3622630|B3|||Age||Years|Mean|7.94|7.94|Standard Deviation|4.31|4.31|||
3793277|NCT01836549|3622631|B2|||Age||Years|Mean|11.33|11.33|Standard Deviation|NA||||Only one Patient
3793278|NCT01836549|3622632|B1|||Age||Years|Mean|10.41|10.41|Standard Deviation|NA||||Only one patient
3793279|NCT01836523|3622658|B5|||Total daily actual insulin dose - Multiple daily injections|Total insulin daily dose of subjects who were on multiple daily insulin injection treatment. Number of subjects analysed=277 (liraglutide 0.6 mg), 242 (liraglutide 1.2 mg), 227 (liraglutide 1.8 mg), 250 (Placebo).|units|Geometric Mean|60.94|60.94|Full Range|||16.0|282.5|
3793280|NCT01836523|3622659|B4|||Total daily actual insulin dose - Multiple daily injections|Total insulin daily dose of subjects who were on multiple daily insulin injection treatment. Number of subjects analysed=277 (liraglutide 0.6 mg), 242 (liraglutide 1.2 mg), 227 (liraglutide 1.8 mg), 250 (Placebo).|units|Geometric Mean|62.42|62.42|Full Range|||20.3|230.0|
3793281|NCT01836523|3622660|B3|||Total daily actual insulin dose - Multiple daily injections|Total insulin daily dose of subjects who were on multiple daily insulin injection treatment. Number of subjects analysed=277 (liraglutide 0.6 mg), 242 (liraglutide 1.2 mg), 227 (liraglutide 1.8 mg), 250 (Placebo).|units|Geometric Mean|62.52|62.52|Full Range|||16.4|271.3|
3793282|NCT01836523|3622661|B2|||Total daily actual insulin dose - Multiple daily injections|Total insulin daily dose of subjects who were on multiple daily insulin injection treatment. Number of subjects analysed=277 (liraglutide 0.6 mg), 242 (liraglutide 1.2 mg), 227 (liraglutide 1.8 mg), 250 (Placebo).|units|Geometric Mean|59.61|59.61|Full Range|||16.0|282.5|
3793283|NCT01836523|3622662|B1|||Total daily actual insulin dose - Multiple daily injections|Total insulin daily dose of subjects who were on multiple daily insulin injection treatment. Number of subjects analysed=277 (liraglutide 0.6 mg), 242 (liraglutide 1.2 mg), 227 (liraglutide 1.8 mg), 250 (Placebo).|units|Geometric Mean|59.54|59.54|Full Range|||22.9|181.6|
3793284|NCT01836523|3622658|B5|||Total daily actual insulin dose-continuous subcutaneous insulin infusion|Total insulin daily dose of subjects who were on continuous subcutaneous insulin infusion treatment. Number of subjects analysed=69 (liraglutide 0.6 mg), 99 (liraglutide 1.2 mg), 113 (liraglutide 1.8 mg), 95 (Placebo).|units|Geometric Mean|50.65|50.65|Full Range|||3.9|176.1|
3793285|NCT01836523|3622659|B4|||Total daily actual insulin dose-continuous subcutaneous insulin infusion|Total insulin daily dose of subjects who were on continuous subcutaneous insulin infusion treatment. Number of subjects analysed=69 (liraglutide 0.6 mg), 99 (liraglutide 1.2 mg), 113 (liraglutide 1.8 mg), 95 (Placebo).|units|Geometric Mean|49.18|49.18|Full Range|||3.9|176.1|
3793286|NCT01836523|3622660|B3|||Total daily actual insulin dose-continuous subcutaneous insulin infusion|Total insulin daily dose of subjects who were on continuous subcutaneous insulin infusion treatment. Number of subjects analysed=69 (liraglutide 0.6 mg), 99 (liraglutide 1.2 mg), 113 (liraglutide 1.8 mg), 95 (Placebo).|units|Geometric Mean|50.46|50.46|Full Range|||8.7|150.2|
3793287|NCT01836523|3622661|B2|||Total daily actual insulin dose-continuous subcutaneous insulin infusion|Total insulin daily dose of subjects who were on continuous subcutaneous insulin infusion treatment. Number of subjects analysed=69 (liraglutide 0.6 mg), 99 (liraglutide 1.2 mg), 113 (liraglutide 1.8 mg), 95 (Placebo).|units|Geometric Mean|50.73|50.73|Full Range|||19.7|160.5|
3793288|NCT01836523|3622662|B1|||Total daily actual insulin dose-continuous subcutaneous insulin infusion|Total insulin daily dose of subjects who were on continuous subcutaneous insulin infusion treatment. Number of subjects analysed=69 (liraglutide 0.6 mg), 99 (liraglutide 1.2 mg), 113 (liraglutide 1.8 mg), 95 (Placebo).|units|Geometric Mean|52.97|52.97|Full Range|||13.8|137.1|
3793289|NCT01836523|3622658|B5|||Body weight||kg|Mean|86.15|86.15|Standard Deviation|17.397|17.397|||
3793290|NCT01836523|3622659|B4|||Body weight||kg|Mean|86.41|86.41|Standard Deviation|17.768|17.768|||
3793291|NCT01836523|3622660|B3|||Body weight||kg|Mean|86.27|86.27|Standard Deviation|17.321|17.321|||
3793292|NCT01836523|3622661|B2|||Body weight||kg|Mean|85.39|85.39|Standard Deviation|17.210|17.21|||
3793293|NCT01836523|3622662|B1|||Body weight||kg|Mean|86.54|86.54|Standard Deviation|17.338|17.338|||
3793294|NCT01836523|3622658|B5|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.16|8.16|Standard Deviation|0.746|0.746|||
3793295|NCT01836523|3622659|B4|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.15|8.15|Standard Deviation|0.728|0.728|||
3793296|NCT01836523|3622660|B3|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.14|8.14|Standard Deviation|0.740|0.74|||
3793297|NCT01836523|3622661|B2|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.16|8.16|Standard Deviation|0.779|0.779|||
3793298|NCT01836523|3622662|B1|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.18|8.18|Standard Deviation|0.738|0.738|||
3793299|NCT01836523|3622658|B5||Male|Gender||Participants|Count of Participants|663|663.0||||||
3793300|NCT01836523|3622659|B4||Male|Gender||Participants|Count of Participants|167|167.0||||||
3793301|NCT01836523|3622660|B3||Male|Gender||Participants|Count of Participants|165|165.0||||||
3793302|NCT01836523|3622661|B2||Male|Gender||Participants|Count of Participants|167|167.0||||||
3793303|NCT01836523|3622662|B1||Male|Gender||Participants|Count of Participants|164|164.0||||||
3793304|NCT01836523|3622658|B5||Female|Gender||Participants|Count of Participants|726|726.0||||||
3793305|NCT01836523|3622659|B4||Female|Gender||Participants|Count of Participants|180|180.0||||||
3793306|NCT01836523|3622660|B3||Female|Gender||Participants|Count of Participants|181|181.0||||||
3793307|NCT01836523|3622661|B2||Female|Gender||Participants|Count of Participants|179|179.0||||||
3793308|NCT01836523|3622662|B1||Female|Gender||Participants|Count of Participants|186|186.0||||||
3793309|NCT01836523|3622658|B5|||Age||years|Mean|43.7|43.7|Standard Deviation|12.93|12.93|||
3793310|NCT01836523|3622659|B4|||Age||years|Mean|43.4|43.4|Standard Deviation|12.57|12.57|||
3793311|NCT01836523|3622660|B3|||Age||years|Mean|43.7|43.7|Standard Deviation|13.33|13.33|||
3793312|NCT01836523|3622661|B2|||Age||years|Mean|43.9|43.9|Standard Deviation|13.06|13.06|||
3793313|NCT01836523|3622662|B1|||Age||years|Mean|43.6|43.6|Standard Deviation|12.78|12.78|||
3793314|NCT01836471|3622687|B6|||ACQ-6 score|Number of participants (n=92,94,51,42,54)|points|Mean|1.63|1.63|Standard Deviation|0.728|0.728|||
3793315|NCT01836471|3622688|B5|||ACQ-6 score|Number of participants (n=92,94,51,42,54)|points|Mean|1.72|1.72|Standard Deviation|0.675|0.675|||
3793316|NCT01836471|3622689|B4|||ACQ-6 score|Number of participants (n=92,94,51,42,54)|points|Mean|1.68|1.68|Standard Deviation|0.749|0.749|||
3793317|NCT01836471|3622690|B3|||ACQ-6 score|Number of participants (n=92,94,51,42,54)|points|Mean|1.55|1.55|Standard Deviation|0.665|0.665|||
3793318|NCT01836471|3622691|B2|||ACQ-6 score|Number of participants (n=92,94,51,42,54)|points|Mean|1.53|1.53|Standard Deviation|0.745|0.745|||
3793319|NCT01836471|3622692|B1|||ACQ-6 score|Number of participants (n=92,94,51,42,54)|points|Mean|1.70|1.7|Standard Deviation|0.762|0.762|||
3793320|NCT01836471|3622687|B6|||Percentage of predicted FEV1 (%) pre-bronchodilator||Percentage|Mean|66.9849|66.9849|Standard Deviation|12.56166|12.56166|||
3793321|NCT01836471|3622688|B5|||Percentage of predicted FEV1 (%) pre-bronchodilator||Percentage|Mean|64.8709|64.8709|Standard Deviation|12.97729|12.97729|||
3793322|NCT01836471|3622689|B4|||Percentage of predicted FEV1 (%) pre-bronchodilator||Percentage|Mean|68.7483|68.7483|Standard Deviation|10.52156|10.52156|||
3793323|NCT01836471|3622690|B3|||Percentage of predicted FEV1 (%) pre-bronchodilator||Percentage|Mean|69.0662|69.0662|Standard Deviation|12.16292|12.16292|||
3793324|NCT01836471|3622691|B2|||Percentage of predicted FEV1 (%) pre-bronchodilator||Percentage|Mean|65.7286|65.7286|Standard Deviation|13.94056|13.94056|||
3793325|NCT01836471|3622692|B1|||Percentage of predicted FEV1 (%) pre-bronchodilator||Percentage|Mean|67.5446|67.5446|Standard Deviation|11.81404|11.81404|||
3793326|NCT01836471|3622687|B6|Atopic||Subject population|Non-atopic defined as history of perennial symptoms with no clear inhaled allergic trigger AND a negative skin prick test (< 3mm diameter above background) or a negative specific IgE (<0.35 IU eq./ml). Atopic/allergic defined as skin prick test (≥ 3mm diameter above background) or a positive specific IgE (e.g.,RAST/CAP) test (≥0.35 IU eq/ml)|Participants|Number|147|147.0||||||
3793327|NCT01836471|3622688|B5|Atopic||Subject population|Non-atopic defined as history of perennial symptoms with no clear inhaled allergic trigger AND a negative skin prick test (< 3mm diameter above background) or a negative specific IgE (<0.35 IU eq./ml). Atopic/allergic defined as skin prick test (≥ 3mm diameter above background) or a positive specific IgE (e.g.,RAST/CAP) test (≥0.35 IU eq/ml)|Participants|Number|54|54.0||||||
3793328|NCT01836471|3622689|B4|Atopic||Subject population|Non-atopic defined as history of perennial symptoms with no clear inhaled allergic trigger AND a negative skin prick test (< 3mm diameter above background) or a negative specific IgE (<0.35 IU eq./ml). Atopic/allergic defined as skin prick test (≥ 3mm diameter above background) or a positive specific IgE (e.g.,RAST/CAP) test (≥0.35 IU eq/ml)|Participants|Number|42|42.0||||||
3793329|NCT01836471|3622690|B3|Atopic||Subject population|Non-atopic defined as history of perennial symptoms with no clear inhaled allergic trigger AND a negative skin prick test (< 3mm diameter above background) or a negative specific IgE (<0.35 IU eq./ml). Atopic/allergic defined as skin prick test (≥ 3mm diameter above background) or a positive specific IgE (e.g.,RAST/CAP) test (≥0.35 IU eq/ml)|Participants|Number|51|51.0||||||
3793330|NCT01836471|3622691|B2|Atopic||Subject population|Non-atopic defined as history of perennial symptoms with no clear inhaled allergic trigger AND a negative skin prick test (< 3mm diameter above background) or a negative specific IgE (<0.35 IU eq./ml). Atopic/allergic defined as skin prick test (≥ 3mm diameter above background) or a positive specific IgE (e.g.,RAST/CAP) test (≥0.35 IU eq/ml)|Participants|Number|0|0.0||||||
3793331|NCT01836471|3622692|B1|Atopic||Subject population|Non-atopic defined as history of perennial symptoms with no clear inhaled allergic trigger AND a negative skin prick test (< 3mm diameter above background) or a negative specific IgE (<0.35 IU eq./ml). Atopic/allergic defined as skin prick test (≥ 3mm diameter above background) or a positive specific IgE (e.g.,RAST/CAP) test (≥0.35 IU eq/ml)|Participants|Number|0|0.0||||||
3793332|NCT01836471|3622687|B6|Non-atopic||Subject population|Non-atopic defined as history of perennial symptoms with no clear inhaled allergic trigger AND a negative skin prick test (< 3mm diameter above background) or a negative specific IgE (<0.35 IU eq./ml). Atopic/allergic defined as skin prick test (≥ 3mm diameter above background) or a positive specific IgE (e.g.,RAST/CAP) test (≥0.35 IU eq/ml)|Participants|Number|187|187.0||||||
3793333|NCT01836471|3622688|B5|Non-atopic||Subject population|Non-atopic defined as history of perennial symptoms with no clear inhaled allergic trigger AND a negative skin prick test (< 3mm diameter above background) or a negative specific IgE (<0.35 IU eq./ml). Atopic/allergic defined as skin prick test (≥ 3mm diameter above background) or a positive specific IgE (e.g.,RAST/CAP) test (≥0.35 IU eq/ml)|Participants|Number|0|0.0||||||
3793334|NCT01836471|3622689|B4|Non-atopic||Subject population|Non-atopic defined as history of perennial symptoms with no clear inhaled allergic trigger AND a negative skin prick test (< 3mm diameter above background) or a negative specific IgE (<0.35 IU eq./ml). Atopic/allergic defined as skin prick test (≥ 3mm diameter above background) or a positive specific IgE (e.g.,RAST/CAP) test (≥0.35 IU eq/ml)|Participants|Number|0|0.0||||||
3793335|NCT01836471|3622690|B3|Non-atopic||Subject population|Non-atopic defined as history of perennial symptoms with no clear inhaled allergic trigger AND a negative skin prick test (< 3mm diameter above background) or a negative specific IgE (<0.35 IU eq./ml). Atopic/allergic defined as skin prick test (≥ 3mm diameter above background) or a positive specific IgE (e.g.,RAST/CAP) test (≥0.35 IU eq/ml)|Participants|Number|0|0.0||||||
3793336|NCT01836471|3622691|B2|Non-atopic||Subject population|Non-atopic defined as history of perennial symptoms with no clear inhaled allergic trigger AND a negative skin prick test (< 3mm diameter above background) or a negative specific IgE (<0.35 IU eq./ml). Atopic/allergic defined as skin prick test (≥ 3mm diameter above background) or a positive specific IgE (e.g.,RAST/CAP) test (≥0.35 IU eq/ml)|Participants|Number|94|94.0||||||
3793337|NCT01836471|3622692|B1|Non-atopic||Subject population|Non-atopic defined as history of perennial symptoms with no clear inhaled allergic trigger AND a negative skin prick test (< 3mm diameter above background) or a negative specific IgE (<0.35 IU eq./ml). Atopic/allergic defined as skin prick test (≥ 3mm diameter above background) or a positive specific IgE (e.g.,RAST/CAP) test (≥0.35 IU eq/ml)|Participants|Number|93|93.0||||||
3793338|NCT01836471|3622687|B6|||Duration of asthma||years|Mean|18.91|18.91|Standard Deviation|15.648|15.648|||
3793339|NCT01836471|3622688|B5|||Duration of asthma||years|Mean|24.09|24.09|Standard Deviation|16.055|16.055|||
3793340|NCT01836471|3622689|B4|||Duration of asthma||years|Mean|27.78|27.78|Standard Deviation|18.039|18.039|||
3793341|NCT01836471|3622690|B3|||Duration of asthma||years|Mean|24.69|24.69|Standard Deviation|17.446|17.446|||
3793342|NCT01836471|3622691|B2|||Duration of asthma||years|Mean|12.82|12.82|Standard Deviation|12.196|12.196|||
3793343|NCT01836471|3622692|B1|||Duration of asthma||years|Mean|14.88|14.88|Standard Deviation|12.349|12.349|||
3793344|NCT01836471|3622687|B6|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3793345|NCT01836471|3622688|B5|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3793346|NCT01836471|3622689|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3793347|NCT01836471|3622690|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3793348|NCT01836471|3622691|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3793349|NCT01836471|3622692|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3793350|NCT01836471|3622687|B6|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3793351|NCT01836471|3622688|B5|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3793352|NCT01836471|3622689|B4|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3793353|NCT01836471|3622690|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3793354|NCT01836471|3622691|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3793355|NCT01836471|3622692|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3793356|NCT01836471|3622687|B6|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3793357|NCT01836471|3622688|B5|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3793358|NCT01836471|3622689|B4|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3793359|NCT01836471|3622690|B3|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3793360|NCT01836471|3622691|B2|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3793361|NCT01836471|3622692|B1|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3793362|NCT01836471|3622687|B6|White||Race/Ethnicity, Customized||participants|Number|248|248.0||||||
3793363|NCT01836471|3622688|B5|White||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
3793364|NCT01836471|3622689|B4|White||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3793365|NCT01836471|3622690|B3|White||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
3793366|NCT01836471|3622691|B2|White||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
3793367|NCT01836471|3622692|B1|White||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
3793368|NCT01836471|3622687|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3793369|NCT01836471|3622688|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3793370|NCT01836471|3622689|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3793371|NCT01836471|3622690|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3793372|NCT01836471|3622691|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3793373|NCT01836471|3622692|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3793374|NCT01836471|3622687|B6|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3793375|NCT01836471|3622688|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3793376|NCT01836471|3622689|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3793377|NCT01836471|3622690|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3793378|NCT01836471|3622691|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3793379|NCT01836471|3622692|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3793380|NCT01836471|3622687|B6|Asian||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
3793381|NCT01836471|3622688|B5|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3793382|NCT01836471|3622689|B4|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3793383|NCT01836471|3622690|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3793384|NCT01836471|3622691|B2|Asian||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3793385|NCT01836471|3622692|B1|Asian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3793386|NCT01836471|3622687|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3793387|NCT01836471|3622688|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3793388|NCT01836471|3622689|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3793389|NCT01836471|3622690|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3793390|NCT01836471|3622691|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3793391|NCT01836471|3622692|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3793392|NCT01836471|3622687|B6||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3793393|NCT01836471|3622688|B5||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3793394|NCT01836471|3622689|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3793395|NCT01836471|3622690|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3793396|NCT01836471|3622691|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3793397|NCT01836471|3622692|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3793398|NCT01836471|3622687|B6||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
3793399|NCT01836471|3622688|B5||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3793400|NCT01836471|3622689|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3793401|NCT01836471|3622690|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3793402|NCT01836471|3622691|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3793403|NCT01836471|3622692|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3793404|NCT01836471|3622687|B6|||Age||years|Mean|51.0|51.0|Standard Deviation|13.81|13.81|||
3793405|NCT01836471|3622688|B5|||Age||years|Mean|48.2|48.2|Standard Deviation|13.58|13.58|||
3793406|NCT01836471|3622689|B4|||Age||years|Mean|48.2|48.2|Standard Deviation|12.16|12.16|||
3793407|NCT01836471|3622690|B3|||Age||years|Mean|50.3|50.3|Standard Deviation|12.75|12.75|||
3793408|NCT01836471|3622691|B2|||Age||years|Mean|53.5|53.5|Standard Deviation|14.37|14.37|||
3793409|NCT01836471|3622692|B1|||Age||years|Mean|51.9|51.9|Standard Deviation|14.33|14.33|||
3793410|NCT01836458|3622721|B5|MALE||Sex/Gender, Customized||participants|Number|25|25.0||||||
3793411|NCT01836458|3622722|B4|MALE||Sex/Gender, Customized||participants|Number|7|7.0||||||
3793412|NCT01836458|3622723|B3|MALE||Sex/Gender, Customized||participants|Number|7|7.0||||||
3793413|NCT01836458|3622724|B2|MALE||Sex/Gender, Customized||participants|Number|4|4.0||||||
3793414|NCT01836458|3622725|B1|MALE||Sex/Gender, Customized||participants|Number|7|7.0||||||
3793415|NCT01836458|3622721|B5|||Age||years|Mean|32.7|32.7|Standard Deviation|9.04|9.04|||
3793416|NCT01836458|3622722|B4|||Age||years|Mean|34.7|34.7|Standard Deviation|8.79|8.79|||
3793417|NCT01836458|3622723|B3|||Age||years|Mean|30.6|30.6|Standard Deviation|8.24|8.24|||
3793418|NCT01836458|3622724|B2|||Age||years|Mean|32.8|32.8|Standard Deviation|7.93|7.93|||
3793419|NCT01836458|3622725|B1|||Age||years|Mean|32.7|32.7|Standard Deviation|11.84|11.84|||
3793420|NCT01836445|3622750|B3||Part Time|Employment|Enrolled participants who were employed and answered follow-up questions on employment status at baseline|Participants|Count of Participants|250|250.0||||||
3793421|NCT01836445|3622751|B2||Part Time|Employment|Enrolled participants who were employed and answered follow-up questions on employment status at baseline|Participants|Count of Participants|135|135.0||||||
3793422|NCT01836445|3622752|B1||Part Time|Employment|Enrolled participants who were employed and answered follow-up questions on employment status at baseline|Participants|Count of Participants|115|115.0||||||
3793423|NCT01836445|3622750|B3||Full Time|Employment|Enrolled participants who were employed and answered follow-up questions on employment status at baseline|Participants|Count of Participants|451|451.0||||||
3793424|NCT01836445|3622751|B2||Full Time|Employment|Enrolled participants who were employed and answered follow-up questions on employment status at baseline|Participants|Count of Participants|228|228.0||||||
3793425|NCT01836445|3622752|B1||Full Time|Employment|Enrolled participants who were employed and answered follow-up questions on employment status at baseline|Participants|Count of Participants|223|223.0||||||
3793426|NCT01836445|3622750|B3|Graduate Degree||Education|Enrolled participants who completed questions on educational background at baseline|Participants|Count of Participants|118|118.0||||||
3793427|NCT01836445|3622751|B2|Graduate Degree||Education|Enrolled participants who completed questions on educational background at baseline|Participants|Count of Participants|62|62.0||||||
3793428|NCT01836445|3622752|B1|Graduate Degree||Education|Enrolled participants who completed questions on educational background at baseline|Participants|Count of Participants|56|56.0||||||
3793466|NCT01836445|3622751|B2|More than one race||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3793429|NCT01836445|3622750|B3|College Education||Education|Enrolled participants who completed questions on educational background at baseline|Participants|Count of Participants|418|418.0||||||
3793430|NCT01836445|3622751|B2|College Education||Education|Enrolled participants who completed questions on educational background at baseline|Participants|Count of Participants|215|215.0||||||
3793431|NCT01836445|3622752|B1|College Education||Education|Enrolled participants who completed questions on educational background at baseline|Participants|Count of Participants|203|203.0||||||
3793432|NCT01836445|3622750|B3|Partial College (at Least One Year)||Education|Enrolled participants who completed questions on educational background at baseline|Participants|Count of Participants|252|252.0||||||
3793433|NCT01836445|3622751|B2|Partial College (at Least One Year)||Education|Enrolled participants who completed questions on educational background at baseline|Participants|Count of Participants|136|136.0||||||
3793434|NCT01836445|3622752|B1|Partial College (at Least One Year)||Education|Enrolled participants who completed questions on educational background at baseline|Participants|Count of Participants|116|116.0||||||
3793435|NCT01836445|3622750|B3|High School Graduate/GED||Education|Enrolled participants who completed questions on educational background at baseline|Participants|Count of Participants|95|95.0||||||
3793436|NCT01836445|3622751|B2|High School Graduate/GED||Education|Enrolled participants who completed questions on educational background at baseline|Participants|Count of Participants|35|35.0||||||
3793437|NCT01836445|3622752|B1|High School Graduate/GED||Education|Enrolled participants who completed questions on educational background at baseline|Participants|Count of Participants|60|60.0||||||
3793438|NCT01836445|3622750|B3|Partial High School||Education|Enrolled participants who completed questions on educational background at baseline|Participants|Count of Participants|17|17.0||||||
3793439|NCT01836445|3622751|B2|Partial High School||Education|Enrolled participants who completed questions on educational background at baseline|Participants|Count of Participants|7|7.0||||||
3793440|NCT01836445|3622752|B1|Partial High School||Education|Enrolled participants who completed questions on educational background at baseline|Participants|Count of Participants|10|10.0||||||
3793441|NCT01836445|3622750|B3|Junior High School||Education|Enrolled participants who completed questions on educational background at baseline|Participants|Count of Participants|1|1.0||||||
3793442|NCT01836445|3622751|B2|Junior High School||Education|Enrolled participants who completed questions on educational background at baseline|Participants|Count of Participants|1|1.0||||||
3793443|NCT01836445|3622752|B1|Junior High School||Education|Enrolled participants who completed questions on educational background at baseline|Participants|Count of Participants|0|0.0||||||
3793444|NCT01836445|3622750|B3|Any STI||Sexually Transmitted Infections|Enrolled participants who returned STI test kits for analysis at Baseline (n = 896)|Participants|Count of Participants|132|132.0||||||
3793445|NCT01836445|3622751|B2|Any STI||Sexually Transmitted Infections|Enrolled participants who returned STI test kits for analysis at Baseline (n = 896)|Participants|Count of Participants|50|50.0||||||
3793446|NCT01836445|3622752|B1|Any STI||Sexually Transmitted Infections|Enrolled participants who returned STI test kits for analysis at Baseline (n = 896)|Participants|Count of Participants|82|82.0||||||
3793447|NCT01836445|3622750|B3|Rectal Gonorrhea||Sexually Transmitted Infections|Enrolled participants who returned STI test kits for analysis at Baseline (n = 896)|Participants|Count of Participants|45|45.0||||||
3793448|NCT01836445|3622751|B2|Rectal Gonorrhea||Sexually Transmitted Infections|Enrolled participants who returned STI test kits for analysis at Baseline (n = 896)|Participants|Count of Participants|16|16.0||||||
3793449|NCT01836445|3622752|B1|Rectal Gonorrhea||Sexually Transmitted Infections|Enrolled participants who returned STI test kits for analysis at Baseline (n = 896)|Participants|Count of Participants|29|29.0||||||
3793450|NCT01836445|3622750|B3|Rectal Chlamydia||Sexually Transmitted Infections|Enrolled participants who returned STI test kits for analysis at Baseline (n = 896)|Participants|Count of Participants|77|77.0||||||
3793451|NCT01836445|3622751|B2|Rectal Chlamydia||Sexually Transmitted Infections|Enrolled participants who returned STI test kits for analysis at Baseline (n = 896)|Participants|Count of Participants|30|30.0||||||
3793452|NCT01836445|3622752|B1|Rectal Chlamydia||Sexually Transmitted Infections|Enrolled participants who returned STI test kits for analysis at Baseline (n = 896)|Participants|Count of Participants|47|47.0||||||
3793453|NCT01836445|3622750|B3|Urethral Gonorrhea||Sexually Transmitted Infections|Enrolled participants who returned STI test kits for analysis at Baseline (n = 896)|Participants|Count of Participants|7|7.0||||||
3793454|NCT01836445|3622751|B2|Urethral Gonorrhea||Sexually Transmitted Infections|Enrolled participants who returned STI test kits for analysis at Baseline (n = 896)|Participants|Count of Participants|4|4.0||||||
3793455|NCT01836445|3622752|B1|Urethral Gonorrhea||Sexually Transmitted Infections|Enrolled participants who returned STI test kits for analysis at Baseline (n = 896)|Participants|Count of Participants|3|3.0||||||
3793456|NCT01836445|3622750|B3|Urethral Chlamydia||Sexually Transmitted Infections|Enrolled participants who returned STI test kits for analysis at Baseline (n = 896)|Participants|Count of Participants|22|22.0||||||
3793457|NCT01836445|3622751|B2|Urethral Chlamydia||Sexually Transmitted Infections|Enrolled participants who returned STI test kits for analysis at Baseline (n = 896)|Participants|Count of Participants|7|7.0||||||
3793458|NCT01836445|3622752|B1|Urethral Chlamydia||Sexually Transmitted Infections|Enrolled participants who returned STI test kits for analysis at Baseline (n = 896)|Participants|Count of Participants|15|15.0||||||
3793459|NCT01836445|3622750|B3|||Condomless Anal Sex||condomless anal sex acts|Mean|3.9|3.9|Standard Deviation|9.9|9.9|||
3793460|NCT01836445|3622751|B2|||Condomless Anal Sex||condomless anal sex acts|Mean|3.4|3.4|Standard Deviation|6.7|6.7|||
3793461|NCT01836445|3622752|B1|||Condomless Anal Sex||condomless anal sex acts|Mean|4.3|4.3|Standard Deviation|13.1|13.1|||
3793462|NCT01836445|3622750|B3|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3793463|NCT01836445|3622751|B2|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3793464|NCT01836445|3622752|B1|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3793465|NCT01836445|3622750|B3|More than one race||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3793467|NCT01836445|3622752|B1|More than one race||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3793468|NCT01836445|3622750|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|330|330.0||||||
3793469|NCT01836445|3622751|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|165|165.0||||||
3793470|NCT01836445|3622752|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|165|165.0||||||
3793471|NCT01836445|3622750|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|260|260.0||||||
3793472|NCT01836445|3622751|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|125|125.0||||||
3793473|NCT01836445|3622752|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|135|135.0||||||
3793474|NCT01836445|3622750|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|219|219.0||||||
3793475|NCT01836445|3622751|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|113|113.0||||||
3793476|NCT01836445|3622752|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|106|106.0||||||
3793477|NCT01836445|3622750|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
3793478|NCT01836445|3622751|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3793479|NCT01836445|3622752|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3793480|NCT01836445|3622750|B3|Native American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3793481|NCT01836445|3622751|B2|Native American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3793482|NCT01836445|3622752|B1|Native American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3793483|NCT01836445|3622750|B3||Male|Sex: Female, Male||Participants|Count of Participants|901|901.0||||||
3793484|NCT01836445|3622751|B2||Male|Sex: Female, Male||Participants|Count of Participants|456|456.0||||||
3793485|NCT01836445|3622752|B1||Male|Sex: Female, Male||Participants|Count of Participants|445|445.0||||||
3793486|NCT01836445|3622750|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3793487|NCT01836445|3622751|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3793488|NCT01836445|3622752|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3793489|NCT01836445|3622750|B3|25 - 29||Age, Customized||Participants|Count of Participants|423|423.0||||||
3793490|NCT01836445|3622751|B2|25 - 29||Age, Customized||Participants|Count of Participants|212|212.0||||||
3793491|NCT01836445|3622752|B1|25 - 29||Age, Customized||Participants|Count of Participants|211|211.0||||||
3793492|NCT01836445|3622750|B3|18 - 24||Age, Customized||Participants|Count of Participants|477|477.0||||||
3793493|NCT01836445|3622751|B2|18 - 24||Age, Customized||Participants|Count of Participants|244|244.0||||||
3793494|NCT01836445|3622752|B1|18 - 24||Age, Customized||Participants|Count of Participants|233|233.0||||||
3793495|NCT01836445|3622750|B3|||Age||years|Mean|24.21|24.21|Standard Deviation|2.95|2.95|||
3793496|NCT01836445|3622751|B2|||Age||years|Mean|24.15|24.15|Standard Deviation|2.89|2.89|||
3793497|NCT01836445|3622752|B1|||Age||years|Mean|24.27|24.27|Standard Deviation|3.02|3.02|||
3793498|NCT01836276|3622811|B3|||Neighborhood problems|Perceived neighborhood disadvantage was assessed using the 10-item Neighborhood Problems questionnaire, which asked participants to identify the degree to which issues such as litter, vandalism, noise, traffic, and safety are problems in their neighborhood. Total scores range from 10-30 with higher scores indicating more neighborhood problems.|units on a scale|Mean|14.5|14.5|Standard Deviation|4.2|4.2|||
3793499|NCT01836276|3622812|B2|||Neighborhood problems|Perceived neighborhood disadvantage was assessed using the 10-item Neighborhood Problems questionnaire, which asked participants to identify the degree to which issues such as litter, vandalism, noise, traffic, and safety are problems in their neighborhood. Total scores range from 10-30 with higher scores indicating more neighborhood problems.|units on a scale|Mean|13.5|13.5|Standard Deviation|3.4|3.4|||
3793500|NCT01836276|3622813|B1|||Neighborhood problems|Perceived neighborhood disadvantage was assessed using the 10-item Neighborhood Problems questionnaire, which asked participants to identify the degree to which issues such as litter, vandalism, noise, traffic, and safety are problems in their neighborhood. Total scores range from 10-30 with higher scores indicating more neighborhood problems.|units on a scale|Mean|15.5|15.5|Standard Deviation|4.7|4.7|||
3793501|NCT01836276|3622811|B3|||Social cohesion and trust|Perceived neighborhood disadvantage was assessed using the 5-item Social Cohesion and Trust questionnaire, which assessed participant’s beliefs about their neighbors trustworthiness, shared values, willingness to help, close-knit connections, and ability to get along with each other. Total scores range from 5-25 with higher scores indicating more perceived neighborhood cohesion.|units on a scale|Mean|17.0|17.0|Standard Deviation|4.7|4.7|||
3793502|NCT01836276|3622812|B2|||Social cohesion and trust|Perceived neighborhood disadvantage was assessed using the 5-item Social Cohesion and Trust questionnaire, which assessed participant’s beliefs about their neighbors trustworthiness, shared values, willingness to help, close-knit connections, and ability to get along with each other. Total scores range from 5-25 with higher scores indicating more perceived neighborhood cohesion.|units on a scale|Mean|17.8|17.8|Standard Deviation|4.5|4.5|||
3793503|NCT01836276|3622813|B1|||Social cohesion and trust|Perceived neighborhood disadvantage was assessed using the 5-item Social Cohesion and Trust questionnaire, which assessed participant’s beliefs about their neighbors trustworthiness, shared values, willingness to help, close-knit connections, and ability to get along with each other. Total scores range from 5-25 with higher scores indicating more perceived neighborhood cohesion.|units on a scale|Mean|16.2|16.2|Standard Deviation|4.7|4.7|||
3793504|NCT01836276|3622811|B3|||Neuroticism/proneness to psychological stress|Neuroticism, an indicator of proneness to psychological distress, was assessed with 4-items from the Neuroticism scale of the NEO Five-Factor Inventory.(92) The 4-items focus on the tendency to feel tense/jittery, worried, helpless, and angry and have demonstrated good psychometric properties in previous studies. Total scores range from 0-48 with higher scores indicating greater proneness to psychological distress.|units on a scale|Mean|12.5|12.5|Standard Deviation|6.7|6.7|||
3793505|NCT01836276|3622812|B2|||Neuroticism/proneness to psychological stress|Neuroticism, an indicator of proneness to psychological distress, was assessed with 4-items from the Neuroticism scale of the NEO Five-Factor Inventory.(92) The 4-items focus on the tendency to feel tense/jittery, worried, helpless, and angry and have demonstrated good psychometric properties in previous studies. Total scores range from 0-48 with higher scores indicating greater proneness to psychological distress.|units on a scale|Mean|12.5|12.5|Standard Deviation|6.3|6.3|||
3793506|NCT01836276|3622813|B1|||Neuroticism/proneness to psychological stress|Neuroticism, an indicator of proneness to psychological distress, was assessed with 4-items from the Neuroticism scale of the NEO Five-Factor Inventory.(92) The 4-items focus on the tendency to feel tense/jittery, worried, helpless, and angry and have demonstrated good psychometric properties in previous studies. Total scores range from 0-48 with higher scores indicating greater proneness to psychological distress.|units on a scale|Mean|12.6|12.6|Standard Deviation|7.1|7.1|||
3793507|NCT01836276|3622811|B3|||Cynicism/distrust of others' intentions|Measured using the 8-item cynicism/distrust subscale from the Cook–Medley Hostility Scale.The 8-items focus on cynical distrust and disparaging views of others’ intentions (e.g., ‘Most people are honest mainly through fear of being caught,’ ‘Most people lie to get ahead’) and have demonstrated good psychometric properties in other studies. Total scores range from 0-8 with higher scores indicating greater distrust of others intentions.|units on a scale|Mean|5.3|5.3|Standard Deviation|1.7|1.7|||
3793508|NCT01836276|3622812|B2|||Cynicism/distrust of others' intentions|Measured using the 8-item cynicism/distrust subscale from the Cook–Medley Hostility Scale.The 8-items focus on cynical distrust and disparaging views of others’ intentions (e.g., ‘Most people are honest mainly through fear of being caught,’ ‘Most people lie to get ahead’) and have demonstrated good psychometric properties in other studies. Total scores range from 0-8 with higher scores indicating greater distrust of others intentions.|units on a scale|Mean|4.8|4.8|Standard Deviation|1.7|1.7|||
3793509|NCT01836276|3622813|B1|||Cynicism/distrust of others' intentions|Measured using the 8-item cynicism/distrust subscale from the Cook–Medley Hostility Scale.The 8-items focus on cynical distrust and disparaging views of others’ intentions (e.g., ‘Most people are honest mainly through fear of being caught,’ ‘Most people lie to get ahead’) and have demonstrated good psychometric properties in other studies. Total scores range from 0-8 with higher scores indicating greater distrust of others intentions.|units on a scale|Mean|5.7|5.7|Standard Deviation|1.6|1.6|||
3793510|NCT01836276|3622811|B3|||Satisfaction with life|The 5-item Satisfaction with Life Scale was used to assess cognitive appraisal of global life satisfaction (e.g., my life if close to ideal, if I could live life over, I would change almost nothing). Total scores range from 5-35 with higher scores indicating greater life satisfaction.|units on a scale|Mean|22.0|22.0|Standard Deviation|6.2|6.2|||
3793511|NCT01836276|3622812|B2|||Satisfaction with life|The 5-item Satisfaction with Life Scale was used to assess cognitive appraisal of global life satisfaction (e.g., my life if close to ideal, if I could live life over, I would change almost nothing). Total scores range from 5-35 with higher scores indicating greater life satisfaction.|units on a scale|Mean|23.8|23.8|Standard Deviation|5.5|5.5|||
3793512|NCT01836276|3622813|B1|||Satisfaction with life|The 5-item Satisfaction with Life Scale was used to assess cognitive appraisal of global life satisfaction (e.g., my life if close to ideal, if I could live life over, I would change almost nothing). Total scores range from 5-35 with higher scores indicating greater life satisfaction.|units on a scale|Mean|20.1|20.1|Standard Deviation|6.3|6.3|||
3793513|NCT01836276|3622811|B3|||Perceived social status|Subjective Social Status was measured using the MacArthur Scale of Subjective Social Status.This mea sure presents a 10-rung ladder with instructions to imagine that it represents where people stand in the U.S., with higher rungs representing people who are the best off (most money, education, respected jobs) and lower rungs representing people who are the worst off. Participants are asked to select the rung (1-10) that represents where they stand in life relative to other people in the U.S. Higher scores indicate greater perceived social status.|units on a scale|Mean|4.9|4.9|Standard Deviation|1.5|1.5|||
3793514|NCT01836276|3622812|B2|||Perceived social status|Subjective Social Status was measured using the MacArthur Scale of Subjective Social Status.This mea sure presents a 10-rung ladder with instructions to imagine that it represents where people stand in the U.S., with higher rungs representing people who are the best off (most money, education, respected jobs) and lower rungs representing people who are the worst off. Participants are asked to select the rung (1-10) that represents where they stand in life relative to other people in the U.S. Higher scores indicate greater perceived social status.|units on a scale|Mean|5.0|5.0|Standard Deviation|1.5|1.5|||
3793515|NCT01836276|3622813|B1|||Perceived social status|Subjective Social Status was measured using the MacArthur Scale of Subjective Social Status.This mea sure presents a 10-rung ladder with instructions to imagine that it represents where people stand in the U.S., with higher rungs representing people who are the best off (most money, education, respected jobs) and lower rungs representing people who are the worst off. Participants are asked to select the rung (1-10) that represents where they stand in life relative to other people in the U.S. Higher scores indicate greater perceived social status.|units on a scale|Mean|4.8|4.8|Standard Deviation|1.5|1.5|||
3793516|NCT01836276|3622811|B3||At least daily|Race Consciousness|This single item from the Behavioral Risk Factor Surveillance System ‘Reactions to Race Module’ measures race consciousness by asking participants to identify the frequency with which they think about their race from 'never' to 'constantly.'|Participants|Count of Participants|61|61.0||||||
3793517|NCT01836276|3622812|B2||At least daily|Race Consciousness|This single item from the Behavioral Risk Factor Surveillance System ‘Reactions to Race Module’ measures race consciousness by asking participants to identify the frequency with which they think about their race from 'never' to 'constantly.'|Participants|Count of Participants|7|7.0||||||
3793518|NCT01836276|3622813|B1||At least daily|Race Consciousness|This single item from the Behavioral Risk Factor Surveillance System ‘Reactions to Race Module’ measures race consciousness by asking participants to identify the frequency with which they think about their race from 'never' to 'constantly.'|Participants|Count of Participants|54|54.0||||||
3793519|NCT01836276|3622811|B3||Once a week|Race Consciousness|This single item from the Behavioral Risk Factor Surveillance System ‘Reactions to Race Module’ measures race consciousness by asking participants to identify the frequency with which they think about their race from 'never' to 'constantly.'|Participants|Count of Participants|31|31.0||||||
3793520|NCT01836276|3622812|B2||Once a week|Race Consciousness|This single item from the Behavioral Risk Factor Surveillance System ‘Reactions to Race Module’ measures race consciousness by asking participants to identify the frequency with which they think about their race from 'never' to 'constantly.'|Participants|Count of Participants|17|17.0||||||
3793521|NCT01836276|3622813|B1||Once a week|Race Consciousness|This single item from the Behavioral Risk Factor Surveillance System ‘Reactions to Race Module’ measures race consciousness by asking participants to identify the frequency with which they think about their race from 'never' to 'constantly.'|Participants|Count of Participants|14|14.0||||||
3793522|NCT01836276|3622811|B3||Once a month|Race Consciousness|This single item from the Behavioral Risk Factor Surveillance System ‘Reactions to Race Module’ measures race consciousness by asking participants to identify the frequency with which they think about their race from 'never' to 'constantly.'|Participants|Count of Participants|40|40.0||||||
3793523|NCT01836276|3622812|B2||Once a month|Race Consciousness|This single item from the Behavioral Risk Factor Surveillance System ‘Reactions to Race Module’ measures race consciousness by asking participants to identify the frequency with which they think about their race from 'never' to 'constantly.'|Participants|Count of Participants|18|18.0||||||
3793524|NCT01836276|3622813|B1||Once a month|Race Consciousness|This single item from the Behavioral Risk Factor Surveillance System ‘Reactions to Race Module’ measures race consciousness by asking participants to identify the frequency with which they think about their race from 'never' to 'constantly.'|Participants|Count of Participants|22|22.0||||||
3793525|NCT01836276|3622811|B3||Once a year|Race Consciousness|This single item from the Behavioral Risk Factor Surveillance System ‘Reactions to Race Module’ measures race consciousness by asking participants to identify the frequency with which they think about their race from 'never' to 'constantly.'|Participants|Count of Participants|50|50.0||||||
3793526|NCT01836276|3622812|B2||Once a year|Race Consciousness|This single item from the Behavioral Risk Factor Surveillance System ‘Reactions to Race Module’ measures race consciousness by asking participants to identify the frequency with which they think about their race from 'never' to 'constantly.'|Participants|Count of Participants|25|25.0||||||
3793527|NCT01836276|3622813|B1||Once a year|Race Consciousness|This single item from the Behavioral Risk Factor Surveillance System ‘Reactions to Race Module’ measures race consciousness by asking participants to identify the frequency with which they think about their race from 'never' to 'constantly.'|Participants|Count of Participants|25|25.0||||||
3793528|NCT01836276|3622811|B3||Never|Race Consciousness|This single item from the Behavioral Risk Factor Surveillance System ‘Reactions to Race Module’ measures race consciousness by asking participants to identify the frequency with which they think about their race from 'never' to 'constantly.'|Participants|Count of Participants|267|267.0||||||
3793529|NCT01836276|3622812|B2||Never|Race Consciousness|This single item from the Behavioral Risk Factor Surveillance System ‘Reactions to Race Module’ measures race consciousness by asking participants to identify the frequency with which they think about their race from 'never' to 'constantly.'|Participants|Count of Participants|158|158.0||||||
3793530|NCT01836276|3622813|B1||Never|Race Consciousness|This single item from the Behavioral Risk Factor Surveillance System ‘Reactions to Race Module’ measures race consciousness by asking participants to identify the frequency with which they think about their race from 'never' to 'constantly.'|Participants|Count of Participants|109|109.0||||||
3793531|NCT01836276|3622811|B3|frequency encountered||Perceived discrimination|The Everyday Discrimination Scale (Short Version) assessed experiences of discrimination across five daily life situations (i.e., treated with less respect, receive poorer service, people act as if you are not smart, people are afraid of you, and feeling harassed/threatened). Total scores are summarized by counting the number of situations encountered (range of 0-5) and the frequency of encounters (range of 0-25).|units on a scale|Mean|5.9|5.9|Standard Deviation|4.9|4.9|||
3793532|NCT01836276|3622812|B2|frequency encountered||Perceived discrimination|The Everyday Discrimination Scale (Short Version) assessed experiences of discrimination across five daily life situations (i.e., treated with less respect, receive poorer service, people act as if you are not smart, people are afraid of you, and feeling harassed/threatened). Total scores are summarized by counting the number of situations encountered (range of 0-5) and the frequency of encounters (range of 0-25).|units on a scale|Mean|5.1|5.1|Standard Deviation|4.1|4.1|||
3793533|NCT01836276|3622813|B1|frequency encountered||Perceived discrimination|The Everyday Discrimination Scale (Short Version) assessed experiences of discrimination across five daily life situations (i.e., treated with less respect, receive poorer service, people act as if you are not smart, people are afraid of you, and feeling harassed/threatened). Total scores are summarized by counting the number of situations encountered (range of 0-5) and the frequency of encounters (range of 0-25).|units on a scale|Mean|6.8|6.8|Standard Deviation|5.1|5.1|||
3793534|NCT01836276|3622811|B3|number of situations encountered||Perceived discrimination|The Everyday Discrimination Scale (Short Version) assessed experiences of discrimination across five daily life situations (i.e., treated with less respect, receive poorer service, people act as if you are not smart, people are afraid of you, and feeling harassed/threatened). Total scores are summarized by counting the number of situations encountered (range of 0-5) and the frequency of encounters (range of 0-25).|units on a scale|Mean|2.7|2.7|Standard Deviation|1.6|1.6|||
3793535|NCT01836276|3622812|B2|number of situations encountered||Perceived discrimination|The Everyday Discrimination Scale (Short Version) assessed experiences of discrimination across five daily life situations (i.e., treated with less respect, receive poorer service, people act as if you are not smart, people are afraid of you, and feeling harassed/threatened). Total scores are summarized by counting the number of situations encountered (range of 0-5) and the frequency of encounters (range of 0-25).|units on a scale|Mean|2.6|2.6|Standard Deviation|1.6|1.6|||
3793536|NCT01836276|3622813|B1|number of situations encountered||Perceived discrimination|The Everyday Discrimination Scale (Short Version) assessed experiences of discrimination across five daily life situations (i.e., treated with less respect, receive poorer service, people act as if you are not smart, people are afraid of you, and feeling harassed/threatened). Total scores are summarized by counting the number of situations encountered (range of 0-5) and the frequency of encounters (range of 0-25).|units on a scale|Mean|2.7|2.7|Standard Deviation|1.6|1.6|||
3793562|NCT01836276|3622812|B2||No partner/spouse|Partner smoking status||Participants|Count of Participants|78|78.0||||||
3793537|NCT01836276|3622811|B3|||Financial strain|An 8-item Financial Strain questionnaire assessed participant’s difficulty with respect to affording food, clothing, major items (e.g., car), furniture, leisure activities, and bills and the amount of money left at the end of the month after covering all bills and expenses (some, just enough, or not enough). Total scores ranged from 8-24 with higher scores indicating greater financial strain.|units on a scale|Mean|15.1|15.1|Standard Deviation|4.2|4.2|||
3793538|NCT01836276|3622812|B2|||Financial strain|An 8-item Financial Strain questionnaire assessed participant’s difficulty with respect to affording food, clothing, major items (e.g., car), furniture, leisure activities, and bills and the amount of money left at the end of the month after covering all bills and expenses (some, just enough, or not enough). Total scores ranged from 8-24 with higher scores indicating greater financial strain.|units on a scale|Mean|14.6|14.6|Standard Deviation|4.1|4.1|||
3793539|NCT01836276|3622813|B1|||Financial strain|An 8-item Financial Strain questionnaire assessed participant’s difficulty with respect to affording food, clothing, major items (e.g., car), furniture, leisure activities, and bills and the amount of money left at the end of the month after covering all bills and expenses (some, just enough, or not enough). Total scores ranged from 8-24 with higher scores indicating greater financial strain.|units on a scale|Mean|15.6|15.6|Standard Deviation|4.3|4.3|||
3793540|NCT01836276|3622811|B3|||Anxiety|The Generalized Anxiety Disorder Questionnaire-7 assessed frequency (‘not at all’ to ‘nearly every day’) of symptoms of generalized anxiety disorder (e.g., on edge, uncontrolled worry, restlessness) experienced over the past two weeks. Total scores range from 0-21 with higher scores indicating more anxiety symptoms.|units on a scale|Mean|2.5|2.5|Standard Deviation|3.2|3.2|||
3793541|NCT01836276|3622812|B2|||Anxiety|The Generalized Anxiety Disorder Questionnaire-7 assessed frequency (‘not at all’ to ‘nearly every day’) of symptoms of generalized anxiety disorder (e.g., on edge, uncontrolled worry, restlessness) experienced over the past two weeks. Total scores range from 0-21 with higher scores indicating more anxiety symptoms.|units on a scale|Mean|2.1|2.1|Standard Deviation|2.7|2.7|||
3793542|NCT01836276|3622813|B1|||Anxiety|The Generalized Anxiety Disorder Questionnaire-7 assessed frequency (‘not at all’ to ‘nearly every day’) of symptoms of generalized anxiety disorder (e.g., on edge, uncontrolled worry, restlessness) experienced over the past two weeks. Total scores range from 0-21 with higher scores indicating more anxiety symptoms.|units on a scale|Mean|3.0|3.0|Standard Deviation|3.6|3.6|||
3793543|NCT01836276|3622811|B3|||Depression|Depressive symptoms were assessed using the Patient Health Questionnaire-9, a depression screener that assesses frequency over the past 2 weeks (‘not at all’ to ‘nearly every day’) of each of the DSM-IV criteria for depression. Total scores range from 0-27 with higher scores indicating greater depressive symptomology..|units on a scale|Mean|1.7|1.7|Standard Deviation|2.7|2.7|||
3793544|NCT01836276|3622812|B2|||Depression|Depressive symptoms were assessed using the Patient Health Questionnaire-9, a depression screener that assesses frequency over the past 2 weeks (‘not at all’ to ‘nearly every day’) of each of the DSM-IV criteria for depression. Total scores range from 0-27 with higher scores indicating greater depressive symptomology..|units on a scale|Mean|1.2|1.2|Standard Deviation|1.8|1.8|||
3793545|NCT01836276|3622813|B1|||Depression|Depressive symptoms were assessed using the Patient Health Questionnaire-9, a depression screener that assesses frequency over the past 2 weeks (‘not at all’ to ‘nearly every day’) of each of the DSM-IV criteria for depression. Total scores range from 0-27 with higher scores indicating greater depressive symptomology..|units on a scale|Mean|2.1|2.1|Standard Deviation|3.4|3.4|||
3793546|NCT01836276|3622811|B3|||Perceived stress|Perceived Stress Scale, a 4-item measure of stress. Total scores range from 0-16 with higher scores indicating greater stress.|units on a scale|Mean|4.1|4.1|Standard Deviation|2.6|2.6|||
3793547|NCT01836276|3622812|B2|||Perceived stress|Perceived Stress Scale, a 4-item measure of stress. Total scores range from 0-16 with higher scores indicating greater stress.|units on a scale|Mean|3.6|3.6|Standard Deviation|2.3|2.3|||
3793548|NCT01836276|3622813|B1|||Perceived stress|Perceived Stress Scale, a 4-item measure of stress. Total scores range from 0-16 with higher scores indicating greater stress.|units on a scale|Mean|4.5|4.5|Standard Deviation|2.7|2.7|||
3793549|NCT01836276|3622811|B3|||Craving|Questionnaire of Smoking Urges-Brief, a 4-item measure of craving. Total scores range from 4-28 with higher scores indicating a greater degree of craving.|units on a scale|Mean|14.7|14.7|Standard Deviation|7.3|7.3|||
3793550|NCT01836276|3622812|B2|||Craving|Questionnaire of Smoking Urges-Brief, a 4-item measure of craving. Total scores range from 4-28 with higher scores indicating a greater degree of craving.|units on a scale|Mean|15.3|15.3|Standard Deviation|6.7|6.7|||
3793551|NCT01836276|3622813|B1|||Craving|Questionnaire of Smoking Urges-Brief, a 4-item measure of craving. Total scores range from 4-28 with higher scores indicating a greater degree of craving.|units on a scale|Mean|14.1|14.1|Standard Deviation|7.9|7.9|||
3793552|NCT01836276|3622811|B3|||Withdrawal|Minnesota Withdrawal Scale total score. Scores range from 0-32 with higher scores indicating more withdrawal.|units on a scale|Mean|5.3|5.3|Standard Deviation|3.8|3.8|||
3793553|NCT01836276|3622812|B2|||Withdrawal|Minnesota Withdrawal Scale total score. Scores range from 0-32 with higher scores indicating more withdrawal.|units on a scale|Mean|5.2|5.2|Standard Deviation|3.1|3.1|||
3793554|NCT01836276|3622813|B1|||Withdrawal|Minnesota Withdrawal Scale total score. Scores range from 0-32 with higher scores indicating more withdrawal.|units on a scale|Mean|5.3|5.3|Standard Deviation|4.3|4.3|||
3793555|NCT01836276|3622811|B3||Partner/spouse is a smoker|Partner smoking status||Participants|Count of Participants|140|140.0||||||
3793556|NCT01836276|3622812|B2||Partner/spouse is a smoker|Partner smoking status||Participants|Count of Participants|78|78.0||||||
3793557|NCT01836276|3622813|B1||Partner/spouse is a smoker|Partner smoking status||Participants|Count of Participants|62|62.0||||||
3793558|NCT01836276|3622811|B3||Partner/spouse is a non-smoker|Partner smoking status||Participants|Count of Participants|137|137.0||||||
3793559|NCT01836276|3622812|B2||Partner/spouse is a non-smoker|Partner smoking status||Participants|Count of Participants|69|69.0||||||
3793560|NCT01836276|3622813|B1||Partner/spouse is a non-smoker|Partner smoking status||Participants|Count of Participants|68|68.0||||||
3793561|NCT01836276|3622811|B3||No partner/spouse|Partner smoking status||Participants|Count of Participants|172|172.0||||||
3793563|NCT01836276|3622813|B1||No partner/spouse|Partner smoking status||Participants|Count of Participants|94|94.0||||||
3793564|NCT01836276|3622811|B3|||Number of smokers in the home(not including self)||cohabitants|Mean|0.6|0.6|Standard Deviation|0.9|0.9|||
3793565|NCT01836276|3622812|B2|||Number of smokers in the home(not including self)||cohabitants|Mean|0.6|0.6|Standard Deviation|0.8|0.8|||
3793566|NCT01836276|3622813|B1|||Number of smokers in the home(not including self)||cohabitants|Mean|0.6|0.6|Standard Deviation|1.0|1.0|||
3793567|NCT01836276|3622811|B3|||Number of your five best friends smoke||friends|Mean|2.8|2.8|Standard Deviation|1.8|1.8|||
3793568|NCT01836276|3622812|B2|||Number of your five best friends smoke||friends|Mean|2.7|2.7|Standard Deviation|1.7|1.7|||
3793569|NCT01836276|3622813|B1|||Number of your five best friends smoke||friends|Mean|2.9|2.9|Standard Deviation|1.8|1.8|||
3793570|NCT01836276|3622811|B3||Within 30 minutes|Time to first cigarette||Participants|Count of Participants|345|345.0||||||
3793571|NCT01836276|3622812|B2||Within 30 minutes|Time to first cigarette||Participants|Count of Participants|168|168.0||||||
3793572|NCT01836276|3622813|B1||Within 30 minutes|Time to first cigarette||Participants|Count of Participants|177|177.0||||||
3793573|NCT01836276|3622811|B3||After 30 minutes|Time to first cigarette||Participants|Count of Participants|104|104.0||||||
3793574|NCT01836276|3622812|B2||After 30 minutes|Time to first cigarette||Participants|Count of Participants|57|57.0||||||
3793575|NCT01836276|3622813|B1||After 30 minutes|Time to first cigarette||Participants|Count of Participants|47|47.0||||||
3793576|NCT01836276|3622811|B3|||Longest quit attempt in months||months|Mean|25.0|25.0|Standard Deviation|62.0|62.0|||
3793577|NCT01836276|3622812|B2|||Longest quit attempt in months||months|Mean|25.3|25.3|Standard Deviation|51.7|51.7|||
3793578|NCT01836276|3622813|B1|||Longest quit attempt in months||months|Mean|24.8|24.8|Standard Deviation|70.9|70.9|||
3793579|NCT01836276|3622811|B3||Menthol|Menthol smoker||Participants|Count of Participants|252|252.0||||||
3793580|NCT01836276|3622812|B2||Menthol|Menthol smoker||Participants|Count of Participants|59|59.0||||||
3793581|NCT01836276|3622813|B1||Menthol|Menthol smoker||Participants|Count of Participants|193|193.0||||||
3793582|NCT01836276|3622811|B3||Non-menthol|Menthol smoker||Participants|Count of Participants|197|197.0||||||
3793583|NCT01836276|3622812|B2||Non-menthol|Menthol smoker||Participants|Count of Participants|166|166.0||||||
3793584|NCT01836276|3622813|B1||Non-menthol|Menthol smoker||Participants|Count of Participants|31|31.0||||||
3793585|NCT01836276|3622811|B3|||Age when you started smoking regularly||years|Mean|17.5|17.5|Standard Deviation|5.8|5.8|||
3793586|NCT01836276|3622812|B2|||Age when you started smoking regularly||years|Mean|16.5|16.5|Standard Deviation|4.8|4.8|||
3793587|NCT01836276|3622813|B1|||Age when you started smoking regularly||years|Mean|18.5|18.5|Standard Deviation|6.5|6.5|||
3793588|NCT01836276|3622811|B3|||Cigarettes per day||Cigarettes|Mean|14.7|14.7|Standard Deviation|5.7|5.7|||
3793589|NCT01836276|3622812|B2|||Cigarettes per day||Cigarettes|Mean|16.9|16.9|Standard Deviation|4.6|4.6|||
3793590|NCT01836276|3622813|B1|||Cigarettes per day||Cigarettes|Mean|12.5|12.5|Standard Deviation|5.7|5.7|||
3793591|NCT01836276|3622811|B3|||Waist circumference in inches||inches|Mean|37.0|37.0|Standard Deviation|6.4|6.4|||
3793592|NCT01836276|3622812|B2|||Waist circumference in inches||inches|Mean|36.3|36.3|Standard Deviation|6.2|6.2|||
3793593|NCT01836276|3622813|B1|||Waist circumference in inches||inches|Mean|37.6|37.6|Standard Deviation|6.7|6.7|||
3793594|NCT01836276|3622811|B3|||BMI||kg/m^2|Mean|29.8|29.8|Standard Deviation|7.7|7.7|||
3793595|NCT01836276|3622812|B2|||BMI||kg/m^2|Mean|28.9|28.9|Standard Deviation|7.1|7.1|||
3793596|NCT01836276|3622813|B1|||BMI||kg/m^2|Mean|30.8|30.8|Standard Deviation|8.1|8.1|||
3793597|NCT01836276|3622811|B3|||Weight in pounds||pounds|Mean|189.1|189.1|Standard Deviation|48.1|48.1|||
3793598|NCT01836276|3622812|B2|||Weight in pounds||pounds|Mean|182.9|182.9|Standard Deviation|44.1|44.1|||
3793599|NCT01836276|3622813|B1|||Weight in pounds||pounds|Mean|195.3|195.3|Standard Deviation|51.2|51.2|||
3793600|NCT01836276|3622811|B3|||Height in inches||inches|Mean|66.8|66.8|Standard Deviation|3.8|3.8|||
3793601|NCT01836276|3622812|B2|||Height in inches||inches|Mean|66.8|66.8|Standard Deviation|3.9|3.9|||
3793602|NCT01836276|3622813|B1|||Height in inches||inches|Mean|66.8|66.8|Standard Deviation|3.7|3.7|||
3793603|NCT01836276|3622811|B3||301%-400%|Percent Federal Poverty Level|% Federal Poverty Level is based on the Department of Health and Human Services Guidelines, published each year in the Federal Register (HHS). It is a calculation of household size (i.e., number of individuals residing in the household) and household income. < or = 100% federal poverty level represents the lowest economic status.|Participants|Count of Participants|56|56.0||||||
3793604|NCT01836276|3622812|B2||301%-400%|Percent Federal Poverty Level|% Federal Poverty Level is based on the Department of Health and Human Services Guidelines, published each year in the Federal Register (HHS). It is a calculation of household size (i.e., number of individuals residing in the household) and household income. < or = 100% federal poverty level represents the lowest economic status.|Participants|Count of Participants|43|43.0||||||
3793605|NCT01836276|3622813|B1||301%-400%|Percent Federal Poverty Level|% Federal Poverty Level is based on the Department of Health and Human Services Guidelines, published each year in the Federal Register (HHS). It is a calculation of household size (i.e., number of individuals residing in the household) and household income. < or = 100% federal poverty level represents the lowest economic status.|Participants|Count of Participants|13|13.0||||||
3793606|NCT01836276|3622811|B3||251%-300%|Percent Federal Poverty Level|% Federal Poverty Level is based on the Department of Health and Human Services Guidelines, published each year in the Federal Register (HHS). It is a calculation of household size (i.e., number of individuals residing in the household) and household income. < or = 100% federal poverty level represents the lowest economic status.|Participants|Count of Participants|36|36.0||||||
3793637|NCT01836276|3622812|B2||Yes|Health insurance that pays for most medical care||Participants|Count of Participants|123|123.0||||||
3793638|NCT01836276|3622813|B1||Yes|Health insurance that pays for most medical care||Participants|Count of Participants|117|117.0||||||
3793607|NCT01836276|3622812|B2||251%-300%|Percent Federal Poverty Level|% Federal Poverty Level is based on the Department of Health and Human Services Guidelines, published each year in the Federal Register (HHS). It is a calculation of household size (i.e., number of individuals residing in the household) and household income. < or = 100% federal poverty level represents the lowest economic status.|Participants|Count of Participants|27|27.0||||||
3793608|NCT01836276|3622813|B1||251%-300%|Percent Federal Poverty Level|% Federal Poverty Level is based on the Department of Health and Human Services Guidelines, published each year in the Federal Register (HHS). It is a calculation of household size (i.e., number of individuals residing in the household) and household income. < or = 100% federal poverty level represents the lowest economic status.|Participants|Count of Participants|9|9.0||||||
3793609|NCT01836276|3622811|B3||201%-250%|Percent Federal Poverty Level|% Federal Poverty Level is based on the Department of Health and Human Services Guidelines, published each year in the Federal Register (HHS). It is a calculation of household size (i.e., number of individuals residing in the household) and household income. < or = 100% federal poverty level represents the lowest economic status.|Participants|Count of Participants|40|40.0||||||
3793610|NCT01836276|3622812|B2||201%-250%|Percent Federal Poverty Level|% Federal Poverty Level is based on the Department of Health and Human Services Guidelines, published each year in the Federal Register (HHS). It is a calculation of household size (i.e., number of individuals residing in the household) and household income. < or = 100% federal poverty level represents the lowest economic status.|Participants|Count of Participants|25|25.0||||||
3793611|NCT01836276|3622813|B1||201%-250%|Percent Federal Poverty Level|% Federal Poverty Level is based on the Department of Health and Human Services Guidelines, published each year in the Federal Register (HHS). It is a calculation of household size (i.e., number of individuals residing in the household) and household income. < or = 100% federal poverty level represents the lowest economic status.|Participants|Count of Participants|15|15.0||||||
3793612|NCT01836276|3622811|B3||101%-200%|Percent Federal Poverty Level|% Federal Poverty Level is based on the Department of Health and Human Services Guidelines, published each year in the Federal Register (HHS). It is a calculation of household size (i.e., number of individuals residing in the household) and household income. < or = 100% federal poverty level represents the lowest economic status.|Participants|Count of Participants|159|159.0||||||
3793613|NCT01836276|3622812|B2||101%-200%|Percent Federal Poverty Level|% Federal Poverty Level is based on the Department of Health and Human Services Guidelines, published each year in the Federal Register (HHS). It is a calculation of household size (i.e., number of individuals residing in the household) and household income. < or = 100% federal poverty level represents the lowest economic status.|Participants|Count of Participants|87|87.0||||||
3793614|NCT01836276|3622813|B1||101%-200%|Percent Federal Poverty Level|% Federal Poverty Level is based on the Department of Health and Human Services Guidelines, published each year in the Federal Register (HHS). It is a calculation of household size (i.e., number of individuals residing in the household) and household income. < or = 100% federal poverty level represents the lowest economic status.|Participants|Count of Participants|72|72.0||||||
3793615|NCT01836276|3622811|B3||< or = 100%|Percent Federal Poverty Level|% Federal Poverty Level is based on the Department of Health and Human Services Guidelines, published each year in the Federal Register (HHS). It is a calculation of household size (i.e., number of individuals residing in the household) and household income. < or = 100% federal poverty level represents the lowest economic status.|Participants|Count of Participants|158|158.0||||||
3793616|NCT01836276|3622812|B2||< or = 100%|Percent Federal Poverty Level|% Federal Poverty Level is based on the Department of Health and Human Services Guidelines, published each year in the Federal Register (HHS). It is a calculation of household size (i.e., number of individuals residing in the household) and household income. < or = 100% federal poverty level represents the lowest economic status.|Participants|Count of Participants|43|43.0||||||
3793617|NCT01836276|3622813|B1||< or = 100%|Percent Federal Poverty Level|% Federal Poverty Level is based on the Department of Health and Human Services Guidelines, published each year in the Federal Register (HHS). It is a calculation of household size (i.e., number of individuals residing in the household) and household income. < or = 100% federal poverty level represents the lowest economic status.|Participants|Count of Participants|115|115.0||||||
3793618|NCT01836276|3622811|B3||Very good/excellent|Perceived Health||Participants|Count of Participants|211|211.0||||||
3793619|NCT01836276|3622812|B2||Very good/excellent|Perceived Health||Participants|Count of Participants|112|112.0||||||
3793620|NCT01836276|3622813|B1||Very good/excellent|Perceived Health||Participants|Count of Participants|99|99.0||||||
3793621|NCT01836276|3622811|B3||Good, fair, or poor|Perceived Health||Participants|Count of Participants|238|238.0||||||
3793622|NCT01836276|3622812|B2||Good, fair, or poor|Perceived Health||Participants|Count of Participants|113|113.0||||||
3793623|NCT01836276|3622813|B1||Good, fair, or poor|Perceived Health||Participants|Count of Participants|125|125.0||||||
3793624|NCT01836276|3622811|B3|Rent or stay with others||Housing||Participants|Count of Participants|334|334.0||||||
3793625|NCT01836276|3622812|B2|Rent or stay with others||Housing||Participants|Count of Participants|148|148.0||||||
3793626|NCT01836276|3622813|B1|Rent or stay with others||Housing||Participants|Count of Participants|186|186.0||||||
3793627|NCT01836276|3622811|B3|Own a home||Housing||Participants|Count of Participants|115|115.0||||||
3793628|NCT01836276|3622812|B2|Own a home||Housing||Participants|Count of Participants|77|77.0||||||
3793629|NCT01836276|3622813|B1|Own a home||Housing||Participants|Count of Participants|38|38.0||||||
3793630|NCT01836276|3622811|B3|||Number of people living in house, including self||Cohabitants|Mean|2.8|2.8|Standard Deviation|1.7|1.7|||
3793631|NCT01836276|3622812|B2|||Number of people living in house, including self||Cohabitants|Mean|3.0|3.0|Standard Deviation|1.8|1.8|||
3793632|NCT01836276|3622813|B1|||Number of people living in house, including self||Cohabitants|Mean|2.7|2.7|Standard Deviation|1.6|1.6|||
3793633|NCT01836276|3622811|B3|||Income||Dollars|Mean|28,566|28.0|Standard Deviation|19,840|19.0|||
3793634|NCT01836276|3622812|B2|||Income||Dollars|Mean|35,806|35.0|Standard Deviation|21,035|21.0|||
3793635|NCT01836276|3622813|B1|||Income||Dollars|Mean|21,293|21.0|Standard Deviation|15,501|15.0|||
3793636|NCT01836276|3622811|B3||Yes|Health insurance that pays for most medical care||Participants|Count of Participants|240|240.0||||||
3793639|NCT01836276|3622811|B3||No|Health insurance that pays for most medical care||Participants|Count of Participants|209|209.0||||||
3793640|NCT01836276|3622812|B2||No|Health insurance that pays for most medical care||Participants|Count of Participants|102|102.0||||||
3793641|NCT01836276|3622813|B1||No|Health insurance that pays for most medical care||Participants|Count of Participants|107|107.0||||||
3793642|NCT01836276|3622811|B3||College graduate or higher|Education level||Participants|Count of Participants|91|91.0||||||
3793643|NCT01836276|3622812|B2||College graduate or higher|Education level||Participants|Count of Participants|51|51.0||||||
3793644|NCT01836276|3622813|B1||College graduate or higher|Education level||Participants|Count of Participants|40|40.0||||||
3793645|NCT01836276|3622811|B3||Some college or tech school|Education level||Participants|Count of Participants|206|206.0||||||
3793646|NCT01836276|3622812|B2||Some college or tech school|Education level||Participants|Count of Participants|116|116.0||||||
3793647|NCT01836276|3622813|B1||Some college or tech school|Education level||Participants|Count of Participants|90|90.0||||||
3793648|NCT01836276|3622811|B3||HS graduate or HS equivalent (GED)|Education level||Participants|Count of Participants|108|108.0||||||
3793649|NCT01836276|3622812|B2||HS graduate or HS equivalent (GED)|Education level||Participants|Count of Participants|44|44.0||||||
3793650|NCT01836276|3622813|B1||HS graduate or HS equivalent (GED)|Education level||Participants|Count of Participants|64|64.0||||||
3793651|NCT01836276|3622811|B3||Less than high school (HS) graduate|Education level||Participants|Count of Participants|44|44.0||||||
3793652|NCT01836276|3622812|B2||Less than high school (HS) graduate|Education level||Participants|Count of Participants|14|14.0||||||
3793653|NCT01836276|3622813|B1||Less than high school (HS) graduate|Education level||Participants|Count of Participants|30|30.0||||||
3793654|NCT01836276|3622811|B3||Student/homemaker|Employment Status||Participants|Count of Participants|41|41.0||||||
3793655|NCT01836276|3622812|B2||Student/homemaker|Employment Status||Participants|Count of Participants|21|21.0||||||
3793656|NCT01836276|3622813|B1||Student/homemaker|Employment Status||Participants|Count of Participants|20|20.0||||||
3793657|NCT01836276|3622811|B3||Retired|Employment Status||Participants|Count of Participants|16|16.0||||||
3793658|NCT01836276|3622812|B2||Retired|Employment Status||Participants|Count of Participants|5|5.0||||||
3793659|NCT01836276|3622813|B1||Retired|Employment Status||Participants|Count of Participants|11|11.0||||||
3793660|NCT01836276|3622811|B3||Not currently employed|Employment Status||Participants|Count of Participants|103|103.0||||||
3793661|NCT01836276|3622812|B2||Not currently employed|Employment Status||Participants|Count of Participants|28|28.0||||||
3793662|NCT01836276|3622813|B1||Not currently employed|Employment Status||Participants|Count of Participants|75|75.0||||||
3793663|NCT01836276|3622811|B3||Employed part-time|Employment Status||Participants|Count of Participants|70|70.0||||||
3793664|NCT01836276|3622812|B2||Employed part-time|Employment Status||Participants|Count of Participants|29|29.0||||||
3793665|NCT01836276|3622813|B1||Employed part-time|Employment Status||Participants|Count of Participants|41|41.0||||||
3793666|NCT01836276|3622811|B3||Employed full-time|Employment Status||Participants|Count of Participants|219|219.0||||||
3793667|NCT01836276|3622812|B2||Employed full-time|Employment Status||Participants|Count of Participants|142|142.0||||||
3793668|NCT01836276|3622813|B1||Employed full-time|Employment Status||Participants|Count of Participants|77|77.0||||||
3793669|NCT01836276|3622811|B3||Living with a partner|Cohabitation Status||Participants|Count of Participants|192|192.0||||||
3793670|NCT01836276|3622812|B2||Living with a partner|Cohabitation Status||Participants|Count of Participants|110|110.0||||||
3793671|NCT01836276|3622813|B1||Living with a partner|Cohabitation Status||Participants|Count of Participants|82|82.0||||||
3793672|NCT01836276|3622811|B3||Living alone|Cohabitation Status||Participants|Count of Participants|257|257.0||||||
3793673|NCT01836276|3622812|B2||Living alone|Cohabitation Status||Participants|Count of Participants|115|115.0||||||
3793674|NCT01836276|3622813|B1||Living alone|Cohabitation Status||Participants|Count of Participants|142|142.0||||||
3793675|NCT01836276|3622811|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793676|NCT01836276|3622812|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793677|NCT01836276|3622813|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793678|NCT01836276|3622811|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793679|NCT01836276|3622812|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793680|NCT01836276|3622813|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793681|NCT01836276|3622811|B3||White|Race (NIH/OMB)||Participants|Count of Participants|225|225.0||||||
3793682|NCT01836276|3622812|B2||White|Race (NIH/OMB)||Participants|Count of Participants|225|225.0||||||
3793683|NCT01836276|3622813|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793684|NCT01836276|3622811|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|224|224.0||||||
3793685|NCT01836276|3622812|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793686|NCT01836276|3622813|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|224|224.0||||||
3793687|NCT01836276|3622811|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793688|NCT01836276|3622812|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793689|NCT01836276|3622813|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793690|NCT01836276|3622811|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793691|NCT01836276|3622812|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793692|NCT01836276|3622813|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793991|NCT01835548|3622995|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3793693|NCT01836276|3622811|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793694|NCT01836276|3622812|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793695|NCT01836276|3622813|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793696|NCT01836276|3622811|B3||Male|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
3793697|NCT01836276|3622812|B2||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3793698|NCT01836276|3622813|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3793699|NCT01836276|3622811|B3||Female|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
3793700|NCT01836276|3622812|B2||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3793701|NCT01836276|3622813|B1||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3793702|NCT01836276|3622811|B3|||Age||years|Mean|41.4|41.4|Standard Deviation|11.6|11.6|||
3793703|NCT01836276|3622812|B2|||Age||years|Mean|40.5|40.5|Standard Deviation|11.2|11.2|||
3793704|NCT01836276|3622813|B1|||Age||years|Mean|42.4|42.4|Standard Deviation|12|12.0|||
3793705|NCT01836185|3622820|B5|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3793706|NCT01836185|3622821|B4|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3793707|NCT01836185|3622822|B3|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3793708|NCT01836185|3622823|B2|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3793709|NCT01836185|3622824|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3793710|NCT01836185|3622820|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793711|NCT01836185|3622821|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793712|NCT01836185|3622822|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793713|NCT01836185|3622823|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793714|NCT01836185|3622824|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793715|NCT01836185|3622820|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793716|NCT01836185|3622821|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793717|NCT01836185|3622822|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793718|NCT01836185|3622823|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793719|NCT01836185|3622824|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793720|NCT01836185|3622820|B5||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3793721|NCT01836185|3622821|B4||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3793722|NCT01836185|3622822|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3793723|NCT01836185|3622823|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3793724|NCT01836185|3622824|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3793725|NCT01836185|3622820|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3793726|NCT01836185|3622821|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793727|NCT01836185|3622822|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793728|NCT01836185|3622823|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3793729|NCT01836185|3622824|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3793730|NCT01836185|3622820|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793731|NCT01836185|3622821|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793732|NCT01836185|3622822|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793733|NCT01836185|3622823|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793734|NCT01836185|3622824|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793735|NCT01836185|3622820|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3793736|NCT01836185|3622821|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793737|NCT01836185|3622822|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793738|NCT01836185|3622823|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3793739|NCT01836185|3622824|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793740|NCT01836185|3622820|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793741|NCT01836185|3622821|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793742|NCT01836185|3622822|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793743|NCT01836185|3622823|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793744|NCT01836185|3622824|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793745|NCT01836185|3622820|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793746|NCT01836185|3622821|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793747|NCT01836185|3622822|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793748|NCT01836185|3622823|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793749|NCT01836185|3622824|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793750|NCT01836185|3622820|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3793751|NCT01836185|3622821|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3793752|NCT01836185|3622822|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3793753|NCT01836185|3622823|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3793754|NCT01836185|3622824|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3793755|NCT01836185|3622820|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3793756|NCT01836185|3622821|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3793757|NCT01836185|3622822|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3793758|NCT01836185|3622823|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3793759|NCT01836185|3622824|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3793760|NCT01836185|3622820|B5||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3793761|NCT01836185|3622821|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3793762|NCT01836185|3622822|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3793763|NCT01836185|3622823|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3793764|NCT01836185|3622824|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3793765|NCT01836185|3622820|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3793766|NCT01836185|3622821|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3793767|NCT01836185|3622822|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3793768|NCT01836185|3622823|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3793769|NCT01836185|3622824|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3793770|NCT01836185|3622820|B5|||Age||years|Mean|56.0|56.0|Standard Deviation|7.2|7.2|||
3793771|NCT01836185|3622821|B4|||Age||years|Mean|57.8|57.8|Standard Deviation|4.7|4.7|||
3793772|NCT01836185|3622822|B3|||Age||years|Mean|58.6|58.6|Standard Deviation|9.6|9.6|||
3793773|NCT01836185|3622823|B2|||Age||years|Mean|54.1|54.1|Standard Deviation|2.9|2.9|||
3793774|NCT01836185|3622824|B1|||Age||years|Mean|54.4|54.4|Standard Deviation|8.6|8.6|||
3793775|NCT01836133|3622845|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3793776|NCT01836133|3622845|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3793777|NCT01836133|3622845|B1|||Age||years|Mean|62|62.0|Standard Deviation|8|8.0|||
3793778|NCT01836042|3622851|B4|United States||Region of Enrollment||participants|Number|108|108.0||||||
3793779|NCT01836042|3622852|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
3793780|NCT01836042|3622853|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
3793781|NCT01836042|3622854|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
3793782|NCT01836042|3622851|B4||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3793783|NCT01836042|3622852|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3793784|NCT01836042|3622853|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3793785|NCT01836042|3622854|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3793786|NCT01836042|3622851|B4||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3793787|NCT01836042|3622852|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3793788|NCT01836042|3622853|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3793789|NCT01836042|3622854|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3793790|NCT01836042|3622851|B4|||Age||years|Mean|71|71.0|Standard Deviation|8.1|8.1|||
3793791|NCT01836042|3622852|B3|||Age||years|Mean|71|71.0|Standard Deviation|8.6|8.6|||
3793792|NCT01836042|3622853|B2|||Age||years|Mean|69|69.0|Standard Deviation|8.4|8.4|||
3793793|NCT01836042|3622854|B1|||Age||years|Mean|72|72.0|Standard Deviation|7.7|7.7|||
3793794|NCT01835912|3622864|B1|Canada||Region of Enrollment||participants|Number|10|10.0||||||
3793795|NCT01835912|3622864|B1|males||Sex/Gender, Customized||participants|Number|10|10.0||||||
3793796|NCT01835912|3622864|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3793797|NCT01835912|3622864|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3793798|NCT01835912|3622864|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
3793799|NCT01835899|3622882|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3793800|NCT01835899|3622883|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3793801|NCT01835899|3622884|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3793802|NCT01835899|3622885|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3793803|NCT01835899|3622882|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3793804|NCT01835899|3622883|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3793805|NCT01835899|3622884|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3793806|NCT01835899|3622885|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3793807|NCT01835899|3622882|B4|||Age||Years|Mean|42.0|42.0|Standard Deviation|8.8|8.8|||
3793808|NCT01835899|3622883|B3|||Age||Years|Mean|44.3|44.3|Standard Deviation|8.3|8.3|||
3793809|NCT01835899|3622884|B2|||Age||Years|Mean|38.7|38.7|Standard Deviation|8.5|8.5|||
3793810|NCT01835899|3622885|B1|||Age||Years|Mean|43.5|43.5|Standard Deviation|9.9|9.9|||
3793992|NCT01835548|3622996|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3793811|NCT01835756|3622905|B3|||Visual Analog Scale (VAS) Degree of Low Back Pain Rating|The Visual Analog Pain Scale (VAS) is one of the three most commonly used scales for assessing chronic pain. The VAS scale ranges from 0 to 100 mm, with 0 indicating no pain and 100 indicating the worst pain imaginable. The subject marks on the line the spot for the pain intensity, which is then measured using a ruler.|units on a scale|Mean|58.56|58.56|Standard Deviation|12.35|12.35|||
3793812|NCT01835756|3622906|B2|||Visual Analog Scale (VAS) Degree of Low Back Pain Rating|The Visual Analog Pain Scale (VAS) is one of the three most commonly used scales for assessing chronic pain. The VAS scale ranges from 0 to 100 mm, with 0 indicating no pain and 100 indicating the worst pain imaginable. The subject marks on the line the spot for the pain intensity, which is then measured using a ruler.|units on a scale|Mean|55.94|55.94|Standard Deviation|10.74|10.74|||
3793813|NCT01835756|3622907|B1|||Visual Analog Scale (VAS) Degree of Low Back Pain Rating|The Visual Analog Pain Scale (VAS) is one of the three most commonly used scales for assessing chronic pain. The VAS scale ranges from 0 to 100 mm, with 0 indicating no pain and 100 indicating the worst pain imaginable. The subject marks on the line the spot for the pain intensity, which is then measured using a ruler.|units on a scale|Mean|61.19|61.19|Standard Deviation|13.24|13.24|||
3793814|NCT01835756|3622905|B3|||Duration of Low Back Pain|Duration of low back pain was recorded as the number of months the subject reporting experiencing ongoing low back pain.|months|Mean|93.05|93.05|Standard Deviation|102.60|102.6|||
3793815|NCT01835756|3622906|B2|||Duration of Low Back Pain|Duration of low back pain was recorded as the number of months the subject reporting experiencing ongoing low back pain.|months|Mean|93.45|93.45|Standard Deviation|110.86|110.86|||
3793816|NCT01835756|3622907|B1|||Duration of Low Back Pain|Duration of low back pain was recorded as the number of months the subject reporting experiencing ongoing low back pain.|months|Mean|92.65|92.65|Standard Deviation|95.42|95.42|||
3793817|NCT01835756|3622905|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
3793818|NCT01835756|3622906|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
3793819|NCT01835756|3622907|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
3793820|NCT01835756|3622905|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793821|NCT01835756|3622906|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793822|NCT01835756|3622907|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793823|NCT01835756|3622905|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793824|NCT01835756|3622906|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793825|NCT01835756|3622907|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793826|NCT01835756|3622905|B3||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3793827|NCT01835756|3622906|B2||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3793828|NCT01835756|3622907|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3793829|NCT01835756|3622905|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3793830|NCT01835756|3622906|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3793831|NCT01835756|3622907|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3793832|NCT01835756|3622905|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793833|NCT01835756|3622906|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793834|NCT01835756|3622907|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793835|NCT01835756|3622905|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793836|NCT01835756|3622906|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793837|NCT01835756|3622907|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793838|NCT01835756|3622905|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3793839|NCT01835756|3622906|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3793840|NCT01835756|3622907|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793841|NCT01835756|3622905|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3793842|NCT01835756|3622906|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3793843|NCT01835756|3622907|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3793844|NCT01835756|3622905|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3793845|NCT01835756|3622906|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3793846|NCT01835756|3622907|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3793847|NCT01835756|3622905|B3|||Age||years|Mean|51.69|51.69|Standard Deviation|14.68|14.68|||
3793848|NCT01835756|3622906|B2|||Age||years|Mean|49.48|49.48|Standard Deviation|16.39|16.39|||
3793849|NCT01835756|3622907|B1|||Age||years|Mean|53.90|53.9|Standard Deviation|12.62|12.62|||
3793850|NCT01835743|3622918|B3|||Degree of Heel Pain at Baseline|Subjects rated the overall degree of pain experienced in the heel region of the heel being treated and evaluated in the study upon waking in the morning and taking the first few steps of the day for 2 consecutive days before receiving the first study procedure with the Erchonia HPS. The degree of pain was recorded by placing a cross along the point that best represented their current heel pain level on the 0-100 mm (0 -10 cm) Visual Analog Pain Scale (VAS) ranging from ‘0: no pain at all’ to ‘100: worst pain imaginable,’. The higher the rating, the greater the heel pain experienced.|units on a scale|Mean|68.48|68.48|Standard Deviation|12.19|12.19|||
3793993|NCT01835548|3622997|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3793994|NCT01835548|3622995|B3|||Age||years|Mean|9.2|9.2|Standard Deviation|1.75|1.75|||
3793995|NCT01835548|3622996|B2|||Age||years|Mean|9.3|9.3|Standard Deviation|1.64|1.64|||
3793851|NCT01835743|3622919|B2|||Degree of Heel Pain at Baseline|Subjects rated the overall degree of pain experienced in the heel region of the heel being treated and evaluated in the study upon waking in the morning and taking the first few steps of the day for 2 consecutive days before receiving the first study procedure with the Erchonia HPS. The degree of pain was recorded by placing a cross along the point that best represented their current heel pain level on the 0-100 mm (0 -10 cm) Visual Analog Pain Scale (VAS) ranging from ‘0: no pain at all’ to ‘100: worst pain imaginable,’. The higher the rating, the greater the heel pain experienced.|units on a scale|Mean|67.70|67.7|Standard Deviation|11.80|11.8|||
3793852|NCT01835743|3622920|B1|||Degree of Heel Pain at Baseline|Subjects rated the overall degree of pain experienced in the heel region of the heel being treated and evaluated in the study upon waking in the morning and taking the first few steps of the day for 2 consecutive days before receiving the first study procedure with the Erchonia HPS. The degree of pain was recorded by placing a cross along the point that best represented their current heel pain level on the 0-100 mm (0 -10 cm) Visual Analog Pain Scale (VAS) ranging from ‘0: no pain at all’ to ‘100: worst pain imaginable,’. The higher the rating, the greater the heel pain experienced.|units on a scale|Mean|69.15|69.15|Standard Deviation|12.65|12.65|||
3793853|NCT01835743|3622918|B3|||Duration of Heel Pain at Baseline|The duration of heel pain at baseline was recorded as subject reported length of experiencing heel pain to that timepoint, in months.|months|Mean|12.29|12.29|Standard Deviation|11.63|11.63|||
3793854|NCT01835743|3622919|B2|||Duration of Heel Pain at Baseline|The duration of heel pain at baseline was recorded as subject reported length of experiencing heel pain to that timepoint, in months.|months|Mean|12.23|12.23|Standard Deviation|12.41|12.41|||
3793855|NCT01835743|3622920|B1|||Duration of Heel Pain at Baseline|The duration of heel pain at baseline was recorded as subject reported length of experiencing heel pain to that timepoint, in months.|months|Mean|12.34|12.34|Standard Deviation|11.08|11.08|||
3793856|NCT01835743|3622918|B3|Left Heel||Heel Side|Heel side (right heel or left heel) that qualified for and received the study procedure administrations|participants|Number|40|40.0||||||
3793857|NCT01835743|3622919|B2|Left Heel||Heel Side|Heel side (right heel or left heel) that qualified for and received the study procedure administrations|participants|Number|23|23.0||||||
3793858|NCT01835743|3622920|B1|Left Heel||Heel Side|Heel side (right heel or left heel) that qualified for and received the study procedure administrations|participants|Number|17|17.0||||||
3793859|NCT01835743|3622918|B3|Right Heel||Heel Side|Heel side (right heel or left heel) that qualified for and received the study procedure administrations|participants|Number|29|29.0||||||
3793860|NCT01835743|3622919|B2|Right Heel||Heel Side|Heel side (right heel or left heel) that qualified for and received the study procedure administrations|participants|Number|9|9.0||||||
3793861|NCT01835743|3622920|B1|Right Heel||Heel Side|Heel side (right heel or left heel) that qualified for and received the study procedure administrations|participants|Number|20|20.0||||||
3793862|NCT01835743|3622918|B3|United States||Region of Enrollment||participants|Number|69|69.0||||||
3793863|NCT01835743|3622919|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
3793864|NCT01835743|3622920|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
3793865|NCT01835743|3622918|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793866|NCT01835743|3622919|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793867|NCT01835743|3622920|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3793868|NCT01835743|3622918|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3793869|NCT01835743|3622919|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3793870|NCT01835743|3622920|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3793871|NCT01835743|3622918|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3793872|NCT01835743|3622919|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3793873|NCT01835743|3622920|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3793874|NCT01835743|3622918|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3793875|NCT01835743|3622919|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3793876|NCT01835743|3622920|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3793877|NCT01835743|3622918|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3793878|NCT01835743|3622919|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3793879|NCT01835743|3622920|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3793880|NCT01835743|3622918|B3|||Age||years|Mean|56.29|56.29|Standard Deviation|11.29|11.29|||
3793881|NCT01835743|3622919|B2|||Age||years|Mean|55.81|55.81|Standard Deviation|12.33|12.33|||
3793882|NCT01835743|3622920|B1|||Age||years|Mean|56.70|56.7|Standard Deviation|10.46|10.46|||
3793883|NCT01835587|3622929|B5||65-84 years|Age||Participants|Count of Participants|15|15.0||||||
3793884|NCT01835587|3622930|B4||65-84 years|Age||Participants|Count of Participants|10|10.0||||||
3793885|NCT01835587|3622931|B3||65-84 years|Age||Participants|Count of Participants|1|1.0||||||
3793886|NCT01835587|3622932|B2||65-84 years|Age||Participants|Count of Participants|1|1.0||||||
3793887|NCT01835587|3622933|B1||65-84 years|Age||Participants|Count of Participants|3|3.0||||||
3793888|NCT01835587|3622929|B5||18-64 years|Age||Participants|Count of Participants|15|15.0||||||
3793889|NCT01835587|3622930|B4||18-64 years|Age||Participants|Count of Participants|9|9.0||||||
3793890|NCT01835587|3622931|B3||18-64 years|Age||Participants|Count of Participants|3|3.0||||||
3793891|NCT01835587|3622932|B2||18-64 years|Age||Participants|Count of Participants|3|3.0||||||
3793892|NCT01835587|3622933|B1||18-64 years|Age||Participants|Count of Participants|0|0.0||||||
3793996|NCT01835548|3622997|B1|||Age||years|Mean|9.1|9.1|Standard Deviation|1.86|1.86|||
3793997|NCT01835496|3623019|B1|Canada||Region of Enrollment||participants|Number|8|8.0||||||
3793893|NCT01835587|3622929|B5|AML Not Otherwise Specified||AML World Health Organization (WHO) Classification|Description:AML is classified using the WHO classification system based upon a combination of morphology, immunophenotype, genetics, and clinical features. There are several broad groups and include: 1. AML with genetic abnormalities; 2. AML with multilineage dysplasia 3. AML related to previous chemotherapy or radiation 4. Unspecified AML - do not fall into the above groups|Participants:Participants|Number|13|13.0||||||
3793894|NCT01835587|3622930|B4|AML Not Otherwise Specified||AML World Health Organization (WHO) Classification|Description:AML is classified using the WHO classification system based upon a combination of morphology, immunophenotype, genetics, and clinical features. There are several broad groups and include: 1. AML with genetic abnormalities; 2. AML with multilineage dysplasia 3. AML related to previous chemotherapy or radiation 4. Unspecified AML - do not fall into the above groups|Participants:Participants|Number|7|7.0||||||
3793895|NCT01835587|3622931|B3|AML Not Otherwise Specified||AML World Health Organization (WHO) Classification|Description:AML is classified using the WHO classification system based upon a combination of morphology, immunophenotype, genetics, and clinical features. There are several broad groups and include: 1. AML with genetic abnormalities; 2. AML with multilineage dysplasia 3. AML related to previous chemotherapy or radiation 4. Unspecified AML - do not fall into the above groups|Participants:Participants|Number|2|2.0||||||
3793896|NCT01835587|3622932|B2|AML Not Otherwise Specified||AML World Health Organization (WHO) Classification|Description:AML is classified using the WHO classification system based upon a combination of morphology, immunophenotype, genetics, and clinical features. There are several broad groups and include: 1. AML with genetic abnormalities; 2. AML with multilineage dysplasia 3. AML related to previous chemotherapy or radiation 4. Unspecified AML - do not fall into the above groups|Participants:Participants|Number|2|2.0||||||
3793897|NCT01835587|3622933|B1|AML Not Otherwise Specified||AML World Health Organization (WHO) Classification|Description:AML is classified using the WHO classification system based upon a combination of morphology, immunophenotype, genetics, and clinical features. There are several broad groups and include: 1. AML with genetic abnormalities; 2. AML with multilineage dysplasia 3. AML related to previous chemotherapy or radiation 4. Unspecified AML - do not fall into the above groups|Participants:Participants|Number|2|2.0||||||
3793898|NCT01835587|3622929|B5|Therapy related Myeloid Neoplasms||AML World Health Organization (WHO) Classification|Description:AML is classified using the WHO classification system based upon a combination of morphology, immunophenotype, genetics, and clinical features. There are several broad groups and include: 1. AML with genetic abnormalities; 2. AML with multilineage dysplasia 3. AML related to previous chemotherapy or radiation 4. Unspecified AML - do not fall into the above groups|Participants:Participants|Number|1|1.0||||||
3793899|NCT01835587|3622930|B4|Therapy related Myeloid Neoplasms||AML World Health Organization (WHO) Classification|Description:AML is classified using the WHO classification system based upon a combination of morphology, immunophenotype, genetics, and clinical features. There are several broad groups and include: 1. AML with genetic abnormalities; 2. AML with multilineage dysplasia 3. AML related to previous chemotherapy or radiation 4. Unspecified AML - do not fall into the above groups|Participants:Participants|Number|0|0.0||||||
3793900|NCT01835587|3622931|B3|Therapy related Myeloid Neoplasms||AML World Health Organization (WHO) Classification|Description:AML is classified using the WHO classification system based upon a combination of morphology, immunophenotype, genetics, and clinical features. There are several broad groups and include: 1. AML with genetic abnormalities; 2. AML with multilineage dysplasia 3. AML related to previous chemotherapy or radiation 4. Unspecified AML - do not fall into the above groups|Participants:Participants|Number|1|1.0||||||
3793901|NCT01835587|3622932|B2|Therapy related Myeloid Neoplasms||AML World Health Organization (WHO) Classification|Description:AML is classified using the WHO classification system based upon a combination of morphology, immunophenotype, genetics, and clinical features. There are several broad groups and include: 1. AML with genetic abnormalities; 2. AML with multilineage dysplasia 3. AML related to previous chemotherapy or radiation 4. Unspecified AML - do not fall into the above groups|Participants:Participants|Number|0|0.0||||||
3793902|NCT01835587|3622933|B1|Therapy related Myeloid Neoplasms||AML World Health Organization (WHO) Classification|Description:AML is classified using the WHO classification system based upon a combination of morphology, immunophenotype, genetics, and clinical features. There are several broad groups and include: 1. AML with genetic abnormalities; 2. AML with multilineage dysplasia 3. AML related to previous chemotherapy or radiation 4. Unspecified AML - do not fall into the above groups|Participants:Participants|Number|0|0.0||||||
3793903|NCT01835587|3622929|B5|AML With Myelodysplasia Related Changes||AML World Health Organization (WHO) Classification|Description:AML is classified using the WHO classification system based upon a combination of morphology, immunophenotype, genetics, and clinical features. There are several broad groups and include: 1. AML with genetic abnormalities; 2. AML with multilineage dysplasia 3. AML related to previous chemotherapy or radiation 4. Unspecified AML - do not fall into the above groups|Participants:Participants|Number|3|3.0||||||
3793904|NCT01835587|3622930|B4|AML With Myelodysplasia Related Changes||AML World Health Organization (WHO) Classification|Description:AML is classified using the WHO classification system based upon a combination of morphology, immunophenotype, genetics, and clinical features. There are several broad groups and include: 1. AML with genetic abnormalities; 2. AML with multilineage dysplasia 3. AML related to previous chemotherapy or radiation 4. Unspecified AML - do not fall into the above groups|Participants:Participants|Number|2|2.0||||||
3793905|NCT01835587|3622931|B3|AML With Myelodysplasia Related Changes||AML World Health Organization (WHO) Classification|Description:AML is classified using the WHO classification system based upon a combination of morphology, immunophenotype, genetics, and clinical features. There are several broad groups and include: 1. AML with genetic abnormalities; 2. AML with multilineage dysplasia 3. AML related to previous chemotherapy or radiation 4. Unspecified AML - do not fall into the above groups|Participants:Participants|Number|1|1.0||||||
3793906|NCT01835587|3622932|B2|AML With Myelodysplasia Related Changes||AML World Health Organization (WHO) Classification|Description:AML is classified using the WHO classification system based upon a combination of morphology, immunophenotype, genetics, and clinical features. There are several broad groups and include: 1. AML with genetic abnormalities; 2. AML with multilineage dysplasia 3. AML related to previous chemotherapy or radiation 4. Unspecified AML - do not fall into the above groups|Participants:Participants|Number|0|0.0||||||
3793998|NCT01835496|3623019|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3793907|NCT01835587|3622933|B1|AML With Myelodysplasia Related Changes||AML World Health Organization (WHO) Classification|Description:AML is classified using the WHO classification system based upon a combination of morphology, immunophenotype, genetics, and clinical features. There are several broad groups and include: 1. AML with genetic abnormalities; 2. AML with multilineage dysplasia 3. AML related to previous chemotherapy or radiation 4. Unspecified AML - do not fall into the above groups|Participants:Participants|Number|0|0.0||||||
3793908|NCT01835587|3622929|B5|AML With Recurrent Genetic Abnormalities||AML World Health Organization (WHO) Classification|Description:AML is classified using the WHO classification system based upon a combination of morphology, immunophenotype, genetics, and clinical features. There are several broad groups and include: 1. AML with genetic abnormalities; 2. AML with multilineage dysplasia 3. AML related to previous chemotherapy or radiation 4. Unspecified AML - do not fall into the above groups|Participants:Participants|Number|9|9.0||||||
3793909|NCT01835587|3622930|B4|AML With Recurrent Genetic Abnormalities||AML World Health Organization (WHO) Classification|Description:AML is classified using the WHO classification system based upon a combination of morphology, immunophenotype, genetics, and clinical features. There are several broad groups and include: 1. AML with genetic abnormalities; 2. AML with multilineage dysplasia 3. AML related to previous chemotherapy or radiation 4. Unspecified AML - do not fall into the above groups|Participants:Participants|Number|7|7.0||||||
3793910|NCT01835587|3622931|B3|AML With Recurrent Genetic Abnormalities||AML World Health Organization (WHO) Classification|Description:AML is classified using the WHO classification system based upon a combination of morphology, immunophenotype, genetics, and clinical features. There are several broad groups and include: 1. AML with genetic abnormalities; 2. AML with multilineage dysplasia 3. AML related to previous chemotherapy or radiation 4. Unspecified AML - do not fall into the above groups|Participants:Participants|Number|0|0.0||||||
3793911|NCT01835587|3622932|B2|AML With Recurrent Genetic Abnormalities||AML World Health Organization (WHO) Classification|Description:AML is classified using the WHO classification system based upon a combination of morphology, immunophenotype, genetics, and clinical features. There are several broad groups and include: 1. AML with genetic abnormalities; 2. AML with multilineage dysplasia 3. AML related to previous chemotherapy or radiation 4. Unspecified AML - do not fall into the above groups|Participants:Participants|Number|2|2.0||||||
3793912|NCT01835587|3622933|B1|AML With Recurrent Genetic Abnormalities||AML World Health Organization (WHO) Classification|Description:AML is classified using the WHO classification system based upon a combination of morphology, immunophenotype, genetics, and clinical features. There are several broad groups and include: 1. AML with genetic abnormalities; 2. AML with multilineage dysplasia 3. AML related to previous chemotherapy or radiation 4. Unspecified AML - do not fall into the above groups|Participants:Participants|Number|0|0.0||||||
3793913|NCT01835587|3622929|B5|||Time from MDS or AML Diagnosis to Allogeneic HSCT||months|Mean|8.9|8.9|Standard Deviation|13.63|13.63|||
3793914|NCT01835587|3622930|B4|||Time from MDS or AML Diagnosis to Allogeneic HSCT||months|Mean|10.6|10.6|Standard Deviation|16.72|16.72|||
3793915|NCT01835587|3622931|B3|||Time from MDS or AML Diagnosis to Allogeneic HSCT||months|Mean|3.5|3.5|Standard Deviation|1.71|1.71|||
3793916|NCT01835587|3622932|B2|||Time from MDS or AML Diagnosis to Allogeneic HSCT||months|Mean|6.4|6.4|Standard Deviation|4.35|4.35|||
3793917|NCT01835587|3622933|B1|||Time from MDS or AML Diagnosis to Allogeneic HSCT||months|Mean|8.6|8.6|Standard Deviation|6.79|6.79|||
3793918|NCT01835587|3622929|B5||2 = Ambulatory but unable to work|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|0|0.0||||||
3793919|NCT01835587|3622930|B4||2 = Ambulatory but unable to work|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|0|0.0||||||
3793920|NCT01835587|3622931|B3||2 = Ambulatory but unable to work|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|0|0.0||||||
3793921|NCT01835587|3622932|B2||2 = Ambulatory but unable to work|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|0|0.0||||||
3793922|NCT01835587|3622933|B1||2 = Ambulatory but unable to work|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|0|0.0||||||
3793999|NCT01835496|3623019|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3794000|NCT01835496|3623019|B1|||Age||years|Mean|33.0|33.0|Standard Deviation|5.9|5.9|||
3794001|NCT01835496|3623019|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3793923|NCT01835587|3622929|B5||1= Restrictive but ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|19|19.0||||||
3793924|NCT01835587|3622930|B4||1= Restrictive but ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|11|11.0||||||
3793925|NCT01835587|3622931|B3||1= Restrictive but ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|3|3.0||||||
3793926|NCT01835587|3622932|B2||1= Restrictive but ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|3|3.0||||||
3793927|NCT01835587|3622933|B1||1= Restrictive but ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|2|2.0||||||
3793928|NCT01835587|3622929|B5||0 = Fully Active|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|11|11.0||||||
3793929|NCT01835587|3622930|B4||0 = Fully Active|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|8|8.0||||||
3793930|NCT01835587|3622931|B3||0 = Fully Active|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|1|1.0||||||
3793931|NCT01835587|3622932|B2||0 = Fully Active|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|1|1.0||||||
3793932|NCT01835587|3622933|B1||0 = Fully Active|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|1|1.0||||||
3793933|NCT01835587|3622929|B5||High|MDS International Prognostic Scoring System (IPSS) Risk Classification|The MDS IPSS score assesses the severity of MDS based on 3 prognostic factors each assigned a score: the percentage of bone marrow blasts, chromosome changes in the marrow cells (karyotype) and the presence of one or more low blood cell counts (cytopenias). The IPSS score is the sum of the bone marrow blast + karyotype + cytopenia score and ranges from 0 (low risk) to 3.5 (high risk). Prognosis is categorized as Low risk (score = 0), Intermediate-1 (score 0.5 to 1.0), Intermediate-2 (score 1.5 to 2.0) or High risk (score ≥ 2.5).|Participants|Count of Participants|1|1.0||||||
3793934|NCT01835587|3622930|B4||High|MDS International Prognostic Scoring System (IPSS) Risk Classification|The MDS IPSS score assesses the severity of MDS based on 3 prognostic factors each assigned a score: the percentage of bone marrow blasts, chromosome changes in the marrow cells (karyotype) and the presence of one or more low blood cell counts (cytopenias). The IPSS score is the sum of the bone marrow blast + karyotype + cytopenia score and ranges from 0 (low risk) to 3.5 (high risk). Prognosis is categorized as Low risk (score = 0), Intermediate-1 (score 0.5 to 1.0), Intermediate-2 (score 1.5 to 2.0) or High risk (score ≥ 2.5).|Participants|Count of Participants|1|1.0||||||
3793935|NCT01835587|3622931|B3||High|MDS International Prognostic Scoring System (IPSS) Risk Classification|The MDS IPSS score assesses the severity of MDS based on 3 prognostic factors each assigned a score: the percentage of bone marrow blasts, chromosome changes in the marrow cells (karyotype) and the presence of one or more low blood cell counts (cytopenias). The IPSS score is the sum of the bone marrow blast + karyotype + cytopenia score and ranges from 0 (low risk) to 3.5 (high risk). Prognosis is categorized as Low risk (score = 0), Intermediate-1 (score 0.5 to 1.0), Intermediate-2 (score 1.5 to 2.0) or High risk (score ≥ 2.5).|Participants|Count of Participants|0|0.0||||||
3793936|NCT01835587|3622932|B2||High|MDS International Prognostic Scoring System (IPSS) Risk Classification|The MDS IPSS score assesses the severity of MDS based on 3 prognostic factors each assigned a score: the percentage of bone marrow blasts, chromosome changes in the marrow cells (karyotype) and the presence of one or more low blood cell counts (cytopenias). The IPSS score is the sum of the bone marrow blast + karyotype + cytopenia score and ranges from 0 (low risk) to 3.5 (high risk). Prognosis is categorized as Low risk (score = 0), Intermediate-1 (score 0.5 to 1.0), Intermediate-2 (score 1.5 to 2.0) or High risk (score ≥ 2.5).|Participants|Count of Participants|0|0.0||||||
3793937|NCT01835587|3622933|B1||High|MDS International Prognostic Scoring System (IPSS) Risk Classification|The MDS IPSS score assesses the severity of MDS based on 3 prognostic factors each assigned a score: the percentage of bone marrow blasts, chromosome changes in the marrow cells (karyotype) and the presence of one or more low blood cell counts (cytopenias). The IPSS score is the sum of the bone marrow blast + karyotype + cytopenia score and ranges from 0 (low risk) to 3.5 (high risk). Prognosis is categorized as Low risk (score = 0), Intermediate-1 (score 0.5 to 1.0), Intermediate-2 (score 1.5 to 2.0) or High risk (score ≥ 2.5).|Participants|Count of Participants|0|0.0||||||
3793938|NCT01835587|3622929|B5||INT-2|MDS International Prognostic Scoring System (IPSS) Risk Classification|The MDS IPSS score assesses the severity of MDS based on 3 prognostic factors each assigned a score: the percentage of bone marrow blasts, chromosome changes in the marrow cells (karyotype) and the presence of one or more low blood cell counts (cytopenias). The IPSS score is the sum of the bone marrow blast + karyotype + cytopenia score and ranges from 0 (low risk) to 3.5 (high risk). Prognosis is categorized as Low risk (score = 0), Intermediate-1 (score 0.5 to 1.0), Intermediate-2 (score 1.5 to 2.0) or High risk (score ≥ 2.5).|Participants|Count of Participants|2|2.0||||||
3793939|NCT01835587|3622930|B4||INT-2|MDS International Prognostic Scoring System (IPSS) Risk Classification|The MDS IPSS score assesses the severity of MDS based on 3 prognostic factors each assigned a score: the percentage of bone marrow blasts, chromosome changes in the marrow cells (karyotype) and the presence of one or more low blood cell counts (cytopenias). The IPSS score is the sum of the bone marrow blast + karyotype + cytopenia score and ranges from 0 (low risk) to 3.5 (high risk). Prognosis is categorized as Low risk (score = 0), Intermediate-1 (score 0.5 to 1.0), Intermediate-2 (score 1.5 to 2.0) or High risk (score ≥ 2.5).|Participants|Count of Participants|1|1.0||||||
3793940|NCT01835587|3622931|B3||INT-2|MDS International Prognostic Scoring System (IPSS) Risk Classification|The MDS IPSS score assesses the severity of MDS based on 3 prognostic factors each assigned a score: the percentage of bone marrow blasts, chromosome changes in the marrow cells (karyotype) and the presence of one or more low blood cell counts (cytopenias). The IPSS score is the sum of the bone marrow blast + karyotype + cytopenia score and ranges from 0 (low risk) to 3.5 (high risk). Prognosis is categorized as Low risk (score = 0), Intermediate-1 (score 0.5 to 1.0), Intermediate-2 (score 1.5 to 2.0) or High risk (score ≥ 2.5).|Participants|Count of Participants|0|0.0||||||
3793941|NCT01835587|3622932|B2||INT-2|MDS International Prognostic Scoring System (IPSS) Risk Classification|The MDS IPSS score assesses the severity of MDS based on 3 prognostic factors each assigned a score: the percentage of bone marrow blasts, chromosome changes in the marrow cells (karyotype) and the presence of one or more low blood cell counts (cytopenias). The IPSS score is the sum of the bone marrow blast + karyotype + cytopenia score and ranges from 0 (low risk) to 3.5 (high risk). Prognosis is categorized as Low risk (score = 0), Intermediate-1 (score 0.5 to 1.0), Intermediate-2 (score 1.5 to 2.0) or High risk (score ≥ 2.5).|Participants|Count of Participants|0|0.0||||||
3793942|NCT01835587|3622933|B1||INT-2|MDS International Prognostic Scoring System (IPSS) Risk Classification|The MDS IPSS score assesses the severity of MDS based on 3 prognostic factors each assigned a score: the percentage of bone marrow blasts, chromosome changes in the marrow cells (karyotype) and the presence of one or more low blood cell counts (cytopenias). The IPSS score is the sum of the bone marrow blast + karyotype + cytopenia score and ranges from 0 (low risk) to 3.5 (high risk). Prognosis is categorized as Low risk (score = 0), Intermediate-1 (score 0.5 to 1.0), Intermediate-2 (score 1.5 to 2.0) or High risk (score ≥ 2.5).|Participants|Count of Participants|1|1.0||||||
3793943|NCT01835587|3622929|B5||INT-1|MDS International Prognostic Scoring System (IPSS) Risk Classification|The MDS IPSS score assesses the severity of MDS based on 3 prognostic factors each assigned a score: the percentage of bone marrow blasts, chromosome changes in the marrow cells (karyotype) and the presence of one or more low blood cell counts (cytopenias). The IPSS score is the sum of the bone marrow blast + karyotype + cytopenia score and ranges from 0 (low risk) to 3.5 (high risk). Prognosis is categorized as Low risk (score = 0), Intermediate-1 (score 0.5 to 1.0), Intermediate-2 (score 1.5 to 2.0) or High risk (score ≥ 2.5).|Participants|Count of Participants|1|1.0||||||
3793944|NCT01835587|3622930|B4||INT-1|MDS International Prognostic Scoring System (IPSS) Risk Classification|The MDS IPSS score assesses the severity of MDS based on 3 prognostic factors each assigned a score: the percentage of bone marrow blasts, chromosome changes in the marrow cells (karyotype) and the presence of one or more low blood cell counts (cytopenias). The IPSS score is the sum of the bone marrow blast + karyotype + cytopenia score and ranges from 0 (low risk) to 3.5 (high risk). Prognosis is categorized as Low risk (score = 0), Intermediate-1 (score 0.5 to 1.0), Intermediate-2 (score 1.5 to 2.0) or High risk (score ≥ 2.5).|Participants|Count of Participants|1|1.0||||||
3793945|NCT01835587|3622931|B3||INT-1|MDS International Prognostic Scoring System (IPSS) Risk Classification|The MDS IPSS score assesses the severity of MDS based on 3 prognostic factors each assigned a score: the percentage of bone marrow blasts, chromosome changes in the marrow cells (karyotype) and the presence of one or more low blood cell counts (cytopenias). The IPSS score is the sum of the bone marrow blast + karyotype + cytopenia score and ranges from 0 (low risk) to 3.5 (high risk). Prognosis is categorized as Low risk (score = 0), Intermediate-1 (score 0.5 to 1.0), Intermediate-2 (score 1.5 to 2.0) or High risk (score ≥ 2.5).|Participants|Count of Participants|0|0.0||||||
3794002|NCT01835496|3623019|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3793946|NCT01835587|3622932|B2||INT-1|MDS International Prognostic Scoring System (IPSS) Risk Classification|The MDS IPSS score assesses the severity of MDS based on 3 prognostic factors each assigned a score: the percentage of bone marrow blasts, chromosome changes in the marrow cells (karyotype) and the presence of one or more low blood cell counts (cytopenias). The IPSS score is the sum of the bone marrow blast + karyotype + cytopenia score and ranges from 0 (low risk) to 3.5 (high risk). Prognosis is categorized as Low risk (score = 0), Intermediate-1 (score 0.5 to 1.0), Intermediate-2 (score 1.5 to 2.0) or High risk (score ≥ 2.5).|Participants|Count of Participants|0|0.0||||||
3793947|NCT01835587|3622933|B1||INT-1|MDS International Prognostic Scoring System (IPSS) Risk Classification|The MDS IPSS score assesses the severity of MDS based on 3 prognostic factors each assigned a score: the percentage of bone marrow blasts, chromosome changes in the marrow cells (karyotype) and the presence of one or more low blood cell counts (cytopenias). The IPSS score is the sum of the bone marrow blast + karyotype + cytopenia score and ranges from 0 (low risk) to 3.5 (high risk). Prognosis is categorized as Low risk (score = 0), Intermediate-1 (score 0.5 to 1.0), Intermediate-2 (score 1.5 to 2.0) or High risk (score ≥ 2.5).|Participants|Count of Participants|0|0.0||||||
3793948|NCT01835587|3622929|B5|Myelodysplastic Syndromes||Diagnosis at Study Entry|The number of participants with a diagnosis of AML or MDS|Participants|Count of Participants|4|4.0||||||
3793949|NCT01835587|3622930|B4|Myelodysplastic Syndromes||Diagnosis at Study Entry|The number of participants with a diagnosis of AML or MDS|Participants|Count of Participants|3|3.0||||||
3793950|NCT01835587|3622931|B3|Myelodysplastic Syndromes||Diagnosis at Study Entry|The number of participants with a diagnosis of AML or MDS|Participants|Count of Participants|0|0.0||||||
3793951|NCT01835587|3622932|B2|Myelodysplastic Syndromes||Diagnosis at Study Entry|The number of participants with a diagnosis of AML or MDS|Participants|Count of Participants|0|0.0||||||
3793952|NCT01835587|3622933|B1|Myelodysplastic Syndromes||Diagnosis at Study Entry|The number of participants with a diagnosis of AML or MDS|Participants|Count of Participants|1|1.0||||||
3793953|NCT01835587|3622929|B5|Acute Myeloid Leukemia||Diagnosis at Study Entry|The number of participants with a diagnosis of AML or MDS|Participants|Count of Participants|26|26.0||||||
3793954|NCT01835587|3622930|B4|Acute Myeloid Leukemia||Diagnosis at Study Entry|The number of participants with a diagnosis of AML or MDS|Participants|Count of Participants|16|16.0||||||
3793955|NCT01835587|3622931|B3|Acute Myeloid Leukemia||Diagnosis at Study Entry|The number of participants with a diagnosis of AML or MDS|Participants|Count of Participants|4|4.0||||||
3793956|NCT01835587|3622932|B2|Acute Myeloid Leukemia||Diagnosis at Study Entry|The number of participants with a diagnosis of AML or MDS|Participants|Count of Participants|4|4.0||||||
3793957|NCT01835587|3622933|B1|Acute Myeloid Leukemia||Diagnosis at Study Entry|The number of participants with a diagnosis of AML or MDS|Participants|Count of Participants|2|2.0||||||
3793958|NCT01835587|3622929|B5|Not Collected or Reported||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3793959|NCT01835587|3622930|B4|Not Collected or Reported||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3793960|NCT01835587|3622931|B3|Not Collected or Reported||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3793961|NCT01835587|3622932|B2|Not Collected or Reported||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3793962|NCT01835587|3622933|B1|Not Collected or Reported||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3793963|NCT01835587|3622929|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3793964|NCT01835587|3622930|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3793965|NCT01835587|3622931|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3793966|NCT01835587|3622932|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3793967|NCT01835587|3622933|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3793968|NCT01835587|3622929|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3793969|NCT01835587|3622930|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3793970|NCT01835587|3622931|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3793971|NCT01835587|3622932|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3793972|NCT01835587|3622933|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3793973|NCT01835587|3622929|B5||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3793974|NCT01835587|3622930|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3793975|NCT01835587|3622931|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3793976|NCT01835587|3622932|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3793977|NCT01835587|3622933|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3793978|NCT01835587|3622929|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3793979|NCT01835587|3622930|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3793980|NCT01835587|3622931|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3793981|NCT01835587|3622932|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3793982|NCT01835587|3622933|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3793983|NCT01835587|3622929|B5|||Age||Years|Mean|60.0|60.0|Standard Deviation|13.11|13.11|||
3793984|NCT01835587|3622930|B4|||Age||Years|Mean|60.8|60.8|Standard Deviation|12.60|12.6|||
3793985|NCT01835587|3622931|B3|||Age||Years|Mean|61.8|61.8|Standard Deviation|8.73|8.73|||
3793986|NCT01835587|3622932|B2|||Age||Years|Mean|47.8|47.8|Standard Deviation|18.26|18.26|||
3793987|NCT01835587|3622933|B1|||Age||Years|Mean|68.3|68.3|Standard Deviation|5.77|5.77|||
3793988|NCT01835548|3622995|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3793989|NCT01835548|3622996|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3793990|NCT01835548|3622997|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3794003|NCT01835496|3623019|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3794004|NCT01835470|3623028|B1|Japan||Region of Enrollment||participants|Number|20|20.0||||||
3794005|NCT01835470|3623028|B1|Japanese||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3794006|NCT01835470|3623028|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3794007|NCT01835470|3623028|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3794008|NCT01835470|3623028|B1|||Age||years|Mean|10.2|10.2|Standard Deviation|3.24|3.24|||
3794009|NCT01835470|3623028|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3794010|NCT01835470|3623028|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3794011|NCT01835470|3623028|B1||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
3794012|NCT01835431|3623038|B3|||Fasting plasma Glucose (FPG)|Capillary blood samples for fasting plasma glucose (FPG) were taken either at home or at the clinic in the morning on the day of visits 2, 14 and 18 by use of a home blood sampling kit. At baseline FPG assessment: IDegAsp OD: 172 subjects, IDet: 166 subjects. In total: 338 subjects|mmol/L|Mean|8.4|8.4|Standard Deviation|4.3|4.3|||
3794013|NCT01835431|3623039|B2|||Fasting plasma Glucose (FPG)|Capillary blood samples for fasting plasma glucose (FPG) were taken either at home or at the clinic in the morning on the day of visits 2, 14 and 18 by use of a home blood sampling kit. At baseline FPG assessment: IDegAsp OD: 172 subjects, IDet: 166 subjects. In total: 338 subjects|mmol/L|Mean|8.1|8.1|Standard Deviation|4.2|4.2|||
3794014|NCT01835431|3623040|B1|||Fasting plasma Glucose (FPG)|Capillary blood samples for fasting plasma glucose (FPG) were taken either at home or at the clinic in the morning on the day of visits 2, 14 and 18 by use of a home blood sampling kit. At baseline FPG assessment: IDegAsp OD: 172 subjects, IDet: 166 subjects. In total: 338 subjects|mmol/L|Mean|8.6|8.6|Standard Deviation|4.4|4.4|||
3794015|NCT01835431|3623038|B3|||HbA1c||percentage (%)|Mean|8.1|8.1|Standard Deviation|1.2|1.2|||
3794016|NCT01835431|3623039|B2|||HbA1c||percentage (%)|Mean|8.1|8.1|Standard Deviation|1.2|1.2|||
3794017|NCT01835431|3623040|B1|||HbA1c||percentage (%)|Mean|8.1|8.1|Standard Deviation|1.2|1.2|||
3794018|NCT01835431|3623038|B3||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
3794019|NCT01835431|3623039|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3794020|NCT01835431|3623040|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3794021|NCT01835431|3623038|B3||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
3794022|NCT01835431|3623039|B2||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3794023|NCT01835431|3623040|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3794024|NCT01835431|3623038|B3|||Age||years|Mean|10.6|10.6|Standard Deviation|4.5|4.5|||
3794025|NCT01835431|3623039|B2|||Age||years|Mean|10.8|10.8|Standard Deviation|4.6|4.6|||
3794026|NCT01835431|3623040|B1|||Age||years|Mean|10.5|10.5|Standard Deviation|4.3|4.3|||
3794027|NCT01835379|3623059|B3|||Body Mass Index (BMI)||kg/m2|Mean|33.3|33.3|Standard Deviation|7.6|7.6|||
3794028|NCT01835379|3623060|B2|||Body Mass Index (BMI)||kg/m2|Mean|33.6|33.6|Standard Deviation|6.1|6.1|||
3794029|NCT01835379|3623061|B1|||Body Mass Index (BMI)||kg/m2|Mean|32.9|32.9|Standard Deviation|8.9|8.9|||
3794030|NCT01835379|3623059|B3|United States||Region of Enrollment||participants|Number|82|82.0||||||
3794031|NCT01835379|3623060|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
3794032|NCT01835379|3623061|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
3794033|NCT01835379|3623059|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3794034|NCT01835379|3623060|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3794035|NCT01835379|3623061|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3794036|NCT01835379|3623059|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794037|NCT01835379|3623060|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794038|NCT01835379|3623061|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794039|NCT01835379|3623059|B3||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3794040|NCT01835379|3623060|B2||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3794041|NCT01835379|3623061|B1||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3794042|NCT01835379|3623059|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3794043|NCT01835379|3623060|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3794044|NCT01835379|3623061|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3794045|NCT01835379|3623059|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794046|NCT01835379|3623060|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794047|NCT01835379|3623061|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794048|NCT01835379|3623059|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3794049|NCT01835379|3623060|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794050|NCT01835379|3623061|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3794051|NCT01835379|3623059|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794052|NCT01835379|3623060|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794053|NCT01835379|3623061|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794054|NCT01835379|3623059|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794111|NCT01835158|3623079|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3794055|NCT01835379|3623060|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794056|NCT01835379|3623061|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794057|NCT01835379|3623059|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3794058|NCT01835379|3623060|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3794059|NCT01835379|3623061|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3794060|NCT01835379|3623059|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3794061|NCT01835379|3623060|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3794062|NCT01835379|3623061|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3794063|NCT01835379|3623059|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3794064|NCT01835379|3623060|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3794065|NCT01835379|3623061|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3794066|NCT01835379|3623059|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3794067|NCT01835379|3623060|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3794068|NCT01835379|3623061|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3794069|NCT01835379|3623059|B3|||Age||years|Mean|56.9|56.9|Standard Deviation|10.8|10.8|||
3794070|NCT01835379|3623060|B2|||Age||years|Mean|56.6|56.6|Standard Deviation|10.8|10.8|||
3794071|NCT01835379|3623061|B1|||Age||years|Mean|57.1|57.1|Standard Deviation|10.9|10.9|||
3794072|NCT01835262|3623070|B3|||Numeric Rating Scale of Pain score|Numeric Rating Scale of Pain Score (0=no pain and 10=severe pain)|score|Mean|8.57|8.57|Standard Deviation|1.5|1.5|||
3794073|NCT01835262|3623071|B2|||Numeric Rating Scale of Pain score|Numeric Rating Scale of Pain Score (0=no pain and 10=severe pain)|score|Mean|8.64|8.64|Standard Deviation|1.5|1.5|||
3794074|NCT01835262|3623072|B1|||Numeric Rating Scale of Pain score|Numeric Rating Scale of Pain Score (0=no pain and 10=severe pain)|score|Mean|8.49|8.49|Standard Deviation|1.5|1.5|||
3794075|NCT01835262|3623070|B3|United States||Region of Enrollment||participants|Number|90|90.0||||||
3794076|NCT01835262|3623071|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
3794077|NCT01835262|3623072|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
3794078|NCT01835262|3623070|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3794079|NCT01835262|3623071|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3794080|NCT01835262|3623072|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3794081|NCT01835262|3623070|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3794082|NCT01835262|3623071|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3794083|NCT01835262|3623072|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3794084|NCT01835262|3623070|B3|||Age||years|Mean|35.0|35.0|Standard Deviation|10.0|10.0|||
3794085|NCT01835262|3623071|B2|||Age||years|Mean|34.8|34.8|Standard Deviation|9.5|9.5|||
3794086|NCT01835262|3623072|B1|||Age||years|Mean|35.7|35.7|Standard Deviation|10.5|10.5|||
3794087|NCT01835158|3623079|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3794088|NCT01835158|3623080|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3794089|NCT01835158|3623081|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3794090|NCT01835158|3623079|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794091|NCT01835158|3623080|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794092|NCT01835158|3623081|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794093|NCT01835158|3623079|B3||White|Race (NIH/OMB)||Participants|Count of Participants|145|145.0||||||
3794094|NCT01835158|3623080|B2||White|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3794095|NCT01835158|3623081|B1||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3794096|NCT01835158|3623079|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3794097|NCT01835158|3623080|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3794098|NCT01835158|3623081|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3794099|NCT01835158|3623079|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3794100|NCT01835158|3623080|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794101|NCT01835158|3623081|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3794102|NCT01835158|3623079|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3794103|NCT01835158|3623080|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794104|NCT01835158|3623081|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3794105|NCT01835158|3623079|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3794106|NCT01835158|3623080|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794107|NCT01835158|3623081|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3794108|NCT01835158|3623079|B3||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3794109|NCT01835158|3623080|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3794110|NCT01835158|3623081|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3794112|NCT01835158|3623080|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3794113|NCT01835158|3623081|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3794114|NCT01835158|3623079|B3|||Age||years|Median|63|63.0|Full Range|||31.0|87.0|
3794115|NCT01835158|3623080|B2|||Age||years|Median|64|64.0|Full Range|||31.0|87.0|
3794116|NCT01835158|3623081|B1|||Age||years|Median|63|63.0|Full Range|||40.0|82.0|
3794117|NCT01835132|3623092|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3794118|NCT01835132|3623092|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3794119|NCT01835132|3623092|B1|||Age||years|Mean|59.88|59.88|Full Range|||34.0|81.0|
3794120|NCT01835132|3623092|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3794121|NCT01835132|3623092|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3794122|NCT01835132|3623092|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3794123|NCT01835015|3623132|B6|Exudative macular degeneration||Primary Diagnosis|Geographic atrophy was classified as atrophic lesions in the macula related to AMD as assessed by Fundus autofluorescence. Exudative (wet) macular degeneration was classified as patients suffering from neovascular (wet) AMD, as assessed by fluorescein angiography, who were not likely to require anti-VEGF (vascular endothelial growth factor) therapy during the study period.|participants|Number|24|24.0||||||
3794124|NCT01835015|3623133|B5|Exudative macular degeneration||Primary Diagnosis|Geographic atrophy was classified as atrophic lesions in the macula related to AMD as assessed by Fundus autofluorescence. Exudative (wet) macular degeneration was classified as patients suffering from neovascular (wet) AMD, as assessed by fluorescein angiography, who were not likely to require anti-VEGF (vascular endothelial growth factor) therapy during the study period.|participants|Number|4|4.0||||||
3794125|NCT01835015|3623134|B4|Exudative macular degeneration||Primary Diagnosis|Geographic atrophy was classified as atrophic lesions in the macula related to AMD as assessed by Fundus autofluorescence. Exudative (wet) macular degeneration was classified as patients suffering from neovascular (wet) AMD, as assessed by fluorescein angiography, who were not likely to require anti-VEGF (vascular endothelial growth factor) therapy during the study period.|participants|Number|5|5.0||||||
3794126|NCT01835015|3623135|B3|Exudative macular degeneration||Primary Diagnosis|Geographic atrophy was classified as atrophic lesions in the macula related to AMD as assessed by Fundus autofluorescence. Exudative (wet) macular degeneration was classified as patients suffering from neovascular (wet) AMD, as assessed by fluorescein angiography, who were not likely to require anti-VEGF (vascular endothelial growth factor) therapy during the study period.|participants|Number|5|5.0||||||
3794127|NCT01835015|3623136|B2|Exudative macular degeneration||Primary Diagnosis|Geographic atrophy was classified as atrophic lesions in the macula related to AMD as assessed by Fundus autofluorescence. Exudative (wet) macular degeneration was classified as patients suffering from neovascular (wet) AMD, as assessed by fluorescein angiography, who were not likely to require anti-VEGF (vascular endothelial growth factor) therapy during the study period.|participants|Number|4|4.0||||||
3794128|NCT01835015|3623137|B1|Exudative macular degeneration||Primary Diagnosis|Geographic atrophy was classified as atrophic lesions in the macula related to AMD as assessed by Fundus autofluorescence. Exudative (wet) macular degeneration was classified as patients suffering from neovascular (wet) AMD, as assessed by fluorescein angiography, who were not likely to require anti-VEGF (vascular endothelial growth factor) therapy during the study period.|participants|Number|6|6.0||||||
3794129|NCT01835015|3623132|B6|Geographic atrophy||Primary Diagnosis|Geographic atrophy was classified as atrophic lesions in the macula related to AMD as assessed by Fundus autofluorescence. Exudative (wet) macular degeneration was classified as patients suffering from neovascular (wet) AMD, as assessed by fluorescein angiography, who were not likely to require anti-VEGF (vascular endothelial growth factor) therapy during the study period.|participants|Number|7|7.0||||||
3794130|NCT01835015|3623133|B5|Geographic atrophy||Primary Diagnosis|Geographic atrophy was classified as atrophic lesions in the macula related to AMD as assessed by Fundus autofluorescence. Exudative (wet) macular degeneration was classified as patients suffering from neovascular (wet) AMD, as assessed by fluorescein angiography, who were not likely to require anti-VEGF (vascular endothelial growth factor) therapy during the study period.|participants|Number|2|2.0||||||
3794131|NCT01835015|3623134|B4|Geographic atrophy||Primary Diagnosis|Geographic atrophy was classified as atrophic lesions in the macula related to AMD as assessed by Fundus autofluorescence. Exudative (wet) macular degeneration was classified as patients suffering from neovascular (wet) AMD, as assessed by fluorescein angiography, who were not likely to require anti-VEGF (vascular endothelial growth factor) therapy during the study period.|participants|Number|1|1.0||||||
3794132|NCT01835015|3623135|B3|Geographic atrophy||Primary Diagnosis|Geographic atrophy was classified as atrophic lesions in the macula related to AMD as assessed by Fundus autofluorescence. Exudative (wet) macular degeneration was classified as patients suffering from neovascular (wet) AMD, as assessed by fluorescein angiography, who were not likely to require anti-VEGF (vascular endothelial growth factor) therapy during the study period.|participants|Number|2|2.0||||||
3794133|NCT01835015|3623136|B2|Geographic atrophy||Primary Diagnosis|Geographic atrophy was classified as atrophic lesions in the macula related to AMD as assessed by Fundus autofluorescence. Exudative (wet) macular degeneration was classified as patients suffering from neovascular (wet) AMD, as assessed by fluorescein angiography, who were not likely to require anti-VEGF (vascular endothelial growth factor) therapy during the study period.|participants|Number|2|2.0||||||
3794134|NCT01835015|3623137|B1|Geographic atrophy||Primary Diagnosis|Geographic atrophy was classified as atrophic lesions in the macula related to AMD as assessed by Fundus autofluorescence. Exudative (wet) macular degeneration was classified as patients suffering from neovascular (wet) AMD, as assessed by fluorescein angiography, who were not likely to require anti-VEGF (vascular endothelial growth factor) therapy during the study period.|participants|Number|0|0.0||||||
3794135|NCT01835015|3623132|B6||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3794136|NCT01835015|3623133|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3794137|NCT01835015|3623134|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3794138|NCT01835015|3623135|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3794139|NCT01835015|3623136|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3794140|NCT01835015|3623137|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3794141|NCT01835015|3623132|B6||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3794142|NCT01835015|3623133|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3794143|NCT01835015|3623134|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3794144|NCT01835015|3623135|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3794145|NCT01835015|3623136|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3794146|NCT01835015|3623137|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3794147|NCT01835015|3623132|B6|||Age||years|Mean|75.3|75.3|Standard Deviation|8.12|8.12|||
3794148|NCT01835015|3623133|B5|||Age||years|Mean|76.5|76.5|Standard Deviation|10.86|10.86|||
3794149|NCT01835015|3623134|B4|||Age||years|Mean|73.3|73.3|Standard Deviation|9.52|9.52|||
3794150|NCT01835015|3623135|B3|||Age||years|Mean|76.1|76.1|Standard Deviation|6.69|6.69|||
3794151|NCT01835015|3623136|B2|||Age||years|Mean|76.2|76.2|Standard Deviation|8.80|8.8|||
3794152|NCT01835015|3623137|B1|||Age||years|Mean|74.2|74.2|Standard Deviation|6.82|6.82|||
3794153|NCT01834651|3623214|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3794154|NCT01834651|3623214|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794155|NCT01834651|3623214|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3794156|NCT01834651|3623214|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794157|NCT01834651|3623214|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794158|NCT01834651|3623214|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794159|NCT01834651|3623214|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794160|NCT01834651|3623214|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3794161|NCT01834651|3623214|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3794162|NCT01834651|3623214|B1|||Age||years|Median|65|65.0|Full Range|||50.0|80.0|
3794163|NCT01834586|3623224|B1|United States||Region of Enrollment|geographic location|Participants|Count of Participants|30|30.0||||||
3794164|NCT01834586|3623224|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3794165|NCT01834586|3623224|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3794166|NCT01834586|3623224|B1|||Age||years|Mean|51|51.0|Standard Deviation|10.6|10.6|||
3794167|NCT01834586|3623224|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3794168|NCT01834586|3623224|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3794169|NCT01834586|3623224|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3794170|NCT01834404|3623229|B3|||Baseline Maximum Tolerated Volume|At visit 2, subjects did a satiation/nutrient drink test. Participants recorded their sensations every 5 minutes using a numerical scale from 0-5, with level 0 being no symptoms, level 3 corresponding to fullness sensation after a typical meal, and level 5 corresponding to the maximal tolerated volume (maximum or unbearable fullness/satiation). This baseline measure is the volume consumed when the fullness sensation reached level 5.|ml|Mean|1297.8|1297.8|Standard Deviation|383.2|383.2|||
3794171|NCT01834404|3623230|B2|||Baseline Maximum Tolerated Volume|At visit 2, subjects did a satiation/nutrient drink test. Participants recorded their sensations every 5 minutes using a numerical scale from 0-5, with level 0 being no symptoms, level 3 corresponding to fullness sensation after a typical meal, and level 5 corresponding to the maximal tolerated volume (maximum or unbearable fullness/satiation). This baseline measure is the volume consumed when the fullness sensation reached level 5.|ml|Mean|1227|1227.0|Standard Deviation|111|111.0|||
3794172|NCT01834404|3623231|B1|||Baseline Maximum Tolerated Volume|At visit 2, subjects did a satiation/nutrient drink test. Participants recorded their sensations every 5 minutes using a numerical scale from 0-5, with level 0 being no symptoms, level 3 corresponding to fullness sensation after a typical meal, and level 5 corresponding to the maximal tolerated volume (maximum or unbearable fullness/satiation). This baseline measure is the volume consumed when the fullness sensation reached level 5.|ml|Mean|1368|1368.0|Standard Deviation|111|111.0|||
3794173|NCT01834404|3623229|B3|||Baseline Volume to Fullness|At visit 2, subjects did a satiation/nutrient drink test. Participants recorded their sensations every 5 minutes using a numerical scale from 0-5, with level 0 being no symptoms, level 3 corresponding to fullness sensation after a typical meal, and level 5 corresponding to the maximal tolerated volume (maximum or unbearable fullness/satiation). This baseline measure is the volume consumed when the fullness sensation reached level 3.|ml|Mean|711.3|711.3|Standard Deviation|306.3|306.3|||
3794174|NCT01834404|3623230|B2|||Baseline Volume to Fullness|At visit 2, subjects did a satiation/nutrient drink test. Participants recorded their sensations every 5 minutes using a numerical scale from 0-5, with level 0 being no symptoms, level 3 corresponding to fullness sensation after a typical meal, and level 5 corresponding to the maximal tolerated volume (maximum or unbearable fullness/satiation). This baseline measure is the volume consumed when the fullness sensation reached level 3.|ml|Mean|710|710.0|Standard Deviation|95|95.0|||
3794175|NCT01834404|3623231|B1|||Baseline Volume to Fullness|At visit 2, subjects did a satiation/nutrient drink test. Participants recorded their sensations every 5 minutes using a numerical scale from 0-5, with level 0 being no symptoms, level 3 corresponding to fullness sensation after a typical meal, and level 5 corresponding to the maximal tolerated volume (maximum or unbearable fullness/satiation). This baseline measure is the volume consumed when the fullness sensation reached level 3.|ml|Mean|712|712.0|Standard Deviation|86|86.0|||
3794176|NCT01834404|3623229|B3|||Fasting Plasma Glucose||mg/dL|Mean|95.3|95.3|Standard Deviation|10.6|10.6|||
3794177|NCT01834404|3623230|B2|||Fasting Plasma Glucose||mg/dL|Mean|96.5|96.5|Standard Deviation|3.6|3.6|||
3794178|NCT01834404|3623231|B1|||Fasting Plasma Glucose||mg/dL|Mean|94.2|94.2|Standard Deviation|2.7|2.7|||
3794179|NCT01834404|3623229|B3|||Waist Circumference||cm|Mean|109.8|109.8|Standard Deviation|7.5|7.5|||
3794180|NCT01834404|3623230|B2|||Waist Circumference||cm|Mean|111.2|111.2|Standard Deviation|2.2|2.2|||
3794181|NCT01834404|3623231|B1|||Waist Circumference||cm|Mean|108.5|108.5|Standard Deviation|2.2|2.2|||
3794182|NCT01834404|3623229|B3|||Body Mass Index (BMI)|Body Mass Index (BMI) is a health index for comparing weight to height. BMI is a person's weight in kilograms (kg) divided by his or her height in meters squared. The body mass index is an indication if a person is at a suitable weight for his height on an approximation of body fat. A body mass index of under 20 is considered to be underweight, while a body mass index between 20 to 25 is considered healthy. A body mass index in the range of 25 to 30 is regarded as overweight. A body mass index over 30 is regarded as obese.|kg/m^2|Mean|34.9|34.9|Standard Deviation|5.1|5.1|||
3794183|NCT01834404|3623230|B2|||Body Mass Index (BMI)|Body Mass Index (BMI) is a health index for comparing weight to height. BMI is a person's weight in kilograms (kg) divided by his or her height in meters squared. The body mass index is an indication if a person is at a suitable weight for his height on an approximation of body fat. A body mass index of under 20 is considered to be underweight, while a body mass index between 20 to 25 is considered healthy. A body mass index in the range of 25 to 30 is regarded as overweight. A body mass index over 30 is regarded as obese.|kg/m^2|Mean|33.9|33.9|Standard Deviation|1.9|1.9|||
3794184|NCT01834404|3623231|B1|||Body Mass Index (BMI)|Body Mass Index (BMI) is a health index for comparing weight to height. BMI is a person's weight in kilograms (kg) divided by his or her height in meters squared. The body mass index is an indication if a person is at a suitable weight for his height on an approximation of body fat. A body mass index of under 20 is considered to be underweight, while a body mass index between 20 to 25 is considered healthy. A body mass index in the range of 25 to 30 is regarded as overweight. A body mass index over 30 is regarded as obese.|kg/m^2|Mean|35.8|35.8|Standard Deviation|0.9|0.9|||
3794185|NCT01834404|3623229|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
3794186|NCT01834404|3623230|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3794187|NCT01834404|3623231|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3794188|NCT01834404|3623229|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3794189|NCT01834404|3623230|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3794190|NCT01834404|3623231|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3794191|NCT01834404|3623229|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3794192|NCT01834404|3623230|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3794193|NCT01834404|3623231|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3794194|NCT01834404|3623229|B3|||Age||years|Mean|34.8|34.8|Standard Deviation|7.4|7.4|||
3794195|NCT01834404|3623230|B2|||Age||years|Mean|38.2|38.2|Standard Deviation|2.4|2.4|||
3794196|NCT01834404|3623231|B1|||Age||years|Mean|31.8|31.8|Standard Deviation|1.8|1.8|||
3794197|NCT01834274|3623262|B3|Ex-smoker||Smoking Classification||participants|Number|13|13.0||||||
3794198|NCT01834274|3623263|B2|Ex-smoker||Smoking Classification||participants|Number|8|8.0||||||
3794199|NCT01834274|3623264|B1|Ex-smoker||Smoking Classification||participants|Number|5|5.0||||||
3794200|NCT01834274|3623262|B3|Current smoker||Smoking Classification||participants|Number|16|16.0||||||
3794201|NCT01834274|3623263|B2|Current smoker||Smoking Classification||participants|Number|9|9.0||||||
3794202|NCT01834274|3623264|B1|Current smoker||Smoking Classification||participants|Number|7|7.0||||||
3794203|NCT01834274|3623262|B3|Never smoked||Smoking Classification||participants|Number|67|67.0||||||
3794204|NCT01834274|3623263|B2|Never smoked||Smoking Classification||participants|Number|29|29.0||||||
3794205|NCT01834274|3623264|B1|Never smoked||Smoking Classification||participants|Number|38|38.0||||||
3794206|NCT01834274|3623262|B3|||Duration of Diabetes||years|Mean|9.501|9.501|Standard Deviation|6.252|6.252|||
3794207|NCT01834274|3623263|B2|||Duration of Diabetes||years|Mean|8.877|8.877|Standard Deviation|5.942|5.942|||
3794208|NCT01834274|3623264|B1|||Duration of Diabetes||years|Mean|10.075|10.075|Standard Deviation|6.530|6.53|||
3794209|NCT01834274|3623262|B3|≥ 9 %||Baseline Glycosylated Hemoglobin (HbA)1c Category||participants|Number|41|41.0||||||
3794210|NCT01834274|3623263|B2|≥ 9 %||Baseline Glycosylated Hemoglobin (HbA)1c Category||participants|Number|18|18.0||||||
3794211|NCT01834274|3623264|B1|≥ 9 %||Baseline Glycosylated Hemoglobin (HbA)1c Category||participants|Number|23|23.0||||||
3794212|NCT01834274|3623262|B3|< 9%||Baseline Glycosylated Hemoglobin (HbA)1c Category||participants|Number|55|55.0||||||
3794213|NCT01834274|3623263|B2|< 9%||Baseline Glycosylated Hemoglobin (HbA)1c Category||participants|Number|28|28.0||||||
3794214|NCT01834274|3623264|B1|< 9%||Baseline Glycosylated Hemoglobin (HbA)1c Category||participants|Number|27|27.0||||||
3794215|NCT01834274|3623262|B3|≥ 30 kg/m^2||Baseline BMI Category||participants|Number|54|54.0||||||
3794216|NCT01834274|3623263|B2|≥ 30 kg/m^2||Baseline BMI Category||participants|Number|35|35.0||||||
3794217|NCT01834274|3623264|B1|≥ 30 kg/m^2||Baseline BMI Category||participants|Number|19|19.0||||||
3794218|NCT01834274|3623262|B3|< 30 kg/m^2||Baseline BMI Category||participants|Number|42|42.0||||||
3794219|NCT01834274|3623263|B2|< 30 kg/m^2||Baseline BMI Category||participants|Number|11|11.0||||||
3794220|NCT01834274|3623264|B1|< 30 kg/m^2||Baseline BMI Category||participants|Number|31|31.0||||||
3794221|NCT01834274|3623262|B3|||Body Mass Index (BMI)||kg/m^2|Mean|31.90|31.9|Standard Deviation|5.614|5.614|||
3794222|NCT01834274|3623263|B2|||Body Mass Index (BMI)||kg/m^2|Mean|33.13|33.13|Standard Deviation|4.787|4.787|||
3794223|NCT01834274|3623264|B1|||Body Mass Index (BMI)||kg/m^2|Mean|30.77|30.77|Standard Deviation|6.112|6.112|||
3794224|NCT01834274|3623262|B3|||Weight||kg|Mean|91.62|91.62|Standard Deviation|19.408|19.408|||
3794225|NCT01834274|3623263|B2|||Weight||kg|Mean|96.09|96.09|Standard Deviation|19.295|19.295|||
3794226|NCT01834274|3623264|B1|||Weight||kg|Mean|87.50|87.5|Standard Deviation|18.769|18.769|||
3794227|NCT01834274|3623262|B3|||Height||cm|Mean|169.3|169.3|Standard Deviation|11.10|11.1|||
3794228|NCT01834274|3623263|B2|||Height||cm|Mean|169.9|169.9|Standard Deviation|10.79|10.79|||
3794229|NCT01834274|3623264|B1|||Height||cm|Mean|168.7|168.7|Standard Deviation|11.45|11.45|||
3794230|NCT01834274|3623262|B3|United States||Region of Enrollment||participants|Number|95|95.0||||||
3794231|NCT01834274|3623263|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
3794232|NCT01834274|3623264|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
3794233|NCT01834274|3623262|B3|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3794234|NCT01834274|3623263|B2|Canada||Region of Enrollment||participants|Number|0|0.0||||||
3794235|NCT01834274|3623264|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3794236|NCT01834274|3623262|B3|Not Available||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3794237|NCT01834274|3623263|B2|Not Available||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3794238|NCT01834274|3623264|B1|Not Available||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3794239|NCT01834274|3623262|B3|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3794240|NCT01834274|3623263|B2|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3794241|NCT01834274|3623264|B1|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3794242|NCT01834274|3623262|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
3794243|NCT01834274|3623263|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3794244|NCT01834274|3623264|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
3794245|NCT01834274|3623262|B3|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3794246|NCT01834274|3623263|B2|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3794247|NCT01834274|3623264|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3794248|NCT01834274|3623262|B3|White||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
3794249|NCT01834274|3623263|B2|White||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
3794250|NCT01834274|3623264|B1|White||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
3794251|NCT01834274|3623262|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3794252|NCT01834274|3623263|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3794253|NCT01834274|3623264|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3794254|NCT01834274|3623262|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3794255|NCT01834274|3623263|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3794256|NCT01834274|3623264|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3794257|NCT01834274|3623262|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3794258|NCT01834274|3623263|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3794259|NCT01834274|3623264|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3794260|NCT01834274|3623262|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3794261|NCT01834274|3623263|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3794262|NCT01834274|3623264|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3794263|NCT01834274|3623262|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3794264|NCT01834274|3623263|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3794265|NCT01834274|3623264|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3794266|NCT01834274|3623262|B3|≥ 65 years||Age, Customized||participants|Number|14|14.0||||||
3794267|NCT01834274|3623263|B2|≥ 65 years||Age, Customized||participants|Number|5|5.0||||||
3794268|NCT01834274|3623264|B1|≥ 65 years||Age, Customized||participants|Number|9|9.0||||||
3794269|NCT01834274|3623262|B3|< 65 years||Age, Customized||participants|Number|82|82.0||||||
3794270|NCT01834274|3623263|B2|< 65 years||Age, Customized||participants|Number|41|41.0||||||
3794271|NCT01834274|3623264|B1|< 65 years||Age, Customized||participants|Number|41|41.0||||||
3794272|NCT01834274|3623262|B3|||Age||Years|Mean|56.4|56.4|Standard Deviation|8.17|8.17|||
3794273|NCT01834274|3623263|B2|||Age||Years|Mean|55.1|55.1|Standard Deviation|9.07|9.07|||
3794274|NCT01834274|3623264|B1|||Age||Years|Mean|57.6|57.6|Standard Deviation|7.14|7.14|||
3794275|NCT01834261|3623275|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
3794276|NCT01834261|3623276|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3794277|NCT01834261|3623277|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3794278|NCT01834261|3623275|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3794279|NCT01834261|3623276|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3794280|NCT01834261|3623277|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3794281|NCT01834261|3623275|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3794282|NCT01834261|3623276|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3794283|NCT01834261|3623277|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3794284|NCT01834261|3623275|B3|||Age||years|Mean|27.6|27.6|Standard Deviation|6.6|6.6|||
3794285|NCT01834261|3623276|B2|||Age||years|Mean|28.1|28.1|Standard Deviation|6.9|6.9|||
3794286|NCT01834261|3623277|B1|||Age||years|Mean|27.1|27.1|Standard Deviation|6.3|6.3|||
3794287|NCT01834261|3623275|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3794288|NCT01834261|3623276|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3794289|NCT01834261|3623277|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3794290|NCT01834261|3623275|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3794291|NCT01834261|3623276|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3794292|NCT01834261|3623277|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3794293|NCT01834261|3623275|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3794294|NCT01834261|3623276|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3794295|NCT01834261|3623277|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3794296|NCT01834222|3623288|B1||Male|Sex: Female, Male||Participants|Count of Participants|321|321.0||||||
3794297|NCT01834222|3623288|B1||Female|Sex: Female, Male||Participants|Count of Participants|337|337.0||||||
3794298|NCT01834222|3623288|B1|||Age||years|Mean|58.81|58.81|Standard Deviation|11.53|11.53|||
3794299|NCT01834144|3623297|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3794300|NCT01834144|3623297|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3794301|NCT01834144|3623298|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3794302|NCT01834144|3623299|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3794303|NCT01834144|3623297|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3794304|NCT01834144|3623298|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3794305|NCT01834144|3623299|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3794306|NCT01834144|3623297|B3|||Age||years|Mean|0|0.0|Standard Deviation|0|0.0|||
3794307|NCT01834144|3623298|B2|||Age||years|Mean|0|0.0|Standard Deviation|0|0.0|||
3794308|NCT01834144|3623299|B1|||Age||years|Mean|0|0.0|Standard Deviation|0|0.0|||
3794309|NCT01834027|3623306|B3|United States||Region of Enrollment||participants|Number|56|56.0||||||
3794310|NCT01834027|3623307|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
3794311|NCT01834027|3623308|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
3794312|NCT01834027|3623306|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3794313|NCT01834027|3623307|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3794314|NCT01834027|3623308|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3794315|NCT01834027|3623306|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3794316|NCT01834027|3623307|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3794317|NCT01834027|3623308|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3794318|NCT01834027|3623306|B3|> 75 years of age||Age, Customized||participants|Number|0|0.0||||||
3794319|NCT01834027|3623307|B2|> 75 years of age||Age, Customized||participants|Number|0|0.0||||||
3794320|NCT01834027|3623308|B1|> 75 years of age||Age, Customized||participants|Number|0|0.0||||||
3794321|NCT01834027|3623306|B3|>=18 and <=75 years||Age, Customized||participants|Number|56|56.0||||||
3794322|NCT01834027|3623307|B2|>=18 and <=75 years||Age, Customized||participants|Number|28|28.0||||||
3794323|NCT01834027|3623308|B1|>=18 and <=75 years||Age, Customized||participants|Number|28|28.0||||||
3794324|NCT01834027|3623306|B3|<18 years of age||Age, Customized||participants|Number|0|0.0||||||
3794325|NCT01834027|3623307|B2|<18 years of age||Age, Customized||participants|Number|0|0.0||||||
3794326|NCT01834027|3623308|B1|<18 years of age||Age, Customized||participants|Number|0|0.0||||||
3794327|NCT01833988|3623319|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
3794328|NCT01833988|3623319|B1|All study participants|Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3794329|NCT01833988|3623319|B1|All study participants|Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3794330|NCT01833988|3623319|B1|||Age||years|Mean|16|16.0|Standard Deviation|3|3.0|||
3794331|NCT01833936|3623374|B3|Never||Tobacco Use||Participants|Count of Participants|31|31.0||||||
3794332|NCT01833936|3623375|B2|Never||Tobacco Use||Participants|Count of Participants|17|17.0||||||
3794333|NCT01833936|3623376|B1|Never||Tobacco Use||Participants|Count of Participants|14|14.0||||||
3794334|NCT01833936|3623374|B3|Former||Tobacco Use||Participants|Count of Participants|6|6.0||||||
3794335|NCT01833936|3623375|B2|Former||Tobacco Use||Participants|Count of Participants|2|2.0||||||
3794336|NCT01833936|3623376|B1|Former||Tobacco Use||Participants|Count of Participants|4|4.0||||||
3794337|NCT01833936|3623374|B3|Current||Tobacco Use||Participants|Count of Participants|3|3.0||||||
3794338|NCT01833936|3623375|B2|Current||Tobacco Use||Participants|Count of Participants|1|1.0||||||
3794339|NCT01833936|3623376|B1|Current||Tobacco Use||Participants|Count of Participants|2|2.0||||||
3794340|NCT01833936|3623374|B3|||Body Mass Index||kg/m^2|Mean|32.2|32.2|Standard Deviation|5.7|5.7|||
3794341|NCT01833936|3623375|B2|||Body Mass Index||kg/m^2|Mean|31.1|31.1|Standard Deviation|5.6|5.6|||
3794342|NCT01833936|3623376|B1|||Body Mass Index||kg/m^2|Mean|33.4|33.4|Standard Deviation|5.6|5.6|||
3794343|NCT01833936|3623374|B3|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3794344|NCT01833936|3623375|B2|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3794345|NCT01833936|3623376|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3794346|NCT01833936|3623374|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794347|NCT01833936|3623375|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794348|NCT01833936|3623376|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794349|NCT01833936|3623374|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794350|NCT01833936|3623375|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794351|NCT01833936|3623376|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794352|NCT01833936|3623374|B3||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3794353|NCT01833936|3623375|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3794354|NCT01833936|3623376|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3794355|NCT01833936|3623374|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3794356|NCT01833936|3623375|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3794357|NCT01833936|3623376|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3794358|NCT01833936|3623374|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794359|NCT01833936|3623375|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794360|NCT01833936|3623376|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794361|NCT01833936|3623374|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794362|NCT01833936|3623375|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794363|NCT01833936|3623376|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794364|NCT01833936|3623374|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794365|NCT01833936|3623375|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794366|NCT01833936|3623376|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794367|NCT01833936|3623374|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3794368|NCT01833936|3623375|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3794369|NCT01833936|3623376|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3794370|NCT01833936|3623374|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3794371|NCT01833936|3623375|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3794372|NCT01833936|3623376|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3794373|NCT01833936|3623374|B3|||Age||years|Mean|48.9|48.9|Standard Deviation|11.1|11.1|||
3794374|NCT01833936|3623375|B2|||Age||years|Mean|45.8|45.8|Standard Deviation|11.8|11.8|||
3794375|NCT01833936|3623376|B1|||Age||years|Mean|52.0|52.0|Standard Deviation|9.6|9.6|||
3794376|NCT01833897|3623383|B1|||Time of treatment resistance||Months|Mean|3.3|3.3|Standard Deviation|4|4.0|||
3794377|NCT01833897|3623383|B1|||Beck's depression inventory|"Ranges from 0-63, with Higher total scores indicate more severe depressive symptoms.~The standardized cutoffs used:~0–13: minimal depression 14–19: mild depression 20–28: moderate depression 29–63: severe depression."|units on a scale|Mean|31.4|31.4|Standard Deviation|10.4|10.4|||
3794378|NCT01833897|3623383|B1|||Hamilton Anxiety Rating Scale (HAM-A)|Each item is scored on a scale of 0 (not present) to 4 (severe), with a total score range of 0–56, where <17 indi- cates mild severity, 18–24 mild to moderate severity and 25–30 moderate to severe.|units on a scale|Mean|12.6|12.6|Standard Deviation|4.2|4.2|||
3794379|NCT01833897|3623383|B1|||Loss of Motivated Behavior HAM-D Factor|Includes the total of four HAM-D items: (Item 7: Work and activities, Item 12. Somatic symptoms (appetite), Item 14. Genital symptoms (libido), and Item 16. Weight loss). Range 0-11, higher scores indicate worse symptoms.|units on a scale|Mean|5|5.0|Standard Deviation|1.6|1.6|||
3794380|NCT01833897|3623383|B1|||Hamilton Depression Rating Scale (HAM-D) suicide item|Item 3 of scale (range 0-4) with higher scores indicating higher symptoms|units on a scale|Mean|1.25|1.25|Standard Deviation|0.9|0.9|||
3794381|NCT01833897|3623383|B1|||Hamilton Depression Rating Scale (HAM-D)|"Depression rating scale: Range 0-53, higher scores indicate worse depression.~0-7 = Normal 8-13 = Mild Depression 14-18 = Moderate Depression 19-22 = Severe Depression~≥ 23 = Very Severe Depression"|units on a scale|Mean|18.8|18.8|Standard Deviation|6.7|6.7|||
3794382|NCT01833897|3623383|B1|||Montgomery Asberg Depression Rating scale|Measure of depression: Higher MADRS score indicates more severe depression, and each item yields a score of 0 to 6. The overall score ranges from 0 to 60|units on a scale|Mean|29|29.0|Standard Deviation|6|6.0|||
3794383|NCT01833897|3623383|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3794384|NCT01833897|3623383|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3794385|NCT01833897|3623383|B1|||Age||years|Mean|37|37.0|Standard Deviation|16|16.0|||
3794386|NCT01833897|3623383|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3794387|NCT01833897|3623383|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3794388|NCT01833897|3623383|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3794389|NCT01833845|3623391|B1|France||Region of Enrollment||participants|Number|4|4.0||||||
3794390|NCT01833845|3623391|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3794391|NCT01833845|3623391|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3794392|NCT01833845|3623391|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3794393|NCT01833845|3623391|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3794394|NCT01833845|3623391|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3794395|NCT01833845|3623391|B1|||Age||years|Mean|57.8|57.8|Standard Deviation|6.0|6.0|||
3794396|NCT01833741|3623395|B1||Male|Sex: Female, Male||Participants|Count of Participants|532|532.0||||||
3794397|NCT01833741|3623395|B1||Female|Sex: Female, Male||Participants|Count of Participants|605|605.0||||||
3794398|NCT01833741|3623395|B1|||Age||Years|Mean|66.7|66.7|Standard Deviation|12.7|12.7|||
3794399|NCT01833546|3623408|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3794400|NCT01833546|3623409|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3794401|NCT01833546|3623410|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3794402|NCT01833546|3623411|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3794403|NCT01833546|3623412|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3794404|NCT01833546|3623408|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3794405|NCT01833546|3623409|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3794406|NCT01833546|3623410|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3794407|NCT01833546|3623411|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3794408|NCT01833546|3623412|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3794409|NCT01833546|3623408|B5|Greater than or equal to (>=) 65 years||Age, Customized||Participants|Count of Participants|10|10.0||||||
3794410|NCT01833546|3623409|B4|Greater than or equal to (>=) 65 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
3794411|NCT01833546|3623410|B3|Greater than or equal to (>=) 65 years||Age, Customized||Participants|Count of Participants|4|4.0||||||
3794412|NCT01833546|3623411|B2|Greater than or equal to (>=) 65 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
3794413|NCT01833546|3623412|B1|Greater than or equal to (>=) 65 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3794414|NCT01833546|3623408|B5|Less than (<) 65 years||Age, Customized||Participants|Count of Participants|10|10.0||||||
3794415|NCT01833546|3623409|B4|Less than (<) 65 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
3794416|NCT01833546|3623410|B3|Less than (<) 65 years||Age, Customized||Participants|Count of Participants|4|4.0||||||
3794417|NCT01833546|3623411|B2|Less than (<) 65 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3794418|NCT01833546|3623412|B1|Less than (<) 65 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
3794419|NCT01833533|3623506|B3||Male|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
3794420|NCT01833533|3623507|B2||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3794421|NCT01833533|3623508|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3794422|NCT01833533|3623506|B3||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3794423|NCT01833533|3623507|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3794424|NCT01833533|3623508|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3794425|NCT01833533|3623506|B3|||Age||years|Mean|51.5|51.5|Standard Deviation|10.74|10.74|||
3794426|NCT01833533|3623507|B2|||Age||years|Mean|51.4|51.4|Standard Deviation|10.64|10.64|||
3794427|NCT01833533|3623508|B1|||Age||years|Mean|51.6|51.6|Standard Deviation|10.99|10.99|||
3794428|NCT01833494|3623523|B1|||Dialysis vintage||months|Mean|85.3|85.3|Standard Deviation|63.2|63.2|||
3794429|NCT01833494|3623523|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794430|NCT01833494|3623523|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794431|NCT01833494|3623523|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794432|NCT01833494|3623523|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794433|NCT01833494|3623523|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794434|NCT01833494|3623523|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|160|160.0||||||
3794435|NCT01833494|3623523|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794436|NCT01833494|3623523|B1||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3794437|NCT01833494|3623523|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3794438|NCT01833494|3623523|B1|||Age||years|Mean|58.5|58.5|Standard Deviation|11.1|11.1|||
3794439|NCT01833481|3623530|B4|Canada||Region of Enrollment||participants|Number|10|10.0||||||
3794440|NCT01833481|3623531|B3|Canada||Region of Enrollment||participants|Number|0|0.0||||||
3794441|NCT01833481|3623532|B2|Canada||Region of Enrollment||participants|Number|10|10.0||||||
3794442|NCT01833481|3623533|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
3794443|NCT01833481|3623530|B4|United States||Region of Enrollment||participants|Number|20|20.0||||||
3794444|NCT01833481|3623531|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3794445|NCT01833481|3623532|B2|United States||Region of Enrollment||participants|Number|0|0.0||||||
3794446|NCT01833481|3623533|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3794447|NCT01833481|3623530|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3794448|NCT01833481|3623531|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3794449|NCT01833481|3623532|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3794450|NCT01833481|3623533|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3794451|NCT01833481|3623530|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3794452|NCT01833481|3623531|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3794453|NCT01833481|3623532|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3794454|NCT01833481|3623533|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3794455|NCT01833481|3623530|B4||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3794456|NCT01833481|3623531|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3794457|NCT01833481|3623532|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3794458|NCT01833481|3623533|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3794459|NCT01833481|3623530|B4||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3794460|NCT01833481|3623531|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3794461|NCT01833481|3623532|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3794462|NCT01833481|3623533|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3794463|NCT01833481|3623530|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3794464|NCT01833481|3623531|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3794465|NCT01833481|3623532|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3794466|NCT01833481|3623533|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3794467|NCT01833481|3623530|B4|||Age||years|Mean|66|66.0|Standard Deviation|7.4|7.4|||
3794468|NCT01833481|3623531|B3|||Age||years|Mean|69|69.0|Standard Deviation|8.7|8.7|||
3794469|NCT01833481|3623532|B2|||Age||years|Mean|67|67.0|Standard Deviation|5.4|5.4|||
3794470|NCT01833481|3623533|B1|||Age||years|Mean|63|63.0|Standard Deviation|7.3|7.3|||
3794471|NCT01833403|3623549|B1|||insulin sensitivity||HOMA IR|Mean|3.55|3.55|Standard Deviation|2.9|2.9|||
3794472|NCT01833403|3623549|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3794473|NCT01833403|3623549|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3794474|NCT01833403|3623549|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3794475|NCT01833403|3623549|B1|||Age||years|Mean|40|40.0|Standard Deviation|4|4.0|||
3794476|NCT01833403|3623549|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3794477|NCT01833403|3623549|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3794478|NCT01833403|3623549|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3794479|NCT01833247|3623554|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3794480|NCT01833247|3623554|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794481|NCT01833247|3623554|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794482|NCT01833247|3623554|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3794483|NCT01833247|3623554|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794484|NCT01833247|3623554|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794485|NCT01833247|3623554|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3794486|NCT01833247|3623554|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794487|NCT01833247|3623554|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794488|NCT01833247|3623554|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3794489|NCT01833247|3623554|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3794490|NCT01833247|3623554|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3794491|NCT01833247|3623554|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3794492|NCT01833247|3623554|B1|||Age||years|Mean|40.8|40.8|Full Range|||26.0|72.0|
3794493|NCT01833169|3623560|B1|||Prior Lines of Antineoplastic Medications||Number of prior lines of treatment|Median|3|3.0|Full Range|||1.0|13.0|
3794494|NCT01833169|3623560|B1|PIK3R1 gene mutation||Protocol pre-defined gene mutation (by local labs)||participants|Number|7|7.0||||||
3794495|NCT01833169|3623560|B1|PIK3CA amplification||Protocol pre-defined gene mutation (by local labs)||participants|Number|19|19.0||||||
3794496|NCT01833169|3623560|B1|PTEN gene mutation||Protocol pre-defined gene mutation (by local labs)||participants|Number|60|60.0||||||
3794497|NCT01833169|3623560|B1|PIK3CA gene mutation||Protocol pre-defined gene mutation (by local labs)||participants|Number|74|74.0||||||
3794498|NCT01833169|3623560|B1|Grade 2||ECOG Grade|"ECOG Scoring: 0=Fully active, able to carry on all pre-disease performance without restriction, 1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g. light housework, office work, 2=Ambulatory and capable of all self-care but unable to carry out any work activities.~Up and about more than 50% of waking hours, 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours, 4=Completely disabled, Cannot carry on any self-care. Totally confined to bed or chair, 5= Dead"|participants|Number|1|1.0||||||
3794499|NCT01833169|3623560|B1|Grade 1||ECOG Grade|"ECOG Scoring: 0=Fully active, able to carry on all pre-disease performance without restriction, 1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g. light housework, office work, 2=Ambulatory and capable of all self-care but unable to carry out any work activities.~Up and about more than 50% of waking hours, 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours, 4=Completely disabled, Cannot carry on any self-care. Totally confined to bed or chair, 5= Dead"|participants|Number|91|91.0||||||
3794500|NCT01833169|3623560|B1|Grade 0||ECOG Grade|"ECOG Scoring: 0=Fully active, able to carry on all pre-disease performance without restriction, 1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g. light housework, office work, 2=Ambulatory and capable of all self-care but unable to carry out any work activities.~Up and about more than 50% of waking hours, 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours, 4=Completely disabled, Cannot carry on any self-care. Totally confined to bed or chair, 5= Dead"|participants|Number|54|54.0||||||
3794501|NCT01833169|3623560|B1|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3794502|NCT01833169|3623560|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3794503|NCT01833169|3623560|B1|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3794504|NCT01833169|3623560|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|130|130.0||||||
3794505|NCT01833169|3623560|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3794506|NCT01833169|3623560|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3794507|NCT01833169|3623560|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|12.91|12.91|||
3794508|NCT01833169|3623560|B1||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
3794509|NCT01833169|3623560|B1||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
3794510|NCT01833169|3623560|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3794511|NCT01833130|3623571|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3794512|NCT01833130|3623572|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3794513|NCT01833130|3623573|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3794514|NCT01833130|3623571|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3794515|NCT01833130|3623572|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3794516|NCT01833130|3623573|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3794517|NCT01833130|3623571|B3|||Age||Years|Mean|42.8|42.8|Standard Deviation|12.2|12.2|||
3794518|NCT01833130|3623572|B2|||Age||Years|Mean|42.2|42.2|Standard Deviation|11.8|11.8|||
3794519|NCT01833130|3623573|B1|||Age||Years|Mean|43.7|43.7|Standard Deviation|13.1|13.1|||
3794520|NCT01833117|3623610|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3794521|NCT01833117|3623611|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3794522|NCT01833117|3623612|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3794523|NCT01833117|3623610|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3794524|NCT01833117|3623611|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3794525|NCT01833117|3623612|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3794526|NCT01833117|3623610|B3|||Age||years|Mean|56.4|56.4|Standard Deviation|14.87|14.87|||
3794527|NCT01833117|3623611|B2|||Age||years|Mean|60.4|60.4|Standard Deviation|14.48|14.48|||
3794528|NCT01833117|3623612|B1|||Age||years|Mean|54.6|54.6|Standard Deviation|14.86|14.86|||
3794529|NCT01833078|3623621|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3794530|NCT01833078|3623621|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3794531|NCT01833078|3623621|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3794532|NCT01833078|3623621|B1|||Age||years|Mean|86|86.0|Full Range|||82.0|87.0|
3794533|NCT01833065|3623626|B4|||Weekly number of SBM|"SBM was defined as a bowel movement that occurred in the absence of a laxative use or manual disimpaction.~Baseline value for the number of SBM was defined as the average of the numbers of SBM per week for over the 2-week Pretreatment Period."|SBM per week|Mean|2.32|2.32|Standard Deviation|1.26|1.26|||
3794534|NCT01833065|3623627|B3|||Weekly number of SBM|"SBM was defined as a bowel movement that occurred in the absence of a laxative use or manual disimpaction.~Baseline value for the number of SBM was defined as the average of the numbers of SBM per week for over the 2-week Pretreatment Period."|SBM per week|Mean|2.45|2.45|Standard Deviation|1.35|1.35|||
3794535|NCT01833065|3623628|B2|||Weekly number of SBM|"SBM was defined as a bowel movement that occurred in the absence of a laxative use or manual disimpaction.~Baseline value for the number of SBM was defined as the average of the numbers of SBM per week for over the 2-week Pretreatment Period."|SBM per week|Mean|2.19|2.19|Standard Deviation|1.13|1.13|||
3794536|NCT01833065|3623629|B1|||Weekly number of SBM|"SBM was defined as a bowel movement that occurred in the absence of a laxative use or manual disimpaction.~Baseline value for the number of SBM was defined as the average of the numbers of SBM per week for over the 2-week Pretreatment Period."|SBM per week|Mean|2.31|2.31|Standard Deviation|1.27|1.27|||
3794537|NCT01833065|3623626|B4|||Weekly number of CSBM|"CSBM was defined as a spontaneous (occurring without laxative within the preceding 24 hours, including no rescue medication within the preceding 24 hours) bowel movement (as interpreted by the patient, with a beginning and an end, including single or multiple stools), accompanied by a patient reported sense of complete evacuation (‘complete’).~Baseline value for the number of CSBM per week was defined as the average of the numbers of CSBM per week for over the 2-week Pretreatment Period."|CSBM per week|Mean|0.36|0.36|Standard Deviation|0.64|0.64|||
3794538|NCT01833065|3623627|B3|||Weekly number of CSBM|"CSBM was defined as a spontaneous (occurring without laxative within the preceding 24 hours, including no rescue medication within the preceding 24 hours) bowel movement (as interpreted by the patient, with a beginning and an end, including single or multiple stools), accompanied by a patient reported sense of complete evacuation (‘complete’).~Baseline value for the number of CSBM per week was defined as the average of the numbers of CSBM per week for over the 2-week Pretreatment Period."|CSBM per week|Mean|0.43|0.43|Standard Deviation|0.68|0.68|||
3794539|NCT01833065|3623628|B2|||Weekly number of CSBM|"CSBM was defined as a spontaneous (occurring without laxative within the preceding 24 hours, including no rescue medication within the preceding 24 hours) bowel movement (as interpreted by the patient, with a beginning and an end, including single or multiple stools), accompanied by a patient reported sense of complete evacuation (‘complete’).~Baseline value for the number of CSBM per week was defined as the average of the numbers of CSBM per week for over the 2-week Pretreatment Period."|CSBM per week|Mean|0.32|0.32|Standard Deviation|0.62|0.62|||
3794540|NCT01833065|3623629|B1|||Weekly number of CSBM|"CSBM was defined as a spontaneous (occurring without laxative within the preceding 24 hours, including no rescue medication within the preceding 24 hours) bowel movement (as interpreted by the patient, with a beginning and an end, including single or multiple stools), accompanied by a patient reported sense of complete evacuation (‘complete’).~Baseline value for the number of CSBM per week was defined as the average of the numbers of CSBM per week for over the 2-week Pretreatment Period."|CSBM per week|Mean|0.33|0.33|Standard Deviation|0.62|0.62|||
3794541|NCT01833065|3623626|B4|Germany||Region of Enrollment||participants|Number|13|13.0||||||
3794542|NCT01833065|3623627|B3|Germany||Region of Enrollment||participants|Number|5|5.0||||||
3794543|NCT01833065|3623628|B2|Germany||Region of Enrollment||participants|Number|4|4.0||||||
3794544|NCT01833065|3623629|B1|Germany||Region of Enrollment||participants|Number|4|4.0||||||
3794545|NCT01833065|3623626|B4|Slovakia||Region of Enrollment||participants|Number|13|13.0||||||
3794546|NCT01833065|3623627|B3|Slovakia||Region of Enrollment||participants|Number|5|5.0||||||
3794547|NCT01833065|3623628|B2|Slovakia||Region of Enrollment||participants|Number|3|3.0||||||
3794548|NCT01833065|3623629|B1|Slovakia||Region of Enrollment||participants|Number|5|5.0||||||
3794549|NCT01833065|3623626|B4|United Kingdom||Region of Enrollment||participants|Number|32|32.0||||||
3794550|NCT01833065|3623627|B3|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
3794551|NCT01833065|3623628|B2|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
3794552|NCT01833065|3623629|B1|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
3794553|NCT01833065|3623626|B4|South Africa||Region of Enrollment||participants|Number|32|32.0||||||
3794554|NCT01833065|3623627|B3|South Africa||Region of Enrollment||participants|Number|13|13.0||||||
3794555|NCT01833065|3623628|B2|South Africa||Region of Enrollment||participants|Number|7|7.0||||||
3794556|NCT01833065|3623629|B1|South Africa||Region of Enrollment||participants|Number|12|12.0||||||
3794557|NCT01833065|3623626|B4|Poland||Region of Enrollment||participants|Number|10|10.0||||||
3794558|NCT01833065|3623627|B3|Poland||Region of Enrollment||participants|Number|3|3.0||||||
3794559|NCT01833065|3623628|B2|Poland||Region of Enrollment||participants|Number|4|4.0||||||
3794560|NCT01833065|3623629|B1|Poland||Region of Enrollment||participants|Number|3|3.0||||||
3794561|NCT01833065|3623626|B4|United States||Region of Enrollment||participants|Number|158|158.0||||||
3794562|NCT01833065|3623627|B3|United States||Region of Enrollment||participants|Number|55|55.0||||||
3794563|NCT01833065|3623628|B2|United States||Region of Enrollment||participants|Number|54|54.0||||||
3794564|NCT01833065|3623629|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
3794565|NCT01833065|3623626|B4|Hungary||Region of Enrollment||participants|Number|42|42.0||||||
3794566|NCT01833065|3623627|B3|Hungary||Region of Enrollment||participants|Number|14|14.0||||||
3794567|NCT01833065|3623628|B2|Hungary||Region of Enrollment||participants|Number|13|13.0||||||
3794568|NCT01833065|3623629|B1|Hungary||Region of Enrollment||participants|Number|15|15.0||||||
3794569|NCT01833065|3623626|B4|Sweden||Region of Enrollment||participants|Number|6|6.0||||||
3794570|NCT01833065|3623627|B3|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
3794571|NCT01833065|3623628|B2|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
3794572|NCT01833065|3623629|B1|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
3794573|NCT01833065|3623626|B4|Czech Republic||Region of Enrollment||participants|Number|4|4.0||||||
3794574|NCT01833065|3623627|B3|Czech Republic||Region of Enrollment||participants|Number|0|0.0||||||
3794575|NCT01833065|3623628|B2|Czech Republic||Region of Enrollment||participants|Number|2|2.0||||||
3794576|NCT01833065|3623629|B1|Czech Republic||Region of Enrollment||participants|Number|2|2.0||||||
3794577|NCT01833065|3623626|B4|Canada||Region of Enrollment||participants|Number|4|4.0||||||
3794578|NCT01833065|3623627|B3|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3794579|NCT01833065|3623628|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
3794580|NCT01833065|3623629|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3794581|NCT01833065|3623626|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794582|NCT01833065|3623627|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794583|NCT01833065|3623628|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794584|NCT01833065|3623629|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794585|NCT01833065|3623626|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794586|NCT01833065|3623627|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794587|NCT01833065|3623628|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794588|NCT01833065|3623629|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794589|NCT01833065|3623626|B4||White|Race (NIH/OMB)||Participants|Count of Participants|264|264.0||||||
3794590|NCT01833065|3623627|B3||White|Race (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
3794591|NCT01833065|3623628|B2||White|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
3794592|NCT01833065|3623629|B1||White|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3794593|NCT01833065|3623626|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3794594|NCT01833065|3623627|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3794595|NCT01833065|3623628|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3794596|NCT01833065|3623629|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3794597|NCT01833065|3623626|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794598|NCT01833065|3623627|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794599|NCT01833065|3623628|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794600|NCT01833065|3623629|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794601|NCT01833065|3623626|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3794602|NCT01833065|3623627|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3794603|NCT01833065|3623628|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3794604|NCT01833065|3623629|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3794605|NCT01833065|3623626|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794606|NCT01833065|3623627|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794607|NCT01833065|3623628|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794608|NCT01833065|3623629|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794609|NCT01833065|3623626|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794610|NCT01833065|3623627|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794611|NCT01833065|3623628|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794612|NCT01833065|3623629|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794613|NCT01833065|3623626|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|285|285.0||||||
3794614|NCT01833065|3623627|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3794615|NCT01833065|3623628|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3794616|NCT01833065|3623629|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3794617|NCT01833065|3623626|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3794618|NCT01833065|3623627|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3794619|NCT01833065|3623628|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3794620|NCT01833065|3623629|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3794621|NCT01833065|3623626|B4||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3794622|NCT01833065|3623627|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3794623|NCT01833065|3623628|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3794624|NCT01833065|3623629|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3794625|NCT01833065|3623626|B4||Female|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
3794626|NCT01833065|3623627|B3||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3794627|NCT01833065|3623628|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3794628|NCT01833065|3623629|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3794629|NCT01833065|3623626|B4|||Age||Years|Mean|49.0|49.0|Standard Deviation|14.7|14.7|||
3794630|NCT01833065|3623627|B3|||Age||Years|Mean|48.0|48.0|Standard Deviation|16.1|16.1|||
3794631|NCT01833065|3623628|B2|||Age||Years|Mean|49.5|49.5|Standard Deviation|13.5|13.5|||
3794632|NCT01833065|3623629|B1|||Age||Years|Mean|49.6|49.6|Standard Deviation|14.3|14.3|||
3794633|NCT01832766|3623664|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3794634|NCT01832766|3623664|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3794635|NCT01832766|3623664|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3794636|NCT01832766|3623664|B1|||Age||years|Mean|32|32.0|Standard Deviation|11.04|11.04|||
3794637|NCT01832766|3623664|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3794638|NCT01832766|3623664|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3794639|NCT01832766|3623664|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3794640|NCT01832506|3623675|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3794641|NCT01832506|3623676|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3794642|NCT01832506|3623677|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3794643|NCT01832506|3623678|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3794644|NCT01832506|3623675|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3794645|NCT01832506|3623676|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3794646|NCT01832506|3623677|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3794647|NCT01832506|3623678|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3794648|NCT01832506|3623675|B4|||Age||years|Mean|63.8|63.8|Standard Deviation|8.3|8.3|||
3794649|NCT01832506|3623676|B3|||Age||years|Mean|65.7|65.7|Standard Deviation|9.8|9.8|||
3794650|NCT01832506|3623677|B2|||Age||years|Mean|62.0|62.0|Standard Deviation|5.0|5.0|||
3794651|NCT01832506|3623678|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|9.6|9.6|||
3794652|NCT01832493|3623731|B1|Hong Kong||Region of Enrollment||participants|Number|11|11.0||||||
3794653|NCT01832493|3623731|B1|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3794654|NCT01832493|3623731|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3794655|NCT01832493|3623731|B1|Canada||Region of Enrollment||participants|Number|18|18.0||||||
3794656|NCT01832493|3623731|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3794657|NCT01832493|3623731|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3794658|NCT01832493|3623731|B1|||Age||years|Mean|63.1|63.1|Standard Deviation|12.9|12.9|||
3794659|NCT01832259|3623738|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794660|NCT01832259|3623739|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794661|NCT01832259|3623740|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794662|NCT01832259|3623738|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794663|NCT01832259|3623739|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794664|NCT01832259|3623740|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794665|NCT01832259|3623738|B3||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3794666|NCT01832259|3623739|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3794667|NCT01832259|3623740|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3794668|NCT01832259|3623738|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794669|NCT01832259|3623739|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794670|NCT01832259|3623740|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794671|NCT01832259|3623738|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794672|NCT01832259|3623739|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794673|NCT01832259|3623740|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794674|NCT01832259|3623738|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794675|NCT01832259|3623739|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794676|NCT01832259|3623740|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794677|NCT01832259|3623738|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794678|NCT01832259|3623739|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794679|NCT01832259|3623740|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794680|NCT01832259|3623738|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794681|NCT01832259|3623739|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794682|NCT01832259|3623740|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794683|NCT01832259|3623738|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3794684|NCT01832259|3623739|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3794685|NCT01832259|3623740|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3794686|NCT01832259|3623738|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3794687|NCT01832259|3623739|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3794688|NCT01832259|3623740|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3794689|NCT01832259|3623738|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3794690|NCT01832259|3623739|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3794691|NCT01832259|3623740|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3794692|NCT01832259|3623738|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3794693|NCT01832259|3623739|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3794694|NCT01832259|3623740|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3794695|NCT01832259|3623738|B3|||Age||years|Mean|63.73|63.73|Standard Deviation|5.56|5.56|||
3794696|NCT01832259|3623739|B2|||Age||years|Mean|64.13|64.13|Standard Deviation|6.26|6.26|||
3794697|NCT01832259|3623740|B1|||Age||years|Mean|63.33|63.33|Standard Deviation|4.71|4.71|||
3794698|NCT01832259|3623738|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3794699|NCT01832259|3623739|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3794700|NCT01832259|3623740|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3794701|NCT01832259|3623738|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3794702|NCT01832259|3623739|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3794703|NCT01832259|3623740|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3794704|NCT01832259|3623738|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3794705|NCT01832259|3623739|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3794706|NCT01832259|3623740|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3794707|NCT01832155|3623751|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
3794708|NCT01832155|3623752|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
3794709|NCT01832155|3623753|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3794710|NCT01832155|3623751|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3794711|NCT01832155|3623752|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3794712|NCT01832155|3623753|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3794713|NCT01832155|3623751|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3794714|NCT01832155|3623752|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3794715|NCT01832155|3623753|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3794716|NCT01832155|3623751|B3|||Age||years|Mean|71.9|71.9|Standard Deviation|5.7|5.7|||
3794717|NCT01832155|3623752|B2|||Age||years|Mean|71.9|71.9|Standard Deviation|5.4|5.4|||
3794718|NCT01832155|3623753|B1|||Age||years|Mean|71.9|71.9|Standard Deviation|6.0|6.0|||
3794719|NCT01832155|3623751|B3||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
3794720|NCT01832155|3623752|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3794721|NCT01832155|3623753|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3794722|NCT01832155|3623751|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3794723|NCT01832155|3623752|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3794724|NCT01832155|3623753|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3794725|NCT01832155|3623751|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3794726|NCT01832155|3623752|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3794727|NCT01832155|3623753|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3794728|NCT01832090|3623775|B3|Left||Hand Dominance||participants|Number|9|9.0||||||
3794729|NCT01832090|3623776|B2|Left||Hand Dominance||participants|Number|3|3.0||||||
3794730|NCT01832090|3623777|B1|Left||Hand Dominance||participants|Number|6|6.0||||||
3794731|NCT01832090|3623775|B3|Right||Hand Dominance||participants|Number|105|105.0||||||
3794732|NCT01832090|3623776|B2|Right||Hand Dominance||participants|Number|26|26.0||||||
3794733|NCT01832090|3623777|B1|Right||Hand Dominance||participants|Number|79|79.0||||||
3794734|NCT01832090|3623775|B3|VI: never burns, tans profusely||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|2|2.0||||||
3794735|NCT01832090|3623776|B2|VI: never burns, tans profusely||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|1|1.0||||||
3794736|NCT01832090|3623777|B1|VI: never burns, tans profusely||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|1|1.0||||||
3794737|NCT01832090|3623775|B3|V: rarely burns, tans profusely||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|6|6.0||||||
3794738|NCT01832090|3623776|B2|V: rarely burns, tans profusely||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|2|2.0||||||
3794739|NCT01832090|3623777|B1|V: rarely burns, tans profusely||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|4|4.0||||||
3794740|NCT01832090|3623775|B3|IV: burns minimally, tans moderately & easily||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|17|17.0||||||
3794741|NCT01832090|3623776|B2|IV: burns minimally, tans moderately & easily||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|4|4.0||||||
3794742|NCT01832090|3623777|B1|IV: burns minimally, tans moderately & easily||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|13|13.0||||||
3794743|NCT01832090|3623775|B3|III: burns moderately, tans moderately & uniformly||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|30|30.0||||||
3794744|NCT01832090|3623776|B2|III: burns moderately, tans moderately & uniformly||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|11|11.0||||||
3794745|NCT01832090|3623777|B1|III: burns moderately, tans moderately & uniformly||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|19|19.0||||||
3794746|NCT01832090|3623775|B3|II: burns easily, tans minimally with difficulty||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|56|56.0||||||
3794747|NCT01832090|3623776|B2|II: burns easily, tans minimally with difficulty||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|11|11.0||||||
3794748|NCT01832090|3623777|B1|II: burns easily, tans minimally with difficulty||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|45|45.0||||||
3794749|NCT01832090|3623775|B3|I: burns easily, never tans||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|3|3.0||||||
3794750|NCT01832090|3623776|B2|I: burns easily, never tans||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|0|0.0||||||
3794751|NCT01832090|3623777|B1|I: burns easily, never tans||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|3|3.0||||||
3794752|NCT01832090|3623775|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3794753|NCT01832090|3623776|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3794754|NCT01832090|3623777|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3794755|NCT01832090|3623775|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3794756|NCT01832090|3623776|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3794757|NCT01832090|3623777|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3794758|NCT01832090|3623775|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3794759|NCT01832090|3623776|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3794760|NCT01832090|3623777|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3794761|NCT01832090|3623775|B3|African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3794762|NCT01832090|3623776|B2|African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3794763|NCT01832090|3623777|B1|African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3794764|NCT01832090|3623775|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|87|87.0||||||
3794765|NCT01832090|3623776|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3794766|NCT01832090|3623777|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
3794767|NCT01832090|3623775|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3794768|NCT01832090|3623776|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3794769|NCT01832090|3623777|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3794770|NCT01832090|3623775|B3||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3794771|NCT01832090|3623776|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3794772|NCT01832090|3623777|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3794773|NCT01832090|3623775|B3|||Age||years|Mean|53.3|53.3|Standard Deviation|8.7|8.7|||
3794774|NCT01832090|3623776|B2|||Age||years|Mean|54.8|54.8|Standard Deviation|10.6|10.6|||
3794775|NCT01832090|3623777|B1|||Age||years|Mean|52.8|52.8|Standard Deviation|8.0|8.0|||
3794776|NCT01831934|3623821|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
3794777|NCT01831934|3623822|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3794778|NCT01831934|3623823|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3794779|NCT01831934|3623821|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3794780|NCT01831934|3623822|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3794781|NCT01831934|3623823|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794782|NCT01831934|3623821|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3794783|NCT01831934|3623822|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3794784|NCT01831934|3623823|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3794785|NCT01831934|3623821|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3794786|NCT01831934|3623822|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3794787|NCT01831934|3623823|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3794788|NCT01831934|3623821|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794789|NCT01831934|3623822|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794790|NCT01831934|3623823|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794791|NCT01831934|3623821|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794908|NCT01831765|3623928|B2||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3794792|NCT01831934|3623822|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794793|NCT01831934|3623823|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794794|NCT01831934|3623821|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3794795|NCT01831934|3623822|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3794796|NCT01831934|3623823|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3794797|NCT01831934|3623821|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794798|NCT01831934|3623822|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794799|NCT01831934|3623823|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794800|NCT01831934|3623821|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3794801|NCT01831934|3623822|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3794802|NCT01831934|3623823|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794803|NCT01831934|3623821|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3794804|NCT01831934|3623822|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3794805|NCT01831934|3623823|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3794806|NCT01831934|3623821|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3794807|NCT01831934|3623822|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794808|NCT01831934|3623823|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3794809|NCT01831934|3623821|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3794810|NCT01831934|3623822|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3794811|NCT01831934|3623823|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3794812|NCT01831934|3623821|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3794813|NCT01831934|3623822|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3794814|NCT01831934|3623823|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3794815|NCT01831934|3623821|B3|||Age||years|Mean|38.13|38.13|Standard Deviation|8.99|8.99|||
3794816|NCT01831934|3623822|B2|||Age||years|Mean|37.39|37.39|Standard Deviation|10.04|10.04|||
3794817|NCT01831934|3623823|B1|||Age||years|Mean|38.74|38.74|Standard Deviation|8.06|8.06|||
3794818|NCT01831921|3623830|B3|||Total Cholesterol||mg/dL|Mean|182.8|182.8|Standard Deviation|34.30|34.3|||
3794819|NCT01831921|3623831|B2|||Total Cholesterol||mg/dL|Mean|181.3|181.3|Standard Deviation|36.6|36.6|||
3794820|NCT01831921|3623832|B1|||Total Cholesterol||mg/dL|Mean|183.6|183.6|Standard Deviation|33.10|33.1|||
3794821|NCT01831921|3623830|B3|||Triglycerides||mg/dL|Mean|141.4|141.4|Standard Deviation|66.30|66.3|||
3794822|NCT01831921|3623831|B2|||Triglycerides||mg/dL|Mean|140.1|140.1|Standard Deviation|61.60|61.6|||
3794823|NCT01831921|3623832|B1|||Triglycerides||mg/dL|Mean|142.1|142.1|Standard Deviation|68.70|68.7|||
3794824|NCT01831921|3623830|B3|||Low Density Lipoprotein (LDL)||mg/dL|Mean|108.8|108.8|Standard Deviation|28.40|28.4|||
3794825|NCT01831921|3623831|B2|||Low Density Lipoprotein (LDL)||mg/dL|Mean|106.7|106.7|Standard Deviation|28.10|28.1|||
3794826|NCT01831921|3623832|B1|||Low Density Lipoprotein (LDL)||mg/dL|Mean|109.9|109.9|Standard Deviation|28.50|28.5|||
3794827|NCT01831921|3623830|B3|||High Density Lipoprotien (HDL)||mg/dL|Mean|45.7|45.7|Standard Deviation|10.6|10.6|||
3794828|NCT01831921|3623831|B2|||High Density Lipoprotien (HDL)||mg/dL|Mean|46.5|46.5|Standard Deviation|10.9|10.9|||
3794829|NCT01831921|3623832|B1|||High Density Lipoprotien (HDL)||mg/dL|Mean|45.3|45.3|Standard Deviation|10.5|10.5|||
3794830|NCT01831921|3623830|B3|||Fasting Glucose||mg/dL|Mean|97.4|97.4|Standard Deviation|9.8|9.8|||
3794831|NCT01831921|3623831|B2|||Fasting Glucose||mg/dL|Mean|96.6|96.6|Standard Deviation|9.6|9.6|||
3794832|NCT01831921|3623832|B1|||Fasting Glucose||mg/dL|Mean|97.7|97.7|Standard Deviation|9.9|9.9|||
3794833|NCT01831921|3623830|B3|||Diastolic Blood Pressure||mmHg|Mean|71.3|71.3|Standard Deviation|9.0|9.0|||
3794834|NCT01831921|3623831|B2|||Diastolic Blood Pressure||mmHg|Mean|69.9|69.9|Standard Deviation|9.8|9.8|||
3794835|NCT01831921|3623832|B1|||Diastolic Blood Pressure||mmHg|Mean|71.9|71.9|Standard Deviation|8.5|8.5|||
3794836|NCT01831921|3623830|B3|||Systolic Blood Pressure||mmHg|Mean|117.8|117.8|Standard Deviation|14.0|14.0|||
3794837|NCT01831921|3623831|B2|||Systolic Blood Pressure||mmHg|Mean|116.5|116.5|Standard Deviation|14.5|14.5|||
3794838|NCT01831921|3623832|B1|||Systolic Blood Pressure||mmHg|Mean|118.5|118.5|Standard Deviation|13.8|13.8|||
3794839|NCT01831921|3623830|B3|||Body Weight||kilograms|Mean|81.4|81.4|Standard Deviation|13.80|13.8|||
3794840|NCT01831921|3623831|B2|||Body Weight||kilograms|Mean|80.3|80.3|Standard Deviation|13.1|13.1|||
3794841|NCT01831921|3623832|B1|||Body Weight||kilograms|Mean|81.9|81.9|Standard Deviation|14.10|14.1|||
3794842|NCT01831921|3623830|B3|||Hemoglobin A1c||percent|Mean|5.9|5.9|Standard Deviation|.3|0.3|||
3794843|NCT01831921|3623831|B2|||Hemoglobin A1c||percent|Mean|5.9|5.9|Standard Deviation|.20|0.2|||
3794844|NCT01831921|3623832|B1|||Hemoglobin A1c||percent|Mean|6.0|6.0|Standard Deviation|.30|0.3|||
3794845|NCT01831921|3623830|B3|United States||Region of Enrollment||Participants|Count of Participants|225|225.0||||||
3794846|NCT01831921|3623831|B2|United States||Region of Enrollment||Participants|Count of Participants|75|75.0||||||
3794847|NCT01831921|3623832|B1|United States||Region of Enrollment||Participants|Count of Participants|150|150.0||||||
3794848|NCT01831921|3623830|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794849|NCT01831921|3623831|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794850|NCT01831921|3623832|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794851|NCT01831921|3623830|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794852|NCT01831921|3623831|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794853|NCT01831921|3623832|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3794854|NCT01831921|3623830|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|225|225.0||||||
3794855|NCT01831921|3623831|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3794856|NCT01831921|3623832|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|150|150.0||||||
3794857|NCT01831921|3623830|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3794858|NCT01831921|3623831|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3794859|NCT01831921|3623832|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3794860|NCT01831921|3623830|B3||Female|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
3794861|NCT01831921|3623831|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3794862|NCT01831921|3623832|B1||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3794863|NCT01831921|3623830|B3|||Age||years|Mean|41.6|41.6|Standard Deviation|9.0|9.0|||
3794864|NCT01831921|3623831|B2|||Age||years|Mean|41.8|41.8|Standard Deviation|9.1|9.1|||
3794865|NCT01831921|3623832|B1|||Age||years|Mean|41.6|41.6|Standard Deviation|9.0|9.0|||
3794866|NCT01831921|3623830|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3794867|NCT01831921|3623831|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3794868|NCT01831921|3623832|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3794869|NCT01831921|3623830|B3||Between 18 and 65 years|Age||Participants|Count of Participants|218|218.0||||||
3794870|NCT01831921|3623831|B2||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
3794871|NCT01831921|3623832|B1||Between 18 and 65 years|Age||Participants|Count of Participants|147|147.0||||||
3794872|NCT01831921|3623830|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3794873|NCT01831921|3623831|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3794874|NCT01831921|3623832|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3794875|NCT01831817|3623855|B5||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3794876|NCT01831817|3623856|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3794877|NCT01831817|3623857|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3794878|NCT01831817|3623858|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3794879|NCT01831817|3623859|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3794880|NCT01831817|3623855|B5||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3794881|NCT01831817|3623856|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3794882|NCT01831817|3623857|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3794883|NCT01831817|3623858|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3794884|NCT01831817|3623859|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3794885|NCT01831817|3623855|B5|||Age||Years|Mean|39.5|39.5|Standard Deviation|9.55|9.55|||
3794886|NCT01831817|3623856|B4|||Age||Years|Mean|42.7|42.7|Standard Deviation|9.10|9.1|||
3794887|NCT01831817|3623857|B3|||Age||Years|Mean|38.3|38.3|Standard Deviation|8.73|8.73|||
3794888|NCT01831817|3623858|B2|||Age||Years|Mean|39.6|39.6|Standard Deviation|9.72|9.72|||
3794889|NCT01831817|3623859|B1|||Age||Years|Mean|36.9|36.9|Standard Deviation|10.08|10.08|||
3794890|NCT01831791|3623900|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|120|120.0||||||
3794891|NCT01831791|3623900|B1||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3794892|NCT01831791|3623900|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3794893|NCT01831791|3623900|B1|||Age||Years|Mean|42.2|42.2|Standard Deviation|5.66|5.66|||
3794894|NCT01831765|3623926|B4|||Glycosylated haemoglobin (HbA1c)||Percentage of glycosylated haemoglobin|Mean|7.61|7.61|Standard Deviation|0.70|0.7|||
3794895|NCT01831765|3623927|B3|||Glycosylated haemoglobin (HbA1c)||Percentage of glycosylated haemoglobin|Mean|7.58|7.58|Standard Deviation|0.68|0.68|||
3794896|NCT01831765|3623928|B2|||Glycosylated haemoglobin (HbA1c)||Percentage of glycosylated haemoglobin|Mean|7.63|7.63|Standard Deviation|0.72|0.72|||
3794897|NCT01831765|3623929|B1|||Glycosylated haemoglobin (HbA1c)||Percentage of glycosylated haemoglobin|Mean|7.62|7.62|Standard Deviation|0.71|0.71|||
3794898|NCT01831765|3623926|B4|||Body Weight||Kg|Mean|79.73|79.73|Standard Deviation|15.36|15.36|||
3794899|NCT01831765|3623927|B3|||Body Weight||Kg|Mean|80.15|80.15|Standard Deviation|15.21|15.21|||
3794900|NCT01831765|3623928|B2|||Body Weight||Kg|Mean|80.49|80.49|Standard Deviation|15.93|15.93|||
3794901|NCT01831765|3623929|B1|||Body Weight||Kg|Mean|78.56|78.56|Standard Deviation|14.89|14.89|||
3794902|NCT01831765|3623926|B4||Male|Sex: Female, Male||Participants|Count of Participants|672|672.0||||||
3794903|NCT01831765|3623927|B3||Male|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
3794904|NCT01831765|3623928|B2||Male|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
3794905|NCT01831765|3623929|B1||Male|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
3794906|NCT01831765|3623926|B4||Female|Sex: Female, Male||Participants|Count of Participants|471|471.0||||||
3794907|NCT01831765|3623927|B3||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3794909|NCT01831765|3623929|B1||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3794910|NCT01831765|3623926|B4|From 65-85 years||Age, Customized||Participants|Count of Participants|86|86.0||||||
3794911|NCT01831765|3623927|B3|From 65-85 years||Age, Customized||Participants|Count of Participants|28|28.0||||||
3794912|NCT01831765|3623928|B2|From 65-85 years||Age, Customized||Participants|Count of Participants|23|23.0||||||
3794913|NCT01831765|3623929|B1|From 65-85 years||Age, Customized||Participants|Count of Participants|35|35.0||||||
3794914|NCT01831765|3623926|B4|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|1057|1057.0||||||
3794915|NCT01831765|3623927|B3|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|352|352.0||||||
3794916|NCT01831765|3623928|B2|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|359|359.0||||||
3794917|NCT01831765|3623929|B1|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|346|346.0||||||
3794918|NCT01831765|3623926|B4|||Age||Years|Mean|44.4|44.4|Standard Deviation|13.9|13.9|||
3794919|NCT01831765|3623927|B3|||Age||Years|Mean|43.7|43.7|Standard Deviation|14|14.0|||
3794920|NCT01831765|3623928|B2|||Age||Years|Mean|43.5|43.5|Standard Deviation|13.7|13.7|||
3794921|NCT01831765|3623929|B1|||Age||Years|Mean|46.1|46.1|Standard Deviation|13.8|13.8|||
3794922|NCT01831726|3623957|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3794923|NCT01831726|3623957|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3794924|NCT01831726|3623957|B1|||Age||years|Mean|58.3|58.3|Standard Deviation|11.62|11.62|||
3794925|NCT01831466|3623964|B13||Male|Sex: Female, Male||Participants|Count of Participants|295|295.0||||||
3794926|NCT01831466|3623965|B12||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3794927|NCT01831466|3623966|B11||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3794928|NCT01831466|3623967|B10||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3794929|NCT01831466|3623968|B9||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3794930|NCT01831466|3623969|B8||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3794931|NCT01831466|3623970|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3794932|NCT01831466|3623971|B6||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3794933|NCT01831466|3623972|B5||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3794934|NCT01831466|3623973|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3794935|NCT01831466|3623974|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3794936|NCT01831466|3623975|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3794937|NCT01831466|3623976|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3794938|NCT01831466|3623964|B13||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
3794939|NCT01831466|3623965|B12||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3794940|NCT01831466|3623966|B11||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3794941|NCT01831466|3623967|B10||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3794942|NCT01831466|3623968|B9||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3794943|NCT01831466|3623969|B8||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3794944|NCT01831466|3623970|B7||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3794945|NCT01831466|3623971|B6||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3794946|NCT01831466|3623972|B5||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3794947|NCT01831466|3623973|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3794948|NCT01831466|3623974|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3794949|NCT01831466|3623975|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3794950|NCT01831466|3623976|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3794951|NCT01831466|3623964|B13|>= 65 years||Age, Customized||Participants|Number|78|78.0||||||
3794952|NCT01831466|3623965|B12|>= 65 years||Age, Customized||Participants|Number|3|3.0||||||
3794953|NCT01831466|3623966|B11|>= 65 years||Age, Customized||Participants|Number|1|1.0||||||
3794954|NCT01831466|3623967|B10|>= 65 years||Age, Customized||Participants|Number|2|2.0||||||
3794955|NCT01831466|3623968|B9|>= 65 years||Age, Customized||Participants|Number|2|2.0||||||
3794956|NCT01831466|3623969|B8|>= 65 years||Age, Customized||Participants|Number|1|1.0||||||
3794957|NCT01831466|3623970|B7|>= 65 years||Age, Customized||Participants|Number|1|1.0||||||
3794958|NCT01831466|3623971|B6|>= 65 years||Age, Customized||Participants|Number|10|10.0||||||
3794959|NCT01831466|3623972|B5|>= 65 years||Age, Customized||Participants|Number|9|9.0||||||
3794960|NCT01831466|3623973|B4|>= 65 years||Age, Customized||Participants|Number|11|11.0||||||
3794961|NCT01831466|3623974|B3|>= 65 years||Age, Customized||Participants|Number|12|12.0||||||
3794962|NCT01831466|3623975|B2|>= 65 years||Age, Customized||Participants|Number|13|13.0||||||
3794963|NCT01831466|3623976|B1|>= 65 years||Age, Customized||Participants|Number|13|13.0||||||
3794964|NCT01831466|3623964|B13|45-64 years||Age, Customized||Participants|Number|228|228.0||||||
3794965|NCT01831466|3623965|B12|45-64 years||Age, Customized||Participants|Number|2|2.0||||||
3794966|NCT01831466|3623966|B11|45-64 years||Age, Customized||Participants|Number|2|2.0||||||
3794967|NCT01831466|3623967|B10|45-64 years||Age, Customized||Participants|Number|2|2.0||||||
3794968|NCT01831466|3623968|B9|45-64 years||Age, Customized||Participants|Number|4|4.0||||||
3794969|NCT01831466|3623969|B8|45-64 years||Age, Customized||Participants|Number|6|6.0||||||
3794970|NCT01831466|3623970|B7|45-64 years||Age, Customized||Participants|Number|4|4.0||||||
3794971|NCT01831466|3623971|B6|45-64 years||Age, Customized||Participants|Number|39|39.0||||||
3794972|NCT01831466|3623972|B5|45-64 years||Age, Customized||Participants|Number|35|35.0||||||
3794973|NCT01831466|3623973|B4|45-64 years||Age, Customized||Participants|Number|38|38.0||||||
3794974|NCT01831466|3623974|B3|45-64 years||Age, Customized||Participants|Number|34|34.0||||||
3794975|NCT01831466|3623975|B2|45-64 years||Age, Customized||Participants|Number|34|34.0||||||
3794976|NCT01831466|3623976|B1|45-64 years||Age, Customized||Participants|Number|28|28.0||||||
3794977|NCT01831466|3623964|B13|18-44 years||Age, Customized||Participants|Number|165|165.0||||||
3794978|NCT01831466|3623965|B12|18-44 years||Age, Customized||Participants|Number|2|2.0||||||
3794979|NCT01831466|3623966|B11|18-44 years||Age, Customized||Participants|Number|3|3.0||||||
3794980|NCT01831466|3623967|B10|18-44 years||Age, Customized||Participants|Number|3|3.0||||||
3794981|NCT01831466|3623968|B9|18-44 years||Age, Customized||Participants|Number|1|1.0||||||
3794982|NCT01831466|3623969|B8|18-44 years||Age, Customized||Participants|Number|0|0.0||||||
3794983|NCT01831466|3623970|B7|18-44 years||Age, Customized||Participants|Number|2|2.0||||||
3794984|NCT01831466|3623971|B6|18-44 years||Age, Customized||Participants|Number|25|25.0||||||
3794985|NCT01831466|3623972|B5|18-44 years||Age, Customized||Participants|Number|30|30.0||||||
3794986|NCT01831466|3623973|B4|18-44 years||Age, Customized||Participants|Number|21|21.0||||||
3794987|NCT01831466|3623974|B3|18-44 years||Age, Customized||Participants|Number|25|25.0||||||
3794988|NCT01831466|3623975|B2|18-44 years||Age, Customized||Participants|Number|23|23.0||||||
3794989|NCT01831466|3623976|B1|18-44 years||Age, Customized||Participants|Number|30|30.0||||||
3794990|NCT01831466|3623964|B13|< 18 years||Age, Customized||Participants|Number|0|0.0||||||
3794991|NCT01831466|3623965|B12|< 18 years||Age, Customized||Participants|Number|0|0.0||||||
3794992|NCT01831466|3623966|B11|< 18 years||Age, Customized||Participants|Number|0|0.0||||||
3794993|NCT01831466|3623967|B10|< 18 years||Age, Customized||Participants|Number|0|0.0||||||
3794994|NCT01831466|3623968|B9|< 18 years||Age, Customized||Participants|Number|0|0.0||||||
3794995|NCT01831466|3623969|B8|< 18 years||Age, Customized||Participants|Number|0|0.0||||||
3794996|NCT01831466|3623970|B7|< 18 years||Age, Customized||Participants|Number|0|0.0||||||
3794997|NCT01831466|3623971|B6|< 18 years||Age, Customized||Participants|Number|0|0.0||||||
3794998|NCT01831466|3623972|B5|< 18 years||Age, Customized||Participants|Number|0|0.0||||||
3794999|NCT01831466|3623973|B4|< 18 years||Age, Customized||Participants|Number|0|0.0||||||
3795000|NCT01831466|3623974|B3|< 18 years||Age, Customized||Participants|Number|0|0.0||||||
3795001|NCT01831466|3623975|B2|< 18 years||Age, Customized||Participants|Number|0|0.0||||||
3795002|NCT01831466|3623976|B1|< 18 years||Age, Customized||Participants|Number|0|0.0||||||
3795003|NCT01831258|3624109|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3795004|NCT01831258|3624109|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3795005|NCT01831258|3624109|B1|||Age||years|Mean|50.78|50.78|Standard Deviation|11.49|11.49|||
3795006|NCT01831232|3624136|B1|Chronic Myelomonocytic Leukemia (CMML)||Diagnosis||Participants|Count of Participants|1|1.0||||||
3795007|NCT01831232|3624136|B1|Myelodysplastic Syndrome (MDS)||Diagnosis||Participants|Count of Participants|2|2.0||||||
3795008|NCT01831232|3624136|B1|Acute Myeloid Leukemia (AML)||Diagnosis||Participants|Count of Participants|21|21.0||||||
3795009|NCT01831232|3624136|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3795010|NCT01831232|3624136|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3795011|NCT01831232|3624136|B1|||Age||years|Median|57|57.0|Full Range|||35.0|72.0|
3795012|NCT01831219|3624145|B3|United States||Region of Enrollment||participants|Number|118|118.0||||||
3795013|NCT01831219|3624146|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
3795014|NCT01831219|3624147|B1|United States||Region of Enrollment||participants|Number|73|73.0||||||
3795015|NCT01831219|3624145|B3||Male|Gender||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3795016|NCT01831219|3624146|B2||Male|Gender||Participants|Count of Participants|NA|||||||The gender breakdown of the original IDE was collected but it is unavailable, because the data has been lost.
3795017|NCT01831219|3624147|B1||Male|Gender||Participants|Count of Participants|NA|||||||The gender breakdown of the original IDE was collected but it is unavailable, because the data has been lost.
3795018|NCT01831219|3624145|B3||Female|Gender||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3795019|NCT01831219|3624146|B2||Female|Gender||Participants|Count of Participants|NA|||||||The gender breakdown of the original IDE was collected but it is unavailable, because the data has been lost.
3795020|NCT01831219|3624147|B1||Female|Gender||Participants|Count of Participants|NA|||||||The gender breakdown of the original IDE was collected but it is unavailable, because the data has been lost.
3795021|NCT01831219|3624145|B3|||Age||years|Mean|73.5|73.5|Standard Deviation|7.7|7.7|||
3795022|NCT01831219|3624146|B2|||Age||years|Mean|72.8|72.8|Standard Deviation|7.6|7.6|||
3795023|NCT01831219|3624147|B1|||Age||years|Mean|74.2|74.2|Standard Deviation|8.2|8.2|||
3795024|NCT01831219|3624145|B3||>=65 years|Age||Participants|Count of Participants|118|118.0||||||
3795025|NCT01831219|3624146|B2||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
3795026|NCT01831219|3624147|B1||>=65 years|Age||Participants|Count of Participants|73|73.0||||||
3795027|NCT01831219|3624145|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3795028|NCT01831219|3624146|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3795029|NCT01831219|3624147|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3795030|NCT01831219|3624145|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3795031|NCT01831219|3624146|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3795032|NCT01831219|3624147|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3795033|NCT01831154|3624166|B4|United States||Region of Enrollment||participants|Number|37|37.0||||||
3795034|NCT01831154|3624167|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3795035|NCT01831154|3624168|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3795036|NCT01831154|3624169|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3795037|NCT01831154|3624166|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795038|NCT01831154|3624167|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795039|NCT01831154|3624168|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795040|NCT01831154|3624169|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795041|NCT01831154|3624166|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795042|NCT01831154|3624167|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795043|NCT01831154|3624168|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795044|NCT01831154|3624169|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795045|NCT01831154|3624166|B4||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3795046|NCT01831154|3624167|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3795047|NCT01831154|3624168|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3795048|NCT01831154|3624169|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3795049|NCT01831154|3624166|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3795050|NCT01831154|3624167|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3795051|NCT01831154|3624168|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795052|NCT01831154|3624169|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795053|NCT01831154|3624166|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795054|NCT01831154|3624167|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795055|NCT01831154|3624168|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795056|NCT01831154|3624169|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795057|NCT01831154|3624166|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795058|NCT01831154|3624167|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795059|NCT01831154|3624168|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795060|NCT01831154|3624169|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795061|NCT01831154|3624166|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795062|NCT01831154|3624167|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795063|NCT01831154|3624168|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795064|NCT01831154|3624169|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795065|NCT01831154|3624166|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795066|NCT01831154|3624167|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795067|NCT01831154|3624168|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795068|NCT01831154|3624169|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795069|NCT01831154|3624166|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3795070|NCT01831154|3624167|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3795071|NCT01831154|3624168|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3795072|NCT01831154|3624169|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3795073|NCT01831154|3624166|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3795074|NCT01831154|3624167|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3795075|NCT01831154|3624168|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3795076|NCT01831154|3624169|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3795077|NCT01831154|3624166|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3795078|NCT01831154|3624167|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3795079|NCT01831154|3624168|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3795080|NCT01831154|3624169|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3795081|NCT01831154|3624166|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3795082|NCT01831154|3624167|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3795083|NCT01831154|3624168|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3795084|NCT01831154|3624169|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3795085|NCT01831154|3624166|B4|||Age||years|Mean|65|65.0|Standard Deviation|6.1|6.1|||
3795086|NCT01831154|3624167|B3|||Age||years|Mean|66|66.0|Standard Deviation|4|4.0|||
3795087|NCT01831154|3624168|B2|||Age||years|Mean|66|66.0|Standard Deviation|7.4|7.4|||
3795088|NCT01831154|3624169|B1|||Age||years|Mean|64|64.0|Standard Deviation|6.9|6.9|||
3795089|NCT01831076|3624194|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
3795090|NCT01831076|3624195|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3795091|NCT01831076|3624196|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
3795092|NCT01831076|3624194|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795093|NCT01831076|3624195|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795094|NCT01831076|3624196|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795095|NCT01831076|3624194|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3795096|NCT01831076|3624195|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795097|NCT01831076|3624196|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3795098|NCT01831076|3624194|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3795099|NCT01831076|3624195|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3795100|NCT01831076|3624196|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3795101|NCT01831076|3624194|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3795102|NCT01831076|3624195|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795103|NCT01831076|3624196|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3795104|NCT01831076|3624194|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795105|NCT01831076|3624195|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795106|NCT01831076|3624196|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795107|NCT01831076|3624194|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3795108|NCT01831076|3624195|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795109|NCT01831076|3624196|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3795110|NCT01831076|3624194|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795111|NCT01831076|3624195|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795112|NCT01831076|3624196|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795113|NCT01831076|3624194|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3795114|NCT01831076|3624195|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3795115|NCT01831076|3624196|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3795116|NCT01831076|3624194|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3795117|NCT01831076|3624195|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3795118|NCT01831076|3624196|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3795119|NCT01831076|3624194|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3795120|NCT01831076|3624195|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3795121|NCT01831076|3624196|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3795122|NCT01831076|3624194|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3795123|NCT01831076|3624195|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3795124|NCT01831076|3624196|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3795125|NCT01831076|3624194|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3795126|NCT01831076|3624195|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3795127|NCT01831076|3624196|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3795128|NCT01830972|3624203|B3|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3795129|NCT01830972|3624204|B2|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3795130|NCT01830972|3624205|B1|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3795131|NCT01830972|3624203|B3|Not Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|57|57.0||||||
3795132|NCT01830972|3624204|B2|Not Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3795133|NCT01830972|3624205|B1|Not Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
3795134|NCT01830972|3624203|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3795135|NCT01830972|3624204|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3795136|NCT01830972|3624205|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3795137|NCT01830972|3624203|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
3795138|NCT01830972|3624204|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3795139|NCT01830972|3624205|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
3795140|NCT01830972|3624203|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3795141|NCT01830972|3624204|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3795142|NCT01830972|3624205|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3795143|NCT01830972|3624203|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3795144|NCT01830972|3624204|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3795145|NCT01830972|3624205|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3795146|NCT01830972|3624203|B3|||Age||years|Mean|39.9|39.9|Standard Deviation|10.79|10.79|||
3795147|NCT01830972|3624204|B2|||Age||years|Mean|35.6|35.6|Standard Deviation|10.97|10.97|||
3795148|NCT01830972|3624205|B1|||Age||years|Mean|41.1|41.1|Standard Deviation|10.55|10.55|||
3795149|NCT01830933|3624230|B3|United States||Region of Enrollment||participants|Number|1235|1235.0||||||
3795150|NCT01830933|3624231|B2|United States||Region of Enrollment||participants|Number|580|580.0||||||
3795151|NCT01830933|3624232|B1|United States||Region of Enrollment||participants|Number|655|655.0||||||
3795152|NCT01830933|3624230|B3|Native American or Other||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3795153|NCT01830933|3624231|B2|Native American or Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3795154|NCT01830933|3624232|B1|Native American or Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3795155|NCT01830933|3624230|B3|Asian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|228|228.0||||||
3795156|NCT01830933|3624231|B2|Asian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|105|105.0||||||
3795157|NCT01830933|3624232|B1|Asian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|123|123.0||||||
3795158|NCT01830933|3624230|B3|Black/ African American||Race/Ethnicity, Customized||participants|Number|275|275.0||||||
3795159|NCT01830933|3624231|B2|Black/ African American||Race/Ethnicity, Customized||participants|Number|125|125.0||||||
3795160|NCT01830933|3624232|B1|Black/ African American||Race/Ethnicity, Customized||participants|Number|150|150.0||||||
3795161|NCT01830933|3624230|B3|Latina||Race/Ethnicity, Customized||participants|Number|285|285.0||||||
3795162|NCT01830933|3624231|B2|Latina||Race/Ethnicity, Customized||participants|Number|141|141.0||||||
3795163|NCT01830933|3624232|B1|Latina||Race/Ethnicity, Customized||participants|Number|144|144.0||||||
3795164|NCT01830933|3624230|B3|Non-Latina White||Race/Ethnicity, Customized||participants|Number|431|431.0||||||
3795165|NCT01830933|3624231|B2|Non-Latina White||Race/Ethnicity, Customized||participants|Number|202|202.0||||||
3795166|NCT01830933|3624232|B1|Non-Latina White||Race/Ethnicity, Customized||participants|Number|229|229.0||||||
3795167|NCT01830933|3624230|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3795168|NCT01830933|3624231|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3795169|NCT01830933|3624232|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3795170|NCT01830933|3624230|B3||Female|Sex: Female, Male||Participants|Count of Participants|1235|1235.0||||||
3795171|NCT01830933|3624231|B2||Female|Sex: Female, Male||Participants|Count of Participants|580|580.0||||||
3795172|NCT01830933|3624232|B1||Female|Sex: Female, Male||Participants|Count of Participants|655|655.0||||||
3795173|NCT01830933|3624230|B3|>65 years||Age, Customized||participants|Number|208|208.0||||||
3795174|NCT01830933|3624231|B2|>65 years||Age, Customized||participants|Number|98|98.0||||||
3795175|NCT01830933|3624232|B1|>65 years||Age, Customized||participants|Number|110|110.0||||||
3795176|NCT01830933|3624230|B3|51-65 years||Age, Customized||participants|Number|662|662.0||||||
3795177|NCT01830933|3624231|B2|51-65 years||Age, Customized||participants|Number|300|300.0||||||
3795178|NCT01830933|3624232|B1|51-65 years||Age, Customized||participants|Number|362|362.0||||||
3795179|NCT01830933|3624230|B3|<50 years||Age, Customized||participants|Number|365|365.0||||||
3795180|NCT01830933|3624231|B2|<50 years||Age, Customized||participants|Number|182|182.0||||||
3795181|NCT01830933|3624232|B1|<50 years||Age, Customized||participants|Number|183|183.0||||||
3795182|NCT01830920|3624245|B6|United States||Region of Enrollment||participants|Number|231|231.0||||||
3795183|NCT01830920|3624246|B5|United States||Region of Enrollment||participants|Number|50|50.0||||||
3795184|NCT01830920|3624247|B4|United States||Region of Enrollment||participants|Number|64|64.0||||||
3795185|NCT01830920|3624248|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3795186|NCT01830920|3624249|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
3795187|NCT01830920|3624250|B1|United States||Region of Enrollment||participants|Number|69|69.0||||||
3795188|NCT01830920|3624245|B6|Canada||Region of Enrollment||participants|Number|200|200.0||||||
3795189|NCT01830920|3624246|B5|Canada||Region of Enrollment||participants|Number|55|55.0||||||
3795190|NCT01830920|3624247|B4|Canada||Region of Enrollment||participants|Number|55|55.0||||||
3795191|NCT01830920|3624248|B3|Canada||Region of Enrollment||participants|Number|27|27.0||||||
3795192|NCT01830920|3624249|B2|Canada||Region of Enrollment||participants|Number|17|17.0||||||
3795193|NCT01830920|3624250|B1|Canada||Region of Enrollment||participants|Number|46|46.0||||||
3795194|NCT01830920|3624245|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3795195|NCT01830920|3624246|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3795196|NCT01830920|3624247|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3795197|NCT01830920|3624248|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3795198|NCT01830920|3624249|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795199|NCT01830920|3624250|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3795200|NCT01830920|3624245|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795201|NCT01830920|3624246|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795202|NCT01830920|3624247|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795203|NCT01830920|3624248|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795204|NCT01830920|3624249|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795205|NCT01830920|3624250|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795206|NCT01830920|3624245|B6||White|Race (NIH/OMB)||Participants|Count of Participants|394|394.0||||||
3795207|NCT01830920|3624246|B5||White|Race (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3795208|NCT01830920|3624247|B4||White|Race (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
3795209|NCT01830920|3624248|B3||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3795210|NCT01830920|3624249|B2||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3795211|NCT01830920|3624250|B1||White|Race (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
3795212|NCT01830920|3624245|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3795213|NCT01830920|3624246|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3795214|NCT01830920|3624247|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3795215|NCT01830920|3624248|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3795216|NCT01830920|3624249|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3795217|NCT01830920|3624250|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3795218|NCT01830920|3624245|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795219|NCT01830920|3624246|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795220|NCT01830920|3624247|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795221|NCT01830920|3624248|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795222|NCT01830920|3624249|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795223|NCT01830920|3624250|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795224|NCT01830920|3624245|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3795225|NCT01830920|3624246|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3795226|NCT01830920|3624247|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3795227|NCT01830920|3624248|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795228|NCT01830920|3624249|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3795229|NCT01830920|3624250|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3795230|NCT01830920|3624245|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3795231|NCT01830920|3624246|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3795232|NCT01830920|3624247|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3795233|NCT01830920|3624248|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3795234|NCT01830920|3624249|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795235|NCT01830920|3624250|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3795236|NCT01830920|3624245|B6||Male|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
3795237|NCT01830920|3624246|B5||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3795238|NCT01830920|3624247|B4||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3795239|NCT01830920|3624248|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3795240|NCT01830920|3624249|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3795241|NCT01830920|3624250|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3795242|NCT01830920|3624245|B6||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3795243|NCT01830920|3624246|B5||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3795244|NCT01830920|3624247|B4||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3795245|NCT01830920|3624248|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3795246|NCT01830920|3624249|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3795247|NCT01830920|3624250|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3795248|NCT01830920|3624245|B6|||Age||years|Mean|71.3|71.3|Inter-Quartile Range|||65.0|79.0|
3795249|NCT01830920|3624246|B5|||Age||years|Mean|70.0|70.0|Inter-Quartile Range|||64.0|77.0|
3795250|NCT01830920|3624247|B4|||Age||years|Mean|72.5|72.5|Inter-Quartile Range|||67.0|78.0|
3795251|NCT01830920|3624248|B3|||Age||years|Mean|72.7|72.7|Inter-Quartile Range|||66.0|79.0|
3795252|NCT01830920|3624249|B2|||Age||years|Mean|68.8|68.8|Inter-Quartile Range|||62.0|77.0|
3795253|NCT01830920|3624250|B1|||Age||years|Mean|71.5|71.5|Inter-Quartile Range|||65.0|80.0|
3795254|NCT01830881|3624291|B3|No||Self-reported anxiety||participants|Number|96|96.0||||||
3795255|NCT01830881|3624292|B2|No||Self-reported anxiety||participants|Number|48|48.0||||||
3795256|NCT01830881|3624293|B1|No||Self-reported anxiety||participants|Number|48|48.0||||||
3795257|NCT01830881|3624291|B3|Yes||Self-reported anxiety||participants|Number|28|28.0||||||
3795258|NCT01830881|3624292|B2|Yes||Self-reported anxiety||participants|Number|14|14.0||||||
3795259|NCT01830881|3624293|B1|Yes||Self-reported anxiety||participants|Number|14|14.0||||||
3795260|NCT01830881|3624291|B3|No||Self-reported depression||participants|Number|91|91.0||||||
3795261|NCT01830881|3624292|B2|No||Self-reported depression||participants|Number|48|48.0||||||
3795262|NCT01830881|3624293|B1|No||Self-reported depression||participants|Number|43|43.0||||||
3795263|NCT01830881|3624291|B3|Yes||Self-reported depression||participants|Number|33|33.0||||||
3795264|NCT01830881|3624292|B2|Yes||Self-reported depression||participants|Number|14|14.0||||||
3795265|NCT01830881|3624293|B1|Yes||Self-reported depression||participants|Number|19|19.0||||||
3795266|NCT01830881|3624291|B3|||BMI||kg/m2|Mean|25.9|25.9|Standard Deviation|5.7|5.7|||
3795267|NCT01830881|3624292|B2|||BMI||kg/m2|Mean|25.9|25.9|Standard Deviation|5.5|5.5|||
3795268|NCT01830881|3624293|B1|||BMI||kg/m2|Mean|25.9|25.9|Standard Deviation|6.0|6.0|||
3795269|NCT01830881|3624291|B3|Requiring medication or unable to attend work||Level of menstrual symptoms||participants|Number|54|54.0||||||
3795270|NCT01830881|3624292|B2|Requiring medication or unable to attend work||Level of menstrual symptoms||participants|Number|22|22.0||||||
3795271|NCT01830881|3624293|B1|Requiring medication or unable to attend work||Level of menstrual symptoms||participants|Number|32|32.0||||||
3795272|NCT01830881|3624291|B3|Easy or mild cramping||Level of menstrual symptoms||participants|Number|70|70.0||||||
3795273|NCT01830881|3624292|B2|Easy or mild cramping||Level of menstrual symptoms||participants|Number|40|40.0||||||
3795274|NCT01830881|3624293|B1|Easy or mild cramping||Level of menstrual symptoms||participants|Number|30|30.0||||||
3795275|NCT01830881|3624291|B3|No||Previous surgical abortion||participants|Number|80|80.0||||||
3795276|NCT01830881|3624292|B2|No||Previous surgical abortion||participants|Number|39|39.0||||||
3795277|NCT01830881|3624293|B1|No||Previous surgical abortion||participants|Number|41|41.0||||||
3795278|NCT01830881|3624291|B3|Yes||Previous surgical abortion||participants|Number|44|44.0||||||
3795279|NCT01830881|3624292|B2|Yes||Previous surgical abortion||participants|Number|23|23.0||||||
3795280|NCT01830881|3624293|B1|Yes||Previous surgical abortion||participants|Number|21|21.0||||||
3795281|NCT01830881|3624291|B3|No||Previous vaginal deliveries||participants|Number|82|82.0||||||
3795282|NCT01830881|3624292|B2|No||Previous vaginal deliveries||participants|Number|40|40.0||||||
3795283|NCT01830881|3624293|B1|No||Previous vaginal deliveries||participants|Number|42|42.0||||||
3795284|NCT01830881|3624291|B3|Yes||Previous vaginal deliveries||participants|Number|42|42.0||||||
3795285|NCT01830881|3624292|B2|Yes||Previous vaginal deliveries||participants|Number|22|22.0||||||
3795286|NCT01830881|3624293|B1|Yes||Previous vaginal deliveries||participants|Number|20|20.0||||||
3795287|NCT01830881|3624291|B3|Parous||Parity||participants|Number|54|54.0||||||
3795288|NCT01830881|3624292|B2|Parous||Parity||participants|Number|30|30.0||||||
3795289|NCT01830881|3624293|B1|Parous||Parity||participants|Number|24|24.0||||||
3795290|NCT01830881|3624291|B3|Nulliparous||Parity||participants|Number|70|70.0||||||
3795291|NCT01830881|3624292|B2|Nulliparous||Parity||participants|Number|32|32.0||||||
3795292|NCT01830881|3624293|B1|Nulliparous||Parity||participants|Number|38|38.0||||||
3795293|NCT01830881|3624291|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795294|NCT01830881|3624292|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795295|NCT01830881|3624293|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795296|NCT01830881|3624291|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3795297|NCT01830881|3624292|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3795298|NCT01830881|3624293|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3795299|NCT01830881|3624291|B3||White|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
3795300|NCT01830881|3624292|B2||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3795301|NCT01830881|3624293|B1||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3795302|NCT01830881|3624291|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3795303|NCT01830881|3624292|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3795304|NCT01830881|3624293|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3795305|NCT01830881|3624291|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795306|NCT01830881|3624292|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795307|NCT01830881|3624293|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795308|NCT01830881|3624291|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3795309|NCT01830881|3624292|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3795310|NCT01830881|3624293|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3795311|NCT01830881|3624291|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795312|NCT01830881|3624292|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795313|NCT01830881|3624293|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795314|NCT01830881|3624291|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795315|NCT01830881|3624292|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795316|NCT01830881|3624293|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795317|NCT01830881|3624291|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
3795318|NCT01830881|3624292|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3795319|NCT01830881|3624293|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3795320|NCT01830881|3624291|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3795321|NCT01830881|3624292|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3795322|NCT01830881|3624293|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3795323|NCT01830881|3624291|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3795324|NCT01830881|3624292|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3795325|NCT01830881|3624293|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3795326|NCT01830881|3624291|B3||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3795327|NCT01830881|3624292|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3795328|NCT01830881|3624293|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3795329|NCT01830881|3624291|B3|||Age||years|Mean|25.6|25.6|Standard Deviation|5.5|5.5|||
3795330|NCT01830881|3624292|B2|||Age||years|Mean|25.5|25.5|Standard Deviation|5.8|5.8|||
3795331|NCT01830881|3624293|B1|||Age||years|Mean|25.8|25.8|Standard Deviation|5.3|5.3|||
3795332|NCT01830855|3624338|B5||Male|Sex: Female, Male||Participants|Count of Participants|1850|1850.0||||||
3795333|NCT01830855|3624339|B4||Male|Sex: Female, Male||Participants|Count of Participants|454|454.0||||||
3795334|NCT01830855|3624340|B3||Male|Sex: Female, Male||Participants|Count of Participants|313|313.0||||||
3795335|NCT01830855|3624341|B2||Male|Sex: Female, Male||Participants|Count of Participants|312|312.0||||||
3795336|NCT01830855|3624342|B1||Male|Sex: Female, Male||Participants|Count of Participants|771|771.0||||||
3795337|NCT01830855|3624338|B5||Female|Sex: Female, Male||Participants|Count of Participants|1740|1740.0||||||
3795338|NCT01830855|3624339|B4||Female|Sex: Female, Male||Participants|Count of Participants|443|443.0||||||
3795339|NCT01830855|3624340|B3||Female|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
3795340|NCT01830855|3624341|B2||Female|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
3795341|NCT01830855|3624342|B1||Female|Sex: Female, Male||Participants|Count of Participants|737|737.0||||||
3795342|NCT01830855|3624338|B5|||Age||Years|Mean|13.9|13.9|Standard Deviation|2.6|2.6|||
3795343|NCT01830855|3624339|B4|||Age||Years|Mean|13.9|13.9|Standard Deviation|2.6|2.6|||
3795344|NCT01830855|3624340|B3|||Age||Years|Mean|13.9|13.9|Standard Deviation|2.6|2.6|||
3795345|NCT01830855|3624341|B2|||Age||Years|Mean|14.0|14.0|Standard Deviation|2.6|2.6|||
3795346|NCT01830855|3624342|B1|||Age||Years|Mean|13.9|13.9|Standard Deviation|2.6|2.6|||
3795347|NCT01830842|3624449|B3|United States||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
3795348|NCT01830842|3624450|B2|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3795349|NCT01830842|3624451|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3795350|NCT01830842|3624449|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3795351|NCT01830842|3624450|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3795352|NCT01830842|3624451|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3795353|NCT01830842|3624449|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3795354|NCT01830842|3624450|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3795355|NCT01830842|3624451|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3795356|NCT01830842|3624449|B3|||Age||years|Mean|34|34.0|Standard Deviation|11|11.0|||
3795357|NCT01830842|3624450|B2|||Age||years|Mean|35|35.0|Standard Deviation|10|10.0|||
3795358|NCT01830842|3624451|B1|||Age||years|Mean|33|33.0|Standard Deviation|11|11.0|||
3795359|NCT01830842|3624449|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3795360|NCT01830842|3624450|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3795361|NCT01830842|3624451|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3795362|NCT01830842|3624449|B3||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3795363|NCT01830842|3624450|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3795364|NCT01830842|3624451|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3795365|NCT01830842|3624449|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3795366|NCT01830842|3624450|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3795367|NCT01830842|3624451|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3795368|NCT01830790|3624458|B3|Male||Gender||participants|Number|6|6.0||||||
3795369|NCT01830790|3624459|B2|Male||Gender||participants|Number|6|6.0||||||
3795370|NCT01830790|3624458|B3|Female||Gender||participants|Number|4|4.0||||||
3795371|NCT01830790|3624459|B2|Female||Gender||participants|Number|4|4.0||||||
3795372|NCT01830790|3624458|B3|>=65 years||Age||participants|Number|8|8.0||||||
3795373|NCT01830790|3624459|B2|>=65 years||Age||participants|Number|8|8.0||||||
3795374|NCT01830790|3624458|B3|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
3795375|NCT01830790|3624459|B2|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
3795376|NCT01830790|3624458|B3|<=18 years||Age||participants|Number|0|0.0||||||
3795377|NCT01830790|3624459|B2|<=18 years||Age||participants|Number|0|0.0||||||
3795378|NCT01830699|3624469|B3|Left Bursa injected||Site of subacromial injection||participants|Number|13|13.0||||||
3795379|NCT01830699|3624470|B2|Left Bursa injected||Site of subacromial injection||participants|Number|6|6.0||||||
3795380|NCT01830699|3624471|B1|Left Bursa injected||Site of subacromial injection||participants|Number|7|7.0||||||
3795381|NCT01830699|3624469|B3|Right Bursa injected||Site of subacromial injection||participants|Number|20|20.0||||||
3795382|NCT01830699|3624470|B2|Right Bursa injected||Site of subacromial injection||participants|Number|14|14.0||||||
3795383|NCT01830699|3624471|B1|Right Bursa injected||Site of subacromial injection||participants|Number|6|6.0||||||
3795384|NCT01830699|3624469|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
3795385|NCT01830699|3624470|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3795386|NCT01830699|3624471|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3795387|NCT01830699|3624469|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795388|NCT01830699|3624470|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795389|NCT01830699|3624471|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795390|NCT01830699|3624469|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795391|NCT01830699|3624470|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795392|NCT01830699|3624471|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795393|NCT01830699|3624469|B3||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3795394|NCT01830699|3624470|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3795395|NCT01830699|3624471|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3795396|NCT01830699|3624469|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3795397|NCT01830699|3624470|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795398|NCT01830699|3624471|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3795399|NCT01830699|3624469|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3795400|NCT01830699|3624470|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795401|NCT01830699|3624471|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3795402|NCT01830699|3624469|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3795403|NCT01830699|3624470|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3795404|NCT01830699|3624471|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795405|NCT01830699|3624469|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795406|NCT01830699|3624470|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795407|NCT01830699|3624471|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795408|NCT01830699|3624469|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3795409|NCT01830699|3624470|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3795410|NCT01830699|3624471|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3795411|NCT01830699|3624469|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3795412|NCT01830699|3624470|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3795413|NCT01830699|3624471|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3795414|NCT01830699|3624469|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3795415|NCT01830699|3624470|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3795416|NCT01830699|3624471|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3795417|NCT01830699|3624469|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3795418|NCT01830699|3624470|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3795419|NCT01830699|3624471|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3795420|NCT01830699|3624469|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3795421|NCT01830699|3624470|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3795422|NCT01830699|3624471|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3795423|NCT01830699|3624469|B3|||Age||years|Mean|65.3|65.3|Standard Deviation|12.5|12.5|||
3795424|NCT01830699|3624470|B2|||Age||years|Mean|64.5|64.5|Standard Deviation|12.1|12.1|||
3795425|NCT01830699|3624471|B1|||Age||years|Mean|65.6|65.6|Standard Deviation|13.7|13.7|||
3795426|NCT01830595|3624482|B1|Beginning of Lactoferrin Treatment||sCD163||mg/L|Mean|0.19|0.19|Standard Deviation|0.10|0.1|||
3795427|NCT01830595|3624482|B1|Beginning of Placebo Treatment||sCD163||mg/L|Mean|0.23|0.23|Standard Deviation|0.15|0.15|||
3795428|NCT01830595|3624482|B1|At Enrollment||sCD163||mg/L|Mean|0.21|0.21|Standard Deviation|0.12|0.12|||
3795429|NCT01830595|3624482|B1|Beginning of Lactoferrin Treatment||Monocyte CD16+||percent of total monocyte population|Mean|11.96|11.96|Standard Deviation|9.56|9.56|||
3795430|NCT01830595|3624482|B1|Beginning of Placebo Treatment||Monocyte CD16+||percent of total monocyte population|Mean|10.41|10.41|Standard Deviation|7.56|7.56|||
3795431|NCT01830595|3624482|B1|At Enrollment||Monocyte CD16+||percent of total monocyte population|Mean|10.55|10.55|Standard Deviation|7.11|7.11|||
3795432|NCT01830595|3624482|B1|Beginning of Lactoferrin Treatment||Large Artery Elasticity||mL/mmHg x 10|Mean|16.89|16.89|Standard Deviation|5.48|5.48|||
3795433|NCT01830595|3624482|B1|Beginning of Placebo Treatment||Large Artery Elasticity||mL/mmHg x 10|Mean|17.02|17.02|Standard Deviation|5.56|5.56|||
3795434|NCT01830595|3624482|B1|At Enrollment||Large Artery Elasticity||mL/mmHg x 10|Mean|16.77|16.77|Standard Deviation|5.74|5.74|||
3795435|NCT01830595|3624482|B1|Beginning of Lactoferrin Treatment||Small Artery Elasticity||mL/mmHg x 100|Mean|6.61|6.61|Standard Deviation|2.87|2.87|||
3795436|NCT01830595|3624482|B1|Beginning of Placebo Treatment||Small Artery Elasticity||mL/mmHg x 100|Mean|6.79|6.79|Standard Deviation|3.04|3.04|||
3795437|NCT01830595|3624482|B1|At Enrollment||Small Artery Elasticity||mL/mmHg x 100|Mean|6.49|6.49|Standard Deviation|2.91|2.91|||
3795438|NCT01830595|3624482|B1|Beginning of Lactoferrin Treatment||Interleukin-6 and D-Dimer Score|"The IL-6 & D-dimer score is defined as: 0. 33*log2 IL-6 + 0.16*log2 D-dimer, where IL-6 is measured in pg/mL and D-dimer in ug/mL. Since the biomarkers are on the log2 scale, associations of risk with the IL-6 & D-dimer score are interpreted as Hazard Ratio (HR)(event) per doubling of IL-6 and D-dimer, or HR(event) per 20% increase in IL-6 and D-dimer; the score itself is unitless.~Among the 3766 study participants for whom the score was developed, the min was -1.7, the max was 2.5.~Higher scores are worse."|scores on a scale|Mean|-002|-2.0|Standard Deviation|0.45|0.45|||
3795491|NCT01830543|3624498|B3|Romania||Region of Enrollment||participants|Number|19|19.0||||||
3795492|NCT01830543|3624499|B2|Romania||Region of Enrollment||participants|Number|16|16.0||||||
3795439|NCT01830595|3624482|B1|Beginning of Placebo Treatment||Interleukin-6 and D-Dimer Score|"The IL-6 & D-dimer score is defined as: 0. 33*log2 IL-6 + 0.16*log2 D-dimer, where IL-6 is measured in pg/mL and D-dimer in ug/mL. Since the biomarkers are on the log2 scale, associations of risk with the IL-6 & D-dimer score are interpreted as Hazard Ratio (HR)(event) per doubling of IL-6 and D-dimer, or HR(event) per 20% increase in IL-6 and D-dimer; the score itself is unitless.~Among the 3766 study participants for whom the score was developed, the min was -1.7, the max was 2.5.~Higher scores are worse."|scores on a scale|Mean|0.02|0.02|Standard Deviation|0.39|0.39|||
3795440|NCT01830595|3624482|B1|At Enrollment||Interleukin-6 and D-Dimer Score|"The IL-6 & D-dimer score is defined as: 0. 33*log2 IL-6 + 0.16*log2 D-dimer, where IL-6 is measured in pg/mL and D-dimer in ug/mL. Since the biomarkers are on the log2 scale, associations of risk with the IL-6 & D-dimer score are interpreted as Hazard Ratio (HR)(event) per doubling of IL-6 and D-dimer, or HR(event) per 20% increase in IL-6 and D-dimer; the score itself is unitless.~Among the 3766 study participants for whom the score was developed, the min was -1.7, the max was 2.5.~Higher scores are worse."|scores on a scale|Mean|-0.00|0.0|Standard Deviation|0.38|0.38|||
3795441|NCT01830595|3624482|B1|||Weight||pounds|Mean|190.0|190.0|Standard Deviation|38.1|38.1|||
3795442|NCT01830595|3624482|B1|Beginning of Lactoferrin Treatment||Systolic Blood Pressure||mm Hg|Mean|127.8|127.8|Standard Deviation|15.6|15.6|||
3795443|NCT01830595|3624482|B1|Beginning of Placebo Treatment||Systolic Blood Pressure||mm Hg|Mean|128.0|128.0|Standard Deviation|14.9|14.9|||
3795444|NCT01830595|3624482|B1|At Enrollment||Systolic Blood Pressure||mm Hg|Mean|129.7|129.7|Standard Deviation|15.4|15.4|||
3795445|NCT01830595|3624482|B1|Beginning of Lactoferrin||Diastolic Blood Pressure||mm HG|Mean|79.3|79.3|Standard Deviation|10.2|10.2|||
3795446|NCT01830595|3624482|B1|Beginning of Placebo Treatment||Diastolic Blood Pressure||mm HG|Mean|78.6|78.6|Standard Deviation|9.9|9.9|||
3795447|NCT01830595|3624482|B1|At Enrollment||Diastolic Blood Pressure||mm HG|Mean|79.5|79.5|Standard Deviation|10.5|10.5|||
3795448|NCT01830595|3624482|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3795449|NCT01830595|3624482|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3795450|NCT01830595|3624482|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3795451|NCT01830595|3624482|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
3795452|NCT01830595|3624482|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3795453|NCT01830595|3624482|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3795454|NCT01830595|3624482|B1|||Age||years|Mean|51.6|51.6|Standard Deviation|7.0|7.0|||
3795455|NCT01830595|3624482|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3795456|NCT01830595|3624482|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3795457|NCT01830595|3624482|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3795458|NCT01830543|3624497|B4|South Africa||Region of Enrollment||participants|Number|5|5.0||||||
3795459|NCT01830543|3624498|B3|South Africa||Region of Enrollment||participants|Number|2|2.0||||||
3795460|NCT01830543|3624499|B2|South Africa||Region of Enrollment||participants|Number|2|2.0||||||
3795461|NCT01830543|3624500|B1|South Africa||Region of Enrollment||participants|Number|1|1.0||||||
3795462|NCT01830543|3624497|B4|United States||Region of Enrollment||participants|Number|151|151.0||||||
3795463|NCT01830543|3624498|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
3795464|NCT01830543|3624499|B2|United States||Region of Enrollment||participants|Number|49|49.0||||||
3795465|NCT01830543|3624500|B1|United States||Region of Enrollment||participants|Number|56|56.0||||||
3795466|NCT01830543|3624497|B4|United Kingdom||Region of Enrollment||participants|Number|131|131.0||||||
3795467|NCT01830543|3624498|B3|United Kingdom||Region of Enrollment||participants|Number|39|39.0||||||
3795468|NCT01830543|3624499|B2|United Kingdom||Region of Enrollment||participants|Number|44|44.0||||||
3795469|NCT01830543|3624500|B1|United Kingdom||Region of Enrollment||participants|Number|48|48.0||||||
3795470|NCT01830543|3624497|B4|Ukraine||Region of Enrollment||participants|Number|60|60.0||||||
3795471|NCT01830543|3624498|B3|Ukraine||Region of Enrollment||participants|Number|17|17.0||||||
3795472|NCT01830543|3624499|B2|Ukraine||Region of Enrollment||participants|Number|24|24.0||||||
3795473|NCT01830543|3624500|B1|Ukraine||Region of Enrollment||participants|Number|19|19.0||||||
3795474|NCT01830543|3624497|B4|Turkey||Region of Enrollment||participants|Number|43|43.0||||||
3795475|NCT01830543|3624498|B3|Turkey||Region of Enrollment||participants|Number|18|18.0||||||
3795476|NCT01830543|3624499|B2|Turkey||Region of Enrollment||participants|Number|14|14.0||||||
3795477|NCT01830543|3624500|B1|Turkey||Region of Enrollment||participants|Number|11|11.0||||||
3795478|NCT01830543|3624497|B4|Taiwan, Province of China||Region of Enrollment||participants|Number|25|25.0||||||
3795479|NCT01830543|3624498|B3|Taiwan, Province of China||Region of Enrollment||participants|Number|9|9.0||||||
3795480|NCT01830543|3624499|B2|Taiwan, Province of China||Region of Enrollment||participants|Number|8|8.0||||||
3795481|NCT01830543|3624500|B1|Taiwan, Province of China||Region of Enrollment||participants|Number|8|8.0||||||
3795482|NCT01830543|3624497|B4|Sweden||Region of Enrollment||participants|Number|47|47.0||||||
3795483|NCT01830543|3624498|B3|Sweden||Region of Enrollment||participants|Number|18|18.0||||||
3795484|NCT01830543|3624499|B2|Sweden||Region of Enrollment||participants|Number|14|14.0||||||
3795485|NCT01830543|3624500|B1|Sweden||Region of Enrollment||participants|Number|15|15.0||||||
3795486|NCT01830543|3624497|B4|Russian Federation||Region of Enrollment||participants|Number|265|265.0||||||
3795487|NCT01830543|3624498|B3|Russian Federation||Region of Enrollment||participants|Number|89|89.0||||||
3795488|NCT01830543|3624499|B2|Russian Federation||Region of Enrollment||participants|Number|86|86.0||||||
3795489|NCT01830543|3624500|B1|Russian Federation||Region of Enrollment||participants|Number|90|90.0||||||
3795490|NCT01830543|3624497|B4|Romania||Region of Enrollment||participants|Number|50|50.0||||||
3795493|NCT01830543|3624500|B1|Romania||Region of Enrollment||participants|Number|15|15.0||||||
3795494|NCT01830543|3624497|B4|Poland||Region of Enrollment||participants|Number|218|218.0||||||
3795495|NCT01830543|3624498|B3|Poland||Region of Enrollment||participants|Number|69|69.0||||||
3795496|NCT01830543|3624499|B2|Poland||Region of Enrollment||participants|Number|78|78.0||||||
3795497|NCT01830543|3624500|B1|Poland||Region of Enrollment||participants|Number|71|71.0||||||
3795498|NCT01830543|3624497|B4|Netherlands||Region of Enrollment||participants|Number|68|68.0||||||
3795499|NCT01830543|3624498|B3|Netherlands||Region of Enrollment||participants|Number|27|27.0||||||
3795500|NCT01830543|3624499|B2|Netherlands||Region of Enrollment||participants|Number|17|17.0||||||
3795501|NCT01830543|3624500|B1|Netherlands||Region of Enrollment||participants|Number|24|24.0||||||
3795502|NCT01830543|3624497|B4|Mexico||Region of Enrollment||participants|Number|13|13.0||||||
3795503|NCT01830543|3624498|B3|Mexico||Region of Enrollment||participants|Number|3|3.0||||||
3795504|NCT01830543|3624499|B2|Mexico||Region of Enrollment||participants|Number|3|3.0||||||
3795505|NCT01830543|3624500|B1|Mexico||Region of Enrollment||participants|Number|7|7.0||||||
3795506|NCT01830543|3624497|B4|Malaysia||Region of Enrollment||participants|Number|11|11.0||||||
3795507|NCT01830543|3624498|B3|Malaysia||Region of Enrollment||participants|Number|5|5.0||||||
3795508|NCT01830543|3624499|B2|Malaysia||Region of Enrollment||participants|Number|5|5.0||||||
3795509|NCT01830543|3624500|B1|Malaysia||Region of Enrollment||participants|Number|1|1.0||||||
3795510|NCT01830543|3624497|B4|Korea, Republic of||Region of Enrollment||participants|Number|39|39.0||||||
3795511|NCT01830543|3624498|B3|Korea, Republic of||Region of Enrollment||participants|Number|17|17.0||||||
3795512|NCT01830543|3624499|B2|Korea, Republic of||Region of Enrollment||participants|Number|11|11.0||||||
3795513|NCT01830543|3624500|B1|Korea, Republic of||Region of Enrollment||participants|Number|11|11.0||||||
3795514|NCT01830543|3624497|B4|Italy||Region of Enrollment||participants|Number|72|72.0||||||
3795515|NCT01830543|3624498|B3|Italy||Region of Enrollment||participants|Number|20|20.0||||||
3795516|NCT01830543|3624499|B2|Italy||Region of Enrollment||participants|Number|26|26.0||||||
3795517|NCT01830543|3624500|B1|Italy||Region of Enrollment||participants|Number|26|26.0||||||
3795518|NCT01830543|3624497|B4|Germany||Region of Enrollment||participants|Number|295|295.0||||||
3795519|NCT01830543|3624498|B3|Germany||Region of Enrollment||participants|Number|101|101.0||||||
3795520|NCT01830543|3624499|B2|Germany||Region of Enrollment||participants|Number|98|98.0||||||
3795521|NCT01830543|3624500|B1|Germany||Region of Enrollment||participants|Number|96|96.0||||||
3795522|NCT01830543|3624497|B4|France||Region of Enrollment||participants|Number|84|84.0||||||
3795523|NCT01830543|3624498|B3|France||Region of Enrollment||participants|Number|25|25.0||||||
3795524|NCT01830543|3624499|B2|France||Region of Enrollment||participants|Number|26|26.0||||||
3795525|NCT01830543|3624500|B1|France||Region of Enrollment||participants|Number|33|33.0||||||
3795526|NCT01830543|3624497|B4|Denmark||Region of Enrollment||participants|Number|12|12.0||||||
3795527|NCT01830543|3624498|B3|Denmark||Region of Enrollment||participants|Number|8|8.0||||||
3795528|NCT01830543|3624499|B2|Denmark||Region of Enrollment||participants|Number|2|2.0||||||
3795529|NCT01830543|3624500|B1|Denmark||Region of Enrollment||participants|Number|2|2.0||||||
3795530|NCT01830543|3624497|B4|Czech Republic||Region of Enrollment||participants|Number|40|40.0||||||
3795531|NCT01830543|3624498|B3|Czech Republic||Region of Enrollment||participants|Number|14|14.0||||||
3795532|NCT01830543|3624499|B2|Czech Republic||Region of Enrollment||participants|Number|9|9.0||||||
3795533|NCT01830543|3624500|B1|Czech Republic||Region of Enrollment||participants|Number|17|17.0||||||
3795534|NCT01830543|3624497|B4|Chile||Region of Enrollment||participants|Number|18|18.0||||||
3795535|NCT01830543|3624498|B3|Chile||Region of Enrollment||participants|Number|6|6.0||||||
3795536|NCT01830543|3624499|B2|Chile||Region of Enrollment||participants|Number|7|7.0||||||
3795537|NCT01830543|3624500|B1|Chile||Region of Enrollment||participants|Number|5|5.0||||||
3795538|NCT01830543|3624497|B4|Canada||Region of Enrollment||participants|Number|66|66.0||||||
3795539|NCT01830543|3624498|B3|Canada||Region of Enrollment||participants|Number|19|19.0||||||
3795540|NCT01830543|3624499|B2|Canada||Region of Enrollment||participants|Number|24|24.0||||||
3795541|NCT01830543|3624500|B1|Canada||Region of Enrollment||participants|Number|23|23.0||||||
3795542|NCT01830543|3624497|B4|Bulgaria||Region of Enrollment||participants|Number|221|221.0||||||
3795543|NCT01830543|3624498|B3|Bulgaria||Region of Enrollment||participants|Number|74|74.0||||||
3795544|NCT01830543|3624499|B2|Bulgaria||Region of Enrollment||participants|Number|80|80.0||||||
3795545|NCT01830543|3624500|B1|Bulgaria||Region of Enrollment||participants|Number|67|67.0||||||
3795546|NCT01830543|3624497|B4|Brazil||Region of Enrollment||participants|Number|41|41.0||||||
3795547|NCT01830543|3624498|B3|Brazil||Region of Enrollment||participants|Number|13|13.0||||||
3795548|NCT01830543|3624499|B2|Brazil||Region of Enrollment||participants|Number|14|14.0||||||
3795549|NCT01830543|3624500|B1|Brazil||Region of Enrollment||participants|Number|14|14.0||||||
3795550|NCT01830543|3624497|B4|Belgium||Region of Enrollment||participants|Number|52|52.0||||||
3795551|NCT01830543|3624498|B3|Belgium||Region of Enrollment||participants|Number|20|20.0||||||
3795552|NCT01830543|3624499|B2|Belgium||Region of Enrollment||participants|Number|18|18.0||||||
3795553|NCT01830543|3624500|B1|Belgium||Region of Enrollment||participants|Number|14|14.0||||||
3795554|NCT01830543|3624497|B4|Australia||Region of Enrollment||participants|Number|15|15.0||||||
3795555|NCT01830543|3624498|B3|Australia||Region of Enrollment||participants|Number|5|5.0||||||
3795556|NCT01830543|3624499|B2|Australia||Region of Enrollment||participants|Number|7|7.0||||||
3795557|NCT01830543|3624500|B1|Australia||Region of Enrollment||participants|Number|3|3.0||||||
3795558|NCT01830543|3624497|B4|Argentina||Region of Enrollment||participants|Number|82|82.0||||||
3795559|NCT01830543|3624498|B3|Argentina||Region of Enrollment||participants|Number|23|23.0||||||
3795560|NCT01830543|3624499|B2|Argentina||Region of Enrollment||participants|Number|27|27.0||||||
3795561|NCT01830543|3624500|B1|Argentina||Region of Enrollment||participants|Number|32|32.0||||||
3795562|NCT01830543|3624497|B4||Male|Sex: Female, Male||Participants|Count of Participants|1581|1581.0||||||
3795563|NCT01830543|3624498|B3||Male|Sex: Female, Male||Participants|Count of Participants|518|518.0||||||
3795564|NCT01830543|3624499|B2||Male|Sex: Female, Male||Participants|Count of Participants|535|535.0||||||
3795565|NCT01830543|3624500|B1||Male|Sex: Female, Male||Participants|Count of Participants|528|528.0||||||
3795566|NCT01830543|3624497|B4||Female|Sex: Female, Male||Participants|Count of Participants|543|543.0||||||
3795567|NCT01830543|3624498|B3||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3795568|NCT01830543|3624499|B2||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3795569|NCT01830543|3624500|B1||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
3795570|NCT01830543|3624497|B4|||Age||years|Mean|70.1|70.1|Standard Deviation|8.97|8.97|||
3795571|NCT01830543|3624498|B3|||Age||years|Mean|69.9|69.9|Standard Deviation|8.67|8.67|||
3795572|NCT01830543|3624499|B2|||Age||years|Mean|70|70.0|Standard Deviation|9.11|9.11|||
3795573|NCT01830543|3624500|B1|||Age||years|Mean|70.4|70.4|Standard Deviation|9.12|9.12|||
3795574|NCT01830205|3624534|B5|United States||Region of Enrollment||participants|Number|36|36.0||||||
3795575|NCT01830205|3624535|B4|United States||Region of Enrollment||participants|Number|12|12.0||||||
3795576|NCT01830205|3624536|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3795577|NCT01830205|3624537|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3795578|NCT01830205|3624538|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3795579|NCT01830205|3624534|B5||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3795580|NCT01830205|3624535|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3795581|NCT01830205|3624536|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3795582|NCT01830205|3624537|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3795583|NCT01830205|3624538|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3795584|NCT01830205|3624534|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3795585|NCT01830205|3624535|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3795586|NCT01830205|3624536|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3795587|NCT01830205|3624537|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3795588|NCT01830205|3624538|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3795589|NCT01830205|3624534|B5|||Age||years|Mean|53.9|53.9|Standard Deviation|12.6|12.6|||
3795590|NCT01830205|3624535|B4|||Age||years|Mean|49.0|49.0|Standard Deviation|11.7|11.7|||
3795591|NCT01830205|3624536|B3|||Age||years|Mean|66.3|66.3|Standard Deviation|9.9|9.9|||
3795592|NCT01830205|3624537|B2|||Age||years|Mean|62.0|62.0|Standard Deviation|12.6|12.6|||
3795593|NCT01830205|3624538|B1|||Age||years|Mean|48.6|48.6|Standard Deviation|8.5|8.5|||
3795594|NCT01830140|3624623|B3||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3795595|NCT01830140|3624624|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3795596|NCT01830140|3624625|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3795597|NCT01830140|3624623|B3||Female|Sex: Female, Male||Participants|Count of Participants|299|299.0||||||
3795598|NCT01830140|3624624|B2||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3795599|NCT01830140|3624625|B1||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3795600|NCT01830140|3624623|B3|≥65 years||Age, Customized||Participants|Number|265|265.0||||||
3795601|NCT01830140|3624624|B2|≥65 years||Age, Customized||Participants|Number|129|129.0||||||
3795602|NCT01830140|3624625|B1|≥65 years||Age, Customized||Participants|Number|136|136.0||||||
3795603|NCT01830140|3624623|B3|Between 45 and 65 years||Age, Customized||Participants|Number|188|188.0||||||
3795604|NCT01830140|3624624|B2|Between 45 and 65 years||Age, Customized||Participants|Number|97|97.0||||||
3795605|NCT01830140|3624625|B1|Between 45 and 65 years||Age, Customized||Participants|Number|91|91.0||||||
3795606|NCT01830140|3624623|B3|< 45 years||Age, Customized||Participants|Number|13|13.0||||||
3795607|NCT01830140|3624624|B2|< 45 years||Age, Customized||Participants|Number|7|7.0||||||
3795608|NCT01830140|3624625|B1|< 45 years||Age, Customized||Participants|Number|6|6.0||||||
3795609|NCT01830127|3624632|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3795610|NCT01830127|3624633|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3795611|NCT01830127|3624634|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3795612|NCT01830127|3624632|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3795613|NCT01830127|3624633|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3795614|NCT01830127|3624634|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3795615|NCT01830127|3624632|B3|||Age||Years|Mean|57.2|57.2|Standard Deviation|9.1|9.1|||
3795616|NCT01830127|3624633|B2|||Age||Years|Mean|56.6|56.6|Standard Deviation|9.7|9.7|||
3795617|NCT01830127|3624634|B1|||Age||Years|Mean|57.8|57.8|Standard Deviation|8.8|8.8|||
3795618|NCT01829919|3624643|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3795619|NCT01829919|3624643|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3795620|NCT01829919|3624643|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3795621|NCT01829919|3624643|B1|||Age||years|Mean|56.2|56.2|Standard Deviation|7.29|7.29|||
3795622|NCT01829919|3624643|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3795623|NCT01829919|3624643|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3795624|NCT01829919|3624643|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3795625|NCT01829711|3624659|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3795626|NCT01829711|3624659|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795627|NCT01829711|3624659|B1||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3795628|NCT01829711|3624659|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3795629|NCT01829711|3624659|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795630|NCT01829711|3624659|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3795631|NCT01829711|3624659|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795632|NCT01829711|3624659|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3795633|NCT01829711|3624659|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3795634|NCT01829711|3624659|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3795635|NCT01829711|3624659|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3795636|NCT01829711|3624659|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3795637|NCT01829711|3624659|B1|||Age||Years|Mean|60.3|60.3|Standard Deviation|11.9|11.9|||
3795638|NCT01829516|3624689|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3795639|NCT01829516|3624689|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3795640|NCT01829516|3624689|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3795641|NCT01829516|3624689|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3795642|NCT01829516|3624689|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3795643|NCT01829503|3624698|B1|||Platelets||10^9 cells per liter|Median|54.5|54.5|Full Range|||14.0|375.0|
3795644|NCT01829503|3624698|B1|||Peripheral Blood blasts (number of blasts/total white blood cell count)||percent|Median|13|13.0|Full Range|||0.0|91.0|
3795645|NCT01829503|3624698|B1|||Bone marrow blasts (number of blasts/total cells in bone marrow)||percent of total white blood cell count|Median|56.65|56.65|Full Range|||20.0|94.3|
3795646|NCT01829503|3624698|B1|||White Blood Cells (WBC)||10^9 white blood cells per liter|Median|5.25|5.25|Full Range|||1.0|104.0|
3795647|NCT01829503|3624698|B1|||Lactate dehydrogenase (LDH)||IU/L|Median|233|233.0|Full Range|||99.0|3314.0|
3795648|NCT01829503|3624698|B1|||Hematocrit (volume of red blood cells / total volume of blood)||percentage of total blood volume|Median|27.9|27.9|Full Range|||17.4|38.9|
3795649|NCT01829503|3624698|B1|||Creatinine||mg/dL|Median|0.97|0.97|Full Range|||0.4|3.5|
3795650|NCT01829503|3624698|B1|||Bilirubin||mg/dL|Median|0.8|0.8|Full Range|||0.3|11.8|
3795651|NCT01829503|3624698|B1|||Albumin||g/dL|Median|3.4|3.4|Full Range|||2.0|4.6|
3795652|NCT01829503|3624698|B1|No data for FLT3 and NPM1 status||FLT and NPM1 Status|FLT3 and NPM1 status was checked on 1 'Favorable', 8 'Intermediate-1' and 3 'Intermediate-2' patients|participants|Number|33|33.0||||||
3795653|NCT01829503|3624698|B1|FLT3-+/NPM1+||FLT and NPM1 Status|FLT3 and NPM1 status was checked on 1 'Favorable', 8 'Intermediate-1' and 3 'Intermediate-2' patients|participants|Number|2|2.0||||||
3795654|NCT01829503|3624698|B1|FLT3+/NPM1-||FLT and NPM1 Status|FLT3 and NPM1 status was checked on 1 'Favorable', 8 'Intermediate-1' and 3 'Intermediate-2' patients|participants|Number|2|2.0||||||
3795655|NCT01829503|3624698|B1|FLT3-/NPM1+||FLT and NPM1 Status|FLT3 and NPM1 status was checked on 1 'Favorable', 8 'Intermediate-1' and 3 'Intermediate-2' patients|participants|Number|2|2.0||||||
3795656|NCT01829503|3624698|B1|FLT3-/NPM1-||FLT and NPM1 Status|FLT3 and NPM1 status was checked on 1 'Favorable', 8 'Intermediate-1' and 3 'Intermediate-2' patients|participants|Number|3|3.0||||||
3795657|NCT01829503|3624698|B1|FLT3 D835+||FLT and NPM1 Status|FLT3 and NPM1 status was checked on 1 'Favorable', 8 'Intermediate-1' and 3 'Intermediate-2' patients|participants|Number|2|2.0||||||
3795658|NCT01829503|3624698|B1|Adverse||FLT (FMS-like tyrosine kinase 3) and NPM1 (nucleophosmin) gene Status|European LeukemiaNet (ELN) recommendations/classifications for diagnosis and management of acute myeloid leukemia (AML) - genetic mutational (+/-) status of NPM1, FLT3-ITD genes and D835 codon.|participants|Number|22|22.0||||||
3795659|NCT01829503|3624698|B1|Intermediate-2||FLT (FMS-like tyrosine kinase 3) and NPM1 (nucleophosmin) gene Status|European LeukemiaNet (ELN) recommendations/classifications for diagnosis and management of acute myeloid leukemia (AML) - genetic mutational (+/-) status of NPM1, FLT3-ITD genes and D835 codon.|participants|Number|3|3.0||||||
3795660|NCT01829503|3624698|B1|Intermediate-1||FLT (FMS-like tyrosine kinase 3) and NPM1 (nucleophosmin) gene Status|European LeukemiaNet (ELN) recommendations/classifications for diagnosis and management of acute myeloid leukemia (AML) - genetic mutational (+/-) status of NPM1, FLT3-ITD genes and D835 codon.|participants|Number|16|16.0||||||
3795661|NCT01829503|3624698|B1|Favorable||FLT (FMS-like tyrosine kinase 3) and NPM1 (nucleophosmin) gene Status|European LeukemiaNet (ELN) recommendations/classifications for diagnosis and management of acute myeloid leukemia (AML) - genetic mutational (+/-) status of NPM1, FLT3-ITD genes and D835 codon.|participants|Number|3|3.0||||||
3795662|NCT01829503|3624698|B1|>6||Charlson comorbidity index|Charlson comorbidity index predicts the one-year mortality for a patient who may have a range of comorbid conditions. Each condition is assigned a score of 1, 2, 3, or 6, depending on the risk of dying associated with each one. A score of >6 indicates metastatic disease/greater risk of death.|participants|Number|18|18.0||||||
3795701|NCT01829477|3624713|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3795702|NCT01829477|3624714|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3795663|NCT01829503|3624698|B1|6||Charlson comorbidity index|Charlson comorbidity index predicts the one-year mortality for a patient who may have a range of comorbid conditions. Each condition is assigned a score of 1, 2, 3, or 6, depending on the risk of dying associated with each one. A score of >6 indicates metastatic disease/greater risk of death.|participants|Number|20|20.0||||||
3795664|NCT01829503|3624698|B1|5||Charlson comorbidity index|Charlson comorbidity index predicts the one-year mortality for a patient who may have a range of comorbid conditions. Each condition is assigned a score of 1, 2, 3, or 6, depending on the risk of dying associated with each one. A score of >6 indicates metastatic disease/greater risk of death.|participants|Number|5|5.0||||||
3795665|NCT01829503|3624698|B1|4||Charlson comorbidity index|Charlson comorbidity index predicts the one-year mortality for a patient who may have a range of comorbid conditions. Each condition is assigned a score of 1, 2, 3, or 6, depending on the risk of dying associated with each one. A score of >6 indicates metastatic disease/greater risk of death.|participants|Number|1|1.0||||||
3795666|NCT01829503|3624698|B1|ECOG Status 2||Baseline ECOG Status|ECOG Scale (patient's level of functioning) ;0-Fully active, able to carry on all pre-disease performance without restriction;1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work;2-Ambulatory and capable of all selfcare but unable to carry out any work; activities. Up and about more than 50% of waking hours;3-Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours;4-Completely disabled. Cannot do any self-care. Totally confined to bed or chair; 5-death|participants|Number|13|13.0||||||
3795667|NCT01829503|3624698|B1|ECOG Status 1||Baseline ECOG Status|ECOG Scale (patient's level of functioning) ;0-Fully active, able to carry on all pre-disease performance without restriction;1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work;2-Ambulatory and capable of all selfcare but unable to carry out any work; activities. Up and about more than 50% of waking hours;3-Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours;4-Completely disabled. Cannot do any self-care. Totally confined to bed or chair; 5-death|participants|Number|24|24.0||||||
3795668|NCT01829503|3624698|B1|ECOG Status 0||Baseline ECOG Status|ECOG Scale (patient's level of functioning) ;0-Fully active, able to carry on all pre-disease performance without restriction;1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work;2-Ambulatory and capable of all selfcare but unable to carry out any work; activities. Up and about more than 50% of waking hours;3-Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours;4-Completely disabled. Cannot do any self-care. Totally confined to bed or chair; 5-death|participants|Number|7|7.0||||||
3795669|NCT01829503|3624698|B1|Treatment-Related AML||Acute myeloid leukemia (AML) Type||participants|Number|8|8.0||||||
3795670|NCT01829503|3624698|B1|Primary AML||Acute myeloid leukemia (AML) Type||participants|Number|12|12.0||||||
3795671|NCT01829503|3624698|B1|AML with MDS Changes||Acute myeloid leukemia (AML) Type||participants|Number|24|24.0||||||
3795672|NCT01829503|3624698|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795673|NCT01829503|3624698|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795674|NCT01829503|3624698|B1||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3795675|NCT01829503|3624698|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3795676|NCT01829503|3624698|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795677|NCT01829503|3624698|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795678|NCT01829503|3624698|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795679|NCT01829503|3624698|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3795680|NCT01829503|3624698|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3795681|NCT01829503|3624698|B1|||Age||years|Median|76.2|76.2|Full Range|||67.1|87.5|
3795682|NCT01829477|3624712|B3|Greater Than or Equal to (>=) 8.5%||Baseline Glycosylated Hemoglobin (HbA1c) Category||participants|Number|12|12.0||||||
3795683|NCT01829477|3624713|B2|Greater Than or Equal to (>=) 8.5%||Baseline Glycosylated Hemoglobin (HbA1c) Category||participants|Number|5|5.0||||||
3795684|NCT01829477|3624714|B1|Greater Than or Equal to (>=) 8.5%||Baseline Glycosylated Hemoglobin (HbA1c) Category||participants|Number|7|7.0||||||
3795685|NCT01829477|3624712|B3|Less Than (<) 8.5 Percent (%)||Baseline Glycosylated Hemoglobin (HbA1c) Category||participants|Number|21|21.0||||||
3795686|NCT01829477|3624713|B2|Less Than (<) 8.5 Percent (%)||Baseline Glycosylated Hemoglobin (HbA1c) Category||participants|Number|11|11.0||||||
3795687|NCT01829477|3624714|B1|Less Than (<) 8.5 Percent (%)||Baseline Glycosylated Hemoglobin (HbA1c) Category||participants|Number|10|10.0||||||
3795688|NCT01829477|3624712|B3|Not Applicable||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3795689|NCT01829477|3624713|B2|Not Applicable||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3795690|NCT01829477|3624714|B1|Not Applicable||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3795691|NCT01829477|3624712|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3795692|NCT01829477|3624713|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3795693|NCT01829477|3624714|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3795694|NCT01829477|3624712|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3795695|NCT01829477|3624713|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3795696|NCT01829477|3624714|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3795697|NCT01829477|3624712|B3|White||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3795698|NCT01829477|3624713|B2|White||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3795699|NCT01829477|3624714|B1|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3795700|NCT01829477|3624712|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3795703|NCT01829477|3624712|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3795704|NCT01829477|3624713|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3795705|NCT01829477|3624714|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3795706|NCT01829477|3624712|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3795707|NCT01829477|3624713|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3795708|NCT01829477|3624714|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3795709|NCT01829477|3624712|B3|65 to 84 years||Age, Customized||Participants|Number|11|11.0||||||
3795710|NCT01829477|3624713|B2|65 to 84 years||Age, Customized||Participants|Number|4|4.0||||||
3795711|NCT01829477|3624714|B1|65 to 84 years||Age, Customized||Participants|Number|7|7.0||||||
3795712|NCT01829477|3624712|B3|18 to 64 years||Age, Customized||Participants|Number|22|22.0||||||
3795713|NCT01829477|3624713|B2|18 to 64 years||Age, Customized||Participants|Number|12|12.0||9.70|9.7|||
3795714|NCT01829477|3624714|B1|18 to 64 years||Age, Customized||Participants|Number|10|10.0||11.82|11.82|||
3795715|NCT01829464|3624725|B4|||Duration of Diabetes||years|Mean|8.154|8.154|Standard Deviation|6.444|6.444|||
3795716|NCT01829464|3624726|B3|||Duration of Diabetes||years|Mean|6.406|6.406|Standard Deviation|4.390|4.39|||
3795717|NCT01829464|3624727|B2|||Duration of Diabetes||years|Mean|8.690|8.69|Standard Deviation|6.180|6.18|||
3795718|NCT01829464|3624728|B1|||Duration of Diabetes||years|Mean|9.291|9.291|Standard Deviation|8.039|8.039|||
3795719|NCT01829464|3624725|B4|>= 8.5%||Baseline Glycosylated Hemoglobin (HbA1c) Category||Participants|Number|43|43.0||||||
3795720|NCT01829464|3624726|B3|>= 8.5%||Baseline Glycosylated Hemoglobin (HbA1c) Category||Participants|Number|14|14.0||||||
3795721|NCT01829464|3624727|B2|>= 8.5%||Baseline Glycosylated Hemoglobin (HbA1c) Category||Participants|Number|15|15.0||||||
3795722|NCT01829464|3624728|B1|>= 8.5%||Baseline Glycosylated Hemoglobin (HbA1c) Category||Participants|Number|14|14.0||||||
3795723|NCT01829464|3624725|B4|< 8.5 percent (%)||Baseline Glycosylated Hemoglobin (HbA1c) Category||Participants|Number|47|47.0||||||
3795724|NCT01829464|3624726|B3|< 8.5 percent (%)||Baseline Glycosylated Hemoglobin (HbA1c) Category||Participants|Number|15|15.0||||||
3795725|NCT01829464|3624727|B2|< 8.5 percent (%)||Baseline Glycosylated Hemoglobin (HbA1c) Category||Participants|Number|16|16.0||||||
3795726|NCT01829464|3624728|B1|< 8.5 percent (%)||Baseline Glycosylated Hemoglobin (HbA1c) Category||Participants|Number|16|16.0||||||
3795727|NCT01829464|3624725|B4|Ex-smoker||Smoking Classification||Participants|Number|18|18.0||||||
3795728|NCT01829464|3624726|B3|Ex-smoker||Smoking Classification||Participants|Number|6|6.0||||||
3795729|NCT01829464|3624727|B2|Ex-smoker||Smoking Classification||Participants|Number|7|7.0||||||
3795730|NCT01829464|3624728|B1|Ex-smoker||Smoking Classification||Participants|Number|5|5.0||||||
3795731|NCT01829464|3624725|B4|Current smoker||Smoking Classification||Participants|Number|13|13.0||||||
3795732|NCT01829464|3624726|B3|Current smoker||Smoking Classification||Participants|Number|1|1.0||||||
3795733|NCT01829464|3624727|B2|Current smoker||Smoking Classification||Participants|Number|5|5.0||||||
3795734|NCT01829464|3624728|B1|Current smoker||Smoking Classification||Participants|Number|7|7.0||||||
3795735|NCT01829464|3624725|B4|Never smoked||Smoking Classification||Participants|Number|59|59.0||||||
3795736|NCT01829464|3624726|B3|Never smoked||Smoking Classification||Participants|Number|22|22.0||||||
3795737|NCT01829464|3624727|B2|Never smoked||Smoking Classification||Participants|Number|19|19.0||||||
3795738|NCT01829464|3624728|B1|Never smoked||Smoking Classification||Participants|Number|18|18.0||||||
3795739|NCT01829464|3624725|B4|||Region of Enrollment|Enrollment in the United States is reported.|Participants|Number|90|90.0||||||
3795740|NCT01829464|3624726|B3|||Region of Enrollment|Enrollment in the United States is reported.|Participants|Number|29|29.0||||||
3795741|NCT01829464|3624727|B2|||Region of Enrollment|Enrollment in the United States is reported.|Participants|Number|31|31.0||||||
3795742|NCT01829464|3624728|B1|||Region of Enrollment|Enrollment in the United States is reported.|Participants|Number|30|30.0||||||
3795743|NCT01829464|3624725|B4|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|33.23|33.23|Standard Deviation|5.286|5.286|||
3795744|NCT01829464|3624726|B3|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|33.10|33.1|Standard Deviation|4.315|4.315|||
3795745|NCT01829464|3624727|B2|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|32.12|32.12|Standard Deviation|5.664|5.664|||
3795746|NCT01829464|3624728|B1|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|34.49|34.49|Standard Deviation|5.623|5.623|||
3795747|NCT01829464|3624725|B4|||Height||centimeter (cm)|Mean|168.0|168.0|Standard Deviation|9.96|9.96|||
3795748|NCT01829464|3624726|B3|||Height||centimeter (cm)|Mean|166.8|166.8|Standard Deviation|10.76|10.76|||
3795749|NCT01829464|3624727|B2|||Height||centimeter (cm)|Mean|169.0|169.0|Standard Deviation|10.02|10.02|||
3795750|NCT01829464|3624728|B1|||Height||centimeter (cm)|Mean|168.3|168.3|Standard Deviation|9.26|9.26|||
3795751|NCT01829464|3624725|B4|More than 1 race (multiracial)||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3795752|NCT01829464|3624726|B3|More than 1 race (multiracial)||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3795753|NCT01829464|3624727|B2|More than 1 race (multiracial)||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3795754|NCT01829464|3624728|B1|More than 1 race (multiracial)||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3795755|NCT01829464|3624725|B4|White||Race/Ethnicity, Customized||Participants|Number|77|77.0||||||
3795756|NCT01829464|3624726|B3|White||Race/Ethnicity, Customized||Participants|Number|26|26.0||||||
3795757|NCT01829464|3624727|B2|White||Race/Ethnicity, Customized||Participants|Number|26|26.0||||||
3795758|NCT01829464|3624728|B1|White||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
3795759|NCT01829464|3624725|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3795760|NCT01829464|3624726|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3795761|NCT01829464|3624727|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3795762|NCT01829464|3624728|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3795763|NCT01829464|3624725|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3795764|NCT01829464|3624726|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3795765|NCT01829464|3624727|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3795766|NCT01829464|3624728|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3795767|NCT01829464|3624725|B4|Asian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3795768|NCT01829464|3624726|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3795769|NCT01829464|3624727|B2|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3795770|NCT01829464|3624728|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3795771|NCT01829464|3624725|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|68|68.0||||||
3795772|NCT01829464|3624726|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
3795773|NCT01829464|3624727|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
3795774|NCT01829464|3624728|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
3795775|NCT01829464|3624725|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
3795776|NCT01829464|3624726|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3795777|NCT01829464|3624727|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3795778|NCT01829464|3624728|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3795779|NCT01829464|3624725|B4|Male||Sex/Gender, Customized||Participants|Number|47|47.0||||||
3795780|NCT01829464|3624726|B3|Male||Sex/Gender, Customized||Participants|Number|13|13.0||||||
3795781|NCT01829464|3624727|B2|Male||Sex/Gender, Customized||Participants|Number|18|18.0||||||
3795782|NCT01829464|3624728|B1|Male||Sex/Gender, Customized||Participants|Number|16|16.0||||||
3795783|NCT01829464|3624725|B4|Female||Sex/Gender, Customized||Participants|Number|43|43.0||||||
3795784|NCT01829464|3624726|B3|Female||Sex/Gender, Customized||Participants|Number|16|16.0||||||
3795785|NCT01829464|3624727|B2|Female||Sex/Gender, Customized||Participants|Number|13|13.0||||||
3795786|NCT01829464|3624728|B1|Female||Sex/Gender, Customized||Participants|Number|14|14.0||||||
3795787|NCT01829464|3624725|B4|>= 65 years||Age, Customized||Participants|Number|17|17.0||||||
3795788|NCT01829464|3624726|B3|>= 65 years||Age, Customized||Participants|Number|5|5.0||||||
3795789|NCT01829464|3624727|B2|>= 65 years||Age, Customized||Participants|Number|4|4.0||||||
3795790|NCT01829464|3624728|B1|>= 65 years||Age, Customized||Participants|Number|8|8.0||||||
3795791|NCT01829464|3624725|B4|Less than (<) 65 years||Age, Customized||Participants|Number|73|73.0||||||
3795792|NCT01829464|3624726|B3|Less than (<) 65 years||Age, Customized||Participants|Number|24|24.0||||||
3795793|NCT01829464|3624727|B2|Less than (<) 65 years||Age, Customized||Participants|Number|27|27.0||||||
3795794|NCT01829464|3624728|B1|Less than (<) 65 years||Age, Customized||Participants|Number|22|22.0||||||
3795795|NCT01829464|3624725|B4|||Age||Years|Mean|54.8|54.8|Standard Deviation|10.38|10.38|||
3795796|NCT01829464|3624726|B3|||Age||Years|Mean|55.2|55.2|Standard Deviation|8.57|8.57|||
3795797|NCT01829464|3624727|B2|||Age||Years|Mean|52.4|52.4|Standard Deviation|11.61|11.61|||
3795798|NCT01829464|3624728|B1|||Age||Years|Mean|57.0|57.0|Standard Deviation|10.45|10.45|||
3795799|NCT01829399|3624744|B3|Non-Dominant Arm||Arm Dominance|Since clinical tourniquet application may be on the patients dominant arm or non-dominant arm, participants were stratified according to dominant or non-dominant arm in order to make the results of this study more generalisable.|participants|Number|12|12.0||||||
3795800|NCT01829399|3624745|B2|Non-Dominant Arm||Arm Dominance|Since clinical tourniquet application may be on the patients dominant arm or non-dominant arm, participants were stratified according to dominant or non-dominant arm in order to make the results of this study more generalisable.|participants|Number|6|6.0||||||
3795801|NCT01829399|3624746|B1|Non-Dominant Arm||Arm Dominance|Since clinical tourniquet application may be on the patients dominant arm or non-dominant arm, participants were stratified according to dominant or non-dominant arm in order to make the results of this study more generalisable.|participants|Number|6|6.0||||||
3795802|NCT01829399|3624744|B3|Dominant Arm||Arm Dominance|Since clinical tourniquet application may be on the patients dominant arm or non-dominant arm, participants were stratified according to dominant or non-dominant arm in order to make the results of this study more generalisable.|participants|Number|12|12.0||||||
3795803|NCT01829399|3624745|B2|Dominant Arm||Arm Dominance|Since clinical tourniquet application may be on the patients dominant arm or non-dominant arm, participants were stratified according to dominant or non-dominant arm in order to make the results of this study more generalisable.|participants|Number|6|6.0||||||
3795804|NCT01829399|3624746|B1|Dominant Arm||Arm Dominance|Since clinical tourniquet application may be on the patients dominant arm or non-dominant arm, participants were stratified according to dominant or non-dominant arm in order to make the results of this study more generalisable.|participants|Number|6|6.0||||||
3795805|NCT01829399|3624744|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
3795806|NCT01829399|3624745|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3795807|NCT01829399|3624746|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3795808|NCT01829399|3624744|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3795809|NCT01829399|3624745|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3795810|NCT01829399|3624746|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3795811|NCT01829399|3624744|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3795812|NCT01829399|3624745|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3795813|NCT01829399|3624746|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3795814|NCT01829399|3624744|B3|||Age||years|Mean|32.0|32.0|Standard Deviation|10.3|10.3|||
3795815|NCT01829399|3624745|B2|||Age||years|Mean|32.3|32.3|Standard Deviation|10.5|10.5|||
3795816|NCT01829399|3624746|B1|||Age||years|Mean|31.7|31.7|Standard Deviation|10.0|10.0|||
3795817|NCT01829399|3624744|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3795818|NCT01829399|3624745|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3795819|NCT01829399|3624746|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3795820|NCT01829399|3624744|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3795821|NCT01829399|3624745|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3795822|NCT01829399|3624746|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3795823|NCT01829399|3624744|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3795824|NCT01829399|3624745|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3795825|NCT01829399|3624746|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3795826|NCT01829243|3624755|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3795827|NCT01829243|3624755|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3795828|NCT01829243|3624755|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3795829|NCT01829243|3624755|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3795830|NCT01829243|3624755|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3795831|NCT01829243|3624755|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3795832|NCT01829243|3624755|B1|||Age||years|Mean|47.6|47.6|Standard Deviation|9.1|9.1|||
3795833|NCT01829230|3624768|B3|United States||Region of Enrollment||participants|Number|82|82.0||||||
3795834|NCT01829230|3624769|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
3795835|NCT01829230|3624770|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3795836|NCT01829230|3624768|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3795837|NCT01829230|3624769|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3795838|NCT01829230|3624770|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3795839|NCT01829230|3624768|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3795840|NCT01829230|3624769|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3795841|NCT01829230|3624770|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3795842|NCT01829230|3624768|B3|||Age||years|Mean|11.1|11.1|Standard Deviation|1.2|1.2|||
3795843|NCT01829230|3624769|B2|||Age||years|Mean|11.0|11.0|Standard Deviation|1.2|1.2|||
3795844|NCT01829230|3624770|B1|||Age||years|Mean|11.1|11.1|Standard Deviation|1.2|1.2|||
3795845|NCT01829230|3624768|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3795846|NCT01829230|3624769|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3795847|NCT01829230|3624770|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3795848|NCT01829230|3624768|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3795849|NCT01829230|3624769|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3795850|NCT01829230|3624770|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3795851|NCT01829230|3624768|B3||<=18 years|Age||Participants|Count of Participants|82|82.0||||||
3795852|NCT01829230|3624769|B2||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
3795853|NCT01829230|3624770|B1||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
3795854|NCT01829217|3624779|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3795855|NCT01829217|3624779|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795856|NCT01829217|3624779|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3795857|NCT01829217|3624779|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3795858|NCT01829217|3624779|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3795859|NCT01829217|3624779|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3795860|NCT01829217|3624779|B1|||Age||years|Median|67|67.0|Full Range|||53.0|76.0|
3795861|NCT01829191|3624783|B3|United States||Region of Enrollment||Participants|Count of Participants|127|127.0||||||
3795862|NCT01829191|3624784|B2|United States||Region of Enrollment||Participants|Count of Participants|64|64.0||||||
3795863|NCT01829191|3624785|B1|United States||Region of Enrollment||Participants|Count of Participants|63|63.0||||||
3795864|NCT01829191|3624783|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3795865|NCT01829191|3624784|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3795866|NCT01829191|3624785|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3795867|NCT01829191|3624783|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3795868|NCT01829191|3624784|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3795869|NCT01829191|3624785|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3795870|NCT01829191|3624783|B3|||Age||years|Mean|9.7|9.7|Standard Deviation|1.1|1.1|||
3795871|NCT01829191|3624784|B2|||Age||years|Mean|9.7|9.7|Standard Deviation|1.1|1.1|||
3795872|NCT01829191|3624785|B1|||Age||years|Mean|9.7|9.7|Standard Deviation|1.1|1.1|||
3795873|NCT01829191|3624783|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3795874|NCT01829191|3624784|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3795875|NCT01829191|3624785|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3795876|NCT01829191|3624783|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3795877|NCT01829191|3624784|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3795878|NCT01829191|3624785|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3795879|NCT01829191|3624783|B3||<=18 years|Age||Participants|Count of Participants|127|127.0||||||
3795880|NCT01829191|3624784|B2||<=18 years|Age||Participants|Count of Participants|64|64.0||||||
3795881|NCT01829191|3624785|B1||<=18 years|Age||Participants|Count of Participants|63|63.0||||||
3795882|NCT01829165|3624793|B3|||Hamilton Depression Rating Scale (HAM-D 24)|The Hamilton Depression Rating Scale (HAM-D) is a 24-item clinician-administered assessment utilized as a way of determining a patient's level of depression before, during, and after treatment. Subscale scores are 0-2 (10 questions), 0-3 (2 questions), and 0-4 (12 questions). Subscales are totaled for an overall score (range 0 -76). For the overall score and all subscales, lower scores correspond to fewer symptoms, and higher scores correspond more symptoms.|units on a scale|Mean|26.9|26.9|Standard Deviation|7.1|7.1|||
3795883|NCT01829165|3624794|B2|||Hamilton Depression Rating Scale (HAM-D 24)|The Hamilton Depression Rating Scale (HAM-D) is a 24-item clinician-administered assessment utilized as a way of determining a patient's level of depression before, during, and after treatment. Subscale scores are 0-2 (10 questions), 0-3 (2 questions), and 0-4 (12 questions). Subscales are totaled for an overall score (range 0 -76). For the overall score and all subscales, lower scores correspond to fewer symptoms, and higher scores correspond more symptoms.|units on a scale|Mean|26.2|26.2|Standard Deviation|5.9|5.9|||
3795884|NCT01829165|3624795|B1|||Hamilton Depression Rating Scale (HAM-D 24)|The Hamilton Depression Rating Scale (HAM-D) is a 24-item clinician-administered assessment utilized as a way of determining a patient's level of depression before, during, and after treatment. Subscale scores are 0-2 (10 questions), 0-3 (2 questions), and 0-4 (12 questions). Subscales are totaled for an overall score (range 0 -76). For the overall score and all subscales, lower scores correspond to fewer symptoms, and higher scores correspond more symptoms.|units on a scale|Mean|27.0|27.0|Standard Deviation|8.0|8.0|||
3795885|NCT01829165|3624793|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795886|NCT01829165|3624794|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795887|NCT01829165|3624795|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795888|NCT01829165|3624793|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3795889|NCT01829165|3624794|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3795890|NCT01829165|3624795|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795891|NCT01829165|3624793|B3||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3795892|NCT01829165|3624794|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3795893|NCT01829165|3624795|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3795894|NCT01829165|3624793|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3795895|NCT01829165|3624794|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795896|NCT01829165|3624795|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3795897|NCT01829165|3624793|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795898|NCT01829165|3624794|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795899|NCT01829165|3624795|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795900|NCT01829165|3624793|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3795901|NCT01829165|3624794|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3795902|NCT01829165|3624795|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3795903|NCT01829165|3624793|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795904|NCT01829165|3624794|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795905|NCT01829165|3624795|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795906|NCT01829165|3624793|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3795907|NCT01829165|3624794|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3795908|NCT01829165|3624795|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3795909|NCT01829165|3624793|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3795910|NCT01829165|3624794|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3795911|NCT01829165|3624795|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3795912|NCT01829165|3624793|B3|||Age||years|Mean|36.2|36.2|Standard Deviation|8.9|8.9|||
3795913|NCT01829165|3624794|B2|||Age||years|Mean|35.0|35.0|Standard Deviation|6.5|6.5|||
3795914|NCT01829165|3624795|B1|||Age||years|Mean|37.2|37.2|Standard Deviation|11.2|11.2|||
3795915|NCT01829165|3624793|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3795916|NCT01829165|3624794|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3795917|NCT01829165|3624795|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3795918|NCT01829165|3624793|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3795919|NCT01829165|3624794|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3795920|NCT01829165|3624795|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3795921|NCT01829165|3624793|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3795922|NCT01829165|3624794|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3795923|NCT01829165|3624795|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3795924|NCT01829113|3624802|B3|United States||Region of Enrollment||Participants|Count of Participants|155|155.0||||||
3795925|NCT01829113|3624803|B2|United States||Region of Enrollment||Participants|Count of Participants|78|78.0||||||
3795926|NCT01829113|3624804|B1|United States||Region of Enrollment||Participants|Count of Participants|77|77.0||||||
3795927|NCT01829113|3624802|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795928|NCT01829113|3624803|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795929|NCT01829113|3624804|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795930|NCT01829113|3624802|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795931|NCT01829113|3624803|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795932|NCT01829113|3624804|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795933|NCT01829113|3624802|B3||White|Race (NIH/OMB)||Participants|Count of Participants|141|141.0||||||
3795934|NCT01829113|3624803|B2||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3795935|NCT01829113|3624804|B1||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3795936|NCT01829113|3624802|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3795937|NCT01829113|3624803|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3795938|NCT01829113|3624804|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3795939|NCT01829113|3624802|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795940|NCT01829113|3624803|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795941|NCT01829113|3624804|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795942|NCT01829113|3624802|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3795943|NCT01829113|3624803|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3795944|NCT01829113|3624804|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795945|NCT01829113|3624802|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795946|NCT01829113|3624803|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795947|NCT01829113|3624804|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3795948|NCT01829113|3624802|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3795949|NCT01829113|3624803|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3795950|NCT01829113|3624804|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3795951|NCT01829113|3624802|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3795952|NCT01829113|3624803|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3795953|NCT01829113|3624804|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3795954|NCT01829113|3624802|B3|||Age||years|Median|66|66.0|Full Range|||32.0|82.0|
3795955|NCT01829113|3624803|B2|||Age||years|Median|67|67.0|Full Range|||38.0|82.0|
3795956|NCT01829113|3624804|B1|||Age||years|Median|66|66.0|Full Range|||32.0|82.0|
3795957|NCT01829113|3624802|B3||>=65 years|Age||Participants|Count of Participants|91|91.0||||||
3795958|NCT01829113|3624803|B2||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
3795959|NCT01829113|3624804|B1||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
3795960|NCT01829113|3624802|B3||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
3795961|NCT01829113|3624803|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3795962|NCT01829113|3624804|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3795963|NCT01829113|3624802|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3795964|NCT01829113|3624803|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3795965|NCT01829113|3624804|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3795966|NCT01829048|3624817|B6||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3795967|NCT01829048|3624818|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3795968|NCT01829048|3624819|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3795969|NCT01829048|3624820|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3795970|NCT01829048|3624821|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3795971|NCT01829048|3624822|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3795972|NCT01829048|3624817|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3795973|NCT01829048|3624818|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3795974|NCT01829048|3624819|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3795975|NCT01829048|3624820|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3795976|NCT01829048|3624821|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3795977|NCT01829048|3624822|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3795978|NCT01829048|3624817|B6|Greater or equal to (>=) 65||Age, Customized||participants|Number|0|0.0||||||
3795979|NCT01829048|3624818|B5|Greater or equal to (>=) 65||Age, Customized||participants|Number|0|0.0||||||
3795980|NCT01829048|3624819|B4|Greater or equal to (>=) 65||Age, Customized||participants|Number|0|0.0||||||
3795981|NCT01829048|3624820|B3|Greater or equal to (>=) 65||Age, Customized||participants|Number|0|0.0||||||
3795982|NCT01829048|3624821|B2|Greater or equal to (>=) 65||Age, Customized||participants|Number|0|0.0||||||
3795983|NCT01829048|3624822|B1|Greater or equal to (>=) 65||Age, Customized||participants|Number|0|0.0||||||
3795984|NCT01829048|3624817|B6|45-64||Age, Customized||participants|Number|21|21.0||||||
3795985|NCT01829048|3624818|B5|45-64||Age, Customized||participants|Number|0|0.0||||||
3795986|NCT01829048|3624819|B4|45-64||Age, Customized||participants|Number|9|9.0||||||
3795987|NCT01829048|3624820|B3|45-64||Age, Customized||participants|Number|6|6.0||||||
3795988|NCT01829048|3624821|B2|45-64||Age, Customized||participants|Number|1|1.0||||||
3795989|NCT01829048|3624822|B1|45-64||Age, Customized||participants|Number|5|5.0||||||
3795990|NCT01829048|3624817|B6|18-44 years||Age, Customized||participants|Number|16|16.0||||||
3795991|NCT01829048|3624818|B5|18-44 years||Age, Customized||participants|Number|2|2.0||||||
3795992|NCT01829048|3624819|B4|18-44 years||Age, Customized||participants|Number|5|5.0||||||
3795993|NCT01829048|3624820|B3|18-44 years||Age, Customized||participants|Number|1|1.0||||||
3795994|NCT01829048|3624821|B2|18-44 years||Age, Customized||participants|Number|7|7.0||||||
3795995|NCT01829048|3624822|B1|18-44 years||Age, Customized||participants|Number|1|1.0||||||
3795996|NCT01829048|3624817|B6|less than (<) 18 years||Age, Customized||participants|Number|0|0.0||||||
3795997|NCT01829048|3624818|B5|less than (<) 18 years||Age, Customized||participants|Number|0|0.0||||||
3795998|NCT01829048|3624819|B4|less than (<) 18 years||Age, Customized||participants|Number|0|0.0||||||
3795999|NCT01829048|3624820|B3|less than (<) 18 years||Age, Customized||participants|Number|0|0.0||||||
3796000|NCT01829048|3624821|B2|less than (<) 18 years||Age, Customized||participants|Number|0|0.0||||||
3796001|NCT01829048|3624822|B1|less than (<) 18 years||Age, Customized||participants|Number|0|0.0||||||
3796002|NCT01828983|3624898|B3|United States||Region of Enrollment||Participants|Count of Participants|161|161.0||||||
3796003|NCT01828983|3624899|B2|United States||Region of Enrollment||Participants|Count of Participants|81|81.0||||||
3796004|NCT01828983|3624900|B1|United States||Region of Enrollment||Participants|Count of Participants|80|80.0||||||
3796005|NCT01828983|3624898|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3796006|NCT01828983|3624899|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3796007|NCT01828983|3624900|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3796008|NCT01828983|3624898|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796009|NCT01828983|3624899|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796010|NCT01828983|3624900|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796011|NCT01828983|3624898|B3||White|Race (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
3796012|NCT01828983|3624899|B2||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3796013|NCT01828983|3624900|B1||White|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3796014|NCT01828983|3624898|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3796015|NCT01828983|3624899|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3796016|NCT01828983|3624900|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3796017|NCT01828983|3624898|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796018|NCT01828983|3624899|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796019|NCT01828983|3624900|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796020|NCT01828983|3624898|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3796021|NCT01828983|3624899|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3796022|NCT01828983|3624900|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3796023|NCT01828983|3624898|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3796024|NCT01828983|3624899|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3796025|NCT01828983|3624900|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3796026|NCT01828983|3624898|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796027|NCT01828983|3624899|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796028|NCT01828983|3624900|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796029|NCT01828983|3624898|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|136|136.0||||||
3796030|NCT01828983|3624899|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3796031|NCT01828983|3624900|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3796032|NCT01828983|3624898|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3796033|NCT01828983|3624899|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3796034|NCT01828983|3624900|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3796035|NCT01828983|3624898|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3796036|NCT01828983|3624899|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3796037|NCT01828983|3624900|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3796038|NCT01828983|3624898|B3||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3796039|NCT01828983|3624899|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3796040|NCT01828983|3624900|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3796041|NCT01828983|3624898|B3|||Age||years|Mean|35.6|35.6|Standard Deviation|8.2|8.2|||
3796042|NCT01828983|3624899|B2|||Age||years|Mean|35.5|35.5|Standard Deviation|8.4|8.4|||
3796043|NCT01828983|3624900|B1|||Age||years|Mean|35.6|35.6|Standard Deviation|8.4|8.4|||
3796044|NCT01828593|3624911|B4|||Plasma viral load||copies/mL|Mean|26|26.0|Standard Deviation|21|21.0|||
3796045|NCT01828593|3624912|B3|||Plasma viral load||copies/mL|Mean|28|28.0|Standard Deviation|28|28.0|||
3796046|NCT01828593|3624913|B2|||Plasma viral load||copies/mL|Mean|27|27.0|Standard Deviation|22|22.0|||
3796047|NCT01828593|3624914|B1|||Plasma viral load||copies/mL|Mean|24|24.0|Standard Deviation|11|11.0|||
3796048|NCT01828593|3624911|B4|||Baseline Plasma CD4+ cell count||cells/microliter|Mean|682|682.0|Standard Deviation|317|317.0|||
3796049|NCT01828593|3624912|B3|||Baseline Plasma CD4+ cell count||cells/microliter|Mean|671|671.0|Standard Deviation|319|319.0|||
3796050|NCT01828593|3624913|B2|||Baseline Plasma CD4+ cell count||cells/microliter|Mean|746|746.0|Standard Deviation|324|324.0|||
3796051|NCT01828593|3624914|B1|||Baseline Plasma CD4+ cell count||cells/microliter|Mean|629|629.0|Standard Deviation|307|307.0|||
3796052|NCT01828593|3624911|B4|||Years with HIV-associated diarrhea||years|Mean|5.9|5.9|Standard Deviation|6.54|6.54|||
3796053|NCT01828593|3624912|B3|||Years with HIV-associated diarrhea||years|Mean|6.6|6.6|Standard Deviation|6.7|6.7|||
3796054|NCT01828593|3624913|B2|||Years with HIV-associated diarrhea||years|Mean|6.9|6.9|Standard Deviation|7.3|7.3|||
3796055|NCT01828593|3624914|B1|||Years with HIV-associated diarrhea||years|Mean|4.4|4.4|Standard Deviation|5.4|5.4|||
3796056|NCT01828593|3624911|B4|||Years with HIV||years|Mean|16.9|16.9|Standard Deviation|6.76|6.76|||
3796057|NCT01828593|3624912|B3|||Years with HIV||years|Mean|17.9|17.9|Standard Deviation|6.3|6.3|||
3796058|NCT01828593|3624913|B2|||Years with HIV||years|Mean|16.9|16.9|Standard Deviation|6.3|6.3|||
3796059|NCT01828593|3624914|B1|||Years with HIV||years|Mean|16|16.0|Standard Deviation|7.6|7.6|||
3796060|NCT01828593|3624911|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796061|NCT01828593|3624912|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796062|NCT01828593|3624913|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796063|NCT01828593|3624914|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796064|NCT01828593|3624911|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796065|NCT01828593|3624912|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796066|NCT01828593|3624913|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796067|NCT01828593|3624914|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796068|NCT01828593|3624911|B4||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3796069|NCT01828593|3624912|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3796070|NCT01828593|3624913|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3796071|NCT01828593|3624914|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3796072|NCT01828593|3624911|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3796073|NCT01828593|3624912|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3796074|NCT01828593|3624913|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3796075|NCT01828593|3624914|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3796076|NCT01828593|3624911|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796077|NCT01828593|3624912|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796078|NCT01828593|3624913|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796079|NCT01828593|3624914|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796080|NCT01828593|3624911|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3796081|NCT01828593|3624912|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3796082|NCT01828593|3624913|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796083|NCT01828593|3624914|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3796084|NCT01828593|3624911|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796085|NCT01828593|3624912|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796086|NCT01828593|3624913|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796087|NCT01828593|3624914|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796088|NCT01828593|3624911|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796089|NCT01828593|3624912|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796090|NCT01828593|3624913|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796091|NCT01828593|3624914|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796092|NCT01828593|3624911|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
3796093|NCT01828593|3624912|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3796094|NCT01828593|3624913|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3796095|NCT01828593|3624914|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3796096|NCT01828593|3624911|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3796097|NCT01828593|3624912|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3796098|NCT01828593|3624913|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3796099|NCT01828593|3624914|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3796100|NCT01828593|3624911|B4||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3796101|NCT01828593|3624912|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3796102|NCT01828593|3624913|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3796103|NCT01828593|3624914|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3796104|NCT01828593|3624911|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3796105|NCT01828593|3624912|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3796106|NCT01828593|3624913|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3796107|NCT01828593|3624914|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3796108|NCT01828593|3624911|B4|||Age||years|Mean|51.1|51.1|Standard Deviation|7.1|7.1|||
3796109|NCT01828593|3624912|B3|||Age||years|Mean|50.7|50.7|Standard Deviation|8|8.0|||
3796110|NCT01828593|3624913|B2|||Age||years|Mean|50.9|50.9|Standard Deviation|6.7|6.7|||
3796111|NCT01828593|3624914|B1|||Age||years|Mean|51.8|51.8|Standard Deviation|6.8|6.8|||
3796112|NCT01828567|3624937|B3|United States||Region of Enrollment||Participants|Count of Participants|417|417.0||||||
3796113|NCT01828567|3624938|B2|United States||Region of Enrollment||Participants|Count of Participants|209|209.0||||||
3796114|NCT01828567|3624939|B1|United States||Region of Enrollment||Participants|Count of Participants|208|208.0||||||
3796115|NCT01828567|3624937|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
3796116|NCT01828567|3624938|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3796117|NCT01828567|3624939|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3796118|NCT01828567|3624937|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|209|209.0||||||
3796119|NCT01828567|3624938|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|110|110.0||||||
3796120|NCT01828567|3624939|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|99|99.0||||||
3796121|NCT01828567|3624937|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|169|169.0||||||
3796122|NCT01828567|3624938|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|79|79.0||||||
3796123|NCT01828567|3624939|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|90|90.0||||||
3796124|NCT01828567|3624937|B3||Male|Sex: Female, Male||Participants|Count of Participants|356|356.0||||||
3796125|NCT01828567|3624938|B2||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3796126|NCT01828567|3624939|B1||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3796127|NCT01828567|3624937|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3796128|NCT01828567|3624938|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3796129|NCT01828567|3624939|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3796130|NCT01828567|3624937|B3|||Age||years|Mean|55.8|55.8|Standard Deviation|12.2|12.2|||
3796131|NCT01828567|3624938|B2|||Age||years|Mean|56.3|56.3|Standard Deviation|11.7|11.7|||
3796132|NCT01828567|3624939|B1|||Age||years|Mean|55.3|55.3|Standard Deviation|12.7|12.7|||
3796133|NCT01828515|3624956|B1|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3796134|NCT01828515|3624956|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796135|NCT01828515|3624956|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3796136|NCT01828515|3624956|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3796137|NCT01828515|3624956|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3796138|NCT01828515|3624956|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796139|NCT01828515|3624956|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3796140|NCT01828515|3624956|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796141|NCT01828515|3624956|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796142|NCT01828515|3624956|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3796143|NCT01828515|3624956|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3796144|NCT01828515|3624956|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3796145|NCT01828515|3624956|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3796146|NCT01828515|3624956|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3796147|NCT01828515|3624956|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3796148|NCT01828515|3624956|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3796149|NCT01828476|3624963|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
3796150|NCT01828476|3624965|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3796151|NCT01828476|3624963|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3796152|NCT01828476|3624965|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3796153|NCT01828476|3624963|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3796154|NCT01828476|3624965|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3796155|NCT01828476|3624963|B3|||Age||years|Median|69|69.0|Full Range|||48.0|82.0|
3796156|NCT01828476|3624965|B1|||Age||years|Median|69|69.0|Full Range|||48.0|82.0|
3796157|NCT01828476|3624963|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3796158|NCT01828476|3624965|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3796159|NCT01828476|3624963|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3796160|NCT01828476|3624965|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3796161|NCT01828476|3624963|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3796162|NCT01828476|3624965|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3796163|NCT01828281|3624986|B3|||Adiponectin||ug/ml|Mean|24.1|24.1|Standard Deviation|23.9|23.9|||
3796164|NCT01828281|3624987|B2|||Adiponectin||ug/ml|Mean|22.5|22.5|Standard Deviation|23.8|23.8|||
3796165|NCT01828281|3624988|B1|||Adiponectin||ug/ml|Mean|25.2|25.2|Standard Deviation|25.9|25.9|||
3796166|NCT01828281|3624986|B3|||Mesenteric fat thickness||cm|Mean|0.98|0.98|Standard Deviation|0.27|0.27|||
3796167|NCT01828281|3624987|B2|||Mesenteric fat thickness||cm|Mean|0.98|0.98|Standard Deviation|0.26|0.26|||
3796168|NCT01828281|3624988|B1|||Mesenteric fat thickness||cm|Mean|0.97|0.97|Standard Deviation|0.28|0.28|||
3796169|NCT01828281|3624986|B3|||Apnea hypopnea index (AHI) (event/hour)||event/hour|Mean|33.2|33.2|Standard Deviation|22.4|22.4|||
3796170|NCT01828281|3624987|B2|||Apnea hypopnea index (AHI) (event/hour)||event/hour|Mean|35.2|35.2|Standard Deviation|25.5|25.5|||
3796171|NCT01828281|3624988|B1|||Apnea hypopnea index (AHI) (event/hour)||event/hour|Mean|30.6|30.6|Standard Deviation|21.4|21.4|||
3796172|NCT01828281|3624986|B3|||Diastolic blood pressure||mmHg|Mean|83.8|83.8|Standard Deviation|13.6|13.6|||
3796173|NCT01828281|3624987|B2|||Diastolic blood pressure||mmHg|Mean|83.9|83.9|Standard Deviation|14.1|14.1|||
3796174|NCT01828281|3624988|B1|||Diastolic blood pressure||mmHg|Mean|83.8|83.8|Standard Deviation|12.9|12.9|||
3796175|NCT01828281|3624986|B3|||Systolic blood pressure||mmHg|Mean|130.2|130.2|Standard Deviation|18.4|18.4|||
3796176|NCT01828281|3624987|B2|||Systolic blood pressure||mmHg|Mean|129.4|129.4|Standard Deviation|21.6|21.6|||
3796177|NCT01828281|3624988|B1|||Systolic blood pressure||mmHg|Mean|132.1|132.1|Standard Deviation|16.4|16.4|||
3796178|NCT01828281|3624986|B3|||Epworth Sleepiness Scale (ESS)|minimum score of the scale is 0 and maximum is 24. The higher the score the sleepier the subject is.|units on a scale|Mean|11.9|11.9|Standard Deviation|5.1|5.1|||
3796179|NCT01828281|3624987|B2|||Epworth Sleepiness Scale (ESS)|minimum score of the scale is 0 and maximum is 24. The higher the score the sleepier the subject is.|units on a scale|Mean|11.3|11.3|Standard Deviation|4.7|4.7|||
3796180|NCT01828281|3624988|B1|||Epworth Sleepiness Scale (ESS)|minimum score of the scale is 0 and maximum is 24. The higher the score the sleepier the subject is.|units on a scale|Mean|12.4|12.4|Standard Deviation|5.9|5.9|||
3796181|NCT01828281|3624986|B3|||BMI (kg/m2)||kg/m2|Mean|28.2|28.2|Standard Deviation|4.1|4.1|||
3796182|NCT01828281|3624987|B2|||BMI (kg/m2)||kg/m2|Mean|28.2|28.2|Standard Deviation|4.5|4.5|||
3796183|NCT01828281|3624988|B1|||BMI (kg/m2)||kg/m2|Mean|28.2|28.2|Standard Deviation|3.9|3.9|||
3796184|NCT01828281|3624986|B3|||Neck circumference (cm)||cm|Mean|39.9|39.9|Standard Deviation|7.5|7.5|||
3796185|NCT01828281|3624987|B2|||Neck circumference (cm)||cm|Mean|39.1|39.1|Standard Deviation|3.7|3.7|||
3796186|NCT01828281|3624988|B1|||Neck circumference (cm)||cm|Mean|40.7|40.7|Standard Deviation|11.3|11.3|||
3796187|NCT01828281|3624986|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3796188|NCT01828281|3624987|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3796189|NCT01828281|3624988|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3796190|NCT01828281|3624986|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3796191|NCT01828281|3624987|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3796192|NCT01828281|3624988|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3796193|NCT01828281|3624986|B3|||Age||years|Mean|49.5|49.5|Standard Deviation|9.5|9.5|||
3796194|NCT01828281|3624987|B2|||Age||years|Mean|48.7|48.7|Standard Deviation|9.0|9.0|||
3796195|NCT01828281|3624988|B1|||Age||years|Mean|50.3|50.3|Standard Deviation|10.1|10.1|||
3796196|NCT01828216|3624999|B3||Male|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
3796197|NCT01828216|3625000|B2||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3796198|NCT01828216|3625001|B1||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3796199|NCT01828216|3624999|B3||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3796200|NCT01828216|3625000|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3796201|NCT01828216|3625001|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3796202|NCT01828216|3624999|B3|||Age||years|Mean|51.4|51.4|Standard Deviation|11.8|11.8|||
3796203|NCT01828216|3625000|B2|||Age||years|Mean|51|51.0|Standard Deviation|12.9|12.9|||
3796204|NCT01828216|3625001|B1|||Age||years|Mean|52.1|52.1|Standard Deviation|11.3|11.3|||
3796205|NCT01828164|3625010|B1|Canada||Region of Enrollment||participants|Number|49|49.0||||||
3796206|NCT01828164|3625010|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3796207|NCT01828164|3625010|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3796208|NCT01828164|3625010|B1|||Age||years|Mean|18.4|18.4|Standard Deviation|5.77|5.77|||
3796209|NCT01828112|3625020|B3|Unknown||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3796210|NCT01828112|3625021|B2|Unknown||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3796211|NCT01828112|3625022|B1|Unknown||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3796212|NCT01828112|3625020|B3|Other||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3796213|NCT01828112|3625021|B2|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3796214|NCT01828112|3625022|B1|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3796215|NCT01828112|3625020|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|149|149.0||||||
3796216|NCT01828112|3625021|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|68|68.0||||||
3796217|NCT01828112|3625022|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|81|81.0||||||
3796218|NCT01828112|3625020|B3|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3796219|NCT01828112|3625021|B2|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3796220|NCT01828112|3625022|B1|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3796221|NCT01828112|3625020|B3|Asian||Race/Ethnicity, Customized||Participants|Number|68|68.0||||||
3796222|NCT01828112|3625021|B2|Asian||Race/Ethnicity, Customized||Participants|Number|38|38.0||||||
3796223|NCT01828112|3625022|B1|Asian||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
3796224|NCT01828112|3625020|B3||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3796225|NCT01828112|3625021|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3796226|NCT01828112|3625022|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3796227|NCT01828112|3625020|B3||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3796228|NCT01828112|3625021|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3796229|NCT01828112|3625022|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3796230|NCT01828112|3625020|B3|||Age||Years|Mean|53.7|53.7|Standard Deviation|11.78|11.78|||
3796231|NCT01828112|3625021|B2|||Age||Years|Mean|54.4|54.4|Standard Deviation|11.61|11.61|||
3796232|NCT01828112|3625022|B1|||Age||Years|Mean|53.1|53.1|Standard Deviation|11.96|11.96|||
3796233|NCT01828099|3625029|B3|Other||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3796234|NCT01828099|3625030|B2|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3796235|NCT01828099|3625031|B1|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3796236|NCT01828099|3625029|B3|Native American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3796237|NCT01828099|3625030|B2|Native American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3796238|NCT01828099|3625031|B1|Native American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3796239|NCT01828099|3625029|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|202|202.0||||||
3796240|NCT01828099|3625030|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|98|98.0||||||
3796241|NCT01828099|3625031|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|104|104.0||||||
3796242|NCT01828099|3625029|B3|Black||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3796243|NCT01828099|3625030|B2|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3796244|NCT01828099|3625031|B1|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3796245|NCT01828099|3625029|B3|Asian||Race/Ethnicity, Customized||Participants|Number|158|158.0||||||
3796246|NCT01828099|3625030|B2|Asian||Race/Ethnicity, Customized||Participants|Number|82|82.0||||||
3796247|NCT01828099|3625031|B1|Asian||Race/Ethnicity, Customized||Participants|Number|76|76.0||||||
3796248|NCT01828099|3625029|B3||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3796249|NCT01828099|3625030|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3796250|NCT01828099|3625031|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3796251|NCT01828099|3625029|B3||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
3796252|NCT01828099|3625030|B2||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3796253|NCT01828099|3625031|B1||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3796254|NCT01828099|3625029|B3|||Age||years|Mean|53.9|53.9|Standard Deviation|12.62|12.62|||
3796255|NCT01828099|3625030|B2|||Age||years|Mean|53.3|53.3|Standard Deviation|12.49|12.49|||
3796256|NCT01828099|3625031|B1|||Age||years|Mean|54.5|54.5|Standard Deviation|12.76|12.76|||
3796257|NCT01827839|3625038|B1|White - Arabic /North African||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3796258|NCT01827839|3625038|B1|Asian - Japanese||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3796259|NCT01827839|3625038|B1|Asian - Central/South Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3796260|NCT01827839|3625038|B1|White - Caucasian/European||Race/Ethnicity, Customized||Participants|Count of Participants|92|92.0||||||
3796261|NCT01827839|3625038|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3796262|NCT01827839|3625038|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3796263|NCT01827839|3625038|B1|||Age||Years|Mean|64.9|64.9|Standard Deviation|10.2|10.2|||
3796264|NCT01827670|3625060|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3796265|NCT01827670|3625061|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||19.3|19.3|||
3796266|NCT01827670|3625062|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||24.6|24.6|||
3796267|NCT01827670|3625060|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3796268|NCT01827670|3625061|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||80.7|80.7|||
3796269|NCT01827670|3625062|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||75.4|75.4|||
3796270|NCT01827670|3625060|B3|||Age||Years|Mean|42.6|42.6|Standard Deviation|11.73|11.73|||
3796271|NCT01827670|3625061|B2|||Age||Years|Mean|42.2|42.2|Standard Deviation|11.27|11.27|||
3796272|NCT01827670|3625062|B1|||Age||Years|Mean|43.1|43.1|Standard Deviation|12.27|12.27|||
3796273|NCT01827592|3625079|B4|||Weekly number of SBM|"SBM was defined as a bowel movement that occurs in the absence of a laxative use or manual disimpaction.~Baseline value for the number of SBM was defined as the average of the numbers of SBM per week for over the 2-week Pretreatment Period."|SBM per week|Mean|2.21|2.21|Standard Deviation|1.35|1.35|||
3796274|NCT01827592|3625080|B3|||Weekly number of SBM|"SBM was defined as a bowel movement that occurs in the absence of a laxative use or manual disimpaction.~Baseline value for the number of SBM was defined as the average of the numbers of SBM per week for over the 2-week Pretreatment Period."|SBM per week|Mean|2.31|2.31|Standard Deviation|1.43|1.43|||
3796275|NCT01827592|3625081|B2|||Weekly number of SBM|"SBM was defined as a bowel movement that occurs in the absence of a laxative use or manual disimpaction.~Baseline value for the number of SBM was defined as the average of the numbers of SBM per week for over the 2-week Pretreatment Period."|SBM per week|Mean|2.13|2.13|Standard Deviation|1.27|1.27|||
3796276|NCT01827592|3625082|B1|||Weekly number of SBM|"SBM was defined as a bowel movement that occurs in the absence of a laxative use or manual disimpaction.~Baseline value for the number of SBM was defined as the average of the numbers of SBM per week for over the 2-week Pretreatment Period."|SBM per week|Mean|2.20|2.2|Standard Deviation|1.34|1.34|||
3796277|NCT01827592|3625079|B4|||Weekly number of CSBM|"CSBM was defined as a spontaneous (occurring without laxative within the preceding 24 hours, including no rescue medication within the preceding 24 hours) bowel movement (as interpreted by the patient, with a beginning and an end, including single or multiple stools), accompanied by a patient reported sense of complete evacuation (‘complete’).~Baseline value for the number of CSBM per week was defined as the average of the numbers of CSBM per week for over the 2-week Pretreatment Period."|CSBM per week|Mean|0.45|0.45|Standard Deviation|0.75|0.75|||
3796278|NCT01827592|3625080|B3|||Weekly number of CSBM|"CSBM was defined as a spontaneous (occurring without laxative within the preceding 24 hours, including no rescue medication within the preceding 24 hours) bowel movement (as interpreted by the patient, with a beginning and an end, including single or multiple stools), accompanied by a patient reported sense of complete evacuation (‘complete’).~Baseline value for the number of CSBM per week was defined as the average of the numbers of CSBM per week for over the 2-week Pretreatment Period."|CSBM per week|Mean|0.54|0.54|Standard Deviation|0.82|0.82|||
3796279|NCT01827592|3625081|B2|||Weekly number of CSBM|"CSBM was defined as a spontaneous (occurring without laxative within the preceding 24 hours, including no rescue medication within the preceding 24 hours) bowel movement (as interpreted by the patient, with a beginning and an end, including single or multiple stools), accompanied by a patient reported sense of complete evacuation (‘complete’).~Baseline value for the number of CSBM per week was defined as the average of the numbers of CSBM per week for over the 2-week Pretreatment Period."|CSBM per week|Mean|0.44|0.44|Standard Deviation|0.75|0.75|||
3796280|NCT01827592|3625082|B1|||Weekly number of CSBM|"CSBM was defined as a spontaneous (occurring without laxative within the preceding 24 hours, including no rescue medication within the preceding 24 hours) bowel movement (as interpreted by the patient, with a beginning and an end, including single or multiple stools), accompanied by a patient reported sense of complete evacuation (‘complete’).~Baseline value for the number of CSBM per week was defined as the average of the numbers of CSBM per week for over the 2-week Pretreatment Period."|CSBM per week|Mean|0.36|0.36|Standard Deviation|0.66|0.66|||
3796281|NCT01827592|3625079|B4|Germany||Region of Enrollment||participants|Number|46|46.0||||||
3796282|NCT01827592|3625080|B3|Germany||Region of Enrollment||participants|Number|15|15.0||||||
3796283|NCT01827592|3625081|B2|Germany||Region of Enrollment||participants|Number|16|16.0||||||
3796284|NCT01827592|3625082|B1|Germany||Region of Enrollment||participants|Number|15|15.0||||||
3796285|NCT01827592|3625079|B4|South Africa||Region of Enrollment||participants|Number|39|39.0||||||
3796286|NCT01827592|3625080|B3|South Africa||Region of Enrollment||participants|Number|14|14.0||||||
3796287|NCT01827592|3625081|B2|South Africa||Region of Enrollment||participants|Number|11|11.0||||||
3796288|NCT01827592|3625082|B1|South Africa||Region of Enrollment||participants|Number|14|14.0||||||
3796289|NCT01827592|3625079|B4|United Kingdom||Region of Enrollment||participants|Number|31|31.0||||||
3796290|NCT01827592|3625080|B3|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
3796291|NCT01827592|3625081|B2|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
3796292|NCT01827592|3625082|B1|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
3796293|NCT01827592|3625079|B4|Poland||Region of Enrollment||participants|Number|3|3.0||||||
3796294|NCT01827592|3625080|B3|Poland||Region of Enrollment||participants|Number|0|0.0||||||
3796295|NCT01827592|3625081|B2|Poland||Region of Enrollment||participants|Number|1|1.0||||||
3796296|NCT01827592|3625082|B1|Poland||Region of Enrollment||participants|Number|2|2.0||||||
3796297|NCT01827592|3625079|B4|United States||Region of Enrollment||participants|Number|228|228.0||||||
3796298|NCT01827592|3625080|B3|United States||Region of Enrollment||participants|Number|77|77.0||||||
3796299|NCT01827592|3625081|B2|United States||Region of Enrollment||participants|Number|78|78.0||||||
3796300|NCT01827592|3625082|B1|United States||Region of Enrollment||participants|Number|73|73.0||||||
3796301|NCT01827592|3625079|B4|Belgium||Region of Enrollment||participants|Number|6|6.0||||||
3796302|NCT01827592|3625080|B3|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
3796303|NCT01827592|3625081|B2|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
3796304|NCT01827592|3625082|B1|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
3796305|NCT01827592|3625079|B4|Czech Republic||Region of Enrollment||participants|Number|6|6.0||||||
3796306|NCT01827592|3625080|B3|Czech Republic||Region of Enrollment||participants|Number|2|2.0||||||
3796307|NCT01827592|3625081|B2|Czech Republic||Region of Enrollment||participants|Number|2|2.0||||||
3796308|NCT01827592|3625082|B1|Czech Republic||Region of Enrollment||participants|Number|2|2.0||||||
3796309|NCT01827592|3625079|B4|Canada||Region of Enrollment||participants|Number|17|17.0||||||
3796310|NCT01827592|3625080|B3|Canada||Region of Enrollment||participants|Number|5|5.0||||||
3796311|NCT01827592|3625081|B2|Canada||Region of Enrollment||participants|Number|6|6.0||||||
3796312|NCT01827592|3625082|B1|Canada||Region of Enrollment||participants|Number|6|6.0||||||
3796313|NCT01827592|3625079|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796314|NCT01827592|3625080|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796315|NCT01827592|3625081|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796316|NCT01827592|3625082|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796317|NCT01827592|3625079|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3796318|NCT01827592|3625080|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796319|NCT01827592|3625081|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3796320|NCT01827592|3625082|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796321|NCT01827592|3625079|B4||White|Race (NIH/OMB)||Participants|Count of Participants|279|279.0||||||
3796322|NCT01827592|3625080|B3||White|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3796323|NCT01827592|3625081|B2||White|Race (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
3796324|NCT01827592|3625082|B1||White|Race (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3796325|NCT01827592|3625079|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3796326|NCT01827592|3625080|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3796327|NCT01827592|3625081|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3796328|NCT01827592|3625082|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3796329|NCT01827592|3625079|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796330|NCT01827592|3625080|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796331|NCT01827592|3625081|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796332|NCT01827592|3625082|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796333|NCT01827592|3625079|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3796334|NCT01827592|3625080|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3796335|NCT01827592|3625081|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3796336|NCT01827592|3625082|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3796337|NCT01827592|3625079|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3796338|NCT01827592|3625080|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3796339|NCT01827592|3625081|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796340|NCT01827592|3625082|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3796341|NCT01827592|3625079|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796342|NCT01827592|3625080|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796343|NCT01827592|3625081|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796344|NCT01827592|3625082|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796345|NCT01827592|3625079|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|290|290.0||||||
3796346|NCT01827592|3625080|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3796347|NCT01827592|3625081|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3796348|NCT01827592|3625082|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3796349|NCT01827592|3625079|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
3796350|NCT01827592|3625080|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3796351|NCT01827592|3625081|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3796352|NCT01827592|3625082|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3796353|NCT01827592|3625079|B4||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3796354|NCT01827592|3625080|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3796355|NCT01827592|3625081|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3796356|NCT01827592|3625082|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3796357|NCT01827592|3625079|B4||Female|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
3796358|NCT01827592|3625080|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3796359|NCT01827592|3625081|B2||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3796360|NCT01827592|3625082|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3796361|NCT01827592|3625079|B4|||Age||Years|Mean|46.6|46.6|Standard Deviation|14.3|14.3|||
3796362|NCT01827592|3625080|B3|||Age||Years|Mean|46.1|46.1|Standard Deviation|14.4|14.4|||
3796363|NCT01827592|3625081|B2|||Age||Years|Mean|45.8|45.8|Standard Deviation|14.1|14.1|||
3796364|NCT01827592|3625082|B1|||Age||Years|Mean|48.0|48.0|Standard Deviation|14.3|14.3|||
3796365|NCT01827592|3625079|B4||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
3796366|NCT01827592|3625080|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3796367|NCT01827592|3625081|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3796368|NCT01827592|3625082|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3796369|NCT01827592|3625079|B4||Between 18 and 65 years|Age||Participants|Count of Participants|335|335.0||||||
3796370|NCT01827592|3625080|B3||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
3796371|NCT01827592|3625081|B2||Between 18 and 65 years|Age||Participants|Count of Participants|113|113.0||||||
3796372|NCT01827592|3625082|B1||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
3796373|NCT01827592|3625079|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3796374|NCT01827592|3625080|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3796375|NCT01827592|3625081|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3796376|NCT01827592|3625082|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3796377|NCT01827475|3625113|B4|United States||Region of Enrollment||participants|Number|90|90.0||||||
3796378|NCT01827475|3625114|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3796379|NCT01827475|3625115|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3796380|NCT01827475|3625116|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3796381|NCT01827475|3625113|B4||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3796382|NCT01827475|3625114|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3796383|NCT01827475|3625115|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3796384|NCT01827475|3625116|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3796385|NCT01827475|3625113|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3796386|NCT01827475|3625114|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3796387|NCT01827475|3625115|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3796388|NCT01827475|3625116|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3796389|NCT01827475|3625113|B4|||Age||years|Mean|36|36.0|Standard Deviation|15|15.0|||
3796390|NCT01827475|3625114|B3|||Age||years|Mean|37|37.0|Standard Deviation|17|17.0|||
3796391|NCT01827475|3625115|B2|||Age||years|Mean|34|34.0|Standard Deviation|12|12.0|||
3796392|NCT01827475|3625116|B1|||Age||years|Mean|31|31.0|Standard Deviation|16|16.0|||
3796393|NCT01827475|3625113|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3796394|NCT01827475|3625114|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3796395|NCT01827475|3625115|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3796396|NCT01827475|3625116|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3796397|NCT01827475|3625113|B4||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
3796398|NCT01827475|3625114|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3796399|NCT01827475|3625115|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3796400|NCT01827475|3625116|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3796401|NCT01827475|3625113|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3796402|NCT01827475|3625114|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3796403|NCT01827475|3625115|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3796404|NCT01827475|3625116|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3796405|NCT01827462|3625129|B4|United States||Region of Enrollment||participants|Number|136|136.0||||||
3796406|NCT01827462|3625130|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3796407|NCT01827462|3625131|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
3796408|NCT01827462|3625132|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
3796409|NCT01827462|3625129|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3796410|NCT01827462|3625130|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796411|NCT01827462|3625131|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796412|NCT01827462|3625132|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3796413|NCT01827462|3625129|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3796414|NCT01827462|3625130|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3796415|NCT01827462|3625131|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796416|NCT01827462|3625132|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3796417|NCT01827462|3625129|B4||White|Race (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
3796418|NCT01827462|3625130|B3||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3796419|NCT01827462|3625131|B2||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3796420|NCT01827462|3625132|B1||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3796421|NCT01827462|3625129|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796422|NCT01827462|3625130|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796423|NCT01827462|3625131|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796424|NCT01827462|3625132|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796425|NCT01827462|3625129|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796426|NCT01827462|3625130|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796427|NCT01827462|3625131|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796428|NCT01827462|3625132|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796429|NCT01827462|3625129|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3796430|NCT01827462|3625130|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3796431|NCT01827462|3625131|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796432|NCT01827462|3625132|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3796433|NCT01827462|3625129|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796434|NCT01827462|3625130|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796435|NCT01827462|3625131|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796436|NCT01827462|3625132|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796437|NCT01827462|3625129|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796438|NCT01827462|3625130|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796439|NCT01827462|3625131|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796440|NCT01827462|3625132|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796441|NCT01827462|3625129|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
3796442|NCT01827462|3625130|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3796443|NCT01827462|3625131|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3796444|NCT01827462|3625132|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3796445|NCT01827462|3625129|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3796446|NCT01827462|3625130|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796447|NCT01827462|3625131|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796448|NCT01827462|3625132|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3796449|NCT01827462|3625129|B4||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3796450|NCT01827462|3625130|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3796451|NCT01827462|3625131|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3796452|NCT01827462|3625132|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3796453|NCT01827462|3625129|B4||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3796454|NCT01827462|3625130|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3796455|NCT01827462|3625131|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3796456|NCT01827462|3625132|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3796457|NCT01827462|3625129|B4|||Age||years|Mean|70.9|70.9|Standard Deviation|23.1|23.1|||
3796458|NCT01827462|3625130|B3|||Age||years|Mean|89.5|89.5|Standard Deviation|4.3|4.3|||
3796459|NCT01827462|3625131|B2|||Age||years|Mean|73.3|73.3|Standard Deviation|5.0|5.0|||
3796460|NCT01827462|3625132|B1|||Age||years|Mean|29.6|29.6|Standard Deviation|2.9|2.9|||
3796461|NCT01827371|3625145|B5|United States||Region of Enrollment||participants|Number|435|435.0||||||
3796462|NCT01827371|3625146|B4|United States||Region of Enrollment||participants|Number|120|120.0||||||
3796463|NCT01827371|3625147|B3|United States||Region of Enrollment||participants|Number|104|104.0||||||
3796464|NCT01827371|3625148|B2|United States||Region of Enrollment||participants|Number|96|96.0||||||
3796465|NCT01827371|3625149|B1|United States||Region of Enrollment||participants|Number|115|115.0||||||
3796466|NCT01827371|3625145|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3796467|NCT01827371|3625146|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796468|NCT01827371|3625147|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3796469|NCT01827371|3625148|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796470|NCT01827371|3625149|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3796471|NCT01827371|3625145|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3796472|NCT01827371|3625146|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3796473|NCT01827371|3625147|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3796474|NCT01827371|3625148|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3796475|NCT01827371|3625149|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3796476|NCT01827371|3625145|B5||White|Race (NIH/OMB)||Participants|Count of Participants|311|311.0||||||
3796477|NCT01827371|3625146|B4||White|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
3796478|NCT01827371|3625147|B3||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3796479|NCT01827371|3625148|B2||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3796480|NCT01827371|3625149|B1||White|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
3796481|NCT01827371|3625145|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3796482|NCT01827371|3625146|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3796483|NCT01827371|3625147|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3796484|NCT01827371|3625148|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3796485|NCT01827371|3625149|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3796486|NCT01827371|3625145|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3796487|NCT01827371|3625146|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796488|NCT01827371|3625147|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3796489|NCT01827371|3625148|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796490|NCT01827371|3625149|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796491|NCT01827371|3625145|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3796492|NCT01827371|3625146|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3796493|NCT01827371|3625147|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3796494|NCT01827371|3625148|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3796495|NCT01827371|3625149|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3796496|NCT01827371|3625145|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796497|NCT01827371|3625146|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796498|NCT01827371|3625147|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796499|NCT01827371|3625148|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796500|NCT01827371|3625149|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796501|NCT01827371|3625145|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3796502|NCT01827371|3625146|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796503|NCT01827371|3625147|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796504|NCT01827371|3625148|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796505|NCT01827371|3625149|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3796506|NCT01827371|3625145|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|401|401.0||||||
3796507|NCT01827371|3625146|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
3796508|NCT01827371|3625147|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
3796509|NCT01827371|3625148|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
3796510|NCT01827371|3625149|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
3796511|NCT01827371|3625145|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3796512|NCT01827371|3625146|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3796513|NCT01827371|3625147|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3796514|NCT01827371|3625148|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3796515|NCT01827371|3625149|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3796516|NCT01827371|3625145|B5||Male|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
3796517|NCT01827371|3625146|B4||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3796518|NCT01827371|3625147|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3796519|NCT01827371|3625148|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3796520|NCT01827371|3625149|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3796521|NCT01827371|3625145|B5||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
3796522|NCT01827371|3625146|B4||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3796523|NCT01827371|3625147|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3796524|NCT01827371|3625148|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3796525|NCT01827371|3625149|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3796526|NCT01827371|3625145|B5|||Age||years|Mean|27.4|27.4|Standard Deviation|5.3|5.3|||
3796527|NCT01827371|3625146|B4|||Age||years|Mean|27.9|27.9|Standard Deviation|5.2|5.2|||
3796528|NCT01827371|3625147|B3|||Age||years|Mean|27.2|27.2|Standard Deviation|5.0|5.0|||
3796529|NCT01827371|3625148|B2|||Age||years|Mean|27.1|27.1|Standard Deviation|5.4|5.4|||
3796530|NCT01827371|3625149|B1|||Age||years|Mean|27.2|27.2|Standard Deviation|5.6|5.6|||
3796531|NCT01827371|3625145|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3796532|NCT01827371|3625146|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3796533|NCT01827371|3625147|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3796534|NCT01827371|3625148|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3796535|NCT01827371|3625149|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3796536|NCT01827371|3625145|B5||Between 18 and 65 years|Age||Participants|Count of Participants|435|435.0||||||
3796537|NCT01827371|3625146|B4||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
3796538|NCT01827371|3625147|B3||Between 18 and 65 years|Age||Participants|Count of Participants|104|104.0||||||
3796539|NCT01827371|3625148|B2||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
3796540|NCT01827371|3625149|B1||Between 18 and 65 years|Age||Participants|Count of Participants|115|115.0||||||
3796541|NCT01827371|3625145|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3796542|NCT01827371|3625146|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3796543|NCT01827371|3625147|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3796544|NCT01827371|3625148|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3796545|NCT01827371|3625149|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3796546|NCT01827358|3625174|B3|United States||Region of Enrollment||participants|Number|155|155.0||||||
3796547|NCT01827358|3625175|B2|United States||Region of Enrollment||participants|Number|75|75.0||||||
3796548|NCT01827358|3625176|B1|United States||Region of Enrollment||participants|Number|80|80.0||||||
3796549|NCT01827358|3625174|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3796550|NCT01827358|3625175|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3796551|NCT01827358|3625176|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3796552|NCT01827358|3625174|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3796553|NCT01827358|3625175|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3796554|NCT01827358|3625176|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3796555|NCT01827358|3625174|B3||White|Race (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3796556|NCT01827358|3625175|B2||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3796557|NCT01827358|3625176|B1||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3796558|NCT01827358|3625174|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3796559|NCT01827358|3625175|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3796560|NCT01827358|3625176|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3796561|NCT01827358|3625174|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796562|NCT01827358|3625175|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796563|NCT01827358|3625176|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796564|NCT01827358|3625174|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3796565|NCT01827358|3625175|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3796566|NCT01827358|3625176|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3796567|NCT01827358|3625174|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796568|NCT01827358|3625175|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796569|NCT01827358|3625176|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3796570|NCT01827358|3625174|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3796571|NCT01827358|3625175|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3796572|NCT01827358|3625176|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3796573|NCT01827358|3625174|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|142|142.0||||||
3796574|NCT01827358|3625175|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3796575|NCT01827358|3625176|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
3796576|NCT01827358|3625174|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3796577|NCT01827358|3625175|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3796578|NCT01827358|3625176|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3796579|NCT01827358|3625174|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3796580|NCT01827358|3625175|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3796581|NCT01827358|3625176|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3796582|NCT01827358|3625174|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3796583|NCT01827358|3625175|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3796584|NCT01827358|3625176|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3796585|NCT01827358|3625174|B3|||Age||Weeks|Mean|4.7|4.7|Standard Deviation|4.0|4.0|||
3796586|NCT01827358|3625175|B2|||Age||Weeks|Mean|4.8|4.8|Standard Deviation|4.4|4.4|||
3796587|NCT01827358|3625176|B1|||Age||Weeks|Mean|4.6|4.6|Standard Deviation|3.6|3.6|||
3796588|NCT01827358|3625174|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3796589|NCT01827358|3625175|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3796590|NCT01827358|3625176|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3796591|NCT01827358|3625174|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3796592|NCT01827358|3625175|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3796593|NCT01827358|3625176|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3796594|NCT01827358|3625174|B3||<=18 years|Age||Participants|Count of Participants|155|155.0||||||
3796595|NCT01827358|3625175|B2||<=18 years|Age||Participants|Count of Participants|75|75.0||||||
3796596|NCT01827358|3625176|B1||<=18 years|Age||Participants|Count of Participants|80|80.0||||||
3796597|NCT01827332|3625209|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
3796598|NCT01827332|3625210|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3796599|NCT01827332|3625211|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3796600|NCT01827332|3625209|B3||Male|Gender||Participants|Count of Participants|10|10.0||||||
3796601|NCT01827332|3625210|B2||Male|Gender||Participants|Count of Participants|5|5.0||||||
3796602|NCT01827332|3625211|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
3796603|NCT01827332|3625209|B3||Female|Gender||Participants|Count of Participants|6|6.0||||||
3796604|NCT01827332|3625210|B2||Female|Gender||Participants|Count of Participants|3|3.0||||||
3796605|NCT01827332|3625211|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
3796606|NCT01827332|3625209|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3796607|NCT01827332|3625210|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3796608|NCT01827332|3625211|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3796609|NCT01827332|3625209|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3796610|NCT01827332|3625210|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3796611|NCT01827332|3625211|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3796612|NCT01827332|3625209|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3796613|NCT01827332|3625210|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3796614|NCT01827332|3625211|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3796615|NCT01827319|3625220|B1|United States||Region of Enrollment||participants|Number|203|203.0||||||
3796616|NCT01827319|3625220|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3796617|NCT01827319|3625220|B1||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3796618|NCT01827319|3625220|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|10.2|10.2|||
3796619|NCT01827306|3625226|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
3796620|NCT01827306|3625227|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3796621|NCT01827306|3625228|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3796622|NCT01827306|3625226|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3796623|NCT01827306|3625227|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3796624|NCT01827306|3625228|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3796625|NCT01827306|3625226|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3796626|NCT01827306|3625227|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3796627|NCT01827306|3625228|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3796628|NCT01827306|3625226|B3|||Age||years|Mean|39.53|39.53|Full Range|||19.0|65.0|
3796629|NCT01827306|3625227|B2|||Age||years|Mean|35.23|35.23|Full Range|||19.0|49.0|
3796630|NCT01827306|3625228|B1|||Age||years|Mean|42.19|42.19|Full Range|||26.0|65.0|
3796631|NCT01827267|3625241|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3796632|NCT01827267|3625242|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3796633|NCT01827267|3625243|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3796634|NCT01827267|3625241|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3796635|NCT01827267|3625242|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3796636|NCT01827267|3625243|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3796637|NCT01827267|3625241|B3|||Age||years|Mean|63.10|63.1|Standard Deviation|11.70|11.7|||
3796638|NCT01827267|3625242|B2|||Age||years|Mean|63.44|63.44|Standard Deviation|12.72|12.72|||
3796639|NCT01827267|3625243|B1|||Age||years|Mean|62.24|62.24|Standard Deviation|8.88|8.88|||
3796640|NCT01827267|3625241|B3||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
3796641|NCT01827267|3625242|B2||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3796642|NCT01827267|3625243|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3796643|NCT01827267|3625241|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3796644|NCT01827267|3625242|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3796645|NCT01827267|3625243|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3796646|NCT01827267|3625241|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3796647|NCT01827267|3625242|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3796648|NCT01827267|3625243|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3796649|NCT01827254|3625259|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3796650|NCT01827254|3625259|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3796651|NCT01827254|3625259|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|9.8|9.8|||
3796652|NCT01826981|3625269|B16|>= 800,000||HCV RNA Category||IU/mL|Number|256|256.0||||||
3796653|NCT01826981|3625270|B15|>= 800,000||HCV RNA Category||IU/mL|Number|6|6.0||||||
3796654|NCT01826981|3625271|B14|>= 800,000||HCV RNA Category||IU/mL|Number|14|14.0||||||
3796655|NCT01826981|3625272|B13|>= 800,000||HCV RNA Category||IU/mL|Number|19|19.0||||||
3796656|NCT01826981|3625273|B12|>= 800,000||HCV RNA Category||IU/mL|Number|16|16.0||||||
3796657|NCT01826981|3625274|B11|>= 800,000||HCV RNA Category||IU/mL|Number|14|14.0||||||
3796658|NCT01826981|3625275|B10|>= 800,000||HCV RNA Category||IU/mL|Number|13|13.0||||||
3796659|NCT01826981|3625276|B9|>= 800,000||HCV RNA Category||IU/mL|Number|15|15.0||||||
3796660|NCT01826981|3625277|B8|>= 800,000||HCV RNA Category||IU/mL|Number|35|35.0||||||
3796661|NCT01826981|3625278|B7|>= 800,000||HCV RNA Category||IU/mL|Number|23|23.0||||||
3796662|NCT01826981|3625279|B6|>= 800,000||HCV RNA Category||IU/mL|Number|20|20.0||||||
3796663|NCT01826981|3625280|B5|>= 800,000||HCV RNA Category||IU/mL|Number|16|16.0||||||
3796664|NCT01826981|3625281|B4|>= 800,000||HCV RNA Category||IU/mL|Number|17|17.0||||||
3796665|NCT01826981|3625282|B3|>= 800,000||HCV RNA Category||IU/mL|Number|23|23.0||||||
3796666|NCT01826981|3625283|B2|>= 800,000||HCV RNA Category||IU/mL|Number|9|9.0||||||
3796667|NCT01826981|3625284|B1|>= 800,000||HCV RNA Category||IU/mL|Number|16|16.0||||||
3796668|NCT01826981|3625269|B16|< 800,000||HCV RNA Category||IU/mL|Number|102|102.0||||||
3796669|NCT01826981|3625270|B15|< 800,000||HCV RNA Category||IU/mL|Number|2|2.0||||||
3796670|NCT01826981|3625271|B14|< 800,000||HCV RNA Category||IU/mL|Number|6|6.0||||||
3796671|NCT01826981|3625272|B13|< 800,000||HCV RNA Category||IU/mL|Number|7|7.0||||||
3796672|NCT01826981|3625273|B12|< 800,000||HCV RNA Category||IU/mL|Number|11|11.0||||||
3796673|NCT01826981|3625274|B11|< 800,000||HCV RNA Category||IU/mL|Number|10|10.0||||||
3796674|NCT01826981|3625275|B10|< 800,000||HCV RNA Category||IU/mL|Number|14|14.0||||||
3796675|NCT01826981|3625276|B9|< 800,000||HCV RNA Category||IU/mL|Number|5|5.0||||||
3796676|NCT01826981|3625277|B8|< 800,000||HCV RNA Category||IU/mL|Number|15|15.0||||||
3796677|NCT01826981|3625278|B7|< 800,000||HCV RNA Category||IU/mL|Number|2|2.0||||||
3796678|NCT01826981|3625279|B6|< 800,000||HCV RNA Category||IU/mL|Number|6|6.0||||||
3796679|NCT01826981|3625280|B5|< 800,000||HCV RNA Category||IU/mL|Number|9|9.0||||||
3796680|NCT01826981|3625281|B4|< 800,000||HCV RNA Category||IU/mL|Number|9|9.0||||||
3796681|NCT01826981|3625282|B3|< 800,000||HCV RNA Category||IU/mL|Number|2|2.0||||||
3796682|NCT01826981|3625283|B2|< 800,000||HCV RNA Category||IU/mL|Number|1|1.0||||||
3796683|NCT01826981|3625284|B1|< 800,000||HCV RNA Category||IU/mL|Number|3|3.0||||||
3796684|NCT01826981|3625269|B16|||HCV RNA||log 10 IU/mL|Median|6.2|6.2|Standard Deviation|0.76|0.76|||
3796685|NCT01826981|3625270|B15|||HCV RNA||log 10 IU/mL|Median|6.0|6.0|Standard Deviation|10.9|10.9|||
3796686|NCT01826981|3625271|B14|||HCV RNA||log 10 IU/mL|Median|6.0|6.0|Standard Deviation|0.48|0.48|||
3796687|NCT01826981|3625272|B13|||HCV RNA||log 10 IU/mL|Median|6.2|6.2|Standard Deviation|0.92|0.92|||
3796688|NCT01826981|3625273|B12|||HCV RNA||log 10 IU/mL|Median|6.0|6.0|Standard Deviation|0.71|0.71|||
3796689|NCT01826981|3625274|B11|||HCV RNA||log 10 IU/mL|Median|6.3|6.3|Standard Deviation|0.69|0.69|||
3796690|NCT01826981|3625275|B10|||HCV RNA||log 10 IU/mL|Median|5.9|5.9|Standard Deviation|0.86|0.86|||
3796691|NCT01826981|3625276|B9|||HCV RNA||log 10 IU/mL|Median|6.0|6.0|Standard Deviation|0.48|0.48|||
3796692|NCT01826981|3625277|B8|||HCV RNA||log 10 IU/mL|Median|6.3|6.3|Standard Deviation|0.76|0.76|||
3796693|NCT01826981|3625278|B7|||HCV RNA||log 10 IU/mL|Median|6.7|6.7|Standard Deviation|0.67|0.67|||
3796694|NCT01826981|3625279|B6|||HCV RNA||log 10 IU/mL|Median|6.3|6.3|Standard Deviation|0.87|0.87|||
3796695|NCT01826981|3625280|B5|||HCV RNA||log 10 IU/mL|Median|6.3|6.3|Standard Deviation|0.88|0.88|||
3796696|NCT01826981|3625281|B4|||HCV RNA||log 10 IU/mL|Median|6.1|6.1|Standard Deviation|0.69|0.69|||
3796697|NCT01826981|3625282|B3|||HCV RNA||log 10 IU/mL|Median|6.5|6.5|Standard Deviation|0.39|0.39|||
3796698|NCT01826981|3625283|B2|||HCV RNA||log 10 IU/mL|Median|6.5|6.5|Standard Deviation|0.63|0.63|||
3796699|NCT01826981|3625284|B1|||HCV RNA||log 10 IU/mL|Median|6.3|6.3|Standard Deviation|0.51|0.51|||
3796700|NCT01826981|3625269|B16|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|54|54.0||||||
3796701|NCT01826981|3625270|B15|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3796702|NCT01826981|3625271|B14|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|6|6.0||||||
3796703|NCT01826981|3625272|B13|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|2|2.0||||||
3796704|NCT01826981|3625273|B12|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3796705|NCT01826981|3625274|B11|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
3796706|NCT01826981|3625275|B10|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|4|4.0||||||
3796707|NCT01826981|3625276|B9|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|7|7.0||||||
3796708|NCT01826981|3625277|B8|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|5|5.0||||||
3796709|NCT01826981|3625278|B7|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3796710|NCT01826981|3625279|B6|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|5|5.0||||||
3796711|NCT01826981|3625280|B5|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|6|6.0||||||
3796712|NCT01826981|3625281|B4|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
3796713|NCT01826981|3625282|B3|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|7|7.0||||||
3796714|NCT01826981|3625283|B2|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|2|2.0||||||
3796715|NCT01826981|3625284|B1|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
3796716|NCT01826981|3625269|B16|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|159|159.0||||||
3796717|NCT01826981|3625270|B15|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3796718|NCT01826981|3625271|B14|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|7|7.0||||||
3796719|NCT01826981|3625272|B13|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|10|10.0||||||
3796720|NCT01826981|3625273|B12|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|11|11.0||||||
3796721|NCT01826981|3625274|B11|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|15|15.0||||||
3796722|NCT01826981|3625275|B10|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|13|13.0||||||
3796723|NCT01826981|3625276|B9|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|6|6.0||||||
3796724|NCT01826981|3625277|B8|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|27|27.0||||||
3796725|NCT01826981|3625278|B7|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|5|5.0||||||
3796726|NCT01826981|3625279|B6|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|6|6.0||||||
3796727|NCT01826981|3625280|B5|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|10|10.0||||||
3796728|NCT01826981|3625281|B4|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|19|19.0||||||
3796729|NCT01826981|3625282|B3|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|12|12.0||||||
3796730|NCT01826981|3625283|B2|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|5|5.0||||||
3796731|NCT01826981|3625284|B1|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|12|12.0||||||
3796732|NCT01826981|3625269|B16|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|145|145.0||||||
3796733|NCT01826981|3625270|B15|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|7|7.0||||||
3796734|NCT01826981|3625271|B14|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|7|7.0||||||
3796735|NCT01826981|3625272|B13|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|14|14.0||||||
3796736|NCT01826981|3625273|B12|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|15|15.0||||||
3796737|NCT01826981|3625274|B11|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|6|6.0||||||
3796738|NCT01826981|3625275|B10|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|10|10.0||||||
3796739|NCT01826981|3625276|B9|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|7|7.0||||||
3796740|NCT01826981|3625277|B8|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|18|18.0||||||
3796741|NCT01826981|3625278|B7|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|20|20.0||||||
3796742|NCT01826981|3625279|B6|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|15|15.0||||||
3796743|NCT01826981|3625280|B5|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|9|9.0||||||
3796744|NCT01826981|3625281|B4|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|4|4.0||||||
3796745|NCT01826981|3625282|B3|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|6|6.0||||||
3796746|NCT01826981|3625283|B2|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
3796747|NCT01826981|3625284|B1|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|4|4.0||||||
3796748|NCT01826981|3625269|B16|Yes||Cirrhosis Status||participants|Number|107|107.0||||||
3796749|NCT01826981|3625270|B15|Yes||Cirrhosis Status||participants|Number|2|2.0||||||
3796750|NCT01826981|3625271|B14|Yes||Cirrhosis Status||participants|Number|14|14.0||||||
3796751|NCT01826981|3625272|B13|Yes||Cirrhosis Status||participants|Number|0|0.0||||||
3796752|NCT01826981|3625273|B12|Yes||Cirrhosis Status||participants|Number|0|0.0||||||
3796753|NCT01826981|3625274|B11|Yes||Cirrhosis Status||participants|Number|0|0.0||||||
3796754|NCT01826981|3625275|B10|Yes||Cirrhosis Status||participants|Number|0|0.0||||||
3796755|NCT01826981|3625276|B9|Yes||Cirrhosis Status||participants|Number|20|20.0||||||
3796756|NCT01826981|3625277|B8|Yes||Cirrhosis Status||participants|Number|22|22.0||||||
3796757|NCT01826981|3625278|B7|Yes||Cirrhosis Status||participants|Number|2|2.0||||||
3796758|NCT01826981|3625279|B6|Yes||Cirrhosis Status||participants|Number|6|6.0||||||
3796759|NCT01826981|3625280|B5|Yes||Cirrhosis Status||participants|Number|4|4.0||||||
3796760|NCT01826981|3625281|B4|Yes||Cirrhosis Status||participants|Number|17|17.0||||||
3796761|NCT01826981|3625282|B3|Yes||Cirrhosis Status||participants|Number|18|18.0||||||
3796762|NCT01826981|3625283|B2|Yes||Cirrhosis Status||participants|Number|1|1.0||||||
3796763|NCT01826981|3625284|B1|Yes||Cirrhosis Status||participants|Number|1|1.0||||||
3796764|NCT01826981|3625269|B16|No||Cirrhosis Status||participants|Number|251|251.0||||||
3796765|NCT01826981|3625270|B15|No||Cirrhosis Status||participants|Number|6|6.0||||||
3796766|NCT01826981|3625271|B14|No||Cirrhosis Status||participants|Number|6|6.0||||||
3796767|NCT01826981|3625272|B13|No||Cirrhosis Status||participants|Number|26|26.0||||||
3796768|NCT01826981|3625273|B12|No||Cirrhosis Status||participants|Number|27|27.0||||||
3796769|NCT01826981|3625274|B11|No||Cirrhosis Status||participants|Number|24|24.0||||||
3796770|NCT01826981|3625275|B10|No||Cirrhosis Status||participants|Number|27|27.0||||||
3796771|NCT01826981|3625276|B9|No||Cirrhosis Status||participants|Number|0|0.0||||||
3796772|NCT01826981|3625277|B8|No||Cirrhosis Status||participants|Number|28|28.0||||||
3796773|NCT01826981|3625278|B7|No||Cirrhosis Status||participants|Number|23|23.0||||||
3796774|NCT01826981|3625279|B6|No||Cirrhosis Status||participants|Number|20|20.0||||||
3796775|NCT01826981|3625280|B5|No||Cirrhosis Status||participants|Number|21|21.0||||||
3796776|NCT01826981|3625281|B4|No||Cirrhosis Status||participants|Number|9|9.0||||||
3796777|NCT01826981|3625282|B3|No||Cirrhosis Status||participants|Number|7|7.0||||||
3796778|NCT01826981|3625283|B2|No||Cirrhosis Status||participants|Number|9|9.0||||||
3796779|NCT01826981|3625284|B1|No||Cirrhosis Status||participants|Number|18|18.0||||||
3796780|NCT01826981|3625269|B16|Missing||HCV Genotype||participants|Number|1|1.0||||||
3796781|NCT01826981|3625270|B15|Missing||HCV Genotype||participants|Number|0|0.0||||||
3796782|NCT01826981|3625271|B14|Missing||HCV Genotype||participants|Number|1|1.0||||||
3796783|NCT01826981|3625272|B13|Missing||HCV Genotype||participants|Number|0|0.0||||||
3796784|NCT01826981|3625273|B12|Missing||HCV Genotype||participants|Number|0|0.0||||||
3796785|NCT01826981|3625274|B11|Missing||HCV Genotype||participants|Number|0|0.0||||||
3796786|NCT01826981|3625275|B10|Missing||HCV Genotype||participants|Number|0|0.0||||||
3796787|NCT01826981|3625276|B9|Missing||HCV Genotype||participants|Number|0|0.0||||||
3796788|NCT01826981|3625277|B8|Missing||HCV Genotype||participants|Number|0|0.0||||||
3796789|NCT01826981|3625278|B7|Missing||HCV Genotype||participants|Number|0|0.0||||||
3796790|NCT01826981|3625279|B6|Missing||HCV Genotype||participants|Number|0|0.0||||||
3796791|NCT01826981|3625280|B5|Missing||HCV Genotype||participants|Number|0|0.0||||||
3796792|NCT01826981|3625281|B4|Missing||HCV Genotype||participants|Number|0|0.0||||||
3796793|NCT01826981|3625282|B3|Missing||HCV Genotype||participants|Number|0|0.0||||||
3796794|NCT01826981|3625283|B2|Missing||HCV Genotype||participants|Number|0|0.0||||||
3796795|NCT01826981|3625284|B1|Missing||HCV Genotype||participants|Number|0|0.0||||||
3796796|NCT01826981|3625269|B16|Indeterminate pattern. Sequencing indicates GT3k||HCV Genotype||participants|Number|1|1.0||||||
3796797|NCT01826981|3625270|B15|Indeterminate pattern. Sequencing indicates GT3k||HCV Genotype||participants|Number|0|0.0||||||
3796798|NCT01826981|3625271|B14|Indeterminate pattern. Sequencing indicates GT3k||HCV Genotype||participants|Number|0|0.0||||||
3796799|NCT01826981|3625272|B13|Indeterminate pattern. Sequencing indicates GT3k||HCV Genotype||participants|Number|0|0.0||||||
3796800|NCT01826981|3625273|B12|Indeterminate pattern. Sequencing indicates GT3k||HCV Genotype||participants|Number|0|0.0||||||
3796801|NCT01826981|3625274|B11|Indeterminate pattern. Sequencing indicates GT3k||HCV Genotype||participants|Number|0|0.0||||||
3796802|NCT01826981|3625275|B10|Indeterminate pattern. Sequencing indicates GT3k||HCV Genotype||participants|Number|0|0.0||||||
3796803|NCT01826981|3625276|B9|Indeterminate pattern. Sequencing indicates GT3k||HCV Genotype||participants|Number|0|0.0||||||
3796804|NCT01826981|3625277|B8|Indeterminate pattern. Sequencing indicates GT3k||HCV Genotype||participants|Number|0|0.0||||||
3796805|NCT01826981|3625278|B7|Indeterminate pattern. Sequencing indicates GT3k||HCV Genotype||participants|Number|0|0.0||||||
3796806|NCT01826981|3625279|B6|Indeterminate pattern. Sequencing indicates GT3k||HCV Genotype||participants|Number|1|1.0||||||
3796807|NCT01826981|3625280|B5|Indeterminate pattern. Sequencing indicates GT3k||HCV Genotype||participants|Number|0|0.0||||||
3796808|NCT01826981|3625281|B4|Indeterminate pattern. Sequencing indicates GT3k||HCV Genotype||participants|Number|0|0.0||||||
3796809|NCT01826981|3625282|B3|Indeterminate pattern. Sequencing indicates GT3k||HCV Genotype||participants|Number|0|0.0||||||
3796810|NCT01826981|3625283|B2|Indeterminate pattern. Sequencing indicates GT3k||HCV Genotype||participants|Number|0|0.0||||||
3796811|NCT01826981|3625284|B1|Indeterminate pattern. Sequencing indicates GT3k||HCV Genotype||participants|Number|0|0.0||||||
3796812|NCT01826981|3625269|B16|Indeterminate genotype. Sequencing indicates GT3a||HCV Genotype||participants|Number|1|1.0||||||
3796813|NCT01826981|3625270|B15|Indeterminate genotype. Sequencing indicates GT3a||HCV Genotype||participants|Number|0|0.0||||||
3796814|NCT01826981|3625271|B14|Indeterminate genotype. Sequencing indicates GT3a||HCV Genotype||participants|Number|0|0.0||||||
3796815|NCT01826981|3625272|B13|Indeterminate genotype. Sequencing indicates GT3a||HCV Genotype||participants|Number|0|0.0||||||
3796816|NCT01826981|3625273|B12|Indeterminate genotype. Sequencing indicates GT3a||HCV Genotype||participants|Number|0|0.0||||||
3796817|NCT01826981|3625274|B11|Indeterminate genotype. Sequencing indicates GT3a||HCV Genotype||participants|Number|0|0.0||||||
3796818|NCT01826981|3625275|B10|Indeterminate genotype. Sequencing indicates GT3a||HCV Genotype||participants|Number|0|0.0||||||
3796819|NCT01826981|3625276|B9|Indeterminate genotype. Sequencing indicates GT3a||HCV Genotype||participants|Number|0|0.0||||||
3796820|NCT01826981|3625277|B8|Indeterminate genotype. Sequencing indicates GT3a||HCV Genotype||participants|Number|1|1.0||||||
3796821|NCT01826981|3625278|B7|Indeterminate genotype. Sequencing indicates GT3a||HCV Genotype||participants|Number|0|0.0||||||
3796822|NCT01826981|3625279|B6|Indeterminate genotype. Sequencing indicates GT3a||HCV Genotype||participants|Number|0|0.0||||||
3796823|NCT01826981|3625280|B5|Indeterminate genotype. Sequencing indicates GT3a||HCV Genotype||participants|Number|0|0.0||||||
3796824|NCT01826981|3625281|B4|Indeterminate genotype. Sequencing indicates GT3a||HCV Genotype||participants|Number|0|0.0||||||
3796825|NCT01826981|3625282|B3|Indeterminate genotype. Sequencing indicates GT3a||HCV Genotype||participants|Number|0|0.0||||||
3796826|NCT01826981|3625283|B2|Indeterminate genotype. Sequencing indicates GT3a||HCV Genotype||participants|Number|0|0.0||||||
3796827|NCT01826981|3625284|B1|Indeterminate genotype. Sequencing indicates GT3a||HCV Genotype||participants|Number|0|0.0||||||
3796828|NCT01826981|3625269|B16|Genotype 6a or 6b||HCV Genotype||participants|Number|8|8.0||||||
3796829|NCT01826981|3625270|B15|Genotype 6a or 6b||HCV Genotype||participants|Number|0|0.0||||||
3796830|NCT01826981|3625271|B14|Genotype 6a or 6b||HCV Genotype||participants|Number|0|0.0||||||
3796831|NCT01826981|3625272|B13|Genotype 6a or 6b||HCV Genotype||participants|Number|0|0.0||||||
3796832|NCT01826981|3625273|B12|Genotype 6a or 6b||HCV Genotype||participants|Number|0|0.0||||||
3796833|NCT01826981|3625274|B11|Genotype 6a or 6b||HCV Genotype||participants|Number|0|0.0||||||
3796834|NCT01826981|3625275|B10|Genotype 6a or 6b||HCV Genotype||participants|Number|0|0.0||||||
3796835|NCT01826981|3625276|B9|Genotype 6a or 6b||HCV Genotype||participants|Number|0|0.0||||||
3796836|NCT01826981|3625277|B8|Genotype 6a or 6b||HCV Genotype||participants|Number|0|0.0||||||
3796837|NCT01826981|3625278|B7|Genotype 6a or 6b||HCV Genotype||participants|Number|8|8.0||||||
3796838|NCT01826981|3625279|B6|Genotype 6a or 6b||HCV Genotype||participants|Number|0|0.0||||||
3796839|NCT01826981|3625280|B5|Genotype 6a or 6b||HCV Genotype||participants|Number|0|0.0||||||
3796840|NCT01826981|3625281|B4|Genotype 6a or 6b||HCV Genotype||participants|Number|0|0.0||||||
3796841|NCT01826981|3625282|B3|Genotype 6a or 6b||HCV Genotype||participants|Number|0|0.0||||||
3796842|NCT01826981|3625283|B2|Genotype 6a or 6b||HCV Genotype||participants|Number|0|0.0||||||
3796843|NCT01826981|3625284|B1|Genotype 6a or 6b||HCV Genotype||participants|Number|0|0.0||||||
3796844|NCT01826981|3625269|B16|Genotype 6 (subtypes c - l)||HCV Genotype||participants|Number|17|17.0||||||
3796845|NCT01826981|3625270|B15|Genotype 6 (subtypes c - l)||HCV Genotype||participants|Number|0|0.0||||||
3796846|NCT01826981|3625271|B14|Genotype 6 (subtypes c - l)||HCV Genotype||participants|Number|0|0.0||||||
3796847|NCT01826981|3625272|B13|Genotype 6 (subtypes c - l)||HCV Genotype||participants|Number|0|0.0||||||
3796848|NCT01826981|3625273|B12|Genotype 6 (subtypes c - l)||HCV Genotype||participants|Number|0|0.0||||||
3796849|NCT01826981|3625274|B11|Genotype 6 (subtypes c - l)||HCV Genotype||participants|Number|0|0.0||||||
3796850|NCT01826981|3625275|B10|Genotype 6 (subtypes c - l)||HCV Genotype||participants|Number|0|0.0||||||
3796851|NCT01826981|3625276|B9|Genotype 6 (subtypes c - l)||HCV Genotype||participants|Number|0|0.0||||||
3796852|NCT01826981|3625277|B8|Genotype 6 (subtypes c - l)||HCV Genotype||participants|Number|0|0.0||||||
3796853|NCT01826981|3625278|B7|Genotype 6 (subtypes c - l)||HCV Genotype||participants|Number|17|17.0||||||
3796854|NCT01826981|3625279|B6|Genotype 6 (subtypes c - l)||HCV Genotype||participants|Number|0|0.0||||||
3796855|NCT01826981|3625280|B5|Genotype 6 (subtypes c - l)||HCV Genotype||participants|Number|0|0.0||||||
3796856|NCT01826981|3625281|B4|Genotype 6 (subtypes c - l)||HCV Genotype||participants|Number|0|0.0||||||
3796857|NCT01826981|3625282|B3|Genotype 6 (subtypes c - l)||HCV Genotype||participants|Number|0|0.0||||||
3796858|NCT01826981|3625283|B2|Genotype 6 (subtypes c - l)||HCV Genotype||participants|Number|0|0.0||||||
3796859|NCT01826981|3625284|B1|Genotype 6 (subtypes c - l)||HCV Genotype||participants|Number|0|0.0||||||
3796860|NCT01826981|3625269|B16|Genotype 3k||HCV Genotype||participants|Number|1|1.0||||||
3796861|NCT01826981|3625270|B15|Genotype 3k||HCV Genotype||participants|Number|0|0.0||||||
3796862|NCT01826981|3625271|B14|Genotype 3k||HCV Genotype||participants|Number|0|0.0||||||
3796863|NCT01826981|3625272|B13|Genotype 3k||HCV Genotype||participants|Number|0|0.0||||||
3796864|NCT01826981|3625273|B12|Genotype 3k||HCV Genotype||participants|Number|0|0.0||||||
3796865|NCT01826981|3625274|B11|Genotype 3k||HCV Genotype||participants|Number|1|1.0||||||
3796866|NCT01826981|3625275|B10|Genotype 3k||HCV Genotype||participants|Number|0|0.0||||||
3796867|NCT01826981|3625276|B9|Genotype 3k||HCV Genotype||participants|Number|0|0.0||||||
3796868|NCT01826981|3625277|B8|Genotype 3k||HCV Genotype||participants|Number|0|0.0||||||
3796869|NCT01826981|3625278|B7|Genotype 3k||HCV Genotype||participants|Number|0|0.0||||||
3796870|NCT01826981|3625279|B6|Genotype 3k||HCV Genotype||participants|Number|0|0.0||||||
3796871|NCT01826981|3625280|B5|Genotype 3k||HCV Genotype||participants|Number|0|0.0||||||
3796872|NCT01826981|3625281|B4|Genotype 3k||HCV Genotype||participants|Number|0|0.0||||||
3796873|NCT01826981|3625282|B3|Genotype 3k||HCV Genotype||participants|Number|0|0.0||||||
3796874|NCT01826981|3625283|B2|Genotype 3k||HCV Genotype||participants|Number|0|0.0||||||
3796875|NCT01826981|3625284|B1|Genotype 3k||HCV Genotype||participants|Number|0|0.0||||||
3796876|NCT01826981|3625269|B16|Genotype 3a||HCV Genotype||participants|Number|215|215.0||||||
3796877|NCT01826981|3625270|B15|Genotype 3a||HCV Genotype||participants|Number|0|0.0||||||
3796878|NCT01826981|3625271|B14|Genotype 3a||HCV Genotype||participants|Number|10|10.0||||||
3796879|NCT01826981|3625272|B13|Genotype 3a||HCV Genotype||participants|Number|26|26.0||||||
3796880|NCT01826981|3625273|B12|Genotype 3a||HCV Genotype||participants|Number|27|27.0||||||
3796881|NCT01826981|3625274|B11|Genotype 3a||HCV Genotype||participants|Number|22|22.0||||||
3796882|NCT01826981|3625275|B10|Genotype 3a||HCV Genotype||participants|Number|25|25.0||||||
3796883|NCT01826981|3625276|B9|Genotype 3a||HCV Genotype||participants|Number|0|0.0||||||
3796884|NCT01826981|3625277|B8|Genotype 3a||HCV Genotype||participants|Number|46|46.0||||||
3796885|NCT01826981|3625278|B7|Genotype 3a||HCV Genotype||participants|Number|0|0.0||||||
3796886|NCT01826981|3625279|B6|Genotype 3a||HCV Genotype||participants|Number|25|25.0||||||
3796887|NCT01826981|3625280|B5|Genotype 3a||HCV Genotype||participants|Number|24|24.0||||||
3796888|NCT01826981|3625281|B4|Genotype 3a||HCV Genotype||participants|Number|0|0.0||||||
3796889|NCT01826981|3625282|B3|Genotype 3a||HCV Genotype||participants|Number|0|0.0||||||
3796890|NCT01826981|3625283|B2|Genotype 3a||HCV Genotype||participants|Number|10|10.0||||||
3796891|NCT01826981|3625284|B1|Genotype 3a||HCV Genotype||participants|Number|0|0.0||||||
3796892|NCT01826981|3625269|B16|Genotype 3||HCV Genotype||participants|Number|7|7.0||||||
3796893|NCT01826981|3625270|B15|Genotype 3||HCV Genotype||participants|Number|0|0.0||||||
3796894|NCT01826981|3625271|B14|Genotype 3||HCV Genotype||participants|Number|0|0.0||||||
3796895|NCT01826981|3625272|B13|Genotype 3||HCV Genotype||participants|Number|0|0.0||||||
3796896|NCT01826981|3625273|B12|Genotype 3||HCV Genotype||participants|Number|0|0.0||||||
3796897|NCT01826981|3625274|B11|Genotype 3||HCV Genotype||participants|Number|1|1.0||||||
3796898|NCT01826981|3625275|B10|Genotype 3||HCV Genotype||participants|Number|2|2.0||||||
3796899|NCT01826981|3625276|B9|Genotype 3||HCV Genotype||participants|Number|0|0.0||||||
3796900|NCT01826981|3625277|B8|Genotype 3||HCV Genotype||participants|Number|3|3.0||||||
3796901|NCT01826981|3625278|B7|Genotype 3||HCV Genotype||participants|Number|0|0.0||||||
3796902|NCT01826981|3625279|B6|Genotype 3||HCV Genotype||participants|Number|0|0.0||||||
3796903|NCT01826981|3625280|B5|Genotype 3||HCV Genotype||participants|Number|1|1.0||||||
3796904|NCT01826981|3625281|B4|Genotype 3||HCV Genotype||participants|Number|0|0.0||||||
3796905|NCT01826981|3625282|B3|Genotype 3||HCV Genotype||participants|Number|0|0.0||||||
3796906|NCT01826981|3625283|B2|Genotype 3||HCV Genotype||participants|Number|0|0.0||||||
3796907|NCT01826981|3625284|B1|Genotype 3||HCV Genotype||participants|Number|0|0.0||||||
3796908|NCT01826981|3625269|B16|Genotype 1b||HCV Genotype||participants|Number|19|19.0||||||
3796909|NCT01826981|3625270|B15|Genotype 1b||HCV Genotype||participants|Number|2|2.0||||||
3796910|NCT01826981|3625271|B14|Genotype 1b||HCV Genotype||participants|Number|0|0.0||||||
3796911|NCT01826981|3625272|B13|Genotype 1b||HCV Genotype||participants|Number|0|0.0||||||
3796912|NCT01826981|3625273|B12|Genotype 1b||HCV Genotype||participants|Number|0|0.0||||||
3796913|NCT01826981|3625274|B11|Genotype 1b||HCV Genotype||participants|Number|0|0.0||||||
3796914|NCT01826981|3625275|B10|Genotype 1b||HCV Genotype||participants|Number|0|0.0||||||
3796915|NCT01826981|3625276|B9|Genotype 1b||HCV Genotype||participants|Number|2|2.0||||||
3796916|NCT01826981|3625277|B8|Genotype 1b||HCV Genotype||participants|Number|0|0.0||||||
3796917|NCT01826981|3625278|B7|Genotype 1b||HCV Genotype||participants|Number|0|0.0||||||
3796918|NCT01826981|3625279|B6|Genotype 1b||HCV Genotype||participants|Number|0|0.0||||||
3796919|NCT01826981|3625280|B5|Genotype 1b||HCV Genotype||participants|Number|0|0.0||||||
3796920|NCT01826981|3625281|B4|Genotype 1b||HCV Genotype||participants|Number|4|4.0||||||
3796921|NCT01826981|3625282|B3|Genotype 1b||HCV Genotype||participants|Number|9|9.0||||||
3796922|NCT01826981|3625283|B2|Genotype 1b||HCV Genotype||participants|Number|0|0.0||||||
3796923|NCT01826981|3625284|B1|Genotype 1b||HCV Genotype||participants|Number|2|2.0||||||
3796924|NCT01826981|3625269|B16|Genotype 1a with possible 6 (subtypes c - l)||HCV Genotype||participants|Number|1|1.0||||||
3796925|NCT01826981|3625270|B15|Genotype 1a with possible 6 (subtypes c - l)||HCV Genotype||participants|Number|0|0.0||||||
3796926|NCT01826981|3625271|B14|Genotype 1a with possible 6 (subtypes c - l)||HCV Genotype||participants|Number|0|0.0||||||
3796927|NCT01826981|3625272|B13|Genotype 1a with possible 6 (subtypes c - l)||HCV Genotype||participants|Number|0|0.0||||||
3796928|NCT01826981|3625273|B12|Genotype 1a with possible 6 (subtypes c - l)||HCV Genotype||participants|Number|0|0.0||||||
3796929|NCT01826981|3625274|B11|Genotype 1a with possible 6 (subtypes c - l)||HCV Genotype||participants|Number|0|0.0||||||
3796930|NCT01826981|3625275|B10|Genotype 1a with possible 6 (subtypes c - l)||HCV Genotype||participants|Number|0|0.0||||||
3796931|NCT01826981|3625276|B9|Genotype 1a with possible 6 (subtypes c - l)||HCV Genotype||participants|Number|0|0.0||||||
3796932|NCT01826981|3625277|B8|Genotype 1a with possible 6 (subtypes c - l)||HCV Genotype||participants|Number|0|0.0||||||
3796933|NCT01826981|3625278|B7|Genotype 1a with possible 6 (subtypes c - l)||HCV Genotype||participants|Number|0|0.0||||||
3796934|NCT01826981|3625279|B6|Genotype 1a with possible 6 (subtypes c - l)||HCV Genotype||participants|Number|0|0.0||||||
3796935|NCT01826981|3625280|B5|Genotype 1a with possible 6 (subtypes c - l)||HCV Genotype||participants|Number|0|0.0||||||
3796936|NCT01826981|3625281|B4|Genotype 1a with possible 6 (subtypes c - l)||HCV Genotype||participants|Number|0|0.0||||||
3796937|NCT01826981|3625282|B3|Genotype 1a with possible 6 (subtypes c - l)||HCV Genotype||participants|Number|0|0.0||||||
3796938|NCT01826981|3625283|B2|Genotype 1a with possible 6 (subtypes c - l)||HCV Genotype||participants|Number|0|0.0||||||
3796939|NCT01826981|3625284|B1|Genotype 1a with possible 6 (subtypes c - l)||HCV Genotype||participants|Number|1|1.0||||||
3796940|NCT01826981|3625269|B16|Genotype 1a||HCV Genotype||participants|Number|86|86.0||||||
3796941|NCT01826981|3625270|B15|Genotype 1a||HCV Genotype||participants|Number|6|6.0||||||
3796942|NCT01826981|3625271|B14|Genotype 1a||HCV Genotype||participants|Number|9|9.0||||||
3796943|NCT01826981|3625272|B13|Genotype 1a||HCV Genotype||participants|Number|0|0.0||||||
3796944|NCT01826981|3625273|B12|Genotype 1a||HCV Genotype||participants|Number|0|0.0||||||
3796945|NCT01826981|3625274|B11|Genotype 1a||HCV Genotype||participants|Number|0|0.0||||||
3796946|NCT01826981|3625275|B10|Genotype 1a||HCV Genotype||participants|Number|0|0.0||||||
3796947|NCT01826981|3625276|B9|Genotype 1a||HCV Genotype||participants|Number|18|18.0||||||
3796948|NCT01826981|3625277|B8|Genotype 1a||HCV Genotype||participants|Number|0|0.0||||||
3796949|NCT01826981|3625278|B7|Genotype 1a||HCV Genotype||participants|Number|0|0.0||||||
3796950|NCT01826981|3625279|B6|Genotype 1a||HCV Genotype||participants|Number|0|0.0||||||
3796951|NCT01826981|3625280|B5|Genotype 1a||HCV Genotype||participants|Number|0|0.0||||||
3796952|NCT01826981|3625281|B4|Genotype 1a||HCV Genotype||participants|Number|22|22.0||||||
3796953|NCT01826981|3625282|B3|Genotype 1a||HCV Genotype||participants|Number|15|15.0||||||
3796954|NCT01826981|3625283|B2|Genotype 1a||HCV Genotype||participants|Number|0|0.0||||||
3796955|NCT01826981|3625284|B1|Genotype 1a||HCV Genotype||participants|Number|16|16.0||||||
3796956|NCT01826981|3625269|B16|1b with possible mixed infection with Genotype 4||HCV Genotype||participants|Number|1|1.0||||||
3796957|NCT01826981|3625270|B15|1b with possible mixed infection with Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3796958|NCT01826981|3625271|B14|1b with possible mixed infection with Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3796959|NCT01826981|3625272|B13|1b with possible mixed infection with Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3796960|NCT01826981|3625273|B12|1b with possible mixed infection with Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3796961|NCT01826981|3625274|B11|1b with possible mixed infection with Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3796962|NCT01826981|3625275|B10|1b with possible mixed infection with Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3796963|NCT01826981|3625276|B9|1b with possible mixed infection with Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3796964|NCT01826981|3625277|B8|1b with possible mixed infection with Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3796965|NCT01826981|3625278|B7|1b with possible mixed infection with Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3796966|NCT01826981|3625279|B6|1b with possible mixed infection with Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3796967|NCT01826981|3625280|B5|1b with possible mixed infection with Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3796968|NCT01826981|3625281|B4|1b with possible mixed infection with Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3796969|NCT01826981|3625282|B3|1b with possible mixed infection with Genotype 4||HCV Genotype||participants|Number|1|1.0||||||
3796970|NCT01826981|3625283|B2|1b with possible mixed infection with Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3796971|NCT01826981|3625284|B1|1b with possible mixed infection with Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3796972|NCT01826981|3625269|B16|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|358|358.0||||||
3796973|NCT01826981|3625270|B15|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3796974|NCT01826981|3625271|B14|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3796975|NCT01826981|3625272|B13|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3796976|NCT01826981|3625273|B12|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
3796977|NCT01826981|3625274|B11|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3796978|NCT01826981|3625275|B10|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
3796979|NCT01826981|3625276|B9|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3796980|NCT01826981|3625277|B8|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
3796981|NCT01826981|3625278|B7|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3796982|NCT01826981|3625279|B6|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3796983|NCT01826981|3625280|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3796984|NCT01826981|3625281|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3796985|NCT01826981|3625282|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3796986|NCT01826981|3625283|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3796987|NCT01826981|3625284|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3796988|NCT01826981|3625269|B16|Other||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3796989|NCT01826981|3625270|B15|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3796990|NCT01826981|3625271|B14|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3796991|NCT01826981|3625272|B13|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3796992|NCT01826981|3625273|B12|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3796993|NCT01826981|3625274|B11|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3796994|NCT01826981|3625275|B10|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3796995|NCT01826981|3625276|B9|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3796996|NCT01826981|3625277|B8|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3796997|NCT01826981|3625278|B7|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3796998|NCT01826981|3625279|B6|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3796999|NCT01826981|3625280|B5|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3797000|NCT01826981|3625281|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3797001|NCT01826981|3625282|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3797002|NCT01826981|3625283|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3797003|NCT01826981|3625284|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3797004|NCT01826981|3625269|B16|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3797005|NCT01826981|3625270|B15|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3797006|NCT01826981|3625271|B14|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3797007|NCT01826981|3625272|B13|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3797008|NCT01826981|3625273|B12|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3797009|NCT01826981|3625274|B11|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3797010|NCT01826981|3625275|B10|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3797011|NCT01826981|3625276|B9|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3797012|NCT01826981|3625277|B8|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3797013|NCT01826981|3625278|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3797014|NCT01826981|3625279|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3797015|NCT01826981|3625280|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3797016|NCT01826981|3625281|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3797017|NCT01826981|3625282|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3797018|NCT01826981|3625283|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3797019|NCT01826981|3625284|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3797020|NCT01826981|3625269|B16|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
3797021|NCT01826981|3625270|B15|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3797022|NCT01826981|3625271|B14|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3797023|NCT01826981|3625272|B13|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3797024|NCT01826981|3625273|B12|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3797025|NCT01826981|3625274|B11|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3797026|NCT01826981|3625275|B10|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3797027|NCT01826981|3625276|B9|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3797028|NCT01826981|3625277|B8|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3797029|NCT01826981|3625278|B7|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3797030|NCT01826981|3625279|B6|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3797031|NCT01826981|3625280|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3797032|NCT01826981|3625281|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3797033|NCT01826981|3625282|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3797034|NCT01826981|3625283|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3797035|NCT01826981|3625284|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3797036|NCT01826981|3625269|B16|Asian||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3797037|NCT01826981|3625270|B15|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3797038|NCT01826981|3625271|B14|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3797039|NCT01826981|3625272|B13|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3797040|NCT01826981|3625273|B12|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3797041|NCT01826981|3625274|B11|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3797042|NCT01826981|3625275|B10|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3797043|NCT01826981|3625276|B9|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3797044|NCT01826981|3625277|B8|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3797045|NCT01826981|3625278|B7|Asian||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3797046|NCT01826981|3625279|B6|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3797047|NCT01826981|3625280|B5|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3797048|NCT01826981|3625281|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3797049|NCT01826981|3625282|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3797050|NCT01826981|3625283|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3797051|NCT01826981|3625284|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3797052|NCT01826981|3625269|B16|White||Race/Ethnicity, Customized||participants|Number|278|278.0||||||
3797053|NCT01826981|3625270|B15|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3797054|NCT01826981|3625271|B14|White||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3797055|NCT01826981|3625272|B13|White||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3797056|NCT01826981|3625273|B12|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3797057|NCT01826981|3625274|B11|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3797058|NCT01826981|3625275|B10|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3797059|NCT01826981|3625276|B9|White||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3797060|NCT01826981|3625277|B8|White||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
3797061|NCT01826981|3625278|B7|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3797062|NCT01826981|3625279|B6|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3797063|NCT01826981|3625280|B5|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3797064|NCT01826981|3625281|B4|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3797065|NCT01826981|3625282|B3|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3797066|NCT01826981|3625283|B2|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3797067|NCT01826981|3625284|B1|White||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3797068|NCT01826981|3625269|B16||Male|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
3797069|NCT01826981|3625270|B15||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3797070|NCT01826981|3625271|B14||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3797071|NCT01826981|3625272|B13||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3797072|NCT01826981|3625273|B12||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3797073|NCT01826981|3625274|B11||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3797074|NCT01826981|3625275|B10||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3797075|NCT01826981|3625276|B9||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3797076|NCT01826981|3625277|B8||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3797077|NCT01826981|3625278|B7||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3797078|NCT01826981|3625279|B6||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3797079|NCT01826981|3625280|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3797080|NCT01826981|3625281|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3797081|NCT01826981|3625282|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3797082|NCT01826981|3625283|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3797083|NCT01826981|3625284|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3797084|NCT01826981|3625269|B16||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3797085|NCT01826981|3625270|B15||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3797086|NCT01826981|3625271|B14||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3797087|NCT01826981|3625272|B13||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3797088|NCT01826981|3625273|B12||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3797089|NCT01826981|3625274|B11||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3797090|NCT01826981|3625275|B10||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3797091|NCT01826981|3625276|B9||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3797092|NCT01826981|3625277|B8||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3797093|NCT01826981|3625278|B7||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3797094|NCT01826981|3625279|B6||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3797095|NCT01826981|3625280|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3797096|NCT01826981|3625281|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3797097|NCT01826981|3625282|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3797098|NCT01826981|3625283|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3797099|NCT01826981|3625284|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3797100|NCT01826981|3625269|B16|||Age||Years|Mean|50.7|50.7|Standard Deviation|9.44|9.44|||
3797101|NCT01826981|3625270|B15|||Age||Years|Mean|53|53.0|Standard Deviation|6.9|6.9|||
3797102|NCT01826981|3625271|B14|||Age||Years|Mean|54|54.0|Standard Deviation|7.0|7.0|||
3797103|NCT01826981|3625272|B13|||Age||Years|Mean|47|47.0|Standard Deviation|10.3|10.3|||
3797104|NCT01826981|3625273|B12|||Age||Years|Mean|50|50.0|Standard Deviation|10.2|10.2|||
3797105|NCT01826981|3625274|B11|||Age||Years|Mean|47|47.0|Standard Deviation|7.9|7.9|||
3797106|NCT01826981|3625275|B10|||Age||Years|Mean|48|48.0|Standard Deviation|7.9|7.9|||
3797107|NCT01826981|3625276|B9|||Age||Years|Mean|56|56.0|Standard Deviation|5.5|5.5|||
3797108|NCT01826981|3625277|B8|||Age||Years|Mean|52|52.0|Standard Deviation|8.2|8.2|||
3797109|NCT01826981|3625278|B7|||Age||Years|Mean|51|51.0|Standard Deviation|13.9|13.9|||
3797110|NCT01826981|3625279|B6|||Age||Years|Mean|48|48.0|Standard Deviation|9.2|9.2|||
3797111|NCT01826981|3625280|B5|||Age||Years|Mean|43|43.0|Standard Deviation|10.2|10.2|||
3797112|NCT01826981|3625281|B4|||Age||Years|Mean|55|55.0|Standard Deviation|6.7|6.7|||
3797113|NCT01826981|3625282|B3|||Age||Years|Mean|56|56.0|Standard Deviation|5.3|5.3|||
3797114|NCT01826981|3625283|B2|||Age||Years|Mean|49|49.0|Standard Deviation|12.5|12.5|||
3797115|NCT01826981|3625284|B1|||Age||Years|Mean|55|55.0|Standard Deviation|6.1|6.1|||
3797116|NCT01826851|3625444|B3|||BMI||kg/m^2|Mean|30.7|30.7|Standard Deviation|4.7|4.7|||
3797117|NCT01826851|3625445|B2|||BMI||kg/m^2|Mean|30.4|30.4|Standard Deviation|4.7|4.7|||
3797118|NCT01826851|3625446|B1|||BMI||kg/m^2|Mean|31|31.0|Standard Deviation|4.8|4.8|||
3797119|NCT01826851|3625444|B3|United States||Region of Enrollment||Participants|Count of Participants|79|79.0||||||
3797120|NCT01826851|3625445|B2|United States||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3797121|NCT01826851|3625446|B1|United States||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
3797122|NCT01826851|3625444|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797123|NCT01826851|3625445|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797124|NCT01826851|3625446|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797125|NCT01826851|3625444|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797126|NCT01826851|3625445|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797127|NCT01826851|3625446|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797128|NCT01826851|3625444|B3||White|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3797129|NCT01826851|3625445|B2||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3797130|NCT01826851|3625446|B1||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3797131|NCT01826851|3625444|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3797132|NCT01826851|3625445|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3797133|NCT01826851|3625446|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797134|NCT01826851|3625444|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797135|NCT01826851|3625445|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797136|NCT01826851|3625446|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797137|NCT01826851|3625444|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797138|NCT01826851|3625445|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797139|NCT01826851|3625446|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797140|NCT01826851|3625444|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797141|NCT01826851|3625445|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797142|NCT01826851|3625446|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797143|NCT01826851|3625444|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3797144|NCT01826851|3625445|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3797145|NCT01826851|3625446|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3797146|NCT01826851|3625444|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3797147|NCT01826851|3625445|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3797148|NCT01826851|3625446|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3797149|NCT01826851|3625444|B3|||Age||years|Mean|65|65.0|Standard Deviation|8.19|8.19|||
3797150|NCT01826851|3625445|B2|||Age||years|Mean|64|64.0|Standard Deviation|8.6|8.6|||
3797151|NCT01826851|3625446|B1|||Age||years|Mean|66|66.0|Standard Deviation|7.7|7.7|||
3797152|NCT01826851|3625444|B3|Age Distribution|>=65 years|Age||Participants|Count of Participants|39|39.0||||||
3797153|NCT01826851|3625445|B2|Age Distribution|>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3797154|NCT01826851|3625446|B1|Age Distribution|>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3797155|NCT01826851|3625444|B3|Age Distribution|Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3797156|NCT01826851|3625445|B2|Age Distribution|Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3797157|NCT01826851|3625446|B1|Age Distribution|Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3797158|NCT01826851|3625444|B3|Age Distribution|<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3797159|NCT01826851|3625445|B2|Age Distribution|<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3797160|NCT01826851|3625446|B1|Age Distribution|<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3797161|NCT01826812|3625465|B3|||Baseline total OSS score|Ocular staining score (OSS) is sum of the corneal and conjuctival staining scores with a total possible maximum score of 12 for each eye. Corneal staining is graded with a maximum possible fluorescein score of 6 for each eye (the punctate epithelial erosions grade between 0-3 plus any extra points for modifiers up to 3). Nasal and temporal conjunctiva are graded separately with a score range between 0 and 3 for each area after instillation of lissamine green. An abnormal OSS is defined as being a total score of 3 or more.|scores on a scale of 0 to 12|Mean|4.3|4.3|Standard Deviation|3.4|3.4|||
3797162|NCT01826812|3625466|B2|||Baseline total OSS score|Ocular staining score (OSS) is sum of the corneal and conjuctival staining scores with a total possible maximum score of 12 for each eye. Corneal staining is graded with a maximum possible fluorescein score of 6 for each eye (the punctate epithelial erosions grade between 0-3 plus any extra points for modifiers up to 3). Nasal and temporal conjunctiva are graded separately with a score range between 0 and 3 for each area after instillation of lissamine green. An abnormal OSS is defined as being a total score of 3 or more.|scores on a scale of 0 to 12|Mean|0.9|0.9|Standard Deviation|0.9|0.9|||
3797163|NCT01826812|3625467|B1|||Baseline total OSS score|Ocular staining score (OSS) is sum of the corneal and conjuctival staining scores with a total possible maximum score of 12 for each eye. Corneal staining is graded with a maximum possible fluorescein score of 6 for each eye (the punctate epithelial erosions grade between 0-3 plus any extra points for modifiers up to 3). Nasal and temporal conjunctiva are graded separately with a score range between 0 and 3 for each area after instillation of lissamine green. An abnormal OSS is defined as being a total score of 3 or more.|scores on a scale of 0 to 12|Mean|4.9|4.9|Standard Deviation|3.3|3.3|||
3797164|NCT01826812|3625465|B3|||Baseline Osmolarity||mOsm/L|Mean|311|311.0|Standard Deviation|26|26.0|||
3797165|NCT01826812|3625466|B2|||Baseline Osmolarity||mOsm/L|Mean|306|306.0|Standard Deviation|10|10.0|||
3797166|NCT01826812|3625467|B1|||Baseline Osmolarity||mOsm/L|Mean|312|312.0|Standard Deviation|28|28.0|||
3797167|NCT01826812|3625465|B3|||Baseline Visual Acuity, logMAR||logMAR|Mean|-0.038|-0.038|Standard Deviation|0.11|0.11|||
3797168|NCT01826812|3625466|B2|||Baseline Visual Acuity, logMAR||logMAR|Mean|-0.03|-0.03|Standard Deviation|0.10|0.1|||
3797169|NCT01826812|3625467|B1|||Baseline Visual Acuity, logMAR||logMAR|Mean|-0.04|-0.04|Standard Deviation|0.11|0.11|||
3797170|NCT01826812|3625465|B3|United States||Region of Enrollment||participants|Number|200|200.0||||||
3797171|NCT01826812|3625466|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
3797172|NCT01826812|3625467|B1|United States||Region of Enrollment||participants|Number|167|167.0||||||
3797173|NCT01826812|3625465|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3797174|NCT01826812|3625466|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3797175|NCT01826812|3625467|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3797176|NCT01826812|3625465|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797177|NCT01826812|3625466|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797178|NCT01826812|3625467|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797179|NCT01826812|3625465|B3||White|Race (NIH/OMB)||Participants|Count of Participants|163|163.0||||||
3797180|NCT01826812|3625466|B2||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3797181|NCT01826812|3625467|B1||White|Race (NIH/OMB)||Participants|Count of Participants|139|139.0||||||
3797182|NCT01826812|3625465|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3797183|NCT01826812|3625466|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3797184|NCT01826812|3625467|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3797185|NCT01826812|3625465|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797186|NCT01826812|3625466|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797187|NCT01826812|3625467|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797188|NCT01826812|3625465|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3797189|NCT01826812|3625466|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3797190|NCT01826812|3625467|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3797191|NCT01826812|3625465|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3797192|NCT01826812|3625466|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3797193|NCT01826812|3625467|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3797194|NCT01826812|3625465|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797195|NCT01826812|3625466|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797196|NCT01826812|3625467|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797197|NCT01826812|3625465|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|192|192.0||||||
3797198|NCT01826812|3625466|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3797199|NCT01826812|3625467|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|160|160.0||||||
3797200|NCT01826812|3625465|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3797201|NCT01826812|3625466|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3797202|NCT01826812|3625467|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3797203|NCT01826812|3625465|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3797204|NCT01826812|3625466|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3797205|NCT01826812|3625467|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3797206|NCT01826812|3625465|B3||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3797207|NCT01826812|3625466|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3797208|NCT01826812|3625467|B1||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3797209|NCT01826812|3625465|B3|||Age||years|Mean|63.7|63.7|Standard Deviation|8.3|8.3|||
3797210|NCT01826812|3625466|B2|||Age||years|Mean|61.4|61.4|Standard Deviation|8.7|8.7|||
3797211|NCT01826812|3625467|B1|||Age||years|Mean|64.1|64.1|Standard Deviation|8.7|8.7|||
3797212|NCT01826604|3625482|B3|||Tobacco Use||participants|Number|73|73.0||||||
3797213|NCT01826604|3625483|B2|||Tobacco Use||participants|Number|46|46.0||||||
3797214|NCT01826604|3625484|B1|||Tobacco Use||participants|Number|27|27.0||||||
3797215|NCT01826604|3625482|B3|||Low transverse-Uterine incision|Not all participants had a low transverse uterine incision-this accounts for the difference from baseline numbers|participants|Number|279|279.0||||||
3797216|NCT01826604|3625483|B2|||Low transverse-Uterine incision|Not all participants had a low transverse uterine incision-this accounts for the difference from baseline numbers|participants|Number|144|144.0||||||
3797217|NCT01826604|3625484|B1|||Low transverse-Uterine incision|Not all participants had a low transverse uterine incision-this accounts for the difference from baseline numbers|participants|Number|135|135.0||||||
3797218|NCT01826604|3625482|B3|||Low transverse-skin incision|Not all participants had a low transverse skin incision-this accounts for the difference from baseline numbers|participants|Number|274|274.0||||||
3797219|NCT01826604|3625483|B2|||Low transverse-skin incision|Not all participants had a low transverse skin incision-this accounts for the difference from baseline numbers|participants|Number|144|144.0||||||
3797220|NCT01826604|3625484|B1|||Low transverse-skin incision|Not all participants had a low transverse skin incision-this accounts for the difference from baseline numbers|participants|Number|130|130.0||||||
3797221|NCT01826604|3625482|B3|||Group beta streptococcus colonization|Not all participants were positive for GBS-this accounts for the difference from baseline numbers|participants|Number|87|87.0||||||
3797222|NCT01826604|3625483|B2|||Group beta streptococcus colonization|Not all participants were positive for GBS-this accounts for the difference from baseline numbers|participants|Number|49|49.0||||||
3797223|NCT01826604|3625484|B1|||Group beta streptococcus colonization|Not all participants were positive for GBS-this accounts for the difference from baseline numbers|participants|Number|38|38.0||||||
3797224|NCT01826604|3625482|B3|||Chorioamnionitis|Not all participants had chorioamnionitis-this accounts for the difference from baseline numbers|participants|Number|14|14.0||||||
3797225|NCT01826604|3625483|B2|||Chorioamnionitis|Not all participants had chorioamnionitis-this accounts for the difference from baseline numbers|participants|Number|6|6.0||||||
3797226|NCT01826604|3625484|B1|||Chorioamnionitis|Not all participants had chorioamnionitis-this accounts for the difference from baseline numbers|participants|Number|8|8.0||||||
3797227|NCT01826604|3625482|B3|||Subcutaneous thickness||cm|Median|3.0|3.0|Full Range|||2.0|4.0|
3797228|NCT01826604|3625483|B2|||Subcutaneous thickness||cm|Median|3.0|3.0|Full Range|||2.3|4.0|
3797229|NCT01826604|3625484|B1|||Subcutaneous thickness||cm|Median|3.0|3.0|Full Range|||2.0|4.0|
3797230|NCT01826604|3625482|B3|||BMI|BMI mean|kg/m2|Median|40.1|40.1|Full Range|||34.9|46.5|
3797231|NCT01826604|3625483|B2|||BMI|BMI mean|kg/m2|Median|40.6|40.6|Full Range|||34.9|46.5|
3797232|NCT01826604|3625484|B1|||BMI|BMI mean|kg/m2|Median|39.9|39.9|Full Range|||35.6|45.6|
3797233|NCT01826604|3625482|B3|||Gravidity||live births|Mean|3|3.0|Full Range|||2.0|4.0|
3797234|NCT01826604|3625483|B2|||Gravidity||live births|Mean|3|3.0|Full Range|||2.0|4.0|
3797235|NCT01826604|3625484|B1|||Gravidity||live births|Mean|3|3.0|Full Range|||2.0|4.0|
3797236|NCT01826604|3625482|B3|United States||Region of Enrollment||participants|Number|301|301.0||||||
3797237|NCT01826604|3625483|B2|United States||Region of Enrollment||participants|Number|157|157.0||||||
3797238|NCT01826604|3625484|B1|United States||Region of Enrollment||participants|Number|144|144.0||||||
3797239|NCT01826604|3625482|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3797240|NCT01826604|3625483|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3797241|NCT01826604|3625484|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3797242|NCT01826604|3625482|B3||Female|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
3797243|NCT01826604|3625483|B2||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3797244|NCT01826604|3625484|B1||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3797245|NCT01826604|3625482|B3|||Age||years|Mean|28.8|28.8|Full Range|||24.0|33.0|
3797246|NCT01826604|3625483|B2|||Age||years|Mean|29|29.0|Full Range|||24.5|32.0|
3797247|NCT01826604|3625484|B1|||Age||years|Mean|28.5|28.5|Full Range|||24.0|33.0|
3797248|NCT01826604|3625482|B3||>=65 years|Age|Age of participants|Participants|Count of Participants|0|0.0||||||
3797249|NCT01826604|3625483|B2||>=65 years|Age|Age of participants|Participants|Count of Participants|0|0.0||||||
3797250|NCT01826604|3625484|B1||>=65 years|Age|Age of participants|Participants|Count of Participants|0|0.0||||||
3797251|NCT01826604|3625482|B3||Between 18 and 65 years|Age|Age of participants|Participants|Count of Participants|301|301.0||||||
3797252|NCT01826604|3625483|B2||Between 18 and 65 years|Age|Age of participants|Participants|Count of Participants|157|157.0||||||
3797253|NCT01826604|3625484|B1||Between 18 and 65 years|Age|Age of participants|Participants|Count of Participants|144|144.0||||||
3797254|NCT01826604|3625482|B3||<=18 years|Age|Age of participants|Participants|Count of Participants|0|0.0||||||
3797255|NCT01826604|3625483|B2||<=18 years|Age|Age of participants|Participants|Count of Participants|0|0.0||||||
3797256|NCT01826604|3625484|B1||<=18 years|Age|Age of participants|Participants|Count of Participants|0|0.0||||||
3797257|NCT01826513|3625493|B4|Australia||Region of Enrollment||participants|Number|25|25.0||||||
3797258|NCT01826513|3625494|B3|Australia||Region of Enrollment||participants|Number|10|10.0||||||
3797259|NCT01826513|3625495|B2|Australia||Region of Enrollment||participants|Number|10|10.0||||||
3797260|NCT01826513|3625496|B1|Australia||Region of Enrollment||participants|Number|5|5.0||||||
3797261|NCT01826513|3625493|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3797262|NCT01826513|3625494|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3797263|NCT01826513|3625495|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3797264|NCT01826513|3625496|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3797265|NCT01826513|3625493|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3797266|NCT01826513|3625494|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3797267|NCT01826513|3625495|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3797268|NCT01826513|3625496|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3797269|NCT01826513|3625493|B4|||Age||years|Mean|44.85|44.85|Standard Deviation|5.02|5.02|||
3797270|NCT01826513|3625494|B3|||Age||years|Mean|45.60|45.6|Standard Deviation|6.13|6.13|||
3797271|NCT01826513|3625495|B2|||Age||years|Mean|44.10|44.1|Standard Deviation|3.78|3.78|||
3797272|NCT01826513|3625496|B1|||Age||years|Mean|43.60|43.6|Standard Deviation|7.70|7.7|||
3797273|NCT01826422|3625527|B3|Mexico||Region of Enrollment||participants|Number|36|36.0||||||
3797274|NCT01826422|3625528|B2|Mexico||Region of Enrollment||participants|Number|19|19.0||||||
3797275|NCT01826422|3625529|B1|Mexico||Region of Enrollment||participants|Number|17|17.0||||||
3797276|NCT01826422|3625527|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3797277|NCT01826422|3625528|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3797278|NCT01826422|3625529|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3797279|NCT01826422|3625527|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3797280|NCT01826422|3625528|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3797281|NCT01826422|3625529|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3797282|NCT01826422|3625527|B3|||Age||years|Mean|8.1|8.1|Standard Deviation|2.9|2.9|||
3797283|NCT01826422|3625528|B2|||Age||years|Mean|8.6|8.6|Standard Deviation|2.9|2.9|||
3797284|NCT01826422|3625529|B1|||Age||years|Mean|7.3|7.3|Standard Deviation|3.1|3.1|||
3797285|NCT01826422|3625527|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3797286|NCT01826422|3625528|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3797287|NCT01826422|3625529|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3797288|NCT01826422|3625527|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3797289|NCT01826422|3625528|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3797290|NCT01826422|3625529|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3797291|NCT01826422|3625527|B3||<=18 years|Age||Participants|Count of Participants|36|36.0||||||
3797292|NCT01826422|3625528|B2||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
3797293|NCT01826422|3625529|B1||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
3797294|NCT01826370|3625574|B1|Male||Gender|Gender information is missing for 4 patients|participants|Number|296|296.0||||||
3797295|NCT01826370|3625574|B1|Female||Gender|Gender information is missing for 4 patients|participants|Number|360|360.0||||||
3797296|NCT01826370|3625574|B1|||Age|Age information is missing for 5 patients|years|Mean|57.67|57.67|Standard Deviation|13.3|13.3|||
3797297|NCT01826227|3625580|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3797298|NCT01826227|3625580|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797299|NCT01826227|3625580|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797300|NCT01826227|3625580|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3797301|NCT01826227|3625580|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797302|NCT01826227|3625580|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797303|NCT01826227|3625580|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3797304|NCT01826227|3625580|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797305|NCT01826227|3625580|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797306|NCT01826227|3625580|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3797307|NCT01826227|3625580|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797308|NCT01826227|3625580|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3797309|NCT01826227|3625580|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3797310|NCT01826227|3625580|B1|||Age||years|Median|62|62.0|Full Range|||44.0|69.0|
3797311|NCT01826214|3625584|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3797312|NCT01826214|3625585|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3797313|NCT01826214|3625586|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3797314|NCT01826214|3625584|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3797315|NCT01826214|3625585|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3797316|NCT01826214|3625586|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3797317|NCT01826214|3625584|B3|||Age||Years|Mean|66.5|66.5|Standard Deviation|11.96|11.96|||
3797318|NCT01826214|3625585|B2|||Age||Years|Mean|67.7|67.7|Standard Deviation|11.65|11.65|||
3797319|NCT01826214|3625586|B1|||Age||Years|Mean|65.3|65.3|Standard Deviation|12.31|12.31|||
3797320|NCT01826201|3625605|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3797321|NCT01826201|3625605|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3797322|NCT01826201|3625605|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3797323|NCT01826201|3625605|B1|||Age||years|Mean|53|53.0|Standard Deviation|11.26|11.26|||
3797324|NCT01825941|3625611|B3|||Duration of headache Prior to Study||Hours|Median|48|48.0|Inter-Quartile Range|||24.0|96.0|
3797325|NCT01825941|3625612|B2|||Duration of headache Prior to Study||Hours|Median|48|48.0|Inter-Quartile Range|||16.0|72.0|
3797326|NCT01825941|3625613|B1|||Duration of headache Prior to Study||Hours|Median|72|72.0|Inter-Quartile Range|||24.0|96.0|
3797327|NCT01825941|3625611|B3|United States||Region of Enrollment||Participants|Count of Participants|208|208.0||||||
3797328|NCT01825941|3625612|B2|United States||Region of Enrollment||Participants|Count of Participants|104|104.0||||||
3797329|NCT01825941|3625613|B1|United States||Region of Enrollment||Participants|Count of Participants|104|104.0||||||
3797330|NCT01825941|3625611|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3797331|NCT01825941|3625611|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3797332|NCT01825941|3625612|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3797333|NCT01825941|3625613|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3797334|NCT01825941|3625611|B3||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3797335|NCT01825941|3625612|B2||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3797336|NCT01825941|3625613|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3797337|NCT01825941|3625611|B3|||Age||years|Mean|35|35.0|Standard Deviation|10|10.0|||
3797338|NCT01825941|3625612|B2|||Age||years|Mean|36|36.0|Standard Deviation|10|10.0|||
3797339|NCT01825941|3625613|B1|||Age||years|Mean|34|34.0|Standard Deviation|11|11.0|||
3797340|NCT01825889|3625620|B3|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3797341|NCT01825889|3625621|B2|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3797342|NCT01825889|3625622|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3797343|NCT01825889|3625620|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797344|NCT01825889|3625621|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797345|NCT01825889|3625622|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797346|NCT01825889|3625620|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3797347|NCT01825889|3625621|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3797348|NCT01825889|3625622|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797349|NCT01825889|3625620|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3797350|NCT01825889|3625621|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3797351|NCT01825889|3625622|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3797352|NCT01825889|3625620|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3797353|NCT01825889|3625621|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797354|NCT01825889|3625622|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3797355|NCT01825889|3625620|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797356|NCT01825889|3625621|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797357|NCT01825889|3625622|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797358|NCT01825889|3625620|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797359|NCT01825889|3625621|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797360|NCT01825889|3625622|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797361|NCT01825889|3625620|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797362|NCT01825889|3625621|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797363|NCT01825889|3625622|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797424|NCT01825798|3625666|B3|Canada||Region of Enrollment||participants|Number|16|16.0||||||
3797364|NCT01825889|3625620|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797365|NCT01825889|3625621|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797366|NCT01825889|3625622|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797367|NCT01825889|3625620|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3797368|NCT01825889|3625621|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3797369|NCT01825889|3625622|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3797370|NCT01825889|3625620|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3797371|NCT01825889|3625621|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3797372|NCT01825889|3625622|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3797373|NCT01825889|3625620|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3797374|NCT01825889|3625621|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3797375|NCT01825889|3625622|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3797376|NCT01825889|3625620|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3797377|NCT01825889|3625621|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3797378|NCT01825889|3625622|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3797379|NCT01825889|3625620|B3|||Age||years|Mean|63.4|63.4|Standard Deviation|8.8|8.8|||
3797380|NCT01825889|3625621|B2|||Age||years|Mean|61.5|61.5|Standard Deviation|8.0|8.0|||
3797381|NCT01825889|3625622|B1|||Age||years|Mean|65.2|65.2|Standard Deviation|9.6|9.6|||
3797382|NCT01825876|3625633|B1|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3797383|NCT01825876|3625633|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797384|NCT01825876|3625633|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797385|NCT01825876|3625633|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3797386|NCT01825876|3625633|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3797387|NCT01825876|3625633|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797388|NCT01825876|3625633|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797389|NCT01825876|3625633|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797390|NCT01825876|3625633|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797391|NCT01825876|3625633|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3797392|NCT01825876|3625633|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3797393|NCT01825876|3625633|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3797394|NCT01825876|3625633|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3797395|NCT01825876|3625633|B1|||Age||years|Mean|38.2|38.2|Standard Deviation|9.4|9.4|||
3797396|NCT01825837|3625651|B5||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3797397|NCT01825837|3625652|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3797398|NCT01825837|3625653|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3797399|NCT01825837|3625654|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3797400|NCT01825837|3625655|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3797401|NCT01825837|3625651|B5||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3797402|NCT01825837|3625652|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3797403|NCT01825837|3625653|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3797404|NCT01825837|3625654|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3797405|NCT01825837|3625655|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3797406|NCT01825837|3625651|B5||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3797407|NCT01825837|3625652|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3797408|NCT01825837|3625653|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3797409|NCT01825837|3625654|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3797410|NCT01825837|3625655|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3797411|NCT01825837|3625651|B5||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
3797412|NCT01825837|3625652|B4||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3797413|NCT01825837|3625653|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3797414|NCT01825837|3625654|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3797415|NCT01825837|3625655|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3797416|NCT01825837|3625651|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3797417|NCT01825837|3625652|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3797418|NCT01825837|3625653|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3797419|NCT01825837|3625654|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3797420|NCT01825837|3625655|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3797421|NCT01825798|3625666|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
3797422|NCT01825798|3625667|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3797423|NCT01825798|3625668|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3797425|NCT01825798|3625667|B2|Canada||Region of Enrollment||participants|Number|8|8.0||||||
3797426|NCT01825798|3625668|B1|Canada||Region of Enrollment||participants|Number|8|8.0||||||
3797427|NCT01825798|3625666|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3797428|NCT01825798|3625667|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3797429|NCT01825798|3625668|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3797430|NCT01825798|3625666|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797431|NCT01825798|3625667|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797432|NCT01825798|3625668|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797433|NCT01825798|3625666|B3||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3797434|NCT01825798|3625667|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3797435|NCT01825798|3625668|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3797436|NCT01825798|3625666|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3797437|NCT01825798|3625667|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3797438|NCT01825798|3625668|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3797439|NCT01825798|3625666|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797440|NCT01825798|3625667|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797441|NCT01825798|3625668|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797442|NCT01825798|3625666|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3797443|NCT01825798|3625667|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3797444|NCT01825798|3625668|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3797445|NCT01825798|3625666|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797446|NCT01825798|3625667|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797447|NCT01825798|3625668|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797448|NCT01825798|3625666|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3797449|NCT01825798|3625667|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797450|NCT01825798|3625668|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3797451|NCT01825798|3625666|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3797452|NCT01825798|3625667|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3797453|NCT01825798|3625668|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3797454|NCT01825798|3625666|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3797455|NCT01825798|3625667|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797456|NCT01825798|3625668|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3797457|NCT01825798|3625666|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3797458|NCT01825798|3625667|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3797459|NCT01825798|3625668|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3797460|NCT01825798|3625666|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3797461|NCT01825798|3625667|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3797462|NCT01825798|3625668|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3797463|NCT01825798|3625666|B3|||Age||years|Mean|12.8|12.8|Standard Deviation|2.7|2.7|||
3797464|NCT01825798|3625667|B2|||Age||years|Mean|12.9|12.9|Standard Deviation|2.85|2.85|||
3797465|NCT01825798|3625668|B1|||Age||years|Mean|12.7|12.7|Standard Deviation|2.64|2.64|||
3797466|NCT01825798|3625666|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3797467|NCT01825798|3625667|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3797468|NCT01825798|3625668|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3797469|NCT01825798|3625666|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3797470|NCT01825798|3625667|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3797471|NCT01825798|3625668|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3797472|NCT01825798|3625666|B3||<=18 years|Age||Participants|Count of Participants|60|60.0||||||
3797473|NCT01825798|3625667|B2||<=18 years|Age||Participants|Count of Participants|28|28.0||||||
3797474|NCT01825798|3625668|B1||<=18 years|Age||Participants|Count of Participants|32|32.0||||||
3797475|NCT01825655|3625697|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3797476|NCT01825655|3625698|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3797477|NCT01825655|3625697|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797478|NCT01825655|3625698|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797479|NCT01825655|3625699|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797480|NCT01825655|3625697|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797481|NCT01825655|3625698|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797482|NCT01825655|3625699|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797483|NCT01825655|3625697|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3797484|NCT01825655|3625698|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3797485|NCT01825655|3625699|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797486|NCT01825655|3625697|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3797487|NCT01825655|3625698|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3797488|NCT01825655|3625699|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797489|NCT01825655|3625697|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797490|NCT01825655|3625698|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797491|NCT01825655|3625699|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797492|NCT01825655|3625697|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797493|NCT01825655|3625698|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797494|NCT01825655|3625699|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797495|NCT01825655|3625697|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797496|NCT01825655|3625698|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797497|NCT01825655|3625699|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797498|NCT01825655|3625697|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3797499|NCT01825655|3625698|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3797500|NCT01825655|3625699|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3797501|NCT01825655|3625697|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3797502|NCT01825655|3625698|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3797503|NCT01825655|3625699|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3797504|NCT01825655|3625697|B3|Between 6 and 21 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
3797505|NCT01825655|3625698|B2|Between 6 and 21 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
3797506|NCT01825655|3625699|B1|Between 6 and 21 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3797507|NCT01825577|3625706|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3797508|NCT01825577|3625706|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3797509|NCT01825577|3625706|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3797510|NCT01825577|3625706|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3797511|NCT01825577|3625706|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3797512|NCT01825577|3625706|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3797513|NCT01825408|3625711|B5||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3797514|NCT01825408|3625712|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3797515|NCT01825408|3625713|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3797516|NCT01825408|3625714|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3797517|NCT01825408|3625715|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3797518|NCT01825408|3625711|B5||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3797519|NCT01825408|3625712|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3797520|NCT01825408|3625713|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3797521|NCT01825408|3625714|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3797522|NCT01825408|3625715|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3797523|NCT01825408|3625711|B5||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3797524|NCT01825408|3625712|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3797525|NCT01825408|3625713|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3797526|NCT01825408|3625714|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3797527|NCT01825408|3625715|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3797528|NCT01825408|3625711|B5||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3797529|NCT01825408|3625712|B4||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3797530|NCT01825408|3625713|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3797531|NCT01825408|3625714|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3797532|NCT01825408|3625715|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3797533|NCT01825408|3625711|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3797534|NCT01825408|3625712|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3797535|NCT01825408|3625713|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3797536|NCT01825408|3625714|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3797537|NCT01825408|3625715|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3797538|NCT01825200|3625728|B3|United States||Region of Enrollment||participants|Number|2627|2627.0||||||
3797539|NCT01825200|3625729|B2|United States||Region of Enrollment||participants|Number|1313|1313.0||||||
3797540|NCT01825200|3625730|B1|United States||Region of Enrollment||participants|Number|1314|1314.0||||||
3797541|NCT01825200|3625728|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797542|NCT01825200|3625729|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797543|NCT01825200|3625730|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797544|NCT01825200|3625728|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2423|2423.0||||||
3797545|NCT01825200|3625729|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1214|1214.0||||||
3797546|NCT01825200|3625730|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1209|1209.0||||||
3797547|NCT01825200|3625728|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|204|204.0||||||
3797548|NCT01825200|3625729|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3797549|NCT01825200|3625730|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
3797550|NCT01825200|3625728|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797551|NCT01825200|3625729|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797552|NCT01825200|3625730|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797553|NCT01825200|3625728|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3797554|NCT01825200|3625729|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3797555|NCT01825200|3625730|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3797556|NCT01825200|3625728|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2181|2181.0||||||
3797557|NCT01825200|3625729|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1083|1083.0||||||
3797558|NCT01825200|3625730|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1098|1098.0||||||
3797559|NCT01825200|3625728|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|409|409.0||||||
3797560|NCT01825200|3625729|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|212|212.0||||||
3797561|NCT01825200|3625730|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|197|197.0||||||
3797562|NCT01825200|3625728|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3797563|NCT01825200|3625729|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3797564|NCT01825200|3625730|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3797565|NCT01825200|3625728|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3797566|NCT01825200|3625729|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3797567|NCT01825200|3625730|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3797568|NCT01825200|3625728|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3797569|NCT01825200|3625729|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3797570|NCT01825200|3625730|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3797571|NCT01825200|3625728|B3||Male|Sex: Female, Male||Participants|Count of Participants|1172|1172.0||||||
3797572|NCT01825200|3625729|B2||Male|Sex: Female, Male||Participants|Count of Participants|588|588.0||||||
3797573|NCT01825200|3625730|B1||Male|Sex: Female, Male||Participants|Count of Participants|584|584.0||||||
3797574|NCT01825200|3625728|B3||Female|Sex: Female, Male||Participants|Count of Participants|1455|1455.0||||||
3797575|NCT01825200|3625729|B2||Female|Sex: Female, Male||Participants|Count of Participants|725|725.0||||||
3797576|NCT01825200|3625730|B1||Female|Sex: Female, Male||Participants|Count of Participants|730|730.0||||||
3797577|NCT01825200|3625728|B3||>=65 years|Age||Participants|Count of Participants|1290|1290.0||||||
3797578|NCT01825200|3625729|B2||>=65 years|Age||Participants|Count of Participants|648|648.0||||||
3797579|NCT01825200|3625730|B1||>=65 years|Age||Participants|Count of Participants|642|642.0||||||
3797580|NCT01825200|3625728|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1337|1337.0||||||
3797581|NCT01825200|3625729|B2||Between 18 and 65 years|Age||Participants|Count of Participants|665|665.0||||||
3797582|NCT01825200|3625730|B1||Between 18 and 65 years|Age||Participants|Count of Participants|672|672.0||||||
3797583|NCT01825200|3625728|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3797584|NCT01825200|3625729|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3797585|NCT01825200|3625730|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3797586|NCT01825200|3625728|B3|||Age||years|Mean|64|64.0|Full Range|||50.0|99.0|
3797587|NCT01825200|3625729|B2|||Age||years|Mean|64|64.0|Full Range|||50.0|93.0|
3797588|NCT01825200|3625730|B1|||Age||years|Mean|64|64.0|Full Range|||50.0|99.0|
3797589|NCT01825122|3625743|B3|United States||Region of Enrollment||participants|Number|155|155.0||||||
3797590|NCT01825122|3625744|B2|United States||Region of Enrollment||participants|Number|78|78.0||||||
3797591|NCT01825122|3625745|B1|United States||Region of Enrollment||participants|Number|77|77.0||||||
3797592|NCT01825122|3625743|B3||Male|Gender||Participants|Count of Participants|77|77.0||||||
3797593|NCT01825122|3625744|B2||Male|Gender||Participants|Count of Participants|45|45.0||||||
3797594|NCT01825122|3625745|B1||Male|Gender||Participants|Count of Participants|32|32.0||||||
3797595|NCT01825122|3625743|B3||Female|Gender||Participants|Count of Participants|78|78.0||||||
3797596|NCT01825122|3625744|B2||Female|Gender||Participants|Count of Participants|33|33.0||||||
3797597|NCT01825122|3625745|B1||Female|Gender||Participants|Count of Participants|45|45.0||||||
3797598|NCT01825122|3625743|B3|||Age||years|Mean|46.06|46.06|Standard Deviation|13.17|13.17|||
3797599|NCT01825122|3625744|B2|||Age||years|Mean|44.08|44.08|Standard Deviation|12.52|12.52|||
3797600|NCT01825122|3625745|B1|||Age||years|Mean|48.08|48.08|Standard Deviation|13.58|13.58|||
3797601|NCT01825122|3625743|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3797602|NCT01825122|3625744|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3797603|NCT01825122|3625745|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3797604|NCT01825122|3625743|B3||Between 18 and 65 years|Age||Participants|Count of Participants|143|143.0||||||
3797605|NCT01825122|3625744|B2||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
3797606|NCT01825122|3625745|B1||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
3797607|NCT01825122|3625743|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3797608|NCT01825122|3625744|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3797609|NCT01825122|3625745|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3797610|NCT01824979|3625752|B3|United States||Region of Enrollment||Participants|Count of Participants|100|100.0||||||
3797611|NCT01824979|3625753|B2|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3797612|NCT01824979|3625754|B1|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3797613|NCT01824979|3625752|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3797614|NCT01824979|3625753|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3797615|NCT01824979|3625754|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3797616|NCT01824979|3625752|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3797617|NCT01824979|3625753|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3797618|NCT01824979|3625754|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3797619|NCT01824979|3625752|B3|≥ 18 years||Age, Customized|Inclusion criteria only confirmed participants were over the age of 18. Full date of birth was not recorded on the case report form. Therefore, the exact breakdown of participants in each age bracket is unable to be provided as is required in the non-customized Baseline measure.|Participants|Count of Participants|100|100.0||||||
3797620|NCT01824979|3625753|B2|≥ 18 years||Age, Customized|Inclusion criteria only confirmed participants were over the age of 18. Full date of birth was not recorded on the case report form. Therefore, the exact breakdown of participants in each age bracket is unable to be provided as is required in the non-customized Baseline measure.|Participants|Count of Participants|50|50.0||||||
3797621|NCT01824979|3625754|B1|≥ 18 years||Age, Customized|Inclusion criteria only confirmed participants were over the age of 18. Full date of birth was not recorded on the case report form. Therefore, the exact breakdown of participants in each age bracket is unable to be provided as is required in the non-customized Baseline measure.|Participants|Count of Participants|50|50.0||||||
3797622|NCT01824901|3625763|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3797623|NCT01824901|3625763|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3797624|NCT01824901|3625763|B1|||Age||years|Median|66.5|66.5|Full Range|||56.0|77.0|
3797625|NCT01824823|3625770|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3797626|NCT01824823|3625771|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3797627|NCT01824823|3625772|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3797628|NCT01824823|3625770|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3797629|NCT01824823|3625771|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3797630|NCT01824823|3625772|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3797631|NCT01824823|3625770|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3797632|NCT01824823|3625771|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3797633|NCT01824823|3625772|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3797634|NCT01824823|3625770|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3797635|NCT01824823|3625771|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3797636|NCT01824823|3625772|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3797637|NCT01824823|3625770|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3797638|NCT01824823|3625771|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3797639|NCT01824823|3625772|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3797640|NCT01824693|3625779|B4|New Zealand||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3797641|NCT01824693|3625780|B3|New Zealand||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3797642|NCT01824693|3625781|B2|New Zealand||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3797643|NCT01824693|3625782|B1|New Zealand||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3797644|NCT01824693|3625779|B4|Kuwait||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3797645|NCT01824693|3625780|B3|Kuwait||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3797646|NCT01824693|3625781|B2|Kuwait||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3797647|NCT01824693|3625782|B1|Kuwait||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3797648|NCT01824693|3625779|B4|Australia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3797649|NCT01824693|3625780|B3|Australia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3797650|NCT01824693|3625781|B2|Australia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3797651|NCT01824693|3625782|B1|Australia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3797652|NCT01824693|3625779|B4|Canada||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3797653|NCT01824693|3625780|B3|Canada||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3797654|NCT01824693|3625781|B2|Canada||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3797655|NCT01824693|3625782|B1|Canada||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3797656|NCT01824693|3625779|B4|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3797657|NCT01824693|3625780|B3|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3797658|NCT01824693|3625781|B2|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3797659|NCT01824693|3625782|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3797660|NCT01824693|3625779|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3797661|NCT01824693|3625780|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3797662|NCT01824693|3625781|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797663|NCT01824693|3625782|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3797664|NCT01824693|3625779|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797665|NCT01824693|3625780|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797666|NCT01824693|3625781|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797667|NCT01824693|3625782|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797668|NCT01824693|3625779|B4||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3797669|NCT01824693|3625780|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3797670|NCT01824693|3625781|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3797671|NCT01824693|3625782|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3797672|NCT01824693|3625779|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3797673|NCT01824693|3625780|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3797674|NCT01824693|3625781|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797675|NCT01824693|3625782|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797676|NCT01824693|3625779|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797677|NCT01824693|3625780|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797678|NCT01824693|3625781|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797679|NCT01824693|3625782|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797680|NCT01824693|3625779|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3797681|NCT01824693|3625780|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3797682|NCT01824693|3625781|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3797683|NCT01824693|3625782|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3797684|NCT01824693|3625779|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3797685|NCT01824693|3625780|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3797686|NCT01824693|3625781|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797687|NCT01824693|3625782|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797688|NCT01824693|3625779|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797689|NCT01824693|3625780|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797690|NCT01824693|3625781|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797691|NCT01824693|3625782|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797692|NCT01824693|3625779|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3797693|NCT01824693|3625780|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3797694|NCT01824693|3625781|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3797695|NCT01824693|3625782|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3797696|NCT01824693|3625779|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3797697|NCT01824693|3625780|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3797698|NCT01824693|3625781|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3797699|NCT01824693|3625782|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797700|NCT01824693|3625779|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3797701|NCT01824693|3625780|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3797702|NCT01824693|3625781|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3797703|NCT01824693|3625782|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3797704|NCT01824693|3625779|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3797705|NCT01824693|3625780|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3797706|NCT01824693|3625781|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3797707|NCT01824693|3625782|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3797708|NCT01824693|3625779|B4|||Age||years|Mean|1.00|1.0|Standard Deviation|2.42|2.42|||
3797709|NCT01824693|3625780|B3|||Age||years|Mean|1.27|1.27|Standard Deviation|1.75|1.75|||
3797710|NCT01824693|3625781|B2|||Age||years|Mean|2.33|2.33|Standard Deviation|3.71|3.71|||
3797711|NCT01824693|3625782|B1|||Age||years|Mean|0.50|0.5|Standard Deviation|0.84|0.84|||
3797712|NCT01824693|3625779|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3797713|NCT01824693|3625780|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3797714|NCT01824693|3625781|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3797715|NCT01824693|3625782|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3797716|NCT01824693|3625779|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3797717|NCT01824693|3625780|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3797718|NCT01824693|3625781|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3797719|NCT01824693|3625782|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3797720|NCT01824693|3625779|B4||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
3797721|NCT01824693|3625780|B3||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
3797722|NCT01824693|3625781|B2||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
3797723|NCT01824693|3625782|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3797724|NCT01824602|3625797|B5||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3797725|NCT01824602|3625798|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3797726|NCT01824602|3625799|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3797727|NCT01824602|3625800|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3797728|NCT01824602|3625801|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3797729|NCT01824602|3625797|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3797730|NCT01824602|3625798|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3797731|NCT01824602|3625799|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3797732|NCT01824602|3625800|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3797733|NCT01824602|3625801|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3797734|NCT01824602|3625797|B5|>=65 years||Age, Customized||participants|Number|1|1.0||||||
3797735|NCT01824602|3625798|B4|>=65 years||Age, Customized||participants|Number|1|1.0||||||
3797736|NCT01824602|3625799|B3|>=65 years||Age, Customized||participants|Number|0|0.0||||||
3797737|NCT01824602|3625800|B2|>=65 years||Age, Customized||participants|Number|0|0.0||||||
3797738|NCT01824602|3625801|B1|>=65 years||Age, Customized||participants|Number|0|0.0||||||
3797739|NCT01824602|3625797|B5|Between 18 and 65 years||Age, Customized||participants|Number|37|37.0||||||
3797740|NCT01824602|3625798|B4|Between 18 and 65 years||Age, Customized||participants|Number|9|9.0||||||
3797741|NCT01824602|3625799|B3|Between 18 and 65 years||Age, Customized||participants|Number|9|9.0||||||
3797742|NCT01824602|3625800|B2|Between 18 and 65 years||Age, Customized||participants|Number|8|8.0||||||
3797743|NCT01824602|3625801|B1|Between 18 and 65 years||Age, Customized||participants|Number|11|11.0||||||
3797744|NCT01824602|3625797|B5|<=18 years||Age, Customized||participants|Number|0|0.0||||||
3797745|NCT01824602|3625798|B4|<=18 years||Age, Customized||participants|Number|0|0.0||||||
3797746|NCT01824602|3625799|B3|<=18 years||Age, Customized||participants|Number|0|0.0||||||
3797747|NCT01824602|3625800|B2|<=18 years||Age, Customized||participants|Number|0|0.0||||||
3797748|NCT01824602|3625801|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
3797749|NCT01824589|3625814|B5|Male||Gender||participants|Number|1|1.0||||||
3797750|NCT01824589|3625818|B1|Male||Gender||participants|Number|1|1.0||||||
3797751|NCT01824589|3625814|B5|Female||Gender||participants|Number|0|0.0||||||
3797752|NCT01824589|3625818|B1|Female||Gender||participants|Number|0|0.0||||||
3797753|NCT01824589|3625814|B5|>=65 years||Age||participants|Number|1|1.0||||||
3797754|NCT01824589|3625818|B1|>=65 years||Age||participants|Number|1|1.0||||||
3797755|NCT01824589|3625814|B5|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
3797756|NCT01824589|3625818|B1|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
3797757|NCT01824589|3625814|B5|<=18 years||Age||participants|Number|0|0.0||||||
3797758|NCT01824589|3625818|B1|<=18 years||Age||participants|Number|0|0.0||||||
3797759|NCT01824576|3625843|B1|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3797760|NCT01824576|3625843|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3797761|NCT01824576|3625843|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3797762|NCT01824576|3625843|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3797763|NCT01824576|3625843|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3797764|NCT01824576|3625843|B1|||Age||years|Mean|44.9|44.9|Standard Deviation|13.1|13.1|||
3797765|NCT01824498|3625855|B7|United States||Region of Enrollment||participants|Number|24|24.0||||||
3797766|NCT01824498|3625856|B6|United States||Region of Enrollment||participants|Number|4|4.0||||||
3797767|NCT01824498|3625857|B5|United States||Region of Enrollment||participants|Number|4|4.0||||||
3797768|NCT01824498|3625858|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
3797769|NCT01824498|3625859|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3797770|NCT01824498|3625860|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3797771|NCT01824498|3625861|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3797772|NCT01824498|3625855|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3797773|NCT01824498|3625856|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3797774|NCT01824498|3625857|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3797775|NCT01824498|3625858|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3797776|NCT01824498|3625859|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3797777|NCT01824498|3625860|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3797778|NCT01824498|3625861|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3797779|NCT01824498|3625855|B7||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3797780|NCT01824498|3625856|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3797781|NCT01824498|3625857|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3797782|NCT01824498|3625858|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3797783|NCT01824498|3625859|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3797784|NCT01824498|3625860|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3797785|NCT01824498|3625861|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3797786|NCT01824498|3625855|B7|||Age||years|Mean|57|57.0|Standard Deviation|2|2.0|||
3797787|NCT01824498|3625856|B6|||Age||years|Mean|57|57.0|Standard Deviation|2|2.0|||
3797788|NCT01824498|3625857|B5|||Age||years|Mean|57|57.0|Standard Deviation|2|2.0|||
3797789|NCT01824498|3625858|B4|||Age||years|Mean|57|57.0|Standard Deviation|2|2.0|||
3797790|NCT01824498|3625859|B3|||Age||years|Mean|57|57.0|Standard Deviation|2|2.0|||
3797791|NCT01824498|3625860|B2|||Age||years|Mean|57|57.0|Standard Deviation|2|2.0|||
3797792|NCT01824498|3625861|B1|||Age||years|Mean|57|57.0|Standard Deviation|2|2.0|||
3797793|NCT01824498|3625855|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3797794|NCT01824498|3625856|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3797795|NCT01824498|3625857|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3797796|NCT01824498|3625858|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3797797|NCT01824498|3625859|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3797798|NCT01824498|3625860|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3797799|NCT01824498|3625861|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3797800|NCT01824498|3625855|B7||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3797801|NCT01824498|3625856|B6||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3797802|NCT01824498|3625857|B5||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3797803|NCT01824498|3625858|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3797804|NCT01824498|3625859|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3797805|NCT01824498|3625860|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3797806|NCT01824498|3625861|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3797807|NCT01824498|3625855|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3797808|NCT01824498|3625856|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3797809|NCT01824498|3625857|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3797810|NCT01824498|3625858|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3797811|NCT01824498|3625859|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3797812|NCT01824498|3625860|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3797813|NCT01824498|3625861|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3797814|NCT01824446|3625874|B1|UNITED STATES||Region of Enrollment||Participants|Number|6|6.0||||||
3797815|NCT01824446|3625874|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3797816|NCT01824446|3625874|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3797817|NCT01824446|3625874|B1|||Age||Years|Mean|29.2|29.2|Standard Deviation|3.76|3.76|||
3797818|NCT01824446|3625874|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3797819|NCT01824446|3625874|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3797820|NCT01824446|3625874|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3797821|NCT01824394|3625897|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3797822|NCT01824394|3625898|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3797823|NCT01824394|3625899|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3797824|NCT01824394|3625900|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3797825|NCT01824394|3625897|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797826|NCT01824394|3625898|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797827|NCT01824394|3625899|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797828|NCT01824394|3625900|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797829|NCT01824394|3625897|B4||White|Race (NIH/OMB)||Participants|Count of Participants|455|455.0||||||
3797830|NCT01824394|3625898|B3||White|Race (NIH/OMB)||Participants|Count of Participants|121|121.0||||||
3797831|NCT01824394|3625899|B2||White|Race (NIH/OMB)||Participants|Count of Participants|165|165.0||||||
3797832|NCT01824394|3625900|B1||White|Race (NIH/OMB)||Participants|Count of Participants|169|169.0||||||
3797833|NCT01824394|3625897|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3797834|NCT01824394|3625898|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797835|NCT01824394|3625899|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797836|NCT01824394|3625900|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3797837|NCT01824394|3625897|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797838|NCT01824394|3625898|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797839|NCT01824394|3625899|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797840|NCT01824394|3625900|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797841|NCT01824394|3625897|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3797842|NCT01824394|3625898|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3797843|NCT01824394|3625899|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797844|NCT01824394|3625900|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3797845|NCT01824394|3625897|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3797846|NCT01824394|3625898|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3797847|NCT01824394|3625899|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3797848|NCT01824394|3625900|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797849|NCT01824394|3625897|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797850|NCT01824394|3625898|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797851|NCT01824394|3625899|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797852|NCT01824394|3625900|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797853|NCT01824394|3625897|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|453|453.0||||||
3797854|NCT01824394|3625898|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
3797855|NCT01824394|3625899|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|165|165.0||||||
3797856|NCT01824394|3625900|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|168|168.0||||||
3797857|NCT01824394|3625897|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3797858|NCT01824394|3625898|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3797859|NCT01824394|3625899|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3797860|NCT01824394|3625900|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3797861|NCT01824394|3625897|B4||Male|Sex: Female, Male||Participants|Count of Participants|292|292.0||||||
3797862|NCT01824394|3625898|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3797863|NCT01824394|3625899|B2||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3797864|NCT01824394|3625900|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3797865|NCT01824394|3625897|B4||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
3797866|NCT01824394|3625898|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3797867|NCT01824394|3625899|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3797868|NCT01824394|3625900|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3797869|NCT01824394|3625897|B4|||Age||Years|Mean|62.4|62.4|Standard Deviation|10.41|10.41|||
3797870|NCT01824394|3625898|B3|||Age||Years|Mean|63.6|63.6|Standard Deviation|9.96|9.96|||
3797871|NCT01824394|3625899|B2|||Age||Years|Mean|61.8|61.8|Standard Deviation|10.40|10.4|||
3797872|NCT01824394|3625900|B1|||Age||Years|Mean|62.0|62.0|Standard Deviation|10.81|10.81|||
3797873|NCT01824355|3625912|B1|United States||Region of Enrollment||participants|Number|113|113.0||||||
3797874|NCT01824355|3625912|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797875|NCT01824355|3625912|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
3797876|NCT01824355|3625912|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3797877|NCT01824355|3625912|B1|Unknown or Not Reported||Race (NIH/OMB)|Subject responses could contain more than one race response, so number of responses will not equal number of participants.|responses|Number|3|3.0||||||
3797878|NCT01824355|3625912|B1|More than one race||Race (NIH/OMB)|Subject responses could contain more than one race response, so number of responses will not equal number of participants.|responses|Number|1|1.0||||||
3797879|NCT01824355|3625912|B1|White||Race (NIH/OMB)|Subject responses could contain more than one race response, so number of responses will not equal number of participants.|responses|Number|84|84.0||||||
3797880|NCT01824355|3625912|B1|Black or African American||Race (NIH/OMB)|Subject responses could contain more than one race response, so number of responses will not equal number of participants.|responses|Number|26|26.0||||||
3797881|NCT01824355|3625912|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|Subject responses could contain more than one race response, so number of responses will not equal number of participants.|responses|Number|0|0.0||||||
3797882|NCT01824355|3625912|B1|Asian||Race (NIH/OMB)|Subject responses could contain more than one race response, so number of responses will not equal number of participants.|responses|Number|0|0.0||||||
3797883|NCT01824355|3625912|B1|American Indian or Alaska Native||Race (NIH/OMB)|Subject responses could contain more than one race response, so number of responses will not equal number of participants.|responses|Number|1|1.0||||||
3797884|NCT01824355|3625912|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3797885|NCT01824355|3625912|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3797886|NCT01824355|3625912|B1|Age of enrolled subjects||Age, Customized||years|Mean|59.1|59.1|Full Range|||26.0|78.0|
3797887|NCT01824342|3625921|B3|||Phosphorus||mmol/L|Mean|1.06|1.06|Standard Deviation|0.22|0.22|||
3797888|NCT01824342|3625922|B2|||Phosphorus||mmol/L|Mean|1.01|1.01|Standard Deviation|0.24|0.24|||
3797889|NCT01824342|3625923|B1|||Phosphorus||mmol/L|Mean|1.09|1.09|Standard Deviation|0.22|0.22|||
3797890|NCT01824342|3625921|B3|||Creatinine||umol/L|Mean|88.89|88.89|Standard Deviation|17.80|17.8|||
3797891|NCT01824342|3625922|B2|||Creatinine||umol/L|Mean|89.66|89.66|Standard Deviation|23.63|23.63|||
3797892|NCT01824342|3625923|B1|||Creatinine||umol/L|Mean|88.40|88.4|Standard Deviation|14.25|14.25|||
3797893|NCT01824342|3625921|B3|||Albumin-adjusted calcium||mmol/L|Mean|2.43|2.43|Standard Deviation|0.08|0.08|||
3797894|NCT01824342|3625922|B2|||Albumin-adjusted calcium||mmol/L|Mean|2.42|2.42|Standard Deviation|0.04|0.04|||
3797895|NCT01824342|3625923|B1|||Albumin-adjusted calcium||mmol/L|Mean|2.44|2.44|Standard Deviation|0.10|0.1|||
3797896|NCT01824342|3625921|B3|Grade 4||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
3797897|NCT01824342|3625922|B2|Grade 4||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
3797898|NCT01824342|3625923|B1|Grade 4||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
3797899|NCT01824342|3625921|B3|Grade 3||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
3797900|NCT01824342|3625922|B2|Grade 3||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
3797901|NCT01824342|3625923|B1|Grade 3||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
3797902|NCT01824342|3625921|B3|Grade 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|1|1.0||||||
3797903|NCT01824342|3625922|B2|Grade 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|1|1.0||||||
3797904|NCT01824342|3625923|B1|Grade 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
3797905|NCT01824342|3625921|B3|Grade 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|5|5.0||||||
3797906|NCT01824342|3625922|B2|Grade 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|1|1.0||||||
3797907|NCT01824342|3625923|B1|Grade 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|4|4.0||||||
3797908|NCT01824342|3625921|B3|Grade 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|12|12.0||||||
3797909|NCT01824342|3625922|B2|Grade 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|5|5.0||||||
3797910|NCT01824342|3625923|B1|Grade 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|7|7.0||||||
3797911|NCT01824342|3625921|B3|White or Caucasian||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3797912|NCT01824342|3625922|B2|White or Caucasian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3797913|NCT01824342|3625923|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3797914|NCT01824342|3625921|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3797915|NCT01824342|3625922|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3797916|NCT01824342|3625923|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3797917|NCT01824342|3625921|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3797918|NCT01824342|3625922|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3797919|NCT01824342|3625923|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3797920|NCT01824342|3625921|B3|||Age||years|Mean|71.1|71.1|Standard Deviation|5.6|5.6|||
3797921|NCT01824342|3625922|B2|||Age||years|Mean|70.3|70.3|Standard Deviation|7.4|7.4|||
3797922|NCT01824342|3625923|B1|||Age||years|Mean|71.6|71.6|Standard Deviation|4.3|4.3|||
3797923|NCT01824303|3625936|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3797924|NCT01824303|3625937|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3797925|NCT01824303|3625938|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3797926|NCT01824303|3625936|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3797927|NCT01824303|3625937|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3797928|NCT01824303|3625938|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3797929|NCT01824303|3625936|B3|||Age||years|Mean|41.9|41.9|Standard Deviation|12.37|12.37|||
3797930|NCT01824303|3625937|B2|||Age||years|Mean|42.1|42.1|Standard Deviation|10.54|10.54|||
3797931|NCT01824303|3625938|B1|||Age||years|Mean|41.7|41.7|Standard Deviation|14.13|14.13|||
3797932|NCT01824160|3625963|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3797933|NCT01824160|3625963|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3797934|NCT01824160|3625963|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3797935|NCT01824160|3625963|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3797936|NCT01824160|3625963|B1||<=18 years|Age||Participants|Count of Participants|28|28.0||||||
3797937|NCT01823679|3625967|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3797938|NCT01823679|3625967|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797939|NCT01823679|3625967|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797940|NCT01823679|3625967|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797941|NCT01823679|3625967|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797942|NCT01823679|3625967|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797943|NCT01823679|3625967|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797944|NCT01823679|3625967|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3797945|NCT01823679|3625967|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3797946|NCT01823679|3625967|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3797947|NCT01823679|3625967|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3797948|NCT01823679|3625967|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3797949|NCT01823679|3625967|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3797950|NCT01823679|3625967|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3797951|NCT01823679|3625967|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3797952|NCT01823653|3625975|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
3797953|NCT01823653|3625975|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
3797954|NCT01823653|3625975|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3797955|NCT01823653|3625975|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3797956|NCT01823653|3625975|B1|||Age||years|Mean|40.4|40.4|Standard Deviation|8.7|8.7|||
3797957|NCT01823614|3625983|B7|||Nadir CD4 cell count||cells/µl|Median|380|380.0|Full Range|50|50.0|5.0|2112.0|
3797958|NCT01823614|3625984|B6|||Nadir CD4 cell count||cells/µl|Median|394|394.0|Full Range|50|50.0|10.0|1201.0|
3797959|NCT01823614|3625985|B5|||Nadir CD4 cell count||cells/µl|Median|350|350.0|Full Range|50|50.0|23.0|2112.0|
3797960|NCT01823614|3625986|B4|||Nadir CD4 cell count||cells/µl|Median|288|288.0|Full Range|50|50.0|5.0|1276.0|
3797961|NCT01823614|3625987|B3|||Nadir CD4 cell count||cells/µl|Median|33|33.0|Full Range|50|50.0|15.0|349.0|
3797962|NCT01823614|3625988|B2|||Nadir CD4 cell count||cells/µl|Median|413|413.0|Full Range|50|50.0|351.0|499.0|
3797963|NCT01823614|3625989|B1|||Nadir CD4 cell count||cells/µl|Median|664|664.0|Full Range|50|50.0|501.0|1716.0|
3797964|NCT01823614|3625983|B7||Male|Sex: Female, Male||Participants|Count of Participants|434|434.0||||||
3797965|NCT01823614|3625984|B6||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3797966|NCT01823614|3625985|B5||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3797967|NCT01823614|3625986|B4||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3797968|NCT01823614|3625987|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3797969|NCT01823614|3625988|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3797970|NCT01823614|3625989|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3797971|NCT01823614|3625983|B7||Female|Sex: Female, Male||Participants|Count of Participants|509|509.0||||||
3797972|NCT01823614|3625984|B6||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3797973|NCT01823614|3625985|B5||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3797974|NCT01823614|3625986|B4||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3797975|NCT01823614|3625987|B3||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3797976|NCT01823614|3625988|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3797977|NCT01823614|3625989|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3797978|NCT01823614|3625983|B7|||Age||years|Mean|35|35.0|Full Range|||18.0|73.0|
3797979|NCT01823614|3625984|B6|||Age||years|Mean|37|37.0|Full Range|||24.0|73.0|
3797980|NCT01823614|3625985|B5|||Age||years|Mean|36|36.0|Full Range|||21.0|68.0|
3797981|NCT01823614|3625986|B4|||Age||years|Mean|35|35.0|Full Range|||18.0|65.0|
3797982|NCT01823614|3625987|B3|||Age||years|Mean|35|35.0|Full Range|||22.0|64.0|
3797983|NCT01823614|3625988|B2|||Age||years|Mean|33|33.0|Full Range|||18.0|63.0|
3797984|NCT01823614|3625989|B1|||Age||years|Mean|32|32.0|Full Range|||18.0|60.0|
3797985|NCT01823536|3626014|B7||Male|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
3797986|NCT01823536|3626015|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3797987|NCT01823536|3626016|B5||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3797988|NCT01823536|3626017|B4||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3797989|NCT01823536|3626018|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3797990|NCT01823536|3626019|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3797991|NCT01823536|3626020|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3797992|NCT01823536|3626014|B7||Female|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
3797993|NCT01823536|3626015|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3797994|NCT01823536|3626016|B5||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3797995|NCT01823536|3626017|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3797996|NCT01823536|3626018|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3797997|NCT01823536|3626019|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3797998|NCT01823536|3626020|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3797999|NCT01823536|3626014|B7|||Age||years|Mean|9.7|9.7|Standard Deviation|2.3|2.3|||
3798000|NCT01823536|3626015|B6|||Age||years|Mean|8.0|8.0|Standard Deviation|1.4|1.4|||
3798001|NCT01823536|3626016|B5|||Age||years|Mean|11.8|11.8|Standard Deviation|1.0|1.0|||
3798002|NCT01823536|3626017|B4|||Age||years|Mean|13.0|13.0|Standard Deviation|1.6|1.6|||
3798003|NCT01823536|3626018|B3|||Age||years|Mean|8.5|8.5|Standard Deviation|1.1|1.1|||
3798004|NCT01823536|3626019|B2|||Age||years|Mean|8.1|8.1|Standard Deviation|1.2|1.2|||
3798005|NCT01823536|3626020|B1|||Age||years|Mean|8.3|8.3|Standard Deviation|1.1|1.1|||
3798006|NCT01823510|3626063|B1|||Smoking||Participants|Count of Participants|3|3.0||||||
3798007|NCT01823510|3626063|B1|||Hypercholesterolemia||Participants|Count of Participants|19|19.0||||||
3798008|NCT01823510|3626063|B1|||Hypertension||Participants|Count of Participants|17|17.0||||||
3798009|NCT01823510|3626063|B1|||Diabetes, type-2||Participants|Count of Participants|20|20.0||||||
3798010|NCT01823510|3626063|B1|||Body Mass Index (BMI)||kg/m^2|Mean|30.9|30.9|Standard Deviation|4.5|4.5|||
3798011|NCT01823510|3626063|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3798012|NCT01823510|3626063|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3798013|NCT01823510|3626063|B1|||Age||years|Mean|57.2|57.2|Standard Deviation|8.3|8.3|||
3798314|NCT01822197|3626365|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3798014|NCT01823341|3626076|B1|Participants 4-10 years old||Daily insulin dose (U/kg/day)||U/kg/day|Median|0.76|0.76|Inter-Quartile Range|||0.69|0.86|
3798015|NCT01823341|3626076|B1|Participants 11-14 years old||Daily insulin dose (U/kg/day)||U/kg/day|Median|0.83|0.83|Inter-Quartile Range|||0.72|0.96|
3798016|NCT01823341|3626076|B1|Participants 3-10 years old||HbA1c (mmol/mol)||mmol/mol|Median|62|62.0|Inter-Quartile Range|||58.0|64.0|
3798017|NCT01823341|3626076|B1|Participants 11-14 years old||HbA1c (mmol/mol)||mmol/mol|Median|61|61.0|Inter-Quartile Range|||56.0|66.0|
3798018|NCT01823341|3626076|B1|Participants 4-10 years old||HbA1c (%)||Percent|Median|7.8|7.8|Inter-Quartile Range|||7.5|8.0|
3798019|NCT01823341|3626076|B1|Participants 11-14 years old||HbA1c (%)||Percent|Median|7.7|7.7|Inter-Quartile Range|||7.3|8.2|
3798020|NCT01823341|3626076|B1|Participants 4-10 years old||Body-mass index percentile (BMI)|Body-mass index percentiles adjusted for age and gender were computed using the 2000 CDC population growth chart data (Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al. CDC growth charts: United States. Adv Data 2000:1-27).|BMI Percentile|Median|69|69.0|Inter-Quartile Range|||51.0|82.0|
3798021|NCT01823341|3626076|B1|Participants 11-14 years old||Body-mass index percentile (BMI)|Body-mass index percentiles adjusted for age and gender were computed using the 2000 CDC population growth chart data (Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al. CDC growth charts: United States. Adv Data 2000:1-27).|BMI Percentile|Median|69|69.0|Inter-Quartile Range|||44.0|82.0|
3798022|NCT01823341|3626076|B1|Participants 4-10 years old||Diabetes Duration||years|Median|3|3.0|Inter-Quartile Range|||2.0|5.0|
3798023|NCT01823341|3626076|B1|Participants 11-14 years old||Diabetes Duration||years|Median|6|6.0|Inter-Quartile Range|||3.0|9.0|
3798024|NCT01823341|3626076|B1|Asian Participants 4-10 years old||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3798025|NCT01823341|3626076|B1|Hispanic Participants 4-10 years old||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3798026|NCT01823341|3626076|B1|White non-Hispanic Participants 4-10 years old||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3798027|NCT01823341|3626076|B1|Asian Participants 11-14 years old||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3798028|NCT01823341|3626076|B1|Hispanic Participants 11-14 years old||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3798029|NCT01823341|3626076|B1|White non-Hispanic Participants 11-14 years old||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
3798030|NCT01823341|3626076|B1|Female Participants 4-10 year old age group||Sex/Gender, Customized||participants|Number|20|20.0||||||
3798031|NCT01823341|3626076|B1|Male Participants 4-10 year old age group||Sex/Gender, Customized||participants|Number|17|17.0||||||
3798032|NCT01823341|3626076|B1|Female Participants 11-14 year old age group||Sex/Gender, Customized||participants|Number|20|20.0||||||
3798033|NCT01823341|3626076|B1|Male Participants 11-14 year old age group||Sex/Gender, Customized||participants|Number|25|25.0||||||
3798034|NCT01823341|3626076|B1|4-10 Year olds||Age, Customized||years|Median|8|8.0|Inter-Quartile Range|||6.0|9.0|
3798035|NCT01823341|3626076|B1|11-14 Year olds||Age, Customized||years|Median|13|13.0|Inter-Quartile Range|||11.0|13.0|
3798036|NCT01823289|3626119|B1||Male|Sex: Female, Male|Out of 71 total participants, baseline characteristic (gender) was available for only 60 participants who were included in the full analysis set (FAS) population.|Participants|Count of Participants|37|37.0||||||
3798037|NCT01823289|3626119|B1||Female|Sex: Female, Male|Out of 71 total participants, baseline characteristic (gender) was available for only 60 participants who were included in the full analysis set (FAS) population.|Participants|Count of Participants|23|23.0||||||
3798038|NCT01823289|3626119|B1|||Age|Out of 71 total participants, baseline characteristic (age) was available for only 60 participants who were included in the full analysis set (FAS) population.|years|Median|55.5|55.5|Full Range|||33.34|79.45|
3798039|NCT01823224|3626125|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3798040|NCT01823224|3626126|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
3798041|NCT01823224|3626127|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
3798042|NCT01823224|3626125|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3798043|NCT01823224|3626126|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3798044|NCT01823224|3626127|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3798045|NCT01823224|3626125|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798046|NCT01823224|3626126|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798047|NCT01823224|3626127|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798048|NCT01823224|3626125|B3||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3798049|NCT01823224|3626126|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3798050|NCT01823224|3626127|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3798051|NCT01823224|3626125|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3798052|NCT01823224|3626126|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3798053|NCT01823224|3626127|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3798054|NCT01823224|3626125|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798055|NCT01823224|3626126|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798056|NCT01823224|3626127|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798057|NCT01823224|3626125|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798058|NCT01823224|3626126|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798059|NCT01823224|3626127|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798060|NCT01823224|3626125|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798061|NCT01823224|3626126|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798062|NCT01823224|3626127|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798063|NCT01823224|3626125|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3798064|NCT01823224|3626126|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3798065|NCT01823224|3626127|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3798066|NCT01823224|3626125|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3798067|NCT01823224|3626126|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3798068|NCT01823224|3626127|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3798069|NCT01823224|3626125|B3|||Age||years|Mean|40.32|40.32|Standard Deviation|11.39|11.39|||
3798070|NCT01823224|3626126|B2|||Age||years|Mean|37.00|37.0|Standard Deviation|10.65|10.65|||
3798071|NCT01823224|3626127|B1|||Age||years|Mean|43.64|43.64|Standard Deviation|12.13|12.13|||
3798072|NCT01823224|3626125|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3798073|NCT01823224|3626126|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3798074|NCT01823224|3626127|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3798075|NCT01823224|3626125|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3798076|NCT01823224|3626126|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3798077|NCT01823224|3626127|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3798078|NCT01823224|3626125|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3798079|NCT01823224|3626126|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3798080|NCT01823224|3626127|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3798081|NCT01823146|3626136|B3|United States||Region of Enrollment||participants|Number|106|106.0||||||
3798082|NCT01823146|3626137|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
3798083|NCT01823146|3626138|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
3798084|NCT01823146|3626136|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3798085|NCT01823146|3626137|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3798086|NCT01823146|3626138|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3798087|NCT01823146|3626136|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3798088|NCT01823146|3626137|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3798089|NCT01823146|3626138|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3798090|NCT01823146|3626136|B3||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
3798091|NCT01823146|3626137|B2||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3798092|NCT01823146|3626138|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3798093|NCT01823146|3626136|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3798094|NCT01823146|3626137|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3798095|NCT01823146|3626138|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3798096|NCT01823146|3626136|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3798097|NCT01823146|3626137|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3798098|NCT01823146|3626138|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3798099|NCT01822899|3626149|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|716|716.0||||||
3798100|NCT01822899|3626150|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|358|358.0||||||
3798101|NCT01822899|3626151|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|358|358.0||||||
3798102|NCT01822899|3626149|B3||Male|Sex: Female, Male||Participants|Count of Participants|515|515.0||||||
3798103|NCT01822899|3626150|B2||Male|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
3798104|NCT01822899|3626151|B1||Male|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
3798105|NCT01822899|3626149|B3||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3798106|NCT01822899|3626150|B2||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3798107|NCT01822899|3626151|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3798108|NCT01822899|3626149|B3|||Age||Years|Mean|61.6|61.6|Standard Deviation|8.00|8.0|||
3798109|NCT01822899|3626150|B2|||Age||Years|Mean|61.4|61.4|Standard Deviation|8.06|8.06|||
3798110|NCT01822899|3626151|B1|||Age||Years|Mean|61.8|61.8|Standard Deviation|7.94|7.94|||
3798111|NCT01822821|3626160|B3||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3798112|NCT01822821|3626161|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3798113|NCT01822821|3626162|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3798114|NCT01822821|3626160|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3798115|NCT01822821|3626161|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3798116|NCT01822821|3626162|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3798117|NCT01822821|3626160|B3|||Age||years|Mean|60.5|60.5|Standard Deviation|14|14.0|||
3798118|NCT01822821|3626161|B2|||Age||years|Mean|59|59.0|Standard Deviation|14|14.0|||
3798119|NCT01822821|3626162|B1|||Age||years|Mean|62|62.0|Standard Deviation|14|14.0|||
3798189|NCT01822678|3626248|B2|30 — 40 Years||Age, Customized||participants|Number|17|17.0||9.5|9.5|||
3798190|NCT01822678|3626249|B1|30 — 40 Years||Age, Customized||participants|Number|15|15.0||10.5|10.5|||
3798120|NCT01822756|3626187|B6|2||Eastern Cooperative Oncology Group (ECOG) performance status|Graded from 0- 2; 0 being fully active, able to carry on all pre-disease performance without restriction 1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature and 2 Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours.|participants|Number|0|0.0||||||
3798121|NCT01822756|3626188|B5|2||Eastern Cooperative Oncology Group (ECOG) performance status|Graded from 0- 2; 0 being fully active, able to carry on all pre-disease performance without restriction 1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature and 2 Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours.|participants|Number|0|0.0||||||
3798122|NCT01822756|3626189|B4|2||Eastern Cooperative Oncology Group (ECOG) performance status|Graded from 0- 2; 0 being fully active, able to carry on all pre-disease performance without restriction 1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature and 2 Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours.|participants|Number|0|0.0||||||
3798123|NCT01822756|3626190|B3|2||Eastern Cooperative Oncology Group (ECOG) performance status|Graded from 0- 2; 0 being fully active, able to carry on all pre-disease performance without restriction 1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature and 2 Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours.|participants|Number|0|0.0||||||
3798124|NCT01822756|3626191|B2|2||Eastern Cooperative Oncology Group (ECOG) performance status|Graded from 0- 2; 0 being fully active, able to carry on all pre-disease performance without restriction 1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature and 2 Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours.|participants|Number|0|0.0||||||
3798125|NCT01822756|3626192|B1|2||Eastern Cooperative Oncology Group (ECOG) performance status|Graded from 0- 2; 0 being fully active, able to carry on all pre-disease performance without restriction 1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature and 2 Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours.|participants|Number|0|0.0||||||
3798126|NCT01822756|3626187|B6|1||Eastern Cooperative Oncology Group (ECOG) performance status|Graded from 0- 2; 0 being fully active, able to carry on all pre-disease performance without restriction 1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature and 2 Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours.|participants|Number|18|18.0||||||
3798127|NCT01822756|3626188|B5|1||Eastern Cooperative Oncology Group (ECOG) performance status|Graded from 0- 2; 0 being fully active, able to carry on all pre-disease performance without restriction 1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature and 2 Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours.|participants|Number|3|3.0||||||
3798128|NCT01822756|3626189|B4|1||Eastern Cooperative Oncology Group (ECOG) performance status|Graded from 0- 2; 0 being fully active, able to carry on all pre-disease performance without restriction 1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature and 2 Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours.|participants|Number|1|1.0||||||
3798129|NCT01822756|3626190|B3|1||Eastern Cooperative Oncology Group (ECOG) performance status|Graded from 0- 2; 0 being fully active, able to carry on all pre-disease performance without restriction 1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature and 2 Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours.|participants|Number|2|2.0||||||
3798130|NCT01822756|3626191|B2|1||Eastern Cooperative Oncology Group (ECOG) performance status|Graded from 0- 2; 0 being fully active, able to carry on all pre-disease performance without restriction 1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature and 2 Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours.|participants|Number|2|2.0||||||
3798131|NCT01822756|3626192|B1|1||Eastern Cooperative Oncology Group (ECOG) performance status|Graded from 0- 2; 0 being fully active, able to carry on all pre-disease performance without restriction 1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature and 2 Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours.|participants|Number|10|10.0||||||
3798132|NCT01822756|3626187|B6|0||Eastern Cooperative Oncology Group (ECOG) performance status|Graded from 0- 2; 0 being fully active, able to carry on all pre-disease performance without restriction 1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature and 2 Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours.|participants|Number|24|24.0||||||
3798133|NCT01822756|3626188|B5|0||Eastern Cooperative Oncology Group (ECOG) performance status|Graded from 0- 2; 0 being fully active, able to carry on all pre-disease performance without restriction 1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature and 2 Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours.|participants|Number|5|5.0||||||
3798134|NCT01822756|3626189|B4|0||Eastern Cooperative Oncology Group (ECOG) performance status|Graded from 0- 2; 0 being fully active, able to carry on all pre-disease performance without restriction 1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature and 2 Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours.|participants|Number|3|3.0||||||
3798191|NCT01822678|3626246|B4|20 — 30 Years||Age, Customized||participants|Number|28|28.0||12.79|12.79|||
3798192|NCT01822678|3626247|B3|20 — 30 Years||Age, Customized||participants|Number|9|9.0||67.85|67.85|||
3798193|NCT01822678|3626248|B2|20 — 30 Years||Age, Customized||participants|Number|10|10.0||76.2|76.2|||
3798135|NCT01822756|3626190|B3|0||Eastern Cooperative Oncology Group (ECOG) performance status|Graded from 0- 2; 0 being fully active, able to carry on all pre-disease performance without restriction 1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature and 2 Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours.|participants|Number|8|8.0||||||
3798136|NCT01822756|3626191|B2|0||Eastern Cooperative Oncology Group (ECOG) performance status|Graded from 0- 2; 0 being fully active, able to carry on all pre-disease performance without restriction 1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature and 2 Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours.|participants|Number|2|2.0||||||
3798137|NCT01822756|3626192|B1|0||Eastern Cooperative Oncology Group (ECOG) performance status|Graded from 0- 2; 0 being fully active, able to carry on all pre-disease performance without restriction 1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature and 2 Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours.|participants|Number|6|6.0||||||
3798138|NCT01822756|3626187|B6||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3798139|NCT01822756|3626188|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3798140|NCT01822756|3626189|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3798141|NCT01822756|3626190|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3798142|NCT01822756|3626191|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3798143|NCT01822756|3626192|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3798144|NCT01822756|3626187|B6||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3798145|NCT01822756|3626188|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3798146|NCT01822756|3626189|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3798147|NCT01822756|3626190|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3798148|NCT01822756|3626191|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3798149|NCT01822756|3626192|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3798150|NCT01822756|3626187|B6|||Age||years|Mean|62.8|62.8|Standard Deviation|8.45|8.45|||
3798151|NCT01822756|3626188|B5|||Age||years|Mean|62.4|62.4|Standard Deviation|8.48|8.48|||
3798152|NCT01822756|3626189|B4|||Age||years|Mean|70.0|70.0|Standard Deviation|7.62|7.62|||
3798153|NCT01822756|3626190|B3|||Age||years|Mean|61.2|61.2|Standard Deviation|9.33|9.33|||
3798154|NCT01822756|3626191|B2|||Age||years|Mean|61.3|61.3|Standard Deviation|6.40|6.4|||
3798155|NCT01822756|3626192|B1|||Age||years|Mean|62.6|62.6|Standard Deviation|8.56|8.56|||
3798156|NCT01822691|3626238|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3798157|NCT01822691|3626238|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3798158|NCT01822691|3626238|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3798159|NCT01822691|3626238|B1|||Age||years|Median|72|72.0|Full Range|||62.0|85.0|
3798160|NCT01822691|3626238|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3798161|NCT01822691|3626238|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3798162|NCT01822691|3626238|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3798163|NCT01822678|3626246|B4||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3798164|NCT01822678|3626247|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3798165|NCT01822678|3626248|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3798166|NCT01822678|3626249|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3798167|NCT01822678|3626246|B4||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3798168|NCT01822678|3626247|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3798169|NCT01822678|3626248|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3798170|NCT01822678|3626249|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3798171|NCT01822678|3626246|B4|70 — 80 Years||Age, Customized||participants|Number|2|2.0||||||
3798172|NCT01822678|3626247|B3|70 — 80 Years||Age, Customized||participants|Number|1|1.0||||||
3798173|NCT01822678|3626248|B2|70 — 80 Years||Age, Customized||participants|Number|1|1.0||||||
3798174|NCT01822678|3626249|B1|70 — 80 Years||Age, Customized||participants|Number|0|0.0||||||
3798175|NCT01822678|3626246|B4|60 — 70 Years||Age, Customized||participants|Number|14|14.0||||||
3798176|NCT01822678|3626247|B3|60 — 70 Years||Age, Customized||participants|Number|3|3.0||||||
3798177|NCT01822678|3626248|B2|60 — 70 Years||Age, Customized||participants|Number|5|5.0||||||
3798178|NCT01822678|3626249|B1|60 — 70 Years||Age, Customized||participants|Number|6|6.0||||||
3798179|NCT01822678|3626246|B4|50 — 60 Years||Age, Customized||participants|Number|33|33.0||||||
3798180|NCT01822678|3626247|B3|50 — 60 Years||Age, Customized||participants|Number|8|8.0||||||
3798181|NCT01822678|3626248|B2|50 — 60 Years||Age, Customized||participants|Number|15|15.0||||||
3798182|NCT01822678|3626249|B1|50 — 60 Years||Age, Customized||participants|Number|10|10.0||||||
3798183|NCT01822678|3626246|B4|40 — 50 Years||Age, Customized||participants|Number|42|42.0||||||
3798184|NCT01822678|3626247|B3|40 — 50 Years||Age, Customized||participants|Number|11|11.0||||||
3798185|NCT01822678|3626248|B2|40 — 50 Years||Age, Customized||participants|Number|16|16.0||||||
3798186|NCT01822678|3626249|B1|40 — 50 Years||Age, Customized||participants|Number|15|15.0||||||
3798187|NCT01822678|3626246|B4|30 — 40 Years||Age, Customized||participants|Number|40|40.0||13.19|13.19|||
3798188|NCT01822678|3626247|B3|30 — 40 Years||Age, Customized||participants|Number|8|8.0||10.0|10.0|||
3798194|NCT01822678|3626249|B1|20 — 30 Years||Age, Customized||participants|Number|9|9.0||70.2|70.2|||
3798195|NCT01822678|3626246|B4|18 — 20 Years||Age, Customized||participants|Number|2|2.0||12.98|12.98|||
3798196|NCT01822678|3626247|B3|18 — 20 Years||Age, Customized||participants|Number|0|0.0||22.5|22.5|||
3798197|NCT01822678|3626248|B2|18 — 20 Years||Age, Customized||participants|Number|0|0.0||14.3|14.3|||
3798198|NCT01822678|3626249|B1|18 — 20 Years||Age, Customized||participants|Number|2|2.0||19.3|19.3|||
3798199|NCT01822665|3626259|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3798200|NCT01822665|3626259|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3798201|NCT01822665|3626259|B1|||Age||Years|Mean|38.1|38.1|Standard Deviation|12.3|12.3|||
3798202|NCT01822574|3626283|B4|United States||Region of Enrollment||participants|Number|90|90.0||||||
3798203|NCT01822574|3626284|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3798204|NCT01822574|3626285|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3798205|NCT01822574|3626286|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3798206|NCT01822574|3626283|B4||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3798207|NCT01822574|3626284|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3798208|NCT01822574|3626285|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3798209|NCT01822574|3626286|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3798210|NCT01822574|3626283|B4||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3798211|NCT01822574|3626284|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3798212|NCT01822574|3626285|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3798213|NCT01822574|3626286|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3798214|NCT01822574|3626283|B4|||Age||years|Mean|67.6|67.6|Full Range|||42.0|86.1|
3798215|NCT01822574|3626284|B3|||Age||years|Mean|67.3|67.3|Full Range|||49.9|84.1|
3798216|NCT01822574|3626285|B2|||Age||years|Mean|64.4|64.4|Full Range|||42.0|72.2|
3798217|NCT01822574|3626286|B1|||Age||years|Mean|71.1|71.1|Full Range|||51.4|86.1|
3798218|NCT01822561|3626302|B1|||Patients with chronic CSCR||Participants|Count of Participants|11|11.0||||||
3798219|NCT01822561|3626302|B1|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3798220|NCT01822561|3626302|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3798221|NCT01822561|3626302|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3798222|NCT01822561|3626302|B1|||Age||years|Mean|55.6|55.6|Standard Deviation|2.3|2.3|||
3798223|NCT01822548|3626310|B3|||Endothelial Progenitor Cells Number||EPC/10^6 cells|Median|38|38.0|Inter-Quartile Range|||24.2|58.2|
3798224|NCT01822548|3626311|B2|||Endothelial Progenitor Cells Number||EPC/10^6 cells|Median|37.5|37.5|Inter-Quartile Range|||25.0|59.8|
3798225|NCT01822548|3626312|B1|||Endothelial Progenitor Cells Number||EPC/10^6 cells|Median|39|39.0|Inter-Quartile Range|||24.0|58.2|
3798226|NCT01822548|3626310|B3|||HBA1C||%|Median|7.7|7.7|Inter-Quartile Range|||7.4|8.1|
3798227|NCT01822548|3626311|B2|||HBA1C||%|Median|7.7|7.7|Inter-Quartile Range|||7.5|8.1|
3798228|NCT01822548|3626312|B1|||HBA1C||%|Median|7.7|7.7|Inter-Quartile Range|||7.4|7.9|
3798229|NCT01822548|3626310|B3|||Body Mass Index||kg/m^2|Median|29.0|29.0|Inter-Quartile Range|||26.2|33.9|
3798230|NCT01822548|3626311|B2|||Body Mass Index||kg/m^2|Median|28.9|28.9|Inter-Quartile Range|||25.4|34.1|
3798231|NCT01822548|3626312|B1|||Body Mass Index||kg/m^2|Median|29.1|29.1|Inter-Quartile Range|||26.8|32.9|
3798232|NCT01822548|3626310|B3|Italy||Region of Enrollment||participants|Number|64|64.0||||||
3798233|NCT01822548|3626311|B2|Italy||Region of Enrollment||participants|Number|24|24.0||||||
3798234|NCT01822548|3626312|B1|Italy||Region of Enrollment||participants|Number|40|40.0||||||
3798235|NCT01822548|3626310|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798236|NCT01822548|3626311|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798237|NCT01822548|3626312|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798238|NCT01822548|3626310|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798239|NCT01822548|3626311|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798240|NCT01822548|3626312|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798241|NCT01822548|3626310|B3||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3798242|NCT01822548|3626311|B2||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3798243|NCT01822548|3626312|B1||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3798244|NCT01822548|3626310|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798245|NCT01822548|3626311|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798246|NCT01822548|3626312|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798247|NCT01822548|3626310|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798248|NCT01822548|3626311|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798249|NCT01822548|3626312|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798250|NCT01822548|3626310|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798251|NCT01822548|3626311|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798252|NCT01822548|3626312|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798313|NCT01822223|3626348|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3798253|NCT01822548|3626310|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798254|NCT01822548|3626311|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798255|NCT01822548|3626312|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798256|NCT01822548|3626310|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798257|NCT01822548|3626311|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798258|NCT01822548|3626312|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798259|NCT01822548|3626310|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3798260|NCT01822548|3626311|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3798261|NCT01822548|3626312|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3798262|NCT01822548|3626310|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798263|NCT01822548|3626311|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798264|NCT01822548|3626312|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798265|NCT01822548|3626310|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3798266|NCT01822548|3626311|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3798267|NCT01822548|3626312|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3798268|NCT01822548|3626310|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3798269|NCT01822548|3626311|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3798270|NCT01822548|3626312|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3798271|NCT01822548|3626310|B3|||Age||years|Mean|62|62.0|Standard Deviation|9|9.0|||
3798272|NCT01822548|3626311|B2|||Age||years|Mean|63|63.0|Standard Deviation|10|10.0|||
3798273|NCT01822548|3626312|B1|||Age||years|Mean|61|61.0|Standard Deviation|9|9.0|||
3798274|NCT01822535|3626321|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
3798275|NCT01822535|3626322|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3798276|NCT01822535|3626323|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3798277|NCT01822535|3626321|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3798278|NCT01822535|3626322|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3798279|NCT01822535|3626323|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3798280|NCT01822535|3626321|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3798281|NCT01822535|3626322|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3798282|NCT01822535|3626323|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3798283|NCT01822535|3626321|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3798284|NCT01822535|3626322|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3798285|NCT01822535|3626323|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3798286|NCT01822535|3626321|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3798287|NCT01822535|3626322|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3798288|NCT01822535|3626323|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3798289|NCT01822535|3626321|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3798290|NCT01822535|3626322|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3798291|NCT01822535|3626323|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3798292|NCT01822301|3626336|B1|||Serial computer tomography imaging||Participants|Count of Participants|3|3.0||||||
3798293|NCT01822301|3626336|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3798294|NCT01822301|3626336|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3798295|NCT01822301|3626336|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3798296|NCT01822301|3626336|B1||>=65 years|Age|18 years or older|Participants|Count of Participants|0|0.0||||||
3798297|NCT01822301|3626336|B1||Between 18 and 65 years|Age|18 years or older|Participants|Count of Participants|5|5.0||||||
3798298|NCT01822301|3626336|B1||<=18 years|Age|18 years or older|Participants|Count of Participants|0|0.0||||||
3798299|NCT01822223|3626346|B3||Male|Gender||Participants|Count of Participants|5|5.0||||||
3798300|NCT01822223|3626347|B2||Male|Gender||Participants|Count of Participants|2|2.0||||||
3798301|NCT01822223|3626348|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
3798302|NCT01822223|3626346|B3||Female|Gender||Participants|Count of Participants|15|15.0||||||
3798303|NCT01822223|3626347|B2||Female|Gender||Participants|Count of Participants|8|8.0||||||
3798304|NCT01822223|3626348|B1||Female|Gender||Participants|Count of Participants|7|7.0||||||
3798305|NCT01822223|3626346|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3798306|NCT01822223|3626347|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3798307|NCT01822223|3626348|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3798308|NCT01822223|3626346|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3798309|NCT01822223|3626347|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3798310|NCT01822223|3626348|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3798311|NCT01822223|3626346|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3798312|NCT01822223|3626347|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3798315|NCT01822197|3626365|B1||Male|Gender||Participants|Count of Participants|17|17.0||||||
3798316|NCT01822197|3626365|B1||Female|Gender||Participants|Count of Participants|13|13.0||||||
3798317|NCT01822197|3626365|B1|||Age||years|Mean|27.7|27.7|Standard Deviation|8.5|8.5|||
3798318|NCT01822197|3626365|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3798319|NCT01822197|3626365|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3798320|NCT01822197|3626365|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3798321|NCT01822119|3626371|B1|Single-sided sensorineural deafness||Type of hearing loss||participants|Number|10|10.0||||||
3798322|NCT01822119|3626371|B1|Conductive hearing loss||Type of hearing loss||participants|Number|17|17.0||||||
3798323|NCT01822119|3626371|B1|Chile||Region of Enrollment||participants|Number|5|5.0||||||
3798324|NCT01822119|3626371|B1|Australia||Region of Enrollment||participants|Number|8|8.0||||||
3798325|NCT01822119|3626371|B1|Israel||Region of Enrollment||participants|Number|6|6.0||||||
3798326|NCT01822119|3626371|B1|Hong Kong||Region of Enrollment||participants|Number|8|8.0||||||
3798327|NCT01822119|3626371|B1||Male|Gender||Participants|Count of Participants|12|12.0||||||
3798328|NCT01822119|3626371|B1||Female|Gender||Participants|Count of Participants|15|15.0||||||
3798329|NCT01822119|3626371|B1|||Age||years|Mean|45.7|45.7|Standard Deviation|13.8|13.8|||
3798330|NCT01821963|3626394|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3798331|NCT01821963|3626394|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3798332|NCT01821963|3626394|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3798333|NCT01821963|3626394|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3798334|NCT01821963|3626394|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3798335|NCT01821963|3626394|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3798336|NCT01821937|3626398|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3798337|NCT01821937|3626399|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3798338|NCT01821937|3626400|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3798339|NCT01821937|3626398|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3798340|NCT01821937|3626399|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3798341|NCT01821937|3626400|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3798342|NCT01821937|3626398|B3|||Age||years|Mean|25.0|25.0|Standard Deviation|5.2|5.2|||
3798343|NCT01821937|3626399|B2|||Age||years|Mean|24.8|24.8|Standard Deviation|5.7|5.7|||
3798344|NCT01821937|3626400|B1|||Age||years|Mean|25.3|25.3|Standard Deviation|4.5|4.5|||
3798345|NCT01821859|3626419|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3798346|NCT01821859|3626419|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3798347|NCT01821859|3626419|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3798348|NCT01821859|3626419|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3798349|NCT01821859|3626419|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3798350|NCT01821859|3626419|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3798351|NCT01821807|3626423|B3|Turkey||Region of Enrollment||participants|Number|260|260.0||||||
3798352|NCT01821807|3626424|B2|Turkey||Region of Enrollment||participants|Number|110|110.0||||||
3798353|NCT01821807|3626425|B1|Turkey||Region of Enrollment||participants|Number|150|150.0||||||
3798354|NCT01821807|3626423|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3798355|NCT01821807|3626424|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3798356|NCT01821807|3626425|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3798357|NCT01821807|3626423|B3||Female|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
3798358|NCT01821807|3626424|B2||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3798359|NCT01821807|3626425|B1||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3798360|NCT01821807|3626423|B3|||Age||years|Mean|29.8|29.8|Standard Deviation|5.2|5.2|||
3798361|NCT01821807|3626424|B2|||Age||years|Mean|29.2|29.2|Standard Deviation|4.8|4.8|||
3798362|NCT01821807|3626425|B1|||Age||years|Mean|30.2|30.2|Standard Deviation|5.5|5.5|||
3798363|NCT01821807|3626423|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3798364|NCT01821807|3626424|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3798365|NCT01821807|3626425|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3798366|NCT01821807|3626423|B3||Between 18 and 65 years|Age||Participants|Count of Participants|260|260.0||||||
3798367|NCT01821807|3626424|B2||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
3798368|NCT01821807|3626425|B1||Between 18 and 65 years|Age||Participants|Count of Participants|150|150.0||||||
3798369|NCT01821807|3626423|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3798370|NCT01821807|3626424|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3798371|NCT01821807|3626425|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3798372|NCT01821560|3626434|B3|United States||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3798373|NCT01821560|3626435|B2|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3798374|NCT01821560|3626436|B1|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3798375|NCT01821560|3626434|B3|Race|White Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3798376|NCT01821560|3626435|B2|Race|White Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3798377|NCT01821560|3626436|B1|Race|White Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3798378|NCT01821560|3626434|B3|Race|Mixed Race|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3798379|NCT01821560|3626435|B2|Race|Mixed Race|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3798380|NCT01821560|3626436|B1|Race|Mixed Race|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3798381|NCT01821560|3626434|B3|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3798382|NCT01821560|3626435|B2|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3798383|NCT01821560|3626436|B1|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3798384|NCT01821560|3626434|B3|Race|White Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3798385|NCT01821560|3626435|B2|Race|White Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3798386|NCT01821560|3626436|B1|Race|White Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3798387|NCT01821560|3626434|B3|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3798388|NCT01821560|3626435|B2|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3798389|NCT01821560|3626436|B1|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3798390|NCT01821560|3626434|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3798391|NCT01821560|3626435|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3798392|NCT01821560|3626436|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3798393|NCT01821560|3626434|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3798394|NCT01821560|3626435|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3798395|NCT01821560|3626436|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3798396|NCT01821560|3626434|B3|||Age||Years|Mean|39.5|39.5|Standard Deviation|11.9|11.9|||
3798397|NCT01821560|3626435|B2|||Age||Years|Mean|38.9|38.9|Standard Deviation|12.0|12.0|||
3798398|NCT01821560|3626436|B1|||Age||Years|Mean|40.2|40.2|Standard Deviation|12.1|12.1|||
3798399|NCT01821534|3626443|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3798400|NCT01821534|3626443|B1||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3798401|NCT01821534|3626443|B1|||Age||Years|Mean|35.5|35.5|Standard Deviation|11.43|11.43|||
3798402|NCT01821417|3626450|B3|United States||Region of Enrollment||participants|Number|68|68.0||||||
3798403|NCT01821417|3626451|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
3798404|NCT01821417|3626452|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
3798405|NCT01821417|3626450|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798406|NCT01821417|3626451|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798407|NCT01821417|3626452|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798408|NCT01821417|3626450|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3798409|NCT01821417|3626451|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798410|NCT01821417|3626452|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3798411|NCT01821417|3626450|B3||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3798412|NCT01821417|3626451|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3798413|NCT01821417|3626452|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3798414|NCT01821417|3626450|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3798415|NCT01821417|3626451|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3798416|NCT01821417|3626452|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3798417|NCT01821417|3626450|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798418|NCT01821417|3626451|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798419|NCT01821417|3626452|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798420|NCT01821417|3626450|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798421|NCT01821417|3626451|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798422|NCT01821417|3626452|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798423|NCT01821417|3626450|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798424|NCT01821417|3626451|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798425|NCT01821417|3626452|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798426|NCT01821417|3626450|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798427|NCT01821417|3626451|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798428|NCT01821417|3626452|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798429|NCT01821417|3626450|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3798430|NCT01821417|3626451|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3798431|NCT01821417|3626452|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3798432|NCT01821417|3626450|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3798609|NCT01820416|3626603|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3798433|NCT01821417|3626451|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798434|NCT01821417|3626452|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3798435|NCT01821417|3626450|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3798436|NCT01821417|3626451|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3798437|NCT01821417|3626452|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3798438|NCT01821417|3626450|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3798439|NCT01821417|3626451|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3798440|NCT01821417|3626452|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3798441|NCT01821417|3626450|B3|Greater than 19 years||Age, Customized||participants|Number|68|68.0||||||
3798442|NCT01821417|3626451|B2|Greater than 19 years||Age, Customized||participants|Number|31|31.0||||||
3798443|NCT01821417|3626452|B1|Greater than 19 years||Age, Customized||participants|Number|37|37.0||||||
3798444|NCT01821378|3626463|B4|Slovakia||Region of Enrollment||participants|Number|27|27.0||||||
3798445|NCT01821378|3626464|B3|Slovakia||Region of Enrollment||participants|Number|9|9.0||||||
3798446|NCT01821378|3626465|B2|Slovakia||Region of Enrollment||participants|Number|12|12.0||||||
3798447|NCT01821378|3626466|B1|Slovakia||Region of Enrollment||participants|Number|6|6.0||||||
3798448|NCT01821378|3626463|B4|Ukraine||Region of Enrollment||participants|Number|60|60.0||||||
3798449|NCT01821378|3626464|B3|Ukraine||Region of Enrollment||participants|Number|13|13.0||||||
3798450|NCT01821378|3626465|B2|Ukraine||Region of Enrollment||participants|Number|31|31.0||||||
3798451|NCT01821378|3626466|B1|Ukraine||Region of Enrollment||participants|Number|16|16.0||||||
3798452|NCT01821378|3626463|B4|United States||Region of Enrollment||participants|Number|128|128.0||||||
3798453|NCT01821378|3626464|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
3798454|NCT01821378|3626465|B2|United States||Region of Enrollment||participants|Number|59|59.0||||||
3798455|NCT01821378|3626466|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
3798456|NCT01821378|3626463|B4|Romania||Region of Enrollment||participants|Number|78|78.0||||||
3798457|NCT01821378|3626464|B3|Romania||Region of Enrollment||participants|Number|18|18.0||||||
3798458|NCT01821378|3626465|B2|Romania||Region of Enrollment||participants|Number|38|38.0||||||
3798459|NCT01821378|3626466|B1|Romania||Region of Enrollment||participants|Number|22|22.0||||||
3798460|NCT01821378|3626463|B4|Russian Federation||Region of Enrollment||participants|Number|99|99.0||||||
3798461|NCT01821378|3626464|B3|Russian Federation||Region of Enrollment||participants|Number|27|27.0||||||
3798462|NCT01821378|3626465|B2|Russian Federation||Region of Enrollment||participants|Number|49|49.0||||||
3798463|NCT01821378|3626466|B1|Russian Federation||Region of Enrollment||participants|Number|23|23.0||||||
3798464|NCT01821378|3626463|B4|Colombia||Region of Enrollment||participants|Number|19|19.0||||||
3798465|NCT01821378|3626464|B3|Colombia||Region of Enrollment||participants|Number|7|7.0||||||
3798466|NCT01821378|3626465|B2|Colombia||Region of Enrollment||participants|Number|9|9.0||||||
3798467|NCT01821378|3626466|B1|Colombia||Region of Enrollment||participants|Number|3|3.0||||||
3798468|NCT01821378|3626463|B4||Male|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
3798469|NCT01821378|3626464|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3798470|NCT01821378|3626465|B2||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3798471|NCT01821378|3626466|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3798472|NCT01821378|3626463|B4||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3798473|NCT01821378|3626464|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3798474|NCT01821378|3626465|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3798475|NCT01821378|3626466|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3798476|NCT01821378|3626463|B4|||Age||years|Mean|40.8|40.8|Standard Deviation|11.34|11.34|||
3798477|NCT01821378|3626464|B3|||Age||years|Mean|40.7|40.7|Standard Deviation|11.58|11.58|||
3798478|NCT01821378|3626465|B2|||Age||years|Mean|40.5|40.5|Standard Deviation|11.44|11.44|||
3798479|NCT01821378|3626466|B1|||Age||years|Mean|41.5|41.5|Standard Deviation|10.96|10.96|||
3798480|NCT01821378|3626463|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3798481|NCT01821378|3626464|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3798482|NCT01821378|3626465|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3798483|NCT01821378|3626466|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3798484|NCT01821378|3626463|B4||Between 18 and 65 years|Age||Participants|Count of Participants|403|403.0||||||
3798485|NCT01821378|3626464|B3||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
3798486|NCT01821378|3626465|B2||Between 18 and 65 years|Age||Participants|Count of Participants|192|192.0||||||
3798487|NCT01821378|3626466|B1||Between 18 and 65 years|Age||Participants|Count of Participants|99|99.0||||||
3798488|NCT01821378|3626463|B4||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3798489|NCT01821378|3626464|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3798490|NCT01821378|3626465|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3798491|NCT01821378|3626466|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3798492|NCT01821352|3626504|B3|||Body Mass Index (BMI)|Body Mass Index (BMI) was calculated as kilograms per meter squared (kg/m2).|kg/m2|Mean|34.04|34.04|Standard Deviation|3.02|3.02|||
3798493|NCT01821352|3626505|B2|||Body Mass Index (BMI)|Body Mass Index (BMI) was calculated as kilograms per meter squared (kg/m2).|kg/m2|Mean|33.60|33.6|Standard Deviation|2.98|2.98|||
3798494|NCT01821352|3626506|B1|||Body Mass Index (BMI)|Body Mass Index (BMI) was calculated as kilograms per meter squared (kg/m2).|kg/m2|Mean|34.58|34.58|Standard Deviation|3.06|3.06|||
3798495|NCT01821352|3626504|B3|||Total Circumference Measurement|Circumference of the hips, waist and the upper abdomen was measured in inches (in) at standardized locations using a flexible tape measure. The 3 individual area circumference measurements were added to attain a total body circumference measurement in inches.|inches|Mean|123.04|123.04|Standard Deviation|10.95|10.95|||
3798496|NCT01821352|3626505|B2|||Total Circumference Measurement|Circumference of the hips, waist and the upper abdomen was measured in inches (in) at standardized locations using a flexible tape measure. The 3 individual area circumference measurements were added to attain a total body circumference measurement in inches.|inches|Mean|122.81|122.81|Standard Deviation|11.85|11.85|||
3798497|NCT01821352|3626506|B1|||Total Circumference Measurement|Circumference of the hips, waist and the upper abdomen was measured in inches (in) at standardized locations using a flexible tape measure. The 3 individual area circumference measurements were added to attain a total body circumference measurement in inches.|inches|Mean|123.35|123.35|Standard Deviation|10.29|10.29|||
3798498|NCT01821352|3626504|B3|United States||Region of Enrollment||participants|Number|53|53.0||||||
3798499|NCT01821352|3626505|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3798500|NCT01821352|3626506|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
3798501|NCT01821352|3626504|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798502|NCT01821352|3626505|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798503|NCT01821352|3626506|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798504|NCT01821352|3626504|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3798505|NCT01821352|3626505|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798506|NCT01821352|3626506|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3798507|NCT01821352|3626504|B3||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3798508|NCT01821352|3626505|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3798509|NCT01821352|3626506|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3798510|NCT01821352|3626504|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3798511|NCT01821352|3626505|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3798512|NCT01821352|3626506|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3798513|NCT01821352|3626504|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798514|NCT01821352|3626505|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798515|NCT01821352|3626506|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798516|NCT01821352|3626504|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798517|NCT01821352|3626505|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798518|NCT01821352|3626506|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798519|NCT01821352|3626504|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798520|NCT01821352|3626505|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798521|NCT01821352|3626506|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798522|NCT01821352|3626504|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3798523|NCT01821352|3626505|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3798524|NCT01821352|3626506|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3798525|NCT01821352|3626504|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3798526|NCT01821352|3626505|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3798527|NCT01821352|3626506|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3798528|NCT01821352|3626504|B3|||Age||years|Mean|47.04|47.04|Standard Deviation|10.12|10.12|||
3798529|NCT01821352|3626505|B2|||Age||years|Mean|47.84|47.84|Standard Deviation|9.30|9.3|||
3798530|NCT01821352|3626506|B1|||Age||years|Mean|46.32|46.32|Standard Deviation|10.91|10.91|||
3798531|NCT01821326|3626517|B1|China||Region of Enrollment||participants|Number|339|339.0||||||
3798532|NCT01821326|3626517|B1||Male|Gender||Participants|Count of Participants|177|177.0||||||
3798533|NCT01821326|3626517|B1||Female|Gender||Participants|Count of Participants|162|162.0||||||
3798534|NCT01821326|3626517|B1|||Age||years|Mean|55|55.0|Standard Deviation|18.4|18.4|||
3798535|NCT01821326|3626517|B1||>=65 years|Age||Participants|Count of Participants|139|139.0||||||
3798536|NCT01821326|3626517|B1||Between 18 and 65 years|Age||Participants|Count of Participants|200|200.0||||||
3798537|NCT01821326|3626517|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3798538|NCT01821118|3626521|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3798539|NCT01821118|3626522|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3798540|NCT01821118|3626523|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3798541|NCT01821118|3626521|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3798542|NCT01821118|3626522|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3798543|NCT01821118|3626523|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3798544|NCT01821118|3626521|B3|||Age||years|Mean|67.6|67.6|Standard Deviation|6.6|6.6|||
3798545|NCT01821118|3626522|B2|||Age||years|Mean|65.0|65.0|Standard Deviation|5.7|5.7|||
3798546|NCT01821118|3626523|B1|||Age||years|Mean|68.8|68.8|Standard Deviation|6.8|6.8|||
3798547|NCT01821105|3626557|B1|||Mean time interval from PET scan to surgery/GP study||days|Median|16|16.0|Full Range|||1.0|41.0|
3798548|NCT01821105|3626557|B1|||Mean time interval from initial treatment to PET scan||months|Median|42|42.0|Full Range|||3.0|102.0|
3798549|NCT01821105|3626557|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3798550|NCT01821105|3626557|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3798551|NCT01821105|3626557|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3798552|NCT01821105|3626557|B1|||Age||years|Mean|54|54.0|Full Range|||31.0|78.0|
3798553|NCT01820754|3626563|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798554|NCT01820754|3626563|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798555|NCT01820754|3626563|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3798556|NCT01820754|3626563|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3798557|NCT01820754|3626563|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798558|NCT01820754|3626563|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798559|NCT01820754|3626563|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798560|NCT01820754|3626563|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3798561|NCT01820754|3626563|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3798562|NCT01820754|3626563|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798563|NCT01820754|3626563|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3798564|NCT01820754|3626563|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3798565|NCT01820754|3626563|B1|||Age||Years|Mean|65.3|65.3|Standard Deviation|8.0|8.0|||
3798566|NCT01820585|3626571|B5||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3798567|NCT01820585|3626572|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3798568|NCT01820585|3626573|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3798569|NCT01820585|3626574|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3798570|NCT01820585|3626575|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3798571|NCT01820585|3626571|B5||Female|Sex: Female, Male||Participants|Count of Participants|487|487.0||||||
3798572|NCT01820585|3626572|B4||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3798573|NCT01820585|3626573|B3||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3798574|NCT01820585|3626574|B2||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3798575|NCT01820585|3626575|B1||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3798576|NCT01820585|3626571|B5|>65 years||Age, Customized||participants|Number|17|17.0||||||
3798577|NCT01820585|3626572|B4|>65 years||Age, Customized||participants|Number|5|5.0||||||
3798578|NCT01820585|3626573|B3|>65 years||Age, Customized||participants|Number|3|3.0||||||
3798579|NCT01820585|3626574|B2|>65 years||Age, Customized||participants|Number|4|4.0||||||
3798580|NCT01820585|3626575|B1|>65 years||Age, Customized||participants|Number|5|5.0||||||
3798581|NCT01820585|3626571|B5|<=65 Years||Age, Customized||participants|Number|511|511.0||||||
3798582|NCT01820585|3626572|B4|<=65 Years||Age, Customized||participants|Number|127|127.0||||||
3798583|NCT01820585|3626573|B3|<=65 Years||Age, Customized||participants|Number|132|132.0||||||
3798584|NCT01820585|3626574|B2|<=65 Years||Age, Customized||participants|Number|126|126.0||||||
3798585|NCT01820585|3626575|B1|<=65 Years||Age, Customized||participants|Number|126|126.0||||||
3798586|NCT01820559|3626588|B4||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3798587|NCT01820559|3626589|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3798588|NCT01820559|3626590|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3798589|NCT01820559|3626591|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3798590|NCT01820559|3626588|B4||Female|Sex: Female, Male||Participants|Count of Participants|346|346.0||||||
3798591|NCT01820559|3626589|B3||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3798592|NCT01820559|3626590|B2||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3798593|NCT01820559|3626591|B1||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3798594|NCT01820559|3626588|B4|>65 years||Age, Customized||participants|Number|4|4.0||||||
3798595|NCT01820559|3626589|B3|>65 years||Age, Customized||participants|Number|3|3.0||||||
3798596|NCT01820559|3626590|B2|>65 years||Age, Customized||participants|Number|0|0.0||||||
3798597|NCT01820559|3626591|B1|>65 years||Age, Customized||participants|Number|1|1.0||||||
3798598|NCT01820559|3626588|B4|<=65 years||Age, Customized||participants|Number|406|406.0||||||
3798599|NCT01820559|3626589|B3|<=65 years||Age, Customized||participants|Number|136|136.0||||||
3798600|NCT01820559|3626590|B2|<=65 years||Age, Customized||participants|Number|135|135.0||||||
3798601|NCT01820559|3626591|B1|<=65 years||Age, Customized||participants|Number|135|135.0||||||
3798602|NCT01820416|3626601|B4|United States||Region of Enrollment||participants|Number|35|35.0||||||
3798603|NCT01820416|3626602|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3798604|NCT01820416|3626603|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3798605|NCT01820416|3626604|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3798606|NCT01820416|3626601|B4|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3798607|NCT01820416|3626601|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3798608|NCT01820416|3626602|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3798610|NCT01820416|3626604|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3798611|NCT01820416|3626601|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3798612|NCT01820416|3626602|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3798613|NCT01820416|3626603|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3798614|NCT01820416|3626604|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3798615|NCT01820416|3626601|B4|||Age||years|Mean|51.46|51.46|Standard Deviation|14.57|14.57|||
3798616|NCT01820416|3626602|B3|||Age||years|Mean|47.09|47.09|Standard Deviation|16.71|16.71|||
3798617|NCT01820416|3626603|B2|||Age||years|Mean|55.58|55.58|Standard Deviation|11.42|11.42|||
3798618|NCT01820416|3626604|B1|||Age||years|Mean|51.33|51.33|Standard Deviation|15.37|15.37|||
3798619|NCT01820364|3626614|B1|1||WHO/ ECOG performance status|"Categories:~0 - Fully active, able to carry on all pre-disease performance without restriction~1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~2 - Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~3 - Capable of only limited self-care, confined to bed or chair more than 50% of waking hours~4 - Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|participants|Number|1|1.0||||||
3798620|NCT01820364|3626614|B1|0||WHO/ ECOG performance status|"Categories:~0 - Fully active, able to carry on all pre-disease performance without restriction~1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~2 - Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~3 - Capable of only limited self-care, confined to bed or chair more than 50% of waking hours~4 - Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|participants|Number|14|14.0||||||
3798621|NCT01820364|3626614|B1|||Height||centimeters|Mean|171.8|171.8|Standard Deviation|9.51|9.51|||
3798622|NCT01820364|3626614|B1|||Weight||kilograms|Mean|80.3|80.3|Standard Deviation|19.11|19.11|||
3798623|NCT01820364|3626614|B1|Spain||Region of Enrollment||participants|Number|3|3.0||||||
3798624|NCT01820364|3626614|B1|Germany||Region of Enrollment||participants|Number|1|1.0||||||
3798625|NCT01820364|3626614|B1|Switzerland||Region of Enrollment||participants|Number|6|6.0||||||
3798626|NCT01820364|3626614|B1|Australia||Region of Enrollment||participants|Number|3|3.0||||||
3798627|NCT01820364|3626614|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3798628|NCT01820364|3626614|B1||Male|Gender||Participants|Count of Participants|8|8.0||||||
3798629|NCT01820364|3626614|B1||Female|Gender||Participants|Count of Participants|7|7.0||||||
3798630|NCT01820364|3626614|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|16.53|16.53|||
3798631|NCT01820364|3626614|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3798632|NCT01820364|3626614|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3798633|NCT01820364|3626614|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3798634|NCT01819935|3626627|B3||Male|Sex: Female, Male||Participants|Count of Participants|5167|5167.0||||||
3798635|NCT01819935|3626628|B2||Male|Sex: Female, Male||Participants|Count of Participants|4844|4844.0||||||
3798636|NCT01819935|3626629|B1||Male|Sex: Female, Male||Participants|Count of Participants|323|323.0||||||
3798637|NCT01819935|3626627|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3798638|NCT01819935|3626628|B2||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3798639|NCT01819935|3626629|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3798640|NCT01819935|3626627|B3|||Age||years|Mean|69.1|69.1|Standard Deviation|12.7|12.7|||
3798641|NCT01819935|3626628|B2|||Age||years|Mean|69.1|69.1|Standard Deviation|12.7|12.7|||
3798642|NCT01819935|3626629|B1|||Age||years|Mean|69.1|69.1|Standard Deviation|12.5|12.5|||
3798643|NCT01819922|3626650|B1|||Physical Work Capacity||beats per minute (bpm)|Mean|154.750|154.75|Standard Deviation|25.3094|25.3094|||
3798644|NCT01819922|3626650|B1|||Aerobic Efficiency||milliliter per watt (mL/watt)|Mean|10.442|10.442|Standard Deviation|0.8544|0.8544|||
3798645|NCT01819922|3626650|B1|||Oxygen pulse||milliliter per beat (mL/beat)|Mean|16.808|16.808|Standard Deviation|2.0518|2.0518|||
3798646|NCT01819922|3626650|B1|||Volume of Oxygen (VO2) at Anaerobic Threshold||milliliter (mL)|Mean|19.467|19.467|Standard Deviation|2.6800|2.68|||
3798647|NCT01819922|3626650|B1|||Minute Ventilation and Carbon Dioxide Production (VE/VCO2 slope)||unitless|Mean|20.800|20.8|Standard Deviation|3.5545|3.5545|||
3798648|NCT01819922|3626650|B1|||Respiratory Exchange Ratio||ratio|Mean|1.313|1.313|Standard Deviation|0.0881|0.0881|||
3798649|NCT01819922|3626650|B1|||Volume of oxygen||milliliter per kilogram per minute|Mean|41.033|41.033|Standard Deviation|3.6084|3.6084|||
3798650|NCT01819922|3626650|B1|||Oxygen Uptake Efficiency Slope (OUES)||milliliter per log10*liter [mL/log10(L)]|Mean|3163.333|3163.333|Standard Deviation|3200.000|3200.0|||
3798651|NCT01819922|3626650|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3798652|NCT01819922|3626650|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3798653|NCT01819922|3626650|B1|||Age||years|Mean|23.8|23.8|Standard Deviation|2.5|2.5|||
3798654|NCT01819883|3626735|B3|||Insulin-like Growth Factor-1 (IGF-1) Blood Level||ng/ml|Median|344|344.0|Inter-Quartile Range|||174.0|809.0|
3798655|NCT01819883|3626736|B2|||Insulin-like Growth Factor-1 (IGF-1) Blood Level||ng/ml|Median|174|174.0|Inter-Quartile Range|||110.0|209.0|
3798656|NCT01819883|3626737|B1|||Insulin-like Growth Factor-1 (IGF-1) Blood Level||ng/ml|Median|787|787.0|Inter-Quartile Range|||641.0|1099.0|
3798657|NCT01819883|3626735|B3|||Insulin Area Under the Curve (AUC)||uU/mLx120 min|Median|4370|4370.0|Inter-Quartile Range|||2640.0|6350.0|
3798658|NCT01819883|3626736|B2|||Insulin Area Under the Curve (AUC)||uU/mLx120 min|Median|3827|3827.0|Inter-Quartile Range|||1854.0|4580.0|
3798659|NCT01819883|3626737|B1|||Insulin Area Under the Curve (AUC)||uU/mLx120 min|Median|6828|6828.0|Inter-Quartile Range|||5152.0|8196.0|
3798660|NCT01819883|3626735|B3|||Fasting Insulin||uU/mL|Median|8|8.0|Inter-Quartile Range|||4.0|14.0|
3798661|NCT01819883|3626736|B2|||Fasting Insulin||uU/mL|Median|6|6.0|Inter-Quartile Range|||3.0|12.0|
3798662|NCT01819883|3626737|B1|||Fasting Insulin||uU/mL|Median|9|9.0|Inter-Quartile Range|||7.0|17.0|
3798663|NCT01819883|3626735|B3|||Thigh Muscle Cross-Sectional Area||Cm^2|Mean|160|160.0|Standard Deviation|39|39.0|||
3798664|NCT01819883|3626736|B2|||Thigh Muscle Cross-Sectional Area||Cm^2|Mean|158|158.0|Standard Deviation|40|40.0|||
3798665|NCT01819883|3626737|B1|||Thigh Muscle Cross-Sectional Area||Cm^2|Mean|162|162.0|Standard Deviation|38|38.0|||
3798666|NCT01819883|3626735|B3|||Visceral Fat Area||Cm^2|Median|124|124.0|Inter-Quartile Range|||59.0|205.0|
3798667|NCT01819883|3626736|B2|||Visceral Fat Area||Cm^2|Median|140|140.0|Inter-Quartile Range|||56.0|208.0|
3798668|NCT01819883|3626737|B1|||Visceral Fat Area||Cm^2|Median|96|96.0|Inter-Quartile Range|||62.0|188.0|
3798669|NCT01819883|3626735|B3|||Intramyocellular Lipids (Muscle Fat)||Arbitrary Units|Median|9.5|9.5|Inter-Quartile Range|||5.1|13.9|
3798670|NCT01819883|3626736|B2|||Intramyocellular Lipids (Muscle Fat)||Arbitrary Units|Median|10.7|10.7|Inter-Quartile Range|||6.4|14.1|
3798671|NCT01819883|3626737|B1|||Intramyocellular Lipids (Muscle Fat)||Arbitrary Units|Median|8.2|8.2|Inter-Quartile Range|||3.9|11.2|
3798672|NCT01819883|3626735|B3|||Intrahepatic Lipids (Liver Fat)|Intrahepatic lipids are reported in lipid to water ratio units.|ratio|Median|0.02|0.02|Inter-Quartile Range|||0.01|0.09|
3798673|NCT01819883|3626736|B2|||Intrahepatic Lipids (Liver Fat)|Intrahepatic lipids are reported in lipid to water ratio units.|ratio|Median|0.06|0.06|Inter-Quartile Range|||0.02|0.22|
3798674|NCT01819883|3626737|B1|||Intrahepatic Lipids (Liver Fat)|Intrahepatic lipids are reported in lipid to water ratio units.|ratio|Median|0.02|0.02|Inter-Quartile Range|||0.01|0.04|
3798675|NCT01819883|3626735|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798676|NCT01819883|3626736|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798677|NCT01819883|3626737|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798678|NCT01819883|3626735|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3798679|NCT01819883|3626736|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798680|NCT01819883|3626737|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3798681|NCT01819883|3626735|B3||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3798682|NCT01819883|3626736|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3798683|NCT01819883|3626737|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3798684|NCT01819883|3626735|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3798685|NCT01819883|3626736|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3798686|NCT01819883|3626737|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3798687|NCT01819883|3626735|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3798688|NCT01819883|3626736|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3798689|NCT01819883|3626737|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798690|NCT01819883|3626735|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798691|NCT01819883|3626736|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798692|NCT01819883|3626737|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798693|NCT01819883|3626735|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798694|NCT01819883|3626736|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798695|NCT01819883|3626737|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798696|NCT01819883|3626735|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3798697|NCT01819883|3626736|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798698|NCT01819883|3626737|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3798699|NCT01819883|3626735|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3798700|NCT01819883|3626736|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3798701|NCT01819883|3626737|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3798702|NCT01819883|3626735|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3798703|NCT01819883|3626736|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3798704|NCT01819883|3626737|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3798705|NCT01819883|3626735|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3798706|NCT01819883|3626736|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3798707|NCT01819883|3626737|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3798708|NCT01819883|3626735|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3798709|NCT01819883|3626736|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3798710|NCT01819883|3626737|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3798711|NCT01819883|3626735|B3|||Age||years|Mean|47|47.0|Standard Deviation|16|16.0|||
3798712|NCT01819883|3626736|B2|||Age||years|Mean|47|47.0|Standard Deviation|17|17.0|||
3798713|NCT01819883|3626737|B1|||Age||years|Mean|47|47.0|Standard Deviation|16|16.0|||
3798714|NCT01819844|3626744|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3798715|NCT01819844|3626744|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3798716|NCT01819844|3626744|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3798717|NCT01819844|3626744|B1|||Age||years|Mean|55|55.0|Standard Deviation|11|11.0|||
3798718|NCT01819844|3626744|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3798719|NCT01819844|3626744|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3798720|NCT01819844|3626744|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3798721|NCT01819727|3626757|B3|United States||Region of Enrollment||Participants|Count of Participants|261|261.0||||||
3798722|NCT01819727|3626758|B2|United States||Region of Enrollment||Participants|Count of Participants|130|130.0||||||
3798723|NCT01819727|3626759|B1|United States||Region of Enrollment||Participants|Count of Participants|131|131.0||||||
3798724|NCT01819727|3626757|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3798725|NCT01819727|3626758|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3798726|NCT01819727|3626759|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3798727|NCT01819727|3626757|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|254|254.0||||||
3798728|NCT01819727|3626758|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|124|124.0||||||
3798729|NCT01819727|3626759|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|130|130.0||||||
3798730|NCT01819727|3626757|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3798731|NCT01819727|3626758|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3798732|NCT01819727|3626759|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3798733|NCT01819727|3626757|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3798734|NCT01819727|3626758|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3798735|NCT01819727|3626759|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3798736|NCT01819727|3626757|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3798737|NCT01819727|3626758|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3798738|NCT01819727|3626759|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3798739|NCT01819727|3626757|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3798740|NCT01819727|3626758|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3798741|NCT01819727|3626759|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3798742|NCT01819727|3626757|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3798743|NCT01819727|3626758|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3798744|NCT01819727|3626759|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798745|NCT01819727|3626757|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|253|253.0||||||
3798746|NCT01819727|3626758|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
3798747|NCT01819727|3626759|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
3798748|NCT01819727|3626757|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3798749|NCT01819727|3626758|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3798750|NCT01819727|3626759|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3798751|NCT01819727|3626757|B3||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3798752|NCT01819727|3626758|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3798753|NCT01819727|3626759|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3798754|NCT01819727|3626757|B3||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3798755|NCT01819727|3626758|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3798756|NCT01819727|3626759|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3798757|NCT01819727|3626757|B3|18 - <66 years||Age, Customized||Participants|Count of Participants|250|250.0||||||
3798758|NCT01819727|3626758|B2|18 - <66 years||Age, Customized||Participants|Count of Participants|124|124.0||||||
3798759|NCT01819727|3626759|B1|18 - <66 years||Age, Customized||Participants|Count of Participants|126|126.0||||||
3798760|NCT01819727|3626757|B3|16 - <18 years||Age, Customized||Participants|Count of Participants|11|11.0||||||
3798761|NCT01819727|3626758|B2|16 - <18 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
3798762|NCT01819727|3626759|B1|16 - <18 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
3798763|NCT01819727|3626757|B3|||Age||years|Mean|29.2|29.2|Standard Deviation|8.75|8.75|||
3798764|NCT01819727|3626758|B2|||Age||years|Mean|28.1|28.1|Standard Deviation|8.77|8.77|||
3798765|NCT01819727|3626759|B1|||Age||years|Mean|30.2|30.2|Standard Deviation|8.63|8.63|||
3798766|NCT01819415|3626770|B5|Canada||Region of Enrollment||participants|Number|40|40.0||||||
3798767|NCT01819415|3626771|B4|Canada||Region of Enrollment||participants|Number|10|10.0||||||
3798768|NCT01819415|3626772|B3|Canada||Region of Enrollment||participants|Number|10|10.0||||||
3798769|NCT01819415|3626773|B2|Canada||Region of Enrollment||participants|Number|10|10.0||||||
3798770|NCT01819415|3626774|B1|Canada||Region of Enrollment||participants|Number|10|10.0||||||
3798771|NCT01819415|3626770|B5||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3798772|NCT01819415|3626771|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3798773|NCT01819415|3626772|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3798774|NCT01819415|3626773|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3798775|NCT01819415|3626774|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3798776|NCT01819415|3626770|B5||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3798777|NCT01819415|3626771|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3798778|NCT01819415|3626772|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3798779|NCT01819415|3626773|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3798780|NCT01819415|3626774|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3798781|NCT01819415|3626770|B5|Age||Age||years|Mean|77.56|77.56|Standard Deviation|2.42|2.42|||
3798782|NCT01819415|3626771|B4|Age||Age||years|Mean|68.25|68.25|Standard Deviation|3.56|3.56|||
3798783|NCT01819415|3626772|B3|Age||Age||years|Mean|79.6|79.6|Standard Deviation|1.81|1.81|||
3798784|NCT01819415|3626773|B2|Age||Age||years|Mean|79.00|79.0|Standard Deviation|1.98|1.98|||
3798785|NCT01819415|3626774|B1|Age||Age||years|Mean|83.38|83.38|Standard Deviation|2.32|2.32|||
3798786|NCT01819415|3626770|B5||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
3798787|NCT01819415|3626771|B4||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3798788|NCT01819415|3626772|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3798789|NCT01819415|3626773|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3798790|NCT01819415|3626774|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3798791|NCT01819415|3626770|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3798792|NCT01819415|3626771|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3798793|NCT01819415|3626772|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3798794|NCT01819415|3626773|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3798795|NCT01819415|3626774|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3798796|NCT01819415|3626770|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3798797|NCT01819415|3626771|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3798798|NCT01819415|3626772|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3798799|NCT01819415|3626773|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3798800|NCT01819415|3626774|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3798801|NCT01819311|3626787|B3|||Screen for Child Anxiety and Related Emotional Disorders - Child Version|The Screen for Child Anxiety Related Emotional Disorders – Child Version (SCARED-C) assesses anxiety symptom severity in youth ages 6-17 years. The child rates his or her anxiety symptoms on 41 items; each item is rated from 0 to 2. Total scores range from 0 to 82, with higher scores indicating greater anxiety severity.|units on a scale|Mean|22.99|22.99|Standard Deviation|14.92|14.92|||
3798802|NCT01819311|3626788|B2|||Screen for Child Anxiety and Related Emotional Disorders - Child Version|The Screen for Child Anxiety Related Emotional Disorders – Child Version (SCARED-C) assesses anxiety symptom severity in youth ages 6-17 years. The child rates his or her anxiety symptoms on 41 items; each item is rated from 0 to 2. Total scores range from 0 to 82, with higher scores indicating greater anxiety severity.|units on a scale|Mean|22.87|22.87|Standard Deviation|15.65|15.65|||
3798803|NCT01819311|3626789|B1|||Screen for Child Anxiety and Related Emotional Disorders - Child Version|The Screen for Child Anxiety Related Emotional Disorders – Child Version (SCARED-C) assesses anxiety symptom severity in youth ages 6-17 years. The child rates his or her anxiety symptoms on 41 items; each item is rated from 0 to 2. Total scores range from 0 to 82, with higher scores indicating greater anxiety severity.|units on a scale|Mean|23.03|23.03|Standard Deviation|12.81|12.81|||
3798804|NCT01819311|3626787|B3|||Screen for Child Anxiety and Related Emotional Disorders - Parent Version|The Screen for Child Anxiety Related Emotional Disorders – Parent Version (SCARED-P) assesses anxiety symptom severity in youth ages 6-17 years. The parent rates youth anxiety symptoms on 41 items; each item is rated from 0 to 2. Total scores range from 0 to 82, with higher scores indicating greater anxiety severity.|units on a scale|Mean|26.76|26.76|Standard Deviation|13.68|13.68|||
3798805|NCT01819311|3626788|B2|||Screen for Child Anxiety and Related Emotional Disorders - Parent Version|The Screen for Child Anxiety Related Emotional Disorders – Parent Version (SCARED-P) assesses anxiety symptom severity in youth ages 6-17 years. The parent rates youth anxiety symptoms on 41 items; each item is rated from 0 to 2. Total scores range from 0 to 82, with higher scores indicating greater anxiety severity.|units on a scale|Mean|26.24|26.24|Standard Deviation|12.46|12.46|||
3798806|NCT01819311|3626789|B1|||Screen for Child Anxiety and Related Emotional Disorders - Parent Version|The Screen for Child Anxiety Related Emotional Disorders – Parent Version (SCARED-P) assesses anxiety symptom severity in youth ages 6-17 years. The parent rates youth anxiety symptoms on 41 items; each item is rated from 0 to 2. Total scores range from 0 to 82, with higher scores indicating greater anxiety severity.|units on a scale|Mean|27.74|27.74|Standard Deviation|14.57|14.57|||
3798807|NCT01819311|3626787|B3|||Pediatric Anxiety Rating Scale|The Pediatric Anxiety Rating Scale (PARS) assesses global anxiety severity across social anxiety disorder, separation anxiety disorder, and generalized anxiety disorder in youth ages 6-17 years. An independent evaluator rates anxiety symptoms on 7 dimensions (i.e., number of symptoms, severity of distress, severity of physical symptoms, frequency, avoidance, interference at home, and interference out of home). Each dimension is rated from 0 to 5. Total scores range from 0 to 35, with higher scores indicating greater anxiety severity.|units on a scale|Mean|13.96|13.96|Standard Deviation|3.84|3.84|||
3798857|NCT01819272|3626807|B6|||Baseline Fasting Plasma Glucose||mg/dL|Mean|180.3|180.3|Standard Deviation|57.52|57.52|||
3798858|NCT01819272|3626808|B5|||Baseline Fasting Plasma Glucose||mg/dL|Mean|165.7|165.7|Standard Deviation|50.01|50.01|||
3798859|NCT01819272|3626809|B4|||Baseline Fasting Plasma Glucose||mg/dL|Mean|172.3|172.3|Standard Deviation|44.45|44.45|||
3798808|NCT01819311|3626788|B2|||Pediatric Anxiety Rating Scale|The Pediatric Anxiety Rating Scale (PARS) assesses global anxiety severity across social anxiety disorder, separation anxiety disorder, and generalized anxiety disorder in youth ages 6-17 years. An independent evaluator rates anxiety symptoms on 7 dimensions (i.e., number of symptoms, severity of distress, severity of physical symptoms, frequency, avoidance, interference at home, and interference out of home). Each dimension is rated from 0 to 5. Total scores range from 0 to 35, with higher scores indicating greater anxiety severity.|units on a scale|Mean|13.12|13.12|Standard Deviation|3.90|3.9|||
3798809|NCT01819311|3626789|B1|||Pediatric Anxiety Rating Scale|The Pediatric Anxiety Rating Scale (PARS) assesses global anxiety severity across social anxiety disorder, separation anxiety disorder, and generalized anxiety disorder in youth ages 6-17 years. An independent evaluator rates anxiety symptoms on 7 dimensions (i.e., number of symptoms, severity of distress, severity of physical symptoms, frequency, avoidance, interference at home, and interference out of home). Each dimension is rated from 0 to 5. Total scores range from 0 to 35, with higher scores indicating greater anxiety severity.|units on a scale|Mean|14.55|14.55|Standard Deviation|3.63|3.63|||
3798810|NCT01819311|3626787|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3798811|NCT01819311|3626788|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798812|NCT01819311|3626789|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3798813|NCT01819311|3626787|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3798814|NCT01819311|3626788|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3798815|NCT01819311|3626789|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3798816|NCT01819311|3626787|B3||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3798817|NCT01819311|3626788|B2||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3798818|NCT01819311|3626789|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3798819|NCT01819311|3626787|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3798820|NCT01819311|3626788|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3798821|NCT01819311|3626789|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798822|NCT01819311|3626787|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798823|NCT01819311|3626788|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798824|NCT01819311|3626789|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798825|NCT01819311|3626787|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3798826|NCT01819311|3626788|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798827|NCT01819311|3626789|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3798828|NCT01819311|3626787|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798829|NCT01819311|3626788|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798830|NCT01819311|3626789|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798831|NCT01819311|3626787|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798832|NCT01819311|3626788|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798833|NCT01819311|3626789|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798834|NCT01819311|3626787|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3798835|NCT01819311|3626788|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3798836|NCT01819311|3626789|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3798837|NCT01819311|3626787|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3798838|NCT01819311|3626788|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3798839|NCT01819311|3626789|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3798840|NCT01819311|3626787|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3798841|NCT01819311|3626788|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3798842|NCT01819311|3626789|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3798843|NCT01819311|3626787|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3798844|NCT01819311|3626788|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3798845|NCT01819311|3626789|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3798846|NCT01819311|3626787|B3|||Age||years|Mean|11.8|11.8|Standard Deviation|2.6|2.6|||
3798847|NCT01819311|3626788|B2|||Age||years|Mean|11.26|11.26|Standard Deviation|2.16|2.16|||
3798848|NCT01819311|3626789|B1|||Age||years|Mean|12.18|12.18|Standard Deviation|2.69|2.69|||
3798849|NCT01819272|3626806|B7|||Baseline HbA1c||%|Mean|7.38|7.38|Standard Deviation|0.928|0.928|||
3798850|NCT01819272|3626807|B6|||Baseline HbA1c||%|Mean|7.38|7.38|Standard Deviation|0.980|0.98|||
3798851|NCT01819272|3626808|B5|||Baseline HbA1c||%|Mean|7.36|7.36|Standard Deviation|0.997|0.997|||
3798852|NCT01819272|3626809|B4|||Baseline HbA1c||%|Mean|7.37|7.37|Standard Deviation|0.890|0.89|||
3798853|NCT01819272|3626810|B3|||Baseline HbA1c||%|Mean|7.33|7.33|Standard Deviation|0.908|0.908|||
3798854|NCT01819272|3626811|B2|||Baseline HbA1c||%|Mean|7.45|7.45|Standard Deviation|0.887|0.887|||
3798855|NCT01819272|3626812|B1|||Baseline HbA1c||%|Mean|7.40|7.4|Standard Deviation|0.951|0.951|||
3798856|NCT01819272|3626806|B7|||Baseline Fasting Plasma Glucose||mg/dL|Mean|173.0|173.0|Standard Deviation|49.72|49.72|||
3798860|NCT01819272|3626810|B3|||Baseline Fasting Plasma Glucose||mg/dL|Mean|162.9|162.9|Standard Deviation|40.10|40.1|||
3798861|NCT01819272|3626811|B2|||Baseline Fasting Plasma Glucose||mg/dL|Mean|180.1|180.1|Standard Deviation|49.72|49.72|||
3798862|NCT01819272|3626812|B1|||Baseline Fasting Plasma Glucose||mg/dL|Mean|176.5|176.5|Standard Deviation|54.70|54.7|||
3798863|NCT01819272|3626806|B7|||Screening HbA1c||%|Mean|7.17|7.17|Standard Deviation|0.846|0.846|||
3798864|NCT01819272|3626807|B6|||Screening HbA1c||%|Mean|7.17|7.17|Standard Deviation|0.869|0.869|||
3798865|NCT01819272|3626808|B5|||Screening HbA1c||%|Mean|7.10|7.1|Standard Deviation|0.819|0.819|||
3798866|NCT01819272|3626809|B4|||Screening HbA1c||%|Mean|7.13|7.13|Standard Deviation|0.899|0.899|||
3798867|NCT01819272|3626810|B3|||Screening HbA1c||%|Mean|7.17|7.17|Standard Deviation|0.829|0.829|||
3798868|NCT01819272|3626811|B2|||Screening HbA1c||%|Mean|7.27|7.27|Standard Deviation|0.864|0.864|||
3798869|NCT01819272|3626812|B1|||Screening HbA1c||%|Mean|7.19|7.19|Standard Deviation|0.838|0.838|||
3798870|NCT01819272|3626806|B7|||Screening Fasting Plasma Glucose||mg/dL|Mean|144.3|144.3|Standard Deviation|36.57|36.57|||
3798871|NCT01819272|3626807|B6|||Screening Fasting Plasma Glucose||mg/dL|Mean|148.9|148.9|Standard Deviation|41.36|41.36|||
3798872|NCT01819272|3626808|B5|||Screening Fasting Plasma Glucose||mg/dL|Mean|139.0|139.0|Standard Deviation|34.22|34.22|||
3798873|NCT01819272|3626809|B4|||Screening Fasting Plasma Glucose||mg/dL|Mean|141.4|141.4|Standard Deviation|29.79|29.79|||
3798874|NCT01819272|3626810|B3|||Screening Fasting Plasma Glucose||mg/dL|Mean|142.4|142.4|Standard Deviation|34.60|34.6|||
3798875|NCT01819272|3626811|B2|||Screening Fasting Plasma Glucose||mg/dL|Mean|147.5|147.5|Standard Deviation|42.56|42.56|||
3798876|NCT01819272|3626812|B1|||Screening Fasting Plasma Glucose||mg/dL|Mean|146.5|146.5|Standard Deviation|36.70|36.7|||
3798877|NCT01819272|3626806|B7|Metformin/DPP-4 inhibitor combination||Previous T2DM Regimen||participants|Number|14|14.0||||||
3798878|NCT01819272|3626807|B6|Metformin/DPP-4 inhibitor combination||Previous T2DM Regimen||participants|Number|2|2.0||||||
3798879|NCT01819272|3626808|B5|Metformin/DPP-4 inhibitor combination||Previous T2DM Regimen||participants|Number|4|4.0||||||
3798880|NCT01819272|3626809|B4|Metformin/DPP-4 inhibitor combination||Previous T2DM Regimen||participants|Number|0|0.0||||||
3798881|NCT01819272|3626810|B3|Metformin/DPP-4 inhibitor combination||Previous T2DM Regimen||participants|Number|3|3.0||||||
3798882|NCT01819272|3626811|B2|Metformin/DPP-4 inhibitor combination||Previous T2DM Regimen||participants|Number|2|2.0||||||
3798883|NCT01819272|3626812|B1|Metformin/DPP-4 inhibitor combination||Previous T2DM Regimen||participants|Number|3|3.0||||||
3798884|NCT01819272|3626806|B7|Metformin alone||Previous T2DM Regimen||participants|Number|198|198.0||||||
3798885|NCT01819272|3626807|B6|Metformin alone||Previous T2DM Regimen||participants|Number|33|33.0||||||
3798886|NCT01819272|3626808|B5|Metformin alone||Previous T2DM Regimen||participants|Number|30|30.0||||||
3798887|NCT01819272|3626809|B4|Metformin alone||Previous T2DM Regimen||participants|Number|36|36.0||||||
3798888|NCT01819272|3626810|B3|Metformin alone||Previous T2DM Regimen||participants|Number|35|35.0||||||
3798889|NCT01819272|3626811|B2|Metformin alone||Previous T2DM Regimen||participants|Number|29|29.0||||||
3798890|NCT01819272|3626812|B1|Metformin alone||Previous T2DM Regimen||participants|Number|35|35.0||||||
3798891|NCT01819272|3626806|B7|DPP-4 inhibitor alone||Previous T2DM Regimen||participants|Number|1|1.0||||||
3798892|NCT01819272|3626807|B6|DPP-4 inhibitor alone||Previous T2DM Regimen||participants|Number|0|0.0||||||
3798893|NCT01819272|3626808|B5|DPP-4 inhibitor alone||Previous T2DM Regimen||participants|Number|0|0.0||||||
3798894|NCT01819272|3626809|B4|DPP-4 inhibitor alone||Previous T2DM Regimen||participants|Number|0|0.0||||||
3798895|NCT01819272|3626810|B3|DPP-4 inhibitor alone||Previous T2DM Regimen||participants|Number|0|0.0||||||
3798896|NCT01819272|3626811|B2|DPP-4 inhibitor alone||Previous T2DM Regimen||participants|Number|1|1.0||||||
3798897|NCT01819272|3626812|B1|DPP-4 inhibitor alone||Previous T2DM Regimen||participants|Number|0|0.0||||||
3798898|NCT01819272|3626806|B7|Diet and exercise alone||Previous T2DM Regimen||participants|Number|27|27.0||||||
3798899|NCT01819272|3626807|B6|Diet and exercise alone||Previous T2DM Regimen||participants|Number|5|5.0||||||
3798900|NCT01819272|3626808|B5|Diet and exercise alone||Previous T2DM Regimen||participants|Number|6|6.0||||||
3798901|NCT01819272|3626809|B4|Diet and exercise alone||Previous T2DM Regimen||participants|Number|4|4.0||||||
3798902|NCT01819272|3626810|B3|Diet and exercise alone||Previous T2DM Regimen||participants|Number|2|2.0||||||
3798903|NCT01819272|3626811|B2|Diet and exercise alone||Previous T2DM Regimen||participants|Number|7|7.0||||||
3798904|NCT01819272|3626812|B1|Diet and exercise alone||Previous T2DM Regimen||participants|Number|3|3.0||||||
3798905|NCT01819272|3626806|B7|||BMI||kg/m²|Mean|33.3|33.3|Standard Deviation|5.44|5.44|||
3798906|NCT01819272|3626807|B6|||BMI||kg/m²|Mean|33.7|33.7|Standard Deviation|5.22|5.22|||
3798907|NCT01819272|3626808|B5|||BMI||kg/m²|Mean|32.8|32.8|Standard Deviation|5.27|5.27|||
3798908|NCT01819272|3626809|B4|||BMI||kg/m²|Mean|33.3|33.3|Standard Deviation|5.55|5.55|||
3798909|NCT01819272|3626810|B3|||BMI||kg/m²|Mean|33.5|33.5|Standard Deviation|5.86|5.86|||
3798910|NCT01819272|3626811|B2|||BMI||kg/m²|Mean|33.1|33.1|Standard Deviation|5.74|5.74|||
3798911|NCT01819272|3626812|B1|||BMI||kg/m²|Mean|33.6|33.6|Standard Deviation|5.28|5.28|||
3798912|NCT01819272|3626806|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3798913|NCT01819272|3626807|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3798914|NCT01819272|3626808|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798915|NCT01819272|3626809|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3798916|NCT01819272|3626810|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798917|NCT01819272|3626811|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798918|NCT01819272|3626812|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798919|NCT01819272|3626806|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798920|NCT01819272|3626807|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798921|NCT01819272|3626808|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798922|NCT01819272|3626809|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798923|NCT01819272|3626810|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798924|NCT01819272|3626811|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798925|NCT01819272|3626812|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798926|NCT01819272|3626806|B7||White|Race (NIH/OMB)||Participants|Count of Participants|162|162.0||||||
3798927|NCT01819272|3626807|B6||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3798928|NCT01819272|3626808|B5||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3798929|NCT01819272|3626809|B4||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3798930|NCT01819272|3626810|B3||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3798931|NCT01819272|3626811|B2||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3798932|NCT01819272|3626812|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3798933|NCT01819272|3626806|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3798934|NCT01819272|3626807|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3798935|NCT01819272|3626808|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3798936|NCT01819272|3626809|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3798937|NCT01819272|3626810|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3798938|NCT01819272|3626811|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3798939|NCT01819272|3626812|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3798940|NCT01819272|3626806|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3798941|NCT01819272|3626807|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798942|NCT01819272|3626808|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798943|NCT01819272|3626809|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798944|NCT01819272|3626810|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3798945|NCT01819272|3626811|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798946|NCT01819272|3626812|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798947|NCT01819272|3626806|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3798948|NCT01819272|3626807|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798949|NCT01819272|3626808|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3798950|NCT01819272|3626809|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798951|NCT01819272|3626810|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3798952|NCT01819272|3626811|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798953|NCT01819272|3626812|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3798954|NCT01819272|3626806|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3798955|NCT01819272|3626807|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798956|NCT01819272|3626808|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798957|NCT01819272|3626809|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798958|NCT01819272|3626810|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798959|NCT01819272|3626811|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798960|NCT01819272|3626812|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3798961|NCT01819272|3626806|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798962|NCT01819272|3626807|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798963|NCT01819272|3626808|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798964|NCT01819272|3626809|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798965|NCT01819272|3626810|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798966|NCT01819272|3626811|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798967|NCT01819272|3626812|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3798968|NCT01819272|3626806|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|165|165.0||||||
3798969|NCT01819272|3626807|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3798970|NCT01819272|3626808|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3798971|NCT01819272|3626809|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3798972|NCT01819272|3626810|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3798973|NCT01819272|3626811|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3798974|NCT01819272|3626812|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3798975|NCT01819272|3626806|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3798976|NCT01819272|3626807|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3798977|NCT01819272|3626808|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3798978|NCT01819272|3626809|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3798979|NCT01819272|3626810|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3798980|NCT01819272|3626811|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3798981|NCT01819272|3626812|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3798982|NCT01819272|3626806|B7||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3798983|NCT01819272|3626807|B6||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3798984|NCT01819272|3626808|B5||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3798985|NCT01819272|3626809|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3798986|NCT01819272|3626810|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3798987|NCT01819272|3626811|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3798988|NCT01819272|3626812|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3798989|NCT01819272|3626806|B7||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3798990|NCT01819272|3626807|B6||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3798991|NCT01819272|3626808|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3798992|NCT01819272|3626809|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3798993|NCT01819272|3626810|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3798994|NCT01819272|3626811|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3798995|NCT01819272|3626812|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3798996|NCT01819272|3626806|B7|||Age||years|Mean|52.0|52.0|Standard Deviation|9.37|9.37|||
3798997|NCT01819272|3626807|B6|||Age||years|Mean|52.0|52.0|Standard Deviation|9.53|9.53|||
3798998|NCT01819272|3626808|B5|||Age||years|Mean|51.0|51.0|Standard Deviation|9.62|9.62|||
3798999|NCT01819272|3626809|B4|||Age||years|Mean|51.8|51.8|Standard Deviation|9.05|9.05|||
3799000|NCT01819272|3626810|B3|||Age||years|Mean|52.6|52.6|Standard Deviation|9.69|9.69|||
3799001|NCT01819272|3626811|B2|||Age||years|Mean|53.5|53.5|Standard Deviation|8.34|8.34|||
3799002|NCT01819272|3626812|B1|||Age||years|Mean|51.4|51.4|Standard Deviation|10.22|10.22|||
3799003|NCT01819194|3626843|B1|United States||Region of Enrollment||participants|Number|64|64.0||||||
3799004|NCT01819194|3626843|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3799005|NCT01819194|3626843|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3799006|NCT01819194|3626843|B1|||Age||years|Mean|24.53|24.53|Standard Deviation|3.050|3.05|||
3799007|NCT01819129|3626848|B3|||Body Weight||Kg|Mean|88.7|88.7|Standard Deviation|16.8|16.8|||
3799008|NCT01819129|3626849|B2|||Body Weight||Kg|Mean|88.3|88.3|Standard Deviation|16.7|16.7|||
3799009|NCT01819129|3626850|B1|||Body Weight||Kg|Mean|89.0|89.0|Standard Deviation|16.9|16.9|||
3799010|NCT01819129|3626848|B3|||Glycosylated haemoglobin A1c (HbA1c)||Percentage of glycosylated haemoglobin|Mean|7.92|7.92|Standard Deviation|0.70|0.7|||
3799011|NCT01819129|3626849|B2|||Glycosylated haemoglobin A1c (HbA1c)||Percentage of glycosylated haemoglobin|Mean|7.89|7.89|Standard Deviation|0.71|0.71|||
3799012|NCT01819129|3626850|B1|||Glycosylated haemoglobin A1c (HbA1c)||Percentage of glycosylated haemoglobin|Mean|7.96|7.96|Standard Deviation|0.68|0.68|||
3799013|NCT01819129|3626848|B3||Male|Sex: Female, Male||Participants|Count of Participants|336|336.0||||||
3799014|NCT01819129|3626849|B2||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
3799015|NCT01819129|3626850|B1||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3799016|NCT01819129|3626848|B3||Female|Sex: Female, Male||Participants|Count of Participants|353|353.0||||||
3799017|NCT01819129|3626849|B2||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3799018|NCT01819129|3626850|B1||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3799019|NCT01819129|3626848|B3|||Age||Years|Mean|59.5|59.5|Standard Deviation|9.4|9.4|||
3799020|NCT01819129|3626849|B2|||Age||Years|Mean|59.4|59.4|Standard Deviation|9.6|9.6|||
3799021|NCT01819129|3626850|B1|||Age||Years|Mean|59.6|59.6|Standard Deviation|9.3|9.3|||
3799022|NCT01819129|3626848|B3||>=65 years|Age||Participants|Count of Participants|200|200.0||||||
3799023|NCT01819129|3626849|B2||>=65 years|Age||Participants|Count of Participants|96|96.0||||||
3799024|NCT01819129|3626850|B1||>=65 years|Age||Participants|Count of Participants|104|104.0||||||
3799025|NCT01819129|3626848|B3||Between 18 and 65 years|Age||Participants|Count of Participants|489|489.0||||||
3799026|NCT01819129|3626849|B2||Between 18 and 65 years|Age||Participants|Count of Participants|248|248.0||||||
3799027|NCT01819129|3626850|B1||Between 18 and 65 years|Age||Participants|Count of Participants|241|241.0||||||
3799028|NCT01819129|3626848|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3799029|NCT01819129|3626849|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3799030|NCT01819129|3626850|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3799043|NCT01818752|3626863|B3|≥ 75 years||Stratification Factor: Age||participants|Number|299|299.0||||||
3799044|NCT01818752|3626864|B2|≥ 75 years||Stratification Factor: Age||participants|Number|151|151.0||||||
3799031|NCT01818752|3626863|B3|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|1|1.0||||||
3799032|NCT01818752|3626864|B2|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
3799033|NCT01818752|3626865|B1|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|1|1.0||||||
3799034|NCT01818752|3626863|B3|2 (Ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|190|190.0||||||
3799035|NCT01818752|3626864|B2|2 (Ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|89|89.0||||||
3799036|NCT01818752|3626865|B1|2 (Ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|101|101.0||||||
3799037|NCT01818752|3626863|B3|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|510|510.0||||||
3799038|NCT01818752|3626864|B2|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|260|260.0||||||
3799039|NCT01818752|3626865|B1|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|250|250.0||||||
3799040|NCT01818752|3626863|B3|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|254|254.0||||||
3799041|NCT01818752|3626864|B2|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|129|129.0||||||
3799042|NCT01818752|3626865|B1|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|125|125.0||||||
3799045|NCT01818752|3626865|B1|≥ 75 years||Stratification Factor: Age||participants|Number|148|148.0||||||
3799046|NCT01818752|3626863|B3|< 75 years||Stratification Factor: Age||participants|Number|656|656.0||||||
3799047|NCT01818752|3626864|B2|< 75 years||Stratification Factor: Age||participants|Number|327|327.0||||||
3799048|NCT01818752|3626865|B1|< 75 years||Stratification Factor: Age||participants|Number|329|329.0||||||
3799049|NCT01818752|3626863|B3|Other||Stratification Factor: Region of Enrollment||participants|Number|17|17.0||||||
3799050|NCT01818752|3626864|B2|Other||Stratification Factor: Region of Enrollment||participants|Number|10|10.0||||||
3799051|NCT01818752|3626865|B1|Other||Stratification Factor: Region of Enrollment||participants|Number|7|7.0||||||
3799052|NCT01818752|3626863|B3|Europe||Stratification Factor: Region of Enrollment||participants|Number|637|637.0||||||
3799053|NCT01818752|3626864|B2|Europe||Stratification Factor: Region of Enrollment||participants|Number|320|320.0||||||
3799054|NCT01818752|3626865|B1|Europe||Stratification Factor: Region of Enrollment||participants|Number|317|317.0||||||
3799055|NCT01818752|3626863|B3|North America||Stratification Factor: Region of Enrollment||participants|Number|20|20.0||||||
3799056|NCT01818752|3626864|B2|North America||Stratification Factor: Region of Enrollment||participants|Number|8|8.0||||||
3799057|NCT01818752|3626865|B1|North America||Stratification Factor: Region of Enrollment||participants|Number|12|12.0||||||
3799058|NCT01818752|3626863|B3|Asia Pacific||Stratification Factor: Region of Enrollment||participants|Number|281|281.0||||||
3799059|NCT01818752|3626864|B2|Asia Pacific||Stratification Factor: Region of Enrollment||participants|Number|140|140.0||||||
3799060|NCT01818752|3626865|B1|Asia Pacific||Stratification Factor: Region of Enrollment||participants|Number|141|141.0||||||
3799061|NCT01818752|3626863|B3|Subcutaneous||Stratification Factor: Route of Bortezomib Administration|The route of bortezomib administration (IV versus SC) was made per investigator's choice, dose modification, or regulatory approval. The investigator selected the route for all participants prior to randomization to treatment group in order to minimize any evaluation bias because of imbalances in potential prognostic factors that might have impacted the investigator’s choice of a particular route.|participants|Number|709|709.0||||||
3799062|NCT01818752|3626864|B2|Subcutaneous||Stratification Factor: Route of Bortezomib Administration|The route of bortezomib administration (IV versus SC) was made per investigator's choice, dose modification, or regulatory approval. The investigator selected the route for all participants prior to randomization to treatment group in order to minimize any evaluation bias because of imbalances in potential prognostic factors that might have impacted the investigator’s choice of a particular route.|participants|Number|355|355.0||||||
3799063|NCT01818752|3626865|B1|Subcutaneous||Stratification Factor: Route of Bortezomib Administration|The route of bortezomib administration (IV versus SC) was made per investigator's choice, dose modification, or regulatory approval. The investigator selected the route for all participants prior to randomization to treatment group in order to minimize any evaluation bias because of imbalances in potential prognostic factors that might have impacted the investigator’s choice of a particular route.|participants|Number|354|354.0||||||
3799064|NCT01818752|3626863|B3|Intravenous||Stratification Factor: Route of Bortezomib Administration|The route of bortezomib administration (IV versus SC) was made per investigator's choice, dose modification, or regulatory approval. The investigator selected the route for all participants prior to randomization to treatment group in order to minimize any evaluation bias because of imbalances in potential prognostic factors that might have impacted the investigator’s choice of a particular route.|participants|Number|246|246.0||||||
3799065|NCT01818752|3626864|B2|Intravenous||Stratification Factor: Route of Bortezomib Administration|The route of bortezomib administration (IV versus SC) was made per investigator's choice, dose modification, or regulatory approval. The investigator selected the route for all participants prior to randomization to treatment group in order to minimize any evaluation bias because of imbalances in potential prognostic factors that might have impacted the investigator’s choice of a particular route.|participants|Number|123|123.0||||||
3799066|NCT01818752|3626865|B1|Intravenous||Stratification Factor: Route of Bortezomib Administration|The route of bortezomib administration (IV versus SC) was made per investigator's choice, dose modification, or regulatory approval. The investigator selected the route for all participants prior to randomization to treatment group in order to minimize any evaluation bias because of imbalances in potential prognostic factors that might have impacted the investigator’s choice of a particular route.|participants|Number|123|123.0||||||
3799067|NCT01818752|3626863|B3|Stage II or III||Stratification Factor: International Staging System (ISS) Stage|"The International Staging System (ISS) for myeloma was published by the International Myeloma Working Group:~Stage I: β2-microglobulin (β2M) < 3.5 mg/L, albumin >= 3.5 g/dL~Stage II: β2M < 3.5 mg/L and albumin < 3.5 g/dL; or β2M 3.5 mg/L - 5.5 mg/L irrespective of the serum albumin~Stage III: β2M ≥ 5.5 mg/L"|participants|Number|761|761.0||||||
3799068|NCT01818752|3626864|B2|Stage II or III||Stratification Factor: International Staging System (ISS) Stage|"The International Staging System (ISS) for myeloma was published by the International Myeloma Working Group:~Stage I: β2-microglobulin (β2M) < 3.5 mg/L, albumin >= 3.5 g/dL~Stage II: β2M < 3.5 mg/L and albumin < 3.5 g/dL; or β2M 3.5 mg/L - 5.5 mg/L irrespective of the serum albumin~Stage III: β2M ≥ 5.5 mg/L"|participants|Number|383|383.0||||||
3799069|NCT01818752|3626865|B1|Stage II or III||Stratification Factor: International Staging System (ISS) Stage|"The International Staging System (ISS) for myeloma was published by the International Myeloma Working Group:~Stage I: β2-microglobulin (β2M) < 3.5 mg/L, albumin >= 3.5 g/dL~Stage II: β2M < 3.5 mg/L and albumin < 3.5 g/dL; or β2M 3.5 mg/L - 5.5 mg/L irrespective of the serum albumin~Stage III: β2M ≥ 5.5 mg/L"|participants|Number|378|378.0||||||
3799070|NCT01818752|3626863|B3|Stage I||Stratification Factor: International Staging System (ISS) Stage|"The International Staging System (ISS) for myeloma was published by the International Myeloma Working Group:~Stage I: β2-microglobulin (β2M) < 3.5 mg/L, albumin >= 3.5 g/dL~Stage II: β2M < 3.5 mg/L and albumin < 3.5 g/dL; or β2M 3.5 mg/L - 5.5 mg/L irrespective of the serum albumin~Stage III: β2M ≥ 5.5 mg/L"|participants|Number|194|194.0||||||
3799126|NCT01818596|3626894|B2|Dominican Republic||Region of Enrollment||participants|Number|0|0.0||||||
3799127|NCT01818596|3626895|B1|Dominican Republic||Region of Enrollment||participants|Number|6|6.0||||||
3799128|NCT01818596|3626893|B3|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
3799071|NCT01818752|3626864|B2|Stage I||Stratification Factor: International Staging System (ISS) Stage|"The International Staging System (ISS) for myeloma was published by the International Myeloma Working Group:~Stage I: β2-microglobulin (β2M) < 3.5 mg/L, albumin >= 3.5 g/dL~Stage II: β2M < 3.5 mg/L and albumin < 3.5 g/dL; or β2M 3.5 mg/L - 5.5 mg/L irrespective of the serum albumin~Stage III: β2M ≥ 5.5 mg/L"|participants|Number|95|95.0||||||
3799072|NCT01818752|3626865|B1|Stage I||Stratification Factor: International Staging System (ISS) Stage|"The International Staging System (ISS) for myeloma was published by the International Myeloma Working Group:~Stage I: β2-microglobulin (β2M) < 3.5 mg/L, albumin >= 3.5 g/dL~Stage II: β2M < 3.5 mg/L and albumin < 3.5 g/dL; or β2M 3.5 mg/L - 5.5 mg/L irrespective of the serum albumin~Stage III: β2M ≥ 5.5 mg/L"|participants|Number|99|99.0||||||
3799073|NCT01818752|3626863|B3|Not Reported||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3799074|NCT01818752|3626864|B2|Not Reported||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3799075|NCT01818752|3626865|B1|Not Reported||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3799076|NCT01818752|3626863|B3|Multiple||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3799077|NCT01818752|3626864|B2|Multiple||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3799078|NCT01818752|3626865|B1|Multiple||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3799079|NCT01818752|3626863|B3|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3799080|NCT01818752|3626864|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3799081|NCT01818752|3626865|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3799082|NCT01818752|3626863|B3|White||Race/Ethnicity, Customized||participants|Number|668|668.0||||||
3799083|NCT01818752|3626864|B2|White||Race/Ethnicity, Customized||participants|Number|329|329.0||||||
3799084|NCT01818752|3626865|B1|White||Race/Ethnicity, Customized||participants|Number|339|339.0||||||
3799085|NCT01818752|3626863|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3799086|NCT01818752|3626864|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3799087|NCT01818752|3626865|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3799088|NCT01818752|3626863|B3|Asian||Race/Ethnicity, Customized||participants|Number|244|244.0||||||
3799089|NCT01818752|3626864|B2|Asian||Race/Ethnicity, Customized||participants|Number|123|123.0||||||
3799090|NCT01818752|3626865|B1|Asian||Race/Ethnicity, Customized||participants|Number|121|121.0||||||
3799091|NCT01818752|3626863|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3799092|NCT01818752|3626864|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3799093|NCT01818752|3626865|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3799094|NCT01818752|3626863|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3799095|NCT01818752|3626864|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3799096|NCT01818752|3626865|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3799097|NCT01818752|3626863|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|870|870.0||||||
3799098|NCT01818752|3626864|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|427|427.0||||||
3799099|NCT01818752|3626865|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|443|443.0||||||
3799100|NCT01818752|3626863|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3799101|NCT01818752|3626864|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3799102|NCT01818752|3626865|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3799103|NCT01818752|3626863|B3||Male|Sex: Female, Male||Participants|Count of Participants|482|482.0||||||
3799104|NCT01818752|3626864|B2||Male|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
3799105|NCT01818752|3626865|B1||Male|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
3799106|NCT01818752|3626863|B3||Female|Sex: Female, Male||Participants|Count of Participants|473|473.0||||||
3799107|NCT01818752|3626864|B2||Female|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
3799108|NCT01818752|3626865|B1||Female|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
3799109|NCT01818752|3626863|B3|||Age||years|Mean|71.7|71.7|Standard Deviation|6.1|6.1|||
3799110|NCT01818752|3626864|B2|||Age||years|Mean|72.0|72.0|Standard Deviation|5.7|5.7|||
3799111|NCT01818752|3626865|B1|||Age||years|Mean|71.5|71.5|Standard Deviation|6.5|6.5|||
3799112|NCT01818700|3626884|B1|Korea, Republic of||Region of Enrollment||participants|Number|241|241.0||||||
3799113|NCT01818700|3626884|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3799114|NCT01818700|3626884|B1||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3799115|NCT01818700|3626884|B1|Age||Age, Customized||years|Mean|63.51|63.51|Standard Deviation|11.53|11.53|||
3799116|NCT01818596|3626893|B3|France||Region of Enrollment||participants|Number|6|6.0||||||
3799117|NCT01818596|3626894|B2|France||Region of Enrollment||participants|Number|0|0.0||||||
3799118|NCT01818596|3626895|B1|France||Region of Enrollment||participants|Number|6|6.0||||||
3799119|NCT01818596|3626893|B3|Australia||Region of Enrollment||participants|Number|12|12.0||||||
3799120|NCT01818596|3626894|B2|Australia||Region of Enrollment||participants|Number|0|0.0||||||
3799121|NCT01818596|3626895|B1|Australia||Region of Enrollment||participants|Number|12|12.0||||||
3799122|NCT01818596|3626893|B3|Mexico||Region of Enrollment||participants|Number|2|2.0||||||
3799123|NCT01818596|3626894|B2|Mexico||Region of Enrollment||participants|Number|0|0.0||||||
3799124|NCT01818596|3626895|B1|Mexico||Region of Enrollment||participants|Number|2|2.0||||||
3799125|NCT01818596|3626893|B3|Dominican Republic||Region of Enrollment||participants|Number|6|6.0||||||
3799129|NCT01818596|3626894|B2|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
3799130|NCT01818596|3626895|B1|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
3799131|NCT01818596|3626893|B3|Spain||Region of Enrollment||participants|Number|13|13.0||||||
3799132|NCT01818596|3626894|B2|Spain||Region of Enrollment||participants|Number|0|0.0||||||
3799133|NCT01818596|3626895|B1|Spain||Region of Enrollment||participants|Number|13|13.0||||||
3799134|NCT01818596|3626893|B3|Thailand||Region of Enrollment||participants|Number|31|31.0||||||
3799135|NCT01818596|3626894|B2|Thailand||Region of Enrollment||participants|Number|1|1.0||||||
3799136|NCT01818596|3626895|B1|Thailand||Region of Enrollment||participants|Number|30|30.0||||||
3799137|NCT01818596|3626893|B3|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
3799138|NCT01818596|3626894|B2|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3799139|NCT01818596|3626895|B1|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
3799140|NCT01818596|3626893|B3|United States||Region of Enrollment||participants|Number|171|171.0||||||
3799141|NCT01818596|3626894|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3799142|NCT01818596|3626895|B1|United States||Region of Enrollment||participants|Number|166|166.0||||||
3799143|NCT01818596|3626893|B3|Not Permitted||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3799144|NCT01818596|3626894|B2|Not Permitted||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3799145|NCT01818596|3626895|B1|Not Permitted||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3799146|NCT01818596|3626893|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|214|214.0||||||
3799147|NCT01818596|3626894|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3799148|NCT01818596|3626895|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|209|209.0||||||
3799149|NCT01818596|3626893|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3799150|NCT01818596|3626894|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3799151|NCT01818596|3626895|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3799152|NCT01818596|3626893|B3|Not Permitted||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3799153|NCT01818596|3626894|B2|Not Permitted||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3799154|NCT01818596|3626895|B1|Not Permitted||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3799155|NCT01818596|3626893|B3|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3799156|NCT01818596|3626894|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3799157|NCT01818596|3626895|B1|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3799158|NCT01818596|3626893|B3|White||Race/Ethnicity, Customized||participants|Number|154|154.0||||||
3799159|NCT01818596|3626894|B2|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3799160|NCT01818596|3626895|B1|White||Race/Ethnicity, Customized||participants|Number|152|152.0||||||
3799161|NCT01818596|3626893|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3799162|NCT01818596|3626894|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3799163|NCT01818596|3626895|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3799164|NCT01818596|3626893|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
3799165|NCT01818596|3626894|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3799166|NCT01818596|3626895|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
3799167|NCT01818596|3626893|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3799168|NCT01818596|3626894|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3799169|NCT01818596|3626895|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3799170|NCT01818596|3626893|B3|Asian||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3799171|NCT01818596|3626894|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3799172|NCT01818596|3626895|B1|Asian||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
3799173|NCT01818596|3626893|B3||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
3799174|NCT01818596|3626894|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3799175|NCT01818596|3626895|B1||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
3799176|NCT01818596|3626893|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3799177|NCT01818596|3626894|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3799178|NCT01818596|3626895|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3799179|NCT01818596|3626893|B3|||Age||years|Mean|58|58.0|Standard Deviation|9.8|9.8|||
3799180|NCT01818596|3626894|B2|||Age||years|Mean|55|55.0|Standard Deviation|7.1|7.1|||
3799181|NCT01818596|3626895|B1|||Age||years|Mean|58|58.0|Standard Deviation|9.9|9.9|||
3799182|NCT01818531|3626927|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799183|NCT01818531|3626928|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799184|NCT01818531|3626929|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799185|NCT01818531|3626927|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799186|NCT01818531|3626928|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799187|NCT01818531|3626929|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799188|NCT01818531|3626927|B3||White|Race (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
3799189|NCT01818531|3626928|B2||White|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3799190|NCT01818531|3626929|B1||White|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3799191|NCT01818531|3626927|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3799192|NCT01818531|3626928|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3799193|NCT01818531|3626929|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3799194|NCT01818531|3626927|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799195|NCT01818531|3626928|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799196|NCT01818531|3626929|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799197|NCT01818531|3626927|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799198|NCT01818531|3626928|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799199|NCT01818531|3626929|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799200|NCT01818531|3626927|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799201|NCT01818531|3626928|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799202|NCT01818531|3626929|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799203|NCT01818531|3626927|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3799204|NCT01818531|3626928|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3799205|NCT01818531|3626929|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3799206|NCT01818531|3626927|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3799207|NCT01818531|3626928|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3799208|NCT01818531|3626929|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3799209|NCT01818531|3626927|B3|||Age||years|Mean|63|63.0|Standard Deviation|10.4|10.4|||
3799210|NCT01818531|3626928|B2|||Age||years|Mean|63|63.0|Standard Deviation|10.5|10.5|||
3799211|NCT01818531|3626929|B1|||Age||years|Mean|63|63.0|Standard Deviation|10.2|10.2|||
3799212|NCT01818427|3626944|B3|United States||Region of Enrollment||Participants|Count of Participants|501|501.0||||||
3799213|NCT01818427|3626945|B2|United States||Region of Enrollment||Participants|Count of Participants|271|271.0||||||
3799214|NCT01818427|3626946|B1|United States||Region of Enrollment||Participants|Count of Participants|230|230.0||||||
3799215|NCT01818427|3626944|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3799216|NCT01818427|3626945|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3799217|NCT01818427|3626946|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3799218|NCT01818427|3626944|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799219|NCT01818427|3626945|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799220|NCT01818427|3626946|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799221|NCT01818427|3626944|B3||White|Race (NIH/OMB)||Participants|Count of Participants|435|435.0||||||
3799222|NCT01818427|3626945|B2||White|Race (NIH/OMB)||Participants|Count of Participants|228|228.0||||||
3799223|NCT01818427|3626946|B1||White|Race (NIH/OMB)||Participants|Count of Participants|207|207.0||||||
3799224|NCT01818427|3626944|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3799225|NCT01818427|3626945|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3799226|NCT01818427|3626946|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3799227|NCT01818427|3626944|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799228|NCT01818427|3626945|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799229|NCT01818427|3626946|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799230|NCT01818427|3626944|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799231|NCT01818427|3626945|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799232|NCT01818427|3626946|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799233|NCT01818427|3626944|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799234|NCT01818427|3626945|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799235|NCT01818427|3626946|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799236|NCT01818427|3626944|B3||Male|Sex: Female, Male||Participants|Count of Participants|364|364.0||||||
3799237|NCT01818427|3626945|B2||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
3799238|NCT01818427|3626946|B1||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3799239|NCT01818427|3626944|B3||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3799240|NCT01818427|3626945|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3799241|NCT01818427|3626946|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3799242|NCT01818427|3626944|B3|||Age||years|Median|45|45.0|Inter-Quartile Range|||29.0|59.0|
3799243|NCT01818427|3626945|B2|||Age||years|Median|46|46.0|Inter-Quartile Range|||28.0|60.0|
3799244|NCT01818427|3626946|B1|||Age||years|Median|44|44.0|Inter-Quartile Range|||31.0|59.0|
3799245|NCT01818414|3626961|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3799246|NCT01818414|3626962|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3799247|NCT01818414|3626963|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3799248|NCT01818414|3626961|B3||Female|Gender||Participants|Count of Participants|29|29.0||||||
3799249|NCT01818414|3626962|B2||Female|Gender||Participants|Count of Participants|15|15.0||||||
3799250|NCT01818414|3626963|B1||Female|Gender||Participants|Count of Participants|14|14.0||||||
3799251|NCT01818414|3626961|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3799252|NCT01818414|3626962|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3799253|NCT01818414|3626963|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3799254|NCT01818414|3626961|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3799255|NCT01818414|3626962|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3799256|NCT01818414|3626963|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3799257|NCT01818414|3626961|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3799258|NCT01818414|3626962|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3799259|NCT01818414|3626963|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3799260|NCT01818336|3626978|B1|Yes||Previous penicillin testing history||participants|Number|17|17.0||||||
3799261|NCT01818336|3626978|B1|No||Previous penicillin testing history||participants|Number|464|464.0||||||
3799262|NCT01818336|3626978|B1|Yes||Penicillin allergy history||participants|Number|455|455.0||||||
3799263|NCT01818336|3626978|B1|No||Penicillin allergy history||participants|Number|26|26.0||||||
3799264|NCT01818336|3626978|B1|United States||Region of Enrollment||participants|Number|481|481.0||||||
3799265|NCT01818336|3626978|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3799266|NCT01818336|3626978|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799267|NCT01818336|3626978|B1||White|Race (NIH/OMB)||Participants|Count of Participants|440|440.0||||||
3799268|NCT01818336|3626978|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3799269|NCT01818336|3626978|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799270|NCT01818336|3626978|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3799271|NCT01818336|3626978|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3799272|NCT01818336|3626978|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799273|NCT01818336|3626978|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|467|467.0||||||
3799274|NCT01818336|3626978|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3799275|NCT01818336|3626978|B1||Male|Gender||Participants|Count of Participants|343|343.0||||||
3799276|NCT01818336|3626978|B1||Female|Gender||Participants|Count of Participants|138|138.0||||||
3799277|NCT01818336|3626978|B1|Retest Population||Age||years|Mean|50.5|50.5|Standard Deviation|15.32|15.32|||
3799278|NCT01818336|3626978|B1|Per-Protocol Population||Age||years|Mean|50.2|50.2|Standard Deviation|16.49|16.49|||
3799279|NCT01818336|3626978|B1|Intent-to-Treat Population||Age||years|Mean|50.2|50.2|Standard Deviation|16.40|16.4|||
3799280|NCT01818336|3626978|B1|Safety Population||Age||years|Mean|49.4|49.4|Standard Deviation|16.34|16.34|||
3799281|NCT01818297|3626985|B3|||Back pain|Average/typical back pain on a scale of 0 (no pain) - 10 (worst pain). Average of a back pain diary assessment.|units on a scale|Mean|6.71|6.71|Standard Deviation|1.08|1.08|||
3799282|NCT01818297|3626986|B2|||Back pain|Average/typical back pain on a scale of 0 (no pain) - 10 (worst pain). Average of a back pain diary assessment.|units on a scale|Mean|6.66|6.66|Standard Deviation|0.88|0.88|||
3799283|NCT01818297|3626987|B1|||Back pain|Average/typical back pain on a scale of 0 (no pain) - 10 (worst pain). Average of a back pain diary assessment.|units on a scale|Mean|6.77|6.77|Standard Deviation|1.25|1.25|||
3799284|NCT01818297|3626985|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
3799285|NCT01818297|3626986|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3799286|NCT01818297|3626987|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
3799287|NCT01818297|3626985|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799288|NCT01818297|3626986|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799289|NCT01818297|3626987|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799290|NCT01818297|3626985|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3799291|NCT01818297|3626986|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3799292|NCT01818297|3626987|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799293|NCT01818297|3626985|B3||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3799294|NCT01818297|3626986|B2||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3799295|NCT01818297|3626987|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3799296|NCT01818297|3626985|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3799297|NCT01818297|3626986|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799298|NCT01818297|3626987|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3799299|NCT01818297|3626985|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799300|NCT01818297|3626986|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799301|NCT01818297|3626987|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799302|NCT01818297|3626985|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799303|NCT01818297|3626986|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799304|NCT01818297|3626987|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799305|NCT01818297|3626985|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799306|NCT01818297|3626986|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799307|NCT01818297|3626987|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799308|NCT01818297|3626985|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799309|NCT01818297|3626986|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799310|NCT01818297|3626987|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799311|NCT01818297|3626985|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3799312|NCT01818297|3626986|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3799313|NCT01818297|3626987|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3799314|NCT01818297|3626985|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799315|NCT01818297|3626986|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799316|NCT01818297|3626987|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799317|NCT01818297|3626985|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3799318|NCT01818297|3626986|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3799319|NCT01818297|3626987|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3799320|NCT01818297|3626985|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3799321|NCT01818297|3626986|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3799322|NCT01818297|3626987|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3799323|NCT01818297|3626985|B3|||Age||years|Mean|60.2|60.2|Standard Deviation|13.3|13.3|||
3799324|NCT01818297|3626986|B2|||Age||years|Mean|59.8|59.8|Standard Deviation|13.7|13.7|||
3799325|NCT01818297|3626987|B1|||Age||years|Mean|60.6|60.6|Standard Deviation|13.1|13.1|||
3799326|NCT01818245|3627004|B3|United States||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
3799327|NCT01818245|3627005|B2|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3799328|NCT01818245|3627006|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3799329|NCT01818245|3627004|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799330|NCT01818245|3627005|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799331|NCT01818245|3627006|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799332|NCT01818245|3627004|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3799333|NCT01818245|3627005|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799334|NCT01818245|3627006|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3799335|NCT01818245|3627004|B3||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3799336|NCT01818245|3627005|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3799337|NCT01818245|3627006|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3799338|NCT01818245|3627004|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3799339|NCT01818245|3627005|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3799340|NCT01818245|3627006|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3799341|NCT01818245|3627004|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799342|NCT01818245|3627005|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799343|NCT01818245|3627006|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799344|NCT01818245|3627004|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799345|NCT01818245|3627005|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799346|NCT01818245|3627006|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799347|NCT01818245|3627004|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799348|NCT01818245|3627005|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799349|NCT01818245|3627006|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799350|NCT01818245|3627004|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799351|NCT01818245|3627005|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799352|NCT01818245|3627006|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799353|NCT01818245|3627004|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3799354|NCT01818245|3627005|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3799355|NCT01818245|3627006|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3799356|NCT01818245|3627004|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3799357|NCT01818245|3627005|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799358|NCT01818245|3627006|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3799359|NCT01818245|3627004|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3799360|NCT01818245|3627005|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3799361|NCT01818245|3627006|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3799362|NCT01818245|3627004|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3799363|NCT01818245|3627005|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3799364|NCT01818245|3627006|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3799365|NCT01818245|3627004|B3|||Age||years|Mean|51.7|51.7|Standard Deviation|18.8|18.8|||
3799366|NCT01818245|3627005|B2|||Age||years|Mean|71.4|71.4|Standard Deviation|6.3|6.3|||
3799367|NCT01818245|3627006|B1|||Age||years|Mean|37.2|37.2|Standard Deviation|9.1|9.1|||
3799368|NCT01818141|3627029|B3|||Baseline vegetative cells CFU|Count (colony forming units, CFU) of vegetative Clostridium difficile in baseline stool.|log10 CFU/g stool|Mean|4.23|4.23|Standard Deviation|2.30|2.3|||
3799369|NCT01818141|3627030|B2|||Baseline vegetative cells CFU|Count (colony forming units, CFU) of vegetative Clostridium difficile in baseline stool.|log10 CFU/g stool|Mean|4.22|4.22|Standard Deviation|2.1|2.1|||
3799370|NCT01818141|3627031|B1|||Baseline vegetative cells CFU|Count (colony forming units, CFU) of vegetative Clostridium difficile in baseline stool.|log10 CFU/g stool|Mean|4.23|4.23|Standard Deviation|2.39|2.39|||
3799371|NCT01818141|3627029|B3|||Baseline spores CFU|The count (colony forming units, CFU) of Clostridium difficile spores at baseline stool.|log10 CFU/g stool|Mean|4.94|4.94|Standard Deviation|1.47|1.47|||
3799372|NCT01818141|3627030|B2|||Baseline spores CFU|The count (colony forming units, CFU) of Clostridium difficile spores at baseline stool.|log10 CFU/g stool|Mean|4.87|4.87|Standard Deviation|1.43|1.43|||
3799373|NCT01818141|3627031|B1|||Baseline spores CFU|The count (colony forming units, CFU) of Clostridium difficile spores at baseline stool.|log10 CFU/g stool|Mean|5.00|5.0|Standard Deviation|1.44|1.44|||
3799374|NCT01818141|3627029|B3|||Baseline total colony forming units (CFU)|Total colony forming units (CFU) of Clostridium difficile per patient at baseline. This is the addition of vegetative cell counts and spore cell counts.|log10 CFU/g stool|Mean|5.19|5.19|Standard Deviation|1.80|1.8|||
3799375|NCT01818141|3627030|B2|||Baseline total colony forming units (CFU)|Total colony forming units (CFU) of Clostridium difficile per patient at baseline. This is the addition of vegetative cell counts and spore cell counts.|log10 CFU/g stool|Mean|4.96|4.96|Standard Deviation|1.81|1.81|||
3799376|NCT01818141|3627031|B1|||Baseline total colony forming units (CFU)|Total colony forming units (CFU) of Clostridium difficile per patient at baseline. This is the addition of vegetative cell counts and spore cell counts.|log10 CFU/g stool|Mean|5.41|5.41|Standard Deviation|1.72|1.72|||
3799377|NCT01818141|3627029|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
3799378|NCT01818141|3627030|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3799379|NCT01818141|3627031|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3799380|NCT01818141|3627029|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799381|NCT01818141|3627030|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799382|NCT01818141|3627031|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799383|NCT01818141|3627029|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799384|NCT01818141|3627030|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799385|NCT01818141|3627031|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799386|NCT01818141|3627029|B3||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3799387|NCT01818141|3627030|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3799388|NCT01818141|3627031|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3799389|NCT01818141|3627029|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3799390|NCT01818141|3627030|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799391|NCT01818141|3627031|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799392|NCT01818141|3627029|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799393|NCT01818141|3627030|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799394|NCT01818141|3627031|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799395|NCT01818141|3627029|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799396|NCT01818141|3627030|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799397|NCT01818141|3627031|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799398|NCT01818141|3627029|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799399|NCT01818141|3627030|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799400|NCT01818141|3627031|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799401|NCT01818141|3627029|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3799402|NCT01818141|3627030|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3799403|NCT01818141|3627031|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3799404|NCT01818141|3627029|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3799405|NCT01818141|3627030|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3799406|NCT01818141|3627031|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3799407|NCT01818141|3627029|B3|||Age||years|Mean|67|67.0|Standard Deviation|15|15.0|||
3799408|NCT01818141|3627030|B2|||Age||years|Mean|66|66.0|Standard Deviation|15|15.0|||
3799409|NCT01818141|3627031|B1|||Age||years|Mean|69|69.0|Standard Deviation|15|15.0|||
3799410|NCT01818063|3627040|B3|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3799411|NCT01818063|3627041|B2|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3799412|NCT01818063|3627042|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3799413|NCT01818063|3627040|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799414|NCT01818063|3627041|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799415|NCT01818063|3627042|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799416|NCT01818063|3627040|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799417|NCT01818063|3627041|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799418|NCT01818063|3627042|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799419|NCT01818063|3627040|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3799420|NCT01818063|3627041|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3799421|NCT01818063|3627042|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3799422|NCT01818063|3627040|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3799423|NCT01818063|3627041|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3799424|NCT01818063|3627042|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799425|NCT01818063|3627040|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799426|NCT01818063|3627041|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799427|NCT01818063|3627042|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799428|NCT01818063|3627040|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799429|NCT01818063|3627041|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799430|NCT01818063|3627042|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799431|NCT01818063|3627040|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799432|NCT01818063|3627041|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799433|NCT01818063|3627042|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799434|NCT01818063|3627040|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799435|NCT01818063|3627041|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799436|NCT01818063|3627042|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799437|NCT01818063|3627040|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3799438|NCT01818063|3627041|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3799439|NCT01818063|3627042|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3799440|NCT01818063|3627040|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799441|NCT01818063|3627041|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799442|NCT01818063|3627042|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799443|NCT01818063|3627040|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3799444|NCT01818063|3627041|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3799445|NCT01818063|3627042|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3799446|NCT01818063|3627040|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3799447|NCT01818063|3627041|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3799448|NCT01818063|3627042|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3799449|NCT01818063|3627040|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3799450|NCT01818063|3627041|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3799451|NCT01818063|3627042|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3799452|NCT01818063|3627040|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3799453|NCT01818063|3627041|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3799454|NCT01818063|3627042|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3799455|NCT01818063|3627040|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3799456|NCT01818063|3627041|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3799457|NCT01818063|3627042|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3799458|NCT01817907|3627049|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
3799459|NCT01817907|3627050|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3799460|NCT01817907|3627051|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3799461|NCT01817907|3627049|B3||Male|Gender||Participants|Count of Participants|6|6.0||||||
3799462|NCT01817907|3627050|B2||Male|Gender||Participants|Count of Participants|2|2.0||||||
3799463|NCT01817907|3627051|B1||Male|Gender||Participants|Count of Participants|4|4.0||||||
3799464|NCT01817907|3627049|B3||Female|Gender||Participants|Count of Participants|9|9.0||||||
3799465|NCT01817907|3627050|B2||Female|Gender||Participants|Count of Participants|5|5.0||||||
3799466|NCT01817907|3627051|B1||Female|Gender||Participants|Count of Participants|4|4.0||||||
3799467|NCT01817907|3627049|B3|||Age||years|Mean|53|53.0|Standard Deviation|10|10.0|||
3799468|NCT01817907|3627050|B2|||Age||years|Mean|53|53.0|Standard Deviation|14|14.0|||
3799469|NCT01817907|3627051|B1|||Age||years|Mean|53|53.0|Standard Deviation|7|7.0|||
3799470|NCT01817855|3627060|B5||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3799471|NCT01817855|3627061|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3799472|NCT01817855|3627062|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3799473|NCT01817855|3627063|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3799474|NCT01817855|3627064|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3799475|NCT01817855|3627060|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3799476|NCT01817855|3627061|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3799477|NCT01817855|3627062|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3799478|NCT01817855|3627063|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3799479|NCT01817855|3627064|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3799480|NCT01817855|3627060|B5|||Age||Years|Mean|45.3|45.3|Standard Deviation|17.1|17.1|||
3799481|NCT01817855|3627061|B4|||Age||Years|Mean|65|65.0|Standard Deviation|8.7|8.7|||
3799482|NCT01817855|3627062|B3|||Age||Years|Mean|65|65.0|Standard Deviation|9.7|9.7|||
3799483|NCT01817855|3627063|B2|||Age||Years|Mean|32|32.0|Standard Deviation|9.1|9.1|||
3799484|NCT01817855|3627064|B1|||Age||Years|Mean|36|36.0|Standard Deviation|9.7|9.7|||
3799485|NCT01817790|3627095|B3||Male|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
3799486|NCT01817790|3627096|B2||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3799487|NCT01817790|3627097|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3799488|NCT01817790|3627095|B3||Female|Sex: Female, Male||Participants|Count of Participants|413|413.0||||||
3799489|NCT01817790|3627096|B2||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3799490|NCT01817790|3627097|B1||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
3799491|NCT01817790|3627095|B3|||Age||Years|Mean|40.5|40.5|Standard Deviation|15.47|15.47|||
3799492|NCT01817790|3627096|B2|||Age||Years|Mean|40.5|40.5|Standard Deviation|16.36|16.36|||
3799493|NCT01817790|3627097|B1|||Age||Years|Mean|40.4|40.4|Standard Deviation|14.55|14.55|||
3799494|NCT01817777|3627140|B3|Caucasic (White)||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3799495|NCT01817777|3627141|B2|Caucasic (White)||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3799496|NCT01817777|3627142|B1|Caucasic (White)||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3799497|NCT01817777|3627140|B3||Male|Gender||Participants|Count of Participants|17|17.0||||||
3799498|NCT01817777|3627141|B2||Male|Gender||Participants|Count of Participants|8|8.0||||||
3799499|NCT01817777|3627142|B1||Male|Gender||Participants|Count of Participants|9|9.0||||||
3799500|NCT01817777|3627140|B3||Female|Gender||Participants|Count of Participants|14|14.0||||||
3799501|NCT01817777|3627141|B2||Female|Gender||Participants|Count of Participants|7|7.0||||||
3799502|NCT01817777|3627142|B1||Female|Gender||Participants|Count of Participants|7|7.0||||||
3799503|NCT01817777|3627140|B3|||Age||Years|Mean|57.3|57.3|Standard Deviation|11.17|11.17|||
3799504|NCT01817777|3627141|B2|||Age||Years|Mean|56.3|56.3|Standard Deviation|10.52|10.52|||
3799505|NCT01817777|3627142|B1|||Age||Years|Mean|58.3|58.3|Standard Deviation|12.01|12.01|||
3799506|NCT01817764|3627166|B3|White - White/Caucasian/European||Race/Ethnicity, Customized||Participants|Number|683|683.0||||||
3799507|NCT01817764|3627167|B2|White - White/Caucasian/European||Race/Ethnicity, Customized||Participants|Number|342|342.0||||||
3799508|NCT01817764|3627168|B1|White - White/Caucasian/European||Race/Ethnicity, Customized||Participants|Number|341|341.0||||||
3799509|NCT01817764|3627166|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3799510|NCT01817764|3627167|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3799511|NCT01817764|3627168|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3799512|NCT01817764|3627166|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3799513|NCT01817764|3627167|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3799514|NCT01817764|3627168|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3799515|NCT01817764|3627166|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3799516|NCT01817764|3627167|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3799517|NCT01817764|3627168|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3799518|NCT01817764|3627166|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
3799519|NCT01817764|3627167|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3799520|NCT01817764|3627168|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3799521|NCT01817764|3627166|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3799522|NCT01817764|3627167|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3799523|NCT01817764|3627168|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3799524|NCT01817764|3627166|B3||Male|Sex: Female, Male||Participants|Count of Participants|497|497.0||||||
3799525|NCT01817764|3627167|B2||Male|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
3799526|NCT01817764|3627168|B1||Male|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
3799527|NCT01817764|3627166|B3||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
3799528|NCT01817764|3627167|B2||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3799529|NCT01817764|3627168|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3799530|NCT01817764|3627166|B3|||Age||Years|Mean|62.8|62.8|Standard Deviation|8.97|8.97|||
3799531|NCT01817764|3627167|B2|||Age||Years|Mean|63.0|63.0|Standard Deviation|8.91|8.91|||
3799532|NCT01817764|3627168|B1|||Age||Years|Mean|62.5|62.5|Standard Deviation|9.05|9.05|||
3799533|NCT01817725|3627177|B1|Taiwan||Region of Enrollment||participants|Number|20|20.0||||||
3799534|NCT01817725|3627177|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3799535|NCT01817725|3627177|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3799536|NCT01817725|3627177|B1|||Age||years|Mean|43.3|43.3|Standard Deviation|12.1|12.1|||
3799537|NCT01817491|3627182|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
3799538|NCT01817491|3627183|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
3799539|NCT01817491|3627184|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
3799540|NCT01817491|3627182|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3799541|NCT01817491|3627183|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3799542|NCT01817491|3627184|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3799543|NCT01817491|3627182|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3799544|NCT01817491|3627183|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3799545|NCT01817491|3627184|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3799546|NCT01817491|3627182|B3|Parents||Age||years|Mean|46.25|46.25|Full Range|||35.0|61.0|
3799547|NCT01817491|3627183|B2|Parents||Age||years|Mean|46.0|46.0|Full Range|||35.0|51.0|
3799548|NCT01817491|3627184|B1|Parents||Age||years|Mean|46.5|46.5|Full Range|||37.0|61.0|
3799549|NCT01817491|3627182|B3|Adolescents||Age||years|Mean|15|15.0|Full Range|||9.0|18.0|
3799550|NCT01817491|3627183|B2|Adolescents||Age||years|Mean|15|15.0|Full Range|||9.0|18.0|
3799551|NCT01817491|3627184|B1|Adolescents||Age||years|Mean|15|15.0|Full Range|||9.0|18.0|
3799552|NCT01817491|3627182|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3799553|NCT01817491|3627183|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3799554|NCT01817491|3627184|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3799555|NCT01817491|3627182|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3799556|NCT01817491|3627183|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3799557|NCT01817491|3627184|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3799558|NCT01817491|3627182|B3||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
3799559|NCT01817491|3627183|B2||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
3799560|NCT01817491|3627184|B1||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
3799561|NCT01817374|3627231|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3799562|NCT01817374|3627231|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3799563|NCT01817374|3627231|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3799564|NCT01817374|3627231|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3799565|NCT01817374|3627231|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3799566|NCT01817374|3627231|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3799567|NCT01816893|3627243|B3|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3799568|NCT01816893|3627244|B2|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3799569|NCT01816893|3627245|B1|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3799570|NCT01816893|3627243|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799571|NCT01816893|3627244|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799572|NCT01816893|3627245|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799573|NCT01816893|3627243|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799574|NCT01816893|3627244|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799575|NCT01816893|3627245|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799576|NCT01816893|3627243|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3799577|NCT01816893|3627244|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3799578|NCT01816893|3627245|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3799579|NCT01816893|3627243|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3799580|NCT01816893|3627244|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799581|NCT01816893|3627245|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3799582|NCT01816893|3627243|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799583|NCT01816893|3627244|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799584|NCT01816893|3627245|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799585|NCT01816893|3627243|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3799586|NCT01816893|3627244|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799587|NCT01816893|3627245|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799588|NCT01816893|3627243|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799589|NCT01816893|3627244|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799590|NCT01816893|3627245|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799591|NCT01816893|3627243|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3799592|NCT01816893|3627244|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3799593|NCT01816893|3627245|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3799594|NCT01816893|3627243|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3799595|NCT01816893|3627244|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3799596|NCT01816893|3627245|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3799597|NCT01816893|3627243|B3|||Age||years|Mean|28|28.0|Standard Deviation|7|7.0|||
3799598|NCT01816893|3627244|B2|||Age||years|Mean|29|29.0|Standard Deviation|8|8.0|||
3799599|NCT01816893|3627245|B1|||Age||years|Mean|28|28.0|Standard Deviation|6|6.0|||
3799600|NCT01816893|3627243|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3799601|NCT01816893|3627244|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3799602|NCT01816893|3627245|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3799603|NCT01816893|3627243|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3799604|NCT01816893|3627244|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3799605|NCT01816893|3627245|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3799606|NCT01816893|3627243|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3799607|NCT01816893|3627244|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3799608|NCT01816893|3627245|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3799609|NCT01816776|3627256|B3|||Concomitant implantable device delivering therapy||Participants|Count of Participants|64|64.0||||||
3799610|NCT01816776|3627257|B2|||Concomitant implantable device delivering therapy||Participants|Count of Participants|33|33.0||||||
3799611|NCT01816776|3627258|B1|||Concomitant implantable device delivering therapy||Participants|Count of Participants|31|31.0||||||
3799612|NCT01816776|3627256|B3|||Coronary artery disease||Participants|Count of Participants|84|84.0||||||
3799613|NCT01816776|3627257|B2|||Coronary artery disease||Participants|Count of Participants|44|44.0||||||
3799614|NCT01816776|3627258|B1|||Coronary artery disease||Participants|Count of Participants|40|40.0||||||
3799615|NCT01816776|3627256|B3|||Stroke||Participants|Count of Participants|12|12.0||||||
3799616|NCT01816776|3627257|B2|||Stroke||Participants|Count of Participants|6|6.0||||||
3799617|NCT01816776|3627258|B1|||Stroke||Participants|Count of Participants|6|6.0||||||
3799618|NCT01816776|3627256|B3|||Atrial fibrillation||Participants|Count of Participants|64|64.0||||||
3799619|NCT01816776|3627257|B2|||Atrial fibrillation||Participants|Count of Participants|32|32.0||||||
3799620|NCT01816776|3627258|B1|||Atrial fibrillation||Participants|Count of Participants|32|32.0||||||
3799621|NCT01816776|3627256|B3|||Left ventricular ejection fraction|Available for N=71 Treatment and N=75 Control participants.|Percent|Mean|39.6|39.6|Standard Deviation|12.1|12.1|||
3799622|NCT01816776|3627257|B2|||Left ventricular ejection fraction|Available for N=71 Treatment and N=75 Control participants.|Percent|Mean|39.4|39.4|Standard Deviation|12.2|12.2|||
3799623|NCT01816776|3627258|B1|||Left ventricular ejection fraction|Available for N=71 Treatment and N=75 Control participants.|Percent|Mean|39.7|39.7|Standard Deviation|12.1|12.1|||
3799624|NCT01816776|3627256|B3|||Heart failure|Defined as New York Heart Association (NYHA) Functional Class ≥ I|Participants|Count of Participants|96|96.0||||||
3799625|NCT01816776|3627257|B2|||Heart failure|Defined as New York Heart Association (NYHA) Functional Class ≥ I|Participants|Count of Participants|48|48.0||||||
3799626|NCT01816776|3627258|B1|||Heart failure|Defined as New York Heart Association (NYHA) Functional Class ≥ I|Participants|Count of Participants|48|48.0||||||
3799627|NCT01816776|3627256|B3|||Hypertension||Participants|Count of Participants|113|113.0||||||
3799628|NCT01816776|3627257|B2|||Hypertension||Participants|Count of Participants|60|60.0||||||
3799629|NCT01816776|3627258|B1|||Hypertension||Participants|Count of Participants|53|53.0||||||
3799630|NCT01816776|3627256|B3|||Body mass index (BMI)||kg/m2|Mean|31.1|31.1|Standard Deviation|6.0|6.0|||
3799631|NCT01816776|3627257|B2|||Body mass index (BMI)||kg/m2|Mean|31.3|31.3|Standard Deviation|6.6|6.6|||
3799632|NCT01816776|3627258|B1|||Body mass index (BMI)||kg/m2|Mean|30.8|30.8|Standard Deviation|5.3|5.3|||
3799633|NCT01816776|3627256|B3|||Epworth Sleepiness Scale (ESS)|The ESS is an assessment to measure a subject’s general level of daytime sleepiness. Scores can range from 0-24, with higher scores indicating higher level of daytime sleepiness.|units on a scale|Mean|9.8|9.8|Standard Deviation|5.5|5.5|||
3799634|NCT01816776|3627257|B2|||Epworth Sleepiness Scale (ESS)|The ESS is an assessment to measure a subject’s general level of daytime sleepiness. Scores can range from 0-24, with higher scores indicating higher level of daytime sleepiness.|units on a scale|Mean|9.5|9.5|Standard Deviation|5.8|5.8|||
3799635|NCT01816776|3627258|B1|||Epworth Sleepiness Scale (ESS)|The ESS is an assessment to measure a subject’s general level of daytime sleepiness. Scores can range from 0-24, with higher scores indicating higher level of daytime sleepiness.|units on a scale|Mean|10.2|10.2|Standard Deviation|5.2|5.2|||
3799636|NCT01816776|3627256|B3|||Obstructive Apnea Index|"The number of obstructive apneas per hour of sleep. An obstructive apnea is defined by 4 characteristics:~There is a drop in the peak thermal sensor excursion or alternate nasal air pressure transducer (inspiratory effort) by > 90% of baseline~The duration of the event lasts at least 10 seconds~At least 90% of the event’s duration meets the amplitude reduction criteria for apnea~An apnea associated with continued or increased inspiratory effort throughout the period"|Events/hour|Mean|2.4|2.4|Standard Deviation|3.0|3.0|||
3799637|NCT01816776|3627257|B2|||Obstructive Apnea Index|"The number of obstructive apneas per hour of sleep. An obstructive apnea is defined by 4 characteristics:~There is a drop in the peak thermal sensor excursion or alternate nasal air pressure transducer (inspiratory effort) by > 90% of baseline~The duration of the event lasts at least 10 seconds~At least 90% of the event’s duration meets the amplitude reduction criteria for apnea~An apnea associated with continued or increased inspiratory effort throughout the period"|Events/hour|Mean|2.3|2.3|Standard Deviation|2.7|2.7|||
3799638|NCT01816776|3627258|B1|||Obstructive Apnea Index|"The number of obstructive apneas per hour of sleep. An obstructive apnea is defined by 4 characteristics:~There is a drop in the peak thermal sensor excursion or alternate nasal air pressure transducer (inspiratory effort) by > 90% of baseline~The duration of the event lasts at least 10 seconds~At least 90% of the event’s duration meets the amplitude reduction criteria for apnea~An apnea associated with continued or increased inspiratory effort throughout the period"|Events/hour|Mean|2.6|2.6|Standard Deviation|3.2|3.2|||
3799639|NCT01816776|3627256|B3|||Oxygen Desaturation Index (ODI4)|Number of times per hour of sleep that the blood's oxygen level drops by ≥4%.|Events/hour|Mean|40.2|40.2|Standard Deviation|19.8|19.8|||
3799640|NCT01816776|3627257|B2|||Oxygen Desaturation Index (ODI4)|Number of times per hour of sleep that the blood's oxygen level drops by ≥4%.|Events/hour|Mean|37.5|37.5|Standard Deviation|17.5|17.5|||
3799641|NCT01816776|3627258|B1|||Oxygen Desaturation Index (ODI4)|Number of times per hour of sleep that the blood's oxygen level drops by ≥4%.|Events/hour|Mean|43.2|43.2|Standard Deviation|21.7|21.7|||
3799642|NCT01816776|3627256|B3|||Rapid Eye Movement Sleep (REM)|REM is a sleep stage. The percentage of sleep in REM is a measure of sleep quality.|Percent|Mean|11.1|11.1|Standard Deviation|7.1|7.1|||
3799643|NCT01816776|3627257|B2|||Rapid Eye Movement Sleep (REM)|REM is a sleep stage. The percentage of sleep in REM is a measure of sleep quality.|Percent|Mean|11.8|11.8|Standard Deviation|7.1|7.1|||
3799644|NCT01816776|3627258|B1|||Rapid Eye Movement Sleep (REM)|REM is a sleep stage. The percentage of sleep in REM is a measure of sleep quality.|Percent|Mean|10.4|10.4|Standard Deviation|7.2|7.2|||
3799645|NCT01816776|3627256|B3|||Arousal Index (ArI)|The number of arousals per hour of sleep. During sleep stages N1, N2, N3 or rapid eye movement (REM), an abrupt shift of electroencephalogram frequency including alpha, theta and/or frequencies greater than 16 Hz that last at least 3 seconds, with at least 10 seconds of stable sleep preceding the change is an arousal.|Events/hour|Mean|44.6|44.6|Standard Deviation|18.5|18.5|||
3799646|NCT01816776|3627257|B2|||Arousal Index (ArI)|The number of arousals per hour of sleep. During sleep stages N1, N2, N3 or rapid eye movement (REM), an abrupt shift of electroencephalogram frequency including alpha, theta and/or frequencies greater than 16 Hz that last at least 3 seconds, with at least 10 seconds of stable sleep preceding the change is an arousal.|Events/hour|Mean|43.6|43.6|Standard Deviation|19.1|19.1|||
3799647|NCT01816776|3627258|B1|||Arousal Index (ArI)|The number of arousals per hour of sleep. During sleep stages N1, N2, N3 or rapid eye movement (REM), an abrupt shift of electroencephalogram frequency including alpha, theta and/or frequencies greater than 16 Hz that last at least 3 seconds, with at least 10 seconds of stable sleep preceding the change is an arousal.|Events/hour|Mean|45.5|45.5|Standard Deviation|17.9|17.9|||
3799648|NCT01816776|3627256|B3|||Central Apnea Index (CAI)|"The number of central apneas per hour of sleep. A central apnea is defined by 4 characteristics:~There is a drop in the peak thermal sensor excursion or alternate nasal air pressure transducer (inspiratory effort) by > 90% of baseline~The duration of the event lasts at least 10 seconds~At least 90% of the event’s duration meets the amplitude reduction criteria for apnea~An apnea associated with absent inspiratory effort throughout the period"|Events/hour|Mean|28.2|28.2|Standard Deviation|17.1|17.1|||
3799649|NCT01816776|3627257|B2|||Central Apnea Index (CAI)|"The number of central apneas per hour of sleep. A central apnea is defined by 4 characteristics:~There is a drop in the peak thermal sensor excursion or alternate nasal air pressure transducer (inspiratory effort) by > 90% of baseline~The duration of the event lasts at least 10 seconds~At least 90% of the event’s duration meets the amplitude reduction criteria for apnea~An apnea associated with absent inspiratory effort throughout the period"|Events/hour|Mean|26.6|26.6|Standard Deviation|16.1|16.1|||
3799650|NCT01816776|3627258|B1|||Central Apnea Index (CAI)|"The number of central apneas per hour of sleep. A central apnea is defined by 4 characteristics:~There is a drop in the peak thermal sensor excursion or alternate nasal air pressure transducer (inspiratory effort) by > 90% of baseline~The duration of the event lasts at least 10 seconds~At least 90% of the event’s duration meets the amplitude reduction criteria for apnea~An apnea associated with absent inspiratory effort throughout the period"|Events/hour|Mean|30.0|30.0|Standard Deviation|18.0|18.0|||
3799651|NCT01816776|3627256|B3|||Apnea-Hypopnea Index (AHI)|"The number of apneas and hypopneas per hour of sleep.~An apnea is defined by 3 characteristics:~There is a drop in the peak thermal sensor excursion or alternate nasal air pressure transducer (inspiratory effort) by > 90% of baseline~The duration of the event lasts at least 10 seconds~At least 90% of the event’s duration meets the amplitude reduction criteria for apnea~Hypopnea defined as 30% reduction in airflow (or alternative hypopnea sensor) for ≥10 seconds over at least 90% of the event’s duration that is associated with a >4% fall in oxygen saturation from baseline."|Events/hour|Mean|46.2|46.2|Standard Deviation|18.2|18.2|||
3799652|NCT01816776|3627257|B2|||Apnea-Hypopnea Index (AHI)|"The number of apneas and hypopneas per hour of sleep.~An apnea is defined by 3 characteristics:~There is a drop in the peak thermal sensor excursion or alternate nasal air pressure transducer (inspiratory effort) by > 90% of baseline~The duration of the event lasts at least 10 seconds~At least 90% of the event’s duration meets the amplitude reduction criteria for apnea~Hypopnea defined as 30% reduction in airflow (or alternative hypopnea sensor) for ≥10 seconds over at least 90% of the event’s duration that is associated with a >4% fall in oxygen saturation from baseline."|Events/hour|Mean|43.7|43.7|Standard Deviation|16.8|16.8|||
3799653|NCT01816776|3627258|B1|||Apnea-Hypopnea Index (AHI)|"The number of apneas and hypopneas per hour of sleep.~An apnea is defined by 3 characteristics:~There is a drop in the peak thermal sensor excursion or alternate nasal air pressure transducer (inspiratory effort) by > 90% of baseline~The duration of the event lasts at least 10 seconds~At least 90% of the event’s duration meets the amplitude reduction criteria for apnea~Hypopnea defined as 30% reduction in airflow (or alternative hypopnea sensor) for ≥10 seconds over at least 90% of the event’s duration that is associated with a >4% fall in oxygen saturation from baseline."|Events/hour|Mean|48.8|48.8|Standard Deviation|19.3|19.3|||
3799654|NCT01816776|3627256|B3|Germany||Region of Enrollment||participants|Number|31|31.0||||||
3799655|NCT01816776|3627257|B2|Germany||Region of Enrollment||participants|Number|17|17.0||||||
3799656|NCT01816776|3627258|B1|Germany||Region of Enrollment||participants|Number|14|14.0||||||
3799657|NCT01816776|3627256|B3|Poland||Region of Enrollment||participants|Number|21|21.0||||||
3799658|NCT01816776|3627257|B2|Poland||Region of Enrollment||participants|Number|11|11.0||||||
3799659|NCT01816776|3627258|B1|Poland||Region of Enrollment||participants|Number|10|10.0||||||
3799660|NCT01816776|3627256|B3|United States||Region of Enrollment||participants|Number|99|99.0||||||
3799661|NCT01816776|3627257|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
3799662|NCT01816776|3627258|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
3799663|NCT01816776|3627256|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799664|NCT01816776|3627257|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799665|NCT01816776|3627258|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799666|NCT01816776|3627256|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799667|NCT01816776|3627257|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799668|NCT01816776|3627258|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799669|NCT01816776|3627256|B3||White|Race (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
3799670|NCT01816776|3627257|B2||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3799671|NCT01816776|3627258|B1||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3799672|NCT01816776|3627256|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3799673|NCT01816776|3627257|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3799674|NCT01816776|3627258|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3799675|NCT01816776|3627256|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799676|NCT01816776|3627257|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799677|NCT01816776|3627258|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799678|NCT01816776|3627256|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799679|NCT01816776|3627257|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799680|NCT01816776|3627258|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799681|NCT01816776|3627256|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799682|NCT01816776|3627257|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799683|NCT01816776|3627258|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799684|NCT01816776|3627256|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799685|NCT01816776|3627257|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799686|NCT01816776|3627258|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799687|NCT01816776|3627256|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
3799688|NCT01816776|3627257|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3799689|NCT01816776|3627258|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3799690|NCT01816776|3627256|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3799691|NCT01816776|3627257|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3799692|NCT01816776|3627258|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799693|NCT01816776|3627256|B3||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3799694|NCT01816776|3627257|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3799695|NCT01816776|3627258|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3799696|NCT01816776|3627256|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3799697|NCT01816776|3627257|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3799698|NCT01816776|3627258|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3799699|NCT01816776|3627256|B3|||Age||years|Mean|65|65.0|Standard Deviation|13|13.0|||
3799700|NCT01816776|3627257|B2|||Age||years|Mean|65|65.0|Standard Deviation|13|13.0|||
3799701|NCT01816776|3627258|B1|||Age||years|Mean|65|65.0|Standard Deviation|12|12.0|||
3799702|NCT01816685|3627279|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3799703|NCT01816685|3627280|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3799704|NCT01816685|3627281|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3799705|NCT01816685|3627279|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3799706|NCT01816685|3627280|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3799707|NCT01816685|3627281|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3799708|NCT01816685|3627279|B3|||Age||years|Mean|65|65.0|Inter-Quartile Range|||60.0|71.0|
3799709|NCT01816685|3627280|B2|||Age||years|Mean|65|65.0|Inter-Quartile Range|||59.0|71.0|
3799710|NCT01816685|3627281|B1|||Age||years|Mean|65|65.0|Inter-Quartile Range|||60.0|70.0|
3799711|NCT01816477|3627290|B3|United States||Region of Enrollment||participants|Number|85|85.0||||||
3799712|NCT01816477|3627291|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
3799713|NCT01816477|3627292|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3799714|NCT01816477|3627290|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3799715|NCT01816477|3627291|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3799716|NCT01816477|3627292|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3799717|NCT01816477|3627290|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3799718|NCT01816477|3627291|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3799719|NCT01816477|3627292|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3799720|NCT01816477|3627290|B3|||Age||years|Mean|32.2|32.2|Standard Deviation|8.9|8.9|||
3799721|NCT01816477|3627291|B2|||Age||years|Mean|32.8|32.8|Standard Deviation|9.4|9.4|||
3799722|NCT01816477|3627292|B1|||Age||years|Mean|31.3|31.3|Standard Deviation|8.4|8.4|||
3799723|NCT01816451|3627303|B4|Brazil||Region of Enrollment||participants|Number|32|32.0||||||
3799724|NCT01816451|3627304|B3|Brazil||Region of Enrollment||participants|Number|8|8.0||||||
3799725|NCT01816451|3627305|B2|Brazil||Region of Enrollment||participants|Number|11|11.0||||||
3799726|NCT01816451|3627306|B1|Brazil||Region of Enrollment||participants|Number|13|13.0||||||
3799727|NCT01816451|3627303|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3799728|NCT01816451|3627304|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3799729|NCT01816451|3627305|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3799730|NCT01816451|3627306|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3799731|NCT01816451|3627303|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3799732|NCT01816451|3627304|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3799733|NCT01816451|3627305|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3799734|NCT01816451|3627306|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3799735|NCT01816451|3627303|B4|||Age||years|Mean|30|30.0|Standard Deviation|2|2.0|||
3799736|NCT01816451|3627304|B3|||Age||years|Mean|29.1|29.1|Standard Deviation|4.4|4.4|||
3799737|NCT01816451|3627305|B2|||Age||years|Mean|30.5|30.5|Standard Deviation|1.0|1.0|||
3799738|NCT01816451|3627306|B1|||Age||years|Mean|30.2|30.2|Standard Deviation|0.8|0.8|||
3799739|NCT01816451|3627303|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3799740|NCT01816451|3627304|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3799741|NCT01816451|3627305|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3799742|NCT01816451|3627306|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3799743|NCT01816451|3627303|B4||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3799744|NCT01816451|3627304|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3799745|NCT01816451|3627305|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3799746|NCT01816451|3627306|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3799747|NCT01816451|3627303|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3799748|NCT01816451|3627304|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3799749|NCT01816451|3627305|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3799750|NCT01816451|3627306|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3799751|NCT01816295|3627345|B3|Both Symptoms Present||Symptoms of Hypogonadism||participants|Number|540|540.0||||||
3799752|NCT01816295|3627346|B2|Both Symptoms Present||Symptoms of Hypogonadism||participants|Number|271|271.0||||||
3799753|NCT01816295|3627347|B1|Both Symptoms Present||Symptoms of Hypogonadism||participants|Number|269|269.0||||||
3799754|NCT01816295|3627345|B3|Only Decreased Sexual Drive||Symptoms of Hypogonadism||participants|Number|79|79.0||||||
3799755|NCT01816295|3627346|B2|Only Decreased Sexual Drive||Symptoms of Hypogonadism||participants|Number|40|40.0||||||
3799756|NCT01816295|3627347|B1|Only Decreased Sexual Drive||Symptoms of Hypogonadism||participants|Number|39|39.0||||||
3799757|NCT01816295|3627345|B3|Only Low Energy||Symptoms of Hypogonadism||participants|Number|96|96.0||||||
3799758|NCT01816295|3627346|B2|Only Low Energy||Symptoms of Hypogonadism||participants|Number|47|47.0||||||
3799759|NCT01816295|3627347|B1|Only Low Energy||Symptoms of Hypogonadism||participants|Number|49|49.0||||||
3799760|NCT01816295|3627345|B3|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilogram per square meter (kg/m²)|Mean|30.6|30.6|Standard Deviation|4.14|4.14|||
3799761|NCT01816295|3627346|B2|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilogram per square meter (kg/m²)|Mean|30.3|30.3|Standard Deviation|4.06|4.06|||
3799762|NCT01816295|3627347|B1|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilogram per square meter (kg/m²)|Mean|30.9|30.9|Standard Deviation|4.21|4.21|||
3799763|NCT01816295|3627345|B3|North America||Region of Enrollment||participants|Number|463|463.0||||||
3799764|NCT01816295|3627346|B2|North America||Region of Enrollment||participants|Number|231|231.0||||||
3799765|NCT01816295|3627347|B1|North America||Region of Enrollment||participants|Number|232|232.0||||||
3799766|NCT01816295|3627345|B3|South America||Region of Enrollment||participants|Number|58|58.0||||||
3799767|NCT01816295|3627346|B2|South America||Region of Enrollment||participants|Number|30|30.0||||||
3799768|NCT01816295|3627347|B1|South America||Region of Enrollment||participants|Number|28|28.0||||||
3799769|NCT01816295|3627345|B3|Europe||Region of Enrollment||participants|Number|120|120.0||||||
3799770|NCT01816295|3627346|B2|Europe||Region of Enrollment||participants|Number|57|57.0||||||
3799771|NCT01816295|3627347|B1|Europe||Region of Enrollment||participants|Number|63|63.0||||||
3799772|NCT01816295|3627345|B3|East Asia||Region of Enrollment||participants|Number|74|74.0||||||
3799773|NCT01816295|3627346|B2|East Asia||Region of Enrollment||participants|Number|40|40.0||||||
3799774|NCT01816295|3627347|B1|East Asia||Region of Enrollment||participants|Number|34|34.0||||||
3799775|NCT01816295|3627345|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799776|NCT01816295|3627346|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799777|NCT01816295|3627347|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799778|NCT01816295|3627345|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3799779|NCT01816295|3627346|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3799780|NCT01816295|3627347|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3799781|NCT01816295|3627345|B3||White|Race (NIH/OMB)||Participants|Count of Participants|563|563.0||||||
3799782|NCT01816295|3627346|B2||White|Race (NIH/OMB)||Participants|Count of Participants|281|281.0||||||
3799783|NCT01816295|3627347|B1||White|Race (NIH/OMB)||Participants|Count of Participants|282|282.0||||||
3799784|NCT01816295|3627345|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3799785|NCT01816295|3627346|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3799786|NCT01816295|3627347|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3799787|NCT01816295|3627345|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3799788|NCT01816295|3627346|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799789|NCT01816295|3627347|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3799790|NCT01816295|3627345|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3799791|NCT01816295|3627346|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3799792|NCT01816295|3627347|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3799793|NCT01816295|3627345|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3799794|NCT01816295|3627346|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799795|NCT01816295|3627347|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3799796|NCT01816295|3627345|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3799797|NCT01816295|3627346|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3799798|NCT01816295|3627347|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3799799|NCT01816295|3627345|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|559|559.0||||||
3799800|NCT01816295|3627346|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|279|279.0||||||
3799801|NCT01816295|3627347|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|280|280.0||||||
3799802|NCT01816295|3627345|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
3799803|NCT01816295|3627346|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3799804|NCT01816295|3627347|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3799805|NCT01816295|3627345|B3||Male|Sex: Female, Male||Participants|Count of Participants|715|715.0||||||
3799806|NCT01816295|3627346|B2||Male|Sex: Female, Male||Participants|Count of Participants|358|358.0||||||
3799807|NCT01816295|3627347|B1||Male|Sex: Female, Male||Participants|Count of Participants|357|357.0||||||
3799808|NCT01816295|3627345|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3799809|NCT01816295|3627346|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3799810|NCT01816295|3627347|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3799811|NCT01816295|3627345|B3|||Age||years|Mean|55.3|55.3|Standard Deviation|10.98|10.98|||
3799812|NCT01816295|3627346|B2|||Age||years|Mean|54.7|54.7|Standard Deviation|10.58|10.58|||
3799813|NCT01816295|3627347|B1|||Age||years|Mean|55.9|55.9|Standard Deviation|11.35|11.35|||
3799814|NCT01816243|3627363|B1|||Pain Intensity Rating|Pain intensity was assessed on 11-point Numeric Rating Scale (NRS); score ranges from 0 to 10, where 0=no pain and 10=worst pain.|units on a scale|Mean|6.54|6.54|Standard Deviation|2.02|2.02|||
3799815|NCT01816243|3627363|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3799816|NCT01816243|3627363|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3799817|NCT01816243|3627363|B1|||Age||Years|Mean|50.39|50.39|Standard Deviation|16.0|16.0|||
3799818|NCT01816074|3627370|B5|Child Race|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799819|NCT01816074|3627371|B4|Child Race|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799820|NCT01816074|3627372|B3|Child Race|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799821|NCT01816074|3627373|B2|Child Race|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799822|NCT01816074|3627374|B1|Child Race|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799823|NCT01816074|3627370|B5|Child Race|More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3799824|NCT01816074|3627371|B4|Child Race|More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799825|NCT01816074|3627372|B3|Child Race|More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3799826|NCT01816074|3627373|B2|Child Race|More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799827|NCT01816074|3627374|B1|Child Race|More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799828|NCT01816074|3627370|B5|Child Race|White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3799829|NCT01816074|3627371|B4|Child Race|White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3799830|NCT01816074|3627372|B3|Child Race|White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3799831|NCT01816074|3627373|B2|Child Race|White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3799832|NCT01816074|3627374|B1|Child Race|White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3799833|NCT01816074|3627370|B5|Child Race|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3799834|NCT01816074|3627371|B4|Child Race|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799835|NCT01816074|3627372|B3|Child Race|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799836|NCT01816074|3627373|B2|Child Race|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799837|NCT01816074|3627374|B1|Child Race|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799838|NCT01816074|3627370|B5|Child Race|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799839|NCT01816074|3627371|B4|Child Race|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799840|NCT01816074|3627372|B3|Child Race|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799841|NCT01816074|3627373|B2|Child Race|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799842|NCT01816074|3627374|B1|Child Race|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799843|NCT01816074|3627370|B5|Child Race|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799844|NCT01816074|3627371|B4|Child Race|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799845|NCT01816074|3627372|B3|Child Race|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799846|NCT01816074|3627373|B2|Child Race|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799847|NCT01816074|3627374|B1|Child Race|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799848|NCT01816074|3627370|B5|Child Race|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799849|NCT01816074|3627371|B4|Child Race|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799850|NCT01816074|3627372|B3|Child Race|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799851|NCT01816074|3627373|B2|Child Race|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799852|NCT01816074|3627374|B1|Child Race|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799853|NCT01816074|3627370|B5|Mother Race|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799854|NCT01816074|3627371|B4|Mother Race|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799855|NCT01816074|3627372|B3|Mother Race|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799856|NCT01816074|3627373|B2|Mother Race|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799857|NCT01816074|3627374|B1|Mother Race|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799858|NCT01816074|3627370|B5|Mother Race|More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3799859|NCT01816074|3627371|B4|Mother Race|More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799860|NCT01816074|3627372|B3|Mother Race|More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3799861|NCT01816074|3627373|B2|Mother Race|More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799862|NCT01816074|3627374|B1|Mother Race|More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799863|NCT01816074|3627370|B5|Mother Race|White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3799864|NCT01816074|3627371|B4|Mother Race|White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3799865|NCT01816074|3627372|B3|Mother Race|White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3799866|NCT01816074|3627373|B2|Mother Race|White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3799867|NCT01816074|3627374|B1|Mother Race|White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3799868|NCT01816074|3627370|B5|Mother Race|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3799869|NCT01816074|3627371|B4|Mother Race|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799870|NCT01816074|3627372|B3|Mother Race|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799871|NCT01816074|3627373|B2|Mother Race|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799872|NCT01816074|3627374|B1|Mother Race|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799873|NCT01816074|3627370|B5|Mother Race|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799874|NCT01816074|3627371|B4|Mother Race|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799875|NCT01816074|3627372|B3|Mother Race|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799876|NCT01816074|3627373|B2|Mother Race|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799877|NCT01816074|3627374|B1|Mother Race|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799878|NCT01816074|3627370|B5|Mother Race|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799879|NCT01816074|3627371|B4|Mother Race|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799880|NCT01816074|3627372|B3|Mother Race|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799881|NCT01816074|3627373|B2|Mother Race|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799882|NCT01816074|3627374|B1|Mother Race|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799883|NCT01816074|3627370|B5|Mother Race|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799884|NCT01816074|3627371|B4|Mother Race|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799885|NCT01816074|3627372|B3|Mother Race|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799886|NCT01816074|3627373|B2|Mother Race|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799887|NCT01816074|3627374|B1|Mother Race|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799888|NCT01816074|3627370|B5|Child|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3799889|NCT01816074|3627371|B4|Child|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799890|NCT01816074|3627372|B3|Child|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3799891|NCT01816074|3627373|B2|Child|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799892|NCT01816074|3627374|B1|Child|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3799893|NCT01816074|3627370|B5|Child|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3799894|NCT01816074|3627371|B4|Child|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3799895|NCT01816074|3627372|B3|Child|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3799896|NCT01816074|3627373|B2|Child|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3799897|NCT01816074|3627374|B1|Child|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3799898|NCT01816074|3627370|B5|Child|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3799899|NCT01816074|3627371|B4|Child|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799900|NCT01816074|3627372|B3|Child|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3799901|NCT01816074|3627373|B2|Child|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799902|NCT01816074|3627374|B1|Child|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799903|NCT01816074|3627370|B5|Mom|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799904|NCT01816074|3627371|B4|Mom|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799905|NCT01816074|3627372|B3|Mom|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799906|NCT01816074|3627373|B2|Mom|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799907|NCT01816074|3627374|B1|Mom|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799908|NCT01816074|3627370|B5|Mom|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3799909|NCT01816074|3627371|B4|Mom|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3799910|NCT01816074|3627372|B3|Mom|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3799911|NCT01816074|3627373|B2|Mom|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3799912|NCT01816074|3627374|B1|Mom|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3799913|NCT01816074|3627370|B5|Mom|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3799914|NCT01816074|3627371|B4|Mom|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799915|NCT01816074|3627372|B3|Mom|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3799916|NCT01816074|3627373|B2|Mom|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799917|NCT01816074|3627374|B1|Mom|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3799918|NCT01816074|3627370|B5|Parent gender|Female|Sex/Gender, Customized||Participants|Count of Participants|41|41.0||||||
3799919|NCT01816074|3627371|B4|Parent gender|Female|Sex/Gender, Customized||Participants|Count of Participants|10|10.0||||||
3799920|NCT01816074|3627372|B3|Parent gender|Female|Sex/Gender, Customized||Participants|Count of Participants|11|11.0||||||
3799921|NCT01816074|3627373|B2|Parent gender|Female|Sex/Gender, Customized||Participants|Count of Participants|9|9.0||||||
3799922|NCT01816074|3627374|B1|Parent gender|Female|Sex/Gender, Customized||Participants|Count of Participants|11|11.0||||||
3799923|NCT01816074|3627370|B5|Parent gender|Male|Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3799924|NCT01816074|3627371|B4|Parent gender|Male|Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3799925|NCT01816074|3627372|B3|Parent gender|Male|Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3799926|NCT01816074|3627373|B2|Parent gender|Male|Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3799927|NCT01816074|3627374|B1|Parent gender|Male|Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3799928|NCT01816074|3627370|B5|Child gender|Female|Sex/Gender, Customized||Participants|Count of Participants|18|18.0||||||
3799929|NCT01816074|3627371|B4|Child gender|Female|Sex/Gender, Customized||Participants|Count of Participants|5|5.0||||||
3799930|NCT01816074|3627372|B3|Child gender|Female|Sex/Gender, Customized||Participants|Count of Participants|5|5.0||||||
3799931|NCT01816074|3627373|B2|Child gender|Female|Sex/Gender, Customized||Participants|Count of Participants|3|3.0||||||
3799932|NCT01816074|3627374|B1|Child gender|Female|Sex/Gender, Customized||Participants|Count of Participants|5|5.0||||||
3799933|NCT01816074|3627370|B5|Child gender|Male|Sex/Gender, Customized||Participants|Count of Participants|23|23.0||||||
3799934|NCT01816074|3627371|B4|Child gender|Male|Sex/Gender, Customized||Participants|Count of Participants|5|5.0||||||
3799935|NCT01816074|3627372|B3|Child gender|Male|Sex/Gender, Customized||Participants|Count of Participants|6|6.0||||||
3799936|NCT01816074|3627373|B2|Child gender|Male|Sex/Gender, Customized||Participants|Count of Participants|6|6.0||||||
3799937|NCT01816074|3627374|B1|Child gender|Male|Sex/Gender, Customized||Participants|Count of Participants|6|6.0||||||
3799938|NCT01816074|3627370|B5|Child age||Age||years|Mean|6.17|6.17|Standard Deviation|1.41|1.41|||
3799939|NCT01816074|3627371|B4|Child age||Age||years|Mean|6.60|6.6|Standard Deviation|1.35|1.35|||
3799940|NCT01816074|3627372|B3|Child age||Age||years|Mean|6.18|6.18|Standard Deviation|1.47|1.47|||
3799941|NCT01816074|3627373|B2|Child age||Age||years|Mean|5.89|5.89|Standard Deviation|1.05|1.05|||
3799942|NCT01816074|3627374|B1|Child age||Age||years|Mean|6.00|6.0|Standard Deviation|1.73|1.73|||
3799943|NCT01816074|3627370|B5|Mom age||Age||years|Mean|39.59|39.59|Standard Deviation|6.38|6.38|||
3799944|NCT01816074|3627371|B4|Mom age||Age||years|Mean|41.00|41.0|Standard Deviation|6.73|6.73|||
3799945|NCT01816074|3627372|B3|Mom age||Age||years|Mean|37.82|37.82|Standard Deviation|5.78|5.78|||
3799946|NCT01816074|3627373|B2|Mom age||Age||years|Mean|39.00|39.0|Standard Deviation|5.94|5.94|||
3799947|NCT01816074|3627374|B1|Mom age||Age||years|Mean|40.55|40.55|Standard Deviation|7.31|7.31|||
3799948|NCT01816048|3627405|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3799949|NCT01816048|3627405|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799950|NCT01816048|3627405|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799951|NCT01816048|3627405|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3799952|NCT01816048|3627405|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799953|NCT01816048|3627405|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799954|NCT01816048|3627405|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799955|NCT01816048|3627405|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799956|NCT01816048|3627405|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799957|NCT01816048|3627405|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3799958|NCT01816048|3627405|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3799959|NCT01816048|3627405|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3799960|NCT01816048|3627405|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3799961|NCT01816048|3627405|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3799962|NCT01816048|3627405|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3799963|NCT01816048|3627405|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3799964|NCT01815918|3627418|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
3799965|NCT01815918|3627419|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3799966|NCT01815918|3627420|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3799967|NCT01815918|3627418|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3799968|NCT01815918|3627419|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3799969|NCT01815918|3627420|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3799970|NCT01815918|3627418|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3799971|NCT01815918|3627419|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3799972|NCT01815918|3627420|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3799973|NCT01815918|3627418|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3799974|NCT01815918|3627419|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3799975|NCT01815918|3627420|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3799976|NCT01815918|3627418|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3799977|NCT01815918|3627419|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3799978|NCT01815918|3627420|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3799979|NCT01815918|3627418|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3799980|NCT01815918|3627419|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3799981|NCT01815918|3627420|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3799982|NCT01815918|3627418|B3|||Age||years|Mean|67|67.0|Standard Deviation|7|7.0|||
3799983|NCT01815918|3627419|B2|||Age||years|Mean|68|68.0|Standard Deviation|6|6.0|||
3799984|NCT01815918|3627420|B1|||Age||years|Mean|66|66.0|Standard Deviation|8|8.0|||
3799985|NCT01815840|3627435|B3||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3799986|NCT01815840|3627436|B2||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3799987|NCT01815840|3627437|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3799988|NCT01815840|3627435|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3799989|NCT01815840|3627436|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3799990|NCT01815840|3627437|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3799991|NCT01815840|3627435|B3|||Age||years|Mean|60.5|60.5|Standard Deviation|14.63|14.63|||
3799992|NCT01815840|3627436|B2|||Age||years|Mean|59.9|59.9|Standard Deviation|15.35|15.35|||
3799993|NCT01815840|3627437|B1|||Age||years|Mean|61.1|61.1|Standard Deviation|13.94|13.94|||
3799994|NCT01815736|3627466|B3|≥ 50 copies/mL||HIV-1 RNA Category||participants|Number|27|27.0||||||
3799995|NCT01815736|3627467|B2|≥ 50 copies/mL||HIV-1 RNA Category||participants|Number|11|11.0||||||
3799996|NCT01815736|3627468|B1|≥ 50 copies/mL||HIV-1 RNA Category||participants|Number|16|16.0||||||
3799997|NCT01815736|3627466|B3|< 50 copies/mL||HIV-1 RNA Category||participants|Number|1409|1409.0||||||
3799998|NCT01815736|3627467|B2|< 50 copies/mL||HIV-1 RNA Category||participants|Number|466|466.0||||||
3799999|NCT01815736|3627468|B1|< 50 copies/mL||HIV-1 RNA Category||participants|Number|943|943.0||||||
3800000|NCT01815736|3627466|B3|Germany||Region of Enrollment||participants|Number|45|45.0||||||
3800001|NCT01815736|3627467|B2|Germany||Region of Enrollment||participants|Number|11|11.0||||||
3800002|NCT01815736|3627468|B1|Germany||Region of Enrollment||participants|Number|34|34.0||||||
3800003|NCT01815736|3627466|B3|France||Region of Enrollment||participants|Number|24|24.0||||||
3800004|NCT01815736|3627467|B2|France||Region of Enrollment||participants|Number|12|12.0||||||
3800005|NCT01815736|3627468|B1|France||Region of Enrollment||participants|Number|12|12.0||||||
3800006|NCT01815736|3627466|B3|Australia||Region of Enrollment||participants|Number|60|60.0||||||
3800007|NCT01815736|3627467|B2|Australia||Region of Enrollment||participants|Number|22|22.0||||||
3800008|NCT01815736|3627468|B1|Australia||Region of Enrollment||participants|Number|38|38.0||||||
3800009|NCT01815736|3627466|B3|Mexico||Region of Enrollment||participants|Number|25|25.0||||||
3800010|NCT01815736|3627467|B2|Mexico||Region of Enrollment||participants|Number|6|6.0||||||
3800011|NCT01815736|3627468|B1|Mexico||Region of Enrollment||participants|Number|19|19.0||||||
3800012|NCT01815736|3627466|B3|Italy||Region of Enrollment||participants|Number|19|19.0||||||
3800013|NCT01815736|3627467|B2|Italy||Region of Enrollment||participants|Number|6|6.0||||||
3800014|NCT01815736|3627468|B1|Italy||Region of Enrollment||participants|Number|13|13.0||||||
3800015|NCT01815736|3627466|B3|Dominican Republic||Region of Enrollment||participants|Number|42|42.0||||||
3800016|NCT01815736|3627467|B2|Dominican Republic||Region of Enrollment||participants|Number|13|13.0||||||
3800017|NCT01815736|3627468|B1|Dominican Republic||Region of Enrollment||participants|Number|29|29.0||||||
3800018|NCT01815736|3627466|B3|Denmark||Region of Enrollment||participants|Number|3|3.0||||||
3800019|NCT01815736|3627467|B2|Denmark||Region of Enrollment||participants|Number|2|2.0||||||
3800020|NCT01815736|3627468|B1|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
3800021|NCT01815736|3627466|B3|Brazil||Region of Enrollment||participants|Number|19|19.0||||||
3800022|NCT01815736|3627467|B2|Brazil||Region of Enrollment||participants|Number|5|5.0||||||
3800023|NCT01815736|3627468|B1|Brazil||Region of Enrollment||participants|Number|14|14.0||||||
3800024|NCT01815736|3627466|B3|Belgium||Region of Enrollment||participants|Number|22|22.0||||||
3800025|NCT01815736|3627467|B2|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
3800026|NCT01815736|3627468|B1|Belgium||Region of Enrollment||participants|Number|14|14.0||||||
3800027|NCT01815736|3627466|B3|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
3800028|NCT01815736|3627467|B2|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
3800029|NCT01815736|3627468|B1|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
3800030|NCT01815736|3627466|B3|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
3800031|NCT01815736|3627467|B2|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
3800032|NCT01815736|3627468|B1|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
3800033|NCT01815736|3627466|B3|Austria||Region of Enrollment||participants|Number|24|24.0||||||
3800034|NCT01815736|3627467|B2|Austria||Region of Enrollment||participants|Number|8|8.0||||||
3800035|NCT01815736|3627468|B1|Austria||Region of Enrollment||participants|Number|16|16.0||||||
3800036|NCT01815736|3627466|B3|Canada||Region of Enrollment||participants|Number|78|78.0||||||
3800037|NCT01815736|3627467|B2|Canada||Region of Enrollment||participants|Number|27|27.0||||||
3800038|NCT01815736|3627468|B1|Canada||Region of Enrollment||participants|Number|51|51.0||||||
3800039|NCT01815736|3627466|B3|Spain||Region of Enrollment||participants|Number|8|8.0||||||
3800040|NCT01815736|3627467|B2|Spain||Region of Enrollment||participants|Number|3|3.0||||||
3800041|NCT01815736|3627468|B1|Spain||Region of Enrollment||participants|Number|5|5.0||||||
3800042|NCT01815736|3627466|B3|Switzerland||Region of Enrollment||participants|Number|9|9.0||||||
3800043|NCT01815736|3627467|B2|Switzerland||Region of Enrollment||participants|Number|4|4.0||||||
3800044|NCT01815736|3627468|B1|Switzerland||Region of Enrollment||participants|Number|5|5.0||||||
3800045|NCT01815736|3627466|B3|Portugal||Region of Enrollment||participants|Number|10|10.0||||||
3800046|NCT01815736|3627467|B2|Portugal||Region of Enrollment||participants|Number|2|2.0||||||
3800047|NCT01815736|3627468|B1|Portugal||Region of Enrollment||participants|Number|8|8.0||||||
3800048|NCT01815736|3627466|B3|Thailand||Region of Enrollment||participants|Number|56|56.0||||||
3800049|NCT01815736|3627467|B2|Thailand||Region of Enrollment||participants|Number|21|21.0||||||
3800050|NCT01815736|3627468|B1|Thailand||Region of Enrollment||participants|Number|35|35.0||||||
3800051|NCT01815736|3627466|B3|United Kingdom||Region of Enrollment||participants|Number|22|22.0||||||
3800052|NCT01815736|3627467|B2|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3800053|NCT01815736|3627468|B1|United Kingdom||Region of Enrollment||participants|Number|14|14.0||||||
3800054|NCT01815736|3627466|B3|United States||Region of Enrollment||participants|Number|964|964.0||||||
3800055|NCT01815736|3627467|B2|United States||Region of Enrollment||participants|Number|316|316.0||||||
3800056|NCT01815736|3627468|B1|United States||Region of Enrollment||participants|Number|648|648.0||||||
3800057|NCT01815736|3627466|B3|Not Permitted||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3800058|NCT01815736|3627467|B2|Not Permitted||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3800059|NCT01815736|3627468|B1|Not Permitted||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3800060|NCT01815736|3627466|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1101|1101.0||||||
3800061|NCT01815736|3627467|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|392|392.0||||||
3800062|NCT01815736|3627468|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|709|709.0||||||
3800063|NCT01815736|3627466|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|330|330.0||||||
3800064|NCT01815736|3627467|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
3800065|NCT01815736|3627468|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|248|248.0||||||
3800066|NCT01815736|3627466|B3|Other||Race/Ethnicity, Customized||participants|Number|89|89.0||||||
3800067|NCT01815736|3627467|B2|Other||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3800068|NCT01815736|3627468|B1|Other||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
3800069|NCT01815736|3627466|B3|Not Permitted||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3800070|NCT01815736|3627467|B2|Not Permitted||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3800071|NCT01815736|3627468|B1|Not Permitted||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3800072|NCT01815736|3627466|B3|White||Race/Ethnicity, Customized||participants|Number|965|965.0||||||
3800073|NCT01815736|3627467|B2|White||Race/Ethnicity, Customized||participants|Number|314|314.0||||||
3800074|NCT01815736|3627468|B1|White||Race/Ethnicity, Customized||participants|Number|651|651.0||||||
3800075|NCT01815736|3627466|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3800076|NCT01815736|3627467|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3800077|NCT01815736|3627468|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3800078|NCT01815736|3627466|B3|Black||Race/Ethnicity, Customized||participants|Number|271|271.0||||||
3800079|NCT01815736|3627467|B2|Black||Race/Ethnicity, Customized||participants|Number|102|102.0||||||
3800080|NCT01815736|3627468|B1|Black||Race/Ethnicity, Customized||participants|Number|169|169.0||||||
3800081|NCT01815736|3627466|B3|Asian||Race/Ethnicity, Customized||participants|Number|94|94.0||||||
3800082|NCT01815736|3627467|B2|Asian||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3800083|NCT01815736|3627468|B1|Asian||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
3800084|NCT01815736|3627466|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3800085|NCT01815736|3627467|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3800086|NCT01815736|3627468|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3800087|NCT01815736|3627466|B3||Male|Sex: Female, Male||Participants|Count of Participants|1283|1283.0||||||
3800088|NCT01815736|3627467|B2||Male|Sex: Female, Male||Participants|Count of Participants|427|427.0||||||
3800089|NCT01815736|3627468|B1||Male|Sex: Female, Male||Participants|Count of Participants|856|856.0||||||
3800090|NCT01815736|3627466|B3||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3800091|NCT01815736|3627467|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3800092|NCT01815736|3627468|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3800093|NCT01815736|3627466|B3|||Age||Years|Mean|41|41.0|Standard Deviation|10.1|10.1|||
3800094|NCT01815736|3627467|B2|||Age||Years|Mean|41|41.0|Standard Deviation|10.1|10.1|||
3800095|NCT01815736|3627468|B1|||Age||Years|Mean|41|41.0|Standard Deviation|10.1|10.1|||
3800096|NCT01815671|3627483|B3|United States||Region of Enrollment||participants|Number|173|173.0||||||
3800097|NCT01815671|3627484|B2|United States||Region of Enrollment||participants|Number|85|85.0||||||
3800098|NCT01815671|3627485|B1|United States||Region of Enrollment||participants|Number|88|88.0||||||
3800099|NCT01815671|3627483|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3800100|NCT01815671|3627484|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3800101|NCT01815671|3627485|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3800102|NCT01815671|3627483|B3||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
3800103|NCT01815671|3627484|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3800104|NCT01815671|3627485|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3800105|NCT01815671|3627483|B3|||Age||years|Mean|55|55.0|Standard Deviation|11|11.0|||
3800106|NCT01815671|3627484|B2|||Age||years|Mean|56|56.0|Standard Deviation|11|11.0|||
3800107|NCT01815671|3627485|B1|||Age||years|Mean|55|55.0|Standard Deviation|12|12.0|||
3800108|NCT01815671|3627483|B3||>=65 years|Age||Participants|Count of Participants|76|76.0||||||
3800109|NCT01815671|3627484|B2||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
3800110|NCT01815671|3627485|B1||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
3800111|NCT01815671|3627483|B3||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
3800112|NCT01815671|3627484|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3800113|NCT01815671|3627485|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3800114|NCT01815671|3627483|B3||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
3800115|NCT01815671|3627484|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3800116|NCT01815671|3627485|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3800117|NCT01815645|3627496|B3|Brazil||Region of Enrollment||participants|Number|65|65.0||||||
3800118|NCT01815645|3627497|B2|Brazil||Region of Enrollment||participants|Number|33|33.0||||||
3800119|NCT01815645|3627498|B1|Brazil||Region of Enrollment||participants|Number|32|32.0||||||
3800120|NCT01815645|3627496|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3800121|NCT01815645|3627497|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3800122|NCT01815645|3627498|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3800123|NCT01815645|3627496|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3800124|NCT01815645|3627497|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3800125|NCT01815645|3627498|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3800126|NCT01815645|3627496|B3|||Age||years|Mean|35.3|35.3|Standard Deviation|8.6|8.6|||
3800127|NCT01815645|3627497|B2|||Age||years|Mean|35.3|35.3|Standard Deviation|8.7|8.7|||
3800128|NCT01815645|3627498|B1|||Age||years|Mean|35.4|35.4|Standard Deviation|8.5|8.5|||
3800129|NCT01815645|3627496|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3800130|NCT01815645|3627497|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3800131|NCT01815645|3627498|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3800132|NCT01815645|3627496|B3||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
3800133|NCT01815645|3627497|B2||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3800134|NCT01815645|3627498|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3800135|NCT01815645|3627496|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3800136|NCT01815645|3627497|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3800137|NCT01815645|3627498|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3800138|NCT01815515|3627515|B1|None||Prior prostate cancer therapy||Participants|Count of Participants|1|1.0||||||
3800139|NCT01815515|3627515|B1|Radium-223 (223Ra)||Prior prostate cancer therapy||Participants|Count of Participants|1|1.0||||||
3800140|NCT01815515|3627515|B1|Prostate brachytherapy||Prior prostate cancer therapy||Participants|Count of Participants|1|1.0||||||
3800141|NCT01815515|3627515|B1|External-beam radiation to the spine||Prior prostate cancer therapy||Participants|Count of Participants|1|1.0||||||
3800142|NCT01815515|3627515|B1|External-beam radiation to the right hip||Prior prostate cancer therapy||Participants|Count of Participants|1|1.0||||||
3800143|NCT01815515|3627515|B1|External-beam radiation to the pelvis||Prior prostate cancer therapy||Participants|Count of Participants|7|7.0||||||
3800144|NCT01815515|3627515|B1|Abiraterone||Prior prostate cancer therapy||Participants|Count of Participants|1|1.0||||||
3800145|NCT01815515|3627515|B1|Tasquinimod||Prior prostate cancer therapy||Participants|Count of Participants|1|1.0||||||
3800146|NCT01815515|3627515|B1|Docetaxel||Prior prostate cancer therapy||Participants|Count of Participants|2|2.0||||||
3800147|NCT01815515|3627515|B1|Androgen deprivation||Prior prostate cancer therapy||Participants|Count of Participants|8|8.0||||||
3800148|NCT01815515|3627515|B1|Prostatectomy||Prior prostate cancer therapy||Participants|Count of Participants|7|7.0||||||
3800149|NCT01815515|3627515|B1|||Testosterone||ng/mL|Mean|396.33|396.33|Full Range|||245.0|746.0|
3800150|NCT01815515|3627515|B1|||Testosterone <20 ng/mL||Participants|Count of Participants|8|8.0||||||
3800151|NCT01815515|3627515|B1|||Red cell folate|Normal range = 160-855 ng/mL|ng/mL|Mean|550.69|550.69|Full Range|||268.0|1049.0|
3800152|NCT01815515|3627515|B1||High (>24 ng/mL)|Serum folate||Participants|Count of Participants|5|5.0||||||
3800153|NCT01815515|3627515|B1||21-24 ng/mL|Serum folate||Participants|Count of Participants|1|1.0||||||
3800154|NCT01815515|3627515|B1||Normal range (2.5-20 ng/mL)|Serum folate||Participants|Count of Participants|11|11.0||||||
3800155|NCT01815515|3627515|B1|||Prostate specific antigen (PSA)||ng/mL|Mean|95.6|95.6|Standard Deviation|141.26|141.26|||
3800156|NCT01815515|3627515|B1|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3800157|NCT01815515|3627515|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3800158|NCT01815515|3627515|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3800159|NCT01815515|3627515|B1|||Age||years|Mean|68.4|68.4|Standard Deviation|7.89|7.89|||
3800160|NCT01815502|3627520|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3800161|NCT01815502|3627521|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3800162|NCT01815502|3627522|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3800163|NCT01815502|3627520|B3|Not Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3800164|NCT01815502|3627521|B2|Not Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3800165|NCT01815502|3627522|B1|Not Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3800166|NCT01815502|3627520|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3800167|NCT01815502|3627521|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3800168|NCT01815502|3627522|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3800169|NCT01815502|3627520|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3800170|NCT01815502|3627521|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3800171|NCT01815502|3627522|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3800172|NCT01815502|3627520|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3800173|NCT01815502|3627521|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3800174|NCT01815502|3627522|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3800175|NCT01815502|3627520|B3|||Age||years|Median|8|8.0|Inter-Quartile Range|||5.0|17.0|
3800176|NCT01815502|3627521|B2|||Age||years|Median|8|8.0|Inter-Quartile Range|||5.0|15.0|
3800177|NCT01815502|3627522|B1|||Age||years|Median|10|10.0|Inter-Quartile Range|||6.0|17.0|
3800178|NCT01815502|3627520|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3800179|NCT01815502|3627521|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3800180|NCT01815502|3627522|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3800181|NCT01815502|3627520|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3800182|NCT01815502|3627521|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3800183|NCT01815502|3627522|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3800184|NCT01815502|3627520|B3||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
3800185|NCT01815502|3627521|B2||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
3800186|NCT01815502|3627522|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
3800187|NCT01815138|3627535|B3|||Follicle Stimulating Hormone (FSH)||IU/L|Mean|5.5|5.5|Standard Deviation|2.1|2.1|||
3800188|NCT01815138|3627536|B2|||Follicle Stimulating Hormone (FSH)||IU/L|Mean|5.2|5.2|Standard Deviation|1.6|1.6|||
3800189|NCT01815138|3627537|B1|||Follicle Stimulating Hormone (FSH)||IU/L|Mean|5.6|5.6|Standard Deviation|1.7|1.7|||
3800190|NCT01815138|3627535|B3|||Anti Mullerian Hormone (AMH)||ng/ml|Mean|8.35|8.35|Standard Deviation|5.2|5.2|||
3800191|NCT01815138|3627536|B2|||Anti Mullerian Hormone (AMH)||ng/ml|Mean|8.4|8.4|Standard Deviation|4.9|4.9|||
3800192|NCT01815138|3627537|B1|||Anti Mullerian Hormone (AMH)||ng/ml|Mean|8.3|8.3|Standard Deviation|5.8|5.8|||
3800193|NCT01815138|3627535|B3|||Body Mass Index (BMI)||"kg/m^2"|Mean|26.9|26.9|Standard Deviation|5.2|5.2|||
3800194|NCT01815138|3627536|B2|||Body Mass Index (BMI)||"kg/m^2"|Mean|27.4|27.4|Standard Deviation|5.5|5.5|||
3800195|NCT01815138|3627537|B1|||Body Mass Index (BMI)||"kg/m^2"|Mean|26.3|26.3|Standard Deviation|4.8|4.8|||
3800196|NCT01815138|3627535|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3800197|NCT01815138|3627535|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3800198|NCT01815138|3627536|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3800199|NCT01815138|3627537|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3800200|NCT01815138|3627535|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3800201|NCT01815138|3627536|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3800202|NCT01815138|3627537|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3800203|NCT01815138|3627535|B3|||Age||years|Mean|31.8|31.8|Standard Deviation|3.4|3.4|||
3800204|NCT01815138|3627536|B2|||Age||years|Mean|32.2|32.2|Standard Deviation|3.4|3.4|||
3800205|NCT01815138|3627537|B1|||Age||years|Mean|31.3|31.3|Standard Deviation|3.3|3.3|||
3800206|NCT01815099|3627550|B1|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3800207|NCT01815099|3627550|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3800208|NCT01815099|3627550|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3800209|NCT01815099|3627550|B1|||Age||years|Mean|42.75|42.75|Standard Deviation|15.10|15.1|||
3800210|NCT01815099|3627550|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3800211|NCT01815099|3627550|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3800212|NCT01815099|3627550|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3800213|NCT01815008|3627555|B1|African Americans||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3800214|NCT01815008|3627555|B1||Male|Gender||Participants|Count of Participants|8|8.0||||||
3800215|NCT01815008|3627555|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
3800216|NCT01815008|3627555|B1|||Age||years|Mean|45.9|45.9|Standard Deviation|5.2|5.2|||
3800217|NCT01814878|3627562|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3800218|NCT01814878|3627563|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3800219|NCT01814878|3627564|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3800220|NCT01814878|3627562|B3||Female|Sex: Female, Male||Participants|Count of Participants|293|293.0||||||
3800221|NCT01814878|3627563|B2||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3800222|NCT01814878|3627564|B1||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3800223|NCT01814878|3627562|B3|||Age||Years|Mean|67.1|67.1|Standard Deviation|6.5|6.5|||
3800224|NCT01814878|3627563|B2|||Age||Years|Mean|67.5|67.5|Standard Deviation|6.6|6.6|||
3800225|NCT01814878|3627564|B1|||Age||Years|Mean|66.8|66.8|Standard Deviation|6.4|6.4|||
3800226|NCT01814800|3627585|B1|Other||PIDD Type|Primary PIDD diagnosis|participants|Number|4|4.0||||||
3800227|NCT01814800|3627585|B1|Antibody Deficiencies||PIDD Type|Primary PIDD diagnosis|participants|Number|4|4.0||||||
3800228|NCT01814800|3627585|B1|X-Linked Agammaglobulinemia||PIDD Type|Primary PIDD diagnosis|participants|Number|6|6.0||||||
3800229|NCT01814800|3627585|B1|Common Variable Immunodeficiency||PIDD Type|Primary PIDD diagnosis|participants|Number|45|45.0||||||
3800230|NCT01814800|3627585|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
3800231|NCT01814800|3627585|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800232|NCT01814800|3627585|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800233|NCT01814800|3627585|B1||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3800234|NCT01814800|3627585|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3800235|NCT01814800|3627585|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800236|NCT01814800|3627585|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800237|NCT01814800|3627585|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800238|NCT01814800|3627585|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800239|NCT01814800|3627585|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3800240|NCT01814800|3627585|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3800241|NCT01814800|3627585|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3800242|NCT01814800|3627585|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3800243|NCT01814800|3627585|B1|||Age||years|Mean|41.8|41.8|Full Range|||3.0|74.0|
3800244|NCT01814800|3627585|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3800245|NCT01814800|3627585|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3800246|NCT01814800|3627585|B1||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
3800247|NCT01814787|3627622|B3|Other/Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|108|108.0||||||
3800248|NCT01814787|3627623|B2|Other/Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
3800249|NCT01814787|3627624|B1|Other/Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|62|62.0||||||
3800250|NCT01814787|3627622|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|114|114.0||||||
3800251|NCT01814787|3627623|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|59|59.0||||||
3800252|NCT01814787|3627624|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|55|55.0||||||
3800253|NCT01814787|3627622|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|435|435.0||||||
3800254|NCT01814787|3627623|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|243|243.0||||||
3800255|NCT01814787|3627624|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|192|192.0||||||
3800256|NCT01814787|3627622|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|712|712.0||||||
3800257|NCT01814787|3627623|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|336|336.0||||||
3800258|NCT01814787|3627624|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|376|376.0||||||
3800259|NCT01814787|3627622|B3||Male|Sex: Female, Male||Participants|Count of Participants|712|712.0||||||
3800260|NCT01814787|3627623|B2||Male|Sex: Female, Male||Participants|Count of Participants|371|371.0||||||
3800261|NCT01814787|3627624|B1||Male|Sex: Female, Male||Participants|Count of Participants|341|341.0||||||
3800262|NCT01814787|3627622|B3||Female|Sex: Female, Male||Participants|Count of Participants|657|657.0||||||
3800263|NCT01814787|3627623|B2||Female|Sex: Female, Male||Participants|Count of Participants|313|313.0||||||
3800264|NCT01814787|3627624|B1||Female|Sex: Female, Male||Participants|Count of Participants|344|344.0||||||
3800265|NCT01814787|3627622|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3800266|NCT01814787|3627623|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3800267|NCT01814787|3627624|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3800268|NCT01814787|3627622|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3800269|NCT01814787|3627623|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3800270|NCT01814787|3627624|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3800271|NCT01814787|3627622|B3||<=18 years|Age||Participants|Count of Participants|1369|1369.0||||||
3800272|NCT01814787|3627623|B2||<=18 years|Age||Participants|Count of Participants|684|684.0||||||
3800273|NCT01814787|3627624|B1||<=18 years|Age||Participants|Count of Participants|685|685.0||||||
3800274|NCT01814774|3627631|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3800275|NCT01814774|3627631|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3800276|NCT01814774|3627631|B1|||Age||years|Mean|64.1|64.1|Standard Deviation|12.37|12.37|||
3800277|NCT01814761|3627643|B3||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
3800278|NCT01814761|3627644|B2||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3800279|NCT01814761|3627645|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3800280|NCT01814761|3627643|B3||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3800281|NCT01814761|3627644|B2||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3800282|NCT01814761|3627645|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3800283|NCT01814761|3627643|B3|||Age||Years|Mean|53.3|53.3|Standard Deviation|14.33|14.33|||
3800284|NCT01814761|3627644|B2|||Age||Years|Mean|53.4|53.4|Standard Deviation|14.45|14.45|||
3800285|NCT01814761|3627645|B1|||Age||Years|Mean|52.5|52.5|Standard Deviation|13.65|13.65|||
3800286|NCT01814748|3627658|B3|||Fasting plasma glucose (FPG)||mg/dL|Mean|165.9|165.9|Standard Deviation|39.7|39.7|||
3800287|NCT01814748|3627659|B2|||Fasting plasma glucose (FPG)||mg/dL|Mean|167.8|167.8|Standard Deviation|40.6|40.6|||
3800288|NCT01814748|3627660|B1|||Fasting plasma glucose (FPG)||mg/dL|Mean|164.0|164.0|Standard Deviation|38.9|38.9|||
3800289|NCT01814748|3627658|B3|||2-hour post-meal glucose (2-hr PMG)|Participants with available data at baseline: Omarigliptin, n=98; Placebo, n=101; Total, n=199|mg/dL|Mean|211.2|211.2|Standard Deviation|62.0|62.0|||
3800290|NCT01814748|3627659|B2|||2-hour post-meal glucose (2-hr PMG)|Participants with available data at baseline: Omarigliptin, n=98; Placebo, n=101; Total, n=199|mg/dL|Mean|217.3|217.3|Standard Deviation|67.7|67.7|||
3800291|NCT01814748|3627660|B1|||2-hour post-meal glucose (2-hr PMG)|Participants with available data at baseline: Omarigliptin, n=98; Placebo, n=101; Total, n=199|mg/dL|Mean|204.9|204.9|Standard Deviation|55.1|55.1|||
3800292|NCT01814748|3627658|B3|||Hemoglobin A1c (A1C)||Percent|Mean|8.0|8.0|Standard Deviation|0.8|0.8|||
3800293|NCT01814748|3627659|B2|||Hemoglobin A1c (A1C)||Percent|Mean|8.1|8.1|Standard Deviation|0.9|0.9|||
3800294|NCT01814748|3627660|B1|||Hemoglobin A1c (A1C)||Percent|Mean|7.9|7.9|Standard Deviation|0.8|0.8|||
3800295|NCT01814748|3627658|B3||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3800296|NCT01814748|3627659|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3800297|NCT01814748|3627660|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3800298|NCT01814748|3627658|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3800299|NCT01814748|3627659|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3800300|NCT01814748|3627660|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3800301|NCT01814748|3627658|B3|||Age||Years|Mean|39.2|39.2|Standard Deviation|4.6|4.6|||
3800302|NCT01814748|3627659|B2|||Age||Years|Mean|39.5|39.5|Standard Deviation|4.5|4.5|||
3800303|NCT01814748|3627660|B1|||Age||Years|Mean|38.8|38.8|Standard Deviation|4.7|4.7|||
3800304|NCT01814722|3627681|B4||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3800305|NCT01814722|3627682|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3800306|NCT01814722|3627683|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3800307|NCT01814722|3627684|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3800308|NCT01814722|3627681|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3800309|NCT01814722|3627682|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3800310|NCT01814722|3627683|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3800311|NCT01814722|3627684|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3800312|NCT01814722|3627681|B4|||Age||Years|Mean|46.3|46.3|Standard Deviation|10.3|10.3|||
3800313|NCT01814722|3627682|B3|||Age||Years|Mean|48.8|48.8|Standard Deviation|4.1|4.1|||
3800314|NCT01814722|3627683|B2|||Age||Years|Mean|45.2|45.2|Standard Deviation|13.8|13.8|||
3800315|NCT01814722|3627684|B1|||Age||Years|Mean|46.7|46.7|Standard Deviation|8.9|8.9|||
3800316|NCT01814696|3627703|B3|||Minnesota Living with Heart Failure Questionnaire (MLHFQ) Emotional Score|"Health-related quality of life is measured using the Minnesota Living with Heart Failure Questionnaire (MLHFQ). The Emotional Sub-scale is created from 5-items from the 21-items that make up the MLHFQ. The items assess the impact of HF and HF treatment on key emotional dimensions of a patient’s life during the past four weeks. Responses are coded from 0 = does not apply and 1 = very little to 5 = very much.~The sub-scale ranges in possible values from 0 to 25. A higher score represents a greater negative HR-related impact on quality of life."|units on a scale|Mean|6.5|6.5|Standard Deviation|6.7|6.7|||
3800317|NCT01814696|3627704|B2|||Minnesota Living with Heart Failure Questionnaire (MLHFQ) Emotional Score|"Health-related quality of life is measured using the Minnesota Living with Heart Failure Questionnaire (MLHFQ). The Emotional Sub-scale is created from 5-items from the 21-items that make up the MLHFQ. The items assess the impact of HF and HF treatment on key emotional dimensions of a patient’s life during the past four weeks. Responses are coded from 0 = does not apply and 1 = very little to 5 = very much.~The sub-scale ranges in possible values from 0 to 25. A higher score represents a greater negative HR-related impact on quality of life."|units on a scale|Mean|7.2|7.2|Standard Deviation|7.7|7.7|||
3800318|NCT01814696|3627705|B1|||Minnesota Living with Heart Failure Questionnaire (MLHFQ) Emotional Score|"Health-related quality of life is measured using the Minnesota Living with Heart Failure Questionnaire (MLHFQ). The Emotional Sub-scale is created from 5-items from the 21-items that make up the MLHFQ. The items assess the impact of HF and HF treatment on key emotional dimensions of a patient’s life during the past four weeks. Responses are coded from 0 = does not apply and 1 = very little to 5 = very much.~The sub-scale ranges in possible values from 0 to 25. A higher score represents a greater negative HR-related impact on quality of life."|units on a scale|Mean|5.9|5.9|Standard Deviation|6.2|6.2|||
3800319|NCT01814696|3627703|B3|||Minnesota Living with Heart Failure Questionnaire (MLHFQ) Physical Score|"Health-related quality of life is measured using the Minnesota Living with Heart Failure Questionnaire (MLHFQ). The Physical Sub-scale is created from 8-items from the 21-items that make up the MLHFQ. The items assess the impact of HF and HF treatment on key physical dimensions of a patient’s life during the past four weeks. Responses are coded from 0 = does not apply and 1 = very little to 5 = very much.~The sub-scale ranges in possible values from 0 to 40. A higher score represents a greater negative HR-related impact on quality of life."|units on a scale|Mean|15.7|15.7|Standard Deviation|12.7|12.7|||
3800320|NCT01814696|3627704|B2|||Minnesota Living with Heart Failure Questionnaire (MLHFQ) Physical Score|"Health-related quality of life is measured using the Minnesota Living with Heart Failure Questionnaire (MLHFQ). The Physical Sub-scale is created from 8-items from the 21-items that make up the MLHFQ. The items assess the impact of HF and HF treatment on key physical dimensions of a patient’s life during the past four weeks. Responses are coded from 0 = does not apply and 1 = very little to 5 = very much.~The sub-scale ranges in possible values from 0 to 40. A higher score represents a greater negative HR-related impact on quality of life."|units on a scale|Mean|21.9|21.9|Standard Deviation|11.8|11.8|||
3800321|NCT01814696|3627705|B1|||Minnesota Living with Heart Failure Questionnaire (MLHFQ) Physical Score|"Health-related quality of life is measured using the Minnesota Living with Heart Failure Questionnaire (MLHFQ). The Physical Sub-scale is created from 8-items from the 21-items that make up the MLHFQ. The items assess the impact of HF and HF treatment on key physical dimensions of a patient’s life during the past four weeks. Responses are coded from 0 = does not apply and 1 = very little to 5 = very much.~The sub-scale ranges in possible values from 0 to 40. A higher score represents a greater negative HR-related impact on quality of life."|units on a scale|Mean|10.8|10.8|Standard Deviation|11.4|11.4|||
3800354|NCT01814696|3627705|B1|Class 2||NYHA Functional Classification|This scale is a categorical measure of severity of heart failure. There are four categories ranging from 1-4 increasing in severity.|participants|Number|1|1.0||||||
3800355|NCT01814696|3627703|B3|Class 1||NYHA Functional Classification|This scale is a categorical measure of severity of heart failure. There are four categories ranging from 1-4 increasing in severity.|participants|Number|12|12.0||||||
3800322|NCT01814696|3627703|B3|||Minnesota Living with Heart Failure Questionnaire (MLHFQ) Total Score|"Health-related quality of life is measured using the Minnesota Living with Heart Failure Questionnaire (MLHFQ). The questionnaire consists of 21 items that assess the impact of HF and HF treatment on key physical, emotional, and social dimensions of a patient’s life during the past four weeks. Responses are coded from 0 = does not apply and 1 = very little to 5 = very much.~A higher score represents a greater negative HR-related impact on quality of life."|units on a scale|Mean|34.3|34.3|Standard Deviation|25.6|25.6|||
3800323|NCT01814696|3627704|B2|||Minnesota Living with Heart Failure Questionnaire (MLHFQ) Total Score|"Health-related quality of life is measured using the Minnesota Living with Heart Failure Questionnaire (MLHFQ). The questionnaire consists of 21 items that assess the impact of HF and HF treatment on key physical, emotional, and social dimensions of a patient’s life during the past four weeks. Responses are coded from 0 = does not apply and 1 = very little to 5 = very much.~A higher score represents a greater negative HR-related impact on quality of life."|units on a scale|Mean|43.7|43.7|Standard Deviation|25.9|25.9|||
3800324|NCT01814696|3627705|B1|||Minnesota Living with Heart Failure Questionnaire (MLHFQ) Total Score|"Health-related quality of life is measured using the Minnesota Living with Heart Failure Questionnaire (MLHFQ). The questionnaire consists of 21 items that assess the impact of HF and HF treatment on key physical, emotional, and social dimensions of a patient’s life during the past four weeks. Responses are coded from 0 = does not apply and 1 = very little to 5 = very much.~A higher score represents a greater negative HR-related impact on quality of life."|units on a scale|Mean|26.2|26.2|Standard Deviation|23.1|23.1|||
3800325|NCT01814696|3627703|B3|||Personal Health Questionnaire Depression Scale, 8-Items (PHQ-8)|The PHQ-8 is a commonly used measure of depression. Each of the 8-items is scored from 0 to 3 to generate a total score from 0 to 24. Generally accepted cut points for depression severity are 5-9 = mild, 10-14 = moderate, 15-19 = moderately severe, and 20-24 = severe.|units on a scale|Mean|5.0|5.0|Standard Deviation|4.8|4.8|||
3800326|NCT01814696|3627704|B2|||Personal Health Questionnaire Depression Scale, 8-Items (PHQ-8)|The PHQ-8 is a commonly used measure of depression. Each of the 8-items is scored from 0 to 3 to generate a total score from 0 to 24. Generally accepted cut points for depression severity are 5-9 = mild, 10-14 = moderate, 15-19 = moderately severe, and 20-24 = severe.|units on a scale|Mean|6.8|6.8|Standard Deviation|4.5|4.5|||
3800327|NCT01814696|3627705|B1|||Personal Health Questionnaire Depression Scale, 8-Items (PHQ-8)|The PHQ-8 is a commonly used measure of depression. Each of the 8-items is scored from 0 to 3 to generate a total score from 0 to 24. Generally accepted cut points for depression severity are 5-9 = mild, 10-14 = moderate, 15-19 = moderately severe, and 20-24 = severe.|units on a scale|Mean|3.5|3.5|Standard Deviation|4.6|4.6|||
3800328|NCT01814696|3627703|B3|Excellent||Self-Rated Health||participants|Number|1|1.0||||||
3800329|NCT01814696|3627704|B2|Excellent||Self-Rated Health||participants|Number|0|0.0||||||
3800330|NCT01814696|3627705|B1|Excellent||Self-Rated Health||participants|Number|1|1.0||||||
3800331|NCT01814696|3627703|B3|Very Good||Self-Rated Health||participants|Number|2|2.0||||||
3800332|NCT01814696|3627704|B2|Very Good||Self-Rated Health||participants|Number|0|0.0||||||
3800333|NCT01814696|3627705|B1|Very Good||Self-Rated Health||participants|Number|2|2.0||||||
3800334|NCT01814696|3627703|B3|Good||Self-Rated Health||participants|Number|10|10.0||||||
3800335|NCT01814696|3627704|B2|Good||Self-Rated Health||participants|Number|5|5.0||||||
3800336|NCT01814696|3627705|B1|Good||Self-Rated Health||participants|Number|5|5.0||||||
3800337|NCT01814696|3627703|B3|Fair||Self-Rated Health||participants|Number|11|11.0||||||
3800338|NCT01814696|3627704|B2|Fair||Self-Rated Health||participants|Number|5|5.0||||||
3800339|NCT01814696|3627705|B1|Fair||Self-Rated Health||participants|Number|6|6.0||||||
3800340|NCT01814696|3627703|B3|Poor||Self-Rated Health||participants|Number|1|1.0||||||
3800341|NCT01814696|3627704|B2|Poor||Self-Rated Health||participants|Number|1|1.0||||||
3800342|NCT01814696|3627705|B1|Poor||Self-Rated Health||participants|Number|0|0.0||||||
3800343|NCT01814696|3627703|B3|Unknown||NYHA Functional Classification|This scale is a categorical measure of severity of heart failure. There are four categories ranging from 1-4 increasing in severity.|participants|Number|1|1.0||||||
3800344|NCT01814696|3627704|B2|Unknown||NYHA Functional Classification|This scale is a categorical measure of severity of heart failure. There are four categories ranging from 1-4 increasing in severity.|participants|Number|0|0.0||||||
3800345|NCT01814696|3627705|B1|Unknown||NYHA Functional Classification|This scale is a categorical measure of severity of heart failure. There are four categories ranging from 1-4 increasing in severity.|participants|Number|1|1.0||||||
3800346|NCT01814696|3627703|B3|Class 4||NYHA Functional Classification|This scale is a categorical measure of severity of heart failure. There are four categories ranging from 1-4 increasing in severity.|participants|Number|0|0.0||||||
3800347|NCT01814696|3627704|B2|Class 4||NYHA Functional Classification|This scale is a categorical measure of severity of heart failure. There are four categories ranging from 1-4 increasing in severity.|participants|Number|0|0.0||||||
3800348|NCT01814696|3627705|B1|Class 4||NYHA Functional Classification|This scale is a categorical measure of severity of heart failure. There are four categories ranging from 1-4 increasing in severity.|participants|Number|0|0.0||||||
3800349|NCT01814696|3627703|B3|Class 3||NYHA Functional Classification|This scale is a categorical measure of severity of heart failure. There are four categories ranging from 1-4 increasing in severity.|participants|Number|2|2.0||||||
3800350|NCT01814696|3627704|B2|Class 3||NYHA Functional Classification|This scale is a categorical measure of severity of heart failure. There are four categories ranging from 1-4 increasing in severity.|participants|Number|1|1.0||||||
3800351|NCT01814696|3627705|B1|Class 3||NYHA Functional Classification|This scale is a categorical measure of severity of heart failure. There are four categories ranging from 1-4 increasing in severity.|participants|Number|1|1.0||||||
3800352|NCT01814696|3627703|B3|Class 2||NYHA Functional Classification|This scale is a categorical measure of severity of heart failure. There are four categories ranging from 1-4 increasing in severity.|participants|Number|10|10.0||||||
3800353|NCT01814696|3627704|B2|Class 2||NYHA Functional Classification|This scale is a categorical measure of severity of heart failure. There are four categories ranging from 1-4 increasing in severity.|participants|Number|9|9.0||||||
3800356|NCT01814696|3627704|B2|Class 1||NYHA Functional Classification|This scale is a categorical measure of severity of heart failure. There are four categories ranging from 1-4 increasing in severity.|participants|Number|1|1.0||||||
3800357|NCT01814696|3627705|B1|Class 1||NYHA Functional Classification|This scale is a categorical measure of severity of heart failure. There are four categories ranging from 1-4 increasing in severity.|participants|Number|11|11.0||||||
3800358|NCT01814696|3627703|B3|Not using a medication reminder||Using a Medication Reminder Tool||participants|Number|7|7.0||||||
3800359|NCT01814696|3627704|B2|Not using a medication reminder||Using a Medication Reminder Tool||participants|Number|4|4.0||||||
3800360|NCT01814696|3627705|B1|Not using a medication reminder||Using a Medication Reminder Tool||participants|Number|3|3.0||||||
3800361|NCT01814696|3627703|B3|Using a medication reminder||Using a Medication Reminder Tool||participants|Number|18|18.0||||||
3800362|NCT01814696|3627704|B2|Using a medication reminder||Using a Medication Reminder Tool||participants|Number|7|7.0||||||
3800363|NCT01814696|3627705|B1|Using a medication reminder||Using a Medication Reminder Tool||participants|Number|11|11.0||||||
3800364|NCT01814696|3627703|B3|Non-adherent||Medical Outcomes Study (MOS) Adhere|"Single Medication Adherence Measures, Medical Outcomes Study (MOS) Adhere"|participants|Number|7|7.0||||||
3800365|NCT01814696|3627704|B2|Non-adherent||Medical Outcomes Study (MOS) Adhere|"Single Medication Adherence Measures, Medical Outcomes Study (MOS) Adhere"|participants|Number|4|4.0||||||
3800366|NCT01814696|3627705|B1|Non-adherent||Medical Outcomes Study (MOS) Adhere|"Single Medication Adherence Measures, Medical Outcomes Study (MOS) Adhere"|participants|Number|3|3.0||||||
3800367|NCT01814696|3627703|B3|Adherent||Medical Outcomes Study (MOS) Adhere|"Single Medication Adherence Measures, Medical Outcomes Study (MOS) Adhere"|participants|Number|18|18.0||||||
3800368|NCT01814696|3627704|B2|Adherent||Medical Outcomes Study (MOS) Adhere|"Single Medication Adherence Measures, Medical Outcomes Study (MOS) Adhere"|participants|Number|7|7.0||||||
3800369|NCT01814696|3627705|B1|Adherent||Medical Outcomes Study (MOS) Adhere|"Single Medication Adherence Measures, Medical Outcomes Study (MOS) Adhere"|participants|Number|11|11.0||||||
3800370|NCT01814696|3627703|B3|Low adherence (score = 3-8)||Morisky Medication Adherence Survey, 8-Item (MMAS-8)|"Subject reported medication adherence. The Morisky Medication Adherence Scale (MMAS) is a valid and reliable instrument that consists of 8 items that measure medication adherence. Responses are summed from the 8-items to yield 3 categories of adherence: 0 = high adherence, 1-2 = medium adherence, and 3-8 = low adherence.~Not all subjects completed these questions on the enrollment questionnaire."|participants|Number|6|6.0||||||
3800371|NCT01814696|3627704|B2|Low adherence (score = 3-8)||Morisky Medication Adherence Survey, 8-Item (MMAS-8)|"Subject reported medication adherence. The Morisky Medication Adherence Scale (MMAS) is a valid and reliable instrument that consists of 8 items that measure medication adherence. Responses are summed from the 8-items to yield 3 categories of adherence: 0 = high adherence, 1-2 = medium adherence, and 3-8 = low adherence.~Not all subjects completed these questions on the enrollment questionnaire."|participants|Number|3|3.0||||||
3800372|NCT01814696|3627705|B1|Low adherence (score = 3-8)||Morisky Medication Adherence Survey, 8-Item (MMAS-8)|"Subject reported medication adherence. The Morisky Medication Adherence Scale (MMAS) is a valid and reliable instrument that consists of 8 items that measure medication adherence. Responses are summed from the 8-items to yield 3 categories of adherence: 0 = high adherence, 1-2 = medium adherence, and 3-8 = low adherence.~Not all subjects completed these questions on the enrollment questionnaire."|participants|Number|3|3.0||||||
3800373|NCT01814696|3627703|B3|Medium adherence (score = 1-2)||Morisky Medication Adherence Survey, 8-Item (MMAS-8)|"Subject reported medication adherence. The Morisky Medication Adherence Scale (MMAS) is a valid and reliable instrument that consists of 8 items that measure medication adherence. Responses are summed from the 8-items to yield 3 categories of adherence: 0 = high adherence, 1-2 = medium adherence, and 3-8 = low adherence.~Not all subjects completed these questions on the enrollment questionnaire."|participants|Number|14|14.0||||||
3800374|NCT01814696|3627704|B2|Medium adherence (score = 1-2)||Morisky Medication Adherence Survey, 8-Item (MMAS-8)|"Subject reported medication adherence. The Morisky Medication Adherence Scale (MMAS) is a valid and reliable instrument that consists of 8 items that measure medication adherence. Responses are summed from the 8-items to yield 3 categories of adherence: 0 = high adherence, 1-2 = medium adherence, and 3-8 = low adherence.~Not all subjects completed these questions on the enrollment questionnaire."|participants|Number|6|6.0||||||
3800375|NCT01814696|3627705|B1|Medium adherence (score = 1-2)||Morisky Medication Adherence Survey, 8-Item (MMAS-8)|"Subject reported medication adherence. The Morisky Medication Adherence Scale (MMAS) is a valid and reliable instrument that consists of 8 items that measure medication adherence. Responses are summed from the 8-items to yield 3 categories of adherence: 0 = high adherence, 1-2 = medium adherence, and 3-8 = low adherence.~Not all subjects completed these questions on the enrollment questionnaire."|participants|Number|8|8.0||||||
3800376|NCT01814696|3627703|B3|High adherence (score = 0)||Morisky Medication Adherence Survey, 8-Item (MMAS-8)|"Subject reported medication adherence. The Morisky Medication Adherence Scale (MMAS) is a valid and reliable instrument that consists of 8 items that measure medication adherence. Responses are summed from the 8-items to yield 3 categories of adherence: 0 = high adherence, 1-2 = medium adherence, and 3-8 = low adherence.~Not all subjects completed these questions on the enrollment questionnaire."|participants|Number|2|2.0||||||
3800377|NCT01814696|3627704|B2|High adherence (score = 0)||Morisky Medication Adherence Survey, 8-Item (MMAS-8)|"Subject reported medication adherence. The Morisky Medication Adherence Scale (MMAS) is a valid and reliable instrument that consists of 8 items that measure medication adherence. Responses are summed from the 8-items to yield 3 categories of adherence: 0 = high adherence, 1-2 = medium adherence, and 3-8 = low adherence.~Not all subjects completed these questions on the enrollment questionnaire."|participants|Number|0|0.0||||||
3800378|NCT01814696|3627705|B1|High adherence (score = 0)||Morisky Medication Adherence Survey, 8-Item (MMAS-8)|"Subject reported medication adherence. The Morisky Medication Adherence Scale (MMAS) is a valid and reliable instrument that consists of 8 items that measure medication adherence. Responses are summed from the 8-items to yield 3 categories of adherence: 0 = high adherence, 1-2 = medium adherence, and 3-8 = low adherence.~Not all subjects completed these questions on the enrollment questionnaire."|participants|Number|2|2.0||||||
3800379|NCT01814696|3627703|B3|Smartphone||Mobile Phone Ownership||participants|Number|4|4.0||||||
3800380|NCT01814696|3627704|B2|Smartphone||Mobile Phone Ownership||participants|Number|2|2.0||||||
3800381|NCT01814696|3627705|B1|Smartphone||Mobile Phone Ownership||participants|Number|2|2.0||||||
3800382|NCT01814696|3627703|B3|Cellphone||Mobile Phone Ownership||participants|Number|18|18.0||||||
3800383|NCT01814696|3627704|B2|Cellphone||Mobile Phone Ownership||participants|Number|7|7.0||||||
3800384|NCT01814696|3627705|B1|Cellphone||Mobile Phone Ownership||participants|Number|11|11.0||||||
3800385|NCT01814696|3627703|B3|No mobile phone||Mobile Phone Ownership||participants|Number|3|3.0||||||
3800386|NCT01814696|3627704|B2|No mobile phone||Mobile Phone Ownership||participants|Number|2|2.0||||||
3800387|NCT01814696|3627705|B1|No mobile phone||Mobile Phone Ownership||participants|Number|1|1.0||||||
3800388|NCT01814696|3627703|B3|Non-Internet User||Internet User||participants|Number|9|9.0||||||
3800389|NCT01814696|3627704|B2|Non-Internet User||Internet User||participants|Number|5|5.0||||||
3800390|NCT01814696|3627705|B1|Non-Internet User||Internet User||participants|Number|4|4.0||||||
3800391|NCT01814696|3627703|B3|Internet User||Internet User||participants|Number|16|16.0||||||
3800392|NCT01814696|3627704|B2|Internet User||Internet User||participants|Number|6|6.0||||||
3800393|NCT01814696|3627705|B1|Internet User||Internet User||participants|Number|10|10.0||||||
3800394|NCT01814696|3627703|B3|1 or more years of college||Education Level||participants|Number|18|18.0||||||
3800395|NCT01814696|3627704|B2|1 or more years of college||Education Level||participants|Number|7|7.0||||||
3800396|NCT01814696|3627705|B1|1 or more years of college||Education Level||participants|Number|11|11.0||||||
3800397|NCT01814696|3627703|B3|Less than 1 year college||Education Level||participants|Number|7|7.0||||||
3800398|NCT01814696|3627704|B2|Less than 1 year college||Education Level||participants|Number|4|4.0||||||
3800399|NCT01814696|3627705|B1|Less than 1 year college||Education Level||participants|Number|3|3.0||||||
3800400|NCT01814696|3627703|B3|Lives with Others in Household||Lives Alone||participants|Number|15|15.0||||||
3800401|NCT01814696|3627704|B2|Lives with Others in Household||Lives Alone||participants|Number|7|7.0||||||
3800402|NCT01814696|3627705|B1|Lives with Others in Household||Lives Alone||participants|Number|8|8.0||||||
3800403|NCT01814696|3627703|B3|Lives Alone||Lives Alone||participants|Number|10|10.0||||||
3800404|NCT01814696|3627704|B2|Lives Alone||Lives Alone||participants|Number|4|4.0||||||
3800405|NCT01814696|3627705|B1|Lives Alone||Lives Alone||participants|Number|6|6.0||||||
3800406|NCT01814696|3627703|B3|Non-married||Marital Status||participants|Number|14|14.0||||||
3800407|NCT01814696|3627704|B2|Non-married||Marital Status||participants|Number|7|7.0||||||
3800408|NCT01814696|3627705|B1|Non-married||Marital Status||participants|Number|7|7.0||||||
3800409|NCT01814696|3627703|B3|Married||Marital Status||participants|Number|11|11.0||||||
3800410|NCT01814696|3627704|B2|Married||Marital Status||participants|Number|4|4.0||||||
3800411|NCT01814696|3627705|B1|Married||Marital Status||participants|Number|7|7.0||||||
3800412|NCT01814696|3627703|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
3800413|NCT01814696|3627704|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3800414|NCT01814696|3627705|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3800415|NCT01814696|3627703|B3|Non-White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3800416|NCT01814696|3627704|B2|Non-White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3800417|NCT01814696|3627705|B1|Non-White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3800418|NCT01814696|3627703|B3|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3800419|NCT01814696|3627704|B2|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3800420|NCT01814696|3627705|B1|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3800421|NCT01814696|3627703|B3||Male|Gender||Participants|Count of Participants|16|16.0||||||
3800422|NCT01814696|3627704|B2||Male|Gender||Participants|Count of Participants|7|7.0||||||
3800423|NCT01814696|3627705|B1||Male|Gender||Participants|Count of Participants|9|9.0||||||
3800424|NCT01814696|3627703|B3||Female|Gender||Participants|Count of Participants|9|9.0||||||
3800425|NCT01814696|3627704|B2||Female|Gender||Participants|Count of Participants|4|4.0||||||
3800426|NCT01814696|3627705|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
3800427|NCT01814696|3627703|B3|||Age||years|Mean|71.7|71.7|Standard Deviation|11.2|11.2|||
3800428|NCT01814696|3627704|B2|||Age||years|Mean|68.4|68.4|Standard Deviation|11.8|11.8|||
3800429|NCT01814696|3627705|B1|||Age||years|Mean|74.4|74.4|Standard Deviation|10.4|10.4|||
3800430|NCT01814670|3627724|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3800431|NCT01814670|3627724|B1||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3800432|NCT01814670|3627724|B1|||Age||Years|Mean|44.8|44.8|Standard Deviation|8.16|8.16|||
3800433|NCT01814553|3627732|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3800434|NCT01814553|3627733|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3800435|NCT01814553|3627734|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3800436|NCT01814553|3627732|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3800437|NCT01814553|3627733|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3800438|NCT01814553|3627734|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3800439|NCT01814553|3627732|B3|||Age||Years|Mean|68.80|68.8|Standard Deviation|8.62|8.62|||
3800440|NCT01814553|3627733|B2|||Age||Years|Mean|68.00|68.0|Standard Deviation|6.50|6.5|||
3800441|NCT01814553|3627734|B1|||Age||Years|Mean|69.70|69.7|Standard Deviation|10.80|10.8|||
3800442|NCT01814397|3627749|B1|||Mean serum estradiol, pg/ml||pg/ml|Mean|6.0|6.0|Standard Deviation|7.6|7.6|||
3800443|NCT01814397|3627749|B1|||Mean conditioned pain modulation (CPM)|Pressure equivalent to the patient's Pain50 was applied to the non-dominant thumbnail for 30 seconds (test stimulus), and the patient rated the intensity of the pressure on a 0-100 pain scale at 10 second intervals. Ten minutes later pressure (conditioning stimulus) was continuously applied to the dominant thumbnail for 60 seconds at the same Pain50 intensity. After 30 seconds, the test stimulus was again applied to the non-dominant thumbnail for 30 seconds and the patient rated the intensity every 10 seconds. CPM magnitude was calculated as the difference of the means of the 3 pain ratings.|units on a scale (0-100 pain scale)|Mean|7.9|7.9|Standard Deviation|14.7|14.7|||
3800444|NCT01814397|3627749|B1|||Mean Pain50, kg/cm^2|Patients rated the intensity of each pressure sensation using a 0 to 100 numerical rating scale (0 = no pain, 100 = worst pain imaginable). Pain50 was defined as the amount of applied pressure in kilograms per square centimeter that evoked a pain intensity rating of 50 out of 100.|kg/cm^2|Mean|4.3|4.3|Standard Deviation|1.5|1.5|||
3800445|NCT01814397|3627749|B1|no prior tamoxifen||Prior tamoxifen||participants|Number|36|36.0||||||
3800446|NCT01814397|3627749|B1|prior tamoxifen||Prior tamoxifen||participants|Number|14|14.0||||||
3800447|NCT01814397|3627749|B1|no prior chemotherapy||Prior chemotherapy||participants|Number|27|27.0||||||
3800448|NCT01814397|3627749|B1|prior chemotherapy||Prior chemotherapy||participants|Number|23|23.0||||||
3800449|NCT01814397|3627749|B1|letrozole 2.5 mg daily||Aromatase inhibitor||participants|Number|9|9.0||||||
3800450|NCT01814397|3627749|B1|exemestane 25 mg daily||Aromatase inhibitor||participants|Number|1|1.0||||||
3800451|NCT01814397|3627749|B1|anastrozole 1 mg daily||Aromatase inhibitor||participants|Number|40|40.0||||||
3800452|NCT01814397|3627749|B1|||Body mass index||kg/m^2|Mean|30.0|30.0|Standard Deviation|6.5|6.5|||
3800453|NCT01814397|3627749|B1|||Weight, kg||kilograms|Mean|80.7|80.7|Standard Deviation|17.8|17.8|||
3800454|NCT01814397|3627749|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800455|NCT01814397|3627749|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800456|NCT01814397|3627749|B1||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3800457|NCT01814397|3627749|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3800458|NCT01814397|3627749|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800459|NCT01814397|3627749|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3800460|NCT01814397|3627749|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800461|NCT01814397|3627749|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3800462|NCT01814397|3627749|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3800463|NCT01814397|3627749|B1|||Age||years|Median|60|60.0|Full Range|||38.0|77.0|
3800464|NCT01814371|3627756|B3|||Weight (pounds)||pounds|Mean|117.85|117.85|Standard Deviation|82.81|82.81|||
3800465|NCT01814371|3627757|B2|||Weight (pounds)||pounds|Mean|121.74|121.74|Standard Deviation|88.25|88.25|||
3800466|NCT01814371|3627758|B1|||Weight (pounds)||pounds|Mean|114.09|114.09|Standard Deviation|77.19|77.19|||
3800467|NCT01814371|3627756|B3|||Height (inches)||inches|Mean|55.09|55.09|Standard Deviation|14.65|14.65|||
3800468|NCT01814371|3627757|B2|||Height (inches)||inches|Mean|55.24|55.24|Standard Deviation|15.80|15.8|||
3800469|NCT01814371|3627758|B1|||Height (inches)||inches|Mean|54.95|54.95|Standard Deviation|14.53|14.53|||
3800470|NCT01814371|3627756|B3|United States||Region of Enrollment||participants|Number|474|474.0||||||
3800471|NCT01814371|3627757|B2|United States||Region of Enrollment||participants|Number|226|226.0||||||
3800472|NCT01814371|3627758|B1|United States||Region of Enrollment||participants|Number|248|248.0||||||
3800473|NCT01814371|3627756|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800474|NCT01814371|3627757|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800475|NCT01814371|3627758|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800476|NCT01814371|3627756|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3800477|NCT01814371|3627757|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3800478|NCT01814371|3627758|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3800479|NCT01814371|3627756|B3||White|Race (NIH/OMB)||Participants|Count of Participants|331|331.0||||||
3800480|NCT01814371|3627757|B2||White|Race (NIH/OMB)||Participants|Count of Participants|162|162.0||||||
3800481|NCT01814371|3627758|B1||White|Race (NIH/OMB)||Participants|Count of Participants|169|169.0||||||
3800482|NCT01814371|3627756|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
3800483|NCT01814371|3627757|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3800484|NCT01814371|3627758|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3800485|NCT01814371|3627756|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800486|NCT01814371|3627757|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800487|NCT01814371|3627758|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800488|NCT01814371|3627756|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800489|NCT01814371|3627757|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800490|NCT01814371|3627758|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800491|NCT01814371|3627756|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800492|NCT01814371|3627757|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800493|NCT01814371|3627758|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800494|NCT01814371|3627756|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800495|NCT01814371|3627757|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800496|NCT01814371|3627758|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800497|NCT01814371|3627756|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|445|445.0||||||
3800498|NCT01814371|3627757|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|213|213.0||||||
3800499|NCT01814371|3627758|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|232|232.0||||||
3800500|NCT01814371|3627756|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3800501|NCT01814371|3627757|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3800502|NCT01814371|3627758|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3800503|NCT01814371|3627756|B3||Male|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
3800504|NCT01814371|3627757|B2||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3800505|NCT01814371|3627758|B1||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3800506|NCT01814371|3627756|B3||Female|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
3800507|NCT01814371|3627757|B2||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3800508|NCT01814371|3627758|B1||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3800509|NCT01814371|3627756|B3|||Age||years|Mean|18.67|18.67|Standard Deviation|16.30|16.3|||
3800510|NCT01814371|3627757|B2|||Age||years|Mean|18.69|18.69|Standard Deviation|15.94|15.94|||
3800511|NCT01814371|3627758|B1|||Age||years|Mean|18.65|18.65|Standard Deviation|16.65|16.65|||
3800512|NCT01814371|3627756|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3800513|NCT01814371|3627757|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3800514|NCT01814371|3627758|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3800515|NCT01814371|3627756|B3||Between 18 and 65 years|Age||Participants|Count of Participants|198|198.0||||||
3800516|NCT01814371|3627757|B2||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
3800517|NCT01814371|3627758|B1||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
3800518|NCT01814371|3627756|B3||<=18 years|Age||Participants|Count of Participants|273|273.0||||||
3800519|NCT01814371|3627757|B2||<=18 years|Age||Participants|Count of Participants|128|128.0||||||
3800520|NCT01814371|3627758|B1||<=18 years|Age||Participants|Count of Participants|145|145.0||||||
3800521|NCT01814332|3627790|B3|United States||Region of Enrollment||participants|Number|128|128.0||||||
3800522|NCT01814332|3627791|B2|United States||Region of Enrollment||participants|Number|65|65.0||||||
3800523|NCT01814332|3627792|B1|United States||Region of Enrollment||participants|Number|63|63.0||||||
3800524|NCT01814332|3627790|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3800525|NCT01814332|3627791|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3800526|NCT01814332|3627792|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3800527|NCT01814332|3627790|B3||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3800528|NCT01814332|3627791|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3800529|NCT01814332|3627792|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3800530|NCT01814332|3627790|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3800531|NCT01814332|3627791|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3800532|NCT01814332|3627792|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3800533|NCT01814332|3627790|B3||Between 18 and 65 years|Age||Participants|Count of Participants|128|128.0||||||
3800534|NCT01814332|3627791|B2||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
3800535|NCT01814332|3627792|B1||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
3800536|NCT01814332|3627790|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3800537|NCT01814332|3627791|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3800538|NCT01814332|3627792|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3800539|NCT01814241|3627805|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3800540|NCT01814241|3627805|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800541|NCT01814241|3627805|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800542|NCT01814241|3627805|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3800543|NCT01814241|3627805|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3800544|NCT01814241|3627805|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800545|NCT01814241|3627805|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3800546|NCT01814241|3627805|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3800547|NCT01814241|3627805|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800548|NCT01814241|3627805|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3800549|NCT01814241|3627805|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800550|NCT01814241|3627805|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3800551|NCT01814241|3627805|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3800552|NCT01814241|3627805|B1|||Age||years|Mean|8.8|8.8|Full Range|||5.9|11.7|
3800553|NCT01814241|3627805|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3800554|NCT01814241|3627805|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3800555|NCT01814241|3627805|B1||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
3800556|NCT01814137|3627813|B3|||Fasting plasma glucose (FPG)||mmol/L|Mean|7.9|7.9|Standard Deviation|3.2|3.2|||
3800557|NCT01814137|3627814|B2|||Fasting plasma glucose (FPG)||mmol/L|Mean|8.6|8.6|Standard Deviation|2.8|2.8|||
3800558|NCT01814137|3627815|B1|||Fasting plasma glucose (FPG)||mmol/L|Mean|7.3|7.3|Standard Deviation|3.5|3.5|||
3800559|NCT01814137|3627813|B3|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|7.8|7.8|Standard Deviation|0.7|0.7|||
3800560|NCT01814137|3627814|B2|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|7.7|7.7|Standard Deviation|0.6|0.6|||
3800561|NCT01814137|3627815|B1|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|7.9|7.9|Standard Deviation|0.7|0.7|||
3800562|NCT01814137|3627813|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3800563|NCT01814137|3627814|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3800564|NCT01814137|3627815|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3800565|NCT01814137|3627813|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3800566|NCT01814137|3627814|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3800567|NCT01814137|3627815|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3800568|NCT01814137|3627813|B3|||Age||years|Mean|57.5|57.5|Standard Deviation|8.0|8.0|||
3800569|NCT01814137|3627814|B2|||Age||years|Mean|56.9|56.9|Standard Deviation|8.1|8.1|||
3800570|NCT01814137|3627815|B1|||Age||years|Mean|58.0|58.0|Standard Deviation|8.0|8.0|||
3800571|NCT01814046|3627830|B3|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3800572|NCT01814046|3627831|B2|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3800573|NCT01814046|3627832|B1|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3800574|NCT01814046|3627830|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800575|NCT01814046|3627831|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800576|NCT01814046|3627832|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800577|NCT01814046|3627830|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800578|NCT01814046|3627831|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800579|NCT01814046|3627832|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800580|NCT01814046|3627830|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3800581|NCT01814046|3627831|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3800582|NCT01814046|3627832|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3800583|NCT01814046|3627830|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800584|NCT01814046|3627831|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800585|NCT01814046|3627832|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800586|NCT01814046|3627830|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800587|NCT01814046|3627831|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800588|NCT01814046|3627832|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800589|NCT01814046|3627830|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800590|NCT01814046|3627831|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800591|NCT01814046|3627832|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800592|NCT01814046|3627830|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800593|NCT01814046|3627831|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800594|NCT01814046|3627832|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800595|NCT01814046|3627830|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800596|NCT01814046|3627831|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800597|NCT01814046|3627832|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800598|NCT01814046|3627830|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3800599|NCT01814046|3627831|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3800600|NCT01814046|3627832|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3800601|NCT01814046|3627830|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800602|NCT01814046|3627831|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800603|NCT01814046|3627832|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800604|NCT01814046|3627830|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3800605|NCT01814046|3627831|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3800606|NCT01814046|3627832|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3800607|NCT01814046|3627830|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3800608|NCT01814046|3627831|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3800609|NCT01814046|3627832|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3800610|NCT01814046|3627830|B3|||Age||years|Mean|57.85|57.85|Standard Deviation|6.3|6.3|||
3800611|NCT01814046|3627831|B2|||Age||years|Mean|64|64.0|Standard Deviation|4.2|4.2|||
3800612|NCT01814046|3627832|B1|||Age||years|Mean|51.7|51.7|Standard Deviation|8.4|8.4|||
3800613|NCT01814046|3627830|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3800614|NCT01814046|3627831|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3800615|NCT01814046|3627832|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3800616|NCT01814046|3627830|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3800617|NCT01814046|3627831|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3800618|NCT01814046|3627832|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3800619|NCT01814046|3627830|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3800620|NCT01814046|3627831|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3800621|NCT01814046|3627832|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3800622|NCT01813890|3627845|B4|Greater than or equal (>=) to 65 years||Age Customized||participants|Number|4|4.0||||||
3800623|NCT01813890|3627846|B3|Greater than or equal (>=) to 65 years||Age Customized||participants|Number|1|1.0||||||
3800624|NCT01813890|3627847|B2|Greater than or equal (>=) to 65 years||Age Customized||participants|Number|1|1.0||||||
3800625|NCT01813890|3627848|B1|Greater than or equal (>=) to 65 years||Age Customized||participants|Number|2|2.0||||||
3800626|NCT01813890|3627845|B4|Less than (<) 65 years||Age Customized||participants|Number|56|56.0||||||
3800627|NCT01813890|3627846|B3|Less than (<) 65 years||Age Customized||participants|Number|18|18.0||||||
3800628|NCT01813890|3627847|B2|Less than (<) 65 years||Age Customized||participants|Number|20|20.0||||||
3800629|NCT01813890|3627848|B1|Less than (<) 65 years||Age Customized||participants|Number|18|18.0||||||
3800630|NCT01813890|3627845|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3800631|NCT01813890|3627846|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3800632|NCT01813890|3627847|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3800633|NCT01813890|3627848|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3800634|NCT01813890|3627845|B4||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3800635|NCT01813890|3627846|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3800636|NCT01813890|3627847|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3800637|NCT01813890|3627848|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3800638|NCT01813890|3627845|B4|||Age||years|Mean|43.3|43.3|Standard Deviation|13.59|13.59|||
3800639|NCT01813890|3627846|B3|||Age||years|Mean|43.3|43.3|Standard Deviation|11.81|11.81|||
3800640|NCT01813890|3627847|B2|||Age||years|Mean|42.3|42.3|Standard Deviation|14.27|14.27|||
3800641|NCT01813890|3627848|B1|||Age||years|Mean|44.4|44.4|Standard Deviation|14.98|14.98|||
3800642|NCT01813721|3627879|B1|≤ 10 years||Number of years in oncology/hematology clinical practice||investigators|Number|48|48.0||||||
3800643|NCT01813721|3627879|B1|> 10 years||Number of years in oncology/hematology clinical practice||investigators|Number|117|117.0||||||
3800644|NCT01813721|3627879|B1|Gynecological Surgeon||Investigator Specialty|Data provided for the Primary analysis Set-Investigators, consisting of the 165 investigators who contributed participants to the primary analysis set.|investigators|Number|2|2.0||||||
3800645|NCT01813721|3627879|B1|Medical Gynecologist||Investigator Specialty|Data provided for the Primary analysis Set-Investigators, consisting of the 165 investigators who contributed participants to the primary analysis set.|investigators|Number|4|4.0||||||
3800646|NCT01813721|3627879|B1|Radiation Oncologist||Investigator Specialty|Data provided for the Primary analysis Set-Investigators, consisting of the 165 investigators who contributed participants to the primary analysis set.|investigators|Number|8|8.0||||||
3800647|NCT01813721|3627879|B1|Pulmonologist||Investigator Specialty|Data provided for the Primary analysis Set-Investigators, consisting of the 165 investigators who contributed participants to the primary analysis set.|investigators|Number|10|10.0||||||
3800648|NCT01813721|3627879|B1|Hematologist||Investigator Specialty|Data provided for the Primary analysis Set-Investigators, consisting of the 165 investigators who contributed participants to the primary analysis set.|investigators|Number|31|31.0||||||
3800649|NCT01813721|3627879|B1|Medical Oncologist||Investigator Specialty|Data provided for the Primary analysis Set-Investigators, consisting of the 165 investigators who contributed participants to the primary analysis set.|investigators|Number|110|110.0||||||
3800650|NCT01813721|3627879|B1|Small-cell lung cancer (SCLC)||Tumor Type||participants|Number|119|119.0||||||
3800651|NCT01813721|3627879|B1|Non-Hodgkin’s lymphoma (NHL)||Tumor Type||participants|Number|182|182.0||||||
3800652|NCT01813721|3627879|B1|Non-small cell lung cancer (NSCLC)||Tumor Type||participants|Number|248|248.0||||||
3800653|NCT01813721|3627879|B1|Breast cancer||Tumor Type||participants|Number|395|395.0||||||
3800654|NCT01813721|3627879|B1||Male|Sex: Female, Male||Participants|Count of Participants|390|390.0||||||
3800655|NCT01813721|3627879|B1||Female|Sex: Female, Male||Participants|Count of Participants|554|554.0||||||
3800656|NCT01813721|3627879|B1|||Age||years|Mean|59.8|59.8|Standard Deviation|11.4|11.4|||
3800657|NCT01813474|3627931|B4||Other|Primary tumour location||Participants|Count of Participants|2|2.0||||||
3800658|NCT01813474|3627932|B3||Other|Primary tumour location||Participants|Count of Participants|1|1.0||||||
3800659|NCT01813474|3627933|B2||Other|Primary tumour location||Participants|Count of Participants|1|1.0||||||
3800660|NCT01813474|3627934|B1||Other|Primary tumour location||Participants|Count of Participants|0|0.0||||||
3800661|NCT01813474|3627931|B4||Gastric Antrum|Primary tumour location||Participants|Count of Participants|1|1.0||||||
3800662|NCT01813474|3627932|B3||Gastric Antrum|Primary tumour location||Participants|Count of Participants|1|1.0||||||
3800663|NCT01813474|3627933|B2||Gastric Antrum|Primary tumour location||Participants|Count of Participants|0|0.0||||||
3800664|NCT01813474|3627934|B1||Gastric Antrum|Primary tumour location||Participants|Count of Participants|0|0.0||||||
3800665|NCT01813474|3627931|B4||Colon|Primary tumour location||Participants|Count of Participants|1|1.0||||||
3800666|NCT01813474|3627932|B3||Colon|Primary tumour location||Participants|Count of Participants|1|1.0||||||
3800667|NCT01813474|3627933|B2||Colon|Primary tumour location||Participants|Count of Participants|0|0.0||||||
3800668|NCT01813474|3627934|B1||Colon|Primary tumour location||Participants|Count of Participants|0|0.0||||||
3800669|NCT01813474|3627931|B4||Cervix|Primary tumour location||Participants|Count of Participants|2|2.0||||||
3800670|NCT01813474|3627932|B3||Cervix|Primary tumour location||Participants|Count of Participants|0|0.0||||||
3800671|NCT01813474|3627933|B2||Cervix|Primary tumour location||Participants|Count of Participants|0|0.0||||||
3800672|NCT01813474|3627934|B1||Cervix|Primary tumour location||Participants|Count of Participants|2|2.0||||||
3800673|NCT01813474|3627931|B4||Uterus|Primary tumour location||Participants|Count of Participants|2|2.0||||||
3800674|NCT01813474|3627932|B3||Uterus|Primary tumour location||Participants|Count of Participants|0|0.0||||||
3800675|NCT01813474|3627933|B2||Uterus|Primary tumour location||Participants|Count of Participants|1|1.0||||||
3800676|NCT01813474|3627934|B1||Uterus|Primary tumour location||Participants|Count of Participants|1|1.0||||||
3800677|NCT01813474|3627931|B4||Ovary|Primary tumour location||Participants|Count of Participants|4|4.0||||||
3800678|NCT01813474|3627932|B3||Ovary|Primary tumour location||Participants|Count of Participants|2|2.0||||||
3800679|NCT01813474|3627933|B2||Ovary|Primary tumour location||Participants|Count of Participants|2|2.0||||||
3800680|NCT01813474|3627934|B1||Ovary|Primary tumour location||Participants|Count of Participants|0|0.0||||||
3800681|NCT01813474|3627931|B4||Pancreas|Primary tumour location||Participants|Count of Participants|1|1.0||||||
3800682|NCT01813474|3627932|B3||Pancreas|Primary tumour location||Participants|Count of Participants|0|0.0||||||
3800683|NCT01813474|3627933|B2||Pancreas|Primary tumour location||Participants|Count of Participants|1|1.0||||||
3800684|NCT01813474|3627934|B1||Pancreas|Primary tumour location||Participants|Count of Participants|0|0.0||||||
3800685|NCT01813474|3627931|B4||Peritoneum|Primary tumour location||Participants|Count of Participants|1|1.0||||||
3800686|NCT01813474|3627932|B3||Peritoneum|Primary tumour location||Participants|Count of Participants|1|1.0||||||
3800687|NCT01813474|3627933|B2||Peritoneum|Primary tumour location||Participants|Count of Participants|0|0.0||||||
3800688|NCT01813474|3627934|B1||Peritoneum|Primary tumour location||Participants|Count of Participants|0|0.0||||||
3800689|NCT01813474|3627931|B4||Lung|Primary tumour location||Participants|Count of Participants|3|3.0||||||
3800690|NCT01813474|3627932|B3||Lung|Primary tumour location||Participants|Count of Participants|2|2.0||||||
3800691|NCT01813474|3627933|B2||Lung|Primary tumour location||Participants|Count of Participants|1|1.0||||||
3800692|NCT01813474|3627934|B1||Lung|Primary tumour location||Participants|Count of Participants|0|0.0||||||
3800693|NCT01813474|3627931|B4||Colorectal|Primary tumour location||Participants|Count of Participants|1|1.0||||||
3800694|NCT01813474|3627932|B3||Colorectal|Primary tumour location||Participants|Count of Participants|1|1.0||||||
3800695|NCT01813474|3627933|B2||Colorectal|Primary tumour location||Participants|Count of Participants|0|0.0||||||
3800696|NCT01813474|3627934|B1||Colorectal|Primary tumour location||Participants|Count of Participants|0|0.0||||||
3800697|NCT01813474|3627931|B4||Breast|Primary tumour location||Participants|Count of Participants|5|5.0||||||
3800698|NCT01813474|3627932|B3||Breast|Primary tumour location||Participants|Count of Participants|3|3.0||||||
3800699|NCT01813474|3627933|B2||Breast|Primary tumour location||Participants|Count of Participants|1|1.0||||||
3800700|NCT01813474|3627934|B1||Breast|Primary tumour location||Participants|Count of Participants|1|1.0||||||
3800701|NCT01813474|3627931|B4|Sex|Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3800702|NCT01813474|3627932|B3|Sex|Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3800703|NCT01813474|3627933|B2|Sex|Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3800704|NCT01813474|3627934|B1|Sex|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3800705|NCT01813474|3627931|B4|Sex|Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3800706|NCT01813474|3627932|B3|Sex|Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3800707|NCT01813474|3627933|B2|Sex|Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3800708|NCT01813474|3627934|B1|Sex|Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3800709|NCT01813474|3627931|B4|||Age||Years|Mean|54.1|54.1|Standard Deviation|11.94|11.94|||
3800710|NCT01813474|3627932|B3|||Age||Years|Mean|57.3|57.3|Standard Deviation|12.43|12.43|||
3800711|NCT01813474|3627933|B2|||Age||Years|Mean|55.4|55.4|Standard Deviation|8.98|8.98|||
3800712|NCT01813474|3627934|B1|||Age||Years|Mean|42.0|42.0|Standard Deviation|8.68|8.68|||
3800713|NCT01813422|3627958|B3|Asia Pacific||Stratification Factor: Geographical Region||participants|Number|101|101.0||||||
3800714|NCT01813422|3627959|B2|Asia Pacific||Stratification Factor: Geographical Region||participants|Number|51|51.0||||||
3800715|NCT01813422|3627960|B1|Asia Pacific||Stratification Factor: Geographical Region||participants|Number|50|50.0||||||
3800716|NCT01813422|3627958|B3|Latin America||Stratification Factor: Geographical Region||participants|Number|31|31.0||||||
3800717|NCT01813422|3627959|B2|Latin America||Stratification Factor: Geographical Region||participants|Number|15|15.0||||||
3800718|NCT01813422|3627960|B1|Latin America||Stratification Factor: Geographical Region||participants|Number|16|16.0||||||
3800719|NCT01813422|3627958|B3|Europe||Stratification Factor: Geographical Region||participants|Number|664|664.0||||||
3800720|NCT01813422|3627959|B2|Europe||Stratification Factor: Geographical Region||participants|Number|332|332.0||||||
3800721|NCT01813422|3627960|B1|Europe||Stratification Factor: Geographical Region||participants|Number|332|332.0||||||
3800722|NCT01813422|3627958|B3|North America||Stratification Factor: Geographical Region||participants|Number|174|174.0||||||
3800723|NCT01813422|3627959|B2|North America||Stratification Factor: Geographical Region||participants|Number|86|86.0||||||
3800724|NCT01813422|3627960|B1|North America||Stratification Factor: Geographical Region||participants|Number|88|88.0||||||
3800725|NCT01813422|3627958|B3|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3800726|NCT01813422|3627959|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3800727|NCT01813422|3627960|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3800728|NCT01813422|3627958|B3|Multiple||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3800729|NCT01813422|3627959|B2|Multiple||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3800730|NCT01813422|3627960|B1|Multiple||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3800731|NCT01813422|3627958|B3|White||Race/Ethnicity, Customized||participants|Number|909|909.0||||||
3800732|NCT01813422|3627959|B2|White||Race/Ethnicity, Customized||participants|Number|456|456.0||||||
3800733|NCT01813422|3627960|B1|White||Race/Ethnicity, Customized||participants|Number|453|453.0||||||
3800734|NCT01813422|3627958|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3800735|NCT01813422|3627959|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3800736|NCT01813422|3627960|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3800737|NCT01813422|3627958|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3800738|NCT01813422|3627959|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3800739|NCT01813422|3627960|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3800740|NCT01813422|3627958|B3|Asian||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3800741|NCT01813422|3627959|B2|Asian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3800742|NCT01813422|3627960|B1|Asian||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3800743|NCT01813422|3627958|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3800744|NCT01813422|3627959|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3800745|NCT01813422|3627960|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3800746|NCT01813422|3627958|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800747|NCT01813422|3627959|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800748|NCT01813422|3627960|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3800749|NCT01813422|3627958|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|912|912.0||||||
3800750|NCT01813422|3627959|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|450|450.0||||||
3800751|NCT01813422|3627960|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|462|462.0||||||
3800752|NCT01813422|3627958|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3800753|NCT01813422|3627959|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3800754|NCT01813422|3627960|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3800755|NCT01813422|3627958|B3||Male|Sex: Female, Male||Participants|Count of Participants|700|700.0||||||
3800756|NCT01813422|3627959|B2||Male|Sex: Female, Male||Participants|Count of Participants|349|349.0||||||
3800757|NCT01813422|3627960|B1||Male|Sex: Female, Male||Participants|Count of Participants|351|351.0||||||
3800758|NCT01813422|3627958|B3||Female|Sex: Female, Male||Participants|Count of Participants|270|270.0||||||
3800759|NCT01813422|3627959|B2||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3800760|NCT01813422|3627960|B1||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3800761|NCT01813422|3627958|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|9.2|9.2|||
3800762|NCT01813422|3627959|B2|||Age||years|Mean|59.8|59.8|Standard Deviation|9.6|9.6|||
3800763|NCT01813422|3627960|B1|||Age||years|Mean|59.8|59.8|Standard Deviation|8.8|8.8|||
3800764|NCT01813214|3627973|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3800765|NCT01813214|3627974|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3800766|NCT01813214|3627975|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3800767|NCT01813214|3627973|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3800768|NCT01813214|3627974|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3800769|NCT01813214|3627975|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3800770|NCT01813214|3627973|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3800771|NCT01813214|3627974|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3800772|NCT01813214|3627975|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3800773|NCT01813214|3627973|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3800774|NCT01813214|3627974|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3800775|NCT01813214|3627975|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3800776|NCT01813214|3627973|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3800777|NCT01813214|3627974|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3800778|NCT01813214|3627975|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3800779|NCT01813214|3627973|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3800780|NCT01813214|3627974|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3800781|NCT01813214|3627975|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3800782|NCT01813110|3627986|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3800783|NCT01813110|3627986|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3800784|NCT01813110|3627986|B1|||Age||years|Mean|27|27.0|Standard Deviation|1|1.0|||
3800785|NCT01813019|3627997|B3||Male|Gender||Participants|Count of Participants|24|24.0||||||
3800786|NCT01813019|3627998|B2||Male|Gender||Participants|Count of Participants|13|13.0||||||
3800787|NCT01813019|3627999|B1||Male|Gender||Participants|Count of Participants|11|11.0||||||
3800788|NCT01813019|3627997|B3||Female|Gender||Participants|Count of Participants|26|26.0||||||
3800789|NCT01813019|3627998|B2||Female|Gender||Participants|Count of Participants|13|13.0||||||
3800790|NCT01813019|3627999|B1||Female|Gender||Participants|Count of Participants|13|13.0||||||
3800791|NCT01813019|3627997|B3|||Age||years|Mean|40.6|40.6|Standard Deviation|11.74|11.74|||
3800792|NCT01813019|3627998|B2|||Age||years|Mean|41.3|41.3|Standard Deviation|13.27|13.27|||
3800793|NCT01813019|3627999|B1|||Age||years|Mean|39.9|39.9|Standard Deviation|10.06|10.06|||
3800794|NCT01812837|3628008|B4|United States||Region of Enrollment||participants|Number|51|51.0||||||
3800795|NCT01812837|3628009|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
3800796|NCT01812837|3628010|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3800797|NCT01812837|3628011|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3800798|NCT01812837|3628008|B4||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3800799|NCT01812837|3628009|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3800800|NCT01812837|3628010|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3800801|NCT01812837|3628011|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3800802|NCT01812837|3628008|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3800803|NCT01812837|3628009|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3800804|NCT01812837|3628010|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3800805|NCT01812837|3628011|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3800806|NCT01812837|3628008|B4|||Age||years|Mean|67.7|67.7|Standard Deviation|9.0|9.0|||
3800807|NCT01812837|3628009|B3|||Age||years|Mean|66.2|66.2|Standard Deviation|10.3|10.3|||
3800808|NCT01812837|3628010|B2|||Age||years|Mean|66.9|66.9|Standard Deviation|9.8|9.8|||
3800809|NCT01812837|3628011|B1|||Age||years|Mean|70.1|70.1|Standard Deviation|6.4|6.4|||
3800810|NCT01812837|3628008|B4||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
3800811|NCT01812837|3628009|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3800812|NCT01812837|3628010|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3800813|NCT01812837|3628011|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3800814|NCT01812837|3628008|B4||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3800815|NCT01812837|3628009|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3800816|NCT01812837|3628010|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3800817|NCT01812837|3628011|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3800818|NCT01812837|3628008|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3800819|NCT01812837|3628009|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3800820|NCT01812837|3628010|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3800821|NCT01812837|3628011|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3800822|NCT01812707|3628021|B5|||LDL-C in mg/dL||mg/dL|Mean|121.2|121.2|Standard Deviation|17.5|17.5|||
3800823|NCT01812707|3628022|B4|||LDL-C in mg/dL||mg/dL|Mean|120.5|120.5|Standard Deviation|16.2|16.2|||
3800824|NCT01812707|3628023|B3|||LDL-C in mg/dL||mg/dL|Mean|120.9|120.9|Standard Deviation|16.7|16.7|||
3800825|NCT01812707|3628024|B2|||LDL-C in mg/dL||mg/dL|Mean|122.2|122.2|Standard Deviation|16.6|16.6|||
3800826|NCT01812707|3628025|B1|||LDL-C in mg/dL||mg/dL|Mean|121.0|121.0|Standard Deviation|21.1|21.1|||
3800827|NCT01812707|3628021|B5|||Low-Density Lipoprotein Cholesterol (LDL-C) in mmol/L||mmol/L|Mean|3.14|3.14|Standard Deviation|0.45|0.45|||
3800828|NCT01812707|3628022|B4|||Low-Density Lipoprotein Cholesterol (LDL-C) in mmol/L||mmol/L|Mean|3.12|3.12|Standard Deviation|0.42|0.42|||
3800829|NCT01812707|3628023|B3|||Low-Density Lipoprotein Cholesterol (LDL-C) in mmol/L||mmol/L|Mean|3.13|3.13|Standard Deviation|0.43|0.43|||
3800830|NCT01812707|3628024|B2|||Low-Density Lipoprotein Cholesterol (LDL-C) in mmol/L||mmol/L|Mean|3.16|3.16|Standard Deviation|0.43|0.43|||
3800831|NCT01812707|3628025|B1|||Low-Density Lipoprotein Cholesterol (LDL-C) in mmol/L||mmol/L|Mean|3.13|3.13|Standard Deviation|0.55|0.55|||
3800832|NCT01812707|3628021|B5||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3800833|NCT01812707|3628022|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3800834|NCT01812707|3628023|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3800835|NCT01812707|3628024|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3800836|NCT01812707|3628025|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3800837|NCT01812707|3628021|B5||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3800838|NCT01812707|3628022|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3800839|NCT01812707|3628023|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3800840|NCT01812707|3628024|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3800841|NCT01812707|3628025|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3800842|NCT01812707|3628021|B5|||Age||years|Mean|57.7|57.7|Standard Deviation|10.6|10.6|||
3800843|NCT01812707|3628022|B4|||Age||years|Mean|58.2|58.2|Standard Deviation|8.8|8.8|||
3800844|NCT01812707|3628023|B3|||Age||years|Mean|56.3|56.3|Standard Deviation|12.0|12.0|||
3800845|NCT01812707|3628024|B2|||Age||years|Mean|57.8|57.8|Standard Deviation|12.3|12.3|||
3800846|NCT01812707|3628025|B1|||Age||years|Mean|58.6|58.6|Standard Deviation|9.2|9.2|||
3800847|NCT01812681|3628062|B3|Turkey||Region of Enrollment||participants|Number|81|81.0||||||
3800848|NCT01812681|3628063|B2|Turkey||Region of Enrollment||participants|Number|24|24.0||||||
3800849|NCT01812681|3628064|B1|Turkey||Region of Enrollment||participants|Number|57|57.0||||||
3800850|NCT01812681|3628062|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3800851|NCT01812681|3628063|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3800852|NCT01812681|3628064|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3800853|NCT01812681|3628062|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3800854|NCT01812681|3628063|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3800855|NCT01812681|3628064|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3800856|NCT01812681|3628062|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3800857|NCT01812681|3628063|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3800858|NCT01812681|3628064|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3800859|NCT01812681|3628062|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3800860|NCT01812681|3628063|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3800861|NCT01812681|3628064|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3800862|NCT01812681|3628062|B3||<=18 years|Age||Participants|Count of Participants|81|81.0||||||
3800863|NCT01812681|3628063|B2||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
3800864|NCT01812681|3628064|B1||<=18 years|Age||Participants|Count of Participants|57|57.0||||||
3800865|NCT01812681|3628062|B3|||Age||weeks|Mean|28.3|28.3|Standard Deviation|3.6|3.6|||
3800866|NCT01812681|3628063|B2|||Age||weeks|Mean|29.2|29.2|Standard Deviation|1.8|1.8|||
3800867|NCT01812681|3628064|B1|||Age||weeks|Mean|27.9|27.9|Standard Deviation|2.4|2.4|||
3800868|NCT01812655|3628073|B4|||Pre-Procedure Pain|Participants rated pre-procedure pain on the Adolescent Pediatric Pain Tool word graphic rating scale with no pain and worst possible pain as anchors on the 0-100mm scale.|Score on a scale|Mean|22.8|22.8|Standard Deviation|26.6|26.6|||
3800869|NCT01812655|3628074|B3|||Pre-Procedure Pain|Participants rated pre-procedure pain on the Adolescent Pediatric Pain Tool word graphic rating scale with no pain and worst possible pain as anchors on the 0-100mm scale.|Score on a scale|Mean|22.9|22.9|Standard Deviation|26.0|26.0|||
3800870|NCT01812655|3628075|B2|||Pre-Procedure Pain|Participants rated pre-procedure pain on the Adolescent Pediatric Pain Tool word graphic rating scale with no pain and worst possible pain as anchors on the 0-100mm scale.|Score on a scale|Mean|8.7|8.7|Standard Deviation|14.5|14.5|||
3800871|NCT01812655|3628076|B1|||Pre-Procedure Pain|Participants rated pre-procedure pain on the Adolescent Pediatric Pain Tool word graphic rating scale with no pain and worst possible pain as anchors on the 0-100mm scale.|Score on a scale|Mean|40.1|40.1|Standard Deviation|30.9|30.9|||
3800872|NCT01812655|3628073|B4|||STAIC - Trait Anxiety|Participants self-rated 20 statements on a three-point rating scale that best described how the person usually feels. Total scores on the scale range from 20-60.|Scores on a scale|Mean|34.0|34.0|Standard Deviation|6.5|6.5|||
3800873|NCT01812655|3628074|B3|||STAIC - Trait Anxiety|Participants self-rated 20 statements on a three-point rating scale that best described how the person usually feels. Total scores on the scale range from 20-60.|Scores on a scale|Mean|34.1|34.1|Standard Deviation|7.1|7.1|||
3800874|NCT01812655|3628075|B2|||STAIC - Trait Anxiety|Participants self-rated 20 statements on a three-point rating scale that best described how the person usually feels. Total scores on the scale range from 20-60.|Scores on a scale|Mean|33.5|33.5|Standard Deviation|7.5|7.5|||
3800875|NCT01812655|3628076|B1|||STAIC - Trait Anxiety|Participants self-rated 20 statements on a three-point rating scale that best described how the person usually feels. Total scores on the scale range from 20-60.|Scores on a scale|Mean|34.6|34.6|Standard Deviation|5.0|5.0|||
3800876|NCT01812655|3628073|B4|||STAIC - State Anxiety|Participants self-rated 20 statements about how the individual feels at the present moment with responses provided on a three-point rating scale. Total scores on the scale range from 20-60.|Scores on a scale|Mean|31.5|31.5|Standard Deviation|8.7|8.7|||
3800877|NCT01812655|3628074|B3|||STAIC - State Anxiety|Participants self-rated 20 statements about how the individual feels at the present moment with responses provided on a three-point rating scale. Total scores on the scale range from 20-60.|Scores on a scale|Mean|33.6|33.6|Standard Deviation|10.6|10.6|||
3800878|NCT01812655|3628075|B2|||STAIC - State Anxiety|Participants self-rated 20 statements about how the individual feels at the present moment with responses provided on a three-point rating scale. Total scores on the scale range from 20-60.|Scores on a scale|Mean|27.0|27.0|Standard Deviation|4.0|4.0|||
3800879|NCT01812655|3628076|B1|||STAIC - State Anxiety|Participants self-rated 20 statements about how the individual feels at the present moment with responses provided on a three-point rating scale. Total scores on the scale range from 20-60.|Scores on a scale|Mean|34.4|34.4|Standard Deviation|9.1|9.1|||
3800880|NCT01812655|3628073|B4|United States||Region of Enrollment||participants|Number|30|30.0||||||
3800881|NCT01812655|3628074|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3800882|NCT01812655|3628075|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3800883|NCT01812655|3628076|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3800884|NCT01812655|3628073|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3800885|NCT01812655|3628074|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3800886|NCT01812655|3628075|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3800887|NCT01812655|3628076|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3800888|NCT01812655|3628073|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3800889|NCT01812655|3628074|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3800890|NCT01812655|3628075|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3800891|NCT01812655|3628076|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3800892|NCT01812655|3628073|B4|||Age||years|Mean|13.5|13.5|Standard Deviation|2.3|2.3|||
3800893|NCT01812655|3628074|B3|||Age||years|Mean|13.9|13.9|Standard Deviation|2.8|2.8|||
3800894|NCT01812655|3628075|B2|||Age||years|Mean|12.6|12.6|Standard Deviation|2.1|2.1|||
3800895|NCT01812655|3628076|B1|||Age||years|Mean|14.3|14.3|Standard Deviation|2.0|2.0|||
3800896|NCT01812655|3628073|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3800897|NCT01812655|3628074|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3800898|NCT01812655|3628075|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3800899|NCT01812655|3628076|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3800900|NCT01812655|3628073|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3800901|NCT01812655|3628074|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3800902|NCT01812655|3628075|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3800903|NCT01812655|3628076|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3800904|NCT01812655|3628073|B4||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
3800905|NCT01812655|3628074|B3||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
3800906|NCT01812655|3628075|B2||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
3800907|NCT01812655|3628076|B1||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
3800908|NCT01812473|3628092|B3|||Number of coadministered drugs bound to proteins for more then 70%||number of coadministered drugs|Mean|3|3.0|Inter-Quartile Range|||2.0|5.0|
3800909|NCT01812473|3628093|B2|||Number of coadministered drugs bound to proteins for more then 70%||number of coadministered drugs|Mean|2.5|2.5|Inter-Quartile Range|||2.0|3.0|
3800910|NCT01812473|3628094|B1|||Number of coadministered drugs bound to proteins for more then 70%||number of coadministered drugs|Mean|4.5|4.5|Inter-Quartile Range|||1.0|6.0|
3800911|NCT01812473|3628092|B3|||Bound voriconazole plasma concentration||milligram / liter|Median|1.62|1.62|Inter-Quartile Range|||0.87|5.07|
3800912|NCT01812473|3628093|B2|||Bound voriconazole plasma concentration||milligram / liter|Median|1.52|1.52|Inter-Quartile Range|||1.07|2.57|
3800913|NCT01812473|3628094|B1|||Bound voriconazole plasma concentration||milligram / liter|Median|1.63|1.63|Inter-Quartile Range|||0.85|5.35|
3800914|NCT01812473|3628092|B3|||Unbound voriconazole plasma concentration||milligram/liter|Median|0.85|0.85|Inter-Quartile Range|||0.46|2.55|
3800915|NCT01812473|3628093|B2|||Unbound voriconazole plasma concentration||milligram/liter|Median|0.71|0.71|Inter-Quartile Range|||0.51|1.46|
3800916|NCT01812473|3628094|B1|||Unbound voriconazole plasma concentration||milligram/liter|Median|0.86|0.86|Inter-Quartile Range|||0.45|2.66|
3800917|NCT01812473|3628092|B3|||Total voriconazole plasma concentration||milligram/liter|Median|2.9|2.9|Inter-Quartile Range|||1.5|9.0|
3800918|NCT01812473|3628093|B2|||Total voriconazole plasma concentration||milligram/liter|Median|2.4|2.4|Inter-Quartile Range|||1.5|4.5|
3800919|NCT01812473|3628094|B1|||Total voriconazole plasma concentration||milligram/liter|Median|NA||Inter-Quartile Range|||0.0|0.0|Plasma was spiked with 1.5, 2.9 and 9 milligram/liter voriconazole
3800920|NCT01812473|3628092|B3|||Voriconazole daily dose||milligram/kilogram/day|Median|NA||Inter-Quartile Range|||0.0|0.0|In study A: Plasma from ICU patients was spiked with 1.5, 2.9 and 9 milligram/liter of voriconazole.
3800921|NCT01812473|3628093|B2|||Voriconazole daily dose||milligram/kilogram/day|Median|8|8.0|Inter-Quartile Range|||7.5|8.3|
3800922|NCT01812473|3628094|B1|||Voriconazole daily dose||milligram/kilogram/day|Median|NA||Inter-Quartile Range|||0.0|0.0|Plasma from ICU patients was spiked with 1.5, 2.9 and 9 milligram/liter of voriconazole.
3800923|NCT01812473|3628092|B3|||C reactive protein plasma concentration||milligram/liter|Median|71.5|71.5|Inter-Quartile Range|||30.8|92.5|
3800924|NCT01812473|3628093|B2|||C reactive protein plasma concentration||milligram/liter|Median|47.2|47.2|Inter-Quartile Range|||21.6|116.9|
3800925|NCT01812473|3628094|B1|||C reactive protein plasma concentration||milligram/liter|Median|72.1|72.1|Inter-Quartile Range|||48.2|89.6|
3800926|NCT01812473|3628092|B3|||estimated Glomerular Filtration Rate (CKD-EPI equation)||ml/min * 1.73m²|Median|74|74.0|Inter-Quartile Range|||40.0|100.0|
3800927|NCT01812473|3628093|B2|||estimated Glomerular Filtration Rate (CKD-EPI equation)||ml/min * 1.73m²|Median|84|84.0|Inter-Quartile Range|||37.5|108.3|
3800928|NCT01812473|3628094|B1|||estimated Glomerular Filtration Rate (CKD-EPI equation)||ml/min * 1.73m²|Median|66|66.0|Inter-Quartile Range|||40.0|93.0|
3800929|NCT01812473|3628092|B3|||Creatinin plasma concentration||milligram/deciliter|Median|1.13|1.13|Inter-Quartile Range|||0.67|1.81|
3800930|NCT01812473|3628093|B2|||Creatinin plasma concentration||milligram/deciliter|Median|0.95|0.95|Inter-Quartile Range|||0.52|1.57|
3800931|NCT01812473|3628094|B1|||Creatinin plasma concentration||milligram/deciliter|Median|1.14|1.14|Inter-Quartile Range|||0.67|1.99|
3800932|NCT01812473|3628092|B3|||Blood Urea Nitrogen||milligram/deciliter|Median|57.5|57.5|Inter-Quartile Range|||37.0|132.5|
3800933|NCT01812473|3628093|B2|||Blood Urea Nitrogen||milligram/deciliter|Median|70|70.0|Inter-Quartile Range|||44.8|112.5|
3800934|NCT01812473|3628094|B1|||Blood Urea Nitrogen||milligram/deciliter|Median|54.5|54.5|Inter-Quartile Range|||37.0|146.0|
3800935|NCT01812473|3628092|B3|||Total plasma bilirubin concentration||milligram/liter|Median|0.67|0.67|Inter-Quartile Range|||0.42|1.8|
3800936|NCT01812473|3628093|B2|||Total plasma bilirubin concentration||milligram/liter|Median|0.41|0.41|Inter-Quartile Range|||0.28|1.69|
3800979|NCT01812057|3628103|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3800937|NCT01812473|3628094|B1|||Total plasma bilirubin concentration||milligram/liter|Median|0.75|0.75|Inter-Quartile Range|||0.42|1.93|
3800938|NCT01812473|3628092|B3|||Total plasma protein concentration||gram/liter|Mean|54.2|54.2|Standard Deviation|11.5|11.5|||
3800939|NCT01812473|3628093|B2|||Total plasma protein concentration||gram/liter|Mean|56.6|56.6|Standard Deviation|7.3|7.3|||
3800940|NCT01812473|3628094|B1|||Total plasma protein concentration||gram/liter|Mean|53.4|53.4|Standard Deviation|12.4|12.4|||
3800941|NCT01812473|3628092|B3|||alfa-1-acid glycoprotein plasma concentration||gram/liter|Median|1.5|1.5|Full Range|||0.0|3.0|
3800942|NCT01812473|3628093|B2|||alfa-1-acid glycoprotein plasma concentration||gram/liter|Median|1.8|1.8|Full Range|||1.1|3.0|
3800943|NCT01812473|3628094|B1|||alfa-1-acid glycoprotein plasma concentration||gram/liter|Median|1.4|1.4|Full Range|||0.0|2.4|
3800944|NCT01812473|3628092|B3|||Albumin plasma concentration||gram/liter|Median|26.7|26.7|Full Range|||13.8|38.7|
3800945|NCT01812473|3628093|B2|||Albumin plasma concentration||gram/liter|Median|31.1|31.1|Full Range|||13.8|38.7|
3800946|NCT01812473|3628094|B1|||Albumin plasma concentration||gram/liter|Median|23.7|23.7|Full Range|||14.4|33.7|
3800947|NCT01812473|3628092|B3|||Acute Physiology and Chronic Health Evaluation (Apache) score|"Calculated as the sum of all parameters described below. Every parameter is scored a value of 0 to +4, 0 being normal +4 being very high or low abnormal. The total apache score ranges from 0 to 71, with higher values being associated with more severe disease and higher mortality risk.~Parameters included:Pa02 (arterial blood oxygen tension), rectal body temperature, Mean arterial pressure, arterial pH, heart rate, respiratory rate, serum sodium, serum potassium, serum creatinine, hematocrit, white blood cell count, glasgow coma scale."|units of the Apache Scoring system|Mean|25.3|25.3|Standard Deviation|8.3|8.3|||
3800948|NCT01812473|3628093|B2|||Acute Physiology and Chronic Health Evaluation (Apache) score|"Calculated as the sum of all parameters described below. Every parameter is scored a value of 0 to +4, 0 being normal +4 being very high or low abnormal. The total apache score ranges from 0 to 71, with higher values being associated with more severe disease and higher mortality risk.~Parameters included:Pa02 (arterial blood oxygen tension), rectal body temperature, Mean arterial pressure, arterial pH, heart rate, respiratory rate, serum sodium, serum potassium, serum creatinine, hematocrit, white blood cell count, glasgow coma scale."|units of the Apache Scoring system|Mean|26.8|26.8|Standard Deviation|6.9|6.9|||
3800949|NCT01812473|3628094|B1|||Acute Physiology and Chronic Health Evaluation (Apache) score|"Calculated as the sum of all parameters described below. Every parameter is scored a value of 0 to +4, 0 being normal +4 being very high or low abnormal. The total apache score ranges from 0 to 71, with higher values being associated with more severe disease and higher mortality risk.~Parameters included:Pa02 (arterial blood oxygen tension), rectal body temperature, Mean arterial pressure, arterial pH, heart rate, respiratory rate, serum sodium, serum potassium, serum creatinine, hematocrit, white blood cell count, glasgow coma scale."|units of the Apache Scoring system|Mean|23.5|23.5|Standard Deviation|10|10.0|||
3800950|NCT01812473|3628092|B3|||Body weight||kilogram|Median|68|68.0|Inter-Quartile Range|||62.0|80.0|
3800951|NCT01812473|3628093|B2|||Body weight||kilogram|Median|68|68.0|Inter-Quartile Range|||61.0|82.5|
3800952|NCT01812473|3628094|B1|||Body weight||kilogram|Median|71|71.0|Inter-Quartile Range|||60.3|80.0|
3800953|NCT01812473|3628092|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3800954|NCT01812473|3628093|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3800955|NCT01812473|3628094|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3800956|NCT01812473|3628092|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3800957|NCT01812473|3628093|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3800958|NCT01812473|3628094|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3800959|NCT01812473|3628092|B3|||Age||years|Median|65|65.0|Inter-Quartile Range|||58.0|73.0|
3800960|NCT01812473|3628093|B2|||Age||years|Median|62|62.0|Inter-Quartile Range|||57.5|71.5|
3800961|NCT01812473|3628094|B1|||Age||years|Median|66|66.0|Inter-Quartile Range|||60.0|74.0|
3800962|NCT01812057|3628101|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
3800963|NCT01812057|3628102|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
3800964|NCT01812057|3628103|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
3800965|NCT01812057|3628101|B3|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3800966|NCT01812057|3628102|B2|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3800967|NCT01812057|3628103|B1|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3800968|NCT01812057|3628101|B3|Race/Ethnicity|Asian/Indian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3800969|NCT01812057|3628102|B2|Race/Ethnicity|Asian/Indian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3800970|NCT01812057|3628103|B1|Race/Ethnicity|Asian/Indian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3800971|NCT01812057|3628101|B3|Race/Ethnicity|Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3800972|NCT01812057|3628102|B2|Race/Ethnicity|Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3800973|NCT01812057|3628103|B1|Race/Ethnicity|Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3800974|NCT01812057|3628101|B3|Race/Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3800975|NCT01812057|3628102|B2|Race/Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3800976|NCT01812057|3628103|B1|Race/Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3800977|NCT01812057|3628101|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3800978|NCT01812057|3628102|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3800980|NCT01812057|3628101|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3800981|NCT01812057|3628102|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3800982|NCT01812057|3628103|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3800983|NCT01812057|3628101|B3|||Age||years|Mean|31.40|31.4|Standard Deviation|5.23|5.23|||
3800984|NCT01812057|3628102|B2|||Age||years|Mean|30.63|30.63|Standard Deviation|5.71|5.71|||
3800985|NCT01812057|3628103|B1|||Age||years|Mean|32.2|32.2|Standard Deviation|4.7|4.7|||
3800986|NCT01812044|3628142|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3800987|NCT01812044|3628143|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3800988|NCT01812044|3628144|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3800989|NCT01812044|3628145|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3800990|NCT01812044|3628142|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3800991|NCT01812044|3628143|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3800992|NCT01812044|3628144|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3800993|NCT01812044|3628145|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3800994|NCT01812044|3628142|B4|||Age||months|Mean|54.9|54.9|Full Range|||13.0|91.0|
3800995|NCT01812044|3628143|B3|||Age||months|Mean|60.9|60.9|Full Range|||27.0|89.0|
3800996|NCT01812044|3628144|B2|||Age||months|Mean|50.1|50.1|Full Range|||19.0|91.0|
3800997|NCT01812044|3628145|B1|||Age||months|Mean|53.6|53.6|Full Range|||13.0|87.0|
3800998|NCT01812005|3628176|B3|United States||Region of Enrollment||patients|Number|14|14.0||||||
3800999|NCT01812005|3628177|B2|United States||Region of Enrollment||patients|Number|13|13.0||||||
3801000|NCT01812005|3628178|B1|United States||Region of Enrollment||patients|Number|1|1.0||||||
3801001|NCT01812005|3628176|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3801002|NCT01812005|3628177|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3801003|NCT01812005|3628178|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3801004|NCT01812005|3628176|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3801005|NCT01812005|3628177|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3801006|NCT01812005|3628178|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3801007|NCT01812005|3628176|B3|||Age||years|Median|67.5|67.5|Full Range|||35.0|77.0|
3801008|NCT01812005|3628177|B2|||Age||years|Median|58|58.0|Full Range|||35.0|73.0|
3801009|NCT01812005|3628178|B1|||Age||years|Median|77|77.0|Full Range|||77.0|77.0|
3801010|NCT01811953|3628201|B7||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3801011|NCT01811953|3628202|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3801012|NCT01811953|3628203|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3801013|NCT01811953|3628204|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3801014|NCT01811953|3628205|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3801015|NCT01811953|3628206|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3801016|NCT01811953|3628207|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3801017|NCT01811953|3628201|B7||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3801018|NCT01811953|3628202|B6||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3801019|NCT01811953|3628203|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3801020|NCT01811953|3628204|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3801021|NCT01811953|3628205|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3801022|NCT01811953|3628206|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3801023|NCT01811953|3628207|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3801024|NCT01811953|3628201|B7|||Age||years|Mean|31.5|31.5|Standard Deviation|8.9|8.9|||
3801025|NCT01811953|3628202|B6|||Age||years|Mean|32.3|32.3|Standard Deviation|9.6|9.6|||
3801026|NCT01811953|3628203|B5|||Age||years|Mean|32.8|32.8|Standard Deviation|9.8|9.8|||
3801027|NCT01811953|3628204|B4|||Age||years|Mean|33.2|33.2|Standard Deviation|7.1|7.1|||
3801028|NCT01811953|3628205|B3|||Age||years|Mean|28.5|28.5|Standard Deviation|9.5|9.5|||
3801029|NCT01811953|3628206|B2|||Age||years|Mean|26.5|26.5|Standard Deviation|9.7|9.7|||
3801030|NCT01811953|3628207|B1|||Age||years|Mean|33.5|33.5|Standard Deviation|6.7|6.7|||
3801031|NCT01811940|3628256|B3|||Currently married||Participants|Count of Participants|20|20.0||||||
3801032|NCT01811940|3628257|B2|||Currently married||Participants|Count of Participants|13|13.0||||||
3801033|NCT01811940|3628258|B1|||Currently married||Participants|Count of Participants|7|7.0||||||
3801034|NCT01811940|3628256|B3||not reported|employment status||Participants|Count of Participants|12|12.0||||||
3801035|NCT01811940|3628257|B2||not reported|employment status||Participants|Count of Participants|2|2.0||||||
3801036|NCT01811940|3628258|B1||not reported|employment status||Participants|Count of Participants|10|10.0||||||
3801037|NCT01811940|3628256|B3||Unemployed/Other|employment status||Participants|Count of Participants|71|71.0||||||
3801038|NCT01811940|3628257|B2||Unemployed/Other|employment status||Participants|Count of Participants|39|39.0||||||
3801039|NCT01811940|3628258|B1||Unemployed/Other|employment status||Participants|Count of Participants|32|32.0||||||
3801040|NCT01811940|3628256|B3||Part-time|employment status||Participants|Count of Participants|13|13.0||||||
3801041|NCT01811940|3628257|B2||Part-time|employment status||Participants|Count of Participants|6|6.0||||||
3801042|NCT01811940|3628258|B1||Part-time|employment status||Participants|Count of Participants|7|7.0||||||
3801043|NCT01811940|3628256|B3||Full-time|employment status||Participants|Count of Participants|31|31.0||||||
3801044|NCT01811940|3628257|B2||Full-time|employment status||Participants|Count of Participants|16|16.0||||||
3801045|NCT01811940|3628258|B1||Full-time|employment status||Participants|Count of Participants|15|15.0||||||
3801046|NCT01811940|3628256|B3||College or graduate school|education||Participants|Count of Participants|21|21.0||||||
3801047|NCT01811940|3628257|B2||College or graduate school|education||Participants|Count of Participants|9|9.0||||||
3801048|NCT01811940|3628258|B1||College or graduate school|education||Participants|Count of Participants|12|12.0||||||
3801049|NCT01811940|3628256|B3||Some College|education||Participants|Count of Participants|27|27.0||||||
3801050|NCT01811940|3628257|B2||Some College|education||Participants|Count of Participants|13|13.0||||||
3801051|NCT01811940|3628258|B1||Some College|education||Participants|Count of Participants|14|14.0||||||
3801052|NCT01811940|3628256|B3||High School or less|education||Participants|Count of Participants|79|79.0||||||
3801053|NCT01811940|3628257|B2||High School or less|education||Participants|Count of Participants|41|41.0||||||
3801054|NCT01811940|3628258|B1||High School or less|education||Participants|Count of Participants|38|38.0||||||
3801055|NCT01811940|3628256|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3801056|NCT01811940|3628257|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3801057|NCT01811940|3628258|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3801058|NCT01811940|3628256|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3801059|NCT01811940|3628257|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3801060|NCT01811940|3628258|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3801061|NCT01811940|3628256|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3801062|NCT01811940|3628257|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3801063|NCT01811940|3628258|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3801064|NCT01811940|3628256|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
3801065|NCT01811940|3628257|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3801066|NCT01811940|3628258|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3801067|NCT01811940|3628256|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801068|NCT01811940|3628257|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801069|NCT01811940|3628258|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801070|NCT01811940|3628256|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801071|NCT01811940|3628257|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801072|NCT01811940|3628258|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801073|NCT01811940|3628256|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801074|NCT01811940|3628257|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801075|NCT01811940|3628258|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801076|NCT01811940|3628256|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801077|NCT01811940|3628257|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801078|NCT01811940|3628258|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801079|NCT01811940|3628256|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
3801080|NCT01811940|3628257|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3801081|NCT01811940|3628258|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3801082|NCT01811940|3628256|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3801083|NCT01811940|3628257|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3801084|NCT01811940|3628258|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3801085|NCT01811940|3628256|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3801086|NCT01811940|3628257|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3801087|NCT01811940|3628258|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3801088|NCT01811940|3628256|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3801089|NCT01811940|3628257|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3801090|NCT01811940|3628258|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3801091|NCT01811940|3628256|B3|||Age||years|Mean|46|46.0|Standard Deviation|8.4|8.4|||
3801092|NCT01811940|3628257|B2|||Age||years|Mean|46.4|46.4|Standard Deviation|8.4|8.4|||
3801093|NCT01811940|3628258|B1|||Age||years|Mean|46.0|46.0|Standard Deviation|8.4|8.4|||
3801094|NCT01811732|3628267|B3|||Presence of Diabetes||Participants|Count of Participants|57|57.0||||||
3801095|NCT01811732|3628268|B2|||Presence of Diabetes||Participants|Count of Participants|27|27.0||||||
3801096|NCT01811732|3628269|B1|||Presence of Diabetes||Participants|Count of Participants|30|30.0||||||
3801097|NCT01811732|3628267|B3|>= 35||BMI ranges||Participants|Count of Participants|95|95.0||||||
3801098|NCT01811732|3628268|B2|>= 35||BMI ranges||Participants|Count of Participants|42|42.0||||||
3801099|NCT01811732|3628269|B1|>= 35||BMI ranges||Participants|Count of Participants|53|53.0||||||
3801100|NCT01811732|3628267|B3|>= 30||BMI ranges||Participants|Count of Participants|214|214.0||||||
3801101|NCT01811732|3628268|B2|>= 30||BMI ranges||Participants|Count of Participants|94|94.0||||||
3801102|NCT01811732|3628269|B1|>= 30||BMI ranges||Participants|Count of Participants|120|120.0||||||
3801103|NCT01811732|3628267|B3|>= 25||BMI ranges||Participants|Count of Participants|422|422.0||||||
3801104|NCT01811732|3628268|B2|>= 25||BMI ranges||Participants|Count of Participants|204|204.0||||||
3801105|NCT01811732|3628269|B1|>= 25||BMI ranges||Participants|Count of Participants|218|218.0||||||
3801106|NCT01811732|3628267|B3|< 25||BMI ranges||Participants|Count of Participants|238|238.0||||||
3801107|NCT01811732|3628268|B2|< 25||BMI ranges||Participants|Count of Participants|125|125.0||||||
3801108|NCT01811732|3628269|B1|< 25||BMI ranges||Participants|Count of Participants|113|113.0||||||
3801109|NCT01811732|3628267|B3|||BMI (Body Mass Index)||kg/m2|Mean|28.11|28.11|Standard Deviation|6.393|6.393|||
3801110|NCT01811732|3628268|B2|||BMI (Body Mass Index)||kg/m2|Mean|27.86|27.86|Standard Deviation|6.363|6.363|||
3801111|NCT01811732|3628269|B1|||BMI (Body Mass Index)||kg/m2|Mean|28.36|28.36|Standard Deviation|6.423|6.423|||
3801112|NCT01811732|3628267|B3|Europe||Region of Enrollment||participants|Number|118|118.0||||||
3801113|NCT01811732|3628268|B2|Europe||Region of Enrollment||participants|Number|55|55.0||||||
3801114|NCT01811732|3628269|B1|Europe||Region of Enrollment||participants|Number|63|63.0||||||
3801115|NCT01811732|3628267|B3|North America||Region of Enrollment||participants|Number|542|542.0||||||
3801116|NCT01811732|3628268|B2|North America||Region of Enrollment||participants|Number|274|274.0||||||
3801117|NCT01811732|3628269|B1|North America||Region of Enrollment||participants|Number|268|268.0||||||
3801118|NCT01811732|3628267|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801119|NCT01811732|3628268|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801120|NCT01811732|3628269|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801121|NCT01811732|3628267|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3801122|NCT01811732|3628268|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3801123|NCT01811732|3628269|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801124|NCT01811732|3628267|B3||White|Race (NIH/OMB)||Participants|Count of Participants|601|601.0||||||
3801125|NCT01811732|3628268|B2||White|Race (NIH/OMB)||Participants|Count of Participants|304|304.0||||||
3801126|NCT01811732|3628269|B1||White|Race (NIH/OMB)||Participants|Count of Participants|297|297.0||||||
3801127|NCT01811732|3628267|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3801128|NCT01811732|3628268|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3801129|NCT01811732|3628269|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3801130|NCT01811732|3628267|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3801131|NCT01811732|3628268|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3801132|NCT01811732|3628269|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3801133|NCT01811732|3628267|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3801134|NCT01811732|3628268|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3801135|NCT01811732|3628269|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3801136|NCT01811732|3628267|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3801137|NCT01811732|3628268|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3801138|NCT01811732|3628269|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3801139|NCT01811732|3628267|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801140|NCT01811732|3628268|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801141|NCT01811732|3628269|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801142|NCT01811732|3628267|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|456|456.0||||||
3801143|NCT01811732|3628268|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|226|226.0||||||
3801144|NCT01811732|3628269|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|230|230.0||||||
3801145|NCT01811732|3628267|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|204|204.0||||||
3801146|NCT01811732|3628268|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
3801147|NCT01811732|3628269|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
3801148|NCT01811732|3628267|B3||Male|Sex: Female, Male||Participants|Count of Participants|415|415.0||||||
3801149|NCT01811732|3628268|B2||Male|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
3801150|NCT01811732|3628269|B1||Male|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
3801151|NCT01811732|3628267|B3||Female|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
3801152|NCT01811732|3628268|B2||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3801153|NCT01811732|3628269|B1||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3801154|NCT01811732|3628267|B3|> 75 years||Age, Customized||Participants|Count of Participants|17|17.0||||||
3801155|NCT01811732|3628268|B2|> 75 years||Age, Customized||Participants|Count of Participants|10|10.0||||||
3801156|NCT01811732|3628269|B1|> 75 years||Age, Customized||Participants|Count of Participants|7|7.0||||||
3801157|NCT01811732|3628267|B3|> 65 years||Age, Customized||Participants|Count of Participants|42|42.0||||||
3801158|NCT01811732|3628268|B2|> 65 years||Age, Customized||Participants|Count of Participants|20|20.0||||||
3801159|NCT01811732|3628269|B1|> 65 years||Age, Customized||Participants|Count of Participants|22|22.0||||||
3801160|NCT01811732|3628267|B3|<= 65 years||Age, Customized||Participants|Count of Participants|618|618.0||||||
3801161|NCT01811732|3628268|B2|<= 65 years||Age, Customized||Participants|Count of Participants|309|309.0||||||
3801162|NCT01811732|3628269|B1|<= 65 years||Age, Customized||Participants|Count of Participants|309|309.0||||||
3801163|NCT01811732|3628267|B3|||Age||years|Mean|45.8|45.8|Standard Deviation|14.18|14.18|||
3801164|NCT01811732|3628268|B2|||Age||years|Mean|45.3|45.3|Standard Deviation|14.44|14.44|||
3801165|NCT01811732|3628269|B1|||Age||years|Mean|46.3|46.3|Standard Deviation|13.91|13.91|||
3801166|NCT01811706|3628280|B1|||SARA at screening visit|Scale for the assessment and rating of ataxia (SARA) is a clinical scale that is based on a semiquantitative assessment of cerebellar ataxia on an impairment level. SARA has 8 items that are related to gait, stance, sitting, speech, finger-chase test, nose-finger test, fast alternating movements and heel-shin test. SARA score ranges from 0 to 40, with higher scores indicating more severe disease.|point|Mean|11.1|11.1|Standard Deviation|3.4|3.4|||
3801167|NCT01811706|3628280|B1|||T25FW at screening visit|Timed 25-Foot Walk (T25FW): The patient is directed to one end of a marked 25-foot course and is instructed to walk 25 feet as quickly as possible, but safely. The time, in seconds, is calculated from the initiation of the instruction to start and ends when the patient has reached the 25-foot mark.|second|Mean|25.5|25.5|Standard Deviation|9.7|9.7|||
3801168|NCT01811706|3628280|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3801169|NCT01811706|3628280|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3801170|NCT01811706|3628280|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3801171|NCT01811706|3628280|B1|||Age||years|Mean|54.9|54.9|Standard Deviation|14.3|14.3|||
3801172|NCT01811680|3628291|B1|Singapore||Region of Enrollment||participants|Number|10|10.0||||||
3801173|NCT01811680|3628291|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801174|NCT01811680|3628291|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801175|NCT01811680|3628291|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801176|NCT01811680|3628291|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801177|NCT01811680|3628291|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801178|NCT01811680|3628291|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3801179|NCT01811680|3628291|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801180|NCT01811680|3628291|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3801181|NCT01811680|3628291|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3801182|NCT01811680|3628291|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3801183|NCT01811680|3628291|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3801184|NCT01811680|3628291|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3801185|NCT01811680|3628291|B1|||Age||years|Mean|55.5|55.5|Standard Deviation|9.85|9.85|||
3801186|NCT01811563|3628296|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
3801187|NCT01811563|3628297|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
3801188|NCT01811563|3628298|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3801189|NCT01811563|3628296|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3801190|NCT01811563|3628297|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3801191|NCT01811563|3628298|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3801192|NCT01811563|3628296|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3801193|NCT01811563|3628297|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3801194|NCT01811563|3628298|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3801195|NCT01811563|3628296|B3|||Age||years|Mean|62.5|62.5|Standard Deviation|7.6|7.6|||
3801196|NCT01811563|3628297|B2|||Age||years|Mean|63.1|63.1|Standard Deviation|7.3|7.3|||
3801197|NCT01811563|3628298|B1|||Age||years|Mean|61.9|61.9|Standard Deviation|8.0|8.0|||
3801198|NCT01811485|3628325|B4||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3801199|NCT01811485|3628326|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3801200|NCT01811485|3628327|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3801201|NCT01811485|3628328|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3801202|NCT01811485|3628325|B4||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3801203|NCT01811485|3628326|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3801204|NCT01811485|3628327|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3801205|NCT01811485|3628328|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3801206|NCT01811485|3628325|B4|||Age||Years|Mean|57.0|57.0|Standard Deviation|10.49|10.49|||
3801207|NCT01811485|3628326|B3|||Age||Years|Mean|56.2|56.2|Standard Deviation|9.75|9.75|||
3801208|NCT01811485|3628327|B2|||Age||Years|Mean|58.3|58.3|Standard Deviation|10.50|10.5|||
3801209|NCT01811485|3628328|B1|||Age||Years|Mean|56.6|56.6|Standard Deviation|11.24|11.24|||
3801210|NCT01811472|3628347|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3801211|NCT01811472|3628348|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3801212|NCT01811472|3628349|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3801213|NCT01811472|3628350|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3801214|NCT01811472|3628347|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3801215|NCT01811472|3628348|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3801216|NCT01811472|3628349|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3801217|NCT01811472|3628350|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3801218|NCT01811472|3628347|B4|||Age||Years|Mean|53.2|53.2|Standard Deviation|10.32|10.32|||
3801219|NCT01811472|3628348|B3|||Age||Years|Mean|47.7|47.7|Standard Deviation|11.76|11.76|||
3801220|NCT01811472|3628349|B2|||Age||Years|Mean|58.7|58.7|Standard Deviation|6.56|6.56|||
3801221|NCT01811472|3628350|B1|||Age||Years|Mean|55.9|55.9|Standard Deviation|7.69|7.69|||
3801222|NCT01811355|3628397|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
3801223|NCT01811355|3628397|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801224|NCT01811355|3628397|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801225|NCT01811355|3628397|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3801226|NCT01811355|3628397|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801227|NCT01811355|3628397|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801228|NCT01811355|3628397|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3801229|NCT01811355|3628397|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801230|NCT01811355|3628397|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801231|NCT01811355|3628397|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3801232|NCT01811355|3628397|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3801233|NCT01811355|3628397|B1|females||Sex/Gender, Customized||Participants|Count of Participants|8|8.0||||||
3801234|NCT01811355|3628397|B1|males||Sex/Gender, Customized||Participants|Count of Participants|15|15.0||||||
3801235|NCT01811355|3628397|B1|Years||Age, Customized||years|Mean|62.4|62.4|Standard Deviation|12.5|12.5|||
3801236|NCT01811316|3628406|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3801237|NCT01811316|3628407|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801238|NCT01811316|3628408|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3801239|NCT01811316|3628409|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801240|NCT01811316|3628406|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801241|NCT01811316|3628407|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801242|NCT01811316|3628408|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801243|NCT01811316|3628409|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801244|NCT01811316|3628406|B4||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3801245|NCT01811316|3628407|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3801246|NCT01811316|3628408|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3801247|NCT01811316|3628409|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3801248|NCT01811316|3628406|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3801249|NCT01811316|3628407|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3801250|NCT01811316|3628408|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3801251|NCT01811316|3628409|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3801252|NCT01811316|3628406|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3801253|NCT01811316|3628407|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3801254|NCT01811316|3628408|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801255|NCT01811316|3628409|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801256|NCT01811316|3628406|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3801257|NCT01811316|3628407|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3801258|NCT01811316|3628408|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3801259|NCT01811316|3628409|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3801260|NCT01811316|3628406|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3801261|NCT01811316|3628407|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801262|NCT01811316|3628408|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801263|NCT01811316|3628409|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3801264|NCT01811316|3628406|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801265|NCT01811316|3628407|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801266|NCT01811316|3628408|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801267|NCT01811316|3628409|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801268|NCT01811316|3628406|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3801269|NCT01811316|3628407|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3801331|NCT01811186|3628461|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3801270|NCT01811316|3628408|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3801271|NCT01811316|3628409|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3801272|NCT01811316|3628406|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3801273|NCT01811316|3628407|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801274|NCT01811316|3628408|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3801275|NCT01811316|3628409|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3801276|NCT01811316|3628406|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3801277|NCT01811316|3628407|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3801278|NCT01811316|3628408|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3801279|NCT01811316|3628409|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3801280|NCT01811316|3628406|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3801281|NCT01811316|3628407|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3801282|NCT01811316|3628408|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3801283|NCT01811316|3628409|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3801284|NCT01811316|3628406|B4|||Age||Year|Mean|40|40.0|Standard Deviation|13|13.0|||
3801285|NCT01811316|3628407|B3|||Age||Year|Mean|34|34.0|Standard Deviation|11|11.0|||
3801286|NCT01811316|3628408|B2|||Age||Year|Mean|44|44.0|Standard Deviation|15|15.0|||
3801287|NCT01811316|3628409|B1|||Age||Year|Mean|40|40.0|Standard Deviation|13|13.0|||
3801288|NCT01811303|3628428|B1|United Kingdom||Region of Enrollment||participants|Number|14|14.0||||||
3801289|NCT01811303|3628428|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3801290|NCT01811303|3628428|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3801291|NCT01811303|3628428|B1|||Age||years|Mean|39.8|39.8|Standard Deviation|11.2|11.2|||
3801292|NCT01811303|3628428|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3801293|NCT01811303|3628428|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3801294|NCT01811303|3628428|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3801295|NCT01811238|3628439|B1|Korea, Republic of||Region of Enrollment||participants|Number|220|220.0||||||
3801296|NCT01811238|3628439|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3801297|NCT01811238|3628439|B1||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3801298|NCT01811238|3628439|B1||>=65 years|Age||Participants|Count of Participants|134|134.0||||||
3801299|NCT01811238|3628439|B1||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
3801300|NCT01811238|3628439|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3801301|NCT01811238|3628439|B1|||Age||years|Mean|62.25|62.25|Standard Deviation|10.42|10.42|||
3801302|NCT01811212|3628448|B1|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3801303|NCT01811212|3628448|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801304|NCT01811212|3628448|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801305|NCT01811212|3628448|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3801306|NCT01811212|3628448|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3801307|NCT01811212|3628448|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801308|NCT01811212|3628448|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3801309|NCT01811212|3628448|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801310|NCT01811212|3628448|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3801311|NCT01811212|3628448|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3801312|NCT01811212|3628448|B1|||Age||years|Median|64|64.0|Full Range|||41.0|81.0|
3801313|NCT01811186|3628461|B3|Korea, Republic of||Region of Enrollment||participants|Number|258|258.0||||||
3801314|NCT01811186|3628462|B2|Korea, Republic of||Region of Enrollment||participants|Number|126|126.0||||||
3801315|NCT01811186|3628463|B1|Korea, Republic of||Region of Enrollment||participants|Number|132|132.0||||||
3801316|NCT01811186|3628461|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3801317|NCT01811186|3628462|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3801318|NCT01811186|3628463|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3801319|NCT01811186|3628461|B3||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3801320|NCT01811186|3628462|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3801321|NCT01811186|3628463|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3801322|NCT01811186|3628461|B3|||Age||years|Mean|60.88|60.88|Standard Deviation|10.83|10.83|||
3801323|NCT01811186|3628462|B2|||Age||years|Mean|61.15|61.15|Standard Deviation|11.94|11.94|||
3801324|NCT01811186|3628463|B1|||Age||years|Mean|60.63|60.63|Standard Deviation|9.69|9.69|||
3801325|NCT01811186|3628461|B3||>=65 years|Age||Participants|Count of Participants|117|117.0||||||
3801326|NCT01811186|3628462|B2||>=65 years|Age||Participants|Count of Participants|62|62.0||||||
3801327|NCT01811186|3628463|B1||>=65 years|Age||Participants|Count of Participants|55|55.0||||||
3801328|NCT01811186|3628461|B3||Between 18 and 65 years|Age||Participants|Count of Participants|141|141.0||||||
3801329|NCT01811186|3628462|B2||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
3801330|NCT01811186|3628463|B1||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
3801332|NCT01811186|3628462|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3801333|NCT01811186|3628463|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3801334|NCT01810952|3628480|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
3801335|NCT01810952|3628481|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3801336|NCT01810952|3628482|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3801337|NCT01810952|3628480|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3801338|NCT01810952|3628481|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3801339|NCT01810952|3628482|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3801340|NCT01810952|3628480|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3801341|NCT01810952|3628481|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3801342|NCT01810952|3628482|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3801343|NCT01810952|3628480|B3|Baseline Participants||Age||years|Mean|63.7|63.7|Standard Deviation|13.7|13.7|||
3801344|NCT01810952|3628481|B2|Baseline Participants||Age||years|Mean|67.1|67.1|Standard Deviation|14.3|14.3|||
3801345|NCT01810952|3628482|B1|Baseline Participants||Age||years|Mean|60.8|60.8|Standard Deviation|12.9|12.9|||
3801346|NCT01810952|3628480|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3801347|NCT01810952|3628481|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3801348|NCT01810952|3628482|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3801349|NCT01810952|3628480|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3801350|NCT01810952|3628481|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3801351|NCT01810952|3628482|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3801352|NCT01810952|3628480|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3801353|NCT01810952|3628481|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3801354|NCT01810952|3628482|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3801355|NCT01810939|3628497|B1||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3801356|NCT01810939|3628497|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3801357|NCT01810939|3628497|B1|||Age||years|Median|64.2|64.2|Full Range|||29.0|80.0|
3801358|NCT01810939|3628497|B1||>=65 years|Age||Participants|Count of Participants|131|131.0||||||
3801359|NCT01810939|3628497|B1||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
3801360|NCT01810939|3628497|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3801361|NCT01810783|3628512|B1|Romania||Region of Enrollment||participants|Number|9|9.0||||||
3801362|NCT01810783|3628512|B1|Poland||Region of Enrollment||participants|Number|9|9.0||||||
3801363|NCT01810783|3628512|B1|Estonia||Region of Enrollment||participants|Number|6|6.0||||||
3801364|NCT01810783|3628512|B1|Russian Federation||Region of Enrollment||participants|Number|52|52.0||||||
3801365|NCT01810783|3628512|B1|Serbia||Region of Enrollment||participants|Number|19|19.0||||||
3801366|NCT01810783|3628512|B1|Slovakia||Region of Enrollment||participants|Number|1|1.0||||||
3801367|NCT01810783|3628512|B1|Ukraine||Region of Enrollment||participants|Number|64|64.0||||||
3801368|NCT01810783|3628512|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3801369|NCT01810783|3628512|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3801370|NCT01810783|3628512|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3801371|NCT01810783|3628512|B1|||Age||years|Mean|40.89|40.89|Standard Deviation|11.35|11.35|||
3801372|NCT01810783|3628512|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3801373|NCT01810783|3628512|B1||Between 18 and 65 years|Age||Participants|Count of Participants|208|208.0||||||
3801374|NCT01810783|3628512|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3801375|NCT01810692|3628516|B3|||Time since diagnosis of COPD||years|Mean|6.1|6.1|Standard Deviation|5.7|5.7|||
3801376|NCT01810692|3628517|B2|||Time since diagnosis of COPD||years|Mean|5.9|5.9|Standard Deviation|5.4|5.4|||
3801377|NCT01810692|3628518|B1|||Time since diagnosis of COPD||years|Mean|6.3|6.3|Standard Deviation|6.0|6.0|||
3801378|NCT01810692|3628516|B3||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3801379|NCT01810692|3628517|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3801380|NCT01810692|3628518|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3801381|NCT01810692|3628516|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3801382|NCT01810692|3628517|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3801383|NCT01810692|3628518|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3801384|NCT01810692|3628516|B3|||Age||years|Mean|68.4|68.4|Standard Deviation|10.0|10.0|||
3801385|NCT01810692|3628517|B2|||Age||years|Mean|67.0|67.0|Standard Deviation|9.9|9.9|||
3801386|NCT01810692|3628518|B1|||Age||years|Mean|69.7|69.7|Standard Deviation|10.0|10.0|||
3801387|NCT01810666|3628531|B1|||Number of Joint Bleeds in Last 3 Months||Bleeds|Mean|8.73|8.73|Standard Deviation|8.07|8.07|||
3801388|NCT01810666|3628531|B1|||Number of Bleeds in Last 3 Months||Bleeds|Mean|12.4|12.4|Standard Deviation|8.71|8.71|||
3801389|NCT01810666|3628531|B1|||Prior FVIII Treatment On-demand||Participants|Number|30|30.0||||||
3801390|NCT01810666|3628531|B1|2||Number of Target Joint||Participants|Number|6|6.0||||||
3801391|NCT01810666|3628531|B1|1||Number of Target Joint||Participants|Number|16|16.0||||||
3801392|NCT01810666|3628531|B1|0||Number of Target Joint||Participants|Number|8|8.0||||||
3801393|NCT01810666|3628531|B1|Yes||Target Joint for Bleeds||Participants|Number|22|22.0||||||
3801394|NCT01810666|3628531|B1|No||Target Joint for Bleeds||Participants|Number|8|8.0||||||
3801395|NCT01810666|3628531|B1|||Baseline body mass index||Kg/m2|Mean|18.65|18.65|Standard Deviation|4.16|4.16|||
3801396|NCT01810666|3628531|B1|||Baseline weight||Kg|Mean|41.42|41.42|Standard Deviation|19.02|19.02|||
3801397|NCT01810666|3628531|B1|Others||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3801398|NCT01810666|3628531|B1|Asian||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
3801399|NCT01810666|3628531|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3801400|NCT01810666|3628531|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3801401|NCT01810666|3628531|B1|||Age||Years|Mean|10|10.0|Standard Deviation|3.9|3.9|||
3801402|NCT01810432|3628537|B1|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3801403|NCT01810432|3628537|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801404|NCT01810432|3628537|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3801405|NCT01810432|3628537|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3801406|NCT01810432|3628537|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3801407|NCT01810432|3628537|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3801408|NCT01810432|3628537|B1|||Age||years|Mean|41.5|41.5|Standard Deviation|13.0|13.0|||
3801409|NCT01810380|3628548|B4|||CGI-S Score|The Clinical Global Impression - Severity of Illness (CGI-S) provides the clinician's impression of the patient's current state of mental illness. The clinician uses his or her clinical experience of this patient population to rate the severity of the patient's current mental illness on a 7-point scale ranging from 1 (normal - not at all ill) to 7 (among the most extremely ill patients). CGI-S score is reported for the full analysis set (FAS); PBO=159, Brex=150, Que=150, and no total value was summarised for reporting|units on a scale|Mean|4.96|4.96|Standard Deviation|0.58|0.58|||
3801410|NCT01810380|3628549|B3|||CGI-S Score|The Clinical Global Impression - Severity of Illness (CGI-S) provides the clinician's impression of the patient's current state of mental illness. The clinician uses his or her clinical experience of this patient population to rate the severity of the patient's current mental illness on a 7-point scale ranging from 1 (normal - not at all ill) to 7 (among the most extremely ill patients). CGI-S score is reported for the full analysis set (FAS); PBO=159, Brex=150, Que=150, and no total value was summarised for reporting|units on a scale|Mean|4.98|4.98|Standard Deviation|0.57|0.57|||
3801411|NCT01810380|3628550|B2|||CGI-S Score|The Clinical Global Impression - Severity of Illness (CGI-S) provides the clinician's impression of the patient's current state of mental illness. The clinician uses his or her clinical experience of this patient population to rate the severity of the patient's current mental illness on a 7-point scale ranging from 1 (normal - not at all ill) to 7 (among the most extremely ill patients). CGI-S score is reported for the full analysis set (FAS); PBO=159, Brex=150, Que=150, and no total value was summarised for reporting|units on a scale|Mean|4.96|4.96|Standard Deviation|0.59|0.59|||
3801412|NCT01810380|3628551|B1|||CGI-S Score|The Clinical Global Impression - Severity of Illness (CGI-S) provides the clinician's impression of the patient's current state of mental illness. The clinician uses his or her clinical experience of this patient population to rate the severity of the patient's current mental illness on a 7-point scale ranging from 1 (normal - not at all ill) to 7 (among the most extremely ill patients). CGI-S score is reported for the full analysis set (FAS); PBO=159, Brex=150, Que=150, and no total value was summarised for reporting|units on a scale|Mean|4.94|4.94|Standard Deviation|0.57|0.57|||
3801413|NCT01810380|3628548|B4|||PANSS total score|The Positive and Negative Syndrome Scale (PANSS) is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS total score (30 items) ranged from 30 to 210 with a higher score indicating greater severity of symptoms. PANSS total score is reported for the full analysis set (FAS); PBO=159, Brex=150, Que=150, and no total value was summarised for reporting|units on a scale|Mean|98.34|98.34|Standard Deviation|10.45|10.45|||
3801414|NCT01810380|3628549|B3|||PANSS total score|The Positive and Negative Syndrome Scale (PANSS) is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS total score (30 items) ranged from 30 to 210 with a higher score indicating greater severity of symptoms. PANSS total score is reported for the full analysis set (FAS); PBO=159, Brex=150, Que=150, and no total value was summarised for reporting|units on a scale|Mean|98.82|98.82|Standard Deviation|10.83|10.83|||
3801415|NCT01810380|3628550|B2|||PANSS total score|The Positive and Negative Syndrome Scale (PANSS) is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS total score (30 items) ranged from 30 to 210 with a higher score indicating greater severity of symptoms. PANSS total score is reported for the full analysis set (FAS); PBO=159, Brex=150, Que=150, and no total value was summarised for reporting|units on a scale|Mean|97.82|97.82|Standard Deviation|10.25|10.25|||
3801416|NCT01810380|3628551|B1|||PANSS total score|The Positive and Negative Syndrome Scale (PANSS) is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS total score (30 items) ranged from 30 to 210 with a higher score indicating greater severity of symptoms. PANSS total score is reported for the full analysis set (FAS); PBO=159, Brex=150, Que=150, and no total value was summarised for reporting|units on a scale|Mean|98.38|98.38|Standard Deviation|10.30|10.3|||
3801417|NCT01810380|3628548|B4|||Time since first antipsychotic treatment (years)||years|Mean|14.08|14.08|Standard Deviation|9.16|9.16|||
3801418|NCT01810380|3628549|B3|||Time since first antipsychotic treatment (years)||years|Mean|14.31|14.31|Standard Deviation|9.34|9.34|||
3801419|NCT01810380|3628550|B2|||Time since first antipsychotic treatment (years)||years|Mean|13.43|13.43|Standard Deviation|9.19|9.19|||
3801420|NCT01810380|3628551|B1|||Time since first antipsychotic treatment (years)||years|Mean|14.48|14.48|Standard Deviation|8.98|8.98|||
3801421|NCT01810380|3628548|B4|||Time since schizophrenia diagnosis (years)||years|Mean|13.62|13.62|Standard Deviation|9.42|9.42|||
3801482|NCT01810380|3628549|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801422|NCT01810380|3628549|B3|||Time since schizophrenia diagnosis (years)||years|Mean|13.78|13.78|Standard Deviation|9.49|9.49|||
3801423|NCT01810380|3628550|B2|||Time since schizophrenia diagnosis (years)||years|Mean|12.88|12.88|Standard Deviation|9.43|9.43|||
3801424|NCT01810380|3628551|B1|||Time since schizophrenia diagnosis (years)||years|Mean|14.15|14.15|Standard Deviation|9.35|9.35|||
3801425|NCT01810380|3628548|B4|Russian Federation||Region of Enrollment||participants|Number|115|115.0||||||
3801426|NCT01810380|3628549|B3|Russian Federation||Region of Enrollment||participants|Number|35|35.0||||||
3801427|NCT01810380|3628550|B2|Russian Federation||Region of Enrollment||participants|Number|37|37.0||||||
3801428|NCT01810380|3628551|B1|Russian Federation||Region of Enrollment||participants|Number|43|43.0||||||
3801429|NCT01810380|3628548|B4|Ukraine||Region of Enrollment||participants|Number|87|87.0||||||
3801430|NCT01810380|3628549|B3|Ukraine||Region of Enrollment||participants|Number|29|29.0||||||
3801431|NCT01810380|3628550|B2|Ukraine||Region of Enrollment||participants|Number|28|28.0||||||
3801432|NCT01810380|3628551|B1|Ukraine||Region of Enrollment||participants|Number|30|30.0||||||
3801433|NCT01810380|3628548|B4|Slovakia||Region of Enrollment||participants|Number|3|3.0||||||
3801434|NCT01810380|3628549|B3|Slovakia||Region of Enrollment||participants|Number|1|1.0||||||
3801435|NCT01810380|3628550|B2|Slovakia||Region of Enrollment||participants|Number|1|1.0||||||
3801436|NCT01810380|3628551|B1|Slovakia||Region of Enrollment||participants|Number|1|1.0||||||
3801437|NCT01810380|3628548|B4|Serbia||Region of Enrollment||participants|Number|35|35.0||||||
3801438|NCT01810380|3628549|B3|Serbia||Region of Enrollment||participants|Number|11|11.0||||||
3801439|NCT01810380|3628550|B2|Serbia||Region of Enrollment||participants|Number|11|11.0||||||
3801440|NCT01810380|3628551|B1|Serbia||Region of Enrollment||participants|Number|13|13.0||||||
3801441|NCT01810380|3628548|B4|Romania||Region of Enrollment||participants|Number|38|38.0||||||
3801442|NCT01810380|3628549|B3|Romania||Region of Enrollment||participants|Number|11|11.0||||||
3801443|NCT01810380|3628550|B2|Romania||Region of Enrollment||participants|Number|13|13.0||||||
3801444|NCT01810380|3628551|B1|Romania||Region of Enrollment||participants|Number|14|14.0||||||
3801445|NCT01810380|3628548|B4|Poland||Region of Enrollment||participants|Number|15|15.0||||||
3801446|NCT01810380|3628549|B3|Poland||Region of Enrollment||participants|Number|5|5.0||||||
3801447|NCT01810380|3628550|B2|Poland||Region of Enrollment||participants|Number|5|5.0||||||
3801448|NCT01810380|3628551|B1|Poland||Region of Enrollment||participants|Number|5|5.0||||||
3801449|NCT01810380|3628548|B4|France||Region of Enrollment||participants|Number|2|2.0||||||
3801450|NCT01810380|3628549|B3|France||Region of Enrollment||participants|Number|1|1.0||||||
3801451|NCT01810380|3628550|B2|France||Region of Enrollment||participants|Number|0|0.0||||||
3801452|NCT01810380|3628551|B1|France||Region of Enrollment||participants|Number|1|1.0||||||
3801453|NCT01810380|3628548|B4|Estonia||Region of Enrollment||participants|Number|11|11.0||||||
3801454|NCT01810380|3628549|B3|Estonia||Region of Enrollment||participants|Number|4|4.0||||||
3801455|NCT01810380|3628550|B2|Estonia||Region of Enrollment||participants|Number|3|3.0||||||
3801456|NCT01810380|3628551|B1|Estonia||Region of Enrollment||participants|Number|4|4.0||||||
3801457|NCT01810380|3628548|B4|United States||Region of Enrollment||participants|Number|158|158.0||||||
3801458|NCT01810380|3628549|B3|United States||Region of Enrollment||participants|Number|56|56.0||||||
3801459|NCT01810380|3628550|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
3801460|NCT01810380|3628551|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3801461|NCT01810380|3628548|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3801462|NCT01810380|3628549|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3801463|NCT01810380|3628550|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3801464|NCT01810380|3628551|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801465|NCT01810380|3628548|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801466|NCT01810380|3628549|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801467|NCT01810380|3628550|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801468|NCT01810380|3628551|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801469|NCT01810380|3628548|B4||White|Race (NIH/OMB)||Participants|Count of Participants|349|349.0||||||
3801470|NCT01810380|3628549|B3||White|Race (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
3801471|NCT01810380|3628550|B2||White|Race (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
3801472|NCT01810380|3628551|B1||White|Race (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
3801473|NCT01810380|3628548|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
3801474|NCT01810380|3628549|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3801475|NCT01810380|3628550|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3801476|NCT01810380|3628551|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3801477|NCT01810380|3628548|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3801478|NCT01810380|3628549|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3801479|NCT01810380|3628550|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801480|NCT01810380|3628551|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3801481|NCT01810380|3628548|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3801483|NCT01810380|3628550|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3801484|NCT01810380|3628551|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3801485|NCT01810380|3628548|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3801486|NCT01810380|3628549|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801487|NCT01810380|3628550|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3801488|NCT01810380|3628551|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801489|NCT01810380|3628548|B4||Male|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
3801490|NCT01810380|3628549|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3801491|NCT01810380|3628550|B2||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3801492|NCT01810380|3628551|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3801493|NCT01810380|3628548|B4||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
3801494|NCT01810380|3628549|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3801495|NCT01810380|3628550|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3801496|NCT01810380|3628551|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3801497|NCT01810380|3628548|B4|||Age||years|Mean|40.56|40.56|Standard Deviation|10.77|10.77|||
3801498|NCT01810380|3628549|B3|||Age||years|Mean|41.12|41.12|Standard Deviation|10.91|10.91|||
3801499|NCT01810380|3628550|B2|||Age||years|Mean|39.68|39.68|Standard Deviation|10.87|10.87|||
3801500|NCT01810380|3628551|B1|||Age||years|Mean|40.85|40.85|Standard Deviation|10.56|10.56|||
3801501|NCT01810302|3628612|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3801502|NCT01810302|3628613|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3801503|NCT01810302|3628614|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3801504|NCT01810302|3628612|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3801505|NCT01810302|3628613|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3801506|NCT01810302|3628614|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3801507|NCT01810302|3628612|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3801508|NCT01810302|3628613|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3801509|NCT01810302|3628614|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3801510|NCT01810302|3628612|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3801511|NCT01810302|3628613|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3801512|NCT01810302|3628614|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3801513|NCT01810302|3628612|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3801514|NCT01810302|3628613|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3801515|NCT01810302|3628614|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3801516|NCT01810302|3628612|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3801517|NCT01810302|3628613|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3801518|NCT01810302|3628614|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3801519|NCT01810289|3628623|B3||Male|Sex: Female, Male||Participants|Count of Participants|4479|4479.0||||||
3801520|NCT01810289|3628624|B2||Male|Sex: Female, Male||Participants|Count of Participants|1917|1917.0||||||
3801521|NCT01810289|3628625|B1||Male|Sex: Female, Male||Participants|Count of Participants|2562|2562.0||||||
3801522|NCT01810289|3628623|B3||Female|Sex: Female, Male||Participants|Count of Participants|7545|7545.0||||||
3801523|NCT01810289|3628624|B2||Female|Sex: Female, Male||Participants|Count of Participants|2830|2830.0||||||
3801524|NCT01810289|3628625|B1||Female|Sex: Female, Male||Participants|Count of Participants|4715|4715.0||||||
3801525|NCT01810289|3628623|B3|||Age||years|Median|31|31.0|Inter-Quartile Range|||26.0|38.0|
3801526|NCT01810289|3628624|B2|||Age||years|Median|30|30.0|Inter-Quartile Range|||25.0|37.0|
3801527|NCT01810289|3628625|B1|||Age||years|Median|31|31.0|Inter-Quartile Range|||26.0|38.0|
3801528|NCT01810263|3628640|B3|Korea, Republic of||Region of Enrollment||participants|Number|34|34.0||||||
3801529|NCT01810263|3628641|B2|Korea, Republic of||Region of Enrollment||participants|Number|18|18.0||||||
3801530|NCT01810263|3628642|B1|Korea, Republic of||Region of Enrollment||participants|Number|16|16.0||||||
3801531|NCT01810263|3628640|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3801532|NCT01810263|3628641|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3801533|NCT01810263|3628642|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3801534|NCT01810263|3628640|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3801535|NCT01810263|3628641|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3801536|NCT01810263|3628642|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3801537|NCT01810263|3628640|B3|||Age||years|Mean|64.4|64.4|Standard Deviation|15.2|15.2|||
3801538|NCT01810263|3628641|B2|||Age||years|Mean|65.8|65.8|Standard Deviation|14.3|14.3|||
3801539|NCT01810263|3628642|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|16.0|16.0|||
3801540|NCT01810042|3628649|B1|||Central subfield macular thickness (um)||micrometer|Median|317|317.0|Full Range|||168.0|793.0|
3801541|NCT01810042|3628649|B1|||Median visual acuity (ETDRS)|Visual acuity was measured using a Early Treatment of Diabetic Retinopathy Study (ETDRS) chart. The ETDRS score represents the number of letters that the patient read correctly. It can be ranged from 0 to 85. An ETDRS score of 85 corresponds to 20/20 vision approximately, and a score of 35 corresponds to 20/200 vision.|ETDRS letter|Median|46|46.0|Full Range|||0.0|81.0|
3801542|NCT01810042|3628649|B1|Korea, Republic of||Region of Enrollment||participants|Number|31|31.0||||||
3801543|NCT01810042|3628649|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3801544|NCT01810042|3628649|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3801545|NCT01810042|3628649|B1|||Age||years|Mean|69|69.0|Full Range|||51.0|85.0|
3801546|NCT01810016|3628656|B4||None|Antigen||Participants|Count of Participants|5|5.0||||||
3801547|NCT01810016|3628657|B3||None|Antigen||Participants|Count of Participants|1|1.0||||||
3801548|NCT01810016|3628658|B2||None|Antigen||Participants|Count of Participants|0|0.0||||||
3801549|NCT01810016|3628659|B1||None|Antigen||Participants|Count of Participants|4|4.0||||||
3801550|NCT01810016|3628656|B4||LAGE-1|Antigen||Participants|Count of Participants|0|0.0||||||
3801551|NCT01810016|3628657|B3||LAGE-1|Antigen||Participants|Count of Participants|0|0.0||||||
3801552|NCT01810016|3628658|B2||LAGE-1|Antigen||Participants|Count of Participants|0|0.0||||||
3801553|NCT01810016|3628659|B1||LAGE-1|Antigen||Participants|Count of Participants|0|0.0||||||
3801554|NCT01810016|3628656|B4||NY-ESO-1|Antigen||Participants|Count of Participants|3|3.0||||||
3801555|NCT01810016|3628657|B3||NY-ESO-1|Antigen||Participants|Count of Participants|0|0.0||||||
3801556|NCT01810016|3628658|B2||NY-ESO-1|Antigen||Participants|Count of Participants|2|2.0||||||
3801557|NCT01810016|3628659|B1||NY-ESO-1|Antigen||Participants|Count of Participants|1|1.0||||||
3801558|NCT01810016|3628656|B4||IV|Tumor Stage at Study Entry|The American Joint Committee on Cancer staging system is used to stage melanoma based on the Tumor, Node, Metastasis (TNM) system. The melanoma tumor stage represents a composite score that accounts for the thickness and ulceration of the primary tumor (T), presence and extent of metastasis to regional lymph nodes (N), and presence and extent of distant metastases (M). Stage IIIC indicates advanced melanoma that has metastasized to the regional lymph nodes, and Stage IV indicates metastasis to distant lymph nodes and/or other organs/tissue.|Participants|Count of Participants|7|7.0||||||
3801559|NCT01810016|3628657|B3||IV|Tumor Stage at Study Entry|The American Joint Committee on Cancer staging system is used to stage melanoma based on the Tumor, Node, Metastasis (TNM) system. The melanoma tumor stage represents a composite score that accounts for the thickness and ulceration of the primary tumor (T), presence and extent of metastasis to regional lymph nodes (N), and presence and extent of distant metastases (M). Stage IIIC indicates advanced melanoma that has metastasized to the regional lymph nodes, and Stage IV indicates metastasis to distant lymph nodes and/or other organs/tissue.|Participants|Count of Participants|1|1.0||||||
3801560|NCT01810016|3628658|B2||IV|Tumor Stage at Study Entry|The American Joint Committee on Cancer staging system is used to stage melanoma based on the Tumor, Node, Metastasis (TNM) system. The melanoma tumor stage represents a composite score that accounts for the thickness and ulceration of the primary tumor (T), presence and extent of metastasis to regional lymph nodes (N), and presence and extent of distant metastases (M). Stage IIIC indicates advanced melanoma that has metastasized to the regional lymph nodes, and Stage IV indicates metastasis to distant lymph nodes and/or other organs/tissue.|Participants|Count of Participants|2|2.0||||||
3801561|NCT01810016|3628659|B1||IV|Tumor Stage at Study Entry|The American Joint Committee on Cancer staging system is used to stage melanoma based on the Tumor, Node, Metastasis (TNM) system. The melanoma tumor stage represents a composite score that accounts for the thickness and ulceration of the primary tumor (T), presence and extent of metastasis to regional lymph nodes (N), and presence and extent of distant metastases (M). Stage IIIC indicates advanced melanoma that has metastasized to the regional lymph nodes, and Stage IV indicates metastasis to distant lymph nodes and/or other organs/tissue.|Participants|Count of Participants|4|4.0||||||
3801562|NCT01810016|3628656|B4||IIIC|Tumor Stage at Study Entry|The American Joint Committee on Cancer staging system is used to stage melanoma based on the Tumor, Node, Metastasis (TNM) system. The melanoma tumor stage represents a composite score that accounts for the thickness and ulceration of the primary tumor (T), presence and extent of metastasis to regional lymph nodes (N), and presence and extent of distant metastases (M). Stage IIIC indicates advanced melanoma that has metastasized to the regional lymph nodes, and Stage IV indicates metastasis to distant lymph nodes and/or other organs/tissue.|Participants|Count of Participants|1|1.0||||||
3801563|NCT01810016|3628657|B3||IIIC|Tumor Stage at Study Entry|The American Joint Committee on Cancer staging system is used to stage melanoma based on the Tumor, Node, Metastasis (TNM) system. The melanoma tumor stage represents a composite score that accounts for the thickness and ulceration of the primary tumor (T), presence and extent of metastasis to regional lymph nodes (N), and presence and extent of distant metastases (M). Stage IIIC indicates advanced melanoma that has metastasized to the regional lymph nodes, and Stage IV indicates metastasis to distant lymph nodes and/or other organs/tissue.|Participants|Count of Participants|0|0.0||||||
3801564|NCT01810016|3628658|B2||IIIC|Tumor Stage at Study Entry|The American Joint Committee on Cancer staging system is used to stage melanoma based on the Tumor, Node, Metastasis (TNM) system. The melanoma tumor stage represents a composite score that accounts for the thickness and ulceration of the primary tumor (T), presence and extent of metastasis to regional lymph nodes (N), and presence and extent of distant metastases (M). Stage IIIC indicates advanced melanoma that has metastasized to the regional lymph nodes, and Stage IV indicates metastasis to distant lymph nodes and/or other organs/tissue.|Participants|Count of Participants|0|0.0||||||
3801565|NCT01810016|3628659|B1||IIIC|Tumor Stage at Study Entry|The American Joint Committee on Cancer staging system is used to stage melanoma based on the Tumor, Node, Metastasis (TNM) system. The melanoma tumor stage represents a composite score that accounts for the thickness and ulceration of the primary tumor (T), presence and extent of metastasis to regional lymph nodes (N), and presence and extent of distant metastases (M). Stage IIIC indicates advanced melanoma that has metastasized to the regional lymph nodes, and Stage IV indicates metastasis to distant lymph nodes and/or other organs/tissue.|Participants|Count of Participants|1|1.0||||||
3801588|NCT01810016|3628658|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801589|NCT01810016|3628659|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801590|NCT01810016|3628656|B4||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3801591|NCT01810016|3628657|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801566|NCT01810016|3628656|B4||1|Eastern Cooperative Oncology Group Performance Status|"grade 0: fully active, able to carry on pre-disease performance without restriction.~grade 1: restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg, light housework, office work.~grade 2: ambulatory and capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours.~grade 3: capable of only limited self-care, confined to bed or chair more than 50% of waking hours.~grade 4: completely disabled, cannot carry on any self-care, totally confined to bed or chair.~grade 5: dead."|Participants|Count of Participants|4|4.0||||||
3801567|NCT01810016|3628657|B3||1|Eastern Cooperative Oncology Group Performance Status|"grade 0: fully active, able to carry on pre-disease performance without restriction.~grade 1: restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg, light housework, office work.~grade 2: ambulatory and capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours.~grade 3: capable of only limited self-care, confined to bed or chair more than 50% of waking hours.~grade 4: completely disabled, cannot carry on any self-care, totally confined to bed or chair.~grade 5: dead."|Participants|Count of Participants|1|1.0||||||
3801568|NCT01810016|3628658|B2||1|Eastern Cooperative Oncology Group Performance Status|"grade 0: fully active, able to carry on pre-disease performance without restriction.~grade 1: restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg, light housework, office work.~grade 2: ambulatory and capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours.~grade 3: capable of only limited self-care, confined to bed or chair more than 50% of waking hours.~grade 4: completely disabled, cannot carry on any self-care, totally confined to bed or chair.~grade 5: dead."|Participants|Count of Participants|1|1.0||||||
3801569|NCT01810016|3628659|B1||1|Eastern Cooperative Oncology Group Performance Status|"grade 0: fully active, able to carry on pre-disease performance without restriction.~grade 1: restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg, light housework, office work.~grade 2: ambulatory and capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours.~grade 3: capable of only limited self-care, confined to bed or chair more than 50% of waking hours.~grade 4: completely disabled, cannot carry on any self-care, totally confined to bed or chair.~grade 5: dead."|Participants|Count of Participants|2|2.0||||||
3801570|NCT01810016|3628656|B4||0|Eastern Cooperative Oncology Group Performance Status|"grade 0: fully active, able to carry on pre-disease performance without restriction.~grade 1: restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg, light housework, office work.~grade 2: ambulatory and capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours.~grade 3: capable of only limited self-care, confined to bed or chair more than 50% of waking hours.~grade 4: completely disabled, cannot carry on any self-care, totally confined to bed or chair.~grade 5: dead."|Participants|Count of Participants|4|4.0||||||
3801571|NCT01810016|3628657|B3||0|Eastern Cooperative Oncology Group Performance Status|"grade 0: fully active, able to carry on pre-disease performance without restriction.~grade 1: restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg, light housework, office work.~grade 2: ambulatory and capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours.~grade 3: capable of only limited self-care, confined to bed or chair more than 50% of waking hours.~grade 4: completely disabled, cannot carry on any self-care, totally confined to bed or chair.~grade 5: dead."|Participants|Count of Participants|0|0.0||||||
3801572|NCT01810016|3628658|B2||0|Eastern Cooperative Oncology Group Performance Status|"grade 0: fully active, able to carry on pre-disease performance without restriction.~grade 1: restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg, light housework, office work.~grade 2: ambulatory and capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours.~grade 3: capable of only limited self-care, confined to bed or chair more than 50% of waking hours.~grade 4: completely disabled, cannot carry on any self-care, totally confined to bed or chair.~grade 5: dead."|Participants|Count of Participants|1|1.0||||||
3801573|NCT01810016|3628659|B1||0|Eastern Cooperative Oncology Group Performance Status|"grade 0: fully active, able to carry on pre-disease performance without restriction.~grade 1: restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg, light housework, office work.~grade 2: ambulatory and capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours.~grade 3: capable of only limited self-care, confined to bed or chair more than 50% of waking hours.~grade 4: completely disabled, cannot carry on any self-care, totally confined to bed or chair.~grade 5: dead."|Participants|Count of Participants|3|3.0||||||
3801574|NCT01810016|3628656|B4|||Body Mass Index||kg/m^2|Mean|32.5|32.5|Standard Deviation|9.6|9.6|||
3801575|NCT01810016|3628657|B3|||Body Mass Index||kg/m^2|Mean|29.0|29.0|Standard Deviation|NA||||Only 1 patient is included in this arm so a standard deviation is not calculable.
3801576|NCT01810016|3628658|B2|||Body Mass Index||kg/m^2|Mean|26.2|26.2|Standard Deviation|0.2|0.2|||
3801577|NCT01810016|3628659|B1|||Body Mass Index||kg/m^2|Mean|36.6|36.6|Standard Deviation|11.5|11.5|||
3801578|NCT01810016|3628656|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
3801579|NCT01810016|3628657|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3801580|NCT01810016|3628658|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3801581|NCT01810016|3628659|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3801582|NCT01810016|3628656|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3801583|NCT01810016|3628657|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3801584|NCT01810016|3628658|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801585|NCT01810016|3628659|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801586|NCT01810016|3628656|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801587|NCT01810016|3628657|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801592|NCT01810016|3628658|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3801593|NCT01810016|3628659|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3801594|NCT01810016|3628656|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801595|NCT01810016|3628657|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801596|NCT01810016|3628658|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801597|NCT01810016|3628659|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801598|NCT01810016|3628656|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801599|NCT01810016|3628657|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801600|NCT01810016|3628658|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801601|NCT01810016|3628659|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801602|NCT01810016|3628656|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801603|NCT01810016|3628657|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801604|NCT01810016|3628658|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801605|NCT01810016|3628659|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801606|NCT01810016|3628656|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801607|NCT01810016|3628657|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801608|NCT01810016|3628658|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801609|NCT01810016|3628659|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801610|NCT01810016|3628656|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3801611|NCT01810016|3628657|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3801612|NCT01810016|3628658|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801613|NCT01810016|3628659|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801614|NCT01810016|3628656|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3801615|NCT01810016|3628657|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801616|NCT01810016|3628658|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3801617|NCT01810016|3628659|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3801618|NCT01810016|3628656|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801619|NCT01810016|3628657|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801620|NCT01810016|3628658|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801621|NCT01810016|3628659|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801622|NCT01810016|3628656|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3801623|NCT01810016|3628657|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3801624|NCT01810016|3628658|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3801625|NCT01810016|3628659|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3801626|NCT01810016|3628656|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3801627|NCT01810016|3628657|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3801628|NCT01810016|3628658|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3801629|NCT01810016|3628659|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3801630|NCT01810016|3628656|B4|||Age||years|Mean|63.6|63.6|Standard Deviation|7.2|7.2|||
3801631|NCT01810016|3628657|B3|||Age||years|Mean|71.0|71.0|Standard Deviation|NA||||Only 1 patient is included in this arm so a standard deviation is not calculable.
3801632|NCT01810016|3628658|B2|||Age||years|Mean|61.5|61.5|Standard Deviation|7.8|7.8|||
3801633|NCT01810016|3628659|B1|||Age||years|Mean|63.0|63.0|Standard Deviation|7.7|7.7|||
3801634|NCT01809938|3628672|B1|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
3801635|NCT01809938|3628672|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3801636|NCT01809938|3628672|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3801637|NCT01809938|3628672|B1|||Age||years|Mean|36|36.0|Standard Deviation|4|4.0|||
3801638|NCT01809938|3628672|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3801639|NCT01809938|3628672|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3801640|NCT01809938|3628672|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3801641|NCT01809899|3628680|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3801642|NCT01809899|3628681|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3801643|NCT01809899|3628682|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3801644|NCT01809899|3628680|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3801645|NCT01809899|3628681|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3801646|NCT01809899|3628682|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3801647|NCT01809899|3628680|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3801648|NCT01809899|3628681|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3801649|NCT01809899|3628682|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3801650|NCT01809899|3628680|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3801651|NCT01809899|3628681|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3801652|NCT01809899|3628682|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3801653|NCT01809899|3628680|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3801654|NCT01809899|3628681|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3801655|NCT01809899|3628682|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3801656|NCT01809899|3628680|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3801657|NCT01809899|3628681|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3801658|NCT01809899|3628682|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3801659|NCT01809834|3628691|B1|Canada||Region of Enrollment||participants|Number|44|44.0||||||
3801660|NCT01809834|3628691|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3801661|NCT01809834|3628691|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3801662|NCT01809834|3628691|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3801663|NCT01809834|3628691|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
3801664|NCT01809834|3628691|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3801665|NCT01809834|3628691|B1|||Age||years|Mean|26.9|26.9|Standard Deviation|9.5|9.5|||
3801666|NCT01809639|3628717|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3801667|NCT01809639|3628718|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3801668|NCT01809639|3628719|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3801669|NCT01809639|3628717|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3801670|NCT01809639|3628718|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3801671|NCT01809639|3628719|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3801672|NCT01809639|3628717|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3801673|NCT01809639|3628718|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3801674|NCT01809639|3628719|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3801675|NCT01809639|3628717|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3801676|NCT01809639|3628718|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3801677|NCT01809639|3628719|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3801678|NCT01809639|3628717|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3801679|NCT01809639|3628718|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3801680|NCT01809639|3628719|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3801681|NCT01809327|3628726|B6|United States||Region of Enrollment||participants|Number|223|223.0||||||
3801682|NCT01809327|3628727|B5|United States||Region of Enrollment||participants|Number|47|47.0||||||
3801683|NCT01809327|3628728|B4|United States||Region of Enrollment||participants|Number|41|41.0||||||
3801684|NCT01809327|3628729|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
3801685|NCT01809327|3628730|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
3801686|NCT01809327|3628731|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
3801687|NCT01809327|3628726|B6|Ukraine||Region of Enrollment||participants|Number|242|242.0||||||
3801688|NCT01809327|3628727|B5|Ukraine||Region of Enrollment||participants|Number|54|54.0||||||
3801689|NCT01809327|3628728|B4|Ukraine||Region of Enrollment||participants|Number|40|40.0||||||
3801690|NCT01809327|3628729|B3|Ukraine||Region of Enrollment||participants|Number|42|42.0||||||
3801691|NCT01809327|3628730|B2|Ukraine||Region of Enrollment||participants|Number|56|56.0||||||
3801692|NCT01809327|3628731|B1|Ukraine||Region of Enrollment||participants|Number|50|50.0||||||
3801693|NCT01809327|3628726|B6|South Korea||Region of Enrollment||participants|Number|12|12.0||||||
3801694|NCT01809327|3628727|B5|South Korea||Region of Enrollment||participants|Number|3|3.0||||||
3801695|NCT01809327|3628728|B4|South Korea||Region of Enrollment||participants|Number|1|1.0||||||
3801696|NCT01809327|3628729|B3|South Korea||Region of Enrollment||participants|Number|2|2.0||||||
3801697|NCT01809327|3628730|B2|South Korea||Region of Enrollment||participants|Number|2|2.0||||||
3801698|NCT01809327|3628731|B1|South Korea||Region of Enrollment||participants|Number|4|4.0||||||
3801699|NCT01809327|3628726|B6|South Africa||Region of Enrollment||participants|Number|22|22.0||||||
3801700|NCT01809327|3628727|B5|South Africa||Region of Enrollment||participants|Number|3|3.0||||||
3801701|NCT01809327|3628728|B4|South Africa||Region of Enrollment||participants|Number|5|5.0||||||
3801702|NCT01809327|3628729|B3|South Africa||Region of Enrollment||participants|Number|4|4.0||||||
3801703|NCT01809327|3628730|B2|South Africa||Region of Enrollment||participants|Number|5|5.0||||||
3801704|NCT01809327|3628731|B1|South Africa||Region of Enrollment||participants|Number|5|5.0||||||
3801705|NCT01809327|3628726|B6|Slovakia||Region of Enrollment||participants|Number|69|69.0||||||
3801706|NCT01809327|3628727|B5|Slovakia||Region of Enrollment||participants|Number|9|9.0||||||
3801707|NCT01809327|3628728|B4|Slovakia||Region of Enrollment||participants|Number|9|9.0||||||
3801708|NCT01809327|3628729|B3|Slovakia||Region of Enrollment||participants|Number|22|22.0||||||
3801709|NCT01809327|3628730|B2|Slovakia||Region of Enrollment||participants|Number|12|12.0||||||
3801710|NCT01809327|3628731|B1|Slovakia||Region of Enrollment||participants|Number|17|17.0||||||
3801711|NCT01809327|3628726|B6|Russian Federation||Region of Enrollment||participants|Number|202|202.0||||||
3801712|NCT01809327|3628727|B5|Russian Federation||Region of Enrollment||participants|Number|37|37.0||||||
3801713|NCT01809327|3628728|B4|Russian Federation||Region of Enrollment||participants|Number|44|44.0||||||
3801714|NCT01809327|3628729|B3|Russian Federation||Region of Enrollment||participants|Number|45|45.0||||||
3801715|NCT01809327|3628730|B2|Russian Federation||Region of Enrollment||participants|Number|38|38.0||||||
3801716|NCT01809327|3628731|B1|Russian Federation||Region of Enrollment||participants|Number|38|38.0||||||
3801717|NCT01809327|3628726|B6|Romania||Region of Enrollment||participants|Number|102|102.0||||||
3801718|NCT01809327|3628727|B5|Romania||Region of Enrollment||participants|Number|14|14.0||||||
3801719|NCT01809327|3628728|B4|Romania||Region of Enrollment||participants|Number|27|27.0||||||
3801720|NCT01809327|3628729|B3|Romania||Region of Enrollment||participants|Number|21|21.0||||||
3801721|NCT01809327|3628730|B2|Romania||Region of Enrollment||participants|Number|16|16.0||||||
3801722|NCT01809327|3628731|B1|Romania||Region of Enrollment||participants|Number|24|24.0||||||
3801723|NCT01809327|3628726|B6|Mexico||Region of Enrollment||participants|Number|159|159.0||||||
3801724|NCT01809327|3628727|B5|Mexico||Region of Enrollment||participants|Number|38|38.0||||||
3801725|NCT01809327|3628728|B4|Mexico||Region of Enrollment||participants|Number|38|38.0||||||
3801726|NCT01809327|3628729|B3|Mexico||Region of Enrollment||participants|Number|19|19.0||||||
3801727|NCT01809327|3628730|B2|Mexico||Region of Enrollment||participants|Number|31|31.0||||||
3801728|NCT01809327|3628731|B1|Mexico||Region of Enrollment||participants|Number|33|33.0||||||
3801729|NCT01809327|3628726|B6|Hungary||Region of Enrollment||participants|Number|28|28.0||||||
3801730|NCT01809327|3628727|B5|Hungary||Region of Enrollment||participants|Number|4|4.0||||||
3801731|NCT01809327|3628728|B4|Hungary||Region of Enrollment||participants|Number|9|9.0||||||
3801732|NCT01809327|3628729|B3|Hungary||Region of Enrollment||participants|Number|8|8.0||||||
3801733|NCT01809327|3628730|B2|Hungary||Region of Enrollment||participants|Number|5|5.0||||||
3801734|NCT01809327|3628731|B1|Hungary||Region of Enrollment||participants|Number|2|2.0||||||
3801735|NCT01809327|3628726|B6|Czech Republic||Region of Enrollment||participants|Number|34|34.0||||||
3801736|NCT01809327|3628727|B5|Czech Republic||Region of Enrollment||participants|Number|8|8.0||||||
3801737|NCT01809327|3628728|B4|Czech Republic||Region of Enrollment||participants|Number|6|6.0||||||
3801738|NCT01809327|3628729|B3|Czech Republic||Region of Enrollment||participants|Number|6|6.0||||||
3801739|NCT01809327|3628730|B2|Czech Republic||Region of Enrollment||participants|Number|6|6.0||||||
3801740|NCT01809327|3628731|B1|Czech Republic||Region of Enrollment||participants|Number|8|8.0||||||
3801741|NCT01809327|3628726|B6|Brazil||Region of Enrollment||participants|Number|4|4.0||||||
3801742|NCT01809327|3628727|B5|Brazil||Region of Enrollment||participants|Number|0|0.0||||||
3801743|NCT01809327|3628728|B4|Brazil||Region of Enrollment||participants|Number|0|0.0||||||
3801744|NCT01809327|3628729|B3|Brazil||Region of Enrollment||participants|Number|1|1.0||||||
3801745|NCT01809327|3628730|B2|Brazil||Region of Enrollment||participants|Number|2|2.0||||||
3801746|NCT01809327|3628731|B1|Brazil||Region of Enrollment||participants|Number|1|1.0||||||
3801747|NCT01809327|3628726|B6|Argentina||Region of Enrollment||participants|Number|89|89.0||||||
3801748|NCT01809327|3628727|B5|Argentina||Region of Enrollment||participants|Number|20|20.0||||||
3801749|NCT01809327|3628728|B4|Argentina||Region of Enrollment||participants|Number|17|17.0||||||
3801750|NCT01809327|3628729|B3|Argentina||Region of Enrollment||participants|Number|21|21.0||||||
3801751|NCT01809327|3628730|B2|Argentina||Region of Enrollment||participants|Number|19|19.0||||||
3801752|NCT01809327|3628731|B1|Argentina||Region of Enrollment||participants|Number|12|12.0||||||
3801753|NCT01809327|3628726|B6||Male|Sex: Female, Male||Participants|Count of Participants|569|569.0||||||
3801754|NCT01809327|3628727|B5||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3801755|NCT01809327|3628728|B4||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3801756|NCT01809327|3628729|B3||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3801757|NCT01809327|3628730|B2||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3801758|NCT01809327|3628731|B1||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3801759|NCT01809327|3628726|B6||Female|Sex: Female, Male||Participants|Count of Participants|617|617.0||||||
3801760|NCT01809327|3628727|B5||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3801761|NCT01809327|3628728|B4||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3801762|NCT01809327|3628729|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3801763|NCT01809327|3628730|B2||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3801764|NCT01809327|3628731|B1||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3801765|NCT01809327|3628726|B6|||Age||years|Mean|54.9|54.9|Standard Deviation|9.91|9.91|||
3801766|NCT01809327|3628727|B5|||Age||years|Mean|55.4|55.4|Standard Deviation|9.84|9.84|||
3801767|NCT01809327|3628728|B4|||Age||years|Mean|54.2|54.2|Standard Deviation|9.58|9.58|||
3801768|NCT01809327|3628729|B3|||Age||years|Mean|55.8|55.8|Standard Deviation|9.56|9.56|||
3801769|NCT01809327|3628730|B2|||Age||years|Mean|54.0|54.0|Standard Deviation|10.70|10.7|||
3801770|NCT01809327|3628731|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|9.75|9.75|||
3801771|NCT01809314|3628777|B1|Unknown||Sex/Gender, Customized||participants|Number|60|60.0||||||
3801772|NCT01809314|3628777|B1|Female||Sex/Gender, Customized||participants|Number|709|709.0||||||
3801773|NCT01809314|3628777|B1|Male||Sex/Gender, Customized||participants|Number|398|398.0||||||
3801774|NCT01809314|3628777|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|13.0|13.0|||
3801775|NCT01809262|3628783|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3801776|NCT01809262|3628783|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3801777|NCT01809262|3628783|B1|||Age||years|Mean|65.0|65.0|Standard Deviation|9.8|9.8|||
3801778|NCT01809210|3628859|B8||White|Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
3801779|NCT01809210|3628860|B7||White|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3801780|NCT01809210|3628861|B6||White|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3801781|NCT01809210|3628862|B5||White|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3801782|NCT01809210|3628863|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3801783|NCT01809210|3628864|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3801784|NCT01809210|3628865|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3801785|NCT01809210|3628866|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3801786|NCT01809210|3628859|B8||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3801787|NCT01809210|3628860|B7||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3801788|NCT01809210|3628861|B6||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3801789|NCT01809210|3628862|B5||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3801790|NCT01809210|3628863|B4||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3801791|NCT01809210|3628864|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3801792|NCT01809210|3628865|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3801793|NCT01809210|3628866|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3801794|NCT01809210|3628859|B8||Black Or African American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3801795|NCT01809210|3628860|B7||Black Or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3801796|NCT01809210|3628861|B6||Black Or African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3801797|NCT01809210|3628862|B5||Black Or African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3801798|NCT01809210|3628863|B4||Black Or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3801799|NCT01809210|3628864|B3||Black Or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3801800|NCT01809210|3628865|B2||Black Or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3801801|NCT01809210|3628866|B1||Black Or African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3801802|NCT01809210|3628859|B8||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3801803|NCT01809210|3628860|B7||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3801804|NCT01809210|3628861|B6||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3801805|NCT01809210|3628862|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3801806|NCT01809210|3628863|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3801807|NCT01809210|3628864|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3801808|NCT01809210|3628865|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3801809|NCT01809210|3628866|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3801810|NCT01809210|3628859|B8||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3801811|NCT01809210|3628860|B7||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3801812|NCT01809210|3628861|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3801813|NCT01809210|3628862|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3801814|NCT01809210|3628863|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3801815|NCT01809210|3628864|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3801816|NCT01809210|3628865|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3801817|NCT01809210|3628866|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3801818|NCT01809210|3628859|B8|||Age||Years|Mean|61.5|61.5|Standard Deviation|7.45|7.45|39.0|76.0|
3801819|NCT01809210|3628860|B7|||Age||Years|Mean|60.2|60.2|Standard Deviation|8.39|8.39|46.0|73.0|
3801820|NCT01809210|3628861|B6|||Age||Years|Mean|61.8|61.8|Standard Deviation|5.86|5.86|54.0|71.0|
3801821|NCT01809210|3628862|B5|||Age||Years|Mean|59.5|59.5|Standard Deviation|5.28|5.28|54.0|66.0|
3801822|NCT01809210|3628863|B4|||Age||Years|Mean|64.7|64.7|Standard Deviation|7.23|7.23|60.0|73.0|
3801823|NCT01809210|3628864|B3|||Age||Years|Mean|55.1|55.1|Standard Deviation|8.65|8.65|39.0|65.0|
3801824|NCT01809210|3628865|B2|||Age||Years|Mean|69.2|69.2|Standard Deviation|3.53|3.53|65.0|76.0|
3801825|NCT01809210|3628866|B1|||Age||Years|Mean|58.7|58.7|Standard Deviation|3.79|3.79|56.0|63.0|
3801826|NCT01809197|3628944|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3801827|NCT01809197|3628945|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3801828|NCT01809197|3628946|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3801829|NCT01809197|3628944|B3||Female|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
3801830|NCT01809197|3628945|B2||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3801831|NCT01809197|3628946|B1||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3801832|NCT01809197|3628944|B3|||Age||years|Mean|33.7|33.7|Standard Deviation|10.70|10.7|||
3801833|NCT01809197|3628945|B2|||Age||years|Mean|35.0|35.0|Standard Deviation|11.14|11.14|||
3801834|NCT01809197|3628946|B1|||Age||years|Mean|32.4|32.4|Standard Deviation|10.12|10.12|||
3801835|NCT01809106|3628953|B5||Male|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
3801836|NCT01809106|3628954|B4||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3801837|NCT01809106|3628955|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3801838|NCT01809106|3628956|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3801839|NCT01809106|3628957|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3801840|NCT01809106|3628953|B5||Female|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
3801841|NCT01809106|3628954|B4||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3801842|NCT01809106|3628955|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3801843|NCT01809106|3628956|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3801844|NCT01809106|3628957|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3801845|NCT01809106|3628953|B5|||Age||years|Mean|66.9|66.9|Standard Deviation|11.8|11.8|||
3801846|NCT01809106|3628954|B4|||Age||years|Mean|68|68.0|Standard Deviation|10.6|10.6|||
3801847|NCT01809106|3628955|B3|||Age||years|Mean|65.2|65.2|Standard Deviation|13.5|13.5|||
3801848|NCT01809106|3628956|B2|||Age||years|Mean|66.9|66.9|Standard Deviation|11.1|11.1|||
3801849|NCT01809106|3628957|B1|||Age||years|Mean|67.5|67.5|Standard Deviation|11.7|11.7|||
3801850|NCT01809054|3628978|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3801851|NCT01809054|3628979|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3801852|NCT01809054|3628980|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3801853|NCT01809054|3628978|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3801854|NCT01809054|3628979|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3801855|NCT01809054|3628980|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3801856|NCT01809054|3628978|B3|||Age||years|Mean|58|58.0|Standard Deviation|14|14.0|||
3801857|NCT01809054|3628979|B2|||Age||years|Mean|58|58.0|Standard Deviation|14|14.0|||
3801858|NCT01809054|3628980|B1|||Age||years|Mean|59|59.0|Standard Deviation|13|13.0|||
3801859|NCT01808963|3628989|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3801860|NCT01808963|3628989|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3801861|NCT01808963|3628989|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3801862|NCT01808963|3628989|B1|||Age||years|Mean|50|50.0|Standard Deviation|14.3|14.3|||
3801863|NCT01808963|3628989|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3801864|NCT01808963|3628989|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3801865|NCT01808963|3628989|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3801866|NCT01808950|3628993|B4|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3801867|NCT01808950|3628995|B2|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3801868|NCT01808950|3628996|B1|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3801869|NCT01808950|3628993|B4|Switzerland||Region of Enrollment||participants|Number|4|4.0||||||
3801870|NCT01808950|3628995|B2|Switzerland||Region of Enrollment||participants|Number|3|3.0||||||
3801871|NCT01808950|3628996|B1|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
3801872|NCT01808950|3628993|B4|Male||Gender||participants|Number|3|3.0||||||
3801873|NCT01808950|3628995|B2|Male||Gender||participants|Number|2|2.0||||||
3801874|NCT01808950|3628996|B1|Male||Gender||participants|Number|1|1.0||||||
3801875|NCT01808950|3628993|B4|Female||Gender||participants|Number|1|1.0||||||
3801876|NCT01808950|3628995|B2|Female||Gender||participants|Number|1|1.0||||||
3801877|NCT01808950|3628996|B1|Female||Gender||participants|Number|0|0.0||||||
3801878|NCT01808950|3628993|B4|>=65 years||Age||participants|Number|4|4.0||||||
3801879|NCT01808950|3628995|B2|>=65 years||Age||participants|Number|3|3.0||||||
3801880|NCT01808950|3628996|B1|>=65 years||Age||participants|Number|1|1.0||||||
3801881|NCT01808950|3628993|B4|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
3801882|NCT01808950|3628995|B2|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
3801883|NCT01808950|3628996|B1|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
3801884|NCT01808950|3628993|B4|<=18 years||Age||participants|Number|0|0.0||||||
3801885|NCT01808950|3628995|B2|<=18 years||Age||participants|Number|0|0.0||||||
3801886|NCT01808950|3628996|B1|<=18 years||Age||participants|Number|0|0.0||||||
3801887|NCT01808755|3629009|B1|||positive urine culture||participants|Number|60|60.0||||||
3801888|NCT01808755|3629009|B1|>75 years||urinary tract infection||participants|Number|0|0.0||||||
3801889|NCT01808755|3629009|B1|Between 18 and 74 years||urinary tract infection||participants|Number|60|60.0||||||
3801890|NCT01808755|3629009|B1|<18 years||urinary tract infection||participants|Number|0|0.0||||||
3801891|NCT01808755|3629009|B1|Italy||Region of Enrollment||participants|Number|60|60.0||||||
3801892|NCT01808755|3629009|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3801893|NCT01808755|3629009|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3801894|NCT01808755|3629009|B1|||Age||years|Mean|42|42.0|Standard Deviation|22|22.0|||
3801895|NCT01808651|3629015|B4|Japan||Region of Enrollment||participants|Number|199|199.0||||||
3801896|NCT01808651|3629016|B3|Japan||Region of Enrollment||participants|Number|36|36.0||||||
3801897|NCT01808651|3629017|B2|Japan||Region of Enrollment||participants|Number|65|65.0||||||
3801898|NCT01808651|3629018|B1|Japan||Region of Enrollment||participants|Number|98|98.0||||||
3801899|NCT01808651|3629015|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801900|NCT01808651|3629016|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801901|NCT01808651|3629017|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801902|NCT01808651|3629018|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801903|NCT01808651|3629015|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801904|NCT01808651|3629016|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801905|NCT01808651|3629017|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801906|NCT01808651|3629018|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801907|NCT01808651|3629015|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801908|NCT01808651|3629016|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801909|NCT01808651|3629017|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801910|NCT01808651|3629018|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801911|NCT01808651|3629015|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801912|NCT01808651|3629016|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801913|NCT01808651|3629017|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801914|NCT01808651|3629018|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801915|NCT01808651|3629015|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801916|NCT01808651|3629016|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801917|NCT01808651|3629017|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801918|NCT01808651|3629018|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801919|NCT01808651|3629015|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|199|199.0||||||
3801920|NCT01808651|3629016|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3801921|NCT01808651|3629017|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3801922|NCT01808651|3629018|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3801923|NCT01808651|3629015|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801924|NCT01808651|3629016|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801925|NCT01808651|3629017|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801926|NCT01808651|3629018|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801927|NCT01808651|3629015|B4||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3801928|NCT01808651|3629016|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3801929|NCT01808651|3629017|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3801930|NCT01808651|3629018|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3801931|NCT01808651|3629015|B4||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3801932|NCT01808651|3629016|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3801933|NCT01808651|3629017|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3801934|NCT01808651|3629018|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3801935|NCT01808651|3629015|B4|||Age||years|Mean|39.44|39.44|Standard Deviation|11.88|11.88|||
3801936|NCT01808651|3629016|B3|||Age||years|Mean|41.20|41.2|Standard Deviation|10.51|10.51|||
3801937|NCT01808651|3629017|B2|||Age||years|Mean|39.72|39.72|Standard Deviation|10.91|10.91|||
3801938|NCT01808651|3629018|B1|||Age||years|Mean|38.60|38.6|Standard Deviation|12.95|12.95|||
3801939|NCT01808612|3629052|B4|Japan||Region of Enrollment||participants|Number|510|510.0||||||
3801940|NCT01808612|3629053|B3|Japan||Region of Enrollment||participants|Number|259|259.0||||||
3801941|NCT01808612|3629054|B2|Japan||Region of Enrollment||participants|Number|83|83.0||||||
3801942|NCT01808612|3629055|B1|Japan||Region of Enrollment||participants|Number|168|168.0||||||
3801943|NCT01808612|3629052|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801944|NCT01808612|3629053|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801945|NCT01808612|3629054|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801946|NCT01808612|3629055|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801947|NCT01808612|3629052|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801948|NCT01808612|3629053|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801949|NCT01808612|3629054|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801950|NCT01808612|3629055|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801951|NCT01808612|3629052|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801952|NCT01808612|3629053|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801953|NCT01808612|3629054|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801954|NCT01808612|3629055|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801955|NCT01808612|3629052|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801956|NCT01808612|3629053|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801957|NCT01808612|3629054|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801958|NCT01808612|3629055|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801959|NCT01808612|3629052|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801960|NCT01808612|3629053|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801961|NCT01808612|3629054|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801962|NCT01808612|3629055|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801963|NCT01808612|3629052|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|510|510.0||||||
3801964|NCT01808612|3629053|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|259|259.0||||||
3801965|NCT01808612|3629054|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3801966|NCT01808612|3629055|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|168|168.0||||||
3801967|NCT01808612|3629052|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801968|NCT01808612|3629053|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801969|NCT01808612|3629054|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801970|NCT01808612|3629055|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801971|NCT01808612|3629052|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|510|510.0||||||
3801972|NCT01808612|3629053|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|259|259.0||||||
3801973|NCT01808612|3629054|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3801974|NCT01808612|3629055|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|168|168.0||||||
3801975|NCT01808612|3629052|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801976|NCT01808612|3629053|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801977|NCT01808612|3629054|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801978|NCT01808612|3629055|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801979|NCT01808612|3629052|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801980|NCT01808612|3629053|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801981|NCT01808612|3629054|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801982|NCT01808612|3629055|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801983|NCT01808612|3629052|B4||Male|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
3801984|NCT01808612|3629053|B3||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3801985|NCT01808612|3629054|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3801986|NCT01808612|3629055|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3801987|NCT01808612|3629052|B4||Female|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
3801988|NCT01808612|3629053|B3||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3801989|NCT01808612|3629054|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3801990|NCT01808612|3629055|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3801991|NCT01808612|3629052|B4|||Age||years|Mean|39.20|39.2|Standard Deviation|11.33|11.33|||
3801992|NCT01808612|3629053|B3|||Age||years|Mean|38.54|38.54|Standard Deviation|11.65|11.65|||
3801993|NCT01808612|3629054|B2|||Age||years|Mean|39.58|39.58|Standard Deviation|10.56|10.56|||
3801994|NCT01808612|3629055|B1|||Age||years|Mean|40.05|40.05|Standard Deviation|11.19|11.19|||
3801995|NCT01808560|3629086|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801996|NCT01808560|3629088|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801997|NCT01808560|3629089|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801998|NCT01808560|3629086|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3801999|NCT01808560|3629088|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802000|NCT01808560|3629089|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802001|NCT01808560|3629086|B4||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3802002|NCT01808560|3629088|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3802003|NCT01808560|3629089|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3802004|NCT01808560|3629086|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802005|NCT01808560|3629088|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802006|NCT01808560|3629089|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802007|NCT01808560|3629086|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802008|NCT01808560|3629088|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802009|NCT01808560|3629089|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802010|NCT01808560|3629086|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802011|NCT01808560|3629088|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802012|NCT01808560|3629089|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802013|NCT01808560|3629086|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802014|NCT01808560|3629088|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802015|NCT01808560|3629089|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802016|NCT01808560|3629086|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802017|NCT01808560|3629088|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802018|NCT01808560|3629089|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802019|NCT01808560|3629086|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3802020|NCT01808560|3629088|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3802021|NCT01808560|3629089|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3802022|NCT01808560|3629086|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802023|NCT01808560|3629088|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802024|NCT01808560|3629089|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802025|NCT01808560|3629086|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3802026|NCT01808560|3629088|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3802027|NCT01808560|3629089|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3802028|NCT01808560|3629086|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3802029|NCT01808560|3629088|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3802030|NCT01808560|3629089|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3802031|NCT01808560|3629086|B4|||Age||years|Mean|70.4|70.4|Standard Deviation|6.2|6.2|||
3802032|NCT01808560|3629088|B2|||Age||years|Mean|68.6|68.6|Standard Deviation|6.4|6.4|||
3802033|NCT01808560|3629089|B1|||Age||years|Mean|71.9|71.9|Standard Deviation|5.7|5.7|||
3802034|NCT01808547|3629114|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3802035|NCT01808547|3629115|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3802036|NCT01808547|3629116|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3802037|NCT01808547|3629114|B3||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3802038|NCT01808547|3629115|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3802039|NCT01808547|3629116|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3802040|NCT01808547|3629114|B3|≥ 65 years||Age, Customized||participants|Number|193|193.0||||||
3802041|NCT01808547|3629115|B2|≥ 65 years||Age, Customized||participants|Number|69|69.0||||||
3802042|NCT01808547|3629116|B1|≥ 65 years||Age, Customized||participants|Number|124|124.0||||||
3802043|NCT01808547|3629114|B3|< 65 years||Age, Customized||participants|Number|60|60.0||||||
3802044|NCT01808547|3629115|B2|< 65 years||Age, Customized||participants|Number|16|16.0||||||
3802045|NCT01808547|3629116|B1|< 65 years||Age, Customized||participants|Number|44|44.0||||||
3802046|NCT01808547|3629114|B3|||Age||years|Mean|70.4|70.4|Standard Deviation|9.01|9.01|||
3802047|NCT01808547|3629115|B2|||Age||years|Mean|72.0|72.0|Standard Deviation|9.07|9.07|||
3802048|NCT01808547|3629116|B1|||Age||years|Mean|69.6|69.6|Standard Deviation|8.90|8.9|||
3802049|NCT01808534|3629123|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802050|NCT01808534|3629123|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802051|NCT01808534|3629123|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3802052|NCT01808534|3629123|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802053|NCT01808534|3629123|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802054|NCT01808534|3629123|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802055|NCT01808534|3629123|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802056|NCT01808534|3629123|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802057|NCT01808534|3629123|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3802058|NCT01808534|3629123|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802059|NCT01808534|3629123|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3802060|NCT01808534|3629123|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3802061|NCT01808534|3629123|B1|||Age||years|Mean|36.6|36.6|Standard Deviation|13.83|13.83|||
3802062|NCT01808534|3629123|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3802063|NCT01808534|3629123|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3802064|NCT01808534|3629123|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3802065|NCT01808508|3629131|B4|United States||Region of Enrollment||participants|Number|23|23.0||||||
3802066|NCT01808508|3629132|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3802067|NCT01808508|3629133|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3802068|NCT01808508|3629134|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3802069|NCT01808508|3629131|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3802070|NCT01808508|3629132|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3802071|NCT01808508|3629133|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3802072|NCT01808508|3629134|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3802073|NCT01808508|3629131|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3802074|NCT01808508|3629132|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3802075|NCT01808508|3629133|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3802076|NCT01808508|3629134|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3802077|NCT01808508|3629131|B4|||Age||years|Median|10|10.0|Inter-Quartile Range|||9.0|14.5|
3802078|NCT01808508|3629132|B3|||Age||years|Median|12|12.0|Inter-Quartile Range|||10.0|13.5|
3802079|NCT01808508|3629133|B2|||Age||years|Median|12.0|12.0|Inter-Quartile Range|||9.0|15.0|
3802080|NCT01808508|3629134|B1|||Age||years|Median|10.0|10.0|Inter-Quartile Range|||9.0|11.5|
3802081|NCT01808339|3629153|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3802082|NCT01808339|3629153|B1|White - Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3802083|NCT01808339|3629153|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
3802084|NCT01808339|3629153|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3802085|NCT01808339|3629153|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3802086|NCT01808339|3629153|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3802087|NCT01808339|3629153|B1||Male|Gender||Participants|Count of Participants|13|13.0||||||
3802088|NCT01808339|3629153|B1||Female|Gender||Participants|Count of Participants|15|15.0||||||
3802089|NCT01808339|3629153|B1|||Age||Years|Mean|31.7|31.7|Standard Deviation|10.99|10.99|||
3802090|NCT01808326|3629175|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3802091|NCT01808326|3629175|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3802092|NCT01808326|3629175|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3802093|NCT01808326|3629175|B1|||Age||Years|Mean|73.2|73.2|Standard Deviation|7.63|7.63|||
3802094|NCT01808313|3629202|B1|Asian-East Asian Heritage||Race/Ethnicity, Customized||Particiopants|Number|133|133.0||||||
3802095|NCT01808313|3629202|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3802096|NCT01808313|3629202|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3802097|NCT01808313|3629202|B1|||Age||Years|Mean|36.1|36.1|Standard Deviation|10.25|10.25|||
3802098|NCT01808261|3629230|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802099|NCT01808261|3629231|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802100|NCT01808261|3629232|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802101|NCT01808261|3629230|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802102|NCT01808261|3629231|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802103|NCT01808261|3629232|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802104|NCT01808261|3629230|B3||White|Race (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
3802105|NCT01808261|3629231|B2||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3802106|NCT01808261|3629232|B1||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3802107|NCT01808261|3629230|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3802108|NCT01808261|3629231|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3802109|NCT01808261|3629232|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3802110|NCT01808261|3629230|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802111|NCT01808261|3629231|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802112|NCT01808261|3629232|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802113|NCT01808261|3629230|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3802114|NCT01808261|3629231|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802115|NCT01808261|3629232|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802116|NCT01808261|3629230|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802117|NCT01808261|3629231|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802118|NCT01808261|3629232|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802119|NCT01808261|3629230|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3802120|NCT01808261|3629231|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3802121|NCT01808261|3629232|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3802122|NCT01808261|3629230|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3802123|NCT01808261|3629231|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3802124|NCT01808261|3629232|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3802125|NCT01808261|3629230|B3|||Age||years|Mean|67.6|67.6|Standard Deviation|11.53|11.53|||
3802126|NCT01808261|3629231|B2|||Age||years|Mean|68.2|68.2|Standard Deviation|11.92|11.92|||
3802127|NCT01808261|3629232|B1|||Age||years|Mean|67.1|67.1|Standard Deviation|11.2|11.2|||
3802128|NCT01808248|3629287|B3|Relapse/Breakthrough||Response to prior HCV treatment||participants|Number|40|40.0||||||
3802129|NCT01808248|3629288|B2|Relapse/Breakthrough||Response to prior HCV treatment||participants|Number|19|19.0||||||
3802130|NCT01808248|3629289|B1|Relapse/Breakthrough||Response to prior HCV treatment||participants|Number|21|21.0||||||
3802131|NCT01808248|3629287|B3|Nonresponse||Response to prior HCV treatment||participants|Number|7|7.0||||||
3802132|NCT01808248|3629288|B2|Nonresponse||Response to prior HCV treatment||participants|Number|5|5.0||||||
3802133|NCT01808248|3629289|B1|Nonresponse||Response to prior HCV treatment||participants|Number|2|2.0||||||
3802134|NCT01808248|3629287|B3|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|30|30.0||||||
3802135|NCT01808248|3629288|B2|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|11|11.0||||||
3802136|NCT01808248|3629289|B1|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|19|19.0||||||
3802137|NCT01808248|3629287|B3|< 6 log10 IU/mL||HCV RNA Category||participants|Number|17|17.0||||||
3802138|NCT01808248|3629288|B2|< 6 log10 IU/mL||HCV RNA Category||participants|Number|13|13.0||||||
3802139|NCT01808248|3629289|B1|< 6 log10 IU/mL||HCV RNA Category||participants|Number|4|4.0||||||
3802140|NCT01808248|3629287|B3|||HCV RNA (log10 IU/mL)||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.66|0.66|||
3802141|NCT01808248|3629288|B2|||HCV RNA (log10 IU/mL)||log10 IU/mL|Mean|6.0|6.0|Standard Deviation|0.62|0.62|||
3802142|NCT01808248|3629289|B1|||HCV RNA (log10 IU/mL)||log10 IU/mL|Mean|6.4|6.4|Standard Deviation|0.66|0.66|||
3802143|NCT01808248|3629287|B3|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|5|5.0||||||
3802144|NCT01808248|3629288|B2|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|2|2.0||||||
3802145|NCT01808248|3629289|B1|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
3802146|NCT01808248|3629287|B3|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|25|25.0||||||
3802147|NCT01808248|3629288|B2|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|15|15.0||||||
3802148|NCT01808248|3629289|B1|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|10|10.0||||||
3802149|NCT01808248|3629287|B3|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|17|17.0||||||
3802150|NCT01808248|3629288|B2|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|7|7.0||||||
3802151|NCT01808248|3629289|B1|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|10|10.0||||||
3802152|NCT01808248|3629287|B3|Yes||Liver Cirrhosis||participants|Number|26|26.0||||||
3802153|NCT01808248|3629288|B2|Yes||Liver Cirrhosis||participants|Number|12|12.0||||||
3802154|NCT01808248|3629289|B1|Yes||Liver Cirrhosis||participants|Number|14|14.0||||||
3802155|NCT01808248|3629287|B3|No||Liver Cirrhosis||participants|Number|21|21.0||||||
3802156|NCT01808248|3629288|B2|No||Liver Cirrhosis||participants|Number|12|12.0||||||
3802157|NCT01808248|3629289|B1|No||Liver Cirrhosis||participants|Number|9|9.0||||||
3802158|NCT01808248|3629287|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3802159|NCT01808248|3629288|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3802160|NCT01808248|3629289|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3802161|NCT01808248|3629287|B3|White||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
3802162|NCT01808248|3629288|B2|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3802163|NCT01808248|3629289|B1|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3802164|NCT01808248|3629287|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3802165|NCT01808248|3629288|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3802166|NCT01808248|3629289|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3802167|NCT01808248|3629287|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802168|NCT01808248|3629288|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802169|NCT01808248|3629289|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802170|NCT01808248|3629287|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3802171|NCT01808248|3629288|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3802172|NCT01808248|3629289|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3802173|NCT01808248|3629287|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3802174|NCT01808248|3629288|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3802175|NCT01808248|3629289|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3802176|NCT01808248|3629287|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3802177|NCT01808248|3629288|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3802178|NCT01808248|3629289|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3802179|NCT01808248|3629287|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3802180|NCT01808248|3629288|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3802181|NCT01808248|3629289|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3802182|NCT01808248|3629287|B3|||Age||years|Mean|56|56.0|Standard Deviation|6.9|6.9|||
3802183|NCT01808248|3629288|B2|||Age||years|Mean|54|54.0|Standard Deviation|6.9|6.9|||
3802184|NCT01808248|3629289|B1|||Age||years|Mean|58|58.0|Standard Deviation|6.1|6.1|||
3802185|NCT01808209|3629301|B3|United Kingdom||Region of Enrollment||participants|Number|59|59.0||||||
3802186|NCT01808209|3629302|B2|United Kingdom||Region of Enrollment||participants|Number|26|26.0||||||
3802187|NCT01808209|3629303|B1|United Kingdom||Region of Enrollment||participants|Number|33|33.0||||||
3802188|NCT01808209|3629301|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3802189|NCT01808209|3629302|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3802190|NCT01808209|3629303|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3802191|NCT01808209|3629301|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3802192|NCT01808209|3629302|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3802193|NCT01808209|3629303|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3802194|NCT01808209|3629301|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3802195|NCT01808209|3629302|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3802196|NCT01808209|3629303|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3802197|NCT01808209|3629301|B3||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
3802198|NCT01808209|3629302|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3802199|NCT01808209|3629303|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3802200|NCT01808209|3629301|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3802201|NCT01808209|3629302|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3802202|NCT01808209|3629303|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3802203|NCT01808144|3629346|B3|New Zealand||Region of Enrollment||Participants|Number|10|10.0||||||
3802204|NCT01808144|3629347|B2|New Zealand||Region of Enrollment||Participants|Number|3|3.0||||||
3802205|NCT01808144|3629348|B1|New Zealand||Region of Enrollment||Participants|Number|7|7.0||||||
3802206|NCT01808144|3629346|B3|Australia||Region of Enrollment||Participants|Number|8|8.0||||||
3802207|NCT01808144|3629347|B2|Australia||Region of Enrollment||Participants|Number|3|3.0||||||
3802208|NCT01808144|3629348|B1|Australia||Region of Enrollment||Participants|Number|5|5.0||||||
3802209|NCT01808144|3629346|B3|Switzerland||Region of Enrollment||Participants|Number|1|1.0||||||
3802210|NCT01808144|3629347|B2|Switzerland||Region of Enrollment||Participants|Number|0|0.0||||||
3802211|NCT01808144|3629348|B1|Switzerland||Region of Enrollment||Participants|Number|1|1.0||||||
3802212|NCT01808144|3629346|B3|Poland||Region of Enrollment||Participants|Number|25|25.0||||||
3802213|NCT01808144|3629347|B2|Poland||Region of Enrollment||Participants|Number|13|13.0||||||
3802214|NCT01808144|3629348|B1|Poland||Region of Enrollment||Participants|Number|12|12.0||||||
3802215|NCT01808144|3629346|B3|Canada||Region of Enrollment||Participants|Number|8|8.0||||||
3802216|NCT01808144|3629347|B2|Canada||Region of Enrollment||Participants|Number|6|6.0||||||
3802217|NCT01808144|3629348|B1|Canada||Region of Enrollment||Participants|Number|2|2.0||||||
3802218|NCT01808144|3629346|B3|United States||Region of Enrollment||Participants|Number|144|144.0||||||
3802219|NCT01808144|3629347|B2|United States||Region of Enrollment||Participants|Number|72|72.0||||||
3802220|NCT01808144|3629348|B1|United States||Region of Enrollment||Participants|Number|72|72.0||||||
3802221|NCT01808144|3629346|B3|Female||Sex/Gender, Customized||Participant|Number|188|188.0||||||
3802222|NCT01808144|3629347|B2|Female||Sex/Gender, Customized||Participant|Number|96|96.0||||||
3802223|NCT01808144|3629348|B1|Female||Sex/Gender, Customized||Participant|Number|92|92.0||||||
3802224|NCT01808144|3629346|B3|Male||Sex/Gender, Customized||Participant|Number|8|8.0||||||
3802225|NCT01808144|3629347|B2|Male||Sex/Gender, Customized||Participant|Number|1|1.0||||||
3802226|NCT01808144|3629348|B1|Male||Sex/Gender, Customized||Participant|Number|7|7.0||||||
3802227|NCT01808144|3629346|B3|>=65 years||Age, Customized||Participants|Number|21|21.0||||||
3802228|NCT01808144|3629347|B2|>=65 years||Age, Customized||Participants|Number|10|10.0||||||
3802229|NCT01808144|3629348|B1|>=65 years||Age, Customized||Participants|Number|11|11.0||||||
3802230|NCT01808144|3629346|B3|< 65 years||Age, Customized||Participants|Number|175|175.0||||||
3802231|NCT01808144|3629347|B2|< 65 years||Age, Customized||Participants|Number|87|87.0||||||
3802232|NCT01808144|3629348|B1|< 65 years||Age, Customized||Participants|Number|88|88.0||||||
3802233|NCT01808144|3629346|B3|||Age||Years|Mean|52.5|52.5|Standard Deviation|10.41|10.41|||
3802234|NCT01808144|3629347|B2|||Age||Years|Mean|52.9|52.9|Standard Deviation|10.24|10.24|||
3802235|NCT01808144|3629348|B1|||Age||Years|Mean|52.1|52.1|Standard Deviation|10.58|10.58|||
3802236|NCT01808118|3629357|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802237|NCT01808118|3629357|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802238|NCT01808118|3629357|B1||White|Race (NIH/OMB)||Participants|Count of Participants|651|651.0||||||
3802239|NCT01808118|3629357|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3802240|NCT01808118|3629357|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802241|NCT01808118|3629357|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3802242|NCT01808118|3629357|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802243|NCT01808118|3629357|B1||Male|Sex: Female, Male||Participants|Count of Participants|330|330.0||||||
3802244|NCT01808118|3629357|B1||Female|Sex: Female, Male||Participants|Count of Participants|343|343.0||||||
3802245|NCT01808118|3629357|B1|||Age||years|Mean|37.3|37.3|Standard Deviation|11.12|11.12|||
3802246|NCT01808092|3629420|B3|White||Race/Ethnicity, Customized||Participants|Number|348|348.0||||||
3802247|NCT01808092|3629421|B2|White||Race/Ethnicity, Customized||Participants|Number|177|177.0||||||
3802248|NCT01808092|3629422|B1|White||Race/Ethnicity, Customized||Participants|Number|171|171.0||||||
3802249|NCT01808092|3629420|B3|Other||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3802250|NCT01808092|3629421|B2|Other||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3802251|NCT01808092|3629422|B1|Other||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3802252|NCT01808092|3629420|B3|Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3802253|NCT01808092|3629421|B2|Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3802254|NCT01808092|3629422|B1|Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3802255|NCT01808092|3629420|B3|Black/African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3802256|NCT01808092|3629421|B2|Black/African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3802257|NCT01808092|3629422|B1|Black/African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3802258|NCT01808092|3629420|B3|Asian||Race/Ethnicity, Customized||Participants|Number|443|443.0||||||
3802259|NCT01808092|3629421|B2|Asian||Race/Ethnicity, Customized||Participants|Number|217|217.0||||||
3802260|NCT01808092|3629422|B1|Asian||Race/Ethnicity, Customized||Participants|Number|226|226.0||||||
3802261|NCT01808092|3629420|B3||Male|Sex: Female, Male||Participants|Count of Participants|602|602.0||||||
3802262|NCT01808092|3629421|B2||Male|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
3802263|NCT01808092|3629422|B1||Male|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
3802264|NCT01808092|3629420|B3||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
3802265|NCT01808092|3629421|B2||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3802266|NCT01808092|3629422|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3802267|NCT01808092|3629420|B3|75-90||Age, Customized||Participants|Number|222|222.0||||||
3802268|NCT01808092|3629421|B2|75-90||Age, Customized||Participants|Number|112|112.0||||||
3802269|NCT01808092|3629422|B1|75-90||Age, Customized||Participants|Number|110|110.0||||||
3802270|NCT01808092|3629420|B3|65-74||Age, Customized||Participants|Number|192|192.0||||||
3802271|NCT01808092|3629421|B2|65-74||Age, Customized||Participants|Number|95|95.0||||||
3802272|NCT01808092|3629422|B1|65-74||Age, Customized||Participants|Number|97|97.0||||||
3802273|NCT01808092|3629420|B3|46-64||Age, Customized||Participants|Number|246|246.0||||||
3802274|NCT01808092|3629421|B2|46-64||Age, Customized||Participants|Number|122|122.0||||||
3802275|NCT01808092|3629422|B1|46-64||Age, Customized||Participants|Number|124|124.0||||||
3802276|NCT01808092|3629420|B3|18-45||Age, Customized||Participants|Number|148|148.0||||||
3802277|NCT01808092|3629421|B2|18-45||Age, Customized||Participants|Number|74|74.0||||||
3802278|NCT01808092|3629422|B1|18-45||Age, Customized||Participants|Number|74|74.0||||||
3802279|NCT01808092|3629420|B3|||Age||Years|Mean|61.7|61.7|Standard Deviation|17.16|17.16|18.0|90.0|
3802280|NCT01808092|3629421|B2|||Age||Years|Mean|61.7|61.7|Standard Deviation|17.57|17.57|18.0|90.0|
3802281|NCT01808092|3629422|B1|||Age||Years|Mean|61.8|61.8|Standard Deviation|16.76|16.76|18.0|89.0|
3802282|NCT01808066|3629525|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3802283|NCT01808066|3629525|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3802284|NCT01808066|3629525|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3802285|NCT01808066|3629525|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3802286|NCT01808066|3629525|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3802287|NCT01808066|3629525|B1||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
3802288|NCT01808066|3629525|B1|||Age||years|Median|8|8.0|Full Range|||5.0|11.0|
3802289|NCT01807949|3629533|B4||Male|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
3802290|NCT01807949|3629534|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3802291|NCT01807949|3629535|B2||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3802292|NCT01807949|3629536|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3802293|NCT01807949|3629533|B4||Female|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
3802294|NCT01807949|3629534|B3||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3802295|NCT01807949|3629535|B2||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3802296|NCT01807949|3629536|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3802297|NCT01807949|3629533|B4|||Age||years|Mean|25.0|25.0|Standard Deviation|9.16|9.16|||
3802298|NCT01807949|3629534|B3|||Age||years|Mean|25.0|25.0|Standard Deviation|9.03|9.03|||
3802299|NCT01807949|3629535|B2|||Age||years|Mean|24.3|24.3|Standard Deviation|8.31|8.31|||
3802300|NCT01807949|3629536|B1|||Age||years|Mean|25.7|25.7|Standard Deviation|10.02|10.02|||
3802301|NCT01807923|3629587|B4||Male|Sex: Female, Male||Participants|Count of Participants|295|295.0||||||
3802302|NCT01807923|3629588|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3802303|NCT01807923|3629589|B2||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3802304|NCT01807923|3629590|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3802305|NCT01807923|3629587|B4||Female|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
3802306|NCT01807923|3629588|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3802307|NCT01807923|3629589|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3802308|NCT01807923|3629590|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3802309|NCT01807923|3629587|B4|||Age||years|Mean|25.1|25.1|Standard Deviation|10.20|10.2|||
3802310|NCT01807923|3629588|B3|||Age||years|Mean|25.5|25.5|Standard Deviation|10.09|10.09|||
3802311|NCT01807923|3629589|B2|||Age||years|Mean|24.7|24.7|Standard Deviation|9.71|9.71|||
3802312|NCT01807923|3629590|B1|||Age||years|Mean|25.0|25.0|Standard Deviation|10.80|10.8|||
3802313|NCT01807871|3629641|B3|United States||Region of Enrollment||participants|Number|701|701.0||||||
3802314|NCT01807871|3629642|B2|United States||Region of Enrollment||participants|Number|345|345.0||||||
3802315|NCT01807871|3629643|B1|United States||Region of Enrollment||participants|Number|356|356.0||||||
3802316|NCT01807871|3629641|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3802317|NCT01807871|3629642|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3802318|NCT01807871|3629643|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3802319|NCT01807871|3629641|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|77|77.0||||||
3802320|NCT01807871|3629642|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3802321|NCT01807871|3629643|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|45|45.0||||||
3802322|NCT01807871|3629641|B3|Black Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|251|251.0||||||
3802323|NCT01807871|3629642|B2|Black Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|123|123.0||||||
3802324|NCT01807871|3629643|B1|Black Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|128|128.0||||||
3802325|NCT01807871|3629641|B3|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|349|349.0||||||
3802326|NCT01807871|3629642|B2|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|179|179.0||||||
3802327|NCT01807871|3629643|B1|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|170|170.0||||||
3802328|NCT01807871|3629641|B3||Male|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
3802329|NCT01807871|3629642|B2||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3802330|NCT01807871|3629643|B1||Male|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3802331|NCT01807871|3629641|B3||Female|Sex: Female, Male||Participants|Count of Participants|397|397.0||||||
3802332|NCT01807871|3629642|B2||Female|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
3802333|NCT01807871|3629643|B1||Female|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
3802334|NCT01807871|3629641|B3|||Age||years|Mean|45|45.0|Standard Deviation|12|12.0|||
3802335|NCT01807871|3629642|B2|||Age||years|Mean|45|45.0|Standard Deviation|12|12.0|||
3802336|NCT01807871|3629643|B1|||Age||years|Mean|44|44.0|Standard Deviation|11|11.0|||
3802337|NCT01807650|3629654|B1|Spain||Region of Enrollment||participants|Number|56|56.0||||||
3802338|NCT01807650|3629654|B1|France||Region of Enrollment||participants|Number|11|11.0||||||
3802339|NCT01807650|3629654|B1|Latvia||Region of Enrollment||participants|Number|31|31.0||||||
3802340|NCT01807650|3629654|B1|Greece||Region of Enrollment||participants|Number|14|14.0||||||
3802341|NCT01807650|3629654|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3802342|NCT01807650|3629654|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3802343|NCT01807650|3629654|B1|||Age||years|Median|49|49.0|Full Range|||19.0|90.0|
3802344|NCT01807650|3629654|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3802345|NCT01807650|3629654|B1||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
3802346|NCT01807650|3629654|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3802347|NCT01807637|3629705|B3|||Stroke Impact Scale Score|Sixteen item scale. Range of scores is 16 to 80. High score means higher functioning.|units on a scale|Mean|58.22|58.22|Standard Deviation|9.55|9.55|||
3802348|NCT01807637|3629706|B2|||Stroke Impact Scale Score|Sixteen item scale. Range of scores is 16 to 80. High score means higher functioning.|units on a scale|Mean|68.67|68.67|Standard Deviation|2.78|2.78|||
3802349|NCT01807637|3629707|B1|||Stroke Impact Scale Score|Sixteen item scale. Range of scores is 16 to 80. High score means higher functioning.|units on a scale|Mean|53.0|53.0|Standard Deviation|1.97|1.97|||
3802350|NCT01807637|3629705|B3|||Slope of recruitment curve|The recruitment curve consists of MEPs plotted for increasing intensities of TMS. The slope reflects the rate at which MEP values increase.|slope of regression line|Mean|6.42|6.42|Standard Deviation|2.09|2.09|||
3802351|NCT01807637|3629706|B2|||Slope of recruitment curve|The recruitment curve consists of MEPs plotted for increasing intensities of TMS. The slope reflects the rate at which MEP values increase.|slope of regression line|Mean|5.19|5.19|Standard Deviation|.87|0.87|||
3802352|NCT01807637|3629707|B1|||Slope of recruitment curve|The recruitment curve consists of MEPs plotted for increasing intensities of TMS. The slope reflects the rate at which MEP values increase.|slope of regression line|Mean|7.24|7.24|Standard Deviation|0.71|0.71|||
3802353|NCT01807637|3629705|B3|||Ankle dorsiflexion angle during the swing phase of gait|Normal dorisflexion in mid-swing is 0. More than -5 degrees of plantar flexion is foot drop.|degrees|Mean|-6.25|-6.25|Standard Deviation|10.21|10.21|||
3802354|NCT01807637|3629706|B2|||Ankle dorsiflexion angle during the swing phase of gait|Normal dorisflexion in mid-swing is 0. More than -5 degrees of plantar flexion is foot drop.|degrees|Mean|-0.19|-0.19|Standard Deviation|4.39|4.39|||
3802355|NCT01807637|3629707|B1|||Ankle dorsiflexion angle during the swing phase of gait|Normal dorisflexion in mid-swing is 0. More than -5 degrees of plantar flexion is foot drop.|degrees|Mean|-9.28|-9.28|Standard Deviation|3.10|3.1|||
3802356|NCT01807637|3629705|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802357|NCT01807637|3629706|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802358|NCT01807637|3629707|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802359|NCT01807637|3629705|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802360|NCT01807637|3629706|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802361|NCT01807637|3629707|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802362|NCT01807637|3629705|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3802363|NCT01807637|3629706|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3802364|NCT01807637|3629707|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3802365|NCT01807637|3629705|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802366|NCT01807637|3629706|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802367|NCT01807637|3629707|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802368|NCT01807637|3629705|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802369|NCT01807637|3629706|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802370|NCT01807637|3629707|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802371|NCT01807637|3629705|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802372|NCT01807637|3629706|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802373|NCT01807637|3629707|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802374|NCT01807637|3629705|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802375|NCT01807637|3629706|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802376|NCT01807637|3629707|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802377|NCT01807637|3629705|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802378|NCT01807637|3629706|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802379|NCT01807637|3629707|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802380|NCT01807637|3629705|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3802381|NCT01807637|3629706|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3802382|NCT01807637|3629707|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3802383|NCT01807637|3629705|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802384|NCT01807637|3629706|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802385|NCT01807637|3629707|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802386|NCT01807637|3629705|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3802387|NCT01807637|3629706|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3802388|NCT01807637|3629707|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3802389|NCT01807637|3629705|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3802390|NCT01807637|3629706|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3802391|NCT01807637|3629707|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3802392|NCT01807637|3629705|B3|||Age||years|Mean|58.0|58.0|Standard Deviation|16.3|16.3|||
3802393|NCT01807637|3629706|B2|||Age||years|Mean|45|45.0|Standard Deviation|26.9|26.9|||
3802394|NCT01807637|3629707|B1|||Age||years|Mean|65.8|65.8|Standard Deviation|8.9|8.9|||
3802395|NCT01807624|3629724|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802396|NCT01807624|3629724|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3802397|NCT01807624|3629724|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3802398|NCT01807624|3629724|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802399|NCT01807624|3629724|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802400|NCT01807624|3629724|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802401|NCT01807624|3629724|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802402|NCT01807624|3629724|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802403|NCT01807624|3629724|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3802404|NCT01807624|3629724|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3802405|NCT01807624|3629724|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3802406|NCT01807624|3629724|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3802407|NCT01807624|3629724|B1|||Age||years|Mean|28.7|28.7|Standard Deviation|9.36|9.36|||
3802408|NCT01807585|3629740|B4||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3802409|NCT01807585|3629741|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3802410|NCT01807585|3629742|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3802411|NCT01807585|3629743|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3802412|NCT01807585|3629740|B4||Female|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
3802413|NCT01807585|3629741|B3||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3802414|NCT01807585|3629742|B2||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3802415|NCT01807585|3629743|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3802416|NCT01807585|3629740|B4|||Age||years|Mean|50.1|50.1|Full Range|||25.0|70.0|
3802417|NCT01807585|3629741|B3|||Age||years|Mean|50.5|50.5|Full Range|||25.0|70.0|
3802418|NCT01807585|3629742|B2|||Age||years|Mean|49.0|49.0|Full Range|||26.0|70.0|
3802419|NCT01807585|3629743|B1|||Age||years|Mean|53.1|53.1|Full Range|||36.0|65.0|
3802420|NCT01807520|3629758|B4||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3802421|NCT01807520|3629759|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3802422|NCT01807520|3629760|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3802423|NCT01807520|3629761|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3802424|NCT01807520|3629758|B4||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3802425|NCT01807520|3629759|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3802426|NCT01807520|3629760|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3802427|NCT01807520|3629761|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3802428|NCT01807520|3629758|B4|||Age||Years|Mean|44.1|44.1|Standard Deviation|11.68|11.68|||
3802429|NCT01807520|3629759|B3|||Age||Years|Mean|43.6|43.6|Standard Deviation|11.2|11.2|||
3802430|NCT01807520|3629760|B2|||Age||Years|Mean|45.1|45.1|Standard Deviation|12.9|12.9|||
3802431|NCT01807520|3629761|B1|||Age||Years|Mean|43.5|43.5|Standard Deviation|10.94|10.94|||
3802432|NCT01807455|3629786|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3802433|NCT01807455|3629786|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3802434|NCT01807455|3629786|B1|||Age||years|Mean|33|33.0|Full Range|||27.0|43.0|
3802435|NCT01807234|3629794|B7|United States||Region of Enrollment||participants|Number|72|72.0||||||
3802436|NCT01807234|3629795|B6|United States||Region of Enrollment||participants|Number|12|12.0||||||
3802437|NCT01807234|3629796|B5|United States||Region of Enrollment||participants|Number|12|12.0||||||
3802438|NCT01807234|3629797|B4|United States||Region of Enrollment||participants|Number|12|12.0||||||
3802439|NCT01807234|3629798|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3802440|NCT01807234|3629799|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3802441|NCT01807234|3629800|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3802442|NCT01807234|3629794|B7||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3802443|NCT01807234|3629795|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3802444|NCT01807234|3629796|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3802445|NCT01807234|3629797|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3802446|NCT01807234|3629798|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3802447|NCT01807234|3629799|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3802448|NCT01807234|3629800|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3802449|NCT01807234|3629794|B7||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3802450|NCT01807234|3629795|B6||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3802451|NCT01807234|3629796|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3802452|NCT01807234|3629797|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3802453|NCT01807234|3629798|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3802454|NCT01807234|3629799|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3802455|NCT01807234|3629800|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3802456|NCT01807234|3629794|B7|||Age|Average age of participants|years|Mean|36.3|36.3|Standard Deviation|9.8|9.8|||
3802457|NCT01807234|3629795|B6|||Age|Average age of participants|years|Mean|36.3|36.3|Standard Deviation|9.8|9.8|||
3802458|NCT01807234|3629796|B5|||Age|Average age of participants|years|Mean|36.3|36.3|Standard Deviation|9.8|9.8|||
3802459|NCT01807234|3629797|B4|||Age|Average age of participants|years|Mean|36.3|36.3|Standard Deviation|9.8|9.8|||
3802460|NCT01807234|3629798|B3|||Age|Average age of participants|years|Mean|36.3|36.3|Standard Deviation|9.8|9.8|||
3802461|NCT01807234|3629799|B2|||Age|Average age of participants|years|Mean|36.3|36.3|Standard Deviation|9.8|9.8|||
3802462|NCT01807234|3629800|B1|||Age|Average age of participants|years|Mean|36.3|36.3|Standard Deviation|9.8|9.8|||
3802463|NCT01807234|3629794|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3802464|NCT01807234|3629795|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3802465|NCT01807234|3629796|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3802466|NCT01807234|3629797|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3802467|NCT01807234|3629798|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3802468|NCT01807234|3629799|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3802469|NCT01807234|3629800|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3802470|NCT01807234|3629794|B7||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
3802471|NCT01807234|3629795|B6||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3802472|NCT01807234|3629796|B5||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3802473|NCT01807234|3629797|B4||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3802474|NCT01807234|3629798|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3802475|NCT01807234|3629799|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3802476|NCT01807234|3629800|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3802477|NCT01807234|3629794|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3802478|NCT01807234|3629795|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3802479|NCT01807234|3629796|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3802480|NCT01807234|3629797|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3802481|NCT01807234|3629798|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3802482|NCT01807234|3629799|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3802483|NCT01807234|3629800|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3802484|NCT01807156|3629840|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3802485|NCT01807156|3629840|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802486|NCT01807156|3629840|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802487|NCT01807156|3629840|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3802488|NCT01807156|3629840|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802489|NCT01807156|3629840|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802490|NCT01807156|3629840|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802491|NCT01807156|3629840|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802492|NCT01807156|3629840|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3802493|NCT01807156|3629840|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3802494|NCT01807156|3629840|B1|||Age||years|Median|55|55.0|Full Range|||31.0|66.0|
3802495|NCT01807000|3629845|B1|UNITED STATES||Region of Enrollment||Participants|Number|6|6.0||||||
3802496|NCT01807000|3629845|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3802497|NCT01807000|3629845|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3802498|NCT01807000|3629845|B1|18 - 64||Age, Customized||Participants|Number|6|6.0||||||
3802499|NCT01807000|3629845|B1|||Age||Years|Mean|35.5|35.5|Standard Deviation|10.45|10.45|||
3802500|NCT01806961|3629864|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3802501|NCT01806961|3629864|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3802502|NCT01806961|3629864|B1|||Age||years|Median|73|73.0|Full Range|||53.0|93.0|
3802503|NCT01806896|3629868|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3802504|NCT01806896|3629869|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3802505|NCT01806896|3629870|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3802506|NCT01806896|3629868|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3802507|NCT01806896|3629869|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3802508|NCT01806896|3629870|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3802509|NCT01806896|3629868|B3|||Age||years|Mean|45.4|45.4|Standard Deviation|12.0|12.0|||
3802510|NCT01806896|3629869|B2|||Age||years|Mean|43.1|43.1|Standard Deviation|11.8|11.8|||
3802511|NCT01806896|3629870|B1|||Age||years|Mean|47.4|47.4|Standard Deviation|12.1|12.1|||
3802512|NCT01806857|3629899|B1|||Baseline CNS Lability Scale Total Score|The Center for Neurologic Study-Lability Scale (CNS-LS) is a 7-item self report scale that assesses pseudobulbar affect (PBA) by measuring the perceived frequency of PBA episodes (laughing or crying). Each item is scored using a 5-point Likert scale, from 1 (applies never) to 5 (applies most of the time). Scores range from 5-35.|units on a scale|Mean|13.67|13.67|Standard Deviation|5.55|5.55|||
3802513|NCT01806857|3629899|B1|||Baseline ALSFRS-R Total Score|The ALSFRS-R is a quickly administered (5 min) ordinal rating scale used to determine a subject's assessment of their capability and independence in 12 functional activities. There are 12 questions, graded by the subject 0-4 (4 is normal). Score of 0 (worst) to 48 (best). Reflects speech and swallowing, fine motor skills, large motor skills, and breathing.|units on a scale|Mean|34.58|34.58|Standard Deviation|6.95|6.95|||
3802514|NCT01806857|3629899|B1|||Baseline CNS-BFS Total Score|The Center for Neurologic Study-Bulbar Function Scale (CNS-BFS) is a 21-item self report scale that assesses three domains of bulbar function: speech, swallowing and salivation (sialorrhea). Scores for each question range from 1 (does not apply) to 5 (applies most of the time). The higher the score, the worse the speech, swallowing and salivation (sialorrhea). [Range of score: 21-105]|units on a scale|Mean|58.15|58.15|Standard Deviation|13.37|13.37|||
3802515|NCT01806857|3629899|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
3802516|NCT01806857|3629899|B1|Caucasian/White||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
3802517|NCT01806857|3629899|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3802518|NCT01806857|3629899|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3802519|NCT01806857|3629899|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3802520|NCT01806857|3629899|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3802521|NCT01806857|3629899|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3802522|NCT01806857|3629899|B1|||Age||years|Mean|58|58.0|Inter-Quartile Range|||26.0|78.0|
3802523|NCT01806779|3629936|B3|United States||Region of Enrollment||participants|Number|174|174.0||||||
3802524|NCT01806779|3629937|B2|United States||Region of Enrollment||participants|Number|84|84.0||||||
3802525|NCT01806779|3629938|B1|United States||Region of Enrollment||participants|Number|90|90.0||||||
3802526|NCT01806779|3629936|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3802527|NCT01806779|3629937|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802528|NCT01806779|3629938|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3802529|NCT01806779|3629936|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802530|NCT01806779|3629937|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802531|NCT01806779|3629938|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802532|NCT01806779|3629936|B3||White|Race (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
3802533|NCT01806779|3629937|B2||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3802534|NCT01806779|3629938|B1||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3802535|NCT01806779|3629936|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3802536|NCT01806779|3629937|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3802537|NCT01806779|3629938|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3802834|NCT01805687|3630150|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3802538|NCT01806779|3629936|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802539|NCT01806779|3629937|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802540|NCT01806779|3629938|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802541|NCT01806779|3629936|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802542|NCT01806779|3629937|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802543|NCT01806779|3629938|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802544|NCT01806779|3629936|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802545|NCT01806779|3629937|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802546|NCT01806779|3629938|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802547|NCT01806779|3629936|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802548|NCT01806779|3629937|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802549|NCT01806779|3629938|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802550|NCT01806779|3629936|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|171|171.0||||||
3802551|NCT01806779|3629937|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3802552|NCT01806779|3629938|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3802553|NCT01806779|3629936|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3802554|NCT01806779|3629937|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802555|NCT01806779|3629938|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3802556|NCT01806779|3629936|B3||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3802557|NCT01806779|3629937|B2||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3802558|NCT01806779|3629938|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3802559|NCT01806779|3629936|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3802560|NCT01806779|3629937|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3802561|NCT01806779|3629938|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3802562|NCT01806779|3629936|B3|||Age||years|Mean|43.96|43.96|Standard Deviation|10.992|10.992|||
3802563|NCT01806779|3629937|B2|||Age||years|Mean|43.12|43.12|Standard Deviation|10.562|10.562|||
3802564|NCT01806779|3629938|B1|||Age||years|Mean|44.75|44.75|Standard Deviation|11.381|11.381|||
3802565|NCT01806779|3629936|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3802566|NCT01806779|3629937|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3802567|NCT01806779|3629938|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3802568|NCT01806779|3629936|B3||Between 18 and 65 years|Age||Participants|Count of Participants|174|174.0||||||
3802569|NCT01806779|3629937|B2||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
3802570|NCT01806779|3629938|B1||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
3802571|NCT01806779|3629936|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3802572|NCT01806779|3629937|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3802573|NCT01806779|3629938|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3802574|NCT01806714|3629953|B3||Male|Sex: Female, Male||Participants|Count of Participants|2081|2081.0||||||
3802575|NCT01806714|3629954|B2||Male|Sex: Female, Male||Participants|Count of Participants|1051|1051.0||||||
3802576|NCT01806714|3629955|B1||Male|Sex: Female, Male||Participants|Count of Participants|1030|1030.0||||||
3802577|NCT01806714|3629953|B3||Female|Sex: Female, Male||Participants|Count of Participants|1731|1731.0||||||
3802578|NCT01806714|3629954|B2||Female|Sex: Female, Male||Participants|Count of Participants|868|868.0||||||
3802579|NCT01806714|3629955|B1||Female|Sex: Female, Male||Participants|Count of Participants|863|863.0||||||
3802580|NCT01806714|3629953|B3|16 year olds||Age, Customized||participants|Number|515|515.0||||||
3802581|NCT01806714|3629954|B2|16 year olds||Age, Customized||participants|Number|250|250.0||||||
3802582|NCT01806714|3629955|B1|16 year olds||Age, Customized||participants|Number|265|265.0||||||
3802583|NCT01806714|3629953|B3|15 year olds||Age, Customized||participants|Number|541|541.0||||||
3802584|NCT01806714|3629954|B2|15 year olds||Age, Customized||participants|Number|270|270.0||||||
3802585|NCT01806714|3629955|B1|15 year olds||Age, Customized||participants|Number|271|271.0||||||
3802586|NCT01806714|3629953|B3|14 year olds||Age, Customized||participants|Number|569|569.0||||||
3802587|NCT01806714|3629954|B2|14 year olds||Age, Customized||participants|Number|288|288.0||||||
3802588|NCT01806714|3629955|B1|14 year olds||Age, Customized||participants|Number|281|281.0||||||
3802589|NCT01806714|3629953|B3|13 year olds||Age, Customized||participants|Number|631|631.0||||||
3802590|NCT01806714|3629954|B2|13 year olds||Age, Customized||participants|Number|324|324.0||||||
3802591|NCT01806714|3629955|B1|13 year olds||Age, Customized||participants|Number|307|307.0||||||
3802592|NCT01806714|3629953|B3|12 year olds||Age, Customized||participants|Number|721|721.0||||||
3802593|NCT01806714|3629954|B2|12 year olds||Age, Customized||participants|Number|380|380.0||||||
3802594|NCT01806714|3629955|B1|12 year olds||Age, Customized||participants|Number|341|341.0||||||
3802595|NCT01806714|3629953|B3|11 year olds||Age, Customized||participants|Number|835|835.0||||||
3802596|NCT01806714|3629954|B2|11 year olds||Age, Customized||participants|Number|407|407.0||||||
3802597|NCT01806714|3629955|B1|11 year olds||Age, Customized||participants|Number|428|428.0||||||
3802598|NCT01806662|3629966|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802599|NCT01806662|3629966|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802600|NCT01806662|3629966|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3802601|NCT01806662|3629966|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3802602|NCT01806662|3629966|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802603|NCT01806662|3629966|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3802604|NCT01806662|3629966|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802605|NCT01806662|3629966|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3802606|NCT01806662|3629966|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3802607|NCT01806662|3629966|B1|||Age||years|Mean|38.5|38.5|Full Range|||18.0|61.0|
3802608|NCT01806662|3629966|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3802609|NCT01806662|3629966|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3802610|NCT01806662|3629966|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3802611|NCT01806623|3629973|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3802612|NCT01806623|3629973|B1||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3802613|NCT01806623|3629973|B1|||Age||years|Mean|31.8|31.8|Standard Deviation|8.5|8.5|||
3802614|NCT01806597|3629990|B4||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3802615|NCT01806597|3629991|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3802616|NCT01806597|3629992|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3802617|NCT01806597|3629993|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3802618|NCT01806597|3629990|B4||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3802619|NCT01806597|3629991|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3802620|NCT01806597|3629992|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3802621|NCT01806597|3629993|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3802622|NCT01806597|3629990|B4|||Age||years|Mean|50.7|50.7|Standard Deviation|13.28|13.28|||
3802623|NCT01806597|3629991|B3|||Age||years|Mean|50.9|50.9|Standard Deviation|12.95|12.95|||
3802624|NCT01806597|3629992|B2|||Age||years|Mean|48.8|48.8|Standard Deviation|14.21|14.21|||
3802625|NCT01806597|3629993|B1|||Age||years|Mean|52.4|52.4|Standard Deviation|12.56|12.56|||
3802626|NCT01806584|3630032|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3802627|NCT01806584|3630033|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3802628|NCT01806584|3630034|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3802629|NCT01806584|3630032|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3802630|NCT01806584|3630033|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3802631|NCT01806584|3630034|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3802632|NCT01806584|3630032|B3|≥65 years||Age, Customized||participants|Number|11|11.0||||||
3802633|NCT01806584|3630033|B2|≥65 years||Age, Customized||participants|Number|6|6.0||||||
3802634|NCT01806584|3630034|B1|≥65 years||Age, Customized||participants|Number|5|5.0||||||
3802635|NCT01806584|3630032|B3|<65 years||Age, Customized||participants|Number|21|21.0||||||
3802636|NCT01806584|3630033|B2|<65 years||Age, Customized||participants|Number|12|12.0||||||
3802637|NCT01806584|3630034|B1|<65 years||Age, Customized||participants|Number|9|9.0||||||
3802638|NCT01806584|3630032|B3|||Age||years|Mean|61.7|61.7|Standard Deviation|8.8|8.8|||
3802639|NCT01806584|3630033|B2|||Age||years|Mean|60.9|60.9|Standard Deviation|7.9|7.9|||
3802640|NCT01806584|3630034|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|10.0|10.0|||
3802641|NCT01806545|3630047|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3802642|NCT01806545|3630048|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3802643|NCT01806545|3630049|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3802644|NCT01806545|3630047|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3802645|NCT01806545|3630048|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3802646|NCT01806545|3630049|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3802647|NCT01806545|3630047|B3|≥65 years||Age, Customized||participants|Number|29|29.0||||||
3802648|NCT01806545|3630048|B2|≥65 years||Age, Customized||participants|Number|12|12.0||||||
3802649|NCT01806545|3630049|B1|≥65 years||Age, Customized||participants|Number|17|17.0||||||
3802650|NCT01806545|3630047|B3|<65 years||Age, Customized||participants|Number|35|35.0||||||
3802651|NCT01806545|3630048|B2|<65 years||Age, Customized||participants|Number|23|23.0||||||
3802652|NCT01806545|3630049|B1|<65 years||Age, Customized||participants|Number|12|12.0||||||
3802653|NCT01806545|3630047|B3|||Age||years|Mean|63.0|63.0|Standard Deviation|12.2|12.2|||
3802654|NCT01806545|3630048|B2|||Age||years|Mean|61.1|61.1|Standard Deviation|10.8|10.8|||
3802655|NCT01806545|3630049|B1|||Age||years|Mean|65.2|65.2|Standard Deviation|13.5|13.5|||
3802656|NCT01806389|3630072|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802657|NCT01806389|3630072|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802658|NCT01806389|3630072|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3802659|NCT01806389|3630072|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802660|NCT01806389|3630072|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802661|NCT01806389|3630072|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802662|NCT01806389|3630072|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802663|NCT01806389|3630072|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3802664|NCT01806389|3630072|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3802665|NCT01806389|3630072|B1|||Age||years|Mean|26.1|26.1|Standard Deviation|4.7|4.7|||
3802666|NCT01806389|3630072|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3802667|NCT01806389|3630072|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3802668|NCT01806389|3630072|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3802669|NCT01806298|3630086|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3802670|NCT01806298|3630086|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3802671|NCT01806298|3630086|B1|||Age||years|Mean|44.5|44.5|Standard Deviation|12.61|12.61|||
3802672|NCT01805895|3630102|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
3802673|NCT01805895|3630103|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3802674|NCT01805895|3630104|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3802675|NCT01805895|3630102|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3802676|NCT01805895|3630103|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3802677|NCT01805895|3630104|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3802678|NCT01805895|3630102|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3802679|NCT01805895|3630103|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3802680|NCT01805895|3630104|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3802681|NCT01805895|3630102|B3|||Age||years|Mean|61.9|61.9|Standard Deviation|12.7|12.7|||
3802682|NCT01805895|3630103|B2|||Age||years|Mean|61.8|61.8|Standard Deviation|11.5|11.5|||
3802683|NCT01805895|3630104|B1|||Age||years|Mean|62|62.0|Standard Deviation|14.6|14.6|||
3802684|NCT01805882|3630113|B10||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3802685|NCT01805882|3630114|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802686|NCT01805882|3630115|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802687|NCT01805882|3630116|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3802688|NCT01805882|3630117|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802689|NCT01805882|3630118|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802690|NCT01805882|3630119|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802691|NCT01805882|3630120|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802692|NCT01805882|3630121|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802693|NCT01805882|3630122|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802694|NCT01805882|3630113|B10||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3802695|NCT01805882|3630114|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802696|NCT01805882|3630115|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802697|NCT01805882|3630116|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3802698|NCT01805882|3630117|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802699|NCT01805882|3630118|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802700|NCT01805882|3630119|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802701|NCT01805882|3630120|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802702|NCT01805882|3630121|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802703|NCT01805882|3630122|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802704|NCT01805882|3630113|B10||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3802705|NCT01805882|3630114|B9||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3802706|NCT01805882|3630115|B8||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3802707|NCT01805882|3630116|B7||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3802708|NCT01805882|3630117|B6||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3802709|NCT01805882|3630118|B5||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802710|NCT01805882|3630119|B4||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3802711|NCT01805882|3630120|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3802712|NCT01805882|3630121|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802713|NCT01805882|3630122|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3802714|NCT01805882|3630113|B10||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|169|169.0||||||
3802715|NCT01805882|3630114|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3802716|NCT01805882|3630115|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3802717|NCT01805882|3630116|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3802718|NCT01805882|3630117|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3802719|NCT01805882|3630118|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3802720|NCT01805882|3630119|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3802721|NCT01805882|3630120|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3802722|NCT01805882|3630121|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3802723|NCT01805882|3630122|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3802724|NCT01805882|3630113|B10||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802725|NCT01805882|3630114|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802726|NCT01805882|3630115|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802727|NCT01805882|3630116|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802728|NCT01805882|3630117|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802729|NCT01805882|3630118|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802730|NCT01805882|3630119|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802731|NCT01805882|3630120|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802732|NCT01805882|3630121|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802733|NCT01805882|3630122|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802734|NCT01805882|3630113|B10||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802735|NCT01805882|3630114|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802736|NCT01805882|3630115|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802737|NCT01805882|3630116|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802738|NCT01805882|3630117|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802739|NCT01805882|3630118|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802740|NCT01805882|3630119|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802741|NCT01805882|3630120|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802742|NCT01805882|3630121|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802743|NCT01805882|3630122|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802744|NCT01805882|3630113|B10||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3802745|NCT01805882|3630114|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802746|NCT01805882|3630115|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802747|NCT01805882|3630116|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802748|NCT01805882|3630117|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802749|NCT01805882|3630118|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802750|NCT01805882|3630119|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802751|NCT01805882|3630120|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802752|NCT01805882|3630121|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802753|NCT01805882|3630122|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802754|NCT01805882|3630113|B10||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802755|NCT01805882|3630114|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802756|NCT01805882|3630115|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802757|NCT01805882|3630116|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802758|NCT01805882|3630117|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802759|NCT01805882|3630118|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802760|NCT01805882|3630119|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802761|NCT01805882|3630120|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802762|NCT01805882|3630121|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802763|NCT01805882|3630122|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802764|NCT01805882|3630113|B10||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|223|223.0||||||
3802765|NCT01805882|3630114|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3802766|NCT01805882|3630115|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3802767|NCT01805882|3630116|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3802768|NCT01805882|3630117|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3802769|NCT01805882|3630118|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3802770|NCT01805882|3630119|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3802771|NCT01805882|3630120|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3802772|NCT01805882|3630121|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3802773|NCT01805882|3630122|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3802774|NCT01805882|3630113|B10||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3802775|NCT01805882|3630114|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802776|NCT01805882|3630115|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802777|NCT01805882|3630116|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3802778|NCT01805882|3630117|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802779|NCT01805882|3630118|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802780|NCT01805882|3630119|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802781|NCT01805882|3630120|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802782|NCT01805882|3630121|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802783|NCT01805882|3630122|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802784|NCT01805882|3630113|B10||Male|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3802785|NCT01805882|3630114|B9||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3802786|NCT01805882|3630115|B8||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3802787|NCT01805882|3630116|B7||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3802788|NCT01805882|3630117|B6||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3802789|NCT01805882|3630118|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3802790|NCT01805882|3630119|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3802791|NCT01805882|3630120|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3802792|NCT01805882|3630121|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3802793|NCT01805882|3630122|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3802794|NCT01805882|3630113|B10||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3802795|NCT01805882|3630114|B9||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3802796|NCT01805882|3630115|B8||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3802797|NCT01805882|3630116|B7||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3802798|NCT01805882|3630117|B6||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3802799|NCT01805882|3630118|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3802800|NCT01805882|3630119|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3802801|NCT01805882|3630120|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3802802|NCT01805882|3630121|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3802803|NCT01805882|3630122|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3802804|NCT01805882|3630113|B10||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3802805|NCT01805882|3630114|B9||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3802806|NCT01805882|3630115|B8||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3802807|NCT01805882|3630116|B7||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3802808|NCT01805882|3630117|B6||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3802809|NCT01805882|3630118|B5||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3802810|NCT01805882|3630119|B4||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3802811|NCT01805882|3630120|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3802812|NCT01805882|3630121|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3802813|NCT01805882|3630122|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3802814|NCT01805882|3630113|B10||Between 18 and 65 years|Age||Participants|Count of Participants|205|205.0||||||
3802815|NCT01805882|3630114|B9||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3802816|NCT01805882|3630115|B8||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3802817|NCT01805882|3630116|B7||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
3802818|NCT01805882|3630117|B6||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3802819|NCT01805882|3630118|B5||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3802820|NCT01805882|3630119|B4||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3802821|NCT01805882|3630120|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3802822|NCT01805882|3630121|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3802823|NCT01805882|3630122|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3802824|NCT01805882|3630113|B10||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3802825|NCT01805882|3630114|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3802826|NCT01805882|3630115|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3802827|NCT01805882|3630116|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3802828|NCT01805882|3630117|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3802829|NCT01805882|3630118|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3802830|NCT01805882|3630119|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3802831|NCT01805882|3630120|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3802832|NCT01805882|3630121|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3802833|NCT01805882|3630122|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3802835|NCT01805687|3630150|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3802836|NCT01805687|3630150|B1|||Age||years|Mean|35|35.0|Standard Deviation|10.2|10.2|||
3802837|NCT01805440|3630154|B4|United States||Region of Enrollment||participants|Number|62|62.0||||||
3802838|NCT01805440|3630155|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
3802839|NCT01805440|3630156|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3802840|NCT01805440|3630157|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3802841|NCT01805440|3630154|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3802842|NCT01805440|3630155|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3802843|NCT01805440|3630156|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3802844|NCT01805440|3630157|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3802845|NCT01805440|3630154|B4||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3802846|NCT01805440|3630155|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3802847|NCT01805440|3630156|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3802848|NCT01805440|3630157|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3802849|NCT01805440|3630154|B4|||Age||years|Mean|17.47|17.47|Standard Deviation|2.54|2.54|||
3802850|NCT01805440|3630155|B3|||Age||years|Mean|18.54|18.54|Standard Deviation|2.37|2.37|||
3802851|NCT01805440|3630156|B2|||Age||years|Mean|18.29|18.29|Standard Deviation|2.62|2.62|||
3802852|NCT01805440|3630157|B1|||Age||years|Mean|16.74|16.74|Standard Deviation|2.28|2.28|||
3802853|NCT01805440|3630154|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3802854|NCT01805440|3630155|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3802855|NCT01805440|3630156|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3802856|NCT01805440|3630157|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3802857|NCT01805440|3630154|B4||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3802858|NCT01805440|3630155|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3802859|NCT01805440|3630156|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3802860|NCT01805440|3630157|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3802861|NCT01805440|3630154|B4||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
3802862|NCT01805440|3630155|B3||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3802863|NCT01805440|3630156|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3802864|NCT01805440|3630157|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
3802865|NCT01805323|3630172|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3802866|NCT01805323|3630172|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3802867|NCT01805323|3630172|B1|||Age||Years|Mean|60.9|60.9|Standard Deviation|14.8|14.8|||
3802868|NCT01805297|3630177|B3|||Central retinal thickness||Microns|Mean|304.5|304.5|Full Range|||304.0|305.0|
3802869|NCT01805297|3630178|B2|||Central retinal thickness||Microns|Mean|305|305.0|Full Range|||305.0|305.0|
3802870|NCT01805297|3630179|B1|||Central retinal thickness||Microns|Mean|304|304.0|Full Range|||304.0|304.0|
3802871|NCT01805297|3630177|B3|||Intraocular pressure||mmHg|Mean|12.6|12.6|Full Range|||6.0|18.0|
3802872|NCT01805297|3630178|B2|||Intraocular pressure||mmHg|Mean|11.2|11.2|Full Range|||6.0|18.0|
3802873|NCT01805297|3630179|B1|||Intraocular pressure||mmHg|Mean|14|14.0|Full Range|||10.0|18.0|
3802874|NCT01805297|3630177|B3|||Mean visual acuity|"Number of letters read on the Early Treatment Diabetic Retinopathy Study visual acuity chart. a higher number indicates a better visual acuity (example, 0 means no letters could be read while 100 means all 100 letters present on chart were read)"|number of letters read on ETDRS Chart|Mean|15.9|15.9|Full Range|||0.0|100.0|
3802875|NCT01805297|3630178|B2|||Mean visual acuity|"Number of letters read on the Early Treatment Diabetic Retinopathy Study visual acuity chart. a higher number indicates a better visual acuity (example, 0 means no letters could be read while 100 means all 100 letters present on chart were read)"|number of letters read on ETDRS Chart|Mean|17.7|17.7|Full Range|||0.0|100.0|
3802876|NCT01805297|3630179|B1|||Mean visual acuity|"Number of letters read on the Early Treatment Diabetic Retinopathy Study visual acuity chart. a higher number indicates a better visual acuity (example, 0 means no letters could be read while 100 means all 100 letters present on chart were read)"|number of letters read on ETDRS Chart|Mean|13.8|13.8|Full Range|||0.0|100.0|
3802877|NCT01805297|3630177|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3802878|NCT01805297|3630178|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3802879|NCT01805297|3630179|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3802880|NCT01805297|3630177|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802881|NCT01805297|3630178|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802882|NCT01805297|3630179|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802883|NCT01805297|3630177|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802884|NCT01805297|3630178|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802885|NCT01805297|3630179|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802886|NCT01805297|3630177|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3802887|NCT01805297|3630178|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3802888|NCT01805297|3630179|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3802889|NCT01805297|3630177|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802890|NCT01805297|3630178|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802891|NCT01805297|3630179|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802892|NCT01805297|3630177|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802893|NCT01805297|3630178|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802894|NCT01805297|3630179|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802895|NCT01805297|3630177|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802896|NCT01805297|3630178|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802897|NCT01805297|3630179|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802898|NCT01805297|3630177|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3802899|NCT01805297|3630178|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802900|NCT01805297|3630179|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802901|NCT01805297|3630177|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3802902|NCT01805297|3630178|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3802903|NCT01805297|3630179|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3802904|NCT01805297|3630177|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3802905|NCT01805297|3630178|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3802906|NCT01805297|3630179|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3802907|NCT01805297|3630177|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3802908|NCT01805297|3630178|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3802909|NCT01805297|3630179|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3802910|NCT01805297|3630177|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3802911|NCT01805297|3630178|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3802912|NCT01805297|3630179|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3802913|NCT01805297|3630177|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3802914|NCT01805297|3630178|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3802915|NCT01805297|3630179|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3802916|NCT01805180|3630192|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802917|NCT01805180|3630193|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802918|NCT01805180|3630194|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802919|NCT01805180|3630192|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3802920|NCT01805180|3630193|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3802921|NCT01805180|3630194|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3802922|NCT01805180|3630192|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3802923|NCT01805180|3630193|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802924|NCT01805180|3630194|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3802925|NCT01805180|3630192|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3802926|NCT01805180|3630193|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802927|NCT01805180|3630194|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802928|NCT01805180|3630192|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802929|NCT01805180|3630193|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802930|NCT01805180|3630194|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802931|NCT01805180|3630192|B3||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3802932|NCT01805180|3630193|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3802933|NCT01805180|3630194|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3802934|NCT01805180|3630192|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802935|NCT01805180|3630193|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802936|NCT01805180|3630194|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802937|NCT01805180|3630192|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802938|NCT01805180|3630193|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802939|NCT01805180|3630194|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802940|NCT01805180|3630192|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802941|NCT01805180|3630193|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3802942|NCT01805180|3630194|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802943|NCT01805180|3630192|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802944|NCT01805180|3630193|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802945|NCT01805180|3630194|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3802946|NCT01805180|3630192|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3802947|NCT01805180|3630193|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3802948|NCT01805180|3630194|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3802949|NCT01805180|3630192|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3802950|NCT01805180|3630193|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3802951|NCT01805180|3630194|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3802952|NCT01805180|3630192|B3|||Age||years|Mean|36.3|36.3|Standard Deviation|12.27|12.27|||
3802953|NCT01805180|3630193|B2|||Age||years|Mean|38.3|38.3|Standard Deviation|13.69|13.69|||
3802954|NCT01805180|3630194|B1|||Age||years|Mean|34.5|34.5|Standard Deviation|10.99|10.99|||
3802955|NCT01805089|3630219|B3|||Mood||CESD global score|Mean|6.3|6.3|Standard Deviation|5.9|5.9|||
3802956|NCT01805089|3630220|B2|||Mood||CESD global score|Mean|6.0|6.0|Standard Deviation|6.3|6.3|||
3802957|NCT01805089|3630221|B1|||Mood||CESD global score|Mean|6.7|6.7|Standard Deviation|5.5|5.5|||
3802958|NCT01805089|3630219|B3|||Hot Flashes||hot flash score|Mean|5.1|5.1|Standard Deviation|5.9|5.9|||
3802959|NCT01805089|3630220|B2|||Hot Flashes||hot flash score|Mean|4.5|4.5|Standard Deviation|5.2|5.2|||
3802960|NCT01805089|3630221|B1|||Hot Flashes||hot flash score|Mean|5.5|5.5|Standard Deviation|6.5|6.5|||
3802961|NCT01805089|3630219|B3|||Sleep (Pittsburgh Sleep Quality Index)|Pittsburgh Sleep Quality Index measures average sleep quality based on self-report over past 7 days. Range is 0 to 21. Higher values are considered worse. There are 7 subscales which are added together.|units on a scale|Mean|6.4|6.4|Standard Deviation|3.9|3.9|||
3802962|NCT01805089|3630220|B2|||Sleep (Pittsburgh Sleep Quality Index)|Pittsburgh Sleep Quality Index measures average sleep quality based on self-report over past 7 days. Range is 0 to 21. Higher values are considered worse. There are 7 subscales which are added together.|units on a scale|Mean|5.5|5.5|Standard Deviation|3.3|3.3|||
3802963|NCT01805089|3630221|B1|||Sleep (Pittsburgh Sleep Quality Index)|Pittsburgh Sleep Quality Index measures average sleep quality based on self-report over past 7 days. Range is 0 to 21. Higher values are considered worse. There are 7 subscales which are added together.|units on a scale|Mean|7.2|7.2|Standard Deviation|4.2|4.2|||
3802964|NCT01805089|3630219|B3|||Insulin-like Growth Factor 1||ng/ml|Mean|179.89|179.89|Standard Deviation|53.6|53.6|||
3802965|NCT01805089|3630220|B2|||Insulin-like Growth Factor 1||ng/ml|Mean|177.83|177.83|Standard Deviation|46.67|46.67|||
3802966|NCT01805089|3630221|B1|||Insulin-like Growth Factor 1||ng/ml|Mean|181.95|181.95|Standard Deviation|60.22|60.22|||
3802967|NCT01805089|3630219|B3|||Estradiol||pg/ml|Mean|3.97|3.97|Standard Deviation|3.29|3.29|||
3802968|NCT01805089|3630220|B2|||Estradiol||pg/ml|Mean|3.35|3.35|Standard Deviation|2.19|2.19|||
3802969|NCT01805089|3630221|B1|||Estradiol||pg/ml|Mean|4.59|4.59|Standard Deviation|4.03|4.03|||
3802970|NCT01805089|3630219|B3|||Body Mass Index (BMI)||Kg/m2|Median|25.6|25.6|Full Range|||19.1|44.9|
3802971|NCT01805089|3630220|B2|||Body Mass Index (BMI)||Kg/m2|Median|25.0|25.0|Full Range|||19.1|39.6|
3802972|NCT01805089|3630221|B1|||Body Mass Index (BMI)||Kg/m2|Median|25.7|25.7|Full Range|||20.1|44.9|
3802973|NCT01805089|3630219|B3|Former Smoker||Smoking Status||participants|Number|45|45.0||||||
3802974|NCT01805089|3630220|B2|Former Smoker||Smoking Status||participants|Number|23|23.0||||||
3802975|NCT01805089|3630221|B1|Former Smoker||Smoking Status||participants|Number|22|22.0||||||
3802976|NCT01805089|3630219|B3|Non-Smoker||Smoking Status||participants|Number|47|47.0||||||
3802977|NCT01805089|3630220|B2|Non-Smoker||Smoking Status||participants|Number|22|22.0||||||
3802978|NCT01805089|3630221|B1|Non-Smoker||Smoking Status||participants|Number|25|25.0||||||
3802979|NCT01805089|3630219|B3|Current Smoker||Smoking Status||participants|Number|2|2.0||||||
3802980|NCT01805089|3630220|B2|Current Smoker||Smoking Status||participants|Number|1|1.0||||||
3802981|NCT01805089|3630221|B1|Current Smoker||Smoking Status||participants|Number|1|1.0||||||
3802982|NCT01805089|3630219|B3|Missing||Smoking Status||participants|Number|1|1.0||||||
3802983|NCT01805089|3630220|B2|Missing||Smoking Status||participants|Number|1|1.0||||||
3802984|NCT01805089|3630221|B1|Missing||Smoking Status||participants|Number|0|0.0||||||
3802985|NCT01805089|3630219|B3|Stage III||Cancer Stage||participants|Number|10|10.0||||||
3802986|NCT01805089|3630220|B2|Stage III||Cancer Stage||participants|Number|4|4.0||||||
3802987|NCT01805089|3630221|B1|Stage III||Cancer Stage||participants|Number|6|6.0||||||
3802988|NCT01805089|3630219|B3|Stage II||Cancer Stage||participants|Number|37|37.0||||||
3802989|NCT01805089|3630220|B2|Stage II||Cancer Stage||participants|Number|22|22.0||||||
3802990|NCT01805089|3630221|B1|Stage II||Cancer Stage||participants|Number|15|15.0||||||
3802991|NCT01805089|3630219|B3|Stage I||Cancer Stage||participants|Number|36|36.0||||||
3802992|NCT01805089|3630220|B2|Stage I||Cancer Stage||participants|Number|15|15.0||||||
3802993|NCT01805089|3630221|B1|Stage I||Cancer Stage||participants|Number|21|21.0||||||
3802994|NCT01805089|3630219|B3|Stage 0||Cancer Stage||participants|Number|12|12.0||||||
3802995|NCT01805089|3630220|B2|Stage 0||Cancer Stage||participants|Number|6|6.0||||||
3802996|NCT01805089|3630221|B1|Stage 0||Cancer Stage||participants|Number|6|6.0||||||
3802997|NCT01805089|3630219|B3|United States||Region of Enrollment||participants|Number|95|95.0||||||
3802998|NCT01805089|3630220|B2|United States||Region of Enrollment||participants|Number|47|47.0||||||
3802999|NCT01805089|3630221|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
3803000|NCT01805089|3630219|B3|Multi-racial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3803001|NCT01805089|3630220|B2|Multi-racial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3803002|NCT01805089|3630221|B1|Multi-racial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3803003|NCT01805089|3630219|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3803004|NCT01805089|3630220|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3803005|NCT01805089|3630221|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3803006|NCT01805089|3630219|B3|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3803007|NCT01805089|3630220|B2|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3803008|NCT01805089|3630221|B1|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3803009|NCT01805089|3630219|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|91|91.0||||||
3803010|NCT01805089|3630220|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
3803011|NCT01805089|3630221|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
3803012|NCT01805089|3630219|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3803013|NCT01805089|3630220|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3803014|NCT01805089|3630221|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3803015|NCT01805089|3630219|B3||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3803016|NCT01805089|3630220|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3803017|NCT01805089|3630221|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3803018|NCT01805089|3630219|B3|||Age||years|Median|59|59.0|Full Range|||38.0|71.0|
3803019|NCT01805089|3630220|B2|||Age||years|Median|60|60.0|Full Range|||38.0|71.0|
3803020|NCT01805089|3630221|B1|||Age||years|Median|58|58.0|Full Range|||48.0|70.0|
3803021|NCT01804946|3630232|B3|Russian Federation||Region of Enrollment||participants|Number|161|161.0||||||
3803022|NCT01804946|3630233|B2|Russian Federation||Region of Enrollment||participants|Number|80|80.0||||||
3803023|NCT01804946|3630234|B1|Russian Federation||Region of Enrollment||participants|Number|81|81.0||||||
3803024|NCT01804946|3630232|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3803025|NCT01804946|3630233|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3803026|NCT01804946|3630234|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3803027|NCT01804946|3630232|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3803028|NCT01804946|3630233|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3803029|NCT01804946|3630234|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3803030|NCT01804946|3630232|B3|||Age||years|Mean|34.7|34.7|Standard Deviation|12.1|12.1|||
3803031|NCT01804946|3630233|B2|||Age||years|Mean|34.9|34.9|Standard Deviation|12.6|12.6|||
3803032|NCT01804946|3630234|B1|||Age||years|Mean|34.5|34.5|Standard Deviation|11.6|11.6|||
3803033|NCT01804881|3630257|B3|||Body Mass Index (kg/m^2)||kg/m^2|Mean|32|32.0|Standard Deviation|5.1|5.1|||
3803034|NCT01804881|3630258|B2|||Body Mass Index (kg/m^2)||kg/m^2|Mean|32.8|32.8|Standard Deviation|5.1|5.1|||
3803035|NCT01804881|3630259|B1|||Body Mass Index (kg/m^2)||kg/m^2|Mean|31.2|31.2|Standard Deviation|5.1|5.1|||
3803036|NCT01804881|3630257|B3|Canada||Region of Enrollment||participants|Number|30|30.0||||||
3803037|NCT01804881|3630258|B2|Canada||Region of Enrollment||participants|Number|14|14.0||||||
3803038|NCT01804881|3630259|B1|Canada||Region of Enrollment||participants|Number|16|16.0||||||
3803039|NCT01804881|3630257|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3803040|NCT01804881|3630258|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3803041|NCT01804881|3630259|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3803042|NCT01804881|3630257|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3803043|NCT01804881|3630258|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3803044|NCT01804881|3630259|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3803045|NCT01804881|3630257|B3|||Age||years|Mean|61.7|61.7|Standard Deviation|6.2|6.2|||
3803046|NCT01804881|3630258|B2|||Age||years|Mean|59.9|59.9|Standard Deviation|7.5|7.5|||
3803047|NCT01804881|3630259|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|4.9|4.9|||
3803048|NCT01804842|3630270|B4|||HbA1c||%|Mean|7.28|7.28|Standard Deviation|1.017|1.017|||
3803049|NCT01804842|3630271|B3|||HbA1c||%|Mean|7.36|7.36|Standard Deviation|1.022|1.022|||
3803050|NCT01804842|3630272|B2|||HbA1c||%|Mean|7.13|7.13|Standard Deviation|1.107|1.107|||
3803051|NCT01804842|3630273|B1|||HbA1c||%|Mean|7.34|7.34|Standard Deviation|1.038|1.038|||
3803052|NCT01804842|3630270|B4|||Fasting Serum Glucose||mg/dL|Mean|167.6|167.6|Standard Deviation|57.04|57.04|||
3803053|NCT01804842|3630271|B3|||Fasting Serum Glucose||mg/dL|Mean|165.0|165.0|Standard Deviation|54.02|54.02|||
3803054|NCT01804842|3630272|B2|||Fasting Serum Glucose||mg/dL|Mean|177.6|177.6|Standard Deviation|84.17|84.17|||
3803055|NCT01804842|3630273|B1|||Fasting Serum Glucose||mg/dL|Mean|161.2|161.2|Standard Deviation|29.94|29.94|||
3803056|NCT01804842|3630270|B4|Metformin and DPP-4 Inhibitors||Diabetes Management||participants|Number|2|2.0||||||
3803057|NCT01804842|3630271|B3|Metformin and DPP-4 Inhibitors||Diabetes Management||participants|Number|0|0.0||||||
3803058|NCT01804842|3630272|B2|Metformin and DPP-4 Inhibitors||Diabetes Management||participants|Number|1|1.0||||||
3803059|NCT01804842|3630273|B1|Metformin and DPP-4 Inhibitors||Diabetes Management||participants|Number|1|1.0||||||
3803060|NCT01804842|3630270|B4|Metformin Alone||Diabetes Management||participants|Number|17|17.0||||||
3803061|NCT01804842|3630271|B3|Metformin Alone||Diabetes Management||participants|Number|7|7.0||||||
3803062|NCT01804842|3630272|B2|Metformin Alone||Diabetes Management||participants|Number|3|3.0||||||
3803063|NCT01804842|3630273|B1|Metformin Alone||Diabetes Management||participants|Number|7|7.0||||||
3803064|NCT01804842|3630270|B4|Diet and Exercise Only||Diabetes Management||participants|Number|7|7.0||||||
3803065|NCT01804842|3630271|B3|Diet and Exercise Only||Diabetes Management||participants|Number|2|2.0||||||
3803066|NCT01804842|3630272|B2|Diet and Exercise Only||Diabetes Management||participants|Number|4|4.0||||||
3803067|NCT01804842|3630273|B1|Diet and Exercise Only||Diabetes Management||participants|Number|1|1.0||||||
3803068|NCT01804842|3630270|B4|||BMI||kg/m^2|Mean|31.5|31.5|Standard Deviation|3.17|3.17|||
3803069|NCT01804842|3630271|B3|||BMI||kg/m^2|Mean|30.7|30.7|Standard Deviation|1.58|1.58|||
3803070|NCT01804842|3630272|B2|||BMI||kg/m^2|Mean|31.6|31.6|Standard Deviation|3.93|3.93|||
3803071|NCT01804842|3630273|B1|||BMI||kg/m^2|Mean|32.3|32.3|Standard Deviation|3.73|3.73|||
3803072|NCT01804842|3630270|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803073|NCT01804842|3630271|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803074|NCT01804842|3630272|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803075|NCT01804842|3630273|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803076|NCT01804842|3630270|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803077|NCT01804842|3630271|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803078|NCT01804842|3630272|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803079|NCT01804842|3630273|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803080|NCT01804842|3630270|B4||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3803081|NCT01804842|3630271|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3803082|NCT01804842|3630272|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3803083|NCT01804842|3630273|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3803084|NCT01804842|3630270|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3803085|NCT01804842|3630271|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3803086|NCT01804842|3630272|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803087|NCT01804842|3630273|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3803088|NCT01804842|3630270|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803089|NCT01804842|3630271|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803090|NCT01804842|3630272|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803091|NCT01804842|3630273|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803092|NCT01804842|3630270|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803093|NCT01804842|3630271|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803094|NCT01804842|3630272|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803095|NCT01804842|3630273|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803096|NCT01804842|3630270|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803097|NCT01804842|3630271|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803098|NCT01804842|3630272|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803099|NCT01804842|3630273|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803100|NCT01804842|3630270|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803101|NCT01804842|3630271|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803102|NCT01804842|3630272|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803103|NCT01804842|3630273|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803104|NCT01804842|3630270|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3803105|NCT01804842|3630271|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3803106|NCT01804842|3630272|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3803107|NCT01804842|3630273|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3803108|NCT01804842|3630270|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3803109|NCT01804842|3630271|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3803110|NCT01804842|3630272|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3803111|NCT01804842|3630273|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3803112|NCT01804842|3630270|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3803113|NCT01804842|3630271|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3803114|NCT01804842|3630272|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3803115|NCT01804842|3630273|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3803116|NCT01804842|3630270|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3803117|NCT01804842|3630271|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3803118|NCT01804842|3630272|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3803119|NCT01804842|3630273|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3803120|NCT01804842|3630270|B4|||Age||years|Mean|50.9|50.9|Standard Deviation|10.90|10.9|||
3803121|NCT01804842|3630271|B3|||Age||years|Mean|49.7|49.7|Standard Deviation|8.49|8.49|||
3803122|NCT01804842|3630272|B2|||Age||years|Mean|51.9|51.9|Standard Deviation|13.47|13.47|||
3803123|NCT01804842|3630273|B1|||Age||years|Mean|51.2|51.2|Standard Deviation|11.73|11.73|||
3803124|NCT01804673|3630292|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3803125|NCT01804673|3630292|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3803126|NCT01804673|3630292|B1|||Age||Years|Mean|49.3|49.3|Standard Deviation|16.7|16.7|||
3803127|NCT01804257|3630308|B1||Schizophrenia|Type of Mental Health Disorder||Participants|Count of Participants|16|16.0||||||
3803128|NCT01804257|3630308|B1||Bipolar Disorder|Type of Mental Health Disorder||Participants|Count of Participants|12|12.0||||||
3803129|NCT01804257|3630308|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3803130|NCT01804257|3630308|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3803131|NCT01804257|3630308|B1|||Age, Customized||years|Mean|42.8|42.8|Standard Deviation|12.7|12.7|||
3803132|NCT01804140|3630312|B1||Male|Gender||Participants|Count of Participants|222|222.0||||||
3803133|NCT01804140|3630312|B1||Female|Gender||Participants|Count of Participants|326|326.0||||||
3803134|NCT01804140|3630312|B1|||Age||years|Mean|63.3|63.3|Standard Deviation|12.38|12.38|||
3803135|NCT01804101|3630317|B3|United States||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
3803136|NCT01804101|3630318|B2|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3803137|NCT01804101|3630319|B1|United States||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
3803138|NCT01804101|3630317|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803139|NCT01804101|3630318|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803140|NCT01804101|3630319|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803141|NCT01804101|3630317|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803142|NCT01804101|3630318|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803143|NCT01804101|3630319|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803144|NCT01804101|3630317|B3||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3803145|NCT01804101|3630318|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3803146|NCT01804101|3630319|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3803147|NCT01804101|3630317|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803148|NCT01804101|3630318|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803149|NCT01804101|3630319|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803150|NCT01804101|3630317|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3803151|NCT01804101|3630318|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803152|NCT01804101|3630319|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3803153|NCT01804101|3630317|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803154|NCT01804101|3630318|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803155|NCT01804101|3630319|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803156|NCT01804101|3630317|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803157|NCT01804101|3630318|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803158|NCT01804101|3630319|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803159|NCT01804101|3630317|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803160|NCT01804101|3630318|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803161|NCT01804101|3630319|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803162|NCT01804101|3630317|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3803163|NCT01804101|3630318|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3803164|NCT01804101|3630319|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3803165|NCT01804101|3630317|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803166|NCT01804101|3630318|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803167|NCT01804101|3630319|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803168|NCT01804101|3630317|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3803169|NCT01804101|3630318|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3803170|NCT01804101|3630319|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3803171|NCT01804101|3630317|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3803172|NCT01804101|3630318|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3803173|NCT01804101|3630319|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3803174|NCT01804101|3630317|B3||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
3803175|NCT01804101|3630318|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3803176|NCT01804101|3630319|B1||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
3803177|NCT01804101|3630317|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3803178|NCT01804101|3630318|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3803179|NCT01804101|3630319|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3803180|NCT01804101|3630317|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3803181|NCT01804101|3630318|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3803182|NCT01804101|3630319|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3803183|NCT01804075|3630328|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3803184|NCT01804075|3630329|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3803185|NCT01804075|3630330|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3803186|NCT01804075|3630328|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3803187|NCT01804075|3630329|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3803188|NCT01804075|3630330|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3803189|NCT01804075|3630328|B3|||Age||days|Mean|2.2|2.2|Standard Deviation|1.1|1.1|||
3803190|NCT01804075|3630329|B2|||Age||days|Mean|2.3|2.3|Standard Deviation|1.2|1.2|||
3803191|NCT01804075|3630330|B1|||Age||days|Mean|2.1|2.1|Standard Deviation|1|1.0|||
3803192|NCT01804062|3630339|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3803193|NCT01804062|3630339|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803194|NCT01804062|3630339|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3803195|NCT01804062|3630339|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3803196|NCT01804062|3630339|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803197|NCT01804062|3630339|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803198|NCT01804062|3630339|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3803199|NCT01804062|3630339|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803200|NCT01804062|3630339|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3803201|NCT01804062|3630339|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3803202|NCT01804062|3630339|B1|||Age||years|Mean|32.9|32.9|Standard Deviation|6.97|6.97|||
3803203|NCT01804036|3630344|B3|Not Provided||Sex/Gender, Customized||participants|Number|1|1.0||||||
3803204|NCT01804036|3630345|B2|Not Provided||Sex/Gender, Customized||participants|Number|0|0.0||||||
3803205|NCT01804036|3630346|B1|Not Provided||Sex/Gender, Customized||participants|Number|1|1.0||||||
3803206|NCT01804036|3630344|B3|Females||Sex/Gender, Customized||participants|Number|60|60.0||||||
3803207|NCT01804036|3630345|B2|Females||Sex/Gender, Customized||participants|Number|35|35.0||||||
3803208|NCT01804036|3630346|B1|Females||Sex/Gender, Customized||participants|Number|25|25.0||||||
3803209|NCT01804036|3630344|B3|Males||Sex/Gender, Customized||participants|Number|10|10.0||||||
3803210|NCT01804036|3630345|B2|Males||Sex/Gender, Customized||participants|Number|5|5.0||||||
3803211|NCT01804036|3630346|B1|Males||Sex/Gender, Customized||participants|Number|5|5.0||||||
3803212|NCT01804036|3630344|B3|||Age||years|Mean|30.0|30.0|Standard Deviation|7.4|7.4|||
3803213|NCT01804036|3630345|B2|||Age||years|Mean|30.1|30.1|Standard Deviation|6.9|6.9|||
3803214|NCT01804036|3630346|B1|||Age||years|Mean|29.9|29.9|Standard Deviation|8.2|8.2|||
3803215|NCT01803737|3630379|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
3803216|NCT01803737|3630380|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3803217|NCT01803737|3630381|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3803218|NCT01803737|3630379|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3803219|NCT01803737|3630380|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3803220|NCT01803737|3630381|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3803221|NCT01803737|3630379|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3803222|NCT01803737|3630380|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3803223|NCT01803737|3630381|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3803224|NCT01803737|3630379|B3|||Age||years|Mean|43.1|43.1|Standard Deviation|8.9|8.9|||
3803225|NCT01803737|3630380|B2|||Age||years|Mean|43.8|43.8|Standard Deviation|9.0|9.0|||
3803226|NCT01803737|3630381|B1|||Age||years|Mean|42.5|42.5|Standard Deviation|9.1|9.1|||
3803227|NCT01803737|3630379|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3803228|NCT01803737|3630380|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3803229|NCT01803737|3630381|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3803230|NCT01803737|3630379|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3803231|NCT01803737|3630380|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3803232|NCT01803737|3630381|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3803233|NCT01803737|3630379|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3803234|NCT01803737|3630380|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3803235|NCT01803737|3630381|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3803236|NCT01803711|3630404|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3803237|NCT01803711|3630405|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3803238|NCT01803711|3630406|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3803239|NCT01803711|3630404|B3|White Non-Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3803240|NCT01803711|3630405|B2|White Non-Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3803241|NCT01803711|3630406|B1|White Non-Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3803242|NCT01803711|3630404|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3803243|NCT01803711|3630405|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3803244|NCT01803711|3630406|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3803245|NCT01803711|3630404|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3803246|NCT01803711|3630405|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3803247|NCT01803711|3630406|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3803248|NCT01803711|3630404|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3803249|NCT01803711|3630405|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3803250|NCT01803711|3630406|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3803251|NCT01803711|3630404|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3803252|NCT01803711|3630405|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3803253|NCT01803711|3630406|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3803254|NCT01803711|3630404|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3803255|NCT01803711|3630405|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3803256|NCT01803711|3630406|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3803257|NCT01803646|3630423|B3|Turkey||Region of Enrollment||participants|Number|11|11.0||||||
3803258|NCT01803646|3630424|B2|Turkey||Region of Enrollment||participants|Number|4|4.0||||||
3803259|NCT01803646|3630425|B1|Turkey||Region of Enrollment||participants|Number|7|7.0||||||
3803260|NCT01803646|3630423|B3|South Korea||Region of Enrollment||participants|Number|27|27.0||||||
3803261|NCT01803646|3630424|B2|South Korea||Region of Enrollment||participants|Number|12|12.0||||||
3803262|NCT01803646|3630425|B1|South Korea||Region of Enrollment||participants|Number|15|15.0||||||
3803263|NCT01803646|3630423|B3|Israel||Region of Enrollment||participants|Number|3|3.0||||||
3803264|NCT01803646|3630424|B2|Israel||Region of Enrollment||participants|Number|1|1.0||||||
3803265|NCT01803646|3630425|B1|Israel||Region of Enrollment||participants|Number|2|2.0||||||
3803266|NCT01803646|3630423|B3|Canada||Region of Enrollment||participants|Number|34|34.0||||||
3803267|NCT01803646|3630424|B2|Canada||Region of Enrollment||participants|Number|14|14.0||||||
3803268|NCT01803646|3630425|B1|Canada||Region of Enrollment||participants|Number|20|20.0||||||
3803269|NCT01803646|3630423|B3|Czechia||Region of Enrollment||participants|Number|64|64.0||||||
3803270|NCT01803646|3630424|B2|Czechia||Region of Enrollment||participants|Number|26|26.0||||||
3803271|NCT01803646|3630425|B1|Czechia||Region of Enrollment||participants|Number|38|38.0||||||
3803272|NCT01803646|3630423|B3|United States||Region of Enrollment||participants|Number|204|204.0||||||
3803273|NCT01803646|3630424|B2|United States||Region of Enrollment||participants|Number|82|82.0||||||
3803274|NCT01803646|3630425|B1|United States||Region of Enrollment||participants|Number|122|122.0||||||
3803275|NCT01803646|3630423|B3||Male|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
3803276|NCT01803646|3630424|B2||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3803277|NCT01803646|3630425|B1||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3803278|NCT01803646|3630423|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3803279|NCT01803646|3630424|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3803280|NCT01803646|3630425|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3803281|NCT01803646|3630423|B3|||Age||years|Mean|43.7|43.7|Standard Deviation|14.8|14.8|||
3803282|NCT01803646|3630424|B2|||Age||years|Mean|44.2|44.2|Standard Deviation|15.2|15.2|||
3803283|NCT01803646|3630425|B1|||Age||years|Mean|43.4|43.4|Standard Deviation|14.6|14.6|||
3803284|NCT01803646|3630423|B3||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
3803285|NCT01803646|3630424|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3803286|NCT01803646|3630425|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3803287|NCT01803646|3630423|B3||Between 18 and 65 years|Age||Participants|Count of Participants|313|313.0||||||
3803288|NCT01803646|3630424|B2||Between 18 and 65 years|Age||Participants|Count of Participants|125|125.0||||||
3803289|NCT01803646|3630425|B1||Between 18 and 65 years|Age||Participants|Count of Participants|188|188.0||||||
3803290|NCT01803646|3630423|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3803291|NCT01803646|3630424|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3803292|NCT01803646|3630425|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3803293|NCT01803607|3630436|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3803294|NCT01803607|3630437|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3803295|NCT01803607|3630438|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3803296|NCT01803607|3630436|B3||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3803297|NCT01803607|3630437|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3803298|NCT01803607|3630438|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3803299|NCT01803607|3630436|B3|||Age||Years|Mean|70.9|70.9|Standard Deviation|7.7|7.7|||
3803300|NCT01803607|3630437|B2|||Age||Years|Mean|70.7|70.7|Standard Deviation|7.6|7.6|||
3803301|NCT01803607|3630438|B1|||Age||Years|Mean|71.7|71.7|Standard Deviation|7.9|7.9|||
3803302|NCT01803464|3630459|B5|United States||Region of Enrollment||participants|Number|29|29.0||||||
3803303|NCT01803464|3630460|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
3803304|NCT01803464|3630461|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3803305|NCT01803464|3630462|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3803306|NCT01803464|3630463|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3803307|NCT01803464|3630459|B5||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3803308|NCT01803464|3630460|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3803309|NCT01803464|3630461|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3803310|NCT01803464|3630462|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3803311|NCT01803464|3630463|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3803312|NCT01803464|3630459|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3803313|NCT01803464|3630460|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3803314|NCT01803464|3630461|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3803315|NCT01803464|3630462|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3803316|NCT01803464|3630463|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3803317|NCT01803464|3630459|B5|||Age||years|Mean|8.13|8.13|Standard Deviation|2.16|2.16|||
3803318|NCT01803464|3630460|B4|||Age||years|Mean|8.71|8.71|Standard Deviation|1.68|1.68|||
3803319|NCT01803464|3630461|B3|||Age||years|Mean|7.61|7.61|Standard Deviation|2.22|2.22|||
3803320|NCT01803464|3630462|B2|||Age||years|Mean|8.50|8.5|Standard Deviation|2.65|2.65|||
3803321|NCT01803464|3630463|B1|||Age||years|Mean|7.73|7.73|Standard Deviation|2.85|2.85|||
3803322|NCT01802775|3630484|B3|Germany||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3803323|NCT01802775|3630485|B2|Germany||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3803324|NCT01802775|3630486|B1|Germany||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3803325|NCT01802775|3630484|B3|Switzerland||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3803326|NCT01802775|3630485|B2|Switzerland||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3803327|NCT01802775|3630486|B1|Switzerland||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3803328|NCT01802775|3630484|B3|Israel||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3803329|NCT01802775|3630485|B2|Israel||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3803330|NCT01802775|3630486|B1|Israel||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3803331|NCT01802775|3630484|B3|United States||Region of Enrollment||Participants|Count of Participants|89|89.0||||||
3803332|NCT01802775|3630485|B2|United States||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3803333|NCT01802775|3630486|B1|United States||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
3803334|NCT01802775|3630484|B3|Belgium||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3803335|NCT01802775|3630485|B2|Belgium||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3803336|NCT01802775|3630486|B1|Belgium||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3803337|NCT01802775|3630484|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3803338|NCT01802775|3630485|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3803339|NCT01802775|3630486|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3803340|NCT01802775|3630484|B3|Austria||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3803341|NCT01802775|3630485|B2|Austria||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3803342|NCT01802775|3630486|B1|Austria||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3803343|NCT01802775|3630484|B3||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3803344|NCT01802775|3630485|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3803345|NCT01802775|3630486|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3803346|NCT01802775|3630484|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3803347|NCT01802775|3630485|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3803348|NCT01802775|3630486|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3803349|NCT01802775|3630484|B3|85 years of age and over||Age, Customized||Participants|Count of Participants|7|7.0||||||
3803350|NCT01802775|3630485|B2|85 years of age and over||Age, Customized||Participants|Count of Participants|6|6.0||||||
3803351|NCT01802775|3630486|B1|85 years of age and over||Age, Customized||Participants|Count of Participants|1|1.0||||||
3803352|NCT01802775|3630484|B3|From 65 to 84 years of age||Age, Customized||Participants|Count of Participants|133|133.0||||||
3803353|NCT01802775|3630485|B2|From 65 to 84 years of age||Age, Customized||Participants|Count of Participants|65|65.0||||||
3803354|NCT01802775|3630486|B1|From 65 to 84 years of age||Age, Customized||Participants|Count of Participants|68|68.0||||||
3803355|NCT01802775|3630484|B3|Adults 18-64 years of age||Age, Customized||Participants|Count of Participants|63|63.0||||||
3803356|NCT01802775|3630485|B2|Adults 18-64 years of age||Age, Customized||Participants|Count of Participants|30|30.0||||||
3803357|NCT01802775|3630486|B1|Adults 18-64 years of age||Age, Customized||Participants|Count of Participants|33|33.0||||||
3803358|NCT01802775|3630484|B3|||Age||years|Mean|67.4|67.4|Standard Deviation|9.49|9.49|||
3803359|NCT01802775|3630485|B2|||Age||years|Mean|68|68.0|Standard Deviation|10.36|10.36|||
3803360|NCT01802775|3630486|B1|||Age||years|Mean|66.7|66.7|Standard Deviation|8.55|8.55|||
3803361|NCT01802632|3630503|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3803362|NCT01802632|3630504|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3803363|NCT01802632|3630505|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3803364|NCT01802632|3630506|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3803427|NCT01802632|3630506|B4|>=75 Years||Age, Customized||Participants|Number|7|7.0||||||
3803365|NCT01802632|3630507|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3803366|NCT01802632|3630508|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3803367|NCT01802632|3630509|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3803368|NCT01802632|3630503|B7|White||Race/Ethnicity, Customized||Participants|Number|197|197.0||||||
3803369|NCT01802632|3630504|B6|White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3803370|NCT01802632|3630505|B5|White||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3803371|NCT01802632|3630506|B4|White||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3803372|NCT01802632|3630507|B3|White||Race/Ethnicity, Customized||Participants|Number|95|95.0||||||
3803373|NCT01802632|3630508|B2|White||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3803374|NCT01802632|3630509|B1|White||Race/Ethnicity, Customized||Participants|Number|76|76.0||||||
3803375|NCT01802632|3630503|B7|Other||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3803376|NCT01802632|3630504|B6|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3803377|NCT01802632|3630505|B5|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3803378|NCT01802632|3630506|B4|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3803379|NCT01802632|3630507|B3|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3803380|NCT01802632|3630508|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3803381|NCT01802632|3630509|B1|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3803382|NCT01802632|3630503|B7|Not Reported||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
3803383|NCT01802632|3630504|B6|Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3803384|NCT01802632|3630505|B5|Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3803385|NCT01802632|3630506|B4|Not Reported||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3803386|NCT01802632|3630507|B3|Not Reported||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3803387|NCT01802632|3630508|B2|Not Reported||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3803388|NCT01802632|3630509|B1|Not Reported||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3803389|NCT01802632|3630503|B7|Missing||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3803390|NCT01802632|3630504|B6|Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3803391|NCT01802632|3630505|B5|Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3803392|NCT01802632|3630506|B4|Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3803393|NCT01802632|3630507|B3|Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3803394|NCT01802632|3630508|B2|Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3803395|NCT01802632|3630509|B1|Missing||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3803396|NCT01802632|3630503|B7|Black Or African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3803397|NCT01802632|3630504|B6|Black Or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3803398|NCT01802632|3630505|B5|Black Or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3803399|NCT01802632|3630506|B4|Black Or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3803400|NCT01802632|3630507|B3|Black Or African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3803401|NCT01802632|3630508|B2|Black Or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3803402|NCT01802632|3630509|B1|Black Or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3803403|NCT01802632|3630503|B7|Asian||Race/Ethnicity, Customized||Participants|Number|370|370.0||||||
3803404|NCT01802632|3630504|B6|Asian||Race/Ethnicity, Customized||Participants|Number|28|28.0||||||
3803405|NCT01802632|3630505|B5|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3803406|NCT01802632|3630506|B4|Asian||Race/Ethnicity, Customized||Participants|Number|43|43.0||||||
3803407|NCT01802632|3630507|B3|Asian||Race/Ethnicity, Customized||Participants|Number|160|160.0||||||
3803408|NCT01802632|3630508|B2|Asian||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
3803409|NCT01802632|3630509|B1|Asian||Race/Ethnicity, Customized||Participants|Number|114|114.0||||||
3803410|NCT01802632|3630503|B7||Male|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
3803411|NCT01802632|3630504|B6||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3803412|NCT01802632|3630505|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3803413|NCT01802632|3630506|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3803414|NCT01802632|3630507|B3||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3803415|NCT01802632|3630508|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3803416|NCT01802632|3630509|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3803417|NCT01802632|3630503|B7||Female|Sex: Female, Male||Participants|Count of Participants|394|394.0||||||
3803418|NCT01802632|3630504|B6||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3803419|NCT01802632|3630505|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3803420|NCT01802632|3630506|B4||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3803421|NCT01802632|3630507|B3||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3803422|NCT01802632|3630508|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3803423|NCT01802632|3630509|B1||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3803424|NCT01802632|3630503|B7|>=75 Years||Age, Customized||Participants|Number|60|60.0||||||
3803425|NCT01802632|3630504|B6|>=75 Years||Age, Customized||Participants|Number|3|3.0||||||
3803426|NCT01802632|3630505|B5|>=75 Years||Age, Customized||Participants|Number|0|0.0||||||
3803428|NCT01802632|3630507|B3|>=75 Years||Age, Customized||Participants|Number|28|28.0||||||
3803429|NCT01802632|3630508|B2|>=75 Years||Age, Customized||Participants|Number|1|1.0||||||
3803430|NCT01802632|3630509|B1|>=75 Years||Age, Customized||Participants|Number|21|21.0||||||
3803431|NCT01802632|3630503|B7|>=65-<75 Years||Age, Customized||Participants|Number|165|165.0||||||
3803432|NCT01802632|3630504|B6|>=65-<75 Years||Age, Customized||Participants|Number|9|9.0||||||
3803433|NCT01802632|3630505|B5|>=65-<75 Years||Age, Customized||Participants|Number|3|3.0||||||
3803434|NCT01802632|3630506|B4|>=65-<75 Years||Age, Customized||Participants|Number|22|22.0||||||
3803435|NCT01802632|3630507|B3|>=65-<75 Years||Age, Customized||Participants|Number|59|59.0||||||
3803436|NCT01802632|3630508|B2|>=65-<75 Years||Age, Customized||Participants|Number|8|8.0||||||
3803437|NCT01802632|3630509|B1|>=65-<75 Years||Age, Customized||Participants|Number|64|64.0||||||
3803438|NCT01802632|3630503|B7|>=50-<65 Years||Age, Customized||Participants|Number|289|289.0||||||
3803439|NCT01802632|3630504|B6|>=50-<65 Years||Age, Customized||Participants|Number|13|13.0||||||
3803440|NCT01802632|3630505|B5|>=50-<65 Years||Age, Customized||Participants|Number|6|6.0||||||
3803441|NCT01802632|3630506|B4|>=50-<65 Years||Age, Customized||Participants|Number|23|23.0||||||
3803442|NCT01802632|3630507|B3|>=50-<65 Years||Age, Customized||Participants|Number|142|142.0||||||
3803443|NCT01802632|3630508|B2|>=50-<65 Years||Age, Customized||Participants|Number|19|19.0||||||
3803444|NCT01802632|3630509|B1|>=50-<65 Years||Age, Customized||Participants|Number|86|86.0||||||
3803445|NCT01802632|3630503|B7|<50 Years||Age, Customized||Participants|Number|89|89.0||||||
3803446|NCT01802632|3630504|B6|<50 Years||Age, Customized||Participants|Number|3|3.0||||||
3803447|NCT01802632|3630505|B5|<50 Years||Age, Customized||Participants|Number|3|3.0||||||
3803448|NCT01802632|3630506|B4|<50 Years||Age, Customized||Participants|Number|8|8.0||||||
3803449|NCT01802632|3630507|B3|<50 Years||Age, Customized||Participants|Number|42|42.0||||||
3803450|NCT01802632|3630508|B2|<50 Years||Age, Customized||Participants|Number|3|3.0||||||
3803451|NCT01802632|3630509|B1|<50 Years||Age, Customized||Participants|Number|30|30.0||||||
3803452|NCT01802554|3630528|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
3803453|NCT01802554|3630529|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
3803454|NCT01802554|3630530|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
3803455|NCT01802554|3630528|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3803456|NCT01802554|3630529|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3803457|NCT01802554|3630530|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3803458|NCT01802554|3630528|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3803459|NCT01802554|3630529|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3803460|NCT01802554|3630530|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3803461|NCT01802554|3630528|B3|||Age||years|Mean|71.1|71.1|Standard Deviation|8.33|8.33|||
3803462|NCT01802554|3630529|B2|||Age||years|Mean|71.33|71.33|Standard Deviation|9.08|9.08|||
3803463|NCT01802554|3630530|B1|||Age||years|Mean|70.86|70.86|Standard Deviation|7.57|7.57|||
3803464|NCT01802554|3630528|B3||>=65 years|Age||Participants|Count of Participants|79|79.0||||||
3803465|NCT01802554|3630529|B2||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
3803466|NCT01802554|3630530|B1||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
3803467|NCT01802554|3630528|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3803468|NCT01802554|3630529|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3803469|NCT01802554|3630530|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3803470|NCT01802554|3630528|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3803471|NCT01802554|3630529|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3803472|NCT01802554|3630530|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3803473|NCT01802515|3630545|B4|United States||Region of Enrollment||participants|Number|14|14.0||||||
3803474|NCT01802515|3630546|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3803475|NCT01802515|3630547|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3803476|NCT01802515|3630548|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3803477|NCT01802515|3630545|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3803478|NCT01802515|3630546|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3803479|NCT01802515|3630547|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3803480|NCT01802515|3630548|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3803481|NCT01802515|3630545|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3803482|NCT01802515|3630546|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3803483|NCT01802515|3630547|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3803484|NCT01802515|3630548|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3803485|NCT01802515|3630545|B4|||Age||years|Mean|42.3|42.3|Standard Deviation|7.4|7.4|||
3803486|NCT01802515|3630546|B3|||Age||years|Mean|43.6|43.6|Standard Deviation|0.95|0.95|||
3803487|NCT01802515|3630547|B2|||Age||years|Mean|47.6|47.6|Standard Deviation|5.63|5.63|||
3803488|NCT01802515|3630548|B1|||Age||years|Mean|36.2|36.2|Standard Deviation|8.0|8.0|||
3803489|NCT01802333|3630561|B4||Tx. related/arose from antecededent hem. disease|Onset of Leukemia||Participants|Count of Participants|73|73.0||||||
3803490|NCT01802333|3630562|B3||Tx. related/arose from antecededent hem. disease|Onset of Leukemia||Participants|Count of Participants|23|23.0||||||
3803491|NCT01802333|3630563|B2||Tx. related/arose from antecededent hem. disease|Onset of Leukemia||Participants|Count of Participants|25|25.0||||||
3803492|NCT01802333|3630564|B1||Tx. related/arose from antecededent hem. disease|Onset of Leukemia||Participants|Count of Participants|25|25.0||||||
3803493|NCT01802333|3630561|B4||De novo|Onset of Leukemia||Participants|Count of Participants|665|665.0||||||
3803494|NCT01802333|3630562|B3||De novo|Onset of Leukemia||Participants|Count of Participants|193|193.0||||||
3803495|NCT01802333|3630563|B2||De novo|Onset of Leukemia||Participants|Count of Participants|236|236.0||||||
3803496|NCT01802333|3630564|B1||De novo|Onset of Leukemia||Participants|Count of Participants|236|236.0||||||
3803497|NCT01802333|3630561|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3803498|NCT01802333|3630562|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3803499|NCT01802333|3630563|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3803500|NCT01802333|3630564|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3803501|NCT01802333|3630561|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3803502|NCT01802333|3630562|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803503|NCT01802333|3630563|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3803504|NCT01802333|3630564|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3803505|NCT01802333|3630561|B4||White|Race (NIH/OMB)||Participants|Count of Participants|613|613.0||||||
3803506|NCT01802333|3630562|B3||White|Race (NIH/OMB)||Participants|Count of Participants|178|178.0||||||
3803507|NCT01802333|3630563|B2||White|Race (NIH/OMB)||Participants|Count of Participants|217|217.0||||||
3803508|NCT01802333|3630564|B1||White|Race (NIH/OMB)||Participants|Count of Participants|218|218.0||||||
3803509|NCT01802333|3630561|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3803510|NCT01802333|3630562|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3803511|NCT01802333|3630563|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3803512|NCT01802333|3630564|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3803513|NCT01802333|3630561|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3803514|NCT01802333|3630562|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803515|NCT01802333|3630563|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3803516|NCT01802333|3630564|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3803517|NCT01802333|3630561|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3803518|NCT01802333|3630562|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3803519|NCT01802333|3630563|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3803520|NCT01802333|3630564|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3803521|NCT01802333|3630561|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3803522|NCT01802333|3630562|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3803523|NCT01802333|3630563|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803524|NCT01802333|3630564|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3803525|NCT01802333|3630561|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3803526|NCT01802333|3630562|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3803527|NCT01802333|3630563|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3803528|NCT01802333|3630564|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3803529|NCT01802333|3630561|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|628|628.0||||||
3803530|NCT01802333|3630562|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|185|185.0||||||
3803531|NCT01802333|3630563|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|217|217.0||||||
3803532|NCT01802333|3630564|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|226|226.0||||||
3803533|NCT01802333|3630561|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3803534|NCT01802333|3630562|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3803535|NCT01802333|3630563|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3803536|NCT01802333|3630564|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3803537|NCT01802333|3630561|B4||Male|Sex: Female, Male||Participants|Count of Participants|378|378.0||||||
3803538|NCT01802333|3630562|B3||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3803539|NCT01802333|3630563|B2||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3803540|NCT01802333|3630564|B1||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3803541|NCT01802333|3630561|B4||Female|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
3803542|NCT01802333|3630562|B3||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3803543|NCT01802333|3630563|B2||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3803544|NCT01802333|3630564|B1||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3803545|NCT01802333|3630561|B4|>= 40 years||Age, Customized||Participants|Count of Participants|550|550.0||||||
3803603|NCT01802151|3630598|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3803546|NCT01802333|3630562|B3|>= 40 years||Age, Customized||Participants|Count of Participants|161|161.0||||||
3803547|NCT01802333|3630563|B2|>= 40 years||Age, Customized||Participants|Count of Participants|196|196.0||||||
3803548|NCT01802333|3630564|B1|>= 40 years||Age, Customized||Participants|Count of Participants|193|193.0||||||
3803549|NCT01802333|3630561|B4|< 40 years||Age, Customized||Participants|Count of Participants|188|188.0||||||
3803550|NCT01802333|3630562|B3|< 40 years||Age, Customized||Participants|Count of Participants|55|55.0||||||
3803551|NCT01802333|3630563|B2|< 40 years||Age, Customized||Participants|Count of Participants|65|65.0||||||
3803552|NCT01802333|3630564|B1|< 40 years||Age, Customized||Participants|Count of Participants|68|68.0||||||
3803553|NCT01802333|3630561|B4|||Age||years|Median|49.8|49.8|Full Range|||18.8|61.0|
3803554|NCT01802333|3630562|B3|||Age||years|Median|48.9|48.9|Full Range|||19.6|61.0|
3803555|NCT01802333|3630563|B2|||Age||years|Median|51.5|51.5|Full Range|||18.8|60.9|
3803556|NCT01802333|3630564|B1|||Age||years|Median|48.3|48.3|Full Range|||19.2|60.8|
3803557|NCT01802320|3630593|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3803558|NCT01802320|3630593|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3803559|NCT01802320|3630593|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803560|NCT01802320|3630593|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3803561|NCT01802320|3630593|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3803562|NCT01802320|3630593|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803563|NCT01802320|3630593|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3803564|NCT01802320|3630593|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803565|NCT01802320|3630593|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3803566|NCT01802320|3630593|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3803567|NCT01802320|3630593|B1|||Age||years|Median|56|56.0|Full Range|||29.0|78.0|
3803568|NCT01802151|3630598|B5|||Activity Level|Minutes of physical activity were assessed according the Global Physical Activity Questionnaire|mins of moderate and intense activity|Mean|185.9|185.9|Standard Deviation|72.4|72.4|||
3803569|NCT01802151|3630599|B4|||Activity Level|Minutes of physical activity were assessed according the Global Physical Activity Questionnaire|mins of moderate and intense activity|Mean|199.0|199.0|Standard Deviation|57.9|57.9|||
3803570|NCT01802151|3630600|B3|||Activity Level|Minutes of physical activity were assessed according the Global Physical Activity Questionnaire|mins of moderate and intense activity|Mean|168.3|168.3|Standard Deviation|74.9|74.9|||
3803571|NCT01802151|3630601|B2|||Activity Level|Minutes of physical activity were assessed according the Global Physical Activity Questionnaire|mins of moderate and intense activity|Mean|197.3|197.3|Standard Deviation|84.5|84.5|||
3803572|NCT01802151|3630602|B1|||Activity Level|Minutes of physical activity were assessed according the Global Physical Activity Questionnaire|mins of moderate and intense activity|Mean|185.5|185.5|Standard Deviation|70.9|70.9|||
3803573|NCT01802151|3630598|B5|>= 95th % (Obese)||BMI Percentiles||participants|Number|11|11.0||||||
3803574|NCT01802151|3630599|B4|>= 95th % (Obese)||BMI Percentiles||participants|Number|2|2.0||||||
3803575|NCT01802151|3630600|B3|>= 95th % (Obese)||BMI Percentiles||participants|Number|3|3.0||||||
3803576|NCT01802151|3630601|B2|>= 95th % (Obese)||BMI Percentiles||participants|Number|2|2.0||||||
3803577|NCT01802151|3630602|B1|>= 95th % (Obese)||BMI Percentiles||participants|Number|4|4.0||||||
3803578|NCT01802151|3630598|B5|85th-94th % (Overweight)||BMI Percentiles||participants|Number|26|26.0||||||
3803579|NCT01802151|3630599|B4|85th-94th % (Overweight)||BMI Percentiles||participants|Number|9|9.0||||||
3803580|NCT01802151|3630600|B3|85th-94th % (Overweight)||BMI Percentiles||participants|Number|4|4.0||||||
3803581|NCT01802151|3630601|B2|85th-94th % (Overweight)||BMI Percentiles||participants|Number|7|7.0||||||
3803582|NCT01802151|3630602|B1|85th-94th % (Overweight)||BMI Percentiles||participants|Number|6|6.0||||||
3803583|NCT01802151|3630598|B5|<85th % (Healthy Weight)||BMI Percentiles||participants|Number|44|44.0||||||
3803584|NCT01802151|3630599|B4|<85th % (Healthy Weight)||BMI Percentiles||participants|Number|9|9.0||||||
3803585|NCT01802151|3630600|B3|<85th % (Healthy Weight)||BMI Percentiles||participants|Number|13|13.0||||||
3803586|NCT01802151|3630601|B2|<85th % (Healthy Weight)||BMI Percentiles||participants|Number|12|12.0||||||
3803587|NCT01802151|3630602|B1|<85th % (Healthy Weight)||BMI Percentiles||participants|Number|10|10.0||||||
3803588|NCT01802151|3630598|B5|United States||Region of Enrollment||participants|Number|81|81.0||||||
3803589|NCT01802151|3630599|B4|United States||Region of Enrollment||participants|Number|20|20.0||||||
3803590|NCT01802151|3630600|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3803591|NCT01802151|3630601|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
3803592|NCT01802151|3630602|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3803593|NCT01802151|3630598|B5|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3803594|NCT01802151|3630599|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3803595|NCT01802151|3630600|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3803596|NCT01802151|3630601|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3803597|NCT01802151|3630602|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3803598|NCT01802151|3630598|B5|White||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
3803599|NCT01802151|3630599|B4|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3803600|NCT01802151|3630600|B3|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3803601|NCT01802151|3630601|B2|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3803602|NCT01802151|3630602|B1|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3803604|NCT01802151|3630599|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3803605|NCT01802151|3630600|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3803606|NCT01802151|3630601|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3803607|NCT01802151|3630602|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3803608|NCT01802151|3630598|B5|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3803609|NCT01802151|3630599|B4|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3803610|NCT01802151|3630600|B3|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3803611|NCT01802151|3630601|B2|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3803612|NCT01802151|3630602|B1|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3803613|NCT01802151|3630598|B5|Asian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3803614|NCT01802151|3630599|B4|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3803615|NCT01802151|3630600|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3803616|NCT01802151|3630601|B2|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3803617|NCT01802151|3630602|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3803618|NCT01802151|3630598|B5||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3803619|NCT01802151|3630599|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3803620|NCT01802151|3630600|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3803621|NCT01802151|3630601|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3803622|NCT01802151|3630602|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3803623|NCT01802151|3630598|B5||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3803624|NCT01802151|3630599|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3803625|NCT01802151|3630600|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3803626|NCT01802151|3630601|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3803627|NCT01802151|3630602|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3803628|NCT01802151|3630598|B5|||Age||years|Median|23|23.0|Full Range|||19.0|49.0|
3803629|NCT01802151|3630599|B4|||Age||years|Median|23|23.0|Full Range|||19.0|46.0|
3803630|NCT01802151|3630600|B3|||Age||years|Median|22|22.0|Full Range|||20.0|31.0|
3803631|NCT01802151|3630601|B2|||Age||years|Median|23|23.0|Full Range|||20.0|49.0|
3803632|NCT01802151|3630602|B1|||Age||years|Median|23|23.0|Full Range|||20.0|46.0|
3803633|NCT01802151|3630598|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3803634|NCT01802151|3630599|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3803635|NCT01802151|3630600|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3803636|NCT01802151|3630601|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3803637|NCT01802151|3630602|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3803638|NCT01802151|3630598|B5||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
3803639|NCT01802151|3630599|B4||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3803640|NCT01802151|3630600|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3803641|NCT01802151|3630601|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3803642|NCT01802151|3630602|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3803643|NCT01802151|3630598|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3803644|NCT01802151|3630599|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3803645|NCT01802151|3630600|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3803646|NCT01802151|3630601|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3803647|NCT01802151|3630602|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3803648|NCT01802073|3630667|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3803649|NCT01802073|3630668|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3803650|NCT01802073|3630669|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3803651|NCT01802073|3630667|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3803652|NCT01802073|3630668|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3803653|NCT01802073|3630669|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3803654|NCT01802073|3630667|B3|18-64 years||Age, Customized||Participants|Count of Participants|21|21.0||||||
3803655|NCT01802073|3630668|B2|18-64 years||Age, Customized||Participants|Count of Participants|20|20.0||||||
3803656|NCT01802073|3630669|B1|18-64 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3803657|NCT01802073|3630667|B3|13-17 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
3803658|NCT01802073|3630668|B2|13-17 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3803659|NCT01802073|3630669|B1|13-17 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
3803660|NCT01802073|3630667|B3|7-12 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
3803661|NCT01802073|3630668|B2|7-12 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3803662|NCT01802073|3630669|B1|7-12 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
3803663|NCT01802073|3630667|B3|0-6 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
3803664|NCT01802073|3630668|B2|0-6 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3803665|NCT01802073|3630669|B1|0-6 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
3803666|NCT01801982|3630686|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3803667|NCT01801982|3630686|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3803668|NCT01801982|3630686|B1|||Age||years|Mean|1.2|1.2|Standard Deviation|NA||||Standard Deviation was not reported as only 1 participant was evaluated.
3803669|NCT01801917|3630696|B5|||Taking DMARD at baseline|Taking a disease-modifying antirheumatic drugs|participants|Number|14|14.0||||||
3803670|NCT01801917|3630697|B4|||Taking DMARD at baseline|Taking a disease-modifying antirheumatic drugs|participants|Number|1|1.0||||||
3803671|NCT01801917|3630698|B3|||Taking DMARD at baseline|Taking a disease-modifying antirheumatic drugs|participants|Number|4|4.0||||||
3803672|NCT01801917|3630699|B2|||Taking DMARD at baseline|Taking a disease-modifying antirheumatic drugs|participants|Number|2|2.0||||||
3803673|NCT01801917|3630700|B1|||Taking DMARD at baseline|Taking a disease-modifying antirheumatic drugs|participants|Number|7|7.0||||||
3803674|NCT01801917|3630696|B5|||Baseline MMT24 Score|Manual muscle testing in 24 muscle groups (MMT24). The scores range was 0 to 260. Higher scores indicate better outcome.|scores on a scale|Mean|193.6|193.6|Standard Deviation|37.90|37.9|||
3803675|NCT01801917|3630697|B4|||Baseline MMT24 Score|Manual muscle testing in 24 muscle groups (MMT24). The scores range was 0 to 260. Higher scores indicate better outcome.|scores on a scale|Mean|166.0|166.0|Standard Deviation|0|0.0|||
3803676|NCT01801917|3630698|B3|||Baseline MMT24 Score|Manual muscle testing in 24 muscle groups (MMT24). The scores range was 0 to 260. Higher scores indicate better outcome.|scores on a scale|Mean|189.5|189.5|Standard Deviation|45.65|45.65|||
3803677|NCT01801917|3630699|B2|||Baseline MMT24 Score|Manual muscle testing in 24 muscle groups (MMT24). The scores range was 0 to 260. Higher scores indicate better outcome.|scores on a scale|Mean|184.0|184.0|Standard Deviation|19.80|19.8|||
3803678|NCT01801917|3630700|B1|||Baseline MMT24 Score|Manual muscle testing in 24 muscle groups (MMT24). The scores range was 0 to 260. Higher scores indicate better outcome.|scores on a scale|Mean|202.6|202.6|Standard Deviation|41.74|41.74|||
3803679|NCT01801917|3630696|B5|||Disease duration||years|Mean|5.6|5.6|Standard Deviation|4.77|4.77|||
3803680|NCT01801917|3630697|B4|||Disease duration||years|Mean|16.9|16.9|Standard Deviation|0|0.0|||
3803681|NCT01801917|3630698|B3|||Disease duration||years|Mean|2.7|2.7|Standard Deviation|1.67|1.67|||
3803682|NCT01801917|3630699|B2|||Disease duration||years|Mean|5.4|5.4|Standard Deviation|2.74|2.74|||
3803683|NCT01801917|3630700|B1|||Disease duration||years|Mean|5.6|5.6|Standard Deviation|4.46|4.46|||
3803684|NCT01801917|3630696|B5|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3803685|NCT01801917|3630697|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3803686|NCT01801917|3630698|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3803687|NCT01801917|3630699|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3803688|NCT01801917|3630700|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3803689|NCT01801917|3630696|B5|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3803690|NCT01801917|3630697|B4|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3803691|NCT01801917|3630698|B3|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3803692|NCT01801917|3630699|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3803693|NCT01801917|3630700|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3803694|NCT01801917|3630696|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3803695|NCT01801917|3630697|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3803696|NCT01801917|3630698|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3803697|NCT01801917|3630699|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3803698|NCT01801917|3630700|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3803699|NCT01801917|3630696|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3803700|NCT01801917|3630697|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3803701|NCT01801917|3630698|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3803702|NCT01801917|3630699|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3803703|NCT01801917|3630700|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3803704|NCT01801917|3630696|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3803705|NCT01801917|3630697|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3803706|NCT01801917|3630698|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3803707|NCT01801917|3630699|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3803708|NCT01801917|3630700|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3803709|NCT01801917|3630696|B5|||Age||years|Mean|49.4|49.4|Standard Deviation|12.51|12.51|||
3803710|NCT01801917|3630697|B4|||Age||years|Mean|53.0|53.0|Standard Deviation|0.0|0.0|||
3803711|NCT01801917|3630698|B3|||Age||years|Mean|48.0|48.0|Standard Deviation|8.83|8.83|||
3803712|NCT01801917|3630699|B2|||Age||years|Mean|47.0|47.0|Standard Deviation|21.21|21.21|||
3803713|NCT01801917|3630700|B1|||Age||years|Mean|50.3|50.3|Standard Deviation|14.78|14.78|||
3803714|NCT01801735|3630723|B1|||Body Mass Index||kg/m^2|Mean|30.65|30.65|Standard Deviation|5.02|5.02|||
3803715|NCT01801735|3630723|B1|||Height||cm|Mean|169.56|169.56|Standard Deviation|10.17|10.17|||
3803716|NCT01801735|3630723|B1|||Weight||kg|Mean|88.50|88.5|Standard Deviation|18.28|18.28|||
3803717|NCT01801735|3630723|B1|White||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|520|520.0||||||
3803718|NCT01801735|3630723|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|1|1.0||||||
3803835|NCT01801358|3630794|B4|Russian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3803719|NCT01801735|3630723|B1|Black or African-American||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|73|73.0||||||
3803720|NCT01801735|3630723|B1|Asian||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|6|6.0||||||
3803721|NCT01801735|3630723|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|2|2.0||||||
3803722|NCT01801735|3630723|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803723|NCT01801735|3630723|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|567|567.0||||||
3803724|NCT01801735|3630723|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3803725|NCT01801735|3630723|B1||Male|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
3803726|NCT01801735|3630723|B1||Female|Sex: Female, Male||Participants|Count of Participants|358|358.0||||||
3803727|NCT01801735|3630723|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|8.68|8.68|||
3803728|NCT01801475|3630727|B4|United States||Region of Enrollment||participants|Number|99|99.0||||||
3803729|NCT01801475|3630728|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
3803730|NCT01801475|3630729|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3803731|NCT01801475|3630730|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3803732|NCT01801475|3630727|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3803733|NCT01801475|3630728|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3803734|NCT01801475|3630729|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3803735|NCT01801475|3630730|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3803736|NCT01801475|3630727|B4||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3803737|NCT01801475|3630728|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3803738|NCT01801475|3630729|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3803739|NCT01801475|3630730|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3803740|NCT01801475|3630727|B4|||Age|"Neonates were in their first day of life thus their age in years is a very small number.~A mean of all participants is not relevant for this reason."|years|Mean|35|35.0|Standard Deviation|5.3|5.3|||
3803741|NCT01801475|3630728|B3|||Age|"Neonates were in their first day of life thus their age in years is a very small number.~A mean of all participants is not relevant for this reason."|years|Mean|0.003|0.003|Standard Deviation|0.001|0.001|||
3803742|NCT01801475|3630729|B2|||Age|"Neonates were in their first day of life thus their age in years is a very small number.~A mean of all participants is not relevant for this reason."|years|Mean|37.7|37.7|Standard Deviation|5.7|5.7|||
3803743|NCT01801475|3630730|B1|||Age|"Neonates were in their first day of life thus their age in years is a very small number.~A mean of all participants is not relevant for this reason."|years|Mean|33|33.0|Standard Deviation|5.2|5.2|||
3803744|NCT01801449|3630745|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3803745|NCT01801449|3630745|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803746|NCT01801449|3630745|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3803747|NCT01801449|3630745|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803748|NCT01801449|3630745|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803749|NCT01801449|3630745|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803750|NCT01801449|3630745|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803751|NCT01801449|3630745|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803752|NCT01801449|3630745|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3803753|NCT01801449|3630745|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3803754|NCT01801449|3630745|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3803755|NCT01801449|3630745|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3803756|NCT01801449|3630745|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3803757|NCT01801449|3630745|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3803758|NCT01801449|3630745|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3803759|NCT01801436|3630759|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3803760|NCT01801436|3630759|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3803761|NCT01801436|3630759|B1|||Age||Years|Mean|62.63|62.63|Standard Deviation|8.31|8.31|||
3803762|NCT01801358|3630791|B7|1:||Baseline WHO Performance Status|"Categories:~0 - Fully active, able to carry on all pre-disease performance without restriction~1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~2 - Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~3 - Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~4 - Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|participants|Number|6|6.0||||||
3803763|NCT01801358|3630792|B6|1:||Baseline WHO Performance Status|"Categories:~0 - Fully active, able to carry on all pre-disease performance without restriction~1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~2 - Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~3 - Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~4 - Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|participants|Number|0|0.0||||||
3803764|NCT01801358|3630793|B5|1:||Baseline WHO Performance Status|"Categories:~0 - Fully active, able to carry on all pre-disease performance without restriction~1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~2 - Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~3 - Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~4 - Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|participants|Number|1|1.0||||||
3803765|NCT01801358|3630794|B4|1:||Baseline WHO Performance Status|"Categories:~0 - Fully active, able to carry on all pre-disease performance without restriction~1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~2 - Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~3 - Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~4 - Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|participants|Number|1|1.0||||||
3803766|NCT01801358|3630795|B3|1:||Baseline WHO Performance Status|"Categories:~0 - Fully active, able to carry on all pre-disease performance without restriction~1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~2 - Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~3 - Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~4 - Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|participants|Number|1|1.0||||||
3803767|NCT01801358|3630796|B2|1:||Baseline WHO Performance Status|"Categories:~0 - Fully active, able to carry on all pre-disease performance without restriction~1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~2 - Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~3 - Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~4 - Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|participants|Number|0|0.0||||||
3803768|NCT01801358|3630797|B1|1:||Baseline WHO Performance Status|"Categories:~0 - Fully active, able to carry on all pre-disease performance without restriction~1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~2 - Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~3 - Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~4 - Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|participants|Number|3|3.0||||||
3803769|NCT01801358|3630791|B7|0:||Baseline WHO Performance Status|"Categories:~0 - Fully active, able to carry on all pre-disease performance without restriction~1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~2 - Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~3 - Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~4 - Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|participants|Number|32|32.0||||||
3803770|NCT01801358|3630792|B6|0:||Baseline WHO Performance Status|"Categories:~0 - Fully active, able to carry on all pre-disease performance without restriction~1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~2 - Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~3 - Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~4 - Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|participants|Number|8|8.0||||||
3803771|NCT01801358|3630793|B5|0:||Baseline WHO Performance Status|"Categories:~0 - Fully active, able to carry on all pre-disease performance without restriction~1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~2 - Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~3 - Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~4 - Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|participants|Number|5|5.0||||||
3803772|NCT01801358|3630794|B4|0:||Baseline WHO Performance Status|"Categories:~0 - Fully active, able to carry on all pre-disease performance without restriction~1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~2 - Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~3 - Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~4 - Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|participants|Number|5|5.0||||||
3803773|NCT01801358|3630795|B3|0:||Baseline WHO Performance Status|"Categories:~0 - Fully active, able to carry on all pre-disease performance without restriction~1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~2 - Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~3 - Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~4 - Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|participants|Number|5|5.0||||||
3803774|NCT01801358|3630796|B2|0:||Baseline WHO Performance Status|"Categories:~0 - Fully active, able to carry on all pre-disease performance without restriction~1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~2 - Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~3 - Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~4 - Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|participants|Number|6|6.0||||||
3803836|NCT01801358|3630795|B3|Russian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3803837|NCT01801358|3630796|B2|Russian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3803838|NCT01801358|3630797|B1|Russian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3803775|NCT01801358|3630797|B1|0:||Baseline WHO Performance Status|"Categories:~0 - Fully active, able to carry on all pre-disease performance without restriction~1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~2 - Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~3 - Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~4 - Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|participants|Number|3|3.0||||||
3803776|NCT01801358|3630791|B7|Spain||Region of Enrollment||participants|Number|6|6.0||||||
3803777|NCT01801358|3630792|B6|Spain||Region of Enrollment||participants|Number|0|0.0||||||
3803778|NCT01801358|3630793|B5|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3803779|NCT01801358|3630794|B4|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3803780|NCT01801358|3630795|B3|Spain||Region of Enrollment||participants|Number|2|2.0||||||
3803781|NCT01801358|3630796|B2|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3803782|NCT01801358|3630797|B1|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3803783|NCT01801358|3630791|B7|Germany||Region of Enrollment||participants|Number|11|11.0||||||
3803784|NCT01801358|3630792|B6|Germany||Region of Enrollment||participants|Number|6|6.0||||||
3803785|NCT01801358|3630793|B5|Germany||Region of Enrollment||participants|Number|1|1.0||||||
3803786|NCT01801358|3630794|B4|Germany||Region of Enrollment||participants|Number|1|1.0||||||
3803787|NCT01801358|3630795|B3|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3803788|NCT01801358|3630796|B2|Germany||Region of Enrollment||participants|Number|1|1.0||||||
3803789|NCT01801358|3630797|B1|Germany||Region of Enrollment||participants|Number|2|2.0||||||
3803790|NCT01801358|3630791|B7|France||Region of Enrollment||participants|Number|7|7.0||||||
3803791|NCT01801358|3630792|B6|France||Region of Enrollment||participants|Number|0|0.0||||||
3803792|NCT01801358|3630793|B5|France||Region of Enrollment||participants|Number|0|0.0||||||
3803793|NCT01801358|3630794|B4|France||Region of Enrollment||participants|Number|1|1.0||||||
3803794|NCT01801358|3630795|B3|France||Region of Enrollment||participants|Number|1|1.0||||||
3803795|NCT01801358|3630796|B2|France||Region of Enrollment||participants|Number|3|3.0||||||
3803796|NCT01801358|3630797|B1|France||Region of Enrollment||participants|Number|2|2.0||||||
3803797|NCT01801358|3630791|B7|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
3803798|NCT01801358|3630792|B6|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3803799|NCT01801358|3630793|B5|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3803800|NCT01801358|3630794|B4|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3803801|NCT01801358|3630795|B3|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3803802|NCT01801358|3630796|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3803803|NCT01801358|3630797|B1|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3803804|NCT01801358|3630791|B7|United States||Region of Enrollment||participants|Number|7|7.0||||||
3803805|NCT01801358|3630792|B6|United States||Region of Enrollment||participants|Number|0|0.0||||||
3803806|NCT01801358|3630793|B5|United States||Region of Enrollment||participants|Number|2|2.0||||||
3803807|NCT01801358|3630794|B4|United States||Region of Enrollment||participants|Number|2|2.0||||||
3803808|NCT01801358|3630795|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3803809|NCT01801358|3630796|B2|United States||Region of Enrollment||participants|Number|0|0.0||||||
3803810|NCT01801358|3630797|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3803811|NCT01801358|3630791|B7|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
3803812|NCT01801358|3630792|B6|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
3803813|NCT01801358|3630793|B5|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
3803814|NCT01801358|3630794|B4|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
3803815|NCT01801358|3630795|B3|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
3803816|NCT01801358|3630796|B2|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
3803817|NCT01801358|3630797|B1|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
3803818|NCT01801358|3630791|B7|Other||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3803819|NCT01801358|3630792|B6|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3803820|NCT01801358|3630793|B5|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3803821|NCT01801358|3630794|B4|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3803822|NCT01801358|3630795|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3803823|NCT01801358|3630796|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3803824|NCT01801358|3630797|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3803825|NCT01801358|3630791|B7|Unknown||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3803826|NCT01801358|3630792|B6|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3803827|NCT01801358|3630793|B5|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3803828|NCT01801358|3630794|B4|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3803829|NCT01801358|3630795|B3|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3803830|NCT01801358|3630796|B2|Unknown||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3803831|NCT01801358|3630797|B1|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3803832|NCT01801358|3630791|B7|Russian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3803833|NCT01801358|3630792|B6|Russian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3803834|NCT01801358|3630793|B5|Russian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3803839|NCT01801358|3630791|B7|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3803840|NCT01801358|3630792|B6|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3803841|NCT01801358|3630793|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3803842|NCT01801358|3630794|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3803843|NCT01801358|3630795|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3803844|NCT01801358|3630796|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3803845|NCT01801358|3630797|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3803846|NCT01801358|3630791|B7||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3803847|NCT01801358|3630792|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3803848|NCT01801358|3630793|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3803849|NCT01801358|3630794|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3803850|NCT01801358|3630795|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3803851|NCT01801358|3630796|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3803852|NCT01801358|3630797|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3803853|NCT01801358|3630791|B7||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3803854|NCT01801358|3630792|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3803855|NCT01801358|3630793|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3803856|NCT01801358|3630794|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3803857|NCT01801358|3630795|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3803858|NCT01801358|3630796|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3803859|NCT01801358|3630797|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3803860|NCT01801358|3630791|B7|||Age||years|Mean|56.4|56.4|Standard Deviation|11.39|11.39|||
3803861|NCT01801358|3630792|B6|||Age||years|Mean|61.5|61.5|Standard Deviation|10.65|10.65|||
3803862|NCT01801358|3630793|B5|||Age||years|Mean|56.8|56.8|Standard Deviation|10.87|10.87|||
3803863|NCT01801358|3630794|B4|||Age||years|Mean|59.8|59.8|Standard Deviation|9.11|9.11|||
3803864|NCT01801358|3630795|B3|||Age||years|Mean|52.8|52.8|Standard Deviation|10.82|10.82|||
3803865|NCT01801358|3630796|B2|||Age||years|Mean|57.0|57.0|Standard Deviation|10.43|10.43|||
3803866|NCT01801358|3630797|B1|||Age||years|Mean|48.7|48.7|Standard Deviation|15.21|15.21|||
3803867|NCT01801358|3630791|B7||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3803868|NCT01801358|3630792|B6||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3803869|NCT01801358|3630793|B5||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3803870|NCT01801358|3630794|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3803871|NCT01801358|3630795|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3803872|NCT01801358|3630796|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3803873|NCT01801358|3630797|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3803874|NCT01801358|3630791|B7||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3803875|NCT01801358|3630792|B6||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3803876|NCT01801358|3630793|B5||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3803877|NCT01801358|3630794|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3803878|NCT01801358|3630795|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3803879|NCT01801358|3630796|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3803880|NCT01801358|3630797|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3803881|NCT01801358|3630791|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3803882|NCT01801358|3630792|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3803883|NCT01801358|3630793|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3803884|NCT01801358|3630794|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3803885|NCT01801358|3630795|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3803886|NCT01801358|3630796|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3803887|NCT01801358|3630797|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3803888|NCT01801280|3630920|B5|||Age at study enrollment||years|Mean|51|51.0|Standard Deviation|16|16.0|||
3803889|NCT01801280|3630921|B4|||Age at study enrollment||years|Mean|51|51.0|Standard Deviation|19|19.0|||
3803890|NCT01801280|3630922|B3|||Age at study enrollment||years|Mean|44|44.0|Standard Deviation|15|15.0|||
3803891|NCT01801280|3630923|B2|||Age at study enrollment||years|Mean|46|46.0|Standard Deviation|16|16.0|||
3803892|NCT01801280|3630924|B1|||Age at study enrollment||years|Mean|63|63.0|Standard Deviation|11|11.0|||
3803893|NCT01801280|3630920|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3803894|NCT01801280|3630921|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3803895|NCT01801280|3630922|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3803896|NCT01801280|3630923|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3803897|NCT01801280|3630924|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3803898|NCT01801280|3630920|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3803899|NCT01801280|3630921|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3803900|NCT01801280|3630922|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3803901|NCT01801280|3630923|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3803902|NCT01801280|3630924|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3803903|NCT01801280|3630920|B5|||Age|Age at transplantation|y|Mean|44|44.0|Standard Deviation|16|16.0|||
3803904|NCT01801280|3630921|B4|||Age|Age at transplantation|y|Mean|43|43.0|Standard Deviation|14|14.0|||
3803905|NCT01801280|3630922|B3|||Age|Age at transplantation|y|Mean|33|33.0|Standard Deviation|17|17.0|||
3803906|NCT01801280|3630923|B2|||Age|Age at transplantation|y|Mean|42|42.0|Standard Deviation|14|14.0|||
3803907|NCT01801280|3630924|B1|||Age|Age at transplantation|y|Mean|59|59.0|Standard Deviation|12|12.0|||
3803908|NCT01801124|3630937|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3803909|NCT01801124|3630937|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3803910|NCT01801124|3630937|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3803911|NCT01801124|3630937|B1|||Age||years|Mean|45.7|45.7|Standard Deviation|12.72|12.72|||
3803912|NCT01801124|3630937|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3803913|NCT01801124|3630937|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3803914|NCT01801124|3630937|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3803915|NCT01801111|3630942|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3803916|NCT01801111|3630942|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3803917|NCT01801111|3630942|B1|||Age||years|Mean|51.5|51.5|Standard Deviation|11.1|11.1|||
3803918|NCT01800968|3630981|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803919|NCT01800968|3630982|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803920|NCT01800968|3630983|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803921|NCT01800968|3630981|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3803922|NCT01800968|3630982|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3803923|NCT01800968|3630983|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3803924|NCT01800968|3630981|B3||White|Race (NIH/OMB)||Participants|Count of Participants|172|172.0||||||
3803925|NCT01800968|3630982|B2||White|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
3803926|NCT01800968|3630983|B1||White|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3803927|NCT01800968|3630981|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
3803928|NCT01800968|3630982|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3803929|NCT01800968|3630983|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3803930|NCT01800968|3630981|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803931|NCT01800968|3630982|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803932|NCT01800968|3630983|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803933|NCT01800968|3630981|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3803934|NCT01800968|3630982|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3803935|NCT01800968|3630983|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803936|NCT01800968|3630981|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3803937|NCT01800968|3630982|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3803938|NCT01800968|3630983|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3803939|NCT01800968|3630981|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803940|NCT01800968|3630982|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803941|NCT01800968|3630983|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803942|NCT01800968|3630981|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|285|285.0||||||
3803943|NCT01800968|3630982|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|135|135.0||||||
3803944|NCT01800968|3630983|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|150|150.0||||||
3803945|NCT01800968|3630981|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3803946|NCT01800968|3630982|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3803947|NCT01800968|3630983|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3803948|NCT01800968|3630981|B3||Male|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
3803949|NCT01800968|3630982|B2||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3803950|NCT01800968|3630983|B1||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3803951|NCT01800968|3630981|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3803952|NCT01800968|3630982|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3803953|NCT01800968|3630983|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3803954|NCT01800968|3630981|B3|||Age||years|Mean|59.7|59.7|Standard Deviation|12.5|12.5|||
3803955|NCT01800968|3630982|B2|||Age||years|Mean|59.6|59.6|Standard Deviation|12.2|12.2|||
3803956|NCT01800968|3630983|B1|||Age||years|Mean|59.9|59.9|Standard Deviation|12.9|12.9|||
3803957|NCT01800916|3631026|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3803958|NCT01800916|3631026|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3803959|NCT01800916|3631026|B1|||Age||years|Mean|59.0|59.0|Standard Deviation|10.8|10.8|||
3803960|NCT01800903|3631044|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3803961|NCT01800903|3631044|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3803962|NCT01800903|3631044|B1|||Age||years|Mean|26.5|26.5|Standard Deviation|8.7|8.7|||
3803963|NCT01800890|3631055|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3803964|NCT01800890|3631055|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3803965|NCT01800890|3631055|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|8.6|8.6|||
3803966|NCT01800786|3631073|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
3803967|NCT01800786|3631074|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3803968|NCT01800786|3631075|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3803969|NCT01800786|3631073|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3803970|NCT01800786|3631074|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3803971|NCT01800786|3631075|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3803972|NCT01800786|3631073|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3803973|NCT01800786|3631074|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3803974|NCT01800786|3631075|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3803975|NCT01800786|3631073|B3|||Age||years|Mean|47.9|47.9|Standard Deviation|12.6|12.6|||
3803976|NCT01800786|3631074|B2|||Age||years|Mean|46.4|46.4|Standard Deviation|13|13.0|||
3803977|NCT01800786|3631075|B1|||Age||years|Mean|48.7|48.7|Standard Deviation|12.4|12.4|||
3803978|NCT01800786|3631073|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3803979|NCT01800786|3631074|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3803980|NCT01800786|3631075|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3803981|NCT01800786|3631073|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3803982|NCT01800786|3631074|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3803983|NCT01800786|3631075|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3803984|NCT01800786|3631073|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3803985|NCT01800786|3631074|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3803986|NCT01800786|3631075|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3803987|NCT01800318|3631082|B5|||Participants per treatment group||participants|Number|162|162.0||||||
3803988|NCT01800318|3631083|B4|||Participants per treatment group||participants|Number|40|40.0||||||
3803989|NCT01800318|3631084|B3|||Participants per treatment group||participants|Number|41|41.0||||||
3803990|NCT01800318|3631085|B2|||Participants per treatment group||participants|Number|42|42.0||||||
3803991|NCT01800318|3631086|B1|||Participants per treatment group||participants|Number|39|39.0||||||
3803992|NCT01800318|3631082|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803993|NCT01800318|3631083|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803994|NCT01800318|3631084|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803995|NCT01800318|3631085|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803996|NCT01800318|3631086|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3803997|NCT01800318|3631082|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3803998|NCT01800318|3631083|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3803999|NCT01800318|3631084|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3804000|NCT01800318|3631085|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804001|NCT01800318|3631086|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804002|NCT01800318|3631082|B5||White|Race (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3804003|NCT01800318|3631083|B4||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3804004|NCT01800318|3631084|B3||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3804005|NCT01800318|3631085|B2||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3804006|NCT01800318|3631086|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3804007|NCT01800318|3631082|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3804008|NCT01800318|3631083|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3804009|NCT01800318|3631084|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3804010|NCT01800318|3631085|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3804011|NCT01800318|3631086|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3804012|NCT01800318|3631082|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804013|NCT01800318|3631083|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804014|NCT01800318|3631084|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804015|NCT01800318|3631085|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804016|NCT01800318|3631086|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804017|NCT01800318|3631082|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3804018|NCT01800318|3631083|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3804019|NCT01800318|3631084|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3804020|NCT01800318|3631085|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3804021|NCT01800318|3631086|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3804022|NCT01800318|3631082|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804023|NCT01800318|3631083|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804024|NCT01800318|3631084|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804025|NCT01800318|3631085|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804026|NCT01800318|3631086|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804027|NCT01800318|3631082|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804028|NCT01800318|3631083|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804029|NCT01800318|3631084|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804030|NCT01800318|3631085|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804031|NCT01800318|3631086|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804032|NCT01800318|3631082|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
3804033|NCT01800318|3631083|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3804034|NCT01800318|3631084|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3804035|NCT01800318|3631085|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3804036|NCT01800318|3631086|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3804037|NCT01800318|3631082|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3804038|NCT01800318|3631083|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3804039|NCT01800318|3631084|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3804040|NCT01800318|3631085|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3804041|NCT01800318|3631086|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3804042|NCT01800318|3631082|B5||Male|Gender||Participants|Count of Participants|88|88.0||||||
3804043|NCT01800318|3631083|B4||Male|Gender||Participants|Count of Participants|23|23.0||||||
3804044|NCT01800318|3631084|B3||Male|Gender||Participants|Count of Participants|25|25.0||||||
3804045|NCT01800318|3631085|B2||Male|Gender||Participants|Count of Participants|16|16.0||||||
3804046|NCT01800318|3631086|B1||Male|Gender||Participants|Count of Participants|24|24.0||||||
3804047|NCT01800318|3631082|B5||Female|Gender||Participants|Count of Participants|74|74.0||||||
3804048|NCT01800318|3631083|B4||Female|Gender||Participants|Count of Participants|17|17.0||||||
3804049|NCT01800318|3631084|B3||Female|Gender||Participants|Count of Participants|16|16.0||||||
3804050|NCT01800318|3631085|B2||Female|Gender||Participants|Count of Participants|26|26.0||||||
3804051|NCT01800318|3631086|B1||Female|Gender||Participants|Count of Participants|15|15.0||||||
3804052|NCT01800318|3631082|B5|||Age||days|Mean|1|1.0|Standard Deviation|0.5|0.5|||
3804053|NCT01800318|3631083|B4|||Age||days|Mean|1|1.0|Standard Deviation|0.5|0.5|||
3804054|NCT01800318|3631084|B3|||Age||days|Mean|1|1.0|Standard Deviation|0.5|0.5|||
3804055|NCT01800318|3631085|B2|||Age||days|Mean|1|1.0|Standard Deviation|0.5|0.5|||
3804056|NCT01800318|3631086|B1|||Age||days|Mean|1|1.0|Standard Deviation|0.5|0.5|||
3804057|NCT01800162|3631115|B4|||Gestational Age||weeks|Number|21|21.0||||||
3804058|NCT01800162|3631116|B3|||Gestational Age||weeks|Number|7|7.0||||||
3804059|NCT01800162|3631118|B1|||Gestational Age||weeks|Number|14|14.0||||||
3804060|NCT01800162|3631115|B4|United States||Region of Enrollment||participants|Number|1|1.0||||||
3804061|NCT01800162|3631116|B3|United States||Region of Enrollment||participants|Number|0|0.0||||||
3804062|NCT01800162|3631118|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3804063|NCT01800162|3631115|B4|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
3804064|NCT01800162|3631116|B3|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
3804065|NCT01800162|3631118|B1|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
3804066|NCT01800162|3631115|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3804067|NCT01800162|3631116|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3804068|NCT01800162|3631117|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3804069|NCT01800162|3631118|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3804070|NCT01800162|3631115|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3804071|NCT01800162|3631116|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3804072|NCT01800162|3631117|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3804073|NCT01800162|3631118|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3804074|NCT01800162|3631115|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3804075|NCT01800162|3631116|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3804076|NCT01800162|3631117|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3804077|NCT01800162|3631118|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3804078|NCT01800162|3631115|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3804079|NCT01800162|3631116|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3804080|NCT01800162|3631117|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3804081|NCT01800162|3631118|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3804082|NCT01800162|3631115|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3804083|NCT01800162|3631116|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3804084|NCT01800162|3631117|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3804085|NCT01800162|3631118|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3804086|NCT01799993|3631144|B3|||CPIS|The Clinical Pulmonary Infection Score (CPIS) is an accepted tool for clinical estimation of ventilator-associated pneumonia (VAP), encompassing five components: tracheal secretions (volume and purulence), temperature, blood leukocytes, oxygenation (P/F ratio). An integer point score from 0 to 2 is assigned for each component; the total CPIS point score (ranges from 0 to 10) is calculated as the sum of the five components ; higher scores imply a more severe disease.|Scores on a scale|Mean|7.0|7.0|Standard Deviation|1.34|1.34|||
3804087|NCT01799993|3631145|B2|||CPIS|The Clinical Pulmonary Infection Score (CPIS) is an accepted tool for clinical estimation of ventilator-associated pneumonia (VAP), encompassing five components: tracheal secretions (volume and purulence), temperature, blood leukocytes, oxygenation (P/F ratio). An integer point score from 0 to 2 is assigned for each component; the total CPIS point score (ranges from 0 to 10) is calculated as the sum of the five components ; higher scores imply a more severe disease.|Scores on a scale|Mean|6.9|6.9|Standard Deviation|1.29|1.29|||
3804088|NCT01799993|3631146|B1|||CPIS|The Clinical Pulmonary Infection Score (CPIS) is an accepted tool for clinical estimation of ventilator-associated pneumonia (VAP), encompassing five components: tracheal secretions (volume and purulence), temperature, blood leukocytes, oxygenation (P/F ratio). An integer point score from 0 to 2 is assigned for each component; the total CPIS point score (ranges from 0 to 10) is calculated as the sum of the five components ; higher scores imply a more severe disease.|Scores on a scale|Mean|7.1|7.1|Standard Deviation|1.38|1.38|||
3804089|NCT01799993|3631144|B3||>=20|APACHE II score|The Acute Physiology and Chronic Health Evaluation II (APACHE II) is a severity of disease classification system (Knaus et al, 1985), one of several ICU scoring systems. After admission of a patient to an ICU, an integer score from 0 to 71 is computed based on several measurements; higher scores imply a more severe disease and a higher risk of death. Participants who met all of the inclusion criteria and none of the exclusion criteria were stratified by geographic region (or country) and disease severity using APACHE II score, and randomized in a 1:1 ratio to one of the two treatment groups.|Participants|Count of Participants|339|339.0||||||
3804090|NCT01799993|3631145|B2||>=20|APACHE II score|The Acute Physiology and Chronic Health Evaluation II (APACHE II) is a severity of disease classification system (Knaus et al, 1985), one of several ICU scoring systems. After admission of a patient to an ICU, an integer score from 0 to 71 is computed based on several measurements; higher scores imply a more severe disease and a higher risk of death. Participants who met all of the inclusion criteria and none of the exclusion criteria were stratified by geographic region (or country) and disease severity using APACHE II score, and randomized in a 1:1 ratio to one of the two treatment groups.|Participants|Count of Participants|172|172.0||||||
3804091|NCT01799993|3631146|B1||>=20|APACHE II score|The Acute Physiology and Chronic Health Evaluation II (APACHE II) is a severity of disease classification system (Knaus et al, 1985), one of several ICU scoring systems. After admission of a patient to an ICU, an integer score from 0 to 71 is computed based on several measurements; higher scores imply a more severe disease and a higher risk of death. Participants who met all of the inclusion criteria and none of the exclusion criteria were stratified by geographic region (or country) and disease severity using APACHE II score, and randomized in a 1:1 ratio to one of the two treatment groups.|Participants|Count of Participants|167|167.0||||||
3804092|NCT01799993|3631144|B3||<20|APACHE II score|The Acute Physiology and Chronic Health Evaluation II (APACHE II) is a severity of disease classification system (Knaus et al, 1985), one of several ICU scoring systems. After admission of a patient to an ICU, an integer score from 0 to 71 is computed based on several measurements; higher scores imply a more severe disease and a higher risk of death. Participants who met all of the inclusion criteria and none of the exclusion criteria were stratified by geographic region (or country) and disease severity using APACHE II score, and randomized in a 1:1 ratio to one of the two treatment groups.|Participants|Count of Participants|373|373.0||||||
3804093|NCT01799993|3631145|B2||<20|APACHE II score|The Acute Physiology and Chronic Health Evaluation II (APACHE II) is a severity of disease classification system (Knaus et al, 1985), one of several ICU scoring systems. After admission of a patient to an ICU, an integer score from 0 to 71 is computed based on several measurements; higher scores imply a more severe disease and a higher risk of death. Participants who met all of the inclusion criteria and none of the exclusion criteria were stratified by geographic region (or country) and disease severity using APACHE II score, and randomized in a 1:1 ratio to one of the two treatment groups.|Participants|Count of Participants|186|186.0||||||
3804094|NCT01799993|3631146|B1||<20|APACHE II score|The Acute Physiology and Chronic Health Evaluation II (APACHE II) is a severity of disease classification system (Knaus et al, 1985), one of several ICU scoring systems. After admission of a patient to an ICU, an integer score from 0 to 71 is computed based on several measurements; higher scores imply a more severe disease and a higher risk of death. Participants who met all of the inclusion criteria and none of the exclusion criteria were stratified by geographic region (or country) and disease severity using APACHE II score, and randomized in a 1:1 ratio to one of the two treatment groups.|Participants|Count of Participants|187|187.0||||||
3804095|NCT01799993|3631144|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3804096|NCT01799993|3631145|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3804097|NCT01799993|3631146|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3804098|NCT01799993|3631144|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|512|512.0||||||
3804099|NCT01799993|3631145|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|250|250.0||||||
3804100|NCT01799993|3631146|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|262|262.0||||||
3804101|NCT01799993|3631144|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
3804102|NCT01799993|3631145|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3804103|NCT01799993|3631146|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3804104|NCT01799993|3631144|B3||Male|Sex: Female, Male||Participants|Count of Participants|498|498.0||||||
3804105|NCT01799993|3631145|B2||Male|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
3804106|NCT01799993|3631146|B1||Male|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
3804107|NCT01799993|3631144|B3||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
3804108|NCT01799993|3631145|B2||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3804109|NCT01799993|3631146|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3804110|NCT01799993|3631144|B3||>=75|Age, Customized||Participants|Count of Participants|211|211.0||||||
3804111|NCT01799993|3631145|B2||>=75|Age, Customized||Participants|Count of Participants|117|117.0||||||
3804112|NCT01799993|3631146|B1||>=75|Age, Customized||Participants|Count of Participants|94|94.0||||||
3804113|NCT01799993|3631144|B3||65 to <75|Age, Customized||Participants|Count of Participants|175|175.0||||||
3804114|NCT01799993|3631145|B2||65 to <75|Age, Customized||Participants|Count of Participants|83|83.0||||||
3804115|NCT01799993|3631146|B1||65 to <75|Age, Customized||Participants|Count of Participants|92|92.0||||||
3804116|NCT01799993|3631144|B3||45 to <65|Age, Customized||Participants|Count of Participants|235|235.0||||||
3804117|NCT01799993|3631145|B2||45 to <65|Age, Customized||Participants|Count of Participants|105|105.0||||||
3804118|NCT01799993|3631146|B1||45 to <65|Age, Customized||Participants|Count of Participants|130|130.0||||||
3804119|NCT01799993|3631144|B3||18 to <45|Age, Customized||Participants|Count of Participants|91|91.0||||||
3804120|NCT01799993|3631145|B2||18 to <45|Age, Customized||Participants|Count of Participants|53|53.0||||||
3804121|NCT01799993|3631146|B1||18 to <45|Age, Customized||Participants|Count of Participants|38|38.0||||||
3804122|NCT01799993|3631144|B3||<18|Age, Customized||Participants|Count of Participants|0|0.0||||||
3804123|NCT01799993|3631145|B2||<18|Age, Customized||Participants|Count of Participants|0|0.0||||||
3804124|NCT01799993|3631146|B1||<18|Age, Customized||Participants|Count of Participants|0|0.0||||||
3804125|NCT01799993|3631144|B3|||Age||Years|Mean|63.9|63.9|Standard Deviation|16.42|16.42|||
3804126|NCT01799993|3631145|B2|||Age||Years|Mean|64.1|64.1|Standard Deviation|17.04|17.04|||
3804127|NCT01799993|3631146|B1|||Age||Years|Mean|63.8|63.8|Standard Deviation|15.78|15.78|||
3804128|NCT01799941|3631179|B1||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3804129|NCT01799941|3631179|B1||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3804130|NCT01799941|3631179|B1||>=65 years|Age||Participants|Count of Participants|152|152.0||||||
3804131|NCT01799941|3631179|B1||Between 18 and 65 years|Age||Participants|Count of Participants|215|215.0||||||
3804132|NCT01799941|3631179|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3804133|NCT01799720|3631233|B4|Spain||Region of Enrollment||participants|Number|52|52.0||||||
3804134|NCT01799720|3631234|B3|Spain||Region of Enrollment||participants|Number|18|18.0||||||
3804135|NCT01799720|3631235|B2|Spain||Region of Enrollment||participants|Number|17|17.0||||||
3804136|NCT01799720|3631236|B1|Spain||Region of Enrollment||participants|Number|17|17.0||||||
3804137|NCT01799720|3631233|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3804138|NCT01799720|3631234|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3804139|NCT01799720|3631235|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3804140|NCT01799720|3631236|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3804141|NCT01799720|3631233|B4||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3804142|NCT01799720|3631234|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3804143|NCT01799720|3631235|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3804144|NCT01799720|3631236|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3804145|NCT01799720|3631233|B4|||Age||years|Mean|55.14|55.14|Standard Deviation|11.87|11.87|||
3804146|NCT01799720|3631234|B3|||Age||years|Mean|51.94|51.94|Standard Deviation|10.80|10.8|||
3804147|NCT01799720|3631235|B2|||Age||years|Mean|56.82|56.82|Standard Deviation|12.18|12.18|||
3804148|NCT01799720|3631236|B1|||Age||years|Mean|56.65|56.65|Standard Deviation|12.65|12.65|||
3804149|NCT01799720|3631233|B4||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3804150|NCT01799720|3631234|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3804151|NCT01799720|3631235|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3804152|NCT01799720|3631236|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3804153|NCT01799720|3631233|B4||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3804154|NCT01799720|3631234|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3804155|NCT01799720|3631235|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3804156|NCT01799720|3631236|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3804157|NCT01799720|3631233|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3804158|NCT01799720|3631234|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3804159|NCT01799720|3631235|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3804160|NCT01799720|3631236|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3804161|NCT01799590|3631273|B4||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3804162|NCT01799590|3631274|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3804163|NCT01799590|3631275|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3804164|NCT01799590|3631276|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3804165|NCT01799590|3631273|B4||Female|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
3804166|NCT01799590|3631274|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3804167|NCT01799590|3631275|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3804168|NCT01799590|3631276|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3804169|NCT01799590|3631273|B4|||Age||Years|Mean|40.3|40.3|Standard Deviation|9.13|9.13|||
3804170|NCT01799590|3631274|B3|||Age||Years|Mean|38.3|38.3|Standard Deviation|9.12|9.12|||
3804171|NCT01799590|3631275|B2|||Age||Years|Mean|40.7|40.7|Standard Deviation|9.28|9.28|||
3804172|NCT01799590|3631276|B1|||Age||Years|Mean|41.5|41.5|Standard Deviation|8.83|8.83|||
3804173|NCT01799278|3631313|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3804174|NCT01799278|3631313|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804175|NCT01799278|3631313|B1||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3804176|NCT01799278|3631313|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3804177|NCT01799278|3631313|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804178|NCT01799278|3631313|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3804179|NCT01799278|3631313|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804180|NCT01799278|3631313|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3804181|NCT01799278|3631313|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3804182|NCT01799278|3631313|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3804183|NCT01799278|3631313|B1||Male|Sex: Female, Male|All subjects are Male|Participants|Count of Participants|60|60.0||||||
3804184|NCT01799278|3631313|B1||Female|Sex: Female, Male|All subjects are Male|Participants|Count of Participants|0|0.0||||||
3804185|NCT01799278|3631313|B1|||Age||years|Median|67|67.0|Full Range|||45.0|87.0|
3804186|NCT01799239|3631321|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3804187|NCT01799239|3631321|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3804188|NCT01799239|3631321|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|15.7|15.7|||
3804189|NCT01799226|3631328|B3|||Bleeding on probing ≤ 10%||Percent of sites bleeding on probing|Mean|0.064|0.064|Full Range|||0.02|0.1|
3804190|NCT01799226|3631329|B2|||Bleeding on probing ≤ 10%||Percent of sites bleeding on probing|Mean|0.063|0.063|Full Range|||0.02|0.1|
3804191|NCT01799226|3631330|B1|||Bleeding on probing ≤ 10%||Percent of sites bleeding on probing|Mean|0.065|0.065|Full Range|||0.02|0.1|
3804192|NCT01799226|3631328|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
3804193|NCT01799226|3631329|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3804194|NCT01799226|3631330|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3804195|NCT01799226|3631328|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3804196|NCT01799226|3631329|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3804197|NCT01799226|3631330|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3804198|NCT01799226|3631328|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804199|NCT01799226|3631329|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804200|NCT01799226|3631330|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804201|NCT01799226|3631328|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3804202|NCT01799226|3631329|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3804203|NCT01799226|3631330|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3804204|NCT01799226|3631328|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3804205|NCT01799226|3631329|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3804206|NCT01799226|3631330|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3804207|NCT01799226|3631328|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804208|NCT01799226|3631329|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804209|NCT01799226|3631330|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804210|NCT01799226|3631328|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3804211|NCT01799226|3631329|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3804212|NCT01799226|3631330|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3804213|NCT01799226|3631328|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804214|NCT01799226|3631329|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804215|NCT01799226|3631330|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804216|NCT01799226|3631328|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3804217|NCT01799226|3631329|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804218|NCT01799226|3631330|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3804270|NCT01798992|3631340|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3804219|NCT01799226|3631328|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3804220|NCT01799226|3631329|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3804221|NCT01799226|3631330|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3804222|NCT01799226|3631328|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3804223|NCT01799226|3631329|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3804224|NCT01799226|3631330|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3804225|NCT01799226|3631328|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3804226|NCT01799226|3631329|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3804227|NCT01799226|3631330|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3804228|NCT01799226|3631328|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3804229|NCT01799226|3631329|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3804230|NCT01799226|3631330|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3804231|NCT01799226|3631328|B3|Age||Age, Customized||years|Mean|26.57|26.57|Full Range|||20.83|32.32|
3804232|NCT01799226|3631329|B2|Age||Age, Customized||years|Mean|26.06|26.06|Full Range|||20.83|31.29|
3804233|NCT01799226|3631330|B1|Age||Age, Customized||years|Mean|27.07|27.07|Full Range|||21.92|32.32|
3804234|NCT01798992|3631339|B5|||LV ejection fraction|Left ventricular ejection fraction = Stroke volume/End diastolic volume. Measured by single-photon emitted computed tomographic (SPECT) imaging or where not available, clinical multi-gated acquisition (MUGA) radionuclide ventriculography|%|Mean|28.6|28.6|Standard Deviation|11.9|11.9|||
3804235|NCT01798992|3631340|B4|||LV ejection fraction|Left ventricular ejection fraction = Stroke volume/End diastolic volume. Measured by single-photon emitted computed tomographic (SPECT) imaging or where not available, clinical multi-gated acquisition (MUGA) radionuclide ventriculography|%|Mean|28.6|28.6|Standard Deviation|8.7|8.7|||
3804236|NCT01798992|3631341|B3|||LV ejection fraction|Left ventricular ejection fraction = Stroke volume/End diastolic volume. Measured by single-photon emitted computed tomographic (SPECT) imaging or where not available, clinical multi-gated acquisition (MUGA) radionuclide ventriculography|%|Mean|28.5|28.5|Standard Deviation|8.7|8.7|||
3804237|NCT01798992|3631342|B2|||LV ejection fraction|Left ventricular ejection fraction = Stroke volume/End diastolic volume. Measured by single-photon emitted computed tomographic (SPECT) imaging or where not available, clinical multi-gated acquisition (MUGA) radionuclide ventriculography|%|Mean|22.5|22.5|Standard Deviation|7.1|7.1|||
3804238|NCT01798992|3631343|B1|||LV ejection fraction|Left ventricular ejection fraction = Stroke volume/End diastolic volume. Measured by single-photon emitted computed tomographic (SPECT) imaging or where not available, clinical multi-gated acquisition (MUGA) radionuclide ventriculography|%|Mean|58.8|58.8|Standard Deviation|7.4|7.4|||
3804239|NCT01798992|3631339|B5|United States||Region of Enrollment||participants|Number|56|56.0||||||
3804240|NCT01798992|3631340|B4|United States||Region of Enrollment||participants|Number|17|17.0||||||
3804241|NCT01798992|3631341|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
3804242|NCT01798992|3631342|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3804243|NCT01798992|3631343|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3804244|NCT01798992|3631339|B5|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3804245|NCT01798992|3631340|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3804246|NCT01798992|3631341|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3804247|NCT01798992|3631342|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3804248|NCT01798992|3631343|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3804249|NCT01798992|3631339|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3804250|NCT01798992|3631340|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3804251|NCT01798992|3631341|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3804252|NCT01798992|3631342|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3804253|NCT01798992|3631343|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3804254|NCT01798992|3631339|B5|African Ancestry||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3804255|NCT01798992|3631340|B4|African Ancestry||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3804256|NCT01798992|3631341|B3|African Ancestry||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3804257|NCT01798992|3631342|B2|African Ancestry||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3804258|NCT01798992|3631343|B1|African Ancestry||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3804259|NCT01798992|3631339|B5|European Ancestry||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
3804260|NCT01798992|3631340|B4|European Ancestry||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3804261|NCT01798992|3631341|B3|European Ancestry||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3804262|NCT01798992|3631342|B2|European Ancestry||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3804263|NCT01798992|3631343|B1|European Ancestry||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3804264|NCT01798992|3631339|B5||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3804265|NCT01798992|3631340|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3804266|NCT01798992|3631341|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3804267|NCT01798992|3631342|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3804268|NCT01798992|3631343|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3804269|NCT01798992|3631339|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3804271|NCT01798992|3631341|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3804272|NCT01798992|3631342|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3804273|NCT01798992|3631343|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3804274|NCT01798992|3631339|B5|||Age|Calculated using enrollment date - birthdate|years|Mean|45.3|45.3|Standard Deviation|12.8|12.8|||
3804275|NCT01798992|3631340|B4|||Age|Calculated using enrollment date - birthdate|years|Mean|44.9|44.9|Standard Deviation|15.1|15.1|||
3804276|NCT01798992|3631341|B3|||Age|Calculated using enrollment date - birthdate|years|Mean|46.0|46.0|Standard Deviation|7.5|7.5|||
3804277|NCT01798992|3631342|B2|||Age|Calculated using enrollment date - birthdate|years|Mean|45.9|45.9|Standard Deviation|13.6|13.6|||
3804278|NCT01798992|3631343|B1|||Age|Calculated using enrollment date - birthdate|years|Mean|41.0|41.0|Standard Deviation|17.1|17.1|||
3804279|NCT01798966|3631360|B1|||Tolerability of CLS|Subjective comfort level using a number between 0-10 with values ranging from 0 (no discomfort) to 10 (very severe discomfort)|units on a scale|Mean|1.5|1.5|Standard Deviation|0.7|0.7|||
3804280|NCT01798966|3631360|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3804281|NCT01798966|3631360|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3804282|NCT01798966|3631360|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3804283|NCT01798966|3631360|B1|||Age||years|Mean|61.8|61.8|Standard Deviation|21.6|21.6|||
3804284|NCT01798927|3631366|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3804285|NCT01798927|3631366|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3804286|NCT01798927|3631366|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3804287|NCT01798927|3631366|B1|||Age||years|Mean|68|68.0|Standard Deviation|5.22|5.22|||
3804288|NCT01798927|3631366|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3804289|NCT01798927|3631366|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3804290|NCT01798927|3631366|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3804291|NCT01798706|3631372|B3|||Duration of Diabetes||years|Mean|14.13|14.13|Standard Deviation|7.62|7.62|||
3804292|NCT01798706|3631373|B2|||Duration of Diabetes||years|Mean|14.63|14.63|Standard Deviation|7.87|7.87|||
3804293|NCT01798706|3631374|B1|||Duration of Diabetes||years|Mean|13.63|13.63|Standard Deviation|7.34|7.34|||
3804294|NCT01798706|3631372|B3|||7-Point Self-monitored Plasma Glucose (SMPG)|333 participants (171 in lixisenatide arm and 162 in placebo arm) were included for 7 point SMPG analysis.|mmol/L|Mean|9.87|9.87|Standard Deviation|2.00|2.0|||
3804295|NCT01798706|3631373|B2|||7-Point Self-monitored Plasma Glucose (SMPG)|333 participants (171 in lixisenatide arm and 162 in placebo arm) were included for 7 point SMPG analysis.|mmol/L|Mean|9.97|9.97|Standard Deviation|1.98|1.98|||
3804296|NCT01798706|3631374|B1|||7-Point Self-monitored Plasma Glucose (SMPG)|333 participants (171 in lixisenatide arm and 162 in placebo arm) were included for 7 point SMPG analysis.|mmol/L|Mean|9.79|9.79|Standard Deviation|2.02|2.02|||
3804297|NCT01798706|3631372|B3|||Glucose Excursion|345 participants (173 in lixisenatide arm and 172 in placebo arm) were included for glucose excursion analysis.|mmol/L|Mean|6.26|6.26|Standard Deviation|3.16|3.16|||
3804298|NCT01798706|3631373|B2|||Glucose Excursion|345 participants (173 in lixisenatide arm and 172 in placebo arm) were included for glucose excursion analysis.|mmol/L|Mean|6.02|6.02|Standard Deviation|3.17|3.17|||
3804299|NCT01798706|3631374|B1|||Glucose Excursion|345 participants (173 in lixisenatide arm and 172 in placebo arm) were included for glucose excursion analysis.|mmol/L|Mean|6.51|6.51|Standard Deviation|3.15|3.15|||
3804300|NCT01798706|3631372|B3|||2-Hour Postprandial Plasma Glucose (PPG)|347 participants (174 in lixisenatide arm and 173 in placebo arm) were included for PPG analysis.|mmol/L|Mean|15.03|15.03|Standard Deviation|3.74|3.74|||
3804301|NCT01798706|3631373|B2|||2-Hour Postprandial Plasma Glucose (PPG)|347 participants (174 in lixisenatide arm and 173 in placebo arm) were included for PPG analysis.|mmol/L|Mean|14.87|14.87|Standard Deviation|3.69|3.69|||
3804302|NCT01798706|3631374|B1|||2-Hour Postprandial Plasma Glucose (PPG)|347 participants (174 in lixisenatide arm and 173 in placebo arm) were included for PPG analysis.|mmol/L|Mean|15.18|15.18|Standard Deviation|3.78|3.78|||
3804303|NCT01798706|3631372|B3|||Fasting Plasma Glucose (FPG)||mmol/L|Mean|8.86|8.86|Standard Deviation|2.32|2.32|||
3804304|NCT01798706|3631373|B2|||Fasting Plasma Glucose (FPG)||mmol/L|Mean|8.89|8.89|Standard Deviation|2.26|2.26|||
3804305|NCT01798706|3631374|B1|||Fasting Plasma Glucose (FPG)||mmol/L|Mean|8.83|8.83|Standard Deviation|2.38|2.38|||
3804306|NCT01798706|3631372|B3|||HbA1c||Percentage of HbA1c|Mean|8.04|8.04|Standard Deviation|0.71|0.71|||
3804307|NCT01798706|3631373|B2|||HbA1c||Percentage of HbA1c|Mean|8.05|8.05|Standard Deviation|0.69|0.69|||
3804308|NCT01798706|3631374|B1|||HbA1c||Percentage of HbA1c|Mean|8.04|8.04|Standard Deviation|0.72|0.72|||
3804309|NCT01798706|3631372|B3|||Body Weight||kg|Mean|80.45|80.45|Standard Deviation|15.66|15.66|||
3804310|NCT01798706|3631373|B2|||Body Weight||kg|Mean|80.08|80.08|Standard Deviation|16.76|16.76|||
3804311|NCT01798706|3631374|B1|||Body Weight||kg|Mean|80.81|80.81|Standard Deviation|14.54|14.54|||
3804312|NCT01798706|3631372|B3|||Body Mass Index (BMI)||kg/m^2|Mean|30.00|30.0|Standard Deviation|4.13|4.13|||
3804313|NCT01798706|3631373|B2|||Body Mass Index (BMI)||kg/m^2|Mean|30.09|30.09|Standard Deviation|4.53|4.53|||
3804314|NCT01798706|3631374|B1|||Body Mass Index (BMI)||kg/m^2|Mean|29.91|29.91|Standard Deviation|3.7|3.7|||
3804315|NCT01798706|3631372|B3|≥30 kg/m^2||Number of Participants with Categorical BMI||participants|Number|152|152.0||||||
3804316|NCT01798706|3631373|B2|≥30 kg/m^2||Number of Participants with Categorical BMI||participants|Number|78|78.0||||||
3804317|NCT01798706|3631374|B1|≥30 kg/m^2||Number of Participants with Categorical BMI||participants|Number|74|74.0||||||
3804318|NCT01798706|3631372|B3|<30 kg/m^2||Number of Participants with Categorical BMI||participants|Number|198|198.0||||||
3804319|NCT01798706|3631373|B2|<30 kg/m^2||Number of Participants with Categorical BMI||participants|Number|96|96.0||||||
3804320|NCT01798706|3631374|B1|<30 kg/m^2||Number of Participants with Categorical BMI||participants|Number|102|102.0||||||
3804321|NCT01798706|3631372|B3|Not Hispanic||Ethnicity||participants|Number|251|251.0||||||
3804322|NCT01798706|3631373|B2|Not Hispanic||Ethnicity||participants|Number|126|126.0||||||
3804323|NCT01798706|3631374|B1|Not Hispanic||Ethnicity||participants|Number|125|125.0||||||
3804324|NCT01798706|3631372|B3|Hispanic||Ethnicity||participants|Number|99|99.0||||||
3804325|NCT01798706|3631373|B2|Hispanic||Ethnicity||participants|Number|48|48.0||||||
3804326|NCT01798706|3631374|B1|Hispanic||Ethnicity||participants|Number|51|51.0||||||
3804327|NCT01798706|3631372|B3|Other||Race||participants|Number|81|81.0||||||
3804328|NCT01798706|3631373|B2|Other||Race||participants|Number|41|41.0||||||
3804329|NCT01798706|3631374|B1|Other||Race||participants|Number|40|40.0||||||
3804330|NCT01798706|3631372|B3|Asian/Oriental||Race||participants|Number|16|16.0||||||
3804331|NCT01798706|3631373|B2|Asian/Oriental||Race||participants|Number|11|11.0||||||
3804332|NCT01798706|3631374|B1|Asian/Oriental||Race||participants|Number|5|5.0||||||
3804333|NCT01798706|3631372|B3|Black||Race||participants|Number|3|3.0||||||
3804334|NCT01798706|3631373|B2|Black||Race||participants|Number|0|0.0||||||
3804335|NCT01798706|3631374|B1|Black||Race||participants|Number|3|3.0||||||
3804336|NCT01798706|3631372|B3|Caucasian/white||Race||participants|Number|250|250.0||||||
3804337|NCT01798706|3631373|B2|Caucasian/white||Race||participants|Number|122|122.0||||||
3804338|NCT01798706|3631374|B1|Caucasian/white||Race||participants|Number|128|128.0||||||
3804339|NCT01798706|3631372|B3||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3804340|NCT01798706|3631373|B2||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3804341|NCT01798706|3631374|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3804342|NCT01798706|3631372|B3||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3804343|NCT01798706|3631373|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3804344|NCT01798706|3631374|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3804345|NCT01798706|3631372|B3|||Age||years|Mean|74.2|74.2|Standard Deviation|3.9|3.9|||
3804346|NCT01798706|3631373|B2|||Age||years|Mean|74.4|74.4|Standard Deviation|3.8|3.8|||
3804347|NCT01798706|3631374|B1|||Age||years|Mean|74|74.0|Standard Deviation|4|4.0|||
3804348|NCT01798641|3631401|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804349|NCT01798641|3631402|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804350|NCT01798641|3631403|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804351|NCT01798641|3631401|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804352|NCT01798641|3631402|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804353|NCT01798641|3631403|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804354|NCT01798641|3631401|B3||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3804355|NCT01798641|3631402|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3804356|NCT01798641|3631403|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3804357|NCT01798641|3631401|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804358|NCT01798641|3631402|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804359|NCT01798641|3631403|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804360|NCT01798641|3631401|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804361|NCT01798641|3631402|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804362|NCT01798641|3631403|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804363|NCT01798641|3631401|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804364|NCT01798641|3631402|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804365|NCT01798641|3631403|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804366|NCT01798641|3631401|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804367|NCT01798641|3631402|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804368|NCT01798641|3631403|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804369|NCT01798641|3631401|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804370|NCT01798641|3631402|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804371|NCT01798641|3631403|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804372|NCT01798641|3631401|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3804373|NCT01798641|3631402|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3804374|NCT01798641|3631403|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3804375|NCT01798641|3631401|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804376|NCT01798641|3631402|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804377|NCT01798641|3631403|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804378|NCT01798641|3631401|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3804379|NCT01798641|3631402|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3804380|NCT01798641|3631403|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3804381|NCT01798641|3631401|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3804382|NCT01798641|3631402|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3804383|NCT01798641|3631403|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3804384|NCT01798641|3631401|B3||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
3804385|NCT01798641|3631402|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3804386|NCT01798641|3631403|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3804387|NCT01798641|3631401|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3804388|NCT01798641|3631402|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3804389|NCT01798641|3631403|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3804390|NCT01798641|3631401|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3804391|NCT01798641|3631402|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3804392|NCT01798641|3631403|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3804393|NCT01798550|3631418|B3|United States||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
3804394|NCT01798550|3631419|B2|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3804395|NCT01798550|3631420|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3804396|NCT01798550|3631418|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804397|NCT01798550|3631419|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804398|NCT01798550|3631420|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804399|NCT01798550|3631418|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804400|NCT01798550|3631419|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804401|NCT01798550|3631420|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804402|NCT01798550|3631418|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3804403|NCT01798550|3631419|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3804404|NCT01798550|3631420|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3804405|NCT01798550|3631418|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3804406|NCT01798550|3631419|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3804407|NCT01798550|3631420|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3804408|NCT01798550|3631418|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804409|NCT01798550|3631419|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804410|NCT01798550|3631420|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804411|NCT01798550|3631418|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804412|NCT01798550|3631419|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804413|NCT01798550|3631420|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804414|NCT01798550|3631418|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804415|NCT01798550|3631419|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804416|NCT01798550|3631420|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804417|NCT01798550|3631418|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3804418|NCT01798550|3631419|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3804419|NCT01798550|3631420|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3804420|NCT01798550|3631418|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3804421|NCT01798550|3631419|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3804422|NCT01798550|3631420|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3804423|NCT01798550|3631418|B3|||Age||years|Median|56|56.0|Full Range|||45.0|63.0|
3804424|NCT01798550|3631419|B2|||Age||years|Median|56|56.0|Full Range|||46.0|63.0|
3804425|NCT01798550|3631420|B1|||Age||years|Median|55|55.0|Full Range|||45.0|62.0|
3804426|NCT01798485|3631435|B3|No||Intra-Thoracic Metastasis only||participants|Number|481|481.0||||||
3804427|NCT01798485|3631436|B2|No||Intra-Thoracic Metastasis only||participants|Number|229|229.0||||||
3804428|NCT01798485|3631437|B1|No||Intra-Thoracic Metastasis only||participants|Number|252|252.0||||||
3804429|NCT01798485|3631435|B3|Yes||Intra-Thoracic Metastasis only||participants|Number|215|215.0||||||
3804430|NCT01798485|3631436|B2|Yes||Intra-Thoracic Metastasis only||participants|Number|120|120.0||||||
3804431|NCT01798485|3631437|B1|Yes||Intra-Thoracic Metastasis only||participants|Number|95|95.0||||||
3804432|NCT01798485|3631435|B3|No||Bone Metastasis||participants|Number|481|481.0||||||
3804433|NCT01798485|3631436|B2|No||Bone Metastasis||participants|Number|249|249.0||||||
3804434|NCT01798485|3631437|B1|No||Bone Metastasis||participants|Number|232|232.0||||||
3804435|NCT01798485|3631435|B3|Yes||Bone Metastasis||participants|Number|215|215.0||||||
3804436|NCT01798485|3631436|B2|Yes||Bone Metastasis||participants|Number|100|100.0||||||
3804437|NCT01798485|3631437|B1|Yes||Bone Metastasis||participants|Number|115|115.0||||||
3804438|NCT01798485|3631435|B3|No||Brain Metastasis||participants|Number|576|576.0||||||
3804439|NCT01798485|3631436|B2|No||Brain Metastasis||participants|Number|294|294.0||||||
3804440|NCT01798485|3631437|B1|No||Brain Metastasis||participants|Number|282|282.0||||||
3804441|NCT01798485|3631435|B3|Yes||Brain Metastasis||participants|Number|120|120.0||||||
3804442|NCT01798485|3631436|B2|Yes||Brain Metastasis||participants|Number|55|55.0||||||
3804443|NCT01798485|3631437|B1|Yes||Brain Metastasis||participants|Number|65|65.0||||||
3804444|NCT01798485|3631435|B3|Elevated||Lactate Dehydrogenase (LDH) at Study Entry||participants|Number|203|203.0||||||
3804445|NCT01798485|3631436|B2|Elevated||Lactate Dehydrogenase (LDH) at Study Entry||participants|Number|102|102.0||||||
3804446|NCT01798485|3631437|B1|Elevated||Lactate Dehydrogenase (LDH) at Study Entry||participants|Number|101|101.0||||||
3804447|NCT01798485|3631435|B3|Normal||Lactate Dehydrogenase (LDH) at Study Entry||participants|Number|493|493.0||||||
3804448|NCT01798485|3631436|B2|Normal||Lactate Dehydrogenase (LDH) at Study Entry||participants|Number|247|247.0||||||
3804449|NCT01798485|3631437|B1|Normal||Lactate Dehydrogenase (LDH) at Study Entry||participants|Number|246|246.0||||||
3804450|NCT01798485|3631435|B3|4 = Completely Disabled||ECOG at Study Entry|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants' disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.|participants|Number|0|0.0||||||
3804451|NCT01798485|3631436|B2|4 = Completely Disabled||ECOG at Study Entry|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants' disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.|participants|Number|0|0.0||||||
3804452|NCT01798485|3631437|B1|4 = Completely Disabled||ECOG at Study Entry|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants' disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.|participants|Number|0|0.0||||||
3804453|NCT01798485|3631435|B3|3 = Limited Self-Care||ECOG at Study Entry|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants' disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.|participants|Number|0|0.0||||||
3804454|NCT01798485|3631436|B2|3 = Limited Self-Care||ECOG at Study Entry|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants' disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.|participants|Number|0|0.0||||||
3804455|NCT01798485|3631437|B1|3 = Limited Self-Care||ECOG at Study Entry|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants' disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.|participants|Number|0|0.0||||||
3804456|NCT01798485|3631435|B3|2 = Ambulatory unable to Work||ECOG at Study Entry|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants' disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.|participants|Number|0|0.0||||||
3804457|NCT01798485|3631436|B2|2 = Ambulatory unable to Work||ECOG at Study Entry|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants' disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.|participants|Number|0|0.0||||||
3804458|NCT01798485|3631437|B1|2 = Ambulatory unable to Work||ECOG at Study Entry|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants' disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.|participants|Number|0|0.0||||||
3804459|NCT01798485|3631435|B3|1 = Restrictive but Ambulatory||ECOG at Study Entry|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants' disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.|participants|Number|447|447.0||||||
3804460|NCT01798485|3631436|B2|1 = Restrictive but Ambulatory||ECOG at Study Entry|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants' disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.|participants|Number|224|224.0||||||
3804461|NCT01798485|3631437|B1|1 = Restrictive but Ambulatory||ECOG at Study Entry|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants' disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.|participants|Number|223|223.0||||||
3804462|NCT01798485|3631435|B3|0 = Fully Active||ECOG at Study Entry|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants' disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.|participants|Number|249|249.0||||||
3804463|NCT01798485|3631436|B2|0 = Fully Active||ECOG at Study Entry|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants' disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.|participants|Number|125|125.0||||||
3804464|NCT01798485|3631437|B1|0 = Fully Active||ECOG at Study Entry|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants' disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.|participants|Number|124|124.0||||||
3804465|NCT01798485|3631435|B3|Unknown||Stage at Initial Diagnosis|Disease stage described using American Joint Committee on Cancer (AJCC). Stages ranged from I (cancer was small and had not spread to the lymph nodes) to IV (cancer spread throughout the body). Stage III (cancer had spread to nearby tissue or lymph nodes) was further differentiated based on regional lymph nodes: Stage IIIA (spread to nearby lymph nodes) and Stage IIIB (spread to distance lymph nodes).|participants|Number|3|3.0||||||
3804483|NCT01798485|3631435|B3|Unknown||Smoking History||participants|Number|6|6.0||||||
3804466|NCT01798485|3631436|B2|Unknown||Stage at Initial Diagnosis|Disease stage described using American Joint Committee on Cancer (AJCC). Stages ranged from I (cancer was small and had not spread to the lymph nodes) to IV (cancer spread throughout the body). Stage III (cancer had spread to nearby tissue or lymph nodes) was further differentiated based on regional lymph nodes: Stage IIIA (spread to nearby lymph nodes) and Stage IIIB (spread to distance lymph nodes).|participants|Number|2|2.0||||||
3804467|NCT01798485|3631437|B1|Unknown||Stage at Initial Diagnosis|Disease stage described using American Joint Committee on Cancer (AJCC). Stages ranged from I (cancer was small and had not spread to the lymph nodes) to IV (cancer spread throughout the body). Stage III (cancer had spread to nearby tissue or lymph nodes) was further differentiated based on regional lymph nodes: Stage IIIA (spread to nearby lymph nodes) and Stage IIIB (spread to distance lymph nodes).|participants|Number|1|1.0||||||
3804468|NCT01798485|3631435|B3|IV||Stage at Initial Diagnosis|Disease stage described using American Joint Committee on Cancer (AJCC). Stages ranged from I (cancer was small and had not spread to the lymph nodes) to IV (cancer spread throughout the body). Stage III (cancer had spread to nearby tissue or lymph nodes) was further differentiated based on regional lymph nodes: Stage IIIA (spread to nearby lymph nodes) and Stage IIIB (spread to distance lymph nodes).|participants|Number|512|512.0||||||
3804469|NCT01798485|3631436|B2|IV||Stage at Initial Diagnosis|Disease stage described using American Joint Committee on Cancer (AJCC). Stages ranged from I (cancer was small and had not spread to the lymph nodes) to IV (cancer spread throughout the body). Stage III (cancer had spread to nearby tissue or lymph nodes) was further differentiated based on regional lymph nodes: Stage IIIA (spread to nearby lymph nodes) and Stage IIIB (spread to distance lymph nodes).|participants|Number|258|258.0||||||
3804470|NCT01798485|3631437|B1|IV||Stage at Initial Diagnosis|Disease stage described using American Joint Committee on Cancer (AJCC). Stages ranged from I (cancer was small and had not spread to the lymph nodes) to IV (cancer spread throughout the body). Stage III (cancer had spread to nearby tissue or lymph nodes) was further differentiated based on regional lymph nodes: Stage IIIA (spread to nearby lymph nodes) and Stage IIIB (spread to distance lymph nodes).|participants|Number|254|254.0||||||
3804471|NCT01798485|3631435|B3|IIIB||Stage at Initial Diagnosis|Disease stage described using American Joint Committee on Cancer (AJCC). Stages ranged from I (cancer was small and had not spread to the lymph nodes) to IV (cancer spread throughout the body). Stage III (cancer had spread to nearby tissue or lymph nodes) was further differentiated based on regional lymph nodes: Stage IIIA (spread to nearby lymph nodes) and Stage IIIB (spread to distance lymph nodes).|participants|Number|104|104.0||||||
3804472|NCT01798485|3631436|B2|IIIB||Stage at Initial Diagnosis|Disease stage described using American Joint Committee on Cancer (AJCC). Stages ranged from I (cancer was small and had not spread to the lymph nodes) to IV (cancer spread throughout the body). Stage III (cancer had spread to nearby tissue or lymph nodes) was further differentiated based on regional lymph nodes: Stage IIIA (spread to nearby lymph nodes) and Stage IIIB (spread to distance lymph nodes).|participants|Number|52|52.0||||||
3804473|NCT01798485|3631437|B1|IIIB||Stage at Initial Diagnosis|Disease stage described using American Joint Committee on Cancer (AJCC). Stages ranged from I (cancer was small and had not spread to the lymph nodes) to IV (cancer spread throughout the body). Stage III (cancer had spread to nearby tissue or lymph nodes) was further differentiated based on regional lymph nodes: Stage IIIA (spread to nearby lymph nodes) and Stage IIIB (spread to distance lymph nodes).|participants|Number|52|52.0||||||
3804474|NCT01798485|3631435|B3|IIIA||Stage at Initial Diagnosis|Disease stage described using American Joint Committee on Cancer (AJCC). Stages ranged from I (cancer was small and had not spread to the lymph nodes) to IV (cancer spread throughout the body). Stage III (cancer had spread to nearby tissue or lymph nodes) was further differentiated based on regional lymph nodes: Stage IIIA (spread to nearby lymph nodes) and Stage IIIB (spread to distance lymph nodes).|participants|Number|36|36.0||||||
3804475|NCT01798485|3631436|B2|IIIA||Stage at Initial Diagnosis|Disease stage described using American Joint Committee on Cancer (AJCC). Stages ranged from I (cancer was small and had not spread to the lymph nodes) to IV (cancer spread throughout the body). Stage III (cancer had spread to nearby tissue or lymph nodes) was further differentiated based on regional lymph nodes: Stage IIIA (spread to nearby lymph nodes) and Stage IIIB (spread to distance lymph nodes).|participants|Number|18|18.0||||||
3804476|NCT01798485|3631437|B1|IIIA||Stage at Initial Diagnosis|Disease stage described using American Joint Committee on Cancer (AJCC). Stages ranged from I (cancer was small and had not spread to the lymph nodes) to IV (cancer spread throughout the body). Stage III (cancer had spread to nearby tissue or lymph nodes) was further differentiated based on regional lymph nodes: Stage IIIA (spread to nearby lymph nodes) and Stage IIIB (spread to distance lymph nodes).|participants|Number|18|18.0||||||
3804477|NCT01798485|3631435|B3|I/II||Stage at Initial Diagnosis|Disease stage described using American Joint Committee on Cancer (AJCC). Stages ranged from I (cancer was small and had not spread to the lymph nodes) to IV (cancer spread throughout the body). Stage III (cancer had spread to nearby tissue or lymph nodes) was further differentiated based on regional lymph nodes: Stage IIIA (spread to nearby lymph nodes) and Stage IIIB (spread to distance lymph nodes).|participants|Number|41|41.0||||||
3804478|NCT01798485|3631436|B2|I/II||Stage at Initial Diagnosis|Disease stage described using American Joint Committee on Cancer (AJCC). Stages ranged from I (cancer was small and had not spread to the lymph nodes) to IV (cancer spread throughout the body). Stage III (cancer had spread to nearby tissue or lymph nodes) was further differentiated based on regional lymph nodes: Stage IIIA (spread to nearby lymph nodes) and Stage IIIB (spread to distance lymph nodes).|participants|Number|19|19.0||||||
3804479|NCT01798485|3631437|B1|I/II||Stage at Initial Diagnosis|Disease stage described using American Joint Committee on Cancer (AJCC). Stages ranged from I (cancer was small and had not spread to the lymph nodes) to IV (cancer spread throughout the body). Stage III (cancer had spread to nearby tissue or lymph nodes) was further differentiated based on regional lymph nodes: Stage IIIA (spread to nearby lymph nodes) and Stage IIIB (spread to distance lymph nodes).|participants|Number|22|22.0||||||
3804480|NCT01798485|3631435|B3|||Time from Advanced NCSLC Diagnosis to Consent|NCSLC = non-small-cell lung cancer|months|Mean|11.65|11.65|Standard Deviation|6.920|6.92|||
3804481|NCT01798485|3631436|B2|||Time from Advanced NCSLC Diagnosis to Consent|NCSLC = non-small-cell lung cancer|months|Mean|11.76|11.76|Standard Deviation|7.740|7.74|||
3804482|NCT01798485|3631437|B1|||Time from Advanced NCSLC Diagnosis to Consent|NCSLC = non-small-cell lung cancer|months|Mean|11.54|11.54|Standard Deviation|5.995|5.995|||
3804484|NCT01798485|3631436|B2|Unknown||Smoking History||participants|Number|3|3.0||||||
3804485|NCT01798485|3631437|B1|Unknown||Smoking History||participants|Number|3|3.0||||||
3804486|NCT01798485|3631435|B3|Ever Smoked||Smoking History||participants|Number|566|566.0||||||
3804487|NCT01798485|3631436|B2|Ever Smoked||Smoking History||participants|Number|284|284.0||||||
3804488|NCT01798485|3631437|B1|Ever Smoked||Smoking History||participants|Number|282|282.0||||||
3804489|NCT01798485|3631435|B3|Never Smoked||Smoking History||participants|Number|124|124.0||||||
3804490|NCT01798485|3631436|B2|Never Smoked||Smoking History||participants|Number|62|62.0||||||
3804491|NCT01798485|3631437|B1|Never Smoked||Smoking History||participants|Number|62|62.0||||||
3804492|NCT01798485|3631435|B3|Rest of World||Geographic region||participants|Number|414|414.0||||||
3804493|NCT01798485|3631436|B2|Rest of World||Geographic region||participants|Number|209|209.0||||||
3804494|NCT01798485|3631437|B1|Rest of World||Geographic region||participants|Number|205|205.0||||||
3804495|NCT01798485|3631435|B3|Western Europe||Geographic region||participants|Number|197|197.0||||||
3804496|NCT01798485|3631436|B2|Western Europe||Geographic region||participants|Number|96|96.0||||||
3804497|NCT01798485|3631437|B1|Western Europe||Geographic region||participants|Number|101|101.0||||||
3804498|NCT01798485|3631435|B3|North America||Geographic region||participants|Number|85|85.0||||||
3804499|NCT01798485|3631436|B2|North America||Geographic region||participants|Number|44|44.0||||||
3804500|NCT01798485|3631437|B1|North America||Geographic region||participants|Number|41|41.0||||||
3804501|NCT01798485|3631435|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3804502|NCT01798485|3631436|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3804503|NCT01798485|3631437|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3804504|NCT01798485|3631435|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804505|NCT01798485|3631436|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804506|NCT01798485|3631437|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804507|NCT01798485|3631435|B3||White|Race (NIH/OMB)||Participants|Count of Participants|681|681.0||||||
3804508|NCT01798485|3631436|B2||White|Race (NIH/OMB)||Participants|Count of Participants|340|340.0||||||
3804509|NCT01798485|3631437|B1||White|Race (NIH/OMB)||Participants|Count of Participants|341|341.0||||||
3804510|NCT01798485|3631435|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3804511|NCT01798485|3631436|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3804512|NCT01798485|3631437|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3804513|NCT01798485|3631435|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804514|NCT01798485|3631436|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804515|NCT01798485|3631437|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804516|NCT01798485|3631435|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3804517|NCT01798485|3631436|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3804518|NCT01798485|3631437|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3804519|NCT01798485|3631435|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804520|NCT01798485|3631436|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804521|NCT01798485|3631437|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804522|NCT01798485|3631435|B3||Male|Sex: Female, Male||Participants|Count of Participants|420|420.0||||||
3804523|NCT01798485|3631436|B2||Male|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
3804524|NCT01798485|3631437|B1||Male|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
3804525|NCT01798485|3631435|B3||Female|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
3804526|NCT01798485|3631436|B2||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3804527|NCT01798485|3631437|B1||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3804528|NCT01798485|3631435|B3|>=65 years||Age, Customized||participants|Number|222|222.0||||||
3804529|NCT01798485|3631436|B2|>=65 years||Age, Customized||participants|Number|102|102.0||||||
3804530|NCT01798485|3631437|B1|>=65 years||Age, Customized||participants|Number|120|120.0||||||
3804531|NCT01798485|3631435|B3|<65 years||Age, Customized||participants|Number|474|474.0||||||
3804532|NCT01798485|3631436|B2|<65 years||Age, Customized||participants|Number|247|247.0||||||
3804533|NCT01798485|3631437|B1|<65 years||Age, Customized||participants|Number|227|227.0||||||
3804534|NCT01798485|3631435|B3|||Age||years|Mean|60.5|60.5|Standard Deviation|8.81|8.81|||
3804535|NCT01798485|3631436|B2|||Age||years|Mean|60.1|60.1|Standard Deviation|8.69|8.69|||
3804536|NCT01798485|3631437|B1|||Age||years|Mean|60.9|60.9|Standard Deviation|8.93|8.93|||
3804537|NCT01798394|3631472|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
3804538|NCT01798394|3631473|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
3804539|NCT01798394|3631474|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3804540|NCT01798394|3631472|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3804541|NCT01798394|3631473|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3804542|NCT01798394|3631474|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3804543|NCT01798394|3631472|B3||Female|Gender||Participants|Count of Participants|46|46.0||||||
3804544|NCT01798394|3631473|B2||Female|Gender||Participants|Count of Participants|22|22.0||||||
3804545|NCT01798394|3631474|B1||Female|Gender||Participants|Count of Participants|24|24.0||||||
3804546|NCT01798394|3631472|B3|||Age||years|Mean|26.5|26.5|Standard Deviation|5.2|5.2|||
3804547|NCT01798394|3631473|B2|||Age||years|Mean|26.7|26.7|Standard Deviation|5.0|5.0|||
3804548|NCT01798394|3631474|B1|||Age||years|Mean|26.2|26.2|Standard Deviation|5.5|5.5|||
3804549|NCT01798394|3631472|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3804550|NCT01798394|3631473|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3804551|NCT01798394|3631474|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3804552|NCT01798394|3631472|B3||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
3804553|NCT01798394|3631473|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3804554|NCT01798394|3631474|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3804555|NCT01798394|3631472|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3804556|NCT01798394|3631473|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3804557|NCT01798394|3631474|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3804558|NCT01798316|3631493|B3|United States||Region of Enrollment||participants|Number|105|105.0||||||
3804559|NCT01798316|3631494|B2|United States||Region of Enrollment||participants|Number|53|53.0||||||
3804560|NCT01798316|3631495|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
3804561|NCT01798316|3631493|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3804562|NCT01798316|3631494|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3804563|NCT01798316|3631495|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3804564|NCT01798316|3631493|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3804565|NCT01798316|3631494|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3804566|NCT01798316|3631495|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3804567|NCT01798316|3631493|B3|||Age||years|Mean|44.7|44.7|Standard Deviation|12.6|12.6|||
3804568|NCT01798316|3631494|B2|||Age||years|Mean|44.9|44.9|Standard Deviation|12.3|12.3|||
3804569|NCT01798316|3631495|B1|||Age||years|Mean|44.6|44.6|Standard Deviation|13.0|13.0|||
3804570|NCT01798264|3631514|B5|United States||Region of Enrollment||participants|Number|44|44.0||||||
3804571|NCT01798264|3631515|B4|United States||Region of Enrollment||participants|Number|11|11.0||||||
3804572|NCT01798264|3631516|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3804573|NCT01798264|3631517|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3804574|NCT01798264|3631518|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3804575|NCT01798264|3631514|B5||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3804576|NCT01798264|3631515|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3804577|NCT01798264|3631516|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3804578|NCT01798264|3631517|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3804579|NCT01798264|3631518|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3804580|NCT01798264|3631514|B5||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3804581|NCT01798264|3631515|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3804582|NCT01798264|3631516|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3804583|NCT01798264|3631517|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3804584|NCT01798264|3631518|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3804585|NCT01798264|3631514|B5|||Age||years|Mean|55.7|55.7|Standard Deviation|6.92|6.92|||
3804586|NCT01798264|3631515|B4|||Age||years|Mean|56.5|56.5|Standard Deviation|4.84|4.84|||
3804587|NCT01798264|3631516|B3|||Age||years|Mean|52.6|52.6|Standard Deviation|9.54|9.54|||
3804588|NCT01798264|3631517|B2|||Age||years|Mean|57.2|57.2|Standard Deviation|6.10|6.1|||
3804589|NCT01798264|3631518|B1|||Age||years|Mean|56.3|56.3|Standard Deviation|6.74|6.74|||
3804590|NCT01798225|3631543|B3|United States||Region of Enrollment||participants|Number|113|113.0||||||
3804591|NCT01798225|3631544|B2|United States||Region of Enrollment||participants|Number|56|56.0||||||
3804592|NCT01798225|3631545|B1|United States||Region of Enrollment||participants|Number|57|57.0||||||
3804593|NCT01798225|3631543|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804594|NCT01798225|3631544|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804595|NCT01798225|3631545|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804596|NCT01798225|3631543|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804597|NCT01798225|3631544|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804598|NCT01798225|3631545|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804599|NCT01798225|3631543|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804600|NCT01798225|3631544|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804601|NCT01798225|3631545|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804602|NCT01798225|3631543|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
3804603|NCT01798225|3631544|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3804604|NCT01798225|3631545|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3804605|NCT01798225|3631543|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804606|NCT01798225|3631544|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804607|NCT01798225|3631545|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804608|NCT01798225|3631543|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804609|NCT01798225|3631544|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804610|NCT01798225|3631545|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804611|NCT01798225|3631543|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804612|NCT01798225|3631544|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804613|NCT01798225|3631545|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804614|NCT01798225|3631543|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804615|NCT01798225|3631544|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804616|NCT01798225|3631545|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804617|NCT01798225|3631543|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
3804618|NCT01798225|3631544|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3804619|NCT01798225|3631545|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3804620|NCT01798225|3631543|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804621|NCT01798225|3631544|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804622|NCT01798225|3631545|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804623|NCT01798225|3631543|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3804624|NCT01798225|3631544|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3804625|NCT01798225|3631545|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3804626|NCT01798225|3631543|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3804627|NCT01798225|3631544|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3804628|NCT01798225|3631545|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3804629|NCT01798225|3631543|B3||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3804630|NCT01798225|3631544|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3804631|NCT01798225|3631545|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3804632|NCT01798225|3631543|B3||Between 18 and 65 years|Age||Participants|Count of Participants|88|88.0||||||
3804633|NCT01798225|3631544|B2||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
3804634|NCT01798225|3631545|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3804635|NCT01798225|3631543|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3804636|NCT01798225|3631544|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3804637|NCT01798225|3631545|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3804638|NCT01798186|3631554|B5|United States||Region of Enrollment||participants|Number|18|18.0||||||
3804639|NCT01798186|3631555|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
3804640|NCT01798186|3631556|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3804641|NCT01798186|3631557|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3804642|NCT01798186|3631558|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3804643|NCT01798186|3631554|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3804644|NCT01798186|3631555|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3804645|NCT01798186|3631556|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3804646|NCT01798186|3631557|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804647|NCT01798186|3631558|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804648|NCT01798186|3631554|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804649|NCT01798186|3631555|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804650|NCT01798186|3631556|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804651|NCT01798186|3631557|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804652|NCT01798186|3631558|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804653|NCT01798186|3631554|B5||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3804654|NCT01798186|3631555|B4||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3804655|NCT01798186|3631556|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3804656|NCT01798186|3631557|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3804657|NCT01798186|3631558|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3804658|NCT01798186|3631554|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3804659|NCT01798186|3631555|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3804660|NCT01798186|3631556|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804661|NCT01798186|3631557|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3804662|NCT01798186|3631558|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3804663|NCT01798186|3631554|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804664|NCT01798186|3631555|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804665|NCT01798186|3631556|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804666|NCT01798186|3631557|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804667|NCT01798186|3631558|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804668|NCT01798186|3631554|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3804669|NCT01798186|3631555|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804670|NCT01798186|3631556|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804671|NCT01798186|3631557|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804672|NCT01798186|3631558|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3804673|NCT01798186|3631554|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804674|NCT01798186|3631555|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804675|NCT01798186|3631556|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804676|NCT01798186|3631557|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804677|NCT01798186|3631558|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804678|NCT01798186|3631554|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804679|NCT01798186|3631555|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804680|NCT01798186|3631556|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804681|NCT01798186|3631557|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804682|NCT01798186|3631558|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804683|NCT01798186|3631554|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3804684|NCT01798186|3631555|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3804685|NCT01798186|3631556|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3804686|NCT01798186|3631557|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3804687|NCT01798186|3631558|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3804688|NCT01798186|3631554|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3804689|NCT01798186|3631555|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3804690|NCT01798186|3631556|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3804691|NCT01798186|3631557|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804692|NCT01798186|3631558|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804693|NCT01798186|3631554|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3804694|NCT01798186|3631555|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3804695|NCT01798186|3631556|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3804696|NCT01798186|3631557|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3804697|NCT01798186|3631558|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3804698|NCT01798186|3631554|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3804699|NCT01798186|3631555|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3804700|NCT01798186|3631556|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3804701|NCT01798186|3631557|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3804702|NCT01798186|3631558|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3804703|NCT01798186|3631554|B5|||Age||years|Mean|28|28.0|Standard Deviation|7|7.0|||
3804704|NCT01798186|3631555|B4|||Age||years|Mean|29|29.0|Standard Deviation|6|6.0|||
3804705|NCT01798186|3631556|B3|||Age||years|Mean|30|30.0|Standard Deviation|8|8.0|||
3804706|NCT01798186|3631557|B2|||Age||years|Mean|29|29.0|Standard Deviation|9|9.0|||
3804707|NCT01798186|3631558|B1|||Age||years|Mean|25|25.0|Standard Deviation|3|3.0|||
3804708|NCT01798134|3631575|B1|Germany||Region of Enrollment||participants|Number|25|25.0||||||
3804709|NCT01798134|3631575|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804710|NCT01798134|3631575|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804711|NCT01798134|3631575|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3804712|NCT01798134|3631575|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804713|NCT01798134|3631575|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804714|NCT01798134|3631575|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3804715|NCT01798134|3631575|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804716|NCT01798134|3631575|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3804717|NCT01798134|3631575|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3804718|NCT01798134|3631575|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804719|NCT01798134|3631575|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3804720|NCT01798134|3631575|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3804721|NCT01798134|3631575|B1|||Age||years|Mean|65|65.0|Full Range|||39.0|85.0|
3804722|NCT01798056|3631582|B3|Geographic ancestry|Missing|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3804723|NCT01798056|3631583|B2|Geographic ancestry|Missing|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3804724|NCT01798056|3631584|B1|Geographic ancestry|Missing|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3804725|NCT01798056|3631582|B3|Geographic ancestry|Mixed Origin|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3804726|NCT01798056|3631583|B2|Geographic ancestry|Mixed Origin|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3804727|NCT01798056|3631584|B1|Geographic ancestry|Mixed Origin|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3804728|NCT01798056|3631582|B3|Geographic ancestry|White - Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|180|180.0||||||
3804729|NCT01798056|3631583|B2|Geographic ancestry|White - Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|88|88.0||||||
3804730|NCT01798056|3631584|B1|Geographic ancestry|White - Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|92|92.0||||||
3804731|NCT01798056|3631582|B3|Geographic ancestry|White - Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3804732|NCT01798056|3631583|B2|Geographic ancestry|White - Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3804733|NCT01798056|3631584|B1|Geographic ancestry|White - Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3804734|NCT01798056|3631582|B3|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3804735|NCT01798056|3631583|B2|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3804736|NCT01798056|3631584|B1|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3804737|NCT01798056|3631582|B3|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3804738|NCT01798056|3631583|B2|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3804739|NCT01798056|3631584|B1|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3804740|NCT01798056|3631582|B3|Geographic ancestry|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3804741|NCT01798056|3631583|B2|Geographic ancestry|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3804742|NCT01798056|3631584|B1|Geographic ancestry|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3804743|NCT01798056|3631582|B3|Geographic ancestry|African Heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3804744|NCT01798056|3631583|B2|Geographic ancestry|African Heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3804745|NCT01798056|3631584|B1|Geographic ancestry|African Heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3804746|NCT01798056|3631582|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3804747|NCT01798056|3631583|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3804748|NCT01798056|3631584|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3804749|NCT01798056|3631582|B3||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3804750|NCT01798056|3631583|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3804751|NCT01798056|3631584|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3804752|NCT01798056|3631582|B3|||Age||Years|Mean|57.79|57.79|Standard Deviation|11.25|11.25|||
3804753|NCT01798056|3631583|B2|||Age||Years|Mean|58.5|58.5|Standard Deviation|11.7|11.7|||
3804754|NCT01798056|3631584|B1|||Age||Years|Mean|57.1|57.1|Standard Deviation|10.8|10.8|||
3804755|NCT01798004|3631619|B1|Australia||Region of Enrollment||participants|Number|3|3.0||||||
3804756|NCT01798004|3631619|B1|United States||Region of Enrollment||participants|Number|132|132.0||||||
3804757|NCT01798004|3631619|B1|Canada||Region of Enrollment||participants|Number|14|14.0||||||
3804758|NCT01798004|3631619|B1|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
3804759|NCT01798004|3631619|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3804760|NCT01798004|3631619|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804761|NCT01798004|3631619|B1||White|Race (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
3804762|NCT01798004|3631619|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3804763|NCT01798004|3631619|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804764|NCT01798004|3631619|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3804765|NCT01798004|3631619|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804766|NCT01798004|3631619|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3804767|NCT01798004|3631619|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
3804768|NCT01798004|3631619|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3804769|NCT01798004|3631619|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3804770|NCT01798004|3631619|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3804771|NCT01798004|3631619|B1|||Age||Years|Median|3.1|3.1|Full Range|||0.4|18.4|
3804772|NCT01798004|3631619|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3804773|NCT01798004|3631619|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3804774|NCT01798004|3631619|B1||<=18 years|Age||Participants|Count of Participants|149|149.0||||||
3804775|NCT01797783|3631623|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3804776|NCT01797783|3631624|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3804777|NCT01797783|3631625|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3804778|NCT01797783|3631623|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3804779|NCT01797783|3631624|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3804780|NCT01797783|3631625|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3804781|NCT01797783|3631623|B3|||Age||years|Mean|49.8|49.8|Standard Deviation|5.16|5.16|||
3804782|NCT01797783|3631624|B2|||Age||years|Mean|49.7|49.7|Standard Deviation|5.21|5.21|||
3804783|NCT01797783|3631625|B1|||Age||years|Mean|49.9|49.9|Standard Deviation|5.19|5.19|||
3804784|NCT01797731|3631648|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3804785|NCT01797731|3631649|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3804786|NCT01797731|3631650|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3804787|NCT01797731|3631648|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3804788|NCT01797731|3631649|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3804789|NCT01797731|3631650|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3804790|NCT01797731|3631648|B3|||Age||Years|Mean|66.12|66.12|Standard Deviation|10.66|10.66|||
3804791|NCT01797731|3631649|B2|||Age||Years|Mean|67.1|67.1|Standard Deviation|7.5|7.5|||
3804792|NCT01797731|3631650|B1|||Age||Years|Mean|66.1|66.1|Standard Deviation|10.1|10.1|||
3804793|NCT01797731|3631648|B3||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
3804794|NCT01797731|3631649|B2||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
3804795|NCT01797731|3631650|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3804796|NCT01797731|3631648|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3804797|NCT01797731|3631649|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3804798|NCT01797731|3631650|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3804799|NCT01797731|3631648|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3804800|NCT01797731|3631649|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3804801|NCT01797731|3631650|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3804802|NCT01797705|3631659|B1|Central Sleep Apnea||Apnea Type at Enrollment|Number of participants with obstructive vs central apnea at enrollment|participants|Number|2|2.0||||||
3804803|NCT01797705|3631659|B1|Obstructive Sleep Apnea||Apnea Type at Enrollment|Number of participants with obstructive vs central apnea at enrollment|participants|Number|26|26.0||||||
3804804|NCT01797705|3631659|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3804805|NCT01797705|3631659|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3804806|NCT01797705|3631659|B1|||Age||years|Mean|54.0|54.0|Standard Deviation|13.1|13.1|||
3804807|NCT01797575|3631663|B5|||YMRS Total Score|The Young Mania Rating Scale (YMRS) is an 11 item instrument with an overall score ranging from 0 to 60 points. A higher score corresponds with more severe manic illness.|units on a scale|Mean|4.92|4.92|Standard Deviation|4.11|4.11|||
3804808|NCT01797575|3631664|B4|||YMRS Total Score|The Young Mania Rating Scale (YMRS) is an 11 item instrument with an overall score ranging from 0 to 60 points. A higher score corresponds with more severe manic illness.|units on a scale|Mean|4.38|4.38|Standard Deviation|4.63|4.63|||
3804809|NCT01797575|3631665|B3|||YMRS Total Score|The Young Mania Rating Scale (YMRS) is an 11 item instrument with an overall score ranging from 0 to 60 points. A higher score corresponds with more severe manic illness.|units on a scale|Mean|5.75|5.75|Standard Deviation|4.27|4.27|||
3804810|NCT01797575|3631666|B2|||YMRS Total Score|The Young Mania Rating Scale (YMRS) is an 11 item instrument with an overall score ranging from 0 to 60 points. A higher score corresponds with more severe manic illness.|units on a scale|Mean|5.5|5.5|Standard Deviation|3.46|3.46|||
3804811|NCT01797575|3631667|B1|||YMRS Total Score|The Young Mania Rating Scale (YMRS) is an 11 item instrument with an overall score ranging from 0 to 60 points. A higher score corresponds with more severe manic illness.|units on a scale|Mean|4|4.0|Standard Deviation|5.42|5.42|||
3804812|NCT01797575|3631663|B5|||MADRS Total Score|The Montgomery–Åsberg Depression Rating Scale (MADRS) is a 10 item instrument with an overall score ranging from 0 to 54 points. A higher score corresponds with more severe depressive illness.|units on a scale|Mean|21.08|21.08|Standard Deviation|5.45|5.45|||
3804813|NCT01797575|3631664|B4|||MADRS Total Score|The Montgomery–Åsberg Depression Rating Scale (MADRS) is a 10 item instrument with an overall score ranging from 0 to 54 points. A higher score corresponds with more severe depressive illness.|units on a scale|Mean|22.88|22.88|Standard Deviation|4.09|4.09|||
3804814|NCT01797575|3631665|B3|||MADRS Total Score|The Montgomery–Åsberg Depression Rating Scale (MADRS) is a 10 item instrument with an overall score ranging from 0 to 54 points. A higher score corresponds with more severe depressive illness.|units on a scale|Mean|19.5|19.5|Standard Deviation|1|1.0|||
3804815|NCT01797575|3631666|B2|||MADRS Total Score|The Montgomery–Åsberg Depression Rating Scale (MADRS) is a 10 item instrument with an overall score ranging from 0 to 54 points. A higher score corresponds with more severe depressive illness.|units on a scale|Mean|19.38|19.38|Standard Deviation|4.87|4.87|||
3804816|NCT01797575|3631667|B1|||MADRS Total Score|The Montgomery–Åsberg Depression Rating Scale (MADRS) is a 10 item instrument with an overall score ranging from 0 to 54 points. A higher score corresponds with more severe depressive illness.|units on a scale|Mean|22.5|22.5|Standard Deviation|10.47|10.47|||
3804817|NCT01797575|3631663|B5|United States||Region of Enrollment||participants|Number|24|24.0||||||
3804818|NCT01797575|3631664|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
3804819|NCT01797575|3631665|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3804820|NCT01797575|3631666|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3804821|NCT01797575|3631667|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3804822|NCT01797575|3631663|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3804823|NCT01797575|3631664|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804824|NCT01797575|3631665|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804825|NCT01797575|3631666|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3804826|NCT01797575|3631667|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804827|NCT01797575|3631663|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3804828|NCT01797575|3631664|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3804829|NCT01797575|3631665|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804830|NCT01797575|3631666|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804831|NCT01797575|3631667|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804832|NCT01797575|3631663|B5||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3804833|NCT01797575|3631664|B4||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3804834|NCT01797575|3631665|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3804835|NCT01797575|3631666|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3804836|NCT01797575|3631667|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3804837|NCT01797575|3631663|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3804838|NCT01797575|3631664|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3804839|NCT01797575|3631665|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804840|NCT01797575|3631666|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3804841|NCT01797575|3631667|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3804842|NCT01797575|3631663|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804843|NCT01797575|3631664|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804844|NCT01797575|3631665|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804845|NCT01797575|3631666|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804846|NCT01797575|3631667|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804847|NCT01797575|3631663|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3804848|NCT01797575|3631664|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804849|NCT01797575|3631665|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804850|NCT01797575|3631666|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804851|NCT01797575|3631667|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3804852|NCT01797575|3631663|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3804853|NCT01797575|3631664|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804854|NCT01797575|3631665|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804855|NCT01797575|3631666|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3804856|NCT01797575|3631667|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804857|NCT01797575|3631663|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3804858|NCT01797575|3631664|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804859|NCT01797575|3631665|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804860|NCT01797575|3631666|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3804861|NCT01797575|3631667|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804862|NCT01797575|3631663|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3804863|NCT01797575|3631664|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3804864|NCT01797575|3631665|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3804865|NCT01797575|3631666|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3804866|NCT01797575|3631667|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3804867|NCT01797575|3631663|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3804868|NCT01797575|3631664|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3804869|NCT01797575|3631665|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3804870|NCT01797575|3631666|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804871|NCT01797575|3631667|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3804872|NCT01797575|3631663|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3804873|NCT01797575|3631664|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3804874|NCT01797575|3631665|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3804875|NCT01797575|3631666|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3804876|NCT01797575|3631667|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3804877|NCT01797575|3631663|B5||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3804878|NCT01797575|3631664|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3804879|NCT01797575|3631665|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3804880|NCT01797575|3631666|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3804881|NCT01797575|3631667|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3804882|NCT01797575|3631663|B5|||Age||years|Mean|40.56|40.56|Standard Deviation|11.72|11.72|||
3804883|NCT01797575|3631664|B4|||Age||years|Mean|39.13|39.13|Standard Deviation|9.99|9.99|||
3804884|NCT01797575|3631665|B3|||Age||years|Mean|40|40.0|Standard Deviation|17.64|17.64|||
3804885|NCT01797575|3631666|B2|||Age||years|Mean|36.38|36.38|Standard Deviation|7.05|7.05|||
3804886|NCT01797575|3631667|B1|||Age||years|Mean|49|49.0|Standard Deviation|15.21|15.21|||
3804887|NCT01797575|3631663|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3804888|NCT01797575|3631664|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3804889|NCT01797575|3631665|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3804890|NCT01797575|3631666|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3804891|NCT01797575|3631667|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3804892|NCT01797575|3631663|B5||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3804893|NCT01797575|3631664|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3804894|NCT01797575|3631665|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3804895|NCT01797575|3631666|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3804896|NCT01797575|3631667|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3804897|NCT01797575|3631663|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3804898|NCT01797575|3631664|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3804899|NCT01797575|3631665|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3804900|NCT01797575|3631666|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3804901|NCT01797575|3631667|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3804902|NCT01797536|3631720|B5||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3804903|NCT01797536|3631721|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3804904|NCT01797536|3631722|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3804905|NCT01797536|3631723|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3804906|NCT01797536|3631724|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3804907|NCT01797536|3631720|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3804908|NCT01797536|3631721|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3804909|NCT01797536|3631722|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3804910|NCT01797536|3631723|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3804911|NCT01797536|3631724|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3804912|NCT01797536|3631720|B5|||Age||Years|Mean|54.35|54.35|Full Range|||39.0|69.0|
3804913|NCT01797536|3631721|B4|||Age||Years|Mean|54|54.0|Full Range|||46.0|69.0|
3804914|NCT01797536|3631722|B3|||Age||Years|Mean|56|56.0|Full Range|||48.0|62.0|
3804915|NCT01797536|3631723|B2|||Age||Years|Mean|54|54.0|Full Range|||42.0|68.0|
3804916|NCT01797536|3631724|B1|||Age||Years|Mean|54|54.0|Full Range|||39.0|66.0|
3804917|NCT01797484|3631757|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3804918|NCT01797484|3631758|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3804919|NCT01797484|3631759|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3804920|NCT01797484|3631757|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3804921|NCT01797484|3631758|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3804922|NCT01797484|3631759|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3804923|NCT01797484|3631757|B3|||Age||years|Mean|70|70.0|Standard Deviation|8|8.0|||
3804924|NCT01797484|3631758|B2|||Age||years|Mean|72|72.0|Standard Deviation|7|7.0|||
3804925|NCT01797484|3631759|B1|||Age||years|Mean|68|68.0|Standard Deviation|9|9.0|||
3804926|NCT01797471|3631766|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3804927|NCT01797471|3631766|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3804928|NCT01797471|3631766|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3804929|NCT01797471|3631766|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3804930|NCT01797471|3631766|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3804931|NCT01797471|3631766|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3804932|NCT01797458|3631775|B4||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3804933|NCT01797458|3631776|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3804934|NCT01797458|3631777|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3804935|NCT01797458|3631778|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3804936|NCT01797458|3631775|B4||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3804937|NCT01797458|3631776|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3804938|NCT01797458|3631777|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3804939|NCT01797458|3631778|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3804940|NCT01797458|3631775|B4|||Age||years|Mean|5.56|5.56|Standard Deviation|1.45|1.45|||
3804941|NCT01797458|3631776|B3|||Age||years|Mean|5.77|5.77|Standard Deviation|1.32|1.32|||
3804942|NCT01797458|3631777|B2|||Age||years|Mean|5.62|5.62|Standard Deviation|1.48|1.48|||
3804943|NCT01797458|3631778|B1|||Age||years|Mean|5.25|5.25|Standard Deviation|1.56|1.56|||
3804944|NCT01797458|3631775|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3804945|NCT01797458|3631776|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3804946|NCT01797458|3631777|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3804947|NCT01797458|3631778|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3804948|NCT01797458|3631775|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3804949|NCT01797458|3631776|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3804950|NCT01797458|3631777|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3804951|NCT01797458|3631778|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3804952|NCT01797458|3631775|B4||<=18 years|Age||Participants|Count of Participants|169|169.0||||||
3804953|NCT01797458|3631776|B3||<=18 years|Age||Participants|Count of Participants|65|65.0||||||
3804954|NCT01797458|3631777|B2||<=18 years|Age||Participants|Count of Participants|52|52.0||||||
3804955|NCT01797458|3631778|B1||<=18 years|Age||Participants|Count of Participants|52|52.0||||||
3804956|NCT01797445|3631797|B3|Unknown||HIV Disease Status||participants|Number|5|5.0||||||
3804957|NCT01797445|3631798|B2|Unknown||HIV Disease Status||participants|Number|3|3.0||||||
3804958|NCT01797445|3631799|B1|Unknown||HIV Disease Status||participants|Number|2|2.0||||||
3804959|NCT01797445|3631797|B3|AIDS||HIV Disease Status||participants|Number|41|41.0||||||
3804960|NCT01797445|3631798|B2|AIDS||HIV Disease Status||participants|Number|19|19.0||||||
3804961|NCT01797445|3631799|B1|AIDS||HIV Disease Status||participants|Number|22|22.0||||||
3804962|NCT01797445|3631797|B3|Symptomatic HIV Infection||HIV Disease Status||participants|Number|49|49.0||||||
3804963|NCT01797445|3631798|B2|Symptomatic HIV Infection||HIV Disease Status||participants|Number|19|19.0||||||
3804964|NCT01797445|3631799|B1|Symptomatic HIV Infection||HIV Disease Status||participants|Number|30|30.0||||||
3804965|NCT01797445|3631797|B3|Asymptomatic||HIV Disease Status||participants|Number|771|771.0||||||
3804966|NCT01797445|3631798|B2|Asymptomatic||HIV Disease Status||participants|Number|394|394.0||||||
3804967|NCT01797445|3631799|B1|Asymptomatic||HIV Disease Status||participants|Number|377|377.0||||||
3804968|NCT01797445|3631797|B3|Missing||CD4 Cell Count Category||participants|Number|1|1.0||||||
3804969|NCT01797445|3631798|B2|Missing||CD4 Cell Count Category||participants|Number|0|0.0||||||
3804970|NCT01797445|3631799|B1|Missing||CD4 Cell Count Category||participants|Number|1|1.0||||||
3804971|NCT01797445|3631797|B3|≥ 500 cells/μL||CD4 Cell Count Category||participants|Number|260|260.0||||||
3804972|NCT01797445|3631798|B2|≥ 500 cells/μL||CD4 Cell Count Category||participants|Number|133|133.0||||||
3804973|NCT01797445|3631799|B1|≥ 500 cells/μL||CD4 Cell Count Category||participants|Number|127|127.0||||||
3804974|NCT01797445|3631797|B3|≥ 350 to < 500 cells/μL||CD4 Cell Count Category||participants|Number|283|283.0||||||
3804975|NCT01797445|3631798|B2|≥ 350 to < 500 cells/μL||CD4 Cell Count Category||participants|Number|149|149.0||||||
3804976|NCT01797445|3631799|B1|≥ 350 to < 500 cells/μL||CD4 Cell Count Category||participants|Number|134|134.0||||||
3804977|NCT01797445|3631797|B3|≥ 200 to < 350 cells/μL||CD4 Cell Count Category||participants|Number|204|204.0||||||
3804978|NCT01797445|3631798|B2|≥ 200 to < 350 cells/μL||CD4 Cell Count Category||participants|Number|89|89.0||||||
3804979|NCT01797445|3631799|B1|≥ 200 to < 350 cells/μL||CD4 Cell Count Category||participants|Number|115|115.0||||||
3804980|NCT01797445|3631797|B3|≥ 50 to < 200 cells/μL||CD4 Cell Count Category||participants|Number|89|89.0||||||
3804981|NCT01797445|3631798|B2|≥ 50 to < 200 cells/μL||CD4 Cell Count Category||participants|Number|49|49.0||||||
3804982|NCT01797445|3631799|B1|≥ 50 to < 200 cells/μL||CD4 Cell Count Category||participants|Number|40|40.0||||||
3804983|NCT01797445|3631797|B3|< 50 cells/μL||CD4 Cell Count Category||participants|Number|29|29.0||||||
3804984|NCT01797445|3631798|B2|< 50 cells/μL||CD4 Cell Count Category||participants|Number|15|15.0||||||
3804985|NCT01797445|3631799|B1|< 50 cells/μL||CD4 Cell Count Category||participants|Number|14|14.0||||||
3804986|NCT01797445|3631797|B3|||CD4 Cell Count||/µL|Mean|423|423.0|Standard Deviation|217.1|217.1|||
3804987|NCT01797445|3631798|B2|||CD4 Cell Count||/µL|Mean|431|431.0|Standard Deviation|226.8|226.8|||
3804988|NCT01797445|3631799|B1|||CD4 Cell Count||/µL|Mean|414|414.0|Standard Deviation|206.8|206.8|||
3804989|NCT01797445|3631797|B3|> 400,000 copies/mL||HIV-1 RNA Category||participants|Number|41|41.0||||||
3804990|NCT01797445|3631798|B2|> 400,000 copies/mL||HIV-1 RNA Category||participants|Number|17|17.0||||||
3804991|NCT01797445|3631799|B1|> 400,000 copies/mL||HIV-1 RNA Category||participants|Number|24|24.0||||||
3804992|NCT01797445|3631797|B3|> 100,000 to ≤ 400,000 copies/mL||HIV-1 RNA Category||participants|Number|150|150.0||||||
3804993|NCT01797445|3631798|B2|> 100,000 to ≤ 400,000 copies/mL||HIV-1 RNA Category||participants|Number|82|82.0||||||
3804994|NCT01797445|3631799|B1|> 100,000 to ≤ 400,000 copies/mL||HIV-1 RNA Category||participants|Number|68|68.0||||||
3804995|NCT01797445|3631797|B3|≤ 100,000 copies/mL||HIV-1 RNA Category||participants|Number|675|675.0||||||
3804996|NCT01797445|3631798|B2|≤ 100,000 copies/mL||HIV-1 RNA Category||participants|Number|336|336.0||||||
3804997|NCT01797445|3631799|B1|≤ 100,000 copies/mL||HIV-1 RNA Category||participants|Number|339|339.0||||||
3804998|NCT01797445|3631797|B3|||HIV-1 RNA||log10 copies/mL|Mean|4.52|4.52|Standard Deviation|0.669|0.669|||
3804999|NCT01797445|3631798|B2|||HIV-1 RNA||log10 copies/mL|Mean|4.50|4.5|Standard Deviation|0.690|0.69|||
3805000|NCT01797445|3631799|B1|||HIV-1 RNA||log10 copies/mL|Mean|4.53|4.53|Standard Deviation|0.647|0.647|||
3805001|NCT01797445|3631797|B3|France||Region of Enrollment||participants|Number|34|34.0||||||
3805002|NCT01797445|3631798|B2|France||Region of Enrollment||participants|Number|18|18.0||||||
3805003|NCT01797445|3631799|B1|France||Region of Enrollment||participants|Number|16|16.0||||||
3805004|NCT01797445|3631797|B3|Mexico||Region of Enrollment||participants|Number|28|28.0||||||
3805005|NCT01797445|3631798|B2|Mexico||Region of Enrollment||participants|Number|12|12.0||||||
3805006|NCT01797445|3631799|B1|Mexico||Region of Enrollment||participants|Number|16|16.0||||||
3805007|NCT01797445|3631797|B3|Italy||Region of Enrollment||participants|Number|18|18.0||||||
3805008|NCT01797445|3631798|B2|Italy||Region of Enrollment||participants|Number|8|8.0||||||
3805009|NCT01797445|3631799|B1|Italy||Region of Enrollment||participants|Number|10|10.0||||||
3805010|NCT01797445|3631797|B3|Dominican Republic||Region of Enrollment||participants|Number|65|65.0||||||
3805011|NCT01797445|3631798|B2|Dominican Republic||Region of Enrollment||participants|Number|35|35.0||||||
3805012|NCT01797445|3631799|B1|Dominican Republic||Region of Enrollment||participants|Number|30|30.0||||||
3805013|NCT01797445|3631797|B3|Sweden||Region of Enrollment||participants|Number|11|11.0||||||
3805014|NCT01797445|3631798|B2|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
3805015|NCT01797445|3631799|B1|Sweden||Region of Enrollment||participants|Number|8|8.0||||||
3805016|NCT01797445|3631797|B3|Netherlands||Region of Enrollment||participants|Number|14|14.0||||||
3805017|NCT01797445|3631798|B2|Netherlands||Region of Enrollment||participants|Number|8|8.0||||||
3805018|NCT01797445|3631799|B1|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
3805019|NCT01797445|3631797|B3|Canada||Region of Enrollment||participants|Number|41|41.0||||||
3805020|NCT01797445|3631798|B2|Canada||Region of Enrollment||participants|Number|22|22.0||||||
3805021|NCT01797445|3631799|B1|Canada||Region of Enrollment||participants|Number|19|19.0||||||
3805022|NCT01797445|3631797|B3|Portugal||Region of Enrollment||participants|Number|37|37.0||||||
3805023|NCT01797445|3631798|B2|Portugal||Region of Enrollment||participants|Number|16|16.0||||||
3805024|NCT01797445|3631799|B1|Portugal||Region of Enrollment||participants|Number|21|21.0||||||
3805025|NCT01797445|3631797|B3|United Kingdom||Region of Enrollment||participants|Number|56|56.0||||||
3805026|NCT01797445|3631798|B2|United Kingdom||Region of Enrollment||participants|Number|31|31.0||||||
3805027|NCT01797445|3631799|B1|United Kingdom||Region of Enrollment||participants|Number|25|25.0||||||
3805028|NCT01797445|3631797|B3|United States||Region of Enrollment||participants|Number|562|562.0||||||
3805029|NCT01797445|3631798|B2|United States||Region of Enrollment||participants|Number|282|282.0||||||
3805030|NCT01797445|3631799|B1|United States||Region of Enrollment||participants|Number|280|280.0||||||
3805031|NCT01797445|3631797|B3|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3805032|NCT01797445|3631798|B2|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3805033|NCT01797445|3631799|B1|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3805034|NCT01797445|3631797|B3|Not Permitted||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3805035|NCT01797445|3631798|B2|Not Permitted||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3805036|NCT01797445|3631799|B1|Not Permitted||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3805037|NCT01797445|3631797|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|659|659.0||||||
3805038|NCT01797445|3631798|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|336|336.0||||||
3805039|NCT01797445|3631799|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|323|323.0||||||
3805040|NCT01797445|3631797|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|204|204.0||||||
3805041|NCT01797445|3631798|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|97|97.0||||||
3805042|NCT01797445|3631799|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|107|107.0||||||
3805043|NCT01797445|3631797|B3|Other||Race/Ethnicity, Customized||participants|Number|91|91.0||||||
3805044|NCT01797445|3631798|B2|Other||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
3805045|NCT01797445|3631799|B1|Other||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
3805046|NCT01797445|3631797|B3|White||Race/Ethnicity, Customized||participants|Number|478|478.0||||||
3805047|NCT01797445|3631798|B2|White||Race/Ethnicity, Customized||participants|Number|243|243.0||||||
3805048|NCT01797445|3631799|B1|White||Race/Ethnicity, Customized||participants|Number|235|235.0||||||
3805049|NCT01797445|3631797|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3805050|NCT01797445|3631798|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3805051|NCT01797445|3631799|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3805052|NCT01797445|3631797|B3|Black||Race/Ethnicity, Customized||participants|Number|261|261.0||||||
3805053|NCT01797445|3631798|B2|Black||Race/Ethnicity, Customized||participants|Number|132|132.0||||||
3805054|NCT01797445|3631799|B1|Black||Race/Ethnicity, Customized||participants|Number|129|129.0||||||
3805055|NCT01797445|3631797|B3|Asian||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
3805056|NCT01797445|3631798|B2|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3805057|NCT01797445|3631799|B1|Asian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3805058|NCT01797445|3631797|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3805119|NCT01797120|3631857|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3805059|NCT01797445|3631798|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3805060|NCT01797445|3631799|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3805061|NCT01797445|3631797|B3||Male|Sex: Female, Male||Participants|Count of Participants|733|733.0||||||
3805062|NCT01797445|3631798|B2||Male|Sex: Female, Male||Participants|Count of Participants|364|364.0||||||
3805063|NCT01797445|3631799|B1||Male|Sex: Female, Male||Participants|Count of Participants|369|369.0||||||
3805064|NCT01797445|3631797|B3||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3805065|NCT01797445|3631798|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3805066|NCT01797445|3631799|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3805067|NCT01797445|3631797|B3|||Age||years|Mean|36|36.0|Standard Deviation|10.9|10.9|||
3805068|NCT01797445|3631798|B2|||Age||years|Mean|36|36.0|Standard Deviation|10.9|10.9|||
3805069|NCT01797445|3631799|B1|||Age||years|Mean|35|35.0|Standard Deviation|10.8|10.8|||
3805070|NCT01797380|3631838|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3805071|NCT01797380|3631839|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3805072|NCT01797380|3631840|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3805073|NCT01797380|3631838|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3805074|NCT01797380|3631839|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3805075|NCT01797380|3631840|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3805076|NCT01797380|3631838|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3805077|NCT01797380|3631839|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3805078|NCT01797380|3631840|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3805079|NCT01797380|3631838|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3805080|NCT01797380|3631839|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3805081|NCT01797380|3631840|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3805082|NCT01797380|3631838|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3805083|NCT01797380|3631839|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3805084|NCT01797380|3631840|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3805085|NCT01797380|3631838|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3805086|NCT01797380|3631839|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3805087|NCT01797380|3631840|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3805088|NCT01797328|3631847|B3|Sweden||Region of Enrollment||participants|Number|28|28.0||||||
3805089|NCT01797328|3631848|B2|Sweden||Region of Enrollment||participants|Number|12|12.0||||||
3805090|NCT01797328|3631849|B1|Sweden||Region of Enrollment||participants|Number|16|16.0||||||
3805091|NCT01797328|3631847|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3805092|NCT01797328|3631848|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3805093|NCT01797328|3631849|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3805094|NCT01797328|3631847|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3805095|NCT01797328|3631848|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3805096|NCT01797328|3631849|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3805097|NCT01797328|3631847|B3|||Age|Continuous data was only available for those 14 participants who completed the study|years|Mean|25.3|25.3|Standard Deviation|3.5|3.5|||
3805098|NCT01797328|3631848|B2|||Age|Continuous data was only available for those 14 participants who completed the study|years|Mean|24.3|24.3|Standard Deviation|2.9|2.9|||
3805099|NCT01797328|3631849|B1|||Age|Continuous data was only available for those 14 participants who completed the study|years|Mean|26.1|26.1|Standard Deviation|3.9|3.9|||
3805100|NCT01797328|3631847|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3805101|NCT01797328|3631848|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3805102|NCT01797328|3631849|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3805103|NCT01797328|3631847|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3805104|NCT01797328|3631848|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3805105|NCT01797328|3631849|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3805106|NCT01797328|3631847|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3805107|NCT01797328|3631848|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3805108|NCT01797328|3631849|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3805109|NCT01797120|3631856|B3||Others|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3805110|NCT01797120|3631857|B2||Others|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3805111|NCT01797120|3631858|B1||Others|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3805112|NCT01797120|3631856|B3||Black|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3805113|NCT01797120|3631857|B2||Black|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3805114|NCT01797120|3631858|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3805115|NCT01797120|3631856|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|105|105.0||||||
3805116|NCT01797120|3631857|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|49|49.0||||||
3805117|NCT01797120|3631858|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|56|56.0||||||
3805118|NCT01797120|3631856|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3805120|NCT01797120|3631858|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3805121|NCT01797120|3631856|B3||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3805122|NCT01797120|3631857|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3805123|NCT01797120|3631858|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3805124|NCT01797120|3631856|B3|||Age||years|Median|63|63.0|Full Range|||35.0|92.0|
3805125|NCT01797120|3631857|B2|||Age||years|Median|59|59.0|Full Range|||35.0|85.0|
3805126|NCT01797120|3631858|B1|||Age||years|Median|64|64.0|Full Range|||39.0|92.0|
3805127|NCT01797094|3631871|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3805128|NCT01797094|3631872|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3805129|NCT01797094|3631873|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3805130|NCT01797094|3631871|B3||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3805131|NCT01797094|3631872|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3805132|NCT01797094|3631873|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3805133|NCT01797094|3631871|B3|> 50 years||Age, Customized||participants|Number|32|32.0||||||
3805134|NCT01797094|3631872|B2|> 50 years||Age, Customized||participants|Number|13|13.0||||||
3805135|NCT01797094|3631873|B1|> 50 years||Age, Customized||participants|Number|19|19.0||||||
3805136|NCT01797094|3631871|B3|≤ 50 years||Age, Customized||participants|Number|69|69.0||||||
3805137|NCT01797094|3631872|B2|≤ 50 years||Age, Customized||participants|Number|40|40.0||||||
3805138|NCT01797094|3631873|B1|≤ 50 years||Age, Customized||participants|Number|29|29.0||||||
3805139|NCT01797081|3631892|B5||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3805140|NCT01797081|3631893|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3805141|NCT01797081|3631894|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3805142|NCT01797081|3631895|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3805143|NCT01797081|3631896|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3805144|NCT01797081|3631892|B5||Female|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
3805145|NCT01797081|3631893|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3805146|NCT01797081|3631894|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3805147|NCT01797081|3631895|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3805148|NCT01797081|3631896|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3805149|NCT01797081|3631892|B5|> 50 years||Age, Customized||participants|Number|131|131.0||||||
3805150|NCT01797081|3631893|B4|> 50 years||Age, Customized||participants|Number|19|19.0||||||
3805151|NCT01797081|3631894|B3|> 50 years||Age, Customized||participants|Number|20|20.0||||||
3805152|NCT01797081|3631895|B2|> 50 years||Age, Customized||participants|Number|41|41.0||||||
3805153|NCT01797081|3631896|B1|> 50 years||Age, Customized||participants|Number|51|51.0||||||
3805154|NCT01797081|3631892|B5|≤ 50 years||Age, Customized||participants|Number|169|169.0||||||
3805155|NCT01797081|3631893|B4|≤ 50 years||Age, Customized||participants|Number|30|30.0||||||
3805156|NCT01797081|3631894|B3|≤ 50 years||Age, Customized||participants|Number|28|28.0||||||
3805157|NCT01797081|3631895|B2|≤ 50 years||Age, Customized||participants|Number|58|58.0||||||
3805158|NCT01797081|3631896|B1|≤ 50 years||Age, Customized||participants|Number|53|53.0||||||
3805159|NCT01797029|3631916|B3|Bangladesh||Region of Enrollment||participants|Number|1761|1761.0||||||
3805160|NCT01797029|3631917|B2|Bangladesh||Region of Enrollment||participants|Number|587|587.0||||||
3805161|NCT01797029|3631918|B1|Bangladesh||Region of Enrollment||participants|Number|1174|1174.0||||||
3805162|NCT01797029|3631916|B3||Male|Sex: Female, Male||Participants|Count of Participants|866|866.0||||||
3805163|NCT01797029|3631917|B2||Male|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
3805164|NCT01797029|3631918|B1||Male|Sex: Female, Male||Participants|Count of Participants|585|585.0||||||
3805165|NCT01797029|3631916|B3||Female|Sex: Female, Male||Participants|Count of Participants|895|895.0||||||
3805166|NCT01797029|3631917|B2||Female|Sex: Female, Male||Participants|Count of Participants|306|306.0||||||
3805167|NCT01797029|3631918|B1||Female|Sex: Female, Male||Participants|Count of Participants|589|589.0||||||
3805168|NCT01797029|3631916|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3805169|NCT01797029|3631917|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3805170|NCT01797029|3631918|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3805171|NCT01797029|3631916|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3805172|NCT01797029|3631917|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3805173|NCT01797029|3631918|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3805174|NCT01797029|3631916|B3||<=18 years|Age||Participants|Count of Participants|1761|1761.0||||||
3805175|NCT01797029|3631917|B2||<=18 years|Age||Participants|Count of Participants|587|587.0||||||
3805176|NCT01797029|3631918|B1||<=18 years|Age||Participants|Count of Participants|1174|1174.0||||||
3805177|NCT01796977|3631927|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3805178|NCT01796977|3631927|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3805179|NCT01796977|3631927|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3805180|NCT01796977|3631927|B1|||Age||years|Mean|45.01|45.01|Standard Deviation|10.9|10.9|||
3805181|NCT01796977|3631927|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3805182|NCT01796977|3631927|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3805183|NCT01796977|3631927|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3805184|NCT01796964|3631938|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3805185|NCT01796964|3631939|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3805186|NCT01796964|3631940|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3805187|NCT01796964|3631938|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3805188|NCT01796964|3631939|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3805189|NCT01796964|3631940|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3805190|NCT01796964|3631938|B3|||Age||years|Mean|78.0|78.0|Standard Deviation|9.4|9.4|||
3805191|NCT01796964|3631939|B2|||Age||years|Mean|77.3|77.3|Standard Deviation|9.1|9.1|||
3805192|NCT01796964|3631940|B1|||Age||years|Mean|78.8|78.8|Standard Deviation|9.7|9.7|||
3805193|NCT01796860|3631963|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3805194|NCT01796860|3631963|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805195|NCT01796860|3631963|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805196|NCT01796860|3631963|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3805197|NCT01796860|3631963|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805198|NCT01796860|3631963|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805199|NCT01796860|3631963|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805200|NCT01796860|3631963|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805201|NCT01796860|3631963|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805202|NCT01796860|3631963|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3805203|NCT01796860|3631963|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805204|NCT01796860|3631963|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3805205|NCT01796860|3631963|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3805206|NCT01796860|3631963|B1|||Age||years|Mean|49.5|49.5|Standard Deviation|5.83|5.83|||
3805207|NCT01796860|3631963|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3805208|NCT01796860|3631963|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3805209|NCT01796860|3631963|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3805210|NCT01796548|3631969|B1|||Maximal Detrusor Pressure|Maximal detrusor pressure represents the maximum pressure (peak amplitude) in the bladder during the first involuntary contraction of the bladder muscle. Detrusor pressure is the component of intravesical (in the bladder) pressure that is created by forces in the bladder wall (passive and active). It was estimated by subtracting abdominal pressure from intravesical pressure.|Centimeter of water|Mean|57.7|57.7|Standard Deviation|28.1|28.1|||
3805211|NCT01796548|3631969|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3805212|NCT01796548|3631969|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3805213|NCT01796548|3631969|B1|||Age||Years|Mean|52.7|52.7|Standard Deviation|20.2|20.2|||
3805214|NCT01796301|3631981|B3|||Serum Type 1 Collagen C-telopeptide (sCTX)||ng/L|Mean|256.2|256.2|Standard Deviation|130.7|130.7|||
3805215|NCT01796301|3631982|B2|||Serum Type 1 Collagen C-telopeptide (sCTX)||ng/L|Mean|252.3|252.3|Standard Deviation|136.4|136.4|||
3805216|NCT01796301|3631983|B1|||Serum Type 1 Collagen C-telopeptide (sCTX)||ng/L|Mean|260.1|260.1|Standard Deviation|124.9|124.9|||
3805217|NCT01796301|3631981|B3|||Femoral Neck BMD T-score||T-score|Mean|-2.46|-2.46|Standard Deviation|0.66|0.66|||
3805218|NCT01796301|3631982|B2|||Femoral Neck BMD T-score||T-score|Mean|-2.49|-2.49|Standard Deviation|0.67|0.67|||
3805219|NCT01796301|3631983|B1|||Femoral Neck BMD T-score||T-score|Mean|-2.43|-2.43|Standard Deviation|0.66|0.66|||
3805220|NCT01796301|3631981|B3|||Total Hip BMD T-score||T-score|Mean|-2.24|-2.24|Standard Deviation|0.74|0.74|||
3805221|NCT01796301|3631982|B2|||Total Hip BMD T-score||T-score|Mean|-2.27|-2.27|Standard Deviation|0.75|0.75|||
3805222|NCT01796301|3631983|B1|||Total Hip BMD T-score||T-score|Mean|-2.21|-2.21|Standard Deviation|0.72|0.72|||
3805223|NCT01796301|3631981|B3|||Lumbar Spine BMD T-score|The T-score is the bone mineral density (BMD) at the site when compared to that of a healthy thirty-year-old. Normal is a T-score of −1.0 or higher; Osteopenia is defined as between −1.0 and −2.5; Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a thirty-year-old man/woman.|T-score|Mean|-2.85|-2.85|Standard Deviation|1.07|1.07|||
3805224|NCT01796301|3631982|B2|||Lumbar Spine BMD T-score|The T-score is the bone mineral density (BMD) at the site when compared to that of a healthy thirty-year-old. Normal is a T-score of −1.0 or higher; Osteopenia is defined as between −1.0 and −2.5; Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a thirty-year-old man/woman.|T-score|Mean|-2.83|-2.83|Standard Deviation|1.10|1.1|||
3805225|NCT01796301|3631983|B1|||Lumbar Spine BMD T-score|The T-score is the bone mineral density (BMD) at the site when compared to that of a healthy thirty-year-old. Normal is a T-score of −1.0 or higher; Osteopenia is defined as between −1.0 and −2.5; Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a thirty-year-old man/woman.|T-score|Mean|-2.87|-2.87|Standard Deviation|1.04|1.04|||
3805226|NCT01796301|3631981|B3||No|Prior Fracture||Participants|Count of Participants|1|1.0||||||
3805227|NCT01796301|3631982|B2||No|Prior Fracture||Participants|Count of Participants|0|0.0||||||
3805228|NCT01796301|3631983|B1||No|Prior Fracture||Participants|Count of Participants|1|1.0||||||
3805229|NCT01796301|3631981|B3||Yes|Prior Fracture||Participants|Count of Participants|435|435.0||||||
3805230|NCT01796301|3631982|B2||Yes|Prior Fracture||Participants|Count of Participants|218|218.0||||||
3805231|NCT01796301|3631983|B1||Yes|Prior Fracture||Participants|Count of Participants|217|217.0||||||
3805232|NCT01796301|3631981|B3||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3805233|NCT01796301|3631982|B2||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3805234|NCT01796301|3631983|B1||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3805235|NCT01796301|3631981|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3805236|NCT01796301|3631982|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3805237|NCT01796301|3631983|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3805238|NCT01796301|3631981|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3805239|NCT01796301|3631982|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3805240|NCT01796301|3631983|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3805241|NCT01796301|3631981|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
3805242|NCT01796301|3631982|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3805243|NCT01796301|3631983|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3805244|NCT01796301|3631981|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|387|387.0||||||
3805245|NCT01796301|3631982|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|191|191.0||||||
3805246|NCT01796301|3631983|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|196|196.0||||||
3805247|NCT01796301|3631981|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3805248|NCT01796301|3631982|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3805249|NCT01796301|3631983|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3805250|NCT01796301|3631981|B3||Female|Sex: Female, Male||Participants|Count of Participants|436|436.0||||||
3805251|NCT01796301|3631982|B2||Female|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
3805252|NCT01796301|3631983|B1||Female|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
3805253|NCT01796301|3631981|B3||≥ 75 years|Age, Customized||Participants|Count of Participants|159|159.0||||||
3805254|NCT01796301|3631982|B2||≥ 75 years|Age, Customized||Participants|Count of Participants|85|85.0||||||
3805255|NCT01796301|3631983|B1||≥ 75 years|Age, Customized||Participants|Count of Participants|74|74.0||||||
3805256|NCT01796301|3631981|B3||≥ 65 to < 75 years|Age, Customized||Participants|Count of Participants|179|179.0||||||
3805257|NCT01796301|3631982|B2||≥ 65 to < 75 years|Age, Customized||Participants|Count of Participants|83|83.0||||||
3805258|NCT01796301|3631983|B1||≥ 65 to < 75 years|Age, Customized||Participants|Count of Participants|96|96.0||||||
3805259|NCT01796301|3631981|B3||< 65 years|Age, Customized||Participants|Count of Participants|98|98.0||||||
3805260|NCT01796301|3631982|B2||< 65 years|Age, Customized||Participants|Count of Participants|50|50.0||||||
3805261|NCT01796301|3631983|B1||< 65 years|Age, Customized||Participants|Count of Participants|48|48.0||||||
3805262|NCT01796301|3631981|B3|||Age||years|Mean|71.5|71.5|Standard Deviation|7.5|7.5|||
3805263|NCT01796301|3631982|B2|||Age||years|Mean|71.8|71.8|Standard Deviation|7.4|7.4|||
3805264|NCT01796301|3631983|B1|||Age||years|Mean|71.2|71.2|Standard Deviation|7.7|7.7|||
3805265|NCT01796236|3632018|B3|Single-Sided Sensorineural||Type of hearing loss||participants|Number|22|22.0||||||
3805266|NCT01796236|3632019|B2|Single-Sided Sensorineural||Type of hearing loss||participants|Number|7|7.0||||||
3805267|NCT01796236|3632020|B1|Single-Sided Sensorineural||Type of hearing loss||participants|Number|15|15.0||||||
3805268|NCT01796236|3632018|B3|Mixed||Type of hearing loss||participants|Number|66|66.0||||||
3805269|NCT01796236|3632019|B2|Mixed||Type of hearing loss||participants|Number|35|35.0||||||
3805270|NCT01796236|3632020|B1|Mixed||Type of hearing loss||participants|Number|31|31.0||||||
3805271|NCT01796236|3632018|B3|Conductive||Type of hearing loss||participants|Number|15|15.0||||||
3805272|NCT01796236|3632019|B2|Conductive||Type of hearing loss||participants|Number|10|10.0||||||
3805273|NCT01796236|3632020|B1|Conductive||Type of hearing loss||participants|Number|5|5.0||||||
3805274|NCT01796236|3632018|B3|Unknown||Use of nicotine||participants|Number|1|1.0||||||
3805275|NCT01796236|3632019|B2|Unknown||Use of nicotine||participants|Number|1|1.0||||||
3805276|NCT01796236|3632020|B1|Unknown||Use of nicotine||participants|Number|0|0.0||||||
3805277|NCT01796236|3632018|B3|Yes||Use of nicotine||participants|Number|27|27.0||||||
3805278|NCT01796236|3632019|B2|Yes||Use of nicotine||participants|Number|13|13.0||||||
3805279|NCT01796236|3632020|B1|Yes||Use of nicotine||participants|Number|14|14.0||||||
3805280|NCT01796236|3632018|B3|No||Use of nicotine||participants|Number|75|75.0||||||
3805281|NCT01796236|3632019|B2|No||Use of nicotine||participants|Number|38|38.0||||||
3805282|NCT01796236|3632020|B1|No||Use of nicotine||participants|Number|37|37.0||||||
3805283|NCT01796236|3632018|B3|Spain||Region of Enrollment||participants|Number|29|29.0||||||
3805284|NCT01796236|3632019|B2|Spain||Region of Enrollment||participants|Number|14|14.0||||||
3805285|NCT01796236|3632020|B1|Spain||Region of Enrollment||participants|Number|15|15.0||||||
3805286|NCT01796236|3632018|B3|France||Region of Enrollment||participants|Number|10|10.0||||||
3805287|NCT01796236|3632019|B2|France||Region of Enrollment||participants|Number|5|5.0||||||
3805288|NCT01796236|3632020|B1|France||Region of Enrollment||participants|Number|5|5.0||||||
3805289|NCT01796236|3632018|B3|Sweden||Region of Enrollment||participants|Number|9|9.0||||||
3805290|NCT01796236|3632019|B2|Sweden||Region of Enrollment||participants|Number|4|4.0||||||
3805291|NCT01796236|3632020|B1|Sweden||Region of Enrollment||participants|Number|5|5.0||||||
3805292|NCT01796236|3632018|B3|Netherlands||Region of Enrollment||participants|Number|55|55.0||||||
3805293|NCT01796236|3632019|B2|Netherlands||Region of Enrollment||participants|Number|29|29.0||||||
3805294|NCT01796236|3632020|B1|Netherlands||Region of Enrollment||participants|Number|26|26.0||||||
3805295|NCT01796236|3632018|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3805296|NCT01796236|3632019|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3805297|NCT01796236|3632020|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3805298|NCT01796236|3632018|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3805299|NCT01796236|3632019|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3805300|NCT01796236|3632020|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3805301|NCT01796236|3632018|B3|||Age||years|Mean|52.4|52.4|Standard Deviation|14.5|14.5|||
3805302|NCT01796236|3632019|B2|||Age||years|Mean|51.5|51.5|Standard Deviation|16.6|16.6|||
3805303|NCT01796236|3632020|B1|||Age||years|Mean|54.2|54.2|Standard Deviation|10.9|10.9|||
3805304|NCT01795937|3632037|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3805305|NCT01795937|3632038|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3805306|NCT01795937|3632039|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3805307|NCT01795937|3632040|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3805308|NCT01795937|3632037|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3805309|NCT01795937|3632038|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3805310|NCT01795937|3632039|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3805311|NCT01795937|3632040|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3805312|NCT01795937|3632037|B4|||Age||years|Mean|39.3|39.3|Standard Deviation|7.6|7.6|||
3805313|NCT01795937|3632038|B3|||Age||years|Mean|38.1|38.1|Standard Deviation|7.4|7.4|||
3805314|NCT01795937|3632039|B2|||Age||years|Mean|40.0|40.0|Standard Deviation|8.3|8.3|||
3805315|NCT01795937|3632040|B1|||Age||years|Mean|39.8|39.8|Standard Deviation|6.8|6.8|||
3805316|NCT01795898|3632071|B1|Very Much improved||Number of Participants With Clinical Global Impression-Improvement (CGI-I) Score: Participant|CGI-I is a 7-point scale that requires the participant to assess how much the participant's illness has improved or worsened relative to a baseline state at the beginning of the intervention and rated as: 1=very much improved; 2=much improved; 3=minimally improved; 4=no change; 5=minimally worse; 6=much worse; 7=very much worse. Number of participants analysed for this study specific Baseline characteristic=203.|Participant|Number|8|8.0||||||
3805317|NCT01795898|3632071|B1|Much improved||Number of Participants With Clinical Global Impression-Improvement (CGI-I) Score: Participant|CGI-I is a 7-point scale that requires the participant to assess how much the participant's illness has improved or worsened relative to a baseline state at the beginning of the intervention and rated as: 1=very much improved; 2=much improved; 3=minimally improved; 4=no change; 5=minimally worse; 6=much worse; 7=very much worse. Number of participants analysed for this study specific Baseline characteristic=203.|Participant|Number|88|88.0||||||
3805318|NCT01795898|3632071|B1|Minimally improved||Number of Participants With Clinical Global Impression-Improvement (CGI-I) Score: Participant|CGI-I is a 7-point scale that requires the participant to assess how much the participant's illness has improved or worsened relative to a baseline state at the beginning of the intervention and rated as: 1=very much improved; 2=much improved; 3=minimally improved; 4=no change; 5=minimally worse; 6=much worse; 7=very much worse. Number of participants analysed for this study specific Baseline characteristic=203.|Participant|Number|40|40.0||||||
3805319|NCT01795898|3632071|B1|No change||Number of Participants With Clinical Global Impression-Improvement (CGI-I) Score: Participant|CGI-I is a 7-point scale that requires the participant to assess how much the participant's illness has improved or worsened relative to a baseline state at the beginning of the intervention and rated as: 1=very much improved; 2=much improved; 3=minimally improved; 4=no change; 5=minimally worse; 6=much worse; 7=very much worse. Number of participants analysed for this study specific Baseline characteristic=203.|Participant|Number|21|21.0||||||
3805320|NCT01795898|3632071|B1|Not evaluated||Number of Participants With Clinical Global Impression-Improvement (CGI-I) Score: Participant|CGI-I is a 7-point scale that requires the participant to assess how much the participant's illness has improved or worsened relative to a baseline state at the beginning of the intervention and rated as: 1=very much improved; 2=much improved; 3=minimally improved; 4=no change; 5=minimally worse; 6=much worse; 7=very much worse. Number of participants analysed for this study specific Baseline characteristic=203.|Participant|Number|46|46.0||||||
3805321|NCT01795898|3632071|B1|Very Much improved||Number of Participants With Clinical Global Impression-Improvement (CGI-I) Score: Clinician|CGI-I is a 7-point scale that requires the clinician to assess how much the participant's illness has improved or worsened relative to a baseline state at the beginning of the intervention and rated as: 1=very much improved; 2=much improved; 3=minimally improved; 4=no change; 5=minimally worse; 6=much worse; 7=very much worse. Here, 'N' signifies the participants analyzed for this study specific Baseline characteristic and is Intent-to-treat population defined as all the participants who received at least 1 dose of study medication and had at least 1 follow-up visit with assessment=203.|Participants|Number|5|5.0||||||
3805322|NCT01795898|3632071|B1|Much improved||Number of Participants With Clinical Global Impression-Improvement (CGI-I) Score: Clinician|CGI-I is a 7-point scale that requires the clinician to assess how much the participant's illness has improved or worsened relative to a baseline state at the beginning of the intervention and rated as: 1=very much improved; 2=much improved; 3=minimally improved; 4=no change; 5=minimally worse; 6=much worse; 7=very much worse. Here, 'N' signifies the participants analyzed for this study specific Baseline characteristic and is Intent-to-treat population defined as all the participants who received at least 1 dose of study medication and had at least 1 follow-up visit with assessment=203.|Participants|Number|93|93.0||||||
3805367|NCT01795716|3632098|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3805368|NCT01795716|3632096|B3|||Age||years|Geometric Mean|33|33.0|Full Range|||17.0|59.0|
3805323|NCT01795898|3632071|B1|Minimally improved||Number of Participants With Clinical Global Impression-Improvement (CGI-I) Score: Clinician|CGI-I is a 7-point scale that requires the clinician to assess how much the participant's illness has improved or worsened relative to a baseline state at the beginning of the intervention and rated as: 1=very much improved; 2=much improved; 3=minimally improved; 4=no change; 5=minimally worse; 6=much worse; 7=very much worse. Here, 'N' signifies the participants analyzed for this study specific Baseline characteristic and is Intent-to-treat population defined as all the participants who received at least 1 dose of study medication and had at least 1 follow-up visit with assessment=203.|Participants|Number|38|38.0||||||
3805324|NCT01795898|3632071|B1|No change||Number of Participants With Clinical Global Impression-Improvement (CGI-I) Score: Clinician|CGI-I is a 7-point scale that requires the clinician to assess how much the participant's illness has improved or worsened relative to a baseline state at the beginning of the intervention and rated as: 1=very much improved; 2=much improved; 3=minimally improved; 4=no change; 5=minimally worse; 6=much worse; 7=very much worse. Here, 'N' signifies the participants analyzed for this study specific Baseline characteristic and is Intent-to-treat population defined as all the participants who received at least 1 dose of study medication and had at least 1 follow-up visit with assessment=203.|Participants|Number|21|21.0||||||
3805325|NCT01795898|3632071|B1|Not evaluated||Number of Participants With Clinical Global Impression-Improvement (CGI-I) Score: Clinician|CGI-I is a 7-point scale that requires the clinician to assess how much the participant's illness has improved or worsened relative to a baseline state at the beginning of the intervention and rated as: 1=very much improved; 2=much improved; 3=minimally improved; 4=no change; 5=minimally worse; 6=much worse; 7=very much worse. Here, 'N' signifies the participants analyzed for this study specific Baseline characteristic and is Intent-to-treat population defined as all the participants who received at least 1 dose of study medication and had at least 1 follow-up visit with assessment=203.|Participants|Number|46|46.0||||||
3805326|NCT01795898|3632071|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3805327|NCT01795898|3632071|B1||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3805328|NCT01795898|3632071|B1|||Age||Years|Mean|48.202|48.202|Standard Deviation|11.137|11.137|||
3805329|NCT01795859|3632079|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805330|NCT01795859|3632080|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805331|NCT01795859|3632081|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805332|NCT01795859|3632079|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3805333|NCT01795859|3632080|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3805334|NCT01795859|3632081|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805335|NCT01795859|3632079|B3||White|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3805336|NCT01795859|3632080|B2||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3805337|NCT01795859|3632081|B1||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3805338|NCT01795859|3632079|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3805339|NCT01795859|3632080|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3805340|NCT01795859|3632081|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805341|NCT01795859|3632079|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805342|NCT01795859|3632080|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805343|NCT01795859|3632081|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805344|NCT01795859|3632079|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805345|NCT01795859|3632080|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805346|NCT01795859|3632081|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805347|NCT01795859|3632079|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805348|NCT01795859|3632080|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805349|NCT01795859|3632081|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805350|NCT01795859|3632079|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3805351|NCT01795859|3632080|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3805352|NCT01795859|3632081|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3805353|NCT01795859|3632079|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3805354|NCT01795859|3632080|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3805355|NCT01795859|3632081|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3805356|NCT01795859|3632079|B3|SD-809||Age, Customized||participants|Mean|53.7|53.7|Standard Deviation|11.98|11.98|||
3805357|NCT01795859|3632080|B2|SD-809||Age, Customized||participants|Mean|52.1|52.1|Standard Deviation|13.36|13.36|||
3805358|NCT01795859|3632081|B1|SD-809||Age, Customized||participants|Mean|55.4|55.4|Standard Deviation|10.32|10.32|||
3805359|NCT01795716|3632096|B3|China||Region of Enrollment||participants|Number|21|21.0||||||
3805360|NCT01795716|3632097|B2|China||Region of Enrollment||participants|Number|11|11.0||||||
3805361|NCT01795716|3632098|B1|China||Region of Enrollment||participants|Number|10|10.0||||||
3805362|NCT01795716|3632096|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3805363|NCT01795716|3632097|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3805364|NCT01795716|3632098|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3805365|NCT01795716|3632096|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3805366|NCT01795716|3632097|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3805369|NCT01795716|3632097|B2|||Age||years|Geometric Mean|33|33.0|Full Range|||17.0|59.0|
3805370|NCT01795716|3632098|B1|||Age||years|Geometric Mean|33|33.0|Full Range|||17.0|59.0|
3805371|NCT01795716|3632096|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3805372|NCT01795716|3632097|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3805373|NCT01795716|3632098|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3805374|NCT01795716|3632096|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3805375|NCT01795716|3632097|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3805376|NCT01795716|3632098|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3805377|NCT01795716|3632096|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3805378|NCT01795716|3632097|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3805379|NCT01795716|3632098|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3805380|NCT01795547|3632105|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3805381|NCT01795547|3632106|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3805382|NCT01795547|3632107|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3805383|NCT01795547|3632105|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805384|NCT01795547|3632106|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805385|NCT01795547|3632107|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805386|NCT01795547|3632105|B3||White|Race (NIH/OMB)||Participants|Count of Participants|204|204.0||||||
3805387|NCT01795547|3632106|B2||White|Race (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
3805388|NCT01795547|3632107|B1||White|Race (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
3805389|NCT01795547|3632105|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3805390|NCT01795547|3632106|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3805391|NCT01795547|3632107|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3805392|NCT01795547|3632105|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805393|NCT01795547|3632106|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805394|NCT01795547|3632107|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805395|NCT01795547|3632105|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3805396|NCT01795547|3632106|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3805397|NCT01795547|3632107|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3805398|NCT01795547|3632105|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805399|NCT01795547|3632106|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805400|NCT01795547|3632107|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805401|NCT01795547|3632105|B3||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
3805402|NCT01795547|3632106|B2||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3805403|NCT01795547|3632107|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3805404|NCT01795547|3632105|B3||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3805405|NCT01795547|3632106|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3805406|NCT01795547|3632107|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3805407|NCT01795547|3632105|B3|||Age||years|Mean|41.8|41.8|Standard Deviation|10.86|10.86|||
3805408|NCT01795547|3632106|B2|||Age||years|Mean|41.0|41.0|Standard Deviation|10.87|10.87|||
3805409|NCT01795547|3632107|B1|||Age||years|Mean|42.6|42.6|Standard Deviation|10.83|10.83|||
3805410|NCT01795534|3632130|B1|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
3805411|NCT01795534|3632130|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805412|NCT01795534|3632130|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3805413|NCT01795534|3632130|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805414|NCT01795534|3632130|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3805415|NCT01795534|3632130|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3805416|NCT01795534|3632130|B1|||Age||years|Mean|37|37.0|Standard Deviation|13|13.0|||
3805417|NCT01795495|3632137|B4|||BMI (kg/m2)||kg/m^2|Mean|22.6|22.6|Standard Deviation|5.3|5.3|||
3805418|NCT01795495|3632138|B3|||BMI (kg/m2)||kg/m^2|Mean|24.2|24.2|Standard Deviation|5.6|5.6|||
3805419|NCT01795495|3632139|B2|||BMI (kg/m2)||kg/m^2|Mean|22.8|22.8|Standard Deviation|5.7|5.7|||
3805420|NCT01795495|3632140|B1|||BMI (kg/m2)||kg/m^2|Mean|21.6|21.6|Standard Deviation|4.3|4.3|||
3805421|NCT01795495|3632137|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3805422|NCT01795495|3632138|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3805423|NCT01795495|3632139|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3805424|NCT01795495|3632140|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3805425|NCT01795495|3632137|B4||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3805426|NCT01795495|3632138|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3805427|NCT01795495|3632139|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3805428|NCT01795495|3632140|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3805429|NCT01795495|3632137|B4|||Age||years|Mean|15.0|15.0|Standard Deviation|1.6|1.6|||
3805430|NCT01795495|3632138|B3|||Age||years|Mean|15.3|15.3|Standard Deviation|1.9|1.9|||
3805431|NCT01795495|3632139|B2|||Age||years|Mean|15.4|15.4|Standard Deviation|1.2|1.2|||
3805432|NCT01795495|3632140|B1|||Age||years|Mean|14.2|14.2|Standard Deviation|1.4|1.4|||
3805433|NCT01794949|3632153|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3805434|NCT01794949|3632154|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3805435|NCT01794949|3632155|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3805436|NCT01794949|3632153|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3805437|NCT01794949|3632154|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3805438|NCT01794949|3632155|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3805439|NCT01794949|3632153|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3805440|NCT01794949|3632154|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3805441|NCT01794949|3632155|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3805442|NCT01794949|3632153|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3805443|NCT01794949|3632154|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3805444|NCT01794949|3632155|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3805445|NCT01794949|3632153|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3805446|NCT01794949|3632154|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3805447|NCT01794949|3632155|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3805448|NCT01794949|3632153|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3805449|NCT01794949|3632154|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3805450|NCT01794949|3632155|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3805451|NCT01794936|3632162|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3805452|NCT01794936|3632162|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3805453|NCT01794936|3632162|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3805454|NCT01794936|3632162|B1|18 years and older||Age, Customized||participants|Number|9|9.0||||||
3805455|NCT01794845|3632167|B1|||Chemotherapy|Number of study participants receiving chemotherapy as treatment for primary tumor.|Participants|Count of Participants|3|3.0||||||
3805456|NCT01794845|3632167|B1|||Surgery|Number of study participants receiving surgery as treatment for primary tumor.|Participants|Count of Participants|1|1.0||||||
3805457|NCT01794845|3632167|B1||Tonsil|Site of Head and Neck Carcinoma||Participants|Count of Participants|1|1.0||||||
3805458|NCT01794845|3632167|B1||Floor of Mouth|Site of Head and Neck Carcinoma||Participants|Count of Participants|1|1.0||||||
3805459|NCT01794845|3632167|B1||Larynx|Site of Head and Neck Carcinoma||Participants|Count of Participants|2|2.0||||||
3805460|NCT01794845|3632167|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3805461|NCT01794845|3632167|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3805462|NCT01794845|3632167|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3805463|NCT01794845|3632167|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3805464|NCT01794845|3632167|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3805465|NCT01794845|3632167|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3805466|NCT01794806|3632174|B3|United States||Region of Enrollment||participants|Number|59|59.0||||||
3805467|NCT01794806|3632175|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
3805468|NCT01794806|3632176|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
3805469|NCT01794806|3632174|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3805470|NCT01794806|3632175|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3805471|NCT01794806|3632176|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3805472|NCT01794806|3632174|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3805473|NCT01794806|3632175|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3805474|NCT01794806|3632176|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3805475|NCT01794806|3632174|B3|||Age||years|Mean|57.84|57.84|Standard Deviation|11.99|11.99|||
3805476|NCT01794806|3632175|B2|||Age||years|Mean|57.24|57.24|Standard Deviation|11.82|11.82|||
3805477|NCT01794806|3632176|B1|||Age||years|Mean|58.46|58.46|Standard Deviation|12.37|12.37|||
3805478|NCT01794806|3632174|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3805479|NCT01794806|3632175|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3805480|NCT01794806|3632176|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3805481|NCT01794806|3632174|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3805482|NCT01794806|3632175|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3805483|NCT01794806|3632176|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3805484|NCT01794806|3632174|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3805485|NCT01794806|3632175|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3805486|NCT01794806|3632176|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3805487|NCT01794741|3632187|B3|United States||Region of Enrollment||participants|Number|405|405.0||||||
3805488|NCT01794741|3632188|B2|United States||Region of Enrollment||participants|Number|101|101.0||||||
3805489|NCT01794741|3632189|B1|United States||Region of Enrollment||participants|Number|304|304.0||||||
3805490|NCT01794741|3632187|B3||Male|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
3805491|NCT01794741|3632188|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3805492|NCT01794741|3632189|B1||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3805493|NCT01794741|3632187|B3||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
3805494|NCT01794741|3632188|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3805495|NCT01794741|3632189|B1||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3805496|NCT01794741|3632187|B3|||Age||years|Mean|8.1|8.1|Standard Deviation|1.9|1.9|||
3805497|NCT01794741|3632188|B2|||Age||years|Mean|8.1|8.1|Standard Deviation|1.94|1.94|||
3805498|NCT01794741|3632189|B1|||Age||years|Mean|8.1|8.1|Standard Deviation|2.07|2.07|||
3805499|NCT01794741|3632187|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3805500|NCT01794741|3632188|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3805501|NCT01794741|3632189|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3805502|NCT01794741|3632187|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3805503|NCT01794741|3632188|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3805504|NCT01794741|3632189|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3805505|NCT01794741|3632187|B3||<=18 years|Age||Participants|Count of Participants|405|405.0||||||
3805506|NCT01794741|3632188|B2||<=18 years|Age||Participants|Count of Participants|101|101.0||||||
3805507|NCT01794741|3632189|B1||<=18 years|Age||Participants|Count of Participants|304|304.0||||||
3805508|NCT01794455|3632196|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3805509|NCT01794455|3632197|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3805510|NCT01794455|3632196|B3|Male||Gender||participants|Number|1|1.0||||||
3805511|NCT01794455|3632197|B2|Male||Gender||participants|Number|1|1.0||||||
3805512|NCT01794455|3632196|B3|Female||Gender||participants|Number|0|0.0||||||
3805513|NCT01794455|3632197|B2|Female||Gender||participants|Number|0|0.0||||||
3805514|NCT01794455|3632196|B3|||Age||years|Mean|67|67.0|Full Range|||67.0|67.0|
3805515|NCT01794455|3632197|B2|||Age||years|Mean|67|67.0|Full Range|||67.0|67.0|
3805516|NCT01794455|3632196|B3|>=65 years||Age||participants|Number|1|1.0||||||
3805517|NCT01794455|3632197|B2|>=65 years||Age||participants|Number|1|1.0||||||
3805518|NCT01794455|3632196|B3|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
3805519|NCT01794455|3632197|B2|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
3805520|NCT01794455|3632196|B3|<=18 years||Age||participants|Number|0|0.0||||||
3805521|NCT01794455|3632197|B2|<=18 years||Age||participants|Number|0|0.0||||||
3805522|NCT01794039|3632215|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805523|NCT01794039|3632216|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805524|NCT01794039|3632217|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805525|NCT01794039|3632215|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805526|NCT01794039|3632216|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805527|NCT01794039|3632217|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805528|NCT01794039|3632215|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3805529|NCT01794039|3632216|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3805530|NCT01794039|3632217|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3805531|NCT01794039|3632215|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805532|NCT01794039|3632216|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805533|NCT01794039|3632217|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805534|NCT01794039|3632215|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805535|NCT01794039|3632216|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805536|NCT01794039|3632217|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805537|NCT01794039|3632215|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805538|NCT01794039|3632216|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805539|NCT01794039|3632217|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805540|NCT01794039|3632215|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805541|NCT01794039|3632216|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805542|NCT01794039|3632217|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805543|NCT01794039|3632215|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3805544|NCT01794039|3632216|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3805545|NCT01794039|3632217|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3805546|NCT01794039|3632215|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3805547|NCT01794039|3632216|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3805548|NCT01794039|3632217|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3805549|NCT01794039|3632215|B3|||Age||years|Median|67|67.0|Full Range|||60.0|75.0|
3805550|NCT01794039|3632216|B2|||Age||years|Median|68.5|68.5|Full Range|||60.0|72.0|
3805551|NCT01794039|3632217|B1|||Age||years|Median|67|67.0|Full Range|||64.0|75.0|
3805552|NCT01794000|3632228|B3|No||Hydroxyurea Use at Baseline||participants|Number|188|188.0||||||
3805553|NCT01794000|3632229|B2|No||Hydroxyurea Use at Baseline||participants|Number|94|94.0||||||
3805554|NCT01794000|3632230|B1|No||Hydroxyurea Use at Baseline||participants|Number|94|94.0||||||
3805555|NCT01794000|3632228|B3|Yes||Hydroxyurea Use at Baseline||participants|Number|153|153.0||||||
3805556|NCT01794000|3632229|B2|Yes||Hydroxyurea Use at Baseline||participants|Number|76|76.0||||||
3805557|NCT01794000|3632230|B1|Yes||Hydroxyurea Use at Baseline||participants|Number|77|77.0||||||
3805558|NCT01794000|3632228|B3|Italy||Region of Enrollment||participants|Number|14|14.0||||||
3805559|NCT01794000|3632229|B2|Italy||Region of Enrollment||participants|Number|7|7.0||||||
3805560|NCT01794000|3632230|B1|Italy||Region of Enrollment||participants|Number|7|7.0||||||
3805561|NCT01794000|3632228|B3|Brazil||Region of Enrollment||participants|Number|1|1.0||||||
3805562|NCT01794000|3632229|B2|Brazil||Region of Enrollment||participants|Number|0|0.0||||||
3805563|NCT01794000|3632230|B1|Brazil||Region of Enrollment||participants|Number|1|1.0||||||
3805564|NCT01794000|3632228|B3|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
3805565|NCT01794000|3632229|B2|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
3805566|NCT01794000|3632230|B1|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
3805567|NCT01794000|3632228|B3|Turkey||Region of Enrollment||participants|Number|42|42.0||||||
3805568|NCT01794000|3632229|B2|Turkey||Region of Enrollment||participants|Number|22|22.0||||||
3805569|NCT01794000|3632230|B1|Turkey||Region of Enrollment||participants|Number|20|20.0||||||
3805570|NCT01794000|3632228|B3|Canada||Region of Enrollment||participants|Number|8|8.0||||||
3805571|NCT01794000|3632229|B2|Canada||Region of Enrollment||participants|Number|4|4.0||||||
3805572|NCT01794000|3632230|B1|Canada||Region of Enrollment||participants|Number|4|4.0||||||
3805573|NCT01794000|3632228|B3|Saudi Arabia||Region of Enrollment||participants|Number|1|1.0||||||
3805574|NCT01794000|3632229|B2|Saudi Arabia||Region of Enrollment||participants|Number|0|0.0||||||
3805575|NCT01794000|3632230|B1|Saudi Arabia||Region of Enrollment||participants|Number|1|1.0||||||
3805576|NCT01794000|3632228|B3|Lebanon||Region of Enrollment||participants|Number|16|16.0||||||
3805577|NCT01794000|3632229|B2|Lebanon||Region of Enrollment||participants|Number|8|8.0||||||
3805578|NCT01794000|3632230|B1|Lebanon||Region of Enrollment||participants|Number|8|8.0||||||
3805579|NCT01794000|3632228|B3|Oman||Region of Enrollment||participants|Number|6|6.0||||||
3805580|NCT01794000|3632229|B2|Oman||Region of Enrollment||participants|Number|4|4.0||||||
3805581|NCT01794000|3632230|B1|Oman||Region of Enrollment||participants|Number|2|2.0||||||
3805582|NCT01794000|3632228|B3|Kenya||Region of Enrollment||participants|Number|91|91.0||||||
3805583|NCT01794000|3632229|B2|Kenya||Region of Enrollment||participants|Number|44|44.0||||||
3805584|NCT01794000|3632230|B1|Kenya||Region of Enrollment||participants|Number|47|47.0||||||
3805585|NCT01794000|3632228|B3|Ghana||Region of Enrollment||participants|Number|57|57.0||||||
3805586|NCT01794000|3632229|B2|Ghana||Region of Enrollment||participants|Number|28|28.0||||||
3805587|NCT01794000|3632230|B1|Ghana||Region of Enrollment||participants|Number|29|29.0||||||
3805588|NCT01794000|3632228|B3|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
3805589|NCT01794000|3632229|B2|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3805590|NCT01794000|3632230|B1|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
3805591|NCT01794000|3632228|B3|Egypt||Region of Enrollment||participants|Number|45|45.0||||||
3805592|NCT01794000|3632229|B2|Egypt||Region of Enrollment||participants|Number|22|22.0||||||
3805593|NCT01794000|3632230|B1|Egypt||Region of Enrollment||participants|Number|23|23.0||||||
3805594|NCT01794000|3632228|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
3805595|NCT01794000|3632229|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3805596|NCT01794000|3632230|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
3805597|NCT01794000|3632228|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3805598|NCT01794000|3632229|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3805599|NCT01794000|3632230|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805600|NCT01794000|3632228|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3805601|NCT01794000|3632229|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3805602|NCT01794000|3632230|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805603|NCT01794000|3632228|B3||White|Race (NIH/OMB)||Participants|Count of Participants|116|116.0||||||
3805604|NCT01794000|3632229|B2||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3805605|NCT01794000|3632230|B1||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3805606|NCT01794000|3632228|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|222|222.0||||||
3805607|NCT01794000|3632229|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|109|109.0||||||
3805608|NCT01794000|3632230|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
3805609|NCT01794000|3632228|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805610|NCT01794000|3632229|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805611|NCT01794000|3632230|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805612|NCT01794000|3632228|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805613|NCT01794000|3632229|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805614|NCT01794000|3632230|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805615|NCT01794000|3632228|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805616|NCT01794000|3632229|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805617|NCT01794000|3632230|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805618|NCT01794000|3632228|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
3805619|NCT01794000|3632229|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3805620|NCT01794000|3632230|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3805621|NCT01794000|3632228|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|192|192.0||||||
3805622|NCT01794000|3632229|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3805623|NCT01794000|3632230|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3805624|NCT01794000|3632228|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3805625|NCT01794000|3632229|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3805626|NCT01794000|3632230|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3805627|NCT01794000|3632228|B3||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3805628|NCT01794000|3632229|B2||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3805629|NCT01794000|3632230|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3805630|NCT01794000|3632228|B3||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
3805631|NCT01794000|3632229|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3805632|NCT01794000|3632230|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3805633|NCT01794000|3632228|B3|||Age||years|Mean|10.593|10.593|Standard Deviation|4.335|4.335|||
3805634|NCT01794000|3632229|B2|||Age||years|Mean|10.580|10.58|Standard Deviation|4.349|4.349|||
3805635|NCT01794000|3632230|B1|||Age||years|Mean|10.606|10.606|Standard Deviation|4.334|4.334|||
3805636|NCT01793935|3632262|B3|||Current Smokers||Participants|Count of Participants|41|41.0||||||
3805637|NCT01793935|3632263|B2|||Current Smokers||Participants|Count of Participants|19|19.0||||||
3805638|NCT01793935|3632264|B1|||Current Smokers||Participants|Count of Participants|22|22.0||||||
3805639|NCT01793935|3632262|B3|||Age at onset of 1st episode||years|Mean|24.16|24.16|Standard Deviation|9.35|9.35|||
3805640|NCT01793935|3632263|B2|||Age at onset of 1st episode||years|Mean|24.00|24.0|Standard Deviation|7.67|7.67|||
3805641|NCT01793935|3632264|B1|||Age at onset of 1st episode||years|Mean|24.32|24.32|Standard Deviation|10.89|10.89|||
3805642|NCT01793935|3632262|B3|||Number of lifetime psychiatric hospitalizations||psychiatric hospitalizations|Mean|7.74|7.74|Standard Deviation|6.63|6.63|||
3805643|NCT01793935|3632263|B2|||Number of lifetime psychiatric hospitalizations||psychiatric hospitalizations|Mean|7.76|7.76|Standard Deviation|6.90|6.9|||
3805644|NCT01793935|3632264|B1|||Number of lifetime psychiatric hospitalizations||psychiatric hospitalizations|Mean|7.71|7.71|Standard Deviation|6.45|6.45|||
3805645|NCT01793935|3632262|B3||Diagnosis Schizoaffective|Diagnosis Schizophrenia or Schizoaffective||Participants|Count of Participants|29|29.0||||||
3805646|NCT01793935|3632263|B2||Diagnosis Schizoaffective|Diagnosis Schizophrenia or Schizoaffective||Participants|Count of Participants|16|16.0||||||
3805647|NCT01793935|3632264|B1||Diagnosis Schizoaffective|Diagnosis Schizophrenia or Schizoaffective||Participants|Count of Participants|13|13.0||||||
3805648|NCT01793935|3632262|B3||Diagnosis Schizophrenia|Diagnosis Schizophrenia or Schizoaffective||Participants|Count of Participants|39|39.0||||||
3805649|NCT01793935|3632263|B2||Diagnosis Schizophrenia|Diagnosis Schizophrenia or Schizoaffective||Participants|Count of Participants|18|18.0||||||
3805650|NCT01793935|3632264|B1||Diagnosis Schizophrenia|Diagnosis Schizophrenia or Schizoaffective||Participants|Count of Participants|21|21.0||||||
3805651|NCT01793935|3632262|B3|United States||Region of Enrollment||Participants|Count of Participants|68|68.0||||||
3805652|NCT01793935|3632263|B2|United States||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3805653|NCT01793935|3632264|B1|United States||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3805654|NCT01793935|3632262|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805655|NCT01793935|3632263|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805656|NCT01793935|3632264|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805657|NCT01793935|3632262|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805658|NCT01793935|3632263|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805659|NCT01793935|3632264|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805660|NCT01793935|3632262|B3||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3805661|NCT01793935|3632263|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3805662|NCT01793935|3632264|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3805663|NCT01793935|3632262|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3805664|NCT01793935|3632263|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3805665|NCT01793935|3632264|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3805666|NCT01793935|3632262|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805667|NCT01793935|3632263|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805668|NCT01793935|3632264|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805669|NCT01793935|3632262|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805670|NCT01793935|3632263|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805671|NCT01793935|3632264|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805672|NCT01793935|3632262|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805673|NCT01793935|3632263|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805674|NCT01793935|3632264|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805675|NCT01793935|3632262|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3805676|NCT01793935|3632263|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3805677|NCT01793935|3632264|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3805678|NCT01793935|3632262|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3805679|NCT01793935|3632263|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3805680|NCT01793935|3632264|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3805681|NCT01793935|3632262|B3|||Age||years|Mean|46.28|46.28|Standard Deviation|12.12|12.12|||
3805682|NCT01793935|3632263|B2|||Age||years|Mean|47.38|47.38|Standard Deviation|11.37|11.37|||
3805683|NCT01793935|3632264|B1|||Age||years|Mean|45.18|45.18|Standard Deviation|12.90|12.9|||
3805684|NCT01793883|3632299|B4|Estonia||Region of Enrollment||participants|Number|39|39.0||||||
3805685|NCT01793883|3632300|B3|Estonia||Region of Enrollment||participants|Number|15|15.0||||||
3805686|NCT01793883|3632301|B2|Estonia||Region of Enrollment||participants|Number|13|13.0||||||
3805687|NCT01793883|3632302|B1|Estonia||Region of Enrollment||participants|Number|11|11.0||||||
3805688|NCT01793883|3632299|B4|Germany||Region of Enrollment||participants|Number|13|13.0||||||
3805689|NCT01793883|3632300|B3|Germany||Region of Enrollment||participants|Number|3|3.0||||||
3805690|NCT01793883|3632301|B2|Germany||Region of Enrollment||participants|Number|4|4.0||||||
3805691|NCT01793883|3632302|B1|Germany||Region of Enrollment||participants|Number|6|6.0||||||
3805692|NCT01793883|3632299|B4|Bulgaria||Region of Enrollment||participants|Number|95|95.0||||||
3805693|NCT01793883|3632300|B3|Bulgaria||Region of Enrollment||participants|Number|36|36.0||||||
3805694|NCT01793883|3632301|B2|Bulgaria||Region of Enrollment||participants|Number|32|32.0||||||
3805695|NCT01793883|3632302|B1|Bulgaria||Region of Enrollment||participants|Number|27|27.0||||||
3805696|NCT01793883|3632299|B4|South Africa||Region of Enrollment||participants|Number|117|117.0||||||
3805697|NCT01793883|3632300|B3|South Africa||Region of Enrollment||participants|Number|39|39.0||||||
3805698|NCT01793883|3632301|B2|South Africa||Region of Enrollment||participants|Number|38|38.0||||||
3805699|NCT01793883|3632302|B1|South Africa||Region of Enrollment||participants|Number|40|40.0||||||
3805700|NCT01793883|3632299|B4|Mexico||Region of Enrollment||participants|Number|29|29.0||||||
3805701|NCT01793883|3632300|B3|Mexico||Region of Enrollment||participants|Number|10|10.0||||||
3805702|NCT01793883|3632301|B2|Mexico||Region of Enrollment||participants|Number|12|12.0||||||
3805703|NCT01793883|3632302|B1|Mexico||Region of Enrollment||participants|Number|7|7.0||||||
3805704|NCT01793883|3632299|B4|Belgium||Region of Enrollment||participants|Number|35|35.0||||||
3805705|NCT01793883|3632300|B3|Belgium||Region of Enrollment||participants|Number|14|14.0||||||
3805706|NCT01793883|3632301|B2|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
3805707|NCT01793883|3632302|B1|Belgium||Region of Enrollment||participants|Number|13|13.0||||||
3805708|NCT01793883|3632299|B4|Latvia||Region of Enrollment||participants|Number|8|8.0||||||
3805709|NCT01793883|3632300|B3|Latvia||Region of Enrollment||participants|Number|4|4.0||||||
3805710|NCT01793883|3632301|B2|Latvia||Region of Enrollment||participants|Number|3|3.0||||||
3805711|NCT01793883|3632302|B1|Latvia||Region of Enrollment||participants|Number|1|1.0||||||
3805712|NCT01793883|3632299|B4|Canada||Region of Enrollment||participants|Number|7|7.0||||||
3805713|NCT01793883|3632300|B3|Canada||Region of Enrollment||participants|Number|3|3.0||||||
3805714|NCT01793883|3632301|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
3805715|NCT01793883|3632302|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
3805716|NCT01793883|3632299|B4|New Zealand||Region of Enrollment||participants|Number|9|9.0||||||
3805717|NCT01793883|3632300|B3|New Zealand||Region of Enrollment||participants|Number|3|3.0||||||
3805718|NCT01793883|3632301|B2|New Zealand||Region of Enrollment||participants|Number|4|4.0||||||
3805719|NCT01793883|3632302|B1|New Zealand||Region of Enrollment||participants|Number|2|2.0||||||
3805720|NCT01793883|3632299|B4|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3805721|NCT01793883|3632300|B3|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3805722|NCT01793883|3632301|B2|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3805723|NCT01793883|3632302|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3805724|NCT01793883|3632299|B4|United States||Region of Enrollment||participants|Number|283|283.0||||||
3805725|NCT01793883|3632300|B3|United States||Region of Enrollment||participants|Number|84|84.0||||||
3805726|NCT01793883|3632301|B2|United States||Region of Enrollment||participants|Number|97|97.0||||||
3805727|NCT01793883|3632302|B1|United States||Region of Enrollment||participants|Number|102|102.0||||||
3805728|NCT01793883|3632299|B4|Hungary||Region of Enrollment||participants|Number|3|3.0||||||
3805729|NCT01793883|3632300|B3|Hungary||Region of Enrollment||participants|Number|1|1.0||||||
3805730|NCT01793883|3632301|B2|Hungary||Region of Enrollment||participants|Number|1|1.0||||||
3805731|NCT01793883|3632302|B1|Hungary||Region of Enrollment||participants|Number|1|1.0||||||
3805732|NCT01793883|3632299|B4||Male|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
3805733|NCT01793883|3632300|B3||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3805734|NCT01793883|3632301|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3805735|NCT01793883|3632302|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3805736|NCT01793883|3632299|B4||Female|Sex: Female, Male||Participants|Count of Participants|362|362.0||||||
3805737|NCT01793883|3632300|B3||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3805738|NCT01793883|3632301|B2||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3805739|NCT01793883|3632302|B1||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3805740|NCT01793883|3632299|B4|||Age||years|Mean|39.3|39.3|Standard Deviation|12.60|12.6|||
3805741|NCT01793883|3632300|B3|||Age||years|Mean|40.3|40.3|Standard Deviation|13.31|13.31|||
3805742|NCT01793883|3632301|B2|||Age||years|Mean|39.2|39.2|Standard Deviation|12.49|12.49|||
3805743|NCT01793883|3632302|B1|||Age||years|Mean|38.5|38.5|Standard Deviation|11.95|11.95|||
3805744|NCT01793688|3632312|B1|Peritonitis||Diagnosis||Participants|Number|48|48.0||||||
3805745|NCT01793688|3632312|B1|Lung Abscess||Diagnosis||Participants|Number|71|71.0||||||
3805746|NCT01793688|3632312|B1|Pneumonia||Diagnosis||Participants|Number|861|861.0||||||
3805747|NCT01793688|3632312|B1||Male|Sex: Female, Male||Participants|Count of Participants|684|684.0||||||
3805748|NCT01793688|3632312|B1||Female|Sex: Female, Male||Participants|Count of Participants|296|296.0||||||
3805749|NCT01793688|3632312|B1|˃=65 years||Age, Customized||Participants|Number|725|725.0||||||
3805750|NCT01793688|3632312|B1|>=15 and <65 years||Age, Customized||Participants|Number|255|255.0||||||
3805751|NCT01793285|3632319|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3805752|NCT01793285|3632319|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3805753|NCT01793285|3632319|B1|||Age||years|Mean|45.90|45.9|Standard Deviation|10.67|10.67|||
3805754|NCT01793142|3632339|B1|||Height Continuous||centimeter|Mean|153.56|153.56|Standard Deviation|5.87|5.87|||
3805755|NCT01793142|3632339|B1|||Weight Continuous||kilograms|Mean|55.12|55.12|Standard Deviation|8.26|8.26|||
3805756|NCT01793142|3632339|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3805757|NCT01793142|3632339|B1||Female|Sex: Female, Male||Participants|Count of Participants|3423|3423.0||||||
3805758|NCT01793142|3632339|B1|Mean Age||Age||years|Mean|69.51|69.51|Standard Deviation|10.03|10.03|||
3805759|NCT01792986|3632350|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3805760|NCT01792986|3632350|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3805761|NCT01792986|3632350|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|7.0|7.0|||
3805762|NCT01792830|3632358|B12|United States||Region of Enrollment||Participants|Count of Participants|175|175.0||||||
3805763|NCT01792830|3632359|B11|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3805764|NCT01792830|3632360|B10|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3805765|NCT01792830|3632361|B9|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3805766|NCT01792830|3632362|B8|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3805767|NCT01792830|3632363|B7|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3805768|NCT01792830|3632364|B6|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3805769|NCT01792830|3632365|B5|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3805770|NCT01792830|3632366|B4|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3805771|NCT01792830|3632367|B3|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3805772|NCT01792830|3632368|B2|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3805773|NCT01792830|3632369|B1|United States||Region of Enrollment||Participants|Count of Participants|84|84.0||||||
3805774|NCT01792830|3632358|B12||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3805775|NCT01792830|3632359|B11||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3805776|NCT01792830|3632360|B10||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3805777|NCT01792830|3632361|B9||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3805778|NCT01792830|3632362|B8||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3805779|NCT01792830|3632363|B7||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3805780|NCT01792830|3632364|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3805781|NCT01792830|3632365|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3805782|NCT01792830|3632366|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3805783|NCT01792830|3632367|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3805784|NCT01792830|3632368|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3805785|NCT01792830|3632369|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3805786|NCT01792830|3632358|B12||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3805787|NCT01792830|3632359|B11||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3805788|NCT01792830|3632360|B10||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3805789|NCT01792830|3632361|B9||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3805790|NCT01792830|3632362|B8||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3805791|NCT01792830|3632363|B7||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3805792|NCT01792830|3632364|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3805793|NCT01792830|3632365|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3805794|NCT01792830|3632366|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3805795|NCT01792830|3632367|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3805796|NCT01792830|3632368|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3805797|NCT01792830|3632369|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3805798|NCT01792830|3632358|B12||>=65 years|Age||Participants|Count of Participants|91|91.0||||||
3805799|NCT01792830|3632359|B11||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3805800|NCT01792830|3632360|B10||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3805801|NCT01792830|3632361|B9||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3805802|NCT01792830|3632362|B8||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3805803|NCT01792830|3632363|B7||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3805804|NCT01792830|3632364|B6||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3805805|NCT01792830|3632365|B5||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3805806|NCT01792830|3632366|B4||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3805807|NCT01792830|3632367|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3805808|NCT01792830|3632368|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3805809|NCT01792830|3632369|B1||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
3805810|NCT01792830|3632358|B12||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
3805811|NCT01792830|3632359|B11||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3805812|NCT01792830|3632360|B10||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3805813|NCT01792830|3632361|B9||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3805814|NCT01792830|3632362|B8||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3805815|NCT01792830|3632363|B7||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3805816|NCT01792830|3632364|B6||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3805817|NCT01792830|3632365|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3805818|NCT01792830|3632366|B4||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3805819|NCT01792830|3632367|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3805820|NCT01792830|3632368|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3805821|NCT01792830|3632369|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3805822|NCT01792830|3632358|B12||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3805823|NCT01792830|3632359|B11||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3805824|NCT01792830|3632360|B10||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3805825|NCT01792830|3632361|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3805826|NCT01792830|3632362|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3805827|NCT01792830|3632363|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3805828|NCT01792830|3632364|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3805829|NCT01792830|3632365|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3805830|NCT01792830|3632366|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3805831|NCT01792830|3632367|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3805832|NCT01792830|3632368|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3805833|NCT01792830|3632369|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3805834|NCT01792817|3632446|B3|||Full Time Employment||Participants|Count of Participants|92|92.0||||||
3805835|NCT01792817|3632447|B2|||Full Time Employment||Participants|Count of Participants|45|45.0||||||
3805836|NCT01792817|3632448|B1|||Full Time Employment||Participants|Count of Participants|47|47.0||||||
3805837|NCT01792817|3632446|B3|||Taking CH Prevention Medicaiton||Participants|Count of Participants|102|102.0||||||
3805838|NCT01792817|3632447|B2|||Taking CH Prevention Medicaiton||Participants|Count of Participants|42|42.0||||||
3805839|NCT01792817|3632448|B1|||Taking CH Prevention Medicaiton||Participants|Count of Participants|60|60.0||||||
3805840|NCT01792817|3632446|B3|Chronic||CH Type||Participants|Count of Participants|49|49.0||||||
3805841|NCT01792817|3632447|B2|Chronic||CH Type||Participants|Count of Participants|23|23.0||||||
3805842|NCT01792817|3632448|B1|Chronic||CH Type||Participants|Count of Participants|26|26.0||||||
3805843|NCT01792817|3632446|B3|Episodic||CH Type||Participants|Count of Participants|101|101.0||||||
3805844|NCT01792817|3632447|B2|Episodic||CH Type||Participants|Count of Participants|50|50.0||||||
3805845|NCT01792817|3632448|B1|Episodic||CH Type||Participants|Count of Participants|51|51.0||||||
3805846|NCT01792817|3632446|B3|||Weight||pounds|Mean|191.3|191.3|Standard Deviation|39.19|39.19|||
3805847|NCT01792817|3632447|B2|||Weight||pounds|Mean|189.5|189.5|Standard Deviation|40.79|40.79|||
3805848|NCT01792817|3632448|B1|||Weight||pounds|Mean|193|193.0|Standard Deviation|37.79|37.79|||
3805849|NCT01792817|3632446|B3|||Height||inches|Mean|69.6|69.6|Standard Deviation|3.73|3.73|||
3805850|NCT01792817|3632447|B2|||Height||inches|Mean|69.4|69.4|Standard Deviation|3.62|3.62|||
3805851|NCT01792817|3632448|B1|||Height||inches|Mean|69.8|69.8|Standard Deviation|3.84|3.84|||
3805852|NCT01792817|3632446|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3805853|NCT01792817|3632447|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3805854|NCT01792817|3632448|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3805855|NCT01792817|3632446|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3805856|NCT01792817|3632447|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3805857|NCT01792817|3632448|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3805858|NCT01792817|3632446|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|131|131.0||||||
3805859|NCT01792817|3632447|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|63|63.0||||||
3805860|NCT01792817|3632448|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|68|68.0||||||
3805861|NCT01792817|3632446|B3||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3805862|NCT01792817|3632447|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3805863|NCT01792817|3632448|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3805864|NCT01792817|3632446|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3805865|NCT01792817|3632447|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3805866|NCT01792817|3632448|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3805867|NCT01792817|3632446|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3805868|NCT01792817|3632447|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3805869|NCT01792817|3632448|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3805870|NCT01792817|3632446|B3||Between 18 and 65 years|Age||Participants|Count of Participants|150|150.0||||||
3805871|NCT01792817|3632447|B2||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
3805872|NCT01792817|3632448|B1||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
3805873|NCT01792817|3632446|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3805874|NCT01792817|3632447|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3805875|NCT01792817|3632448|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3805876|NCT01792635|3632463|B4|Female||Sex/Gender, Customized||Participants|Number|4|4.0||||||
3805877|NCT01792635|3632464|B3|Female||Sex/Gender, Customized||Participants|Number|2|2.0||||||
3805878|NCT01792635|3632465|B2|Female||Sex/Gender, Customized||Participants|Number|1|1.0||||||
3805879|NCT01792635|3632466|B1|Female||Sex/Gender, Customized||Participants|Number|1|1.0||||||
3805880|NCT01792635|3632463|B4|Male||Sex/Gender, Customized||Participants|Number|15|15.0||||||
3805881|NCT01792635|3632464|B3|Male||Sex/Gender, Customized||Participants|Number|5|5.0||||||
3805882|NCT01792635|3632465|B2|Male||Sex/Gender, Customized||Participants|Number|5|5.0||||||
3805883|NCT01792635|3632466|B1|Male||Sex/Gender, Customized||Participants|Number|5|5.0||||||
3805884|NCT01792635|3632463|B4|||Age||Years|Mean|51.9|51.9|Standard Deviation|7.9|7.9|||
3805885|NCT01792635|3632464|B3|||Age||Years|Mean|55.1|55.1|Standard Deviation|4.6|4.6|||
3805886|NCT01792635|3632465|B2|||Age||Years|Mean|49.3|49.3|Standard Deviation|9.2|9.2|||
3805887|NCT01792635|3632466|B1|||Age||Years|Mean|50.7|50.7|Standard Deviation|9.5|9.5|||
3805888|NCT01792518|3632494|B3||Male|Gender||Participants|Count of Participants|229|229.0||||||
3805889|NCT01792518|3632495|B2||Male|Gender||Participants|Count of Participants|116|116.0||||||
3805890|NCT01792518|3632496|B1||Male|Gender||Participants|Count of Participants|113|113.0||||||
3805891|NCT01792518|3632494|B3||Female|Gender||Participants|Count of Participants|131|131.0||||||
3805892|NCT01792518|3632495|B2||Female|Gender||Participants|Count of Participants|66|66.0||||||
3805893|NCT01792518|3632496|B1||Female|Gender||Participants|Count of Participants|65|65.0||||||
3805894|NCT01792518|3632494|B3|||Age||Years|Mean|60.6|60.6|Standard Deviation|9.6|9.6|||
3805895|NCT01792518|3632495|B2|||Age||Years|Mean|61.0|61.0|Standard Deviation|10.0|10.0|||
3805896|NCT01792518|3632496|B1|||Age||Years|Mean|60.1|60.1|Standard Deviation|9.3|9.3|||
3805897|NCT01792284|3632507|B1|Puerto Rico||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3805898|NCT01792284|3632507|B1|United States||Region of Enrollment||Participants|Count of Participants|199|199.0||||||
3805899|NCT01792284|3632507|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805900|NCT01792284|3632507|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3805901|NCT01792284|3632507|B1||White|Race (NIH/OMB)||Participants|Count of Participants|203|203.0||||||
3805902|NCT01792284|3632507|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3805903|NCT01792284|3632507|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805904|NCT01792284|3632507|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3805905|NCT01792284|3632507|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3805906|NCT01792284|3632507|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3805907|NCT01792284|3632507|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|186|186.0||||||
3805908|NCT01792284|3632507|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3805909|NCT01792284|3632507|B1||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3805910|NCT01792284|3632507|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3805911|NCT01792284|3632507|B1|||Age||years|Mean|43.08|43.08|Standard Deviation|13.59|13.59|||
3805912|NCT01792024|3632547|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3805913|NCT01792024|3632547|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3805914|NCT01792024|3632547|B1|||Age||years|Median|62|62.0|Full Range|||47.0|81.0|
3805915|NCT01791972|3632555|B3|||Body Mass Index||kg/m^2|Mean|26.7|26.7|Standard Deviation|4.47|4.47|||
3805916|NCT01791972|3632556|B2|||Body Mass Index||kg/m^2|Mean|25.3|25.3|Standard Deviation|4.58|4.58|||
3805917|NCT01791972|3632557|B1|||Body Mass Index||kg/m^2|Mean|28.1|28.1|Standard Deviation|4.00|4.0|||
3805918|NCT01791972|3632555|B3|||Height||cm|Mean|170.6|170.6|Standard Deviation|11.63|11.63|||
3805919|NCT01791972|3632556|B2|||Height||cm|Mean|169.8|169.8|Standard Deviation|11.46|11.46|||
3805920|NCT01791972|3632557|B1|||Height||cm|Mean|171.4|171.4|Standard Deviation|12.06|12.06|||
3805921|NCT01791972|3632555|B3|||Weight||kg|Mean|78.4|78.4|Standard Deviation|18.75|18.75|||
3805922|NCT01791972|3632556|B2|||Weight||kg|Mean|74.2|74.2|Standard Deviation|21.04|21.04|||
3805923|NCT01791972|3632557|B1|||Weight||kg|Mean|82.7|82.7|Standard Deviation|15.54|15.54|||
3805924|NCT01791972|3632555|B3|Non-Hispanic and non-Latino||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
3805925|NCT01791972|3632556|B2|Non-Hispanic and non-Latino||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3805926|NCT01791972|3632557|B1|Non-Hispanic and non-Latino||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3805927|NCT01791972|3632555|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3805928|NCT01791972|3632556|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3805929|NCT01791972|3632557|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3805930|NCT01791972|3632555|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3805931|NCT01791972|3632556|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3805932|NCT01791972|3632557|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3805933|NCT01791972|3632555|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3805934|NCT01791972|3632556|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3805935|NCT01791972|3632557|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3805936|NCT01791972|3632555|B3|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3805937|NCT01791972|3632556|B2|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3805938|NCT01791972|3632557|B1|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3805939|NCT01791972|3632555|B3|White||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3805940|NCT01791972|3632556|B2|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3805941|NCT01791972|3632557|B1|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3805942|NCT01791972|3632555|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3805943|NCT01791972|3632556|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3805944|NCT01791972|3632557|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3805945|NCT01791972|3632555|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3805946|NCT01791972|3632556|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3805947|NCT01791972|3632557|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3805948|NCT01791972|3632555|B3|>=18 years||Age, Customized||participants|Number|36|36.0||||||
3805949|NCT01791972|3632556|B2|>=18 years||Age, Customized||participants|Number|18|18.0||||||
3805950|NCT01791972|3632557|B1|>=18 years||Age, Customized||participants|Number|18|18.0||||||
3805951|NCT01791972|3632555|B3|<18 years||Age, Customized||participants|Number|2|2.0||||||
3805952|NCT01791972|3632556|B2|<18 years||Age, Customized||participants|Number|1|1.0||||||
3805953|NCT01791972|3632557|B1|<18 years||Age, Customized||participants|Number|1|1.0||||||
3805954|NCT01791972|3632555|B3|||Age||years|Mean|31.8|31.8|Standard Deviation|7.93|7.93|||
3805955|NCT01791972|3632556|B2|||Age||years|Mean|31.9|31.9|Standard Deviation|8.87|8.87|||
3805956|NCT01791972|3632557|B1|||Age||years|Mean|31.7|31.7|Standard Deviation|7.11|7.11|||
3805957|NCT01791894|3632568|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3805958|NCT01791894|3632568|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3805959|NCT01791894|3632568|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3805960|NCT01791894|3632568|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3805961|NCT01791894|3632568|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3805962|NCT01791894|3632568|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3805963|NCT01791803|3632575|B5|||Lost to Follow up (Considered non-quitters)||Participants|Count of Participants|56|56.0||||||
3805964|NCT01791803|3632576|B4|||Lost to Follow up (Considered non-quitters)||Participants|Count of Participants|17|17.0||||||
3805965|NCT01791803|3632577|B3|||Lost to Follow up (Considered non-quitters)||Participants|Count of Participants|13|13.0||||||
3805966|NCT01791803|3632578|B2|||Lost to Follow up (Considered non-quitters)||Participants|Count of Participants|12|12.0||||||
3805967|NCT01791803|3632579|B1|||Lost to Follow up (Considered non-quitters)||Participants|Count of Participants|14|14.0||||||
3805968|NCT01791803|3632575|B5|||Admitted with Cardiac Diagnosis||Participants|Count of Participants|100|100.0||||||
3805969|NCT01791803|3632576|B4|||Admitted with Cardiac Diagnosis||Participants|Count of Participants|27|27.0||||||
3805970|NCT01791803|3632577|B3|||Admitted with Cardiac Diagnosis||Participants|Count of Participants|22|22.0||||||
3805971|NCT01791803|3632578|B2|||Admitted with Cardiac Diagnosis||Participants|Count of Participants|25|25.0||||||
3805972|NCT01791803|3632579|B1|||Admitted with Cardiac Diagnosis||Participants|Count of Participants|26|26.0||||||
3805973|NCT01791803|3632575|B5|||Living with a smoker||Participants|Count of Participants|61|61.0||||||
3805974|NCT01791803|3632576|B4|||Living with a smoker||Participants|Count of Participants|14|14.0||||||
3805975|NCT01791803|3632577|B3|||Living with a smoker||Participants|Count of Participants|13|13.0||||||
3805976|NCT01791803|3632578|B2|||Living with a smoker||Participants|Count of Participants|16|16.0||||||
3805977|NCT01791803|3632579|B1|||Living with a smoker||Participants|Count of Participants|18|18.0||||||
3805978|NCT01791803|3632575|B5|||Total years of smoking||years|Mean|34.55|34.55|Standard Deviation|12.4|12.4|||
3805979|NCT01791803|3632576|B4|||Total years of smoking||years|Mean|33.2|33.2|Standard Deviation|10.8|10.8|||
3805980|NCT01791803|3632577|B3|||Total years of smoking||years|Mean|34.3|34.3|Standard Deviation|11.7|11.7|||
3805981|NCT01791803|3632578|B2|||Total years of smoking||years|Mean|34.2|34.2|Standard Deviation|14.4|14.4|||
3805982|NCT01791803|3632579|B1|||Total years of smoking||years|Mean|36.5|36.5|Standard Deviation|12.7|12.7|||
3805983|NCT01791803|3632575|B5|||Number of cigarettes smoked||Cigarettes smoked /day|Mean|19.12|19.12|Standard Deviation|11.12|11.12|||
3805984|NCT01791803|3632576|B4|||Number of cigarettes smoked||Cigarettes smoked /day|Mean|15|15.0|Standard Deviation|10|10.0|||
3805985|NCT01791803|3632577|B3|||Number of cigarettes smoked||Cigarettes smoked /day|Mean|20.5|20.5|Standard Deviation|9.3|9.3|||
3805986|NCT01791803|3632578|B2|||Number of cigarettes smoked||Cigarettes smoked /day|Mean|21.2|21.2|Standard Deviation|12.6|12.6|||
3805987|NCT01791803|3632579|B1|||Number of cigarettes smoked||Cigarettes smoked /day|Mean|19.8|19.8|Standard Deviation|12.6|12.6|||
3805988|NCT01791803|3632575|B5|||Years of education||years|Mean|13|13.0|Standard Deviation|1.9|1.9|||
3805989|NCT01791803|3632576|B4|||Years of education||years|Mean|13.2|13.2|Standard Deviation|1.9|1.9|||
3805990|NCT01791803|3632577|B3|||Years of education||years|Mean|13.2|13.2|Standard Deviation|1.8|1.8|||
3805991|NCT01791803|3632578|B2|||Years of education||years|Mean|12.6|12.6|Standard Deviation|2|2.0|||
3805992|NCT01791803|3632579|B1|||Years of education||years|Mean|13|13.0|Standard Deviation|2|2.0|||
3805993|NCT01791803|3632575|B5|United States||Region of Enrollment||participants|Number|164|164.0||||||
3805994|NCT01791803|3632576|B4|United States||Region of Enrollment||participants|Number|42|42.0||||||
3805995|NCT01791803|3632577|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3805996|NCT01791803|3632578|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
3805997|NCT01791803|3632579|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
3805998|NCT01791803|3632575|B5||Unknown or Not Reported|Race (NIH/OMB)|White Race ( n, %)|Participants|Count of Participants|27|27.0||||||
3805999|NCT01791803|3632576|B4||Unknown or Not Reported|Race (NIH/OMB)|White Race ( n, %)|Participants|Count of Participants|6|6.0||||||
3806000|NCT01791803|3632577|B3||Unknown or Not Reported|Race (NIH/OMB)|White Race ( n, %)|Participants|Count of Participants|9|9.0||||||
3806001|NCT01791803|3632578|B2||Unknown or Not Reported|Race (NIH/OMB)|White Race ( n, %)|Participants|Count of Participants|9|9.0||||||
3806002|NCT01791803|3632579|B1||Unknown or Not Reported|Race (NIH/OMB)|White Race ( n, %)|Participants|Count of Participants|3|3.0||||||
3806003|NCT01791803|3632575|B5||More than one race|Race (NIH/OMB)|White Race ( n, %)|Participants|Count of Participants|0|0.0||||||
3806004|NCT01791803|3632576|B4||More than one race|Race (NIH/OMB)|White Race ( n, %)|Participants|Count of Participants|0|0.0||||||
3806005|NCT01791803|3632577|B3||More than one race|Race (NIH/OMB)|White Race ( n, %)|Participants|Count of Participants|0|0.0||||||
3806006|NCT01791803|3632578|B2||More than one race|Race (NIH/OMB)|White Race ( n, %)|Participants|Count of Participants|0|0.0||||||
3806007|NCT01791803|3632579|B1||More than one race|Race (NIH/OMB)|White Race ( n, %)|Participants|Count of Participants|0|0.0||||||
3806008|NCT01791803|3632575|B5||White|Race (NIH/OMB)|White Race ( n, %)|Participants|Count of Participants|137|137.0||||||
3806009|NCT01791803|3632576|B4||White|Race (NIH/OMB)|White Race ( n, %)|Participants|Count of Participants|36|36.0||||||
3806010|NCT01791803|3632577|B3||White|Race (NIH/OMB)|White Race ( n, %)|Participants|Count of Participants|31|31.0||||||
3806011|NCT01791803|3632578|B2||White|Race (NIH/OMB)|White Race ( n, %)|Participants|Count of Participants|32|32.0||||||
3806012|NCT01791803|3632579|B1||White|Race (NIH/OMB)|White Race ( n, %)|Participants|Count of Participants|38|38.0||||||
3806013|NCT01791803|3632575|B5||Black or African American|Race (NIH/OMB)|White Race ( n, %)|Participants|Count of Participants|0|0.0||||||
3806014|NCT01791803|3632576|B4||Black or African American|Race (NIH/OMB)|White Race ( n, %)|Participants|Count of Participants|0|0.0||||||
3806015|NCT01791803|3632577|B3||Black or African American|Race (NIH/OMB)|White Race ( n, %)|Participants|Count of Participants|0|0.0||||||
3806016|NCT01791803|3632578|B2||Black or African American|Race (NIH/OMB)|White Race ( n, %)|Participants|Count of Participants|0|0.0||||||
3806017|NCT01791803|3632579|B1||Black or African American|Race (NIH/OMB)|White Race ( n, %)|Participants|Count of Participants|0|0.0||||||
3806018|NCT01791803|3632575|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|White Race ( n, %)|Participants|Count of Participants|0|0.0||||||
3806019|NCT01791803|3632576|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|White Race ( n, %)|Participants|Count of Participants|0|0.0||||||
3806020|NCT01791803|3632577|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|White Race ( n, %)|Participants|Count of Participants|0|0.0||||||
3806021|NCT01791803|3632578|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|White Race ( n, %)|Participants|Count of Participants|0|0.0||||||
3806022|NCT01791803|3632579|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|White Race ( n, %)|Participants|Count of Participants|0|0.0||||||
3806023|NCT01791803|3632575|B5||Asian|Race (NIH/OMB)|White Race ( n, %)|Participants|Count of Participants|0|0.0||||||
3806024|NCT01791803|3632576|B4||Asian|Race (NIH/OMB)|White Race ( n, %)|Participants|Count of Participants|0|0.0||||||
3806025|NCT01791803|3632577|B3||Asian|Race (NIH/OMB)|White Race ( n, %)|Participants|Count of Participants|0|0.0||||||
3806026|NCT01791803|3632578|B2||Asian|Race (NIH/OMB)|White Race ( n, %)|Participants|Count of Participants|0|0.0||||||
3806027|NCT01791803|3632579|B1||Asian|Race (NIH/OMB)|White Race ( n, %)|Participants|Count of Participants|0|0.0||||||
3806028|NCT01791803|3632575|B5||American Indian or Alaska Native|Race (NIH/OMB)|White Race ( n, %)|Participants|Count of Participants|0|0.0||||||
3806029|NCT01791803|3632576|B4||American Indian or Alaska Native|Race (NIH/OMB)|White Race ( n, %)|Participants|Count of Participants|0|0.0||||||
3806030|NCT01791803|3632577|B3||American Indian or Alaska Native|Race (NIH/OMB)|White Race ( n, %)|Participants|Count of Participants|0|0.0||||||
3806031|NCT01791803|3632578|B2||American Indian or Alaska Native|Race (NIH/OMB)|White Race ( n, %)|Participants|Count of Participants|0|0.0||||||
3806032|NCT01791803|3632579|B1||American Indian or Alaska Native|Race (NIH/OMB)|White Race ( n, %)|Participants|Count of Participants|0|0.0||||||
3806033|NCT01791803|3632575|B5||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3806034|NCT01791803|3632576|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3806035|NCT01791803|3632577|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3806036|NCT01791803|3632578|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3806037|NCT01791803|3632579|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3806038|NCT01791803|3632575|B5||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3806039|NCT01791803|3632576|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3806040|NCT01791803|3632577|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3806041|NCT01791803|3632578|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3806042|NCT01791803|3632579|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3806043|NCT01791803|3632575|B5|||Age||years|Mean|55.17|55.17|Standard Deviation|1.4|1.4|||
3806044|NCT01791803|3632576|B4|||Age||years|Mean|56.0|56.0|Standard Deviation|10.7|10.7|||
3806045|NCT01791803|3632577|B3|||Age||years|Mean|54.4|54.4|Standard Deviation|8.9|8.9|||
3806046|NCT01791803|3632578|B2|||Age||years|Mean|55.3|55.3|Standard Deviation|12.2|12.2|||
3806047|NCT01791803|3632579|B1|||Age||years|Mean|55.0|55.0|Standard Deviation|10.6|10.6|||
3806048|NCT01791803|3632575|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3806049|NCT01791803|3632576|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3806050|NCT01791803|3632577|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3806051|NCT01791803|3632578|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3806052|NCT01791803|3632579|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3806053|NCT01791803|3632575|B5||Between 18 and 65 years|Age||Participants|Count of Participants|164|164.0||||||
3806054|NCT01791803|3632576|B4||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3806055|NCT01791803|3632577|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3806056|NCT01791803|3632578|B2||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3806057|NCT01791803|3632579|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3806058|NCT01791803|3632575|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3806059|NCT01791803|3632576|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3806060|NCT01791803|3632577|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3806061|NCT01791803|3632578|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3806062|NCT01791803|3632579|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3806063|NCT01791725|3632597|B4|||IQ Score|IQ was measured by the Kaufman Brief Intelligence Test (KBIT)|units on a scale|Mean|54.3|54.3|Standard Deviation|13.75|13.75|||
3806064|NCT01791725|3632598|B3|||IQ Score|IQ was measured by the Kaufman Brief Intelligence Test (KBIT)|units on a scale|Mean|55.8|55.8|Standard Deviation|6.65|6.65|||
3806065|NCT01791725|3632599|B2|||IQ Score|IQ was measured by the Kaufman Brief Intelligence Test (KBIT)|units on a scale|Mean|63.3|63.3|Standard Deviation|19.62|19.62|||
3806066|NCT01791725|3632600|B1|||IQ Score|IQ was measured by the Kaufman Brief Intelligence Test (KBIT)|units on a scale|Mean|50.6|50.6|Standard Deviation|13.81|13.81|||
3806067|NCT01791725|3632597|B4|United States||Region of Enrollment||participants|Number|23|23.0||||||
3806068|NCT01791725|3632598|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3806069|NCT01791725|3632599|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3806070|NCT01791725|3632600|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3806071|NCT01791725|3632597|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806072|NCT01791725|3632598|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806073|NCT01791725|3632599|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806074|NCT01791725|3632600|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806075|NCT01791725|3632597|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806076|NCT01791725|3632598|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806077|NCT01791725|3632599|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806078|NCT01791725|3632600|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806079|NCT01791725|3632597|B4||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3806080|NCT01791725|3632598|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3806081|NCT01791725|3632599|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3806082|NCT01791725|3632600|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3806083|NCT01791725|3632597|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3806084|NCT01791725|3632598|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806085|NCT01791725|3632599|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3806202|NCT01791413|3632698|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3806086|NCT01791725|3632600|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3806087|NCT01791725|3632597|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806088|NCT01791725|3632598|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806089|NCT01791725|3632599|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806090|NCT01791725|3632600|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806091|NCT01791725|3632597|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3806092|NCT01791725|3632598|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806093|NCT01791725|3632599|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806094|NCT01791725|3632600|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3806095|NCT01791725|3632597|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806096|NCT01791725|3632598|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806097|NCT01791725|3632599|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806098|NCT01791725|3632600|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806099|NCT01791725|3632597|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806100|NCT01791725|3632598|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806101|NCT01791725|3632599|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806102|NCT01791725|3632600|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806103|NCT01791725|3632597|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3806104|NCT01791725|3632598|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3806105|NCT01791725|3632599|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3806106|NCT01791725|3632600|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3806107|NCT01791725|3632597|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3806108|NCT01791725|3632598|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3806109|NCT01791725|3632599|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806110|NCT01791725|3632600|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3806111|NCT01791725|3632597|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3806112|NCT01791725|3632598|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3806113|NCT01791725|3632599|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3806114|NCT01791725|3632600|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3806115|NCT01791725|3632597|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3806116|NCT01791725|3632598|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3806117|NCT01791725|3632599|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3806118|NCT01791725|3632600|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3806119|NCT01791725|3632597|B4|||Age||years|Mean|27.6|27.6|Standard Deviation|6.49|6.49|||
3806120|NCT01791725|3632598|B3|||Age||years|Mean|30.0|30.0|Standard Deviation|5.93|5.93|||
3806121|NCT01791725|3632599|B2|||Age||years|Mean|27.8|27.8|Standard Deviation|4.03|4.03|||
3806122|NCT01791725|3632600|B1|||Age||years|Mean|26.3|26.3|Standard Deviation|7.43|7.43|||
3806123|NCT01791517|3632622|B4|United Kingdom||Region of Enrollment||Participants|Count of Participants|79|79.0||||||
3806124|NCT01791517|3632623|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3806125|NCT01791517|3632624|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3806126|NCT01791517|3632625|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3806127|NCT01791517|3632622|B4|United States||Region of Enrollment||Participants|Count of Participants|77|77.0||||||
3806128|NCT01791517|3632623|B3|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3806129|NCT01791517|3632624|B2|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3806130|NCT01791517|3632625|B1|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3806131|NCT01791517|3632622|B4|Canada||Region of Enrollment||Participants|Count of Participants|80|80.0||||||
3806132|NCT01791517|3632623|B3|Canada||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3806133|NCT01791517|3632624|B2|Canada||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3806134|NCT01791517|3632625|B1|Canada||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3806135|NCT01791517|3632622|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3806136|NCT01791517|3632623|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3806137|NCT01791517|3632624|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3806138|NCT01791517|3632625|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3806139|NCT01791517|3632622|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|140|140.0||||||
3806140|NCT01791517|3632623|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
3806141|NCT01791517|3632624|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|45|45.0||||||
3806142|NCT01791517|3632625|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|52|52.0||||||
3806143|NCT01791517|3632622|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3806144|NCT01791517|3632623|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3806145|NCT01791517|3632624|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3806146|NCT01791517|3632625|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3806147|NCT01791517|3632622|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3806148|NCT01791517|3632623|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3806149|NCT01791517|3632624|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3806150|NCT01791517|3632625|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3806151|NCT01791517|3632622|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|58|58.0||||||
3806152|NCT01791517|3632623|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3806153|NCT01791517|3632624|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3806154|NCT01791517|3632625|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3806155|NCT01791517|3632622|B4||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3806156|NCT01791517|3632623|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3806157|NCT01791517|3632624|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3806158|NCT01791517|3632625|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3806159|NCT01791517|3632622|B4||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3806160|NCT01791517|3632623|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3806161|NCT01791517|3632624|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3806162|NCT01791517|3632625|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3806163|NCT01791517|3632622|B4|||Age||years|Mean|30.17|30.17|Standard Deviation|9.879|9.879|||
3806164|NCT01791517|3632623|B3|||Age||years|Mean|29.78|29.78|Standard Deviation|9.938|9.938|||
3806165|NCT01791517|3632624|B2|||Age||years|Mean|30.38|30.38|Standard Deviation|10.091|10.091|||
3806166|NCT01791517|3632625|B1|||Age||years|Mean|30.33|30.33|Standard Deviation|9.726|9.726|||
3806167|NCT01791491|3632662|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806168|NCT01791491|3632662|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806169|NCT01791491|3632662|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3806170|NCT01791491|3632662|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3806171|NCT01791491|3632662|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806172|NCT01791491|3632662|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806173|NCT01791491|3632662|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806174|NCT01791491|3632662|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806175|NCT01791491|3632662|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3806176|NCT01791491|3632662|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3806177|NCT01791491|3632662|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3806178|NCT01791491|3632662|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3806179|NCT01791491|3632662|B1|||Age||years|Mean|15.1|15.1|Standard Deviation|1.17|1.17|||
3806180|NCT01791465|3632674|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3806181|NCT01791465|3632674|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3806182|NCT01791465|3632674|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3806183|NCT01791465|3632674|B1|||Age||years|Median|51|51.0|Inter-Quartile Range|||45.0|70.0|
3806184|NCT01791413|3632698|B3|Thailand||Region of Enrollment||participants|Number|34|34.0||||||
3806185|NCT01791413|3632699|B2|Thailand||Region of Enrollment||participants|Number|15|15.0||||||
3806186|NCT01791413|3632700|B1|Thailand||Region of Enrollment||participants|Number|19|19.0||||||
3806187|NCT01791413|3632698|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3806188|NCT01791413|3632699|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3806189|NCT01791413|3632700|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3806190|NCT01791413|3632698|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3806191|NCT01791413|3632699|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3806192|NCT01791413|3632700|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3806193|NCT01791413|3632698|B3|||Age||years|Mean|32.53|32.53|Standard Deviation|6.13|6.13|||
3806194|NCT01791413|3632699|B2|||Age||years|Mean|32.46|32.46|Standard Deviation|6.46|6.46|||
3806195|NCT01791413|3632700|B1|||Age||years|Mean|32.57|32.57|Standard Deviation|5.67|5.67|||
3806196|NCT01791413|3632698|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3806197|NCT01791413|3632699|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3806198|NCT01791413|3632700|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3806199|NCT01791413|3632698|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3806200|NCT01791413|3632699|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3806201|NCT01791413|3632700|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3806203|NCT01791413|3632699|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3806204|NCT01791413|3632700|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3806205|NCT01791244|3632708|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3806206|NCT01791244|3632709|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3806207|NCT01791244|3632710|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3806208|NCT01791244|3632708|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3806209|NCT01791244|3632709|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3806210|NCT01791244|3632710|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3806211|NCT01791244|3632708|B3|Greater than (>) 72 years||Age, Customized||Participants|Number|0|0.0||||||
3806212|NCT01791244|3632709|B2|Greater than (>) 72 years||Age, Customized||Participants|Number|0|0.0||||||
3806213|NCT01791244|3632710|B1|Greater than (>) 72 years||Age, Customized||Participants|Number|0|0.0||||||
3806214|NCT01791244|3632708|B3|Between 18 to 72 years||Age, Customized||Participants|Number|77|77.0||||||
3806215|NCT01791244|3632709|B2|Between 18 to 72 years||Age, Customized||Participants|Number|39|39.0||||||
3806216|NCT01791244|3632710|B1|Between 18 to 72 years||Age, Customized||Participants|Number|38|38.0||||||
3806217|NCT01791205|3632745|B3||Male|Gender||Participants|Count of Participants|47|47.0||||||
3806218|NCT01791205|3632746|B2||Male|Gender||Participants|Count of Participants|25|25.0||||||
3806219|NCT01791205|3632747|B1||Male|Gender||Participants|Count of Participants|22|22.0||||||
3806220|NCT01791205|3632745|B3||Female|Gender||Participants|Count of Participants|257|257.0||||||
3806221|NCT01791205|3632746|B2||Female|Gender||Participants|Count of Participants|127|127.0||||||
3806222|NCT01791205|3632747|B1||Female|Gender||Participants|Count of Participants|130|130.0||||||
3806223|NCT01791205|3632745|B3|||Age||years|Mean|58.4|58.4|Standard Deviation|11.8|11.8|||
3806224|NCT01791205|3632746|B2|||Age||years|Mean|59.4|59.4|Standard Deviation|10.9|10.9|||
3806225|NCT01791205|3632747|B1|||Age||years|Mean|57.4|57.4|Standard Deviation|12.5|12.5|||
3806226|NCT01791153|3632828|B5||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3806227|NCT01791153|3632829|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3806228|NCT01791153|3632830|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3806229|NCT01791153|3632831|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3806230|NCT01791153|3632832|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3806231|NCT01791153|3632828|B5||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
3806232|NCT01791153|3632829|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3806233|NCT01791153|3632830|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3806234|NCT01791153|3632831|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3806235|NCT01791153|3632832|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3806236|NCT01791153|3632828|B5|||Age||years|Mean|69.1|69.1|Standard Deviation|8.21|8.21|||
3806237|NCT01791153|3632829|B4|||Age||years|Mean|67.8|67.8|Standard Deviation|7.70|7.7|||
3806238|NCT01791153|3632830|B3|||Age||years|Mean|69.3|69.3|Standard Deviation|8.14|8.14|||
3806239|NCT01791153|3632831|B2|||Age||years|Mean|69.4|69.4|Standard Deviation|8.29|8.29|||
3806240|NCT01791153|3632832|B1|||Age||years|Mean|69.5|69.5|Standard Deviation|8.50|8.5|||
3806241|NCT01790828|3632891|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3806242|NCT01790828|3632891|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3806243|NCT01790828|3632891|B1|||Age||years|Mean|36.4|36.4|Standard Deviation|14.50|14.5|||
3806244|NCT01790750|3632914|B1|||Body Weight|Mean body weight|kg|Mean|2.470|2.47|Standard Deviation|1.157|1.157|||
3806245|NCT01790750|3632914|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3806246|NCT01790750|3632914|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3806247|NCT01790750|3632914|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3806248|NCT01790750|3632914|B1|||Age||weeks|Mean|34.8|34.8|Standard Deviation|4.98|4.98|||
3806249|NCT01790750|3632914|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3806250|NCT01790750|3632914|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3806251|NCT01790750|3632914|B1||<=18 years|Age||Participants|Count of Participants|50|50.0||||||
3806252|NCT01790685|3632919|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3806253|NCT01790685|3632920|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3806254|NCT01790685|3632921|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3806255|NCT01790685|3632919|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3806256|NCT01790685|3632920|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3806257|NCT01790685|3632921|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3806258|NCT01790685|3632919|B3|||Age||years|Median|73|73.0|Full Range|||54.0|90.0|
3806259|NCT01790685|3632920|B2|||Age||years|Median|72|72.0|Full Range|||54.0|89.0|
3806260|NCT01790685|3632921|B1|||Age||years|Median|74|74.0|Full Range|||54.0|90.0|
3806261|NCT01790659|3632928|B3|||Length of time between initial presence current lesions and treatment|Length of time in days before treatment that lesions were first noticed|Days|Mean|60.9|60.9|Standard Deviation|55.6|55.6|||
3806262|NCT01790659|3632929|B2|||Length of time between initial presence current lesions and treatment|Length of time in days before treatment that lesions were first noticed|Days|Mean|62.1|62.1|Standard Deviation|57.7|57.7|||
3806320|NCT01790633|3632949|B1|||No health insurance plan||participants|Number|162|162.0||||||
3806263|NCT01790659|3632930|B1|||Length of time between initial presence current lesions and treatment|Length of time in days before treatment that lesions were first noticed|Days|Mean|59.7|59.7|Standard Deviation|53.6|53.6|||
3806264|NCT01790659|3632928|B3|||Lesion sizes|Lesion size was calculated in mm|mm|Mean|120|120.0|Standard Deviation|149|149.0|||
3806265|NCT01790659|3632929|B2|||Lesion sizes|Lesion size was calculated in mm|mm|Mean|121|121.0|Standard Deviation|152|152.0|||
3806266|NCT01790659|3632930|B1|||Lesion sizes|Lesion size was calculated in mm|mm|Mean|120|120.0|Standard Deviation|146|146.0|||
3806267|NCT01790659|3632928|B3|||Number of baseline lesions||Lesions|Mean|2.20|2.2|Standard Deviation|1.67|1.67|||
3806268|NCT01790659|3632929|B2|||Number of baseline lesions||Lesions|Mean|2.13|2.13|Standard Deviation|1.63|1.63|||
3806269|NCT01790659|3632930|B1|||Number of baseline lesions||Lesions|Mean|2.27|2.27|Standard Deviation|1.71|1.71|||
3806270|NCT01790659|3632928|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3806271|NCT01790659|3632929|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3806272|NCT01790659|3632930|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3806273|NCT01790659|3632928|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|390|390.0||||||
3806274|NCT01790659|3632929|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|192|192.0||||||
3806275|NCT01790659|3632930|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|198|198.0||||||
3806276|NCT01790659|3632928|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806277|NCT01790659|3632929|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806278|NCT01790659|3632930|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806279|NCT01790659|3632928|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806280|NCT01790659|3632929|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806281|NCT01790659|3632930|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806282|NCT01790659|3632928|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806283|NCT01790659|3632929|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806284|NCT01790659|3632930|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806285|NCT01790659|3632928|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806286|NCT01790659|3632929|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806287|NCT01790659|3632930|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806288|NCT01790659|3632928|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806289|NCT01790659|3632929|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806290|NCT01790659|3632930|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806291|NCT01790659|3632928|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3806292|NCT01790659|3632929|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3806293|NCT01790659|3632930|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806294|NCT01790659|3632928|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3806295|NCT01790659|3632929|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3806296|NCT01790659|3632930|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806297|NCT01790659|3632928|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|397|397.0||||||
3806298|NCT01790659|3632929|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|196|196.0||||||
3806299|NCT01790659|3632930|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|201|201.0||||||
3806300|NCT01790659|3632928|B3||Male|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
3806301|NCT01790659|3632929|B2||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3806302|NCT01790659|3632930|B1||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3806303|NCT01790659|3632928|B3||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3806304|NCT01790659|3632929|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3806305|NCT01790659|3632930|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3806306|NCT01790659|3632928|B3|||Age||years|Mean|23.2|23.2|Standard Deviation|16.0|16.0|||
3806307|NCT01790659|3632929|B2|||Age||years|Mean|23.6|23.6|Standard Deviation|15.1|15.1|||
3806308|NCT01790659|3632930|B1|||Age||years|Mean|22.9|22.9|Standard Deviation|16.8|16.8|||
3806309|NCT01790659|3632928|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3806310|NCT01790659|3632929|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3806311|NCT01790659|3632930|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3806312|NCT01790659|3632928|B3||Between 18 and 65 years|Age||Participants|Count of Participants|215|215.0||||||
3806313|NCT01790659|3632929|B2||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
3806314|NCT01790659|3632930|B1||Between 18 and 65 years|Age||Participants|Count of Participants|105|105.0||||||
3806315|NCT01790659|3632928|B3||<=18 years|Age||Participants|Count of Participants|184|184.0||||||
3806316|NCT01790659|3632929|B2||<=18 years|Age||Participants|Count of Participants|88|88.0||||||
3806317|NCT01790659|3632930|B1||<=18 years|Age||Participants|Count of Participants|96|96.0||||||
3806318|NCT01790633|3632947|B3|||No health insurance plan||participants|Number|324|324.0||||||
3806319|NCT01790633|3632948|B2|||No health insurance plan||participants|Number|162|162.0||||||
3806321|NCT01790633|3632947|B3|High (>8.0%)||HBV prevalence of birth country||participants|Number|257|257.0||||||
3806322|NCT01790633|3632948|B2|High (>8.0%)||HBV prevalence of birth country||participants|Number|124|124.0||||||
3806323|NCT01790633|3632949|B1|High (>8.0%)||HBV prevalence of birth country||participants|Number|133|133.0||||||
3806324|NCT01790633|3632947|B3|Intermediate (2.0%-8.0%)||HBV prevalence of birth country||participants|Number|64|64.0||||||
3806325|NCT01790633|3632948|B2|Intermediate (2.0%-8.0%)||HBV prevalence of birth country||participants|Number|37|37.0||||||
3806326|NCT01790633|3632949|B1|Intermediate (2.0%-8.0%)||HBV prevalence of birth country||participants|Number|27|27.0||||||
3806327|NCT01790633|3632947|B3|Low (<2.0%)||HBV prevalence of birth country||participants|Number|3|3.0||||||
3806328|NCT01790633|3632948|B2|Low (<2.0%)||HBV prevalence of birth country||participants|Number|1|1.0||||||
3806329|NCT01790633|3632949|B1|Low (<2.0%)||HBV prevalence of birth country||participants|Number|2|2.0||||||
3806330|NCT01790633|3632947|B3||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3806331|NCT01790633|3632948|B2||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3806332|NCT01790633|3632949|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3806333|NCT01790633|3632947|B3||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3806334|NCT01790633|3632948|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3806335|NCT01790633|3632949|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3806336|NCT01790633|3632947|B3|||Age||years|Mean|37.6|37.6|Standard Deviation|12.1|12.1|||
3806337|NCT01790633|3632948|B2|||Age||years|Mean|37.0|37.0|Standard Deviation|12.2|12.2|||
3806338|NCT01790633|3632949|B1|||Age||years|Mean|39.0|39.0|Standard Deviation|12.2|12.2|||
3806339|NCT01790594|3632961|B3|United States||Region of Enrollment||participants|Number|43|43.0||||||
3806340|NCT01790594|3632962|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
3806341|NCT01790594|3632963|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3806342|NCT01790594|3632961|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3806343|NCT01790594|3632962|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3806344|NCT01790594|3632963|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3806345|NCT01790594|3632961|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806346|NCT01790594|3632962|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806347|NCT01790594|3632963|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806348|NCT01790594|3632961|B3||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3806349|NCT01790594|3632962|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3806350|NCT01790594|3632963|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3806351|NCT01790594|3632961|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3806352|NCT01790594|3632962|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3806353|NCT01790594|3632963|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3806354|NCT01790594|3632961|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3806355|NCT01790594|3632962|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3806356|NCT01790594|3632963|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806357|NCT01790594|3632961|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806358|NCT01790594|3632962|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806359|NCT01790594|3632963|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806360|NCT01790594|3632961|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806361|NCT01790594|3632962|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806362|NCT01790594|3632963|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806363|NCT01790594|3632961|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3806364|NCT01790594|3632962|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3806365|NCT01790594|3632963|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3806366|NCT01790594|3632961|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3806367|NCT01790594|3632962|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3806368|NCT01790594|3632963|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3806369|NCT01790594|3632961|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3806370|NCT01790594|3632962|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3806371|NCT01790594|3632963|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3806372|NCT01790594|3632961|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3806373|NCT01790594|3632962|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3806374|NCT01790594|3632963|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3806375|NCT01790594|3632961|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3806376|NCT01790594|3632962|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3806377|NCT01790594|3632963|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3806378|NCT01790594|3632961|B3|||Age||years|Mean|39.3|39.3|Standard Deviation|6.97|6.97|||
3806379|NCT01790594|3632962|B2|||Age||years|Mean|38.8|38.8|Standard Deviation|6.98|6.98|||
3806380|NCT01790594|3632963|B1|||Age||years|Mean|39.7|39.7|Standard Deviation|7.10|7.1|||
3806381|NCT01790594|3632961|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3806382|NCT01790594|3632962|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3806383|NCT01790594|3632963|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3806384|NCT01790594|3632961|B3||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
3806385|NCT01790594|3632962|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3806386|NCT01790594|3632963|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3806387|NCT01790594|3632961|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3806388|NCT01790594|3632962|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3806389|NCT01790594|3632963|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3806390|NCT01790581|3633031|B3|||Star Excursion Balance Test- Posteriolateral Reach|To conduct the reach trials, participants placed the test limb in a grid center and kept their hands on their hips. Participants then reached as far as possible in the test direction with the non-test limb. Reach distance was defined as the farthest point that an individual could touch without accepting weight and maintaining balance through the return to a bilateral stance. Reach distance was normalized to the participant’s leg length (distance from the anterior superior iliac spine to the ipsilateral medial malleolus). This is a reliable measure of dynamic balance (ICC2,1=0.85-0.96).|% of leg length|Mean|74.0|74.0|Standard Deviation|11.7|11.7|||
3806391|NCT01790581|3633032|B2|||Star Excursion Balance Test- Posteriolateral Reach|To conduct the reach trials, participants placed the test limb in a grid center and kept their hands on their hips. Participants then reached as far as possible in the test direction with the non-test limb. Reach distance was defined as the farthest point that an individual could touch without accepting weight and maintaining balance through the return to a bilateral stance. Reach distance was normalized to the participant’s leg length (distance from the anterior superior iliac spine to the ipsilateral medial malleolus). This is a reliable measure of dynamic balance (ICC2,1=0.85-0.96).|% of leg length|Mean|72.3|72.3|Standard Deviation|11.3|11.3|||
3806392|NCT01790581|3633033|B1|||Star Excursion Balance Test- Posteriolateral Reach|To conduct the reach trials, participants placed the test limb in a grid center and kept their hands on their hips. Participants then reached as far as possible in the test direction with the non-test limb. Reach distance was defined as the farthest point that an individual could touch without accepting weight and maintaining balance through the return to a bilateral stance. Reach distance was normalized to the participant’s leg length (distance from the anterior superior iliac spine to the ipsilateral medial malleolus). This is a reliable measure of dynamic balance (ICC2,1=0.85-0.96).|% of leg length|Mean|75.7|75.7|Standard Deviation|12.4|12.4|||
3806393|NCT01790581|3633031|B3|||Star Excursion Balance Test- Posteriomedial Reach|To conduct the reach trials, participants placed the test limb in a grid center and kept their hands on their hips. Participants then reached as far as possible in the test direction with the non-test limb. Reach distance was defined as the farthest point that an individual could touch without accepting weight and maintaining balance through the return to a bilateral stance. Reach distance was normalized to the participant’s leg length (distance from the anterior superior iliac spine to the ipsilateral medial malleolus). This is a reliable measure of dynamic balance (ICC2,1=0.85-0.96).|% of leg length|Mean|79.0|79.0|Standard Deviation|8.0|8.0|||
3806394|NCT01790581|3633032|B2|||Star Excursion Balance Test- Posteriomedial Reach|To conduct the reach trials, participants placed the test limb in a grid center and kept their hands on their hips. Participants then reached as far as possible in the test direction with the non-test limb. Reach distance was defined as the farthest point that an individual could touch without accepting weight and maintaining balance through the return to a bilateral stance. Reach distance was normalized to the participant’s leg length (distance from the anterior superior iliac spine to the ipsilateral medial malleolus). This is a reliable measure of dynamic balance (ICC2,1=0.85-0.96).|% of leg length|Mean|78.5|78.5|Standard Deviation|6.7|6.7|||
3806395|NCT01790581|3633033|B1|||Star Excursion Balance Test- Posteriomedial Reach|To conduct the reach trials, participants placed the test limb in a grid center and kept their hands on their hips. Participants then reached as far as possible in the test direction with the non-test limb. Reach distance was defined as the farthest point that an individual could touch without accepting weight and maintaining balance through the return to a bilateral stance. Reach distance was normalized to the participant’s leg length (distance from the anterior superior iliac spine to the ipsilateral medial malleolus). This is a reliable measure of dynamic balance (ICC2,1=0.85-0.96).|% of leg length|Mean|79.5|79.5|Standard Deviation|9.3|9.3|||
3806396|NCT01790581|3633031|B3|||Star Excursion Balance Test- Anterior Reach|To conduct the reach trials, participants placed the test limb in a grid center and kept their hands on their hips. Participants then reached as far as possible in the test direction with the non-test limb. Reach distance was defined as the farthest point that an individual could touch without accepting weight and maintaining balance through the return to a bilateral stance. Reach distance was normalized to the participant’s leg length (distance from the anterior superior iliac spine to the ipsilateral medial malleolus). This is a reliable measure of dynamic balance (ICC2,1=0.85-0.96).|% of leg length|Mean|67.5|67.5|Standard Deviation|7.6|7.6|||
3806397|NCT01790581|3633032|B2|||Star Excursion Balance Test- Anterior Reach|To conduct the reach trials, participants placed the test limb in a grid center and kept their hands on their hips. Participants then reached as far as possible in the test direction with the non-test limb. Reach distance was defined as the farthest point that an individual could touch without accepting weight and maintaining balance through the return to a bilateral stance. Reach distance was normalized to the participant’s leg length (distance from the anterior superior iliac spine to the ipsilateral medial malleolus). This is a reliable measure of dynamic balance (ICC2,1=0.85-0.96).|% of leg length|Mean|66.2|66.2|Standard Deviation|6.9|6.9|||
3806438|NCT01790516|3633051|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806439|NCT01790516|3633049|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806398|NCT01790581|3633033|B1|||Star Excursion Balance Test- Anterior Reach|To conduct the reach trials, participants placed the test limb in a grid center and kept their hands on their hips. Participants then reached as far as possible in the test direction with the non-test limb. Reach distance was defined as the farthest point that an individual could touch without accepting weight and maintaining balance through the return to a bilateral stance. Reach distance was normalized to the participant’s leg length (distance from the anterior superior iliac spine to the ipsilateral medial malleolus). This is a reliable measure of dynamic balance (ICC2,1=0.85-0.96).|% of leg length|Mean|68.7|68.7|Standard Deviation|8.3|8.3|||
3806399|NCT01790581|3633031|B3|||Foot and Ankle Ability Measure-Sport|The Foot and Ankle Ability Measure- Sports (FAAM-S) contains 8 activity related items (max score of 32). Lower percentages (patient’s score divided by max score) represent greater disability. The FAAM-S has been found to be reliable and precise (r=0.87, SEM= 4.5) in people with CAI.|% of total questionnaire points|Mean|68.9|68.9|Standard Deviation|11.4|11.4|||
3806400|NCT01790581|3633032|B2|||Foot and Ankle Ability Measure-Sport|The Foot and Ankle Ability Measure- Sports (FAAM-S) contains 8 activity related items (max score of 32). Lower percentages (patient’s score divided by max score) represent greater disability. The FAAM-S has been found to be reliable and precise (r=0.87, SEM= 4.5) in people with CAI.|% of total questionnaire points|Mean|72.2|72.2|Standard Deviation|10.4|10.4|||
3806401|NCT01790581|3633033|B1|||Foot and Ankle Ability Measure-Sport|The Foot and Ankle Ability Measure- Sports (FAAM-S) contains 8 activity related items (max score of 32). Lower percentages (patient’s score divided by max score) represent greater disability. The FAAM-S has been found to be reliable and precise (r=0.87, SEM= 4.5) in people with CAI.|% of total questionnaire points|Mean|66.2|66.2|Standard Deviation|12.0|12.0|||
3806402|NCT01790581|3633031|B3|||Foot and Ankle Ability Measure|The Foot and Ankle Ability Measure (FAAM) contains 21 activity related items (max score of 84). Lower percentages (patient’s score divided by max score) represent greater disability. The FAAM has been found to be reliable and precise (r=0.89, SEM= 2.1) in people with CAI.|% of total questionnaire points|Mean|86.8|86.8|Standard Deviation|6.9|6.9|||
3806403|NCT01790581|3633032|B2|||Foot and Ankle Ability Measure|The Foot and Ankle Ability Measure (FAAM) contains 21 activity related items (max score of 84). Lower percentages (patient’s score divided by max score) represent greater disability. The FAAM has been found to be reliable and precise (r=0.89, SEM= 2.1) in people with CAI.|% of total questionnaire points|Mean|86.5|86.5|Standard Deviation|5.6|5.6|||
3806404|NCT01790581|3633033|B1|||Foot and Ankle Ability Measure|The Foot and Ankle Ability Measure (FAAM) contains 21 activity related items (max score of 84). Lower percentages (patient’s score divided by max score) represent greater disability. The FAAM has been found to be reliable and precise (r=0.89, SEM= 2.1) in people with CAI.|% of total questionnaire points|Mean|87.1|87.1|Standard Deviation|8.1|8.1|||
3806405|NCT01790581|3633031|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
3806406|NCT01790581|3633032|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3806407|NCT01790581|3633033|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3806408|NCT01790581|3633031|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3806409|NCT01790581|3633032|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3806410|NCT01790581|3633033|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3806411|NCT01790581|3633031|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3806412|NCT01790581|3633032|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3806413|NCT01790581|3633033|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3806414|NCT01790581|3633031|B3|||Age||years|Mean|21.5|21.5|Standard Deviation|2.1|2.1|||
3806415|NCT01790581|3633032|B2|||Age||years|Mean|21.8|21.8|Standard Deviation|2.5|2.5|||
3806416|NCT01790581|3633033|B1|||Age||years|Mean|21.3|21.3|Standard Deviation|1.7|1.7|||
3806417|NCT01790568|3633042|B1|Race/Ethnicity|Not reported|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3806418|NCT01790568|3633042|B1|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3806419|NCT01790568|3633042|B1|Race/Ethnicity|White, Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3806420|NCT01790568|3633042|B1|Race/Ethnicity|White, non-hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3806421|NCT01790568|3633042|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3806422|NCT01790568|3633042|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3806423|NCT01790568|3633042|B1|||Age||years|Median|56|56.0|Full Range|||18.0|69.0|
3806424|NCT01790516|3633049|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3806425|NCT01790516|3633050|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3806426|NCT01790516|3633051|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3806427|NCT01790516|3633049|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806428|NCT01790516|3633050|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806429|NCT01790516|3633051|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806430|NCT01790516|3633049|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806431|NCT01790516|3633050|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806432|NCT01790516|3633051|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806433|NCT01790516|3633049|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3806434|NCT01790516|3633050|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3806435|NCT01790516|3633051|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3806436|NCT01790516|3633049|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806437|NCT01790516|3633050|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806440|NCT01790516|3633050|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806441|NCT01790516|3633051|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806442|NCT01790516|3633049|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806443|NCT01790516|3633050|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806444|NCT01790516|3633051|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806445|NCT01790516|3633049|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806446|NCT01790516|3633050|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806447|NCT01790516|3633051|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806448|NCT01790516|3633049|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806449|NCT01790516|3633050|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806450|NCT01790516|3633051|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806451|NCT01790516|3633049|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3806452|NCT01790516|3633050|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3806453|NCT01790516|3633051|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3806454|NCT01790516|3633049|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806455|NCT01790516|3633050|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806456|NCT01790516|3633051|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806457|NCT01790516|3633049|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3806458|NCT01790516|3633050|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3806459|NCT01790516|3633051|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3806460|NCT01790516|3633049|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3806461|NCT01790516|3633050|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3806462|NCT01790516|3633051|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3806463|NCT01790516|3633049|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3806464|NCT01790516|3633050|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3806465|NCT01790516|3633051|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3806466|NCT01790516|3633049|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3806467|NCT01790516|3633050|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3806468|NCT01790516|3633051|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3806469|NCT01790516|3633049|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3806470|NCT01790516|3633050|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3806471|NCT01790516|3633051|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3806472|NCT01790490|3633058|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
3806473|NCT01790490|3633059|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3806474|NCT01790490|3633060|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3806475|NCT01790490|3633061|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3806476|NCT01790490|3633058|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3806477|NCT01790490|3633059|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3806478|NCT01790490|3633060|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3806479|NCT01790490|3633061|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3806480|NCT01790490|3633058|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3806481|NCT01790490|3633059|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3806482|NCT01790490|3633060|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3806483|NCT01790490|3633061|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3806484|NCT01790490|3633058|B4|||Age||years|Mean|47.5|47.5|Standard Deviation|5.5|5.5|||
3806485|NCT01790490|3633059|B3|||Age||years|Mean|44.2|44.2|Standard Deviation|8.2|8.2|||
3806486|NCT01790490|3633060|B2|||Age||years|Mean|48.2|48.2|Standard Deviation|6.1|6.1|||
3806487|NCT01790490|3633061|B1|||Age||years|Mean|46.8|46.8|Standard Deviation|9|9.0|||
3806488|NCT01790490|3633058|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3806489|NCT01790490|3633059|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3806490|NCT01790490|3633060|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3806491|NCT01790490|3633061|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3806492|NCT01790490|3633058|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3806493|NCT01790490|3633059|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3806494|NCT01790490|3633060|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3806495|NCT01790490|3633061|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3806496|NCT01790490|3633058|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3806497|NCT01790490|3633059|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3806498|NCT01790490|3633060|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3806499|NCT01790490|3633061|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3806500|NCT01790438|3633074|B3|||Duration of Diabetes||years|Mean|11.05|11.05|Standard Deviation|6.65|6.65|||
3806501|NCT01790438|3633075|B2|||Duration of Diabetes||years|Mean|11.40|11.4|Standard Deviation|7.01|7.01|||
3806502|NCT01790438|3633076|B1|||Duration of Diabetes||years|Mean|10.87|10.87|Standard Deviation|6.46|6.46|||
3806503|NCT01790438|3633074|B3|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters (kg/m^2)|Mean|30.88|30.88|Standard Deviation|5.40|5.4|||
3806504|NCT01790438|3633075|B2|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters (kg/m^2)|Mean|31.04|31.04|Standard Deviation|5.03|5.03|||
3806505|NCT01790438|3633076|B1|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters (kg/m^2)|Mean|30.80|30.8|Standard Deviation|5.57|5.57|||
3806506|NCT01790438|3633074|B3|South Korea||Region of Enrollment||Participants|Count of Participants|73|73.0||||||
3806507|NCT01790438|3633075|B2|South Korea||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3806508|NCT01790438|3633076|B1|South Korea||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3806509|NCT01790438|3633074|B3|Germany||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3806510|NCT01790438|3633075|B2|Germany||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3806511|NCT01790438|3633076|B1|Germany||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3806512|NCT01790438|3633074|B3|Spain||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3806513|NCT01790438|3633075|B2|Spain||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3806514|NCT01790438|3633076|B1|Spain||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3806515|NCT01790438|3633074|B3|Poland||Region of Enrollment||Participants|Count of Participants|56|56.0||||||
3806516|NCT01790438|3633075|B2|Poland||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3806517|NCT01790438|3633076|B1|Poland||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3806518|NCT01790438|3633074|B3|Argentina||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3806519|NCT01790438|3633075|B2|Argentina||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3806520|NCT01790438|3633076|B1|Argentina||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3806521|NCT01790438|3633074|B3|Canada||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
3806522|NCT01790438|3633075|B2|Canada||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3806523|NCT01790438|3633076|B1|Canada||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3806524|NCT01790438|3633074|B3|Puerto Rico||Region of Enrollment||Participants|Count of Participants|65|65.0||||||
3806525|NCT01790438|3633075|B2|Puerto Rico||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3806526|NCT01790438|3633076|B1|Puerto Rico||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
3806527|NCT01790438|3633074|B3|Mexico||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3806528|NCT01790438|3633075|B2|Mexico||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3806529|NCT01790438|3633076|B1|Mexico||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3806530|NCT01790438|3633074|B3|Czechia||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3806531|NCT01790438|3633075|B2|Czechia||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3806532|NCT01790438|3633076|B1|Czechia||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3806533|NCT01790438|3633074|B3|Hungary||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3806534|NCT01790438|3633075|B2|Hungary||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3806535|NCT01790438|3633076|B1|Hungary||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3806536|NCT01790438|3633074|B3|United States||Region of Enrollment||Participants|Count of Participants|172|172.0||||||
3806537|NCT01790438|3633075|B2|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3806538|NCT01790438|3633076|B1|United States||Region of Enrollment||Participants|Count of Participants|112|112.0||||||
3806539|NCT01790438|3633074|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3806540|NCT01790438|3633075|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806541|NCT01790438|3633076|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3806542|NCT01790438|3633074|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3806543|NCT01790438|3633075|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3806544|NCT01790438|3633076|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806545|NCT01790438|3633074|B3||White|Race (NIH/OMB)||Participants|Count of Participants|523|523.0||||||
3806546|NCT01790438|3633075|B2||White|Race (NIH/OMB)||Participants|Count of Participants|178|178.0||||||
3806547|NCT01790438|3633076|B1||White|Race (NIH/OMB)||Participants|Count of Participants|345|345.0||||||
3806548|NCT01790438|3633074|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3806549|NCT01790438|3633075|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3806550|NCT01790438|3633076|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3806551|NCT01790438|3633074|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806552|NCT01790438|3633075|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806553|NCT01790438|3633076|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806554|NCT01790438|3633074|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3806555|NCT01790438|3633075|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3806556|NCT01790438|3633076|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3806557|NCT01790438|3633074|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3806558|NCT01790438|3633075|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806559|NCT01790438|3633076|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3806560|NCT01790438|3633074|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)|"Participants who were not located in the United States were reported in the Unknown or Not Reported category for ethnicity."|Participants|Count of Participants|120|120.0||||||
3806561|NCT01790438|3633075|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)|"Participants who were not located in the United States were reported in the Unknown or Not Reported category for ethnicity."|Participants|Count of Participants|35|35.0||||||
3806562|NCT01790438|3633076|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|"Participants who were not located in the United States were reported in the Unknown or Not Reported category for ethnicity."|Participants|Count of Participants|85|85.0||||||
3806563|NCT01790438|3633074|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)|"Participants who were not located in the United States were reported in the Unknown or Not Reported category for ethnicity."|Participants|Count of Participants|300|300.0||||||
3806564|NCT01790438|3633075|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)|"Participants who were not located in the United States were reported in the Unknown or Not Reported category for ethnicity."|Participants|Count of Participants|105|105.0||||||
3806565|NCT01790438|3633076|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|"Participants who were not located in the United States were reported in the Unknown or Not Reported category for ethnicity."|Participants|Count of Participants|195|195.0||||||
3806566|NCT01790438|3633074|B3||Hispanic or Latino|Ethnicity (NIH/OMB)|"Participants who were not located in the United States were reported in the Unknown or Not Reported category for ethnicity."|Participants|Count of Participants|221|221.0||||||
3806567|NCT01790438|3633075|B2||Hispanic or Latino|Ethnicity (NIH/OMB)|"Participants who were not located in the United States were reported in the Unknown or Not Reported category for ethnicity."|Participants|Count of Participants|73|73.0||||||
3806568|NCT01790438|3633076|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|"Participants who were not located in the United States were reported in the Unknown or Not Reported category for ethnicity."|Participants|Count of Participants|148|148.0||||||
3806569|NCT01790438|3633074|B3||Male|Sex: Female, Male||Participants|Count of Participants|325|325.0||||||
3806570|NCT01790438|3633075|B2||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3806571|NCT01790438|3633076|B1||Male|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
3806572|NCT01790438|3633074|B3||Female|Sex: Female, Male||Participants|Count of Participants|316|316.0||||||
3806573|NCT01790438|3633075|B2||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3806574|NCT01790438|3633076|B1||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
3806575|NCT01790438|3633074|B3|||Age||years|Mean|59.17|59.17|Standard Deviation|9.87|9.87|||
3806576|NCT01790438|3633075|B2|||Age||years|Mean|59.79|59.79|Standard Deviation|10.10|10.1|||
3806577|NCT01790438|3633076|B1|||Age||years|Mean|58.86|58.86|Standard Deviation|9.76|9.76|||
3806578|NCT01790178|3633127|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3806579|NCT01790178|3633128|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
3806580|NCT01790178|3633129|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3806581|NCT01790178|3633127|B3||Male|Gender||Participants|Count of Participants|14|14.0||||||
3806582|NCT01790178|3633128|B2||Male|Gender||Participants|Count of Participants|7|7.0||||||
3806583|NCT01790178|3633129|B1||Male|Gender||Participants|Count of Participants|7|7.0||||||
3806584|NCT01790178|3633127|B3||Female|Gender||Participants|Count of Participants|26|26.0||||||
3806585|NCT01790178|3633128|B2||Female|Gender||Participants|Count of Participants|17|17.0||||||
3806586|NCT01790178|3633129|B1||Female|Gender||Participants|Count of Participants|9|9.0||||||
3806587|NCT01790178|3633127|B3|||Age||years|Mean|55.7|55.7|Standard Deviation|15.7|15.7|||
3806588|NCT01790178|3633128|B2|||Age||years|Mean|55.375|55.375|Standard Deviation|12.8|12.8|||
3806589|NCT01790178|3633129|B1|||Age||years|Mean|56.1875|56.1875|Standard Deviation|19.8|19.8|||
3806590|NCT01790178|3633127|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3806591|NCT01790178|3633128|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3806592|NCT01790178|3633129|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3806593|NCT01790178|3633127|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3806594|NCT01790178|3633128|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3806595|NCT01790178|3633129|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3806596|NCT01790178|3633127|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3806597|NCT01790178|3633128|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3806598|NCT01790178|3633129|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3806599|NCT01789970|3633144|B3|||Average Daily Hydrocodone Equivalent Dose||mg|Mean|20.2|20.2|Standard Deviation|29.43|29.43|||
3806600|NCT01789970|3633145|B2|||Average Daily Hydrocodone Equivalent Dose||mg|Mean|22.1|22.1|Standard Deviation|30.18|30.18|||
3806601|NCT01789970|3633146|B1|||Average Daily Hydrocodone Equivalent Dose||mg|Mean|18.2|18.2|Standard Deviation|28.55|28.55|||
3806602|NCT01789970|3633144|B3|||Duration of Opioid Therapy||years|Mean|3.2|3.2|Standard Deviation|4.37|4.37|||
3806603|NCT01789970|3633145|B2|||Duration of Opioid Therapy||years|Mean|3.5|3.5|Standard Deviation|4.85|4.85|||
3806604|NCT01789970|3633146|B1|||Duration of Opioid Therapy||years|Mean|2.9|2.9|Standard Deviation|3.76|3.76|||
3806605|NCT01789970|3633144|B3|||Duration Since Diagnosis of Chronic Low Back Pain||years|Mean|11.4|11.4|Standard Deviation|10.31|10.31|||
3806606|NCT01789970|3633145|B2|||Duration Since Diagnosis of Chronic Low Back Pain||years|Mean|11.3|11.3|Standard Deviation|10.29|10.29|||
3806607|NCT01789970|3633146|B1|||Duration Since Diagnosis of Chronic Low Back Pain||years|Mean|11.5|11.5|Standard Deviation|10.35|10.35|||
3806608|NCT01789970|3633144|B3|Opioid-experienced||Participant Opioid Status|Opioid-naïve patients were defined as those who were taking tramadol or less than 10 mg per day of oxycodone, or equivalent (including around-the-clock and rescue medication) for the 14 days before screening. Opioid-experienced patients were defined as those who were taking 10 mg or more per day of oxycodone, or equivalent (including around-the-clock and rescue medication) for the 14 days before screening. Opioid-experienced patients requiring more than 135 mg/day of oxycodone, or equivalent, during the 14 days before study entry were excluded from the study.|Participants|Count of Participants|156|156.0||||||
3806609|NCT01789970|3633145|B2|Opioid-experienced||Participant Opioid Status|Opioid-naïve patients were defined as those who were taking tramadol or less than 10 mg per day of oxycodone, or equivalent (including around-the-clock and rescue medication) for the 14 days before screening. Opioid-experienced patients were defined as those who were taking 10 mg or more per day of oxycodone, or equivalent (including around-the-clock and rescue medication) for the 14 days before screening. Opioid-experienced patients requiring more than 135 mg/day of oxycodone, or equivalent, during the 14 days before study entry were excluded from the study.|Participants|Count of Participants|81|81.0||||||
3806610|NCT01789970|3633146|B1|Opioid-experienced||Participant Opioid Status|Opioid-naïve patients were defined as those who were taking tramadol or less than 10 mg per day of oxycodone, or equivalent (including around-the-clock and rescue medication) for the 14 days before screening. Opioid-experienced patients were defined as those who were taking 10 mg or more per day of oxycodone, or equivalent (including around-the-clock and rescue medication) for the 14 days before screening. Opioid-experienced patients requiring more than 135 mg/day of oxycodone, or equivalent, during the 14 days before study entry were excluded from the study.|Participants|Count of Participants|75|75.0||||||
3806611|NCT01789970|3633144|B3|Opioid-naive||Participant Opioid Status|Opioid-naïve patients were defined as those who were taking tramadol or less than 10 mg per day of oxycodone, or equivalent (including around-the-clock and rescue medication) for the 14 days before screening. Opioid-experienced patients were defined as those who were taking 10 mg or more per day of oxycodone, or equivalent (including around-the-clock and rescue medication) for the 14 days before screening. Opioid-experienced patients requiring more than 135 mg/day of oxycodone, or equivalent, during the 14 days before study entry were excluded from the study.|Participants|Count of Participants|215|215.0||||||
3806612|NCT01789970|3633145|B2|Opioid-naive||Participant Opioid Status|Opioid-naïve patients were defined as those who were taking tramadol or less than 10 mg per day of oxycodone, or equivalent (including around-the-clock and rescue medication) for the 14 days before screening. Opioid-experienced patients were defined as those who were taking 10 mg or more per day of oxycodone, or equivalent (including around-the-clock and rescue medication) for the 14 days before screening. Opioid-experienced patients requiring more than 135 mg/day of oxycodone, or equivalent, during the 14 days before study entry were excluded from the study.|Participants|Count of Participants|110|110.0||||||
3806613|NCT01789970|3633146|B1|Opioid-naive||Participant Opioid Status|Opioid-naïve patients were defined as those who were taking tramadol or less than 10 mg per day of oxycodone, or equivalent (including around-the-clock and rescue medication) for the 14 days before screening. Opioid-experienced patients were defined as those who were taking 10 mg or more per day of oxycodone, or equivalent (including around-the-clock and rescue medication) for the 14 days before screening. Opioid-experienced patients requiring more than 135 mg/day of oxycodone, or equivalent, during the 14 days before study entry were excluded from the study.|Participants|Count of Participants|105|105.0||||||
3806614|NCT01789970|3633144|B3|||Body Mass Index||kg/m^2|Mean|31.4|31.4|Standard Deviation|7.78|7.78|||
3806615|NCT01789970|3633145|B2|||Body Mass Index||kg/m^2|Mean|31.3|31.3|Standard Deviation|7.37|7.37|||
3806616|NCT01789970|3633146|B1|||Body Mass Index||kg/m^2|Mean|31.5|31.5|Standard Deviation|8.22|8.22|||
3806617|NCT01789970|3633144|B3|Unknown||Ethnicity||Participants|Count of Participants|1|1.0||||||
3806618|NCT01789970|3633145|B2|Unknown||Ethnicity||Participants|Count of Participants|0|0.0||||||
3806619|NCT01789970|3633146|B1|Unknown||Ethnicity||Participants|Count of Participants|1|1.0||||||
3806620|NCT01789970|3633144|B3|Non-Hispanic and non-Latino||Ethnicity||Participants|Count of Participants|323|323.0||||||
3806621|NCT01789970|3633145|B2|Non-Hispanic and non-Latino||Ethnicity||Participants|Count of Participants|167|167.0||||||
3806622|NCT01789970|3633146|B1|Non-Hispanic and non-Latino||Ethnicity||Participants|Count of Participants|156|156.0||||||
3806623|NCT01789970|3633144|B3|Hispanic or Latino||Ethnicity||Participants|Count of Participants|47|47.0||||||
3806624|NCT01789970|3633145|B2|Hispanic or Latino||Ethnicity||Participants|Count of Participants|24|24.0||||||
3806625|NCT01789970|3633146|B1|Hispanic or Latino||Ethnicity||Participants|Count of Participants|23|23.0||||||
3806626|NCT01789970|3633144|B3|Other||Race||Participants|Count of Participants|3|3.0||||||
3806627|NCT01789970|3633145|B2|Other||Race||Participants|Count of Participants|3|3.0||||||
3806628|NCT01789970|3633146|B1|Other||Race||Participants|Count of Participants|0|0.0||||||
3806629|NCT01789970|3633144|B3|Native Hawaiian or other Pacific Islander||Race||Participants|Count of Participants|1|1.0||||||
3806630|NCT01789970|3633145|B2|Native Hawaiian or other Pacific Islander||Race||Participants|Count of Participants|1|1.0||||||
3806631|NCT01789970|3633146|B1|Native Hawaiian or other Pacific Islander||Race||Participants|Count of Participants|0|0.0||||||
3806632|NCT01789970|3633144|B3|American Indian or Alaska Native||Race||Participants|Count of Participants|4|4.0||||||
3806633|NCT01789970|3633145|B2|American Indian or Alaska Native||Race||Participants|Count of Participants|2|2.0||||||
3806634|NCT01789970|3633146|B1|American Indian or Alaska Native||Race||Participants|Count of Participants|2|2.0||||||
3806635|NCT01789970|3633144|B3|Asian||Race||Participants|Count of Participants|21|21.0||||||
3806636|NCT01789970|3633145|B2|Asian||Race||Participants|Count of Participants|13|13.0||||||
3806637|NCT01789970|3633146|B1|Asian||Race||Participants|Count of Participants|8|8.0||||||
3806638|NCT01789970|3633144|B3|Black||Race||Participants|Count of Participants|80|80.0||||||
3806639|NCT01789970|3633145|B2|Black||Race||Participants|Count of Participants|39|39.0||||||
3806640|NCT01789970|3633146|B1|Black||Race||Participants|Count of Participants|41|41.0||||||
3806641|NCT01789970|3633144|B3|White||Race||Participants|Count of Participants|262|262.0||||||
3806642|NCT01789970|3633145|B2|White||Race||Participants|Count of Participants|133|133.0||||||
3806643|NCT01789970|3633146|B1|White||Race||Participants|Count of Participants|129|129.0||||||
3806644|NCT01789970|3633144|B3||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3806645|NCT01789970|3633145|B2||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3806646|NCT01789970|3633146|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3806647|NCT01789970|3633144|B3||Female|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
3806648|NCT01789970|3633145|B2||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3806649|NCT01789970|3633146|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3806650|NCT01789970|3633144|B3|> 65 years||Age, Customized||Participants|Count of Participants|61|61.0||||||
3806651|NCT01789970|3633145|B2|> 65 years||Age, Customized||Participants|Count of Participants|35|35.0||||||
3806652|NCT01789970|3633146|B1|> 65 years||Age, Customized||Participants|Count of Participants|26|26.0||||||
3806653|NCT01789970|3633144|B3|<= 65 years||Age, Customized||Participants|Count of Participants|310|310.0||||||
3806654|NCT01789970|3633145|B2|<= 65 years||Age, Customized||Participants|Count of Participants|156|156.0||||||
3806655|NCT01789970|3633146|B1|<= 65 years||Age, Customized||Participants|Count of Participants|154|154.0||||||
3806656|NCT01789970|3633144|B3|||Age||years|Mean|51.8|51.8|Standard Deviation|13.00|13.0|||
3806657|NCT01789970|3633145|B2|||Age||years|Mean|51.7|51.7|Standard Deviation|13.48|13.48|||
3806658|NCT01789970|3633146|B1|||Age||years|Mean|51.8|51.8|Standard Deviation|12.51|12.51|||
3806659|NCT01789905|3633180|B1|Race and Ethnicity Not Collected||Race/Ethnicity, Customized||Participants|Number|116|116.0||||||
3806660|NCT01789905|3633180|B1|Female||Sex/Gender, Customized||Participants|Number|52|52.0||||||
3806661|NCT01789905|3633180|B1|Male||Sex/Gender, Customized||Participants|Number|64|64.0||||||
3806662|NCT01789905|3633180|B1|≥65 years||Age, Customized||Participants|Number|64|64.0||||||
3806663|NCT01789905|3633180|B1|≥15 and <65 years||Age, Customized||Participants|Number|47|47.0||||||
3806664|NCT01789905|3633180|B1|<15 years||Age, Customized||Participants|Number|5|5.0||||||
3806665|NCT01789814|3633186|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806666|NCT01789814|3633187|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806667|NCT01789814|3633188|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806668|NCT01789814|3633186|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806669|NCT01789814|3633187|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806670|NCT01789814|3633188|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806671|NCT01789814|3633186|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3806672|NCT01789814|3633187|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3806673|NCT01789814|3633188|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3806674|NCT01789814|3633186|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806675|NCT01789814|3633187|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806676|NCT01789814|3633188|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806677|NCT01789814|3633186|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806678|NCT01789814|3633187|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806679|NCT01789814|3633188|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806680|NCT01789814|3633186|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3806681|NCT01789814|3633187|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3806682|NCT01789814|3633188|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3806683|NCT01789814|3633186|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806684|NCT01789814|3633187|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806685|NCT01789814|3633188|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806686|NCT01789814|3633186|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3806687|NCT01789814|3633187|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3806688|NCT01789814|3633188|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3806689|NCT01789814|3633186|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3806690|NCT01789814|3633187|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3806691|NCT01789814|3633188|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3806692|NCT01789814|3633186|B3|||Age||years|Mean|61.99|61.99|Standard Deviation|8.82|8.82|||
3806693|NCT01789814|3633187|B2|||Age||years|Mean|62.5|62.5|Standard Deviation|80.5|80.5|||
3806694|NCT01789814|3633188|B1|||Age||years|Mean|60.41|60.41|Standard Deviation|9.80|9.8|||
3806695|NCT01789814|3633186|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3806696|NCT01789814|3633187|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3806697|NCT01789814|3633188|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3806698|NCT01789814|3633186|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3806699|NCT01789814|3633187|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3806700|NCT01789814|3633188|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3806701|NCT01789814|3633186|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3806702|NCT01789814|3633187|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3806703|NCT01789814|3633188|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3806704|NCT01789775|3633195|B3|Sweden||Region of Enrollment||participants|Number|6|6.0||||||
3806705|NCT01789775|3633196|B2|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
3806706|NCT01789775|3633197|B1|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
3806707|NCT01789775|3633195|B3|Russian Federation||Region of Enrollment||participants|Number|92|92.0||||||
3806708|NCT01789775|3633196|B2|Russian Federation||Region of Enrollment||participants|Number|46|46.0||||||
3806709|NCT01789775|3633197|B1|Russian Federation||Region of Enrollment||participants|Number|46|46.0||||||
3806710|NCT01789775|3633195|B3|France||Region of Enrollment||participants|Number|14|14.0||||||
3806711|NCT01789775|3633196|B2|France||Region of Enrollment||participants|Number|8|8.0||||||
3806712|NCT01789775|3633197|B1|France||Region of Enrollment||participants|Number|6|6.0||||||
3806713|NCT01789775|3633195|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3806714|NCT01789775|3633196|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3806715|NCT01789775|3633197|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3806716|NCT01789775|3633195|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3806717|NCT01789775|3633196|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3806718|NCT01789775|3633197|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3806719|NCT01789775|3633195|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3806720|NCT01789775|3633196|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3806721|NCT01789775|3633197|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3806722|NCT01789775|3633195|B3||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
3806723|NCT01789775|3633196|B2||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
3806724|NCT01789775|3633197|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3806725|NCT01789775|3633195|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3806726|NCT01789775|3633196|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3806727|NCT01789775|3633197|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3806728|NCT01789775|3633195|B3|||Age||years|Mean|44.0|44.0|Standard Deviation|11.4|11.4|||
3806729|NCT01789775|3633196|B2|||Age||years|Mean|43.2|43.2|Standard Deviation|10.8|10.8|||
3806730|NCT01789775|3633197|B1|||Age||years|Mean|44.9|44.9|Standard Deviation|12.1|12.1|||
3806731|NCT01789606|3633204|B3|Unknown||Sex/Gender, Customized||participants|Number|44|44.0||||||
3806732|NCT01789606|3633205|B2|Unknown||Sex/Gender, Customized||participants|Number|21|21.0||||||
3806733|NCT01789606|3633206|B1|Unknown||Sex/Gender, Customized||participants|Number|23|23.0||||||
3806734|NCT01789606|3633204|B3|Male||Sex/Gender, Customized||participants|Number|517|517.0||||||
3806735|NCT01789606|3633205|B2|Male||Sex/Gender, Customized||participants|Number|403|403.0||||||
3806736|NCT01789606|3633206|B1|Male||Sex/Gender, Customized||participants|Number|114|114.0||||||
3806737|NCT01789606|3633204|B3|Female||Sex/Gender, Customized||participants|Number|522|522.0||||||
3806738|NCT01789606|3633205|B2|Female||Sex/Gender, Customized||participants|Number|408|408.0||||||
3806739|NCT01789606|3633206|B1|Female||Sex/Gender, Customized||participants|Number|114|114.0||||||
3806740|NCT01789606|3633204|B3|Unknown||Age, Customized||participants|Number|2|2.0||||||
3806741|NCT01789606|3633205|B2|Unknown||Age, Customized||participants|Number|0|0.0||||||
3806742|NCT01789606|3633206|B1|Unknown||Age, Customized||participants|Number|2|2.0||||||
3806743|NCT01789606|3633204|B3|Greater Than or Equal to (>=) 18 years||Age, Customized||participants|Number|1074|1074.0||||||
3806744|NCT01789606|3633205|B2|Greater Than or Equal to (>=) 18 years||Age, Customized||participants|Number|827|827.0||||||
3806745|NCT01789606|3633206|B1|Greater Than or Equal to (>=) 18 years||Age, Customized||participants|Number|247|247.0||||||
3806746|NCT01789606|3633204|B3|Less Than (<)18 years||Age, Customized||participants|Number|7|7.0||||||
3806747|NCT01789606|3633205|B2|Less Than (<)18 years||Age, Customized||participants|Number|5|5.0||||||
3806748|NCT01789606|3633206|B1|Less Than (<)18 years||Age, Customized||participants|Number|2|2.0||||||
3806749|NCT01789567|3633225|B1|No peripheral vascular disease||Peripheral vascular disease||participants|Number|10|10.0||||||
3806750|NCT01789567|3633225|B1|Peripheral vascular disease||Peripheral vascular disease||participants|Number|10|10.0||||||
3806751|NCT01789567|3633225|B1|||STS Risk of Mortality|The Society of Thoracic Surgeons (STS) Risk of Mortality model predicts the risk of operative mortality and morbidity after adult cardiac surgery on the basis of patient demographic and clinical variables; scores are interpreted as follows: <4%, low risk; 4% to <8%, intermediate risk; 8% to <12%, high risk; ≥ 12%, very high risk.|%|Mean|5.9|5.9|Standard Deviation|4.7|4.7|||
3806752|NCT01789567|3633225|B1|Germany||Region of Enrollment||participants|Number|14|14.0||||||
3806753|NCT01789567|3633225|B1|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3806754|NCT01789567|3633225|B1|Czech Republic||Region of Enrollment||participants|Number|3|3.0||||||
3806755|NCT01789567|3633225|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3806756|NCT01789567|3633225|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3806757|NCT01789567|3633225|B1|||Age||years|Mean|80.6|80.6|Standard Deviation|3.4|3.4|||
3806758|NCT01789567|3633225|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3806759|NCT01789567|3633225|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3806760|NCT01789567|3633225|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3806761|NCT01789476|3633232|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
3806762|NCT01789476|3633233|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3806763|NCT01789476|3633234|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
3806764|NCT01789476|3633232|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806765|NCT01789476|3633233|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806766|NCT01789476|3633234|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806767|NCT01789476|3633232|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806768|NCT01789476|3633233|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806769|NCT01789476|3633234|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806770|NCT01789476|3633232|B3||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3806771|NCT01789476|3633233|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3806772|NCT01789476|3633234|B1||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3806773|NCT01789476|3633232|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3806774|NCT01789476|3633233|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3806775|NCT01789476|3633234|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3806776|NCT01789476|3633232|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3806777|NCT01789476|3633233|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806778|NCT01789476|3633234|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3806779|NCT01789476|3633232|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3806780|NCT01789476|3633233|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3806781|NCT01789476|3633234|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806782|NCT01789476|3633232|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806783|NCT01789476|3633233|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806784|NCT01789476|3633234|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806785|NCT01789476|3633232|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806786|NCT01789476|3633233|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806787|NCT01789476|3633234|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806788|NCT01789476|3633232|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3806789|NCT01789476|3633233|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3806790|NCT01789476|3633234|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3806791|NCT01789476|3633232|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3806792|NCT01789476|3633233|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806793|NCT01789476|3633234|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3806794|NCT01789476|3633232|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3806795|NCT01789476|3633233|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3806796|NCT01789476|3633234|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3806797|NCT01789476|3633232|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3806798|NCT01789476|3633233|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3806799|NCT01789476|3633234|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3806800|NCT01789476|3633232|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3806801|NCT01789476|3633233|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3806802|NCT01789476|3633234|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3806803|NCT01789476|3633232|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
3806804|NCT01789476|3633233|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3806805|NCT01789476|3633234|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3806806|NCT01789476|3633232|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3806807|NCT01789476|3633233|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3806808|NCT01789476|3633234|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3806809|NCT01789255|3633245|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3806810|NCT01789255|3633245|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3806811|NCT01789255|3633245|B1|||Age||years|Median|49|49.0|Inter-Quartile Range|||45.0|58.0|
3806812|NCT01789138|3633255|B3|data not available||Treatment adherence|Patient self-reported 3-day recall measure: Counting pills prescribed and taken in past 3 days. Adherent when >=95% of pills taken as prescribed.|participants|Number|86|86.0||||||
3806813|NCT01789138|3633256|B2|data not available||Treatment adherence|Patient self-reported 3-day recall measure: Counting pills prescribed and taken in past 3 days. Adherent when >=95% of pills taken as prescribed.|participants|Number|44|44.0||||||
3806814|NCT01789138|3633257|B1|data not available||Treatment adherence|Patient self-reported 3-day recall measure: Counting pills prescribed and taken in past 3 days. Adherent when >=95% of pills taken as prescribed.|participants|Number|42|42.0||||||
3806815|NCT01789138|3633255|B3|non-adherent||Treatment adherence|Patient self-reported 3-day recall measure: Counting pills prescribed and taken in past 3 days. Adherent when >=95% of pills taken as prescribed.|participants|Number|47|47.0||||||
3806816|NCT01789138|3633256|B2|non-adherent||Treatment adherence|Patient self-reported 3-day recall measure: Counting pills prescribed and taken in past 3 days. Adherent when >=95% of pills taken as prescribed.|participants|Number|25|25.0||||||
3806817|NCT01789138|3633257|B1|non-adherent||Treatment adherence|Patient self-reported 3-day recall measure: Counting pills prescribed and taken in past 3 days. Adherent when >=95% of pills taken as prescribed.|participants|Number|22|22.0||||||
3806818|NCT01789138|3633255|B3|adherent||Treatment adherence|Patient self-reported 3-day recall measure: Counting pills prescribed and taken in past 3 days. Adherent when >=95% of pills taken as prescribed.|participants|Number|379|379.0||||||
3806819|NCT01789138|3633256|B2|adherent||Treatment adherence|Patient self-reported 3-day recall measure: Counting pills prescribed and taken in past 3 days. Adherent when >=95% of pills taken as prescribed.|participants|Number|189|189.0||||||
3806820|NCT01789138|3633257|B1|adherent||Treatment adherence|Patient self-reported 3-day recall measure: Counting pills prescribed and taken in past 3 days. Adherent when >=95% of pills taken as prescribed.|participants|Number|190|190.0||||||
3806821|NCT01789138|3633255|B3|data not available||Viral load|HIV-1 RNA (viral load) with sensitivity of 40 copies/mL.|participants|Number|144|144.0||||||
3806822|NCT01789138|3633256|B2|data not available||Viral load|HIV-1 RNA (viral load) with sensitivity of 40 copies/mL.|participants|Number|80|80.0||||||
3806823|NCT01789138|3633257|B1|data not available||Viral load|HIV-1 RNA (viral load) with sensitivity of 40 copies/mL.|participants|Number|64|64.0||||||
3806824|NCT01789138|3633255|B3|detectable viral load||Viral load|HIV-1 RNA (viral load) with sensitivity of 40 copies/mL.|participants|Number|172|172.0||||||
3806825|NCT01789138|3633256|B2|detectable viral load||Viral load|HIV-1 RNA (viral load) with sensitivity of 40 copies/mL.|participants|Number|91|91.0||||||
3806826|NCT01789138|3633257|B1|detectable viral load||Viral load|HIV-1 RNA (viral load) with sensitivity of 40 copies/mL.|participants|Number|81|81.0||||||
3806827|NCT01789138|3633255|B3|undetectable viral load||Viral load|HIV-1 RNA (viral load) with sensitivity of 40 copies/mL.|participants|Number|196|196.0||||||
3806828|NCT01789138|3633256|B2|undetectable viral load||Viral load|HIV-1 RNA (viral load) with sensitivity of 40 copies/mL.|participants|Number|87|87.0||||||
3806829|NCT01789138|3633257|B1|undetectable viral load||Viral load|HIV-1 RNA (viral load) with sensitivity of 40 copies/mL.|participants|Number|109|109.0||||||
3806830|NCT01789138|3633255|B3|Estonia||Region of Enrollment||participants|Number|512|512.0||||||
3806831|NCT01789138|3633256|B2|Estonia||Region of Enrollment||participants|Number|258|258.0||||||
3806832|NCT01789138|3633257|B1|Estonia||Region of Enrollment||participants|Number|254|254.0||||||
3806833|NCT01789138|3633255|B3||Male|Sex: Female, Male||Participants|Count of Participants|305|305.0||||||
3806834|NCT01789138|3633256|B2||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3806835|NCT01789138|3633257|B1||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3806836|NCT01789138|3633255|B3||Female|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
3806837|NCT01789138|3633256|B2||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3806838|NCT01789138|3633257|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3806839|NCT01789138|3633255|B3|||Age||years|Mean|34.00|34.0|Standard Deviation|7.83|7.83|||
3806840|NCT01789138|3633256|B2|||Age||years|Mean|33.92|33.92|Standard Deviation|7.65|7.65|||
3806841|NCT01789138|3633257|B1|||Age||years|Mean|34.08|34.08|Standard Deviation|8.02|8.02|||
3806842|NCT01788943|3633266|B3|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3806843|NCT01788943|3633267|B2|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3806844|NCT01788943|3633268|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3806845|NCT01788943|3633266|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806846|NCT01788943|3633267|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806847|NCT01788943|3633268|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806848|NCT01788943|3633266|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806849|NCT01788943|3633267|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806850|NCT01788943|3633268|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806851|NCT01788943|3633266|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3806852|NCT01788943|3633267|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3806853|NCT01788943|3633268|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3806854|NCT01788943|3633266|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3806855|NCT01788943|3633267|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3806856|NCT01788943|3633268|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3806857|NCT01788943|3633266|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806858|NCT01788943|3633267|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806859|NCT01788943|3633268|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806860|NCT01788943|3633266|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806861|NCT01788943|3633267|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806862|NCT01788943|3633268|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806863|NCT01788943|3633266|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806864|NCT01788943|3633267|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806865|NCT01788943|3633268|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3806866|NCT01788943|3633266|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3806867|NCT01788943|3633267|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3806868|NCT01788943|3633268|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3806869|NCT01788943|3633266|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3806870|NCT01788943|3633267|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3806871|NCT01788943|3633268|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3806872|NCT01788943|3633266|B3|||Age||years|Mean|47.1|47.1|Full Range|||23.0|62.0|
3806873|NCT01788943|3633267|B2|||Age||years|Mean|45.5|45.5|Full Range|||23.0|62.0|
3806874|NCT01788943|3633268|B1|||Age||years|Mean|48.7|48.7|Full Range|||35.0|64.0|
3806875|NCT01788631|3633277|B3|United States||Region of Enrollment||Participants|Number|100|100.0||||||
3806876|NCT01788631|3633278|B2|United States||Region of Enrollment||Participants|Number|47|47.0||||||
3806877|NCT01788631|3633279|B1|United States||Region of Enrollment||Participants|Number|53|53.0||||||
3806878|NCT01788631|3633277|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3806879|NCT01788631|3633278|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3806880|NCT01788631|3633279|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3806881|NCT01788631|3633277|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3806882|NCT01788631|3633278|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3806883|NCT01788631|3633279|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3806884|NCT01788631|3633277|B3|||Age||years|Median|25|25.0|Full Range|||10.0|56.0|
3806885|NCT01788631|3633278|B2|||Age||years|Median|26|26.0|Full Range|||13.0|56.0|
3806886|NCT01788631|3633279|B1|||Age||years|Median|25|25.0|Full Range|||10.0|54.0|
3806887|NCT01788566|3633298|B1|Korea, Republic of||Region of Enrollment||participants|Number|3|3.0||||||
3806888|NCT01788566|3633298|B1|Spain||Region of Enrollment||participants|Number|25|25.0||||||
3806889|NCT01788566|3633298|B1|France||Region of Enrollment||participants|Number|3|3.0||||||
3806890|NCT01788566|3633298|B1|Mexico||Region of Enrollment||participants|Number|1|1.0||||||
3806891|NCT01788566|3633298|B1|Taiwan||Region of Enrollment||participants|Number|8|8.0||||||
3806892|NCT01788566|3633298|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3806893|NCT01788566|3633298|B1|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
3806894|NCT01788566|3633298|B1|Canada||Region of Enrollment||participants|Number|5|5.0||||||
3806895|NCT01788566|3633298|B1|Missing||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3806896|NCT01788566|3633298|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3806897|NCT01788566|3633298|B1|Asian||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3806898|NCT01788566|3633298|B1|White||Race/Ethnicity, Customized||Participants|Number|48|48.0||||||
3806899|NCT01788566|3633298|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3806900|NCT01788566|3633298|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3806901|NCT01788566|3633298|B1||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
3806902|NCT01788566|3633298|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3806903|NCT01788566|3633298|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3806904|NCT01788358|3633308|B1|||Diastolic blood pressure||mmHg|Mean|95.6|95.6|Standard Deviation|10.4|10.4|||
3806905|NCT01788358|3633308|B1|||Systolic blood pressure||millimeter of mercury (mmHg)|Mean|170.7|170.7|Standard Deviation|8.9|8.9|||
3806906|NCT01788358|3633308|B1||Male|Sex: Female, Male||Participants|Count of Participants|322|322.0||||||
3806907|NCT01788358|3633308|B1||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
3806908|NCT01788358|3633308|B1|||Age||years|Mean|59|59.0|Standard Deviation|10.2|10.2|||
3806909|NCT01788228|3633320|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3806910|NCT01788228|3633321|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3806911|NCT01788228|3633322|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3806912|NCT01788228|3633320|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3806913|NCT01788228|3633321|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3806914|NCT01788228|3633322|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3806915|NCT01788228|3633320|B3|||Age||Years|Mean|43.35|43.35|Standard Deviation|12.18|12.18|||
3806916|NCT01788228|3633321|B2|||Age||Years|Mean|85.0|85.0|Standard Deviation|NA||||As this group has only 1 subject, SD cannot be calculated.
3806917|NCT01788228|3633322|B1|||Age||Years|Mean|42.5|42.5|Standard Deviation|10.7|10.7|||
3806918|NCT01788215|3633340|B3|||serum hormone binding globulin (SHBG)||nmol/L|Mean|49.5|49.5|Standard Deviation|13.4|13.4|||
3806919|NCT01788215|3633341|B2|||serum hormone binding globulin (SHBG)||nmol/L|Mean|44.0|44.0|Standard Deviation|13.5|13.5|||
3806920|NCT01788215|3633342|B1|||serum hormone binding globulin (SHBG)||nmol/L|Mean|55.0|55.0|Standard Deviation|13.2|13.2|||
3806921|NCT01788215|3633340|B3|||free serum testosterone||pg/mL|Mean|1.25|1.25|Standard Deviation|0.48|0.48|||
3806922|NCT01788215|3633341|B2|||free serum testosterone||pg/mL|Mean|1.36|1.36|Standard Deviation|0.39|0.39|||
3806923|NCT01788215|3633342|B1|||free serum testosterone||pg/mL|Mean|1.14|1.14|Standard Deviation|0.57|0.57|||
3806924|NCT01788215|3633340|B3|||total serum testosterone||ng/dL|Mean|50.1|50.1|Standard Deviation|8.2|8.2|||
3806925|NCT01788215|3633341|B2|||total serum testosterone||ng/dL|Mean|49.6|49.6|Standard Deviation|8.2|8.2|||
3806926|NCT01788215|3633342|B1|||total serum testosterone||ng/dL|Mean|50.6|50.6|Standard Deviation|8.2|8.2|||
3806927|NCT01788215|3633340|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3806928|NCT01788215|3633341|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3806929|NCT01788215|3633342|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3806930|NCT01788215|3633340|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3806931|NCT01788215|3633341|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3806932|NCT01788215|3633342|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3806933|NCT01788215|3633340|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3806934|NCT01788215|3633341|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3806935|NCT01788215|3633342|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3806936|NCT01788215|3633340|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3806937|NCT01788215|3633341|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3806938|NCT01788215|3633342|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3806939|NCT01788215|3633340|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3806940|NCT01788215|3633341|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3806941|NCT01788215|3633342|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3806942|NCT01788215|3633340|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3806943|NCT01788215|3633341|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3806944|NCT01788215|3633342|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3806945|NCT01788163|3633363|B10||Male|Sex: Female, Male|Frequency distribution of Male/Female|Participants|Count of Participants|2240|2240.0||||||
3806946|NCT01788163|3633364|B9||Male|Sex: Female, Male|Frequency distribution of Male/Female|Participants|Count of Participants|727|727.0||||||
3806947|NCT01788163|3633365|B8||Male|Sex: Female, Male|Frequency distribution of Male/Female|Participants|Count of Participants|205|205.0||||||
3806948|NCT01788163|3633366|B7||Male|Sex: Female, Male|Frequency distribution of Male/Female|Participants|Count of Participants|36|36.0||||||
3806949|NCT01788163|3633367|B6||Male|Sex: Female, Male|Frequency distribution of Male/Female|Participants|Count of Participants|60|60.0||||||
3806950|NCT01788163|3633368|B5||Male|Sex: Female, Male|Frequency distribution of Male/Female|Participants|Count of Participants|54|54.0||||||
3806951|NCT01788163|3633369|B4||Male|Sex: Female, Male|Frequency distribution of Male/Female|Participants|Count of Participants|35|35.0||||||
3806952|NCT01788163|3633370|B3||Male|Sex: Female, Male|Frequency distribution of Male/Female|Participants|Count of Participants|40|40.0||||||
3806953|NCT01788163|3633371|B2||Male|Sex: Female, Male|Frequency distribution of Male/Female|Participants|Count of Participants|160|160.0||||||
3806954|NCT01788163|3633372|B1||Male|Sex: Female, Male|Frequency distribution of Male/Female|Participants|Count of Participants|923|923.0||||||
3806955|NCT01788163|3633363|B10||Female|Sex: Female, Male|Frequency distribution of Male/Female|Participants|Count of Participants|1142|1142.0||||||
3806956|NCT01788163|3633364|B9||Female|Sex: Female, Male|Frequency distribution of Male/Female|Participants|Count of Participants|245|245.0||||||
3806957|NCT01788163|3633365|B8||Female|Sex: Female, Male|Frequency distribution of Male/Female|Participants|Count of Participants|97|97.0||||||
3806958|NCT01788163|3633366|B7||Female|Sex: Female, Male|Frequency distribution of Male/Female|Participants|Count of Participants|14|14.0||||||
3806959|NCT01788163|3633367|B6||Female|Sex: Female, Male|Frequency distribution of Male/Female|Participants|Count of Participants|42|42.0||||||
3806960|NCT01788163|3633368|B5||Female|Sex: Female, Male|Frequency distribution of Male/Female|Participants|Count of Participants|40|40.0||||||
3806961|NCT01788163|3633369|B4||Female|Sex: Female, Male|Frequency distribution of Male/Female|Participants|Count of Participants|36|36.0||||||
3806962|NCT01788163|3633370|B3||Female|Sex: Female, Male|Frequency distribution of Male/Female|Participants|Count of Participants|22|22.0||||||
3806963|NCT01788163|3633371|B2||Female|Sex: Female, Male|Frequency distribution of Male/Female|Participants|Count of Participants|111|111.0||||||
3806964|NCT01788163|3633372|B1||Female|Sex: Female, Male|Frequency distribution of Male/Female|Participants|Count of Participants|535|535.0||||||
3806965|NCT01788163|3633363|B10|Age (years)||Age|Calculated from birth date to screening visit date|Years|Mean|60.4|60.4|Standard Deviation|10.73|10.73|||
3806966|NCT01788163|3633364|B9|Age (years)||Age|Calculated from birth date to screening visit date|Years|Mean|59.8|59.8|Standard Deviation|8.9|8.9|||
3806967|NCT01788163|3633365|B8|Age (years)||Age|Calculated from birth date to screening visit date|Years|Mean|57.1|57.1|Standard Deviation|11.46|11.46|||
3806968|NCT01788163|3633366|B7|Age (years)||Age|Calculated from birth date to screening visit date|Years|Mean|58.7|58.7|Standard Deviation|10.5|10.5|||
3806969|NCT01788163|3633367|B6|Age (years)||Age|Calculated from birth date to screening visit date|Years|Mean|63.3|63.3|Standard Deviation|10.79|10.79|||
3806970|NCT01788163|3633368|B5|Age (years)||Age|Calculated from birth date to screening visit date|Years|Mean|61.2|61.2|Standard Deviation|12.3|12.3|||
3806971|NCT01788163|3633369|B4|Age (years)||Age|Calculated from birth date to screening visit date|Years|Mean|67.1|67.1|Standard Deviation|10.02|10.02|||
3806972|NCT01788163|3633370|B3|Age (years)||Age|Calculated from birth date to screening visit date|Years|Mean|65.9|65.9|Standard Deviation|11.91|11.91|||
3806973|NCT01788163|3633371|B2|Age (years)||Age|Calculated from birth date to screening visit date|Years|Mean|66.4|66.4|Standard Deviation|12.66|12.66|||
3806974|NCT01788163|3633372|B1|Age (years)||Age|Calculated from birth date to screening visit date|Years|Mean|59.8|59.8|Standard Deviation|10.57|10.57|||
3806975|NCT01788046|3633541|B3|||Corrected Calcium Phosphorus Product (cCa x P)|Data available for 257 and 251 participants in each treatment group respectively|mg²/dL²|Mean|55.84|55.84|Standard Deviation|14.88|14.88|||
3806976|NCT01788046|3633542|B2|||Corrected Calcium Phosphorus Product (cCa x P)|Data available for 257 and 251 participants in each treatment group respectively|mg²/dL²|Mean|55.30|55.3|Standard Deviation|15.27|15.27|||
3806977|NCT01788046|3633543|B1|||Corrected Calcium Phosphorus Product (cCa x P)|Data available for 257 and 251 participants in each treatment group respectively|mg²/dL²|Mean|56.37|56.37|Standard Deviation|14.50|14.5|||
3806978|NCT01788046|3633541|B3|||Corrected Calcium (cCa)||mg/dL|Mean|9.66|9.66|Standard Deviation|0.67|0.67|||
3806979|NCT01788046|3633542|B2|||Corrected Calcium (cCa)||mg/dL|Mean|9.63|9.63|Standard Deviation|0.65|0.65|||
3806980|NCT01788046|3633543|B1|||Corrected Calcium (cCa)||mg/dL|Mean|9.70|9.7|Standard Deviation|0.69|0.69|||
3806981|NCT01788046|3633541|B3|||Phosphorus|Data available for 257 and 251 participants in each treatment group respectively|mg/dL|Mean|5.79|5.79|Standard Deviation|1.53|1.53|||
3806982|NCT01788046|3633542|B2|||Phosphorus|Data available for 257 and 251 participants in each treatment group respectively|mg/dL|Mean|5.76|5.76|Standard Deviation|1.60|1.6|||
3806983|NCT01788046|3633543|B1|||Phosphorus|Data available for 257 and 251 participants in each treatment group respectively|mg/dL|Mean|5.83|5.83|Standard Deviation|1.45|1.45|||
3806984|NCT01788046|3633541|B3|||Parathyroid Hormone||pg/mL|Mean|848.4|848.4|Standard Deviation|510.0|510.0|||
3806985|NCT01788046|3633542|B2|||Parathyroid Hormone||pg/mL|Mean|845.0|845.0|Standard Deviation|464.3|464.3|||
3806986|NCT01788046|3633543|B1|||Parathyroid Hormone||pg/mL|Mean|851.7|851.7|Standard Deviation|552.0|552.0|||
3806987|NCT01788046|3633541|B3|Non-North America||Stratification Factor: Region||participants|Number|219|219.0||||||
3806988|NCT01788046|3633542|B2|Non-North America||Stratification Factor: Region||participants|Number|109|109.0||||||
3806989|NCT01788046|3633543|B1|Non-North America||Stratification Factor: Region||participants|Number|110|110.0||||||
3806990|NCT01788046|3633541|B3|North America||Stratification Factor: Region||participants|Number|296|296.0||||||
3806991|NCT01788046|3633542|B2|North America||Stratification Factor: Region||participants|Number|146|146.0||||||
3806992|NCT01788046|3633543|B1|North America||Stratification Factor: Region||participants|Number|150|150.0||||||
3806993|NCT01788046|3633541|B3|No||Stratification Factor: Cinacalcet Use Within 8 Weeks of Randomization||participants|Number|453|453.0||||||
3806994|NCT01788046|3633542|B2|No||Stratification Factor: Cinacalcet Use Within 8 Weeks of Randomization||participants|Number|226|226.0||||||
3806995|NCT01788046|3633543|B1|No||Stratification Factor: Cinacalcet Use Within 8 Weeks of Randomization||participants|Number|227|227.0||||||
3806996|NCT01788046|3633541|B3|Yes||Stratification Factor: Cinacalcet Use Within 8 Weeks of Randomization||participants|Number|62|62.0||||||
3806997|NCT01788046|3633542|B2|Yes||Stratification Factor: Cinacalcet Use Within 8 Weeks of Randomization||participants|Number|29|29.0||||||
3806998|NCT01788046|3633543|B1|Yes||Stratification Factor: Cinacalcet Use Within 8 Weeks of Randomization||participants|Number|33|33.0||||||
3806999|NCT01788046|3633541|B3|> 1000 pg/mL||Stratification Factor: Screening Serum Parathroid Hormone||participants|Number|108|108.0||||||
3807000|NCT01788046|3633542|B2|> 1000 pg/mL||Stratification Factor: Screening Serum Parathroid Hormone||participants|Number|53|53.0||||||
3807001|NCT01788046|3633543|B1|> 1000 pg/mL||Stratification Factor: Screening Serum Parathroid Hormone||participants|Number|55|55.0||||||
3807002|NCT01788046|3633541|B3|≥ 600 to ≤ 1000 pg/mL||Stratification Factor: Screening Serum Parathroid Hormone||participants|Number|239|239.0||||||
3807003|NCT01788046|3633542|B2|≥ 600 to ≤ 1000 pg/mL||Stratification Factor: Screening Serum Parathroid Hormone||participants|Number|118|118.0||||||
3807004|NCT01788046|3633543|B1|≥ 600 to ≤ 1000 pg/mL||Stratification Factor: Screening Serum Parathroid Hormone||participants|Number|121|121.0||||||
3807005|NCT01788046|3633541|B3|< 600 pg/mL||Stratification Factor: Screening Serum Parathroid Hormone||participants|Number|168|168.0||||||
3807006|NCT01788046|3633542|B2|< 600 pg/mL||Stratification Factor: Screening Serum Parathroid Hormone||participants|Number|84|84.0||||||
3807007|NCT01788046|3633543|B1|< 600 pg/mL||Stratification Factor: Screening Serum Parathroid Hormone||participants|Number|84|84.0||||||
3807008|NCT01788046|3633541|B3|Missing||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3807009|NCT01788046|3633542|B2|Missing||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3807010|NCT01788046|3633543|B1|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3807011|NCT01788046|3633541|B3|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|448|448.0||||||
3807012|NCT01788046|3633542|B2|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|221|221.0||||||
3807013|NCT01788046|3633543|B1|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|227|227.0||||||
3807014|NCT01788046|3633541|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
3807015|NCT01788046|3633542|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3807016|NCT01788046|3633543|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
3807017|NCT01788046|3633541|B3|Missing||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3807018|NCT01788046|3633542|B2|Missing||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3807019|NCT01788046|3633543|B1|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3807020|NCT01788046|3633541|B3|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3807021|NCT01788046|3633542|B2|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3807022|NCT01788046|3633543|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3807023|NCT01788046|3633541|B3|White||Race/Ethnicity, Customized||participants|Number|332|332.0||||||
3807024|NCT01788046|3633542|B2|White||Race/Ethnicity, Customized||participants|Number|163|163.0||||||
3807025|NCT01788046|3633543|B1|White||Race/Ethnicity, Customized||participants|Number|169|169.0||||||
3807136|NCT01787591|3633606|B1|||HDL cholesterol||mg/dL|Mean|56.0|56.0|Standard Deviation|9.9|9.9|||
3807026|NCT01788046|3633541|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3807027|NCT01788046|3633542|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3807028|NCT01788046|3633543|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3807029|NCT01788046|3633541|B3|Black (or African American)||Race/Ethnicity, Customized||participants|Number|144|144.0||||||
3807030|NCT01788046|3633542|B2|Black (or African American)||Race/Ethnicity, Customized||participants|Number|64|64.0||||||
3807031|NCT01788046|3633543|B1|Black (or African American)||Race/Ethnicity, Customized||participants|Number|80|80.0||||||
3807032|NCT01788046|3633541|B3|Asian||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3807033|NCT01788046|3633542|B2|Asian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3807034|NCT01788046|3633543|B1|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3807035|NCT01788046|3633541|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3807036|NCT01788046|3633542|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3807037|NCT01788046|3633543|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3807038|NCT01788046|3633541|B3||Male|Sex: Female, Male||Participants|Count of Participants|327|327.0||||||
3807039|NCT01788046|3633542|B2||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3807040|NCT01788046|3633543|B1||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3807041|NCT01788046|3633541|B3||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3807042|NCT01788046|3633542|B2||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3807043|NCT01788046|3633543|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3807044|NCT01788046|3633541|B3|||Age||years|Mean|58.7|58.7|Standard Deviation|14.3|14.3|||
3807045|NCT01788046|3633542|B2|||Age||years|Mean|58.4|58.4|Standard Deviation|14.6|14.6|||
3807046|NCT01788046|3633543|B1|||Age||years|Mean|59.0|59.0|Standard Deviation|13.9|13.9|||
3807047|NCT01787916|3633560|B1|Canada||Region of Enrollment||participants|Number|15|15.0||||||
3807048|NCT01787916|3633560|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3807049|NCT01787916|3633560|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3807050|NCT01787916|3633560|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3807051|NCT01787916|3633560|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3807052|NCT01787916|3633560|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3807053|NCT01787838|3633567|B1|United States||Region of Enrollment||participants|Number|2509|2509.0||||||
3807054|NCT01787838|3633567|B1||Male|Sex: Female, Male||Participants|Count of Participants|978|978.0||||||
3807055|NCT01787838|3633567|B1||Female|Sex: Female, Male||Participants|Count of Participants|1531|1531.0||||||
3807056|NCT01787838|3633567|B1||>=65 years|Age||Participants|Count of Participants|752|752.0||||||
3807057|NCT01787838|3633567|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1757|1757.0||||||
3807058|NCT01787838|3633567|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3807059|NCT01787838|3633567|B1|||Age||years|Mean|57|57.0|Full Range|||19.0|84.0|
3807060|NCT01787825|3633571|B1|United States||Region of Enrollment||participants|Number|80|80.0||||||
3807061|NCT01787825|3633571|B1|Canada||Region of Enrollment||participants|Number|40|40.0||||||
3807062|NCT01787825|3633571|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3807063|NCT01787825|3633571|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807064|NCT01787825|3633571|B1||White|Race (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
3807065|NCT01787825|3633571|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3807066|NCT01787825|3633571|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3807067|NCT01787825|3633571|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3807068|NCT01787825|3633571|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807069|NCT01787825|3633571|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807070|NCT01787825|3633571|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3807071|NCT01787825|3633571|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3807072|NCT01787825|3633571|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3807073|NCT01787825|3633571|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3807074|NCT01787825|3633571|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|15.42|15.42|||
3807075|NCT01787799|3633583|B1|Percent Diameter Stenosis||Lesion Characteristics||mm|Mean|67.54|67.54|Standard Deviation|9.59|9.59|||
3807076|NCT01787799|3633583|B1|Minimum Lumen Diameter||Lesion Characteristics||mm|Mean|0.86|0.86|Standard Deviation|0.28|0.28|||
3807077|NCT01787799|3633583|B1|Lesion Length||Lesion Characteristics||mm|Mean|14.38|14.38|Standard Deviation|7.49|7.49|||
3807078|NCT01787799|3633583|B1|Reference Vessel Diameter||Lesion Characteristics||mm|Mean|2.66|2.66|Standard Deviation|0.46|0.46|||
3807079|NCT01787799|3633583|B1|Current Diabetes Mellitus; Medically Treated||Cardiac Risk Factors|The same participant may be included in more than one category therefore the number of participants does not equal the total number of participants in the group.|participants|Number|17|17.0||||||
3807080|NCT01787799|3633583|B1|History of Myocardial Infarction||Cardiac Risk Factors|The same participant may be included in more than one category therefore the number of participants does not equal the total number of participants in the group.|participants|Number|18|18.0||||||
3807137|NCT01787591|3633604|B3|||Triglyceride||mg/dL|Mean|117.4|117.4|Standard Deviation|62.8|62.8|||
3807081|NCT01787799|3633583|B1|History of PCI||Cardiac Risk Factors|The same participant may be included in more than one category therefore the number of participants does not equal the total number of participants in the group.|participants|Number|33|33.0||||||
3807082|NCT01787799|3633583|B1|Family History of Coronary Artery Disease||Cardiac Risk Factors|The same participant may be included in more than one category therefore the number of participants does not equal the total number of participants in the group.|participants|Number|57|57.0||||||
3807083|NCT01787799|3633583|B1|Hypertension Requiring Medication||Cardiac Risk Factors|The same participant may be included in more than one category therefore the number of participants does not equal the total number of participants in the group.|participants|Number|71|71.0||||||
3807084|NCT01787799|3633583|B1|Hyperlipidemia Requiring Medication||Cardiac Risk Factors|The same participant may be included in more than one category therefore the number of participants does not equal the total number of participants in the group.|participants|Number|90|90.0||||||
3807085|NCT01787799|3633583|B1|Australia||Region of Enrollment||participants|Number|10|10.0||||||
3807086|NCT01787799|3633583|B1|Japan||Region of Enrollment||participants|Number|10|10.0||||||
3807087|NCT01787799|3633583|B1|Singapore||Region of Enrollment||participants|Number|11|11.0||||||
3807088|NCT01787799|3633583|B1|New Zealand||Region of Enrollment||participants|Number|69|69.0||||||
3807089|NCT01787799|3633583|B1|Not disclosed||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3807090|NCT01787799|3633583|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3807091|NCT01787799|3633583|B1|Native Hawaiian or other Pacific Islader||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3807092|NCT01787799|3633583|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3807093|NCT01787799|3633583|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
3807094|NCT01787799|3633583|B1|Black, of African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3807095|NCT01787799|3633583|B1|Asian||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3807096|NCT01787799|3633583|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3807097|NCT01787799|3633583|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3807098|NCT01787799|3633583|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3807099|NCT01787799|3633583|B1|||Age||years|Mean|64.49|64.49|Standard Deviation|10.21|10.21|||
3807100|NCT01787760|3633587|B4|United States|Hong Kong|Region of Enrollment||Participants|Count of Participants|152|152.0||||||
3807101|NCT01787760|3633588|B3|United States|Hong Kong|Region of Enrollment||Participants|Count of Participants|51|51.0||||||
3807102|NCT01787760|3633589|B2|United States|Hong Kong|Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3807103|NCT01787760|3633590|B1|United States|Hong Kong|Region of Enrollment||Participants|Count of Participants|51|51.0||||||
3807104|NCT01787760|3633587|B4||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3807105|NCT01787760|3633588|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3807106|NCT01787760|3633589|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3807107|NCT01787760|3633590|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3807108|NCT01787760|3633587|B4||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3807109|NCT01787760|3633588|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3807110|NCT01787760|3633589|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3807111|NCT01787760|3633590|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3807112|NCT01787760|3633587|B4|||Age||years|Mean|9.5|9.5|Standard Deviation|1.1|1.1|||
3807113|NCT01787760|3633588|B3|||Age||years|Mean|9.5|9.5|Standard Deviation|1.1|1.1|||
3807114|NCT01787760|3633589|B2|||Age||years|Mean|9.6|9.6|Standard Deviation|1.1|1.1|||
3807115|NCT01787760|3633590|B1|||Age||years|Mean|9.5|9.5|Standard Deviation|1.1|1.1|||
3807116|NCT01787760|3633587|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3807117|NCT01787760|3633588|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3807118|NCT01787760|3633589|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3807119|NCT01787760|3633590|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3807120|NCT01787760|3633587|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3807121|NCT01787760|3633588|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3807122|NCT01787760|3633589|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3807123|NCT01787760|3633590|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3807124|NCT01787760|3633587|B4||<=18 years|Age||Participants|Count of Participants|152|152.0||||||
3807125|NCT01787760|3633588|B3||<=18 years|Age||Participants|Count of Participants|51|51.0||||||
3807126|NCT01787760|3633589|B2||<=18 years|Age||Participants|Count of Participants|50|50.0||||||
3807127|NCT01787760|3633590|B1||<=18 years|Age||Participants|Count of Participants|51|51.0||||||
3807128|NCT01787591|3633604|B3|||alpha-tocopherol||umol/mmol lipid|Mean|4.13|4.13|Standard Deviation|0.93|0.93|||
3807129|NCT01787591|3633605|B2|||alpha-tocopherol||umol/mmol lipid|Mean|3.71|3.71|Standard Deviation|0.85|0.85|||
3807130|NCT01787591|3633606|B1|||alpha-tocopherol||umol/mmol lipid|Mean|4.54|4.54|Standard Deviation|0.85|0.85|||
3807131|NCT01787591|3633604|B3|||alpha-tocopherol||umol/L|Mean|23.1|23.1|Standard Deviation|3.4|3.4|||
3807132|NCT01787591|3633605|B2|||alpha-tocopherol||umol/L|Mean|23.9|23.9|Standard Deviation|2.8|2.8|||
3807133|NCT01787591|3633606|B1|||alpha-tocopherol||umol/L|Mean|22.2|22.2|Standard Deviation|3.9|3.9|||
3807134|NCT01787591|3633604|B3|||HDL cholesterol||mg/dL|Mean|48.6|48.6|Standard Deviation|12.6|12.6|||
3807135|NCT01787591|3633605|B2|||HDL cholesterol||mg/dL|Mean|41.2|41.2|Standard Deviation|10.8|10.8|||
3807138|NCT01787591|3633605|B2|||Triglyceride||mg/dL|Mean|152.7|152.7|Standard Deviation|68.1|68.1|||
3807139|NCT01787591|3633606|B1|||Triglyceride||mg/dL|Mean|82.0|82.0|Standard Deviation|30.4|30.4|||
3807140|NCT01787591|3633604|B3|||Waist Circumference||cm|Mean|95.7|95.7|Standard Deviation|27.0|27.0|||
3807141|NCT01787591|3633605|B2|||Waist Circumference||cm|Mean|116.1|116.1|Standard Deviation|23.7|23.7|||
3807142|NCT01787591|3633606|B1|||Waist Circumference||cm|Mean|75.2|75.2|Standard Deviation|6.5|6.5|||
3807143|NCT01787591|3633604|B3|||Diastolic Blood Pressure||mmHg|Mean|76.5|76.5|Standard Deviation|9.2|9.2|||
3807144|NCT01787591|3633605|B2|||Diastolic Blood Pressure||mmHg|Mean|79.0|79.0|Standard Deviation|10.1|10.1|||
3807145|NCT01787591|3633606|B1|||Diastolic Blood Pressure||mmHg|Mean|74.0|74.0|Standard Deviation|7.9|7.9|||
3807146|NCT01787591|3633604|B3|||Systolic Blood Pressure||mmHg|Mean|123.5|123.5|Standard Deviation|18.1|18.1|||
3807147|NCT01787591|3633605|B2|||Systolic Blood Pressure||mmHg|Mean|128.2|128.2|Standard Deviation|23.6|23.6|||
3807148|NCT01787591|3633606|B1|||Systolic Blood Pressure||mmHg|Mean|118.8|118.8|Standard Deviation|9.5|9.5|||
3807149|NCT01787591|3633604|B3|||Glucose||mg/dL|Mean|98.4|98.4|Standard Deviation|13.9|13.9|||
3807150|NCT01787591|3633605|B2|||Glucose||mg/dL|Mean|107.6|107.6|Standard Deviation|4.2|4.2|||
3807151|NCT01787591|3633606|B1|||Glucose||mg/dL|Mean|89.2|89.2|Standard Deviation|6.2|6.2|||
3807152|NCT01787591|3633604|B3|||Body mass index||kg/m2|Mean|30.2|30.2|Standard Deviation|10.2|10.2|||
3807153|NCT01787591|3633605|B2|||Body mass index||kg/m2|Mean|37.7|37.7|Standard Deviation|9.4|9.4|||
3807154|NCT01787591|3633606|B1|||Body mass index||kg/m2|Mean|22.6|22.6|Standard Deviation|2.2|2.2|||
3807155|NCT01787591|3633604|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3807156|NCT01787591|3633605|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3807157|NCT01787591|3633606|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3807158|NCT01787591|3633604|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3807159|NCT01787591|3633605|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3807160|NCT01787591|3633606|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3807161|NCT01787591|3633604|B3|||Age||years|Mean|31.6|31.6|Standard Deviation|4.7|4.7|||
3807162|NCT01787591|3633605|B2|||Age||years|Mean|32.8|32.8|Standard Deviation|5.1|5.1|||
3807163|NCT01787591|3633606|B1|||Age||years|Mean|30.3|30.3|Standard Deviation|4|4.0|||
3807164|NCT01787461|3633635|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3807165|NCT01787461|3633636|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3807166|NCT01787461|3633637|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3807167|NCT01787461|3633635|B3||Female|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
3807168|NCT01787461|3633636|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3807169|NCT01787461|3633637|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3807170|NCT01787461|3633635|B3|||Age||years|Mean|52.6|52.6|Standard Deviation|6.96|6.96|||
3807171|NCT01787461|3633636|B2|||Age||years|Mean|52.7|52.7|Standard Deviation|6.58|6.58|||
3807172|NCT01787461|3633637|B1|||Age||years|Mean|52.5|52.5|Standard Deviation|7.38|7.38|||
3807173|NCT01787383|3633664|B3|Spain||Region of Enrollment||participants|Number|75|75.0||||||
3807174|NCT01787383|3633665|B2|Spain||Region of Enrollment||participants|Number|37|37.0||||||
3807175|NCT01787383|3633666|B1|Spain||Region of Enrollment||participants|Number|38|38.0||||||
3807176|NCT01787383|3633664|B3|Italy||Region of Enrollment||participants|Number|124|124.0||||||
3807177|NCT01787383|3633665|B2|Italy||Region of Enrollment||participants|Number|61|61.0||||||
3807178|NCT01787383|3633666|B1|Italy||Region of Enrollment||participants|Number|63|63.0||||||
3807179|NCT01787383|3633664|B3||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3807180|NCT01787383|3633665|B2||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3807181|NCT01787383|3633666|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3807182|NCT01787383|3633664|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3807183|NCT01787383|3633665|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3807184|NCT01787383|3633666|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3807185|NCT01787383|3633664|B3|||Age||years|Mean|74.5|74.5|Full Range|||43.0|94.0|
3807186|NCT01787383|3633665|B2|||Age||years|Mean|74.5|74.5|Full Range|||48.0|92.0|
3807187|NCT01787383|3633666|B1|||Age||years|Mean|74.4|74.4|Full Range|||43.0|94.0|
3807188|NCT01787383|3633664|B3||>=65 years|Age||Participants|Count of Participants|178|178.0||||||
3807189|NCT01787383|3633665|B2||>=65 years|Age||Participants|Count of Participants|89|89.0||||||
3807190|NCT01787383|3633666|B1||>=65 years|Age||Participants|Count of Participants|89|89.0||||||
3807191|NCT01787383|3633664|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3807192|NCT01787383|3633665|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3807193|NCT01787383|3633666|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3807194|NCT01787383|3633664|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3807195|NCT01787383|3633665|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3807196|NCT01787383|3633666|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3807197|NCT01787331|3633687|B1|||PSA doubling time at the time of study entry||months|Mean|5.72|5.72|Full Range|||1.16|13.05|
3807198|NCT01787331|3633687|B1|||Time interval from biochemical relapse to study entry||years|Mean|4.01|4.01|Full Range|||0.13|16.44|
3807343|NCT01787032|3633792|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3807199|NCT01787331|3633687|B1|Gleason grade > 7 (high grade)||Gleason Grade at Time of Diagnosis|Gleason grade is determined at the time of diagnosis based on pathology review of prostate cancer biopsy or surgical specimen. A higher Gleason grade (> 7) is associated with a higher chance for disease recurrence and shorter long-term survival.|Participants|Count of Participants|7|7.0||||||
3807200|NCT01787331|3633687|B1|Gleason grade ≤ 7 (low/intermediate grade)||Gleason Grade at Time of Diagnosis|Gleason grade is determined at the time of diagnosis based on pathology review of prostate cancer biopsy or surgical specimen. A higher Gleason grade (> 7) is associated with a higher chance for disease recurrence and shorter long-term survival.|Participants|Count of Participants|14|14.0||||||
3807201|NCT01787331|3633687|B1|||Years since diagnosis of prostate cancer||years|Mean|7.83|7.83|Full Range|||0.63|18.01|
3807202|NCT01787331|3633687|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807203|NCT01787331|3633687|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807204|NCT01787331|3633687|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3807205|NCT01787331|3633687|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807206|NCT01787331|3633687|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807207|NCT01787331|3633687|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3807208|NCT01787331|3633687|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807209|NCT01787331|3633687|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807210|NCT01787331|3633687|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3807211|NCT01787331|3633687|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3807212|NCT01787331|3633687|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3807213|NCT01787331|3633687|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3807214|NCT01787331|3633687|B1|70-79 Years||Age, Customized||participants|Number|9|9.0||||||
3807215|NCT01787331|3633687|B1|60-69 Years||Age, Customized||participants|Number|10|10.0||||||
3807216|NCT01787331|3633687|B1|50-59 Years||Age, Customized||participants|Number|1|1.0||||||
3807217|NCT01787331|3633687|B1|40-49 Years||Age, Customized||participants|Number|1|1.0||||||
3807218|NCT01787279|3633694|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3807219|NCT01787279|3633694|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3807220|NCT01787279|3633694|B1|||Age||years|Mean|41|41.0|Standard Deviation|11|11.0|||
3807221|NCT01787240|3633703|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3807222|NCT01787240|3633704|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3807223|NCT01787240|3633705|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3807224|NCT01787240|3633703|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3807225|NCT01787240|3633704|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3807226|NCT01787240|3633705|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3807227|NCT01787240|3633703|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3807228|NCT01787240|3633704|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3807229|NCT01787240|3633705|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3807230|NCT01787240|3633703|B3|||Age||Years|Mean|32.7|32.7|Standard Deviation|13.23|13.23|||
3807231|NCT01787240|3633704|B2|||Age||Years|Mean|33|33.0|Standard Deviation|11.64|11.64|||
3807232|NCT01787240|3633705|B1|||Age||Years|Mean|32.6|32.6|Standard Deviation|14.10|14.1|||
3807233|NCT01787240|3633703|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3807234|NCT01787240|3633704|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3807235|NCT01787240|3633705|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3807236|NCT01787240|3633703|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3807237|NCT01787240|3633704|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3807238|NCT01787240|3633705|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3807239|NCT01787240|3633703|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3807240|NCT01787240|3633704|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3807241|NCT01787240|3633705|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3807242|NCT01787188|3633717|B4|||Baseline Total Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Score|"The pain, stiffness, and physical function in subjects with osteoarthritis were measured at baseline using the total Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scale. The total WOMAC score is the average of the mean visual analogue scale scores, with 0 mm meaning No Limitation and 100 mm meaning Extreme Limitation.~Baseline total WOMAC score was calculated for 138 subjects in the Meloxicam 5 mg once daily group, 130 subjects in the Meloxicam 10 mg once daily group, and 131 subjects in the placebo group."|mm|Mean|68.91|68.91|Standard Deviation|15.870|15.87|||
3807243|NCT01787188|3633718|B3|||Baseline Total Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Score|"The pain, stiffness, and physical function in subjects with osteoarthritis were measured at baseline using the total Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scale. The total WOMAC score is the average of the mean visual analogue scale scores, with 0 mm meaning No Limitation and 100 mm meaning Extreme Limitation.~Baseline total WOMAC score was calculated for 138 subjects in the Meloxicam 5 mg once daily group, 130 subjects in the Meloxicam 10 mg once daily group, and 131 subjects in the placebo group."|mm|Mean|69.75|69.75|Standard Deviation|16.134|16.134|||
3807284|NCT01787188|3633719|B2|Asian||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|1|1.0||||||
3807244|NCT01787188|3633719|B2|||Baseline Total Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Score|"The pain, stiffness, and physical function in subjects with osteoarthritis were measured at baseline using the total Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scale. The total WOMAC score is the average of the mean visual analogue scale scores, with 0 mm meaning No Limitation and 100 mm meaning Extreme Limitation.~Baseline total WOMAC score was calculated for 138 subjects in the Meloxicam 5 mg once daily group, 130 subjects in the Meloxicam 10 mg once daily group, and 131 subjects in the placebo group."|mm|Mean|68.74|68.74|Standard Deviation|15.193|15.193|||
3807245|NCT01787188|3633720|B1|||Baseline Total Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Score|"The pain, stiffness, and physical function in subjects with osteoarthritis were measured at baseline using the total Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scale. The total WOMAC score is the average of the mean visual analogue scale scores, with 0 mm meaning No Limitation and 100 mm meaning Extreme Limitation.~Baseline total WOMAC score was calculated for 138 subjects in the Meloxicam 5 mg once daily group, 130 subjects in the Meloxicam 10 mg once daily group, and 131 subjects in the placebo group."|mm|Mean|68.27|68.27|Standard Deviation|16.315|16.315|||
3807246|NCT01787188|3633717|B4|||Baseline Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Stiffness Subscore|"The stiffness in osteoarthritis subjects within the past 24 hours was measured at baseline using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) stiffness subscale score. The WOMAC stiffness subscale score is calculated as the mean of the visual analogue scale scores from 2 stiffness subscale questions, with 0 mm meaning No Stiffness and 100 mm meaning Worst Possible Stiffness.~The stiffness subscale score was calculated for 139 subjects in the Meloxicam 5 mg group, 130 in the Meloxicam 10 mg group, and 132 in the placebo group."|mm|Mean|70.71|70.71|Standard Deviation|18.363|18.363|||
3807247|NCT01787188|3633718|B3|||Baseline Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Stiffness Subscore|"The stiffness in osteoarthritis subjects within the past 24 hours was measured at baseline using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) stiffness subscale score. The WOMAC stiffness subscale score is calculated as the mean of the visual analogue scale scores from 2 stiffness subscale questions, with 0 mm meaning No Stiffness and 100 mm meaning Worst Possible Stiffness.~The stiffness subscale score was calculated for 139 subjects in the Meloxicam 5 mg group, 130 in the Meloxicam 10 mg group, and 132 in the placebo group."|mm|Mean|72.65|72.65|Standard Deviation|17.056|17.056|||
3807248|NCT01787188|3633719|B2|||Baseline Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Stiffness Subscore|"The stiffness in osteoarthritis subjects within the past 24 hours was measured at baseline using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) stiffness subscale score. The WOMAC stiffness subscale score is calculated as the mean of the visual analogue scale scores from 2 stiffness subscale questions, with 0 mm meaning No Stiffness and 100 mm meaning Worst Possible Stiffness.~The stiffness subscale score was calculated for 139 subjects in the Meloxicam 5 mg group, 130 in the Meloxicam 10 mg group, and 132 in the placebo group."|mm|Mean|69.19|69.19|Standard Deviation|19.569|19.569|||
3807249|NCT01787188|3633720|B1|||Baseline Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Stiffness Subscore|"The stiffness in osteoarthritis subjects within the past 24 hours was measured at baseline using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) stiffness subscale score. The WOMAC stiffness subscale score is calculated as the mean of the visual analogue scale scores from 2 stiffness subscale questions, with 0 mm meaning No Stiffness and 100 mm meaning Worst Possible Stiffness.~The stiffness subscale score was calculated for 139 subjects in the Meloxicam 5 mg group, 130 in the Meloxicam 10 mg group, and 132 in the placebo group."|mm|Mean|70.30|70.3|Standard Deviation|18.367|18.367|||
3807250|NCT01787188|3633717|B4|||Baseline Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Function Subscore|"The function in osteoarthritis subjects within the past 24 hours was measured at baseline using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) function subscale score. The WOMAC function subscale score is calculated as the mean of the visual analogue scale scores from 17 function subscale questions, with 0 mm meaning No Functional Limitation and 100 mm meaning Worst Possible Functional Limitation.~The function subscale score was calculated for 138 subjects in the Meloxicam 5 mg group, 130 in the Meloxicam 10 mg group, and 132 in the placebo group."|mm|Mean|67.69|67.69|Standard Deviation|17.505|17.505|||
3807251|NCT01787188|3633718|B3|||Baseline Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Function Subscore|"The function in osteoarthritis subjects within the past 24 hours was measured at baseline using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) function subscale score. The WOMAC function subscale score is calculated as the mean of the visual analogue scale scores from 17 function subscale questions, with 0 mm meaning No Functional Limitation and 100 mm meaning Worst Possible Functional Limitation.~The function subscale score was calculated for 138 subjects in the Meloxicam 5 mg group, 130 in the Meloxicam 10 mg group, and 132 in the placebo group."|mm|Mean|68.61|68.61|Standard Deviation|17.623|17.623|||
3807252|NCT01787188|3633719|B2|||Baseline Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Function Subscore|"The function in osteoarthritis subjects within the past 24 hours was measured at baseline using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) function subscale score. The WOMAC function subscale score is calculated as the mean of the visual analogue scale scores from 17 function subscale questions, with 0 mm meaning No Functional Limitation and 100 mm meaning Worst Possible Functional Limitation.~The function subscale score was calculated for 138 subjects in the Meloxicam 5 mg group, 130 in the Meloxicam 10 mg group, and 132 in the placebo group."|mm|Mean|67.66|67.66|Standard Deviation|16.873|16.873|||
3807253|NCT01787188|3633720|B1|||Baseline Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Function Subscore|"The function in osteoarthritis subjects within the past 24 hours was measured at baseline using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) function subscale score. The WOMAC function subscale score is calculated as the mean of the visual analogue scale scores from 17 function subscale questions, with 0 mm meaning No Functional Limitation and 100 mm meaning Worst Possible Functional Limitation.~The function subscale score was calculated for 138 subjects in the Meloxicam 5 mg group, 130 in the Meloxicam 10 mg group, and 132 in the placebo group."|mm|Mean|66.83|66.83|Standard Deviation|18.051|18.051|||
3807285|NCT01787188|3633720|B1|Asian||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|0|0.0||||||
3807254|NCT01787188|3633717|B4|||Baseline Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscale Score|"The pain in osteoarthritis subjects within the past 24 hours was measured at baseline using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain subscale score. The WOMAC pain subscale score is calculated as the mean of the visual analogue scale scores from 5 pain subscale questions, with 0 mm meaning No Pain and 100 mm meaning Worst Possible Pain.~The pain subscore was calculated for 139 subjects in the Meloxicam 5 mg group, 130 in the Meloxicam 10 mg group, and 133 in the placebo group."|mm|Mean|72.64|72.64|Standard Deviation|14.922|14.922|||
3807255|NCT01787188|3633718|B3|||Baseline Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscale Score|"The pain in osteoarthritis subjects within the past 24 hours was measured at baseline using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain subscale score. The WOMAC pain subscale score is calculated as the mean of the visual analogue scale scores from 5 pain subscale questions, with 0 mm meaning No Pain and 100 mm meaning Worst Possible Pain.~The pain subscore was calculated for 139 subjects in the Meloxicam 5 mg group, 130 in the Meloxicam 10 mg group, and 133 in the placebo group."|mm|Mean|73.20|73.2|Standard Deviation|15.472|15.472|||
3807256|NCT01787188|3633719|B2|||Baseline Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscale Score|"The pain in osteoarthritis subjects within the past 24 hours was measured at baseline using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain subscale score. The WOMAC pain subscale score is calculated as the mean of the visual analogue scale scores from 5 pain subscale questions, with 0 mm meaning No Pain and 100 mm meaning Worst Possible Pain.~The pain subscore was calculated for 139 subjects in the Meloxicam 5 mg group, 130 in the Meloxicam 10 mg group, and 133 in the placebo group."|mm|Mean|72.19|72.19|Standard Deviation|13.938|13.938|||
3807257|NCT01787188|3633720|B1|||Baseline Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscale Score|"The pain in osteoarthritis subjects within the past 24 hours was measured at baseline using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain subscale score. The WOMAC pain subscale score is calculated as the mean of the visual analogue scale scores from 5 pain subscale questions, with 0 mm meaning No Pain and 100 mm meaning Worst Possible Pain.~The pain subscore was calculated for 139 subjects in the Meloxicam 5 mg group, 130 in the Meloxicam 10 mg group, and 133 in the placebo group."|mm|Mean|72.51|72.51|Standard Deviation|15.360|15.36|||
3807258|NCT01787188|3633717|B4|||Body Mass Index||kg/m^2|Mean|30.9|30.9|Standard Deviation|5.01|5.01|||
3807259|NCT01787188|3633718|B3|||Body Mass Index||kg/m^2|Mean|31.3|31.3|Standard Deviation|4.95|4.95|||
3807260|NCT01787188|3633719|B2|||Body Mass Index||kg/m^2|Mean|30.5|30.5|Standard Deviation|5.31|5.31|||
3807261|NCT01787188|3633720|B1|||Body Mass Index||kg/m^2|Mean|31.1|31.1|Standard Deviation|4.77|4.77|||
3807262|NCT01787188|3633717|B4|||Height||cm|Mean|168.5|168.5|Standard Deviation|10.10|10.1|||
3807263|NCT01787188|3633718|B3|||Height||cm|Mean|168.6|168.6|Standard Deviation|10.37|10.37|||
3807264|NCT01787188|3633719|B2|||Height||cm|Mean|167.9|167.9|Standard Deviation|9.66|9.66|||
3807265|NCT01787188|3633720|B1|||Height||cm|Mean|168.9|168.9|Standard Deviation|10.28|10.28|||
3807266|NCT01787188|3633717|B4|||Weight||kg|Mean|88.1|88.1|Standard Deviation|17.06|17.06|||
3807267|NCT01787188|3633718|B3|||Weight||kg|Mean|89.2|89.2|Standard Deviation|17.27|17.27|||
3807268|NCT01787188|3633719|B2|||Weight||kg|Mean|85.9|85.9|Standard Deviation|16.82|16.82|||
3807269|NCT01787188|3633720|B1|||Weight||kg|Mean|89.0|89.0|Standard Deviation|17.00|17.0|||
3807270|NCT01787188|3633717|B4|White||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|316|316.0||||||
3807271|NCT01787188|3633718|B3|White||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|110|110.0||||||
3807272|NCT01787188|3633719|B2|White||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|98|98.0||||||
3807273|NCT01787188|3633720|B1|White||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|108|108.0||||||
3807274|NCT01787188|3633717|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|4|4.0||||||
3807275|NCT01787188|3633718|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|0|0.0||||||
3807276|NCT01787188|3633719|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|2|2.0||||||
3807277|NCT01787188|3633720|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|2|2.0||||||
3807278|NCT01787188|3633717|B4|Black or African-American||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|79|79.0||||||
3807279|NCT01787188|3633718|B3|Black or African-American||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|23|23.0||||||
3807280|NCT01787188|3633719|B2|Black or African-American||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|29|29.0||||||
3807281|NCT01787188|3633720|B1|Black or African-American||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|27|27.0||||||
3807282|NCT01787188|3633717|B4|Asian||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|1|1.0||||||
3807283|NCT01787188|3633718|B3|Asian||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|0|0.0||||||
3807342|NCT01787032|3633791|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3807286|NCT01787188|3633717|B4|American Indian or Alaska Native||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|3|3.0||||||
3807287|NCT01787188|3633718|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|0|0.0||||||
3807288|NCT01787188|3633719|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|1|1.0||||||
3807289|NCT01787188|3633720|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|2|2.0||||||
3807290|NCT01787188|3633717|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807291|NCT01787188|3633718|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807292|NCT01787188|3633719|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807293|NCT01787188|3633720|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807294|NCT01787188|3633717|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|369|369.0||||||
3807295|NCT01787188|3633718|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
3807296|NCT01787188|3633719|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
3807297|NCT01787188|3633720|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
3807298|NCT01787188|3633717|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3807299|NCT01787188|3633718|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3807300|NCT01787188|3633719|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3807301|NCT01787188|3633720|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3807302|NCT01787188|3633717|B4||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3807303|NCT01787188|3633718|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3807304|NCT01787188|3633719|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3807305|NCT01787188|3633720|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3807306|NCT01787188|3633717|B4||Female|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
3807307|NCT01787188|3633718|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3807308|NCT01787188|3633719|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3807309|NCT01787188|3633720|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3807310|NCT01787188|3633717|B4|||Age||years|Mean|60.7|60.7|Standard Deviation|9.01|9.01|||
3807311|NCT01787188|3633718|B3|||Age||years|Mean|61.1|61.1|Standard Deviation|9.26|9.26|||
3807312|NCT01787188|3633719|B2|||Age||years|Mean|60.2|60.2|Standard Deviation|8.77|8.77|||
3807313|NCT01787188|3633720|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|9.05|9.05|||
3807314|NCT01787175|3633775|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
3807315|NCT01787175|3633776|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
3807316|NCT01787175|3633777|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3807317|NCT01787175|3633775|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3807318|NCT01787175|3633776|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3807319|NCT01787175|3633777|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3807320|NCT01787175|3633775|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3807321|NCT01787175|3633776|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3807322|NCT01787175|3633777|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3807323|NCT01787175|3633775|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3807324|NCT01787175|3633776|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3807325|NCT01787175|3633777|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3807326|NCT01787175|3633775|B3||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3807327|NCT01787175|3633776|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3807328|NCT01787175|3633777|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3807329|NCT01787175|3633775|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3807330|NCT01787175|3633776|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3807331|NCT01787175|3633777|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3807332|NCT01787032|3633788|B7||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3807333|NCT01787032|3633789|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3807334|NCT01787032|3633790|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3807335|NCT01787032|3633791|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3807336|NCT01787032|3633792|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3807337|NCT01787032|3633793|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3807338|NCT01787032|3633794|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3807339|NCT01787032|3633788|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3807340|NCT01787032|3633789|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3807341|NCT01787032|3633790|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3807344|NCT01787032|3633793|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3807345|NCT01787032|3633794|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3807346|NCT01787032|3633788|B7|||Age||Years|Mean|36.3|36.3|Standard Deviation|9.2|9.2|||
3807347|NCT01787032|3633789|B6|||Age||Years|Mean|37.3|37.3|Standard Deviation|12.5|12.5|||
3807348|NCT01787032|3633790|B5|||Age||Years|Mean|32.8|32.8|Standard Deviation|9.9|9.9|||
3807349|NCT01787032|3633791|B4|||Age||Years|Mean|35.3|35.3|Standard Deviation|8.4|8.4|||
3807350|NCT01787032|3633792|B3|||Age||Years|Mean|35.0|35.0|Standard Deviation|6.2|6.2|||
3807351|NCT01787032|3633793|B2|||Age||Years|Mean|33.3|33.3|Standard Deviation|12.3|12.3|||
3807352|NCT01787032|3633794|B1|||Age||Years|Mean|45.0|45.0|Standard Deviation|1.7|1.7|||
3807353|NCT01786993|3633821|B3|None||Cardiomyopathy Etiology||participants|Number|3|3.0||||||
3807354|NCT01786993|3633822|B2|None||Cardiomyopathy Etiology||participants|Number|1|1.0||||||
3807355|NCT01786993|3633823|B1|None||Cardiomyopathy Etiology||participants|Number|2|2.0||||||
3807356|NCT01786993|3633821|B3|Non-ischemic||Cardiomyopathy Etiology||participants|Number|194|194.0||||||
3807357|NCT01786993|3633822|B2|Non-ischemic||Cardiomyopathy Etiology||participants|Number|91|91.0||||||
3807358|NCT01786993|3633823|B1|Non-ischemic||Cardiomyopathy Etiology||participants|Number|103|103.0||||||
3807359|NCT01786993|3633821|B3|Ischemic||Cardiomyopathy Etiology||participants|Number|184|184.0||||||
3807360|NCT01786993|3633822|B2|Ischemic||Cardiomyopathy Etiology||participants|Number|88|88.0||||||
3807361|NCT01786993|3633823|B1|Ischemic||Cardiomyopathy Etiology||participants|Number|96|96.0||||||
3807362|NCT01786993|3633821|B3|Unknown||QRS Morphology||participants|Number|2|2.0||||||
3807363|NCT01786993|3633822|B2|Unknown||QRS Morphology||participants|Number|0|0.0||||||
3807364|NCT01786993|3633823|B1|Unknown||QRS Morphology||participants|Number|2|2.0||||||
3807365|NCT01786993|3633821|B3|Interventricular Conduction Delay (IVCD)||QRS Morphology||participants|Number|53|53.0||||||
3807366|NCT01786993|3633822|B2|Interventricular Conduction Delay (IVCD)||QRS Morphology||participants|Number|21|21.0||||||
3807367|NCT01786993|3633823|B1|Interventricular Conduction Delay (IVCD)||QRS Morphology||participants|Number|32|32.0||||||
3807368|NCT01786993|3633821|B3|Right Bundle Branch Block (RBBB)||QRS Morphology||participants|Number|41|41.0||||||
3807369|NCT01786993|3633822|B2|Right Bundle Branch Block (RBBB)||QRS Morphology||participants|Number|20|20.0||||||
3807370|NCT01786993|3633823|B1|Right Bundle Branch Block (RBBB)||QRS Morphology||participants|Number|21|21.0||||||
3807371|NCT01786993|3633821|B3|Left Bundle Branch Block (LBBB)||QRS Morphology||participants|Number|285|285.0||||||
3807372|NCT01786993|3633822|B2|Left Bundle Branch Block (LBBB)||QRS Morphology||participants|Number|139|139.0||||||
3807373|NCT01786993|3633823|B1|Left Bundle Branch Block (LBBB)||QRS Morphology||participants|Number|146|146.0||||||
3807374|NCT01786993|3633821|B3|||QRS Duration||ms|Mean|156|156.0|Standard Deviation|22|22.0|||
3807375|NCT01786993|3633822|B2|||QRS Duration||ms|Mean|154|154.0|Standard Deviation|20|20.0|||
3807376|NCT01786993|3633823|B1|||QRS Duration||ms|Mean|158|158.0|Standard Deviation|24|24.0|||
3807377|NCT01786993|3633821|B3|Other||RACE||participants|Number|5|5.0||||||
3807378|NCT01786993|3633822|B2|Other||RACE||participants|Number|1|1.0||||||
3807379|NCT01786993|3633823|B1|Other||RACE||participants|Number|4|4.0||||||
3807380|NCT01786993|3633821|B3|Asian||RACE||participants|Number|2|2.0||||||
3807381|NCT01786993|3633822|B2|Asian||RACE||participants|Number|0|0.0||||||
3807382|NCT01786993|3633823|B1|Asian||RACE||participants|Number|2|2.0||||||
3807383|NCT01786993|3633821|B3|Black or African American||RACE||participants|Number|35|35.0||||||
3807384|NCT01786993|3633822|B2|Black or African American||RACE||participants|Number|16|16.0||||||
3807385|NCT01786993|3633823|B1|Black or African American||RACE||participants|Number|19|19.0||||||
3807386|NCT01786993|3633821|B3|White||RACE||participants|Number|339|339.0||||||
3807387|NCT01786993|3633822|B2|White||RACE||participants|Number|163|163.0||||||
3807388|NCT01786993|3633823|B1|White||RACE||participants|Number|176|176.0||||||
3807389|NCT01786993|3633821|B3|Non-Hispanic or Latino||Ethnicity||participants|Number|366|366.0||||||
3807390|NCT01786993|3633822|B2|Non-Hispanic or Latino||Ethnicity||participants|Number|175|175.0||||||
3807391|NCT01786993|3633823|B1|Non-Hispanic or Latino||Ethnicity||participants|Number|191|191.0||||||
3807392|NCT01786993|3633821|B3|Hispanic or Latino||Ethnicity||participants|Number|15|15.0||||||
3807393|NCT01786993|3633822|B2|Hispanic or Latino||Ethnicity||participants|Number|5|5.0||||||
3807394|NCT01786993|3633823|B1|Hispanic or Latino||Ethnicity||participants|Number|10|10.0||||||
3807395|NCT01786993|3633821|B3|United States||Region of Enrollment||participants|Number|381|381.0||||||
3807396|NCT01786993|3633822|B2|United States||Region of Enrollment||participants|Number|180|180.0||||||
3807397|NCT01786993|3633823|B1|United States||Region of Enrollment||participants|Number|201|201.0||||||
3807398|NCT01786993|3633821|B3||Male|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
3807399|NCT01786993|3633822|B2||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3807400|NCT01786993|3633823|B1||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3807401|NCT01786993|3633821|B3||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3807402|NCT01786993|3633822|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3807403|NCT01786993|3633823|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3807404|NCT01786993|3633821|B3|||Age||years|Mean|68|68.0|Standard Deviation|10|10.0|||
3807405|NCT01786993|3633822|B2|||Age||years|Mean|68|68.0|Standard Deviation|10|10.0|||
3807406|NCT01786993|3633823|B1|||Age||years|Mean|67|67.0|Standard Deviation|10|10.0|||
3807450|NCT01786707|3633881|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3807407|NCT01786967|3633831|B1|||Overactive bladder questionnaire - quality of life|Overactive bladder questionnaire (OABq) short form is a validated questionnaire that assesses symptom bother from OAB as well as health-related quality of life impact from overactive bladder (condition of urinary urgency, frequency and/or urgency incontinence). Subscales include coping, sleep and social. Higher scores indicate better health-related quality of life. Transformed scores range from 0-100.|units on a scale|Mean|48.0|48.0|Standard Deviation|19.8|19.8|||
3807408|NCT01786967|3633831|B1|||Overactive bladder questionnaire - symptom bother|Overactive bladder questionnaire (OABq) short form is a validated questionnaire that assesses symptom bother from OAB as well as health-related quality of life impact from overactive bladder (condition of urinary urgency, frequency and/or urgency incontinence). Higher scores indicate greater symptom severity. Transformed scores range from 0-100.|units on a scale|Mean|68.1|68.1|Standard Deviation|19.9|19.9|||
3807409|NCT01786967|3633831|B1|||Lawton IADL (Instrumental Activities of Daily Living Scale) score (total)|The Lawton Instrumental Activities of Daily Living Scale (IADL) assesses skills that are more complex than the basic activities of daily living (ie Katz ADLs). There are 8 domains of function including telephone use, food preparation, housekeeping, laundering, transportation, responsibility for own medications and handling finances. Scores for each of the 8 domains range from 0 to 1 such that total scores range from 0 to 8, with higher scores indicating higher function.|units on a scale|Median|8|8.0|Inter-Quartile Range|||8.0|8.0|
3807410|NCT01786967|3633831|B1|||Katz ADL (Activities of Daily Living) score (total)|The Katz Index of Independence in Activities of Daily Living (Katz ADL) assesses functional status as a measurement of the client’s ability to perform activities of daily living independently. The Index ranks adequacy of performance in the six functions of bathing, dressing, toileting, transferring, continence, and feeding. Participants are scored No or Yes (no=0 and yes=1) for independence in each of the six functions; thus, total scores range from 0 to 6, with a higher score indicating better function.|units on a scale|Median|5|5.0|Inter-Quartile Range|||5.0|5.0|
3807411|NCT01786967|3633831|B1||Current smoker-No|Current smoker||Participants|Count of Participants|59|59.0||||||
3807412|NCT01786967|3633831|B1||Current smoker-Yes|Current smoker||Participants|Count of Participants|2|2.0||||||
3807413|NCT01786967|3633831|B1|||Functional Comorbidity Index Score|The Functional Comorbidity Index (FCI) consists of 18 diagnoses associated with diminishing function where 1 point is assigned for the presence of each diagnosis. Points are summarized for an overall score ranging from 0 to 18. Higher scores reflect the presence of a greater number of comorbid conditions.|units on a scale|Median|3|3.0|Inter-Quartile Range|||2.5|4.5|
3807414|NCT01786967|3633831|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807415|NCT01786967|3633831|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807416|NCT01786967|3633831|B1||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3807417|NCT01786967|3633831|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3807418|NCT01786967|3633831|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807419|NCT01786967|3633831|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807420|NCT01786967|3633831|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807421|NCT01786967|3633831|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807422|NCT01786967|3633831|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3807423|NCT01786967|3633831|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3807424|NCT01786967|3633831|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3807425|NCT01786967|3633831|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3807426|NCT01786967|3633831|B1|||Age||years|Mean|69.2|69.2|Standard Deviation|8.1|8.1|||
3807427|NCT01786954|3633840|B1|United States||Region of Enrollment||participants|Number|68|68.0||||||
3807428|NCT01786954|3633840|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3807429|NCT01786954|3633840|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3807430|NCT01786954|3633840|B1|||Age||years|Mean|63|63.0|Standard Deviation|13|13.0|||
3807431|NCT01786902|3633851|B3|Korea, Republic of||Region of Enrollment||participants|Number|70|70.0||||||
3807432|NCT01786902|3633852|B2|Korea, Republic of||Region of Enrollment||participants|Number|34|34.0||||||
3807433|NCT01786902|3633853|B1|Korea, Republic of||Region of Enrollment||participants|Number|36|36.0||||||
3807434|NCT01786902|3633851|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3807435|NCT01786902|3633852|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3807436|NCT01786902|3633853|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3807437|NCT01786902|3633851|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3807438|NCT01786902|3633852|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3807439|NCT01786902|3633853|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3807440|NCT01786902|3633851|B3|||Age||years|Mean|6.96|6.96|Standard Deviation|2.07|2.07|||
3807441|NCT01786902|3633852|B2|||Age||years|Mean|7.17|7.17|Standard Deviation|2.34|2.34|||
3807442|NCT01786902|3633853|B1|||Age||years|Mean|6.75|6.75|Standard Deviation|1.79|1.79|||
3807443|NCT01786876|3633864|B1|UNITED STATES||Region of Enrollment||Participants|Number|6|6.0||||||
3807444|NCT01786876|3633864|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3807445|NCT01786876|3633864|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3807446|NCT01786876|3633864|B1|||Age||Years|Mean|29.5|29.5|Standard Deviation|2.07|2.07|||
3807447|NCT01786876|3633864|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3807448|NCT01786876|3633864|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3807449|NCT01786876|3633864|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3807451|NCT01786707|3633882|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3807452|NCT01786707|3633883|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3807453|NCT01786707|3633881|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3807454|NCT01786707|3633882|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3807455|NCT01786707|3633883|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3807456|NCT01786707|3633881|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3807457|NCT01786707|3633882|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3807458|NCT01786707|3633883|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3807459|NCT01786707|3633881|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3807460|NCT01786707|3633882|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3807461|NCT01786707|3633883|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3807462|NCT01786707|3633881|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3807463|NCT01786707|3633882|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3807464|NCT01786707|3633883|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3807465|NCT01786668|3633892|B5||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3807466|NCT01786668|3633893|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3807467|NCT01786668|3633894|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3807468|NCT01786668|3633895|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3807469|NCT01786668|3633896|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3807470|NCT01786668|3633892|B5||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3807471|NCT01786668|3633893|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3807472|NCT01786668|3633894|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3807473|NCT01786668|3633895|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3807474|NCT01786668|3633896|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3807475|NCT01786668|3633892|B5|Age||Age||Years|Mean|41.6|41.6|Standard Deviation|11.9|11.9|||
3807476|NCT01786668|3633893|B4|Age||Age||Years|Mean|41.9|41.9|Standard Deviation|12.9|12.9|||
3807477|NCT01786668|3633894|B3|Age||Age||Years|Mean|41.6|41.6|Standard Deviation|12.2|12.2|||
3807478|NCT01786668|3633895|B2|Age||Age||Years|Mean|41.2|41.2|Standard Deviation|10.3|10.3|||
3807479|NCT01786668|3633896|B1|Age||Age||Years|Mean|41.8|41.8|Standard Deviation|12.3|12.3|||
3807480|NCT01786629|3633997|B3|||Weight||lbs|Mean|190|190.0|Standard Deviation|45|45.0|||
3807481|NCT01786629|3633998|B2|||Weight||lbs|Mean|192|192.0|Standard Deviation|49|49.0|||
3807482|NCT01786629|3633999|B1|||Weight||lbs|Mean|188|188.0|Standard Deviation|39|39.0|||
3807483|NCT01786629|3633997|B3|United States||Region of Enrollment||participants|Number|338|338.0||||||
3807484|NCT01786629|3633998|B2|United States||Region of Enrollment||participants|Number|169|169.0||||||
3807485|NCT01786629|3633999|B1|United States||Region of Enrollment||participants|Number|169|169.0||||||
3807486|NCT01786629|3633997|B3||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3807487|NCT01786629|3633998|B2||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3807488|NCT01786629|3633999|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3807489|NCT01786629|3633997|B3||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
3807490|NCT01786629|3633998|B2||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3807491|NCT01786629|3633999|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3807492|NCT01786629|3633997|B3|||Age||years|Mean|57.8|57.8|Standard Deviation|10.0|10.0|||
3807493|NCT01786629|3633998|B2|||Age||years|Mean|57.8|57.8|Standard Deviation|9.6|9.6|||
3807494|NCT01786629|3633999|B1|||Age||years|Mean|57.9|57.9|Standard Deviation|10.4|10.4|||
3807495|NCT01786551|3634006|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3807496|NCT01786551|3634006|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3807497|NCT01786551|3634006|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3807498|NCT01786551|3634006|B1|||Age||years|Mean|25|25.0|Standard Deviation|8|8.0|||
3807499|NCT01786330|3634012|B3|||Number of pads used during 24 hours postoperative||pads used|Mean|5.38|5.38|Standard Deviation|2.1|2.1|||
3807500|NCT01786330|3634013|B2|||Number of pads used during 24 hours postoperative||pads used|Mean|5.48|5.48|Standard Deviation|1.95|1.95|||
3807501|NCT01786330|3634014|B1|||Number of pads used during 24 hours postoperative||pads used|Mean|5.29|5.29|Standard Deviation|2.27|2.27|||
3807502|NCT01786330|3634012|B3|||Received Duramorph||participants|Number|56|56.0||||||
3807503|NCT01786330|3634013|B2|||Received Duramorph||participants|Number|27|27.0||||||
3807504|NCT01786330|3634014|B1|||Received Duramorph||participants|Number|29|29.0||||||
3807505|NCT01786330|3634012|B3|||Received epidural||participants|Number|55|55.0||||||
3807506|NCT01786330|3634013|B2|||Received epidural||participants|Number|27|27.0||||||
3807507|NCT01786330|3634014|B1|||Received epidural||participants|Number|28|28.0||||||
3807508|NCT01786330|3634012|B3|||Breech presentation||participants|Number|6|6.0||||||
3807509|NCT01786330|3634013|B2|||Breech presentation||participants|Number|3|3.0||||||
3807510|NCT01786330|3634014|B1|||Breech presentation||participants|Number|3|3.0||||||
3807511|NCT01786330|3634012|B3|||Infant birth weight||grams|Mean|3580.8|3580.8|Standard Deviation|480.6|480.6|||
3807512|NCT01786330|3634013|B2|||Infant birth weight||grams|Mean|3525.2|3525.2|Standard Deviation|514.8|514.8|||
3807513|NCT01786330|3634014|B1|||Infant birth weight||grams|Mean|3632.5|3632.5|Standard Deviation|449.2|449.2|||
3807514|NCT01786330|3634012|B3|||Gestational age at cesarean delivery||weeks|Mean|39.2|39.2|Standard Deviation|0.5|0.5|||
3807515|NCT01786330|3634013|B2|||Gestational age at cesarean delivery||weeks|Mean|39.3|39.3|Standard Deviation|0.6|0.6|||
3807516|NCT01786330|3634014|B1|||Gestational age at cesarean delivery||weeks|Mean|39.1|39.1|Standard Deviation|0.3|0.3|||
3807517|NCT01786330|3634012|B3|||Body mass index calculated during 1st visit||kg/m^2|Mean|28.7|28.7|Standard Deviation|6.4|6.4|||
3807518|NCT01786330|3634013|B2|||Body mass index calculated during 1st visit||kg/m^2|Mean|28.6|28.6|Standard Deviation|6.3|6.3|||
3807519|NCT01786330|3634014|B1|||Body mass index calculated during 1st visit||kg/m^2|Mean|28.9|28.9|Standard Deviation|6.6|6.6|||
3807520|NCT01786330|3634012|B3|||Previous cesarean deliveries||cesarean deliveries|Median|1|1.0|Full Range|||0.0|4.0|
3807521|NCT01786330|3634013|B2|||Previous cesarean deliveries||cesarean deliveries|Median|1|1.0|Full Range|||0.0|3.0|
3807522|NCT01786330|3634014|B1|||Previous cesarean deliveries||cesarean deliveries|Median|1|1.0|Full Range|||0.0|4.0|
3807523|NCT01786330|3634012|B3|||Previous vaginal births||vaginal births|Median|0|0.0|Full Range|||0.0|3.0|
3807524|NCT01786330|3634013|B2|||Previous vaginal births||vaginal births|Median|0|0.0|Full Range|||0.0|1.0|
3807525|NCT01786330|3634014|B1|||Previous vaginal births||vaginal births|Median|0|0.0|Full Range|||0.0|3.0|
3807526|NCT01786330|3634012|B3|United States||Region of Enrollment||participants|Number|56|56.0||||||
3807527|NCT01786330|3634013|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
3807528|NCT01786330|3634014|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3807529|NCT01786330|3634012|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3807530|NCT01786330|3634013|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3807531|NCT01786330|3634014|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3807532|NCT01786330|3634012|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3807533|NCT01786330|3634013|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3807534|NCT01786330|3634014|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3807535|NCT01786330|3634012|B3|||Age||years|Mean|28.1|28.1|Standard Deviation|4.6|4.6|||
3807536|NCT01786330|3634013|B2|||Age||years|Mean|27.7|27.7|Standard Deviation|4.4|4.4|||
3807537|NCT01786330|3634014|B1|||Age||years|Mean|28.5|28.5|Standard Deviation|4.7|4.7|||
3807538|NCT01786252|3634027|B3|||Oocytes Retrieved||number of oocytes|Mean|19.9|19.9|Standard Deviation|8.7|8.7|||
3807539|NCT01786252|3634028|B2|||Oocytes Retrieved||number of oocytes|Mean|20.5|20.5|Standard Deviation|8.1|8.1|||
3807540|NCT01786252|3634029|B1|||Oocytes Retrieved||number of oocytes|Mean|19.1|19.1|Standard Deviation|9.9|9.9|||
3807541|NCT01786252|3634027|B3|||Cycle Length||Days|Mean|12.8|12.8|Standard Deviation|1.26|1.26|||
3807542|NCT01786252|3634028|B2|||Cycle Length||Days|Mean|13.25|13.25|Standard Deviation|1.49|1.49|||
3807543|NCT01786252|3634029|B1|||Cycle Length||Days|Mean|12.29|12.29|Standard Deviation|0.76|0.76|||
3807544|NCT01786252|3634027|B3|||Average Ovulatory hCG Provided||IU|Mean|7000|7000.0|Standard Deviation|2535|2535.0|||
3807545|NCT01786252|3634028|B2|||Average Ovulatory hCG Provided||IU|Mean|7500|7500.0|Standard Deviation|2673|2673.0|||
3807546|NCT01786252|3634029|B1|||Average Ovulatory hCG Provided||IU|Mean|6429|6429.0|Standard Deviation|2440|2440.0|||
3807547|NCT01786252|3634027|B3|||Max E2 Level Prior to Oocyte Retrieval||ng/mL|Mean|4274|4274.0|Standard Deviation|1255|1255.0|||
3807548|NCT01786252|3634028|B2|||Max E2 Level Prior to Oocyte Retrieval||ng/mL|Mean|4428|4428.0|Standard Deviation|1425|1425.0|||
3807549|NCT01786252|3634029|B1|||Max E2 Level Prior to Oocyte Retrieval||ng/mL|Mean|4097|4097.0|Standard Deviation|1112|1112.0|||
3807550|NCT01786252|3634027|B3|||Parity||Number of deliveries|Mean|1.2|1.2|Standard Deviation|0.9|0.9|||
3807551|NCT01786252|3634028|B2|||Parity||Number of deliveries|Mean|1.25|1.25|Standard Deviation|0.89|0.89|||
3807552|NCT01786252|3634029|B1|||Parity||Number of deliveries|Mean|1.14|1.14|Standard Deviation|1.07|1.07|||
3807553|NCT01786252|3634027|B3|||Gravidity||Number of times pregnant|Mean|1.53|1.53|Standard Deviation|1.19|1.19|||
3807554|NCT01786252|3634028|B2|||Gravidity||Number of times pregnant|Mean|1.63|1.63|Standard Deviation|1.30|1.3|||
3807555|NCT01786252|3634029|B1|||Gravidity||Number of times pregnant|Mean|1.43|1.43|Standard Deviation|1.13|1.13|||
3807556|NCT01786252|3634027|B3|||BMI||kg/m^2|Mean|24.3|24.3|Standard Deviation|3.2|3.2|||
3807557|NCT01786252|3634028|B2|||BMI||kg/m^2|Mean|23.3|23.3|Standard Deviation|2.2|2.2|||
3807558|NCT01786252|3634029|B1|||BMI||kg/m^2|Mean|25.3|25.3|Standard Deviation|3.8|3.8|||
3807559|NCT01786252|3634027|B3|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3807560|NCT01786252|3634028|B2|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3807561|NCT01786252|3634029|B1|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3807562|NCT01786252|3634027|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3807563|NCT01786252|3634028|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3807564|NCT01786252|3634029|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3807565|NCT01786252|3634027|B3||Female|Gender||Participants|Count of Participants|15|15.0||||||
3807566|NCT01786252|3634028|B2||Female|Gender||Participants|Count of Participants|8|8.0||||||
3807567|NCT01786252|3634029|B1||Female|Gender||Participants|Count of Participants|7|7.0||||||
3807568|NCT01786252|3634027|B3|||Age||years|Mean|25.7|25.7|Standard Deviation|3.2|3.2|||
3807569|NCT01786252|3634028|B2|||Age||years|Mean|26.3|26.3|Standard Deviation|1.35|1.35|||
3807570|NCT01786252|3634029|B1|||Age||years|Mean|25.0|25.0|Standard Deviation|0.976|0.976|||
3807571|NCT01786239|3634042|B3|Schizoaffective Disorder||Structured Clinical interview for DMS-IV (SCID)||participants|Number|1|1.0||||||
3807572|NCT01786239|3634043|B2|Schizoaffective Disorder||Structured Clinical interview for DMS-IV (SCID)||participants|Number|0|0.0||||||
3807573|NCT01786239|3634044|B1|Schizoaffective Disorder||Structured Clinical interview for DMS-IV (SCID)||participants|Number|1|1.0||||||
3807574|NCT01786239|3634042|B3|Psychosis NOS||Structured Clinical interview for DMS-IV (SCID)||participants|Number|1|1.0||||||
3807575|NCT01786239|3634043|B2|Psychosis NOS||Structured Clinical interview for DMS-IV (SCID)||participants|Number|1|1.0||||||
3807576|NCT01786239|3634044|B1|Psychosis NOS||Structured Clinical interview for DMS-IV (SCID)||participants|Number|0|0.0||||||
3807577|NCT01786239|3634042|B3|Bipolar 1 Disorder||Structured Clinical interview for DMS-IV (SCID)||participants|Number|4|4.0||||||
3807578|NCT01786239|3634043|B2|Bipolar 1 Disorder||Structured Clinical interview for DMS-IV (SCID)||participants|Number|2|2.0||||||
3807579|NCT01786239|3634044|B1|Bipolar 1 Disorder||Structured Clinical interview for DMS-IV (SCID)||participants|Number|2|2.0||||||
3807580|NCT01786239|3634042|B3|Schizophrenia||Structured Clinical interview for DMS-IV (SCID)||participants|Number|34|34.0||||||
3807581|NCT01786239|3634043|B2|Schizophrenia||Structured Clinical interview for DMS-IV (SCID)||participants|Number|17|17.0||||||
3807582|NCT01786239|3634044|B1|Schizophrenia||Structured Clinical interview for DMS-IV (SCID)||participants|Number|17|17.0||||||
3807583|NCT01786239|3634042|B3|Schizophreriform||Structured Clinical interview for DMS-IV (SCID)||participants|Number|10|10.0||||||
3807584|NCT01786239|3634043|B2|Schizophreriform||Structured Clinical interview for DMS-IV (SCID)||participants|Number|5|5.0||||||
3807585|NCT01786239|3634044|B1|Schizophreriform||Structured Clinical interview for DMS-IV (SCID)||participants|Number|5|5.0||||||
3807586|NCT01786239|3634042|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3807587|NCT01786239|3634043|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3807588|NCT01786239|3634044|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3807589|NCT01786239|3634042|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3807590|NCT01786239|3634043|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3807591|NCT01786239|3634044|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3807592|NCT01786239|3634042|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3807593|NCT01786239|3634043|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3807594|NCT01786239|3634044|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3807595|NCT01786239|3634042|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3807596|NCT01786239|3634043|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3807597|NCT01786239|3634044|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3807598|NCT01786239|3634042|B3||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3807599|NCT01786239|3634043|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3807600|NCT01786239|3634044|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3807601|NCT01786239|3634042|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3807602|NCT01786239|3634043|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3807603|NCT01786239|3634044|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3807604|NCT01786174|3634051|B3|||Body Mass Index (BMI)||kilograms/meter^2 (kg/m^2)|Mean|26.2|26.2|Standard Deviation|3.7|3.7|||
3807605|NCT01786174|3634052|B2|||Body Mass Index (BMI)||kilograms/meter^2 (kg/m^2)|Mean|26.3|26.3|Standard Deviation|4.9|4.9|||
3807606|NCT01786174|3634053|B1|||Body Mass Index (BMI)||kilograms/meter^2 (kg/m^2)|Mean|26.1|26.1|Standard Deviation|3.0|3.0|||
3807607|NCT01786174|3634051|B3|||Slow Vital Capacity (max %-predicted)|The vital capacity (VC) (percent of predicted normal) was determined using the slow VC method. Vital Capacity is the maximum amount of air a person can expel from the lungs after a maximum inhalation. A subject's VC depends on their age, sex and height. The value is recorded as a percent of predicted normal.|% of Predicted Max Value|Mean|89.2|89.2|Standard Deviation|20.0|20.0|||
3807608|NCT01786174|3634052|B2|||Slow Vital Capacity (max %-predicted)|The vital capacity (VC) (percent of predicted normal) was determined using the slow VC method. Vital Capacity is the maximum amount of air a person can expel from the lungs after a maximum inhalation. A subject's VC depends on their age, sex and height. The value is recorded as a percent of predicted normal.|% of Predicted Max Value|Mean|82.8|82.8|Standard Deviation|21.9|21.9|||
3807609|NCT01786174|3634053|B1|||Slow Vital Capacity (max %-predicted)|The vital capacity (VC) (percent of predicted normal) was determined using the slow VC method. Vital Capacity is the maximum amount of air a person can expel from the lungs after a maximum inhalation. A subject's VC depends on their age, sex and height. The value is recorded as a percent of predicted normal.|% of Predicted Max Value|Mean|92.8|92.8|Standard Deviation|18.5|18.5|||
3807610|NCT01786174|3634051|B3|||ALS Functional Rating Scale - Revised (ALSFRS-R) Total Score|The ALSFRS-R is a quickly administered (5 min) ordinal rating scale used to determine a subject's assessment of their capability and independence in 12 functional activities. There are 12 questions, graded by the subject 0-4 (4 is normal). Score of 0 (worst) to 48 (best). Reflects speech and swallowing, fine motor skills, large motor skills, and breathing.|Score on a Scale|Mean|38.5|38.5|Standard Deviation|4.7|4.7|||
3807611|NCT01786174|3634052|B2|||ALS Functional Rating Scale - Revised (ALSFRS-R) Total Score|The ALSFRS-R is a quickly administered (5 min) ordinal rating scale used to determine a subject's assessment of their capability and independence in 12 functional activities. There are 12 questions, graded by the subject 0-4 (4 is normal). Score of 0 (worst) to 48 (best). Reflects speech and swallowing, fine motor skills, large motor skills, and breathing.|Score on a Scale|Mean|37.9|37.9|Standard Deviation|5.8|5.8|||
3807651|NCT01786174|3634053|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807652|NCT01786174|3634051|B3||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3807653|NCT01786174|3634052|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3807612|NCT01786174|3634053|B1|||ALS Functional Rating Scale - Revised (ALSFRS-R) Total Score|The ALSFRS-R is a quickly administered (5 min) ordinal rating scale used to determine a subject's assessment of their capability and independence in 12 functional activities. There are 12 questions, graded by the subject 0-4 (4 is normal). Score of 0 (worst) to 48 (best). Reflects speech and swallowing, fine motor skills, large motor skills, and breathing.|Score on a Scale|Mean|38.8|38.8|Standard Deviation|4.1|4.1|||
3807613|NCT01786174|3634051|B3|||Forced Expiratory Volume (FEV1) (max %-predicted)|Forced Expiratory Volume (FEV1) is the amount of air which can be forcibly exhaled from the lungs in the first second of a forced exhalation. It will be measured using procedures analogous to those described for the upright SVC.|% of Predicted Max Value|Mean|82.8|82.8|Standard Deviation|20.6|20.6|||
3807614|NCT01786174|3634052|B2|||Forced Expiratory Volume (FEV1) (max %-predicted)|Forced Expiratory Volume (FEV1) is the amount of air which can be forcibly exhaled from the lungs in the first second of a forced exhalation. It will be measured using procedures analogous to those described for the upright SVC.|% of Predicted Max Value|Mean|81.4|81.4|Standard Deviation|27.9|27.9|||
3807615|NCT01786174|3634053|B1|||Forced Expiratory Volume (FEV1) (max %-predicted)|Forced Expiratory Volume (FEV1) is the amount of air which can be forcibly exhaled from the lungs in the first second of a forced exhalation. It will be measured using procedures analogous to those described for the upright SVC.|% of Predicted Max Value|Mean|83.5|83.5|Standard Deviation|16.1|16.1|||
3807616|NCT01786174|3634051|B3|Not on riluzole at screening||Riluzole Usage at Screening||participants|Number|11|11.0||||||
3807617|NCT01786174|3634052|B2|Not on riluzole at screening||Riluzole Usage at Screening||participants|Number|4|4.0||||||
3807618|NCT01786174|3634053|B1|Not on riluzole at screening||Riluzole Usage at Screening||participants|Number|7|7.0||||||
3807619|NCT01786174|3634051|B3|On riluzole at screening||Riluzole Usage at Screening||participants|Number|17|17.0||||||
3807620|NCT01786174|3634052|B2|On riluzole at screening||Riluzole Usage at Screening||participants|Number|6|6.0||||||
3807621|NCT01786174|3634053|B1|On riluzole at screening||Riluzole Usage at Screening||participants|Number|11|11.0||||||
3807622|NCT01786174|3634051|B3|Other||Bulbar Onset||participants|Number|22|22.0||||||
3807623|NCT01786174|3634052|B2|Other||Bulbar Onset||participants|Number|6|6.0||||||
3807624|NCT01786174|3634053|B1|Other||Bulbar Onset||participants|Number|16|16.0||||||
3807625|NCT01786174|3634051|B3|Bulbar Onset||Bulbar Onset||participants|Number|6|6.0||||||
3807626|NCT01786174|3634052|B2|Bulbar Onset||Bulbar Onset||participants|Number|4|4.0||||||
3807627|NCT01786174|3634053|B1|Bulbar Onset||Bulbar Onset||participants|Number|2|2.0||||||
3807628|NCT01786174|3634051|B3|Probable Laboratory Supported||El Escorial Criteria (EEC)|El Escorial Criteria (EEC) lists out the criteria for the diagnosis of Amyotrophic Lateral Sclerosis utilizing clinical, electrophysiological or neuropathic examinations.|participants|Number|4|4.0||||||
3807629|NCT01786174|3634052|B2|Probable Laboratory Supported||El Escorial Criteria (EEC)|El Escorial Criteria (EEC) lists out the criteria for the diagnosis of Amyotrophic Lateral Sclerosis utilizing clinical, electrophysiological or neuropathic examinations.|participants|Number|3|3.0||||||
3807630|NCT01786174|3634053|B1|Probable Laboratory Supported||El Escorial Criteria (EEC)|El Escorial Criteria (EEC) lists out the criteria for the diagnosis of Amyotrophic Lateral Sclerosis utilizing clinical, electrophysiological or neuropathic examinations.|participants|Number|1|1.0||||||
3807631|NCT01786174|3634051|B3|Probable||El Escorial Criteria (EEC)|El Escorial Criteria (EEC) lists out the criteria for the diagnosis of Amyotrophic Lateral Sclerosis utilizing clinical, electrophysiological or neuropathic examinations.|participants|Number|9|9.0||||||
3807632|NCT01786174|3634052|B2|Probable||El Escorial Criteria (EEC)|El Escorial Criteria (EEC) lists out the criteria for the diagnosis of Amyotrophic Lateral Sclerosis utilizing clinical, electrophysiological or neuropathic examinations.|participants|Number|3|3.0||||||
3807633|NCT01786174|3634053|B1|Probable||El Escorial Criteria (EEC)|El Escorial Criteria (EEC) lists out the criteria for the diagnosis of Amyotrophic Lateral Sclerosis utilizing clinical, electrophysiological or neuropathic examinations.|participants|Number|6|6.0||||||
3807634|NCT01786174|3634051|B3|Definite||El Escorial Criteria (EEC)|El Escorial Criteria (EEC) lists out the criteria for the diagnosis of Amyotrophic Lateral Sclerosis utilizing clinical, electrophysiological or neuropathic examinations.|participants|Number|15|15.0||||||
3807635|NCT01786174|3634052|B2|Definite||El Escorial Criteria (EEC)|El Escorial Criteria (EEC) lists out the criteria for the diagnosis of Amyotrophic Lateral Sclerosis utilizing clinical, electrophysiological or neuropathic examinations.|participants|Number|4|4.0||||||
3807636|NCT01786174|3634053|B1|Definite||El Escorial Criteria (EEC)|El Escorial Criteria (EEC) lists out the criteria for the diagnosis of Amyotrophic Lateral Sclerosis utilizing clinical, electrophysiological or neuropathic examinations.|participants|Number|11|11.0||||||
3807637|NCT01786174|3634051|B3|||Months Since Diagnosis||Months|Mean|5.7|5.7|Standard Deviation|3.9|3.9|||
3807638|NCT01786174|3634052|B2|||Months Since Diagnosis||Months|Mean|6.0|6.0|Standard Deviation|4.0|4.0|||
3807639|NCT01786174|3634053|B1|||Months Since Diagnosis||Months|Mean|5.5|5.5|Standard Deviation|3.9|3.9|||
3807640|NCT01786174|3634051|B3|||Months Since Symptom Onset||Months|Mean|13.5|13.5|Standard Deviation|5.3|5.3|||
3807641|NCT01786174|3634052|B2|||Months Since Symptom Onset||Months|Mean|15.0|15.0|Standard Deviation|6.2|6.2|||
3807642|NCT01786174|3634053|B1|||Months Since Symptom Onset||Months|Mean|12.6|12.6|Standard Deviation|4.8|4.8|||
3807643|NCT01786174|3634051|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
3807644|NCT01786174|3634052|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3807645|NCT01786174|3634053|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3807646|NCT01786174|3634051|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807647|NCT01786174|3634052|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807648|NCT01786174|3634053|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807649|NCT01786174|3634051|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807650|NCT01786174|3634052|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807654|NCT01786174|3634053|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3807655|NCT01786174|3634051|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3807656|NCT01786174|3634052|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3807657|NCT01786174|3634053|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807658|NCT01786174|3634051|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807659|NCT01786174|3634052|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807660|NCT01786174|3634053|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807661|NCT01786174|3634051|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807662|NCT01786174|3634052|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807663|NCT01786174|3634053|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807664|NCT01786174|3634051|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807665|NCT01786174|3634052|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807666|NCT01786174|3634053|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807667|NCT01786174|3634051|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807668|NCT01786174|3634052|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807669|NCT01786174|3634053|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807670|NCT01786174|3634051|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3807671|NCT01786174|3634052|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3807672|NCT01786174|3634053|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3807673|NCT01786174|3634051|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3807674|NCT01786174|3634052|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3807675|NCT01786174|3634053|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3807676|NCT01786174|3634051|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3807677|NCT01786174|3634052|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3807678|NCT01786174|3634053|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3807679|NCT01786174|3634051|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3807680|NCT01786174|3634052|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3807681|NCT01786174|3634053|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3807682|NCT01786174|3634051|B3|||Age||years|Mean|55.9|55.9|Standard Deviation|9.1|9.1|||
3807683|NCT01786174|3634052|B2|||Age||years|Mean|55.1|55.1|Standard Deviation|11.3|11.3|||
3807684|NCT01786174|3634053|B1|||Age||years|Mean|56.4|56.4|Standard Deviation|8.0|8.0|||
3807685|NCT01786161|3634068|B3|United States||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3807686|NCT01786161|3634069|B2|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3807687|NCT01786161|3634070|B1|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3807688|NCT01786161|3634068|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3807689|NCT01786161|3634069|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3807690|NCT01786161|3634070|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3807691|NCT01786161|3634068|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3807692|NCT01786161|3634069|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3807693|NCT01786161|3634070|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3807694|NCT01786161|3634068|B3|||Age||years|Mean|56.8|56.8|Standard Deviation|14.05|14.05|||
3807695|NCT01786161|3634069|B2|||Age||years|Mean|53.7|53.7|Standard Deviation|13.5|13.5|||
3807696|NCT01786161|3634070|B1|||Age||years|Mean|60|60.0|Standard Deviation|14.1|14.1|||
3807697|NCT01786109|3634081|B4|||Body Mass Index||kg/m^2|Mean|28.3|28.3|Standard Deviation|5.5|5.5|||
3807698|NCT01786109|3634082|B3|||Body Mass Index||kg/m^2|Mean|28.9|28.9|Standard Deviation|1.2|1.2|||
3807699|NCT01786109|3634083|B2|||Body Mass Index||kg/m^2|Mean|29.7|29.7|Standard Deviation|1.1|1.1|||
3807700|NCT01786109|3634084|B1|||Body Mass Index||kg/m^2|Mean|26.7|26.7|Standard Deviation|1.0|1.0|||
3807701|NCT01786109|3634081|B4|United States||Region of Enrollment||participants|Number|75|75.0||||||
3807702|NCT01786109|3634082|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
3807703|NCT01786109|3634083|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
3807704|NCT01786109|3634084|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3807705|NCT01786109|3634081|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3807706|NCT01786109|3634082|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3807707|NCT01786109|3634083|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3807708|NCT01786109|3634084|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3807709|NCT01786109|3634081|B4||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3807710|NCT01786109|3634082|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3807711|NCT01786109|3634083|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3807712|NCT01786109|3634084|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3807713|NCT01786109|3634081|B4|||Age||years|Mean|40.8|40.8|Standard Deviation|11.935|11.935|||
3807714|NCT01786109|3634082|B3|||Age||years|Mean|43.2|43.2|Standard Deviation|2.5|2.5|||
3807715|NCT01786109|3634083|B2|||Age||years|Mean|43.7|43.7|Standard Deviation|2.1|2.1|||
3807716|NCT01786109|3634084|B1|||Age||years|Mean|36.1|36.1|Standard Deviation|2.5|2.5|||
3807717|NCT01785875|3634115|B1|||Corrected Calcium Phosphorus Product (cCa x P)|Data available for 887 participants|mg²/dL²|Mean|54.36|54.36|Standard Deviation|17.17|17.17|||
3807718|NCT01785875|3634115|B1|||Phosphorus|Data available for 887 participants|mg/dL|Mean|5.63|5.63|Standard Deviation|1.75|1.75|||
3807719|NCT01785875|3634115|B1|||Corrected Calcium|Data available for 889 participants|mg/dL|Mean|9.67|9.67|Standard Deviation|0.68|0.68|||
3807720|NCT01785875|3634115|B1|||PTH Concentration|Data available for 854 participants|pg/mL|Mean|769.5|769.5|Standard Deviation|574.4|574.4|||
3807721|NCT01785875|3634115|B1|Missing||Parathyroid Hormone (PTH) Level||participants|Number|37|37.0||||||
3807722|NCT01785875|3634115|B1|> 1000 pg/mL||Parathyroid Hormone (PTH) Level||participants|Number|228|228.0||||||
3807723|NCT01785875|3634115|B1|600 - ≤ 1000 pg/mL||Parathyroid Hormone (PTH) Level||participants|Number|221|221.0||||||
3807724|NCT01785875|3634115|B1|< 600 pg/mL||Parathyroid Hormone (PTH) Level||participants|Number|405|405.0||||||
3807725|NCT01785875|3634115|B1|Not Hispanic/Latino||Ethnicity||participants|Number|769|769.0||||||
3807726|NCT01785875|3634115|B1|Hispanic/Latino||Ethnicity||participants|Number|122|122.0||||||
3807727|NCT01785875|3634115|B1|Other||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3807728|NCT01785875|3634115|B1|White||Race/Ethnicity, Customized||participants|Number|567|567.0||||||
3807729|NCT01785875|3634115|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3807730|NCT01785875|3634115|B1|Black (or African American)||Race/Ethnicity, Customized||participants|Number|270|270.0||||||
3807731|NCT01785875|3634115|B1|Asian||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3807732|NCT01785875|3634115|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3807733|NCT01785875|3634115|B1||Male|Sex: Female, Male||Participants|Count of Participants|550|550.0||||||
3807734|NCT01785875|3634115|B1||Female|Sex: Female, Male||Participants|Count of Participants|341|341.0||||||
3807735|NCT01785875|3634115|B1|≥ 65 years||Age, Customized||participants|Number|314|314.0||||||
3807736|NCT01785875|3634115|B1|< 65 years||Age, Customized||participants|Number|577|577.0||||||
3807737|NCT01785875|3634115|B1|||Age||years|Mean|58.3|58.3|Standard Deviation|14.4|14.4|||
3807738|NCT01785849|3634184|B3|||Corrected Calcium Phosphorus Product (cCa x P)|Data were available for 249 and 250 subjects in each treatment group respectively.|mg²/dL²|Mean|56.46|56.46|Standard Deviation|15.67|15.67|||
3807739|NCT01785849|3634185|B2|||Corrected Calcium Phosphorus Product (cCa x P)|Data were available for 249 and 250 subjects in each treatment group respectively.|mg²/dL²|Mean|57.37|57.37|Standard Deviation|15.51|15.51|||
3807740|NCT01785849|3634186|B1|||Corrected Calcium Phosphorus Product (cCa x P)|Data were available for 249 and 250 subjects in each treatment group respectively.|mg²/dL²|Mean|55.54|55.54|Standard Deviation|15.81|15.81|||
3807741|NCT01785849|3634184|B3|||Corrected Calcium||mg/dL|Mean|9.63|9.63|Standard Deviation|0.63|0.63|||
3807742|NCT01785849|3634185|B2|||Corrected Calcium||mg/dL|Mean|9.65|9.65|Standard Deviation|0.66|0.66|||
3807743|NCT01785849|3634186|B1|||Corrected Calcium||mg/dL|Mean|9.61|9.61|Standard Deviation|0.60|0.6|||
3807744|NCT01785849|3634184|B3|||Phosphorus|Data were available for 250 subjects in each treatment group.|mg/dL|Mean|5.87|5.87|Standard Deviation|1.59|1.59|||
3807745|NCT01785849|3634185|B2|||Phosphorus|Data were available for 250 subjects in each treatment group.|mg/dL|Mean|5.95|5.95|Standard Deviation|1.59|1.59|||
3807746|NCT01785849|3634186|B1|||Phosphorus|Data were available for 250 subjects in each treatment group.|mg/dL|Mean|5.78|5.78|Standard Deviation|1.60|1.6|||
3807747|NCT01785849|3634184|B3|||Parathyroid Hormone (PTH)||pg/mL|Mean|834.2|834.2|Standard Deviation|457.9|457.9|||
3807748|NCT01785849|3634185|B2|||Parathyroid Hormone (PTH)||pg/mL|Mean|848.7|848.7|Standard Deviation|520.4|520.4|||
3807749|NCT01785849|3634186|B1|||Parathyroid Hormone (PTH)||pg/mL|Mean|819.7|819.7|Standard Deviation|386.0|386.0|||
3807750|NCT01785849|3634184|B3|Non-North America||Stratification Factor: Region||participants|Number|247|247.0||||||
3807751|NCT01785849|3634185|B2|Non-North America||Stratification Factor: Region||participants|Number|122|122.0||||||
3807752|NCT01785849|3634186|B1|Non-North America||Stratification Factor: Region||participants|Number|125|125.0||||||
3807753|NCT01785849|3634184|B3|North America||Stratification Factor: Region||participants|Number|261|261.0||||||
3807754|NCT01785849|3634185|B2|North America||Stratification Factor: Region||participants|Number|132|132.0||||||
3807755|NCT01785849|3634186|B1|North America||Stratification Factor: Region||participants|Number|129|129.0||||||
3807756|NCT01785849|3634184|B3|No||Stratification Factor: Cinacalcet Use Within 8 Weeks of Randomization||participants|Number|441|441.0||||||
3807757|NCT01785849|3634185|B2|No||Stratification Factor: Cinacalcet Use Within 8 Weeks of Randomization||participants|Number|221|221.0||||||
3807758|NCT01785849|3634186|B1|No||Stratification Factor: Cinacalcet Use Within 8 Weeks of Randomization||participants|Number|220|220.0||||||
3807759|NCT01785849|3634184|B3|Yes||Stratification Factor: Cinacalcet Use Within 8 Weeks of Randomization||participants|Number|67|67.0||||||
3807760|NCT01785849|3634185|B2|Yes||Stratification Factor: Cinacalcet Use Within 8 Weeks of Randomization||participants|Number|33|33.0||||||
3807761|NCT01785849|3634186|B1|Yes||Stratification Factor: Cinacalcet Use Within 8 Weeks of Randomization||participants|Number|34|34.0||||||
3807762|NCT01785849|3634184|B3|> 1000 pg/mL||Stratification Factor: Mean Screening Serum Parathyroid Hormone (PTH)|Mean screening parathyroid hormone (PTH) obtained within 2 weeks prior to randomization.|participants|Number|108|108.0||||||
3807763|NCT01785849|3634185|B2|> 1000 pg/mL||Stratification Factor: Mean Screening Serum Parathyroid Hormone (PTH)|Mean screening parathyroid hormone (PTH) obtained within 2 weeks prior to randomization.|participants|Number|52|52.0||||||
3807764|NCT01785849|3634186|B1|> 1000 pg/mL||Stratification Factor: Mean Screening Serum Parathyroid Hormone (PTH)|Mean screening parathyroid hormone (PTH) obtained within 2 weeks prior to randomization.|participants|Number|56|56.0||||||
3807765|NCT01785849|3634184|B3|≥ 600 to ≤ 1000 pg/mL||Stratification Factor: Mean Screening Serum Parathyroid Hormone (PTH)|Mean screening parathyroid hormone (PTH) obtained within 2 weeks prior to randomization.|participants|Number|229|229.0||||||
3807766|NCT01785849|3634185|B2|≥ 600 to ≤ 1000 pg/mL||Stratification Factor: Mean Screening Serum Parathyroid Hormone (PTH)|Mean screening parathyroid hormone (PTH) obtained within 2 weeks prior to randomization.|participants|Number|115|115.0||||||
3807767|NCT01785849|3634186|B1|≥ 600 to ≤ 1000 pg/mL||Stratification Factor: Mean Screening Serum Parathyroid Hormone (PTH)|Mean screening parathyroid hormone (PTH) obtained within 2 weeks prior to randomization.|participants|Number|114|114.0||||||
3807768|NCT01785849|3634184|B3|< 600 pg/mL||Stratification Factor: Mean Screening Serum Parathyroid Hormone (PTH)|Mean screening parathyroid hormone (PTH) obtained within 2 weeks prior to randomization.|participants|Number|171|171.0||||||
3807769|NCT01785849|3634185|B2|< 600 pg/mL||Stratification Factor: Mean Screening Serum Parathyroid Hormone (PTH)|Mean screening parathyroid hormone (PTH) obtained within 2 weeks prior to randomization.|participants|Number|87|87.0||||||
3807770|NCT01785849|3634186|B1|< 600 pg/mL||Stratification Factor: Mean Screening Serum Parathyroid Hormone (PTH)|Mean screening parathyroid hormone (PTH) obtained within 2 weeks prior to randomization.|participants|Number|84|84.0||||||
3807771|NCT01785849|3634184|B3|Missing||Race||participants|Number|1|1.0||||||
3807772|NCT01785849|3634185|B2|Missing||Race||participants|Number|0|0.0||||||
3807773|NCT01785849|3634186|B1|Missing||Race||participants|Number|1|1.0||||||
3807774|NCT01785849|3634184|B3|Other||Race||participants|Number|8|8.0||||||
3807775|NCT01785849|3634185|B2|Other||Race||participants|Number|4|4.0||||||
3807776|NCT01785849|3634186|B1|Other||Race||participants|Number|4|4.0||||||
3807777|NCT01785849|3634184|B3|White||Race||participants|Number|348|348.0||||||
3807778|NCT01785849|3634185|B2|White||Race||participants|Number|173|173.0||||||
3807779|NCT01785849|3634186|B1|White||Race||participants|Number|175|175.0||||||
3807780|NCT01785849|3634184|B3|Native Hawaiian or Other Pacific Islander||Race||participants|Number|2|2.0||||||
3807781|NCT01785849|3634185|B2|Native Hawaiian or Other Pacific Islander||Race||participants|Number|0|0.0||||||
3807782|NCT01785849|3634186|B1|Native Hawaiian or Other Pacific Islander||Race||participants|Number|2|2.0||||||
3807783|NCT01785849|3634184|B3|Black (or African American)||Race||participants|Number|141|141.0||||||
3807784|NCT01785849|3634185|B2|Black (or African American)||Race||participants|Number|72|72.0||||||
3807785|NCT01785849|3634186|B1|Black (or African American)||Race||participants|Number|69|69.0||||||
3807786|NCT01785849|3634184|B3|Asian||Race||participants|Number|8|8.0||||||
3807787|NCT01785849|3634185|B2|Asian||Race||participants|Number|5|5.0||||||
3807788|NCT01785849|3634186|B1|Asian||Race||participants|Number|3|3.0||||||
3807789|NCT01785849|3634184|B3|American Indian or Alaska Native||Race||participants|Number|0|0.0||||||
3807790|NCT01785849|3634185|B2|American Indian or Alaska Native||Race||participants|Number|0|0.0||||||
3807791|NCT01785849|3634186|B1|American Indian or Alaska Native||Race||participants|Number|0|0.0||||||
3807792|NCT01785849|3634184|B3||Male|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
3807793|NCT01785849|3634185|B2||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3807794|NCT01785849|3634186|B1||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3807795|NCT01785849|3634184|B3||Female|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
3807796|NCT01785849|3634185|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3807797|NCT01785849|3634186|B1||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3807798|NCT01785849|3634184|B3|||Age||years|Mean|57.7|57.7|Standard Deviation|14.6|14.6|||
3807799|NCT01785849|3634185|B2|||Age||years|Mean|58.4|58.4|Standard Deviation|14.6|14.6|||
3807800|NCT01785849|3634186|B1|||Age||years|Mean|57.1|57.1|Standard Deviation|14.5|14.5|||
3807801|NCT01785628|3634203|B3|Taiwan||Region of Enrollment||participants|Number|30|30.0||||||
3807802|NCT01785628|3634204|B2|Taiwan||Region of Enrollment||participants|Number|15|15.0||||||
3807803|NCT01785628|3634205|B1|Taiwan||Region of Enrollment||participants|Number|15|15.0||||||
3807804|NCT01785628|3634203|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3807805|NCT01785628|3634204|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3807806|NCT01785628|3634205|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3807807|NCT01785628|3634203|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3807808|NCT01785628|3634204|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3807809|NCT01785628|3634205|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3807810|NCT01785628|3634203|B3|||Age||years|Mean|76.8|76.8|Standard Deviation|5.9|5.9|||
3807811|NCT01785628|3634204|B2|||Age||years|Mean|77.3|77.3|Standard Deviation|6.6|6.6|||
3807812|NCT01785628|3634205|B1|||Age||years|Mean|76.3|76.3|Standard Deviation|5.3|5.3|||
3807813|NCT01785628|3634203|B3||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
3807814|NCT01785628|3634204|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3807815|NCT01785628|3634205|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3807816|NCT01785628|3634203|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3807817|NCT01785628|3634204|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3807818|NCT01785628|3634205|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3807819|NCT01785628|3634203|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3807820|NCT01785628|3634204|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3807821|NCT01785628|3634205|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3807822|NCT01785615|3634226|B4|United States||Region of Enrollment||participants|Number|88|88.0||||||
3807823|NCT01785615|3634227|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
3807824|NCT01785615|3634228|B2|United States||Region of Enrollment||participants|Number|44|44.0||||||
3807825|NCT01785615|3634229|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
3807826|NCT01785615|3634226|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3807827|NCT01785615|3634227|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3807828|NCT01785615|3634228|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3807829|NCT01785615|3634229|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3807830|NCT01785615|3634226|B4||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3807831|NCT01785615|3634227|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3807832|NCT01785615|3634228|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3807833|NCT01785615|3634229|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3807834|NCT01785615|3634226|B4|||Age||years|Mean|52.1|52.1|Standard Deviation|9|9.0|||
3807835|NCT01785615|3634227|B3|||Age||years|Mean|53.7|53.7|Standard Deviation|9.0|9.0|||
3807836|NCT01785615|3634228|B2|||Age||years|Mean|52|52.0|Standard Deviation|9|9.0|||
3807837|NCT01785615|3634229|B1|||Age||years|Mean|51|51.0|Standard Deviation|9|9.0|||
3807838|NCT01785602|3634302|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3807839|NCT01785602|3634303|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3807840|NCT01785602|3634304|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3807841|NCT01785602|3634302|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3807842|NCT01785602|3634303|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3807843|NCT01785602|3634304|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3807844|NCT01785602|3634302|B3|||Age||Years|Mean|36.3|36.3|Standard Deviation|12.37|12.37|||
3807845|NCT01785602|3634303|B2|||Age||Years|Mean|38.7|38.7|Standard Deviation|9.95|9.95|||
3807846|NCT01785602|3634304|B1|||Age||Years|Mean|35.5|35.5|Standard Deviation|13.08|13.08|||
3807847|NCT01785524|3634313|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3807848|NCT01785524|3634314|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3807849|NCT01785524|3634315|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3807850|NCT01785524|3634313|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3807851|NCT01785524|3634314|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3807852|NCT01785524|3634315|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3807853|NCT01785524|3634313|B3|||Age||years|Mean|71.63|71.63|Standard Deviation|5.04|5.04|||
3807854|NCT01785524|3634314|B2|||Age||years|Mean|74.25|74.25|Standard Deviation|5.1|5.1|||
3807855|NCT01785524|3634315|B1|||Age||years|Mean|70.1|70.1|Standard Deviation|4.7|4.7|||
3807856|NCT01785472|3634332|B4||Male|Gender||Participants|Count of Participants|756|756.0||||||
3807857|NCT01785472|3634333|B3||Male|Gender||Participants|Count of Participants|261|261.0||||||
3807858|NCT01785472|3634334|B2||Male|Gender||Participants|Count of Participants|243|243.0||||||
3807859|NCT01785472|3634335|B1||Male|Gender||Participants|Count of Participants|252|252.0||||||
3807860|NCT01785472|3634332|B4||Female|Gender||Participants|Count of Participants|679|679.0||||||
3807861|NCT01785472|3634333|B3||Female|Gender||Participants|Count of Participants|223|223.0||||||
3807862|NCT01785472|3634334|B2||Female|Gender||Participants|Count of Participants|229|229.0||||||
3807863|NCT01785472|3634335|B1||Female|Gender||Participants|Count of Participants|227|227.0||||||
3807864|NCT01785472|3634332|B4|||Age||Years|Mean|57.7|57.7|Standard Deviation|10.01|10.01|||
3807865|NCT01785472|3634333|B3|||Age||Years|Mean|57.4|57.4|Standard Deviation|10.14|10.14|||
3807866|NCT01785472|3634334|B2|||Age||Years|Mean|58.1|58.1|Standard Deviation|9.71|9.71|||
3807867|NCT01785472|3634335|B1|||Age||Years|Mean|57.5|57.5|Standard Deviation|10.17|10.17|||
3807868|NCT01785186|3634379|B6|||HIV Positive Participants||participants|Number|24|24.0||||||
3807869|NCT01785186|3634380|B5|||HIV Positive Participants||participants|Number|9|9.0||||||
3807870|NCT01785186|3634381|B4|||HIV Positive Participants||participants|Number|3|3.0||||||
3807871|NCT01785186|3634382|B3|||HIV Positive Participants||participants|Number|3|3.0||||||
3807872|NCT01785186|3634383|B2|||HIV Positive Participants||participants|Number|4|4.0||||||
3807873|NCT01785186|3634384|B1|||HIV Positive Participants||participants|Number|5|5.0||||||
3807874|NCT01785186|3634379|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3807875|NCT01785186|3634380|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3807876|NCT01785186|3634381|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807877|NCT01785186|3634382|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807878|NCT01785186|3634383|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807879|NCT01785186|3634384|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807880|NCT01785186|3634379|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3807881|NCT01785186|3634380|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3807882|NCT01785186|3634381|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3807883|NCT01785186|3634382|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3807884|NCT01785186|3634383|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3807885|NCT01785186|3634384|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3807886|NCT01785186|3634379|B6||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3807887|NCT01785186|3634380|B5||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807888|NCT01785186|3634381|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807889|NCT01785186|3634382|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3807890|NCT01785186|3634383|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3807891|NCT01785186|3634384|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807892|NCT01785186|3634379|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|300|300.0||||||
3807893|NCT01785186|3634380|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
3807894|NCT01785186|3634381|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3807895|NCT01785186|3634382|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3807896|NCT01785186|3634383|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3807897|NCT01785186|3634384|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3807898|NCT01785186|3634379|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807899|NCT01785186|3634380|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807900|NCT01785186|3634381|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807901|NCT01785186|3634382|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807902|NCT01785186|3634383|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807903|NCT01785186|3634384|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807904|NCT01785186|3634379|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807905|NCT01785186|3634380|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807906|NCT01785186|3634381|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807907|NCT01785186|3634382|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807908|NCT01785186|3634383|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807909|NCT01785186|3634384|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807910|NCT01785186|3634379|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807911|NCT01785186|3634380|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807912|NCT01785186|3634381|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807913|NCT01785186|3634382|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807914|NCT01785186|3634383|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807915|NCT01785186|3634384|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807916|NCT01785186|3634379|B6||Male|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
3807917|NCT01785186|3634380|B5||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3807918|NCT01785186|3634381|B4||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3807919|NCT01785186|3634382|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3807920|NCT01785186|3634383|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3807921|NCT01785186|3634384|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3807922|NCT01785186|3634379|B6||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3807923|NCT01785186|3634380|B5||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3807924|NCT01785186|3634381|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3807925|NCT01785186|3634382|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3807926|NCT01785186|3634383|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3807927|NCT01785186|3634384|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3807928|NCT01785186|3634379|B6|||Age, Customized||years|Median|32.9|32.9|Inter-Quartile Range|||23.8|40.2|
3807929|NCT01785186|3634380|B5|||Age, Customized||years|Median|34|34.0|Inter-Quartile Range|||26.0|41.0|
3807930|NCT01785186|3634381|B4|||Age, Customized||years|Median|31|31.0|Inter-Quartile Range|||24.0|38.0|
3807931|NCT01785186|3634382|B3|||Age, Customized||years|Median|34|34.0|Inter-Quartile Range|||27.0|41.0|
3807932|NCT01785186|3634383|B2|||Age, Customized||years|Median|33|33.0|Inter-Quartile Range|||23.0|40.0|
3807933|NCT01785186|3634384|B1|||Age, Customized||years|Median|32|32.0|Inter-Quartile Range|||25.0|40.0|
3807934|NCT01785160|3634410|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3807935|NCT01785160|3634410|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3807936|NCT01785160|3634410|B1|||Age||years|Mean|40.8|40.8|Standard Deviation|8.8|8.8|||
3807937|NCT01785134|3634418|B3|Sweden||Region of Enrollment||participants|Number|81|81.0||||||
3807938|NCT01785134|3634419|B2|Sweden||Region of Enrollment||participants|Number|40|40.0||||||
3807939|NCT01785134|3634420|B1|Sweden||Region of Enrollment||participants|Number|41|41.0||||||
3807940|NCT01785134|3634418|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3807941|NCT01785134|3634419|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3807942|NCT01785134|3634420|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3807943|NCT01785134|3634418|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3807944|NCT01785134|3634419|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3807945|NCT01785134|3634420|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3807946|NCT01785134|3634418|B3|||Age||years|Mean|42|42.0|Standard Deviation|9|9.0|||
3807947|NCT01785134|3634419|B2|||Age||years|Mean|43|43.0|Standard Deviation|9|9.0|||
3807948|NCT01785134|3634420|B1|||Age||years|Mean|41|41.0|Standard Deviation|9|9.0|||
3807949|NCT01785095|3634435|B1|||BMI (kg/m2)||kg/m2|Mean|21.7|21.7|Standard Deviation|2.0|2.0|||
3807950|NCT01785095|3634435|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807951|NCT01785095|3634435|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807952|NCT01785095|3634435|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3807953|NCT01785095|3634435|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807954|NCT01785095|3634435|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807955|NCT01785095|3634435|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807956|NCT01785095|3634435|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3807957|NCT01785095|3634435|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3807958|NCT01785095|3634435|B1||Female|Gender||Participants|Count of Participants|27|27.0||||||
3807959|NCT01785095|3634435|B1|||Age||years|Mean|25.7|25.7|Standard Deviation|5.4|5.4|||
3807960|NCT01784965|3634443|B3|||BMI||kg/m^2|Mean|31.9|31.9|Standard Deviation|3.1|3.1|||
3807961|NCT01784965|3634444|B2|||BMI||kg/m^2|Mean|31.9|31.9|Standard Deviation|2.7|2.7|||
3807962|NCT01784965|3634445|B1|||BMI||kg/m^2|Mean|31.9|31.9|Standard Deviation|3.5|3.5|||
3807963|NCT01784965|3634443|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
3807964|NCT01784965|3634444|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
3807965|NCT01784965|3634445|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3807966|NCT01784965|3634443|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3807967|NCT01784965|3634444|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3807968|NCT01784965|3634445|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3807969|NCT01784965|3634443|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3807970|NCT01784965|3634444|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3807971|NCT01784965|3634445|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3807972|NCT01784965|3634443|B3|||Age||years|Mean|58|58.0|Standard Deviation|7.5|7.5|||
3807973|NCT01784965|3634444|B2|||Age||years|Mean|58|58.0|Standard Deviation|7|7.0|||
3807974|NCT01784965|3634445|B1|||Age||years|Mean|58|58.0|Standard Deviation|8|8.0|||
3807975|NCT01784770|3634456|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3807976|NCT01784770|3634456|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3807977|NCT01784770|3634456|B1|≥65 years||Age, Customized||Participants|Number|7|7.0||||||
3807978|NCT01784770|3634456|B1|≥15 and <65 years||Age, Customized||Participants|Number|14|14.0||||||
3807979|NCT01784770|3634456|B1|<15 years||Age, Customized||Participants|Number|0|0.0||||||
3807980|NCT01784666|3634461|B4|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3807981|NCT01784666|3634462|B3|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3807982|NCT01784666|3634463|B2|United States||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3807983|NCT01784666|3634464|B1|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3807984|NCT01784666|3634461|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3807985|NCT01784666|3634462|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3807986|NCT01784666|3634463|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3807987|NCT01784666|3634464|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3807988|NCT01784666|3634461|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3807989|NCT01784666|3634462|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3807990|NCT01784666|3634463|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3807991|NCT01784666|3634464|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3807992|NCT01784666|3634461|B4|||Age||years|Mean|50|50.0|Full Range|||44.0|56.0|
3807993|NCT01784666|3634462|B3|||Age||years|Mean|44|44.0|Full Range|||44.0|44.0|
3807994|NCT01784666|3634464|B1|||Age||years|Mean|56|56.0|Full Range|||56.0|56.0|
3807995|NCT01784666|3634461|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3807996|NCT01784666|3634462|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3807997|NCT01784666|3634463|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3807998|NCT01784666|3634464|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3807999|NCT01784666|3634461|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3808000|NCT01784666|3634462|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3808001|NCT01784666|3634463|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3808002|NCT01784666|3634464|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3808003|NCT01784666|3634461|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3808004|NCT01784666|3634462|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3808005|NCT01784666|3634463|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3808006|NCT01784666|3634464|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3808007|NCT01784614|3634474|B1|Japan||Region of Enrollment||participants|Number|24|24.0||||||
3808008|NCT01784614|3634474|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3808009|NCT01784614|3634474|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3808010|NCT01784614|3634474|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3808011|NCT01784614|3634474|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3808012|NCT01784614|3634474|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3808013|NCT01784614|3634474|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3808014|NCT01784614|3634474|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3808015|NCT01784614|3634474|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3808016|NCT01784614|3634474|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3808017|NCT01784614|3634474|B1|||Age||years|Mean|54.1|54.1|Standard Deviation|14.1|14.1|||
3808018|NCT01784055|3634515|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3808019|NCT01784055|3634515|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3808020|NCT01784055|3634515|B1|||Age||years|Mean|66|66.0|Standard Deviation|14|14.0|||
3808021|NCT01784029|3634519|B4||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3808022|NCT01784029|3634520|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3808023|NCT01784029|3634521|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3808024|NCT01784029|3634522|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3808025|NCT01784029|3634519|B4||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3808026|NCT01784029|3634520|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3808027|NCT01784029|3634521|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3808028|NCT01784029|3634522|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3808029|NCT01784029|3634519|B4|||Age||years|Mean|16.6|16.6|Standard Deviation|2.2|2.2|||
3808030|NCT01784029|3634520|B3|||Age||years|Mean|16.6|16.6|Standard Deviation|2.1|2.1|||
3808031|NCT01784029|3634521|B2|||Age||years|Mean|16.5|16.5|Standard Deviation|2.4|2.4|||
3808032|NCT01784029|3634522|B1|||Age||years|Mean|16.8|16.8|Standard Deviation|2.1|2.1|||
3808033|NCT01783938|3634532|B3|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all pre-disease performance without restriction and (worst score) 5=death.|participants|Number|54|54.0||||||
3808034|NCT01783938|3634533|B2|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all pre-disease performance without restriction and (worst score) 5=death.|participants|Number|33|33.0||||||
3808035|NCT01783938|3634534|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all pre-disease performance without restriction and (worst score) 5=death.|participants|Number|21|21.0||||||
3808036|NCT01783938|3634532|B3|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all pre-disease performance without restriction and (worst score) 5=death.|participants|Number|84|84.0||||||
3808037|NCT01783938|3634533|B2|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all pre-disease performance without restriction and (worst score) 5=death.|participants|Number|37|37.0||||||
3808038|NCT01783938|3634534|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all pre-disease performance without restriction and (worst score) 5=death.|participants|Number|47|47.0||||||
3808039|NCT01783938|3634532|B3|Not Reported||B-Raf proto-oncogene (BRAF) Status||participants|Number|12|12.0||||||
3808040|NCT01783938|3634533|B2|Not Reported||B-Raf proto-oncogene (BRAF) Status||participants|Number|7|7.0||||||
3808041|NCT01783938|3634534|B1|Not Reported||B-Raf proto-oncogene (BRAF) Status||participants|Number|5|5.0||||||
3808042|NCT01783938|3634532|B3|Wildtype||B-Raf proto-oncogene (BRAF) Status||participants|Number|87|87.0||||||
3808043|NCT01783938|3634533|B2|Wildtype||B-Raf proto-oncogene (BRAF) Status||participants|Number|43|43.0||||||
3808044|NCT01783938|3634534|B1|Wildtype||B-Raf proto-oncogene (BRAF) Status||participants|Number|44|44.0||||||
3808045|NCT01783938|3634532|B3|Mutant||B-Raf proto-oncogene (BRAF) Status||participants|Number|39|39.0||||||
3808046|NCT01783938|3634533|B2|Mutant||B-Raf proto-oncogene (BRAF) Status||participants|Number|20|20.0||||||
3808047|NCT01783938|3634534|B1|Mutant||B-Raf proto-oncogene (BRAF) Status||participants|Number|19|19.0||||||
3808048|NCT01783938|3634532|B3|Not Reported||History of Brain Metastases||participants|Number|14|14.0||||||
3808049|NCT01783938|3634533|B2|Not Reported||History of Brain Metastases||participants|Number|8|8.0||||||
3808050|NCT01783938|3634534|B1|Not Reported||History of Brain Metastases||participants|Number|6|6.0||||||
3808051|NCT01783938|3634532|B3|No||History of Brain Metastases||participants|Number|113|113.0||||||
3808052|NCT01783938|3634533|B2|No||History of Brain Metastases||participants|Number|60|60.0||||||
3808053|NCT01783938|3634534|B1|No||History of Brain Metastases||participants|Number|53|53.0||||||
3808054|NCT01783938|3634532|B3|Yes||History of Brain Metastases||participants|Number|11|11.0||||||
3808055|NCT01783938|3634533|B2|Yes||History of Brain Metastases||participants|Number|2|2.0||||||
3808056|NCT01783938|3634534|B1|Yes||History of Brain Metastases||participants|Number|9|9.0||||||
3808057|NCT01783938|3634532|B3|Higher than 2*ULN||Baseline Lactate Dehydrogenase (LDH) Level||participants|Number|21|21.0||||||
3808058|NCT01783938|3634533|B2|Higher than 2*ULN||Baseline Lactate Dehydrogenase (LDH) Level||participants|Number|12|12.0||||||
3808059|NCT01783938|3634534|B1|Higher than 2*ULN||Baseline Lactate Dehydrogenase (LDH) Level||participants|Number|9|9.0||||||
3808060|NCT01783938|3634532|B3|Higher than ULN||Baseline Lactate Dehydrogenase (LDH) Level||participants|Number|52|52.0||||||
3808061|NCT01783938|3634533|B2|Higher than ULN||Baseline Lactate Dehydrogenase (LDH) Level||participants|Number|29|29.0||||||
3808062|NCT01783938|3634534|B1|Higher than ULN||Baseline Lactate Dehydrogenase (LDH) Level||participants|Number|23|23.0||||||
3808063|NCT01783938|3634532|B3|Upper limit of normal (ULN) or lower||Baseline Lactate Dehydrogenase (LDH) Level||participants|Number|86|86.0||||||
3808064|NCT01783938|3634533|B2|Upper limit of normal (ULN) or lower||Baseline Lactate Dehydrogenase (LDH) Level||participants|Number|41|41.0||||||
3808065|NCT01783938|3634534|B1|Upper limit of normal (ULN) or lower||Baseline Lactate Dehydrogenase (LDH) Level||participants|Number|45|45.0||||||
3808066|NCT01783938|3634532|B3|Other||Subtype of Disease||participants|Number|7|7.0||||||
3808067|NCT01783938|3634533|B2|Other||Subtype of Disease||participants|Number|3|3.0||||||
3808068|NCT01783938|3634534|B1|Other||Subtype of Disease||participants|Number|4|4.0||||||
3808069|NCT01783938|3634532|B3|Ocular/Uveal||Subtype of Disease||participants|Number|12|12.0||||||
3808070|NCT01783938|3634533|B2|Ocular/Uveal||Subtype of Disease||participants|Number|6|6.0||||||
3808071|NCT01783938|3634534|B1|Ocular/Uveal||Subtype of Disease||participants|Number|6|6.0||||||
3808072|NCT01783938|3634532|B3|Acral||Subtype of Disease||participants|Number|5|5.0||||||
3808073|NCT01783938|3634533|B2|Acral||Subtype of Disease||participants|Number|4|4.0||||||
3808074|NCT01783938|3634534|B1|Acral||Subtype of Disease||participants|Number|1|1.0||||||
3808075|NCT01783938|3634532|B3|Cutaneous||Subtype of Disease||participants|Number|107|107.0||||||
3808076|NCT01783938|3634533|B2|Cutaneous||Subtype of Disease||participants|Number|55|55.0||||||
3808077|NCT01783938|3634534|B1|Cutaneous||Subtype of Disease||participants|Number|52|52.0||||||
3808078|NCT01783938|3634532|B3|Mucosal||Subtype of Disease||participants|Number|7|7.0||||||
3808079|NCT01783938|3634533|B2|Mucosal||Subtype of Disease||participants|Number|2|2.0||||||
3808080|NCT01783938|3634534|B1|Mucosal||Subtype of Disease||participants|Number|5|5.0||||||
3808081|NCT01783938|3634532|B3|United States||Region of Enrollment||participants|Number|138|138.0||||||
3808082|NCT01783938|3634533|B2|United States||Region of Enrollment||participants|Number|70|70.0||||||
3808083|NCT01783938|3634534|B1|United States||Region of Enrollment||participants|Number|68|68.0||||||
3808084|NCT01783938|3634532|B3|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3808085|NCT01783938|3634533|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3808086|NCT01783938|3634534|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3808087|NCT01783938|3634532|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3808088|NCT01783938|3634533|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3808089|NCT01783938|3634534|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3808090|NCT01783938|3634532|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3808091|NCT01783938|3634533|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3808092|NCT01783938|3634534|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3808093|NCT01783938|3634532|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3808094|NCT01783938|3634533|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3808095|NCT01783938|3634534|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3808096|NCT01783938|3634532|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3808097|NCT01783938|3634533|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3808098|NCT01783938|3634534|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3808099|NCT01783938|3634532|B3|White||Race/Ethnicity, Customized||participants|Number|131|131.0||||||
3808100|NCT01783938|3634533|B2|White||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
3808101|NCT01783938|3634534|B1|White||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
3808102|NCT01783938|3634532|B3||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3808103|NCT01783938|3634533|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3808104|NCT01783938|3634534|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3808105|NCT01783938|3634532|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3808106|NCT01783938|3634533|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3808107|NCT01783938|3634534|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3808108|NCT01783938|3634532|B3|Categorization II, >=75 years||Age, Customized||participants|Number|19|19.0||||||
3808109|NCT01783938|3634533|B2|Categorization II, >=75 years||Age, Customized||participants|Number|12|12.0||||||
3808110|NCT01783938|3634534|B1|Categorization II, >=75 years||Age, Customized||participants|Number|7|7.0||||||
3808111|NCT01783938|3634532|B3|Categorization II, >=65 and <75 years||Age, Customized||participants|Number|37|37.0||||||
3808112|NCT01783938|3634533|B2|Categorization II, >=65 and <75 years||Age, Customized||participants|Number|18|18.0||||||
3808113|NCT01783938|3634534|B1|Categorization II, >=65 and <75 years||Age, Customized||participants|Number|19|19.0||||||
3808114|NCT01783938|3634532|B3|Categorization II, <65 years||Age, Customized||participants|Number|82|82.0||||||
3808115|NCT01783938|3634533|B2|Categorization II, <65 years||Age, Customized||participants|Number|40|40.0||||||
3808116|NCT01783938|3634534|B1|Categorization II, <65 years||Age, Customized||participants|Number|42|42.0||||||
3808117|NCT01783938|3634532|B3|Categorization I, >=65 years||Age, Customized||participants|Number|56|56.0||||||
3808118|NCT01783938|3634533|B2|Categorization I, >=65 years||Age, Customized||participants|Number|30|30.0||||||
3808119|NCT01783938|3634534|B1|Categorization I, >=65 years||Age, Customized||participants|Number|26|26.0||||||
3808120|NCT01783938|3634532|B3|Categorization I, <65 years||Age, Customized||participants|Number|82|82.0||||||
3808121|NCT01783938|3634533|B2|Categorization I, <65 years||Age, Customized||participants|Number|40|40.0||||||
3808122|NCT01783938|3634534|B1|Categorization I, <65 years||Age, Customized||participants|Number|42|42.0||||||
3808123|NCT01783938|3634532|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|14.61|14.61|||
3808124|NCT01783938|3634533|B2|||Age||years|Mean|60.6|60.6|Standard Deviation|15.17|15.17|||
3808125|NCT01783938|3634534|B1|||Age||years|Mean|59.1|59.1|Standard Deviation|14.08|14.08|||
3808126|NCT01783912|3634547|B4|United States||Region of Enrollment||participants|Number|270|270.0||||||
3808127|NCT01783912|3634548|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
3808128|NCT01783912|3634549|B2|United States||Region of Enrollment||participants|Number|104|104.0||||||
3808129|NCT01783912|3634550|B1|United States||Region of Enrollment||participants|Number|118|118.0||||||
3808130|NCT01783912|3634547|B4||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3808131|NCT01783912|3634548|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3808132|NCT01783912|3634549|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3808133|NCT01783912|3634550|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3808134|NCT01783912|3634547|B4||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3808135|NCT01783912|3634548|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3808136|NCT01783912|3634549|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3808137|NCT01783912|3634550|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3808138|NCT01783912|3634547|B4|||Age||years|Mean|44.0|44.0|Standard Deviation|9.87|9.87|||
3808139|NCT01783912|3634548|B3|||Age||years|Mean|45.0|45.0|Standard Deviation|9.54|9.54|||
3808140|NCT01783912|3634549|B2|||Age||years|Mean|43.6|43.6|Standard Deviation|10.05|10.05|||
3808141|NCT01783912|3634550|B1|||Age||years|Mean|43.8|43.8|Standard Deviation|9.88|9.88|||
3808142|NCT01783886|3634560|B4|Other Asia-Pacific (Hong Kong, Korea)||Region of Enrollment|Geographic region|participants|Number|48|48.0||||||
3808143|NCT01783886|3634561|B3|Other Asia-Pacific (Hong Kong, Korea)||Region of Enrollment|Geographic region|participants|Number|16|16.0||||||
3808144|NCT01783886|3634562|B2|Other Asia-Pacific (Hong Kong, Korea)||Region of Enrollment|Geographic region|participants|Number|16|16.0||||||
3808145|NCT01783886|3634563|B1|Other Asia-Pacific (Hong Kong, Korea)||Region of Enrollment|Geographic region|participants|Number|16|16.0||||||
3808146|NCT01783886|3634560|B4|Russia||Region of Enrollment|Geographic region|participants|Number|29|29.0||||||
3808147|NCT01783886|3634561|B3|Russia||Region of Enrollment|Geographic region|participants|Number|9|9.0||||||
3808148|NCT01783886|3634562|B2|Russia||Region of Enrollment|Geographic region|participants|Number|10|10.0||||||
3808149|NCT01783886|3634563|B1|Russia||Region of Enrollment|Geographic region|participants|Number|10|10.0||||||
3808150|NCT01783886|3634560|B4|China||Region of Enrollment|Geographic region|participants|Number|301|301.0||||||
3808151|NCT01783886|3634561|B3|China||Region of Enrollment|Geographic region|participants|Number|99|99.0||||||
3808152|NCT01783886|3634562|B2|China||Region of Enrollment|Geographic region|participants|Number|101|101.0||||||
3808153|NCT01783886|3634563|B1|China||Region of Enrollment|Geographic region|participants|Number|101|101.0||||||
3808154|NCT01783886|3634560|B4||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
3808155|NCT01783886|3634561|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3808156|NCT01783886|3634562|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3808157|NCT01783886|3634563|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3808158|NCT01783886|3634560|B4||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3808159|NCT01783886|3634561|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3808160|NCT01783886|3634562|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3808161|NCT01783886|3634563|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3808162|NCT01783886|3634560|B4|||Age||years|Mean|58.5|58.5|Standard Deviation|10.3|10.3|||
3808163|NCT01783886|3634561|B3|||Age||years|Mean|58.8|58.8|Standard Deviation|10.5|10.5|||
3808164|NCT01783886|3634562|B2|||Age||years|Mean|57.6|57.6|Standard Deviation|10.1|10.1|||
3808165|NCT01783886|3634563|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|10.3|10.3|||
3808166|NCT01783860|3634591|B3|Iran, Islamic Republic of||Region of Enrollment||participants|Number|100|100.0||||||
3808167|NCT01783860|3634592|B2|Iran, Islamic Republic of||Region of Enrollment||participants|Number|50|50.0||||||
3808168|NCT01783860|3634593|B1|Iran, Islamic Republic of||Region of Enrollment||participants|Number|50|50.0||||||
3808169|NCT01783860|3634591|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3808170|NCT01783860|3634592|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3808171|NCT01783860|3634593|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3808172|NCT01783860|3634591|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3808173|NCT01783860|3634592|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3808174|NCT01783860|3634593|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3808175|NCT01783860|3634591|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3808176|NCT01783860|3634592|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3808177|NCT01783860|3634593|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3808178|NCT01783860|3634591|B3||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
3808179|NCT01783860|3634592|B2||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
3808180|NCT01783860|3634593|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
3808181|NCT01783860|3634591|B3||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3808182|NCT01783860|3634592|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3808183|NCT01783860|3634593|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3808184|NCT01783847|3634610|B4|Iran, Islamic Republic of||Region of Enrollment||participants|Number|117|117.0||||||
3808185|NCT01783847|3634611|B3|Iran, Islamic Republic of||Region of Enrollment||participants|Number|16|16.0||||||
3808186|NCT01783847|3634612|B2|Iran, Islamic Republic of||Region of Enrollment||participants|Number|16|16.0||||||
3808187|NCT01783847|3634613|B1|Iran, Islamic Republic of||Region of Enrollment||participants|Number|85|85.0||||||
3808188|NCT01783847|3634610|B4||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3808189|NCT01783847|3634611|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3808190|NCT01783847|3634612|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3808191|NCT01783847|3634613|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3808192|NCT01783847|3634610|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3808193|NCT01783847|3634611|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3808194|NCT01783847|3634612|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3808195|NCT01783847|3634613|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3808196|NCT01783847|3634610|B4|||Age||years|Mean|27.8|27.8|Standard Deviation|13.4|13.4|||
3808197|NCT01783847|3634611|B3|||Age||years|Mean|29.0|29.0|Standard Deviation|13.7|13.7|||
3808198|NCT01783847|3634612|B2|||Age||years|Mean|23.5|23.5|Standard Deviation|9.4|9.4|||
3808199|NCT01783847|3634613|B1|||Age||years|Mean|28.4|28.4|Standard Deviation|13.9|13.9|||
3808200|NCT01783847|3634610|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3808201|NCT01783847|3634611|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3808202|NCT01783847|3634612|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3808203|NCT01783847|3634613|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3808204|NCT01783847|3634610|B4||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
3808205|NCT01783847|3634611|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3808206|NCT01783847|3634612|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3808207|NCT01783847|3634613|B1||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
3808208|NCT01783847|3634610|B4||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
3808209|NCT01783847|3634611|B3||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3808210|NCT01783847|3634612|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3808211|NCT01783847|3634613|B1||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
3808212|NCT01783821|3634623|B3|United States||Region of Enrollment||participants|Number|59|59.0||||||
3808213|NCT01783821|3634624|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3808214|NCT01783821|3634625|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3808215|NCT01783821|3634623|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3808216|NCT01783821|3634624|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3808217|NCT01783821|3634625|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3808218|NCT01783821|3634623|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3808219|NCT01783821|3634624|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3808220|NCT01783821|3634625|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3808221|NCT01783821|3634623|B3|||Age||years|Median|64|64.0|Inter-Quartile Range|||51.0|74.0|
3808222|NCT01783821|3634624|B2|||Age||years|Median|57|57.0|Inter-Quartile Range|||49.0|67.0|
3808223|NCT01783821|3634625|B1|||Age||years|Median|71|71.0|Inter-Quartile Range|||59.0|79.0|
3808224|NCT01783743|3634642|B3|Tanzania||Region of Enrollment||Participants|Count of Participants|27473|27473.0||||||
3808225|NCT01783743|3634643|B2|Tanzania||Region of Enrollment||Participants|Count of Participants|13964|13964.0||||||
3808226|NCT01783743|3634644|B1|Tanzania||Region of Enrollment||Participants|Count of Participants|13509|13509.0||||||
3808227|NCT01783743|3634642|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3808228|NCT01783743|3634642|B3||Male|Sex: Female, Male||Participants|Count of Participants|12912|12912.0||||||
3808229|NCT01783743|3634643|B2||Male|Sex: Female, Male||Participants|Count of Participants|6563|6563.0||||||
3808230|NCT01783743|3634644|B1||Male|Sex: Female, Male||Participants|Count of Participants|6349|6349.0||||||
3808511|NCT01783548|3634792|B2|4 to 5 years||Age, Customized||participants|Number|31|31.0||||||
3808231|NCT01783743|3634642|B3||Female|Sex: Female, Male||Participants|Count of Participants|14561|14561.0||||||
3808232|NCT01783743|3634643|B2||Female|Sex: Female, Male||Participants|Count of Participants|7401|7401.0||||||
3808233|NCT01783743|3634644|B1||Female|Sex: Female, Male||Participants|Count of Participants|7160|7160.0||||||
3808234|NCT01783743|3634642|B3|60 and older||Age, Customized||participants|Median|82|82.0|Inter-Quartile Range|||61.0|108.0|
3808235|NCT01783743|3634643|B2|60 and older||Age, Customized||participants|Median|83|83.0|Inter-Quartile Range|||67.0|108.0|
3808236|NCT01783743|3634644|B1|60 and older||Age, Customized||participants|Median|81|81.0|Inter-Quartile Range|||54.0|107.0|
3808237|NCT01783743|3634642|B3|40-59 years||Age, Customized||participants|Median|160|160.0|Inter-Quartile Range|||108.0|205.0|
3808238|NCT01783743|3634643|B2|40-59 years||Age, Customized||participants|Median|152|152.0|Inter-Quartile Range|||119.0|206.0|
3808239|NCT01783743|3634644|B1|40-59 years||Age, Customized||participants|Median|168|168.0|Inter-Quartile Range|||97.0|203.0|
3808240|NCT01783743|3634642|B3|15-39 years||Age, Customized||participants|Median|488|488.0|Inter-Quartile Range|||364.0|663.0|
3808241|NCT01783743|3634643|B2|15-39 years||Age, Customized||participants|Median|482|482.0|Inter-Quartile Range|||398.0|644.0|
3808242|NCT01783743|3634644|B1|15-39 years||Age, Customized||participants|Median|494|494.0|Inter-Quartile Range|||327.0|682.0|
3808243|NCT01783730|3634659|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3808244|NCT01783730|3634659|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3808245|NCT01783730|3634659|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|13.9|13.9|||
3808246|NCT01783678|3634678|B7|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|193|193.0||||||
3808247|NCT01783678|3634679|B6|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|19|19.0||||||
3808248|NCT01783678|3634680|B5|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|37|37.0||||||
3808249|NCT01783678|3634681|B4|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|36|36.0||||||
3808250|NCT01783678|3634682|B3|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|5|5.0||||||
3808251|NCT01783678|3634683|B2|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|79|79.0||||||
3808252|NCT01783678|3634684|B1|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|17|17.0||||||
3808253|NCT01783678|3634678|B7|< 6 log10 IU/mL||HCV RNA Category||participants|Number|81|81.0||||||
3808254|NCT01783678|3634679|B6|< 6 log10 IU/mL||HCV RNA Category||participants|Number|12|12.0||||||
3808255|NCT01783678|3634680|B5|< 6 log10 IU/mL||HCV RNA Category||participants|Number|12|12.0||||||
3808256|NCT01783678|3634681|B4|< 6 log10 IU/mL||HCV RNA Category||participants|Number|21|21.0||||||
3808257|NCT01783678|3634682|B3|< 6 log10 IU/mL||HCV RNA Category||participants|Number|1|1.0||||||
3808258|NCT01783678|3634683|B2|< 6 log10 IU/mL||HCV RNA Category||participants|Number|33|33.0||||||
3808259|NCT01783678|3634684|B1|< 6 log10 IU/mL||HCV RNA Category||participants|Number|2|2.0||||||
3808260|NCT01783678|3634678|B7|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.75|0.75|||
3808261|NCT01783678|3634679|B6|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|5.9|5.9|Standard Deviation|0.85|0.85|||
3808262|NCT01783678|3634680|B5|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.77|0.77|||
3808263|NCT01783678|3634681|B4|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.71|0.71|||
3808264|NCT01783678|3634682|B3|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.4|6.4|Standard Deviation|0.62|0.62|||
3808265|NCT01783678|3634683|B2|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.72|0.72|||
3808266|NCT01783678|3634684|B1|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.7|6.7|Standard Deviation|0.66|0.66|||
3808267|NCT01783678|3634678|B7|Missing||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3808268|NCT01783678|3634679|B6|Missing||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3808269|NCT01783678|3634680|B5|Missing||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3808270|NCT01783678|3634681|B4|Missing||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3808271|NCT01783678|3634682|B3|Missing||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3808272|NCT01783678|3634683|B2|Missing||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3808273|NCT01783678|3634684|B1|Missing||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3808274|NCT01783678|3634678|B7|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|40|40.0||||||
3808275|NCT01783678|3634679|B6|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|8|8.0||||||
3808276|NCT01783678|3634680|B5|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|4|4.0||||||
3808277|NCT01783678|3634681|B4|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|6|6.0||||||
3808278|NCT01783678|3634682|B3|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|2|2.0||||||
3808279|NCT01783678|3634683|B2|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|18|18.0||||||
3808280|NCT01783678|3634684|B1|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|2|2.0||||||
3808281|NCT01783678|3634678|B7|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|106|106.0||||||
3808282|NCT01783678|3634679|B6|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|14|14.0||||||
3808283|NCT01783678|3634680|B5|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|20|20.0||||||
3808284|NCT01783678|3634681|B4|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|21|21.0||||||
3808285|NCT01783678|3634682|B3|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3808286|NCT01783678|3634683|B2|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|45|45.0||||||
3808287|NCT01783678|3634684|B1|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|5|5.0||||||
3808288|NCT01783678|3634678|B7|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|127|127.0||||||
3808289|NCT01783678|3634679|B6|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|9|9.0||||||
3808290|NCT01783678|3634680|B5|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|25|25.0||||||
3808291|NCT01783678|3634681|B4|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|30|30.0||||||
3808292|NCT01783678|3634682|B3|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
3808293|NCT01783678|3634683|B2|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|48|48.0||||||
3808294|NCT01783678|3634684|B1|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|12|12.0||||||
3808295|NCT01783678|3634678|B7|Yes||Cirrhosis Status||participants|Number|54|54.0||||||
3808296|NCT01783678|3634679|B6|Yes||Cirrhosis Status||participants|Number|8|8.0||||||
3808297|NCT01783678|3634680|B5|Yes||Cirrhosis Status||participants|Number|23|23.0||||||
3808298|NCT01783678|3634681|B4|Yes||Cirrhosis Status||participants|Number|3|3.0||||||
3808299|NCT01783678|3634682|B3|Yes||Cirrhosis Status||participants|Number|2|2.0||||||
3808300|NCT01783678|3634683|B2|Yes||Cirrhosis Status||participants|Number|17|17.0||||||
3808301|NCT01783678|3634684|B1|Yes||Cirrhosis Status||participants|Number|1|1.0||||||
3808302|NCT01783678|3634678|B7|No||Cirrhosis Status||participants|Number|220|220.0||||||
3808303|NCT01783678|3634679|B6|No||Cirrhosis Status||participants|Number|23|23.0||||||
3808304|NCT01783678|3634680|B5|No||Cirrhosis Status||participants|Number|26|26.0||||||
3808305|NCT01783678|3634681|B4|No||Cirrhosis Status||participants|Number|54|54.0||||||
3808306|NCT01783678|3634682|B3|No||Cirrhosis Status||participants|Number|4|4.0||||||
3808307|NCT01783678|3634683|B2|No||Cirrhosis Status||participants|Number|95|95.0||||||
3808308|NCT01783678|3634684|B1|No||Cirrhosis Status||participants|Number|18|18.0||||||
3808309|NCT01783678|3634678|B7|Not Permitted||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3808310|NCT01783678|3634679|B6|Not Permitted||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3808311|NCT01783678|3634680|B5|Not Permitted||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3808312|NCT01783678|3634681|B4|Not Permitted||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3808313|NCT01783678|3634682|B3|Not Permitted||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3808314|NCT01783678|3634683|B2|Not Permitted||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3808315|NCT01783678|3634684|B1|Not Permitted||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3808316|NCT01783678|3634678|B7|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|255|255.0||||||
3808317|NCT01783678|3634679|B6|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3808318|NCT01783678|3634680|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
3808319|NCT01783678|3634681|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
3808320|NCT01783678|3634682|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3808321|NCT01783678|3634683|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|106|106.0||||||
3808322|NCT01783678|3634684|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3808323|NCT01783678|3634678|B7|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3808324|NCT01783678|3634679|B6|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3808325|NCT01783678|3634680|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3808326|NCT01783678|3634681|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3808327|NCT01783678|3634682|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3808328|NCT01783678|3634683|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3808329|NCT01783678|3634684|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3808330|NCT01783678|3634678|B7|Not Permitted||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3808331|NCT01783678|3634679|B6|Not Permitted||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3808332|NCT01783678|3634680|B5|Not Permitted||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3808333|NCT01783678|3634681|B4|Not Permitted||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3808334|NCT01783678|3634682|B3|Not Permitted||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3808335|NCT01783678|3634683|B2|Not Permitted||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3808336|NCT01783678|3634684|B1|Not Permitted||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3808337|NCT01783678|3634678|B7|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3808338|NCT01783678|3634679|B6|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3808339|NCT01783678|3634680|B5|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3808340|NCT01783678|3634681|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3808341|NCT01783678|3634682|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3808342|NCT01783678|3634683|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3808343|NCT01783678|3634684|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3808344|NCT01783678|3634678|B7|American Indian/Alaska Native/First Nations||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3808345|NCT01783678|3634679|B6|American Indian/Alaska Native/First Nations||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3808346|NCT01783678|3634680|B5|American Indian/Alaska Native/First Nations||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3808347|NCT01783678|3634681|B4|American Indian/Alaska Native/First Nations||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3808348|NCT01783678|3634682|B3|American Indian/Alaska Native/First Nations||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3808349|NCT01783678|3634683|B2|American Indian/Alaska Native/First Nations||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3808350|NCT01783678|3634684|B1|American Indian/Alaska Native/First Nations||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3808351|NCT01783678|3634678|B7|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3808352|NCT01783678|3634679|B6|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3808353|NCT01783678|3634680|B5|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3808354|NCT01783678|3634681|B4|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3808355|NCT01783678|3634682|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3808356|NCT01783678|3634683|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3808357|NCT01783678|3634684|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3808358|NCT01783678|3634678|B7|White||Race/Ethnicity, Customized||participants|Number|259|259.0||||||
3808359|NCT01783678|3634679|B6|White||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3808360|NCT01783678|3634680|B5|White||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
3808361|NCT01783678|3634681|B4|White||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
3808362|NCT01783678|3634682|B3|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3808363|NCT01783678|3634683|B2|White||Race/Ethnicity, Customized||participants|Number|104|104.0||||||
3808364|NCT01783678|3634684|B1|White||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3808365|NCT01783678|3634678|B7|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3808366|NCT01783678|3634679|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3808367|NCT01783678|3634680|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3808368|NCT01783678|3634681|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3808369|NCT01783678|3634682|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3808370|NCT01783678|3634683|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3808371|NCT01783678|3634684|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3808372|NCT01783678|3634678|B7||Male|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
3808373|NCT01783678|3634679|B6||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3808374|NCT01783678|3634680|B5||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3808375|NCT01783678|3634681|B4||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3808376|NCT01783678|3634682|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3808377|NCT01783678|3634683|B2||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3808378|NCT01783678|3634684|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3808379|NCT01783678|3634678|B7||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3808380|NCT01783678|3634679|B6||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3808381|NCT01783678|3634680|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3808382|NCT01783678|3634681|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3808383|NCT01783678|3634682|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3808384|NCT01783678|3634683|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3808385|NCT01783678|3634684|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3808386|NCT01783678|3634678|B7|||Age||years|Mean|47|47.0|Standard Deviation|7.4|7.4|||
3808387|NCT01783678|3634679|B6|||Age||years|Mean|47|47.0|Standard Deviation|5.9|5.9|||
3808388|NCT01783678|3634680|B5|||Age||years|Mean|49|49.0|Standard Deviation|6.2|6.2|||
3808389|NCT01783678|3634681|B4|||Age||years|Mean|47|47.0|Standard Deviation|5.4|5.4|||
3808390|NCT01783678|3634682|B3|||Age||years|Mean|55|55.0|Standard Deviation|10.2|10.2|||
3808391|NCT01783678|3634683|B2|||Age||years|Mean|45|45.0|Standard Deviation|7.6|7.6|||
3808392|NCT01783678|3634684|B1|||Age||years|Mean|55|55.0|Standard Deviation|8.2|8.2|||
3808393|NCT01783639|3634761|B1|Germany||Region of Enrollment||participants|Number|69|69.0||||||
3808394|NCT01783639|3634761|B1|Italy||Region of Enrollment||participants|Number|40|40.0||||||
3808395|NCT01783639|3634761|B1|Belgium||Region of Enrollment||participants|Number|11|11.0||||||
3808396|NCT01783639|3634761|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3808397|NCT01783639|3634761|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3808398|NCT01783639|3634761|B1|||Age||years|Mean|74.9|74.9|Standard Deviation|8.0|8.0|||
3808399|NCT01783639|3634761|B1||>=65 years|Age||Participants|Count of Participants|107|107.0||||||
3808400|NCT01783639|3634761|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3808401|NCT01783639|3634761|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3808402|NCT01783574|3634765|B3|||Derogatis Inventory of Sexual Function|Derogatis Interview of Sexual Function (Total Score): This scale measures sexual function. Lower scores indicate worse sexual function. The score range for this questionnaire is 0-160.|units on a scale|Mean|35.7|35.7|Standard Deviation|28.7|28.7|||
3808403|NCT01783574|3634766|B2|||Derogatis Inventory of Sexual Function|Derogatis Interview of Sexual Function (Total Score): This scale measures sexual function. Lower scores indicate worse sexual function. The score range for this questionnaire is 0-160.|units on a scale|Mean|38.7|38.7|Standard Deviation|30.1|30.1|||
3808404|NCT01783574|3634767|B1|||Derogatis Inventory of Sexual Function|Derogatis Interview of Sexual Function (Total Score): This scale measures sexual function. Lower scores indicate worse sexual function. The score range for this questionnaire is 0-160.|units on a scale|Mean|32.8|32.8|Standard Deviation|27.3|27.3|||
3808405|NCT01783574|3634765|B3|||Brief Fatigue Inventory|Brief Fatigue Inventory: This inventory measures fatigue severity. Higher scores indicate more severe fatigue. The range is 0-10 units on a scale.|units on a scale|Mean|5.9|5.9|Standard Deviation|2.0|2.0|||
3808406|NCT01783574|3634766|B2|||Brief Fatigue Inventory|Brief Fatigue Inventory: This inventory measures fatigue severity. Higher scores indicate more severe fatigue. The range is 0-10 units on a scale.|units on a scale|Mean|5.6|5.6|Standard Deviation|2.0|2.0|||
3808407|NCT01783574|3634767|B1|||Brief Fatigue Inventory|Brief Fatigue Inventory: This inventory measures fatigue severity. Higher scores indicate more severe fatigue. The range is 0-10 units on a scale.|units on a scale|Mean|6.2|6.2|Standard Deviation|1.9|1.9|||
3808408|NCT01783574|3634765|B3|||Postmenopausal||Participants|Count of Participants|46|46.0||||||
3808409|NCT01783574|3634766|B2|||Postmenopausal||Participants|Count of Participants|26|26.0||||||
3808410|NCT01783574|3634767|B1|||Postmenopausal||Participants|Count of Participants|20|20.0||||||
3808411|NCT01783574|3634765|B3|||Mean MADRS Score|Montgomery-Asberg Depression Rating Score (MADRS) Score: This scale measures depression symptom severity. Higher scores indicate more severe depression symptom severity. The score range is 0-60 units on a scale.|units on a scale|Mean|26.6|26.6|Standard Deviation|5.9|5.9|||
3808412|NCT01783574|3634766|B2|||Mean MADRS Score|Montgomery-Asberg Depression Rating Score (MADRS) Score: This scale measures depression symptom severity. Higher scores indicate more severe depression symptom severity. The score range is 0-60 units on a scale.|units on a scale|Mean|26.3|26.3|Standard Deviation|5.4|5.4|||
3808413|NCT01783574|3634767|B1|||Mean MADRS Score|Montgomery-Asberg Depression Rating Score (MADRS) Score: This scale measures depression symptom severity. Higher scores indicate more severe depression symptom severity. The score range is 0-60 units on a scale.|units on a scale|Mean|26.8|26.8|Standard Deviation|6.3|6.3|||
3808414|NCT01783574|3634765|B3|||BMI||kg/m2|Mean|29.2|29.2|Standard Deviation|7.8|7.8|||
3808415|NCT01783574|3634766|B2|||BMI||kg/m2|Mean|30.3|30.3|Standard Deviation|7.9|7.9|||
3808416|NCT01783574|3634767|B1|||BMI||kg/m2|Mean|28.2|28.2|Standard Deviation|7.6|7.6|||
3808417|NCT01783574|3634765|B3|United States||Region of Enrollment||participants|Number|101|101.0||||||
3808418|NCT01783574|3634766|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
3808419|NCT01783574|3634767|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
3808420|NCT01783574|3634765|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3808421|NCT01783574|3634766|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3808422|NCT01783574|3634767|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3808423|NCT01783574|3634765|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3808424|NCT01783574|3634766|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3808425|NCT01783574|3634767|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3808426|NCT01783574|3634765|B3||White|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
3808427|NCT01783574|3634766|B2||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3808428|NCT01783574|3634767|B1||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3808429|NCT01783574|3634765|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3808430|NCT01783574|3634766|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3808431|NCT01783574|3634767|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3808432|NCT01783574|3634765|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3808433|NCT01783574|3634766|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3808434|NCT01783574|3634767|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3808435|NCT01783574|3634765|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3808436|NCT01783574|3634766|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3808437|NCT01783574|3634767|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3808438|NCT01783574|3634765|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3808439|NCT01783574|3634766|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3808440|NCT01783574|3634767|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3808441|NCT01783574|3634765|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3808442|NCT01783574|3634766|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3808443|NCT01783574|3634767|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3808444|NCT01783574|3634765|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3808445|NCT01783574|3634766|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3808446|NCT01783574|3634767|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3808447|NCT01783574|3634765|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3808448|NCT01783574|3634766|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3808449|NCT01783574|3634767|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3808450|NCT01783574|3634765|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3808451|NCT01783574|3634766|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3808452|NCT01783574|3634767|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3808453|NCT01783574|3634765|B3||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3808454|NCT01783574|3634766|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3808455|NCT01783574|3634767|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3808456|NCT01783574|3634765|B3|||Age||years|Mean|47|47.0|Standard Deviation|14|14.0|||
3808457|NCT01783574|3634766|B2|||Age||years|Mean|48|48.0|Standard Deviation|14|14.0|||
3808458|NCT01783574|3634767|B1|||Age||years|Mean|46|46.0|Standard Deviation|14|14.0|||
3808459|NCT01783561|3634778|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
3808460|NCT01783561|3634779|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3808461|NCT01783561|3634780|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3808462|NCT01783561|3634778|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3808463|NCT01783561|3634779|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3808464|NCT01783561|3634780|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3808465|NCT01783561|3634778|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3808466|NCT01783561|3634779|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3808467|NCT01783561|3634780|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3808468|NCT01783561|3634778|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3808469|NCT01783561|3634779|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3808470|NCT01783561|3634780|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3808471|NCT01783561|3634778|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3808472|NCT01783561|3634779|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3808473|NCT01783561|3634780|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3808474|NCT01783561|3634778|B3||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
3808475|NCT01783561|3634779|B2||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
3808476|NCT01783561|3634780|B1||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
3808477|NCT01783548|3634791|B3|||Body Mass Index||kg/m^2|Mean|18.7|18.7|Standard Deviation|4.25|4.25|||
3808478|NCT01783548|3634792|B2|||Body Mass Index||kg/m^2|Mean|18.9|18.9|Standard Deviation|4.33|4.33|||
3808479|NCT01783548|3634793|B1|||Body Mass Index||kg/m^2|Mean|18.6|18.6|Standard Deviation|4.22|4.22|||
3808480|NCT01783548|3634791|B3|||Weight||kg|Mean|33.5|33.5|Standard Deviation|13.34|13.34|||
3808481|NCT01783548|3634792|B2|||Weight||kg|Mean|33.8|33.8|Standard Deviation|13.24|13.24|||
3808482|NCT01783548|3634793|B1|||Weight||kg|Mean|33.4|33.4|Standard Deviation|13.40|13.4|||
3808483|NCT01783548|3634791|B3|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3808484|NCT01783548|3634792|B2|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3808485|NCT01783548|3634793|B1|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3808486|NCT01783548|3634791|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|327|327.0||||||
3808487|NCT01783548|3634792|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|110|110.0||||||
3808488|NCT01783548|3634793|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|217|217.0||||||
3808489|NCT01783548|3634791|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|219|219.0||||||
3808490|NCT01783548|3634792|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|75|75.0||||||
3808491|NCT01783548|3634793|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|144|144.0||||||
3808492|NCT01783548|3634791|B3|Other||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
3808493|NCT01783548|3634792|B2|Other||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3808494|NCT01783548|3634793|B1|Other||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3808495|NCT01783548|3634791|B3|Black||Race/Ethnicity, Customized||participants|Number|90|90.0||||||
3808496|NCT01783548|3634792|B2|Black||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3808497|NCT01783548|3634793|B1|Black||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
3808498|NCT01783548|3634791|B3|White||Race/Ethnicity, Customized||participants|Number|417|417.0||||||
3808499|NCT01783548|3634792|B2|White||Race/Ethnicity, Customized||participants|Number|145|145.0||||||
3808500|NCT01783548|3634793|B1|White||Race/Ethnicity, Customized||participants|Number|272|272.0||||||
3808501|NCT01783548|3634791|B3||Male|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
3808502|NCT01783548|3634792|B2||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3808503|NCT01783548|3634793|B1||Male|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
3808504|NCT01783548|3634791|B3||Female|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
3808505|NCT01783548|3634792|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3808506|NCT01783548|3634793|B1||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
3808507|NCT01783548|3634791|B3|6 to 11 years||Age, Customized||participants|Number|454|454.0||||||
3808508|NCT01783548|3634792|B2|6 to 11 years||Age, Customized||participants|Number|154|154.0||||||
3808509|NCT01783548|3634793|B1|6 to 11 years||Age, Customized||participants|Number|300|300.0||||||
3808510|NCT01783548|3634791|B3|4 to 5 years||Age, Customized||participants|Number|93|93.0||||||
3808512|NCT01783548|3634793|B1|4 to 5 years||Age, Customized||participants|Number|62|62.0||||||
3808513|NCT01783548|3634791|B3|||Age||years|Mean|8.0|8.0|Standard Deviation|2.18|2.18|||
3808514|NCT01783548|3634792|B2|||Age||years|Mean|8.0|8.0|Standard Deviation|2.23|2.23|||
3808515|NCT01783548|3634793|B1|||Age||years|Mean|8.0|8.0|Standard Deviation|2.16|2.16|||
3808516|NCT01783496|3634806|B7|||Mean Fasil Laxity Scale|(Fasil Laxity Scale: 0 = absent – 5 = severe)|units on a scale|Mean|2.7|2.7|Standard Deviation|0.5|0.5|||
3808517|NCT01783496|3634807|B6|||Mean Fasil Laxity Scale|(Fasil Laxity Scale: 0 = absent – 5 = severe)|units on a scale|Mean|3.0|3.0|Standard Deviation|0.5|0.5|||
3808518|NCT01783496|3634808|B5|||Mean Fasil Laxity Scale|(Fasil Laxity Scale: 0 = absent – 5 = severe)|units on a scale|Mean|2.5|2.5|Standard Deviation|0.4|0.4|||
3808519|NCT01783496|3634809|B4|||Mean Fasil Laxity Scale|(Fasil Laxity Scale: 0 = absent – 5 = severe)|units on a scale|Mean|2.7|2.7|Standard Deviation|0.8|0.8|||
3808520|NCT01783496|3634810|B3|||Mean Fasil Laxity Scale|(Fasil Laxity Scale: 0 = absent – 5 = severe)|units on a scale|Mean|2.7|2.7|Standard Deviation|0.3|0.3|||
3808521|NCT01783496|3634811|B2|||Mean Fasil Laxity Scale|(Fasil Laxity Scale: 0 = absent – 5 = severe)|units on a scale|Mean|2.6|2.6|Standard Deviation|0.5|0.5|||
3808522|NCT01783496|3634812|B1|||Mean Fasil Laxity Scale|(Fasil Laxity Scale: 0 = absent – 5 = severe)|units on a scale|Mean|2.7|2.7|Standard Deviation|0.4|0.4|||
3808523|NCT01783496|3634806|B7|United States||Region of Enrollment||participants|Number|50|50.0||||||
3808524|NCT01783496|3634807|B6|United States||Region of Enrollment||participants|Number|5|5.0||||||
3808525|NCT01783496|3634808|B5|United States||Region of Enrollment||participants|Number|5|5.0||||||
3808526|NCT01783496|3634809|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
3808527|NCT01783496|3634810|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3808528|NCT01783496|3634811|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3808529|NCT01783496|3634812|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3808530|NCT01783496|3634806|B7||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3808531|NCT01783496|3634807|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3808532|NCT01783496|3634808|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3808533|NCT01783496|3634809|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3808534|NCT01783496|3634810|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3808535|NCT01783496|3634811|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3808536|NCT01783496|3634812|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3808537|NCT01783496|3634806|B7||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3808538|NCT01783496|3634807|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3808539|NCT01783496|3634808|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3808540|NCT01783496|3634809|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3808541|NCT01783496|3634810|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3808542|NCT01783496|3634811|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3808543|NCT01783496|3634812|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3808544|NCT01783496|3634806|B7|||Age||years|Mean|51.6|51.6|Standard Deviation|7.6|7.6|||
3808545|NCT01783496|3634807|B6|||Age||years|Mean|53.2|53.2|Standard Deviation|8.0|8.0|||
3808546|NCT01783496|3634808|B5|||Age||years|Mean|51.0|51.0|Standard Deviation|9.3|9.3|||
3808547|NCT01783496|3634809|B4|||Age||years|Mean|52.2|52.2|Standard Deviation|7.5|7.5|||
3808548|NCT01783496|3634810|B3|||Age||years|Mean|49.1|49.1|Standard Deviation|7.9|7.9|||
3808549|NCT01783496|3634811|B2|||Age||years|Mean|51.2|51.2|Standard Deviation|8.1|8.1|||
3808550|NCT01783496|3634812|B1|||Age||years|Mean|53.6|53.6|Standard Deviation|6.7|6.7|||
3808551|NCT01783483|3634843|B3|||Inspirometry Volume||mL|Mean|2417.8|2417.8|Standard Deviation|976.8|976.8|||
3808552|NCT01783483|3634844|B2|||Inspirometry Volume||mL|Mean|2398.7|2398.7|Standard Deviation|1025.7|1025.7|||
3808553|NCT01783483|3634845|B1|||Inspirometry Volume||mL|Mean|2436.3|2436.3|Standard Deviation|931.1|931.1|||
3808554|NCT01783483|3634843|B3||None or Never|Risk Factor [Previous Myocardial Infarction]||Participants|Count of Participants|192|192.0||||||
3808555|NCT01783483|3634844|B2||None or Never|Risk Factor [Previous Myocardial Infarction]||Participants|Count of Participants|92|92.0||||||
3808556|NCT01783483|3634845|B1||None or Never|Risk Factor [Previous Myocardial Infarction]||Participants|Count of Participants|100|100.0||||||
3808557|NCT01783483|3634843|B3||More than 21 days|Risk Factor [Previous Myocardial Infarction]||Participants|Count of Participants|1|1.0||||||
3808558|NCT01783483|3634844|B2||More than 21 days|Risk Factor [Previous Myocardial Infarction]||Participants|Count of Participants|1|1.0||||||
3808559|NCT01783483|3634845|B1||More than 21 days|Risk Factor [Previous Myocardial Infarction]||Participants|Count of Participants|0|0.0||||||
3808560|NCT01783483|3634843|B3||More than 8 days but less than 21 days|Risk Factor [Previous Myocardial Infarction]||Participants|Count of Participants|34|34.0||||||
3808561|NCT01783483|3634844|B2||More than 8 days but less than 21 days|Risk Factor [Previous Myocardial Infarction]||Participants|Count of Participants|16|16.0||||||
3808562|NCT01783483|3634845|B1||More than 8 days but less than 21 days|Risk Factor [Previous Myocardial Infarction]||Participants|Count of Participants|18|18.0||||||
3808563|NCT01783483|3634843|B3||More than 1 day but less than 7 days|Risk Factor [Previous Myocardial Infarction]||Participants|Count of Participants|6|6.0||||||
3808564|NCT01783483|3634844|B2||More than 1 day but less than 7 days|Risk Factor [Previous Myocardial Infarction]||Participants|Count of Participants|4|4.0||||||
3808565|NCT01783483|3634845|B1||More than 1 day but less than 7 days|Risk Factor [Previous Myocardial Infarction]||Participants|Count of Participants|2|2.0||||||
3808566|NCT01783483|3634843|B3||More than 6h but less than 24h|Risk Factor [Previous Myocardial Infarction]||Participants|Count of Participants|3|3.0||||||
3808567|NCT01783483|3634844|B2||More than 6h but less than 24h|Risk Factor [Previous Myocardial Infarction]||Participants|Count of Participants|3|3.0||||||
3808568|NCT01783483|3634845|B1||More than 6h but less than 24h|Risk Factor [Previous Myocardial Infarction]||Participants|Count of Participants|0|0.0||||||
3808569|NCT01783483|3634843|B3|||Risk Factor [Left Main Disease]||Participants|Count of Participants|50|50.0||||||
3808570|NCT01783483|3634844|B2|||Risk Factor [Left Main Disease]||Participants|Count of Participants|26|26.0||||||
3808571|NCT01783483|3634845|B1|||Risk Factor [Left Main Disease]||Participants|Count of Participants|24|24.0||||||
3808572|NCT01783483|3634843|B3|||Risk Factor [Cerebral Vascular Disease]||Participants|Count of Participants|17|17.0||||||
3808573|NCT01783483|3634844|B2|||Risk Factor [Cerebral Vascular Disease]||Participants|Count of Participants|10|10.0||||||
3808574|NCT01783483|3634845|B1|||Risk Factor [Cerebral Vascular Disease]||Participants|Count of Participants|7|7.0||||||
3808575|NCT01783483|3634843|B3|||Risk Factor [Peripheral Artery Disease]||Participants|Count of Participants|17|17.0||||||
3808576|NCT01783483|3634844|B2|||Risk Factor [Peripheral Artery Disease]||Participants|Count of Participants|12|12.0||||||
3808577|NCT01783483|3634845|B1|||Risk Factor [Peripheral Artery Disease]||Participants|Count of Participants|5|5.0||||||
3808578|NCT01783483|3634843|B3||None (No heart failure present)|Risk Factor [Congestive Heart Failure by NYHA Classification]|The New York Heart Association (NYHA) classifies heart failure according to the severity of patients' symptoms. Grades I through 4 of heart failure by NYHA is a functional classification, placing patients in one of four categories based on how much they are limited during physical activity. Grade I represents better outcome since there is no limitation of physical activities while Grade IV (exclusionary for this trial) represents the worst outcome, since patients are unable to carry on any physical activity without discomfort, even at rest.|Participants|Count of Participants|135|135.0||||||
3808579|NCT01783483|3634844|B2||None (No heart failure present)|Risk Factor [Congestive Heart Failure by NYHA Classification]|The New York Heart Association (NYHA) classifies heart failure according to the severity of patients' symptoms. Grades I through 4 of heart failure by NYHA is a functional classification, placing patients in one of four categories based on how much they are limited during physical activity. Grade I represents better outcome since there is no limitation of physical activities while Grade IV (exclusionary for this trial) represents the worst outcome, since patients are unable to carry on any physical activity without discomfort, even at rest.|Participants|Count of Participants|70|70.0||||||
3808580|NCT01783483|3634845|B1||None (No heart failure present)|Risk Factor [Congestive Heart Failure by NYHA Classification]|The New York Heart Association (NYHA) classifies heart failure according to the severity of patients' symptoms. Grades I through 4 of heart failure by NYHA is a functional classification, placing patients in one of four categories based on how much they are limited during physical activity. Grade I represents better outcome since there is no limitation of physical activities while Grade IV (exclusionary for this trial) represents the worst outcome, since patients are unable to carry on any physical activity without discomfort, even at rest.|Participants|Count of Participants|65|65.0||||||
3808581|NCT01783483|3634843|B3||Class III - Marked limitation of physical activity|Risk Factor [Congestive Heart Failure by NYHA Classification]|The New York Heart Association (NYHA) classifies heart failure according to the severity of patients' symptoms. Grades I through 4 of heart failure by NYHA is a functional classification, placing patients in one of four categories based on how much they are limited during physical activity. Grade I represents better outcome since there is no limitation of physical activities while Grade IV (exclusionary for this trial) represents the worst outcome, since patients are unable to carry on any physical activity without discomfort, even at rest.|Participants|Count of Participants|26|26.0||||||
3808582|NCT01783483|3634844|B2||Class III - Marked limitation of physical activity|Risk Factor [Congestive Heart Failure by NYHA Classification]|The New York Heart Association (NYHA) classifies heart failure according to the severity of patients' symptoms. Grades I through 4 of heart failure by NYHA is a functional classification, placing patients in one of four categories based on how much they are limited during physical activity. Grade I represents better outcome since there is no limitation of physical activities while Grade IV (exclusionary for this trial) represents the worst outcome, since patients are unable to carry on any physical activity without discomfort, even at rest.|Participants|Count of Participants|15|15.0||||||
3808583|NCT01783483|3634845|B1||Class III - Marked limitation of physical activity|Risk Factor [Congestive Heart Failure by NYHA Classification]|The New York Heart Association (NYHA) classifies heart failure according to the severity of patients' symptoms. Grades I through 4 of heart failure by NYHA is a functional classification, placing patients in one of four categories based on how much they are limited during physical activity. Grade I represents better outcome since there is no limitation of physical activities while Grade IV (exclusionary for this trial) represents the worst outcome, since patients are unable to carry on any physical activity without discomfort, even at rest.|Participants|Count of Participants|11|11.0||||||
3808584|NCT01783483|3634843|B3||Class II - Slight limitation of physical activity|Risk Factor [Congestive Heart Failure by NYHA Classification]|The New York Heart Association (NYHA) classifies heart failure according to the severity of patients' symptoms. Grades I through 4 of heart failure by NYHA is a functional classification, placing patients in one of four categories based on how much they are limited during physical activity. Grade I represents better outcome since there is no limitation of physical activities while Grade IV (exclusionary for this trial) represents the worst outcome, since patients are unable to carry on any physical activity without discomfort, even at rest.|Participants|Count of Participants|48|48.0||||||
3808585|NCT01783483|3634844|B2||Class II - Slight limitation of physical activity|Risk Factor [Congestive Heart Failure by NYHA Classification]|The New York Heart Association (NYHA) classifies heart failure according to the severity of patients' symptoms. Grades I through 4 of heart failure by NYHA is a functional classification, placing patients in one of four categories based on how much they are limited during physical activity. Grade I represents better outcome since there is no limitation of physical activities while Grade IV (exclusionary for this trial) represents the worst outcome, since patients are unable to carry on any physical activity without discomfort, even at rest.|Participants|Count of Participants|21|21.0||||||
3808625|NCT01783483|3634845|B1|Not Given||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3808586|NCT01783483|3634845|B1||Class II - Slight limitation of physical activity|Risk Factor [Congestive Heart Failure by NYHA Classification]|The New York Heart Association (NYHA) classifies heart failure according to the severity of patients' symptoms. Grades I through 4 of heart failure by NYHA is a functional classification, placing patients in one of four categories based on how much they are limited during physical activity. Grade I represents better outcome since there is no limitation of physical activities while Grade IV (exclusionary for this trial) represents the worst outcome, since patients are unable to carry on any physical activity without discomfort, even at rest.|Participants|Count of Participants|27|27.0||||||
3808587|NCT01783483|3634843|B3||Class I - No limitation of physical activity|Risk Factor [Congestive Heart Failure by NYHA Classification]|The New York Heart Association (NYHA) classifies heart failure according to the severity of patients' symptoms. Grades I through 4 of heart failure by NYHA is a functional classification, placing patients in one of four categories based on how much they are limited during physical activity. Grade I represents better outcome since there is no limitation of physical activities while Grade IV (exclusionary for this trial) represents the worst outcome, since patients are unable to carry on any physical activity without discomfort, even at rest.|Participants|Count of Participants|27|27.0||||||
3808588|NCT01783483|3634844|B2||Class I - No limitation of physical activity|Risk Factor [Congestive Heart Failure by NYHA Classification]|The New York Heart Association (NYHA) classifies heart failure according to the severity of patients' symptoms. Grades I through 4 of heart failure by NYHA is a functional classification, placing patients in one of four categories based on how much they are limited during physical activity. Grade I represents better outcome since there is no limitation of physical activities while Grade IV (exclusionary for this trial) represents the worst outcome, since patients are unable to carry on any physical activity without discomfort, even at rest.|Participants|Count of Participants|10|10.0||||||
3808589|NCT01783483|3634845|B1||Class I - No limitation of physical activity|Risk Factor [Congestive Heart Failure by NYHA Classification]|The New York Heart Association (NYHA) classifies heart failure according to the severity of patients' symptoms. Grades I through 4 of heart failure by NYHA is a functional classification, placing patients in one of four categories based on how much they are limited during physical activity. Grade I represents better outcome since there is no limitation of physical activities while Grade IV (exclusionary for this trial) represents the worst outcome, since patients are unable to carry on any physical activity without discomfort, even at rest.|Participants|Count of Participants|17|17.0||||||
3808590|NCT01783483|3634843|B3|||Risk Factor [Ejection Fraction]||percentage|Mean|55.3|55.3|Standard Deviation|11.6|11.6|||
3808591|NCT01783483|3634844|B2|||Risk Factor [Ejection Fraction]||percentage|Mean|55.2|55.2|Standard Deviation|11.9|11.9|||
3808592|NCT01783483|3634845|B1|||Risk Factor [Ejection Fraction]||percentage|Mean|55.4|55.4|Standard Deviation|11.3|11.3|||
3808593|NCT01783483|3634843|B3|||Risk Factor [Previous Sternotomy]||Participants|Count of Participants|13|13.0||||||
3808594|NCT01783483|3634844|B2|||Risk Factor [Previous Sternotomy]||Participants|Count of Participants|8|8.0||||||
3808595|NCT01783483|3634845|B1|||Risk Factor [Previous Sternotomy]||Participants|Count of Participants|5|5.0||||||
3808596|NCT01783483|3634843|B3||None|Risk Factor [Chronic Lung Disease]||Participants|Count of Participants|192|192.0||||||
3808597|NCT01783483|3634844|B2||None|Risk Factor [Chronic Lung Disease]||Participants|Count of Participants|94|94.0||||||
3808598|NCT01783483|3634845|B1||None|Risk Factor [Chronic Lung Disease]||Participants|Count of Participants|98|98.0||||||
3808599|NCT01783483|3634843|B3||Severe|Risk Factor [Chronic Lung Disease]||Participants|Count of Participants|0|0.0||||||
3808600|NCT01783483|3634844|B2||Severe|Risk Factor [Chronic Lung Disease]||Participants|Count of Participants|0|0.0||||||
3808601|NCT01783483|3634845|B1||Severe|Risk Factor [Chronic Lung Disease]||Participants|Count of Participants|0|0.0||||||
3808602|NCT01783483|3634843|B3||Moderate|Risk Factor [Chronic Lung Disease]||Participants|Count of Participants|11|11.0||||||
3808603|NCT01783483|3634844|B2||Moderate|Risk Factor [Chronic Lung Disease]||Participants|Count of Participants|4|4.0||||||
3808604|NCT01783483|3634845|B1||Moderate|Risk Factor [Chronic Lung Disease]||Participants|Count of Participants|7|7.0||||||
3808605|NCT01783483|3634843|B3||Mild|Risk Factor [Chronic Lung Disease]||Participants|Count of Participants|33|33.0||||||
3808606|NCT01783483|3634844|B2||Mild|Risk Factor [Chronic Lung Disease]||Participants|Count of Participants|18|18.0||||||
3808607|NCT01783483|3634845|B1||Mild|Risk Factor [Chronic Lung Disease]||Participants|Count of Participants|15|15.0||||||
3808608|NCT01783483|3634843|B3|||Risk Factor [Hypertension]||Participants|Count of Participants|169|169.0||||||
3808609|NCT01783483|3634844|B2|||Risk Factor [Hypertension]||Participants|Count of Participants|86|86.0||||||
3808610|NCT01783483|3634845|B1|||Risk Factor [Hypertension]||Participants|Count of Participants|83|83.0||||||
3808611|NCT01783483|3634843|B3|||Risk Factor [Current Cigarette Smoker]||Participants|Count of Participants|24|24.0||||||
3808612|NCT01783483|3634844|B2|||Risk Factor [Current Cigarette Smoker]||Participants|Count of Participants|14|14.0||||||
3808613|NCT01783483|3634845|B1|||Risk Factor [Current Cigarette Smoker]||Participants|Count of Participants|10|10.0||||||
3808614|NCT01783483|3634843|B3|||Risk Factor [Renal Failure]||Participants|Count of Participants|2|2.0||||||
3808615|NCT01783483|3634844|B2|||Risk Factor [Renal Failure]||Participants|Count of Participants|0|0.0||||||
3808616|NCT01783483|3634845|B1|||Risk Factor [Renal Failure]||Participants|Count of Participants|2|2.0||||||
3808617|NCT01783483|3634843|B3|||Risk Factor [Diabetes]||Participants|Count of Participants|79|79.0||||||
3808618|NCT01783483|3634844|B2|||Risk Factor [Diabetes]||Participants|Count of Participants|35|35.0||||||
3808619|NCT01783483|3634845|B1|||Risk Factor [Diabetes]||Participants|Count of Participants|44|44.0||||||
3808620|NCT01783483|3634843|B3|||BMI||Kg/m^2|Mean|29.1|29.1|Standard Deviation|4.7|4.7|||
3808621|NCT01783483|3634844|B2|||BMI||Kg/m^2|Mean|28.8|28.8|Standard Deviation|4.7|4.7|||
3808622|NCT01783483|3634845|B1|||BMI||Kg/m^2|Mean|29.4|29.4|Standard Deviation|4.6|4.6|||
3808623|NCT01783483|3634843|B3|Not Given||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3808624|NCT01783483|3634844|B2|Not Given||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3808626|NCT01783483|3634843|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3808627|NCT01783483|3634844|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3808628|NCT01783483|3634845|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3808629|NCT01783483|3634843|B3|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3808630|NCT01783483|3634844|B2|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3808631|NCT01783483|3634845|B1|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3808632|NCT01783483|3634843|B3|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3808633|NCT01783483|3634844|B2|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3808634|NCT01783483|3634845|B1|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3808635|NCT01783483|3634843|B3|White/Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|205|205.0||||||
3808636|NCT01783483|3634844|B2|White/Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|103|103.0||||||
3808637|NCT01783483|3634845|B1|White/Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|102|102.0||||||
3808638|NCT01783483|3634843|B3||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
3808639|NCT01783483|3634844|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3808640|NCT01783483|3634845|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3808641|NCT01783483|3634843|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3808642|NCT01783483|3634844|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3808643|NCT01783483|3634845|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3808644|NCT01783483|3634843|B3|||Age||Years|Mean|65.5|65.5|Standard Deviation|12.2|12.2|||
3808645|NCT01783483|3634844|B2|||Age||Years|Mean|65.3|65.3|Standard Deviation|13.0|13.0|||
3808646|NCT01783483|3634845|B1|||Age||Years|Mean|65.7|65.7|Standard Deviation|11.4|11.4|||
3808647|NCT01783470|3634874|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3808648|NCT01783470|3634874|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3808649|NCT01783470|3634874|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3808650|NCT01783470|3634874|B1|||Age||years|Mean|22.2|22.2|Standard Deviation|0.6|0.6|||
3808651|NCT01783418|3634882|B3|Canada||Region of Enrollment||participants|Number|13|13.0||||||
3808652|NCT01783418|3634883|B2|Canada||Region of Enrollment||participants|Number|6|6.0||||||
3808653|NCT01783418|3634884|B1|Canada||Region of Enrollment||participants|Number|7|7.0||||||
3808654|NCT01783418|3634882|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3808655|NCT01783418|3634883|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3808656|NCT01783418|3634884|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3808657|NCT01783418|3634882|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3808658|NCT01783418|3634883|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3808659|NCT01783418|3634884|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3808660|NCT01783418|3634882|B3|||Age||years|Mean|15.4|15.4|Standard Deviation|1.5|1.5|||
3808661|NCT01783418|3634883|B2|||Age||years|Mean|15.3|15.3|Standard Deviation|2.2|2.2|||
3808662|NCT01783418|3634884|B1|||Age||years|Mean|15.6|15.6|Standard Deviation|0.9|0.9|||
3808663|NCT01783236|3634903|B3|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3808664|NCT01783236|3634904|B2|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3808665|NCT01783236|3634905|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3808666|NCT01783236|3634903|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3808667|NCT01783236|3634904|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3808668|NCT01783236|3634905|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3808669|NCT01783236|3634903|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3808670|NCT01783236|3634904|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3808671|NCT01783236|3634905|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3808672|NCT01783236|3634903|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3808673|NCT01783236|3634904|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3808674|NCT01783236|3634905|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3808675|NCT01783236|3634903|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3808676|NCT01783236|3634904|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3808677|NCT01783236|3634905|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3808678|NCT01783236|3634903|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3808679|NCT01783236|3634904|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3808680|NCT01783236|3634905|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3808681|NCT01783236|3634903|B3|||Age||years|Mean|61.8|61.8|Standard Deviation|11.28|11.28|||
3808682|NCT01783236|3634904|B2|||Age||years|Mean|64.6|64.6|Standard Deviation|8.23|8.23|||
3808683|NCT01783236|3634905|B1|||Age||years|Mean|59.5|59.5|Standard Deviation|13.18|13.18|||
3808684|NCT01783080|3634920|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3808685|NCT01783080|3634920|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3808686|NCT01783080|3634920|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3808687|NCT01783080|3634920|B1|||Age||years|Mean|44|44.0|Standard Deviation|12.3|12.3|||
3808688|NCT01783080|3634920|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3808689|NCT01783080|3634920|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3808690|NCT01783080|3634920|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3808691|NCT01783054|3634927|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3808692|NCT01783054|3634927|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3808693|NCT01783054|3634927|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3808694|NCT01783054|3634927|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3808695|NCT01783054|3634927|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3808696|NCT01783054|3634927|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3808697|NCT01783054|3634927|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3808698|NCT01783054|3634927|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3808699|NCT01783054|3634927|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3808700|NCT01783054|3634927|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3808701|NCT01783054|3634927|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3808702|NCT01783054|3634927|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3808703|NCT01783054|3634927|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3808704|NCT01783054|3634927|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3808705|NCT01783054|3634927|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3808706|NCT01783054|3634927|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3808707|NCT01783015|3634936|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3808708|NCT01783015|3634937|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3808709|NCT01783015|3634938|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3808710|NCT01783015|3634936|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3808711|NCT01783015|3634937|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3808712|NCT01783015|3634938|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3808713|NCT01783015|3634936|B3|||Age||Years|Mean|54.6|54.6|Standard Deviation|14.91|14.91|||
3808714|NCT01783015|3634937|B2|||Age||Years|Mean|54.8|54.8|Standard Deviation|19.56|19.56|||
3808715|NCT01783015|3634938|B1|||Age||Years|Mean|54.5|54.5|Standard Deviation|13.43|13.43|||
3808716|NCT01782963|3635025|B1|||Body Mass Index (BMI)||Kg/m^2|Median|28|28.0|Full Range|||18.0|45.0|
3808717|NCT01782963|3635025|B1||Unknown|Serum Heavy/Light Chain|The serum heavy/light chain immunoassay quantifies the light chain types of each immunoglobulin (Ig) class based on a sample of the participants blood. Typical antibodies consist of two Ig heavy chains connected to two Ig light chains. When the plasma cells become cancerous, it can result in an increase in monoclonal immunoglobulin in the blood serum. This is used as a measure of the tumor load. The information below gives which specific monoclonal immunoglobulin was detected.|Participants|Count of Participants|2|2.0||||||
3808718|NCT01782963|3635025|B1||Light-chain only|Serum Heavy/Light Chain|The serum heavy/light chain immunoassay quantifies the light chain types of each immunoglobulin (Ig) class based on a sample of the participants blood. Typical antibodies consist of two Ig heavy chains connected to two Ig light chains. When the plasma cells become cancerous, it can result in an increase in monoclonal immunoglobulin in the blood serum. This is used as a measure of the tumor load. The information below gives which specific monoclonal immunoglobulin was detected.|Participants|Count of Participants|5|5.0||||||
3808719|NCT01782963|3635025|B1||IgA|Serum Heavy/Light Chain|The serum heavy/light chain immunoassay quantifies the light chain types of each immunoglobulin (Ig) class based on a sample of the participants blood. Typical antibodies consist of two Ig heavy chains connected to two Ig light chains. When the plasma cells become cancerous, it can result in an increase in monoclonal immunoglobulin in the blood serum. This is used as a measure of the tumor load. The information below gives which specific monoclonal immunoglobulin was detected.|Participants|Count of Participants|9|9.0||||||
3808720|NCT01782963|3635025|B1||IgG|Serum Heavy/Light Chain|The serum heavy/light chain immunoassay quantifies the light chain types of each immunoglobulin (Ig) class based on a sample of the participants blood. Typical antibodies consist of two Ig heavy chains connected to two Ig light chains. When the plasma cells become cancerous, it can result in an increase in monoclonal immunoglobulin in the blood serum. This is used as a measure of the tumor load. The information below gives which specific monoclonal immunoglobulin was detected.|Participants|Count of Participants|34|34.0||||||
3808721|NCT01782963|3635025|B1||Unknown|High-Risk Cytogenetics|Cytogenetics risk is determined by doing a genetic analysis of the participants bone marrow. The participants chromosomes are assessed for things like translocations (rearrangement of non-homologous chromosomes) or deletions (part of the genetic sequence is lost). Participants were considered high-risk if they had certain specific genetic changes. Translocations are noted as t(chromosome 1; chromosome 2) where the two chromosomes represent which non homologous chromosomes swapped genetic material. The high-risk cytogenetics included a deletion on chromosome 17, t(4;14), t(14;16), and t(14;20).|Participants|Count of Participants|2|2.0||||||
3808771|NCT01782898|3635038|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3808772|NCT01782898|3635039|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3808773|NCT01782898|3635040|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3808774|NCT01782898|3635038|B3||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3808722|NCT01782963|3635025|B1||No|High-Risk Cytogenetics|Cytogenetics risk is determined by doing a genetic analysis of the participants bone marrow. The participants chromosomes are assessed for things like translocations (rearrangement of non-homologous chromosomes) or deletions (part of the genetic sequence is lost). Participants were considered high-risk if they had certain specific genetic changes. Translocations are noted as t(chromosome 1; chromosome 2) where the two chromosomes represent which non homologous chromosomes swapped genetic material. The high-risk cytogenetics included a deletion on chromosome 17, t(4;14), t(14;16), and t(14;20).|Participants|Count of Participants|42|42.0||||||
3808723|NCT01782963|3635025|B1||Yes|High-Risk Cytogenetics|Cytogenetics risk is determined by doing a genetic analysis of the participants bone marrow. The participants chromosomes are assessed for things like translocations (rearrangement of non-homologous chromosomes) or deletions (part of the genetic sequence is lost). Participants were considered high-risk if they had certain specific genetic changes. Translocations are noted as t(chromosome 1; chromosome 2) where the two chromosomes represent which non homologous chromosomes swapped genetic material. The high-risk cytogenetics included a deletion on chromosome 17, t(4;14), t(14;16), and t(14;20).|Participants|Count of Participants|6|6.0||||||
3808724|NCT01782963|3635025|B1||5|ECOG Performance Status|"The Eastern Cooperative Oncology Group (ECOG) Performance Status Score~0: Asymptomatic (Fully active, no restrictions in self care)~1: Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature)~2: Symptomatic, <50% time in bed during the day (Ambulatory and capable of all self care but unable to carry out any work activities)~3: Symptomatic, >50% time in bed during waking hours (Capable of only limited self-care)~4: Bedbound (Completely disabled. Cannot carry on any self-care)~5: Death"|Participants|Count of Participants|0|0.0||||||
3808725|NCT01782963|3635025|B1||4|ECOG Performance Status|"The Eastern Cooperative Oncology Group (ECOG) Performance Status Score~0: Asymptomatic (Fully active, no restrictions in self care)~1: Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature)~2: Symptomatic, <50% time in bed during the day (Ambulatory and capable of all self care but unable to carry out any work activities)~3: Symptomatic, >50% time in bed during waking hours (Capable of only limited self-care)~4: Bedbound (Completely disabled. Cannot carry on any self-care)~5: Death"|Participants|Count of Participants|0|0.0||||||
3808726|NCT01782963|3635025|B1||3|ECOG Performance Status|"The Eastern Cooperative Oncology Group (ECOG) Performance Status Score~0: Asymptomatic (Fully active, no restrictions in self care)~1: Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature)~2: Symptomatic, <50% time in bed during the day (Ambulatory and capable of all self care but unable to carry out any work activities)~3: Symptomatic, >50% time in bed during waking hours (Capable of only limited self-care)~4: Bedbound (Completely disabled. Cannot carry on any self-care)~5: Death"|Participants|Count of Participants|0|0.0||||||
3808727|NCT01782963|3635025|B1||2|ECOG Performance Status|"The Eastern Cooperative Oncology Group (ECOG) Performance Status Score~0: Asymptomatic (Fully active, no restrictions in self care)~1: Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature)~2: Symptomatic, <50% time in bed during the day (Ambulatory and capable of all self care but unable to carry out any work activities)~3: Symptomatic, >50% time in bed during waking hours (Capable of only limited self-care)~4: Bedbound (Completely disabled. Cannot carry on any self-care)~5: Death"|Participants|Count of Participants|7|7.0||||||
3808728|NCT01782963|3635025|B1||1|ECOG Performance Status|"The Eastern Cooperative Oncology Group (ECOG) Performance Status Score~0: Asymptomatic (Fully active, no restrictions in self care)~1: Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature)~2: Symptomatic, <50% time in bed during the day (Ambulatory and capable of all self care but unable to carry out any work activities)~3: Symptomatic, >50% time in bed during waking hours (Capable of only limited self-care)~4: Bedbound (Completely disabled. Cannot carry on any self-care)~5: Death"|Participants|Count of Participants|18|18.0||||||
3808729|NCT01782963|3635025|B1||0|ECOG Performance Status|"The Eastern Cooperative Oncology Group (ECOG) Performance Status Score~0: Asymptomatic (Fully active, no restrictions in self care)~1: Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature)~2: Symptomatic, <50% time in bed during the day (Ambulatory and capable of all self care but unable to carry out any work activities)~3: Symptomatic, >50% time in bed during waking hours (Capable of only limited self-care)~4: Bedbound (Completely disabled. Cannot carry on any self-care)~5: Death"|Participants|Count of Participants|25|25.0||||||
3808730|NCT01782963|3635025|B1||III|Durie-Salmon Stage|"Stage III represents more advanced disease and stage I less advanced.~Stage I:~Hemoglobin value 10 g/dL~Serum calcium value normal or =12 mg/dL~Bone x-ray, normal bone structure (scale 0) or solitary bone plasmacytoma only~Low M-component production rate (IgG value <5 g/dL; IgA value <3 g/dL; Bence Jones protein <4 g/24 hr)~Stage II:~Neither stage I nor stage III~Stage III:~On or more of the following:~Hemoglobin value 12 mg/dL~Advanced lytic bone lesions (scale 3)~High M-component production rate – IgG value >7 g/dL; IgA value>5 g/dL; Bence Jones protein >12 g/24 h"|Participants|Count of Participants|18|18.0||||||
3808731|NCT01782963|3635025|B1||II|Durie-Salmon Stage|"Stage III represents more advanced disease and stage I less advanced.~Stage I:~Hemoglobin value 10 g/dL~Serum calcium value normal or =12 mg/dL~Bone x-ray, normal bone structure (scale 0) or solitary bone plasmacytoma only~Low M-component production rate (IgG value <5 g/dL; IgA value <3 g/dL; Bence Jones protein <4 g/24 hr)~Stage II:~Neither stage I nor stage III~Stage III:~On or more of the following:~Hemoglobin value 12 mg/dL~Advanced lytic bone lesions (scale 3)~High M-component production rate – IgG value >7 g/dL; IgA value>5 g/dL; Bence Jones protein >12 g/24 h"|Participants|Count of Participants|16|16.0||||||
3808732|NCT01782963|3635025|B1||I|Durie-Salmon Stage|"Stage III represents more advanced disease and stage I less advanced.~Stage I:~Hemoglobin value 10 g/dL~Serum calcium value normal or =12 mg/dL~Bone x-ray, normal bone structure (scale 0) or solitary bone plasmacytoma only~Low M-component production rate (IgG value <5 g/dL; IgA value <3 g/dL; Bence Jones protein <4 g/24 hr)~Stage II:~Neither stage I nor stage III~Stage III:~On or more of the following:~Hemoglobin value 12 mg/dL~Advanced lytic bone lesions (scale 3)~High M-component production rate – IgG value >7 g/dL; IgA value>5 g/dL; Bence Jones protein >12 g/24 h"|Participants|Count of Participants|16|16.0||||||
3808775|NCT01782898|3635039|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3808733|NCT01782963|3635025|B1||III|ISS Stage at Diagnosis|"International Staging System for Multiple Myeloma, divides multiple myeloma into three categories with III representing more advanced disease and I less advanced disease~Stage I :~Serum beta-2 microglobulin is less than 3.5 mg/L~AND Albumin level is 3.5 g/dL or greater~AND Cytogenetics are considered not high risk~AND Lactate dehydrogenase (LDH) levels are normal~Stage II: Not stage I or stage II~Stage III:~Serum beta-2 microglobulin is 5.5 (mg/L) or greater~AND Cytogenetics are considered “high-risk”~AND/OR LDH levels are high"|Participants|Count of Participants|14|14.0||||||
3808734|NCT01782963|3635025|B1||II|ISS Stage at Diagnosis|"International Staging System for Multiple Myeloma, divides multiple myeloma into three categories with III representing more advanced disease and I less advanced disease~Stage I :~Serum beta-2 microglobulin is less than 3.5 mg/L~AND Albumin level is 3.5 g/dL or greater~AND Cytogenetics are considered not high risk~AND Lactate dehydrogenase (LDH) levels are normal~Stage II: Not stage I or stage II~Stage III:~Serum beta-2 microglobulin is 5.5 (mg/L) or greater~AND Cytogenetics are considered “high-risk”~AND/OR LDH levels are high"|Participants|Count of Participants|17|17.0||||||
3808735|NCT01782963|3635025|B1||I|ISS Stage at Diagnosis|"International Staging System for Multiple Myeloma, divides multiple myeloma into three categories with III representing more advanced disease and I less advanced disease~Stage I :~Serum beta-2 microglobulin is less than 3.5 mg/L~AND Albumin level is 3.5 g/dL or greater~AND Cytogenetics are considered not high risk~AND Lactate dehydrogenase (LDH) levels are normal~Stage II: Not stage I or stage II~Stage III:~Serum beta-2 microglobulin is 5.5 (mg/L) or greater~AND Cytogenetics are considered “high-risk”~AND/OR LDH levels are high"|Participants|Count of Participants|19|19.0||||||
3808736|NCT01782963|3635025|B1|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3808737|NCT01782963|3635025|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3808738|NCT01782963|3635025|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3808739|NCT01782963|3635025|B1||Black or African-American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3808740|NCT01782963|3635025|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3808741|NCT01782963|3635025|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3808742|NCT01782963|3635025|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3808743|NCT01782963|3635025|B1|||Age||years|Median|73|73.0|Full Range|||65.0|91.0|
3808744|NCT01782898|3635038|B3|ASA Class 2||American Society of Anesthesiologist Classification|The grading system is to evaluate the degree of a patient's physical state before undergoing anesthetic procedure. 1-6 1 being healthy patient and 6 being brain dead.|participants|Number|35|35.0||||||
3808745|NCT01782898|3635039|B2|ASA Class 2||American Society of Anesthesiologist Classification|The grading system is to evaluate the degree of a patient's physical state before undergoing anesthetic procedure. 1-6 1 being healthy patient and 6 being brain dead.|participants|Number|18|18.0||||||
3808746|NCT01782898|3635040|B1|ASA Class 2||American Society of Anesthesiologist Classification|The grading system is to evaluate the degree of a patient's physical state before undergoing anesthetic procedure. 1-6 1 being healthy patient and 6 being brain dead.|participants|Number|17|17.0||||||
3808747|NCT01782898|3635038|B3|ASA Class 1||American Society of Anesthesiologist Classification|The grading system is to evaluate the degree of a patient's physical state before undergoing anesthetic procedure. 1-6 1 being healthy patient and 6 being brain dead.|participants|Number|23|23.0||||||
3808748|NCT01782898|3635039|B2|ASA Class 1||American Society of Anesthesiologist Classification|The grading system is to evaluate the degree of a patient's physical state before undergoing anesthetic procedure. 1-6 1 being healthy patient and 6 being brain dead.|participants|Number|11|11.0||||||
3808749|NCT01782898|3635040|B1|ASA Class 1||American Society of Anesthesiologist Classification|The grading system is to evaluate the degree of a patient's physical state before undergoing anesthetic procedure. 1-6 1 being healthy patient and 6 being brain dead.|participants|Number|12|12.0||||||
3808750|NCT01782898|3635038|B3|||Surgical Duration||Minutes|Median|77|77.0|Full Range|||67.0|99.0|
3808751|NCT01782898|3635039|B2|||Surgical Duration||Minutes|Median|72|72.0|Full Range|||66.0|83.0|
3808752|NCT01782898|3635040|B1|||Surgical Duration||Minutes|Median|82|82.0|Full Range|||67.0|99.0|
3808753|NCT01782898|3635038|B3|||Intraoperative Fentanyl (mcg)||micrograms|Median|100|100.0|Full Range|||50.0|150.0|
3808754|NCT01782898|3635039|B2|||Intraoperative Fentanyl (mcg)||micrograms|Median|100|100.0|Full Range|||50.0|150.0|
3808755|NCT01782898|3635040|B1|||Intraoperative Fentanyl (mcg)||micrograms|Median|100|100.0|Full Range|||50.0|150.0|
3808756|NCT01782898|3635038|B3|||BMI (kg/m^2)|"BMI is the abbreviation for body mass index which is represented by the following:~(kg/m^2)"|(kg/m^2)|Median|24|24.0|Full Range|||22.0|29.0|
3808757|NCT01782898|3635039|B2|||BMI (kg/m^2)|"BMI is the abbreviation for body mass index which is represented by the following:~(kg/m^2)"|(kg/m^2)|Median|24|24.0|Full Range|||23.0|26.0|
3808758|NCT01782898|3635040|B1|||BMI (kg/m^2)|"BMI is the abbreviation for body mass index which is represented by the following:~(kg/m^2)"|(kg/m^2)|Median|23|23.0|Full Range|||22.0|29.0|
3808759|NCT01782898|3635038|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
3808760|NCT01782898|3635039|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
3808761|NCT01782898|3635040|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3808762|NCT01782898|3635038|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3808763|NCT01782898|3635039|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3808764|NCT01782898|3635040|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3808765|NCT01782898|3635038|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3808766|NCT01782898|3635039|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3808767|NCT01782898|3635040|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3808768|NCT01782898|3635038|B3|||Age||Years|Median|39|39.0|Inter-Quartile Range|||31.0|50.0|
3808769|NCT01782898|3635039|B2|||Age||Years|Median|41|41.0|Inter-Quartile Range|||32.0|50.0|
3808770|NCT01782898|3635040|B1|||Age||Years|Median|38|38.0|Inter-Quartile Range|||31.0|45.0|
3808776|NCT01782898|3635040|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3808777|NCT01782898|3635038|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3808778|NCT01782898|3635039|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3808779|NCT01782898|3635040|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3808780|NCT01782885|3635051|B3|||Western Ontario and McMaster Universities Arthritis Index (WOMAC)|The WOMAC measures five items for pain (score range 0–20), two for stiffness (score range 0–8), and 17 for functional limitation (score range 0–68). A total WOMAC score is created by summing the items for all three subscales. Higher scores on the WOMAC indicate worse pain, stiffness, and functional limitations.|units on a scale|Mean|35.6|35.6|Standard Deviation|19.3|19.3|||
3808781|NCT01782885|3635052|B2|||Western Ontario and McMaster Universities Arthritis Index (WOMAC)|The WOMAC measures five items for pain (score range 0–20), two for stiffness (score range 0–8), and 17 for functional limitation (score range 0–68). A total WOMAC score is created by summing the items for all three subscales. Higher scores on the WOMAC indicate worse pain, stiffness, and functional limitations.|units on a scale|Mean|35.7|35.7|Standard Deviation|19.5|19.5|||
3808782|NCT01782885|3635053|B1|||Western Ontario and McMaster Universities Arthritis Index (WOMAC)|The WOMAC measures five items for pain (score range 0–20), two for stiffness (score range 0–8), and 17 for functional limitation (score range 0–68). A total WOMAC score is created by summing the items for all three subscales. Higher scores on the WOMAC indicate worse pain, stiffness, and functional limitations.|units on a scale|Mean|35.5|35.5|Standard Deviation|19.0|19.0|||
3808783|NCT01782885|3635051|B3|||Visual Analog Scale (VAS)|The visual analog scale (VAS) is a psychometric response scale which measures subjective characteristics or attitudes that cannot be directly measured. When responding to a VAS item, respondents specify their current level of pain by indicating a position along a continuous line of 10 cm. Subject is asked: on a scale of 0 to 10, with 0 being no pain and 10 being the worst pain imaginable, what you rate your current pain?|cm|Mean|5.4|5.4|Standard Deviation|2.3|2.3|||
3808784|NCT01782885|3635052|B2|||Visual Analog Scale (VAS)|The visual analog scale (VAS) is a psychometric response scale which measures subjective characteristics or attitudes that cannot be directly measured. When responding to a VAS item, respondents specify their current level of pain by indicating a position along a continuous line of 10 cm. Subject is asked: on a scale of 0 to 10, with 0 being no pain and 10 being the worst pain imaginable, what you rate your current pain?|cm|Mean|4.9|4.9|Standard Deviation|2.4|2.4|||
3808785|NCT01782885|3635053|B1|||Visual Analog Scale (VAS)|The visual analog scale (VAS) is a psychometric response scale which measures subjective characteristics or attitudes that cannot be directly measured. When responding to a VAS item, respondents specify their current level of pain by indicating a position along a continuous line of 10 cm. Subject is asked: on a scale of 0 to 10, with 0 being no pain and 10 being the worst pain imaginable, what you rate your current pain?|cm|Mean|5.9|5.9|Standard Deviation|2.2|2.2|||
3808786|NCT01782885|3635051|B3|Kellgren-Lawrence Grade II||Grade of Osteoarthritis|Grade 0: No radiographic features of osteoarthritis, Grade I: Possible joint space narrowing and osteophyte formation, Grade II: Definite osteophyte formation with possible joint space narrowing, Grade III: Multiple osteophytes, definite joint space narrowing, sclerosis and possible bony deformity, Grade IV: Large osteophytes, marked joint space narrowing, severe sclerosis and definite bony deformity|participants|Number|42|42.0||||||
3808787|NCT01782885|3635052|B2|Kellgren-Lawrence Grade II||Grade of Osteoarthritis|Grade 0: No radiographic features of osteoarthritis, Grade I: Possible joint space narrowing and osteophyte formation, Grade II: Definite osteophyte formation with possible joint space narrowing, Grade III: Multiple osteophytes, definite joint space narrowing, sclerosis and possible bony deformity, Grade IV: Large osteophytes, marked joint space narrowing, severe sclerosis and definite bony deformity|participants|Number|22|22.0||||||
3808788|NCT01782885|3635053|B1|Kellgren-Lawrence Grade II||Grade of Osteoarthritis|Grade 0: No radiographic features of osteoarthritis, Grade I: Possible joint space narrowing and osteophyte formation, Grade II: Definite osteophyte formation with possible joint space narrowing, Grade III: Multiple osteophytes, definite joint space narrowing, sclerosis and possible bony deformity, Grade IV: Large osteophytes, marked joint space narrowing, severe sclerosis and definite bony deformity|participants|Number|20|20.0||||||
3808789|NCT01782885|3635051|B3|Kellgren-Lawrence Grade I||Grade of Osteoarthritis|Grade 0: No radiographic features of osteoarthritis, Grade I: Possible joint space narrowing and osteophyte formation, Grade II: Definite osteophyte formation with possible joint space narrowing, Grade III: Multiple osteophytes, definite joint space narrowing, sclerosis and possible bony deformity, Grade IV: Large osteophytes, marked joint space narrowing, severe sclerosis and definite bony deformity|participants|Number|23|23.0||||||
3808790|NCT01782885|3635052|B2|Kellgren-Lawrence Grade I||Grade of Osteoarthritis|Grade 0: No radiographic features of osteoarthritis, Grade I: Possible joint space narrowing and osteophyte formation, Grade II: Definite osteophyte formation with possible joint space narrowing, Grade III: Multiple osteophytes, definite joint space narrowing, sclerosis and possible bony deformity, Grade IV: Large osteophytes, marked joint space narrowing, severe sclerosis and definite bony deformity|participants|Number|11|11.0||||||
3808791|NCT01782885|3635053|B1|Kellgren-Lawrence Grade I||Grade of Osteoarthritis|Grade 0: No radiographic features of osteoarthritis, Grade I: Possible joint space narrowing and osteophyte formation, Grade II: Definite osteophyte formation with possible joint space narrowing, Grade III: Multiple osteophytes, definite joint space narrowing, sclerosis and possible bony deformity, Grade IV: Large osteophytes, marked joint space narrowing, severe sclerosis and definite bony deformity|participants|Number|12|12.0||||||
3808792|NCT01782885|3635051|B3|||Body Mass Index (BMI)||kg/m2|Mean|30.9|30.9|Standard Deviation|5.0|5.0|||
3808793|NCT01782885|3635052|B2|||Body Mass Index (BMI)||kg/m2|Mean|32.2|32.2|Standard Deviation|6.2|6.2|||
3808794|NCT01782885|3635053|B1|||Body Mass Index (BMI)||kg/m2|Mean|29.5|29.5|Standard Deviation|3.8|3.8|||
3808795|NCT01782885|3635051|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3808796|NCT01782885|3635052|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3808797|NCT01782885|3635053|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3808798|NCT01782885|3635051|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3808799|NCT01782885|3635052|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3808800|NCT01782885|3635053|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3808801|NCT01782885|3635051|B3|||Age||years|Mean|56.4|56.4|Standard Deviation|9.8|9.8|||
3808802|NCT01782885|3635052|B2|||Age||years|Mean|57.2|57.2|Standard Deviation|8.1|8.1|||
3808803|NCT01782885|3635053|B1|||Age||years|Mean|55.6|55.6|Standard Deviation|11.4|11.4|||
3808804|NCT01782872|3635076|B5|||BMI||kg/m^2|Mean|28|28.0|Standard Deviation|5|5.0|||
3808805|NCT01782872|3635077|B4|||BMI||kg/m^2|Mean|31|31.0|Standard Deviation|6|6.0|||
3808806|NCT01782872|3635078|B3|||BMI||kg/m^2|Mean|27|27.0|Standard Deviation|4|4.0|||
3808807|NCT01782872|3635079|B2|||BMI||kg/m^2|Mean|25|25.0|Standard Deviation|3|3.0|||
3808808|NCT01782872|3635080|B1|||BMI||kg/m^2|Mean|28|28.0|Standard Deviation|4|4.0|||
3808809|NCT01782872|3635076|B5|United States||Region of Enrollment||participants|Number|80|80.0||||||
3808810|NCT01782872|3635077|B4|United States||Region of Enrollment||participants|Number|20|20.0||||||
3808811|NCT01782872|3635078|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3808812|NCT01782872|3635079|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3808813|NCT01782872|3635080|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3808814|NCT01782872|3635076|B5||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3808815|NCT01782872|3635077|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3808816|NCT01782872|3635078|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3808817|NCT01782872|3635079|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3808818|NCT01782872|3635080|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3808819|NCT01782872|3635076|B5||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3808820|NCT01782872|3635077|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3808821|NCT01782872|3635078|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3808822|NCT01782872|3635079|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3808823|NCT01782872|3635080|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3808824|NCT01782872|3635076|B5|||Age||years|Mean|67|67.0|Standard Deviation|7|7.0|||
3808825|NCT01782872|3635077|B4|||Age||years|Mean|68|68.0|Standard Deviation|7|7.0|||
3808826|NCT01782872|3635078|B3|||Age||years|Mean|69|69.0|Standard Deviation|7|7.0|||
3808827|NCT01782872|3635079|B2|||Age||years|Mean|64|64.0|Standard Deviation|9|9.0|||
3808828|NCT01782872|3635080|B1|||Age||years|Mean|66|66.0|Standard Deviation|8|8.0|||
3808829|NCT01782859|3635105|B3|||Body mass index||kg/(m^2)|Mean|27.00|27.0|Standard Deviation|4.43|4.43|||
3808830|NCT01782859|3635106|B2|||Body mass index||kg/(m^2)|Mean|28.03|28.03|Standard Deviation|4.86|4.86|||
3808831|NCT01782859|3635107|B1|||Body mass index||kg/(m^2)|Mean|26.04|26.04|Standard Deviation|3.92|3.92|||
3808832|NCT01782859|3635105|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
3808833|NCT01782859|3635106|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3808834|NCT01782859|3635107|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3808835|NCT01782859|3635105|B3||Male|Gender||Participants|Count of Participants|10|10.0||||||
3808836|NCT01782859|3635106|B2||Male|Gender||Participants|Count of Participants|4|4.0||||||
3808837|NCT01782859|3635107|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
3808838|NCT01782859|3635105|B3||Female|Gender||Participants|Count of Participants|17|17.0||||||
3808839|NCT01782859|3635106|B2||Female|Gender||Participants|Count of Participants|9|9.0||||||
3808840|NCT01782859|3635107|B1||Female|Gender||Participants|Count of Participants|8|8.0||||||
3808841|NCT01782859|3635105|B3|||Age||years|Mean|65.66|65.66|Standard Deviation|7.87|7.87|||
3808842|NCT01782859|3635106|B2|||Age||years|Mean|66.21|66.21|Standard Deviation|8.80|8.8|||
3808843|NCT01782859|3635107|B1|||Age||years|Mean|65.13|65.13|Standard Deviation|7.16|7.16|||
3808844|NCT01782833|3635122|B1||Male|Sex: Female, Male||Participants|Count of Participants|1445|1445.0||||||
3808845|NCT01782833|3635122|B1||Female|Sex: Female, Male||Participants|Count of Participants|1920|1920.0||||||
3808846|NCT01782833|3635122|B1|||Age||years|Mean|66.27|66.27|Standard Deviation|10.92|10.92|||
3808847|NCT01782742|3635128|B3|Homozygotes||ApoE4 Status||participants|Number|6|6.0||||||
3808848|NCT01782742|3635129|B2|Homozygotes||ApoE4 Status||participants|Number|0|0.0||||||
3808849|NCT01782742|3635130|B1|Homozygotes||ApoE4 Status||participants|Number|6|6.0||||||
3808850|NCT01782742|3635128|B3|Heterozygotes||ApoE4 Status||participants|Number|7|7.0||||||
3808851|NCT01782742|3635129|B2|Heterozygotes||ApoE4 Status||participants|Number|1|1.0||||||
3808852|NCT01782742|3635130|B1|Heterozygotes||ApoE4 Status||participants|Number|6|6.0||||||
3808853|NCT01782742|3635128|B3|Non-carriers||ApoE4 Status||participants|Number|7|7.0||||||
3808854|NCT01782742|3635129|B2|Non-carriers||ApoE4 Status||participants|Number|3|3.0||||||
3808855|NCT01782742|3635130|B1|Non-carriers||ApoE4 Status||participants|Number|4|4.0||||||
3808856|NCT01782742|3635128|B3|||ADCS-ADL score|The ADCS-ADL is an activities-of-daily-living inventory developed by the ADCS to assess functional performance in participants with AD (Galasko et al., 1997). Using a structured interview format, study partners are queried as to whether participants attempted each item in the inventory during the prior 4 weeks and their level of performance. Overall score range from 0 meaning fully independent to 78 meaning fully dependent on assistance for activities of daily living.|units on a scale|Mean|55.9|55.9|Full Range|||34.0|77.0|
3808919|NCT01782664|3635180|B7||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3808920|NCT01782664|3635181|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3808857|NCT01782742|3635129|B2|||ADCS-ADL score|The ADCS-ADL is an activities-of-daily-living inventory developed by the ADCS to assess functional performance in participants with AD (Galasko et al., 1997). Using a structured interview format, study partners are queried as to whether participants attempted each item in the inventory during the prior 4 weeks and their level of performance. Overall score range from 0 meaning fully independent to 78 meaning fully dependent on assistance for activities of daily living.|units on a scale|Mean|64.5|64.5|Full Range|||37.0|76.0|
3808858|NCT01782742|3635130|B1|||ADCS-ADL score|The ADCS-ADL is an activities-of-daily-living inventory developed by the ADCS to assess functional performance in participants with AD (Galasko et al., 1997). Using a structured interview format, study partners are queried as to whether participants attempted each item in the inventory during the prior 4 weeks and their level of performance. Overall score range from 0 meaning fully independent to 78 meaning fully dependent on assistance for activities of daily living.|units on a scale|Mean|53.7|53.7|Full Range|||34.0|77.0|
3808859|NCT01782742|3635128|B3|||NPI Distress Score|NPI distress score measures the distress that the caregiver experiences during the previous 4 weeks from the assessment date. Distress score is measured on a scale between 0 to 5. 0 being not at all distressed to 5 very severely or extremely distressed. The scores for all 12 domains are added up becomes the total score. 0 means no caregiver distress and 60 means extreme caregiver distress.|units on a scale|Mean|6.1|6.1|Full Range|||0.0|35.0|
3808860|NCT01782742|3635129|B2|||NPI Distress Score|NPI distress score measures the distress that the caregiver experiences during the previous 4 weeks from the assessment date. Distress score is measured on a scale between 0 to 5. 0 being not at all distressed to 5 very severely or extremely distressed. The scores for all 12 domains are added up becomes the total score. 0 means no caregiver distress and 60 means extreme caregiver distress.|units on a scale|Mean|4.3|4.3|Full Range|||2.0|6.0|
3808861|NCT01782742|3635130|B1|||NPI Distress Score|NPI distress score measures the distress that the caregiver experiences during the previous 4 weeks from the assessment date. Distress score is measured on a scale between 0 to 5. 0 being not at all distressed to 5 very severely or extremely distressed. The scores for all 12 domains are added up becomes the total score. 0 means no caregiver distress and 60 means extreme caregiver distress.|units on a scale|Mean|6.5|6.5|Full Range|||0.0|35.0|
3808862|NCT01782742|3635128|B3|||NPI score|The NPI is a well validated, reliable, multi-item instrument to assess psychopathology in AD based on interview with the study partner. The NPI evaluates both the frequency and severity of 10 neuropsychiatric disturbances. Frequency assessments range from 1 (occasionally, less than once per week) to 4 (very frequently, once or more per day or continuously) as well as severity (1=mild, 2=moderate, 3=severe). The overall score and the score for each subscale are the product of severity and frequency. Overall score range from 0 meaning no disturbance to 144 meaning severe disturbance.|units on a scale|Mean|8.4|8.4|Full Range|||0.0|29.0|
3808863|NCT01782742|3635129|B2|||NPI score|The NPI is a well validated, reliable, multi-item instrument to assess psychopathology in AD based on interview with the study partner. The NPI evaluates both the frequency and severity of 10 neuropsychiatric disturbances. Frequency assessments range from 1 (occasionally, less than once per week) to 4 (very frequently, once or more per day or continuously) as well as severity (1=mild, 2=moderate, 3=severe). The overall score and the score for each subscale are the product of severity and frequency. Overall score range from 0 meaning no disturbance to 144 meaning severe disturbance.|units on a scale|Mean|7.0|7.0|Full Range|||2.0|16.0|
3808864|NCT01782742|3635130|B1|||NPI score|The NPI is a well validated, reliable, multi-item instrument to assess psychopathology in AD based on interview with the study partner. The NPI evaluates both the frequency and severity of 10 neuropsychiatric disturbances. Frequency assessments range from 1 (occasionally, less than once per week) to 4 (very frequently, once or more per day or continuously) as well as severity (1=mild, 2=moderate, 3=severe). The overall score and the score for each subscale are the product of severity and frequency. Overall score range from 0 meaning no disturbance to 144 meaning severe disturbance.|units on a scale|Mean|8.7|8.7|Full Range|||0.0|29.0|
3808865|NCT01782742|3635128|B3|||CDR score|The CDR is a clinical scale that rates the severity of dementia as absent, questionable, mild, moderate, or severe (CDR score of 0, 0.5, 1, 2, or 3, respectively). Higher score means more severe dementia rating. The score is based on interviews with the participant and study partner, using a structured interview that assesses six domains: memory, orientation, judgment and problem solving, community affairs, home and hobbies, and personal care.|units on a scale|Mean|1.4|1.4|Full Range|||0.0|2.0|
3808866|NCT01782742|3635129|B2|||CDR score|The CDR is a clinical scale that rates the severity of dementia as absent, questionable, mild, moderate, or severe (CDR score of 0, 0.5, 1, 2, or 3, respectively). Higher score means more severe dementia rating. The score is based on interviews with the participant and study partner, using a structured interview that assesses six domains: memory, orientation, judgment and problem solving, community affairs, home and hobbies, and personal care.|units on a scale|Mean|1.1|1.1|Full Range|||0.0|2.0|
3808867|NCT01782742|3635130|B1|||CDR score|The CDR is a clinical scale that rates the severity of dementia as absent, questionable, mild, moderate, or severe (CDR score of 0, 0.5, 1, 2, or 3, respectively). Higher score means more severe dementia rating. The score is based on interviews with the participant and study partner, using a structured interview that assesses six domains: memory, orientation, judgment and problem solving, community affairs, home and hobbies, and personal care.|units on a scale|Mean|1.4|1.4|Full Range|||0.0|2.0|
3808868|NCT01782742|3635128|B3|||ADAS-Cog score|The ADAS-Cog is a psychometric instrument that evaluates memory, attention, reasoning, language, orientation, and praxis. A higher score indicates more impairment. Scores from the original portion of the test range from 0 (best) to 85 (worse). A positive change indicates cognitive worsening.|units on a scale|Mean|48.0|48.0|Full Range|||28.0|65.0|
3808869|NCT01782742|3635129|B2|||ADAS-Cog score|The ADAS-Cog is a psychometric instrument that evaluates memory, attention, reasoning, language, orientation, and praxis. A higher score indicates more impairment. Scores from the original portion of the test range from 0 (best) to 85 (worse). A positive change indicates cognitive worsening.|units on a scale|Mean|40.3|40.3|Full Range|||28.0|54.0|
3808870|NCT01782742|3635130|B1|||ADAS-Cog score|The ADAS-Cog is a psychometric instrument that evaluates memory, attention, reasoning, language, orientation, and praxis. A higher score indicates more impairment. Scores from the original portion of the test range from 0 (best) to 85 (worse). A positive change indicates cognitive worsening.|units on a scale|Mean|49.9|49.9|Full Range|||35.0|65.0|
3808921|NCT01782664|3635182|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3808871|NCT01782742|3635128|B3|||MMSE total score|The MMSE evaluates orientation, memory, attention, concentration, naming, repetition, comprehension, and ability to create a sentence and to copy two overlapping pentagons. A lower score indicates more cognitive impairment. The lowest score that any particular person can get is 0 and the highest score is 30.|units on a scale|Mean|14.4|14.4|Full Range|||8.0|23.0|
3808872|NCT01782742|3635129|B2|||MMSE total score|The MMSE evaluates orientation, memory, attention, concentration, naming, repetition, comprehension, and ability to create a sentence and to copy two overlapping pentagons. A lower score indicates more cognitive impairment. The lowest score that any particular person can get is 0 and the highest score is 30.|units on a scale|Mean|17.0|17.0|Full Range|||11.0|23.0|
3808873|NCT01782742|3635130|B1|||MMSE total score|The MMSE evaluates orientation, memory, attention, concentration, naming, repetition, comprehension, and ability to create a sentence and to copy two overlapping pentagons. A lower score indicates more cognitive impairment. The lowest score that any particular person can get is 0 and the highest score is 30.|units on a scale|Mean|13.7|13.7|Full Range|||8.0|23.0|
3808874|NCT01782742|3635128|B3|||Years of Cognitive Symptoms||years|Mean|4.3|4.3|Standard Deviation|1.9|1.9|||
3808875|NCT01782742|3635129|B2|||Years of Cognitive Symptoms||years|Mean|2.8|2.8|Standard Deviation|0.96|0.96|||
3808876|NCT01782742|3635130|B1|||Years of Cognitive Symptoms||years|Mean|4.6|4.6|Standard Deviation|1.9|1.9|||
3808877|NCT01782742|3635128|B3|||Years of Education||years|Mean|14.2|14.2|Standard Deviation|4.7|4.7|||
3808878|NCT01782742|3635129|B2|||Years of Education||years|Mean|12.3|12.3|Standard Deviation|3.3|3.3|||
3808879|NCT01782742|3635130|B1|||Years of Education||years|Mean|14.7|14.7|Standard Deviation|4.9|4.9|||
3808880|NCT01782742|3635128|B3|Race - African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3808881|NCT01782742|3635129|B2|Race - African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3808882|NCT01782742|3635130|B1|Race - African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3808883|NCT01782742|3635128|B3|Race - Caucasian||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3808884|NCT01782742|3635129|B2|Race - Caucasian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3808885|NCT01782742|3635130|B1|Race - Caucasian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3808886|NCT01782742|3635128|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3808887|NCT01782742|3635129|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3808888|NCT01782742|3635130|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3808889|NCT01782742|3635128|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3808890|NCT01782742|3635129|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3808891|NCT01782742|3635130|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3808892|NCT01782742|3635128|B3|Age at Screening||Age, Customized|Age at Screening|years|Mean|75.5|75.5|Standard Deviation|6.8|6.8|||
3808893|NCT01782742|3635129|B2|Age at Screening||Age, Customized|Age at Screening|years|Mean|78.1|78.1|Standard Deviation|8.0|8.0|||
3808894|NCT01782742|3635130|B1|Age at Screening||Age, Customized|Age at Screening|years|Mean|74.9|74.9|Standard Deviation|6.6|6.6|||
3808895|NCT01782690|3635164|B1||Male|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
3808896|NCT01782690|3635164|B1||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3808897|NCT01782690|3635164|B1|||Age||years|Mean|66.9|66.9|Standard Deviation|9.1|9.1|||
3808898|NCT01782664|3635180|B7|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|64|64.0||||||
3808899|NCT01782664|3635181|B6|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3808900|NCT01782664|3635182|B5|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3808901|NCT01782664|3635183|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3808902|NCT01782664|3635184|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3808903|NCT01782664|3635185|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3808904|NCT01782664|3635186|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3808905|NCT01782664|3635180|B7|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3808906|NCT01782664|3635181|B6|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3808907|NCT01782664|3635182|B5|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3808908|NCT01782664|3635183|B4|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3808909|NCT01782664|3635184|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3808910|NCT01782664|3635185|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3808911|NCT01782664|3635186|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3808912|NCT01782664|3635180|B7|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3808913|NCT01782664|3635181|B6|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3808914|NCT01782664|3635182|B5|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3808915|NCT01782664|3635183|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3808916|NCT01782664|3635184|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3808917|NCT01782664|3635185|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3808918|NCT01782664|3635186|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3808922|NCT01782664|3635183|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3808923|NCT01782664|3635184|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3808924|NCT01782664|3635185|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3808925|NCT01782664|3635186|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3808926|NCT01782664|3635180|B7||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3808927|NCT01782664|3635181|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3808928|NCT01782664|3635182|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3808929|NCT01782664|3635183|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3808930|NCT01782664|3635184|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3808931|NCT01782664|3635185|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3808932|NCT01782664|3635186|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3808933|NCT01782664|3635180|B7|||Age||Years|Mean|46.6|46.6|Standard Deviation|13.11|13.11|||
3808934|NCT01782664|3635181|B6|||Age||Years|Mean|53.5|53.5|Standard Deviation|2.12|2.12|||
3808935|NCT01782664|3635182|B5|||Age||Years|Mean|50.7|50.7|Standard Deviation|11.96|11.96|||
3808936|NCT01782664|3635183|B4|||Age||Years|Mean|41.5|41.5|Standard Deviation|12.08|12.08|||
3808937|NCT01782664|3635184|B3|||Age||Years|Mean|49.0|49.0|Standard Deviation|13.24|13.24|||
3808938|NCT01782664|3635185|B2|||Age||Years|Mean|43.9|43.9|Standard Deviation|14.10|14.1|||
3808939|NCT01782664|3635186|B1|||Age||Years|Mean|49.0|49.0|Standard Deviation|13.79|13.79|||
3808940|NCT01782495|3635337|B12||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3808941|NCT01782495|3635338|B11||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3808942|NCT01782495|3635339|B10||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3808943|NCT01782495|3635340|B9||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3808944|NCT01782495|3635341|B8||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3808945|NCT01782495|3635342|B7||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3808946|NCT01782495|3635343|B6||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3808947|NCT01782495|3635344|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3808948|NCT01782495|3635345|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3808949|NCT01782495|3635346|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3808950|NCT01782495|3635347|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3808951|NCT01782495|3635348|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3808952|NCT01782495|3635337|B12||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3808953|NCT01782495|3635338|B11||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3808954|NCT01782495|3635339|B10||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3808955|NCT01782495|3635340|B9||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3808956|NCT01782495|3635341|B8||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3808957|NCT01782495|3635342|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3808958|NCT01782495|3635343|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3808959|NCT01782495|3635344|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3808960|NCT01782495|3635345|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3808961|NCT01782495|3635346|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3808962|NCT01782495|3635347|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3808963|NCT01782495|3635348|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3808964|NCT01782495|3635337|B12|||Age||years|Mean|59.6|59.6|Standard Deviation|7.73|7.73|||
3808965|NCT01782495|3635338|B11|||Age||years|Mean|50.0|50.0|Standard Deviation|NA||||The estimated standard deviation of one sample is undefined
3808966|NCT01782495|3635339|B10|||Age||years|Mean|63.5|63.5|Standard Deviation|7.78|7.78|||
3808967|NCT01782495|3635340|B9|||Age||years|Mean|57.3|57.3|Standard Deviation|9.29|9.29|||
3808968|NCT01782495|3635341|B8|||Age||years|Mean|58.0|58.0|Standard Deviation|8.00|8.0|||
3808969|NCT01782495|3635342|B7|||Age||years|Mean|62.2|62.2|Standard Deviation|7.64|7.64|||
3808970|NCT01782495|3635343|B6|||Age||years|Mean|58.3|58.3|Standard Deviation|9.35|9.35|||
3808971|NCT01782495|3635344|B5|||Age||years|Mean|78.0|78.0|Standard Deviation|1.41|1.41|||
3808972|NCT01782495|3635345|B4|||Age||years|Mean|59.8|59.8|Standard Deviation|10.78|10.78|||
3808973|NCT01782495|3635346|B3|||Age||years|Mean|61.8|61.8|Standard Deviation|5.76|5.76|||
3808974|NCT01782495|3635347|B2|||Age||years|Mean|58.0|58.0|Standard Deviation|6.66|6.66|||
3808975|NCT01782495|3635348|B1|||Age||years|Mean|59.6|59.6|Standard Deviation|6.62|6.62|||
3808976|NCT01782482|3635415|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3808977|NCT01782482|3635416|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3808978|NCT01782482|3635417|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3808979|NCT01782482|3635415|B3||Female|Sex: Female, Male||Participants|Count of Participants|501|501.0||||||
3808980|NCT01782482|3635416|B2||Female|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
3808981|NCT01782482|3635417|B1||Female|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
3808982|NCT01782482|3635415|B3|≥65 years||Age, Customized||participants|Number|0|0.0||||||
3808983|NCT01782482|3635416|B2|≥65 years||Age, Customized||participants|Number|0|0.0||||||
3808984|NCT01782482|3635417|B1|≥65 years||Age, Customized||participants|Number|0|0.0||||||
3808985|NCT01782482|3635415|B3|18-64 years||Age, Customized||participants|Number|530|530.0||||||
3808986|NCT01782482|3635416|B2|18-64 years||Age, Customized||participants|Number|263|263.0||||||
3808987|NCT01782482|3635417|B1|18-64 years||Age, Customized||participants|Number|267|267.0||||||
3808988|NCT01782482|3635415|B3|16-17 years||Age, Customized||participants|Number|22|22.0||||||
3808989|NCT01782482|3635416|B2|16-17 years||Age, Customized||participants|Number|11|11.0||||||
3808990|NCT01782482|3635417|B1|16-17 years||Age, Customized||participants|Number|11|11.0||||||
3808991|NCT01782469|3635426|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3808992|NCT01782469|3635426|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3808993|NCT01782469|3635426|B1|||Age||years|Mean|36.5|36.5|Standard Deviation|9.27|9.27|||
3808994|NCT01782326|3635434|B3||Male|Sex: Female, Male||Participants|Count of Participants|2557|2557.0||||||
3808995|NCT01782326|3635435|B2||Male|Sex: Female, Male||Participants|Count of Participants|1258|1258.0||||||
3808996|NCT01782326|3635436|B1||Male|Sex: Female, Male||Participants|Count of Participants|1299|1299.0||||||
3808997|NCT01782326|3635434|B3||Female|Sex: Female, Male||Participants|Count of Participants|805|805.0||||||
3808998|NCT01782326|3635435|B2||Female|Sex: Female, Male||Participants|Count of Participants|424|424.0||||||
3808999|NCT01782326|3635436|B1||Female|Sex: Female, Male||Participants|Count of Participants|381|381.0||||||
3809000|NCT01782326|3635434|B3|||Age||Years|Mean|64.6|64.6|Standard Deviation|7.79|7.79|||
3809001|NCT01782326|3635435|B2|||Age||Years|Mean|64.5|64.5|Standard Deviation|7.70|7.7|||
3809002|NCT01782326|3635436|B1|||Age||Years|Mean|64.6|64.6|Standard Deviation|7.89|7.89|||
3809003|NCT01782313|3635497|B1|No prior anti-VEGF therapy||Prior anti-overexpress vascular endothelial growth factor (VEGF) therapy or anti-VEGF therapy naive||Participants|Count of Participants|34|34.0||||||
3809004|NCT01782313|3635497|B1|Prior anti-VEGF therapy||Prior anti-overexpress vascular endothelial growth factor (VEGF) therapy or anti-VEGF therapy naive||Participants|Count of Participants|24|24.0||||||
3809005|NCT01782313|3635497|B1|United States||Region of Enrollment||Participants|Count of Participants|58|58.0||||||
3809006|NCT01782313|3635497|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|57|57.0||||||
3809007|NCT01782313|3635497|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3809008|NCT01782313|3635497|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809009|NCT01782313|3635497|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809010|NCT01782313|3635497|B1||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3809011|NCT01782313|3635497|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3809012|NCT01782313|3635497|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809013|NCT01782313|3635497|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3809014|NCT01782313|3635497|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809015|NCT01782313|3635497|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3809016|NCT01782313|3635497|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3809017|NCT01782313|3635497|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3809018|NCT01782313|3635497|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3809019|NCT01782313|3635497|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3809020|NCT01782222|3635508|B4|||Body Mass Index (BMI)||kilogram per square meter|Mean|27.42|27.42|Standard Deviation|4.57|4.57|||
3809021|NCT01782222|3635509|B3|||Body Mass Index (BMI)||kilogram per square meter|Mean|26.90|26.9|Standard Deviation|3.86|3.86|||
3809022|NCT01782222|3635510|B2|||Body Mass Index (BMI)||kilogram per square meter|Mean|26.86|26.86|Standard Deviation|4.89|4.89|||
3809023|NCT01782222|3635511|B1|||Body Mass Index (BMI)||kilogram per square meter|Mean|28.53|28.53|Standard Deviation|4.79|4.79|||
3809024|NCT01782222|3635508|B4|||Height||centimeters|Mean|169.10|169.1|Standard Deviation|10.70|10.7|||
3809025|NCT01782222|3635509|B3|||Height||centimeters|Mean|170.88|170.88|Standard Deviation|10.94|10.94|||
3809026|NCT01782222|3635510|B2|||Height||centimeters|Mean|169.25|169.25|Standard Deviation|10.76|10.76|||
3809027|NCT01782222|3635511|B1|||Height||centimeters|Mean|167.16|167.16|Standard Deviation|10.34|10.34|||
3809028|NCT01782222|3635508|B4|||Weight||kilograms|Mean|78.62|78.62|Standard Deviation|16.17|16.17|||
3809029|NCT01782222|3635509|B3|||Weight||kilograms|Mean|78.96|78.96|Standard Deviation|15.96|15.96|||
3809030|NCT01782222|3635510|B2|||Weight||kilograms|Mean|77.34|77.34|Standard Deviation|17.93|17.93|||
3809031|NCT01782222|3635511|B1|||Weight||kilograms|Mean|79.59|79.59|Standard Deviation|14.73|14.73|||
3809032|NCT01782222|3635508|B4|Other/mixed||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3809033|NCT01782222|3635509|B3|Other/mixed||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3809034|NCT01782222|3635510|B2|Other/mixed||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3809035|NCT01782222|3635511|B1|Other/mixed||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3809036|NCT01782222|3635508|B4|White||Race/Ethnicity, Customized||participants|Number|117|117.0||||||
3809037|NCT01782222|3635509|B3|White||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
3809038|NCT01782222|3635510|B2|White||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
3809039|NCT01782222|3635511|B1|White||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
3809040|NCT01782222|3635508|B4|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3809041|NCT01782222|3635509|B3|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3809042|NCT01782222|3635510|B2|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3809043|NCT01782222|3635511|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3809044|NCT01782222|3635508|B4||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3809045|NCT01782222|3635509|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3809046|NCT01782222|3635510|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3809047|NCT01782222|3635511|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3809048|NCT01782222|3635508|B4||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3809049|NCT01782222|3635509|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3809050|NCT01782222|3635510|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3809051|NCT01782222|3635511|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3809052|NCT01782222|3635508|B4|≥ 65 years||Age, Customized||participants|Number|79|79.0||||||
3809053|NCT01782222|3635509|B3|≥ 65 years||Age, Customized||participants|Number|29|29.0||||||
3809054|NCT01782222|3635510|B2|≥ 65 years||Age, Customized||participants|Number|24|24.0||||||
3809055|NCT01782222|3635511|B1|≥ 65 years||Age, Customized||participants|Number|26|26.0||||||
3809056|NCT01782222|3635508|B4|>18 - < 65 years||Age, Customized||participants|Number|43|43.0||||||
3809057|NCT01782222|3635509|B3|>18 - < 65 years||Age, Customized||participants|Number|12|12.0||||||
3809058|NCT01782222|3635510|B2|>18 - < 65 years||Age, Customized||participants|Number|17|17.0||||||
3809059|NCT01782222|3635511|B1|>18 - < 65 years||Age, Customized||participants|Number|14|14.0||||||
3809060|NCT01782222|3635508|B4|||Age||years|Mean|69.1|69.1|Standard Deviation|10.1|10.1|||
3809061|NCT01782222|3635509|B3|||Age||years|Mean|70.2|70.2|Standard Deviation|8.0|8.0|||
3809062|NCT01782222|3635510|B2|||Age||years|Mean|68.1|68.1|Standard Deviation|10.5|10.5|||
3809063|NCT01782222|3635511|B1|||Age||years|Mean|69.0|69.0|Standard Deviation|11.7|11.7|||
3809064|NCT01781975|3635545|B3||5|Number of Autoantibodies Positive||Participants|Count of Participants|16|16.0||||||
3809065|NCT01781975|3635546|B2||5|Number of Autoantibodies Positive||Participants|Count of Participants|7|7.0||||||
3809066|NCT01781975|3635547|B1||5|Number of Autoantibodies Positive||Participants|Count of Participants|9|9.0||||||
3809067|NCT01781975|3635545|B3||4|Number of Autoantibodies Positive||Participants|Count of Participants|14|14.0||||||
3809068|NCT01781975|3635546|B2||4|Number of Autoantibodies Positive||Participants|Count of Participants|6|6.0||||||
3809069|NCT01781975|3635547|B1||4|Number of Autoantibodies Positive||Participants|Count of Participants|8|8.0||||||
3809070|NCT01781975|3635545|B3||3|Number of Autoantibodies Positive||Participants|Count of Participants|13|13.0||||||
3809071|NCT01781975|3635546|B2||3|Number of Autoantibodies Positive||Participants|Count of Participants|1|1.0||||||
3809072|NCT01781975|3635547|B1||3|Number of Autoantibodies Positive||Participants|Count of Participants|12|12.0||||||
3809073|NCT01781975|3635545|B3||2|Number of Autoantibodies Positive||Participants|Count of Participants|12|12.0||||||
3809074|NCT01781975|3635546|B2||2|Number of Autoantibodies Positive||Participants|Count of Participants|4|4.0||||||
3809075|NCT01781975|3635547|B1||2|Number of Autoantibodies Positive||Participants|Count of Participants|8|8.0||||||
3809076|NCT01781975|3635545|B3||1|Number of Autoantibodies Positive||Participants|Count of Participants|12|12.0||||||
3809077|NCT01781975|3635546|B2||1|Number of Autoantibodies Positive||Participants|Count of Participants|4|4.0||||||
3809078|NCT01781975|3635547|B1||1|Number of Autoantibodies Positive||Participants|Count of Participants|8|8.0||||||
3809079|NCT01781975|3635545|B3|Australia||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3809080|NCT01781975|3635546|B2|Australia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3809081|NCT01781975|3635547|B1|Australia||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3809082|NCT01781975|3635545|B3|United States||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
3809083|NCT01781975|3635546|B2|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3809084|NCT01781975|3635547|B1|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3809085|NCT01781975|3635545|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809086|NCT01781975|3635546|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809087|NCT01781975|3635547|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809088|NCT01781975|3635545|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3809089|NCT01781975|3635546|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3809090|NCT01781975|3635547|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809091|NCT01781975|3635545|B3||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3809092|NCT01781975|3635546|B2||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3809093|NCT01781975|3635547|B1||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3809094|NCT01781975|3635545|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809095|NCT01781975|3635546|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809096|NCT01781975|3635547|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809097|NCT01781975|3635545|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809098|NCT01781975|3635546|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809099|NCT01781975|3635547|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809100|NCT01781975|3635545|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3809101|NCT01781975|3635546|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809102|NCT01781975|3635547|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3809103|NCT01781975|3635545|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809104|NCT01781975|3635546|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809105|NCT01781975|3635547|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809106|NCT01781975|3635545|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809107|NCT01781975|3635546|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809108|NCT01781975|3635547|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809109|NCT01781975|3635545|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3809110|NCT01781975|3635546|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3809111|NCT01781975|3635547|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3809112|NCT01781975|3635545|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3809113|NCT01781975|3635546|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3809114|NCT01781975|3635547|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3809115|NCT01781975|3635545|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3809116|NCT01781975|3635546|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3809117|NCT01781975|3635547|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3809118|NCT01781975|3635545|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3809119|NCT01781975|3635546|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3809120|NCT01781975|3635547|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3809121|NCT01781975|3635545|B3|||Age||years|Mean|27|27.0|Standard Deviation|7.1|7.1|||
3809122|NCT01781975|3635546|B2|||Age||years|Mean|26.2|26.2|Standard Deviation|6.6|6.6|||
3809123|NCT01781975|3635547|B1|||Age||years|Mean|28.2|28.2|Standard Deviation|7.2|7.2|||
3809124|NCT01781975|3635545|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3809125|NCT01781975|3635546|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3809126|NCT01781975|3635547|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3809127|NCT01781975|3635545|B3||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
3809128|NCT01781975|3635546|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3809129|NCT01781975|3635547|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3809130|NCT01781975|3635545|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3809131|NCT01781975|3635546|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3809132|NCT01781975|3635547|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3809133|NCT01781962|3635554|B1||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3809134|NCT01781962|3635554|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3809135|NCT01781962|3635554|B1|>65 years||Age, Customized||Participants|Number|24|24.0||||||
3809136|NCT01781962|3635554|B1|45 to 65 years||Age, Customized||Participants|Number|71|71.0||||||
3809137|NCT01781962|3635554|B1|<45 years||Age, Customized||Participants|Number|111|111.0||||||
3809138|NCT01781832|3635560|B1|||Age||years|Mean|4.6|4.6|Full Range|||1.0|15.0|
3809139|NCT01781832|3635560|B1|United States||Region of Enrollment|The study location was a large tertiary pediatric hospital in the Midwest of the United States.|Participants|Count of Participants|26|26.0||||||
3809140|NCT01781832|3635560|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3809141|NCT01781832|3635560|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3809142|NCT01781832|3635560|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3809143|NCT01781832|3635560|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3809144|NCT01781832|3635560|B1||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
3809145|NCT01781806|3635565|B3|$50,001 or more||Family Income||Participants|Count of Participants|95|95.0||||||
3809146|NCT01781806|3635566|B2|$50,001 or more||Family Income||Participants|Count of Participants|1|1.0||||||
3809147|NCT01781806|3635567|B1|$50,001 or more||Family Income||Participants|Count of Participants|94|94.0||||||
3809148|NCT01781806|3635565|B3|$20,001 - $50,000||Family Income||Participants|Count of Participants|114|114.0||||||
3809149|NCT01781806|3635566|B2|$20,001 - $50,000||Family Income||Participants|Count of Participants|3|3.0||||||
3809150|NCT01781806|3635567|B1|$20,001 - $50,000||Family Income||Participants|Count of Participants|111|111.0||||||
3809151|NCT01781806|3635565|B3|$20,000 or less||Family Income||Participants|Count of Participants|92|92.0||||||
3809152|NCT01781806|3635566|B2|$20,000 or less||Family Income||Participants|Count of Participants|0|0.0||||||
3809153|NCT01781806|3635567|B1|$20,000 or less||Family Income||Participants|Count of Participants|92|92.0||||||
3809154|NCT01781806|3635565|B3||Unknown|Marital Status||Participants|Count of Participants|1|1.0||||||
3809155|NCT01781806|3635566|B2||Unknown|Marital Status||Participants|Count of Participants|0|0.0||||||
3809156|NCT01781806|3635567|B1||Unknown|Marital Status||Participants|Count of Participants|1|1.0||||||
3809157|NCT01781806|3635565|B3||Other|Marital Status||Participants|Count of Participants|12|12.0||||||
3809158|NCT01781806|3635566|B2||Other|Marital Status||Participants|Count of Participants|0|0.0||||||
3809159|NCT01781806|3635567|B1||Other|Marital Status||Participants|Count of Participants|12|12.0||||||
3809160|NCT01781806|3635565|B3||Single/divorced/widowed|Marital Status||Participants|Count of Participants|198|198.0||||||
3809161|NCT01781806|3635566|B2||Single/divorced/widowed|Marital Status||Participants|Count of Participants|4|4.0||||||
3809162|NCT01781806|3635567|B1||Single/divorced/widowed|Marital Status||Participants|Count of Participants|194|194.0||||||
3809163|NCT01781806|3635565|B3||Have primary or main partner, not living together|Marital Status||Participants|Count of Participants|39|39.0||||||
3809164|NCT01781806|3635566|B2||Have primary or main partner, not living together|Marital Status||Participants|Count of Participants|0|0.0||||||
3809165|NCT01781806|3635567|B1||Have primary or main partner, not living together|Marital Status||Participants|Count of Participants|39|39.0||||||
3809166|NCT01781806|3635565|B3||Living with primary or main partner|Marital Status||Participants|Count of Participants|42|42.0||||||
3809167|NCT01781806|3635566|B2||Living with primary or main partner|Marital Status||Participants|Count of Participants|0|0.0||||||
3809168|NCT01781806|3635567|B1||Living with primary or main partner|Marital Status||Participants|Count of Participants|42|42.0||||||
3809169|NCT01781806|3635565|B3||Married/civil union/legal partnership|Marital Status||Participants|Count of Participants|9|9.0||||||
3809170|NCT01781806|3635566|B2||Married/civil union/legal partnership|Marital Status||Participants|Count of Participants|0|0.0||||||
3809171|NCT01781806|3635567|B1||Married/civil union/legal partnership|Marital Status||Participants|Count of Participants|9|9.0||||||
3809172|NCT01781806|3635565|B3||Unknown|Insurance||Participants|Count of Participants|7|7.0||||||
3809173|NCT01781806|3635566|B2||Unknown|Insurance||Participants|Count of Participants|1|1.0||||||
3809174|NCT01781806|3635567|B1||Unknown|Insurance||Participants|Count of Participants|6|6.0||||||
3809175|NCT01781806|3635565|B3||Insured|Insurance||Participants|Count of Participants|201|201.0||||||
3809176|NCT01781806|3635566|B2||Insured|Insurance||Participants|Count of Participants|1|1.0||||||
3809177|NCT01781806|3635567|B1||Insured|Insurance||Participants|Count of Participants|200|200.0||||||
3809178|NCT01781806|3635565|B3||Uninsured|Insurance||Participants|Count of Participants|93|93.0||||||
3809179|NCT01781806|3635566|B2||Uninsured|Insurance||Participants|Count of Participants|2|2.0||||||
3809180|NCT01781806|3635567|B1||Uninsured|Insurance||Participants|Count of Participants|91|91.0||||||
3809181|NCT01781806|3635565|B3||Any postgraduate|Education||Participants|Count of Participants|56|56.0||||||
3809182|NCT01781806|3635566|B2||Any postgraduate|Education||Participants|Count of Participants|1|1.0||||||
3809183|NCT01781806|3635567|B1||Any postgraduate|Education||Participants|Count of Participants|55|55.0||||||
3809184|NCT01781806|3635565|B3||College graduate|Education||Participants|Count of Participants|106|106.0||||||
3809185|NCT01781806|3635566|B2||College graduate|Education||Participants|Count of Participants|2|2.0||||||
3809186|NCT01781806|3635567|B1||College graduate|Education||Participants|Count of Participants|104|104.0||||||
3809187|NCT01781806|3635565|B3||Some college|Education||Participants|Count of Participants|106|106.0||||||
3809188|NCT01781806|3635566|B2||Some college|Education||Participants|Count of Participants|1|1.0||||||
3809189|NCT01781806|3635567|B1||Some college|Education||Participants|Count of Participants|105|105.0||||||
3809190|NCT01781806|3635565|B3||High school or less|Education||Participants|Count of Participants|33|33.0||||||
3809191|NCT01781806|3635566|B2||High school or less|Education||Participants|Count of Participants|0|0.0||||||
3809192|NCT01781806|3635567|B1||High school or less|Education||Participants|Count of Participants|33|33.0||||||
3809193|NCT01781806|3635565|B3|United States||Region of Enrollment||Participants|Count of Participants|301|301.0||||||
3809194|NCT01781806|3635566|B2|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3809195|NCT01781806|3635567|B1|United States||Region of Enrollment||Participants|Count of Participants|297|297.0||||||
3809196|NCT01781806|3635565|B3|Mixed Race/Other||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3809197|NCT01781806|3635566|B2|Mixed Race/Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3809198|NCT01781806|3635567|B1|Mixed Race/Other||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3809199|NCT01781806|3635565|B3|Pacific Islander/Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3809200|NCT01781806|3635566|B2|Pacific Islander/Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3809201|NCT01781806|3635567|B1|Pacific Islander/Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3809202|NCT01781806|3635565|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3809203|NCT01781806|3635566|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3809204|NCT01781806|3635567|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3809205|NCT01781806|3635565|B3|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|83|83.0||||||
3809206|NCT01781806|3635566|B2|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3809207|NCT01781806|3635567|B1|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|82|82.0||||||
3809208|NCT01781806|3635565|B3|Non-Hispanic Black||Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3809209|NCT01781806|3635566|B2|Non-Hispanic Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3809210|NCT01781806|3635567|B1|Non-Hispanic Black||Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3809211|NCT01781806|3635565|B3|Non-Hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|151|151.0||||||
3809212|NCT01781806|3635566|B2|Non-Hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3809213|NCT01781806|3635567|B1|Non-Hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|150|150.0||||||
3809214|NCT01781806|3635565|B3|Male|Transfemale|Sex/Gender, Customized||Participants|Count of Participants|1|1.0||||||
3809215|NCT01781806|3635566|B2|Male|Transfemale|Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3809216|NCT01781806|3635567|B1|Male|Transfemale|Sex/Gender, Customized||Participants|Count of Participants|1|1.0||||||
3809217|NCT01781806|3635565|B3|Male|Male|Sex/Gender, Customized||Participants|Count of Participants|300|300.0||||||
3809218|NCT01781806|3635566|B2|Male|Male|Sex/Gender, Customized||Participants|Count of Participants|4|4.0||||||
3809219|NCT01781806|3635567|B1|Male|Male|Sex/Gender, Customized||Participants|Count of Participants|296|296.0||||||
3809220|NCT01781806|3635565|B3|||Age||years|Median|34|34.0|Inter-Quartile Range|||28.0|42.0|
3809221|NCT01781806|3635566|B2|||Age||years|Median|35|35.0|Inter-Quartile Range|||32.0|39.0|
3809222|NCT01781806|3635567|B1|||Age||years|Median|33|33.0|Inter-Quartile Range|||28.0|42.0|
3809223|NCT01781637|3635578|B3|||Baseline population||Participants|Count of Participants|37|37.0||||||
3809224|NCT01781637|3635579|B2|||Baseline population||Participants|Count of Participants|8|8.0||||||
3809225|NCT01781637|3635580|B1|||Baseline population||Participants|Count of Participants|29|29.0||||||
3809226|NCT01781637|3635578|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3809227|NCT01781637|3635579|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3809228|NCT01781637|3635580|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3809229|NCT01781637|3635578|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3809230|NCT01781637|3635579|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3809231|NCT01781637|3635580|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3809232|NCT01781637|3635578|B3|||Age||years|Median|10|10.0|Full Range|||6.0|19.0|
3809233|NCT01781637|3635579|B2|||Age||years|Median|10|10.0|Full Range|||6.0|17.0|
3809234|NCT01781637|3635580|B1|||Age||years|Median|10|10.0|Full Range|||7.0|19.0|
3809235|NCT01781481|3635589|B1|Canada||Region of Enrollment||participants|Number|148|148.0||||||
3809236|NCT01781481|3635589|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3809237|NCT01781481|3635589|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3809238|NCT01781481|3635589|B1|||Age||years|Median|14.00|14.0|Inter-Quartile Range|||10.25|17.75|
3809239|NCT01781403|3635648|B1|Korea, Republic of||Region of Enrollment||participants|Number|22|22.0||||||
3809240|NCT01781403|3635648|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3809241|NCT01781403|3635648|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3809242|NCT01781403|3635648|B1|||Age||years|Median|54|54.0|Full Range|||41.0|77.0|
3809243|NCT01781299|3635666|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
3809244|NCT01781299|3635667|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3809245|NCT01781299|3635668|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3809246|NCT01781299|3635666|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809247|NCT01781299|3635667|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809248|NCT01781299|3635668|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809249|NCT01781299|3635666|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809250|NCT01781299|3635667|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809251|NCT01781299|3635668|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809252|NCT01781299|3635666|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3809253|NCT01781299|3635667|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3809254|NCT01781299|3635668|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3809255|NCT01781299|3635666|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809256|NCT01781299|3635667|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809257|NCT01781299|3635668|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809258|NCT01781299|3635666|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809259|NCT01781299|3635667|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809260|NCT01781299|3635668|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809261|NCT01781299|3635666|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809262|NCT01781299|3635667|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809263|NCT01781299|3635668|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809264|NCT01781299|3635666|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809265|NCT01781299|3635667|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809266|NCT01781299|3635668|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809267|NCT01781299|3635666|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3809268|NCT01781299|3635667|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809269|NCT01781299|3635668|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3809270|NCT01781299|3635666|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3809271|NCT01781299|3635667|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3809272|NCT01781299|3635668|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3809273|NCT01781299|3635666|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809274|NCT01781299|3635667|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809275|NCT01781299|3635668|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809276|NCT01781299|3635666|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3809277|NCT01781299|3635667|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3809278|NCT01781299|3635668|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3809279|NCT01781299|3635666|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3809280|NCT01781299|3635667|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3809281|NCT01781299|3635668|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3809282|NCT01781299|3635666|B3|||Age||years|Mean|48.7|48.7|Standard Deviation|10.0|10.0|||
3809283|NCT01781299|3635667|B2|||Age||years|Mean|42|42.0|Standard Deviation|3.9|3.9|||
3809284|NCT01781299|3635668|B1|||Age||years|Mean|57|57.0|Standard Deviation|8.8|8.8|||
3809285|NCT01781299|3635666|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3809286|NCT01781299|3635667|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3809287|NCT01781299|3635668|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3809288|NCT01781299|3635666|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3809289|NCT01781299|3635667|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3809290|NCT01781299|3635668|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3809291|NCT01781299|3635666|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3809292|NCT01781299|3635667|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3809293|NCT01781299|3635668|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3809294|NCT01781286|3635677|B1|||Commonly consumed cereal as a snack||% of total participants|Number|25|25.0||||||
3809295|NCT01781286|3635677|B1|||Commonly consumed fruit as a snack||% of total participants|Number|61|61.0||||||
3809296|NCT01781286|3635677|B1|||Commonly consumed chips/crackers as a snack||% of total participants|Number|64|64.0||||||
3809297|NCT01781286|3635677|B1|||Frequency of Snacking||days/week|Mean|6|6.0|Standard Deviation|1|1.0|||
3809298|NCT01781286|3635677|B1|||BMI (%)||Percentile|Mean|58.4|58.4|Standard Deviation|4.4|4.4|||
3809299|NCT01781286|3635677|B1|||BMI (kg/m2)||kg/m2|Mean|22.3|22.3|Standard Deviation|0.4|0.4|||
3809300|NCT01781286|3635677|B1|||Weight||kilograms|Mean|65.6|65.6|Standard Deviation|2.1|2.1|||
3809301|NCT01781286|3635677|B1|||Height||centimeters|Mean|171|171.0|Standard Deviation|2|2.0|||
3809302|NCT01781286|3635677|B1|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3809303|NCT01781286|3635677|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3809304|NCT01781286|3635677|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3809305|NCT01781286|3635677|B1|||Age||years|Mean|17|17.0|Standard Deviation|1|1.0|||
3809306|NCT01781234|3635705|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
3809307|NCT01781234|3635706|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
3809308|NCT01781234|3635707|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3809309|NCT01781234|3635705|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3809310|NCT01781234|3635706|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3809311|NCT01781234|3635707|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3809312|NCT01781234|3635705|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3809313|NCT01781234|3635706|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3809314|NCT01781234|3635707|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809315|NCT01781234|3635705|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3809316|NCT01781234|3635706|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3809317|NCT01781234|3635707|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3809318|NCT01781234|3635705|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3809319|NCT01781234|3635706|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809320|NCT01781234|3635707|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3809321|NCT01781234|3635705|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809322|NCT01781234|3635706|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809323|NCT01781234|3635707|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809324|NCT01781234|3635705|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809325|NCT01781234|3635706|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809326|NCT01781234|3635707|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809327|NCT01781234|3635705|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809328|NCT01781234|3635706|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809329|NCT01781234|3635707|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809330|NCT01781234|3635705|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809331|NCT01781234|3635706|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809332|NCT01781234|3635707|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809333|NCT01781234|3635705|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3809334|NCT01781234|3635706|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3809335|NCT01781234|3635707|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3809336|NCT01781234|3635705|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3809337|NCT01781234|3635706|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3809338|NCT01781234|3635707|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3809339|NCT01781234|3635705|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3809340|NCT01781234|3635706|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3809341|NCT01781234|3635707|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3809342|NCT01781234|3635705|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3809343|NCT01781234|3635706|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3809344|NCT01781234|3635707|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3809345|NCT01781234|3635705|B3|||Age||years|Mean|37.34694|37.34694|Standard Deviation|12.45417|12.45417|||
3809346|NCT01781234|3635706|B2|||Age||years|Mean|40.19|40.19|Standard Deviation|13.74|13.74|||
3809347|NCT01781234|3635707|B1|||Age||years|Mean|35.75|35.75|Standard Deviation|13.23|13.23|||
3809348|NCT01781234|3635705|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3809349|NCT01781234|3635706|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3809350|NCT01781234|3635707|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3809351|NCT01781234|3635705|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3809352|NCT01781234|3635706|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3809353|NCT01781234|3635707|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3809354|NCT01781234|3635705|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3809355|NCT01781234|3635706|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3809356|NCT01781234|3635707|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3809357|NCT01781208|3635718|B1|United States||Region of Enrollment||participants|Number|62|62.0||||||
3809358|NCT01781208|3635718|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3809359|NCT01781208|3635718|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3809360|NCT01781208|3635718|B1|||Age||years|Mean|8.0|8.0|Full Range|||0.0|18.0|
3809361|NCT01781208|3635718|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3809362|NCT01781208|3635718|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3809363|NCT01781208|3635718|B1||<=18 years|Age||Participants|Count of Participants|62|62.0||||||
3809364|NCT01781169|3635723|B3|China||Region of Enrollment||participants|Number|42|42.0||||||
3809365|NCT01781169|3635724|B2|China||Region of Enrollment||participants|Number|21|21.0||||||
3809366|NCT01781169|3635725|B1|China||Region of Enrollment||participants|Number|21|21.0||||||
3809367|NCT01781169|3635723|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3809368|NCT01781169|3635724|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3809369|NCT01781169|3635725|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3809370|NCT01781169|3635723|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3809371|NCT01781169|3635724|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3809372|NCT01781169|3635725|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3809373|NCT01781169|3635723|B3|||Age||years|Mean|39.5|39.5|Standard Deviation|9.8|9.8|||
3809374|NCT01781169|3635724|B2|||Age||years|Mean|44.7|44.7|Standard Deviation|8.8|8.8|||
3809375|NCT01781169|3635725|B1|||Age||years|Mean|34.4|34.4|Standard Deviation|8|8.0|||
3809376|NCT01781169|3635723|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3809377|NCT01781169|3635724|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3809378|NCT01781169|3635725|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3809379|NCT01781169|3635723|B3||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3809380|NCT01781169|3635724|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3809381|NCT01781169|3635725|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3809382|NCT01781169|3635723|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3809383|NCT01781169|3635724|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3809384|NCT01781169|3635725|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3809385|NCT01781078|3635732|B3|Australia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3809386|NCT01781078|3635733|B2|Australia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3809387|NCT01781078|3635734|B1|Australia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3809388|NCT01781078|3635732|B3|Israel||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3809389|NCT01781078|3635733|B2|Israel||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3809390|NCT01781078|3635734|B1|Israel||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3809391|NCT01781078|3635732|B3|Malaysia||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3809392|NCT01781078|3635733|B2|Malaysia||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3809393|NCT01781078|3635734|B1|Malaysia||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3809394|NCT01781078|3635732|B3|China||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3809395|NCT01781078|3635733|B2|China||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3809396|NCT01781078|3635734|B1|China||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3809397|NCT01781078|3635732|B3|United States||Region of Enrollment||Participants|Count of Participants|245|245.0||||||
3809398|NCT01781078|3635733|B2|United States||Region of Enrollment||Participants|Count of Participants|83|83.0||||||
3809399|NCT01781078|3635734|B1|United States||Region of Enrollment||Participants|Count of Participants|162|162.0||||||
3809400|NCT01781078|3635732|B3|Singapore||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3809401|NCT01781078|3635733|B2|Singapore||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3809402|NCT01781078|3635734|B1|Singapore||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3809403|NCT01781078|3635732|B3|Canada||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3809404|NCT01781078|3635733|B2|Canada||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3809405|NCT01781078|3635734|B1|Canada||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3809406|NCT01781078|3635732|B3||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3809407|NCT01781078|3635733|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3809408|NCT01781078|3635734|B1||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3809409|NCT01781078|3635732|B3||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3809410|NCT01781078|3635733|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3809411|NCT01781078|3635734|B1||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3809412|NCT01781078|3635732|B3|||Age||years|Mean|69.4|69.4|Standard Deviation|12.8|12.8|||
3809413|NCT01781078|3635733|B2|||Age||years|Mean|70.4|70.4|Standard Deviation|11.9|11.9|||
3809414|NCT01781078|3635734|B1|||Age||years|Mean|69.0|69.0|Standard Deviation|13.0|13.0|||
3809415|NCT01781026|3635746|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3809416|NCT01781026|3635746|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3809417|NCT01781026|3635746|B1|||Age||years|Mean|42|42.0|Full Range|||37.0|46.0|
3809418|NCT01780987|3635750|B3|PE||Primary Diagnosis, Deep Venous Thrombosis (DVT)/Pulmonary Embolism (PE)||participants|Number|35|35.0||||||
3809419|NCT01780987|3635751|B2|PE||Primary Diagnosis, Deep Venous Thrombosis (DVT)/Pulmonary Embolism (PE)||participants|Number|17|17.0||||||
3809420|NCT01780987|3635752|B1|PE||Primary Diagnosis, Deep Venous Thrombosis (DVT)/Pulmonary Embolism (PE)||participants|Number|18|18.0||||||
3809421|NCT01780987|3635750|B3|DVT||Primary Diagnosis, Deep Venous Thrombosis (DVT)/Pulmonary Embolism (PE)||participants|Number|45|45.0||||||
3809422|NCT01780987|3635751|B2|DVT||Primary Diagnosis, Deep Venous Thrombosis (DVT)/Pulmonary Embolism (PE)||participants|Number|23|23.0||||||
3809423|NCT01780987|3635752|B1|DVT||Primary Diagnosis, Deep Venous Thrombosis (DVT)/Pulmonary Embolism (PE)||participants|Number|22|22.0||||||
3809424|NCT01780987|3635750|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3809425|NCT01780987|3635751|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3809426|NCT01780987|3635752|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3809427|NCT01780987|3635750|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3809428|NCT01780987|3635751|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3809429|NCT01780987|3635752|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3809430|NCT01780987|3635750|B3|||Age||years|Mean|65.2|65.2|Standard Deviation|15.64|15.64|||
3809431|NCT01780987|3635751|B2|||Age||years|Mean|66.1|66.1|Standard Deviation|17.72|17.72|||
3809432|NCT01780987|3635752|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|13.40|13.4|||
3809433|NCT01780974|3635769|B3|||Docosahexaenoic Acid (DHA)||% composition of blood|Mean|2.58|2.58|Standard Deviation|0.82|0.82|||
3809434|NCT01780974|3635770|B2|||Docosahexaenoic Acid (DHA)||% composition of blood|Mean|2.53|2.53|Standard Deviation|0.59|0.59|||
3809435|NCT01780974|3635771|B1|||Docosahexaenoic Acid (DHA)||% composition of blood|Mean|2.62|2.62|Standard Deviation|1.01|1.01|||
3809436|NCT01780974|3635769|B3|||Eicosapentaenoic Acid (EPA)||% composition of blood|Mean|0.73|0.73|Standard Deviation|0.33|0.33|||
3809437|NCT01780974|3635770|B2|||Eicosapentaenoic Acid (EPA)||% composition of blood|Mean|0.62|0.62|Standard Deviation|0.19|0.19|||
3809438|NCT01780974|3635771|B1|||Eicosapentaenoic Acid (EPA)||% composition of blood|Mean|0.84|0.84|Standard Deviation|0.41|0.41|||
3809439|NCT01780974|3635769|B3|||Arachidonic Acid (AA)||% composition of blood|Mean|9.98|9.98|Standard Deviation|1.61|1.61|||
3809440|NCT01780974|3635770|B2|||Arachidonic Acid (AA)||% composition of blood|Mean|10.64|10.64|Standard Deviation|1.56|1.56|||
3809441|NCT01780974|3635771|B1|||Arachidonic Acid (AA)||% composition of blood|Mean|9.33|9.33|Standard Deviation|1.40|1.4|||
3809442|NCT01780974|3635769|B3||Smoker|Smoking||Participants|Count of Participants|0|0.0||||||
3809443|NCT01780974|3635770|B2||Smoker|Smoking||Participants|Count of Participants|0|0.0||||||
3809444|NCT01780974|3635771|B1||Smoker|Smoking||Participants|Count of Participants|0|0.0||||||
3809445|NCT01780974|3635769|B3||Former smoker|Smoking||Participants|Count of Participants|19|19.0||||||
3809446|NCT01780974|3635770|B2||Former smoker|Smoking||Participants|Count of Participants|9|9.0||||||
3809447|NCT01780974|3635771|B1||Former smoker|Smoking||Participants|Count of Participants|10|10.0||||||
3809448|NCT01780974|3635769|B3||Non-smoker|Smoking||Participants|Count of Participants|21|21.0||||||
3809449|NCT01780974|3635770|B2||Non-smoker|Smoking||Participants|Count of Participants|11|11.0||||||
3809450|NCT01780974|3635771|B1||Non-smoker|Smoking||Participants|Count of Participants|10|10.0||||||
3809451|NCT01780974|3635769|B3||Exercises 2+ times/week|Exercise||Participants|Count of Participants|29|29.0||||||
3809452|NCT01780974|3635770|B2||Exercises 2+ times/week|Exercise||Participants|Count of Participants|15|15.0||||||
3809453|NCT01780974|3635771|B1||Exercises 2+ times/week|Exercise||Participants|Count of Participants|14|14.0||||||
3809454|NCT01780974|3635769|B3||Some exercise|Exercise||Participants|Count of Participants|5|5.0||||||
3809455|NCT01780974|3635770|B2||Some exercise|Exercise||Participants|Count of Participants|3|3.0||||||
3809456|NCT01780974|3635771|B1||Some exercise|Exercise||Participants|Count of Participants|2|2.0||||||
3809457|NCT01780974|3635769|B3||Doesn't exercise|Exercise||Participants|Count of Participants|5|5.0||||||
3809458|NCT01780974|3635770|B2||Doesn't exercise|Exercise||Participants|Count of Participants|2|2.0||||||
3809459|NCT01780974|3635771|B1||Doesn't exercise|Exercise||Participants|Count of Participants|3|3.0||||||
3809460|NCT01780974|3635769|B3|||Diastolic BP||mmHg|Mean|75.67|75.67|Standard Deviation|10.26|10.26|||
3809461|NCT01780974|3635770|B2|||Diastolic BP||mmHg|Mean|77.05|77.05|Standard Deviation|9.76|9.76|||
3809462|NCT01780974|3635771|B1|||Diastolic BP||mmHg|Mean|74.29|74.29|Standard Deviation|10.79|10.79|||
3809463|NCT01780974|3635769|B3|||Systolic BP||mmHg|Mean|136.71|136.71|Standard Deviation|15.84|15.84|||
3809464|NCT01780974|3635770|B2|||Systolic BP||mmHg|Mean|141.67|141.67|Standard Deviation|14.64|14.64|||
3809465|NCT01780974|3635771|B1|||Systolic BP||mmHg|Mean|131.76|131.76|Standard Deviation|15.77|15.77|||
3809466|NCT01780974|3635769|B3||No|Apo E4 Carrier||Participants|Count of Participants|28|28.0||||||
3809467|NCT01780974|3635770|B2||No|Apo E4 Carrier||Participants|Count of Participants|13|13.0||||||
3809468|NCT01780974|3635771|B1||No|Apo E4 Carrier||Participants|Count of Participants|15|15.0||||||
3809469|NCT01780974|3635769|B3||Yes|Apo E4 Carrier||Participants|Count of Participants|12|12.0||||||
3809470|NCT01780974|3635770|B2||Yes|Apo E4 Carrier||Participants|Count of Participants|7|7.0||||||
3809471|NCT01780974|3635771|B1||Yes|Apo E4 Carrier||Participants|Count of Participants|5|5.0||||||
3809472|NCT01780974|3635769|B3||Masters/Graduate School|Education||Participants|Count of Participants|21|21.0||||||
3809473|NCT01780974|3635770|B2||Masters/Graduate School|Education||Participants|Count of Participants|11|11.0||||||
3809474|NCT01780974|3635771|B1||Masters/Graduate School|Education||Participants|Count of Participants|10|10.0||||||
3809475|NCT01780974|3635769|B3||Completed college|Education||Participants|Count of Participants|12|12.0||||||
3809476|NCT01780974|3635770|B2||Completed college|Education||Participants|Count of Participants|7|7.0||||||
3809477|NCT01780974|3635771|B1||Completed college|Education||Participants|Count of Participants|5|5.0||||||
3809478|NCT01780974|3635769|B3||Some college|Education||Participants|Count of Participants|4|4.0||||||
3809479|NCT01780974|3635770|B2||Some college|Education||Participants|Count of Participants|2|2.0||||||
3809480|NCT01780974|3635771|B1||Some college|Education||Participants|Count of Participants|2|2.0||||||
3809481|NCT01780974|3635769|B3||High school or less|Education||Participants|Count of Participants|5|5.0||||||
3809482|NCT01780974|3635770|B2||High school or less|Education||Participants|Count of Participants|1|1.0||||||
3809483|NCT01780974|3635771|B1||High school or less|Education||Participants|Count of Participants|4|4.0||||||
3809484|NCT01780974|3635769|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3809485|NCT01780974|3635770|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809486|NCT01780974|3635771|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3809487|NCT01780974|3635769|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3809488|NCT01780974|3635770|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3809489|NCT01780974|3635771|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809490|NCT01780974|3635769|B3||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3809491|NCT01780974|3635770|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3809492|NCT01780974|3635771|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3809493|NCT01780974|3635769|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3809494|NCT01780974|3635770|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3809495|NCT01780974|3635771|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809496|NCT01780974|3635769|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809497|NCT01780974|3635770|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809498|NCT01780974|3635771|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809499|NCT01780974|3635769|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3809500|NCT01780974|3635770|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3809501|NCT01780974|3635771|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809502|NCT01780974|3635769|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809503|NCT01780974|3635770|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809504|NCT01780974|3635771|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809505|NCT01780974|3635769|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809506|NCT01780974|3635770|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809507|NCT01780974|3635771|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809508|NCT01780974|3635769|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3809509|NCT01780974|3635770|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3809510|NCT01780974|3635771|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3809511|NCT01780974|3635769|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3809512|NCT01780974|3635770|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3809513|NCT01780974|3635771|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3809514|NCT01780974|3635769|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3809515|NCT01780974|3635770|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3809516|NCT01780974|3635771|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3809517|NCT01780974|3635769|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3809518|NCT01780974|3635770|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3809519|NCT01780974|3635771|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3809520|NCT01780974|3635769|B3|||Age||years|Mean|65.71|65.71|Standard Deviation|7.03|7.03|||
3809521|NCT01780974|3635770|B2|||Age||years|Mean|65.38|65.38|Standard Deviation|5.84|5.84|||
3809522|NCT01780974|3635771|B1|||Age||years|Mean|66.05|66.05|Standard Deviation|8.19|8.19|||
3809523|NCT01780935|3635780|B3||Male|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
3809524|NCT01780935|3635781|B2||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3809525|NCT01780935|3635782|B1||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3809526|NCT01780935|3635780|B3||Female|Sex: Female, Male||Participants|Count of Participants|407|407.0||||||
3809527|NCT01780935|3635781|B2||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
3809528|NCT01780935|3635782|B1||Female|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
3809529|NCT01780935|3635780|B3|||Age||years|Mean|74.6|74.6|Standard Deviation|7.91|7.91|||
3809530|NCT01780935|3635781|B2|||Age||years|Mean|75.3|75.3|Standard Deviation|7.91|7.91|||
3809531|NCT01780935|3635782|B1|||Age||years|Mean|73.9|73.9|Standard Deviation|7.86|7.86|||
3809532|NCT01780922|3635813|B1|||Body Mass Index||kg/m^2|Mean|23.7|23.7|Standard Deviation|3.0|3.0|||
3809533|NCT01780922|3635813|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3809534|NCT01780922|3635813|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3809535|NCT01780922|3635813|B1|||Age||years|Mean|27.5|27.5|Standard Deviation|4.3|4.3|||
3809536|NCT01780870|3635871|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3809537|NCT01780870|3635872|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3809538|NCT01780870|3635871|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3809539|NCT01780870|3635872|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3809540|NCT01780870|3635871|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3809541|NCT01780870|3635872|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3809542|NCT01780870|3635871|B3|||Age||years|Mean|32.8|32.8|Standard Deviation|3.1|3.1|||
3809543|NCT01780870|3635872|B2|||Age||years|Mean|32.8|32.8|Standard Deviation|3.1|3.1|||
3809544|NCT01780870|3635871|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3809545|NCT01780870|3635872|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3809546|NCT01780870|3635871|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3809547|NCT01780870|3635872|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3809548|NCT01780870|3635871|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3809549|NCT01780870|3635872|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3809550|NCT01780584|3635884|B4|Indonesia||Region of Enrollment||participants|Number|45|45.0||||||
3809551|NCT01780584|3635885|B3|Indonesia||Region of Enrollment||participants|Number|15|15.0||||||
3809552|NCT01780584|3635886|B2|Indonesia||Region of Enrollment||participants|Number|15|15.0||||||
3809553|NCT01780584|3635887|B1|Indonesia||Region of Enrollment||participants|Number|15|15.0||||||
3809554|NCT01780584|3635884|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3809555|NCT01780584|3635885|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3809556|NCT01780584|3635886|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3809557|NCT01780584|3635887|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3809558|NCT01780584|3635884|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3809559|NCT01780584|3635885|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3809560|NCT01780584|3635886|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3809561|NCT01780584|3635887|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3809562|NCT01780584|3635884|B4|||Age||years|Mean|0.9|0.9|Standard Deviation|0.5|0.5|||
3809563|NCT01780584|3635885|B3|||Age||years|Mean|0.8|0.8|Standard Deviation|0.6|0.6|||
3809564|NCT01780584|3635886|B2|||Age||years|Mean|0.8|0.8|Standard Deviation|0.4|0.4|||
3809565|NCT01780584|3635887|B1|||Age||years|Mean|0.9|0.9|Standard Deviation|0.5|0.5|||
3809566|NCT01780584|3635884|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3809567|NCT01780584|3635885|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3809568|NCT01780584|3635886|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3809569|NCT01780584|3635887|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3809570|NCT01780584|3635884|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3809571|NCT01780584|3635885|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3809572|NCT01780584|3635886|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3809573|NCT01780584|3635887|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3809574|NCT01780584|3635884|B4||<=18 years|Age||Participants|Count of Participants|45|45.0||||||
3809575|NCT01780584|3635885|B3||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
3809576|NCT01780584|3635886|B2||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
3809577|NCT01780584|3635887|B1||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
3809578|NCT01780545|3635909|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3809579|NCT01780545|3635910|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3809580|NCT01780545|3635911|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3809581|NCT01780545|3635909|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809582|NCT01780545|3635910|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809583|NCT01780545|3635911|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809584|NCT01780545|3635909|B3||White|Race (NIH/OMB)||Participants|Count of Participants|181|181.0||||||
3809585|NCT01780545|3635910|B2||White|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
3809586|NCT01780545|3635911|B1||White|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
3809587|NCT01780545|3635909|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3809588|NCT01780545|3635910|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3809589|NCT01780545|3635911|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3809590|NCT01780545|3635909|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809591|NCT01780545|3635910|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809592|NCT01780545|3635911|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809593|NCT01780545|3635909|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3809594|NCT01780545|3635910|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3809595|NCT01780545|3635911|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3809596|NCT01780545|3635909|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809597|NCT01780545|3635910|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809598|NCT01780545|3635911|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809599|NCT01780545|3635909|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3809600|NCT01780545|3635910|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3809601|NCT01780545|3635911|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3809602|NCT01780545|3635909|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|192|192.0||||||
3809603|NCT01780545|3635910|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3809604|NCT01780545|3635911|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3809605|NCT01780545|3635909|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3809606|NCT01780545|3635910|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3809607|NCT01780545|3635911|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3809608|NCT01780545|3635909|B3||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3809609|NCT01780545|3635910|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3809610|NCT01780545|3635911|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3809611|NCT01780545|3635909|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3809612|NCT01780545|3635910|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3809613|NCT01780545|3635911|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3809614|NCT01780545|3635909|B3|||Age||years|Median|67|67.0|Full Range|||35.0|92.0|
3809615|NCT01780545|3635910|B2|||Age||years|Median|67|67.0|Full Range|||35.0|92.0|
3809616|NCT01780545|3635911|B1|||Age||years|Median|68|68.0|Full Range|||43.0|90.0|
3809617|NCT01780506|3635928|B3||Unknown|HIV Disease Status||Participants|Count of Participants|2|2.0||||||
3809618|NCT01780506|3635929|B2||Unknown|HIV Disease Status||Participants|Count of Participants|1|1.0||||||
3809619|NCT01780506|3635930|B1||Unknown|HIV Disease Status||Participants|Count of Participants|1|1.0||||||
3809620|NCT01780506|3635928|B3||AIDS|HIV Disease Status||Participants|Count of Participants|19|19.0||||||
3809621|NCT01780506|3635929|B2||AIDS|HIV Disease Status||Participants|Count of Participants|10|10.0||||||
3809622|NCT01780506|3635930|B1||AIDS|HIV Disease Status||Participants|Count of Participants|9|9.0||||||
3809623|NCT01780506|3635928|B3||Symptomatic HIV Infection|HIV Disease Status||Participants|Count of Participants|38|38.0||||||
3809624|NCT01780506|3635929|B2||Symptomatic HIV Infection|HIV Disease Status||Participants|Count of Participants|15|15.0||||||
3809625|NCT01780506|3635930|B1||Symptomatic HIV Infection|HIV Disease Status||Participants|Count of Participants|23|23.0||||||
3809626|NCT01780506|3635928|B3||Asymptomatic|HIV Disease Status||Participants|Count of Participants|808|808.0||||||
3809627|NCT01780506|3635929|B2||Asymptomatic|HIV Disease Status||Participants|Count of Participants|406|406.0||||||
3809628|NCT01780506|3635930|B1||Asymptomatic|HIV Disease Status||Participants|Count of Participants|402|402.0||||||
3809629|NCT01780506|3635928|B3||≥ 500 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|285|285.0||||||
3809630|NCT01780506|3635929|B2||≥ 500 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|133|133.0||||||
3809631|NCT01780506|3635930|B1||≥ 500 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|152|152.0||||||
3809632|NCT01780506|3635928|B3||≥ 350 to < 500 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|257|257.0||||||
3809633|NCT01780506|3635929|B2||≥ 350 to < 500 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|135|135.0||||||
3809634|NCT01780506|3635930|B1||≥ 350 to < 500 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|122|122.0||||||
3809635|NCT01780506|3635928|B3||≥ 200 to < 350 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|214|214.0||||||
3809636|NCT01780506|3635929|B2||≥ 200 to < 350 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|111|111.0||||||
3809637|NCT01780506|3635930|B1||≥ 200 to < 350 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|103|103.0||||||
3809638|NCT01780506|3635928|B3||≥ 50 to < 200 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|89|89.0||||||
3809639|NCT01780506|3635929|B2||≥ 50 to < 200 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|41|41.0||||||
3809640|NCT01780506|3635930|B1||≥ 50 to < 200 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|48|48.0||||||
3809641|NCT01780506|3635928|B3||< 50 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|22|22.0||||||
3809642|NCT01780506|3635929|B2||< 50 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|12|12.0||||||
3809643|NCT01780506|3635930|B1||< 50 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|10|10.0||||||
3809644|NCT01780506|3635928|B3|||CD4 Cell Count||cells/µL|Mean|432|432.0|Standard Deviation|218.0|218.0|||
3809645|NCT01780506|3635929|B2|||CD4 Cell Count||cells/µL|Mean|426|426.0|Standard Deviation|212.3|212.3|||
3809646|NCT01780506|3635930|B1|||CD4 Cell Count||cells/µL|Mean|437|437.0|Standard Deviation|223.7|223.7|||
3809647|NCT01780506|3635928|B3||> 400,000 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|49|49.0||||||
3809648|NCT01780506|3635929|B2||> 400,000 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|24|24.0||||||
3809649|NCT01780506|3635930|B1||> 400,000 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|25|25.0||||||
3809650|NCT01780506|3635928|B3||> 100,000 to ≤ 400,000 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|151|151.0||||||
3809651|NCT01780506|3635929|B2||> 100,000 to ≤ 400,000 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|72|72.0||||||
3809652|NCT01780506|3635930|B1||> 100,000 to ≤ 400,000 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|79|79.0||||||
3809653|NCT01780506|3635928|B3||≤ 100,000 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|667|667.0||||||
3809654|NCT01780506|3635929|B2||≤ 100,000 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|336|336.0||||||
3809655|NCT01780506|3635930|B1||≤ 100,000 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|331|331.0||||||
3809656|NCT01780506|3635928|B3|||HIV-1 RNA (log10 copies/mL)||log10 copies/mL|Mean|4.55|4.55|Standard Deviation|0.678|0.678|||
3809657|NCT01780506|3635929|B2|||HIV-1 RNA (log10 copies/mL)||log10 copies/mL|Mean|4.55|4.55|Standard Deviation|0.674|0.674|||
3809658|NCT01780506|3635930|B1|||HIV-1 RNA (log10 copies/mL)||log10 copies/mL|Mean|4.55|4.55|Standard Deviation|0.682|0.682|||
3809659|NCT01780506|3635928|B3|Australia||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3809660|NCT01780506|3635929|B2|Australia||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3809661|NCT01780506|3635930|B1|Australia||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3809662|NCT01780506|3635928|B3|Italy||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3809663|NCT01780506|3635929|B2|Italy||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3809664|NCT01780506|3635930|B1|Italy||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3809665|NCT01780506|3635928|B3|Belgium||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3809666|NCT01780506|3635929|B2|Belgium||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3809667|NCT01780506|3635930|B1|Belgium||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3809668|NCT01780506|3635928|B3|Austria||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3809669|NCT01780506|3635929|B2|Austria||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3809670|NCT01780506|3635930|B1|Austria||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3809671|NCT01780506|3635928|B3|Canada||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
3809672|NCT01780506|3635929|B2|Canada||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3809673|NCT01780506|3635930|B1|Canada||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3809674|NCT01780506|3635928|B3|Spain||Region of Enrollment||Participants|Count of Participants|84|84.0||||||
3809675|NCT01780506|3635929|B2|Spain||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3809676|NCT01780506|3635930|B1|Spain||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3809677|NCT01780506|3635928|B3|Switzerland||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3809678|NCT01780506|3635929|B2|Switzerland||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3809679|NCT01780506|3635930|B1|Switzerland||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3809680|NCT01780506|3635928|B3|Thailand||Region of Enrollment||Participants|Count of Participants|121|121.0||||||
3809681|NCT01780506|3635929|B2|Thailand||Region of Enrollment||Participants|Count of Participants|58|58.0||||||
3809682|NCT01780506|3635930|B1|Thailand||Region of Enrollment||Participants|Count of Participants|63|63.0||||||
3809683|NCT01780506|3635928|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3809684|NCT01780506|3635929|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3809685|NCT01780506|3635930|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3809686|NCT01780506|3635928|B3|Japan||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3809687|NCT01780506|3635929|B2|Japan||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3809688|NCT01780506|3635930|B1|Japan||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3809689|NCT01780506|3635928|B3|United States||Region of Enrollment||Participants|Count of Participants|502|502.0||||||
3809690|NCT01780506|3635929|B2|United States||Region of Enrollment||Participants|Count of Participants|250|250.0||||||
3809691|NCT01780506|3635930|B1|United States||Region of Enrollment||Participants|Count of Participants|252|252.0||||||
3809692|NCT01780506|3635928|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3809693|NCT01780506|3635929|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3809694|NCT01780506|3635930|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3809695|NCT01780506|3635928|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|505|505.0||||||
3809696|NCT01780506|3635929|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|255|255.0||||||
3809697|NCT01780506|3635930|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|250|250.0||||||
3809698|NCT01780506|3635928|B3||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3809699|NCT01780506|3635929|B2||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3809700|NCT01780506|3635930|B1||Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3809701|NCT01780506|3635928|B3||Black|Race/Ethnicity, Customized||Participants|Count of Participants|175|175.0||||||
3809702|NCT01780506|3635929|B2||Black|Race/Ethnicity, Customized||Participants|Count of Participants|81|81.0||||||
3809703|NCT01780506|3635930|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|94|94.0||||||
3809704|NCT01780506|3635928|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|153|153.0||||||
3809705|NCT01780506|3635929|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|77|77.0||||||
3809706|NCT01780506|3635930|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|76|76.0||||||
3809707|NCT01780506|3635928|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3809708|NCT01780506|3635929|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3809709|NCT01780506|3635930|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3809710|NCT01780506|3635928|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809711|NCT01780506|3635929|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809712|NCT01780506|3635930|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809713|NCT01780506|3635928|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|737|737.0||||||
3809714|NCT01780506|3635929|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|362|362.0||||||
3809715|NCT01780506|3635930|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|375|375.0||||||
3809716|NCT01780506|3635928|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
3809717|NCT01780506|3635929|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3809718|NCT01780506|3635930|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3809719|NCT01780506|3635928|B3||Male|Sex: Female, Male||Participants|Count of Participants|740|740.0||||||
3809720|NCT01780506|3635929|B2||Male|Sex: Female, Male||Participants|Count of Participants|376|376.0||||||
3809721|NCT01780506|3635930|B1||Male|Sex: Female, Male||Participants|Count of Participants|364|364.0||||||
3809722|NCT01780506|3635928|B3||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3809723|NCT01780506|3635929|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3809724|NCT01780506|3635930|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3809725|NCT01780506|3635928|B3|||Age||years|Mean|35|35.0|Standard Deviation|10.3|10.3|||
3809726|NCT01780506|3635929|B2|||Age||years|Mean|36|36.0|Standard Deviation|10.5|10.5|||
3809727|NCT01780506|3635930|B1|||Age||years|Mean|35|35.0|Standard Deviation|10.0|10.0|||
3809728|NCT01780389|3635985|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3809729|NCT01780389|3635985|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3809730|NCT01780389|3635985|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3809731|NCT01780389|3635985|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3809732|NCT01780389|3635985|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3809733|NCT01780389|3635985|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3809734|NCT01780350|3635996|B1|United States||Region of Enrollment||participants|Number|200|200.0||||||
3809735|NCT01780350|3635996|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3809736|NCT01780350|3635996|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3809737|NCT01780350|3635996|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|18.2|18.2|||
3809738|NCT01780337|3636001|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3809739|NCT01780337|3636002|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3809740|NCT01780337|3636003|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3809741|NCT01780337|3636001|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3809742|NCT01780337|3636002|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3809743|NCT01780337|3636003|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3809744|NCT01780337|3636001|B3|||Age||years|Mean|66.0|66.0|Standard Deviation|11.0|11.0|||
3809745|NCT01780337|3636002|B2|||Age||years|Mean|68.1|68.1|Standard Deviation|3.7|3.7|||
3809746|NCT01780337|3636003|B1|||Age||years|Mean|63.8|63.8|Standard Deviation|15.5|15.5|||
3809747|NCT01780324|3636014|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
3809748|NCT01780324|3636015|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
3809749|NCT01780324|3636016|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
3809750|NCT01780324|3636014|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3809751|NCT01780324|3636015|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3809752|NCT01780324|3636016|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3809753|NCT01780324|3636014|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3809754|NCT01780324|3636015|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3809755|NCT01780324|3636016|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3809756|NCT01780324|3636014|B3|||Age||months|Mean|12|12.0|Standard Deviation|8.3|8.3|||
3809757|NCT01780324|3636015|B2|||Age||months|Mean|13|13.0|Standard Deviation|8.5|8.5|||
3809758|NCT01780324|3636016|B1|||Age||months|Mean|12|12.0|Standard Deviation|8.1|8.1|||
3809759|NCT01780324|3636014|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3809760|NCT01780324|3636015|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3809761|NCT01780324|3636016|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3809762|NCT01780324|3636014|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3809763|NCT01780324|3636015|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3809764|NCT01780324|3636016|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3809765|NCT01780324|3636014|B3||<=18 years|Age||Participants|Count of Participants|80|80.0||||||
3809766|NCT01780324|3636015|B2||<=18 years|Age||Participants|Count of Participants|39|39.0||||||
3809767|NCT01780324|3636016|B1||<=18 years|Age||Participants|Count of Participants|41|41.0||||||
3809768|NCT01779869|3636023|B1|||Scheduled to undergo ICA||Participants|Count of Participants|16|16.0||||||
3809769|NCT01779869|3636023|B1|||Positive cardiac SPECT stress test (2 contiguous segments)||Participants|Count of Participants|16|16.0||||||
3809770|NCT01779869|3636023|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3809771|NCT01779869|3636023|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3809772|NCT01779869|3636023|B1|||Age||years|Mean|55|55.0|Standard Deviation|12.4|12.4|||
3809773|NCT01779648|3636027|B3|Male||Body Mass Index||kg/m2|Mean|27.4|27.4|Standard Deviation|2.7|2.7|||
3809774|NCT01779648|3636028|B2|Male||Body Mass Index||kg/m2|Mean|28.0|28.0|Standard Deviation|1.6|1.6|||
3809775|NCT01779648|3636029|B1|Male||Body Mass Index||kg/m2|Mean|26.5|26.5|Standard Deviation|4.6|4.6|||
3809776|NCT01779648|3636027|B3|Female||Body Mass Index||kg/m2|Mean|26.7|26.7|Standard Deviation|4.8|4.8|||
3809777|NCT01779648|3636028|B2|Female||Body Mass Index||kg/m2|Mean|26.3|26.3|Standard Deviation|4.4|4.4|||
3809778|NCT01779648|3636029|B1|Female||Body Mass Index||kg/m2|Mean|27.1|27.1|Standard Deviation|5.2|5.2|||
3809779|NCT01779648|3636027|B3|Korea, Republic of||Region of Enrollment||participants|Number|55|55.0||||||
3809780|NCT01779648|3636028|B2|Korea, Republic of||Region of Enrollment||participants|Number|27|27.0||||||
3809781|NCT01779648|3636029|B1|Korea, Republic of||Region of Enrollment||participants|Number|28|28.0||||||
3809782|NCT01779648|3636027|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3809783|NCT01779648|3636028|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3809784|NCT01779648|3636029|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3809785|NCT01779648|3636027|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3809786|NCT01779648|3636028|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3809787|NCT01779648|3636029|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3809788|NCT01779648|3636027|B3|||Age||years|Mean|70.1|70.1|Standard Deviation|7.4|7.4|||
3809789|NCT01779648|3636028|B2|||Age||years|Mean|72.3|72.3|Standard Deviation|5.9|5.9|||
3809790|NCT01779648|3636029|B1|||Age||years|Mean|68.0|68.0|Standard Deviation|8.1|8.1|||
3809791|NCT01779648|3636027|B3||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
3809792|NCT01779648|3636028|B2||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
3809793|NCT01779648|3636029|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3809794|NCT01779648|3636027|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3809795|NCT01779648|3636028|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3809796|NCT01779648|3636029|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3809797|NCT01779648|3636027|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3809798|NCT01779648|3636028|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3809799|NCT01779648|3636029|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3809800|NCT01779440|3636058|B3|||Mean cigarettes per day||cigarettes|Mean|12.3|12.3|Standard Deviation|9.0|9.0|||
3809801|NCT01779440|3636059|B2|||Mean cigarettes per day||cigarettes|Mean|13.9|13.9|Standard Deviation|9.4|9.4|||
3809802|NCT01779440|3636060|B1|||Mean cigarettes per day||cigarettes|Mean|10.9|10.9|Standard Deviation|8.6|8.6|||
3809803|NCT01779440|3636058|B3|Other race||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3809804|NCT01779440|3636059|B2|Other race||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3809805|NCT01779440|3636060|B1|Other race||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3809806|NCT01779440|3636058|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3809807|NCT01779440|3636059|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3809808|NCT01779440|3636060|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3809809|NCT01779440|3636058|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3809810|NCT01779440|3636059|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3809811|NCT01779440|3636060|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3809812|NCT01779440|3636058|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3809813|NCT01779440|3636059|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3809814|NCT01779440|3636060|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3809815|NCT01779440|3636058|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3809816|NCT01779440|3636059|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3809817|NCT01779440|3636060|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3809818|NCT01779440|3636058|B3|||Age||years|Mean|24.2|24.2|Standard Deviation|3.4|3.4|||
3809819|NCT01779440|3636059|B2|||Age||years|Mean|25.0|25.0|Standard Deviation|3.2|3.2|||
3809820|NCT01779440|3636060|B1|||Age||years|Mean|23.5|23.5|Standard Deviation|3.9|3.9|||
3809821|NCT01779375|3636069|B3|||2-hour OGTT glucose||mg/dl|Mean|183.9|183.9|Standard Deviation|47.3|47.3|||
3809822|NCT01779375|3636070|B2|||2-hour OGTT glucose||mg/dl|Mean|183.5|183.5|Standard Deviation|44.5|44.5|||
3809823|NCT01779375|3636071|B1|||2-hour OGTT glucose||mg/dl|Mean|184.2|184.2|Standard Deviation|50.2|50.2|||
3809824|NCT01779375|3636069|B3|||Fasting glucose||mg/dl|Mean|108.3|108.3|Standard Deviation|17.1|17.1|||
3809825|NCT01779375|3636070|B2|||Fasting glucose||mg/dl|Mean|107.5|107.5|Standard Deviation|14.1|14.1|||
3809826|NCT01779375|3636071|B1|||Fasting glucose||mg/dl|Mean|109.2|109.2|Standard Deviation|19.7|19.7|||
3809827|NCT01779375|3636069|B3|||HbA1c||% of glycosylated hemoglobin|Mean|5.7|5.7|Standard Deviation|0.6|0.6|||
3809828|NCT01779375|3636070|B2|||HbA1c||% of glycosylated hemoglobin|Mean|5.7|5.7|Standard Deviation|0.6|0.6|||
3809829|NCT01779375|3636071|B1|||HbA1c||% of glycosylated hemoglobin|Mean|5.7|5.7|Standard Deviation|0.6|0.6|||
3809830|NCT01779375|3636069|B3|||BMI||kg/m^2|Mean|36.7|36.7|Standard Deviation|6.4|6.4|||
3809831|NCT01779375|3636070|B2|||BMI||kg/m^2|Mean|36.5|36.5|Standard Deviation|6.4|6.4|||
3809832|NCT01779375|3636071|B1|||BMI||kg/m^2|Mean|36.9|36.9|Standard Deviation|6.4|6.4|||
3809833|NCT01779375|3636069|B3|All othe||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3809834|NCT01779375|3636070|B2|All othe||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3809835|NCT01779375|3636071|B1|All othe||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3809836|NCT01779375|3636069|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3809837|NCT01779375|3636070|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3809838|NCT01779375|3636071|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3809839|NCT01779375|3636069|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3809840|NCT01779375|3636070|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3809841|NCT01779375|3636071|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3809842|NCT01779375|3636069|B3|Non-hispanic white||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3809843|NCT01779375|3636070|B2|Non-hispanic white||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3809844|NCT01779375|3636071|B1|Non-hispanic white||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3809845|NCT01779375|3636069|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3809846|NCT01779375|3636070|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3809847|NCT01779375|3636071|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3809848|NCT01779375|3636069|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3809849|NCT01779375|3636070|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3809850|NCT01779375|3636071|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3809851|NCT01779375|3636069|B3|||Age||Years|Mean|14.4|14.4|Standard Deviation|2.1|2.1|||
3809852|NCT01779375|3636070|B2|||Age||Years|Mean|14.9|14.9|Standard Deviation|2.0|2.0|||
3809853|NCT01779375|3636071|B1|||Age||Years|Mean|13.9|13.9|Standard Deviation|2.1|2.1|||
3809854|NCT01779375|3636069|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3809855|NCT01779375|3636070|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3809856|NCT01779375|3636071|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3809857|NCT01779375|3636069|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3809858|NCT01779375|3636070|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3809859|NCT01779375|3636071|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3809860|NCT01779375|3636069|B3||<=18 years|Age||Participants|Count of Participants|89|89.0||||||
3809861|NCT01779375|3636070|B2||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
3809862|NCT01779375|3636071|B1||<=18 years|Age||Participants|Count of Participants|47|47.0||||||
3809863|NCT01779219|3636086|B3|Diabetes not recorded||Diabetes|Number of participants with preoperative diabetes.|participants|Number|30|30.0||||||
3809864|NCT01779219|3636087|B2|Diabetes not recorded||Diabetes|Number of participants with preoperative diabetes.|participants|Number|15|15.0||||||
3809865|NCT01779219|3636088|B1|Diabetes not recorded||Diabetes|Number of participants with preoperative diabetes.|participants|Number|15|15.0||||||
3809866|NCT01779219|3636086|B3|Diabetes recorded||Diabetes|Number of participants with preoperative diabetes.|participants|Number|12|12.0||||||
3809867|NCT01779219|3636087|B2|Diabetes recorded||Diabetes|Number of participants with preoperative diabetes.|participants|Number|6|6.0||||||
3809868|NCT01779219|3636088|B1|Diabetes recorded||Diabetes|Number of participants with preoperative diabetes.|participants|Number|6|6.0||||||
3809869|NCT01779219|3636086|B3|extra-thalamic localisation of the tumor||Thalamic localization|Number of participants with thalamic localisation of the tumor.|participants|Number|36|36.0||||||
3809870|NCT01779219|3636087|B2|extra-thalamic localisation of the tumor||Thalamic localization|Number of participants with thalamic localisation of the tumor.|participants|Number|17|17.0||||||
3809871|NCT01779219|3636088|B1|extra-thalamic localisation of the tumor||Thalamic localization|Number of participants with thalamic localisation of the tumor.|participants|Number|19|19.0||||||
3809872|NCT01779219|3636086|B3|thalamic localisation of the tumor||Thalamic localization|Number of participants with thalamic localisation of the tumor.|participants|Number|6|6.0||||||
3809873|NCT01779219|3636087|B2|thalamic localisation of the tumor||Thalamic localization|Number of participants with thalamic localisation of the tumor.|participants|Number|4|4.0||||||
3809874|NCT01779219|3636088|B1|thalamic localisation of the tumor||Thalamic localization|Number of participants with thalamic localisation of the tumor.|participants|Number|2|2.0||||||
3809875|NCT01779219|3636086|B3|non-basal localisation of the tumor||Basal localization|Number of participants with basal localisation of the tumor.|participants|Number|26|26.0||||||
3809876|NCT01779219|3636087|B2|non-basal localisation of the tumor||Basal localization|Number of participants with basal localisation of the tumor.|participants|Number|12|12.0||||||
3809877|NCT01779219|3636088|B1|non-basal localisation of the tumor||Basal localization|Number of participants with basal localisation of the tumor.|participants|Number|14|14.0||||||
3809878|NCT01779219|3636086|B3|basal localisation of the tumor||Basal localization|Number of participants with basal localisation of the tumor.|participants|Number|16|16.0||||||
3809879|NCT01779219|3636087|B2|basal localisation of the tumor||Basal localization|Number of participants with basal localisation of the tumor.|participants|Number|9|9.0||||||
3809880|NCT01779219|3636088|B1|basal localisation of the tumor||Basal localization|Number of participants with basal localisation of the tumor.|participants|Number|7|7.0||||||
3809881|NCT01779219|3636086|B3|No enhancement noted||Tumour enhancement|Number of participants with contrast-enhancing tumors.|participants|Number|13|13.0||||||
3809882|NCT01779219|3636087|B2|No enhancement noted||Tumour enhancement|Number of participants with contrast-enhancing tumors.|participants|Number|8|8.0||||||
3809883|NCT01779219|3636088|B1|No enhancement noted||Tumour enhancement|Number of participants with contrast-enhancing tumors.|participants|Number|5|5.0||||||
3809884|NCT01779219|3636086|B3|Enhancement noted||Tumour enhancement|Number of participants with contrast-enhancing tumors.|participants|Number|29|29.0||||||
3809885|NCT01779219|3636087|B2|Enhancement noted||Tumour enhancement|Number of participants with contrast-enhancing tumors.|participants|Number|13|13.0||||||
3809886|NCT01779219|3636088|B1|Enhancement noted||Tumour enhancement|Number of participants with contrast-enhancing tumors.|participants|Number|16|16.0||||||
3809887|NCT01779219|3636086|B3|||Maximum tumour diameter||mm|Mean|51|51.0|Standard Deviation|18|18.0|||
3809888|NCT01779219|3636087|B2|||Maximum tumour diameter||mm|Mean|54|54.0|Standard Deviation|18|18.0|||
3809889|NCT01779219|3636088|B1|||Maximum tumour diameter||mm|Mean|48|48.0|Standard Deviation|19|19.0|||
3809890|NCT01779219|3636086|B3|||ECOG Performance Status|"The ECOG Scale of Performance Status:~0 - Fully active, able to carry on all pre-disease performance without restriction~- Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work~- Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~- Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~- Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~- Dead"|units on a scale|Median|2|2.0|Inter-Quartile Range|||0.0|4.0|
3809891|NCT01779219|3636087|B2|||ECOG Performance Status|"The ECOG Scale of Performance Status:~0 - Fully active, able to carry on all pre-disease performance without restriction~- Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work~- Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~- Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~- Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~- Dead"|units on a scale|Median|2|2.0|Inter-Quartile Range|||1.0|2.0|
3809892|NCT01779219|3636088|B1|||ECOG Performance Status|"The ECOG Scale of Performance Status:~0 - Fully active, able to carry on all pre-disease performance without restriction~- Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work~- Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~- Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~- Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~- Dead"|units on a scale|Median|2|2.0|Inter-Quartile Range|||1.0|3.0|
3809893|NCT01779219|3636086|B3|Poland||Region of Enrollment||participants|Number|42|42.0||||||
3809894|NCT01779219|3636087|B2|Poland||Region of Enrollment||participants|Number|21|21.0||||||
3809895|NCT01779219|3636088|B1|Poland||Region of Enrollment||participants|Number|21|21.0||||||
3809896|NCT01779219|3636086|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3809897|NCT01779219|3636087|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3809898|NCT01779219|3636088|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3809899|NCT01779219|3636086|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3809900|NCT01779219|3636087|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3809901|NCT01779219|3636088|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3809902|NCT01779219|3636086|B3|||Age||years|Mean|54|54.0|Standard Deviation|16|16.0|||
3809903|NCT01779219|3636087|B2|||Age||years|Mean|55|55.0|Standard Deviation|15|15.0|||
3809904|NCT01779219|3636088|B1|||Age||years|Mean|52|52.0|Standard Deviation|17|17.0|||
3809905|NCT01779219|3636086|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3809906|NCT01779219|3636087|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3809907|NCT01779219|3636088|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3809908|NCT01779219|3636086|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3809909|NCT01779219|3636087|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3809910|NCT01779219|3636088|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3809911|NCT01779219|3636086|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3809912|NCT01779219|3636087|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3809913|NCT01779219|3636088|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3809914|NCT01779167|3636101|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3809915|NCT01779167|3636101|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3809916|NCT01779167|3636101|B1|80-89||Age, Customized||Participants|Count of Participants|1|1.0||||||
3809917|NCT01779167|3636101|B1|60-69||Age, Customized||Participants|Count of Participants|1|1.0||||||
3809918|NCT01779167|3636101|B1|50-59||Age, Customized||Participants|Count of Participants|1|1.0||||||
3809919|NCT01779024|3636110|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3809920|NCT01779024|3636110|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3809921|NCT01779024|3636110|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3809922|NCT01779024|3636110|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3809923|NCT01779024|3636110|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809924|NCT01779024|3636110|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809925|NCT01779024|3636110|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809926|NCT01779024|3636110|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3809927|NCT01779024|3636110|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3809928|NCT01779024|3636110|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3809929|NCT01779024|3636110|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3809930|NCT01779024|3636110|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3809931|NCT01779024|3636110|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3809932|NCT01779024|3636110|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3809933|NCT01779024|3636110|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3809934|NCT01778985|3636117|B3|||Body mass index||kg/m^2|Mean|30.5|30.5|Standard Deviation|4.9|4.9|||
3809935|NCT01778985|3636118|B2|||Body mass index||kg/m^2|Mean|31.7|31.7|Standard Deviation|4.1|4.1|||
3809936|NCT01778985|3636119|B1|||Body mass index||kg/m^2|Mean|29.2|29.2|Standard Deviation|5.4|5.4|||
3809937|NCT01778985|3636117|B3|||Parity||deliveries|Median|4|4.0|Inter-Quartile Range|||3.0|6.0|
3809938|NCT01778985|3636118|B2|||Parity||deliveries|Median|4|4.0|Inter-Quartile Range|||3.0|6.0|
3809939|NCT01778985|3636119|B1|||Parity||deliveries|Median|3|3.0|Inter-Quartile Range|||2.0|4.0|
3809940|NCT01778985|3636117|B3|Hispanic White||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3809941|NCT01778985|3636118|B2|Hispanic White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3809942|NCT01778985|3636119|B1|Hispanic White||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3809943|NCT01778985|3636117|B3|Non-Hispanic Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3809944|NCT01778985|3636118|B2|Non-Hispanic Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3809945|NCT01778985|3636119|B1|Non-Hispanic Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3809946|NCT01778985|3636117|B3|Non-Hispanic White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3809947|NCT01778985|3636118|B2|Non-Hispanic White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3809948|NCT01778985|3636119|B1|Non-Hispanic White||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3809949|NCT01778985|3636117|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3809950|NCT01778985|3636118|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3809951|NCT01778985|3636119|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3809952|NCT01778985|3636117|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3809953|NCT01778985|3636118|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3809954|NCT01778985|3636119|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3809955|NCT01778985|3636117|B3|||Age||years|Mean|57.2|57.2|Standard Deviation|5.5|5.5|||
3809956|NCT01778985|3636118|B2|||Age||years|Mean|58.9|58.9|Standard Deviation|5.1|5.1|||
3809957|NCT01778985|3636119|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|5.4|5.4|||
3809958|NCT01778855|3636164|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3809959|NCT01778855|3636165|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3809960|NCT01778855|3636166|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3809961|NCT01778855|3636164|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3809962|NCT01778855|3636165|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3809963|NCT01778855|3636166|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3809964|NCT01778855|3636164|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3809965|NCT01778855|3636165|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3809966|NCT01778855|3636166|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3809967|NCT01778855|3636164|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3809968|NCT01778855|3636165|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3809969|NCT01778855|3636166|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3809970|NCT01778855|3636164|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3809971|NCT01778855|3636165|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3809972|NCT01778855|3636166|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3809973|NCT01778855|3636164|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3809974|NCT01778855|3636165|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3809975|NCT01778855|3636166|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3809976|NCT01778751|3636173|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3809977|NCT01778751|3636174|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3809978|NCT01778751|3636175|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3809979|NCT01778751|3636173|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3809980|NCT01778751|3636174|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809981|NCT01778751|3636175|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3809982|NCT01778751|3636173|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3809983|NCT01778751|3636174|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809984|NCT01778751|3636175|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3809985|NCT01778751|3636173|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3809986|NCT01778751|3636174|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3809987|NCT01778751|3636175|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3809988|NCT01778751|3636173|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3809989|NCT01778751|3636174|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3809990|NCT01778751|3636175|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3809991|NCT01778751|3636173|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809992|NCT01778751|3636174|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809993|NCT01778751|3636175|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809994|NCT01778751|3636173|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809995|NCT01778751|3636174|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809996|NCT01778751|3636175|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809997|NCT01778751|3636173|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809998|NCT01778751|3636174|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3809999|NCT01778751|3636175|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810000|NCT01778751|3636173|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810001|NCT01778751|3636174|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810002|NCT01778751|3636175|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810003|NCT01778751|3636173|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3810004|NCT01778751|3636174|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3810005|NCT01778751|3636175|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3810006|NCT01778751|3636173|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3810007|NCT01778751|3636174|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3810008|NCT01778751|3636175|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3810009|NCT01778751|3636173|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3810010|NCT01778751|3636174|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3810011|NCT01778751|3636175|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3810012|NCT01778751|3636173|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3810013|NCT01778751|3636174|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3810014|NCT01778751|3636175|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3810015|NCT01778751|3636173|B3|||Age||years|Mean|59.9|59.9|Standard Deviation|8.7|8.7|||
3810016|NCT01778751|3636174|B2|||Age||years|Mean|60.2|60.2|Standard Deviation|8.4|8.4|||
3810017|NCT01778751|3636175|B1|||Age||years|Mean|59.5|59.5|Standard Deviation|9.2|9.2|||
3810018|NCT01778634|3636188|B3|||Ureaplasma-positive|Any subject who had a respiratory sample (tracheal aspirate and/or nasopharyngeal aspirate) at any time point that was positive for Ureaplasma species confirmed by culture and/or PCR was considered a Ureaplasma-positive subject.|Participants|Count of Participants|44|44.0||||||
3810019|NCT01778634|3636189|B2|||Ureaplasma-positive|Any subject who had a respiratory sample (tracheal aspirate and/or nasopharyngeal aspirate) at any time point that was positive for Ureaplasma species confirmed by culture and/or PCR was considered a Ureaplasma-positive subject.|Participants|Count of Participants|19|19.0||||||
3810020|NCT01778634|3636190|B1|||Ureaplasma-positive|Any subject who had a respiratory sample (tracheal aspirate and/or nasopharyngeal aspirate) at any time point that was positive for Ureaplasma species confirmed by culture and/or PCR was considered a Ureaplasma-positive subject.|Participants|Count of Participants|25|25.0||||||
3810021|NCT01778634|3636188|B3|United States||Region of Enrollment||Participants|Count of Participants|121|121.0||||||
3810022|NCT01778634|3636189|B2|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3810023|NCT01778634|3636190|B1|United States||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
3810024|NCT01778634|3636188|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810025|NCT01778634|3636189|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810026|NCT01778634|3636190|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810027|NCT01778634|3636188|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3810028|NCT01778634|3636189|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3810029|NCT01778634|3636190|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3810030|NCT01778634|3636188|B3||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3810031|NCT01778634|3636189|B2||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3810032|NCT01778634|3636190|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3810033|NCT01778634|3636188|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3810034|NCT01778634|3636189|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3810035|NCT01778634|3636190|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3810036|NCT01778634|3636188|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810037|NCT01778634|3636189|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810038|NCT01778634|3636190|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810039|NCT01778634|3636188|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3810040|NCT01778634|3636189|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810041|NCT01778634|3636190|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3810042|NCT01778634|3636188|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810043|NCT01778634|3636189|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810044|NCT01778634|3636190|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810045|NCT01778634|3636188|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810046|NCT01778634|3636189|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810047|NCT01778634|3636190|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810048|NCT01778634|3636188|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
3810049|NCT01778634|3636189|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3810050|NCT01778634|3636190|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3810051|NCT01778634|3636188|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3810052|NCT01778634|3636189|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3810053|NCT01778634|3636190|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810054|NCT01778634|3636188|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3810055|NCT01778634|3636189|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3810056|NCT01778634|3636190|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3810057|NCT01778634|3636188|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3810058|NCT01778634|3636189|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3810059|NCT01778634|3636190|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3810060|NCT01778634|3636188|B3|||Age|gestational age in weeks|weeks gestation|Mean|26.2|26.2|Standard Deviation|1.4|1.4|||
3810061|NCT01778634|3636189|B2|||Age|gestational age in weeks|weeks gestation|Mean|26.2|26.2|Standard Deviation|1.4|1.4|||
3810062|NCT01778634|3636190|B1|||Age|gestational age in weeks|weeks gestation|Mean|26.2|26.2|Standard Deviation|1.4|1.4|||
3810063|NCT01778530|3636227|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3810064|NCT01778530|3636227|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810065|NCT01778530|3636227|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3810066|NCT01778530|3636227|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810168|NCT01778127|3636258|B1|Other Solid Tumor||Diagnosis||participants|Number|5|5.0||||||
3810067|NCT01778530|3636227|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810068|NCT01778530|3636227|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810069|NCT01778530|3636227|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3810070|NCT01778530|3636227|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810071|NCT01778530|3636227|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810072|NCT01778530|3636227|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810073|NCT01778530|3636227|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810074|NCT01778530|3636227|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3810075|NCT01778530|3636227|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3810076|NCT01778530|3636227|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3810077|NCT01778530|3636227|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3810078|NCT01778530|3636227|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3810079|NCT01778530|3636227|B1|||Age||years|Mean|48|48.0|Standard Deviation|7.5|7.5|||
3810080|NCT01778426|3636232|B3||Male|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
3810081|NCT01778426|3636233|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3810082|NCT01778426|3636234|B1||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3810083|NCT01778426|3636232|B3||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
3810084|NCT01778426|3636233|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3810085|NCT01778426|3636234|B1||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3810086|NCT01778426|3636232|B3|||Age||years|Mean|52.0|52.0|Standard Deviation|10.8|10.8|||
3810087|NCT01778426|3636233|B2|||Age||years|Mean|56.5|56.5|Standard Deviation|11.4|11.4|||
3810088|NCT01778426|3636234|B1|||Age||years|Mean|49.6|49.6|Standard Deviation|9.6|9.6|||
3810089|NCT01778296|3636251|B1|||Tissue reconstruction with the neurocutaneous island flap|The patients treated with the he neurocutaneous island flap are included in the study|participants|Number|12|12.0||1.2|1.2|||
3810090|NCT01778296|3636251|B1|China||Region of Enrollment||participants|Number|12|12.0||||||
3810091|NCT01778296|3636251|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3810092|NCT01778296|3636251|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3810093|NCT01778296|3636251|B1|||Age||years|Mean|34.5|34.5|Standard Deviation|9.4|9.4|||
3810094|NCT01778296|3636251|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3810095|NCT01778296|3636251|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3810096|NCT01778296|3636251|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3810097|NCT01778127|3636255|B4|at 60 degrees/second||Dorsiflexion||Nm/kg|Mean|23.5|23.5|Standard Deviation|10.3|10.3|||
3810098|NCT01778127|3636256|B3|at 60 degrees/second||Dorsiflexion||Nm/kg|Mean|25.5|25.5|Standard Deviation|11.1|11.1|||
3810099|NCT01778127|3636257|B2|at 60 degrees/second||Dorsiflexion||Nm/kg|Mean|24.7|24.7|Standard Deviation|12.0|12.0|||
3810100|NCT01778127|3636258|B1|at 60 degrees/second||Dorsiflexion||Nm/kg|Mean|19.9|19.9|Standard Deviation|7.4|7.4|||
3810101|NCT01778127|3636255|B4|at 30 degrees/second||Dorsiflexion||Nm/kg|Mean|25.5|25.5|Standard Deviation|13.0|13.0|||
3810102|NCT01778127|3636256|B3|at 30 degrees/second||Dorsiflexion||Nm/kg|Mean|27.9|27.9|Standard Deviation|15.0|15.0|||
3810103|NCT01778127|3636257|B2|at 30 degrees/second||Dorsiflexion||Nm/kg|Mean|26.5|26.5|Standard Deviation|14.9|14.9|||
3810104|NCT01778127|3636258|B1|at 30 degrees/second||Dorsiflexion||Nm/kg|Mean|21.7|21.7|Standard Deviation|8.7|8.7|||
3810105|NCT01778127|3636255|B4|at 180 degrees/second||Quadriceps||Newton meters (Nm)/kg|Mean|119.4|119.4|Standard Deviation|33.3|33.3|||
3810106|NCT01778127|3636256|B3|at 180 degrees/second||Quadriceps||Newton meters (Nm)/kg|Mean|118.6|118.6|Standard Deviation|29.5|29.5|||
3810107|NCT01778127|3636257|B2|at 180 degrees/second||Quadriceps||Newton meters (Nm)/kg|Mean|121.7|121.7|Standard Deviation|36.7|36.7|||
3810108|NCT01778127|3636258|B1|at 180 degrees/second||Quadriceps||Newton meters (Nm)/kg|Mean|117.6|117.6|Standard Deviation|32.9|32.9|||
3810109|NCT01778127|3636255|B4|at 120 degrees/second||Quadriceps||Newton meters (Nm)/kg|Mean|139.0|139.0|Standard Deviation|38.4|38.4|||
3810110|NCT01778127|3636256|B3|at 120 degrees/second||Quadriceps||Newton meters (Nm)/kg|Mean|137.8|137.8|Standard Deviation|36.5|36.5|||
3810111|NCT01778127|3636257|B2|at 120 degrees/second||Quadriceps||Newton meters (Nm)/kg|Mean|142.0|142.0|Standard Deviation|41.7|41.7|||
3810112|NCT01778127|3636258|B1|at 120 degrees/second||Quadriceps||Newton meters (Nm)/kg|Mean|136.5|136.5|Standard Deviation|36.2|36.2|||
3810113|NCT01778127|3636255|B4|at 60 degrees/second||Quadriceps||Newton meters (Nm)/kg|Mean|160.4|160.4|Standard Deviation|44.5|44.5|||
3810114|NCT01778127|3636256|B3|at 60 degrees/second||Quadriceps||Newton meters (Nm)/kg|Mean|159.9|159.9|Standard Deviation|41.0|41.0|||
3810115|NCT01778127|3636257|B2|at 60 degrees/second||Quadriceps||Newton meters (Nm)/kg|Mean|164.2|164.2|Standard Deviation|46.3|46.3|||
3810116|NCT01778127|3636258|B1|at 60 degrees/second||Quadriceps||Newton meters (Nm)/kg|Mean|156.3|156.3|Standard Deviation|46.0|46.0|||
3810117|NCT01778127|3636255|B4|||Pushup|This measure assessed the number of push-ups done in 30 seconds.|push-ups|Mean|11.9|11.9|Standard Deviation|6.6|6.6|||
3810118|NCT01778127|3636256|B3|||Pushup|This measure assessed the number of push-ups done in 30 seconds.|push-ups|Mean|12.4|12.4|Standard Deviation|7.5|7.5|||
3810119|NCT01778127|3636257|B2|||Pushup|This measure assessed the number of push-ups done in 30 seconds.|push-ups|Mean|13.3|13.3|Standard Deviation|5.9|5.9|||
3810120|NCT01778127|3636258|B1|||Pushup|This measure assessed the number of push-ups done in 30 seconds.|push-ups|Mean|9.6|9.6|Standard Deviation|6.6|6.6|||
3810121|NCT01778127|3636255|B4|||Sit-up|This measure assessed the number of sit-ups done in 30 seconds.|sit-ups|Mean|15.2|15.2|Standard Deviation|5.8|5.8|||
3810122|NCT01778127|3636256|B3|||Sit-up|This measure assessed the number of sit-ups done in 30 seconds.|sit-ups|Mean|16.2|16.2|Standard Deviation|6.2|6.2|||
3810123|NCT01778127|3636257|B2|||Sit-up|This measure assessed the number of sit-ups done in 30 seconds.|sit-ups|Mean|15.2|15.2|Standard Deviation|6.1|6.1|||
3810124|NCT01778127|3636258|B1|||Sit-up|This measure assessed the number of sit-ups done in 30 seconds.|sit-ups|Mean|14.3|14.3|Standard Deviation|5.1|5.1|||
3810125|NCT01778127|3636255|B4|||Hand grip|Hand grip is a measure of how much muscle power a person can generate gripping an object.|kg|Mean|20.7|20.7|Standard Deviation|6.3|6.3|||
3810126|NCT01778127|3636256|B3|||Hand grip|Hand grip is a measure of how much muscle power a person can generate gripping an object.|kg|Mean|22.5|22.5|Standard Deviation|7.1|7.1|||
3810127|NCT01778127|3636257|B2|||Hand grip|Hand grip is a measure of how much muscle power a person can generate gripping an object.|kg|Mean|19.0|19.0|Standard Deviation|5.6|5.6|||
3810128|NCT01778127|3636258|B1|||Hand grip|Hand grip is a measure of how much muscle power a person can generate gripping an object.|kg|Mean|20.9|20.9|Standard Deviation|6.3|6.3|||
3810129|NCT01778127|3636255|B4|||Active dorsiflexion|Active dorsiflexion is a measure of ankle flexibility.|degrees|Mean|13.7|13.7|Standard Deviation|8.1|8.1|||
3810130|NCT01778127|3636256|B3|||Active dorsiflexion|Active dorsiflexion is a measure of ankle flexibility.|degrees|Mean|14.3|14.3|Standard Deviation|8.6|8.6|||
3810131|NCT01778127|3636257|B2|||Active dorsiflexion|Active dorsiflexion is a measure of ankle flexibility.|degrees|Mean|13.6|13.6|Standard Deviation|8.1|8.1|||
3810132|NCT01778127|3636258|B1|||Active dorsiflexion|Active dorsiflexion is a measure of ankle flexibility.|degrees|Mean|13.1|13.1|Standard Deviation|7.6|7.6|||
3810133|NCT01778127|3636255|B4|||Sit and reach|Sit and reach is a measure of low back and hamstring flexibility.|cm|Mean|21.1|21.1|Standard Deviation|9.7|9.7|||
3810134|NCT01778127|3636256|B3|||Sit and reach|Sit and reach is a measure of low back and hamstring flexibility.|cm|Mean|22.2|22.2|Standard Deviation|10.4|10.4|||
3810135|NCT01778127|3636257|B2|||Sit and reach|Sit and reach is a measure of low back and hamstring flexibility.|cm|Mean|19.6|19.6|Standard Deviation|9.8|9.8|||
3810136|NCT01778127|3636258|B1|||Sit and reach|Sit and reach is a measure of low back and hamstring flexibility.|cm|Mean|21.7|21.7|Standard Deviation|8.9|8.9|||
3810137|NCT01778127|3636255|B4|||Peak VO2|Peak VO2 is a measure of exercise capacity: volume of oxygen uptake per minute adjusted for weight.|ml/kg/min|Mean|30.4|30.4|Standard Deviation|7.5|7.5|||
3810138|NCT01778127|3636256|B3|||Peak VO2|Peak VO2 is a measure of exercise capacity: volume of oxygen uptake per minute adjusted for weight.|ml/kg/min|Mean|31.2|31.2|Standard Deviation|6.6|6.6|||
3810139|NCT01778127|3636257|B2|||Peak VO2|Peak VO2 is a measure of exercise capacity: volume of oxygen uptake per minute adjusted for weight.|ml/kg/min|Mean|30.0|30.0|Standard Deviation|7.8|7.8|||
3810140|NCT01778127|3636258|B1|||Peak VO2|Peak VO2 is a measure of exercise capacity: volume of oxygen uptake per minute adjusted for weight.|ml/kg/min|Mean|30.0|30.0|Standard Deviation|7.9|7.9|||
3810141|NCT01778127|3636255|B4|Diastolic||Blood pressure (BP)||mmHG|Mean|67.5|67.5|Standard Deviation|7.9|7.9|||
3810142|NCT01778127|3636256|B3|Diastolic||Blood pressure (BP)||mmHG|Mean|68.5|68.5|Standard Deviation|9.3|9.3|||
3810143|NCT01778127|3636257|B2|Diastolic||Blood pressure (BP)||mmHG|Mean|66.2|66.2|Standard Deviation|7.2|7.2|||
3810144|NCT01778127|3636258|B1|Diastolic||Blood pressure (BP)||mmHG|Mean|68.2|68.2|Standard Deviation|7.3|7.3|||
3810145|NCT01778127|3636255|B4|Systolic||Blood pressure (BP)||mmHG|Mean|115.4|115.4|Standard Deviation|10.3|10.3|||
3810146|NCT01778127|3636256|B3|Systolic||Blood pressure (BP)||mmHG|Mean|117.6|117.6|Standard Deviation|11.2|11.2|||
3810147|NCT01778127|3636257|B2|Systolic||Blood pressure (BP)||mmHG|Mean|113.5|113.5|Standard Deviation|9.9|9.9|||
3810148|NCT01778127|3636258|B1|Systolic||Blood pressure (BP)||mmHG|Mean|115.6|115.6|Standard Deviation|9.8|9.8|||
3810149|NCT01778127|3636255|B4|||Resting respiratory rate (RR)||breaths/minute|Mean|18.9|18.9|Standard Deviation|1.4|1.4|||
3810150|NCT01778127|3636256|B3|||Resting respiratory rate (RR)||breaths/minute|Mean|18.4|18.4|Standard Deviation|1.7|1.7|||
3810151|NCT01778127|3636257|B2|||Resting respiratory rate (RR)||breaths/minute|Mean|19.0|19.0|Standard Deviation|1.3|1.3|||
3810152|NCT01778127|3636258|B1|||Resting respiratory rate (RR)||breaths/minute|Mean|19.2|19.2|Standard Deviation|1.1|1.1|||
3810153|NCT01778127|3636255|B4|||Resting heart rate (HR)||beats/minute|Mean|81.5|81.5|Standard Deviation|13.6|13.6|||
3810154|NCT01778127|3636256|B3|||Resting heart rate (HR)||beats/minute|Mean|81.5|81.5|Standard Deviation|14.9|14.9|||
3810155|NCT01778127|3636257|B2|||Resting heart rate (HR)||beats/minute|Mean|80.4|80.4|Standard Deviation|14.5|14.5|||
3810156|NCT01778127|3636258|B1|||Resting heart rate (HR)||beats/minute|Mean|82.8|82.8|Standard Deviation|11.2|11.2|||
3810157|NCT01778127|3636255|B4|||Body mass index (BMI)||kg/m^2|Mean|23.4|23.4|Standard Deviation|6.1|6.1|||
3810158|NCT01778127|3636256|B3|||Body mass index (BMI)||kg/m^2|Mean|22.8|22.8|Standard Deviation|5.5|5.5|||
3810159|NCT01778127|3636257|B2|||Body mass index (BMI)||kg/m^2|Mean|22.6|22.6|Standard Deviation|6.3|6.3|||
3810160|NCT01778127|3636258|B1|||Body mass index (BMI)||kg/m^2|Mean|25.0|25.0|Standard Deviation|6.6|6.6|||
3810161|NCT01778127|3636255|B4|||Daily Moderate to Vigorous Physical Activity (MVPA)||minutes|Mean|29.0|29.0|Standard Deviation|18.2|18.2|||
3810162|NCT01778127|3636256|B3|||Daily Moderate to Vigorous Physical Activity (MVPA)||minutes|Mean|32.3|32.3|Standard Deviation|22.6|22.6|||
3810163|NCT01778127|3636257|B2|||Daily Moderate to Vigorous Physical Activity (MVPA)||minutes|Mean|28.0|28.0|Standard Deviation|16.6|16.6|||
3810164|NCT01778127|3636258|B1|||Daily Moderate to Vigorous Physical Activity (MVPA)||minutes|Mean|26.8|26.8|Standard Deviation|15.7|15.7|||
3810165|NCT01778127|3636255|B4|Other Solid Tumor||Diagnosis||participants|Number|24|24.0||||||
3810166|NCT01778127|3636256|B3|Other Solid Tumor||Diagnosis||participants|Number|9|9.0||||||
3810167|NCT01778127|3636257|B2|Other Solid Tumor||Diagnosis||participants|Number|10|10.0||||||
3810169|NCT01778127|3636255|B4|Retinoblastoma||Diagnosis||participants|Number|13|13.0||||||
3810170|NCT01778127|3636256|B3|Retinoblastoma||Diagnosis||participants|Number|2|2.0||||||
3810171|NCT01778127|3636257|B2|Retinoblastoma||Diagnosis||participants|Number|5|5.0||||||
3810172|NCT01778127|3636258|B1|Retinoblastoma||Diagnosis||participants|Number|6|6.0||||||
3810173|NCT01778127|3636255|B4|Lymphoma||Diagnosis||participants|Number|8|8.0||||||
3810174|NCT01778127|3636256|B3|Lymphoma||Diagnosis||participants|Number|4|4.0||||||
3810175|NCT01778127|3636257|B2|Lymphoma||Diagnosis||participants|Number|2|2.0||||||
3810176|NCT01778127|3636258|B1|Lymphoma||Diagnosis||participants|Number|2|2.0||||||
3810177|NCT01778127|3636255|B4|Central Nervous System Tumor||Diagnosis||participants|Number|18|18.0||||||
3810178|NCT01778127|3636256|B3|Central Nervous System Tumor||Diagnosis||participants|Number|4|4.0||||||
3810179|NCT01778127|3636257|B2|Central Nervous System Tumor||Diagnosis||participants|Number|7|7.0||||||
3810180|NCT01778127|3636258|B1|Central Nervous System Tumor||Diagnosis||participants|Number|7|7.0||||||
3810181|NCT01778127|3636255|B4|Leukemia||Diagnosis||participants|Number|19|19.0||||||
3810182|NCT01778127|3636256|B3|Leukemia||Diagnosis||participants|Number|7|7.0||||||
3810183|NCT01778127|3636257|B2|Leukemia||Diagnosis||participants|Number|7|7.0||||||
3810184|NCT01778127|3636258|B1|Leukemia||Diagnosis||participants|Number|5|5.0||||||
3810185|NCT01778127|3636255|B4|White||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
3810186|NCT01778127|3636256|B3|White||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3810187|NCT01778127|3636257|B2|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3810188|NCT01778127|3636258|B1|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3810189|NCT01778127|3636255|B4|Non-White||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3810190|NCT01778127|3636256|B3|Non-White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3810191|NCT01778127|3636257|B2|Non-White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3810192|NCT01778127|3636258|B1|Non-White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3810193|NCT01778127|3636255|B4||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3810194|NCT01778127|3636256|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3810195|NCT01778127|3636257|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3810196|NCT01778127|3636258|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3810197|NCT01778127|3636255|B4||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3810198|NCT01778127|3636256|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3810199|NCT01778127|3636257|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3810200|NCT01778127|3636258|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3810201|NCT01778127|3636255|B4|Time since diagnosis||Age, Customized||years|Mean|9.2|9.2|Standard Deviation|2.9|2.9|||
3810202|NCT01778127|3636256|B3|Time since diagnosis||Age, Customized||years|Mean|9.0|9.0|Standard Deviation|2.7|2.7|||
3810203|NCT01778127|3636257|B2|Time since diagnosis||Age, Customized||years|Mean|8.6|8.6|Standard Deviation|3.1|3.1|||
3810204|NCT01778127|3636258|B1|Time since diagnosis||Age, Customized||years|Mean|10.0|10.0|Standard Deviation|3.0|3.0|||
3810205|NCT01778127|3636255|B4|Age at diagnosis||Age, Customized||years|Mean|3.6|3.6|Standard Deviation|2.9|2.9|||
3810206|NCT01778127|3636256|B3|Age at diagnosis||Age, Customized||years|Mean|3.6|3.6|Standard Deviation|2.5|2.5|||
3810207|NCT01778127|3636257|B2|Age at diagnosis||Age, Customized||years|Mean|4.2|4.2|Standard Deviation|3.0|3.0|||
3810208|NCT01778127|3636258|B1|Age at diagnosis||Age, Customized||years|Mean|3.0|3.0|Standard Deviation|3.1|3.1|||
3810209|NCT01778127|3636255|B4|||Age||years|Mean|12.8|12.8|Standard Deviation|1.1|1.1|||
3810210|NCT01778127|3636256|B3|||Age||years|Mean|12.6|12.6|Standard Deviation|1.2|1.2|||
3810211|NCT01778127|3636257|B2|||Age||years|Mean|12.8|12.8|Standard Deviation|0.9|0.9|||
3810212|NCT01778127|3636258|B1|||Age||years|Mean|13.0|13.0|Standard Deviation|1.2|1.2|||
3810213|NCT01778062|3636301|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3810214|NCT01778062|3636302|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3810215|NCT01778062|3636303|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3810216|NCT01778062|3636301|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3810217|NCT01778062|3636302|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3810218|NCT01778062|3636303|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3810219|NCT01778062|3636301|B3|||Age||Years|Mean|64.29|64.29|Standard Deviation|10.06|10.06|||
3810220|NCT01778062|3636302|B2|||Age||Years|Mean|64.62|64.62|Standard Deviation|9.20|9.2|||
3810221|NCT01778062|3636303|B1|||Age||Years|Mean|63.96|63.96|Standard Deviation|10.90|10.9|||
3810222|NCT01778049|3636316|B3||Male|Sex: Female, Male||Participants|Count of Participants|400|400.0||||||
3810223|NCT01778049|3636317|B2||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
3810224|NCT01778049|3636318|B1||Male|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
3810225|NCT01778049|3636316|B3||Female|Sex: Female, Male||Participants|Count of Participants|306|306.0||||||
3810226|NCT01778049|3636317|B2||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3810227|NCT01778049|3636318|B1||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3810228|NCT01778049|3636316|B3|||Age||Years|Mean|56.8|56.8|Standard Deviation|9.8|9.8|||
3810229|NCT01778049|3636317|B2|||Age||Years|Mean|56.7|56.7|Standard Deviation|9.9|9.9|||
3810230|NCT01778049|3636318|B1|||Age||Years|Mean|57.0|57.0|Standard Deviation|9.6|9.6|||
3810281|NCT01777854|3636436|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3810231|NCT01778023|3636339|B3|||Height|N=32, 15 due to missing baseline values for this characteristics.|cm|Mean|107.1|107.1|Standard Deviation|8.3|8.3|||
3810232|NCT01778023|3636340|B2|||Height|N=32, 15 due to missing baseline values for this characteristics.|cm|Mean|105.8|105.8|Standard Deviation|7.5|7.5|||
3810233|NCT01778023|3636341|B1|||Height|N=32, 15 due to missing baseline values for this characteristics.|cm|Mean|107.7|107.7|Standard Deviation|8.7|8.7|||
3810234|NCT01778023|3636339|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3810235|NCT01778023|3636340|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3810236|NCT01778023|3636341|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3810237|NCT01778023|3636339|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3810238|NCT01778023|3636340|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3810239|NCT01778023|3636341|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3810240|NCT01778023|3636339|B3|||Age||years|Mean|6.2|6.2|Standard Deviation|1.5|1.5|||
3810241|NCT01778023|3636340|B2|||Age||years|Mean|5.9|5.9|Standard Deviation|1.2|1.2|||
3810242|NCT01778023|3636341|B1|||Age||years|Mean|6.3|6.3|Standard Deviation|1.5|1.5|||
3810243|NCT01778010|3636359|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3810244|NCT01778010|3636359|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3810245|NCT01778010|3636359|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3810246|NCT01778010|3636359|B1|||Age||years|Mean|38.5|38.5|Standard Deviation|2.8|2.8|||
3810247|NCT01778010|3636359|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3810248|NCT01778010|3636359|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3810249|NCT01778010|3636359|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3810250|NCT01777997|3636400|B1|||Quality of life (QoL) index|"QoL index was obtained by averaging the five responses on the Euro-Quality of Life questionnaire (EQ-5D), where a response of 0 indicates no problems/no discomfort, 1 indicates some problems/moderate discomfort and 2 indicates unable to perform activities/extreme discomfort. Baseline QoL index is the mean of the two averages obtained prior to the start of ART (study entry and study week 12)."|units on a scale|Median|0.2|0.2|Inter-Quartile Range|||0.1|0.3|
3810251|NCT01777997|3636400|B1|||D-dimer|Baseline D-dimer is the mean of the two log10-transformed measurements obtained prior to the start of ART (study entry and study week 12).|log10(ng/mL)|Median|2.58|2.58|Inter-Quartile Range|||2.39|2.82|
3810252|NCT01777997|3636400|B1|||Interleukin (IL)-6|Baseline IL-6 is the mean of the two log10-transformed measurements obtained prior to the start of ART (study entry and study week 12).|log10(pg/mL)|Median|0.17|0.17|Inter-Quartile Range|||0.08|0.38|
3810253|NCT01777997|3636400|B1|||Percentage of CD4+ T-cells that are CD38+HLA-DR+|Baseline CD4+ T-cell activation is the mean of the two measurements obtained prior to the start of ART (study entry and study week 12).|% of CD4+ T-cells|Median|2.6|2.6|Inter-Quartile Range|||2.2|4.1|
3810254|NCT01777997|3636400|B1|||Percentage of CD8+ T-cells that are CD38+HLA-DR+|Baseline CD8+ T-cell activation is the mean of the two measurements obtained prior to the start of ART (study entry and study week 12).|% of CD8+ T-cells|Median|24.6|24.6|Inter-Quartile Range|||19.6|33.4|
3810255|NCT01777997|3636400|B1|Week 0 on ART (study week 12)|>=40 copies/mL|HIV-1 RNA by Abbott Assay||Participants|Count of Participants|22|22.0||||||
3810256|NCT01777997|3636400|B1|Week 0 on ART (study week 12)|<40 copies/mL|HIV-1 RNA by Abbott Assay||Participants|Count of Participants|13|13.0||||||
3810257|NCT01777997|3636400|B1|Pre-ART (study entry)|>=40 copies/mL|HIV-1 RNA by Abbott Assay||Participants|Count of Participants|19|19.0||||||
3810258|NCT01777997|3636400|B1|Pre-ART (study entry)|<40 copies/mL|HIV-1 RNA by Abbott Assay||Participants|Count of Participants|16|16.0||||||
3810259|NCT01777997|3636400|B1|||CD4+ T-cell count|Baseline CD4+ T-cell count is the mean of the two measurements obtained prior to the start of ART (study entry and study week 12).|cells/mm^3|Median|682|682.0|Inter-Quartile Range|||564.0|1003.0|
3810260|NCT01777997|3636400|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3810261|NCT01777997|3636400|B1|Hispanic (regardless of race)||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3810262|NCT01777997|3636400|B1|Black non-Hispanic||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3810263|NCT01777997|3636400|B1|White non-Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3810264|NCT01777997|3636400|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3810265|NCT01777997|3636400|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3810266|NCT01777997|3636400|B1|||Age||years|Median|47|47.0|Inter-Quartile Range|||32.0|54.0|
3810267|NCT01777945|3636412|B1|Hungary||Region of Enrollment||participants|Number|45|45.0||||||
3810268|NCT01777945|3636412|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3810269|NCT01777945|3636412|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3810270|NCT01777945|3636412|B1|||Age||years|Mean|58.58|58.58|Standard Deviation|11.359|11.359|||
3810271|NCT01777945|3636412|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3810272|NCT01777945|3636412|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3810273|NCT01777945|3636412|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3810274|NCT01777932|3636422|B1|Missing/unknown||Sex/Gender, Customized||participants|Number|1|1.0||||||
3810275|NCT01777932|3636422|B1|Male||Sex/Gender, Customized||participants|Number|1|1.0||||||
3810276|NCT01777932|3636422|B1|Female||Sex/Gender, Customized||participants|Number|218|218.0||||||
3810277|NCT01777932|3636422|B1||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
3810278|NCT01777932|3636422|B1||Between 18 and 65 years|Age||Participants|Count of Participants|187|187.0||||||
3810279|NCT01777932|3636422|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3810280|NCT01777854|3636436|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3810282|NCT01777854|3636436|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3810283|NCT01777854|3636436|B1|||Age||years|Mean|14|14.0|Full Range|||7.0|17.0|
3810284|NCT01777854|3636436|B1||>=65 years|Age|between 7 and 18|Participants|Count of Participants|0|0.0||||||
3810285|NCT01777854|3636436|B1||Between 18 and 65 years|Age|between 7 and 18|Participants|Count of Participants|0|0.0||||||
3810286|NCT01777854|3636436|B1||<=18 years|Age|between 7 and 18|Participants|Count of Participants|6|6.0||||||
3810287|NCT01777776|3636441|B5|2||WHO/ECOG performance status|"Categories:~0 - Fully active, able to carry on all pre-disease performance without restriction~1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~2 - Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~3 - Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~4 - Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|participants|Number|1|1.0||||||
3810288|NCT01777776|3636442|B4|2||WHO/ECOG performance status|"Categories:~0 - Fully active, able to carry on all pre-disease performance without restriction~1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~2 - Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~3 - Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~4 - Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|participants|Number|0|0.0||||||
3810289|NCT01777776|3636443|B3|2||WHO/ECOG performance status|"Categories:~0 - Fully active, able to carry on all pre-disease performance without restriction~1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~2 - Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~3 - Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~4 - Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|participants|Number|0|0.0||||||
3810290|NCT01777776|3636444|B2|2||WHO/ECOG performance status|"Categories:~0 - Fully active, able to carry on all pre-disease performance without restriction~1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~2 - Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~3 - Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~4 - Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|participants|Number|1|1.0||||||
3810291|NCT01777776|3636445|B1|2||WHO/ECOG performance status|"Categories:~0 - Fully active, able to carry on all pre-disease performance without restriction~1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~2 - Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~3 - Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~4 - Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|participants|Number|0|0.0||||||
3810292|NCT01777776|3636441|B5|1||WHO/ECOG performance status|"Categories:~0 - Fully active, able to carry on all pre-disease performance without restriction~1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~2 - Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~3 - Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~4 - Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|participants|Number|19|19.0||||||
3810293|NCT01777776|3636442|B4|1||WHO/ECOG performance status|"Categories:~0 - Fully active, able to carry on all pre-disease performance without restriction~1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~2 - Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~3 - Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~4 - Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|participants|Number|3|3.0||||||
3810294|NCT01777776|3636443|B3|1||WHO/ECOG performance status|"Categories:~0 - Fully active, able to carry on all pre-disease performance without restriction~1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~2 - Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~3 - Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~4 - Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|participants|Number|5|5.0||||||
3810295|NCT01777776|3636444|B2|1||WHO/ECOG performance status|"Categories:~0 - Fully active, able to carry on all pre-disease performance without restriction~1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~2 - Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~3 - Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~4 - Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|participants|Number|7|7.0||||||
3810296|NCT01777776|3636445|B1|1||WHO/ECOG performance status|"Categories:~0 - Fully active, able to carry on all pre-disease performance without restriction~1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~2 - Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~3 - Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~4 - Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|participants|Number|4|4.0||||||
3810338|NCT01777763|3636506|B2||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3810339|NCT01777763|3636507|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3810340|NCT01777763|3636505|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3810341|NCT01777763|3636506|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3810297|NCT01777776|3636441|B5|0||WHO/ECOG performance status|"Categories:~0 - Fully active, able to carry on all pre-disease performance without restriction~1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~2 - Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~3 - Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~4 - Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|participants|Number|8|8.0||||||
3810298|NCT01777776|3636442|B4|0||WHO/ECOG performance status|"Categories:~0 - Fully active, able to carry on all pre-disease performance without restriction~1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~2 - Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~3 - Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~4 - Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|participants|Number|1|1.0||||||
3810299|NCT01777776|3636443|B3|0||WHO/ECOG performance status|"Categories:~0 - Fully active, able to carry on all pre-disease performance without restriction~1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~2 - Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~3 - Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~4 - Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|participants|Number|1|1.0||||||
3810300|NCT01777776|3636444|B2|0||WHO/ECOG performance status|"Categories:~0 - Fully active, able to carry on all pre-disease performance without restriction~1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~2 - Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~3 - Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~4 - Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|participants|Number|4|4.0||||||
3810301|NCT01777776|3636445|B1|0||WHO/ECOG performance status|"Categories:~0 - Fully active, able to carry on all pre-disease performance without restriction~1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~2 - Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~3 - Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~4 - Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|participants|Number|2|2.0||||||
3810302|NCT01777776|3636441|B5|||Weight||kilograms|Mean|79.44|79.44|Standard Deviation|14.450|14.45|||
3810303|NCT01777776|3636442|B4|||Weight||kilograms|Mean|74.70|74.7|Standard Deviation|16.415|16.415|||
3810304|NCT01777776|3636443|B3|||Weight||kilograms|Mean|80.17|80.17|Standard Deviation|10.308|10.308|||
3810305|NCT01777776|3636444|B2|||Weight||kilograms|Mean|78.08|78.08|Standard Deviation|17.069|17.069|||
3810306|NCT01777776|3636445|B1|||Weight||kilograms|Mean|84.60|84.6|Standard Deviation|12.793|12.793|||
3810307|NCT01777776|3636441|B5||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3810308|NCT01777776|3636442|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3810309|NCT01777776|3636443|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3810310|NCT01777776|3636444|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3810311|NCT01777776|3636445|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3810312|NCT01777776|3636441|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3810313|NCT01777776|3636442|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3810314|NCT01777776|3636443|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3810315|NCT01777776|3636444|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3810316|NCT01777776|3636445|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3810317|NCT01777776|3636441|B5|||Age||years|Mean|56.6|56.6|Standard Deviation|13.90|13.9|||
3810318|NCT01777776|3636442|B4|||Age||years|Mean|62.0|62.0|Standard Deviation|17.63|17.63|||
3810319|NCT01777776|3636443|B3|||Age||years|Mean|58.0|58.0|Standard Deviation|10.55|10.55|||
3810320|NCT01777776|3636444|B2|||Age||years|Mean|49.8|49.8|Standard Deviation|13.66|13.66|||
3810321|NCT01777776|3636445|B1|||Age||years|Mean|65.0|65.0|Standard Deviation|10.71|10.71|||
3810322|NCT01777776|3636441|B5||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3810323|NCT01777776|3636442|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3810324|NCT01777776|3636443|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3810325|NCT01777776|3636444|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3810326|NCT01777776|3636445|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3810327|NCT01777776|3636441|B5||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3810328|NCT01777776|3636442|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3810329|NCT01777776|3636443|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3810330|NCT01777776|3636444|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3810331|NCT01777776|3636445|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3810332|NCT01777776|3636441|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3810333|NCT01777776|3636442|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3810334|NCT01777776|3636443|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3810335|NCT01777776|3636444|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3810336|NCT01777776|3636445|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3810337|NCT01777763|3636505|B3||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3810342|NCT01777763|3636507|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3810343|NCT01777763|3636505|B3|||Age||years|Mean|51.0|51.0|Standard Deviation|14.0|14.0|||
3810344|NCT01777763|3636506|B2|||Age||years|Mean|51.0|51.0|Standard Deviation|14.1|14.1|||
3810345|NCT01777763|3636507|B1|||Age||years|Mean|51.0|51.0|Standard Deviation|13.2|13.2|||
3810346|NCT01777620|3636530|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3810347|NCT01777620|3636531|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3810348|NCT01777620|3636532|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3810349|NCT01777620|3636530|B3||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3810350|NCT01777620|3636531|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3810351|NCT01777620|3636532|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3810352|NCT01777620|3636530|B3|45 – 65 years||Age, Customized||Participants|Number|68|68.0||||||
3810353|NCT01777620|3636531|B2|45 – 65 years||Age, Customized||Participants|Number|33|33.0||||||
3810354|NCT01777620|3636532|B1|45 – 65 years||Age, Customized||Participants|Number|35|35.0||||||
3810355|NCT01777620|3636530|B3|< 45 years||Age, Customized||Participants|Number|49|49.0||||||
3810356|NCT01777620|3636531|B2|< 45 years||Age, Customized||Participants|Number|24|24.0||||||
3810357|NCT01777620|3636532|B1|< 45 years||Age, Customized||Participants|Number|25|25.0||||||
3810358|NCT01777581|3636557|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3810359|NCT01777581|3636558|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3810360|NCT01777581|3636559|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3810361|NCT01777581|3636557|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3810362|NCT01777581|3636558|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3810363|NCT01777581|3636559|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3810364|NCT01777581|3636557|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3810365|NCT01777581|3636558|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3810366|NCT01777581|3636559|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3810367|NCT01777581|3636557|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3810368|NCT01777581|3636558|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3810369|NCT01777581|3636559|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3810370|NCT01777581|3636557|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3810371|NCT01777581|3636558|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3810372|NCT01777581|3636559|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3810373|NCT01777581|3636557|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3810374|NCT01777581|3636558|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3810375|NCT01777581|3636559|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3810376|NCT01777542|3636578|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3810377|NCT01777542|3636578|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3810378|NCT01777542|3636578|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3810379|NCT01777542|3636578|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3810380|NCT01777542|3636578|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3810381|NCT01777542|3636578|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3810382|NCT01777542|3636578|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3810383|NCT01777542|3636578|B1||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
3810384|NCT01777438|3636618|B3|Belgium||Region of Enrollment||participants|Number|434|434.0||||||
3810385|NCT01777438|3636619|B2|Belgium||Region of Enrollment||participants|Number|82|82.0||||||
3810386|NCT01777438|3636620|B1|Belgium||Region of Enrollment||participants|Number|352|352.0||||||
3810387|NCT01777438|3636618|B3||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
3810388|NCT01777438|3636619|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3810389|NCT01777438|3636620|B1||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3810390|NCT01777438|3636618|B3||Female|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
3810391|NCT01777438|3636619|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3810392|NCT01777438|3636620|B1||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3810393|NCT01777438|3636618|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3810394|NCT01777438|3636619|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3810395|NCT01777438|3636620|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3810396|NCT01777438|3636618|B3||Between 18 and 65 years|Age||Participants|Count of Participants|434|434.0||||||
3810397|NCT01777438|3636619|B2||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
3810398|NCT01777438|3636620|B1||Between 18 and 65 years|Age||Participants|Count of Participants|352|352.0||||||
3810399|NCT01777438|3636618|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3810400|NCT01777438|3636619|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3810401|NCT01777438|3636620|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3810402|NCT01777425|3636633|B1|Belgium||Region of Enrollment||participants|Number|389|389.0||||||
3810403|NCT01777425|3636633|B1||Male|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
3810404|NCT01777425|3636633|B1||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3810405|NCT01777425|3636633|B1|||Age||years|Mean|47.3|47.3|Standard Deviation|14.1|14.1|||
3810406|NCT01777425|3636633|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3810407|NCT01777425|3636633|B1||Between 18 and 65 years|Age||Participants|Count of Participants|389|389.0||||||
3810408|NCT01777425|3636633|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3810409|NCT01777412|3636639|B1|Negative||Anti-AQP4 antibody serostatus||participants|Number|4|4.0||||||
3810410|NCT01777412|3636639|B1|Positive||Anti-AQP4 antibody serostatus||participants|Number|6|6.0||||||
3810411|NCT01777412|3636639|B1|High risk for NMO||Diagnosis||participants|Number|3|3.0||||||
3810412|NCT01777412|3636639|B1|NMO/NMOSD||Diagnosis||participants|Number|7|7.0||||||
3810413|NCT01777412|3636639|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810414|NCT01777412|3636639|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810415|NCT01777412|3636639|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3810416|NCT01777412|3636639|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3810417|NCT01777412|3636639|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810418|NCT01777412|3636639|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3810419|NCT01777412|3636639|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810420|NCT01777412|3636639|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3810421|NCT01777412|3636639|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3810422|NCT01777412|3636639|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|15.5|15.5|||
3810423|NCT01777334|3636645|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3810424|NCT01777334|3636646|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3810425|NCT01777334|3636647|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3810426|NCT01777334|3636645|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3810427|NCT01777334|3636646|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3810428|NCT01777334|3636647|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3810429|NCT01777334|3636645|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3810430|NCT01777334|3636646|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3810431|NCT01777334|3636647|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3810432|NCT01777334|3636645|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
3810433|NCT01777334|3636646|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3810434|NCT01777334|3636647|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
3810435|NCT01777334|3636645|B3|White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|880|880.0||||||
3810436|NCT01777334|3636646|B2|White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|442|442.0||||||
3810437|NCT01777334|3636647|B1|White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|438|438.0||||||
3810438|NCT01777334|3636645|B3||Male|Sex: Female, Male||Participants|Count of Participants|613|613.0||||||
3810439|NCT01777334|3636646|B2||Male|Sex: Female, Male||Participants|Count of Participants|303|303.0||||||
3810440|NCT01777334|3636647|B1||Male|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
3810441|NCT01777334|3636645|B3||Female|Sex: Female, Male||Participants|Count of Participants|292|292.0||||||
3810442|NCT01777334|3636646|B2||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3810443|NCT01777334|3636647|B1||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3810444|NCT01777334|3636645|B3|||Age||Years|Mean|62.3|62.3|Standard Deviation|8.46|8.46|||
3810445|NCT01777334|3636646|B2|||Age||Years|Mean|62.7|62.7|Standard Deviation|8.50|8.5|||
3810446|NCT01777334|3636647|B1|||Age||Years|Mean|61.9|61.9|Standard Deviation|8.41|8.41|||
3810447|NCT01777321|3636656|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3810448|NCT01777321|3636657|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3810449|NCT01777321|3636658|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3810450|NCT01777321|3636656|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3810451|NCT01777321|3636657|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3810452|NCT01777321|3636658|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3810453|NCT01777321|3636656|B3|||Age||Years|Mean|61.90|61.9|Standard Deviation|7.65|7.65|||
3810454|NCT01777321|3636657|B2|||Age||Years|Mean|62.2|62.2|Standard Deviation|7.83|7.83|||
3810455|NCT01777321|3636658|B1|||Age||Years|Mean|61.6|61.6|Standard Deviation|7.59|7.59|||
3810456|NCT01777282|3636695|B6|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|374|374.0||||||
3810457|NCT01777282|3636696|B5|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|61|61.0||||||
3810458|NCT01777282|3636697|B4|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|61|61.0||||||
3810459|NCT01777282|3636698|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|65|65.0||||||
3810460|NCT01777282|3636699|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|67|67.0||||||
3810461|NCT01777282|3636700|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|120|120.0||||||
3810462|NCT01777282|3636695|B6||Male|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
3810463|NCT01777282|3636696|B5||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3810464|NCT01777282|3636697|B4||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3810465|NCT01777282|3636698|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3810466|NCT01777282|3636699|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3810467|NCT01777282|3636700|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3810468|NCT01777282|3636695|B6||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3810469|NCT01777282|3636696|B5||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3810470|NCT01777282|3636697|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3810471|NCT01777282|3636698|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3810472|NCT01777282|3636699|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3810473|NCT01777282|3636700|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3810474|NCT01777282|3636695|B6|||Age||Years|Mean|57.7|57.7|Standard Deviation|9.89|9.89|||
3810475|NCT01777282|3636696|B5|||Age||Years|Mean|57.4|57.4|Standard Deviation|10.47|10.47|||
3810476|NCT01777282|3636697|B4|||Age||Years|Mean|59.0|59.0|Standard Deviation|10.54|10.54|||
3810477|NCT01777282|3636698|B3|||Age||Years|Mean|55.7|55.7|Standard Deviation|11.07|11.07|||
3810478|NCT01777282|3636699|B2|||Age||Years|Mean|57.0|57.0|Standard Deviation|8.55|8.55|||
3810479|NCT01777282|3636700|B1|||Age||Years|Mean|58.5|58.5|Standard Deviation|9.19|9.19|||
3810480|NCT01777269|3636746|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3810481|NCT01777269|3636747|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3810482|NCT01777269|3636748|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3810483|NCT01777269|3636746|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|476|476.0||||||
3810484|NCT01777269|3636747|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|237|237.0||||||
3810485|NCT01777269|3636748|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|239|239.0||||||
3810486|NCT01777269|3636746|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3810487|NCT01777269|3636747|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3810488|NCT01777269|3636748|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3810489|NCT01777269|3636746|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3810490|NCT01777269|3636747|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3810491|NCT01777269|3636748|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3810492|NCT01777269|3636746|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3810493|NCT01777269|3636747|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3810494|NCT01777269|3636748|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3810495|NCT01777269|3636746|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3810496|NCT01777269|3636747|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3810497|NCT01777269|3636748|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3810498|NCT01777269|3636746|B3||Male|Sex: Female, Male||Participants|Count of Participants|489|489.0||||||
3810499|NCT01777269|3636747|B2||Male|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
3810500|NCT01777269|3636748|B1||Male|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
3810501|NCT01777269|3636746|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3810502|NCT01777269|3636747|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3810503|NCT01777269|3636748|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3810504|NCT01777269|3636746|B3|||Age||Years|Mean|65.5|65.5|Standard Deviation|6.53|6.53|||
3810505|NCT01777269|3636747|B2|||Age||Years|Mean|65.7|65.7|Standard Deviation|6.59|6.59|||
3810506|NCT01777269|3636748|B1|||Age||Years|Mean|65.4|65.4|Standard Deviation|6.49|6.49|||
3810507|NCT01777217|3636775|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3810508|NCT01777217|3636776|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3810509|NCT01777217|3636777|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3810510|NCT01777217|3636775|B3||Male|Sex: Female, Male|The participant population are all males|Participants|Count of Participants|8|8.0||||||
3810511|NCT01777217|3636776|B2||Male|Sex: Female, Male|The participant population are all males|Participants|Count of Participants|4|4.0||||||
3810512|NCT01777217|3636777|B1||Male|Sex: Female, Male|The participant population are all males|Participants|Count of Participants|4|4.0||||||
3810513|NCT01777217|3636775|B3||Female|Sex: Female, Male|The participant population are all males|Participants|Count of Participants|0|0.0||||||
3810514|NCT01777217|3636776|B2||Female|Sex: Female, Male|The participant population are all males|Participants|Count of Participants|0|0.0||||||
3810515|NCT01777217|3636777|B1||Female|Sex: Female, Male|The participant population are all males|Participants|Count of Participants|0|0.0||||||
3810516|NCT01777217|3636775|B3||>=65 years|Age|Participant population is >=50|Participants|Count of Participants|5|5.0||||||
3810517|NCT01777217|3636776|B2||>=65 years|Age|Participant population is >=50|Participants|Count of Participants|3|3.0||||||
3810518|NCT01777217|3636777|B1||>=65 years|Age|Participant population is >=50|Participants|Count of Participants|2|2.0||||||
3810519|NCT01777217|3636775|B3||Between 18 and 65 years|Age|Participant population is >=50|Participants|Count of Participants|3|3.0||||||
3810520|NCT01777217|3636776|B2||Between 18 and 65 years|Age|Participant population is >=50|Participants|Count of Participants|1|1.0||||||
3810521|NCT01777217|3636777|B1||Between 18 and 65 years|Age|Participant population is >=50|Participants|Count of Participants|2|2.0||||||
3810522|NCT01777217|3636775|B3||<=18 years|Age|Participant population is >=50|Participants|Count of Participants|0|0.0||||||
3810523|NCT01777217|3636776|B2||<=18 years|Age|Participant population is >=50|Participants|Count of Participants|0|0.0||||||
3810524|NCT01777217|3636777|B1||<=18 years|Age|Participant population is >=50|Participants|Count of Participants|0|0.0||||||
3810525|NCT01777217|3636775|B3|||Age||Years|Mean|65.25|65.25|Standard Deviation|7.61|7.61|||
3810526|NCT01777217|3636776|B2|||Age||Years|Mean|66|66.0|Standard Deviation|7.57|7.57|||
3810527|NCT01777217|3636777|B1|||Age||Years|Mean|64.5|64.5|Standard Deviation|8.74|8.74|||
3810528|NCT01777191|3636784|B3|I am confident my dose is complete (n=98,101)||Baseline in Subcutaneous Administration Assessment Questionnaire (SQAAQ)|"SQAAQ is a self-administered questionnaire which provides an assessment of ease of use and confidence with using a device to administer a subcutaneous injection of drug. Participants and injection assistants responded to questionnaire items using a 7-point Likert scale (from Strongly Disagree to Strongly Agree). 1 represents Strongly Disagree and 7 represents Strongly Agree."|units on a scale|Mean|6.6|6.6|Standard Deviation|0.99|0.99|||
3810529|NCT01777191|3636785|B2|I am confident my dose is complete (n=98,101)||Baseline in Subcutaneous Administration Assessment Questionnaire (SQAAQ)|"SQAAQ is a self-administered questionnaire which provides an assessment of ease of use and confidence with using a device to administer a subcutaneous injection of drug. Participants and injection assistants responded to questionnaire items using a 7-point Likert scale (from Strongly Disagree to Strongly Agree). 1 represents Strongly Disagree and 7 represents Strongly Agree."|units on a scale|Mean|6.7|6.7|Standard Deviation|0.89|0.89|||
3810530|NCT01777191|3636786|B1|I am confident my dose is complete (n=98,101)||Baseline in Subcutaneous Administration Assessment Questionnaire (SQAAQ)|"SQAAQ is a self-administered questionnaire which provides an assessment of ease of use and confidence with using a device to administer a subcutaneous injection of drug. Participants and injection assistants responded to questionnaire items using a 7-point Likert scale (from Strongly Disagree to Strongly Agree). 1 represents Strongly Disagree and 7 represents Strongly Agree."|units on a scale|Mean|6.6|6.6|Standard Deviation|1.09|1.09|||
3810531|NCT01777191|3636784|B3|Confident in ability to use the device (n=99, 101)||Baseline in Subcutaneous Administration Assessment Questionnaire (SQAAQ)|"SQAAQ is a self-administered questionnaire which provides an assessment of ease of use and confidence with using a device to administer a subcutaneous injection of drug. Participants and injection assistants responded to questionnaire items using a 7-point Likert scale (from Strongly Disagree to Strongly Agree). 1 represents Strongly Disagree and 7 represents Strongly Agree."|units on a scale|Mean|6.5|6.5|Standard Deviation|1.12|1.12|||
3810532|NCT01777191|3636785|B2|Confident in ability to use the device (n=99, 101)||Baseline in Subcutaneous Administration Assessment Questionnaire (SQAAQ)|"SQAAQ is a self-administered questionnaire which provides an assessment of ease of use and confidence with using a device to administer a subcutaneous injection of drug. Participants and injection assistants responded to questionnaire items using a 7-point Likert scale (from Strongly Disagree to Strongly Agree). 1 represents Strongly Disagree and 7 represents Strongly Agree."|units on a scale|Mean|6.7|6.7|Standard Deviation|1.06|1.06|||
3810533|NCT01777191|3636786|B1|Confident in ability to use the device (n=99, 101)||Baseline in Subcutaneous Administration Assessment Questionnaire (SQAAQ)|"SQAAQ is a self-administered questionnaire which provides an assessment of ease of use and confidence with using a device to administer a subcutaneous injection of drug. Participants and injection assistants responded to questionnaire items using a 7-point Likert scale (from Strongly Disagree to Strongly Agree). 1 represents Strongly Disagree and 7 represents Strongly Agree."|units on a scale|Mean|6.4|6.4|Standard Deviation|1.16|1.16|||
3810534|NCT01777191|3636784|B3|Device is stable during injection (n=99, 101)||Baseline in Subcutaneous Administration Assessment Questionnaire (SQAAQ)|"SQAAQ is a self-administered questionnaire which provides an assessment of ease of use and confidence with using a device to administer a subcutaneous injection of drug. Participants and injection assistants responded to questionnaire items using a 7-point Likert scale (from Strongly Disagree to Strongly Agree). 1 represents Strongly Disagree and 7 represents Strongly Agree."|units on a scale|Mean|6.5|6.5|Standard Deviation|1.12|1.12|||
3810535|NCT01777191|3636785|B2|Device is stable during injection (n=99, 101)||Baseline in Subcutaneous Administration Assessment Questionnaire (SQAAQ)|"SQAAQ is a self-administered questionnaire which provides an assessment of ease of use and confidence with using a device to administer a subcutaneous injection of drug. Participants and injection assistants responded to questionnaire items using a 7-point Likert scale (from Strongly Disagree to Strongly Agree). 1 represents Strongly Disagree and 7 represents Strongly Agree."|units on a scale|Mean|6.6|6.6|Standard Deviation|1.06|1.06|||
3810536|NCT01777191|3636786|B1|Device is stable during injection (n=99, 101)||Baseline in Subcutaneous Administration Assessment Questionnaire (SQAAQ)|"SQAAQ is a self-administered questionnaire which provides an assessment of ease of use and confidence with using a device to administer a subcutaneous injection of drug. Participants and injection assistants responded to questionnaire items using a 7-point Likert scale (from Strongly Disagree to Strongly Agree). 1 represents Strongly Disagree and 7 represents Strongly Agree."|units on a scale|Mean|6.3|6.3|Standard Deviation|1.18|1.18|||
3810537|NCT01777191|3636784|B3|Overall, easy to use (n=99,101)||Baseline in Subcutaneous Administration Assessment Questionnaire (SQAAQ)|"SQAAQ is a self-administered questionnaire which provides an assessment of ease of use and confidence with using a device to administer a subcutaneous injection of drug. Participants and injection assistants responded to questionnaire items using a 7-point Likert scale (from Strongly Disagree to Strongly Agree). 1 represents Strongly Disagree and 7 represents Strongly Agree."|units on a scale|Mean|6.5|6.5|Standard Deviation|1.05|1.05|||
3810583|NCT01777191|3636785|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810584|NCT01777191|3636786|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3810585|NCT01777191|3636784|B3||White|Race (NIH/OMB)||Participants|Count of Participants|177|177.0||||||
3810538|NCT01777191|3636785|B2|Overall, easy to use (n=99,101)||Baseline in Subcutaneous Administration Assessment Questionnaire (SQAAQ)|"SQAAQ is a self-administered questionnaire which provides an assessment of ease of use and confidence with using a device to administer a subcutaneous injection of drug. Participants and injection assistants responded to questionnaire items using a 7-point Likert scale (from Strongly Disagree to Strongly Agree). 1 represents Strongly Disagree and 7 represents Strongly Agree."|units on a scale|Mean|6.6|6.6|Standard Deviation|0.99|0.99|||
3810539|NCT01777191|3636786|B1|Overall, easy to use (n=99,101)||Baseline in Subcutaneous Administration Assessment Questionnaire (SQAAQ)|"SQAAQ is a self-administered questionnaire which provides an assessment of ease of use and confidence with using a device to administer a subcutaneous injection of drug. Participants and injection assistants responded to questionnaire items using a 7-point Likert scale (from Strongly Disagree to Strongly Agree). 1 represents Strongly Disagree and 7 represents Strongly Agree."|units on a scale|Mean|6.4|6.4|Standard Deviation|1.10|1.1|||
3810540|NCT01777191|3636784|B3|Easy to pick up (n=99, 100)||Baseline in Subcutaneous Administration Assessment Questionnaire (SQAAQ)|"SQAAQ is a self-administered questionnaire which provides an assessment of ease of use and confidence with using a device to administer a subcutaneous injection of drug. Participants and injection assistants responded to questionnaire items using a 7-point Likert scale (from Strongly Disagree to Strongly Agree). 1 represents Strongly Disagree and 7 represents Strongly Agree."|units on a scale|Mean|6.7|6.7|Standard Deviation|0.81|0.81|||
3810541|NCT01777191|3636785|B2|Easy to pick up (n=99, 100)||Baseline in Subcutaneous Administration Assessment Questionnaire (SQAAQ)|"SQAAQ is a self-administered questionnaire which provides an assessment of ease of use and confidence with using a device to administer a subcutaneous injection of drug. Participants and injection assistants responded to questionnaire items using a 7-point Likert scale (from Strongly Disagree to Strongly Agree). 1 represents Strongly Disagree and 7 represents Strongly Agree."|units on a scale|Mean|6.7|6.7|Standard Deviation|0.94|0.94|||
3810542|NCT01777191|3636786|B1|Easy to pick up (n=99, 100)||Baseline in Subcutaneous Administration Assessment Questionnaire (SQAAQ)|"SQAAQ is a self-administered questionnaire which provides an assessment of ease of use and confidence with using a device to administer a subcutaneous injection of drug. Participants and injection assistants responded to questionnaire items using a 7-point Likert scale (from Strongly Disagree to Strongly Agree). 1 represents Strongly Disagree and 7 represents Strongly Agree."|units on a scale|Mean|6.7|6.7|Standard Deviation|0.67|0.67|||
3810543|NCT01777191|3636784|B3|Easy to remove needle shield/cover (n=99, 100)||Baseline in Subcutaneous Administration Assessment Questionnaire (SQAAQ)|"SQAAQ is a self-administered questionnaire which provides an assessment of ease of use and confidence with using a device to administer a subcutaneous injection of drug. Participants and injection assistants responded to questionnaire items using a 7-point Likert scale (from Strongly Disagree to Strongly Agree). 1 represents Strongly Disagree and 7 represents Strongly Agree."|units on a scale|Mean|6.6|6.6|Standard Deviation|0.91|0.91|||
3810544|NCT01777191|3636785|B2|Easy to remove needle shield/cover (n=99, 100)||Baseline in Subcutaneous Administration Assessment Questionnaire (SQAAQ)|"SQAAQ is a self-administered questionnaire which provides an assessment of ease of use and confidence with using a device to administer a subcutaneous injection of drug. Participants and injection assistants responded to questionnaire items using a 7-point Likert scale (from Strongly Disagree to Strongly Agree). 1 represents Strongly Disagree and 7 represents Strongly Agree."|units on a scale|Mean|6.6|6.6|Standard Deviation|1.09|1.09|||
3810545|NCT01777191|3636786|B1|Easy to remove needle shield/cover (n=99, 100)||Baseline in Subcutaneous Administration Assessment Questionnaire (SQAAQ)|"SQAAQ is a self-administered questionnaire which provides an assessment of ease of use and confidence with using a device to administer a subcutaneous injection of drug. Participants and injection assistants responded to questionnaire items using a 7-point Likert scale (from Strongly Disagree to Strongly Agree). 1 represents Strongly Disagree and 7 represents Strongly Agree."|units on a scale|Mean|6.6|6.6|Standard Deviation|0.67|0.67|||
3810546|NCT01777191|3636784|B3|Easy to store device in refrigerator (n=94, 97)||Baseline in Subcutaneous Administration Assessment Questionnaire (SQAAQ)|"SQAAQ is a self-administered questionnaire which provides an assessment of ease of use and confidence with using a device to administer a subcutaneous injection of drug. Participants and injection assistants responded to questionnaire items using a 7-point Likert scale (from Strongly Disagree to Strongly Agree). 1 represents Strongly Disagree and 7 represents Strongly Agree."|units on a scale|Mean|6.5|6.5|Standard Deviation|0.94|0.94|||
3810547|NCT01777191|3636785|B2|Easy to store device in refrigerator (n=94, 97)||Baseline in Subcutaneous Administration Assessment Questionnaire (SQAAQ)|"SQAAQ is a self-administered questionnaire which provides an assessment of ease of use and confidence with using a device to administer a subcutaneous injection of drug. Participants and injection assistants responded to questionnaire items using a 7-point Likert scale (from Strongly Disagree to Strongly Agree). 1 represents Strongly Disagree and 7 represents Strongly Agree."|units on a scale|Mean|6.6|6.6|Standard Deviation|1.00|1.0|||
3810548|NCT01777191|3636786|B1|Easy to store device in refrigerator (n=94, 97)||Baseline in Subcutaneous Administration Assessment Questionnaire (SQAAQ)|"SQAAQ is a self-administered questionnaire which provides an assessment of ease of use and confidence with using a device to administer a subcutaneous injection of drug. Participants and injection assistants responded to questionnaire items using a 7-point Likert scale (from Strongly Disagree to Strongly Agree). 1 represents Strongly Disagree and 7 represents Strongly Agree."|units on a scale|Mean|6.5|6.5|Standard Deviation|0.88|0.88|||
3810549|NCT01777191|3636784|B3|Easy to know that my dose is complete (n=99,101)||Baseline in Subcutaneous Administration Assessment Questionnaire (SQAAQ)|"SQAAQ is a self-administered questionnaire which provides an assessment of ease of use and confidence with using a device to administer a subcutaneous injection of drug. Participants and injection assistants responded to questionnaire items using a 7-point Likert scale (from Strongly Disagree to Strongly Agree). 1 represents Strongly Disagree and 7 represents Strongly Agree."|units on a scale|Mean|6.6|6.6|Standard Deviation|1.07|1.07|||
3810586|NCT01777191|3636785|B2||White|Race (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3810587|NCT01777191|3636786|B1||White|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3810588|NCT01777191|3636784|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3810589|NCT01777191|3636785|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3810550|NCT01777191|3636785|B2|Easy to know that my dose is complete (n=99,101)||Baseline in Subcutaneous Administration Assessment Questionnaire (SQAAQ)|"SQAAQ is a self-administered questionnaire which provides an assessment of ease of use and confidence with using a device to administer a subcutaneous injection of drug. Participants and injection assistants responded to questionnaire items using a 7-point Likert scale (from Strongly Disagree to Strongly Agree). 1 represents Strongly Disagree and 7 represents Strongly Agree."|units on a scale|Mean|6.7|6.7|Standard Deviation|0.93|0.93|||
3810551|NCT01777191|3636786|B1|Easy to know that my dose is complete (n=99,101)||Baseline in Subcutaneous Administration Assessment Questionnaire (SQAAQ)|"SQAAQ is a self-administered questionnaire which provides an assessment of ease of use and confidence with using a device to administer a subcutaneous injection of drug. Participants and injection assistants responded to questionnaire items using a 7-point Likert scale (from Strongly Disagree to Strongly Agree). 1 represents Strongly Disagree and 7 represents Strongly Agree."|units on a scale|Mean|6.4|6.4|Standard Deviation|1.20|1.2|||
3810552|NCT01777191|3636784|B3|Easy to inject my dose (n=99,101)||Baseline in Subcutaneous Administration Assessment Questionnaire (SQAAQ)|"SQAAQ is a self-administered questionnaire which provides an assessment of ease of use and confidence with using a device to administer a subcutaneous injection of drug. Participants and injection assistants responded to questionnaire items using a 7-point Likert scale (from Strongly Disagree to Strongly Agree). 1 represents Strongly Disagree and 7 represents Strongly Agree."|units on a scale|Mean|6.4|6.4|Standard Deviation|1.18|1.18|||
3810553|NCT01777191|3636785|B2|Easy to inject my dose (n=99,101)||Baseline in Subcutaneous Administration Assessment Questionnaire (SQAAQ)|"SQAAQ is a self-administered questionnaire which provides an assessment of ease of use and confidence with using a device to administer a subcutaneous injection of drug. Participants and injection assistants responded to questionnaire items using a 7-point Likert scale (from Strongly Disagree to Strongly Agree). 1 represents Strongly Disagree and 7 represents Strongly Agree."|units on a scale|Mean|6.6|6.6|Standard Deviation|1.00|1.0|||
3810554|NCT01777191|3636786|B1|Easy to inject my dose (n=99,101)||Baseline in Subcutaneous Administration Assessment Questionnaire (SQAAQ)|"SQAAQ is a self-administered questionnaire which provides an assessment of ease of use and confidence with using a device to administer a subcutaneous injection of drug. Participants and injection assistants responded to questionnaire items using a 7-point Likert scale (from Strongly Disagree to Strongly Agree). 1 represents Strongly Disagree and 7 represents Strongly Agree."|units on a scale|Mean|6.2|6.2|Standard Deviation|1.32|1.32|||
3810555|NCT01777191|3636784|B3|Easy to hold in hand when I inject dose (n=99,101)||Baseline in Subcutaneous Administration Assessment Questionnaire (SQAAQ)|"SQAAQ is a self-administered questionnaire which provides an assessment of ease of use and confidence with using a device to administer a subcutaneous injection of drug. Participants and injection assistants responded to questionnaire items using a 7-point Likert scale (from Strongly Disagree to Strongly Agree). 1 represents Strongly Disagree and 7 represents Strongly Agree."|units on a scale|Mean|6.4|6.4|Standard Deviation|1.14|1.14|||
3810556|NCT01777191|3636785|B2|Easy to hold in hand when I inject dose (n=99,101)||Baseline in Subcutaneous Administration Assessment Questionnaire (SQAAQ)|"SQAAQ is a self-administered questionnaire which provides an assessment of ease of use and confidence with using a device to administer a subcutaneous injection of drug. Participants and injection assistants responded to questionnaire items using a 7-point Likert scale (from Strongly Disagree to Strongly Agree). 1 represents Strongly Disagree and 7 represents Strongly Agree."|units on a scale|Mean|6.6|6.6|Standard Deviation|0.97|0.97|||
3810557|NCT01777191|3636786|B1|Easy to hold in hand when I inject dose (n=99,101)||Baseline in Subcutaneous Administration Assessment Questionnaire (SQAAQ)|"SQAAQ is a self-administered questionnaire which provides an assessment of ease of use and confidence with using a device to administer a subcutaneous injection of drug. Participants and injection assistants responded to questionnaire items using a 7-point Likert scale (from Strongly Disagree to Strongly Agree). 1 represents Strongly Disagree and 7 represents Strongly Agree."|units on a scale|Mean|6.3|6.3|Standard Deviation|1.27|1.27|||
3810558|NCT01777191|3636784|B3|Easy for me to unlock (n=93,101)||Baseline in Subcutaneous Administration Assessment Questionnaire (SQAAQ)|"SQAAQ is a self-administered questionnaire which provides an assessment of ease of use and confidence with using a device to administer a subcutaneous injection of drug. Participants and injection assistants responded to questionnaire items using a 7-point Likert scale (from Strongly Disagree to Strongly Agree). 1 represents Strongly Disagree and 7 represents Strongly Agree."|units on a scale|Mean|6.6|6.6|Standard Deviation|0.98|0.98|||
3810559|NCT01777191|3636785|B2|Easy for me to unlock (n=93,101)||Baseline in Subcutaneous Administration Assessment Questionnaire (SQAAQ)|"SQAAQ is a self-administered questionnaire which provides an assessment of ease of use and confidence with using a device to administer a subcutaneous injection of drug. Participants and injection assistants responded to questionnaire items using a 7-point Likert scale (from Strongly Disagree to Strongly Agree). 1 represents Strongly Disagree and 7 represents Strongly Agree."|units on a scale|Mean|6.7|6.7|Standard Deviation|1.01|1.01|||
3810560|NCT01777191|3636786|B1|Easy for me to unlock (n=93,101)||Baseline in Subcutaneous Administration Assessment Questionnaire (SQAAQ)|"SQAAQ is a self-administered questionnaire which provides an assessment of ease of use and confidence with using a device to administer a subcutaneous injection of drug. Participants and injection assistants responded to questionnaire items using a 7-point Likert scale (from Strongly Disagree to Strongly Agree). 1 represents Strongly Disagree and 7 represents Strongly Agree."|units on a scale|Mean|6.4|6.4|Standard Deviation|0.94|0.94|||
3810561|NCT01777191|3636784|B3|Easy for me to learn how to use (n=99,101)||Baseline in Subcutaneous Administration Assessment Questionnaire (SQAAQ)|"SQAAQ is a self-administered questionnaire which provides an assessment of ease of use and confidence with using a device to administer a subcutaneous injection of drug. Participants and injection assistants responded to questionnaire items using a 7-point Likert scale (from Strongly Disagree to Strongly Agree). 1 represents Strongly Disagree and 7 represents Strongly Agree."|units on a scale|Mean|6.6|6.6|Standard Deviation|1.01|1.01|||
3810590|NCT01777191|3636786|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3810591|NCT01777191|3636784|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810592|NCT01777191|3636785|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810562|NCT01777191|3636785|B2|Easy for me to learn how to use (n=99,101)||Baseline in Subcutaneous Administration Assessment Questionnaire (SQAAQ)|"SQAAQ is a self-administered questionnaire which provides an assessment of ease of use and confidence with using a device to administer a subcutaneous injection of drug. Participants and injection assistants responded to questionnaire items using a 7-point Likert scale (from Strongly Disagree to Strongly Agree). 1 represents Strongly Disagree and 7 represents Strongly Agree."|units on a scale|Mean|6.7|6.7|Standard Deviation|0.91|0.91|||
3810563|NCT01777191|3636786|B1|Easy for me to learn how to use (n=99,101)||Baseline in Subcutaneous Administration Assessment Questionnaire (SQAAQ)|"SQAAQ is a self-administered questionnaire which provides an assessment of ease of use and confidence with using a device to administer a subcutaneous injection of drug. Participants and injection assistants responded to questionnaire items using a 7-point Likert scale (from Strongly Disagree to Strongly Agree). 1 represents Strongly Disagree and 7 represents Strongly Agree."|units on a scale|Mean|6.4|6.4|Standard Deviation|1.08|1.08|||
3810564|NCT01777191|3636784|B3|sPGA=4, 5||Baseline in Static Physician Global Assessment (sPGA) Score|The sPGA is the physician’s determination of the participant’s Ps lesions overall at a given time point. The sPGA is recommended as an endpoint to use to assess efficacy in the treatment of Ps (EMEA 2004). Overall lesions are categorized by descriptions for induration, erythema, and scaling. For the analysis of responses, the participant's Ps is assessed at a given time point on a 6-point scale in which 0 = cleared, 1 = minimal, 2 = mild, 3 = moderate; 4 = severe, 5 = very severe.|participants|Number|96|96.0||||||
3810565|NCT01777191|3636785|B2|sPGA=4, 5||Baseline in Static Physician Global Assessment (sPGA) Score|The sPGA is the physician’s determination of the participant’s Ps lesions overall at a given time point. The sPGA is recommended as an endpoint to use to assess efficacy in the treatment of Ps (EMEA 2004). Overall lesions are categorized by descriptions for induration, erythema, and scaling. For the analysis of responses, the participant's Ps is assessed at a given time point on a 6-point scale in which 0 = cleared, 1 = minimal, 2 = mild, 3 = moderate; 4 = severe, 5 = very severe.|participants|Number|49|49.0||||||
3810566|NCT01777191|3636786|B1|sPGA=4, 5||Baseline in Static Physician Global Assessment (sPGA) Score|The sPGA is the physician’s determination of the participant’s Ps lesions overall at a given time point. The sPGA is recommended as an endpoint to use to assess efficacy in the treatment of Ps (EMEA 2004). Overall lesions are categorized by descriptions for induration, erythema, and scaling. For the analysis of responses, the participant's Ps is assessed at a given time point on a 6-point scale in which 0 = cleared, 1 = minimal, 2 = mild, 3 = moderate; 4 = severe, 5 = very severe.|participants|Number|47|47.0||||||
3810567|NCT01777191|3636784|B3|sPGA=3||Baseline in Static Physician Global Assessment (sPGA) Score|The sPGA is the physician’s determination of the participant’s Ps lesions overall at a given time point. The sPGA is recommended as an endpoint to use to assess efficacy in the treatment of Ps (EMEA 2004). Overall lesions are categorized by descriptions for induration, erythema, and scaling. For the analysis of responses, the participant's Ps is assessed at a given time point on a 6-point scale in which 0 = cleared, 1 = minimal, 2 = mild, 3 = moderate; 4 = severe, 5 = very severe.|participants|Number|108|108.0||||||
3810568|NCT01777191|3636785|B2|sPGA=3||Baseline in Static Physician Global Assessment (sPGA) Score|The sPGA is the physician’s determination of the participant’s Ps lesions overall at a given time point. The sPGA is recommended as an endpoint to use to assess efficacy in the treatment of Ps (EMEA 2004). Overall lesions are categorized by descriptions for induration, erythema, and scaling. For the analysis of responses, the participant's Ps is assessed at a given time point on a 6-point scale in which 0 = cleared, 1 = minimal, 2 = mild, 3 = moderate; 4 = severe, 5 = very severe.|participants|Number|53|53.0||||||
3810569|NCT01777191|3636786|B1|sPGA=3||Baseline in Static Physician Global Assessment (sPGA) Score|The sPGA is the physician’s determination of the participant’s Ps lesions overall at a given time point. The sPGA is recommended as an endpoint to use to assess efficacy in the treatment of Ps (EMEA 2004). Overall lesions are categorized by descriptions for induration, erythema, and scaling. For the analysis of responses, the participant's Ps is assessed at a given time point on a 6-point scale in which 0 = cleared, 1 = minimal, 2 = mild, 3 = moderate; 4 = severe, 5 = very severe.|participants|Number|55|55.0||||||
3810570|NCT01777191|3636784|B3|||Baseline in Psoriasis Area and Severity Index (PASI)|The PASI combines assessments of the extent of body-surface involvement in 4 anatomical regions (head, trunk, arms, and legs) and the severity of desquamation, erythema, and plaque induration/infiltration (thickness) in each region, yielding an overall score of 0 or no Ps to 72 for the most severe disease.|units on a scale|Mean|19.40|19.4|Standard Deviation|8.078|8.078|||
3810571|NCT01777191|3636785|B2|||Baseline in Psoriasis Area and Severity Index (PASI)|The PASI combines assessments of the extent of body-surface involvement in 4 anatomical regions (head, trunk, arms, and legs) and the severity of desquamation, erythema, and plaque induration/infiltration (thickness) in each region, yielding an overall score of 0 or no Ps to 72 for the most severe disease.|units on a scale|Mean|17.76|17.76|Standard Deviation|6.141|6.141|||
3810572|NCT01777191|3636786|B1|||Baseline in Psoriasis Area and Severity Index (PASI)|The PASI combines assessments of the extent of body-surface involvement in 4 anatomical regions (head, trunk, arms, and legs) and the severity of desquamation, erythema, and plaque induration/infiltration (thickness) in each region, yielding an overall score of 0 or no Ps to 72 for the most severe disease.|units on a scale|Mean|21.05|21.05|Standard Deviation|9.379|9.379|||
3810573|NCT01777191|3636784|B3|United States||Region of Enrollment||participants|Number|165|165.0||||||
3810574|NCT01777191|3636785|B2|United States||Region of Enrollment||participants|Number|82|82.0||||||
3810575|NCT01777191|3636786|B1|United States||Region of Enrollment||participants|Number|83|83.0||||||
3810576|NCT01777191|3636784|B3|Puerto Rico||Region of Enrollment||participants|Number|39|39.0||||||
3810577|NCT01777191|3636785|B2|Puerto Rico||Region of Enrollment||participants|Number|20|20.0||||||
3810578|NCT01777191|3636786|B1|Puerto Rico||Region of Enrollment||participants|Number|19|19.0||||||
3810579|NCT01777191|3636784|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810580|NCT01777191|3636785|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810581|NCT01777191|3636786|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810582|NCT01777191|3636784|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3810593|NCT01777191|3636786|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810594|NCT01777191|3636784|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3810595|NCT01777191|3636785|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3810596|NCT01777191|3636786|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3810597|NCT01777191|3636784|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3810598|NCT01777191|3636785|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810599|NCT01777191|3636786|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3810600|NCT01777191|3636784|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810601|NCT01777191|3636785|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810602|NCT01777191|3636786|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810603|NCT01777191|3636784|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|142|142.0||||||
3810604|NCT01777191|3636785|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3810605|NCT01777191|3636786|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3810606|NCT01777191|3636784|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3810607|NCT01777191|3636785|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3810608|NCT01777191|3636786|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3810609|NCT01777191|3636784|B3||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3810610|NCT01777191|3636785|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3810611|NCT01777191|3636786|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3810612|NCT01777191|3636784|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3810613|NCT01777191|3636785|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3810614|NCT01777191|3636786|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3810615|NCT01777191|3636784|B3|||Age||years|Mean|46.5|46.5|Standard Deviation|13.80|13.8|||
3810616|NCT01777191|3636785|B2|||Age||years|Mean|46.8|46.8|Standard Deviation|13.09|13.09|||
3810617|NCT01777191|3636786|B1|||Age||years|Mean|46.3|46.3|Standard Deviation|14.53|14.53|||
3810618|NCT01777126|3636815|B3|||Nasogastric tube removal day||day|Median|2|2.0|Inter-Quartile Range|||1.0|3.0|
3810619|NCT01777126|3636816|B2|||Nasogastric tube removal day||day|Median|2|2.0|Inter-Quartile Range|||1.0|3.0|
3810620|NCT01777126|3636817|B1|||Nasogastric tube removal day||day|Median|2|2.0|Inter-Quartile Range|||1.0|4.75|
3810621|NCT01777126|3636815|B3|no POI||Postoperative ileus|Postoperative ileus was defined as the inability to tolerate solid food, the need to place a nasogastric tube in suction or the need to stop oral intake due to abdominal distention, nausea or emesis.|participants|Number|72|72.0||||||
3810622|NCT01777126|3636816|B2|no POI||Postoperative ileus|Postoperative ileus was defined as the inability to tolerate solid food, the need to place a nasogastric tube in suction or the need to stop oral intake due to abdominal distention, nausea or emesis.|participants|Number|33|33.0||||||
3810623|NCT01777126|3636817|B1|no POI||Postoperative ileus|Postoperative ileus was defined as the inability to tolerate solid food, the need to place a nasogastric tube in suction or the need to stop oral intake due to abdominal distention, nausea or emesis.|participants|Number|39|39.0||||||
3810624|NCT01777126|3636815|B3|POI||Postoperative ileus|Postoperative ileus was defined as the inability to tolerate solid food, the need to place a nasogastric tube in suction or the need to stop oral intake due to abdominal distention, nausea or emesis.|participants|Number|22|22.0||||||
3810625|NCT01777126|3636816|B2|POI||Postoperative ileus|Postoperative ileus was defined as the inability to tolerate solid food, the need to place a nasogastric tube in suction or the need to stop oral intake due to abdominal distention, nausea or emesis.|participants|Number|13|13.0||||||
3810626|NCT01777126|3636817|B1|POI||Postoperative ileus|Postoperative ileus was defined as the inability to tolerate solid food, the need to place a nasogastric tube in suction or the need to stop oral intake due to abdominal distention, nausea or emesis.|participants|Number|9|9.0||||||
3810627|NCT01777126|3636815|B3|||Duration of procedure||minute|Median|210|210.0|Inter-Quartile Range|51.1|51.1|180.0|240.0|
3810628|NCT01777126|3636816|B2|||Duration of procedure||minute|Median|187.5|187.5|Inter-Quartile Range|46.8|46.8|180.0|240.0|
3810629|NCT01777126|3636817|B1|||Duration of procedure||minute|Median|210|210.0|Inter-Quartile Range|55.4|55.4|180.0|240.0|
3810630|NCT01777126|3636815|B3|||Blood loss|Volume of blood loss during surgery.|ml|Median|1000|1000.0|Inter-Quartile Range|595|595.0|575.0|1500.0|
3810631|NCT01777126|3636816|B2|||Blood loss|Volume of blood loss during surgery.|ml|Median|1000|1000.0|Inter-Quartile Range|589|589.0|600.0|1650.0|
3810632|NCT01777126|3636817|B1|||Blood loss|Volume of blood loss during surgery.|ml|Median|1000|1000.0|Inter-Quartile Range|600|600.0|500.0|1475.0|
3810633|NCT01777126|3636815|B3|Surgeon 4.||Surgeon||participants|Number|48|48.0||||||
3810634|NCT01777126|3636816|B2|Surgeon 4.||Surgeon||participants|Number|29|29.0||||||
3810635|NCT01777126|3636817|B1|Surgeon 4.||Surgeon||participants|Number|19|19.0||||||
3810636|NCT01777126|3636815|B3|Surgeon 3.||Surgeon||participants|Number|8|8.0||||||
3810637|NCT01777126|3636816|B2|Surgeon 3.||Surgeon||participants|Number|3|3.0||||||
3810638|NCT01777126|3636817|B1|Surgeon 3.||Surgeon||participants|Number|5|5.0||||||
3810639|NCT01777126|3636815|B3|Surgeon 2.||Surgeon||participants|Number|33|33.0||||||
3810640|NCT01777126|3636816|B2|Surgeon 2.||Surgeon||participants|Number|14|14.0||||||
3810641|NCT01777126|3636817|B1|Surgeon 2.||Surgeon||participants|Number|19|19.0||||||
3810642|NCT01777126|3636815|B3|Surgeon 1.||Surgeon||participants|Number|5|5.0||||||
3810643|NCT01777126|3636816|B2|Surgeon 1.||Surgeon||participants|Number|0|0.0||||||
3810644|NCT01777126|3636817|B1|Surgeon 1.||Surgeon||participants|Number|5|5.0||||||
3810645|NCT01777126|3636815|B3|Continent cutaneous diversion||Type of urinary diversion||participants|Number|2|2.0||||||
3810646|NCT01777126|3636816|B2|Continent cutaneous diversion||Type of urinary diversion||participants|Number|0|0.0||||||
3810647|NCT01777126|3636817|B1|Continent cutaneous diversion||Type of urinary diversion||participants|Number|2|2.0||||||
3810648|NCT01777126|3636815|B3|Orthothopic neobladder||Type of urinary diversion||participants|Number|13|13.0||||||
3810649|NCT01777126|3636816|B2|Orthothopic neobladder||Type of urinary diversion||participants|Number|7|7.0||||||
3810650|NCT01777126|3636817|B1|Orthothopic neobladder||Type of urinary diversion||participants|Number|6|6.0||||||
3810651|NCT01777126|3636815|B3|Ileal conduit||Type of urinary diversion||participants|Number|79|79.0||||||
3810652|NCT01777126|3636816|B2|Ileal conduit||Type of urinary diversion||participants|Number|39|39.0||||||
3810653|NCT01777126|3636817|B1|Ileal conduit||Type of urinary diversion||participants|Number|40|40.0||||||
3810654|NCT01777126|3636815|B3|T0N0M0||Bladder staging|"The TNM system has been widely adopted in bladder staging. The number of Ts Ns and Ms depend on the tumour / site.~T: Tumour N: Node M: Metastases"|participants|Number|13|13.0||||||
3810655|NCT01777126|3636816|B2|T0N0M0||Bladder staging|"The TNM system has been widely adopted in bladder staging. The number of Ts Ns and Ms depend on the tumour / site.~T: Tumour N: Node M: Metastases"|participants|Number|5|5.0||||||
3810656|NCT01777126|3636817|B1|T0N0M0||Bladder staging|"The TNM system has been widely adopted in bladder staging. The number of Ts Ns and Ms depend on the tumour / site.~T: Tumour N: Node M: Metastases"|participants|Number|8|8.0||||||
3810657|NCT01777126|3636815|B3|T+N+M+||Bladder staging|"The TNM system has been widely adopted in bladder staging. The number of Ts Ns and Ms depend on the tumour / site.~T: Tumour N: Node M: Metastases"|participants|Number|78|78.0||||||
3810658|NCT01777126|3636816|B2|T+N+M+||Bladder staging|"The TNM system has been widely adopted in bladder staging. The number of Ts Ns and Ms depend on the tumour / site.~T: Tumour N: Node M: Metastases"|participants|Number|40|40.0||||||
3810659|NCT01777126|3636817|B1|T+N+M+||Bladder staging|"The TNM system has been widely adopted in bladder staging. The number of Ts Ns and Ms depend on the tumour / site.~T: Tumour N: Node M: Metastases"|participants|Number|38|38.0||||||
3810660|NCT01777126|3636815|B3|T+N+M0||Bladder staging|"The TNM system has been widely adopted in bladder staging. The number of Ts Ns and Ms depend on the tumour / site.~T: Tumour N: Node M: Metastases"|participants|Number|1|1.0||||||
3810661|NCT01777126|3636816|B2|T+N+M0||Bladder staging|"The TNM system has been widely adopted in bladder staging. The number of Ts Ns and Ms depend on the tumour / site.~T: Tumour N: Node M: Metastases"|participants|Number|0|0.0||||||
3810662|NCT01777126|3636817|B1|T+N+M0||Bladder staging|"The TNM system has been widely adopted in bladder staging. The number of Ts Ns and Ms depend on the tumour / site.~T: Tumour N: Node M: Metastases"|participants|Number|1|1.0||||||
3810663|NCT01777126|3636815|B3|T+N0M0||Bladder staging|"The TNM system has been widely adopted in bladder staging. The number of Ts Ns and Ms depend on the tumour / site.~T: Tumour N: Node M: Metastases"|participants|Number|2|2.0||||||
3810664|NCT01777126|3636816|B2|T+N0M0||Bladder staging|"The TNM system has been widely adopted in bladder staging. The number of Ts Ns and Ms depend on the tumour / site.~T: Tumour N: Node M: Metastases"|participants|Number|1|1.0||||||
3810665|NCT01777126|3636817|B1|T+N0M0||Bladder staging|"The TNM system has been widely adopted in bladder staging. The number of Ts Ns and Ms depend on the tumour / site.~T: Tumour N: Node M: Metastases"|participants|Number|1|1.0||||||
3810666|NCT01777126|3636815|B3|Oncologic||Indication||participants|Number|79|79.0||||||
3810667|NCT01777126|3636816|B2|Oncologic||Indication||participants|Number|40|40.0||||||
3810668|NCT01777126|3636817|B1|Oncologic||Indication||participants|Number|39|39.0||||||
3810669|NCT01777126|3636815|B3|Neurogenic||Indication||participants|Number|15|15.0||||||
3810670|NCT01777126|3636816|B2|Neurogenic||Indication||participants|Number|6|6.0||||||
3810671|NCT01777126|3636817|B1|Neurogenic||Indication||participants|Number|9|9.0||||||
3810672|NCT01777126|3636815|B3|||Age-adjusted Charlson Comorbidity Index|The Age-adjusted Charlson Comorbidity index encompasses 19 medical conditions weighted 1–6 with total scores ranging from 0–37. Mortality for each disease was converted to a relative risk of death within 12 months and a weight was then assigned. From the weighted conditions, a sum score can be tallied to yield the total comorbidity score. The CCI can be further adapted to account for increasing age. To account for the effects of increasing age, one point can be added to the CCI score for each decade of life over the age of 50 [13].|Points|Median|4|4.0|Inter-Quartile Range|2.3|2.3|3.0|6.0|
3810673|NCT01777126|3636816|B2|||Age-adjusted Charlson Comorbidity Index|The Age-adjusted Charlson Comorbidity index encompasses 19 medical conditions weighted 1–6 with total scores ranging from 0–37. Mortality for each disease was converted to a relative risk of death within 12 months and a weight was then assigned. From the weighted conditions, a sum score can be tallied to yield the total comorbidity score. The CCI can be further adapted to account for increasing age. To account for the effects of increasing age, one point can be added to the CCI score for each decade of life over the age of 50 [13].|Points|Median|5|5.0|Inter-Quartile Range|2.6|2.6|3.0|6.0|
3810674|NCT01777126|3636817|B1|||Age-adjusted Charlson Comorbidity Index|The Age-adjusted Charlson Comorbidity index encompasses 19 medical conditions weighted 1–6 with total scores ranging from 0–37. Mortality for each disease was converted to a relative risk of death within 12 months and a weight was then assigned. From the weighted conditions, a sum score can be tallied to yield the total comorbidity score. The CCI can be further adapted to account for increasing age. To account for the effects of increasing age, one point can be added to the CCI score for each decade of life over the age of 50 [13].|Points|Median|4|4.0|Inter-Quartile Range|1.7|1.7|3.0|5.0|
3810675|NCT01777126|3636815|B3|||Body Mass Index||kg/m²|Mean|25.7|25.7|Standard Deviation|4.1|4.1|||
3810676|NCT01777126|3636816|B2|||Body Mass Index||kg/m²|Mean|25.8|25.8|Standard Deviation|4.3|4.3|||
3810677|NCT01777126|3636817|B1|||Body Mass Index||kg/m²|Mean|25.5|25.5|Standard Deviation|4.0|4.0|||
3810678|NCT01777126|3636815|B3|||Weight||kg|Mean|74.6|74.6|Standard Deviation|14.1|14.1|||
3810679|NCT01777126|3636816|B2|||Weight||kg|Mean|75.4|75.4|Standard Deviation|14.2|14.2|||
3810680|NCT01777126|3636817|B1|||Weight||kg|Mean|73.7|73.7|Standard Deviation|13.9|13.9|||
3810681|NCT01777126|3636815|B3|||Length||cm|Mean|170.3|170.3|Standard Deviation|8.1|8.1|||
3810682|NCT01777126|3636816|B2|||Length||cm|Mean|170.8|170.8|Standard Deviation|8.0|8.0|||
3810683|NCT01777126|3636817|B1|||Length||cm|Mean|169.7|169.7|Standard Deviation|8.2|8.2|||
3810684|NCT01777126|3636815|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3810685|NCT01777126|3636816|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3810686|NCT01777126|3636817|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3810687|NCT01777126|3636815|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3810688|NCT01777126|3636816|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3810689|NCT01777126|3636817|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3810690|NCT01777126|3636815|B3|Age||Age||years|Median|66|66.0|Inter-Quartile Range|11.6|11.6|55.75|75.0|
3810691|NCT01777126|3636816|B2|Age||Age||years|Median|65.5|65.5|Inter-Quartile Range|10.8|10.8|57.0|72.5|
3810692|NCT01777126|3636817|B1|Age||Age||years|Median|66.0|66.0|Inter-Quartile Range|12.5|12.5|55.0|75.0|
3810693|NCT01776645|3636839|B3|United States||Region of Enrollment||participants|Number|56|56.0||||||
3810694|NCT01776645|3636840|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
3810695|NCT01776645|3636841|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
3810696|NCT01776645|3636839|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3810697|NCT01776645|3636840|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3810698|NCT01776645|3636841|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3810699|NCT01776645|3636839|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3810700|NCT01776645|3636840|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3810701|NCT01776645|3636841|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3810702|NCT01776645|3636839|B3|||Age||years|Mean|50.16|50.16|Standard Deviation|11.75|11.75|||
3810703|NCT01776645|3636840|B2|||Age||years|Mean|50.71|50.71|Standard Deviation|12.59|12.59|||
3810704|NCT01776645|3636841|B1|||Age||years|Mean|49.61|49.61|Standard Deviation|10.59|10.59|||
3810705|NCT01776645|3636839|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3810706|NCT01776645|3636840|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3810707|NCT01776645|3636841|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3810708|NCT01776645|3636839|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3810709|NCT01776645|3636840|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3810710|NCT01776645|3636841|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3810711|NCT01776645|3636839|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3810712|NCT01776645|3636840|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3810713|NCT01776645|3636841|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3810714|NCT01776554|3636848|B3||Male|Sex: Female, Male||Participants|Count of Participants|346|346.0||||||
3810715|NCT01776554|3636849|B2||Male|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3810716|NCT01776554|3636850|B1||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3810717|NCT01776554|3636848|B3||Female|Sex: Female, Male||Participants|Count of Participants|316|316.0||||||
3810718|NCT01776554|3636849|B2||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3810719|NCT01776554|3636850|B1||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3810720|NCT01776554|3636848|B3|||Age||Months|Mean|78.4|78.4|Standard Deviation|55.7|55.7|||
3810721|NCT01776554|3636849|B2|||Age||Months|Mean|78.1|78.1|Standard Deviation|55.6|55.6|||
3810722|NCT01776554|3636850|B1|||Age||Months|Mean|78.7|78.7|Standard Deviation|55.9|55.9|||
3810723|NCT01776541|3636892|B3||Male|Sex: Female, Male||Participants|Count of Participants|435|435.0||||||
3810724|NCT01776541|3636893|B2||Male|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
3810725|NCT01776541|3636894|B1||Male|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
3810726|NCT01776541|3636892|B3||Female|Sex: Female, Male||Participants|Count of Participants|544|544.0||||||
3810727|NCT01776541|3636893|B2||Female|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
3810728|NCT01776541|3636894|B1||Female|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
3810729|NCT01776541|3636892|B3|||Age||years|Mean|38.7|38.7|Standard Deviation|14.0|14.0|||
3810730|NCT01776541|3636893|B2|||Age||years|Mean|38.4|38.4|Standard Deviation|14.2|14.2|||
3810731|NCT01776541|3636894|B1|||Age||years|Mean|39.0|39.0|Standard Deviation|13.7|13.7|||
3810732|NCT01776424|3636914|B4||Other|Race/Ethnicity, Customized||Participants|Count of Participants|559|559.0||||||
3810733|NCT01776424|3636915|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|197|197.0||||||
3810734|NCT01776424|3636916|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|179|179.0||||||
3810735|NCT01776424|3636917|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|183|183.0||||||
3810736|NCT01776424|3636914|B4||Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|262|262.0||||||
3810737|NCT01776424|3636915|B3||Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|92|92.0||||||
3810738|NCT01776424|3636916|B2||Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|94|94.0||||||
3810739|NCT01776424|3636917|B1||Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|76|76.0||||||
3810740|NCT01776424|3636914|B4||Other Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2809|2809.0||||||
3810741|NCT01776424|3636915|B3||Other Asian|Race/Ethnicity, Customized||Participants|Count of Participants|915|915.0||||||
3810742|NCT01776424|3636916|B2||Other Asian|Race/Ethnicity, Customized||Participants|Count of Participants|938|938.0||||||
3810743|NCT01776424|3636917|B1||Other Asian|Race/Ethnicity, Customized||Participants|Count of Participants|956|956.0||||||
3810744|NCT01776424|3636914|B4||South Asian|Race/Ethnicity, Customized||Participants|Count of Participants|315|315.0||||||
3810745|NCT01776424|3636915|B3||South Asian|Race/Ethnicity, Customized||Participants|Count of Participants|106|106.0||||||
3810746|NCT01776424|3636916|B2||South Asian|Race/Ethnicity, Customized||Participants|Count of Participants|102|102.0||||||
3810747|NCT01776424|3636917|B1||South Asian|Race/Ethnicity, Customized||Participants|Count of Participants|107|107.0||||||
3810748|NCT01776424|3636914|B4||White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|17027|17027.0||||||
3810749|NCT01776424|3636915|B3||White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|5682|5682.0||||||
3810750|NCT01776424|3636916|B2||White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|5672|5672.0||||||
3810751|NCT01776424|3636917|B1||White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|5673|5673.0||||||
3810752|NCT01776424|3636914|B4||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|5278|5278.0||||||
3810753|NCT01776424|3636915|B3||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1758|1758.0||||||
3810754|NCT01776424|3636916|B2||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1751|1751.0||||||
3810755|NCT01776424|3636917|B1||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1769|1769.0||||||
3810756|NCT01776424|3636914|B4||Chinese|Race/Ethnicity, Customized||Participants|Count of Participants|1145|1145.0||||||
3810757|NCT01776424|3636915|B3||Chinese|Race/Ethnicity, Customized||Participants|Count of Participants|376|376.0||||||
3810758|NCT01776424|3636916|B2||Chinese|Race/Ethnicity, Customized||Participants|Count of Participants|381|381.0||||||
3810759|NCT01776424|3636917|B1||Chinese|Race/Ethnicity, Customized||Participants|Count of Participants|388|388.0||||||
3810760|NCT01776424|3636914|B4||Male|Sex: Female, Male||Participants|Count of Participants|21375|21375.0||||||
3810761|NCT01776424|3636915|B3||Male|Sex: Female, Male||Participants|Count of Participants|7137|7137.0||||||
3810762|NCT01776424|3636916|B2||Male|Sex: Female, Male||Participants|Count of Participants|7145|7145.0||||||
3810763|NCT01776424|3636917|B1||Male|Sex: Female, Male||Participants|Count of Participants|7093|7093.0||||||
3810764|NCT01776424|3636914|B4||Female|Sex: Female, Male||Participants|Count of Participants|6020|6020.0||||||
3810765|NCT01776424|3636915|B3||Female|Sex: Female, Male||Participants|Count of Participants|1989|1989.0||||||
3810766|NCT01776424|3636916|B2||Female|Sex: Female, Male||Participants|Count of Participants|1972|1972.0||||||
3810767|NCT01776424|3636917|B1||Female|Sex: Female, Male||Participants|Count of Participants|2059|2059.0||||||
3810768|NCT01776424|3636914|B4|||Age||Years|Mean|68.2|68.2|Standard Deviation|7.9|7.9|||
3810769|NCT01776424|3636915|B3|||Age||Years|Mean|68.2|68.2|Standard Deviation|8.0|8.0|||
3810770|NCT01776424|3636916|B2|||Age||Years|Mean|68.2|68.2|Standard Deviation|7.9|7.9|||
3810771|NCT01776424|3636917|B1|||Age||Years|Mean|68.3|68.3|Standard Deviation|7.9|7.9|||
3810772|NCT01776268|3636939|B3|||APGAR|"APGAR 0=worst 10=best Activity, Pulse, Grimace, Appearance, and Respiration.~Activity 0 Limp~Some flexion of arms and legs~Active motion~Pulse 0 No heart rate~<100 beats per minute~At least 100 beats/minute~Grimace during suctioning 0 No response~Grimace~Grimace and pull away, cough~Appearance 0 whole body bluish-gray or pale~Good color in body with bluish hands or feet~Good color all over~Respiration 0 Not breathing~Weak cry; , slow or irregular breathing~Good, strong cry; normal rate and effort of breathing"|units on a scale|Mean|7|7.0|Inter-Quartile Range|||6.0|8.0|
3810773|NCT01776268|3636940|B2|||APGAR|"APGAR 0=worst 10=best Activity, Pulse, Grimace, Appearance, and Respiration.~Activity 0 Limp~Some flexion of arms and legs~Active motion~Pulse 0 No heart rate~<100 beats per minute~At least 100 beats/minute~Grimace during suctioning 0 No response~Grimace~Grimace and pull away, cough~Appearance 0 whole body bluish-gray or pale~Good color in body with bluish hands or feet~Good color all over~Respiration 0 Not breathing~Weak cry; , slow or irregular breathing~Good, strong cry; normal rate and effort of breathing"|units on a scale|Mean|7|7.0|Inter-Quartile Range|||6.0|8.0|
3810774|NCT01776268|3636941|B1|||APGAR|"APGAR 0=worst 10=best Activity, Pulse, Grimace, Appearance, and Respiration.~Activity 0 Limp~Some flexion of arms and legs~Active motion~Pulse 0 No heart rate~<100 beats per minute~At least 100 beats/minute~Grimace during suctioning 0 No response~Grimace~Grimace and pull away, cough~Appearance 0 whole body bluish-gray or pale~Good color in body with bluish hands or feet~Good color all over~Respiration 0 Not breathing~Weak cry; , slow or irregular breathing~Good, strong cry; normal rate and effort of breathing"|units on a scale|Mean|7|7.0|Inter-Quartile Range|||6.0|8.0|
3810775|NCT01776268|3636939|B3|||Birth Weight||grams|Mean|1219|1219.0|Inter-Quartile Range|||905.0|1602.0|
3810776|NCT01776268|3636940|B2|||Birth Weight||grams|Mean|1170|1170.0|Inter-Quartile Range|||905.0|1340.0|
3810777|NCT01776268|3636941|B1|||Birth Weight||grams|Mean|1272|1272.0|Inter-Quartile Range|||988.0|1602.0|
3810778|NCT01776268|3636939|B3|United States||Region of Enrollment||participants|Number|99|99.0||||||
3810779|NCT01776268|3636940|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
3810780|NCT01776268|3636941|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
3810781|NCT01776268|3636939|B3||Unknown or Not Reported|Race (NIH/OMB)|Mother's Race is reported|Participants|Count of Participants|1|1.0||||||
3810782|NCT01776268|3636940|B2||Unknown or Not Reported|Race (NIH/OMB)|Mother's Race is reported|Participants|Count of Participants|1|1.0||||||
3810783|NCT01776268|3636941|B1||Unknown or Not Reported|Race (NIH/OMB)|Mother's Race is reported|Participants|Count of Participants|0|0.0||||||
3810784|NCT01776268|3636939|B3||More than one race|Race (NIH/OMB)|Mother's Race is reported|Participants|Count of Participants|3|3.0||||||
3810785|NCT01776268|3636940|B2||More than one race|Race (NIH/OMB)|Mother's Race is reported|Participants|Count of Participants|2|2.0||||||
3810877|NCT01775995|3636964|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3810786|NCT01776268|3636941|B1||More than one race|Race (NIH/OMB)|Mother's Race is reported|Participants|Count of Participants|1|1.0||||||
3810787|NCT01776268|3636939|B3||White|Race (NIH/OMB)|Mother's Race is reported|Participants|Count of Participants|63|63.0||||||
3810788|NCT01776268|3636940|B2||White|Race (NIH/OMB)|Mother's Race is reported|Participants|Count of Participants|35|35.0||||||
3810789|NCT01776268|3636941|B1||White|Race (NIH/OMB)|Mother's Race is reported|Participants|Count of Participants|28|28.0||||||
3810790|NCT01776268|3636939|B3||Black or African American|Race (NIH/OMB)|Mother's Race is reported|Participants|Count of Participants|32|32.0||||||
3810791|NCT01776268|3636940|B2||Black or African American|Race (NIH/OMB)|Mother's Race is reported|Participants|Count of Participants|13|13.0||||||
3810792|NCT01776268|3636941|B1||Black or African American|Race (NIH/OMB)|Mother's Race is reported|Participants|Count of Participants|19|19.0||||||
3810793|NCT01776268|3636939|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Mother's Race is reported|Participants|Count of Participants|0|0.0||||||
3810794|NCT01776268|3636940|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Mother's Race is reported|Participants|Count of Participants|0|0.0||||||
3810795|NCT01776268|3636941|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Mother's Race is reported|Participants|Count of Participants|0|0.0||||||
3810796|NCT01776268|3636939|B3||Asian|Race (NIH/OMB)|Mother's Race is reported|Participants|Count of Participants|0|0.0||||||
3810797|NCT01776268|3636940|B2||Asian|Race (NIH/OMB)|Mother's Race is reported|Participants|Count of Participants|0|0.0||||||
3810798|NCT01776268|3636941|B1||Asian|Race (NIH/OMB)|Mother's Race is reported|Participants|Count of Participants|0|0.0||||||
3810799|NCT01776268|3636939|B3||American Indian or Alaska Native|Race (NIH/OMB)|Mother's Race is reported|Participants|Count of Participants|0|0.0||||||
3810800|NCT01776268|3636940|B2||American Indian or Alaska Native|Race (NIH/OMB)|Mother's Race is reported|Participants|Count of Participants|0|0.0||||||
3810801|NCT01776268|3636941|B1||American Indian or Alaska Native|Race (NIH/OMB)|Mother's Race is reported|Participants|Count of Participants|0|0.0||||||
3810802|NCT01776268|3636939|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)|Mother's Ethnicity is reported|Participants|Count of Participants|0|0.0||||||
3810803|NCT01776268|3636940|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)|Mother's Ethnicity is reported|Participants|Count of Participants|0|0.0||||||
3810804|NCT01776268|3636941|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|Mother's Ethnicity is reported|Participants|Count of Participants|0|0.0||||||
3810805|NCT01776268|3636939|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Mother's Ethnicity is reported|Participants|Count of Participants|84|84.0||||||
3810806|NCT01776268|3636940|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Mother's Ethnicity is reported|Participants|Count of Participants|44|44.0||||||
3810807|NCT01776268|3636941|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Mother's Ethnicity is reported|Participants|Count of Participants|40|40.0||||||
3810808|NCT01776268|3636939|B3||Hispanic or Latino|Ethnicity (NIH/OMB)|Mother's Ethnicity is reported|Participants|Count of Participants|15|15.0||||||
3810809|NCT01776268|3636940|B2||Hispanic or Latino|Ethnicity (NIH/OMB)|Mother's Ethnicity is reported|Participants|Count of Participants|7|7.0||||||
3810810|NCT01776268|3636941|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|Mother's Ethnicity is reported|Participants|Count of Participants|8|8.0||||||
3810811|NCT01776268|3636939|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3810812|NCT01776268|3636940|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3810813|NCT01776268|3636941|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3810814|NCT01776268|3636939|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3810815|NCT01776268|3636940|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3810816|NCT01776268|3636941|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3810817|NCT01776268|3636939|B3|||Age|Gestational age in weeks|weeks|Mean|29|29.0|Inter-Quartile Range|||27.0|31.0|
3810818|NCT01776268|3636940|B2|||Age|Gestational age in weeks|weeks|Mean|29|29.0|Inter-Quartile Range|||28.0|30.0|
3810819|NCT01776268|3636941|B1|||Age|Gestational age in weeks|weeks|Mean|30|30.0|Inter-Quartile Range|||27.0|31.0|
3810820|NCT01776008|3636950|B1|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3810821|NCT01776008|3636950|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3810822|NCT01776008|3636950|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3810823|NCT01776008|3636950|B1|||Age||years|Median|57.5|57.5|Full Range|||40.0|77.0|
3810824|NCT01775995|3636962|B3|||Opioid Use|Opioid use was measured using the Timeline Followback Method which looked at the past 28 days of opioid use. Opioid use was standardized [daily morphine-equivalent dose (MED)] across different opioids for each participant.|mg/day|Mean|148.3|148.3|Standard Deviation|129.2|129.2|||
3810825|NCT01775995|3636963|B2|||Opioid Use|Opioid use was measured using the Timeline Followback Method which looked at the past 28 days of opioid use. Opioid use was standardized [daily morphine-equivalent dose (MED)] across different opioids for each participant.|mg/day|Mean|120.3|120.3|Standard Deviation|76.9|76.9|||
3810826|NCT01775995|3636964|B1|||Opioid Use|Opioid use was measured using the Timeline Followback Method which looked at the past 28 days of opioid use. Opioid use was standardized [daily morphine-equivalent dose (MED)] across different opioids for each participant.|mg/day|Mean|166.9|166.9|Standard Deviation|153.7|153.7|||
3810827|NCT01775995|3636962|B3|||Averaged Pain|Averaged pain is the average of 4 responses on a 0-10 numerical rating scale (0=no pain; 10=worst possible pain) from the Brief Pain Inventory (BPI): 1) describe your pain at its worst in the last week 2) describe your pain at its least in the last week 3) describe your pain on the average 4) describe your pain right now.|units on a scale|Mean|5.8|5.8|Standard Deviation|1.4|1.4|||
3810828|NCT01775995|3636963|B2|||Averaged Pain|Averaged pain is the average of 4 responses on a 0-10 numerical rating scale (0=no pain; 10=worst possible pain) from the Brief Pain Inventory (BPI): 1) describe your pain at its worst in the last week 2) describe your pain at its least in the last week 3) describe your pain on the average 4) describe your pain right now.|units on a scale|Mean|4.9|4.9|Standard Deviation|1.1|1.1|||
3810829|NCT01775995|3636964|B1|||Averaged Pain|Averaged pain is the average of 4 responses on a 0-10 numerical rating scale (0=no pain; 10=worst possible pain) from the Brief Pain Inventory (BPI): 1) describe your pain at its worst in the last week 2) describe your pain at its least in the last week 3) describe your pain on the average 4) describe your pain right now.|units on a scale|Mean|6.3|6.3|Standard Deviation|1.2|1.2|||
3810830|NCT01775995|3636962|B3|||Physical Function|"Physical function was assessed using the 10-item Oswestry Disability Index. This measure's total score (0-100) reflects the percent of chronic low back pain related disability today. Zero to 20% is considered minimal disability, 21 to 40% moderate disability, 41 to 60% severe disability, 61 to 80% crippled, and 81 to 100% bed bound."|percent|Mean|66.7|66.7|Standard Deviation|11.4|11.4|||
3810831|NCT01775995|3636963|B2|||Physical Function|"Physical function was assessed using the 10-item Oswestry Disability Index. This measure's total score (0-100) reflects the percent of chronic low back pain related disability today. Zero to 20% is considered minimal disability, 21 to 40% moderate disability, 41 to 60% severe disability, 61 to 80% crippled, and 81 to 100% bed bound."|percent|Mean|64.5|64.5|Standard Deviation|14.1|14.1|||
3810832|NCT01775995|3636964|B1|||Physical Function|"Physical function was assessed using the 10-item Oswestry Disability Index. This measure's total score (0-100) reflects the percent of chronic low back pain related disability today. Zero to 20% is considered minimal disability, 21 to 40% moderate disability, 41 to 60% severe disability, 61 to 80% crippled, and 81 to 100% bed bound."|percent|Mean|68.1|68.1|Standard Deviation|9.3|9.3|||
3810833|NCT01775995|3636962|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
3810834|NCT01775995|3636963|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3810835|NCT01775995|3636964|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3810836|NCT01775995|3636962|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810837|NCT01775995|3636963|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810838|NCT01775995|3636964|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810839|NCT01775995|3636962|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3810840|NCT01775995|3636963|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810841|NCT01775995|3636964|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3810842|NCT01775995|3636962|B3||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3810843|NCT01775995|3636963|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3810844|NCT01775995|3636964|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3810845|NCT01775995|3636962|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3810846|NCT01775995|3636963|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3810847|NCT01775995|3636964|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3810848|NCT01775995|3636962|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810849|NCT01775995|3636963|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810850|NCT01775995|3636964|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810851|NCT01775995|3636962|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810852|NCT01775995|3636963|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810853|NCT01775995|3636964|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810854|NCT01775995|3636962|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810855|NCT01775995|3636963|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810856|NCT01775995|3636964|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810857|NCT01775995|3636962|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810858|NCT01775995|3636963|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810859|NCT01775995|3636964|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810860|NCT01775995|3636962|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3810861|NCT01775995|3636963|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3810862|NCT01775995|3636964|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3810863|NCT01775995|3636962|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3810864|NCT01775995|3636963|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3810865|NCT01775995|3636964|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810866|NCT01775995|3636962|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3810867|NCT01775995|3636963|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3810868|NCT01775995|3636964|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3810869|NCT01775995|3636962|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3810870|NCT01775995|3636963|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3810871|NCT01775995|3636964|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3810872|NCT01775995|3636962|B3|||Age||years|Mean|51.8|51.8|Standard Deviation|9.7|9.7|||
3810873|NCT01775995|3636963|B2|||Age||years|Mean|50.5|50.5|Standard Deviation|8.6|8.6|||
3810874|NCT01775995|3636964|B1|||Age||years|Mean|52.7|52.7|Standard Deviation|10.5|10.5|||
3810875|NCT01775995|3636962|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3810876|NCT01775995|3636963|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3810878|NCT01775995|3636962|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3810879|NCT01775995|3636963|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3810880|NCT01775995|3636964|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3810881|NCT01775995|3636962|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3810882|NCT01775995|3636963|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3810883|NCT01775995|3636964|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3810884|NCT01775865|3637025|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3810885|NCT01775865|3637026|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3810886|NCT01775865|3637027|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3810887|NCT01775865|3637028|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3810888|NCT01775865|3637025|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3810889|NCT01775865|3637026|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3810890|NCT01775865|3637027|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3810891|NCT01775865|3637028|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3810892|NCT01775865|3637025|B4|||Age||Years|Mean|48.1|48.1|Standard Deviation|16.8|16.8|||
3810893|NCT01775865|3637026|B3|||Age||Years|Mean|26.2|26.2|Standard Deviation|5.2|5.2|||
3810894|NCT01775865|3637027|B2|||Age||Years|Mean|55.8|55.8|Standard Deviation|5.3|5.3|||
3810895|NCT01775865|3637028|B1|||Age||Years|Mean|60.6|60.6|Standard Deviation|7.4|7.4|||
3810896|NCT01775852|3637044|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3810897|NCT01775852|3637045|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3810898|NCT01775852|3637046|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3810899|NCT01775852|3637044|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3810900|NCT01775852|3637045|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3810901|NCT01775852|3637046|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3810902|NCT01775852|3637044|B3|||Age||years|Mean|33|33.0|Standard Deviation|13.1|13.1|||
3810903|NCT01775852|3637045|B2|||Age||years|Mean|33.5|33.5|Standard Deviation|12.9|12.9|||
3810904|NCT01775852|3637046|B1|||Age||years|Mean|32.5|32.5|Standard Deviation|13.3|13.3|||
3810905|NCT01775800|3637059|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810906|NCT01775800|3637060|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810907|NCT01775800|3637061|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810908|NCT01775800|3637059|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810909|NCT01775800|3637060|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810910|NCT01775800|3637061|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810911|NCT01775800|3637059|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3810912|NCT01775800|3637060|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3810913|NCT01775800|3637061|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3810914|NCT01775800|3637059|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3810915|NCT01775800|3637060|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3810916|NCT01775800|3637061|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3810917|NCT01775800|3637059|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810918|NCT01775800|3637060|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810919|NCT01775800|3637061|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810920|NCT01775800|3637059|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810921|NCT01775800|3637060|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810922|NCT01775800|3637061|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810923|NCT01775800|3637059|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810924|NCT01775800|3637060|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810925|NCT01775800|3637061|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810926|NCT01775800|3637059|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3810927|NCT01775800|3637060|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3810928|NCT01775800|3637061|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3810929|NCT01775800|3637059|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3810930|NCT01775800|3637060|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3810931|NCT01775800|3637061|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3810932|NCT01775800|3637059|B3|||Age||years|Mean|70.94|70.94|Standard Deviation|13.42|13.42|||
3810933|NCT01775800|3637060|B2|||Age||years|Mean|69.50|69.5|Standard Deviation|16.59|16.59|||
3810934|NCT01775800|3637061|B1|||Age||years|Mean|72.38|72.38|Standard Deviation|10.29|10.29|||
3810935|NCT01775800|3637059|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3810936|NCT01775800|3637060|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3810937|NCT01775800|3637061|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3810938|NCT01775800|3637059|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3810939|NCT01775800|3637060|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3810940|NCT01775800|3637061|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3810941|NCT01775800|3637059|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3810942|NCT01775800|3637060|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3810943|NCT01775800|3637061|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3810944|NCT01775787|3637069|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3810945|NCT01775787|3637069|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3810946|NCT01775787|3637069|B1|||Age||years|Mean|43|43.0|Standard Deviation|10.24|10.24|||
3810947|NCT01775787|3637069|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3810948|NCT01775787|3637069|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3810949|NCT01775787|3637069|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3810950|NCT01775774|3637078|B4|Pre-eclampsia||Primary cause of ARDS||participants|Number|1|1.0||||||
3810951|NCT01775774|3637079|B3|Pre-eclampsia||Primary cause of ARDS||participants|Number|0|0.0||||||
3810952|NCT01775774|3637080|B2|Pre-eclampsia||Primary cause of ARDS||participants|Number|0|0.0||||||
3810953|NCT01775774|3637081|B1|Pre-eclampsia||Primary cause of ARDS||participants|Number|1|1.0||||||
3810954|NCT01775774|3637078|B4|Sepsis||Primary cause of ARDS||participants|Number|1|1.0||||||
3810955|NCT01775774|3637079|B3|Sepsis||Primary cause of ARDS||participants|Number|1|1.0||||||
3810956|NCT01775774|3637080|B2|Sepsis||Primary cause of ARDS||participants|Number|0|0.0||||||
3810957|NCT01775774|3637081|B1|Sepsis||Primary cause of ARDS||participants|Number|0|0.0||||||
3810958|NCT01775774|3637078|B4|Aspiration||Primary cause of ARDS||participants|Number|3|3.0||||||
3810959|NCT01775774|3637079|B3|Aspiration||Primary cause of ARDS||participants|Number|0|0.0||||||
3810960|NCT01775774|3637080|B2|Aspiration||Primary cause of ARDS||participants|Number|2|2.0||||||
3810961|NCT01775774|3637081|B1|Aspiration||Primary cause of ARDS||participants|Number|1|1.0||||||
3810962|NCT01775774|3637078|B4|Pneumonia||Primary cause of ARDS||participants|Number|4|4.0||||||
3810963|NCT01775774|3637079|B3|Pneumonia||Primary cause of ARDS||participants|Number|2|2.0||||||
3810964|NCT01775774|3637080|B2|Pneumonia||Primary cause of ARDS||participants|Number|1|1.0||||||
3810965|NCT01775774|3637081|B1|Pneumonia||Primary cause of ARDS||participants|Number|1|1.0||||||
3810966|NCT01775774|3637078|B4|||APACHE III Score|Acute Physiology and Chronic Health Evaluation III score, a severity-of-disease classification system. Higher score predicts worse clinical outcome. The scale of APACHE III is 0 - 299, where 0 = best outcome and 299 = worst outcome.|scores on a scale|Mean|89.9|89.9|Full Range|||54.0|115.0|
3810967|NCT01775774|3637079|B3|||APACHE III Score|Acute Physiology and Chronic Health Evaluation III score, a severity-of-disease classification system. Higher score predicts worse clinical outcome. The scale of APACHE III is 0 - 299, where 0 = best outcome and 299 = worst outcome.|scores on a scale|Mean|88.3|88.3|Full Range|||54.0|108.0|
3810968|NCT01775774|3637080|B2|||APACHE III Score|Acute Physiology and Chronic Health Evaluation III score, a severity-of-disease classification system. Higher score predicts worse clinical outcome. The scale of APACHE III is 0 - 299, where 0 = best outcome and 299 = worst outcome.|scores on a scale|Mean|89.7|89.7|Full Range|||64.0|115.0|
3810969|NCT01775774|3637081|B1|||APACHE III Score|Acute Physiology and Chronic Health Evaluation III score, a severity-of-disease classification system. Higher score predicts worse clinical outcome. The scale of APACHE III is 0 - 299, where 0 = best outcome and 299 = worst outcome.|scores on a scale|Mean|91.7|91.7|Full Range|||62.0|111.0|
3810970|NCT01775774|3637078|B4|United States||Region of Enrollment||participants|Number|9|9.0||||||
3810971|NCT01775774|3637079|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3810972|NCT01775774|3637080|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3810973|NCT01775774|3637081|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3810974|NCT01775774|3637078|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3810975|NCT01775774|3637079|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3810976|NCT01775774|3637080|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810977|NCT01775774|3637081|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810978|NCT01775774|3637078|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810979|NCT01775774|3637079|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810980|NCT01775774|3637080|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810981|NCT01775774|3637081|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810982|NCT01775774|3637078|B4||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3810983|NCT01775774|3637079|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3810984|NCT01775774|3637080|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3810985|NCT01775774|3637081|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3810986|NCT01775774|3637078|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810987|NCT01775774|3637079|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810988|NCT01775774|3637080|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810989|NCT01775774|3637081|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810990|NCT01775774|3637078|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810991|NCT01775774|3637079|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810992|NCT01775774|3637080|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810993|NCT01775774|3637081|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810994|NCT01775774|3637078|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3810995|NCT01775774|3637079|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810996|NCT01775774|3637080|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810997|NCT01775774|3637081|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3810998|NCT01775774|3637078|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3810999|NCT01775774|3637079|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811000|NCT01775774|3637080|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811001|NCT01775774|3637081|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811002|NCT01775774|3637078|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811003|NCT01775774|3637079|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811004|NCT01775774|3637080|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811005|NCT01775774|3637081|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811006|NCT01775774|3637078|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3811007|NCT01775774|3637079|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3811008|NCT01775774|3637080|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3811009|NCT01775774|3637081|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3811010|NCT01775774|3637078|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3811011|NCT01775774|3637079|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811012|NCT01775774|3637080|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3811013|NCT01775774|3637081|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811014|NCT01775774|3637078|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3811015|NCT01775774|3637079|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3811016|NCT01775774|3637080|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3811017|NCT01775774|3637081|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3811018|NCT01775774|3637078|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3811019|NCT01775774|3637079|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3811020|NCT01775774|3637080|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3811021|NCT01775774|3637081|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3811022|NCT01775774|3637078|B4|||Age||years|Mean|54.9|54.9|Full Range|||29.0|86.0|
3811023|NCT01775774|3637079|B3|||Age||years|Mean|48.3|48.3|Full Range|||38.0|55.0|
3811024|NCT01775774|3637080|B2|||Age||years|Mean|58.3|58.3|Full Range|||46.0|67.0|
3811025|NCT01775774|3637081|B1|||Age||years|Mean|58.0|58.0|Full Range|||29.0|86.0|
3811026|NCT01775774|3637078|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3811027|NCT01775774|3637079|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3811028|NCT01775774|3637080|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3811029|NCT01775774|3637081|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3811030|NCT01775774|3637078|B4||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3811031|NCT01775774|3637079|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3811032|NCT01775774|3637080|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3811033|NCT01775774|3637081|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3811034|NCT01775774|3637078|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3811035|NCT01775774|3637079|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3811036|NCT01775774|3637080|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3811037|NCT01775774|3637081|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3811038|NCT01775735|3637109|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
3811039|NCT01775735|3637110|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3811040|NCT01775735|3637111|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3811041|NCT01775735|3637109|B3|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3811042|NCT01775735|3637110|B2|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3811043|NCT01775735|3637111|B1|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3811044|NCT01775735|3637109|B3|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3811045|NCT01775735|3637110|B2|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3811046|NCT01775735|3637111|B1|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3811047|NCT01775735|3637109|B3|Race/Ethnicity|Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3811104|NCT01775553|3637153|B1|Ibrutinib, DEX||Carfilzomib Regimen Combination||Participants|Count of Participants|1|1.0||||||
3811048|NCT01775735|3637110|B2|Race/Ethnicity|Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3811049|NCT01775735|3637111|B1|Race/Ethnicity|Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3811050|NCT01775735|3637109|B3|Race/Ethnicity|Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3811051|NCT01775735|3637110|B2|Race/Ethnicity|Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3811052|NCT01775735|3637111|B1|Race/Ethnicity|Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3811053|NCT01775735|3637109|B3|Race/Ethnicity|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3811054|NCT01775735|3637110|B2|Race/Ethnicity|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3811055|NCT01775735|3637111|B1|Race/Ethnicity|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3811056|NCT01775735|3637109|B3|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3811057|NCT01775735|3637110|B2|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3811058|NCT01775735|3637111|B1|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3811059|NCT01775735|3637109|B3|Race/Ethnicity|American Indian or Alaska native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3811060|NCT01775735|3637110|B2|Race/Ethnicity|American Indian or Alaska native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3811061|NCT01775735|3637111|B1|Race/Ethnicity|American Indian or Alaska native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3811062|NCT01775735|3637109|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3811063|NCT01775735|3637110|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3811064|NCT01775735|3637111|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3811065|NCT01775735|3637109|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3811066|NCT01775735|3637110|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3811067|NCT01775735|3637111|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3811068|NCT01775735|3637109|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3811069|NCT01775735|3637110|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3811070|NCT01775735|3637111|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3811071|NCT01775735|3637109|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3811072|NCT01775735|3637110|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3811073|NCT01775735|3637111|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3811074|NCT01775735|3637109|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3811075|NCT01775735|3637110|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3811076|NCT01775735|3637111|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3811077|NCT01775722|3637118|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3811078|NCT01775722|3637118|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3811079|NCT01775722|3637118|B1||>=65 years|Age|Combined Bipolar Radiofrequency&Pulsed Dye Laser Treatment|Participants|Count of Participants|0|0.0||||||
3811080|NCT01775722|3637118|B1||Between 18 and 65 years|Age|Combined Bipolar Radiofrequency&Pulsed Dye Laser Treatment|Participants|Count of Participants|21|21.0||||||
3811081|NCT01775722|3637118|B1||<=18 years|Age|Combined Bipolar Radiofrequency&Pulsed Dye Laser Treatment|Participants|Count of Participants|1|1.0||||||
3811082|NCT01775670|3637124|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3811083|NCT01775670|3637125|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3811084|NCT01775670|3637126|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3811085|NCT01775670|3637124|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3811086|NCT01775670|3637125|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3811087|NCT01775670|3637126|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3811088|NCT01775670|3637124|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3811089|NCT01775670|3637125|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3811090|NCT01775670|3637126|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3811091|NCT01775670|3637124|B3|||Age||years|Mean|64.8|64.8|Standard Deviation|4.6|4.6|||
3811092|NCT01775670|3637125|B2|||Age||years|Mean|66.3|66.3|Standard Deviation|4.2|4.2|||
3811093|NCT01775670|3637126|B1|||Age||years|Mean|60|60.0|Standard Deviation|NA||||There is only one participant in this study arm.
3811094|NCT01775670|3637124|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3811095|NCT01775670|3637125|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3811096|NCT01775670|3637126|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3811097|NCT01775670|3637124|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3811098|NCT01775670|3637125|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3811099|NCT01775670|3637126|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3811100|NCT01775670|3637124|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3811101|NCT01775670|3637125|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3811102|NCT01775670|3637126|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3811103|NCT01775553|3637153|B1|Bendamustine||Carfilzomib Regimen Combination||Participants|Count of Participants|1|1.0||||||
3811105|NCT01775553|3637153|B1|Cyclophosphamide, DEX||Carfilzomib Regimen Combination||Participants|Count of Participants|2|2.0||||||
3811106|NCT01775553|3637153|B1|Pomalidomide, DEX||Carfilzomib Regimen Combination||Participants|Count of Participants|2|2.0||||||
3811107|NCT01775553|3637153|B1|Weekly 40 mg DEX||Carfilzomib Regimen Combination||Participants|Count of Participants|11|11.0||||||
3811108|NCT01775553|3637153|B1|Carfilzomib Regimen Combination||Carfilzomib Regimen Combination||Participants|Count of Participants|13|13.0||||||
3811109|NCT01775553|3637153|B1|||Prior Autologous Stem Cell Transplant||Participants|Count of Participants|7|7.0||||||
3811110|NCT01775553|3637153|B1|Bortezomib : Refractory||Prior therapy||participants|Number|9|9.0||||||
3811111|NCT01775553|3637153|B1|Bortezomib : Exposed||Prior therapy||participants|Number|13|13.0||||||
3811112|NCT01775553|3637153|B1|Pomalidomide : Refractory||Prior therapy||participants|Number|8|8.0||||||
3811113|NCT01775553|3637153|B1|Pomalidomide : Exposed||Prior therapy||participants|Number|8|8.0||||||
3811114|NCT01775553|3637153|B1|Lenalidomide : Refractory||Prior therapy||participants|Number|9|9.0||||||
3811115|NCT01775553|3637153|B1|Lenalidomide : Exposed||Prior therapy||participants|Number|13|13.0||||||
3811116|NCT01775553|3637153|B1|Thalidomide : Refractory||Prior therapy||participants|Number|1|1.0||||||
3811117|NCT01775553|3637153|B1|Thalidomide : Exposed||Prior therapy||participants|Number|7|7.0||||||
3811118|NCT01775553|3637153|B1|Dexamethasone : Refractory||Prior therapy||participants|Number|13|13.0||||||
3811119|NCT01775553|3637153|B1|Dexamethasone : Exposed||Prior therapy||participants|Number|13|13.0||||||
3811120|NCT01775553|3637153|B1|||Number of prior regimens||prior regimens|Median|5|5.0|Full Range|||2.0|10.0|
3811121|NCT01775553|3637153|B1|||Prior therapies since diagnosis||years|Median|7|7.0|Full Range|||2.0|10.0|
3811122|NCT01775553|3637153|B1|Any abnormality||FISH|Fluorescence in situ hybridization (FISH), a molecular cytogenetic technique that tags genetic material with fluorescent molecules. FISH is useful for identifying chromosomes and parts of chromosomes, deciphering chromosome rearrangements, detecting chromosome abnormalities, and detecting and mapping genes.|Participants|Count of Participants|6|6.0||||||
3811123|NCT01775553|3637153|B1|Normal||FISH|Fluorescence in situ hybridization (FISH), a molecular cytogenetic technique that tags genetic material with fluorescent molecules. FISH is useful for identifying chromosomes and parts of chromosomes, deciphering chromosome rearrangements, detecting chromosome abnormalities, and detecting and mapping genes.|Participants|Count of Participants|7|7.0||||||
3811124|NCT01775553|3637153|B1|L||Light-chain subtype||Participants|Count of Participants|6|6.0||||||
3811125|NCT01775553|3637153|B1|K||Light-chain subtype||Participants|Count of Participants|7|7.0||||||
3811126|NCT01775553|3637153|B1|none||Immunoglobulin subtype||Participants|Count of Participants|0|0.0||||||
3811127|NCT01775553|3637153|B1|IgM||Immunoglobulin subtype||Participants|Count of Participants|0|0.0||||||
3811128|NCT01775553|3637153|B1|IgA||Immunoglobulin subtype||Participants|Count of Participants|3|3.0||||||
3811129|NCT01775553|3637153|B1|IgG||Immunoglobulin subtype||Participants|Count of Participants|10|10.0||||||
3811130|NCT01775553|3637153|B1|Stage 3||ISS Staging|"The International Staging System (ISS): The ISS is based on the assessment of two blood test results: beta 2-microglobulin (ß2-M) and albumin.~Stage I - ß2-M < 3.5 mg/dL and albumin =3.5 g/dL Stage II - Neither stage I nor stage III Stage III - ß2-M ≥ 5.5 mg/L"|Participants|Count of Participants|3|3.0||||||
3811131|NCT01775553|3637153|B1|Stage 2||ISS Staging|"The International Staging System (ISS): The ISS is based on the assessment of two blood test results: beta 2-microglobulin (ß2-M) and albumin.~Stage I - ß2-M < 3.5 mg/dL and albumin =3.5 g/dL Stage II - Neither stage I nor stage III Stage III - ß2-M ≥ 5.5 mg/L"|Participants|Count of Participants|5|5.0||||||
3811132|NCT01775553|3637153|B1|Stage 1||ISS Staging|"The International Staging System (ISS): The ISS is based on the assessment of two blood test results: beta 2-microglobulin (ß2-M) and albumin.~Stage I - ß2-M < 3.5 mg/dL and albumin =3.5 g/dL Stage II - Neither stage I nor stage III Stage III - ß2-M ≥ 5.5 mg/L"|Participants|Count of Participants|5|5.0||||||
3811133|NCT01775553|3637153|B1|2||ECOG Performance Status|"The Eastern Cooperative Oncology Group (ECOG) measures level of functioning in terms of daily living abilities:~0. - Fully active, able to carry on all pre-disease performance without restriction~- Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~- Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|Participants|Count of Participants|3|3.0||||||
3811134|NCT01775553|3637153|B1|1||ECOG Performance Status|"The Eastern Cooperative Oncology Group (ECOG) measures level of functioning in terms of daily living abilities:~0. - Fully active, able to carry on all pre-disease performance without restriction~- Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~- Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|Participants|Count of Participants|5|5.0||||||
3811135|NCT01775553|3637153|B1|0||ECOG Performance Status|"The Eastern Cooperative Oncology Group (ECOG) measures level of functioning in terms of daily living abilities:~0. - Fully active, able to carry on all pre-disease performance without restriction~- Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~- Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|Participants|Count of Participants|5|5.0||||||
3811136|NCT01775553|3637153|B1|||Age >65 years||Participants|Count of Participants|6|6.0||||||
3811137|NCT01775553|3637153|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3811138|NCT01775553|3637153|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3811139|NCT01775553|3637153|B1|||Age||years|Mean|62.9|62.9|Full Range|||49.0|75.0|
3811140|NCT01775189|3637161|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3811141|NCT01775189|3637161|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3811142|NCT01775189|3637161|B1|||Age||years|Mean|35.6|35.6|Standard Deviation|9.0|9.0|||
3811315|NCT01774981|3637449|B1|||Age||years|Mean|61|61.0|Standard Deviation|10.0|10.0|||
3811143|NCT01775137|3637386|B1|||Forced expiratory flow from 25 to 75 % (FEF2575%) % predicted||Percent predicted|Mean|24.7|24.7|Standard Deviation|14.86|14.86|||
3811144|NCT01775137|3637386|B1|||Forced vital capacity (FVC) % predicted||Percent predicted|Mean|73.2|73.2|Standard Deviation|17.49|17.49|||
3811145|NCT01775137|3637386|B1|||Forced expiratory volume in one second (FEV1) percent (%) predicted||Percent predicted|Mean|52.2|52.2|Standard Deviation|15.01|15.01|||
3811146|NCT01775137|3637386|B1|<= 8 ug/mL||Pseudomonas aeruginosa tobramycin minimal inhibitory concentration (MIC)||Participants|Number|33|33.0||||||
3811147|NCT01775137|3637386|B1|> 8 microgram/milliliter(ug/mL)||Pseudomonas aeruginosa tobramycin minimal inhibitory concentration (MIC)||Participants|Number|12|12.0||||||
3811148|NCT01775137|3637386|B1|Spain||Region of Enrollment||participants|Number|6|6.0||||||
3811149|NCT01775137|3637386|B1|Germany||Region of Enrollment||participants|Number|5|5.0||||||
3811150|NCT01775137|3637386|B1|Australia||Region of Enrollment||participants|Number|5|5.0||||||
3811151|NCT01775137|3637386|B1|Mexico||Region of Enrollment||participants|Number|5|5.0||||||
3811152|NCT01775137|3637386|B1|Italy||Region of Enrollment||participants|Number|7|7.0||||||
3811153|NCT01775137|3637386|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3811154|NCT01775137|3637386|B1|Hungary||Region of Enrollment||participants|Number|1|1.0||||||
3811155|NCT01775137|3637386|B1|Argentina||Region of Enrollment||participants|Number|9|9.0||||||
3811156|NCT01775137|3637386|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3811157|NCT01775137|3637386|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3811158|NCT01775137|3637386|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3811159|NCT01775137|3637386|B1|||Age||years|Mean|24.5|24.5|Standard Deviation|10.79|10.79|||
3811160|NCT01775137|3637386|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3811161|NCT01775137|3637386|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3811162|NCT01775137|3637386|B1||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
3811163|NCT01775124|3637411|B3||Male|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
3811164|NCT01775124|3637412|B2||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3811165|NCT01775124|3637413|B1||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3811166|NCT01775124|3637411|B3||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3811167|NCT01775124|3637412|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3811168|NCT01775124|3637413|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3811169|NCT01775124|3637411|B3|||Age||Years|Mean|66.2|66.2|Standard Deviation|8.38|8.38|||
3811170|NCT01775124|3637412|B2|||Age||Years|Mean|66.8|66.8|Standard Deviation|8.31|8.31|||
3811171|NCT01775124|3637413|B1|||Age||Years|Mean|65.6|65.6|Standard Deviation|8.43|8.43|||
3811172|NCT01774981|3637441|B9|United Kingdom||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3811173|NCT01774981|3637442|B8|United Kingdom||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3811174|NCT01774981|3637443|B7|United Kingdom||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3811175|NCT01774981|3637444|B6|United Kingdom||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3811176|NCT01774981|3637445|B5|United Kingdom||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3811177|NCT01774981|3637446|B4|United Kingdom||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3811178|NCT01774981|3637447|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3811179|NCT01774981|3637448|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3811180|NCT01774981|3637449|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3811181|NCT01774981|3637441|B9|Bulgaria||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3811182|NCT01774981|3637442|B8|Bulgaria||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3811183|NCT01774981|3637443|B7|Bulgaria||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3811184|NCT01774981|3637444|B6|Bulgaria||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3811185|NCT01774981|3637445|B5|Bulgaria||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3811186|NCT01774981|3637446|B4|Bulgaria||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3811187|NCT01774981|3637447|B3|Bulgaria||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3811188|NCT01774981|3637448|B2|Bulgaria||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3811189|NCT01774981|3637449|B1|Bulgaria||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3811190|NCT01774981|3637441|B9|United States||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3811191|NCT01774981|3637442|B8|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3811192|NCT01774981|3637443|B7|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3811193|NCT01774981|3637444|B6|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3811194|NCT01774981|3637445|B5|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3811195|NCT01774981|3637446|B4|United States||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3811196|NCT01774981|3637447|B3|United States||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3811197|NCT01774981|3637448|B2|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3811198|NCT01774981|3637449|B1|United States||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3811199|NCT01774981|3637441|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811200|NCT01774981|3637442|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811201|NCT01774981|3637443|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811202|NCT01774981|3637444|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811203|NCT01774981|3637445|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811204|NCT01774981|3637446|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811205|NCT01774981|3637447|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811206|NCT01774981|3637448|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811207|NCT01774981|3637449|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811208|NCT01774981|3637441|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811209|NCT01774981|3637442|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811210|NCT01774981|3637443|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811211|NCT01774981|3637444|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811212|NCT01774981|3637445|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811213|NCT01774981|3637446|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811214|NCT01774981|3637447|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811215|NCT01774981|3637448|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811216|NCT01774981|3637449|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811217|NCT01774981|3637441|B9||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3811218|NCT01774981|3637442|B8||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3811219|NCT01774981|3637443|B7||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3811220|NCT01774981|3637444|B6||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3811221|NCT01774981|3637445|B5||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3811222|NCT01774981|3637446|B4||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3811223|NCT01774981|3637447|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3811224|NCT01774981|3637448|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3811225|NCT01774981|3637449|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3811226|NCT01774981|3637441|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3811227|NCT01774981|3637442|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811228|NCT01774981|3637443|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811229|NCT01774981|3637444|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3811230|NCT01774981|3637445|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811231|NCT01774981|3637446|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811232|NCT01774981|3637447|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811233|NCT01774981|3637448|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811234|NCT01774981|3637449|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811235|NCT01774981|3637441|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811236|NCT01774981|3637442|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811237|NCT01774981|3637443|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811238|NCT01774981|3637444|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811239|NCT01774981|3637445|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811240|NCT01774981|3637446|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811241|NCT01774981|3637447|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811242|NCT01774981|3637448|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811243|NCT01774981|3637449|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811244|NCT01774981|3637441|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811245|NCT01774981|3637442|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811246|NCT01774981|3637443|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811247|NCT01774981|3637444|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811248|NCT01774981|3637445|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811249|NCT01774981|3637446|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811250|NCT01774981|3637447|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811251|NCT01774981|3637448|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811252|NCT01774981|3637449|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811253|NCT01774981|3637441|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811254|NCT01774981|3637442|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811255|NCT01774981|3637443|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811256|NCT01774981|3637444|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811316|NCT01774968|3637486|B3|Puerto Rico||Region of Enrollment||participants|Number|30|30.0||||||
3811257|NCT01774981|3637445|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811258|NCT01774981|3637446|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811259|NCT01774981|3637447|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811260|NCT01774981|3637448|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811261|NCT01774981|3637449|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811262|NCT01774981|3637441|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811263|NCT01774981|3637442|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811264|NCT01774981|3637443|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811265|NCT01774981|3637444|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811266|NCT01774981|3637445|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811267|NCT01774981|3637446|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811268|NCT01774981|3637447|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811269|NCT01774981|3637448|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811270|NCT01774981|3637449|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811271|NCT01774981|3637441|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3811272|NCT01774981|3637442|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3811273|NCT01774981|3637443|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3811274|NCT01774981|3637444|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3811275|NCT01774981|3637445|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3811276|NCT01774981|3637446|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3811277|NCT01774981|3637447|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3811278|NCT01774981|3637448|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3811279|NCT01774981|3637449|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3811280|NCT01774981|3637441|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3811281|NCT01774981|3637442|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3811282|NCT01774981|3637443|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811283|NCT01774981|3637444|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3811284|NCT01774981|3637445|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3811285|NCT01774981|3637446|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811286|NCT01774981|3637447|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811287|NCT01774981|3637448|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811288|NCT01774981|3637449|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811289|NCT01774981|3637441|B9||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3811290|NCT01774981|3637442|B8||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3811291|NCT01774981|3637443|B7||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3811292|NCT01774981|3637444|B6||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3811293|NCT01774981|3637445|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3811294|NCT01774981|3637446|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3811295|NCT01774981|3637447|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3811296|NCT01774981|3637448|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3811297|NCT01774981|3637449|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3811298|NCT01774981|3637441|B9||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3811299|NCT01774981|3637442|B8||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3811300|NCT01774981|3637443|B7||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3811301|NCT01774981|3637444|B6||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3811302|NCT01774981|3637445|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3811303|NCT01774981|3637446|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3811304|NCT01774981|3637447|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3811305|NCT01774981|3637448|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3811306|NCT01774981|3637449|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3811307|NCT01774981|3637441|B9|||Age||years|Mean|58.5|58.5|Standard Deviation|9.6|9.6|||
3811308|NCT01774981|3637442|B8|||Age||years|Mean|59|59.0|Standard Deviation|9.5|9.5|||
3811309|NCT01774981|3637443|B7|||Age||years|Mean|55|55.0|Standard Deviation|12.7|12.7|||
3811310|NCT01774981|3637444|B6|||Age||years|Mean|63|63.0|Standard Deviation|8.3|8.3|||
3811311|NCT01774981|3637445|B5|||Age||years|Mean|55|55.0|Standard Deviation|5.0|5.0|||
3811312|NCT01774981|3637446|B4|||Age||years|Mean|62|62.0|Standard Deviation|11.6|11.6|||
3811313|NCT01774981|3637447|B3|||Age||years|Mean|56|56.0|Standard Deviation|6.1|6.1|||
3811314|NCT01774981|3637448|B2|||Age||years|Mean|57|57.0|Standard Deviation|7.2|7.2|||
3811317|NCT01774968|3637487|B2|Puerto Rico||Region of Enrollment||participants|Number|14|14.0||||||
3811318|NCT01774968|3637488|B1|Puerto Rico||Region of Enrollment||participants|Number|16|16.0||||||
3811319|NCT01774968|3637486|B3|United States||Region of Enrollment||participants|Number|295|295.0||||||
3811320|NCT01774968|3637487|B2|United States||Region of Enrollment||participants|Number|149|149.0||||||
3811321|NCT01774968|3637488|B1|United States||Region of Enrollment||participants|Number|146|146.0||||||
3811322|NCT01774968|3637486|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811323|NCT01774968|3637487|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811324|NCT01774968|3637488|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811325|NCT01774968|3637486|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3811326|NCT01774968|3637487|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3811327|NCT01774968|3637488|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3811328|NCT01774968|3637486|B3||White|Race (NIH/OMB)||Participants|Count of Participants|266|266.0||||||
3811329|NCT01774968|3637487|B2||White|Race (NIH/OMB)||Participants|Count of Participants|133|133.0||||||
3811330|NCT01774968|3637488|B1||White|Race (NIH/OMB)||Participants|Count of Participants|133|133.0||||||
3811331|NCT01774968|3637486|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3811332|NCT01774968|3637487|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3811333|NCT01774968|3637488|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3811334|NCT01774968|3637486|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3811335|NCT01774968|3637487|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3811336|NCT01774968|3637488|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811337|NCT01774968|3637486|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3811338|NCT01774968|3637487|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3811339|NCT01774968|3637488|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3811340|NCT01774968|3637486|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3811341|NCT01774968|3637487|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3811342|NCT01774968|3637488|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3811343|NCT01774968|3637486|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811344|NCT01774968|3637487|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811345|NCT01774968|3637488|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811346|NCT01774968|3637486|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|263|263.0||||||
3811347|NCT01774968|3637487|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|133|133.0||||||
3811348|NCT01774968|3637488|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
3811349|NCT01774968|3637486|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3811350|NCT01774968|3637487|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3811351|NCT01774968|3637488|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3811352|NCT01774968|3637486|B3||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3811353|NCT01774968|3637487|B2||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3811354|NCT01774968|3637488|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3811355|NCT01774968|3637486|B3||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3811356|NCT01774968|3637487|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3811357|NCT01774968|3637488|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3811358|NCT01774968|3637486|B3|||Age||years|Mean|55.41|55.41|Standard Deviation|9.78|9.78|||
3811359|NCT01774968|3637487|B2|||Age||years|Mean|55.50|55.5|Standard Deviation|9.03|9.03|||
3811360|NCT01774968|3637488|B1|||Age||years|Mean|55.31|55.31|Standard Deviation|10.51|10.51|||
3811361|NCT01774929|3637523|B1|||Pain Intensity Score by Visual Analog Scale (VAS)|Assessed by 10 cm of VAS from 0 to 10, where 0 cm=no pain and 10 cm=worse pain.|Centimeter [cm]|Mean|7.86|7.86|Standard Deviation|2.02|2.02|||
3811362|NCT01774929|3637523|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3811363|NCT01774929|3637523|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3811364|NCT01774929|3637523|B1|||Age||Years|Mean|66.03|66.03|Standard Deviation|8.25|8.25|||
3811365|NCT01774903|3637529|B1|||Pain Intensity Score by Visual Analog Scale (VAS)|Assessed by 10 cm VAS from 0 to 10, where 0 cm=no pain and 10 cm=worse pain.|centimeter (cm)|Mean|6.57|6.57|Standard Deviation|1.44|1.44|||
3811366|NCT01774903|3637529|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3811367|NCT01774903|3637529|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3811368|NCT01774903|3637529|B1|||Age||years|Mean|55.80|55.8|Standard Deviation|11.53|11.53|||
3811369|NCT01774851|3637536|B3|||Weight||kg|Median|72.51|72.51|Full Range|||41.2|126.6|
3811370|NCT01774851|3637537|B2|||Weight||kg|Median|68|68.0|Full Range|||41.2|98.2|
3811371|NCT01774851|3637538|B1|||Weight||kg|Median|73.97|73.97|Full Range|||47.1|126.6|
3811372|NCT01774851|3637536|B3|||Height||cm|Median|171|171.0|Full Range|||152.4|193.0|
3811373|NCT01774851|3637537|B2|||Height||cm|Median|170.19|170.19|Full Range|||152.4|193.0|
3811374|NCT01774851|3637538|B1|||Height||cm|Median|172|172.0|Full Range|||154.2|190.5|
3811375|NCT01774851|3637536|B3|||Subject of child bearing potential||Participants|Count of Participants|2|2.0||||||
3811376|NCT01774851|3637537|B2|||Subject of child bearing potential||Participants|Count of Participants|2|2.0||||||
3811377|NCT01774851|3637538|B1|||Subject of child bearing potential||Participants|Count of Participants|0|0.0||||||
3811378|NCT01774851|3637536|B3|United Kingdom||Region of Enrollment||participants|Number|14|14.0||||||
3811379|NCT01774851|3637537|B2|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3811380|NCT01774851|3637538|B1|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3811381|NCT01774851|3637536|B3|Taiwan||Region of Enrollment||participants|Number|4|4.0||||||
3811382|NCT01774851|3637537|B2|Taiwan||Region of Enrollment||participants|Number|2|2.0||||||
3811383|NCT01774851|3637538|B1|Taiwan||Region of Enrollment||participants|Number|2|2.0||||||
3811384|NCT01774851|3637536|B3|Spain||Region of Enrollment||participants|Number|17|17.0||||||
3811385|NCT01774851|3637537|B2|Spain||Region of Enrollment||participants|Number|8|8.0||||||
3811386|NCT01774851|3637538|B1|Spain||Region of Enrollment||participants|Number|9|9.0||||||
3811387|NCT01774851|3637536|B3|Korea, Republic of||Region of Enrollment||participants|Number|21|21.0||||||
3811388|NCT01774851|3637537|B2|Korea, Republic of||Region of Enrollment||participants|Number|10|10.0||||||
3811389|NCT01774851|3637538|B1|Korea, Republic of||Region of Enrollment||participants|Number|11|11.0||||||
3811390|NCT01774851|3637536|B3|France||Region of Enrollment||participants|Number|1|1.0||||||
3811391|NCT01774851|3637537|B2|France||Region of Enrollment||participants|Number|0|0.0||||||
3811392|NCT01774851|3637538|B1|France||Region of Enrollment||participants|Number|1|1.0||||||
3811393|NCT01774851|3637536|B3|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
3811394|NCT01774851|3637537|B2|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
3811395|NCT01774851|3637538|B1|Denmark||Region of Enrollment||participants|Number|0|0.0||||||
3811396|NCT01774851|3637536|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
3811397|NCT01774851|3637537|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3811398|NCT01774851|3637538|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3811399|NCT01774851|3637536|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811400|NCT01774851|3637537|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811401|NCT01774851|3637538|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811402|NCT01774851|3637536|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811403|NCT01774851|3637537|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811404|NCT01774851|3637538|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811405|NCT01774851|3637536|B3||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3811406|NCT01774851|3637537|B2||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3811407|NCT01774851|3637538|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3811408|NCT01774851|3637536|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3811409|NCT01774851|3637537|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3811410|NCT01774851|3637538|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811411|NCT01774851|3637536|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811412|NCT01774851|3637537|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811413|NCT01774851|3637538|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811414|NCT01774851|3637536|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3811415|NCT01774851|3637537|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3811416|NCT01774851|3637538|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3811417|NCT01774851|3637536|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811418|NCT01774851|3637537|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811419|NCT01774851|3637538|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811420|NCT01774851|3637536|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811421|NCT01774851|3637537|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811422|NCT01774851|3637538|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811423|NCT01774851|3637536|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3811424|NCT01774851|3637537|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3811425|NCT01774851|3637538|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3811426|NCT01774851|3637536|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3811427|NCT01774851|3637537|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3811428|NCT01774851|3637538|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3811429|NCT01774851|3637536|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3811430|NCT01774851|3637537|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3811431|NCT01774851|3637538|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3811432|NCT01774851|3637536|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3811433|NCT01774851|3637537|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3811434|NCT01774851|3637538|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3811435|NCT01774851|3637536|B3|||Age||years|Median|63|63.0|Full Range|||31.0|81.0|
3811436|NCT01774851|3637537|B2|||Age||years|Median|63.5|63.5|Full Range|||31.0|78.0|
3811437|NCT01774851|3637538|B1|||Age||years|Median|62.5|62.5|Full Range|||35.0|81.0|
3811438|NCT01774786|3637545|B3||Male|Sex: Female, Male||Participants|Count of Participants|617|617.0||||||
3811439|NCT01774786|3637546|B2||Male|Sex: Female, Male||Participants|Count of Participants|323|323.0||||||
3811440|NCT01774786|3637547|B1||Male|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
3811441|NCT01774786|3637545|B3||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3811442|NCT01774786|3637546|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3811443|NCT01774786|3637547|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3811444|NCT01774786|3637545|B3|||Age||Years|Mean|60.5|60.5|Standard Deviation|11.0|11.0|||
3811445|NCT01774786|3637546|B2|||Age||Years|Mean|60.1|60.1|Standard Deviation|10.7|10.7|||
3811446|NCT01774786|3637547|B1|||Age||Years|Mean|60.9|60.9|Standard Deviation|11.3|11.3|||
3811447|NCT01774721|3637576|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811448|NCT01774721|3637577|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811449|NCT01774721|3637578|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811450|NCT01774721|3637576|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811451|NCT01774721|3637577|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811452|NCT01774721|3637578|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811453|NCT01774721|3637576|B3||White|Race (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
3811454|NCT01774721|3637577|B2||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3811455|NCT01774721|3637578|B1||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3811456|NCT01774721|3637576|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3811457|NCT01774721|3637577|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811458|NCT01774721|3637578|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3811459|NCT01774721|3637576|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811460|NCT01774721|3637577|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811461|NCT01774721|3637578|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811462|NCT01774721|3637576|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|346|346.0||||||
3811463|NCT01774721|3637577|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|176|176.0||||||
3811464|NCT01774721|3637578|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|170|170.0||||||
3811465|NCT01774721|3637576|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811466|NCT01774721|3637577|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811467|NCT01774721|3637578|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811468|NCT01774721|3637576|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811469|NCT01774721|3637577|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811470|NCT01774721|3637578|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811471|NCT01774721|3637576|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|452|452.0||||||
3811472|NCT01774721|3637577|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|225|225.0||||||
3811473|NCT01774721|3637578|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|227|227.0||||||
3811474|NCT01774721|3637576|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811475|NCT01774721|3637577|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811476|NCT01774721|3637578|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811477|NCT01774721|3637576|B3||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
3811478|NCT01774721|3637577|B2||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3811479|NCT01774721|3637578|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3811480|NCT01774721|3637576|B3||Female|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
3811481|NCT01774721|3637577|B2||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3811482|NCT01774721|3637578|B1||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3811483|NCT01774721|3637576|B3|||Age||years|Mean|61.1|61.1|Standard Deviation|10.72|10.72|||
3811484|NCT01774721|3637577|B2|||Age||years|Mean|60.9|60.9|Standard Deviation|10.17|10.17|||
3811485|NCT01774721|3637578|B1|||Age||years|Mean|61.2|61.2|Standard Deviation|11.26|11.26|||
3811486|NCT01774604|3637621|B3|||Periprocedural Fluid Volume||Milliliters|Mean|704|704.0|Standard Deviation|345|345.0|||
3811487|NCT01774604|3637622|B2|||Periprocedural Fluid Volume||Milliliters|Mean|703|703.0|Standard Deviation|355|355.0|||
3811488|NCT01774604|3637623|B1|||Periprocedural Fluid Volume||Milliliters|Mean|705|705.0|Standard Deviation|335|335.0|||
3811489|NCT01774604|3637621|B3|No||Concomitant Endoscopic Ultrasound with Fine Needle Aspiration (EUS/FNA)||participants|Number|368|368.0||||||
3811490|NCT01774604|3637622|B2|No||Concomitant Endoscopic Ultrasound with Fine Needle Aspiration (EUS/FNA)||participants|Number|186|186.0||||||
3811491|NCT01774604|3637623|B1|No||Concomitant Endoscopic Ultrasound with Fine Needle Aspiration (EUS/FNA)||participants|Number|182|182.0||||||
3811492|NCT01774604|3637621|B3|Yes||Concomitant Endoscopic Ultrasound with Fine Needle Aspiration (EUS/FNA)||participants|Number|81|81.0||||||
3811493|NCT01774604|3637622|B2|Yes||Concomitant Endoscopic Ultrasound with Fine Needle Aspiration (EUS/FNA)||participants|Number|40|40.0||||||
3811494|NCT01774604|3637623|B1|Yes||Concomitant Endoscopic Ultrasound with Fine Needle Aspiration (EUS/FNA)||participants|Number|41|41.0||||||
3811495|NCT01774604|3637621|B3|No||Trainee Involvement||participants|Number|129|129.0||||||
3811496|NCT01774604|3637622|B2|No||Trainee Involvement||participants|Number|58|58.0||||||
3811497|NCT01774604|3637623|B1|No||Trainee Involvement||participants|Number|71|71.0||||||
3811498|NCT01774604|3637621|B3|Yes||Trainee Involvement||participants|Number|320|320.0||||||
3811499|NCT01774604|3637622|B2|Yes||Trainee Involvement||participants|Number|168|168.0||||||
3811500|NCT01774604|3637623|B1|Yes||Trainee Involvement||participants|Number|152|152.0||||||
3811501|NCT01774604|3637621|B3|No||Pancreatic Stent Placement||participants|Number|378|378.0||||||
3811502|NCT01774604|3637622|B2|No||Pancreatic Stent Placement||participants|Number|191|191.0||||||
3811503|NCT01774604|3637623|B1|No||Pancreatic Stent Placement||participants|Number|187|187.0||||||
3811504|NCT01774604|3637621|B3|Yes||Pancreatic Stent Placement||participants|Number|71|71.0||||||
3811505|NCT01774604|3637622|B2|Yes||Pancreatic Stent Placement||participants|Number|35|35.0||||||
3811506|NCT01774604|3637623|B1|Yes||Pancreatic Stent Placement||participants|Number|36|36.0||||||
3811507|NCT01774604|3637621|B3|No||Biliary Strent Placement||participants|Number|276|276.0||||||
3811508|NCT01774604|3637622|B2|No||Biliary Strent Placement||participants|Number|142|142.0||||||
3811509|NCT01774604|3637623|B1|No||Biliary Strent Placement||participants|Number|134|134.0||||||
3811510|NCT01774604|3637621|B3|Yes||Biliary Strent Placement||participants|Number|173|173.0||||||
3811511|NCT01774604|3637622|B2|Yes||Biliary Strent Placement||participants|Number|84|84.0||||||
3811512|NCT01774604|3637623|B1|Yes||Biliary Strent Placement||participants|Number|89|89.0||||||
3811513|NCT01774604|3637621|B3|No||Pancreatic Acinarization||participants|Number|440|440.0||||||
3811514|NCT01774604|3637622|B2|No||Pancreatic Acinarization||participants|Number|222|222.0||||||
3811515|NCT01774604|3637623|B1|No||Pancreatic Acinarization||participants|Number|218|218.0||||||
3811516|NCT01774604|3637621|B3|Yes||Pancreatic Acinarization||participants|Number|9|9.0||||||
3811517|NCT01774604|3637622|B2|Yes||Pancreatic Acinarization||participants|Number|4|4.0||||||
3811518|NCT01774604|3637623|B1|Yes||Pancreatic Acinarization||participants|Number|5|5.0||||||
3811519|NCT01774604|3637621|B3|No||Pancreatography||participants|Number|350|350.0||||||
3811520|NCT01774604|3637622|B2|No||Pancreatography||participants|Number|177|177.0||||||
3811521|NCT01774604|3637623|B1|No||Pancreatography||participants|Number|173|173.0||||||
3811522|NCT01774604|3637621|B3|Yes||Pancreatography||participants|Number|99|99.0||||||
3811523|NCT01774604|3637622|B2|Yes||Pancreatography||participants|Number|49|49.0||||||
3811524|NCT01774604|3637623|B1|Yes||Pancreatography||participants|Number|50|50.0||||||
3811525|NCT01774604|3637621|B3|No||Wire Cannulation of Pancreatic Duct||participants|Number|270|270.0||||||
3811526|NCT01774604|3637622|B2|No||Wire Cannulation of Pancreatic Duct||participants|Number|137|137.0||||||
3811527|NCT01774604|3637623|B1|No||Wire Cannulation of Pancreatic Duct||participants|Number|133|133.0||||||
3811528|NCT01774604|3637621|B3|Yes||Wire Cannulation of Pancreatic Duct||participants|Number|179|179.0||||||
3811529|NCT01774604|3637622|B2|Yes||Wire Cannulation of Pancreatic Duct||participants|Number|89|89.0||||||
3811530|NCT01774604|3637623|B1|Yes||Wire Cannulation of Pancreatic Duct||participants|Number|90|90.0||||||
3811531|NCT01774604|3637621|B3|No||Balloon Dilation of Biliary Sphincter||participants|Number|408|408.0||||||
3811532|NCT01774604|3637622|B2|No||Balloon Dilation of Biliary Sphincter||participants|Number|206|206.0||||||
3811533|NCT01774604|3637623|B1|No||Balloon Dilation of Biliary Sphincter||participants|Number|202|202.0||||||
3811534|NCT01774604|3637621|B3|Yes||Balloon Dilation of Biliary Sphincter||participants|Number|41|41.0||||||
3811535|NCT01774604|3637622|B2|Yes||Balloon Dilation of Biliary Sphincter||participants|Number|20|20.0||||||
3811536|NCT01774604|3637623|B1|Yes||Balloon Dilation of Biliary Sphincter||participants|Number|21|21.0||||||
3811537|NCT01774604|3637621|B3|No||Minor Duct Sphincterotomy||participants|Number|440|440.0||||||
3811538|NCT01774604|3637622|B2|No||Minor Duct Sphincterotomy||participants|Number|222|222.0||||||
3811539|NCT01774604|3637623|B1|No||Minor Duct Sphincterotomy||participants|Number|218|218.0||||||
3811540|NCT01774604|3637621|B3|Yes||Minor Duct Sphincterotomy||participants|Number|9|9.0||||||
3811541|NCT01774604|3637622|B2|Yes||Minor Duct Sphincterotomy||participants|Number|4|4.0||||||
3811542|NCT01774604|3637623|B1|Yes||Minor Duct Sphincterotomy||participants|Number|5|5.0||||||
3811543|NCT01774604|3637621|B3|No||Therapeutic Pancreatic Sphincterotomy||participants|Number|432|432.0||||||
3811544|NCT01774604|3637622|B2|No||Therapeutic Pancreatic Sphincterotomy||participants|Number|221|221.0||||||
3811545|NCT01774604|3637623|B1|No||Therapeutic Pancreatic Sphincterotomy||participants|Number|211|211.0||||||
3811546|NCT01774604|3637621|B3|Yes||Therapeutic Pancreatic Sphincterotomy||participants|Number|17|17.0||||||
3811547|NCT01774604|3637622|B2|Yes||Therapeutic Pancreatic Sphincterotomy||participants|Number|5|5.0||||||
3811548|NCT01774604|3637623|B1|Yes||Therapeutic Pancreatic Sphincterotomy||participants|Number|12|12.0||||||
3811549|NCT01774604|3637621|B3|No||Therapeutic Biliary Sphincterotomy||participants|Number|229|229.0||||||
3811550|NCT01774604|3637622|B2|No||Therapeutic Biliary Sphincterotomy||participants|Number|112|112.0||||||
3811551|NCT01774604|3637623|B1|No||Therapeutic Biliary Sphincterotomy||participants|Number|117|117.0||||||
3811552|NCT01774604|3637621|B3|Yes||Therapeutic Biliary Sphincterotomy||participants|Number|220|220.0||||||
3811553|NCT01774604|3637622|B2|Yes||Therapeutic Biliary Sphincterotomy||participants|Number|114|114.0||||||
3811554|NCT01774604|3637623|B1|Yes||Therapeutic Biliary Sphincterotomy||participants|Number|106|106.0||||||
3811555|NCT01774604|3637621|B3|No||Precut Biliary Sphincterotomy||participants|Number|422|422.0||||||
3811556|NCT01774604|3637622|B2|No||Precut Biliary Sphincterotomy||participants|Number|210|210.0||||||
3811557|NCT01774604|3637623|B1|No||Precut Biliary Sphincterotomy||participants|Number|212|212.0||||||
3811558|NCT01774604|3637621|B3|Yes||Precut Biliary Sphincterotomy||participants|Number|27|27.0||||||
3811559|NCT01774604|3637622|B2|Yes||Precut Biliary Sphincterotomy||participants|Number|16|16.0||||||
3811560|NCT01774604|3637623|B1|Yes||Precut Biliary Sphincterotomy||participants|Number|11|11.0||||||
3811561|NCT01774604|3637621|B3|No||Difficult Cannulation|Difficult Cannulation was defined by >8 attempts at cannulation|participants|Number|361|361.0||||||
3811562|NCT01774604|3637622|B2|No||Difficult Cannulation|Difficult Cannulation was defined by >8 attempts at cannulation|participants|Number|184|184.0||||||
3811563|NCT01774604|3637623|B1|No||Difficult Cannulation|Difficult Cannulation was defined by >8 attempts at cannulation|participants|Number|177|177.0||||||
3811564|NCT01774604|3637621|B3|Yes||Difficult Cannulation|Difficult Cannulation was defined by >8 attempts at cannulation|participants|Number|88|88.0||||||
3811565|NCT01774604|3637622|B2|Yes||Difficult Cannulation|Difficult Cannulation was defined by >8 attempts at cannulation|participants|Number|42|42.0||||||
3811566|NCT01774604|3637623|B1|Yes||Difficult Cannulation|Difficult Cannulation was defined by >8 attempts at cannulation|participants|Number|46|46.0||||||
3811567|NCT01774604|3637621|B3|No||Previous ERCP||participants|Number|289|289.0||||||
3811568|NCT01774604|3637622|B2|No||Previous ERCP||participants|Number|147|147.0||||||
3811569|NCT01774604|3637623|B1|No||Previous ERCP||participants|Number|142|142.0||||||
3811570|NCT01774604|3637621|B3|Yes||Previous ERCP||participants|Number|160|160.0||||||
3811571|NCT01774604|3637622|B2|Yes||Previous ERCP||participants|Number|79|79.0||||||
3811572|NCT01774604|3637623|B1|Yes||Previous ERCP||participants|Number|81|81.0||||||
3811573|NCT01774604|3637621|B3|No||History of Previous Sphincterotomy||participants|Number|306|306.0||||||
3811574|NCT01774604|3637622|B2|No||History of Previous Sphincterotomy||participants|Number|155|155.0||||||
3811575|NCT01774604|3637623|B1|No||History of Previous Sphincterotomy||participants|Number|151|151.0||||||
3811576|NCT01774604|3637621|B3|Yes||History of Previous Sphincterotomy||participants|Number|143|143.0||||||
3811577|NCT01774604|3637622|B2|Yes||History of Previous Sphincterotomy||participants|Number|71|71.0||||||
3811578|NCT01774604|3637623|B1|Yes||History of Previous Sphincterotomy||participants|Number|72|72.0||||||
3811579|NCT01774604|3637621|B3|No||History of post-ERCP Pancreatitis||participants|Number|431|431.0||||||
3811580|NCT01774604|3637622|B2|No||History of post-ERCP Pancreatitis||participants|Number|217|217.0||||||
3811581|NCT01774604|3637623|B1|No||History of post-ERCP Pancreatitis||participants|Number|214|214.0||||||
3811582|NCT01774604|3637621|B3|Yes||History of post-ERCP Pancreatitis||participants|Number|18|18.0||||||
3811583|NCT01774604|3637622|B2|Yes||History of post-ERCP Pancreatitis||participants|Number|9|9.0||||||
3811584|NCT01774604|3637623|B1|Yes||History of post-ERCP Pancreatitis||participants|Number|9|9.0||||||
3811585|NCT01774604|3637621|B3|Other||Indication||participants|Number|47|47.0||||||
3811586|NCT01774604|3637622|B2|Other||Indication||participants|Number|31|31.0||||||
3811587|NCT01774604|3637623|B1|Other||Indication||participants|Number|16|16.0||||||
3811588|NCT01774604|3637621|B3|Ampullectomy||Indication||participants|Number|11|11.0||||||
3811589|NCT01774604|3637622|B2|Ampullectomy||Indication||participants|Number|5|5.0||||||
3811590|NCT01774604|3637623|B1|Ampullectomy||Indication||participants|Number|6|6.0||||||
3811591|NCT01774604|3637621|B3|Recurrent Acute Pancreatitis||Indication||participants|Number|7|7.0||||||
3811592|NCT01774604|3637622|B2|Recurrent Acute Pancreatitis||Indication||participants|Number|2|2.0||||||
3811593|NCT01774604|3637623|B1|Recurrent Acute Pancreatitis||Indication||participants|Number|5|5.0||||||
3811594|NCT01774604|3637621|B3|Pancreatic Duct Stone||Indication||participants|Number|5|5.0||||||
3811595|NCT01774604|3637622|B2|Pancreatic Duct Stone||Indication||participants|Number|2|2.0||||||
3811596|NCT01774604|3637623|B1|Pancreatic Duct Stone||Indication||participants|Number|3|3.0||||||
3811597|NCT01774604|3637621|B3|Pancreatic Leak/Disruption||Indication||participants|Number|23|23.0||||||
3811598|NCT01774604|3637622|B2|Pancreatic Leak/Disruption||Indication||participants|Number|12|12.0||||||
3811599|NCT01774604|3637623|B1|Pancreatic Leak/Disruption||Indication||participants|Number|11|11.0||||||
3811600|NCT01774604|3637621|B3|Suspected Sphincter of Oddi Dysfunction (SOD)||Indication||participants|Number|14|14.0||||||
3811601|NCT01774604|3637622|B2|Suspected Sphincter of Oddi Dysfunction (SOD)||Indication||participants|Number|8|8.0||||||
3811602|NCT01774604|3637623|B1|Suspected Sphincter of Oddi Dysfunction (SOD)||Indication||participants|Number|6|6.0||||||
3811603|NCT01774604|3637621|B3|Pancreatic Stricture||Indication||participants|Number|8|8.0||||||
3811604|NCT01774604|3637622|B2|Pancreatic Stricture||Indication||participants|Number|5|5.0||||||
3811605|NCT01774604|3637623|B1|Pancreatic Stricture||Indication||participants|Number|3|3.0||||||
3811606|NCT01774604|3637621|B3|Increased Liver Tests/Jaundice||Indication||participants|Number|22|22.0||||||
3811607|NCT01774604|3637622|B2|Increased Liver Tests/Jaundice||Indication||participants|Number|9|9.0||||||
3811608|NCT01774604|3637623|B1|Increased Liver Tests/Jaundice||Indication||participants|Number|13|13.0||||||
3811609|NCT01774604|3637621|B3|Biliary Leak||Indication||participants|Number|23|23.0||||||
3811610|NCT01774604|3637622|B2|Biliary Leak||Indication||participants|Number|12|12.0||||||
3811611|NCT01774604|3637623|B1|Biliary Leak||Indication||participants|Number|11|11.0||||||
3811612|NCT01774604|3637621|B3|Biliary Stent Change||Indication||participants|Number|50|50.0||||||
3811613|NCT01774604|3637622|B2|Biliary Stent Change||Indication||participants|Number|25|25.0||||||
3811614|NCT01774604|3637623|B1|Biliary Stent Change||Indication||participants|Number|25|25.0||||||
3811615|NCT01774604|3637621|B3|Malignant Biliary Obstruction||Indication||participants|Number|103|103.0||||||
3811616|NCT01774604|3637622|B2|Malignant Biliary Obstruction||Indication||participants|Number|50|50.0||||||
3811617|NCT01774604|3637623|B1|Malignant Biliary Obstruction||Indication||participants|Number|53|53.0||||||
3811618|NCT01774604|3637621|B3|Choledocholithiasis||Indication||participants|Number|111|111.0||||||
3811619|NCT01774604|3637622|B2|Choledocholithiasis||Indication||participants|Number|52|52.0||||||
3811620|NCT01774604|3637623|B1|Choledocholithiasis||Indication||participants|Number|59|59.0||||||
3811621|NCT01774604|3637621|B3|Acute Cholangitis||Indication||participants|Number|25|25.0||||||
3811622|NCT01774604|3637622|B2|Acute Cholangitis||Indication||participants|Number|13|13.0||||||
3811623|NCT01774604|3637623|B1|Acute Cholangitis||Indication||participants|Number|12|12.0||||||
3811624|NCT01774604|3637621|B3||Male|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
3811625|NCT01774604|3637622|B2||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3811626|NCT01774604|3637623|B1||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3811627|NCT01774604|3637621|B3||Female|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
3811628|NCT01774604|3637622|B2||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3811629|NCT01774604|3637623|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3811630|NCT01774604|3637621|B3|||Age||years|Mean|64.6|64.6|Standard Deviation|19.9|19.9|||
3811631|NCT01774604|3637622|B2|||Age||years|Mean|64.3|64.3|Standard Deviation|15.1|15.1|||
3811632|NCT01774604|3637623|B1|||Age||years|Mean|64.9|64.9|Standard Deviation|23.7|23.7|||
3811633|NCT01774591|3637642|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3811634|NCT01774591|3637643|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3811635|NCT01774591|3637644|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3811636|NCT01774591|3637642|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3811637|NCT01774591|3637643|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3811638|NCT01774591|3637644|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3811639|NCT01774591|3637642|B3|||Age||years|Median|57|57.0|Inter-Quartile Range|||54.0|62.0|
3811640|NCT01774591|3637643|B2|||Age||years|Median|55|55.0|Inter-Quartile Range|||53.0|57.0|
3811641|NCT01774591|3637644|B1|||Age||years|Median|61|61.0|Inter-Quartile Range|||56.0|63.0|
3811642|NCT01774344|3637655|B3|Presence||Extrahepatic disease (IVRS)||Subjects|Number|382|382.0||||||
3811643|NCT01774344|3637656|B2|Presence||Extrahepatic disease (IVRS)||Subjects|Number|250|250.0||||||
3811644|NCT01774344|3637657|B1|Presence||Extrahepatic disease (IVRS)||Subjects|Number|132|132.0||||||
3811645|NCT01774344|3637655|B3|Absence||Extrahepatic disease (IVRS)||Subjects|Number|191|191.0||||||
3811646|NCT01774344|3637656|B2|Absence||Extrahepatic disease (IVRS)||Subjects|Number|129|129.0||||||
3811647|NCT01774344|3637657|B1|Absence||Extrahepatic disease (IVRS)||Subjects|Number|62|62.0||||||
3811648|NCT01774344|3637655|B3|Presence||Extrahepatic disease (RAVE)||Subjects|Number|412|412.0||||||
3811649|NCT01774344|3637656|B2|Presence||Extrahepatic disease (RAVE)||Subjects|Number|265|265.0||||||
3811650|NCT01774344|3637657|B1|Presence||Extrahepatic disease (RAVE)||Subjects|Number|147|147.0||||||
3811651|NCT01774344|3637655|B3|Absence||Extrahepatic disease (RAVE)||Subjects|Number|161|161.0||||||
3811652|NCT01774344|3637656|B2|Absence||Extrahepatic disease (RAVE)||Subjects|Number|114|114.0||||||
3811653|NCT01774344|3637657|B1|Absence||Extrahepatic disease (RAVE)||Subjects|Number|47|47.0||||||
3811654|NCT01774344|3637655|B3|Advanced stage||The Barcelona-Clinic Liver Cancer (BCLC) stage at study entry||Subjects|Number|497|497.0||||||
3811655|NCT01774344|3637656|B2|Advanced stage||The Barcelona-Clinic Liver Cancer (BCLC) stage at study entry||Subjects|Number|325|325.0||||||
3811656|NCT01774344|3637657|B1|Advanced stage||The Barcelona-Clinic Liver Cancer (BCLC) stage at study entry||Subjects|Number|172|172.0||||||
3811657|NCT01774344|3637655|B3|Intermediate stage||The Barcelona-Clinic Liver Cancer (BCLC) stage at study entry||Subjects|Number|75|75.0||||||
3811658|NCT01774344|3637656|B2|Intermediate stage||The Barcelona-Clinic Liver Cancer (BCLC) stage at study entry||Subjects|Number|53|53.0||||||
3811659|NCT01774344|3637657|B1|Intermediate stage||The Barcelona-Clinic Liver Cancer (BCLC) stage at study entry||Subjects|Number|22|22.0||||||
3811660|NCT01774344|3637655|B3|Early stage||The Barcelona-Clinic Liver Cancer (BCLC) stage at study entry||Subjects|Number|1|1.0||||||
3811661|NCT01774344|3637656|B2|Early stage||The Barcelona-Clinic Liver Cancer (BCLC) stage at study entry||Subjects|Number|1|1.0||||||
3811662|NCT01774344|3637657|B1|Early stage||The Barcelona-Clinic Liver Cancer (BCLC) stage at study entry||Subjects|Number|0|0.0||||||
3811663|NCT01774344|3637655|B3|Presence||Macrovascular invasion (IVRS)||Subjects|Number|176|176.0||||||
3811664|NCT01774344|3637656|B2|Presence||Macrovascular invasion (IVRS)||Subjects|Number|117|117.0||||||
3811665|NCT01774344|3637657|B1|Presence||Macrovascular invasion (IVRS)||Subjects|Number|59|59.0||||||
3811666|NCT01774344|3637655|B3|Absence||Macrovascular invasion (IVRS)||Subjects|Number|397|397.0||||||
3811667|NCT01774344|3637656|B2|Absence||Macrovascular invasion (IVRS)||Subjects|Number|262|262.0||||||
3811668|NCT01774344|3637657|B1|Absence||Macrovascular invasion (IVRS)||Subjects|Number|135|135.0||||||
3811669|NCT01774344|3637655|B3|Presence||Macrovascular invasion (RAVE)||Subjects|Number|164|164.0||||||
3811670|NCT01774344|3637656|B2|Presence||Macrovascular invasion (RAVE)||Subjects|Number|110|110.0||||||
3811671|NCT01774344|3637657|B1|Presence||Macrovascular invasion (RAVE)||Subjects|Number|54|54.0||||||
3811672|NCT01774344|3637655|B3|Absence||Macrovascular invasion (RAVE)||Subjects|Number|409|409.0||||||
3811673|NCT01774344|3637656|B2|Absence||Macrovascular invasion (RAVE)||Subjects|Number|269|269.0||||||
3811674|NCT01774344|3637657|B1|Absence||Macrovascular invasion (RAVE)||Subjects|Number|140|140.0||||||
3811675|NCT01774344|3637655|B3|>= 400 ng/mL||Alpha-fetoprotein (AFP) (IVRS)||Subjects|Number|256|256.0||||||
3811676|NCT01774344|3637656|B2|>= 400 ng/mL||Alpha-fetoprotein (AFP) (IVRS)||Subjects|Number|167|167.0||||||
3811677|NCT01774344|3637657|B1|>= 400 ng/mL||Alpha-fetoprotein (AFP) (IVRS)||Subjects|Number|89|89.0||||||
3811678|NCT01774344|3637655|B3|< 400 ng/mL||Alpha-fetoprotein (AFP) (IVRS)||Subjects|Number|317|317.0||||||
3811679|NCT01774344|3637656|B2|< 400 ng/mL||Alpha-fetoprotein (AFP) (IVRS)||Subjects|Number|212|212.0||||||
3811680|NCT01774344|3637657|B1|< 400 ng/mL||Alpha-fetoprotein (AFP) (IVRS)||Subjects|Number|105|105.0||||||
3811681|NCT01774344|3637655|B3|greater than or equal to (>=) 400 ng/mL||Alpha-fetoprotein (AFP) (RAVE)||Subjects|Number|249|249.0||||||
3811682|NCT01774344|3637656|B2|greater than or equal to (>=) 400 ng/mL||Alpha-fetoprotein (AFP) (RAVE)||Subjects|Number|162|162.0||||||
3811683|NCT01774344|3637657|B1|greater than or equal to (>=) 400 ng/mL||Alpha-fetoprotein (AFP) (RAVE)||Subjects|Number|87|87.0||||||
3811684|NCT01774344|3637655|B3|less than (<) 400 nanogram per milliliter (ng/mL)||Alpha-fetoprotein (AFP) (RAVE)||Subjects|Number|324|324.0||||||
3811685|NCT01774344|3637656|B2|less than (<) 400 nanogram per milliliter (ng/mL)||Alpha-fetoprotein (AFP) (RAVE)||Subjects|Number|217|217.0||||||
3811686|NCT01774344|3637657|B1|less than (<) 400 nanogram per milliliter (ng/mL)||Alpha-fetoprotein (AFP) (RAVE)||Subjects|Number|107|107.0||||||
3811687|NCT01774344|3637655|B3|Grade 1||ECOG PS: Interactive voice response system (IVRS)|ECOG PS is a standard criteria for measuring how the disease impacts a cancer patient’s daily living abilities in a scale of 0 to 4. Grade 0=Fully active, able to carry on all pre-diseases performance. Grade 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work. Grade 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Grade 3=Capable of only limited self-care, confined to bed/chair more than 50% of waking hours. Grade 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed/chair.|Subjects|Number|193|193.0||||||
3811688|NCT01774344|3637656|B2|Grade 1||ECOG PS: Interactive voice response system (IVRS)|ECOG PS is a standard criteria for measuring how the disease impacts a cancer patient’s daily living abilities in a scale of 0 to 4. Grade 0=Fully active, able to carry on all pre-diseases performance. Grade 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work. Grade 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Grade 3=Capable of only limited self-care, confined to bed/chair more than 50% of waking hours. Grade 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed/chair.|Subjects|Number|128|128.0||||||
3811689|NCT01774344|3637657|B1|Grade 1||ECOG PS: Interactive voice response system (IVRS)|ECOG PS is a standard criteria for measuring how the disease impacts a cancer patient’s daily living abilities in a scale of 0 to 4. Grade 0=Fully active, able to carry on all pre-diseases performance. Grade 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work. Grade 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Grade 3=Capable of only limited self-care, confined to bed/chair more than 50% of waking hours. Grade 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed/chair.|Subjects|Number|65|65.0||||||
3811690|NCT01774344|3637655|B3|Grade 0||ECOG PS: Interactive voice response system (IVRS)|ECOG PS is a standard criteria for measuring how the disease impacts a cancer patient’s daily living abilities in a scale of 0 to 4. Grade 0=Fully active, able to carry on all pre-diseases performance. Grade 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work. Grade 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Grade 3=Capable of only limited self-care, confined to bed/chair more than 50% of waking hours. Grade 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed/chair.|Subjects|Number|380|380.0||||||
3811691|NCT01774344|3637656|B2|Grade 0||ECOG PS: Interactive voice response system (IVRS)|ECOG PS is a standard criteria for measuring how the disease impacts a cancer patient’s daily living abilities in a scale of 0 to 4. Grade 0=Fully active, able to carry on all pre-diseases performance. Grade 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work. Grade 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Grade 3=Capable of only limited self-care, confined to bed/chair more than 50% of waking hours. Grade 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed/chair.|Subjects|Number|251|251.0||||||
3811692|NCT01774344|3637657|B1|Grade 0||ECOG PS: Interactive voice response system (IVRS)|ECOG PS is a standard criteria for measuring how the disease impacts a cancer patient’s daily living abilities in a scale of 0 to 4. Grade 0=Fully active, able to carry on all pre-diseases performance. Grade 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work. Grade 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Grade 3=Capable of only limited self-care, confined to bed/chair more than 50% of waking hours. Grade 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed/chair.|Subjects|Number|129|129.0||||||
3811693|NCT01774344|3637655|B3|Grade 1||Eastern cooperative oncology group (ECOG) Performance Status (PS) (data collection system-RAVE)|ECOG PS is a standard criteria for measuring how the disease impacts a cancer patient’s daily living abilities in a scale of 0 to 4. Grade 0=Fully active, able to carry on all pre-diseases performance. Grade 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work. Grade 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Grade 3=Capable of only limited self-care, confined to bed/chair more than 50% of waking hours. Grade 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed/chair.|Subjects|Number|196|196.0||||||
3811694|NCT01774344|3637656|B2|Grade 1||Eastern cooperative oncology group (ECOG) Performance Status (PS) (data collection system-RAVE)|ECOG PS is a standard criteria for measuring how the disease impacts a cancer patient’s daily living abilities in a scale of 0 to 4. Grade 0=Fully active, able to carry on all pre-diseases performance. Grade 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work. Grade 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Grade 3=Capable of only limited self-care, confined to bed/chair more than 50% of waking hours. Grade 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed/chair.|Subjects|Number|132|132.0||||||
3811795|NCT01774097|3637709|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811695|NCT01774344|3637657|B1|Grade 1||Eastern cooperative oncology group (ECOG) Performance Status (PS) (data collection system-RAVE)|ECOG PS is a standard criteria for measuring how the disease impacts a cancer patient’s daily living abilities in a scale of 0 to 4. Grade 0=Fully active, able to carry on all pre-diseases performance. Grade 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work. Grade 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Grade 3=Capable of only limited self-care, confined to bed/chair more than 50% of waking hours. Grade 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed/chair.|Subjects|Number|64|64.0||||||
3811696|NCT01774344|3637655|B3|Grade 0||Eastern cooperative oncology group (ECOG) Performance Status (PS) (data collection system-RAVE)|ECOG PS is a standard criteria for measuring how the disease impacts a cancer patient’s daily living abilities in a scale of 0 to 4. Grade 0=Fully active, able to carry on all pre-diseases performance. Grade 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work. Grade 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Grade 3=Capable of only limited self-care, confined to bed/chair more than 50% of waking hours. Grade 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed/chair.|Subjects|Number|377|377.0||||||
3811697|NCT01774344|3637656|B2|Grade 0||Eastern cooperative oncology group (ECOG) Performance Status (PS) (data collection system-RAVE)|ECOG PS is a standard criteria for measuring how the disease impacts a cancer patient’s daily living abilities in a scale of 0 to 4. Grade 0=Fully active, able to carry on all pre-diseases performance. Grade 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work. Grade 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Grade 3=Capable of only limited self-care, confined to bed/chair more than 50% of waking hours. Grade 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed/chair.|Subjects|Number|247|247.0||||||
3811698|NCT01774344|3637657|B1|Grade 0||Eastern cooperative oncology group (ECOG) Performance Status (PS) (data collection system-RAVE)|ECOG PS is a standard criteria for measuring how the disease impacts a cancer patient’s daily living abilities in a scale of 0 to 4. Grade 0=Fully active, able to carry on all pre-diseases performance. Grade 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work. Grade 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Grade 3=Capable of only limited self-care, confined to bed/chair more than 50% of waking hours. Grade 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed/chair.|Subjects|Number|130|130.0||||||
3811699|NCT01774344|3637655|B3||Male|Sex: Female, Male||Participants|Count of Participants|504|504.0||||||
3811700|NCT01774344|3637656|B2||Male|Sex: Female, Male||Participants|Count of Participants|333|333.0||||||
3811701|NCT01774344|3637657|B1||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3811702|NCT01774344|3637655|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3811703|NCT01774344|3637656|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3811704|NCT01774344|3637657|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3811705|NCT01774344|3637655|B3|||Age||years|Mean|61.6|61.6|Standard Deviation|12.1|12.1|||
3811706|NCT01774344|3637656|B2|||Age||years|Mean|61.8|61.8|Standard Deviation|12.4|12.4|||
3811707|NCT01774344|3637657|B1|||Age||years|Mean|61.1|61.1|Standard Deviation|11.6|11.6|||
3811708|NCT01774305|3637672|B3|non-smoking||smoking|It has been known that smoking history is related to coughing.|participants|Number|111|111.0||||||
3811709|NCT01774305|3637673|B2|non-smoking||smoking|It has been known that smoking history is related to coughing.|participants|Number|53|53.0||||||
3811710|NCT01774305|3637674|B1|non-smoking||smoking|It has been known that smoking history is related to coughing.|participants|Number|58|58.0||||||
3811711|NCT01774305|3637672|B3|smoking||smoking|It has been known that smoking history is related to coughing.|participants|Number|30|30.0||||||
3811712|NCT01774305|3637673|B2|smoking||smoking|It has been known that smoking history is related to coughing.|participants|Number|18|18.0||||||
3811713|NCT01774305|3637674|B1|smoking||smoking|It has been known that smoking history is related to coughing.|participants|Number|12|12.0||||||
3811714|NCT01774305|3637672|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3811715|NCT01774305|3637673|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3811716|NCT01774305|3637674|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3811717|NCT01774305|3637672|B3||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3811718|NCT01774305|3637673|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3811719|NCT01774305|3637674|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3811720|NCT01774305|3637672|B3|||Age||years|Mean|45.5|45.5|Standard Deviation|11.3|11.3|||
3811721|NCT01774305|3637673|B2|||Age||years|Mean|45.6|45.6|Standard Deviation|12.3|12.3|||
3811722|NCT01774305|3637674|B1|||Age||years|Mean|45.3|45.3|Standard Deviation|10.4|10.4|||
3811723|NCT01774305|3637672|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3811724|NCT01774305|3637673|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3811725|NCT01774305|3637674|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3811726|NCT01774305|3637672|B3||Between 18 and 65 years|Age||Participants|Count of Participants|141|141.0||||||
3811727|NCT01774305|3637673|B2||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
3811728|NCT01774305|3637674|B1||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
3811729|NCT01774305|3637672|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3811730|NCT01774305|3637673|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3811731|NCT01774305|3637674|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3811732|NCT01774253|3637683|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3811733|NCT01774253|3637683|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811734|NCT01774253|3637683|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3811735|NCT01774253|3637683|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811736|NCT01774253|3637683|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811737|NCT01774253|3637683|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811738|NCT01774253|3637683|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811739|NCT01774253|3637683|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3811740|NCT01774253|3637683|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3811741|NCT01774253|3637683|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3811742|NCT01774253|3637683|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
3811743|NCT01774253|3637683|B1||Female|Gender||Participants|Count of Participants|4|4.0||||||
3811744|NCT01774253|3637683|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3811745|NCT01774253|3637683|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3811746|NCT01774253|3637683|B1||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
3811747|NCT01774149|3637691|B3|||HbA1c||%|Mean|8.20|8.2|Standard Deviation|1.11|1.11|||
3811748|NCT01774149|3637692|B2|||HbA1c||%|Mean|8.33|8.33|Standard Deviation|0.87|0.87|||
3811749|NCT01774149|3637693|B1|||HbA1c||%|Mean|8.06|8.06|Standard Deviation|1.32|1.32|||
3811750|NCT01774149|3637691|B3|Norway||Region of Enrollment||participants|Number|30|30.0||||||
3811751|NCT01774149|3637692|B2|Norway||Region of Enrollment||participants|Number|15|15.0||||||
3811752|NCT01774149|3637693|B1|Norway||Region of Enrollment||participants|Number|15|15.0||||||
3811753|NCT01774149|3637691|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3811754|NCT01774149|3637692|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3811755|NCT01774149|3637693|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3811756|NCT01774149|3637691|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3811757|NCT01774149|3637692|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3811758|NCT01774149|3637693|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3811759|NCT01774149|3637691|B3|||Age||years|Mean|39.7|39.7|Standard Deviation|10.8|10.8|||
3811760|NCT01774149|3637692|B2|||Age||years|Mean|41.1|41.1|Standard Deviation|13.5|13.5|||
3811761|NCT01774149|3637693|B1|||Age||years|Mean|38.3|38.3|Standard Deviation|7.3|7.3|||
3811762|NCT01774149|3637691|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3811763|NCT01774149|3637692|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3811764|NCT01774149|3637693|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3811765|NCT01774149|3637691|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3811766|NCT01774149|3637692|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3811767|NCT01774149|3637693|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3811768|NCT01774149|3637691|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3811769|NCT01774149|3637692|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3811770|NCT01774149|3637693|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3811771|NCT01774110|3637702|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3811772|NCT01774110|3637702|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3811773|NCT01774110|3637702|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3811774|NCT01774110|3637702|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3811775|NCT01774110|3637702|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3811776|NCT01774097|3637708|B3|United States||Region of Enrollment||participants|Number|78|78.0||||||
3811777|NCT01774097|3637709|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
3811778|NCT01774097|3637710|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
3811779|NCT01774097|3637708|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811780|NCT01774097|3637709|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811781|NCT01774097|3637710|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811782|NCT01774097|3637708|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811783|NCT01774097|3637709|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811784|NCT01774097|3637710|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811785|NCT01774097|3637708|B3||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3811786|NCT01774097|3637709|B2||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3811787|NCT01774097|3637710|B1||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3811788|NCT01774097|3637708|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3811789|NCT01774097|3637709|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3811790|NCT01774097|3637710|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3811791|NCT01774097|3637708|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811792|NCT01774097|3637709|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811793|NCT01774097|3637710|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811794|NCT01774097|3637708|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3811796|NCT01774097|3637710|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3811797|NCT01774097|3637708|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811798|NCT01774097|3637709|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811799|NCT01774097|3637710|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811800|NCT01774097|3637708|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3811801|NCT01774097|3637709|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3811802|NCT01774097|3637710|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3811803|NCT01774097|3637708|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3811804|NCT01774097|3637709|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3811805|NCT01774097|3637710|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3811806|NCT01774097|3637708|B3|||Age||Years|Mean|66.2|66.2|Standard Deviation|8.65|8.65|||
3811807|NCT01774097|3637709|B2|||Age||Years|Mean|66.2|66.2|Standard Deviation|8.7|8.7|||
3811808|NCT01774097|3637710|B1|||Age||Years|Mean|66.3|66.3|Standard Deviation|8.6|8.6|||
3811809|NCT01774084|3637739|B3|Sweden||Region of Enrollment||participants|Number|22|22.0||||||
3811810|NCT01774084|3637740|B2|Sweden||Region of Enrollment||participants|Number|12|12.0||||||
3811811|NCT01774084|3637741|B1|Sweden||Region of Enrollment||participants|Number|10|10.0||||||
3811812|NCT01774084|3637739|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3811813|NCT01774084|3637740|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3811814|NCT01774084|3637741|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3811815|NCT01774084|3637739|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3811816|NCT01774084|3637740|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3811817|NCT01774084|3637741|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3811818|NCT01774084|3637739|B3|||Age||years|Mean|67|67.0|Standard Deviation|4|4.0|||
3811819|NCT01774084|3637740|B2|||Age||years|Mean|68|68.0|Standard Deviation|4|4.0|||
3811820|NCT01774084|3637741|B1|||Age||years|Mean|66|66.0|Standard Deviation|4|4.0|||
3811821|NCT01774084|3637739|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3811822|NCT01774084|3637740|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3811823|NCT01774084|3637741|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3811824|NCT01774084|3637739|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3811825|NCT01774084|3637740|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3811826|NCT01774084|3637741|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3811827|NCT01774084|3637739|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3811828|NCT01774084|3637740|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3811829|NCT01774084|3637741|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3811830|NCT01774045|3637750|B3|Taiwan||Region of Enrollment||participants|Number|30|30.0||||||
3811831|NCT01774045|3637751|B2|Taiwan||Region of Enrollment||participants|Number|7|7.0||||||
3811832|NCT01774045|3637752|B1|Taiwan||Region of Enrollment||participants|Number|23|23.0||||||
3811833|NCT01774045|3637750|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3811834|NCT01774045|3637751|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3811835|NCT01774045|3637752|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3811836|NCT01774045|3637750|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3811837|NCT01774045|3637751|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3811838|NCT01774045|3637752|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3811839|NCT01774045|3637750|B3|||Age||years|Mean|26.8|26.8|Standard Deviation|3.3|3.3|||
3811840|NCT01774045|3637751|B2|||Age||years|Mean|27.2|27.2|Standard Deviation|3.5|3.5|||
3811841|NCT01774045|3637752|B1|||Age||years|Mean|26.7|26.7|Standard Deviation|3.3|3.3|||
3811842|NCT01773954|3637767|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3811843|NCT01773954|3637767|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3811844|NCT01773954|3637767|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3811845|NCT01773954|3637767|B1|||Age||years|Mean|81.3|81.3|Standard Deviation|7.4|7.4|||
3811846|NCT01773889|3637772|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3811847|NCT01773889|3637772|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3811848|NCT01773889|3637772|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3811849|NCT01773889|3637772|B1|||Age||years|Mean|57|57.0|Standard Deviation|3|3.0|||
3811850|NCT01773889|3637772|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3811851|NCT01773889|3637772|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3811852|NCT01773889|3637772|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3811853|NCT01773473|3637776|B3|||Duration of Type-2 Diabetes Mellitus (T2DM)||years|Mean|9.45|9.45|Standard Deviation|6.250|6.25|||
3811854|NCT01773473|3637777|B2|||Duration of Type-2 Diabetes Mellitus (T2DM)||years|Mean|9.15|9.15|Standard Deviation|6.336|6.336|||
3811855|NCT01773473|3637778|B1|||Duration of Type-2 Diabetes Mellitus (T2DM)||years|Mean|9.74|9.74|Standard Deviation|6.169|6.169|||
3811856|NCT01773473|3637776|B3|Korea, Republic of||Region of Enrollment||participants|Number|46|46.0||||||
3811857|NCT01773473|3637777|B2|Korea, Republic of||Region of Enrollment||participants|Number|22|22.0||||||
3811858|NCT01773473|3637778|B1|Korea, Republic of||Region of Enrollment||participants|Number|24|24.0||||||
3811859|NCT01773473|3637776|B3|China||Region of Enrollment||participants|Number|156|156.0||||||
3811860|NCT01773473|3637777|B2|China||Region of Enrollment||participants|Number|76|76.0||||||
3811861|NCT01773473|3637778|B1|China||Region of Enrollment||participants|Number|80|80.0||||||
3811862|NCT01773473|3637776|B3|Japan||Region of Enrollment||participants|Number|172|172.0||||||
3811863|NCT01773473|3637777|B2|Japan||Region of Enrollment||participants|Number|84|84.0||||||
3811864|NCT01773473|3637778|B1|Japan||Region of Enrollment||participants|Number|88|88.0||||||
3811865|NCT01773473|3637776|B3|Turkey||Region of Enrollment||participants|Number|29|29.0||||||
3811866|NCT01773473|3637777|B2|Turkey||Region of Enrollment||participants|Number|14|14.0||||||
3811867|NCT01773473|3637778|B1|Turkey||Region of Enrollment||participants|Number|15|15.0||||||
3811868|NCT01773473|3637776|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811869|NCT01773473|3637777|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811870|NCT01773473|3637778|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811871|NCT01773473|3637776|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811872|NCT01773473|3637777|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811873|NCT01773473|3637778|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811874|NCT01773473|3637776|B3||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3811875|NCT01773473|3637777|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3811876|NCT01773473|3637778|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3811877|NCT01773473|3637776|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811878|NCT01773473|3637777|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811879|NCT01773473|3637778|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811880|NCT01773473|3637776|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811881|NCT01773473|3637777|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811882|NCT01773473|3637778|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811883|NCT01773473|3637776|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|374|374.0||||||
3811884|NCT01773473|3637777|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|182|182.0||||||
3811885|NCT01773473|3637778|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|192|192.0||||||
3811886|NCT01773473|3637776|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811887|NCT01773473|3637777|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811888|NCT01773473|3637778|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3811889|NCT01773473|3637776|B3||Male|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
3811890|NCT01773473|3637777|B2||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3811891|NCT01773473|3637778|B1||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3811892|NCT01773473|3637776|B3||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3811893|NCT01773473|3637777|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3811894|NCT01773473|3637778|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3811895|NCT01773473|3637776|B3|||Age||years|Mean|56.52|56.52|Standard Deviation|9.871|9.871|||
3811896|NCT01773473|3637777|B2|||Age||years|Mean|57.34|57.34|Standard Deviation|9.664|9.664|||
3811897|NCT01773473|3637778|B1|||Age||years|Mean|55.74|55.74|Standard Deviation|10.026|10.026|||
3811898|NCT01773291|3637797|B4|Taiwan||Region of Enrollment||participants|Number|22|22.0||||||
3811899|NCT01773291|3637798|B3|Taiwan||Region of Enrollment||participants|Number|6|6.0||||||
3811900|NCT01773291|3637799|B2|Taiwan||Region of Enrollment||participants|Number|9|9.0||||||
3811901|NCT01773291|3637800|B1|Taiwan||Region of Enrollment||participants|Number|7|7.0||||||
3811902|NCT01773291|3637797|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3811903|NCT01773291|3637798|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3811904|NCT01773291|3637799|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3811905|NCT01773291|3637800|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3811906|NCT01773291|3637797|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3811907|NCT01773291|3637798|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3811908|NCT01773291|3637799|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3811909|NCT01773291|3637800|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3811910|NCT01773291|3637797|B4|||Age||years|Mean|45.77|45.77|Standard Deviation|17.82|17.82|||
3811911|NCT01773291|3637798|B3|||Age||years|Mean|47.17|47.17|Standard Deviation|21.47|21.47|||
3811912|NCT01773291|3637799|B2|||Age||years|Mean|49.11|49.11|Standard Deviation|16.86|16.86|||
3811913|NCT01773291|3637800|B1|||Age||years|Mean|40.29|40.29|Standard Deviation|17.14|17.14|||
3811914|NCT01773226|3637813|B1|Netherlands||Region of Enrollment||participants|Number|11|11.0||||||
3811915|NCT01773226|3637813|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3811916|NCT01773226|3637813|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3811917|NCT01773226|3637813|B1|||Age||Years|Mean|57|57.0|Standard Deviation|9.5|9.5|||
3811918|NCT01773226|3637813|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3811919|NCT01773226|3637813|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3811920|NCT01773226|3637813|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3811921|NCT01773135|3637821|B3|||gestational age at admission||weeks|Median|31|31.0|Inter-Quartile Range|||30.0|33.0|
3811922|NCT01773135|3637822|B2|||gestational age at admission||weeks|Median|31|31.0|Inter-Quartile Range|||30.0|33.0|
3811923|NCT01773135|3637823|B1|||gestational age at admission||weeks|Median|31|31.0|Inter-Quartile Range|||29.0|33.0|
3811924|NCT01773135|3637821|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3811925|NCT01773135|3637822|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3811926|NCT01773135|3637823|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3811927|NCT01773135|3637821|B3||Female|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
3811928|NCT01773135|3637822|B2||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3811929|NCT01773135|3637823|B1||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3811930|NCT01773135|3637821|B3|||Age||years|Median|26|26.0|Inter-Quartile Range|||22.0|30.0|
3811931|NCT01773135|3637822|B2|||Age||years|Median|26|26.0|Inter-Quartile Range|||22.0|30.0|
3811932|NCT01773135|3637823|B1|||Age||years|Median|26|26.0|Inter-Quartile Range|||22.0|29.0|
3811933|NCT01773122|3637828|B5||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3811934|NCT01773122|3637829|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3811935|NCT01773122|3637830|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3811936|NCT01773122|3637831|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3811937|NCT01773122|3637832|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3811938|NCT01773122|3637828|B5||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3811939|NCT01773122|3637829|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3811940|NCT01773122|3637830|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3811941|NCT01773122|3637831|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3811942|NCT01773122|3637832|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3811943|NCT01773122|3637828|B5|18 to 35 years||Age, Customized||Participants|Number|48|48.0||||||
3811944|NCT01773122|3637829|B4|18 to 35 years||Age, Customized||Participants|Number|12|12.0||||||
3811945|NCT01773122|3637830|B3|18 to 35 years||Age, Customized||Participants|Number|12|12.0||||||
3811946|NCT01773122|3637831|B2|18 to 35 years||Age, Customized||Participants|Number|12|12.0||||||
3811947|NCT01773122|3637832|B1|18 to 35 years||Age, Customized||Participants|Number|12|12.0||||||
3811948|NCT01773122|3637828|B5|12 to 17 years||Age, Customized||Participants|Number|29|29.0||||||
3811949|NCT01773122|3637829|B4|12 to 17 years||Age, Customized||Participants|Number|7|7.0||||||
3811950|NCT01773122|3637830|B3|12 to 17 years||Age, Customized||Participants|Number|7|7.0||||||
3811951|NCT01773122|3637831|B2|12 to 17 years||Age, Customized||Participants|Number|7|7.0||||||
3811952|NCT01773122|3637832|B1|12 to 17 years||Age, Customized||Participants|Number|8|8.0||||||
3811953|NCT01773070|3637849|B1||Male|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
3811954|NCT01773070|3637849|B1||Female|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
3811955|NCT01773070|3637849|B1|||Age||years|Mean|53.0|53.0|Standard Deviation|9.85|9.85|||
3811956|NCT01772823|3637857|B3||Obese (=>30 kg/m^2)|BMI||Participants|Count of Participants|39|39.0||||||
3811957|NCT01772823|3637858|B2||Obese (=>30 kg/m^2)|BMI||Participants|Count of Participants|10|10.0||||||
3811958|NCT01772823|3637859|B1||Obese (=>30 kg/m^2)|BMI||Participants|Count of Participants|29|29.0||||||
3811959|NCT01772823|3637857|B3||Overweight (25.0-<30 kg/m^2)|BMI||Participants|Count of Participants|43|43.0||||||
3811960|NCT01772823|3637858|B2||Overweight (25.0-<30 kg/m^2)|BMI||Participants|Count of Participants|18|18.0||||||
3811961|NCT01772823|3637859|B1||Overweight (25.0-<30 kg/m^2)|BMI||Participants|Count of Participants|25|25.0||||||
3811962|NCT01772823|3637857|B3||Normal (18.5-<25 kg/m^2)|BMI||Participants|Count of Participants|109|109.0||||||
3811963|NCT01772823|3637858|B2||Normal (18.5-<25 kg/m^2)|BMI||Participants|Count of Participants|38|38.0||||||
3811964|NCT01772823|3637859|B1||Normal (18.5-<25 kg/m^2)|BMI||Participants|Count of Participants|71|71.0||||||
3811965|NCT01772823|3637857|B3||Underweight (<18.5 kg/m^2)|BMI||Participants|Count of Participants|9|9.0||||||
3811966|NCT01772823|3637858|B2||Underweight (<18.5 kg/m^2)|BMI||Participants|Count of Participants|6|6.0||||||
3811967|NCT01772823|3637859|B1||Underweight (<18.5 kg/m^2)|BMI||Participants|Count of Participants|3|3.0||||||
3811968|NCT01772823|3637857|B3|United States||Region of Enrollment||Participants|Count of Participants|200|200.0||||||
3811969|NCT01772823|3637858|B2|United States||Region of Enrollment||Participants|Count of Participants|72|72.0||||||
3811970|NCT01772823|3637859|B1|United States||Region of Enrollment||Participants|Count of Participants|128|128.0||||||
3811971|NCT01772823|3637857|B3|Hispanic Ethnicity|Refused|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3811972|NCT01772823|3637858|B2|Hispanic Ethnicity|Refused|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3811973|NCT01772823|3637859|B1|Hispanic Ethnicity|Refused|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3811974|NCT01772823|3637857|B3|Hispanic Ethnicity|Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|145|145.0||||||
3811975|NCT01772823|3637858|B2|Hispanic Ethnicity|Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|56|56.0||||||
3811976|NCT01772823|3637859|B1|Hispanic Ethnicity|Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|89|89.0||||||
3811977|NCT01772823|3637857|B3|Hispanic Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|53|53.0||||||
3811978|NCT01772823|3637858|B2|Hispanic Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3811979|NCT01772823|3637859|B1|Hispanic Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
3811980|NCT01772823|3637857|B3|Race/ethnicity|Other/Mixed Race|Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3811981|NCT01772823|3637858|B2|Race/ethnicity|Other/Mixed Race|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3811982|NCT01772823|3637859|B1|Race/ethnicity|Other/Mixed Race|Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3811983|NCT01772823|3637857|B3|Race/ethnicity|White/Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3811984|NCT01772823|3637858|B2|Race/ethnicity|White/Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3811985|NCT01772823|3637859|B1|Race/ethnicity|White/Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3811986|NCT01772823|3637857|B3|Race/ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3811987|NCT01772823|3637858|B2|Race/ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3811988|NCT01772823|3637859|B1|Race/ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3811989|NCT01772823|3637857|B3|Race/ethnicity|Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|93|93.0||||||
3811990|NCT01772823|3637858|B2|Race/ethnicity|Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
3811991|NCT01772823|3637859|B1|Race/ethnicity|Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|55|55.0||||||
3811992|NCT01772823|3637857|B3|Race/ethnicity|Asian/Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3811993|NCT01772823|3637858|B2|Race/ethnicity|Asian/Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3811994|NCT01772823|3637859|B1|Race/ethnicity|Asian/Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3811995|NCT01772823|3637857|B3||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
3811996|NCT01772823|3637858|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3811997|NCT01772823|3637859|B1||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3811998|NCT01772823|3637857|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3811999|NCT01772823|3637858|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3812000|NCT01772823|3637859|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3812001|NCT01772823|3637857|B3|||Age||years|Mean|20.18|20.18|Standard Deviation|1.34|1.34|||
3812002|NCT01772823|3637858|B2|||Age||years|Mean|20.25|20.25|Standard Deviation|1.23|1.23|||
3812003|NCT01772823|3637859|B1|||Age||years|Mean|20.14|20.14|Standard Deviation|1.40|1.4|||
3812004|NCT01772758|3637956|B5|||Weight||kg|Mean|53.8|53.8|Standard Deviation|15.3|15.3|||
3812005|NCT01772758|3637957|B4|||Weight||kg|Mean|52.5|52.5|Standard Deviation|16.5|16.5|||
3812006|NCT01772758|3637958|B3|||Weight||kg|Mean|57.8|57.8|Standard Deviation|14.7|14.7|||
3812007|NCT01772758|3637959|B2|||Weight||kg|Mean|53.0|53.0|Standard Deviation|14.6|14.6|||
3812008|NCT01772758|3637960|B1|||Weight||kg|Mean|53.1|53.1|Standard Deviation|14.7|14.7|||
3812009|NCT01772758|3637956|B5|||Height||cm|Mean|160.3|160.3|Standard Deviation|14.0|14.0|||
3812010|NCT01772758|3637957|B4|||Height||cm|Mean|162.9|162.9|Standard Deviation|14.7|14.7|||
3812011|NCT01772758|3637958|B3|||Height||cm|Mean|162.1|162.1|Standard Deviation|11.1|11.1|||
3812012|NCT01772758|3637959|B2|||Height||cm|Mean|158.1|158.1|Standard Deviation|14.1|14.1|||
3812013|NCT01772758|3637960|B1|||Height||cm|Mean|158.6|158.6|Standard Deviation|14.2|14.2|||
3812014|NCT01772758|3637956|B5||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3812015|NCT01772758|3637957|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3812016|NCT01772758|3637958|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3812017|NCT01772758|3637959|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3812018|NCT01772758|3637960|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3812019|NCT01772758|3637956|B5||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3812020|NCT01772758|3637957|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3812021|NCT01772758|3637958|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3812022|NCT01772758|3637959|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3812023|NCT01772758|3637960|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3812024|NCT01772758|3637956|B5|||Age||years|Mean|17.3|17.3|Standard Deviation|7.0|7.0|||
3812025|NCT01772758|3637957|B4|||Age||years|Mean|15.7|15.7|Standard Deviation|5.2|5.2|||
3812026|NCT01772758|3637958|B3|||Age||years|Mean|19|19.0|Standard Deviation|8|8.0|||
3812027|NCT01772758|3637959|B2|||Age||years|Mean|17|17.0|Standard Deviation|7|7.0|||
3812028|NCT01772758|3637960|B1|||Age||years|Mean|17.9|17.9|Standard Deviation|7.5|7.5|||
3812029|NCT01772654|3637973|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
3812030|NCT01772654|3637974|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3812031|NCT01772654|3637975|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3812032|NCT01772654|3637973|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3812033|NCT01772654|3637974|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3812034|NCT01772654|3637975|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3812035|NCT01772654|3637973|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3812036|NCT01772654|3637974|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3812037|NCT01772654|3637975|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3812038|NCT01772654|3637973|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3812039|NCT01772654|3637974|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3812040|NCT01772654|3637975|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3812041|NCT01772654|3637973|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3812042|NCT01772654|3637974|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3812043|NCT01772654|3637975|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3812044|NCT01772654|3637973|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812045|NCT01772654|3637974|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812046|NCT01772654|3637975|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812047|NCT01772576|3637982|B1|Spain||Region of Enrollment||participants|Number|4|4.0||||||
3812048|NCT01772576|3637982|B1|Germany||Region of Enrollment||participants|Number|20|20.0||||||
3812049|NCT01772576|3637982|B1|Portugal||Region of Enrollment||participants|Number|4|4.0||||||
3812050|NCT01772576|3637982|B1|France||Region of Enrollment||participants|Number|4|4.0||||||
3812051|NCT01772576|3637982|B1|Israel||Region of Enrollment||participants|Number|44|44.0||||||
3812052|NCT01772576|3637982|B1|Italy||Region of Enrollment||participants|Number|15|15.0||||||
3812053|NCT01772576|3637982|B1|United Kingdom||Region of Enrollment||participants|Number|22|22.0||||||
3812054|NCT01772576|3637982|B1|Denmark||Region of Enrollment||participants|Number|25|25.0||||||
3812055|NCT01772576|3637982|B1|China||Region of Enrollment||participants|Number|10|10.0||||||
3812056|NCT01772576|3637982|B1|Sweden||Region of Enrollment||participants|Number|9|9.0||||||
3812057|NCT01772576|3637982|B1|Austria||Region of Enrollment||participants|Number|10|10.0||||||
3812058|NCT01772576|3637982|B1||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3812059|NCT01772576|3637982|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3812060|NCT01772576|3637982|B1|||Age||years|Mean|65.26|65.26|Standard Deviation|10.94|10.94|||
3812061|NCT01772576|3637982|B1||>=65 years|Age||Participants|Count of Participants|102|102.0||||||
3812062|NCT01772576|3637982|B1||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
3812063|NCT01772576|3637982|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812064|NCT01772550|3637991|B4||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3812065|NCT01772550|3637992|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3812066|NCT01772550|3637993|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3812067|NCT01772550|3637994|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3812068|NCT01772550|3637991|B4||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3812069|NCT01772550|3637992|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3812070|NCT01772550|3637993|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3812071|NCT01772550|3637994|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3812072|NCT01772550|3637991|B4|||Age||years|Mean|60.5|60.5|Standard Deviation|13.1|13.1|||
3812073|NCT01772550|3637992|B3|||Age||years|Mean|58.8|58.8|Standard Deviation|12.3|12.3|||
3812074|NCT01772550|3637993|B2|||Age||years|Mean|60.0|60.0|Standard Deviation|13.6|13.6|||
3812075|NCT01772550|3637994|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|12.9|12.9|||
3812076|NCT01772537|3638034|B4|United States||Region of Enrollment||participants|Number|14|14.0||||||
3812077|NCT01772537|3638035|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3812078|NCT01772537|3638036|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3812079|NCT01772537|3638037|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3812080|NCT01772537|3638034|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3812081|NCT01772537|3638035|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3812082|NCT01772537|3638036|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3812083|NCT01772537|3638037|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3812084|NCT01772537|3638034|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3812085|NCT01772537|3638035|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3812086|NCT01772537|3638036|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3812087|NCT01772537|3638037|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3812088|NCT01772537|3638034|B4|||Age||years|Mean|65.7|65.7|Standard Deviation|11.2|11.2|||
3812089|NCT01772537|3638035|B3|||Age||years|Mean|71|71.0|Standard Deviation|5.3|5.3|||
3812090|NCT01772537|3638036|B2|||Age||years|Mean|62|62.0|Standard Deviation|13|13.0|||
3812091|NCT01772537|3638037|B1|||Age||years|Mean|67|67.0|Standard Deviation|13|13.0|||
3812092|NCT01772537|3638034|B4||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3812093|NCT01772537|3638035|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3812094|NCT01772537|3638036|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3812095|NCT01772537|3638037|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3812096|NCT01772537|3638034|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3812097|NCT01772537|3638035|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3812098|NCT01772537|3638036|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3812099|NCT01772537|3638037|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3812100|NCT01772537|3638034|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812101|NCT01772537|3638035|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812102|NCT01772537|3638036|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812103|NCT01772537|3638037|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812104|NCT01772368|3638053|B1|||Body Mass Index||kg/m^2|Mean|27.3|27.3|Standard Deviation|3.35|3.35|||
3812105|NCT01772368|3638053|B1|||Height||cm|Mean|170.0|170.0|Standard Deviation|9.76|9.76|||
3812106|NCT01772368|3638053|B1|||Weight||kg|Mean|79.2|79.2|Standard Deviation|14.17|14.17|||
3812107|NCT01772368|3638053|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3812108|NCT01772368|3638053|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3812109|NCT01772368|3638053|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|64|64.0||||||
3812110|NCT01772368|3638053|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3812111|NCT01772368|3638053|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3812112|NCT01772368|3638053|B1|||Age||years|Mean|42.5|42.5|Standard Deviation|13.87|13.87|||
3812113|NCT01772316|3638099|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3812114|NCT01772316|3638099|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3812115|NCT01772316|3638099|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|10.3|10.3|||
3812116|NCT01772147|3638117|B4|White||Race/Ethnicity, Customized||Participants|Number|496|496.0||||||
3812117|NCT01772147|3638118|B3|White||Race/Ethnicity, Customized||Participants|Number|171|171.0||||||
3812118|NCT01772147|3638119|B2|White||Race/Ethnicity, Customized||Participants|Number|164|164.0||||||
3812119|NCT01772147|3638120|B1|White||Race/Ethnicity, Customized||Participants|Number|161|161.0||||||
3812120|NCT01772147|3638117|B4|Japanese/East Asian Heritage/South East Asian||Race/Ethnicity, Customized||Participants|Number|97|97.0||||||
3812121|NCT01772147|3638118|B3|Japanese/East Asian Heritage/South East Asian||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
3812122|NCT01772147|3638119|B2|Japanese/East Asian Heritage/South East Asian||Race/Ethnicity, Customized||Participants|Number|33|33.0||||||
3812123|NCT01772147|3638120|B1|Japanese/East Asian Heritage/South East Asian||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
3812124|NCT01772147|3638117|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3812125|NCT01772147|3638118|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3812126|NCT01772147|3638119|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3812127|NCT01772147|3638120|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3812128|NCT01772147|3638117|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3812129|NCT01772147|3638118|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3812130|NCT01772147|3638119|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3812131|NCT01772147|3638120|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3812132|NCT01772147|3638117|B4||Male|Sex: Female, Male||Participants|Count of Participants|383|383.0||||||
3812133|NCT01772147|3638118|B3||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3812134|NCT01772147|3638119|B2||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3812135|NCT01772147|3638120|B1||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3812136|NCT01772147|3638117|B4||Female|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
3812137|NCT01772147|3638118|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3812138|NCT01772147|3638119|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3812139|NCT01772147|3638120|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3812140|NCT01772147|3638117|B4|||Age||Years|Mean|65.2|65.2|Standard Deviation|8.04|8.04|||
3812141|NCT01772147|3638118|B3|||Age||Years|Mean|65.5|65.5|Standard Deviation|7.89|7.89|||
3812142|NCT01772147|3638119|B2|||Age||Years|Mean|64.5|64.5|Standard Deviation|8.31|8.31|||
3812143|NCT01772147|3638120|B1|||Age||Years|Mean|65.7|65.7|Standard Deviation|7.92|7.92|||
3812144|NCT01772134|3638139|B4|White||Race/Ethnicity, Customized||Participants|Number|538|538.0||||||
3812145|NCT01772134|3638140|B3|White||Race/Ethnicity, Customized||Participants|Number|182|182.0||||||
3812146|NCT01772134|3638141|B2|White||Race/Ethnicity, Customized||Participants|Number|175|175.0||||||
3812147|NCT01772134|3638142|B1|White||Race/Ethnicity, Customized||Participants|Number|181|181.0||||||
3812148|NCT01772134|3638139|B4|Japanese/East Asian Heritage/ South East Asian||Race/Ethnicity, Customized||Participants|Number|63|63.0||||||
3812149|NCT01772134|3638140|B3|Japanese/East Asian Heritage/ South East Asian||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
3812150|NCT01772134|3638141|B2|Japanese/East Asian Heritage/ South East Asian||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
3812151|NCT01772134|3638142|B1|Japanese/East Asian Heritage/ South East Asian||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
3812152|NCT01772134|3638139|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3812153|NCT01772134|3638140|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3812154|NCT01772134|3638141|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3812155|NCT01772134|3638142|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3812156|NCT01772134|3638139|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3812157|NCT01772134|3638140|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3812158|NCT01772134|3638141|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3812159|NCT01772134|3638142|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3812160|NCT01772134|3638139|B4||Male|Sex: Female, Male||Participants|Count of Participants|407|407.0||||||
3812161|NCT01772134|3638140|B3||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3812162|NCT01772134|3638141|B2||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3812163|NCT01772134|3638142|B1||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3812164|NCT01772134|3638139|B4||Female|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
3812165|NCT01772134|3638140|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3812166|NCT01772134|3638141|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3812167|NCT01772134|3638142|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3812168|NCT01772134|3638139|B4|||Age||Years|Mean|63.1|63.1|Standard Deviation|8.36|8.36|||
3812169|NCT01772134|3638140|B3|||Age||Years|Mean|63.2|63.2|Standard Deviation|8.95|8.95|||
3812170|NCT01772134|3638141|B2|||Age||Years|Mean|62.7|62.7|Standard Deviation|7.84|7.84|||
3812171|NCT01772134|3638142|B1|||Age||Years|Mean|63.4|63.4|Standard Deviation|8.27|8.27|||
3812172|NCT01771991|3638161|B3|United States||Region of Enrollment||participants|Number|74|74.0||||||
3812173|NCT01771991|3638162|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
3812174|NCT01771991|3638163|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
3812175|NCT01771991|3638161|B3||Male|Gender||Participants|Count of Participants|59|59.0||||||
3812176|NCT01771991|3638162|B2||Male|Gender||Participants|Count of Participants|29|29.0||||||
3812177|NCT01771991|3638163|B1||Male|Gender||Participants|Count of Participants|30|30.0||||||
3812178|NCT01771991|3638161|B3||Female|Gender||Participants|Count of Participants|15|15.0||||||
3812179|NCT01771991|3638162|B2||Female|Gender||Participants|Count of Participants|7|7.0||||||
3812180|NCT01771991|3638163|B1||Female|Gender||Participants|Count of Participants|8|8.0||||||
3812181|NCT01771991|3638161|B3|||Age||years|Mean|61.3|61.3|Standard Deviation|9.62|9.62|||
3812182|NCT01771991|3638162|B2|||Age||years|Mean|61.64|61.64|Standard Deviation|9.73|9.73|||
3812183|NCT01771991|3638163|B1|||Age||years|Mean|60.98|60.98|Standard Deviation|9.64|9.64|||
3812184|NCT01771991|3638161|B3||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3812185|NCT01771991|3638162|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3812186|NCT01771991|3638163|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3812187|NCT01771991|3638161|B3||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3812188|NCT01771991|3638162|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3812189|NCT01771991|3638163|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3812190|NCT01771991|3638161|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812191|NCT01771991|3638162|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812192|NCT01771991|3638163|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812193|NCT01771965|3638170|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
3812194|NCT01771965|3638171|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3812195|NCT01771965|3638172|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3812196|NCT01771965|3638170|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3812197|NCT01771965|3638171|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3812198|NCT01771965|3638172|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3812199|NCT01771965|3638170|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3812200|NCT01771965|3638171|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3812201|NCT01771965|3638172|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3812202|NCT01771965|3638170|B3|||Age||years|Mean|41.2|41.2|Standard Deviation|15.9|15.9|||
3812203|NCT01771965|3638171|B2|||Age||years|Mean|39.8|39.8|Standard Deviation|14.6|14.6|||
3812204|NCT01771965|3638172|B1|||Age||years|Mean|44.6|44.6|Standard Deviation|17.9|17.9|||
3812205|NCT01771965|3638170|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3812206|NCT01771965|3638171|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3812207|NCT01771965|3638172|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3812208|NCT01771965|3638170|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3812209|NCT01771965|3638171|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3812210|NCT01771965|3638172|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3812211|NCT01771965|3638170|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812212|NCT01771965|3638171|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812213|NCT01771965|3638172|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812214|NCT01771913|3638179|B3|||breast volume||mL|Mean|613.3|613.3|Standard Deviation|198.5|198.5|||
3812215|NCT01771913|3638180|B2|||breast volume||mL|Mean|650.1|650.1|Standard Deviation|206.8|206.8|||
3812216|NCT01771913|3638181|B1|||breast volume||mL|Mean|562.8|562.8|Standard Deviation|187.7|187.7|||
3812217|NCT01771913|3638179|B3|Brazil||Region of Enrollment||participants|Number|19|19.0||||||
3812218|NCT01771913|3638180|B2|Brazil||Region of Enrollment||participants|Number|11|11.0||||||
3812219|NCT01771913|3638181|B1|Brazil||Region of Enrollment||participants|Number|8|8.0||||||
3812220|NCT01771913|3638179|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3812221|NCT01771913|3638180|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3812222|NCT01771913|3638181|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3812223|NCT01771913|3638179|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3812224|NCT01771913|3638180|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3812225|NCT01771913|3638181|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3812226|NCT01771913|3638179|B3|||Age||years|Mean|49.7|49.7|Standard Deviation|8.3|8.3|||
3812227|NCT01771913|3638180|B2|||Age||years|Mean|49.6|49.6|Standard Deviation|5.7|5.7|||
3812228|NCT01771913|3638181|B1|||Age||years|Mean|49.8|49.8|Standard Deviation|11.5|11.5|||
3812229|NCT01771913|3638179|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3812230|NCT01771913|3638180|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3812231|NCT01771913|3638181|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3812232|NCT01771913|3638179|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3812233|NCT01771913|3638180|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3812234|NCT01771913|3638181|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3812235|NCT01771913|3638179|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812236|NCT01771913|3638180|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812237|NCT01771913|3638181|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812238|NCT01771666|3638192|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3812239|NCT01771666|3638192|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812240|NCT01771666|3638192|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3812241|NCT01771666|3638192|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812242|NCT01771666|3638192|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3812243|NCT01771666|3638192|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3812244|NCT01771666|3638192|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812245|NCT01771666|3638192|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812246|NCT01771666|3638192|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3812247|NCT01771666|3638192|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3812248|NCT01771666|3638192|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3812249|NCT01771666|3638192|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3812250|NCT01771666|3638192|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3812251|NCT01771666|3638192|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3812252|NCT01771666|3638192|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812253|NCT01771172|3638197|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3812254|NCT01771172|3638197|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3812255|NCT01771172|3638197|B1|||Age||years|Mean|57.7|57.7|Standard Deviation|12.3|12.3|||
3812256|NCT01770860|3638201|B1|Fitzpatrick Skin Classification - III||Fitzpatrick Skin Classification|The Fitzpatrick skin classification is based on the skin’s unprotected response to the first 30-45 minutes of sun exposure after a winter season without sun exposure. The classification is on a scale from I to VI where I = always burns easily; never tans and VI =Never burns; deeply pigmented.|participants|Number|34|34.0||||||
3812257|NCT01770860|3638201|B1|Fitzpatrick Skin Classification - II||Fitzpatrick Skin Classification|The Fitzpatrick skin classification is based on the skin’s unprotected response to the first 30-45 minutes of sun exposure after a winter season without sun exposure. The classification is on a scale from I to VI where I = always burns easily; never tans and VI =Never burns; deeply pigmented.|participants|Number|11|11.0||||||
3812258|NCT01770860|3638201|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
3812259|NCT01770860|3638201|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812260|NCT01770860|3638201|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3812261|NCT01770860|3638201|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3812262|NCT01770860|3638201|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812263|NCT01770860|3638201|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812264|NCT01770860|3638201|B1||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3812265|NCT01770860|3638201|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812266|NCT01770860|3638201|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812267|NCT01770860|3638201|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812268|NCT01770860|3638201|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812269|NCT01770860|3638201|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3812270|NCT01770860|3638201|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3812271|NCT01770860|3638201|B1|||Age||years|Mean|44.4|44.4|Standard Deviation|7.47|7.47|||
3812272|NCT01770743|3638244|B6|United States||Region of Enrollment||participants|Number|168|168.0||||||
3812273|NCT01770743|3638245|B5|United States||Region of Enrollment||participants|Number|23|23.0||||||
3812274|NCT01770743|3638246|B4|United States||Region of Enrollment||participants|Number|44|44.0||||||
3812275|NCT01770743|3638247|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
3812276|NCT01770743|3638248|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
3812277|NCT01770743|3638249|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
3812278|NCT01770743|3638244|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812279|NCT01770743|3638245|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812280|NCT01770743|3638246|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812281|NCT01770743|3638247|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812282|NCT01770743|3638248|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812283|NCT01770743|3638249|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812284|NCT01770743|3638244|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|139|139.0||||||
3812285|NCT01770743|3638245|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3812286|NCT01770743|3638246|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3812287|NCT01770743|3638247|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3812288|NCT01770743|3638248|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3812289|NCT01770743|3638249|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3812290|NCT01770743|3638244|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3812291|NCT01770743|3638245|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3812292|NCT01770743|3638246|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3812293|NCT01770743|3638247|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3812294|NCT01770743|3638248|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3812295|NCT01770743|3638249|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3812296|NCT01770743|3638244|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812297|NCT01770743|3638245|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812298|NCT01770743|3638246|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812299|NCT01770743|3638247|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812300|NCT01770743|3638248|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812301|NCT01770743|3638249|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812302|NCT01770743|3638244|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812303|NCT01770743|3638245|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812304|NCT01770743|3638246|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812305|NCT01770743|3638247|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812306|NCT01770743|3638248|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812307|NCT01770743|3638249|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812308|NCT01770743|3638244|B6||White|Race (NIH/OMB)||Participants|Count of Participants|154|154.0||||||
3812309|NCT01770743|3638245|B5||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3812310|NCT01770743|3638246|B4||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3812311|NCT01770743|3638247|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3812312|NCT01770743|3638248|B2||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3812313|NCT01770743|3638249|B1||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3812314|NCT01770743|3638244|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3812315|NCT01770743|3638245|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3812316|NCT01770743|3638246|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3812317|NCT01770743|3638247|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3812318|NCT01770743|3638248|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3812319|NCT01770743|3638249|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3812320|NCT01770743|3638244|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3812321|NCT01770743|3638245|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812322|NCT01770743|3638246|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3812323|NCT01770743|3638247|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812324|NCT01770743|3638248|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812325|NCT01770743|3638249|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812326|NCT01770743|3638244|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3812327|NCT01770743|3638245|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812328|NCT01770743|3638246|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812329|NCT01770743|3638247|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812330|NCT01770743|3638248|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812331|NCT01770743|3638249|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3812332|NCT01770743|3638244|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812333|NCT01770743|3638245|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812334|NCT01770743|3638246|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812335|NCT01770743|3638247|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812336|NCT01770743|3638248|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812337|NCT01770743|3638249|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812338|NCT01770743|3638244|B6||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3812339|NCT01770743|3638245|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3812340|NCT01770743|3638246|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3812341|NCT01770743|3638247|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3812342|NCT01770743|3638248|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3812343|NCT01770743|3638249|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3812344|NCT01770743|3638244|B6||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3812345|NCT01770743|3638245|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3812346|NCT01770743|3638246|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3812347|NCT01770743|3638247|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3812348|NCT01770743|3638248|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3812349|NCT01770743|3638249|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3812350|NCT01770743|3638244|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3812351|NCT01770743|3638245|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3812352|NCT01770743|3638246|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3812353|NCT01770743|3638247|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3812354|NCT01770743|3638248|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3812355|NCT01770743|3638249|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3812356|NCT01770743|3638244|B6||Between 18 and 65 years|Age||Participants|Count of Participants|164|164.0||||||
3812357|NCT01770743|3638245|B5||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3812358|NCT01770743|3638246|B4||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3812359|NCT01770743|3638247|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3812360|NCT01770743|3638248|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3812361|NCT01770743|3638249|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3812362|NCT01770743|3638244|B6||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3812363|NCT01770743|3638245|B5||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3812364|NCT01770743|3638246|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812365|NCT01770743|3638247|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3812366|NCT01770743|3638248|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3812367|NCT01770743|3638249|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812368|NCT01770743|3638244|B6|||Age||years|Mean|32.5|32.5|Standard Deviation|9.5|9.5|||
3812369|NCT01770743|3638245|B5|||Age||years|Mean|32.5|32.5|Standard Deviation|10.4|10.4|||
3812370|NCT01770743|3638246|B4|||Age||years|Mean|32.8|32.8|Standard Deviation|9.2|9.2|||
3812371|NCT01770743|3638247|B3|||Age||years|Mean|29.7|29.7|Standard Deviation|10.2|10.2|||
3812372|NCT01770743|3638248|B2|||Age||years|Mean|32.7|32.7|Standard Deviation|9.7|9.7|||
3812373|NCT01770743|3638249|B1|||Age||years|Mean|33.4|33.4|Standard Deviation|9.0|9.0|||
3812374|NCT01770691|3638305|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812375|NCT01770691|3638305|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3812376|NCT01770691|3638305|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812377|NCT01770691|3638305|B1|Female||Sex/Gender, Customized||Participants|Number|7|7.0||||||
3812378|NCT01770691|3638305|B1|||Age||Years|Mean|54.67|54.67|Full Range|||47.1|62.9|
3812379|NCT01770652|3638312|B5|Canada||Region of Enrollment||participants|Number|32|32.0||||||
3812380|NCT01770652|3638313|B4|Canada||Region of Enrollment||participants|Number|8|8.0||||||
3812381|NCT01770652|3638314|B3|Canada||Region of Enrollment||participants|Number|8|8.0||||||
3812382|NCT01770652|3638315|B2|Canada||Region of Enrollment||participants|Number|8|8.0||||||
3812383|NCT01770652|3638316|B1|Canada||Region of Enrollment||participants|Number|8|8.0||||||
3812384|NCT01770652|3638312|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3812385|NCT01770652|3638313|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3812386|NCT01770652|3638314|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3812387|NCT01770652|3638315|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3812388|NCT01770652|3638316|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3812389|NCT01770652|3638312|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812390|NCT01770652|3638313|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812391|NCT01770652|3638314|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812392|NCT01770652|3638315|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812393|NCT01770652|3638316|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812394|NCT01770652|3638312|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812395|NCT01770652|3638313|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812396|NCT01770652|3638314|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812397|NCT01770652|3638315|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812398|NCT01770652|3638316|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812399|NCT01770652|3638312|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812400|NCT01770652|3638313|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812401|NCT01770652|3638314|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812402|NCT01770652|3638315|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812403|NCT01770652|3638316|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812404|NCT01770652|3638312|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812405|NCT01770652|3638313|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812406|NCT01770652|3638314|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812407|NCT01770652|3638315|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812408|NCT01770652|3638316|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812409|NCT01770652|3638312|B5||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3812410|NCT01770652|3638313|B4||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3812411|NCT01770652|3638314|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3812412|NCT01770652|3638315|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3812413|NCT01770652|3638316|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3812414|NCT01770652|3638312|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3812415|NCT01770652|3638313|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812416|NCT01770652|3638314|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812417|NCT01770652|3638315|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3812418|NCT01770652|3638316|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812419|NCT01770652|3638312|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812420|NCT01770652|3638313|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812421|NCT01770652|3638314|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812422|NCT01770652|3638315|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812423|NCT01770652|3638316|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812424|NCT01770652|3638312|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812425|NCT01770652|3638313|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812426|NCT01770652|3638314|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812427|NCT01770652|3638315|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812428|NCT01770652|3638316|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812429|NCT01770652|3638312|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812430|NCT01770652|3638313|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812431|NCT01770652|3638314|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812432|NCT01770652|3638315|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812433|NCT01770652|3638316|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812434|NCT01770652|3638312|B5||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3812435|NCT01770652|3638313|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3812436|NCT01770652|3638314|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3812437|NCT01770652|3638315|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3812438|NCT01770652|3638316|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3812439|NCT01770652|3638312|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3812440|NCT01770652|3638313|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3812441|NCT01770652|3638314|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3812442|NCT01770652|3638315|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3812443|NCT01770652|3638316|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3812444|NCT01770652|3638312|B5||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3812445|NCT01770652|3638313|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3812446|NCT01770652|3638314|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3812447|NCT01770652|3638315|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3812448|NCT01770652|3638316|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3812449|NCT01770652|3638312|B5||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3812450|NCT01770652|3638313|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3812451|NCT01770652|3638314|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3812452|NCT01770652|3638315|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3812453|NCT01770652|3638316|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3812454|NCT01770652|3638312|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812455|NCT01770652|3638313|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812456|NCT01770652|3638314|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812457|NCT01770652|3638315|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812458|NCT01770652|3638316|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812459|NCT01770509|3638353|B3|Israel||Region of Enrollment||participants|Number|29|29.0||||||
3812460|NCT01770509|3638354|B2|Israel||Region of Enrollment||participants|Number|17|17.0||||||
3812461|NCT01770509|3638355|B1|Israel||Region of Enrollment||participants|Number|12|12.0||||||
3812462|NCT01770509|3638353|B3||Male|Gender||Participants|Count of Participants|15|15.0||||||
3812463|NCT01770509|3638354|B2||Male|Gender||Participants|Count of Participants|8|8.0||||||
3812464|NCT01770509|3638355|B1||Male|Gender||Participants|Count of Participants|7|7.0||||||
3812465|NCT01770509|3638353|B3||Female|Gender||Participants|Count of Participants|14|14.0||||||
3812466|NCT01770509|3638354|B2||Female|Gender||Participants|Count of Participants|9|9.0||||||
3812467|NCT01770509|3638355|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
3812468|NCT01770509|3638353|B3|||Age||years|Mean|70.9|70.9|Standard Deviation|12.6|12.6|||
3812469|NCT01770509|3638354|B2|||Age||years|Mean|68.17|68.17|Standard Deviation|13.9|13.9|||
3812470|NCT01770509|3638355|B1|||Age||years|Mean|75.54|75.54|Standard Deviation|7.7|7.7|||
3812471|NCT01770483|3638370|B3|Pakistan||Region of Enrollment||participants|Number|66|66.0||||||
3812472|NCT01770483|3638371|B2|Pakistan||Region of Enrollment||participants|Number|33|33.0||||||
3812473|NCT01770483|3638372|B1|Pakistan||Region of Enrollment||participants|Number|33|33.0||||||
3812474|NCT01770483|3638370|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3812475|NCT01770483|3638371|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3812476|NCT01770483|3638372|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3812477|NCT01770483|3638370|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3812478|NCT01770483|3638371|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3812479|NCT01770483|3638372|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3812480|NCT01770483|3638370|B3|||Age||years|Mean|47.26|47.26|Standard Deviation|5.73|5.73|||
3812481|NCT01770483|3638371|B2|||Age||years|Mean|47.21|47.21|Standard Deviation|5.464|5.464|||
3812482|NCT01770483|3638372|B1|||Age||years|Mean|47.30|47.3|Standard Deviation|6.07|6.07|||
3812483|NCT01770483|3638370|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3812484|NCT01770483|3638371|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3812485|NCT01770483|3638372|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3812486|NCT01770483|3638370|B3||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
3812487|NCT01770483|3638371|B2||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3812488|NCT01770483|3638372|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3812489|NCT01770483|3638370|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812490|NCT01770483|3638371|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812491|NCT01770483|3638372|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812492|NCT01770431|3638381|B3||Multiple tumors|Number of tumor||Participants|Count of Participants|133|133.0||||||
3812493|NCT01770431|3638382|B2||Multiple tumors|Number of tumor||Participants|Count of Participants|42|42.0||||||
3812494|NCT01770431|3638383|B1||Multiple tumors|Number of tumor||Participants|Count of Participants|91|91.0||||||
3812495|NCT01770431|3638381|B3||Single tumor|Number of tumor||Participants|Count of Participants|869|869.0||||||
3812496|NCT01770431|3638382|B2||Single tumor|Number of tumor||Participants|Count of Participants|274|274.0||||||
3812497|NCT01770431|3638383|B1||Single tumor|Number of tumor||Participants|Count of Participants|595|595.0||||||
3812498|NCT01770431|3638381|B3|China||Region of Enrollment||Participants|Count of Participants|1002|1002.0||||||
3812499|NCT01770431|3638382|B2|China||Region of Enrollment||Participants|Count of Participants|316|316.0||||||
3812500|NCT01770431|3638383|B1|China||Region of Enrollment||Participants|Count of Participants|686|686.0||||||
3812501|NCT01770431|3638381|B3||Male|Sex: Female, Male||Participants|Count of Participants|820|820.0||||||
3812502|NCT01770431|3638382|B2||Male|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
3812503|NCT01770431|3638383|B1||Male|Sex: Female, Male||Participants|Count of Participants|565|565.0||||||
3812504|NCT01770431|3638381|B3||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3812505|NCT01770431|3638382|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3812506|NCT01770431|3638383|B1||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3812507|NCT01770431|3638381|B3||>=65 years|Age||Participants|Count of Participants|154|154.0||||||
3812508|NCT01770431|3638382|B2||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
3812509|NCT01770431|3638383|B1||>=65 years|Age||Participants|Count of Participants|113|113.0||||||
3812510|NCT01770431|3638381|B3||Between 18 and 65 years|Age||Participants|Count of Participants|848|848.0||||||
3812511|NCT01770431|3638382|B2||Between 18 and 65 years|Age||Participants|Count of Participants|275|275.0||||||
3812512|NCT01770431|3638383|B1||Between 18 and 65 years|Age||Participants|Count of Participants|573|573.0||||||
3812513|NCT01770431|3638381|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812514|NCT01770431|3638382|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812515|NCT01770431|3638383|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812516|NCT01770392|3638392|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3812517|NCT01770392|3638392|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3812518|NCT01770392|3638392|B1|||Age||years|Mean|37.3|37.3|Standard Deviation|8.7|8.7|||
3812519|NCT01770379|3638404|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3812520|NCT01770379|3638405|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3812521|NCT01770379|3638406|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3812522|NCT01770379|3638407|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3812523|NCT01770379|3638404|B4||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3812524|NCT01770379|3638405|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3812525|NCT01770379|3638406|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3812526|NCT01770379|3638407|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3812527|NCT01770379|3638404|B4||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
3812528|NCT01770379|3638405|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3812529|NCT01770379|3638406|B2||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3812530|NCT01770379|3638407|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3812531|NCT01770379|3638404|B4||Between 18 and 65 years|Age||Participants|Count of Participants|201|201.0||||||
3812532|NCT01770379|3638405|B3||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
3812533|NCT01770379|3638406|B2||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
3812534|NCT01770379|3638407|B1||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
3812535|NCT01770379|3638404|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812536|NCT01770379|3638405|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812537|NCT01770379|3638406|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812538|NCT01770379|3638407|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812539|NCT01770366|3638426|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3812540|NCT01770366|3638427|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3812541|NCT01770366|3638428|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3812542|NCT01770366|3638426|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3812543|NCT01770366|3638427|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3812544|NCT01770366|3638428|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3812545|NCT01770366|3638426|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3812546|NCT01770366|3638427|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3812547|NCT01770366|3638428|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3812548|NCT01770366|3638426|B3|||Age||years|Mean|49.4|49.4|Standard Deviation|13.0|13.0|||
3812549|NCT01770366|3638427|B2|||Age||years|Mean|46.5|46.5|Standard Deviation|12.5|12.5|||
3812550|NCT01770366|3638428|B1|||Age||years|Mean|55.3|55.3|Standard Deviation|9.4|9.4|||
3812551|NCT01770314|3638435|B3|United States||Region of Enrollment||participants|Number|176|176.0||||||
3812552|NCT01770314|3638436|B2|United States||Region of Enrollment||participants|Number|86|86.0||||||
3812553|NCT01770314|3638437|B1|United States||Region of Enrollment||participants|Number|90|90.0||||||
3812554|NCT01770314|3638435|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3812555|NCT01770314|3638436|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3812556|NCT01770314|3638437|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3812557|NCT01770314|3638435|B3||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3812558|NCT01770314|3638436|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3812559|NCT01770314|3638437|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3812560|NCT01770314|3638435|B3|||Age||years|Mean|46|46.0|Standard Deviation|11.2|11.2|||
3812561|NCT01770314|3638436|B2|||Age||years|Mean|45|45.0|Standard Deviation|10.5|10.5|||
3812562|NCT01770314|3638437|B1|||Age||years|Mean|47|47.0|Standard Deviation|11.8|11.8|||
3812563|NCT01770314|3638435|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3812564|NCT01770314|3638436|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3812565|NCT01770314|3638437|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3812566|NCT01770314|3638435|B3||Between 18 and 65 years|Age||Participants|Count of Participants|168|168.0||||||
3812567|NCT01770314|3638436|B2||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
3812568|NCT01770314|3638437|B1||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
3812569|NCT01770314|3638435|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812570|NCT01770314|3638436|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812571|NCT01770314|3638437|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812572|NCT01770145|3638446|B1|||Average Daily Time to On||minutes|Mean|59.13|59.13|Standard Deviation|18.13|18.13|||
3812573|NCT01770145|3638446|B1|Unknown||Duration of Akinesia (years)||participants|Number|4|4.0||||||
3812574|NCT01770145|3638446|B1|>6 years||Duration of Akinesia (years)||participants|Number|28|28.0||||||
3812575|NCT01770145|3638446|B1|5-6 years||Duration of Akinesia (years)||participants|Number|16|16.0||||||
3812576|NCT01770145|3638446|B1|2-4 years||Duration of Akinesia (years)||participants|Number|35|35.0||||||
3812577|NCT01770145|3638446|B1|<2 years||Duration of Akinesia (years)||participants|Number|44|44.0||||||
3812578|NCT01770145|3638446|B1|15+ years||Duration of Parkinson's Disease (years)||participants|Number|24|24.0||||||
3812579|NCT01770145|3638446|B1|11-15 years||Duration of Parkinson's Disease (years)||participants|Number|34|34.0||||||
3812580|NCT01770145|3638446|B1|6-10 years||Duration of Parkinson's Disease (years)||participants|Number|48|48.0||||||
3812581|NCT01770145|3638446|B1|0-5 years||Duration of Parkinson's Disease (years)||participants|Number|21|21.0||||||
3812582|NCT01770145|3638446|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3812583|NCT01770145|3638446|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|121|121.0||||||
3812584|NCT01770145|3638446|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3812585|NCT01770145|3638446|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3812586|NCT01770145|3638446|B1|||Age||years|Mean|65.20|65.2|Standard Deviation|9.72|9.72|||
3812587|NCT01769612|3638451|B1|Leg||Lesion Location||Participants|Count of Participants|59|59.0||||||
3812588|NCT01769612|3638451|B1|Hand||Lesion Location||Participants|Count of Participants|14|14.0||||||
3812589|NCT01769612|3638451|B1|Foot||Lesion Location||Participants|Count of Participants|35|35.0||||||
3812590|NCT01769612|3638451|B1|Face||Lesion Location||Participants|Count of Participants|4|4.0||||||
3812591|NCT01769612|3638451|B1|Back of head||Lesion Location||Participants|Count of Participants|1|1.0||||||
3812592|NCT01769612|3638451|B1|Arm||Lesion Location||Participants|Count of Participants|55|55.0||||||
3812593|NCT01769612|3638451|B1|Abdomen||Lesion Location||Participants|Count of Participants|0|0.0||||||
3812594|NCT01769612|3638451|B1|Secondary bacterial infection||Lesion Characteristics||Participants|Count of Participants|74|74.0||||||
3812595|NCT01769612|3638451|B1|Nobular||Lesion Characteristics||Participants|Count of Participants|0|0.0||||||
3812596|NCT01769612|3638451|B1|Ulcerated||Lesion Characteristics||Participants|Count of Participants|168|168.0||||||
3812597|NCT01769612|3638451|B1|||Lesion Age||days|Mean|36.2|36.2|Standard Deviation|22.6|22.6|||
3812598|NCT01769612|3638451|B1|Tunisia||Region of Enrollment||participants|Number|168|168.0||||||
3812599|NCT01769612|3638451|B1|North African||Race/Ethnicity, Customized||Participants|Count of Participants|168|168.0||||||
3812600|NCT01769612|3638451|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3812601|NCT01769612|3638451|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3812602|NCT01769612|3638451|B1|||Age||years|Mean|40.2|40.2|Standard Deviation|15.8|15.8|||
3812603|NCT01769586|3638457|B3||Male|Gender||Participants|Count of Participants|187|187.0||||||
3812604|NCT01769586|3638458|B2||Male|Gender||Participants|Count of Participants|93|93.0||||||
3812605|NCT01769586|3638459|B1||Male|Gender||Participants|Count of Participants|94|94.0||||||
3812606|NCT01769586|3638457|B3||Female|Gender||Participants|Count of Participants|13|13.0||||||
3812607|NCT01769586|3638458|B2||Female|Gender||Participants|Count of Participants|7|7.0||||||
3812608|NCT01769586|3638459|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
3812609|NCT01769586|3638457|B3|||Age||years|Mean|60|60.0|Full Range|||27.0|76.0|
3812610|NCT01769586|3638458|B2|||Age||years|Mean|61|61.0|Full Range|||27.0|76.0|
3812611|NCT01769586|3638459|B1|||Age||years|Mean|60|60.0|Full Range|||28.0|76.0|
3812612|NCT01769508|3638466|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3812613|NCT01769508|3638466|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3812614|NCT01769508|3638466|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3812615|NCT01769508|3638466|B1|||Age||years|Median|64|64.0|Full Range|||42.0|75.0|
3812616|NCT01769456|3638475|B1|||Number of male sexual partners in the last month|"From the participant ACASI question:~During the past month, how many male partners have you had sexual contact with (oral or anal)?"|male sexual partners|Mean|1.95|1.95|Standard Deviation|2.15|2.15|||
3812617|NCT01769456|3638475|B1|||Number of participants reporting unprotected sex with a male partner in the past month|"From the participant ACASI question referring to male partners in the past month:~“Of these males, how many did you have unprotected oral or anal sex with in the past month?”~An event is defined as an answer of greater than 0."|Participants|Count of Participants|52|52.0||||||
3812618|NCT01769456|3638475|B1|||Total hip bone mineral density (BMD)||g/cm2|Mean|1.06|1.06|Standard Deviation|0.15|0.15|||
3812619|NCT01769456|3638475|B1|||Total body bone mineral density (BMD)||g/cm2|Mean|1.15|1.15|Standard Deviation|0.11|0.11|||
3812620|NCT01769456|3638475|B1|||Femoral neck bone mineral density (BMD)||g/cm2|Mean|0.99|0.99|Standard Deviation|0.16|0.16|||
3812621|NCT01769456|3638475|B1|||Lumbar spine bone mineral density (BMD)||g/cm2|Mean|1.03|1.03|Standard Deviation|0.15|0.15|||
3812622|NCT01769456|3638475|B1|United States||Region of Enrollment||Participants|Count of Participants|78|78.0||||||
3812623|NCT01769456|3638475|B1|Race/ethnicity|Other/Mixed Race|Race/Ethnicity, Customized|Derived variable combining information on race and ethnicity.|Participants|Count of Participants|26|26.0||||||
3812624|NCT01769456|3638475|B1|Race/ethnicity|White/Hispanic|Race/Ethnicity, Customized|Derived variable combining information on race and ethnicity.|Participants|Count of Participants|16|16.0||||||
3812625|NCT01769456|3638475|B1|Race/ethnicity|White|Race/Ethnicity, Customized|Derived variable combining information on race and ethnicity.|Participants|Count of Participants|11|11.0||||||
3812626|NCT01769456|3638475|B1|Race/ethnicity|Black/African American|Race/Ethnicity, Customized|Derived variable combining information on race and ethnicity.|Participants|Count of Participants|23|23.0||||||
3812627|NCT01769456|3638475|B1|Race/ethnicity|Asian/Pacific Islander|Race/Ethnicity, Customized|Derived variable combining information on race and ethnicity.|Participants|Count of Participants|2|2.0||||||
3812628|NCT01769456|3638475|B1|Black/African-American|Non-Black/African-American|Race/Ethnicity, Customized|Modified binary variable for race, distinguishing only those who identified as Black/African-American from those who did not.|Participants|Count of Participants|45|45.0||||||
3812629|NCT01769456|3638475|B1|Black/African-American|Black/African-American|Race/Ethnicity, Customized|Modified binary variable for race, distinguishing only those who identified as Black/African-American from those who did not.|Participants|Count of Participants|33|33.0||||||
3812630|NCT01769456|3638475|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3812631|NCT01769456|3638475|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3812632|NCT01769456|3638475|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3812633|NCT01769456|3638475|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3812634|NCT01769456|3638475|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3812635|NCT01769456|3638475|B1|||Age||years|Mean|16.52|16.52|Standard Deviation|0.66|0.66|||
3812636|NCT01769443|3638494|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3812637|NCT01769443|3638495|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3812638|NCT01769443|3638496|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3812639|NCT01769443|3638494|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812640|NCT01769443|3638495|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812641|NCT01769443|3638496|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812642|NCT01769443|3638494|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812643|NCT01769443|3638495|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812644|NCT01769443|3638496|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812645|NCT01769443|3638494|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3812646|NCT01769443|3638495|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3812647|NCT01769443|3638496|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3812648|NCT01769443|3638494|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812649|NCT01769443|3638495|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812650|NCT01769443|3638496|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812651|NCT01769443|3638494|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812652|NCT01769443|3638495|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812653|NCT01769443|3638496|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812654|NCT01769443|3638494|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812655|NCT01769443|3638495|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812656|NCT01769443|3638496|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812657|NCT01769443|3638494|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812658|NCT01769443|3638495|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812659|NCT01769443|3638496|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812660|NCT01769443|3638494|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812661|NCT01769443|3638495|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812662|NCT01769443|3638496|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812663|NCT01769443|3638494|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3812664|NCT01769443|3638495|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3812665|NCT01769443|3638496|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3812666|NCT01769443|3638494|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812667|NCT01769443|3638495|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812668|NCT01769443|3638496|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812669|NCT01769443|3638494|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3812670|NCT01769443|3638495|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3812671|NCT01769443|3638496|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3812672|NCT01769443|3638494|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3812673|NCT01769443|3638495|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3812674|NCT01769443|3638496|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3812675|NCT01769443|3638494|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3812676|NCT01769443|3638495|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3812677|NCT01769443|3638496|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3812678|NCT01769443|3638494|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3812679|NCT01769443|3638495|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3812680|NCT01769443|3638496|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3812681|NCT01769443|3638494|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812682|NCT01769443|3638495|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812683|NCT01769443|3638496|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812684|NCT01769391|3638539|B3|Germany||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3812685|NCT01769391|3638540|B2|Germany||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3812686|NCT01769391|3638541|B1|Germany||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3812687|NCT01769391|3638539|B3|Mexico||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3812688|NCT01769391|3638540|B2|Mexico||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3812689|NCT01769391|3638541|B1|Mexico||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3812690|NCT01769391|3638539|B3|South Korea||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3812691|NCT01769391|3638540|B2|South Korea||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3812692|NCT01769391|3638541|B1|South Korea||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3812693|NCT01769391|3638539|B3|Poland||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3812694|NCT01769391|3638540|B2|Poland||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3812695|NCT01769391|3638541|B1|Poland||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3812696|NCT01769391|3638539|B3|United States||Region of Enrollment||Participants|Count of Participants|78|78.0||||||
3812697|NCT01769391|3638540|B2|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3812698|NCT01769391|3638541|B1|United States||Region of Enrollment||Participants|Count of Participants|53|53.0||||||
3812699|NCT01769391|3638539|B3|Russia||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3812700|NCT01769391|3638540|B2|Russia||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3812701|NCT01769391|3638541|B1|Russia||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3812702|NCT01769391|3638539|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812703|NCT01769391|3638540|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812704|NCT01769391|3638541|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812705|NCT01769391|3638539|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812706|NCT01769391|3638540|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812707|NCT01769391|3638541|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812708|NCT01769391|3638539|B3||White|Race (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
3812709|NCT01769391|3638540|B2||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3812710|NCT01769391|3638541|B1||White|Race (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
3812711|NCT01769391|3638539|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3812712|NCT01769391|3638540|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3812713|NCT01769391|3638541|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3812714|NCT01769391|3638539|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812715|NCT01769391|3638540|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812716|NCT01769391|3638541|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812717|NCT01769391|3638539|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3812718|NCT01769391|3638540|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3812719|NCT01769391|3638541|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3812720|NCT01769391|3638539|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3812721|NCT01769391|3638540|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3812722|NCT01769391|3638541|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812723|NCT01769391|3638539|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3812724|NCT01769391|3638540|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812725|NCT01769391|3638541|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3812726|NCT01769391|3638539|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|158|158.0||||||
3812727|NCT01769391|3638540|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3812728|NCT01769391|3638541|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
3812729|NCT01769391|3638539|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3812730|NCT01769391|3638540|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3812731|NCT01769391|3638541|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3812732|NCT01769391|3638539|B3||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3812733|NCT01769391|3638540|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3812734|NCT01769391|3638541|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3812735|NCT01769391|3638539|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3812736|NCT01769391|3638540|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3812737|NCT01769391|3638541|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3812738|NCT01769391|3638539|B3|||Age||years|Mean|65.3|65.3|Standard Deviation|8.98|8.98|||
3812739|NCT01769391|3638540|B2|||Age||years|Mean|64.7|64.7|Standard Deviation|8.27|8.27|||
3812740|NCT01769391|3638541|B1|||Age||years|Mean|65.5|65.5|Standard Deviation|9.36|9.36|||
3812741|NCT01769378|3638559|B3|Puerto Rico||Region of Enrollment||participants|Number|3|3.0||||||
3812742|NCT01769378|3638560|B2|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
3812743|NCT01769378|3638561|B1|Puerto Rico||Region of Enrollment||participants|Number|2|2.0||||||
3812744|NCT01769378|3638559|B3|Croatia||Region of Enrollment||participants|Number|11|11.0||||||
3812745|NCT01769378|3638560|B2|Croatia||Region of Enrollment||participants|Number|2|2.0||||||
3812746|NCT01769378|3638561|B1|Croatia||Region of Enrollment||participants|Number|9|9.0||||||
3812747|NCT01769378|3638559|B3|Slovenia||Region of Enrollment||participants|Number|16|16.0||||||
3812748|NCT01769378|3638560|B2|Slovenia||Region of Enrollment||participants|Number|3|3.0||||||
3812749|NCT01769378|3638561|B1|Slovenia||Region of Enrollment||participants|Number|13|13.0||||||
3812750|NCT01769378|3638559|B3|Mexico||Region of Enrollment||participants|Number|50|50.0||||||
3812751|NCT01769378|3638560|B2|Mexico||Region of Enrollment||participants|Number|10|10.0||||||
3812752|NCT01769378|3638561|B1|Mexico||Region of Enrollment||participants|Number|40|40.0||||||
3812753|NCT01769378|3638559|B3|South Africa||Region of Enrollment||participants|Number|10|10.0||||||
3812754|NCT01769378|3638560|B2|South Africa||Region of Enrollment||participants|Number|3|3.0||||||
3812755|NCT01769378|3638561|B1|South Africa||Region of Enrollment||participants|Number|7|7.0||||||
3812756|NCT01769378|3638559|B3|United States||Region of Enrollment||participants|Number|71|71.0||||||
3812757|NCT01769378|3638560|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3812758|NCT01769378|3638561|B1|United States||Region of Enrollment||participants|Number|57|57.0||||||
3812759|NCT01769378|3638559|B3|Romania||Region of Enrollment||participants|Number|96|96.0||||||
3812760|NCT01769378|3638560|B2|Romania||Region of Enrollment||participants|Number|18|18.0||||||
3812761|NCT01769378|3638561|B1|Romania||Region of Enrollment||participants|Number|78|78.0||||||
3812762|NCT01769378|3638559|B3|Austria||Region of Enrollment||participants|Number|5|5.0||||||
3812763|NCT01769378|3638560|B2|Austria||Region of Enrollment||participants|Number|1|1.0||||||
3812764|NCT01769378|3638561|B1|Austria||Region of Enrollment||participants|Number|4|4.0||||||
3812765|NCT01769378|3638559|B3|Argentina||Region of Enrollment||participants|Number|37|37.0||||||
3812766|NCT01769378|3638560|B2|Argentina||Region of Enrollment||participants|Number|8|8.0||||||
3812767|NCT01769378|3638561|B1|Argentina||Region of Enrollment||participants|Number|29|29.0||||||
3812768|NCT01769378|3638559|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812769|NCT01769378|3638560|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812770|NCT01769378|3638561|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812771|NCT01769378|3638559|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3812772|NCT01769378|3638560|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3812773|NCT01769378|3638561|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3812774|NCT01769378|3638559|B3||White|Race (NIH/OMB)||Participants|Count of Participants|249|249.0||||||
3812775|NCT01769378|3638560|B2||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3812776|NCT01769378|3638561|B1||White|Race (NIH/OMB)||Participants|Count of Participants|202|202.0||||||
3812777|NCT01769378|3638559|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3812778|NCT01769378|3638560|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3812779|NCT01769378|3638561|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3812780|NCT01769378|3638559|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812781|NCT01769378|3638560|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812782|NCT01769378|3638561|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812783|NCT01769378|3638559|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3812784|NCT01769378|3638560|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3812785|NCT01769378|3638561|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3812786|NCT01769378|3638559|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3812787|NCT01769378|3638560|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3812788|NCT01769378|3638561|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3812789|NCT01769378|3638559|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812790|NCT01769378|3638560|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812791|NCT01769378|3638561|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812792|NCT01769378|3638559|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|160|160.0||||||
3812793|NCT01769378|3638560|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3812794|NCT01769378|3638561|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|127|127.0||||||
3812795|NCT01769378|3638559|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|139|139.0||||||
3812796|NCT01769378|3638560|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3812797|NCT01769378|3638561|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|112|112.0||||||
3812798|NCT01769378|3638559|B3||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3812799|NCT01769378|3638560|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3812800|NCT01769378|3638561|B1||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3812801|NCT01769378|3638559|B3||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3812802|NCT01769378|3638560|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3812803|NCT01769378|3638561|B1||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3812804|NCT01769378|3638559|B3|||Age||years|Mean|57.83|57.83|Standard Deviation|9.70|9.7|||
3812805|NCT01769378|3638560|B2|||Age||years|Mean|58.23|58.23|Standard Deviation|7.40|7.4|||
3812806|NCT01769378|3638561|B1|||Age||years|Mean|57.73|57.73|Standard Deviation|10.20|10.2|||
3812807|NCT01769378|3638559|B3||>=65 years|Age||Participants|Count of Participants|68|68.0||||||
3812808|NCT01769378|3638560|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3812809|NCT01769378|3638561|B1||>=65 years|Age||Participants|Count of Participants|57|57.0||||||
3812810|NCT01769378|3638559|B3||Between 18 and 65 years|Age||Participants|Count of Participants|231|231.0||||||
3812811|NCT01769378|3638560|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3812812|NCT01769378|3638561|B1||Between 18 and 65 years|Age||Participants|Count of Participants|182|182.0||||||
3812813|NCT01769378|3638559|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812814|NCT01769378|3638560|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812815|NCT01769378|3638561|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812816|NCT01769365|3638597|B4|Taiwan||Region of Enrollment||participants|Number|307|307.0||||||
3812817|NCT01769365|3638598|B3|Taiwan||Region of Enrollment||participants|Number|103|103.0||||||
3812818|NCT01769365|3638599|B2|Taiwan||Region of Enrollment||participants|Number|102|102.0||||||
3812819|NCT01769365|3638600|B1|Taiwan||Region of Enrollment||participants|Number|102|102.0||||||
3812820|NCT01769365|3638597|B4||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
3812821|NCT01769365|3638598|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3812822|NCT01769365|3638599|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3812823|NCT01769365|3638600|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3812824|NCT01769365|3638597|B4||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3812825|NCT01769365|3638598|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3812826|NCT01769365|3638599|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3812827|NCT01769365|3638600|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3812828|NCT01769365|3638597|B4|||Age||years|Mean|54.88|54.88|Standard Deviation|12.73|12.73|||
3812829|NCT01769365|3638598|B3|||Age||years|Mean|56.08|56.08|Standard Deviation|14.00|14.0|||
3812830|NCT01769365|3638599|B2|||Age||years|Mean|54.96|54.96|Standard Deviation|12.00|12.0|||
3812831|NCT01769365|3638600|B1|||Age||years|Mean|53.85|53.85|Standard Deviation|12.31|12.31|||
3812832|NCT01769365|3638597|B4||>=65 years|Age||Participants|Count of Participants|96|96.0||||||
3812833|NCT01769365|3638598|B3||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
3812834|NCT01769365|3638599|B2||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
3812835|NCT01769365|3638600|B1||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
3812836|NCT01769365|3638597|B4||Between 18 and 65 years|Age||Participants|Count of Participants|211|211.0||||||
3812837|NCT01769365|3638598|B3||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
3812838|NCT01769365|3638599|B2||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
3812839|NCT01769365|3638600|B1||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
3812840|NCT01769365|3638597|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812841|NCT01769365|3638598|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812842|NCT01769365|3638599|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812843|NCT01769365|3638600|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3812844|NCT01769352|3638610|B5|||IOP at Baseline, mean+SEM (mmHg)||mmHg|Mean|15.1|15.1|Standard Deviation|0.6|0.6|||
3812845|NCT01769352|3638611|B4|||IOP at Baseline, mean+SEM (mmHg)||mmHg|Mean|16.0|16.0|Standard Deviation|2.2|2.2|||
3812846|NCT01769352|3638612|B3|||IOP at Baseline, mean+SEM (mmHg)||mmHg|Mean|14.8|14.8|Standard Deviation|0.9|0.9|||
3812847|NCT01769352|3638613|B2|||IOP at Baseline, mean+SEM (mmHg)||mmHg|Mean|15.6|15.6|Standard Deviation|0.8|0.8|||
3812848|NCT01769352|3638614|B1|||IOP at Baseline, mean+SEM (mmHg)||mmHg|Mean|14.2|14.2|Standard Deviation|1.3|1.3|||
3812849|NCT01769352|3638610|B5|||CST at Baseline, mean+SEM (µm)||µm|Mean|485.0|485.0|Standard Deviation|16.9|16.9|||
3812850|NCT01769352|3638611|B4|||CST at Baseline, mean+SEM (µm)||µm|Mean|489.1|489.1|Standard Deviation|29.5|29.5|||
3812851|NCT01769352|3638612|B3|||CST at Baseline, mean+SEM (µm)||µm|Mean|487.3|487.3|Standard Deviation|33.3|33.3|||
3812852|NCT01769352|3638613|B2|||CST at Baseline, mean+SEM (µm)||µm|Mean|447.6|447.6|Standard Deviation|33.9|33.9|||
3812853|NCT01769352|3638614|B1|||CST at Baseline, mean+SEM (µm)||µm|Mean|515.5|515.5|Standard Deviation|33.9|33.9|||
3812854|NCT01769352|3638610|B5|||Best Corrected Visual Acuity at Baseline mean+SEM (Letter Score)|Best corrected visual acuity (BCVA) is a test which assesses visual acuity using an eye exam. Higher the number, better is the visual acuity and vice versa. The total score ranges from 5 to 100, with 100 representing the best visual acuity.|letters|Mean|55.8|55.8|Full Range|||19.0|80.0|
3812903|NCT01769352|3638614|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812855|NCT01769352|3638611|B4|||Best Corrected Visual Acuity at Baseline mean+SEM (Letter Score)|Best corrected visual acuity (BCVA) is a test which assesses visual acuity using an eye exam. Higher the number, better is the visual acuity and vice versa. The total score ranges from 5 to 100, with 100 representing the best visual acuity.|letters|Mean|50.9|50.9|Full Range|||20.0|73.0|
3812856|NCT01769352|3638612|B3|||Best Corrected Visual Acuity at Baseline mean+SEM (Letter Score)|Best corrected visual acuity (BCVA) is a test which assesses visual acuity using an eye exam. Higher the number, better is the visual acuity and vice versa. The total score ranges from 5 to 100, with 100 representing the best visual acuity.|letters|Mean|53.4|53.4|Full Range|||19.0|68.0|
3812857|NCT01769352|3638613|B2|||Best Corrected Visual Acuity at Baseline mean+SEM (Letter Score)|Best corrected visual acuity (BCVA) is a test which assesses visual acuity using an eye exam. Higher the number, better is the visual acuity and vice versa. The total score ranges from 5 to 100, with 100 representing the best visual acuity.|letters|Mean|60.9|60.9|Full Range|||29.0|75.0|
3812858|NCT01769352|3638614|B1|||Best Corrected Visual Acuity at Baseline mean+SEM (Letter Score)|Best corrected visual acuity (BCVA) is a test which assesses visual acuity using an eye exam. Higher the number, better is the visual acuity and vice versa. The total score ranges from 5 to 100, with 100 representing the best visual acuity.|letters|Mean|55.7|55.7|Full Range|||31.0|80.0|
3812859|NCT01769352|3638610|B5|||Number of Surgeries at the Time of Enrollment, mean+SEM||surgeries|Mean|1.8|1.8|Standard Deviation|0.1|0.1|||
3812860|NCT01769352|3638611|B4|||Number of Surgeries at the Time of Enrollment, mean+SEM||surgeries|Mean|2.1|2.1|Standard Deviation|0.3|0.3|||
3812861|NCT01769352|3638612|B3|||Number of Surgeries at the Time of Enrollment, mean+SEM||surgeries|Mean|2.1|2.1|Standard Deviation|0.4|0.4|||
3812862|NCT01769352|3638613|B2|||Number of Surgeries at the Time of Enrollment, mean+SEM||surgeries|Mean|1.4|1.4|Standard Deviation|0.2|0.2|||
3812863|NCT01769352|3638614|B1|||Number of Surgeries at the Time of Enrollment, mean+SEM||surgeries|Mean|1.8|1.8|Standard Deviation|0.2|0.2|||
3812864|NCT01769352|3638610|B5|United States||Region of Enrollment||participants|Number|42|42.0||||||
3812865|NCT01769352|3638611|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
3812866|NCT01769352|3638612|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
3812867|NCT01769352|3638613|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3812868|NCT01769352|3638614|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3812869|NCT01769352|3638610|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3812870|NCT01769352|3638611|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812871|NCT01769352|3638612|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3812872|NCT01769352|3638613|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812873|NCT01769352|3638614|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3812874|NCT01769352|3638610|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812875|NCT01769352|3638611|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812876|NCT01769352|3638612|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812877|NCT01769352|3638613|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812878|NCT01769352|3638614|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812879|NCT01769352|3638610|B5||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3812880|NCT01769352|3638611|B4||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3812881|NCT01769352|3638612|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3812882|NCT01769352|3638613|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3812883|NCT01769352|3638614|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3812884|NCT01769352|3638610|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3812885|NCT01769352|3638611|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3812886|NCT01769352|3638612|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812887|NCT01769352|3638613|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3812888|NCT01769352|3638614|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3812889|NCT01769352|3638610|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812890|NCT01769352|3638611|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812891|NCT01769352|3638612|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812892|NCT01769352|3638613|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812893|NCT01769352|3638614|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812894|NCT01769352|3638610|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812895|NCT01769352|3638611|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812896|NCT01769352|3638612|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812897|NCT01769352|3638613|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812898|NCT01769352|3638614|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812899|NCT01769352|3638610|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812900|NCT01769352|3638611|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812901|NCT01769352|3638612|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812902|NCT01769352|3638613|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812904|NCT01769352|3638610|B5||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3812905|NCT01769352|3638611|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3812906|NCT01769352|3638612|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3812907|NCT01769352|3638613|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3812908|NCT01769352|3638614|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3812909|NCT01769352|3638610|B5||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3812910|NCT01769352|3638611|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3812911|NCT01769352|3638612|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3812912|NCT01769352|3638613|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3812913|NCT01769352|3638614|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3812914|NCT01769352|3638610|B5|||Age||years|Mean|67.4|67.4|Standard Deviation|1.4|1.4|||
3812915|NCT01769352|3638611|B4|||Age||years|Mean|60.1|60.1|Standard Deviation|4.8|4.8|||
3812916|NCT01769352|3638612|B3|||Age||years|Mean|66.2|66.2|Standard Deviation|1.9|1.9|||
3812917|NCT01769352|3638613|B2|||Age||years|Mean|69.9|69.9|Standard Deviation|2.4|2.4|||
3812918|NCT01769352|3638614|B1|||Age||years|Mean|70.4|70.4|Standard Deviation|2.0|2.0|||
3812919|NCT01769339|3638642|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3812920|NCT01769339|3638642|B1||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3812921|NCT01769339|3638642|B1|||Age||years|Mean|37.76|37.76|Standard Deviation|9.39|9.39|||
3812922|NCT01769326|3638649|B5|United States||Region of Enrollment||participants|Number|33|33.0||||||
3812923|NCT01769326|3638650|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
3812924|NCT01769326|3638651|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3812925|NCT01769326|3638652|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3812926|NCT01769326|3638653|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3812927|NCT01769326|3638649|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812928|NCT01769326|3638650|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812929|NCT01769326|3638651|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812930|NCT01769326|3638652|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812931|NCT01769326|3638653|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812932|NCT01769326|3638649|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3812933|NCT01769326|3638650|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3812934|NCT01769326|3638651|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3812935|NCT01769326|3638652|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3812936|NCT01769326|3638653|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3812937|NCT01769326|3638649|B5||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3812938|NCT01769326|3638650|B4||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3812939|NCT01769326|3638651|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3812940|NCT01769326|3638652|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3812941|NCT01769326|3638653|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3812942|NCT01769326|3638649|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3812943|NCT01769326|3638650|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3812944|NCT01769326|3638651|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812945|NCT01769326|3638652|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3812946|NCT01769326|3638653|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812947|NCT01769326|3638649|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812948|NCT01769326|3638650|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812949|NCT01769326|3638651|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812950|NCT01769326|3638652|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812951|NCT01769326|3638653|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812952|NCT01769326|3638649|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3812953|NCT01769326|3638650|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3812954|NCT01769326|3638651|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3812955|NCT01769326|3638652|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3812956|NCT01769326|3638653|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3812957|NCT01769326|3638649|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812958|NCT01769326|3638650|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812959|NCT01769326|3638651|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812960|NCT01769326|3638652|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812961|NCT01769326|3638653|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812962|NCT01769326|3638649|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812963|NCT01769326|3638650|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812964|NCT01769326|3638651|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812965|NCT01769326|3638652|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812966|NCT01769326|3638653|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3812967|NCT01769326|3638649|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3812968|NCT01769326|3638650|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3812969|NCT01769326|3638651|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3812970|NCT01769326|3638652|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3812971|NCT01769326|3638653|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3812972|NCT01769326|3638649|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3812973|NCT01769326|3638650|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3812974|NCT01769326|3638651|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3812975|NCT01769326|3638652|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3812976|NCT01769326|3638653|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3812977|NCT01769326|3638649|B5||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3812978|NCT01769326|3638650|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3812979|NCT01769326|3638651|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3812980|NCT01769326|3638652|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3812981|NCT01769326|3638653|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3812982|NCT01769326|3638649|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3812983|NCT01769326|3638650|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3812984|NCT01769326|3638651|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3812985|NCT01769326|3638652|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3812986|NCT01769326|3638653|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3812987|NCT01769326|3638649|B5|||Age||years|Mean|60|60.0|Full Range|||32.0|80.0|
3812988|NCT01769326|3638650|B4|||Age||years|Mean|54|54.0|Full Range|||39.0|76.0|
3812989|NCT01769326|3638651|B3|||Age||years|Mean|61|61.0|Full Range|||32.0|80.0|
3812990|NCT01769326|3638652|B2|||Age||years|Mean|59|59.0|Full Range|||35.0|74.0|
3812991|NCT01769326|3638653|B1|||Age||years|Mean|60|60.0|Full Range|||45.0|74.0|
3812992|NCT01769248|3638666|B3|United States||Region of Enrollment||participants|Number|140|140.0||||||
3812993|NCT01769248|3638667|B2|United States||Region of Enrollment||participants|Number|70|70.0||||||
3812994|NCT01769248|3638668|B1|United States||Region of Enrollment||participants|Number|70|70.0||||||
3812995|NCT01769248|3638666|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3812996|NCT01769248|3638667|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3812997|NCT01769248|3638668|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3812998|NCT01769248|3638666|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3812999|NCT01769248|3638667|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3813000|NCT01769248|3638668|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3813001|NCT01769248|3638666|B3|||Age||years|Mean|63.8|63.8|Standard Deviation|14.5|14.5|||
3813002|NCT01769248|3638667|B2|||Age||years|Mean|64.1|64.1|Standard Deviation|14.4|14.4|||
3813003|NCT01769248|3638668|B1|||Age||years|Mean|63.7|63.7|Standard Deviation|14.4|14.4|||
3813004|NCT01769248|3638666|B3||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
3813005|NCT01769248|3638667|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3813006|NCT01769248|3638668|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3813007|NCT01769248|3638666|B3||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
3813008|NCT01769248|3638667|B2||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
3813009|NCT01769248|3638668|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3813010|NCT01769248|3638666|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3813011|NCT01769248|3638667|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3813012|NCT01769248|3638668|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3813013|NCT01769222|3638679|B3|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3813014|NCT01769222|3638681|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3813015|NCT01769222|3638679|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813016|NCT01769222|3638681|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813017|NCT01769222|3638679|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813018|NCT01769222|3638681|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813019|NCT01769222|3638679|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3813020|NCT01769222|3638681|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3813021|NCT01769222|3638679|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813022|NCT01769222|3638681|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813023|NCT01769222|3638679|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813024|NCT01769222|3638681|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813025|NCT01769222|3638679|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813026|NCT01769222|3638681|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813027|NCT01769222|3638679|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813028|NCT01769222|3638681|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813029|NCT01769222|3638679|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813030|NCT01769222|3638681|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813031|NCT01769222|3638679|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3813032|NCT01769222|3638681|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3813033|NCT01769222|3638679|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813034|NCT01769222|3638681|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813035|NCT01769222|3638679|B3||Male|Gender||Participants|Count of Participants|1|1.0||||||
3813036|NCT01769222|3638681|B1||Male|Gender||Participants|Count of Participants|1|1.0||||||
3813037|NCT01769222|3638679|B3||Female|Gender||Participants|Count of Participants|2|2.0||||||
3813038|NCT01769222|3638681|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
3813039|NCT01769222|3638679|B3|||Age||years|Median|61|61.0|Full Range|||58.0|78.0|
3813040|NCT01769222|3638681|B1|||Age||years|Median|61|61.0|Full Range|||58.0|78.0|
3813041|NCT01769222|3638679|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3813042|NCT01769222|3638680|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3813043|NCT01769222|3638681|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3813044|NCT01769222|3638679|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3813045|NCT01769222|3638680|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3813046|NCT01769222|3638681|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3813047|NCT01769222|3638679|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3813048|NCT01769222|3638680|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3813049|NCT01769222|3638681|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3813050|NCT01769209|3638696|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3813051|NCT01769209|3638696|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3813052|NCT01769209|3638696|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813053|NCT01769209|3638696|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3813054|NCT01769209|3638696|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813055|NCT01769209|3638696|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813056|NCT01769209|3638696|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3813057|NCT01769209|3638696|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813058|NCT01769209|3638696|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813059|NCT01769209|3638696|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3813060|NCT01769209|3638696|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3813061|NCT01769209|3638696|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3813062|NCT01769209|3638696|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3813063|NCT01769209|3638696|B1|||Age||years|Median|37.2|37.2|Standard Deviation|8.1|8.1|||
3813064|NCT01769209|3638696|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3813065|NCT01769209|3638696|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3813066|NCT01769209|3638696|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3813067|NCT01769196|3638707|B3|||Baseline Serum LOXL2||pg/mL|Mean|88.2|88.2|Standard Deviation|61.48|61.48|||
3813068|NCT01769196|3638708|B2|||Baseline Serum LOXL2||pg/mL|Mean|86.7|86.7|Standard Deviation|51.99|51.99|||
3813069|NCT01769196|3638709|B1|||Baseline Serum LOXL2||pg/mL|Mean|89.8|89.8|Standard Deviation|70.06|70.06|||
3813070|NCT01769196|3638707|B3|Severe||FVC % Predicted Category||Participants|Count of Participants|159|159.0||||||
3813071|NCT01769196|3638708|B2|Severe||FVC % Predicted Category||Participants|Count of Participants|76|76.0||||||
3813072|NCT01769196|3638709|B1|Severe||FVC % Predicted Category||Participants|Count of Participants|83|83.0||||||
3813073|NCT01769196|3638707|B3|Moderate||FVC % Predicted Category||Participants|Count of Participants|302|302.0||||||
3813074|NCT01769196|3638708|B2|Moderate||FVC % Predicted Category||Participants|Count of Participants|150|150.0||||||
3813075|NCT01769196|3638709|B1|Moderate||FVC % Predicted Category||Participants|Count of Participants|152|152.0||||||
3813076|NCT01769196|3638707|B3|Mild||FVC % Predicted Category||Participants|Count of Participants|83|83.0||||||
3813077|NCT01769196|3638708|B2|Mild||FVC % Predicted Category||Participants|Count of Participants|46|46.0||||||
3813078|NCT01769196|3638709|B1|Mild||FVC % Predicted Category||Participants|Count of Participants|37|37.0||||||
3813079|NCT01769196|3638707|B3|||Forced vital capacity (FVC) Percent Predicted||FVC % predicted|Mean|61.8|61.8|Standard Deviation|12.19|12.19|||
3813080|NCT01769196|3638708|B2|||Forced vital capacity (FVC) Percent Predicted||FVC % predicted|Mean|62.3|62.3|Standard Deviation|12.22|12.22|||
3813081|NCT01769196|3638709|B1|||Forced vital capacity (FVC) Percent Predicted||FVC % predicted|Mean|61.4|61.4|Standard Deviation|12.17|12.17|||
3813082|NCT01769196|3638707|B3|Switzerland||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3813083|NCT01769196|3638708|B2|Switzerland||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3813084|NCT01769196|3638709|B1|Switzerland||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3813085|NCT01769196|3638707|B3|Germany||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3813086|NCT01769196|3638708|B2|Germany||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3813087|NCT01769196|3638709|B1|Germany||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3813088|NCT01769196|3638707|B3|France||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3813089|NCT01769196|3638708|B2|France||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3813090|NCT01769196|3638709|B1|France||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3813091|NCT01769196|3638707|B3|Australia||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3813092|NCT01769196|3638708|B2|Australia||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3813093|NCT01769196|3638709|B1|Australia||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3813094|NCT01769196|3638707|B3|Israel||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3813095|NCT01769196|3638708|B2|Israel||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3813096|NCT01769196|3638709|B1|Israel||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3813097|NCT01769196|3638707|B3|Italy||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3813098|NCT01769196|3638708|B2|Italy||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3813099|NCT01769196|3638709|B1|Italy||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3813100|NCT01769196|3638707|B3|Poland||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3813101|NCT01769196|3638708|B2|Poland||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3813102|NCT01769196|3638709|B1|Poland||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3813103|NCT01769196|3638707|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3813104|NCT01769196|3638708|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3813105|NCT01769196|3638709|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3813106|NCT01769196|3638707|B3|Belgium||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3813107|NCT01769196|3638708|B2|Belgium||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3813108|NCT01769196|3638709|B1|Belgium||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3813109|NCT01769196|3638707|B3|Czech Republic||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3813110|NCT01769196|3638708|B2|Czech Republic||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3813111|NCT01769196|3638709|B1|Czech Republic||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3813112|NCT01769196|3638707|B3|Canada||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3813113|NCT01769196|3638708|B2|Canada||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3813114|NCT01769196|3638709|B1|Canada||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3813115|NCT01769196|3638707|B3|Spain||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3813116|NCT01769196|3638708|B2|Spain||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3813117|NCT01769196|3638709|B1|Spain||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3813118|NCT01769196|3638707|B3|Korea, Republic of||Region of Enrollment||Participants|Count of Participants|69|69.0||||||
3813119|NCT01769196|3638708|B2|Korea, Republic of||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3813120|NCT01769196|3638709|B1|Korea, Republic of||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3813121|NCT01769196|3638707|B3|United States||Region of Enrollment||Participants|Count of Participants|208|208.0||||||
3813122|NCT01769196|3638708|B2|United States||Region of Enrollment||Participants|Count of Participants|106|106.0||||||
3813123|NCT01769196|3638709|B1|United States||Region of Enrollment||Participants|Count of Participants|102|102.0||||||
3813124|NCT01769196|3638707|B3|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3813125|NCT01769196|3638708|B2|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3813126|NCT01769196|3638709|B1|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3813127|NCT01769196|3638707|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|531|531.0||||||
3813128|NCT01769196|3638708|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|264|264.0||||||
3813129|NCT01769196|3638709|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|267|267.0||||||
3813130|NCT01769196|3638707|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3813131|NCT01769196|3638708|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3813132|NCT01769196|3638709|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3813133|NCT01769196|3638707|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3813134|NCT01769196|3638708|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3813135|NCT01769196|3638709|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3813136|NCT01769196|3638707|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|460|460.0||||||
3813137|NCT01769196|3638708|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|229|229.0||||||
3813138|NCT01769196|3638709|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|231|231.0||||||
3813139|NCT01769196|3638707|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3813140|NCT01769196|3638708|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3813141|NCT01769196|3638709|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3813142|NCT01769196|3638707|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|71|71.0||||||
3813143|NCT01769196|3638708|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3813144|NCT01769196|3638709|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
3813145|NCT01769196|3638707|B3||Male|Sex: Female, Male||Participants|Count of Participants|452|452.0||||||
3813146|NCT01769196|3638708|B2||Male|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
3813147|NCT01769196|3638709|B1||Male|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
3813148|NCT01769196|3638707|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3813149|NCT01769196|3638708|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3813150|NCT01769196|3638709|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3813151|NCT01769196|3638707|B3|||Age||years|Mean|68.1|68.1|Standard Deviation|7.34|7.34|||
3813152|NCT01769196|3638708|B2|||Age||years|Mean|68.5|68.5|Standard Deviation|7.07|7.07|||
3813153|NCT01769196|3638709|B1|||Age||years|Mean|67.7|67.7|Standard Deviation|7.60|7.6|||
3813154|NCT01769105|3638738|B3|Germany||Region of Enrollment||participants|Number|31|31.0||||||
3813155|NCT01769105|3638739|B2|Germany||Region of Enrollment||participants|Number|17|17.0||||||
3813156|NCT01769105|3638740|B1|Germany||Region of Enrollment||participants|Number|14|14.0||||||
3813157|NCT01769105|3638738|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3813158|NCT01769105|3638739|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3813159|NCT01769105|3638740|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3813160|NCT01769105|3638738|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3813161|NCT01769105|3638739|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3813162|NCT01769105|3638740|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3813163|NCT01769105|3638738|B3|||Age||years|Mean|47|47.0|Standard Deviation|21|21.0|||
3813164|NCT01769105|3638739|B2|||Age||years|Mean|45|45.0|Standard Deviation|23|23.0|||
3813165|NCT01769105|3638740|B1|||Age||years|Mean|50|50.0|Standard Deviation|19|19.0|||
3813166|NCT01768832|3638760|B4|||Disease Duration|Years since being diagnosed with Parkinson's disease|years|Mean|5.47|5.47|Standard Deviation|4.59|4.59|||
3813167|NCT01768832|3638761|B3|||Disease Duration|Years since being diagnosed with Parkinson's disease|years|Mean|4.40|4.4|Standard Deviation|5.04|5.04|||
3813168|NCT01768832|3638762|B2|||Disease Duration|Years since being diagnosed with Parkinson's disease|years|Mean|6.10|6.1|Standard Deviation|4.82|4.82|||
3813169|NCT01768832|3638763|B1|||Disease Duration|Years since being diagnosed with Parkinson's disease|years|Mean|5.59|5.59|Standard Deviation|3.81|3.81|||
3813170|NCT01768832|3638760|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813171|NCT01768832|3638761|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813172|NCT01768832|3638762|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813173|NCT01768832|3638763|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813174|NCT01768832|3638760|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813175|NCT01768832|3638761|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813176|NCT01768832|3638762|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813177|NCT01768832|3638763|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813178|NCT01768832|3638760|B4||White|Race (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3813179|NCT01768832|3638761|B3||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3813180|NCT01768832|3638762|B2||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3813181|NCT01768832|3638763|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3813182|NCT01768832|3638760|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3813183|NCT01768832|3638761|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3813184|NCT01768832|3638762|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813185|NCT01768832|3638763|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3813186|NCT01768832|3638760|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813187|NCT01768832|3638761|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813188|NCT01768832|3638762|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813189|NCT01768832|3638763|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813190|NCT01768832|3638760|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3813191|NCT01768832|3638761|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3813192|NCT01768832|3638762|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813193|NCT01768832|3638763|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813194|NCT01768832|3638760|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3813195|NCT01768832|3638761|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813196|NCT01768832|3638762|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813197|NCT01768832|3638763|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3813198|NCT01768832|3638760|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813199|NCT01768832|3638761|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813200|NCT01768832|3638762|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813201|NCT01768832|3638763|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813202|NCT01768832|3638760|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3813203|NCT01768832|3638761|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3813204|NCT01768832|3638762|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3813205|NCT01768832|3638763|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3813206|NCT01768832|3638760|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3813207|NCT01768832|3638761|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813208|NCT01768832|3638762|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813209|NCT01768832|3638763|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3813210|NCT01768832|3638760|B4||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3813211|NCT01768832|3638761|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3813212|NCT01768832|3638762|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3813213|NCT01768832|3638763|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3813214|NCT01768832|3638760|B4||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3813215|NCT01768832|3638761|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3813216|NCT01768832|3638762|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3813217|NCT01768832|3638763|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3813218|NCT01768832|3638760|B4|||Age||years|Mean|67.16|67.16|Standard Deviation|8.94|8.94|||
3813219|NCT01768832|3638761|B3|||Age||years|Mean|66.18|66.18|Standard Deviation|7.30|7.3|||
3813220|NCT01768832|3638762|B2|||Age||years|Mean|66.73|66.73|Standard Deviation|9.52|9.52|||
3813221|NCT01768832|3638763|B1|||Age||years|Mean|68.52|68.52|Standard Deviation|9.54|9.54|||
3813222|NCT01768676|3638797|B3|||Baseline sperm concentration||million sperm/mL|Mean|76.2|76.2|Standard Deviation|41.75|41.75|||
3813223|NCT01768676|3638798|B2|||Baseline sperm concentration||million sperm/mL|Mean|76.3|76.3|Standard Deviation|40.65|40.65|||
3813224|NCT01768676|3638799|B1|||Baseline sperm concentration||million sperm/mL|Mean|76.1|76.1|Standard Deviation|43.05|43.05|||
3813225|NCT01768676|3638797|B3|United States||Region of Enrollment||participants|Number|181|181.0||||||
3813226|NCT01768676|3638798|B2|United States||Region of Enrollment||participants|Number|91|91.0||||||
3813227|NCT01768676|3638799|B1|United States||Region of Enrollment||participants|Number|90|90.0||||||
3813228|NCT01768676|3638797|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813229|NCT01768676|3638798|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813230|NCT01768676|3638799|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813231|NCT01768676|3638797|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3813232|NCT01768676|3638798|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3813233|NCT01768676|3638799|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813234|NCT01768676|3638797|B3||White|Race (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
3813235|NCT01768676|3638798|B2||White|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3813236|NCT01768676|3638799|B1||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3813237|NCT01768676|3638797|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3813238|NCT01768676|3638798|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3813239|NCT01768676|3638799|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3813240|NCT01768676|3638797|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813241|NCT01768676|3638798|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813242|NCT01768676|3638799|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813243|NCT01768676|3638797|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3813244|NCT01768676|3638798|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3813245|NCT01768676|3638799|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3813246|NCT01768676|3638797|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813247|NCT01768676|3638798|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813248|NCT01768676|3638799|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813249|NCT01768676|3638797|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813250|NCT01768676|3638798|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813251|NCT01768676|3638799|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813252|NCT01768676|3638797|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
3813253|NCT01768676|3638798|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3813254|NCT01768676|3638799|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3813255|NCT01768676|3638797|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3813256|NCT01768676|3638798|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3813257|NCT01768676|3638799|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3813258|NCT01768676|3638797|B3||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
3813259|NCT01768676|3638798|B2||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3813260|NCT01768676|3638799|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3813261|NCT01768676|3638797|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3813262|NCT01768676|3638798|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3813263|NCT01768676|3638799|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3813264|NCT01768676|3638797|B3|||Age||years|Mean|33.8|33.8|Standard Deviation|7.21|7.21|||
3813265|NCT01768676|3638798|B2|||Age||years|Mean|32.9|32.9|Standard Deviation|7.11|7.11|||
3813266|NCT01768676|3638799|B1|||Age||years|Mean|34.8|34.8|Standard Deviation|7.23|7.23|||
3813267|NCT01768572|3638814|B4|||Disease Activity Score for 28 Joints- C-reactive protein (DAS28-CRP)|The DAS28-CRP is a composite score that contains 4 variables: Tender Joints Count (based on 28 joints), Swollen Joints Count (based on 28 joints), general health assessment and high sensitivity C-reactive protein (hs-CRP) in mg/L or erythrocyte sedimentation rate (ESR) in mm/hr. It ranges from 0-10 with a lower score indicating less disease activity. A DAS28-CRP above 5.1 indicates high disease activity, whereas a below 3.2 indicates low disease activity and below 2.6 as disease remission.|score on scale|Mean|5.89|5.89|Standard Deviation|0.97|0.97|||
3813268|NCT01768572|3638815|B3|||Disease Activity Score for 28 Joints- C-reactive protein (DAS28-CRP)|The DAS28-CRP is a composite score that contains 4 variables: Tender Joints Count (based on 28 joints), Swollen Joints Count (based on 28 joints), general health assessment and high sensitivity C-reactive protein (hs-CRP) in mg/L or erythrocyte sedimentation rate (ESR) in mm/hr. It ranges from 0-10 with a lower score indicating less disease activity. A DAS28-CRP above 5.1 indicates high disease activity, whereas a below 3.2 indicates low disease activity and below 2.6 as disease remission.|score on scale|Mean|5.91|5.91|Standard Deviation|1.01|1.01|||
3813269|NCT01768572|3638816|B2|||Disease Activity Score for 28 Joints- C-reactive protein (DAS28-CRP)|The DAS28-CRP is a composite score that contains 4 variables: Tender Joints Count (based on 28 joints), Swollen Joints Count (based on 28 joints), general health assessment and high sensitivity C-reactive protein (hs-CRP) in mg/L or erythrocyte sedimentation rate (ESR) in mm/hr. It ranges from 0-10 with a lower score indicating less disease activity. A DAS28-CRP above 5.1 indicates high disease activity, whereas a below 3.2 indicates low disease activity and below 2.6 as disease remission.|score on scale|Mean|5.88|5.88|Standard Deviation|0.97|0.97|||
3813270|NCT01768572|3638817|B1|||Disease Activity Score for 28 Joints- C-reactive protein (DAS28-CRP)|The DAS28-CRP is a composite score that contains 4 variables: Tender Joints Count (based on 28 joints), Swollen Joints Count (based on 28 joints), general health assessment and high sensitivity C-reactive protein (hs-CRP) in mg/L or erythrocyte sedimentation rate (ESR) in mm/hr. It ranges from 0-10 with a lower score indicating less disease activity. A DAS28-CRP above 5.1 indicates high disease activity, whereas a below 3.2 indicates low disease activity and below 2.6 as disease remission.|score on scale|Mean|5.85|5.85|Standard Deviation|0.92|0.92|||
3813271|NCT01768572|3638814|B4|||Health Assessment Questionnaire Disability Index (HAQ-DI)|Participant-reported assessment of ability to perform tasks in 8 categories of daily living activities: HAQ-DI is consisted of 20 questions in 8 domains: dressing/grooming, arising, eating, walking, hygiene, reach, grip; activities are rated on a 4-point scale where 0=best and 3=worst. Overall score was computed as the sum of domain scores and divided by the number of domains answered, ranging from 0 to 3, where 0 = no disability and 3 = very severe, high-dependency disability.|units on a scale|Mean|1.72|1.72|Standard Deviation|0.63|0.63|||
3813272|NCT01768572|3638815|B3|||Health Assessment Questionnaire Disability Index (HAQ-DI)|Participant-reported assessment of ability to perform tasks in 8 categories of daily living activities: HAQ-DI is consisted of 20 questions in 8 domains: dressing/grooming, arising, eating, walking, hygiene, reach, grip; activities are rated on a 4-point scale where 0=best and 3=worst. Overall score was computed as the sum of domain scores and divided by the number of domains answered, ranging from 0 to 3, where 0 = no disability and 3 = very severe, high-dependency disability.|units on a scale|Mean|1.78|1.78|Standard Deviation|0.63|0.63|||
3813273|NCT01768572|3638816|B2|||Health Assessment Questionnaire Disability Index (HAQ-DI)|Participant-reported assessment of ability to perform tasks in 8 categories of daily living activities: HAQ-DI is consisted of 20 questions in 8 domains: dressing/grooming, arising, eating, walking, hygiene, reach, grip; activities are rated on a 4-point scale where 0=best and 3=worst. Overall score was computed as the sum of domain scores and divided by the number of domains answered, ranging from 0 to 3, where 0 = no disability and 3 = very severe, high-dependency disability.|units on a scale|Mean|1.71|1.71|Standard Deviation|0.60|0.6|||
3813274|NCT01768572|3638817|B1|||Health Assessment Questionnaire Disability Index (HAQ-DI)|Participant-reported assessment of ability to perform tasks in 8 categories of daily living activities: HAQ-DI is consisted of 20 questions in 8 domains: dressing/grooming, arising, eating, walking, hygiene, reach, grip; activities are rated on a 4-point scale where 0=best and 3=worst. Overall score was computed as the sum of domain scores and divided by the number of domains answered, ranging from 0 to 3, where 0 = no disability and 3 = very severe, high-dependency disability.|units on a scale|Mean|1.63|1.63|Standard Deviation|0.66|0.66|||
3813357|NCT01768559|3638829|B2|No||Metformin Use at Screening||participants|Number|38|38.0||||||
3813358|NCT01768559|3638830|B1|No||Metformin Use at Screening||participants|Number|36|36.0||||||
3813275|NCT01768572|3638814|B4|IV||RA functional class|RA Class I participants: completely able to perform usual activities of daily living (self-care, vocational and avocational); Class II participants: able to perform usual self-care and vocational activities, but limited in avocational activities; Class III participants: able to perform usual self-care activities, but limited in vocational and avocational activities; Class IV participants: limited in ability to perform usual self-care, vocational and avocational activities.|participants|Number|0|0.0||||||
3813276|NCT01768572|3638815|B3|IV||RA functional class|RA Class I participants: completely able to perform usual activities of daily living (self-care, vocational and avocational); Class II participants: able to perform usual self-care and vocational activities, but limited in avocational activities; Class III participants: able to perform usual self-care activities, but limited in vocational and avocational activities; Class IV participants: limited in ability to perform usual self-care, vocational and avocational activities.|participants|Number|0|0.0||||||
3813277|NCT01768572|3638816|B2|IV||RA functional class|RA Class I participants: completely able to perform usual activities of daily living (self-care, vocational and avocational); Class II participants: able to perform usual self-care and vocational activities, but limited in avocational activities; Class III participants: able to perform usual self-care activities, but limited in vocational and avocational activities; Class IV participants: limited in ability to perform usual self-care, vocational and avocational activities.|participants|Number|0|0.0||||||
3813278|NCT01768572|3638817|B1|IV||RA functional class|RA Class I participants: completely able to perform usual activities of daily living (self-care, vocational and avocational); Class II participants: able to perform usual self-care and vocational activities, but limited in avocational activities; Class III participants: able to perform usual self-care activities, but limited in vocational and avocational activities; Class IV participants: limited in ability to perform usual self-care, vocational and avocational activities.|participants|Number|0|0.0||||||
3813279|NCT01768572|3638814|B4|III||RA functional class|RA Class I participants: completely able to perform usual activities of daily living (self-care, vocational and avocational); Class II participants: able to perform usual self-care and vocational activities, but limited in avocational activities; Class III participants: able to perform usual self-care activities, but limited in vocational and avocational activities; Class IV participants: limited in ability to perform usual self-care, vocational and avocational activities.|participants|Number|52|52.0||||||
3813280|NCT01768572|3638815|B3|III||RA functional class|RA Class I participants: completely able to perform usual activities of daily living (self-care, vocational and avocational); Class II participants: able to perform usual self-care and vocational activities, but limited in avocational activities; Class III participants: able to perform usual self-care activities, but limited in vocational and avocational activities; Class IV participants: limited in ability to perform usual self-care, vocational and avocational activities.|participants|Number|24|24.0||||||
3813281|NCT01768572|3638816|B2|III||RA functional class|RA Class I participants: completely able to perform usual activities of daily living (self-care, vocational and avocational); Class II participants: able to perform usual self-care and vocational activities, but limited in avocational activities; Class III participants: able to perform usual self-care activities, but limited in vocational and avocational activities; Class IV participants: limited in ability to perform usual self-care, vocational and avocational activities.|participants|Number|14|14.0||||||
3813282|NCT01768572|3638817|B1|III||RA functional class|RA Class I participants: completely able to perform usual activities of daily living (self-care, vocational and avocational); Class II participants: able to perform usual self-care and vocational activities, but limited in avocational activities; Class III participants: able to perform usual self-care activities, but limited in vocational and avocational activities; Class IV participants: limited in ability to perform usual self-care, vocational and avocational activities.|participants|Number|14|14.0||||||
3813283|NCT01768572|3638814|B4|II||RA functional class|RA Class I participants: completely able to perform usual activities of daily living (self-care, vocational and avocational); Class II participants: able to perform usual self-care and vocational activities, but limited in avocational activities; Class III participants: able to perform usual self-care activities, but limited in vocational and avocational activities; Class IV participants: limited in ability to perform usual self-care, vocational and avocational activities.|participants|Number|120|120.0||||||
3813284|NCT01768572|3638815|B3|II||RA functional class|RA Class I participants: completely able to perform usual activities of daily living (self-care, vocational and avocational); Class II participants: able to perform usual self-care and vocational activities, but limited in avocational activities; Class III participants: able to perform usual self-care activities, but limited in vocational and avocational activities; Class IV participants: limited in ability to perform usual self-care, vocational and avocational activities.|participants|Number|62|62.0||||||
3813285|NCT01768572|3638816|B2|II||RA functional class|RA Class I participants: completely able to perform usual activities of daily living (self-care, vocational and avocational); Class II participants: able to perform usual self-care and vocational activities, but limited in avocational activities; Class III participants: able to perform usual self-care activities, but limited in vocational and avocational activities; Class IV participants: limited in ability to perform usual self-care, vocational and avocational activities.|participants|Number|33|33.0||||||
3813286|NCT01768572|3638817|B1|II||RA functional class|RA Class I participants: completely able to perform usual activities of daily living (self-care, vocational and avocational); Class II participants: able to perform usual self-care and vocational activities, but limited in avocational activities; Class III participants: able to perform usual self-care activities, but limited in vocational and avocational activities; Class IV participants: limited in ability to perform usual self-care, vocational and avocational activities.|participants|Number|25|25.0||||||
3813287|NCT01768572|3638814|B4|I||RA functional class|RA Class I participants: completely able to perform usual activities of daily living (self-care, vocational and avocational); Class II participants: able to perform usual self-care and vocational activities, but limited in avocational activities; Class III participants: able to perform usual self-care activities, but limited in vocational and avocational activities; Class IV participants: limited in ability to perform usual self-care, vocational and avocational activities.|participants|Number|30|30.0||||||
3813322|NCT01768559|3638830|B1|||2-Hour Glucose Excursion|243 participants (73 in Lixisenatide arm, 74 in Insulin glulisine QD and 96 in Insulin glulisine TID) were included for 2-hour glucose excursion analysis.|mmol/L|Mean|7.31|7.31|Standard Deviation|3.19|3.19|||
3813288|NCT01768572|3638815|B3|I||RA functional class|RA Class I participants: completely able to perform usual activities of daily living (self-care, vocational and avocational); Class II participants: able to perform usual self-care and vocational activities, but limited in avocational activities; Class III participants: able to perform usual self-care activities, but limited in vocational and avocational activities; Class IV participants: limited in ability to perform usual self-care, vocational and avocational activities.|participants|Number|16|16.0||||||
3813289|NCT01768572|3638816|B2|I||RA functional class|RA Class I participants: completely able to perform usual activities of daily living (self-care, vocational and avocational); Class II participants: able to perform usual self-care and vocational activities, but limited in avocational activities; Class III participants: able to perform usual self-care activities, but limited in vocational and avocational activities; Class IV participants: limited in ability to perform usual self-care, vocational and avocational activities.|participants|Number|4|4.0||||||
3813290|NCT01768572|3638817|B1|I||RA functional class|RA Class I participants: completely able to perform usual activities of daily living (self-care, vocational and avocational); Class II participants: able to perform usual self-care and vocational activities, but limited in avocational activities; Class III participants: able to perform usual self-care activities, but limited in vocational and avocational activities; Class IV participants: limited in ability to perform usual self-care, vocational and avocational activities.|participants|Number|10|10.0||||||
3813291|NCT01768572|3638814|B4|||Duration of rheumatoid arthritis (RA) since diagnosis||years|Mean|11.41|11.41|Standard Deviation|8.48|8.48|||
3813292|NCT01768572|3638815|B3|||Duration of rheumatoid arthritis (RA) since diagnosis||years|Mean|10.84|10.84|Standard Deviation|8.91|8.91|||
3813293|NCT01768572|3638816|B2|||Duration of rheumatoid arthritis (RA) since diagnosis||years|Mean|10.45|10.45|Standard Deviation|7.57|7.57|||
3813294|NCT01768572|3638817|B1|||Duration of rheumatoid arthritis (RA) since diagnosis||years|Mean|13.59|13.59|Standard Deviation|8.24|8.24|||
3813295|NCT01768572|3638814|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3813296|NCT01768572|3638815|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3813297|NCT01768572|3638816|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3813298|NCT01768572|3638817|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3813299|NCT01768572|3638814|B4||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3813300|NCT01768572|3638815|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3813301|NCT01768572|3638816|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3813302|NCT01768572|3638817|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3813303|NCT01768572|3638814|B4|||Age||years|Mean|51.8|51.8|Standard Deviation|12.8|12.8|||
3813304|NCT01768572|3638815|B3|||Age||years|Mean|50.4|50.4|Standard Deviation|13.0|13.0|||
3813305|NCT01768572|3638816|B2|||Age||years|Mean|51.7|51.7|Standard Deviation|13.1|13.1|||
3813306|NCT01768572|3638817|B1|||Age||years|Mean|54.8|54.8|Standard Deviation|12.1|12.1|||
3813307|NCT01768559|3638827|B4|||Duration of Diabetes||years|Mean|12.21|12.21|Standard Deviation|6.66|6.66|||
3813308|NCT01768559|3638828|B3|||Duration of Diabetes||years|Mean|12.41|12.41|Standard Deviation|6.80|6.8|||
3813309|NCT01768559|3638829|B2|||Duration of Diabetes||years|Mean|12.33|12.33|Standard Deviation|6.75|6.75|||
3813310|NCT01768559|3638830|B1|||Duration of Diabetes||years|Mean|11.89|11.89|Standard Deviation|6.43|6.43|||
3813311|NCT01768559|3638827|B4|||Insulin Glargine Dose|893 participants (298 in Lixisenatide arm; 298 in Insulin glulisine QD and 297 in Insulin glulisine TID) were included for Insulin glargine dose analysis.|Units (U)|Mean|65.65|65.65|Standard Deviation|30.39|30.39|||
3813312|NCT01768559|3638828|B3|||Insulin Glargine Dose|893 participants (298 in Lixisenatide arm; 298 in Insulin glulisine QD and 297 in Insulin glulisine TID) were included for Insulin glargine dose analysis.|Units (U)|Mean|64.97|64.97|Standard Deviation|26.90|26.9|||
3813313|NCT01768559|3638829|B2|||Insulin Glargine Dose|893 participants (298 in Lixisenatide arm; 298 in Insulin glulisine QD and 297 in Insulin glulisine TID) were included for Insulin glargine dose analysis.|Units (U)|Mean|64.72|64.72|Standard Deviation|32.07|32.07|||
3813314|NCT01768559|3638830|B1|||Insulin Glargine Dose|893 participants (298 in Lixisenatide arm; 298 in Insulin glulisine QD and 297 in Insulin glulisine TID) were included for Insulin glargine dose analysis.|Units (U)|Mean|67.25|67.25|Standard Deviation|31.95|31.95|||
3813315|NCT01768559|3638827|B4|||Average 7-Point Self-monitored Plasma Glucose (SMPG)|877 participants (292 in Lixisenatide arm; 291 in Insulin glulisine QD and 294 in Insulin glulisine TID) were included for average 7-point SMPG analysis.|mmol/L|Mean|9.02|9.02|Standard Deviation|1.68|1.68|||
3813316|NCT01768559|3638828|B3|||Average 7-Point Self-monitored Plasma Glucose (SMPG)|877 participants (292 in Lixisenatide arm; 291 in Insulin glulisine QD and 294 in Insulin glulisine TID) were included for average 7-point SMPG analysis.|mmol/L|Mean|8.99|8.99|Standard Deviation|1.57|1.57|||
3813317|NCT01768559|3638829|B2|||Average 7-Point Self-monitored Plasma Glucose (SMPG)|877 participants (292 in Lixisenatide arm; 291 in Insulin glulisine QD and 294 in Insulin glulisine TID) were included for average 7-point SMPG analysis.|mmol/L|Mean|9.07|9.07|Standard Deviation|1.74|1.74|||
3813318|NCT01768559|3638830|B1|||Average 7-Point Self-monitored Plasma Glucose (SMPG)|877 participants (292 in Lixisenatide arm; 291 in Insulin glulisine QD and 294 in Insulin glulisine TID) were included for average 7-point SMPG analysis.|mmol/L|Mean|9.02|9.02|Standard Deviation|1.75|1.75|||
3813319|NCT01768559|3638827|B4|||2-Hour Glucose Excursion|243 participants (73 in Lixisenatide arm, 74 in Insulin glulisine QD and 96 in Insulin glulisine TID) were included for 2-hour glucose excursion analysis.|mmol/L|Mean|7.33|7.33|Standard Deviation|3.37|3.37|||
3813320|NCT01768559|3638828|B3|||2-Hour Glucose Excursion|243 participants (73 in Lixisenatide arm, 74 in Insulin glulisine QD and 96 in Insulin glulisine TID) were included for 2-hour glucose excursion analysis.|mmol/L|Mean|7.35|7.35|Standard Deviation|3.34|3.34|||
3813321|NCT01768559|3638829|B2|||2-Hour Glucose Excursion|243 participants (73 in Lixisenatide arm, 74 in Insulin glulisine QD and 96 in Insulin glulisine TID) were included for 2-hour glucose excursion analysis.|mmol/L|Mean|7.31|7.31|Standard Deviation|3.63|3.63|||
3813323|NCT01768559|3638827|B4|||2-Hour Postprandial Plasma Glucose (PPG)|258 participants (79 in Lixisenatide arm; 77 in Insulin glulisine QD and 102 in Insulin glulisine TID) were included for PPG analysis.|mmol/L|Mean|14.18|14.18|Standard Deviation|3.47|3.47|||
3813324|NCT01768559|3638828|B3|||2-Hour Postprandial Plasma Glucose (PPG)|258 participants (79 in Lixisenatide arm; 77 in Insulin glulisine QD and 102 in Insulin glulisine TID) were included for PPG analysis.|mmol/L|Mean|14.25|14.25|Standard Deviation|3.35|3.35|||
3813325|NCT01768559|3638829|B2|||2-Hour Postprandial Plasma Glucose (PPG)|258 participants (79 in Lixisenatide arm; 77 in Insulin glulisine QD and 102 in Insulin glulisine TID) were included for PPG analysis.|mmol/L|Mean|14.02|14.02|Standard Deviation|3.59|3.59|||
3813326|NCT01768559|3638830|B1|||2-Hour Postprandial Plasma Glucose (PPG)|258 participants (79 in Lixisenatide arm; 77 in Insulin glulisine QD and 102 in Insulin glulisine TID) were included for PPG analysis.|mmol/L|Mean|14.26|14.26|Standard Deviation|3.55|3.55|||
3813327|NCT01768559|3638827|B4|||Fasting Plasma Glucose (FPG)|893 participants (298 in Lixisenatide arm; 298 in Insulin glulisine QD and 297 in Insulin glulisine TID) were included for FPG analysis.|mmol/L|Mean|6.69|6.69|Standard Deviation|1.90|1.9|||
3813328|NCT01768559|3638828|B3|||Fasting Plasma Glucose (FPG)|893 participants (298 in Lixisenatide arm; 298 in Insulin glulisine QD and 297 in Insulin glulisine TID) were included for FPG analysis.|mmol/L|Mean|6.65|6.65|Standard Deviation|1.89|1.89|||
3813329|NCT01768559|3638829|B2|||Fasting Plasma Glucose (FPG)|893 participants (298 in Lixisenatide arm; 298 in Insulin glulisine QD and 297 in Insulin glulisine TID) were included for FPG analysis.|mmol/L|Mean|6.84|6.84|Standard Deviation|1.98|1.98|||
3813330|NCT01768559|3638830|B1|||Fasting Plasma Glucose (FPG)|893 participants (298 in Lixisenatide arm; 298 in Insulin glulisine QD and 297 in Insulin glulisine TID) were included for FPG analysis.|mmol/L|Mean|6.58|6.58|Standard Deviation|1.82|1.82|||
3813331|NCT01768559|3638827|B4|||HbA1c|893 participants (298 in Lixisenatide arm; 298 in Insulin glulisine QD and 297 in Insulin glulisine TID) were included for HbA1c analysis.|percentage of hemoglobin|Mean|7.76|7.76|Standard Deviation|0.58|0.58|||
3813332|NCT01768559|3638828|B3|||HbA1c|893 participants (298 in Lixisenatide arm; 298 in Insulin glulisine QD and 297 in Insulin glulisine TID) were included for HbA1c analysis.|percentage of hemoglobin|Mean|7.79|7.79|Standard Deviation|0.60|0.6|||
3813333|NCT01768559|3638829|B2|||HbA1c|893 participants (298 in Lixisenatide arm; 298 in Insulin glulisine QD and 297 in Insulin glulisine TID) were included for HbA1c analysis.|percentage of hemoglobin|Mean|7.73|7.73|Standard Deviation|0.59|0.59|||
3813334|NCT01768559|3638830|B1|||HbA1c|893 participants (298 in Lixisenatide arm; 298 in Insulin glulisine QD and 297 in Insulin glulisine TID) were included for HbA1c analysis.|percentage of hemoglobin|Mean|7.77|7.77|Standard Deviation|0.55|0.55|||
3813335|NCT01768559|3638827|B4|||Weight|893 participants (298 in Lixisenatide arm, 298 in Insulin glulisine QD and 297 in Insulin glulisine TID) were included for baseline weight analysis.|kg|Mean|89.53|89.53|Standard Deviation|16.79|16.79|||
3813336|NCT01768559|3638828|B3|||Weight|893 participants (298 in Lixisenatide arm, 298 in Insulin glulisine QD and 297 in Insulin glulisine TID) were included for baseline weight analysis.|kg|Mean|90.08|90.08|Standard Deviation|17.18|17.18|||
3813337|NCT01768559|3638829|B2|||Weight|893 participants (298 in Lixisenatide arm, 298 in Insulin glulisine QD and 297 in Insulin glulisine TID) were included for baseline weight analysis.|kg|Mean|88.45|88.45|Standard Deviation|15.84|15.84|||
3813338|NCT01768559|3638830|B1|||Weight|893 participants (298 in Lixisenatide arm, 298 in Insulin glulisine QD and 297 in Insulin glulisine TID) were included for baseline weight analysis.|kg|Mean|90.06|90.06|Standard Deviation|17.31|17.31|||
3813339|NCT01768559|3638827|B4|||BMI|893 participants (298 in Lixisenatide arm; 298 in Insulin glulisine QD and 297 in Insulin glulisine TID) were included for baseline BMI analysis.|kg/m^2|Mean|32.21|32.21|Standard Deviation|4.52|4.52|||
3813340|NCT01768559|3638828|B3|||BMI|893 participants (298 in Lixisenatide arm; 298 in Insulin glulisine QD and 297 in Insulin glulisine TID) were included for baseline BMI analysis.|kg/m^2|Mean|32.50|32.5|Standard Deviation|4.60|4.6|||
3813341|NCT01768559|3638829|B2|||BMI|893 participants (298 in Lixisenatide arm; 298 in Insulin glulisine QD and 297 in Insulin glulisine TID) were included for baseline BMI analysis.|kg/m^2|Mean|31.86|31.86|Standard Deviation|4.39|4.39|||
3813342|NCT01768559|3638830|B1|||BMI|893 participants (298 in Lixisenatide arm; 298 in Insulin glulisine QD and 297 in Insulin glulisine TID) were included for baseline BMI analysis.|kg/m^2|Mean|32.27|32.27|Standard Deviation|4.57|4.57|||
3813343|NCT01768559|3638827|B4|Participants not analyzed for BMI||Number of Participants with Categorical Body Mass Index (BMI)||participants|Number|1|1.0||||||
3813344|NCT01768559|3638828|B3|Participants not analyzed for BMI||Number of Participants with Categorical Body Mass Index (BMI)||participants|Number|1|1.0||||||
3813345|NCT01768559|3638829|B2|Participants not analyzed for BMI||Number of Participants with Categorical Body Mass Index (BMI)||participants|Number|0|0.0||||||
3813346|NCT01768559|3638830|B1|Participants not analyzed for BMI||Number of Participants with Categorical Body Mass Index (BMI)||participants|Number|0|0.0||||||
3813347|NCT01768559|3638827|B4|≥30 kg/m^2||Number of Participants with Categorical Body Mass Index (BMI)||participants|Number|581|581.0||||||
3813348|NCT01768559|3638828|B3|≥30 kg/m^2||Number of Participants with Categorical Body Mass Index (BMI)||participants|Number|200|200.0||||||
3813349|NCT01768559|3638829|B2|≥30 kg/m^2||Number of Participants with Categorical Body Mass Index (BMI)||participants|Number|180|180.0||||||
3813350|NCT01768559|3638830|B1|≥30 kg/m^2||Number of Participants with Categorical Body Mass Index (BMI)||participants|Number|201|201.0||||||
3813351|NCT01768559|3638827|B4|<30 kg/m^2||Number of Participants with Categorical Body Mass Index (BMI)||participants|Number|312|312.0||||||
3813352|NCT01768559|3638828|B3|<30 kg/m^2||Number of Participants with Categorical Body Mass Index (BMI)||participants|Number|97|97.0||||||
3813353|NCT01768559|3638829|B2|<30 kg/m^2||Number of Participants with Categorical Body Mass Index (BMI)||participants|Number|118|118.0||||||
3813354|NCT01768559|3638830|B1|<30 kg/m^2||Number of Participants with Categorical Body Mass Index (BMI)||participants|Number|97|97.0||||||
3813355|NCT01768559|3638827|B4|No||Metformin Use at Screening||participants|Number|113|113.0||||||
3813356|NCT01768559|3638828|B3|No||Metformin Use at Screening||participants|Number|39|39.0||||||
3813359|NCT01768559|3638827|B4|Yes||Metformin Use at Screening||participants|Number|781|781.0||||||
3813360|NCT01768559|3638828|B3|Yes||Metformin Use at Screening||participants|Number|259|259.0||||||
3813361|NCT01768559|3638829|B2|Yes||Metformin Use at Screening||participants|Number|260|260.0||||||
3813362|NCT01768559|3638830|B1|Yes||Metformin Use at Screening||participants|Number|262|262.0||||||
3813363|NCT01768559|3638827|B4|Non-Hispanic||Ethnicity||participants|Number|705|705.0||||||
3813364|NCT01768559|3638828|B3|Non-Hispanic||Ethnicity||participants|Number|230|230.0||||||
3813365|NCT01768559|3638829|B2|Non-Hispanic||Ethnicity||participants|Number|240|240.0||||||
3813366|NCT01768559|3638830|B1|Non-Hispanic||Ethnicity||participants|Number|235|235.0||||||
3813367|NCT01768559|3638827|B4|Hispanic||Ethnicity||participants|Number|189|189.0||||||
3813368|NCT01768559|3638828|B3|Hispanic||Ethnicity||participants|Number|68|68.0||||||
3813369|NCT01768559|3638829|B2|Hispanic||Ethnicity||participants|Number|58|58.0||||||
3813370|NCT01768559|3638830|B1|Hispanic||Ethnicity||participants|Number|63|63.0||||||
3813371|NCT01768559|3638827|B4|Other||Race||participants|Number|1|1.0||||||
3813372|NCT01768559|3638828|B3|Other||Race||participants|Number|1|1.0||||||
3813373|NCT01768559|3638829|B2|Other||Race||participants|Number|0|0.0||||||
3813374|NCT01768559|3638830|B1|Other||Race||participants|Number|0|0.0||||||
3813375|NCT01768559|3638827|B4|Asian/Oriental||Race||participants|Number|29|29.0||||||
3813376|NCT01768559|3638828|B3|Asian/Oriental||Race||participants|Number|13|13.0||||||
3813377|NCT01768559|3638829|B2|Asian/Oriental||Race||participants|Number|7|7.0||||||
3813378|NCT01768559|3638830|B1|Asian/Oriental||Race||participants|Number|9|9.0||||||
3813379|NCT01768559|3638827|B4|Black||Race||participants|Number|36|36.0||||||
3813380|NCT01768559|3638828|B3|Black||Race||participants|Number|12|12.0||||||
3813381|NCT01768559|3638829|B2|Black||Race||participants|Number|11|11.0||||||
3813382|NCT01768559|3638830|B1|Black||Race||participants|Number|13|13.0||||||
3813383|NCT01768559|3638827|B4|Caucasian/White||Race||participants|Number|828|828.0||||||
3813384|NCT01768559|3638828|B3|Caucasian/White||Race||participants|Number|272|272.0||||||
3813385|NCT01768559|3638829|B2|Caucasian/White||Race||participants|Number|280|280.0||||||
3813386|NCT01768559|3638830|B1|Caucasian/White||Race||participants|Number|276|276.0||||||
3813387|NCT01768559|3638827|B4||Male|Gender||Participants|Count of Participants|405|405.0||||||
3813388|NCT01768559|3638828|B3||Male|Gender||Participants|Count of Participants|132|132.0||||||
3813389|NCT01768559|3638829|B2||Male|Gender||Participants|Count of Participants|135|135.0||||||
3813390|NCT01768559|3638830|B1||Male|Gender||Participants|Count of Participants|138|138.0||||||
3813391|NCT01768559|3638827|B4||Female|Gender||Participants|Count of Participants|489|489.0||||||
3813392|NCT01768559|3638828|B3||Female|Gender||Participants|Count of Participants|166|166.0||||||
3813393|NCT01768559|3638829|B2||Female|Gender||Participants|Count of Participants|163|163.0||||||
3813394|NCT01768559|3638830|B1||Female|Gender||Participants|Count of Participants|160|160.0||||||
3813395|NCT01768559|3638827|B4|||Age||years|Mean|59.8|59.8|Standard Deviation|8.9|8.9|||
3813396|NCT01768559|3638828|B3|||Age||years|Mean|59.4|59.4|Standard Deviation|9.5|9.5|||
3813397|NCT01768559|3638829|B2|||Age||years|Mean|60.2|60.2|Standard Deviation|8.6|8.6|||
3813398|NCT01768559|3638830|B1|||Age||years|Mean|59.8|59.8|Standard Deviation|8.6|8.6|||
3813399|NCT01768325|3638880|B3|United States||Region of Enrollment||participants|Number|78|78.0||||||
3813400|NCT01768325|3638881|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
3813401|NCT01768325|3638882|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
3813402|NCT01768325|3638880|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3813403|NCT01768325|3638881|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3813404|NCT01768325|3638882|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3813405|NCT01768325|3638880|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3813406|NCT01768325|3638881|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3813407|NCT01768325|3638882|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3813408|NCT01768325|3638880|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3813409|NCT01768325|3638881|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3813410|NCT01768325|3638882|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3813411|NCT01768325|3638880|B3||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
3813412|NCT01768325|3638881|B2||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3813413|NCT01768325|3638882|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3813414|NCT01768325|3638880|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3813415|NCT01768325|3638881|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3813416|NCT01768325|3638882|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3813417|NCT01768286|3638893|B5|IFN-alfa-2b+RBV||Prior HCV Treatment|IFN-alfa-2b = interferon-alfa 2b; PEG-IFN-alfa-2a = pegylated interferon alfa-2a; PEG-IFN-alfa-2b - pegylated interferon alfa-2b; RBV = ribavirin; PI = protease inhibitor|participants|Number|2|2.0||||||
3813418|NCT01768286|3638894|B4|IFN-alfa-2b+RBV||Prior HCV Treatment|IFN-alfa-2b = interferon-alfa 2b; PEG-IFN-alfa-2a = pegylated interferon alfa-2a; PEG-IFN-alfa-2b - pegylated interferon alfa-2b; RBV = ribavirin; PI = protease inhibitor|participants|Number|1|1.0||||||
3813419|NCT01768286|3638895|B3|IFN-alfa-2b+RBV||Prior HCV Treatment|IFN-alfa-2b = interferon-alfa 2b; PEG-IFN-alfa-2a = pegylated interferon alfa-2a; PEG-IFN-alfa-2b - pegylated interferon alfa-2b; RBV = ribavirin; PI = protease inhibitor|participants|Number|1|1.0||||||
3813461|NCT01768286|3638897|B1|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|103|103.0||||||
3813420|NCT01768286|3638896|B2|IFN-alfa-2b+RBV||Prior HCV Treatment|IFN-alfa-2b = interferon-alfa 2b; PEG-IFN-alfa-2a = pegylated interferon alfa-2a; PEG-IFN-alfa-2b - pegylated interferon alfa-2b; RBV = ribavirin; PI = protease inhibitor|participants|Number|0|0.0||||||
3813421|NCT01768286|3638897|B1|IFN-alfa-2b+RBV||Prior HCV Treatment|IFN-alfa-2b = interferon-alfa 2b; PEG-IFN-alfa-2a = pegylated interferon alfa-2a; PEG-IFN-alfa-2b - pegylated interferon alfa-2b; RBV = ribavirin; PI = protease inhibitor|participants|Number|0|0.0||||||
3813422|NCT01768286|3638893|B5|PI+PEG-IFN-alfa-2a or PEG-IFN-alfa-2b+RBV||Prior HCV Treatment|IFN-alfa-2b = interferon-alfa 2b; PEG-IFN-alfa-2a = pegylated interferon alfa-2a; PEG-IFN-alfa-2b - pegylated interferon alfa-2b; RBV = ribavirin; PI = protease inhibitor|participants|Number|231|231.0||||||
3813423|NCT01768286|3638894|B4|PI+PEG-IFN-alfa-2a or PEG-IFN-alfa-2b+RBV||Prior HCV Treatment|IFN-alfa-2b = interferon-alfa 2b; PEG-IFN-alfa-2a = pegylated interferon alfa-2a; PEG-IFN-alfa-2b - pegylated interferon alfa-2b; RBV = ribavirin; PI = protease inhibitor|participants|Number|51|51.0||||||
3813424|NCT01768286|3638895|B3|PI+PEG-IFN-alfa-2a or PEG-IFN-alfa-2b+RBV||Prior HCV Treatment|IFN-alfa-2b = interferon-alfa 2b; PEG-IFN-alfa-2a = pegylated interferon alfa-2a; PEG-IFN-alfa-2b - pegylated interferon alfa-2b; RBV = ribavirin; PI = protease inhibitor|participants|Number|50|50.0||||||
3813425|NCT01768286|3638896|B2|PI+PEG-IFN-alfa-2a or PEG-IFN-alfa-2b+RBV||Prior HCV Treatment|IFN-alfa-2b = interferon-alfa 2b; PEG-IFN-alfa-2a = pegylated interferon alfa-2a; PEG-IFN-alfa-2b - pegylated interferon alfa-2b; RBV = ribavirin; PI = protease inhibitor|participants|Number|64|64.0||||||
3813426|NCT01768286|3638897|B1|PI+PEG-IFN-alfa-2a or PEG-IFN-alfa-2b+RBV||Prior HCV Treatment|IFN-alfa-2b = interferon-alfa 2b; PEG-IFN-alfa-2a = pegylated interferon alfa-2a; PEG-IFN-alfa-2b - pegylated interferon alfa-2b; RBV = ribavirin; PI = protease inhibitor|participants|Number|66|66.0||||||
3813427|NCT01768286|3638893|B5|PEG-IFN-alfa-2a or PEG-IFN-alfa-2b+RBV||Prior HCV Treatment|IFN-alfa-2b = interferon-alfa 2b; PEG-IFN-alfa-2a = pegylated interferon alfa-2a; PEG-IFN-alfa-2b - pegylated interferon alfa-2b; RBV = ribavirin; PI = protease inhibitor|participants|Number|207|207.0||||||
3813428|NCT01768286|3638894|B4|PEG-IFN-alfa-2a or PEG-IFN-alfa-2b+RBV||Prior HCV Treatment|IFN-alfa-2b = interferon-alfa 2b; PEG-IFN-alfa-2a = pegylated interferon alfa-2a; PEG-IFN-alfa-2b - pegylated interferon alfa-2b; RBV = ribavirin; PI = protease inhibitor|participants|Number|59|59.0||||||
3813429|NCT01768286|3638895|B3|PEG-IFN-alfa-2a or PEG-IFN-alfa-2b+RBV||Prior HCV Treatment|IFN-alfa-2b = interferon-alfa 2b; PEG-IFN-alfa-2a = pegylated interferon alfa-2a; PEG-IFN-alfa-2b - pegylated interferon alfa-2b; RBV = ribavirin; PI = protease inhibitor|participants|Number|58|58.0||||||
3813430|NCT01768286|3638896|B2|PEG-IFN-alfa-2a or PEG-IFN-alfa-2b+RBV||Prior HCV Treatment|IFN-alfa-2b = interferon-alfa 2b; PEG-IFN-alfa-2a = pegylated interferon alfa-2a; PEG-IFN-alfa-2b - pegylated interferon alfa-2b; RBV = ribavirin; PI = protease inhibitor|participants|Number|47|47.0||||||
3813431|NCT01768286|3638897|B1|PEG-IFN-alfa-2a or PEG-IFN-alfa-2b+RBV||Prior HCV Treatment|IFN-alfa-2b = interferon-alfa 2b; PEG-IFN-alfa-2a = pegylated interferon alfa-2a; PEG-IFN-alfa-2b - pegylated interferon alfa-2b; RBV = ribavirin; PI = protease inhibitor|participants|Number|43|43.0||||||
3813432|NCT01768286|3638893|B5|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|102|102.0||||||
3813433|NCT01768286|3638894|B4|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|25|25.0||||||
3813434|NCT01768286|3638895|B3|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|25|25.0||||||
3813435|NCT01768286|3638896|B2|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|23|23.0||||||
3813436|NCT01768286|3638897|B1|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|29|29.0||||||
3813437|NCT01768286|3638893|B5|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|283|283.0||||||
3813438|NCT01768286|3638894|B4|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|68|68.0||||||
3813439|NCT01768286|3638895|B3|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|68|68.0||||||
3813440|NCT01768286|3638896|B2|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|77|77.0||||||
3813441|NCT01768286|3638897|B1|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|70|70.0||||||
3813442|NCT01768286|3638893|B5|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|55|55.0||||||
3813443|NCT01768286|3638894|B4|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|18|18.0||||||
3813444|NCT01768286|3638895|B3|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|16|16.0||||||
3813445|NCT01768286|3638896|B2|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|11|11.0||||||
3813446|NCT01768286|3638897|B1|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|10|10.0||||||
3813447|NCT01768286|3638893|B5|Genotype 1b||HCV Genotype||participants|Number|93|93.0||||||
3813448|NCT01768286|3638894|B4|Genotype 1b||HCV Genotype||participants|Number|23|23.0||||||
3813449|NCT01768286|3638895|B3|Genotype 1b||HCV Genotype||participants|Number|24|24.0||||||
3813450|NCT01768286|3638896|B2|Genotype 1b||HCV Genotype||participants|Number|23|23.0||||||
3813451|NCT01768286|3638897|B1|Genotype 1b||HCV Genotype||participants|Number|23|23.0||||||
3813452|NCT01768286|3638893|B5|Genotype 1a||HCV Genotype||participants|Number|347|347.0||||||
3813453|NCT01768286|3638894|B4|Genotype 1a||HCV Genotype||participants|Number|88|88.0||||||
3813454|NCT01768286|3638895|B3|Genotype 1a||HCV Genotype||participants|Number|85|85.0||||||
3813455|NCT01768286|3638896|B2|Genotype 1a||HCV Genotype||participants|Number|88|88.0||||||
3813456|NCT01768286|3638897|B1|Genotype 1a||HCV Genotype||participants|Number|86|86.0||||||
3813457|NCT01768286|3638893|B5|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|390|390.0||||||
3813458|NCT01768286|3638894|B4|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|96|96.0||||||
3813459|NCT01768286|3638895|B3|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|93|93.0||||||
3813460|NCT01768286|3638896|B2|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|98|98.0||||||
3813462|NCT01768286|3638893|B5|< 800,000 IU/mL||HCV RNA Category||participants|Number|50|50.0||||||
3813463|NCT01768286|3638894|B4|< 800,000 IU/mL||HCV RNA Category||participants|Number|15|15.0||||||
3813464|NCT01768286|3638895|B3|< 800,000 IU/mL||HCV RNA Category||participants|Number|16|16.0||||||
3813465|NCT01768286|3638896|B2|< 800,000 IU/mL||HCV RNA Category||participants|Number|13|13.0||||||
3813466|NCT01768286|3638897|B1|< 800,000 IU/mL||HCV RNA Category||participants|Number|6|6.0||||||
3813467|NCT01768286|3638893|B5|||HCV RNA||log10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.54|0.54|||
3813468|NCT01768286|3638894|B4|||HCV RNA||log10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.60|0.6|||
3813469|NCT01768286|3638895|B3|||HCV RNA||log10 IU/mL|Mean|6.4|6.4|Standard Deviation|0.57|0.57|||
3813470|NCT01768286|3638896|B2|||HCV RNA||log10 IU/mL|Mean|6.4|6.4|Standard Deviation|0.54|0.54|||
3813471|NCT01768286|3638897|B1|||HCV RNA||log10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.44|0.44|||
3813472|NCT01768286|3638893|B5|Not Disclosed||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3813473|NCT01768286|3638894|B4|Not Disclosed||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3813474|NCT01768286|3638895|B3|Not Disclosed||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3813475|NCT01768286|3638896|B2|Not Disclosed||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3813476|NCT01768286|3638897|B1|Not Disclosed||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3813477|NCT01768286|3638893|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|396|396.0||||||
3813478|NCT01768286|3638894|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|99|99.0||||||
3813479|NCT01768286|3638895|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|98|98.0||||||
3813480|NCT01768286|3638896|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|99|99.0||||||
3813481|NCT01768286|3638897|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|100|100.0||||||
3813482|NCT01768286|3638893|B5|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
3813483|NCT01768286|3638894|B4|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3813484|NCT01768286|3638895|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3813485|NCT01768286|3638896|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3813486|NCT01768286|3638897|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3813487|NCT01768286|3638893|B5|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3813488|NCT01768286|3638894|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3813489|NCT01768286|3638895|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3813490|NCT01768286|3638896|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3813491|NCT01768286|3638897|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3813492|NCT01768286|3638893|B5|Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3813493|NCT01768286|3638894|B4|Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3813494|NCT01768286|3638895|B3|Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3813495|NCT01768286|3638896|B2|Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3813496|NCT01768286|3638897|B1|Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3813497|NCT01768286|3638893|B5|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3813498|NCT01768286|3638894|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3813499|NCT01768286|3638895|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3813500|NCT01768286|3638896|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3813501|NCT01768286|3638897|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3813502|NCT01768286|3638893|B5|White||Race/Ethnicity, Customized||participants|Number|358|358.0||||||
3813503|NCT01768286|3638894|B4|White||Race/Ethnicity, Customized||participants|Number|89|89.0||||||
3813504|NCT01768286|3638895|B3|White||Race/Ethnicity, Customized||participants|Number|91|91.0||||||
3813505|NCT01768286|3638896|B2|White||Race/Ethnicity, Customized||participants|Number|94|94.0||||||
3813506|NCT01768286|3638897|B1|White||Race/Ethnicity, Customized||participants|Number|84|84.0||||||
3813507|NCT01768286|3638893|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
3813508|NCT01768286|3638894|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3813509|NCT01768286|3638895|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3813510|NCT01768286|3638896|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3813511|NCT01768286|3638897|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3813512|NCT01768286|3638893|B5||Male|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
3813513|NCT01768286|3638894|B4||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3813514|NCT01768286|3638895|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3813515|NCT01768286|3638896|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3813516|NCT01768286|3638897|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3813517|NCT01768286|3638893|B5||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3813518|NCT01768286|3638894|B4||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3813519|NCT01768286|3638895|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3813520|NCT01768286|3638896|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3813521|NCT01768286|3638897|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3813522|NCT01768286|3638893|B5|||Age||years|Mean|56|56.0|Standard Deviation|7.8|7.8|||
3813523|NCT01768286|3638894|B4|||Age||years|Mean|55|55.0|Standard Deviation|7.8|7.8|||
3813524|NCT01768286|3638895|B3|||Age||years|Mean|56|56.0|Standard Deviation|8.3|8.3|||
3813525|NCT01768286|3638896|B2|||Age||years|Mean|57|57.0|Standard Deviation|8.0|8.0|||
3813526|NCT01768286|3638897|B1|||Age||years|Mean|56|56.0|Standard Deviation|6.9|6.9|||
3813527|NCT01768117|3638962|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3813528|NCT01768117|3638962|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3813529|NCT01768117|3638962|B1|Greater than (>) 40 years||Age, Customized||participants|Number|8|8.0||||||
3813530|NCT01768117|3638962|B1|18- 40 years||Age, Customized||participants|Number|5|5.0||||||
3813531|NCT01768013|3638970|B1|Japan||Region of Enrollment||participants|Number|13|13.0||||||
3813532|NCT01768013|3638970|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3813533|NCT01768013|3638970|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3813534|NCT01768013|3638970|B1|||Age||years|Mean|54.2|54.2|Standard Deviation|15.4|15.4|||
3813535|NCT01768013|3638970|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3813536|NCT01768013|3638970|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3813537|NCT01768013|3638970|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3813538|NCT01768000|3638999|B5|Live with family||Housing|Housing data was collected only for the participant with psychosis and NOT the family member.|Participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3813539|NCT01768000|3639000|B4|Live with family||Housing|Housing data was collected only for the participant with psychosis and NOT the family member.|Participants|Number|NA|||||||Housing data was collected only for the participant with psychosis and NOT the family member.
3813540|NCT01768000|3639001|B3|Live with family||Housing|Housing data was collected only for the participant with psychosis and NOT the family member.|Participants|Number|6|6.0||||||
3813541|NCT01768000|3639002|B2|Live with family||Housing|Housing data was collected only for the participant with psychosis and NOT the family member.|Participants|Number|NA|||||||Housing data was collected only for the participant with psychosis and NOT the family member.
3813542|NCT01768000|3639003|B1|Live with family||Housing|Housing data was collected only for the participant with psychosis and NOT the family member.|Participants|Number|9|9.0||||||
3813543|NCT01768000|3638999|B5|Supported housing||Housing|Housing data was collected only for the participant with psychosis and NOT the family member.|Participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3813544|NCT01768000|3639000|B4|Supported housing||Housing|Housing data was collected only for the participant with psychosis and NOT the family member.|Participants|Number|NA|||||||Housing data was collected only for the participant with psychosis and NOT the family member.
3813545|NCT01768000|3639001|B3|Supported housing||Housing|Housing data was collected only for the participant with psychosis and NOT the family member.|Participants|Number|1|1.0||||||
3813546|NCT01768000|3639002|B2|Supported housing||Housing|Housing data was collected only for the participant with psychosis and NOT the family member.|Participants|Number|NA|||||||Housing data was collected only for the participant with psychosis and NOT the family member.
3813547|NCT01768000|3639003|B1|Supported housing||Housing|Housing data was collected only for the participant with psychosis and NOT the family member.|Participants|Number|1|1.0||||||
3813548|NCT01768000|3638999|B5|Own/rent apartment or home||Housing|Housing data was collected only for the participant with psychosis and NOT the family member.|Participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3813549|NCT01768000|3639000|B4|Own/rent apartment or home||Housing|Housing data was collected only for the participant with psychosis and NOT the family member.|Participants|Number|NA|||||||Housing data was collected only for the participant with psychosis and NOT the family member.
3813550|NCT01768000|3639001|B3|Own/rent apartment or home||Housing|Housing data was collected only for the participant with psychosis and NOT the family member.|Participants|Number|2|2.0||||||
3813551|NCT01768000|3639002|B2|Own/rent apartment or home||Housing|Housing data was collected only for the participant with psychosis and NOT the family member.|Participants|Number|NA|||||||Housing data was collected only for the participant with psychosis and NOT the family member.
3813552|NCT01768000|3639003|B1|Own/rent apartment or home||Housing|Housing data was collected only for the participant with psychosis and NOT the family member.|Participants|Number|0|0.0||||||
3813553|NCT01768000|3638999|B5|Not specified||Level of education||participants|Number|2|2.0||||||
3813554|NCT01768000|3639000|B4|Not specified||Level of education||participants|Number|1|1.0||||||
3813555|NCT01768000|3639001|B3|Not specified||Level of education||participants|Number|0|0.0||||||
3813556|NCT01768000|3639002|B2|Not specified||Level of education||participants|Number|0|0.0||||||
3813557|NCT01768000|3639003|B1|Not specified||Level of education||participants|Number|1|1.0||||||
3813558|NCT01768000|3638999|B5|Partial high school||Level of education||participants|Number|2|2.0||||||
3813559|NCT01768000|3639000|B4|Partial high school||Level of education||participants|Number|0|0.0||||||
3813560|NCT01768000|3639001|B3|Partial high school||Level of education||participants|Number|1|1.0||||||
3813561|NCT01768000|3639002|B2|Partial high school||Level of education||participants|Number|0|0.0||||||
3813562|NCT01768000|3639003|B1|Partial high school||Level of education||participants|Number|1|1.0||||||
3813563|NCT01768000|3638999|B5|Completion of high school||Level of education||participants|Number|5|5.0||||||
3813564|NCT01768000|3639000|B4|Completion of high school||Level of education||participants|Number|2|2.0||||||
3813565|NCT01768000|3639001|B3|Completion of high school||Level of education||participants|Number|1|1.0||||||
3813566|NCT01768000|3639002|B2|Completion of high school||Level of education||participants|Number|1|1.0||||||
3813567|NCT01768000|3639003|B1|Completion of high school||Level of education||participants|Number|1|1.0||||||
3813568|NCT01768000|3638999|B5|Partial undergraduate university/college||Level of education||participants|Number|14|14.0||||||
3813569|NCT01768000|3639000|B4|Partial undergraduate university/college||Level of education||participants|Number|0|0.0||||||
3813570|NCT01768000|3639001|B3|Partial undergraduate university/college||Level of education||participants|Number|5|5.0||||||
3813571|NCT01768000|3639002|B2|Partial undergraduate university/college||Level of education||participants|Number|2|2.0||||||
3813572|NCT01768000|3639003|B1|Partial undergraduate university/college||Level of education||participants|Number|7|7.0||||||
3813573|NCT01768000|3638999|B5|Completion of undergraduate university/college||Level of education||participants|Number|11|11.0||||||
3813574|NCT01768000|3639000|B4|Completion of undergraduate university/college||Level of education||participants|Number|4|4.0||||||
3813575|NCT01768000|3639001|B3|Completion of undergraduate university/college||Level of education||participants|Number|2|2.0||||||
3813576|NCT01768000|3639002|B2|Completion of undergraduate university/college||Level of education||participants|Number|5|5.0||||||
3813577|NCT01768000|3639003|B1|Completion of undergraduate university/college||Level of education||participants|Number|0|0.0||||||
3813578|NCT01768000|3638999|B5|Completion of graduate school||Level of education||participants|Number|4|4.0||||||
3813579|NCT01768000|3639000|B4|Completion of graduate school||Level of education||participants|Number|2|2.0||||||
3813580|NCT01768000|3639001|B3|Completion of graduate school||Level of education||participants|Number|0|0.0||||||
3813581|NCT01768000|3639002|B2|Completion of graduate school||Level of education||participants|Number|2|2.0||||||
3813582|NCT01768000|3639003|B1|Completion of graduate school||Level of education||participants|Number|0|0.0||||||
3813583|NCT01768000|3638999|B5|Not specified||Employment status||participants|Number|1|1.0||||||
3813584|NCT01768000|3639000|B4|Not specified||Employment status||participants|Number|1|1.0||||||
3813585|NCT01768000|3639001|B3|Not specified||Employment status||participants|Number|0|0.0||||||
3813586|NCT01768000|3639002|B2|Not specified||Employment status||participants|Number|0|0.0||||||
3813587|NCT01768000|3639003|B1|Not specified||Employment status||participants|Number|0|0.0||||||
3813588|NCT01768000|3638999|B5|Contract work||Employment status||participants|Number|3|3.0||||||
3813589|NCT01768000|3639000|B4|Contract work||Employment status||participants|Number|0|0.0||||||
3813590|NCT01768000|3639001|B3|Contract work||Employment status||participants|Number|0|0.0||||||
3813591|NCT01768000|3639002|B2|Contract work||Employment status||participants|Number|3|3.0||||||
3813592|NCT01768000|3639003|B1|Contract work||Employment status||participants|Number|0|0.0||||||
3813593|NCT01768000|3638999|B5|Retired||Employment status||participants|Number|1|1.0||||||
3813594|NCT01768000|3639000|B4|Retired||Employment status||participants|Number|0|0.0||||||
3813595|NCT01768000|3639001|B3|Retired||Employment status||participants|Number|1|1.0||||||
3813596|NCT01768000|3639002|B2|Retired||Employment status||participants|Number|0|0.0||||||
3813597|NCT01768000|3639003|B1|Retired||Employment status||participants|Number|0|0.0||||||
3813598|NCT01768000|3638999|B5|Unemployed||Employment status||participants|Number|12|12.0||||||
3813599|NCT01768000|3639000|B4|Unemployed||Employment status||participants|Number|1|1.0||||||
3813600|NCT01768000|3639001|B3|Unemployed||Employment status||participants|Number|5|5.0||||||
3813601|NCT01768000|3639002|B2|Unemployed||Employment status||participants|Number|1|1.0||||||
3813602|NCT01768000|3639003|B1|Unemployed||Employment status||participants|Number|5|5.0||||||
3813603|NCT01768000|3638999|B5|In school||Employment status||participants|Number|4|4.0||||||
3813604|NCT01768000|3639000|B4|In school||Employment status||participants|Number|0|0.0||||||
3813605|NCT01768000|3639001|B3|In school||Employment status||participants|Number|1|1.0||||||
3813606|NCT01768000|3639002|B2|In school||Employment status||participants|Number|0|0.0||||||
3813607|NCT01768000|3639003|B1|In school||Employment status||participants|Number|3|3.0||||||
3813608|NCT01768000|3638999|B5|Part-time||Employment status||participants|Number|7|7.0||||||
3813609|NCT01768000|3639000|B4|Part-time||Employment status||participants|Number|3|3.0||||||
3813610|NCT01768000|3639001|B3|Part-time||Employment status||participants|Number|1|1.0||||||
3813611|NCT01768000|3639002|B2|Part-time||Employment status||participants|Number|2|2.0||||||
3813612|NCT01768000|3639003|B1|Part-time||Employment status||participants|Number|1|1.0||||||
3813613|NCT01768000|3638999|B5|Full-time||Employment status||participants|Number|10|10.0||||||
3813614|NCT01768000|3639000|B4|Full-time||Employment status||participants|Number|4|4.0||||||
3813615|NCT01768000|3639001|B3|Full-time||Employment status||participants|Number|1|1.0||||||
3813616|NCT01768000|3639002|B2|Full-time||Employment status||participants|Number|4|4.0||||||
3813617|NCT01768000|3639003|B1|Full-time||Employment status||participants|Number|1|1.0||||||
3813618|NCT01768000|3638999|B5|Canada||Region of Enrollment||participants|Number|38|38.0||||||
3813619|NCT01768000|3639000|B4|Canada||Region of Enrollment||participants|Number|9|9.0||||||
3813620|NCT01768000|3639001|B3|Canada||Region of Enrollment||participants|Number|9|9.0||||||
3813621|NCT01768000|3639002|B2|Canada||Region of Enrollment||participants|Number|10|10.0||||||
3813622|NCT01768000|3639003|B1|Canada||Region of Enrollment||participants|Number|10|10.0||||||
3813623|NCT01768000|3638999|B5|Not specified||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3813624|NCT01768000|3639000|B4|Not specified||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3813625|NCT01768000|3639001|B3|Not specified||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3813626|NCT01768000|3639002|B2|Not specified||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3813627|NCT01768000|3639003|B1|Not specified||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3813628|NCT01768000|3638999|B5|Asian (not specified)||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3813629|NCT01768000|3639000|B4|Asian (not specified)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3813630|NCT01768000|3639001|B3|Asian (not specified)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3813631|NCT01768000|3639002|B2|Asian (not specified)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3813632|NCT01768000|3639003|B1|Asian (not specified)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3813633|NCT01768000|3638999|B5|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3813634|NCT01768000|3639000|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3813635|NCT01768000|3639001|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3813636|NCT01768000|3639002|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3813637|NCT01768000|3639003|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3813638|NCT01768000|3638999|B5|White European||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3813639|NCT01768000|3639000|B4|White European||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3813640|NCT01768000|3639001|B3|White European||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3813641|NCT01768000|3639002|B2|White European||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3813642|NCT01768000|3639003|B1|White European||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3813643|NCT01768000|3638999|B5|White Canadian||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3813644|NCT01768000|3639000|B4|White Canadian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3813645|NCT01768000|3639001|B3|White Canadian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3813646|NCT01768000|3639002|B2|White Canadian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3813647|NCT01768000|3639003|B1|White Canadian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3813648|NCT01768000|3638999|B5|Latin American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3813649|NCT01768000|3639000|B4|Latin American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3813650|NCT01768000|3639001|B3|Latin American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3813651|NCT01768000|3639002|B2|Latin American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3813652|NCT01768000|3639003|B1|Latin American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3813653|NCT01768000|3638999|B5|Black Canadian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3813654|NCT01768000|3639000|B4|Black Canadian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3813655|NCT01768000|3639001|B3|Black Canadian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3813656|NCT01768000|3639002|B2|Black Canadian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3813657|NCT01768000|3639003|B1|Black Canadian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3813658|NCT01768000|3638999|B5|Asian South East||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3813659|NCT01768000|3639000|B4|Asian South East||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3813660|NCT01768000|3639001|B3|Asian South East||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3813661|NCT01768000|3639002|B2|Asian South East||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3813662|NCT01768000|3639003|B1|Asian South East||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3813663|NCT01768000|3638999|B5|Asian South||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3813664|NCT01768000|3639000|B4|Asian South||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3813665|NCT01768000|3639001|B3|Asian South||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3813666|NCT01768000|3639002|B2|Asian South||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3813667|NCT01768000|3639003|B1|Asian South||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3813668|NCT01768000|3638999|B5|Asian East||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3813669|NCT01768000|3639000|B4|Asian East||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3813670|NCT01768000|3639001|B3|Asian East||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3813671|NCT01768000|3639002|B2|Asian East||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3813672|NCT01768000|3639003|B1|Asian East||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3813673|NCT01768000|3638999|B5||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3813674|NCT01768000|3639000|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3813675|NCT01768000|3639001|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3813676|NCT01768000|3639002|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3813677|NCT01768000|3639003|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3813678|NCT01768000|3638999|B5||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3813679|NCT01768000|3639000|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3813680|NCT01768000|3639001|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3813681|NCT01768000|3639002|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3813682|NCT01768000|3639003|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3813683|NCT01768000|3638999|B5||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3813684|NCT01768000|3639000|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3813685|NCT01768000|3639001|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3813686|NCT01768000|3639002|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3813687|NCT01768000|3639003|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3813688|NCT01768000|3638999|B5||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3813689|NCT01768000|3639000|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3813690|NCT01768000|3639001|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3813691|NCT01768000|3639002|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3813692|NCT01768000|3639003|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3813693|NCT01768000|3638999|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3813694|NCT01768000|3639000|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3813695|NCT01768000|3639001|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3813696|NCT01768000|3639002|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3813697|NCT01768000|3639003|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3813698|NCT01767987|3639024|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3813699|NCT01767987|3639025|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3813700|NCT01767987|3639026|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3813701|NCT01767987|3639024|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3813702|NCT01767987|3639025|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3813703|NCT01767987|3639026|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3813704|NCT01767987|3639024|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3813705|NCT01767987|3639025|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3813706|NCT01767987|3639026|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3813707|NCT01767987|3639024|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3813708|NCT01767987|3639025|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3813709|NCT01767987|3639026|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3813710|NCT01767987|3639024|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3813711|NCT01767987|3639025|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3813712|NCT01767987|3639026|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3813713|NCT01767987|3639024|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3813714|NCT01767987|3639025|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3813715|NCT01767987|3639026|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3813716|NCT01767987|3639024|B3|||Age||years|Mean|63.5|63.5|Full Range|||51.0|70.0|
3813717|NCT01767987|3639025|B2|||Age||years|Mean|67.5|67.5|Full Range|||65.0|70.0|
3813718|NCT01767987|3639026|B1|||Age||years|Mean|61.5|61.5|Full Range|||51.0|66.0|
3813719|NCT01767935|3639049|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3813720|NCT01767935|3639049|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813721|NCT01767935|3639049|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813722|NCT01767935|3639049|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3813723|NCT01767935|3639049|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813724|NCT01767935|3639049|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813725|NCT01767935|3639049|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813726|NCT01767935|3639049|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813727|NCT01767935|3639049|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813728|NCT01767935|3639049|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3813729|NCT01767935|3639049|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813730|NCT01767935|3639049|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3813731|NCT01767935|3639049|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3813732|NCT01767935|3639049|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3813733|NCT01767935|3639049|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3813734|NCT01767935|3639049|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3813735|NCT01767701|3639057|B1|United Kingdom||Region of Enrollment||participants|Number|20|20.0||||||
3813736|NCT01767701|3639057|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3813737|NCT01767701|3639057|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3813738|NCT01767701|3639057|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3813739|NCT01767701|3639057|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3813740|NCT01767701|3639057|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3813741|NCT01767688|3639068|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3813742|NCT01767688|3639069|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3813743|NCT01767688|3639070|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3813744|NCT01767688|3639068|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3813745|NCT01767688|3639069|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3813746|NCT01767688|3639070|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3813747|NCT01767688|3639068|B3|||Age||Years|Mean|55|55.0|Full Range|7.55|7.55|41.0|68.0|
3813748|NCT01767688|3639069|B2|||Age||Years|Mean|53|53.0|Full Range|8.45|8.45|41.0|68.0|
3813749|NCT01767688|3639070|B1|||Age||Years|Mean|57|57.0|Full Range|6.45|6.45|45.0|62.0|
3813750|NCT01767597|3639091|B3|CMU||Health insurance plan||participants|Number|58|58.0||||||
3813751|NCT01767597|3639092|B2|CMU||Health insurance plan||participants|Number|27|27.0||||||
3813752|NCT01767597|3639093|B1|CMU||Health insurance plan||participants|Number|31|31.0||||||
3813753|NCT01767597|3639091|B3|Social security||Health insurance plan||participants|Number|937|937.0||||||
3813754|NCT01767597|3639092|B2|Social security||Health insurance plan||participants|Number|472|472.0||||||
3813755|NCT01767597|3639093|B1|Social security||Health insurance plan||participants|Number|465|465.0||||||
3813756|NCT01767597|3639091|B3|High (>8.0%)||HBV prevalence of birth country||participants|Number|175|175.0||||||
3813757|NCT01767597|3639092|B2|High (>8.0%)||HBV prevalence of birth country||participants|Number|87|87.0||||||
3813758|NCT01767597|3639093|B1|High (>8.0%)||HBV prevalence of birth country||participants|Number|88|88.0||||||
3813759|NCT01767597|3639091|B3|Intermediate (2.0–8.0%)||HBV prevalence of birth country||participants|Number|253|253.0||||||
3813760|NCT01767597|3639092|B2|Intermediate (2.0–8.0%)||HBV prevalence of birth country||participants|Number|137|137.0||||||
3813761|NCT01767597|3639093|B1|Intermediate (2.0–8.0%)||HBV prevalence of birth country||participants|Number|116|116.0||||||
3813762|NCT01767597|3639091|B3|Low (<2.0%)||HBV prevalence of birth country||participants|Number|567|567.0||||||
3813763|NCT01767597|3639092|B2|Low (<2.0%)||HBV prevalence of birth country||participants|Number|275|275.0||||||
3813764|NCT01767597|3639093|B1|Low (<2.0%)||HBV prevalence of birth country||participants|Number|292|292.0||||||
3813765|NCT01767597|3639091|B3||Male|Sex: Female, Male||Participants|Count of Participants|473|473.0||||||
3813766|NCT01767597|3639092|B2||Male|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
3813767|NCT01767597|3639093|B1||Male|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
3813768|NCT01767597|3639091|B3||Female|Sex: Female, Male||Participants|Count of Participants|522|522.0||||||
3813769|NCT01767597|3639092|B2||Female|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
3813770|NCT01767597|3639093|B1||Female|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
3813771|NCT01767597|3639091|B3|||Age||years|Mean|40.4|40.4|Standard Deviation|15.8|15.8|||
3813772|NCT01767597|3639092|B2|||Age||years|Mean|40.1|40.1|Standard Deviation|15.6|15.6|||
3813773|NCT01767597|3639093|B1|||Age||years|Mean|40.7|40.7|Standard Deviation|16.0|16.0|||
3813774|NCT01767519|3639100|B4||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3813775|NCT01767519|3639101|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3813776|NCT01767519|3639102|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3813777|NCT01767519|3639103|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3813778|NCT01767519|3639100|B4||Female|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
3813779|NCT01767519|3639101|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3813780|NCT01767519|3639102|B2||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3813781|NCT01767519|3639103|B1||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3813782|NCT01767519|3639100|B4|≥65 years||Age, Customized||Participants|Number|166|166.0||||||
3813783|NCT01767519|3639101|B3|≥65 years||Age, Customized||Participants|Number|26|26.0||||||
3813784|NCT01767519|3639102|B2|≥65 years||Age, Customized||Participants|Number|72|72.0||||||
3813785|NCT01767519|3639103|B1|≥65 years||Age, Customized||Participants|Number|68|68.0||||||
3813786|NCT01767519|3639100|B4|<65 years||Age, Customized||Participants|Number|190|190.0||||||
3813787|NCT01767519|3639101|B3|<65 years||Age, Customized||Participants|Number|34|34.0||||||
3813788|NCT01767519|3639102|B2|<65 years||Age, Customized||Participants|Number|79|79.0||||||
3813789|NCT01767519|3639103|B1|<65 years||Age, Customized||Participants|Number|77|77.0||||||
3813790|NCT01767506|3639131|B3|Tanzania||Region of Enrollment||community|Number|52|52.0||||||
3813791|NCT01767506|3639132|B2|Tanzania||Region of Enrollment||community|Number|26|26.0||||||
3813792|NCT01767506|3639133|B1|Tanzania||Region of Enrollment||community|Number|26|26.0||||||
3813793|NCT01767506|3639131|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3813794|NCT01767506|3639131|B3||Male|Sex: Female, Male|We collected and analyzed data on community level.Sex was not part of final analysis.|community|Count of Units|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3813795|NCT01767506|3639132|B2||Male|Sex: Female, Male|We collected and analyzed data on community level.Sex was not part of final analysis.|community|Count of Units|NA|||||||We collected and analyzed data on community level.Sex was not part of final analysis.
3813796|NCT01767506|3639133|B1||Male|Sex: Female, Male|We collected and analyzed data on community level.Sex was not part of final analysis.|community|Count of Units|NA|||||||We collected and analyzed data on community level.Sex was not part of final analysis.
3813797|NCT01767506|3639131|B3||Female|Sex: Female, Male|We collected and analyzed data on community level.Sex was not part of final analysis.|community|Count of Units|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3813798|NCT01767506|3639132|B2||Female|Sex: Female, Male|We collected and analyzed data on community level.Sex was not part of final analysis.|community|Count of Units|NA|||||||We collected and analyzed data on community level.Sex was not part of final analysis.
3813799|NCT01767506|3639133|B1||Female|Sex: Female, Male|We collected and analyzed data on community level.Sex was not part of final analysis.|community|Count of Units|NA|||||||We collected and analyzed data on community level.Sex was not part of final analysis.
3813800|NCT01767506|3639131|B3|Age not analyzed at community level||Age, Customized||community|Count of Units|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3813801|NCT01767506|3639132|B2|Age not analyzed at community level||Age, Customized||community|Count of Units|NA|||||||We collected and analyzed data on community level.Age was not part of final analysis.
3813802|NCT01767506|3639133|B1|Age not analyzed at community level||Age, Customized||community|Count of Units|NA|||||||We collected and analyzed data on community level.Age was not part of final analysis.
3813803|NCT01767467|3639144|B3|Geographic ancestry|Missing|Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3813804|NCT01767467|3639145|B2|Geographic ancestry|Missing|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3813805|NCT01767467|3639146|B1|Geographic ancestry|Missing|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3813806|NCT01767467|3639144|B3|Geographic ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3813807|NCT01767467|3639145|B2|Geographic ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3813808|NCT01767467|3639146|B1|Geographic ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3813809|NCT01767467|3639144|B3|Geographic ancestry|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|384|384.0||||||
3813810|NCT01767467|3639145|B2|Geographic ancestry|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|186|186.0||||||
3813811|NCT01767467|3639146|B1|Geographic ancestry|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|198|198.0||||||
3813812|NCT01767467|3639144|B3|Geographic ancestry|White - Arabic / North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3813813|NCT01767467|3639145|B2|Geographic ancestry|White - Arabic / North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3813814|NCT01767467|3639146|B1|Geographic ancestry|White - Arabic / North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3813815|NCT01767467|3639144|B3|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3813816|NCT01767467|3639145|B2|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3813817|NCT01767467|3639146|B1|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3813818|NCT01767467|3639144|B3|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|117|117.0||||||
3813819|NCT01767467|3639145|B2|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|60|60.0||||||
3813820|NCT01767467|3639146|B1|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|57|57.0||||||
3813821|NCT01767467|3639144|B3|Geographic ancestry|Asian - Central / South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3813822|NCT01767467|3639145|B2|Geographic ancestry|Asian - Central / South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3813823|NCT01767467|3639146|B1|Geographic ancestry|Asian - Central / South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3813824|NCT01767467|3639144|B3|Geographic ancestry|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3813825|NCT01767467|3639145|B2|Geographic ancestry|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3813826|NCT01767467|3639146|B1|Geographic ancestry|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3813827|NCT01767467|3639144|B3|Geographic ancestry|African Heritage / African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3813828|NCT01767467|3639145|B2|Geographic ancestry|African Heritage / African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3813829|NCT01767467|3639146|B1|Geographic ancestry|African Heritage / African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3813830|NCT01767467|3639144|B3||Male|Sex: Female, Male||Participants|Count of Participants|334|334.0||||||
3813831|NCT01767467|3639145|B2||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3813832|NCT01767467|3639146|B1||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3813833|NCT01767467|3639144|B3||Female|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
3813834|NCT01767467|3639145|B2||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3813835|NCT01767467|3639146|B1||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3813836|NCT01767467|3639144|B3|||Age||Years|Mean|57.3|57.3|Standard Deviation|15.2|15.2|||
3813837|NCT01767467|3639145|B2|||Age||Years|Mean|57.8|57.8|Standard Deviation|14.9|14.9|||
3813838|NCT01767467|3639146|B1|||Age||Years|Mean|56.8|56.8|Standard Deviation|15.5|15.5|||
3813839|NCT01767415|3639195|B1||Neurological Defect|Tumor Diagnosis||Participants|Count of Participants|2|2.0||||||
3813840|NCT01767415|3639195|B1||Headache|Tumor Diagnosis||Participants|Count of Participants|1|1.0||||||
3813841|NCT01767415|3639195|B1||Seizures|Tumor Diagnosis||Participants|Count of Participants|1|1.0||||||
3813842|NCT01767415|3639195|B1||Recurrent Disease|Tumor Diagnosis||Participants|Count of Participants|3|3.0||||||
3813843|NCT01767415|3639195|B1||Incidental finding|Tumor Diagnosis||Participants|Count of Participants|3|3.0||||||
3813844|NCT01767415|3639195|B1||Lt parietal|Tumor Location||Participants|Count of Participants|1|1.0||||||
3813845|NCT01767415|3639195|B1||Rt occipital|Tumor Location||Participants|Count of Participants|1|1.0||||||
3813846|NCT01767415|3639195|B1||Rt parietal|Tumor Location||Participants|Count of Participants|1|1.0||||||
3813847|NCT01767415|3639195|B1||Lt Occipital|Tumor Location||Participants|Count of Participants|2|2.0||||||
3813848|NCT01767415|3639195|B1||Rt frontal|Tumor Location||Participants|Count of Participants|2|2.0||||||
3813849|NCT01767415|3639195|B1||Lt Frontal|Tumor Location||Participants|Count of Participants|2|2.0||||||
3813850|NCT01767415|3639195|B1||Lt Temporal|Tumor Location||Participants|Count of Participants|1|1.0||||||
3813851|NCT01767415|3639195|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3813852|NCT01767415|3639195|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3813853|NCT01767415|3639195|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813854|NCT01767415|3639195|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813855|NCT01767415|3639195|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813856|NCT01767415|3639195|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813857|NCT01767415|3639195|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813858|NCT01767415|3639195|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813859|NCT01767415|3639195|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3813860|NCT01767415|3639195|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813861|NCT01767415|3639195|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813862|NCT01767415|3639195|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3813863|NCT01767415|3639195|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3813864|NCT01767415|3639195|B1|||Age||years|Mean|49|49.0|Full Range|||25.0|74.0|
3813865|NCT01767376|3639200|B4|Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|178|178.0||||||
3813866|NCT01767376|3639201|B3|Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|59|59.0||||||
3813867|NCT01767376|3639202|B2|Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|59|59.0||||||
3813868|NCT01767376|3639203|B1|Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|60|60.0||||||
3813869|NCT01767376|3639200|B4|Ethnicity|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|181|181.0||||||
3813870|NCT01767376|3639201|B3|Ethnicity|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|61|61.0||||||
3813871|NCT01767376|3639202|B2|Ethnicity|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|60|60.0||||||
3813872|NCT01767376|3639203|B1|Ethnicity|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|60|60.0||||||
3813873|NCT01767376|3639200|B4|Ethnicity|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3813874|NCT01767376|3639201|B3|Ethnicity|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3813875|NCT01767376|3639202|B2|Ethnicity|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3813876|NCT01767376|3639203|B1|Ethnicity|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3813877|NCT01767376|3639200|B4|Ethnicity|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|331|331.0||||||
3813878|NCT01767376|3639201|B3|Ethnicity|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|111|111.0||||||
3813879|NCT01767376|3639202|B2|Ethnicity|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|109|109.0||||||
3813880|NCT01767376|3639203|B1|Ethnicity|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|111|111.0||||||
3813881|NCT01767376|3639200|B4||Male|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
3813882|NCT01767376|3639201|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3813883|NCT01767376|3639202|B2||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3813884|NCT01767376|3639203|B1||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3813885|NCT01767376|3639200|B4||Female|Sex: Female, Male||Participants|Count of Participants|400|400.0||||||
3813886|NCT01767376|3639201|B3||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3813887|NCT01767376|3639202|B2||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3813888|NCT01767376|3639203|B1||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3813889|NCT01767376|3639200|B4|||Age||Years|Mean|18.2|18.2|Standard Deviation|4.4|4.4|||
3813890|NCT01767376|3639201|B3|||Age||Years|Mean|18.3|18.3|Standard Deviation|4.4|4.4|||
3813891|NCT01767376|3639202|B2|||Age||Years|Mean|18.2|18.2|Standard Deviation|4.5|4.5|||
3813892|NCT01767376|3639203|B1|||Age||Years|Mean|18.1|18.1|Standard Deviation|4.2|4.2|||
3813893|NCT01767285|3639250|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
3813894|NCT01767285|3639251|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
3813895|NCT01767285|3639252|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3813896|NCT01767285|3639250|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3813897|NCT01767285|3639251|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3813898|NCT01767285|3639252|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3813899|NCT01767285|3639250|B3||Female|Gender||Participants|Count of Participants|59|59.0||||||
3813900|NCT01767285|3639251|B2||Female|Gender||Participants|Count of Participants|30|30.0||||||
3813901|NCT01767285|3639252|B1||Female|Gender||Participants|Count of Participants|29|29.0||||||
3813902|NCT01767285|3639250|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3813903|NCT01767285|3639251|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3813904|NCT01767285|3639252|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3813905|NCT01767285|3639250|B3||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
3813906|NCT01767285|3639251|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3813907|NCT01767285|3639252|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3813908|NCT01767285|3639250|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3813909|NCT01767285|3639251|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3813910|NCT01767285|3639252|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3813911|NCT01767155|3639269|B3|Recurrent||Stage of endometrial cancer at study entry|Advanced disease comprising FIGO (The International Federation of Gynecology and Obstetrics) III or IV|Participants|Count of Participants|142|142.0||||||
3813912|NCT01767155|3639270|B2|Recurrent||Stage of endometrial cancer at study entry|Advanced disease comprising FIGO (The International Federation of Gynecology and Obstetrics) III or IV|Participants|Count of Participants|71|71.0||||||
3813913|NCT01767155|3639271|B1|Recurrent||Stage of endometrial cancer at study entry|Advanced disease comprising FIGO (The International Federation of Gynecology and Obstetrics) III or IV|Participants|Count of Participants|71|71.0||||||
3813914|NCT01767155|3639269|B3|Metastatic||Stage of endometrial cancer at study entry|Advanced disease comprising FIGO (The International Federation of Gynecology and Obstetrics) III or IV|Participants|Count of Participants|176|176.0||||||
3813915|NCT01767155|3639270|B2|Metastatic||Stage of endometrial cancer at study entry|Advanced disease comprising FIGO (The International Federation of Gynecology and Obstetrics) III or IV|Participants|Count of Participants|90|90.0||||||
3813916|NCT01767155|3639271|B1|Metastatic||Stage of endometrial cancer at study entry|Advanced disease comprising FIGO (The International Federation of Gynecology and Obstetrics) III or IV|Participants|Count of Participants|86|86.0||||||
3813917|NCT01767155|3639269|B3|Advanced (FIGO III or IV)||Stage of endometrial cancer at study entry|Advanced disease comprising FIGO (The International Federation of Gynecology and Obstetrics) III or IV|Participants|Count of Participants|193|193.0||||||
3813918|NCT01767155|3639270|B2|Advanced (FIGO III or IV)||Stage of endometrial cancer at study entry|Advanced disease comprising FIGO (The International Federation of Gynecology and Obstetrics) III or IV|Participants|Count of Participants|94|94.0||||||
3813919|NCT01767155|3639271|B1|Advanced (FIGO III or IV)||Stage of endometrial cancer at study entry|Advanced disease comprising FIGO (The International Federation of Gynecology and Obstetrics) III or IV|Participants|Count of Participants|99|99.0||||||
3813920|NCT01767155|3639269|B3|unknown||ECOG (Eastern Cooperative Oncology Group) PS (Performance Status)|"ECOG PS = Eastern Cooperation Oncology Group Performance Status.~Status Scale Grade:~0: Fully active, able to carry on all pre-disease Performance without restriction.~Symptoms ambulatory, restricted in activity, able to carry out work of light nature~In bed <50% of time, ambulatory + capable of all selfcare, unable to carry out any work activities.~In bed>50% of time, capable of only limited self-care, confirmed to bed or chair >50%.~100% bedridden, completely disabled, cannot carry on any self-care. 5. Dead"|Participants|Count of Participants|1|1.0||||||
3813921|NCT01767155|3639270|B2|unknown||ECOG (Eastern Cooperative Oncology Group) PS (Performance Status)|"ECOG PS = Eastern Cooperation Oncology Group Performance Status.~Status Scale Grade:~0: Fully active, able to carry on all pre-disease Performance without restriction.~Symptoms ambulatory, restricted in activity, able to carry out work of light nature~In bed <50% of time, ambulatory + capable of all selfcare, unable to carry out any work activities.~In bed>50% of time, capable of only limited self-care, confirmed to bed or chair >50%.~100% bedridden, completely disabled, cannot carry on any self-care. 5. Dead"|Participants|Count of Participants|1|1.0||||||
3813922|NCT01767155|3639271|B1|unknown||ECOG (Eastern Cooperative Oncology Group) PS (Performance Status)|"ECOG PS = Eastern Cooperation Oncology Group Performance Status.~Status Scale Grade:~0: Fully active, able to carry on all pre-disease Performance without restriction.~Symptoms ambulatory, restricted in activity, able to carry out work of light nature~In bed <50% of time, ambulatory + capable of all selfcare, unable to carry out any work activities.~In bed>50% of time, capable of only limited self-care, confirmed to bed or chair >50%.~100% bedridden, completely disabled, cannot carry on any self-care. 5. Dead"|Participants|Count of Participants|0|0.0||||||
3813923|NCT01767155|3639269|B3|2||ECOG (Eastern Cooperative Oncology Group) PS (Performance Status)|"ECOG PS = Eastern Cooperation Oncology Group Performance Status.~Status Scale Grade:~0: Fully active, able to carry on all pre-disease Performance without restriction.~Symptoms ambulatory, restricted in activity, able to carry out work of light nature~In bed <50% of time, ambulatory + capable of all selfcare, unable to carry out any work activities.~In bed>50% of time, capable of only limited self-care, confirmed to bed or chair >50%.~100% bedridden, completely disabled, cannot carry on any self-care. 5. Dead"|Participants|Count of Participants|26|26.0||||||
3813924|NCT01767155|3639270|B2|2||ECOG (Eastern Cooperative Oncology Group) PS (Performance Status)|"ECOG PS = Eastern Cooperation Oncology Group Performance Status.~Status Scale Grade:~0: Fully active, able to carry on all pre-disease Performance without restriction.~Symptoms ambulatory, restricted in activity, able to carry out work of light nature~In bed <50% of time, ambulatory + capable of all selfcare, unable to carry out any work activities.~In bed>50% of time, capable of only limited self-care, confirmed to bed or chair >50%.~100% bedridden, completely disabled, cannot carry on any self-care. 5. Dead"|Participants|Count of Participants|11|11.0||||||
3813925|NCT01767155|3639271|B1|2||ECOG (Eastern Cooperative Oncology Group) PS (Performance Status)|"ECOG PS = Eastern Cooperation Oncology Group Performance Status.~Status Scale Grade:~0: Fully active, able to carry on all pre-disease Performance without restriction.~Symptoms ambulatory, restricted in activity, able to carry out work of light nature~In bed <50% of time, ambulatory + capable of all selfcare, unable to carry out any work activities.~In bed>50% of time, capable of only limited self-care, confirmed to bed or chair >50%.~100% bedridden, completely disabled, cannot carry on any self-care. 5. Dead"|Participants|Count of Participants|15|15.0||||||
3813926|NCT01767155|3639269|B3|1||ECOG (Eastern Cooperative Oncology Group) PS (Performance Status)|"ECOG PS = Eastern Cooperation Oncology Group Performance Status.~Status Scale Grade:~0: Fully active, able to carry on all pre-disease Performance without restriction.~Symptoms ambulatory, restricted in activity, able to carry out work of light nature~In bed <50% of time, ambulatory + capable of all selfcare, unable to carry out any work activities.~In bed>50% of time, capable of only limited self-care, confirmed to bed or chair >50%.~100% bedridden, completely disabled, cannot carry on any self-care. 5. Dead"|Participants|Count of Participants|239|239.0||||||
3813927|NCT01767155|3639270|B2|1||ECOG (Eastern Cooperative Oncology Group) PS (Performance Status)|"ECOG PS = Eastern Cooperation Oncology Group Performance Status.~Status Scale Grade:~0: Fully active, able to carry on all pre-disease Performance without restriction.~Symptoms ambulatory, restricted in activity, able to carry out work of light nature~In bed <50% of time, ambulatory + capable of all selfcare, unable to carry out any work activities.~In bed>50% of time, capable of only limited self-care, confirmed to bed or chair >50%.~100% bedridden, completely disabled, cannot carry on any self-care. 5. Dead"|Participants|Count of Participants|118|118.0||||||
3813968|NCT01767116|3639284|B3||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
3813969|NCT01767116|3639285|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3813970|NCT01767116|3639286|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3813971|NCT01767116|3639284|B3||Female|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
3813972|NCT01767116|3639285|B2||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3813928|NCT01767155|3639271|B1|1||ECOG (Eastern Cooperative Oncology Group) PS (Performance Status)|"ECOG PS = Eastern Cooperation Oncology Group Performance Status.~Status Scale Grade:~0: Fully active, able to carry on all pre-disease Performance without restriction.~Symptoms ambulatory, restricted in activity, able to carry out work of light nature~In bed <50% of time, ambulatory + capable of all selfcare, unable to carry out any work activities.~In bed>50% of time, capable of only limited self-care, confirmed to bed or chair >50%.~100% bedridden, completely disabled, cannot carry on any self-care. 5. Dead"|Participants|Count of Participants|121|121.0||||||
3813929|NCT01767155|3639269|B3|0||ECOG (Eastern Cooperative Oncology Group) PS (Performance Status)|"ECOG PS = Eastern Cooperation Oncology Group Performance Status.~Status Scale Grade:~0: Fully active, able to carry on all pre-disease Performance without restriction.~Symptoms ambulatory, restricted in activity, able to carry out work of light nature~In bed <50% of time, ambulatory + capable of all selfcare, unable to carry out any work activities.~In bed>50% of time, capable of only limited self-care, confirmed to bed or chair >50%.~100% bedridden, completely disabled, cannot carry on any self-care. 5. Dead"|Participants|Count of Participants|245|245.0||||||
3813930|NCT01767155|3639270|B2|0||ECOG (Eastern Cooperative Oncology Group) PS (Performance Status)|"ECOG PS = Eastern Cooperation Oncology Group Performance Status.~Status Scale Grade:~0: Fully active, able to carry on all pre-disease Performance without restriction.~Symptoms ambulatory, restricted in activity, able to carry out work of light nature~In bed <50% of time, ambulatory + capable of all selfcare, unable to carry out any work activities.~In bed>50% of time, capable of only limited self-care, confirmed to bed or chair >50%.~100% bedridden, completely disabled, cannot carry on any self-care. 5. Dead"|Participants|Count of Participants|125|125.0||||||
3813931|NCT01767155|3639271|B1|0||ECOG (Eastern Cooperative Oncology Group) PS (Performance Status)|"ECOG PS = Eastern Cooperation Oncology Group Performance Status.~Status Scale Grade:~0: Fully active, able to carry on all pre-disease Performance without restriction.~Symptoms ambulatory, restricted in activity, able to carry out work of light nature~In bed <50% of time, ambulatory + capable of all selfcare, unable to carry out any work activities.~In bed>50% of time, capable of only limited self-care, confirmed to bed or chair >50%.~100% bedridden, completely disabled, cannot carry on any self-care. 5. Dead"|Participants|Count of Participants|120|120.0||||||
3813932|NCT01767155|3639269|B3|Race/Ethnicity|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3813933|NCT01767155|3639270|B2|Race/Ethnicity|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3813934|NCT01767155|3639271|B1|Race/Ethnicity|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3813935|NCT01767155|3639269|B3|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3813936|NCT01767155|3639270|B2|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3813937|NCT01767155|3639271|B1|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3813938|NCT01767155|3639269|B3|Race/Ethnicity|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3813939|NCT01767155|3639270|B2|Race/Ethnicity|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3813940|NCT01767155|3639271|B1|Race/Ethnicity|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3813941|NCT01767155|3639269|B3|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3813942|NCT01767155|3639270|B2|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3813943|NCT01767155|3639271|B1|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3813944|NCT01767155|3639269|B3|Race/Ethnicity|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3813945|NCT01767155|3639270|B2|Race/Ethnicity|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3813946|NCT01767155|3639271|B1|Race/Ethnicity|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3813947|NCT01767155|3639269|B3|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|477|477.0||||||
3813948|NCT01767155|3639270|B2|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|240|240.0||||||
3813949|NCT01767155|3639271|B1|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|237|237.0||||||
3813950|NCT01767155|3639269|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3813951|NCT01767155|3639270|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3813952|NCT01767155|3639271|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3813953|NCT01767155|3639269|B3||Female|Sex: Female, Male||Participants|Count of Participants|511|511.0||||||
3813954|NCT01767155|3639270|B2||Female|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
3813955|NCT01767155|3639271|B1||Female|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
3813956|NCT01767155|3639269|B3|||Age||years|Mean|63.7|63.7|Standard Deviation|8.71|8.71|||
3813957|NCT01767155|3639270|B2|||Age||years|Mean|63.8|63.8|Standard Deviation|8.81|8.81|||
3813958|NCT01767155|3639271|B1|||Age||years|Mean|63.7|63.7|Standard Deviation|8.63|8.63|||
3813959|NCT01767155|3639269|B3||>=65 years|Age||Participants|Count of Participants|245|245.0||||||
3813960|NCT01767155|3639270|B2||>=65 years|Age||Participants|Count of Participants|119|119.0||||||
3813961|NCT01767155|3639271|B1||>=65 years|Age||Participants|Count of Participants|126|126.0||||||
3813962|NCT01767155|3639269|B3||Between 18 and 65 years|Age||Participants|Count of Participants|266|266.0||||||
3813963|NCT01767155|3639270|B2||Between 18 and 65 years|Age||Participants|Count of Participants|136|136.0||||||
3813964|NCT01767155|3639271|B1||Between 18 and 65 years|Age||Participants|Count of Participants|130|130.0||||||
3813965|NCT01767155|3639269|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3813966|NCT01767155|3639270|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3813967|NCT01767155|3639271|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3813973|NCT01767116|3639286|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3813974|NCT01767116|3639284|B3|||Age||years|Mean|48.8|48.8|Standard Deviation|11.98|11.98|||
3813975|NCT01767116|3639285|B2|||Age||years|Mean|49.2|49.2|Standard Deviation|12.03|12.03|||
3813976|NCT01767116|3639286|B1|||Age||years|Mean|48.4|48.4|Standard Deviation|11.94|11.94|||
3813977|NCT01767103|3639303|B4|United States||Region of Enrollment||participants|Number|21|21.0||||||
3813978|NCT01767103|3639304|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
3813979|NCT01767103|3639305|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3813980|NCT01767103|3639306|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3813981|NCT01767103|3639303|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813982|NCT01767103|3639304|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813983|NCT01767103|3639305|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813984|NCT01767103|3639306|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813985|NCT01767103|3639303|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813986|NCT01767103|3639304|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813987|NCT01767103|3639305|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813988|NCT01767103|3639306|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813989|NCT01767103|3639303|B4||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3813990|NCT01767103|3639304|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3813991|NCT01767103|3639305|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3813992|NCT01767103|3639306|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3813993|NCT01767103|3639303|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3813994|NCT01767103|3639304|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3813995|NCT01767103|3639305|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813996|NCT01767103|3639306|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3813997|NCT01767103|3639303|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813998|NCT01767103|3639304|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3813999|NCT01767103|3639305|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814000|NCT01767103|3639306|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814001|NCT01767103|3639303|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814002|NCT01767103|3639304|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814003|NCT01767103|3639305|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814004|NCT01767103|3639306|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814005|NCT01767103|3639303|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814006|NCT01767103|3639304|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814007|NCT01767103|3639305|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814008|NCT01767103|3639306|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814009|NCT01767103|3639303|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3814010|NCT01767103|3639304|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3814011|NCT01767103|3639305|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3814012|NCT01767103|3639306|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3814013|NCT01767103|3639303|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3814014|NCT01767103|3639304|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3814015|NCT01767103|3639305|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3814016|NCT01767103|3639306|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3814017|NCT01767103|3639303|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3814018|NCT01767103|3639304|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3814019|NCT01767103|3639305|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3814020|NCT01767103|3639306|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3814021|NCT01767103|3639303|B4||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3814022|NCT01767103|3639304|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3814023|NCT01767103|3639305|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3814024|NCT01767103|3639306|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3814025|NCT01767103|3639303|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3814026|NCT01767103|3639304|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3814027|NCT01767103|3639305|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3814028|NCT01767103|3639306|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3814029|NCT01767064|3639334|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
3814030|NCT01767064|3639335|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3814031|NCT01767064|3639336|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3814032|NCT01767064|3639334|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3814033|NCT01767064|3639334|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3814034|NCT01767064|3639335|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3814035|NCT01767064|3639336|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3814036|NCT01767064|3639334|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3814037|NCT01767064|3639335|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3814038|NCT01767064|3639336|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3814039|NCT01767064|3639334|B3|||Age||years|Mean|54.3|54.3|Standard Deviation|10.64|10.64|||
3814040|NCT01767064|3639335|B2|||Age||years|Mean|55|55.0|Standard Deviation|9.5|9.5|||
3814041|NCT01767064|3639336|B1|||Age||years|Mean|53|53.0|Standard Deviation|12.9|12.9|||
3814042|NCT01766921|3639343|B3||Male|Sex: Female, Male||Participants|Count of Participants|568|568.0||||||
3814043|NCT01766921|3639344|B2||Male|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
3814044|NCT01766921|3639345|B1||Male|Sex: Female, Male||Participants|Count of Participants|293|293.0||||||
3814045|NCT01766921|3639343|B3||Female|Sex: Female, Male||Participants|Count of Participants|825|825.0||||||
3814046|NCT01766921|3639344|B2||Female|Sex: Female, Male||Participants|Count of Participants|418|418.0||||||
3814047|NCT01766921|3639345|B1||Female|Sex: Female, Male||Participants|Count of Participants|407|407.0||||||
3814048|NCT01766921|3639343|B3|||Age||year|Mean|71.0|71.0|Standard Deviation|4.9|4.9|||
3814049|NCT01766921|3639344|B2|||Age||year|Mean|70.7|70.7|Standard Deviation|4.7|4.7|||
3814050|NCT01766921|3639345|B1|||Age||year|Mean|71.2|71.2|Standard Deviation|5.1|5.1|||
3814051|NCT01766778|3639365|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3814052|NCT01766778|3639366|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3814053|NCT01766778|3639367|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3814054|NCT01766778|3639365|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3814055|NCT01766778|3639366|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3814056|NCT01766778|3639367|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3814057|NCT01766778|3639365|B3|||Age||Years|Mean|58|58.0|Standard Deviation|10.1|10.1|||
3814058|NCT01766778|3639366|B2|||Age||Years|Mean|59|59.0|Standard Deviation|10.0|10.0|||
3814059|NCT01766778|3639367|B1|||Age||Years|Mean|58|58.0|Standard Deviation|10.3|10.3|||
3814060|NCT01766713|3639384|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3814061|NCT01766713|3639385|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3814062|NCT01766713|3639386|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3814063|NCT01766713|3639384|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3814064|NCT01766713|3639385|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3814065|NCT01766713|3639386|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3814066|NCT01766713|3639384|B3|||Age||years|Mean|49.5|49.5|Standard Deviation|14.1|14.1|||
3814067|NCT01766713|3639385|B2|||Age||years|Mean|49.5|49.5|Standard Deviation|13.7|13.7|||
3814068|NCT01766713|3639386|B1|||Age||years|Mean|49.0|49.0|Standard Deviation|14.9|14.9|||
3814069|NCT01766466|3639393|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3814070|NCT01766466|3639394|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3814071|NCT01766466|3639395|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3814072|NCT01766466|3639393|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3814073|NCT01766466|3639394|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3814074|NCT01766466|3639395|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3814075|NCT01766466|3639393|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3814076|NCT01766466|3639394|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3814077|NCT01766466|3639395|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3814078|NCT01766466|3639393|B3|||Age||years|Mean|66.4|66.4|Standard Deviation|5.65|5.65|||
3814079|NCT01766466|3639394|B2|||Age||years|Mean|66.5|66.5|Standard Deviation|4.32|4.32|||
3814080|NCT01766466|3639395|B1|||Age||years|Mean|66.3|66.3|Standard Deviation|7.17|7.17|||
3814081|NCT01766440|3639411|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3814082|NCT01766440|3639411|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3814083|NCT01766440|3639411|B1|||Age||years|Mean|8.4|8.4|Standard Deviation|3.0|3.0|||
3814084|NCT01766336|3639420|B3|Europe||Region of Enrollment||participants|Number|25|25.0||||||
3814085|NCT01766336|3639421|B2|Europe||Region of Enrollment||participants|Number|12|12.0||||||
3814086|NCT01766336|3639422|B1|Europe||Region of Enrollment||participants|Number|13|13.0||||||
3814087|NCT01766336|3639420|B3|North America||Region of Enrollment||participants|Number|271|271.0||||||
3814088|NCT01766336|3639421|B2|North America||Region of Enrollment||participants|Number|134|134.0||||||
3814089|NCT01766336|3639422|B1|North America||Region of Enrollment||participants|Number|137|137.0||||||
3814090|NCT01766336|3639420|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3814091|NCT01766336|3639421|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3814092|NCT01766336|3639422|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3814093|NCT01766336|3639420|B3|White||Race/Ethnicity, Customized||participants|Number|265|265.0||||||
3814094|NCT01766336|3639421|B2|White||Race/Ethnicity, Customized||participants|Number|127|127.0||||||
3814095|NCT01766336|3639422|B1|White||Race/Ethnicity, Customized||participants|Number|138|138.0||||||
3814096|NCT01766336|3639420|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
3814097|NCT01766336|3639421|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3814098|NCT01766336|3639422|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3814099|NCT01766336|3639420|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3814100|NCT01766336|3639421|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3814101|NCT01766336|3639422|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3814102|NCT01766336|3639420|B3||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3814103|NCT01766336|3639421|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3814104|NCT01766336|3639422|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3814105|NCT01766336|3639420|B3||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3814106|NCT01766336|3639421|B2||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3814107|NCT01766336|3639422|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3814108|NCT01766336|3639420|B3|||Age||years|Mean|76.2|76.2|Standard Deviation|8.3|8.3|||
3814109|NCT01766336|3639421|B2|||Age||years|Mean|75.9|75.9|Standard Deviation|8.7|8.7|||
3814110|NCT01766336|3639422|B1|||Age||years|Mean|76.6|76.6|Standard Deviation|7.9|7.9|||
3814111|NCT01766310|3639429|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3814112|NCT01766310|3639430|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3814113|NCT01766310|3639431|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3814114|NCT01766310|3639429|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3814115|NCT01766310|3639430|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3814116|NCT01766310|3639431|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3814117|NCT01766310|3639429|B3|||Age||years|Mean|10.90|10.9|Standard Deviation|1.60|1.6|||
3814118|NCT01766310|3639430|B2|||Age||years|Mean|11.08|11.08|Standard Deviation|1.57|1.57|||
3814119|NCT01766310|3639431|B1|||Age||years|Mean|10.73|10.73|Standard Deviation|1.64|1.64|||
3814120|NCT01766206|3639440|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3814121|NCT01766206|3639440|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3814122|NCT01766206|3639440|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3937|3937.0||||||
3814123|NCT01766206|3639440|B1||Male|Sex: Female, Male||Participants|Count of Participants|1758|1758.0||||||
3814124|NCT01766206|3639440|B1||Female|Sex: Female, Male||Participants|Count of Participants|2181|2181.0||||||
3814125|NCT01766206|3639440|B1|≥ 56 years||Age, Customized||Participants|Number|15|15.0||||||
3814126|NCT01766206|3639440|B1|35 - 55 years||Age, Customized||Participants|Number|661|661.0||||||
3814127|NCT01766206|3639440|B1|19-34 years||Age, Customized||Participants|Number|1286|1286.0||||||
3814128|NCT01766206|3639440|B1|11-18 years||Age, Customized||Participants|Number|433|433.0||||||
3814129|NCT01766206|3639440|B1|6-10 years||Age, Customized||Participants|Number|339|339.0||||||
3814130|NCT01766206|3639440|B1|2-5 years||Age, Customized||Participants|Number|551|551.0||||||
3814131|NCT01766206|3639440|B1|2-10 years||Age, Customized||Participants|Number|890|890.0||||||
3814132|NCT01766206|3639440|B1|2- 23 months||Age, Customized||Participants|Number|654|654.0||||||
3814133|NCT01766206|3639440|B1|||Age||Years|Mean|18.37|18.37|Standard Deviation|15.4|15.4|||
3814134|NCT01766102|3639447|B3|ALND||Axillary Surgery|"Type of axillary lymph node surgery~SLNB= Sentinel Lymph Node Biopsy~ALND= Axillary Lymph Node Dissection"|Participants|Count of Participants|1|1.0||||||
3814135|NCT01766102|3639448|B2|ALND||Axillary Surgery|"Type of axillary lymph node surgery~SLNB= Sentinel Lymph Node Biopsy~ALND= Axillary Lymph Node Dissection"|Participants|Count of Participants|0|0.0||||||
3814136|NCT01766102|3639449|B1|ALND||Axillary Surgery|"Type of axillary lymph node surgery~SLNB= Sentinel Lymph Node Biopsy~ALND= Axillary Lymph Node Dissection"|Participants|Count of Participants|1|1.0||||||
3814137|NCT01766102|3639447|B3|SLNB||Axillary Surgery|"Type of axillary lymph node surgery~SLNB= Sentinel Lymph Node Biopsy~ALND= Axillary Lymph Node Dissection"|Participants|Count of Participants|40|40.0||||||
3814138|NCT01766102|3639448|B2|SLNB||Axillary Surgery|"Type of axillary lymph node surgery~SLNB= Sentinel Lymph Node Biopsy~ALND= Axillary Lymph Node Dissection"|Participants|Count of Participants|20|20.0||||||
3814139|NCT01766102|3639449|B1|SLNB||Axillary Surgery|"Type of axillary lymph node surgery~SLNB= Sentinel Lymph Node Biopsy~ALND= Axillary Lymph Node Dissection"|Participants|Count of Participants|20|20.0||||||
3814140|NCT01766102|3639447|B3|None||Axillary Surgery|"Type of axillary lymph node surgery~SLNB= Sentinel Lymph Node Biopsy~ALND= Axillary Lymph Node Dissection"|Participants|Count of Participants|31|31.0||||||
3814141|NCT01766102|3639448|B2|None||Axillary Surgery|"Type of axillary lymph node surgery~SLNB= Sentinel Lymph Node Biopsy~ALND= Axillary Lymph Node Dissection"|Participants|Count of Participants|16|16.0||||||
3814142|NCT01766102|3639449|B1|None||Axillary Surgery|"Type of axillary lymph node surgery~SLNB= Sentinel Lymph Node Biopsy~ALND= Axillary Lymph Node Dissection"|Participants|Count of Participants|15|15.0||||||
3814143|NCT01766102|3639447|B3|General||Anesthesia Type|The type of anesthesia used during the procedure. Monitored anesthesia care (MAC) is when a patient undergoes local anesthesia together with sedation and analgesia. General anesthesia is anesthesia that affects the whole body and usually induces a loss of consciousness.|Participants|Count of Participants|27|27.0||||||
3814144|NCT01766102|3639448|B2|General||Anesthesia Type|The type of anesthesia used during the procedure. Monitored anesthesia care (MAC) is when a patient undergoes local anesthesia together with sedation and analgesia. General anesthesia is anesthesia that affects the whole body and usually induces a loss of consciousness.|Participants|Count of Participants|15|15.0||||||
3814145|NCT01766102|3639449|B1|General||Anesthesia Type|The type of anesthesia used during the procedure. Monitored anesthesia care (MAC) is when a patient undergoes local anesthesia together with sedation and analgesia. General anesthesia is anesthesia that affects the whole body and usually induces a loss of consciousness.|Participants|Count of Participants|12|12.0||||||
3814146|NCT01766102|3639447|B3|MAC||Anesthesia Type|The type of anesthesia used during the procedure. Monitored anesthesia care (MAC) is when a patient undergoes local anesthesia together with sedation and analgesia. General anesthesia is anesthesia that affects the whole body and usually induces a loss of consciousness.|Participants|Count of Participants|45|45.0||||||
3814147|NCT01766102|3639448|B2|MAC||Anesthesia Type|The type of anesthesia used during the procedure. Monitored anesthesia care (MAC) is when a patient undergoes local anesthesia together with sedation and analgesia. General anesthesia is anesthesia that affects the whole body and usually induces a loss of consciousness.|Participants|Count of Participants|21|21.0||||||
3814148|NCT01766102|3639449|B1|MAC||Anesthesia Type|The type of anesthesia used during the procedure. Monitored anesthesia care (MAC) is when a patient undergoes local anesthesia together with sedation and analgesia. General anesthesia is anesthesia that affects the whole body and usually induces a loss of consciousness.|Participants|Count of Participants|24|24.0||||||
3814149|NCT01766102|3639447|B3|Mass/ Calcs/ Arch distort||Wire-localization Target|A thin wire is inserted down to the target area of breast so that during surgery the surgeon can follow the guide wire down to the target area and remove the wire and the tissue around it. A clip is a marker that is placed in the breast during a biopsy that can be used a target for wire insertion. Mass means a solid mass in the breast. Calculated means that the target location was either manually or computer calculated. Architectural distortion (arch distort) is when a mammogram shows tethering or indentation of breast tissue but without an apparent associated mass.|Participants|Count of Participants|10|10.0||||||
3814150|NCT01766102|3639448|B2|Mass/ Calcs/ Arch distort||Wire-localization Target|A thin wire is inserted down to the target area of breast so that during surgery the surgeon can follow the guide wire down to the target area and remove the wire and the tissue around it. A clip is a marker that is placed in the breast during a biopsy that can be used a target for wire insertion. Mass means a solid mass in the breast. Calculated means that the target location was either manually or computer calculated. Architectural distortion (arch distort) is when a mammogram shows tethering or indentation of breast tissue but without an apparent associated mass.|Participants|Count of Participants|3|3.0||||||
3814151|NCT01766102|3639449|B1|Mass/ Calcs/ Arch distort||Wire-localization Target|A thin wire is inserted down to the target area of breast so that during surgery the surgeon can follow the guide wire down to the target area and remove the wire and the tissue around it. A clip is a marker that is placed in the breast during a biopsy that can be used a target for wire insertion. Mass means a solid mass in the breast. Calculated means that the target location was either manually or computer calculated. Architectural distortion (arch distort) is when a mammogram shows tethering or indentation of breast tissue but without an apparent associated mass.|Participants|Count of Participants|7|7.0||||||
3814152|NCT01766102|3639447|B3|Clip||Wire-localization Target|A thin wire is inserted down to the target area of breast so that during surgery the surgeon can follow the guide wire down to the target area and remove the wire and the tissue around it. A clip is a marker that is placed in the breast during a biopsy that can be used a target for wire insertion. Mass means a solid mass in the breast. Calculated means that the target location was either manually or computer calculated. Architectural distortion (arch distort) is when a mammogram shows tethering or indentation of breast tissue but without an apparent associated mass.|Participants|Count of Participants|62|62.0||||||
3814153|NCT01766102|3639448|B2|Clip||Wire-localization Target|A thin wire is inserted down to the target area of breast so that during surgery the surgeon can follow the guide wire down to the target area and remove the wire and the tissue around it. A clip is a marker that is placed in the breast during a biopsy that can be used a target for wire insertion. Mass means a solid mass in the breast. Calculated means that the target location was either manually or computer calculated. Architectural distortion (arch distort) is when a mammogram shows tethering or indentation of breast tissue but without an apparent associated mass.|Participants|Count of Participants|33|33.0||||||
3814154|NCT01766102|3639449|B1|Clip||Wire-localization Target|A thin wire is inserted down to the target area of breast so that during surgery the surgeon can follow the guide wire down to the target area and remove the wire and the tissue around it. A clip is a marker that is placed in the breast during a biopsy that can be used a target for wire insertion. Mass means a solid mass in the breast. Calculated means that the target location was either manually or computer calculated. Architectural distortion (arch distort) is when a mammogram shows tethering or indentation of breast tissue but without an apparent associated mass.|Participants|Count of Participants|29|29.0||||||
3814155|NCT01766102|3639447|B3|Invasive Carcinoma/DCIS||Reason for excision|"The indication for the excision:~An Excisional biopsy is a procedure where the entire abnormality or area of interest is removed.~Atypical Hyperplasia is a precancerous condition that is defined by an atypical accumulation of abnormal cells in the breast.~Ductal carcinoma in situ (DCIS) is the presence of abnormal cells inside a milk duct in the breast. DCIS is considered the earliest form of breast cancer.~Invasive Carcinoma is a cancer that began growing in a duct in the breast and has since invaded the fatty tissue of the breast outside of the duct."|Participants|Count of Participants|53|53.0||||||
3814156|NCT01766102|3639448|B2|Invasive Carcinoma/DCIS||Reason for excision|"The indication for the excision:~An Excisional biopsy is a procedure where the entire abnormality or area of interest is removed.~Atypical Hyperplasia is a precancerous condition that is defined by an atypical accumulation of abnormal cells in the breast.~Ductal carcinoma in situ (DCIS) is the presence of abnormal cells inside a milk duct in the breast. DCIS is considered the earliest form of breast cancer.~Invasive Carcinoma is a cancer that began growing in a duct in the breast and has since invaded the fatty tissue of the breast outside of the duct."|Participants|Count of Participants|28|28.0||||||
3814157|NCT01766102|3639449|B1|Invasive Carcinoma/DCIS||Reason for excision|"The indication for the excision:~An Excisional biopsy is a procedure where the entire abnormality or area of interest is removed.~Atypical Hyperplasia is a precancerous condition that is defined by an atypical accumulation of abnormal cells in the breast.~Ductal carcinoma in situ (DCIS) is the presence of abnormal cells inside a milk duct in the breast. DCIS is considered the earliest form of breast cancer.~Invasive Carcinoma is a cancer that began growing in a duct in the breast and has since invaded the fatty tissue of the breast outside of the duct."|Participants|Count of Participants|25|25.0||||||
3814158|NCT01766102|3639447|B3|Atypia||Reason for excision|"The indication for the excision:~An Excisional biopsy is a procedure where the entire abnormality or area of interest is removed.~Atypical Hyperplasia is a precancerous condition that is defined by an atypical accumulation of abnormal cells in the breast.~Ductal carcinoma in situ (DCIS) is the presence of abnormal cells inside a milk duct in the breast. DCIS is considered the earliest form of breast cancer.~Invasive Carcinoma is a cancer that began growing in a duct in the breast and has since invaded the fatty tissue of the breast outside of the duct."|Participants|Count of Participants|12|12.0||||||
3814159|NCT01766102|3639448|B2|Atypia||Reason for excision|"The indication for the excision:~An Excisional biopsy is a procedure where the entire abnormality or area of interest is removed.~Atypical Hyperplasia is a precancerous condition that is defined by an atypical accumulation of abnormal cells in the breast.~Ductal carcinoma in situ (DCIS) is the presence of abnormal cells inside a milk duct in the breast. DCIS is considered the earliest form of breast cancer.~Invasive Carcinoma is a cancer that began growing in a duct in the breast and has since invaded the fatty tissue of the breast outside of the duct."|Participants|Count of Participants|5|5.0||||||
3814160|NCT01766102|3639449|B1|Atypia||Reason for excision|"The indication for the excision:~An Excisional biopsy is a procedure where the entire abnormality or area of interest is removed.~Atypical Hyperplasia is a precancerous condition that is defined by an atypical accumulation of abnormal cells in the breast.~Ductal carcinoma in situ (DCIS) is the presence of abnormal cells inside a milk duct in the breast. DCIS is considered the earliest form of breast cancer.~Invasive Carcinoma is a cancer that began growing in a duct in the breast and has since invaded the fatty tissue of the breast outside of the duct."|Participants|Count of Participants|7|7.0||||||
3814161|NCT01766102|3639447|B3|Excisional Biopsy||Reason for excision|"The indication for the excision:~An Excisional biopsy is a procedure where the entire abnormality or area of interest is removed.~Atypical Hyperplasia is a precancerous condition that is defined by an atypical accumulation of abnormal cells in the breast.~Ductal carcinoma in situ (DCIS) is the presence of abnormal cells inside a milk duct in the breast. DCIS is considered the earliest form of breast cancer.~Invasive Carcinoma is a cancer that began growing in a duct in the breast and has since invaded the fatty tissue of the breast outside of the duct."|Participants|Count of Participants|7|7.0||||||
3814162|NCT01766102|3639448|B2|Excisional Biopsy||Reason for excision|"The indication for the excision:~An Excisional biopsy is a procedure where the entire abnormality or area of interest is removed.~Atypical Hyperplasia is a precancerous condition that is defined by an atypical accumulation of abnormal cells in the breast.~Ductal carcinoma in situ (DCIS) is the presence of abnormal cells inside a milk duct in the breast. DCIS is considered the earliest form of breast cancer.~Invasive Carcinoma is a cancer that began growing in a duct in the breast and has since invaded the fatty tissue of the breast outside of the duct."|Participants|Count of Participants|3|3.0||||||
3814163|NCT01766102|3639449|B1|Excisional Biopsy||Reason for excision|"The indication for the excision:~An Excisional biopsy is a procedure where the entire abnormality or area of interest is removed.~Atypical Hyperplasia is a precancerous condition that is defined by an atypical accumulation of abnormal cells in the breast.~Ductal carcinoma in situ (DCIS) is the presence of abnormal cells inside a milk duct in the breast. DCIS is considered the earliest form of breast cancer.~Invasive Carcinoma is a cancer that began growing in a duct in the breast and has since invaded the fatty tissue of the breast outside of the duct."|Participants|Count of Participants|4|4.0||||||
3814164|NCT01766102|3639447|B3|||BMI|Body Mass Index is a weight to height ratio calculated by dividing someone's weight in Kg by the square of someone's height in meters.|Kg/m^2|Median|26|26.0|Full Range|||18.0|46.0|
3814165|NCT01766102|3639448|B2|||BMI|Body Mass Index is a weight to height ratio calculated by dividing someone's weight in Kg by the square of someone's height in meters.|Kg/m^2|Median|25|25.0|Full Range|||18.0|46.0|
3814166|NCT01766102|3639449|B1|||BMI|Body Mass Index is a weight to height ratio calculated by dividing someone's weight in Kg by the square of someone's height in meters.|Kg/m^2|Median|27|27.0|Full Range|||18.0|38.0|
3814167|NCT01766102|3639447|B3|United States||Region of Enrollment||Participants|Count of Participants|72|72.0||||||
3814168|NCT01766102|3639448|B2|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3814169|NCT01766102|3639449|B1|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3814170|NCT01766102|3639447|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3814171|NCT01766102|3639448|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3814172|NCT01766102|3639449|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3814173|NCT01766102|3639447|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3814174|NCT01766102|3639448|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3814175|NCT01766102|3639449|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3814176|NCT01766102|3639447|B3|||Age||years|Median|58|58.0|Full Range|||36.0|79.0|
3814177|NCT01766102|3639448|B2|||Age||years|Median|57|57.0|Full Range|||40.0|78.0|
3814178|NCT01766102|3639449|B1|||Age||years|Median|59|59.0|Full Range|||36.0|79.0|
3814179|NCT01766076|3639458|B3|||CD4 T-cell activation||percenatage of activated CD4 T-cells|Median|4.2|4.2|Inter-Quartile Range|||1.5|8.3|
3814180|NCT01766076|3639459|B2|||CD4 T-cell activation||percenatage of activated CD4 T-cells|Median|2.9|2.9|Inter-Quartile Range|||2.9|5.0|
3814181|NCT01766076|3639460|B1|||CD4 T-cell activation||percenatage of activated CD4 T-cells|Median|4.2|4.2|Inter-Quartile Range|||3.7|6.2|
3814182|NCT01766076|3639458|B3|Uganda||Region of Enrollment||participants|Number|30|30.0||||||
3814183|NCT01766076|3639459|B2|Uganda||Region of Enrollment||participants|Number|15|15.0||||||
3814184|NCT01766076|3639460|B1|Uganda||Region of Enrollment||participants|Number|15|15.0||||||
3814185|NCT01766076|3639458|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3814186|NCT01766076|3639459|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3814187|NCT01766076|3639460|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3814188|NCT01766076|3639458|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3814189|NCT01766076|3639459|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3814190|NCT01766076|3639460|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3814191|NCT01766076|3639458|B3|||Age||years|Median|46|46.0|Inter-Quartile Range|||40.0|51.0|
3814192|NCT01766076|3639459|B2|||Age||years|Median|47|47.0|Inter-Quartile Range|||43.0|51.0|
3814193|NCT01766076|3639460|B1|||Age||years|Median|41|41.0|Inter-Quartile Range|||40.0|50.0|
3814194|NCT01766076|3639458|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3814195|NCT01766076|3639459|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3814196|NCT01766076|3639460|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3814197|NCT01766076|3639458|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3814198|NCT01766076|3639459|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3814199|NCT01766076|3639460|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3814200|NCT01766076|3639458|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3814201|NCT01766076|3639459|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3814202|NCT01766076|3639460|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3814203|NCT01766050|3639467|B1|||Body Mass Index (kg/m^2)|body mass index (BMI): weight in kilograms (kg)/[height in meters (m)]2|kg/m^2|Mean|24.62|24.62|Standard Deviation|2.886|2.886|||
3814204|NCT01766050|3639467|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3814205|NCT01766050|3639467|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814206|NCT01766050|3639467|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814207|NCT01766050|3639467|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3814208|NCT01766050|3639467|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3814209|NCT01766050|3639467|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814210|NCT01766050|3639467|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814211|NCT01766050|3639467|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814212|NCT01766050|3639467|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3814213|NCT01766050|3639467|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3814214|NCT01766050|3639467|B1|||Age||years|Mean|31.5|31.5|Standard Deviation|5.96|5.96|||
3814215|NCT01766037|3639600|B3|||Baseline Weight||Kilograms|Mean|115.4|115.4|Standard Deviation|19.6|19.6|||
3814216|NCT01766037|3639601|B2|||Baseline Weight||Kilograms|Mean|112.8|112.8|Standard Deviation|16.1|16.1|||
3814217|NCT01766037|3639602|B1|||Baseline Weight||Kilograms|Mean|116.9|116.9|Standard Deviation|21.2|21.2|||
3814218|NCT01766037|3639600|B3|United States||Region of Enrollment||participants|Number|171|171.0||||||
3814219|NCT01766037|3639601|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
3814220|NCT01766037|3639602|B1|United States||Region of Enrollment||participants|Number|111|111.0||||||
3814221|NCT01766037|3639600|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814222|NCT01766037|3639601|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814223|NCT01766037|3639602|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814224|NCT01766037|3639600|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3814225|NCT01766037|3639601|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3814226|NCT01766037|3639602|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3814227|NCT01766037|3639600|B3||White|Race (NIH/OMB)||Participants|Count of Participants|116|116.0||||||
3814228|NCT01766037|3639601|B2||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3814229|NCT01766037|3639602|B1||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3814230|NCT01766037|3639600|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3814231|NCT01766037|3639601|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3814232|NCT01766037|3639602|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3814233|NCT01766037|3639600|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814234|NCT01766037|3639601|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814235|NCT01766037|3639602|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814236|NCT01766037|3639600|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814237|NCT01766037|3639601|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814238|NCT01766037|3639602|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814239|NCT01766037|3639600|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814240|NCT01766037|3639601|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814241|NCT01766037|3639602|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814242|NCT01766037|3639600|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3814243|NCT01766037|3639601|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814244|NCT01766037|3639602|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3814245|NCT01766037|3639600|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|148|148.0||||||
3814246|NCT01766037|3639601|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3814247|NCT01766037|3639602|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3814248|NCT01766037|3639600|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3814249|NCT01766037|3639601|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3814250|NCT01766037|3639602|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3814251|NCT01766037|3639600|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3814252|NCT01766037|3639601|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3814253|NCT01766037|3639602|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3814254|NCT01766037|3639600|B3||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3814255|NCT01766037|3639601|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3814256|NCT01766037|3639602|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3814257|NCT01766037|3639600|B3|||Age||years|Mean|43.9|43.9|Standard Deviation|10.7|10.7|||
3814258|NCT01766037|3639601|B2|||Age||years|Mean|46.8|46.8|Standard Deviation|11.6|11.6|||
3814259|NCT01766037|3639602|B1|||Age||years|Mean|42.4|42.4|Standard Deviation|10.0|10.0|||
3814260|NCT01766037|3639600|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3814261|NCT01766037|3639601|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3814262|NCT01766037|3639602|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3814263|NCT01766037|3639600|B3||Between 18 and 65 years|Age||Participants|Count of Participants|171|171.0||||||
3814264|NCT01766037|3639601|B2||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3814265|NCT01766037|3639602|B1||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
3814266|NCT01766037|3639600|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3814267|NCT01766037|3639601|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3814268|NCT01766037|3639602|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3814269|NCT01766024|3639638|B3|Russian Federation||Region of Enrollment||participants|Number|32|32.0||||||
3814270|NCT01766024|3639639|B2|Russian Federation||Region of Enrollment||participants|Number|16|16.0||||||
3814271|NCT01766024|3639640|B1|Russian Federation||Region of Enrollment||participants|Number|16|16.0||||||
3814272|NCT01766024|3639638|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814273|NCT01766024|3639639|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814274|NCT01766024|3639640|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814275|NCT01766024|3639638|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814276|NCT01766024|3639639|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814277|NCT01766024|3639640|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814278|NCT01766024|3639638|B3||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3814279|NCT01766024|3639639|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3814280|NCT01766024|3639640|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3814281|NCT01766024|3639638|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814282|NCT01766024|3639639|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814283|NCT01766024|3639640|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814284|NCT01766024|3639638|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814285|NCT01766024|3639639|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814286|NCT01766024|3639640|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814287|NCT01766024|3639638|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814288|NCT01766024|3639639|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814289|NCT01766024|3639640|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814290|NCT01766024|3639638|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814291|NCT01766024|3639639|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814292|NCT01766024|3639640|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814293|NCT01766024|3639638|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3814294|NCT01766024|3639639|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3814295|NCT01766024|3639640|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3814296|NCT01766024|3639638|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3814297|NCT01766024|3639639|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3814298|NCT01766024|3639640|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3814299|NCT01766024|3639638|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3814300|NCT01766024|3639639|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3814301|NCT01766024|3639640|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3814302|NCT01766024|3639638|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3814303|NCT01766024|3639639|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3814304|NCT01766024|3639640|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3814305|NCT01766024|3639638|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3814306|NCT01766024|3639639|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3814307|NCT01766024|3639640|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3814308|NCT01765972|3639651|B1|Canada||Region of Enrollment||participants|Number|24|24.0||||||
3814309|NCT01765972|3639651|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814310|NCT01765972|3639651|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814311|NCT01765972|3639651|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814312|NCT01765972|3639651|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814313|NCT01765972|3639651|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814314|NCT01765972|3639651|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3814315|NCT01765972|3639651|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814316|NCT01765972|3639651|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3814317|NCT01765972|3639651|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3814318|NCT01765972|3639651|B1|||Age||years|Mean|21.13|21.13|Standard Deviation|2.437|2.437|||
3814319|NCT01765803|3639664|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3814320|NCT01765803|3639664|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3814321|NCT01765803|3639664|B1|||Age||years|Median|34|34.0|Full Range|||24.0|43.0|
3814322|NCT01765764|3639669|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3814323|NCT01765764|3639670|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3814324|NCT01765764|3639671|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3814325|NCT01765764|3639672|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3814326|NCT01765764|3639669|B4||Female|Sex: Female, Male||Participants|Count of Participants|338|338.0||||||
3814327|NCT01765764|3639670|B3||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3814328|NCT01765764|3639671|B2||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3814329|NCT01765764|3639672|B1||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3814330|NCT01765764|3639669|B4|≥45 years||Age, Customized||Participants|Number|298|298.0||||||
3814331|NCT01765764|3639670|B3|≥45 years||Age, Customized||Participants|Number|99|99.0||||||
3814332|NCT01765764|3639671|B2|≥45 years||Age, Customized||Participants|Number|99|99.0||||||
3814333|NCT01765764|3639672|B1|≥45 years||Age, Customized||Participants|Number|100|100.0||||||
3814334|NCT01765764|3639669|B4|18 to <45 years||Age, Customized||Participants|Number|59|59.0||||||
3814335|NCT01765764|3639670|B3|18 to <45 years||Age, Customized||Participants|Number|22|22.0||||||
3814336|NCT01765764|3639671|B2|18 to <45 years||Age, Customized||Participants|Number|19|19.0||||||
3814337|NCT01765764|3639672|B1|18 to <45 years||Age, Customized||Participants|Number|18|18.0||||||
3814338|NCT01765751|3639691|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3814339|NCT01765751|3639692|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3814340|NCT01765751|3639693|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3814341|NCT01765751|3639694|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3814342|NCT01765751|3639691|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3814343|NCT01765751|3639692|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3814344|NCT01765751|3639693|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3814345|NCT01765751|3639694|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3814346|NCT01765751|3639691|B4|||Age||years|Mean|46.8|46.8|Standard Deviation|12.5|12.5|||
3814347|NCT01765751|3639692|B3|||Age||years|Mean|51.2|51.2|Standard Deviation|13.7|13.7|||
3814348|NCT01765751|3639693|B2|||Age||years|Mean|47.0|47.0|Standard Deviation|11.4|11.4|||
3814349|NCT01765751|3639694|B1|||Age||years|Mean|42.2|42.2|Standard Deviation|11.2|11.2|||
3814350|NCT01765673|3639728|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3814351|NCT01765673|3639728|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814352|NCT01765673|3639728|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814353|NCT01765673|3639728|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3814354|NCT01765673|3639728|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3814355|NCT01765673|3639728|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814356|NCT01765673|3639728|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814357|NCT01765673|3639728|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814358|NCT01765673|3639728|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3814359|NCT01765673|3639728|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3814360|NCT01765673|3639728|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|9.83|9.83|||
3814361|NCT01765582|3639751|B4||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3814362|NCT01765582|3639752|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3814363|NCT01765582|3639753|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3814364|NCT01765582|3639754|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3814365|NCT01765582|3639751|B4||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3814366|NCT01765582|3639752|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3814367|NCT01765582|3639753|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3814368|NCT01765582|3639754|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3814369|NCT01765582|3639751|B4|||Age||Years|Mean|56.7|56.7|Standard Deviation|10.63|10.63|||
3814370|NCT01765582|3639752|B3|||Age||Years|Mean|57.9|57.9|Standard Deviation|9.86|9.86|||
3814371|NCT01765582|3639753|B2|||Age||Years|Mean|56.0|56.0|Standard Deviation|10.46|10.46|||
3814372|NCT01765582|3639754|B1|||Age||Years|Mean|56.0|56.0|Standard Deviation|11.53|11.53|||
3814373|NCT01765569|3639789|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3814374|NCT01765569|3639789|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3814375|NCT01765569|3639789|B1|||Age||years|Mean|47.8|47.8|Standard Deviation|13.7|13.7|||
3814376|NCT01765543|3639810|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3814377|NCT01765543|3639810|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3814378|NCT01765543|3639810|B1|||Age||years|Mean|57.9|57.9|Standard Deviation|13.0|13.0|||
3814379|NCT01765530|3639832|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3814380|NCT01765530|3639833|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3814381|NCT01765530|3639834|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3814382|NCT01765530|3639832|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3814383|NCT01765530|3639833|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3814384|NCT01765530|3639834|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3814385|NCT01765530|3639832|B3|||Age||years|Mean|62|62.0|Standard Deviation|18|18.0|||
3814386|NCT01765530|3639833|B2|||Age||years|Mean|64|64.0|Standard Deviation|17|17.0|||
3814387|NCT01765530|3639834|B1|||Age||years|Mean|59|59.0|Standard Deviation|19|19.0|||
3814388|NCT01765465|3639843|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3814389|NCT01765465|3639844|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3814390|NCT01765465|3639845|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3814391|NCT01765465|3639843|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3814392|NCT01765465|3639844|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3814393|NCT01765465|3639845|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3814394|NCT01765465|3639843|B3|||Age||years|Mean|49.78|49.78|Standard Deviation|14.79|14.79|||
3814395|NCT01765465|3639844|B2|||Age||years|Mean|47.99|47.99|Standard Deviation|13.81|13.81|||
3814396|NCT01765465|3639845|B1|||Age||years|Mean|51.48|51.48|Standard Deviation|15.56|15.56|||
3814397|NCT01765426|3639858|B5|Seronegative||Seropositivity Status at Baseline||participants|Number|59|59.0||||||
3814398|NCT01765426|3639859|B4|Seronegative||Seropositivity Status at Baseline||participants|Number|13|13.0||||||
3814399|NCT01765426|3639860|B3|Seronegative||Seropositivity Status at Baseline||participants|Number|16|16.0||||||
3814400|NCT01765426|3639861|B2|Seronegative||Seropositivity Status at Baseline||participants|Number|13|13.0||||||
3814401|NCT01765426|3639862|B1|Seronegative||Seropositivity Status at Baseline||participants|Number|17|17.0||||||
3814402|NCT01765426|3639858|B5|Seropositive||Seropositivity Status at Baseline||participants|Number|8|8.0||||||
3814403|NCT01765426|3639859|B4|Seropositive||Seropositivity Status at Baseline||participants|Number|2|2.0||||||
3814404|NCT01765426|3639860|B3|Seropositive||Seropositivity Status at Baseline||participants|Number|1|1.0||||||
3814405|NCT01765426|3639861|B2|Seropositive||Seropositivity Status at Baseline||participants|Number|4|4.0||||||
3814406|NCT01765426|3639862|B1|Seropositive||Seropositivity Status at Baseline||participants|Number|1|1.0||||||
3814407|NCT01765426|3639858|B5|||Body Mass Index (BMI)||kg/m^2|Mean|25.29|25.29|Standard Deviation|4.733|4.733|||
3814408|NCT01765426|3639859|B4|||Body Mass Index (BMI)||kg/m^2|Mean|25.93|25.93|Standard Deviation|3.743|3.743|||
3814409|NCT01765426|3639860|B3|||Body Mass Index (BMI)||kg/m^2|Mean|23.66|23.66|Standard Deviation|3.406|3.406|||
3814410|NCT01765426|3639861|B2|||Body Mass Index (BMI)||kg/m^2|Mean|25.73|25.73|Standard Deviation|4.516|4.516|||
3814411|NCT01765426|3639862|B1|||Body Mass Index (BMI)||kg/m^2|Mean|25.89|25.89|Standard Deviation|6.458|6.458|||
3814412|NCT01765426|3639858|B5|||Height||cm|Mean|175.41|175.41|Standard Deviation|10.114|10.114|||
3814413|NCT01765426|3639859|B4|||Height||cm|Mean|169.13|169.13|Standard Deviation|10.593|10.593|||
3814414|NCT01765426|3639860|B3|||Height||cm|Mean|179.77|179.77|Standard Deviation|8.833|8.833|||
3814415|NCT01765426|3639861|B2|||Height||cm|Mean|177.58|177.58|Standard Deviation|9.891|9.891|||
3814416|NCT01765426|3639862|B1|||Height||cm|Mean|174.47|174.47|Standard Deviation|8.934|8.934|||
3814417|NCT01765426|3639858|B5|||Weight||kg|Mean|77.73|77.73|Standard Deviation|15.354|15.354|||
3814418|NCT01765426|3639859|B4|||Weight||kg|Mean|73.73|73.73|Standard Deviation|8.939|8.939|||
3814419|NCT01765426|3639860|B3|||Weight||kg|Mean|76.72|76.72|Standard Deviation|13.672|13.672|||
3814420|NCT01765426|3639861|B2|||Weight||kg|Mean|81.19|81.19|Standard Deviation|15.673|15.673|||
3814421|NCT01765426|3639862|B1|||Weight||kg|Mean|78.77|78.77|Standard Deviation|20.349|20.349|||
3814422|NCT01765426|3639858|B5|United States||Region of Enrollment||participants|Number|67|67.0||||||
3814423|NCT01765426|3639859|B4|United States||Region of Enrollment||participants|Number|15|15.0||||||
3814424|NCT01765426|3639860|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
3814425|NCT01765426|3639861|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3814426|NCT01765426|3639862|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3814427|NCT01765426|3639858|B5|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3814428|NCT01765426|3639859|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3814429|NCT01765426|3639860|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3814430|NCT01765426|3639861|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3814431|NCT01765426|3639862|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3814432|NCT01765426|3639858|B5|Multi-Racial||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3814433|NCT01765426|3639859|B4|Multi-Racial||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3814434|NCT01765426|3639860|B3|Multi-Racial||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3814435|NCT01765426|3639861|B2|Multi-Racial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3814436|NCT01765426|3639862|B1|Multi-Racial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3814437|NCT01765426|3639858|B5|White||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
3814438|NCT01765426|3639859|B4|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3814439|NCT01765426|3639860|B3|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3814440|NCT01765426|3639861|B2|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3814441|NCT01765426|3639862|B1|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3814442|NCT01765426|3639858|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3814443|NCT01765426|3639859|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3814444|NCT01765426|3639860|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3814445|NCT01765426|3639861|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3814446|NCT01765426|3639862|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3814447|NCT01765426|3639858|B5|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3814448|NCT01765426|3639859|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3814449|NCT01765426|3639860|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3814450|NCT01765426|3639861|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3814451|NCT01765426|3639862|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3814452|NCT01765426|3639858|B5|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
3814453|NCT01765426|3639859|B4|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3814454|NCT01765426|3639860|B3|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3814455|NCT01765426|3639861|B2|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3814456|NCT01765426|3639862|B1|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3814457|NCT01765426|3639858|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3814458|NCT01765426|3639859|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3814459|NCT01765426|3639860|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3814460|NCT01765426|3639861|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3814461|NCT01765426|3639862|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3814462|NCT01765426|3639858|B5||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3814463|NCT01765426|3639859|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3814464|NCT01765426|3639860|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3814465|NCT01765426|3639861|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3814466|NCT01765426|3639862|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3814467|NCT01765426|3639858|B5||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3814468|NCT01765426|3639859|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3814469|NCT01765426|3639860|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3814470|NCT01765426|3639861|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3814471|NCT01765426|3639862|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3814472|NCT01765426|3639858|B5|||Age||years|Mean|29.9|29.9|Standard Deviation|8.10|8.1|||
3814473|NCT01765426|3639859|B4|||Age||years|Mean|27.5|27.5|Standard Deviation|6.84|6.84|||
3814474|NCT01765426|3639860|B3|||Age||years|Mean|30.1|30.1|Standard Deviation|7.90|7.9|||
3814475|NCT01765426|3639861|B2|||Age||years|Mean|32.4|32.4|Standard Deviation|8.87|8.87|||
3814476|NCT01765426|3639862|B1|||Age||years|Mean|29.3|29.3|Standard Deviation|8.47|8.47|||
3814477|NCT01765270|3639919|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3814478|NCT01765270|3639920|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3814479|NCT01765270|3639921|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3814480|NCT01765270|3639919|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814481|NCT01765270|3639920|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814482|NCT01765270|3639921|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814483|NCT01765270|3639919|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814484|NCT01765270|3639920|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814485|NCT01765270|3639921|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814486|NCT01765270|3639919|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3814487|NCT01765270|3639920|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3814488|NCT01765270|3639921|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3814489|NCT01765270|3639919|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3814490|NCT01765270|3639920|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3814491|NCT01765270|3639921|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3814492|NCT01765270|3639919|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814493|NCT01765270|3639920|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814494|NCT01765270|3639921|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814495|NCT01765270|3639919|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814496|NCT01765270|3639920|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814497|NCT01765270|3639921|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814498|NCT01765270|3639919|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814499|NCT01765270|3639920|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814500|NCT01765270|3639921|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814501|NCT01765270|3639919|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814502|NCT01765270|3639920|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814503|NCT01765270|3639921|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814504|NCT01765270|3639919|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3814505|NCT01765270|3639920|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3814506|NCT01765270|3639921|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3814507|NCT01765270|3639919|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3814508|NCT01765270|3639920|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814509|NCT01765270|3639921|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3814510|NCT01765270|3639919|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3814511|NCT01765270|3639920|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3814512|NCT01765270|3639921|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3814513|NCT01765270|3639919|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3814514|NCT01765270|3639920|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3814515|NCT01765270|3639921|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3814516|NCT01765270|3639919|B3|||Age||years|Mean|59.2|59.2|Standard Deviation|6.9|6.9|||
3814517|NCT01765270|3639920|B2|||Age||years|Mean|60.2|60.2|Standard Deviation|8.1|8.1|||
3814518|NCT01765270|3639921|B1|||Age||years|Mean|57.9|57.9|Standard Deviation|5.3|5.3|||
3814519|NCT01765192|3639942|B3|Ex-smoker||Smoking History||participants|Number|21|21.0||||||
3814520|NCT01765192|3639943|B2|Ex-smoker||Smoking History||participants|Number|11|11.0||||||
3814521|NCT01765192|3639944|B1|Ex-smoker||Smoking History||participants|Number|10|10.0||||||
3814522|NCT01765192|3639942|B3|Current smoker||Smoking History||participants|Number|0|0.0||||||
3814523|NCT01765192|3639943|B2|Current smoker||Smoking History||participants|Number|0|0.0||||||
3814524|NCT01765192|3639944|B1|Current smoker||Smoking History||participants|Number|0|0.0||||||
3814525|NCT01765192|3639942|B3|Never smoked||Smoking History||participants|Number|43|43.0||||||
3814526|NCT01765192|3639943|B2|Never smoked||Smoking History||participants|Number|21|21.0||||||
3814527|NCT01765192|3639944|B1|Never smoked||Smoking History||participants|Number|22|22.0||||||
3814528|NCT01765192|3639942|B3|||Body Mass Index (BMI)||kg/m^2|Mean|29.79|29.79|Standard Deviation|6.354|6.354|||
3814529|NCT01765192|3639943|B2|||Body Mass Index (BMI)||kg/m^2|Mean|30.06|30.06|Standard Deviation|5.605|5.605|||
3814530|NCT01765192|3639944|B1|||Body Mass Index (BMI)||kg/m^2|Mean|29.53|29.53|Standard Deviation|7.105|7.105|||
3814531|NCT01765192|3639942|B3|||Weight||kg|Mean|82.11|82.11|Standard Deviation|18.227|18.227|||
3814532|NCT01765192|3639943|B2|||Weight||kg|Mean|85.16|85.16|Standard Deviation|17.491|17.491|||
3814533|NCT01765192|3639944|B1|||Weight||kg|Mean|79.06|79.06|Standard Deviation|18.708|18.708|||
3814534|NCT01765192|3639942|B3|||Height||cm|Mean|166.0|166.0|Standard Deviation|9.85|9.85|||
3814535|NCT01765192|3639943|B2|||Height||cm|Mean|168.3|168.3|Standard Deviation|10.68|10.68|||
3814536|NCT01765192|3639944|B1|||Height||cm|Mean|163.7|163.7|Standard Deviation|8.47|8.47|||
3814537|NCT01765192|3639942|B3|Hungary||Region of Enrollment||participants|Number|17|17.0||||||
3814538|NCT01765192|3639943|B2|Hungary||Region of Enrollment||participants|Number|9|9.0||||||
3814539|NCT01765192|3639944|B1|Hungary||Region of Enrollment||participants|Number|8|8.0||||||
3814540|NCT01765192|3639942|B3|Germany||Region of Enrollment||participants|Number|20|20.0||||||
3814541|NCT01765192|3639943|B2|Germany||Region of Enrollment||participants|Number|12|12.0||||||
3814542|NCT01765192|3639944|B1|Germany||Region of Enrollment||participants|Number|8|8.0||||||
3814543|NCT01765192|3639942|B3|South Africa||Region of Enrollment||participants|Number|27|27.0||||||
3814544|NCT01765192|3639943|B2|South Africa||Region of Enrollment||participants|Number|11|11.0||||||
3814545|NCT01765192|3639944|B1|South Africa||Region of Enrollment||participants|Number|16|16.0||||||
3814546|NCT01765192|3639942|B3|White||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
3814547|NCT01765192|3639943|B2|White||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3814548|NCT01765192|3639944|B1|White||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3814549|NCT01765192|3639942|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3814550|NCT01765192|3639943|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3814551|NCT01765192|3639944|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3814552|NCT01765192|3639942|B3||Male|Gender||Participants|Count of Participants|23|23.0||||||
3814553|NCT01765192|3639943|B2||Male|Gender||Participants|Count of Participants|12|12.0||||||
3814554|NCT01765192|3639944|B1||Male|Gender||Participants|Count of Participants|11|11.0||||||
3814555|NCT01765192|3639942|B3||Female|Gender||Participants|Count of Participants|41|41.0||||||
3814556|NCT01765192|3639943|B2||Female|Gender||Participants|Count of Participants|20|20.0||||||
3814557|NCT01765192|3639944|B1||Female|Gender||Participants|Count of Participants|21|21.0||||||
3814558|NCT01765192|3639942|B3|≥ 65 years||Age, Customized||participants|Number|10|10.0||||||
3814559|NCT01765192|3639943|B2|≥ 65 years||Age, Customized||participants|Number|5|5.0||||||
3814560|NCT01765192|3639944|B1|≥ 65 years||Age, Customized||participants|Number|5|5.0||||||
3814561|NCT01765192|3639942|B3|< 65 years||Age, Customized||participants|Number|54|54.0||||||
3814562|NCT01765192|3639943|B2|< 65 years||Age, Customized||participants|Number|27|27.0||||||
3814563|NCT01765192|3639944|B1|< 65 years||Age, Customized||participants|Number|27|27.0||||||
3814564|NCT01765192|3639942|B3|||Age||years|Mean|50.1|50.1|Standard Deviation|13.84|13.84|||
3814565|NCT01765192|3639943|B2|||Age||years|Mean|50.0|50.0|Standard Deviation|14.10|14.1|||
3814566|NCT01765192|3639944|B1|||Age||years|Mean|50.3|50.3|Standard Deviation|13.80|13.8|||
3814567|NCT01765179|3639963|B1|United States||Region of Enrollment||Participants|Count of Participants|144|144.0||||||
3814568|NCT01765179|3639963|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3814569|NCT01765179|3639963|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|114|114.0||||||
3814570|NCT01765179|3639963|B1|Race|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3814571|NCT01765179|3639963|B1|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3814572|NCT01765179|3639963|B1|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3814573|NCT01765179|3639963|B1|Race|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3814574|NCT01765179|3639963|B1||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3814575|NCT01765179|3639963|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3814576|NCT01765179|3639963|B1|||Age||years|Mean|54.8|54.8|Standard Deviation|10.60|10.6|||
3814577|NCT01765179|3639963|B1||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
3814578|NCT01765179|3639963|B1||Between 18 and 65 years|Age||Participants|Count of Participants|116|116.0||||||
3814579|NCT01765179|3639963|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3814580|NCT01765153|3639968|B3|Canada||Region of Enrollment||participants|Number|21|21.0||||||
3814581|NCT01765153|3639969|B2|Canada||Region of Enrollment||participants|Number|11|11.0||||||
3814582|NCT01765153|3639970|B1|Canada||Region of Enrollment||participants|Number|10|10.0||||||
3814583|NCT01765153|3639968|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3814584|NCT01765153|3639969|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3814585|NCT01765153|3639970|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3814586|NCT01765153|3639968|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3814587|NCT01765153|3639969|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3814588|NCT01765153|3639970|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3814589|NCT01765153|3639968|B3|||Age||years|Mean|45.9|45.9|Standard Deviation|13.3|13.3|||
3814590|NCT01765153|3639969|B2|||Age||years|Mean|44.0|44.0|Standard Deviation|13.2|13.2|||
3814591|NCT01765153|3639970|B1|||Age||years|Mean|48.1|48.1|Standard Deviation|14.4|14.4|||
3814592|NCT01764997|3640073|B6||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3814593|NCT01764997|3640074|B5||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3814594|NCT01764997|3640075|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3814595|NCT01764997|3640076|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3814596|NCT01764997|3640077|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3814597|NCT01764997|3640078|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3814598|NCT01764997|3640073|B6||Female|Sex: Female, Male||Participants|Count of Participants|637|637.0||||||
3814599|NCT01764997|3640074|B5||Female|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
3814600|NCT01764997|3640075|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3814601|NCT01764997|3640076|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3814602|NCT01764997|3640077|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3814603|NCT01764997|3640078|B1||Female|Sex: Female, Male||Participants|Count of Participants|342|342.0||||||
3814604|NCT01764997|3640073|B6||>=65 years|Age||Participants|Count of Participants|108|108.0||||||
3814605|NCT01764997|3640074|B5||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
3814606|NCT01764997|3640075|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3814607|NCT01764997|3640076|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3814608|NCT01764997|3640077|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3814609|NCT01764997|3640078|B1||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
3814610|NCT01764997|3640073|B6||Between 18 and 65 years|Age||Participants|Count of Participants|668|668.0||||||
3814611|NCT01764997|3640074|B5||Between 18 and 65 years|Age||Participants|Count of Participants|274|274.0||||||
3814612|NCT01764997|3640075|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3814613|NCT01764997|3640076|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3814614|NCT01764997|3640077|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3814615|NCT01764997|3640078|B1||Between 18 and 65 years|Age||Participants|Count of Participants|360|360.0||||||
3814616|NCT01764997|3640073|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3814617|NCT01764997|3640074|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3814618|NCT01764997|3640075|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3814619|NCT01764997|3640076|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3814620|NCT01764997|3640077|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3814621|NCT01764997|3640078|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3814622|NCT01764945|3640101|B9||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3814623|NCT01764945|3640102|B8||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3814624|NCT01764945|3640103|B7||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3814625|NCT01764945|3640104|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3814626|NCT01764945|3640105|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3814627|NCT01764945|3640106|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3814628|NCT01764945|3640107|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3814629|NCT01764945|3640108|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3814630|NCT01764945|3640109|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3814631|NCT01764945|3640101|B9||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3814632|NCT01764945|3640102|B8||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3814633|NCT01764945|3640103|B7||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3814634|NCT01764945|3640104|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3814635|NCT01764945|3640105|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3814636|NCT01764945|3640106|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3814637|NCT01764945|3640107|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3814638|NCT01764945|3640108|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3814639|NCT01764945|3640109|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3814640|NCT01764945|3640101|B9|||Age||years|Mean|38.1|38.1|Standard Deviation|8.5|8.5|||
3814641|NCT01764945|3640102|B8|||Age||years|Mean|34.9|34.9|Standard Deviation|9.5|9.5|||
3814642|NCT01764945|3640103|B7|||Age||years|Mean|39.4|39.4|Standard Deviation|8.1|8.1|||
3814643|NCT01764945|3640104|B6|||Age||years|Mean|38.6|38.6|Standard Deviation|9.6|9.6|||
3814644|NCT01764945|3640105|B5|||Age||years|Mean|33.9|33.9|Standard Deviation|9.7|9.7|||
3814645|NCT01764945|3640106|B4|||Age||years|Mean|44.4|44.4|Standard Deviation|4.2|4.2|||
3814646|NCT01764945|3640107|B3|||Age||years|Mean|38.0|38.0|Standard Deviation|10.2|10.2|||
3814647|NCT01764945|3640108|B2|||Age||years|Mean|39.8|39.8|Standard Deviation|5.1|5.1|||
3814648|NCT01764945|3640109|B1|||Age||years|Mean|41.2|41.2|Standard Deviation|5.3|5.3|||
3814649|NCT01764919|3640150|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3814650|NCT01764919|3640150|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3814651|NCT01764919|3640150|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3814652|NCT01764919|3640150|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3814653|NCT01764919|3640150|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3814654|NCT01764841|3640158|B5|||Forced Expiratory Volume in One Second (FEV1)|FEV1 was the maximal volume of air exhaled in the first second of a forced expiration from a position of full inspiration, expressed in liters at body temperature and ambient pressure saturated with water vapor (BTPS).|Liter|Mean|1.524|1.524|Standard Deviation|0.587|0.587|||
3814655|NCT01764841|3640159|B4|||Forced Expiratory Volume in One Second (FEV1)|FEV1 was the maximal volume of air exhaled in the first second of a forced expiration from a position of full inspiration, expressed in liters at body temperature and ambient pressure saturated with water vapor (BTPS).|Liter|Mean|1.468|1.468|Standard Deviation|0.574|0.574|||
3814656|NCT01764841|3640160|B3|||Forced Expiratory Volume in One Second (FEV1)|FEV1 was the maximal volume of air exhaled in the first second of a forced expiration from a position of full inspiration, expressed in liters at body temperature and ambient pressure saturated with water vapor (BTPS).|Liter|Mean|1.577|1.577|Standard Deviation|0.651|0.651|||
3814657|NCT01764841|3640161|B2|||Forced Expiratory Volume in One Second (FEV1)|FEV1 was the maximal volume of air exhaled in the first second of a forced expiration from a position of full inspiration, expressed in liters at body temperature and ambient pressure saturated with water vapor (BTPS).|Liter|Mean|1.528|1.528|Standard Deviation|0.625|0.625|||
3814658|NCT01764841|3640162|B1|||Forced Expiratory Volume in One Second (FEV1)|FEV1 was the maximal volume of air exhaled in the first second of a forced expiration from a position of full inspiration, expressed in liters at body temperature and ambient pressure saturated with water vapor (BTPS).|Liter|Mean|1.521|1.521|Standard Deviation|0.521|0.521|||
3814676|NCT01764841|3640160|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3814677|NCT01764841|3640161|B2||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3814678|NCT01764841|3640162|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3814679|NCT01764841|3640158|B5|||Age||Years|Mean|64.7|64.7|Standard Deviation|12.9|12.9|||
3814659|NCT01764841|3640158|B5|||Quality of Life Questionnaire for Bronchiectasis (QoL-B) Respiratory Symptoms Domain Score|The QoL-B was a disease-specific questionnaire developed for non-Cystic fibrosis Bronchiectasis. It covers 8 dimensions: physical functioning, role functioning, emotional functioning, social functioning, vitality, treatment burden, health perceptions, and respiratory symptoms. Each dimension was scored separately on a scale of 0 to 100, and higher scores represent better outcomes. For this baseline measure, the respiratory symptoms domain score was reported.|Score on a scale|Mean|54.57|54.57|Standard Deviation|18.87|18.87|||
3814660|NCT01764841|3640159|B4|||Quality of Life Questionnaire for Bronchiectasis (QoL-B) Respiratory Symptoms Domain Score|The QoL-B was a disease-specific questionnaire developed for non-Cystic fibrosis Bronchiectasis. It covers 8 dimensions: physical functioning, role functioning, emotional functioning, social functioning, vitality, treatment burden, health perceptions, and respiratory symptoms. Each dimension was scored separately on a scale of 0 to 100, and higher scores represent better outcomes. For this baseline measure, the respiratory symptoms domain score was reported.|Score on a scale|Mean|50.67|50.67|Standard Deviation|19.59|19.59|||
3814661|NCT01764841|3640160|B3|||Quality of Life Questionnaire for Bronchiectasis (QoL-B) Respiratory Symptoms Domain Score|The QoL-B was a disease-specific questionnaire developed for non-Cystic fibrosis Bronchiectasis. It covers 8 dimensions: physical functioning, role functioning, emotional functioning, social functioning, vitality, treatment burden, health perceptions, and respiratory symptoms. Each dimension was scored separately on a scale of 0 to 100, and higher scores represent better outcomes. For this baseline measure, the respiratory symptoms domain score was reported.|Score on a scale|Mean|55.82|55.82|Standard Deviation|18.04|18.04|||
3814662|NCT01764841|3640161|B2|||Quality of Life Questionnaire for Bronchiectasis (QoL-B) Respiratory Symptoms Domain Score|The QoL-B was a disease-specific questionnaire developed for non-Cystic fibrosis Bronchiectasis. It covers 8 dimensions: physical functioning, role functioning, emotional functioning, social functioning, vitality, treatment burden, health perceptions, and respiratory symptoms. Each dimension was scored separately on a scale of 0 to 100, and higher scores represent better outcomes. For this baseline measure, the respiratory symptoms domain score was reported.|Score on a scale|Mean|57.69|57.69|Standard Deviation|18.72|18.72|||
3814663|NCT01764841|3640162|B1|||Quality of Life Questionnaire for Bronchiectasis (QoL-B) Respiratory Symptoms Domain Score|The QoL-B was a disease-specific questionnaire developed for non-Cystic fibrosis Bronchiectasis. It covers 8 dimensions: physical functioning, role functioning, emotional functioning, social functioning, vitality, treatment burden, health perceptions, and respiratory symptoms. Each dimension was scored separately on a scale of 0 to 100, and higher scores represent better outcomes. For this baseline measure, the respiratory symptoms domain score was reported.|Score on a scale|Mean|53.01|53.01|Standard Deviation|18.71|18.71|||
3814664|NCT01764841|3640158|B5|||Saint George's Respiratory Questionnaire (SGRQ) Symptoms Component Score|The SGRQ was a validated, disease-specific instrument that measures health-related quality of life (HRQoL) in adults with chronic obstructive pulmonary disease (COPD) and asthma and was later validated for use in bronchiectasis. The SGRQ covers 3 dimensions: symptoms, activity and impact on daily life. To determine the outcome, a score ranging from 1 to 100 was calculated for each individual domain and for the total score, and smaller scores indicate better health status. For this baseline measure, the symptoms component score was reported.|Score on a scale|Mean|56.84|56.84|Standard Deviation|20.95|20.95|||
3814665|NCT01764841|3640159|B4|||Saint George's Respiratory Questionnaire (SGRQ) Symptoms Component Score|The SGRQ was a validated, disease-specific instrument that measures health-related quality of life (HRQoL) in adults with chronic obstructive pulmonary disease (COPD) and asthma and was later validated for use in bronchiectasis. The SGRQ covers 3 dimensions: symptoms, activity and impact on daily life. To determine the outcome, a score ranging from 1 to 100 was calculated for each individual domain and for the total score, and smaller scores indicate better health status. For this baseline measure, the symptoms component score was reported.|Score on a scale|Mean|58.72|58.72|Standard Deviation|20.4|20.4|||
3814666|NCT01764841|3640160|B3|||Saint George's Respiratory Questionnaire (SGRQ) Symptoms Component Score|The SGRQ was a validated, disease-specific instrument that measures health-related quality of life (HRQoL) in adults with chronic obstructive pulmonary disease (COPD) and asthma and was later validated for use in bronchiectasis. The SGRQ covers 3 dimensions: symptoms, activity and impact on daily life. To determine the outcome, a score ranging from 1 to 100 was calculated for each individual domain and for the total score, and smaller scores indicate better health status. For this baseline measure, the symptoms component score was reported.|Score on a scale|Mean|55.52|55.52|Standard Deviation|22.07|22.07|||
3814667|NCT01764841|3640161|B2|||Saint George's Respiratory Questionnaire (SGRQ) Symptoms Component Score|The SGRQ was a validated, disease-specific instrument that measures health-related quality of life (HRQoL) in adults with chronic obstructive pulmonary disease (COPD) and asthma and was later validated for use in bronchiectasis. The SGRQ covers 3 dimensions: symptoms, activity and impact on daily life. To determine the outcome, a score ranging from 1 to 100 was calculated for each individual domain and for the total score, and smaller scores indicate better health status. For this baseline measure, the symptoms component score was reported.|Score on a scale|Mean|52.51|52.51|Standard Deviation|21.48|21.48|||
3814668|NCT01764841|3640162|B1|||Saint George's Respiratory Questionnaire (SGRQ) Symptoms Component Score|The SGRQ was a validated, disease-specific instrument that measures health-related quality of life (HRQoL) in adults with chronic obstructive pulmonary disease (COPD) and asthma and was later validated for use in bronchiectasis. The SGRQ covers 3 dimensions: symptoms, activity and impact on daily life. To determine the outcome, a score ranging from 1 to 100 was calculated for each individual domain and for the total score, and smaller scores indicate better health status. For this baseline measure, the symptoms component score was reported.|Score on a scale|Mean|60.72|60.72|Standard Deviation|19.47|19.47|||
3814669|NCT01764841|3640158|B5||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3814670|NCT01764841|3640159|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3814671|NCT01764841|3640160|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3814672|NCT01764841|3640161|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3814673|NCT01764841|3640162|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3814674|NCT01764841|3640158|B5||Female|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
3814675|NCT01764841|3640159|B4||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3814680|NCT01764841|3640159|B4|||Age||Years|Mean|65.5|65.5|Standard Deviation|12.9|12.9|||
3814681|NCT01764841|3640160|B3|||Age||Years|Mean|64|64.0|Standard Deviation|13.5|13.5|||
3814682|NCT01764841|3640161|B2|||Age||Years|Mean|65.2|65.2|Standard Deviation|13.5|13.5|||
3814683|NCT01764841|3640162|B1|||Age||Years|Mean|64.2|64.2|Standard Deviation|12.1|12.1|||
3814684|NCT01764685|3640197|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3814685|NCT01764685|3640198|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3814686|NCT01764685|3640197|B3|Male||Gender||participants|Number|4|4.0||||||
3814687|NCT01764685|3640198|B2|Male||Gender||participants|Number|4|4.0||||||
3814688|NCT01764685|3640197|B3|Female||Gender||participants|Number|0|0.0||||||
3814689|NCT01764685|3640198|B2|Female||Gender||participants|Number|0|0.0||||||
3814690|NCT01764685|3640197|B3|||Age||years|Mean|50|50.0|Full Range|||35.0|63.0|
3814691|NCT01764685|3640198|B2|||Age||years|Mean|50|50.0|Full Range|||35.0|63.0|
3814692|NCT01764685|3640197|B3|>=65 years||Age||participants|Number|0|0.0||||||
3814693|NCT01764685|3640198|B2|>=65 years||Age||participants|Number|0|0.0||||||
3814694|NCT01764685|3640197|B3|Between 18 and 65 years||Age||participants|Number|4|4.0||||||
3814695|NCT01764685|3640198|B2|Between 18 and 65 years||Age||participants|Number|4|4.0||||||
3814696|NCT01764685|3640197|B3|<=18 years||Age||participants|Number|0|0.0||||||
3814697|NCT01764685|3640198|B2|<=18 years||Age||participants|Number|0|0.0||||||
3814698|NCT01764633|3640206|B3||Asia Pacific|Geographical Region||Participants|Count of Participants|3835|3835.0||||||
3814699|NCT01764633|3640207|B2||Asia Pacific|Geographical Region||Participants|Count of Participants|1918|1918.0||||||
3814700|NCT01764633|3640208|B1||Asia Pacific|Geographical Region||Participants|Count of Participants|1917|1917.0||||||
3814701|NCT01764633|3640206|B3||Latin America|Geographical Region||Participants|Count of Participants|1823|1823.0||||||
3814702|NCT01764633|3640207|B2||Latin America|Geographical Region||Participants|Count of Participants|913|913.0||||||
3814703|NCT01764633|3640208|B1||Latin America|Geographical Region||Participants|Count of Participants|910|910.0||||||
3814704|NCT01764633|3640206|B3||North America|Geographical Region||Participants|Count of Participants|4570|4570.0||||||
3814705|NCT01764633|3640207|B2||North America|Geographical Region||Participants|Count of Participants|2286|2286.0||||||
3814706|NCT01764633|3640208|B1||North America|Geographical Region||Participants|Count of Participants|2284|2284.0||||||
3814707|NCT01764633|3640206|B3||Europe|Geographical Region||Participants|Count of Participants|17336|17336.0||||||
3814708|NCT01764633|3640207|B2||Europe|Geographical Region||Participants|Count of Participants|8667|8667.0||||||
3814709|NCT01764633|3640208|B1||Europe|Geographical Region||Participants|Count of Participants|8669|8669.0||||||
3814710|NCT01764633|3640206|B3||≥ 85 mg/dL|Low-density Lipoprotein Cholesterol||Participants|Count of Participants|17952|17952.0||||||
3814711|NCT01764633|3640207|B2||≥ 85 mg/dL|Low-density Lipoprotein Cholesterol||Participants|Count of Participants|8975|8975.0||||||
3814712|NCT01764633|3640208|B1||≥ 85 mg/dL|Low-density Lipoprotein Cholesterol||Participants|Count of Participants|8977|8977.0||||||
3814713|NCT01764633|3640206|B3||< 85 mg/dL|Low-density Lipoprotein Cholesterol||Participants|Count of Participants|9612|9612.0||||||
3814714|NCT01764633|3640207|B2||< 85 mg/dL|Low-density Lipoprotein Cholesterol||Participants|Count of Participants|4809|4809.0||||||
3814715|NCT01764633|3640208|B1||< 85 mg/dL|Low-density Lipoprotein Cholesterol||Participants|Count of Participants|4803|4803.0||||||
3814716|NCT01764633|3640206|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|517|517.0||||||
3814717|NCT01764633|3640207|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|251|251.0||||||
3814718|NCT01764633|3640208|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|266|266.0||||||
3814719|NCT01764633|3640206|B3||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3814720|NCT01764633|3640207|B2||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3814721|NCT01764633|3640208|B1||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3814722|NCT01764633|3640206|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|23458|23458.0||||||
3814723|NCT01764633|3640207|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|11748|11748.0||||||
3814724|NCT01764633|3640208|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|11710|11710.0||||||
3814725|NCT01764633|3640206|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3814726|NCT01764633|3640207|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3814727|NCT01764633|3640208|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3814728|NCT01764633|3640206|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|669|669.0||||||
3814729|NCT01764633|3640207|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|317|317.0||||||
3814730|NCT01764633|3640208|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|352|352.0||||||
3814731|NCT01764633|3640206|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2723|2723.0||||||
3814732|NCT01764633|3640207|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1374|1374.0||||||
3814733|NCT01764633|3640208|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1349|1349.0||||||
3814734|NCT01764633|3640206|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|140|140.0||||||
3814735|NCT01764633|3640207|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|60|60.0||||||
3814736|NCT01764633|3640208|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|80|80.0||||||
3814737|NCT01764633|3640206|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3814738|NCT01764633|3640207|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3814739|NCT01764633|3640208|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3814740|NCT01764633|3640206|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25382|25382.0||||||
3814741|NCT01764633|3640207|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12688|12688.0||||||
3814742|NCT01764633|3640208|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12694|12694.0||||||
3814743|NCT01764633|3640206|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2177|2177.0||||||
3814744|NCT01764633|3640207|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1093|1093.0||||||
3814745|NCT01764633|3640208|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1084|1084.0||||||
3814746|NCT01764633|3640206|B3||Male|Sex: Female, Male||Participants|Count of Participants|20795|20795.0||||||
3814747|NCT01764633|3640207|B2||Male|Sex: Female, Male||Participants|Count of Participants|10397|10397.0||||||
3814748|NCT01764633|3640208|B1||Male|Sex: Female, Male||Participants|Count of Participants|10398|10398.0||||||
3814749|NCT01764633|3640206|B3||Female|Sex: Female, Male||Participants|Count of Participants|6769|6769.0||||||
3814750|NCT01764633|3640207|B2||Female|Sex: Female, Male||Participants|Count of Participants|3387|3387.0||||||
3814751|NCT01764633|3640208|B1||Female|Sex: Female, Male||Participants|Count of Participants|3382|3382.0||||||
3814752|NCT01764633|3640206|B3||≥ 65 years|Age, Customized||Participants|Count of Participants|12254|12254.0||||||
3814753|NCT01764633|3640207|B2||≥ 65 years|Age, Customized||Participants|Count of Participants|6161|6161.0||||||
3814754|NCT01764633|3640208|B1||≥ 65 years|Age, Customized||Participants|Count of Participants|6093|6093.0||||||
3814755|NCT01764633|3640206|B3||< 65 years|Age, Customized||Participants|Count of Participants|15310|15310.0||||||
3814756|NCT01764633|3640207|B2||< 65 years|Age, Customized||Participants|Count of Participants|7623|7623.0||||||
3814757|NCT01764633|3640208|B1||< 65 years|Age, Customized||Participants|Count of Participants|7687|7687.0||||||
3814758|NCT01764633|3640206|B3|||Age||years|Mean|62.5|62.5|Standard Deviation|9.0|9.0|||
3814759|NCT01764633|3640207|B2|||Age||years|Mean|62.5|62.5|Standard Deviation|9.1|9.1|||
3814760|NCT01764633|3640208|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|8.9|8.9|||
3814761|NCT01764607|3640231|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3814762|NCT01764607|3640231|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3814763|NCT01764607|3640231|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3814764|NCT01764607|3640231|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3814765|NCT01764607|3640231|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3814766|NCT01764607|3640231|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3814767|NCT01764386|3640236|B3|||Baseline BMI||kg/m^2|Mean|36.31|36.31|Standard Deviation|4.254|4.254|||
3814768|NCT01764386|3640237|B2|||Baseline BMI||kg/m^2|Mean|36.26|36.26|Standard Deviation|4.369|4.369|||
3814769|NCT01764386|3640238|B1|||Baseline BMI||kg/m^2|Mean|36.33|36.33|Standard Deviation|4.200|4.2|||
3814770|NCT01764386|3640236|B3|||Weight||kg|Mean|100.9|100.9|Standard Deviation|15.63|15.63|||
3814771|NCT01764386|3640237|B2|||Weight||kg|Mean|100.2|100.2|Standard Deviation|16.58|16.58|||
3814772|NCT01764386|3640238|B1|||Weight||kg|Mean|101.4|101.4|Standard Deviation|15.09|15.09|||
3814773|NCT01764386|3640236|B3|United States||Region of Enrollment||participants|Number|242|242.0||||||
3814774|NCT01764386|3640237|B2|United States||Region of Enrollment||participants|Number|89|89.0||||||
3814775|NCT01764386|3640238|B1|United States||Region of Enrollment||participants|Number|153|153.0||||||
3814776|NCT01764386|3640236|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814777|NCT01764386|3640237|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814778|NCT01764386|3640238|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814779|NCT01764386|3640236|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814780|NCT01764386|3640237|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814781|NCT01764386|3640238|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814782|NCT01764386|3640236|B3||White|Race (NIH/OMB)||Participants|Count of Participants|188|188.0||||||
3814783|NCT01764386|3640237|B2||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3814784|NCT01764386|3640238|B1||White|Race (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
3814785|NCT01764386|3640236|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3814786|NCT01764386|3640237|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3814787|NCT01764386|3640238|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3814788|NCT01764386|3640236|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814789|NCT01764386|3640237|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814790|NCT01764386|3640238|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814791|NCT01764386|3640236|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3814792|NCT01764386|3640237|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814793|NCT01764386|3640238|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3814794|NCT01764386|3640236|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3814795|NCT01764386|3640237|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3814796|NCT01764386|3640238|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814797|NCT01764386|3640236|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814798|NCT01764386|3640237|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814799|NCT01764386|3640238|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3814800|NCT01764386|3640236|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|233|233.0||||||
3814801|NCT01764386|3640237|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3814802|NCT01764386|3640238|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|149|149.0||||||
3814803|NCT01764386|3640236|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3814804|NCT01764386|3640237|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3814805|NCT01764386|3640238|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3814806|NCT01764386|3640236|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3814807|NCT01764386|3640237|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3814808|NCT01764386|3640238|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3814809|NCT01764386|3640236|B3||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3814810|NCT01764386|3640237|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3814811|NCT01764386|3640238|B1||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3814812|NCT01764386|3640236|B3|||Age||years|Mean|46.5|46.5|Standard Deviation|9.77|9.77|||
3814813|NCT01764386|3640237|B2|||Age||years|Mean|47.0|47.0|Standard Deviation|9.98|9.98|||
3814814|NCT01764386|3640238|B1|||Age||years|Mean|46.1|46.1|Standard Deviation|9.66|9.66|||
3814815|NCT01764022|3640280|B3|Unknown histilogic type||Histologic type of cancer||Participants|Count of Participants|27|27.0||||||
3814816|NCT01764022|3640281|B2|Unknown histilogic type||Histologic type of cancer||Participants|Count of Participants|13|13.0||||||
3814817|NCT01764022|3640282|B1|Unknown histilogic type||Histologic type of cancer||Participants|Count of Participants|14|14.0||||||
3814818|NCT01764022|3640280|B3|Micropapillary||Histologic type of cancer||Participants|Count of Participants|1|1.0||||||
3814819|NCT01764022|3640281|B2|Micropapillary||Histologic type of cancer||Participants|Count of Participants|0|0.0||||||
3814820|NCT01764022|3640282|B1|Micropapillary||Histologic type of cancer||Participants|Count of Participants|1|1.0||||||
3814821|NCT01764022|3640280|B3|Mucinouse||Histologic type of cancer||Participants|Count of Participants|8|8.0||||||
3814822|NCT01764022|3640281|B2|Mucinouse||Histologic type of cancer||Participants|Count of Participants|5|5.0||||||
3814823|NCT01764022|3640282|B1|Mucinouse||Histologic type of cancer||Participants|Count of Participants|3|3.0||||||
3814824|NCT01764022|3640280|B3|Tubular||Histologic type of cancer||Participants|Count of Participants|72|72.0||||||
3814825|NCT01764022|3640281|B2|Tubular||Histologic type of cancer||Participants|Count of Participants|37|37.0||||||
3814826|NCT01764022|3640282|B1|Tubular||Histologic type of cancer||Participants|Count of Participants|35|35.0||||||
3814827|NCT01764022|3640280|B3|Lobular||Histologic type of cancer||Participants|Count of Participants|41|41.0||||||
3814828|NCT01764022|3640281|B2|Lobular||Histologic type of cancer||Participants|Count of Participants|18|18.0||||||
3814829|NCT01764022|3640282|B1|Lobular||Histologic type of cancer||Participants|Count of Participants|23|23.0||||||
3814830|NCT01764022|3640280|B3|Medullar||Histologic type of cancer||Participants|Count of Participants|7|7.0||||||
3814831|NCT01764022|3640281|B2|Medullar||Histologic type of cancer||Participants|Count of Participants|4|4.0||||||
3814832|NCT01764022|3640282|B1|Medullar||Histologic type of cancer||Participants|Count of Participants|3|3.0||||||
3814833|NCT01764022|3640280|B3|Ductal||Histologic type of cancer||Participants|Count of Participants|69|69.0||||||
3814834|NCT01764022|3640281|B2|Ductal||Histologic type of cancer||Participants|Count of Participants|33|33.0||||||
3814835|NCT01764022|3640282|B1|Ductal||Histologic type of cancer||Participants|Count of Participants|36|36.0||||||
3814836|NCT01764022|3640280|B3|Unknown||HER2 Expression||Participants|Count of Participants|1|1.0||||||
3814837|NCT01764022|3640281|B2|Unknown||HER2 Expression||Participants|Count of Participants|0|0.0||||||
3814838|NCT01764022|3640282|B1|Unknown||HER2 Expression||Participants|Count of Participants|1|1.0||||||
3814839|NCT01764022|3640280|B3|HER2 ++||HER2 Expression||Participants|Count of Participants|27|27.0||||||
3814840|NCT01764022|3640281|B2|HER2 ++||HER2 Expression||Participants|Count of Participants|13|13.0||||||
3814841|NCT01764022|3640282|B1|HER2 ++||HER2 Expression||Participants|Count of Participants|14|14.0||||||
3814842|NCT01764022|3640280|B3|HER2 +++||HER2 Expression||Participants|Count of Participants|197|197.0||||||
3814843|NCT01764022|3640281|B2|HER2 +++||HER2 Expression||Participants|Count of Participants|97|97.0||||||
3814844|NCT01764022|3640282|B1|HER2 +++||HER2 Expression||Participants|Count of Participants|100|100.0||||||
3814845|NCT01764022|3640280|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3814846|NCT01764022|3640281|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3814847|NCT01764022|3640282|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3814848|NCT01764022|3640280|B3||Female|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
3814849|NCT01764022|3640281|B2||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3814850|NCT01764022|3640282|B1||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3814851|NCT01764022|3640280|B3|||Age||years|Mean|50.63|50.63|Standard Deviation|10.415|10.415|||
3814852|NCT01764022|3640281|B2|||Age||years|Mean|50.573|50.573|Standard Deviation|9.877|9.877|||
3814853|NCT01764022|3640282|B1|||Age||years|Mean|50.687|50.687|Standard Deviation|10.948|10.948|||
3814854|NCT01763996|3640315|B1|||Left Ventricular Ejection Fraction||percent|Mean|56.8|56.8|Standard Deviation|9.24|9.24|||
3814855|NCT01763996|3640315|B1|||Body Mass Index (BMI)||kg/m^2|Mean|28.3|28.3|Standard Deviation|4.12|4.12|||
3814856|NCT01763996|3640315|B1|||Weight||kg|Mean|87.8|87.8|Standard Deviation|16|16.0|||
3814857|NCT01763996|3640315|B1|||Height||cm|Mean|176|176.0|Standard Deviation|7.7|7.7|||
3814858|NCT01763996|3640315|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3814859|NCT01763996|3640315|B1|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3814860|NCT01763996|3640315|B1|African-American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3814861|NCT01763996|3640315|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3814862|NCT01763996|3640315|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3814863|NCT01763996|3640315|B1|||Age||years|Mean|59|59.0|Standard Deviation|7.7|7.7|||
3814864|NCT01763918|3640342|B5|||HDL-C Concentration|Data are provided for the full analysis set|mg/dL|Mean|51.1|51.1|Standard Deviation|15.6|15.6|||
3814865|NCT01763918|3640343|B4|||HDL-C Concentration|Data are provided for the full analysis set|mg/dL|Mean|51.9|51.9|Standard Deviation|16.0|16.0|||
3814866|NCT01763918|3640344|B3|||HDL-C Concentration|Data are provided for the full analysis set|mg/dL|Mean|50.4|50.4|Standard Deviation|16.1|16.1|||
3814867|NCT01763918|3640345|B2|||HDL-C Concentration|Data are provided for the full analysis set|mg/dL|Mean|49.1|49.1|Standard Deviation|12.7|12.7|||
3814868|NCT01763918|3640346|B1|||HDL-C Concentration|Data are provided for the full analysis set|mg/dL|Mean|53.2|53.2|Standard Deviation|16.5|16.5|||
3814869|NCT01763918|3640342|B5|||Very Low-Density Lipoprotein Cholesterol (VLDL-C) Concentration|Data are provided for the full analysis set|mg/dL|Mean|24.8|24.8|Standard Deviation|11.4|11.4|||
3814870|NCT01763918|3640343|B4|||Very Low-Density Lipoprotein Cholesterol (VLDL-C) Concentration|Data are provided for the full analysis set|mg/dL|Mean|24.9|24.9|Standard Deviation|11.7|11.7|||
3814871|NCT01763918|3640344|B3|||Very Low-Density Lipoprotein Cholesterol (VLDL-C) Concentration|Data are provided for the full analysis set|mg/dL|Mean|25.9|25.9|Standard Deviation|11.8|11.8|||
3814872|NCT01763918|3640345|B2|||Very Low-Density Lipoprotein Cholesterol (VLDL-C) Concentration|Data are provided for the full analysis set|mg/dL|Mean|23.9|23.9|Standard Deviation|10.5|10.5|||
3814873|NCT01763918|3640346|B1|||Very Low-Density Lipoprotein Cholesterol (VLDL-C) Concentration|Data are provided for the full analysis set|mg/dL|Mean|23.1|23.1|Standard Deviation|10.7|10.7|||
3814874|NCT01763918|3640342|B5|||Triglyceride Concentration|Data are provided for the full analysis set|mg/dL|Median|110.0|110.0|Inter-Quartile Range|||81.5|154.0|
3814875|NCT01763918|3640343|B4|||Triglyceride Concentration|Data are provided for the full analysis set|mg/dL|Median|112.5|112.5|Inter-Quartile Range|||84.5|156.5|
3814876|NCT01763918|3640344|B3|||Triglyceride Concentration|Data are provided for the full analysis set|mg/dL|Median|118.5|118.5|Inter-Quartile Range|||86.5|160.5|
3814877|NCT01763918|3640345|B2|||Triglyceride Concentration|Data are provided for the full analysis set|mg/dL|Median|102.0|102.0|Inter-Quartile Range|||79.0|151.0|
3814878|NCT01763918|3640346|B1|||Triglyceride Concentration|Data are provided for the full analysis set|mg/dL|Median|95.8|95.8|Inter-Quartile Range|||74.5|143.0|
3814879|NCT01763918|3640342|B5|||Lipoprotein(a) Concentration|Data are provided for the full analysis set|nmol/L|Median|65.0|65.0|Inter-Quartile Range|||25.0|199.0|
3814880|NCT01763918|3640343|B4|||Lipoprotein(a) Concentration|Data are provided for the full analysis set|nmol/L|Median|61.0|61.0|Inter-Quartile Range|||17.0|194.0|
3814881|NCT01763918|3640344|B3|||Lipoprotein(a) Concentration|Data are provided for the full analysis set|nmol/L|Median|77.5|77.5|Inter-Quartile Range|||29.0|205.5|
3814882|NCT01763918|3640345|B2|||Lipoprotein(a) Concentration|Data are provided for the full analysis set|nmol/L|Median|87.0|87.0|Inter-Quartile Range|||36.0|219.0|
3814883|NCT01763918|3640346|B1|||Lipoprotein(a) Concentration|Data are provided for the full analysis set|nmol/L|Median|44.0|44.0|Inter-Quartile Range|||24.0|105.0|
3814884|NCT01763918|3640342|B5|||Apolipoprotein B/Apolipoprotein A1 Ratio|Data are provided for the full analysis set|ratio|Mean|0.857|0.857|Standard Deviation|0.305|0.305|||
3814885|NCT01763918|3640343|B4|||Apolipoprotein B/Apolipoprotein A1 Ratio|Data are provided for the full analysis set|ratio|Mean|0.850|0.85|Standard Deviation|0.331|0.331|||
3814886|NCT01763918|3640344|B3|||Apolipoprotein B/Apolipoprotein A1 Ratio|Data are provided for the full analysis set|ratio|Mean|0.888|0.888|Standard Deviation|0.322|0.322|||
3814887|NCT01763918|3640345|B2|||Apolipoprotein B/Apolipoprotein A1 Ratio|Data are provided for the full analysis set|ratio|Mean|0.851|0.851|Standard Deviation|0.249|0.249|||
3814888|NCT01763918|3640346|B1|||Apolipoprotein B/Apolipoprotein A1 Ratio|Data are provided for the full analysis set|ratio|Mean|0.815|0.815|Standard Deviation|0.264|0.264|||
3814889|NCT01763918|3640342|B5|||Total cholesterol/HDL-C Ratio|Data are provided for the full analysis set|ratio|Mean|4.924|4.924|Standard Deviation|1.845|1.845|||
3814890|NCT01763918|3640343|B4|||Total cholesterol/HDL-C Ratio|Data are provided for the full analysis set|ratio|Mean|4.842|4.842|Standard Deviation|1.801|1.801|||
3814891|NCT01763918|3640344|B3|||Total cholesterol/HDL-C Ratio|Data are provided for the full analysis set|ratio|Mean|5.159|5.159|Standard Deviation|2.031|2.031|||
3814892|NCT01763918|3640345|B2|||Total cholesterol/HDL-C Ratio|Data are provided for the full analysis set|ratio|Mean|4.844|4.844|Standard Deviation|1.435|1.435|||
3814893|NCT01763918|3640346|B1|||Total cholesterol/HDL-C Ratio|Data are provided for the full analysis set|ratio|Mean|4.695|4.695|Standard Deviation|1.905|1.905|||
3814894|NCT01763918|3640342|B5|||Apolipoprotein B Concentration|Data are provided for the full analysis set|mg/dL|Mean|115.4|115.4|Standard Deviation|27.5|27.5|||
3814895|NCT01763918|3640343|B4|||Apolipoprotein B Concentration|Data are provided for the full analysis set|mg/dL|Mean|114.9|114.9|Standard Deviation|25.5|25.5|||
3814896|NCT01763918|3640344|B3|||Apolipoprotein B Concentration|Data are provided for the full analysis set|mg/dL|Mean|119.0|119.0|Standard Deviation|30.7|30.7|||
3814945|NCT01763918|3640343|B4|White||Race/Ethnicity, Customized||participants|Number|98|98.0||||||
3814897|NCT01763918|3640345|B2|||Apolipoprotein B Concentration|Data are provided for the full analysis set|mg/dL|Mean|110.3|110.3|Standard Deviation|21.7|21.7|||
3814898|NCT01763918|3640346|B1|||Apolipoprotein B Concentration|Data are provided for the full analysis set|mg/dL|Mean|114.3|114.3|Standard Deviation|29.8|29.8|||
3814899|NCT01763918|3640342|B5|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration|Data are provided for the full analysis set|mg/dL|Mean|180.4|180.4|Standard Deviation|49.5|49.5|||
3814900|NCT01763918|3640343|B4|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration|Data are provided for the full analysis set|mg/dL|Mean|178.5|178.5|Standard Deviation|45.8|45.8|||
3814901|NCT01763918|3640344|B3|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration|Data are provided for the full analysis set|mg/dL|Mean|187.4|187.4|Standard Deviation|56.7|56.7|||
3814902|NCT01763918|3640345|B2|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration|Data are provided for the full analysis set|mg/dL|Mean|175.4|175.4|Standard Deviation|45.9|45.9|||
3814903|NCT01763918|3640346|B1|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration|Data are provided for the full analysis set|mg/dL|Mean|175.4|175.4|Standard Deviation|43.9|43.9|||
3814904|NCT01763918|3640342|B5|||LDL-C Concentration|"Data are provided for the full analysis set (all randomized participants who received at least~1 dose of investigational product)"|mg/dL|Mean|155.5|155.5|Standard Deviation|44.9|44.9|||
3814905|NCT01763918|3640343|B4|||LDL-C Concentration|"Data are provided for the full analysis set (all randomized participants who received at least~1 dose of investigational product)"|mg/dL|Mean|153.6|153.6|Standard Deviation|43.3|43.3|||
3814906|NCT01763918|3640344|B3|||LDL-C Concentration|"Data are provided for the full analysis set (all randomized participants who received at least~1 dose of investigational product)"|mg/dL|Mean|161.4|161.4|Standard Deviation|51.0|51.0|||
3814907|NCT01763918|3640345|B2|||LDL-C Concentration|"Data are provided for the full analysis set (all randomized participants who received at least~1 dose of investigational product)"|mg/dL|Mean|151.5|151.5|Standard Deviation|42.5|42.5|||
3814908|NCT01763918|3640346|B1|||LDL-C Concentration|"Data are provided for the full analysis set (all randomized participants who received at least~1 dose of investigational product)"|mg/dL|Mean|151.1|151.1|Standard Deviation|36.5|36.5|||
3814909|NCT01763918|3640342|B5|Yes||Baseline Ezetimibe Use||participants|Number|202|202.0||||||
3814910|NCT01763918|3640343|B4|Yes||Baseline Ezetimibe Use||participants|Number|67|67.0||||||
3814911|NCT01763918|3640344|B3|Yes||Baseline Ezetimibe Use||participants|Number|68|68.0||||||
3814912|NCT01763918|3640345|B2|Yes||Baseline Ezetimibe Use||participants|Number|34|34.0||||||
3814913|NCT01763918|3640346|B1|Yes||Baseline Ezetimibe Use||participants|Number|33|33.0||||||
3814914|NCT01763918|3640342|B5|No||Baseline Ezetimibe Use||participants|Number|129|129.0||||||
3814915|NCT01763918|3640343|B4|No||Baseline Ezetimibe Use||participants|Number|43|43.0||||||
3814916|NCT01763918|3640344|B3|No||Baseline Ezetimibe Use||participants|Number|43|43.0||||||
3814917|NCT01763918|3640345|B2|No||Baseline Ezetimibe Use||participants|Number|21|21.0||||||
3814918|NCT01763918|3640346|B1|No||Baseline Ezetimibe Use||participants|Number|22|22.0||||||
3814919|NCT01763918|3640342|B5|≥ 160 mg/dL||Stratification Factor: Low-Density Lipoprotein Cholesterol (LDL-C) Level||participants|Number|121|121.0||||||
3814920|NCT01763918|3640343|B4|≥ 160 mg/dL||Stratification Factor: Low-Density Lipoprotein Cholesterol (LDL-C) Level||participants|Number|40|40.0||||||
3814921|NCT01763918|3640344|B3|≥ 160 mg/dL||Stratification Factor: Low-Density Lipoprotein Cholesterol (LDL-C) Level||participants|Number|41|41.0||||||
3814922|NCT01763918|3640345|B2|≥ 160 mg/dL||Stratification Factor: Low-Density Lipoprotein Cholesterol (LDL-C) Level||participants|Number|20|20.0||||||
3814923|NCT01763918|3640346|B1|≥ 160 mg/dL||Stratification Factor: Low-Density Lipoprotein Cholesterol (LDL-C) Level||participants|Number|20|20.0||||||
3814924|NCT01763918|3640342|B5|< 160 mg/dL||Stratification Factor: Low-Density Lipoprotein Cholesterol (LDL-C) Level||participants|Number|210|210.0||||||
3814925|NCT01763918|3640343|B4|< 160 mg/dL||Stratification Factor: Low-Density Lipoprotein Cholesterol (LDL-C) Level||participants|Number|70|70.0||||||
3814926|NCT01763918|3640344|B3|< 160 mg/dL||Stratification Factor: Low-Density Lipoprotein Cholesterol (LDL-C) Level||participants|Number|70|70.0||||||
3814927|NCT01763918|3640345|B2|< 160 mg/dL||Stratification Factor: Low-Density Lipoprotein Cholesterol (LDL-C) Level||participants|Number|35|35.0||||||
3814928|NCT01763918|3640346|B1|< 160 mg/dL||Stratification Factor: Low-Density Lipoprotein Cholesterol (LDL-C) Level||participants|Number|35|35.0||||||
3814929|NCT01763918|3640342|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|329|329.0||||||
3814930|NCT01763918|3640343|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|109|109.0||||||
3814931|NCT01763918|3640344|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|111|111.0||||||
3814932|NCT01763918|3640345|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
3814933|NCT01763918|3640346|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
3814934|NCT01763918|3640342|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3814935|NCT01763918|3640343|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3814936|NCT01763918|3640344|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3814937|NCT01763918|3640345|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3814938|NCT01763918|3640346|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3814939|NCT01763918|3640342|B5|Other||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3814940|NCT01763918|3640343|B4|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3814941|NCT01763918|3640344|B3|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3814942|NCT01763918|3640345|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3814943|NCT01763918|3640346|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3814944|NCT01763918|3640342|B5|White||Race/Ethnicity, Customized||participants|Number|298|298.0||||||
3814946|NCT01763918|3640344|B3|White||Race/Ethnicity, Customized||participants|Number|100|100.0||||||
3814947|NCT01763918|3640345|B2|White||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
3814948|NCT01763918|3640346|B1|White||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
3814949|NCT01763918|3640342|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3814950|NCT01763918|3640343|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3814951|NCT01763918|3640344|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3814952|NCT01763918|3640345|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3814953|NCT01763918|3640346|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3814954|NCT01763918|3640342|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3814955|NCT01763918|3640343|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3814956|NCT01763918|3640344|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3814957|NCT01763918|3640345|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3814958|NCT01763918|3640346|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3814959|NCT01763918|3640342|B5|Asian||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3814960|NCT01763918|3640343|B4|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3814961|NCT01763918|3640344|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3814962|NCT01763918|3640345|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3814963|NCT01763918|3640346|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3814964|NCT01763918|3640342|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3814965|NCT01763918|3640343|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3814966|NCT01763918|3640344|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3814967|NCT01763918|3640345|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3814968|NCT01763918|3640346|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3814969|NCT01763918|3640342|B5||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
3814970|NCT01763918|3640343|B4||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3814971|NCT01763918|3640344|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3814972|NCT01763918|3640345|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3814973|NCT01763918|3640346|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3814974|NCT01763918|3640342|B5||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3814975|NCT01763918|3640343|B4||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3814976|NCT01763918|3640344|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3814977|NCT01763918|3640345|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3814978|NCT01763918|3640346|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3814979|NCT01763918|3640342|B5|||Age||years|Mean|51.1|51.1|Standard Deviation|12.7|12.7|||
3814980|NCT01763918|3640343|B4|||Age||years|Mean|51.9|51.9|Standard Deviation|12.0|12.0|||
3814981|NCT01763918|3640344|B3|||Age||years|Mean|52.3|52.3|Standard Deviation|12.6|12.6|||
3814982|NCT01763918|3640345|B2|||Age||years|Mean|46.8|46.8|Standard Deviation|12.1|12.1|||
3814983|NCT01763918|3640346|B1|||Age||years|Mean|51.1|51.1|Standard Deviation|14.1|14.1|||
3814984|NCT01763905|3640443|B5|||High-Density Lipoprotein Cholesterol (HDL-C)||mg/dL|Mean|51.8|51.8|Standard Deviation|15.9|15.9|||
3814985|NCT01763905|3640444|B4|||High-Density Lipoprotein Cholesterol (HDL-C)||mg/dL|Mean|54.0|54.0|Standard Deviation|16.0|16.0|||
3814986|NCT01763905|3640445|B3|||High-Density Lipoprotein Cholesterol (HDL-C)||mg/dL|Mean|51.1|51.1|Standard Deviation|16.4|16.4|||
3814987|NCT01763905|3640446|B2|||High-Density Lipoprotein Cholesterol (HDL-C)||mg/dL|Mean|48.0|48.0|Standard Deviation|11.0|11.0|||
3814988|NCT01763905|3640447|B1|||High-Density Lipoprotein Cholesterol (HDL-C)||mg/dL|Mean|52.4|52.4|Standard Deviation|18.3|18.3|||
3814989|NCT01763905|3640443|B5|||Very Low-density Lipoprotein Cholesterol (VLDL-C) Concentration||mg/dL|Mean|34.0|34.0|Standard Deviation|14.6|14.6|||
3814990|NCT01763905|3640444|B4|||Very Low-density Lipoprotein Cholesterol (VLDL-C) Concentration||mg/dL|Mean|29.9|29.9|Standard Deviation|12.6|12.6|||
3814991|NCT01763905|3640445|B3|||Very Low-density Lipoprotein Cholesterol (VLDL-C) Concentration||mg/dL|Mean|35.2|35.2|Standard Deviation|14.5|14.5|||
3814992|NCT01763905|3640446|B2|||Very Low-density Lipoprotein Cholesterol (VLDL-C) Concentration||mg/dL|Mean|37.1|37.1|Standard Deviation|15.8|15.8|||
3814993|NCT01763905|3640447|B1|||Very Low-density Lipoprotein Cholesterol (VLDL-C) Concentration||mg/dL|Mean|36.7|36.7|Standard Deviation|16.0|16.0|||
3814994|NCT01763905|3640443|B5|||Triglyceride Concentration||mg/dL|Mean|171.5|171.5|Standard Deviation|76.3|76.3|||
3814995|NCT01763905|3640444|B4|||Triglyceride Concentration||mg/dL|Mean|149.3|149.3|Standard Deviation|63.1|63.1|||
3814996|NCT01763905|3640445|B3|||Triglyceride Concentration||mg/dL|Mean|179.8|179.8|Standard Deviation|80.0|80.0|||
3814997|NCT01763905|3640446|B2|||Triglyceride Concentration||mg/dL|Mean|187.0|187.0|Standard Deviation|81.5|81.5|||
3814998|NCT01763905|3640447|B1|||Triglyceride Concentration||mg/dL|Mean|183.4|183.4|Standard Deviation|79.8|79.8|||
3814999|NCT01763905|3640443|B5|||Lipoprotein(a) Concentration||nmol/L|Mean|76.2|76.2|Standard Deviation|91.9|91.9|||
3815000|NCT01763905|3640444|B4|||Lipoprotein(a) Concentration||nmol/L|Mean|70.9|70.9|Standard Deviation|99.9|99.9|||
3815001|NCT01763905|3640445|B3|||Lipoprotein(a) Concentration||nmol/L|Mean|66.2|66.2|Standard Deviation|72.5|72.5|||
3815002|NCT01763905|3640446|B2|||Lipoprotein(a) Concentration||nmol/L|Mean|76.6|76.6|Standard Deviation|96.7|96.7|||
3815003|NCT01763905|3640447|B1|||Lipoprotein(a) Concentration||nmol/L|Mean|106.3|106.3|Standard Deviation|101.0|101.0|||
3815004|NCT01763905|3640443|B5|||Apolipoprotein B/Apolipoprotein A1 Ratio||ratio|Mean|0.952|0.952|Standard Deviation|0.298|0.298|||
3815005|NCT01763905|3640444|B4|||Apolipoprotein B/Apolipoprotein A1 Ratio||ratio|Mean|0.901|0.901|Standard Deviation|0.283|0.283|||
3815006|NCT01763905|3640445|B3|||Apolipoprotein B/Apolipoprotein A1 Ratio||ratio|Mean|0.980|0.98|Standard Deviation|0.318|0.318|||
3815007|NCT01763905|3640446|B2|||Apolipoprotein B/Apolipoprotein A1 Ratio||ratio|Mean|1.005|1.005|Standard Deviation|0.294|0.294|||
3815008|NCT01763905|3640447|B1|||Apolipoprotein B/Apolipoprotein A1 Ratio||ratio|Mean|0.943|0.943|Standard Deviation|0.282|0.282|||
3815009|NCT01763905|3640443|B5|||Total Cholesterol/High-Density Lipoprotein Cholesterol Ratio||ratio|Mean|5.827|5.827|Standard Deviation|1.956|1.956|||
3815010|NCT01763905|3640444|B4|||Total Cholesterol/High-Density Lipoprotein Cholesterol Ratio||ratio|Mean|5.506|5.506|Standard Deviation|1.925|1.925|||
3815011|NCT01763905|3640445|B3|||Total Cholesterol/High-Density Lipoprotein Cholesterol Ratio||ratio|Mean|5.912|5.912|Standard Deviation|1.929|1.929|||
3815012|NCT01763905|3640446|B2|||Total Cholesterol/High-Density Lipoprotein Cholesterol Ratio||ratio|Mean|6.137|6.137|Standard Deviation|1.787|1.787|||
3815013|NCT01763905|3640447|B1|||Total Cholesterol/High-Density Lipoprotein Cholesterol Ratio||ratio|Mean|5.989|5.989|Standard Deviation|2.190|2.19|||
3815014|NCT01763905|3640443|B5|||Apolipoprotein B Concentration||mg/dL|Mean|137.8|137.8|Standard Deviation|32.8|32.8|||
3815015|NCT01763905|3640444|B4|||Apolipoprotein B Concentration||mg/dL|Mean|133.1|133.1|Standard Deviation|32.2|32.2|||
3815016|NCT01763905|3640445|B3|||Apolipoprotein B Concentration||mg/dL|Mean|140.2|140.2|Standard Deviation|32.1|32.1|||
3815017|NCT01763905|3640446|B2|||Apolipoprotein B Concentration||mg/dL|Mean|140.0|140.0|Standard Deviation|31.1|31.1|||
3815018|NCT01763905|3640447|B1|||Apolipoprotein B Concentration||mg/dL|Mean|140.0|140.0|Standard Deviation|37.0|37.0|||
3815019|NCT01763905|3640443|B5|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|227.4|227.4|Standard Deviation|60.4|60.4|||
3815020|NCT01763905|3640444|B4|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|222.1|222.1|Standard Deviation|63.2|63.2|||
3815021|NCT01763905|3640445|B3|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|227.9|227.9|Standard Deviation|56.6|56.6|||
3815022|NCT01763905|3640446|B2|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|232.9|232.9|Standard Deviation|57.0|57.0|||
3815023|NCT01763905|3640447|B1|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|231.4|231.4|Standard Deviation|66.0|66.0|||
3815024|NCT01763905|3640443|B5|||LDL-C Concentration||mg/dL|Mean|193.1|193.1|Standard Deviation|58.5|58.5|||
3815025|NCT01763905|3640444|B4|||LDL-C Concentration||mg/dL|Mean|192.2|192.2|Standard Deviation|61.2|61.2|||
3815026|NCT01763905|3640445|B3|||LDL-C Concentration||mg/dL|Mean|192.0|192.0|Standard Deviation|57.0|57.0|||
3815027|NCT01763905|3640446|B2|||LDL-C Concentration||mg/dL|Mean|195.2|195.2|Standard Deviation|51.8|51.8|||
3815028|NCT01763905|3640447|B1|||LDL-C Concentration||mg/dL|Mean|194.7|194.7|Standard Deviation|63.8|63.8|||
3815029|NCT01763905|3640443|B5|Yes||Stratification Factor: Baseline Statin Use||participants|Number|58|58.0||||||
3815030|NCT01763905|3640444|B4|Yes||Stratification Factor: Baseline Statin Use||participants|Number|20|20.0||||||
3815031|NCT01763905|3640445|B3|Yes||Stratification Factor: Baseline Statin Use||participants|Number|19|19.0||||||
3815032|NCT01763905|3640446|B2|Yes||Stratification Factor: Baseline Statin Use||participants|Number|9|9.0||||||
3815033|NCT01763905|3640447|B1|Yes||Stratification Factor: Baseline Statin Use||participants|Number|10|10.0||||||
3815034|NCT01763905|3640443|B5|No||Stratification Factor: Baseline Statin Use||participants|Number|249|249.0||||||
3815035|NCT01763905|3640444|B4|No||Stratification Factor: Baseline Statin Use||participants|Number|82|82.0||||||
3815036|NCT01763905|3640445|B3|No||Stratification Factor: Baseline Statin Use||participants|Number|84|84.0||||||
3815037|NCT01763905|3640446|B2|No||Stratification Factor: Baseline Statin Use||participants|Number|42|42.0||||||
3815038|NCT01763905|3640447|B1|No||Stratification Factor: Baseline Statin Use||participants|Number|41|41.0||||||
3815039|NCT01763905|3640443|B5|≥ 180 mg/dL||Stratification Factor: Low-density Lipoprotein Cholesterol (LDL-C) Level||participants|Number|151|151.0||||||
3815040|NCT01763905|3640444|B4|≥ 180 mg/dL||Stratification Factor: Low-density Lipoprotein Cholesterol (LDL-C) Level||participants|Number|50|50.0||||||
3815041|NCT01763905|3640445|B3|≥ 180 mg/dL||Stratification Factor: Low-density Lipoprotein Cholesterol (LDL-C) Level||participants|Number|51|51.0||||||
3815042|NCT01763905|3640446|B2|≥ 180 mg/dL||Stratification Factor: Low-density Lipoprotein Cholesterol (LDL-C) Level||participants|Number|25|25.0||||||
3815043|NCT01763905|3640447|B1|≥ 180 mg/dL||Stratification Factor: Low-density Lipoprotein Cholesterol (LDL-C) Level||participants|Number|25|25.0||||||
3815044|NCT01763905|3640443|B5|< 180 mg/dL||Stratification Factor: Low-density Lipoprotein Cholesterol (LDL-C) Level||participants|Number|156|156.0||||||
3815045|NCT01763905|3640444|B4|< 180 mg/dL||Stratification Factor: Low-density Lipoprotein Cholesterol (LDL-C) Level||participants|Number|52|52.0||||||
3815046|NCT01763905|3640445|B3|< 180 mg/dL||Stratification Factor: Low-density Lipoprotein Cholesterol (LDL-C) Level||participants|Number|52|52.0||||||
3815047|NCT01763905|3640446|B2|< 180 mg/dL||Stratification Factor: Low-density Lipoprotein Cholesterol (LDL-C) Level||participants|Number|26|26.0||||||
3815048|NCT01763905|3640447|B1|< 180 mg/dL||Stratification Factor: Low-density Lipoprotein Cholesterol (LDL-C) Level||participants|Number|26|26.0||||||
3815049|NCT01763905|3640443|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|300|300.0||||||
3815050|NCT01763905|3640444|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|101|101.0||||||
3815051|NCT01763905|3640445|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|100|100.0||||||
3815445|NCT01763866|3640560|B9|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815052|NCT01763905|3640446|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
3815053|NCT01763905|3640447|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
3815054|NCT01763905|3640443|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3815055|NCT01763905|3640444|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815056|NCT01763905|3640445|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3815057|NCT01763905|3640446|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3815058|NCT01763905|3640447|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815059|NCT01763905|3640443|B5|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3815060|NCT01763905|3640444|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815061|NCT01763905|3640445|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815062|NCT01763905|3640446|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815063|NCT01763905|3640447|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815064|NCT01763905|3640443|B5|White||Race/Ethnicity, Customized||participants|Number|287|287.0||||||
3815065|NCT01763905|3640444|B4|White||Race/Ethnicity, Customized||participants|Number|98|98.0||||||
3815066|NCT01763905|3640445|B3|White||Race/Ethnicity, Customized||participants|Number|94|94.0||||||
3815067|NCT01763905|3640446|B2|White||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
3815068|NCT01763905|3640447|B1|White||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
3815069|NCT01763905|3640443|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815070|NCT01763905|3640444|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815071|NCT01763905|3640445|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815072|NCT01763905|3640446|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815073|NCT01763905|3640447|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815074|NCT01763905|3640443|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3815075|NCT01763905|3640444|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3815076|NCT01763905|3640445|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3815077|NCT01763905|3640446|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815078|NCT01763905|3640447|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815079|NCT01763905|3640443|B5|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3815080|NCT01763905|3640444|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815081|NCT01763905|3640445|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3815082|NCT01763905|3640446|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3815083|NCT01763905|3640447|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815084|NCT01763905|3640443|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815085|NCT01763905|3640444|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815086|NCT01763905|3640445|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815087|NCT01763905|3640446|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815088|NCT01763905|3640447|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815089|NCT01763905|3640443|B5||Male|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3815090|NCT01763905|3640444|B4||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3815091|NCT01763905|3640445|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3815092|NCT01763905|3640446|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3815093|NCT01763905|3640447|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3815094|NCT01763905|3640443|B5||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3815095|NCT01763905|3640444|B4||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3815096|NCT01763905|3640445|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3815097|NCT01763905|3640446|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3815098|NCT01763905|3640447|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3815099|NCT01763905|3640443|B5|||Age||years|Mean|61.5|61.5|Standard Deviation|9.8|9.8|||
3815100|NCT01763905|3640444|B4|||Age||years|Mean|62.9|62.9|Standard Deviation|10.2|10.2|||
3815101|NCT01763905|3640445|B3|||Age||years|Mean|60.5|60.5|Standard Deviation|9.7|9.7|||
3815102|NCT01763905|3640446|B2|||Age||years|Mean|60.2|60.2|Standard Deviation|8.7|8.7|||
3815103|NCT01763905|3640447|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|10.1|10.1|||
3815104|NCT01763866|3640544|B25|||HDL-C Concentration|Data are provided for the full anlaysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|53.5|53.5|Standard Deviation|15.9|15.9|||
3815105|NCT01763866|3640545|B24|||HDL-C Concentration|Data are provided for the full anlaysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|57.3|57.3|Standard Deviation|17.4|17.4|||
3815106|NCT01763866|3640546|B23|||HDL-C Concentration|Data are provided for the full anlaysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|49.7|49.7|Standard Deviation|12.6|12.6|||
3815446|NCT01763866|3640561|B8|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815107|NCT01763866|3640547|B22|||HDL-C Concentration|Data are provided for the full anlaysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|59.9|59.9|Standard Deviation|21.8|21.8|||
3815108|NCT01763866|3640548|B21|||HDL-C Concentration|Data are provided for the full anlaysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|55.0|55.0|Standard Deviation|14.2|14.2|||
3815109|NCT01763866|3640549|B20|||HDL-C Concentration|Data are provided for the full anlaysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|53.8|53.8|Standard Deviation|14.6|14.6|||
3815110|NCT01763866|3640550|B19|||HDL-C Concentration|Data are provided for the full anlaysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|53.2|53.2|Standard Deviation|16.4|16.4|||
3815111|NCT01763866|3640551|B18|||HDL-C Concentration|Data are provided for the full anlaysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|56.0|56.0|Standard Deviation|18.7|18.7|||
3815112|NCT01763866|3640552|B17|||HDL-C Concentration|Data are provided for the full anlaysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|52.8|52.8|Standard Deviation|12.9|12.9|||
3815113|NCT01763866|3640553|B16|||HDL-C Concentration|Data are provided for the full anlaysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|54.0|54.0|Standard Deviation|16.0|16.0|||
3815114|NCT01763866|3640554|B15|||HDL-C Concentration|Data are provided for the full anlaysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|54.5|54.5|Standard Deviation|15.0|15.0|||
3815115|NCT01763866|3640555|B14|||HDL-C Concentration|Data are provided for the full anlaysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|55.5|55.5|Standard Deviation|16.0|16.0|||
3815116|NCT01763866|3640556|B13|||HDL-C Concentration|Data are provided for the full anlaysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|52.1|52.1|Standard Deviation|14.9|14.9|||
3815117|NCT01763866|3640557|B12|||HDL-C Concentration|Data are provided for the full anlaysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|50.8|50.8|Standard Deviation|13.5|13.5|||
3815118|NCT01763866|3640558|B11|||HDL-C Concentration|Data are provided for the full anlaysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|48.5|48.5|Standard Deviation|12.9|12.9|||
3815119|NCT01763866|3640559|B10|||HDL-C Concentration|Data are provided for the full anlaysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|51.6|51.6|Standard Deviation|15.1|15.1|||
3815120|NCT01763866|3640560|B9|||HDL-C Concentration|Data are provided for the full anlaysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|48.7|48.7|Standard Deviation|12.6|12.6|||
3815121|NCT01763866|3640561|B8|||HDL-C Concentration|Data are provided for the full anlaysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|50.9|50.9|Standard Deviation|13.0|13.0|||
3815122|NCT01763866|3640562|B7|||HDL-C Concentration|Data are provided for the full anlaysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|50.6|50.6|Standard Deviation|15.6|15.6|||
3815123|NCT01763866|3640563|B6|||HDL-C Concentration|Data are provided for the full anlaysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|56.1|56.1|Standard Deviation|17.8|17.8|||
3815124|NCT01763866|3640564|B5|||HDL-C Concentration|Data are provided for the full anlaysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|56.0|56.0|Standard Deviation|17.9|17.9|||
3815125|NCT01763866|3640565|B4|||HDL-C Concentration|Data are provided for the full anlaysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|52.7|52.7|Standard Deviation|13.7|13.7|||
3815126|NCT01763866|3640566|B3|||HDL-C Concentration|Data are provided for the full anlaysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|54.1|54.1|Standard Deviation|17.2|17.2|||
3815127|NCT01763866|3640567|B2|||HDL-C Concentration|Data are provided for the full anlaysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|57.9|57.9|Standard Deviation|18.4|18.4|||
3815128|NCT01763866|3640568|B1|||HDL-C Concentration|Data are provided for the full anlaysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|54.1|54.1|Standard Deviation|16.6|16.6|||
3815129|NCT01763866|3640544|B25|||Very Low Density Lipoprotein Cholesterol (VLDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|23.0|23.0|Inter-Quartile Range|||17.0|32.0|
3815130|NCT01763866|3640545|B24|||Very Low Density Lipoprotein Cholesterol (VLDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|22.0|22.0|Inter-Quartile Range|||17.0|32.0|
3815131|NCT01763866|3640546|B23|||Very Low Density Lipoprotein Cholesterol (VLDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|26.0|26.0|Inter-Quartile Range|||18.5|39.0|
3815132|NCT01763866|3640547|B22|||Very Low Density Lipoprotein Cholesterol (VLDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|21.0|21.0|Inter-Quartile Range|||17.0|26.0|
3815133|NCT01763866|3640548|B21|||Very Low Density Lipoprotein Cholesterol (VLDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|25.0|25.0|Inter-Quartile Range|||18.0|34.5|
3815134|NCT01763866|3640549|B20|||Very Low Density Lipoprotein Cholesterol (VLDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|24.0|24.0|Inter-Quartile Range|||17.0|30.0|
3815135|NCT01763866|3640550|B19|||Very Low Density Lipoprotein Cholesterol (VLDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|20.0|20.0|Inter-Quartile Range|||16.0|30.0|
3815136|NCT01763866|3640551|B18|||Very Low Density Lipoprotein Cholesterol (VLDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|23.0|23.0|Inter-Quartile Range|||16.0|32.0|
3815137|NCT01763866|3640552|B17|||Very Low Density Lipoprotein Cholesterol (VLDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|26.0|26.0|Inter-Quartile Range|||18.5|32.5|
3815138|NCT01763866|3640553|B16|||Very Low Density Lipoprotein Cholesterol (VLDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|24.0|24.0|Inter-Quartile Range|||19.0|32.0|
3815139|NCT01763866|3640554|B15|||Very Low Density Lipoprotein Cholesterol (VLDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|23.0|23.0|Inter-Quartile Range|||18.0|34.0|
3815140|NCT01763866|3640555|B14|||Very Low Density Lipoprotein Cholesterol (VLDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|27.0|27.0|Inter-Quartile Range|||17.0|37.0|
3815141|NCT01763866|3640556|B13|||Very Low Density Lipoprotein Cholesterol (VLDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|22.5|22.5|Inter-Quartile Range|||18.0|30.0|
3815142|NCT01763866|3640557|B12|||Very Low Density Lipoprotein Cholesterol (VLDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|21.0|21.0|Inter-Quartile Range|||16.0|27.0|
3815143|NCT01763866|3640558|B11|||Very Low Density Lipoprotein Cholesterol (VLDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|21.0|21.0|Inter-Quartile Range|||16.0|33.0|
3815144|NCT01763866|3640559|B10|||Very Low Density Lipoprotein Cholesterol (VLDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|22.0|22.0|Inter-Quartile Range|||16.0|34.0|
3815145|NCT01763866|3640560|B9|||Very Low Density Lipoprotein Cholesterol (VLDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|26.5|26.5|Inter-Quartile Range|||18.0|31.0|
3815146|NCT01763866|3640561|B8|||Very Low Density Lipoprotein Cholesterol (VLDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|21.0|21.0|Inter-Quartile Range|||15.0|25.0|
3815147|NCT01763866|3640562|B7|||Very Low Density Lipoprotein Cholesterol (VLDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|21.0|21.0|Inter-Quartile Range|||16.0|28.0|
3815148|NCT01763866|3640563|B6|||Very Low Density Lipoprotein Cholesterol (VLDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|24.0|24.0|Inter-Quartile Range|||17.0|32.0|
3815149|NCT01763866|3640564|B5|||Very Low Density Lipoprotein Cholesterol (VLDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|27.0|27.0|Inter-Quartile Range|||20.0|38.0|
3815150|NCT01763866|3640565|B4|||Very Low Density Lipoprotein Cholesterol (VLDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|24.0|24.0|Inter-Quartile Range|||17.0|33.0|
3815151|NCT01763866|3640566|B3|||Very Low Density Lipoprotein Cholesterol (VLDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|25.5|25.5|Inter-Quartile Range|||19.0|30.0|
3815152|NCT01763866|3640567|B2|||Very Low Density Lipoprotein Cholesterol (VLDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|22.0|22.0|Inter-Quartile Range|||17.0|29.0|
3815153|NCT01763866|3640568|B1|||Very Low Density Lipoprotein Cholesterol (VLDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|22.0|22.0|Inter-Quartile Range|||17.0|35.0|
3815154|NCT01763866|3640544|B25|||Triglyceride Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|116.0|116.0|Inter-Quartile Range|||86.0|158.0|
3815155|NCT01763866|3640545|B24|||Triglyceride Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|110.0|110.0|Inter-Quartile Range|||84.0|161.0|
3815447|NCT01763866|3640562|B7|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3815156|NCT01763866|3640546|B23|||Triglyceride Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|129.0|129.0|Inter-Quartile Range|||91.5|195.0|
3815157|NCT01763866|3640547|B22|||Triglyceride Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|106.0|106.0|Inter-Quartile Range|||87.0|139.0|
3815158|NCT01763866|3640548|B21|||Triglyceride Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|124.0|124.0|Inter-Quartile Range|||90.0|173.0|
3815159|NCT01763866|3640549|B20|||Triglyceride Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|119.5|119.5|Inter-Quartile Range|||87.0|149.5|
3815160|NCT01763866|3640550|B19|||Triglyceride Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|102.0|102.0|Inter-Quartile Range|||79.0|151.0|
3815161|NCT01763866|3640551|B18|||Triglyceride Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|116.0|116.0|Inter-Quartile Range|||78.0|160.0|
3815162|NCT01763866|3640552|B17|||Triglyceride Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|128.0|128.0|Inter-Quartile Range|||91.5|162.0|
3815163|NCT01763866|3640553|B16|||Triglyceride Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|121.0|121.0|Inter-Quartile Range|||93.0|161.0|
3815164|NCT01763866|3640554|B15|||Triglyceride Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|116.0|116.0|Inter-Quartile Range|||90.0|168.0|
3815165|NCT01763866|3640555|B14|||Triglyceride Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|134.0|134.0|Inter-Quartile Range|||86.0|184.0|
3815166|NCT01763866|3640556|B13|||Triglyceride Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|112.5|112.5|Inter-Quartile Range|||89.0|148.0|
3815167|NCT01763866|3640557|B12|||Triglyceride Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|106.5|106.5|Inter-Quartile Range|||79.0|137.0|
3815168|NCT01763866|3640558|B11|||Triglyceride Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|104.0|104.0|Inter-Quartile Range|||81.0|163.0|
3815169|NCT01763866|3640559|B10|||Triglyceride Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|109.0|109.0|Inter-Quartile Range|||80.0|171.0|
3815170|NCT01763866|3640560|B9|||Triglyceride Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|133.0|133.0|Inter-Quartile Range|||89.0|155.0|
3815171|NCT01763866|3640561|B8|||Triglyceride Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|104.0|104.0|Inter-Quartile Range|||76.0|124.0|
3815172|NCT01763866|3640562|B7|||Triglyceride Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|104.0|104.0|Inter-Quartile Range|||82.0|142.0|
3815173|NCT01763866|3640563|B6|||Triglyceride Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|119.0|119.0|Inter-Quartile Range|||84.0|161.0|
3815174|NCT01763866|3640564|B5|||Triglyceride Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|135.0|135.0|Inter-Quartile Range|||99.0|189.0|
3815175|NCT01763866|3640565|B4|||Triglyceride Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|119.0|119.0|Inter-Quartile Range|||87.0|168.0|
3815176|NCT01763866|3640566|B3|||Triglyceride Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|129.5|129.5|Inter-Quartile Range|||94.0|151.5|
3815177|NCT01763866|3640567|B2|||Triglyceride Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|108.0|108.0|Inter-Quartile Range|||83.0|145.0|
3815178|NCT01763866|3640568|B1|||Triglyceride Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Median|112.0|112.0|Inter-Quartile Range|||83.0|176.0|
3815179|NCT01763866|3640544|B25|||Lipoprotein(a) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|nmol/L|Median|34.0|34.0|Inter-Quartile Range|||11.0|161.5|
3815180|NCT01763866|3640545|B24|||Lipoprotein(a) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|nmol/L|Median|37.0|37.0|Inter-Quartile Range|||11.0|141.0|
3815181|NCT01763866|3640546|B23|||Lipoprotein(a) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|nmol/L|Median|32.5|32.5|Inter-Quartile Range|||13.0|157.0|
3815182|NCT01763866|3640547|B22|||Lipoprotein(a) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|nmol/L|Median|28.0|28.0|Inter-Quartile Range|||13.0|180.0|
3815183|NCT01763866|3640548|B21|||Lipoprotein(a) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|nmol/L|Median|36.5|36.5|Inter-Quartile Range|||17.5|140.5|
3815184|NCT01763866|3640549|B20|||Lipoprotein(a) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|nmol/L|Median|49.5|49.5|Inter-Quartile Range|||11.0|184.5|
3815185|NCT01763866|3640550|B19|||Lipoprotein(a) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|nmol/L|Median|41.0|41.0|Inter-Quartile Range|||10.0|183.0|
3815186|NCT01763866|3640551|B18|||Lipoprotein(a) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|nmol/L|Median|33.0|33.0|Inter-Quartile Range|||11.0|148.0|
3815187|NCT01763866|3640552|B17|||Lipoprotein(a) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|nmol/L|Median|28.5|28.5|Inter-Quartile Range|||7.0|171.0|
3815188|NCT01763866|3640553|B16|||Lipoprotein(a) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|nmol/L|Median|32.0|32.0|Inter-Quartile Range|||9.0|172.0|
3815189|NCT01763866|3640554|B15|||Lipoprotein(a) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|nmol/L|Median|38.0|38.0|Inter-Quartile Range|||11.0|165.0|
3815190|NCT01763866|3640555|B14|||Lipoprotein(a) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|nmol/L|Median|35.0|35.0|Inter-Quartile Range|||14.0|156.5|
3815191|NCT01763866|3640556|B13|||Lipoprotein(a) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|nmol/L|Median|34.0|34.0|Inter-Quartile Range|||8.0|158.0|
3815192|NCT01763866|3640557|B12|||Lipoprotein(a) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|nmol/L|Median|24.5|24.5|Inter-Quartile Range|||8.0|93.0|
3815193|NCT01763866|3640558|B11|||Lipoprotein(a) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|nmol/L|Median|32.0|32.0|Inter-Quartile Range|||11.5|135.5|
3815194|NCT01763866|3640559|B10|||Lipoprotein(a) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|nmol/L|Median|61.5|61.5|Inter-Quartile Range|||12.0|192.0|
3815195|NCT01763866|3640560|B9|||Lipoprotein(a) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|nmol/L|Median|25.0|25.0|Inter-Quartile Range|||12.0|108.0|
3815196|NCT01763866|3640561|B8|||Lipoprotein(a) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|nmol/L|Median|50.0|50.0|Inter-Quartile Range|||13.0|152.0|
3815197|NCT01763866|3640562|B7|||Lipoprotein(a) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|nmol/L|Median|53.0|53.0|Inter-Quartile Range|||15.0|177.0|
3815198|NCT01763866|3640563|B6|||Lipoprotein(a) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|nmol/L|Median|49.0|49.0|Inter-Quartile Range|||11.0|169.0|
3815199|NCT01763866|3640564|B5|||Lipoprotein(a) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|nmol/L|Median|27.0|27.0|Inter-Quartile Range|||8.0|120.0|
3815200|NCT01763866|3640565|B4|||Lipoprotein(a) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|nmol/L|Median|33.0|33.0|Inter-Quartile Range|||8.0|163.0|
3815201|NCT01763866|3640566|B3|||Lipoprotein(a) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|nmol/L|Median|37.0|37.0|Inter-Quartile Range|||9.5|190.0|
3815202|NCT01763866|3640567|B2|||Lipoprotein(a) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|nmol/L|Median|41.0|41.0|Inter-Quartile Range|||15.0|106.0|
3815203|NCT01763866|3640568|B1|||Lipoprotein(a) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|nmol/L|Median|31.5|31.5|Inter-Quartile Range|||13.0|87.5|
3815204|NCT01763866|3640544|B25|||Apolipoprotein B/Apolipoprotein A1 Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|0.614|0.614|Standard Deviation|0.229|0.229|||
3815205|NCT01763866|3640545|B24|||Apolipoprotein B/Apolipoprotein A1 Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|0.639|0.639|Standard Deviation|0.224|0.224|||
3815206|NCT01763866|3640546|B23|||Apolipoprotein B/Apolipoprotein A1 Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|0.657|0.657|Standard Deviation|0.193|0.193|||
3815448|NCT01763866|3640563|B6|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815207|NCT01763866|3640547|B22|||Apolipoprotein B/Apolipoprotein A1 Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|0.581|0.581|Standard Deviation|0.174|0.174|||
3815208|NCT01763866|3640548|B21|||Apolipoprotein B/Apolipoprotein A1 Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|0.611|0.611|Standard Deviation|0.179|0.179|||
3815209|NCT01763866|3640549|B20|||Apolipoprotein B/Apolipoprotein A1 Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|0.536|0.536|Standard Deviation|0.193|0.193|||
3815210|NCT01763866|3640550|B19|||Apolipoprotein B/Apolipoprotein A1 Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|0.538|0.538|Standard Deviation|0.227|0.227|||
3815211|NCT01763866|3640551|B18|||Apolipoprotein B/Apolipoprotein A1 Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|0.562|0.562|Standard Deviation|0.217|0.217|||
3815212|NCT01763866|3640552|B17|||Apolipoprotein B/Apolipoprotein A1 Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|0.479|0.479|Standard Deviation|0.129|0.129|||
3815213|NCT01763866|3640553|B16|||Apolipoprotein B/Apolipoprotein A1 Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|0.676|0.676|Standard Deviation|0.341|0.341|||
3815214|NCT01763866|3640554|B15|||Apolipoprotein B/Apolipoprotein A1 Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|0.640|0.64|Standard Deviation|0.249|0.249|||
3815215|NCT01763866|3640555|B14|||Apolipoprotein B/Apolipoprotein A1 Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|0.636|0.636|Standard Deviation|0.207|0.207|||
3815216|NCT01763866|3640556|B13|||Apolipoprotein B/Apolipoprotein A1 Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|0.661|0.661|Standard Deviation|0.273|0.273|||
3815217|NCT01763866|3640557|B12|||Apolipoprotein B/Apolipoprotein A1 Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|0.562|0.562|Standard Deviation|0.171|0.171|||
3815218|NCT01763866|3640558|B11|||Apolipoprotein B/Apolipoprotein A1 Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|0.593|0.593|Standard Deviation|0.227|0.227|||
3815219|NCT01763866|3640559|B10|||Apolipoprotein B/Apolipoprotein A1 Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|0.560|0.56|Standard Deviation|0.157|0.157|||
3815220|NCT01763866|3640560|B9|||Apolipoprotein B/Apolipoprotein A1 Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|0.640|0.64|Standard Deviation|0.234|0.234|||
3815221|NCT01763866|3640561|B8|||Apolipoprotein B/Apolipoprotein A1 Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|0.571|0.571|Standard Deviation|0.189|0.189|||
3815222|NCT01763866|3640562|B7|||Apolipoprotein B/Apolipoprotein A1 Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|0.603|0.603|Standard Deviation|0.221|0.221|||
3815223|NCT01763866|3640563|B6|||Apolipoprotein B/Apolipoprotein A1 Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|0.659|0.659|Standard Deviation|0.249|0.249|||
3815224|NCT01763866|3640564|B5|||Apolipoprotein B/Apolipoprotein A1 Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|0.663|0.663|Standard Deviation|0.217|0.217|||
3815225|NCT01763866|3640565|B4|||Apolipoprotein B/Apolipoprotein A1 Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|0.640|0.64|Standard Deviation|0.169|0.169|||
3815226|NCT01763866|3640566|B3|||Apolipoprotein B/Apolipoprotein A1 Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|0.692|0.692|Standard Deviation|0.243|0.243|||
3815227|NCT01763866|3640567|B2|||Apolipoprotein B/Apolipoprotein A1 Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|0.647|0.647|Standard Deviation|0.266|0.266|||
3815228|NCT01763866|3640568|B1|||Apolipoprotein B/Apolipoprotein A1 Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|0.666|0.666|Standard Deviation|0.216|0.216|||
3815229|NCT01763866|3640544|B25|||Total Cholesterol/HDL-C Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|3.786|3.786|Standard Deviation|1.353|1.353|||
3815230|NCT01763866|3640545|B24|||Total Cholesterol/HDL-C Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|3.924|3.924|Standard Deviation|1.420|1.42|||
3815231|NCT01763866|3640546|B23|||Total Cholesterol/HDL-C Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|4.196|4.196|Standard Deviation|1.436|1.436|||
3815232|NCT01763866|3640547|B22|||Total Cholesterol/HDL-C Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|3.595|3.595|Standard Deviation|1.345|1.345|||
3815233|NCT01763866|3640548|B21|||Total Cholesterol/HDL-C Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|3.733|3.733|Standard Deviation|1.079|1.079|||
3815234|NCT01763866|3640549|B20|||Total Cholesterol/HDL-C Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|3.307|3.307|Standard Deviation|1.061|1.061|||
3815235|NCT01763866|3640550|B19|||Total Cholesterol/HDL-C Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|3.413|3.413|Standard Deviation|1.355|1.355|||
3815236|NCT01763866|3640551|B18|||Total Cholesterol/HDL-C Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|3.547|3.547|Standard Deviation|1.355|1.355|||
3815237|NCT01763866|3640552|B17|||Total Cholesterol/HDL-C Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|3.086|3.086|Standard Deviation|0.728|0.728|||
3815238|NCT01763866|3640553|B16|||Total Cholesterol/HDL-C Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|4.178|4.178|Standard Deviation|1.932|1.932|||
3815239|NCT01763866|3640554|B15|||Total Cholesterol/HDL-C Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|3.915|3.915|Standard Deviation|1.216|1.216|||
3815240|NCT01763866|3640555|B14|||Total Cholesterol/HDL-C Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|3.891|3.891|Standard Deviation|1.234|1.234|||
3815241|NCT01763866|3640556|B13|||Total Cholesterol/HDL-C Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|4.044|4.044|Standard Deviation|1.685|1.685|||
3815242|NCT01763866|3640557|B12|||Total Cholesterol/HDL-C Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|3.462|3.462|Standard Deviation|1.000|1.0|||
3815243|NCT01763866|3640558|B11|||Total Cholesterol/HDL-C Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|3.696|3.696|Standard Deviation|1.371|1.371|||
3815244|NCT01763866|3640559|B10|||Total Cholesterol/HDL-C Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|3.540|3.54|Standard Deviation|1.100|1.1|||
3815245|NCT01763866|3640560|B9|||Total Cholesterol/HDL-C Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|3.748|3.748|Standard Deviation|1.099|1.099|||
3815246|NCT01763866|3640561|B8|||Total Cholesterol/HDL-C Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|3.461|3.461|Standard Deviation|1.093|1.093|||
3815247|NCT01763866|3640562|B7|||Total Cholesterol/HDL-C Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|3.704|3.704|Standard Deviation|1.260|1.26|||
3815248|NCT01763866|3640563|B6|||Total Cholesterol/HDL-C Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|4.100|4.1|Standard Deviation|1.636|1.636|||
3815249|NCT01763866|3640564|B5|||Total Cholesterol/HDL-C Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|3.980|3.98|Standard Deviation|1.224|1.224|||
3815250|NCT01763866|3640565|B4|||Total Cholesterol/HDL-C Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|4.002|4.002|Standard Deviation|1.100|1.1|||
3815251|NCT01763866|3640566|B3|||Total Cholesterol/HDL-C Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|4.112|4.112|Standard Deviation|1.311|1.311|||
3815252|NCT01763866|3640567|B2|||Total Cholesterol/HDL-C Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|3.859|3.859|Standard Deviation|1.396|1.396|||
3815253|NCT01763866|3640568|B1|||Total Cholesterol/HDL-C Ratio|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|ratio|Mean|3.988|3.988|Standard Deviation|1.154|1.154|||
3815254|NCT01763866|3640544|B25|||Apolipoprotein B Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|89.1|89.1|Standard Deviation|26.1|26.1|||
3815255|NCT01763866|3640545|B24|||Apolipoprotein B Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|96.5|96.5|Standard Deviation|27.5|27.5|||
3815256|NCT01763866|3640546|B23|||Apolipoprotein B Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|94.2|94.2|Standard Deviation|24.0|24.0|||
3815449|NCT01763866|3640564|B5|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815450|NCT01763866|3640565|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815257|NCT01763866|3640547|B22|||Apolipoprotein B Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|89.8|89.8|Standard Deviation|20.7|20.7|||
3815258|NCT01763866|3640548|B21|||Apolipoprotein B Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|91.6|91.6|Standard Deviation|18.4|18.4|||
3815259|NCT01763866|3640549|B20|||Apolipoprotein B Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|78.7|78.7|Standard Deviation|23.1|23.1|||
3815260|NCT01763866|3640550|B19|||Apolipoprotein B Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|77.4|77.4|Standard Deviation|22.3|22.3|||
3815261|NCT01763866|3640551|B18|||Apolipoprotein B Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|84.8|84.8|Standard Deviation|29.7|29.7|||
3815262|NCT01763866|3640552|B17|||Apolipoprotein B Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|71.0|71.0|Standard Deviation|16.6|16.6|||
3815263|NCT01763866|3640553|B16|||Apolipoprotein B Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|97.2|97.2|Standard Deviation|26.9|26.9|||
3815264|NCT01763866|3640554|B15|||Apolipoprotein B Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|95.4|95.4|Standard Deviation|27.0|27.0|||
3815265|NCT01763866|3640555|B14|||Apolipoprotein B Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|95.9|95.9|Standard Deviation|25.2|25.2|||
3815266|NCT01763866|3640556|B13|||Apolipoprotein B Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|93.1|93.1|Standard Deviation|27.3|27.3|||
3815267|NCT01763866|3640557|B12|||Apolipoprotein B Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|77.9|77.9|Standard Deviation|21.5|21.5|||
3815268|NCT01763866|3640558|B11|||Apolipoprotein B Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|79.9|79.9|Standard Deviation|25.1|25.1|||
3815269|NCT01763866|3640559|B10|||Apolipoprotein B Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|78.7|78.7|Standard Deviation|16.9|16.9|||
3815270|NCT01763866|3640560|B9|||Apolipoprotein B Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|85.3|85.3|Standard Deviation|23.1|23.1|||
3815271|NCT01763866|3640561|B8|||Apolipoprotein B Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|80.1|80.1|Standard Deviation|21.4|21.4|||
3815272|NCT01763866|3640562|B7|||Apolipoprotein B Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|81.1|81.1|Standard Deviation|22.1|22.1|||
3815273|NCT01763866|3640563|B6|||Apolipoprotein B Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|97.3|97.3|Standard Deviation|28.9|28.9|||
3815274|NCT01763866|3640564|B5|||Apolipoprotein B Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|99.7|99.7|Standard Deviation|26.4|26.4|||
3815275|NCT01763866|3640565|B4|||Apolipoprotein B Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|94.6|94.6|Standard Deviation|20.4|20.4|||
3815276|NCT01763866|3640566|B3|||Apolipoprotein B Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|101.3|101.3|Standard Deviation|31.2|31.2|||
3815277|NCT01763866|3640567|B2|||Apolipoprotein B Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|95.3|95.3|Standard Deviation|29.6|29.6|||
3815278|NCT01763866|3640568|B1|||Apolipoprotein B Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|95.3|95.3|Standard Deviation|26.0|26.0|||
3815279|NCT01763866|3640544|B25|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|150.3|150.3|Standard Deviation|27.6|27.6|||
3815280|NCT01763866|3640545|B24|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|151.2|151.2|Standard Deviation|51.5|51.5|||
3815281|NCT01763866|3640546|B23|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|146.8|146.8|Standard Deviation|41.8|41.8|||
3815451|NCT01763866|3640566|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815282|NCT01763866|3640547|B22|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|135.7|135.7|Standard Deviation|38.4|38.4|||
3815283|NCT01763866|3640548|B21|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|138.4|138.4|Standard Deviation|29.3|29.3|||
3815284|NCT01763866|3640549|B20|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|114.3|114.3|Standard Deviation|34.7|34.7|||
3815285|NCT01763866|3640550|B19|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|113.5|113.5|Standard Deviation|36.0|36.0|||
3815286|NCT01763866|3640551|B18|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|128.7|128.7|Standard Deviation|53.4|53.4|||
3815287|NCT01763866|3640552|B17|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|103.9|103.9|Standard Deviation|25.7|25.7|||
3815288|NCT01763866|3640553|B16|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|152.0|152.0|Standard Deviation|46.4|46.4|||
3815289|NCT01763866|3640554|B15|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|146.6|146.6|Standard Deviation|43.2|43.2|||
3815290|NCT01763866|3640555|B14|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|148.3|148.3|Standard Deviation|43.3|43.3|||
3815291|NCT01763866|3640556|B13|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|141.1|141.1|Standard Deviation|41.6|41.6|||
3815292|NCT01763866|3640557|B12|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|117.2|117.2|Standard Deviation|36.3|36.3|||
3815293|NCT01763866|3640558|B11|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|120.2|120.2|Standard Deviation|42.3|42.3|||
3815294|NCT01763866|3640559|B10|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|118.4|118.4|Standard Deviation|25.5|25.5|||
3815295|NCT01763866|3640560|B9|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|124.8|124.8|Standard Deviation|35.4|35.4|||
3815296|NCT01763866|3640561|B8|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|116.5|116.5|Standard Deviation|35.7|35.7|||
3815297|NCT01763866|3640562|B7|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|124.2|124.2|Standard Deviation|39.3|39.3|||
3815298|NCT01763866|3640563|B6|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|154.3|154.3|Standard Deviation|53.1|53.1|||
3815299|NCT01763866|3640564|B5|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|152.3|152.3|Standard Deviation|45.6|45.6|||
3815300|NCT01763866|3640565|B4|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|148.3|148.3|Standard Deviation|36.8|36.8|||
3815301|NCT01763866|3640566|B3|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|153.8|153.8|Standard Deviation|53.2|53.2|||
3815302|NCT01763866|3640567|B2|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|147.7|147.7|Standard Deviation|51.4|51.4|||
3815303|NCT01763866|3640568|B1|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration|Data are provided for the full analysis set. Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|149.1|149.1|Standard Deviation|46.9|46.9|||
3815343|NCT01763866|3640558|B11|No statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|29|29.0||||||
3815304|NCT01763866|3640544|B25|||Low-Density Lipoprotein Cholesterol (LDL-C) Concentration|Data are provided for the full analysis set (all participants randomized to investigational product (IP) who received at least 1 dose of IP (subcutaneously or orally). Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|109.1|109.1|Standard Deviation|41.1|41.1|||
3815305|NCT01763866|3640545|B24|||Low-Density Lipoprotein Cholesterol (LDL-C) Concentration|Data are provided for the full analysis set (all participants randomized to investigational product (IP) who received at least 1 dose of IP (subcutaneously or orally). Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|123.7|123.7|Standard Deviation|48.5|48.5|||
3815306|NCT01763866|3640546|B23|||Low-Density Lipoprotein Cholesterol (LDL-C) Concentration|Data are provided for the full analysis set (all participants randomized to investigational product (IP) who received at least 1 dose of IP (subcutaneously or orally). Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|114.9|114.9|Standard Deviation|34.5|34.5|||
3815307|NCT01763866|3640547|B22|||Low-Density Lipoprotein Cholesterol (LDL-C) Concentration|Data are provided for the full analysis set (all participants randomized to investigational product (IP) who received at least 1 dose of IP (subcutaneously or orally). Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|108.6|108.6|Standard Deviation|30.9|30.9|||
3815308|NCT01763866|3640548|B21|||Low-Density Lipoprotein Cholesterol (LDL-C) Concentration|Data are provided for the full analysis set (all participants randomized to investigational product (IP) who received at least 1 dose of IP (subcutaneously or orally). Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|110.3|110.3|Standard Deviation|28.0|28.0|||
3815309|NCT01763866|3640549|B20|||Low-Density Lipoprotein Cholesterol (LDL-C) Concentration|Data are provided for the full analysis set (all participants randomized to investigational product (IP) who received at least 1 dose of IP (subcutaneously or orally). Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|88.5|88.5|Standard Deviation|31.3|31.3|||
3815310|NCT01763866|3640550|B19|||Low-Density Lipoprotein Cholesterol (LDL-C) Concentration|Data are provided for the full analysis set (all participants randomized to investigational product (IP) who received at least 1 dose of IP (subcutaneously or orally). Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|88.5|88.5|Standard Deviation|31.5|31.5|||
3815311|NCT01763866|3640551|B18|||Low-Density Lipoprotein Cholesterol (LDL-C) Concentration|Data are provided for the full analysis set (all participants randomized to investigational product (IP) who received at least 1 dose of IP (subcutaneously or orally). Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|102.9|102.9|Standard Deviation|49.3|49.3|||
3815312|NCT01763866|3640552|B17|||Low-Density Lipoprotein Cholesterol (LDL-C) Concentration|Data are provided for the full analysis set (all participants randomized to investigational product (IP) who received at least 1 dose of IP (subcutaneously or orally). Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|77.4|77.4|Standard Deviation|20.9|20.9|||
3815313|NCT01763866|3640553|B16|||Low-Density Lipoprotein Cholesterol (LDL-C) Concentration|Data are provided for the full analysis set (all participants randomized to investigational product (IP) who received at least 1 dose of IP (subcutaneously or orally). Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|122.9|122.9|Standard Deviation|42.0|42.0|||
3815314|NCT01763866|3640554|B15|||Low-Density Lipoprotein Cholesterol (LDL-C) Concentration|Data are provided for the full analysis set (all participants randomized to investigational product (IP) who received at least 1 dose of IP (subcutaneously or orally). Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|118.7|118.7|Standard Deviation|40.9|40.9|||
3815315|NCT01763866|3640555|B14|||Low-Density Lipoprotein Cholesterol (LDL-C) Concentration|Data are provided for the full analysis set (all participants randomized to investigational product (IP) who received at least 1 dose of IP (subcutaneously or orally). Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|119.9|119.9|Standard Deviation|39.1|39.1|||
3815316|NCT01763866|3640556|B13|||Low-Density Lipoprotein Cholesterol (LDL-C) Concentration|Data are provided for the full analysis set (all participants randomized to investigational product (IP) who received at least 1 dose of IP (subcutaneously or orally). Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|115.6|115.6|Standard Deviation|39.8|39.8|||
3815317|NCT01763866|3640557|B12|||Low-Density Lipoprotein Cholesterol (LDL-C) Concentration|Data are provided for the full analysis set (all participants randomized to investigational product (IP) who received at least 1 dose of IP (subcutaneously or orally). Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|93.8|93.8|Standard Deviation|32.3|32.3|||
3815318|NCT01763866|3640558|B11|||Low-Density Lipoprotein Cholesterol (LDL-C) Concentration|Data are provided for the full analysis set (all participants randomized to investigational product (IP) who received at least 1 dose of IP (subcutaneously or orally). Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|94.2|94.2|Standard Deviation|34.8|34.8|||
3815319|NCT01763866|3640559|B10|||Low-Density Lipoprotein Cholesterol (LDL-C) Concentration|Data are provided for the full analysis set (all participants randomized to investigational product (IP) who received at least 1 dose of IP (subcutaneously or orally). Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|92.3|92.3|Standard Deviation|19.3|19.3|||
3815320|NCT01763866|3640560|B9|||Low-Density Lipoprotein Cholesterol (LDL-C) Concentration|Data are provided for the full analysis set (all participants randomized to investigational product (IP) who received at least 1 dose of IP (subcutaneously or orally). Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|98.7|98.7|Standard Deviation|34.0|34.0|||
3815442|NCT01763866|3640557|B12|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815443|NCT01763866|3640558|B11|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815321|NCT01763866|3640561|B8|||Low-Density Lipoprotein Cholesterol (LDL-C) Concentration|Data are provided for the full analysis set (all participants randomized to investigational product (IP) who received at least 1 dose of IP (subcutaneously or orally). Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|94.7|94.7|Standard Deviation|31.9|31.9|||
3815322|NCT01763866|3640562|B7|||Low-Density Lipoprotein Cholesterol (LDL-C) Concentration|Data are provided for the full analysis set (all participants randomized to investigational product (IP) who received at least 1 dose of IP (subcutaneously or orally). Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|100.3|100.3|Standard Deviation|36.2|36.2|||
3815323|NCT01763866|3640563|B6|||Low-Density Lipoprotein Cholesterol (LDL-C) Concentration|Data are provided for the full analysis set (all participants randomized to investigational product (IP) who received at least 1 dose of IP (subcutaneously or orally). Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|126.1|126.1|Standard Deviation|50.4|50.4|||
3815324|NCT01763866|3640564|B5|||Low-Density Lipoprotein Cholesterol (LDL-C) Concentration|Data are provided for the full analysis set (all participants randomized to investigational product (IP) who received at least 1 dose of IP (subcutaneously or orally). Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|124.2|124.2|Standard Deviation|43.4|43.4|||
3815325|NCT01763866|3640565|B4|||Low-Density Lipoprotein Cholesterol (LDL-C) Concentration|Data are provided for the full analysis set (all participants randomized to investigational product (IP) who received at least 1 dose of IP (subcutaneously or orally). Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|119.3|119.3|Standard Deviation|28.1|28.1|||
3815326|NCT01763866|3640566|B3|||Low-Density Lipoprotein Cholesterol (LDL-C) Concentration|Data are provided for the full analysis set (all participants randomized to investigational product (IP) who received at least 1 dose of IP (subcutaneously or orally). Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|126.8|126.8|Standard Deviation|49.6|49.6|||
3815327|NCT01763866|3640567|B2|||Low-Density Lipoprotein Cholesterol (LDL-C) Concentration|Data are provided for the full analysis set (all participants randomized to investigational product (IP) who received at least 1 dose of IP (subcutaneously or orally). Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|123.7|123.7|Standard Deviation|47.9|47.9|||
3815328|NCT01763866|3640568|B1|||Low-Density Lipoprotein Cholesterol (LDL-C) Concentration|Data are provided for the full analysis set (all participants randomized to investigational product (IP) who received at least 1 dose of IP (subcutaneously or orally). Baseline was measured after the lipid stabilization period and before administration of first dose of study drug.|mg/dL|Mean|123.0|123.0|Standard Deviation|46.6|46.6|||
3815329|NCT01763866|3640544|B25|No statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|561|561.0||||||
3815330|NCT01763866|3640545|B24|No statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|33|33.0||||||
3815331|NCT01763866|3640546|B23|No statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|36|36.0||||||
3815332|NCT01763866|3640547|B22|No statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|16|16.0||||||
3815333|NCT01763866|3640548|B21|No statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|16|16.0||||||
3815334|NCT01763866|3640549|B20|No statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|31|31.0||||||
3815335|NCT01763866|3640550|B19|No statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|28|28.0||||||
3815336|NCT01763866|3640551|B18|No statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|21|21.0||||||
3815337|NCT01763866|3640552|B17|No statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|20|20.0||||||
3815338|NCT01763866|3640553|B16|No statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|35|35.0||||||
3815339|NCT01763866|3640554|B15|No statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|32|32.0||||||
3815340|NCT01763866|3640555|B14|No statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|16|16.0||||||
3815341|NCT01763866|3640556|B13|No statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|20|20.0||||||
3815342|NCT01763866|3640557|B12|No statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|29|29.0||||||
3815344|NCT01763866|3640559|B10|No statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|22|22.0||||||
3815345|NCT01763866|3640560|B9|No statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|13|13.0||||||
3815346|NCT01763866|3640561|B8|No statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|16|16.0||||||
3815347|NCT01763866|3640562|B7|No statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|18|18.0||||||
3815348|NCT01763866|3640563|B6|No statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|35|35.0||||||
3815349|NCT01763866|3640564|B5|No statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|30|30.0||||||
3815350|NCT01763866|3640565|B4|No statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|20|20.0||||||
3815351|NCT01763866|3640566|B3|No statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|16|16.0||||||
3815352|NCT01763866|3640567|B2|No statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|11|11.0||||||
3815353|NCT01763866|3640568|B1|No statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|18|18.0||||||
3815354|NCT01763866|3640544|B25|Non-intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|796|796.0||||||
3815355|NCT01763866|3640545|B24|Non-intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|48|48.0||||||
3815356|NCT01763866|3640546|B23|Non-intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|45|45.0||||||
3815357|NCT01763866|3640547|B22|Non-intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|26|26.0||||||
3815358|NCT01763866|3640548|B21|Non-intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|21|21.0||||||
3815359|NCT01763866|3640549|B20|Non-intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|44|44.0||||||
3815360|NCT01763866|3640550|B19|Non-intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|50|50.0||||||
3815361|NCT01763866|3640551|B18|Non-intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|22|22.0||||||
3815362|NCT01763866|3640552|B17|Non-intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|23|23.0||||||
3815363|NCT01763866|3640553|B16|Non-intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|42|42.0||||||
3815364|NCT01763866|3640554|B15|Non-intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|49|49.0||||||
3815365|NCT01763866|3640555|B14|Non-intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|28|28.0||||||
3815366|NCT01763866|3640556|B13|Non-intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|25|25.0||||||
3815367|NCT01763866|3640557|B12|Non-intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|46|46.0||||||
3815368|NCT01763866|3640558|B11|Non-intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|47|47.0||||||
3815444|NCT01763866|3640559|B10|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815369|NCT01763866|3640559|B10|Non-intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|21|21.0||||||
3815370|NCT01763866|3640560|B9|Non-intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|22|22.0||||||
3815371|NCT01763866|3640561|B8|Non-intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|27|27.0||||||
3815372|NCT01763866|3640562|B7|Non-intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|22|22.0||||||
3815373|NCT01763866|3640563|B6|Non-intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|40|40.0||||||
3815374|NCT01763866|3640564|B5|Non-intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|52|52.0||||||
3815375|NCT01763866|3640565|B4|Non-intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|21|21.0||||||
3815376|NCT01763866|3640566|B3|Non-intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|30|30.0||||||
3815377|NCT01763866|3640567|B2|Non-intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|25|25.0||||||
3815378|NCT01763866|3640568|B1|Non-intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|20|20.0||||||
3815379|NCT01763866|3640544|B25|Intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|542|542.0||||||
3815380|NCT01763866|3640545|B24|Intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|34|34.0||||||
3815381|NCT01763866|3640546|B23|Intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|31|31.0||||||
3815382|NCT01763866|3640547|B22|Intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|13|13.0||||||
3815383|NCT01763866|3640548|B21|Intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|19|19.0||||||
3815384|NCT01763866|3640549|B20|Intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|37|37.0||||||
3815385|NCT01763866|3640550|B19|Intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|33|33.0||||||
3815386|NCT01763866|3640551|B18|Intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|13|13.0||||||
3815387|NCT01763866|3640552|B17|Intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|13|13.0||||||
3815388|NCT01763866|3640553|B16|Intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|38|38.0||||||
3815389|NCT01763866|3640554|B15|Intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|33|33.0||||||
3815390|NCT01763866|3640555|B14|Intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|13|13.0||||||
3815391|NCT01763866|3640556|B13|Intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|13|13.0||||||
3815392|NCT01763866|3640557|B12|Intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|35|35.0||||||
3815393|NCT01763866|3640558|B11|Intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|34|34.0||||||
3815394|NCT01763866|3640559|B10|Intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|11|11.0||||||
3815395|NCT01763866|3640560|B9|Intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|21|21.0||||||
3815396|NCT01763866|3640561|B8|Intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|12|12.0||||||
3815397|NCT01763866|3640562|B7|Intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|15|15.0||||||
3815398|NCT01763866|3640563|B6|Intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|35|35.0||||||
3815399|NCT01763866|3640564|B5|Intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|28|28.0||||||
3815400|NCT01763866|3640565|B4|Intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|14|14.0||||||
3815401|NCT01763866|3640566|B3|Intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|10|10.0||||||
3815402|NCT01763866|3640567|B2|Intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|19|19.0||||||
3815403|NCT01763866|3640568|B1|Intensive statin use||Stratification Factor: Entry Statin Therapy|Intensive statin use was defined as daily atorvastatin (40 mg or greater), rosuvastatin (20 mg or greater), simvastatin (80 mg), or any statin plus ezetimibe.|participants|Number|18|18.0||||||
3815404|NCT01763866|3640544|B25|Mixed Race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3815405|NCT01763866|3640545|B24|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815406|NCT01763866|3640546|B23|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815407|NCT01763866|3640547|B22|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815408|NCT01763866|3640548|B21|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815409|NCT01763866|3640549|B20|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815410|NCT01763866|3640550|B19|Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815411|NCT01763866|3640551|B18|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815412|NCT01763866|3640552|B17|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815413|NCT01763866|3640553|B16|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815414|NCT01763866|3640554|B15|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815415|NCT01763866|3640555|B14|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815416|NCT01763866|3640556|B13|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815417|NCT01763866|3640557|B12|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815418|NCT01763866|3640558|B11|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815419|NCT01763866|3640559|B10|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815420|NCT01763866|3640560|B9|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815421|NCT01763866|3640561|B8|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815422|NCT01763866|3640562|B7|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815423|NCT01763866|3640563|B6|Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815424|NCT01763866|3640564|B5|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815425|NCT01763866|3640565|B4|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815426|NCT01763866|3640566|B3|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815427|NCT01763866|3640567|B2|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815428|NCT01763866|3640568|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815429|NCT01763866|3640544|B25|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3815430|NCT01763866|3640545|B24|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815431|NCT01763866|3640546|B23|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815432|NCT01763866|3640547|B22|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815433|NCT01763866|3640548|B21|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815434|NCT01763866|3640549|B20|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815435|NCT01763866|3640550|B19|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815436|NCT01763866|3640551|B18|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815437|NCT01763866|3640552|B17|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815438|NCT01763866|3640553|B16|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815439|NCT01763866|3640554|B15|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815440|NCT01763866|3640555|B14|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815441|NCT01763866|3640556|B13|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815452|NCT01763866|3640567|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815453|NCT01763866|3640568|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815454|NCT01763866|3640544|B25|White||Race/Ethnicity, Customized||participants|Number|1785|1785.0||||||
3815455|NCT01763866|3640545|B24|White||Race/Ethnicity, Customized||participants|Number|110|110.0||||||
3815456|NCT01763866|3640546|B23|White||Race/Ethnicity, Customized||participants|Number|106|106.0||||||
3815457|NCT01763866|3640547|B22|White||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
3815458|NCT01763866|3640548|B21|White||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
3815459|NCT01763866|3640549|B20|White||Race/Ethnicity, Customized||participants|Number|109|109.0||||||
3815460|NCT01763866|3640550|B19|White||Race/Ethnicity, Customized||participants|Number|105|105.0||||||
3815461|NCT01763866|3640551|B18|White||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
3815462|NCT01763866|3640552|B17|White||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
3815463|NCT01763866|3640553|B16|White||Race/Ethnicity, Customized||participants|Number|107|107.0||||||
3815464|NCT01763866|3640554|B15|White||Race/Ethnicity, Customized||participants|Number|104|104.0||||||
3815465|NCT01763866|3640555|B14|White||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
3815466|NCT01763866|3640556|B13|White||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
3815467|NCT01763866|3640557|B12|White||Race/Ethnicity, Customized||participants|Number|105|105.0||||||
3815468|NCT01763866|3640558|B11|White||Race/Ethnicity, Customized||participants|Number|105|105.0||||||
3815469|NCT01763866|3640559|B10|White||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
3815470|NCT01763866|3640560|B9|White||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
3815471|NCT01763866|3640561|B8|White||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
3815472|NCT01763866|3640562|B7|White||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
3815473|NCT01763866|3640563|B6|White||Race/Ethnicity, Customized||participants|Number|101|101.0||||||
3815474|NCT01763866|3640564|B5|White||Race/Ethnicity, Customized||participants|Number|97|97.0||||||
3815475|NCT01763866|3640565|B4|White||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
3815476|NCT01763866|3640566|B3|White||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
3815477|NCT01763866|3640567|B2|White||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
3815478|NCT01763866|3640568|B1|White||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
3815479|NCT01763866|3640544|B25|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3815480|NCT01763866|3640545|B24|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815481|NCT01763866|3640546|B23|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815482|NCT01763866|3640547|B22|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815483|NCT01763866|3640548|B21|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815484|NCT01763866|3640549|B20|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815485|NCT01763866|3640550|B19|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815486|NCT01763866|3640551|B18|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815487|NCT01763866|3640552|B17|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815488|NCT01763866|3640553|B16|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815489|NCT01763866|3640554|B15|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815490|NCT01763866|3640555|B14|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815491|NCT01763866|3640556|B13|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815492|NCT01763866|3640557|B12|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815493|NCT01763866|3640558|B11|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815494|NCT01763866|3640559|B10|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815495|NCT01763866|3640560|B9|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815496|NCT01763866|3640561|B8|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815497|NCT01763866|3640562|B7|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815498|NCT01763866|3640563|B6|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815499|NCT01763866|3640564|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815500|NCT01763866|3640565|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815501|NCT01763866|3640566|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815502|NCT01763866|3640567|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815503|NCT01763866|3640568|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815504|NCT01763866|3640544|B25|Black or African American||Race/Ethnicity, Customized||participants|Number|75|75.0||||||
3815505|NCT01763866|3640545|B24|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3815506|NCT01763866|3640546|B23|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3815681|NCT01763866|3640546|B23|||Age||years|Mean|59.7|59.7|Standard Deviation|9.2|9.2|||
3815507|NCT01763866|3640547|B22|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815508|NCT01763866|3640548|B21|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3815509|NCT01763866|3640549|B20|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3815510|NCT01763866|3640550|B19|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3815511|NCT01763866|3640551|B18|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3815512|NCT01763866|3640552|B17|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815513|NCT01763866|3640553|B16|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3815514|NCT01763866|3640554|B15|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3815515|NCT01763866|3640555|B14|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815516|NCT01763866|3640556|B13|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3815517|NCT01763866|3640557|B12|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3815518|NCT01763866|3640558|B11|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3815519|NCT01763866|3640559|B10|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3815520|NCT01763866|3640560|B9|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3815521|NCT01763866|3640561|B8|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3815522|NCT01763866|3640562|B7|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815523|NCT01763866|3640563|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3815524|NCT01763866|3640564|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3815525|NCT01763866|3640565|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3815526|NCT01763866|3640566|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815527|NCT01763866|3640567|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815528|NCT01763866|3640568|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3815529|NCT01763866|3640544|B25|Asian||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3815530|NCT01763866|3640545|B24|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815531|NCT01763866|3640546|B23|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815532|NCT01763866|3640547|B22|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815533|NCT01763866|3640548|B21|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3815534|NCT01763866|3640549|B20|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815535|NCT01763866|3640550|B19|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815536|NCT01763866|3640551|B18|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815537|NCT01763866|3640552|B17|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815538|NCT01763866|3640553|B16|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815539|NCT01763866|3640554|B15|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3815540|NCT01763866|3640555|B14|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815541|NCT01763866|3640556|B13|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815542|NCT01763866|3640557|B12|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815543|NCT01763866|3640558|B11|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815544|NCT01763866|3640559|B10|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3815545|NCT01763866|3640560|B9|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815546|NCT01763866|3640561|B8|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815547|NCT01763866|3640562|B7|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815548|NCT01763866|3640563|B6|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3815549|NCT01763866|3640564|B5|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3815550|NCT01763866|3640565|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815551|NCT01763866|3640566|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3815552|NCT01763866|3640567|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815553|NCT01763866|3640568|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815554|NCT01763866|3640544|B25|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815555|NCT01763866|3640545|B24|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815556|NCT01763866|3640546|B23|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815557|NCT01763866|3640547|B22|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815558|NCT01763866|3640548|B21|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815559|NCT01763866|3640549|B20|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815560|NCT01763866|3640550|B19|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815561|NCT01763866|3640551|B18|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815562|NCT01763866|3640552|B17|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815563|NCT01763866|3640553|B16|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815564|NCT01763866|3640554|B15|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815565|NCT01763866|3640555|B14|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815566|NCT01763866|3640556|B13|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815567|NCT01763866|3640557|B12|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815568|NCT01763866|3640558|B11|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815569|NCT01763866|3640559|B10|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815570|NCT01763866|3640560|B9|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815571|NCT01763866|3640561|B8|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815572|NCT01763866|3640562|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815573|NCT01763866|3640563|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815574|NCT01763866|3640564|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815575|NCT01763866|3640565|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815576|NCT01763866|3640566|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815577|NCT01763866|3640567|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815578|NCT01763866|3640568|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815579|NCT01763866|3640544|B25|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1812|1812.0||||||
3815580|NCT01763866|3640545|B24|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|110|110.0||||||
3815581|NCT01763866|3640546|B23|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|109|109.0||||||
3815582|NCT01763866|3640547|B22|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
3815583|NCT01763866|3640548|B21|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
3815584|NCT01763866|3640549|B20|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|107|107.0||||||
3815585|NCT01763866|3640550|B19|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|105|105.0||||||
3815586|NCT01763866|3640551|B18|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
3815587|NCT01763866|3640552|B17|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
3815588|NCT01763866|3640553|B16|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|112|112.0||||||
3815589|NCT01763866|3640554|B15|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|108|108.0||||||
3815590|NCT01763866|3640555|B14|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
3815591|NCT01763866|3640556|B13|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
3815592|NCT01763866|3640557|B12|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|103|103.0||||||
3815593|NCT01763866|3640558|B11|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|105|105.0||||||
3815594|NCT01763866|3640559|B10|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
3815595|NCT01763866|3640560|B9|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
3815596|NCT01763866|3640561|B8|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
3815597|NCT01763866|3640562|B7|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
3815598|NCT01763866|3640563|B6|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|108|108.0||||||
3815599|NCT01763866|3640564|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|105|105.0||||||
3815600|NCT01763866|3640565|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
3815601|NCT01763866|3640566|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
3815602|NCT01763866|3640567|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
3815603|NCT01763866|3640568|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
3815604|NCT01763866|3640544|B25|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|87|87.0||||||
3815605|NCT01763866|3640545|B24|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3815606|NCT01763866|3640546|B23|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3815607|NCT01763866|3640547|B22|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3815608|NCT01763866|3640548|B21|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815609|NCT01763866|3640549|B20|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3815610|NCT01763866|3640550|B19|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3815611|NCT01763866|3640551|B18|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3815612|NCT01763866|3640552|B17|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3815613|NCT01763866|3640553|B16|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3815614|NCT01763866|3640554|B15|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3815615|NCT01763866|3640555|B14|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3815616|NCT01763866|3640556|B13|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3815617|NCT01763866|3640557|B12|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3815618|NCT01763866|3640558|B11|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3815619|NCT01763866|3640559|B10|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3815620|NCT01763866|3640560|B9|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3815621|NCT01763866|3640561|B8|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3815622|NCT01763866|3640562|B7|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3815623|NCT01763866|3640563|B6|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3815624|NCT01763866|3640564|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3815625|NCT01763866|3640565|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815626|NCT01763866|3640566|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3815627|NCT01763866|3640567|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3815628|NCT01763866|3640568|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3815629|NCT01763866|3640544|B25||Male|Sex: Female, Male||Participants|Count of Participants|1028|1028.0||||||
3815630|NCT01763866|3640545|B24||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3815631|NCT01763866|3640546|B23||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3815632|NCT01763866|3640547|B22||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3815633|NCT01763866|3640548|B21||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3815634|NCT01763866|3640549|B20||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3815635|NCT01763866|3640550|B19||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3815636|NCT01763866|3640551|B18||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3815637|NCT01763866|3640552|B17||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3815638|NCT01763866|3640553|B16||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3815639|NCT01763866|3640554|B15||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3815640|NCT01763866|3640555|B14||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3815641|NCT01763866|3640556|B13||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3815642|NCT01763866|3640557|B12||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3815643|NCT01763866|3640558|B11||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3815644|NCT01763866|3640559|B10||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3815645|NCT01763866|3640560|B9||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3815646|NCT01763866|3640561|B8||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3815647|NCT01763866|3640562|B7||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3815648|NCT01763866|3640563|B6||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3815649|NCT01763866|3640564|B5||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3815650|NCT01763866|3640565|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3815651|NCT01763866|3640566|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3815652|NCT01763866|3640567|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3815653|NCT01763866|3640568|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3815654|NCT01763866|3640544|B25||Female|Sex: Female, Male||Participants|Count of Participants|871|871.0||||||
3815655|NCT01763866|3640545|B24||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3815656|NCT01763866|3640546|B23||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3815657|NCT01763866|3640547|B22||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3815658|NCT01763866|3640548|B21||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3815659|NCT01763866|3640549|B20||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3815660|NCT01763866|3640550|B19||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3815661|NCT01763866|3640551|B18||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3815662|NCT01763866|3640552|B17||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3815663|NCT01763866|3640553|B16||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3815664|NCT01763866|3640554|B15||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3815665|NCT01763866|3640555|B14||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3815666|NCT01763866|3640556|B13||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3815667|NCT01763866|3640557|B12||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3815668|NCT01763866|3640558|B11||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3815669|NCT01763866|3640559|B10||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3815670|NCT01763866|3640560|B9||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3815671|NCT01763866|3640561|B8||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3815672|NCT01763866|3640562|B7||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3815673|NCT01763866|3640563|B6||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3815674|NCT01763866|3640564|B5||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3815675|NCT01763866|3640565|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3815676|NCT01763866|3640566|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3815677|NCT01763866|3640567|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3815678|NCT01763866|3640568|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3815679|NCT01763866|3640544|B25|||Age||years|Mean|59.8|59.8|Standard Deviation|9.9|9.9|||
3815680|NCT01763866|3640545|B24|||Age||years|Mean|61.5|61.5|Standard Deviation|9.6|9.6|||
3815682|NCT01763866|3640547|B22|||Age||years|Mean|61.5|61.5|Standard Deviation|10.3|10.3|||
3815683|NCT01763866|3640548|B21|||Age||years|Mean|61.9|61.9|Standard Deviation|9.7|9.7|||
3815684|NCT01763866|3640549|B20|||Age||years|Mean|59.6|59.6|Standard Deviation|9.0|9.0|||
3815685|NCT01763866|3640550|B19|||Age||years|Mean|59.5|59.5|Standard Deviation|9.2|9.2|||
3815686|NCT01763866|3640551|B18|||Age||years|Mean|58.3|58.3|Standard Deviation|11.3|11.3|||
3815687|NCT01763866|3640552|B17|||Age||years|Mean|60.2|60.2|Standard Deviation|8.7|8.7|||
3815688|NCT01763866|3640553|B16|||Age||years|Mean|59.3|59.3|Standard Deviation|10.5|10.5|||
3815689|NCT01763866|3640554|B15|||Age||years|Mean|58.9|58.9|Standard Deviation|11.2|11.2|||
3815690|NCT01763866|3640555|B14|||Age||years|Mean|59.6|59.6|Standard Deviation|9.2|9.2|||
3815691|NCT01763866|3640556|B13|||Age||years|Mean|61.2|61.2|Standard Deviation|9.1|9.1|||
3815692|NCT01763866|3640557|B12|||Age||years|Mean|60.1|60.1|Standard Deviation|10.2|10.2|||
3815693|NCT01763866|3640558|B11|||Age||years|Mean|59.7|59.7|Standard Deviation|10.2|10.2|||
3815694|NCT01763866|3640559|B10|||Age||years|Mean|61.1|61.1|Standard Deviation|8.9|8.9|||
3815695|NCT01763866|3640560|B9|||Age||years|Mean|60.5|60.5|Standard Deviation|10.2|10.2|||
3815696|NCT01763866|3640561|B8|||Age||years|Mean|58.8|58.8|Standard Deviation|11.5|11.5|||
3815697|NCT01763866|3640562|B7|||Age||years|Mean|57.1|57.1|Standard Deviation|9.9|9.9|||
3815698|NCT01763866|3640563|B6|||Age||years|Mean|59.6|59.6|Standard Deviation|11.1|11.1|||
3815699|NCT01763866|3640564|B5|||Age||years|Mean|58.3|58.3|Standard Deviation|8.4|8.4|||
3815700|NCT01763866|3640565|B4|||Age||years|Mean|60.6|60.6|Standard Deviation|9.2|9.2|||
3815701|NCT01763866|3640566|B3|||Age||years|Mean|61.0|61.0|Standard Deviation|9.0|9.0|||
3815702|NCT01763866|3640567|B2|||Age||years|Mean|62.2|62.2|Standard Deviation|10.4|10.4|||
3815703|NCT01763866|3640568|B1|||Age||years|Mean|58.3|58.3|Standard Deviation|10.5|10.5|||
3815704|NCT01763827|3641145|B7|||High-density Lipoprotein Cholesterol (HDL-C) Concentration|Data are provided for the full analysis set|mg/dL|Median|55.3|55.3|Inter-Quartile Range|18.7|18.7|44.5|67.5|
3815705|NCT01763827|3641146|B6|||High-density Lipoprotein Cholesterol (HDL-C) Concentration|Data are provided for the full analysis set|mg/dL|Median|56.5|56.5|Inter-Quartile Range|18.0|18.0|46.5|65.5|
3815706|NCT01763827|3641147|B5|||High-density Lipoprotein Cholesterol (HDL-C) Concentration|Data are provided for the full analysis set|mg/dL|Median|53.0|53.0|Inter-Quartile Range|18.0|18.0|44.5|67.0|
3815707|NCT01763827|3641148|B4|||High-density Lipoprotein Cholesterol (HDL-C) Concentration|Data are provided for the full analysis set|mg/dL|Median|53.5|53.5|Inter-Quartile Range|18.5|18.5|42.0|67.5|
3815708|NCT01763827|3641149|B3|||High-density Lipoprotein Cholesterol (HDL-C) Concentration|Data are provided for the full analysis set|mg/dL|Median|58.5|58.5|Inter-Quartile Range|16.8|16.8|47.0|69.5|
3815709|NCT01763827|3641150|B2|||High-density Lipoprotein Cholesterol (HDL-C) Concentration|Data are provided for the full analysis set|mg/dL|Median|54.0|54.0|Inter-Quartile Range|17.8|17.8|44.5|65.5|
3815710|NCT01763827|3641151|B1|||High-density Lipoprotein Cholesterol (HDL-C) Concentration|Data are provided for the full analysis set|mg/dL|Median|57.0|57.0|Inter-Quartile Range|23.6|23.6|43.8|77.3|
3815711|NCT01763827|3641145|B7|||Very Low-density Lipoprotein Cholesterol (VLDL-C) Concentration|Data are provided for the full analysis set|mg/dL|Median|23.0|23.0|Inter-Quartile Range|12.4|12.4|16.5|32.5|
3815712|NCT01763827|3641146|B6|||Very Low-density Lipoprotein Cholesterol (VLDL-C) Concentration|Data are provided for the full analysis set|mg/dL|Median|23.5|23.5|Inter-Quartile Range|11.8|11.8|16.5|33.5|
3815713|NCT01763827|3641147|B5|||Very Low-density Lipoprotein Cholesterol (VLDL-C) Concentration|Data are provided for the full analysis set|mg/dL|Median|22.5|22.5|Inter-Quartile Range|11.5|11.5|16.5|29.5|
3815714|NCT01763827|3641148|B4|||Very Low-density Lipoprotein Cholesterol (VLDL-C) Concentration|Data are provided for the full analysis set|mg/dL|Median|23.5|23.5|Inter-Quartile Range|10.5|10.5|18.0|31.5|
3815715|NCT01763827|3641149|B3|||Very Low-density Lipoprotein Cholesterol (VLDL-C) Concentration|Data are provided for the full analysis set|mg/dL|Median|22.5|22.5|Inter-Quartile Range|12.4|12.4|16.5|32.0|
3815716|NCT01763827|3641150|B2|||Very Low-density Lipoprotein Cholesterol (VLDL-C) Concentration|Data are provided for the full analysis set|mg/dL|Median|23.8|23.8|Inter-Quartile Range|15.4|15.4|17.0|35.5|
3815717|NCT01763827|3641151|B1|||Very Low-density Lipoprotein Cholesterol (VLDL-C) Concentration|Data are provided for the full analysis set|mg/dL|Median|22.5|22.5|Inter-Quartile Range|13.2|13.2|16.8|34.3|
3815718|NCT01763827|3641145|B7|||Triglycerides|Data are provided for the full analysis set|mg/dL|Median|115.3|115.3|Inter-Quartile Range|65.5|65.5|83.5|163.0|
3815719|NCT01763827|3641146|B6|||Triglycerides|Data are provided for the full analysis set|mg/dL|Median|119.0|119.0|Inter-Quartile Range|59.1|59.1|82.5|168.5|
3815720|NCT01763827|3641147|B5|||Triglycerides|Data are provided for the full analysis set|mg/dL|Median|112.0|112.0|Inter-Quartile Range|62.6|62.6|81.5|147.5|
3815721|NCT01763827|3641148|B4|||Triglycerides|Data are provided for the full analysis set|mg/dL|Median|116.5|116.5|Inter-Quartile Range|52.4|52.4|90.0|159.0|
3815722|NCT01763827|3641149|B3|||Triglycerides|Data are provided for the full analysis set|mg/dL|Median|112.5|112.5|Inter-Quartile Range|64.9|64.9|83.5|158.0|
3815723|NCT01763827|3641150|B2|||Triglycerides|Data are provided for the full analysis set|mg/dL|Median|118.0|118.0|Inter-Quartile Range|83.4|83.4|85.5|178.5|
3815724|NCT01763827|3641151|B1|||Triglycerides|Data are provided for the full analysis set|mg/dL|Median|113.5|113.5|Inter-Quartile Range|74.7|74.7|83.3|178.0|
3815725|NCT01763827|3641145|B7|||Lipoprotein(a)|Data are provided for the full analysis set|nmol/L|Median|25.0|25.0|Inter-Quartile Range|74.5|74.5|9.0|71.0|
3815726|NCT01763827|3641146|B6|||Lipoprotein(a)|Data are provided for the full analysis set|nmol/L|Median|28.0|28.0|Inter-Quartile Range|86.9|86.9|9.0|104.0|
3815727|NCT01763827|3641147|B5|||Lipoprotein(a)|Data are provided for the full analysis set|nmol/L|Median|20.0|20.0|Inter-Quartile Range|61.5|61.5|7.0|58.0|
3815728|NCT01763827|3641148|B4|||Lipoprotein(a)|Data are provided for the full analysis set|nmol/L|Median|28.0|28.0|Inter-Quartile Range|65.7|65.7|12.0|64.0|
3815877|NCT01763567|3641317|B1|||Age||years|Mean|64.2|64.2|Standard Deviation|12.1|12.1|||
3815729|NCT01763827|3641149|B3|||Lipoprotein(a)|Data are provided for the full analysis set|nmol/L|Median|28.0|28.0|Inter-Quartile Range|79.1|79.1|11.0|120.0|
3815730|NCT01763827|3641150|B2|||Lipoprotein(a)|Data are provided for the full analysis set|nmol/L|Median|21.5|21.5|Inter-Quartile Range|84.0|84.0|7.0|62.0|
3815731|NCT01763827|3641151|B1|||Lipoprotein(a)|Data are provided for the full analysis set|nmol/L|Median|21.0|21.0|Inter-Quartile Range|62.9|62.9|9.0|49.0|
3815732|NCT01763827|3641145|B7|||Apolipoprotein B/Apolipoprotein A-1 Ratio|Data are provided for the full analysis set|ratio|Mean|0.697|0.697|Standard Deviation|0.178|0.178|||
3815733|NCT01763827|3641146|B6|||Apolipoprotein B/Apolipoprotein A-1 Ratio|Data are provided for the full analysis set|ratio|Mean|0.707|0.707|Standard Deviation|0.170|0.17|||
3815734|NCT01763827|3641147|B5|||Apolipoprotein B/Apolipoprotein A-1 Ratio|Data are provided for the full analysis set|ratio|Mean|0.687|0.687|Standard Deviation|0.169|0.169|||
3815735|NCT01763827|3641148|B4|||Apolipoprotein B/Apolipoprotein A-1 Ratio|Data are provided for the full analysis set|ratio|Mean|0.712|0.712|Standard Deviation|0.173|0.173|||
3815736|NCT01763827|3641149|B3|||Apolipoprotein B/Apolipoprotein A-1 Ratio|Data are provided for the full analysis set|ratio|Mean|0.691|0.691|Standard Deviation|0.187|0.187|||
3815737|NCT01763827|3641150|B2|||Apolipoprotein B/Apolipoprotein A-1 Ratio|Data are provided for the full analysis set|ratio|Mean|0.713|0.713|Standard Deviation|0.194|0.194|||
3815738|NCT01763827|3641151|B1|||Apolipoprotein B/Apolipoprotein A-1 Ratio|Data are provided for the full analysis set|ratio|Mean|0.671|0.671|Standard Deviation|0.193|0.193|||
3815739|NCT01763827|3641145|B7|||Total Cholesterol/High-density Lipoprotein Cholesterol Ratio|Data are provided for the full analysis set|ratio|Mean|4.210|4.21|Standard Deviation|1.191|1.191|||
3815740|NCT01763827|3641146|B6|||Total Cholesterol/High-density Lipoprotein Cholesterol Ratio|Data are provided for the full analysis set|ratio|Mean|4.175|4.175|Standard Deviation|1.071|1.071|||
3815741|NCT01763827|3641147|B5|||Total Cholesterol/High-density Lipoprotein Cholesterol Ratio|Data are provided for the full analysis set|ratio|Mean|4.170|4.17|Standard Deviation|1.170|1.17|||
3815742|NCT01763827|3641148|B4|||Total Cholesterol/High-density Lipoprotein Cholesterol Ratio|Data are provided for the full analysis set|ratio|Mean|4.335|4.335|Standard Deviation|1.118|1.118|||
3815743|NCT01763827|3641149|B3|||Total Cholesterol/High-density Lipoprotein Cholesterol Ratio|Data are provided for the full analysis set|ratio|Mean|4.055|4.055|Standard Deviation|1.082|1.082|||
3815744|NCT01763827|3641150|B2|||Total Cholesterol/High-density Lipoprotein Cholesterol Ratio|Data are provided for the full analysis set|ratio|Mean|4.444|4.444|Standard Deviation|1.465|1.465|||
3815745|NCT01763827|3641151|B1|||Total Cholesterol/High-density Lipoprotein Cholesterol Ratio|Data are provided for the full analysis set|ratio|Mean|4.148|4.148|Standard Deviation|1.311|1.311|||
3815746|NCT01763827|3641145|B7|||Apolipoprotein B Concentration|Data are provided for the full analysis set|mg/dL|Mean|106.2|106.2|Standard Deviation|18.1|18.1|||
3815747|NCT01763827|3641146|B6|||Apolipoprotein B Concentration|Data are provided for the full analysis set|mg/dL|Mean|108.3|108.3|Standard Deviation|17.9|17.9|||
3815748|NCT01763827|3641147|B5|||Apolipoprotein B Concentration|Data are provided for the full analysis set|mg/dL|Mean|104.5|104.5|Standard Deviation|17.2|17.2|||
3815749|NCT01763827|3641148|B4|||Apolipoprotein B Concentration|Data are provided for the full analysis set|mg/dL|Mean|106.2|106.2|Standard Deviation|17.8|17.8|||
3815750|NCT01763827|3641149|B3|||Apolipoprotein B Concentration|Data are provided for the full analysis set|mg/dL|Mean|107.2|107.2|Standard Deviation|19.7|19.7|||
3815751|NCT01763827|3641150|B2|||Apolipoprotein B Concentration|Data are provided for the full analysis set|mg/dL|Mean|107.3|107.3|Standard Deviation|19.9|19.9|||
3815752|NCT01763827|3641151|B1|||Apolipoprotein B Concentration|Data are provided for the full analysis set|mg/dL|Mean|103.7|103.7|Standard Deviation|16.8|16.8|||
3815753|NCT01763827|3641145|B7|||Non-High-Density Lipoprotein Cholesterol (Non-HDL-C) Concentration|Data are provided for the full analysis set|mg/dL|Mean|169.0|169.0|Standard Deviation|27.2|27.2|||
3815754|NCT01763827|3641146|B6|||Non-High-Density Lipoprotein Cholesterol (Non-HDL-C) Concentration|Data are provided for the full analysis set|mg/dL|Mean|170.4|170.4|Standard Deviation|26.6|26.6|||
3815755|NCT01763827|3641147|B5|||Non-High-Density Lipoprotein Cholesterol (Non-HDL-C) Concentration|Data are provided for the full analysis set|mg/dL|Mean|166.5|166.5|Standard Deviation|25.6|25.6|||
3815756|NCT01763827|3641148|B4|||Non-High-Density Lipoprotein Cholesterol (Non-HDL-C) Concentration|Data are provided for the full analysis set|mg/dL|Mean|169.4|169.4|Standard Deviation|27.3|27.3|||
3815757|NCT01763827|3641149|B3|||Non-High-Density Lipoprotein Cholesterol (Non-HDL-C) Concentration|Data are provided for the full analysis set|mg/dL|Mean|168.8|168.8|Standard Deviation|28.9|28.9|||
3815758|NCT01763827|3641150|B2|||Non-High-Density Lipoprotein Cholesterol (Non-HDL-C) Concentration|Data are provided for the full analysis set|mg/dL|Mean|172.8|172.8|Standard Deviation|31.0|31.0|||
3815759|NCT01763827|3641151|B1|||Non-High-Density Lipoprotein Cholesterol (Non-HDL-C) Concentration|Data are provided for the full analysis set|mg/dL|Mean|167.4|167.4|Standard Deviation|25.8|25.8|||
3815760|NCT01763827|3641145|B7|||LDL-C Concentration|Data are provided for the full analysis set (all randomized participants who received at least 1 dose of investigational product (subcutaneously or orally).|mg/dL|Mean|142.9|142.9|Standard Deviation|22.9|22.9|||
3815761|NCT01763827|3641146|B6|||LDL-C Concentration|Data are provided for the full analysis set (all randomized participants who received at least 1 dose of investigational product (subcutaneously or orally).|mg/dL|Mean|144.4|144.4|Standard Deviation|23.3|23.3|||
3815762|NCT01763827|3641147|B5|||LDL-C Concentration|Data are provided for the full analysis set (all randomized participants who received at least 1 dose of investigational product (subcutaneously or orally).|mg/dL|Mean|141.7|141.7|Standard Deviation|22.3|22.3|||
3815763|NCT01763827|3641148|B4|||LDL-C Concentration|Data are provided for the full analysis set (all randomized participants who received at least 1 dose of investigational product (subcutaneously or orally).|mg/dL|Mean|143.5|143.5|Standard Deviation|23.1|23.1|||
3815764|NCT01763827|3641149|B3|||LDL-C Concentration|Data are provided for the full analysis set (all randomized participants who received at least 1 dose of investigational product (subcutaneously or orally).|mg/dL|Mean|143.3|143.3|Standard Deviation|23.8|23.8|||
3815878|NCT01763567|3641317|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3815765|NCT01763827|3641150|B2|||LDL-C Concentration|Data are provided for the full analysis set (all randomized participants who received at least 1 dose of investigational product (subcutaneously or orally).|mg/dL|Mean|144.3|144.3|Standard Deviation|23.9|23.9|||
3815766|NCT01763827|3641151|B1|||LDL-C Concentration|Data are provided for the full analysis set (all randomized participants who received at least 1 dose of investigational product (subcutaneously or orally).|mg/dL|Mean|139.5|139.5|Standard Deviation|21.3|21.3|||
3815767|NCT01763827|3641145|B7|≥ 130 mg/dL||Stratification Factor: Low-density Lipoprotein Cholesterol (LDL-C)||participants|Number|434|434.0||||||
3815768|NCT01763827|3641146|B6|≥ 130 mg/dL||Stratification Factor: Low-density Lipoprotein Cholesterol (LDL-C)||participants|Number|108|108.0||||||
3815769|NCT01763827|3641147|B5|≥ 130 mg/dL||Stratification Factor: Low-density Lipoprotein Cholesterol (LDL-C)||participants|Number|108|108.0||||||
3815770|NCT01763827|3641148|B4|≥ 130 mg/dL||Stratification Factor: Low-density Lipoprotein Cholesterol (LDL-C)||participants|Number|55|55.0||||||
3815771|NCT01763827|3641149|B3|≥ 130 mg/dL||Stratification Factor: Low-density Lipoprotein Cholesterol (LDL-C)||participants|Number|55|55.0||||||
3815772|NCT01763827|3641150|B2|≥ 130 mg/dL||Stratification Factor: Low-density Lipoprotein Cholesterol (LDL-C)||participants|Number|54|54.0||||||
3815773|NCT01763827|3641151|B1|≥ 130 mg/dL||Stratification Factor: Low-density Lipoprotein Cholesterol (LDL-C)||participants|Number|54|54.0||||||
3815774|NCT01763827|3641145|B7|< 130 mg/dL||Stratification Factor: Low-density Lipoprotein Cholesterol (LDL-C)||participants|Number|181|181.0||||||
3815775|NCT01763827|3641146|B6|< 130 mg/dL||Stratification Factor: Low-density Lipoprotein Cholesterol (LDL-C)||participants|Number|45|45.0||||||
3815776|NCT01763827|3641147|B5|< 130 mg/dL||Stratification Factor: Low-density Lipoprotein Cholesterol (LDL-C)||participants|Number|45|45.0||||||
3815777|NCT01763827|3641148|B4|< 130 mg/dL||Stratification Factor: Low-density Lipoprotein Cholesterol (LDL-C)||participants|Number|22|22.0||||||
3815778|NCT01763827|3641149|B3|< 130 mg/dL||Stratification Factor: Low-density Lipoprotein Cholesterol (LDL-C)||participants|Number|22|22.0||||||
3815779|NCT01763827|3641150|B2|< 130 mg/dL||Stratification Factor: Low-density Lipoprotein Cholesterol (LDL-C)||participants|Number|24|24.0||||||
3815780|NCT01763827|3641151|B1|< 130 mg/dL||Stratification Factor: Low-density Lipoprotein Cholesterol (LDL-C)||participants|Number|23|23.0||||||
3815781|NCT01763827|3641145|B7|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|546|546.0||||||
3815782|NCT01763827|3641146|B6|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|132|132.0||||||
3815783|NCT01763827|3641147|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|139|139.0||||||
3815784|NCT01763827|3641148|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
3815785|NCT01763827|3641149|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
3815786|NCT01763827|3641150|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
3815787|NCT01763827|3641151|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|71|71.0||||||
3815788|NCT01763827|3641145|B7|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
3815789|NCT01763827|3641146|B6|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3815790|NCT01763827|3641147|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3815791|NCT01763827|3641148|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3815792|NCT01763827|3641149|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3815793|NCT01763827|3641150|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3815794|NCT01763827|3641151|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3815795|NCT01763827|3641145|B7|Mixed Race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3815796|NCT01763827|3641146|B6|Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815797|NCT01763827|3641147|B5|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815798|NCT01763827|3641148|B4|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815799|NCT01763827|3641149|B3|Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815800|NCT01763827|3641150|B2|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815801|NCT01763827|3641151|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815802|NCT01763827|3641145|B7|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815803|NCT01763827|3641146|B6|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815804|NCT01763827|3641147|B5|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815805|NCT01763827|3641148|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815806|NCT01763827|3641149|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815807|NCT01763827|3641150|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815808|NCT01763827|3641151|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815809|NCT01763827|3641145|B7|White||Race/Ethnicity, Customized||participants|Number|511|511.0||||||
3815810|NCT01763827|3641146|B6|White||Race/Ethnicity, Customized||participants|Number|129|129.0||||||
3815811|NCT01763827|3641147|B5|White||Race/Ethnicity, Customized||participants|Number|132|132.0||||||
3815812|NCT01763827|3641148|B4|White||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
3815813|NCT01763827|3641149|B3|White||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
3815814|NCT01763827|3641150|B2|White||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
3815815|NCT01763827|3641151|B1|White||Race/Ethnicity, Customized||participants|Number|64|64.0||||||
3815816|NCT01763827|3641145|B7|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815817|NCT01763827|3641146|B6|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815818|NCT01763827|3641147|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815819|NCT01763827|3641148|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815820|NCT01763827|3641149|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815821|NCT01763827|3641150|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815822|NCT01763827|3641151|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815823|NCT01763827|3641145|B7|Black or African American||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
3815824|NCT01763827|3641146|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3815825|NCT01763827|3641147|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3815826|NCT01763827|3641148|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3815827|NCT01763827|3641149|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3815828|NCT01763827|3641150|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3815829|NCT01763827|3641151|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3815830|NCT01763827|3641145|B7|Asian||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
3815831|NCT01763827|3641146|B6|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3815832|NCT01763827|3641147|B5|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3815833|NCT01763827|3641148|B4|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3815834|NCT01763827|3641149|B3|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3815835|NCT01763827|3641150|B2|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3815836|NCT01763827|3641151|B1|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3815837|NCT01763827|3641145|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3815838|NCT01763827|3641146|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3815839|NCT01763827|3641147|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815840|NCT01763827|3641148|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815841|NCT01763827|3641149|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815842|NCT01763827|3641150|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815843|NCT01763827|3641151|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815844|NCT01763827|3641145|B7||Male|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
3815845|NCT01763827|3641146|B6||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3815846|NCT01763827|3641147|B5||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3815847|NCT01763827|3641148|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3815848|NCT01763827|3641149|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3815849|NCT01763827|3641150|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3815850|NCT01763827|3641151|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3815851|NCT01763827|3641145|B7||Female|Sex: Female, Male||Participants|Count of Participants|406|406.0||||||
3815852|NCT01763827|3641146|B6||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3815853|NCT01763827|3641147|B5||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3815854|NCT01763827|3641148|B4||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3815855|NCT01763827|3641149|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3815856|NCT01763827|3641150|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3815857|NCT01763827|3641151|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3815858|NCT01763827|3641145|B7|||Age||years|Mean|53.1|53.1|Standard Deviation|12.1|12.1|||
3815859|NCT01763827|3641146|B6|||Age||years|Mean|52.9|52.9|Standard Deviation|12.1|12.1|||
3815860|NCT01763827|3641147|B5|||Age||years|Mean|52.5|52.5|Standard Deviation|13.7|13.7|||
3815861|NCT01763827|3641148|B4|||Age||years|Mean|53.0|53.0|Standard Deviation|12.7|12.7|||
3815862|NCT01763827|3641149|B3|||Age||years|Mean|53.9|53.9|Standard Deviation|11.3|11.3|||
3815863|NCT01763827|3641150|B2|||Age||years|Mean|52.6|52.6|Standard Deviation|10.7|10.7|||
3815864|NCT01763827|3641151|B1|||Age||years|Mean|54.4|54.4|Standard Deviation|10.3|10.3|||
3815865|NCT01763645|3641296|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3815866|NCT01763645|3641297|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3815867|NCT01763645|3641298|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3815868|NCT01763645|3641296|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3815869|NCT01763645|3641297|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3815870|NCT01763645|3641298|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3815871|NCT01763645|3641296|B3|||Age||years|Mean|58.23|58.23|Standard Deviation|8.61|8.61|||
3815872|NCT01763645|3641297|B2|||Age||years|Mean|58.67|58.67|Standard Deviation|8.33|8.33|||
3815873|NCT01763645|3641298|B1|||Age||years|Mean|57.79|57.79|Standard Deviation|8.88|8.88|||
3815874|NCT01763567|3641317|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3815875|NCT01763567|3641317|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3815876|NCT01763567|3641317|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3815879|NCT01763567|3641317|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3815880|NCT01763567|3641317|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3815881|NCT01763047|3641325|B3|United States||Region of Enrollment||participants|Number|276|276.0||||||
3815882|NCT01763047|3641326|B2|United States||Region of Enrollment||participants|Number|137|137.0||||||
3815883|NCT01763047|3641327|B1|United States||Region of Enrollment||participants|Number|139|139.0||||||
3815884|NCT01763047|3641325|B3|other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815885|NCT01763047|3641326|B2|other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815886|NCT01763047|3641327|B1|other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815887|NCT01763047|3641325|B3|White||Race/Ethnicity, Customized||participants|Number|244|244.0||||||
3815888|NCT01763047|3641326|B2|White||Race/Ethnicity, Customized||participants|Number|123|123.0||||||
3815889|NCT01763047|3641327|B1|White||Race/Ethnicity, Customized||participants|Number|121|121.0||||||
3815890|NCT01763047|3641325|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815891|NCT01763047|3641326|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3815892|NCT01763047|3641327|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815893|NCT01763047|3641325|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3815894|NCT01763047|3641326|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3815895|NCT01763047|3641327|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3815896|NCT01763047|3641325|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3815897|NCT01763047|3641326|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3815898|NCT01763047|3641327|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3815899|NCT01763047|3641325|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3815900|NCT01763047|3641326|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3815901|NCT01763047|3641327|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3815902|NCT01763047|3641325|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3815903|NCT01763047|3641326|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3815904|NCT01763047|3641327|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3815905|NCT01763047|3641325|B3||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
3815906|NCT01763047|3641326|B2||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3815907|NCT01763047|3641327|B1||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3815908|NCT01763047|3641325|B3|||Age||years|Mean|50.69|50.69|Standard Deviation|6.691|6.691|||
3815909|NCT01763047|3641326|B2|||Age||years|Mean|50.90|50.9|Standard Deviation|6.775|6.775|||
3815910|NCT01763047|3641327|B1|||Age||years|Mean|50.49|50.49|Standard Deviation|6.626|6.626|||
3815911|NCT01762982|3641344|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3815912|NCT01762982|3641344|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3815913|NCT01762982|3641344|B1|||Age||Years|Mean|36.2|36.2|Standard Deviation|12.27|12.27|||
3815914|NCT01762943|3641365|B3|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3815915|NCT01762943|3641366|B2|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3815916|NCT01762943|3641367|B1|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3815917|NCT01762943|3641365|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3815918|NCT01762943|3641366|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3815919|NCT01762943|3641367|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3815920|NCT01762943|3641365|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3815921|NCT01762943|3641366|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3815922|NCT01762943|3641367|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3815923|NCT01762943|3641365|B3||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3815924|NCT01762943|3641366|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3815925|NCT01762943|3641367|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3815926|NCT01762943|3641365|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3815927|NCT01762943|3641366|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3815928|NCT01762943|3641367|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3815929|NCT01762943|3641365|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3815930|NCT01762943|3641366|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3815931|NCT01762943|3641367|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3815932|NCT01762943|3641365|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3815933|NCT01762943|3641366|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3815934|NCT01762943|3641367|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3815935|NCT01762943|3641365|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3815936|NCT01762943|3641366|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3815937|NCT01762943|3641367|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3815938|NCT01762943|3641365|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3815939|NCT01762943|3641366|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3815940|NCT01762943|3641367|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3815941|NCT01762943|3641365|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3815942|NCT01762943|3641366|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3815943|NCT01762943|3641367|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3815944|NCT01762943|3641365|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3815945|NCT01762943|3641366|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3815946|NCT01762943|3641367|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3815947|NCT01762943|3641365|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3815948|NCT01762943|3641366|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3815949|NCT01762943|3641367|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3815950|NCT01762943|3641365|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3815951|NCT01762943|3641366|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3815952|NCT01762943|3641367|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3815953|NCT01762943|3641365|B3|||Age||years|Mean|35.639|35.639|Standard Deviation|4.580|4.58|||
3815954|NCT01762943|3641366|B2|||Age||years|Mean|36.294|36.294|Standard Deviation|4.224|4.224|||
3815955|NCT01762943|3641367|B1|||Age||years|Mean|35.053|35.053|Standard Deviation|4.916|4.916|||
3815956|NCT01762943|3641365|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3815957|NCT01762943|3641366|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3815958|NCT01762943|3641367|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3815959|NCT01762943|3641365|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3815960|NCT01762943|3641366|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3815961|NCT01762943|3641367|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3815962|NCT01762943|3641365|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3815963|NCT01762943|3641366|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3815964|NCT01762943|3641367|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3815965|NCT01762904|3641376|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3815966|NCT01762904|3641376|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3815967|NCT01762904|3641376|B1|||Age||years|Median|22|22.0|Inter-Quartile Range|||20.0|24.0|
3815968|NCT01762800|3641383|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|404|404.0||||||
3815969|NCT01762800|3641384|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|203|203.0||||||
3815970|NCT01762800|3641385|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|201|201.0||||||
3815971|NCT01762800|3641383|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3815972|NCT01762800|3641384|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3815973|NCT01762800|3641385|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3815974|NCT01762800|3641383|B3||Male|Sex: Female, Male||Participants|Count of Participants|385|385.0||||||
3815975|NCT01762800|3641384|B2||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
3815976|NCT01762800|3641385|B1||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
3815977|NCT01762800|3641383|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3815978|NCT01762800|3641384|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3815979|NCT01762800|3641385|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3815980|NCT01762800|3641383|B3|||Age||Years|Mean|68.3|68.3|Standard Deviation|7.02|7.02|||
3815981|NCT01762800|3641384|B2|||Age||Years|Mean|68.6|68.6|Standard Deviation|6.93|6.93|||
3815982|NCT01762800|3641385|B1|||Age||Years|Mean|68.0|68.0|Standard Deviation|7.12|7.12|||
3815983|NCT01762761|3641458|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|155|155.0||||||
3815984|NCT01762761|3641459|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|104|104.0||||||
3815985|NCT01762761|3641460|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|51|51.0||||||
3815986|NCT01762761|3641458|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3815987|NCT01762761|3641459|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3815988|NCT01762761|3641460|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3815989|NCT01762761|3641458|B3||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3815990|NCT01762761|3641459|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3815991|NCT01762761|3641460|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3815992|NCT01762761|3641458|B3|||Age||Years|Mean|43.6|43.6|Standard Deviation|15.01|15.01|||
3815993|NCT01762761|3641459|B2|||Age||Years|Mean|44.7|44.7|Standard Deviation|15.91|15.91|||
3815994|NCT01762761|3641460|B1|||Age||Years|Mean|41.3|41.3|Standard Deviation|12.83|12.83|||
3815995|NCT01762722|3641513|B3|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3815996|NCT01762722|3641514|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3815997|NCT01762722|3641515|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3815998|NCT01762722|3641513|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
3815999|NCT01762722|3641514|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3816000|NCT01762722|3641515|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
3816001|NCT01762722|3641513|B3|African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3816002|NCT01762722|3641514|B2|African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3816003|NCT01762722|3641515|B1|African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3816004|NCT01762722|3641513|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3816005|NCT01762722|3641514|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3816006|NCT01762722|3641515|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3816007|NCT01762722|3641513|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3816008|NCT01762722|3641514|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3816009|NCT01762722|3641515|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3816010|NCT01762722|3641513|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3816011|NCT01762722|3641514|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3816012|NCT01762722|3641515|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3816013|NCT01762722|3641513|B3|||Age||years|Mean|25|25.0|Full Range|6|6.0|21.0|34.0|
3816014|NCT01762722|3641514|B2|||Age||years|Mean|25|25.0|Full Range|4|4.0|21.0|31.0|
3816015|NCT01762722|3641515|B1|||Age||years|Mean|27|27.0|Full Range|6|6.0|22.0|36.0|
3816016|NCT01762501|3641522|B3|||24-hour DBP||mmHg|Mean|89.8|89.8|Standard Deviation|9.0|9.0|||
3816017|NCT01762501|3641523|B2|||24-hour DBP||mmHg|Mean|90.4|90.4|Standard Deviation|9.3|9.3|||
3816018|NCT01762501|3641524|B1|||24-hour DBP||mmHg|Mean|89.3|89.3|Standard Deviation|8.6|8.6|||
3816019|NCT01762501|3641522|B3|||24-hour SBP||mmHg|Mean|151.5|151.5|Standard Deviation|13.4|13.4|||
3816020|NCT01762501|3641523|B2|||24-hour SBP||mmHg|Mean|152.4|152.4|Standard Deviation|13.7|13.7|||
3816021|NCT01762501|3641524|B1|||24-hour SBP||mmHg|Mean|150.6|150.6|Standard Deviation|13.0|13.0|||
3816022|NCT01762501|3641522|B3|||Clinic DBP||mmHg|Mean|90.1|90.1|Standard Deviation|9.5|9.5|||
3816023|NCT01762501|3641523|B2|||Clinic DBP||mmHg|Mean|89.8|89.8|Standard Deviation|9.6|9.6|||
3816024|NCT01762501|3641524|B1|||Clinic DBP||mmHg|Mean|90.3|90.3|Standard Deviation|9.4|9.4|||
3816025|NCT01762501|3641522|B3|||Clinic SBP||mmHg|Mean|150.1|150.1|Standard Deviation|10.2|10.2|||
3816026|NCT01762501|3641523|B2|||Clinic SBP||mmHg|Mean|150.5|150.5|Standard Deviation|10.2|10.2|||
3816027|NCT01762501|3641524|B1|||Clinic SBP||mmHg|Mean|149.6|149.6|Standard Deviation|10.2|10.2|||
3816028|NCT01762501|3641522|B3|Japan||Region of Enrollment||participants|Number|718|718.0||||||
3816029|NCT01762501|3641523|B2|Japan||Region of Enrollment||participants|Number|359|359.0||||||
3816030|NCT01762501|3641524|B1|Japan||Region of Enrollment||participants|Number|359|359.0||||||
3816031|NCT01762501|3641522|B3||Male|Sex: Female, Male||Participants|Count of Participants|404|404.0||||||
3816032|NCT01762501|3641523|B2||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3816033|NCT01762501|3641524|B1||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3816034|NCT01762501|3641522|B3||Female|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
3816035|NCT01762501|3641523|B2||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3816036|NCT01762501|3641524|B1||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3816037|NCT01762501|3641522|B3|||Age||years|Mean|61|61.0|Standard Deviation|12|12.0|||
3816038|NCT01762501|3641523|B2|||Age||years|Mean|61|61.0|Standard Deviation|12|12.0|||
3816039|NCT01762501|3641524|B1|||Age||years|Mean|61|61.0|Standard Deviation|12|12.0|||
3816040|NCT01762345|3641539|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3816041|NCT01762345|3641539|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3816042|NCT01762345|3641539|B1|||Age||years|Mean|52.7|52.7|Standard Deviation|9.25|9.25|||
3816043|NCT01762059|3641549|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3816044|NCT01762059|3641549|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3816045|NCT01762059|3641549|B1|||Age||years|Mean|40|40.0|Standard Deviation|16|16.0|||
3816046|NCT01761747|3641576|B1|||Disease|Non-small cell lung cancer|participants|Number|3|3.0||||||
3816047|NCT01761747|3641576|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3816048|NCT01761747|3641576|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3816049|NCT01761747|3641576|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3816050|NCT01761747|3641576|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3816051|NCT01761747|3641576|B1|||Age||years|Mean|61|61.0|Full Range|||37.0|74.0|
3816052|NCT01761565|3641587|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3816053|NCT01761565|3641587|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3816054|NCT01761565|3641587|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3816055|NCT01761565|3641587|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3816056|NCT01761565|3641587|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3816057|NCT01761565|3641587|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3816058|NCT01761279|3641596|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3816059|NCT01761279|3641596|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3816060|NCT01761279|3641596|B1|||Age||Years|Mean|67.6|67.6|Full Range|||60.0|85.0|
3816061|NCT01761266|3641609|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3816062|NCT01761266|3641610|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3816063|NCT01761266|3641611|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3816064|NCT01761266|3641609|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816065|NCT01761266|3641610|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816066|NCT01761266|3641611|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816067|NCT01761266|3641609|B3||White|Race (NIH/OMB)||Participants|Count of Participants|276|276.0||||||
3816068|NCT01761266|3641610|B2||White|Race (NIH/OMB)||Participants|Count of Participants|141|141.0||||||
3816069|NCT01761266|3641611|B1||White|Race (NIH/OMB)||Participants|Count of Participants|135|135.0||||||
3816070|NCT01761266|3641609|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3816071|NCT01761266|3641610|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3816072|NCT01761266|3641611|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3816073|NCT01761266|3641609|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3816074|NCT01761266|3641610|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3816075|NCT01761266|3641611|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816076|NCT01761266|3641609|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|660|660.0||||||
3816077|NCT01761266|3641610|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|326|326.0||||||
3816078|NCT01761266|3641611|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|334|334.0||||||
3816079|NCT01761266|3641609|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3816080|NCT01761266|3641610|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816081|NCT01761266|3641611|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3816082|NCT01761266|3641609|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816083|NCT01761266|3641610|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816084|NCT01761266|3641611|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816085|NCT01761266|3641609|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|937|937.0||||||
3816086|NCT01761266|3641610|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|465|465.0||||||
3816087|NCT01761266|3641611|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|472|472.0||||||
3816088|NCT01761266|3641609|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3816089|NCT01761266|3641610|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3816090|NCT01761266|3641611|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3816091|NCT01761266|3641609|B3||Male|Sex: Female, Male||Participants|Count of Participants|806|806.0||||||
3816092|NCT01761266|3641610|B2||Male|Sex: Female, Male||Participants|Count of Participants|401|401.0||||||
3816093|NCT01761266|3641611|B1||Male|Sex: Female, Male||Participants|Count of Participants|405|405.0||||||
3816094|NCT01761266|3641609|B3||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3816095|NCT01761266|3641610|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3816096|NCT01761266|3641611|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3816097|NCT01761266|3641609|B3|||Age||years|Mean|61.3|61.3|Standard Deviation|11.84|11.84|||
3816098|NCT01761266|3641610|B2|||Age||years|Mean|61.2|61.2|Standard Deviation|12.01|12.01|||
3816099|NCT01761266|3641611|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|11.69|11.69|||
3816100|NCT01761175|3641638|B3|Elbow||Site of surgery||participants|Number|11|11.0||||||
3816101|NCT01761175|3641639|B2|Elbow||Site of surgery||participants|Number|6|6.0||||||
3816102|NCT01761175|3641640|B1|Elbow||Site of surgery||participants|Number|5|5.0||||||
3816103|NCT01761175|3641638|B3|Forearm||Site of surgery||participants|Number|6|6.0||||||
3816104|NCT01761175|3641639|B2|Forearm||Site of surgery||participants|Number|2|2.0||||||
3816105|NCT01761175|3641640|B1|Forearm||Site of surgery||participants|Number|4|4.0||||||
3816106|NCT01761175|3641638|B3|Wrist||Site of surgery||participants|Number|48|48.0||||||
3816107|NCT01761175|3641639|B2|Wrist||Site of surgery||participants|Number|25|25.0||||||
3816108|NCT01761175|3641640|B1|Wrist||Site of surgery||participants|Number|23|23.0||||||
3816109|NCT01761175|3641638|B3|Hand||Site of surgery||participants|Number|159|159.0||||||
3816110|NCT01761175|3641639|B2|Hand||Site of surgery||participants|Number|79|79.0||||||
3816111|NCT01761175|3641640|B1|Hand||Site of surgery||participants|Number|80|80.0||||||
3816112|NCT01761175|3641638|B3|ASA 3||American Society of Anesthesiologists (ASA) preoperative classification|ASA 1: A normal healthy patient ASA 2: A patient with mild systemic disease with no functional limitation ASA 3: A patient with severe systemic disease and functional limitations|participants|Number|9|9.0||||||
3816113|NCT01761175|3641639|B2|ASA 3||American Society of Anesthesiologists (ASA) preoperative classification|ASA 1: A normal healthy patient ASA 2: A patient with mild systemic disease with no functional limitation ASA 3: A patient with severe systemic disease and functional limitations|participants|Number|7|7.0||||||
3816161|NCT01760954|3641702|B5||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3816114|NCT01761175|3641640|B1|ASA 3||American Society of Anesthesiologists (ASA) preoperative classification|ASA 1: A normal healthy patient ASA 2: A patient with mild systemic disease with no functional limitation ASA 3: A patient with severe systemic disease and functional limitations|participants|Number|2|2.0||||||
3816115|NCT01761175|3641638|B3|ASA 2||American Society of Anesthesiologists (ASA) preoperative classification|ASA 1: A normal healthy patient ASA 2: A patient with mild systemic disease with no functional limitation ASA 3: A patient with severe systemic disease and functional limitations|participants|Number|82|82.0||||||
3816116|NCT01761175|3641639|B2|ASA 2||American Society of Anesthesiologists (ASA) preoperative classification|ASA 1: A normal healthy patient ASA 2: A patient with mild systemic disease with no functional limitation ASA 3: A patient with severe systemic disease and functional limitations|participants|Number|45|45.0||||||
3816117|NCT01761175|3641640|B1|ASA 2||American Society of Anesthesiologists (ASA) preoperative classification|ASA 1: A normal healthy patient ASA 2: A patient with mild systemic disease with no functional limitation ASA 3: A patient with severe systemic disease and functional limitations|participants|Number|37|37.0||||||
3816118|NCT01761175|3641638|B3|ASA 1||American Society of Anesthesiologists (ASA) preoperative classification|ASA 1: A normal healthy patient ASA 2: A patient with mild systemic disease with no functional limitation ASA 3: A patient with severe systemic disease and functional limitations|participants|Number|133|133.0||||||
3816119|NCT01761175|3641639|B2|ASA 1||American Society of Anesthesiologists (ASA) preoperative classification|ASA 1: A normal healthy patient ASA 2: A patient with mild systemic disease with no functional limitation ASA 3: A patient with severe systemic disease and functional limitations|participants|Number|60|60.0||||||
3816120|NCT01761175|3641640|B1|ASA 1||American Society of Anesthesiologists (ASA) preoperative classification|ASA 1: A normal healthy patient ASA 2: A patient with mild systemic disease with no functional limitation ASA 3: A patient with severe systemic disease and functional limitations|participants|Number|73|73.0||||||
3816121|NCT01761175|3641638|B3|||Diabetes||participants|Number|13|13.0||||||
3816122|NCT01761175|3641639|B2|||Diabetes||participants|Number|4|4.0||||||
3816123|NCT01761175|3641640|B1|||Diabetes||participants|Number|9|9.0||||||
3816124|NCT01761175|3641638|B3|||Body mass index (BMI)||kg/m^2|Mean|25.8|25.8|Standard Deviation|4.0|4.0|||
3816125|NCT01761175|3641639|B2|||Body mass index (BMI)||kg/m^2|Mean|26.4|26.4|Standard Deviation|4.1|4.1|||
3816126|NCT01761175|3641640|B1|||Body mass index (BMI)||kg/m^2|Mean|25.3|25.3|Standard Deviation|3.8|3.8|||
3816127|NCT01761175|3641638|B3||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3816128|NCT01761175|3641639|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3816129|NCT01761175|3641640|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3816130|NCT01761175|3641638|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3816131|NCT01761175|3641639|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3816132|NCT01761175|3641640|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3816133|NCT01761175|3641638|B3|||Age||years|Mean|50|50.0|Standard Deviation|17|17.0|||
3816134|NCT01761175|3641639|B2|||Age||years|Mean|48|48.0|Standard Deviation|19|19.0|||
3816135|NCT01761175|3641640|B1|||Age||years|Mean|52|52.0|Standard Deviation|16|16.0|||
3816136|NCT01761162|3641669|B1||Male|Gender||Participants|Count of Participants|158|158.0||||||
3816137|NCT01761162|3641669|B1||Female|Gender||Participants|Count of Participants|71|71.0||||||
3816138|NCT01761162|3641669|B1|||Age||years|Mean|71.2|71.2|Standard Deviation|10.7|10.7|||
3816139|NCT01761019|3641677|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3816140|NCT01761019|3641677|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3816141|NCT01761019|3641677|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3816142|NCT01761019|3641677|B1|||Age||years|Mean|51.375|51.375|Full Range|||38.0|65.0|
3816143|NCT01761019|3641677|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3816144|NCT01761019|3641677|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3816145|NCT01761019|3641677|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3816146|NCT01760954|3641702|B5||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3816147|NCT01760954|3641703|B4||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3816148|NCT01760954|3641704|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3816149|NCT01760954|3641705|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3816150|NCT01760954|3641706|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3816151|NCT01760954|3641702|B5||Multi race|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3816152|NCT01760954|3641703|B4||Multi race|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3816153|NCT01760954|3641704|B3||Multi race|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3816154|NCT01760954|3641705|B2||Multi race|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3816155|NCT01760954|3641706|B1||Multi race|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3816156|NCT01760954|3641702|B5||American Indian/Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3816157|NCT01760954|3641703|B4||American Indian/Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3816158|NCT01760954|3641704|B3||American Indian/Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3816159|NCT01760954|3641705|B2||American Indian/Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3816160|NCT01760954|3641706|B1||American Indian/Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3816162|NCT01760954|3641703|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3816163|NCT01760954|3641704|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3816164|NCT01760954|3641705|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3816165|NCT01760954|3641706|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3816166|NCT01760954|3641702|B5||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
3816167|NCT01760954|3641703|B4||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3816168|NCT01760954|3641704|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3816169|NCT01760954|3641705|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3816170|NCT01760954|3641706|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3816171|NCT01760954|3641702|B5||White|Race/Ethnicity, Customized||Participants|Count of Participants|450|450.0||||||
3816172|NCT01760954|3641703|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|95|95.0||||||
3816173|NCT01760954|3641704|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|96|96.0||||||
3816174|NCT01760954|3641705|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|126|126.0||||||
3816175|NCT01760954|3641706|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|133|133.0||||||
3816176|NCT01760954|3641702|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816177|NCT01760954|3641703|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816178|NCT01760954|3641704|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816179|NCT01760954|3641705|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816180|NCT01760954|3641706|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816181|NCT01760954|3641702|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|419|419.0||||||
3816182|NCT01760954|3641703|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3816183|NCT01760954|3641704|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
3816184|NCT01760954|3641705|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|117|117.0||||||
3816185|NCT01760954|3641706|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
3816186|NCT01760954|3641702|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3816187|NCT01760954|3641703|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3816188|NCT01760954|3641704|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3816189|NCT01760954|3641705|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3816190|NCT01760954|3641706|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3816191|NCT01760954|3641702|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3816192|NCT01760954|3641703|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3816193|NCT01760954|3641704|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3816194|NCT01760954|3641705|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3816195|NCT01760954|3641706|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3816196|NCT01760954|3641702|B5||Female|Sex: Female, Male||Participants|Count of Participants|504|504.0||||||
3816197|NCT01760954|3641703|B4||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3816198|NCT01760954|3641704|B3||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3816199|NCT01760954|3641705|B2||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3816200|NCT01760954|3641706|B1||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3816201|NCT01760954|3641702|B5|||Age||years|Mean|31.9|31.9|Standard Deviation|6.34|6.34|||
3816202|NCT01760954|3641703|B4|||Age||years|Mean|32.2|32.2|Standard Deviation|6.38|6.38|||
3816203|NCT01760954|3641704|B3|||Age||years|Mean|32.4|32.4|Standard Deviation|6.08|6.08|||
3816204|NCT01760954|3641705|B2|||Age||years|Mean|31.3|31.3|Standard Deviation|6.32|6.32|||
3816205|NCT01760954|3641706|B1|||Age||years|Mean|31.8|31.8|Standard Deviation|6.52|6.52|||
3816206|NCT01760941|3641787|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3816207|NCT01760941|3641787|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3816208|NCT01760941|3641787|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3816209|NCT01760941|3641787|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3816210|NCT01760941|3641787|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3816211|NCT01760941|3641787|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3816212|NCT01760876|3641846|B1|Hong Kong||Region of Enrollment||participants|Number|104|104.0||||||
3816213|NCT01760876|3641846|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3816214|NCT01760876|3641846|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3816215|NCT01760876|3641846|B1|||Age||years|Mean|63.99|63.99|Standard Deviation|10.71|10.71|||
3816216|NCT01760876|3641846|B1||>=65 years|Age||Participants|Count of Participants|55|55.0||||||
3816217|NCT01760876|3641846|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3816218|NCT01760876|3641846|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3816219|NCT01760785|3641850|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3816220|NCT01760785|3641851|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3816221|NCT01760785|3641852|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3816222|NCT01760785|3641850|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3816223|NCT01760785|3641851|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3816224|NCT01760785|3641852|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3816225|NCT01760785|3641850|B3|||Age||years|Mean|45.7|45.7|Standard Deviation|10.23|10.23|||
3816226|NCT01760785|3641851|B2|||Age||years|Mean|45.3|45.3|Standard Deviation|9.66|9.66|||
3816227|NCT01760785|3641852|B1|||Age||years|Mean|46.2|46.2|Standard Deviation|10.99|10.99|||
3816228|NCT01760785|3641850|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3816229|NCT01760785|3641851|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3816230|NCT01760785|3641852|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3816231|NCT01760785|3641850|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3816232|NCT01760785|3641851|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3816233|NCT01760785|3641852|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3816234|NCT01760785|3641850|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3816235|NCT01760785|3641851|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3816236|NCT01760785|3641852|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3816237|NCT01760473|3641859|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3816238|NCT01760473|3641859|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3816239|NCT01760473|3641859|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3816240|NCT01760473|3641859|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3816241|NCT01760473|3641859|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3816242|NCT01760473|3641859|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816243|NCT01760473|3641859|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3816244|NCT01760473|3641859|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816245|NCT01760473|3641859|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3816246|NCT01760473|3641859|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3816247|NCT01760473|3641859|B1|||Age||years|Mean|39.3|39.3|Standard Deviation|7.7|7.7|||
3816248|NCT01760304|3641880|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3816249|NCT01760304|3641881|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3816250|NCT01760304|3641882|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3816251|NCT01760304|3641880|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816252|NCT01760304|3641881|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816253|NCT01760304|3641882|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816254|NCT01760304|3641880|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816255|NCT01760304|3641881|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816256|NCT01760304|3641882|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816257|NCT01760304|3641880|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3816258|NCT01760304|3641881|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3816259|NCT01760304|3641882|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3816260|NCT01760304|3641880|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816261|NCT01760304|3641881|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816262|NCT01760304|3641882|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816263|NCT01760304|3641880|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816264|NCT01760304|3641881|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816265|NCT01760304|3641882|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816266|NCT01760304|3641880|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816267|NCT01760304|3641881|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816268|NCT01760304|3641882|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816269|NCT01760304|3641880|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816270|NCT01760304|3641881|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816271|NCT01760304|3641882|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816272|NCT01760304|3641880|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3816273|NCT01760304|3641881|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3816274|NCT01760304|3641882|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3816275|NCT01760304|3641880|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3816276|NCT01760304|3641881|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3816277|NCT01760304|3641882|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3816278|NCT01760304|3641880|B3|||Age||years|Mean|67|67.0|Standard Deviation|9|9.0|||
3816279|NCT01760304|3641881|B2|||Age||years|Mean|70|70.0|Standard Deviation|10|10.0|||
3816280|NCT01760304|3641882|B1|||Age||years|Mean|62|62.0|Standard Deviation|7|7.0|||
3816281|NCT01760187|3641893|B11|United Kingdom||Region of Enrollment||participants|Number|72|72.0||||||
3816282|NCT01760187|3641894|B10|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3816283|NCT01760187|3641895|B9|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3816284|NCT01760187|3641896|B8|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3816285|NCT01760187|3641897|B7|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3816286|NCT01760187|3641898|B6|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3816287|NCT01760187|3641899|B5|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3816288|NCT01760187|3641900|B4|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
3816289|NCT01760187|3641901|B3|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
3816290|NCT01760187|3641902|B2|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3816291|NCT01760187|3641903|B1|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3816292|NCT01760187|3641893|B11||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3816293|NCT01760187|3641894|B10||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3816294|NCT01760187|3641895|B9||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3816295|NCT01760187|3641896|B8||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3816296|NCT01760187|3641897|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3816297|NCT01760187|3641898|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3816298|NCT01760187|3641899|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3816299|NCT01760187|3641900|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3816300|NCT01760187|3641901|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3816301|NCT01760187|3641902|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3816302|NCT01760187|3641903|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3816303|NCT01760187|3641893|B11||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3816304|NCT01760187|3641894|B10||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3816305|NCT01760187|3641895|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3816306|NCT01760187|3641896|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3816307|NCT01760187|3641897|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3816308|NCT01760187|3641898|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3816309|NCT01760187|3641899|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3816310|NCT01760187|3641900|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3816311|NCT01760187|3641901|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3816312|NCT01760187|3641902|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3816313|NCT01760187|3641903|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3816314|NCT01760187|3641893|B11|||Age||years|Mean|33.3|33.3|Standard Deviation|6.2|6.2|||
3816315|NCT01760187|3641894|B10|||Age||years|Mean|37.7|37.7|Standard Deviation|3.4|3.4|||
3816316|NCT01760187|3641895|B9|||Age||years|Mean|30.2|30.2|Standard Deviation|5.4|5.4|||
3816317|NCT01760187|3641896|B8|||Age||years|Mean|31.2|31.2|Standard Deviation|9.7|9.7|||
3816318|NCT01760187|3641897|B7|||Age||years|Mean|32.5|32.5|Standard Deviation|4.6|4.6|||
3816319|NCT01760187|3641898|B6|||Age||years|Mean|36.0|36.0|Standard Deviation|7.5|7.5|||
3816320|NCT01760187|3641899|B5|||Age||years|Mean|32.2|32.2|Standard Deviation|5.4|5.4|||
3816321|NCT01760187|3641900|B4|||Age||years|Mean|31.2|31.2|Standard Deviation|6.6|6.6|||
3816322|NCT01760187|3641901|B3|||Age||years|Mean|33.8|33.8|Standard Deviation|6.0|6.0|||
3816323|NCT01760187|3641902|B2|||Age||years|Mean|33.6|33.6|Standard Deviation|7.3|7.3|||
3816324|NCT01760187|3641903|B1|||Age||years|Mean|34.1|34.1|Standard Deviation|6.0|6.0|||
3816325|NCT01760187|3641893|B11||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3816326|NCT01760187|3641894|B10||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3816327|NCT01760187|3641895|B9||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3816328|NCT01760187|3641896|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3816329|NCT01760187|3641897|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3816330|NCT01760187|3641898|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3816331|NCT01760187|3641899|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3816332|NCT01760187|3641900|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3816333|NCT01760187|3641901|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3816334|NCT01760187|3641902|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3816335|NCT01760187|3641903|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3816336|NCT01760187|3641893|B11||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
3816337|NCT01760187|3641894|B10||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3816338|NCT01760187|3641895|B9||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3816339|NCT01760187|3641896|B8||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3816340|NCT01760187|3641897|B7||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3816341|NCT01760187|3641898|B6||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3816342|NCT01760187|3641899|B5||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3816343|NCT01760187|3641900|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3816344|NCT01760187|3641901|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3816345|NCT01760187|3641902|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3816346|NCT01760187|3641903|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3816347|NCT01760187|3641893|B11||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3816348|NCT01760187|3641894|B10||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3816349|NCT01760187|3641895|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3816350|NCT01760187|3641896|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3816351|NCT01760187|3641897|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3816352|NCT01760187|3641898|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3816353|NCT01760187|3641899|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3816354|NCT01760187|3641900|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3816355|NCT01760187|3641901|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3816356|NCT01760187|3641902|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3816357|NCT01760187|3641903|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3816358|NCT01759602|3642135|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3816359|NCT01759602|3642135|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3816360|NCT01759602|3642135|B1|||Age||years|Median|41|41.0|Full Range|||21.0|63.0|
3816361|NCT01759511|3642143|B1|||Hemoglobin-Corrected Carbon dioxide diffusing capacity (DLCO) Predicted||DLCO % predicted|Mean|12.2|12.2|Standard Deviation|4.22|4.22|||
3816362|NCT01759511|3642143|B1|||Forced expirator volume in the first second of expiration (FEV1)/FVC Ratio||liter|Mean|0.8|0.8|Standard Deviation|0.23|0.23|||
3816363|NCT01759511|3642143|B1|Severe||FVC % Predicted Category||Participants|Count of Participants|6|6.0||||||
3816364|NCT01759511|3642143|B1|Moderate||FVC % Predicted Category||Participants|Count of Participants|16|16.0||||||
3816365|NCT01759511|3642143|B1|Mild||FVC % Predicted Category||Participants|Count of Participants|12|12.0||||||
3816366|NCT01759511|3642143|B1|||Forced vital capacity (FVC) Percent Predicted||FVC % predicted|Mean|69.9|69.9|Standard Deviation|14.18|14.18|||
3816367|NCT01759511|3642143|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3816368|NCT01759511|3642143|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3816369|NCT01759511|3642143|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3816370|NCT01759511|3642143|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3816371|NCT01759511|3642143|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3816372|NCT01759511|3642143|B1|||Age||years|Mean|67.9|67.9|Standard Deviation|7.25|7.25|||
3816373|NCT01759446|3642151|B6|United States||Region of Enrollment||participants|Number|40|40.0||||||
3816374|NCT01759446|3642152|B5|United States||Region of Enrollment||participants|Number|8|8.0||||||
3816375|NCT01759446|3642153|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
3816376|NCT01759446|3642154|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3816377|NCT01759446|3642155|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3816378|NCT01759446|3642156|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3816379|NCT01759446|3642151|B6||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3816380|NCT01759446|3642152|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3816381|NCT01759446|3642153|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3816382|NCT01759446|3642154|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3816383|NCT01759446|3642155|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3816384|NCT01759446|3642156|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3816385|NCT01759446|3642151|B6||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3816386|NCT01759446|3642152|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3816387|NCT01759446|3642153|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3816388|NCT01759446|3642154|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3816389|NCT01759446|3642155|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3816390|NCT01759446|3642156|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3816391|NCT01759446|3642151|B6|||Age||years|Mean|24.4|24.4|Standard Deviation|3.99|3.99|||
3816392|NCT01759446|3642152|B5|||Age||years|Mean|24.4|24.4|Standard Deviation|3.99|3.99|||
3816393|NCT01759446|3642153|B4|||Age||years|Mean|24.4|24.4|Standard Deviation|3.99|3.99|||
3816394|NCT01759446|3642154|B3|||Age||years|Mean|24.4|24.4|Standard Deviation|3.99|3.99|||
3816395|NCT01759446|3642155|B2|||Age||years|Mean|24.4|24.4|Standard Deviation|3.99|3.99|||
3816396|NCT01759446|3642156|B1|||Age||years|Mean|24.4|24.4|Standard Deviation|3.99|3.99|||
3816397|NCT01759446|3642151|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3816398|NCT01759446|3642152|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3816399|NCT01759446|3642153|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3816400|NCT01759446|3642154|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3816401|NCT01759446|3642155|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3816402|NCT01759446|3642156|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3816403|NCT01759446|3642151|B6||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3816404|NCT01759446|3642152|B5||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3816405|NCT01759446|3642153|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3816406|NCT01759446|3642154|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3816407|NCT01759446|3642155|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3816408|NCT01759446|3642156|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3816409|NCT01759446|3642151|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3816410|NCT01759446|3642152|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3816411|NCT01759446|3642153|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3816412|NCT01759446|3642154|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3816413|NCT01759446|3642155|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3816414|NCT01759446|3642156|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3816415|NCT01759420|3642172|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3816416|NCT01759420|3642172|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3816417|NCT01759420|3642172|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3816418|NCT01759420|3642172|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3816419|NCT01759420|3642172|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3816420|NCT01759407|3642177|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3816421|NCT01759407|3642177|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3816422|NCT01759407|3642178|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3816423|NCT01759407|3642179|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3816424|NCT01759407|3642177|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3816425|NCT01759407|3642178|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3816426|NCT01759407|3642179|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3816427|NCT01759407|3642177|B3|||Age||years|Mean|8|8.0|Standard Deviation|3|3.0|||
3816428|NCT01759407|3642178|B2|||Age||years|Mean|7.7|7.7|Standard Deviation|3.4|3.4|||
3816429|NCT01759407|3642179|B1|||Age||years|Mean|8.1|8.1|Standard Deviation|3.5|3.5|||
3816430|NCT01759381|3642190|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
3816431|NCT01759381|3642191|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3816432|NCT01759381|3642192|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3816433|NCT01759381|3642190|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3816434|NCT01759381|3642191|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3816435|NCT01759381|3642192|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3816436|NCT01759381|3642190|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3816437|NCT01759381|3642191|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3816438|NCT01759381|3642192|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3816439|NCT01759381|3642190|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3816440|NCT01759381|3642191|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3816441|NCT01759381|3642192|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3816442|NCT01759381|3642190|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3816443|NCT01759381|3642191|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3816444|NCT01759381|3642192|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3816445|NCT01759381|3642190|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3816446|NCT01759381|3642191|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3816447|NCT01759381|3642192|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3816448|NCT01759368|3642199|B3|||NT-proBNP|Plasma concentration of brain natriuretic peptide propeptide|ng/l|Median|1700|1700.0|Inter-Quartile Range|||727.0|3433.0|
3816449|NCT01759368|3642200|B2|||NT-proBNP|Plasma concentration of brain natriuretic peptide propeptide|ng/l|Median|1338|1338.0|Inter-Quartile Range|||474.0|2974.0|
3816450|NCT01759368|3642201|B1|||NT-proBNP|Plasma concentration of brain natriuretic peptide propeptide|ng/l|Median|2347|2347.0|Inter-Quartile Range|||998.0|3568.0|
3816451|NCT01759368|3642199|B3|||Diastolic blood pressure||mmHg|Mean|72|72.0|Standard Deviation|10|10.0|||
3816452|NCT01759368|3642200|B2|||Diastolic blood pressure||mmHg|Mean|72|72.0|Standard Deviation|10|10.0|||
3816453|NCT01759368|3642201|B1|||Diastolic blood pressure||mmHg|Mean|71|71.0|Standard Deviation|10|10.0|||
3816454|NCT01759368|3642199|B3|||Systolic blood pressure||mmHg|Mean|114|114.0|Standard Deviation|15|15.0|||
3816455|NCT01759368|3642200|B2|||Systolic blood pressure||mmHg|Mean|116|116.0|Standard Deviation|16|16.0|||
3816456|NCT01759368|3642201|B1|||Systolic blood pressure||mmHg|Mean|112|112.0|Standard Deviation|13|13.0|||
3816457|NCT01759368|3642199|B3|Non-smoker||Smoking||participants|Number|17|17.0||||||
3816458|NCT01759368|3642200|B2|Non-smoker||Smoking||participants|Number|5|5.0||||||
3816459|NCT01759368|3642201|B1|Non-smoker||Smoking||participants|Number|12|12.0||||||
3816460|NCT01759368|3642199|B3|Smoker||Smoking||participants|Number|77|77.0||||||
3816461|NCT01759368|3642200|B2|Smoker||Smoking||participants|Number|42|42.0||||||
3816462|NCT01759368|3642201|B1|Smoker||Smoking||participants|Number|35|35.0||||||
3816463|NCT01759368|3642199|B3|||Body mass index||kg/m2|Mean|28.2|28.2|Standard Deviation|5.4|5.4|||
3816464|NCT01759368|3642200|B2|||Body mass index||kg/m2|Mean|27.9|27.9|Standard Deviation|4.0|4.0|||
3816465|NCT01759368|3642201|B1|||Body mass index||kg/m2|Mean|28.4|28.4|Standard Deviation|6.0|6.0|||
3816466|NCT01759368|3642199|B3|‘Severe limitations in physical activity class IV||NYHA ( Functional Classification of the New York Heart Association)||participants|Number|3|3.0||||||
3816467|NCT01759368|3642200|B2|‘Severe limitations in physical activity class IV||NYHA ( Functional Classification of the New York Heart Association)||participants|Number|2|2.0||||||
3816468|NCT01759368|3642201|B1|‘Severe limitations in physical activity class IV||NYHA ( Functional Classification of the New York Heart Association)||participants|Number|1|1.0||||||
3816469|NCT01759368|3642199|B3|‘Marked limitation in physical activity class III||NYHA ( Functional Classification of the New York Heart Association)||participants|Number|55|55.0||||||
3816470|NCT01759368|3642200|B2|‘Marked limitation in physical activity class III||NYHA ( Functional Classification of the New York Heart Association)||participants|Number|28|28.0||||||
3816471|NCT01759368|3642201|B1|‘Marked limitation in physical activity class III||NYHA ( Functional Classification of the New York Heart Association)||participants|Number|27|27.0||||||
3816472|NCT01759368|3642199|B3|‘Slight limitations in physical activity class II’||NYHA ( Functional Classification of the New York Heart Association)||participants|Number|36|36.0||||||
3816473|NCT01759368|3642200|B2|‘Slight limitations in physical activity class II’||NYHA ( Functional Classification of the New York Heart Association)||participants|Number|17|17.0||||||
3816474|NCT01759368|3642201|B1|‘Slight limitations in physical activity class II’||NYHA ( Functional Classification of the New York Heart Association)||participants|Number|19|19.0||||||
3816475|NCT01759368|3642199|B3|||left ventricular ejection fraction||percentage|Mean|28.0|28.0|Standard Deviation|5.0|5.0|||
3816476|NCT01759368|3642200|B2|||left ventricular ejection fraction||percentage|Mean|28.6|28.6|Standard Deviation|5.0|5.0|||
3816477|NCT01759368|3642201|B1|||left ventricular ejection fraction||percentage|Mean|27.3|27.3|Standard Deviation|4.9|4.9|||
3816478|NCT01759368|3642199|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3816479|NCT01759368|3642200|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3816480|NCT01759368|3642201|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3816481|NCT01759368|3642199|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3816482|NCT01759368|3642200|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3816483|NCT01759368|3642201|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3816484|NCT01759368|3642199|B3|||Age||years|Mean|58.0|58.0|Standard Deviation|11.7|11.7|||
3816485|NCT01759368|3642200|B2|||Age||years|Mean|58.3|58.3|Standard Deviation|11.6|11.6|||
3816486|NCT01759368|3642201|B1|||Age||years|Mean|57.9|57.9|Standard Deviation|11.9|11.9|||
3816487|NCT01759290|3642220|B1|Philippines||Region of Enrollment||participants|Number|5|5.0||||||
3816488|NCT01759290|3642220|B1|Italy||Region of Enrollment||participants|Number|12|12.0||||||
3816489|NCT01759290|3642220|B1|Poland||Region of Enrollment||participants|Number|22|22.0||||||
3816490|NCT01759290|3642220|B1|Vietnam||Region of Enrollment||participants|Number|33|33.0||||||
3816491|NCT01759290|3642220|B1|Bahrain||Region of Enrollment||participants|Number|33|33.0||||||
3816492|NCT01759290|3642220|B1|Jordan||Region of Enrollment||participants|Number|37|37.0||||||
3816493|NCT01759290|3642220|B1|Saudi Arabia||Region of Enrollment||participants|Number|39|39.0||||||
3816494|NCT01759290|3642220|B1|New Zealand||Region of Enrollment||participants|Number|42|42.0||||||
3816495|NCT01759290|3642220|B1|Austria||Region of Enrollment||participants|Number|51|51.0||||||
3816496|NCT01759290|3642220|B1|Switzerland||Region of Enrollment||participants|Number|59|59.0||||||
3816497|NCT01759290|3642220|B1|France||Region of Enrollment||participants|Number|59|59.0||||||
3816498|NCT01759290|3642220|B1|Indonesia||Region of Enrollment||participants|Number|64|64.0||||||
3816499|NCT01759290|3642220|B1|United Arab Emirates||Region of Enrollment||participants|Number|65|65.0||||||
3816500|NCT01759290|3642220|B1|Colombia||Region of Enrollment||participants|Number|74|74.0||||||
3816501|NCT01759290|3642220|B1|Thailand||Region of Enrollment||participants|Number|75|75.0||||||
3816502|NCT01759290|3642220|B1|Malaysia||Region of Enrollment||participants|Number|88|88.0||||||
3816503|NCT01759290|3642220|B1|Singapore||Region of Enrollment||participants|Number|93|93.0||||||
3816504|NCT01759290|3642220|B1|Belgium||Region of Enrollment||participants|Number|119|119.0||||||
3816505|NCT01759290|3642220|B1|Netherlands||Region of Enrollment||participants|Number|144|144.0||||||
3816506|NCT01759290|3642220|B1|Spain||Region of Enrollment||participants|Number|308|308.0||||||
3816507|NCT01759290|3642220|B1|Germany||Region of Enrollment||participants|Number|378|378.0||||||
3816508|NCT01759290|3642220|B1||Male|Sex: Female, Male||Participants|Count of Participants|1438|1438.0||||||
3816509|NCT01759290|3642220|B1||Female|Sex: Female, Male||Participants|Count of Participants|362|362.0||||||
3816510|NCT01759290|3642220|B1|||Age||years|Mean|58.8|58.8|Standard Deviation|11|11.0|||
3816511|NCT01759264|3642280|B1|Per PP Set (N=83)||Fecal Calprotectin||microgram/gram|Mean|1871.02|1871.02|Standard Deviation|2345.65|2345.65|||
3816512|NCT01759264|3642280|B1|Per ITT Set (N=92)||Fecal Calprotectin||microgram/gram|Mean|1799.59|1799.59|Standard Deviation|2275.28|2275.28|||
3816513|NCT01759264|3642280|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3816514|NCT01759264|3642280|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3816515|NCT01759264|3642280|B1|||Age||Years|Mean|30.72|30.72|Standard Deviation|8.90|8.9|||
3816516|NCT01759251|3642293|B1|Russian Federation||Region of Enrollment||participants|Number|207|207.0||||||
3816517|NCT01759251|3642293|B1|Ukraine||Region of Enrollment||participants|Number|102|102.0||||||
3816518|NCT01759251|3642293|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3816519|NCT01759251|3642293|B1||Female|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
3816520|NCT01759251|3642293|B1|||Age||years|Mean|53.5|53.5|Standard Deviation|15.1|15.1|||
3816521|NCT01759160|3642297|B3|China||Region of Enrollment||participants|Number|60|60.0||||||
3816522|NCT01759160|3642298|B2|China||Region of Enrollment||participants|Number|30|30.0||||||
3816523|NCT01759160|3642299|B1|China||Region of Enrollment||participants|Number|30|30.0||||||
3816524|NCT01759160|3642297|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3816525|NCT01759160|3642298|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3816526|NCT01759160|3642299|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3816527|NCT01759160|3642297|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3816528|NCT01759160|3642298|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3816529|NCT01759160|3642299|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3816530|NCT01759160|3642297|B3|||Age||years|Mean|40.9|40.9|Standard Deviation|11.8|11.8|||
3816531|NCT01759160|3642298|B2|||Age||years|Mean|41.6|41.6|Standard Deviation|10.6|10.6|||
3816532|NCT01759160|3642299|B1|||Age||years|Mean|40.1|40.1|Standard Deviation|13.1|13.1|||
3816533|NCT01759160|3642297|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3816534|NCT01759160|3642298|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3816535|NCT01759160|3642299|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3816536|NCT01759160|3642297|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3816537|NCT01759160|3642298|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3816538|NCT01759160|3642299|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3816539|NCT01759160|3642297|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3816540|NCT01759160|3642298|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3816541|NCT01759160|3642299|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3816542|NCT01758900|3642306|B3|Vomiting||indications||participants|Number|4|4.0||||||
3816543|NCT01758900|3642307|B2|Vomiting||indications||participants|Number|2|2.0||||||
3816544|NCT01758900|3642308|B1|Vomiting||indications||participants|Number|2|2.0||||||
3816545|NCT01758900|3642306|B3|Nausea||indications||participants|Number|2|2.0||||||
3816546|NCT01758900|3642307|B2|Nausea||indications||participants|Number|0|0.0||||||
3816547|NCT01758900|3642308|B1|Nausea||indications||participants|Number|2|2.0||||||
3816548|NCT01758900|3642306|B3|Weight loss||indications||participants|Number|4|4.0||||||
3816549|NCT01758900|3642307|B2|Weight loss||indications||participants|Number|2|2.0||||||
3816550|NCT01758900|3642308|B1|Weight loss||indications||participants|Number|2|2.0||||||
3816551|NCT01758900|3642306|B3|Abdominal distension||indications||participants|Number|12|12.0||||||
3816552|NCT01758900|3642307|B2|Abdominal distension||indications||participants|Number|5|5.0||||||
3816553|NCT01758900|3642308|B1|Abdominal distension||indications||participants|Number|7|7.0||||||
3816554|NCT01758900|3642306|B3|Diarrhoea||indications||participants|Number|25|25.0||||||
3816555|NCT01758900|3642307|B2|Diarrhoea||indications||participants|Number|14|14.0||||||
3816556|NCT01758900|3642308|B1|Diarrhoea||indications||participants|Number|11|11.0||||||
3816557|NCT01758900|3642306|B3|occult gastrointestinal bleeding||indications||participants|Number|79|79.0||||||
3816558|NCT01758900|3642307|B2|occult gastrointestinal bleeding||indications||participants|Number|38|38.0||||||
3816559|NCT01758900|3642308|B1|occult gastrointestinal bleeding||indications||participants|Number|41|41.0||||||
3816560|NCT01758900|3642306|B3|abdominal pain||indications||participants|Number|88|88.0||||||
3816561|NCT01758900|3642307|B2|abdominal pain||indications||participants|Number|47|47.0||||||
3816562|NCT01758900|3642308|B1|abdominal pain||indications||participants|Number|41|41.0||||||
3816563|NCT01758900|3642306|B3|||Course of disease (month)||months|Mean|13.5|13.5|Standard Deviation|21.1|21.1|||
3816564|NCT01758900|3642307|B2|||Course of disease (month)||months|Mean|13.9|13.9|Standard Deviation|22.1|22.1|||
3816565|NCT01758900|3642308|B1|||Course of disease (month)||months|Mean|13.1|13.1|Standard Deviation|20.2|20.2|||
3816566|NCT01758900|3642306|B3||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3816567|NCT01758900|3642307|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3816568|NCT01758900|3642308|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3816569|NCT01758900|3642306|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3816570|NCT01758900|3642307|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3816571|NCT01758900|3642308|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3816572|NCT01758900|3642306|B3|||Age||years|Mean|40.8|40.8|Standard Deviation|16|16.0|||
3816573|NCT01758900|3642307|B2|||Age||years|Mean|40.5|40.5|Standard Deviation|17.6|17.6|||
3816574|NCT01758900|3642308|B1|||Age||years|Mean|41.2|41.2|Standard Deviation|14.3|14.3|||
3816575|NCT01758588|3642327|B3|United States|Emory University|Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3816576|NCT01758588|3642328|B2|United States|Emory University|Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3816577|NCT01758588|3642329|B1|United States|Emory University|Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3816578|NCT01758588|3642327|B3|United States|Weill Cornell Medicine|Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3816579|NCT01758588|3642328|B2|United States|Weill Cornell Medicine|Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3816580|NCT01758588|3642329|B1|United States|Weill Cornell Medicine|Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3816581|NCT01758588|3642327|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3816582|NCT01758588|3642328|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816583|NCT01758588|3642329|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3816584|NCT01758588|3642327|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816585|NCT01758588|3642328|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816586|NCT01758588|3642329|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816587|NCT01758588|3642327|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3816588|NCT01758588|3642328|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3816589|NCT01758588|3642329|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3816590|NCT01758588|3642327|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816591|NCT01758588|3642328|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816592|NCT01758588|3642329|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816593|NCT01758588|3642327|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816594|NCT01758588|3642328|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816595|NCT01758588|3642329|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816596|NCT01758588|3642327|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816597|NCT01758588|3642328|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816598|NCT01758588|3642329|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816599|NCT01758588|3642327|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816600|NCT01758588|3642328|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816601|NCT01758588|3642329|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816602|NCT01758588|3642327|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3816603|NCT01758588|3642328|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3816604|NCT01758588|3642329|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3816605|NCT01758588|3642327|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3816606|NCT01758588|3642328|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3816607|NCT01758588|3642329|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3816608|NCT01758588|3642327|B3|||Age||years|Mean|69.9|69.9|Standard Deviation|7.1|7.1|||
3816609|NCT01758588|3642328|B2|||Age||years|Mean|69.1|69.1|Standard Deviation|5.5|5.5|||
3816610|NCT01758588|3642329|B1|||Age||years|Mean|71.9|71.9|Standard Deviation|6.2|6.2|||
3816611|NCT01758588|3642327|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3816612|NCT01758588|3642328|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3816613|NCT01758588|3642329|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3816614|NCT01758588|3642327|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3816615|NCT01758588|3642328|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3816616|NCT01758588|3642329|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3816617|NCT01758588|3642327|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3816618|NCT01758588|3642328|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3816619|NCT01758588|3642329|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3816620|NCT01758432|3642340|B8||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3816621|NCT01758432|3642341|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3816622|NCT01758432|3642342|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3816623|NCT01758432|3642343|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3816624|NCT01758432|3642344|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3816625|NCT01758432|3642345|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3816626|NCT01758432|3642346|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3816627|NCT01758432|3642347|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3816628|NCT01758432|3642340|B8||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3816629|NCT01758432|3642341|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3816630|NCT01758432|3642342|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3816631|NCT01758432|3642343|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3816632|NCT01758432|3642344|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3816633|NCT01758432|3642345|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3816634|NCT01758432|3642346|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3816635|NCT01758432|3642347|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3816636|NCT01758432|3642340|B8|||Age|54 subjects were enrolled in this study.|years|Mean|33.2|33.2|Standard Deviation|7.42|7.42|||
3816637|NCT01758432|3642341|B7|||Age|54 subjects were enrolled in this study.|years|Mean|31.8|31.8|Standard Deviation|6.97|6.97|||
3816638|NCT01758432|3642342|B6|||Age|54 subjects were enrolled in this study.|years|Mean|32.5|32.5|Standard Deviation|8.60|8.6|||
3816639|NCT01758432|3642343|B5|||Age|54 subjects were enrolled in this study.|years|Mean|31.7|31.7|Standard Deviation|9.50|9.5|||
3816640|NCT01758432|3642344|B4|||Age|54 subjects were enrolled in this study.|years|Mean|33.8|33.8|Standard Deviation|5.78|5.78|||
3816641|NCT01758432|3642345|B3|||Age|54 subjects were enrolled in this study.|years|Mean|35.0|35.0|Standard Deviation|7.32|7.32|||
3816642|NCT01758432|3642346|B2|||Age|54 subjects were enrolled in this study.|years|Mean|33.7|33.7|Standard Deviation|8.48|8.48|||
3816643|NCT01758432|3642347|B1|||Age|54 subjects were enrolled in this study.|years|Mean|33.4|33.4|Standard Deviation|7.69|7.69|||
3816644|NCT01758289|3642425|B1|Not Reported||Sex/Gender, Customized||participants|Number|1|1.0||||||
3816645|NCT01758289|3642425|B1|Male||Sex/Gender, Customized||participants|Number|67|67.0||||||
3816646|NCT01758289|3642425|B1|Female||Sex/Gender, Customized||participants|Number|37|37.0||||||
3816647|NCT01758289|3642425|B1|||Age|Missing data of one (1) participant, for whom age (years) was not reported.|years|Mean|53.00|53.0|Standard Deviation|13.90|13.9|||
3816648|NCT01757964|3642442|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3816649|NCT01757964|3642443|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3816650|NCT01757964|3642444|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3816651|NCT01757964|3642442|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3816652|NCT01757964|3642443|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3816653|NCT01757964|3642444|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3816654|NCT01757964|3642442|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3816655|NCT01757964|3642443|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3816656|NCT01757964|3642444|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3816657|NCT01757964|3642442|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3816658|NCT01757964|3642443|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3816659|NCT01757964|3642444|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3816660|NCT01757964|3642442|B3||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
3816661|NCT01757964|3642443|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3816662|NCT01757964|3642444|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3816663|NCT01757847|3642449|B3|||Binge Eating Scale|This measure contains 16 questions that describe both behavioral and emotional manifestations of a binge episode. This scale was specifically developed to assess binge eating severity and associated emotional distress in overweight and obese individuals. The total score for the measure ranges from 0-46 points with higher scores indicating greater problems with binge eating and lower scores indicating better outcome.|units on a scale|Mean|16.47|16.47|Standard Deviation|8.80|8.8|||
3816664|NCT01757847|3642450|B2|||Binge Eating Scale|This measure contains 16 questions that describe both behavioral and emotional manifestations of a binge episode. This scale was specifically developed to assess binge eating severity and associated emotional distress in overweight and obese individuals. The total score for the measure ranges from 0-46 points with higher scores indicating greater problems with binge eating and lower scores indicating better outcome.|units on a scale|Mean|15.53|15.53|Standard Deviation|9.28|9.28|||
3816665|NCT01757847|3642451|B1|||Binge Eating Scale|This measure contains 16 questions that describe both behavioral and emotional manifestations of a binge episode. This scale was specifically developed to assess binge eating severity and associated emotional distress in overweight and obese individuals. The total score for the measure ranges from 0-46 points with higher scores indicating greater problems with binge eating and lower scores indicating better outcome.|units on a scale|Mean|17.48|17.48|Standard Deviation|8.25|8.25|||
3816666|NCT01757847|3642449|B3|United States||Region of Enrollment||participants|Number|90|90.0||||||
3816667|NCT01757847|3642450|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
3816668|NCT01757847|3642451|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
3816669|NCT01757847|3642449|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3816670|NCT01757847|3642450|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816671|NCT01757847|3642451|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3816672|NCT01757847|3642449|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816673|NCT01757847|3642450|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816674|NCT01757847|3642451|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816675|NCT01757847|3642449|B3||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3816676|NCT01757847|3642450|B2||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3816677|NCT01757847|3642451|B1||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3816678|NCT01757847|3642449|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3816679|NCT01757847|3642450|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3816680|NCT01757847|3642451|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3816681|NCT01757847|3642449|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816682|NCT01757847|3642450|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816683|NCT01757847|3642451|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816684|NCT01757847|3642449|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3816685|NCT01757847|3642450|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3816686|NCT01757847|3642451|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816687|NCT01757847|3642449|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3816688|NCT01757847|3642450|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3816749|NCT01757704|3642475|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3816689|NCT01757847|3642451|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3816690|NCT01757847|3642449|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816691|NCT01757847|3642450|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816692|NCT01757847|3642451|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816693|NCT01757847|3642449|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3816694|NCT01757847|3642450|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3816695|NCT01757847|3642451|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3816696|NCT01757847|3642449|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3816697|NCT01757847|3642450|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3816698|NCT01757847|3642451|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3816699|NCT01757847|3642449|B3||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3816700|NCT01757847|3642450|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3816701|NCT01757847|3642451|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3816702|NCT01757847|3642449|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3816703|NCT01757847|3642450|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3816704|NCT01757847|3642451|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3816705|NCT01757847|3642449|B3|||Age||years|Mean|56.87|56.87|Standard Deviation|9.83|9.83|||
3816706|NCT01757847|3642450|B2|||Age||years|Mean|56.23|56.23|Standard Deviation|10.34|10.34|||
3816707|NCT01757847|3642451|B1|||Age||years|Mean|57.52|57.52|Standard Deviation|9.33|9.33|||
3816708|NCT01757821|3642460|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3816709|NCT01757821|3642460|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3816710|NCT01757821|3642460|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3816711|NCT01757821|3642460|B1|||Age||years|Mean|66|66.0|Standard Deviation|9.4|9.4|||
3816712|NCT01757821|3642460|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3816713|NCT01757821|3642460|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3816714|NCT01757821|3642460|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3816715|NCT01757717|3642468|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3816716|NCT01757717|3642468|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3816717|NCT01757717|3642468|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816718|NCT01757717|3642468|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3816719|NCT01757717|3642468|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816720|NCT01757717|3642468|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816721|NCT01757717|3642468|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3816722|NCT01757717|3642468|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816723|NCT01757717|3642468|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3816724|NCT01757717|3642468|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3816725|NCT01757717|3642468|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816726|NCT01757717|3642468|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3816727|NCT01757717|3642468|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3816728|NCT01757717|3642468|B1|||Age||years|Mean|64|64.0|Full Range|||46.0|76.0|
3816729|NCT01757704|3642473|B3|Sweden||Region of Enrollment||participants|Number|20|20.0||||||
3816730|NCT01757704|3642474|B2|Sweden||Region of Enrollment||participants|Number|10|10.0||||||
3816731|NCT01757704|3642475|B1|Sweden||Region of Enrollment||participants|Number|10|10.0||||||
3816732|NCT01757704|3642473|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3816733|NCT01757704|3642474|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3816734|NCT01757704|3642475|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3816735|NCT01757704|3642473|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3816736|NCT01757704|3642474|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3816737|NCT01757704|3642475|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3816738|NCT01757704|3642473|B3|||Age||years|Mean|70.2|70.2|Standard Deviation|11.7|11.7|||
3816739|NCT01757704|3642474|B2|||Age||years|Mean|71.1|71.1|Standard Deviation|11.5|11.5|||
3816740|NCT01757704|3642475|B1|||Age||years|Mean|69.2|69.2|Standard Deviation|12.5|12.5|||
3816741|NCT01757704|3642473|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3816742|NCT01757704|3642474|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3816743|NCT01757704|3642475|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3816744|NCT01757704|3642473|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3816745|NCT01757704|3642474|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3816746|NCT01757704|3642475|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3816747|NCT01757704|3642473|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3816748|NCT01757704|3642474|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3816750|NCT01757691|3642494|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3816751|NCT01757691|3642494|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3816752|NCT01757691|3642494|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3816753|NCT01757691|3642494|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3816754|NCT01757691|3642494|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3816755|NCT01757678|3642508|B1|||Left ventricular ejection fraction, %||percent|Mean|62|62.0|Standard Deviation|7|7.0|||
3816756|NCT01757678|3642508|B1|||Creatinine, mg/dl||mg/dl|Mean|0.9|0.9|Standard Deviation|.2|0.2|||
3816757|NCT01757678|3642508|B1|||Body Mass Index, kg/m^2||kg/m^2|Mean|26|26.0|Standard Deviation|4|4.0|||
3816758|NCT01757678|3642508|B1|No Previous Myocardial Infarction||Previous myocardial infarction||participants|Number|271|271.0||||||
3816759|NCT01757678|3642508|B1|Previous Myocardial Infarction||Previous myocardial infarction||participants|Number|5|5.0||||||
3816760|NCT01757678|3642508|B1|Unknown||Current smoker||participants|Number|2|2.0||||||
3816761|NCT01757678|3642508|B1|Never Smoked||Current smoker||participants|Number|118|118.0||||||
3816762|NCT01757678|3642508|B1|Former Smoker||Current smoker||participants|Number|106|106.0||||||
3816763|NCT01757678|3642508|B1|Current Smoker||Current smoker||participants|Number|50|50.0||||||
3816764|NCT01757678|3642508|B1|Unknown Hiperlipidemia Status||Hyperlipidemia||participants|Number|2|2.0||||||
3816765|NCT01757678|3642508|B1|Without Hyperlipidemia||Hyperlipidemia||participants|Number|60|60.0||||||
3816766|NCT01757678|3642508|B1|With Hyperlipidemia||Hyperlipidemia||participants|Number|214|214.0||||||
3816767|NCT01757678|3642508|B1|Without Hypertension||Hypertension||participants|Number|88|88.0||||||
3816768|NCT01757678|3642508|B1|With Hypertension||Hypertension||participants|Number|188|188.0||||||
3816769|NCT01757678|3642508|B1|Without Diabetes||Diabetes||participants|Number|214|214.0||||||
3816770|NCT01757678|3642508|B1|With Diabetes||Diabetes||participants|Number|62|62.0||||||
3816771|NCT01757678|3642508|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3816772|NCT01757678|3642508|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816773|NCT01757678|3642508|B1||White|Race (NIH/OMB)||Participants|Count of Participants|179|179.0||||||
3816774|NCT01757678|3642508|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816775|NCT01757678|3642508|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816776|NCT01757678|3642508|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3816777|NCT01757678|3642508|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816778|NCT01757678|3642508|B1||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
3816779|NCT01757678|3642508|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3816780|NCT01757678|3642508|B1|||Age||years|Mean|64|64.0|Standard Deviation|10|10.0|||
3816781|NCT01757561|3642520|B5|ASA Ⅲ||ASA|"ASA I No organic, physiologic, biochemical or psychiatric disturbance ASA II A patient with mild systemic disease that results in no functional limitation. Examples: well-controlled hypertension, uncomplicated diabetes mellitus.~ASA III A patient with severe systemic disease that results in functional impairment ASA IV Severe systemic disease that is a constant threat to life. ASA V Moribund condition in a patient who is not expected to survive with or without the operation.~ASA VI Declared brain death patient whose organs are being harvested for transplantation."|participants|Number|24|24.0||||||
3816782|NCT01757561|3642521|B4|ASA Ⅲ||ASA|"ASA I No organic, physiologic, biochemical or psychiatric disturbance ASA II A patient with mild systemic disease that results in no functional limitation. Examples: well-controlled hypertension, uncomplicated diabetes mellitus.~ASA III A patient with severe systemic disease that results in functional impairment ASA IV Severe systemic disease that is a constant threat to life. ASA V Moribund condition in a patient who is not expected to survive with or without the operation.~ASA VI Declared brain death patient whose organs are being harvested for transplantation."|participants|Number|8|8.0||||||
3816783|NCT01757561|3642522|B3|ASA Ⅲ||ASA|"ASA I No organic, physiologic, biochemical or psychiatric disturbance ASA II A patient with mild systemic disease that results in no functional limitation. Examples: well-controlled hypertension, uncomplicated diabetes mellitus.~ASA III A patient with severe systemic disease that results in functional impairment ASA IV Severe systemic disease that is a constant threat to life. ASA V Moribund condition in a patient who is not expected to survive with or without the operation.~ASA VI Declared brain death patient whose organs are being harvested for transplantation."|participants|Number|8|8.0||||||
3816784|NCT01757561|3642523|B2|ASA Ⅲ||ASA|"ASA I No organic, physiologic, biochemical or psychiatric disturbance ASA II A patient with mild systemic disease that results in no functional limitation. Examples: well-controlled hypertension, uncomplicated diabetes mellitus.~ASA III A patient with severe systemic disease that results in functional impairment ASA IV Severe systemic disease that is a constant threat to life. ASA V Moribund condition in a patient who is not expected to survive with or without the operation.~ASA VI Declared brain death patient whose organs are being harvested for transplantation."|participants|Number|6|6.0||||||
3816785|NCT01757561|3642524|B1|ASA Ⅲ||ASA|"ASA I No organic, physiologic, biochemical or psychiatric disturbance ASA II A patient with mild systemic disease that results in no functional limitation. Examples: well-controlled hypertension, uncomplicated diabetes mellitus.~ASA III A patient with severe systemic disease that results in functional impairment ASA IV Severe systemic disease that is a constant threat to life. ASA V Moribund condition in a patient who is not expected to survive with or without the operation.~ASA VI Declared brain death patient whose organs are being harvested for transplantation."|participants|Number|2|2.0||||||
3816826|NCT01757275|3642562|B1|<=2 cm||Number of patients with ulcers of different sizes||participants|Number|105|105.0||||||
3816827|NCT01757275|3642560|B3|Stomach and Duodenum||Ulcer location||participants|Number|17|17.0||||||
3816828|NCT01757275|3642561|B2|Stomach and Duodenum||Ulcer location||participants|Number|10|10.0||||||
3816829|NCT01757275|3642562|B1|Stomach and Duodenum||Ulcer location||participants|Number|7|7.0||||||
3816786|NCT01757561|3642520|B5|ASAⅡ||ASA|"ASA I No organic, physiologic, biochemical or psychiatric disturbance ASA II A patient with mild systemic disease that results in no functional limitation. Examples: well-controlled hypertension, uncomplicated diabetes mellitus.~ASA III A patient with severe systemic disease that results in functional impairment ASA IV Severe systemic disease that is a constant threat to life. ASA V Moribund condition in a patient who is not expected to survive with or without the operation.~ASA VI Declared brain death patient whose organs are being harvested for transplantation."|participants|Number|92|92.0||||||
3816787|NCT01757561|3642521|B4|ASAⅡ||ASA|"ASA I No organic, physiologic, biochemical or psychiatric disturbance ASA II A patient with mild systemic disease that results in no functional limitation. Examples: well-controlled hypertension, uncomplicated diabetes mellitus.~ASA III A patient with severe systemic disease that results in functional impairment ASA IV Severe systemic disease that is a constant threat to life. ASA V Moribund condition in a patient who is not expected to survive with or without the operation.~ASA VI Declared brain death patient whose organs are being harvested for transplantation."|participants|Number|17|17.0||||||
3816788|NCT01757561|3642522|B3|ASAⅡ||ASA|"ASA I No organic, physiologic, biochemical or psychiatric disturbance ASA II A patient with mild systemic disease that results in no functional limitation. Examples: well-controlled hypertension, uncomplicated diabetes mellitus.~ASA III A patient with severe systemic disease that results in functional impairment ASA IV Severe systemic disease that is a constant threat to life. ASA V Moribund condition in a patient who is not expected to survive with or without the operation.~ASA VI Declared brain death patient whose organs are being harvested for transplantation."|participants|Number|23|23.0||||||
3816789|NCT01757561|3642523|B2|ASAⅡ||ASA|"ASA I No organic, physiologic, biochemical or psychiatric disturbance ASA II A patient with mild systemic disease that results in no functional limitation. Examples: well-controlled hypertension, uncomplicated diabetes mellitus.~ASA III A patient with severe systemic disease that results in functional impairment ASA IV Severe systemic disease that is a constant threat to life. ASA V Moribund condition in a patient who is not expected to survive with or without the operation.~ASA VI Declared brain death patient whose organs are being harvested for transplantation."|participants|Number|22|22.0||||||
3816790|NCT01757561|3642524|B1|ASAⅡ||ASA|"ASA I No organic, physiologic, biochemical or psychiatric disturbance ASA II A patient with mild systemic disease that results in no functional limitation. Examples: well-controlled hypertension, uncomplicated diabetes mellitus.~ASA III A patient with severe systemic disease that results in functional impairment ASA IV Severe systemic disease that is a constant threat to life. ASA V Moribund condition in a patient who is not expected to survive with or without the operation.~ASA VI Declared brain death patient whose organs are being harvested for transplantation."|participants|Number|30|30.0||||||
3816791|NCT01757561|3642520|B5||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3816792|NCT01757561|3642521|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3816793|NCT01757561|3642522|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3816794|NCT01757561|3642523|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3816795|NCT01757561|3642524|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3816796|NCT01757561|3642520|B5||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3816797|NCT01757561|3642521|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3816798|NCT01757561|3642522|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3816799|NCT01757561|3642523|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3816800|NCT01757561|3642524|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3816801|NCT01757561|3642520|B5|||Age||years|Mean|65.7|65.7|Standard Deviation|8.6|8.6|||
3816802|NCT01757561|3642521|B4|||Age||years|Mean|67.2|67.2|Standard Deviation|8.5|8.5|||
3816803|NCT01757561|3642522|B3|||Age||years|Mean|64.2|64.2|Standard Deviation|8.3|8.3|||
3816804|NCT01757561|3642523|B2|||Age||years|Mean|69|69.0|Standard Deviation|10.5|10.5|||
3816805|NCT01757561|3642524|B1|||Age||years|Mean|63.5|63.5|Standard Deviation|7.6|7.6|||
3816806|NCT01757405|3642541|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3816807|NCT01757405|3642542|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3816808|NCT01757405|3642543|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3816809|NCT01757405|3642541|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3816810|NCT01757405|3642542|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3816811|NCT01757405|3642543|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3816812|NCT01757405|3642541|B3|||Age||Years|Median|28|28.0|Full Range|||12.0|54.0|
3816813|NCT01757405|3642542|B2|||Age||Years|Median|28|28.0|Full Range|||12.0|54.0|
3816814|NCT01757405|3642543|B1|||Age||Years|Median|28|28.0|Full Range|||12.0|53.0|
3816815|NCT01757275|3642560|B3|Multiple||Number of patients with single and multiple ulcers||participants|Number|37|37.0||||||
3816816|NCT01757275|3642561|B2|Multiple||Number of patients with single and multiple ulcers||participants|Number|18|18.0||||||
3816817|NCT01757275|3642562|B1|Multiple||Number of patients with single and multiple ulcers||participants|Number|19|19.0||||||
3816818|NCT01757275|3642560|B3|Single||Number of patients with single and multiple ulcers||participants|Number|178|178.0||||||
3816819|NCT01757275|3642561|B2|Single||Number of patients with single and multiple ulcers||participants|Number|89|89.0||||||
3816820|NCT01757275|3642562|B1|Single||Number of patients with single and multiple ulcers||participants|Number|89|89.0||||||
3816821|NCT01757275|3642560|B3|>2 cm||Number of patients with ulcers of different sizes||participants|Number|4|4.0||||||
3816822|NCT01757275|3642561|B2|>2 cm||Number of patients with ulcers of different sizes||participants|Number|1|1.0||||||
3816823|NCT01757275|3642562|B1|>2 cm||Number of patients with ulcers of different sizes||participants|Number|3|3.0||||||
3816824|NCT01757275|3642560|B3|<=2 cm||Number of patients with ulcers of different sizes||participants|Number|211|211.0||||||
3816825|NCT01757275|3642561|B2|<=2 cm||Number of patients with ulcers of different sizes||participants|Number|106|106.0||||||
3816830|NCT01757275|3642560|B3|Duodenum||Ulcer location||participants|Number|173|173.0||||||
3816831|NCT01757275|3642561|B2|Duodenum||Ulcer location||participants|Number|89|89.0||||||
3816832|NCT01757275|3642562|B1|Duodenum||Ulcer location||participants|Number|84|84.0||||||
3816833|NCT01757275|3642560|B3|Stomach||Ulcer location||participants|Number|25|25.0||||||
3816834|NCT01757275|3642561|B2|Stomach||Ulcer location||participants|Number|8|8.0||||||
3816835|NCT01757275|3642562|B1|Stomach||Ulcer location||participants|Number|17|17.0||||||
3816836|NCT01757275|3642560|B3|||Bleeding ulcer size||mm|Mean|8.1|8.1|Standard Deviation|4.3|4.3|||
3816837|NCT01757275|3642561|B2|||Bleeding ulcer size||mm|Mean|8.1|8.1|Standard Deviation|3.6|3.6|||
3816838|NCT01757275|3642562|B1|||Bleeding ulcer size||mm|Mean|8.2|8.2|Standard Deviation|4.8|4.8|||
3816839|NCT01757275|3642560|B3|IIb||Forrest class|Forrest classification of PUB (Forrest et al 1974): Ia = arterial bleeding; Ib = oozing bleeding; IIa = non-bleeding visible vessel; IIb = adherent clot.|participants|Number|27|27.0||||||
3816840|NCT01757275|3642561|B2|IIb||Forrest class|Forrest classification of PUB (Forrest et al 1974): Ia = arterial bleeding; Ib = oozing bleeding; IIa = non-bleeding visible vessel; IIb = adherent clot.|participants|Number|15|15.0||||||
3816841|NCT01757275|3642562|B1|IIb||Forrest class|Forrest classification of PUB (Forrest et al 1974): Ia = arterial bleeding; Ib = oozing bleeding; IIa = non-bleeding visible vessel; IIb = adherent clot.|participants|Number|12|12.0||||||
3816842|NCT01757275|3642560|B3|IIa||Forrest class|Forrest classification of PUB (Forrest et al 1974): Ia = arterial bleeding; Ib = oozing bleeding; IIa = non-bleeding visible vessel; IIb = adherent clot.|participants|Number|57|57.0||||||
3816843|NCT01757275|3642561|B2|IIa||Forrest class|Forrest classification of PUB (Forrest et al 1974): Ia = arterial bleeding; Ib = oozing bleeding; IIa = non-bleeding visible vessel; IIb = adherent clot.|participants|Number|24|24.0||||||
3816844|NCT01757275|3642562|B1|IIa||Forrest class|Forrest classification of PUB (Forrest et al 1974): Ia = arterial bleeding; Ib = oozing bleeding; IIa = non-bleeding visible vessel; IIb = adherent clot.|participants|Number|33|33.0||||||
3816845|NCT01757275|3642560|B3|Ib||Forrest class|Forrest classification of PUB (Forrest et al 1974): Ia = arterial bleeding; Ib = oozing bleeding; IIa = non-bleeding visible vessel; IIb = adherent clot.|participants|Number|122|122.0||||||
3816846|NCT01757275|3642561|B2|Ib||Forrest class|Forrest classification of PUB (Forrest et al 1974): Ia = arterial bleeding; Ib = oozing bleeding; IIa = non-bleeding visible vessel; IIb = adherent clot.|participants|Number|64|64.0||||||
3816847|NCT01757275|3642562|B1|Ib||Forrest class|Forrest classification of PUB (Forrest et al 1974): Ia = arterial bleeding; Ib = oozing bleeding; IIa = non-bleeding visible vessel; IIb = adherent clot.|participants|Number|58|58.0||||||
3816848|NCT01757275|3642560|B3|Ia||Forrest class|Forrest classification of PUB (Forrest et al 1974): Ia = arterial bleeding; Ib = oozing bleeding; IIa = non-bleeding visible vessel; IIb = adherent clot.|participants|Number|9|9.0||||||
3816849|NCT01757275|3642561|B2|Ia||Forrest class|Forrest classification of PUB (Forrest et al 1974): Ia = arterial bleeding; Ib = oozing bleeding; IIa = non-bleeding visible vessel; IIb = adherent clot.|participants|Number|4|4.0||||||
3816850|NCT01757275|3642562|B1|Ia||Forrest class|Forrest classification of PUB (Forrest et al 1974): Ia = arterial bleeding; Ib = oozing bleeding; IIa = non-bleeding visible vessel; IIb = adherent clot.|participants|Number|5|5.0||||||
3816851|NCT01757275|3642560|B3|||Number of patients with one bleeding ulcer||participants|Number|215|215.0||||||
3816852|NCT01757275|3642561|B2|||Number of patients with one bleeding ulcer||participants|Number|107|107.0||||||
3816853|NCT01757275|3642562|B1|||Number of patients with one bleeding ulcer||participants|Number|108|108.0||||||
3816854|NCT01757275|3642560|B3|Asian/Chinese||Race/Ethnicity, Customized||participants|Number|215|215.0||||||
3816855|NCT01757275|3642561|B2|Asian/Chinese||Race/Ethnicity, Customized||participants|Number|107|107.0||||||
3816856|NCT01757275|3642562|B1|Asian/Chinese||Race/Ethnicity, Customized||participants|Number|108|108.0||||||
3816857|NCT01757275|3642560|B3||Male|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3816858|NCT01757275|3642561|B2||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3816859|NCT01757275|3642562|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3816860|NCT01757275|3642560|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3816861|NCT01757275|3642561|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3816862|NCT01757275|3642562|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3816863|NCT01757275|3642560|B3|>65 years||Age, Customized||participants|Number|8|8.0||||||
3816864|NCT01757275|3642561|B2|>65 years||Age, Customized||participants|Number|4|4.0||||||
3816865|NCT01757275|3642562|B1|>65 years||Age, Customized||participants|Number|4|4.0||||||
3816866|NCT01757275|3642560|B3|<=65 years||Age, Customized||participants|Number|207|207.0||||||
3816867|NCT01757275|3642561|B2|<=65 years||Age, Customized||participants|Number|103|103.0||||||
3816868|NCT01757275|3642562|B1|<=65 years||Age, Customized||participants|Number|104|104.0||||||
3816869|NCT01757275|3642560|B3|Age||Age||years|Mean|42.1|42.1|Standard Deviation|12.85|12.85|||
3816870|NCT01757275|3642561|B2|Age||Age||years|Mean|41.8|41.8|Standard Deviation|12.96|12.96|||
3816871|NCT01757275|3642562|B1|Age||Age||years|Mean|42.4|42.4|Standard Deviation|12.79|12.79|||
3816872|NCT01757197|3642585|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816873|NCT01757197|3642585|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816874|NCT01757197|3642585|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3816875|NCT01757197|3642585|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3816876|NCT01757197|3642585|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816877|NCT01757197|3642585|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816878|NCT01757197|3642585|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816879|NCT01757197|3642585|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3816880|NCT01757197|3642585|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3816881|NCT01757197|3642585|B1|||Age||years|Mean|60|60.0|Full Range|||58.0|62.0|
3816882|NCT01757184|3642592|B3|Croatia||Region of Enrollment||participants|Number|1|1.0||||||
3816883|NCT01757184|3642593|B2|Croatia||Region of Enrollment||participants|Number|1|1.0||||||
3816884|NCT01757184|3642594|B1|Croatia||Region of Enrollment||participants|Number|0|0.0||||||
3816885|NCT01757184|3642592|B3|Germany||Region of Enrollment||participants|Number|2|2.0||||||
3816886|NCT01757184|3642593|B2|Germany||Region of Enrollment||participants|Number|2|2.0||||||
3816887|NCT01757184|3642594|B1|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3816888|NCT01757184|3642592|B3|France||Region of Enrollment||participants|Number|5|5.0||||||
3816889|NCT01757184|3642593|B2|France||Region of Enrollment||participants|Number|3|3.0||||||
3816890|NCT01757184|3642594|B1|France||Region of Enrollment||participants|Number|2|2.0||||||
3816891|NCT01757184|3642592|B3|Australia||Region of Enrollment||participants|Number|4|4.0||||||
3816892|NCT01757184|3642593|B2|Australia||Region of Enrollment||participants|Number|2|2.0||||||
3816893|NCT01757184|3642594|B1|Australia||Region of Enrollment||participants|Number|2|2.0||||||
3816894|NCT01757184|3642592|B3|Mexico||Region of Enrollment||participants|Number|4|4.0||||||
3816895|NCT01757184|3642593|B2|Mexico||Region of Enrollment||participants|Number|1|1.0||||||
3816896|NCT01757184|3642594|B1|Mexico||Region of Enrollment||participants|Number|3|3.0||||||
3816897|NCT01757184|3642592|B3|Italy||Region of Enrollment||participants|Number|3|3.0||||||
3816898|NCT01757184|3642593|B2|Italy||Region of Enrollment||participants|Number|1|1.0||||||
3816899|NCT01757184|3642594|B1|Italy||Region of Enrollment||participants|Number|2|2.0||||||
3816900|NCT01757184|3642592|B3|Poland||Region of Enrollment||participants|Number|7|7.0||||||
3816901|NCT01757184|3642593|B2|Poland||Region of Enrollment||participants|Number|3|3.0||||||
3816902|NCT01757184|3642594|B1|Poland||Region of Enrollment||participants|Number|4|4.0||||||
3816903|NCT01757184|3642592|B3|Turkey||Region of Enrollment||participants|Number|4|4.0||||||
3816904|NCT01757184|3642593|B2|Turkey||Region of Enrollment||participants|Number|1|1.0||||||
3816905|NCT01757184|3642594|B1|Turkey||Region of Enrollment||participants|Number|3|3.0||||||
3816906|NCT01757184|3642592|B3|Czech Republic||Region of Enrollment||participants|Number|5|5.0||||||
3816907|NCT01757184|3642593|B2|Czech Republic||Region of Enrollment||participants|Number|3|3.0||||||
3816908|NCT01757184|3642594|B1|Czech Republic||Region of Enrollment||participants|Number|2|2.0||||||
3816909|NCT01757184|3642592|B3|Spain||Region of Enrollment||participants|Number|4|4.0||||||
3816910|NCT01757184|3642593|B2|Spain||Region of Enrollment||participants|Number|2|2.0||||||
3816911|NCT01757184|3642594|B1|Spain||Region of Enrollment||participants|Number|2|2.0||||||
3816912|NCT01757184|3642592|B3|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3816913|NCT01757184|3642593|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3816914|NCT01757184|3642594|B1|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3816915|NCT01757184|3642592|B3|Japan||Region of Enrollment||participants|Number|2|2.0||||||
3816916|NCT01757184|3642593|B2|Japan||Region of Enrollment||participants|Number|0|0.0||||||
3816917|NCT01757184|3642594|B1|Japan||Region of Enrollment||participants|Number|2|2.0||||||
3816918|NCT01757184|3642592|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
3816919|NCT01757184|3642593|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3816920|NCT01757184|3642594|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3816921|NCT01757184|3642592|B3|Russian Federation||Region of Enrollment||participants|Number|4|4.0||||||
3816922|NCT01757184|3642593|B2|Russian Federation||Region of Enrollment||participants|Number|4|4.0||||||
3816923|NCT01757184|3642594|B1|Russian Federation||Region of Enrollment||participants|Number|0|0.0||||||
3816924|NCT01757184|3642592|B3|Argentina||Region of Enrollment||participants|Number|1|1.0||||||
3816925|NCT01757184|3642593|B2|Argentina||Region of Enrollment||participants|Number|0|0.0||||||
3816926|NCT01757184|3642594|B1|Argentina||Region of Enrollment||participants|Number|1|1.0||||||
3816927|NCT01757184|3642592|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3816928|NCT01757184|3642593|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3816929|NCT01757184|3642594|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3816930|NCT01757184|3642592|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816931|NCT01757184|3642593|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816932|NCT01757184|3642594|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816933|NCT01757184|3642592|B3||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3816934|NCT01757184|3642593|B2||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3816935|NCT01757184|3642594|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3816936|NCT01757184|3642592|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3816937|NCT01757184|3642593|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816938|NCT01757184|3642594|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3816939|NCT01757184|3642592|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816940|NCT01757184|3642593|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816941|NCT01757184|3642594|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816942|NCT01757184|3642592|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3816943|NCT01757184|3642593|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816944|NCT01757184|3642594|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3816945|NCT01757184|3642592|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816946|NCT01757184|3642593|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816947|NCT01757184|3642594|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816948|NCT01757184|3642592|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816949|NCT01757184|3642593|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816950|NCT01757184|3642594|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816951|NCT01757184|3642592|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3816952|NCT01757184|3642593|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3816953|NCT01757184|3642594|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3816954|NCT01757184|3642592|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3816955|NCT01757184|3642593|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3816956|NCT01757184|3642594|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3816957|NCT01757184|3642592|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3816958|NCT01757184|3642593|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3816959|NCT01757184|3642594|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3816960|NCT01757184|3642592|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3816961|NCT01757184|3642593|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3816962|NCT01757184|3642594|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3816963|NCT01757184|3642592|B3|||Age||years|Mean|16.1|16.1|Standard Deviation|10.9|10.9|||
3816964|NCT01757184|3642593|B2|||Age||years|Mean|15.2|15.2|Standard Deviation|10.2|10.2|||
3816965|NCT01757184|3642594|B1|||Age||years|Mean|16.9|16.9|Standard Deviation|11.6|11.6|||
3816966|NCT01757184|3642592|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3816967|NCT01757184|3642593|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3816968|NCT01757184|3642594|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3816969|NCT01757184|3642592|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3816970|NCT01757184|3642593|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3816971|NCT01757184|3642594|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3816972|NCT01757184|3642592|B3||<=18 years|Age||Participants|Count of Participants|47|47.0||||||
3816973|NCT01757184|3642593|B2||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
3816974|NCT01757184|3642594|B1||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
3816975|NCT01757171|3642617|B3|United States||Region of Enrollment||Participants|Count of Participants|76|76.0||||||
3816976|NCT01757171|3642618|B2|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3816977|NCT01757171|3642619|B1|United States||Region of Enrollment||Participants|Count of Participants|53|53.0||||||
3816978|NCT01757171|3642617|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3816979|NCT01757171|3642618|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3816980|NCT01757171|3642619|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3816981|NCT01757171|3642617|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816982|NCT01757171|3642618|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816983|NCT01757171|3642619|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816984|NCT01757171|3642617|B3||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3816985|NCT01757171|3642618|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3816986|NCT01757171|3642619|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3816987|NCT01757171|3642617|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3816988|NCT01757171|3642618|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816989|NCT01757171|3642619|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3816990|NCT01757171|3642617|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816991|NCT01757171|3642618|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816992|NCT01757171|3642619|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816993|NCT01757171|3642617|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3816994|NCT01757171|3642618|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3816995|NCT01757171|3642619|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3816996|NCT01757171|3642617|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816997|NCT01757171|3642618|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816998|NCT01757171|3642619|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3816999|NCT01757171|3642617|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3817000|NCT01757171|3642618|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3817001|NCT01757171|3642619|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3817002|NCT01757171|3642617|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3817003|NCT01757171|3642618|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3817004|NCT01757171|3642619|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3817005|NCT01757171|3642617|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3817006|NCT01757171|3642618|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3817007|NCT01757171|3642619|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3817008|NCT01757171|3642617|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3817009|NCT01757171|3642618|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3817010|NCT01757171|3642619|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3817011|NCT01757171|3642617|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3817012|NCT01757171|3642618|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3817013|NCT01757171|3642619|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3817014|NCT01757171|3642617|B3|||Age||years|Median|61.67|61.67|Full Range|||35.46|91.76|
3817015|NCT01757171|3642618|B2|||Age||years|Median|57.34|57.34|Full Range|||36.89|73.45|
3817016|NCT01757171|3642619|B1|||Age||years|Median|62.1|62.1|Full Range|||35.46|91.76|
3817017|NCT01756976|3642632|B3|United States||Region of Enrollment||participants|Number|84|84.0||||||
3817018|NCT01756976|3642633|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3817019|NCT01756976|3642634|B1|United States||Region of Enrollment||participants|Number|76|76.0||||||
3817020|NCT01756976|3642632|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3817021|NCT01756976|3642633|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3817022|NCT01756976|3642634|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3817023|NCT01756976|3642632|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3817024|NCT01756976|3642633|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3817025|NCT01756976|3642634|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3817026|NCT01756976|3642632|B3|||Age||years|Mean|55|55.0|Standard Deviation|19|19.0|||
3817027|NCT01756976|3642633|B2|||Age||years|Mean|46|46.0|Standard Deviation|9|9.0|||
3817028|NCT01756976|3642634|B1|||Age||years|Mean|56|56.0|Standard Deviation|19|19.0|||
3817029|NCT01756976|3642632|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3817030|NCT01756976|3642633|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3817031|NCT01756976|3642634|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3817032|NCT01756976|3642632|B3||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
3817033|NCT01756976|3642633|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3817034|NCT01756976|3642634|B1||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3817035|NCT01756976|3642632|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817036|NCT01756976|3642633|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817037|NCT01756976|3642634|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817038|NCT01756586|3642641|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3817039|NCT01756586|3642642|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3817040|NCT01756586|3642643|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3817041|NCT01756586|3642641|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3817042|NCT01756586|3642642|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3817043|NCT01756586|3642643|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3817044|NCT01756586|3642641|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3817045|NCT01756586|3642642|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3817046|NCT01756586|3642643|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3817047|NCT01756586|3642641|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3817048|NCT01756586|3642642|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3817049|NCT01756586|3642643|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3817050|NCT01756586|3642641|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3817051|NCT01756586|3642642|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3817052|NCT01756586|3642643|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3817053|NCT01756586|3642641|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817054|NCT01756586|3642642|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817055|NCT01756586|3642643|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817056|NCT01756391|3642650|B1|United States||Region of Enrollment|Students with asthma from participating schools|participants|Number|351|351.0||||||
3817057|NCT01756391|3642650|B1||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3817058|NCT01756391|3642650|B1||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3817059|NCT01756391|3642650|B1|||Age||years|Mean|7.9|7.9|Full Range|||4.0|13.0|
3817060|NCT01756300|3642654|B1|Italy||Region of Enrollment||participants|Number|2|2.0||||||
3817061|NCT01756300|3642654|B1|Australia||Region of Enrollment||participants|Number|15|15.0||||||
3817062|NCT01756300|3642654|B1|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
3817063|NCT01756300|3642654|B1|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
3817064|NCT01756300|3642654|B1|Czech Republic||Region of Enrollment||participants|Number|12|12.0||||||
3817065|NCT01756300|3642654|B1|Not African Descent||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3817066|NCT01756300|3642654|B1|African Descent||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3817067|NCT01756300|3642654|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3817068|NCT01756300|3642654|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3817069|NCT01756300|3642654|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|9.5|9.5|||
3817070|NCT01756274|3642676|B1|Other||Nursery Location||blood samples|Number|22|22.0||||||
3817071|NCT01756274|3642676|B1|NICU (Neonatal Intensive Care Unit)||Nursery Location||blood samples|Number|30|30.0||||||
3817072|NCT01756274|3642676|B1|Well Baby||Nursery Location||blood samples|Number|58|58.0||||||
3817073|NCT01756274|3642676|B1|Special Care||Nursery Location||blood samples|Number|101|101.0||||||
3817074|NCT01756274|3642676|B1|United States||Region of Enrollment||blood samples|Number|211|211.0||||||
3817075|NCT01756274|3642676|B1|Male||Sex/Gender, Customized||blood samples|Number|111|111.0||||||
3817076|NCT01756274|3642676|B1|Female||Sex/Gender, Customized||blood samples|Number|100|100.0||||||
3817077|NCT01756274|3642676|B1|1-29 days||Age, Customized||blood samples|Number|186|186.0||||||
3817078|NCT01756274|3642676|B1|< 24 hours||Age, Customized||blood samples|Number|25|25.0||||||
3817079|NCT01756235|3642683|B1||Male|Gender||Participants|Count of Participants|82|82.0||||||
3817080|NCT01756235|3642683|B1||Female|Gender||Participants|Count of Participants|378|378.0||||||
3817081|NCT01756235|3642683|B1|||Age||years|Mean|53.9|53.9|Standard Deviation|12.1|12.1|||
3817082|NCT01756157|3642704|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3817083|NCT01756157|3642704|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3817084|NCT01756157|3642704|B1|||Age||years|Mean|39.0|39.0|Standard Deviation|14.6|14.6|||
3817085|NCT01756079|3642719|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3817086|NCT01756079|3642719|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3817087|NCT01756079|3642719|B1|||Age||Years|Mean|59.3|59.3|Standard Deviation|9.2|9.2|||
3817088|NCT01756053|3642725|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3817089|NCT01756053|3642725|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817090|NCT01756053|3642725|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817091|NCT01756053|3642725|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3817092|NCT01756053|3642725|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3817093|NCT01756053|3642725|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817094|NCT01756053|3642725|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817095|NCT01756053|3642725|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817096|NCT01756053|3642725|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3817097|NCT01756053|3642725|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3817098|NCT01756053|3642725|B1|||Age||Years|Mean|41.76471|41.76471|Standard Deviation|11.20563|11.20563|||
3817099|NCT01755702|3642746|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3817100|NCT01755702|3642746|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3817101|NCT01755702|3642746|B1|||Age||Years|Mean|42.0|42.0|Standard Deviation|12.46|12.46|||
3817102|NCT01755689|3642788|B6|Geographic ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|434|434.0||||||
3817103|NCT01755689|3642789|B5|Geographic ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|87|87.0||||||
3817104|NCT01755689|3642790|B4|Geographic ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|86|86.0||||||
3817105|NCT01755689|3642791|B3|Geographic ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|88|88.0||||||
3817106|NCT01755689|3642792|B2|Geographic ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|87|87.0||||||
3817107|NCT01755689|3642793|B1|Geographic ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|86|86.0||||||
3817108|NCT01755689|3642788|B6|Geographic ancestry|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|435|435.0||||||
3817109|NCT01755689|3642789|B5|Geographic ancestry|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|88|88.0||||||
3817110|NCT01755689|3642790|B4|Geographic ancestry|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|87|87.0||||||
3817111|NCT01755689|3642791|B3|Geographic ancestry|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|87|87.0||||||
3817112|NCT01755689|3642792|B2|Geographic ancestry|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|86|86.0||||||
3817113|NCT01755689|3642793|B1|Geographic ancestry|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|87|87.0||||||
3817114|NCT01755689|3642788|B6|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|430|430.0||||||
3817115|NCT01755689|3642789|B5|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|86|86.0||||||
3817116|NCT01755689|3642790|B4|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|86|86.0||||||
3817117|NCT01755689|3642791|B3|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|86|86.0||||||
3817118|NCT01755689|3642792|B2|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|86|86.0||||||
3817119|NCT01755689|3642793|B1|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|86|86.0||||||
3817120|NCT01755689|3642788|B6|Geographic ancestry|African Heritage / African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3817121|NCT01755689|3642789|B5|Geographic ancestry|African Heritage / African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3817122|NCT01755689|3642790|B4|Geographic ancestry|African Heritage / African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3817123|NCT01755689|3642791|B3|Geographic ancestry|African Heritage / African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3817124|NCT01755689|3642792|B2|Geographic ancestry|African Heritage / African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3817125|NCT01755689|3642793|B1|Geographic ancestry|African Heritage / African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3817126|NCT01755689|3642788|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3817127|NCT01755689|3642789|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3817128|NCT01755689|3642790|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3817129|NCT01755689|3642791|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3817130|NCT01755689|3642792|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3817131|NCT01755689|3642793|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3817132|NCT01755689|3642788|B6||Female|Sex: Female, Male||Participants|Count of Participants|1300|1300.0||||||
3817133|NCT01755689|3642789|B5||Female|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
3817134|NCT01755689|3642790|B4||Female|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
3817135|NCT01755689|3642791|B3||Female|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
3817136|NCT01755689|3642792|B2||Female|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
3817137|NCT01755689|3642793|B1||Female|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
3817138|NCT01755689|3642788|B6|||Age||Participants|Mean|16.5|16.5|Standard Deviation|4.5|4.5|||
3817139|NCT01755689|3642789|B5|||Age||Participants|Mean|16.6|16.6|Standard Deviation|4.5|4.5|||
3817140|NCT01755689|3642790|B4|||Age||Participants|Mean|16.6|16.6|Standard Deviation|4.6|4.6|||
3817141|NCT01755689|3642791|B3|||Age||Participants|Mean|16.6|16.6|Standard Deviation|4.6|4.6|||
3817142|NCT01755689|3642792|B2|||Age||Participants|Mean|16.6|16.6|Standard Deviation|4.4|4.4|||
3817143|NCT01755689|3642793|B1|||Age||Participants|Mean|16.3|16.3|Standard Deviation|4.6|4.6|||
3817144|NCT01755637|3642872|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3817145|NCT01755637|3642872|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3817146|NCT01755637|3642872|B1|||Age||Years|Mean|24.21|24.21|Standard Deviation|2.715|2.715|||
3817147|NCT01755546|3642891|B1||Osteoarthritis|Chronic Pain||Participants|Count of Participants|1|1.0||||||
3817148|NCT01755546|3642891|B1||Neuropathic Pain|Chronic Pain||Participants|Count of Participants|1|1.0||||||
3817149|NCT01755546|3642891|B1||Lower Back Pain|Chronic Pain||Participants|Count of Participants|222|222.0||||||
3817150|NCT01755546|3642891|B1|||NRS Pain Intensity|The NRS Pain intensity score is a segmented version of a visual analog scale used to measure pain. The scale is from 0 (no pain) to 10. Scores between greater than 0 and 3 are considered mild pain, scores from greater than 3 to 6 are moderate and greater than 6 to 10 are severe. The daily average is calculated and used as baseline.|units on a scale|Mean|3|3.0|Standard Deviation|1.30|1.3|||
3817151|NCT01755546|3642891|B1|||BMI (kg/m^2)||kg/m^2|Mean|32.1|32.1|Standard Deviation|7.20|7.2|||
3817152|NCT01755546|3642891|B1|||Height (cm)||centimeters|Mean|169.5|169.5|Standard Deviation|10.39|10.39|||
3817153|NCT01755546|3642891|B1|||Weight (kg)||kilograms|Mean|92.2|92.2|Standard Deviation|21.57|21.57|||
3817154|NCT01755546|3642891|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817155|NCT01755546|3642891|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817156|NCT01755546|3642891|B1||White|Race (NIH/OMB)||Participants|Count of Participants|158|158.0||||||
3817157|NCT01755546|3642891|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3817158|NCT01755546|3642891|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817159|NCT01755546|3642891|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3817160|NCT01755546|3642891|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3817161|NCT01755546|3642891|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817162|NCT01755546|3642891|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|185|185.0||||||
3817163|NCT01755546|3642891|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3817164|NCT01755546|3642891|B1||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3817165|NCT01755546|3642891|B1||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3817166|NCT01755546|3642891|B1|||Age||Years|Mean|52|52.0|Standard Deviation|11.80|11.8|||
3817167|NCT01755546|3642891|B1||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
3817168|NCT01755546|3642891|B1||Between 18 and 65 years|Age||Participants|Count of Participants|193|193.0||||||
3817169|NCT01755546|3642891|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817170|NCT01755455|3642895|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3817171|NCT01755455|3642895|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3817172|NCT01755455|3642895|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3817173|NCT01755455|3642895|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3817174|NCT01755455|3642895|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817175|NCT01755455|3642895|B1|||Age||years|Mean|32.1|32.1|Standard Deviation|13.6|13.6|||
3817176|NCT01755416|3642908|B1|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3817177|NCT01755416|3642908|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3817178|NCT01755416|3642908|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3817179|NCT01755416|3642908|B1|||Age||Years|Mean|26|26.0|Standard Deviation|5.8|5.8|||
3817180|NCT01755416|3642908|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3817181|NCT01755416|3642908|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3817182|NCT01755416|3642908|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817183|NCT01755234|3642915|B3|United States||Region of Enrollment||participants|Number|90|90.0||||||
3817184|NCT01755234|3642916|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
3817185|NCT01755234|3642917|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
3817186|NCT01755234|3642915|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3817187|NCT01755234|3642916|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3817188|NCT01755234|3642917|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3817189|NCT01755234|3642915|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3817190|NCT01755234|3642916|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3817191|NCT01755234|3642917|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3817192|NCT01755234|3642915|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3817193|NCT01755234|3642916|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3817194|NCT01755234|3642917|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3817195|NCT01755234|3642915|B3||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
3817196|NCT01755234|3642916|B2||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3817197|NCT01755234|3642917|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3817198|NCT01755234|3642915|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817199|NCT01755234|3642916|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817200|NCT01755234|3642917|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817201|NCT01755169|3642930|B5|United States||Region of Enrollment||participants|Number|4|4.0||||||
3817202|NCT01755169|3642931|B4|United States||Region of Enrollment||participants|Number|1|1.0||||||
3817203|NCT01755169|3642933|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3817204|NCT01755169|3642934|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3817205|NCT01755169|3642930|B5||Male|Gender||Participants|Count of Participants|2|2.0||||||
3817206|NCT01755169|3642931|B4||Male|Gender||Participants|Count of Participants|1|1.0||||||
3817207|NCT01755169|3642932|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3817208|NCT01755169|3642933|B2||Male|Gender||Participants|Count of Participants|1|1.0||||||
3817209|NCT01755169|3642934|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3817210|NCT01755169|3642930|B5||Female|Gender||Participants|Count of Participants|2|2.0||||||
3817211|NCT01755169|3642931|B4||Female|Gender||Participants|Count of Participants|0|0.0||||||
3817212|NCT01755169|3642932|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
3817213|NCT01755169|3642933|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
3817214|NCT01755169|3642934|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
3817215|NCT01755169|3642930|B5|8-20 years||Age, Customized||Participants|Count of Participants|4|4.0||||||
3817216|NCT01755169|3642931|B4|8-20 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3817217|NCT01755169|3642932|B3|8-20 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3817218|NCT01755169|3642933|B2|8-20 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3817219|NCT01755169|3642934|B1|8-20 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
3817220|NCT01755156|3642947|B3|||Fasting plasma glucose (FPG)||mg/dL|Mean|168.7|168.7|Standard Deviation|37.4|37.4|||
3817221|NCT01755156|3642948|B2|||Fasting plasma glucose (FPG)||mg/dL|Mean|168.6|168.6|Standard Deviation|37.2|37.2|||
3817222|NCT01755156|3642949|B1|||Fasting plasma glucose (FPG)||mg/dL|Mean|168.8|168.8|Standard Deviation|37.6|37.6|||
3817223|NCT01755156|3642947|B3|||2-hour post-meal glucose (2-hr PMG)|Omarigliptin (Phase A), n=192; Placebo to omarigliptin (Phase A), n=193; Total, n=385|mg/dL|Mean|238.1|238.1|Standard Deviation|60.2|60.2|||
3817224|NCT01755156|3642948|B2|||2-hour post-meal glucose (2-hr PMG)|Omarigliptin (Phase A), n=192; Placebo to omarigliptin (Phase A), n=193; Total, n=385|mg/dL|Mean|236.0|236.0|Standard Deviation|59.9|59.9|||
3817225|NCT01755156|3642949|B1|||2-hour post-meal glucose (2-hr PMG)|Omarigliptin (Phase A), n=192; Placebo to omarigliptin (Phase A), n=193; Total, n=385|mg/dL|Mean|240.2|240.2|Standard Deviation|60.5|60.5|||
3817226|NCT01755156|3642947|B3|||Hemoglobin A1C (A1C)||Percent|Mean|8.04|8.04|Standard Deviation|0.88|0.88|||
3817459|NCT01754714|3643112|B2|Germany||Region of Enrollment||participants|Number|14|14.0||||||
3817227|NCT01755156|3642948|B2|||Hemoglobin A1C (A1C)||Percent|Mean|8.02|8.02|Standard Deviation|0.89|0.89|||
3817228|NCT01755156|3642949|B1|||Hemoglobin A1C (A1C)||Percent|Mean|8.06|8.06|Standard Deviation|0.87|0.87|||
3817229|NCT01755156|3642947|B3||Male|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
3817230|NCT01755156|3642948|B2||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3817231|NCT01755156|3642949|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3817232|NCT01755156|3642947|B3||Female|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
3817233|NCT01755156|3642948|B2||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3817234|NCT01755156|3642949|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3817235|NCT01755156|3642947|B3|||Age||Years|Mean|57.2|57.2|Standard Deviation|8.6|8.6|||
3817236|NCT01755156|3642948|B2|||Age||Years|Mean|56.8|56.8|Standard Deviation|9.1|9.1|||
3817237|NCT01755156|3642949|B1|||Age||Years|Mean|57.5|57.5|Standard Deviation|8.1|8.1|||
3817238|NCT01755143|3642994|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3817239|NCT01755143|3642995|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3817240|NCT01755143|3642996|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3817241|NCT01755143|3642994|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3817242|NCT01755143|3642995|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3817243|NCT01755143|3642996|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3817244|NCT01755143|3642994|B3||White|Race (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
3817245|NCT01755143|3642995|B2||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3817246|NCT01755143|3642996|B1||White|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3817247|NCT01755143|3642994|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817248|NCT01755143|3642995|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817249|NCT01755143|3642996|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817250|NCT01755143|3642994|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817251|NCT01755143|3642995|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817252|NCT01755143|3642996|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817253|NCT01755143|3642994|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3817254|NCT01755143|3642995|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3817255|NCT01755143|3642996|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3817256|NCT01755143|3642994|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817257|NCT01755143|3642995|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817258|NCT01755143|3642996|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817259|NCT01755143|3642994|B3||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3817260|NCT01755143|3642995|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3817261|NCT01755143|3642996|B1||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3817262|NCT01755143|3642994|B3||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3817263|NCT01755143|3642995|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3817264|NCT01755143|3642996|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3817265|NCT01755143|3642994|B3|||Age||Years|Mean|69.2|69.2|Standard Deviation|12.2|12.2|||
3817266|NCT01755143|3642995|B2|||Age||Years|Mean|67.8|67.8|Standard Deviation|15.1|15.1|||
3817267|NCT01755143|3642996|B1|||Age||Years|Mean|70.0|70.0|Standard Deviation|10.4|10.4|||
3817268|NCT01755091|3643011|B4|||Sleep Efficiency|Sleep Efficiency is calculated as the total time spent asleep divided by the total amount of time spent in bed, multiplied by 100.|%|Mean|79.58|79.58|Standard Deviation|12.25|12.25|||
3817269|NCT01755091|3643012|B3|||Sleep Efficiency|Sleep Efficiency is calculated as the total time spent asleep divided by the total amount of time spent in bed, multiplied by 100.|%|Mean|82.74|82.74|Standard Deviation|12.22|12.22|||
3817270|NCT01755091|3643013|B2|||Sleep Efficiency|Sleep Efficiency is calculated as the total time spent asleep divided by the total amount of time spent in bed, multiplied by 100.|%|Mean|80.52|80.52|Standard Deviation|11.11|11.11|||
3817271|NCT01755091|3643014|B1|||Sleep Efficiency|Sleep Efficiency is calculated as the total time spent asleep divided by the total amount of time spent in bed, multiplied by 100.|%|Mean|75.51|75.51|Standard Deviation|12.50|12.5|||
3817272|NCT01755091|3643011|B4|||Minimum Arterial Oxygen Saturation||%|Mean|79.79|79.79|Standard Deviation|7.84|7.84|||
3817273|NCT01755091|3643012|B3|||Minimum Arterial Oxygen Saturation||%|Mean|79.96|79.96|Standard Deviation|6.93|6.93|||
3817274|NCT01755091|3643013|B2|||Minimum Arterial Oxygen Saturation||%|Mean|79.82|79.82|Standard Deviation|6.83|6.83|||
3817275|NCT01755091|3643014|B1|||Minimum Arterial Oxygen Saturation||%|Mean|79.58|79.58|Standard Deviation|9.62|9.62|||
3817276|NCT01755091|3643011|B4|||Apnea/Hypopnea Index||events/hour|Mean|25.67|25.67|Standard Deviation|11.29|11.29|||
3817277|NCT01755091|3643012|B3|||Apnea/Hypopnea Index||events/hour|Mean|26.04|26.04|Standard Deviation|11.92|11.92|||
3817278|NCT01755091|3643013|B2|||Apnea/Hypopnea Index||events/hour|Mean|27.54|27.54|Standard Deviation|12.57|12.57|||
3817279|NCT01755091|3643014|B1|||Apnea/Hypopnea Index||events/hour|Mean|23.72|23.72|Standard Deviation|9.47|9.47|||
3817280|NCT01755091|3643011|B4|||Body Mass Index||kg/m^2|Mean|33.35|33.35|Standard Deviation|6.33|6.33|||
3817281|NCT01755091|3643012|B3|||Body Mass Index||kg/m^2|Mean|33.45|33.45|Standard Deviation|4.85|4.85|||
3817282|NCT01755091|3643013|B2|||Body Mass Index||kg/m^2|Mean|33.19|33.19|Standard Deviation|5.09|5.09|||
3817283|NCT01755091|3643014|B1|||Body Mass Index||kg/m^2|Mean|33.39|33.39|Standard Deviation|6.33|6.33|||
3817284|NCT01755091|3643011|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3817285|NCT01755091|3643012|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817286|NCT01755091|3643013|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817287|NCT01755091|3643014|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3817288|NCT01755091|3643011|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817289|NCT01755091|3643012|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817290|NCT01755091|3643013|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817291|NCT01755091|3643014|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817292|NCT01755091|3643011|B4||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3817293|NCT01755091|3643012|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3817294|NCT01755091|3643013|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3817295|NCT01755091|3643014|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3817296|NCT01755091|3643011|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3817297|NCT01755091|3643012|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3817298|NCT01755091|3643013|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3817299|NCT01755091|3643014|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3817300|NCT01755091|3643011|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3817301|NCT01755091|3643012|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817302|NCT01755091|3643013|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3817303|NCT01755091|3643014|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817304|NCT01755091|3643011|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3817305|NCT01755091|3643012|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3817306|NCT01755091|3643013|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817307|NCT01755091|3643014|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3817308|NCT01755091|3643011|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817309|NCT01755091|3643012|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817310|NCT01755091|3643013|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817311|NCT01755091|3643014|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817312|NCT01755091|3643011|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3817313|NCT01755091|3643012|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3817314|NCT01755091|3643013|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817315|NCT01755091|3643014|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817316|NCT01755091|3643011|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3817317|NCT01755091|3643012|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3817318|NCT01755091|3643013|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3817319|NCT01755091|3643014|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3817320|NCT01755091|3643011|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3817321|NCT01755091|3643012|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3817322|NCT01755091|3643013|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3817323|NCT01755091|3643014|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3817324|NCT01755091|3643011|B4||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3817325|NCT01755091|3643012|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3817326|NCT01755091|3643013|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3817327|NCT01755091|3643014|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3817328|NCT01755091|3643011|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3817329|NCT01755091|3643012|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3817330|NCT01755091|3643013|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3817331|NCT01755091|3643014|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3817332|NCT01755091|3643011|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3817333|NCT01755091|3643012|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3817334|NCT01755091|3643013|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3817335|NCT01755091|3643014|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3817336|NCT01755091|3643011|B4||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
3817337|NCT01755091|3643012|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3817338|NCT01755091|3643013|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3817339|NCT01755091|3643014|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3817340|NCT01755091|3643011|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817341|NCT01755091|3643012|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817342|NCT01755091|3643013|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817343|NCT01755091|3643014|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817344|NCT01755026|3643039|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
3817345|NCT01755026|3643040|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3817346|NCT01755026|3643041|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3817347|NCT01755026|3643039|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3817348|NCT01755026|3643040|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3817349|NCT01755026|3643041|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3817350|NCT01755026|3643039|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3817351|NCT01755026|3643040|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3817352|NCT01755026|3643041|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3817353|NCT01755026|3643039|B3|||Age||years|Mean|31|31.0|Standard Deviation|5|5.0|||
3817354|NCT01755026|3643040|B2|||Age||years|Mean|31.09|31.09|Standard Deviation|6.46|6.46|||
3817355|NCT01755026|3643041|B1|||Age||years|Mean|30.33|30.33|Standard Deviation|4.64|4.64|||
3817356|NCT01755026|3643039|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3817357|NCT01755026|3643040|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3817358|NCT01755026|3643041|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3817359|NCT01755026|3643039|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3817360|NCT01755026|3643040|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3817361|NCT01755026|3643041|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3817362|NCT01755026|3643039|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817363|NCT01755026|3643040|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817364|NCT01755026|3643041|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817365|NCT01754987|3643048|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3817366|NCT01754987|3643050|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3817367|NCT01754987|3643048|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817368|NCT01754987|3643050|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817369|NCT01754987|3643048|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817370|NCT01754987|3643050|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817371|NCT01754987|3643048|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3817372|NCT01754987|3643050|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3817373|NCT01754987|3643048|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3817374|NCT01754987|3643050|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3817375|NCT01754987|3643048|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817376|NCT01754987|3643050|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817377|NCT01754987|3643048|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817378|NCT01754987|3643050|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817379|NCT01754987|3643048|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817380|NCT01754987|3643050|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817381|NCT01754987|3643048|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817382|NCT01754987|3643050|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817383|NCT01754987|3643048|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3817384|NCT01754987|3643050|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3817385|NCT01754987|3643048|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817386|NCT01754987|3643050|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817387|NCT01754987|3643048|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3817388|NCT01754987|3643050|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3817389|NCT01754987|3643048|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3817390|NCT01754987|3643050|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3817391|NCT01754987|3643048|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3817392|NCT01754987|3643050|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3817393|NCT01754987|3643048|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3817394|NCT01754987|3643050|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3817395|NCT01754987|3643048|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817396|NCT01754987|3643050|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817397|NCT01754922|3643063|B3|||Tobacco Pack Years||Pack Years|Mean|1.5|1.5|Standard Deviation|4.08|4.08|||
3817398|NCT01754922|3643064|B2|||Tobacco Pack Years||Pack Years|Mean|1.65|1.65|Standard Deviation|5.2|5.2|||
3817399|NCT01754922|3643065|B1|||Tobacco Pack Years||Pack Years|Mean|1.45|1.45|Standard Deviation|3.42|3.42|||
3817400|NCT01754922|3643063|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3817401|NCT01754922|3643064|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
3817402|NCT01754922|3643065|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
3817403|NCT01754922|3643063|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817404|NCT01754922|3643064|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817405|NCT01754922|3643065|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817406|NCT01754922|3643063|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817407|NCT01754922|3643064|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817408|NCT01754922|3643065|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817409|NCT01754922|3643063|B3||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3817410|NCT01754922|3643064|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3817411|NCT01754922|3643065|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3817412|NCT01754922|3643063|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3817413|NCT01754922|3643064|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3817414|NCT01754922|3643065|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3817415|NCT01754922|3643063|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817416|NCT01754922|3643064|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817417|NCT01754922|3643065|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817418|NCT01754922|3643063|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3817419|NCT01754922|3643064|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817420|NCT01754922|3643065|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3817421|NCT01754922|3643063|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817422|NCT01754922|3643064|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817423|NCT01754922|3643065|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817424|NCT01754922|3643063|B3||Male|Gender||Participants|Count of Participants|39|39.0||||||
3817425|NCT01754922|3643064|B2||Male|Gender||Participants|Count of Participants|13|13.0||||||
3817426|NCT01754922|3643065|B1||Male|Gender||Participants|Count of Participants|26|26.0||||||
3817427|NCT01754922|3643063|B3||Female|Gender||Participants|Count of Participants|11|11.0||||||
3817428|NCT01754922|3643064|B2||Female|Gender||Participants|Count of Participants|5|5.0||||||
3817429|NCT01754922|3643065|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
3817430|NCT01754922|3643063|B3|||Age||years|Mean|34.6|34.6|Standard Deviation|8.7|8.7|||
3817431|NCT01754922|3643064|B2|||Age||years|Mean|33.2|33.2|Standard Deviation|9.7|9.7|||
3817432|NCT01754922|3643065|B1|||Age||years|Mean|34.8|34.8|Standard Deviation|8.1|8.1|||
3817433|NCT01754766|3643076|B4||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3817434|NCT01754766|3643077|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3817435|NCT01754766|3643078|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3817436|NCT01754766|3643079|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3817437|NCT01754766|3643076|B4||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3817438|NCT01754766|3643077|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3817439|NCT01754766|3643078|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3817440|NCT01754766|3643079|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3817441|NCT01754766|3643076|B4|>40 years||Age, Customized||Participants|Number|44|44.0||||||
3817442|NCT01754766|3643077|B3|>40 years||Age, Customized||Participants|Number|16|16.0||||||
3817443|NCT01754766|3643078|B2|>40 years||Age, Customized||Participants|Number|15|15.0||||||
3817444|NCT01754766|3643079|B1|>40 years||Age, Customized||Participants|Number|13|13.0||||||
3817445|NCT01754766|3643076|B4|>30-40 years||Age, Customized||Participants|Number|24|24.0||||||
3817446|NCT01754766|3643077|B3|>30-40 years||Age, Customized||Participants|Number|10|10.0||||||
3817447|NCT01754766|3643078|B2|>30-40 years||Age, Customized||Participants|Number|7|7.0||||||
3817448|NCT01754766|3643079|B1|>30-40 years||Age, Customized||Participants|Number|7|7.0||||||
3817449|NCT01754766|3643076|B4|20-30 years||Age, Customized||Participants|Number|22|22.0||||||
3817450|NCT01754766|3643077|B3|20-30 years||Age, Customized||Participants|Number|4|4.0||||||
3817451|NCT01754766|3643078|B2|20-30 years||Age, Customized||Participants|Number|7|7.0||||||
3817452|NCT01754766|3643079|B1|20-30 years||Age, Customized||Participants|Number|11|11.0||||||
3817453|NCT01754727|3643095|B1||Male|Gender||Participants|Count of Participants|309|309.0||||||
3817454|NCT01754727|3643095|B1||Female|Gender||Participants|Count of Participants|141|141.0||||||
3817455|NCT01754727|3643095|B1|||Age||years|Mean|42.9|42.9|Standard Deviation|12.1|12.1|||
3817456|NCT01754714|3643109|B5|Germany||Region of Enrollment||participants|Number|49|49.0||||||
3817457|NCT01754714|3643110|B4|Germany||Region of Enrollment||participants|Number|11|11.0||||||
3817458|NCT01754714|3643111|B3|Germany||Region of Enrollment||participants|Number|11|11.0||||||
3817460|NCT01754714|3643113|B1|Germany||Region of Enrollment||participants|Number|13|13.0||||||
3817461|NCT01754714|3643109|B5|France||Region of Enrollment||participants|Number|24|24.0||||||
3817462|NCT01754714|3643110|B4|France||Region of Enrollment||participants|Number|9|9.0||||||
3817463|NCT01754714|3643111|B3|France||Region of Enrollment||participants|Number|4|4.0||||||
3817464|NCT01754714|3643112|B2|France||Region of Enrollment||participants|Number|5|5.0||||||
3817465|NCT01754714|3643113|B1|France||Region of Enrollment||participants|Number|6|6.0||||||
3817466|NCT01754714|3643109|B5|Poland||Region of Enrollment||participants|Number|17|17.0||||||
3817467|NCT01754714|3643110|B4|Poland||Region of Enrollment||participants|Number|6|6.0||||||
3817468|NCT01754714|3643111|B3|Poland||Region of Enrollment||participants|Number|6|6.0||||||
3817469|NCT01754714|3643112|B2|Poland||Region of Enrollment||participants|Number|2|2.0||||||
3817470|NCT01754714|3643113|B1|Poland||Region of Enrollment||participants|Number|3|3.0||||||
3817471|NCT01754714|3643109|B5|Russian Federation||Region of Enrollment||participants|Number|18|18.0||||||
3817472|NCT01754714|3643110|B4|Russian Federation||Region of Enrollment||participants|Number|2|2.0||||||
3817473|NCT01754714|3643111|B3|Russian Federation||Region of Enrollment||participants|Number|5|5.0||||||
3817474|NCT01754714|3643112|B2|Russian Federation||Region of Enrollment||participants|Number|6|6.0||||||
3817475|NCT01754714|3643113|B1|Russian Federation||Region of Enrollment||participants|Number|5|5.0||||||
3817476|NCT01754714|3643109|B5||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3817477|NCT01754714|3643110|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3817478|NCT01754714|3643111|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3817479|NCT01754714|3643112|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3817480|NCT01754714|3643113|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3817481|NCT01754714|3643109|B5||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3817482|NCT01754714|3643110|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3817483|NCT01754714|3643111|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3817484|NCT01754714|3643112|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3817485|NCT01754714|3643113|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3817486|NCT01754714|3643109|B5|||Age||years|Mean|51.9|51.9|Standard Deviation|13.1|13.1|||
3817487|NCT01754714|3643110|B4|||Age||years|Mean|56.6|56.6|Standard Deviation|11.6|11.6|||
3817488|NCT01754714|3643111|B3|||Age||years|Mean|49.5|49.5|Standard Deviation|14.2|14.2|||
3817489|NCT01754714|3643112|B2|||Age||years|Mean|50.0|50.0|Standard Deviation|12.3|12.3|||
3817490|NCT01754714|3643113|B1|||Age||years|Mean|51.2|51.2|Standard Deviation|13.8|13.8|||
3817491|NCT01754714|3643109|B5||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3817492|NCT01754714|3643110|B4||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3817493|NCT01754714|3643111|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3817494|NCT01754714|3643112|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3817495|NCT01754714|3643113|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3817496|NCT01754714|3643109|B5||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
3817497|NCT01754714|3643110|B4||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3817498|NCT01754714|3643111|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3817499|NCT01754714|3643112|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3817500|NCT01754714|3643113|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3817501|NCT01754714|3643109|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817502|NCT01754714|3643110|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817503|NCT01754714|3643111|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817504|NCT01754714|3643112|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817505|NCT01754714|3643113|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817506|NCT01754623|3643206|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3817507|NCT01754623|3643206|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3817508|NCT01754623|3643206|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3817509|NCT01754623|3643206|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3817510|NCT01754623|3643206|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3817511|NCT01754623|3643206|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817512|NCT01754519|3643213|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3817513|NCT01754519|3643213|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3817514|NCT01754519|3643213|B1|||Age||years|Mean|65|65.0|Standard Deviation|NA||||1 participant
3817515|NCT01754493|3643222|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3817516|NCT01754493|3643222|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817517|NCT01754493|3643222|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817518|NCT01754493|3643222|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3817519|NCT01754493|3643222|B1||Male|Gender||Participants|Count of Participants|4|4.0||||||
3817520|NCT01754493|3643222|B1||Female|Gender||Participants|Count of Participants|13|13.0||||||
3817521|NCT01754493|3643222|B1|||Age||years|Mean|42.7|42.7|Standard Deviation|11.0|11.0|||
3817522|NCT01754480|3643230|B3|Serbia||Region of Enrollment||participants|Number|103|103.0||||||
3817523|NCT01754480|3643231|B2|Serbia||Region of Enrollment||participants|Number|50|50.0||||||
3817524|NCT01754480|3643232|B1|Serbia||Region of Enrollment||participants|Number|53|53.0||||||
3817525|NCT01754480|3643230|B3|United States||Region of Enrollment||participants|Number|179|179.0||||||
3817526|NCT01754480|3643231|B2|United States||Region of Enrollment||participants|Number|91|91.0||||||
3817527|NCT01754480|3643232|B1|United States||Region of Enrollment||participants|Number|88|88.0||||||
3817528|NCT01754480|3643230|B3|Hungary||Region of Enrollment||participants|Number|38|38.0||||||
3817529|NCT01754480|3643231|B2|Hungary||Region of Enrollment||participants|Number|19|19.0||||||
3817530|NCT01754480|3643232|B1|Hungary||Region of Enrollment||participants|Number|19|19.0||||||
3817531|NCT01754480|3643230|B3|Russian Federation||Region of Enrollment||participants|Number|5|5.0||||||
3817532|NCT01754480|3643231|B2|Russian Federation||Region of Enrollment||participants|Number|2|2.0||||||
3817533|NCT01754480|3643232|B1|Russian Federation||Region of Enrollment||participants|Number|3|3.0||||||
3817534|NCT01754480|3643230|B3||Male|Gender||Participants|Count of Participants|170|170.0||||||
3817535|NCT01754480|3643231|B2||Male|Gender||Participants|Count of Participants|85|85.0||||||
3817536|NCT01754480|3643232|B1||Male|Gender||Participants|Count of Participants|85|85.0||||||
3817537|NCT01754480|3643230|B3||Female|Gender||Participants|Count of Participants|155|155.0||||||
3817538|NCT01754480|3643231|B2||Female|Gender||Participants|Count of Participants|77|77.0||||||
3817539|NCT01754480|3643232|B1||Female|Gender||Participants|Count of Participants|78|78.0||||||
3817540|NCT01754480|3643230|B3|>=65 years||Age, Customized||participants|Number|119|119.0||||||
3817541|NCT01754480|3643231|B2|>=65 years||Age, Customized||participants|Number|58|58.0||||||
3817542|NCT01754480|3643232|B1|>=65 years||Age, Customized||participants|Number|61|61.0||||||
3817543|NCT01754480|3643230|B3|Between 18 and 64 years||Age, Customized||participants|Number|201|201.0||||||
3817544|NCT01754480|3643231|B2|Between 18 and 64 years||Age, Customized||participants|Number|101|101.0||||||
3817545|NCT01754480|3643232|B1|Between 18 and 64 years||Age, Customized||participants|Number|100|100.0||||||
3817546|NCT01754480|3643230|B3|Between 12 and 17 years||Age, Customized||participants|Number|2|2.0||||||
3817547|NCT01754480|3643231|B2|Between 12 and 17 years||Age, Customized||participants|Number|2|2.0||||||
3817548|NCT01754480|3643232|B1|Between 12 and 17 years||Age, Customized||participants|Number|0|0.0||||||
3817549|NCT01754480|3643230|B3|<=11 years||Age, Customized||participants|Number|3|3.0||||||
3817550|NCT01754480|3643231|B2|<=11 years||Age, Customized||participants|Number|1|1.0||||||
3817551|NCT01754480|3643232|B1|<=11 years||Age, Customized||participants|Number|2|2.0||||||
3817552|NCT01754480|3643230|B3|||Age||years|Mean|57.93|57.93|Standard Deviation|14.494|14.494|||
3817553|NCT01754480|3643231|B2|||Age||years|Mean|57.04|57.04|Standard Deviation|15.194|15.194|||
3817554|NCT01754480|3643232|B1|||Age||years|Mean|58.82|58.82|Standard Deviation|13.753|13.753|||
3817555|NCT01754467|3643247|B1|||Body Mass Index||kg/m^2|Mean|37.4|37.4|Standard Deviation|9.9|9.9|||
3817556|NCT01754467|3643247|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3817557|NCT01754467|3643247|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817558|NCT01754467|3643247|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817559|NCT01754467|3643247|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3817560|NCT01754467|3643247|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3817561|NCT01754467|3643247|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817562|NCT01754467|3643247|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817563|NCT01754467|3643247|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817564|NCT01754467|3643247|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817565|NCT01754467|3643247|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3817566|NCT01754467|3643247|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817567|NCT01754467|3643247|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3817568|NCT01754467|3643247|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3817569|NCT01754467|3643247|B1|||Age||years|Mean|53.1|53.1|Standard Deviation|10.7|10.7|||
3817570|NCT01754467|3643247|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3817571|NCT01754467|3643247|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3817572|NCT01754467|3643247|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817573|NCT01754402|3643254|B4|United States||Region of Enrollment||participants|Number|38|38.0||||||
3817574|NCT01754402|3643255|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3817575|NCT01754402|3643256|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3817576|NCT01754402|3643257|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3817577|NCT01754402|3643254|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817578|NCT01754402|3643255|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817579|NCT01754402|3643256|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817580|NCT01754402|3643257|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817581|NCT01754402|3643254|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817582|NCT01754402|3643255|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817583|NCT01754402|3643256|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817584|NCT01754402|3643257|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817585|NCT01754402|3643254|B4||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3817586|NCT01754402|3643255|B3||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3817587|NCT01754402|3643256|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3817588|NCT01754402|3643257|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3817589|NCT01754402|3643254|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3817590|NCT01754402|3643255|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3817591|NCT01754402|3643256|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3817592|NCT01754402|3643257|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817593|NCT01754402|3643254|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817594|NCT01754402|3643255|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817595|NCT01754402|3643256|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817596|NCT01754402|3643257|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817597|NCT01754402|3643254|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817598|NCT01754402|3643255|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817599|NCT01754402|3643256|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817600|NCT01754402|3643257|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817601|NCT01754402|3643254|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817602|NCT01754402|3643255|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817603|NCT01754402|3643256|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817604|NCT01754402|3643257|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817605|NCT01754402|3643254|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3817606|NCT01754402|3643255|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3817607|NCT01754402|3643256|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817608|NCT01754402|3643257|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817609|NCT01754402|3643254|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3817610|NCT01754402|3643255|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3817611|NCT01754402|3643256|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3817612|NCT01754402|3643257|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3817613|NCT01754402|3643254|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817614|NCT01754402|3643255|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817615|NCT01754402|3643256|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817616|NCT01754402|3643257|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817617|NCT01754402|3643254|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3817618|NCT01754402|3643255|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3817619|NCT01754402|3643256|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3817620|NCT01754402|3643257|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3817621|NCT01754402|3643254|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3817622|NCT01754402|3643255|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3817623|NCT01754402|3643256|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3817624|NCT01754402|3643257|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3817625|NCT01754402|3643254|B4||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3817626|NCT01754402|3643255|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3817627|NCT01754402|3643256|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3817628|NCT01754402|3643257|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3817629|NCT01754402|3643254|B4||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3817630|NCT01754402|3643255|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3817631|NCT01754402|3643256|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3817632|NCT01754402|3643257|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3817633|NCT01754402|3643254|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817634|NCT01754402|3643255|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817635|NCT01754402|3643256|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817636|NCT01754402|3643257|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817637|NCT01754389|3643268|B4|United States||Region of Enrollment||participants|Number|138|138.0||||||
3817638|NCT01754389|3643269|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
3817639|NCT01754389|3643270|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
3817640|NCT01754389|3643271|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
3817641|NCT01754389|3643268|B4||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3817642|NCT01754389|3643269|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3817643|NCT01754389|3643270|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3817644|NCT01754389|3643271|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3817645|NCT01754389|3643268|B4||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3817646|NCT01754389|3643269|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3817647|NCT01754389|3643270|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3817648|NCT01754389|3643271|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3817649|NCT01754389|3643268|B4|||Age||years|Median|64|64.0|Full Range|||24.0|75.0|
3817650|NCT01754389|3643269|B3|||Age||years|Median|62|62.0|Full Range|||24.0|73.0|
3817651|NCT01754389|3643270|B2|||Age||years|Median|65|65.0|Full Range|||30.0|75.0|
3817652|NCT01754389|3643271|B1|||Age||years|Median|65|65.0|Full Range|||29.0|74.0|
3817653|NCT01754389|3643268|B4||>=65 years|Age||Participants|Count of Participants|68|68.0||||||
3817654|NCT01754389|3643269|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3817655|NCT01754389|3643270|B2||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3817656|NCT01754389|3643271|B1||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
3817657|NCT01754389|3643268|B4||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
3817658|NCT01754389|3643269|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3817659|NCT01754389|3643270|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3817660|NCT01754389|3643271|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3817661|NCT01754389|3643268|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817662|NCT01754389|3643269|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817663|NCT01754389|3643270|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817664|NCT01754389|3643271|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817665|NCT01754376|3643293|B1|Adjuvant interferon-alfa||Previous treatments||Participants|Count of Participants|5|5.0||||||
3817666|NCT01754376|3643293|B1|Surgery||Previous treatments||Participants|Count of Participants|6|6.0||||||
3817667|NCT01754376|3643293|B1|ECOG Status = 1||ECOG Status|The ECOG Scale of Performance Status describes a patient’s level of functioning in terms of their ability to care for themself, daily activity, and physical ability. A score of 0 indicates fully active, and a score of 5 indicates dead. (A score of one = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work)|Participants|Count of Participants|3|3.0||||||
3817668|NCT01754376|3643293|B1|ECOG Status = 0||ECOG Status|The ECOG Scale of Performance Status describes a patient’s level of functioning in terms of their ability to care for themself, daily activity, and physical ability. A score of 0 indicates fully active, and a score of 5 indicates dead. (A score of one = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work)|Participants|Count of Participants|3|3.0||||||
3817669|NCT01754376|3643293|B1|||Brain Metastasis present||Participants|Count of Participants|1|1.0||||||
3817670|NCT01754376|3643293|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3817671|NCT01754376|3643293|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817672|NCT01754376|3643293|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817673|NCT01754376|3643293|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3817674|NCT01754376|3643293|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817675|NCT01754376|3643293|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817676|NCT01754376|3643293|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817677|NCT01754376|3643293|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817678|NCT01754376|3643293|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3817679|NCT01754376|3643293|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3817680|NCT01754376|3643293|B1|||Age||years|Median|42|42.0|Full Range|||23.0|58.0|
3817681|NCT01754259|3643302|B3|United States||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
3817682|NCT01754259|3643303|B2|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3817683|NCT01754259|3643304|B1|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3817684|NCT01754259|3643302|B3|Indian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3817685|NCT01754259|3643303|B2|Indian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3817686|NCT01754259|3643304|B1|Indian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3817687|NCT01754259|3643302|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3817688|NCT01754259|3643303|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3817689|NCT01754259|3643304|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3817690|NCT01754259|3643302|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3817691|NCT01754259|3643303|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3817692|NCT01754259|3643304|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3817693|NCT01754259|3643302|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3817694|NCT01754259|3643303|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3817695|NCT01754259|3643304|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3817696|NCT01754259|3643302|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3817697|NCT01754259|3643303|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3817698|NCT01754259|3643304|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3817699|NCT01754259|3643302|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3817700|NCT01754259|3643303|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3817701|NCT01754259|3643304|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3817702|NCT01754259|3643302|B3||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
3817703|NCT01754259|3643303|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3817704|NCT01754259|3643304|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3817705|NCT01754259|3643302|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3817706|NCT01754259|3643303|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3817707|NCT01754259|3643304|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3817708|NCT01754259|3643302|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817709|NCT01754259|3643303|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817710|NCT01754259|3643304|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817711|NCT01754194|3643313|B3|Public Health Insurance||Type of Insurance (Public/Private)||participants|Number|19|19.0||||||
3817712|NCT01754194|3643314|B2|Public Health Insurance||Type of Insurance (Public/Private)||participants|Number|5|5.0||||||
3817713|NCT01754194|3643315|B1|Public Health Insurance||Type of Insurance (Public/Private)||participants|Number|14|14.0||||||
3817714|NCT01754194|3643313|B3|Private Health Insurance||Type of Insurance (Public/Private)||participants|Number|274|274.0||||||
3817715|NCT01754194|3643314|B2|Private Health Insurance||Type of Insurance (Public/Private)||participants|Number|119|119.0||||||
3817716|NCT01754194|3643315|B1|Private Health Insurance||Type of Insurance (Public/Private)||participants|Number|155|155.0||||||
3817717|NCT01754194|3643313|B3|||Body Mass Index (kg/m^2)||kg/m^2|Mean|46.8|46.8|Standard Deviation|4.9|4.9|||
3817718|NCT01754194|3643314|B2|||Body Mass Index (kg/m^2)||kg/m^2|Mean|45.8|45.8|Standard Deviation|5.0|5.0|||
3817719|NCT01754194|3643315|B1|||Body Mass Index (kg/m^2)||kg/m^2|Mean|47.6|47.6|Standard Deviation|4.6|4.6|||
3817720|NCT01754194|3643313|B3|||Weight (Kgs)||Kgs|Mean|137.2|137.2|Standard Deviation|20.8|20.8|||
3817721|NCT01754194|3643314|B2|||Weight (Kgs)||Kgs|Mean|132.3|132.3|Standard Deviation|20.2|20.2|||
3817722|NCT01754194|3643315|B1|||Weight (Kgs)||Kgs|Mean|140.8|140.8|Standard Deviation|20.6|20.6|||
3817723|NCT01754194|3643313|B3|Germany||Region of Enrollment||participants|Number|293|293.0||||||
3817724|NCT01754194|3643314|B2|Germany||Region of Enrollment||participants|Number|124|124.0||||||
3817725|NCT01754194|3643315|B1|Germany||Region of Enrollment||participants|Number|169|169.0||||||
3817726|NCT01754194|3643313|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3817727|NCT01754194|3643314|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3817728|NCT01754194|3643315|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3817729|NCT01754194|3643313|B3||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
3817730|NCT01754194|3643314|B2||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3817731|NCT01754194|3643315|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3817732|NCT01754194|3643313|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3817733|NCT01754194|3643314|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3817734|NCT01754194|3643315|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3817735|NCT01754194|3643313|B3||Between 18 and 65 years|Age||Participants|Count of Participants|293|293.0||||||
3817736|NCT01754194|3643314|B2||Between 18 and 65 years|Age||Participants|Count of Participants|124|124.0||||||
3817737|NCT01754194|3643315|B1||Between 18 and 65 years|Age||Participants|Count of Participants|169|169.0||||||
3817738|NCT01754194|3643313|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817739|NCT01754194|3643314|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817740|NCT01754194|3643315|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817741|NCT01754129|3643336|B1|||Time since onset of Parkinson's disease motor fluctuations||years|Mean|5.9|5.9|Standard Deviation|3.94|3.94|||
3817742|NCT01754129|3643336|B1|||Time since Parkinson's disease diagnosis||years|Mean|14.7|14.7|Standard Deviation|6.46|6.46|||
3817743|NCT01754129|3643336|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3817744|NCT01754129|3643336|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3817745|NCT01754129|3643336|B1|||Age||years|Mean|70.4|70.4|Standard Deviation|7.71|7.71|||
3817746|NCT01753999|3643359|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3817747|NCT01753999|3643359|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3817748|NCT01753999|3643359|B1||White|Race (NIH/OMB)||Participants|Count of Participants|227|227.0||||||
3817749|NCT01753999|3643359|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3817750|NCT01753999|3643359|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817751|NCT01753999|3643359|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3817752|NCT01753999|3643359|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817753|NCT01753999|3643359|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3817754|NCT01753999|3643359|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|264|264.0||||||
3817755|NCT01753999|3643359|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3817756|NCT01753999|3643359|B1||Male|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
3817757|NCT01753999|3643359|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3817758|NCT01753999|3643359|B1|||Age||years|Mean|53.29|53.29|Standard Deviation|8.23|8.23|||
3817759|NCT01753999|3643359|B1||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
3817760|NCT01753999|3643359|B1||Between 18 and 65 years|Age||Participants|Count of Participants|288|288.0||||||
3817761|NCT01753999|3643359|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817762|NCT01753856|3643368|B3|Canada||Region of Enrollment||participants|Number|21|21.0||||||
3817763|NCT01753856|3643369|B2|Canada||Region of Enrollment||participants|Number|9|9.0||||||
3817764|NCT01753856|3643370|B1|Canada||Region of Enrollment||participants|Number|12|12.0||||||
3817765|NCT01753856|3643368|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
3817766|NCT01753856|3643369|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
3817767|NCT01753856|3643370|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3817768|NCT01753856|3643368|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817769|NCT01753856|3643369|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817770|NCT01753856|3643370|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817771|NCT01753856|3643368|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3817772|NCT01753856|3643369|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3817773|NCT01753856|3643370|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3817774|NCT01753856|3643368|B3||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3817775|NCT01753856|3643369|B2||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3817776|NCT01753856|3643370|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3817777|NCT01753856|3643368|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3817778|NCT01753856|3643369|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3817779|NCT01753856|3643370|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3817780|NCT01753856|3643368|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817781|NCT01753856|3643369|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817782|NCT01753856|3643370|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817783|NCT01753856|3643368|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3817784|NCT01753856|3643369|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3817785|NCT01753856|3643370|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817786|NCT01753856|3643368|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817787|NCT01753856|3643369|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817788|NCT01753856|3643370|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817789|NCT01753856|3643368|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3817790|NCT01753856|3643369|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3817791|NCT01753856|3643370|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817792|NCT01753856|3643368|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3817793|NCT01753856|3643369|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3817794|NCT01753856|3643370|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3817795|NCT01753856|3643368|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3817796|NCT01753856|3643369|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3817797|NCT01753856|3643370|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3817798|NCT01753856|3643368|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3817799|NCT01753856|3643369|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3817800|NCT01753856|3643370|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3817801|NCT01753856|3643368|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3817802|NCT01753856|3643369|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3817803|NCT01753856|3643370|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3817804|NCT01753856|3643368|B3|||Age||years|Mean|63.45|63.45|Standard Deviation|7.42|7.42|||
3817805|NCT01753856|3643369|B2|||Age||years|Mean|65.17|65.17|Standard Deviation|8.32|8.32|||
3817806|NCT01753856|3643370|B1|||Age||years|Mean|61.58|61.58|Standard Deviation|5.84|5.84|||
3817807|NCT01753713|3643421|B3|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3817808|NCT01753713|3643422|B2|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3817809|NCT01753713|3643423|B1|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3817810|NCT01753713|3643421|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3817811|NCT01753713|3643422|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3817812|NCT01753713|3643423|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817813|NCT01753713|3643421|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3817814|NCT01753713|3643422|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817815|NCT01753713|3643423|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3817816|NCT01753713|3643421|B3||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3817817|NCT01753713|3643422|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3817818|NCT01753713|3643423|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3817819|NCT01753713|3643421|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3817820|NCT01753713|3643422|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3817821|NCT01753713|3643423|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3817822|NCT01753713|3643421|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3817823|NCT01753713|3643422|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3817824|NCT01753713|3643423|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817825|NCT01753713|3643421|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3817826|NCT01753713|3643422|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817827|NCT01753713|3643423|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3817828|NCT01753713|3643421|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817829|NCT01753713|3643422|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817830|NCT01753713|3643423|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817831|NCT01753713|3643421|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3817832|NCT01753713|3643422|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3817833|NCT01753713|3643423|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817834|NCT01753713|3643421|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3817835|NCT01753713|3643422|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3817836|NCT01753713|3643423|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3817837|NCT01753713|3643421|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817838|NCT01753713|3643422|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817839|NCT01753713|3643423|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3817840|NCT01753713|3643421|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3817841|NCT01753713|3643422|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3817842|NCT01753713|3643423|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3817843|NCT01753713|3643421|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3817844|NCT01753713|3643422|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3817845|NCT01753713|3643423|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3817846|NCT01753713|3643421|B3|||Age||years|Median|57|57.0|Full Range|||26.0|68.0|
3817847|NCT01753713|3643422|B2|||Age||years|Median|51|51.0|Full Range|||26.0|66.0|
3817848|NCT01753713|3643423|B1|||Age||years|Median|58|58.0|Full Range|||33.0|68.0|
3817849|NCT01753713|3643421|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3817850|NCT01753713|3643422|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3817851|NCT01753713|3643423|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3817852|NCT01753713|3643421|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3817853|NCT01753713|3643422|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3817854|NCT01753713|3643423|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3817855|NCT01753713|3643421|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817856|NCT01753713|3643422|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817857|NCT01753713|3643423|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3817858|NCT01753570|3643440|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3817859|NCT01753570|3643441|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3817860|NCT01753570|3643442|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3817861|NCT01753570|3643443|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3817862|NCT01753570|3643440|B4||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3817863|NCT01753570|3643441|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3817864|NCT01753570|3643442|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3817865|NCT01753570|3643443|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3817866|NCT01753570|3643440|B4|||Age||years|Mean|58.4|58.4|Standard Deviation|8.7|8.7|||
3817867|NCT01753570|3643441|B3|||Age||years|Mean|55.4|55.4|Standard Deviation|7.7|7.7|||
3817868|NCT01753570|3643442|B2|||Age||years|Mean|57.6|57.6|Standard Deviation|10.5|10.5|||
3817869|NCT01753570|3643443|B1|||Age||years|Mean|60.5|60.5|Standard Deviation|6.4|6.4|||
3817870|NCT01753557|3643467|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3817871|NCT01753557|3643468|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3817872|NCT01753557|3643469|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3817873|NCT01753557|3643467|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3817874|NCT01753557|3643468|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3817875|NCT01753557|3643469|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3817876|NCT01753557|3643467|B3|||Age||years|Mean|52.6|52.6|Standard Deviation|10.1|10.1|||
3817877|NCT01753557|3643468|B2|||Age||years|Mean|54.3|54.3|Standard Deviation|9.5|9.5|||
3817878|NCT01753557|3643469|B1|||Age||years|Mean|51.7|51.7|Standard Deviation|10.5|10.5|||
3817879|NCT01753518|3643486|B3|||Resident year of postgraduate education||years|Median|2|2.0|Inter-Quartile Range|||2.0|4.0|
3817880|NCT01753518|3643487|B2|||Resident year of postgraduate education||years|Median|2|2.0|Inter-Quartile Range|||2.0|3.0|
3817881|NCT01753518|3643488|B1|||Resident year of postgraduate education||years|Median|2|2.0|Inter-Quartile Range|||2.0|4.0|
3817882|NCT01753518|3643486|B3|United States||Region of Enrollment||participants|Number|206|206.0||||||
3817883|NCT01753518|3643487|B2|United States||Region of Enrollment||participants|Number|103|103.0||||||
3817884|NCT01753518|3643488|B1|United States||Region of Enrollment||participants|Number|103|103.0||||||
3817885|NCT01753518|3643486|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3817886|NCT01753518|3643487|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3817887|NCT01753518|3643488|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3817888|NCT01753518|3643486|B3||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
3817889|NCT01753518|3643487|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3817890|NCT01753518|3643488|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3817891|NCT01753518|3643486|B3|||Age||years|Median|30.5|30.5|Inter-Quartile Range|||27.0|34.0|
3817892|NCT01753518|3643487|B2|||Age||years|Median|31|31.0|Inter-Quartile Range|||27.0|34.0|
3817893|NCT01753518|3643488|B1|||Age||years|Median|30|30.0|Inter-Quartile Range|||27.0|33.0|
3817894|NCT01753336|3643511|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3817895|NCT01753336|3643511|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3817896|NCT01753336|3643511|B1|+75 years||Age, Customized||Participants|Number|5|5.0||||||
3817897|NCT01753336|3643511|B1|65-74 years||Age, Customized||Participants|Number|26|26.0||||||
3817898|NCT01753336|3643511|B1|55-64 years||Age, Customized||Participants|Number|33|33.0||||||
3817899|NCT01753336|3643511|B1|45-54 years||Age, Customized||Participants|Number|34|34.0||||||
3817900|NCT01753336|3643511|B1|35-44 years||Age, Customized||Participants|Number|13|13.0||||||
3817901|NCT01753336|3643511|B1|25-34 years||Age, Customized||Participants|Number|1|1.0||||||
3817902|NCT01753336|3643511|B1|18-24 years||Age, Customized||Participants|Number|0|0.0||||||
3817903|NCT01753323|3643520|B4|||Sex/Gender, Customized|Males only|Participants|Number|43|43.0||||||
3817904|NCT01753323|3643521|B3|||Sex/Gender, Customized|Males only|Participants|Number|22|22.0||||||
3817905|NCT01753323|3643522|B2|||Sex/Gender, Customized|Males only|Participants|Number|10|10.0||||||
3817906|NCT01753323|3643523|B1|||Sex/Gender, Customized|Males only|Participants|Number|11|11.0||||||
3817907|NCT01753323|3643520|B4|||Age||Years|Mean|31.2|31.2|Standard Deviation|8.77|8.77|||
3817908|NCT01753323|3643521|B3|||Age||Years|Mean|28.9|28.9|Standard Deviation|7.00|7.0|||
3817909|NCT01753323|3643522|B2|||Age||Years|Mean|36.7|36.7|Standard Deviation|10.90|10.9|||
3817910|NCT01753323|3643523|B1|||Age||Years|Mean|28.1|28.1|Standard Deviation|8.42|8.42|||
3817911|NCT01753310|3643561|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3817912|NCT01753310|3643562|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3817913|NCT01753310|3643563|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3817914|NCT01753310|3643561|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3817915|NCT01753310|3643562|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3817916|NCT01753310|3643563|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3817917|NCT01753310|3643561|B3|>75 years||Age, Customized||participants|Number|6|6.0||||||
3817918|NCT01753310|3643562|B2|>75 years||Age, Customized||participants|Number|2|2.0||||||
3817919|NCT01753310|3643563|B1|>75 years||Age, Customized||participants|Number|4|4.0||||||
3817920|NCT01753310|3643561|B3|65-74 years||Age, Customized||participants|Number|33|33.0||||||
3817921|NCT01753310|3643562|B2|65-74 years||Age, Customized||participants|Number|11|11.0||||||
3817922|NCT01753310|3643563|B1|65-74 years||Age, Customized||participants|Number|22|22.0||||||
3817923|NCT01753310|3643561|B3|55-64 years||Age, Customized||participants|Number|38|38.0||||||
3817924|NCT01753310|3643562|B2|55-64 years||Age, Customized||participants|Number|12|12.0||||||
3817925|NCT01753310|3643563|B1|55-64 years||Age, Customized||participants|Number|26|26.0||||||
3817926|NCT01753310|3643561|B3|45-54 years||Age, Customized||participants|Number|40|40.0||||||
3817927|NCT01753310|3643562|B2|45-54 years||Age, Customized||participants|Number|14|14.0||||||
3817928|NCT01753310|3643563|B1|45-54 years||Age, Customized||participants|Number|26|26.0||||||
3817929|NCT01753310|3643561|B3|35-44 years||Age, Customized||participants|Number|13|13.0||||||
3817930|NCT01753310|3643562|B2|35-44 years||Age, Customized||participants|Number|4|4.0||||||
3817931|NCT01753310|3643563|B1|35-44 years||Age, Customized||participants|Number|9|9.0||||||
3817932|NCT01753310|3643561|B3|25-34 years||Age, Customized||participants|Number|4|4.0||||||
3817933|NCT01753310|3643562|B2|25-34 years||Age, Customized||participants|Number|2|2.0||||||
3817934|NCT01753310|3643563|B1|25-34 years||Age, Customized||participants|Number|2|2.0||||||
3817935|NCT01753310|3643561|B3|18-24 years||Age, Customized||participants|Number|0|0.0||||||
3817936|NCT01753310|3643562|B2|18-24 years||Age, Customized||participants|Number|0|0.0||||||
3817937|NCT01753310|3643563|B1|18-24 years||Age, Customized||participants|Number|0|0.0||||||
3817938|NCT01753115|3643584|B4|Multiple||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3817939|NCT01753115|3643585|B3|Multiple||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3817940|NCT01753115|3643586|B2|Multiple||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3817941|NCT01753115|3643587|B1|Multiple||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3817942|NCT01753115|3643584|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3817943|NCT01753115|3643585|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3817944|NCT01753115|3643586|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3817945|NCT01753115|3643587|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3817946|NCT01753115|3643584|B4|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3817947|NCT01753115|3643585|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3817948|NCT01753115|3643586|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3817949|NCT01753115|3643587|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3817950|NCT01753115|3643584|B4|Black or African America||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
3817951|NCT01753115|3643585|B3|Black or African America||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
3817952|NCT01753115|3643586|B2|Black or African America||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3817953|NCT01753115|3643587|B1|Black or African America||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3817954|NCT01753115|3643584|B4|White||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
3817955|NCT01753115|3643585|B3|White||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
3817956|NCT01753115|3643586|B2|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3817957|NCT01753115|3643587|B1|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3817958|NCT01753115|3643584|B4||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3817959|NCT01753115|3643585|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3817960|NCT01753115|3643586|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3817961|NCT01753115|3643587|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3817962|NCT01753115|3643584|B4||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3817963|NCT01753115|3643585|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3817964|NCT01753115|3643586|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3817965|NCT01753115|3643587|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3817966|NCT01753115|3643584|B4|31 - 45 years||Age, Customized||participants|Number|77|77.0||||||
3817967|NCT01753115|3643585|B3|31 - 45 years||Age, Customized||participants|Number|35|35.0||||||
3817968|NCT01753115|3643586|B2|31 - 45 years||Age, Customized||participants|Number|20|20.0||||||
3817969|NCT01753115|3643587|B1|31 - 45 years||Age, Customized||participants|Number|22|22.0||||||
3817970|NCT01753115|3643584|B4|18 - 30 years||Age, Customized||participants|Number|77|77.0||||||
3817971|NCT01753115|3643585|B3|18 - 30 years||Age, Customized||participants|Number|35|35.0||||||
3817972|NCT01753115|3643586|B2|18 - 30 years||Age, Customized||participants|Number|20|20.0||||||
3817973|NCT01753115|3643587|B1|18 - 30 years||Age, Customized||participants|Number|22|22.0||||||
3817974|NCT01753115|3643584|B4|||Age||years|Mean|30.4|30.4|Standard Deviation|7.88|7.88|||
3817975|NCT01753115|3643585|B3|||Age||years|Mean|30.2|30.2|Standard Deviation|7.29|7.29|||
3817976|NCT01753115|3643586|B2|||Age||years|Mean|30.8|30.8|Standard Deviation|8.05|8.05|||
3817977|NCT01753115|3643587|B1|||Age||years|Mean|30.5|30.5|Standard Deviation|8.76|8.76|||
3817978|NCT01753076|3643597|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3817979|NCT01753076|3643598|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3817980|NCT01753076|3643599|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3817981|NCT01753076|3643597|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|245|245.0||||||
3817982|NCT01753076|3643598|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|121|121.0||||||
3817983|NCT01753076|3643599|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|124|124.0||||||
3817984|NCT01753076|3643597|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3817985|NCT01753076|3643598|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3817986|NCT01753076|3643599|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3817987|NCT01753076|3643597|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
3817988|NCT01753076|3643598|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3817989|NCT01753076|3643599|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
3817990|NCT01753076|3643597|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
3817991|NCT01753076|3643598|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
3817992|NCT01753076|3643599|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3817993|NCT01753076|3643597|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3818108|NCT01752023|3643693|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3817994|NCT01753076|3643598|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3817995|NCT01753076|3643599|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3817996|NCT01753076|3643597|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3817997|NCT01753076|3643598|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3817998|NCT01753076|3643599|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3817999|NCT01753076|3643597|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3818000|NCT01753076|3643598|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3818001|NCT01753076|3643599|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3818002|NCT01753076|3643597|B3||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
3818003|NCT01753076|3643598|B2||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3818004|NCT01753076|3643599|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3818005|NCT01753076|3643597|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3818006|NCT01753076|3643598|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3818007|NCT01753076|3643599|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3818008|NCT01753076|3643597|B3|||Age||Years|Mean|55.6|55.6|Standard Deviation|10.70|10.7|||
3818009|NCT01753076|3643598|B2|||Age||Years|Mean|55.7|55.7|Standard Deviation|10.40|10.4|||
3818010|NCT01753076|3643599|B1|||Age||Years|Mean|55.5|55.5|Standard Deviation|11.04|11.04|||
3818011|NCT01752907|3643624|B3|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3818012|NCT01752907|3643625|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3818013|NCT01752907|3643626|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3818014|NCT01752907|3643624|B3|White||Race/Ethnicity, Customized||participants|Number|252|252.0||||||
3818015|NCT01752907|3643625|B2|White||Race/Ethnicity, Customized||participants|Number|124|124.0||||||
3818016|NCT01752907|3643626|B1|White||Race/Ethnicity, Customized||participants|Number|128|128.0||||||
3818017|NCT01752907|3643624|B3|Black (or African American)||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
3818018|NCT01752907|3643625|B2|Black (or African American)||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3818019|NCT01752907|3643626|B1|Black (or African American)||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3818020|NCT01752907|3643624|B3|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3818021|NCT01752907|3643625|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3818022|NCT01752907|3643626|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3818023|NCT01752907|3643624|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3818024|NCT01752907|3643625|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3818025|NCT01752907|3643626|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3818026|NCT01752907|3643624|B3||Female|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
3818027|NCT01752907|3643625|B2||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3818028|NCT01752907|3643626|B1||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3818029|NCT01752907|3643624|B3|||Age||years|Mean|54.0|54.0|Standard Deviation|10.4|10.4|||
3818030|NCT01752907|3643625|B2|||Age||years|Mean|54.5|54.5|Standard Deviation|10.4|10.4|||
3818031|NCT01752907|3643626|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|10.4|10.4|||
3818032|NCT01752855|3643645|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3818033|NCT01752855|3643646|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3818034|NCT01752855|3643647|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3818035|NCT01752855|3643645|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3818036|NCT01752855|3643646|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3818037|NCT01752855|3643647|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3818038|NCT01752855|3643645|B3|||Age||years|Mean|53.9|53.9|Standard Deviation|11.5|11.5|||
3818039|NCT01752855|3643646|B2|||Age||years|Mean|52.0|52.0|Standard Deviation|12.0|12.0|||
3818040|NCT01752855|3643647|B1|||Age||years|Mean|55.7|55.7|Standard Deviation|10.8|10.8|||
3818041|NCT01752712|3643662|B3|United States||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
3818042|NCT01752712|3643663|B2|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3818043|NCT01752712|3643664|B1|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3818044|NCT01752712|3643662|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818045|NCT01752712|3643663|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818046|NCT01752712|3643664|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818047|NCT01752712|3643662|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3818048|NCT01752712|3643663|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3818049|NCT01752712|3643664|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3818050|NCT01752712|3643662|B3||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3818051|NCT01752712|3643663|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3818052|NCT01752712|3643664|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3818053|NCT01752712|3643662|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3818054|NCT01752712|3643663|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3818055|NCT01752712|3643664|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3818056|NCT01752712|3643662|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3818057|NCT01752712|3643663|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818058|NCT01752712|3643664|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3818059|NCT01752712|3643662|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3818060|NCT01752712|3643663|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3818061|NCT01752712|3643664|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3818062|NCT01752712|3643662|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3818063|NCT01752712|3643663|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818064|NCT01752712|3643664|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3818065|NCT01752712|3643662|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3818066|NCT01752712|3643663|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3818067|NCT01752712|3643664|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3818068|NCT01752712|3643662|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3818069|NCT01752712|3643663|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3818070|NCT01752712|3643664|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3818071|NCT01752712|3643662|B3|||Age||years|Mean|41.92|41.92|Standard Deviation|9.46|9.46|||
3818072|NCT01752712|3643663|B2|||Age||years|Mean|40.7|40.7|Standard Deviation|10.2|10.2|||
3818073|NCT01752712|3643664|B1|||Age||years|Mean|42.8|42.8|Standard Deviation|8.7|8.7|||
3818074|NCT01752712|3643662|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3818075|NCT01752712|3643663|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3818076|NCT01752712|3643664|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3818077|NCT01752712|3643662|B3||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
3818078|NCT01752712|3643663|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3818079|NCT01752712|3643664|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3818080|NCT01752712|3643662|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3818081|NCT01752712|3643663|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3818082|NCT01752712|3643664|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3818083|NCT01752400|3643681|B1|Certinib||Previous ALK Inhibitors|"ALK: anaplastic lymphoma kinase~Participants that received more than one ALK inhibitor were counted once for each inhibitor received"|participants|Number|2|2.0||||||
3818084|NCT01752400|3643681|B1|Alectinib||Previous ALK Inhibitors|"ALK: anaplastic lymphoma kinase~Participants that received more than one ALK inhibitor were counted once for each inhibitor received"|participants|Number|1|1.0||||||
3818085|NCT01752400|3643681|B1|Crizotinib||Previous ALK Inhibitors|"ALK: anaplastic lymphoma kinase~Participants that received more than one ALK inhibitor were counted once for each inhibitor received"|participants|Number|5|5.0||||||
3818086|NCT01752400|3643681|B1|||Median Number of Prior Lines of Therapy||Prior Lines of Therapy|Median|3|3.0|Full Range|||2.0|4.0|
3818087|NCT01752400|3643681|B1||Heavy Smoker (>10 pack years)|Smoking Status|A pack year is the number of packs of cigarettes (1 pack= 20 cigarettes) smoked per day multiplied by the number of years smoking.|Participants|Count of Participants|2|2.0||||||
3818088|NCT01752400|3643681|B1||Light Smoker (≤ 10 pack years)|Smoking Status|A pack year is the number of packs of cigarettes (1 pack= 20 cigarettes) smoked per day multiplied by the number of years smoking.|Participants|Count of Participants|2|2.0||||||
3818089|NCT01752400|3643681|B1||Never Smoker|Smoking Status|A pack year is the number of packs of cigarettes (1 pack= 20 cigarettes) smoked per day multiplied by the number of years smoking.|Participants|Count of Participants|2|2.0||||||
3818090|NCT01752400|3643681|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3818091|NCT01752400|3643681|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3818092|NCT01752400|3643681|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3818093|NCT01752400|3643681|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3818094|NCT01752400|3643681|B1|||Age||years|Median|52.5|52.5|Full Range|||42.0|54.0|
3818095|NCT01752023|3643692|B3|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3818096|NCT01752023|3643693|B2|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3818097|NCT01752023|3643694|B1|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3818098|NCT01752023|3643692|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3818099|NCT01752023|3643693|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3818100|NCT01752023|3643694|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3818101|NCT01752023|3643692|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3818102|NCT01752023|3643693|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3818103|NCT01752023|3643694|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3818104|NCT01752023|3643692|B3|||Age||years|Mean|66|66.0|Full Range|||52.0|67.0|
3818105|NCT01752023|3643693|B2|||Age||years|Mean|67|67.0|Full Range|||67.0|67.0|
3818106|NCT01752023|3643694|B1|||Age||years|Mean|59|59.0|Full Range|||52.0|66.0|
3818107|NCT01752023|3643692|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3818109|NCT01752023|3643694|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3818110|NCT01752023|3643692|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3818111|NCT01752023|3643693|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3818112|NCT01752023|3643694|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3818113|NCT01752023|3643692|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3818114|NCT01752023|3643693|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3818115|NCT01752023|3643694|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3818116|NCT01751971|3643711|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3818117|NCT01751971|3643712|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3818118|NCT01751971|3643713|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3818119|NCT01751971|3643711|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3818120|NCT01751971|3643712|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3818121|NCT01751971|3643713|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3818122|NCT01751971|3643711|B3|||Age||years|Mean|52|52.0|Standard Deviation|19|19.0|||
3818123|NCT01751971|3643712|B2|||Age||years|Mean|49|49.0|Standard Deviation|22|22.0|||
3818124|NCT01751971|3643713|B1|||Age||years|Mean|56|56.0|Standard Deviation|13|13.0|||
3818125|NCT01751906|3643729|B3|||Stable Angina||Participants|Count of Participants|1174|1174.0||||||
3818126|NCT01751906|3643730|B2|||Stable Angina||Participants|Count of Participants|417|417.0||||||
3818127|NCT01751906|3643731|B1|||Stable Angina||Participants|Count of Participants|757|757.0||||||
3818128|NCT01751906|3643729|B3|||Prior Coronary Intervention||Participants|Count of Participants|772|772.0||||||
3818129|NCT01751906|3643730|B2|||Prior Coronary Intervention||Participants|Count of Participants|260|260.0||||||
3818130|NCT01751906|3643731|B1|||Prior Coronary Intervention||Participants|Count of Participants|512|512.0||||||
3818131|NCT01751906|3643729|B3|||Dyslipidemia Requiring Medication||Participants|Count of Participants|1542|1542.0||||||
3818132|NCT01751906|3643730|B2|||Dyslipidemia Requiring Medication||Participants|Count of Participants|533|533.0||||||
3818133|NCT01751906|3643731|B1|||Dyslipidemia Requiring Medication||Participants|Count of Participants|1009|1009.0||||||
3818134|NCT01751906|3643729|B3|||Hypertension Requiring Medication||Participants|Count of Participants|1624|1624.0||||||
3818135|NCT01751906|3643730|B2|||Hypertension Requiring Medication||Participants|Count of Participants|553|553.0||||||
3818136|NCT01751906|3643731|B1|||Hypertension Requiring Medication||Participants|Count of Participants|1071|1071.0||||||
3818137|NCT01751906|3643729|B3|United States||Region of Enrollment||Participants|Count of Participants|2008|2008.0||||||
3818138|NCT01751906|3643730|B2|United States||Region of Enrollment||Participants|Count of Participants|686|686.0||||||
3818139|NCT01751906|3643731|B1|United States||Region of Enrollment||Participants|Count of Participants|1322|1322.0||||||
3818140|NCT01751906|3643729|B3||Male|Sex: Female, Male||Participants|Count of Participants|1415|1415.0||||||
3818141|NCT01751906|3643730|B2||Male|Sex: Female, Male||Participants|Count of Participants|481|481.0||||||
3818142|NCT01751906|3643731|B1||Male|Sex: Female, Male||Participants|Count of Participants|934|934.0||||||
3818143|NCT01751906|3643729|B3||Female|Sex: Female, Male||Participants|Count of Participants|593|593.0||||||
3818144|NCT01751906|3643730|B2||Female|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
3818145|NCT01751906|3643731|B1||Female|Sex: Female, Male||Participants|Count of Participants|388|388.0||||||
3818146|NCT01751906|3643729|B3|||Age||years|Mean|63.5|63.5|Standard Deviation|10.5|10.5|||
3818147|NCT01751906|3643730|B2|||Age||years|Mean|63.6|63.6|Standard Deviation|10.3|10.3|||
3818148|NCT01751906|3643731|B1|||Age||years|Mean|63.5|63.5|Standard Deviation|10.6|10.6|||
3818149|NCT01751867|3643934|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3818150|NCT01751867|3643935|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3818151|NCT01751867|3643936|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3818152|NCT01751867|3643934|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3818153|NCT01751867|3643935|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3818154|NCT01751867|3643936|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3818155|NCT01751867|3643934|B3|Greater than or equal to (>=) 60 Y||Age, Customized||Participants|Number|41|41.0||||||
3818156|NCT01751867|3643935|B2|Greater than or equal to (>=) 60 Y||Age, Customized||Participants|Number|30|30.0||||||
3818157|NCT01751867|3643936|B1|Greater than or equal to (>=) 60 Y||Age, Customized||Participants|Number|11|11.0||||||
3818158|NCT01751867|3643934|B3|18-60 Years (Y) (including 18 Y, excluding 60 Y)||Age, Customized||Participants|Number|94|94.0||||||
3818159|NCT01751867|3643935|B2|18-60 Years (Y) (including 18 Y, excluding 60 Y)||Age, Customized||Participants|Number|69|69.0||||||
3818160|NCT01751867|3643936|B1|18-60 Years (Y) (including 18 Y, excluding 60 Y)||Age, Customized||Participants|Number|25|25.0||||||
3818161|NCT01751867|3643934|B3|||Age||Years|Mean|51.0|51.0|Standard Deviation|15.11|15.11|||
3818162|NCT01751867|3643935|B2|||Age||Years|Mean|51.6|51.6|Standard Deviation|14.78|14.78|||
3818163|NCT01751867|3643936|B1|||Age||Years|Mean|49.2|49.2|Standard Deviation|16.04|16.04|||
3818164|NCT01751802|3643955|B3|||BMI||kg/m^2|Mean|14.8|14.8|Full Range|||13.1|18.1|
3818165|NCT01751802|3643956|B2|||BMI||kg/m^2|Mean|13.8|13.8|Full Range|||13.1|15.5|
3818166|NCT01751802|3643957|B1|||BMI||kg/m^2|Mean|15.6|15.6|Full Range|||13.9|18.1|
3818167|NCT01751802|3643955|B3|||Weight||kg|Mean|25.4|25.4|Full Range|||16.0|55.4|
3818168|NCT01751802|3643956|B2|||Weight||kg|Mean|21.9|21.9|Full Range|||16.0|26.5|
3818169|NCT01751802|3643957|B1|||Weight||kg|Mean|28.3|28.3|Full Range|||16.5|55.4|
3818170|NCT01751802|3643955|B3|Spain||Region of Enrollment||participants|Number|6|6.0||||||
3818171|NCT01751802|3643956|B2|Spain||Region of Enrollment||participants|Number|3|3.0||||||
3818172|NCT01751802|3643957|B1|Spain||Region of Enrollment||participants|Number|3|3.0||||||
3818173|NCT01751802|3643955|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3818174|NCT01751802|3643956|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3818175|NCT01751802|3643957|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3818176|NCT01751802|3643955|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3818177|NCT01751802|3643956|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3818178|NCT01751802|3643957|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3818179|NCT01751802|3643955|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3818180|NCT01751802|3643956|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3818181|NCT01751802|3643957|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3818182|NCT01751802|3643955|B3|||Age||years|Mean|10.3|10.3|Full Range|||6.0|22.0|
3818183|NCT01751802|3643956|B2|||Age||years|Mean|9.8|9.8|Full Range|||6.0|12.0|
3818184|NCT01751802|3643957|B1|||Age||years|Mean|10.8|10.8|Full Range|||6.0|22.0|
3818185|NCT01751724|3643970|B3|||Mean airway pressure at enrollment||centimeters of water|Median|9|9.0|Inter-Quartile Range|||8.0|10.0|
3818186|NCT01751724|3643971|B2|||Mean airway pressure at enrollment||centimeters of water|Median|8|8.0|Inter-Quartile Range|||8.0|10.0|
3818187|NCT01751724|3643972|B1|||Mean airway pressure at enrollment||centimeters of water|Median|9|9.0|Inter-Quartile Range|||8.0|11.0|
3818188|NCT01751724|3643970|B3|||Fraction of inspired oxygen at enrollment||oxygen fraction|Median|.24|0.24|Inter-Quartile Range|||0.21|0.33|
3818189|NCT01751724|3643971|B2|||Fraction of inspired oxygen at enrollment||oxygen fraction|Median|0.23|0.23|Inter-Quartile Range|||0.21|0.3|
3818190|NCT01751724|3643972|B1|||Fraction of inspired oxygen at enrollment||oxygen fraction|Median|0.25|0.25|Inter-Quartile Range|||0.21|0.37|
3818191|NCT01751724|3643970|B3|||Birth weight||grams|Median|700|700.0|Inter-Quartile Range|||615.0|906.0|
3818192|NCT01751724|3643971|B2|||Birth weight||grams|Median|720|720.0|Inter-Quartile Range|||643.0|894.0|
3818193|NCT01751724|3643972|B1|||Birth weight||grams|Median|670|670.0|Inter-Quartile Range|||605.0|915.0|
3818194|NCT01751724|3643970|B3|||Gestational age||weeks|Median|25.9|25.9|Inter-Quartile Range|||24.2|27.5|
3818195|NCT01751724|3643971|B2|||Gestational age||weeks|Median|26.1|26.1|Inter-Quartile Range|||24.2|28.4|
3818196|NCT01751724|3643972|B1|||Gestational age||weeks|Median|25.7|25.7|Inter-Quartile Range|||24.3|27.0|
3818197|NCT01751724|3643970|B3|Black race||Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3818198|NCT01751724|3643971|B2|Black race||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3818199|NCT01751724|3643972|B1|Black race||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3818200|NCT01751724|3643970|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3818201|NCT01751724|3643971|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3818202|NCT01751724|3643972|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3818203|NCT01751724|3643970|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3818204|NCT01751724|3643971|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3818205|NCT01751724|3643972|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3818206|NCT01751724|3643970|B3|||Age||hours|Mean|48|48.0|Standard Deviation|28|28.0|||
3818207|NCT01751724|3643971|B2|||Age||hours|Mean|49|49.0|Standard Deviation|31|31.0|||
3818208|NCT01751724|3643972|B1|||Age||hours|Mean|48|48.0|Standard Deviation|25|25.0|||
3818209|NCT01751412|3643999|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3818210|NCT01751412|3643999|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818211|NCT01751412|3643999|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818212|NCT01751412|3643999|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3818213|NCT01751412|3643999|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818214|NCT01751412|3643999|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818215|NCT01751412|3643999|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818216|NCT01751412|3643999|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818217|NCT01751412|3643999|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3818218|NCT01751412|3643999|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3818219|NCT01751412|3643999|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818220|NCT01751412|3643999|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3818221|NCT01751412|3643999|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3818222|NCT01751412|3643999|B1|||Age||years|Median|28|28.0|Full Range|||17.0|61.0|
3818223|NCT01751412|3643999|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3818224|NCT01751412|3643999|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3818225|NCT01751412|3643999|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3818226|NCT01751399|3644009|B5|||Participants with Diabetes||Participants|Count of Participants|1|1.0||||||
3818227|NCT01751399|3644010|B4|||Participants with Diabetes||Participants|Count of Participants|0|0.0||||||
3818228|NCT01751399|3644011|B3|||Participants with Diabetes||Participants|Count of Participants|1|1.0||||||
3818229|NCT01751399|3644012|B2|||Participants with Diabetes||Participants|Count of Participants|0|0.0||||||
3818230|NCT01751399|3644013|B1|||Participants with Diabetes||Participants|Count of Participants|0|0.0||||||
3818231|NCT01751399|3644009|B5|Germany||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3818232|NCT01751399|3644010|B4|Germany||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3818233|NCT01751399|3644011|B3|Germany||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3818234|NCT01751399|3644012|B2|Germany||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3818235|NCT01751399|3644013|B1|Germany||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3818236|NCT01751399|3644009|B5|Hungary||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3818237|NCT01751399|3644010|B4|Hungary||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3818238|NCT01751399|3644011|B3|Hungary||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3818239|NCT01751399|3644012|B2|Hungary||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3818240|NCT01751399|3644013|B1|Hungary||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3818241|NCT01751399|3644009|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818242|NCT01751399|3644010|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818243|NCT01751399|3644011|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818244|NCT01751399|3644012|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818245|NCT01751399|3644013|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818246|NCT01751399|3644009|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818247|NCT01751399|3644010|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818248|NCT01751399|3644011|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818249|NCT01751399|3644012|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818250|NCT01751399|3644013|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818251|NCT01751399|3644009|B5||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3818252|NCT01751399|3644010|B4||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3818253|NCT01751399|3644011|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3818254|NCT01751399|3644012|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3818255|NCT01751399|3644013|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3818256|NCT01751399|3644009|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818257|NCT01751399|3644010|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818258|NCT01751399|3644011|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818259|NCT01751399|3644012|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818260|NCT01751399|3644013|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818261|NCT01751399|3644009|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818262|NCT01751399|3644010|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818263|NCT01751399|3644011|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818264|NCT01751399|3644012|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818265|NCT01751399|3644013|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818266|NCT01751399|3644009|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818267|NCT01751399|3644010|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818268|NCT01751399|3644011|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818269|NCT01751399|3644012|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818270|NCT01751399|3644013|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818271|NCT01751399|3644009|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818272|NCT01751399|3644010|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818273|NCT01751399|3644011|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818274|NCT01751399|3644012|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818275|NCT01751399|3644013|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818276|NCT01751399|3644009|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818277|NCT01751399|3644010|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818278|NCT01751399|3644011|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818279|NCT01751399|3644012|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818280|NCT01751399|3644013|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818281|NCT01751399|3644009|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3818282|NCT01751399|3644010|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3818283|NCT01751399|3644011|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3818284|NCT01751399|3644012|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3818285|NCT01751399|3644013|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3818286|NCT01751399|3644009|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818287|NCT01751399|3644010|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818288|NCT01751399|3644011|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818289|NCT01751399|3644012|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818290|NCT01751399|3644013|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818291|NCT01751399|3644009|B5||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3818292|NCT01751399|3644010|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3818293|NCT01751399|3644011|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3818294|NCT01751399|3644012|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3818295|NCT01751399|3644013|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3818296|NCT01751399|3644009|B5||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3818297|NCT01751399|3644010|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3818298|NCT01751399|3644011|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3818299|NCT01751399|3644012|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3818300|NCT01751399|3644013|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3818301|NCT01751399|3644009|B5|||Age||years|Mean|54.6|54.6|Standard Deviation|6.8|6.8|||
3818302|NCT01751399|3644010|B4|||Age||years|Mean|57.6|57.6|Standard Deviation|3.3|3.3|||
3818303|NCT01751399|3644011|B3|||Age||years|Mean|52.4|52.4|Standard Deviation|9.9|9.9|||
3818304|NCT01751399|3644012|B2|||Age||years|Mean|56.0|56.0|Standard Deviation|5.9|5.9|||
3818305|NCT01751399|3644013|B1|||Age||years|Mean|53.5|53.5|Standard Deviation|6.4|6.4|||
3818306|NCT01751386|3644030|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818307|NCT01751386|3644031|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818308|NCT01751386|3644032|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818309|NCT01751386|3644030|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3818310|NCT01751386|3644031|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3818311|NCT01751386|3644032|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3818312|NCT01751386|3644030|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3818313|NCT01751386|3644031|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3818314|NCT01751386|3644032|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3818315|NCT01751386|3644030|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3818316|NCT01751386|3644031|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3818317|NCT01751386|3644032|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3818318|NCT01751386|3644030|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818319|NCT01751386|3644031|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818320|NCT01751386|3644032|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818321|NCT01751386|3644030|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3818322|NCT01751386|3644031|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3818323|NCT01751386|3644032|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818324|NCT01751386|3644030|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818325|NCT01751386|3644031|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818326|NCT01751386|3644032|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818327|NCT01751386|3644030|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818328|NCT01751386|3644031|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818329|NCT01751386|3644032|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818330|NCT01751386|3644030|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3818331|NCT01751386|3644031|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3818332|NCT01751386|3644032|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3818333|NCT01751386|3644030|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818334|NCT01751386|3644031|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818335|NCT01751386|3644032|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818336|NCT01751386|3644030|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3818337|NCT01751386|3644031|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3818338|NCT01751386|3644032|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3818339|NCT01751386|3644030|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3818340|NCT01751386|3644031|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3818341|NCT01751386|3644032|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3818342|NCT01751386|3644030|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3818343|NCT01751386|3644031|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3818344|NCT01751386|3644032|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3818345|NCT01751386|3644030|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3818346|NCT01751386|3644031|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3818347|NCT01751386|3644032|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3818348|NCT01751386|3644030|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3818349|NCT01751386|3644031|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3818350|NCT01751386|3644032|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3818351|NCT01751308|3644039|B6||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3818352|NCT01751308|3644040|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3818353|NCT01751308|3644041|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3818354|NCT01751308|3644042|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3818355|NCT01751308|3644043|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3818356|NCT01751308|3644044|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3818357|NCT01751308|3644039|B6||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3818358|NCT01751308|3644040|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3818359|NCT01751308|3644041|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3818360|NCT01751308|3644042|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3818361|NCT01751308|3644043|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3818362|NCT01751308|3644044|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3818363|NCT01751308|3644039|B6|12-18 years||Age, Customized||participants|Number|13|13.0||||||
3818364|NCT01751308|3644040|B5|12-18 years||Age, Customized||participants|Number|6|6.0||||||
3818365|NCT01751308|3644041|B4|12-18 years||Age, Customized||participants|Number|1|1.0||||||
3818366|NCT01751308|3644042|B3|12-18 years||Age, Customized||participants|Number|2|2.0||||||
3818367|NCT01751308|3644043|B2|12-18 years||Age, Customized||participants|Number|1|1.0||||||
3818368|NCT01751308|3644044|B1|12-18 years||Age, Customized||participants|Number|3|3.0||||||
3818369|NCT01751308|3644039|B6|7-11 years||Age, Customized||participants|Number|14|14.0||||||
3818370|NCT01751308|3644040|B5|7-11 years||Age, Customized||participants|Number|4|4.0||||||
3818371|NCT01751308|3644041|B4|7-11 years||Age, Customized||participants|Number|5|5.0||||||
3818372|NCT01751308|3644042|B3|7-11 years||Age, Customized||participants|Number|3|3.0||||||
3818373|NCT01751308|3644043|B2|7-11 years||Age, Customized||participants|Number|1|1.0||||||
3818374|NCT01751308|3644044|B1|7-11 years||Age, Customized||participants|Number|1|1.0||||||
3818375|NCT01751308|3644039|B6|5-6 years||Age, Customized||participants|Number|8|8.0||||||
3818376|NCT01751308|3644040|B5|5-6 years||Age, Customized||participants|Number|4|4.0||||||
3818377|NCT01751308|3644041|B4|5-6 years||Age, Customized||participants|Number|1|1.0||||||
3818378|NCT01751308|3644042|B3|5-6 years||Age, Customized||participants|Number|0|0.0||||||
3818379|NCT01751308|3644043|B2|5-6 years||Age, Customized||participants|Number|1|1.0||||||
3818380|NCT01751308|3644044|B1|5-6 years||Age, Customized||participants|Number|2|2.0||||||
3818381|NCT01751308|3644039|B6|2-4 years||Age, Customized||participants|Number|4|4.0||||||
3818382|NCT01751308|3644040|B5|2-4 years||Age, Customized||participants|Number|2|2.0||||||
3818383|NCT01751308|3644041|B4|2-4 years||Age, Customized||participants|Number|0|0.0||||||
3818384|NCT01751308|3644042|B3|2-4 years||Age, Customized||participants|Number|2|2.0||||||
3818385|NCT01751308|3644043|B2|2-4 years||Age, Customized||participants|Number|0|0.0||||||
3818386|NCT01751308|3644044|B1|2-4 years||Age, Customized||participants|Number|0|0.0||||||
3818387|NCT01751178|3644085|B4||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3818388|NCT01751178|3644086|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3818389|NCT01751178|3644087|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3818390|NCT01751178|3644088|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3818391|NCT01751178|3644085|B4||Female|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
3818392|NCT01751178|3644086|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3818393|NCT01751178|3644087|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3818394|NCT01751178|3644088|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3818395|NCT01751178|3644085|B4|||Age||Years|Mean|36.8|36.8|Standard Deviation|10.89|10.89|||
3818396|NCT01751178|3644086|B3|||Age||Years|Mean|36.5|36.5|Standard Deviation|10.48|10.48|||
3818397|NCT01751178|3644087|B2|||Age||Years|Mean|36.2|36.2|Standard Deviation|11.31|11.31|||
3818398|NCT01751178|3644088|B1|||Age||Years|Mean|37.8|37.8|Standard Deviation|10.89|10.89|||
3818399|NCT01751165|3644107|B4||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3818400|NCT01751165|3644108|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3818401|NCT01751165|3644109|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3818402|NCT01751165|3644110|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3818403|NCT01751165|3644107|B4||Female|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
3818404|NCT01751165|3644108|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3818405|NCT01751165|3644109|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3818406|NCT01751165|3644110|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3818407|NCT01751165|3644107|B4|||Age||Years|Mean|64.2|64.2|Standard Deviation|8.88|8.88|||
3818408|NCT01751165|3644108|B3|||Age||Years|Mean|64.1|64.1|Standard Deviation|9.2|9.2|||
3818409|NCT01751165|3644109|B2|||Age||Years|Mean|64|64.0|Standard Deviation|8.6|8.6|||
3818410|NCT01751165|3644110|B1|||Age||Years|Mean|64.5|64.5|Standard Deviation|8.9|8.9|||
3818411|NCT01751113|3644152|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|53|53.0||||||
3818412|NCT01751113|3644152|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3818413|NCT01751113|3644152|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3818414|NCT01751113|3644152|B1|||Age||Years|Mean|67.2|67.2|Standard Deviation|6.56|6.56|||
3818415|NCT01751087|3644195|B4|United States||Region of Enrollment||participants|Number|300|300.0||||||
3818416|NCT01751087|3644196|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
3818417|NCT01751087|3644197|B2|United States||Region of Enrollment||participants|Number|100|100.0||||||
3818418|NCT01751087|3644198|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
3818419|NCT01751087|3644195|B4|Other||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3818420|NCT01751087|3644196|B3|Other||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3818421|NCT01751087|3644197|B2|Other||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3818422|NCT01751087|3644198|B1|Other||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3818423|NCT01751087|3644195|B4|White or European American||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
3818424|NCT01751087|3644196|B3|White or European American||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3818425|NCT01751087|3644197|B2|White or European American||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3818426|NCT01751087|3644198|B1|White or European American||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3818427|NCT01751087|3644195|B4|African American or black||Race/Ethnicity, Customized||participants|Number|123|123.0||||||
3818428|NCT01751087|3644196|B3|African American or black||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3818429|NCT01751087|3644197|B2|African American or black||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
3818430|NCT01751087|3644198|B1|African American or black||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
3818431|NCT01751087|3644195|B4|Hispanic or Latina||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
3818432|NCT01751087|3644196|B3|Hispanic or Latina||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3818433|NCT01751087|3644197|B2|Hispanic or Latina||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3818434|NCT01751087|3644198|B1|Hispanic or Latina||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3818435|NCT01751087|3644195|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3818436|NCT01751087|3644196|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3818437|NCT01751087|3644197|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3818438|NCT01751087|3644198|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3818439|NCT01751087|3644195|B4||Female|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
3818440|NCT01751087|3644196|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3818441|NCT01751087|3644197|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3818442|NCT01751087|3644198|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3818443|NCT01751087|3644195|B4|||Age||years|Mean|25.25|25.25|Standard Deviation|5.8|5.8|||
3818444|NCT01751087|3644196|B3|||Age||years|Mean|25.3|25.3|Standard Deviation|5.8|5.8|||
3818445|NCT01751087|3644197|B2|||Age||years|Mean|25.9|25.9|Standard Deviation|5.9|5.9|||
3818446|NCT01751087|3644198|B1|||Age||years|Mean|24.6|24.6|Standard Deviation|5.7|5.7|||
3818447|NCT01751022|3644232|B4|||QRS (Electrocardiogram Complex)||ms|Mean|156|156.0|Standard Deviation|23|23.0|||
3818448|NCT01751022|3644233|B3|||QRS (Electrocardiogram Complex)||ms|Mean|156|156.0|Standard Deviation|23|23.0|||
3818449|NCT01751022|3644234|B2|||QRS (Electrocardiogram Complex)||ms|Mean|156|156.0|Standard Deviation|24|24.0|||
3818450|NCT01751022|3644235|B1|||QRS (Electrocardiogram Complex)||ms|Mean|155|155.0|Standard Deviation|23|23.0|||
3818451|NCT01751022|3644232|B4|||Left Ventricular Ejection Fraction (LVEF)||%|Mean|26|26.0|Standard Deviation|7|7.0|||
3818452|NCT01751022|3644233|B3|||Left Ventricular Ejection Fraction (LVEF)||%|Mean|27|27.0|Standard Deviation|7|7.0|||
3818453|NCT01751022|3644234|B2|||Left Ventricular Ejection Fraction (LVEF)||%|Mean|26|26.0|Standard Deviation|7|7.0|||
3818454|NCT01751022|3644235|B1|||Left Ventricular Ejection Fraction (LVEF)||%|Mean|25|25.0|Standard Deviation|7|7.0|||
3818455|NCT01751022|3644232|B4|IV||New York Heart Association Classification (NYHA)|NYHA Functional Classification is assessed as following. Class I: No limitation of physical activity. Class II:Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Unable to carry on any physical activity without discomfort. For more details see American Heart Association website http://www.heart.org/HEARTORG/Conditions/HeartFailure/AboutHeartFailure/Classes-of-Heart-Failure_UCM_306328_Article.jsp#.V_5rPPkrJD8|participants|Number|35|35.0||||||
3818456|NCT01751022|3644233|B3|IV||New York Heart Association Classification (NYHA)|NYHA Functional Classification is assessed as following. Class I: No limitation of physical activity. Class II:Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Unable to carry on any physical activity without discomfort. For more details see American Heart Association website http://www.heart.org/HEARTORG/Conditions/HeartFailure/AboutHeartFailure/Classes-of-Heart-Failure_UCM_306328_Article.jsp#.V_5rPPkrJD8|participants|Number|9|9.0||||||
3818531|NCT01751022|3644232|B4|Romania||Region of Enrollment||participants|Number|12|12.0||||||
3818532|NCT01751022|3644233|B3|Romania||Region of Enrollment||participants|Number|1|1.0||||||
3818533|NCT01751022|3644234|B2|Romania||Region of Enrollment||participants|Number|0|0.0||||||
3818457|NCT01751022|3644234|B2|IV||New York Heart Association Classification (NYHA)|NYHA Functional Classification is assessed as following. Class I: No limitation of physical activity. Class II:Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Unable to carry on any physical activity without discomfort. For more details see American Heart Association website http://www.heart.org/HEARTORG/Conditions/HeartFailure/AboutHeartFailure/Classes-of-Heart-Failure_UCM_306328_Article.jsp#.V_5rPPkrJD8|participants|Number|12|12.0||||||
3818458|NCT01751022|3644235|B1|IV||New York Heart Association Classification (NYHA)|NYHA Functional Classification is assessed as following. Class I: No limitation of physical activity. Class II:Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Unable to carry on any physical activity without discomfort. For more details see American Heart Association website http://www.heart.org/HEARTORG/Conditions/HeartFailure/AboutHeartFailure/Classes-of-Heart-Failure_UCM_306328_Article.jsp#.V_5rPPkrJD8|participants|Number|14|14.0||||||
3818459|NCT01751022|3644232|B4|III||New York Heart Association Classification (NYHA)|NYHA Functional Classification is assessed as following. Class I: No limitation of physical activity. Class II:Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Unable to carry on any physical activity without discomfort. For more details see American Heart Association website http://www.heart.org/HEARTORG/Conditions/HeartFailure/AboutHeartFailure/Classes-of-Heart-Failure_UCM_306328_Article.jsp#.V_5rPPkrJD8|participants|Number|766|766.0||||||
3818460|NCT01751022|3644233|B3|III||New York Heart Association Classification (NYHA)|NYHA Functional Classification is assessed as following. Class I: No limitation of physical activity. Class II:Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Unable to carry on any physical activity without discomfort. For more details see American Heart Association website http://www.heart.org/HEARTORG/Conditions/HeartFailure/AboutHeartFailure/Classes-of-Heart-Failure_UCM_306328_Article.jsp#.V_5rPPkrJD8|participants|Number|198|198.0||||||
3818461|NCT01751022|3644234|B2|III||New York Heart Association Classification (NYHA)|NYHA Functional Classification is assessed as following. Class I: No limitation of physical activity. Class II:Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Unable to carry on any physical activity without discomfort. For more details see American Heart Association website http://www.heart.org/HEARTORG/Conditions/HeartFailure/AboutHeartFailure/Classes-of-Heart-Failure_UCM_306328_Article.jsp#.V_5rPPkrJD8|participants|Number|216|216.0||||||
3818462|NCT01751022|3644235|B1|III||New York Heart Association Classification (NYHA)|NYHA Functional Classification is assessed as following. Class I: No limitation of physical activity. Class II:Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Unable to carry on any physical activity without discomfort. For more details see American Heart Association website http://www.heart.org/HEARTORG/Conditions/HeartFailure/AboutHeartFailure/Classes-of-Heart-Failure_UCM_306328_Article.jsp#.V_5rPPkrJD8|participants|Number|352|352.0||||||
3818463|NCT01751022|3644232|B4|II||New York Heart Association Classification (NYHA)|NYHA Functional Classification is assessed as following. Class I: No limitation of physical activity. Class II:Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Unable to carry on any physical activity without discomfort. For more details see American Heart Association website http://www.heart.org/HEARTORG/Conditions/HeartFailure/AboutHeartFailure/Classes-of-Heart-Failure_UCM_306328_Article.jsp#.V_5rPPkrJD8|participants|Number|308|308.0||||||
3818464|NCT01751022|3644233|B3|II||New York Heart Association Classification (NYHA)|NYHA Functional Classification is assessed as following. Class I: No limitation of physical activity. Class II:Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Unable to carry on any physical activity without discomfort. For more details see American Heart Association website http://www.heart.org/HEARTORG/Conditions/HeartFailure/AboutHeartFailure/Classes-of-Heart-Failure_UCM_306328_Article.jsp#.V_5rPPkrJD8|participants|Number|89|89.0||||||
3818465|NCT01751022|3644234|B2|II||New York Heart Association Classification (NYHA)|NYHA Functional Classification is assessed as following. Class I: No limitation of physical activity. Class II:Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Unable to carry on any physical activity without discomfort. For more details see American Heart Association website http://www.heart.org/HEARTORG/Conditions/HeartFailure/AboutHeartFailure/Classes-of-Heart-Failure_UCM_306328_Article.jsp#.V_5rPPkrJD8|participants|Number|94|94.0||||||
3818466|NCT01751022|3644235|B1|II||New York Heart Association Classification (NYHA)|NYHA Functional Classification is assessed as following. Class I: No limitation of physical activity. Class II:Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Unable to carry on any physical activity without discomfort. For more details see American Heart Association website http://www.heart.org/HEARTORG/Conditions/HeartFailure/AboutHeartFailure/Classes-of-Heart-Failure_UCM_306328_Article.jsp#.V_5rPPkrJD8|participants|Number|125|125.0||||||
3818467|NCT01751022|3644232|B4|I||New York Heart Association Classification (NYHA)|NYHA Functional Classification is assessed as following. Class I: No limitation of physical activity. Class II:Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Unable to carry on any physical activity without discomfort. For more details see American Heart Association website http://www.heart.org/HEARTORG/Conditions/HeartFailure/AboutHeartFailure/Classes-of-Heart-Failure_UCM_306328_Article.jsp#.V_5rPPkrJD8|participants|Number|16|16.0||||||
3818468|NCT01751022|3644233|B3|I||New York Heart Association Classification (NYHA)|NYHA Functional Classification is assessed as following. Class I: No limitation of physical activity. Class II:Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Unable to carry on any physical activity without discomfort. For more details see American Heart Association website http://www.heart.org/HEARTORG/Conditions/HeartFailure/AboutHeartFailure/Classes-of-Heart-Failure_UCM_306328_Article.jsp#.V_5rPPkrJD8|participants|Number|4|4.0||||||
3818469|NCT01751022|3644234|B2|I||New York Heart Association Classification (NYHA)|NYHA Functional Classification is assessed as following. Class I: No limitation of physical activity. Class II:Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Unable to carry on any physical activity without discomfort. For more details see American Heart Association website http://www.heart.org/HEARTORG/Conditions/HeartFailure/AboutHeartFailure/Classes-of-Heart-Failure_UCM_306328_Article.jsp#.V_5rPPkrJD8|participants|Number|4|4.0||||||
3818534|NCT01751022|3644235|B1|Romania||Region of Enrollment||participants|Number|11|11.0||||||
3818470|NCT01751022|3644235|B1|I||New York Heart Association Classification (NYHA)|NYHA Functional Classification is assessed as following. Class I: No limitation of physical activity. Class II:Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Unable to carry on any physical activity without discomfort. For more details see American Heart Association website http://www.heart.org/HEARTORG/Conditions/HeartFailure/AboutHeartFailure/Classes-of-Heart-Failure_UCM_306328_Article.jsp#.V_5rPPkrJD8|participants|Number|8|8.0||||||
3818471|NCT01751022|3644232|B4|Germany||Region of Enrollment||participants|Number|29|29.0||||||
3818472|NCT01751022|3644233|B3|Germany||Region of Enrollment||participants|Number|19|19.0||||||
3818473|NCT01751022|3644234|B2|Germany||Region of Enrollment||participants|Number|3|3.0||||||
3818474|NCT01751022|3644235|B1|Germany||Region of Enrollment||participants|Number|7|7.0||||||
3818475|NCT01751022|3644232|B4|Australia||Region of Enrollment||participants|Number|23|23.0||||||
3818476|NCT01751022|3644233|B3|Australia||Region of Enrollment||participants|Number|5|5.0||||||
3818477|NCT01751022|3644234|B2|Australia||Region of Enrollment||participants|Number|1|1.0||||||
3818478|NCT01751022|3644235|B1|Australia||Region of Enrollment||participants|Number|17|17.0||||||
3818479|NCT01751022|3644232|B4|Israel||Region of Enrollment||participants|Number|4|4.0||||||
3818480|NCT01751022|3644233|B3|Israel||Region of Enrollment||participants|Number|2|2.0||||||
3818481|NCT01751022|3644234|B2|Israel||Region of Enrollment||participants|Number|2|2.0||||||
3818482|NCT01751022|3644235|B1|Israel||Region of Enrollment||participants|Number|0|0.0||||||
3818483|NCT01751022|3644232|B4|South Africa||Region of Enrollment||participants|Number|7|7.0||||||
3818484|NCT01751022|3644233|B3|South Africa||Region of Enrollment||participants|Number|2|2.0||||||
3818485|NCT01751022|3644234|B2|South Africa||Region of Enrollment||participants|Number|2|2.0||||||
3818486|NCT01751022|3644235|B1|South Africa||Region of Enrollment||participants|Number|3|3.0||||||
3818487|NCT01751022|3644232|B4|Italy||Region of Enrollment||participants|Number|28|28.0||||||
3818488|NCT01751022|3644233|B3|Italy||Region of Enrollment||participants|Number|10|10.0||||||
3818489|NCT01751022|3644234|B2|Italy||Region of Enrollment||participants|Number|10|10.0||||||
3818490|NCT01751022|3644235|B1|Italy||Region of Enrollment||participants|Number|8|8.0||||||
3818491|NCT01751022|3644232|B4|Denmark||Region of Enrollment||participants|Number|10|10.0||||||
3818492|NCT01751022|3644233|B3|Denmark||Region of Enrollment||participants|Number|8|8.0||||||
3818493|NCT01751022|3644234|B2|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
3818494|NCT01751022|3644235|B1|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
3818495|NCT01751022|3644232|B4|Finland||Region of Enrollment||participants|Number|4|4.0||||||
3818496|NCT01751022|3644233|B3|Finland||Region of Enrollment||participants|Number|1|1.0||||||
3818497|NCT01751022|3644234|B2|Finland||Region of Enrollment||participants|Number|3|3.0||||||
3818498|NCT01751022|3644235|B1|Finland||Region of Enrollment||participants|Number|0|0.0||||||
3818499|NCT01751022|3644232|B4|Norway||Region of Enrollment||participants|Number|5|5.0||||||
3818500|NCT01751022|3644233|B3|Norway||Region of Enrollment||participants|Number|0|0.0||||||
3818501|NCT01751022|3644234|B2|Norway||Region of Enrollment||participants|Number|0|0.0||||||
3818502|NCT01751022|3644235|B1|Norway||Region of Enrollment||participants|Number|5|5.0||||||
3818503|NCT01751022|3644232|B4|Belgium||Region of Enrollment||participants|Number|9|9.0||||||
3818504|NCT01751022|3644233|B3|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
3818505|NCT01751022|3644234|B2|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
3818506|NCT01751022|3644235|B1|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
3818507|NCT01751022|3644232|B4|Canada||Region of Enrollment||participants|Number|60|60.0||||||
3818508|NCT01751022|3644233|B3|Canada||Region of Enrollment||participants|Number|21|21.0||||||
3818509|NCT01751022|3644234|B2|Canada||Region of Enrollment||participants|Number|22|22.0||||||
3818510|NCT01751022|3644235|B1|Canada||Region of Enrollment||participants|Number|17|17.0||||||
3818511|NCT01751022|3644232|B4|Spain||Region of Enrollment||participants|Number|4|4.0||||||
3818512|NCT01751022|3644233|B3|Spain||Region of Enrollment||participants|Number|0|0.0||||||
3818513|NCT01751022|3644234|B2|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3818514|NCT01751022|3644235|B1|Spain||Region of Enrollment||participants|Number|3|3.0||||||
3818515|NCT01751022|3644232|B4|India||Region of Enrollment||participants|Number|21|21.0||||||
3818516|NCT01751022|3644233|B3|India||Region of Enrollment||participants|Number|15|15.0||||||
3818517|NCT01751022|3644234|B2|India||Region of Enrollment||participants|Number|3|3.0||||||
3818518|NCT01751022|3644235|B1|India||Region of Enrollment||participants|Number|3|3.0||||||
3818519|NCT01751022|3644232|B4|Switzerland||Region of Enrollment||participants|Number|4|4.0||||||
3818520|NCT01751022|3644233|B3|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
3818521|NCT01751022|3644234|B2|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
3818522|NCT01751022|3644235|B1|Switzerland||Region of Enrollment||participants|Number|2|2.0||||||
3818523|NCT01751022|3644232|B4|United Kingdom||Region of Enrollment||participants|Number|31|31.0||||||
3818524|NCT01751022|3644233|B3|United Kingdom||Region of Enrollment||participants|Number|14|14.0||||||
3818525|NCT01751022|3644234|B2|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3818526|NCT01751022|3644235|B1|United Kingdom||Region of Enrollment||participants|Number|13|13.0||||||
3818527|NCT01751022|3644232|B4|Hungary||Region of Enrollment||participants|Number|7|7.0||||||
3818528|NCT01751022|3644233|B3|Hungary||Region of Enrollment||participants|Number|4|4.0||||||
3818529|NCT01751022|3644234|B2|Hungary||Region of Enrollment||participants|Number|3|3.0||||||
3818530|NCT01751022|3644235|B1|Hungary||Region of Enrollment||participants|Number|0|0.0||||||
3818535|NCT01751022|3644232|B4|Serbia||Region of Enrollment||participants|Number|10|10.0||||||
3818536|NCT01751022|3644233|B3|Serbia||Region of Enrollment||participants|Number|8|8.0||||||
3818537|NCT01751022|3644234|B2|Serbia||Region of Enrollment||participants|Number|2|2.0||||||
3818538|NCT01751022|3644235|B1|Serbia||Region of Enrollment||participants|Number|0|0.0||||||
3818539|NCT01751022|3644232|B4|France||Region of Enrollment||participants|Number|10|10.0||||||
3818540|NCT01751022|3644233|B3|France||Region of Enrollment||participants|Number|8|8.0||||||
3818541|NCT01751022|3644234|B2|France||Region of Enrollment||participants|Number|2|2.0||||||
3818542|NCT01751022|3644235|B1|France||Region of Enrollment||participants|Number|0|0.0||||||
3818543|NCT01751022|3644232|B4|Chile||Region of Enrollment||participants|Number|12|12.0||||||
3818544|NCT01751022|3644233|B3|Chile||Region of Enrollment||participants|Number|0|0.0||||||
3818545|NCT01751022|3644234|B2|Chile||Region of Enrollment||participants|Number|0|0.0||||||
3818546|NCT01751022|3644235|B1|Chile||Region of Enrollment||participants|Number|12|12.0||||||
3818547|NCT01751022|3644232|B4|Slovenia||Region of Enrollment||participants|Number|8|8.0||||||
3818548|NCT01751022|3644233|B3|Slovenia||Region of Enrollment||participants|Number|3|3.0||||||
3818549|NCT01751022|3644234|B2|Slovenia||Region of Enrollment||participants|Number|5|5.0||||||
3818550|NCT01751022|3644235|B1|Slovenia||Region of Enrollment||participants|Number|0|0.0||||||
3818551|NCT01751022|3644232|B4|Slovakia||Region of Enrollment||participants|Number|13|13.0||||||
3818552|NCT01751022|3644233|B3|Slovakia||Region of Enrollment||participants|Number|7|7.0||||||
3818553|NCT01751022|3644234|B2|Slovakia||Region of Enrollment||participants|Number|2|2.0||||||
3818554|NCT01751022|3644235|B1|Slovakia||Region of Enrollment||participants|Number|4|4.0||||||
3818555|NCT01751022|3644232|B4|Netherlands||Region of Enrollment||participants|Number|23|23.0||||||
3818556|NCT01751022|3644233|B3|Netherlands||Region of Enrollment||participants|Number|9|9.0||||||
3818557|NCT01751022|3644234|B2|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
3818558|NCT01751022|3644235|B1|Netherlands||Region of Enrollment||participants|Number|13|13.0||||||
3818559|NCT01751022|3644232|B4|Austria||Region of Enrollment||participants|Number|10|10.0||||||
3818560|NCT01751022|3644233|B3|Austria||Region of Enrollment||participants|Number|2|2.0||||||
3818561|NCT01751022|3644234|B2|Austria||Region of Enrollment||participants|Number|0|0.0||||||
3818562|NCT01751022|3644235|B1|Austria||Region of Enrollment||participants|Number|8|8.0||||||
3818563|NCT01751022|3644232|B4|Saudi Arabia||Region of Enrollment||participants|Number|17|17.0||||||
3818564|NCT01751022|3644233|B3|Saudi Arabia||Region of Enrollment||participants|Number|2|2.0||||||
3818565|NCT01751022|3644234|B2|Saudi Arabia||Region of Enrollment||participants|Number|6|6.0||||||
3818566|NCT01751022|3644235|B1|Saudi Arabia||Region of Enrollment||participants|Number|9|9.0||||||
3818567|NCT01751022|3644232|B4|Greece||Region of Enrollment||participants|Number|1|1.0||||||
3818568|NCT01751022|3644233|B3|Greece||Region of Enrollment||participants|Number|0|0.0||||||
3818569|NCT01751022|3644234|B2|Greece||Region of Enrollment||participants|Number|1|1.0||||||
3818570|NCT01751022|3644235|B1|Greece||Region of Enrollment||participants|Number|0|0.0||||||
3818571|NCT01751022|3644232|B4|Malaysia||Region of Enrollment||participants|Number|2|2.0||||||
3818572|NCT01751022|3644233|B3|Malaysia||Region of Enrollment||participants|Number|1|1.0||||||
3818573|NCT01751022|3644234|B2|Malaysia||Region of Enrollment||participants|Number|1|1.0||||||
3818574|NCT01751022|3644235|B1|Malaysia||Region of Enrollment||participants|Number|0|0.0||||||
3818575|NCT01751022|3644232|B4|United States||Region of Enrollment||participants|Number|761|761.0||||||
3818576|NCT01751022|3644233|B3|United States||Region of Enrollment||participants|Number|152|152.0||||||
3818577|NCT01751022|3644234|B2|United States||Region of Enrollment||participants|Number|249|249.0||||||
3818578|NCT01751022|3644235|B1|United States||Region of Enrollment||participants|Number|360|360.0||||||
3818579|NCT01751022|3644232|B4|Two or more races||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3818580|NCT01751022|3644233|B3|Two or more races||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3818581|NCT01751022|3644234|B2|Two or more races||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3818582|NCT01751022|3644235|B1|Two or more races||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3818583|NCT01751022|3644232|B4|White or Caucasian||Race/Ethnicity, Customized||participants|Number|836|836.0||||||
3818584|NCT01751022|3644233|B3|White or Caucasian||Race/Ethnicity, Customized||participants|Number|197|197.0||||||
3818585|NCT01751022|3644234|B2|White or Caucasian||Race/Ethnicity, Customized||participants|Number|252|252.0||||||
3818586|NCT01751022|3644235|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|387|387.0||||||
3818587|NCT01751022|3644232|B4|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3818588|NCT01751022|3644233|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3818589|NCT01751022|3644234|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3818590|NCT01751022|3644235|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3818591|NCT01751022|3644232|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
3818592|NCT01751022|3644233|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3818593|NCT01751022|3644234|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3818594|NCT01751022|3644235|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3818595|NCT01751022|3644232|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
3818596|NCT01751022|3644233|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3818597|NCT01751022|3644234|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3818598|NCT01751022|3644235|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
3818599|NCT01751022|3644232|B4|Asian||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3818600|NCT01751022|3644233|B3|Asian||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3818601|NCT01751022|3644234|B2|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3818602|NCT01751022|3644235|B1|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3818603|NCT01751022|3644232|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3818604|NCT01751022|3644233|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3818605|NCT01751022|3644234|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3818606|NCT01751022|3644235|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3818607|NCT01751022|3644232|B4|Not reportable per local laws or regulations||Race/Ethnicity, Customized||participants|Number|99|99.0||||||
3818608|NCT01751022|3644233|B3|Not reportable per local laws or regulations||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
3818609|NCT01751022|3644234|B2|Not reportable per local laws or regulations||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3818610|NCT01751022|3644235|B1|Not reportable per local laws or regulations||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3818611|NCT01751022|3644232|B4|Subject/physician chose not to provide information||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3818612|NCT01751022|3644233|B3|Subject/physician chose not to provide information||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3818613|NCT01751022|3644234|B2|Subject/physician chose not to provide information||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3818614|NCT01751022|3644235|B1|Subject/physician chose not to provide information||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3818615|NCT01751022|3644232|B4||Male|Sex: Female, Male||Participants|Count of Participants|796|796.0||||||
3818616|NCT01751022|3644233|B3||Male|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
3818617|NCT01751022|3644234|B2||Male|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
3818618|NCT01751022|3644235|B1||Male|Sex: Female, Male||Participants|Count of Participants|356|356.0||||||
3818619|NCT01751022|3644232|B4||Female|Sex: Female, Male||Participants|Count of Participants|329|329.0||||||
3818620|NCT01751022|3644233|B3||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3818621|NCT01751022|3644234|B2||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3818622|NCT01751022|3644235|B1||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3818623|NCT01751022|3644232|B4|||Age||years|Mean|67|67.0|Standard Deviation|11|11.0|||
3818624|NCT01751022|3644233|B3|||Age||years|Mean|67|67.0|Standard Deviation|11|11.0|||
3818625|NCT01751022|3644234|B2|||Age||years|Mean|66|66.0|Standard Deviation|11|11.0|||
3818626|NCT01751022|3644235|B1|||Age||years|Mean|68|68.0|Standard Deviation|11|11.0|||
3818627|NCT01750931|3644269|B1|India||Region of Enrollment||Participants|Number|28|28.0||||||
3818628|NCT01750931|3644269|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3818629|NCT01750931|3644269|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3818630|NCT01750931|3644269|B1|Years||Age||Years|Mean|25.04|25.04|Standard Deviation|4.14|4.14|||
3818631|NCT01750840|3644288|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3818632|NCT01750840|3644288|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3818633|NCT01750840|3644288|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3818634|NCT01750840|3644288|B1|||Age||years|Mean|40|40.0|Full Range|||9.0|63.0|
3818635|NCT01750840|3644288|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3818636|NCT01750840|3644288|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3818637|NCT01750840|3644288|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3818638|NCT01750684|3644293|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818639|NCT01750684|3644294|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818640|NCT01750684|3644295|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818641|NCT01750684|3644293|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818642|NCT01750684|3644294|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818643|NCT01750684|3644295|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818644|NCT01750684|3644293|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3818645|NCT01750684|3644294|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3818646|NCT01750684|3644295|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3818647|NCT01750684|3644293|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3818648|NCT01750684|3644294|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3818649|NCT01750684|3644295|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818650|NCT01750684|3644293|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818651|NCT01750684|3644294|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818652|NCT01750684|3644295|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818653|NCT01750684|3644293|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818654|NCT01750684|3644294|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818655|NCT01750684|3644295|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818656|NCT01750684|3644293|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3818657|NCT01750684|3644294|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818658|NCT01750684|3644295|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3818659|NCT01750684|3644293|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3818660|NCT01750684|3644294|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3818661|NCT01750684|3644295|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3818662|NCT01750684|3644293|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3818663|NCT01750684|3644294|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3818664|NCT01750684|3644295|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3818665|NCT01750684|3644293|B3|||Age||years|Mean|37.7|37.7|Standard Deviation|4.50|4.5|||
3818666|NCT01750684|3644294|B2|||Age||years|Mean|38.3|38.3|Standard Deviation|6.23|6.23|||
3818667|NCT01750684|3644295|B1|||Age||years|Mean|37.0|37.0|Standard Deviation|7.12|7.12|||
3818668|NCT01750502|3644304|B3|||LDL-C||mmol/L|Mean|2.44|2.44|Standard Deviation|0.98|0.98|||
3818669|NCT01750502|3644305|B2|||LDL-C||mmol/L|Mean|2.4|2.4|Standard Deviation|1.43|1.43|||
3818670|NCT01750502|3644306|B1|||LDL-C||mmol/L|Mean|2.47|2.47|Standard Deviation|0.74|0.74|||
3818671|NCT01750502|3644304|B3|||HDL-C||mmol/L|Mean|0.99|0.99|Standard Deviation|0.22|0.22|||
3818672|NCT01750502|3644305|B2|||HDL-C||mmol/L|Mean|0.98|0.98|Standard Deviation|0.22|0.22|||
3818673|NCT01750502|3644306|B1|||HDL-C||mmol/L|Mean|1.01|1.01|Standard Deviation|0.23|0.23|||
3818674|NCT01750502|3644304|B3|Not Hypertension||Hypertension||participants|Number|99|99.0||||||
3818675|NCT01750502|3644305|B2|Not Hypertension||Hypertension||participants|Number|75|75.0||||||
3818676|NCT01750502|3644306|B1|Not Hypertension||Hypertension||participants|Number|24|24.0||||||
3818677|NCT01750502|3644304|B3|Hypertension||Hypertension||participants|Number|157|157.0||||||
3818678|NCT01750502|3644305|B2|Hypertension||Hypertension||participants|Number|111|111.0||||||
3818679|NCT01750502|3644306|B1|Hypertension||Hypertension||participants|Number|46|46.0||||||
3818680|NCT01750502|3644304|B3|China||Region of Enrollment||participants|Number|256|256.0||||||
3818681|NCT01750502|3644305|B2|China||Region of Enrollment||participants|Number|186|186.0||||||
3818682|NCT01750502|3644306|B1|China||Region of Enrollment||participants|Number|70|70.0||||||
3818683|NCT01750502|3644304|B3||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3818684|NCT01750502|3644305|B2||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3818685|NCT01750502|3644306|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3818686|NCT01750502|3644304|B3||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3818687|NCT01750502|3644305|B2||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3818688|NCT01750502|3644306|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3818689|NCT01750502|3644304|B3|||Age||years|Mean|64.96|64.96|Standard Deviation|9.07|9.07|||
3818690|NCT01750502|3644305|B2|||Age||years|Mean|65.9|65.9|Standard Deviation|10.03|10.03|||
3818691|NCT01750502|3644306|B1|||Age||years|Mean|64.02|64.02|Standard Deviation|8.57|8.57|||
3818692|NCT01750502|3644304|B3||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
3818693|NCT01750502|3644305|B2||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
3818694|NCT01750502|3644306|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3818695|NCT01750502|3644304|B3||Between 18 and 65 years|Age||Participants|Count of Participants|210|210.0||||||
3818696|NCT01750502|3644305|B2||Between 18 and 65 years|Age||Participants|Count of Participants|151|151.0||||||
3818697|NCT01750502|3644306|B1||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
3818698|NCT01750502|3644304|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3818699|NCT01750502|3644305|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3818700|NCT01750502|3644306|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3818701|NCT01750398|3644320|B1|Positive for RECIST evaluable lesions||Patients with RECIST evaluable disease||Number of patients|Number|13|13.0||||||
3818702|NCT01750398|3644320|B1|No RECIST evaluable lesions||Patients with RECIST evaluable disease||Number of patients|Number|20|20.0||||||
3818703|NCT01750398|3644320|B1|Positive for bone metastases||Patients with bone metastases||Number of patients|Number|14|14.0||||||
3818704|NCT01750398|3644320|B1|No bone metastases||Patients with bone metastases||Number of patients|Number|19|19.0||||||
3818705|NCT01750398|3644320|B1|No metastases||Any metastatic disease||Number of patients|Number|13|13.0||||||
3818706|NCT01750398|3644320|B1|Positive for metastases||Any metastatic disease||Number of patients|Number|20|20.0||||||
3818707|NCT01750398|3644320|B1|ECOG 1||ECOG|"ECOG 0: no functional limitation.~ECOG 1: restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Determination of ECOG score was based on clinical assessment."|Number of patients|Number|2|2.0||||||
3818708|NCT01750398|3644320|B1|ECOG 0||ECOG|"ECOG 0: no functional limitation.~ECOG 1: restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Determination of ECOG score was based on clinical assessment."|Number of patients|Number|31|31.0||||||
3818709|NCT01750398|3644320|B1|Radical prostatectomy||Local treatment||Number of patients|Number|22|22.0||||||
3818710|NCT01750398|3644320|B1|Radiation||Local treatment||Number of patients|Number|8|8.0||||||
3818711|NCT01750398|3644320|B1|No local treatment||Local treatment||Number of patients|Number|3|3.0||||||
3818785|NCT01750281|3644368|B1|White||Race/Ethnicity, Customized||Participants|Number|41|41.0||||||
3818712|NCT01750398|3644320|B1|Gleason 9||Gleason score (higher score is associated with worse outcomes)|Gleason score was based on clinical interpretation of the needle biopsy specimen or prostatectomy specimen by an expert pathologist. A pathologist examined this tissue specimens under the microscope and assigned a Gleason score based on the microscopic appearance of the prostate cancer.|Number of patients|Number|9|9.0||||||
3818713|NCT01750398|3644320|B1|Gleason 8||Gleason score (higher score is associated with worse outcomes)|Gleason score was based on clinical interpretation of the needle biopsy specimen or prostatectomy specimen by an expert pathologist. A pathologist examined this tissue specimens under the microscope and assigned a Gleason score based on the microscopic appearance of the prostate cancer.|Number of patients|Number|5|5.0||||||
3818714|NCT01750398|3644320|B1|Gleason 7||Gleason score (higher score is associated with worse outcomes)|Gleason score was based on clinical interpretation of the needle biopsy specimen or prostatectomy specimen by an expert pathologist. A pathologist examined this tissue specimens under the microscope and assigned a Gleason score based on the microscopic appearance of the prostate cancer.|Number of patients|Number|16|16.0||||||
3818715|NCT01750398|3644320|B1|Gleason 6||Gleason score (higher score is associated with worse outcomes)|Gleason score was based on clinical interpretation of the needle biopsy specimen or prostatectomy specimen by an expert pathologist. A pathologist examined this tissue specimens under the microscope and assigned a Gleason score based on the microscopic appearance of the prostate cancer.|Number of patients|Number|3|3.0||||||
3818716|NCT01750398|3644320|B1|||PSA doubling time||months|Median|5|5.0|Full Range|||1.0|23.0|
3818717|NCT01750398|3644320|B1|||PSA||ng/mL|Median|27.6|27.6|Full Range|||5.6|257.3|
3818718|NCT01750398|3644320|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3818719|NCT01750398|3644320|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818720|NCT01750398|3644320|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3818721|NCT01750398|3644320|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3818722|NCT01750398|3644320|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818723|NCT01750398|3644320|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818724|NCT01750398|3644320|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818725|NCT01750398|3644320|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3818726|NCT01750398|3644320|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3818727|NCT01750398|3644320|B1|||Age||years|Median|63|63.0|Full Range|||46.0|75.0|
3818728|NCT01750346|3644330|B4|||Blepharospasm Disability Scale|The Blepharospasm Disability Scale (BDS) is a scale which measures the impact of blepharospasm on the activities of daily living, i.e., need to wear sunglasses (1 or 2) and the impact on the following activities: driving (1 to 5), reading (1 to 3), watching tv (1 to 3), watching movies (1 to 3), shopping (1 to 3), walking about (1 to 4) and housework or job (1 to 3). Patients self-report disability in all areas for a total score between 0 to 26, where 0 indicates no symptoms and 26 indicates severe disability.|units on a scale|Mean|17.25|17.25|Full Range|||15.0|21.0|
3818729|NCT01750346|3644331|B3|||Blepharospasm Disability Scale|The Blepharospasm Disability Scale (BDS) is a scale which measures the impact of blepharospasm on the activities of daily living, i.e., need to wear sunglasses (1 or 2) and the impact on the following activities: driving (1 to 5), reading (1 to 3), watching tv (1 to 3), watching movies (1 to 3), shopping (1 to 3), walking about (1 to 4) and housework or job (1 to 3). Patients self-report disability in all areas for a total score between 0 to 26, where 0 indicates no symptoms and 26 indicates severe disability.|units on a scale|Mean|17.33|17.33|Full Range|||16.0|19.0|
3818730|NCT01750346|3644332|B2|||Blepharospasm Disability Scale|The Blepharospasm Disability Scale (BDS) is a scale which measures the impact of blepharospasm on the activities of daily living, i.e., need to wear sunglasses (1 or 2) and the impact on the following activities: driving (1 to 5), reading (1 to 3), watching tv (1 to 3), watching movies (1 to 3), shopping (1 to 3), walking about (1 to 4) and housework or job (1 to 3). Patients self-report disability in all areas for a total score between 0 to 26, where 0 indicates no symptoms and 26 indicates severe disability.|units on a scale|Mean|16|16.0|Full Range|||15.0|17.0|
3818731|NCT01750346|3644333|B1|||Blepharospasm Disability Scale|The Blepharospasm Disability Scale (BDS) is a scale which measures the impact of blepharospasm on the activities of daily living, i.e., need to wear sunglasses (1 or 2) and the impact on the following activities: driving (1 to 5), reading (1 to 3), watching tv (1 to 3), watching movies (1 to 3), shopping (1 to 3), walking about (1 to 4) and housework or job (1 to 3). Patients self-report disability in all areas for a total score between 0 to 26, where 0 indicates no symptoms and 26 indicates severe disability.|units on a scale|Mean|18|18.0|Full Range|||16.0|21.0|
3818732|NCT01750346|3644330|B4|||Jankovic Blepharospasm Rating Scale|The Jankovic Blepharospasm Rating Scale (JBRS) is a clinical scale measuring the severity and frequency of blepharospasm. Severity and frequency are rated on a 5-point scales ranging from 0 to 4, where 0 indicates no symptoms and 4 indicates the most severe or frequent symptoms. A total score is obtained by adding the severity and frequency subscale scores with total scores ranging from 0 to 8.|units on a scale|Mean|6.375|6.375|Full Range|||5.0|8.0|
3818733|NCT01750346|3644331|B3|||Jankovic Blepharospasm Rating Scale|The Jankovic Blepharospasm Rating Scale (JBRS) is a clinical scale measuring the severity and frequency of blepharospasm. Severity and frequency are rated on a 5-point scales ranging from 0 to 4, where 0 indicates no symptoms and 4 indicates the most severe or frequent symptoms. A total score is obtained by adding the severity and frequency subscale scores with total scores ranging from 0 to 8.|units on a scale|Mean|6|6.0|Full Range|||5.0|7.0|
3818734|NCT01750346|3644332|B2|||Jankovic Blepharospasm Rating Scale|The Jankovic Blepharospasm Rating Scale (JBRS) is a clinical scale measuring the severity and frequency of blepharospasm. Severity and frequency are rated on a 5-point scales ranging from 0 to 4, where 0 indicates no symptoms and 4 indicates the most severe or frequent symptoms. A total score is obtained by adding the severity and frequency subscale scores with total scores ranging from 0 to 8.|units on a scale|Mean|6|6.0|Full Range|||6.0|6.0|
3818786|NCT01750281|3644365|B4|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3818787|NCT01750281|3644366|B3|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3818735|NCT01750346|3644333|B1|||Jankovic Blepharospasm Rating Scale|The Jankovic Blepharospasm Rating Scale (JBRS) is a clinical scale measuring the severity and frequency of blepharospasm. Severity and frequency are rated on a 5-point scales ranging from 0 to 4, where 0 indicates no symptoms and 4 indicates the most severe or frequent symptoms. A total score is obtained by adding the severity and frequency subscale scores with total scores ranging from 0 to 8.|units on a scale|Mean|7|7.0|Full Range|||6.0|8.0|
3818736|NCT01750346|3644330|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3818737|NCT01750346|3644331|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3818738|NCT01750346|3644332|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3818739|NCT01750346|3644333|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3818740|NCT01750346|3644330|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3818741|NCT01750346|3644331|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3818742|NCT01750346|3644332|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3818743|NCT01750346|3644333|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3818744|NCT01750346|3644330|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3818745|NCT01750346|3644331|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3818746|NCT01750346|3644332|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3818747|NCT01750346|3644333|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3818748|NCT01750346|3644330|B4||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3818749|NCT01750346|3644331|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3818750|NCT01750346|3644332|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3818751|NCT01750346|3644333|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3818752|NCT01750346|3644330|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3818753|NCT01750346|3644331|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3818754|NCT01750346|3644332|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3818755|NCT01750346|3644333|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3818756|NCT01750294|3644361|B1|||Estimated GFR|Measured after two-week run-in|mL/min/1.73m2|Mean|26.8|26.8|Standard Deviation|8.8|8.8|||
3818757|NCT01750294|3644361|B1|Stage 5||Chronic Kidney Disease (CKD) Stage|Staging captured according to estimated glomerular filtration rate (eGFR) at baseline using the National Kidney Foundation (NKF) Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines for staging chronic kidney disease (CKD).|participants|Number|2|2.0||||||
3818758|NCT01750294|3644361|B1|Stage 4||Chronic Kidney Disease (CKD) Stage|Staging captured according to estimated glomerular filtration rate (eGFR) at baseline using the National Kidney Foundation (NKF) Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines for staging chronic kidney disease (CKD).|participants|Number|8|8.0||||||
3818759|NCT01750294|3644361|B1|Stage 3B||Chronic Kidney Disease (CKD) Stage|Staging captured according to estimated glomerular filtration rate (eGFR) at baseline using the National Kidney Foundation (NKF) Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines for staging chronic kidney disease (CKD).|participants|Number|4|4.0||||||
3818760|NCT01750294|3644361|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818761|NCT01750294|3644361|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818762|NCT01750294|3644361|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3818763|NCT01750294|3644361|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3818764|NCT01750294|3644361|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818765|NCT01750294|3644361|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818766|NCT01750294|3644361|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818767|NCT01750294|3644361|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3818768|NCT01750294|3644361|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3818769|NCT01750294|3644361|B1|||Age||years|Mean|67.5|67.5|Standard Deviation|10.2|10.2|||
3818770|NCT01750281|3644365|B4|KRAS mutation unknown||KRAS Mutation Status at Baseline||Participants|Number|22|22.0||||||
3818771|NCT01750281|3644366|B3|KRAS mutation unknown||KRAS Mutation Status at Baseline||Participants|Number|11|11.0||||||
3818772|NCT01750281|3644367|B2|KRAS mutation unknown||KRAS Mutation Status at Baseline||Participants|Number|8|8.0||||||
3818773|NCT01750281|3644368|B1|KRAS mutation unknown||KRAS Mutation Status at Baseline||Participants|Number|3|3.0||||||
3818774|NCT01750281|3644365|B4|KRAS mutation positive||KRAS Mutation Status at Baseline||Participants|Number|44|44.0||||||
3818775|NCT01750281|3644366|B3|KRAS mutation positive||KRAS Mutation Status at Baseline||Participants|Number|19|19.0||||||
3818776|NCT01750281|3644367|B2|KRAS mutation positive||KRAS Mutation Status at Baseline||Participants|Number|15|15.0||||||
3818777|NCT01750281|3644368|B1|KRAS mutation positive||KRAS Mutation Status at Baseline||Participants|Number|10|10.0||||||
3818778|NCT01750281|3644365|B4|KRAS no mutation detected (NMD)||KRAS Mutation Status at Baseline||Participants|Number|146|146.0||||||
3818779|NCT01750281|3644366|B3|KRAS no mutation detected (NMD)||KRAS Mutation Status at Baseline||Participants|Number|54|54.0||||||
3818780|NCT01750281|3644367|B2|KRAS no mutation detected (NMD)||KRAS Mutation Status at Baseline||Participants|Number|62|62.0||||||
3818781|NCT01750281|3644368|B1|KRAS no mutation detected (NMD)||KRAS Mutation Status at Baseline||Participants|Number|30|30.0||||||
3818782|NCT01750281|3644365|B4|White||Race/Ethnicity, Customized||Participants|Number|199|199.0||||||
3818783|NCT01750281|3644366|B3|White||Race/Ethnicity, Customized||Participants|Number|78|78.0||||||
3818784|NCT01750281|3644367|B2|White||Race/Ethnicity, Customized||Participants|Number|80|80.0||||||
3818788|NCT01750281|3644367|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3818789|NCT01750281|3644368|B1|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3818790|NCT01750281|3644365|B4|Black Or African American||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
3818791|NCT01750281|3644366|B3|Black Or African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3818792|NCT01750281|3644367|B2|Black Or African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3818793|NCT01750281|3644368|B1|Black Or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3818794|NCT01750281|3644365|B4||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3818795|NCT01750281|3644366|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3818796|NCT01750281|3644367|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3818797|NCT01750281|3644368|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3818798|NCT01750281|3644365|B4||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3818799|NCT01750281|3644366|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3818800|NCT01750281|3644367|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3818801|NCT01750281|3644368|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3818802|NCT01750281|3644365|B4|||Age||Years|Mean|61.8|61.8|Standard Deviation|8.77|8.77|38.0|84.0|
3818803|NCT01750281|3644366|B3|||Age||Years|Mean|60.4|60.4|Standard Deviation|9.35|9.35|38.0|79.0|
3818804|NCT01750281|3644367|B2|||Age||Years|Mean|62.4|62.4|Standard Deviation|8.53|8.53|41.0|84.0|
3818805|NCT01750281|3644368|B1|||Age||Years|Mean|63.6|63.6|Standard Deviation|7.75|7.75|47.0|76.0|
3818806|NCT01750255|3644381|B3|Colombia||Region of Enrollment||participants|Number|92|92.0||||||
3818807|NCT01750255|3644382|B2|Colombia||Region of Enrollment||participants|Number|43|43.0||||||
3818808|NCT01750255|3644383|B1|Colombia||Region of Enrollment||participants|Number|49|49.0||||||
3818809|NCT01750255|3644381|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3818810|NCT01750255|3644382|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3818811|NCT01750255|3644383|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3818812|NCT01750255|3644381|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3818813|NCT01750255|3644382|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3818814|NCT01750255|3644383|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3818815|NCT01750255|3644381|B3|||Age||years|Mean|42.8|42.8|Standard Deviation|10.9|10.9|||
3818816|NCT01750255|3644382|B2|||Age||years|Mean|41.9|41.9|Standard Deviation|9.9|9.9|||
3818817|NCT01750255|3644383|B1|||Age||years|Mean|43.7|43.7|Standard Deviation|11.8|11.8|||
3818818|NCT01750255|3644381|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3818819|NCT01750255|3644382|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3818820|NCT01750255|3644383|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3818821|NCT01750255|3644381|B3||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
3818822|NCT01750255|3644382|B2||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
3818823|NCT01750255|3644383|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3818824|NCT01750255|3644381|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3818825|NCT01750255|3644382|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3818826|NCT01750255|3644383|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3818827|NCT01750242|3644400|B1|||UPDRS III scores at baseline|Patients with documented improvement of UPDRS III scores of at least 35% were included in the study. A higher score means more motor dysfunction. The score can range from 0 -108.|units on a scale|Mean|39.4|39.4|Standard Deviation|12.2|12.2|||
3818828|NCT01750242|3644400|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3818829|NCT01750242|3644400|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3818830|NCT01750242|3644400|B1|||Age||years|Mean|68|68.0|Standard Deviation|7.8|7.8|||
3818831|NCT01750229|3644405|B1|||Baseline VAS back pain score|Visual Analog Scale (VAS) back pain scores were recorded once a day on a multi-day diary, where subjects rate the pain by making a vertical slash mark through the 0-10cm line that best describes their pain during the last 24 hours, with 0 = No pain and 10 = Worst pain imaginable. The higher VAS back pain score represented worse back pain. The average VAS back pain scores from 7 days in the diary were used for summary.|units on a scale|Mean|7.75|7.75|Standard Deviation|1.13|1.13|||
3818832|NCT01750229|3644405|B1|United Kingdom||Region of Enrollment||participants|Number|24|24.0||||||
3818833|NCT01750229|3644405|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3818834|NCT01750229|3644405|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3818835|NCT01750229|3644405|B1|||Age||years|Mean|47.9|47.9|Standard Deviation|7.7|7.7|||
3818836|NCT01750086|3644415|B3|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3818837|NCT01750086|3644416|B2|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3818838|NCT01750086|3644417|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3818839|NCT01750086|3644415|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3818840|NCT01750086|3644416|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3818841|NCT01750086|3644417|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3818842|NCT01750086|3644415|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3818843|NCT01750086|3644416|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3818844|NCT01750086|3644417|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3818845|NCT01750086|3644415|B3|||Age||years|Mean|66|66.0|Standard Deviation|8|8.0|||
3818846|NCT01750086|3644416|B2|||Age||years|Mean|66|66.0|Standard Deviation|8|8.0|||
3818847|NCT01750086|3644417|B1|||Age||years|Mean|66|66.0|Standard Deviation|7|7.0|||
3818848|NCT01749982|3644424|B5|Bangladesh||Region of Enrollment||participants|Number|60|60.0||||||
3818849|NCT01749982|3644425|B4|Bangladesh||Region of Enrollment||participants|Number|15|15.0||||||
3818850|NCT01749982|3644426|B3|Bangladesh||Region of Enrollment||participants|Number|15|15.0||||||
3818851|NCT01749982|3644427|B2|Bangladesh||Region of Enrollment||participants|Number|15|15.0||||||
3818852|NCT01749982|3644428|B1|Bangladesh||Region of Enrollment||participants|Number|15|15.0||||||
3818853|NCT01749982|3644424|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818854|NCT01749982|3644425|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818855|NCT01749982|3644426|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818856|NCT01749982|3644427|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818857|NCT01749982|3644428|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818858|NCT01749982|3644424|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3818859|NCT01749982|3644425|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3818860|NCT01749982|3644426|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3818861|NCT01749982|3644427|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3818862|NCT01749982|3644428|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3818863|NCT01749982|3644424|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818864|NCT01749982|3644425|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818865|NCT01749982|3644426|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818866|NCT01749982|3644427|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818867|NCT01749982|3644428|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818868|NCT01749982|3644424|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818869|NCT01749982|3644425|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818870|NCT01749982|3644426|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818871|NCT01749982|3644427|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818872|NCT01749982|3644428|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818873|NCT01749982|3644424|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818874|NCT01749982|3644425|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818875|NCT01749982|3644426|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818876|NCT01749982|3644427|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818877|NCT01749982|3644428|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818878|NCT01749982|3644424|B5||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818879|NCT01749982|3644425|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818880|NCT01749982|3644426|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818881|NCT01749982|3644427|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818882|NCT01749982|3644428|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818883|NCT01749982|3644424|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818884|NCT01749982|3644425|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818885|NCT01749982|3644426|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818886|NCT01749982|3644427|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818887|NCT01749982|3644428|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818888|NCT01749982|3644424|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818889|NCT01749982|3644425|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818890|NCT01749982|3644426|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818891|NCT01749982|3644427|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818892|NCT01749982|3644428|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818893|NCT01749982|3644424|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3818894|NCT01749982|3644425|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3818895|NCT01749982|3644426|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3818896|NCT01749982|3644427|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3818897|NCT01749982|3644428|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3818898|NCT01749982|3644424|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818899|NCT01749982|3644425|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818900|NCT01749982|3644426|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818901|NCT01749982|3644427|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818902|NCT01749982|3644428|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818903|NCT01749982|3644424|B5||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3818904|NCT01749982|3644425|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3818905|NCT01749982|3644426|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3818906|NCT01749982|3644427|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3818907|NCT01749982|3644428|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3818908|NCT01749982|3644424|B5||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3818909|NCT01749982|3644425|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3818910|NCT01749982|3644426|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3818911|NCT01749982|3644427|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3818912|NCT01749982|3644428|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3818913|NCT01749982|3644424|B5|||Age, Customized||years|Median|31.0|31.0|Full Range|||21.0|48.0|
3818914|NCT01749982|3644425|B4|||Age, Customized||years|Median|32.0|32.0|Full Range|||20.0|48.0|
3818915|NCT01749982|3644426|B3|||Age, Customized||years|Median|29.0|29.0|Full Range|||25.0|45.0|
3818916|NCT01749982|3644427|B2|||Age, Customized||years|Median|34.0|34.0|Full Range|||25.0|43.0|
3818917|NCT01749982|3644428|B1|||Age, Customized||years|Median|30.0|30.0|Full Range|||21.0|42.0|
3818918|NCT01749956|3644449|B1|Could not be assessed||Histologic Grade at Baseline||participants|Number|5|5.0||||||
3818919|NCT01749956|3644449|B1|Poorly differentiated||Histologic Grade at Baseline||participants|Number|2|2.0||||||
3818920|NCT01749956|3644449|B1|Moderately differentiated||Histologic Grade at Baseline||participants|Number|28|28.0||||||
3818921|NCT01749956|3644449|B1|Well differentiated||Histologic Grade at Baseline||participants|Number|4|4.0||||||
3818922|NCT01749956|3644449|B1|ECOG Performance Status = 1||Baseline ECOG Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status~0=Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity. Ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|participants|Number|7|7.0||||||
3818923|NCT01749956|3644449|B1|ECOG Performance Status = 0||Baseline ECOG Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status~0=Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity. Ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|participants|Number|32|32.0||||||
3818924|NCT01749956|3644449|B1|Stage III||Carcinoma Stage at Initial Diagnosis|Eligible patients with a histologically confirmed diagnosis of Stage II or Stage III rectal cancer, staged according to the American Joint Committee on Cancer (AJCC) Staging Manual - Edition 7.|participants|Number|27|27.0||||||
3818925|NCT01749956|3644449|B1|Stage II||Carcinoma Stage at Initial Diagnosis|Eligible patients with a histologically confirmed diagnosis of Stage II or Stage III rectal cancer, staged according to the American Joint Committee on Cancer (AJCC) Staging Manual - Edition 7.|participants|Number|12|12.0||||||
3818926|NCT01749956|3644449|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
3818927|NCT01749956|3644449|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3818928|NCT01749956|3644449|B1|White/Caucasian||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
3818929|NCT01749956|3644449|B1||Male|Gender||Participants|Count of Participants|25|25.0||||||
3818930|NCT01749956|3644449|B1||Female|Gender||Participants|Count of Participants|14|14.0||||||
3818931|NCT01749956|3644449|B1|||Age||years|Median|60|60.0|Full Range|||36.0|89.0|
3818932|NCT01749930|3644459|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818933|NCT01749930|3644460|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818934|NCT01749930|3644461|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818935|NCT01749930|3644459|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818936|NCT01749930|3644460|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818937|NCT01749930|3644461|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818938|NCT01749930|3644459|B3||White|Race (NIH/OMB)||Participants|Count of Participants|293|293.0||||||
3818939|NCT01749930|3644460|B2||White|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
3818940|NCT01749930|3644461|B1||White|Race (NIH/OMB)||Participants|Count of Participants|204|204.0||||||
3818941|NCT01749930|3644459|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
3818942|NCT01749930|3644460|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3818943|NCT01749930|3644461|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3818944|NCT01749930|3644459|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818945|NCT01749930|3644460|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818946|NCT01749930|3644461|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818947|NCT01749930|3644459|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3818948|NCT01749930|3644460|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3818949|NCT01749930|3644461|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3818950|NCT01749930|3644459|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3818951|NCT01749930|3644460|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818952|NCT01749930|3644461|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3818953|NCT01749930|3644459|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818954|NCT01749930|3644460|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818955|NCT01749930|3644461|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818956|NCT01749930|3644459|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|359|359.0||||||
3818957|NCT01749930|3644460|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|117|117.0||||||
3818958|NCT01749930|3644461|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|242|242.0||||||
3818959|NCT01749930|3644459|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3818960|NCT01749930|3644460|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3818961|NCT01749930|3644461|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3818962|NCT01749930|3644459|B3||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
3818963|NCT01749930|3644460|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3818964|NCT01749930|3644461|B1||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3818965|NCT01749930|3644459|B3||Female|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
3818966|NCT01749930|3644460|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3818967|NCT01749930|3644461|B1||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3818968|NCT01749930|3644459|B3|||Age||years|Mean|64.7|64.7|Standard Deviation|9.75|9.75|||
3818969|NCT01749930|3644460|B2|||Age||years|Mean|64.1|64.1|Standard Deviation|9.71|9.71|||
3818970|NCT01749930|3644461|B1|||Age||years|Mean|65.0|65.0|Standard Deviation|9.77|9.77|||
3818971|NCT01749904|3644476|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3818972|NCT01749904|3644477|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818973|NCT01749904|3644478|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3818974|NCT01749904|3644476|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818975|NCT01749904|3644477|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818976|NCT01749904|3644478|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818977|NCT01749904|3644476|B3||White|Race (NIH/OMB)||Participants|Count of Participants|325|325.0||||||
3818978|NCT01749904|3644477|B2||White|Race (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
3818979|NCT01749904|3644478|B1||White|Race (NIH/OMB)||Participants|Count of Participants|217|217.0||||||
3818980|NCT01749904|3644476|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3818981|NCT01749904|3644477|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3818982|NCT01749904|3644478|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3818983|NCT01749904|3644476|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818984|NCT01749904|3644477|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818985|NCT01749904|3644478|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818986|NCT01749904|3644476|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3818987|NCT01749904|3644477|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3818988|NCT01749904|3644478|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3818989|NCT01749904|3644476|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818990|NCT01749904|3644477|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818991|NCT01749904|3644478|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818992|NCT01749904|3644476|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818993|NCT01749904|3644477|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818994|NCT01749904|3644478|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3818995|NCT01749904|3644476|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|374|374.0||||||
3818996|NCT01749904|3644477|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
3818997|NCT01749904|3644478|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|254|254.0||||||
3818998|NCT01749904|3644476|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3818999|NCT01749904|3644477|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3819000|NCT01749904|3644478|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3819001|NCT01749904|3644476|B3||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3819002|NCT01749904|3644477|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3819003|NCT01749904|3644478|B1||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3819004|NCT01749904|3644476|B3||Female|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
3819005|NCT01749904|3644477|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3819006|NCT01749904|3644478|B1||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3819007|NCT01749904|3644476|B3|||Age||years|Mean|64.2|64.2|Standard Deviation|10.63|10.63|||
3819008|NCT01749904|3644477|B2|||Age||years|Mean|63.1|63.1|Standard Deviation|11.23|11.23|||
3819009|NCT01749904|3644478|B1|||Age||years|Mean|64.7|64.7|Standard Deviation|10.32|10.32|||
3819010|NCT01749800|3644493|B4|||Sustained Attention to Response Task|Subjects are presented with objects (one at the time) on a computer screen and are instructed to press a key on the keyboard according to the characteristics of the object shown on the computer screen. Error rates are measured as percentage of erroneous key selections.|percentage error|Mean|22|22.0|Full Range|||7.0|33.0|
3819011|NCT01749800|3644495|B2|||Sustained Attention to Response Task|Subjects are presented with objects (one at the time) on a computer screen and are instructed to press a key on the keyboard according to the characteristics of the object shown on the computer screen. Error rates are measured as percentage of erroneous key selections.|percentage error|Mean|20|20.0|Full Range|||20.0|20.0|
3819012|NCT01749800|3644496|B1|||Sustained Attention to Response Task|Subjects are presented with objects (one at the time) on a computer screen and are instructed to press a key on the keyboard according to the characteristics of the object shown on the computer screen. Error rates are measured as percentage of erroneous key selections.|percentage error|Mean|23|23.0|Full Range|||7.0|33.0|
3819013|NCT01749800|3644493|B4|United States||Region of Enrollment||participants|Number|7|7.0||||||
3819014|NCT01749800|3644495|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3819015|NCT01749800|3644496|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3819016|NCT01749800|3644493|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819017|NCT01749800|3644494|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819018|NCT01749800|3644495|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819019|NCT01749800|3644496|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819020|NCT01749800|3644493|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819021|NCT01749800|3644494|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819022|NCT01749800|3644495|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819023|NCT01749800|3644496|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819024|NCT01749800|3644493|B4||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3819025|NCT01749800|3644494|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819026|NCT01749800|3644495|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3819027|NCT01749800|3644496|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3819028|NCT01749800|3644493|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3819029|NCT01749800|3644494|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819030|NCT01749800|3644495|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819031|NCT01749800|3644496|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3819032|NCT01749800|3644493|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819033|NCT01749800|3644494|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819034|NCT01749800|3644495|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819035|NCT01749800|3644496|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819036|NCT01749800|3644493|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819037|NCT01749800|3644494|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819038|NCT01749800|3644495|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819039|NCT01749800|3644496|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819040|NCT01749800|3644493|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819041|NCT01749800|3644494|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819042|NCT01749800|3644495|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819043|NCT01749800|3644496|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819044|NCT01749800|3644493|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3819045|NCT01749800|3644494|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3819046|NCT01749800|3644495|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3819047|NCT01749800|3644496|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3819048|NCT01749800|3644493|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3819049|NCT01749800|3644494|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3819050|NCT01749800|3644495|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3819051|NCT01749800|3644496|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3819052|NCT01749800|3644493|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3819053|NCT01749800|3644494|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3819054|NCT01749800|3644495|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3819055|NCT01749800|3644496|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3819056|NCT01749800|3644493|B4||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3819057|NCT01749800|3644494|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3819058|NCT01749800|3644495|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3819059|NCT01749800|3644496|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3819060|NCT01749800|3644493|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3819061|NCT01749800|3644494|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3819062|NCT01749800|3644495|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3819063|NCT01749800|3644496|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3819064|NCT01749735|3644506|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3819065|NCT01749735|3644508|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3819066|NCT01749735|3644506|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3819067|NCT01749735|3644508|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3819068|NCT01749735|3644506|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3819069|NCT01749735|3644508|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3819070|NCT01749735|3644506|B3|||Age||years|Mean|52.5|52.5|Standard Deviation|8|8.0|||
3819071|NCT01749735|3644508|B1|||Age||years|Mean|52.5|52.5|Standard Deviation|8|8.0|||
3819072|NCT01749735|3644506|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3819073|NCT01749735|3644508|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3819074|NCT01749735|3644506|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3819075|NCT01749735|3644508|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3819076|NCT01749735|3644506|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3819077|NCT01749735|3644508|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3819078|NCT01749631|3644517|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3819079|NCT01749631|3644517|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3819080|NCT01749631|3644517|B1|||Age||years|Mean|48.8|48.8|Standard Deviation|15.04|15.04|||
3819081|NCT01749605|3644527|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
3819082|NCT01749605|3644528|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3819083|NCT01749605|3644529|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3819084|NCT01749605|3644527|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3819085|NCT01749605|3644528|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3819086|NCT01749605|3644529|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3819087|NCT01749605|3644527|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819088|NCT01749605|3644528|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819089|NCT01749605|3644529|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819090|NCT01749605|3644527|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819091|NCT01749605|3644528|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819092|NCT01749605|3644529|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819093|NCT01749605|3644527|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819094|NCT01749605|3644528|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819095|NCT01749605|3644529|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819096|NCT01749605|3644527|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819097|NCT01749605|3644528|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819098|NCT01749605|3644529|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819099|NCT01749605|3644527|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819100|NCT01749605|3644528|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819101|NCT01749605|3644529|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819102|NCT01749605|3644527|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819103|NCT01749605|3644528|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819104|NCT01749605|3644529|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819105|NCT01749605|3644527|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3819106|NCT01749605|3644528|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3819107|NCT01749605|3644529|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3819108|NCT01749605|3644527|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3819109|NCT01749605|3644528|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3819110|NCT01749605|3644529|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3819111|NCT01749605|3644527|B3|||Age||years|Mean|24.75|24.75|Full Range|||18.0|44.0|
3819112|NCT01749605|3644528|B2|||Age||years|Mean|25.1|25.1|Full Range|||18.0|44.0|
3819113|NCT01749605|3644529|B1|||Age||years|Mean|24.4|24.4|Full Range|||18.0|44.0|
3819114|NCT01749501|3644536|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
3819115|NCT01749501|3644537|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
3819116|NCT01749501|3644538|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3819117|NCT01749501|3644536|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3819118|NCT01749501|3644537|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3819119|NCT01749501|3644538|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3819120|NCT01749501|3644536|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3819121|NCT01749501|3644537|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3819122|NCT01749501|3644538|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3819123|NCT01749501|3644536|B3|||Age||post menstrual age (PMA) weeks|Mean|34.62|34.62|Standard Deviation|4.1|4.1|||
3819124|NCT01749501|3644537|B2|||Age||post menstrual age (PMA) weeks|Mean|33.88|33.88|Standard Deviation|3.65|3.65|||
3819125|NCT01749501|3644538|B1|||Age||post menstrual age (PMA) weeks|Mean|35.4|35.4|Standard Deviation|4.47|4.47|||
3819126|NCT01749501|3644536|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3819127|NCT01749501|3644537|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3819128|NCT01749501|3644538|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3819129|NCT01749501|3644536|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3819130|NCT01749501|3644537|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3819131|NCT01749501|3644538|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3819132|NCT01749501|3644536|B3||<=18 years|Age||Participants|Count of Participants|45|45.0||||||
3819133|NCT01749501|3644537|B2||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
3819134|NCT01749501|3644538|B1||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
3819135|NCT01749410|3644547|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3819136|NCT01749410|3644547|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3819137|NCT01749410|3644547|B1|||Age||Years|Mean|43.97|43.97|Standard Deviation|11.07|11.07|||
3819138|NCT01748955|3644551|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3819139|NCT01748955|3644552|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3819140|NCT01748955|3644553|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3819141|NCT01748955|3644551|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3819142|NCT01748955|3644552|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3819143|NCT01748955|3644553|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3819144|NCT01748955|3644551|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3819145|NCT01748955|3644552|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3819146|NCT01748955|3644553|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3819147|NCT01748955|3644551|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3819148|NCT01748955|3644552|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3819149|NCT01748955|3644553|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3819150|NCT01748955|3644551|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3819151|NCT01748955|3644552|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3819152|NCT01748955|3644553|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3819153|NCT01748942|3644562|B3|||UM-QOL eating score|"The University of Michigan Head and Neck Quality of Life Questionnaire (UM-QOL) is 20 item, 1-5 scale, questionnaire that measures how much the patient has been bothered during various activities as a result of head and neck condition or treatment in the past four weeks with 1= Not at all and 5=Extremely."|units on a scale|Mean|89.6|89.6|Standard Deviation|17.8|17.8|||
3819154|NCT01748942|3644563|B2|||UM-QOL eating score|"The University of Michigan Head and Neck Quality of Life Questionnaire (UM-QOL) is 20 item, 1-5 scale, questionnaire that measures how much the patient has been bothered during various activities as a result of head and neck condition or treatment in the past four weeks with 1= Not at all and 5=Extremely."|units on a scale|Mean|93.75|93.75|Standard Deviation|12.7|12.7|||
3819155|NCT01748942|3644564|B1|||UM-QOL eating score|"The University of Michigan Head and Neck Quality of Life Questionnaire (UM-QOL) is 20 item, 1-5 scale, questionnaire that measures how much the patient has been bothered during various activities as a result of head and neck condition or treatment in the past four weeks with 1= Not at all and 5=Extremely."|units on a scale|Mean|89.6|89.6|Standard Deviation|17.8|17.8|||
3819156|NCT01748942|3644562|B3|||PSS normalcy of diet|"Performance Status Score (PSS) - Normalcy of Diet score is a 0-100 scale that measures diet restrictions with 0= Non-oral feeding (tube fed) and 100 = Full diet (no restrictions)"|units on a scale|Mean|93.8|93.8|Standard Deviation|15.4|15.4|||
3819157|NCT01748942|3644563|B2|||PSS normalcy of diet|"Performance Status Score (PSS) - Normalcy of Diet score is a 0-100 scale that measures diet restrictions with 0= Non-oral feeding (tube fed) and 100 = Full diet (no restrictions)"|units on a scale|Mean|94.2|94.2|Standard Deviation|15.0|15.0|||
3819158|NCT01748942|3644564|B1|||PSS normalcy of diet|"Performance Status Score (PSS) - Normalcy of Diet score is a 0-100 scale that measures diet restrictions with 0= Non-oral feeding (tube fed) and 100 = Full diet (no restrictions)"|units on a scale|Mean|92.3|92.3|Standard Deviation|16.4|16.4|||
3819159|NCT01748942|3644562|B3|||EAT-10 score|"Mean overall score of the EAT-10 tool. The Eating Assessment Tool (EAT-10) is a 10 item questionnaire that evaluates swallowing and the extent of how problematic with certain eating activities. Questions are answered using a five point (0-4) plus Not Applicable scale with 0 = No problem and 4= Severe problem."|units on a scale|Mean|4.6|4.6|Standard Deviation|6.9|6.9|||
3819160|NCT01748942|3644563|B2|||EAT-10 score|"Mean overall score of the EAT-10 tool. The Eating Assessment Tool (EAT-10) is a 10 item questionnaire that evaluates swallowing and the extent of how problematic with certain eating activities. Questions are answered using a five point (0-4) plus Not Applicable scale with 0 = No problem and 4= Severe problem."|units on a scale|Mean|3.5|3.5|Standard Deviation|6.2|6.2|||
3819161|NCT01748942|3644564|B1|||EAT-10 score|"Mean overall score of the EAT-10 tool. The Eating Assessment Tool (EAT-10) is a 10 item questionnaire that evaluates swallowing and the extent of how problematic with certain eating activities. Questions are answered using a five point (0-4) plus Not Applicable scale with 0 = No problem and 4= Severe problem."|units on a scale|Mean|5.9|5.9|Standard Deviation|7.6|7.6|||
3819162|NCT01748942|3644562|B3||T2|Tumor stage|"Tumor stage is assessed using American Joint Committee on Cancer (AJCC) TNM staging of oropharyngeal squamous cell carcinoma:~T1 = Tumor 2 cm or less in greatest dimension. T2 = Tumor more than 2 cm but not more than 4 cm in greatest dimension. T3 = Tumor more than 4 cm in greatest dimension or extension to lingual surface of epiglottis.~T4a = Moderately advanced local disease. T4b = Very advance local disease."|Participants|Count of Participants|32|32.0||||||
3819163|NCT01748942|3644563|B2||T2|Tumor stage|"Tumor stage is assessed using American Joint Committee on Cancer (AJCC) TNM staging of oropharyngeal squamous cell carcinoma:~T1 = Tumor 2 cm or less in greatest dimension. T2 = Tumor more than 2 cm but not more than 4 cm in greatest dimension. T3 = Tumor more than 4 cm in greatest dimension or extension to lingual surface of epiglottis.~T4a = Moderately advanced local disease. T4b = Very advance local disease."|Participants|Count of Participants|18|18.0||||||
3819164|NCT01748942|3644564|B1||T2|Tumor stage|"Tumor stage is assessed using American Joint Committee on Cancer (AJCC) TNM staging of oropharyngeal squamous cell carcinoma:~T1 = Tumor 2 cm or less in greatest dimension. T2 = Tumor more than 2 cm but not more than 4 cm in greatest dimension. T3 = Tumor more than 4 cm in greatest dimension or extension to lingual surface of epiglottis.~T4a = Moderately advanced local disease. T4b = Very advance local disease."|Participants|Count of Participants|14|14.0||||||
3819165|NCT01748942|3644562|B3||T1|Tumor stage|"Tumor stage is assessed using American Joint Committee on Cancer (AJCC) TNM staging of oropharyngeal squamous cell carcinoma:~T1 = Tumor 2 cm or less in greatest dimension. T2 = Tumor more than 2 cm but not more than 4 cm in greatest dimension. T3 = Tumor more than 4 cm in greatest dimension or extension to lingual surface of epiglottis.~T4a = Moderately advanced local disease. T4b = Very advance local disease."|Participants|Count of Participants|36|36.0||||||
3819166|NCT01748942|3644563|B2||T1|Tumor stage|"Tumor stage is assessed using American Joint Committee on Cancer (AJCC) TNM staging of oropharyngeal squamous cell carcinoma:~T1 = Tumor 2 cm or less in greatest dimension. T2 = Tumor more than 2 cm but not more than 4 cm in greatest dimension. T3 = Tumor more than 4 cm in greatest dimension or extension to lingual surface of epiglottis.~T4a = Moderately advanced local disease. T4b = Very advance local disease."|Participants|Count of Participants|15|15.0||||||
3819167|NCT01748942|3644564|B1||T1|Tumor stage|"Tumor stage is assessed using American Joint Committee on Cancer (AJCC) TNM staging of oropharyngeal squamous cell carcinoma:~T1 = Tumor 2 cm or less in greatest dimension. T2 = Tumor more than 2 cm but not more than 4 cm in greatest dimension. T3 = Tumor more than 4 cm in greatest dimension or extension to lingual surface of epiglottis.~T4a = Moderately advanced local disease. T4b = Very advance local disease."|Participants|Count of Participants|21|21.0||||||
3819168|NCT01748942|3644562|B3|||VAS pain score|"Visual Analog Scale (VAS) is a 0-10 scale for patients to indicate intensity level of pain with 0 indicating No pain and 10 indicating Worst possible, unbearable, excruciating pain."|units on a scale|Mean|0.9|0.9|Standard Deviation|1.6|1.6|||
3819169|NCT01748942|3644563|B2|||VAS pain score|"Visual Analog Scale (VAS) is a 0-10 scale for patients to indicate intensity level of pain with 0 indicating No pain and 10 indicating Worst possible, unbearable, excruciating pain."|units on a scale|Mean|0.6|0.6|Standard Deviation|1.3|1.3|||
3819170|NCT01748942|3644564|B1|||VAS pain score|"Visual Analog Scale (VAS) is a 0-10 scale for patients to indicate intensity level of pain with 0 indicating No pain and 10 indicating Worst possible, unbearable, excruciating pain."|units on a scale|Mean|1.1|1.1|Standard Deviation|1.8|1.8|||
3819171|NCT01748942|3644562|B3|United States||Region of Enrollment||participants|Number|68|68.0||||||
3819172|NCT01748942|3644563|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
3819173|NCT01748942|3644564|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3819174|NCT01748942|3644562|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3819175|NCT01748942|3644563|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3819176|NCT01748942|3644564|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3819177|NCT01748942|3644562|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3819178|NCT01748942|3644563|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3819179|NCT01748942|3644564|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3819180|NCT01748942|3644562|B3|||Age||years|Mean|58|58.0|Full Range|||44.0|75.0|
3819181|NCT01748942|3644563|B2|||Age||years|Mean|60|60.0|Full Range|||44.0|75.0|
3819182|NCT01748942|3644564|B1|||Age||years|Mean|56|56.0|Full Range|||44.0|72.0|
3819183|NCT01748942|3644562|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3819184|NCT01748942|3644563|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3819185|NCT01748942|3644564|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3819186|NCT01748942|3644562|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3819187|NCT01748942|3644563|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3819188|NCT01748942|3644564|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3819189|NCT01748942|3644562|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3819190|NCT01748942|3644563|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3819191|NCT01748942|3644564|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3819192|NCT01748916|3644585|B1|Costa Rica||Region of Enrollment||participants|Number|16|16.0||||||
3819193|NCT01748916|3644585|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3819194|NCT01748916|3644585|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3819195|NCT01748916|3644585|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3819196|NCT01748916|3644585|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3819197|NCT01748916|3644585|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3819198|NCT01748916|3644585|B1|||Age||years|Median|27|27.0|Full Range|||21.0|44.0|
3819199|NCT01748799|3644602|B9|Canada||Region of Enrollment||participants|Number|16|16.0||||||
3819200|NCT01748799|3644603|B8|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3819201|NCT01748799|3644604|B7|Canada||Region of Enrollment||participants|Number|2|2.0||||||
3819202|NCT01748799|3644605|B6|Canada||Region of Enrollment||participants|Number|2|2.0||||||
3819203|NCT01748799|3644606|B5|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3819204|NCT01748799|3644607|B4|Canada||Region of Enrollment||participants|Number|2|2.0||||||
3819205|NCT01748799|3644608|B3|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3819206|NCT01748799|3644609|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3819207|NCT01748799|3644610|B1|Canada||Region of Enrollment||participants|Number|6|6.0||||||
3819208|NCT01748799|3644602|B9||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3819209|NCT01748799|3644603|B8||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3819210|NCT01748799|3644604|B7||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3819211|NCT01748799|3644605|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3819212|NCT01748799|3644606|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3819213|NCT01748799|3644607|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3819214|NCT01748799|3644608|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3819215|NCT01748799|3644609|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3819216|NCT01748799|3644610|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3819217|NCT01748799|3644602|B9||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3819218|NCT01748799|3644603|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3819219|NCT01748799|3644604|B7||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3819220|NCT01748799|3644605|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3819221|NCT01748799|3644606|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3819222|NCT01748799|3644607|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3819223|NCT01748799|3644608|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3819224|NCT01748799|3644609|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3819225|NCT01748799|3644610|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3819226|NCT01748799|3644602|B9|||Age||years|Mean|34.8|34.8|Standard Deviation|10.5|10.5|||
3819227|NCT01748799|3644603|B8|||Age||years|Mean|22.0|22.0|Standard Deviation|0.0|0.0|||
3819228|NCT01748799|3644604|B7|||Age||years|Mean|43.0|43.0|Standard Deviation|5.6|5.6|||
3819229|NCT01748799|3644605|B6|||Age||years|Mean|41.5|41.5|Standard Deviation|6.4|6.4|||
3819230|NCT01748799|3644606|B5|||Age||years|Mean|36.0|36.0|Standard Deviation|0.0|0.0|||
3819231|NCT01748799|3644607|B4|||Age||years|Mean|46.5|46.5|Standard Deviation|6.4|6.4|||
3819232|NCT01748799|3644608|B3|||Age||years|Mean|19.0|19.0|Standard Deviation|0.0|0.0|||
3819233|NCT01748799|3644609|B2|||Age||years|Mean|24.0|24.0|Standard Deviation|0.0|0.0|||
3819234|NCT01748799|3644610|B1|||Age||years|Mean|35.7|35.7|Standard Deviation|8.6|8.6|||
3819235|NCT01748760|3644651|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3819236|NCT01748760|3644652|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3819237|NCT01748760|3644653|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3819238|NCT01748760|3644651|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3819239|NCT01748760|3644652|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3819240|NCT01748760|3644653|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3819241|NCT01748760|3644651|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3819242|NCT01748760|3644652|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3819243|NCT01748760|3644653|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3819244|NCT01748760|3644651|B3||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3819245|NCT01748760|3644652|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3819246|NCT01748760|3644653|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3819247|NCT01748760|3644651|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3819248|NCT01748760|3644652|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3819249|NCT01748760|3644653|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3819250|NCT01748760|3644651|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819251|NCT01748760|3644652|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819252|NCT01748760|3644653|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819253|NCT01748760|3644651|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3819254|NCT01748760|3644652|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819255|NCT01748760|3644653|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3819256|NCT01748760|3644651|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819257|NCT01748760|3644652|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819258|NCT01748760|3644653|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819259|NCT01748760|3644651|B3|Other||Sex/Gender, Customized||participants|Number|1|1.0||||||
3819260|NCT01748760|3644652|B2|Other||Sex/Gender, Customized||participants|Number|0|0.0||||||
3819261|NCT01748760|3644653|B1|Other||Sex/Gender, Customized||participants|Number|1|1.0||||||
3819262|NCT01748760|3644651|B3|Female||Sex/Gender, Customized||participants|Number|40|40.0||||||
3819263|NCT01748760|3644652|B2|Female||Sex/Gender, Customized||participants|Number|19|19.0||||||
3819264|NCT01748760|3644653|B1|Female||Sex/Gender, Customized||participants|Number|21|21.0||||||
3819265|NCT01748760|3644651|B3|Male||Sex/Gender, Customized||participants|Number|9|9.0||||||
3819266|NCT01748760|3644652|B2|Male||Sex/Gender, Customized||participants|Number|6|6.0||||||
3819267|NCT01748760|3644653|B1|Male||Sex/Gender, Customized||participants|Number|3|3.0||||||
3819268|NCT01748760|3644651|B3|||Age||years|Mean|15.74|15.74|Standard Deviation|1.32|1.32|||
3819269|NCT01748760|3644652|B2|||Age||years|Mean|15.52|15.52|Standard Deviation|1.42|1.42|||
3819270|NCT01748760|3644653|B1|||Age||years|Mean|15.96|15.96|Standard Deviation|1.21|1.21|||
3819271|NCT01748695|3644660|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3819272|NCT01748695|3644660|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3819273|NCT01748695|3644660|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3819274|NCT01748695|3644660|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3819275|NCT01748695|3644660|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3819276|NCT01748643|3644669|B3|||Forced vital capacity||L/min|Mean|2.8|2.8|Standard Deviation|0.8|0.8|||
3819277|NCT01748643|3644670|B2|||Forced vital capacity||L/min|Mean|2.7|2.7|Standard Deviation|0.8|0.8|||
3819278|NCT01748643|3644671|B1|||Forced vital capacity||L/min|Mean|3.0|3.0|Standard Deviation|0.9|0.9|||
3819279|NCT01748643|3644669|B3|||Forced expiratory volume in 1 second||L/min|Mean|2.3|2.3|Standard Deviation|0.7|0.7|||
3819280|NCT01748643|3644670|B2|||Forced expiratory volume in 1 second||L/min|Mean|2.2|2.2|Standard Deviation|0.6|0.6|||
3819281|NCT01748643|3644671|B1|||Forced expiratory volume in 1 second||L/min|Mean|2.4|2.4|Standard Deviation|0.9|0.9|||
3819282|NCT01748643|3644669|B3|||Peak expiratory flow||L/min|Mean|295|295.0|Standard Deviation|97|97.0|||
3819283|NCT01748643|3644670|B2|||Peak expiratory flow||L/min|Mean|276|276.0|Standard Deviation|81|81.0|||
3819284|NCT01748643|3644671|B1|||Peak expiratory flow||L/min|Mean|314|314.0|Standard Deviation|109|109.0|||
3819285|NCT01748643|3644669|B3|||Body Mass Index||kg/m2|Mean|41|41.0|Standard Deviation|5|5.0|||
3819286|NCT01748643|3644670|B2|||Body Mass Index||kg/m2|Mean|41|41.0|Standard Deviation|7|7.0|||
3819287|NCT01748643|3644671|B1|||Body Mass Index||kg/m2|Mean|40|40.0|Standard Deviation|3|3.0|||
3819288|NCT01748643|3644669|B3|Belgium||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3819289|NCT01748643|3644670|B2|Belgium||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3819290|NCT01748643|3644671|B1|Belgium||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3819291|NCT01748643|3644669|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3819292|NCT01748643|3644670|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3819293|NCT01748643|3644671|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3819294|NCT01748643|3644669|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3819295|NCT01748643|3644670|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3819296|NCT01748643|3644671|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3819297|NCT01748643|3644669|B3|||Age||years|Mean|41.6|41.6|Standard Deviation|12.0|12.0|||
3819298|NCT01748643|3644670|B2|||Age||years|Mean|42|42.0|Standard Deviation|11|11.0|||
3819299|NCT01748643|3644671|B1|||Age||years|Mean|41|41.0|Standard Deviation|13|13.0|||
3819300|NCT01748292|3644688|B3|||Central Retinal Thickness||microns|Mean|511|511.0|Full Range|||265.0|1007.0|
3819301|NCT01748292|3644689|B2|||Central Retinal Thickness||microns|Mean|489|489.0|Full Range|||265.0|1007.0|
3819302|NCT01748292|3644690|B1|||Central Retinal Thickness||microns|Mean|533|533.0|Full Range|||323.0|839.0|
3819303|NCT01748292|3644688|B3|||Early Treatment Diabetic Retinopathy Study Best-Corrected Visual Acuity||letters|Mean|60.0|60.0|Full Range|||18.0|78.0|
3819304|NCT01748292|3644689|B2|||Early Treatment Diabetic Retinopathy Study Best-Corrected Visual Acuity||letters|Mean|59.9|59.9|Full Range|||18.0|78.0|
3819305|NCT01748292|3644690|B1|||Early Treatment Diabetic Retinopathy Study Best-Corrected Visual Acuity||letters|Mean|60.3|60.3|Full Range|||31.0|76.0|
3819306|NCT01748292|3644688|B3|||Hypertension||Participants|Count of Participants|47|47.0||||||
3819307|NCT01748292|3644689|B2|||Hypertension||Participants|Count of Participants|31|31.0||||||
3819308|NCT01748292|3644690|B1|||Hypertension||Participants|Count of Participants|16|16.0||||||
3819309|NCT01748292|3644688|B3|||Diabetes Mellitus||Participants|Count of Participants|11|11.0||||||
3819310|NCT01748292|3644689|B2|||Diabetes Mellitus||Participants|Count of Participants|9|9.0||||||
3819311|NCT01748292|3644690|B1|||Diabetes Mellitus||Participants|Count of Participants|2|2.0||||||
3819312|NCT01748292|3644688|B3|||Number of Participants with Posterior Chamber Intraocular Lenses||Participants|Count of Participants|32|32.0||||||
3819313|NCT01748292|3644689|B2|||Number of Participants with Posterior Chamber Intraocular Lenses||Participants|Count of Participants|22|22.0||||||
3819314|NCT01748292|3644690|B1|||Number of Participants with Posterior Chamber Intraocular Lenses||Participants|Count of Participants|10|10.0||||||
3819315|NCT01748292|3644688|B3|||Number of Right Eyes Enrolled||Participants|Count of Participants|26|26.0||||||
3819316|NCT01748292|3644689|B2|||Number of Right Eyes Enrolled||Participants|Count of Participants|16|16.0||||||
3819317|NCT01748292|3644690|B1|||Number of Right Eyes Enrolled||Participants|Count of Participants|10|10.0||||||
3819318|NCT01748292|3644688|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3819319|NCT01748292|3644688|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3819320|NCT01748292|3644689|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3819321|NCT01748292|3644690|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3819322|NCT01748292|3644688|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3819323|NCT01748292|3644689|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3819324|NCT01748292|3644690|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3819325|NCT01748292|3644688|B3|||Age||years|Mean|77|77.0|Full Range|||59.0|96.0|
3819326|NCT01748292|3644689|B2|||Age||years|Mean|76|76.0|Full Range|||59.0|91.0|
3819327|NCT01748292|3644690|B1|||Age||years|Mean|79|79.0|Full Range|||60.0|96.0|
3819328|NCT01748240|3644707|B1|France||Region of Enrollment||participants|Number|21|21.0||||||
3819329|NCT01748240|3644707|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3819330|NCT01748240|3644707|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3819331|NCT01748240|3644707|B1|||Age||years|Median|72|72.0|Full Range|||43.0|81.0|
3819332|NCT01748240|3644707|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3819333|NCT01748240|3644707|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3819334|NCT01748240|3644707|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3819335|NCT01748227|3644711|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3819336|NCT01748227|3644711|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3819337|NCT01748227|3644711|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3819338|NCT01748227|3644711|B1|||Age||years|Mean|58|58.0|Full Range|||35.0|66.0|
3819339|NCT01748227|3644711|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3819340|NCT01748227|3644711|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3819341|NCT01748227|3644711|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3819342|NCT01748162|3644719|B3|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3819343|NCT01748162|3644720|B2|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3819344|NCT01748162|3644721|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3819345|NCT01748162|3644719|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3819346|NCT01748162|3644720|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3819347|NCT01748162|3644721|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3819348|NCT01748162|3644719|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3819349|NCT01748162|3644720|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3819350|NCT01748162|3644721|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3819351|NCT01748162|3644719|B3|6 months to 15 years||Age, Customized|Age brackets of children participating:|Participants|Count of Participants|10|10.0||||||
3819352|NCT01748162|3644720|B2|6 months to 15 years||Age, Customized|Age brackets of children participating:|Participants|Count of Participants|5|5.0||||||
3819353|NCT01748162|3644721|B1|6 months to 15 years||Age, Customized|Age brackets of children participating:|Participants|Count of Participants|5|5.0||||||
3819354|NCT01748071|3644730|B4|China||Region of Enrollment||participants|Number|120|120.0||||||
3819355|NCT01748071|3644731|B3|China||Region of Enrollment||participants|Number|40|40.0||||||
3819356|NCT01748071|3644732|B2|China||Region of Enrollment||participants|Number|40|40.0||||||
3819357|NCT01748071|3644733|B1|China||Region of Enrollment||participants|Number|40|40.0||||||
3819358|NCT01748071|3644730|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3819359|NCT01748071|3644731|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3819360|NCT01748071|3644732|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3819361|NCT01748071|3644733|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3819362|NCT01748071|3644730|B4||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3819363|NCT01748071|3644731|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3819364|NCT01748071|3644732|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3819365|NCT01748071|3644733|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3819366|NCT01748071|3644730|B4|||Age||years|Mean|48|48.0|Standard Deviation|13|13.0|||
3819367|NCT01748071|3644731|B3|||Age||years|Mean|49|49.0|Standard Deviation|11|11.0|||
3819368|NCT01748071|3644732|B2|||Age||years|Mean|47|47.0|Standard Deviation|13|13.0|||
3819369|NCT01748071|3644733|B1|||Age||years|Mean|49|49.0|Standard Deviation|12|12.0|||
3819370|NCT01748071|3644730|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3819371|NCT01748071|3644731|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3819372|NCT01748071|3644732|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3819373|NCT01748071|3644733|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3819374|NCT01748071|3644730|B4||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
3819375|NCT01748071|3644731|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3819376|NCT01748071|3644732|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3819377|NCT01748071|3644733|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3819378|NCT01748071|3644730|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3819379|NCT01748071|3644731|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3819380|NCT01748071|3644732|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3819381|NCT01748071|3644733|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3819382|NCT01748045|3644755|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3819383|NCT01748045|3644756|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819384|NCT01748045|3644757|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3819385|NCT01748045|3644755|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819386|NCT01748045|3644756|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819387|NCT01748045|3644757|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819388|NCT01748045|3644755|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819389|NCT01748045|3644756|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819390|NCT01748045|3644757|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819391|NCT01748045|3644755|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3819392|NCT01748045|3644756|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3819393|NCT01748045|3644757|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819394|NCT01748045|3644755|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819395|NCT01748045|3644756|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819396|NCT01748045|3644757|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819397|NCT01748045|3644755|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819398|NCT01748045|3644756|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819399|NCT01748045|3644757|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819400|NCT01748045|3644755|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819401|NCT01748045|3644756|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819402|NCT01748045|3644757|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819403|NCT01748045|3644755|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3819404|NCT01748045|3644756|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819405|NCT01748045|3644757|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3819406|NCT01748045|3644755|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3819407|NCT01748045|3644756|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3819408|NCT01748045|3644757|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819409|NCT01748045|3644755|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819410|NCT01748045|3644756|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819411|NCT01748045|3644757|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819412|NCT01748045|3644755|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3819413|NCT01748045|3644756|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3819414|NCT01748045|3644757|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3819415|NCT01748045|3644755|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3819416|NCT01748045|3644756|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3819417|NCT01748045|3644757|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3819418|NCT01748045|3644755|B3|||Age||days|Mean|1|1.0|Standard Deviation|0|0.0|||
3819419|NCT01748045|3644756|B2|||Age||days|Mean|1|1.0|Standard Deviation|0|0.0|||
3819420|NCT01748045|3644757|B1|||Age||days|Mean|1|1.0|Standard Deviation|0|0.0|||
3819421|NCT01747928|3644776|B9||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3819422|NCT01747928|3644777|B8||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3819423|NCT01747928|3644778|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3819424|NCT01747928|3644779|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3819425|NCT01747928|3644780|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3819426|NCT01747928|3644781|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3819427|NCT01747928|3644782|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3819428|NCT01747928|3644783|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3819429|NCT01747928|3644784|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3819430|NCT01747928|3644776|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3819431|NCT01747928|3644777|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3819432|NCT01747928|3644778|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3819433|NCT01747928|3644779|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3819434|NCT01747928|3644780|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3819435|NCT01747928|3644781|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3819436|NCT01747928|3644782|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3819437|NCT01747928|3644783|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3819438|NCT01747928|3644784|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3819439|NCT01747928|3644776|B9|||Age||years|Mean|54.8|54.8|Standard Deviation|7.9|7.9|||
3819440|NCT01747928|3644777|B8|||Age||years|Mean|51.8|51.8|Standard Deviation|5.6|5.6|||
3819441|NCT01747928|3644778|B7|||Age||years|Mean|57.8|57.8|Standard Deviation|6.8|6.8|||
3819442|NCT01747928|3644779|B6|||Age||years|Mean|55.3|55.3|Standard Deviation|4.8|4.8|||
3819443|NCT01747928|3644780|B5|||Age||years|Mean|63.0|63.0|Standard Deviation|2.5|2.5|||
3819444|NCT01747928|3644781|B4|||Age||years|Mean|53.5|53.5|Standard Deviation|9.0|9.0|||
3819445|NCT01747928|3644782|B3|||Age||years|Mean|51.3|51.3|Standard Deviation|9.0|9.0|||
3819446|NCT01747928|3644783|B2|||Age||years|Mean|52.7|52.7|Standard Deviation|10.0|10.0|||
3819447|NCT01747928|3644784|B1|||Age||years|Mean|53.0|53.0|Standard Deviation|9.1|9.1|||
3819448|NCT01747850|3644995|B4|Canada||Region of Enrollment||participants|Number|45|45.0||||||
3819449|NCT01747850|3644996|B3|Canada||Region of Enrollment||participants|Number|5|5.0||||||
3819450|NCT01747850|3644997|B2|Canada||Region of Enrollment||participants|Number|20|20.0||||||
3819451|NCT01747850|3644998|B1|Canada||Region of Enrollment||participants|Number|20|20.0||||||
3819452|NCT01747850|3644995|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3819453|NCT01747850|3644996|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3819454|NCT01747850|3644997|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3819455|NCT01747850|3644998|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3819456|NCT01747850|3644995|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3819457|NCT01747850|3644996|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3819458|NCT01747850|3644997|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3819459|NCT01747850|3644998|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3819460|NCT01747850|3644995|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3819461|NCT01747850|3644996|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3819462|NCT01747850|3644997|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3819463|NCT01747850|3644998|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3819464|NCT01747850|3644995|B4||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3819465|NCT01747850|3644996|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3819466|NCT01747850|3644997|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3819467|NCT01747850|3644998|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3819468|NCT01747850|3644995|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3819469|NCT01747850|3644996|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3819470|NCT01747850|3644997|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3819471|NCT01747850|3644998|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3819472|NCT01747811|3645020|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
3819473|NCT01747811|3645021|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3819474|NCT01747811|3645022|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3819475|NCT01747811|3645020|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3819476|NCT01747811|3645021|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3819477|NCT01747811|3645022|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3819478|NCT01747811|3645020|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3819479|NCT01747811|3645021|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3819480|NCT01747811|3645022|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3819481|NCT01747811|3645020|B3|||Age||Years|Mean|23.24|23.24|Standard Deviation|7.85|7.85|||
3819482|NCT01747811|3645021|B2|||Age||Years|Mean|23.46|23.46|Standard Deviation|8.64|8.64|||
3819483|NCT01747811|3645022|B1|||Age||Years|Mean|23.07|23.07|Standard Deviation|7.50|7.5|||
3819484|NCT01747811|3645020|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3819485|NCT01747811|3645021|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3819486|NCT01747811|3645022|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3819487|NCT01747811|3645020|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3819488|NCT01747811|3645021|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3819489|NCT01747811|3645022|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3819490|NCT01747811|3645020|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3819491|NCT01747811|3645021|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3819492|NCT01747811|3645022|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3819493|NCT01747772|3645039|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3819494|NCT01747772|3645039|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3819495|NCT01747772|3645039|B1|||Age||years|Mean|48|48.0|Standard Deviation|13|13.0|||
3819496|NCT01747655|3645047|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3819497|NCT01747655|3645047|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3819498|NCT01747655|3645047|B1|||Age||years|Mean|70.4|70.4|Standard Deviation|7.8|7.8|||
3819499|NCT01747629|3645076|B3|||Body Mass Index||kg/m^2|Mean|27.7|27.7|Standard Deviation|6.21|6.21|||
3819500|NCT01747629|3645077|B2|||Body Mass Index||kg/m^2|Mean|27.4|27.4|Standard Deviation|5.90|5.9|||
3819501|NCT01747629|3645078|B1|||Body Mass Index||kg/m^2|Mean|28.1|28.1|Standard Deviation|6.48|6.48|||
3819502|NCT01747629|3645076|B3|||Height||cm|Mean|168.7|168.7|Standard Deviation|10.08|10.08|||
3819503|NCT01747629|3645077|B2|||Height||cm|Mean|169.8|169.8|Standard Deviation|10.93|10.93|||
3819504|NCT01747629|3645078|B1|||Height||cm|Mean|167.8|167.8|Standard Deviation|9.23|9.23|||
3819505|NCT01747629|3645076|B3|||Weight||kg|Mean|79.7|79.7|Standard Deviation|21.77|21.77|||
3819506|NCT01747629|3645077|B2|||Weight||kg|Mean|79.6|79.6|Standard Deviation|20.75|20.75|||
3819507|NCT01747629|3645078|B1|||Weight||kg|Mean|79.8|79.8|Standard Deviation|22.76|22.76|||
3819508|NCT01747629|3645076|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|146|146.0||||||
3819509|NCT01747629|3645077|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
3819510|NCT01747629|3645078|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
3819511|NCT01747629|3645076|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3819512|NCT01747629|3645077|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3819513|NCT01747629|3645078|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3819514|NCT01747629|3645076|B3|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3819515|NCT01747629|3645077|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3819516|NCT01747629|3645078|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3819517|NCT01747629|3645076|B3|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3819518|NCT01747629|3645077|B2|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3819519|NCT01747629|3645078|B1|Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3819520|NCT01747629|3645076|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3819521|NCT01747629|3645077|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3819522|NCT01747629|3645078|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3819523|NCT01747629|3645076|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3819524|NCT01747629|3645077|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3819525|NCT01747629|3645078|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3819526|NCT01747629|3645076|B3|Black||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3819527|NCT01747629|3645077|B2|Black||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3819528|NCT01747629|3645078|B1|Black||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3819529|NCT01747629|3645076|B3|White||Race/Ethnicity, Customized||participants|Number|125|125.0||||||
3819530|NCT01747629|3645077|B2|White||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
3819531|NCT01747629|3645078|B1|White||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
3819532|NCT01747629|3645076|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3819533|NCT01747629|3645077|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3819534|NCT01747629|3645078|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3819535|NCT01747629|3645076|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3819536|NCT01747629|3645077|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3819537|NCT01747629|3645078|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3819538|NCT01747629|3645076|B3|65+ years||Age, Customized||participants|Number|4|4.0||||||
3819539|NCT01747629|3645077|B2|65+ years||Age, Customized||participants|Number|3|3.0||||||
3819540|NCT01747629|3645078|B1|65+ years||Age, Customized||participants|Number|1|1.0||||||
3819541|NCT01747629|3645076|B3|18-64 years||Age, Customized||participants|Number|125|125.0||||||
3819542|NCT01747629|3645077|B2|18-64 years||Age, Customized||participants|Number|58|58.0||||||
3819543|NCT01747629|3645078|B1|18-64 years||Age, Customized||participants|Number|67|67.0||||||
3819544|NCT01747629|3645076|B3|12-17 years||Age, Customized||participants|Number|31|31.0||||||
3819545|NCT01747629|3645077|B2|12-17 years||Age, Customized||participants|Number|14|14.0||||||
3819546|NCT01747629|3645078|B1|12-17 years||Age, Customized||participants|Number|17|17.0||||||
3819547|NCT01747629|3645076|B3|||Age||years|Mean|38.2|38.2|Standard Deviation|16.99|16.99|||
3819548|NCT01747629|3645077|B2|||Age||years|Mean|40.0|40.0|Standard Deviation|18.06|18.06|||
3819549|NCT01747629|3645078|B1|||Age||years|Mean|36.7|36.7|Standard Deviation|15.94|15.94|||
3819550|NCT01747551|3645111|B3|United States||Region of Enrollment||Participants|Count of Participants|64|64.0||||||
3819551|NCT01747551|3645112|B2|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3819552|NCT01747551|3645113|B1|United States||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
3819553|NCT01747551|3645111|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3819554|NCT01747551|3645112|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3819555|NCT01747551|3645113|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3819556|NCT01747551|3645111|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819557|NCT01747551|3645112|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819558|NCT01747551|3645113|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819559|NCT01747551|3645111|B3||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3819560|NCT01747551|3645112|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3819561|NCT01747551|3645113|B1||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3819562|NCT01747551|3645111|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3819563|NCT01747551|3645112|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3819564|NCT01747551|3645113|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819565|NCT01747551|3645111|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819566|NCT01747551|3645112|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819567|NCT01747551|3645113|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819568|NCT01747551|3645111|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3819569|NCT01747551|3645112|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3819570|NCT01747551|3645113|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819571|NCT01747551|3645111|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819572|NCT01747551|3645112|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819573|NCT01747551|3645113|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819574|NCT01747551|3645111|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3819575|NCT01747551|3645112|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3819576|NCT01747551|3645113|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3819577|NCT01747551|3645111|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3819578|NCT01747551|3645112|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3819579|NCT01747551|3645113|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3819580|NCT01747551|3645111|B3|||Age||years|Median|62|62.0|Full Range|||21.0|83.0|
3819581|NCT01747551|3645112|B2|||Age||years|Median|62|62.0|Full Range|||40.0|79.0|
3819582|NCT01747551|3645113|B1|||Age||years|Median|62|62.0|Full Range|||32.0|83.0|
3819583|NCT01747343|3645126|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3819584|NCT01747343|3645126|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3819585|NCT01747343|3645126|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3819586|NCT01747343|3645126|B1|||Age||years|Mean|2.02|2.02|Standard Deviation|0.24|0.24|||
3819587|NCT01747343|3645126|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3819588|NCT01747343|3645126|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3819589|NCT01747343|3645126|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3819590|NCT01747330|3645132|B1|Russian Federation||Region of Enrollment||participants|Number|40|40.0||||||
3819591|NCT01747330|3645132|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3819592|NCT01747330|3645132|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3819593|NCT01747330|3645132|B1|||Age||years|Mean|1.7|1.7|Standard Deviation|1.2|1.2|||
3819594|NCT01747330|3645132|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3819595|NCT01747330|3645132|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3819596|NCT01747330|3645132|B1||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
3819597|NCT01746979|3645144|B3||Male|Sex: Female, Male||Participants|Count of Participants|370|370.0||||||
3819598|NCT01746979|3645145|B2||Male|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
3819599|NCT01746979|3645146|B1||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
3819600|NCT01746979|3645144|B3||Female|Sex: Female, Male||Participants|Count of Participants|323|323.0||||||
3819601|NCT01746979|3645145|B2||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3819602|NCT01746979|3645146|B1||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3819603|NCT01746979|3645144|B3|||Age||years|Mean|64.4|64.4|Standard Deviation|9.77|9.77|||
3819604|NCT01746979|3645145|B2|||Age||years|Mean|63.8|63.8|Standard Deviation|9.82|9.82|||
3819605|NCT01746979|3645146|B1|||Age||years|Mean|65|65.0|Standard Deviation|9.70|9.7|||
3819606|NCT01746940|3645155|B5||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3819607|NCT01746940|3645156|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3819608|NCT01746940|3645157|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3819609|NCT01746940|3645158|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3819610|NCT01746940|3645159|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3819611|NCT01746940|3645155|B5||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3819612|NCT01746940|3645156|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3819613|NCT01746940|3645157|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3819614|NCT01746940|3645158|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3819615|NCT01746940|3645159|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3819616|NCT01746940|3645155|B5|||Age||years|Mean|38.96|38.96|Standard Deviation|13.14|13.14|||
3819617|NCT01746940|3645156|B4|||Age||years|Mean|51.67|51.67|Standard Deviation|16.17|16.17|||
3819618|NCT01746940|3645157|B3|||Age||years|Mean|34.58|34.58|Standard Deviation|13.82|13.82|||
3819619|NCT01746940|3645158|B2|||Age||years|Mean|40.98|40.98|Standard Deviation|12.45|12.45|||
3819620|NCT01746940|3645159|B1|||Age||years|Mean|39.26|39.26|Standard Deviation|12.55|12.55|||
3819621|NCT01746901|3645170|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3819622|NCT01746901|3645170|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3819623|NCT01746901|3645170|B1|||Age||years|Mean|38.6|38.6|Standard Deviation|9.1|9.1|||
3819624|NCT01746862|3645499|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3819625|NCT01746862|3645500|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3819626|NCT01746862|3645501|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3819627|NCT01746862|3645499|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3819628|NCT01746862|3645500|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3819629|NCT01746862|3645501|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3819630|NCT01746862|3645499|B3|||Age||years|Mean|6.80|6.8|Standard Deviation|1.55|1.55|||
3819631|NCT01746862|3645500|B2|||Age||years|Mean|6.83|6.83|Standard Deviation|1.61|1.61|||
3819632|NCT01746862|3645501|B1|||Age||years|Mean|6.79|6.79|Standard Deviation|1.54|1.54|||
3819633|NCT01746784|3645522|B6|||Sweat Chloride||mEq/L|Mean|100.8|100.8|Standard Deviation|10.7|10.7|||
3819634|NCT01746784|3645523|B5|||Sweat Chloride||mEq/L|Mean|100.3|100.3|Standard Deviation|8.3|8.3|||
3819635|NCT01746784|3645524|B4|||Sweat Chloride||mEq/L|Mean|93.1|93.1|Standard Deviation|9.2|9.2|||
3819636|NCT01746784|3645525|B3|||Sweat Chloride||mEq/L|Mean|107.3|107.3|Standard Deviation|6.7|6.7|||
3819637|NCT01746784|3645526|B2|||Sweat Chloride||mEq/L|Mean|103.3|103.3|Standard Deviation|6.9|6.9|||
3819638|NCT01746784|3645527|B1|||Sweat Chloride||mEq/L|Mean|100.4|100.4|Standard Deviation|12.9|12.9|||
3819639|NCT01746784|3645522|B6|||FEV1 Percent Predicted|Percent Predicted FEV1 at baseline|percent|Mean|70.1|70.1|Standard Deviation|21.3|21.3|||
3819640|NCT01746784|3645523|B5|||FEV1 Percent Predicted|Percent Predicted FEV1 at baseline|percent|Mean|73.9|73.9|Standard Deviation|21.9|21.9|||
3819641|NCT01746784|3645524|B4|||FEV1 Percent Predicted|Percent Predicted FEV1 at baseline|percent|Mean|63.2|63.2|Standard Deviation|21.1|21.1|||
3819642|NCT01746784|3645525|B3|||FEV1 Percent Predicted|Percent Predicted FEV1 at baseline|percent|Mean|63.3|63.3|Standard Deviation|17.5|17.5|||
3819643|NCT01746784|3645526|B2|||FEV1 Percent Predicted|Percent Predicted FEV1 at baseline|percent|Mean|70.7|70.7|Standard Deviation|19.5|19.5|||
3819644|NCT01746784|3645527|B1|||FEV1 Percent Predicted|Percent Predicted FEV1 at baseline|percent|Mean|72.5|72.5|Standard Deviation|23.7|23.7|||
3819645|NCT01746784|3645522|B6|||FEV1 (L)|Liter of air|L|Mean|2.5|2.5|Standard Deviation|0.97|0.97|||
3819646|NCT01746784|3645523|B5|||FEV1 (L)|Liter of air|L|Mean|2.8|2.8|Standard Deviation|1.12|1.12|||
3819647|NCT01746784|3645524|B4|||FEV1 (L)|Liter of air|L|Mean|2.1|2.1|Standard Deviation|0.66|0.66|||
3819648|NCT01746784|3645525|B3|||FEV1 (L)|Liter of air|L|Mean|2.2|2.2|Standard Deviation|0.91|0.91|||
3819649|NCT01746784|3645526|B2|||FEV1 (L)|Liter of air|L|Mean|2.6|2.6|Standard Deviation|0.88|0.88|||
3819650|NCT01746784|3645527|B1|||FEV1 (L)|Liter of air|L|Mean|2.7|2.7|Standard Deviation|0.85|0.85|||
3819651|NCT01746784|3645522|B6|||Weight|kilograms|kg|Mean|61.0|61.0|Standard Deviation|11.96|11.96|||
3819652|NCT01746784|3645523|B5|||Weight|kilograms|kg|Mean|63.8|63.8|Standard Deviation|12.53|12.53|||
3819653|NCT01746784|3645524|B4|||Weight|kilograms|kg|Mean|56.3|56.3|Standard Deviation|13.59|13.59|||
3819654|NCT01746784|3645525|B3|||Weight|kilograms|kg|Mean|59.1|59.1|Standard Deviation|9.06|9.06|||
3819655|NCT01746784|3645526|B2|||Weight|kilograms|kg|Mean|61.8|61.8|Standard Deviation|11.73|11.73|||
3819656|NCT01746784|3645527|B1|||Weight|kilograms|kg|Mean|62.9|62.9|Standard Deviation|11.50|11.5|||
3819657|NCT01746784|3645522|B6|||Body Mass Index (BMI)|kilograms per meter square|kg/^m2|Mean|21.9|21.9|Standard Deviation|3.25|3.25|||
3819658|NCT01746784|3645523|B5|||Body Mass Index (BMI)|kilograms per meter square|kg/^m2|Mean|22.5|22.5|Standard Deviation|2.62|2.62|||
3819659|NCT01746784|3645524|B4|||Body Mass Index (BMI)|kilograms per meter square|kg/^m2|Mean|21.0|21.0|Standard Deviation|3.80|3.8|||
3819660|NCT01746784|3645525|B3|||Body Mass Index (BMI)|kilograms per meter square|kg/^m2|Mean|21.7|21.7|Standard Deviation|2.27|2.27|||
3819661|NCT01746784|3645526|B2|||Body Mass Index (BMI)|kilograms per meter square|kg/^m2|Mean|21.7|21.7|Standard Deviation|4.59|4.59|||
3819662|NCT01746784|3645527|B1|||Body Mass Index (BMI)|kilograms per meter square|kg/^m2|Mean|21.4|21.4|Standard Deviation|3.25|3.25|||
3819663|NCT01746784|3645522|B6|United States||Region of Enrollment||participants|Number|66|66.0||||||
3819664|NCT01746784|3645523|B5|United States||Region of Enrollment||participants|Number|19|19.0||||||
3819665|NCT01746784|3645524|B4|United States||Region of Enrollment||participants|Number|9|9.0||||||
3819666|NCT01746784|3645525|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
3819667|NCT01746784|3645526|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3819668|NCT01746784|3645527|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3819669|NCT01746784|3645522|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819670|NCT01746784|3645523|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819671|NCT01746784|3645524|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819672|NCT01746784|3645525|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819673|NCT01746784|3645526|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819674|NCT01746784|3645527|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819675|NCT01746784|3645522|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819676|NCT01746784|3645523|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819677|NCT01746784|3645524|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819678|NCT01746784|3645525|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819679|NCT01746784|3645526|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819680|NCT01746784|3645527|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819681|NCT01746784|3645522|B6||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3819682|NCT01746784|3645523|B5||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3819683|NCT01746784|3645524|B4||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3819684|NCT01746784|3645525|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3819685|NCT01746784|3645526|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3819686|NCT01746784|3645527|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3819687|NCT01746784|3645522|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819688|NCT01746784|3645523|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819689|NCT01746784|3645524|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819690|NCT01746784|3645525|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819691|NCT01746784|3645526|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819692|NCT01746784|3645527|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819693|NCT01746784|3645522|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819694|NCT01746784|3645523|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819695|NCT01746784|3645524|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819696|NCT01746784|3645525|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819697|NCT01746784|3645526|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819698|NCT01746784|3645527|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819699|NCT01746784|3645522|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819700|NCT01746784|3645523|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819701|NCT01746784|3645524|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819702|NCT01746784|3645525|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819703|NCT01746784|3645526|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819704|NCT01746784|3645527|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819705|NCT01746784|3645522|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819706|NCT01746784|3645523|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819707|NCT01746784|3645524|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819708|NCT01746784|3645525|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819709|NCT01746784|3645526|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819710|NCT01746784|3645527|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819711|NCT01746784|3645522|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819712|NCT01746784|3645523|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819713|NCT01746784|3645524|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819714|NCT01746784|3645525|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819715|NCT01746784|3645526|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819716|NCT01746784|3645527|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819717|NCT01746784|3645522|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3819718|NCT01746784|3645523|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3819719|NCT01746784|3645524|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3819720|NCT01746784|3645525|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3819721|NCT01746784|3645526|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3819722|NCT01746784|3645527|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3819723|NCT01746784|3645522|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819724|NCT01746784|3645523|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819725|NCT01746784|3645524|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819726|NCT01746784|3645525|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819727|NCT01746784|3645526|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819728|NCT01746784|3645527|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819729|NCT01746784|3645522|B6||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3819730|NCT01746784|3645523|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3819731|NCT01746784|3645524|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3819732|NCT01746784|3645525|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3819733|NCT01746784|3645526|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3819734|NCT01746784|3645527|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3819735|NCT01746784|3645522|B6||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3819736|NCT01746784|3645523|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3819737|NCT01746784|3645524|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3819738|NCT01746784|3645525|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3819739|NCT01746784|3645526|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3819740|NCT01746784|3645527|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3819741|NCT01746784|3645522|B6|||Age||years|Mean|28.9|28.9|Standard Deviation|7.93|7.93|||
3819742|NCT01746784|3645523|B5|||Age||years|Mean|28.4|28.4|Standard Deviation|8.46|8.46|||
3819743|NCT01746784|3645524|B4|||Age||years|Mean|28.6|28.6|Standard Deviation|10.3|10.3|||
3819744|NCT01746784|3645525|B3|||Age||years|Mean|32.3|32.3|Standard Deviation|7.84|7.84|||
3819745|NCT01746784|3645526|B2|||Age||years|Mean|26.9|26.9|Standard Deviation|6.33|6.33|||
3819746|NCT01746784|3645527|B1|||Age||years|Mean|29.0|29.0|Standard Deviation|7.27|7.27|||
3819747|NCT01746732|3645553|B1|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3819748|NCT01746732|3645553|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819749|NCT01746732|3645553|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3819750|NCT01746732|3645553|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3819751|NCT01746732|3645553|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3819752|NCT01746732|3645553|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819753|NCT01746732|3645553|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3819754|NCT01746732|3645553|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819755|NCT01746732|3645553|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819756|NCT01746732|3645553|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3819757|NCT01746732|3645553|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3819758|NCT01746732|3645553|B1|Females||Sex/Gender, Customized||Participants|Number|22|22.0||||||
3819759|NCT01746732|3645553|B1|||Age||years|Mean|33.0|33.0|Standard Deviation|6.8|6.8|||
3819760|NCT01746511|3645576|B3|PO-both formula and breastmilk||Feeding stratum|"NPO is infants receiving ≤ 20 mL/kg/day of fluids enterally at the time of therapy PO is infants being enterally fed > 20 mL/kg/day of total fluids at the time of therapy.~All participants that started the study were included in this baseline measure description."|participants|Number|18|18.0||||||
3819761|NCT01746511|3645577|B2|PO-both formula and breastmilk||Feeding stratum|"NPO is infants receiving ≤ 20 mL/kg/day of fluids enterally at the time of therapy PO is infants being enterally fed > 20 mL/kg/day of total fluids at the time of therapy.~All participants that started the study were included in this baseline measure description."|participants|Number|10|10.0||||||
3819762|NCT01746511|3645578|B1|PO-both formula and breastmilk||Feeding stratum|"NPO is infants receiving ≤ 20 mL/kg/day of fluids enterally at the time of therapy PO is infants being enterally fed > 20 mL/kg/day of total fluids at the time of therapy.~All participants that started the study were included in this baseline measure description."|participants|Number|8|8.0||||||
3819763|NCT01746511|3645576|B3|PO -breastmilk||Feeding stratum|"NPO is infants receiving ≤ 20 mL/kg/day of fluids enterally at the time of therapy PO is infants being enterally fed > 20 mL/kg/day of total fluids at the time of therapy.~All participants that started the study were included in this baseline measure description."|participants|Number|13|13.0||||||
3819764|NCT01746511|3645577|B2|PO -breastmilk||Feeding stratum|"NPO is infants receiving ≤ 20 mL/kg/day of fluids enterally at the time of therapy PO is infants being enterally fed > 20 mL/kg/day of total fluids at the time of therapy.~All participants that started the study were included in this baseline measure description."|participants|Number|6|6.0||||||
3819765|NCT01746511|3645578|B1|PO -breastmilk||Feeding stratum|"NPO is infants receiving ≤ 20 mL/kg/day of fluids enterally at the time of therapy PO is infants being enterally fed > 20 mL/kg/day of total fluids at the time of therapy.~All participants that started the study were included in this baseline measure description."|participants|Number|7|7.0||||||
3819766|NCT01746511|3645576|B3|PO-formula||Feeding stratum|"NPO is infants receiving ≤ 20 mL/kg/day of fluids enterally at the time of therapy PO is infants being enterally fed > 20 mL/kg/day of total fluids at the time of therapy.~All participants that started the study were included in this baseline measure description."|participants|Number|14|14.0||||||
3819767|NCT01746511|3645577|B2|PO-formula||Feeding stratum|"NPO is infants receiving ≤ 20 mL/kg/day of fluids enterally at the time of therapy PO is infants being enterally fed > 20 mL/kg/day of total fluids at the time of therapy.~All participants that started the study were included in this baseline measure description."|participants|Number|7|7.0||||||
3819768|NCT01746511|3645578|B1|PO-formula||Feeding stratum|"NPO is infants receiving ≤ 20 mL/kg/day of fluids enterally at the time of therapy PO is infants being enterally fed > 20 mL/kg/day of total fluids at the time of therapy.~All participants that started the study were included in this baseline measure description."|participants|Number|7|7.0||||||
3819769|NCT01746511|3645576|B3|NPO||Feeding stratum|"NPO is infants receiving ≤ 20 mL/kg/day of fluids enterally at the time of therapy PO is infants being enterally fed > 20 mL/kg/day of total fluids at the time of therapy.~All participants that started the study were included in this baseline measure description."|participants|Number|34|34.0||||||
3819770|NCT01746511|3645577|B2|NPO||Feeding stratum|"NPO is infants receiving ≤ 20 mL/kg/day of fluids enterally at the time of therapy PO is infants being enterally fed > 20 mL/kg/day of total fluids at the time of therapy.~All participants that started the study were included in this baseline measure description."|participants|Number|16|16.0||||||
3819771|NCT01746511|3645578|B1|NPO||Feeding stratum|"NPO is infants receiving ≤ 20 mL/kg/day of fluids enterally at the time of therapy PO is infants being enterally fed > 20 mL/kg/day of total fluids at the time of therapy.~All participants that started the study were included in this baseline measure description."|participants|Number|18|18.0||||||
3819772|NCT01746511|3645576|B3|||Gestation age|All participants that started the study were included in this baseline measure description.|weeks|Mean|33.1|33.1|Standard Deviation|1.3|1.3|||
3819773|NCT01746511|3645577|B2|||Gestation age|All participants that started the study were included in this baseline measure description.|weeks|Mean|33.0|33.0|Standard Deviation|1.1|1.1|||
3819774|NCT01746511|3645578|B1|||Gestation age|All participants that started the study were included in this baseline measure description.|weeks|Mean|33.2|33.2|Standard Deviation|1.4|1.4|||
3819775|NCT01746511|3645576|B3|||First observed total bilirubin|All participants that started the study were included in this baseline measure description.|mg/dL|Mean|8.2|8.2|Standard Deviation|3.1|3.1|||
3819776|NCT01746511|3645577|B2|||First observed total bilirubin|All participants that started the study were included in this baseline measure description.|mg/dL|Mean|8.3|8.3|Standard Deviation|3.3|3.3|||
3819777|NCT01746511|3645578|B1|||First observed total bilirubin|All participants that started the study were included in this baseline measure description.|mg/dL|Mean|8.1|8.1|Standard Deviation|3.0|3.0|||
3819778|NCT01746511|3645576|B3|||Birth Weight|All participants that started the study were included in this baseline measure description.|grams|Mean|1862|1862.0|Standard Deviation|415|415.0|||
3819779|NCT01746511|3645577|B2|||Birth Weight|All participants that started the study were included in this baseline measure description.|grams|Mean|1933|1933.0|Standard Deviation|315|315.0|||
3819780|NCT01746511|3645578|B1|||Birth Weight|All participants that started the study were included in this baseline measure description.|grams|Mean|1792|1792.0|Standard Deviation|513|513.0|||
3819781|NCT01746511|3645576|B3|United States||Region of Enrollment||participants|Number|77|77.0||||||
3819782|NCT01746511|3645577|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
3819783|NCT01746511|3645578|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
3819784|NCT01746511|3645576|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3819785|NCT01746511|3645577|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3819786|NCT01746511|3645578|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3819787|NCT01746511|3645576|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819788|NCT01746511|3645577|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819789|NCT01746511|3645578|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819790|NCT01746511|3645576|B3||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3819791|NCT01746511|3645577|B2||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3819792|NCT01746511|3645578|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3819793|NCT01746511|3645576|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3819794|NCT01746511|3645577|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3819795|NCT01746511|3645578|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3819796|NCT01746511|3645576|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819797|NCT01746511|3645577|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819798|NCT01746511|3645578|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819799|NCT01746511|3645576|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819800|NCT01746511|3645577|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819801|NCT01746511|3645578|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819802|NCT01746511|3645576|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819803|NCT01746511|3645577|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819804|NCT01746511|3645578|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819805|NCT01746511|3645576|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3819806|NCT01746511|3645577|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3819807|NCT01746511|3645578|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3819808|NCT01746511|3645576|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3819809|NCT01746511|3645577|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3819810|NCT01746511|3645578|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3819811|NCT01746511|3645576|B3|||Age||hours|Mean|67.4|67.4|Standard Deviation|22.1|22.1|||
3819812|NCT01746511|3645577|B2|||Age||hours|Mean|72.7|72.7|Standard Deviation|25.2|25.2|||
3819813|NCT01746511|3645578|B1|||Age||hours|Mean|62.2|62.2|Standard Deviation|19.1|19.1|||
3819814|NCT01746368|3645593|B3|No||Desire for Risks, Benefits, and Alternatives Information About Life-sustaining Procedures||Participants|Number|11|11.0||||||
3819815|NCT01746368|3645594|B2|No||Desire for Risks, Benefits, and Alternatives Information About Life-sustaining Procedures||Participants|Number|7|7.0||||||
3819816|NCT01746368|3645595|B1|No||Desire for Risks, Benefits, and Alternatives Information About Life-sustaining Procedures||Participants|Number|4|4.0||||||
3819817|NCT01746368|3645593|B3|Yes||Desire for Risks, Benefits, and Alternatives Information About Life-sustaining Procedures||Participants|Number|39|39.0||||||
3819818|NCT01746368|3645594|B2|Yes||Desire for Risks, Benefits, and Alternatives Information About Life-sustaining Procedures||Participants|Number|10|10.0||||||
3819819|NCT01746368|3645595|B1|Yes||Desire for Risks, Benefits, and Alternatives Information About Life-sustaining Procedures||Participants|Number|29|29.0||||||
3819820|NCT01746368|3645593|B3|No answer||Desire for Help Completing an Advance Directive||Participants|Number|1|1.0||||||
3819821|NCT01746368|3645594|B2|No answer||Desire for Help Completing an Advance Directive||Participants|Number|0|0.0||||||
3819822|NCT01746368|3645595|B1|No answer||Desire for Help Completing an Advance Directive||Participants|Number|1|1.0||||||
3819823|NCT01746368|3645593|B3|No||Desire for Help Completing an Advance Directive||Participants|Number|8|8.0||||||
3819824|NCT01746368|3645594|B2|No||Desire for Help Completing an Advance Directive||Participants|Number|5|5.0||||||
3819825|NCT01746368|3645595|B1|No||Desire for Help Completing an Advance Directive||Participants|Number|3|3.0||||||
3819826|NCT01746368|3645593|B3|Yes||Desire for Help Completing an Advance Directive||Participants|Number|41|41.0||||||
3819827|NCT01746368|3645594|B2|Yes||Desire for Help Completing an Advance Directive||Participants|Number|12|12.0||||||
3819828|NCT01746368|3645595|B1|Yes||Desire for Help Completing an Advance Directive||Participants|Number|29|29.0||||||
3819829|NCT01746368|3645593|B3|No||Desire for Information About Advance Directives||Participants|Number|7|7.0||||||
3819830|NCT01746368|3645594|B2|No||Desire for Information About Advance Directives||Participants|Number|3|3.0||||||
3819831|NCT01746368|3645595|B1|No||Desire for Information About Advance Directives||Participants|Number|4|4.0||||||
3819832|NCT01746368|3645593|B3|Yes||Desire for Information About Advance Directives||Participants|Number|43|43.0||||||
3819833|NCT01746368|3645594|B2|Yes||Desire for Information About Advance Directives||Participants|Number|14|14.0||||||
3819834|NCT01746368|3645595|B1|Yes||Desire for Information About Advance Directives||Participants|Number|29|29.0||||||
3819835|NCT01746368|3645593|B3|Non-rural zip code||Rurality||Participants|Number|30|30.0||||||
3819836|NCT01746368|3645594|B2|Non-rural zip code||Rurality||Participants|Number|11|11.0||||||
3819837|NCT01746368|3645595|B1|Non-rural zip code||Rurality||Participants|Number|19|19.0||||||
3819838|NCT01746368|3645593|B3|Rural zip code||Rurality||Participants|Number|20|20.0||||||
3819839|NCT01746368|3645594|B2|Rural zip code||Rurality||Participants|Number|6|6.0||||||
3819840|NCT01746368|3645595|B1|Rural zip code||Rurality||Participants|Number|14|14.0||||||
3819841|NCT01746368|3645593|B3|Unknown/Not Reported||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3819842|NCT01746368|3645594|B2|Unknown/Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3819843|NCT01746368|3645595|B1|Unknown/Not Reported||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3819844|NCT01746368|3645593|B3|Other Non-Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3819845|NCT01746368|3645594|B2|Other Non-Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3819846|NCT01746368|3645595|B1|Other Non-Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3819847|NCT01746368|3645593|B3|2 or more races Non-Hispanic||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3819848|NCT01746368|3645594|B2|2 or more races Non-Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3819849|NCT01746368|3645595|B1|2 or more races Non-Hispanic||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3819850|NCT01746368|3645593|B3|Black Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3819851|NCT01746368|3645594|B2|Black Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3819852|NCT01746368|3645595|B1|Black Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3819853|NCT01746368|3645593|B3|Black Non-Hispanic||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
3819854|NCT01746368|3645594|B2|Black Non-Hispanic||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3819855|NCT01746368|3645595|B1|Black Non-Hispanic||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
3819856|NCT01746368|3645593|B3|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
3819857|NCT01746368|3645594|B2|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3819858|NCT01746368|3645595|B1|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3819859|NCT01746368|3645593|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3819860|NCT01746368|3645594|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3819861|NCT01746368|3645595|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3819862|NCT01746368|3645593|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3819863|NCT01746368|3645594|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3819864|NCT01746368|3645595|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3819865|NCT01746368|3645593|B3|||Age||Years|Mean|50.26|50.26|Standard Deviation|12.68|12.68|||
3819866|NCT01746368|3645594|B2|||Age||Years|Mean|48.35|48.35|Standard Deviation|14.95|14.95|||
3819867|NCT01746368|3645595|B1|||Age||Years|Mean|51.24|51.24|Standard Deviation|11.48|11.48|||
3819868|NCT01746368|3645593|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3819869|NCT01746368|3645594|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3819870|NCT01746368|3645595|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3819871|NCT01746368|3645593|B3||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3819872|NCT01746368|3645594|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3819873|NCT01746368|3645595|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3819874|NCT01746368|3645593|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3819875|NCT01746368|3645594|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3819876|NCT01746368|3645595|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3819877|NCT01746264|3645604|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3819878|NCT01746264|3645604|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3819879|NCT01746264|3645604|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3819880|NCT01746264|3645604|B1|||Age||years|Mean|15.8|15.8|Standard Deviation|1.7|1.7|||
3819881|NCT01746173|3645623|B1|Stage IV||Stage|Stage per Ann Arbor Classification|Participants|Count of Participants|2|2.0||||||
3819882|NCT01746173|3645623|B1|Stage III||Stage|Stage per Ann Arbor Classification|Participants|Count of Participants|2|2.0||||||
3820173|NCT01745133|3645798|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819883|NCT01746173|3645623|B1|Stage II||Stage|Stage per Ann Arbor Classification|Participants|Count of Participants|0|0.0||||||
3819884|NCT01746173|3645623|B1|Stage I||Stage|Stage per Ann Arbor Classification|Participants|Count of Participants|1|1.0||||||
3819885|NCT01746173|3645623|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3819886|NCT01746173|3645623|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
3819887|NCT01746173|3645623|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
3819888|NCT01746173|3645623|B1|||Age||years|Mean|55|55.0|Full Range|||39.0|69.0|
3819889|NCT01746108|3645628|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3819890|NCT01746108|3645629|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3819891|NCT01746108|3645630|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3819892|NCT01746108|3645631|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3819893|NCT01746108|3645628|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3819894|NCT01746108|3645629|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3819895|NCT01746108|3645630|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3819896|NCT01746108|3645631|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3819897|NCT01746108|3645628|B4|||Age||Years|Mean|8.87|8.87|Standard Deviation|4.55|4.55|||
3819898|NCT01746108|3645629|B3|||Age||Years|Mean|2.8|2.8|Standard Deviation|0.8|0.8|||
3819899|NCT01746108|3645630|B2|||Age||Years|Mean|8.6|8.6|Standard Deviation|4.2|4.2|||
3819900|NCT01746108|3645631|B1|||Age||Years|Mean|11.3|11.3|Standard Deviation|3.8|3.8|||
3819901|NCT01746043|3645669|B5|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3819902|NCT01746043|3645670|B4|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3819903|NCT01746043|3645671|B3|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3819904|NCT01746043|3645672|B2|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3819905|NCT01746043|3645673|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3819906|NCT01746043|3645669|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819907|NCT01746043|3645670|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819908|NCT01746043|3645671|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819909|NCT01746043|3645672|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819910|NCT01746043|3645673|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819911|NCT01746043|3645669|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3819912|NCT01746043|3645670|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3819913|NCT01746043|3645671|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3819914|NCT01746043|3645672|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3819915|NCT01746043|3645673|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3819916|NCT01746043|3645669|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819917|NCT01746043|3645670|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819918|NCT01746043|3645671|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819919|NCT01746043|3645672|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819920|NCT01746043|3645673|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819921|NCT01746043|3645669|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3819922|NCT01746043|3645670|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3819923|NCT01746043|3645671|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3819924|NCT01746043|3645672|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3819925|NCT01746043|3645673|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3819926|NCT01746043|3645669|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3819927|NCT01746043|3645670|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3819928|NCT01746043|3645671|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3819929|NCT01746043|3645672|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3819930|NCT01746043|3645673|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3819931|NCT01746043|3645669|B5|||Age||years|Mean|61.4|61.4|Standard Deviation|5.1|5.1|||
3819932|NCT01746043|3645670|B4|||Age||years|Mean|56.2|56.2|Standard Deviation|4.9|4.9|||
3819933|NCT01746043|3645671|B3|||Age||years|Mean|61.6|61.6|Standard Deviation|10.2|10.2|||
3819934|NCT01746043|3645672|B2|||Age||years|Mean|64.5|64.5|Standard Deviation|0.6|0.6|||
3819935|NCT01746043|3645673|B1|||Age||years|Mean|63.4|63.4|Standard Deviation|4.6|4.6|||
3819936|NCT01746043|3645669|B5||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3819937|NCT01746043|3645670|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3819938|NCT01746043|3645671|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3819939|NCT01746043|3645672|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3819940|NCT01746043|3645673|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3819941|NCT01746043|3645669|B5||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3819942|NCT01746043|3645670|B4||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3819943|NCT01746043|3645671|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3819944|NCT01746043|3645672|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3819945|NCT01746043|3645673|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3819946|NCT01746043|3645669|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3819947|NCT01746043|3645670|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3819948|NCT01746043|3645671|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3819949|NCT01746043|3645672|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3819950|NCT01746043|3645673|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3819951|NCT01745952|3645686|B1|||baseline seizure frequency per week||seizures/week|Mean|24.9|24.9|Full Range|||0.5|124.6|
3819952|NCT01745952|3645686|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3819953|NCT01745952|3645686|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3819954|NCT01745952|3645686|B1|||Age||years|Mean|35|35.0|Full Range|||24.0|61.0|
3819955|NCT01745952|3645686|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3819956|NCT01745952|3645686|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3819957|NCT01745952|3645686|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3819958|NCT01745913|3645712|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3819959|NCT01745913|3645713|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3819960|NCT01745913|3645714|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3819961|NCT01745913|3645712|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3819962|NCT01745913|3645713|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3819963|NCT01745913|3645714|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3819964|NCT01745913|3645712|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3819965|NCT01745913|3645713|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3819966|NCT01745913|3645714|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3819967|NCT01745913|3645712|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3819968|NCT01745913|3645713|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3819969|NCT01745913|3645714|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3819970|NCT01745913|3645712|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3819971|NCT01745913|3645713|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3819972|NCT01745913|3645714|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3819973|NCT01745913|3645712|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3819974|NCT01745913|3645713|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3819975|NCT01745913|3645714|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3819976|NCT01745848|3645731|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
3819977|NCT01745848|3645731|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819978|NCT01745848|3645731|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819979|NCT01745848|3645731|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3819980|NCT01745848|3645731|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3819981|NCT01745848|3645731|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819982|NCT01745848|3645731|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819983|NCT01745848|3645731|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3819984|NCT01745848|3645731|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3819985|NCT01745848|3645731|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3819986|NCT01745848|3645731|B1|||Age||years|Mean|65.3|65.3|Full Range|||55.0|74.0|
3819987|NCT01745393|3645736|B3|||child (log) cotinine||log transformed ng/mL|Mean|1.21|1.21|Standard Deviation|0.52|0.52|||
3819988|NCT01745393|3645737|B2|||child (log) cotinine||log transformed ng/mL|Mean|1.24|1.24|Standard Deviation|0.50|0.5|||
3819989|NCT01745393|3645738|B1|||child (log) cotinine||log transformed ng/mL|Mean|1.17|1.17|Standard Deviation|0.53|0.53|||
3819990|NCT01745393|3645736|B3|||parents' cigarettes per day smoked||cigarettes smoked per day|Mean|11.45|11.45|Standard Deviation|7.56|7.56|||
3819991|NCT01745393|3645737|B2|||parents' cigarettes per day smoked||cigarettes smoked per day|Mean|10.72|10.72|Standard Deviation|5.84|5.84|||
3819992|NCT01745393|3645738|B1|||parents' cigarettes per day smoked||cigarettes smoked per day|Mean|12.18|12.18|Standard Deviation|8.92|8.92|||
3819993|NCT01745393|3645736|B3|||child age|measured in months|months|Mean|64.29|64.29|Standard Deviation|32.70|32.7|||
3819994|NCT01745393|3645737|B2|||child age|measured in months|months|Mean|64.04|64.04|Standard Deviation|33.87|33.87|||
3819995|NCT01745393|3645738|B1|||child age|measured in months|months|Mean|64.53|64.53|Standard Deviation|31.59|31.59|||
3819996|NCT01745393|3645736|B3|||income below poverty level||Participants|Count of Participants|257|257.0||||||
3819997|NCT01745393|3645737|B2|||income below poverty level||Participants|Count of Participants|129|129.0||||||
3819998|NCT01745393|3645738|B1|||income below poverty level||Participants|Count of Participants|128|128.0||||||
3819999|NCT01745393|3645736|B3|||less than high school education||Participants|Count of Participants|89|89.0||||||
3820000|NCT01745393|3645737|B2|||less than high school education||Participants|Count of Participants|46|46.0||||||
3820001|NCT01745393|3645738|B1|||less than high school education||Participants|Count of Participants|43|43.0||||||
3820002|NCT01745393|3645736|B3|||married, living with partner||Participants|Count of Participants|134|134.0||||||
3820003|NCT01745393|3645737|B2|||married, living with partner||Participants|Count of Participants|63|63.0||||||
3820004|NCT01745393|3645738|B1|||married, living with partner||Participants|Count of Participants|71|71.0||||||
3820005|NCT01745393|3645736|B3|United States||Region of Enrollment||participants|Number|327|327.0||||||
3820006|NCT01745393|3645737|B2|United States||Region of Enrollment||participants|Number|164|164.0||||||
3820007|NCT01745393|3645738|B1|United States||Region of Enrollment||participants|Number|163|163.0||||||
3820008|NCT01745393|3645736|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3820009|NCT01745393|3645737|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3820010|NCT01745393|3645738|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3820011|NCT01745393|3645736|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3820012|NCT01745393|3645737|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3820013|NCT01745393|3645738|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3820014|NCT01745393|3645736|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3820015|NCT01745393|3645737|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3820016|NCT01745393|3645738|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3820017|NCT01745393|3645736|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|272|272.0||||||
3820018|NCT01745393|3645737|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
3820019|NCT01745393|3645738|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
3820020|NCT01745393|3645736|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820021|NCT01745393|3645737|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820022|NCT01745393|3645738|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820023|NCT01745393|3645736|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820024|NCT01745393|3645737|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820025|NCT01745393|3645738|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820026|NCT01745393|3645736|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3820027|NCT01745393|3645737|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3820028|NCT01745393|3645738|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3820029|NCT01745393|3645736|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3820030|NCT01745393|3645737|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3820031|NCT01745393|3645738|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3820032|NCT01745393|3645736|B3||Female|Sex: Female, Male||Participants|Count of Participants|273|273.0||||||
3820033|NCT01745393|3645737|B2||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3820034|NCT01745393|3645738|B1||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3820035|NCT01745393|3645736|B3|||Age||years|Mean|33.31|33.31|Standard Deviation|8.60|8.6|||
3820036|NCT01745393|3645737|B2|||Age||years|Mean|33.88|33.88|Standard Deviation|9.20|9.2|||
3820037|NCT01745393|3645738|B1|||Age||years|Mean|32.74|32.74|Standard Deviation|7.94|7.94|||
3820038|NCT01745380|3645749|B3|United States||Region of Enrollment||participants|Number|150|150.0||||||
3820039|NCT01745380|3645750|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
3820040|NCT01745380|3645751|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
3820041|NCT01745380|3645749|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3820042|NCT01745380|3645750|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3820043|NCT01745380|3645751|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3820044|NCT01745380|3645749|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820045|NCT01745380|3645750|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820046|NCT01745380|3645751|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820047|NCT01745380|3645749|B3||White|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3820048|NCT01745380|3645750|B2||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3820049|NCT01745380|3645751|B1||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3820050|NCT01745380|3645749|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3820051|NCT01745380|3645750|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3820052|NCT01745380|3645751|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3820053|NCT01745380|3645749|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3820054|NCT01745380|3645750|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3820055|NCT01745380|3645751|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3820056|NCT01745380|3645749|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820057|NCT01745380|3645750|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820058|NCT01745380|3645751|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820059|NCT01745380|3645749|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820060|NCT01745380|3645750|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820061|NCT01745380|3645751|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820062|NCT01745380|3645749|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820063|NCT01745380|3645750|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820064|NCT01745380|3645751|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820065|NCT01745380|3645749|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
3820066|NCT01745380|3645750|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3820067|NCT01745380|3645751|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3820068|NCT01745380|3645749|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3820069|NCT01745380|3645750|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3820070|NCT01745380|3645751|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3820071|NCT01745380|3645749|B3||Male|Gender||Participants|Count of Participants|68|68.0||||||
3820072|NCT01745380|3645750|B2||Male|Gender||Participants|Count of Participants|25|25.0||||||
3820073|NCT01745380|3645751|B1||Male|Gender||Participants|Count of Participants|43|43.0||||||
3820074|NCT01745380|3645749|B3||Female|Gender||Participants|Count of Participants|82|82.0||||||
3820075|NCT01745380|3645750|B2||Female|Gender||Participants|Count of Participants|25|25.0||||||
3820076|NCT01745380|3645751|B1||Female|Gender||Participants|Count of Participants|57|57.0||||||
3820077|NCT01745380|3645749|B3|||Age||years|Mean|41.2|41.2|Standard Deviation|14.37|14.37|||
3820078|NCT01745380|3645750|B2|||Age||years|Mean|40.3|40.3|Standard Deviation|15.23|15.23|||
3820079|NCT01745380|3645751|B1|||Age||years|Mean|41.6|41.6|Standard Deviation|13.98|13.98|||
3820080|NCT01745146|3645788|B3|||Median Time Post Injury|Number of months between date of injury and start of participation|Months|Median|71|71.0|Full Range|||6.0|339.0|
3820081|NCT01745146|3645789|B2|||Median Time Post Injury|Number of months between date of injury and start of participation|Months|Median|69|69.0|Full Range|||6.0|298.0|
3820082|NCT01745146|3645790|B1|||Median Time Post Injury|Number of months between date of injury and start of participation|Months|Median|72|72.0|Full Range|||6.0|339.0|
3820083|NCT01745146|3645788|B3|FrSBe Self-Report||Neuropsychological Status|Intelligence Quotient (IQ) from Wechsler Abbreviated Scale of Intelligence (WASI)Vocabulary and Matrix Reasoning subtests; Range 55-157 (157=best) Rey Auditory Verbal Learning Test (RAVLT) Total; Range 0-75 (75=best) Trail Making Test Part B T-score; Range 7-88 (88=best) Brixton Spatial Anticipation Test error score; Range 0-55 (0=best) Glasgow Outcome Scale-Extended (GOS-E); Range 1-8 (8=best) Global Severity Index (GSI) from the Brief Symptom Inventory (BSI); Range 30-81 (30=best) Frontal Systems Behavior Scale (FrSBe) T-score; Range 9-176 (9=best)|units on a scale|Mean|63.08|63.08|Standard Deviation|16.2|16.2|||
3820084|NCT01745146|3645789|B2|FrSBe Self-Report||Neuropsychological Status|Intelligence Quotient (IQ) from Wechsler Abbreviated Scale of Intelligence (WASI)Vocabulary and Matrix Reasoning subtests; Range 55-157 (157=best) Rey Auditory Verbal Learning Test (RAVLT) Total; Range 0-75 (75=best) Trail Making Test Part B T-score; Range 7-88 (88=best) Brixton Spatial Anticipation Test error score; Range 0-55 (0=best) Glasgow Outcome Scale-Extended (GOS-E); Range 1-8 (8=best) Global Severity Index (GSI) from the Brief Symptom Inventory (BSI); Range 30-81 (30=best) Frontal Systems Behavior Scale (FrSBe) T-score; Range 9-176 (9=best)|units on a scale|Mean|62.4|62.4|Standard Deviation|15.7|15.7|||
3820085|NCT01745146|3645790|B1|FrSBe Self-Report||Neuropsychological Status|Intelligence Quotient (IQ) from Wechsler Abbreviated Scale of Intelligence (WASI)Vocabulary and Matrix Reasoning subtests; Range 55-157 (157=best) Rey Auditory Verbal Learning Test (RAVLT) Total; Range 0-75 (75=best) Trail Making Test Part B T-score; Range 7-88 (88=best) Brixton Spatial Anticipation Test error score; Range 0-55 (0=best) Glasgow Outcome Scale-Extended (GOS-E); Range 1-8 (8=best) Global Severity Index (GSI) from the Brief Symptom Inventory (BSI); Range 30-81 (30=best) Frontal Systems Behavior Scale (FrSBe) T-score; Range 9-176 (9=best)|units on a scale|Mean|64.4|64.4|Standard Deviation|17.4|17.4|||
3820086|NCT01745146|3645788|B3|BSI GSI||Neuropsychological Status|Intelligence Quotient (IQ) from Wechsler Abbreviated Scale of Intelligence (WASI)Vocabulary and Matrix Reasoning subtests; Range 55-157 (157=best) Rey Auditory Verbal Learning Test (RAVLT) Total; Range 0-75 (75=best) Trail Making Test Part B T-score; Range 7-88 (88=best) Brixton Spatial Anticipation Test error score; Range 0-55 (0=best) Glasgow Outcome Scale-Extended (GOS-E); Range 1-8 (8=best) Global Severity Index (GSI) from the Brief Symptom Inventory (BSI); Range 30-81 (30=best) Frontal Systems Behavior Scale (FrSBe) T-score; Range 9-176 (9=best)|units on a scale|Mean|68.2|68.2|Standard Deviation|8.84|8.84|||
3820087|NCT01745146|3645789|B2|BSI GSI||Neuropsychological Status|Intelligence Quotient (IQ) from Wechsler Abbreviated Scale of Intelligence (WASI)Vocabulary and Matrix Reasoning subtests; Range 55-157 (157=best) Rey Auditory Verbal Learning Test (RAVLT) Total; Range 0-75 (75=best) Trail Making Test Part B T-score; Range 7-88 (88=best) Brixton Spatial Anticipation Test error score; Range 0-55 (0=best) Glasgow Outcome Scale-Extended (GOS-E); Range 1-8 (8=best) Global Severity Index (GSI) from the Brief Symptom Inventory (BSI); Range 30-81 (30=best) Frontal Systems Behavior Scale (FrSBe) T-score; Range 9-176 (9=best)|units on a scale|Mean|68.9|68.9|Standard Deviation|8.0|8.0|||
3820088|NCT01745146|3645790|B1|BSI GSI||Neuropsychological Status|Intelligence Quotient (IQ) from Wechsler Abbreviated Scale of Intelligence (WASI)Vocabulary and Matrix Reasoning subtests; Range 55-157 (157=best) Rey Auditory Verbal Learning Test (RAVLT) Total; Range 0-75 (75=best) Trail Making Test Part B T-score; Range 7-88 (88=best) Brixton Spatial Anticipation Test error score; Range 0-55 (0=best) Glasgow Outcome Scale-Extended (GOS-E); Range 1-8 (8=best) Global Severity Index (GSI) from the Brief Symptom Inventory (BSI); Range 30-81 (30=best) Frontal Systems Behavior Scale (FrSBe) T-score; Range 9-176 (9=best)|units on a scale|Mean|66.7|66.7|Standard Deviation|10.3|10.3|||
3820117|NCT01745146|3645789|B2||Other|Cause of Injury|How Traumatic Brain Injury Occurred|Participants|Count of Participants|7|7.0||||||
3820118|NCT01745146|3645790|B1||Other|Cause of Injury|How Traumatic Brain Injury Occurred|Participants|Count of Participants|2|2.0||||||
3820089|NCT01745146|3645788|B3|GOS-E||Neuropsychological Status|Intelligence Quotient (IQ) from Wechsler Abbreviated Scale of Intelligence (WASI)Vocabulary and Matrix Reasoning subtests; Range 55-157 (157=best) Rey Auditory Verbal Learning Test (RAVLT) Total; Range 0-75 (75=best) Trail Making Test Part B T-score; Range 7-88 (88=best) Brixton Spatial Anticipation Test error score; Range 0-55 (0=best) Glasgow Outcome Scale-Extended (GOS-E); Range 1-8 (8=best) Global Severity Index (GSI) from the Brief Symptom Inventory (BSI); Range 30-81 (30=best) Frontal Systems Behavior Scale (FrSBe) T-score; Range 9-176 (9=best)|units on a scale|Mean|5.87|5.87|Standard Deviation|0.96|0.96|||
3820090|NCT01745146|3645789|B2|GOS-E||Neuropsychological Status|Intelligence Quotient (IQ) from Wechsler Abbreviated Scale of Intelligence (WASI)Vocabulary and Matrix Reasoning subtests; Range 55-157 (157=best) Rey Auditory Verbal Learning Test (RAVLT) Total; Range 0-75 (75=best) Trail Making Test Part B T-score; Range 7-88 (88=best) Brixton Spatial Anticipation Test error score; Range 0-55 (0=best) Glasgow Outcome Scale-Extended (GOS-E); Range 1-8 (8=best) Global Severity Index (GSI) from the Brief Symptom Inventory (BSI); Range 30-81 (30=best) Frontal Systems Behavior Scale (FrSBe) T-score; Range 9-176 (9=best)|units on a scale|Mean|6|6.0|Standard Deviation|1|1.0|||
3820091|NCT01745146|3645790|B1|GOS-E||Neuropsychological Status|Intelligence Quotient (IQ) from Wechsler Abbreviated Scale of Intelligence (WASI)Vocabulary and Matrix Reasoning subtests; Range 55-157 (157=best) Rey Auditory Verbal Learning Test (RAVLT) Total; Range 0-75 (75=best) Trail Making Test Part B T-score; Range 7-88 (88=best) Brixton Spatial Anticipation Test error score; Range 0-55 (0=best) Glasgow Outcome Scale-Extended (GOS-E); Range 1-8 (8=best) Global Severity Index (GSI) from the Brief Symptom Inventory (BSI); Range 30-81 (30=best) Frontal Systems Behavior Scale (FrSBe) T-score; Range 9-176 (9=best)|units on a scale|Mean|5.6|5.6|Standard Deviation|0.9|0.9|||
3820092|NCT01745146|3645788|B3|Trail Making Test Part B: T-Score||Neuropsychological Status|Intelligence Quotient (IQ) from Wechsler Abbreviated Scale of Intelligence (WASI)Vocabulary and Matrix Reasoning subtests; Range 55-157 (157=best) Rey Auditory Verbal Learning Test (RAVLT) Total; Range 0-75 (75=best) Trail Making Test Part B T-score; Range 7-88 (88=best) Brixton Spatial Anticipation Test error score; Range 0-55 (0=best) Glasgow Outcome Scale-Extended (GOS-E); Range 1-8 (8=best) Global Severity Index (GSI) from the Brief Symptom Inventory (BSI); Range 30-81 (30=best) Frontal Systems Behavior Scale (FrSBe) T-score; Range 9-176 (9=best)|units on a scale|Mean|40.81|40.81|Standard Deviation|13.71|13.71|||
3820093|NCT01745146|3645789|B2|Trail Making Test Part B: T-Score||Neuropsychological Status|Intelligence Quotient (IQ) from Wechsler Abbreviated Scale of Intelligence (WASI)Vocabulary and Matrix Reasoning subtests; Range 55-157 (157=best) Rey Auditory Verbal Learning Test (RAVLT) Total; Range 0-75 (75=best) Trail Making Test Part B T-score; Range 7-88 (88=best) Brixton Spatial Anticipation Test error score; Range 0-55 (0=best) Glasgow Outcome Scale-Extended (GOS-E); Range 1-8 (8=best) Global Severity Index (GSI) from the Brief Symptom Inventory (BSI); Range 30-81 (30=best) Frontal Systems Behavior Scale (FrSBe) T-score; Range 9-176 (9=best)|units on a scale|Mean|41.2|41.2|Standard Deviation|13|13.0|||
3820094|NCT01745146|3645790|B1|Trail Making Test Part B: T-Score||Neuropsychological Status|Intelligence Quotient (IQ) from Wechsler Abbreviated Scale of Intelligence (WASI)Vocabulary and Matrix Reasoning subtests; Range 55-157 (157=best) Rey Auditory Verbal Learning Test (RAVLT) Total; Range 0-75 (75=best) Trail Making Test Part B T-score; Range 7-88 (88=best) Brixton Spatial Anticipation Test error score; Range 0-55 (0=best) Glasgow Outcome Scale-Extended (GOS-E); Range 1-8 (8=best) Global Severity Index (GSI) from the Brief Symptom Inventory (BSI); Range 30-81 (30=best) Frontal Systems Behavior Scale (FrSBe) T-score; Range 9-176 (9=best)|units on a scale|Mean|40|40.0|Standard Deviation|15.2|15.2|||
3820095|NCT01745146|3645788|B3|Brixton Spatial Anticipation Test: Error Score||Neuropsychological Status|Intelligence Quotient (IQ) from Wechsler Abbreviated Scale of Intelligence (WASI)Vocabulary and Matrix Reasoning subtests; Range 55-157 (157=best) Rey Auditory Verbal Learning Test (RAVLT) Total; Range 0-75 (75=best) Trail Making Test Part B T-score; Range 7-88 (88=best) Brixton Spatial Anticipation Test error score; Range 0-55 (0=best) Glasgow Outcome Scale-Extended (GOS-E); Range 1-8 (8=best) Global Severity Index (GSI) from the Brief Symptom Inventory (BSI); Range 30-81 (30=best) Frontal Systems Behavior Scale (FrSBe) T-score; Range 9-176 (9=best)|units on a scale|Mean|17.91|17.91|Standard Deviation|7.39|7.39|||
3820096|NCT01745146|3645789|B2|Brixton Spatial Anticipation Test: Error Score||Neuropsychological Status|Intelligence Quotient (IQ) from Wechsler Abbreviated Scale of Intelligence (WASI)Vocabulary and Matrix Reasoning subtests; Range 55-157 (157=best) Rey Auditory Verbal Learning Test (RAVLT) Total; Range 0-75 (75=best) Trail Making Test Part B T-score; Range 7-88 (88=best) Brixton Spatial Anticipation Test error score; Range 0-55 (0=best) Glasgow Outcome Scale-Extended (GOS-E); Range 1-8 (8=best) Global Severity Index (GSI) from the Brief Symptom Inventory (BSI); Range 30-81 (30=best) Frontal Systems Behavior Scale (FrSBe) T-score; Range 9-176 (9=best)|units on a scale|Mean|17.2|17.2|Standard Deviation|7.7|7.7|||
3820097|NCT01745146|3645790|B1|Brixton Spatial Anticipation Test: Error Score||Neuropsychological Status|Intelligence Quotient (IQ) from Wechsler Abbreviated Scale of Intelligence (WASI)Vocabulary and Matrix Reasoning subtests; Range 55-157 (157=best) Rey Auditory Verbal Learning Test (RAVLT) Total; Range 0-75 (75=best) Trail Making Test Part B T-score; Range 7-88 (88=best) Brixton Spatial Anticipation Test error score; Range 0-55 (0=best) Glasgow Outcome Scale-Extended (GOS-E); Range 1-8 (8=best) Global Severity Index (GSI) from the Brief Symptom Inventory (BSI); Range 30-81 (30=best) Frontal Systems Behavior Scale (FrSBe) T-score; Range 9-176 (9=best)|units on a scale|Mean|19.3|19.3|Standard Deviation|6.7|6.7|||
3820098|NCT01745146|3645788|B3|RAVLT: Sum 5 Trials||Neuropsychological Status|Intelligence Quotient (IQ) from Wechsler Abbreviated Scale of Intelligence (WASI)Vocabulary and Matrix Reasoning subtests; Range 55-157 (157=best) Rey Auditory Verbal Learning Test (RAVLT) Total; Range 0-75 (75=best) Trail Making Test Part B T-score; Range 7-88 (88=best) Brixton Spatial Anticipation Test error score; Range 0-55 (0=best) Glasgow Outcome Scale-Extended (GOS-E); Range 1-8 (8=best) Global Severity Index (GSI) from the Brief Symptom Inventory (BSI); Range 30-81 (30=best) Frontal Systems Behavior Scale (FrSBe) T-score; Range 9-176 (9=best)|units on a scale|Mean|39.43|39.43|Standard Deviation|10.9|10.9|||
3820099|NCT01745146|3645789|B2|RAVLT: Sum 5 Trials||Neuropsychological Status|Intelligence Quotient (IQ) from Wechsler Abbreviated Scale of Intelligence (WASI)Vocabulary and Matrix Reasoning subtests; Range 55-157 (157=best) Rey Auditory Verbal Learning Test (RAVLT) Total; Range 0-75 (75=best) Trail Making Test Part B T-score; Range 7-88 (88=best) Brixton Spatial Anticipation Test error score; Range 0-55 (0=best) Glasgow Outcome Scale-Extended (GOS-E); Range 1-8 (8=best) Global Severity Index (GSI) from the Brief Symptom Inventory (BSI); Range 30-81 (30=best) Frontal Systems Behavior Scale (FrSBe) T-score; Range 9-176 (9=best)|units on a scale|Mean|40.3|40.3|Standard Deviation|11.5|11.5|||
3820100|NCT01745146|3645790|B1|RAVLT: Sum 5 Trials||Neuropsychological Status|Intelligence Quotient (IQ) from Wechsler Abbreviated Scale of Intelligence (WASI)Vocabulary and Matrix Reasoning subtests; Range 55-157 (157=best) Rey Auditory Verbal Learning Test (RAVLT) Total; Range 0-75 (75=best) Trail Making Test Part B T-score; Range 7-88 (88=best) Brixton Spatial Anticipation Test error score; Range 0-55 (0=best) Glasgow Outcome Scale-Extended (GOS-E); Range 1-8 (8=best) Global Severity Index (GSI) from the Brief Symptom Inventory (BSI); Range 30-81 (30=best) Frontal Systems Behavior Scale (FrSBe) T-score; Range 9-176 (9=best)|units on a scale|Mean|37.8|37.8|Standard Deviation|9.5|9.5|||
3820101|NCT01745146|3645788|B3|IQ Determined from WASI||Neuropsychological Status|Intelligence Quotient (IQ) from Wechsler Abbreviated Scale of Intelligence (WASI)Vocabulary and Matrix Reasoning subtests; Range 55-157 (157=best) Rey Auditory Verbal Learning Test (RAVLT) Total; Range 0-75 (75=best) Trail Making Test Part B T-score; Range 7-88 (88=best) Brixton Spatial Anticipation Test error score; Range 0-55 (0=best) Glasgow Outcome Scale-Extended (GOS-E); Range 1-8 (8=best) Global Severity Index (GSI) from the Brief Symptom Inventory (BSI); Range 30-81 (30=best) Frontal Systems Behavior Scale (FrSBe) T-score; Range 9-176 (9=best)|units on a scale|Mean|95.97|95.97|Standard Deviation|16.13|16.13|||
3820102|NCT01745146|3645789|B2|IQ Determined from WASI||Neuropsychological Status|Intelligence Quotient (IQ) from Wechsler Abbreviated Scale of Intelligence (WASI)Vocabulary and Matrix Reasoning subtests; Range 55-157 (157=best) Rey Auditory Verbal Learning Test (RAVLT) Total; Range 0-75 (75=best) Trail Making Test Part B T-score; Range 7-88 (88=best) Brixton Spatial Anticipation Test error score; Range 0-55 (0=best) Glasgow Outcome Scale-Extended (GOS-E); Range 1-8 (8=best) Global Severity Index (GSI) from the Brief Symptom Inventory (BSI); Range 30-81 (30=best) Frontal Systems Behavior Scale (FrSBe) T-score; Range 9-176 (9=best)|units on a scale|Mean|97|97.0|Standard Deviation|16.1|16.1|||
3820103|NCT01745146|3645790|B1|IQ Determined from WASI||Neuropsychological Status|Intelligence Quotient (IQ) from Wechsler Abbreviated Scale of Intelligence (WASI)Vocabulary and Matrix Reasoning subtests; Range 55-157 (157=best) Rey Auditory Verbal Learning Test (RAVLT) Total; Range 0-75 (75=best) Trail Making Test Part B T-score; Range 7-88 (88=best) Brixton Spatial Anticipation Test error score; Range 0-55 (0=best) Glasgow Outcome Scale-Extended (GOS-E); Range 1-8 (8=best) Global Severity Index (GSI) from the Brief Symptom Inventory (BSI); Range 30-81 (30=best) Frontal Systems Behavior Scale (FrSBe) T-score; Range 9-176 (9=best)|units on a scale|Mean|94|94.0|Standard Deviation|16.3|16.3|||
3820104|NCT01745146|3645788|B3||> 90 days|Median PTA Duration|Median number of days spent in post-traumatic amnesia following TBI. This was ascertained using a structured interview that has been used in other studies of chronic TBI, with the retrospective estimate found to correlate reasonably well with PTA measured prospectively.|Participants|Count of Participants|15|15.0||||||
3820105|NCT01745146|3645789|B2||> 90 days|Median PTA Duration|Median number of days spent in post-traumatic amnesia following TBI. This was ascertained using a structured interview that has been used in other studies of chronic TBI, with the retrospective estimate found to correlate reasonably well with PTA measured prospectively.|Participants|Count of Participants|12|12.0||||||
3820106|NCT01745146|3645790|B1||> 90 days|Median PTA Duration|Median number of days spent in post-traumatic amnesia following TBI. This was ascertained using a structured interview that has been used in other studies of chronic TBI, with the retrospective estimate found to correlate reasonably well with PTA measured prospectively.|Participants|Count of Participants|3|3.0||||||
3820107|NCT01745146|3645788|B3||31 - 90 days|Median PTA Duration|Median number of days spent in post-traumatic amnesia following TBI. This was ascertained using a structured interview that has been used in other studies of chronic TBI, with the retrospective estimate found to correlate reasonably well with PTA measured prospectively.|Participants|Count of Participants|26|26.0||||||
3820108|NCT01745146|3645789|B2||31 - 90 days|Median PTA Duration|Median number of days spent in post-traumatic amnesia following TBI. This was ascertained using a structured interview that has been used in other studies of chronic TBI, with the retrospective estimate found to correlate reasonably well with PTA measured prospectively.|Participants|Count of Participants|15|15.0||||||
3820109|NCT01745146|3645790|B1||31 - 90 days|Median PTA Duration|Median number of days spent in post-traumatic amnesia following TBI. This was ascertained using a structured interview that has been used in other studies of chronic TBI, with the retrospective estimate found to correlate reasonably well with PTA measured prospectively.|Participants|Count of Participants|11|11.0||||||
3820110|NCT01745146|3645788|B3||15 - 30 days|Median PTA Duration|Median number of days spent in post-traumatic amnesia following TBI. This was ascertained using a structured interview that has been used in other studies of chronic TBI, with the retrospective estimate found to correlate reasonably well with PTA measured prospectively.|Participants|Count of Participants|27|27.0||||||
3820111|NCT01745146|3645789|B2||15 - 30 days|Median PTA Duration|Median number of days spent in post-traumatic amnesia following TBI. This was ascertained using a structured interview that has been used in other studies of chronic TBI, with the retrospective estimate found to correlate reasonably well with PTA measured prospectively.|Participants|Count of Participants|18|18.0||||||
3820112|NCT01745146|3645790|B1||15 - 30 days|Median PTA Duration|Median number of days spent in post-traumatic amnesia following TBI. This was ascertained using a structured interview that has been used in other studies of chronic TBI, with the retrospective estimate found to correlate reasonably well with PTA measured prospectively.|Participants|Count of Participants|9|9.0||||||
3820113|NCT01745146|3645788|B3||< 15 days|Median PTA Duration|Median number of days spent in post-traumatic amnesia following TBI. This was ascertained using a structured interview that has been used in other studies of chronic TBI, with the retrospective estimate found to correlate reasonably well with PTA measured prospectively.|Participants|Count of Participants|22|22.0||||||
3820114|NCT01745146|3645789|B2||< 15 days|Median PTA Duration|Median number of days spent in post-traumatic amnesia following TBI. This was ascertained using a structured interview that has been used in other studies of chronic TBI, with the retrospective estimate found to correlate reasonably well with PTA measured prospectively.|Participants|Count of Participants|15|15.0||||||
3820115|NCT01745146|3645790|B1||< 15 days|Median PTA Duration|Median number of days spent in post-traumatic amnesia following TBI. This was ascertained using a structured interview that has been used in other studies of chronic TBI, with the retrospective estimate found to correlate reasonably well with PTA measured prospectively.|Participants|Count of Participants|7|7.0||||||
3820116|NCT01745146|3645788|B3||Other|Cause of Injury|How Traumatic Brain Injury Occurred|Participants|Count of Participants|9|9.0||||||
3820119|NCT01745146|3645788|B3||Intentional Injury|Cause of Injury|How Traumatic Brain Injury Occurred|Participants|Count of Participants|12|12.0||||||
3820120|NCT01745146|3645789|B2||Intentional Injury|Cause of Injury|How Traumatic Brain Injury Occurred|Participants|Count of Participants|7|7.0||||||
3820121|NCT01745146|3645790|B1||Intentional Injury|Cause of Injury|How Traumatic Brain Injury Occurred|Participants|Count of Participants|5|5.0||||||
3820122|NCT01745146|3645788|B3||Fall|Cause of Injury|How Traumatic Brain Injury Occurred|Participants|Count of Participants|14|14.0||||||
3820123|NCT01745146|3645789|B2||Fall|Cause of Injury|How Traumatic Brain Injury Occurred|Participants|Count of Participants|8|8.0||||||
3820124|NCT01745146|3645790|B1||Fall|Cause of Injury|How Traumatic Brain Injury Occurred|Participants|Count of Participants|6|6.0||||||
3820125|NCT01745146|3645788|B3||Vehicular Incident|Cause of Injury|How Traumatic Brain Injury Occurred|Participants|Count of Participants|55|55.0||||||
3820126|NCT01745146|3645789|B2||Vehicular Incident|Cause of Injury|How Traumatic Brain Injury Occurred|Participants|Count of Participants|38|38.0||||||
3820127|NCT01745146|3645790|B1||Vehicular Incident|Cause of Injury|How Traumatic Brain Injury Occurred|Participants|Count of Participants|17|17.0||||||
3820128|NCT01745146|3645788|B3|||Education|Last year of school completed|years|Mean|13.4|13.4|Standard Deviation|2.2|2.2|||
3820129|NCT01745146|3645789|B2|||Education|Last year of school completed|years|Mean|13.4|13.4|Standard Deviation|2.1|2.1|||
3820130|NCT01745146|3645790|B1|||Education|Last year of school completed|years|Mean|13.4|13.4|Standard Deviation|2.5|2.5|||
3820131|NCT01745146|3645788|B3|Hispanic or Other||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3820132|NCT01745146|3645789|B2|Hispanic or Other||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3820133|NCT01745146|3645790|B1|Hispanic or Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3820134|NCT01745146|3645788|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|62|62.0||||||
3820135|NCT01745146|3645789|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3820136|NCT01745146|3645790|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3820137|NCT01745146|3645788|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3820138|NCT01745146|3645789|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3820139|NCT01745146|3645790|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3820140|NCT01745146|3645788|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3820141|NCT01745146|3645789|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3820142|NCT01745146|3645790|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3820143|NCT01745146|3645788|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3820144|NCT01745146|3645789|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3820145|NCT01745146|3645790|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3820146|NCT01745146|3645788|B3|||Age||years|Mean|32.1|32.1|Standard Deviation|11.5|11.5|||
3820147|NCT01745146|3645789|B2|||Age||years|Mean|30.4|30.4|Standard Deviation|10.2|10.2|||
3820148|NCT01745146|3645790|B1|||Age||years|Mean|36.2|36.2|Standard Deviation|13.3|13.3|||
3820149|NCT01745133|3645798|B4|United States||Region of Enrollment||Participants|Count of Participants|58|58.0||||||
3820150|NCT01745133|3645799|B3|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3820151|NCT01745133|3645800|B2|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3820152|NCT01745133|3645801|B1|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3820153|NCT01745133|3645798|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820154|NCT01745133|3645799|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820155|NCT01745133|3645800|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820156|NCT01745133|3645801|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820157|NCT01745133|3645798|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820158|NCT01745133|3645799|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820159|NCT01745133|3645800|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820160|NCT01745133|3645801|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820161|NCT01745133|3645798|B4||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3820162|NCT01745133|3645799|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3820163|NCT01745133|3645800|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3820164|NCT01745133|3645801|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3820165|NCT01745133|3645798|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3820166|NCT01745133|3645799|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3820167|NCT01745133|3645800|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3820168|NCT01745133|3645801|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3820169|NCT01745133|3645798|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820170|NCT01745133|3645799|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820171|NCT01745133|3645800|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820172|NCT01745133|3645801|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820174|NCT01745133|3645799|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820175|NCT01745133|3645800|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820176|NCT01745133|3645801|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820177|NCT01745133|3645798|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820178|NCT01745133|3645799|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820179|NCT01745133|3645800|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820180|NCT01745133|3645801|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820181|NCT01745133|3645798|B4||Male|Gender||Participants|Count of Participants|26|26.0||||||
3820182|NCT01745133|3645799|B3||Male|Gender||Participants|Count of Participants|07|7.0||||||
3820183|NCT01745133|3645800|B2||Male|Gender||Participants|Count of Participants|10|10.0||||||
3820184|NCT01745133|3645801|B1||Male|Gender||Participants|Count of Participants|9|9.0||||||
3820185|NCT01745133|3645798|B4||Female|Gender||Participants|Count of Participants|32|32.0||||||
3820186|NCT01745133|3645799|B3||Female|Gender||Participants|Count of Participants|12|12.0||||||
3820187|NCT01745133|3645800|B2||Female|Gender||Participants|Count of Participants|10|10.0||||||
3820188|NCT01745133|3645801|B1||Female|Gender||Participants|Count of Participants|10|10.0||||||
3820189|NCT01745133|3645798|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3820190|NCT01745133|3645799|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3820191|NCT01745133|3645800|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3820192|NCT01745133|3645801|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3820193|NCT01745133|3645798|B4||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3820194|NCT01745133|3645799|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3820195|NCT01745133|3645800|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3820196|NCT01745133|3645801|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3820197|NCT01745133|3645798|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3820198|NCT01745133|3645799|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3820199|NCT01745133|3645800|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3820200|NCT01745133|3645801|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3820201|NCT01745094|3645811|B5|||Postvoid Residual (PVR) Volume|Measurement of PVR volume was made using either ultrasonography or urethral catheterization, provided that the same method was used for the same participant throughout the study.|mL|Mean|12.76|12.76|Standard Deviation|19.273|19.273|||
3820202|NCT01745094|3645812|B4|||Postvoid Residual (PVR) Volume|Measurement of PVR volume was made using either ultrasonography or urethral catheterization, provided that the same method was used for the same participant throughout the study.|mL|Mean|12.11|12.11|Standard Deviation|20.199|20.199|||
3820203|NCT01745094|3645813|B3|||Postvoid Residual (PVR) Volume|Measurement of PVR volume was made using either ultrasonography or urethral catheterization, provided that the same method was used for the same participant throughout the study.|mL|Mean|13.93|13.93|Standard Deviation|17.188|17.188|||
3820204|NCT01745094|3645814|B2|||Postvoid Residual (PVR) Volume|Measurement of PVR volume was made using either ultrasonography or urethral catheterization, provided that the same method was used for the same participant throughout the study.|mL|Mean|10.51|10.51|Standard Deviation|16.066|16.066|||
3820205|NCT01745094|3645815|B1|||Postvoid Residual (PVR) Volume|Measurement of PVR volume was made using either ultrasonography or urethral catheterization, provided that the same method was used for the same participant throughout the study.|mL|Mean|14.95|14.95|Standard Deviation|23.214|23.214|||
3820206|NCT01745094|3645811|B5|||Number of Nocturia Episodes per Night|"A nocturia episode was defined as waking at night 1 or more times to void. Night time was defined as the period between bedtime and the wake-up time the following day (micturitions at the same time as the wake-up time were excluded). The mean number of nocturia episodes per night was calculated by taking the sum of nocturia episodes in the patient diary where the variable urinated was indicated during the night time, divided by the number of nights. Only participants who had a nocturia episode at baseline was included in the analysis."|nocturia episodes|Mean|1.74|1.74|Standard Deviation|1.018|1.018|||
3820207|NCT01745094|3645812|B4|||Number of Nocturia Episodes per Night|"A nocturia episode was defined as waking at night 1 or more times to void. Night time was defined as the period between bedtime and the wake-up time the following day (micturitions at the same time as the wake-up time were excluded). The mean number of nocturia episodes per night was calculated by taking the sum of nocturia episodes in the patient diary where the variable urinated was indicated during the night time, divided by the number of nights. Only participants who had a nocturia episode at baseline was included in the analysis."|nocturia episodes|Mean|1.72|1.72|Standard Deviation|1.084|1.084|||
3820208|NCT01745094|3645813|B3|||Number of Nocturia Episodes per Night|"A nocturia episode was defined as waking at night 1 or more times to void. Night time was defined as the period between bedtime and the wake-up time the following day (micturitions at the same time as the wake-up time were excluded). The mean number of nocturia episodes per night was calculated by taking the sum of nocturia episodes in the patient diary where the variable urinated was indicated during the night time, divided by the number of nights. Only participants who had a nocturia episode at baseline was included in the analysis."|nocturia episodes|Mean|1.85|1.85|Standard Deviation|1.006|1.006|||
3820209|NCT01745094|3645814|B2|||Number of Nocturia Episodes per Night|"A nocturia episode was defined as waking at night 1 or more times to void. Night time was defined as the period between bedtime and the wake-up time the following day (micturitions at the same time as the wake-up time were excluded). The mean number of nocturia episodes per night was calculated by taking the sum of nocturia episodes in the patient diary where the variable urinated was indicated during the night time, divided by the number of nights. Only participants who had a nocturia episode at baseline was included in the analysis."|nocturia episodes|Mean|1.55|1.55|Standard Deviation|0.783|0.783|||
3820210|NCT01745094|3645815|B1|||Number of Nocturia Episodes per Night|"A nocturia episode was defined as waking at night 1 or more times to void. Night time was defined as the period between bedtime and the wake-up time the following day (micturitions at the same time as the wake-up time were excluded). The mean number of nocturia episodes per night was calculated by taking the sum of nocturia episodes in the patient diary where the variable urinated was indicated during the night time, divided by the number of nights. Only participants who had a nocturia episode at baseline was included in the analysis."|nocturia episodes|Mean|1.79|1.79|Standard Deviation|1.075|1.075|||
3820211|NCT01745094|3645811|B5|||Volume Voided per Micturition|"The mean volume per micturition was calculated by taking the sum of the urinary volumes where the volume voided was > 0 and where urinary incontinence was not indicated in the patient diary, divided by the number of micturitions where the volume voided was > 0 and where urinary incontinence was not indicated. Only participants who had volume voided was > 0 at baseline was included in the analysis."|mL|Mean|171.029|171.029|Standard Deviation|49.7826|49.7826|||
3820212|NCT01745094|3645812|B4|||Volume Voided per Micturition|"The mean volume per micturition was calculated by taking the sum of the urinary volumes where the volume voided was > 0 and where urinary incontinence was not indicated in the patient diary, divided by the number of micturitions where the volume voided was > 0 and where urinary incontinence was not indicated. Only participants who had volume voided was > 0 at baseline was included in the analysis."|mL|Mean|173.658|173.658|Standard Deviation|47.5973|47.5973|||
3820213|NCT01745094|3645813|B3|||Volume Voided per Micturition|"The mean volume per micturition was calculated by taking the sum of the urinary volumes where the volume voided was > 0 and where urinary incontinence was not indicated in the patient diary, divided by the number of micturitions where the volume voided was > 0 and where urinary incontinence was not indicated. Only participants who had volume voided was > 0 at baseline was included in the analysis."|mL|Mean|182.362|182.362|Standard Deviation|56.3405|56.3405|||
3820214|NCT01745094|3645814|B2|||Volume Voided per Micturition|"The mean volume per micturition was calculated by taking the sum of the urinary volumes where the volume voided was > 0 and where urinary incontinence was not indicated in the patient diary, divided by the number of micturitions where the volume voided was > 0 and where urinary incontinence was not indicated. Only participants who had volume voided was > 0 at baseline was included in the analysis."|mL|Mean|158.633|158.633|Standard Deviation|43.6678|43.6678|||
3820215|NCT01745094|3645815|B1|||Volume Voided per Micturition|"The mean volume per micturition was calculated by taking the sum of the urinary volumes where the volume voided was > 0 and where urinary incontinence was not indicated in the patient diary, divided by the number of micturitions where the volume voided was > 0 and where urinary incontinence was not indicated. Only participants who had volume voided was > 0 at baseline was included in the analysis."|mL|Mean|158.627|158.627|Standard Deviation|47.0511|47.0511|||
3820216|NCT01745094|3645811|B5|||Number of Urge Incontinence Episodes per 24 Hours|"An urge incontinence episode was defined as any episode when both urgency and incontinence occurred concurrently. The mean number of incontinence episodes per 24 hours was calculated by taking the sum of all marked episodes in the patient diary where the variable urgency and urinary incontinence’ were indicated, divided by the number of days on which episodes were recorded. Only participants who had an urge incontinence episode at baseline was included in the analysis."|urge incontinence episodes|Mean|1.43|1.43|Standard Deviation|1.245|1.245|||
3820217|NCT01745094|3645812|B4|||Number of Urge Incontinence Episodes per 24 Hours|"An urge incontinence episode was defined as any episode when both urgency and incontinence occurred concurrently. The mean number of incontinence episodes per 24 hours was calculated by taking the sum of all marked episodes in the patient diary where the variable urgency and urinary incontinence’ were indicated, divided by the number of days on which episodes were recorded. Only participants who had an urge incontinence episode at baseline was included in the analysis."|urge incontinence episodes|Mean|1.30|1.3|Standard Deviation|1.138|1.138|||
3820218|NCT01745094|3645813|B3|||Number of Urge Incontinence Episodes per 24 Hours|"An urge incontinence episode was defined as any episode when both urgency and incontinence occurred concurrently. The mean number of incontinence episodes per 24 hours was calculated by taking the sum of all marked episodes in the patient diary where the variable urgency and urinary incontinence’ were indicated, divided by the number of days on which episodes were recorded. Only participants who had an urge incontinence episode at baseline was included in the analysis."|urge incontinence episodes|Mean|1.69|1.69|Standard Deviation|1.366|1.366|||
3820219|NCT01745094|3645814|B2|||Number of Urge Incontinence Episodes per 24 Hours|"An urge incontinence episode was defined as any episode when both urgency and incontinence occurred concurrently. The mean number of incontinence episodes per 24 hours was calculated by taking the sum of all marked episodes in the patient diary where the variable urgency and urinary incontinence’ were indicated, divided by the number of days on which episodes were recorded. Only participants who had an urge incontinence episode at baseline was included in the analysis."|urge incontinence episodes|Mean|1.42|1.42|Standard Deviation|1.243|1.243|||
3820220|NCT01745094|3645815|B1|||Number of Urge Incontinence Episodes per 24 Hours|"An urge incontinence episode was defined as any episode when both urgency and incontinence occurred concurrently. The mean number of incontinence episodes per 24 hours was calculated by taking the sum of all marked episodes in the patient diary where the variable urgency and urinary incontinence’ were indicated, divided by the number of days on which episodes were recorded. Only participants who had an urge incontinence episode at baseline was included in the analysis."|urge incontinence episodes|Mean|1.42|1.42|Standard Deviation|1.506|1.506|||
3820221|NCT01745094|3645811|B5|||Number of Incontinence Episodes per 24 Hours|"An incontinence episode was defined as the complaint of any involuntary leakage of urine. The mean number of incontinence episodes per 24 hours was calculated by taking the sum of all marked episodes in the patient diary where the variable urinary incontinence’ was indicated, divided by the number of days on which episodes were recorded. Only participants who had an incontinence episode at baseline was included in the analysis."|incontinence episodes|Mean|1.64|1.64|Standard Deviation|1.616|1.616|||
3820222|NCT01745094|3645812|B4|||Number of Incontinence Episodes per 24 Hours|"An incontinence episode was defined as the complaint of any involuntary leakage of urine. The mean number of incontinence episodes per 24 hours was calculated by taking the sum of all marked episodes in the patient diary where the variable urinary incontinence’ was indicated, divided by the number of days on which episodes were recorded. Only participants who had an incontinence episode at baseline was included in the analysis."|incontinence episodes|Mean|1.51|1.51|Standard Deviation|1.520|1.52|||
3820223|NCT01745094|3645813|B3|||Number of Incontinence Episodes per 24 Hours|"An incontinence episode was defined as the complaint of any involuntary leakage of urine. The mean number of incontinence episodes per 24 hours was calculated by taking the sum of all marked episodes in the patient diary where the variable urinary incontinence’ was indicated, divided by the number of days on which episodes were recorded. Only participants who had an incontinence episode at baseline was included in the analysis."|incontinence episodes|Mean|2.09|2.09|Standard Deviation|2.121|2.121|||
3820224|NCT01745094|3645814|B2|||Number of Incontinence Episodes per 24 Hours|"An incontinence episode was defined as the complaint of any involuntary leakage of urine. The mean number of incontinence episodes per 24 hours was calculated by taking the sum of all marked episodes in the patient diary where the variable urinary incontinence’ was indicated, divided by the number of days on which episodes were recorded. Only participants who had an incontinence episode at baseline was included in the analysis."|incontinence episodes|Mean|1.54|1.54|Standard Deviation|1.248|1.248|||
3820225|NCT01745094|3645815|B1|||Number of Incontinence Episodes per 24 Hours|"An incontinence episode was defined as the complaint of any involuntary leakage of urine. The mean number of incontinence episodes per 24 hours was calculated by taking the sum of all marked episodes in the patient diary where the variable urinary incontinence’ was indicated, divided by the number of days on which episodes were recorded. Only participants who had an incontinence episode at baseline was included in the analysis."|incontinence episodes|Mean|1.45|1.45|Standard Deviation|1.454|1.454|||
3820226|NCT01745094|3645811|B5|||Number of Urgency Episodes per 24 Hours|"An urgency episode was defined as a complaint of a sudden, compelling desire to pass urine, which is difficult to defer. The mean number of urgency episodes per 24 hours was calculated by taking the sum of all marked episodes in the patient diary where the variable urgency was indicated, divided by the number of days on which episodes were recorded. Only participants who had an urgency episode at baseline was included in the analysis."|urgency episodes|Mean|3.42|3.42|Standard Deviation|2.586|2.586|||
3820227|NCT01745094|3645812|B4|||Number of Urgency Episodes per 24 Hours|"An urgency episode was defined as a complaint of a sudden, compelling desire to pass urine, which is difficult to defer. The mean number of urgency episodes per 24 hours was calculated by taking the sum of all marked episodes in the patient diary where the variable urgency was indicated, divided by the number of days on which episodes were recorded. Only participants who had an urgency episode at baseline was included in the analysis."|urgency episodes|Mean|3.63|3.63|Standard Deviation|2.846|2.846|||
3820228|NCT01745094|3645813|B3|||Number of Urgency Episodes per 24 Hours|"An urgency episode was defined as a complaint of a sudden, compelling desire to pass urine, which is difficult to defer. The mean number of urgency episodes per 24 hours was calculated by taking the sum of all marked episodes in the patient diary where the variable urgency was indicated, divided by the number of days on which episodes were recorded. Only participants who had an urgency episode at baseline was included in the analysis."|urgency episodes|Mean|2.86|2.86|Standard Deviation|1.997|1.997|||
3820229|NCT01745094|3645814|B2|||Number of Urgency Episodes per 24 Hours|"An urgency episode was defined as a complaint of a sudden, compelling desire to pass urine, which is difficult to defer. The mean number of urgency episodes per 24 hours was calculated by taking the sum of all marked episodes in the patient diary where the variable urgency was indicated, divided by the number of days on which episodes were recorded. Only participants who had an urgency episode at baseline was included in the analysis."|urgency episodes|Mean|4.12|4.12|Standard Deviation|2.586|2.586|||
3820230|NCT01745094|3645815|B1|||Number of Urgency Episodes per 24 Hours|"An urgency episode was defined as a complaint of a sudden, compelling desire to pass urine, which is difficult to defer. The mean number of urgency episodes per 24 hours was calculated by taking the sum of all marked episodes in the patient diary where the variable urgency was indicated, divided by the number of days on which episodes were recorded. Only participants who had an urgency episode at baseline was included in the analysis."|urgency episodes|Mean|2.86|2.86|Standard Deviation|2.433|2.433|||
3820231|NCT01745094|3645811|B5|||Number of Micturitions per 24 Hours|"The mean number of micturitions per 24 hours was calculated by taking the sum of all marked episodes in the patient diary where the variable urinated was indicated, divided by the number of days on which episodes were recorded."|micturitions|Mean|10.26|10.26|Standard Deviation|2.302|2.302|||
3820232|NCT01745094|3645812|B4|||Number of Micturitions per 24 Hours|"The mean number of micturitions per 24 hours was calculated by taking the sum of all marked episodes in the patient diary where the variable urinated was indicated, divided by the number of days on which episodes were recorded."|micturitions|Mean|10.15|10.15|Standard Deviation|2.331|2.331|||
3820233|NCT01745094|3645813|B3|||Number of Micturitions per 24 Hours|"The mean number of micturitions per 24 hours was calculated by taking the sum of all marked episodes in the patient diary where the variable urinated was indicated, divided by the number of days on which episodes were recorded."|micturitions|Mean|9.81|9.81|Standard Deviation|1.918|1.918|||
3820234|NCT01745094|3645814|B2|||Number of Micturitions per 24 Hours|"The mean number of micturitions per 24 hours was calculated by taking the sum of all marked episodes in the patient diary where the variable urinated was indicated, divided by the number of days on which episodes were recorded."|micturitions|Mean|11.12|11.12|Standard Deviation|2.722|2.722|||
3820235|NCT01745094|3645815|B1|||Number of Micturitions per 24 Hours|"The mean number of micturitions per 24 hours was calculated by taking the sum of all marked episodes in the patient diary where the variable urinated was indicated, divided by the number of days on which episodes were recorded."|micturitions|Mean|10.38|10.38|Standard Deviation|2.128|2.128|||
3820236|NCT01745094|3645811|B5|||OAB-q SF Score: Total Health-Related Quality of Life (HRQOL)|The OAB-q SF questionnaire was a questionnaire completed by participants composed of 2 sections: Severity Symptom and the HRQL. The HRQL section included 13 questions. For each participant, the total HRQL score was derived as a sum of scores for Questions 7 to 19. The total score ranges from 13 to 78 with higher total HRQL score indicating greater HRQL. OAB-q SF data obtained at week 0 visit were used as baseline.|Units on a Scale|Mean|74.49|74.49|Standard Deviation|18.743|18.743|||
3820250|NCT01745094|3645815|B1|||Overactive Bladder Symptom Score (OABSS)|The OABSS questionnaire was a questionnaire completed by participants with 4 questions regarding their OAB symptoms. For each participant, the OABSS total score was calculated from the sum total of the score of each question. The total score ranges from 0 to 15 with higher score indicating more symptoms. The OABSS data obtained at week 0 were used as baseline.|Units on a Scale|Mean|7.1|7.1|Standard Deviation|2.31|2.31|||
3820237|NCT01745094|3645812|B4|||OAB-q SF Score: Total Health-Related Quality of Life (HRQOL)|The OAB-q SF questionnaire was a questionnaire completed by participants composed of 2 sections: Severity Symptom and the HRQL. The HRQL section included 13 questions. For each participant, the total HRQL score was derived as a sum of scores for Questions 7 to 19. The total score ranges from 13 to 78 with higher total HRQL score indicating greater HRQL. OAB-q SF data obtained at week 0 visit were used as baseline.|Units on a Scale|Mean|76.06|76.06|Standard Deviation|19.341|19.341|||
3820238|NCT01745094|3645813|B3|||OAB-q SF Score: Total Health-Related Quality of Life (HRQOL)|The OAB-q SF questionnaire was a questionnaire completed by participants composed of 2 sections: Severity Symptom and the HRQL. The HRQL section included 13 questions. For each participant, the total HRQL score was derived as a sum of scores for Questions 7 to 19. The total score ranges from 13 to 78 with higher total HRQL score indicating greater HRQL. OAB-q SF data obtained at week 0 visit were used as baseline.|Units on a Scale|Mean|75.10|75.1|Standard Deviation|17.708|17.708|||
3820239|NCT01745094|3645814|B2|||OAB-q SF Score: Total Health-Related Quality of Life (HRQOL)|The OAB-q SF questionnaire was a questionnaire completed by participants composed of 2 sections: Severity Symptom and the HRQL. The HRQL section included 13 questions. For each participant, the total HRQL score was derived as a sum of scores for Questions 7 to 19. The total score ranges from 13 to 78 with higher total HRQL score indicating greater HRQL. OAB-q SF data obtained at week 0 visit were used as baseline.|Units on a Scale|Mean|70.31|70.31|Standard Deviation|18.873|18.873|||
3820240|NCT01745094|3645815|B1|||OAB-q SF Score: Total Health-Related Quality of Life (HRQOL)|The OAB-q SF questionnaire was a questionnaire completed by participants composed of 2 sections: Severity Symptom and the HRQL. The HRQL section included 13 questions. For each participant, the total HRQL score was derived as a sum of scores for Questions 7 to 19. The total score ranges from 13 to 78 with higher total HRQL score indicating greater HRQL. OAB-q SF data obtained at week 0 visit were used as baseline.|Units on a Scale|Mean|73.71|73.71|Standard Deviation|18.662|18.662|||
3820241|NCT01745094|3645811|B5|||Overactive Bladder questionnaire Short Form (OAB-q SF) Score: Symptom Severity|The OAB-q SF questionnaire was a questionnaire completed by participants composed of 2 sections: Severity Symptom and the Health-related Quality of Life (HRQL). The Severity Symptom section included 6 questions. For each participant, the symptom severity score was derived as a sum of scores for Questions 1 to 6. The total score ranges from 6 to 36 with higher symptom severity score indicating greater symptom bother. OAB-q SF data obtained at week 0 visit were used as baseline.|Units on a Scale|Mean|33.27|33.27|Standard Deviation|19.328|19.328|||
3820242|NCT01745094|3645812|B4|||Overactive Bladder questionnaire Short Form (OAB-q SF) Score: Symptom Severity|The OAB-q SF questionnaire was a questionnaire completed by participants composed of 2 sections: Severity Symptom and the Health-related Quality of Life (HRQL). The Severity Symptom section included 6 questions. For each participant, the symptom severity score was derived as a sum of scores for Questions 1 to 6. The total score ranges from 6 to 36 with higher symptom severity score indicating greater symptom bother. OAB-q SF data obtained at week 0 visit were used as baseline.|Units on a Scale|Mean|31.29|31.29|Standard Deviation|19.205|19.205|||
3820243|NCT01745094|3645813|B3|||Overactive Bladder questionnaire Short Form (OAB-q SF) Score: Symptom Severity|The OAB-q SF questionnaire was a questionnaire completed by participants composed of 2 sections: Severity Symptom and the Health-related Quality of Life (HRQL). The Severity Symptom section included 6 questions. For each participant, the symptom severity score was derived as a sum of scores for Questions 1 to 6. The total score ranges from 6 to 36 with higher symptom severity score indicating greater symptom bother. OAB-q SF data obtained at week 0 visit were used as baseline.|Units on a Scale|Mean|32.12|32.12|Standard Deviation|17.701|17.701|||
3820244|NCT01745094|3645814|B2|||Overactive Bladder questionnaire Short Form (OAB-q SF) Score: Symptom Severity|The OAB-q SF questionnaire was a questionnaire completed by participants composed of 2 sections: Severity Symptom and the Health-related Quality of Life (HRQL). The Severity Symptom section included 6 questions. For each participant, the symptom severity score was derived as a sum of scores for Questions 1 to 6. The total score ranges from 6 to 36 with higher symptom severity score indicating greater symptom bother. OAB-q SF data obtained at week 0 visit were used as baseline.|Units on a Scale|Mean|39.37|39.37|Standard Deviation|20.470|20.47|||
3820245|NCT01745094|3645815|B1|||Overactive Bladder questionnaire Short Form (OAB-q SF) Score: Symptom Severity|The OAB-q SF questionnaire was a questionnaire completed by participants composed of 2 sections: Severity Symptom and the Health-related Quality of Life (HRQL). The Severity Symptom section included 6 questions. For each participant, the symptom severity score was derived as a sum of scores for Questions 1 to 6. The total score ranges from 6 to 36 with higher symptom severity score indicating greater symptom bother. OAB-q SF data obtained at week 0 visit were used as baseline.|Units on a Scale|Mean|33.94|33.94|Standard Deviation|20.386|20.386|||
3820246|NCT01745094|3645811|B5|||Overactive Bladder Symptom Score (OABSS)|The OABSS questionnaire was a questionnaire completed by participants with 4 questions regarding their OAB symptoms. For each participant, the OABSS total score was calculated from the sum total of the score of each question. The total score ranges from 0 to 15 with higher score indicating more symptoms. The OABSS data obtained at week 0 were used as baseline.|Units on a Scale|Mean|7.8|7.8|Standard Deviation|2.49|2.49|||
3820247|NCT01745094|3645812|B4|||Overactive Bladder Symptom Score (OABSS)|The OABSS questionnaire was a questionnaire completed by participants with 4 questions regarding their OAB symptoms. For each participant, the OABSS total score was calculated from the sum total of the score of each question. The total score ranges from 0 to 15 with higher score indicating more symptoms. The OABSS data obtained at week 0 were used as baseline.|Units on a Scale|Mean|8.1|8.1|Standard Deviation|2.45|2.45|||
3820248|NCT01745094|3645813|B3|||Overactive Bladder Symptom Score (OABSS)|The OABSS questionnaire was a questionnaire completed by participants with 4 questions regarding their OAB symptoms. For each participant, the OABSS total score was calculated from the sum total of the score of each question. The total score ranges from 0 to 15 with higher score indicating more symptoms. The OABSS data obtained at week 0 were used as baseline.|Units on a Scale|Mean|7.5|7.5|Standard Deviation|2.67|2.67|||
3820249|NCT01745094|3645814|B2|||Overactive Bladder Symptom Score (OABSS)|The OABSS questionnaire was a questionnaire completed by participants with 4 questions regarding their OAB symptoms. For each participant, the OABSS total score was calculated from the sum total of the score of each question. The total score ranges from 0 to 15 with higher score indicating more symptoms. The OABSS data obtained at week 0 were used as baseline.|Units on a Scale|Mean|8.5|8.5|Standard Deviation|2.36|2.36|||
3820251|NCT01745094|3645811|B5||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3820252|NCT01745094|3645812|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3820253|NCT01745094|3645813|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3820254|NCT01745094|3645814|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3820255|NCT01745094|3645815|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3820256|NCT01745094|3645811|B5||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
3820257|NCT01745094|3645812|B4||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3820258|NCT01745094|3645813|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3820259|NCT01745094|3645814|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3820260|NCT01745094|3645815|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3820261|NCT01745094|3645811|B5|||Age||Years|Mean|64.7|64.7|Standard Deviation|9.92|9.92|||
3820262|NCT01745094|3645812|B4|||Age||Years|Mean|63.8|63.8|Standard Deviation|10.34|10.34|||
3820263|NCT01745094|3645813|B3|||Age||Years|Mean|66.9|66.9|Standard Deviation|9.47|9.47|||
3820264|NCT01745094|3645814|B2|||Age||Years|Mean|62.8|62.8|Standard Deviation|10.27|10.27|||
3820265|NCT01745094|3645815|B1|||Age||Years|Mean|65.6|65.6|Standard Deviation|8.71|8.71|||
3820266|NCT01745055|3645884|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3820267|NCT01745055|3645884|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3820268|NCT01745055|3645884|B1|||Age||years|Mean|57.3|57.3|Standard Deviation|10.2|10.2|||
3820269|NCT01744977|3645917|B3|United States||Region of Enrollment||participants|Number|240|240.0||||||
3820270|NCT01744977|3645918|B2|United States||Region of Enrollment||participants|Number|120|120.0||||||
3820271|NCT01744977|3645919|B1|United States||Region of Enrollment||participants|Number|120|120.0||||||
3820272|NCT01744977|3645917|B3|African American or Other||Race/Ethnicity, Customized||participants|Number|152|152.0||||||
3820273|NCT01744977|3645918|B2|African American or Other||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
3820274|NCT01744977|3645919|B1|African American or Other||Race/Ethnicity, Customized||participants|Number|73|73.0||||||
3820275|NCT01744977|3645917|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|88|88.0||||||
3820276|NCT01744977|3645918|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
3820277|NCT01744977|3645919|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
3820278|NCT01744977|3645917|B3||Male|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
3820279|NCT01744977|3645918|B2||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3820280|NCT01744977|3645919|B1||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3820281|NCT01744977|3645917|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3820282|NCT01744977|3645918|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3820283|NCT01744977|3645919|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3820284|NCT01744977|3645917|B3|||Age||years|Mean|62.6|62.6|Standard Deviation|8.7|8.7|||
3820285|NCT01744977|3645918|B2|||Age||years|Mean|62.9|62.9|Standard Deviation|8.6|8.6|||
3820286|NCT01744977|3645919|B1|||Age||years|Mean|62.4|62.4|Standard Deviation|8.9|8.9|||
3820287|NCT01744860|3645928|B1||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms
3820288|NCT01744860|3645928|B1||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms
3820289|NCT01744860|3645928|B1||>=65 years|Age||Participants|Count of Participants|NA|||||||This study has analysed sample data rather than participants
3820290|NCT01744860|3645928|B1||Between 18 and 65 years|Age||Participants|Count of Participants|NA|||||||This study has analysed sample data rather than participants
3820291|NCT01744860|3645928|B1||<=18 years|Age||Participants|Count of Participants|NA|||||||This study has analysed sample data rather than participants
3820292|NCT01744821|3645962|B5|United States||Region of Enrollment||participants|Number|7|7.0||||||
3820293|NCT01744821|3645963|B4|United States||Region of Enrollment||participants|Number|1|1.0||||||
3820294|NCT01744821|3645964|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3820295|NCT01744821|3645965|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3820296|NCT01744821|3645966|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3820297|NCT01744821|3645962|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3820298|NCT01744821|3645963|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3820299|NCT01744821|3645964|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3820300|NCT01744821|3645965|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3820301|NCT01744821|3645966|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3820302|NCT01744821|3645962|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3820303|NCT01744821|3645963|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3820304|NCT01744821|3645964|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3820305|NCT01744821|3645965|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3820306|NCT01744821|3645966|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3820307|NCT01744821|3645962|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3820308|NCT01744821|3645963|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3820309|NCT01744821|3645964|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3820310|NCT01744821|3645965|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3820311|NCT01744821|3645966|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3820312|NCT01744821|3645962|B5||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3820313|NCT01744821|3645963|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3820314|NCT01744821|3645964|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3820315|NCT01744821|3645965|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3820316|NCT01744821|3645966|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3820317|NCT01744821|3645962|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3820318|NCT01744821|3645963|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3820319|NCT01744821|3645964|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3820320|NCT01744821|3645965|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3820321|NCT01744821|3645966|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3820322|NCT01744782|3645991|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3820323|NCT01744782|3645991|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3820324|NCT01744782|3645991|B1|||Age||years|Mean|3.80|3.8|Standard Deviation|5.116|5.116|||
3820325|NCT01744730|3645999|B6|||Body Mass Index (BMI)|There were fewer than 178 participants included in the analysis here. N=104 participants with available data in the Patients Less Than 21 Years of Age (NCT01431326) Arm. BMI was only calculated for children >=2y of age. As such, BMI was calculated for all 22 participants in this study but only 104/178 (58%) of participants in NCT01431326/POP01.|Percentile|Mean|85.2|85.2|Standard Deviation|24.1|24.1|||
3820326|NCT01744730|3646000|B5|||Body Mass Index (BMI)|There were fewer than 178 participants included in the analysis here. N=104 participants with available data in the Patients Less Than 21 Years of Age (NCT01431326) Arm. BMI was only calculated for children >=2y of age. As such, BMI was calculated for all 22 participants in this study but only 104/178 (58%) of participants in NCT01431326/POP01.|Percentile|Mean|83.1|83.1|Standard Deviation|25.9|25.9|||
3820327|NCT01744730|3646001|B4|||Body Mass Index (BMI)|There were fewer than 178 participants included in the analysis here. N=104 participants with available data in the Patients Less Than 21 Years of Age (NCT01431326) Arm. BMI was only calculated for children >=2y of age. As such, BMI was calculated for all 22 participants in this study but only 104/178 (58%) of participants in NCT01431326/POP01.|Percentile|Mean|98.3|98.3|Standard Deviation|1.3|1.3|||
3820328|NCT01744730|3646002|B3|||Body Mass Index (BMI)|There were fewer than 178 participants included in the analysis here. N=104 participants with available data in the Patients Less Than 21 Years of Age (NCT01431326) Arm. BMI was only calculated for children >=2y of age. As such, BMI was calculated for all 22 participants in this study but only 104/178 (58%) of participants in NCT01431326/POP01.|Percentile|Mean|91.7|91.7|Standard Deviation|3.0|3.0|||
3820329|NCT01744730|3646003|B2|||Body Mass Index (BMI)|There were fewer than 178 participants included in the analysis here. N=104 participants with available data in the Patients Less Than 21 Years of Age (NCT01431326) Arm. BMI was only calculated for children >=2y of age. As such, BMI was calculated for all 22 participants in this study but only 104/178 (58%) of participants in NCT01431326/POP01.|Percentile|Mean|97.4|97.4|Standard Deviation|1.2|1.2|||
3820330|NCT01744730|3646004|B1|||Body Mass Index (BMI)|There were fewer than 178 participants included in the analysis here. N=104 participants with available data in the Patients Less Than 21 Years of Age (NCT01431326) Arm. BMI was only calculated for children >=2y of age. As such, BMI was calculated for all 22 participants in this study but only 104/178 (58%) of participants in NCT01431326/POP01.|Percentile|Mean|90.5|90.5|Standard Deviation|3.6|3.6|||
3820331|NCT01744730|3645999|B6|United States||Region of Enrollment||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3820332|NCT01744730|3646000|B5|United States||Region of Enrollment||participants|Number|NA|||||||NCT01431326 did not collect region of enrollment.
3820333|NCT01744730|3646001|B4|United States||Region of Enrollment||participants|Number|11|11.0||||||
3820334|NCT01744730|3646002|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3820335|NCT01744730|3646003|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3820336|NCT01744730|3646004|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3820337|NCT01744730|3645999|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3820338|NCT01744730|3646000|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3820339|NCT01744730|3646001|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820340|NCT01744730|3646002|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3820341|NCT01744730|3646003|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3820342|NCT01744730|3646004|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820343|NCT01744730|3645999|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3820344|NCT01744730|3646000|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3820345|NCT01744730|3646001|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820346|NCT01744730|3646002|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820347|NCT01744730|3646003|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820348|NCT01744730|3646004|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820349|NCT01744730|3645999|B6||White|Race (NIH/OMB)||Participants|Count of Participants|150|150.0||||||
3820350|NCT01744730|3646000|B5||White|Race (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
3820351|NCT01744730|3646001|B4||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3820352|NCT01744730|3646002|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3820353|NCT01744730|3646003|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3820354|NCT01744730|3646004|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3820355|NCT01744730|3645999|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3820356|NCT01744730|3646000|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3820357|NCT01744730|3646001|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3820358|NCT01744730|3646002|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3820359|NCT01744730|3646003|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820360|NCT01744730|3646004|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820361|NCT01744730|3645999|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3820362|NCT01744730|3646000|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3820363|NCT01744730|3646001|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820364|NCT01744730|3646002|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820365|NCT01744730|3646003|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820366|NCT01744730|3646004|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820367|NCT01744730|3645999|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3820368|NCT01744730|3646000|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3820369|NCT01744730|3646001|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820370|NCT01744730|3646002|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820371|NCT01744730|3646003|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820372|NCT01744730|3646004|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820373|NCT01744730|3645999|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820374|NCT01744730|3646000|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820375|NCT01744730|3646001|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820376|NCT01744730|3646002|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820377|NCT01744730|3646003|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820378|NCT01744730|3646004|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820379|NCT01744730|3645999|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3820380|NCT01744730|3646000|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3820381|NCT01744730|3646001|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820382|NCT01744730|3646002|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3820383|NCT01744730|3646003|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3820384|NCT01744730|3646004|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820385|NCT01744730|3645999|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|142|142.0||||||
3820386|NCT01744730|3646000|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
3820387|NCT01744730|3646001|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3820388|NCT01744730|3646002|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3820389|NCT01744730|3646003|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3820390|NCT01744730|3646004|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3820391|NCT01744730|3645999|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3820392|NCT01744730|3646000|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3820393|NCT01744730|3646001|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3820394|NCT01744730|3646002|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820395|NCT01744730|3646003|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820396|NCT01744730|3646004|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3820397|NCT01744730|3645999|B6||Male|Gender||Participants|Count of Participants|122|122.0||||||
3820398|NCT01744730|3646000|B5||Male|Gender||Participants|Count of Participants|104|104.0||||||
3820399|NCT01744730|3646001|B4||Male|Gender||Participants|Count of Participants|10|10.0||||||
3820400|NCT01744730|3646002|B3||Male|Gender||Participants|Count of Participants|3|3.0||||||
3820401|NCT01744730|3646003|B2||Male|Gender||Participants|Count of Participants|3|3.0||||||
3820402|NCT01744730|3646004|B1||Male|Gender||Participants|Count of Participants|2|2.0||||||
3820403|NCT01744730|3645999|B6||Female|Gender||Participants|Count of Participants|78|78.0||||||
3820404|NCT01744730|3646000|B5||Female|Gender||Participants|Count of Participants|74|74.0||||||
3820405|NCT01744730|3646001|B4||Female|Gender||Participants|Count of Participants|1|1.0||||||
3820406|NCT01744730|3646002|B3||Female|Gender||Participants|Count of Participants|1|1.0||||||
3820407|NCT01744730|3646003|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
3820408|NCT01744730|3646004|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
3820409|NCT01744730|3645999|B6|||Age||years|Mean|7.8|7.8|Standard Deviation|6.8|6.8|||
3820410|NCT01744730|3646000|B5|||Age||years|Mean|7.2|7.2|Standard Deviation|6.9|6.9|||
3820411|NCT01744730|3646001|B4|||Age||years|Mean|14.8|14.8|Standard Deviation|1.7|1.7|||
3820412|NCT01744730|3646002|B3|||Age||years|Mean|14.6|14.6|Standard Deviation|1.7|1.7|||
3820413|NCT01744730|3646003|B2|||Age||years|Mean|10.6|10.6|Standard Deviation|1.4|1.4|||
3820414|NCT01744730|3646004|B1|||Age||years|Mean|9.4|9.4|Standard Deviation|2.7|2.7|||
3820415|NCT01744730|3645999|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3820416|NCT01744730|3646000|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3820417|NCT01744730|3646001|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3820418|NCT01744730|3646002|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3820419|NCT01744730|3646003|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3820420|NCT01744730|3646004|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3820421|NCT01744730|3645999|B6||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3820422|NCT01744730|3646000|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3820423|NCT01744730|3646001|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3820424|NCT01744730|3646002|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3820425|NCT01744730|3646003|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3820426|NCT01744730|3646004|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3820427|NCT01744730|3645999|B6||<=18 years|Age||Participants|Count of Participants|200|200.0||||||
3820428|NCT01744730|3646000|B5||<=18 years|Age||Participants|Count of Participants|178|178.0||||||
3820429|NCT01744730|3646001|B4||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
3820430|NCT01744730|3646002|B3||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3820431|NCT01744730|3646003|B2||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3820432|NCT01744730|3646004|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3820433|NCT01744691|3646051|B1||Male|Gender||Participants|Count of Participants|96|96.0||||||
3820434|NCT01744691|3646051|B1||Female|Gender||Participants|Count of Participants|48|48.0||||||
3820435|NCT01744691|3646051|B1|||Age||years|Mean|64.4|64.4|Standard Deviation|9.9|9.9|||
3820436|NCT01744691|3646051|B1||>=65 years|Age||Participants|Count of Participants|69|69.0||||||
3820437|NCT01744691|3646051|B1||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
3820438|NCT01744691|3646051|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3820439|NCT01744574|3646056|B5|Race (white)||Race/Ethnicity, Customized||Participants|Count of Participants|128|128.0||||||
3820440|NCT01744574|3646057|B4|Race (white)||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3820441|NCT01744574|3646058|B3|Race (white)||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3820442|NCT01744574|3646059|B2|Race (white)||Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3820443|NCT01744574|3646060|B1|Race (white)||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3820444|NCT01744574|3646056|B5|Race (non-white)||Race/Ethnicity, Customized||Participants|Count of Participants|88|88.0||||||
3820445|NCT01744574|3646057|B4|Race (non-white)||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3820446|NCT01744574|3646058|B3|Race (non-white)||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3820447|NCT01744574|3646059|B2|Race (non-white)||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3820448|NCT01744574|3646060|B1|Race (non-white)||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3820449|NCT01744574|3646056|B5||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3820450|NCT01744574|3646057|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3820451|NCT01744574|3646058|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3820452|NCT01744574|3646059|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3820453|NCT01744574|3646060|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3820454|NCT01744574|3646056|B5||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3820455|NCT01744574|3646057|B4||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3820456|NCT01744574|3646058|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3820457|NCT01744574|3646059|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3820458|NCT01744574|3646060|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3820459|NCT01744574|3646056|B5|||Age||years|Mean|37.1|37.1|Standard Deviation|9.6|9.6|||
3820460|NCT01744574|3646057|B4|||Age||years|Mean|37.6|37.6|Standard Deviation|7.4|7.4|||
3820461|NCT01744574|3646058|B3|||Age||years|Mean|36.0|36.0|Standard Deviation|7.8|7.8|||
3820462|NCT01744574|3646059|B2|||Age||years|Mean|37.9|37.9|Standard Deviation|10.6|10.6|||
3820463|NCT01744574|3646060|B1|||Age||years|Mean|36.8|36.8|Standard Deviation|11.8|11.8|||
3820464|NCT01744496|3646097|B3|||Body Mass Index (BMI)||kilogram per squaremeter|Mean|27.96|27.96|Standard Deviation|5.49|5.49|||
3820465|NCT01744496|3646098|B2|||Body Mass Index (BMI)||kilogram per squaremeter|Mean|27.42|27.42|Standard Deviation|4.74|4.74|||
3820466|NCT01744496|3646099|B1|||Body Mass Index (BMI)||kilogram per squaremeter|Mean|28.54|28.54|Standard Deviation|6.21|6.21|||
3820467|NCT01744496|3646097|B3|||Height||centimeters|Mean|167.92|167.92|Standard Deviation|9.85|9.85|||
3820468|NCT01744496|3646098|B2|||Height||centimeters|Mean|168.63|168.63|Standard Deviation|9.87|9.87|||
3820469|NCT01744496|3646099|B1|||Height||centimeters|Mean|167.17|167.17|Standard Deviation|9.92|9.92|||
3820470|NCT01744496|3646097|B3|||Weight||kilograms|Mean|78.94|78.94|Standard Deviation|16.97|16.97|||
3820471|NCT01744496|3646098|B2|||Weight||kilograms|Mean|77.80|77.8|Standard Deviation|13.71|13.71|||
3820472|NCT01744496|3646099|B1|||Weight||kilograms|Mean|80.15|80.15|Standard Deviation|20.00|20.0|||
3820473|NCT01744496|3646097|B3|Other / mixed||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3820474|NCT01744496|3646098|B2|Other / mixed||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3820475|NCT01744496|3646099|B1|Other / mixed||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3820476|NCT01744496|3646097|B3|White||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
3820477|NCT01744496|3646098|B2|White||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3820478|NCT01744496|3646099|B1|White||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3820479|NCT01744496|3646097|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3820480|NCT01744496|3646098|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3820481|NCT01744496|3646099|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3820482|NCT01744496|3646097|B3|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3820483|NCT01744496|3646098|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3820484|NCT01744496|3646099|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3820485|NCT01744496|3646097|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3820486|NCT01744496|3646098|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3820487|NCT01744496|3646099|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3820488|NCT01744496|3646097|B3|American Indian / Alaskan native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3820489|NCT01744496|3646098|B2|American Indian / Alaskan native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3820490|NCT01744496|3646099|B1|American Indian / Alaskan native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3820491|NCT01744496|3646097|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3820492|NCT01744496|3646098|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3820493|NCT01744496|3646099|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3820494|NCT01744496|3646097|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3820495|NCT01744496|3646098|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3820496|NCT01744496|3646099|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3820497|NCT01744496|3646097|B3|||Age||years|Mean|65.9|65.9|Standard Deviation|12.8|12.8|||
3820498|NCT01744496|3646098|B2|||Age||years|Mean|66.5|66.5|Standard Deviation|11.9|11.9|||
3820499|NCT01744496|3646099|B1|||Age||years|Mean|65.3|65.3|Standard Deviation|13.8|13.8|||
3820500|NCT01744496|3646097|B3||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
3820501|NCT01744496|3646098|B2||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3820502|NCT01744496|3646099|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3820503|NCT01744496|3646097|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3820504|NCT01744496|3646098|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3820505|NCT01744496|3646099|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3820506|NCT01744496|3646097|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3820507|NCT01744496|3646098|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3820508|NCT01744496|3646099|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3820509|NCT01744483|3646118|B4|United States||Region of Enrollment||participants|Number|102|102.0||||||
3820510|NCT01744483|3646119|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
3820511|NCT01744483|3646120|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
3820512|NCT01744483|3646121|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
3820513|NCT01744483|3646118|B4||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3820514|NCT01744483|3646119|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3820515|NCT01744483|3646120|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3820516|NCT01744483|3646121|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3820517|NCT01744483|3646118|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3820518|NCT01744483|3646119|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3820519|NCT01744483|3646120|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3820520|NCT01744483|3646121|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3820521|NCT01744483|3646118|B4||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
3820522|NCT01744483|3646119|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3820523|NCT01744483|3646120|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3820524|NCT01744483|3646121|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3820525|NCT01744483|3646118|B4||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
3820526|NCT01744483|3646119|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3820527|NCT01744483|3646120|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3820528|NCT01744483|3646121|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3820529|NCT01744483|3646118|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3820530|NCT01744483|3646119|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3820531|NCT01744483|3646120|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3820532|NCT01744483|3646121|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3820533|NCT01744392|3646131|B1|Not Employed||Employed (full or part-time)||participants|Number|16|16.0||||||
3820534|NCT01744392|3646131|B1|Employed||Employed (full or part-time)||participants|Number|7|7.0||||||
3820535|NCT01744392|3646131|B1|High Health Literacy||Health Literacy|Health Literacy is measured using the Rapid Assessment of Adult Literacy in Medication, a 66-item word recognition evaluation.The REALM scores range from 0 - 66, with scores from 0-18 consistent with <= 3rd grade health literacy, 19-44 = 4th - 6th grade, 45-60 = 7th - 8th grade, 61-66 >= 9th grade. For the purposes of this study Low Health Literacy is defined as a REALM score <60 vs High Health Literacy as a REALM score >= 61.|participants|Number|14|14.0||||||
3820536|NCT01744392|3646131|B1|Low Health Literacy||Health Literacy|Health Literacy is measured using the Rapid Assessment of Adult Literacy in Medication, a 66-item word recognition evaluation.The REALM scores range from 0 - 66, with scores from 0-18 consistent with <= 3rd grade health literacy, 19-44 = 4th - 6th grade, 45-60 = 7th - 8th grade, 61-66 >= 9th grade. For the purposes of this study Low Health Literacy is defined as a REALM score <60 vs High Health Literacy as a REALM score >= 61.|participants|Number|9|9.0||||||
3820537|NCT01744392|3646131|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
3820538|NCT01744392|3646131|B1|African American||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3820539|NCT01744392|3646131|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3820540|NCT01744392|3646131|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3820541|NCT01744392|3646131|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3820542|NCT01744392|3646131|B1|||Age||years|Mean|66.6|66.6|Standard Deviation|8.4|8.4|||
3820543|NCT01744353|3646144|B4|United States||Region of Enrollment||participants|Number|35|35.0||||||
3820544|NCT01744353|3646145|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3820545|NCT01744353|3646146|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
3820546|NCT01744353|3646147|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3820547|NCT01744353|3646144|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3820548|NCT01744353|3646145|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3820549|NCT01744353|3646146|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3820550|NCT01744353|3646147|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3820551|NCT01744353|3646144|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3820552|NCT01744353|3646145|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3820553|NCT01744353|3646146|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3820554|NCT01744353|3646147|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3820555|NCT01744353|3646144|B4|||Age||years|Mean|61.85|61.85|Full Range|||35.0|82.0|
3820556|NCT01744353|3646145|B3|||Age||years|Mean|63.33|63.33|Full Range|||58.0|67.0|
3820557|NCT01744353|3646146|B2|||Age||years|Mean|63.38|63.38|Full Range|||41.0|82.0|
3820558|NCT01744353|3646147|B1|||Age||years|Mean|58.83|58.83|Full Range|||35.0|70.0|
3820559|NCT01744353|3646144|B4||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3820560|NCT01744353|3646145|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3820561|NCT01744353|3646146|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3820562|NCT01744353|3646147|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3820563|NCT01744353|3646144|B4||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3820564|NCT01744353|3646145|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3820565|NCT01744353|3646146|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3820566|NCT01744353|3646147|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3820567|NCT01744353|3646144|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3820568|NCT01744353|3646145|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3820569|NCT01744353|3646146|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3820570|NCT01744353|3646147|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3820571|NCT01744340|3646158|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
3820572|NCT01744340|3646159|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3820573|NCT01744340|3646160|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3820574|NCT01744340|3646158|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3820575|NCT01744340|3646159|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3820576|NCT01744340|3646160|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3820577|NCT01744340|3646158|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3820578|NCT01744340|3646159|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3820579|NCT01744340|3646160|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3820580|NCT01744340|3646158|B3|||Age||years|Mean|60.6|60.6|Full Range|||41.0|86.0|
3820581|NCT01744340|3646159|B2|||Age||years|Mean|71|71.0|Full Range|||41.0|86.0|
3820582|NCT01744340|3646160|B1|||Age||years|Mean|58.5|58.5|Full Range|||45.0|70.0|
3820583|NCT01744340|3646158|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3820584|NCT01744340|3646159|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3820585|NCT01744340|3646160|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3820586|NCT01744340|3646158|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3820587|NCT01744340|3646159|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3820588|NCT01744340|3646160|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3820589|NCT01744340|3646158|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3820590|NCT01744340|3646159|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3820591|NCT01744340|3646160|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3820592|NCT01744197|3646169|B3|United States||Region of Enrollment||participants|Number|61|61.0||||||
3820593|NCT01744197|3646170|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
3820594|NCT01744197|3646171|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
3820595|NCT01744197|3646169|B3|Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3820596|NCT01744197|3646170|B2|Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3820597|NCT01744197|3646171|B1|Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3820598|NCT01744197|3646169|B3|African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3820599|NCT01744197|3646170|B2|African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3820600|NCT01744197|3646171|B1|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3820601|NCT01744197|3646169|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
3820602|NCT01744197|3646170|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3820603|NCT01744197|3646171|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3820604|NCT01744197|3646169|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3820605|NCT01744197|3646170|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3820606|NCT01744197|3646171|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3820607|NCT01744197|3646169|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3820608|NCT01744197|3646170|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3820609|NCT01744197|3646171|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3820610|NCT01744197|3646169|B3|||Age||years|Mean|60.5|60.5|Standard Deviation|12.0|12.0|||
3820611|NCT01744197|3646170|B2|||Age||years|Mean|60.3|60.3|Standard Deviation|13.0|13.0|||
3820612|NCT01744197|3646171|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|11.2|11.2|||
3820613|NCT01744093|3646182|B3|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3820614|NCT01744093|3646183|B2|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3820615|NCT01744093|3646184|B1|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3820616|NCT01744093|3646182|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820617|NCT01744093|3646183|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820618|NCT01744093|3646184|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820619|NCT01744093|3646182|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3820620|NCT01744093|3646183|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820621|NCT01744093|3646184|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3820622|NCT01744093|3646182|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3820623|NCT01744093|3646183|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3820624|NCT01744093|3646184|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3820625|NCT01744093|3646182|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3820626|NCT01744093|3646183|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3820627|NCT01744093|3646184|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3820628|NCT01744093|3646182|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820629|NCT01744093|3646183|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820630|NCT01744093|3646184|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820631|NCT01744093|3646182|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820632|NCT01744093|3646183|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820633|NCT01744093|3646184|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820634|NCT01744093|3646182|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3820635|NCT01744093|3646183|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820636|NCT01744093|3646184|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3820637|NCT01744093|3646182|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3820638|NCT01744093|3646183|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3820639|NCT01744093|3646184|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3820640|NCT01744093|3646182|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820641|NCT01744093|3646183|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820642|NCT01744093|3646184|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820643|NCT01744093|3646182|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3820644|NCT01744093|3646183|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820645|NCT01744093|3646184|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3820646|NCT01744093|3646182|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3820647|NCT01744093|3646183|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3820648|NCT01744093|3646184|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3820649|NCT01744093|3646182|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3820650|NCT01744093|3646183|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3820651|NCT01744093|3646184|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3820652|NCT01744093|3646182|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3820653|NCT01744093|3646183|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3820654|NCT01744093|3646184|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3820655|NCT01744093|3646182|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3820656|NCT01744093|3646183|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3820657|NCT01744093|3646184|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3820658|NCT01744093|3646182|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3820659|NCT01744093|3646183|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3820660|NCT01744093|3646184|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3820661|NCT01743963|3646193|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
3820662|NCT01743963|3646194|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3820663|NCT01743963|3646195|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3820664|NCT01743963|3646193|B3||Male|Sex: Female, Male|We were not authorized by IRB to record this information.|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3820665|NCT01743963|3646194|B2||Male|Sex: Female, Male|We were not authorized by IRB to record this information.|Participants|Count of Participants|NA|||||||We were not authorized by IRB to record this information.
3820666|NCT01743963|3646195|B1||Male|Sex: Female, Male|We were not authorized by IRB to record this information.|Participants|Count of Participants|NA|||||||We were not authorized by IRB to record this information.
3820667|NCT01743963|3646193|B3||Female|Sex: Female, Male|We were not authorized by IRB to record this information.|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3820668|NCT01743963|3646194|B2||Female|Sex: Female, Male|We were not authorized by IRB to record this information.|Participants|Count of Participants|NA|||||||We were not authorized by IRB to record this information.
3820669|NCT01743963|3646195|B1||Female|Sex: Female, Male|We were not authorized by IRB to record this information.|Participants|Count of Participants|NA|||||||We were not authorized by IRB to record this information.
3820670|NCT01743963|3646193|B3|18 to 90 years||Age, Customized|We were not authorized by the IRB to record this information; however, all participants were between the ages of 18 and 90, as specified in the inclusion criteria.|participants|Number|38|38.0||||||
3820671|NCT01743963|3646194|B2|18 to 90 years||Age, Customized|We were not authorized by the IRB to record this information; however, all participants were between the ages of 18 and 90, as specified in the inclusion criteria.|participants|Number|17|17.0||||||
3820672|NCT01743963|3646195|B1|18 to 90 years||Age, Customized|We were not authorized by the IRB to record this information; however, all participants were between the ages of 18 and 90, as specified in the inclusion criteria.|participants|Number|21|21.0||||||
3820673|NCT01743729|3646202|B3||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3820674|NCT01743729|3646203|B2||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3820675|NCT01743729|3646204|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3820676|NCT01743729|3646202|B3||Female|Sex: Female, Male||Participants|Count of Participants|550|550.0||||||
3820677|NCT01743729|3646203|B2||Female|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
3820678|NCT01743729|3646204|B1||Female|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
3820679|NCT01743729|3646202|B3|||Age||years|Mean|58.8|58.8|Standard Deviation|14.09|14.09|||
3820680|NCT01743729|3646203|B2|||Age||years|Mean|58.9|58.9|Standard Deviation|14.26|14.26|||
3820681|NCT01743729|3646204|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|13.93|13.93|||
3820682|NCT01743521|3646213|B5|||HIV infection||participants|Number|11|11.0||||||
3820683|NCT01743521|3646214|B4|||HIV infection||participants|Number|2|2.0||||||
3820684|NCT01743521|3646215|B3|||HIV infection||participants|Number|2|2.0||||||
3820685|NCT01743521|3646216|B2|||HIV infection||participants|Number|2|2.0||||||
3820686|NCT01743521|3646217|B1|||HIV infection||participants|Number|5|5.0||||||
3820687|NCT01743521|3646213|B5|||Estimated Duration of infection at baseline||weeks|Median|40.9|40.9|Inter-Quartile Range|||36.4|56.4|
3820688|NCT01743521|3646214|B4|||Estimated Duration of infection at baseline||weeks|Median|33|33.0|Inter-Quartile Range|||24.0|41.0|
3820689|NCT01743521|3646215|B3|||Estimated Duration of infection at baseline||weeks|Median|50|50.0|Inter-Quartile Range|||41.0|59.0|
3820690|NCT01743521|3646216|B2|||Estimated Duration of infection at baseline||weeks|Median|46|46.0|Inter-Quartile Range|||36.0|75.0|
3820691|NCT01743521|3646217|B1|||Estimated Duration of infection at baseline||weeks|Median|39|39.0|Inter-Quartile Range|||25.0|56.0|
3820692|NCT01743521|3646213|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820693|NCT01743521|3646214|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820694|NCT01743521|3646215|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820695|NCT01743521|3646216|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820696|NCT01743521|3646217|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820697|NCT01743521|3646213|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3820698|NCT01743521|3646214|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3820699|NCT01743521|3646215|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3820700|NCT01743521|3646216|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3820701|NCT01743521|3646217|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3820702|NCT01743521|3646213|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820703|NCT01743521|3646214|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820704|NCT01743521|3646215|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820705|NCT01743521|3646216|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820706|NCT01743521|3646217|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820707|NCT01743521|3646213|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3820708|NCT01743521|3646214|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3820709|NCT01743521|3646215|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3820710|NCT01743521|3646216|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3820711|NCT01743521|3646217|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3820712|NCT01743521|3646213|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3820713|NCT01743521|3646214|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3820714|NCT01743521|3646215|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3820715|NCT01743521|3646216|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3820716|NCT01743521|3646217|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3820717|NCT01743521|3646213|B5|||Age||years|Median|48|48.0|Full Range|||28.0|68.0|
3820718|NCT01743521|3646214|B4|||Age||years|Median|57|57.0|Full Range|||46.0|68.0|
3820719|NCT01743521|3646215|B3|||Age||years|Median|44|44.0|Full Range|||33.0|54.0|
3820720|NCT01743521|3646216|B2|||Age||years|Median|45|45.0|Full Range|||35.0|49.0|
3820721|NCT01743521|3646217|B1|||Age||years|Median|49|49.0|Full Range|||28.0|65.0|
3820722|NCT01743469|3646270|B5|Spain||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3820723|NCT01743469|3646271|B4|Spain||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3820724|NCT01743469|3646272|B3|Spain||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3820725|NCT01743469|3646273|B2|Spain||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3820726|NCT01743469|3646274|B1|Spain||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3820727|NCT01743469|3646270|B5|France||Region of Enrollment||Participants|Count of Participants|66|66.0||||||
3820728|NCT01743469|3646271|B4|France||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3820729|NCT01743469|3646272|B3|France||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3820730|NCT01743469|3646273|B2|France||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3820731|NCT01743469|3646274|B1|France||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
3820732|NCT01743469|3646270|B5|United Kingdom||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3820733|NCT01743469|3646271|B4|United Kingdom||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3820734|NCT01743469|3646272|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3820735|NCT01743469|3646273|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3820736|NCT01743469|3646274|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3820737|NCT01743469|3646270|B5|Belgium||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3820738|NCT01743469|3646271|B4|Belgium||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3820739|NCT01743469|3646272|B3|Belgium||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3820740|NCT01743469|3646273|B2|Belgium||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3820741|NCT01743469|3646274|B1|Belgium||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3820742|NCT01743469|3646270|B5|Canada||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
3820743|NCT01743469|3646271|B4|Canada||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3820744|NCT01743469|3646272|B3|Canada||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3820745|NCT01743469|3646273|B2|Canada||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3820746|NCT01743469|3646274|B1|Canada||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3820747|NCT01743469|3646270|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3820748|NCT01743469|3646271|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3820749|NCT01743469|3646272|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3820750|NCT01743469|3646273|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3820751|NCT01743469|3646274|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3820752|NCT01743469|3646270|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820753|NCT01743469|3646271|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820754|NCT01743469|3646272|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820755|NCT01743469|3646273|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820756|NCT01743469|3646274|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820757|NCT01743469|3646270|B5||White|Race (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
3820758|NCT01743469|3646271|B4||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3820759|NCT01743469|3646272|B3||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3820760|NCT01743469|3646273|B2||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3820761|NCT01743469|3646274|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3820762|NCT01743469|3646270|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3820763|NCT01743469|3646271|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820764|NCT01743469|3646272|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820765|NCT01743469|3646273|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3820766|NCT01743469|3646274|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3820767|NCT01743469|3646270|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820768|NCT01743469|3646271|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820769|NCT01743469|3646272|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820770|NCT01743469|3646273|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820771|NCT01743469|3646274|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820772|NCT01743469|3646270|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3820773|NCT01743469|3646271|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3820774|NCT01743469|3646272|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820775|NCT01743469|3646273|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3820776|NCT01743469|3646274|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3820777|NCT01743469|3646270|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820778|NCT01743469|3646271|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820779|NCT01743469|3646272|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820780|NCT01743469|3646273|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820781|NCT01743469|3646274|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820782|NCT01743469|3646270|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3820783|NCT01743469|3646271|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3820784|NCT01743469|3646272|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3820785|NCT01743469|3646273|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3820786|NCT01743469|3646274|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3820787|NCT01743469|3646270|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
3820788|NCT01743469|3646271|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3820789|NCT01743469|3646272|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3820790|NCT01743469|3646273|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3820791|NCT01743469|3646274|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3820792|NCT01743469|3646270|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3820793|NCT01743469|3646271|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820794|NCT01743469|3646272|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3820795|NCT01743469|3646273|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3820796|NCT01743469|3646274|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3820797|NCT01743469|3646270|B5||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3820798|NCT01743469|3646271|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3820799|NCT01743469|3646272|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3820800|NCT01743469|3646273|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3820801|NCT01743469|3646274|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3820802|NCT01743469|3646270|B5||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3820803|NCT01743469|3646271|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3820804|NCT01743469|3646272|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3820805|NCT01743469|3646273|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3820806|NCT01743469|3646274|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3820807|NCT01743469|3646270|B5||>=65 years|Age||Participants|Count of Participants|78|78.0||||||
3820808|NCT01743469|3646271|B4||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3820809|NCT01743469|3646272|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3820810|NCT01743469|3646273|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3820811|NCT01743469|3646274|B1||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
3820812|NCT01743469|3646270|B5||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
3820813|NCT01743469|3646271|B4||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3820814|NCT01743469|3646272|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3820815|NCT01743469|3646273|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3820816|NCT01743469|3646274|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3820817|NCT01743469|3646270|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3820818|NCT01743469|3646271|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3820819|NCT01743469|3646272|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3820820|NCT01743469|3646273|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3820821|NCT01743469|3646274|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3820822|NCT01743092|3646315|B3|Canada||Region of Enrollment||participants|Number|59|59.0||||||
3820823|NCT01743092|3646316|B2|Canada||Region of Enrollment||participants|Number|26|26.0||||||
3820824|NCT01743092|3646317|B1|Canada||Region of Enrollment||participants|Number|33|33.0||||||
3820825|NCT01743092|3646315|B3|other||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3820826|NCT01743092|3646316|B2|other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3820827|NCT01743092|3646317|B1|other||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3820828|NCT01743092|3646315|B3|white / european||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
3820829|NCT01743092|3646316|B2|white / european||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3820830|NCT01743092|3646317|B1|white / european||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3820831|NCT01743092|3646315|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3820832|NCT01743092|3646316|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3820833|NCT01743092|3646317|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3820834|NCT01743092|3646315|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3820835|NCT01743092|3646316|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3820836|NCT01743092|3646317|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3820837|NCT01743092|3646315|B3|||Age||years|Mean|53|53.0|Full Range|||28.0|70.0|
3820838|NCT01743092|3646316|B2|||Age||years|Mean|56|56.0|Full Range|||28.0|70.0|
3820839|NCT01743092|3646317|B1|||Age||years|Mean|51|51.0|Full Range|||32.0|67.0|
3820840|NCT01743027|3646326|B5||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3820841|NCT01743027|3646327|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3820842|NCT01743027|3646328|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3820843|NCT01743027|3646329|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3820844|NCT01743027|3646330|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3820845|NCT01743027|3646326|B5||Female|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
3820846|NCT01743027|3646327|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3820847|NCT01743027|3646328|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3820848|NCT01743027|3646329|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3820849|NCT01743027|3646330|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3820850|NCT01743027|3646326|B5|≥75 - <85 Years||Age, Customized||participants|Number|1|1.0||||||
3820851|NCT01743027|3646327|B4|≥75 - <85 Years||Age, Customized||participants|Number|0|0.0||||||
3820852|NCT01743027|3646328|B3|≥75 - <85 Years||Age, Customized||participants|Number|0|0.0||||||
3820853|NCT01743027|3646329|B2|≥75 - <85 Years||Age, Customized||participants|Number|1|1.0||||||
3820854|NCT01743027|3646330|B1|≥75 - <85 Years||Age, Customized||participants|Number|0|0.0||||||
3820855|NCT01743027|3646326|B5|≥65 - <75 Years||Age, Customized||participants|Number|11|11.0||||||
3820856|NCT01743027|3646327|B4|≥65 - <75 Years||Age, Customized||participants|Number|1|1.0||||||
3820857|NCT01743027|3646328|B3|≥65 - <75 Years||Age, Customized||participants|Number|4|4.0||||||
3820858|NCT01743027|3646329|B2|≥65 - <75 Years||Age, Customized||participants|Number|5|5.0||||||
3820859|NCT01743027|3646330|B1|≥65 - <75 Years||Age, Customized||participants|Number|1|1.0||||||
3820860|NCT01743027|3646326|B5|18-64 Years||Age, Customized||participants|Number|333|333.0||||||
3820861|NCT01743027|3646327|B4|18-64 Years||Age, Customized||participants|Number|48|48.0||||||
3820862|NCT01743027|3646328|B3|18-64 Years||Age, Customized||participants|Number|95|95.0||||||
3820863|NCT01743027|3646329|B2|18-64 Years||Age, Customized||participants|Number|93|93.0||||||
3820864|NCT01743027|3646330|B1|18-64 Years||Age, Customized||participants|Number|97|97.0||||||
3820865|NCT01743001|3646371|B3|class IV||WHO functional class|Class I: no symptoms with exercise or at rest. No limitation of activity. Class II: No symptoms at rest but slight limitation with ordinary activities causing symptoms (e.g. short of breath with climbing a flight of stairs, grocery shopping, or making the bed). Class III: may not have symptoms at rest but activities greatly limited by shortness of breath, fatigue, or near fainting. Class IV: symptoms at rest (e.g. dyspnea and/or fatigue) and inability to carry out any physical activity without symptoms. Patients in class IV manifest signs of right heart failure.|Participants|Count of Participants|0|0.0||||||
3820866|NCT01743001|3646372|B2|class IV||WHO functional class|Class I: no symptoms with exercise or at rest. No limitation of activity. Class II: No symptoms at rest but slight limitation with ordinary activities causing symptoms (e.g. short of breath with climbing a flight of stairs, grocery shopping, or making the bed). Class III: may not have symptoms at rest but activities greatly limited by shortness of breath, fatigue, or near fainting. Class IV: symptoms at rest (e.g. dyspnea and/or fatigue) and inability to carry out any physical activity without symptoms. Patients in class IV manifest signs of right heart failure.|Participants|Count of Participants|0|0.0||||||
3820909|NCT01743001|3646373|B1|12 - 17 years||Age, Customized||Participants|Count of Participants|13|13.0||||||
3820867|NCT01743001|3646373|B1|class IV||WHO functional class|Class I: no symptoms with exercise or at rest. No limitation of activity. Class II: No symptoms at rest but slight limitation with ordinary activities causing symptoms (e.g. short of breath with climbing a flight of stairs, grocery shopping, or making the bed). Class III: may not have symptoms at rest but activities greatly limited by shortness of breath, fatigue, or near fainting. Class IV: symptoms at rest (e.g. dyspnea and/or fatigue) and inability to carry out any physical activity without symptoms. Patients in class IV manifest signs of right heart failure.|Participants|Count of Participants|0|0.0||||||
3820868|NCT01743001|3646371|B3|class III||WHO functional class|Class I: no symptoms with exercise or at rest. No limitation of activity. Class II: No symptoms at rest but slight limitation with ordinary activities causing symptoms (e.g. short of breath with climbing a flight of stairs, grocery shopping, or making the bed). Class III: may not have symptoms at rest but activities greatly limited by shortness of breath, fatigue, or near fainting. Class IV: symptoms at rest (e.g. dyspnea and/or fatigue) and inability to carry out any physical activity without symptoms. Patients in class IV manifest signs of right heart failure.|Participants|Count of Participants|91|91.0||||||
3820869|NCT01743001|3646372|B2|class III||WHO functional class|Class I: no symptoms with exercise or at rest. No limitation of activity. Class II: No symptoms at rest but slight limitation with ordinary activities causing symptoms (e.g. short of breath with climbing a flight of stairs, grocery shopping, or making the bed). Class III: may not have symptoms at rest but activities greatly limited by shortness of breath, fatigue, or near fainting. Class IV: symptoms at rest (e.g. dyspnea and/or fatigue) and inability to carry out any physical activity without symptoms. Patients in class IV manifest signs of right heart failure.|Participants|Count of Participants|46|46.0||||||
3820870|NCT01743001|3646373|B1|class III||WHO functional class|Class I: no symptoms with exercise or at rest. No limitation of activity. Class II: No symptoms at rest but slight limitation with ordinary activities causing symptoms (e.g. short of breath with climbing a flight of stairs, grocery shopping, or making the bed). Class III: may not have symptoms at rest but activities greatly limited by shortness of breath, fatigue, or near fainting. Class IV: symptoms at rest (e.g. dyspnea and/or fatigue) and inability to carry out any physical activity without symptoms. Patients in class IV manifest signs of right heart failure.|Participants|Count of Participants|45|45.0||||||
3820871|NCT01743001|3646371|B3|class II||WHO functional class|Class I: no symptoms with exercise or at rest. No limitation of activity. Class II: No symptoms at rest but slight limitation with ordinary activities causing symptoms (e.g. short of breath with climbing a flight of stairs, grocery shopping, or making the bed). Class III: may not have symptoms at rest but activities greatly limited by shortness of breath, fatigue, or near fainting. Class IV: symptoms at rest (e.g. dyspnea and/or fatigue) and inability to carry out any physical activity without symptoms. Patients in class IV manifest signs of right heart failure.|Participants|Count of Participants|135|135.0||||||
3820872|NCT01743001|3646372|B2|class II||WHO functional class|Class I: no symptoms with exercise or at rest. No limitation of activity. Class II: No symptoms at rest but slight limitation with ordinary activities causing symptoms (e.g. short of breath with climbing a flight of stairs, grocery shopping, or making the bed). Class III: may not have symptoms at rest but activities greatly limited by shortness of breath, fatigue, or near fainting. Class IV: symptoms at rest (e.g. dyspnea and/or fatigue) and inability to carry out any physical activity without symptoms. Patients in class IV manifest signs of right heart failure.|Participants|Count of Participants|66|66.0||||||
3820873|NCT01743001|3646373|B1|class II||WHO functional class|Class I: no symptoms with exercise or at rest. No limitation of activity. Class II: No symptoms at rest but slight limitation with ordinary activities causing symptoms (e.g. short of breath with climbing a flight of stairs, grocery shopping, or making the bed). Class III: may not have symptoms at rest but activities greatly limited by shortness of breath, fatigue, or near fainting. Class IV: symptoms at rest (e.g. dyspnea and/or fatigue) and inability to carry out any physical activity without symptoms. Patients in class IV manifest signs of right heart failure.|Participants|Count of Participants|69|69.0||||||
3820874|NCT01743001|3646371|B3|class I||WHO functional class|Class I: no symptoms with exercise or at rest. No limitation of activity. Class II: No symptoms at rest but slight limitation with ordinary activities causing symptoms (e.g. short of breath with climbing a flight of stairs, grocery shopping, or making the bed). Class III: may not have symptoms at rest but activities greatly limited by shortness of breath, fatigue, or near fainting. Class IV: symptoms at rest (e.g. dyspnea and/or fatigue) and inability to carry out any physical activity without symptoms. Patients in class IV manifest signs of right heart failure.|Participants|Count of Participants|0|0.0||||||
3820875|NCT01743001|3646372|B2|class I||WHO functional class|Class I: no symptoms with exercise or at rest. No limitation of activity. Class II: No symptoms at rest but slight limitation with ordinary activities causing symptoms (e.g. short of breath with climbing a flight of stairs, grocery shopping, or making the bed). Class III: may not have symptoms at rest but activities greatly limited by shortness of breath, fatigue, or near fainting. Class IV: symptoms at rest (e.g. dyspnea and/or fatigue) and inability to carry out any physical activity without symptoms. Patients in class IV manifest signs of right heart failure.|Participants|Count of Participants|0|0.0||||||
3820876|NCT01743001|3646373|B1|class I||WHO functional class|Class I: no symptoms with exercise or at rest. No limitation of activity. Class II: No symptoms at rest but slight limitation with ordinary activities causing symptoms (e.g. short of breath with climbing a flight of stairs, grocery shopping, or making the bed). Class III: may not have symptoms at rest but activities greatly limited by shortness of breath, fatigue, or near fainting. Class IV: symptoms at rest (e.g. dyspnea and/or fatigue) and inability to carry out any physical activity without symptoms. Patients in class IV manifest signs of right heart failure.|Participants|Count of Participants|0|0.0||||||
3820877|NCT01743001|3646371|B3|||Body Mass Index (BMI)||kg/m^2|Median|21.35|21.35|Full Range|||11.9|42.2|
3820878|NCT01743001|3646372|B2|||Body Mass Index (BMI)||kg/m^2|Median|21.55|21.55|Full Range|||14.5|42.2|
3820879|NCT01743001|3646373|B1|||Body Mass Index (BMI)||kg/m^2|Median|21.15|21.15|Full Range|||11.9|38.9|
3820880|NCT01743001|3646371|B3|Western Europe - Israel||Region of Enrollment|Asia-Pacific includes: China, Malaysia, Philippines, Vietnam; Eastern Europe: Bulgaria, Poland, Romania, Russian Federation, Serbia; Latin America: Chile, Mexico; North America: United States; Western Europe - Israel: Austria, France, Germany, Greece, Israel, Portugal, Spain, Turkey, United Kingdom|Participants|Count of Participants|39|39.0||||||
3820910|NCT01743001|3646371|B3|||Age||Years|Median|32.0|32.0|Full Range|||12.0|82.0|
3820881|NCT01743001|3646372|B2|Western Europe - Israel||Region of Enrollment|Asia-Pacific includes: China, Malaysia, Philippines, Vietnam; Eastern Europe: Bulgaria, Poland, Romania, Russian Federation, Serbia; Latin America: Chile, Mexico; North America: United States; Western Europe - Israel: Austria, France, Germany, Greece, Israel, Portugal, Spain, Turkey, United Kingdom|Participants|Count of Participants|18|18.0||||||
3820882|NCT01743001|3646373|B1|Western Europe - Israel||Region of Enrollment|Asia-Pacific includes: China, Malaysia, Philippines, Vietnam; Eastern Europe: Bulgaria, Poland, Romania, Russian Federation, Serbia; Latin America: Chile, Mexico; North America: United States; Western Europe - Israel: Austria, France, Germany, Greece, Israel, Portugal, Spain, Turkey, United Kingdom|Participants|Count of Participants|21|21.0||||||
3820883|NCT01743001|3646371|B3|North America||Region of Enrollment|Asia-Pacific includes: China, Malaysia, Philippines, Vietnam; Eastern Europe: Bulgaria, Poland, Romania, Russian Federation, Serbia; Latin America: Chile, Mexico; North America: United States; Western Europe - Israel: Austria, France, Germany, Greece, Israel, Portugal, Spain, Turkey, United Kingdom|Participants|Count of Participants|7|7.0||||||
3820884|NCT01743001|3646372|B2|North America||Region of Enrollment|Asia-Pacific includes: China, Malaysia, Philippines, Vietnam; Eastern Europe: Bulgaria, Poland, Romania, Russian Federation, Serbia; Latin America: Chile, Mexico; North America: United States; Western Europe - Israel: Austria, France, Germany, Greece, Israel, Portugal, Spain, Turkey, United Kingdom|Participants|Count of Participants|5|5.0||||||
3820885|NCT01743001|3646373|B1|North America||Region of Enrollment|Asia-Pacific includes: China, Malaysia, Philippines, Vietnam; Eastern Europe: Bulgaria, Poland, Romania, Russian Federation, Serbia; Latin America: Chile, Mexico; North America: United States; Western Europe - Israel: Austria, France, Germany, Greece, Israel, Portugal, Spain, Turkey, United Kingdom|Participants|Count of Participants|2|2.0||||||
3820886|NCT01743001|3646371|B3|Latin America||Region of Enrollment|Asia-Pacific includes: China, Malaysia, Philippines, Vietnam; Eastern Europe: Bulgaria, Poland, Romania, Russian Federation, Serbia; Latin America: Chile, Mexico; North America: United States; Western Europe - Israel: Austria, France, Germany, Greece, Israel, Portugal, Spain, Turkey, United Kingdom|Participants|Count of Participants|37|37.0||||||
3820887|NCT01743001|3646372|B2|Latin America||Region of Enrollment|Asia-Pacific includes: China, Malaysia, Philippines, Vietnam; Eastern Europe: Bulgaria, Poland, Romania, Russian Federation, Serbia; Latin America: Chile, Mexico; North America: United States; Western Europe - Israel: Austria, France, Germany, Greece, Israel, Portugal, Spain, Turkey, United Kingdom|Participants|Count of Participants|18|18.0||||||
3820888|NCT01743001|3646373|B1|Latin America||Region of Enrollment|Asia-Pacific includes: China, Malaysia, Philippines, Vietnam; Eastern Europe: Bulgaria, Poland, Romania, Russian Federation, Serbia; Latin America: Chile, Mexico; North America: United States; Western Europe - Israel: Austria, France, Germany, Greece, Israel, Portugal, Spain, Turkey, United Kingdom|Participants|Count of Participants|19|19.0||||||
3820889|NCT01743001|3646371|B3|Eastern Europe||Region of Enrollment|Asia-Pacific includes: China, Malaysia, Philippines, Vietnam; Eastern Europe: Bulgaria, Poland, Romania, Russian Federation, Serbia; Latin America: Chile, Mexico; North America: United States; Western Europe - Israel: Austria, France, Germany, Greece, Israel, Portugal, Spain, Turkey, United Kingdom|Participants|Count of Participants|52|52.0||||||
3820890|NCT01743001|3646372|B2|Eastern Europe||Region of Enrollment|Asia-Pacific includes: China, Malaysia, Philippines, Vietnam; Eastern Europe: Bulgaria, Poland, Romania, Russian Federation, Serbia; Latin America: Chile, Mexico; North America: United States; Western Europe - Israel: Austria, France, Germany, Greece, Israel, Portugal, Spain, Turkey, United Kingdom|Participants|Count of Participants|27|27.0||||||
3820891|NCT01743001|3646373|B1|Eastern Europe||Region of Enrollment|Asia-Pacific includes: China, Malaysia, Philippines, Vietnam; Eastern Europe: Bulgaria, Poland, Romania, Russian Federation, Serbia; Latin America: Chile, Mexico; North America: United States; Western Europe - Israel: Austria, France, Germany, Greece, Israel, Portugal, Spain, Turkey, United Kingdom|Participants|Count of Participants|25|25.0||||||
3820892|NCT01743001|3646371|B3|Asia-Pacific||Region of Enrollment|Asia-Pacific includes: China, Malaysia, Philippines, Vietnam; Eastern Europe: Bulgaria, Poland, Romania, Russian Federation, Serbia; Latin America: Chile, Mexico; North America: United States; Western Europe - Israel: Austria, France, Germany, Greece, Israel, Portugal, Spain, Turkey, United Kingdom|Participants|Count of Participants|91|91.0||||||
3820893|NCT01743001|3646372|B2|Asia-Pacific||Region of Enrollment|Asia-Pacific includes: China, Malaysia, Philippines, Vietnam; Eastern Europe: Bulgaria, Poland, Romania, Russian Federation, Serbia; Latin America: Chile, Mexico; North America: United States; Western Europe - Israel: Austria, France, Germany, Greece, Israel, Portugal, Spain, Turkey, United Kingdom|Participants|Count of Participants|44|44.0||||||
3820894|NCT01743001|3646373|B1|Asia-Pacific||Region of Enrollment|Asia-Pacific includes: China, Malaysia, Philippines, Vietnam; Eastern Europe: Bulgaria, Poland, Romania, Russian Federation, Serbia; Latin America: Chile, Mexico; North America: United States; Western Europe - Israel: Austria, France, Germany, Greece, Israel, Portugal, Spain, Turkey, United Kingdom|Participants|Count of Participants|47|47.0||||||
3820895|NCT01743001|3646371|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3820896|NCT01743001|3646372|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3820897|NCT01743001|3646373|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3820898|NCT01743001|3646371|B3||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3820899|NCT01743001|3646372|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3820900|NCT01743001|3646373|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3820901|NCT01743001|3646371|B3|≥ 56 years||Age, Customized||Participants|Count of Participants|16|16.0||||||
3820902|NCT01743001|3646372|B2|≥ 56 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
3820903|NCT01743001|3646373|B1|≥ 56 years||Age, Customized||Participants|Count of Participants|11|11.0||||||
3820904|NCT01743001|3646371|B3|18 - 55 years||Age, Customized||Participants|Count of Participants|195|195.0||||||
3820905|NCT01743001|3646372|B2|18 - 55 years||Age, Customized||Participants|Count of Participants|105|105.0||||||
3820906|NCT01743001|3646373|B1|18 - 55 years||Age, Customized||Participants|Count of Participants|90|90.0||||||
3820907|NCT01743001|3646371|B3|12 - 17 years||Age, Customized||Participants|Count of Participants|15|15.0||||||
3820908|NCT01743001|3646372|B2|12 - 17 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
3820911|NCT01743001|3646372|B2|||Age||Years|Median|31.0|31.0|Full Range|||13.0|62.0|
3820912|NCT01743001|3646373|B1|||Age||Years|Median|33.0|33.0|Full Range|||12.0|82.0|
3820913|NCT01742936|3646386|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
3820914|NCT01742936|3646387|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
3820915|NCT01742936|3646388|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3820916|NCT01742936|3646386|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3820917|NCT01742936|3646387|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3820918|NCT01742936|3646388|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3820919|NCT01742936|3646386|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3820920|NCT01742936|3646387|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3820921|NCT01742936|3646388|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3820922|NCT01742936|3646386|B3|||Age||years|Mean|12|12.0|Standard Deviation|4|4.0|||
3820923|NCT01742936|3646387|B2|||Age||years|Mean|9.4|9.4|Standard Deviation|4.4|4.4|||
3820924|NCT01742936|3646388|B1|||Age||years|Mean|14.1|14.1|Standard Deviation|2.2|2.2|||
3820925|NCT01742897|3646397|B1|Overall||Western Ontario McMaster Universities Osteoarthritis Index (WOMAC) Scores|The WOMAC is a self administered, participant health related questionnaire consisting of three subscales (pain, stiffness and physical function). Pain subscale score ranges from 0-100 mm (0 mm=no pain to 100 mm=extreme pain); stiffness subscale score ranges from 0-100 mm (0 mm=no stiffness to 100 mm=extreme stiffness) and physical function subscale ranges from 0-100 mm (0 mm=no difficulty to 100 mm=extreme difficulty). The overall WOMAC score is the sum of the 3 subscale scores which ranges from 0-300 mm (0 mm=none to 300 mm=extreme/worst).|Millimeter (mm)|Mean|133.1|133.1|Standard Deviation|4.04|4.04|||
3820926|NCT01742897|3646397|B1|Physical function||Western Ontario McMaster Universities Osteoarthritis Index (WOMAC) Scores|The WOMAC is a self administered, participant health related questionnaire consisting of three subscales (pain, stiffness and physical function). Pain subscale score ranges from 0-100 mm (0 mm=no pain to 100 mm=extreme pain); stiffness subscale score ranges from 0-100 mm (0 mm=no stiffness to 100 mm=extreme stiffness) and physical function subscale ranges from 0-100 mm (0 mm=no difficulty to 100 mm=extreme difficulty). The overall WOMAC score is the sum of the 3 subscale scores which ranges from 0-300 mm (0 mm=none to 300 mm=extreme/worst).|Millimeter (mm)|Mean|47.6|47.6|Standard Deviation|1.12|1.12|||
3820927|NCT01742897|3646397|B1|Stiffness||Western Ontario McMaster Universities Osteoarthritis Index (WOMAC) Scores|The WOMAC is a self administered, participant health related questionnaire consisting of three subscales (pain, stiffness and physical function). Pain subscale score ranges from 0-100 mm (0 mm=no pain to 100 mm=extreme pain); stiffness subscale score ranges from 0-100 mm (0 mm=no stiffness to 100 mm=extreme stiffness) and physical function subscale ranges from 0-100 mm (0 mm=no difficulty to 100 mm=extreme difficulty). The overall WOMAC score is the sum of the 3 subscale scores which ranges from 0-300 mm (0 mm=none to 300 mm=extreme/worst).|Millimeter (mm)|Mean|41.6|41.6|Standard Deviation|1.92|1.92|||
3820928|NCT01742897|3646397|B1|Pain||Western Ontario McMaster Universities Osteoarthritis Index (WOMAC) Scores|The WOMAC is a self administered, participant health related questionnaire consisting of three subscales (pain, stiffness and physical function). Pain subscale score ranges from 0-100 mm (0 mm=no pain to 100 mm=extreme pain); stiffness subscale score ranges from 0-100 mm (0 mm=no stiffness to 100 mm=extreme stiffness) and physical function subscale ranges from 0-100 mm (0 mm=no difficulty to 100 mm=extreme difficulty). The overall WOMAC score is the sum of the 3 subscale scores which ranges from 0-300 mm (0 mm=none to 300 mm=extreme/worst).|Millimeter (mm)|Mean|43.9|43.9|Standard Deviation|1.51|1.51|||
3820929|NCT01742897|3646397|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3820930|NCT01742897|3646397|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3820931|NCT01742897|3646397|B1|||Age||Years|Mean|66.34|66.34|Standard Deviation|6.11|6.11|||
3820932|NCT01742832|3646401|B3|United States||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3820933|NCT01742832|3646402|B2|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3820934|NCT01742832|3646403|B1|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3820935|NCT01742832|3646401|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3820936|NCT01742832|3646402|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3820937|NCT01742832|3646403|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3820938|NCT01742832|3646401|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3820939|NCT01742832|3646402|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3820940|NCT01742832|3646403|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3820941|NCT01742832|3646401|B3|||Age||years|Mean|35.4|35.4|Standard Deviation|11.6|11.6|||
3820942|NCT01742832|3646402|B2|||Age||years|Mean|38.6|38.6|Standard Deviation|11.1|11.1|||
3820943|NCT01742832|3646403|B1|||Age||years|Mean|31.7|31.7|Standard Deviation|11.3|11.3|||
3820944|NCT01742832|3646401|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3820945|NCT01742832|3646402|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3820946|NCT01742832|3646403|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3820947|NCT01742832|3646401|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3820948|NCT01742832|3646402|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3820949|NCT01742832|3646403|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3820950|NCT01742832|3646401|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3820951|NCT01742832|3646402|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3820952|NCT01742832|3646403|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3820953|NCT01742364|3646410|B5||Male|Gender||Participants|Count of Participants|39|39.0||||||
3820954|NCT01742364|3646411|B4||Male|Gender||Participants|Count of Participants|5|5.0||||||
3820955|NCT01742364|3646412|B3||Male|Gender||Participants|Count of Participants|2|2.0||||||
3820956|NCT01742364|3646413|B2||Male|Gender||Participants|Count of Participants|17|17.0||||||
3820957|NCT01742364|3646414|B1||Male|Gender||Participants|Count of Participants|15|15.0||||||
3820958|NCT01742364|3646410|B5||Female|Gender||Participants|Count of Participants|57|57.0||||||
3820959|NCT01742364|3646411|B4||Female|Gender||Participants|Count of Participants|10|10.0||||||
3820960|NCT01742364|3646412|B3||Female|Gender||Participants|Count of Participants|13|13.0||||||
3820961|NCT01742364|3646413|B2||Female|Gender||Participants|Count of Participants|16|16.0||||||
3820962|NCT01742364|3646414|B1||Female|Gender||Participants|Count of Participants|18|18.0||||||
3820963|NCT01742364|3646410|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3820964|NCT01742364|3646411|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3820965|NCT01742364|3646412|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3820966|NCT01742364|3646413|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3820967|NCT01742364|3646414|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3820968|NCT01742364|3646410|B5||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3820969|NCT01742364|3646411|B4||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3820970|NCT01742364|3646412|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3820971|NCT01742364|3646413|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3820972|NCT01742364|3646414|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3820973|NCT01742364|3646410|B5||<=18 years|Age||Participants|Count of Participants|66|66.0||||||
3820974|NCT01742364|3646411|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3820975|NCT01742364|3646412|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3820976|NCT01742364|3646413|B2||<=18 years|Age||Participants|Count of Participants|33|33.0||||||
3820977|NCT01742364|3646414|B1||<=18 years|Age||Participants|Count of Participants|33|33.0||||||
3820978|NCT01742091|3646443|B7|United States||Region of Enrollment||participants|Number|59|59.0||||||
3820979|NCT01742091|3646444|B6|United States||Region of Enrollment||participants|Number|12|12.0||||||
3820980|NCT01742091|3646445|B5|United States||Region of Enrollment||participants|Number|8|8.0||||||
3820981|NCT01742091|3646446|B4|United States||Region of Enrollment||participants|Number|9|9.0||||||
3820982|NCT01742091|3646447|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3820983|NCT01742091|3646448|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3820984|NCT01742091|3646449|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3820985|NCT01742091|3646443|B7|White||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
3820986|NCT01742091|3646444|B6|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3820987|NCT01742091|3646445|B5|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3820988|NCT01742091|3646446|B4|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3820989|NCT01742091|3646447|B3|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3820990|NCT01742091|3646448|B2|White||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3820991|NCT01742091|3646449|B1|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3820992|NCT01742091|3646443|B7|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3820993|NCT01742091|3646444|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3820994|NCT01742091|3646445|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3820995|NCT01742091|3646446|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3820996|NCT01742091|3646447|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3820997|NCT01742091|3646448|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3820998|NCT01742091|3646449|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3820999|NCT01742091|3646443|B7|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3821000|NCT01742091|3646444|B6|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3821001|NCT01742091|3646445|B5|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3821002|NCT01742091|3646446|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3821003|NCT01742091|3646447|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3821004|NCT01742091|3646448|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3821005|NCT01742091|3646449|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3821006|NCT01742091|3646443|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821007|NCT01742091|3646444|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821008|NCT01742091|3646445|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821009|NCT01742091|3646446|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821010|NCT01742091|3646447|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821011|NCT01742091|3646448|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821012|NCT01742091|3646449|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821013|NCT01742091|3646443|B7||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3821014|NCT01742091|3646444|B6||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3821015|NCT01742091|3646445|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3821016|NCT01742091|3646446|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3821017|NCT01742091|3646447|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3821018|NCT01742091|3646448|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3821019|NCT01742091|3646449|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3821020|NCT01742091|3646443|B7|||Age||years|Mean|59|59.0|Standard Deviation|8.3|8.3|||
3821021|NCT01742091|3646444|B6|||Age||years|Mean|62|62.0|Standard Deviation|10.5|10.5|||
3821022|NCT01742091|3646445|B5|||Age||years|Mean|66|66.0|Standard Deviation|8.8|8.8|||
3821023|NCT01742091|3646446|B4|||Age||years|Mean|57|57.0|Standard Deviation|8.3|8.3|||
3821024|NCT01742091|3646447|B3|||Age||years|Mean|56|56.0|Standard Deviation|7.5|7.5|||
3821025|NCT01742091|3646448|B2|||Age||years|Mean|57|57.0|Standard Deviation|5.5|5.5|||
3821026|NCT01742091|3646449|B1|||Age||years|Mean|58|58.0|Standard Deviation|5.1|5.1|||
3821027|NCT01741792|3646491|B4|≥ 1||Number of Previous Autologous Hematopoietic Stem Cell Transplants (HSCT)||participants|Number|7|7.0||||||
3821028|NCT01741792|3646492|B3|≥ 1||Number of Previous Autologous Hematopoietic Stem Cell Transplants (HSCT)||participants|Number|4|4.0||||||
3821029|NCT01741792|3646493|B2|≥ 1||Number of Previous Autologous Hematopoietic Stem Cell Transplants (HSCT)||participants|Number|1|1.0||||||
3821030|NCT01741792|3646494|B1|≥ 1||Number of Previous Autologous Hematopoietic Stem Cell Transplants (HSCT)||participants|Number|2|2.0||||||
3821031|NCT01741792|3646491|B4|None||Number of Previous Autologous Hematopoietic Stem Cell Transplants (HSCT)||participants|Number|18|18.0||||||
3821032|NCT01741792|3646492|B3|None||Number of Previous Autologous Hematopoietic Stem Cell Transplants (HSCT)||participants|Number|10|10.0||||||
3821033|NCT01741792|3646493|B2|None||Number of Previous Autologous Hematopoietic Stem Cell Transplants (HSCT)||participants|Number|1|1.0||||||
3821034|NCT01741792|3646494|B1|None||Number of Previous Autologous Hematopoietic Stem Cell Transplants (HSCT)||participants|Number|7|7.0||||||
3821035|NCT01741792|3646491|B4|Refractory||Relapsed/refractory Status to Last Prior Treatment||participants|Number|16|16.0||||||
3821036|NCT01741792|3646492|B3|Refractory||Relapsed/refractory Status to Last Prior Treatment||participants|Number|10|10.0||||||
3821037|NCT01741792|3646493|B2|Refractory||Relapsed/refractory Status to Last Prior Treatment||participants|Number|1|1.0||||||
3821038|NCT01741792|3646494|B1|Refractory||Relapsed/refractory Status to Last Prior Treatment||participants|Number|5|5.0||||||
3821039|NCT01741792|3646491|B4|Relapsed||Relapsed/refractory Status to Last Prior Treatment||participants|Number|9|9.0||||||
3821040|NCT01741792|3646492|B3|Relapsed||Relapsed/refractory Status to Last Prior Treatment||participants|Number|4|4.0||||||
3821041|NCT01741792|3646493|B2|Relapsed||Relapsed/refractory Status to Last Prior Treatment||participants|Number|1|1.0||||||
3821042|NCT01741792|3646494|B1|Relapsed||Relapsed/refractory Status to Last Prior Treatment||participants|Number|4|4.0||||||
3821043|NCT01741792|3646491|B4|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3821044|NCT01741792|3646492|B3|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3821045|NCT01741792|3646493|B2|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3821046|NCT01741792|3646494|B1|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3821047|NCT01741792|3646491|B4||Male|Gender||Participants|Count of Participants|14|14.0||||||
3821048|NCT01741792|3646492|B3||Male|Gender||Participants|Count of Participants|10|10.0||||||
3821049|NCT01741792|3646493|B2||Male|Gender||Participants|Count of Participants|2|2.0||||||
3821050|NCT01741792|3646494|B1||Male|Gender||Participants|Count of Participants|2|2.0||||||
3821051|NCT01741792|3646491|B4||Female|Gender||Participants|Count of Participants|11|11.0||||||
3821052|NCT01741792|3646492|B3||Female|Gender||Participants|Count of Participants|4|4.0||||||
3821053|NCT01741792|3646493|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
3821054|NCT01741792|3646494|B1||Female|Gender||Participants|Count of Participants|7|7.0||||||
3821055|NCT01741792|3646491|B4|||Age||years|Mean|62.9|62.9|Standard Deviation|13.3|13.3|||
3821056|NCT01741792|3646492|B3|||Age||years|Mean|57.1|57.1|Standard Deviation|13.6|13.6|||
3821057|NCT01741792|3646493|B2|||Age||years|Mean|64.5|64.5|Standard Deviation|13.4|13.4|||
3821058|NCT01741792|3646494|B1|||Age||years|Mean|71.7|71.7|Standard Deviation|7.8|7.8|||
3821059|NCT01741701|3646561|B3|||PD Duration||years|Mean|3.0|3.0|Standard Deviation|1.6|1.6|||
3821060|NCT01741701|3646562|B2|||PD Duration||years|Mean|3.1|3.1|Standard Deviation|1.7|1.7|||
3821061|NCT01741701|3646563|B1|||PD Duration||years|Mean|2.9|2.9|Standard Deviation|1.5|1.5|||
3821062|NCT01741701|3646561|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
3821063|NCT01741701|3646562|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3821064|NCT01741701|3646563|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3821065|NCT01741701|3646561|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3821066|NCT01741701|3646562|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3821067|NCT01741701|3646563|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3821068|NCT01741701|3646561|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3821069|NCT01741701|3646562|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3821070|NCT01741701|3646563|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3821071|NCT01741701|3646561|B3|||Age||years|Mean|63.4|63.4|Standard Deviation|10.5|10.5|||
3821072|NCT01741701|3646562|B2|||Age||years|Mean|64.6|64.6|Standard Deviation|9.4|9.4|||
3821073|NCT01741701|3646563|B1|||Age||years|Mean|62.4|62.4|Standard Deviation|11.4|11.4|||
3821074|NCT01741701|3646561|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3821075|NCT01741701|3646562|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3821076|NCT01741701|3646563|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3821077|NCT01741701|3646561|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3821078|NCT01741701|3646562|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3821079|NCT01741701|3646563|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3821080|NCT01741701|3646561|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3821081|NCT01741701|3646562|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3821082|NCT01741701|3646563|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3821083|NCT01741688|3646580|B1|Peru||Region of Enrollment||participants|Number|16|16.0||||||
3821084|NCT01741688|3646580|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3821085|NCT01741688|3646580|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3821086|NCT01741688|3646580|B1|||Age||years|Median|55|55.0|Full Range|||33.4|68.0|
3821087|NCT01741480|3646597|B3|United States||Region of Enrollment|Saint louis Region|participants|Number|571|571.0||||||
3821088|NCT01741480|3646598|B2|United States||Region of Enrollment|Saint louis Region|participants|Number|286|286.0||||||
3821089|NCT01741480|3646599|B1|United States||Region of Enrollment|Saint louis Region|participants|Number|285|285.0||||||
3821090|NCT01741480|3646597|B3||Male|Sex: Female, Male||Participants|Count of Participants|299|299.0||||||
3821091|NCT01741480|3646598|B2||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3821092|NCT01741480|3646599|B1||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3821093|NCT01741480|3646597|B3||Female|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
3821094|NCT01741480|3646598|B2||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3821095|NCT01741480|3646599|B1||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3821096|NCT01741480|3646597|B3|||Age||years|Mean|63.3|63.3|Standard Deviation|15.5|15.5|||
3821097|NCT01741480|3646598|B2|||Age||years|Mean|63.7|63.7|Standard Deviation|16|16.0|||
3821098|NCT01741480|3646599|B1|||Age||years|Mean|63.1|63.1|Standard Deviation|15.4|15.4|||
3821099|NCT01741350|3646606|B3|United States||Region of Enrollment||participants|Number|304|304.0||||||
3821100|NCT01741350|3646607|B2|United States||Region of Enrollment||participants|Number|155|155.0||||||
3821101|NCT01741350|3646608|B1|United States||Region of Enrollment||participants|Number|149|149.0||||||
3821102|NCT01741350|3646606|B3||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3821103|NCT01741350|3646607|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3821104|NCT01741350|3646608|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3821105|NCT01741350|3646606|B3||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3821106|NCT01741350|3646607|B2||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3821107|NCT01741350|3646608|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3821108|NCT01741350|3646606|B3|||Age||years|Mean|33.87|33.87|Standard Deviation|9.532|9.532|||
3821109|NCT01741350|3646607|B2|||Age||years|Mean|33.50|33.5|Standard Deviation|9.141|9.141|||
3821110|NCT01741350|3646608|B1|||Age||years|Mean|34.26|34.26|Standard Deviation|9.939|9.939|||
3821111|NCT01741350|3646606|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3821112|NCT01741350|3646607|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3821113|NCT01741350|3646608|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3821114|NCT01741350|3646606|B3||Between 18 and 65 years|Age||Participants|Count of Participants|304|304.0||||||
3821115|NCT01741350|3646607|B2||Between 18 and 65 years|Age||Participants|Count of Participants|155|155.0||||||
3821116|NCT01741350|3646608|B1||Between 18 and 65 years|Age||Participants|Count of Participants|149|149.0||||||
3821117|NCT01741350|3646606|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3821118|NCT01741350|3646607|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3821119|NCT01741350|3646608|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3821120|NCT01741272|3646743|B3|Canada||Region of Enrollment||participants|Number|189|189.0||||||
3821121|NCT01741272|3646744|B2|Canada||Region of Enrollment||participants|Number|97|97.0||||||
3821122|NCT01741272|3646745|B1|Canada||Region of Enrollment||participants|Number|92|92.0||||||
3821123|NCT01741272|3646743|B3||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3821124|NCT01741272|3646744|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3821125|NCT01741272|3646745|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3821126|NCT01741272|3646743|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3821127|NCT01741272|3646744|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3821128|NCT01741272|3646745|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3821129|NCT01741272|3646743|B3|||Age||years|Mean|55.1|55.1|Inter-Quartile Range|||35.0|86.0|
3821130|NCT01741272|3646744|B2|||Age||years|Mean|55.4|55.4|Inter-Quartile Range|||38.0|86.0|
3821131|NCT01741272|3646745|B1|||Age||years|Mean|54.9|54.9|Inter-Quartile Range|||35.0|78.0|
3821132|NCT01741259|3646760|B3|||BMI||kg/m^2|Mean|33.09|33.09|Standard Deviation|6.76|6.76|||
3821133|NCT01741259|3646761|B2|||BMI||kg/m^2|Mean|32.18|32.18|Standard Deviation|6.17|6.17|||
3821134|NCT01741259|3646762|B1|||BMI||kg/m^2|Mean|34.03|34.03|Standard Deviation|7.22|7.22|||
3821135|NCT01741259|3646760|B3||Repeat CS|Primary vs repeat Cesarean Section||Participants|Count of Participants|178|178.0||||||
3821136|NCT01741259|3646761|B2||Repeat CS|Primary vs repeat Cesarean Section||Participants|Count of Participants|88|88.0||||||
3821137|NCT01741259|3646762|B1||Repeat CS|Primary vs repeat Cesarean Section||Participants|Count of Participants|90|90.0||||||
3821138|NCT01741259|3646760|B3||Primary CS|Primary vs repeat Cesarean Section||Participants|Count of Participants|78|78.0||||||
3821139|NCT01741259|3646761|B2||Primary CS|Primary vs repeat Cesarean Section||Participants|Count of Participants|41|41.0||||||
3821140|NCT01741259|3646762|B1||Primary CS|Primary vs repeat Cesarean Section||Participants|Count of Participants|37|37.0||||||
3821141|NCT01741259|3646760|B3|United States||Region of Enrollment||participants|Number|256|256.0||||||
3821142|NCT01741259|3646761|B2|United States||Region of Enrollment||participants|Number|129|129.0||||||
3821143|NCT01741259|3646762|B1|United States||Region of Enrollment||participants|Number|127|127.0||||||
3821144|NCT01741259|3646760|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821145|NCT01741259|3646761|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821146|NCT01741259|3646762|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821147|NCT01741259|3646760|B3||Female|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
3821148|NCT01741259|3646761|B2||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3821149|NCT01741259|3646762|B1||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3821150|NCT01741259|3646760|B3|||Age||years|Median|31|31.0|Standard Deviation|4.60|4.6|||
3821151|NCT01741259|3646761|B2|||Age||years|Median|31|31.0|Standard Deviation|4.81|4.81|||
3821152|NCT01741259|3646762|B1|||Age||years|Median|31|31.0|Standard Deviation|4.39|4.39|||
3821153|NCT01741012|3646817|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
3821154|NCT01741012|3646817|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821155|NCT01741012|3646817|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3821156|NCT01741012|3646817|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3821157|NCT01741012|3646817|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3821158|NCT01741012|3646817|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821159|NCT01741012|3646817|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821160|NCT01741012|3646817|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821161|NCT01741012|3646817|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821162|NCT01741012|3646817|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3821163|NCT01741012|3646817|B1|||Age||years|Mean|38.1|38.1|Standard Deviation|7.9|7.9|||
3821164|NCT01740817|3646824|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3821165|NCT01740817|3646824|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3821166|NCT01740817|3646824|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3821167|NCT01740817|3646824|B1|||Age||years|Mean|39|39.0|Standard Deviation|11|11.0|||
3821168|NCT01740726|3646835|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3821169|NCT01740726|3646836|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3821170|NCT01740726|3646835|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821171|NCT01740726|3646836|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821172|NCT01740726|3646835|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3821173|NCT01740726|3646836|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3821174|NCT01740726|3646835|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3821175|NCT01740726|3646836|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3821176|NCT01740726|3646835|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3821177|NCT01740726|3646836|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3821178|NCT01740726|3646835|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3821179|NCT01740726|3646836|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3821180|NCT01740713|3646860|B4|Italy||Region of Enrollment||participants|Number|21|21.0||||||
3821181|NCT01740713|3646861|B3|Italy||Region of Enrollment||participants|Number|7|7.0||||||
3821182|NCT01740713|3646862|B2|Italy||Region of Enrollment||participants|Number|8|8.0||||||
3821183|NCT01740713|3646863|B1|Italy||Region of Enrollment||participants|Number|6|6.0||||||
3821184|NCT01740713|3646860|B4||Male|Gender||Participants|Count of Participants|10|10.0||||||
3821185|NCT01740713|3646861|B3||Male|Gender||Participants|Count of Participants|3|3.0||||||
3821186|NCT01740713|3646862|B2||Male|Gender||Participants|Count of Participants|4|4.0||||||
3821187|NCT01740713|3646863|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
3821188|NCT01740713|3646860|B4||Female|Gender||Participants|Count of Participants|11|11.0||||||
3821189|NCT01740713|3646861|B3||Female|Gender||Participants|Count of Participants|4|4.0||||||
3821190|NCT01740713|3646862|B2||Female|Gender||Participants|Count of Participants|4|4.0||||||
3821191|NCT01740713|3646863|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
3821192|NCT01740713|3646860|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3821193|NCT01740713|3646861|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3821194|NCT01740713|3646862|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3821195|NCT01740713|3646863|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3821196|NCT01740713|3646860|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3821197|NCT01740713|3646861|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3821198|NCT01740713|3646862|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3821199|NCT01740713|3646863|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3821200|NCT01740713|3646860|B4||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
3821201|NCT01740713|3646861|B3||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
3821202|NCT01740713|3646862|B2||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
3821203|NCT01740713|3646863|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3821204|NCT01740440|3646889|B1|||Sex/Gender, Customized||female participants|Number|30|30.0||||||
3821205|NCT01740440|3646889|B1|||Age||years|Mean|45|45.0|Standard Deviation|3.7|3.7|||
3821206|NCT01740427|3646895|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821207|NCT01740427|3646896|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821208|NCT01740427|3646897|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821209|NCT01740427|3646895|B3||Female|Sex: Female, Male||Participants|Count of Participants|666|666.0||||||
3821210|NCT01740427|3646896|B2||Female|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
3821211|NCT01740427|3646897|B1||Female|Sex: Female, Male||Participants|Count of Participants|444|444.0||||||
3821212|NCT01740427|3646895|B3|||Age||years|Mean|61.3|61.3|Standard Deviation|10.8|10.8|||
3821213|NCT01740427|3646896|B2|||Age||years|Mean|60.6|60.6|Standard Deviation|11.2|11.2|||
3821214|NCT01740427|3646897|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|10.6|10.6|||
3821215|NCT01740414|3646925|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3821216|NCT01740414|3646926|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3821217|NCT01740414|3646927|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3821218|NCT01740414|3646925|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3821219|NCT01740414|3646926|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3821220|NCT01740414|3646927|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3821221|NCT01740414|3646925|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3821222|NCT01740414|3646926|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3821223|NCT01740414|3646927|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821224|NCT01740414|3646925|B3|||Age||years|Mean|42.2|42.2|Standard Deviation|8.7|8.7|||
3821225|NCT01740414|3646926|B2|||Age||years|Mean|49.5|49.5|Standard Deviation|1.7|1.7|||
3821226|NCT01740414|3646927|B1|||Age||years|Mean|41.3|41.3|Standard Deviation|10.8|10.8|||
3821227|NCT01740401|3646950|B1|Unknown Primary MM||Malignant Melanoma (MM) site||Participants|Count of Participants|1|1.0||||||
3821228|NCT01740401|3646950|B1|Ocular MM||Malignant Melanoma (MM) site||Participants|Count of Participants|2|2.0||||||
3821229|NCT01740401|3646950|B1|Cutaneous MM||Malignant Melanoma (MM) site||Participants|Count of Participants|7|7.0||||||
3821230|NCT01740401|3646950|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3821231|NCT01740401|3646950|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3821232|NCT01740401|3646950|B1|||Age||years|Median|59|59.0|Full Range|||36.0|75.0|
3821233|NCT01740388|3646957|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3821234|NCT01740388|3646958|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3821235|NCT01740388|3646959|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3821236|NCT01740388|3646957|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821237|NCT01740388|3646958|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821238|NCT01740388|3646959|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821239|NCT01740388|3646957|B3||White|Race (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
3821240|NCT01740388|3646958|B2||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3821241|NCT01740388|3646959|B1||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3821242|NCT01740388|3646957|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3821243|NCT01740388|3646958|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3821244|NCT01740388|3646959|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3821245|NCT01740388|3646957|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3821246|NCT01740388|3646958|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3821247|NCT01740388|3646959|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3821248|NCT01740388|3646957|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3821249|NCT01740388|3646958|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3821250|NCT01740388|3646959|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3821251|NCT01740388|3646957|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821252|NCT01740388|3646958|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821253|NCT01740388|3646959|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821254|NCT01740388|3646957|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3821255|NCT01740388|3646958|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3821256|NCT01740388|3646959|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3821257|NCT01740388|3646957|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3821258|NCT01740388|3646958|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3821259|NCT01740388|3646959|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3821260|NCT01740388|3646957|B3|||Age||years|Mean|47.8|47.8|Standard Deviation|22.03|22.03|||
3821261|NCT01740388|3646958|B2|||Age||years|Mean|50.6|50.6|Standard Deviation|21.36|21.36|||
3821262|NCT01740388|3646959|B1|||Age||years|Mean|44.6|44.6|Standard Deviation|22.52|22.52|||
3821263|NCT01740362|3646976|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3821264|NCT01740362|3646977|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3821265|NCT01740362|3646978|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3821266|NCT01740362|3646979|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3821267|NCT01740362|3646980|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3821268|NCT01740362|3646976|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3821269|NCT01740362|3646977|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3821270|NCT01740362|3646978|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3821271|NCT01740362|3646979|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3821272|NCT01740362|3646980|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3821273|NCT01740362|3646976|B5|||Age||years|Mean|56.1|56.1|Standard Deviation|10.7|10.7|||
3821274|NCT01740362|3646977|B4|||Age||years|Mean|59.0|59.0|Standard Deviation|14.6|14.6|||
3821275|NCT01740362|3646978|B3|||Age||years|Mean|53.5|53.5|Standard Deviation|11.1|11.1|||
3821276|NCT01740362|3646979|B2|||Age||years|Mean|61.2|61.2|Standard Deviation|2.8|2.8|||
3821277|NCT01740362|3646980|B1|||Age||years|Mean|50.8|50.8|Standard Deviation|9.7|9.7|||
3821278|NCT01740297|3647009|B4|Missing/Unknown||BRAF V600 Mutation Status|Mutation status of v-raf murine sarcoma viral oncogene homolog B1 (BRAF) gene was based on a gene mutation that results in an amino acid substitution from valine (V) to glutamic acid (E) at codon 600 (V600E) and/or a substitution from valine to lysine (K) (V600K).|participants|Number|7|7.0||||||
3821279|NCT01740297|3647010|B3|Missing/Unknown||BRAF V600 Mutation Status|Mutation status of v-raf murine sarcoma viral oncogene homolog B1 (BRAF) gene was based on a gene mutation that results in an amino acid substitution from valine (V) to glutamic acid (E) at codon 600 (V600E) and/or a substitution from valine to lysine (K) (V600K).|participants|Number|1|1.0||||||
3821280|NCT01740297|3647011|B2|Missing/Unknown||BRAF V600 Mutation Status|Mutation status of v-raf murine sarcoma viral oncogene homolog B1 (BRAF) gene was based on a gene mutation that results in an amino acid substitution from valine (V) to glutamic acid (E) at codon 600 (V600E) and/or a substitution from valine to lysine (K) (V600K).|participants|Number|6|6.0||||||
3821281|NCT01740297|3647012|B1|Missing/Unknown||BRAF V600 Mutation Status|Mutation status of v-raf murine sarcoma viral oncogene homolog B1 (BRAF) gene was based on a gene mutation that results in an amino acid substitution from valine (V) to glutamic acid (E) at codon 600 (V600E) and/or a substitution from valine to lysine (K) (V600K).|participants|Number|0|0.0||||||
3821282|NCT01740297|3647009|B4|Wild-type||BRAF V600 Mutation Status|Mutation status of v-raf murine sarcoma viral oncogene homolog B1 (BRAF) gene was based on a gene mutation that results in an amino acid substitution from valine (V) to glutamic acid (E) at codon 600 (V600E) and/or a substitution from valine to lysine (K) (V600K).|participants|Number|129|129.0||||||
3821283|NCT01740297|3647010|B3|Wild-type||BRAF V600 Mutation Status|Mutation status of v-raf murine sarcoma viral oncogene homolog B1 (BRAF) gene was based on a gene mutation that results in an amino acid substitution from valine (V) to glutamic acid (E) at codon 600 (V600E) and/or a substitution from valine to lysine (K) (V600K).|participants|Number|62|62.0||||||
3821284|NCT01740297|3647011|B2|Wild-type||BRAF V600 Mutation Status|Mutation status of v-raf murine sarcoma viral oncogene homolog B1 (BRAF) gene was based on a gene mutation that results in an amino acid substitution from valine (V) to glutamic acid (E) at codon 600 (V600E) and/or a substitution from valine to lysine (K) (V600K).|participants|Number|60|60.0||||||
3821285|NCT01740297|3647012|B1|Wild-type||BRAF V600 Mutation Status|Mutation status of v-raf murine sarcoma viral oncogene homolog B1 (BRAF) gene was based on a gene mutation that results in an amino acid substitution from valine (V) to glutamic acid (E) at codon 600 (V600E) and/or a substitution from valine to lysine (K) (V600K).|participants|Number|7|7.0||||||
3821286|NCT01740297|3647009|B4|Mutation||BRAF V600 Mutation Status|Mutation status of v-raf murine sarcoma viral oncogene homolog B1 (BRAF) gene was based on a gene mutation that results in an amino acid substitution from valine (V) to glutamic acid (E) at codon 600 (V600E) and/or a substitution from valine to lysine (K) (V600K).|participants|Number|81|81.0||||||
3821287|NCT01740297|3647010|B3|Mutation||BRAF V600 Mutation Status|Mutation status of v-raf murine sarcoma viral oncogene homolog B1 (BRAF) gene was based on a gene mutation that results in an amino acid substitution from valine (V) to glutamic acid (E) at codon 600 (V600E) and/or a substitution from valine to lysine (K) (V600K).|participants|Number|35|35.0||||||
3821288|NCT01740297|3647011|B2|Mutation||BRAF V600 Mutation Status|Mutation status of v-raf murine sarcoma viral oncogene homolog B1 (BRAF) gene was based on a gene mutation that results in an amino acid substitution from valine (V) to glutamic acid (E) at codon 600 (V600E) and/or a substitution from valine to lysine (K) (V600K).|participants|Number|34|34.0||||||
3821289|NCT01740297|3647012|B1|Mutation||BRAF V600 Mutation Status|Mutation status of v-raf murine sarcoma viral oncogene homolog B1 (BRAF) gene was based on a gene mutation that results in an amino acid substitution from valine (V) to glutamic acid (E) at codon 600 (V600E) and/or a substitution from valine to lysine (K) (V600K).|participants|Number|12|12.0||||||
3821290|NCT01740297|3647009|B4|Stage IVM1b/c||Tumor, Node, Metastasis (TNM) Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs, normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|102|102.0||||||
3821337|NCT01740297|3647012|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821338|NCT01740297|3647009|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|212|212.0||||||
3821291|NCT01740297|3647010|B3|Stage IVM1b/c||Tumor, Node, Metastasis (TNM) Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs, normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|48|48.0||||||
3821292|NCT01740297|3647011|B2|Stage IVM1b/c||Tumor, Node, Metastasis (TNM) Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs, normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|43|43.0||||||
3821293|NCT01740297|3647012|B1|Stage IVM1b/c||Tumor, Node, Metastasis (TNM) Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs, normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|11|11.0||||||
3821294|NCT01740297|3647009|B4|Stage IIIB - IVM1a||Tumor, Node, Metastasis (TNM) Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs, normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|115|115.0||||||
3821295|NCT01740297|3647010|B3|Stage IIIB - IVM1a||Tumor, Node, Metastasis (TNM) Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs, normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|50|50.0||||||
3821296|NCT01740297|3647011|B2|Stage IIIB - IVM1a||Tumor, Node, Metastasis (TNM) Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs, normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|57|57.0||||||
3821297|NCT01740297|3647012|B1|Stage IIIB - IVM1a||Tumor, Node, Metastasis (TNM) Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs, normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|8|8.0||||||
3821298|NCT01740297|3647009|B4|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|61|61.0||||||
3821299|NCT01740297|3647010|B3|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|29|29.0||||||
3821300|NCT01740297|3647011|B2|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|27|27.0||||||
3821339|NCT01740297|3647010|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3821340|NCT01740297|3647011|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3821341|NCT01740297|3647012|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3821301|NCT01740297|3647012|B1|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|5|5.0||||||
3821302|NCT01740297|3647009|B4|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|156|156.0||||||
3821303|NCT01740297|3647010|B3|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|69|69.0||||||
3821304|NCT01740297|3647011|B2|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|73|73.0||||||
3821305|NCT01740297|3647012|B1|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|14|14.0||||||
3821306|NCT01740297|3647009|B4|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3821307|NCT01740297|3647010|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3821308|NCT01740297|3647011|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3821309|NCT01740297|3647012|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3821310|NCT01740297|3647009|B4|White||Race/Ethnicity, Customized||participants|Number|207|207.0||||||
3821311|NCT01740297|3647010|B3|White||Race/Ethnicity, Customized||participants|Number|97|97.0||||||
3821312|NCT01740297|3647011|B2|White||Race/Ethnicity, Customized||participants|Number|92|92.0||||||
3821313|NCT01740297|3647012|B1|White||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3821314|NCT01740297|3647009|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3821315|NCT01740297|3647010|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3821316|NCT01740297|3647011|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3821317|NCT01740297|3647012|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3821318|NCT01740297|3647009|B4|Multiple||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3821319|NCT01740297|3647010|B3|Multiple||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3821320|NCT01740297|3647011|B2|Multiple||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3821321|NCT01740297|3647012|B1|Multiple||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3821322|NCT01740297|3647009|B4|Black (or African American)||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3821323|NCT01740297|3647010|B3|Black (or African American)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3821324|NCT01740297|3647011|B2|Black (or African American)||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3821325|NCT01740297|3647012|B1|Black (or African American)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3821326|NCT01740297|3647009|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3821327|NCT01740297|3647010|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3821328|NCT01740297|3647011|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3821329|NCT01740297|3647012|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3821330|NCT01740297|3647009|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3821331|NCT01740297|3647010|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3821332|NCT01740297|3647011|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3821333|NCT01740297|3647012|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3821334|NCT01740297|3647009|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821335|NCT01740297|3647010|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821336|NCT01740297|3647011|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821342|NCT01740297|3647009|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3821343|NCT01740297|3647010|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821344|NCT01740297|3647011|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3821345|NCT01740297|3647012|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3821346|NCT01740297|3647009|B4||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3821347|NCT01740297|3647010|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3821348|NCT01740297|3647011|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3821349|NCT01740297|3647012|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3821350|NCT01740297|3647009|B4||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3821351|NCT01740297|3647010|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3821352|NCT01740297|3647011|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3821353|NCT01740297|3647012|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3821354|NCT01740297|3647009|B4|≥ 65 years||Age, Customized||Participants|Count of Participants|106|106.0||||||
3821355|NCT01740297|3647010|B3|≥ 65 years||Age, Customized||Participants|Count of Participants|52|52.0||||||
3821356|NCT01740297|3647011|B2|≥ 65 years||Age, Customized||Participants|Count of Participants|46|46.0||||||
3821357|NCT01740297|3647012|B1|≥ 65 years||Age, Customized||Participants|Count of Participants|8|8.0||||||
3821358|NCT01740297|3647009|B4|< 65 years||Age, Customized||Participants|Count of Participants|111|111.0||||||
3821359|NCT01740297|3647010|B3|< 65 years||Age, Customized||Participants|Count of Participants|46|46.0||||||
3821360|NCT01740297|3647011|B2|< 65 years||Age, Customized||Participants|Count of Participants|54|54.0||||||
3821361|NCT01740297|3647012|B1|< 65 years||Age, Customized||Participants|Count of Participants|11|11.0||||||
3821362|NCT01740297|3647009|B4|||Age||years|Mean|63.6|63.6|Standard Deviation|13.5|13.5|||
3821363|NCT01740297|3647010|B3|||Age||years|Mean|63.6|63.6|Standard Deviation|14.0|14.0|||
3821364|NCT01740297|3647011|B2|||Age||years|Mean|64.2|64.2|Standard Deviation|13.3|13.3|||
3821365|NCT01740297|3647012|B1|||Age||years|Mean|61.1|61.1|Standard Deviation|12.1|12.1|||
3821366|NCT01740206|3647044|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3821367|NCT01740206|3647045|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3821368|NCT01740206|3647046|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3821369|NCT01740206|3647044|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3821370|NCT01740206|3647045|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3821371|NCT01740206|3647046|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3821372|NCT01740206|3647044|B3|||Age||years|Mean|9.32|9.32|Standard Deviation|2.70|2.7|||
3821373|NCT01740206|3647045|B2|||Age||years|Mean|9.35|9.35|Standard Deviation|2.79|2.79|||
3821374|NCT01740206|3647046|B1|||Age||years|Mean|9.25|9.25|Standard Deviation|2.56|2.56|||
3821375|NCT01740154|3647063|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3821376|NCT01740154|3647063|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821377|NCT01740154|3647063|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821378|NCT01740154|3647063|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3821379|NCT01740154|3647063|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821380|NCT01740154|3647063|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821381|NCT01740154|3647063|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821382|NCT01740154|3647063|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821383|NCT01740154|3647063|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821384|NCT01740154|3647063|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3821385|NCT01740154|3647063|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3821386|NCT01740154|3647063|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3821387|NCT01740154|3647063|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3821388|NCT01740154|3647063|B1|70-79 years||Age, Customized||participants|Number|2|2.0||||||
3821389|NCT01740154|3647063|B1|60-69 years||Age, Customized||participants|Number|5|5.0||||||
3821390|NCT01740154|3647063|B1|50-59 years||Age, Customized||participants|Number|5|5.0||||||
3821391|NCT01740154|3647063|B1|40-49 years||Age, Customized||participants|Number|1|1.0||||||
3821392|NCT01740128|3647069|B3|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3821393|NCT01740128|3647070|B2|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3821394|NCT01740128|3647071|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3821395|NCT01740128|3647069|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3821396|NCT01740128|3647070|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3821397|NCT01740128|3647071|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3821398|NCT01740128|3647069|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821399|NCT01740128|3647070|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821400|NCT01740128|3647071|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821401|NCT01740128|3647069|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3821402|NCT01740128|3647070|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3821403|NCT01740128|3647071|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3821404|NCT01740128|3647069|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3821405|NCT01740128|3647070|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3821406|NCT01740128|3647071|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3821407|NCT01740128|3647069|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821408|NCT01740128|3647070|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821409|NCT01740128|3647071|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821410|NCT01740128|3647069|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3821411|NCT01740128|3647070|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3821412|NCT01740128|3647071|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821413|NCT01740128|3647069|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821414|NCT01740128|3647070|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821415|NCT01740128|3647071|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821416|NCT01740128|3647069|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3821417|NCT01740128|3647070|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3821418|NCT01740128|3647071|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3821419|NCT01740128|3647069|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3821420|NCT01740128|3647070|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3821421|NCT01740128|3647071|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3821422|NCT01740128|3647069|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3821423|NCT01740128|3647070|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3821424|NCT01740128|3647071|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3821425|NCT01740128|3647069|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3821426|NCT01740128|3647070|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3821427|NCT01740128|3647071|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3821428|NCT01740128|3647069|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3821429|NCT01740128|3647070|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3821430|NCT01740128|3647071|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3821431|NCT01740089|3647098|B4|T/T||Interleukin 28B (IL-28B) genotype||participants|Number|25|25.0||||||
3821432|NCT01740089|3647099|B3|T/T||Interleukin 28B (IL-28B) genotype||participants|Number|11|11.0||||||
3821433|NCT01740089|3647100|B2|T/T||Interleukin 28B (IL-28B) genotype||participants|Number|7|7.0||||||
3821434|NCT01740089|3647101|B1|T/T||Interleukin 28B (IL-28B) genotype||participants|Number|7|7.0||||||
3821435|NCT01740089|3647098|B4|C/T||Interleukin 28B (IL-28B) genotype||participants|Number|76|76.0||||||
3821436|NCT01740089|3647099|B3|C/T||Interleukin 28B (IL-28B) genotype||participants|Number|26|26.0||||||
3821437|NCT01740089|3647100|B2|C/T||Interleukin 28B (IL-28B) genotype||participants|Number|26|26.0||||||
3821438|NCT01740089|3647101|B1|C/T||Interleukin 28B (IL-28B) genotype||participants|Number|24|24.0||||||
3821439|NCT01740089|3647098|B4|C/C||Interleukin 28B (IL-28B) genotype||participants|Number|49|49.0||||||
3821440|NCT01740089|3647099|B3|C/C||Interleukin 28B (IL-28B) genotype||participants|Number|13|13.0||||||
3821441|NCT01740089|3647100|B2|C/C||Interleukin 28B (IL-28B) genotype||participants|Number|17|17.0||||||
3821442|NCT01740089|3647101|B1|C/C||Interleukin 28B (IL-28B) genotype||participants|Number|19|19.0||||||
3821443|NCT01740089|3647098|B4|Low (≤8х10^5 IU/ml)||Initial Viral load||participants|Number|103|103.0||||||
3821444|NCT01740089|3647099|B3|Low (≤8х10^5 IU/ml)||Initial Viral load||participants|Number|36|36.0||||||
3821445|NCT01740089|3647100|B2|Low (≤8х10^5 IU/ml)||Initial Viral load||participants|Number|34|34.0||||||
3821446|NCT01740089|3647101|B1|Low (≤8х10^5 IU/ml)||Initial Viral load||participants|Number|33|33.0||||||
3821447|NCT01740089|3647098|B4|High (>8х10^5 IU/ml)||Initial Viral load||participants|Number|47|47.0||||||
3821448|NCT01740089|3647099|B3|High (>8х10^5 IU/ml)||Initial Viral load||participants|Number|14|14.0||||||
3821449|NCT01740089|3647100|B2|High (>8х10^5 IU/ml)||Initial Viral load||participants|Number|16|16.0||||||
3821450|NCT01740089|3647101|B1|High (>8х10^5 IU/ml)||Initial Viral load||participants|Number|17|17.0||||||
3821451|NCT01740089|3647098|B4|HCV 3||HCV genotype||participants|Number|64|64.0||||||
3821452|NCT01740089|3647099|B3|HCV 3||HCV genotype||participants|Number|21|21.0||||||
3821453|NCT01740089|3647100|B2|HCV 3||HCV genotype||participants|Number|21|21.0||||||
3821454|NCT01740089|3647101|B1|HCV 3||HCV genotype||participants|Number|22|22.0||||||
3821455|NCT01740089|3647098|B4|HCV 2||HCV genotype||participants|Number|5|5.0||||||
3821456|NCT01740089|3647099|B3|HCV 2||HCV genotype||participants|Number|1|1.0||||||
3821457|NCT01740089|3647100|B2|HCV 2||HCV genotype||participants|Number|2|2.0||||||
3821458|NCT01740089|3647101|B1|HCV 2||HCV genotype||participants|Number|2|2.0||||||
3821459|NCT01740089|3647098|B4|HCV 1a||HCV genotype||participants|Number|7|7.0||||||
3821460|NCT01740089|3647099|B3|HCV 1a||HCV genotype||participants|Number|2|2.0||||||
3821461|NCT01740089|3647100|B2|HCV 1a||HCV genotype||participants|Number|1|1.0||||||
3821462|NCT01740089|3647101|B1|HCV 1a||HCV genotype||participants|Number|4|4.0||||||
3821463|NCT01740089|3647098|B4|HCV 1b||HCV genotype||participants|Number|74|74.0||||||
3821464|NCT01740089|3647099|B3|HCV 1b||HCV genotype||participants|Number|26|26.0||||||
3821465|NCT01740089|3647100|B2|HCV 1b||HCV genotype||participants|Number|26|26.0||||||
3821466|NCT01740089|3647101|B1|HCV 1b||HCV genotype||participants|Number|22|22.0||||||
3821467|NCT01740089|3647098|B4|Russian Federation||Region of Enrollment||participants|Number|150|150.0||||||
3821468|NCT01740089|3647099|B3|Russian Federation||Region of Enrollment||participants|Number|50|50.0||||||
3821469|NCT01740089|3647100|B2|Russian Federation||Region of Enrollment||participants|Number|50|50.0||||||
3821470|NCT01740089|3647101|B1|Russian Federation||Region of Enrollment||participants|Number|50|50.0||||||
3821471|NCT01740089|3647098|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821472|NCT01740089|3647099|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821473|NCT01740089|3647100|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821474|NCT01740089|3647101|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821475|NCT01740089|3647098|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821476|NCT01740089|3647099|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821477|NCT01740089|3647100|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821478|NCT01740089|3647101|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821479|NCT01740089|3647098|B4||White|Race (NIH/OMB)||Participants|Count of Participants|149|149.0||||||
3821480|NCT01740089|3647099|B3||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3821481|NCT01740089|3647100|B2||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3821482|NCT01740089|3647101|B1||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3821483|NCT01740089|3647098|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821484|NCT01740089|3647099|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821485|NCT01740089|3647100|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821486|NCT01740089|3647101|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821487|NCT01740089|3647098|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821488|NCT01740089|3647099|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821489|NCT01740089|3647100|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821490|NCT01740089|3647101|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821491|NCT01740089|3647098|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3821492|NCT01740089|3647099|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821493|NCT01740089|3647100|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3821494|NCT01740089|3647101|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821495|NCT01740089|3647098|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821496|NCT01740089|3647099|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821497|NCT01740089|3647100|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821498|NCT01740089|3647101|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821499|NCT01740089|3647098|B4||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3821500|NCT01740089|3647099|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3821501|NCT01740089|3647100|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3821502|NCT01740089|3647101|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3821503|NCT01740089|3647098|B4||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3821504|NCT01740089|3647099|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3821505|NCT01740089|3647100|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3821506|NCT01740089|3647101|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3821507|NCT01740089|3647098|B4|||Age||years|Median|35|35.0|Inter-Quartile Range|||30.0|41.0|
3821508|NCT01740089|3647099|B3|||Age||years|Median|36|36.0|Inter-Quartile Range|||30.0|41.0|
3821509|NCT01740089|3647100|B2|||Age||years|Median|34|34.0|Inter-Quartile Range|||29.0|42.0|
3821510|NCT01740089|3647101|B1|||Age||years|Median|35|35.0|Inter-Quartile Range|||30.0|39.0|
3821511|NCT01739803|3647119|B3|United States||Region of Enrollment||participants|Number|150|150.0||||||
3821512|NCT01739803|3647120|B2|United States||Region of Enrollment||participants|Number|74|74.0||||||
3821513|NCT01739803|3647121|B1|United States||Region of Enrollment||participants|Number|76|76.0||||||
3821514|NCT01739803|3647119|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3821515|NCT01739803|3647120|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3821516|NCT01739803|3647121|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3821517|NCT01739803|3647119|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3821518|NCT01739803|3647120|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3821519|NCT01739803|3647121|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3821520|NCT01739803|3647119|B3|||Age||years|Mean|52.06|52.06|Standard Deviation|13.59|13.59|||
3821521|NCT01739803|3647120|B2|||Age||years|Mean|51.32|51.32|Standard Deviation|13.69|13.69|||
3821522|NCT01739803|3647121|B1|||Age||years|Mean|52.78|52.78|Standard Deviation|13.55|13.55|||
3821523|NCT01739803|3647119|B3||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
3821524|NCT01739803|3647120|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3821525|NCT01739803|3647121|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3821526|NCT01739803|3647119|B3||Between 18 and 65 years|Age||Participants|Count of Participants|121|121.0||||||
3821527|NCT01739803|3647120|B2||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
3821528|NCT01739803|3647121|B1||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
3821529|NCT01739803|3647119|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3821530|NCT01739803|3647120|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3821531|NCT01739803|3647121|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3821532|NCT01739790|3647132|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3821533|NCT01739790|3647133|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3821534|NCT01739790|3647134|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3821535|NCT01739790|3647132|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3821536|NCT01739790|3647133|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3821537|NCT01739790|3647134|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3821538|NCT01739790|3647132|B3|||Age||Years|Mean|69.5|69.5|Full Range|||60.7|77.8|
3821539|NCT01739790|3647133|B2|||Age||Years|Mean|70.1|70.1|Full Range|||62.4|77.8|
3821540|NCT01739790|3647134|B1|||Age||Years|Mean|68.9|68.9|Full Range|||60.7|77.1|
3821541|NCT01739595|3647141|B4|United States||Region of Enrollment||participants|Number|181|181.0||||||
3821542|NCT01739595|3647142|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
3821543|NCT01739595|3647143|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
3821544|NCT01739595|3647144|B1|United States||Region of Enrollment||participants|Number|112|112.0||||||
3821545|NCT01739595|3647141|B4||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
3821546|NCT01739595|3647142|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3821547|NCT01739595|3647143|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3821548|NCT01739595|3647144|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3821549|NCT01739595|3647141|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821550|NCT01739595|3647142|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821551|NCT01739595|3647143|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821552|NCT01739595|3647144|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821553|NCT01739595|3647141|B4|||Age||years|Mean|44.5|44.5|Standard Deviation|9.7|9.7|||
3821554|NCT01739595|3647142|B3|||Age||years|Mean|43.6|43.6|Standard Deviation|10.5|10.5|||
3821555|NCT01739595|3647143|B2|||Age||years|Mean|45.8|45.8|Standard Deviation|8.6|8.6|||
3821556|NCT01739595|3647144|B1|||Age||years|Mean|44.6|44.6|Standard Deviation|9.6|9.6|||
3821557|NCT01739361|3647154|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3821558|NCT01739361|3647155|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3821559|NCT01739361|3647156|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3821560|NCT01739361|3647154|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3821561|NCT01739361|3647155|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3821562|NCT01739361|3647156|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3821563|NCT01739361|3647154|B3|||Age||years|Median|55.5|55.5|Inter-Quartile Range|||44.0|63.0|
3821564|NCT01739361|3647155|B2|||Age||years|Median|58.5|58.5|Inter-Quartile Range|||47.5|63.5|
3821565|NCT01739361|3647156|B1|||Age||years|Median|50|50.0|Inter-Quartile Range|||41.0|64.0|
3821566|NCT01739348|3647167|B5|||Mini-Mental State Examination (MMSE) Score|The MMSE is a cognitive assessment of 5 domains including: orientation; attention; memory; language; and constructional praxis. These domains are assessed with 11 total questions related to the participant. Participants are scored based on the number of correct responses; depending on the question, potential scores range from 0 (no correct response) to either 1 (4 questions), 2 (1 question), 3 (3 questions), or 5 (3 questions). Scores from each question are summed to the total MMSE score, with total scores ranging from 0-30. Higher scores indicate better cognitive performance.|Score on a Scale|Mean|20.3|20.3|Standard Deviation|3.3|3.3|||
3821567|NCT01739348|3647168|B4|||Mini-Mental State Examination (MMSE) Score|The MMSE is a cognitive assessment of 5 domains including: orientation; attention; memory; language; and constructional praxis. These domains are assessed with 11 total questions related to the participant. Participants are scored based on the number of correct responses; depending on the question, potential scores range from 0 (no correct response) to either 1 (4 questions), 2 (1 question), 3 (3 questions), or 5 (3 questions). Scores from each question are summed to the total MMSE score, with total scores ranging from 0-30. Higher scores indicate better cognitive performance.|Score on a Scale|Mean|20.3|20.3|Standard Deviation|3.2|3.2|||
3821568|NCT01739348|3647169|B3|||Mini-Mental State Examination (MMSE) Score|The MMSE is a cognitive assessment of 5 domains including: orientation; attention; memory; language; and constructional praxis. These domains are assessed with 11 total questions related to the participant. Participants are scored based on the number of correct responses; depending on the question, potential scores range from 0 (no correct response) to either 1 (4 questions), 2 (1 question), 3 (3 questions), or 5 (3 questions). Scores from each question are summed to the total MMSE score, with total scores ranging from 0-30. Higher scores indicate better cognitive performance.|Score on a Scale|Mean|20.6|20.6|Standard Deviation|3.3|3.3|||
3821612|NCT01739348|3647169|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3821569|NCT01739348|3647170|B2|||Mini-Mental State Examination (MMSE) Score|The MMSE is a cognitive assessment of 5 domains including: orientation; attention; memory; language; and constructional praxis. These domains are assessed with 11 total questions related to the participant. Participants are scored based on the number of correct responses; depending on the question, potential scores range from 0 (no correct response) to either 1 (4 questions), 2 (1 question), 3 (3 questions), or 5 (3 questions). Scores from each question are summed to the total MMSE score, with total scores ranging from 0-30. Higher scores indicate better cognitive performance.|Score on a Scale|Mean|20.2|20.2|Standard Deviation|3.3|3.3|||
3821570|NCT01739348|3647171|B1|||Mini-Mental State Examination (MMSE) Score|The MMSE is a cognitive assessment of 5 domains including: orientation; attention; memory; language; and constructional praxis. These domains are assessed with 11 total questions related to the participant. Participants are scored based on the number of correct responses; depending on the question, potential scores range from 0 (no correct response) to either 1 (4 questions), 2 (1 question), 3 (3 questions), or 5 (3 questions). Scores from each question are summed to the total MMSE score, with total scores ranging from 0-30. Higher scores indicate better cognitive performance.|Score on a Scale|Mean|20.4|20.4|Standard Deviation|3.3|3.3|||
3821571|NCT01739348|3647167|B5|||Neuropsychiatric Inventory (NPI) Score|NPI is a clinical assessment of psychiatric status, covering 12 domains. Based on an interview of the participant’s caregiver, each domain is assessed for symptom frequency [range: 1 (occasional) to 4 (very frequent)] and severity [range: 1 (mild) to 3 (severe)]. Domain scores [range: 0 to 12] are calculated as the product of the frequency and severity scores (i.e. frequency x severity); if no symptoms are present, domain score is 0. The 12 domain scores sum to a total NPI score [range: 0 (no symptoms in any domain) to 144]. Higher scores reflect more severe psychiatric impairment.|Score on a Scale|Mean|8.64|8.64|Standard Deviation|10.6|10.6|||
3821572|NCT01739348|3647168|B4|||Neuropsychiatric Inventory (NPI) Score|NPI is a clinical assessment of psychiatric status, covering 12 domains. Based on an interview of the participant’s caregiver, each domain is assessed for symptom frequency [range: 1 (occasional) to 4 (very frequent)] and severity [range: 1 (mild) to 3 (severe)]. Domain scores [range: 0 to 12] are calculated as the product of the frequency and severity scores (i.e. frequency x severity); if no symptoms are present, domain score is 0. The 12 domain scores sum to a total NPI score [range: 0 (no symptoms in any domain) to 144]. Higher scores reflect more severe psychiatric impairment.|Score on a Scale|Mean|9.2|9.2|Standard Deviation|11.6|11.6|||
3821573|NCT01739348|3647169|B3|||Neuropsychiatric Inventory (NPI) Score|NPI is a clinical assessment of psychiatric status, covering 12 domains. Based on an interview of the participant’s caregiver, each domain is assessed for symptom frequency [range: 1 (occasional) to 4 (very frequent)] and severity [range: 1 (mild) to 3 (severe)]. Domain scores [range: 0 to 12] are calculated as the product of the frequency and severity scores (i.e. frequency x severity); if no symptoms are present, domain score is 0. The 12 domain scores sum to a total NPI score [range: 0 (no symptoms in any domain) to 144]. Higher scores reflect more severe psychiatric impairment.|Score on a Scale|Mean|6.9|6.9|Standard Deviation|9.5|9.5|||
3821574|NCT01739348|3647170|B2|||Neuropsychiatric Inventory (NPI) Score|NPI is a clinical assessment of psychiatric status, covering 12 domains. Based on an interview of the participant’s caregiver, each domain is assessed for symptom frequency [range: 1 (occasional) to 4 (very frequent)] and severity [range: 1 (mild) to 3 (severe)]. Domain scores [range: 0 to 12] are calculated as the product of the frequency and severity scores (i.e. frequency x severity); if no symptoms are present, domain score is 0. The 12 domain scores sum to a total NPI score [range: 0 (no symptoms in any domain) to 144]. Higher scores reflect more severe psychiatric impairment.|Score on a Scale|Mean|8.2|8.2|Standard Deviation|9.8|9.8|||
3821575|NCT01739348|3647171|B1|||Neuropsychiatric Inventory (NPI) Score|NPI is a clinical assessment of psychiatric status, covering 12 domains. Based on an interview of the participant’s caregiver, each domain is assessed for symptom frequency [range: 1 (occasional) to 4 (very frequent)] and severity [range: 1 (mild) to 3 (severe)]. Domain scores [range: 0 to 12] are calculated as the product of the frequency and severity scores (i.e. frequency x severity); if no symptoms are present, domain score is 0. The 12 domain scores sum to a total NPI score [range: 0 (no symptoms in any domain) to 144]. Higher scores reflect more severe psychiatric impairment.|Score on a Scale|Mean|8.7|8.7|Standard Deviation|10.5|10.5|||
3821576|NCT01739348|3647167|B5|||[18F]Flutemetamol Positron Emission Tomography (PET) Standard Uptake Value Ratio (SUVR)|[18F]Flutemetamol PET SUVR measures brain cortical amyloid load. The PET tracer [18F]Flutemetamol was given intravenously (IV). After 90 minutes, participants receive 4 PET scans. Using the PET scan images, regional SUVRs are calculated for brain regions of interest (ROIs), defined as the ratio of pixel intensities at a specific ROI compared to a reference region (RR; subcortical white matter). Regional SUVRs are averaged to compute a composite SUVR. Higher composite SUVR values indicate increased amyloid load.|SUVR|Mean|0.88|0.88|Standard Deviation|0.10|0.1|||
3821577|NCT01739348|3647168|B4|||[18F]Flutemetamol Positron Emission Tomography (PET) Standard Uptake Value Ratio (SUVR)|[18F]Flutemetamol PET SUVR measures brain cortical amyloid load. The PET tracer [18F]Flutemetamol was given intravenously (IV). After 90 minutes, participants receive 4 PET scans. Using the PET scan images, regional SUVRs are calculated for brain regions of interest (ROIs), defined as the ratio of pixel intensities at a specific ROI compared to a reference region (RR; subcortical white matter). Regional SUVRs are averaged to compute a composite SUVR. Higher composite SUVR values indicate increased amyloid load.|SUVR|Mean|0.88|0.88|Standard Deviation|0.11|0.11|||
3821578|NCT01739348|3647170|B2|||[18F]Flutemetamol Positron Emission Tomography (PET) Standard Uptake Value Ratio (SUVR)|[18F]Flutemetamol PET SUVR measures brain cortical amyloid load. The PET tracer [18F]Flutemetamol was given intravenously (IV). After 90 minutes, participants receive 4 PET scans. Using the PET scan images, regional SUVRs are calculated for brain regions of interest (ROIs), defined as the ratio of pixel intensities at a specific ROI compared to a reference region (RR; subcortical white matter). Regional SUVRs are averaged to compute a composite SUVR. Higher composite SUVR values indicate increased amyloid load.|SUVR|Mean|0.87|0.87|Standard Deviation|0.11|0.11|||
3821613|NCT01739348|3647170|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3821614|NCT01739348|3647171|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3821615|NCT01739348|3647167|B5||White|Race (NIH/OMB)||Participants|Count of Participants|1779|1779.0||||||
3821616|NCT01739348|3647168|B4||White|Race (NIH/OMB)||Participants|Count of Participants|578|578.0||||||
3821579|NCT01739348|3647171|B1|||[18F]Flutemetamol Positron Emission Tomography (PET) Standard Uptake Value Ratio (SUVR)|[18F]Flutemetamol PET SUVR measures brain cortical amyloid load. The PET tracer [18F]Flutemetamol was given intravenously (IV). After 90 minutes, participants receive 4 PET scans. Using the PET scan images, regional SUVRs are calculated for brain regions of interest (ROIs), defined as the ratio of pixel intensities at a specific ROI compared to a reference region (RR; subcortical white matter). Regional SUVRs are averaged to compute a composite SUVR. Higher composite SUVR values indicate increased amyloid load.|SUVR|Mean|0.89|0.89|Standard Deviation|0.10|0.1|||
3821580|NCT01739348|3647167|B5|||Cerebrospinal Fluid (CSF) Total Tau Concentration|Total Tau concentration in the cerebrospinal fluid (CSF) was monitored as a measure of brain tau pathology.|picograms (pg)/mL|Mean|232.2|232.2|Standard Deviation|137.3|137.3|||
3821581|NCT01739348|3647168|B4|||Cerebrospinal Fluid (CSF) Total Tau Concentration|Total Tau concentration in the cerebrospinal fluid (CSF) was monitored as a measure of brain tau pathology.|picograms (pg)/mL|Mean|246.2|246.2|Standard Deviation|192.9|192.9|||
3821582|NCT01739348|3647169|B3|||Cerebrospinal Fluid (CSF) Total Tau Concentration|Total Tau concentration in the cerebrospinal fluid (CSF) was monitored as a measure of brain tau pathology.|picograms (pg)/mL|Mean|268.6|268.6|Standard Deviation|136.2|136.2|||
3821583|NCT01739348|3647170|B2|||Cerebrospinal Fluid (CSF) Total Tau Concentration|Total Tau concentration in the cerebrospinal fluid (CSF) was monitored as a measure of brain tau pathology.|picograms (pg)/mL|Mean|231.5|231.5|Standard Deviation|113.9|113.9|||
3821584|NCT01739348|3647171|B1|||Cerebrospinal Fluid (CSF) Total Tau Concentration|Total Tau concentration in the cerebrospinal fluid (CSF) was monitored as a measure of brain tau pathology.|picograms (pg)/mL|Mean|206.7|206.7|Standard Deviation|90.4|90.4|||
3821585|NCT01739348|3647167|B5|||Total Hippocampal Volume|Total Hippocampal Volume (THV) was measured by volumetric magnetic resonance imaging (vMRI).|Microliters|Mean|5829.4|5829.4|Standard Deviation|1162.6|1162.6|||
3821586|NCT01739348|3647168|B4|||Total Hippocampal Volume|Total Hippocampal Volume (THV) was measured by volumetric magnetic resonance imaging (vMRI).|Microliters|Mean|5800.7|5800.7|Standard Deviation|1069.2|1069.2|||
3821587|NCT01739348|3647169|B3|||Total Hippocampal Volume|Total Hippocampal Volume (THV) was measured by volumetric magnetic resonance imaging (vMRI).|Microliters|Mean|5653.5|5653.5|Standard Deviation|1148.4|1148.4|||
3821588|NCT01739348|3647170|B2|||Total Hippocampal Volume|Total Hippocampal Volume (THV) was measured by volumetric magnetic resonance imaging (vMRI).|Microliters|Mean|5823.4|5823.4|Standard Deviation|1189.9|1189.9|||
3821589|NCT01739348|3647171|B1|||Total Hippocampal Volume|Total Hippocampal Volume (THV) was measured by volumetric magnetic resonance imaging (vMRI).|Microliters|Mean|5894.1|5894.1|Standard Deviation|1231.5|1231.5|||
3821590|NCT01739348|3647167|B5|||Clinical Dementia Rating Sum of Boxes (CDR-SB) Score|The CDR-SB score is a clinical rating of global cognitive function, comprised of 6 domains including: memory; orientation; judgment and problem solving; community affairs; home and hobbies; and personal care. For each domain, the degree of impairment is assessed by a semi-structured interview of the participant as well as the participant’s caregiver. For each domain, potential scores range from 0 (no impairment) to 3 (severe impairment). Individual domain scores sum to the total CDR-SB score, with total scores ranging from 0-18. Higher scores indicate more severe cognitive impairment.|Score on a Scale|Mean|5.43|5.43|Standard Deviation|2.17|2.17|||
3821591|NCT01739348|3647168|B4|||Clinical Dementia Rating Sum of Boxes (CDR-SB) Score|The CDR-SB score is a clinical rating of global cognitive function, comprised of 6 domains including: memory; orientation; judgment and problem solving; community affairs; home and hobbies; and personal care. For each domain, the degree of impairment is assessed by a semi-structured interview of the participant as well as the participant’s caregiver. For each domain, potential scores range from 0 (no impairment) to 3 (severe impairment). Individual domain scores sum to the total CDR-SB score, with total scores ranging from 0-18. Higher scores indicate more severe cognitive impairment.|Score on a Scale|Mean|5.6|5.6|Standard Deviation|2.3|2.3|||
3821592|NCT01739348|3647169|B3|||Clinical Dementia Rating Sum of Boxes (CDR-SB) Score|The CDR-SB score is a clinical rating of global cognitive function, comprised of 6 domains including: memory; orientation; judgment and problem solving; community affairs; home and hobbies; and personal care. For each domain, the degree of impairment is assessed by a semi-structured interview of the participant as well as the participant’s caregiver. For each domain, potential scores range from 0 (no impairment) to 3 (severe impairment). Individual domain scores sum to the total CDR-SB score, with total scores ranging from 0-18. Higher scores indicate more severe cognitive impairment.|Score on a Scale|Mean|5.5|5.5|Standard Deviation|2.3|2.3|||
3821593|NCT01739348|3647170|B2|||Clinical Dementia Rating Sum of Boxes (CDR-SB) Score|The CDR-SB score is a clinical rating of global cognitive function, comprised of 6 domains including: memory; orientation; judgment and problem solving; community affairs; home and hobbies; and personal care. For each domain, the degree of impairment is assessed by a semi-structured interview of the participant as well as the participant’s caregiver. For each domain, potential scores range from 0 (no impairment) to 3 (severe impairment). Individual domain scores sum to the total CDR-SB score, with total scores ranging from 0-18. Higher scores indicate more severe cognitive impairment.|Score on a Scale|Mean|5.3|5.3|Standard Deviation|2.1|2.1|||
3821594|NCT01739348|3647171|B1|||Clinical Dementia Rating Sum of Boxes (CDR-SB) Score|The CDR-SB score is a clinical rating of global cognitive function, comprised of 6 domains including: memory; orientation; judgment and problem solving; community affairs; home and hobbies; and personal care. For each domain, the degree of impairment is assessed by a semi-structured interview of the participant as well as the participant’s caregiver. For each domain, potential scores range from 0 (no impairment) to 3 (severe impairment). Individual domain scores sum to the total CDR-SB score, with total scores ranging from 0-18. Higher scores indicate more severe cognitive impairment.|Score on a Scale|Mean|5.4|5.4|Standard Deviation|2.1|2.1|||
3821595|NCT01739348|3647167|B5|||Alzheimer’s Disease Cooperative Study-Activities of Daily Living (ADCS-ADL) Score|The ADCS-ADL score measures the performance of activities of daily living, calculated from a 24-question survey. For each of the 24 questions, scores range from 0 (no independence) to (depending on the question) either 2 (1 question), 3 (17 questions), 4 (5 questions), or 5 (1 question), with higher scores indicating greater independence in activity performance. Scores from individual questions are summed into a total ADCS-ADL score, with total scores ranging from 0 to 78. Lower scores indicate less independence in activity performance.|Score on a Scale|Mean|62.74|62.74|Standard Deviation|9.93|9.93|||
3821596|NCT01739348|3647168|B4|||Alzheimer’s Disease Cooperative Study-Activities of Daily Living (ADCS-ADL) Score|The ADCS-ADL score measures the performance of activities of daily living, calculated from a 24-question survey. For each of the 24 questions, scores range from 0 (no independence) to (depending on the question) either 2 (1 question), 3 (17 questions), 4 (5 questions), or 5 (1 question), with higher scores indicating greater independence in activity performance. Scores from individual questions are summed into a total ADCS-ADL score, with total scores ranging from 0 to 78. Lower scores indicate less independence in activity performance.|Score on a Scale|Mean|62.1|62.1|Standard Deviation|10.4|10.4|||
3821597|NCT01739348|3647169|B3|||Alzheimer’s Disease Cooperative Study-Activities of Daily Living (ADCS-ADL) Score|The ADCS-ADL score measures the performance of activities of daily living, calculated from a 24-question survey. For each of the 24 questions, scores range from 0 (no independence) to (depending on the question) either 2 (1 question), 3 (17 questions), 4 (5 questions), or 5 (1 question), with higher scores indicating greater independence in activity performance. Scores from individual questions are summed into a total ADCS-ADL score, with total scores ranging from 0 to 78. Lower scores indicate less independence in activity performance.|Score on a Scale|Mean|63.5|63.5|Standard Deviation|10.3|10.3|||
3821598|NCT01739348|3647170|B2|||Alzheimer’s Disease Cooperative Study-Activities of Daily Living (ADCS-ADL) Score|The ADCS-ADL score measures the performance of activities of daily living, calculated from a 24-question survey. For each of the 24 questions, scores range from 0 (no independence) to (depending on the question) either 2 (1 question), 3 (17 questions), 4 (5 questions), or 5 (1 question), with higher scores indicating greater independence in activity performance. Scores from individual questions are summed into a total ADCS-ADL score, with total scores ranging from 0 to 78. Lower scores indicate less independence in activity performance.|Score on a Scale|Mean|62.9|62.9|Standard Deviation|9.8|9.8|||
3821599|NCT01739348|3647171|B1|||Alzheimer’s Disease Cooperative Study-Activities of Daily Living (ADCS-ADL) Score|The ADCS-ADL score measures the performance of activities of daily living, calculated from a 24-question survey. For each of the 24 questions, scores range from 0 (no independence) to (depending on the question) either 2 (1 question), 3 (17 questions), 4 (5 questions), or 5 (1 question), with higher scores indicating greater independence in activity performance. Scores from individual questions are summed into a total ADCS-ADL score, with total scores ranging from 0 to 78. Lower scores indicate less independence in activity performance.|Score on a Scale|Mean|63.0|63.0|Standard Deviation|9.5|9.5|||
3821600|NCT01739348|3647167|B5|||Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) Score|ADAS-Cog measures cognition by assessing 11 metrics impaired in Alzheimer’s Disease (AD): speech; speech comprehension; word finding; word recall; object/finger naming; orientation; obeying commands; ideational praxis; constructional praxis; word recognition; and remembering instruction. For each metric, scores range from 0 (no impairment) to (depending on the metric) either 5 (8 metrics), 8, 10, or 12 (1 metric each); higher scores indicate more severe impairment. Individual scores sum to a total ADAS-Cog score, ranging from 0-70. Higher total scores indicate greater cognitive impairment.|Score on a Scale|Mean|21.42|21.42|Standard Deviation|7.49|7.49|||
3821601|NCT01739348|3647168|B4|||Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) Score|ADAS-Cog measures cognition by assessing 11 metrics impaired in Alzheimer’s Disease (AD): speech; speech comprehension; word finding; word recall; object/finger naming; orientation; obeying commands; ideational praxis; constructional praxis; word recognition; and remembering instruction. For each metric, scores range from 0 (no impairment) to (depending on the metric) either 5 (8 metrics), 8, 10, or 12 (1 metric each); higher scores indicate more severe impairment. Individual scores sum to a total ADAS-Cog score, ranging from 0-70. Higher total scores indicate greater cognitive impairment.|Score on a Scale|Mean|21.7|21.7|Standard Deviation|7.6|7.6|||
3821602|NCT01739348|3647169|B3|||Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) Score|ADAS-Cog measures cognition by assessing 11 metrics impaired in Alzheimer’s Disease (AD): speech; speech comprehension; word finding; word recall; object/finger naming; orientation; obeying commands; ideational praxis; constructional praxis; word recognition; and remembering instruction. For each metric, scores range from 0 (no impairment) to (depending on the metric) either 5 (8 metrics), 8, 10, or 12 (1 metric each); higher scores indicate more severe impairment. Individual scores sum to a total ADAS-Cog score, ranging from 0-70. Higher total scores indicate greater cognitive impairment.|Score on a Scale|Mean|20.6|20.6|Standard Deviation|6.2|6.2|||
3821603|NCT01739348|3647170|B2|||Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) Score|ADAS-Cog measures cognition by assessing 11 metrics impaired in Alzheimer’s Disease (AD): speech; speech comprehension; word finding; word recall; object/finger naming; orientation; obeying commands; ideational praxis; constructional praxis; word recognition; and remembering instruction. For each metric, scores range from 0 (no impairment) to (depending on the metric) either 5 (8 metrics), 8, 10, or 12 (1 metric each); higher scores indicate more severe impairment. Individual scores sum to a total ADAS-Cog score, ranging from 0-70. Higher total scores indicate greater cognitive impairment.|Score on a Scale|Mean|21.3|21.3|Standard Deviation|7.6|7.6|||
3821604|NCT01739348|3647171|B1|||Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) Score|ADAS-Cog measures cognition by assessing 11 metrics impaired in Alzheimer’s Disease (AD): speech; speech comprehension; word finding; word recall; object/finger naming; orientation; obeying commands; ideational praxis; constructional praxis; word recognition; and remembering instruction. For each metric, scores range from 0 (no impairment) to (depending on the metric) either 5 (8 metrics), 8, 10, or 12 (1 metric each); higher scores indicate more severe impairment. Individual scores sum to a total ADAS-Cog score, ranging from 0-70. Higher total scores indicate greater cognitive impairment.|Score on a Scale|Mean|21.4|21.4|Standard Deviation|7.5|7.5|||
3821605|NCT01739348|3647167|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3821606|NCT01739348|3647168|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3821607|NCT01739348|3647169|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821608|NCT01739348|3647170|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3821609|NCT01739348|3647171|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3821610|NCT01739348|3647167|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3821611|NCT01739348|3647168|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821617|NCT01739348|3647169|B3||White|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3821618|NCT01739348|3647170|B2||White|Race (NIH/OMB)||Participants|Count of Participants|547|547.0||||||
3821619|NCT01739348|3647171|B1||White|Race (NIH/OMB)||Participants|Count of Participants|566|566.0||||||
3821620|NCT01739348|3647167|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3821621|NCT01739348|3647168|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3821622|NCT01739348|3647169|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3821623|NCT01739348|3647170|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3821624|NCT01739348|3647171|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3821625|NCT01739348|3647167|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821626|NCT01739348|3647168|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821627|NCT01739348|3647169|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821628|NCT01739348|3647170|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821629|NCT01739348|3647171|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821630|NCT01739348|3647167|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|369|369.0||||||
3821631|NCT01739348|3647168|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
3821632|NCT01739348|3647169|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3821633|NCT01739348|3647170|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
3821634|NCT01739348|3647171|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|118|118.0||||||
3821635|NCT01739348|3647167|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3821636|NCT01739348|3647168|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3821637|NCT01739348|3647169|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821638|NCT01739348|3647170|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3821639|NCT01739348|3647171|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3821640|NCT01739348|3647167|B5||Male|Sex: Female, Male||Participants|Count of Participants|993|993.0||||||
3821641|NCT01739348|3647168|B4||Male|Sex: Female, Male||Participants|Count of Participants|329|329.0||||||
3821642|NCT01739348|3647169|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3821643|NCT01739348|3647170|B2||Male|Sex: Female, Male||Participants|Count of Participants|297|297.0||||||
3821644|NCT01739348|3647171|B1||Male|Sex: Female, Male||Participants|Count of Participants|320|320.0||||||
3821645|NCT01739348|3647167|B5||Female|Sex: Female, Male||Participants|Count of Participants|1218|1218.0||||||
3821646|NCT01739348|3647168|B4||Female|Sex: Female, Male||Participants|Count of Participants|376|376.0||||||
3821647|NCT01739348|3647169|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3821648|NCT01739348|3647170|B2||Female|Sex: Female, Male||Participants|Count of Participants|403|403.0||||||
3821649|NCT01739348|3647171|B1||Female|Sex: Female, Male||Participants|Count of Participants|383|383.0||||||
3821650|NCT01739348|3647167|B5|||Age||Years|Mean|71.8|71.8|Standard Deviation|7.5|7.5|||
3821651|NCT01739348|3647168|B4|||Age||Years|Mean|72.4|72.4|Standard Deviation|7.6|7.6|||
3821652|NCT01739348|3647169|B3|||Age||Years|Mean|72.3|72.3|Standard Deviation|7.4|7.4|||
3821653|NCT01739348|3647170|B2|||Age||Years|Mean|71.8|71.8|Standard Deviation|7.6|7.6|||
3821654|NCT01739348|3647171|B1|||Age||Years|Mean|71.2|71.2|Standard Deviation|7.4|7.4|||
3821655|NCT01739335|3647244|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821656|NCT01739335|3647245|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821657|NCT01739335|3647246|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821658|NCT01739335|3647244|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3821659|NCT01739335|3647245|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3821660|NCT01739335|3647246|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3821661|NCT01739335|3647244|B3||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3821662|NCT01739335|3647245|B2||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3821663|NCT01739335|3647246|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3821664|NCT01739335|3647244|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3821665|NCT01739335|3647245|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3821666|NCT01739335|3647246|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3821667|NCT01739335|3647244|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3821668|NCT01739335|3647245|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3821669|NCT01739335|3647246|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821670|NCT01739335|3647244|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3821671|NCT01739335|3647245|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821672|NCT01739335|3647246|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3821673|NCT01739335|3647244|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3821674|NCT01739335|3647245|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821675|NCT01739335|3647246|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3821676|NCT01739335|3647244|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821677|NCT01739335|3647245|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821678|NCT01739335|3647246|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821679|NCT01739335|3647244|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3821680|NCT01739335|3647245|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3821681|NCT01739335|3647246|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3821682|NCT01739335|3647244|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3821683|NCT01739335|3647245|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3821684|NCT01739335|3647246|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3821685|NCT01739335|3647244|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3821686|NCT01739335|3647245|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3821687|NCT01739335|3647246|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3821688|NCT01739335|3647244|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821689|NCT01739335|3647245|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821690|NCT01739335|3647246|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821691|NCT01739335|3647244|B3|||Age||years|Median|40|40.0|Inter-Quartile Range|||31.0|55.5|
3821692|NCT01739335|3647245|B2|||Age||years|Median|37|37.0|Inter-Quartile Range|||30.0|56.0|
3821693|NCT01739335|3647246|B1|||Age||years|Median|43|43.0|Inter-Quartile Range|||33.0|53.0|
3821694|NCT01739231|3647279|B7|Part B||Weight||pounds|Mean|185.7|185.7|Full Range|||122.0|249.0|
3821695|NCT01739231|3647280|B6|Part B||Weight||pounds|Mean|184.5|184.5|Full Range|||141.0|247.0|
3821696|NCT01739231|3647281|B5|Part B||Weight||pounds|Mean|176.5|176.5|Full Range|||122.0|226.0|
3821697|NCT01739231|3647282|B4|Part B||Weight||pounds|Mean|197.8|197.8|Full Range|||155.0|249.0|
3821698|NCT01739231|3647279|B7|Part A||Weight||pounds|Mean|180.0|180.0|Full Range|||119.0|242.0|
3821699|NCT01739231|3647283|B3|Part A||Weight||pounds|Mean|176.2|176.2|Full Range|||150.0|232.0|
3821700|NCT01739231|3647284|B2|Part A||Weight||pounds|Mean|171.7|171.7|Full Range|||119.0|223.0|
3821701|NCT01739231|3647285|B1|Part A||Weight||pounds|Mean|190.3|190.3|Full Range|||127.0|242.0|
3821702|NCT01739231|3647279|B7|Part B||Height||inches|Mean|68.7|68.7|Full Range|||61.0|75.0|
3821703|NCT01739231|3647280|B6|Part B||Height||inches|Mean|69|69.0|Full Range|||63.0|74.0|
3821704|NCT01739231|3647281|B5|Part B||Height||inches|Mean|66.7|66.7|Full Range|||61.0|75.0|
3821705|NCT01739231|3647282|B4|Part B||Height||inches|Mean|70.0|70.0|Full Range|||65.0|74.0|
3821706|NCT01739231|3647279|B7|Part A||Height||inches|Mean|68.5|68.5|Full Range|||59.0|76.0|
3821707|NCT01739231|3647283|B3|Part A||Height||inches|Mean|69.1|69.1|Full Range|||65.0|73.0|
3821708|NCT01739231|3647284|B2|Part A||Height||inches|Mean|67.4|67.4|Full Range|||61.0|73.0|
3821709|NCT01739231|3647285|B1|Part A||Height||inches|Mean|69.4|69.4|Full Range|||59.0|76.0|
3821710|NCT01739231|3647279|B7|Part B|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821711|NCT01739231|3647280|B6|Part B|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821712|NCT01739231|3647281|B5|Part B|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821713|NCT01739231|3647282|B4|Part B|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821714|NCT01739231|3647279|B7|Part B|More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821715|NCT01739231|3647280|B6|Part B|More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821716|NCT01739231|3647281|B5|Part B|More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821717|NCT01739231|3647282|B4|Part B|More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821718|NCT01739231|3647279|B7|Part B|White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3821719|NCT01739231|3647280|B6|Part B|White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3821720|NCT01739231|3647281|B5|Part B|White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3821721|NCT01739231|3647282|B4|Part B|White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3821722|NCT01739231|3647279|B7|Part B|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3821723|NCT01739231|3647280|B6|Part B|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3821724|NCT01739231|3647281|B5|Part B|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3821725|NCT01739231|3647282|B4|Part B|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3821726|NCT01739231|3647279|B7|Part B|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821727|NCT01739231|3647280|B6|Part B|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821728|NCT01739231|3647281|B5|Part B|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821729|NCT01739231|3647282|B4|Part B|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821730|NCT01739231|3647279|B7|Part B|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821731|NCT01739231|3647280|B6|Part B|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821732|NCT01739231|3647281|B5|Part B|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821733|NCT01739231|3647282|B4|Part B|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821734|NCT01739231|3647279|B7|Part B|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3821735|NCT01739231|3647280|B6|Part B|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821736|NCT01739231|3647281|B5|Part B|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821737|NCT01739231|3647282|B4|Part B|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3821738|NCT01739231|3647279|B7|Part A|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821739|NCT01739231|3647283|B3|Part A|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821740|NCT01739231|3647284|B2|Part A|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821741|NCT01739231|3647285|B1|Part A|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821742|NCT01739231|3647279|B7|Part A|More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821743|NCT01739231|3647283|B3|Part A|More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821744|NCT01739231|3647284|B2|Part A|More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821745|NCT01739231|3647285|B1|Part A|More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821746|NCT01739231|3647279|B7|Part A|White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3821747|NCT01739231|3647283|B3|Part A|White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821748|NCT01739231|3647284|B2|Part A|White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3821749|NCT01739231|3647285|B1|Part A|White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3821750|NCT01739231|3647279|B7|Part A|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3821751|NCT01739231|3647283|B3|Part A|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3821752|NCT01739231|3647284|B2|Part A|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3821753|NCT01739231|3647285|B1|Part A|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3821754|NCT01739231|3647279|B7|Part A|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821755|NCT01739231|3647283|B3|Part A|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821756|NCT01739231|3647284|B2|Part A|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821757|NCT01739231|3647285|B1|Part A|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821758|NCT01739231|3647279|B7|Part A|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821759|NCT01739231|3647283|B3|Part A|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821760|NCT01739231|3647284|B2|Part A|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821761|NCT01739231|3647285|B1|Part A|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821762|NCT01739231|3647279|B7|Part A|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3821763|NCT01739231|3647283|B3|Part A|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821764|NCT01739231|3647284|B2|Part A|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821765|NCT01739231|3647285|B1|Part A|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3821766|NCT01739231|3647279|B7|Part B|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821767|NCT01739231|3647280|B6|Part B|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821768|NCT01739231|3647281|B5|Part B|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821769|NCT01739231|3647282|B4|Part B|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821770|NCT01739231|3647283|B3|Part B|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821771|NCT01739231|3647284|B2|Part B|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821772|NCT01739231|3647285|B1|Part B|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821773|NCT01739231|3647279|B7|Part B|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3821774|NCT01739231|3647280|B6|Part B|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3821775|NCT01739231|3647281|B5|Part B|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3821776|NCT01739231|3647282|B4|Part B|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3821777|NCT01739231|3647283|B3|Part B|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821778|NCT01739231|3647284|B2|Part B|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821779|NCT01739231|3647285|B1|Part B|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821780|NCT01739231|3647279|B7|Part B|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3821781|NCT01739231|3647280|B6|Part B|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3821782|NCT01739231|3647281|B5|Part B|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3821783|NCT01739231|3647282|B4|Part B|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3821784|NCT01739231|3647283|B3|Part B|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821785|NCT01739231|3647284|B2|Part B|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821786|NCT01739231|3647285|B1|Part B|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821787|NCT01739231|3647279|B7|Part A|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821788|NCT01739231|3647280|B6|Part A|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821789|NCT01739231|3647281|B5|Part A|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821790|NCT01739231|3647282|B4|Part A|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821791|NCT01739231|3647283|B3|Part A|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821792|NCT01739231|3647284|B2|Part A|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821793|NCT01739231|3647285|B1|Part A|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821794|NCT01739231|3647279|B7|Part A|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3821795|NCT01739231|3647280|B6|Part A|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821796|NCT01739231|3647281|B5|Part A|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821797|NCT01739231|3647282|B4|Part A|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821798|NCT01739231|3647283|B3|Part A|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3821799|NCT01739231|3647284|B2|Part A|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3821800|NCT01739231|3647285|B1|Part A|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3821801|NCT01739231|3647279|B7|Part A|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3821802|NCT01739231|3647280|B6|Part A|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821803|NCT01739231|3647281|B5|Part A|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821804|NCT01739231|3647282|B4|Part A|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3821805|NCT01739231|3647283|B3|Part A|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3821806|NCT01739231|3647284|B2|Part A|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3821807|NCT01739231|3647285|B1|Part A|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3821808|NCT01739231|3647279|B7|Part B|Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3821809|NCT01739231|3647280|B6|Part B|Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3821810|NCT01739231|3647281|B5|Part B|Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3821811|NCT01739231|3647282|B4|Part B|Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3821812|NCT01739231|3647283|B3|Part B|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821813|NCT01739231|3647284|B2|Part B|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821814|NCT01739231|3647285|B1|Part B|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821815|NCT01739231|3647279|B7|Part B|Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3821816|NCT01739231|3647280|B6|Part B|Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3821817|NCT01739231|3647281|B5|Part B|Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3821818|NCT01739231|3647282|B4|Part B|Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3821819|NCT01739231|3647283|B3|Part B|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821820|NCT01739231|3647284|B2|Part B|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821821|NCT01739231|3647285|B1|Part B|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821822|NCT01739231|3647279|B7|Part A|Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3821823|NCT01739231|3647280|B6|Part A|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821824|NCT01739231|3647281|B5|Part A|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821825|NCT01739231|3647282|B4|Part A|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821826|NCT01739231|3647283|B3|Part A|Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3821827|NCT01739231|3647284|B2|Part A|Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3821828|NCT01739231|3647285|B1|Part A|Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3821829|NCT01739231|3647279|B7|Part A|Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3821830|NCT01739231|3647280|B6|Part A|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821831|NCT01739231|3647281|B5|Part A|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821832|NCT01739231|3647282|B4|Part A|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821833|NCT01739231|3647283|B3|Part A|Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3821834|NCT01739231|3647284|B2|Part A|Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3821835|NCT01739231|3647285|B1|Part A|Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3821836|NCT01739231|3647279|B7|Part B||Age||years|Mean|36.9|36.9|Full Range|||21.0|49.0|
3821837|NCT01739231|3647280|B6|Part B||Age||years|Mean|36.5|36.5|Full Range|||23.0|49.0|
3821838|NCT01739231|3647281|B5|Part B||Age||years|Mean|37.6|37.6|Full Range|||27.0|49.0|
3821839|NCT01739231|3647282|B4|Part B||Age||years|Mean|37.0|37.0|Full Range|||21.0|49.0|
3821840|NCT01739231|3647279|B7|Part A||Age||years|Mean|36.8|36.8|Full Range|||19.0|49.0|
3821841|NCT01739231|3647283|B3|Part A||Age||years|Mean|37.0|37.0|Full Range|||26.0|49.0|
3821842|NCT01739231|3647284|B2|Part A||Age||years|Mean|37.6|37.6|Full Range|||19.0|49.0|
3821843|NCT01739231|3647285|B1|Part A||Age||years|Mean|35.8|35.8|Full Range|||21.0|48.0|
3821844|NCT01738984|3647455|B3|||Number meeting goal of 150 moderate-to-vigorous min/week|For this outcome I wanted to report the percent of sample meeting goal of 150 minutes of moderate-to-vigorous physical activity per week and standard error - but drop downs below did not let me report percentage and SE - so listed just number for value|participants|Number|116|116.0||||||
3821845|NCT01738984|3647456|B2|||Number meeting goal of 150 moderate-to-vigorous min/week|For this outcome I wanted to report the percent of sample meeting goal of 150 minutes of moderate-to-vigorous physical activity per week and standard error - but drop downs below did not let me report percentage and SE - so listed just number for value|participants|Number|71|71.0||||||
3821846|NCT01738984|3647457|B1|||Number meeting goal of 150 moderate-to-vigorous min/week|For this outcome I wanted to report the percent of sample meeting goal of 150 minutes of moderate-to-vigorous physical activity per week and standard error - but drop downs below did not let me report percentage and SE - so listed just number for value|participants|Number|45|45.0||||||
3821847|NCT01738984|3647455|B3|||Minutes per week of moderate-to-vigorous of physical activity (MVPA min/wk)||minutes per week|Mean|76.15|76.15|Standard Deviation|119|119.0|||
3821848|NCT01738984|3647456|B2|||Minutes per week of moderate-to-vigorous of physical activity (MVPA min/wk)||minutes per week|Mean|85.8|85.8|Standard Deviation|138.3|138.3|||
3821849|NCT01738984|3647457|B1|||Minutes per week of moderate-to-vigorous of physical activity (MVPA min/wk)||minutes per week|Mean|66.5|66.5|Standard Deviation|99.7|99.7|||
3821850|NCT01738984|3647455|B3|United States||Region of Enrollment||participants|Number|499|499.0||||||
3821851|NCT01738984|3647456|B2|United States||Region of Enrollment||participants|Number|249|249.0||||||
3821852|NCT01738984|3647457|B1|United States||Region of Enrollment||participants|Number|250|250.0||||||
3821853|NCT01738984|3647455|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3821854|NCT01738984|3647456|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3821855|NCT01738984|3647457|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3821856|NCT01738984|3647455|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3821857|NCT01738984|3647456|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3821858|NCT01738984|3647457|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3821859|NCT01738984|3647455|B3||White|Race (NIH/OMB)||Participants|Count of Participants|403|403.0||||||
3821860|NCT01738984|3647456|B2||White|Race (NIH/OMB)||Participants|Count of Participants|207|207.0||||||
3821861|NCT01738984|3647457|B1||White|Race (NIH/OMB)||Participants|Count of Participants|196|196.0||||||
3821862|NCT01738984|3647455|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3821863|NCT01738984|3647456|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3821864|NCT01738984|3647457|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3821865|NCT01738984|3647455|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3821866|NCT01738984|3647456|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3821867|NCT01738984|3647457|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3821868|NCT01738984|3647455|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3821869|NCT01738984|3647456|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3821870|NCT01738984|3647457|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3821871|NCT01738984|3647455|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3821872|NCT01738984|3647456|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3821873|NCT01738984|3647457|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3821874|NCT01738984|3647455|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3821875|NCT01738984|3647456|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3821876|NCT01738984|3647457|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3821877|NCT01738984|3647455|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|441|441.0||||||
3821878|NCT01738984|3647456|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|212|212.0||||||
3821879|NCT01738984|3647457|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|229|229.0||||||
3821880|NCT01738984|3647455|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3821881|NCT01738984|3647456|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3821882|NCT01738984|3647457|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3821883|NCT01738984|3647455|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821884|NCT01738984|3647456|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821885|NCT01738984|3647457|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821886|NCT01738984|3647455|B3||Female|Sex: Female, Male||Participants|Count of Participants|499|499.0||||||
3821887|NCT01738984|3647456|B2||Female|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
3821888|NCT01738984|3647457|B1||Female|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
3821889|NCT01738984|3647455|B3|||Age||years|Mean|29.8|29.8|Standard Deviation|5.25|5.25|||
3821890|NCT01738984|3647456|B2|||Age||years|Mean|29.4|29.4|Standard Deviation|5.3|5.3|||
3821891|NCT01738984|3647457|B1|||Age||years|Mean|30.2|30.2|Standard Deviation|5.2|5.2|||
3821892|NCT01738971|3647468|B4|Other method||Contraception use at time of enrollment||participants|Number|7|7.0||||||
3821893|NCT01738971|3647469|B3|Other method||Contraception use at time of enrollment||participants|Number|0|0.0||||||
3821894|NCT01738971|3647470|B2|Other method||Contraception use at time of enrollment||participants|Number|3|3.0||||||
3821895|NCT01738971|3647471|B1|Other method||Contraception use at time of enrollment||participants|Number|4|4.0||||||
3821896|NCT01738971|3647468|B4|Condoms||Contraception use at time of enrollment||participants|Number|62|62.0||||||
3821897|NCT01738971|3647469|B3|Condoms||Contraception use at time of enrollment||participants|Number|26|26.0||||||
3821898|NCT01738971|3647470|B2|Condoms||Contraception use at time of enrollment||participants|Number|17|17.0||||||
3821899|NCT01738971|3647471|B1|Condoms||Contraception use at time of enrollment||participants|Number|19|19.0||||||
3821900|NCT01738971|3647468|B4|None||Contraception use at time of enrollment||participants|Number|33|33.0||||||
3821901|NCT01738971|3647469|B3|None||Contraception use at time of enrollment||participants|Number|13|13.0||||||
3821902|NCT01738971|3647470|B2|None||Contraception use at time of enrollment||participants|Number|8|8.0||||||
3821903|NCT01738971|3647471|B1|None||Contraception use at time of enrollment||participants|Number|12|12.0||||||
3821904|NCT01738971|3647468|B4|United Kingdom||Region of Enrollment||participants|Number|102|102.0||||||
3821905|NCT01738971|3647469|B3|United Kingdom||Region of Enrollment||participants|Number|39|39.0||||||
3821906|NCT01738971|3647470|B2|United Kingdom||Region of Enrollment||participants|Number|28|28.0||||||
3821907|NCT01738971|3647471|B1|United Kingdom||Region of Enrollment||participants|Number|35|35.0||||||
3821908|NCT01738971|3647468|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821909|NCT01738971|3647469|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821910|NCT01738971|3647470|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821911|NCT01738971|3647471|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3821912|NCT01738971|3647468|B4||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3821913|NCT01738971|3647469|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3821914|NCT01738971|3647470|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3821915|NCT01738971|3647471|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3821916|NCT01738971|3647468|B4|||Age||years|Mean|23|23.0|Standard Deviation|5.2|5.2|||
3821917|NCT01738971|3647469|B3|||Age||years|Mean|22|22.0|Standard Deviation|5.2|5.2|||
3821918|NCT01738971|3647470|B2|||Age||years|Mean|25|25.0|Standard Deviation|5.6|5.6|||
3821919|NCT01738971|3647471|B1|||Age||years|Mean|23|23.0|Standard Deviation|4.5|4.5|||
3821920|NCT01738919|3647487|B3|Denmark||Region of Enrollment||participants|Number|32|32.0||||||
3821921|NCT01738919|3647488|B2|Denmark||Region of Enrollment||participants|Number|17|17.0||||||
3821922|NCT01738919|3647489|B1|Denmark||Region of Enrollment||participants|Number|15|15.0||||||
3821923|NCT01738919|3647487|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3821924|NCT01738919|3647488|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3821925|NCT01738919|3647489|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3821926|NCT01738919|3647487|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3821927|NCT01738919|3647488|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3821928|NCT01738919|3647489|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3821929|NCT01738919|3647487|B3|||Age||years|Median|31|31.0|Inter-Quartile Range|||26.0|48.0|
3821930|NCT01738919|3647488|B2|||Age||years|Median|42|42.0|Inter-Quartile Range|||26.0|51.0|
3821931|NCT01738919|3647489|B1|||Age||years|Median|30|30.0|Inter-Quartile Range|||26.0|44.0|
3821932|NCT01738750|3647506|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
3821933|NCT01738750|3647507|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
3821934|NCT01738750|3647508|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
3821935|NCT01738750|3647506|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3821936|NCT01738750|3647507|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3821937|NCT01738750|3647508|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3821938|NCT01738750|3647506|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3821939|NCT01738750|3647507|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3821940|NCT01738750|3647508|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3821941|NCT01738750|3647506|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3821942|NCT01738750|3647507|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3821943|NCT01738750|3647508|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3821944|NCT01738750|3647506|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3821945|NCT01738750|3647507|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3821946|NCT01738750|3647508|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3821947|NCT01738750|3647506|B3||<=18 years|Age||Participants|Count of Participants|100|100.0||||||
3821948|NCT01738750|3647507|B2||<=18 years|Age||Participants|Count of Participants|51|51.0||||||
3821949|NCT01738750|3647508|B1||<=18 years|Age||Participants|Count of Participants|49|49.0||||||
3821950|NCT01738750|3647506|B3|||Age||years|Mean|10.7|10.7|Standard Deviation|3.2|3.2|||
3821951|NCT01738750|3647507|B2|||Age||years|Mean|10.6|10.6|Standard Deviation|3.2|3.2|||
3821952|NCT01738750|3647508|B1|||Age||years|Mean|10.8|10.8|Standard Deviation|3.3|3.3|||
3821953|NCT01738737|3647517|B6|||Hamstring shortening||degrees|Median|24.6|24.6|Inter-Quartile Range|||17.9|32.2|
3821954|NCT01738737|3647518|B5|||Hamstring shortening||degrees|Median|24.0|24.0|Inter-Quartile Range|||19.5|31.5|
3821955|NCT01738737|3647519|B4|||Hamstring shortening||degrees|Median|26.0|26.0|Inter-Quartile Range|||15.0|39.0|
3821956|NCT01738737|3647520|B3|||Hamstring shortening||degrees|Median|25.0|25.0|Inter-Quartile Range|||19.5|29.5|
3821957|NCT01738737|3647521|B2|||Hamstring shortening||degrees|Median|28.0|28.0|Inter-Quartile Range|||20.7|32.5|
3821958|NCT01738737|3647522|B1|||Hamstring shortening||degrees|Median|20.0|20.0|Inter-Quartile Range|||15.0|28.7|
3821959|NCT01738737|3647517|B6|||Knee range of motion||degrees|Median|102.6|102.6|Inter-Quartile Range|||92.0|112.0|
3821960|NCT01738737|3647518|B5|||Knee range of motion||degrees|Median|104.0|104.0|Inter-Quartile Range|||100.7|112.7|
3821961|NCT01738737|3647519|B4|||Knee range of motion||degrees|Median|93.0|93.0|Inter-Quartile Range|||81.5|107.0|
3821962|NCT01738737|3647520|B3|||Knee range of motion||degrees|Median|102.0|102.0|Inter-Quartile Range|||88.0|116.0|
3821963|NCT01738737|3647521|B2|||Knee range of motion||degrees|Median|106.0|106.0|Inter-Quartile Range|||96.2|109.0|
3821964|NCT01738737|3647522|B1|||Knee range of motion||degrees|Median|108.0|108.0|Inter-Quartile Range|||93.5|115.2|
3821965|NCT01738737|3647517|B6|||Mobility - Timed Get up and Go (TUG)|TUG measures the time a person spends to get up from a chair, walks at the usual speed for 3m, turns, walk back and sit down.|seconds|Mean|15.0|15.0|Standard Deviation|3.3|3.3|||
3821966|NCT01738737|3647518|B5|||Mobility - Timed Get up and Go (TUG)|TUG measures the time a person spends to get up from a chair, walks at the usual speed for 3m, turns, walk back and sit down.|seconds|Mean|13.5|13.5|Standard Deviation|2.4|2.4|||
3821967|NCT01738737|3647519|B4|||Mobility - Timed Get up and Go (TUG)|TUG measures the time a person spends to get up from a chair, walks at the usual speed for 3m, turns, walk back and sit down.|seconds|Mean|16.0|16.0|Standard Deviation|3.0|3.0|||
3821968|NCT01738737|3647520|B3|||Mobility - Timed Get up and Go (TUG)|TUG measures the time a person spends to get up from a chair, walks at the usual speed for 3m, turns, walk back and sit down.|seconds|Mean|14.8|14.8|Standard Deviation|4.0|4.0|||
3821969|NCT01738737|3647521|B2|||Mobility - Timed Get up and Go (TUG)|TUG measures the time a person spends to get up from a chair, walks at the usual speed for 3m, turns, walk back and sit down.|seconds|Mean|15.8|15.8|Standard Deviation|4.0|4.0|||
3821970|NCT01738737|3647522|B1|||Mobility - Timed Get up and Go (TUG)|TUG measures the time a person spends to get up from a chair, walks at the usual speed for 3m, turns, walk back and sit down.|seconds|Mean|15.0|15.0|Standard Deviation|3.0|3.0|||
3821971|NCT01738737|3647517|B6|||Function|The questionnaire varies from 0 to 24. Higher values represent worse outcome.|units on Lequesne Functional Question.|Mean|10.3|10.3|Standard Deviation|4.7|4.7|||
3821972|NCT01738737|3647518|B5|||Function|The questionnaire varies from 0 to 24. Higher values represent worse outcome.|units on Lequesne Functional Question.|Mean|9.3|9.3|Standard Deviation|4.5|4.5|||
3821973|NCT01738737|3647519|B4|||Function|The questionnaire varies from 0 to 24. Higher values represent worse outcome.|units on Lequesne Functional Question.|Mean|11.4|11.4|Standard Deviation|5.6|5.6|||
3821974|NCT01738737|3647520|B3|||Function|The questionnaire varies from 0 to 24. Higher values represent worse outcome.|units on Lequesne Functional Question.|Mean|10.7|10.7|Standard Deviation|4.5|4.5|||
3821975|NCT01738737|3647521|B2|||Function|The questionnaire varies from 0 to 24. Higher values represent worse outcome.|units on Lequesne Functional Question.|Mean|10.1|10.1|Standard Deviation|4.7|4.7|||
3821976|NCT01738737|3647522|B1|||Function|The questionnaire varies from 0 to 24. Higher values represent worse outcome.|units on Lequesne Functional Question.|Mean|10.1|10.1|Standard Deviation|4.4|4.4|||
3821977|NCT01738737|3647517|B6|||Self-reported symptoms|Western Ontario & McMaster Universities Osteoarthritis Index (WOMAC) asses self reported symptoms of pain, function and stiffness. The total scores varies from 0 (no impairment) to 96 (worse outcome).|units on scale WOMAC|Mean|34.7|34.7|Standard Deviation|16.9|16.9|||
3821978|NCT01738737|3647518|B5|||Self-reported symptoms|Western Ontario & McMaster Universities Osteoarthritis Index (WOMAC) asses self reported symptoms of pain, function and stiffness. The total scores varies from 0 (no impairment) to 96 (worse outcome).|units on scale WOMAC|Mean|33.4|33.4|Standard Deviation|17.6|17.6|||
3821979|NCT01738737|3647519|B4|||Self-reported symptoms|Western Ontario & McMaster Universities Osteoarthritis Index (WOMAC) asses self reported symptoms of pain, function and stiffness. The total scores varies from 0 (no impairment) to 96 (worse outcome).|units on scale WOMAC|Mean|39.5|39.5|Standard Deviation|20.7|20.7|||
3821980|NCT01738737|3647520|B3|||Self-reported symptoms|Western Ontario & McMaster Universities Osteoarthritis Index (WOMAC) asses self reported symptoms of pain, function and stiffness. The total scores varies from 0 (no impairment) to 96 (worse outcome).|units on scale WOMAC|Mean|32.2|32.2|Standard Deviation|14.8|14.8|||
3821981|NCT01738737|3647521|B2|||Self-reported symptoms|Western Ontario & McMaster Universities Osteoarthritis Index (WOMAC) asses self reported symptoms of pain, function and stiffness. The total scores varies from 0 (no impairment) to 96 (worse outcome).|units on scale WOMAC|Mean|33.4|33.4|Standard Deviation|16.6|16.6|||
3821982|NCT01738737|3647522|B1|||Self-reported symptoms|Western Ontario & McMaster Universities Osteoarthritis Index (WOMAC) asses self reported symptoms of pain, function and stiffness. The total scores varies from 0 (no impairment) to 96 (worse outcome).|units on scale WOMAC|Mean|35.2|35.2|Standard Deviation|14.8|14.8|||
3821983|NCT01738737|3647517|B6|||Pain|Scale varies from 0 (no pain) to 10 (worst pain possible).|cm on Visual Analogue Scale (0-10)|Mean|6.0|6.0|Standard Deviation|1.9|1.9|||
3821984|NCT01738737|3647518|B5|||Pain|Scale varies from 0 (no pain) to 10 (worst pain possible).|cm on Visual Analogue Scale (0-10)|Mean|5.3|5.3|Standard Deviation|1.9|1.9|||
3821985|NCT01738737|3647519|B4|||Pain|Scale varies from 0 (no pain) to 10 (worst pain possible).|cm on Visual Analogue Scale (0-10)|Mean|5.7|5.7|Standard Deviation|2.1|2.1|||
3821986|NCT01738737|3647520|B3|||Pain|Scale varies from 0 (no pain) to 10 (worst pain possible).|cm on Visual Analogue Scale (0-10)|Mean|6.0|6.0|Standard Deviation|2.2|2.2|||
3821987|NCT01738737|3647521|B2|||Pain|Scale varies from 0 (no pain) to 10 (worst pain possible).|cm on Visual Analogue Scale (0-10)|Mean|6.5|6.5|Standard Deviation|1.7|1.7|||
3822048|NCT01738503|3647671|B5|||Body Mass Index||kg/m^2|Mean|25.67|25.67|Standard Deviation|3.635|3.635|||
3821988|NCT01738737|3647522|B1|||Pain|Scale varies from 0 (no pain) to 10 (worst pain possible).|cm on Visual Analogue Scale (0-10)|Mean|6.5|6.5|Standard Deviation|1.4|1.4|||
3821989|NCT01738737|3647517|B6||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3821990|NCT01738737|3647518|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3821991|NCT01738737|3647519|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3821992|NCT01738737|3647520|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3821993|NCT01738737|3647521|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3821994|NCT01738737|3647522|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3821995|NCT01738737|3647517|B6||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3821996|NCT01738737|3647518|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3821997|NCT01738737|3647519|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3821998|NCT01738737|3647520|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3821999|NCT01738737|3647521|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3822000|NCT01738737|3647522|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3822001|NCT01738737|3647517|B6|||Age||years|Mean|63.5|63.5|Standard Deviation|6.7|6.7|||
3822002|NCT01738737|3647518|B5|||Age||years|Mean|62.4|62.4|Standard Deviation|6.3|6.3|||
3822003|NCT01738737|3647519|B4|||Age||years|Mean|66.4|66.4|Standard Deviation|5.9|5.9|||
3822004|NCT01738737|3647520|B3|||Age||years|Mean|62.7|62.7|Standard Deviation|6.8|6.8|||
3822005|NCT01738737|3647521|B2|||Age||years|Mean|64.8|64.8|Standard Deviation|6.3|6.3|||
3822006|NCT01738737|3647522|B1|||Age||years|Mean|61.4|61.4|Standard Deviation|8.1|8.1|||
3822007|NCT01738672|3647631|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3822008|NCT01738672|3647631|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3822009|NCT01738672|3647631|B1|||Age||years|Median|30|30.0|Inter-Quartile Range|||25.0|33.0|
3822010|NCT01738646|3647640|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3822011|NCT01738646|3647640|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3822012|NCT01738646|3647640|B1|||Age||years|Mean|52.4|52.4|Standard Deviation|11.0|11.0|||
3822013|NCT01738581|3647648|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
3822014|NCT01738581|3647649|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3822015|NCT01738581|3647650|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3822016|NCT01738581|3647648|B3||Male|Gender||Participants|Count of Participants|6|6.0||||||
3822017|NCT01738581|3647649|B2||Male|Gender||Participants|Count of Participants|3|3.0||||||
3822018|NCT01738581|3647650|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
3822019|NCT01738581|3647648|B3||Female|Gender||Participants|Count of Participants|3|3.0||||||
3822020|NCT01738581|3647649|B2||Female|Gender||Participants|Count of Participants|1|1.0||||||
3822021|NCT01738581|3647650|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
3822022|NCT01738581|3647648|B3|||Age||years|Mean|46|46.0|Standard Deviation|10.64320336|10.64320336|||
3822023|NCT01738581|3647649|B2|||Age||years|Mean|44|44.0|Standard Deviation|6.751543034|6.751543034|||
3822024|NCT01738581|3647650|B1|||Age||years|Mean|48|48.0|Standard Deviation|13.55359731|13.55359731|||
3822025|NCT01738503|3647669|B7|||Smoking History (Nicotine Use)||years|Mean|15.30|15.3|Standard Deviation|11.243|11.243|||
3822026|NCT01738503|3647670|B6|||Smoking History (Nicotine Use)||years|Mean|17.31|17.31|Standard Deviation|13.054|13.054|||
3822027|NCT01738503|3647671|B5|||Smoking History (Nicotine Use)||years|Mean|20.07|20.07|Standard Deviation|11.526|11.526|||
3822028|NCT01738503|3647672|B4|||Smoking History (Nicotine Use)||years|Mean|19.83|19.83|Standard Deviation|14.282|14.282|||
3822029|NCT01738503|3647673|B3|||Smoking History (Nicotine Use)||years|Mean|9.57|9.57|Standard Deviation|8.225|8.225|||
3822030|NCT01738503|3647674|B2|||Smoking History (Nicotine Use)||years|Mean|10.64|10.64|Standard Deviation|5.387|5.387|||
3822031|NCT01738503|3647675|B1|||Smoking History (Nicotine Use)||years|Mean|15.14|15.14|Standard Deviation|10.596|10.596|||
3822032|NCT01738503|3647669|B7|||Heroin Use||years|Mean|9.62|9.62|Standard Deviation|10.292|10.292|||
3822033|NCT01738503|3647670|B6|||Heroin Use||years|Mean|8.56|8.56|Standard Deviation|12.471|12.471|||
3822034|NCT01738503|3647671|B5|||Heroin Use||years|Mean|10.70|10.7|Standard Deviation|7.987|7.987|||
3822035|NCT01738503|3647672|B4|||Heroin Use||years|Mean|11.64|11.64|Standard Deviation|12.549|12.549|||
3822036|NCT01738503|3647673|B3|||Heroin Use||years|Mean|5.00|5.0|Standard Deviation|5.604|5.604|||
3822037|NCT01738503|3647674|B2|||Heroin Use||years|Mean|9.78|9.78|Standard Deviation|11.454|11.454|||
3822038|NCT01738503|3647675|B1|||Heroin Use||years|Mean|11.25|11.25|Standard Deviation|10.463|10.463|||
3822039|NCT01738503|3647669|B7|||Other Opioid Use||years|Mean|6.15|6.15|Standard Deviation|6.165|6.165|||
3822040|NCT01738503|3647670|B6|||Other Opioid Use||years|Mean|6.30|6.3|Standard Deviation|8.693|8.693|||
3822041|NCT01738503|3647671|B5|||Other Opioid Use||years|Mean|8.36|8.36|Standard Deviation|9.770|9.77|||
3822042|NCT01738503|3647672|B4|||Other Opioid Use||years|Mean|5.27|5.27|Standard Deviation|3.927|3.927|||
3822043|NCT01738503|3647673|B3|||Other Opioid Use||years|Mean|4.17|4.17|Standard Deviation|2.887|2.887|||
3822044|NCT01738503|3647674|B2|||Other Opioid Use||years|Mean|6.18|6.18|Standard Deviation|4.191|4.191|||
3822045|NCT01738503|3647675|B1|||Other Opioid Use||years|Mean|6.75|6.75|Standard Deviation|5.545|5.545|||
3822046|NCT01738503|3647669|B7|||Body Mass Index||kg/m^2|Mean|24.64|24.64|Standard Deviation|3.394|3.394|||
3822047|NCT01738503|3647670|B6|||Body Mass Index||kg/m^2|Mean|25.36|25.36|Standard Deviation|3.355|3.355|||
3822049|NCT01738503|3647672|B4|||Body Mass Index||kg/m^2|Mean|25.26|25.26|Standard Deviation|4.295|4.295|||
3822050|NCT01738503|3647673|B3|||Body Mass Index||kg/m^2|Mean|23.39|23.39|Standard Deviation|2.298|2.298|||
3822051|NCT01738503|3647674|B2|||Body Mass Index||kg/m^2|Mean|24.67|24.67|Standard Deviation|3.239|3.239|||
3822052|NCT01738503|3647675|B1|||Body Mass Index||kg/m^2|Mean|23.55|23.55|Standard Deviation|3.084|3.084|||
3822053|NCT01738503|3647669|B7|||Height||cm|Mean|171.22|171.22|Standard Deviation|9.906|9.906|||
3822054|NCT01738503|3647670|B6|||Height||cm|Mean|170.64|170.64|Standard Deviation|11.469|11.469|||
3822055|NCT01738503|3647671|B5|||Height||cm|Mean|168.71|168.71|Standard Deviation|10.963|10.963|||
3822056|NCT01738503|3647672|B4|||Height||cm|Mean|171.17|171.17|Standard Deviation|8.701|8.701|||
3822057|NCT01738503|3647673|B3|||Height||cm|Mean|170.50|170.5|Standard Deviation|11.738|11.738|||
3822058|NCT01738503|3647674|B2|||Height||cm|Mean|172.87|172.87|Standard Deviation|8.532|8.532|||
3822059|NCT01738503|3647675|B1|||Height||cm|Mean|173.41|173.41|Standard Deviation|8.514|8.514|||
3822060|NCT01738503|3647669|B7|||Weight||kg|Mean|72.50|72.5|Standard Deviation|13.159|13.159|||
3822061|NCT01738503|3647670|B6|||Weight||kg|Mean|74.64|74.64|Standard Deviation|16.825|16.825|||
3822062|NCT01738503|3647671|B5|||Weight||kg|Mean|73.16|73.16|Standard Deviation|12.753|12.753|||
3822063|NCT01738503|3647672|B4|||Weight||kg|Mean|74.43|74.43|Standard Deviation|15.995|15.995|||
3822064|NCT01738503|3647673|B3|||Weight||kg|Mean|68.08|68.08|Standard Deviation|9.900|9.9|||
3822065|NCT01738503|3647674|B2|||Weight||kg|Mean|73.71|73.71|Standard Deviation|10.411|10.411|||
3822066|NCT01738503|3647675|B1|||Weight||kg|Mean|71.12|71.12|Standard Deviation|12.929|12.929|||
3822067|NCT01738503|3647669|B7|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|85|85.0||||||
3822068|NCT01738503|3647670|B6|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3822069|NCT01738503|3647671|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3822070|NCT01738503|3647672|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3822071|NCT01738503|3647673|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3822072|NCT01738503|3647674|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3822073|NCT01738503|3647675|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3822074|NCT01738503|3647669|B7|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3822075|NCT01738503|3647670|B6|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3822076|NCT01738503|3647671|B5|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3822077|NCT01738503|3647672|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3822078|NCT01738503|3647673|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3822079|NCT01738503|3647674|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3822080|NCT01738503|3647675|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3822081|NCT01738503|3647669|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3822082|NCT01738503|3647670|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822083|NCT01738503|3647671|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822084|NCT01738503|3647672|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822085|NCT01738503|3647673|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822086|NCT01738503|3647674|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3822087|NCT01738503|3647675|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822088|NCT01738503|3647669|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822089|NCT01738503|3647670|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822090|NCT01738503|3647671|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822091|NCT01738503|3647672|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822092|NCT01738503|3647673|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822093|NCT01738503|3647674|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822094|NCT01738503|3647675|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822095|NCT01738503|3647669|B7||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3822096|NCT01738503|3647670|B6||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3822097|NCT01738503|3647671|B5||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3822098|NCT01738503|3647672|B4||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3822099|NCT01738503|3647673|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3822100|NCT01738503|3647674|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3822101|NCT01738503|3647675|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3822102|NCT01738503|3647669|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3822103|NCT01738503|3647670|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3822104|NCT01738503|3647671|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3822105|NCT01738503|3647672|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3822164|NCT01738477|3647878|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3822106|NCT01738503|3647673|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3822107|NCT01738503|3647674|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3822108|NCT01738503|3647675|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3822109|NCT01738503|3647669|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822110|NCT01738503|3647670|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822111|NCT01738503|3647671|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822112|NCT01738503|3647672|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822113|NCT01738503|3647673|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822114|NCT01738503|3647674|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822115|NCT01738503|3647675|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822116|NCT01738503|3647669|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822117|NCT01738503|3647670|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822118|NCT01738503|3647671|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822119|NCT01738503|3647672|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822120|NCT01738503|3647673|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822121|NCT01738503|3647674|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822122|NCT01738503|3647675|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822123|NCT01738503|3647669|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822124|NCT01738503|3647670|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822125|NCT01738503|3647671|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822126|NCT01738503|3647672|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822127|NCT01738503|3647673|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822128|NCT01738503|3647674|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822129|NCT01738503|3647675|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822130|NCT01738503|3647669|B7||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3822131|NCT01738503|3647670|B6||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3822132|NCT01738503|3647671|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3822133|NCT01738503|3647672|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3822134|NCT01738503|3647673|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3822135|NCT01738503|3647674|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3822136|NCT01738503|3647675|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3822137|NCT01738503|3647669|B7||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3822138|NCT01738503|3647670|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3822139|NCT01738503|3647671|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3822140|NCT01738503|3647672|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3822141|NCT01738503|3647673|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3822142|NCT01738503|3647674|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3822143|NCT01738503|3647675|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3822144|NCT01738503|3647669|B7|||Age||years|Mean|33.8|33.8|Standard Deviation|12.10|12.1|||
3822145|NCT01738503|3647670|B6|||Age||years|Mean|32.9|32.9|Standard Deviation|11.00|11.0|||
3822146|NCT01738503|3647671|B5|||Age||years|Mean|36.2|36.2|Standard Deviation|12.85|12.85|||
3822147|NCT01738503|3647672|B4|||Age||years|Mean|36.1|36.1|Standard Deviation|14.87|14.87|||
3822148|NCT01738503|3647673|B3|||Age||years|Mean|30.1|30.1|Standard Deviation|11.21|11.21|||
3822149|NCT01738503|3647674|B2|||Age||years|Mean|31.1|31.1|Standard Deviation|11.14|11.14|||
3822150|NCT01738503|3647675|B1|||Age||years|Mean|36.5|36.5|Standard Deviation|11.36|11.36|||
3822151|NCT01738477|3647877|B3|White/caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|145|145.0||||||
3822152|NCT01738477|3647878|B2|White/caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|114|114.0||||||
3822153|NCT01738477|3647879|B1|White/caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3822154|NCT01738477|3647877|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3822155|NCT01738477|3647878|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3822156|NCT01738477|3647879|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3822157|NCT01738477|3647877|B3|Oriental||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3822158|NCT01738477|3647878|B2|Oriental||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3822159|NCT01738477|3647879|B1|Oriental||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3822160|NCT01738477|3647877|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3822161|NCT01738477|3647878|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3822162|NCT01738477|3647879|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3822163|NCT01738477|3647877|B3||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3822165|NCT01738477|3647879|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3822166|NCT01738477|3647877|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3822167|NCT01738477|3647878|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3822168|NCT01738477|3647879|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3822169|NCT01738477|3647877|B3|||Age||Years|Mean|23.5|23.5|Standard Deviation|2.1|2.1|||
3822170|NCT01738477|3647878|B2|||Age||Years|Mean|23.5|23.5|Standard Deviation|2.1|2.1|||
3822171|NCT01738477|3647879|B1|||Age||Years|Mean|23.3|23.3|Standard Deviation|2.4|2.4|||
3822172|NCT01738438|3647908|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3822173|NCT01738438|3647908|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822174|NCT01738438|3647908|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822175|NCT01738438|3647908|B1||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3822176|NCT01738438|3647908|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3822177|NCT01738438|3647908|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822178|NCT01738438|3647908|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822179|NCT01738438|3647908|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822180|NCT01738438|3647908|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3822181|NCT01738438|3647908|B1||Female|Gender||Participants|Count of Participants|35|35.0||||||
3822182|NCT01738438|3647908|B1|||Age||years|Median|50|50.0|Full Range|||31.0|78.0|
3822183|NCT01738321|3647914|B3|United States||Region of Enrollment||participants|Number|63|63.0||||||
3822184|NCT01738321|3647915|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3822185|NCT01738321|3647916|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
3822186|NCT01738321|3647914|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3822187|NCT01738321|3647915|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3822188|NCT01738321|3647916|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3822189|NCT01738321|3647914|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3822190|NCT01738321|3647915|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3822191|NCT01738321|3647916|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3822192|NCT01738321|3647914|B3|||Age||years|Mean|8.2|8.2|Standard Deviation|6.7|6.7|||
3822193|NCT01738321|3647915|B2|||Age||years|Mean|9.9|9.9|Standard Deviation|5.1|5.1|||
3822194|NCT01738321|3647916|B1|||Age||years|Mean|2.8|2.8|Standard Deviation|3.6|3.6|||
3822195|NCT01738321|3647914|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3822196|NCT01738321|3647915|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3822197|NCT01738321|3647916|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3822198|NCT01738321|3647914|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3822199|NCT01738321|3647915|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3822200|NCT01738321|3647916|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3822201|NCT01738321|3647914|B3||<=18 years|Age||Participants|Count of Participants|63|63.0||||||
3822202|NCT01738321|3647915|B2||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
3822203|NCT01738321|3647916|B1||<=18 years|Age||Participants|Count of Participants|33|33.0||||||
3822204|NCT01738191|3647923|B3|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3822205|NCT01738191|3647924|B2|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3822206|NCT01738191|3647925|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3822207|NCT01738191|3647923|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822208|NCT01738191|3647924|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822209|NCT01738191|3647925|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822210|NCT01738191|3647923|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822211|NCT01738191|3647924|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822212|NCT01738191|3647925|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822213|NCT01738191|3647923|B3||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3822214|NCT01738191|3647924|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3822215|NCT01738191|3647925|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3822216|NCT01738191|3647923|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822217|NCT01738191|3647924|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822218|NCT01738191|3647925|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822219|NCT01738191|3647923|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822220|NCT01738191|3647924|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822221|NCT01738191|3647925|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822222|NCT01738191|3647923|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3822223|NCT01738191|3647924|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3822224|NCT01738191|3647925|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822225|NCT01738191|3647923|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822226|NCT01738191|3647924|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822227|NCT01738191|3647925|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822228|NCT01738191|3647923|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3822229|NCT01738191|3647924|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822230|NCT01738191|3647925|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3822231|NCT01738191|3647923|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3822232|NCT01738191|3647924|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3822233|NCT01738191|3647925|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3822234|NCT01738191|3647923|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822235|NCT01738191|3647924|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822236|NCT01738191|3647925|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822237|NCT01738191|3647923|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3822238|NCT01738191|3647924|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3822239|NCT01738191|3647925|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3822240|NCT01738191|3647923|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3822241|NCT01738191|3647924|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3822242|NCT01738191|3647925|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3822243|NCT01738191|3647923|B3|||Age||years|Mean|66.8|66.8|Standard Deviation|7|7.0|||
3822244|NCT01738191|3647924|B2|||Age||years|Mean|66.7|66.7|Standard Deviation|7.7|7.7|||
3822245|NCT01738191|3647925|B1|||Age||years|Mean|66.9|66.9|Standard Deviation|6.5|6.5|||
3822246|NCT01737996|3647946|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3822247|NCT01737996|3647947|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3822248|NCT01737996|3647948|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3822249|NCT01737996|3647949|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3822250|NCT01737996|3647946|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3822251|NCT01737996|3647947|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3822252|NCT01737996|3647948|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3822253|NCT01737996|3647949|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3822254|NCT01737996|3647946|B4|||Age||years|Mean|38.3|38.3|Standard Deviation|9.3|9.3|||
3822255|NCT01737996|3647947|B3|||Age||years|Mean|38.3|38.3|Standard Deviation|10.6|10.6|||
3822256|NCT01737996|3647948|B2|||Age||years|Mean|37.3|37.3|Standard Deviation|5.1|5.1|||
3822257|NCT01737996|3647949|B1|||Age||years|Mean|39.5|39.5|Standard Deviation|10.4|10.4|||
3822258|NCT01737944|3647988|B5|United States||Region of Enrollment||participants|Number|36|36.0||||||
3822259|NCT01737944|3647989|B4|United States||Region of Enrollment||participants|Number|9|9.0||||||
3822260|NCT01737944|3647990|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
3822261|NCT01737944|3647991|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3822262|NCT01737944|3647992|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3822263|NCT01737944|3647988|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3822264|NCT01737944|3647989|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3822265|NCT01737944|3647990|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3822266|NCT01737944|3647991|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3822267|NCT01737944|3647992|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3822268|NCT01737944|3647988|B5||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3822269|NCT01737944|3647989|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3822270|NCT01737944|3647990|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3822271|NCT01737944|3647991|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3822272|NCT01737944|3647992|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3822273|NCT01737944|3647988|B5|||Age||years|Mean|62.1|62.1|Standard Deviation|7.76|7.76|||
3822274|NCT01737944|3647989|B4|||Age||years|Mean|63.0|63.0|Standard Deviation|6.80|6.8|||
3822275|NCT01737944|3647990|B3|||Age||years|Mean|60.8|60.8|Standard Deviation|6.18|6.18|||
3822276|NCT01737944|3647991|B2|||Age||years|Mean|63.4|63.4|Standard Deviation|7.26|7.26|||
3822277|NCT01737944|3647992|B1|||Age||years|Mean|61.2|61.2|Standard Deviation|10.97|10.97|||
3822278|NCT01737944|3647988|B5||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3822279|NCT01737944|3647989|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3822280|NCT01737944|3647990|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3822281|NCT01737944|3647991|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3822282|NCT01737944|3647992|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3822283|NCT01737944|3647988|B5||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3822284|NCT01737944|3647989|B4||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3822285|NCT01737944|3647990|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3822286|NCT01737944|3647991|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3822287|NCT01737944|3647992|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3822288|NCT01737944|3647988|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3822289|NCT01737944|3647989|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3822290|NCT01737944|3647990|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3822291|NCT01737944|3647991|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3822292|NCT01737944|3647992|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3822293|NCT01737931|3648010|B4|Korea, Republic of||Region of Enrollment||participants|Number|117|117.0||||||
3822294|NCT01737931|3648011|B3|Korea, Republic of||Region of Enrollment||participants|Number|39|39.0||||||
3822295|NCT01737931|3648012|B2|Korea, Republic of||Region of Enrollment||participants|Number|40|40.0||||||
3822296|NCT01737931|3648013|B1|Korea, Republic of||Region of Enrollment||participants|Number|38|38.0||||||
3822297|NCT01737931|3648010|B4||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3822298|NCT01737931|3648011|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3822299|NCT01737931|3648012|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3822300|NCT01737931|3648013|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3822301|NCT01737931|3648010|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3822302|NCT01737931|3648011|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3822303|NCT01737931|3648012|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3822304|NCT01737931|3648013|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3822305|NCT01737931|3648010|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3822306|NCT01737931|3648011|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3822307|NCT01737931|3648012|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3822308|NCT01737931|3648013|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3822309|NCT01737931|3648010|B4||Between 18 and 65 years|Age||Participants|Count of Participants|117|117.0||||||
3822310|NCT01737931|3648011|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3822311|NCT01737931|3648012|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3822312|NCT01737931|3648013|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3822313|NCT01737931|3648010|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3822314|NCT01737931|3648011|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3822315|NCT01737931|3648012|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3822316|NCT01737931|3648013|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3822317|NCT01737931|3648010|B4|||Age||years|Mean|26.5|26.5|Standard Deviation|4.3|4.3|||
3822318|NCT01737931|3648011|B3|||Age||years|Mean|26.1|26.1|Standard Deviation|3.7|3.7|||
3822319|NCT01737931|3648012|B2|||Age||years|Mean|26.7|26.7|Standard Deviation|4.8|4.8|||
3822320|NCT01737931|3648013|B1|||Age||years|Mean|26.7|26.7|Standard Deviation|4.2|4.2|||
3822321|NCT01737879|3648030|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3822322|NCT01737879|3648030|B1|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3822323|NCT01737879|3648030|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3822324|NCT01737879|3648030|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3822325|NCT01737879|3648030|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3822326|NCT01737879|3648030|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|16.6|16.6|||
3822327|NCT01737840|3648037|B3|Turkey||Region of Enrollment||participants|Number|66|66.0||||||
3822328|NCT01737840|3648038|B2|Turkey||Region of Enrollment||participants|Number|33|33.0||||||
3822329|NCT01737840|3648039|B1|Turkey||Region of Enrollment||participants|Number|33|33.0||||||
3822330|NCT01737840|3648037|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3822331|NCT01737840|3648038|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3822332|NCT01737840|3648039|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3822333|NCT01737840|3648037|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3822334|NCT01737840|3648038|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3822335|NCT01737840|3648039|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3822336|NCT01737840|3648037|B3|||Age||years|Mean|36.6|36.6|Standard Deviation|15|15.0|||
3822337|NCT01737840|3648038|B2|||Age||years|Mean|34.8|34.8|Standard Deviation|13.9|13.9|||
3822338|NCT01737840|3648039|B1|||Age||years|Mean|38.4|38.4|Standard Deviation|16.4|16.4|||
3822339|NCT01737840|3648037|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3822340|NCT01737840|3648038|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3822341|NCT01737840|3648039|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3822342|NCT01737840|3648037|B3||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
3822343|NCT01737840|3648038|B2||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3822344|NCT01737840|3648039|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3822345|NCT01737840|3648037|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3822346|NCT01737840|3648038|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3822347|NCT01737840|3648039|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3822348|NCT01737762|3648048|B3|United States||Region of Enrollment||participants|Number|132|132.0||||||
3822349|NCT01737762|3648049|B2|United States||Region of Enrollment||participants|Number|67|67.0||||||
3822350|NCT01737762|3648050|B1|United States||Region of Enrollment||participants|Number|65|65.0||||||
3822351|NCT01737762|3648048|B3|Canada||Region of Enrollment||participants|Number|7|7.0||||||
3822352|NCT01737762|3648049|B2|Canada||Region of Enrollment||participants|Number|3|3.0||||||
3822353|NCT01737762|3648050|B1|Canada||Region of Enrollment||participants|Number|4|4.0||||||
3822354|NCT01737762|3648048|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3822355|NCT01737762|3648049|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822356|NCT01737762|3648050|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3822357|NCT01737762|3648048|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822358|NCT01737762|3648049|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822359|NCT01737762|3648050|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822360|NCT01737762|3648048|B3||White|Race (NIH/OMB)||Participants|Count of Participants|109|109.0||||||
3822361|NCT01737762|3648049|B2||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3822362|NCT01737762|3648050|B1||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3822363|NCT01737762|3648048|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3822364|NCT01737762|3648049|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3822365|NCT01737762|3648050|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3822366|NCT01737762|3648048|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822367|NCT01737762|3648049|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822368|NCT01737762|3648050|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822369|NCT01737762|3648048|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3822370|NCT01737762|3648049|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822371|NCT01737762|3648050|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3822372|NCT01737762|3648048|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3822373|NCT01737762|3648049|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3822374|NCT01737762|3648050|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3822375|NCT01737762|3648048|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822376|NCT01737762|3648049|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822377|NCT01737762|3648050|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822378|NCT01737762|3648048|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
3822379|NCT01737762|3648049|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3822380|NCT01737762|3648050|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3822381|NCT01737762|3648048|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3822382|NCT01737762|3648049|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3822383|NCT01737762|3648050|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3822384|NCT01737762|3648048|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3822385|NCT01737762|3648049|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3822386|NCT01737762|3648050|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3822387|NCT01737762|3648048|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3822388|NCT01737762|3648049|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3822389|NCT01737762|3648050|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3822390|NCT01737762|3648048|B3|||Age||years|Mean|61.7|61.7|Standard Deviation|13.6|13.6|||
3822391|NCT01737762|3648049|B2|||Age||years|Mean|61.0|61.0|Standard Deviation|12.1|12.1|||
3822392|NCT01737762|3648050|B1|||Age||years|Mean|62.4|62.4|Standard Deviation|15.1|15.1|||
3822393|NCT01737762|3648048|B3||>=65 years|Age||Participants|Count of Participants|58|58.0||||||
3822394|NCT01737762|3648049|B2||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
3822395|NCT01737762|3648050|B1||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
3822396|NCT01737762|3648048|B3||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
3822397|NCT01737762|3648049|B2||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3822398|NCT01737762|3648050|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3822399|NCT01737762|3648048|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3822400|NCT01737762|3648049|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3822401|NCT01737762|3648050|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3822435|NCT01737710|3648062|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3822436|NCT01737710|3648063|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3822437|NCT01737710|3648064|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3822438|NCT01737710|3648059|B6||White|Race (NIH/OMB)||Participants|Count of Participants|216|216.0||||||
3822402|NCT01737710|3648059|B6|||Seroprotected at Baseline – influenza H3N2|The number of participants that achieved seroprotection against influenza H3N2 at baseline prior to vaccination. Seroprotection is defined as having a serum hemagglutination-inhibition [HAI] antibody titer of 1:40 or greater, which represents a sufficient antibody amount to avoid disease in half of the individuals infected with influenza H3N2. The goal of the study was to examine the immune response to influenza vaccination against influenza H3N2. Participants who were already seroprotected against influenza H3N2 prior to vaccination were excluded from all relevant analyses for influenza H3N2.|Participants|Count of Participants|172|172.0||||||
3822403|NCT01737710|3648060|B5|||Seroprotected at Baseline – influenza H3N2|The number of participants that achieved seroprotection against influenza H3N2 at baseline prior to vaccination. Seroprotection is defined as having a serum hemagglutination-inhibition [HAI] antibody titer of 1:40 or greater, which represents a sufficient antibody amount to avoid disease in half of the individuals infected with influenza H3N2. The goal of the study was to examine the immune response to influenza vaccination against influenza H3N2. Participants who were already seroprotected against influenza H3N2 prior to vaccination were excluded from all relevant analyses for influenza H3N2.|Participants|Count of Participants|9|9.0||||||
3822404|NCT01737710|3648061|B4|||Seroprotected at Baseline – influenza H3N2|The number of participants that achieved seroprotection against influenza H3N2 at baseline prior to vaccination. Seroprotection is defined as having a serum hemagglutination-inhibition [HAI] antibody titer of 1:40 or greater, which represents a sufficient antibody amount to avoid disease in half of the individuals infected with influenza H3N2. The goal of the study was to examine the immune response to influenza vaccination against influenza H3N2. Participants who were already seroprotected against influenza H3N2 prior to vaccination were excluded from all relevant analyses for influenza H3N2.|Participants|Count of Participants|12|12.0||||||
3822405|NCT01737710|3648062|B3|||Seroprotected at Baseline – influenza H3N2|The number of participants that achieved seroprotection against influenza H3N2 at baseline prior to vaccination. Seroprotection is defined as having a serum hemagglutination-inhibition [HAI] antibody titer of 1:40 or greater, which represents a sufficient antibody amount to avoid disease in half of the individuals infected with influenza H3N2. The goal of the study was to examine the immune response to influenza vaccination against influenza H3N2. Participants who were already seroprotected against influenza H3N2 prior to vaccination were excluded from all relevant analyses for influenza H3N2.|Participants|Count of Participants|55|55.0||||||
3822406|NCT01737710|3648063|B2|||Seroprotected at Baseline – influenza H3N2|The number of participants that achieved seroprotection against influenza H3N2 at baseline prior to vaccination. Seroprotection is defined as having a serum hemagglutination-inhibition [HAI] antibody titer of 1:40 or greater, which represents a sufficient antibody amount to avoid disease in half of the individuals infected with influenza H3N2. The goal of the study was to examine the immune response to influenza vaccination against influenza H3N2. Participants who were already seroprotected against influenza H3N2 prior to vaccination were excluded from all relevant analyses for influenza H3N2.|Participants|Count of Participants|45|45.0||||||
3822407|NCT01737710|3648064|B1|||Seroprotected at Baseline – influenza H3N2|The number of participants that achieved seroprotection against influenza H3N2 at baseline prior to vaccination. Seroprotection is defined as having a serum hemagglutination-inhibition [HAI] antibody titer of 1:40 or greater, which represents a sufficient antibody amount to avoid disease in half of the individuals infected with influenza H3N2. The goal of the study was to examine the immune response to influenza vaccination against influenza H3N2. Participants who were already seroprotected against influenza H3N2 prior to vaccination were excluded from all relevant analyses for influenza H3N2.|Participants|Count of Participants|51|51.0||||||
3822408|NCT01737710|3648059|B6|||Seroprotected at Baseline – influenza H1N1|The number of participants that achieved seroprotection against influenza H1N1 at baseline prior to vaccination. Seroprotection is defined as having a serum hemagglutination-inhibition [HAI] antibody titer of 1:40 or greater, which represents a sufficient antibody amount to avoid disease in half of the individuals infected with influenza H1N1. The goal of the study was to examine the immune response to influenza vaccination against influenza H1N1. Participants who were already seroprotected against influenza H1N1 prior to vaccination were excluded from all relevant analyses for influenza H1N1.|Participants|Count of Participants|173|173.0||||||
3822409|NCT01737710|3648060|B5|||Seroprotected at Baseline – influenza H1N1|The number of participants that achieved seroprotection against influenza H1N1 at baseline prior to vaccination. Seroprotection is defined as having a serum hemagglutination-inhibition [HAI] antibody titer of 1:40 or greater, which represents a sufficient antibody amount to avoid disease in half of the individuals infected with influenza H1N1. The goal of the study was to examine the immune response to influenza vaccination against influenza H1N1. Participants who were already seroprotected against influenza H1N1 prior to vaccination were excluded from all relevant analyses for influenza H1N1.|Participants|Count of Participants|9|9.0||||||
3822410|NCT01737710|3648061|B4|||Seroprotected at Baseline – influenza H1N1|The number of participants that achieved seroprotection against influenza H1N1 at baseline prior to vaccination. Seroprotection is defined as having a serum hemagglutination-inhibition [HAI] antibody titer of 1:40 or greater, which represents a sufficient antibody amount to avoid disease in half of the individuals infected with influenza H1N1. The goal of the study was to examine the immune response to influenza vaccination against influenza H1N1. Participants who were already seroprotected against influenza H1N1 prior to vaccination were excluded from all relevant analyses for influenza H1N1.|Participants|Count of Participants|12|12.0||||||
3822411|NCT01737710|3648062|B3|||Seroprotected at Baseline – influenza H1N1|The number of participants that achieved seroprotection against influenza H1N1 at baseline prior to vaccination. Seroprotection is defined as having a serum hemagglutination-inhibition [HAI] antibody titer of 1:40 or greater, which represents a sufficient antibody amount to avoid disease in half of the individuals infected with influenza H1N1. The goal of the study was to examine the immune response to influenza vaccination against influenza H1N1. Participants who were already seroprotected against influenza H1N1 prior to vaccination were excluded from all relevant analyses for influenza H1N1.|Participants|Count of Participants|55|55.0||||||
3822439|NCT01737710|3648060|B5||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3822440|NCT01737710|3648061|B4||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3822441|NCT01737710|3648062|B3||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3822442|NCT01737710|3648063|B2||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3822412|NCT01737710|3648063|B2|||Seroprotected at Baseline – influenza H1N1|The number of participants that achieved seroprotection against influenza H1N1 at baseline prior to vaccination. Seroprotection is defined as having a serum hemagglutination-inhibition [HAI] antibody titer of 1:40 or greater, which represents a sufficient antibody amount to avoid disease in half of the individuals infected with influenza H1N1. The goal of the study was to examine the immune response to influenza vaccination against influenza H1N1. Participants who were already seroprotected against influenza H1N1 prior to vaccination were excluded from all relevant analyses for influenza H1N1.|Participants|Count of Participants|45|45.0||||||
3822413|NCT01737710|3648064|B1|||Seroprotected at Baseline – influenza H1N1|The number of participants that achieved seroprotection against influenza H1N1 at baseline prior to vaccination. Seroprotection is defined as having a serum hemagglutination-inhibition [HAI] antibody titer of 1:40 or greater, which represents a sufficient antibody amount to avoid disease in half of the individuals infected with influenza H1N1. The goal of the study was to examine the immune response to influenza vaccination against influenza H1N1. Participants who were already seroprotected against influenza H1N1 prior to vaccination were excluded from all relevant analyses for influenza H1N1.|Participants|Count of Participants|52|52.0||||||
3822414|NCT01737710|3648059|B6|||Seroprotected at Baseline – influenza B|The number of participants that achieved seroprotection against influenza B at baseline prior to vaccination. Seroprotection is defined as having a serum hemagglutination-inhibition [HAI] antibody titer of 1:40 or greater, which represents a sufficient antibody amount to avoid disease in half of the individuals infected with influenza B. The goal of the study was to examine the immune response to influenza vaccination against influenza B. Participants who were already seroprotected against influenza B prior to vaccination were excluded from all relevant analyses for influenza B.|Participants|Count of Participants|31|31.0||||||
3822415|NCT01737710|3648060|B5|||Seroprotected at Baseline – influenza B|The number of participants that achieved seroprotection against influenza B at baseline prior to vaccination. Seroprotection is defined as having a serum hemagglutination-inhibition [HAI] antibody titer of 1:40 or greater, which represents a sufficient antibody amount to avoid disease in half of the individuals infected with influenza B. The goal of the study was to examine the immune response to influenza vaccination against influenza B. Participants who were already seroprotected against influenza B prior to vaccination were excluded from all relevant analyses for influenza B.|Participants|Count of Participants|1|1.0||||||
3822416|NCT01737710|3648061|B4|||Seroprotected at Baseline – influenza B|The number of participants that achieved seroprotection against influenza B at baseline prior to vaccination. Seroprotection is defined as having a serum hemagglutination-inhibition [HAI] antibody titer of 1:40 or greater, which represents a sufficient antibody amount to avoid disease in half of the individuals infected with influenza B. The goal of the study was to examine the immune response to influenza vaccination against influenza B. Participants who were already seroprotected against influenza B prior to vaccination were excluded from all relevant analyses for influenza B.|Participants|Count of Participants|5|5.0||||||
3822417|NCT01737710|3648062|B3|||Seroprotected at Baseline – influenza B|The number of participants that achieved seroprotection against influenza B at baseline prior to vaccination. Seroprotection is defined as having a serum hemagglutination-inhibition [HAI] antibody titer of 1:40 or greater, which represents a sufficient antibody amount to avoid disease in half of the individuals infected with influenza B. The goal of the study was to examine the immune response to influenza vaccination against influenza B. Participants who were already seroprotected against influenza B prior to vaccination were excluded from all relevant analyses for influenza B.|Participants|Count of Participants|11|11.0||||||
3822418|NCT01737710|3648063|B2|||Seroprotected at Baseline – influenza B|The number of participants that achieved seroprotection against influenza B at baseline prior to vaccination. Seroprotection is defined as having a serum hemagglutination-inhibition [HAI] antibody titer of 1:40 or greater, which represents a sufficient antibody amount to avoid disease in half of the individuals infected with influenza B. The goal of the study was to examine the immune response to influenza vaccination against influenza B. Participants who were already seroprotected against influenza B prior to vaccination were excluded from all relevant analyses for influenza B.|Participants|Count of Participants|5|5.0||||||
3822419|NCT01737710|3648064|B1|||Seroprotected at Baseline – influenza B|The number of participants that achieved seroprotection against influenza B at baseline prior to vaccination. Seroprotection is defined as having a serum hemagglutination-inhibition [HAI] antibody titer of 1:40 or greater, which represents a sufficient antibody amount to avoid disease in half of the individuals infected with influenza B. The goal of the study was to examine the immune response to influenza vaccination against influenza B. Participants who were already seroprotected against influenza B prior to vaccination were excluded from all relevant analyses for influenza B.|Participants|Count of Participants|9|9.0||||||
3822420|NCT01737710|3648059|B6|United States||Region of Enrollment||participants|Number|368|368.0||||||
3822421|NCT01737710|3648060|B5|United States||Region of Enrollment||participants|Number|21|21.0||||||
3822422|NCT01737710|3648061|B4|United States||Region of Enrollment||participants|Number|23|23.0||||||
3822423|NCT01737710|3648062|B3|United States||Region of Enrollment||participants|Number|105|105.0||||||
3822424|NCT01737710|3648063|B2|United States||Region of Enrollment||participants|Number|105|105.0||||||
3822425|NCT01737710|3648064|B1|United States||Region of Enrollment||participants|Number|114|114.0||||||
3822426|NCT01737710|3648059|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3822427|NCT01737710|3648060|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822428|NCT01737710|3648061|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3822429|NCT01737710|3648062|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3822430|NCT01737710|3648063|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3822431|NCT01737710|3648064|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3822432|NCT01737710|3648059|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3822433|NCT01737710|3648060|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822434|NCT01737710|3648061|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822443|NCT01737710|3648064|B1||White|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3822444|NCT01737710|3648059|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|112|112.0||||||
3822445|NCT01737710|3648060|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3822446|NCT01737710|3648061|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3822447|NCT01737710|3648062|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3822448|NCT01737710|3648063|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3822449|NCT01737710|3648064|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3822450|NCT01737710|3648059|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822451|NCT01737710|3648060|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822452|NCT01737710|3648061|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822453|NCT01737710|3648062|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822454|NCT01737710|3648063|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822455|NCT01737710|3648064|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822456|NCT01737710|3648059|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3822457|NCT01737710|3648060|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822458|NCT01737710|3648061|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3822459|NCT01737710|3648062|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3822460|NCT01737710|3648063|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3822461|NCT01737710|3648064|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3822462|NCT01737710|3648059|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3822463|NCT01737710|3648060|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822464|NCT01737710|3648061|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3822465|NCT01737710|3648062|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3822466|NCT01737710|3648063|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3822467|NCT01737710|3648064|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3822468|NCT01737710|3648059|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822469|NCT01737710|3648060|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822470|NCT01737710|3648061|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822471|NCT01737710|3648062|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822472|NCT01737710|3648063|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822473|NCT01737710|3648064|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822474|NCT01737710|3648059|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|327|327.0||||||
3822475|NCT01737710|3648060|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3822476|NCT01737710|3648061|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3822477|NCT01737710|3648062|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3822478|NCT01737710|3648063|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3822479|NCT01737710|3648064|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
3822480|NCT01737710|3648059|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3822481|NCT01737710|3648060|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3822482|NCT01737710|3648061|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3822483|NCT01737710|3648062|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3822484|NCT01737710|3648063|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3822485|NCT01737710|3648064|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3822486|NCT01737710|3648059|B6||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3822487|NCT01737710|3648060|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3822488|NCT01737710|3648061|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3822489|NCT01737710|3648062|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3822490|NCT01737710|3648063|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3822491|NCT01737710|3648064|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3822492|NCT01737710|3648059|B6||Female|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
3822493|NCT01737710|3648060|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3822494|NCT01737710|3648061|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3822495|NCT01737710|3648062|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3822496|NCT01737710|3648063|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3822497|NCT01737710|3648064|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3822498|NCT01737710|3648059|B6|||Age||years|Mean|36.65|36.65|Standard Deviation|11.85|11.85|||
3822499|NCT01737710|3648060|B5|||Age||years|Mean|36.43|36.43|Standard Deviation|14.14|14.14|||
3822500|NCT01737710|3648061|B4|||Age||years|Mean|34.30|34.3|Standard Deviation|9.79|9.79|||
3822501|NCT01737710|3648062|B3|||Age||years|Mean|36.39|36.39|Standard Deviation|12.04|12.04|||
3822502|NCT01737710|3648063|B2|||Age||years|Mean|35.11|35.11|Standard Deviation|11.29|11.29|||
3822503|NCT01737710|3648064|B1|||Age||years|Mean|38.82|38.82|Standard Deviation|11.96|11.96|||
3822504|NCT01737710|3648059|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3822505|NCT01737710|3648060|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3822506|NCT01737710|3648061|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3822507|NCT01737710|3648062|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3822508|NCT01737710|3648063|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3822509|NCT01737710|3648064|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3822510|NCT01737710|3648059|B6||Between 18 and 65 years|Age||Participants|Count of Participants|361|361.0||||||
3822511|NCT01737710|3648060|B5||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3822512|NCT01737710|3648061|B4||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3822513|NCT01737710|3648062|B3||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
3822514|NCT01737710|3648063|B2||Between 18 and 65 years|Age||Participants|Count of Participants|103|103.0||||||
3822515|NCT01737710|3648064|B1||Between 18 and 65 years|Age||Participants|Count of Participants|114|114.0||||||
3822516|NCT01737710|3648059|B6||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
3822517|NCT01737710|3648060|B5||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3822518|NCT01737710|3648061|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3822519|NCT01737710|3648062|B3||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3822520|NCT01737710|3648063|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3822521|NCT01737710|3648064|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3822522|NCT01737697|3648105|B6|≥60 mL/min||Baseline eGFR|Acute phase baseline - estimated Glomerular filtration rate (eGFR)|Participants|Count of Participants|183|183.0||||||
3822523|NCT01737697|3648106|B5|≥60 mL/min||Baseline eGFR|Acute phase baseline - estimated Glomerular filtration rate (eGFR)|Participants|Count of Participants|41|41.0||||||
3822524|NCT01737697|3648107|B4|≥60 mL/min||Baseline eGFR|Acute phase baseline - estimated Glomerular filtration rate (eGFR)|Participants|Count of Participants|39|39.0||||||
3822525|NCT01737697|3648108|B3|≥60 mL/min||Baseline eGFR|Acute phase baseline - estimated Glomerular filtration rate (eGFR)|Participants|Count of Participants|37|37.0||||||
3822526|NCT01737697|3648109|B2|≥60 mL/min||Baseline eGFR|Acute phase baseline - estimated Glomerular filtration rate (eGFR)|Participants|Count of Participants|28|28.0||||||
3822527|NCT01737697|3648110|B1|≥60 mL/min||Baseline eGFR|Acute phase baseline - estimated Glomerular filtration rate (eGFR)|Participants|Count of Participants|38|38.0||||||
3822528|NCT01737697|3648105|B6|30-59+ mL/min||Baseline eGFR|Acute phase baseline - estimated Glomerular filtration rate (eGFR)|Participants|Count of Participants|296|296.0||||||
3822529|NCT01737697|3648106|B5|30-59+ mL/min||Baseline eGFR|Acute phase baseline - estimated Glomerular filtration rate (eGFR)|Participants|Count of Participants|50|50.0||||||
3822530|NCT01737697|3648107|B4|30-59+ mL/min||Baseline eGFR|Acute phase baseline - estimated Glomerular filtration rate (eGFR)|Participants|Count of Participants|64|64.0||||||
3822531|NCT01737697|3648108|B3|30-59+ mL/min||Baseline eGFR|Acute phase baseline - estimated Glomerular filtration rate (eGFR)|Participants|Count of Participants|48|48.0||||||
3822532|NCT01737697|3648109|B2|30-59+ mL/min||Baseline eGFR|Acute phase baseline - estimated Glomerular filtration rate (eGFR)|Participants|Count of Participants|73|73.0||||||
3822533|NCT01737697|3648110|B1|30-59+ mL/min||Baseline eGFR|Acute phase baseline - estimated Glomerular filtration rate (eGFR)|Participants|Count of Participants|61|61.0||||||
3822534|NCT01737697|3648105|B6|15-29+ ml/min||Baseline eGFR|Acute phase baseline - estimated Glomerular filtration rate (eGFR)|Participants|Count of Participants|209|209.0||||||
3822535|NCT01737697|3648106|B5|15-29+ ml/min||Baseline eGFR|Acute phase baseline - estimated Glomerular filtration rate (eGFR)|Participants|Count of Participants|42|42.0||||||
3822536|NCT01737697|3648107|B4|15-29+ ml/min||Baseline eGFR|Acute phase baseline - estimated Glomerular filtration rate (eGFR)|Participants|Count of Participants|43|43.0||||||
3822537|NCT01737697|3648108|B3|15-29+ ml/min||Baseline eGFR|Acute phase baseline - estimated Glomerular filtration rate (eGFR)|Participants|Count of Participants|38|38.0||||||
3822538|NCT01737697|3648109|B2|15-29+ ml/min||Baseline eGFR|Acute phase baseline - estimated Glomerular filtration rate (eGFR)|Participants|Count of Participants|42|42.0||||||
3822539|NCT01737697|3648110|B1|15-29+ ml/min||Baseline eGFR|Acute phase baseline - estimated Glomerular filtration rate (eGFR)|Participants|Count of Participants|44|44.0||||||
3822540|NCT01737697|3648105|B6|<15 ml/min||Baseline eGFR|Acute phase baseline - estimated Glomerular filtration rate (eGFR)|Participants|Count of Participants|56|56.0||||||
3822541|NCT01737697|3648106|B5|<15 ml/min||Baseline eGFR|Acute phase baseline - estimated Glomerular filtration rate (eGFR)|Participants|Count of Participants|10|10.0||||||
3822542|NCT01737697|3648107|B4|<15 ml/min||Baseline eGFR|Acute phase baseline - estimated Glomerular filtration rate (eGFR)|Participants|Count of Participants|8|8.0||||||
3822543|NCT01737697|3648108|B3|<15 ml/min||Baseline eGFR|Acute phase baseline - estimated Glomerular filtration rate (eGFR)|Participants|Count of Participants|15|15.0||||||
3822544|NCT01737697|3648109|B2|<15 ml/min||Baseline eGFR|Acute phase baseline - estimated Glomerular filtration rate (eGFR)|Participants|Count of Participants|8|8.0||||||
3822545|NCT01737697|3648110|B1|<15 ml/min||Baseline eGFR|Acute phase baseline - estimated Glomerular filtration rate (eGFR)|Participants|Count of Participants|15|15.0||||||
3822546|NCT01737697|3648105|B6|RAAS inhibitor medication||Etiology of elevated S-K|Etiology of elevated S-K. Categories are not mutually exclusive|Participants|Count of Participants|502|502.0||||||
3822547|NCT01737697|3648106|B5|RAAS inhibitor medication||Etiology of elevated S-K|Etiology of elevated S-K. Categories are not mutually exclusive|Participants|Count of Participants|96|96.0||||||
3822548|NCT01737697|3648107|B4|RAAS inhibitor medication||Etiology of elevated S-K|Etiology of elevated S-K. Categories are not mutually exclusive|Participants|Count of Participants|99|99.0||||||
3822549|NCT01737697|3648108|B3|RAAS inhibitor medication||Etiology of elevated S-K|Etiology of elevated S-K. Categories are not mutually exclusive|Participants|Count of Participants|97|97.0||||||
3822550|NCT01737697|3648109|B2|RAAS inhibitor medication||Etiology of elevated S-K|Etiology of elevated S-K. Categories are not mutually exclusive|Participants|Count of Participants|109|109.0||||||
3822551|NCT01737697|3648110|B1|RAAS inhibitor medication||Etiology of elevated S-K|Etiology of elevated S-K. Categories are not mutually exclusive|Participants|Count of Participants|101|101.0||||||
3822552|NCT01737697|3648105|B6|Diabetes mellitus||Etiology of elevated S-K|Etiology of elevated S-K. Categories are not mutually exclusive|Participants|Count of Participants|451|451.0||||||
3822553|NCT01737697|3648106|B5|Diabetes mellitus||Etiology of elevated S-K|Etiology of elevated S-K. Categories are not mutually exclusive|Participants|Count of Participants|81|81.0||||||
3822554|NCT01737697|3648107|B4|Diabetes mellitus||Etiology of elevated S-K|Etiology of elevated S-K. Categories are not mutually exclusive|Participants|Count of Participants|96|96.0||||||
3822555|NCT01737697|3648108|B3|Diabetes mellitus||Etiology of elevated S-K|Etiology of elevated S-K. Categories are not mutually exclusive|Participants|Count of Participants|84|84.0||||||
3822556|NCT01737697|3648109|B2|Diabetes mellitus||Etiology of elevated S-K|Etiology of elevated S-K. Categories are not mutually exclusive|Participants|Count of Participants|94|94.0||||||
3822557|NCT01737697|3648110|B1|Diabetes mellitus||Etiology of elevated S-K|Etiology of elevated S-K. Categories are not mutually exclusive|Participants|Count of Participants|96|96.0||||||
3822558|NCT01737697|3648105|B6|Congestive heart failure||Etiology of elevated S-K|Etiology of elevated S-K. Categories are not mutually exclusive|Participants|Count of Participants|300|300.0||||||
3822559|NCT01737697|3648106|B5|Congestive heart failure||Etiology of elevated S-K|Etiology of elevated S-K. Categories are not mutually exclusive|Participants|Count of Participants|59|59.0||||||
3822560|NCT01737697|3648107|B4|Congestive heart failure||Etiology of elevated S-K|Etiology of elevated S-K. Categories are not mutually exclusive|Participants|Count of Participants|64|64.0||||||
3822561|NCT01737697|3648108|B3|Congestive heart failure||Etiology of elevated S-K|Etiology of elevated S-K. Categories are not mutually exclusive|Participants|Count of Participants|54|54.0||||||
3822562|NCT01737697|3648109|B2|Congestive heart failure||Etiology of elevated S-K|Etiology of elevated S-K. Categories are not mutually exclusive|Participants|Count of Participants|57|57.0||||||
3822563|NCT01737697|3648110|B1|Congestive heart failure||Etiology of elevated S-K|Etiology of elevated S-K. Categories are not mutually exclusive|Participants|Count of Participants|66|66.0||||||
3822564|NCT01737697|3648105|B6|Chronic kidney disease||Etiology of elevated S-K|Etiology of elevated S-K. Categories are not mutually exclusive|Participants|Count of Participants|463|463.0||||||
3822565|NCT01737697|3648106|B5|Chronic kidney disease||Etiology of elevated S-K|Etiology of elevated S-K. Categories are not mutually exclusive|Participants|Count of Participants|83|83.0||||||
3822566|NCT01737697|3648107|B4|Chronic kidney disease||Etiology of elevated S-K|Etiology of elevated S-K. Categories are not mutually exclusive|Participants|Count of Participants|93|93.0||||||
3822567|NCT01737697|3648108|B3|Chronic kidney disease||Etiology of elevated S-K|Etiology of elevated S-K. Categories are not mutually exclusive|Participants|Count of Participants|89|89.0||||||
3822568|NCT01737697|3648109|B2|Chronic kidney disease||Etiology of elevated S-K|Etiology of elevated S-K. Categories are not mutually exclusive|Participants|Count of Participants|102|102.0||||||
3822569|NCT01737697|3648110|B1|Chronic kidney disease||Etiology of elevated S-K|Etiology of elevated S-K. Categories are not mutually exclusive|Participants|Count of Participants|96|96.0||||||
3822570|NCT01737697|3648105|B6||> 5.5 mmol/L|Acute S-K baseline||Participants|Count of Participants|174|174.0||||||
3822571|NCT01737697|3648106|B5||> 5.5 mmol/L|Acute S-K baseline||Participants|Count of Participants|22|22.0||||||
3822572|NCT01737697|3648107|B4||> 5.5 mmol/L|Acute S-K baseline||Participants|Count of Participants|31|31.0||||||
3822573|NCT01737697|3648108|B3||> 5.5 mmol/L|Acute S-K baseline||Participants|Count of Participants|40|40.0||||||
3822574|NCT01737697|3648109|B2||> 5.5 mmol/L|Acute S-K baseline||Participants|Count of Participants|40|40.0||||||
3822575|NCT01737697|3648110|B1||> 5.5 mmol/L|Acute S-K baseline||Participants|Count of Participants|41|41.0||||||
3822576|NCT01737697|3648105|B6||5.4-5.5 mmol/L|Acute S-K baseline||Participants|Count of Participants|152|152.0||||||
3822577|NCT01737697|3648106|B5||5.4-5.5 mmol/L|Acute S-K baseline||Participants|Count of Participants|27|27.0||||||
3822578|NCT01737697|3648107|B4||5.4-5.5 mmol/L|Acute S-K baseline||Participants|Count of Participants|36|36.0||||||
3822579|NCT01737697|3648108|B3||5.4-5.5 mmol/L|Acute S-K baseline||Participants|Count of Participants|29|29.0||||||
3822580|NCT01737697|3648109|B2||5.4-5.5 mmol/L|Acute S-K baseline||Participants|Count of Participants|38|38.0||||||
3822581|NCT01737697|3648110|B1||5.4-5.5 mmol/L|Acute S-K baseline||Participants|Count of Participants|22|22.0||||||
3822582|NCT01737697|3648105|B6||≤ 5.3 mmol/L|Acute S-K baseline||Participants|Count of Participants|427|427.0||||||
3822583|NCT01737697|3648106|B5||≤ 5.3 mmol/L|Acute S-K baseline||Participants|Count of Participants|94|94.0||||||
3822584|NCT01737697|3648107|B4||≤ 5.3 mmol/L|Acute S-K baseline||Participants|Count of Participants|90|90.0||||||
3822585|NCT01737697|3648108|B3||≤ 5.3 mmol/L|Acute S-K baseline||Participants|Count of Participants|72|72.0||||||
3822586|NCT01737697|3648109|B2||≤ 5.3 mmol/L|Acute S-K baseline||Participants|Count of Participants|76|76.0||||||
3822587|NCT01737697|3648110|B1||≤ 5.3 mmol/L|Acute S-K baseline||Participants|Count of Participants|95|95.0||||||
3822588|NCT01737697|3648105|B6|Multiple Races||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|1|1.0||||||
3822589|NCT01737697|3648106|B5|Multiple Races||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|0|0.0||||||
3822590|NCT01737697|3648107|B4|Multiple Races||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|0|0.0||||||
3822591|NCT01737697|3648108|B3|Multiple Races||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|1|1.0||||||
3822592|NCT01737697|3648109|B2|Multiple Races||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|0|0.0||||||
3822593|NCT01737697|3648110|B1|Multiple Races||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|0|0.0||||||
3822594|NCT01737697|3648105|B6|Other||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|2|2.0||||||
3822595|NCT01737697|3648106|B5|Other||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|0|0.0||||||
3822596|NCT01737697|3648107|B4|Other||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|1|1.0||||||
3822597|NCT01737697|3648108|B3|Other||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|1|1.0||||||
3822598|NCT01737697|3648109|B2|Other||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|0|0.0||||||
3822599|NCT01737697|3648110|B1|Other||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|0|0.0||||||
3822600|NCT01737697|3648105|B6|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|5|5.0||||||
3822601|NCT01737697|3648106|B5|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|1|1.0||||||
3822602|NCT01737697|3648107|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|0|0.0||||||
3822603|NCT01737697|3648108|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|0|0.0||||||
3822604|NCT01737697|3648109|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|3|3.0||||||
3822605|NCT01737697|3648110|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|1|1.0||||||
3822606|NCT01737697|3648105|B6|American Indian or Alaska Native||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|4|4.0||||||
3822607|NCT01737697|3648106|B5|American Indian or Alaska Native||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|1|1.0||||||
3822608|NCT01737697|3648107|B4|American Indian or Alaska Native||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|1|1.0||||||
3822609|NCT01737697|3648108|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|0|0.0||||||
3822610|NCT01737697|3648109|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|0|0.0||||||
3822611|NCT01737697|3648110|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|2|2.0||||||
3822612|NCT01737697|3648105|B6|Asian||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|12|12.0||||||
3822613|NCT01737697|3648106|B5|Asian||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|2|2.0||||||
3822614|NCT01737697|3648107|B4|Asian||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|3|3.0||||||
3822615|NCT01737697|3648108|B3|Asian||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|5|5.0||||||
3822616|NCT01737697|3648109|B2|Asian||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|0|0.0||||||
3822617|NCT01737697|3648110|B1|Asian||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|2|2.0||||||
3822618|NCT01737697|3648105|B6|Black or African American||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|87|87.0||||||
3822619|NCT01737697|3648106|B5|Black or African American||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|19|19.0||||||
3822620|NCT01737697|3648107|B4|Black or African American||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|20|20.0||||||
3822621|NCT01737697|3648108|B3|Black or African American||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|11|11.0||||||
3822622|NCT01737697|3648109|B2|Black or African American||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|20|20.0||||||
3822623|NCT01737697|3648110|B1|Black or African American||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|17|17.0||||||
3822624|NCT01737697|3648105|B6|White||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|644|644.0||||||
3822625|NCT01737697|3648106|B5|White||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|120|120.0||||||
3822626|NCT01737697|3648107|B4|White||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|132|132.0||||||
3822627|NCT01737697|3648108|B3|White||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|125|125.0||||||
3822628|NCT01737697|3648109|B2|White||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|131|131.0||||||
3822629|NCT01737697|3648110|B1|White||Race/Ethnicity, Customized|Race/Ethnicity, Customized. Categories are not mutually exclusive|Participants|Number|136|136.0||||||
3822682|NCT01737021|3648278|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3822630|NCT01737697|3648105|B6||Male|Sex/Gender, Customized|Sex/Gender, Customized. Gender by Acute Phase|Participants|Count of Participants|448|448.0||||||
3822631|NCT01737697|3648106|B5||Male|Sex/Gender, Customized|Sex/Gender, Customized. Gender by Acute Phase|Participants|Count of Participants|80|80.0||||||
3822632|NCT01737697|3648107|B4||Male|Sex/Gender, Customized|Sex/Gender, Customized. Gender by Acute Phase|Participants|Count of Participants|96|96.0||||||
3822633|NCT01737697|3648108|B3||Male|Sex/Gender, Customized|Sex/Gender, Customized. Gender by Acute Phase|Participants|Count of Participants|91|91.0||||||
3822634|NCT01737697|3648109|B2||Male|Sex/Gender, Customized|Sex/Gender, Customized. Gender by Acute Phase|Participants|Count of Participants|83|83.0||||||
3822635|NCT01737697|3648110|B1||Male|Sex/Gender, Customized|Sex/Gender, Customized. Gender by Acute Phase|Participants|Count of Participants|98|98.0||||||
3822636|NCT01737697|3648105|B6||Female|Sex/Gender, Customized|Sex/Gender, Customized. Gender by Acute Phase|Participants|Count of Participants|305|305.0||||||
3822637|NCT01737697|3648106|B5||Female|Sex/Gender, Customized|Sex/Gender, Customized. Gender by Acute Phase|Participants|Count of Participants|63|63.0||||||
3822638|NCT01737697|3648107|B4||Female|Sex/Gender, Customized|Sex/Gender, Customized. Gender by Acute Phase|Participants|Count of Participants|61|61.0||||||
3822639|NCT01737697|3648108|B3||Female|Sex/Gender, Customized|Sex/Gender, Customized. Gender by Acute Phase|Participants|Count of Participants|50|50.0||||||
3822640|NCT01737697|3648109|B2||Female|Sex/Gender, Customized|Sex/Gender, Customized. Gender by Acute Phase|Participants|Count of Participants|71|71.0||||||
3822641|NCT01737697|3648110|B1||Female|Sex/Gender, Customized|Sex/Gender, Customized. Gender by Acute Phase|Participants|Count of Participants|60|60.0||||||
3822642|NCT01737697|3648105|B6|Acute Phase||Age, Customized||Years|Mean|65.6|65.6|Standard Deviation|12.24|12.24|||
3822643|NCT01737697|3648106|B5|Acute Phase||Age, Customized||Years|Mean|66.2|66.2|Standard Deviation|12.16|12.16|||
3822644|NCT01737697|3648107|B4|Acute Phase||Age, Customized||Years|Mean|65.2|65.2|Standard Deviation|11.91|11.91|||
3822645|NCT01737697|3648108|B3|Acute Phase||Age, Customized||Years|Mean|65.9|65.9|Standard Deviation|11.73|11.73|||
3822646|NCT01737697|3648109|B2|Acute Phase||Age, Customized||Years|Mean|65.4|65.4|Standard Deviation|13.07|13.07|||
3822647|NCT01737697|3648110|B1|Acute Phase||Age, Customized||Years|Mean|65.6|65.6|Standard Deviation|12.24|12.24|||
3822648|NCT01737684|3648211|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3822649|NCT01737684|3648212|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3822650|NCT01737684|3648213|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3822651|NCT01737684|3648211|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3822652|NCT01737684|3648212|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3822653|NCT01737684|3648213|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3822654|NCT01737684|3648211|B3|||Age||Years|Mean|56|56.0|Full Range|||45.0|66.0|
3822655|NCT01737684|3648212|B2|||Age||Years|Mean|54|54.0|Full Range|||45.0|60.0|
3822656|NCT01737684|3648213|B1|||Age||Years|Mean|58|58.0|Full Range|||51.0|66.0|
3822657|NCT01737593|3648231|B4|United States||Region of Enrollment||participants|Number|108|108.0||||||
3822658|NCT01737593|3648232|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
3822659|NCT01737593|3648233|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
3822660|NCT01737593|3648234|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
3822661|NCT01737593|3648231|B4||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3822662|NCT01737593|3648232|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3822663|NCT01737593|3648233|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3822664|NCT01737593|3648234|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3822665|NCT01737593|3648231|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3822666|NCT01737593|3648232|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3822667|NCT01737593|3648233|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3822668|NCT01737593|3648234|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3822669|NCT01737593|3648231|B4|||Age||years|Mean|2.23|2.23|Standard Deviation|1.49|1.49|||
3822670|NCT01737593|3648232|B3|||Age||years|Mean|2.31|2.31|Standard Deviation|1.53|1.53|||
3822671|NCT01737593|3648233|B2|||Age||years|Mean|2.20|2.2|Standard Deviation|1.58|1.58|||
3822672|NCT01737593|3648234|B1|||Age||years|Mean|2.08|2.08|Standard Deviation|1.39|1.39|||
3822673|NCT01737268|3648265|B1|||Hamilton Depression Scale (HAM-D17) Total Score|The HAM-D17 is a clinician-rated 17-item scale for assessing the severity of depression symptoms. The scores for each item range from 0 to 4 or 0 to 2, where 0 represents no symptoms. The rating is based on the past 7 days prior to the time of assessment. The total score ranges from 0 to 52 with lower scores indicating less depressive symptoms.|Units of a scale|Mean|19.3|19.3|Standard Deviation|4.9|4.9|||
3822674|NCT01737268|3648265|B1|||Montgomery-Asberg Depression Rating Scale (MADRS) Total Score|The MADRS is a 10-item scale to measure the severity of depressive episodes, where each item is rated on a scale from 0 to 6. The MADRS total score ranges from 0 to 60 with lower scores indicating less depressive symptoms.|Units of a scale|Mean|25.1|25.1|Standard Deviation|6.4|6.4|||
3822675|NCT01737268|3648265|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3822676|NCT01737268|3648265|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3822677|NCT01737268|3648265|B1|||Age||Years|Mean|70.9|70.9|Standard Deviation|5.3|5.3|||
3822678|NCT01737021|3648277|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3822679|NCT01737021|3648278|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3822680|NCT01737021|3648279|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3822681|NCT01737021|3648277|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3822683|NCT01737021|3648279|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3822684|NCT01737021|3648277|B3|||Age||years|Median|6.00|6.0|Inter-Quartile Range|||6.0|11.0|
3822685|NCT01737021|3648278|B2|||Age||years|Median|9.00|9.0|Inter-Quartile Range|||5.5|11.0|
3822686|NCT01737021|3648279|B1|||Age||years|Median|6.00|6.0|Inter-Quartile Range|||5.5|10.5|
3822687|NCT01736930|3648286|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3822688|NCT01736930|3648286|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822689|NCT01736930|3648286|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3822690|NCT01736930|3648286|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822691|NCT01736930|3648286|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822692|NCT01736930|3648286|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822693|NCT01736930|3648286|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822694|NCT01736930|3648286|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3822695|NCT01736930|3648286|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3822696|NCT01736930|3648286|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3822697|NCT01736930|3648286|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3822698|NCT01736930|3648286|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3822699|NCT01736917|3648326|B1|Cisplatin, Epirubicin||Chemotherapy Regimen||participants|Number|1|1.0||||||
3822700|NCT01736917|3648326|B1|Vinblastine, ifosfamide, cisplatin||Chemotherapy Regimen||participants|Number|2|2.0||||||
3822701|NCT01736917|3648326|B1|Etoposide, cisplatin||Chemotherapy Regimen||participants|Number|10|10.0||||||
3822702|NCT01736917|3648326|B1|Bleomycin, etoposide, cisplatin||Chemotherapy Regimen||participants|Number|51|51.0||||||
3822703|NCT01736917|3648326|B1|Participants without Prior Chemotherapy||Prior Chemotherapy||participants|Number|59|59.0||||||
3822704|NCT01736917|3648326|B1|Participants with Prior Chemotherapy||Prior Chemotherapy||participants|Number|5|5.0||||||
3822705|NCT01736917|3648326|B1|Cancer Stage Unknown||Cancer Stage|"Stage 0 Abnormal cells are present but have not spread to nearby tissue. Also called carcinoma in situ, or CIS. CIS is not cancer, but it may become cancer.~Stage I, Stage II, and Stage III Cancer is present. The higher the number, the larger the cancer tumor and the more it has spread into nearby tissues.~Stage IV The cancer has spread to distant parts of the body."|participants|Number|1|1.0||||||
3822706|NCT01736917|3648326|B1|Cancer Stage IS||Cancer Stage|"Stage 0 Abnormal cells are present but have not spread to nearby tissue. Also called carcinoma in situ, or CIS. CIS is not cancer, but it may become cancer.~Stage I, Stage II, and Stage III Cancer is present. The higher the number, the larger the cancer tumor and the more it has spread into nearby tissues.~Stage IV The cancer has spread to distant parts of the body."|participants|Number|1|1.0||||||
3822707|NCT01736917|3648326|B1|Cancer Stage III||Cancer Stage|"Stage 0 Abnormal cells are present but have not spread to nearby tissue. Also called carcinoma in situ, or CIS. CIS is not cancer, but it may become cancer.~Stage I, Stage II, and Stage III Cancer is present. The higher the number, the larger the cancer tumor and the more it has spread into nearby tissues.~Stage IV The cancer has spread to distant parts of the body."|participants|Number|11|11.0||||||
3822708|NCT01736917|3648326|B1|Cancer Stage II||Cancer Stage|"Stage 0 Abnormal cells are present but have not spread to nearby tissue. Also called carcinoma in situ, or CIS. CIS is not cancer, but it may become cancer.~Stage I, Stage II, and Stage III Cancer is present. The higher the number, the larger the cancer tumor and the more it has spread into nearby tissues.~Stage IV The cancer has spread to distant parts of the body."|participants|Number|24|24.0||||||
3822709|NCT01736917|3648326|B1|Cancer Stage I||Cancer Stage|"Stage 0 Abnormal cells are present but have not spread to nearby tissue. Also called carcinoma in situ, or CIS. CIS is not cancer, but it may become cancer.~Stage I, Stage II, and Stage III Cancer is present. The higher the number, the larger the cancer tumor and the more it has spread into nearby tissues.~Stage IV The cancer has spread to distant parts of the body."|participants|Number|27|27.0||||||
3822710|NCT01736917|3648326|B1|ECOG PS 2||Eastern Cooperative Oncology Group (ECOG) performance status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0-5 that describes a patient's level of functioning where 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Dead:|participants|Number|1|1.0||||||
3822711|NCT01736917|3648326|B1|ECOG PS 1||Eastern Cooperative Oncology Group (ECOG) performance status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0-5 that describes a patient's level of functioning where 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Dead:|participants|Number|4|4.0||||||
3822712|NCT01736917|3648326|B1|ECOG PS 0||Eastern Cooperative Oncology Group (ECOG) performance status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0-5 that describes a patient's level of functioning where 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Dead:|participants|Number|59|59.0||||||
3822713|NCT01736917|3648326|B1|United States||Region of Enrollment||participants|Number|64|64.0||||||
3822714|NCT01736917|3648326|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822715|NCT01736917|3648326|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822716|NCT01736917|3648326|B1||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3822717|NCT01736917|3648326|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822718|NCT01736917|3648326|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822719|NCT01736917|3648326|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822720|NCT01736917|3648326|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822721|NCT01736917|3648326|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822722|NCT01736917|3648326|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3822723|NCT01736917|3648326|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3822724|NCT01736917|3648326|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3822725|NCT01736917|3648326|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3822726|NCT01736917|3648326|B1|||Age||years|Median|33|33.0|Full Range|||15.0|66.0|
3822727|NCT01736696|3648333|B8||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3822728|NCT01736696|3648334|B7||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3822729|NCT01736696|3648335|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3822730|NCT01736696|3648336|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3822731|NCT01736696|3648337|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3822732|NCT01736696|3648338|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3822733|NCT01736696|3648339|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3822734|NCT01736696|3648340|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3822735|NCT01736696|3648333|B8||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3822736|NCT01736696|3648334|B7||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3822737|NCT01736696|3648335|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3822738|NCT01736696|3648336|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3822739|NCT01736696|3648337|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3822740|NCT01736696|3648338|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3822741|NCT01736696|3648339|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3822742|NCT01736696|3648340|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3822743|NCT01736696|3648333|B8|||Age||years|Mean|43.9|43.9|Standard Deviation|10.3|10.3|||
3822744|NCT01736696|3648334|B7|||Age||years|Mean|44.4|44.4|Standard Deviation|10.4|10.4|||
3822745|NCT01736696|3648335|B6|||Age||years|Mean|47.1|47.1|Standard Deviation|9.7|9.7|||
3822746|NCT01736696|3648336|B5|||Age||years|Mean|46.9|46.9|Standard Deviation|10.2|10.2|||
3822747|NCT01736696|3648337|B4|||Age||years|Mean|44.6|44.6|Standard Deviation|11.1|11.1|||
3822748|NCT01736696|3648338|B3|||Age||years|Mean|39.6|39.6|Standard Deviation|11.1|11.1|||
3822749|NCT01736696|3648339|B2|||Age||years|Mean|43.8|43.8|Standard Deviation|7.4|7.4|||
3822750|NCT01736696|3648340|B1|||Age||years|Mean|40.2|40.2|Standard Deviation|12.8|12.8|||
3822751|NCT01736657|3648663|B1|United States||Region of Enrollment||participants|Number|72|72.0||||||
3822752|NCT01736657|3648663|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3822753|NCT01736657|3648663|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3822754|NCT01736657|3648663|B1|||Age||years|Mean|23.0|23.0|Standard Deviation|10.32|10.32|||
3822755|NCT01736657|3648663|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3822756|NCT01736657|3648663|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
3822757|NCT01736657|3648663|B1||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
3822758|NCT01736579|3648670|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3822759|NCT01736579|3648671|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3822760|NCT01736579|3648672|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3822761|NCT01736579|3648670|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3822762|NCT01736579|3648671|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3822763|NCT01736579|3648672|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3822764|NCT01736579|3648670|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3822765|NCT01736579|3648671|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3822766|NCT01736579|3648672|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3822767|NCT01736579|3648670|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3822768|NCT01736579|3648671|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3822769|NCT01736579|3648672|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3822770|NCT01736579|3648670|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3822771|NCT01736579|3648671|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3822772|NCT01736579|3648672|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3822773|NCT01736566|3648707|B6|United States||Region of Enrollment||participants|Number|213|213.0||||||
3822774|NCT01736566|3648708|B5|United States||Region of Enrollment||participants|Number|10|10.0||||||
3822775|NCT01736566|3648709|B4|United States||Region of Enrollment||participants|Number|52|52.0||||||
3822776|NCT01736566|3648710|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3822777|NCT01736566|3648711|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
3822778|NCT01736566|3648712|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
3822779|NCT01736566|3648707|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3822780|NCT01736566|3648708|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822781|NCT01736566|3648709|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3822782|NCT01736566|3648710|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3822783|NCT01736566|3648711|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3822784|NCT01736566|3648712|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3822785|NCT01736566|3648707|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3822786|NCT01736566|3648708|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822787|NCT01736566|3648709|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3822788|NCT01736566|3648710|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822789|NCT01736566|3648711|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3822790|NCT01736566|3648712|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822791|NCT01736566|3648707|B6||White|Race (NIH/OMB)||Participants|Count of Participants|181|181.0||||||
3822792|NCT01736566|3648708|B5||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822793|NCT01736566|3648709|B4||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3822794|NCT01736566|3648710|B3||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3822795|NCT01736566|3648711|B2||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3822796|NCT01736566|3648712|B1||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3822797|NCT01736566|3648707|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3822798|NCT01736566|3648708|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3822799|NCT01736566|3648709|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822800|NCT01736566|3648710|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3822801|NCT01736566|3648711|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3822802|NCT01736566|3648712|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3822803|NCT01736566|3648707|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822804|NCT01736566|3648708|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822805|NCT01736566|3648709|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822806|NCT01736566|3648710|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822807|NCT01736566|3648711|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822808|NCT01736566|3648712|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822809|NCT01736566|3648707|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3822810|NCT01736566|3648708|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822811|NCT01736566|3648709|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3822812|NCT01736566|3648710|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3822813|NCT01736566|3648711|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822814|NCT01736566|3648712|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3822815|NCT01736566|3648707|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822816|NCT01736566|3648708|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822817|NCT01736566|3648709|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822818|NCT01736566|3648710|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822819|NCT01736566|3648711|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822820|NCT01736566|3648712|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822821|NCT01736566|3648707|B6||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3822822|NCT01736566|3648708|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3822823|NCT01736566|3648709|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3822824|NCT01736566|3648710|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3822825|NCT01736566|3648711|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3822826|NCT01736566|3648712|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3822827|NCT01736566|3648707|B6||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3822828|NCT01736566|3648708|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3822829|NCT01736566|3648709|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3822830|NCT01736566|3648710|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3822831|NCT01736566|3648711|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3822832|NCT01736566|3648712|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3822833|NCT01736566|3648707|B6|||Age||years|Mean|55.4|55.4|Standard Deviation|11.3|11.3|||
3822834|NCT01736566|3648708|B5|||Age||years|Mean|51.4|51.4|Standard Deviation|8.3|8.3|||
3822835|NCT01736566|3648709|B4|||Age||years|Mean|55.9|55.9|Standard Deviation|12.2|12.2|||
3822836|NCT01736566|3648710|B3|||Age||years|Mean|55.9|55.9|Standard Deviation|16.1|16.1|||
3822837|NCT01736566|3648711|B2|||Age||years|Mean|54.6|54.6|Standard Deviation|7.6|7.6|||
3822838|NCT01736566|3648712|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|7.0|7.0|||
3822839|NCT01736566|3648707|B6||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
3822840|NCT01736566|3648708|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3822841|NCT01736566|3648709|B4||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3822842|NCT01736566|3648710|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3822843|NCT01736566|3648711|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3822844|NCT01736566|3648712|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3822845|NCT01736566|3648707|B6||Between 18 and 65 years|Age||Participants|Count of Participants|174|174.0||||||
3822846|NCT01736566|3648708|B5||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3822847|NCT01736566|3648709|B4||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3822848|NCT01736566|3648710|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3822849|NCT01736566|3648711|B2||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3822850|NCT01736566|3648712|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3822851|NCT01736566|3648707|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3822852|NCT01736566|3648708|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3822853|NCT01736566|3648709|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3822854|NCT01736566|3648710|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3822855|NCT01736566|3648711|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3822856|NCT01736566|3648712|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3822857|NCT01736553|3648799|B3|||Birth Length||inches|Mean|20|20.0|Standard Deviation|1.1|1.1|||
3822858|NCT01736553|3648800|B2|||Birth Length||inches|Mean|20|20.0|Standard Deviation|1.0|1.0|||
3822859|NCT01736553|3648801|B1|||Birth Length||inches|Mean|20|20.0|Standard Deviation|1.2|1.2|||
3822860|NCT01736553|3648799|B3|||Birth Weight||lbs|Mean|7|7.0|Standard Deviation|1.3|1.3|||
3822861|NCT01736553|3648800|B2|||Birth Weight||lbs|Mean|7|7.0|Standard Deviation|1.4|1.4|||
3822862|NCT01736553|3648801|B1|||Birth Weight||lbs|Mean|7|7.0|Standard Deviation|1.2|1.2|||
3822863|NCT01736553|3648799|B3||Unknown|SMN2 Copy Number||Participants|Count of Participants|5|5.0||||||
3822864|NCT01736553|3648800|B2||Unknown|SMN2 Copy Number||Participants|Count of Participants|1|1.0||||||
3822865|NCT01736553|3648801|B1||Unknown|SMN2 Copy Number||Participants|Count of Participants|4|4.0||||||
3822866|NCT01736553|3648799|B3||4|SMN2 Copy Number||Participants|Count of Participants|1|1.0||||||
3822867|NCT01736553|3648800|B2||4|SMN2 Copy Number||Participants|Count of Participants|0|0.0||||||
3822868|NCT01736553|3648801|B1||4|SMN2 Copy Number||Participants|Count of Participants|1|1.0||||||
3822869|NCT01736553|3648799|B3||3|SMN2 Copy Number||Participants|Count of Participants|6|6.0||||||
3822870|NCT01736553|3648800|B2||3|SMN2 Copy Number||Participants|Count of Participants|1|1.0||||||
3822871|NCT01736553|3648801|B1||3|SMN2 Copy Number||Participants|Count of Participants|5|5.0||||||
3822872|NCT01736553|3648799|B3||2|SMN2 Copy Number||Participants|Count of Participants|29|29.0||||||
3822873|NCT01736553|3648800|B2||2|SMN2 Copy Number||Participants|Count of Participants|13|13.0||||||
3822874|NCT01736553|3648801|B1||2|SMN2 Copy Number||Participants|Count of Participants|16|16.0||||||
3822875|NCT01736553|3648799|B3||1|SMN2 Copy Number||Participants|Count of Participants|12|12.0||||||
3822876|NCT01736553|3648800|B2||1|SMN2 Copy Number||Participants|Count of Participants|12|12.0||||||
3822877|NCT01736553|3648801|B1||1|SMN2 Copy Number||Participants|Count of Participants|0|0.0||||||
3822878|NCT01736553|3648799|B3|United States||Region of Enrollment||Participants|Count of Participants|53|53.0||||||
3822879|NCT01736553|3648800|B2|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3822880|NCT01736553|3648801|B1|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3822881|NCT01736553|3648799|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3822882|NCT01736553|3648800|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3822883|NCT01736553|3648801|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822884|NCT01736553|3648799|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3822885|NCT01736553|3648800|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3822886|NCT01736553|3648801|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822887|NCT01736553|3648799|B3||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3822888|NCT01736553|3648800|B2||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3822889|NCT01736553|3648801|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3822890|NCT01736553|3648799|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3822891|NCT01736553|3648800|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3822892|NCT01736553|3648801|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3822893|NCT01736553|3648799|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3822894|NCT01736553|3648800|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822895|NCT01736553|3648801|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3822896|NCT01736553|3648799|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3822897|NCT01736553|3648800|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3822898|NCT01736553|3648801|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822899|NCT01736553|3648799|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822900|NCT01736553|3648800|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822901|NCT01736553|3648801|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822902|NCT01736553|3648799|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823045|NCT01736241|3649011|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822903|NCT01736553|3648800|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822904|NCT01736553|3648801|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822905|NCT01736553|3648799|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3822906|NCT01736553|3648800|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3822907|NCT01736553|3648801|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3822908|NCT01736553|3648799|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3822909|NCT01736553|3648800|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3822910|NCT01736553|3648801|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3822911|NCT01736553|3648799|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3822912|NCT01736553|3648800|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3822913|NCT01736553|3648801|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3822914|NCT01736553|3648799|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3822915|NCT01736553|3648800|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3822916|NCT01736553|3648801|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3822917|NCT01736553|3648799|B3|Age at Enrollment|5-6 Months|Age, Customized|Age at Enrollment|Participants|Count of Participants|14|14.0||||||
3822918|NCT01736553|3648800|B2|Age at Enrollment|5-6 Months|Age, Customized|Age at Enrollment|Participants|Count of Participants|8|8.0||||||
3822919|NCT01736553|3648801|B1|Age at Enrollment|5-6 Months|Age, Customized|Age at Enrollment|Participants|Count of Participants|6|6.0||||||
3822920|NCT01736553|3648799|B3|Age at Enrollment|2-4 Months|Age, Customized|Age at Enrollment|Participants|Count of Participants|25|25.0||||||
3822921|NCT01736553|3648800|B2|Age at Enrollment|2-4 Months|Age, Customized|Age at Enrollment|Participants|Count of Participants|9|9.0||||||
3822922|NCT01736553|3648801|B1|Age at Enrollment|2-4 Months|Age, Customized|Age at Enrollment|Participants|Count of Participants|16|16.0||||||
3822923|NCT01736553|3648799|B3|Age at Enrollment|0-2 Months|Age, Customized|Age at Enrollment|Participants|Count of Participants|14|14.0||||||
3822924|NCT01736553|3648800|B2|Age at Enrollment|0-2 Months|Age, Customized|Age at Enrollment|Participants|Count of Participants|10|10.0||||||
3822925|NCT01736553|3648801|B1|Age at Enrollment|0-2 Months|Age, Customized|Age at Enrollment|Participants|Count of Participants|4|4.0||||||
3822926|NCT01736553|3648799|B3|||Age|Gestational age at birth is reported.|Weeks|Mean|39|39.0|Standard Deviation|1.45|1.45|||
3822927|NCT01736553|3648800|B2|||Age|Gestational age at birth is reported.|Weeks|Mean|39|39.0|Standard Deviation|1.4|1.4|||
3822928|NCT01736553|3648801|B1|||Age|Gestational age at birth is reported.|Weeks|Mean|39|39.0|Standard Deviation|1.5|1.5|||
3822929|NCT01736540|3648853|B1||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3822930|NCT01736540|3648853|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3822931|NCT01736540|3648853|B1|||Age||Years|Mean|52.8|52.8|Standard Deviation|20.92|20.92|||
3822932|NCT01736527|3648910|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3822933|NCT01736527|3648910|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3822934|NCT01736527|3648910|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3822935|NCT01736527|3648910|B1|||Age, Customized||years|Mean|45.6|45.6|Standard Deviation|11.37|11.37|||
3822936|NCT01736475|3648917|B3||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3822937|NCT01736475|3648918|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3822938|NCT01736475|3648919|B1||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3822939|NCT01736475|3648917|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3822940|NCT01736475|3648918|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3822941|NCT01736475|3648919|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3822942|NCT01736475|3648917|B3|||Age||Years|Mean|30.0|30.0|Standard Deviation|12.34|12.34|||
3822943|NCT01736475|3648918|B2|||Age||Years|Mean|31.5|31.5|Standard Deviation|11.05|11.05|||
3822944|NCT01736475|3648919|B1|||Age||Years|Mean|29.8|29.8|Standard Deviation|12.53|12.53|||
3822945|NCT01736397|3648973|B3||Other|Chronic kidney disease (CKD), stage at baseline|"The stage of CKD disease was measured by the estimated glomerular filtration rate (eGFR), where CKD Stage III relates to better kidney function compare to CKD Stage V, that has worse kidney function.~Stage III: eGFR 30-59 mL/min/1.73 m2 Stage IV eGFR 15-29 mL/min/1.73 m2 Stage V eGFR<15 mL/min/1.73 m2 Other eGFR >=60 mL/min/1.73 m2"|Participants|Count of Participants|2|2.0||||||
3822946|NCT01736397|3648974|B2||Other|Chronic kidney disease (CKD), stage at baseline|"The stage of CKD disease was measured by the estimated glomerular filtration rate (eGFR), where CKD Stage III relates to better kidney function compare to CKD Stage V, that has worse kidney function.~Stage III: eGFR 30-59 mL/min/1.73 m2 Stage IV eGFR 15-29 mL/min/1.73 m2 Stage V eGFR<15 mL/min/1.73 m2 Other eGFR >=60 mL/min/1.73 m2"|Participants|Count of Participants|1|1.0||||||
3822947|NCT01736397|3648975|B1||Other|Chronic kidney disease (CKD), stage at baseline|"The stage of CKD disease was measured by the estimated glomerular filtration rate (eGFR), where CKD Stage III relates to better kidney function compare to CKD Stage V, that has worse kidney function.~Stage III: eGFR 30-59 mL/min/1.73 m2 Stage IV eGFR 15-29 mL/min/1.73 m2 Stage V eGFR<15 mL/min/1.73 m2 Other eGFR >=60 mL/min/1.73 m2"|Participants|Count of Participants|1|1.0||||||
3822948|NCT01736397|3648973|B3||Stage V|Chronic kidney disease (CKD), stage at baseline|"The stage of CKD disease was measured by the estimated glomerular filtration rate (eGFR), where CKD Stage III relates to better kidney function compare to CKD Stage V, that has worse kidney function.~Stage III: eGFR 30-59 mL/min/1.73 m2 Stage IV eGFR 15-29 mL/min/1.73 m2 Stage V eGFR<15 mL/min/1.73 m2 Other eGFR >=60 mL/min/1.73 m2"|Participants|Count of Participants|38|38.0||||||
3822949|NCT01736397|3648974|B2||Stage V|Chronic kidney disease (CKD), stage at baseline|"The stage of CKD disease was measured by the estimated glomerular filtration rate (eGFR), where CKD Stage III relates to better kidney function compare to CKD Stage V, that has worse kidney function.~Stage III: eGFR 30-59 mL/min/1.73 m2 Stage IV eGFR 15-29 mL/min/1.73 m2 Stage V eGFR<15 mL/min/1.73 m2 Other eGFR >=60 mL/min/1.73 m2"|Participants|Count of Participants|17|17.0||||||
3822950|NCT01736397|3648975|B1||Stage V|Chronic kidney disease (CKD), stage at baseline|"The stage of CKD disease was measured by the estimated glomerular filtration rate (eGFR), where CKD Stage III relates to better kidney function compare to CKD Stage V, that has worse kidney function.~Stage III: eGFR 30-59 mL/min/1.73 m2 Stage IV eGFR 15-29 mL/min/1.73 m2 Stage V eGFR<15 mL/min/1.73 m2 Other eGFR >=60 mL/min/1.73 m2"|Participants|Count of Participants|21|21.0||||||
3822951|NCT01736397|3648973|B3||Stage IV|Chronic kidney disease (CKD), stage at baseline|"The stage of CKD disease was measured by the estimated glomerular filtration rate (eGFR), where CKD Stage III relates to better kidney function compare to CKD Stage V, that has worse kidney function.~Stage III: eGFR 30-59 mL/min/1.73 m2 Stage IV eGFR 15-29 mL/min/1.73 m2 Stage V eGFR<15 mL/min/1.73 m2 Other eGFR >=60 mL/min/1.73 m2"|Participants|Count of Participants|78|78.0||||||
3822952|NCT01736397|3648974|B2||Stage IV|Chronic kidney disease (CKD), stage at baseline|"The stage of CKD disease was measured by the estimated glomerular filtration rate (eGFR), where CKD Stage III relates to better kidney function compare to CKD Stage V, that has worse kidney function.~Stage III: eGFR 30-59 mL/min/1.73 m2 Stage IV eGFR 15-29 mL/min/1.73 m2 Stage V eGFR<15 mL/min/1.73 m2 Other eGFR >=60 mL/min/1.73 m2"|Participants|Count of Participants|39|39.0||||||
3822953|NCT01736397|3648975|B1||Stage IV|Chronic kidney disease (CKD), stage at baseline|"The stage of CKD disease was measured by the estimated glomerular filtration rate (eGFR), where CKD Stage III relates to better kidney function compare to CKD Stage V, that has worse kidney function.~Stage III: eGFR 30-59 mL/min/1.73 m2 Stage IV eGFR 15-29 mL/min/1.73 m2 Stage V eGFR<15 mL/min/1.73 m2 Other eGFR >=60 mL/min/1.73 m2"|Participants|Count of Participants|39|39.0||||||
3822954|NCT01736397|3648973|B3||Stage III|Chronic kidney disease (CKD), stage at baseline|"The stage of CKD disease was measured by the estimated glomerular filtration rate (eGFR), where CKD Stage III relates to better kidney function compare to CKD Stage V, that has worse kidney function.~Stage III: eGFR 30-59 mL/min/1.73 m2 Stage IV eGFR 15-29 mL/min/1.73 m2 Stage V eGFR<15 mL/min/1.73 m2 Other eGFR >=60 mL/min/1.73 m2"|Participants|Count of Participants|30|30.0||||||
3822955|NCT01736397|3648974|B2||Stage III|Chronic kidney disease (CKD), stage at baseline|"The stage of CKD disease was measured by the estimated glomerular filtration rate (eGFR), where CKD Stage III relates to better kidney function compare to CKD Stage V, that has worse kidney function.~Stage III: eGFR 30-59 mL/min/1.73 m2 Stage IV eGFR 15-29 mL/min/1.73 m2 Stage V eGFR<15 mL/min/1.73 m2 Other eGFR >=60 mL/min/1.73 m2"|Participants|Count of Participants|16|16.0||||||
3822956|NCT01736397|3648975|B1||Stage III|Chronic kidney disease (CKD), stage at baseline|"The stage of CKD disease was measured by the estimated glomerular filtration rate (eGFR), where CKD Stage III relates to better kidney function compare to CKD Stage V, that has worse kidney function.~Stage III: eGFR 30-59 mL/min/1.73 m2 Stage IV eGFR 15-29 mL/min/1.73 m2 Stage V eGFR<15 mL/min/1.73 m2 Other eGFR >=60 mL/min/1.73 m2"|Participants|Count of Participants|14|14.0||||||
3822957|NCT01736397|3648973|B3|United States||Region of Enrollment||Participants|Count of Participants|148|148.0||||||
3822958|NCT01736397|3648974|B2|United States||Region of Enrollment||Participants|Count of Participants|73|73.0||||||
3822959|NCT01736397|3648975|B1|United States||Region of Enrollment||Participants|Count of Participants|75|75.0||||||
3822960|NCT01736397|3648973|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822961|NCT01736397|3648974|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822962|NCT01736397|3648975|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822963|NCT01736397|3648973|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822964|NCT01736397|3648974|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822965|NCT01736397|3648975|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822966|NCT01736397|3648973|B3||White|Race (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
3822967|NCT01736397|3648974|B2||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3822968|NCT01736397|3648975|B1||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3822969|NCT01736397|3648973|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3822970|NCT01736397|3648974|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3822971|NCT01736397|3648975|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3822972|NCT01736397|3648973|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822973|NCT01736397|3648974|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822974|NCT01736397|3648975|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822975|NCT01736397|3648973|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3822976|NCT01736397|3648974|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3822977|NCT01736397|3648975|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822978|NCT01736397|3648973|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822979|NCT01736397|3648974|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822980|NCT01736397|3648975|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822981|NCT01736397|3648973|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822982|NCT01736397|3648974|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822983|NCT01736397|3648975|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3822984|NCT01736397|3648973|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|112|112.0||||||
3822985|NCT01736397|3648974|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3822986|NCT01736397|3648975|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3822987|NCT01736397|3648973|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3822988|NCT01736397|3648974|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3822989|NCT01736397|3648975|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3822990|NCT01736397|3648973|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3822991|NCT01736397|3648974|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3822992|NCT01736397|3648975|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3822993|NCT01736397|3648973|B3||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3822994|NCT01736397|3648974|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3822995|NCT01736397|3648975|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3822996|NCT01736397|3648973|B3|||Age||years|Mean|65.1|65.1|Standard Deviation|12.83|12.83|||
3822997|NCT01736397|3648974|B2|||Age||years|Mean|64.5|64.5|Standard Deviation|13.55|13.55|||
3822998|NCT01736397|3648975|B1|||Age||years|Mean|65.8|65.8|Standard Deviation|12.15|12.15|||
3822999|NCT01736397|3648973|B3||>=65 years|Age||Participants|Count of Participants|83|83.0||||||
3823000|NCT01736397|3648974|B2||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
3823001|NCT01736397|3648975|B1||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
3823002|NCT01736397|3648973|B3||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
3823003|NCT01736397|3648974|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3823004|NCT01736397|3648975|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3823005|NCT01736397|3648973|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3823006|NCT01736397|3648974|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3823007|NCT01736397|3648975|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3823008|NCT01736254|3648988|B1|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3823009|NCT01736254|3648988|B1|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3823010|NCT01736254|3648988|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3823011|NCT01736254|3648988|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3823012|NCT01736254|3648988|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3823013|NCT01736254|3648988|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3823014|NCT01736254|3648988|B1|||Age||years|Mean|41.8|41.8|Standard Deviation|10.4|10.4|||
3823015|NCT01736241|3649005|B8|Singapore||Region of Enrollment||participants|Number|41|41.0||||||
3823016|NCT01736241|3649006|B7|Singapore||Region of Enrollment||participants|Number|6|6.0||||||
3823017|NCT01736241|3649007|B6|Singapore||Region of Enrollment||participants|Number|6|6.0||||||
3823018|NCT01736241|3649008|B5|Singapore||Region of Enrollment||participants|Number|6|6.0||||||
3823019|NCT01736241|3649009|B4|Singapore||Region of Enrollment||participants|Number|5|5.0||||||
3823020|NCT01736241|3649010|B3|Singapore||Region of Enrollment||participants|Number|6|6.0||||||
3823021|NCT01736241|3649011|B2|Singapore||Region of Enrollment||participants|Number|6|6.0||||||
3823022|NCT01736241|3649012|B1|Singapore||Region of Enrollment||participants|Number|6|6.0||||||
3823023|NCT01736241|3649005|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823024|NCT01736241|3649006|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823025|NCT01736241|3649007|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823026|NCT01736241|3649008|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823027|NCT01736241|3649009|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823028|NCT01736241|3649010|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823029|NCT01736241|3649011|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823030|NCT01736241|3649012|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823031|NCT01736241|3649005|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823032|NCT01736241|3649006|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823033|NCT01736241|3649007|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823034|NCT01736241|3649008|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823035|NCT01736241|3649009|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823036|NCT01736241|3649010|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823037|NCT01736241|3649011|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823038|NCT01736241|3649012|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823039|NCT01736241|3649005|B8||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3823040|NCT01736241|3649006|B7||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3823041|NCT01736241|3649007|B6||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823042|NCT01736241|3649008|B5||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3823043|NCT01736241|3649009|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823044|NCT01736241|3649010|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3823046|NCT01736241|3649012|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823047|NCT01736241|3649005|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823048|NCT01736241|3649006|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823049|NCT01736241|3649007|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823050|NCT01736241|3649008|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823051|NCT01736241|3649009|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823052|NCT01736241|3649010|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823053|NCT01736241|3649011|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823054|NCT01736241|3649012|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823055|NCT01736241|3649005|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823056|NCT01736241|3649006|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823057|NCT01736241|3649007|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823058|NCT01736241|3649008|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823059|NCT01736241|3649009|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823060|NCT01736241|3649010|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823061|NCT01736241|3649011|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823062|NCT01736241|3649012|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823063|NCT01736241|3649005|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3823064|NCT01736241|3649006|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3823065|NCT01736241|3649007|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3823066|NCT01736241|3649008|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3823067|NCT01736241|3649009|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3823068|NCT01736241|3649010|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3823069|NCT01736241|3649011|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3823070|NCT01736241|3649012|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3823071|NCT01736241|3649005|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823072|NCT01736241|3649006|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823073|NCT01736241|3649007|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823074|NCT01736241|3649008|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823075|NCT01736241|3649009|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823076|NCT01736241|3649010|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823077|NCT01736241|3649011|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823078|NCT01736241|3649012|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823079|NCT01736241|3649005|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823080|NCT01736241|3649006|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823081|NCT01736241|3649007|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823082|NCT01736241|3649008|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823083|NCT01736241|3649009|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823084|NCT01736241|3649010|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823085|NCT01736241|3649011|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823086|NCT01736241|3649012|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823087|NCT01736241|3649005|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3823088|NCT01736241|3649006|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3823089|NCT01736241|3649007|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3823090|NCT01736241|3649008|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3823091|NCT01736241|3649009|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3823092|NCT01736241|3649010|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3823093|NCT01736241|3649011|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3823094|NCT01736241|3649012|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3823095|NCT01736241|3649005|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823096|NCT01736241|3649006|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823097|NCT01736241|3649007|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823098|NCT01736241|3649008|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823099|NCT01736241|3649009|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823100|NCT01736241|3649010|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823101|NCT01736241|3649011|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823102|NCT01736241|3649012|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823103|NCT01736241|3649005|B8||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3823104|NCT01736241|3649006|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3823105|NCT01736241|3649007|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3823106|NCT01736241|3649008|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3823107|NCT01736241|3649009|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3823108|NCT01736241|3649010|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3823109|NCT01736241|3649011|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3823110|NCT01736241|3649012|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3823111|NCT01736241|3649005|B8||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3823112|NCT01736241|3649006|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3823113|NCT01736241|3649007|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3823114|NCT01736241|3649008|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3823115|NCT01736241|3649009|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3823116|NCT01736241|3649010|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3823117|NCT01736241|3649011|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3823118|NCT01736241|3649012|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3823119|NCT01736241|3649005|B8|||Age||years|Mean|34.8|34.8|Standard Deviation|9.4|9.4|||
3823120|NCT01736241|3649006|B7|||Age||years|Mean|34.5|34.5|Standard Deviation|7.4|7.4|||
3823121|NCT01736241|3649007|B6|||Age||years|Mean|31.0|31.0|Standard Deviation|8.9|8.9|||
3823122|NCT01736241|3649008|B5|||Age||years|Mean|34.3|34.3|Standard Deviation|10.7|10.7|||
3823123|NCT01736241|3649009|B4|||Age||years|Mean|36.2|36.2|Standard Deviation|14.7|14.7|||
3823124|NCT01736241|3649010|B3|||Age||years|Mean|39.7|39.7|Standard Deviation|11.1|11.1|||
3823125|NCT01736241|3649011|B2|||Age||years|Mean|33.2|33.2|Standard Deviation|4.3|4.3|||
3823126|NCT01736241|3649012|B1|||Age||years|Mean|35.2|35.2|Standard Deviation|9.7|9.7|||
3823127|NCT01736215|3649053|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3823128|NCT01736215|3649053|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3823129|NCT01736215|3649053|B1|||Age||Years|Mean|59.20|59.2|Standard Deviation|8.63|8.63|||
3823130|NCT01736176|3649065|B1|||Non-Motor Symptoms Scale (NMSS) Total Score|The NMSS assesses non-motor symptoms in Parkinson's Disease. It consists of 30 questions grouped into 9 domains: cardiovascular, sleep/fatigue, mood/cognition, perceptual problems/hallucinations, attention/memory, gastro-intestinal tract, urinary, sexual function, and miscellaneous. Severity is rated on a scale from 0 (none) to 3 (severe). Frequency is rated on a scale from 1 (rarely) to 4 (very frequent). The NMSS total score ranges from 0 to 360 with a lower score more desirable than a higher score. Baseline was the last measurement before the first dose of oral study drug.|units on a scale|Mean|48.3|48.3|Standard Deviation|35.63|35.63|||
3823131|NCT01736176|3649065|B1|Postural instability||PD Symptoms Present||Participants|Count of Participants|22|22.0||||||
3823132|NCT01736176|3649065|B1|Resting tremor||PD Symptoms Present||Participants|Count of Participants|25|25.0||||||
3823133|NCT01736176|3649065|B1|Muscular rigidity||PD Symptoms Present||Participants|Count of Participants|33|33.0||||||
3823134|NCT01736176|3649065|B1|Bradykinesia||PD Symptoms Present||Participants|Count of Participants|37|37.0||||||
3823135|NCT01736176|3649065|B1|||Duration of PD||years|Mean|11.5|11.5|Standard Deviation|5.34|5.34|||
3823136|NCT01736176|3649065|B1||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
3823137|NCT01736176|3649065|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3823138|NCT01736176|3649065|B1||Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3823139|NCT01736176|3649065|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3823140|NCT01736176|3649065|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3823141|NCT01736176|3649065|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3823142|NCT01736176|3649065|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3823143|NCT01736176|3649065|B1||Male|Gender||Participants|Count of Participants|23|23.0||||||
3823144|NCT01736176|3649065|B1||Female|Gender||Participants|Count of Participants|16|16.0||||||
3823145|NCT01736176|3649065|B1||≥ 65 years|Age, Customized||Participants|Count of Participants|22|22.0||||||
3823146|NCT01736176|3649065|B1||< 65 years|Age, Customized||Participants|Count of Participants|17|17.0||||||
3823147|NCT01736176|3649065|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|10.23|10.23|||
3823148|NCT01735916|3649109|B4|Not Reported||New York Heart Association classification|New York Heart Association Classification is a measure of the degree of heart failure a subject has on a 4 class scale, with NYHA Class I being the healthiest score and NYHA Class IV being the sickest score.|participants|Number|2|2.0||||||
3823149|NCT01735916|3649110|B3|Not Reported||New York Heart Association classification|New York Heart Association Classification is a measure of the degree of heart failure a subject has on a 4 class scale, with NYHA Class I being the healthiest score and NYHA Class IV being the sickest score.|participants|Number|0|0.0||||||
3823278|NCT01735630|3649151|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3823279|NCT01735630|3649152|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3823150|NCT01735916|3649111|B2|Not Reported||New York Heart Association classification|New York Heart Association Classification is a measure of the degree of heart failure a subject has on a 4 class scale, with NYHA Class I being the healthiest score and NYHA Class IV being the sickest score.|participants|Number|0|0.0||||||
3823151|NCT01735916|3649112|B1|Not Reported||New York Heart Association classification|New York Heart Association Classification is a measure of the degree of heart failure a subject has on a 4 class scale, with NYHA Class I being the healthiest score and NYHA Class IV being the sickest score.|participants|Number|2|2.0||||||
3823152|NCT01735916|3649109|B4|NYHA Class III||New York Heart Association classification|New York Heart Association Classification is a measure of the degree of heart failure a subject has on a 4 class scale, with NYHA Class I being the healthiest score and NYHA Class IV being the sickest score.|participants|Number|26|26.0||||||
3823153|NCT01735916|3649110|B3|NYHA Class III||New York Heart Association classification|New York Heart Association Classification is a measure of the degree of heart failure a subject has on a 4 class scale, with NYHA Class I being the healthiest score and NYHA Class IV being the sickest score.|participants|Number|4|4.0||||||
3823154|NCT01735916|3649111|B2|NYHA Class III||New York Heart Association classification|New York Heart Association Classification is a measure of the degree of heart failure a subject has on a 4 class scale, with NYHA Class I being the healthiest score and NYHA Class IV being the sickest score.|participants|Number|17|17.0||||||
3823155|NCT01735916|3649112|B1|NYHA Class III||New York Heart Association classification|New York Heart Association Classification is a measure of the degree of heart failure a subject has on a 4 class scale, with NYHA Class I being the healthiest score and NYHA Class IV being the sickest score.|participants|Number|5|5.0||||||
3823156|NCT01735916|3649109|B4|NYHA Class II||New York Heart Association classification|New York Heart Association Classification is a measure of the degree of heart failure a subject has on a 4 class scale, with NYHA Class I being the healthiest score and NYHA Class IV being the sickest score.|participants|Number|16|16.0||||||
3823157|NCT01735916|3649110|B3|NYHA Class II||New York Heart Association classification|New York Heart Association Classification is a measure of the degree of heart failure a subject has on a 4 class scale, with NYHA Class I being the healthiest score and NYHA Class IV being the sickest score.|participants|Number|3|3.0||||||
3823158|NCT01735916|3649111|B2|NYHA Class II||New York Heart Association classification|New York Heart Association Classification is a measure of the degree of heart failure a subject has on a 4 class scale, with NYHA Class I being the healthiest score and NYHA Class IV being the sickest score.|participants|Number|2|2.0||||||
3823159|NCT01735916|3649112|B1|NYHA Class II||New York Heart Association classification|New York Heart Association Classification is a measure of the degree of heart failure a subject has on a 4 class scale, with NYHA Class I being the healthiest score and NYHA Class IV being the sickest score.|participants|Number|11|11.0||||||
3823160|NCT01735916|3649109|B4|||Diastolic blood pressure|Not all data were available for non-randomized subjects due to exiting prior to randomization. Diastolic blood pressure was available for 8 of the non-randomized subjects and was not available for 10 of the 18 non-randomized subjects.|mm Hg|Mean|72.8|72.8|Standard Deviation|10.5|10.5|||
3823161|NCT01735916|3649110|B3|||Diastolic blood pressure|Not all data were available for non-randomized subjects due to exiting prior to randomization. Diastolic blood pressure was available for 8 of the non-randomized subjects and was not available for 10 of the 18 non-randomized subjects.|mm Hg|Mean|66.6|66.6|Standard Deviation|11.5|11.5|||
3823162|NCT01735916|3649111|B2|||Diastolic blood pressure|Not all data were available for non-randomized subjects due to exiting prior to randomization. Diastolic blood pressure was available for 8 of the non-randomized subjects and was not available for 10 of the 18 non-randomized subjects.|mm Hg|Mean|74.4|74.4|Standard Deviation|10.2|10.2|||
3823163|NCT01735916|3649112|B1|||Diastolic blood pressure|Not all data were available for non-randomized subjects due to exiting prior to randomization. Diastolic blood pressure was available for 8 of the non-randomized subjects and was not available for 10 of the 18 non-randomized subjects.|mm Hg|Mean|74.4|74.4|Standard Deviation|9.4|9.4|||
3823164|NCT01735916|3649109|B4|||Systolic blood pressure|Not all data were available for non-randomized subjects due to exiting prior to randomization. Systolic blood pressure was available for 8 of the non-randomized subjects and was not available for 10 of the 18 non-randomized subjects.|mm Hg|Mean|129.2|129.2|Standard Deviation|20.6|20.6|||
3823165|NCT01735916|3649110|B3|||Systolic blood pressure|Not all data were available for non-randomized subjects due to exiting prior to randomization. Systolic blood pressure was available for 8 of the non-randomized subjects and was not available for 10 of the 18 non-randomized subjects.|mm Hg|Mean|121.1|121.1|Standard Deviation|19.0|19.0|||
3823166|NCT01735916|3649111|B2|||Systolic blood pressure|Not all data were available for non-randomized subjects due to exiting prior to randomization. Systolic blood pressure was available for 8 of the non-randomized subjects and was not available for 10 of the 18 non-randomized subjects.|mm Hg|Mean|131.5|131.5|Standard Deviation|21.4|21.4|||
3823167|NCT01735916|3649112|B1|||Systolic blood pressure|Not all data were available for non-randomized subjects due to exiting prior to randomization. Systolic blood pressure was available for 8 of the non-randomized subjects and was not available for 10 of the 18 non-randomized subjects.|mm Hg|Mean|130.9|130.9|Standard Deviation|20.7|20.7|||
3823168|NCT01735916|3649109|B4|||Heart rate|Not all data were available for non-randomized subjects due to exiting prior to randomization. Heart rate was available for 8 of the non-randomized subjects and was not available for 10 of the 18 non-randomized subjects.|intrinsic beats/minute|Mean|68.7|68.7|Standard Deviation|11.0|11.0|||
3823169|NCT01735916|3649110|B3|||Heart rate|Not all data were available for non-randomized subjects due to exiting prior to randomization. Heart rate was available for 8 of the non-randomized subjects and was not available for 10 of the 18 non-randomized subjects.|intrinsic beats/minute|Mean|64.3|64.3|Standard Deviation|6.7|6.7|||
3823170|NCT01735916|3649111|B2|||Heart rate|Not all data were available for non-randomized subjects due to exiting prior to randomization. Heart rate was available for 8 of the non-randomized subjects and was not available for 10 of the 18 non-randomized subjects.|intrinsic beats/minute|Mean|72.6|72.6|Standard Deviation|10.3|10.3|||
3823218|NCT01735916|3649111|B2|||Age|Not all data were available for non-randomized subjects due to exiting prior to randomization. Age was available for 8 of the non-randomized subjects and was not available for 10 of the 18 non-randomized subjects.|years|Mean|69.2|69.2|Standard Deviation|10.3|10.3|||
3823171|NCT01735916|3649112|B1|||Heart rate|Not all data were available for non-randomized subjects due to exiting prior to randomization. Heart rate was available for 8 of the non-randomized subjects and was not available for 10 of the 18 non-randomized subjects.|intrinsic beats/minute|Mean|63.4|63.4|Standard Deviation|12.8|12.8|||
3823172|NCT01735916|3649109|B4|||Body Mass Index (BMI)|Not all data were available for non-randomized subjects due to exiting prior to randomization. BMI was available for 8 of the non-randomized subjects and was not available for 10 of the 18 non-randomized subjects.|kilogram/(meter*meter)|Mean|31.2|31.2|Standard Deviation|6.0|6.0|||
3823173|NCT01735916|3649110|B3|||Body Mass Index (BMI)|Not all data were available for non-randomized subjects due to exiting prior to randomization. BMI was available for 8 of the non-randomized subjects and was not available for 10 of the 18 non-randomized subjects.|kilogram/(meter*meter)|Mean|32.5|32.5|Standard Deviation|3.6|3.6|||
3823174|NCT01735916|3649111|B2|||Body Mass Index (BMI)|Not all data were available for non-randomized subjects due to exiting prior to randomization. BMI was available for 8 of the non-randomized subjects and was not available for 10 of the 18 non-randomized subjects.|kilogram/(meter*meter)|Mean|31.5|31.5|Standard Deviation|7.0|7.0|||
3823175|NCT01735916|3649112|B1|||Body Mass Index (BMI)|Not all data were available for non-randomized subjects due to exiting prior to randomization. BMI was available for 8 of the non-randomized subjects and was not available for 10 of the 18 non-randomized subjects.|kilogram/(meter*meter)|Mean|29.3|29.3|Standard Deviation|4.9|4.9|||
3823176|NCT01735916|3649109|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3823177|NCT01735916|3649110|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823178|NCT01735916|3649111|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823179|NCT01735916|3649112|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3823180|NCT01735916|3649109|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823181|NCT01735916|3649110|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823182|NCT01735916|3649111|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823183|NCT01735916|3649112|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823184|NCT01735916|3649109|B4||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3823185|NCT01735916|3649110|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3823186|NCT01735916|3649111|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3823187|NCT01735916|3649112|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3823188|NCT01735916|3649109|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823189|NCT01735916|3649110|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823190|NCT01735916|3649111|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823191|NCT01735916|3649112|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823192|NCT01735916|3649109|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823193|NCT01735916|3649110|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823194|NCT01735916|3649111|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823195|NCT01735916|3649112|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823196|NCT01735916|3649109|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3823197|NCT01735916|3649110|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823198|NCT01735916|3649111|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3823199|NCT01735916|3649112|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3823200|NCT01735916|3649109|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823201|NCT01735916|3649110|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823202|NCT01735916|3649111|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823203|NCT01735916|3649112|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823204|NCT01735916|3649109|B4|Not Reported||Sex/Gender, Customized||participants|Number|10|10.0||||||
3823205|NCT01735916|3649110|B3|Not Reported||Sex/Gender, Customized||participants|Number|0|0.0||||||
3823206|NCT01735916|3649111|B2|Not Reported||Sex/Gender, Customized||participants|Number|0|0.0||||||
3823207|NCT01735916|3649112|B1|Not Reported||Sex/Gender, Customized||participants|Number|10|10.0||||||
3823208|NCT01735916|3649109|B4|Female||Sex/Gender, Customized||participants|Number|18|18.0||||||
3823209|NCT01735916|3649110|B3|Female||Sex/Gender, Customized||participants|Number|1|1.0||||||
3823210|NCT01735916|3649111|B2|Female||Sex/Gender, Customized||participants|Number|14|14.0||||||
3823211|NCT01735916|3649112|B1|Female||Sex/Gender, Customized||participants|Number|3|3.0||||||
3823212|NCT01735916|3649109|B4|Male||Sex/Gender, Customized||participants|Number|16|16.0||||||
3823213|NCT01735916|3649110|B3|Male||Sex/Gender, Customized||participants|Number|6|6.0||||||
3823214|NCT01735916|3649111|B2|Male||Sex/Gender, Customized||participants|Number|5|5.0||||||
3823215|NCT01735916|3649112|B1|Male||Sex/Gender, Customized||participants|Number|5|5.0||||||
3823216|NCT01735916|3649109|B4|||Age|Not all data were available for non-randomized subjects due to exiting prior to randomization. Age was available for 8 of the non-randomized subjects and was not available for 10 of the 18 non-randomized subjects.|years|Mean|69.0|69.0|Standard Deviation|9.5|9.5|||
3823217|NCT01735916|3649110|B3|||Age|Not all data were available for non-randomized subjects due to exiting prior to randomization. Age was available for 8 of the non-randomized subjects and was not available for 10 of the 18 non-randomized subjects.|years|Mean|69.3|69.3|Standard Deviation|7.0|7.0|||
3823219|NCT01735916|3649112|B1|||Age|Not all data were available for non-randomized subjects due to exiting prior to randomization. Age was available for 8 of the non-randomized subjects and was not available for 10 of the 18 non-randomized subjects.|years|Mean|68.5|68.5|Standard Deviation|10.4|10.4|||
3823220|NCT01735877|3649133|B3|India||Region of Enrollment||participants|Number|48|48.0||||||
3823221|NCT01735877|3649134|B2|India||Region of Enrollment||participants|Number|21|21.0||||||
3823222|NCT01735877|3649135|B1|India||Region of Enrollment||participants|Number|27|27.0||||||
3823223|NCT01735877|3649133|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3823224|NCT01735877|3649134|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3823225|NCT01735877|3649135|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3823226|NCT01735877|3649133|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3823227|NCT01735877|3649134|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3823228|NCT01735877|3649135|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3823229|NCT01735877|3649133|B3|||Age||years|Mean|63.65|63.65|Standard Deviation|11.27|11.27|||
3823230|NCT01735877|3649134|B2|||Age||years|Mean|64.29|64.29|Standard Deviation|12.02|12.02|||
3823231|NCT01735877|3649135|B1|||Age||years|Mean|63.15|63.15|Standard Deviation|11.07|11.07|||
3823232|NCT01735630|3649150|B3|Spain||Region of Enrollment||participants|Number|23|23.0||||||
3823233|NCT01735630|3649151|B2|Spain||Region of Enrollment||participants|Number|10|10.0||||||
3823234|NCT01735630|3649152|B1|Spain||Region of Enrollment||participants|Number|13|13.0||||||
3823235|NCT01735630|3649150|B3|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
3823236|NCT01735630|3649151|B2|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3823237|NCT01735630|3649152|B1|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
3823238|NCT01735630|3649150|B3|United States||Region of Enrollment||participants|Number|305|305.0||||||
3823239|NCT01735630|3649151|B2|United States||Region of Enrollment||participants|Number|152|152.0||||||
3823240|NCT01735630|3649152|B1|United States||Region of Enrollment||participants|Number|153|153.0||||||
3823241|NCT01735630|3649150|B3|Canada||Region of Enrollment||participants|Number|17|17.0||||||
3823242|NCT01735630|3649151|B2|Canada||Region of Enrollment||participants|Number|10|10.0||||||
3823243|NCT01735630|3649152|B1|Canada||Region of Enrollment||participants|Number|7|7.0||||||
3823244|NCT01735630|3649150|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3823245|NCT01735630|3649151|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3823246|NCT01735630|3649152|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3823247|NCT01735630|3649150|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823248|NCT01735630|3649151|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823249|NCT01735630|3649152|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823250|NCT01735630|3649150|B3||White|Race (NIH/OMB)||Participants|Count of Participants|306|306.0||||||
3823251|NCT01735630|3649151|B2||White|Race (NIH/OMB)||Participants|Count of Participants|151|151.0||||||
3823252|NCT01735630|3649152|B1||White|Race (NIH/OMB)||Participants|Count of Participants|155|155.0||||||
3823253|NCT01735630|3649150|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3823254|NCT01735630|3649151|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3823255|NCT01735630|3649152|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3823256|NCT01735630|3649150|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823257|NCT01735630|3649151|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823258|NCT01735630|3649152|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823259|NCT01735630|3649150|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3823260|NCT01735630|3649151|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3823261|NCT01735630|3649152|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3823262|NCT01735630|3649150|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823263|NCT01735630|3649151|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823264|NCT01735630|3649152|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823265|NCT01735630|3649150|B3||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3823266|NCT01735630|3649151|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3823267|NCT01735630|3649152|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3823268|NCT01735630|3649150|B3||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
3823269|NCT01735630|3649151|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3823270|NCT01735630|3649152|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3823271|NCT01735630|3649150|B3|||Age||years|Mean|76.0|76.0|Standard Deviation|8.19|8.19|||
3823272|NCT01735630|3649151|B2|||Age||years|Mean|75.9|75.9|Standard Deviation|8.51|8.51|||
3823273|NCT01735630|3649152|B1|||Age||years|Mean|76.2|76.2|Standard Deviation|7.89|7.89|||
3823274|NCT01735630|3649150|B3||>=65 years|Age||Participants|Count of Participants|317|317.0||||||
3823275|NCT01735630|3649151|B2||>=65 years|Age||Participants|Count of Participants|155|155.0||||||
3823276|NCT01735630|3649152|B1||>=65 years|Age||Participants|Count of Participants|162|162.0||||||
3823277|NCT01735630|3649150|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3823280|NCT01735630|3649150|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3823281|NCT01735630|3649151|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3823282|NCT01735630|3649152|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3823283|NCT01735617|3649167|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3823284|NCT01735617|3649167|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3823285|NCT01735617|3649167|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3823286|NCT01735617|3649167|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3823287|NCT01735617|3649167|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3823288|NCT01735617|3649167|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823289|NCT01735617|3649167|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823290|NCT01735617|3649167|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823291|NCT01735617|3649167|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3823292|NCT01735617|3649167|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3823293|NCT01735617|3649167|B1|||Age||years|Mean|28.7|28.7|Standard Deviation|12.97|12.97|||
3823294|NCT01735396|3649180|B1||ECOG 1|Performance Status: ECOG|"ECOG (Eastern Cooperative Oncology Group) Performance Status:~0= Fully active; 1=restricted in physically strenuous activity but ambulatory, light work; 2= ambulatory and capable of self care, but no any work activities; 3= capable of only limited self care; 4 = completely disabled, 5= dead"|Participants|Count of Participants|3|3.0||||||
3823295|NCT01735396|3649180|B1||ECOG 0|Performance Status: ECOG|"ECOG (Eastern Cooperative Oncology Group) Performance Status:~0= Fully active; 1=restricted in physically strenuous activity but ambulatory, light work; 2= ambulatory and capable of self care, but no any work activities; 3= capable of only limited self care; 4 = completely disabled, 5= dead"|Participants|Count of Participants|8|8.0||||||
3823296|NCT01735396|3649180|B1|||Number of prior systemic therapies||prior therapies|Median|3|3.0|Full Range|||1.0|4.0|
3823297|NCT01735396|3649180|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3823298|NCT01735396|3649180|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3823299|NCT01735396|3649180|B1|||Age||years|Median|66|66.0|Full Range|||54.0|78.0|
3823300|NCT01735214|3649189|B1||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
3823301|NCT01735214|3649189|B1||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3823302|NCT01735214|3649189|B1|81 to 90 years||Age, Customized||participants|Number|16|16.0||||||
3823303|NCT01735214|3649189|B1|71 to 80 years||Age, Customized||participants|Number|81|81.0||||||
3823304|NCT01735214|3649189|B1|61 to 70 years||Age, Customized||participants|Number|125|125.0||||||
3823305|NCT01735214|3649189|B1|51 to 60 years||Age, Customized||participants|Number|89|89.0||||||
3823306|NCT01735214|3649189|B1|41 to 50 years||Age, Customized||participants|Number|28|28.0||||||
3823307|NCT01735214|3649189|B1|31 to 40 years||Age, Customized||participants|Number|9|9.0||||||
3823308|NCT01735214|3649189|B1|18 to 30 years||Age, Customized||participants|Number|10|10.0||||||
3823309|NCT01735201|3649201|B9||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3823310|NCT01735201|3649202|B8||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3823311|NCT01735201|3649203|B7||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3823312|NCT01735201|3649204|B6||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3823313|NCT01735201|3649205|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3823314|NCT01735201|3649206|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3823315|NCT01735201|3649207|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3823316|NCT01735201|3649208|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3823317|NCT01735201|3649209|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3823318|NCT01735201|3649201|B9||Female|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
3823319|NCT01735201|3649202|B8||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3823320|NCT01735201|3649203|B7||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3823321|NCT01735201|3649204|B6||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3823322|NCT01735201|3649205|B5||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3823323|NCT01735201|3649206|B4||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3823324|NCT01735201|3649207|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3823325|NCT01735201|3649208|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3823326|NCT01735201|3649209|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3823327|NCT01735201|3649201|B9|>= 65 years||Age, Customized||Participants|Number|36|36.0||||||
3823328|NCT01735201|3649202|B8|>= 65 years||Age, Customized||Participants|Number|7|7.0||||||
3823329|NCT01735201|3649203|B7|>= 65 years||Age, Customized||Participants|Number|2|2.0||||||
3823330|NCT01735201|3649204|B6|>= 65 years||Age, Customized||Participants|Number|5|5.0||||||
3823331|NCT01735201|3649205|B5|>= 65 years||Age, Customized||Participants|Number|3|3.0||||||
3823332|NCT01735201|3649206|B4|>= 65 years||Age, Customized||Participants|Number|6|6.0||||||
3823333|NCT01735201|3649207|B3|>= 65 years||Age, Customized||Participants|Number|6|6.0||||||
3823334|NCT01735201|3649208|B2|>= 65 years||Age, Customized||Participants|Number|6|6.0||||||
3823335|NCT01735201|3649209|B1|>= 65 years||Age, Customized||Participants|Number|1|1.0||||||
3823336|NCT01735201|3649201|B9|45-64 years||Age, Customized||Participants|Number|215|215.0||||||
3823337|NCT01735201|3649202|B8|45-64 years||Age, Customized||Participants|Number|28|28.0||||||
3823338|NCT01735201|3649203|B7|45-64 years||Age, Customized||Participants|Number|27|27.0||||||
3823339|NCT01735201|3649204|B6|45-64 years||Age, Customized||Participants|Number|29|29.0||||||
3823340|NCT01735201|3649205|B5|45-64 years||Age, Customized||Participants|Number|26|26.0||||||
3823341|NCT01735201|3649206|B4|45-64 years||Age, Customized||Participants|Number|24|24.0||||||
3823342|NCT01735201|3649207|B3|45-64 years||Age, Customized||Participants|Number|28|28.0||||||
3823343|NCT01735201|3649208|B2|45-64 years||Age, Customized||Participants|Number|23|23.0||||||
3823344|NCT01735201|3649209|B1|45-64 years||Age, Customized||Participants|Number|30|30.0||||||
3823345|NCT01735201|3649201|B9|< 45 years||Age, Customized||Participants|Number|105|105.0||||||
3823346|NCT01735201|3649202|B8|< 45 years||Age, Customized||Participants|Number|9|9.0||||||
3823347|NCT01735201|3649203|B7|< 45 years||Age, Customized||Participants|Number|16|16.0||||||
3823348|NCT01735201|3649204|B6|< 45 years||Age, Customized||Participants|Number|11|11.0||||||
3823349|NCT01735201|3649205|B5|< 45 years||Age, Customized||Participants|Number|16|16.0||||||
3823350|NCT01735201|3649206|B4|< 45 years||Age, Customized||Participants|Number|14|14.0||||||
3823351|NCT01735201|3649207|B3|< 45 years||Age, Customized||Participants|Number|10|10.0||||||
3823352|NCT01735201|3649208|B2|< 45 years||Age, Customized||Participants|Number|15|15.0||||||
3823353|NCT01735201|3649209|B1|< 45 years||Age, Customized||Participants|Number|14|14.0||||||
3823354|NCT01735175|3649250|B3|1 (restricted in physically strenuous activity)||ECOG performance status|ECOG = Eastern Cooperative Oncology Group|Participants|Count of Participants|65|65.0||||||
3823355|NCT01735175|3649251|B2|1 (restricted in physically strenuous activity)||ECOG performance status|ECOG = Eastern Cooperative Oncology Group|Participants|Count of Participants|34|34.0||||||
3823356|NCT01735175|3649252|B1|1 (restricted in physically strenuous activity)||ECOG performance status|ECOG = Eastern Cooperative Oncology Group|Participants|Count of Participants|31|31.0||||||
3823357|NCT01735175|3649250|B3|0 (fully active)||ECOG performance status|ECOG = Eastern Cooperative Oncology Group|Participants|Count of Participants|251|251.0||||||
3823358|NCT01735175|3649251|B2|0 (fully active)||ECOG performance status|ECOG = Eastern Cooperative Oncology Group|Participants|Count of Participants|123|123.0||||||
3823359|NCT01735175|3649252|B1|0 (fully active)||ECOG performance status|ECOG = Eastern Cooperative Oncology Group|Participants|Count of Participants|128|128.0||||||
3823360|NCT01735175|3649250|B3|||Previous radiotherapy||Participants|Count of Participants|16|16.0||||||
3823361|NCT01735175|3649251|B2|||Previous radiotherapy||Participants|Count of Participants|9|9.0||||||
3823362|NCT01735175|3649252|B1|||Previous radiotherapy||Participants|Count of Participants|7|7.0||||||
3823363|NCT01735175|3649250|B3|||Previous breast cancer surgery||Participants|Count of Participants|295|295.0||||||
3823364|NCT01735175|3649251|B2|||Previous breast cancer surgery||Participants|Count of Participants|146|146.0||||||
3823365|NCT01735175|3649252|B1|||Previous breast cancer surgery||Participants|Count of Participants|149|149.0||||||
3823366|NCT01735175|3649250|B3|IV||Disease stage|TNM Disease stage was defined according to the American Joint Committee on Cancer (AJCC): (I) = T1 N0 M0 / T0 N1mi M0 / T1 N1mi M0; (II) = T0 N1 M0 / T1 N1 M0 / T2 N0 M0 / T2 N1 M0 / T3 N0 M0; (III) = T0 N2 M0 / T1 N2 M0 / T2 N2 M0 / T3 N1 M0 / T3 N2 M0 / T4 N0 M0 / T4 N1 M0 / T4 N2 M0 / AnyT N3 M0; (IV) = AnyT AnyN M1; T: size or direct extent of the primary tumour; N: degree of spread to regional lymph nodes; N1mi: Micrometastases (> 0.2 mm and/or > 200 cells, but none > 2.0 mm); M: presence of distant; https://www.cancer.gov/types/breast/hp/breast-treatment-pdq#link/_27|Participants|Count of Participants|3|3.0||||||
3823367|NCT01735175|3649251|B2|IV||Disease stage|TNM Disease stage was defined according to the American Joint Committee on Cancer (AJCC): (I) = T1 N0 M0 / T0 N1mi M0 / T1 N1mi M0; (II) = T0 N1 M0 / T1 N1 M0 / T2 N0 M0 / T2 N1 M0 / T3 N0 M0; (III) = T0 N2 M0 / T1 N2 M0 / T2 N2 M0 / T3 N1 M0 / T3 N2 M0 / T4 N0 M0 / T4 N1 M0 / T4 N2 M0 / AnyT N3 M0; (IV) = AnyT AnyN M1; T: size or direct extent of the primary tumour; N: degree of spread to regional lymph nodes; N1mi: Micrometastases (> 0.2 mm and/or > 200 cells, but none > 2.0 mm); M: presence of distant; https://www.cancer.gov/types/breast/hp/breast-treatment-pdq#link/_27|Participants|Count of Participants|3|3.0||||||
3823368|NCT01735175|3649252|B1|IV||Disease stage|TNM Disease stage was defined according to the American Joint Committee on Cancer (AJCC): (I) = T1 N0 M0 / T0 N1mi M0 / T1 N1mi M0; (II) = T0 N1 M0 / T1 N1 M0 / T2 N0 M0 / T2 N1 M0 / T3 N0 M0; (III) = T0 N2 M0 / T1 N2 M0 / T2 N2 M0 / T3 N1 M0 / T3 N2 M0 / T4 N0 M0 / T4 N1 M0 / T4 N2 M0 / AnyT N3 M0; (IV) = AnyT AnyN M1; T: size or direct extent of the primary tumour; N: degree of spread to regional lymph nodes; N1mi: Micrometastases (> 0.2 mm and/or > 200 cells, but none > 2.0 mm); M: presence of distant; https://www.cancer.gov/types/breast/hp/breast-treatment-pdq#link/_27|Participants|Count of Participants|0|0.0||||||
3823369|NCT01735175|3649250|B3|III||Disease stage|TNM Disease stage was defined according to the American Joint Committee on Cancer (AJCC): (I) = T1 N0 M0 / T0 N1mi M0 / T1 N1mi M0; (II) = T0 N1 M0 / T1 N1 M0 / T2 N0 M0 / T2 N1 M0 / T3 N0 M0; (III) = T0 N2 M0 / T1 N2 M0 / T2 N2 M0 / T3 N1 M0 / T3 N2 M0 / T4 N0 M0 / T4 N1 M0 / T4 N2 M0 / AnyT N3 M0; (IV) = AnyT AnyN M1; T: size or direct extent of the primary tumour; N: degree of spread to regional lymph nodes; N1mi: Micrometastases (> 0.2 mm and/or > 200 cells, but none > 2.0 mm); M: presence of distant; https://www.cancer.gov/types/breast/hp/breast-treatment-pdq#link/_27|Participants|Count of Participants|159|159.0||||||
3823370|NCT01735175|3649251|B2|III||Disease stage|TNM Disease stage was defined according to the American Joint Committee on Cancer (AJCC): (I) = T1 N0 M0 / T0 N1mi M0 / T1 N1mi M0; (II) = T0 N1 M0 / T1 N1 M0 / T2 N0 M0 / T2 N1 M0 / T3 N0 M0; (III) = T0 N2 M0 / T1 N2 M0 / T2 N2 M0 / T3 N1 M0 / T3 N2 M0 / T4 N0 M0 / T4 N1 M0 / T4 N2 M0 / AnyT N3 M0; (IV) = AnyT AnyN M1; T: size or direct extent of the primary tumour; N: degree of spread to regional lymph nodes; N1mi: Micrometastases (> 0.2 mm and/or > 200 cells, but none > 2.0 mm); M: presence of distant; https://www.cancer.gov/types/breast/hp/breast-treatment-pdq#link/_27|Participants|Count of Participants|78|78.0||||||
3823392|NCT01735175|3649252|B1||White|Race (NIH/OMB)|More than one race patients (n = 6) were of Mestizo or Parda origin.|Participants|Count of Participants|129|129.0||||||
3823393|NCT01735175|3649250|B3||Black or African American|Race (NIH/OMB)|More than one race patients (n = 6) were of Mestizo or Parda origin.|Participants|Count of Participants|0|0.0||||||
3823371|NCT01735175|3649252|B1|III||Disease stage|TNM Disease stage was defined according to the American Joint Committee on Cancer (AJCC): (I) = T1 N0 M0 / T0 N1mi M0 / T1 N1mi M0; (II) = T0 N1 M0 / T1 N1 M0 / T2 N0 M0 / T2 N1 M0 / T3 N0 M0; (III) = T0 N2 M0 / T1 N2 M0 / T2 N2 M0 / T3 N1 M0 / T3 N2 M0 / T4 N0 M0 / T4 N1 M0 / T4 N2 M0 / AnyT N3 M0; (IV) = AnyT AnyN M1; T: size or direct extent of the primary tumour; N: degree of spread to regional lymph nodes; N1mi: Micrometastases (> 0.2 mm and/or > 200 cells, but none > 2.0 mm); M: presence of distant; https://www.cancer.gov/types/breast/hp/breast-treatment-pdq#link/_27|Participants|Count of Participants|81|81.0||||||
3823372|NCT01735175|3649250|B3|II||Disease stage|TNM Disease stage was defined according to the American Joint Committee on Cancer (AJCC): (I) = T1 N0 M0 / T0 N1mi M0 / T1 N1mi M0; (II) = T0 N1 M0 / T1 N1 M0 / T2 N0 M0 / T2 N1 M0 / T3 N0 M0; (III) = T0 N2 M0 / T1 N2 M0 / T2 N2 M0 / T3 N1 M0 / T3 N2 M0 / T4 N0 M0 / T4 N1 M0 / T4 N2 M0 / AnyT N3 M0; (IV) = AnyT AnyN M1; T: size or direct extent of the primary tumour; N: degree of spread to regional lymph nodes; N1mi: Micrometastases (> 0.2 mm and/or > 200 cells, but none > 2.0 mm); M: presence of distant; https://www.cancer.gov/types/breast/hp/breast-treatment-pdq#link/_27|Participants|Count of Participants|147|147.0||||||
3823373|NCT01735175|3649251|B2|II||Disease stage|TNM Disease stage was defined according to the American Joint Committee on Cancer (AJCC): (I) = T1 N0 M0 / T0 N1mi M0 / T1 N1mi M0; (II) = T0 N1 M0 / T1 N1 M0 / T2 N0 M0 / T2 N1 M0 / T3 N0 M0; (III) = T0 N2 M0 / T1 N2 M0 / T2 N2 M0 / T3 N1 M0 / T3 N2 M0 / T4 N0 M0 / T4 N1 M0 / T4 N2 M0 / AnyT N3 M0; (IV) = AnyT AnyN M1; T: size or direct extent of the primary tumour; N: degree of spread to regional lymph nodes; N1mi: Micrometastases (> 0.2 mm and/or > 200 cells, but none > 2.0 mm); M: presence of distant; https://www.cancer.gov/types/breast/hp/breast-treatment-pdq#link/_27|Participants|Count of Participants|73|73.0||||||
3823374|NCT01735175|3649252|B1|II||Disease stage|TNM Disease stage was defined according to the American Joint Committee on Cancer (AJCC): (I) = T1 N0 M0 / T0 N1mi M0 / T1 N1mi M0; (II) = T0 N1 M0 / T1 N1 M0 / T2 N0 M0 / T2 N1 M0 / T3 N0 M0; (III) = T0 N2 M0 / T1 N2 M0 / T2 N2 M0 / T3 N1 M0 / T3 N2 M0 / T4 N0 M0 / T4 N1 M0 / T4 N2 M0 / AnyT N3 M0; (IV) = AnyT AnyN M1; T: size or direct extent of the primary tumour; N: degree of spread to regional lymph nodes; N1mi: Micrometastases (> 0.2 mm and/or > 200 cells, but none > 2.0 mm); M: presence of distant; https://www.cancer.gov/types/breast/hp/breast-treatment-pdq#link/_27|Participants|Count of Participants|74|74.0||||||
3823375|NCT01735175|3649250|B3|I||Disease stage|TNM Disease stage was defined according to the American Joint Committee on Cancer (AJCC): (I) = T1 N0 M0 / T0 N1mi M0 / T1 N1mi M0; (II) = T0 N1 M0 / T1 N1 M0 / T2 N0 M0 / T2 N1 M0 / T3 N0 M0; (III) = T0 N2 M0 / T1 N2 M0 / T2 N2 M0 / T3 N1 M0 / T3 N2 M0 / T4 N0 M0 / T4 N1 M0 / T4 N2 M0 / AnyT N3 M0; (IV) = AnyT AnyN M1; T: size or direct extent of the primary tumour; N: degree of spread to regional lymph nodes; N1mi: Micrometastases (> 0.2 mm and/or > 200 cells, but none > 2.0 mm); M: presence of distant; https://www.cancer.gov/types/breast/hp/breast-treatment-pdq#link/_27|Participants|Count of Participants|7|7.0||||||
3823376|NCT01735175|3649251|B2|I||Disease stage|TNM Disease stage was defined according to the American Joint Committee on Cancer (AJCC): (I) = T1 N0 M0 / T0 N1mi M0 / T1 N1mi M0; (II) = T0 N1 M0 / T1 N1 M0 / T2 N0 M0 / T2 N1 M0 / T3 N0 M0; (III) = T0 N2 M0 / T1 N2 M0 / T2 N2 M0 / T3 N1 M0 / T3 N2 M0 / T4 N0 M0 / T4 N1 M0 / T4 N2 M0 / AnyT N3 M0; (IV) = AnyT AnyN M1; T: size or direct extent of the primary tumour; N: degree of spread to regional lymph nodes; N1mi: Micrometastases (> 0.2 mm and/or > 200 cells, but none > 2.0 mm); M: presence of distant; https://www.cancer.gov/types/breast/hp/breast-treatment-pdq#link/_27|Participants|Count of Participants|3|3.0||||||
3823377|NCT01735175|3649252|B1|I||Disease stage|TNM Disease stage was defined according to the American Joint Committee on Cancer (AJCC): (I) = T1 N0 M0 / T0 N1mi M0 / T1 N1mi M0; (II) = T0 N1 M0 / T1 N1 M0 / T2 N0 M0 / T2 N1 M0 / T3 N0 M0; (III) = T0 N2 M0 / T1 N2 M0 / T2 N2 M0 / T3 N1 M0 / T3 N2 M0 / T4 N0 M0 / T4 N1 M0 / T4 N2 M0 / AnyT N3 M0; (IV) = AnyT AnyN M1; T: size or direct extent of the primary tumour; N: degree of spread to regional lymph nodes; N1mi: Micrometastases (> 0.2 mm and/or > 200 cells, but none > 2.0 mm); M: presence of distant; https://www.cancer.gov/types/breast/hp/breast-treatment-pdq#link/_27|Participants|Count of Participants|4|4.0||||||
3823378|NCT01735175|3649250|B3|||Time since diagnosis|For 4 patients in the LA-EP2006 treatment group, time since initial diagnosis was > 12 months. It was confirmed by the respective study site that the patients had not received treatment between diagnosis and study entry.|months|Median|1.38|1.38|Full Range|||0.1|76.0|
3823379|NCT01735175|3649251|B2|||Time since diagnosis|For 4 patients in the LA-EP2006 treatment group, time since initial diagnosis was > 12 months. It was confirmed by the respective study site that the patients had not received treatment between diagnosis and study entry.|months|Median|1.38|1.38|Full Range|||0.2|10.9|
3823380|NCT01735175|3649252|B1|||Time since diagnosis|For 4 patients in the LA-EP2006 treatment group, time since initial diagnosis was > 12 months. It was confirmed by the respective study site that the patients had not received treatment between diagnosis and study entry.|months|Median|1.35|1.35|Full Range|||0.1|76.0|
3823381|NCT01735175|3649250|B3|||BMI||kg/m^2|Mean|27.45|27.45|Standard Deviation|26.40|26.4|||
3823382|NCT01735175|3649251|B2|||BMI||kg/m^2|Mean|27.44|27.44|Standard Deviation|26.35|26.35|||
3823383|NCT01735175|3649252|B1|||BMI||kg/m^2|Mean|27.47|27.47|Standard Deviation|26.76|26.76|||
3823384|NCT01735175|3649250|B3||Unknown or Not Reported|Race (NIH/OMB)|More than one race patients (n = 6) were of Mestizo or Parda origin.|Participants|Count of Participants|0|0.0||||||
3823385|NCT01735175|3649251|B2||Unknown or Not Reported|Race (NIH/OMB)|More than one race patients (n = 6) were of Mestizo or Parda origin.|Participants|Count of Participants|0|0.0||||||
3823386|NCT01735175|3649252|B1||Unknown or Not Reported|Race (NIH/OMB)|More than one race patients (n = 6) were of Mestizo or Parda origin.|Participants|Count of Participants|0|0.0||||||
3823387|NCT01735175|3649250|B3||More than one race|Race (NIH/OMB)|More than one race patients (n = 6) were of Mestizo or Parda origin.|Participants|Count of Participants|6|6.0||||||
3823388|NCT01735175|3649251|B2||More than one race|Race (NIH/OMB)|More than one race patients (n = 6) were of Mestizo or Parda origin.|Participants|Count of Participants|4|4.0||||||
3823389|NCT01735175|3649252|B1||More than one race|Race (NIH/OMB)|More than one race patients (n = 6) were of Mestizo or Parda origin.|Participants|Count of Participants|2|2.0||||||
3823390|NCT01735175|3649250|B3||White|Race (NIH/OMB)|More than one race patients (n = 6) were of Mestizo or Parda origin.|Participants|Count of Participants|256|256.0||||||
3823391|NCT01735175|3649251|B2||White|Race (NIH/OMB)|More than one race patients (n = 6) were of Mestizo or Parda origin.|Participants|Count of Participants|127|127.0||||||
3823394|NCT01735175|3649251|B2||Black or African American|Race (NIH/OMB)|More than one race patients (n = 6) were of Mestizo or Parda origin.|Participants|Count of Participants|0|0.0||||||
3823395|NCT01735175|3649252|B1||Black or African American|Race (NIH/OMB)|More than one race patients (n = 6) were of Mestizo or Parda origin.|Participants|Count of Participants|0|0.0||||||
3823396|NCT01735175|3649250|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|More than one race patients (n = 6) were of Mestizo or Parda origin.|Participants|Count of Participants|0|0.0||||||
3823397|NCT01735175|3649251|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|More than one race patients (n = 6) were of Mestizo or Parda origin.|Participants|Count of Participants|0|0.0||||||
3823398|NCT01735175|3649252|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|More than one race patients (n = 6) were of Mestizo or Parda origin.|Participants|Count of Participants|0|0.0||||||
3823399|NCT01735175|3649250|B3||Asian|Race (NIH/OMB)|More than one race patients (n = 6) were of Mestizo or Parda origin.|Participants|Count of Participants|54|54.0||||||
3823400|NCT01735175|3649251|B2||Asian|Race (NIH/OMB)|More than one race patients (n = 6) were of Mestizo or Parda origin.|Participants|Count of Participants|26|26.0||||||
3823401|NCT01735175|3649252|B1||Asian|Race (NIH/OMB)|More than one race patients (n = 6) were of Mestizo or Parda origin.|Participants|Count of Participants|28|28.0||||||
3823402|NCT01735175|3649250|B3||American Indian or Alaska Native|Race (NIH/OMB)|More than one race patients (n = 6) were of Mestizo or Parda origin.|Participants|Count of Participants|0|0.0||||||
3823403|NCT01735175|3649251|B2||American Indian or Alaska Native|Race (NIH/OMB)|More than one race patients (n = 6) were of Mestizo or Parda origin.|Participants|Count of Participants|0|0.0||||||
3823404|NCT01735175|3649252|B1||American Indian or Alaska Native|Race (NIH/OMB)|More than one race patients (n = 6) were of Mestizo or Parda origin.|Participants|Count of Participants|0|0.0||||||
3823405|NCT01735175|3649250|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823406|NCT01735175|3649251|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823407|NCT01735175|3649252|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823408|NCT01735175|3649250|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|287|287.0||||||
3823409|NCT01735175|3649251|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|139|139.0||||||
3823410|NCT01735175|3649252|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|148|148.0||||||
3823411|NCT01735175|3649250|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3823412|NCT01735175|3649251|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3823413|NCT01735175|3649252|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3823414|NCT01735175|3649250|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3823415|NCT01735175|3649251|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3823416|NCT01735175|3649252|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3823417|NCT01735175|3649250|B3||Female|Sex: Female, Male||Participants|Count of Participants|316|316.0||||||
3823418|NCT01735175|3649251|B2||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3823419|NCT01735175|3649252|B1||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
3823420|NCT01735175|3649250|B3|||Age||years|Mean|50.2|50.2|Standard Deviation|10.20|10.2|||
3823421|NCT01735175|3649251|B2|||Age||years|Mean|50.5|50.5|Standard Deviation|10.87|10.87|||
3823422|NCT01735175|3649252|B1|||Age||years|Mean|49.9|49.9|Standard Deviation|9.53|9.53|||
3823423|NCT01734993|3649273|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3823424|NCT01734993|3649273|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3823425|NCT01734993|3649273|B1|||Age||years|Mean|63.91|63.91|Standard Deviation|11.96|11.96|||
3823426|NCT01734889|3649299|B1|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
3823427|NCT01734889|3649299|B1|Germany||Region of Enrollment||participants|Number|4|4.0||||||
3823428|NCT01734889|3649299|B1|France||Region of Enrollment||participants|Number|2|2.0||||||
3823429|NCT01734889|3649299|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3823430|NCT01734889|3649299|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3823431|NCT01734889|3649299|B1|||Age||years|Mean|8.03|8.03|Standard Deviation|5.60|5.6|||
3823432|NCT01734889|3649299|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3823433|NCT01734889|3649299|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3823434|NCT01734889|3649299|B1||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
3823435|NCT01734785|3649307|B4||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
3823436|NCT01734785|3649308|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3823437|NCT01734785|3649309|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3823438|NCT01734785|3649310|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3823439|NCT01734785|3649307|B4||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3823440|NCT01734785|3649308|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3823441|NCT01734785|3649309|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3823442|NCT01734785|3649310|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3823443|NCT01734785|3649307|B4|||Age||Years|Mean|55.2|55.2|Standard Deviation|9.7|9.7|||
3823444|NCT01734785|3649308|B3|||Age||Years|Mean|55.9|55.9|Standard Deviation|9.6|9.6|||
3823445|NCT01734785|3649309|B2|||Age||Years|Mean|54.3|54.3|Standard Deviation|9.5|9.5|||
3823446|NCT01734785|3649310|B1|||Age||Years|Mean|55.4|55.4|Standard Deviation|9.9|9.9|||
3823447|NCT01734772|3649328|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3823448|NCT01734772|3649329|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3823449|NCT01734772|3649330|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3823450|NCT01734772|3649328|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3823451|NCT01734772|3649329|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3823452|NCT01734772|3649330|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3823453|NCT01734772|3649328|B3|||Age||years|Mean|28.3|28.3|Standard Deviation|7.15|7.15|||
3823454|NCT01734772|3649329|B2|||Age||years|Mean|28.6|28.6|Standard Deviation|7.1|7.1|||
3823455|NCT01734772|3649330|B1|||Age||years|Mean|28.0|28.0|Standard Deviation|7.2|7.2|||
3823456|NCT01734746|3649348|B1|Netherlands||Region of Enrollment||participants|Number|21|21.0||||||
3823457|NCT01734746|3649348|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3823458|NCT01734746|3649348|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3823459|NCT01734746|3649348|B1|||Age|Ages (continuous) of participants at the time of surgery.|years|Mean|58.6|58.6|Full Range|||22.0|75.0|
3823460|NCT01734746|3649348|B1||>=65 years|Age|Age (categorical) of participants at the time of surgery.;|Participants|Count of Participants|10|10.0||||||
3823461|NCT01734746|3649348|B1||Between 18 and 65 years|Age|Age (categorical) of participants at the time of surgery.;|Participants|Count of Participants|12|12.0||||||
3823462|NCT01734746|3649348|B1||<=18 years|Age|Age (categorical) of participants at the time of surgery.;|Participants|Count of Participants|0|0.0||||||
3823463|NCT01734655|3649354|B1|||Current Body Weight||kg|Mean|86.5|86.5|Standard Deviation|14.9|14.9|||
3823464|NCT01734655|3649354|B1|||Current BMI||kg/m2|Mean|31.8|31.8|Standard Deviation|4.7|4.7|||
3823465|NCT01734655|3649354|B1|||Gestational Age||weeks|Mean|19.9|19.9|Standard Deviation|8.3|8.3|||
3823466|NCT01734655|3649354|B1|||Pre-pregnancy Body Weight||kg|Mean|83.5|83.5|Standard Deviation|17.6|17.6|||
3823467|NCT01734655|3649354|B1|||Pre-pregnancy BMI||kg/m2|Mean|30.0|30.0|Standard Deviation|4.1|4.1|||
3823468|NCT01734655|3649354|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3823469|NCT01734655|3649354|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3823470|NCT01734655|3649354|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3823471|NCT01734655|3649354|B1|||Age||years|Mean|30|30.0|Standard Deviation|4|4.0|||
3823472|NCT01734551|3649363|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
3823473|NCT01734551|3649364|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3823474|NCT01734551|3649365|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3823475|NCT01734551|3649363|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3823476|NCT01734551|3649364|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3823477|NCT01734551|3649365|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3823478|NCT01734551|3649363|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3823479|NCT01734551|3649364|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3823480|NCT01734551|3649365|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3823481|NCT01734551|3649363|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3823482|NCT01734551|3649364|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3823483|NCT01734551|3649365|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3823484|NCT01734551|3649363|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3823485|NCT01734551|3649364|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3823486|NCT01734551|3649365|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3823487|NCT01734551|3649363|B3||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
3823488|NCT01734551|3649364|B2||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
3823489|NCT01734551|3649365|B1||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
3823490|NCT01734434|3649378|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3823491|NCT01734434|3649379|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3823492|NCT01734434|3649380|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3823493|NCT01734434|3649381|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3823494|NCT01734434|3649382|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3823495|NCT01734434|3649378|B5||Female|Sex: Female, Male||Participants|Count of Participants|3240|3240.0||||||
3823496|NCT01734434|3649379|B4||Female|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
3823497|NCT01734434|3649380|B3||Female|Sex: Female, Male||Participants|Count of Participants|1989|1989.0||||||
3823498|NCT01734434|3649381|B2||Female|Sex: Female, Male||Participants|Count of Participants|500|500.0||||||
3823499|NCT01734434|3649382|B1||Female|Sex: Female, Male||Participants|Count of Participants|500|500.0||||||
3823500|NCT01734434|3649378|B5|||Age||Years|Mean|26.19|26.19|Standard Deviation|5.99|5.99|||
3823501|NCT01734434|3649379|B4|||Age||Years|Mean|25.01|25.01|Standard Deviation|6.26|6.26|||
3823502|NCT01734434|3649380|B3|||Age||Years|Mean|27.05|27.05|Standard Deviation|6.05|6.05|||
3823503|NCT01734434|3649381|B2|||Age||Years|Mean|25.08|25.08|Standard Deviation|5.65|5.65|||
3823504|NCT01734434|3649382|B1|||Age||Years|Mean|24.49|24.49|Standard Deviation|5.28|5.28|||
3823551|NCT01733953|3649443|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3823552|NCT01733953|3649444|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3823553|NCT01733953|3649442|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3823554|NCT01733953|3649443|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3823505|NCT01734395|3649407|B1|Mild dementia||Severity of symptoms of dementia|Dementia is a general term for a decline in mental ability severe enough to interfere with daily life. Some of the most common form of dementia is Alzheimer's disease. The severity of dementia is divided as: (1) Suspected dementia (it is also named as Pre-dementia - often mistakenly attributed to ageing or stress), (2) Mild dementia, (3) Moderate dementia, (4) Sever dementia, and (5) Late (very severe) dementia.|Participants|Number|598|598.0||||||
3823506|NCT01734395|3649407|B1|Late (very severe) dementia||Severity of symptoms of dementia|Dementia is a general term for a decline in mental ability severe enough to interfere with daily life. Some of the most common form of dementia is Alzheimer's disease. The severity of dementia is divided as: (1) Suspected dementia (it is also named as Pre-dementia - often mistakenly attributed to ageing or stress), (2) Mild dementia, (3) Moderate dementia, (4) Sever dementia, and (5) Late (very severe) dementia.|Participants|Number|6|6.0||||||
3823507|NCT01734395|3649407|B1|Severe dementia||Severity of symptoms of dementia|Dementia is a general term for a decline in mental ability severe enough to interfere with daily life. Some of the most common form of dementia is Alzheimer's disease. The severity of dementia is divided as: (1) Suspected dementia (it is also named as Pre-dementia - often mistakenly attributed to ageing or stress), (2) Mild dementia, (3) Moderate dementia, (4) Sever dementia, and (5) Late (very severe) dementia.|Participants|Number|94|94.0||||||
3823508|NCT01734395|3649407|B1|Moderate dementia||Severity of symptoms of dementia|Dementia is a general term for a decline in mental ability severe enough to interfere with daily life. Some of the most common form of dementia is Alzheimer's disease. The severity of dementia is divided as: (1) Suspected dementia (it is also named as Pre-dementia - often mistakenly attributed to ageing or stress), (2) Mild dementia, (3) Moderate dementia, (4) Sever dementia, and (5) Late (very severe) dementia.|Participants|Number|668|668.0||||||
3823509|NCT01734395|3649407|B1|Suspected dementia||Severity of symptoms of dementia|Dementia is a general term for a decline in mental ability severe enough to interfere with daily life. Some of the most common form of dementia is Alzheimer's disease. The severity of dementia is divided as: (1) Suspected dementia (it is also named as Pre-dementia - often mistakenly attributed to ageing or stress), (2) Mild dementia, (3) Moderate dementia, (4) Sever dementia, and (5) Late (very severe) dementia.|Participants|Number|27|27.0||||||
3823510|NCT01734395|3649407|B1||Male|Sex: Female, Male||Participants|Count of Participants|498|498.0||||||
3823511|NCT01734395|3649407|B1||Female|Sex: Female, Male||Participants|Count of Participants|895|895.0||||||
3823512|NCT01734395|3649407|B1|||Age||Years|Mean|74.11|74.11|Standard Deviation|8.80|8.8|||
3823513|NCT01734317|3649413|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3823514|NCT01734317|3649413|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3823515|NCT01734317|3649413|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3823516|NCT01734317|3649413|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|18.7|18.7|||
3823517|NCT01734317|3649413|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3823518|NCT01734317|3649413|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3823519|NCT01734317|3649413|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3823520|NCT01734239|3649417|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3823521|NCT01734239|3649418|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3823522|NCT01734239|3649419|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3823523|NCT01734239|3649417|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3823524|NCT01734239|3649418|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3823525|NCT01734239|3649419|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3823526|NCT01734239|3649417|B3|||Age||Years|Mean|40.4|40.4|Standard Deviation|23.1|23.1|||
3823527|NCT01734239|3649418|B2|||Age||Years|Mean|60.4|60.4|Standard Deviation|7.7|7.7|||
3823528|NCT01734239|3649419|B1|||Age||Years|Mean|21.2|21.2|Standard Deviation|15.3|15.3|||
3823529|NCT01734161|3649433|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3823530|NCT01734161|3649434|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3823531|NCT01734161|3649435|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3823532|NCT01734161|3649433|B3||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3823533|NCT01734161|3649434|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3823534|NCT01734161|3649435|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3823535|NCT01734161|3649433|B3|||Age||years|Mean|35.5|35.5|Standard Deviation|4.5|4.5|||
3823536|NCT01734161|3649434|B2|||Age||years|Mean|35.7|35.7|Standard Deviation|3.7|3.7|||
3823537|NCT01734161|3649435|B1|||Age||years|Mean|35.2|35.2|Standard Deviation|5.2|5.2|||
3823538|NCT01733953|3649442|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
3823539|NCT01733953|3649443|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3823540|NCT01733953|3649444|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3823541|NCT01733953|3649442|B3||Male|Gender||Participants|Count of Participants|14|14.0||||||
3823542|NCT01733953|3649443|B2||Male|Gender||Participants|Count of Participants|8|8.0||||||
3823543|NCT01733953|3649444|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
3823544|NCT01733953|3649442|B3||Female|Gender||Participants|Count of Participants|13|13.0||||||
3823545|NCT01733953|3649443|B2||Female|Gender||Participants|Count of Participants|5|5.0||||||
3823546|NCT01733953|3649444|B1||Female|Gender||Participants|Count of Participants|8|8.0||||||
3823547|NCT01733953|3649442|B3|||Age||years|Mean|26.8|26.8|Standard Deviation|6.2|6.2|||
3823548|NCT01733953|3649443|B2|||Age||years|Mean|26.9|26.9|Standard Deviation|6.9|6.9|||
3823549|NCT01733953|3649444|B1|||Age||years|Mean|26.6|26.6|Standard Deviation|5.7|5.7|||
3823550|NCT01733953|3649442|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3823555|NCT01733953|3649444|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3823556|NCT01733953|3649442|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3823557|NCT01733953|3649443|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3823558|NCT01733953|3649444|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3823559|NCT01733758|3649461|B5|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|490|490.0||||||
3823560|NCT01733758|3649462|B4|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|103|103.0||||||
3823561|NCT01733758|3649463|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|150|150.0||||||
3823562|NCT01733758|3649464|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|160|160.0||||||
3823563|NCT01733758|3649465|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|77|77.0||||||
3823564|NCT01733758|3649461|B5||Male|Sex: Female, Male||Participants|Count of Participants|372|372.0||||||
3823565|NCT01733758|3649462|B4||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3823566|NCT01733758|3649463|B3||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3823567|NCT01733758|3649464|B2||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3823568|NCT01733758|3649465|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3823569|NCT01733758|3649461|B5||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3823570|NCT01733758|3649462|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3823571|NCT01733758|3649463|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3823572|NCT01733758|3649464|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3823573|NCT01733758|3649465|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3823574|NCT01733758|3649461|B5|||Age||Years|Mean|58.4|58.4|Standard Deviation|9.70|9.7|||
3823575|NCT01733758|3649462|B4|||Age||Years|Mean|58.4|58.4|Standard Deviation|9.72|9.72|||
3823576|NCT01733758|3649463|B3|||Age||Years|Mean|57.7|57.7|Standard Deviation|9.51|9.51|||
3823577|NCT01733758|3649464|B2|||Age||Years|Mean|59.6|59.6|Standard Deviation|9.00|9.0|||
3823578|NCT01733758|3649465|B1|||Age||Years|Mean|57.3|57.3|Standard Deviation|11.27|11.27|||
3823579|NCT01733745|3649519|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3823580|NCT01733745|3649520|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3823581|NCT01733745|3649521|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3823582|NCT01733745|3649519|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3823583|NCT01733745|3649520|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3823584|NCT01733745|3649521|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3823585|NCT01733745|3649519|B3|||Age||years|Mean|41.7|41.7|Standard Deviation|19.8|19.8|||
3823586|NCT01733745|3649520|B2|||Age||years|Mean|45.4|45.4|Standard Deviation|19.8|19.8|||
3823587|NCT01733745|3649521|B1|||Age||years|Mean|38.1|38.1|Standard Deviation|19.9|19.9|||
3823588|NCT01733732|3649532|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3823589|NCT01733732|3649533|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3823590|NCT01733732|3649534|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3823591|NCT01733732|3649532|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3823592|NCT01733732|3649533|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3823593|NCT01733732|3649534|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3823594|NCT01733732|3649532|B3|||Age||years|Mean|63.0|63.0|Standard Deviation|13.6|13.6|||
3823595|NCT01733732|3649533|B2|||Age||years|Mean|63.8|63.8|Standard Deviation|12.8|12.8|||
3823596|NCT01733732|3649534|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|14.5|14.5|||
3823597|NCT01733680|3649569|B3|||CGI|"Clinical Global Impressions (CGI)~Normal, not at all ill~Borderline mentally ill~Mildly ill~Moderately ill~Markedly ill~Severely ill~Among the most extremely ill patients"|units on a scale|Mean|4.33|4.33|Full Range|||4.0|5.0|
3823598|NCT01733680|3649570|B2|||CGI|"Clinical Global Impressions (CGI)~Normal, not at all ill~Borderline mentally ill~Mildly ill~Moderately ill~Markedly ill~Severely ill~Among the most extremely ill patients"|units on a scale|Mean|5|5.0|Full Range|||5.0|5.0|
3823599|NCT01733680|3649571|B1|||CGI|"Clinical Global Impressions (CGI)~Normal, not at all ill~Borderline mentally ill~Mildly ill~Moderately ill~Markedly ill~Severely ill~Among the most extremely ill patients"|units on a scale|Mean|4.0|4.0|Full Range|||4.0|4.0|
3823600|NCT01733680|3649569|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3823601|NCT01733680|3649570|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3823602|NCT01733680|3649571|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3823603|NCT01733680|3649569|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823604|NCT01733680|3649570|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823605|NCT01733680|3649571|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823606|NCT01733680|3649569|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823607|NCT01733680|3649570|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823608|NCT01733680|3649571|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823609|NCT01733680|3649569|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3823610|NCT01733680|3649570|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3823611|NCT01733680|3649571|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3823612|NCT01733680|3649569|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823613|NCT01733680|3649570|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823614|NCT01733680|3649571|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823615|NCT01733680|3649569|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823616|NCT01733680|3649570|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823617|NCT01733680|3649571|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823618|NCT01733680|3649569|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823619|NCT01733680|3649570|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823620|NCT01733680|3649571|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823621|NCT01733680|3649569|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823622|NCT01733680|3649570|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823623|NCT01733680|3649571|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823624|NCT01733680|3649569|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823625|NCT01733680|3649570|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823626|NCT01733680|3649571|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823627|NCT01733680|3649569|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3823628|NCT01733680|3649570|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3823629|NCT01733680|3649571|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3823630|NCT01733680|3649569|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823631|NCT01733680|3649570|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823632|NCT01733680|3649571|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823633|NCT01733680|3649569|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3823634|NCT01733680|3649570|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3823635|NCT01733680|3649571|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3823636|NCT01733680|3649569|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3823637|NCT01733680|3649570|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3823638|NCT01733680|3649571|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3823639|NCT01733680|3649569|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3823640|NCT01733680|3649570|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3823641|NCT01733680|3649571|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3823642|NCT01733680|3649569|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3823643|NCT01733680|3649570|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3823644|NCT01733680|3649571|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3823645|NCT01733680|3649569|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3823646|NCT01733680|3649570|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3823647|NCT01733680|3649571|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3823648|NCT01733407|3649582|B3|||Charcot-Marie-Tooth Neuropathy Score|The Charcot Marie Tooth Neuropathy Score (CMTNS) is a 36-point composite scoring assessment that assesses disease severity in neuropathies. It is composed of 9 items that evaluate functions related to disease progression including assessing sensory symptoms, motor symptoms, pinprick sensibility, vibration, leg strength, arm strength, and nerve conduction tests. Each item is scored from 0 to 4 with the lower scores representing less severe symptoms and higher scores representing more severe symptoms.The individual item scores are then totaled to provide a global measure of disease severity|scores on a scale|Mean|22.6|22.6|Standard Deviation|8.6|8.6|||
3823649|NCT01733407|3649583|B2|||Charcot-Marie-Tooth Neuropathy Score|The Charcot Marie Tooth Neuropathy Score (CMTNS) is a 36-point composite scoring assessment that assesses disease severity in neuropathies. It is composed of 9 items that evaluate functions related to disease progression including assessing sensory symptoms, motor symptoms, pinprick sensibility, vibration, leg strength, arm strength, and nerve conduction tests. Each item is scored from 0 to 4 with the lower scores representing less severe symptoms and higher scores representing more severe symptoms.The individual item scores are then totaled to provide a global measure of disease severity|scores on a scale|Mean|20.6|20.6|Standard Deviation|10.0|10.0|||
3823650|NCT01733407|3649584|B1|||Charcot-Marie-Tooth Neuropathy Score|The Charcot Marie Tooth Neuropathy Score (CMTNS) is a 36-point composite scoring assessment that assesses disease severity in neuropathies. It is composed of 9 items that evaluate functions related to disease progression including assessing sensory symptoms, motor symptoms, pinprick sensibility, vibration, leg strength, arm strength, and nerve conduction tests. Each item is scored from 0 to 4 with the lower scores representing less severe symptoms and higher scores representing more severe symptoms.The individual item scores are then totaled to provide a global measure of disease severity|scores on a scale|Mean|24.6|24.6|Standard Deviation|7.0|7.0|||
3823651|NCT01733407|3649582|B3|Canada||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3823652|NCT01733407|3649583|B2|Canada||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3823653|NCT01733407|3649584|B1|Canada||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3823654|NCT01733407|3649582|B3|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3823655|NCT01733407|3649583|B2|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3823656|NCT01733407|3649584|B1|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3823657|NCT01733407|3649582|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823658|NCT01733407|3649583|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823659|NCT01733407|3649584|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823660|NCT01733407|3649582|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823661|NCT01733407|3649583|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823662|NCT01733407|3649584|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823663|NCT01733407|3649582|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3823664|NCT01733407|3649583|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3823665|NCT01733407|3649584|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3823666|NCT01733407|3649582|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823667|NCT01733407|3649583|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823668|NCT01733407|3649584|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823669|NCT01733407|3649582|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823670|NCT01733407|3649583|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823671|NCT01733407|3649584|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823672|NCT01733407|3649582|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823673|NCT01733407|3649583|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823674|NCT01733407|3649584|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823675|NCT01733407|3649582|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823676|NCT01733407|3649583|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823677|NCT01733407|3649584|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3823678|NCT01733407|3649582|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3823679|NCT01733407|3649583|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3823680|NCT01733407|3649584|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3823681|NCT01733407|3649582|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3823682|NCT01733407|3649583|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3823683|NCT01733407|3649584|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3823684|NCT01733407|3649582|B3|||Age||years|Mean|47.8|47.8|Standard Deviation|14.0|14.0|||
3823685|NCT01733407|3649583|B2|||Age||years|Mean|45.8|45.8|Standard Deviation|11.0|11.0|||
3823686|NCT01733407|3649584|B1|||Age||years|Mean|49.9|49.9|Standard Deviation|16.9|16.9|||
3823687|NCT01733407|3649582|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3823688|NCT01733407|3649583|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3823689|NCT01733407|3649584|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3823690|NCT01733407|3649582|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3823691|NCT01733407|3649583|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3823692|NCT01733407|3649584|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3823693|NCT01733407|3649582|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3823694|NCT01733407|3649583|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3823695|NCT01733407|3649584|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3823696|NCT01733368|3649601|B1|||Left Ventricular End Systolic Volume (LVESV)||milliliters (ml)|Mean|155.17|155.17|Standard Deviation|75.10|75.1|||
3823697|NCT01733368|3649601|B1|||Ejection Fraction (EF)||percentage (%)|Mean|26.87|26.87|Standard Deviation|7.38|7.38|||
3823698|NCT01733368|3649601|B1||Unknown|QRS Morphology||Participants|Count of Participants|2|2.0||||||
3823699|NCT01733368|3649601|B1||Interventricular Conduction Delay (IVCD)|QRS Morphology||Participants|Count of Participants|8|8.0||||||
3823700|NCT01733368|3649601|B1||Right Bundle Branch Block (RBBB)|QRS Morphology||Participants|Count of Participants|20|20.0||||||
3823701|NCT01733368|3649601|B1||Left Bundle Branch Block (LBBB)|QRS Morphology||Participants|Count of Participants|168|168.0||||||
3823702|NCT01733368|3649601|B1|||QRS Duration||miliseconds (ms)|Mean|168|168.0|Standard Deviation|22.22|22.22|||
3823703|NCT01733368|3649601|B1||Non-ischemic|Cardiovascular Etiology: Ischemic, Non-ischemic||Participants|Count of Participants|118|118.0||||||
3823704|NCT01733368|3649601|B1||Ischemic|Cardiovascular Etiology: Ischemic, Non-ischemic||Participants|Count of Participants|80|80.0||||||
3823705|NCT01733368|3649601|B1||NYHA IV|New York Heart Association (NYHA) Classification|"The NYHA Functional Classification provides a simple way of classifying the extent of heart failure:~I Cardiac disease, but no symptoms and no limitation in ordinary physical activity.~II Mild symptoms and slight limitation during ordinary activity. III Marked limitation in activity due to symptoms, even during less-than-ordinary activity. Comfortable only at rest.~IV Severe limitations. Experiences symptoms even while at rest."|Participants|Count of Participants|5|5.0||||||
3823706|NCT01733368|3649601|B1||NYHA III|New York Heart Association (NYHA) Classification|"The NYHA Functional Classification provides a simple way of classifying the extent of heart failure:~I Cardiac disease, but no symptoms and no limitation in ordinary physical activity.~II Mild symptoms and slight limitation during ordinary activity. III Marked limitation in activity due to symptoms, even during less-than-ordinary activity. Comfortable only at rest.~IV Severe limitations. Experiences symptoms even while at rest."|Participants|Count of Participants|111|111.0||||||
3823707|NCT01733368|3649601|B1||NYHA II|New York Heart Association (NYHA) Classification|"The NYHA Functional Classification provides a simple way of classifying the extent of heart failure:~I Cardiac disease, but no symptoms and no limitation in ordinary physical activity.~II Mild symptoms and slight limitation during ordinary activity. III Marked limitation in activity due to symptoms, even during less-than-ordinary activity. Comfortable only at rest.~IV Severe limitations. Experiences symptoms even while at rest."|Participants|Count of Participants|77|77.0||||||
3823708|NCT01733368|3649601|B1||NYHA I|New York Heart Association (NYHA) Classification|"The NYHA Functional Classification provides a simple way of classifying the extent of heart failure:~I Cardiac disease, but no symptoms and no limitation in ordinary physical activity.~II Mild symptoms and slight limitation during ordinary activity. III Marked limitation in activity due to symptoms, even during less-than-ordinary activity. Comfortable only at rest.~IV Severe limitations. Experiences symptoms even while at rest."|Participants|Count of Participants|5|5.0||||||
3823709|NCT01733368|3649601|B1||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3823710|NCT01733368|3649601|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3823711|NCT01733368|3649601|B1|||Age||years|Mean|66.01|66.01|Standard Deviation|10.22|10.22|||
3823712|NCT01733329|3649609|B3|Mexico||Region of Enrollment||participants|Number|123|123.0||||||
3823713|NCT01733329|3649610|B2|Mexico||Region of Enrollment||participants|Number|61|61.0||||||
3823714|NCT01733329|3649611|B1|Mexico||Region of Enrollment||participants|Number|62|62.0||||||
3823715|NCT01733329|3649609|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3823716|NCT01733329|3649610|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3823717|NCT01733329|3649611|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3823718|NCT01733329|3649609|B3||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3823719|NCT01733329|3649610|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3823720|NCT01733329|3649611|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3823721|NCT01733329|3649609|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3823722|NCT01733329|3649610|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3823723|NCT01733329|3649611|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3823724|NCT01733329|3649609|B3||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
3823725|NCT01733329|3649610|B2||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
3823726|NCT01733329|3649611|B1||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
3823727|NCT01733329|3649609|B3||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
3823728|NCT01733329|3649610|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3823729|NCT01733329|3649611|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
3823730|NCT01733329|3649609|B3|||Age||years|Mean|24.62|24.62|Standard Deviation|5.83|5.83|||
3823731|NCT01733329|3649610|B2|||Age||years|Mean|25.18|25.18|Standard Deviation|6.29|6.29|||
3823732|NCT01733329|3649611|B1|||Age||years|Mean|24.05|24.05|Standard Deviation|5.32|5.32|||
3823733|NCT01733316|3649624|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3823734|NCT01733316|3649624|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3823735|NCT01733316|3649624|B1|||Age||years|Mean|24.5|24.5|Standard Deviation|11.56|11.56|||
3823736|NCT01733277|3649638|B3|||VAS Pain (0-100)|Visual Analogue Scale (VAS) for global knee pain (0 mm = no pain, 100 mm = most severe pain)|units on a scale|Mean|64|64.0|Standard Deviation|13|13.0|||
3823737|NCT01733277|3649639|B2|||VAS Pain (0-100)|Visual Analogue Scale (VAS) for global knee pain (0 mm = no pain, 100 mm = most severe pain)|units on a scale|Mean|62|62.0|Standard Deviation|14|14.0|||
3823738|NCT01733277|3649640|B1|||VAS Pain (0-100)|Visual Analogue Scale (VAS) for global knee pain (0 mm = no pain, 100 mm = most severe pain)|units on a scale|Mean|67|67.0|Standard Deviation|13|13.0|||
3823739|NCT01733277|3649638|B3|||PainDetect (0-38)|The presence of neuropathic was determined based on use of PainDETECT questionnaire which can discriminate patients with neuropathic knee pain (score ≥ 13; the higher the score, the worst is the pain).|units on a scale|Mean|14.6|14.6|Standard Deviation|7.8|7.8|||
3823740|NCT01733277|3649639|B2|||PainDetect (0-38)|The presence of neuropathic was determined based on use of PainDETECT questionnaire which can discriminate patients with neuropathic knee pain (score ≥ 13; the higher the score, the worst is the pain).|units on a scale|Mean|8.1|8.1|Standard Deviation|2.6|2.6|||
3823741|NCT01733277|3649640|B1|||PainDetect (0-38)|The presence of neuropathic was determined based on use of PainDETECT questionnaire which can discriminate patients with neuropathic knee pain (score ≥ 13; the higher the score, the worst is the pain).|units on a scale|Mean|21.1|21.1|Standard Deviation|5.4|5.4|||
3823742|NCT01733277|3649638|B3|Canada||Region of Enrollment||participants|Number|50|50.0||||||
3823743|NCT01733277|3649639|B2|Canada||Region of Enrollment||participants|Number|25|25.0||||||
3823744|NCT01733277|3649640|B1|Canada||Region of Enrollment||participants|Number|25|25.0||||||
3823745|NCT01733277|3649638|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3823746|NCT01733277|3649639|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3823747|NCT01733277|3649640|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3823748|NCT01733277|3649638|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3823749|NCT01733277|3649639|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3823750|NCT01733277|3649640|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3823751|NCT01733277|3649638|B3|40-90 years||Age, Customized||participants|Number|50|50.0||||||
3823752|NCT01733277|3649639|B2|40-90 years||Age, Customized||participants|Number|25|25.0||||||
3823753|NCT01733277|3649640|B1|40-90 years||Age, Customized||participants|Number|25|25.0||||||
3823754|NCT01733212|3649651|B3|United States||Region of Enrollment||participants|Number|239|239.0||||||
3823755|NCT01733212|3649652|B2|United States||Region of Enrollment||participants|Number|123|123.0||||||
3823756|NCT01733212|3649653|B1|United States||Region of Enrollment||participants|Number|116|116.0||||||
3823757|NCT01733212|3649651|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3823758|NCT01733212|3649652|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3823759|NCT01733212|3649653|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3823760|NCT01733212|3649651|B3||Female|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
3823761|NCT01733212|3649652|B2||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3823762|NCT01733212|3649653|B1||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3823763|NCT01733212|3649651|B3|||Age||years|Mean|32.9|32.9|Standard Deviation|5.0|5.0|||
3823764|NCT01733212|3649652|B2|||Age||years|Mean|33.0|33.0|Standard Deviation|4.8|4.8|||
3823765|NCT01733212|3649653|B1|||Age||years|Mean|32.8|32.8|Standard Deviation|5.3|5.3|||
3823766|NCT01733212|3649651|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3823767|NCT01733212|3649652|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3823768|NCT01733212|3649653|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3823769|NCT01733212|3649651|B3||Between 18 and 65 years|Age||Participants|Count of Participants|239|239.0||||||
3823770|NCT01733212|3649652|B2||Between 18 and 65 years|Age||Participants|Count of Participants|123|123.0||||||
3823771|NCT01733212|3649653|B1||Between 18 and 65 years|Age||Participants|Count of Participants|116|116.0||||||
3823772|NCT01733212|3649651|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3823773|NCT01733212|3649652|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3823774|NCT01733212|3649653|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3823775|NCT01733121|3649660|B3|||Baseline AIMS Total Dyskinesia Score|The AIMS Total Dyskinesia Score rates a total of 7 items, rating involuntary movement from 0 (no dyskinesia) to 4 (severe dyskinesia). Items 1 through 7 include facial and oral movements (Items 1-4), extremity movements (Items 5-6), and trunk movements (Item 7). The AIMS dyskinesia total score for Items 1-7 ranges from 0 to 28; a higher score reflects increased severity.|units on a scale|Mean|8.0|8.0|Standard Deviation|4.0|4.0|||
3823776|NCT01733121|3649661|B2|||Baseline AIMS Total Dyskinesia Score|The AIMS Total Dyskinesia Score rates a total of 7 items, rating involuntary movement from 0 (no dyskinesia) to 4 (severe dyskinesia). Items 1 through 7 include facial and oral movements (Items 1-4), extremity movements (Items 5-6), and trunk movements (Item 7). The AIMS dyskinesia total score for Items 1-7 ranges from 0 to 28; a higher score reflects increased severity.|units on a scale|Mean|8.0|8.0|Standard Deviation|3.5|3.5|||
3823777|NCT01733121|3649662|B1|||Baseline AIMS Total Dyskinesia Score|The AIMS Total Dyskinesia Score rates a total of 7 items, rating involuntary movement from 0 (no dyskinesia) to 4 (severe dyskinesia). Items 1 through 7 include facial and oral movements (Items 1-4), extremity movements (Items 5-6), and trunk movements (Item 7). The AIMS dyskinesia total score for Items 1-7 ranges from 0 to 28; a higher score reflects increased severity.|units on a scale|Mean|7.9|7.9|Standard Deviation|4.5|4.5|||
3823778|NCT01733121|3649660|B3|||BPRS Total Score|The Brief Psychiatric Rating Scale (BPRS) is a clinician-rated tool designed to assess change in the severity of psychopathology in patients with schizophrenia and other psychotic disorders (Overall and Gorham, 1962, 1988). The severity of each of the 18 items of the BPRS is rated on a scale of 1 (not present) to 7 (extremely severe) (total score range: 18 to 126). Higher scores represent greater symptom severity.|units on a scale|Mean|30.1|30.1|Full Range|||19.0|49.0|
3823779|NCT01733121|3649661|B2|||BPRS Total Score|The Brief Psychiatric Rating Scale (BPRS) is a clinician-rated tool designed to assess change in the severity of psychopathology in patients with schizophrenia and other psychotic disorders (Overall and Gorham, 1962, 1988). The severity of each of the 18 items of the BPRS is rated on a scale of 1 (not present) to 7 (extremely severe) (total score range: 18 to 126). Higher scores represent greater symptom severity.|units on a scale|Mean|30.1|30.1|Full Range|||19.0|48.0|
3823780|NCT01733121|3649662|B1|||BPRS Total Score|The Brief Psychiatric Rating Scale (BPRS) is a clinician-rated tool designed to assess change in the severity of psychopathology in patients with schizophrenia and other psychotic disorders (Overall and Gorham, 1962, 1988). The severity of each of the 18 items of the BPRS is rated on a scale of 1 (not present) to 7 (extremely severe) (total score range: 18 to 126). Higher scores represent greater symptom severity.|units on a scale|Mean|30.1|30.1|Full Range|||19.0|49.0|
3823781|NCT01733121|3649660|B3|||Age at TD Diagnosis||years|Mean|49.2|49.2|Full Range|||23.0|77.0|
3823782|NCT01733121|3649661|B2|||Age at TD Diagnosis||years|Mean|48.9|48.9|Full Range|||25.0|70.0|
3823783|NCT01733121|3649662|B1|||Age at TD Diagnosis||years|Mean|49.5|49.5|Full Range|||23.0|77.0|
3823784|NCT01733121|3649660|B3||Gastrointestinal disorder|Disease Category||Participants|Count of Participants|4|4.0||||||
3823785|NCT01733121|3649661|B2||Gastrointestinal disorder|Disease Category||Participants|Count of Participants|3|3.0||||||
3823786|NCT01733121|3649662|B1||Gastrointestinal disorder|Disease Category||Participants|Count of Participants|1|1.0||||||
3823787|NCT01733121|3649660|B3||Mood disorder|Disease Category||Participants|Count of Participants|38|38.0||||||
3823788|NCT01733121|3649661|B2||Mood disorder|Disease Category||Participants|Count of Participants|20|20.0||||||
3823789|NCT01733121|3649662|B1||Mood disorder|Disease Category||Participants|Count of Participants|18|18.0||||||
3823790|NCT01733121|3649660|B3||Schizophrenia or schizoaffective disorder|Disease Category||Participants|Count of Participants|58|58.0||||||
3823791|NCT01733121|3649661|B2||Schizophrenia or schizoaffective disorder|Disease Category||Participants|Count of Participants|28|28.0||||||
3823792|NCT01733121|3649662|B1||Schizophrenia or schizoaffective disorder|Disease Category||Participants|Count of Participants|30|30.0||||||
3823793|NCT01733121|3649660|B3|||Body Mass Index||kg/m^2|Mean|28.62|28.62|Full Range|||18.0|42.0|
3823794|NCT01733121|3649661|B2|||Body Mass Index||kg/m^2|Mean|29.02|29.02|Full Range|||18.1|42.0|
3823795|NCT01733121|3649662|B1|||Body Mass Index||kg/m^2|Mean|28.19|28.19|Full Range|||18.0|38.3|
3823796|NCT01733121|3649660|B3|Other/mixed||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3823797|NCT01733121|3649661|B2|Other/mixed||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3823798|NCT01733121|3649662|B1|Other/mixed||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3823799|NCT01733121|3649660|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|63|63.0||||||
3823800|NCT01733121|3649661|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3823801|NCT01733121|3649662|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3823802|NCT01733121|3649660|B3|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3823803|NCT01733121|3649661|B2|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3823804|NCT01733121|3649662|B1|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3823805|NCT01733121|3649660|B3|American Indian/Alaska native, Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3823806|NCT01733121|3649661|B2|American Indian/Alaska native, Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3823807|NCT01733121|3649662|B1|American Indian/Alaska native, Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3823808|NCT01733121|3649660|B3|American Indian/Alaska native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3823809|NCT01733121|3649661|B2|American Indian/Alaska native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3823810|NCT01733121|3649662|B1|American Indian/Alaska native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3823811|NCT01733121|3649660|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3823812|NCT01733121|3649661|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3823813|NCT01733121|3649662|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3823814|NCT01733121|3649660|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3823815|NCT01733121|3649661|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3823816|NCT01733121|3649662|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3823817|NCT01733121|3649660|B3|||Age||years|Mean|56.2|56.2|Full Range|||32.0|78.0|
3823818|NCT01733121|3649661|B2|||Age||years|Mean|56.7|56.7|Full Range|||32.0|78.0|
3823819|NCT01733121|3649662|B1|||Age||years|Mean|55.6|55.6|Full Range|||34.0|78.0|
3823820|NCT01733069|3649675|B3|United States||Region of Enrollment||participants|Number|1862|1862.0||||||
3823821|NCT01733069|3649676|B2|United States||Region of Enrollment||participants|Number|1598|1598.0||||||
3823822|NCT01733069|3649677|B1|United States||Region of Enrollment||participants|Number|264|264.0||||||
3823823|NCT01733069|3649675|B3||Male|Sex: Female, Male||Participants|Count of Participants|549|549.0||||||
3823824|NCT01733069|3649676|B2||Male|Sex: Female, Male||Participants|Count of Participants|428|428.0||||||
3823825|NCT01733069|3649677|B1||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3823826|NCT01733069|3649675|B3||Female|Sex: Female, Male||Participants|Count of Participants|1313|1313.0||||||
3823827|NCT01733069|3649676|B2||Female|Sex: Female, Male||Participants|Count of Participants|1170|1170.0||||||
3823828|NCT01733069|3649677|B1||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3823829|NCT01733069|3649675|B3|||Age||years|Mean|27.4|27.4|Standard Deviation|9.5|9.5|||
3823830|NCT01733069|3649676|B2|||Age||years|Mean|28.1|28.1|Standard Deviation|9.8|9.8|||
3823831|NCT01733069|3649677|B1|||Age||years|Mean|23.5|23.5|Standard Deviation|5.5|5.5|||
3823832|NCT01733069|3649675|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3823833|NCT01733069|3649676|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3823834|NCT01733069|3649677|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3823835|NCT01733069|3649675|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1683|1683.0||||||
3823836|NCT01733069|3649676|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1449|1449.0||||||
3823837|NCT01733069|3649677|B1||Between 18 and 65 years|Age||Participants|Count of Participants|234|234.0||||||
3823838|NCT01733069|3649675|B3||<=18 years|Age||Participants|Count of Participants|176|176.0||||||
3823839|NCT01733069|3649676|B2||<=18 years|Age||Participants|Count of Participants|146|146.0||||||
3823840|NCT01733069|3649677|B1||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
3823841|NCT01733056|3649684|B4|United States||Region of Enrollment||participants|Number|43|43.0||||||
3823842|NCT01733056|3649685|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3823843|NCT01733056|3649686|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3823844|NCT01733056|3649687|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3823845|NCT01733056|3649684|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3823846|NCT01733056|3649685|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3823847|NCT01733056|3649686|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3823848|NCT01733056|3649687|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3823849|NCT01733056|3649684|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3823850|NCT01733056|3649685|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3823851|NCT01733056|3649686|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3823852|NCT01733056|3649687|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3823853|NCT01733056|3649684|B4|||Age||years|Mean|38.1|38.1|Standard Deviation|15.1|15.1|||
3823854|NCT01733056|3649685|B3|||Age||years|Mean|40|40.0|Standard Deviation|11.6|11.6|||
3823855|NCT01733056|3649686|B2|||Age||years|Mean|57|57.0|Standard Deviation|7.3|7.3|||
3823856|NCT01733056|3649687|B1|||Age||years|Mean|33|33.0|Standard Deviation|9.5|9.5|||
3823857|NCT01733056|3649684|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3823858|NCT01733056|3649685|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3823859|NCT01733056|3649686|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3823860|NCT01733056|3649687|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3823861|NCT01733056|3649684|B4||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3823862|NCT01733056|3649685|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3823863|NCT01733056|3649686|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3823864|NCT01733056|3649687|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3823865|NCT01733056|3649684|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3823866|NCT01733056|3649685|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3823867|NCT01733056|3649686|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3823868|NCT01733056|3649687|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3823869|NCT01732926|3649703|B3|Germany||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3823870|NCT01732926|3649704|B2|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3823871|NCT01732926|3649705|B1|Germany||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3823872|NCT01732926|3649703|B3|Australia||Region of Enrollment||Participants|Count of Participants|67|67.0||||||
3823873|NCT01732926|3649704|B2|Australia||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3823874|NCT01732926|3649705|B1|Australia||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3823875|NCT01732926|3649703|B3|France||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
3823876|NCT01732926|3649704|B2|France||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3823877|NCT01732926|3649705|B1|France||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3823878|NCT01732926|3649703|B3|Israel||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3823879|NCT01732926|3649704|B2|Israel||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3823880|NCT01732926|3649705|B1|Israel||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3823881|NCT01732926|3649703|B3|Italy||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3823882|NCT01732926|3649704|B2|Italy||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3823883|NCT01732926|3649705|B1|Italy||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3823884|NCT01732926|3649703|B3|Korea, Republic of||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3823885|NCT01732926|3649704|B2|Korea, Republic of||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3823886|NCT01732926|3649705|B1|Korea, Republic of||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3823887|NCT01732926|3649703|B3|Poland||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3823888|NCT01732926|3649704|B2|Poland||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3823889|NCT01732926|3649705|B1|Poland||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3823890|NCT01732926|3649703|B3|Taiwan||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3823891|NCT01732926|3649704|B2|Taiwan||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3823892|NCT01732926|3649705|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3823893|NCT01732926|3649703|B3|Sweden||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3823894|NCT01732926|3649704|B2|Sweden||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3823895|NCT01732926|3649705|B1|Sweden||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3823896|NCT01732926|3649703|B3|Czech Republic||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3823897|NCT01732926|3649704|B2|Czech Republic||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3823898|NCT01732926|3649705|B1|Czech Republic||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3823899|NCT01732926|3649703|B3|Canada||Region of Enrollment||Participants|Count of Participants|66|66.0||||||
3823900|NCT01732926|3649704|B2|Canada||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3823901|NCT01732926|3649705|B1|Canada||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
3823902|NCT01732926|3649703|B3|Spain||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3823903|NCT01732926|3649704|B2|Spain||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3823904|NCT01732926|3649705|B1|Spain||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3823905|NCT01732926|3649703|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|53|53.0||||||
3823906|NCT01732926|3649704|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3823907|NCT01732926|3649705|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3823908|NCT01732926|3649703|B3|United States||Region of Enrollment||Participants|Count of Participants|49|49.0||||||
3823909|NCT01732926|3649704|B2|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3823910|NCT01732926|3649705|B1|United States||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3823911|NCT01732926|3649703|B3|Russian Federation||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3823912|NCT01732926|3649704|B2|Russian Federation||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3823913|NCT01732926|3649705|B1|Russian Federation||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3823914|NCT01732926|3649703|B3|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|60|60.0||||||
3823915|NCT01732926|3649704|B2|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3823916|NCT01732926|3649705|B1|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3823917|NCT01732926|3649703|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|391|391.0||||||
3823918|NCT01732926|3649704|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|129|129.0||||||
3823919|NCT01732926|3649705|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|262|262.0||||||
3823920|NCT01732926|3649703|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3823921|NCT01732926|3649704|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3823922|NCT01732926|3649705|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3823923|NCT01732926|3649703|B3|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|62|62.0||||||
3823924|NCT01732926|3649704|B2|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3823925|NCT01732926|3649705|B1|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
3823926|NCT01732926|3649703|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3823927|NCT01732926|3649704|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3823928|NCT01732926|3649705|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3823929|NCT01732926|3649703|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|369|369.0||||||
3823930|NCT01732926|3649704|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|122|122.0||||||
3823931|NCT01732926|3649705|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|247|247.0||||||
3823932|NCT01732926|3649703|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3823933|NCT01732926|3649704|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3823934|NCT01732926|3649705|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3823935|NCT01732926|3649703|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3823936|NCT01732926|3649704|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3823937|NCT01732926|3649705|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3823938|NCT01732926|3649703|B3||Male|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
3823939|NCT01732926|3649704|B2||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3823940|NCT01732926|3649705|B1||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3823941|NCT01732926|3649703|B3||Female|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
3823942|NCT01732926|3649704|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3823943|NCT01732926|3649705|B1||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3823944|NCT01732926|3649703|B3|||Age||years|Mean|62|62.0|Standard Deviation|10.9|10.9|||
3823945|NCT01732926|3649704|B2|||Age||years|Mean|62|62.0|Standard Deviation|11.1|11.1|||
3823946|NCT01732926|3649705|B1|||Age||years|Mean|62|62.0|Standard Deviation|10.5|10.5|||
3823947|NCT01732913|3649720|B3|Germany||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3823948|NCT01732913|3649721|B2|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3823949|NCT01732913|3649722|B1|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3823950|NCT01732913|3649720|B3|France||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3823951|NCT01732913|3649721|B2|France||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3823952|NCT01732913|3649722|B1|France||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3823953|NCT01732913|3649720|B3|Australia||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3823954|NCT01732913|3649721|B2|Australia||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3823955|NCT01732913|3649722|B1|Australia||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3823956|NCT01732913|3649720|B3|Israel||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3823957|NCT01732913|3649721|B2|Israel||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3823958|NCT01732913|3649722|B1|Israel||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3823959|NCT01732913|3649720|B3|Italy||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3823960|NCT01732913|3649721|B2|Italy||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3823961|NCT01732913|3649722|B1|Italy||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3823962|NCT01732913|3649720|B3|Korea, Republic of||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3823963|NCT01732913|3649721|B2|Korea, Republic of||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3823964|NCT01732913|3649722|B1|Korea, Republic of||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3823965|NCT01732913|3649720|B3|Poland||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3823966|NCT01732913|3649721|B2|Poland||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3823967|NCT01732913|3649722|B1|Poland||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3823968|NCT01732913|3649720|B3|Taiwan||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3823969|NCT01732913|3649721|B2|Taiwan||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3823970|NCT01732913|3649722|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3823971|NCT01732913|3649720|B3|Sweden||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3823972|NCT01732913|3649721|B2|Sweden||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3823973|NCT01732913|3649722|B1|Sweden||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3823974|NCT01732913|3649720|B3|Czech Republic||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3823975|NCT01732913|3649721|B2|Czech Republic||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3823976|NCT01732913|3649722|B1|Czech Republic||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3823977|NCT01732913|3649720|B3|Spain||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3823978|NCT01732913|3649721|B2|Spain||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3823979|NCT01732913|3649722|B1|Spain||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3823980|NCT01732913|3649720|B3|Portugal||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3823981|NCT01732913|3649721|B2|Portugal||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3823982|NCT01732913|3649722|B1|Portugal||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3823983|NCT01732913|3649720|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3823984|NCT01732913|3649721|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3823985|NCT01732913|3649722|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3823986|NCT01732913|3649720|B3|Japan||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3823987|NCT01732913|3649721|B2|Japan||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3823988|NCT01732913|3649722|B1|Japan||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3823989|NCT01732913|3649720|B3|United States||Region of Enrollment||Participants|Count of Participants|99|99.0||||||
3823990|NCT01732913|3649721|B2|United States||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3823991|NCT01732913|3649722|B1|United States||Region of Enrollment||Participants|Count of Participants|65|65.0||||||
3823992|NCT01732913|3649720|B3|Hungary||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3823993|NCT01732913|3649721|B2|Hungary||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3823994|NCT01732913|3649722|B1|Hungary||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3823995|NCT01732913|3649720|B3|Romania||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3823996|NCT01732913|3649721|B2|Romania||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3823997|NCT01732913|3649722|B1|Romania||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3823998|NCT01732913|3649720|B3|Singapore||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3823999|NCT01732913|3649721|B2|Singapore||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3824000|NCT01732913|3649722|B1|Singapore||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3824001|NCT01732913|3649720|B3|Russian Federation||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3824002|NCT01732913|3649721|B2|Russian Federation||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3824003|NCT01732913|3649722|B1|Russian Federation||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3824004|NCT01732913|3649720|B3|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|55|55.0||||||
3824005|NCT01732913|3649721|B2|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3824006|NCT01732913|3649722|B1|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3824007|NCT01732913|3649720|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|225|225.0||||||
3824008|NCT01732913|3649721|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|75|75.0||||||
3824009|NCT01732913|3649722|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|150|150.0||||||
3824010|NCT01732913|3649720|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3824011|NCT01732913|3649721|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3824012|NCT01732913|3649722|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3824013|NCT01732913|3649720|B3|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
3824014|NCT01732913|3649721|B2|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3824015|NCT01732913|3649722|B1|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3824016|NCT01732913|3649720|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3824017|NCT01732913|3649721|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3824018|NCT01732913|3649722|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3824019|NCT01732913|3649720|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|177|177.0||||||
3824020|NCT01732913|3649721|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|54|54.0||||||
3824021|NCT01732913|3649722|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|123|123.0||||||
3824022|NCT01732913|3649720|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3824023|NCT01732913|3649721|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3824024|NCT01732913|3649722|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3824025|NCT01732913|3649720|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|52|52.0||||||
3824026|NCT01732913|3649721|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3824027|NCT01732913|3649722|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
3824028|NCT01732913|3649720|B3||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3824029|NCT01732913|3649721|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3824030|NCT01732913|3649722|B1||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3824031|NCT01732913|3649720|B3||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3824032|NCT01732913|3649721|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3824033|NCT01732913|3649722|B1||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3824034|NCT01732913|3649720|B3|||Age||years|Mean|65|65.0|Standard Deviation|11.4|11.4|||
3824035|NCT01732913|3649721|B2|||Age||years|Mean|67|67.0|Standard Deviation|11.4|11.4|||
3824036|NCT01732913|3649722|B1|||Age||years|Mean|64|64.0|Standard Deviation|11.4|11.4|||
3824037|NCT01732835|3649737|B1|||Cardiac index|Cardiac index is the cardiac output divided by body surface area.|l/min/m^2|Mean|3.16|3.16|Standard Deviation|1.11|1.11|||
3824038|NCT01732835|3649737|B1|||Cardiac output|Echocardiographic parameter determined by core laboratory.|l/min|Mean|6.20|6.2|Standard Deviation|2.17|2.17|||
3824039|NCT01732835|3649737|B1|||Left ventricular ejection fraction (LVEF)|Left ventricular ejection fraction. Echocardiographic parameter determined by core laboratory.|%|Mean|54.2|54.2|Standard Deviation|4.4|4.4|||
3824040|NCT01732835|3649737|B1|||LV systolic volume|Left ventricular systolic volume. Echocardiographic parameter determined by core laboratory.|ml|Mean|76.5|76.5|Standard Deviation|37.7|37.7|||
3824041|NCT01732835|3649737|B1|||LV diastolic volume|Left ventricular diastolic volume. Echocardiographic parameter determined by core laboratory.|ml|Mean|155.3|155.3|Standard Deviation|63.3|63.3|||
3824042|NCT01732835|3649737|B1|||LVID systole|Left ventricular internal dimension. Echocardiographic parameter determined by core laboratory.|cm|Mean|4.02|4.02|Standard Deviation|0.83|0.83|||
3824043|NCT01732835|3649737|B1|||Left ventricular internal dimension (LVID) diastole|Left ventricular internal dimension. Echocardiographic parameter determined by core laboratory.|cm|Mean|5.50|5.5|Standard Deviation|0.86|0.86|||
3824044|NCT01732835|3649737|B1|||Left ventricular (LV) mass|Left ventricular mass. Echocardiographic parameter determined by core laboratory.|g|Mean|244.1|244.1|Standard Deviation|85.2|85.2|||
3824045|NCT01732835|3649737|B1|||Mean gradient|Echocardiographic parameter determined by core laboratory.|mm Hg|Mean|5.5|5.5|Standard Deviation|2.4|2.4|||
3824046|NCT01732835|3649737|B1|||Peak gradient|Echocardiographic parameter determined by core laboratory.|mm Hg|Mean|11.1|11.1|Standard Deviation|4.7|4.7|||
3824047|NCT01732835|3649737|B1|IV||New York Heart Association (NYHA) Functional Capacity|Four classes describing the effect of cardiac disease on physical activity: Class I - disease does not limit activity; Class II - slight limitation; Class III - marked imitation; Class IV - inability to carry out any physical activity without discomfort|participants|Number|0|0.0||||||
3824048|NCT01732835|3649737|B1|III||New York Heart Association (NYHA) Functional Capacity|Four classes describing the effect of cardiac disease on physical activity: Class I - disease does not limit activity; Class II - slight limitation; Class III - marked imitation; Class IV - inability to carry out any physical activity without discomfort|participants|Number|13|13.0||||||
3824049|NCT01732835|3649737|B1|II||New York Heart Association (NYHA) Functional Capacity|Four classes describing the effect of cardiac disease on physical activity: Class I - disease does not limit activity; Class II - slight limitation; Class III - marked imitation; Class IV - inability to carry out any physical activity without discomfort|participants|Number|25|25.0||||||
3824050|NCT01732835|3649737|B1|I||New York Heart Association (NYHA) Functional Capacity|Four classes describing the effect of cardiac disease on physical activity: Class I - disease does not limit activity; Class II - slight limitation; Class III - marked imitation; Class IV - inability to carry out any physical activity without discomfort|participants|Number|11|11.0||||||
3824051|NCT01732835|3649737|B1|Not evaluable||Aortic Insufficiency|Grade assigned to degree of aortic regurgitation determined by core laboratory analysis of echocardiogram: 0=None/trace, 1+=Mild, 2+=Moderate, 3+=Moderate-to-Severe, 4+=Severe|participants|Number|6|6.0||||||
3824052|NCT01732835|3649737|B1|4+||Aortic Insufficiency|Grade assigned to degree of aortic regurgitation determined by core laboratory analysis of echocardiogram: 0=None/trace, 1+=Mild, 2+=Moderate, 3+=Moderate-to-Severe, 4+=Severe|participants|Number|12|12.0||||||
3824053|NCT01732835|3649737|B1|3+||Aortic Insufficiency|Grade assigned to degree of aortic regurgitation determined by core laboratory analysis of echocardiogram: 0=None/trace, 1+=Mild, 2+=Moderate, 3+=Moderate-to-Severe, 4+=Severe|participants|Number|18|18.0||||||
3824054|NCT01732835|3649737|B1|2+||Aortic Insufficiency|Grade assigned to degree of aortic regurgitation determined by core laboratory analysis of echocardiogram: 0=None/trace, 1+=Mild, 2+=Moderate, 3+=Moderate-to-Severe, 4+=Severe|participants|Number|10|10.0||||||
3824055|NCT01732835|3649737|B1|1+||Aortic Insufficiency|Grade assigned to degree of aortic regurgitation determined by core laboratory analysis of echocardiogram: 0=None/trace, 1+=Mild, 2+=Moderate, 3+=Moderate-to-Severe, 4+=Severe|participants|Number|3|3.0||||||
3824056|NCT01732835|3649737|B1|0||Aortic Insufficiency|Grade assigned to degree of aortic regurgitation determined by core laboratory analysis of echocardiogram: 0=None/trace, 1+=Mild, 2+=Moderate, 3+=Moderate-to-Severe, 4+=Severe|participants|Number|0|0.0||||||
3824057|NCT01732835|3649737|B1|Germany||Region of Enrollment||participants|Number|44|44.0||||||
3824058|NCT01732835|3649737|B1|Czech Republic||Region of Enrollment||participants|Number|5|5.0||||||
3824059|NCT01732835|3649737|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3824060|NCT01732835|3649737|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3824061|NCT01732835|3649737|B1|||Age||years|Mean|61.0|61.0|Standard Deviation|13.6|13.6|||
3824062|NCT01732835|3649737|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3824063|NCT01732835|3649737|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3824064|NCT01732835|3649737|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3824065|NCT01732822|3649768|B3|White||Race/Ethnicity, Customized||Participants|Number|11310|11310.0||||||
3824066|NCT01732822|3649769|B2|White||Race/Ethnicity, Customized||Participants|Number|5659|5659.0||||||
3824067|NCT01732822|3649770|B1|White||Race/Ethnicity, Customized||Participants|Number|5651|5651.0||||||
3824068|NCT01732822|3649768|B3|Other||Race/Ethnicity, Customized||Participants|Number|242|242.0||||||
3824069|NCT01732822|3649769|B2|Other||Race/Ethnicity, Customized||Participants|Number|132|132.0||||||
3824070|NCT01732822|3649770|B1|Other||Race/Ethnicity, Customized||Participants|Number|110|110.0||||||
3824071|NCT01732822|3649768|B3|Native Hawaiian Or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3824072|NCT01732822|3649769|B2|Native Hawaiian Or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3824073|NCT01732822|3649770|B1|Native Hawaiian Or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3824074|NCT01732822|3649768|B3|Black Or African American||Race/Ethnicity, Customized||Participants|Number|569|569.0||||||
3824075|NCT01732822|3649769|B2|Black Or African American||Race/Ethnicity, Customized||Participants|Number|289|289.0||||||
3824076|NCT01732822|3649770|B1|Black Or African American||Race/Ethnicity, Customized||Participants|Number|280|280.0||||||
3824077|NCT01732822|3649768|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1634|1634.0||||||
3824078|NCT01732822|3649769|B2|Asian||Race/Ethnicity, Customized||Participants|Number|810|810.0||||||
3824079|NCT01732822|3649770|B1|Asian||Race/Ethnicity, Customized||Participants|Number|824|824.0||||||
3824080|NCT01732822|3649768|B3|American Indian Or Alaska Native||Race/Ethnicity, Customized||Participants|Number|125|125.0||||||
3824081|NCT01732822|3649769|B2|American Indian Or Alaska Native||Race/Ethnicity, Customized||Participants|Number|62|62.0||||||
3824082|NCT01732822|3649770|B1|American Indian Or Alaska Native||Race/Ethnicity, Customized||Participants|Number|63|63.0||||||
3824083|NCT01732822|3649768|B3|Not Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Number|11772|11772.0||||||
3824084|NCT01732822|3649769|B2|Not Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Number|5888|5888.0||||||
3824085|NCT01732822|3649770|B1|Not Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Number|5884|5884.0||||||
3824086|NCT01732822|3649768|B3|Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Number|2113|2113.0||||||
3824087|NCT01732822|3649769|B2|Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Number|1067|1067.0||||||
3824088|NCT01732822|3649770|B1|Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Number|1046|1046.0||||||
3824089|NCT01732822|3649768|B3||Male|Sex: Female, Male||Participants|Count of Participants|9997|9997.0||||||
3824090|NCT01732822|3649769|B2||Male|Sex: Female, Male||Participants|Count of Participants|4975|4975.0||||||
3824091|NCT01732822|3649770|B1||Male|Sex: Female, Male||Participants|Count of Participants|5022|5022.0||||||
3824092|NCT01732822|3649768|B3||Female|Sex: Female, Male||Participants|Count of Participants|3888|3888.0||||||
3824093|NCT01732822|3649769|B2||Female|Sex: Female, Male||Participants|Count of Participants|1980|1980.0||||||
3824094|NCT01732822|3649770|B1||Female|Sex: Female, Male||Participants|Count of Participants|1908|1908.0||||||
3824095|NCT01732822|3649768|B3|>75 years||Age, Customized||Participants|Number|2225|2225.0||||||
3824096|NCT01732822|3649769|B2|>75 years||Age, Customized||Participants|Number|1120|1120.0||||||
3824097|NCT01732822|3649770|B1|>75 years||Age, Customized||Participants|Number|1105|1105.0||||||
3824098|NCT01732822|3649768|B3|Between 65 and 75 years||Age, Customized||Participants|Number|5775|5775.0||||||
3824099|NCT01732822|3649769|B2|Between 65 and 75 years||Age, Customized||Participants|Number|2850|2850.0||||||
3824100|NCT01732822|3649770|B1|Between 65 and 75 years||Age, Customized||Participants|Number|2925|2925.0||||||
3824101|NCT01732822|3649768|B3|<65 years||Age, Customized||Participants|Number|5885|5885.0||||||
3824102|NCT01732822|3649769|B2|<65 years||Age, Customized||Participants|Number|2985|2985.0||||||
3824103|NCT01732822|3649770|B1|<65 years||Age, Customized||Participants|Number|2900|2900.0||||||
3824104|NCT01732822|3649768|B3|Age||Age||Years|Mean|66.6|66.6|Standard Deviation|8.4|8.4|||
3824105|NCT01732822|3649769|B2|Age||Age||Years|Mean|66.5|66.5|Standard Deviation|8.5|8.5|||
3824106|NCT01732822|3649770|B1|Age||Age||Years|Mean|66.6|66.6|Standard Deviation|8.4|8.4|||
3824107|NCT01732796|3649841|B4||Male|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
3824108|NCT01732796|3649842|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3824109|NCT01732796|3649843|B2||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3824110|NCT01732796|3649844|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3824111|NCT01732796|3649841|B4||Female|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
3824112|NCT01732796|3649842|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3824113|NCT01732796|3649843|B2||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3824114|NCT01732796|3649844|B1||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3824115|NCT01732796|3649841|B4|||Age||Years|Mean|51.4|51.4|Standard Deviation|12.6|12.6|||
3824116|NCT01732796|3649842|B3|||Age||Years|Mean|57.9|57.9|Standard Deviation|8.8|8.8|||
3824117|NCT01732796|3649843|B2|||Age||Years|Mean|51.1|51.1|Standard Deviation|12.9|12.9|||
3824118|NCT01732796|3649844|B1|||Age||Years|Mean|50.1|50.1|Standard Deviation|12.7|12.7|||
3824119|NCT01732783|3649862|B4|Other||Metastatic Disease Lesion Sites||participants|Number|71|71.0||||||
3824120|NCT01732783|3649863|B3|Other||Metastatic Disease Lesion Sites||participants|Number|4|4.0||||||
3824121|NCT01732783|3649864|B2|Other||Metastatic Disease Lesion Sites||participants|Number|11|11.0||||||
3824122|NCT01732783|3649865|B1|Other||Metastatic Disease Lesion Sites||participants|Number|56|56.0||||||
3824123|NCT01732783|3649862|B4|Lung||Metastatic Disease Lesion Sites||participants|Number|53|53.0||||||
3824124|NCT01732783|3649863|B3|Lung||Metastatic Disease Lesion Sites||participants|Number|4|4.0||||||
3824125|NCT01732783|3649864|B2|Lung||Metastatic Disease Lesion Sites||participants|Number|13|13.0||||||
3824126|NCT01732783|3649865|B1|Lung||Metastatic Disease Lesion Sites||participants|Number|36|36.0||||||
3824127|NCT01732783|3649862|B4|Liver||Metastatic Disease Lesion Sites||participants|Number|153|153.0||||||
3824128|NCT01732783|3649863|B3|Liver||Metastatic Disease Lesion Sites||participants|Number|5|5.0||||||
3824129|NCT01732783|3649864|B2|Liver||Metastatic Disease Lesion Sites||participants|Number|25|25.0||||||
3824130|NCT01732783|3649865|B1|Liver||Metastatic Disease Lesion Sites||participants|Number|123|123.0||||||
3824131|NCT01732783|3649862|B4||Unknown|Metastatic Colorectal Cancer Status|"Synchronous colorectal neoplasias are defined as 2 or more primary tumors identified in the same patient and at the same time.~Metachronous refers to lesions that appear after diagnosis of the primary lesion."|Participants|Count of Participants|2|2.0||||||
3824132|NCT01732783|3649863|B3||Unknown|Metastatic Colorectal Cancer Status|"Synchronous colorectal neoplasias are defined as 2 or more primary tumors identified in the same patient and at the same time.~Metachronous refers to lesions that appear after diagnosis of the primary lesion."|Participants|Count of Participants|0|0.0||||||
3824133|NCT01732783|3649864|B2||Unknown|Metastatic Colorectal Cancer Status|"Synchronous colorectal neoplasias are defined as 2 or more primary tumors identified in the same patient and at the same time.~Metachronous refers to lesions that appear after diagnosis of the primary lesion."|Participants|Count of Participants|1|1.0||||||
3824134|NCT01732783|3649865|B1||Unknown|Metastatic Colorectal Cancer Status|"Synchronous colorectal neoplasias are defined as 2 or more primary tumors identified in the same patient and at the same time.~Metachronous refers to lesions that appear after diagnosis of the primary lesion."|Participants|Count of Participants|1|1.0||||||
3824135|NCT01732783|3649862|B4||Missing|Metastatic Colorectal Cancer Status|"Synchronous colorectal neoplasias are defined as 2 or more primary tumors identified in the same patient and at the same time.~Metachronous refers to lesions that appear after diagnosis of the primary lesion."|Participants|Count of Participants|11|11.0||||||
3824136|NCT01732783|3649863|B3||Missing|Metastatic Colorectal Cancer Status|"Synchronous colorectal neoplasias are defined as 2 or more primary tumors identified in the same patient and at the same time.~Metachronous refers to lesions that appear after diagnosis of the primary lesion."|Participants|Count of Participants|0|0.0||||||
3824137|NCT01732783|3649864|B2||Missing|Metastatic Colorectal Cancer Status|"Synchronous colorectal neoplasias are defined as 2 or more primary tumors identified in the same patient and at the same time.~Metachronous refers to lesions that appear after diagnosis of the primary lesion."|Participants|Count of Participants|2|2.0||||||
3824138|NCT01732783|3649865|B1||Missing|Metastatic Colorectal Cancer Status|"Synchronous colorectal neoplasias are defined as 2 or more primary tumors identified in the same patient and at the same time.~Metachronous refers to lesions that appear after diagnosis of the primary lesion."|Participants|Count of Participants|9|9.0||||||
3824139|NCT01732783|3649862|B4||Metachronous|Metastatic Colorectal Cancer Status|"Synchronous colorectal neoplasias are defined as 2 or more primary tumors identified in the same patient and at the same time.~Metachronous refers to lesions that appear after diagnosis of the primary lesion."|Participants|Count of Participants|60|60.0||||||
3824140|NCT01732783|3649863|B3||Metachronous|Metastatic Colorectal Cancer Status|"Synchronous colorectal neoplasias are defined as 2 or more primary tumors identified in the same patient and at the same time.~Metachronous refers to lesions that appear after diagnosis of the primary lesion."|Participants|Count of Participants|7|7.0||||||
3824141|NCT01732783|3649864|B2||Metachronous|Metastatic Colorectal Cancer Status|"Synchronous colorectal neoplasias are defined as 2 or more primary tumors identified in the same patient and at the same time.~Metachronous refers to lesions that appear after diagnosis of the primary lesion."|Participants|Count of Participants|14|14.0||||||
3824142|NCT01732783|3649865|B1||Metachronous|Metastatic Colorectal Cancer Status|"Synchronous colorectal neoplasias are defined as 2 or more primary tumors identified in the same patient and at the same time.~Metachronous refers to lesions that appear after diagnosis of the primary lesion."|Participants|Count of Participants|39|39.0||||||
3824143|NCT01732783|3649862|B4||Synchronous|Metastatic Colorectal Cancer Status|"Synchronous colorectal neoplasias are defined as 2 or more primary tumors identified in the same patient and at the same time.~Metachronous refers to lesions that appear after diagnosis of the primary lesion."|Participants|Count of Participants|140|140.0||||||
3824144|NCT01732783|3649863|B3||Synchronous|Metastatic Colorectal Cancer Status|"Synchronous colorectal neoplasias are defined as 2 or more primary tumors identified in the same patient and at the same time.~Metachronous refers to lesions that appear after diagnosis of the primary lesion."|Participants|Count of Participants|5|5.0||||||
3824145|NCT01732783|3649864|B2||Synchronous|Metastatic Colorectal Cancer Status|"Synchronous colorectal neoplasias are defined as 2 or more primary tumors identified in the same patient and at the same time.~Metachronous refers to lesions that appear after diagnosis of the primary lesion."|Participants|Count of Participants|20|20.0||||||
3824146|NCT01732783|3649865|B1||Synchronous|Metastatic Colorectal Cancer Status|"Synchronous colorectal neoplasias are defined as 2 or more primary tumors identified in the same patient and at the same time.~Metachronous refers to lesions that appear after diagnosis of the primary lesion."|Participants|Count of Participants|115|115.0||||||
3824147|NCT01732783|3649862|B4||Rectum|Primary Colorectal Cancer Type||Participants|Count of Participants|80|80.0||||||
3824148|NCT01732783|3649863|B3||Rectum|Primary Colorectal Cancer Type||Participants|Count of Participants|1|1.0||||||
3824149|NCT01732783|3649864|B2||Rectum|Primary Colorectal Cancer Type||Participants|Count of Participants|13|13.0||||||
3824150|NCT01732783|3649865|B1||Rectum|Primary Colorectal Cancer Type||Participants|Count of Participants|66|66.0||||||
3824151|NCT01732783|3649862|B4||Colon|Primary Colorectal Cancer Type||Participants|Count of Participants|5|5.0||||||
3824152|NCT01732783|3649863|B3||Colon|Primary Colorectal Cancer Type||Participants|Count of Participants|0|0.0||||||
3824153|NCT01732783|3649864|B2||Colon|Primary Colorectal Cancer Type||Participants|Count of Participants|2|2.0||||||
3824154|NCT01732783|3649865|B1||Colon|Primary Colorectal Cancer Type||Participants|Count of Participants|3|3.0||||||
3824155|NCT01732783|3649862|B4||Colon, right of mid-line|Primary Colorectal Cancer Type||Participants|Count of Participants|56|56.0||||||
3824202|NCT01732783|3649865|B1|||Age||years|Mean|64.8|64.8|Standard Deviation|9.6|9.6|||
3824156|NCT01732783|3649863|B3||Colon, right of mid-line|Primary Colorectal Cancer Type||Participants|Count of Participants|7|7.0||||||
3824157|NCT01732783|3649864|B2||Colon, right of mid-line|Primary Colorectal Cancer Type||Participants|Count of Participants|8|8.0||||||
3824158|NCT01732783|3649865|B1||Colon, right of mid-line|Primary Colorectal Cancer Type||Participants|Count of Participants|41|41.0||||||
3824159|NCT01732783|3649862|B4||Colon, left of mid-line|Primary Colorectal Cancer Type||Participants|Count of Participants|72|72.0||||||
3824160|NCT01732783|3649863|B3||Colon, left of mid-line|Primary Colorectal Cancer Type||Participants|Count of Participants|4|4.0||||||
3824161|NCT01732783|3649864|B2||Colon, left of mid-line|Primary Colorectal Cancer Type||Participants|Count of Participants|14|14.0||||||
3824162|NCT01732783|3649865|B1||Colon, left of mid-line|Primary Colorectal Cancer Type||Participants|Count of Participants|54|54.0||||||
3824163|NCT01732783|3649862|B4||Missing|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|106|106.0||||||
3824164|NCT01732783|3649863|B3||Missing|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|5|5.0||||||
3824165|NCT01732783|3649864|B2||Missing|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|17|17.0||||||
3824166|NCT01732783|3649865|B1||Missing|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|84|84.0||||||
3824167|NCT01732783|3649862|B4||2 - Ambulatory but unable to work|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|10|10.0||||||
3824168|NCT01732783|3649863|B3||2 - Ambulatory but unable to work|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|0|0.0||||||
3824169|NCT01732783|3649864|B2||2 - Ambulatory but unable to work|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|2|2.0||||||
3824170|NCT01732783|3649865|B1||2 - Ambulatory but unable to work|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|8|8.0||||||
3824171|NCT01732783|3649862|B4||1 - Restricted but ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|42|42.0||||||
3824203|NCT01732770|3649929|B3|||Body Mass Index (BMI)||kg/m²|Mean|24.29|24.29|Standard Deviation|4.08|4.08|||
3824204|NCT01732770|3649930|B2|||Body Mass Index (BMI)||kg/m²|Mean|24.27|24.27|Standard Deviation|3.99|3.99|||
3824205|NCT01732770|3649931|B1|||Body Mass Index (BMI)||kg/m²|Mean|24.31|24.31|Standard Deviation|4.18|4.18|||
3824246|NCT01732770|3649930|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3824172|NCT01732783|3649863|B3||1 - Restricted but ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|3|3.0||||||
3824173|NCT01732783|3649864|B2||1 - Restricted but ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|11|11.0||||||
3824174|NCT01732783|3649865|B1||1 - Restricted but ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|28|28.0||||||
3824175|NCT01732783|3649862|B4||0 - Fully active|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|55|55.0||||||
3824176|NCT01732783|3649863|B3||0 - Fully active|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|4|4.0||||||
3824177|NCT01732783|3649864|B2||0 - Fully active|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|7|7.0||||||
3824178|NCT01732783|3649865|B1||0 - Fully active|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|44|44.0||||||
3824179|NCT01732783|3649862|B4||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3824180|NCT01732783|3649863|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3824181|NCT01732783|3649864|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3824182|NCT01732783|3649865|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3824183|NCT01732783|3649862|B4||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3824184|NCT01732783|3649863|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3824185|NCT01732783|3649864|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3824186|NCT01732783|3649865|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3824187|NCT01732783|3649862|B4||≥ 75 years|Age, Customized||Participants|Count of Participants|31|31.0||||||
3824188|NCT01732783|3649863|B3||≥ 75 years|Age, Customized||Participants|Count of Participants|3|3.0||||||
3824189|NCT01732783|3649864|B2||≥ 75 years|Age, Customized||Participants|Count of Participants|5|5.0||||||
3824190|NCT01732783|3649865|B1||≥ 75 years|Age, Customized||Participants|Count of Participants|23|23.0||||||
3824191|NCT01732783|3649862|B4||≥ 65 to < 75 years|Age, Customized||Participants|Count of Participants|89|89.0||||||
3824192|NCT01732783|3649863|B3||≥ 65 to < 75 years|Age, Customized||Participants|Count of Participants|7|7.0||||||
3824193|NCT01732783|3649864|B2||≥ 65 to < 75 years|Age, Customized||Participants|Count of Participants|14|14.0||||||
3824194|NCT01732783|3649865|B1||≥ 65 to < 75 years|Age, Customized||Participants|Count of Participants|68|68.0||||||
3824195|NCT01732783|3649862|B4||< 65 years|Age, Customized||Participants|Count of Participants|93|93.0||||||
3824196|NCT01732783|3649863|B3||< 65 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
3824197|NCT01732783|3649864|B2||< 65 years|Age, Customized||Participants|Count of Participants|18|18.0||||||
3824198|NCT01732783|3649865|B1||< 65 years|Age, Customized||Participants|Count of Participants|73|73.0||||||
3824199|NCT01732783|3649862|B4|||Age||years|Mean|65.2|65.2|Standard Deviation|9.5|9.5|||
3824200|NCT01732783|3649863|B3|||Age||years|Mean|69.0|69.0|Standard Deviation|7.6|7.6|||
3824201|NCT01732783|3649864|B2|||Age||years|Mean|65.8|65.8|Standard Deviation|9.9|9.9|||
3824206|NCT01732770|3649929|B3|Prior osteoporotic fracture||Historical Fractures|An osteoporotic fracture is defined as a reported fracture excluding skull fracture, facial bones fracture, fingers fracture and toes fracture, fractures with high trauma severity, and pathological fractures.|participants|Number|241|241.0||||||
3824207|NCT01732770|3649930|B2|Prior osteoporotic fracture||Historical Fractures|An osteoporotic fracture is defined as a reported fracture excluding skull fracture, facial bones fracture, fingers fracture and toes fracture, fractures with high trauma severity, and pathological fractures.|participants|Number|120|120.0||||||
3824208|NCT01732770|3649931|B1|Prior osteoporotic fracture||Historical Fractures|An osteoporotic fracture is defined as a reported fracture excluding skull fracture, facial bones fracture, fingers fracture and toes fracture, fractures with high trauma severity, and pathological fractures.|participants|Number|121|121.0||||||
3824209|NCT01732770|3649929|B3|Any prior fracture||Historical Fractures|An osteoporotic fracture is defined as a reported fracture excluding skull fracture, facial bones fracture, fingers fracture and toes fracture, fractures with high trauma severity, and pathological fractures.|participants|Number|328|328.0||||||
3824210|NCT01732770|3649930|B2|Any prior fracture||Historical Fractures|An osteoporotic fracture is defined as a reported fracture excluding skull fracture, facial bones fracture, fingers fracture and toes fracture, fractures with high trauma severity, and pathological fractures.|participants|Number|169|169.0||||||
3824211|NCT01732770|3649931|B1|Any prior fracture||Historical Fractures|An osteoporotic fracture is defined as a reported fracture excluding skull fracture, facial bones fracture, fingers fracture and toes fracture, fractures with high trauma severity, and pathological fractures.|participants|Number|159|159.0||||||
3824212|NCT01732770|3649929|B3|||Prior Oral Bisphosphonate Duration||years|Mean|6.28|6.28|Standard Deviation|3.76|3.76|||
3824213|NCT01732770|3649930|B2|||Prior Oral Bisphosphonate Duration||years|Mean|6.21|6.21|Standard Deviation|3.84|3.84|||
3824214|NCT01732770|3649931|B1|||Prior Oral Bisphosphonate Duration||years|Mean|6.35|6.35|Standard Deviation|3.68|3.68|||
3824215|NCT01732770|3649929|B3|||Femoral Neck BMD T-score||T-score|Mean|-2.17|-2.17|Standard Deviation|0.67|0.67|||
3824216|NCT01732770|3649930|B2|||Femoral Neck BMD T-score||T-score|Mean|-2.17|-2.17|Standard Deviation|0.66|0.66|||
3824217|NCT01732770|3649931|B1|||Femoral Neck BMD T-score||T-score|Mean|-2.17|-2.17|Standard Deviation|0.68|0.68|||
3824218|NCT01732770|3649929|B3|||Total Hip BMD T-score||T-score|Mean|-1.93|-1.93|Standard Deviation|0.77|0.77|||
3824219|NCT01732770|3649930|B2|||Total Hip BMD T-score||T-score|Mean|-1.93|-1.93|Standard Deviation|0.74|0.74|||
3824220|NCT01732770|3649931|B1|||Total Hip BMD T-score||T-score|Mean|-1.93|-1.93|Standard Deviation|0.80|0.8|||
3824221|NCT01732770|3649929|B3|||Lumbar Spine Bone Mineral Density (BMD) T-score|BMD was measured using dual-energy x-ray absorptiometry (DXA) of the lumbar spine. The T-score is a comparison of a person's bone density with that of a healthy 30-year-old of the same sex. Lower scores (more negative) mean lower bone density: A T-score of -2.5 or lower qualifies as osteoporosis and a T-score of -1.0 to -2.5 signifies osteopenia, meaning below-normal bone density without full osteoporosis.|T-score|Mean|-2.69|-2.69|Standard Deviation|0.84|0.84|||
3824222|NCT01732770|3649930|B2|||Lumbar Spine Bone Mineral Density (BMD) T-score|BMD was measured using dual-energy x-ray absorptiometry (DXA) of the lumbar spine. The T-score is a comparison of a person's bone density with that of a healthy 30-year-old of the same sex. Lower scores (more negative) mean lower bone density: A T-score of -2.5 or lower qualifies as osteoporosis and a T-score of -1.0 to -2.5 signifies osteopenia, meaning below-normal bone density without full osteoporosis.|T-score|Mean|-2.74|-2.74|Standard Deviation|0.83|0.83|||
3824223|NCT01732770|3649931|B1|||Lumbar Spine Bone Mineral Density (BMD) T-score|BMD was measured using dual-energy x-ray absorptiometry (DXA) of the lumbar spine. The T-score is a comparison of a person's bone density with that of a healthy 30-year-old of the same sex. Lower scores (more negative) mean lower bone density: A T-score of -2.5 or lower qualifies as osteoporosis and a T-score of -1.0 to -2.5 signifies osteopenia, meaning below-normal bone density without full osteoporosis.|T-score|Mean|-2.64|-2.64|Standard Deviation|0.86|0.86|||
3824224|NCT01732770|3649929|B3|Missing||Screening serum CTX||participants|Number|2|2.0||||||
3824225|NCT01732770|3649930|B2|Missing||Screening serum CTX||participants|Number|0|0.0||||||
3824226|NCT01732770|3649931|B1|Missing||Screening serum CTX||participants|Number|2|2.0||||||
3824227|NCT01732770|3649929|B3|≥ 0.3 ng/mL||Screening serum CTX||participants|Number|160|160.0||||||
3824228|NCT01732770|3649930|B2|≥ 0.3 ng/mL||Screening serum CTX||participants|Number|82|82.0||||||
3824229|NCT01732770|3649931|B1|≥ 0.3 ng/mL||Screening serum CTX||participants|Number|78|78.0||||||
3824230|NCT01732770|3649929|B3|< 0.3 ng/mL||Screening serum CTX||participants|Number|481|481.0||||||
3824231|NCT01732770|3649930|B2|< 0.3 ng/mL||Screening serum CTX||participants|Number|239|239.0||||||
3824232|NCT01732770|3649931|B1|< 0.3 ng/mL||Screening serum CTX||participants|Number|242|242.0||||||
3824233|NCT01732770|3649929|B3|Multiple||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3824234|NCT01732770|3649930|B2|Multiple||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3824235|NCT01732770|3649931|B1|Multiple||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3824236|NCT01732770|3649929|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3824237|NCT01732770|3649930|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3824238|NCT01732770|3649931|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3824239|NCT01732770|3649929|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3824240|NCT01732770|3649930|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3824241|NCT01732770|3649931|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3824242|NCT01732770|3649929|B3|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3824243|NCT01732770|3649930|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3824244|NCT01732770|3649931|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3824245|NCT01732770|3649929|B3|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3824247|NCT01732770|3649931|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3824248|NCT01732770|3649929|B3|White||Race/Ethnicity, Customized||participants|Number|623|623.0||||||
3824249|NCT01732770|3649930|B2|White||Race/Ethnicity, Customized||participants|Number|309|309.0||||||
3824250|NCT01732770|3649931|B1|White||Race/Ethnicity, Customized||participants|Number|314|314.0||||||
3824251|NCT01732770|3649929|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3824252|NCT01732770|3649930|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3824253|NCT01732770|3649931|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3824254|NCT01732770|3649929|B3||Female|Sex: Female, Male||Participants|Count of Participants|643|643.0||||||
3824255|NCT01732770|3649930|B2||Female|Sex: Female, Male||Participants|Count of Participants|321|321.0||||||
3824256|NCT01732770|3649931|B1||Female|Sex: Female, Male||Participants|Count of Participants|322|322.0||||||
3824257|NCT01732770|3649929|B3|||Age||years|Mean|69.0|69.0|Standard Deviation|7.4|7.4|||
3824258|NCT01732770|3649930|B2|||Age||years|Mean|68.5|68.5|Standard Deviation|7.1|7.1|||
3824259|NCT01732770|3649931|B1|||Age||years|Mean|69.5|69.5|Standard Deviation|7.7|7.7|||
3824260|NCT01732757|3649944|B4||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3824261|NCT01732757|3649945|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3824262|NCT01732757|3649946|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3824263|NCT01732757|3649947|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3824264|NCT01732757|3649944|B4||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3824265|NCT01732757|3649945|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3824266|NCT01732757|3649946|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3824267|NCT01732757|3649947|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3824268|NCT01732757|3649944|B4|||Age||Years|Mean|37.2|37.2|Standard Deviation|13.88|13.88|||
3824269|NCT01732757|3649945|B3|||Age||Years|Mean|34.7|34.7|Standard Deviation|12.58|12.58|||
3824270|NCT01732757|3649946|B2|||Age||Years|Mean|38.7|38.7|Standard Deviation|15.10|15.1|||
3824271|NCT01732757|3649947|B1|||Age||Years|Mean|38.2|38.2|Standard Deviation|13.78|13.78|||
3824272|NCT01732692|3649987|B3|Kazakhstan||Region of Enrollment||participants|Number|20|20.0||||||
3824273|NCT01732692|3649988|B2|Kazakhstan||Region of Enrollment||participants|Number|7|7.0||||||
3824274|NCT01732692|3649989|B1|Kazakhstan||Region of Enrollment||participants|Number|13|13.0||||||
3824275|NCT01732692|3649987|B3|Russia||Region of Enrollment||participants|Number|120|120.0||||||
3824276|NCT01732692|3649988|B2|Russia||Region of Enrollment||participants|Number|63|63.0||||||
3824277|NCT01732692|3649989|B1|Russia||Region of Enrollment||participants|Number|57|57.0||||||
3824278|NCT01732692|3649987|B3|||Body Mass Index (BMI)||kg/m^2|Mean|25.1|25.1|Standard Deviation|5.25|5.25|||
3824279|NCT01732692|3649988|B2|||Body Mass Index (BMI)||kg/m^2|Mean|25.1|25.1|Standard Deviation|5.10|5.1|||
3824280|NCT01732692|3649989|B1|||Body Mass Index (BMI)||kg/m^2|Mean|25.1|25.1|Standard Deviation|5.30|5.3|||
3824281|NCT01732692|3649987|B3|||Weight||kg|Mean|71.1|71.1|Standard Deviation|15.75|15.75|||
3824282|NCT01732692|3649988|B2|||Weight||kg|Mean|68.3|68.3|Standard Deviation|13.86|13.86|||
3824283|NCT01732692|3649989|B1|||Weight||kg|Mean|73.5|73.5|Standard Deviation|16.92|16.92|||
3824284|NCT01732692|3649987|B3|||Height||cm|Mean|168.1|168.1|Standard Deviation|9.07|9.07|||
3824285|NCT01732692|3649988|B2|||Height||cm|Mean|165.1|165.1|Standard Deviation|7.83|7.83|||
3824286|NCT01732692|3649989|B1|||Height||cm|Mean|171.1|171.1|Standard Deviation|9.36|9.36|||
3824287|NCT01732692|3649987|B3|White||Race/Ethnicity, Customized||participants|Number|130|130.0||||||
3824288|NCT01732692|3649988|B2|White||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
3824289|NCT01732692|3649989|B1|White||Race/Ethnicity, Customized||participants|Number|64|64.0||||||
3824290|NCT01732692|3649987|B3|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3824291|NCT01732692|3649988|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3824292|NCT01732692|3649989|B1|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3824293|NCT01732692|3649987|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3824294|NCT01732692|3649988|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3824295|NCT01732692|3649989|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3824296|NCT01732692|3649987|B3||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3824297|NCT01732692|3649988|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3824298|NCT01732692|3649989|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3824299|NCT01732692|3649987|B3|||Age||years|Mean|49.8|49.8|Standard Deviation|16.79|16.79|||
3824300|NCT01732692|3649988|B2|||Age||years|Mean|49.1|49.1|Standard Deviation|16.26|16.26|||
3824301|NCT01732692|3649989|B1|||Age||years|Mean|50.3|50.3|Standard Deviation|17.41|17.41|||
3824302|NCT01732640|3650004|B1||Oral Cavity|Disease Site||Participants|Count of Participants|1|1.0||||||
3824303|NCT01732640|3650004|B1||Oropharynx|Disease Site||Participants|Count of Participants|6|6.0||||||
3824304|NCT01732640|3650004|B1||Larynx|Disease Site||Participants|Count of Participants|2|2.0||||||
3824305|NCT01732640|3650004|B1|1||ECOG Status|ECOG of 0 is best value; Normal, no complaints. ECOG of 1 is second best value; Able to carry on normal activities. Minor signs or symptoms of disease.|Participants|Count of Participants|3|3.0||||||
3824306|NCT01732640|3650004|B1|0||ECOG Status|ECOG of 0 is best value; Normal, no complaints. ECOG of 1 is second best value; Able to carry on normal activities. Minor signs or symptoms of disease.|Participants|Count of Participants|6|6.0||||||
3824307|NCT01732640|3650004|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3824308|NCT01732640|3650004|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824309|NCT01732640|3650004|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824310|NCT01732640|3650004|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3824311|NCT01732640|3650004|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3824312|NCT01732640|3650004|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824313|NCT01732640|3650004|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824314|NCT01732640|3650004|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824315|NCT01732640|3650004|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824316|NCT01732640|3650004|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3824317|NCT01732640|3650004|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824318|NCT01732640|3650004|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3824319|NCT01732640|3650004|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3824320|NCT01732640|3650004|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3824321|NCT01732640|3650004|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3824322|NCT01732640|3650004|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3824323|NCT01732588|3650020|B4|||weight||kg|Mean|77.95|77.95|Standard Deviation|10.58|10.58|||
3824324|NCT01732588|3650021|B3|||weight||kg|Mean|80.83|80.83|Standard Deviation|1.44|1.44|||
3824325|NCT01732588|3650022|B2|||weight||kg|Mean|68|68.0|Standard Deviation|8.86|8.86|||
3824326|NCT01732588|3650023|B1|||weight||kg|Mean|82.53|82.53|Standard Deviation|13.44|13.44|||
3824327|NCT01732588|3650020|B4|||Body Mass Index||kg/m^2|Mean|26.09|26.09|Standard Deviation|2.47|2.47|||
3824328|NCT01732588|3650021|B3|||Body Mass Index||kg/m^2|Mean|26.75|26.75|Standard Deviation|1.89|1.89|||
3824329|NCT01732588|3650022|B2|||Body Mass Index||kg/m^2|Mean|24.67|24.67|Standard Deviation|0.58|0.58|||
3824330|NCT01732588|3650023|B1|||Body Mass Index||kg/m^2|Mean|26.50|26.5|Standard Deviation|3.7|3.7|||
3824331|NCT01732588|3650020|B4|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
3824332|NCT01732588|3650021|B3|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3824333|NCT01732588|3650022|B2|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3824334|NCT01732588|3650023|B1|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3824335|NCT01732588|3650020|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3824336|NCT01732588|3650021|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3824337|NCT01732588|3650022|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3824338|NCT01732588|3650023|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3824339|NCT01732588|3650020|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3824340|NCT01732588|3650021|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3824341|NCT01732588|3650022|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3824342|NCT01732588|3650023|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3824343|NCT01732588|3650020|B4|||Age||years|Mean|38.1|38.1|Standard Deviation|11.8|11.8|||
3824344|NCT01732588|3650021|B3|||Age||years|Mean|36.8|36.8|Standard Deviation|12.3|12.3|||
3824345|NCT01732588|3650022|B2|||Age||years|Mean|35.3|35.3|Standard Deviation|14.6|14.6|||
3824346|NCT01732588|3650023|B1|||Age||years|Mean|41.5|41.5|Standard Deviation|12.0|12.0|||
3824347|NCT01732549|3650039|B3|Western Europe||Region||participants|Number|110|110.0||||||
3824348|NCT01732549|3650040|B2|Western Europe||Region||participants|Number|57|57.0||||||
3824349|NCT01732549|3650041|B1|Western Europe||Region||participants|Number|53|53.0||||||
3824350|NCT01732549|3650039|B3|Eastern Europe||Region||participants|Number|34|34.0||||||
3824351|NCT01732549|3650040|B2|Eastern Europe||Region||participants|Number|16|16.0||||||
3824352|NCT01732549|3650041|B1|Eastern Europe||Region||participants|Number|18|18.0||||||
3824353|NCT01732549|3650039|B3|Missing||ECOG Performance Status Score|Eastern Co-operative Oncology Group (ECOG) Score: 0=Fully active, able to carry on all pre-disease performance without restriction, 1=Restricted in physically strenuous activity, but ambulatory & able to carry out work of a light or sedentary nature, e.g. light house work, office work, 2=Ambulatory & capable of all self-care but unable to carry out any work activities. Up & about more than 50% of waking hours, 3=Capable of limited self-care,confined to bed or chair more than 50% of waking hours, 4=Completely disabled. Cannot carry on any self care. Totally confined to bed or chair, 5=Dead|participants|Number|4|4.0||||||
3824354|NCT01732549|3650040|B2|Missing||ECOG Performance Status Score|Eastern Co-operative Oncology Group (ECOG) Score: 0=Fully active, able to carry on all pre-disease performance without restriction, 1=Restricted in physically strenuous activity, but ambulatory & able to carry out work of a light or sedentary nature, e.g. light house work, office work, 2=Ambulatory & capable of all self-care but unable to carry out any work activities. Up & about more than 50% of waking hours, 3=Capable of limited self-care,confined to bed or chair more than 50% of waking hours, 4=Completely disabled. Cannot carry on any self care. Totally confined to bed or chair, 5=Dead|participants|Number|4|4.0||||||
3824355|NCT01732549|3650041|B1|Missing||ECOG Performance Status Score|Eastern Co-operative Oncology Group (ECOG) Score: 0=Fully active, able to carry on all pre-disease performance without restriction, 1=Restricted in physically strenuous activity, but ambulatory & able to carry out work of a light or sedentary nature, e.g. light house work, office work, 2=Ambulatory & capable of all self-care but unable to carry out any work activities. Up & about more than 50% of waking hours, 3=Capable of limited self-care,confined to bed or chair more than 50% of waking hours, 4=Completely disabled. Cannot carry on any self care. Totally confined to bed or chair, 5=Dead|participants|Number|0|0.0||||||
3824356|NCT01732549|3650039|B3|1 (Restricted Activity)||ECOG Performance Status Score|Eastern Co-operative Oncology Group (ECOG) Score: 0=Fully active, able to carry on all pre-disease performance without restriction, 1=Restricted in physically strenuous activity, but ambulatory & able to carry out work of a light or sedentary nature, e.g. light house work, office work, 2=Ambulatory & capable of all self-care but unable to carry out any work activities. Up & about more than 50% of waking hours, 3=Capable of limited self-care,confined to bed or chair more than 50% of waking hours, 4=Completely disabled. Cannot carry on any self care. Totally confined to bed or chair, 5=Dead|participants|Number|70|70.0||||||
3824357|NCT01732549|3650040|B2|1 (Restricted Activity)||ECOG Performance Status Score|Eastern Co-operative Oncology Group (ECOG) Score: 0=Fully active, able to carry on all pre-disease performance without restriction, 1=Restricted in physically strenuous activity, but ambulatory & able to carry out work of a light or sedentary nature, e.g. light house work, office work, 2=Ambulatory & capable of all self-care but unable to carry out any work activities. Up & about more than 50% of waking hours, 3=Capable of limited self-care,confined to bed or chair more than 50% of waking hours, 4=Completely disabled. Cannot carry on any self care. Totally confined to bed or chair, 5=Dead|participants|Number|38|38.0||||||
3824358|NCT01732549|3650041|B1|1 (Restricted Activity)||ECOG Performance Status Score|Eastern Co-operative Oncology Group (ECOG) Score: 0=Fully active, able to carry on all pre-disease performance without restriction, 1=Restricted in physically strenuous activity, but ambulatory & able to carry out work of a light or sedentary nature, e.g. light house work, office work, 2=Ambulatory & capable of all self-care but unable to carry out any work activities. Up & about more than 50% of waking hours, 3=Capable of limited self-care,confined to bed or chair more than 50% of waking hours, 4=Completely disabled. Cannot carry on any self care. Totally confined to bed or chair, 5=Dead|participants|Number|32|32.0||||||
3824359|NCT01732549|3650039|B3|0 (Normal Activity)||ECOG Performance Status Score|Eastern Co-operative Oncology Group (ECOG) Score: 0=Fully active, able to carry on all pre-disease performance without restriction, 1=Restricted in physically strenuous activity, but ambulatory & able to carry out work of a light or sedentary nature, e.g. light house work, office work, 2=Ambulatory & capable of all self-care but unable to carry out any work activities. Up & about more than 50% of waking hours, 3=Capable of limited self-care,confined to bed or chair more than 50% of waking hours, 4=Completely disabled. Cannot carry on any self care. Totally confined to bed or chair, 5=Dead|participants|Number|70|70.0||||||
3824360|NCT01732549|3650040|B2|0 (Normal Activity)||ECOG Performance Status Score|Eastern Co-operative Oncology Group (ECOG) Score: 0=Fully active, able to carry on all pre-disease performance without restriction, 1=Restricted in physically strenuous activity, but ambulatory & able to carry out work of a light or sedentary nature, e.g. light house work, office work, 2=Ambulatory & capable of all self-care but unable to carry out any work activities. Up & about more than 50% of waking hours, 3=Capable of limited self-care,confined to bed or chair more than 50% of waking hours, 4=Completely disabled. Cannot carry on any self care. Totally confined to bed or chair, 5=Dead|participants|Number|31|31.0||||||
3824361|NCT01732549|3650041|B1|0 (Normal Activity)||ECOG Performance Status Score|Eastern Co-operative Oncology Group (ECOG) Score: 0=Fully active, able to carry on all pre-disease performance without restriction, 1=Restricted in physically strenuous activity, but ambulatory & able to carry out work of a light or sedentary nature, e.g. light house work, office work, 2=Ambulatory & capable of all self-care but unable to carry out any work activities. Up & about more than 50% of waking hours, 3=Capable of limited self-care,confined to bed or chair more than 50% of waking hours, 4=Completely disabled. Cannot carry on any self care. Totally confined to bed or chair, 5=Dead|participants|Number|39|39.0||||||
3824362|NCT01732549|3650039|B3|Missing||Ethnicity||participants|Number|31|31.0||||||
3824363|NCT01732549|3650040|B2|Missing||Ethnicity||participants|Number|14|14.0||||||
3824364|NCT01732549|3650041|B1|Missing||Ethnicity||participants|Number|17|17.0||||||
3824365|NCT01732549|3650039|B3|Not Hispanic or Latino||Ethnicity||participants|Number|107|107.0||||||
3824366|NCT01732549|3650040|B2|Not Hispanic or Latino||Ethnicity||participants|Number|55|55.0||||||
3824367|NCT01732549|3650041|B1|Not Hispanic or Latino||Ethnicity||participants|Number|52|52.0||||||
3824368|NCT01732549|3650039|B3|Hispanic or Latino||Ethnicity||participants|Number|6|6.0||||||
3824369|NCT01732549|3650040|B2|Hispanic or Latino||Ethnicity||participants|Number|4|4.0||||||
3824370|NCT01732549|3650041|B1|Hispanic or Latino||Ethnicity||participants|Number|2|2.0||||||
3824371|NCT01732549|3650039|B3|||BMI||kg/m^2|Mean|27.84|27.84|Standard Deviation|3.987|3.987|||
3824372|NCT01732549|3650040|B2|||BMI||kg/m^2|Mean|28.01|28.01|Standard Deviation|4.399|4.399|||
3824373|NCT01732549|3650041|B1|||BMI||kg/m^2|Mean|27.67|27.67|Standard Deviation|3.543|3.543|||
3824374|NCT01732549|3650039|B3|||Weight||kg|Mean|83.6|83.6|Standard Deviation|13.86|13.86|||
3824375|NCT01732549|3650040|B2|||Weight||kg|Mean|83.4|83.4|Standard Deviation|15.09|15.09|||
3824376|NCT01732549|3650041|B1|||Weight||kg|Mean|83.7|83.7|Standard Deviation|12.57|12.57|||
3824377|NCT01732549|3650039|B3|Spain||Region of Enrollment||participants|Number|15|15.0||||||
3824378|NCT01732549|3650040|B2|Spain||Region of Enrollment||participants|Number|10|10.0||||||
3824379|NCT01732549|3650041|B1|Spain||Region of Enrollment||participants|Number|5|5.0||||||
3824380|NCT01732549|3650039|B3|Germany||Region of Enrollment||participants|Number|6|6.0||||||
3824381|NCT01732549|3650040|B2|Germany||Region of Enrollment||participants|Number|3|3.0||||||
3824382|NCT01732549|3650041|B1|Germany||Region of Enrollment||participants|Number|3|3.0||||||
3824383|NCT01732549|3650039|B3|Lithuania||Region of Enrollment||participants|Number|17|17.0||||||
3824384|NCT01732549|3650040|B2|Lithuania||Region of Enrollment||participants|Number|10|10.0||||||
3824385|NCT01732549|3650041|B1|Lithuania||Region of Enrollment||participants|Number|7|7.0||||||
3824386|NCT01732549|3650039|B3|France||Region of Enrollment||participants|Number|31|31.0||||||
3824387|NCT01732549|3650040|B2|France||Region of Enrollment||participants|Number|14|14.0||||||
3824388|NCT01732549|3650041|B1|France||Region of Enrollment||participants|Number|17|17.0||||||
3824389|NCT01732549|3650039|B3|United Kingdom||Region of Enrollment||participants|Number|14|14.0||||||
3824390|NCT01732549|3650040|B2|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3824391|NCT01732549|3650041|B1|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3824392|NCT01732549|3650039|B3|Italy||Region of Enrollment||participants|Number|14|14.0||||||
3824393|NCT01732549|3650040|B2|Italy||Region of Enrollment||participants|Number|5|5.0||||||
3824394|NCT01732549|3650041|B1|Italy||Region of Enrollment||participants|Number|9|9.0||||||
3824395|NCT01732549|3650039|B3|Poland||Region of Enrollment||participants|Number|7|7.0||||||
3824396|NCT01732549|3650040|B2|Poland||Region of Enrollment||participants|Number|3|3.0||||||
3824397|NCT01732549|3650041|B1|Poland||Region of Enrollment||participants|Number|4|4.0||||||
3824398|NCT01732549|3650039|B3|Denmark||Region of Enrollment||participants|Number|19|19.0||||||
3824399|NCT01732549|3650040|B2|Denmark||Region of Enrollment||participants|Number|13|13.0||||||
3824400|NCT01732549|3650041|B1|Denmark||Region of Enrollment||participants|Number|6|6.0||||||
3824401|NCT01732549|3650039|B3|Hungary||Region of Enrollment||participants|Number|4|4.0||||||
3824402|NCT01732549|3650040|B2|Hungary||Region of Enrollment||participants|Number|2|2.0||||||
3824403|NCT01732549|3650041|B1|Hungary||Region of Enrollment||participants|Number|2|2.0||||||
3824404|NCT01732549|3650039|B3|Belgium||Region of Enrollment||participants|Number|11|11.0||||||
3824405|NCT01732549|3650040|B2|Belgium||Region of Enrollment||participants|Number|6|6.0||||||
3824406|NCT01732549|3650041|B1|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
3824407|NCT01732549|3650039|B3|Czech Republic||Region of Enrollment||participants|Number|6|6.0||||||
3824408|NCT01732549|3650040|B2|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
3824409|NCT01732549|3650041|B1|Czech Republic||Region of Enrollment||participants|Number|5|5.0||||||
3824410|NCT01732549|3650039|B3|Missing||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3824411|NCT01732549|3650040|B2|Missing||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3824412|NCT01732549|3650041|B1|Missing||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3824413|NCT01732549|3650039|B3|Multiple Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3824414|NCT01732549|3650040|B2|Multiple Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3824415|NCT01732549|3650041|B1|Multiple Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3824416|NCT01732549|3650039|B3|Caucasian/White||Race/Ethnicity, Customized||participants|Number|110|110.0||||||
3824417|NCT01732549|3650040|B2|Caucasian/White||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
3824418|NCT01732549|3650041|B1|Caucasian/White||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
3824419|NCT01732549|3650039|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3824420|NCT01732549|3650040|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3824421|NCT01732549|3650041|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3824422|NCT01732549|3650039|B3||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3824423|NCT01732549|3650040|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3824424|NCT01732549|3650041|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3824425|NCT01732549|3650039|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3824426|NCT01732549|3650040|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3824427|NCT01732549|3650041|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3824428|NCT01732549|3650039|B3|> 75 years||Age, Customized||participants|Number|24|24.0||||||
3824429|NCT01732549|3650040|B2|> 75 years||Age, Customized||participants|Number|11|11.0||||||
3824430|NCT01732549|3650041|B1|> 75 years||Age, Customized||participants|Number|13|13.0||||||
3824431|NCT01732549|3650039|B3|66 to ≤ 75 years||Age, Customized||participants|Number|85|85.0||||||
3824432|NCT01732549|3650040|B2|66 to ≤ 75 years||Age, Customized||participants|Number|45|45.0||||||
3824433|NCT01732549|3650041|B1|66 to ≤ 75 years||Age, Customized||participants|Number|40|40.0||||||
3824434|NCT01732549|3650039|B3|18 to ≤ 65 years||Age, Customized||participants|Number|35|35.0||||||
3824435|NCT01732549|3650040|B2|18 to ≤ 65 years||Age, Customized||participants|Number|17|17.0||||||
3824436|NCT01732549|3650041|B1|18 to ≤ 65 years||Age, Customized||participants|Number|18|18.0||||||
3824437|NCT01732549|3650039|B3|||Age||years|Mean|69.6|69.6|Standard Deviation|6.39|6.39|||
3824438|NCT01732549|3650040|B2|||Age||years|Mean|69.6|69.6|Standard Deviation|5.57|5.57|||
3824439|NCT01732549|3650041|B1|||Age||years|Mean|69.6|69.6|Standard Deviation|7.18|7.18|||
3824440|NCT01732536|3650062|B3|United States||Region of Enrollment||Participants|Count of Participants|100|100.0||||||
3824441|NCT01732536|3650063|B2|United States||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
3824442|NCT01732536|3650064|B1|United States||Region of Enrollment||Participants|Count of Participants|53|53.0||||||
3824443|NCT01732536|3650062|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824444|NCT01732536|3650063|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824445|NCT01732536|3650064|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824446|NCT01732536|3650062|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824447|NCT01732536|3650063|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824448|NCT01732536|3650064|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824449|NCT01732536|3650062|B3||White|Race (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3824450|NCT01732536|3650063|B2||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3824451|NCT01732536|3650064|B1||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3824452|NCT01732536|3650062|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3824453|NCT01732536|3650063|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3824454|NCT01732536|3650064|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3824455|NCT01732536|3650062|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824456|NCT01732536|3650063|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824457|NCT01732536|3650064|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824458|NCT01732536|3650062|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3824459|NCT01732536|3650063|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3824460|NCT01732536|3650064|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824461|NCT01732536|3650062|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824462|NCT01732536|3650063|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824463|NCT01732536|3650064|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824464|NCT01732536|3650062|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824465|NCT01732536|3650063|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824466|NCT01732536|3650064|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824467|NCT01732536|3650062|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3824468|NCT01732536|3650063|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3824469|NCT01732536|3650064|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3824470|NCT01732536|3650062|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3824471|NCT01732536|3650063|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3824472|NCT01732536|3650064|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3824473|NCT01732536|3650062|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3824474|NCT01732536|3650063|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3824475|NCT01732536|3650064|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3824476|NCT01732536|3650062|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3824477|NCT01732536|3650063|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3824478|NCT01732536|3650064|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3824479|NCT01732536|3650062|B3|||Age||years|Mean|49.6|49.6|Standard Deviation|12.93|12.93|||
3824480|NCT01732536|3650063|B2|||Age||years|Mean|51.6|51.6|Standard Deviation|13.12|13.12|||
3824481|NCT01732536|3650064|B1|||Age||years|Mean|47.8|47.8|Standard Deviation|12.61|12.61|||
3824482|NCT01732510|3650081|B8||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3824483|NCT01732510|3650082|B7||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3824484|NCT01732510|3650083|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3824485|NCT01732510|3650084|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3824486|NCT01732510|3650085|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3824487|NCT01732510|3650086|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3824488|NCT01732510|3650087|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3824489|NCT01732510|3650088|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3824490|NCT01732510|3650081|B8||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3824491|NCT01732510|3650082|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3824492|NCT01732510|3650083|B6||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3824493|NCT01732510|3650084|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3824494|NCT01732510|3650085|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3824495|NCT01732510|3650086|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3824496|NCT01732510|3650087|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3824497|NCT01732510|3650088|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3824498|NCT01732510|3650081|B8|||Age||years|Mean|38.0|38.0|Standard Deviation|12.9|12.9|||
3824499|NCT01732510|3650082|B7|||Age||years|Mean|33.9|33.9|Standard Deviation|12.9|12.9|||
3824500|NCT01732510|3650083|B6|||Age||years|Mean|38.3|38.3|Standard Deviation|11.5|11.5|||
3824501|NCT01732510|3650084|B5|||Age||years|Mean|37.8|37.8|Standard Deviation|14.2|14.2|||
3824502|NCT01732510|3650085|B4|||Age||years|Mean|34.7|34.7|Standard Deviation|10.2|10.2|||
3824503|NCT01732510|3650086|B3|||Age||years|Mean|41.6|41.6|Standard Deviation|12.6|12.6|||
3824504|NCT01732510|3650087|B2|||Age||years|Mean|30.8|30.8|Standard Deviation|13.4|13.4|||
3824505|NCT01732510|3650088|B1|||Age||years|Mean|49.0|49.0|Standard Deviation|11.8|11.8|||
3824506|NCT01732510|3650081|B8||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3824507|NCT01732510|3650082|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3824508|NCT01732510|3650083|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3824509|NCT01732510|3650084|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3824510|NCT01732510|3650085|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3824511|NCT01732510|3650086|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3824512|NCT01732510|3650087|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3824513|NCT01732510|3650088|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3824514|NCT01732510|3650081|B8||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
3824515|NCT01732510|3650082|B7||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3824516|NCT01732510|3650083|B6||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3824517|NCT01732510|3650084|B5||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3824518|NCT01732510|3650085|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3824519|NCT01732510|3650086|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3824520|NCT01732510|3650087|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3824521|NCT01732510|3650088|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3824522|NCT01732510|3650081|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3824523|NCT01732510|3650082|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3824524|NCT01732510|3650083|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3824525|NCT01732510|3650084|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3824526|NCT01732510|3650085|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3824527|NCT01732510|3650086|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3824528|NCT01732510|3650087|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3824529|NCT01732510|3650088|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3824530|NCT01732484|3650173|B1|Austria||Region of Enrollment||participants|Number|100|100.0||||||
3824531|NCT01732484|3650173|B1|Male||Gender||participants|Number|32|32.0||||||
3824532|NCT01732484|3650173|B1|Female||Gender||participants|Number|42|42.0||||||
3824533|NCT01732484|3650173|B1|||Age||years|Mean|72|72.0|Standard Deviation|9|9.0|||
3824534|NCT01732484|3650173|B1||>=65 years|Age||Participants|Count of Participants|100|100.0||||||
3824535|NCT01732484|3650173|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3824536|NCT01732484|3650173|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3824537|NCT01732471|3650181|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3824538|NCT01732471|3650181|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3824539|NCT01732471|3650181|B1|||Age||years|Mean|9.59|9.59|Standard Deviation|4.09|4.09|||
3824540|NCT01732458|3650188|B5||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3824541|NCT01732458|3650189|B4||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3824542|NCT01732458|3650190|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3824543|NCT01732458|3650191|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3824544|NCT01732458|3650192|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3824545|NCT01732458|3650188|B5||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3824546|NCT01732458|3650189|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3824547|NCT01732458|3650190|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3824548|NCT01732458|3650191|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3824549|NCT01732458|3650192|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3824550|NCT01732458|3650188|B5|12 years to 17 years||Age, Customized||participants|Number|58|58.0||||||
3824551|NCT01732458|3650189|B4|12 years to 17 years||Age, Customized||participants|Number|14|14.0||||||
3824552|NCT01732458|3650190|B3|12 years to 17 years||Age, Customized||participants|Number|14|14.0||||||
3824553|NCT01732458|3650191|B2|12 years to 17 years||Age, Customized||participants|Number|14|14.0||||||
3824554|NCT01732458|3650192|B1|12 years to 17 years||Age, Customized||participants|Number|16|16.0||||||
3824555|NCT01732458|3650188|B5|6 years to <12 years||Age, Customized||participants|Number|55|55.0||||||
3824556|NCT01732458|3650189|B4|6 years to <12 years||Age, Customized||participants|Number|13|13.0||||||
3824557|NCT01732458|3650190|B3|6 years to <12 years||Age, Customized||participants|Number|14|14.0||||||
3824558|NCT01732458|3650191|B2|6 years to <12 years||Age, Customized||participants|Number|15|15.0||||||
3824559|NCT01732458|3650192|B1|6 years to <12 years||Age, Customized||participants|Number|13|13.0||||||
3824560|NCT01732458|3650188|B5|2 years to <6 years||Age, Customized||participants|Number|57|57.0||||||
3824561|NCT01732458|3650189|B4|2 years to <6 years||Age, Customized||participants|Number|14|14.0||||||
3824562|NCT01732458|3650190|B3|2 years to <6 years||Age, Customized||participants|Number|15|15.0||||||
3824563|NCT01732458|3650191|B2|2 years to <6 years||Age, Customized||participants|Number|14|14.0||||||
3824564|NCT01732458|3650192|B1|2 years to <6 years||Age, Customized||participants|Number|14|14.0||||||
3824565|NCT01732458|3650188|B5|Birth to <2 years||Age, Customized||participants|Number|50|50.0||||||
3824566|NCT01732458|3650189|B4|Birth to <2 years||Age, Customized||participants|Number|11|11.0||||||
3824567|NCT01732458|3650190|B3|Birth to <2 years||Age, Customized||participants|Number|13|13.0||||||
3824568|NCT01732458|3650191|B2|Birth to <2 years||Age, Customized||participants|Number|12|12.0||||||
3824569|NCT01732458|3650192|B1|Birth to <2 years||Age, Customized||participants|Number|14|14.0||||||
3824570|NCT01732458|3650188|B5|||Age||months|Mean|87.3|87.3|Standard Deviation|63.0|63.0|||
3824571|NCT01732458|3650189|B4|||Age||months|Mean|86.0|86.0|Standard Deviation|65.0|65.0|||
3824572|NCT01732458|3650190|B3|||Age||months|Mean|85.1|85.1|Standard Deviation|59.7|59.7|||
3824573|NCT01732458|3650191|B2|||Age||months|Mean|87.5|87.5|Standard Deviation|64.6|64.6|||
3824574|NCT01732458|3650192|B1|||Age||months|Mean|90.4|90.4|Standard Deviation|64.3|64.3|||
3824575|NCT01732445|3650257|B1|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3824576|NCT01732445|3650257|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3824577|NCT01732445|3650257|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3824578|NCT01732445|3650257|B1|||Age||years|Median|70.5|70.5|Full Range|||43.0|78.0|
3824579|NCT01732263|3650264|B3|UNITED STATES||Region of Enrollment||Participants|Number|43|43.0||||||
3824580|NCT01732263|3650265|B2|UNITED STATES||Region of Enrollment||Participants|Number|20|20.0||||||
3824581|NCT01732263|3650266|B1|UNITED STATES||Region of Enrollment||Participants|Number|23|23.0||||||
3824582|NCT01732263|3650264|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3824583|NCT01732263|3650265|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3824584|NCT01732263|3650266|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3824585|NCT01732263|3650264|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3824586|NCT01732263|3650265|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3824587|NCT01732263|3650266|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3824588|NCT01732263|3650264|B3|Between 18 and 65 years||Age, Customized||Participants|Number|42|42.0||||||
3824589|NCT01732263|3650265|B2|Between 18 and 65 years||Age, Customized||Participants|Number|20|20.0||||||
3824590|NCT01732263|3650266|B1|Between 18 and 65 years||Age, Customized||Participants|Number|22|22.0||||||
3824591|NCT01732263|3650264|B3|>=65 years||Age, Customized||Participants|Number|1|1.0||||||
3824592|NCT01732263|3650265|B2|>=65 years||Age, Customized||Participants|Number|0|0.0||||||
3824593|NCT01732263|3650266|B1|>=65 years||Age, Customized||Participants|Number|1|1.0||||||
3824594|NCT01732263|3650264|B3|||Age||Years|Mean|55.7|55.7|Standard Deviation|5.28|5.28|||
3824595|NCT01732263|3650265|B2|||Age||Years|Mean|55.1|55.1|Standard Deviation|5.51|5.51|||
3824596|NCT01732263|3650266|B1|||Age||Years|Mean|56.3|56.3|Standard Deviation|5.13|5.13|||
3824597|NCT01732107|3650307|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3824598|NCT01732107|3650307|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3824599|NCT01732107|3650307|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824600|NCT01732107|3650307|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3824601|NCT01732107|3650307|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3824602|NCT01732107|3650307|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824603|NCT01732107|3650307|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824604|NCT01732107|3650307|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824605|NCT01732107|3650307|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824606|NCT01732107|3650307|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3824607|NCT01732107|3650307|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3824608|NCT01732107|3650307|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3824609|NCT01732107|3650307|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3824610|NCT01732107|3650307|B1|||Age||years|Median|70|70.0|Full Range|||57.0|78.0|
3824611|NCT01731990|3650322|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3824612|NCT01731990|3650323|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3824613|NCT01731990|3650324|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3824614|NCT01731990|3650322|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3824615|NCT01731990|3650323|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3824616|NCT01731990|3650324|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3824617|NCT01731990|3650322|B3|||Age||years|Mean|64.7|64.7|Standard Deviation|8.29|8.29|||
3824618|NCT01731990|3650323|B2|||Age||years|Mean|63.5|63.5|Standard Deviation|7.98|7.98|||
3824619|NCT01731990|3650324|B1|||Age||years|Mean|66.0|66.0|Standard Deviation|8.64|8.64|||
3824620|NCT01731938|3650337|B5|Not Specified||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3824621|NCT01731938|3650338|B4|Not Specified||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3824622|NCT01731938|3650339|B3|Not Specified||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3824623|NCT01731938|3650340|B2|Not Specified||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3824624|NCT01731938|3650341|B1|Not Specified||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3824625|NCT01731938|3650337|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|266|266.0||||||
3824626|NCT01731938|3650338|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|81|81.0||||||
3824627|NCT01731938|3650339|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|93|93.0||||||
3824628|NCT01731938|3650340|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
3824629|NCT01731938|3650341|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
3824630|NCT01731938|3650337|B5|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|57|57.0||||||
3824631|NCT01731938|3650338|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3824632|NCT01731938|3650339|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3824633|NCT01731938|3650340|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3824634|NCT01731938|3650341|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3824635|NCT01731938|3650337|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3824636|NCT01731938|3650338|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3824637|NCT01731938|3650339|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3824638|NCT01731938|3650340|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3824639|NCT01731938|3650341|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3824640|NCT01731938|3650337|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3824641|NCT01731938|3650338|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3824642|NCT01731938|3650339|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3824643|NCT01731938|3650340|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3824644|NCT01731938|3650341|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3824645|NCT01731938|3650337|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824646|NCT01731938|3650338|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824647|NCT01731938|3650339|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824648|NCT01731938|3650340|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824649|NCT01731938|3650341|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824650|NCT01731938|3650337|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|286|286.0||||||
3824651|NCT01731938|3650338|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3824652|NCT01731938|3650339|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3824653|NCT01731938|3650340|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3824654|NCT01731938|3650341|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3824655|NCT01731938|3650337|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3824656|NCT01731938|3650338|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3824657|NCT01731938|3650339|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3824658|NCT01731938|3650340|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3824659|NCT01731938|3650341|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3824660|NCT01731938|3650337|B5||Male|Gender||Participants|Count of Participants|99|99.0||||||
3824661|NCT01731938|3650338|B4||Male|Gender||Participants|Count of Participants|22|22.0||||||
3824662|NCT01731938|3650339|B3||Male|Gender||Participants|Count of Participants|29|29.0||||||
3824663|NCT01731938|3650340|B2||Male|Gender||Participants|Count of Participants|24|24.0||||||
3824664|NCT01731938|3650341|B1||Male|Gender||Participants|Count of Participants|24|24.0||||||
3824665|NCT01731938|3650337|B5||Female|Gender||Participants|Count of Participants|228|228.0||||||
3824666|NCT01731938|3650338|B4||Female|Gender||Participants|Count of Participants|86|86.0||||||
3824667|NCT01731938|3650339|B3||Female|Gender||Participants|Count of Participants|87|87.0||||||
3824668|NCT01731938|3650340|B2||Female|Gender||Participants|Count of Participants|28|28.0||||||
3824669|NCT01731938|3650341|B1||Female|Gender||Participants|Count of Participants|27|27.0||||||
3824670|NCT01731938|3650337|B5|>=65 years||Age, Customized||Participants|Count of Participants|66|66.0||||||
3824671|NCT01731938|3650338|B4|>=65 years||Age, Customized||Participants|Count of Participants|18|18.0||||||
3824672|NCT01731938|3650339|B3|>=65 years||Age, Customized||Participants|Count of Participants|17|17.0||||||
3824673|NCT01731938|3650340|B2|>=65 years||Age, Customized||Participants|Count of Participants|15|15.0||||||
3824674|NCT01731938|3650341|B1|>=65 years||Age, Customized||Participants|Count of Participants|16|16.0||||||
3824675|NCT01731938|3650337|B5|Between 18 and 64 years||Age, Customized||Participants|Count of Participants|243|243.0||||||
3824676|NCT01731938|3650338|B4|Between 18 and 64 years||Age, Customized||Participants|Count of Participants|90|90.0||||||
3824677|NCT01731938|3650339|B3|Between 18 and 64 years||Age, Customized||Participants|Count of Participants|98|98.0||||||
3824678|NCT01731938|3650340|B2|Between 18 and 64 years||Age, Customized||Participants|Count of Participants|28|28.0||||||
3824679|NCT01731938|3650341|B1|Between 18 and 64 years||Age, Customized||Participants|Count of Participants|27|27.0||||||
3824680|NCT01731938|3650337|B5|<18 years||Age, Customized||Participants|Count of Participants|18|18.0||||||
3824681|NCT01731938|3650338|B4|<18 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3824682|NCT01731938|3650339|B3|<18 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3824683|NCT01731938|3650340|B2|<18 years||Age, Customized||Participants|Count of Participants|9|9.0||||||
3824684|NCT01731938|3650341|B1|<18 years||Age, Customized||Participants|Count of Participants|8|8.0||||||
3824685|NCT01731938|3650337|B5|||Age||years|Mean|47.21|47.21|Standard Deviation|18.444|18.444|||
3824686|NCT01731938|3650338|B4|||Age||years|Mean|46.72|46.72|Standard Deviation|14.330|14.33|||
3824687|NCT01731938|3650339|B3|||Age||years|Mean|48.51|48.51|Standard Deviation|14.369|14.369|||
3824688|NCT01731938|3650340|B2|||Age||years|Mean|45.39|45.39|Standard Deviation|25.024|25.024|||
3824689|NCT01731938|3650341|B1|||Age||years|Mean|47.17|47.17|Standard Deviation|25.635|25.635|||
3824690|NCT01731470|3650354|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3824691|NCT01731470|3650354|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824692|NCT01731470|3650354|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824693|NCT01731470|3650354|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3824694|NCT01731470|3650354|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3824695|NCT01731470|3650354|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824696|NCT01731470|3650354|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824697|NCT01731470|3650354|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824698|NCT01731470|3650354|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
3824699|NCT01731470|3650354|B1||Female|Gender||Participants|Count of Participants|13|13.0||||||
3824700|NCT01731470|3650354|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3824701|NCT01731470|3650354|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3824702|NCT01731470|3650354|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3824703|NCT01731119|3650359|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3824704|NCT01731119|3650359|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824705|NCT01731119|3650359|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3824706|NCT01731119|3650359|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3824707|NCT01731119|3650359|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824708|NCT01731119|3650359|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824709|NCT01731119|3650359|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824710|NCT01731119|3650359|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824711|NCT01731119|3650359|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3824712|NCT01731119|3650359|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3824713|NCT01731119|3650359|B1|||Age||years|Mean|11.4|11.4|Standard Deviation|3.2|3.2|||
3824714|NCT01731041|3650367|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
3824715|NCT01731041|3650368|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3824716|NCT01731041|3650369|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3824717|NCT01731041|3650367|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824718|NCT01731041|3650368|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824719|NCT01731041|3650369|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824720|NCT01731041|3650367|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824721|NCT01731041|3650368|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824722|NCT01731041|3650369|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824723|NCT01731041|3650367|B3||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3824724|NCT01731041|3650368|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3824725|NCT01731041|3650369|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3824726|NCT01731041|3650367|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3824727|NCT01731041|3650368|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3824728|NCT01731041|3650369|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3824729|NCT01731041|3650367|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824730|NCT01731041|3650368|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824731|NCT01731041|3650369|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824732|NCT01731041|3650367|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3824733|NCT01731041|3650368|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3824734|NCT01731041|3650369|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824735|NCT01731041|3650367|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824736|NCT01731041|3650368|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824737|NCT01731041|3650369|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824738|NCT01731041|3650367|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3824739|NCT01731041|3650368|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3824740|NCT01731041|3650369|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3824741|NCT01731041|3650367|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3824742|NCT01731041|3650368|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3824743|NCT01731041|3650369|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3824744|NCT01731041|3650367|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3824745|NCT01731041|3650368|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3824746|NCT01731041|3650369|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3824747|NCT01731041|3650367|B3||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3824748|NCT01731041|3650368|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3824749|NCT01731041|3650369|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3824750|NCT01731041|3650367|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3824751|NCT01731041|3650368|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3824752|NCT01731041|3650369|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3824753|NCT01731002|3650378|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3824754|NCT01731002|3650379|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824755|NCT01731002|3650380|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3824756|NCT01731002|3650381|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824757|NCT01731002|3650378|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824758|NCT01731002|3650379|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824759|NCT01731002|3650380|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824760|NCT01731002|3650381|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824761|NCT01731002|3650378|B4||White|Race (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
3824762|NCT01731002|3650379|B3||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3824763|NCT01731002|3650380|B2||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3824764|NCT01731002|3650381|B1||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3824765|NCT01731002|3650378|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3824766|NCT01731002|3650379|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3824767|NCT01731002|3650380|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3824768|NCT01731002|3650381|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3824769|NCT01731002|3650378|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824770|NCT01731002|3650379|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824771|NCT01731002|3650380|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824772|NCT01731002|3650381|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824773|NCT01731002|3650378|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3824774|NCT01731002|3650379|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824775|NCT01731002|3650380|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3824776|NCT01731002|3650381|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3824777|NCT01731002|3650378|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824778|NCT01731002|3650379|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824779|NCT01731002|3650380|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824780|NCT01731002|3650381|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824781|NCT01731002|3650378|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824782|NCT01731002|3650379|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824783|NCT01731002|3650380|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824784|NCT01731002|3650381|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824785|NCT01731002|3650378|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|178|178.0||||||
3824786|NCT01731002|3650379|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3824787|NCT01731002|3650380|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3824788|NCT01731002|3650381|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3824789|NCT01731002|3650378|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3824790|NCT01731002|3650379|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3824791|NCT01731002|3650380|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3824792|NCT01731002|3650381|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3824793|NCT01731002|3650378|B4||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3824794|NCT01731002|3650379|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3824795|NCT01731002|3650380|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3824796|NCT01731002|3650381|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3824797|NCT01731002|3650378|B4||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3824798|NCT01731002|3650379|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3824799|NCT01731002|3650380|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3824800|NCT01731002|3650381|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3824801|NCT01731002|3650378|B4|||Age||years|Mean|65.1|65.1|Standard Deviation|11.26|11.26|||
3824802|NCT01731002|3650379|B3|||Age||years|Mean|65.7|65.7|Standard Deviation|11.82|11.82|||
3824803|NCT01731002|3650380|B2|||Age||years|Mean|66.3|66.3|Standard Deviation|10.25|10.25|||
3824804|NCT01731002|3650381|B1|||Age||years|Mean|63.5|63.5|Standard Deviation|11.54|11.54|||
3824805|NCT01730846|3650394|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3824806|NCT01730846|3650395|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3824807|NCT01730846|3650396|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3824808|NCT01730846|3650397|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3824809|NCT01730846|3650394|B4|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3824810|NCT01730846|3650395|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3824811|NCT01730846|3650396|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3824812|NCT01730846|3650397|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3824813|NCT01730846|3650394|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3824814|NCT01730846|3650395|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3824815|NCT01730846|3650396|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3824816|NCT01730846|3650397|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3824817|NCT01730846|3650394|B4|African American||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3824818|NCT01730846|3650395|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3824819|NCT01730846|3650396|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3824820|NCT01730846|3650397|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3824821|NCT01730846|3650394|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3824822|NCT01730846|3650395|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3824823|NCT01730846|3650396|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3824824|NCT01730846|3650397|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3824825|NCT01730846|3650394|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3824826|NCT01730846|3650395|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3824827|NCT01730846|3650396|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3824828|NCT01730846|3650397|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3824829|NCT01730846|3650394|B4|||Age||years|Mean|35.40|35.4|Standard Deviation|9.80|9.8|||
3824830|NCT01730846|3650395|B3|||Age||years|Mean|34.23|34.23|Standard Deviation|9.83|9.83|||
3824831|NCT01730846|3650396|B2|||Age||years|Mean|34.82|34.82|Standard Deviation|10.85|10.85|||
3824832|NCT01730846|3650397|B1|||Age||years|Mean|37.36|37.36|Standard Deviation|9.29|9.29|||
3824833|NCT01730378|3650410|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3824834|NCT01730378|3650411|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3824835|NCT01730378|3650412|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3824836|NCT01730378|3650410|B3||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3824837|NCT01730378|3650411|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3824838|NCT01730378|3650412|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3824839|NCT01730378|3650410|B3|||Age||Years|Mean|39.69|39.69|Standard Deviation|10.69|10.69|||
3824840|NCT01730378|3650411|B2|||Age||Years|Mean|40.4|40.4|Standard Deviation|10.3|10.3|||
3824841|NCT01730378|3650412|B1|||Age||Years|Mean|39.3|39.3|Standard Deviation|10.94|10.94|||
3824842|NCT01730339|3650442|B3|||Pre-Surgery Participant Photoguide Score|Participants rated severity of each scar using a photonumeric guide on a scale ranging from 1 to 5 (where 1 = minimal, 2 = mild, 3 = moderate, 4 = severe, 5 = very severe).|units on scale|Mean|4.26|4.26|Standard Deviation|0.639|0.639|||
3824843|NCT01730339|3650443|B2|||Pre-Surgery Participant Photoguide Score|Participants rated severity of each scar using a photonumeric guide on a scale ranging from 1 to 5 (where 1 = minimal, 2 = mild, 3 = moderate, 4 = severe, 5 = very severe).|units on scale|Mean|4.28|4.28|Standard Deviation|0.637|0.637|||
3824844|NCT01730339|3650444|B1|||Pre-Surgery Participant Photoguide Score|Participants rated severity of each scar using a photonumeric guide on a scale ranging from 1 to 5 (where 1 = minimal, 2 = mild, 3 = moderate, 4 = severe, 5 = very severe).|units on scale|Mean|4.24|4.24|Standard Deviation|0.648|0.648|||
3824845|NCT01730339|3650442|B3|||Pre-Surgery Physician Photoguide Score|Physician rated severity of each scar using a photonumeric guide on a scale ranging from 1 to 5 (where 1 = minimal, 2 = mild, 3 = moderate, 4 = severe, 5 = very severe).|units on scale|Mean|3.98|3.98|Standard Deviation|0.702|0.702|||
3824846|NCT01730339|3650443|B2|||Pre-Surgery Physician Photoguide Score|Physician rated severity of each scar using a photonumeric guide on a scale ranging from 1 to 5 (where 1 = minimal, 2 = mild, 3 = moderate, 4 = severe, 5 = very severe).|units on scale|Mean|3.98|3.98|Standard Deviation|0.725|0.725|||
3824847|NCT01730339|3650444|B1|||Pre-Surgery Physician Photoguide Score|Physician rated severity of each scar using a photonumeric guide on a scale ranging from 1 to 5 (where 1 = minimal, 2 = mild, 3 = moderate, 4 = severe, 5 = very severe).|units on scale|Mean|3.97|3.97|Standard Deviation|0.682|0.682|||
3824848|NCT01730339|3650442|B3|||Pre-Surgery Subject Global Assessment Score|Patient global assessment was performed using the overall opinion question of the POSAS scale. Participants were asked to rate the severity of their scar compared to normal skin. The overall opinion scale score ranged from 1 (normal skin) to 10 (very different from normal skin).|units on scale|Mean|8.72|8.72|Standard Deviation|1.465|1.465|||
3824849|NCT01730339|3650443|B2|||Pre-Surgery Subject Global Assessment Score|Patient global assessment was performed using the overall opinion question of the POSAS scale. Participants were asked to rate the severity of their scar compared to normal skin. The overall opinion scale score ranged from 1 (normal skin) to 10 (very different from normal skin).|units on scale|Mean|8.49|8.49|Standard Deviation|1.617|1.617|||
3824894|NCT01730053|3650482|B4|||Low density lipoprotein cholesterol (LDL-C) in mg/dL|Calculated LDL-C from Friedewald formula.|mg/dL|Mean|112.9|112.9|Standard Deviation|43.3|43.3|||
3824850|NCT01730339|3650444|B1|||Pre-Surgery Subject Global Assessment Score|Patient global assessment was performed using the overall opinion question of the POSAS scale. Participants were asked to rate the severity of their scar compared to normal skin. The overall opinion scale score ranged from 1 (normal skin) to 10 (very different from normal skin).|units on scale|Mean|9.00|9.0|Standard Deviation|1.219|1.219|||
3824851|NCT01730339|3650442|B3|||Pre-Surgery Physician Overall Opinion POSAS Score|Physician global assessment was performed using the overall opinion question of the POSAS scale. Physicians were asked to rate the severity of the participant’s scar compared to normal skin. The overall opinion scale score ranged from 1 (normal skin) to 10 (worst imaginable scar).|units on scale|Mean|6.76|6.76|Standard Deviation|1.404|1.404|||
3824852|NCT01730339|3650443|B2|||Pre-Surgery Physician Overall Opinion POSAS Score|Physician global assessment was performed using the overall opinion question of the POSAS scale. Physicians were asked to rate the severity of the participant’s scar compared to normal skin. The overall opinion scale score ranged from 1 (normal skin) to 10 (worst imaginable scar).|units on scale|Mean|6.88|6.88|Standard Deviation|1.277|1.277|||
3824853|NCT01730339|3650444|B1|||Pre-Surgery Physician Overall Opinion POSAS Score|Physician global assessment was performed using the overall opinion question of the POSAS scale. Physicians were asked to rate the severity of the participant’s scar compared to normal skin. The overall opinion scale score ranged from 1 (normal skin) to 10 (worst imaginable scar).|units on scale|Mean|6.62|6.62|Standard Deviation|1.545|1.545|||
3824854|NCT01730339|3650442|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3824855|NCT01730339|3650443|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824856|NCT01730339|3650444|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3824857|NCT01730339|3650442|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824858|NCT01730339|3650443|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824859|NCT01730339|3650444|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824860|NCT01730339|3650442|B3||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3824861|NCT01730339|3650443|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3824862|NCT01730339|3650444|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3824863|NCT01730339|3650442|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3824864|NCT01730339|3650443|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3824865|NCT01730339|3650444|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3824866|NCT01730339|3650442|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824867|NCT01730339|3650443|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824868|NCT01730339|3650444|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824869|NCT01730339|3650442|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3824870|NCT01730339|3650443|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824871|NCT01730339|3650444|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3824872|NCT01730339|3650442|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824873|NCT01730339|3650443|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824874|NCT01730339|3650444|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3824875|NCT01730339|3650442|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3824876|NCT01730339|3650443|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3824877|NCT01730339|3650444|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3824878|NCT01730339|3650442|B3||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3824879|NCT01730339|3650443|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3824880|NCT01730339|3650444|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3824881|NCT01730339|3650442|B3|||Age||years|Mean|37.9|37.9|Standard Deviation|9.13|9.13|||
3824882|NCT01730339|3650443|B2|||Age||years|Mean|37.6|37.6|Standard Deviation|9.64|9.64|||
3824883|NCT01730339|3650444|B1|||Age||years|Mean|38.2|38.2|Standard Deviation|8.55|8.55|||
3824884|NCT01730053|3650479|B7|||LDL-C in mmol/L|Calculated LDL-C from Friedewald formula.|mmol/L|Mean|2.882|2.882|Standard Deviation|1.009|1.009|||
3824885|NCT01730053|3650480|B6|||LDL-C in mmol/L|Calculated LDL-C from Friedewald formula.|mmol/L|Mean|3.065|3.065|Standard Deviation|0.834|0.834|||
3824886|NCT01730053|3650481|B5|||LDL-C in mmol/L|Calculated LDL-C from Friedewald formula.|mmol/L|Mean|3.082|3.082|Standard Deviation|1.243|1.243|||
3824887|NCT01730053|3650482|B4|||LDL-C in mmol/L|Calculated LDL-C from Friedewald formula.|mmol/L|Mean|2.924|2.924|Standard Deviation|1.122|1.122|||
3824888|NCT01730053|3650483|B3|||LDL-C in mmol/L|Calculated LDL-C from Friedewald formula.|mmol/L|Mean|2.78|2.78|Standard Deviation|0.684|0.684|||
3824889|NCT01730053|3650484|B2|||LDL-C in mmol/L|Calculated LDL-C from Friedewald formula.|mmol/L|Mean|2.653|2.653|Standard Deviation|1.085|1.085|||
3824890|NCT01730053|3650485|B1|||LDL-C in mmol/L|Calculated LDL-C from Friedewald formula.|mmol/L|Mean|2.743|2.743|Standard Deviation|0.933|0.933|||
3824891|NCT01730053|3650479|B7|||Low density lipoprotein cholesterol (LDL-C) in mg/dL|Calculated LDL-C from Friedewald formula.|mg/dL|Mean|111.3|111.3|Standard Deviation|39.0|39.0|||
3824892|NCT01730053|3650480|B6|||Low density lipoprotein cholesterol (LDL-C) in mg/dL|Calculated LDL-C from Friedewald formula.|mg/dL|Mean|118.3|118.3|Standard Deviation|32.2|32.2|||
3824893|NCT01730053|3650481|B5|||Low density lipoprotein cholesterol (LDL-C) in mg/dL|Calculated LDL-C from Friedewald formula.|mg/dL|Mean|119.0|119.0|Standard Deviation|48.0|48.0|||
3824947|NCT01730040|3650646|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3824895|NCT01730053|3650483|B3|||Low density lipoprotein cholesterol (LDL-C) in mg/dL|Calculated LDL-C from Friedewald formula.|mg/dL|Mean|107.3|107.3|Standard Deviation|26.4|26.4|||
3824896|NCT01730053|3650484|B2|||Low density lipoprotein cholesterol (LDL-C) in mg/dL|Calculated LDL-C from Friedewald formula.|mg/dL|Mean|102.4|102.4|Standard Deviation|41.9|41.9|||
3824897|NCT01730053|3650485|B1|||Low density lipoprotein cholesterol (LDL-C) in mg/dL|Calculated LDL-C from Friedewald formula.|mg/dL|Mean|105.9|105.9|Standard Deviation|36.0|36.0|||
3824898|NCT01730053|3650479|B7||Male|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
3824899|NCT01730053|3650480|B6||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3824900|NCT01730053|3650481|B5||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3824901|NCT01730053|3650482|B4||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3824902|NCT01730053|3650483|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3824903|NCT01730053|3650484|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3824904|NCT01730053|3650485|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3824905|NCT01730053|3650479|B7||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3824906|NCT01730053|3650480|B6||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3824907|NCT01730053|3650481|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3824908|NCT01730053|3650482|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3824909|NCT01730053|3650483|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3824910|NCT01730053|3650484|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3824911|NCT01730053|3650485|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3824912|NCT01730053|3650479|B7|||Age||years|Mean|60.9|60.9|Standard Deviation|10.4|10.4|||
3824913|NCT01730053|3650480|B6|||Age||years|Mean|57.9|57.9|Standard Deviation|8.86|8.86|||
3824914|NCT01730053|3650481|B5|||Age||years|Mean|63.1|63.1|Standard Deviation|10.2|10.2|||
3824915|NCT01730053|3650482|B4|||Age||years|Mean|60.6|60.6|Standard Deviation|10.11|10.11|||
3824916|NCT01730053|3650483|B3|||Age||years|Mean|62.2|62.2|Standard Deviation|11.11|11.11|||
3824917|NCT01730053|3650484|B2|||Age||years|Mean|60.4|60.4|Standard Deviation|10.38|10.38|||
3824918|NCT01730053|3650485|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|11.15|11.15|||
3824919|NCT01730040|3650642|B8|||LDL-C in mmol/L|Calculated LDL-C from Friedewald formula.|mmol/L|Mean|2.723|2.723|Standard Deviation|0.884|0.884|||
3824920|NCT01730040|3650643|B7|||LDL-C in mmol/L|Calculated LDL-C from Friedewald formula.|mmol/L|Mean|3.016|3.016|Standard Deviation|0.968|0.968|||
3824921|NCT01730040|3650644|B6|||LDL-C in mmol/L|Calculated LDL-C from Friedewald formula.|mmol/L|Mean|2.562|2.562|Standard Deviation|0.756|0.756|||
3824922|NCT01730040|3650645|B5|||LDL-C in mmol/L|Calculated LDL-C from Friedewald formula.|mmol/L|Mean|2.844|2.844|Standard Deviation|1.011|1.011|||
3824923|NCT01730040|3650646|B4|||LDL-C in mmol/L|Calculated LDL-C from Friedewald formula.|mmol/L|Mean|2.813|2.813|Standard Deviation|0.97|0.97|||
3824924|NCT01730040|3650647|B3|||LDL-C in mmol/L|Calculated LDL-C from Friedewald formula.|mmol/L|Mean|2.692|2.692|Standard Deviation|0.905|0.905|||
3824925|NCT01730040|3650648|B2|||LDL-C in mmol/L|Calculated LDL-C from Friedewald formula.|mmol/L|Mean|2.599|2.599|Standard Deviation|0.765|0.765|||
3824926|NCT01730040|3650649|B1|||LDL-C in mmol/L|Calculated LDL-C from Friedewald formula.|mmol/L|Mean|2.957|2.957|Standard Deviation|0.773|0.773|||
3824927|NCT01730040|3650642|B8|||Low density lipoprotein cholesterol (LDL-C) in mg/dL|Calculated LDL-C from Friedewald formula.|mg/dL|Mean|105.1|105.1|Standard Deviation|34.1|34.1|||
3824928|NCT01730040|3650643|B7|||Low density lipoprotein cholesterol (LDL-C) in mg/dL|Calculated LDL-C from Friedewald formula.|mg/dL|Mean|116.4|116.4|Standard Deviation|37.4|37.4|||
3824929|NCT01730040|3650644|B6|||Low density lipoprotein cholesterol (LDL-C) in mg/dL|Calculated LDL-C from Friedewald formula.|mg/dL|Mean|98.9|98.9|Standard Deviation|29.2|29.2|||
3824930|NCT01730040|3650645|B5|||Low density lipoprotein cholesterol (LDL-C) in mg/dL|Calculated LDL-C from Friedewald formula.|mg/dL|Mean|109.8|109.8|Standard Deviation|39.0|39.0|||
3824931|NCT01730040|3650646|B4|||Low density lipoprotein cholesterol (LDL-C) in mg/dL|Calculated LDL-C from Friedewald formula.|mg/dL|Mean|108.6|108.6|Standard Deviation|37.5|37.5|||
3824932|NCT01730040|3650647|B3|||Low density lipoprotein cholesterol (LDL-C) in mg/dL|Calculated LDL-C from Friedewald formula.|mg/dL|Mean|103.9|103.9|Standard Deviation|34.9|34.9|||
3824933|NCT01730040|3650648|B2|||Low density lipoprotein cholesterol (LDL-C) in mg/dL|Calculated LDL-C from Friedewald formula.|mg/dL|Mean|100.4|100.4|Standard Deviation|29.5|29.5|||
3824934|NCT01730040|3650649|B1|||Low density lipoprotein cholesterol (LDL-C) in mg/dL|Calculated LDL-C from Friedewald formula.|mg/dL|Mean|100.3|100.3|Standard Deviation|29.8|29.8|||
3824935|NCT01730040|3650642|B8||Male|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
3824936|NCT01730040|3650643|B7||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3824937|NCT01730040|3650644|B6||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3824938|NCT01730040|3650645|B5||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3824939|NCT01730040|3650646|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3824940|NCT01730040|3650647|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3824941|NCT01730040|3650648|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3824942|NCT01730040|3650649|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3824943|NCT01730040|3650642|B8||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3824944|NCT01730040|3650643|B7||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3824945|NCT01730040|3650644|B6||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3824946|NCT01730040|3650645|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3824948|NCT01730040|3650647|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3824949|NCT01730040|3650648|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3824950|NCT01730040|3650649|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3824951|NCT01730040|3650642|B8|||Age||years|Mean|62.9|62.9|Standard Deviation|10.2|10.2|||
3824952|NCT01730040|3650643|B7|||Age||years|Mean|64.2|64.2|Standard Deviation|10.36|10.36|||
3824953|NCT01730040|3650644|B6|||Age||years|Mean|63.9|63.9|Standard Deviation|10.33|10.33|||
3824954|NCT01730040|3650645|B5|||Age||years|Mean|57.5|57.5|Standard Deviation|9.96|9.96|||
3824955|NCT01730040|3650646|B4|||Age||years|Mean|63.2|63.2|Standard Deviation|10.89|10.89|||
3824956|NCT01730040|3650647|B3|||Age||years|Mean|62.2|62.2|Standard Deviation|10.03|10.03|||
3824957|NCT01730040|3650648|B2|||Age||years|Mean|65.7|65.7|Standard Deviation|8.96|8.96|||
3824958|NCT01730040|3650649|B1|||Age||years|Mean|63|63.0|Standard Deviation|9.91|9.91|||
3824959|NCT01729923|3650832|B1|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3824960|NCT01729923|3650832|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3824961|NCT01729923|3650832|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3824962|NCT01729923|3650832|B1|||Age||years|Median|46|46.0|Full Range|||30.0|75.0|
3824963|NCT01729923|3650832|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3824964|NCT01729923|3650832|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3824965|NCT01729923|3650832|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3824966|NCT01729871|3650842|B3|||Systolic Blood Pressure||mmHg|Mean|132.2|132.2|Standard Deviation|16.67|16.67|||
3824967|NCT01729871|3650843|B2|||Systolic Blood Pressure||mmHg|Mean|131.2|131.2|Standard Deviation|17.68|17.68|||
3824968|NCT01729871|3650844|B1|||Systolic Blood Pressure||mmHg|Mean|133.3|133.3|Standard Deviation|15.6|15.6|||
3824969|NCT01729871|3650842|B3|||Diastolic Blood Pressure||mmHg|Mean|80.2|80.2|Standard Deviation|10.34|10.34|||
3824970|NCT01729871|3650843|B2|||Diastolic Blood Pressure||mmHg|Mean|79.4|79.4|Standard Deviation|10.78|10.78|||
3824971|NCT01729871|3650844|B1|||Diastolic Blood Pressure||mmHg|Mean|81|81.0|Standard Deviation|9.85|9.85|||
3824972|NCT01729871|3650842|B3|||Body-Mass Index||kg/m^2|Mean|29.4|29.4|Standard Deviation|5.62|5.62|||
3824973|NCT01729871|3650843|B2|||Body-Mass Index||kg/m^2|Mean|28.9|28.9|Standard Deviation|5.49|5.49|||
3824974|NCT01729871|3650844|B1|||Body-Mass Index||kg/m^2|Mean|29.8|29.8|Standard Deviation|5.74|5.74|||
3824975|NCT01729871|3650842|B3|NOT HISPANIC/LATINO||Ethnicity||participants|Number|184|184.0||||||
3824976|NCT01729871|3650843|B2|NOT HISPANIC/LATINO||Ethnicity||participants|Number|94|94.0||||||
3824977|NCT01729871|3650844|B1|NOT HISPANIC/LATINO||Ethnicity||participants|Number|90|90.0||||||
3824978|NCT01729871|3650842|B3|N/A||Ethnicity||participants|Number|60|60.0||||||
3824979|NCT01729871|3650843|B2|N/A||Ethnicity||participants|Number|26|26.0||||||
3824980|NCT01729871|3650844|B1|N/A||Ethnicity||participants|Number|34|34.0||||||
3824981|NCT01729871|3650842|B3|HISPANIC/LATINO||Ethnicity||participants|Number|4|4.0||||||
3824982|NCT01729871|3650843|B2|HISPANIC/LATINO||Ethnicity||participants|Number|4|4.0||||||
3824983|NCT01729871|3650844|B1|HISPANIC/LATINO||Ethnicity||participants|Number|0|0.0||||||
3824984|NCT01729871|3650842|B3|WHITE||Race||participants|Number|228|228.0||||||
3824985|NCT01729871|3650843|B2|WHITE||Race||participants|Number|116|116.0||||||
3824986|NCT01729871|3650844|B1|WHITE||Race||participants|Number|112|112.0||||||
3824987|NCT01729871|3650842|B3|N/A||Race||participants|Number|7|7.0||||||
3824988|NCT01729871|3650843|B2|N/A||Race||participants|Number|3|3.0||||||
3824989|NCT01729871|3650844|B1|N/A||Race||participants|Number|4|4.0||||||
3824990|NCT01729871|3650842|B3|BLACK||Race||participants|Number|6|6.0||||||
3824991|NCT01729871|3650843|B2|BLACK||Race||participants|Number|3|3.0||||||
3824992|NCT01729871|3650844|B1|BLACK||Race||participants|Number|3|3.0||||||
3824993|NCT01729871|3650842|B3|ASIAN||Race||participants|Number|7|7.0||||||
3824994|NCT01729871|3650843|B2|ASIAN||Race||participants|Number|2|2.0||||||
3824995|NCT01729871|3650844|B1|ASIAN||Race||participants|Number|5|5.0||||||
3824996|NCT01729871|3650842|B3|United States of America||Region of Enrollment||participants|Number|77|77.0||||||
3824997|NCT01729871|3650843|B2|United States of America||Region of Enrollment||participants|Number|38|38.0||||||
3824998|NCT01729871|3650844|B1|United States of America||Region of Enrollment||participants|Number|39|39.0||||||
3824999|NCT01729871|3650842|B3|Great Britain||Region of Enrollment||participants|Number|48|48.0||||||
3825000|NCT01729871|3650843|B2|Great Britain||Region of Enrollment||participants|Number|24|24.0||||||
3825001|NCT01729871|3650844|B1|Great Britain||Region of Enrollment||participants|Number|24|24.0||||||
3825002|NCT01729871|3650842|B3|Germany||Region of Enrollment||participants|Number|37|37.0||||||
3825003|NCT01729871|3650843|B2|Germany||Region of Enrollment||participants|Number|19|19.0||||||
3825004|NCT01729871|3650844|B1|Germany||Region of Enrollment||participants|Number|18|18.0||||||
3825005|NCT01729871|3650842|B3|France||Region of Enrollment||participants|Number|38|38.0||||||
3825006|NCT01729871|3650843|B2|France||Region of Enrollment||participants|Number|19|19.0||||||
3825007|NCT01729871|3650844|B1|France||Region of Enrollment||participants|Number|19|19.0||||||
3825008|NCT01729871|3650842|B3|Belgium||Region of Enrollment||participants|Number|48|48.0||||||
3825009|NCT01729871|3650843|B2|Belgium||Region of Enrollment||participants|Number|24|24.0||||||
3825010|NCT01729871|3650844|B1|Belgium||Region of Enrollment||participants|Number|24|24.0||||||
3825011|NCT01729871|3650842|B3||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
3825012|NCT01729871|3650843|B2||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3825013|NCT01729871|3650844|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3825014|NCT01729871|3650842|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3825015|NCT01729871|3650843|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3825016|NCT01729871|3650844|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3825017|NCT01729871|3650842|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|10.21|10.21|||
3825018|NCT01729871|3650843|B2|||Age||years|Mean|60.5|60.5|Standard Deviation|10.51|10.51|||
3825019|NCT01729871|3650844|B1|||Age||years|Mean|58.6|58.6|Standard Deviation|9.86|9.86|||
3825020|NCT01729845|3650861|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3825021|NCT01729845|3650862|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3825022|NCT01729845|3650863|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3825023|NCT01729845|3650864|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3825024|NCT01729845|3650861|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3825025|NCT01729845|3650862|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3825026|NCT01729845|3650863|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3825027|NCT01729845|3650864|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3825028|NCT01729845|3650861|B4|||Age||years|Median|55|55.0|Full Range|||19.0|72.0|
3825029|NCT01729845|3650862|B3|||Age||years|Median|57|57.0|Full Range|||32.0|72.0|
3825030|NCT01729845|3650863|B2|||Age||years|Median|55|55.0|Full Range|||19.0|70.0|
3825031|NCT01729845|3650864|B1|||Age||years|Median|54|54.0|Full Range|||54.0|66.0|
3825032|NCT01729819|3650877|B3|||Mean Time to First Nocturnal Void||Minutes|Mean|135|135.0|Standard Deviation|51.6|51.6|||
3825033|NCT01729819|3650878|B2|||Mean Time to First Nocturnal Void||Minutes|Mean|143|143.0|Standard Deviation|56.1|56.1|||
3825034|NCT01729819|3650879|B1|||Mean Time to First Nocturnal Void||Minutes|Mean|125|125.0|Standard Deviation|44.6|44.6|||
3825035|NCT01729819|3650877|B3|||Mean Nocturnal Urine Volume||mL|Mean|541|541.0|Standard Deviation|278|278.0|||
3825036|NCT01729819|3650878|B2|||Mean Nocturnal Urine Volume||mL|Mean|537|537.0|Standard Deviation|278|278.0|||
3825037|NCT01729819|3650879|B1|||Mean Nocturnal Urine Volume||mL|Mean|546|546.0|Standard Deviation|281|281.0|||
3825038|NCT01729819|3650877|B3|||Mean Number of Day time Voids||Voids|Mean|9.91|9.91|Standard Deviation|1.71|1.71|||
3825039|NCT01729819|3650878|B2|||Mean Number of Day time Voids||Voids|Mean|10.1|10.1|Standard Deviation|1.97|1.97|||
3825040|NCT01729819|3650879|B1|||Mean Number of Day time Voids||Voids|Mean|9.69|9.69|Standard Deviation|1.35|1.35|||
3825041|NCT01729819|3650877|B3|||Mean Number of Nocturnal Voids||Voids|Mean|3.24|3.24|Standard Deviation|1.02|1.02|||
3825042|NCT01729819|3650878|B2|||Mean Number of Nocturnal Voids||Voids|Mean|3.11|3.11|Standard Deviation|1.06|1.06|||
3825043|NCT01729819|3650879|B1|||Mean Number of Nocturnal Voids||Voids|Mean|3.38|3.38|Standard Deviation|0.97|0.97|||
3825044|NCT01729819|3650877|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825045|NCT01729819|3650878|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825046|NCT01729819|3650879|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825047|NCT01729819|3650877|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825048|NCT01729819|3650878|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825049|NCT01729819|3650879|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825050|NCT01729819|3650877|B3||White|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3825051|NCT01729819|3650878|B2||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3825052|NCT01729819|3650879|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3825053|NCT01729819|3650877|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3825054|NCT01729819|3650878|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3825055|NCT01729819|3650879|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3825056|NCT01729819|3650877|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825057|NCT01729819|3650878|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825058|NCT01729819|3650879|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825059|NCT01729819|3650877|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825060|NCT01729819|3650878|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825061|NCT01729819|3650879|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825062|NCT01729819|3650877|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825063|NCT01729819|3650878|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825064|NCT01729819|3650879|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825065|NCT01729819|3650877|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825066|NCT01729819|3650878|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825067|NCT01729819|3650879|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825068|NCT01729819|3650877|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3825069|NCT01729819|3650878|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3825070|NCT01729819|3650879|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3825071|NCT01729819|3650877|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3825072|NCT01729819|3650878|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3825073|NCT01729819|3650879|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3825074|NCT01729819|3650877|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3825075|NCT01729819|3650878|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3825076|NCT01729819|3650879|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3825077|NCT01729819|3650877|B3||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3825078|NCT01729819|3650878|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3825079|NCT01729819|3650879|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3825080|NCT01729819|3650877|B3|||Age||Years|Mean|53.4|53.4|Standard Deviation|11.5|11.5|||
3825081|NCT01729819|3650878|B2|||Age||Years|Mean|51.8|51.8|Standard Deviation|10.3|10.3|||
3825082|NCT01729819|3650879|B1|||Age||Years|Mean|55.3|55.3|Standard Deviation|12.6|12.6|||
3825083|NCT01729754|3650895|B5|||Psoriasis Area Sensitivity Index (PASI)|The PASI is a measure of the average redness, thickness, and scaliness of lesions (each graded on a 0–4 scale), weighed by the area of involvement. Calculated PASI score ranges from 0 to 72, with higher score indicating more severe disease status.|Score on a scale|Mean|20.1|20.1|Standard Deviation|7.51|7.51|||
3825084|NCT01729754|3650896|B4|||Psoriasis Area Sensitivity Index (PASI)|The PASI is a measure of the average redness, thickness, and scaliness of lesions (each graded on a 0–4 scale), weighed by the area of involvement. Calculated PASI score ranges from 0 to 72, with higher score indicating more severe disease status.|Score on a scale|Mean|20.2|20.2|Standard Deviation|7.36|7.36|||
3825085|NCT01729754|3650897|B3|||Psoriasis Area Sensitivity Index (PASI)|The PASI is a measure of the average redness, thickness, and scaliness of lesions (each graded on a 0–4 scale), weighed by the area of involvement. Calculated PASI score ranges from 0 to 72, with higher score indicating more severe disease status.|Score on a scale|Mean|20.0|20.0|Standard Deviation|7.57|7.57|||
3825086|NCT01729754|3650898|B2|||Psoriasis Area Sensitivity Index (PASI)|The PASI is a measure of the average redness, thickness, and scaliness of lesions (each graded on a 0–4 scale), weighed by the area of involvement. Calculated PASI score ranges from 0 to 72, with higher score indicating more severe disease status.|Score on a scale|Mean|20.5|20.5|Standard Deviation|7.63|7.63|||
3825087|NCT01729754|3650899|B1|||Psoriasis Area Sensitivity Index (PASI)|The PASI is a measure of the average redness, thickness, and scaliness of lesions (each graded on a 0–4 scale), weighed by the area of involvement. Calculated PASI score ranges from 0 to 72, with higher score indicating more severe disease status.|Score on a scale|Mean|19.8|19.8|Standard Deviation|7.52|7.52|||
3825088|NCT01729754|3650895|B5|No||Prior exposure to biologic therapy for psoriasis|The following therapies constitute biologics therapy for psoriasis: efalizumab (RAPTIVA®), alefacept (AMEVIVE®), infliximab (REMICADE®), adalimumab (HUMIRA®), ustekinumab (STELARA®), and etanercept (Enbrel®)|Participants|Count of Participants|956|956.0||||||
3825089|NCT01729754|3650896|B4|No||Prior exposure to biologic therapy for psoriasis|The following therapies constitute biologics therapy for psoriasis: efalizumab (RAPTIVA®), alefacept (AMEVIVE®), infliximab (REMICADE®), adalimumab (HUMIRA®), ustekinumab (STELARA®), and etanercept (Enbrel®)|Participants|Count of Participants|276|276.0||||||
3825090|NCT01729754|3650897|B3|No||Prior exposure to biologic therapy for psoriasis|The following therapies constitute biologics therapy for psoriasis: efalizumab (RAPTIVA®), alefacept (AMEVIVE®), infliximab (REMICADE®), adalimumab (HUMIRA®), ustekinumab (STELARA®), and etanercept (Enbrel®)|Participants|Count of Participants|136|136.0||||||
3825091|NCT01729754|3650898|B2|No||Prior exposure to biologic therapy for psoriasis|The following therapies constitute biologics therapy for psoriasis: efalizumab (RAPTIVA®), alefacept (AMEVIVE®), infliximab (REMICADE®), adalimumab (HUMIRA®), ustekinumab (STELARA®), and etanercept (Enbrel®)|Participants|Count of Participants|268|268.0||||||
3825092|NCT01729754|3650899|B1|No||Prior exposure to biologic therapy for psoriasis|The following therapies constitute biologics therapy for psoriasis: efalizumab (RAPTIVA®), alefacept (AMEVIVE®), infliximab (REMICADE®), adalimumab (HUMIRA®), ustekinumab (STELARA®), and etanercept (Enbrel®)|Participants|Count of Participants|276|276.0||||||
3825093|NCT01729754|3650895|B5|Yes||Prior exposure to biologic therapy for psoriasis|The following therapies constitute biologics therapy for psoriasis: efalizumab (RAPTIVA®), alefacept (AMEVIVE®), infliximab (REMICADE®), adalimumab (HUMIRA®), ustekinumab (STELARA®), and etanercept (Enbrel®)|Participants|Count of Participants|134|134.0||||||
3825094|NCT01729754|3650896|B4|Yes||Prior exposure to biologic therapy for psoriasis|The following therapies constitute biologics therapy for psoriasis: efalizumab (RAPTIVA®), alefacept (AMEVIVE®), infliximab (REMICADE®), adalimumab (HUMIRA®), ustekinumab (STELARA®), and etanercept (Enbrel®)|Participants|Count of Participants|37|37.0||||||
3825095|NCT01729754|3650897|B3|Yes||Prior exposure to biologic therapy for psoriasis|The following therapies constitute biologics therapy for psoriasis: efalizumab (RAPTIVA®), alefacept (AMEVIVE®), infliximab (REMICADE®), adalimumab (HUMIRA®), ustekinumab (STELARA®), and etanercept (Enbrel®)|Participants|Count of Participants|20|20.0||||||
3825096|NCT01729754|3650898|B2|Yes||Prior exposure to biologic therapy for psoriasis|The following therapies constitute biologics therapy for psoriasis: efalizumab (RAPTIVA®), alefacept (AMEVIVE®), infliximab (REMICADE®), adalimumab (HUMIRA®), ustekinumab (STELARA®), and etanercept (Enbrel®)|Participants|Count of Participants|39|39.0||||||
3825097|NCT01729754|3650899|B1|Yes||Prior exposure to biologic therapy for psoriasis|The following therapies constitute biologics therapy for psoriasis: efalizumab (RAPTIVA®), alefacept (AMEVIVE®), infliximab (REMICADE®), adalimumab (HUMIRA®), ustekinumab (STELARA®), and etanercept (Enbrel®)|Participants|Count of Participants|38|38.0||||||
3825098|NCT01729754|3650895|B5|>90 kg||Body weight||Participants|Count of Participants|464|464.0||||||
3825099|NCT01729754|3650896|B4|>90 kg||Body weight||Participants|Count of Participants|133|133.0||||||
3825100|NCT01729754|3650897|B3|>90 kg||Body weight||Participants|Count of Participants|66|66.0||||||
3825101|NCT01729754|3650898|B2|>90 kg||Body weight||Participants|Count of Participants|131|131.0||||||
3825102|NCT01729754|3650899|B1|>90 kg||Body weight||Participants|Count of Participants|134|134.0||||||
3825103|NCT01729754|3650895|B5|<=90 kg||Body weight||Participants|Count of Participants|626|626.0||||||
3825104|NCT01729754|3650896|B4|<=90 kg||Body weight||Participants|Count of Participants|180|180.0||||||
3825105|NCT01729754|3650897|B3|<=90 kg||Body weight||Participants|Count of Participants|90|90.0||||||
3825106|NCT01729754|3650898|B2|<=90 kg||Body weight||Participants|Count of Participants|176|176.0||||||
3825107|NCT01729754|3650899|B1|<=90 kg||Body weight||Participants|Count of Participants|180|180.0||||||
3825108|NCT01729754|3650895|B5||Male|Sex: Female, Male||Participants|Count of Participants|779|779.0||||||
3825109|NCT01729754|3650896|B4||Male|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
3825110|NCT01729754|3650897|B3||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3825111|NCT01729754|3650898|B2||Male|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
3825112|NCT01729754|3650899|B1||Male|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
3825113|NCT01729754|3650895|B5||Female|Sex: Female, Male||Participants|Count of Participants|311|311.0||||||
3825114|NCT01729754|3650896|B4||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3825115|NCT01729754|3650897|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3825116|NCT01729754|3650898|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3825117|NCT01729754|3650899|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3825118|NCT01729754|3650895|B5|||Age||Years|Mean|45.2|45.2|Standard Deviation|13.52|13.52|||
3825119|NCT01729754|3650896|B4|||Age||Years|Mean|45.8|45.8|Standard Deviation|13.97|13.97|||
3825120|NCT01729754|3650897|B3|||Age||Years|Mean|46.4|46.4|Standard Deviation|12.20|12.2|||
3825121|NCT01729754|3650898|B2|||Age||Years|Mean|44.6|44.6|Standard Deviation|13.59|13.59|||
3825122|NCT01729754|3650899|B1|||Age||Years|Mean|44.6|44.6|Standard Deviation|13.62|13.62|||
3825123|NCT01729728|3651112|B4|||Height||centimeter|Mean|136.9|136.9|Standard Deviation|28.3|28.3|||
3825124|NCT01729728|3651113|B3|||Height||centimeter|Mean|101.7|101.7|Standard Deviation|8.1|8.1|||
3825125|NCT01729728|3651114|B2|||Height||centimeter|Mean|132.9|132.9|Standard Deviation|11.1|11.1|||
3825126|NCT01729728|3651115|B1|||Height||centimeter|Mean|170.6|170.6|Standard Deviation|10.7|10.7|||
3825127|NCT01729728|3651112|B4|||Weight||kilograms|Mean|35.95|35.95|Standard Deviation|19.36|19.36|||
3825128|NCT01729728|3651113|B3|||Weight||kilograms|Mean|16.34|16.34|Standard Deviation|2.20|2.2|||
3825129|NCT01729728|3651114|B2|||Weight||kilograms|Mean|28.85|28.85|Standard Deviation|5.89|5.89|||
3825130|NCT01729728|3651115|B1|||Weight||kilograms|Mean|61.30|61.3|Standard Deviation|9.78|9.78|||
3825131|NCT01729728|3651112|B4|United States||Region of Enrollment||participants|Number|66|66.0||||||
3825132|NCT01729728|3651113|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
3825133|NCT01729728|3651114|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
3825134|NCT01729728|3651115|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3825135|NCT01729728|3651112|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3825136|NCT01729728|3651113|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3825137|NCT01729728|3651114|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825138|NCT01729728|3651115|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825139|NCT01729728|3651112|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825140|NCT01729728|3651113|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825141|NCT01729728|3651114|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825142|NCT01729728|3651115|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825143|NCT01729728|3651112|B4||White|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3825144|NCT01729728|3651113|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3825145|NCT01729728|3651114|B2||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3825146|NCT01729728|3651115|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3825147|NCT01729728|3651112|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3825148|NCT01729728|3651113|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825149|NCT01729728|3651114|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3825150|NCT01729728|3651115|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825151|NCT01729728|3651112|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825152|NCT01729728|3651113|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825153|NCT01729728|3651114|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825154|NCT01729728|3651115|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825155|NCT01729728|3651112|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825156|NCT01729728|3651113|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825157|NCT01729728|3651114|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825158|NCT01729728|3651115|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825159|NCT01729728|3651112|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825160|NCT01729728|3651113|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825161|NCT01729728|3651114|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825162|NCT01729728|3651115|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825163|NCT01729728|3651112|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3825164|NCT01729728|3651113|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3825165|NCT01729728|3651114|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3825166|NCT01729728|3651115|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3825167|NCT01729728|3651112|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3825168|NCT01729728|3651113|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3825169|NCT01729728|3651114|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3825170|NCT01729728|3651115|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3825171|NCT01729728|3651112|B4|||Age||years|Mean|9.3|9.3|Standard Deviation|4.9|4.9|||
3825172|NCT01729728|3651113|B3|||Age||years|Mean|3.4|3.4|Standard Deviation|1.1|1.1|||
3825173|NCT01729728|3651114|B2|||Age||years|Mean|8.3|8.3|Standard Deviation|1.6|1.6|||
3825174|NCT01729728|3651115|B1|||Age||years|Mean|15.5|15.5|Standard Deviation|1.6|1.6|||
3825175|NCT01729559|3651248|B3|||Injury Severity Score|The Injury Severity Score (ISS) is an anatomical scoring system that provides an overall score for patients with multiple injuries. Each injury is assigned an Abbreviated Injury Scale (AIS) score allocated to one of six body regions (Head, Face, Chest, Abdomen, Extremities, External). The highest AIS scores among the three most severely injured body regions are squared and added together to produce the total ISS score. The ISS score ranges from 0 to 75. Each AIS score ranges from 1 to 6 (6 denotes an unsurvivable injury).|units on a scale|Median|9|9.0|Full Range|||1.0|50.0|
3825176|NCT01729559|3651249|B2|||Injury Severity Score|The Injury Severity Score (ISS) is an anatomical scoring system that provides an overall score for patients with multiple injuries. Each injury is assigned an Abbreviated Injury Scale (AIS) score allocated to one of six body regions (Head, Face, Chest, Abdomen, Extremities, External). The highest AIS scores among the three most severely injured body regions are squared and added together to produce the total ISS score. The ISS score ranges from 0 to 75. Each AIS score ranges from 1 to 6 (6 denotes an unsurvivable injury).|units on a scale|Median|9|9.0|Full Range|||1.0|38.0|
3825177|NCT01729559|3651250|B1|||Injury Severity Score|The Injury Severity Score (ISS) is an anatomical scoring system that provides an overall score for patients with multiple injuries. Each injury is assigned an Abbreviated Injury Scale (AIS) score allocated to one of six body regions (Head, Face, Chest, Abdomen, Extremities, External). The highest AIS scores among the three most severely injured body regions are squared and added together to produce the total ISS score. The ISS score ranges from 0 to 75. Each AIS score ranges from 1 to 6 (6 denotes an unsurvivable injury).|units on a scale|Median|10|10.0|Full Range|||1.0|50.0|
3825178|NCT01729559|3651248|B3|||Body Mass Index||kg/m^2|Mean|26.5|26.5|Standard Deviation|4.9|4.9|||
3825179|NCT01729559|3651249|B2|||Body Mass Index||kg/m^2|Mean|26.9|26.9|Standard Deviation|5.2|5.2|||
3825180|NCT01729559|3651250|B1|||Body Mass Index||kg/m^2|Mean|26.1|26.1|Standard Deviation|4.5|4.5|||
3825181|NCT01729559|3651248|B3|United States||Region of Enrollment||participants|Number|436|436.0||||||
3825182|NCT01729559|3651249|B2|United States||Region of Enrollment||participants|Number|216|216.0||||||
3825183|NCT01729559|3651250|B1|United States||Region of Enrollment||participants|Number|220|220.0||||||
3825184|NCT01729559|3651248|B3||Male|Sex: Female, Male||Participants|Count of Participants|312|312.0||||||
3825185|NCT01729559|3651249|B2||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3825186|NCT01729559|3651250|B1||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3825187|NCT01729559|3651248|B3||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3825188|NCT01729559|3651249|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3825189|NCT01729559|3651250|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3825190|NCT01729559|3651248|B3|||Age||years|Mean|46.4|46.4|Standard Deviation|21.0|21.0|||
3825191|NCT01729559|3651249|B2|||Age||years|Mean|46.4|46.4|Standard Deviation|20.8|20.8|||
3825192|NCT01729559|3651250|B1|||Age||years|Mean|46.5|46.5|Standard Deviation|21.2|21.2|||
3825193|NCT01729338|3651263|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3825194|NCT01729338|3651263|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3825195|NCT01729338|3651263|B1|||Age||years|Mean|76.5|76.5|Standard Deviation|6.7|6.7|||
3825196|NCT01729247|3651278|B1|Nasal Decongestant||Current Medications used for Pulmonary and/or Allergy Conditions|Provided is a summary of medications taken by >= 5% of participants that are used for pulmonary and/or allergy conditions. The most common medications included short-acting beta-agonist bronchodilators (SABA), inhaled corticosteroid (ICS) and long-acting beta-agonist bronchodilators (LABA) combination products, H1-receptor antagonist and ICS|participants|Number|4|4.0||||||
3825197|NCT01729247|3651278|B1|Leukotriene Receptor Antagonist||Current Medications used for Pulmonary and/or Allergy Conditions|Provided is a summary of medications taken by >= 5% of participants that are used for pulmonary and/or allergy conditions. The most common medications included short-acting beta-agonist bronchodilators (SABA), inhaled corticosteroid (ICS) and long-acting beta-agonist bronchodilators (LABA) combination products, H1-receptor antagonist and ICS|participants|Number|8|8.0||||||
3825198|NCT01729247|3651278|B1|Intranasal Corticosteroid||Current Medications used for Pulmonary and/or Allergy Conditions|Provided is a summary of medications taken by >= 5% of participants that are used for pulmonary and/or allergy conditions. The most common medications included short-acting beta-agonist bronchodilators (SABA), inhaled corticosteroid (ICS) and long-acting beta-agonist bronchodilators (LABA) combination products, H1-receptor antagonist and ICS|participants|Number|9|9.0||||||
3825238|NCT01729039|3651292|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825239|NCT01729039|3651293|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825199|NCT01729247|3651278|B1|Antihistamine||Current Medications used for Pulmonary and/or Allergy Conditions|Provided is a summary of medications taken by >= 5% of participants that are used for pulmonary and/or allergy conditions. The most common medications included short-acting beta-agonist bronchodilators (SABA), inhaled corticosteroid (ICS) and long-acting beta-agonist bronchodilators (LABA) combination products, H1-receptor antagonist and ICS|participants|Number|9|9.0||||||
3825200|NCT01729247|3651278|B1|ICS||Current Medications used for Pulmonary and/or Allergy Conditions|Provided is a summary of medications taken by >= 5% of participants that are used for pulmonary and/or allergy conditions. The most common medications included short-acting beta-agonist bronchodilators (SABA), inhaled corticosteroid (ICS) and long-acting beta-agonist bronchodilators (LABA) combination products, H1-receptor antagonist and ICS|participants|Number|10|10.0||||||
3825201|NCT01729247|3651278|B1|H1-Receptor Antagonist||Current Medications used for Pulmonary and/or Allergy Conditions|Provided is a summary of medications taken by >= 5% of participants that are used for pulmonary and/or allergy conditions. The most common medications included short-acting beta-agonist bronchodilators (SABA), inhaled corticosteroid (ICS) and long-acting beta-agonist bronchodilators (LABA) combination products, H1-receptor antagonist and ICS|participants|Number|17|17.0||||||
3825202|NCT01729247|3651278|B1|ICS/LABA Combination||Current Medications used for Pulmonary and/or Allergy Conditions|Provided is a summary of medications taken by >= 5% of participants that are used for pulmonary and/or allergy conditions. The most common medications included short-acting beta-agonist bronchodilators (SABA), inhaled corticosteroid (ICS) and long-acting beta-agonist bronchodilators (LABA) combination products, H1-receptor antagonist and ICS|participants|Number|20|20.0||||||
3825203|NCT01729247|3651278|B1|SABA||Current Medications used for Pulmonary and/or Allergy Conditions|Provided is a summary of medications taken by >= 5% of participants that are used for pulmonary and/or allergy conditions. The most common medications included short-acting beta-agonist bronchodilators (SABA), inhaled corticosteroid (ICS) and long-acting beta-agonist bronchodilators (LABA) combination products, H1-receptor antagonist and ICS|participants|Number|47|47.0||||||
3825204|NCT01729247|3651278|B1|Past Smoker||Smoking Status|At study visit, participants responded to a questionnaire regarding their smoking history. Participants were classified as having never smoked, current smoker, or past smoker.|participants|Number|15|15.0||||||
3825205|NCT01729247|3651278|B1|Current Smoker||Smoking Status|At study visit, participants responded to a questionnaire regarding their smoking history. Participants were classified as having never smoked, current smoker, or past smoker.|participants|Number|0|0.0||||||
3825206|NCT01729247|3651278|B1|Never Smoked||Smoking Status|At study visit, participants responded to a questionnaire regarding their smoking history. Participants were classified as having never smoked, current smoker, or past smoker.|participants|Number|35|35.0||||||
3825207|NCT01729247|3651278|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3825208|NCT01729247|3651278|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3825209|NCT01729247|3651278|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3825210|NCT01729247|3651278|B1|||Age||years|Mean|35.1|35.1|Standard Deviation|15.81|15.81|||
3825211|NCT01729039|3651292|B3|||10 Meter Walk Test|This measure assesses walking speed over a short distance. Subjects were asked to walk at their preferred gait speed for a distance of 30 feet which allowed 5 feet for acceleration and deceleration at the beginning and end of the walk. The time it took to walk 20 feet was recorded using a calibrated stopwatch and gait speed (ft/s) was calculated.|ft/s|Mean|3.00|3.0|Standard Deviation|0.57|0.57|||
3825212|NCT01729039|3651293|B2|||10 Meter Walk Test|This measure assesses walking speed over a short distance. Subjects were asked to walk at their preferred gait speed for a distance of 30 feet which allowed 5 feet for acceleration and deceleration at the beginning and end of the walk. The time it took to walk 20 feet was recorded using a calibrated stopwatch and gait speed (ft/s) was calculated.|ft/s|Mean|2.96|2.96|Standard Deviation|0.58|0.58|||
3825213|NCT01729039|3651294|B1|||10 Meter Walk Test|This measure assesses walking speed over a short distance. Subjects were asked to walk at their preferred gait speed for a distance of 30 feet which allowed 5 feet for acceleration and deceleration at the beginning and end of the walk. The time it took to walk 20 feet was recorded using a calibrated stopwatch and gait speed (ft/s) was calculated.|ft/s|Mean|3.05|3.05|Standard Deviation|0.58|0.58|||
3825214|NCT01729039|3651292|B3|||Activities-specific balance confidence scale|As a result of their disequilibrium, subjects report decreased confidence that they can maintain their balance in a variety of situations. The Activities-specific balance confidence scale (ABC) was developed to measure confidence with balance across a range of 16 activities of increasing challenge. Items are rated on a rating scale that ranges from 0 - 100% with a score of zero representing no confidence and a score of 100 representing complete confidence. An overall score is calculated by averaging the items with higher scores indicating higher (better) balance confidence.|percentage|Mean|74.00|74.0|Standard Deviation|16.42|16.42|||
3825215|NCT01729039|3651293|B2|||Activities-specific balance confidence scale|As a result of their disequilibrium, subjects report decreased confidence that they can maintain their balance in a variety of situations. The Activities-specific balance confidence scale (ABC) was developed to measure confidence with balance across a range of 16 activities of increasing challenge. Items are rated on a rating scale that ranges from 0 - 100% with a score of zero representing no confidence and a score of 100 representing complete confidence. An overall score is calculated by averaging the items with higher scores indicating higher (better) balance confidence.|percentage|Mean|78.03|78.03|Standard Deviation|9.68|9.68|||
3825216|NCT01729039|3651294|B1|||Activities-specific balance confidence scale|As a result of their disequilibrium, subjects report decreased confidence that they can maintain their balance in a variety of situations. The Activities-specific balance confidence scale (ABC) was developed to measure confidence with balance across a range of 16 activities of increasing challenge. Items are rated on a rating scale that ranges from 0 - 100% with a score of zero representing no confidence and a score of 100 representing complete confidence. An overall score is calculated by averaging the items with higher scores indicating higher (better) balance confidence.|percentage|Mean|69.64|69.64|Standard Deviation|21.12|21.12|||
3825240|NCT01729039|3651294|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825241|NCT01729039|3651292|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825242|NCT01729039|3651293|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825217|NCT01729039|3651292|B3|||Dynamic Gait Index|The dynamic gait index (DGI) assesses an individual’s ability to modify balance while walking in the presence of external demands. The 8 items of the DGI include walking while changing speed and turning the head, walking over and around obstacles, and stair climbing. Scoring of the DGI is based on a 4-point scale from 0 to 3 with 0 indicating severe impairment and 3 indicating normal ability. A maximum total score of 24 is possible and scores of < 20 indicate high risk for falling.|units on a scale|Mean|18.41|18.41|Standard Deviation|2.83|2.83|||
3825218|NCT01729039|3651293|B2|||Dynamic Gait Index|The dynamic gait index (DGI) assesses an individual’s ability to modify balance while walking in the presence of external demands. The 8 items of the DGI include walking while changing speed and turning the head, walking over and around obstacles, and stair climbing. Scoring of the DGI is based on a 4-point scale from 0 to 3 with 0 indicating severe impairment and 3 indicating normal ability. A maximum total score of 24 is possible and scores of < 20 indicate high risk for falling.|units on a scale|Mean|18.36|18.36|Standard Deviation|2.62|2.62|||
3825219|NCT01729039|3651294|B1|||Dynamic Gait Index|The dynamic gait index (DGI) assesses an individual’s ability to modify balance while walking in the presence of external demands. The 8 items of the DGI include walking while changing speed and turning the head, walking over and around obstacles, and stair climbing. Scoring of the DGI is based on a 4-point scale from 0 to 3 with 0 indicating severe impairment and 3 indicating normal ability. A maximum total score of 24 is possible and scores of < 20 indicate high risk for falling.|units on a scale|Mean|18.46|18.46|Standard Deviation|3.15|3.15|||
3825220|NCT01729039|3651292|B3|||Visual Analog Scale - Disequilibrium|This scale was used to measure perceived level of unsteadiness while walking. This technique uses a 10-cm line with one end being no symptoms (score = 0) and the other representing the worse possible symptoms (score = 10) and is commonly used to assess perception of pain. The subject is asked to place a mark on the 10-cm line at a point which indicates the intensity of his/her perception of symptoms of unsteadiness and the distance along that line is measured. Scores range from 0 to 10 with higher scores indicating worse perceived unsteadiness.|units on a scale|Mean|2.29|2.29|Standard Deviation|1.95|1.95|||
3825221|NCT01729039|3651293|B2|||Visual Analog Scale - Disequilibrium|This scale was used to measure perceived level of unsteadiness while walking. This technique uses a 10-cm line with one end being no symptoms (score = 0) and the other representing the worse possible symptoms (score = 10) and is commonly used to assess perception of pain. The subject is asked to place a mark on the 10-cm line at a point which indicates the intensity of his/her perception of symptoms of unsteadiness and the distance along that line is measured. Scores range from 0 to 10 with higher scores indicating worse perceived unsteadiness.|units on a scale|Mean|2.74|2.74|Standard Deviation|2.10|2.1|||
3825222|NCT01729039|3651294|B1|||Visual Analog Scale - Disequilibrium|This scale was used to measure perceived level of unsteadiness while walking. This technique uses a 10-cm line with one end being no symptoms (score = 0) and the other representing the worse possible symptoms (score = 10) and is commonly used to assess perception of pain. The subject is asked to place a mark on the 10-cm line at a point which indicates the intensity of his/her perception of symptoms of unsteadiness and the distance along that line is measured. Scores range from 0 to 10 with higher scores indicating worse perceived unsteadiness.|units on a scale|Mean|1.77|1.77|Standard Deviation|1.69|1.69|||
3825223|NCT01729039|3651292|B3|||Visual Analog Scale - Head Movement|This scale was used to measure perceived level of dizziness after one minute of horizontal head movement at 1 Hz. This technique uses a 10-cm line with one end being no symptoms (score = 0) and the other representing the worse possible symptoms (score = 10) and is commonly used to assess perception of pain. The subject is asked to place a mark on the 10-cm line at a point which indicates the intensity of his/her perception of symptoms of dizziness and the distance along that line is measured. Scores range from 0 to 10 with higher scores indicating worse perceived dizziness.|units on a scale|Mean|2.33|2.33|Standard Deviation|2.68|2.68|||
3825224|NCT01729039|3651293|B2|||Visual Analog Scale - Head Movement|This scale was used to measure perceived level of dizziness after one minute of horizontal head movement at 1 Hz. This technique uses a 10-cm line with one end being no symptoms (score = 0) and the other representing the worse possible symptoms (score = 10) and is commonly used to assess perception of pain. The subject is asked to place a mark on the 10-cm line at a point which indicates the intensity of his/her perception of symptoms of dizziness and the distance along that line is measured. Scores range from 0 to 10 with higher scores indicating worse perceived dizziness.|units on a scale|Mean|2.58|2.58|Standard Deviation|2.74|2.74|||
3825225|NCT01729039|3651294|B1|||Visual Analog Scale - Head Movement|This scale was used to measure perceived level of dizziness after one minute of horizontal head movement at 1 Hz. This technique uses a 10-cm line with one end being no symptoms (score = 0) and the other representing the worse possible symptoms (score = 10) and is commonly used to assess perception of pain. The subject is asked to place a mark on the 10-cm line at a point which indicates the intensity of his/her perception of symptoms of dizziness and the distance along that line is measured. Scores range from 0 to 10 with higher scores indicating worse perceived dizziness.|units on a scale|Mean|2.06|2.06|Standard Deviation|2.69|2.69|||
3825226|NCT01729039|3651292|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825227|NCT01729039|3651293|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825228|NCT01729039|3651294|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825229|NCT01729039|3651292|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3825230|NCT01729039|3651293|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3825231|NCT01729039|3651294|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825232|NCT01729039|3651292|B3||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3825233|NCT01729039|3651293|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3825234|NCT01729039|3651294|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3825235|NCT01729039|3651292|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825236|NCT01729039|3651293|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825237|NCT01729039|3651294|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825243|NCT01729039|3651294|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825244|NCT01729039|3651292|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3825245|NCT01729039|3651293|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3825246|NCT01729039|3651294|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825247|NCT01729039|3651292|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825248|NCT01729039|3651293|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825249|NCT01729039|3651294|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825250|NCT01729039|3651292|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3825251|NCT01729039|3651293|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3825252|NCT01729039|3651294|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3825253|NCT01729039|3651292|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825254|NCT01729039|3651293|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825255|NCT01729039|3651294|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825256|NCT01729039|3651292|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3825257|NCT01729039|3651293|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3825258|NCT01729039|3651294|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3825259|NCT01729039|3651292|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3825260|NCT01729039|3651293|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3825261|NCT01729039|3651294|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3825262|NCT01729039|3651292|B3|||Age||years|Mean|71.15|71.15|Standard Deviation|7.47|7.47|||
3825263|NCT01729039|3651293|B2|||Age||years|Mean|72.36|72.36|Standard Deviation|6.07|6.07|||
3825264|NCT01729039|3651294|B1|||Age||years|Mean|69.85|69.85|Standard Deviation|8.80|8.8|||
3825265|NCT01729026|3651309|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3825266|NCT01729026|3651310|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3825267|NCT01729026|3651311|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3825268|NCT01729026|3651309|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3825269|NCT01729026|3651310|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3825270|NCT01729026|3651311|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3825271|NCT01729026|3651309|B3|||Age||years|Mean|42.1|42.1|Standard Deviation|12.6|12.6|||
3825272|NCT01729026|3651310|B2|||Age||years|Mean|39.2|39.2|Standard Deviation|11.4|11.4|||
3825273|NCT01729026|3651311|B1|||Age||years|Mean|45.0|45.0|Standard Deviation|13.8|13.8|||
3825274|NCT01728792|3651318|B6|United States||Region of Enrollment||participants|Number|80|80.0||||||
3825275|NCT01728792|3651319|B5|United States||Region of Enrollment||participants|Number|16|16.0||||||
3825276|NCT01728792|3651320|B4|United States||Region of Enrollment||participants|Number|17|17.0||||||
3825277|NCT01728792|3651321|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
3825278|NCT01728792|3651322|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3825279|NCT01728792|3651323|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3825280|NCT01728792|3651318|B6|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3825281|NCT01728792|3651319|B5|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3825282|NCT01728792|3651320|B4|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3825283|NCT01728792|3651321|B3|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3825284|NCT01728792|3651322|B2|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3825285|NCT01728792|3651323|B1|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3825286|NCT01728792|3651318|B6|White||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
3825287|NCT01728792|3651319|B5|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3825288|NCT01728792|3651320|B4|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3825289|NCT01728792|3651321|B3|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3825290|NCT01728792|3651322|B2|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3825291|NCT01728792|3651323|B1|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3825292|NCT01728792|3651318|B6|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3825293|NCT01728792|3651319|B5|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3825294|NCT01728792|3651320|B4|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3825295|NCT01728792|3651321|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3825296|NCT01728792|3651322|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3825297|NCT01728792|3651323|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3825298|NCT01728792|3651318|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3825299|NCT01728792|3651319|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3825300|NCT01728792|3651320|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3825301|NCT01728792|3651321|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3825302|NCT01728792|3651322|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3825303|NCT01728792|3651323|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3825304|NCT01728792|3651318|B6|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3825305|NCT01728792|3651319|B5|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3825306|NCT01728792|3651320|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3825307|NCT01728792|3651321|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3825308|NCT01728792|3651322|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3825309|NCT01728792|3651323|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3825310|NCT01728792|3651318|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3825311|NCT01728792|3651319|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3825312|NCT01728792|3651320|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3825313|NCT01728792|3651321|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3825314|NCT01728792|3651322|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3825315|NCT01728792|3651323|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3825316|NCT01728792|3651318|B6|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
3825317|NCT01728792|3651319|B5|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3825318|NCT01728792|3651320|B4|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3825319|NCT01728792|3651321|B3|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3825320|NCT01728792|3651322|B2|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3825321|NCT01728792|3651323|B1|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3825322|NCT01728792|3651318|B6|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3825323|NCT01728792|3651319|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3825324|NCT01728792|3651320|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3825325|NCT01728792|3651321|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3825326|NCT01728792|3651322|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3825327|NCT01728792|3651323|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3825328|NCT01728792|3651318|B6||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3825329|NCT01728792|3651319|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3825330|NCT01728792|3651320|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3825331|NCT01728792|3651321|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3825332|NCT01728792|3651322|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3825333|NCT01728792|3651323|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3825334|NCT01728792|3651318|B6||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3825335|NCT01728792|3651319|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3825336|NCT01728792|3651320|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3825337|NCT01728792|3651321|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3825338|NCT01728792|3651322|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3825339|NCT01728792|3651323|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3825340|NCT01728792|3651318|B6|||Age||years|Mean|29.4|29.4|Standard Deviation|7.31|7.31|||
3825341|NCT01728792|3651319|B5|||Age||years|Mean|30.8|30.8|Standard Deviation|7.79|7.79|||
3825342|NCT01728792|3651320|B4|||Age||years|Mean|30.4|30.4|Standard Deviation|7.48|7.48|||
3825343|NCT01728792|3651321|B3|||Age||years|Mean|27.5|27.5|Standard Deviation|7.92|7.92|||
3825344|NCT01728792|3651322|B2|||Age||years|Mean|30.2|30.2|Standard Deviation|7.49|7.49|||
3825345|NCT01728792|3651323|B1|||Age||years|Mean|28.2|28.2|Standard Deviation|5.81|5.81|||
3825346|NCT01728584|3651374|B5||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3825347|NCT01728584|3651375|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3825348|NCT01728584|3651376|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3825349|NCT01728584|3651377|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3825350|NCT01728584|3651378|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3825351|NCT01728584|3651374|B5||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3825352|NCT01728584|3651375|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3825353|NCT01728584|3651376|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3825354|NCT01728584|3651377|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3825355|NCT01728584|3651378|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3825356|NCT01728584|3651374|B5|||Age||years|Mean|43.9|43.9|Standard Deviation|15.5|15.5|||
3825357|NCT01728584|3651375|B4|||Age||years|Mean|46.7|46.7|Standard Deviation|13.8|13.8|||
3825358|NCT01728584|3651376|B3|||Age||years|Mean|43.5|43.5|Standard Deviation|15.6|15.6|||
3825359|NCT01728584|3651377|B2|||Age||years|Mean|39.1|39.1|Standard Deviation|13.6|13.6|||
3825360|NCT01728584|3651378|B1|||Age||years|Mean|46.1|46.1|Standard Deviation|17.7|17.7|||
3825361|NCT01728376|3651433|B7||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3825362|NCT01728376|3651434|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3825363|NCT01728376|3651435|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3825364|NCT01728376|3651436|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3825365|NCT01728376|3651437|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3825366|NCT01728376|3651438|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3825367|NCT01728376|3651439|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3825368|NCT01728376|3651433|B7||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3825369|NCT01728376|3651434|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3825370|NCT01728376|3651435|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3825371|NCT01728376|3651436|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3825372|NCT01728376|3651437|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3825373|NCT01728376|3651438|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3825374|NCT01728376|3651439|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3825375|NCT01728376|3651433|B7|||Age||Years|Mean|8.70|8.7|Standard Deviation|4.468|4.468|||
3825376|NCT01728376|3651434|B6|||Age||Years|Mean|14.56|14.56|Standard Deviation|1.868|1.868|||
3825377|NCT01728376|3651435|B5|||Age||Years|Mean|14.14|14.14|Standard Deviation|1.677|1.677|||
3825378|NCT01728376|3651436|B4|||Age||Years|Mean|9.46|9.46|Standard Deviation|1.345|1.345|||
3825379|NCT01728376|3651437|B3|||Age||Years|Mean|10.25|10.25|Standard Deviation|1.217|1.217|||
3825380|NCT01728376|3651438|B2|||Age||Years|Mean|4.13|4.13|Standard Deviation|1.752|1.752|||
3825381|NCT01728376|3651439|B1|||Age||Years|Mean|3.81|3.81|Standard Deviation|1.232|1.232|||
3825382|NCT01728337|3651506|B1|||Evoked Compound Muscle Action Potentials|Evoked Compound Muscle Action Potentials|mV|Mean|1053|1053.0|Standard Deviation|282|282.0|||
3825383|NCT01728337|3651506|B1|Brazil||Region of Enrollment||participants|Number|80|80.0||||||
3825384|NCT01728337|3651506|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3825385|NCT01728337|3651506|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3825386|NCT01728337|3651506|B1|||Age||years|Mean|47|47.0|Standard Deviation|9|9.0|||
3825387|NCT01728337|3651506|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3825388|NCT01728337|3651506|B1||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
3825389|NCT01728337|3651506|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3825390|NCT01728324|3651514|B4||Male|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
3825391|NCT01728324|3651515|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3825392|NCT01728324|3651516|B2||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3825393|NCT01728324|3651517|B1||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3825394|NCT01728324|3651514|B4||Female|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
3825395|NCT01728324|3651515|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3825396|NCT01728324|3651516|B2||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3825397|NCT01728324|3651517|B1||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3825398|NCT01728324|3651514|B4|||Age||Years|Mean|51.5|51.5|Standard Deviation|12.2|12.2|||
3825399|NCT01728324|3651515|B3|||Age||Years|Mean|58.0|58.0|Standard Deviation|8.8|8.8|||
3825400|NCT01728324|3651516|B2|||Age||Years|Mean|50.5|50.5|Standard Deviation|12.3|12.3|||
3825401|NCT01728324|3651517|B1|||Age||Years|Mean|50.3|50.3|Standard Deviation|12.5|12.5|||
3825402|NCT01728246|3651538|B3|Unknown||Sex/Gender, Customized||participants|Number|3|3.0||||||
3825403|NCT01728246|3651539|B2|Unknown||Sex/Gender, Customized||participants|Number|1|1.0||||||
3825404|NCT01728246|3651540|B1|Unknown||Sex/Gender, Customized||participants|Number|2|2.0||||||
3825405|NCT01728246|3651538|B3|Male||Sex/Gender, Customized||participants|Number|122|122.0||||||
3825406|NCT01728246|3651539|B2|Male||Sex/Gender, Customized||participants|Number|53|53.0||||||
3825407|NCT01728246|3651540|B1|Male||Sex/Gender, Customized||participants|Number|69|69.0||||||
3825408|NCT01728246|3651538|B3|Female||Sex/Gender, Customized||participants|Number|348|348.0||||||
3825409|NCT01728246|3651539|B2|Female||Sex/Gender, Customized||participants|Number|177|177.0||||||
3825410|NCT01728246|3651540|B1|Female||Sex/Gender, Customized||participants|Number|171|171.0||||||
3825411|NCT01728246|3651538|B3|||Age||years|Mean|62.19|62.19|Standard Deviation|12.248|12.248|||
3825412|NCT01728246|3651539|B2|||Age||years|Mean|62.40|62.4|Standard Deviation|12.437|12.437|||
3825413|NCT01728246|3651540|B1|||Age||years|Mean|61.991|61.991|Standard Deviation|12.084|12.084|||
3825414|NCT01728116|3651557|B3|||HbA1c (%) fasting bloodwork||percent|Mean|8.8|8.8|Standard Deviation|0.91|0.91|||
3825415|NCT01728116|3651558|B2|||HbA1c (%) fasting bloodwork||percent|Mean|8.9|8.9|Standard Deviation|0.89|0.89|||
3825416|NCT01728116|3651559|B1|||HbA1c (%) fasting bloodwork||percent|Mean|8.8|8.8|Standard Deviation|0.92|0.92|||
3825417|NCT01728116|3651557|B3|||Baseline BMI||kg/m2|Mean|38.4|38.4|Standard Deviation|5.60|5.6|||
3825418|NCT01728116|3651558|B2|||Baseline BMI||kg/m2|Mean|38.3|38.3|Standard Deviation|5.33|5.33|||
3825419|NCT01728116|3651559|B1|||Baseline BMI||kg/m2|Mean|38.4|38.4|Standard Deviation|5.74|5.74|||
3825420|NCT01728116|3651557|B3|||Baseline Weight (lbs)||lbs|Mean|245.2|245.2|Standard Deviation|46.32|46.32|||
3825421|NCT01728116|3651558|B2|||Baseline Weight (lbs)||lbs|Mean|245.6|245.6|Standard Deviation|44.20|44.2|||
3825422|NCT01728116|3651559|B1|||Baseline Weight (lbs)||lbs|Mean|245.0|245.0|Standard Deviation|47.46|47.46|||
3825423|NCT01728116|3651557|B3|Unknown or Not Reported||Race/Ethnicity, Customized|Subjects were allowed to select more than one race.|participants|Number|2|2.0||||||
3825424|NCT01728116|3651558|B2|Unknown or Not Reported||Race/Ethnicity, Customized|Subjects were allowed to select more than one race.|participants|Number|1|1.0||||||
3825425|NCT01728116|3651559|B1|Unknown or Not Reported||Race/Ethnicity, Customized|Subjects were allowed to select more than one race.|participants|Number|1|1.0||||||
3825426|NCT01728116|3651557|B3|More than one race||Race/Ethnicity, Customized|Subjects were allowed to select more than one race.|participants|Number|2|2.0||||||
3825427|NCT01728116|3651558|B2|More than one race||Race/Ethnicity, Customized|Subjects were allowed to select more than one race.|participants|Number|1|1.0||||||
3825428|NCT01728116|3651559|B1|More than one race||Race/Ethnicity, Customized|Subjects were allowed to select more than one race.|participants|Number|1|1.0||||||
3825429|NCT01728116|3651557|B3|White||Race/Ethnicity, Customized|Subjects were allowed to select more than one race.|participants|Number|245|245.0||||||
3825430|NCT01728116|3651558|B2|White||Race/Ethnicity, Customized|Subjects were allowed to select more than one race.|participants|Number|80|80.0||||||
3825431|NCT01728116|3651559|B1|White||Race/Ethnicity, Customized|Subjects were allowed to select more than one race.|participants|Number|165|165.0||||||
3825432|NCT01728116|3651557|B3|Black or African American||Race/Ethnicity, Customized|Subjects were allowed to select more than one race.|participants|Number|66|66.0||||||
3825433|NCT01728116|3651558|B2|Black or African American||Race/Ethnicity, Customized|Subjects were allowed to select more than one race.|participants|Number|22|22.0||||||
3825434|NCT01728116|3651559|B1|Black or African American||Race/Ethnicity, Customized|Subjects were allowed to select more than one race.|participants|Number|44|44.0||||||
3825435|NCT01728116|3651557|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Subjects were allowed to select more than one race.|participants|Number|0|0.0||||||
3825436|NCT01728116|3651558|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Subjects were allowed to select more than one race.|participants|Number|0|0.0||||||
3825437|NCT01728116|3651559|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Subjects were allowed to select more than one race.|participants|Number|0|0.0||||||
3825438|NCT01728116|3651557|B3|Asian||Race/Ethnicity, Customized|Subjects were allowed to select more than one race.|participants|Number|2|2.0||||||
3825439|NCT01728116|3651558|B2|Asian||Race/Ethnicity, Customized|Subjects were allowed to select more than one race.|participants|Number|1|1.0||||||
3825440|NCT01728116|3651559|B1|Asian||Race/Ethnicity, Customized|Subjects were allowed to select more than one race.|participants|Number|1|1.0||||||
3825441|NCT01728116|3651557|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|Subjects were allowed to select more than one race.|participants|Number|9|9.0||||||
3825442|NCT01728116|3651558|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|Subjects were allowed to select more than one race.|participants|Number|3|3.0||||||
3825443|NCT01728116|3651559|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Subjects were allowed to select more than one race.|participants|Number|6|6.0||||||
3825444|NCT01728116|3651557|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825445|NCT01728116|3651558|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825446|NCT01728116|3651559|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825447|NCT01728116|3651557|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|287|287.0||||||
3825448|NCT01728116|3651558|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
3825449|NCT01728116|3651559|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|194|194.0||||||
3825450|NCT01728116|3651557|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3825451|NCT01728116|3651558|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3825452|NCT01728116|3651559|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3825453|NCT01728116|3651557|B3||Male|Gender|In both arms (Device and Sham) of the mITT population, 61.3% were female and 38.8% were male|Participants|Count of Participants|124|124.0||||||
3825454|NCT01728116|3651558|B2||Male|Gender|In both arms (Device and Sham) of the mITT population, 61.3% were female and 38.8% were male|Participants|Count of Participants|38|38.0||||||
3825455|NCT01728116|3651559|B1||Male|Gender|In both arms (Device and Sham) of the mITT population, 61.3% were female and 38.8% were male|Participants|Count of Participants|86|86.0||||||
3825456|NCT01728116|3651557|B3||Female|Gender|In both arms (Device and Sham) of the mITT population, 61.3% were female and 38.8% were male|Participants|Count of Participants|196|196.0||||||
3825457|NCT01728116|3651558|B2||Female|Gender|In both arms (Device and Sham) of the mITT population, 61.3% were female and 38.8% were male|Participants|Count of Participants|69|69.0||||||
3825458|NCT01728116|3651559|B1||Female|Gender|In both arms (Device and Sham) of the mITT population, 61.3% were female and 38.8% were male|Participants|Count of Participants|127|127.0||||||
3825459|NCT01728116|3651557|B3|||Age|Age, range 25 to 65 years|years|Mean|52.5|52.5|Standard Deviation|8.20|8.2|||
3825460|NCT01728116|3651558|B2|||Age|Age, range 25 to 65 years|years|Mean|51.8|51.8|Standard Deviation|8.21|8.21|||
3825461|NCT01728116|3651559|B1|||Age|Age, range 25 to 65 years|years|Mean|52.9|52.9|Standard Deviation|8.19|8.19|||
3825462|NCT01728077|3651583|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3825463|NCT01728077|3651584|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3825464|NCT01728077|3651585|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3825465|NCT01728077|3651583|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3825466|NCT01728077|3651584|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3825467|NCT01728077|3651585|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3825468|NCT01728077|3651583|B3|Arithmetic mean (standard deviation)||Age||years|Mean|36.5|36.5|Standard Deviation|11.9|11.9|||
3825469|NCT01728077|3651584|B2|Arithmetic mean (standard deviation)||Age||years|Mean|30.7|30.7|Standard Deviation|13.2|13.2|||
3825470|NCT01728077|3651585|B1|Arithmetic mean (standard deviation)||Age||years|Mean|38.6|38.6|Standard Deviation|10.9|10.9|||
3825471|NCT01728077|3651583|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3825472|NCT01728077|3651584|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3825473|NCT01728077|3651585|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3825474|NCT01728077|3651583|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3825475|NCT01728077|3651584|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3825476|NCT01728077|3651585|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3825477|NCT01728077|3651583|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3825478|NCT01728077|3651584|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3825479|NCT01728077|3651585|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3825480|NCT01727895|3651599|B3|||TNF-α Secretion by ex Vivo LPS-Stimulated Peripheral Blood mononuclear cells||pg/ml|Median|720|720.0|Inter-Quartile Range|||282.0|1905.0|
3825481|NCT01727895|3651600|B2|||TNF-α Secretion by ex Vivo LPS-Stimulated Peripheral Blood mononuclear cells||pg/ml|Median|749|749.0|Inter-Quartile Range|||287.0|1160.0|
3825482|NCT01727895|3651601|B1|||TNF-α Secretion by ex Vivo LPS-Stimulated Peripheral Blood mononuclear cells||pg/ml|Median|691|691.0|Inter-Quartile Range|||276.0|2649.0|
3825483|NCT01727895|3651599|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3825484|NCT01727895|3651600|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3825485|NCT01727895|3651601|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3825486|NCT01727895|3651599|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3825487|NCT01727895|3651600|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3825488|NCT01727895|3651601|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3825489|NCT01727895|3651599|B3|||Age||years|Median|20|20.0|Inter-Quartile Range|||19.0|23.0|
3825490|NCT01727895|3651600|B2|||Age||years|Median|20|20.0|Inter-Quartile Range|||19.0|24.0|
3825491|NCT01727895|3651601|B1|||Age||years|Median|20|20.0|Inter-Quartile Range|||19.0|22.0|
3825492|NCT01727791|3651608|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3825493|NCT01727791|3651608|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3825494|NCT01727791|3651608|B1|||Age||years|Mean|31.7|31.7|Standard Deviation|4.5|4.5|||
3825495|NCT01727726|3651638|B4||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3825496|NCT01727726|3651639|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3825497|NCT01727726|3651640|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3825498|NCT01727726|3651641|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3825499|NCT01727726|3651638|B4||Female|Sex: Female, Male||Participants|Count of Participants|343|343.0||||||
3825500|NCT01727726|3651639|B3||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3825501|NCT01727726|3651640|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3825502|NCT01727726|3651641|B1||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3825503|NCT01727726|3651638|B4|||Age||years|Mean|43|43.0|Standard Deviation|11.7|11.7|||
3825504|NCT01727726|3651639|B3|||Age||years|Mean|41.8|41.8|Standard Deviation|11.7|11.7|||
3825505|NCT01727726|3651640|B2|||Age||years|Mean|44.6|44.6|Standard Deviation|11.6|11.6|||
3825506|NCT01727726|3651641|B1|||Age||years|Mean|43.6|43.6|Standard Deviation|11.5|11.5|||
3825507|NCT01727726|3651638|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3825508|NCT01727726|3651639|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3825509|NCT01727726|3651640|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3825510|NCT01727726|3651641|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3825511|NCT01727726|3651638|B4||Between 18 and 65 years|Age||Participants|Count of Participants|503|503.0||||||
3825512|NCT01727726|3651639|B3||Between 18 and 65 years|Age||Participants|Count of Participants|206|206.0||||||
3825513|NCT01727726|3651640|B2||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
3825514|NCT01727726|3651641|B1||Between 18 and 65 years|Age||Participants|Count of Participants|197|197.0||||||
3825515|NCT01727726|3651638|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3825516|NCT01727726|3651639|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3825517|NCT01727726|3651640|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3825518|NCT01727726|3651641|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3825519|NCT01727713|3651675|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3825520|NCT01727713|3651675|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3825521|NCT01727713|3651675|B1|||Age||Years|Mean|11.7|11.7|Standard Deviation|2.9|2.9|||
3825522|NCT01727700|3651699|B4||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3825523|NCT01727700|3651700|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3825524|NCT01727700|3651701|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3825525|NCT01727700|3651702|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3825526|NCT01727700|3651699|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3825527|NCT01727700|3651700|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3825528|NCT01727700|3651701|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3825529|NCT01727700|3651702|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3825530|NCT01727700|3651699|B4|||Age||Years|Mean|11.5|11.5|Standard Deviation|2.9|2.9|||
3825531|NCT01727700|3651700|B3|||Age||Years|Mean|11.6|11.6|Standard Deviation|2.8|2.8|||
3825532|NCT01727700|3651701|B2|||Age||Years|Mean|11.8|11.8|Standard Deviation|2.8|2.8|||
3825533|NCT01727700|3651702|B1|||Age||Years|Mean|11.1|11.1|Standard Deviation|3.1|3.1|||
3825534|NCT01727505|3651727|B1|||Fraction of Inspired Oxygen||fraction|Mean|0.38|0.38|Standard Deviation|0.09|0.09|||
3825535|NCT01727505|3651727|B1|||Positive end expiratory pressure||cm H2O|Mean|5.3|5.3|Standard Deviation|0.47|0.47|||
3825536|NCT01727505|3651727|B1|||Pressure support||cm H2O|Mean|10.4|10.4|Standard Deviation|1.7|1.7|||
3825537|NCT01727505|3651727|B1|||Peak inspiratory pressure||cm H2O|Mean|19.4|19.4|Standard Deviation|1.5|1.5|||
3825538|NCT01727505|3651727|B1|||Ventilator mandatory rate||breaths per minute|Mean|33|33.0|Standard Deviation|8.7|8.7|||
3825539|NCT01727505|3651727|B1|||Birth weight||grams|Mean|685|685.0|Standard Deviation|216|216.0|||
3825540|NCT01727505|3651727|B1|||Gestational age||weeks|Mean|25|25.0|Standard Deviation|1.5|1.5|||
3825541|NCT01727505|3651727|B1||Male|Gender||Participants|Count of Participants|11|11.0||||||
3825542|NCT01727505|3651727|B1||Female|Gender||Participants|Count of Participants|13|13.0||||||
3825543|NCT01727505|3651727|B1|||Age||days|Mean|32|32.0|Standard Deviation|22|22.0|||
3825544|NCT01727414|3651744|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825545|NCT01727414|3651745|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825546|NCT01727414|3651746|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825547|NCT01727414|3651744|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3825548|NCT01727414|3651745|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825549|NCT01727414|3651746|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3825550|NCT01727414|3651744|B3||White|Race (NIH/OMB)||Participants|Count of Participants|139|139.0||||||
3825551|NCT01727414|3651745|B2||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3825552|NCT01727414|3651746|B1||White|Race (NIH/OMB)||Participants|Count of Participants|109|109.0||||||
3825553|NCT01727414|3651744|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3825554|NCT01727414|3651745|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3825555|NCT01727414|3651746|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3825556|NCT01727414|3651744|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825557|NCT01727414|3651745|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825558|NCT01727414|3651746|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825559|NCT01727414|3651744|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3825560|NCT01727414|3651745|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825561|NCT01727414|3651746|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3825562|NCT01727414|3651744|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3825563|NCT01727414|3651745|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825564|NCT01727414|3651746|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3825565|NCT01727414|3651744|B3||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3825566|NCT01727414|3651745|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3825567|NCT01727414|3651746|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3825568|NCT01727414|3651744|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3825569|NCT01727414|3651745|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3825570|NCT01727414|3651746|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3825571|NCT01727414|3651744|B3|||Age||years|Mean|8.4|8.4|Standard Deviation|1.3|1.3|||
3825572|NCT01727414|3651745|B2|||Age||years|Mean|7.9|7.9|Standard Deviation|1.0|1.0|||
3825573|NCT01727414|3651746|B1|||Age||years|Mean|8.6|8.6|Standard Deviation|1.3|1.3|||
3825574|NCT01727297|3651753|B1|Spain||Region of Enrollment||participants|Number|7|7.0||||||
3825575|NCT01727297|3651753|B1|Germany||Region of Enrollment||participants|Number|39|39.0||||||
3825576|NCT01727297|3651753|B1|Slovenia||Region of Enrollment||participants|Number|4|4.0||||||
3825577|NCT01727297|3651753|B1|Italy||Region of Enrollment||participants|Number|19|19.0||||||
3825578|NCT01727297|3651753|B1|United States||Region of Enrollment||participants|Number|302|302.0||||||
3825579|NCT01727297|3651753|B1|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
3825580|NCT01727297|3651753|B1|Austria||Region of Enrollment||participants|Number|18|18.0||||||
3825581|NCT01727297|3651753|B1||Male|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
3825582|NCT01727297|3651753|B1||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3825583|NCT01727297|3651753|B1|||Age||years|Mean|71.6|71.6|Standard Deviation|9.8|9.8|||
3825584|NCT01727297|3651753|B1||>=65 years|Age||Participants|Count of Participants|307|307.0||||||
3825585|NCT01727297|3651753|B1||Between 18 and 65 years|Age||Participants|Count of Participants|88|88.0||||||
3825586|NCT01727297|3651753|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3825587|NCT01727258|3651767|B4|USA||Region of Enrollment||participants|Number|153|153.0||||||
3825588|NCT01727258|3651768|B3|USA||Region of Enrollment||participants|Number|51|51.0||||||
3825589|NCT01727258|3651769|B2|USA||Region of Enrollment||participants|Number|51|51.0||||||
3825590|NCT01727258|3651770|B1|USA||Region of Enrollment||participants|Number|51|51.0||||||
3825591|NCT01727258|3651767|B4||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3825592|NCT01727258|3651768|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3825593|NCT01727258|3651769|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3825594|NCT01727258|3651770|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3825595|NCT01727258|3651767|B4||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3825596|NCT01727258|3651768|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3825597|NCT01727258|3651769|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3825598|NCT01727258|3651770|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3825599|NCT01727258|3651767|B4|||Age||years|Mean|38.4|38.4|Standard Deviation|11.00|11.0|||
3825600|NCT01727258|3651768|B3|||Age||years|Mean|39.9|39.9|Standard Deviation|10.46|10.46|||
3825601|NCT01727258|3651769|B2|||Age||years|Mean|37.0|37.0|Standard Deviation|11.56|11.56|||
3825602|NCT01727258|3651770|B1|||Age||years|Mean|38.4|38.4|Standard Deviation|10.97|10.97|||
3825603|NCT01727180|3651795|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3825604|NCT01727180|3651795|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3825605|NCT01727180|3651795|B1|||Age||years|Mean|61.1|61.1|Standard Deviation|12.9|12.9|||
3825606|NCT01727141|3651810|B5||Male|Sex: Female, Male||Participants|Count of Participants|708|708.0||||||
3825607|NCT01727141|3651811|B4||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3825608|NCT01727141|3651812|B3||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3825609|NCT01727141|3651813|B2||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
3825610|NCT01727141|3651814|B1||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
3825611|NCT01727141|3651810|B5||Female|Sex: Female, Male||Participants|Count of Participants|334|334.0||||||
3825612|NCT01727141|3651811|B4||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3825613|NCT01727141|3651812|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3825614|NCT01727141|3651813|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3825615|NCT01727141|3651814|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3825616|NCT01727141|3651810|B5|||Age||Years|Mean|63.8|63.8|Standard Deviation|8.33|8.33|||
3825617|NCT01727141|3651811|B4|||Age||Years|Mean|63.7|63.7|Standard Deviation|8.19|8.19|||
3825618|NCT01727141|3651812|B3|||Age||Years|Mean|63.7|63.7|Standard Deviation|8.35|8.35|||
3825619|NCT01727141|3651813|B2|||Age||Years|Mean|63.7|63.7|Standard Deviation|8.07|8.07|||
3825620|NCT01727141|3651814|B1|||Age||Years|Mean|63.9|63.9|Standard Deviation|8.76|8.76|||
3825621|NCT01727089|3651867|B3|United States||Region of Enrollment||participants|Number|59|59.0||||||
3825622|NCT01727089|3651868|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3825623|NCT01727089|3651869|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3825624|NCT01727089|3651867|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825625|NCT01727089|3651868|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825626|NCT01727089|3651869|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825627|NCT01727089|3651867|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825628|NCT01727089|3651868|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825629|NCT01727089|3651869|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825630|NCT01727089|3651867|B3||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3825631|NCT01727089|3651868|B2||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3825632|NCT01727089|3651869|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3825633|NCT01727089|3651867|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3825634|NCT01727089|3651868|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3825635|NCT01727089|3651869|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3825636|NCT01727089|3651867|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825637|NCT01727089|3651868|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825638|NCT01727089|3651869|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825639|NCT01727089|3651867|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3825640|NCT01727089|3651868|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825641|NCT01727089|3651869|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3825642|NCT01727089|3651867|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825643|NCT01727089|3651868|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825644|NCT01727089|3651869|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825645|NCT01727089|3651867|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825646|NCT01727089|3651868|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825647|NCT01727089|3651869|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825648|NCT01727089|3651867|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3825649|NCT01727089|3651868|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3825650|NCT01727089|3651869|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3825651|NCT01727089|3651867|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3825652|NCT01727089|3651868|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3825653|NCT01727089|3651869|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3825654|NCT01727089|3651867|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3825655|NCT01727089|3651868|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3825656|NCT01727089|3651869|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3825657|NCT01727089|3651867|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3825658|NCT01727089|3651868|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3825659|NCT01727089|3651869|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3825660|NCT01727089|3651867|B3|||Age||years|Median|60|60.0|Full Range|||24.0|82.0|
3825661|NCT01727089|3651868|B2|||Age||years|Median|65|65.0|Full Range|||24.0|78.0|
3825662|NCT01727089|3651869|B1|||Age||years|Median|58|58.0|Full Range|||25.0|82.0|
3825663|NCT01727024|3651882|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3825664|NCT01727024|3651882|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3825665|NCT01727024|3651882|B1|||Age||Years|Mean|63.5|63.5|Standard Deviation|8.2|8.2|||
3825666|NCT01726803|3651896|B3|United States||Region of Enrollment||participants|Number|220|220.0||||||
3825667|NCT01726803|3651897|B2|United States||Region of Enrollment||participants|Number|108|108.0||||||
3825668|NCT01726803|3651898|B1|United States||Region of Enrollment||participants|Number|112|112.0||||||
3825669|NCT01726803|3651896|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3825670|NCT01726803|3651897|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3825671|NCT01726803|3651898|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3825672|NCT01726803|3651896|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3825673|NCT01726803|3651897|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3825674|NCT01726803|3651898|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3825675|NCT01726803|3651896|B3||White|Race (NIH/OMB)||Participants|Count of Participants|179|179.0||||||
3825676|NCT01726803|3651897|B2||White|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
3825677|NCT01726803|3651898|B1||White|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
3825678|NCT01726803|3651896|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3825679|NCT01726803|3651897|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3825680|NCT01726803|3651898|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3825681|NCT01726803|3651896|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3825682|NCT01726803|3651897|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3825683|NCT01726803|3651898|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3825684|NCT01726803|3651896|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3825685|NCT01726803|3651897|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3825686|NCT01726803|3651898|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3825687|NCT01726803|3651896|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3825688|NCT01726803|3651897|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3825689|NCT01726803|3651898|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3825690|NCT01726803|3651896|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825691|NCT01726803|3651897|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825692|NCT01726803|3651898|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825693|NCT01726803|3651896|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|202|202.0||||||
3825694|NCT01726803|3651897|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
3825695|NCT01726803|3651898|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3825696|NCT01726803|3651896|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3825697|NCT01726803|3651897|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3825698|NCT01726803|3651898|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3825699|NCT01726803|3651896|B3||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3825700|NCT01726803|3651897|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3825701|NCT01726803|3651898|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3825702|NCT01726803|3651896|B3||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3825703|NCT01726803|3651897|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3825704|NCT01726803|3651898|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3825705|NCT01726803|3651896|B3|||Age||Years|Mean|37.5|37.5|Standard Deviation|10.3|10.3|||
3825706|NCT01726803|3651897|B2|||Age||Years|Mean|38.3|38.3|Standard Deviation|10.4|10.4|||
3825707|NCT01726803|3651898|B1|||Age||Years|Mean|36.5|36.5|Standard Deviation|10.2|10.2|||
3825708|NCT01726673|3651919|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3825709|NCT01726673|3651920|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3825710|NCT01726673|3651921|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825711|NCT01726673|3651919|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825712|NCT01726673|3651920|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825713|NCT01726673|3651921|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825714|NCT01726673|3651919|B3||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3825715|NCT01726673|3651920|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3825716|NCT01726673|3651921|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3825717|NCT01726673|3651919|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3825718|NCT01726673|3651920|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3825719|NCT01726673|3651921|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3825720|NCT01726673|3651919|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825721|NCT01726673|3651920|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825722|NCT01726673|3651921|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825723|NCT01726673|3651919|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3825724|NCT01726673|3651920|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3825725|NCT01726673|3651921|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3825726|NCT01726673|3651919|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825727|NCT01726673|3651920|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825728|NCT01726673|3651921|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825729|NCT01726673|3651919|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3825730|NCT01726673|3651920|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3825731|NCT01726673|3651921|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3825732|NCT01726673|3651919|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3825733|NCT01726673|3651920|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3825734|NCT01726673|3651921|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3825735|NCT01726673|3651919|B3||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3825736|NCT01726673|3651920|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3825737|NCT01726673|3651921|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3825738|NCT01726673|3651919|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3825739|NCT01726673|3651920|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3825740|NCT01726673|3651921|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3825741|NCT01726673|3651919|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3825742|NCT01726673|3651920|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3825743|NCT01726673|3651921|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3825744|NCT01726621|3651932|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3825745|NCT01726621|3651932|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3825746|NCT01726621|3651932|B1|||Age||years|Mean|31.3|31.3|Standard Deviation|16.91|16.91|||
3825747|NCT01726621|3651932|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3825748|NCT01726621|3651932|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3825749|NCT01726621|3651932|B1||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
3825750|NCT01726517|3651936|B6|Yes||Cirrhosis||participants|Number|22|22.0||||||
3825751|NCT01726517|3651937|B5|Yes||Cirrhosis||participants|Number|11|11.0||||||
3825752|NCT01726517|3651938|B4|Yes||Cirrhosis||participants|Number|11|11.0||||||
3825753|NCT01726517|3651939|B3|Yes||Cirrhosis||participants|Number|0|0.0||||||
3825754|NCT01726517|3651940|B2|Yes||Cirrhosis||participants|Number|0|0.0||||||
3825755|NCT01726517|3651941|B1|Yes||Cirrhosis||participants|Number|0|0.0||||||
3825756|NCT01726517|3651936|B6|No||Cirrhosis||participants|Number|78|78.0||||||
3825757|NCT01726517|3651937|B5|No||Cirrhosis||participants|Number|10|10.0||||||
3825758|NCT01726517|3651938|B4|No||Cirrhosis||participants|Number|8|8.0||||||
3825759|NCT01726517|3651939|B3|No||Cirrhosis||participants|Number|19|19.0||||||
3825760|NCT01726517|3651940|B2|No||Cirrhosis||participants|Number|21|21.0||||||
3825761|NCT01726517|3651941|B1|No||Cirrhosis||participants|Number|20|20.0||||||
3825762|NCT01726517|3651936|B6|Relapse/Breakthrough to PI telaprevir||Prior HCV Treatment and Response|Prior HCV treatment and response was only collected for treatment-experienced participants in the LDV/SOF 12 Weeks (TE) and LDV/SOF+RBV 12 Weeks (TE) groups.|participants|Number|9|9.0||||||
3825763|NCT01726517|3651937|B5|Relapse/Breakthrough to PI telaprevir||Prior HCV Treatment and Response|Prior HCV treatment and response was only collected for treatment-experienced participants in the LDV/SOF 12 Weeks (TE) and LDV/SOF+RBV 12 Weeks (TE) groups.|participants|Number|4|4.0||||||
3825764|NCT01726517|3651938|B4|Relapse/Breakthrough to PI telaprevir||Prior HCV Treatment and Response|Prior HCV treatment and response was only collected for treatment-experienced participants in the LDV/SOF 12 Weeks (TE) and LDV/SOF+RBV 12 Weeks (TE) groups.|participants|Number|5|5.0||||||
3825765|NCT01726517|3651939|B3|Relapse/Breakthrough to PI telaprevir||Prior HCV Treatment and Response|Prior HCV treatment and response was only collected for treatment-experienced participants in the LDV/SOF 12 Weeks (TE) and LDV/SOF+RBV 12 Weeks (TE) groups.|participants|Number|0|0.0||||||
3825766|NCT01726517|3651940|B2|Relapse/Breakthrough to PI telaprevir||Prior HCV Treatment and Response|Prior HCV treatment and response was only collected for treatment-experienced participants in the LDV/SOF 12 Weeks (TE) and LDV/SOF+RBV 12 Weeks (TE) groups.|participants|Number|0|0.0||||||
3825767|NCT01726517|3651941|B1|Relapse/Breakthrough to PI telaprevir||Prior HCV Treatment and Response|Prior HCV treatment and response was only collected for treatment-experienced participants in the LDV/SOF 12 Weeks (TE) and LDV/SOF+RBV 12 Weeks (TE) groups.|participants|Number|0|0.0||||||
3825768|NCT01726517|3651936|B6|Non-responder to PI telaprevir||Prior HCV Treatment and Response|Prior HCV treatment and response was only collected for treatment-experienced participants in the LDV/SOF 12 Weeks (TE) and LDV/SOF+RBV 12 Weeks (TE) groups.|participants|Number|9|9.0||||||
3825769|NCT01726517|3651937|B5|Non-responder to PI telaprevir||Prior HCV Treatment and Response|Prior HCV treatment and response was only collected for treatment-experienced participants in the LDV/SOF 12 Weeks (TE) and LDV/SOF+RBV 12 Weeks (TE) groups.|participants|Number|6|6.0||||||
3825770|NCT01726517|3651938|B4|Non-responder to PI telaprevir||Prior HCV Treatment and Response|Prior HCV treatment and response was only collected for treatment-experienced participants in the LDV/SOF 12 Weeks (TE) and LDV/SOF+RBV 12 Weeks (TE) groups.|participants|Number|3|3.0||||||
3825771|NCT01726517|3651939|B3|Non-responder to PI telaprevir||Prior HCV Treatment and Response|Prior HCV treatment and response was only collected for treatment-experienced participants in the LDV/SOF 12 Weeks (TE) and LDV/SOF+RBV 12 Weeks (TE) groups.|participants|Number|0|0.0||||||
3825772|NCT01726517|3651940|B2|Non-responder to PI telaprevir||Prior HCV Treatment and Response|Prior HCV treatment and response was only collected for treatment-experienced participants in the LDV/SOF 12 Weeks (TE) and LDV/SOF+RBV 12 Weeks (TE) groups.|participants|Number|0|0.0||||||
3825773|NCT01726517|3651941|B1|Non-responder to PI telaprevir||Prior HCV Treatment and Response|Prior HCV treatment and response was only collected for treatment-experienced participants in the LDV/SOF 12 Weeks (TE) and LDV/SOF+RBV 12 Weeks (TE) groups.|participants|Number|0|0.0||||||
3825774|NCT01726517|3651936|B6|Relapse/Breakthrough to PI boceprevir||Prior HCV Treatment and Response|Prior HCV treatment and response was only collected for treatment-experienced participants in the LDV/SOF 12 Weeks (TE) and LDV/SOF+RBV 12 Weeks (TE) groups.|participants|Number|4|4.0||||||
3825775|NCT01726517|3651937|B5|Relapse/Breakthrough to PI boceprevir||Prior HCV Treatment and Response|Prior HCV treatment and response was only collected for treatment-experienced participants in the LDV/SOF 12 Weeks (TE) and LDV/SOF+RBV 12 Weeks (TE) groups.|participants|Number|2|2.0||||||
3825776|NCT01726517|3651938|B4|Relapse/Breakthrough to PI boceprevir||Prior HCV Treatment and Response|Prior HCV treatment and response was only collected for treatment-experienced participants in the LDV/SOF 12 Weeks (TE) and LDV/SOF+RBV 12 Weeks (TE) groups.|participants|Number|2|2.0||||||
3825777|NCT01726517|3651939|B3|Relapse/Breakthrough to PI boceprevir||Prior HCV Treatment and Response|Prior HCV treatment and response was only collected for treatment-experienced participants in the LDV/SOF 12 Weeks (TE) and LDV/SOF+RBV 12 Weeks (TE) groups.|participants|Number|0|0.0||||||
3825778|NCT01726517|3651940|B2|Relapse/Breakthrough to PI boceprevir||Prior HCV Treatment and Response|Prior HCV treatment and response was only collected for treatment-experienced participants in the LDV/SOF 12 Weeks (TE) and LDV/SOF+RBV 12 Weeks (TE) groups.|participants|Number|0|0.0||||||
3825779|NCT01726517|3651941|B1|Relapse/Breakthrough to PI boceprevir||Prior HCV Treatment and Response|Prior HCV treatment and response was only collected for treatment-experienced participants in the LDV/SOF 12 Weeks (TE) and LDV/SOF+RBV 12 Weeks (TE) groups.|participants|Number|0|0.0||||||
3825780|NCT01726517|3651936|B6|Non-responder to PI boceprevir||Prior HCV Treatment and Response|Prior HCV treatment and response was only collected for treatment-experienced participants in the LDV/SOF 12 Weeks (TE) and LDV/SOF+RBV 12 Weeks (TE) groups.|participants|Number|18|18.0||||||
3825781|NCT01726517|3651937|B5|Non-responder to PI boceprevir||Prior HCV Treatment and Response|Prior HCV treatment and response was only collected for treatment-experienced participants in the LDV/SOF 12 Weeks (TE) and LDV/SOF+RBV 12 Weeks (TE) groups.|participants|Number|9|9.0||||||
3825782|NCT01726517|3651938|B4|Non-responder to PI boceprevir||Prior HCV Treatment and Response|Prior HCV treatment and response was only collected for treatment-experienced participants in the LDV/SOF 12 Weeks (TE) and LDV/SOF+RBV 12 Weeks (TE) groups.|participants|Number|9|9.0||||||
3825783|NCT01726517|3651939|B3|Non-responder to PI boceprevir||Prior HCV Treatment and Response|Prior HCV treatment and response was only collected for treatment-experienced participants in the LDV/SOF 12 Weeks (TE) and LDV/SOF+RBV 12 Weeks (TE) groups.|participants|Number|0|0.0||||||
3825784|NCT01726517|3651940|B2|Non-responder to PI boceprevir||Prior HCV Treatment and Response|Prior HCV treatment and response was only collected for treatment-experienced participants in the LDV/SOF 12 Weeks (TE) and LDV/SOF+RBV 12 Weeks (TE) groups.|participants|Number|0|0.0||||||
3825785|NCT01726517|3651941|B1|Non-responder to PI boceprevir||Prior HCV Treatment and Response|Prior HCV treatment and response was only collected for treatment-experienced participants in the LDV/SOF 12 Weeks (TE) and LDV/SOF+RBV 12 Weeks (TE) groups.|participants|Number|0|0.0||||||
3825786|NCT01726517|3651936|B6|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|68|68.0||||||
3825787|NCT01726517|3651937|B5|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|16|16.0||||||
3825788|NCT01726517|3651938|B4|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|15|15.0||||||
3825789|NCT01726517|3651939|B3|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|12|12.0||||||
3825790|NCT01726517|3651940|B2|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|14|14.0||||||
3825791|NCT01726517|3651941|B1|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|11|11.0||||||
3825792|NCT01726517|3651936|B6|< 800,000 IU/mL||HCV RNA Category||participants|Number|32|32.0||||||
3825793|NCT01726517|3651937|B5|< 800,000 IU/mL||HCV RNA Category||participants|Number|5|5.0||||||
3825794|NCT01726517|3651938|B4|< 800,000 IU/mL||HCV RNA Category||participants|Number|4|4.0||||||
3825795|NCT01726517|3651939|B3|< 800,000 IU/mL||HCV RNA Category||participants|Number|7|7.0||||||
3825796|NCT01726517|3651940|B2|< 800,000 IU/mL||HCV RNA Category||participants|Number|7|7.0||||||
3825797|NCT01726517|3651941|B1|< 800,000 IU/mL||HCV RNA Category||participants|Number|9|9.0||||||
3825798|NCT01726517|3651936|B6|||HCV RNA (log10 IU/mL)||log10 IU/mL|Mean|6.1|6.1|Standard Deviation|0.69|0.69|||
3825799|NCT01726517|3651937|B5|||HCV RNA (log10 IU/mL)||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.42|0.42|||
3825800|NCT01726517|3651938|B4|||HCV RNA (log10 IU/mL)||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.49|0.49|||
3825801|NCT01726517|3651939|B3|||HCV RNA (log10 IU/mL)||log10 IU/mL|Mean|6.1|6.1|Standard Deviation|0.79|0.79|||
3825802|NCT01726517|3651940|B2|||HCV RNA (log10 IU/mL)||log10 IU/mL|Mean|6.0|6.0|Standard Deviation|0.84|0.84|||
3825803|NCT01726517|3651941|B1|||HCV RNA (log10 IU/mL)||log10 IU/mL|Mean|6.1|6.1|Standard Deviation|0.82|0.82|||
3825804|NCT01726517|3651936|B6|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|24|24.0||||||
3825805|NCT01726517|3651937|B5|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|9|9.0||||||
3825806|NCT01726517|3651938|B4|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|4|4.0||||||
3825807|NCT01726517|3651939|B3|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|4|4.0||||||
3825808|NCT01726517|3651940|B2|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
3825809|NCT01726517|3651941|B1|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|4|4.0||||||
3825810|NCT01726517|3651936|B6|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|61|61.0||||||
3825811|NCT01726517|3651937|B5|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|11|11.0||||||
3825812|NCT01726517|3651938|B4|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|13|13.0||||||
3825813|NCT01726517|3651939|B3|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|14|14.0||||||
3825814|NCT01726517|3651940|B2|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|11|11.0||||||
3825815|NCT01726517|3651941|B1|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|12|12.0||||||
3825816|NCT01726517|3651936|B6|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|15|15.0||||||
3825817|NCT01726517|3651937|B5|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3825818|NCT01726517|3651938|B4|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|2|2.0||||||
3825819|NCT01726517|3651939|B3|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3825820|NCT01726517|3651940|B2|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|7|7.0||||||
3825821|NCT01726517|3651941|B1|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|4|4.0||||||
3825822|NCT01726517|3651936|B6|1b||Hepatitis C Virus (HCV) Genotype|There are variations within HCV genotype 1 which are distinct enough to be referred to as genotypes 1a or 1b.|participants|Number|13|13.0||||||
3825823|NCT01726517|3651937|B5|1b||Hepatitis C Virus (HCV) Genotype|There are variations within HCV genotype 1 which are distinct enough to be referred to as genotypes 1a or 1b.|participants|Number|5|5.0||||||
3825824|NCT01726517|3651938|B4|1b||Hepatitis C Virus (HCV) Genotype|There are variations within HCV genotype 1 which are distinct enough to be referred to as genotypes 1a or 1b.|participants|Number|1|1.0||||||
3825825|NCT01726517|3651939|B3|1b||Hepatitis C Virus (HCV) Genotype|There are variations within HCV genotype 1 which are distinct enough to be referred to as genotypes 1a or 1b.|participants|Number|2|2.0||||||
3825826|NCT01726517|3651940|B2|1b||Hepatitis C Virus (HCV) Genotype|There are variations within HCV genotype 1 which are distinct enough to be referred to as genotypes 1a or 1b.|participants|Number|2|2.0||||||
3825827|NCT01726517|3651941|B1|1b||Hepatitis C Virus (HCV) Genotype|There are variations within HCV genotype 1 which are distinct enough to be referred to as genotypes 1a or 1b.|participants|Number|3|3.0||||||
3825828|NCT01726517|3651936|B6|1a||Hepatitis C Virus (HCV) Genotype|There are variations within HCV genotype 1 which are distinct enough to be referred to as genotypes 1a or 1b.|participants|Number|87|87.0||||||
3825829|NCT01726517|3651937|B5|1a||Hepatitis C Virus (HCV) Genotype|There are variations within HCV genotype 1 which are distinct enough to be referred to as genotypes 1a or 1b.|participants|Number|16|16.0||||||
3825830|NCT01726517|3651938|B4|1a||Hepatitis C Virus (HCV) Genotype|There are variations within HCV genotype 1 which are distinct enough to be referred to as genotypes 1a or 1b.|participants|Number|18|18.0||||||
3825831|NCT01726517|3651939|B3|1a||Hepatitis C Virus (HCV) Genotype|There are variations within HCV genotype 1 which are distinct enough to be referred to as genotypes 1a or 1b.|participants|Number|17|17.0||||||
3825832|NCT01726517|3651940|B2|1a||Hepatitis C Virus (HCV) Genotype|There are variations within HCV genotype 1 which are distinct enough to be referred to as genotypes 1a or 1b.|participants|Number|19|19.0||||||
3825833|NCT01726517|3651941|B1|1a||Hepatitis C Virus (HCV) Genotype|There are variations within HCV genotype 1 which are distinct enough to be referred to as genotypes 1a or 1b.|participants|Number|17|17.0||||||
3825834|NCT01726517|3651936|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825835|NCT01726517|3651937|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825836|NCT01726517|3651938|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825837|NCT01726517|3651939|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825838|NCT01726517|3651940|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825839|NCT01726517|3651941|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825840|NCT01726517|3651936|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825841|NCT01726517|3651937|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825842|NCT01726517|3651938|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825843|NCT01726517|3651939|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825844|NCT01726517|3651940|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825845|NCT01726517|3651941|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825846|NCT01726517|3651936|B6||White|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3825847|NCT01726517|3651937|B5||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3825848|NCT01726517|3651938|B4||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3825849|NCT01726517|3651939|B3||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3825850|NCT01726517|3651940|B2||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3825851|NCT01726517|3651941|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3825852|NCT01726517|3651936|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3825853|NCT01726517|3651937|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3825854|NCT01726517|3651938|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3825855|NCT01726517|3651939|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3825856|NCT01726517|3651940|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825857|NCT01726517|3651941|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3825858|NCT01726517|3651936|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825859|NCT01726517|3651937|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825860|NCT01726517|3651938|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825861|NCT01726517|3651939|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825862|NCT01726517|3651940|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825863|NCT01726517|3651941|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825864|NCT01726517|3651936|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3825865|NCT01726517|3651937|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825866|NCT01726517|3651938|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825867|NCT01726517|3651939|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3825868|NCT01726517|3651940|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825869|NCT01726517|3651941|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3825870|NCT01726517|3651936|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3825871|NCT01726517|3651937|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825872|NCT01726517|3651938|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3825873|NCT01726517|3651939|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825874|NCT01726517|3651940|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825875|NCT01726517|3651941|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825876|NCT01726517|3651936|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825877|NCT01726517|3651937|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825878|NCT01726517|3651938|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825879|NCT01726517|3651939|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825880|NCT01726517|3651940|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825881|NCT01726517|3651941|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3825882|NCT01726517|3651936|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3825883|NCT01726517|3651937|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3825884|NCT01726517|3651938|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3825885|NCT01726517|3651939|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3825886|NCT01726517|3651940|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3825887|NCT01726517|3651941|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3825888|NCT01726517|3651936|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3825889|NCT01726517|3651937|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3825890|NCT01726517|3651938|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3825891|NCT01726517|3651939|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3825892|NCT01726517|3651940|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3825893|NCT01726517|3651941|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3825894|NCT01726517|3651936|B6||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3825895|NCT01726517|3651937|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3825896|NCT01726517|3651938|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3825897|NCT01726517|3651939|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3825898|NCT01726517|3651940|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3825899|NCT01726517|3651941|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3825900|NCT01726517|3651936|B6||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3825901|NCT01726517|3651937|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3825902|NCT01726517|3651938|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3825903|NCT01726517|3651939|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3825904|NCT01726517|3651940|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3825905|NCT01726517|3651941|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3825906|NCT01726517|3651936|B6|||Age||years|Mean|50|50.0|Standard Deviation|10.4|10.4|||
3825907|NCT01726517|3651937|B5|||Age||years|Mean|52|52.0|Standard Deviation|9.8|9.8|||
3825908|NCT01726517|3651938|B4|||Age||years|Mean|54|54.0|Standard Deviation|6.6|6.6|||
3825909|NCT01726517|3651939|B3|||Age||years|Mean|46|46.0|Standard Deviation|11.6|11.6|||
3825910|NCT01726517|3651940|B2|||Age||years|Mean|50|50.0|Standard Deviation|11.1|11.1|||
3825911|NCT01726517|3651941|B1|||Age||years|Mean|48|48.0|Standard Deviation|10.7|10.7|||
3825912|NCT01726504|3651972|B3|||Score of Patient Assessment of Constipation Quality of Life(PAC-QOL)|The PAC-QOL was administered by research assistants at the baseline visit and was reported by participants.Data were tested using Student’s t test.PAC-QOL scale ranges are 28-140,and higher values represent a worse outcome.Subscales are summed to compute the total score.|scores on a scale|Mean|76.06|76.06|Standard Deviation|19.28|19.28|||
3825913|NCT01726504|3651973|B2|||Score of Patient Assessment of Constipation Quality of Life(PAC-QOL)|The PAC-QOL was administered by research assistants at the baseline visit and was reported by participants.Data were tested using Student’s t test.PAC-QOL scale ranges are 28-140,and higher values represent a worse outcome.Subscales are summed to compute the total score.|scores on a scale|Mean|75.06|75.06|Standard Deviation|19.26|19.26|||
3825914|NCT01726504|3651974|B1|||Score of Patient Assessment of Constipation Quality of Life(PAC-QOL)|The PAC-QOL was administered by research assistants at the baseline visit and was reported by participants.Data were tested using Student’s t test.PAC-QOL scale ranges are 28-140,and higher values represent a worse outcome.Subscales are summed to compute the total score.|scores on a scale|Mean|77.06|77.06|Standard Deviation|19.27|19.27|||
3825915|NCT01726504|3651972|B3|||Spontaneous Bowel Movements (CSBMs) Per Week|SBMs/week during the 2-week screening period was calculated from participants’ diaries by summing weekly CSBMs or SBMs then dividing by two.|number of times|Mean|1.96|1.96|Standard Deviation|1.40|1.4|||
3825916|NCT01726504|3651973|B2|||Spontaneous Bowel Movements (CSBMs) Per Week|SBMs/week during the 2-week screening period was calculated from participants’ diaries by summing weekly CSBMs or SBMs then dividing by two.|number of times|Mean|2.02|2.02|Standard Deviation|1.45|1.45|||
3825917|NCT01726504|3651974|B1|||Spontaneous Bowel Movements (CSBMs) Per Week|SBMs/week during the 2-week screening period was calculated from participants’ diaries by summing weekly CSBMs or SBMs then dividing by two.|number of times|Mean|1.90|1.9|Standard Deviation|1.34|1.34|||
3825918|NCT01726504|3651972|B3|||Complete Spontaneous Bowel Movements (CSBMs) Per Week|Number of CSBMs/week during the 2-week screening period was calculated from participants’ diaries by summing weekly CSBMs or SBMs then dividing by two.Data were tested using Student’s t test.|number of times|Mean|0.41|0.41|Standard Deviation|0.62|0.62|||
3825919|NCT01726504|3651973|B2|||Complete Spontaneous Bowel Movements (CSBMs) Per Week|Number of CSBMs/week during the 2-week screening period was calculated from participants’ diaries by summing weekly CSBMs or SBMs then dividing by two.Data were tested using Student’s t test.|number of times|Mean|0.42|0.42|Standard Deviation|0.62|0.62|||
3825920|NCT01726504|3651974|B1|||Complete Spontaneous Bowel Movements (CSBMs) Per Week|Number of CSBMs/week during the 2-week screening period was calculated from participants’ diaries by summing weekly CSBMs or SBMs then dividing by two.Data were tested using Student’s t test.|number of times|Mean|0.39|0.39|Standard Deviation|0.62|0.62|||
3825921|NCT01726504|3651972|B3|Others||average number of times other measures were used|Average number of times other measures were used self-reported by participants.Data were tested using Student’s t test.|number of times per week|Mean|0.07|0.07|Standard Deviation|0.51|0.51|||
3825922|NCT01726504|3651973|B2|Others||average number of times other measures were used|Average number of times other measures were used self-reported by participants.Data were tested using Student’s t test.|number of times per week|Mean|0.06|0.06|Standard Deviation|0.43|0.43|||
3825923|NCT01726504|3651974|B1|Others||average number of times other measures were used|Average number of times other measures were used self-reported by participants.Data were tested using Student’s t test.|number of times per week|Mean|0.08|0.08|Standard Deviation|0.58|0.58|||
3825924|NCT01726504|3651972|B3|Rescue medicine||average number of times other measures were used|Average number of times other measures were used self-reported by participants.Data were tested using Student’s t test.|number of times per week|Mean|0.64|0.64|Standard Deviation|1.71|1.71|||
3825925|NCT01726504|3651973|B2|Rescue medicine||average number of times other measures were used|Average number of times other measures were used self-reported by participants.Data were tested using Student’s t test.|number of times per week|Mean|0.62|0.62|Standard Deviation|1.91|1.91|||
3825926|NCT01726504|3651974|B1|Rescue medicine||average number of times other measures were used|Average number of times other measures were used self-reported by participants.Data were tested using Student’s t test.|number of times per week|Mean|0.66|0.66|Standard Deviation|1.47|1.47|||
3825927|NCT01726504|3651972|B3|None||Use of Other Measures by Participants|Use of Other Measures by Participants:Data were tested using chi-square test.|participants|Number|722|722.0||||||
3825928|NCT01726504|3651973|B2|None||Use of Other Measures by Participants|Use of Other Measures by Participants:Data were tested using chi-square test.|participants|Number|373|373.0||||||
3825929|NCT01726504|3651974|B1|None||Use of Other Measures by Participants|Use of Other Measures by Participants:Data were tested using chi-square test.|participants|Number|349|349.0||||||
3825930|NCT01726504|3651972|B3|Others||Use of Other Measures by Participants|Use of Other Measures by Participants:Data were tested using chi-square test.|participants|Number|36|36.0||||||
3825931|NCT01726504|3651973|B2|Others||Use of Other Measures by Participants|Use of Other Measures by Participants:Data were tested using chi-square test.|participants|Number|19|19.0||||||
3825932|NCT01726504|3651974|B1|Others||Use of Other Measures by Participants|Use of Other Measures by Participants:Data were tested using chi-square test.|participants|Number|17|17.0||||||
3825933|NCT01726504|3651972|B3|Rescue medicine||Use of Other Measures by Participants|Use of Other Measures by Participants:Data were tested using chi-square test.|participants|Number|317|317.0||||||
3825934|NCT01726504|3651973|B2|Rescue medicine||Use of Other Measures by Participants|Use of Other Measures by Participants:Data were tested using chi-square test.|participants|Number|147|147.0||||||
3825935|NCT01726504|3651974|B1|Rescue medicine||Use of Other Measures by Participants|Use of Other Measures by Participants:Data were tested using chi-square test.|participants|Number|170|170.0||||||
3825936|NCT01726504|3651972|B3|None||Coexisting illness|Coexisting illnesses was self-reported by participants.Data were tested using chi-square test.|participants|Number|798|798.0||||||
3825937|NCT01726504|3651973|B2|None||Coexisting illness|Coexisting illnesses was self-reported by participants.Data were tested using chi-square test.|participants|Number|403|403.0||||||
3825938|NCT01726504|3651974|B1|None||Coexisting illness|Coexisting illnesses was self-reported by participants.Data were tested using chi-square test.|participants|Number|395|395.0||||||
3825939|NCT01726504|3651972|B3|Others||Coexisting illness|Coexisting illnesses was self-reported by participants.Data were tested using chi-square test.|participants|Number|149|149.0||||||
3825940|NCT01726504|3651973|B2|Others||Coexisting illness|Coexisting illnesses was self-reported by participants.Data were tested using chi-square test.|participants|Number|71|71.0||||||
3825941|NCT01726504|3651974|B1|Others||Coexisting illness|Coexisting illnesses was self-reported by participants.Data were tested using chi-square test.|participants|Number|78|78.0||||||
3825942|NCT01726504|3651972|B3|Digestive system disease||Coexisting illness|Coexisting illnesses was self-reported by participants.Data were tested using chi-square test.|participants|Number|27|27.0||||||
3825943|NCT01726504|3651973|B2|Digestive system disease||Coexisting illness|Coexisting illnesses was self-reported by participants.Data were tested using chi-square test.|participants|Number|16|16.0||||||
3825944|NCT01726504|3651974|B1|Digestive system disease||Coexisting illness|Coexisting illnesses was self-reported by participants.Data were tested using chi-square test.|participants|Number|11|11.0||||||
3825945|NCT01726504|3651972|B3|Hypertension||Coexisting illness|Coexisting illnesses was self-reported by participants.Data were tested using chi-square test.|participants|Number|80|80.0||||||
3825946|NCT01726504|3651973|B2|Hypertension||Coexisting illness|Coexisting illnesses was self-reported by participants.Data were tested using chi-square test.|participants|Number|39|39.0||||||
3825947|NCT01726504|3651974|B1|Hypertension||Coexisting illness|Coexisting illnesses was self-reported by participants.Data were tested using chi-square test.|participants|Number|41|41.0||||||
3825948|NCT01726504|3651972|B3|Diabetes||Coexisting illness|Coexisting illnesses was self-reported by participants.Data were tested using chi-square test.|participants|Number|21|21.0||||||
3825949|NCT01726504|3651973|B2|Diabetes||Coexisting illness|Coexisting illnesses was self-reported by participants.Data were tested using chi-square test.|participants|Number|10|10.0||||||
3825950|NCT01726504|3651974|B1|Diabetes||Coexisting illness|Coexisting illnesses was self-reported by participants.Data were tested using chi-square test.|participants|Number|11|11.0||||||
3825951|NCT01726504|3651972|B3|||Constipation duration (mon)|Constipation duration was self-reported by participants.Data were tested using Student’s t test.|month|Mean|131.76|131.76|Standard Deviation|124.78|124.78|||
3825952|NCT01726504|3651973|B2|||Constipation duration (mon)|Constipation duration was self-reported by participants.Data were tested using Student’s t test.|month|Mean|132.71|132.71|Standard Deviation|127.00|127.0|||
3825953|NCT01726504|3651974|B1|||Constipation duration (mon)|Constipation duration was self-reported by participants.Data were tested using Student’s t test.|month|Mean|130.81|130.81|Standard Deviation|122.61|122.61|||
3825954|NCT01726504|3651972|B3|||Body-mass index|Body-mass index was measured by research assistants.Data were tested using Student’s t test.|kg/m^2|Mean|22.54|22.54|Standard Deviation|3.03|3.03|||
3825955|NCT01726504|3651973|B2|||Body-mass index|Body-mass index was measured by research assistants.Data were tested using Student’s t test.|kg/m^2|Mean|22.75|22.75|Standard Deviation|3.00|3.0|||
3825956|NCT01726504|3651974|B1|||Body-mass index|Body-mass index was measured by research assistants.Data were tested using Student’s t test.|kg/m^2|Mean|22.32|22.32|Standard Deviation|3.04|3.04|||
3825957|NCT01726504|3651972|B3|other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3825958|NCT01726504|3651973|B2|other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3825959|NCT01726504|3651974|B1|other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3825960|NCT01726504|3651972|B3|Wei||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3825961|NCT01726504|3651973|B2|Wei||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3825962|NCT01726504|3651974|B1|Wei||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3825963|NCT01726504|3651972|B3|Miao||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3825964|NCT01726504|3651973|B2|Miao||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3825965|NCT01726504|3651974|B1|Miao||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3825966|NCT01726504|3651972|B3|Zhuang||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3825967|NCT01726504|3651973|B2|Zhuang||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3825968|NCT01726504|3651974|B1|Zhuang||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3825969|NCT01726504|3651972|B3|Hui||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3825970|NCT01726504|3651973|B2|Hui||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3825971|NCT01726504|3651974|B1|Hui||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3825972|NCT01726504|3651972|B3|Man||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3825973|NCT01726504|3651973|B2|Man||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3825974|NCT01726504|3651974|B1|Man||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3825975|NCT01726504|3651972|B3|Han||Race/Ethnicity, Customized||participants|Number|1045|1045.0||||||
3825976|NCT01726504|3651973|B2|Han||Race/Ethnicity, Customized||participants|Number|526|526.0||||||
3825977|NCT01726504|3651974|B1|Han||Race/Ethnicity, Customized||participants|Number|519|519.0||||||
3825978|NCT01726504|3651972|B3||Male|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
3825979|NCT01726504|3651973|B2||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3825980|NCT01726504|3651974|B1||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3825981|NCT01726504|3651972|B3||Female|Sex: Female, Male||Participants|Count of Participants|822|822.0||||||
3825982|NCT01726504|3651973|B2||Female|Sex: Female, Male||Participants|Count of Participants|407|407.0||||||
3825983|NCT01726504|3651974|B1||Female|Sex: Female, Male||Participants|Count of Participants|415|415.0||||||
3825984|NCT01726504|3651972|B3||>=65 years|Age||Participants|Count of Participants|171|171.0||||||
3825985|NCT01726504|3651973|B2||>=65 years|Age||Participants|Count of Participants|82|82.0||||||
3825986|NCT01726504|3651974|B1||>=65 years|Age||Participants|Count of Participants|89|89.0||||||
3825987|NCT01726504|3651972|B3||Between 18 and 65 years|Age||Participants|Count of Participants|904|904.0||||||
3825988|NCT01726504|3651973|B2||Between 18 and 65 years|Age||Participants|Count of Participants|457|457.0||||||
3825989|NCT01726504|3651974|B1||Between 18 and 65 years|Age||Participants|Count of Participants|447|447.0||||||
3825990|NCT01726504|3651972|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3825991|NCT01726504|3651973|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3825992|NCT01726504|3651974|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3825993|NCT01726335|3652001|B1|||Positive and Negative Syndromes Scale (PANSS) Total Score|The PANSS is a 30-item scale designed to assess various symptoms of schizophrenia including delusions, grandiosity, blunted affect, poor attention, and poor impulse control. The 30 symptoms are rated on a 7-point scale that ranges from 1 (absent) to 7 (extreme psychopathology). The PANSS total score consists of the sum of all 30 PANSS items and ranges from 30 to 210. Higher scores indicate worsening.|Units on a scale|Mean|58.80|58.8|Standard Deviation|1.82|1.82|||
3825994|NCT01726335|3652001|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3825995|NCT01726335|3652001|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3825996|NCT01726335|3652001|B1|||Age||Years|Mean|33.6|33.6|Standard Deviation|9.1|9.1|||
3825997|NCT01726049|3652017|B3|Netherlands||Region of Enrollment||participants|Number|52|52.0||||||
3825998|NCT01726049|3652018|B2|Netherlands||Region of Enrollment||participants|Number|26|26.0||||||
3825999|NCT01726049|3652019|B1|Netherlands||Region of Enrollment||participants|Number|26|26.0||||||
3826000|NCT01726049|3652017|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3826001|NCT01726049|3652018|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3826002|NCT01726049|3652019|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3826003|NCT01726049|3652017|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3826004|NCT01726049|3652018|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3826005|NCT01726049|3652019|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3826006|NCT01726049|3652017|B3|||Age||years|Mean|74|74.0|Standard Deviation|10|10.0|||
3826007|NCT01726049|3652018|B2|||Age||years|Mean|76|76.0|Standard Deviation|7|7.0|||
3826008|NCT01726049|3652019|B1|||Age||years|Mean|72|72.0|Standard Deviation|12|12.0|||
3826009|NCT01726023|3652032|B3|Asian||Race/Ethnicity, Customized||Participants|Number|431|431.0||||||
3826010|NCT01726023|3652033|B2|Asian||Race/Ethnicity, Customized||Participants|Number|217|217.0||||||
3826011|NCT01726023|3652034|B1|Asian||Race/Ethnicity, Customized||Participants|Number|214|214.0||||||
3826012|NCT01726023|3652032|B3||Male|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
3826013|NCT01726023|3652033|B2||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3826014|NCT01726023|3652034|B1||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3826015|NCT01726023|3652032|B3||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3826016|NCT01726023|3652033|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3826017|NCT01726023|3652034|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3826018|NCT01726023|3652032|B3|75-90 Years||Age, Customized||Participants|Number|31|31.0||||||
3826019|NCT01726023|3652033|B2|75-90 Years||Age, Customized||Participants|Number|19|19.0||||||
3826020|NCT01726023|3652034|B1|75-90 Years||Age, Customized||Participants|Number|12|12.0||||||
3826021|NCT01726023|3652032|B3|65-74 Years||Age, Customized||Participants|Number|58|58.0||||||
3826022|NCT01726023|3652033|B2|65-74 Years||Age, Customized||Participants|Number|30|30.0||||||
3826023|NCT01726023|3652034|B1|65-74 Years||Age, Customized||Participants|Number|28|28.0||||||
3826024|NCT01726023|3652032|B3|46-64 Years||Age, Customized||Participants|Number|157|157.0||||||
3826025|NCT01726023|3652033|B2|46-64 Years||Age, Customized||Participants|Number|72|72.0||||||
3826026|NCT01726023|3652034|B1|46-64 Years||Age, Customized||Participants|Number|85|85.0||||||
3826027|NCT01726023|3652032|B3|18-45 Years||Age, Customized||Participants|Number|185|185.0||||||
3826028|NCT01726023|3652033|B2|18-45 Years||Age, Customized||Participants|Number|96|96.0||||||
3826029|NCT01726023|3652034|B1|18-45 Years||Age, Customized||Participants|Number|89|89.0||||||
3826030|NCT01726023|3652032|B3|||Age||Years|Mean|48.5|48.5|Standard Deviation|17.11|17.11|||
3826031|NCT01726023|3652033|B2|||Age||Years|Mean|48.5|48.5|Standard Deviation|17.43|17.43|||
3826032|NCT01726023|3652034|B1|||Age||Years|Mean|48.5|48.5|Standard Deviation|16.83|16.83|||
3826033|NCT01725984|3652125|B3|Germany||Region of Enrollment||participants|Number|80|80.0||||||
3826034|NCT01725984|3652126|B2|Germany||Region of Enrollment||participants|Number|41|41.0||||||
3826035|NCT01725984|3652127|B1|Germany||Region of Enrollment||participants|Number|39|39.0||||||
3826036|NCT01725984|3652125|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3826037|NCT01725984|3652126|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3826038|NCT01725984|3652127|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3826039|NCT01725984|3652125|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3826040|NCT01725984|3652126|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3826041|NCT01725984|3652127|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3826042|NCT01725984|3652125|B3|||Age||Years|Mean|69.5|69.5|Standard Deviation|5.1|5.1|||
3826043|NCT01725984|3652126|B2|||Age||Years|Mean|68.8|68.8|Standard Deviation|5.3|5.3|||
3826044|NCT01725984|3652127|B1|||Age||Years|Mean|70.2|70.2|Standard Deviation|4.9|4.9|||
3826045|NCT01725750|3652152|B3|||Years of education completed||years|Mean|15.747|15.747|Standard Deviation|2.580|2.58|||
3826046|NCT01725750|3652153|B2|||Years of education completed||years|Mean|15.651|15.651|Standard Deviation|2.654|2.654|||
3826047|NCT01725750|3652154|B1|||Years of education completed||years|Mean|15.841|15.841|Standard Deviation|2.533|2.533|||
3826048|NCT01725750|3652152|B3|More than one race/Other||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3826049|NCT01725750|3652153|B2|More than one race/Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3826050|NCT01725750|3652154|B1|More than one race/Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3826051|NCT01725750|3652152|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
3826052|NCT01725750|3652153|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3826053|NCT01725750|3652154|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3826054|NCT01725750|3652152|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3826055|NCT01725750|3652153|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3826056|NCT01725750|3652154|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3826057|NCT01725750|3652152|B3|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3826058|NCT01725750|3652153|B2|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3826059|NCT01725750|3652154|B1|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3826060|NCT01725750|3652152|B3|Asian/Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3826061|NCT01725750|3652153|B2|Asian/Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3826062|NCT01725750|3652154|B1|Asian/Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3826063|NCT01725750|3652152|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3826064|NCT01725750|3652153|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3826065|NCT01725750|3652154|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3826066|NCT01725750|3652152|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3826067|NCT01725750|3652153|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3826068|NCT01725750|3652154|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3826069|NCT01725750|3652152|B3|||Age||years|Mean|46.614|46.614|Standard Deviation|14.808|14.808|||
3826070|NCT01725750|3652153|B2|||Age||years|Mean|45.182|45.182|Standard Deviation|13.138|13.138|||
3826071|NCT01725750|3652154|B1|||Age||years|Mean|48.045|48.045|Standard Deviation|16.335|16.335|||
3826072|NCT01725529|3652179|B4||Male|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
3826073|NCT01725529|3652180|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3826074|NCT01725529|3652181|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3826075|NCT01725529|3652182|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3826076|NCT01725529|3652179|B4||Female|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
3826077|NCT01725529|3652180|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3826078|NCT01725529|3652181|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3826079|NCT01725529|3652182|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3826080|NCT01725529|3652179|B4|||Age||years|Median|45|45.0|Full Range|||18.0|68.0|
3826081|NCT01725529|3652180|B3|||Age||years|Median|44|44.0|Full Range|||19.0|68.0|
3826082|NCT01725529|3652181|B2|||Age||years|Median|45|45.0|Full Range|||18.0|68.0|
3826083|NCT01725529|3652182|B1|||Age||years|Median|45|45.0|Full Range|||18.0|68.0|
3826084|NCT01725451|3652210|B1|||Screening Testosterone||nanograms per deciliter (ng/dL)|Mean|290.8|290.8|Standard Deviation|78.2|78.2|||
3826085|NCT01725451|3652210|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3826086|NCT01725451|3652210|B1|White||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3826087|NCT01725451|3652210|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3826088|NCT01725451|3652210|B1|American Indian or Alaska Native/White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3826089|NCT01725451|3652210|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3826090|NCT01725451|3652210|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3826091|NCT01725451|3652210|B1|||Age||years|Mean|59.7|59.7|Standard Deviation|7.9|7.9|||
3826092|NCT01725386|3652233|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3826093|NCT01725386|3652234|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3826094|NCT01725386|3652235|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3826095|NCT01725386|3652233|B3||Female|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
3826096|NCT01725386|3652234|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3826097|NCT01725386|3652235|B1||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3826098|NCT01725386|3652233|B3|||Age||years|Median|47.00|47.0|Standard Deviation|12.11|12.11|||
3826099|NCT01725386|3652234|B2|||Age||years|Median|45.00|45.0|Standard Deviation|15.19|15.19|||
3826100|NCT01725386|3652235|B1|||Age||years|Median|47.00|47.0|Standard Deviation|12.35|12.35|||
3826101|NCT01725308|3652252|B4|||Number of Participants wirth MADRS Remission|MADRS remission was defined as MADRS total score of 12 or less. The MADRS is a 10-item scale to measure the severity of depressive episodes, where each item is rated on a scale from 0 to 6. The MADRS total score ranges from 0 to 60 with lower scores indicating less depressive symptoms.|Participants|Count of Participants|1|1.0||||||
3826102|NCT01725308|3652253|B3|||Number of Participants wirth MADRS Remission|MADRS remission was defined as MADRS total score of 12 or less. The MADRS is a 10-item scale to measure the severity of depressive episodes, where each item is rated on a scale from 0 to 6. The MADRS total score ranges from 0 to 60 with lower scores indicating less depressive symptoms.|Participants|Count of Participants|0|0.0||||||
3826103|NCT01725308|3652254|B2|||Number of Participants wirth MADRS Remission|MADRS remission was defined as MADRS total score of 12 or less. The MADRS is a 10-item scale to measure the severity of depressive episodes, where each item is rated on a scale from 0 to 6. The MADRS total score ranges from 0 to 60 with lower scores indicating less depressive symptoms.|Participants|Count of Participants|1|1.0||||||
3826104|NCT01725308|3652255|B1|||Number of Participants wirth MADRS Remission|MADRS remission was defined as MADRS total score of 12 or less. The MADRS is a 10-item scale to measure the severity of depressive episodes, where each item is rated on a scale from 0 to 6. The MADRS total score ranges from 0 to 60 with lower scores indicating less depressive symptoms.|Participants|Count of Participants|0|0.0||||||
3826105|NCT01725308|3652252|B4|||Total Hamilton Depression Rating Scale (HAM-D17) Score|The HAM-D17 is a clinician-rated 17-item scale for assessing the severity of depression symptoms. The scores for each item range from 0 to 4 or 0 to 2, where 0 represents no symptoms. The rating is based on the past 7 days prior to the time of assessment. The total score ranges from 0 to 52, where a higher score indicates a greater depressive state.|units on a scale|Mean|23.1|23.1|Standard Deviation|3.0|3.0|||
3826106|NCT01725308|3652253|B3|||Total Hamilton Depression Rating Scale (HAM-D17) Score|The HAM-D17 is a clinician-rated 17-item scale for assessing the severity of depression symptoms. The scores for each item range from 0 to 4 or 0 to 2, where 0 represents no symptoms. The rating is based on the past 7 days prior to the time of assessment. The total score ranges from 0 to 52, where a higher score indicates a greater depressive state.|units on a scale|Mean|23.0|23.0|Standard Deviation|3.0|3.0|||
3826107|NCT01725308|3652254|B2|||Total Hamilton Depression Rating Scale (HAM-D17) Score|The HAM-D17 is a clinician-rated 17-item scale for assessing the severity of depression symptoms. The scores for each item range from 0 to 4 or 0 to 2, where 0 represents no symptoms. The rating is based on the past 7 days prior to the time of assessment. The total score ranges from 0 to 52, where a higher score indicates a greater depressive state.|units on a scale|Mean|23.3|23.3|Standard Deviation|3.4|3.4|||
3826108|NCT01725308|3652255|B1|||Total Hamilton Depression Rating Scale (HAM-D17) Score|The HAM-D17 is a clinician-rated 17-item scale for assessing the severity of depression symptoms. The scores for each item range from 0 to 4 or 0 to 2, where 0 represents no symptoms. The rating is based on the past 7 days prior to the time of assessment. The total score ranges from 0 to 52, where a higher score indicates a greater depressive state.|units on a scale|Mean|23.1|23.1|Standard Deviation|2.8|2.8|||
3826109|NCT01725308|3652252|B4|||Total Montgomery-Åsberg Depression Rating Scale (MADRS) score|The MADRS is a10-item scale to measure the severity of depressive episodes, where each item is rated on a scale from 0 to 6. The MADRS total score ranges from 0 to 60 with lower scores indicating less depressive symptoms.|units on a scale|Mean|30.7|30.7|Standard Deviation|6.7|6.7|||
3826110|NCT01725308|3652253|B3|||Total Montgomery-Åsberg Depression Rating Scale (MADRS) score|The MADRS is a10-item scale to measure the severity of depressive episodes, where each item is rated on a scale from 0 to 6. The MADRS total score ranges from 0 to 60 with lower scores indicating less depressive symptoms.|units on a scale|Mean|30.9|30.9|Standard Deviation|6.9|6.9|||
3826111|NCT01725308|3652254|B2|||Total Montgomery-Åsberg Depression Rating Scale (MADRS) score|The MADRS is a10-item scale to measure the severity of depressive episodes, where each item is rated on a scale from 0 to 6. The MADRS total score ranges from 0 to 60 with lower scores indicating less depressive symptoms.|units on a scale|Mean|30.2|30.2|Standard Deviation|6.8|6.8|||
3826112|NCT01725308|3652255|B1|||Total Montgomery-Åsberg Depression Rating Scale (MADRS) score|The MADRS is a10-item scale to measure the severity of depressive episodes, where each item is rated on a scale from 0 to 6. The MADRS total score ranges from 0 to 60 with lower scores indicating less depressive symptoms.|units on a scale|Mean|30.8|30.8|Standard Deviation|6.4|6.4|||
3826113|NCT01725308|3652252|B4||Male|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
3826114|NCT01725308|3652253|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3826115|NCT01725308|3652254|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3826116|NCT01725308|3652255|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3826117|NCT01725308|3652252|B4||Female|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
3826118|NCT01725308|3652253|B3||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3826119|NCT01725308|3652254|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3826120|NCT01725308|3652255|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3826121|NCT01725308|3652252|B4|||Age||Years|Mean|38.6|38.6|Standard Deviation|10.9|10.9|||
3826122|NCT01725308|3652253|B3|||Age||Years|Mean|38.1|38.1|Standard Deviation|11.2|11.2|||
3826123|NCT01725308|3652254|B2|||Age||Years|Mean|39.2|39.2|Standard Deviation|10.2|10.2|||
3826124|NCT01725308|3652255|B1|||Age||Years|Mean|38.8|38.8|Standard Deviation|11.0|11.0|||
3826125|NCT01725282|3652400|B5|||Hamilton Depression Scale 17-Item (HAM D17)|HAM-D17 is a clinician-rated 17-item scale for assessing the severity of depression symptoms. The scores for each item range from 0 to 4 or 0 to 2, where 0 represents no symptoms. The rating is based on the past 7 days prior to the time of assessment. The total score ranges from 0 to 52, where a higher score indicates a greater depressive state.|units on a scale|Mean|22.8|22.8|Standard Deviation|2.6|2.6|||
3826126|NCT01725282|3652401|B4|||Hamilton Depression Scale 17-Item (HAM D17)|HAM-D17 is a clinician-rated 17-item scale for assessing the severity of depression symptoms. The scores for each item range from 0 to 4 or 0 to 2, where 0 represents no symptoms. The rating is based on the past 7 days prior to the time of assessment. The total score ranges from 0 to 52, where a higher score indicates a greater depressive state.|units on a scale|Mean|22.9|22.9|Standard Deviation|2.5|2.5|||
3826127|NCT01725282|3652402|B3|||Hamilton Depression Scale 17-Item (HAM D17)|HAM-D17 is a clinician-rated 17-item scale for assessing the severity of depression symptoms. The scores for each item range from 0 to 4 or 0 to 2, where 0 represents no symptoms. The rating is based on the past 7 days prior to the time of assessment. The total score ranges from 0 to 52, where a higher score indicates a greater depressive state.|units on a scale|Mean|23.3|23.3|Standard Deviation|3.0|3.0|||
3826128|NCT01725282|3652403|B2|||Hamilton Depression Scale 17-Item (HAM D17)|HAM-D17 is a clinician-rated 17-item scale for assessing the severity of depression symptoms. The scores for each item range from 0 to 4 or 0 to 2, where 0 represents no symptoms. The rating is based on the past 7 days prior to the time of assessment. The total score ranges from 0 to 52, where a higher score indicates a greater depressive state.|units on a scale|Mean|22.6|22.6|Standard Deviation|2.4|2.4|||
3826129|NCT01725282|3652404|B1|||Hamilton Depression Scale 17-Item (HAM D17)|HAM-D17 is a clinician-rated 17-item scale for assessing the severity of depression symptoms. The scores for each item range from 0 to 4 or 0 to 2, where 0 represents no symptoms. The rating is based on the past 7 days prior to the time of assessment. The total score ranges from 0 to 52, where a higher score indicates a greater depressive state.|units on a scale|Mean|22.6|22.6|Standard Deviation|2.3|2.3|||
3826130|NCT01725282|3652400|B5|||Montgomery Åsberg Depression Rating Scale (MADRS)|MADRS is a10-item scale to measure the severity of depressive episodes, where each item is rated on a scale from 0 to 6. The MADRS total score ranges from 0 to 60 with lower scores indicating less depressive symptoms.|units on a scale|Mean|28.9|28.9|Standard Deviation|5.4|5.4|||
3826131|NCT01725282|3652401|B4|||Montgomery Åsberg Depression Rating Scale (MADRS)|MADRS is a10-item scale to measure the severity of depressive episodes, where each item is rated on a scale from 0 to 6. The MADRS total score ranges from 0 to 60 with lower scores indicating less depressive symptoms.|units on a scale|Mean|29.3|29.3|Standard Deviation|5.4|5.4|||
3826132|NCT01725282|3652402|B3|||Montgomery Åsberg Depression Rating Scale (MADRS)|MADRS is a10-item scale to measure the severity of depressive episodes, where each item is rated on a scale from 0 to 6. The MADRS total score ranges from 0 to 60 with lower scores indicating less depressive symptoms.|units on a scale|Mean|29.0|29.0|Standard Deviation|5.4|5.4|||
3826133|NCT01725282|3652403|B2|||Montgomery Åsberg Depression Rating Scale (MADRS)|MADRS is a10-item scale to measure the severity of depressive episodes, where each item is rated on a scale from 0 to 6. The MADRS total score ranges from 0 to 60 with lower scores indicating less depressive symptoms.|units on a scale|Mean|28.7|28.7|Standard Deviation|5.9|5.9|||
3826134|NCT01725282|3652404|B1|||Montgomery Åsberg Depression Rating Scale (MADRS)|MADRS is a10-item scale to measure the severity of depressive episodes, where each item is rated on a scale from 0 to 6. The MADRS total score ranges from 0 to 60 with lower scores indicating less depressive symptoms.|units on a scale|Mean|28.5|28.5|Standard Deviation|5.1|5.1|||
3826135|NCT01725282|3652400|B5|Japan||Region of Enrollment||participants|Number|172|172.0||||||
3826136|NCT01725282|3652401|B4|Japan||Region of Enrollment||participants|Number|43|43.0||||||
3826137|NCT01725282|3652402|B3|Japan||Region of Enrollment||participants|Number|41|41.0||||||
3826138|NCT01725282|3652403|B2|Japan||Region of Enrollment||participants|Number|44|44.0||||||
3826139|NCT01725282|3652404|B1|Japan||Region of Enrollment||participants|Number|44|44.0||||||
3826140|NCT01725282|3652400|B5||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3826141|NCT01725282|3652401|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3826142|NCT01725282|3652402|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3826143|NCT01725282|3652403|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3826144|NCT01725282|3652404|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3826145|NCT01725282|3652400|B5||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3826146|NCT01725282|3652401|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3826147|NCT01725282|3652402|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3826148|NCT01725282|3652403|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3826149|NCT01725282|3652404|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3826150|NCT01725282|3652400|B5|||Age||years|Mean|37.9|37.9|Standard Deviation|9.9|9.9|||
3826151|NCT01725282|3652401|B4|||Age||years|Mean|37.3|37.3|Standard Deviation|9.7|9.7|||
3826152|NCT01725282|3652402|B3|||Age||years|Mean|35.2|35.2|Standard Deviation|8.6|8.6|||
3826153|NCT01725282|3652403|B2|||Age||years|Mean|39.0|39.0|Standard Deviation|9.5|9.5|||
3826154|NCT01725282|3652404|B1|||Age||years|Mean|39.8|39.8|Standard Deviation|11.2|11.2|||
3826155|NCT01725217|3652437|B4||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3826156|NCT01725217|3652438|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3826157|NCT01725217|3652439|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3826158|NCT01725217|3652440|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3826159|NCT01725217|3652437|B4||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3826160|NCT01725217|3652438|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3826161|NCT01725217|3652439|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3826162|NCT01725217|3652440|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3826163|NCT01725217|3652437|B4|||Age||year|Mean|19.6|19.6|Standard Deviation|15.9|15.9|||
3826164|NCT01725217|3652438|B3|||Age||year|Mean|38.8|38.8|Standard Deviation|12.5|12.5|||
3826165|NCT01725217|3652439|B2|||Age||year|Mean|13.8|13.8|Standard Deviation|2.1|2.1|||
3826166|NCT01725217|3652440|B1|||Age||year|Mean|6.0|6.0|Standard Deviation|2.7|2.7|||
3826167|NCT01725126|3652470|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826168|NCT01725126|3652471|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826169|NCT01725126|3652472|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826170|NCT01725126|3652473|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826171|NCT01725126|3652474|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826172|NCT01725126|3652475|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826173|NCT01725126|3652476|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826174|NCT01725126|3652470|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826175|NCT01725126|3652471|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826176|NCT01725126|3652472|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826177|NCT01725126|3652473|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826178|NCT01725126|3652474|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826179|NCT01725126|3652475|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826180|NCT01725126|3652476|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826181|NCT01725126|3652470|B7||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3826182|NCT01725126|3652471|B6||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3826183|NCT01725126|3652472|B5||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3826184|NCT01725126|3652473|B4||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3826185|NCT01725126|3652474|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3826186|NCT01725126|3652475|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3826187|NCT01725126|3652476|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3826188|NCT01725126|3652470|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3826189|NCT01725126|3652471|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3826190|NCT01725126|3652472|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826191|NCT01725126|3652473|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3826192|NCT01725126|3652474|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3826193|NCT01725126|3652475|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3826194|NCT01725126|3652476|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3826195|NCT01725126|3652470|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826196|NCT01725126|3652471|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826197|NCT01725126|3652472|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826198|NCT01725126|3652473|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826199|NCT01725126|3652474|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826200|NCT01725126|3652475|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826201|NCT01725126|3652476|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826202|NCT01725126|3652470|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826203|NCT01725126|3652471|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826204|NCT01725126|3652472|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826205|NCT01725126|3652473|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826206|NCT01725126|3652474|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826207|NCT01725126|3652475|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826208|NCT01725126|3652476|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826209|NCT01725126|3652470|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826210|NCT01725126|3652471|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826211|NCT01725126|3652472|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826212|NCT01725126|3652473|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826213|NCT01725126|3652474|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826214|NCT01725126|3652475|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826215|NCT01725126|3652476|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826216|NCT01725126|3652470|B7||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3826217|NCT01725126|3652471|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3826218|NCT01725126|3652472|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3826219|NCT01725126|3652473|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3826220|NCT01725126|3652474|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3826221|NCT01725126|3652475|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3826222|NCT01725126|3652476|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3826223|NCT01725126|3652470|B7||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3826224|NCT01725126|3652471|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3826225|NCT01725126|3652472|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3826226|NCT01725126|3652473|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3826227|NCT01725126|3652474|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3826228|NCT01725126|3652475|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3826229|NCT01725126|3652476|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3826230|NCT01725126|3652470|B7|18 to 70 years||Age, Customized||Participants|Count of Participants|53|53.0||||||
3826231|NCT01725126|3652471|B6|18 to 70 years||Age, Customized||Participants|Count of Participants|12|12.0||||||
3826232|NCT01725126|3652472|B5|18 to 70 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
3826233|NCT01725126|3652473|B4|18 to 70 years||Age, Customized||Participants|Count of Participants|14|14.0||||||
3826234|NCT01725126|3652474|B3|18 to 70 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
3826235|NCT01725126|3652475|B2|18 to 70 years||Age, Customized||Participants|Count of Participants|11|11.0||||||
3826236|NCT01725126|3652476|B1|18 to 70 years||Age, Customized||Participants|Count of Participants|4|4.0||||||
3826237|NCT01724528|3652677|B3|Lymphoma||Type of Hematologic Malignancy||participants|Number|113|113.0||||||
3826238|NCT01724528|3652678|B2|Lymphoma||Type of Hematologic Malignancy||participants|Number|54|54.0||||||
3826239|NCT01724528|3652679|B1|Lymphoma||Type of Hematologic Malignancy||participants|Number|59|59.0||||||
3826240|NCT01724528|3652677|B3|Chronic lymphocytic leukemia||Type of Hematologic Malignancy||participants|Number|174|174.0||||||
3826241|NCT01724528|3652678|B2|Chronic lymphocytic leukemia||Type of Hematologic Malignancy||participants|Number|94|94.0||||||
3826242|NCT01724528|3652679|B1|Chronic lymphocytic leukemia||Type of Hematologic Malignancy||participants|Number|80|80.0||||||
3826243|NCT01724528|3652677|B3|Acute leukemia||Type of Hematologic Malignancy||participants|Number|59|59.0||||||
3826244|NCT01724528|3652678|B2|Acute leukemia||Type of Hematologic Malignancy||participants|Number|25|25.0||||||
3826245|NCT01724528|3652679|B1|Acute leukemia||Type of Hematologic Malignancy||participants|Number|34|34.0||||||
3826246|NCT01724528|3652677|B3|High||TLS risk||participants|Number|62|62.0||||||
3826247|NCT01724528|3652678|B2|High||TLS risk||participants|Number|32|32.0||||||
3826248|NCT01724528|3652679|B1|High||TLS risk||participants|Number|30|30.0||||||
3826249|NCT01724528|3652677|B3|Intermediate||TLS risk||participants|Number|284|284.0||||||
3826250|NCT01724528|3652678|B2|Intermediate||TLS risk||participants|Number|141|141.0||||||
3826251|NCT01724528|3652679|B1|Intermediate||TLS risk||participants|Number|143|143.0||||||
3826252|NCT01724528|3652677|B3|> 7.5 mg/dL||serum uric acid (sUA)||participants|Number|43|43.0||||||
3826253|NCT01724528|3652678|B2|> 7.5 mg/dL||serum uric acid (sUA)||participants|Number|21|21.0||||||
3826254|NCT01724528|3652679|B1|> 7.5 mg/dL||serum uric acid (sUA)||participants|Number|22|22.0||||||
3826255|NCT01724528|3652677|B3|< or = 7.5 mg/dL||serum uric acid (sUA)||participants|Number|303|303.0||||||
3826256|NCT01724528|3652678|B2|< or = 7.5 mg/dL||serum uric acid (sUA)||participants|Number|152|152.0||||||
3826257|NCT01724528|3652679|B1|< or = 7.5 mg/dL||serum uric acid (sUA)||participants|Number|151|151.0||||||
3826258|NCT01724528|3652677|B3||Male|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
3826259|NCT01724528|3652678|B2||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3826260|NCT01724528|3652679|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3826261|NCT01724528|3652677|B3||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3826262|NCT01724528|3652678|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3826263|NCT01724528|3652679|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3826264|NCT01724528|3652677|B3|||Age||years|Mean|58.4|58.4|Standard Deviation|13.75|13.75|||
3826265|NCT01724528|3652678|B2|||Age||years|Mean|58.3|58.3|Standard Deviation|13.26|13.26|||
3826266|NCT01724528|3652679|B1|||Age||years|Mean|58.5|58.5|Standard Deviation|14.26|14.26|||
3826267|NCT01724359|3652694|B1|Colombia||Region of Enrollment||participants|Number|58|58.0||||||
3826268|NCT01724359|3652694|B1|Argentina||Region of Enrollment||participants|Number|37|37.0||||||
3826269|NCT01724359|3652694|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3826270|NCT01724359|3652694|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3826271|NCT01724359|3652694|B1|||Age||years|Mean|35.86|35.86|Standard Deviation|12.28|12.28|||
3826272|NCT01724216|3652707|B1|United States||Region of Enrollment||particpants with images collected|Number|10|10.0||||||
3826273|NCT01724216|3652707|B1|||Sex/Gender, Customized||participants with images collected|Number|NA|||||||Gender was not a data point collected during the study.
3826274|NCT01724216|3652707|B1|>=65 years||Age, Customized||participants with images collected|Number|0|0.0||||||
3826275|NCT01724216|3652707|B1|Between 18 and 65 years||Age, Customized||participants with images collected|Number|10|10.0||||||
3826276|NCT01724216|3652707|B1|<=18 years||Age, Customized||participants with images collected|Number|0|0.0||||||
3826324|NCT01723397|3652776|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
3826325|NCT01723397|3652777|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3826277|NCT01724177|3652711|B1|3 = Limited Self-Care||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Number|0|0.0||||||
3826278|NCT01724177|3652711|B1|2 = Ambulatory but Unable to Work||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Number|4|4.0||||||
3826279|NCT01724177|3652711|B1|1 = Restrictive but Ambulatory||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Number|9|9.0||||||
3826280|NCT01724177|3652711|B1|0 = Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Number|13|13.0||||||
3826281|NCT01724177|3652711|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3826282|NCT01724177|3652711|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3826283|NCT01724177|3652711|B1|||Age||years|Mean|67.5|67.5|Standard Deviation|7.20|7.2|||
3826284|NCT01724021|3652722|B3||Male|Sex: Female, Male||Participants|Count of Participants|373|373.0||||||
3826285|NCT01724021|3652723|B2||Male|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
3826286|NCT01724021|3652724|B1||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3826287|NCT01724021|3652722|B3||Female|Sex: Female, Male||Participants|Count of Participants|367|367.0||||||
3826288|NCT01724021|3652723|B2||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3826289|NCT01724021|3652724|B1||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
3826290|NCT01724021|3652722|B3|||Age||years|Mean|58.8|58.8|Standard Deviation|12.92|12.92|||
3826291|NCT01724021|3652723|B2|||Age||years|Mean|59.4|59.4|Standard Deviation|12.64|12.64|||
3826292|NCT01724021|3652724|B1|||Age||years|Mean|58.2|58.2|Standard Deviation|13.18|13.18|||
3826293|NCT01723904|3652757|B1|Korea, Republic of||Region of Enrollment||participants|Number|66|66.0||||||
3826294|NCT01723904|3652757|B1|Australia||Region of Enrollment||participants|Number|6|6.0||||||
3826295|NCT01723904|3652757|B1|Singapore||Region of Enrollment||participants|Number|4|4.0||||||
3826296|NCT01723904|3652757|B1|Malaysia||Region of Enrollment||participants|Number|6|6.0||||||
3826297|NCT01723904|3652757|B1|Taiwan||Region of Enrollment||participants|Number|8|8.0||||||
3826298|NCT01723904|3652757|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3826299|NCT01723904|3652757|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3826300|NCT01723904|3652757|B1|>= 65 years||Age, Customized||participants|Number|33|33.0||||||
3826301|NCT01723904|3652757|B1|< 65 years||Age, Customized||participants|Number|57|57.0||||||
3826302|NCT01723904|3652757|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|9.3|9.3|||
3826303|NCT01723722|3652767|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3826304|NCT01723722|3652768|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3826305|NCT01723722|3652769|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3826306|NCT01723722|3652767|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3826307|NCT01723722|3652768|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3826308|NCT01723722|3652769|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3826309|NCT01723722|3652767|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3826310|NCT01723722|3652768|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3826311|NCT01723722|3652769|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3826312|NCT01723722|3652767|B3|||Age||years|Mean|0.005|0.005|Standard Deviation|0|0.0|||
3826313|NCT01723722|3652768|B2|||Age||years|Mean|0.005|0.005|Standard Deviation|0|0.0|||
3826314|NCT01723722|3652769|B1|||Age||years|Mean|0.005|0.005|Standard Deviation|0|0.0|||
3826315|NCT01723722|3652767|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3826316|NCT01723722|3652768|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3826317|NCT01723722|3652769|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3826318|NCT01723722|3652767|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3826319|NCT01723722|3652768|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3826320|NCT01723722|3652769|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3826321|NCT01723722|3652767|B3||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
3826322|NCT01723722|3652768|B2||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
3826323|NCT01723722|3652769|B1||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
3826326|NCT01723397|3652778|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3826327|NCT01723397|3652776|B3||Male|Gender||Participants|Count of Participants|5|5.0||||||
3826328|NCT01723397|3652777|B2||Male|Gender||Participants|Count of Participants|3|3.0||||||
3826329|NCT01723397|3652778|B1||Male|Gender||Participants|Count of Participants|2|2.0||||||
3826330|NCT01723397|3652776|B3||Female|Gender||Participants|Count of Participants|9|9.0||||||
3826331|NCT01723397|3652777|B2||Female|Gender||Participants|Count of Participants|4|4.0||||||
3826332|NCT01723397|3652778|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
3826333|NCT01723397|3652776|B3|||Age||years|Mean|25.8|25.8|Standard Deviation|8.1|8.1|||
3826334|NCT01723397|3652777|B2|||Age||years|Mean|28.0|28.0|Standard Deviation|7.5|7.5|||
3826335|NCT01723397|3652778|B1|||Age||years|Mean|23.6|23.6|Standard Deviation|8.6|8.6|||
3826336|NCT01723254|3652785|B9||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3826337|NCT01723254|3652786|B8||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3826338|NCT01723254|3652787|B7||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3826339|NCT01723254|3652788|B6||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3826340|NCT01723254|3652789|B5||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3826341|NCT01723254|3652790|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3826342|NCT01723254|3652791|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3826343|NCT01723254|3652792|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3826344|NCT01723254|3652793|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3826345|NCT01723254|3652785|B9||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3826346|NCT01723254|3652786|B8||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3826347|NCT01723254|3652787|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3826348|NCT01723254|3652788|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3826349|NCT01723254|3652789|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3826350|NCT01723254|3652790|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3826351|NCT01723254|3652791|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3826352|NCT01723254|3652792|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3826353|NCT01723254|3652793|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3826354|NCT01723254|3652785|B9|||Age||years|Mean|34.4|34.4|Standard Deviation|9.7|9.7|||
3826355|NCT01723254|3652786|B8|||Age||years|Mean|34.7|34.7|Standard Deviation|8.8|8.8|||
3826356|NCT01723254|3652787|B7|||Age||years|Mean|33.6|33.6|Standard Deviation|12.0|12.0|||
3826357|NCT01723254|3652788|B6|||Age||years|Mean|35.9|35.9|Standard Deviation|11.0|11.0|||
3826358|NCT01723254|3652789|B5|||Age||years|Mean|35.4|35.4|Standard Deviation|9.2|9.2|||
3826359|NCT01723254|3652790|B4|||Age||years|Mean|33.5|33.5|Standard Deviation|9.3|9.3|||
3826360|NCT01723254|3652791|B3|||Age||years|Mean|35.7|35.7|Standard Deviation|10.0|10.0|||
3826361|NCT01723254|3652792|B2|||Age||years|Mean|31.6|31.6|Standard Deviation|8.8|8.8|||
3826362|NCT01723254|3652793|B1|||Age||years|Mean|36.7|36.7|Standard Deviation|13.3|13.3|||
3826363|NCT01723228|3652850|B3||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3826364|NCT01723228|3652851|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3826365|NCT01723228|3652852|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3826366|NCT01723228|3652850|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3826367|NCT01723228|3652851|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3826368|NCT01723228|3652852|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3826369|NCT01723228|3652850|B3|||Age||years|Mean|67.5|67.5|Standard Deviation|7.84|7.84|||
3826370|NCT01723228|3652851|B2|||Age||years|Mean|68.1|68.1|Standard Deviation|8.22|8.22|||
3826371|NCT01723228|3652852|B1|||Age||years|Mean|66.9|66.9|Standard Deviation|7.44|7.44|||
3826372|NCT01722994|3652869|B3|United States||Region of Enrollment||participants|Number|97|97.0||||||
3826373|NCT01722994|3652870|B2|United States||Region of Enrollment||participants|Number|48|48.0||||||
3826374|NCT01722994|3652871|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
3826375|NCT01722994|3652869|B3|Not collected||Sex/Gender, Customized|Gender was was not thought to impact the speed at which suture material would degrade, this data was not collected.|participants|Number|97|97.0||||||
3826376|NCT01722994|3652870|B2|Not collected||Sex/Gender, Customized|Gender was was not thought to impact the speed at which suture material would degrade, this data was not collected.|participants|Number|48|48.0||||||
3826377|NCT01722994|3652871|B1|Not collected||Sex/Gender, Customized|Gender was was not thought to impact the speed at which suture material would degrade, this data was not collected.|participants|Number|49|49.0||||||
3826378|NCT01722994|3652869|B3|18 years and older||Age, Customized|Age was was not thought to impact the speed at which suture material would degrade, this data was not collected.|participants|Number|97|97.0||||||
3826379|NCT01722994|3652870|B2|18 years and older||Age, Customized|Age was was not thought to impact the speed at which suture material would degrade, this data was not collected.|participants|Number|48|48.0||||||
3826380|NCT01722994|3652871|B1|18 years and older||Age, Customized|Age was was not thought to impact the speed at which suture material would degrade, this data was not collected.|participants|Number|49|49.0||||||
3826381|NCT01722929|3652886|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3826382|NCT01722929|3652886|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3826383|NCT01722929|3652886|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3826384|NCT01722929|3652886|B1|||Age||years|Mean|69.75|69.75|Standard Deviation|12.21|12.21|||
3826385|NCT01722877|3652891|B1|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3826386|NCT01722877|3652891|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3826387|NCT01722877|3652891|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3826388|NCT01722877|3652891|B1|||Age||years|Mean|69.9|69.9|Standard Deviation|11.7|11.7|||
3826389|NCT01722734|3652898|B4|Ghana||Region of Enrollment||participants|Number|1140|1140.0||||||
3826390|NCT01722734|3652899|B3|Ghana||Region of Enrollment||participants|Number|309|309.0||||||
3826391|NCT01722734|3652900|B2|Ghana||Region of Enrollment||participants|Number|277|277.0||||||
3826392|NCT01722734|3652901|B1|Ghana||Region of Enrollment||participants|Number|554|554.0||||||
3826393|NCT01722734|3652898|B4||Male|Sex: Female, Male||Participants|Count of Participants|506|506.0||||||
3826394|NCT01722734|3652899|B3||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3826395|NCT01722734|3652900|B2||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3826396|NCT01722734|3652901|B1||Male|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
3826397|NCT01722734|3652898|B4||Female|Sex: Female, Male||Participants|Count of Participants|634|634.0||||||
3826398|NCT01722734|3652899|B3||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3826399|NCT01722734|3652900|B2||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3826400|NCT01722734|3652901|B1||Female|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
3826401|NCT01722734|3652898|B4|||Age|Age reflects age of the patient. For patients of age 18 and younger, caregivers were enrolled and interviewed and thus primary study subjects.|years|Mean|24.3|24.3|Standard Deviation|17.6|17.6|||
3826402|NCT01722734|3652899|B3|||Age|Age reflects age of the patient. For patients of age 18 and younger, caregivers were enrolled and interviewed and thus primary study subjects.|years|Mean|23.8|23.8|Standard Deviation|17.8|17.8|||
3826403|NCT01722734|3652900|B2|||Age|Age reflects age of the patient. For patients of age 18 and younger, caregivers were enrolled and interviewed and thus primary study subjects.|years|Mean|23|23.0|Standard Deviation|17.1|17.1|||
3826404|NCT01722734|3652901|B1|||Age|Age reflects age of the patient. For patients of age 18 and younger, caregivers were enrolled and interviewed and thus primary study subjects.|years|Mean|25.3|25.3|Standard Deviation|17.7|17.7|||
3826405|NCT01722734|3652898|B4||>=65 years|Age|Age is reported for the sick person in the household, which includes children in the care of adults, who were enrolled in the study and who received the message treatments.|Participants|Count of Participants|92|92.0||||||
3826406|NCT01722734|3652899|B3||>=65 years|Age|Age is reported for the sick person in the household, which includes children in the care of adults, who were enrolled in the study and who received the message treatments.|Participants|Count of Participants|32|32.0||||||
3826407|NCT01722734|3652900|B2||>=65 years|Age|Age is reported for the sick person in the household, which includes children in the care of adults, who were enrolled in the study and who received the message treatments.|Participants|Count of Participants|14|14.0||||||
3826408|NCT01722734|3652901|B1||>=65 years|Age|Age is reported for the sick person in the household, which includes children in the care of adults, who were enrolled in the study and who received the message treatments.|Participants|Count of Participants|46|46.0||||||
3826409|NCT01722734|3652898|B4||Between 18 and 65 years|Age|Age is reported for the sick person in the household, which includes children in the care of adults, who were enrolled in the study and who received the message treatments.|Participants|Count of Participants|666|666.0||||||
3826410|NCT01722734|3652899|B3||Between 18 and 65 years|Age|Age is reported for the sick person in the household, which includes children in the care of adults, who were enrolled in the study and who received the message treatments.|Participants|Count of Participants|166|166.0||||||
3826411|NCT01722734|3652900|B2||Between 18 and 65 years|Age|Age is reported for the sick person in the household, which includes children in the care of adults, who were enrolled in the study and who received the message treatments.|Participants|Count of Participants|158|158.0||||||
3826412|NCT01722734|3652901|B1||Between 18 and 65 years|Age|Age is reported for the sick person in the household, which includes children in the care of adults, who were enrolled in the study and who received the message treatments.|Participants|Count of Participants|342|342.0||||||
3826413|NCT01722734|3652898|B4||<=18 years|Age|Age is reported for the sick person in the household, which includes children in the care of adults, who were enrolled in the study and who received the message treatments.|Participants|Count of Participants|382|382.0||||||
3826414|NCT01722734|3652899|B3||<=18 years|Age|Age is reported for the sick person in the household, which includes children in the care of adults, who were enrolled in the study and who received the message treatments.|Participants|Count of Participants|111|111.0||||||
3826415|NCT01722734|3652900|B2||<=18 years|Age|Age is reported for the sick person in the household, which includes children in the care of adults, who were enrolled in the study and who received the message treatments.|Participants|Count of Participants|105|105.0||||||
3826416|NCT01722734|3652901|B1||<=18 years|Age|Age is reported for the sick person in the household, which includes children in the care of adults, who were enrolled in the study and who received the message treatments.|Participants|Count of Participants|166|166.0||||||
3826417|NCT01722643|3652911|B3|||HbA1c||percentage glycated hemoglobin|Mean|9.1|9.1|Standard Deviation|0.9|0.9|||
3826418|NCT01722643|3652912|B2|||HbA1c||percentage glycated hemoglobin|Mean|9.2|9.2|Standard Deviation|0.9|0.9|||
3826419|NCT01722643|3652913|B1|||HbA1c||percentage glycated hemoglobin|Mean|9.1|9.1|Standard Deviation|1.0|1.0|||
3826420|NCT01722643|3652911|B3|United States||Region of Enrollment||participants|Number|61|61.0||||||
3826421|NCT01722643|3652912|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
3826422|NCT01722643|3652913|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3826423|NCT01722643|3652911|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826424|NCT01722643|3652912|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826425|NCT01722643|3652913|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826426|NCT01722643|3652911|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3826427|NCT01722643|3652912|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3826428|NCT01722643|3652913|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826429|NCT01722643|3652911|B3||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3826430|NCT01722643|3652912|B2||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3826431|NCT01722643|3652913|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3826432|NCT01722643|3652911|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826433|NCT01722643|3652912|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826434|NCT01722643|3652913|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826435|NCT01722643|3652911|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826436|NCT01722643|3652912|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826437|NCT01722643|3652913|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826438|NCT01722643|3652911|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826439|NCT01722643|3652912|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826440|NCT01722643|3652913|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826441|NCT01722643|3652911|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826442|NCT01722643|3652912|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826443|NCT01722643|3652913|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826444|NCT01722643|3652911|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826445|NCT01722643|3652912|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826446|NCT01722643|3652913|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826447|NCT01722643|3652911|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3826448|NCT01722643|3652912|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3826449|NCT01722643|3652913|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3826450|NCT01722643|3652911|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3826451|NCT01722643|3652912|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826452|NCT01722643|3652913|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3826453|NCT01722643|3652911|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3826454|NCT01722643|3652912|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3826455|NCT01722643|3652913|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3826456|NCT01722643|3652911|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3826457|NCT01722643|3652912|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3826458|NCT01722643|3652913|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3826459|NCT01722643|3652911|B3|||Age||years|Mean|15.1|15.1|Standard Deviation|1.4|1.4|||
3826460|NCT01722643|3652912|B2|||Age||years|Mean|14.9|14.9|Standard Deviation|1.5|1.5|||
3826461|NCT01722643|3652913|B1|||Age||years|Mean|15.2|15.2|Standard Deviation|1.4|1.4|||
3826462|NCT01722552|3652922|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826463|NCT01722552|3652922|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826464|NCT01722552|3652922|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826465|NCT01722552|3652922|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826466|NCT01722552|3652922|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826467|NCT01722552|3652922|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3826468|NCT01722552|3652922|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826469|NCT01722552|3652922|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3826470|NCT01722552|3652922|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3826471|NCT01722552|3652922|B1|||Age||years|Mean|36.9|36.9|Standard Deviation|11.1|11.1|||
3826472|NCT01722487|3652930|B3||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3826473|NCT01722487|3652931|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3826474|NCT01722487|3652932|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3826475|NCT01722487|3652930|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3826476|NCT01722487|3652931|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3826477|NCT01722487|3652932|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3826478|NCT01722487|3652930|B3|||Age||years|Mean|73.3|73.3|Standard Deviation|5.81|5.81|||
3826479|NCT01722487|3652931|B2|||Age||years|Mean|73.4|73.4|Standard Deviation|5.95|5.95|||
3826480|NCT01722487|3652932|B1|||Age||years|Mean|73.1|73.1|Standard Deviation|5.67|5.67|||
3826481|NCT01722487|3652930|B3||>=65 years|Age||Participants|Count of Participants|269|269.0||||||
3826482|NCT01722487|3652931|B2||>=65 years|Age||Participants|Count of Participants|133|133.0||||||
3826483|NCT01722487|3652932|B1||>=65 years|Age||Participants|Count of Participants|136|136.0||||||
3826484|NCT01722487|3652930|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3826485|NCT01722487|3652931|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3826486|NCT01722487|3652932|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3826487|NCT01722487|3652930|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3826488|NCT01722487|3652931|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3826489|NCT01722487|3652932|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3826490|NCT01722435|3652951|B1|buprenorphine||Average dose of medication taken||milligrams|Mean|14.3|14.3|Standard Deviation|8.2|8.2|||
3826491|NCT01722435|3652951|B1|levomethadone||Average dose of medication taken||milligrams|Mean|26.6|26.6|Standard Deviation|21.6|21.6|||
3826492|NCT01722435|3652951|B1|d,l-methadone||Average dose of medication taken||milligrams|Mean|54.8|54.8|Standard Deviation|41.8|41.8|||
3826493|NCT01722435|3652951|B1|buprenorphine||Participants on specific medication||participants|Number|4|4.0||||||
3826494|NCT01722435|3652951|B1|levometahdone||Participants on specific medication||participants|Number|37|37.0||||||
3826495|NCT01722435|3652951|B1|d,l-methadone||Participants on specific medication||participants|Number|37|37.0||||||
3826496|NCT01722435|3652951|B1|||Lengths of OST before study entry||months|Mean|92.9|92.9|Standard Deviation|59.5|59.5|||
3826497|NCT01722435|3652951|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3826498|NCT01722435|3652951|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3826499|NCT01722435|3652951|B1|||Age||years|Mean|39.5|39.5|Standard Deviation|7.9|7.9|||
3826500|NCT01722331|3652959|B4||No|Prior exposure to biologics therapy for psoriasis|The following therapies constitute biologics therapy for psoriasis: efalizumab, alefacept, infliximab, adalimumab, ustekinumab, and etanercept.|Participants|Count of Participants|595|595.0||||||
3826501|NCT01722331|3652960|B3||No|Prior exposure to biologics therapy for psoriasis|The following therapies constitute biologics therapy for psoriasis: efalizumab, alefacept, infliximab, adalimumab, ustekinumab, and etanercept.|Participants|Count of Participants|120|120.0||||||
3826502|NCT01722331|3652961|B2||No|Prior exposure to biologics therapy for psoriasis|The following therapies constitute biologics therapy for psoriasis: efalizumab, alefacept, infliximab, adalimumab, ustekinumab, and etanercept.|Participants|Count of Participants|238|238.0||||||
3826503|NCT01722331|3652962|B1||No|Prior exposure to biologics therapy for psoriasis|The following therapies constitute biologics therapy for psoriasis: efalizumab, alefacept, infliximab, adalimumab, ustekinumab, and etanercept.|Participants|Count of Participants|237|237.0||||||
3826504|NCT01722331|3652959|B4||Yes|Prior exposure to biologics therapy for psoriasis|The following therapies constitute biologics therapy for psoriasis: efalizumab, alefacept, infliximab, adalimumab, ustekinumab, and etanercept.|Participants|Count of Participants|177|177.0||||||
3826505|NCT01722331|3652960|B3||Yes|Prior exposure to biologics therapy for psoriasis|The following therapies constitute biologics therapy for psoriasis: efalizumab, alefacept, infliximab, adalimumab, ustekinumab, and etanercept.|Participants|Count of Participants|35|35.0||||||
3826506|NCT01722331|3652961|B2||Yes|Prior exposure to biologics therapy for psoriasis|The following therapies constitute biologics therapy for psoriasis: efalizumab, alefacept, infliximab, adalimumab, ustekinumab, and etanercept.|Participants|Count of Participants|71|71.0||||||
3826507|NCT01722331|3652962|B1||Yes|Prior exposure to biologics therapy for psoriasis|The following therapies constitute biologics therapy for psoriasis: efalizumab, alefacept, infliximab, adalimumab, ustekinumab, and etanercept.|Participants|Count of Participants|71|71.0||||||
3826508|NCT01722331|3652959|B4||>90 kg|Body weight||Participants|Count of Participants|314|314.0||||||
3826509|NCT01722331|3652960|B3||>90 kg|Body weight||Participants|Count of Participants|62|62.0||||||
3826510|NCT01722331|3652961|B2||>90 kg|Body weight||Participants|Count of Participants|126|126.0||||||
3826511|NCT01722331|3652962|B1||>90 kg|Body weight||Participants|Count of Participants|126|126.0||||||
3826512|NCT01722331|3652959|B4||<=90 kg|Body weight||Participants|Count of Participants|458|458.0||||||
3826513|NCT01722331|3652960|B3||<=90 kg|Body weight||Participants|Count of Participants|93|93.0||||||
3826514|NCT01722331|3652961|B2||<=90 kg|Body weight||Participants|Count of Participants|183|183.0||||||
3826515|NCT01722331|3652962|B1||<=90 kg|Body weight||Participants|Count of Participants|182|182.0||||||
3826516|NCT01722331|3652959|B4||5|Physician’s Global Assessment (PGA) score|The PGA is used to determine the overall severity of a participant’s psoriasis lesions at a given time point. Overall lesions will be graded for thickness, erythema, and scaling on a scale from 0 to 5. The sum of the 3 scales will be divided by 3 to obtain the PGA score. PGA is assessed as: 0= Cleared, except for residual discoloration; 1= Minimal; 2 =Mild; 3= Moderate; 4= Marked; 5= Severe. Round average to the nearest whole number.|Participants|Count of Participants|20|20.0||||||
3826517|NCT01722331|3652960|B3||5|Physician’s Global Assessment (PGA) score|The PGA is used to determine the overall severity of a participant’s psoriasis lesions at a given time point. Overall lesions will be graded for thickness, erythema, and scaling on a scale from 0 to 5. The sum of the 3 scales will be divided by 3 to obtain the PGA score. PGA is assessed as: 0= Cleared, except for residual discoloration; 1= Minimal; 2 =Mild; 3= Moderate; 4= Marked; 5= Severe. Round average to the nearest whole number.|Participants|Count of Participants|2|2.0||||||
3826518|NCT01722331|3652961|B2||5|Physician’s Global Assessment (PGA) score|The PGA is used to determine the overall severity of a participant’s psoriasis lesions at a given time point. Overall lesions will be graded for thickness, erythema, and scaling on a scale from 0 to 5. The sum of the 3 scales will be divided by 3 to obtain the PGA score. PGA is assessed as: 0= Cleared, except for residual discoloration; 1= Minimal; 2 =Mild; 3= Moderate; 4= Marked; 5= Severe. Round average to the nearest whole number.|Participants|Count of Participants|7|7.0||||||
3826534|NCT01722331|3652961|B2||Male|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
3826535|NCT01722331|3652962|B1||Male|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
3826536|NCT01722331|3652959|B4||Female|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
3826519|NCT01722331|3652962|B1||5|Physician’s Global Assessment (PGA) score|The PGA is used to determine the overall severity of a participant’s psoriasis lesions at a given time point. Overall lesions will be graded for thickness, erythema, and scaling on a scale from 0 to 5. The sum of the 3 scales will be divided by 3 to obtain the PGA score. PGA is assessed as: 0= Cleared, except for residual discoloration; 1= Minimal; 2 =Mild; 3= Moderate; 4= Marked; 5= Severe. Round average to the nearest whole number.|Participants|Count of Participants|11|11.0||||||
3826520|NCT01722331|3652959|B4||4|Physician’s Global Assessment (PGA) score|The PGA is used to determine the overall severity of a participant’s psoriasis lesions at a given time point. Overall lesions will be graded for thickness, erythema, and scaling on a scale from 0 to 5. The sum of the 3 scales will be divided by 3 to obtain the PGA score. PGA is assessed as: 0= Cleared, except for residual discoloration; 1= Minimal; 2 =Mild; 3= Moderate; 4= Marked; 5= Severe. Round average to the nearest whole number.|Participants|Count of Participants|231|231.0||||||
3826521|NCT01722331|3652960|B3||4|Physician’s Global Assessment (PGA) score|The PGA is used to determine the overall severity of a participant’s psoriasis lesions at a given time point. Overall lesions will be graded for thickness, erythema, and scaling on a scale from 0 to 5. The sum of the 3 scales will be divided by 3 to obtain the PGA score. PGA is assessed as: 0= Cleared, except for residual discoloration; 1= Minimal; 2 =Mild; 3= Moderate; 4= Marked; 5= Severe. Round average to the nearest whole number.|Participants|Count of Participants|41|41.0||||||
3826522|NCT01722331|3652961|B2||4|Physician’s Global Assessment (PGA) score|The PGA is used to determine the overall severity of a participant’s psoriasis lesions at a given time point. Overall lesions will be graded for thickness, erythema, and scaling on a scale from 0 to 5. The sum of the 3 scales will be divided by 3 to obtain the PGA score. PGA is assessed as: 0= Cleared, except for residual discoloration; 1= Minimal; 2 =Mild; 3= Moderate; 4= Marked; 5= Severe. Round average to the nearest whole number.|Participants|Count of Participants|95|95.0||||||
3826523|NCT01722331|3652962|B1||4|Physician’s Global Assessment (PGA) score|The PGA is used to determine the overall severity of a participant’s psoriasis lesions at a given time point. Overall lesions will be graded for thickness, erythema, and scaling on a scale from 0 to 5. The sum of the 3 scales will be divided by 3 to obtain the PGA score. PGA is assessed as: 0= Cleared, except for residual discoloration; 1= Minimal; 2 =Mild; 3= Moderate; 4= Marked; 5= Severe. Round average to the nearest whole number.|Participants|Count of Participants|95|95.0||||||
3826524|NCT01722331|3652959|B4||3|Physician’s Global Assessment (PGA) score|The PGA is used to determine the overall severity of a participant’s psoriasis lesions at a given time point. Overall lesions will be graded for thickness, erythema, and scaling on a scale from 0 to 5. The sum of the 3 scales will be divided by 3 to obtain the PGA score. PGA is assessed as: 0= Cleared, except for residual discoloration; 1= Minimal; 2 =Mild; 3= Moderate; 4= Marked; 5= Severe. Round average to the nearest whole number.|Participants|Count of Participants|519|519.0||||||
3826525|NCT01722331|3652960|B3||3|Physician’s Global Assessment (PGA) score|The PGA is used to determine the overall severity of a participant’s psoriasis lesions at a given time point. Overall lesions will be graded for thickness, erythema, and scaling on a scale from 0 to 5. The sum of the 3 scales will be divided by 3 to obtain the PGA score. PGA is assessed as: 0= Cleared, except for residual discoloration; 1= Minimal; 2 =Mild; 3= Moderate; 4= Marked; 5= Severe. Round average to the nearest whole number.|Participants|Count of Participants|111|111.0||||||
3826526|NCT01722331|3652961|B2||3|Physician’s Global Assessment (PGA) score|The PGA is used to determine the overall severity of a participant’s psoriasis lesions at a given time point. Overall lesions will be graded for thickness, erythema, and scaling on a scale from 0 to 5. The sum of the 3 scales will be divided by 3 to obtain the PGA score. PGA is assessed as: 0= Cleared, except for residual discoloration; 1= Minimal; 2 =Mild; 3= Moderate; 4= Marked; 5= Severe. Round average to the nearest whole number.|Participants|Count of Participants|206|206.0||||||
3826527|NCT01722331|3652962|B1||3|Physician’s Global Assessment (PGA) score|The PGA is used to determine the overall severity of a participant’s psoriasis lesions at a given time point. Overall lesions will be graded for thickness, erythema, and scaling on a scale from 0 to 5. The sum of the 3 scales will be divided by 3 to obtain the PGA score. PGA is assessed as: 0= Cleared, except for residual discoloration; 1= Minimal; 2 =Mild; 3= Moderate; 4= Marked; 5= Severe. Round average to the nearest whole number.|Participants|Count of Participants|202|202.0||||||
3826528|NCT01722331|3652959|B4||<3|Physician’s Global Assessment (PGA) score|The PGA is used to determine the overall severity of a participant’s psoriasis lesions at a given time point. Overall lesions will be graded for thickness, erythema, and scaling on a scale from 0 to 5. The sum of the 3 scales will be divided by 3 to obtain the PGA score. PGA is assessed as: 0= Cleared, except for residual discoloration; 1= Minimal; 2 =Mild; 3= Moderate; 4= Marked; 5= Severe. Round average to the nearest whole number.|Participants|Count of Participants|1|1.0||||||
3826529|NCT01722331|3652960|B3||<3|Physician’s Global Assessment (PGA) score|The PGA is used to determine the overall severity of a participant’s psoriasis lesions at a given time point. Overall lesions will be graded for thickness, erythema, and scaling on a scale from 0 to 5. The sum of the 3 scales will be divided by 3 to obtain the PGA score. PGA is assessed as: 0= Cleared, except for residual discoloration; 1= Minimal; 2 =Mild; 3= Moderate; 4= Marked; 5= Severe. Round average to the nearest whole number.|Participants|Count of Participants|0|0.0||||||
3826530|NCT01722331|3652961|B2||<3|Physician’s Global Assessment (PGA) score|The PGA is used to determine the overall severity of a participant’s psoriasis lesions at a given time point. Overall lesions will be graded for thickness, erythema, and scaling on a scale from 0 to 5. The sum of the 3 scales will be divided by 3 to obtain the PGA score. PGA is assessed as: 0= Cleared, except for residual discoloration; 1= Minimal; 2 =Mild; 3= Moderate; 4= Marked; 5= Severe. Round average to the nearest whole number.|Participants|Count of Participants|1|1.0||||||
3826531|NCT01722331|3652962|B1||<3|Physician’s Global Assessment (PGA) score|The PGA is used to determine the overall severity of a participant’s psoriasis lesions at a given time point. Overall lesions will be graded for thickness, erythema, and scaling on a scale from 0 to 5. The sum of the 3 scales will be divided by 3 to obtain the PGA score. PGA is assessed as: 0= Cleared, except for residual discoloration; 1= Minimal; 2 =Mild; 3= Moderate; 4= Marked; 5= Severe. Round average to the nearest whole number.|Participants|Count of Participants|0|0.0||||||
3826532|NCT01722331|3652959|B4||Male|Sex: Female, Male||Participants|Count of Participants|533|533.0||||||
3826533|NCT01722331|3652960|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3826537|NCT01722331|3652960|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3826538|NCT01722331|3652961|B2||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3826539|NCT01722331|3652962|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3826540|NCT01722331|3652959|B4|||Age||Years|Mean|46.9|46.9|Standard Deviation|13.21|13.21|||
3826541|NCT01722331|3652960|B3|||Age||Years|Mean|47.9|47.9|Standard Deviation|13.55|13.55|||
3826542|NCT01722331|3652961|B2|||Age||Years|Mean|46.4|46.4|Standard Deviation|13.09|13.09|||
3826543|NCT01722331|3652962|B1|||Age||Years|Mean|46.9|46.9|Standard Deviation|13.16|13.16|||
3826544|NCT01722318|3653007|B6||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3826545|NCT01722318|3653008|B5||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3826546|NCT01722318|3653009|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3826547|NCT01722318|3653010|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3826548|NCT01722318|3653011|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3826549|NCT01722318|3653012|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3826550|NCT01722318|3653007|B6||Female|Sex: Female, Male||Participants|Count of Participants|344|344.0||||||
3826551|NCT01722318|3653008|B5||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3826552|NCT01722318|3653009|B4||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3826553|NCT01722318|3653010|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3826554|NCT01722318|3653011|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3826555|NCT01722318|3653012|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3826556|NCT01722318|3653007|B6|||Age||years|Mean|45.9|45.9|Standard Deviation|12.30|12.3|||
3826557|NCT01722318|3653008|B5|||Age||years|Mean|45.4|45.4|Standard Deviation|12.02|12.02|||
3826558|NCT01722318|3653009|B4|||Age||years|Mean|45.3|45.3|Standard Deviation|12.00|12.0|||
3826559|NCT01722318|3653010|B3|||Age||years|Mean|47.2|47.2|Standard Deviation|12.89|12.89|||
3826560|NCT01722318|3653011|B2|||Age||years|Mean|44.6|44.6|Standard Deviation|12.58|12.58|||
3826561|NCT01722318|3653012|B1|||Age||years|Mean|47.2|47.2|Standard Deviation|12.02|12.02|||
3826562|NCT01722292|3653043|B4|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3826563|NCT01722292|3653044|B3|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3826564|NCT01722292|3653045|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3826565|NCT01722292|3653046|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3826566|NCT01722292|3653043|B4|United States||Region of Enrollment||participants|Number|20|20.0||||||
3826567|NCT01722292|3653044|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3826568|NCT01722292|3653045|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3826569|NCT01722292|3653046|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3826570|NCT01722292|3653043|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3826571|NCT01722292|3653044|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826572|NCT01722292|3653045|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3826573|NCT01722292|3653046|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826574|NCT01722292|3653043|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826575|NCT01722292|3653044|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826576|NCT01722292|3653045|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826577|NCT01722292|3653046|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826578|NCT01722292|3653043|B4||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3826579|NCT01722292|3653044|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3826580|NCT01722292|3653045|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3826581|NCT01722292|3653046|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3826582|NCT01722292|3653043|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3826583|NCT01722292|3653044|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3826584|NCT01722292|3653045|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3826585|NCT01722292|3653046|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826586|NCT01722292|3653043|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826587|NCT01722292|3653044|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826588|NCT01722292|3653045|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826589|NCT01722292|3653046|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826590|NCT01722292|3653043|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826591|NCT01722292|3653044|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826592|NCT01722292|3653045|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826593|NCT01722292|3653046|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826594|NCT01722292|3653043|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826595|NCT01722292|3653044|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826596|NCT01722292|3653045|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826597|NCT01722292|3653046|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826598|NCT01722292|3653043|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826599|NCT01722292|3653044|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826600|NCT01722292|3653045|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826601|NCT01722292|3653046|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826602|NCT01722292|3653043|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3826603|NCT01722292|3653044|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3826604|NCT01722292|3653045|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3826605|NCT01722292|3653046|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3826606|NCT01722292|3653043|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3826607|NCT01722292|3653044|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826608|NCT01722292|3653045|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3826609|NCT01722292|3653046|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826610|NCT01722292|3653043|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3826611|NCT01722292|3653044|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3826612|NCT01722292|3653045|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3826613|NCT01722292|3653046|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3826614|NCT01722292|3653043|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3826615|NCT01722292|3653044|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3826616|NCT01722292|3653045|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3826617|NCT01722292|3653046|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3826618|NCT01722292|3653043|B4|||Age||years|Mean|62.2|62.2|Standard Deviation|11.33|11.33|||
3826619|NCT01722292|3653044|B3|||Age||years|Mean|60.2|60.2|Standard Deviation|12.19|12.19|||
3826620|NCT01722292|3653045|B2|||Age||years|Mean|64.8|64.8|Standard Deviation|11.96|11.96|||
3826621|NCT01722292|3653046|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|9.35|9.35|||
3826622|NCT01722266|3653080|B5|||Age of Type 1 Diabetes Diagnosis||years|Mean|20|20.0|Standard Deviation|1|1.0|||
3826623|NCT01722266|3653081|B4|||Age of Type 1 Diabetes Diagnosis||years|Mean|19|19.0|Standard Deviation|3|3.0|||
3826624|NCT01722266|3653082|B3|||Age of Type 1 Diabetes Diagnosis||years|Mean|21|21.0|Standard Deviation|3|3.0|||
3826625|NCT01722266|3653083|B2|||Age of Type 1 Diabetes Diagnosis||years|Mean|21|21.0|Standard Deviation|3|3.0|||
3826626|NCT01722266|3653084|B1|||Age of Type 1 Diabetes Diagnosis||years|Mean|19|19.0|Standard Deviation|3|3.0|||
3826627|NCT01722266|3653080|B5|United States||Region of Enrollment||participants|Number|63|63.0||||||
3826628|NCT01722266|3653081|B4|United States||Region of Enrollment||participants|Number|18|18.0||||||
3826629|NCT01722266|3653082|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
3826630|NCT01722266|3653083|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3826631|NCT01722266|3653084|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3826632|NCT01722266|3653080|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826633|NCT01722266|3653081|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826634|NCT01722266|3653082|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826635|NCT01722266|3653083|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826636|NCT01722266|3653084|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826637|NCT01722266|3653080|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826638|NCT01722266|3653081|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826639|NCT01722266|3653082|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826640|NCT01722266|3653083|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826641|NCT01722266|3653084|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826642|NCT01722266|3653080|B5||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3826643|NCT01722266|3653081|B4||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3826644|NCT01722266|3653082|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3826645|NCT01722266|3653083|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3826646|NCT01722266|3653084|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3826647|NCT01722266|3653080|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3826648|NCT01722266|3653081|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826649|NCT01722266|3653082|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826650|NCT01722266|3653083|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826651|NCT01722266|3653084|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3826652|NCT01722266|3653080|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826653|NCT01722266|3653081|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826654|NCT01722266|3653082|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826655|NCT01722266|3653083|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826656|NCT01722266|3653084|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826657|NCT01722266|3653080|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3826658|NCT01722266|3653081|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3826659|NCT01722266|3653082|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826660|NCT01722266|3653083|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826661|NCT01722266|3653084|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3826662|NCT01722266|3653080|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826663|NCT01722266|3653081|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826664|NCT01722266|3653082|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826665|NCT01722266|3653083|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826666|NCT01722266|3653084|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826667|NCT01722266|3653080|B5||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3826668|NCT01722266|3653081|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3826669|NCT01722266|3653082|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3826670|NCT01722266|3653083|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3826671|NCT01722266|3653084|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3826672|NCT01722266|3653080|B5||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3826673|NCT01722266|3653081|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3826674|NCT01722266|3653082|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3826675|NCT01722266|3653083|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3826676|NCT01722266|3653084|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3826677|NCT01722266|3653080|B5|||Age||years|Mean|44|44.0|Standard Deviation|2|2.0|||
3826678|NCT01722266|3653081|B4|||Age||years|Mean|45|45.0|Standard Deviation|4|4.0|||
3826679|NCT01722266|3653082|B3|||Age||years|Mean|42|42.0|Standard Deviation|3|3.0|||
3826680|NCT01722266|3653083|B2|||Age||years|Mean|42|42.0|Standard Deviation|3|3.0|||
3826681|NCT01722266|3653084|B1|||Age||years|Mean|50|50.0|Standard Deviation|3|3.0|||
3826682|NCT01722162|3653113|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
3826683|NCT01722162|3653114|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
3826684|NCT01722162|3653115|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
3826685|NCT01722162|3653113|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3826686|NCT01722162|3653114|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3826687|NCT01722162|3653115|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3826688|NCT01722162|3653113|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3826689|NCT01722162|3653114|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3826690|NCT01722162|3653115|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3826691|NCT01722162|3653113|B3|||Age||years|Median|60|60.0|Full Range|||36.0|80.0|
3826692|NCT01722162|3653114|B2|||Age||years|Median|57.5|57.5|Full Range|||36.0|76.0|
3826693|NCT01722162|3653115|B1|||Age||years|Median|62|62.0|Full Range|||39.0|80.0|
3826694|NCT01722097|3653124|B3|||Total hysterectomy||participants|Number|57|57.0||||||
3826695|NCT01722097|3653125|B2|||Total hysterectomy||participants|Number|28|28.0||||||
3826696|NCT01722097|3653126|B1|||Total hysterectomy||participants|Number|29|29.0||||||
3826697|NCT01722097|3653124|B3|||American Society of Anesthesiologists Physical Status Classification 2||participants|Number|9|9.0||||||
3826698|NCT01722097|3653125|B2|||American Society of Anesthesiologists Physical Status Classification 2||participants|Number|6|6.0||||||
3826699|NCT01722097|3653126|B1|||American Society of Anesthesiologists Physical Status Classification 2||participants|Number|3|3.0||||||
3826700|NCT01722097|3653124|B3|||Subtotal hysterectomy||participants|Number|53|53.0||||||
3826701|NCT01722097|3653125|B2|||Subtotal hysterectomy||participants|Number|27|27.0||||||
3826702|NCT01722097|3653126|B1|||Subtotal hysterectomy||participants|Number|26|26.0||||||
3826703|NCT01722097|3653124|B3|||Previous abdominal surgery||participants|Number|61|61.0||||||
3826704|NCT01722097|3653125|B2|||Previous abdominal surgery||participants|Number|35|35.0||||||
3826705|NCT01722097|3653126|B1|||Previous abdominal surgery||participants|Number|26|26.0||||||
3826706|NCT01722097|3653124|B3|||Parity (full term pregnancies)||pregnancies|Median|2|2.0|Full Range|||0.0|4.0|
3826707|NCT01722097|3653125|B2|||Parity (full term pregnancies)||pregnancies|Median|2|2.0|Full Range|||0.0|4.0|
3826708|NCT01722097|3653126|B1|||Parity (full term pregnancies)||pregnancies|Median|2|2.0|Full Range|||0.0|4.0|
3826709|NCT01722097|3653124|B3|||American Society of Anesthesiologists Physical Status Classification 1|"American Society of Anesthesiologists (ASA) PHYSICAL STATUS CLASSIFICATION SYSTEM 1-6.~A normal healthy patient~A patient with mild systemic disease~A patient with severe systemic disease~A patient with severe systemic disease that is a constant threat to life~A moribund patient who is not expected to survive without the operation~A declared brain-dead patient whose organs are being removed for donor purposes"|participants|Number|101|101.0||||||
3826761|NCT01721772|3653165|B3|Visceral, other||Site of lesion||Participants|Number|80|80.0||||||
3826762|NCT01721772|3653166|B2|Visceral, other||Site of lesion||Participants|Number|50|50.0||||||
3826710|NCT01722097|3653125|B2|||American Society of Anesthesiologists Physical Status Classification 1|"American Society of Anesthesiologists (ASA) PHYSICAL STATUS CLASSIFICATION SYSTEM 1-6.~A normal healthy patient~A patient with mild systemic disease~A patient with severe systemic disease~A patient with severe systemic disease that is a constant threat to life~A moribund patient who is not expected to survive without the operation~A declared brain-dead patient whose organs are being removed for donor purposes"|participants|Number|49|49.0||||||
3826711|NCT01722097|3653126|B1|||American Society of Anesthesiologists Physical Status Classification 1|"American Society of Anesthesiologists (ASA) PHYSICAL STATUS CLASSIFICATION SYSTEM 1-6.~A normal healthy patient~A patient with mild systemic disease~A patient with severe systemic disease~A patient with severe systemic disease that is a constant threat to life~A moribund patient who is not expected to survive without the operation~A declared brain-dead patient whose organs are being removed for donor purposes"|participants|Number|52|52.0||||||
3826712|NCT01722097|3653124|B3|||BMI||kg/m^2|Mean|23.6|23.6|Standard Deviation|3.1|3.1|||
3826713|NCT01722097|3653125|B2|||BMI||kg/m^2|Mean|24.2|24.2|Standard Deviation|3.1|3.1|||
3826714|NCT01722097|3653126|B1|||BMI||kg/m^2|Mean|23.1|23.1|Standard Deviation|3.0|3.0|||
3826715|NCT01722097|3653124|B3|Denmark||Region of Enrollment||participants|Number|110|110.0||||||
3826716|NCT01722097|3653125|B2|Denmark||Region of Enrollment||participants|Number|55|55.0||||||
3826717|NCT01722097|3653126|B1|Denmark||Region of Enrollment||participants|Number|55|55.0||||||
3826718|NCT01722097|3653124|B3|women||Sex/Gender, Customized|In total 110 women participated in the study|participants|Number|110|110.0||||||
3826719|NCT01722097|3653125|B2|women||Sex/Gender, Customized|In total 110 women participated in the study|participants|Number|55|55.0||||||
3826720|NCT01722097|3653126|B1|women||Sex/Gender, Customized|In total 110 women participated in the study|participants|Number|55|55.0||||||
3826721|NCT01722097|3653124|B3|||Age||years|Mean|47|47.0|Standard Deviation|5|5.0|||
3826722|NCT01722097|3653125|B2|||Age||years|Mean|48|48.0|Standard Deviation|5|5.0|||
3826723|NCT01722097|3653126|B1|||Age||years|Mean|47|47.0|Standard Deviation|5|5.0|||
3826724|NCT01722071|3653135|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3826725|NCT01722071|3653135|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3826726|NCT01722071|3653135|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3826727|NCT01722071|3653135|B1|||Age||years|Mean|22|22.0|Standard Deviation|2|2.0|||
3826728|NCT01722071|3653135|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3826729|NCT01722071|3653135|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3826730|NCT01722071|3653135|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3826731|NCT01722045|3653142|B1|Fellow eye||Corneal Endothelial Cell Density - Endothelial Cell Density Evaluable Set (EES)|Central ECD of the corneal endothelium in the study eye and the fellow eye was evaluated by specular microscopy.|cells/mm^2|Mean|2388.0|2388.0|Standard Deviation|383.93|383.93|||
3826732|NCT01722045|3653142|B1|Study eye||Corneal Endothelial Cell Density - Endothelial Cell Density Evaluable Set (EES)|Central ECD of the corneal endothelium in the study eye and the fellow eye was evaluated by specular microscopy.|cells/mm^2|Mean|2409.8|2409.8|Standard Deviation|363.89|363.89|||
3826733|NCT01722045|3653142|B1|||Central Subfield Thickness in the study eye by Optical Coherence Tomography (OCT)|Retinal and lesion characteristics (wet or dry) were evaluated using spectral domain OCT on the study eye and the fellow eye at every study visit.|micrometers (μm)|Mean|420.5|420.5|Standard Deviation|134.90|134.9|||
3826734|NCT01722045|3653142|B1|||Best Corrected Visual Acuity (BCVA) in the study eye (Letters Read)|Visual function of the study eye was assessed at a distance of 4 meters at every study visit using the Early Treatment Diabetic Retinopathy Study (ETDRS) Best Corrected Visual Acuity (BCVA) letter score. A higher score represents better vision.|letters correctly read|Mean|54.3|54.3|Standard Deviation|13.47|13.47|||
3826735|NCT01722045|3653142|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3826736|NCT01722045|3653142|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3826737|NCT01722045|3653142|B1||>=65 years|Age||Participants|Count of Participants|137|137.0||||||
3826738|NCT01722045|3653142|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3826739|NCT01722045|3653142|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3826740|NCT01721967|3653152|B1|Clinical summary||Kansas City Cardiomyopathy Questionnaire (KCCQ)|Similarly, the Kansas City Cardiomyopathy Questionnaire (KCCQ) is a new, self-administered, 23-item questionnaire developed to provide a better description of health-related quality of life in patients with heart failure. It quantifies, in a disease-specific fashion, physical limitation, symptoms (frequency, severity and recent change over time), quality of life, social interference and self-efficacy. All categories of questions are scored from 0-100, with higher number indicating better health.|units on a scale|Mean|58.8|58.8|Standard Deviation|20.9|20.9|||
3826741|NCT01721967|3653152|B1|Overall summary||Kansas City Cardiomyopathy Questionnaire (KCCQ)|Similarly, the Kansas City Cardiomyopathy Questionnaire (KCCQ) is a new, self-administered, 23-item questionnaire developed to provide a better description of health-related quality of life in patients with heart failure. It quantifies, in a disease-specific fashion, physical limitation, symptoms (frequency, severity and recent change over time), quality of life, social interference and self-efficacy. All categories of questions are scored from 0-100, with higher number indicating better health.|units on a scale|Mean|51.2|51.2|Standard Deviation|22.3|22.3|||
3826742|NCT01721967|3653152|B1|Social limitation||Kansas City Cardiomyopathy Questionnaire (KCCQ)|Similarly, the Kansas City Cardiomyopathy Questionnaire (KCCQ) is a new, self-administered, 23-item questionnaire developed to provide a better description of health-related quality of life in patients with heart failure. It quantifies, in a disease-specific fashion, physical limitation, symptoms (frequency, severity and recent change over time), quality of life, social interference and self-efficacy. All categories of questions are scored from 0-100, with higher number indicating better health.|units on a scale|Mean|46.0|46.0|Standard Deviation|31.5|31.5|||
3826760|NCT01721837|3653161|B1|||Age|For 5 patients the documentation of date of birth is missing, so age could be calculated for N=2115 patients.|years|Mean|75.2|75.2|Standard Deviation|8.8|8.8|||
3826743|NCT01721967|3653152|B1|Quality of life||Kansas City Cardiomyopathy Questionnaire (KCCQ)|Similarly, the Kansas City Cardiomyopathy Questionnaire (KCCQ) is a new, self-administered, 23-item questionnaire developed to provide a better description of health-related quality of life in patients with heart failure. It quantifies, in a disease-specific fashion, physical limitation, symptoms (frequency, severity and recent change over time), quality of life, social interference and self-efficacy. All categories of questions are scored from 0-100, with higher number indicating better health.|units on a scale|Mean|39.4|39.4|Standard Deviation|26.6|26.6|||
3826744|NCT01721967|3653152|B1|Self-efficacy||Kansas City Cardiomyopathy Questionnaire (KCCQ)|Similarly, the Kansas City Cardiomyopathy Questionnaire (KCCQ) is a new, self-administered, 23-item questionnaire developed to provide a better description of health-related quality of life in patients with heart failure. It quantifies, in a disease-specific fashion, physical limitation, symptoms (frequency, severity and recent change over time), quality of life, social interference and self-efficacy. All categories of questions are scored from 0-100, with higher number indicating better health.|units on a scale|Mean|78.4|78.4|Standard Deviation|21.7|21.7|||
3826745|NCT01721967|3653152|B1|Total symptom score||Kansas City Cardiomyopathy Questionnaire (KCCQ)|Similarly, the Kansas City Cardiomyopathy Questionnaire (KCCQ) is a new, self-administered, 23-item questionnaire developed to provide a better description of health-related quality of life in patients with heart failure. It quantifies, in a disease-specific fashion, physical limitation, symptoms (frequency, severity and recent change over time), quality of life, social interference and self-efficacy. All categories of questions are scored from 0-100, with higher number indicating better health.|units on a scale|Mean|55.9|55.9|Standard Deviation|24.2|24.2|||
3826746|NCT01721967|3653152|B1|Symptom burden||Kansas City Cardiomyopathy Questionnaire (KCCQ)|Similarly, the Kansas City Cardiomyopathy Questionnaire (KCCQ) is a new, self-administered, 23-item questionnaire developed to provide a better description of health-related quality of life in patients with heart failure. It quantifies, in a disease-specific fashion, physical limitation, symptoms (frequency, severity and recent change over time), quality of life, social interference and self-efficacy. All categories of questions are scored from 0-100, with higher number indicating better health.|units on a scale|Mean|55.3|55.3|Standard Deviation|29.4|29.4|||
3826747|NCT01721967|3653152|B1|Symptom frequency||Kansas City Cardiomyopathy Questionnaire (KCCQ)|Similarly, the Kansas City Cardiomyopathy Questionnaire (KCCQ) is a new, self-administered, 23-item questionnaire developed to provide a better description of health-related quality of life in patients with heart failure. It quantifies, in a disease-specific fashion, physical limitation, symptoms (frequency, severity and recent change over time), quality of life, social interference and self-efficacy. All categories of questions are scored from 0-100, with higher number indicating better health.|units on a scale|Mean|56.4|56.4|Standard Deviation|20.6|20.6|||
3826748|NCT01721967|3653152|B1|Symptom stability||Kansas City Cardiomyopathy Questionnaire (KCCQ)|Similarly, the Kansas City Cardiomyopathy Questionnaire (KCCQ) is a new, self-administered, 23-item questionnaire developed to provide a better description of health-related quality of life in patients with heart failure. It quantifies, in a disease-specific fashion, physical limitation, symptoms (frequency, severity and recent change over time), quality of life, social interference and self-efficacy. All categories of questions are scored from 0-100, with higher number indicating better health.|units on a scale|Mean|43.2|43.2|Standard Deviation|16.2|16.2|||
3826749|NCT01721967|3653152|B1|Physical limitation||Kansas City Cardiomyopathy Questionnaire (KCCQ)|Similarly, the Kansas City Cardiomyopathy Questionnaire (KCCQ) is a new, self-administered, 23-item questionnaire developed to provide a better description of health-related quality of life in patients with heart failure. It quantifies, in a disease-specific fashion, physical limitation, symptoms (frequency, severity and recent change over time), quality of life, social interference and self-efficacy. All categories of questions are scored from 0-100, with higher number indicating better health.|units on a scale|Mean|61.7|61.7|Standard Deviation|20.6|20.6|||
3826750|NCT01721967|3653152|B1|Quality of life||Seattle Angina Questionnaire|The SAQ is a self-report instrument with 19 items that yields five subscale scores: physical limitation, angina stability, angina frequency, treatment satisfaction, and disease perception. The possible range of scores for each of the five subscales is 0 to 100, with higher scores indicating better quality of life.|units on a scale|Mean|40.9|40.9|Standard Deviation|24.6|24.6|||
3826751|NCT01721967|3653152|B1|Treatment satisfaction||Seattle Angina Questionnaire|The SAQ is a self-report instrument with 19 items that yields five subscale scores: physical limitation, angina stability, angina frequency, treatment satisfaction, and disease perception. The possible range of scores for each of the five subscales is 0 to 100, with higher scores indicating better quality of life.|units on a scale|Mean|85.2|85.2|Standard Deviation|12.6|12.6|||
3826752|NCT01721967|3653152|B1|Anginal frequency||Seattle Angina Questionnaire|The SAQ is a self-report instrument with 19 items that yields five subscale scores: physical limitation, angina stability, angina frequency, treatment satisfaction, and disease perception. The possible range of scores for each of the five subscales is 0 to 100, with higher scores indicating better quality of life.|units on a scale|Mean|65.5|65.5|Standard Deviation|13.4|13.4|||
3826753|NCT01721967|3653152|B1|Anginal stability||Seattle Angina Questionnaire|The SAQ is a self-report instrument with 19 items that yields five subscale scores: physical limitation, angina stability, angina frequency, treatment satisfaction, and disease perception. The possible range of scores for each of the five subscales is 0 to 100, with higher scores indicating better quality of life.|units on a scale|Mean|45.5|45.5|Standard Deviation|27.0|27.0|||
3826754|NCT01721967|3653152|B1|Physical limitation||Seattle Angina Questionnaire|The SAQ is a self-report instrument with 19 items that yields five subscale scores: physical limitation, angina stability, angina frequency, treatment satisfaction, and disease perception. The possible range of scores for each of the five subscales is 0 to 100, with higher scores indicating better quality of life.|units on a scale|Mean|49.6|49.6|Standard Deviation|18.7|18.7|||
3826755|NCT01721967|3653152|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3826756|NCT01721967|3653152|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3826757|NCT01721967|3653152|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|9.0|9.0|||
3826758|NCT01721837|3653161|B1|Male||Gender|For 4 patients the documentation of gender is missing.|participants|Number|1101|1101.0||||||
3826759|NCT01721837|3653161|B1|Female||Gender|For 4 patients the documentation of gender is missing.|participants|Number|1015|1015.0||||||
3826763|NCT01721772|3653167|B1|Visceral, other||Site of lesion||Participants|Number|30|30.0||||||
3826764|NCT01721772|3653165|B3|Soft tissue||Site of lesion||Participants|Number|98|98.0||||||
3826765|NCT01721772|3653166|B2|Soft tissue||Site of lesion||Participants|Number|58|58.0||||||
3826766|NCT01721772|3653167|B1|Soft tissue||Site of lesion||Participants|Number|40|40.0||||||
3826767|NCT01721772|3653165|B3|Skin||Site of lesion||Participants|Number|60|60.0||||||
3826768|NCT01721772|3653166|B2|Skin||Site of lesion||Participants|Number|37|37.0||||||
3826769|NCT01721772|3653167|B1|Skin||Site of lesion||Participants|Number|23|23.0||||||
3826770|NCT01721772|3653165|B3|Other||Site of lesion||Participants|Number|101|101.0||||||
3826771|NCT01721772|3653166|B2|Other||Site of lesion||Participants|Number|47|47.0||||||
3826772|NCT01721772|3653167|B1|Other||Site of lesion||Participants|Number|54|54.0||||||
3826773|NCT01721772|3653165|B3|Lymph node||Site of lesion||Participants|Number|241|241.0||||||
3826774|NCT01721772|3653166|B2|Lymph node||Site of lesion||Participants|Number|121|121.0||||||
3826775|NCT01721772|3653167|B1|Lymph node||Site of lesion||Participants|Number|120|120.0||||||
3826776|NCT01721772|3653165|B3|Lung||Site of lesion||Participants|Number|253|253.0||||||
3826777|NCT01721772|3653166|B2|Lung||Site of lesion||Participants|Number|125|125.0||||||
3826778|NCT01721772|3653167|B1|Lung||Site of lesion||Participants|Number|128|128.0||||||
3826779|NCT01721772|3653165|B3|Liver||Site of lesion||Participants|Number|128|128.0||||||
3826780|NCT01721772|3653166|B2|Liver||Site of lesion||Participants|Number|60|60.0||||||
3826781|NCT01721772|3653167|B1|Liver||Site of lesion||Participants|Number|68|68.0||||||
3826782|NCT01721772|3653165|B3|Intestine||Site of lesion||Participants|Number|9|9.0||||||
3826783|NCT01721772|3653166|B2|Intestine||Site of lesion||Participants|Number|3|3.0||||||
3826784|NCT01721772|3653167|B1|Intestine||Site of lesion||Participants|Number|6|6.0||||||
3826785|NCT01721772|3653165|B3|Bone||Site of lesion||Participants|Number|43|43.0||||||
3826786|NCT01721772|3653166|B2|Bone||Site of lesion||Participants|Number|18|18.0||||||
3826787|NCT01721772|3653167|B1|Bone||Site of lesion||Participants|Number|25|25.0||||||
3826788|NCT01721772|3653165|B3|||Participants with at least 1 lesion||Participants|Number|417|417.0||||||
3826789|NCT01721772|3653166|B2|||Participants with at least 1 lesion||Participants|Number|208|208.0||||||
3826790|NCT01721772|3653167|B1|||Participants with at least 1 lesion||Participants|Number|209|209.0||||||
3826791|NCT01721772|3653165|B3|||Time from initial diagnosis||Years|Median|1.83|1.83|Full Range|||0.1|32.6|
3826792|NCT01721772|3653166|B2|||Time from initial diagnosis||Years|Median|1.65|1.65|Full Range|||0.1|22.2|
3826793|NCT01721772|3653167|B1|||Time from initial diagnosis||Years|Median|1.93|1.93|Full Range|||0.1|32.6|
3826794|NCT01721772|3653165|B3|Negative/indeterminate||Stratification programmed cell death ligand 1 status||Participants|Number|270|270.0||||||
3826795|NCT01721772|3653166|B2|Negative/indeterminate||Stratification programmed cell death ligand 1 status||Participants|Number|134|134.0||||||
3826796|NCT01721772|3653167|B1|Negative/indeterminate||Stratification programmed cell death ligand 1 status||Participants|Number|136|136.0||||||
3826797|NCT01721772|3653165|B3|Positive||Stratification programmed cell death ligand 1 status||Participants|Number|148|148.0||||||
3826798|NCT01721772|3653166|B2|Positive||Stratification programmed cell death ligand 1 status||Participants|Number|74|74.0||||||
3826799|NCT01721772|3653167|B1|Positive||Stratification programmed cell death ligand 1 status||Participants|Number|74|74.0||||||
3826800|NCT01721772|3653165|B3|M1c||M-stage at study entry|M-stage=melanoma stage by American Joint Committee on Cancer Melanoma Staging and Classification, 2009. M0=no distant metastases; M1a=distant skin, subcutaneous, or nodal metastases; M1b=lung metastases; M1c=all other visceral metastases|Participants|Number|255|255.0||||||
3826801|NCT01721772|3653166|B2|M1c||M-stage at study entry|M-stage=melanoma stage by American Joint Committee on Cancer Melanoma Staging and Classification, 2009. M0=no distant metastases; M1a=distant skin, subcutaneous, or nodal metastases; M1b=lung metastases; M1c=all other visceral metastases|Participants|Number|127|127.0||||||
3826802|NCT01721772|3653167|B1|M1c||M-stage at study entry|M-stage=melanoma stage by American Joint Committee on Cancer Melanoma Staging and Classification, 2009. M0=no distant metastases; M1a=distant skin, subcutaneous, or nodal metastases; M1b=lung metastases; M1c=all other visceral metastases|Participants|Number|128|128.0||||||
3826803|NCT01721772|3653165|B3|M1b||M-stage at study entry|M-stage=melanoma stage by American Joint Committee on Cancer Melanoma Staging and Classification, 2009. M0=no distant metastases; M1a=distant skin, subcutaneous, or nodal metastases; M1b=lung metastases; M1c=all other visceral metastases|Participants|Number|92|92.0||||||
3826804|NCT01721772|3653166|B2|M1b||M-stage at study entry|M-stage=melanoma stage by American Joint Committee on Cancer Melanoma Staging and Classification, 2009. M0=no distant metastases; M1a=distant skin, subcutaneous, or nodal metastases; M1b=lung metastases; M1c=all other visceral metastases|Participants|Number|48|48.0||||||
3826805|NCT01721772|3653167|B1|M1b||M-stage at study entry|M-stage=melanoma stage by American Joint Committee on Cancer Melanoma Staging and Classification, 2009. M0=no distant metastases; M1a=distant skin, subcutaneous, or nodal metastases; M1b=lung metastases; M1c=all other visceral metastases|Participants|Number|44|44.0||||||
3826806|NCT01721772|3653165|B3|M1a||M-stage at study entry|M-stage=melanoma stage by American Joint Committee on Cancer Melanoma Staging and Classification, 2009. M0=no distant metastases; M1a=distant skin, subcutaneous, or nodal metastases; M1b=lung metastases; M1c=all other visceral metastases|Participants|Number|41|41.0||||||
3826807|NCT01721772|3653166|B2|M1a||M-stage at study entry|M-stage=melanoma stage by American Joint Committee on Cancer Melanoma Staging and Classification, 2009. M0=no distant metastases; M1a=distant skin, subcutaneous, or nodal metastases; M1b=lung metastases; M1c=all other visceral metastases|Participants|Number|20|20.0||||||
3826808|NCT01721772|3653167|B1|M1a||M-stage at study entry|M-stage=melanoma stage by American Joint Committee on Cancer Melanoma Staging and Classification, 2009. M0=no distant metastases; M1a=distant skin, subcutaneous, or nodal metastases; M1b=lung metastases; M1c=all other visceral metastases|Participants|Number|21|21.0||||||
3826852|NCT01721759|3653188|B1|Other||Cell type||Participants|Number|0|0.0||||||
3826809|NCT01721772|3653165|B3|M0||M-stage at study entry|M-stage=melanoma stage by American Joint Committee on Cancer Melanoma Staging and Classification, 2009. M0=no distant metastases; M1a=distant skin, subcutaneous, or nodal metastases; M1b=lung metastases; M1c=all other visceral metastases|Participants|Number|30|30.0||||||
3826810|NCT01721772|3653166|B2|M0||M-stage at study entry|M-stage=melanoma stage by American Joint Committee on Cancer Melanoma Staging and Classification, 2009. M0=no distant metastases; M1a=distant skin, subcutaneous, or nodal metastases; M1b=lung metastases; M1c=all other visceral metastases|Participants|Number|13|13.0||||||
3826811|NCT01721772|3653167|B1|M0||M-stage at study entry|M-stage=melanoma stage by American Joint Committee on Cancer Melanoma Staging and Classification, 2009. M0=no distant metastases; M1a=distant skin, subcutaneous, or nodal metastases; M1b=lung metastases; M1c=all other visceral metastases|Participants|Number|17|17.0||||||
3826812|NCT01721772|3653165|B3|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3826813|NCT01721772|3653166|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3826814|NCT01721772|3653167|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3826815|NCT01721772|3653165|B3|American Indian or Alaskan native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3826816|NCT01721772|3653166|B2|American Indian or Alaskan native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3826817|NCT01721772|3653167|B1|American Indian or Alaskan native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3826818|NCT01721772|3653165|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3826819|NCT01721772|3653166|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3826820|NCT01721772|3653167|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3826821|NCT01721772|3653165|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3826822|NCT01721772|3653166|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3826823|NCT01721772|3653167|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3826824|NCT01721772|3653165|B3|White||Race/Ethnicity, Customized||Participants|Number|416|416.0||||||
3826825|NCT01721772|3653166|B2|White||Race/Ethnicity, Customized||Participants|Number|207|207.0||||||
3826826|NCT01721772|3653167|B1|White||Race/Ethnicity, Customized||Participants|Number|209|209.0||||||
3826827|NCT01721772|3653165|B3||Male|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
3826828|NCT01721772|3653166|B2||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3826829|NCT01721772|3653167|B1||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3826830|NCT01721772|3653165|B3||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3826831|NCT01721772|3653166|B2||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3826832|NCT01721772|3653167|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3826833|NCT01721772|3653165|B3|75 years and older||Age, Customized||Participants|Number|67|67.0||||||
3826834|NCT01721772|3653166|B2|75 years and older||Age, Customized||Participants|Number|40|40.0||||||
3826835|NCT01721772|3653167|B1|75 years and older||Age, Customized||Participants|Number|27|27.0||||||
3826836|NCT01721772|3653165|B3|65 to younger than 75 years||Age, Customized||Participants|Number|151|151.0||||||
3826837|NCT01721772|3653166|B2|65 to younger than 75 years||Age, Customized||Participants|Number|74|74.0||||||
3826838|NCT01721772|3653167|B1|65 to younger than 75 years||Age, Customized||Participants|Number|77|77.0||||||
3826839|NCT01721772|3653165|B3|Younger than 65 years||Age, Customized||Participants|Number|200|200.0||||||
3826840|NCT01721772|3653166|B2|Younger than 65 years||Age, Customized||Participants|Number|94|94.0||||||
3826841|NCT01721772|3653167|B1|Younger than 65 years||Age, Customized||Participants|Number|106|106.0||||||
3826842|NCT01721772|3653165|B3|||Age||Years|Mean|62.7|62.7|Standard Deviation|12.83|12.83|||
3826843|NCT01721772|3653166|B2|||Age||Years|Mean|63.7|63.7|Standard Deviation|12.60|12.6|||
3826844|NCT01721772|3653167|B1|||Age||Years|Mean|61.6|61.6|Standard Deviation|13.00|13.0|||
3826845|NCT01721759|3653188|B1|No||Central nervous system metastasis||Participants|Number|115|115.0||||||
3826846|NCT01721759|3653188|B1|Yes||Central nervous system metastasis||Participants|Number|2|2.0||||||
3826847|NCT01721759|3653188|B1|4||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|0|0.0||||||
3826848|NCT01721759|3653188|B1|3||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|0|0.0||||||
3826849|NCT01721759|3653188|B1|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|0|0.0||||||
3826850|NCT01721759|3653188|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|91|91.0||||||
3826851|NCT01721759|3653188|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|26|26.0||||||
3826853|NCT01721759|3653188|B1|Squamous cell carcinoma||Cell type||Participants|Number|117|117.0||||||
3826854|NCT01721759|3653188|B1|Stage IV||Disease stage|Non-Small Cell Lung Cancer is categorized in 4 Stages (I-IV). I: Cancer located only in lungs and has not spread to any lymph nodes. II: Cancer in the lung and nearby lymph nodes. III: Cancer in the lung and lymph nodes in the middle of the chest. Stage III has two subtypes, IIIA (cancer has spread only to lymph nodes on the same side of the chest where the cancer started) and IIIB (cancer has spread to the lymph nodes on the opposite side of the chest, or above the collar bone). IV: Cancer has spread to both lungs, to fluid in the area around the lungs, or to another part of the body|Participants|Number|97|97.0||||||
3826855|NCT01721759|3653188|B1|Stage IIIB||Disease stage|Non-Small Cell Lung Cancer is categorized in 4 Stages (I-IV). I: Cancer located only in lungs and has not spread to any lymph nodes. II: Cancer in the lung and nearby lymph nodes. III: Cancer in the lung and lymph nodes in the middle of the chest. Stage III has two subtypes, IIIA (cancer has spread only to lymph nodes on the same side of the chest where the cancer started) and IIIB (cancer has spread to the lymph nodes on the opposite side of the chest, or above the collar bone). IV: Cancer has spread to both lungs, to fluid in the area around the lungs, or to another part of the body|Participants|Number|20|20.0||||||
3826856|NCT01721759|3653188|B1|Other||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3826857|NCT01721759|3653188|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3826858|NCT01721759|3653188|B1|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3826859|NCT01721759|3653188|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3826860|NCT01721759|3653188|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3826861|NCT01721759|3653188|B1|White||Race/Ethnicity, Customized||Participants|Number|99|99.0||||||
3826862|NCT01721759|3653188|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3826863|NCT01721759|3653188|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3826864|NCT01721759|3653188|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826865|NCT01721759|3653188|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3826866|NCT01721759|3653188|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3826867|NCT01721759|3653188|B1|75 years and older||Age, Customized||Participants|Number|16|16.0||||||
3826868|NCT01721759|3653188|B1|At least 65 years and younger than 75 years||Age, Customized||Participants|Number|43|43.0||||||
3826869|NCT01721759|3653188|B1|Younger than 65 years||Age, Customized||Participants|Number|58|58.0||||||
3826870|NCT01721759|3653188|B1|||Age||Years|Mean|64.1|64.1|Standard Deviation|9.11|9.11|||
3826871|NCT01721746|3653194|B3|||Quantifiable Programmed Death-ligand 1 (PD-L1) Expression||Participants|Count of Participants|347|347.0||||||
3826872|NCT01721746|3653195|B2|||Quantifiable Programmed Death-ligand 1 (PD-L1) Expression||Participants|Count of Participants|99|99.0||||||
3826873|NCT01721746|3653196|B1|||Quantifiable Programmed Death-ligand 1 (PD-L1) Expression||Participants|Count of Participants|248|248.0||||||
3826874|NCT01721746|3653194|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3826875|NCT01721746|3653195|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3826876|NCT01721746|3653196|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3826877|NCT01721746|3653194|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3826878|NCT01721746|3653195|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3826879|NCT01721746|3653196|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3826880|NCT01721746|3653194|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3826881|NCT01721746|3653195|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3826882|NCT01721746|3653196|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3826883|NCT01721746|3653194|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3826884|NCT01721746|3653195|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3826885|NCT01721746|3653196|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3826886|NCT01721746|3653194|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3826887|NCT01721746|3653195|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3826888|NCT01721746|3653196|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3826889|NCT01721746|3653194|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|398|398.0||||||
3826890|NCT01721746|3653195|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|129|129.0||||||
3826891|NCT01721746|3653196|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|269|269.0||||||
3826892|NCT01721746|3653194|B3||Male|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
3826893|NCT01721746|3653195|B2||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3826894|NCT01721746|3653196|B1||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
3826895|NCT01721746|3653194|B3||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3826896|NCT01721746|3653195|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3826897|NCT01721746|3653196|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3826898|NCT01721746|3653194|B3|>=85 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
3826899|NCT01721746|3653195|B2|>=85 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3826900|NCT01721746|3653196|B1|>=85 years||Age, Customized||Participants|Count of Participants|4|4.0||||||
3826901|NCT01721746|3653194|B3|>=75 years and < 85 years||Age, Customized||Participants|Count of Participants|51|51.0||||||
3826902|NCT01721746|3653195|B2|>=75 years and < 85 years||Age, Customized||Participants|Count of Participants|15|15.0||||||
3826903|NCT01721746|3653196|B1|>=75 years and < 85 years||Age, Customized||Participants|Count of Participants|36|36.0||||||
3826904|NCT01721746|3653194|B3|>=65 years and < 75 years||Age, Customized||Participants|Count of Participants|92|92.0||||||
3826905|NCT01721746|3653195|B2|>=65 years and < 75 years||Age, Customized||Participants|Count of Participants|37|37.0||||||
3826906|NCT01721746|3653196|B1|>=65 years and < 75 years||Age, Customized||Participants|Count of Participants|55|55.0||||||
3826907|NCT01721746|3653194|B3|< 65 years||Age, Customized||Participants|Count of Participants|257|257.0||||||
3826908|NCT01721746|3653195|B2|< 65 years||Age, Customized||Participants|Count of Participants|80|80.0||||||
3826909|NCT01721746|3653196|B1|< 65 years||Age, Customized||Participants|Count of Participants|177|177.0||||||
3826910|NCT01721746|3653194|B3|||Age||years|Mean|59.2|59.2|Standard Deviation|13.59|13.59|||
3826911|NCT01721746|3653195|B2|||Age||years|Mean|60.3|60.3|Standard Deviation|12.43|12.43|||
3826912|NCT01721746|3653196|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|14.12|14.12|||
3826913|NCT01721681|3653214|B1|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
3826914|NCT01721681|3653214|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3826915|NCT01721681|3653214|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3826916|NCT01721681|3653214|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3826917|NCT01721681|3653214|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3826918|NCT01721681|3653214|B1||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
3826919|NCT01721603|3653220|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3826920|NCT01721603|3653220|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3826921|NCT01721603|3653220|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3826922|NCT01721603|3653220|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3826923|NCT01721603|3653220|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3826924|NCT01721603|3653220|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3826925|NCT01721564|3653231|B1|Australia||Region of Enrollment||participants|Number|8|8.0||||||
3826926|NCT01721564|3653231|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3826927|NCT01721564|3653231|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3826928|NCT01721564|3653231|B1|||Age||years|Mean|66|66.0|Standard Deviation|4|4.0|||
3826929|NCT01721564|3653231|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3826930|NCT01721564|3653231|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3826931|NCT01721564|3653231|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3826932|NCT01721486|3653236|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3826933|NCT01721486|3653237|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3826934|NCT01721486|3653238|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3826935|NCT01721486|3653236|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3826936|NCT01721486|3653237|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3826937|NCT01721486|3653238|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3826938|NCT01721486|3653236|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3826939|NCT01721486|3653237|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3826940|NCT01721486|3653238|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3826941|NCT01721486|3653236|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3826942|NCT01721486|3653237|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3826943|NCT01721486|3653238|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3826944|NCT01721486|3653236|B3||<=18 years|Age||Participants|Count of Participants|39|39.0||||||
3826945|NCT01721486|3653237|B2||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
3826946|NCT01721486|3653238|B1||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
3826947|NCT01721460|3653251|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3826948|NCT01721460|3653251|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3826949|NCT01721460|3653251|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3826950|NCT01721460|3653251|B1|||Age||years|Mean|61.5|61.5|Full Range|||53.0|71.0|
3826951|NCT01721408|3653258|B3||Male|Sex: Female, Male||Participants|Count of Participants|299|299.0||||||
3826952|NCT01721408|3653259|B2||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3826953|NCT01721408|3653260|B1||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3826954|NCT01721408|3653258|B3||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3826955|NCT01721408|3653259|B2||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3826956|NCT01721408|3653260|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3826957|NCT01721408|3653258|B3|||Age||years|Mean|48.3|48.3|Standard Deviation|17.8|17.8|||
3826958|NCT01721408|3653259|B2|||Age||years|Mean|48.2|48.2|Standard Deviation|17.6|17.6|||
3826959|NCT01721408|3653260|B1|||Age||years|Mean|48.4|48.4|Standard Deviation|18.1|18.1|||
3826960|NCT01721330|3653275|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826961|NCT01721330|3653276|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826962|NCT01721330|3653277|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826963|NCT01721330|3653275|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826964|NCT01721330|3653276|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826965|NCT01721330|3653277|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826966|NCT01721330|3653275|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3826967|NCT01721330|3653276|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3826968|NCT01721330|3653277|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3826969|NCT01721330|3653275|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826970|NCT01721330|3653276|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826971|NCT01721330|3653277|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826972|NCT01721330|3653275|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826973|NCT01721330|3653276|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826974|NCT01721330|3653277|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826975|NCT01721330|3653275|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826976|NCT01721330|3653276|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826977|NCT01721330|3653277|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826978|NCT01721330|3653275|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826979|NCT01721330|3653276|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826980|NCT01721330|3653277|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826981|NCT01721330|3653275|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826982|NCT01721330|3653276|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826983|NCT01721330|3653277|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826984|NCT01721330|3653275|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3826985|NCT01721330|3653276|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3826986|NCT01721330|3653277|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3826987|NCT01721330|3653275|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826988|NCT01721330|3653276|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826989|NCT01721330|3653277|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3826990|NCT01721330|3653275|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3826991|NCT01721330|3653276|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3826992|NCT01721330|3653277|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3826993|NCT01721330|3653275|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3826994|NCT01721330|3653276|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3826995|NCT01721330|3653277|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3826996|NCT01721330|3653275|B3|||Age||years|Mean|33.58|33.58|Standard Deviation|2.61|2.61|||
3826997|NCT01721330|3653276|B2|||Age||years|Mean|32.21|32.21|Standard Deviation|2.13|2.13|||
3826998|NCT01721330|3653277|B1|||Age||years|Mean|36.33|36.33|Standard Deviation|NA||||Only one subject
3826999|NCT01721330|3653275|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3827000|NCT01721330|3653276|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3827001|NCT01721330|3653277|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3827002|NCT01721330|3653275|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3827003|NCT01721330|3653276|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3827004|NCT01721330|3653277|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3827005|NCT01721330|3653275|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3827006|NCT01721330|3653276|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3827007|NCT01721330|3653277|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3827008|NCT01721317|3653284|B3|White - White/Caucasian/European||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3827009|NCT01721317|3653285|B2|White - White/Caucasian/European||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3827010|NCT01721317|3653286|B1|White - White/Caucasian/European||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3827011|NCT01721317|3653284|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3827012|NCT01721317|3653285|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3827013|NCT01721317|3653286|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3827014|NCT01721317|3653284|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3827015|NCT01721317|3653285|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3827016|NCT01721317|3653286|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3827017|NCT01721317|3653284|B3|||Age||Years|Mean|42.7|42.7|Standard Deviation|13.50|13.5|||
3827018|NCT01721317|3653285|B2|||Age||Years|Mean|42.8|42.8|Standard Deviation|16.32|16.32|||
3827019|NCT01721317|3653286|B1|||Age||Years|Mean|42.5|42.5|Standard Deviation|10.61|10.61|||
3827020|NCT01721226|3653353|B3|Not virally suppressed (PVL >=100)||Baseline Viral Suppression||participants|Number|39|39.0||||||
3827021|NCT01721226|3653354|B2|Not virally suppressed (PVL >=100)||Baseline Viral Suppression||participants|Number|22|22.0||||||
3827022|NCT01721226|3653355|B1|Not virally suppressed (PVL >=100)||Baseline Viral Suppression||participants|Number|17|17.0||||||
3827023|NCT01721226|3653353|B3|Virally suppressed (PVL<100)||Baseline Viral Suppression||participants|Number|69|69.0||||||
3827024|NCT01721226|3653354|B2|Virally suppressed (PVL<100)||Baseline Viral Suppression||participants|Number|32|32.0||||||
3827025|NCT01721226|3653355|B1|Virally suppressed (PVL<100)||Baseline Viral Suppression||participants|Number|37|37.0||||||
3827026|NCT01721226|3653353|B3|Transgender||Sex/Gender, Customized||participants|Number|20|20.0||||||
3827027|NCT01721226|3653354|B2|Transgender||Sex/Gender, Customized||participants|Number|10|10.0||||||
3827028|NCT01721226|3653355|B1|Transgender||Sex/Gender, Customized||participants|Number|10|10.0||||||
3827029|NCT01721226|3653353|B3|Female||Sex/Gender, Customized||participants|Number|27|27.0||||||
3827030|NCT01721226|3653354|B2|Female||Sex/Gender, Customized||participants|Number|14|14.0||||||
3827031|NCT01721226|3653355|B1|Female||Sex/Gender, Customized||participants|Number|13|13.0||||||
3827032|NCT01721226|3653353|B3|Male||Sex/Gender, Customized||participants|Number|65|65.0||||||
3827033|NCT01721226|3653354|B2|Male||Sex/Gender, Customized||participants|Number|33|33.0||||||
3827034|NCT01721226|3653355|B1|Male||Sex/Gender, Customized||participants|Number|32|32.0||||||
3827035|NCT01721226|3653353|B3|||Age||years|Median|41.5|41.5|Inter-Quartile Range|||30.0|49.0|
3827036|NCT01721226|3653354|B2|||Age||years|Median|42|42.0|Inter-Quartile Range|||30.0|50.0|
3827037|NCT01721226|3653355|B1|||Age||years|Median|39|39.0|Inter-Quartile Range|||30.0|57.0|
3827038|NCT01721200|3653364|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3827039|NCT01721200|3653365|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3827040|NCT01721200|3653366|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3827041|NCT01721200|3653364|B3|More than one of the above races||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3827042|NCT01721200|3653365|B2|More than one of the above races||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3827043|NCT01721200|3653366|B1|More than one of the above races||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3827044|NCT01721200|3653364|B3|White||Race/Ethnicity, Customized||participants|Number|118|118.0||||||
3827045|NCT01721200|3653365|B2|White||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
3827046|NCT01721200|3653366|B1|White||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
3827047|NCT01721200|3653364|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3827048|NCT01721200|3653365|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3827049|NCT01721200|3653366|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3827050|NCT01721200|3653364|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3827051|NCT01721200|3653365|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3827052|NCT01721200|3653366|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3827053|NCT01721200|3653364|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3827054|NCT01721200|3653365|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3827055|NCT01721200|3653366|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3827056|NCT01721200|3653364|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3827057|NCT01721200|3653365|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3827058|NCT01721200|3653366|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3827059|NCT01721200|3653364|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3827060|NCT01721200|3653365|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3827061|NCT01721200|3653366|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3827062|NCT01721200|3653364|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3827063|NCT01721200|3653365|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3827064|NCT01721200|3653366|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3827065|NCT01721200|3653364|B3|||Age||years|Mean|55.3|55.3|Standard Deviation|12.4|12.4|||
3827066|NCT01721200|3653365|B2|||Age||years|Mean|56.2|56.2|Standard Deviation|11.4|11.4|||
3827067|NCT01721200|3653366|B1|||Age||years|Mean|54.3|54.3|Standard Deviation|13.3|13.3|||
3827068|NCT01721200|3653364|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3827069|NCT01721200|3653365|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3827070|NCT01721200|3653366|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3827071|NCT01721200|3653364|B3||Between 18 and 65 years|Age||Participants|Count of Participants|125|125.0||||||
3827072|NCT01721200|3653365|B2||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
3827073|NCT01721200|3653366|B1||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
3827074|NCT01721200|3653364|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3827075|NCT01721200|3653365|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3827076|NCT01721200|3653366|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3827077|NCT01721161|3653390|B3|||Volume of brain T2 lesions before first dose|n=38 in each group, total n=76.|mL|Mean|1.09|1.09|Standard Deviation|1.63|1.63|||
3827078|NCT01721161|3653391|B2|||Volume of brain T2 lesions before first dose|n=38 in each group, total n=76.|mL|Mean|1.09|1.09|Standard Deviation|1.90|1.9|||
3827079|NCT01721161|3653392|B1|||Volume of brain T2 lesions before first dose|n=38 in each group, total n=76.|mL|Mean|1.09|1.09|Standard Deviation|1.32|1.32|||
3827080|NCT01721161|3653390|B3|||Brain Gd+ lesions before first dose|Gd+=gadolinium-enhancing. n=38 in each group, total n=76.|lesions|Mean|0.4|0.4|Standard Deviation|1.4|1.4|||
3827081|NCT01721161|3653391|B2|||Brain Gd+ lesions before first dose|Gd+=gadolinium-enhancing. n=38 in each group, total n=76.|lesions|Mean|0.2|0.2|Standard Deviation|1.0|1.0|||
3827082|NCT01721161|3653392|B1|||Brain Gd+ lesions before first dose|Gd+=gadolinium-enhancing. n=38 in each group, total n=76.|lesions|Mean|0.5|0.5|Standard Deviation|1.6|1.6|||
3827083|NCT01721161|3653390|B3|||RGCL/IPL thickness in the affected eye at baseline|RGCL/IPL=retinal ganglion cell layer/inner plexiform retinal layer. n=38 in the placebo group and n=40 in the anti-LINGO-1 group, total n=78.|microns|Mean|64.8|64.8|Standard Deviation|7.2|7.2|||
3827084|NCT01721161|3653391|B2|||RGCL/IPL thickness in the affected eye at baseline|RGCL/IPL=retinal ganglion cell layer/inner plexiform retinal layer. n=38 in the placebo group and n=40 in the anti-LINGO-1 group, total n=78.|microns|Mean|63.8|63.8|Standard Deviation|7.4|7.4|||
3827085|NCT01721161|3653392|B1|||RGCL/IPL thickness in the affected eye at baseline|RGCL/IPL=retinal ganglion cell layer/inner plexiform retinal layer. n=38 in the placebo group and n=40 in the anti-LINGO-1 group, total n=78.|microns|Mean|66.0|66.0|Standard Deviation|6.9|6.9|||
3827086|NCT01721161|3653390|B3|||FF-VEP latency in the fellow eye at baseline||ms|Mean|102.2|102.2|Standard Deviation|5.8|5.8|||
3827087|NCT01721161|3653391|B2|||FF-VEP latency in the fellow eye at baseline||ms|Mean|102.7|102.7|Standard Deviation|6.4|6.4|||
3827088|NCT01721161|3653392|B1|||FF-VEP latency in the fellow eye at baseline||ms|Mean|101.7|101.7|Standard Deviation|5.25|5.25|||
3827089|NCT01721161|3653390|B3|No FF-VEP conduction block||FF-VEP conduction block in the affected eye at baseline|FF-VEP=full-field visual evoked potentials|participants|Number|67|67.0||||||
3827090|NCT01721161|3653391|B2|No FF-VEP conduction block||FF-VEP conduction block in the affected eye at baseline|FF-VEP=full-field visual evoked potentials|participants|Number|31|31.0||||||
3827091|NCT01721161|3653392|B1|No FF-VEP conduction block||FF-VEP conduction block in the affected eye at baseline|FF-VEP=full-field visual evoked potentials|participants|Number|36|36.0||||||
3827092|NCT01721161|3653390|B3|FF-VEP conduction block||FF-VEP conduction block in the affected eye at baseline|FF-VEP=full-field visual evoked potentials|participants|Number|15|15.0||||||
3827093|NCT01721161|3653391|B2|FF-VEP conduction block||FF-VEP conduction block in the affected eye at baseline|FF-VEP=full-field visual evoked potentials|participants|Number|10|10.0||||||
3827094|NCT01721161|3653392|B1|FF-VEP conduction block||FF-VEP conduction block in the affected eye at baseline|FF-VEP=full-field visual evoked potentials|participants|Number|5|5.0||||||
3827095|NCT01721161|3653390|B3|Relative afferent pupillary defect||AON signs and symptoms at screening or baseline|Symptoms were not uniformly tested in accordance with a predefined protocol.|participants|Number|63|63.0||||||
3827096|NCT01721161|3653391|B2|Relative afferent pupillary defect||AON signs and symptoms at screening or baseline|Symptoms were not uniformly tested in accordance with a predefined protocol.|participants|Number|30|30.0||||||
3827097|NCT01721161|3653392|B1|Relative afferent pupillary defect||AON signs and symptoms at screening or baseline|Symptoms were not uniformly tested in accordance with a predefined protocol.|participants|Number|33|33.0||||||
3827098|NCT01721161|3653390|B3|Swollen optic disc||AON signs and symptoms at screening or baseline|Symptoms were not uniformly tested in accordance with a predefined protocol.|participants|Number|20|20.0||||||
3827099|NCT01721161|3653391|B2|Swollen optic disc||AON signs and symptoms at screening or baseline|Symptoms were not uniformly tested in accordance with a predefined protocol.|participants|Number|12|12.0||||||
3827100|NCT01721161|3653392|B1|Swollen optic disc||AON signs and symptoms at screening or baseline|Symptoms were not uniformly tested in accordance with a predefined protocol.|participants|Number|8|8.0||||||
3827101|NCT01721161|3653390|B3|Uhthoff's symptom||AON signs and symptoms at screening or baseline|Symptoms were not uniformly tested in accordance with a predefined protocol.|participants|Number|26|26.0||||||
3827102|NCT01721161|3653391|B2|Uhthoff's symptom||AON signs and symptoms at screening or baseline|Symptoms were not uniformly tested in accordance with a predefined protocol.|participants|Number|18|18.0||||||
3827103|NCT01721161|3653392|B1|Uhthoff's symptom||AON signs and symptoms at screening or baseline|Symptoms were not uniformly tested in accordance with a predefined protocol.|participants|Number|8|8.0||||||
3827104|NCT01721161|3653390|B3|Color desaturation||AON signs and symptoms at screening or baseline|Symptoms were not uniformly tested in accordance with a predefined protocol.|participants|Number|65|65.0||||||
3827105|NCT01721161|3653391|B2|Color desaturation||AON signs and symptoms at screening or baseline|Symptoms were not uniformly tested in accordance with a predefined protocol.|participants|Number|32|32.0||||||
3827106|NCT01721161|3653392|B1|Color desaturation||AON signs and symptoms at screening or baseline|Symptoms were not uniformly tested in accordance with a predefined protocol.|participants|Number|33|33.0||||||
3827107|NCT01721161|3653390|B3|Visual field defect||AON signs and symptoms at screening or baseline|Symptoms were not uniformly tested in accordance with a predefined protocol.|participants|Number|63|63.0||||||
3827108|NCT01721161|3653391|B2|Visual field defect||AON signs and symptoms at screening or baseline|Symptoms were not uniformly tested in accordance with a predefined protocol.|participants|Number|34|34.0||||||
3827109|NCT01721161|3653392|B1|Visual field defect||AON signs and symptoms at screening or baseline|Symptoms were not uniformly tested in accordance with a predefined protocol.|participants|Number|29|29.0||||||
3827110|NCT01721161|3653390|B3|Not specified||Criteria for AON diagnosis||participants|Number|9|9.0||||||
3827111|NCT01721161|3653391|B2|Not specified||Criteria for AON diagnosis||participants|Number|4|4.0||||||
3827112|NCT01721161|3653392|B1|Not specified||Criteria for AON diagnosis||participants|Number|5|5.0||||||
3827113|NCT01721161|3653390|B3|Ocular pain||Criteria for AON diagnosis||participants|Number|67|67.0||||||
3827114|NCT01721161|3653391|B2|Ocular pain||Criteria for AON diagnosis||participants|Number|36|36.0||||||
3827115|NCT01721161|3653392|B1|Ocular pain||Criteria for AON diagnosis||participants|Number|31|31.0||||||
3827116|NCT01721161|3653390|B3|Visual field defect||Criteria for AON diagnosis||participants|Number|69|69.0||||||
3827117|NCT01721161|3653391|B2|Visual field defect||Criteria for AON diagnosis||participants|Number|37|37.0||||||
3827118|NCT01721161|3653392|B1|Visual field defect||Criteria for AON diagnosis||participants|Number|32|32.0||||||
3827119|NCT01721161|3653390|B3|Relative afferent pupillary defect||Criteria for AON diagnosis||participants|Number|65|65.0||||||
3827120|NCT01721161|3653391|B2|Relative afferent pupillary defect||Criteria for AON diagnosis||participants|Number|31|31.0||||||
3827121|NCT01721161|3653392|B1|Relative afferent pupillary defect||Criteria for AON diagnosis||participants|Number|34|34.0||||||
3827122|NCT01721161|3653390|B3|Decreased color vision||Criteria for AON diagnosis||participants|Number|63|63.0||||||
3827123|NCT01721161|3653391|B2|Decreased color vision||Criteria for AON diagnosis||participants|Number|33|33.0||||||
3827124|NCT01721161|3653392|B1|Decreased color vision||Criteria for AON diagnosis||participants|Number|30|30.0||||||
3827125|NCT01721161|3653390|B3|Decreased visual acuity||Criteria for AON diagnosis||participants|Number|77|77.0||||||
3827126|NCT01721161|3653391|B2|Decreased visual acuity||Criteria for AON diagnosis||participants|Number|41|41.0||||||
3827127|NCT01721161|3653392|B1|Decreased visual acuity||Criteria for AON diagnosis||participants|Number|36|36.0||||||
3827128|NCT01721161|3653390|B3|Left eye||Affected eye||participants|Number|38|38.0||||||
3827129|NCT01721161|3653391|B2|Left eye||Affected eye||participants|Number|16|16.0||||||
3827130|NCT01721161|3653392|B1|Left eye||Affected eye||participants|Number|22|22.0||||||
3827131|NCT01721161|3653390|B3|Right eye||Affected eye||participants|Number|44|44.0||||||
3827132|NCT01721161|3653391|B2|Right eye||Affected eye||participants|Number|25|25.0||||||
3827133|NCT01721161|3653392|B1|Right eye||Affected eye||participants|Number|19|19.0||||||
3827134|NCT01721161|3653390|B3|||Days from confirmed AON diagnosis to first dose||days|Mean|19.0|19.0|Standard Deviation|4.8|4.8|||
3827135|NCT01721161|3653391|B2|||Days from confirmed AON diagnosis to first dose||days|Mean|18.7|18.7|Standard Deviation|4.7|4.7|||
3827136|NCT01721161|3653392|B1|||Days from confirmed AON diagnosis to first dose||days|Mean|19.2|19.2|Standard Deviation|4.9|4.9|||
3827137|NCT01721161|3653390|B3|||Days from first AON symptom to first dose|First dose given, on average, 2 weeks after completion of high-dose (1 g daily for 3 to 5 days) IV methylprednisolone treatment.|days|Mean|24.1|24.1|Standard Deviation|3.7|3.7|||
3827138|NCT01721161|3653391|B2|||Days from first AON symptom to first dose|First dose given, on average, 2 weeks after completion of high-dose (1 g daily for 3 to 5 days) IV methylprednisolone treatment.|days|Mean|23.6|23.6|Standard Deviation|4.0|4.0|||
3827139|NCT01721161|3653392|B1|||Days from first AON symptom to first dose|First dose given, on average, 2 weeks after completion of high-dose (1 g daily for 3 to 5 days) IV methylprednisolone treatment.|days|Mean|24.6|24.6|Standard Deviation|3.4|3.4|||
3827140|NCT01721161|3653390|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3827141|NCT01721161|3653391|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3827142|NCT01721161|3653392|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3827143|NCT01721161|3653390|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3827144|NCT01721161|3653391|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3827145|NCT01721161|3653392|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3827146|NCT01721161|3653390|B3|||Age||years|Mean|32.1|32.1|Standard Deviation|8.01|8.01|||
3827147|NCT01721161|3653391|B2|||Age||years|Mean|31.8|31.8|Standard Deviation|7.17|7.17|||
3827148|NCT01721161|3653392|B1|||Age||years|Mean|32.4|32.4|Standard Deviation|8.85|8.85|||
3827149|NCT01721109|3653416|B1||≥ 500 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|10|10.0||||||
3827150|NCT01721109|3653416|B1||350 ≥ and ≤ 499 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|22|22.0||||||
3827151|NCT01721109|3653416|B1||200 ≥ and ≤ 349 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|16|16.0||||||
3827152|NCT01721109|3653416|B1||≤ 199 cells/µL|CD4 Cell Count Category||Participants|Count of Participants|2|2.0||||||
3827153|NCT01721109|3653416|B1|||CD4 Cell Count||cells/µL|Mean|399|399.0|Standard Deviation|127.6|127.6|||
3827154|NCT01721109|3653416|B1||> 100,000 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|10|10.0||||||
3827155|NCT01721109|3653416|B1||≤ 100,000 copies/mL|HIV-1 RNA Category||Participants|Count of Participants|40|40.0||||||
3827156|NCT01721109|3653416|B1|||HIV-1 RNA||log10 copies/mL|Mean|4.60|4.6|Standard Deviation|0.551|0.551|||
3827157|NCT01721109|3653416|B1|Thailand||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3827158|NCT01721109|3653416|B1|South Africa||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3827159|NCT01721109|3653416|B1|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3827160|NCT01721109|3653416|B1||Not Permitted|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3827161|NCT01721109|3653416|B1||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
3827162|NCT01721109|3653416|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3827163|NCT01721109|3653416|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3827164|NCT01721109|3653416|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3827165|NCT01721109|3653416|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3827166|NCT01721109|3653416|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3827167|NCT01721109|3653416|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3827168|NCT01721109|3653416|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3827169|NCT01721109|3653416|B1|||Age||years|Mean|15|15.0|Standard Deviation|1.5|1.5|||
3827170|NCT01721096|3653429|B3|Japan||Region of Enrollment||Participants|Count of Participants|536|536.0||||||
3827339|NCT01721057|3653592|B1||Female|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
3827171|NCT01721096|3653430|B2|Japan||Region of Enrollment||Participants|Count of Participants|213|213.0||||||
3827172|NCT01721096|3653431|B1|Japan||Region of Enrollment||Participants|Count of Participants|323|323.0||||||
3827173|NCT01721096|3653429|B3||Male|Sex: Female, Male||Participants|Count of Participants|431|431.0||||||
3827174|NCT01721096|3653430|B2||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3827175|NCT01721096|3653431|B1||Male|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
3827176|NCT01721096|3653429|B3||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3827177|NCT01721096|3653430|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3827178|NCT01721096|3653431|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3827179|NCT01721096|3653429|B3|||Age||years|Mean|68.8|68.8|Standard Deviation|10.6|10.6|||
3827180|NCT01721096|3653430|B2|||Age||years|Mean|69.1|69.1|Standard Deviation|10.4|10.4|||
3827181|NCT01721096|3653431|B1|||Age||years|Mean|68.6|68.6|Standard Deviation|10.7|10.7|||
3827182|NCT01721070|3653581|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3827183|NCT01721070|3653581|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3827184|NCT01721070|3653581|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3827185|NCT01721070|3653581|B1||>=65 years|Age|Subjects must have been between 18 and 45 years of age, inclusive|Participants|Count of Participants|0|0.0||||||
3827186|NCT01721070|3653581|B1||Between 18 and 65 years|Age|Subjects must have been between 18 and 45 years of age, inclusive|Participants|Count of Participants|19|19.0||||||
3827187|NCT01721070|3653581|B1||<=18 years|Age|Subjects must have been between 18 and 45 years of age, inclusive|Participants|Count of Participants|0|0.0||||||
3827188|NCT01721057|3653589|B4|||High Sensitivity C-Reactive Protein (hsCRP)||milligram per Liter (mg/L)|Mean|16.7|16.7|Standard Deviation|19.1|19.1|||
3827189|NCT01721057|3653590|B3|||High Sensitivity C-Reactive Protein (hsCRP)||milligram per Liter (mg/L)|Mean|14.2|14.2|Standard Deviation|14.5|14.5|||
3827190|NCT01721057|3653591|B2|||High Sensitivity C-Reactive Protein (hsCRP)||milligram per Liter (mg/L)|Mean|18.2|18.2|Standard Deviation|21.5|21.5|||
3827191|NCT01721057|3653592|B1|||High Sensitivity C-Reactive Protein (hsCRP)||milligram per Liter (mg/L)|Mean|17.7|17.7|Standard Deviation|20.4|20.4|||
3827192|NCT01721057|3653589|B4|||Swollen Joint Count of 66 Evaluable Joints||Number of Joints|Mean|13.4|13.4|Standard Deviation|7.6|7.6|||
3827193|NCT01721057|3653590|B3|||Swollen Joint Count of 66 Evaluable Joints||Number of Joints|Mean|13.5|13.5|Standard Deviation|6.9|6.9|||
3827194|NCT01721057|3653591|B2|||Swollen Joint Count of 66 Evaluable Joints||Number of Joints|Mean|13.6|13.6|Standard Deviation|8.7|8.7|||
3827195|NCT01721057|3653592|B1|||Swollen Joint Count of 66 Evaluable Joints||Number of Joints|Mean|13.1|13.1|Standard Deviation|7.2|7.2|||
3827196|NCT01721057|3653589|B4|||Tender Joint Count of 68 Evaluable Joints||Number of Joints|Mean|24.0|24.0|Standard Deviation|14.3|14.3|||
3827197|NCT01721057|3653590|B3|||Tender Joint Count of 68 Evaluable Joints||Number of Joints|Mean|24.3|24.3|Standard Deviation|14.0|14.0|||
3827198|NCT01721057|3653591|B2|||Tender Joint Count of 68 Evaluable Joints||Number of Joints|Mean|23.5|23.5|Standard Deviation|14.1|14.1|||
3827199|NCT01721057|3653592|B1|||Tender Joint Count of 68 Evaluable Joints||Number of Joints|Mean|24.3|24.3|Standard Deviation|15.0|15.0|||
3827200|NCT01721057|3653589|B4|||Duration of Rheumatoid Arthritis||years|Mean|7.5|7.5|Standard Deviation|7.6|7.6|||
3827201|NCT01721057|3653590|B3|||Duration of Rheumatoid Arthritis||years|Mean|7.7|7.7|Standard Deviation|7.9|7.9|||
3827202|NCT01721057|3653591|B2|||Duration of Rheumatoid Arthritis||years|Mean|7.6|7.6|Standard Deviation|7.6|7.6|||
3827203|NCT01721057|3653592|B1|||Duration of Rheumatoid Arthritis||years|Mean|7.2|7.2|Standard Deviation|7.5|7.5|||
3827204|NCT01721057|3653589|B4|United States||Region of Enrollment||Participants|Count of Participants|176|176.0||||||
3827205|NCT01721057|3653590|B3|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3827206|NCT01721057|3653591|B2|United States||Region of Enrollment||Participants|Count of Participants|58|58.0||||||
3827207|NCT01721057|3653592|B1|United States||Region of Enrollment||Participants|Count of Participants|58|58.0||||||
3827208|NCT01721057|3653589|B4|United Kingdom||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3827209|NCT01721057|3653590|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3827210|NCT01721057|3653591|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3827211|NCT01721057|3653592|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3827212|NCT01721057|3653589|B4|Taiwan||Region of Enrollment||Participants|Count of Participants|82|82.0||||||
3827213|NCT01721057|3653590|B3|Taiwan||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3827214|NCT01721057|3653591|B2|Taiwan||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3827215|NCT01721057|3653592|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3827216|NCT01721057|3653589|B4|Spain||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3827217|NCT01721057|3653590|B3|Spain||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3827218|NCT01721057|3653591|B2|Spain||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3827219|NCT01721057|3653592|B1|Spain||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3827220|NCT01721057|3653589|B4|Slovakia||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3827221|NCT01721057|3653590|B3|Slovakia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3827222|NCT01721057|3653591|B2|Slovakia||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3827223|NCT01721057|3653592|B1|Slovakia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3827224|NCT01721057|3653589|B4|Russian Federation||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3827225|NCT01721057|3653590|B3|Russian Federation||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3827226|NCT01721057|3653591|B2|Russian Federation||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3827227|NCT01721057|3653592|B1|Russian Federation||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3827228|NCT01721057|3653589|B4|Romania||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3827229|NCT01721057|3653590|B3|Romania||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3827230|NCT01721057|3653591|B2|Romania||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3827231|NCT01721057|3653592|B1|Romania||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3827232|NCT01721057|3653589|B4|Portugal||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3827233|NCT01721057|3653590|B3|Portugal||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3827234|NCT01721057|3653591|B2|Portugal||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3827235|NCT01721057|3653592|B1|Portugal||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3827236|NCT01721057|3653589|B4|Poland||Region of Enrollment||Participants|Count of Participants|51|51.0||||||
3827237|NCT01721057|3653590|B3|Poland||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3827238|NCT01721057|3653591|B2|Poland||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3827239|NCT01721057|3653592|B1|Poland||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3827240|NCT01721057|3653589|B4|Mexico||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3827241|NCT01721057|3653590|B3|Mexico||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3827242|NCT01721057|3653591|B2|Mexico||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3827243|NCT01721057|3653592|B1|Mexico||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3827244|NCT01721057|3653589|B4|Korea, Republic of||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3827245|NCT01721057|3653590|B3|Korea, Republic of||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3827246|NCT01721057|3653591|B2|Korea, Republic of||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3827247|NCT01721057|3653592|B1|Korea, Republic of||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3827248|NCT01721057|3653589|B4|Japan||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3827249|NCT01721057|3653590|B3|Japan||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3827250|NCT01721057|3653591|B2|Japan||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3827251|NCT01721057|3653592|B1|Japan||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3827252|NCT01721057|3653589|B4|Italy||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3827253|NCT01721057|3653590|B3|Italy||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3827254|NCT01721057|3653591|B2|Italy||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3827255|NCT01721057|3653592|B1|Italy||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3827256|NCT01721057|3653589|B4|India||Region of Enrollment||Participants|Count of Participants|58|58.0||||||
3827257|NCT01721057|3653590|B3|India||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3827258|NCT01721057|3653591|B2|India||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3827259|NCT01721057|3653592|B1|India||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3827260|NCT01721057|3653589|B4|Hungary||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3827261|NCT01721057|3653590|B3|Hungary||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3827262|NCT01721057|3653591|B2|Hungary||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3827263|NCT01721057|3653592|B1|Hungary||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3827264|NCT01721057|3653589|B4|Germany||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3827265|NCT01721057|3653590|B3|Germany||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3827266|NCT01721057|3653591|B2|Germany||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3827267|NCT01721057|3653592|B1|Germany||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3827268|NCT01721057|3653589|B4|Czech Republic||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3827269|NCT01721057|3653590|B3|Czech Republic||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3827270|NCT01721057|3653591|B2|Czech Republic||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3827271|NCT01721057|3653592|B1|Czech Republic||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3827272|NCT01721057|3653589|B4|Croatia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3827273|NCT01721057|3653590|B3|Croatia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3827274|NCT01721057|3653591|B2|Croatia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3827275|NCT01721057|3653592|B1|Croatia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3827276|NCT01721057|3653589|B4|Canada||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3827277|NCT01721057|3653590|B3|Canada||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3827278|NCT01721057|3653591|B2|Canada||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3827279|NCT01721057|3653592|B1|Canada||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3827280|NCT01721057|3653589|B4|Belgium||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3827281|NCT01721057|3653590|B3|Belgium||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3827282|NCT01721057|3653591|B2|Belgium||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3827283|NCT01721057|3653592|B1|Belgium||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3827284|NCT01721057|3653589|B4|Australia||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3827285|NCT01721057|3653590|B3|Australia||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3827286|NCT01721057|3653591|B2|Australia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3827287|NCT01721057|3653592|B1|Australia||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3827288|NCT01721057|3653589|B4|Argentina||Region of Enrollment||Participants|Count of Participants|64|64.0||||||
3827289|NCT01721057|3653590|B3|Argentina||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3827290|NCT01721057|3653591|B2|Argentina||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3827291|NCT01721057|3653592|B1|Argentina||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3827292|NCT01721057|3653589|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3827293|NCT01721057|3653590|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3827294|NCT01721057|3653591|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827295|NCT01721057|3653592|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827296|NCT01721057|3653589|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3827297|NCT01721057|3653590|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3827298|NCT01721057|3653591|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3827299|NCT01721057|3653592|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3827300|NCT01721057|3653589|B4||White|Race (NIH/OMB)||Participants|Count of Participants|457|457.0||||||
3827301|NCT01721057|3653590|B3||White|Race (NIH/OMB)||Participants|Count of Participants|148|148.0||||||
3827302|NCT01721057|3653591|B2||White|Race (NIH/OMB)||Participants|Count of Participants|156|156.0||||||
3827303|NCT01721057|3653592|B1||White|Race (NIH/OMB)||Participants|Count of Participants|153|153.0||||||
3827304|NCT01721057|3653589|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3827305|NCT01721057|3653590|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3827306|NCT01721057|3653591|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3827307|NCT01721057|3653592|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3827308|NCT01721057|3653589|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3827309|NCT01721057|3653590|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827310|NCT01721057|3653591|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827311|NCT01721057|3653592|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3827312|NCT01721057|3653589|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|180|180.0||||||
3827313|NCT01721057|3653590|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3827314|NCT01721057|3653591|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3827315|NCT01721057|3653592|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3827316|NCT01721057|3653589|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3827317|NCT01721057|3653590|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3827318|NCT01721057|3653591|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3827319|NCT01721057|3653592|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3827320|NCT01721057|3653589|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|509|509.0||||||
3827321|NCT01721057|3653590|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
3827322|NCT01721057|3653591|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|171|171.0||||||
3827323|NCT01721057|3653592|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|171|171.0||||||
3827324|NCT01721057|3653589|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
3827325|NCT01721057|3653590|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3827326|NCT01721057|3653591|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3827327|NCT01721057|3653592|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3827328|NCT01721057|3653589|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3827329|NCT01721057|3653590|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3827330|NCT01721057|3653591|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3827331|NCT01721057|3653592|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3827332|NCT01721057|3653589|B4||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3827333|NCT01721057|3653590|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3827334|NCT01721057|3653591|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3827335|NCT01721057|3653592|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3827336|NCT01721057|3653589|B4||Female|Sex: Female, Male||Participants|Count of Participants|560|560.0||||||
3827337|NCT01721057|3653590|B3||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
3827338|NCT01721057|3653591|B2||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3827340|NCT01721057|3653589|B4|||Age||years|Mean|51.8|51.8|Standard Deviation|12.3|12.3|||
3827341|NCT01721057|3653590|B3|||Age||years|Mean|51.8|51.8|Standard Deviation|12.1|12.1|||
3827342|NCT01721057|3653591|B2|||Age||years|Mean|52.2|52.2|Standard Deviation|12.3|12.3|||
3827343|NCT01721057|3653592|B1|||Age||years|Mean|51.4|51.4|Standard Deviation|12.5|12.5|||
3827344|NCT01721044|3653668|B4|||High Sensitivity C-Reactive Protein (hsCRP)||milligrams/liter (mg/L)|Mean|20.09|20.09|Standard Deviation|24.19|24.19|||
3827345|NCT01721044|3653669|B3|||High Sensitivity C-Reactive Protein (hsCRP)||milligrams/liter (mg/L)|Mean|19.76|19.76|Standard Deviation|24.84|24.84|||
3827346|NCT01721044|3653670|B2|||High Sensitivity C-Reactive Protein (hsCRP)||milligrams/liter (mg/L)|Mean|19.87|19.87|Standard Deviation|22.48|22.48|||
3827347|NCT01721044|3653671|B1|||High Sensitivity C-Reactive Protein (hsCRP)||milligrams/liter (mg/L)|Mean|20.64|20.64|Standard Deviation|25.26|25.26|||
3827348|NCT01721044|3653668|B4|||Swollen Joint Count of 66 Evaluable Joints||Number of Joints|Mean|17.4|17.4|Standard Deviation|10.8|10.8|||
3827349|NCT01721044|3653669|B3|||Swollen Joint Count of 66 Evaluable Joints||Number of Joints|Mean|16.3|16.3|Standard Deviation|8.9|8.9|||
3827350|NCT01721044|3653670|B2|||Swollen Joint Count of 66 Evaluable Joints||Number of Joints|Mean|18.6|18.6|Standard Deviation|12.3|12.3|||
3827351|NCT01721044|3653671|B1|||Swollen Joint Count of 66 Evaluable Joints||Number of Joints|Mean|17.2|17.2|Standard Deviation|10.8|10.8|||
3827352|NCT01721044|3653668|B4|||Tender Joint Count of 68 Evaluable Joints||Number of Joints|Mean|29.1|29.1|Standard Deviation|16.1|16.1|||
3827353|NCT01721044|3653669|B3|||Tender Joint Count of 68 Evaluable Joints||Number of Joints|Mean|28.1|28.1|Standard Deviation|15.6|15.6|||
3827354|NCT01721044|3653670|B2|||Tender Joint Count of 68 Evaluable Joints||Number of Joints|Mean|31.0|31.0|Standard Deviation|16.3|16.3|||
3827355|NCT01721044|3653671|B1|||Tender Joint Count of 68 Evaluable Joints||Number of Joints|Mean|28.3|28.3|Standard Deviation|16.4|16.4|||
3827356|NCT01721044|3653668|B4|||Duration of Rheumatoid Arthritis|Time from Symptom Onset of Rheumatoid Arthritis|Years|Mean|14.0|14.0|Standard Deviation|9.0|9.0|||
3827357|NCT01721044|3653669|B3|||Duration of Rheumatoid Arthritis|Time from Symptom Onset of Rheumatoid Arthritis|Years|Mean|14.3|14.3|Standard Deviation|9.4|9.4|||
3827358|NCT01721044|3653670|B2|||Duration of Rheumatoid Arthritis|Time from Symptom Onset of Rheumatoid Arthritis|Years|Mean|13.7|13.7|Standard Deviation|8.0|8.0|||
3827359|NCT01721044|3653671|B1|||Duration of Rheumatoid Arthritis|Time from Symptom Onset of Rheumatoid Arthritis|Years|Mean|14.0|14.0|Standard Deviation|9.6|9.6|||
3827360|NCT01721044|3653668|B4|United States||Region of Enrollment||Participants|Count of Participants|226|226.0||||||
3827361|NCT01721044|3653669|B3|United States||Region of Enrollment||Participants|Count of Participants|75|75.0||||||
3827362|NCT01721044|3653670|B2|United States||Region of Enrollment||Participants|Count of Participants|74|74.0||||||
3827363|NCT01721044|3653671|B1|United States||Region of Enrollment||Participants|Count of Participants|77|77.0||||||
3827364|NCT01721044|3653668|B4|United Kingdom||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3827365|NCT01721044|3653669|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3827366|NCT01721044|3653670|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3827367|NCT01721044|3653671|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3827368|NCT01721044|3653668|B4|Turkey||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3827369|NCT01721044|3653669|B3|Turkey||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3827370|NCT01721044|3653670|B2|Turkey||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3827371|NCT01721044|3653671|B1|Turkey||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3827372|NCT01721044|3653668|B4|Switzerland||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3827373|NCT01721044|3653669|B3|Switzerland||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3827374|NCT01721044|3653670|B2|Switzerland||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3827375|NCT01721044|3653671|B1|Switzerland||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3827376|NCT01721044|3653668|B4|Spain||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3827377|NCT01721044|3653669|B3|Spain||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3827378|NCT01721044|3653670|B2|Spain||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3827379|NCT01721044|3653671|B1|Spain||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3827380|NCT01721044|3653668|B4|South Korea||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3827381|NCT01721044|3653669|B3|South Korea||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3827382|NCT01721044|3653670|B2|South Korea||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3827383|NCT01721044|3653671|B1|South Korea||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3827384|NCT01721044|3653668|B4|Poland||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3827385|NCT01721044|3653669|B3|Poland||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3827386|NCT01721044|3653670|B2|Poland||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3827387|NCT01721044|3653671|B1|Poland||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3827388|NCT01721044|3653668|B4|Netherlands||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3827389|NCT01721044|3653669|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3827390|NCT01721044|3653670|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3827391|NCT01721044|3653671|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3827392|NCT01721044|3653668|B4|Mexico||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3827393|NCT01721044|3653669|B3|Mexico||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3827394|NCT01721044|3653670|B2|Mexico||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3827395|NCT01721044|3653671|B1|Mexico||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3827396|NCT01721044|3653668|B4|Japan||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3827397|NCT01721044|3653669|B3|Japan||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3827398|NCT01721044|3653670|B2|Japan||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3827399|NCT01721044|3653671|B1|Japan||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3827400|NCT01721044|3653668|B4|Italy||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3827401|NCT01721044|3653669|B3|Italy||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3827402|NCT01721044|3653670|B2|Italy||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3827403|NCT01721044|3653671|B1|Italy||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3827404|NCT01721044|3653668|B4|Israel||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3827405|NCT01721044|3653669|B3|Israel||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3827406|NCT01721044|3653670|B2|Israel||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3827407|NCT01721044|3653671|B1|Israel||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3827408|NCT01721044|3653668|B4|Greece||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3827409|NCT01721044|3653669|B3|Greece||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3827410|NCT01721044|3653670|B2|Greece||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3827411|NCT01721044|3653671|B1|Greece||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3827412|NCT01721044|3653668|B4|Germany||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3827413|NCT01721044|3653669|B3|Germany||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3827414|NCT01721044|3653670|B2|Germany||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3827415|NCT01721044|3653671|B1|Germany||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3827416|NCT01721044|3653668|B4|France||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3827417|NCT01721044|3653669|B3|France||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3827418|NCT01721044|3653670|B2|France||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3827419|NCT01721044|3653671|B1|France||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3827420|NCT01721044|3653668|B4|Denmark||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3827421|NCT01721044|3653669|B3|Denmark||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3827422|NCT01721044|3653670|B2|Denmark||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3827423|NCT01721044|3653671|B1|Denmark||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3827424|NCT01721044|3653668|B4|Canada||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3827425|NCT01721044|3653669|B3|Canada||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3827426|NCT01721044|3653670|B2|Canada||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3827427|NCT01721044|3653671|B1|Canada||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3827428|NCT01721044|3653668|B4|Belgium||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3827429|NCT01721044|3653669|B3|Belgium||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3827430|NCT01721044|3653670|B2|Belgium||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3827431|NCT01721044|3653671|B1|Belgium||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3827432|NCT01721044|3653668|B4|Austria||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3827433|NCT01721044|3653669|B3|Austria||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3827434|NCT01721044|3653670|B2|Austria||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3827435|NCT01721044|3653671|B1|Austria||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3827436|NCT01721044|3653668|B4|Australia||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3827437|NCT01721044|3653669|B3|Australia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3827438|NCT01721044|3653670|B2|Australia||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3827439|NCT01721044|3653671|B1|Australia||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3827440|NCT01721044|3653668|B4|Argentina||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3827441|NCT01721044|3653669|B3|Argentina||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3827442|NCT01721044|3653670|B2|Argentina||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3827443|NCT01721044|3653671|B1|Argentina||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3827444|NCT01721044|3653668|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3827445|NCT01721044|3653669|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3827446|NCT01721044|3653670|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827447|NCT01721044|3653671|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827448|NCT01721044|3653668|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3827449|NCT01721044|3653669|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827450|NCT01721044|3653670|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827451|NCT01721044|3653671|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3827452|NCT01721044|3653668|B4||White|Race (NIH/OMB)||Participants|Count of Participants|435|435.0||||||
3827453|NCT01721044|3653669|B3||White|Race (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
3827454|NCT01721044|3653670|B2||White|Race (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
3827455|NCT01721044|3653671|B1||White|Race (NIH/OMB)||Participants|Count of Participants|147|147.0||||||
3827456|NCT01721044|3653668|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3827457|NCT01721044|3653669|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3827458|NCT01721044|3653670|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3827459|NCT01721044|3653671|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3827460|NCT01721044|3653668|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827461|NCT01721044|3653669|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827462|NCT01721044|3653670|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827463|NCT01721044|3653671|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827464|NCT01721044|3653668|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3827465|NCT01721044|3653669|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3827466|NCT01721044|3653670|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3827467|NCT01721044|3653671|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3827468|NCT01721044|3653668|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3827469|NCT01721044|3653669|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3827470|NCT01721044|3653670|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3827471|NCT01721044|3653671|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3827472|NCT01721044|3653668|B4||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3827473|NCT01721044|3653669|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3827474|NCT01721044|3653670|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3827475|NCT01721044|3653671|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3827476|NCT01721044|3653668|B4||Female|Sex: Female, Male||Participants|Count of Participants|431|431.0||||||
3827477|NCT01721044|3653669|B3||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3827478|NCT01721044|3653670|B2||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3827479|NCT01721044|3653671|B1||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3827480|NCT01721044|3653668|B4|||Age||Years|Mean|55.7|55.7|Standard Deviation|11.0|11.0|||
3827481|NCT01721044|3653669|B3|||Age||Years|Mean|55.9|55.9|Standard Deviation|11.3|11.3|||
3827482|NCT01721044|3653670|B2|||Age||Years|Mean|55.1|55.1|Standard Deviation|11.1|11.1|||
3827483|NCT01721044|3653671|B1|||Age||Years|Mean|56.0|56.0|Standard Deviation|10.7|10.7|||
3827484|NCT01720797|3653744|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
3827485|NCT01720797|3653745|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3827486|NCT01720797|3653746|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3827487|NCT01720797|3653744|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3827488|NCT01720797|3653745|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3827489|NCT01720797|3653746|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3827490|NCT01720797|3653744|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3827491|NCT01720797|3653745|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3827492|NCT01720797|3653746|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3827493|NCT01720797|3653744|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3827494|NCT01720797|3653745|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3827495|NCT01720797|3653746|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3827496|NCT01720797|3653744|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3827497|NCT01720797|3653745|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3827498|NCT01720797|3653746|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3827499|NCT01720797|3653744|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3827500|NCT01720797|3653745|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3827501|NCT01720797|3653746|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3827502|NCT01720602|3653753|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3827503|NCT01720602|3653753|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3827504|NCT01720602|3653753|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3827505|NCT01720602|3653753|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3827506|NCT01720602|3653753|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3827507|NCT01720446|3653759|B5|||Free fatty acids||mmol/L|Geometric Mean|0.82|0.82|Full Range|||0.04|4.22|
3827508|NCT01720446|3653760|B4|||Free fatty acids||mmol/L|Geometric Mean|0.81|0.81|Full Range|||0.04|4.22|
3827509|NCT01720446|3653761|B3|||Free fatty acids||mmol/L|Geometric Mean|0.83|0.83|Full Range|||0.04|3.34|
3827510|NCT01720446|3653762|B2|||Free fatty acids||mmol/L|Geometric Mean|0.80|0.8|Full Range|||0.04|4.2|
3827511|NCT01720446|3653763|B1|||Free fatty acids||mmol/L|Geometric Mean|0.83|0.83|Full Range|||0.04|3.82|
3827512|NCT01720446|3653759|B5|||Triglycerides||mg/dL|Geometric Mean|161.96|161.96|Full Range|||10.68|3378.44|
3827513|NCT01720446|3653760|B4|||Triglycerides||mg/dL|Geometric Mean|163.00|163.0|Full Range|||35.6|2435.93|
3827514|NCT01720446|3653761|B3|||Triglycerides||mg/dL|Geometric Mean|162.30|162.3|Full Range|||30.26|1438.24|
3827515|NCT01720446|3653762|B2|||Triglycerides||mg/dL|Geometric Mean|158.93|158.93|Full Range|||10.68|3378.44|
3827516|NCT01720446|3653763|B1|||Triglycerides||mg/dL|Geometric Mean|163.66|163.66|Full Range|||27.59|1913.5|
3827517|NCT01720446|3653759|B5|||Total cholesterol||mg/dL|Geometric Mean|165.17|165.17|Full Range|||64.86|632.43|
3827518|NCT01720446|3653760|B4|||Total cholesterol||mg/dL|Geometric Mean|165.97|165.97|Full Range|||64.86|537.07|
3827519|NCT01720446|3653761|B3|||Total cholesterol||mg/dL|Geometric Mean|164.38|164.38|Full Range|||70.27|378.38|
3827520|NCT01720446|3653762|B2|||Total cholesterol||mg/dL|Geometric Mean|164.96|164.96|Full Range|||79.54|562.16|
3827521|NCT01720446|3653763|B1|||Total cholesterol||mg/dL|Geometric Mean|165.38|165.38|Full Range|||65.25|632.43|
3827522|NCT01720446|3653759|B5|||Pulse rate||beats/min|Mean|72.05|72.05|Standard Deviation|10.91|10.91|||
3827523|NCT01720446|3653760|B4|||Pulse rate||beats/min|Mean|71.95|71.95|Standard Deviation|10.92|10.92|||
3827524|NCT01720446|3653761|B3|||Pulse rate||beats/min|Mean|72.01|72.01|Standard Deviation|10.62|10.62|||
3827525|NCT01720446|3653762|B2|||Pulse rate||beats/min|Mean|71.53|71.53|Standard Deviation|10.86|10.86|||
3827526|NCT01720446|3653763|B1|||Pulse rate||beats/min|Mean|72.69|72.69|Standard Deviation|11.22|11.22|||
3827527|NCT01720446|3653759|B5|||Diastolic BP||mmHg|Mean|77.05|77.05|Standard Deviation|10.02|10.02|||
3827528|NCT01720446|3653760|B4|||Diastolic BP||mmHg|Mean|76.66|76.66|Standard Deviation|10.21|10.21|||
3827529|NCT01720446|3653761|B3|||Diastolic BP||mmHg|Mean|77.54|77.54|Standard Deviation|9.85|9.85|||
3827530|NCT01720446|3653762|B2|||Diastolic BP||mmHg|Mean|76.88|76.88|Standard Deviation|10.21|10.21|||
3827531|NCT01720446|3653763|B1|||Diastolic BP||mmHg|Mean|77.10|77.1|Standard Deviation|9.78|9.78|||
3827532|NCT01720446|3653759|B5|||Systolic BP||mmHg|Mean|135.6|135.6|Standard Deviation|17.15|17.15|||
3827533|NCT01720446|3653760|B4|||Systolic BP||mmHg|Mean|134.8|134.8|Standard Deviation|17.45|17.45|||
3827534|NCT01720446|3653761|B3|||Systolic BP||mmHg|Mean|135.8|135.8|Standard Deviation|16.16|16.16|||
3827535|NCT01720446|3653762|B2|||Systolic BP||mmHg|Mean|135.8|135.8|Standard Deviation|16.96|16.96|||
3827536|NCT01720446|3653763|B1|||Systolic BP||mmHg|Mean|136.1|136.1|Standard Deviation|17.97|17.97|||
3827537|NCT01720446|3653759|B5|||HDL-cholesterol||mg/dL|Mean|45.33|45.33|Standard Deviation|12.66|12.66|||
3827538|NCT01720446|3653760|B4|||HDL-cholesterol||mg/dL|Mean|44.61|44.61|Standard Deviation|12.26|12.26|||
3827539|NCT01720446|3653761|B3|||HDL-cholesterol||mg/dL|Mean|45.82|45.82|Standard Deviation|12.92|12.92|||
3827540|NCT01720446|3653762|B2|||HDL-cholesterol||mg/dL|Mean|44.97|44.97|Standard Deviation|12.42|12.42|||
3827541|NCT01720446|3653763|B1|||HDL-cholesterol||mg/dL|Mean|45.92|45.92|Standard Deviation|13.00|13.0|||
3827542|NCT01720446|3653759|B5|||LDL-cholesterol||mg/dL|Mean|89.87|89.87|Standard Deviation|37.49|37.49|||
3827543|NCT01720446|3653760|B4|||LDL-cholesterol||mg/dL|Mean|91.14|91.14|Standard Deviation|37.90|37.9|||
3827544|NCT01720446|3653761|B3|||LDL-cholesterol||mg/dL|Mean|89.01|89.01|Standard Deviation|38.35|38.35|||
3827545|NCT01720446|3653762|B2|||LDL-cholesterol||mg/dL|Mean|89.72|89.72|Standard Deviation|34.49|34.49|||
3827546|NCT01720446|3653763|B1|||LDL-cholesterol||mg/dL|Mean|89.62|89.62|Standard Deviation|39.08|39.08|||
3827547|NCT01720446|3653759|B5|||Body weight||kg|Mean|92.09|92.09|Standard Deviation|20.60|20.6|||
3827548|NCT01720446|3653760|B4|||Body weight||kg|Mean|91.90|91.9|Standard Deviation|20.75|20.75|||
3827549|NCT01720446|3653761|B3|||Body weight||kg|Mean|91.83|91.83|Standard Deviation|20.35|20.35|||
3827550|NCT01720446|3653762|B2|||Body weight||kg|Mean|92.86|92.86|Standard Deviation|21.05|21.05|||
3827551|NCT01720446|3653763|B1|||Body weight||kg|Mean|91.80|91.8|Standard Deviation|20.25|20.25|||
3827552|NCT01720446|3653759|B5|||Fasting plasma glucose||mg/dL|Mean|184.7|184.7|Standard Deviation|66.37|66.37|||
3827553|NCT01720446|3653760|B4|||Fasting plasma glucose||mg/dL|Mean|184.6|184.6|Standard Deviation|63.08|63.08|||
3827554|NCT01720446|3653761|B3|||Fasting plasma glucose||mg/dL|Mean|185.8|185.8|Standard Deviation|68.23|68.23|||
3827555|NCT01720446|3653762|B2|||Fasting plasma glucose||mg/dL|Mean|182.9|182.9|Standard Deviation|68.04|68.04|||
3827556|NCT01720446|3653763|B1|||Fasting plasma glucose||mg/dL|Mean|185.4|185.4|Standard Deviation|66.09|66.09|||
3827557|NCT01720446|3653759|B5|||Glycosylated haemoglobin||percentage of glycosylated haemoglobin|Mean|8.70|8.7|Standard Deviation|1.46|1.46|||
3827558|NCT01720446|3653760|B4|||Glycosylated haemoglobin||percentage of glycosylated haemoglobin|Mean|8.70|8.7|Standard Deviation|1.45|1.45|||
3827559|NCT01720446|3653761|B3|||Glycosylated haemoglobin||percentage of glycosylated haemoglobin|Mean|8.70|8.7|Standard Deviation|1.49|1.49|||
3827560|NCT01720446|3653762|B2|||Glycosylated haemoglobin||percentage of glycosylated haemoglobin|Mean|8.73|8.73|Standard Deviation|1.51|1.51|||
3827561|NCT01720446|3653763|B1|||Glycosylated haemoglobin||percentage of glycosylated haemoglobin|Mean|8.67|8.67|Standard Deviation|1.39|1.39|||
3827562|NCT01720446|3653759|B5||Male|Sex: Female, Male||Participants|Count of Participants|2002|2002.0||||||
3827563|NCT01720446|3653760|B4||Male|Sex: Female, Male||Participants|Count of Participants|507|507.0||||||
3827564|NCT01720446|3653761|B3||Male|Sex: Female, Male||Participants|Count of Participants|482|482.0||||||
3827565|NCT01720446|3653762|B2||Male|Sex: Female, Male||Participants|Count of Participants|518|518.0||||||
3827566|NCT01720446|3653763|B1||Male|Sex: Female, Male||Participants|Count of Participants|495|495.0||||||
3827567|NCT01720446|3653759|B5||Female|Sex: Female, Male||Participants|Count of Participants|1295|1295.0||||||
3827568|NCT01720446|3653760|B4||Female|Sex: Female, Male||Participants|Count of Participants|318|318.0||||||
3827569|NCT01720446|3653761|B3||Female|Sex: Female, Male||Participants|Count of Participants|342|342.0||||||
3827570|NCT01720446|3653762|B2||Female|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
3827571|NCT01720446|3653763|B1||Female|Sex: Female, Male||Participants|Count of Participants|331|331.0||||||
3827572|NCT01720446|3653759|B5|85 and over||Age, Customized||participants|Number|20|20.0||||||
3827573|NCT01720446|3653760|B4|85 and over||Age, Customized||participants|Number|4|4.0||||||
3827574|NCT01720446|3653761|B3|85 and over||Age, Customized||participants|Number|6|6.0||||||
3827575|NCT01720446|3653762|B2|85 and over||Age, Customized||participants|Number|7|7.0||||||
3827576|NCT01720446|3653763|B1|85 and over||Age, Customized||participants|Number|3|3.0||||||
3827577|NCT01720446|3653759|B5|75-84 years||Age, Customized||participants|Number|301|301.0||||||
3827578|NCT01720446|3653760|B4|75-84 years||Age, Customized||participants|Number|79|79.0||||||
3827579|NCT01720446|3653761|B3|75-84 years||Age, Customized||participants|Number|75|75.0||||||
3827580|NCT01720446|3653762|B2|75-84 years||Age, Customized||participants|Number|76|76.0||||||
3827581|NCT01720446|3653763|B1|75-84 years||Age, Customized||participants|Number|71|71.0||||||
3827582|NCT01720446|3653759|B5|65-74 years||Age, Customized||participants|Number|1277|1277.0||||||
3827583|NCT01720446|3653760|B4|65-74 years||Age, Customized||participants|Number|317|317.0||||||
3827584|NCT01720446|3653761|B3|65-74 years||Age, Customized||participants|Number|324|324.0||||||
3827585|NCT01720446|3653762|B2|65-74 years||Age, Customized||participants|Number|324|324.0||||||
3827586|NCT01720446|3653763|B1|65-74 years||Age, Customized||participants|Number|312|312.0||||||
3827587|NCT01720446|3653759|B5|50-64 years||Age, Customized||participants|Number|1699|1699.0||||||
3827588|NCT01720446|3653760|B4|50-64 years||Age, Customized||participants|Number|425|425.0||||||
3827589|NCT01720446|3653761|B3|50-64 years||Age, Customized||participants|Number|419|419.0||||||
3827590|NCT01720446|3653762|B2|50-64 years||Age, Customized||participants|Number|415|415.0||||||
3827591|NCT01720446|3653763|B1|50-64 years||Age, Customized||participants|Number|440|440.0||||||
3827592|NCT01720316|3653825|B3|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3827593|NCT01720316|3653826|B2|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3827594|NCT01720316|3653827|B1|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3827595|NCT01720316|3653825|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827596|NCT01720316|3653826|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827597|NCT01720316|3653827|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827598|NCT01720316|3653825|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827599|NCT01720316|3653826|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827600|NCT01720316|3653827|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827601|NCT01720316|3653825|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3827602|NCT01720316|3653826|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3827603|NCT01720316|3653827|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3827604|NCT01720316|3653825|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827605|NCT01720316|3653826|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827606|NCT01720316|3653827|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827607|NCT01720316|3653825|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827608|NCT01720316|3653826|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827609|NCT01720316|3653827|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827610|NCT01720316|3653825|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827611|NCT01720316|3653826|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827612|NCT01720316|3653827|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827613|NCT01720316|3653825|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827614|NCT01720316|3653826|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827615|NCT01720316|3653827|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827616|NCT01720316|3653825|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827617|NCT01720316|3653826|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827618|NCT01720316|3653827|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827619|NCT01720316|3653825|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3827620|NCT01720316|3653826|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3827621|NCT01720316|3653827|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3827622|NCT01720316|3653825|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827623|NCT01720316|3653826|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827624|NCT01720316|3653827|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827625|NCT01720316|3653825|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3827626|NCT01720316|3653826|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3827627|NCT01720316|3653827|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3827628|NCT01720316|3653825|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3827629|NCT01720316|3653826|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3827630|NCT01720316|3653827|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3827631|NCT01720316|3653825|B3|age||Age|age at beginning of study|years|Mean|45.5|45.5|Full Range|||32.0|59.0|
3827632|NCT01720316|3653826|B2|age||Age|age at beginning of study|years|Mean|32|32.0|Full Range|||0.0|0.0|Single participant in each arm
3827633|NCT01720316|3653827|B1|age||Age|age at beginning of study|years|Mean|59|59.0|Full Range|||0.0|0.0|Single participant in each arm
3827634|NCT01720277|3653874|B3|||Number of nursing facilities that are part of a chain||nursing homes|Number|16|16.0||||||
3827635|NCT01720277|3653875|B2|||Number of nursing facilities that are part of a chain||nursing homes|Number|6|6.0||||||
3827636|NCT01720277|3653876|B1|||Number of nursing facilities that are part of a chain||nursing homes|Number|10|10.0||||||
3827637|NCT01720277|3653874|B3|||Percent of residents in for-profit nursing facilities||percent|Mean|71.8|71.8|Standard Deviation|45.6|45.6|||
3827638|NCT01720277|3653875|B2|||Percent of residents in for-profit nursing facilities||percent|Mean|73.6|73.6|Standard Deviation|45.2|45.2|||
3827639|NCT01720277|3653876|B1|||Percent of residents in for-profit nursing facilities||percent|Mean|70.0|70.0|Standard Deviation|47.0|47.0|||
3827640|NCT01720277|3653874|B3|||Percent of residents with Medicaid as payer||percent|Mean|62.7|62.7|Standard Deviation|15.0|15.0|||
3827641|NCT01720277|3653875|B2|||Percent of residents with Medicaid as payer||percent|Mean|62.9|62.9|Standard Deviation|17.4|17.4|||
3827642|NCT01720277|3653876|B1|||Percent of residents with Medicaid as payer||percent|Mean|62.5|62.5|Standard Deviation|12.8|12.8|||
3827643|NCT01720277|3653874|B3|||Number of long-stay residents who are over 65 years of age||participants|Mean|78|78.0|Standard Deviation|40|40.0|||
3827644|NCT01720277|3653875|B2|||Number of long-stay residents who are over 65 years of age||participants|Mean|78|78.0|Standard Deviation|44|44.0|||
3827645|NCT01720277|3653876|B1|||Number of long-stay residents who are over 65 years of age||participants|Mean|78|78.0|Standard Deviation|37|37.0|||
3827646|NCT01720277|3653874|B3|||Percent of residents who are long-stay||percent|Mean|87.2|87.2|Standard Deviation|9.7|9.7|||
3827647|NCT01720277|3653875|B2|||Percent of residents who are long-stay||percent|Mean|86.5|86.5|Standard Deviation|12.1|12.1|||
3827648|NCT01720277|3653876|B1|||Percent of residents who are long-stay||percent|Mean|88.0|88.0|Standard Deviation|6.5|6.5|||
3827649|NCT01720277|3653874|B3|||Number of residents per nursing home||participants|Mean|116|116.0|Standard Deviation|51|51.0|||
3827650|NCT01720277|3653875|B2|||Number of residents per nursing home||participants|Mean|124|124.0|Standard Deviation|54|54.0|||
3827651|NCT01720277|3653876|B1|||Number of residents per nursing home||participants|Mean|108|108.0|Standard Deviation|49|49.0|||
3827652|NCT01720277|3653874|B3|Percent of female nursing home residents||Sex/Gender, Customized||Participants|Count of Participants|2207|2207.0||||||
3827653|NCT01720277|3653875|B2|Percent of female nursing home residents||Sex/Gender, Customized||Participants|Count of Participants|1113|1113.0||||||
3827654|NCT01720277|3653876|B1|Percent of female nursing home residents||Sex/Gender, Customized||Participants|Count of Participants|1094|1094.0||||||
3827655|NCT01720277|3653874|B3|Average age||Age, Customized||years|Mean|84.0|84.0|Standard Deviation|8.6|8.6|||
3827656|NCT01720277|3653875|B2|Average age||Age, Customized||years|Mean|83.4|83.4|Standard Deviation|8.7|8.7|||
3827657|NCT01720277|3653876|B1|Average age||Age, Customized||years|Mean|84.5|84.5|Standard Deviation|8.4|8.4|||
3827658|NCT01720251|3653887|B4||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3827659|NCT01720251|3653888|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3827660|NCT01720251|3653889|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3827661|NCT01720251|3653890|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3827662|NCT01720251|3653887|B4||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3827663|NCT01720251|3653888|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3827664|NCT01720251|3653889|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3827665|NCT01720251|3653890|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3827666|NCT01720251|3653887|B4|||Age||years|Mean|35.6|35.6|Standard Deviation|9.45|9.45|||
3827667|NCT01720251|3653888|B3|||Age||years|Mean|36.4|36.4|Standard Deviation|9.36|9.36|||
3827668|NCT01720251|3653889|B2|||Age||years|Mean|36.2|36.2|Standard Deviation|9.92|9.92|||
3827669|NCT01720251|3653890|B1|||Age||years|Mean|34.1|34.1|Standard Deviation|9.08|9.08|||
3827670|NCT01720173|3653900|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3827671|NCT01720173|3653900|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3827672|NCT01720173|3653900|B1|70-79 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
3827673|NCT01720173|3653900|B1|60-69 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
3827674|NCT01720173|3653900|B1|50-59 years||Age, Customized||Participants|Count of Participants|13|13.0||||||
3827675|NCT01720173|3653900|B1|40-49 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
3827676|NCT01720173|3653900|B1|30-39 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3827677|NCT01720173|3653900|B1|||Age||years|Mean|57.0|57.0|Standard Deviation|9.2|9.2|||
3827678|NCT01720043|3653908|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3827679|NCT01720043|3653908|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827680|NCT01720043|3653908|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827681|NCT01720043|3653908|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3827682|NCT01720043|3653908|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827683|NCT01720043|3653908|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827684|NCT01720043|3653908|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827685|NCT01720043|3653908|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827686|NCT01720043|3653908|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3827687|NCT01720043|3653908|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3827688|NCT01720043|3653908|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3827689|NCT01720043|3653908|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3827690|NCT01720043|3653908|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3827691|NCT01719861|3653912|B1|Large Cell Neuroendocrine Carcinoma of Pancreas||Histology||participants|Number|1|1.0||||||
3827692|NCT01719861|3653912|B1|Large Cell Neuroendocrine Carcinoma of Lung||Histology||participants|Number|2|2.0||||||
3827693|NCT01719861|3653912|B1|Small Cell Carcinoma of Lung||Histology||participants|Number|3|3.0||||||
3827694|NCT01719861|3653912|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827695|NCT01719861|3653912|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827696|NCT01719861|3653912|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3827697|NCT01719861|3653912|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827698|NCT01719861|3653912|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827699|NCT01719861|3653912|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3827700|NCT01719861|3653912|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827701|NCT01719861|3653912|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827702|NCT01719861|3653912|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3827703|NCT01719861|3653912|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3827704|NCT01719861|3653912|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3827705|NCT01719861|3653912|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3827706|NCT01719861|3653912|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3827707|NCT01719861|3653912|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3827708|NCT01719861|3653912|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3827709|NCT01719783|3653920|B3|Russia||Region of Enrollment||participants|Number|40|40.0||||||
3827710|NCT01719783|3653921|B2|Russia||Region of Enrollment||participants|Number|10|10.0||||||
3827711|NCT01719783|3653922|B1|Russia||Region of Enrollment||participants|Number|30|30.0||||||
3827712|NCT01719783|3653920|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3827713|NCT01719783|3653921|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3827714|NCT01719783|3653922|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3827715|NCT01719783|3653920|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3827716|NCT01719783|3653921|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3827717|NCT01719783|3653922|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3827718|NCT01719783|3653920|B3|||Age||years|Mean|28.1|28.1|Standard Deviation|10.4|10.4|||
3827719|NCT01719783|3653921|B2|||Age||years|Mean|29.2|29.2|Standard Deviation|10.8|10.8|||
3827720|NCT01719783|3653922|B1|||Age||years|Mean|27.7|27.7|Standard Deviation|10.4|10.4|||
3827721|NCT01719757|3654009|B1|Korea, Republic of||Region of Enrollment||participants|Number|359|359.0||||||
3827722|NCT01719757|3654009|B1||Male|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
3827723|NCT01719757|3654009|B1||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3827724|NCT01719757|3654009|B1|||Age||years|Mean|67.73|67.73|Standard Deviation|11.07|11.07|||
3827725|NCT01719757|3654009|B1||>=65 years|Age||Participants|Count of Participants|180|180.0||||||
3827726|NCT01719757|3654009|B1||Between 18 and 65 years|Age||Participants|Count of Participants|179|179.0||||||
3827727|NCT01719757|3654009|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3827728|NCT01719744|3654017|B1|Canada||Region of Enrollment||participants|Number|25|25.0||||||
3827729|NCT01719744|3654017|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3827730|NCT01719744|3654017|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3827731|NCT01719744|3654017|B1|||Age||years|Median|54|54.0|Full Range|||22.0|73.0|
3827732|NCT01719744|3654017|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3827733|NCT01719744|3654017|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3827734|NCT01719744|3654017|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3827735|NCT01719653|3654023|B6|United States||Region of Enrollment||participants|Number|1000|1000.0||||||
3827736|NCT01719653|3654024|B5|United States||Region of Enrollment||participants|Number|200|200.0||||||
3827737|NCT01719653|3654025|B4|United States||Region of Enrollment||participants|Number|200|200.0||||||
3827738|NCT01719653|3654026|B3|United States||Region of Enrollment||participants|Number|200|200.0||||||
3827739|NCT01719653|3654027|B2|United States||Region of Enrollment||participants|Number|200|200.0||||||
3827740|NCT01719653|3654028|B1|United States||Region of Enrollment||participants|Number|200|200.0||||||
3827741|NCT01719653|3654023|B6||Male|Sex: Female, Male||Participants|Count of Participants|505|505.0||||||
3827742|NCT01719653|3654024|B5||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3827743|NCT01719653|3654025|B4||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3827744|NCT01719653|3654026|B3||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3827745|NCT01719653|3654027|B2||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3827746|NCT01719653|3654028|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3827747|NCT01719653|3654023|B6||Female|Sex: Female, Male||Participants|Count of Participants|495|495.0||||||
3827748|NCT01719653|3654024|B5||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3827749|NCT01719653|3654025|B4||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3827750|NCT01719653|3654026|B3||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3827751|NCT01719653|3654027|B2||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3827752|NCT01719653|3654028|B1||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3827753|NCT01719653|3654023|B6|||Age||years|Mean|60.4|60.4|Standard Deviation|11.8|11.8|||
3827754|NCT01719653|3654024|B5|||Age||years|Mean|60.6|60.6|Standard Deviation|11.2|11.2|||
3827755|NCT01719653|3654025|B4|||Age||years|Mean|60.1|60.1|Standard Deviation|11.4|11.4|||
3827756|NCT01719653|3654026|B3|||Age||years|Mean|59.1|59.1|Standard Deviation|11.3|11.3|||
3827757|NCT01719653|3654027|B2|||Age||years|Mean|61.3|61.3|Standard Deviation|12.4|12.4|||
3827758|NCT01719653|3654028|B1|||Age||years|Mean|60.9|60.9|Standard Deviation|12.7|12.7|||
3827759|NCT01719224|3654054|B1|||Delivery method: C-Section||participants|Number|11|11.0||||||
3827760|NCT01719224|3654054|B1|||BMI end of pregnancy||kg/m²|Mean|30.84|30.84|Standard Deviation|7|7.0|||
3827761|NCT01719224|3654054|B1|||BMI prior to pregnancy||kg/m^2|Mean|25.82|25.82|Standard Deviation|6.8|6.8|||
3827762|NCT01719224|3654054|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3827763|NCT01719224|3654054|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3827764|NCT01719224|3654054|B1|||Age||years|Mean|33.13|33.13|Standard Deviation|5.1|5.1|||
3827765|NCT01719172|3654064|B1|||Weight||kilograms|Mean|75.0|75.0|Standard Deviation|19.0|19.0|||
3827766|NCT01719172|3654064|B1|||Height||centimeters|Mean|174.0|174.0|Standard Deviation|7.6|7.6|||
3827767|NCT01719172|3654064|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827768|NCT01719172|3654064|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827769|NCT01719172|3654064|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3827770|NCT01719172|3654064|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827771|NCT01719172|3654064|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827772|NCT01719172|3654064|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827773|NCT01719172|3654064|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827774|NCT01719172|3654064|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827775|NCT01719172|3654064|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3827776|NCT01719172|3654064|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3827777|NCT01719172|3654064|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3827778|NCT01719172|3654064|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3827779|NCT01719172|3654064|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|12.3|12.3|||
3827780|NCT01719003|3654070|B9||Male|Sex: Female, Male||Participants|Count of Participants|747|747.0||||||
3827781|NCT01719003|3654071|B8||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3827782|NCT01719003|3654072|B7||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3827783|NCT01719003|3654073|B6||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3827784|NCT01719003|3654074|B5||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3827785|NCT01719003|3654075|B4||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3827786|NCT01719003|3654076|B3||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3827787|NCT01719003|3654077|B2||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3827788|NCT01719003|3654078|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3827789|NCT01719003|3654070|B9||Female|Sex: Female, Male||Participants|Count of Participants|580|580.0||||||
3827790|NCT01719003|3654071|B8||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3827791|NCT01719003|3654072|B7||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3827792|NCT01719003|3654073|B6||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3827793|NCT01719003|3654074|B5||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3827794|NCT01719003|3654075|B4||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3827795|NCT01719003|3654076|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3827796|NCT01719003|3654077|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3827797|NCT01719003|3654078|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3827798|NCT01719003|3654070|B9|||Age||years|Mean|52.6|52.6|Standard Deviation|10.9|10.9|||
3827799|NCT01719003|3654071|B8|||Age||years|Mean|53.4|53.4|Standard Deviation|10.9|10.9|||
3827800|NCT01719003|3654072|B7|||Age||years|Mean|51.6|51.6|Standard Deviation|10.8|10.8|||
3827801|NCT01719003|3654073|B6|||Age||years|Mean|53.1|53.1|Standard Deviation|10.7|10.7|||
3827802|NCT01719003|3654074|B5|||Age||years|Mean|53.3|53.3|Standard Deviation|10.7|10.7|||
3827803|NCT01719003|3654075|B4|||Age||years|Mean|52.2|52.2|Standard Deviation|11.7|11.7|||
3827804|NCT01719003|3654076|B3|||Age||years|Mean|52.3|52.3|Standard Deviation|11.3|11.3|||
3827805|NCT01719003|3654077|B2|||Age||years|Mean|51.0|51.0|Standard Deviation|10.7|10.7|||
3827806|NCT01719003|3654078|B1|||Age||years|Mean|53.6|53.6|Standard Deviation|10.7|10.7|||
3827807|NCT01718691|3654121|B3|High||IPI risk category|"The criteria for International Prognostic Index are shown below.~Low: 0 or 1poor prognostic factors~Intermediate (Low): 2 poor prognostic factors~Intermediate (High): 3 poor prognostic factors~High: 4 or 5 poor prognostic factors"|participants|Number|2|2.0||||||
3827808|NCT01718691|3654122|B2|High||IPI risk category|"The criteria for International Prognostic Index are shown below.~Low: 0 or 1poor prognostic factors~Intermediate (Low): 2 poor prognostic factors~Intermediate (High): 3 poor prognostic factors~High: 4 or 5 poor prognostic factors"|participants|Number|1|1.0||||||
3827809|NCT01718691|3654123|B1|High||IPI risk category|"The criteria for International Prognostic Index are shown below.~Low: 0 or 1poor prognostic factors~Intermediate (Low): 2 poor prognostic factors~Intermediate (High): 3 poor prognostic factors~High: 4 or 5 poor prognostic factors"|participants|Number|1|1.0||||||
3827810|NCT01718691|3654121|B3|Intermediate (High)||IPI risk category|"The criteria for International Prognostic Index are shown below.~Low: 0 or 1poor prognostic factors~Intermediate (Low): 2 poor prognostic factors~Intermediate (High): 3 poor prognostic factors~High: 4 or 5 poor prognostic factors"|participants|Number|17|17.0||||||
3827811|NCT01718691|3654122|B2|Intermediate (High)||IPI risk category|"The criteria for International Prognostic Index are shown below.~Low: 0 or 1poor prognostic factors~Intermediate (Low): 2 poor prognostic factors~Intermediate (High): 3 poor prognostic factors~High: 4 or 5 poor prognostic factors"|participants|Number|7|7.0||||||
3827812|NCT01718691|3654123|B1|Intermediate (High)||IPI risk category|"The criteria for International Prognostic Index are shown below.~Low: 0 or 1poor prognostic factors~Intermediate (Low): 2 poor prognostic factors~Intermediate (High): 3 poor prognostic factors~High: 4 or 5 poor prognostic factors"|participants|Number|10|10.0||||||
3827813|NCT01718691|3654121|B3|Intermediate (Low)||IPI risk category|"The criteria for International Prognostic Index are shown below.~Low: 0 or 1poor prognostic factors~Intermediate (Low): 2 poor prognostic factors~Intermediate (High): 3 poor prognostic factors~High: 4 or 5 poor prognostic factors"|participants|Number|23|23.0||||||
3827814|NCT01718691|3654122|B2|Intermediate (Low)||IPI risk category|"The criteria for International Prognostic Index are shown below.~Low: 0 or 1poor prognostic factors~Intermediate (Low): 2 poor prognostic factors~Intermediate (High): 3 poor prognostic factors~High: 4 or 5 poor prognostic factors"|participants|Number|2|2.0||||||
3827815|NCT01718691|3654123|B1|Intermediate (Low)||IPI risk category|"The criteria for International Prognostic Index are shown below.~Low: 0 or 1poor prognostic factors~Intermediate (Low): 2 poor prognostic factors~Intermediate (High): 3 poor prognostic factors~High: 4 or 5 poor prognostic factors"|participants|Number|21|21.0||||||
3827816|NCT01718691|3654121|B3|Low||IPI risk category|"The criteria for International Prognostic Index are shown below.~Low: 0 or 1poor prognostic factors~Intermediate (Low): 2 poor prognostic factors~Intermediate (High): 3 poor prognostic factors~High: 4 or 5 poor prognostic factors"|participants|Number|27|27.0||||||
3827817|NCT01718691|3654122|B2|Low||IPI risk category|"The criteria for International Prognostic Index are shown below.~Low: 0 or 1poor prognostic factors~Intermediate (Low): 2 poor prognostic factors~Intermediate (High): 3 poor prognostic factors~High: 4 or 5 poor prognostic factors"|participants|Number|0|0.0||||||
3827818|NCT01718691|3654123|B1|Low||IPI risk category|"The criteria for International Prognostic Index are shown below.~Low: 0 or 1poor prognostic factors~Intermediate (Low): 2 poor prognostic factors~Intermediate (High): 3 poor prognostic factors~High: 4 or 5 poor prognostic factors"|participants|Number|27|27.0||||||
3827819|NCT01718691|3654121|B3|High||FLIPI risk category|"The criteria for Follicular Lymphoma International Prognostic Index (FLIPI) are shown below.~Low: No or 1 poor prognostic factor(s)~Intermediate: 2 poor prognostic factors~High: 3-5 poor prognostic factors"|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3827820|NCT01718691|3654122|B2|High||FLIPI risk category|"The criteria for Follicular Lymphoma International Prognostic Index (FLIPI) are shown below.~Low: No or 1 poor prognostic factor(s)~Intermediate: 2 poor prognostic factors~High: 3-5 poor prognostic factors"|participants|Number|NA|||||||The subjects with mantle cell lymphoma were not included in this examination.
3827821|NCT01718691|3654123|B1|High||FLIPI risk category|"The criteria for Follicular Lymphoma International Prognostic Index (FLIPI) are shown below.~Low: No or 1 poor prognostic factor(s)~Intermediate: 2 poor prognostic factors~High: 3-5 poor prognostic factors"|participants|Number|18|18.0||||||
3827822|NCT01718691|3654121|B3|Intermediate||FLIPI risk category|"The criteria for Follicular Lymphoma International Prognostic Index (FLIPI) are shown below.~Low: No or 1 poor prognostic factor(s)~Intermediate: 2 poor prognostic factors~High: 3-5 poor prognostic factors"|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3827823|NCT01718691|3654122|B2|Intermediate||FLIPI risk category|"The criteria for Follicular Lymphoma International Prognostic Index (FLIPI) are shown below.~Low: No or 1 poor prognostic factor(s)~Intermediate: 2 poor prognostic factors~High: 3-5 poor prognostic factors"|participants|Number|NA|||||||The subjects with mantle cell lymphoma were not included in this examination.
3827824|NCT01718691|3654123|B1|Intermediate||FLIPI risk category|"The criteria for Follicular Lymphoma International Prognostic Index (FLIPI) are shown below.~Low: No or 1 poor prognostic factor(s)~Intermediate: 2 poor prognostic factors~High: 3-5 poor prognostic factors"|participants|Number|24|24.0||||||
3827825|NCT01718691|3654121|B3|Low||FLIPI risk category|"The criteria for Follicular Lymphoma International Prognostic Index (FLIPI) are shown below.~Low: No or 1 poor prognostic factor(s)~Intermediate: 2 poor prognostic factors~High: 3-5 poor prognostic factors"|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3827826|NCT01718691|3654122|B2|Low||FLIPI risk category|"The criteria for Follicular Lymphoma International Prognostic Index (FLIPI) are shown below.~Low: No or 1 poor prognostic factor(s)~Intermediate: 2 poor prognostic factors~High: 3-5 poor prognostic factors"|participants|Number|NA|||||||The subjects with mantle cell lymphoma were not included in this examination.
3827891|NCT01718691|3654121|B3|Yes||B symptoms (fever)||participants|Number|0|0.0||||||
3827827|NCT01718691|3654123|B1|Low||FLIPI risk category|"The criteria for Follicular Lymphoma International Prognostic Index (FLIPI) are shown below.~Low: No or 1 poor prognostic factor(s)~Intermediate: 2 poor prognostic factors~High: 3-5 poor prognostic factors"|participants|Number|17|17.0||||||
3827828|NCT01718691|3654121|B3|No||Concomitant disease||participants|Number|6|6.0||||||
3827829|NCT01718691|3654122|B2|No||Concomitant disease||participants|Number|0|0.0||||||
3827830|NCT01718691|3654123|B1|No||Concomitant disease||participants|Number|6|6.0||||||
3827831|NCT01718691|3654121|B3|Yes||Concomitant disease||participants|Number|63|63.0||||||
3827832|NCT01718691|3654122|B2|Yes||Concomitant disease||participants|Number|10|10.0||||||
3827833|NCT01718691|3654123|B1|Yes||Concomitant disease||participants|Number|53|53.0||||||
3827834|NCT01718691|3654121|B3|No||Previous medical history||participants|Number|31|31.0||||||
3827835|NCT01718691|3654122|B2|No||Previous medical history||participants|Number|3|3.0||||||
3827836|NCT01718691|3654123|B1|No||Previous medical history||participants|Number|28|28.0||||||
3827837|NCT01718691|3654121|B3|Yes||Previous medical history||participants|Number|38|38.0||||||
3827838|NCT01718691|3654122|B2|Yes||Previous medical history||participants|Number|7|7.0||||||
3827839|NCT01718691|3654123|B1|Yes||Previous medical history||participants|Number|31|31.0||||||
3827840|NCT01718691|3654121|B3|Unknown||Chromosome abnormality||participants|Number|4|4.0||||||
3827841|NCT01718691|3654122|B2|Unknown||Chromosome abnormality||participants|Number|1|1.0||||||
3827842|NCT01718691|3654123|B1|Unknown||Chromosome abnormality||participants|Number|3|3.0||||||
3827843|NCT01718691|3654121|B3|No||Chromosome abnormality||participants|Number|48|48.0||||||
3827844|NCT01718691|3654122|B2|No||Chromosome abnormality||participants|Number|5|5.0||||||
3827845|NCT01718691|3654123|B1|No||Chromosome abnormality||participants|Number|43|43.0||||||
3827846|NCT01718691|3654121|B3|Yes||Chromosome abnormality||participants|Number|17|17.0||||||
3827847|NCT01718691|3654122|B2|Yes||Chromosome abnormality||participants|Number|4|4.0||||||
3827848|NCT01718691|3654123|B1|Yes||Chromosome abnormality||participants|Number|13|13.0||||||
3827849|NCT01718691|3654121|B3|Undetermined||Bone marrow invasion||participants|Number|1|1.0||||||
3827850|NCT01718691|3654122|B2|Undetermined||Bone marrow invasion||participants|Number|0|0.0||||||
3827851|NCT01718691|3654123|B1|Undetermined||Bone marrow invasion||participants|Number|1|1.0||||||
3827852|NCT01718691|3654121|B3|Negative||Bone marrow invasion||participants|Number|26|26.0||||||
3827853|NCT01718691|3654122|B2|Negative||Bone marrow invasion||participants|Number|2|2.0||||||
3827854|NCT01718691|3654123|B1|Negative||Bone marrow invasion||participants|Number|24|24.0||||||
3827855|NCT01718691|3654121|B3|Positive||Bone marrow invasion||participants|Number|42|42.0||||||
3827856|NCT01718691|3654122|B2|Positive||Bone marrow invasion||participants|Number|8|8.0||||||
3827857|NCT01718691|3654123|B1|Positive||Bone marrow invasion||participants|Number|34|34.0||||||
3827858|NCT01718691|3654121|B3|No||Pleural effusion/ascites retention||participants|Number|64|64.0||||||
3827859|NCT01718691|3654122|B2|No||Pleural effusion/ascites retention||participants|Number|10|10.0||||||
3827860|NCT01718691|3654123|B1|No||Pleural effusion/ascites retention||participants|Number|54|54.0||||||
3827861|NCT01718691|3654121|B3|Yes||Pleural effusion/ascites retention||participants|Number|5|5.0||||||
3827862|NCT01718691|3654122|B2|Yes||Pleural effusion/ascites retention||participants|Number|0|0.0||||||
3827863|NCT01718691|3654123|B1|Yes||Pleural effusion/ascites retention||participants|Number|5|5.0||||||
3827864|NCT01718691|3654121|B3|No||Pressure symptoms||participants|Number|55|55.0||||||
3827865|NCT01718691|3654122|B2|No||Pressure symptoms||participants|Number|10|10.0||||||
3827866|NCT01718691|3654123|B1|No||Pressure symptoms||participants|Number|45|45.0||||||
3827867|NCT01718691|3654121|B3|Yes||Pressure symptoms||participants|Number|14|14.0||||||
3827868|NCT01718691|3654122|B2|Yes||Pressure symptoms||participants|Number|0|0.0||||||
3827869|NCT01718691|3654123|B1|Yes||Pressure symptoms||participants|Number|14|14.0||||||
3827870|NCT01718691|3654121|B3|No||Symptomatic splenomegaly||participants|Number|64|64.0||||||
3827871|NCT01718691|3654122|B2|No||Symptomatic splenomegaly||participants|Number|10|10.0||||||
3827872|NCT01718691|3654123|B1|No||Symptomatic splenomegaly||participants|Number|54|54.0||||||
3827873|NCT01718691|3654121|B3|Yes||Symptomatic splenomegaly||participants|Number|5|5.0||||||
3827874|NCT01718691|3654122|B2|Yes||Symptomatic splenomegaly||participants|Number|0|0.0||||||
3827875|NCT01718691|3654123|B1|Yes||Symptomatic splenomegaly||participants|Number|5|5.0||||||
3827876|NCT01718691|3654121|B3|No||B symptoms (weight loss)||participants|Number|67|67.0||||||
3827877|NCT01718691|3654122|B2|No||B symptoms (weight loss)||participants|Number|10|10.0||||||
3827878|NCT01718691|3654123|B1|No||B symptoms (weight loss)||participants|Number|57|57.0||||||
3827879|NCT01718691|3654121|B3|Yes||B symptoms (weight loss)||participants|Number|2|2.0||||||
3827880|NCT01718691|3654122|B2|Yes||B symptoms (weight loss)||participants|Number|0|0.0||||||
3827881|NCT01718691|3654123|B1|Yes||B symptoms (weight loss)||participants|Number|2|2.0||||||
3827882|NCT01718691|3654121|B3|No||B symptoms (night sweats)||participants|Number|66|66.0||||||
3827883|NCT01718691|3654122|B2|No||B symptoms (night sweats)||participants|Number|10|10.0||||||
3827884|NCT01718691|3654123|B1|No||B symptoms (night sweats)||participants|Number|56|56.0||||||
3827885|NCT01718691|3654121|B3|Yes||B symptoms (night sweats)||participants|Number|3|3.0||||||
3827886|NCT01718691|3654122|B2|Yes||B symptoms (night sweats)||participants|Number|0|0.0||||||
3827887|NCT01718691|3654123|B1|Yes||B symptoms (night sweats)||participants|Number|3|3.0||||||
3827888|NCT01718691|3654121|B3|No||B symptoms (fever)||participants|Number|69|69.0||||||
3827889|NCT01718691|3654122|B2|No||B symptoms (fever)||participants|Number|10|10.0||||||
3827890|NCT01718691|3654123|B1|No||B symptoms (fever)||participants|Number|59|59.0||||||
3827892|NCT01718691|3654122|B2|Yes||B symptoms (fever)||participants|Number|0|0.0||||||
3827893|NCT01718691|3654123|B1|Yes||B symptoms (fever)||participants|Number|0|0.0||||||
3827894|NCT01718691|3654121|B3|No||Enlarged kidney||participants|Number|68|68.0||||||
3827895|NCT01718691|3654122|B2|No||Enlarged kidney||participants|Number|10|10.0||||||
3827896|NCT01718691|3654123|B1|No||Enlarged kidney||participants|Number|58|58.0||||||
3827897|NCT01718691|3654121|B3|Yes||Enlarged kidney||participants|Number|1|1.0||||||
3827898|NCT01718691|3654122|B2|Yes||Enlarged kidney||participants|Number|0|0.0||||||
3827899|NCT01718691|3654123|B1|Yes||Enlarged kidney||participants|Number|1|1.0||||||
3827900|NCT01718691|3654121|B3|No||Splenomegaly||participants|Number|50|50.0||||||
3827901|NCT01718691|3654122|B2|No||Splenomegaly||participants|Number|10|10.0||||||
3827902|NCT01718691|3654123|B1|No||Splenomegaly||participants|Number|40|40.0||||||
3827903|NCT01718691|3654121|B3|Yes||Splenomegaly||participants|Number|19|19.0||||||
3827904|NCT01718691|3654122|B2|Yes||Splenomegaly||participants|Number|0|0.0||||||
3827905|NCT01718691|3654123|B1|Yes||Splenomegaly||participants|Number|19|19.0||||||
3827906|NCT01718691|3654121|B3|No||Hepatomegaly||participants|Number|65|65.0||||||
3827907|NCT01718691|3654122|B2|No||Hepatomegaly||participants|Number|9|9.0||||||
3827908|NCT01718691|3654123|B1|No||Hepatomegaly||participants|Number|56|56.0||||||
3827909|NCT01718691|3654121|B3|Yes||Hepatomegaly||participants|Number|4|4.0||||||
3827910|NCT01718691|3654122|B2|Yes||Hepatomegaly||participants|Number|1|1.0||||||
3827911|NCT01718691|3654123|B1|Yes||Hepatomegaly||participants|Number|3|3.0||||||
3827912|NCT01718691|3654121|B3|High||C-reactive protein (CRP)||participants|Number|22|22.0||||||
3827913|NCT01718691|3654122|B2|High||C-reactive protein (CRP)||participants|Number|2|2.0||||||
3827914|NCT01718691|3654123|B1|High||C-reactive protein (CRP)||participants|Number|20|20.0||||||
3827915|NCT01718691|3654121|B3|≤ upper limit of normal range||C-reactive protein (CRP)||participants|Number|47|47.0||||||
3827916|NCT01718691|3654122|B2|≤ upper limit of normal range||C-reactive protein (CRP)||participants|Number|8|8.0||||||
3827917|NCT01718691|3654123|B1|≤ upper limit of normal range||C-reactive protein (CRP)||participants|Number|39|39.0||||||
3827918|NCT01718691|3654121|B3|High||Beta 2 microglobulin||participants|Number|51|51.0||||||
3827919|NCT01718691|3654122|B2|High||Beta 2 microglobulin||participants|Number|7|7.0||||||
3827920|NCT01718691|3654123|B1|High||Beta 2 microglobulin||participants|Number|44|44.0||||||
3827921|NCT01718691|3654121|B3|≤ upper limit of normal range||Beta 2 microglobulin||participants|Number|18|18.0||||||
3827922|NCT01718691|3654122|B2|≤ upper limit of normal range||Beta 2 microglobulin||participants|Number|3|3.0||||||
3827923|NCT01718691|3654123|B1|≤ upper limit of normal range||Beta 2 microglobulin||participants|Number|15|15.0||||||
3827924|NCT01718691|3654121|B3|High||Lactate dehydrogenase (LDH)||participants|Number|17|17.0||||||
3827925|NCT01718691|3654122|B2|High||Lactate dehydrogenase (LDH)||participants|Number|3|3.0||||||
3827926|NCT01718691|3654123|B1|High||Lactate dehydrogenase (LDH)||participants|Number|14|14.0||||||
3827927|NCT01718691|3654121|B3|≤ upper limit of normal range||Lactate dehydrogenase (LDH)||participants|Number|52|52.0||||||
3827928|NCT01718691|3654122|B2|≤ upper limit of normal range||Lactate dehydrogenase (LDH)||participants|Number|7|7.0||||||
3827929|NCT01718691|3654123|B1|≤ upper limit of normal range||Lactate dehydrogenase (LDH)||participants|Number|45|45.0||||||
3827930|NCT01718691|3654121|B3|˂7 cm||Tumor diameter (2)||participants|Number|40|40.0||||||
3827931|NCT01718691|3654122|B2|˂7 cm||Tumor diameter (2)||participants|Number|9|9.0||||||
3827932|NCT01718691|3654123|B1|˂7 cm||Tumor diameter (2)||participants|Number|31|31.0||||||
3827933|NCT01718691|3654121|B3|≥7 cm||Tumor diameter (2)||participants|Number|29|29.0||||||
3827934|NCT01718691|3654122|B2|≥7 cm||Tumor diameter (2)||participants|Number|1|1.0||||||
3827935|NCT01718691|3654123|B1|≥7 cm||Tumor diameter (2)||participants|Number|28|28.0||||||
3827936|NCT01718691|3654121|B3|˂5 cm||Tumor diameter (1)||participants|Number|27|27.0||||||
3827937|NCT01718691|3654122|B2|˂5 cm||Tumor diameter (1)||participants|Number|6|6.0||||||
3827938|NCT01718691|3654123|B1|˂5 cm||Tumor diameter (1)||participants|Number|21|21.0||||||
3827939|NCT01718691|3654121|B3|≥5 cm||Tumor diameter (1)||participants|Number|42|42.0||||||
3827940|NCT01718691|3654122|B2|≥5 cm||Tumor diameter (1)||participants|Number|4|4.0||||||
3827941|NCT01718691|3654123|B1|≥5 cm||Tumor diameter (1)||participants|Number|38|38.0||||||
3827942|NCT01718691|3654121|B3|2 or more lesions||Number of extranodal lesions||participants|Number|15|15.0||||||
3827943|NCT01718691|3654122|B2|2 or more lesions||Number of extranodal lesions||participants|Number|6|6.0||||||
3827944|NCT01718691|3654123|B1|2 or more lesions||Number of extranodal lesions||participants|Number|9|9.0||||||
3827945|NCT01718691|3654121|B3|0 - 1 lesion||Number of extranodal lesions||participants|Number|54|54.0||||||
3827946|NCT01718691|3654122|B2|0 - 1 lesion||Number of extranodal lesions||participants|Number|4|4.0||||||
3827947|NCT01718691|3654123|B1|0 - 1 lesion||Number of extranodal lesions||participants|Number|50|50.0||||||
3827948|NCT01718691|3654121|B3|4 regions or more||Number of lymph node regions||participants|Number|43|43.0||||||
3827949|NCT01718691|3654122|B2|4 regions or more||Number of lymph node regions||participants|Number|6|6.0||||||
3827950|NCT01718691|3654123|B1|4 regions or more||Number of lymph node regions||participants|Number|37|37.0||||||
3827951|NCT01718691|3654121|B3|3 regions||Number of lymph node regions||participants|Number|6|6.0||||||
3827952|NCT01718691|3654122|B2|3 regions||Number of lymph node regions||participants|Number|2|2.0||||||
3827953|NCT01718691|3654123|B1|3 regions||Number of lymph node regions||participants|Number|4|4.0||||||
3827954|NCT01718691|3654121|B3|2 regions||Number of lymph node regions||participants|Number|7|7.0||||||
3827955|NCT01718691|3654122|B2|2 regions||Number of lymph node regions||participants|Number|1|1.0||||||
3827956|NCT01718691|3654123|B1|2 regions||Number of lymph node regions||participants|Number|6|6.0||||||
3827957|NCT01718691|3654121|B3|1 region||Number of lymph node regions||participants|Number|13|13.0||||||
3827958|NCT01718691|3654122|B2|1 region||Number of lymph node regions||participants|Number|1|1.0||||||
3827959|NCT01718691|3654123|B1|1 region||Number of lymph node regions||participants|Number|12|12.0||||||
3827960|NCT01718691|3654121|B3|0 region||Number of lymph node regions||participants|Number|0|0.0||||||
3827961|NCT01718691|3654122|B2|0 region||Number of lymph node regions||participants|Number|0|0.0||||||
3827962|NCT01718691|3654123|B1|0 region||Number of lymph node regions||participants|Number|0|0.0||||||
3827963|NCT01718691|3654121|B3|IV||Clinical stage (Ann Arbor staging classification)|"The criteria of Ann Arbor staging classification are shown below.~I: Invasion of 1 lymph node region II: Invasion of 2 or more lymphatic regions confined to 1 side of the diaphragm III: Invasion of multiple lymph node regions spanning above and below the diaphragm IV: Diffuse invasion to an organ or area other than 1 or multiple lymphatic tissues, regardless of the presence/absence of lymph node lesions."|participants|Number|45|45.0||||||
3827964|NCT01718691|3654122|B2|IV||Clinical stage (Ann Arbor staging classification)|"The criteria of Ann Arbor staging classification are shown below.~I: Invasion of 1 lymph node region II: Invasion of 2 or more lymphatic regions confined to 1 side of the diaphragm III: Invasion of multiple lymph node regions spanning above and below the diaphragm IV: Diffuse invasion to an organ or area other than 1 or multiple lymphatic tissues, regardless of the presence/absence of lymph node lesions."|participants|Number|10|10.0||||||
3827965|NCT01718691|3654123|B1|IV||Clinical stage (Ann Arbor staging classification)|"The criteria of Ann Arbor staging classification are shown below.~I: Invasion of 1 lymph node region II: Invasion of 2 or more lymphatic regions confined to 1 side of the diaphragm III: Invasion of multiple lymph node regions spanning above and below the diaphragm IV: Diffuse invasion to an organ or area other than 1 or multiple lymphatic tissues, regardless of the presence/absence of lymph node lesions."|participants|Number|35|35.0||||||
3827966|NCT01718691|3654121|B3|III||Clinical stage (Ann Arbor staging classification)|"The criteria of Ann Arbor staging classification are shown below.~I: Invasion of 1 lymph node region II: Invasion of 2 or more lymphatic regions confined to 1 side of the diaphragm III: Invasion of multiple lymph node regions spanning above and below the diaphragm IV: Diffuse invasion to an organ or area other than 1 or multiple lymphatic tissues, regardless of the presence/absence of lymph node lesions."|participants|Number|9|9.0||||||
3827967|NCT01718691|3654122|B2|III||Clinical stage (Ann Arbor staging classification)|"The criteria of Ann Arbor staging classification are shown below.~I: Invasion of 1 lymph node region II: Invasion of 2 or more lymphatic regions confined to 1 side of the diaphragm III: Invasion of multiple lymph node regions spanning above and below the diaphragm IV: Diffuse invasion to an organ or area other than 1 or multiple lymphatic tissues, regardless of the presence/absence of lymph node lesions."|participants|Number|0|0.0||||||
3827968|NCT01718691|3654123|B1|III||Clinical stage (Ann Arbor staging classification)|"The criteria of Ann Arbor staging classification are shown below.~I: Invasion of 1 lymph node region II: Invasion of 2 or more lymphatic regions confined to 1 side of the diaphragm III: Invasion of multiple lymph node regions spanning above and below the diaphragm IV: Diffuse invasion to an organ or area other than 1 or multiple lymphatic tissues, regardless of the presence/absence of lymph node lesions."|participants|Number|9|9.0||||||
3827969|NCT01718691|3654121|B3|I - II||Clinical stage (Ann Arbor staging classification)|"The criteria of Ann Arbor staging classification are shown below.~I: Invasion of 1 lymph node region II: Invasion of 2 or more lymphatic regions confined to 1 side of the diaphragm III: Invasion of multiple lymph node regions spanning above and below the diaphragm IV: Diffuse invasion to an organ or area other than 1 or multiple lymphatic tissues, regardless of the presence/absence of lymph node lesions."|participants|Number|15|15.0||||||
3827970|NCT01718691|3654122|B2|I - II||Clinical stage (Ann Arbor staging classification)|"The criteria of Ann Arbor staging classification are shown below.~I: Invasion of 1 lymph node region II: Invasion of 2 or more lymphatic regions confined to 1 side of the diaphragm III: Invasion of multiple lymph node regions spanning above and below the diaphragm IV: Diffuse invasion to an organ or area other than 1 or multiple lymphatic tissues, regardless of the presence/absence of lymph node lesions."|participants|Number|0|0.0||||||
3827971|NCT01718691|3654123|B1|I - II||Clinical stage (Ann Arbor staging classification)|"The criteria of Ann Arbor staging classification are shown below.~I: Invasion of 1 lymph node region II: Invasion of 2 or more lymphatic regions confined to 1 side of the diaphragm III: Invasion of multiple lymph node regions spanning above and below the diaphragm IV: Diffuse invasion to an organ or area other than 1 or multiple lymphatic tissues, regardless of the presence/absence of lymph node lesions."|participants|Number|15|15.0||||||
3827972|NCT01718691|3654121|B3|Mantle cell lymphoma||Diagnosis (WHO classification)||participants|Number|10|10.0||||||
3827973|NCT01718691|3654122|B2|Mantle cell lymphoma||Diagnosis (WHO classification)||participants|Number|10|10.0||||||
3827974|NCT01718691|3654123|B1|Mantle cell lymphoma||Diagnosis (WHO classification)||participants|Number|0|0.0||||||
3827975|NCT01718691|3654121|B3|Follicular lymphoma||Diagnosis (WHO classification)||participants|Number|51|51.0||||||
3827976|NCT01718691|3654122|B2|Follicular lymphoma||Diagnosis (WHO classification)||participants|Number|0|0.0||||||
3827977|NCT01718691|3654123|B1|Follicular lymphoma||Diagnosis (WHO classification)||participants|Number|51|51.0||||||
3827978|NCT01718691|3654121|B3|Nodal marginal zone B-cell lymphoma||Diagnosis (WHO classification)||participants|Number|0|0.0||||||
3827979|NCT01718691|3654122|B2|Nodal marginal zone B-cell lymphoma||Diagnosis (WHO classification)||participants|Number|0|0.0||||||
3827980|NCT01718691|3654123|B1|Nodal marginal zone B-cell lymphoma||Diagnosis (WHO classification)||participants|Number|0|0.0||||||
3827981|NCT01718691|3654121|B3|B-EMZL(MALT lymphoma)||Diagnosis (WHO classification)||participants|Number|4|4.0||||||
3827982|NCT01718691|3654122|B2|B-EMZL(MALT lymphoma)||Diagnosis (WHO classification)||participants|Number|0|0.0||||||
3827983|NCT01718691|3654123|B1|B-EMZL(MALT lymphoma)||Diagnosis (WHO classification)||participants|Number|4|4.0||||||
3827984|NCT01718691|3654121|B3|Splenic marginal zone lymphoma||Diagnosis (WHO classification)||participants|Number|0|0.0||||||
3827985|NCT01718691|3654122|B2|Splenic marginal zone lymphoma||Diagnosis (WHO classification)||participants|Number|0|0.0||||||
3827986|NCT01718691|3654123|B1|Splenic marginal zone lymphoma||Diagnosis (WHO classification)||participants|Number|0|0.0||||||
3827987|NCT01718691|3654121|B3|Lymphoplasmacytic lymphoma||Diagnosis (WHO classification)||participants|Number|2|2.0||||||
3827988|NCT01718691|3654122|B2|Lymphoplasmacytic lymphoma||Diagnosis (WHO classification)||participants|Number|0|0.0||||||
3827989|NCT01718691|3654123|B1|Lymphoplasmacytic lymphoma||Diagnosis (WHO classification)||participants|Number|2|2.0||||||
3827990|NCT01718691|3654121|B3|Small lymphocytic lymphoma||Diagnosis (WHO classification)||participants|Number|2|2.0||||||
3827991|NCT01718691|3654122|B2|Small lymphocytic lymphoma||Diagnosis (WHO classification)||participants|Number|0|0.0||||||
3827992|NCT01718691|3654123|B1|Small lymphocytic lymphoma||Diagnosis (WHO classification)||participants|Number|2|2.0||||||
3827993|NCT01718691|3654121|B3|2||Performance status (ECOG scale)|"The criteria of Eastern Cooperative Oncology Group (ECOG) performance status are shown below.~0: Symptoms are absent, no restrictions on lifestyle~Symptoms are present; no restrictions on walking; Strenuous physical activity is restricted~Symptoms are present; able to walk; able to perform self-care; Spends over 50% of waking hours out of bed"|participants|Number|1|1.0||||||
3827994|NCT01718691|3654122|B2|2||Performance status (ECOG scale)|"The criteria of Eastern Cooperative Oncology Group (ECOG) performance status are shown below.~0: Symptoms are absent, no restrictions on lifestyle~Symptoms are present; no restrictions on walking; Strenuous physical activity is restricted~Symptoms are present; able to walk; able to perform self-care; Spends over 50% of waking hours out of bed"|participants|Number|0|0.0||||||
3827995|NCT01718691|3654123|B1|2||Performance status (ECOG scale)|"The criteria of Eastern Cooperative Oncology Group (ECOG) performance status are shown below.~0: Symptoms are absent, no restrictions on lifestyle~Symptoms are present; no restrictions on walking; Strenuous physical activity is restricted~Symptoms are present; able to walk; able to perform self-care; Spends over 50% of waking hours out of bed"|participants|Number|1|1.0||||||
3827996|NCT01718691|3654121|B3|1||Performance status (ECOG scale)|"The criteria of Eastern Cooperative Oncology Group (ECOG) performance status are shown below.~0: Symptoms are absent, no restrictions on lifestyle~Symptoms are present; no restrictions on walking; Strenuous physical activity is restricted~Symptoms are present; able to walk; able to perform self-care; Spends over 50% of waking hours out of bed"|participants|Number|19|19.0||||||
3827997|NCT01718691|3654122|B2|1||Performance status (ECOG scale)|"The criteria of Eastern Cooperative Oncology Group (ECOG) performance status are shown below.~0: Symptoms are absent, no restrictions on lifestyle~Symptoms are present; no restrictions on walking; Strenuous physical activity is restricted~Symptoms are present; able to walk; able to perform self-care; Spends over 50% of waking hours out of bed"|participants|Number|3|3.0||||||
3827998|NCT01718691|3654123|B1|1||Performance status (ECOG scale)|"The criteria of Eastern Cooperative Oncology Group (ECOG) performance status are shown below.~0: Symptoms are absent, no restrictions on lifestyle~Symptoms are present; no restrictions on walking; Strenuous physical activity is restricted~Symptoms are present; able to walk; able to perform self-care; Spends over 50% of waking hours out of bed"|participants|Number|16|16.0||||||
3827999|NCT01718691|3654121|B3|0||Performance status (ECOG scale)|"The criteria of Eastern Cooperative Oncology Group (ECOG) performance status are shown below.~0: Symptoms are absent, no restrictions on lifestyle~Symptoms are present; no restrictions on walking; Strenuous physical activity is restricted~Symptoms are present; able to walk; able to perform self-care; Spends over 50% of waking hours out of bed"|participants|Number|49|49.0||||||
3828000|NCT01718691|3654122|B2|0||Performance status (ECOG scale)|"The criteria of Eastern Cooperative Oncology Group (ECOG) performance status are shown below.~0: Symptoms are absent, no restrictions on lifestyle~Symptoms are present; no restrictions on walking; Strenuous physical activity is restricted~Symptoms are present; able to walk; able to perform self-care; Spends over 50% of waking hours out of bed"|participants|Number|7|7.0||||||
3828001|NCT01718691|3654123|B1|0||Performance status (ECOG scale)|"The criteria of Eastern Cooperative Oncology Group (ECOG) performance status are shown below.~0: Symptoms are absent, no restrictions on lifestyle~Symptoms are present; no restrictions on walking; Strenuous physical activity is restricted~Symptoms are present; able to walk; able to perform self-care; Spends over 50% of waking hours out of bed"|participants|Number|42|42.0||||||
3828002|NCT01718691|3654121|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3828003|NCT01718691|3654122|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3828004|NCT01718691|3654123|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3828005|NCT01718691|3654121|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3828006|NCT01718691|3654122|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3828007|NCT01718691|3654123|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3828008|NCT01718691|3654121|B3|≥65 years||Age, Customized||participants|Number|33|33.0||||||
3828009|NCT01718691|3654122|B2|≥65 years||Age, Customized||participants|Number|10|10.0||||||
3828010|NCT01718691|3654123|B1|≥65 years||Age, Customized||participants|Number|23|23.0||||||
3828011|NCT01718691|3654121|B3|˂65 years||Age, Customized||participants|Number|36|36.0||||||
3828012|NCT01718691|3654122|B2|˂65 years||Age, Customized||participants|Number|0|0.0||||||
3828013|NCT01718691|3654123|B1|˂65 years||Age, Customized||participants|Number|36|36.0||||||
3828014|NCT01718535|3654157|B11|Canada||Region of Enrollment||participants|Number|325|325.0||||||
3828015|NCT01718535|3654158|B10|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3828016|NCT01718535|3654159|B9|Canada||Region of Enrollment||participants|Number|15|15.0||||||
3828017|NCT01718535|3654160|B8|Canada||Region of Enrollment||participants|Number|6|6.0||||||
3828018|NCT01718535|3654161|B7|Canada||Region of Enrollment||participants|Number|11|11.0||||||
3828019|NCT01718535|3654162|B6|Canada||Region of Enrollment||participants|Number|40|40.0||||||
3828020|NCT01718535|3654163|B5|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3828021|NCT01718535|3654164|B4|Canada||Region of Enrollment||participants|Number|7|7.0||||||
3828022|NCT01718535|3654165|B3|Canada||Region of Enrollment||participants|Number|19|19.0||||||
3828023|NCT01718535|3654166|B2|Canada||Region of Enrollment||participants|Number|95|95.0||||||
3828024|NCT01718535|3654167|B1|Canada||Region of Enrollment||participants|Number|130|130.0||||||
3828025|NCT01718535|3654157|B11|Gender Not Collected||Sex/Gender, Customized||Participants|Number|325|325.0||||||
3828026|NCT01718535|3654158|B10|Gender Not Collected||Sex/Gender, Customized||Participants|Number|1|1.0||||||
3828027|NCT01718535|3654159|B9|Gender Not Collected||Sex/Gender, Customized||Participants|Number|15|15.0||||||
3828028|NCT01718535|3654160|B8|Gender Not Collected||Sex/Gender, Customized||Participants|Number|6|6.0||||||
3828029|NCT01718535|3654161|B7|Gender Not Collected||Sex/Gender, Customized||Participants|Number|11|11.0||||||
3828030|NCT01718535|3654162|B6|Gender Not Collected||Sex/Gender, Customized||Participants|Number|40|40.0||||||
3828031|NCT01718535|3654163|B5|Gender Not Collected||Sex/Gender, Customized||Participants|Number|1|1.0||||||
3828032|NCT01718535|3654164|B4|Gender Not Collected||Sex/Gender, Customized||Participants|Number|7|7.0||||||
3828033|NCT01718535|3654165|B3|Gender Not Collected||Sex/Gender, Customized||Participants|Number|19|19.0||||||
3828034|NCT01718535|3654166|B2|Gender Not Collected||Sex/Gender, Customized||Participants|Number|95|95.0||||||
3828035|NCT01718535|3654167|B1|Gender Not Collected||Sex/Gender, Customized||Participants|Number|130|130.0||||||
3828036|NCT01718535|3654157|B11||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3828037|NCT01718535|3654158|B10||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3828038|NCT01718535|3654159|B9||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3828039|NCT01718535|3654160|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3828040|NCT01718535|3654161|B7||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3828041|NCT01718535|3654162|B6||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3828042|NCT01718535|3654163|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3828043|NCT01718535|3654164|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3828044|NCT01718535|3654165|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3828045|NCT01718535|3654166|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3828046|NCT01718535|3654167|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3828047|NCT01718535|3654157|B11||Between 18 and 65 years|Age||Participants|Count of Participants|315|315.0||||||
3828048|NCT01718535|3654158|B10||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3828049|NCT01718535|3654159|B9||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3828050|NCT01718535|3654160|B8||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3828051|NCT01718535|3654161|B7||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3828052|NCT01718535|3654162|B6||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3828053|NCT01718535|3654163|B5||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3828054|NCT01718535|3654164|B4||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3828055|NCT01718535|3654165|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3828056|NCT01718535|3654166|B2||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
3828057|NCT01718535|3654167|B1||Between 18 and 65 years|Age||Participants|Count of Participants|124|124.0||||||
3828058|NCT01718535|3654157|B11||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3828059|NCT01718535|3654158|B10||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3828060|NCT01718535|3654159|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3828061|NCT01718535|3654160|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3828062|NCT01718535|3654161|B7||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3828063|NCT01718535|3654162|B6||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3828064|NCT01718535|3654163|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3828065|NCT01718535|3654164|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3828066|NCT01718535|3654165|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3828067|NCT01718535|3654166|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3828068|NCT01718535|3654167|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3828069|NCT01718509|3654198|B3|UNITED STATES||Region of Enrollment||Participants|Number|346|346.0||||||
3828070|NCT01718509|3654199|B2|UNITED STATES||Region of Enrollment||Participants|Number|170|170.0||||||
3828071|NCT01718509|3654200|B1|UNITED STATES||Region of Enrollment||Participants|Number|176|176.0||||||
3828072|NCT01718509|3654198|B3|GERMANY||Region of Enrollment||Participants|Number|20|20.0||||||
3828073|NCT01718509|3654199|B2|GERMANY||Region of Enrollment||Participants|Number|11|11.0||||||
3828074|NCT01718509|3654200|B1|GERMANY||Region of Enrollment||Participants|Number|9|9.0||||||
3828075|NCT01718509|3654198|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3828076|NCT01718509|3654199|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3828077|NCT01718509|3654200|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3828078|NCT01718509|3654198|B3||Female|Sex: Female, Male||Participants|Count of Participants|312|312.0||||||
3828079|NCT01718509|3654199|B2||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
3828080|NCT01718509|3654200|B1||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3828081|NCT01718509|3654198|B3|>= 40 years||Age, Customized||Participants|Number|168|168.0||||||
3828082|NCT01718509|3654199|B2|>= 40 years||Age, Customized||Participants|Number|73|73.0||||||
3828083|NCT01718509|3654200|B1|>= 40 years||Age, Customized||Participants|Number|95|95.0||||||
3828084|NCT01718509|3654198|B3|< 40 years||Age, Customized||Participants|Number|198|198.0||||||
3828085|NCT01718509|3654199|B2|< 40 years||Age, Customized||Participants|Number|108|108.0||||||
3828086|NCT01718509|3654200|B1|< 40 years||Age, Customized||Participants|Number|90|90.0||||||
3828087|NCT01718509|3654198|B3|||Age||Years|Mean|37.9|37.9|Standard Deviation|10.02|10.02|||
3828088|NCT01718509|3654199|B2|||Age||Years|Mean|37.1|37.1|Standard Deviation|10.00|10.0|||
3828089|NCT01718509|3654200|B1|||Age||Years|Mean|38.7|38.7|Standard Deviation|10.01|10.01|||
3828090|NCT01718483|3654245|B3|UNITED STATES||Region of Enrollment||Participants|Number|338|338.0||||||
3828091|NCT01718483|3654246|B2|UNITED STATES||Region of Enrollment||Participants|Number|173|173.0||||||
3828092|NCT01718483|3654247|B1|UNITED STATES||Region of Enrollment||Participants|Number|165|165.0||||||
3828093|NCT01718483|3654245|B3|SWEDEN||Region of Enrollment||Participants|Number|28|28.0||||||
3828094|NCT01718483|3654246|B2|SWEDEN||Region of Enrollment||Participants|Number|13|13.0||||||
3828095|NCT01718483|3654247|B1|SWEDEN||Region of Enrollment||Participants|Number|15|15.0||||||
3828096|NCT01718483|3654245|B3|SPAIN||Region of Enrollment||Participants|Number|10|10.0||||||
3828097|NCT01718483|3654246|B2|SPAIN||Region of Enrollment||Participants|Number|5|5.0||||||
3828098|NCT01718483|3654247|B1|SPAIN||Region of Enrollment||Participants|Number|5|5.0||||||
3828099|NCT01718483|3654245|B3|GERMANY||Region of Enrollment||Participants|Number|3|3.0||||||
3828100|NCT01718483|3654246|B2|GERMANY||Region of Enrollment||Participants|Number|1|1.0||||||
3828101|NCT01718483|3654247|B1|GERMANY||Region of Enrollment||Participants|Number|2|2.0||||||
3828102|NCT01718483|3654245|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3828103|NCT01718483|3654246|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3828104|NCT01718483|3654247|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3828105|NCT01718483|3654245|B3||Female|Sex: Female, Male||Participants|Count of Participants|328|328.0||||||
3828106|NCT01718483|3654246|B2||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3828107|NCT01718483|3654247|B1||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3828108|NCT01718483|3654245|B3|>=40 years||Age, Customized||Participants|Number|179|179.0||||||
3828109|NCT01718483|3654246|B2|>=40 years||Age, Customized||Participants|Number|94|94.0||||||
3828110|NCT01718483|3654247|B1|>=40 years||Age, Customized||Participants|Number|85|85.0||||||
3828111|NCT01718483|3654245|B3|<40 years||Age, Customized||Participants|Number|200|200.0||||||
3828112|NCT01718483|3654246|B2|<40 years||Age, Customized||Participants|Number|98|98.0||||||
3828113|NCT01718483|3654247|B1|<40 years||Age, Customized||Participants|Number|102|102.0||||||
3828114|NCT01718483|3654245|B3|||Age||Years|Mean|38.1|38.1|Standard Deviation|10.3|10.3|||
3828115|NCT01718483|3654246|B2|||Age||Years|Mean|38.5|38.5|Standard Deviation|10.4|10.4|||
3828116|NCT01718483|3654247|B1|||Age||Years|Mean|37.6|37.6|Standard Deviation|10.21|10.21|||
3828117|NCT01718353|3654292|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3828118|NCT01718353|3654293|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3828119|NCT01718353|3654294|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3828120|NCT01718353|3654292|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3828121|NCT01718353|3654293|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3828122|NCT01718353|3654294|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3828123|NCT01718353|3654292|B3|||Age||years|Mean|69.7|69.7|Standard Deviation|8.4|8.4|||
3828124|NCT01718353|3654293|B2|||Age||years|Mean|69.2|69.2|Standard Deviation|9.5|9.5|||
3828125|NCT01718353|3654294|B1|||Age||years|Mean|69.9|69.9|Standard Deviation|7.8|7.8|||
3828126|NCT01718028|3654311|B3|Argentina||Region of Enrollment||participants|Number|49|49.0||||||
3828127|NCT01718028|3654312|B2|Argentina||Region of Enrollment||participants|Number|24|24.0||||||
3828128|NCT01718028|3654313|B1|Argentina||Region of Enrollment||participants|Number|25|25.0||||||
3828129|NCT01718028|3654311|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3828130|NCT01718028|3654312|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3828131|NCT01718028|3654313|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3828132|NCT01718028|3654311|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3828133|NCT01718028|3654312|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3828134|NCT01718028|3654313|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3828135|NCT01718028|3654311|B3|||Age||years|Mean|44.27|44.27|Standard Deviation|18.79|18.79|||
3828136|NCT01718028|3654312|B2|||Age||years|Mean|42.96|42.96|Standard Deviation|17.71|17.71|||
3828137|NCT01718028|3654313|B1|||Age||years|Mean|45.52|45.52|Standard Deviation|20.06|20.06|||
3828138|NCT01717989|3654326|B1|Missing||Dialysis modality at enrollment||participants|Number|3|3.0||||||
3828139|NCT01717989|3654326|B1|Home hemodialysis||Dialysis modality at enrollment||participants|Number|13|13.0||||||
3828140|NCT01717989|3654326|B1|Hemodialysis (in center)||Dialysis modality at enrollment||participants|Number|2107|2107.0||||||
3828141|NCT01717989|3654326|B1|Peritoneal||Dialysis modality at enrollment||participants|Number|125|125.0||||||
3828142|NCT01717989|3654326|B1|Neither Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1602|1602.0||||||
3828143|NCT01717989|3654326|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|646|646.0||||||
3828144|NCT01717989|3654326|B1|Unknown||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3828145|NCT01717989|3654326|B1|Other||Race/Ethnicity, Customized||participants|Number|171|171.0||||||
3828146|NCT01717989|3654326|B1|White||Race/Ethnicity, Customized||participants|Number|1246|1246.0||||||
3828147|NCT01717989|3654326|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|557|557.0||||||
3828301|NCT01717768|3654465|B7|75 years or older||Age, Customized||participants|Number|1|1.0||||||
3828148|NCT01717989|3654326|B1|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|258|258.0||||||
3828149|NCT01717989|3654326|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3828150|NCT01717989|3654326|B1||Male|Sex: Female, Male||Participants|Count of Participants|1282|1282.0||||||
3828151|NCT01717989|3654326|B1||Female|Sex: Female, Male||Participants|Count of Participants|966|966.0||||||
3828152|NCT01717989|3654326|B1|||Age||years|Mean|61.1|61.1|Standard Deviation|15.4|15.4|||
3828153|NCT01717976|3654392|B3||Male|Sex: Female, Male||Participants|Count of Participants|399|399.0||||||
3828154|NCT01717976|3654393|B2||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3828155|NCT01717976|3654394|B1||Male|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
3828156|NCT01717976|3654392|B3||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3828157|NCT01717976|3654393|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3828158|NCT01717976|3654394|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3828159|NCT01717976|3654392|B3|||Age||years|Mean|59.1|59.1|Standard Deviation|12.1|12.1|||
3828160|NCT01717976|3654393|B2|||Age||years|Mean|59.4|59.4|Standard Deviation|11.5|11.5|||
3828161|NCT01717976|3654394|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|12.7|12.7|||
3828162|NCT01717898|3654409|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3828163|NCT01717898|3654409|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3828164|NCT01717898|3654409|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3828165|NCT01717898|3654409|B1|||Age||years|Median|71|71.0|Full Range|||59.0|75.0|
3828166|NCT01717872|3654437|B3|||percent of glottic opening||percentage|Median|80|80.0|Inter-Quartile Range|||60.0|100.0|
3828167|NCT01717872|3654438|B2|||percent of glottic opening||percentage|Median|80|80.0|Inter-Quartile Range|||60.0|100.0|
3828168|NCT01717872|3654439|B1|||percent of glottic opening||percentage|Median|80|80.0|Inter-Quartile Range|||80.0|100.0|
3828169|NCT01717872|3654437|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3828170|NCT01717872|3654438|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3828171|NCT01717872|3654439|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3828172|NCT01717872|3654437|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3828173|NCT01717872|3654438|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3828174|NCT01717872|3654439|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3828175|NCT01717872|3654437|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3828176|NCT01717872|3654438|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3828177|NCT01717872|3654439|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3828178|NCT01717872|3654437|B3|Age||Age||months|Median|14|14.0|Full Range|||4.0|23.0|
3828179|NCT01717872|3654438|B2|Age||Age||months|Median|14|14.0|Full Range|||5.0|23.0|
3828180|NCT01717872|3654439|B1|Age||Age||months|Median|15|15.0|Full Range|||4.0|23.0|
3828181|NCT01717859|3654450|B1|||Max Joint Grey-Scale Ultrasound (GSUS)|GSUS Stands for Grey-Scale Ultrasound. This measure is a score of ultrasound images for rheumatoid arthritis activity in assessed joints. B-mode grey scale synovial hypertrophy will be graded semiquantitatively from 0 to 3 as follows: Grade 0: absent, Grade 1: mild, Grade 2: moderate, and Grade 3: severe. The measure ranges from 0 to 96. Scoring of the images was performed as per OMERACT guidelines by ultrasonographers at both sites.|units on a scale|Mean|43.61|43.61|Standard Deviation|14.68|14.68|||
3828182|NCT01717859|3654450|B1|||Max Joint Power Doppler Ultrasound (PDUS)|PDUS stands for power doppler ultrasound. This measure is a score of ultrasound images for rheumatoid arthritis activity in assessed joints. The Power Doppler signals are graded on a scale from 0 to 3 as follows: Grade 0: absent, no synovial flow. Grade 1: mild, 3 isolated signals, Grade 2: moderate, greater than 3 isolated signals or confluent signal in less than half of the synovial area, Grade 3: marked signals in more than half of the synovial area. The measure ranges from 0 to 96. Scoring of the images was performed as per OMERACT guidelines by ultrasonographers at both sites.|units on a scale|Mean|29.59|29.59|Standard Deviation|16.06|16.06|||
3828183|NCT01717859|3654450|B1|||Health Assessment Questionnaire- Disability Index (HAQ-DI)|HAQ-DI stands for Health Assessment Questionnaire- Disability Index. HAQ-DI is derived from the HAQ, Health Assessment Questionnaire, developed in the 1980's. The HAQ-DI measures the quality of life of the patient by asking the patient to report answers to their abilities to perform daily life tasks such as getting in and out of bed. It ranges from 0 to a maximum value of 3. Values in the range of 0 to 1 implies the patient has mild difficulties to moderate disability, 1 to 2 implies that the patient has a moderate to severe disability, and 2 to 3 implies a very severe disability.|units on a scale|Mean|1.47|1.47|Standard Deviation|0.60|0.6|||
3828184|NCT01717859|3654450|B1|||Clinical Disease Activity Index (CDAI)|"CDAI stands for Clinical Disease Activity Index and is a measure used to assess rheumatoid arthritis activity. This scale sums the count of swollen joints, the count of tender joints (both out of 28 assessed joints), and the final scores of both a patient global health assessment and a care provider global health assessment for the patient on a continuous scale from 0-10. CDAI ranges from 0 to 76, and <2.8 implies remission, <10.0 implies low disease activity, <22.0 implies moderate disease activity, and >22.0 implies high disease activity."|units on a scale|Mean|39.04|39.04|Standard Deviation|11.90|11.9|||
3828185|NCT01717859|3654450|B1|||Disease Activity Score All Joints (DAS28)/ Erythrocyte Sedimentation Rate (ESR)|DAS28 is a measure of disease activity in rheumatoid arthritis (RA). DAS stands for 'disease activity score' and the number 28 refers to the 28 joints that are examined in this assessment. The calculation takes into account the number of swollen joints, the number of tender joints (both out of 28 assessed joints), the erythrocyte sedimentation rate (ESR), and a self-reported global assessment of health from the patient. DAS28 ranges from 0 to a maximum of 9.48. A DAS28 more than 5.1 implies active disease, less than 3.2 implies low disease activity, and less than 2.6 implies remission.|units on a scale|Mean|6.30|6.3|Standard Deviation|1.03|1.03|||
3828186|NCT01717859|3654450|B1|||Disease duration||years|Mean|9.94|9.94|Standard Deviation|7.50|7.5|||
3828187|NCT01717859|3654450|B1|United States||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
3828188|NCT01717859|3654450|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3828189|NCT01717859|3654450|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828190|NCT01717859|3654450|B1||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3828191|NCT01717859|3654450|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3828192|NCT01717859|3654450|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3828193|NCT01717859|3654450|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3828194|NCT01717859|3654450|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3828195|NCT01717859|3654450|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3828196|NCT01717859|3654450|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3828197|NCT01717859|3654450|B1|||Age||years|Mean|51.87|51.87|Standard Deviation|15.16|15.16|||
3828198|NCT01717768|3654461|B11|United States||Region of Enrollment||participants|Number|130|130.0||||||
3828199|NCT01717768|3654462|B10|United States||Region of Enrollment||participants|Number|16|16.0||||||
3828200|NCT01717768|3654463|B9|United States||Region of Enrollment||participants|Number|16|16.0||||||
3828201|NCT01717768|3654464|B8|United States||Region of Enrollment||participants|Number|16|16.0||||||
3828202|NCT01717768|3654465|B7|United States||Region of Enrollment||participants|Number|17|17.0||||||
3828203|NCT01717768|3654466|B6|United States||Region of Enrollment||participants|Number|5|5.0||||||
3828204|NCT01717768|3654467|B5|United States||Region of Enrollment||participants|Number|5|5.0||||||
3828205|NCT01717768|3654468|B4|United States||Region of Enrollment||participants|Number|4|4.0||||||
3828206|NCT01717768|3654469|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
3828207|NCT01717768|3654470|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3828208|NCT01717768|3654471|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3828209|NCT01717768|3654461|B11||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828210|NCT01717768|3654462|B10||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828211|NCT01717768|3654463|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828212|NCT01717768|3654464|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828213|NCT01717768|3654465|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828214|NCT01717768|3654466|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828215|NCT01717768|3654467|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828216|NCT01717768|3654468|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828217|NCT01717768|3654469|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828218|NCT01717768|3654470|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828219|NCT01717768|3654471|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828220|NCT01717768|3654461|B11||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3828221|NCT01717768|3654462|B10||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828222|NCT01717768|3654463|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828223|NCT01717768|3654464|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828224|NCT01717768|3654465|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828225|NCT01717768|3654466|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828226|NCT01717768|3654467|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828227|NCT01717768|3654468|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828228|NCT01717768|3654469|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828229|NCT01717768|3654470|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828230|NCT01717768|3654471|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3828231|NCT01717768|3654461|B11||White|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3828232|NCT01717768|3654462|B10||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3828233|NCT01717768|3654463|B9||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3828234|NCT01717768|3654464|B8||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3828235|NCT01717768|3654465|B7||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3828236|NCT01717768|3654466|B6||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3828237|NCT01717768|3654467|B5||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3828238|NCT01717768|3654468|B4||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3828239|NCT01717768|3654469|B3||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3828240|NCT01717768|3654470|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3828241|NCT01717768|3654471|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3828242|NCT01717768|3654461|B11||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3828243|NCT01717768|3654462|B10||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3828244|NCT01717768|3654463|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3828245|NCT01717768|3654464|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3828246|NCT01717768|3654465|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3828247|NCT01717768|3654466|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3828248|NCT01717768|3654467|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3828249|NCT01717768|3654468|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3828250|NCT01717768|3654469|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828251|NCT01717768|3654470|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3828252|NCT01717768|3654471|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3828253|NCT01717768|3654461|B11||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3828254|NCT01717768|3654462|B10||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3828255|NCT01717768|3654463|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828256|NCT01717768|3654464|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828257|NCT01717768|3654465|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3828258|NCT01717768|3654466|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828259|NCT01717768|3654467|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828260|NCT01717768|3654468|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828261|NCT01717768|3654469|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828262|NCT01717768|3654470|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828263|NCT01717768|3654471|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828264|NCT01717768|3654461|B11||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3828265|NCT01717768|3654462|B10||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3828266|NCT01717768|3654463|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828267|NCT01717768|3654464|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828268|NCT01717768|3654465|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3828269|NCT01717768|3654466|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828270|NCT01717768|3654467|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828271|NCT01717768|3654468|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828272|NCT01717768|3654469|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828273|NCT01717768|3654470|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828274|NCT01717768|3654471|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828275|NCT01717768|3654461|B11||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3828276|NCT01717768|3654462|B10||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3828277|NCT01717768|3654463|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828278|NCT01717768|3654464|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828279|NCT01717768|3654465|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3828280|NCT01717768|3654466|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828281|NCT01717768|3654467|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828282|NCT01717768|3654468|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828283|NCT01717768|3654469|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828284|NCT01717768|3654470|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828285|NCT01717768|3654471|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828286|NCT01717768|3654461|B11|Male||Sex/Gender, Customized||participants|Number|130|130.0||||||
3828287|NCT01717768|3654462|B10|Male||Sex/Gender, Customized||participants|Number|16|16.0||||||
3828288|NCT01717768|3654463|B9|Male||Sex/Gender, Customized||participants|Number|16|16.0||||||
3828289|NCT01717768|3654464|B8|Male||Sex/Gender, Customized||participants|Number|16|16.0||||||
3828290|NCT01717768|3654465|B7|Male||Sex/Gender, Customized||participants|Number|17|17.0||||||
3828291|NCT01717768|3654466|B6|Male||Sex/Gender, Customized||participants|Number|5|5.0||||||
3828292|NCT01717768|3654467|B5|Male||Sex/Gender, Customized||participants|Number|5|5.0||||||
3828293|NCT01717768|3654468|B4|Male||Sex/Gender, Customized||participants|Number|4|4.0||||||
3828294|NCT01717768|3654469|B3|Male||Sex/Gender, Customized||participants|Number|17|17.0||||||
3828295|NCT01717768|3654470|B2|Male||Sex/Gender, Customized||participants|Number|17|17.0||||||
3828296|NCT01717768|3654471|B1|Male||Sex/Gender, Customized||participants|Number|17|17.0||||||
3828297|NCT01717768|3654461|B11|75 years or older||Age, Customized||participants|Number|4|4.0||||||
3828298|NCT01717768|3654462|B10|75 years or older||Age, Customized||participants|Number|0|0.0||||||
3828299|NCT01717768|3654463|B9|75 years or older||Age, Customized||participants|Number|0|0.0||||||
3828300|NCT01717768|3654464|B8|75 years or older||Age, Customized||participants|Number|0|0.0||||||
3828302|NCT01717768|3654466|B6|75 years or older||Age, Customized||participants|Number|0|0.0||||||
3828303|NCT01717768|3654467|B5|75 years or older||Age, Customized||participants|Number|0|0.0||||||
3828304|NCT01717768|3654468|B4|75 years or older||Age, Customized||participants|Number|1|1.0||||||
3828305|NCT01717768|3654469|B3|75 years or older||Age, Customized||participants|Number|1|1.0||||||
3828306|NCT01717768|3654470|B2|75 years or older||Age, Customized||participants|Number|0|0.0||||||
3828307|NCT01717768|3654471|B1|75 years or older||Age, Customized||participants|Number|1|1.0||||||
3828308|NCT01717768|3654461|B11|65-74 years||Age, Customized||participants|Number|19|19.0||||||
3828309|NCT01717768|3654462|B10|65-74 years||Age, Customized||participants|Number|2|2.0||||||
3828310|NCT01717768|3654463|B9|65-74 years||Age, Customized||participants|Number|0|0.0||||||
3828311|NCT01717768|3654464|B8|65-74 years||Age, Customized||participants|Number|4|4.0||||||
3828312|NCT01717768|3654465|B7|65-74 years||Age, Customized||participants|Number|3|3.0||||||
3828313|NCT01717768|3654466|B6|65-74 years||Age, Customized||participants|Number|1|1.0||||||
3828314|NCT01717768|3654467|B5|65-74 years||Age, Customized||participants|Number|0|0.0||||||
3828315|NCT01717768|3654468|B4|65-74 years||Age, Customized||participants|Number|1|1.0||||||
3828316|NCT01717768|3654469|B3|65-74 years||Age, Customized||participants|Number|3|3.0||||||
3828317|NCT01717768|3654470|B2|65-74 years||Age, Customized||participants|Number|2|2.0||||||
3828318|NCT01717768|3654471|B1|65-74 years||Age, Customized||participants|Number|3|3.0||||||
3828319|NCT01717768|3654461|B11|50-64 years||Age, Customized||participants|Number|69|69.0||||||
3828320|NCT01717768|3654462|B10|50-64 years||Age, Customized||participants|Number|9|9.0||||||
3828321|NCT01717768|3654463|B9|50-64 years||Age, Customized||participants|Number|7|7.0||||||
3828322|NCT01717768|3654464|B8|50-64 years||Age, Customized||participants|Number|8|8.0||||||
3828323|NCT01717768|3654465|B7|50-64 years||Age, Customized||participants|Number|9|9.0||||||
3828324|NCT01717768|3654466|B6|50-64 years||Age, Customized||participants|Number|4|4.0||||||
3828325|NCT01717768|3654467|B5|50-64 years||Age, Customized||participants|Number|4|4.0||||||
3828326|NCT01717768|3654468|B4|50-64 years||Age, Customized||participants|Number|1|1.0||||||
3828327|NCT01717768|3654469|B3|50-64 years||Age, Customized||participants|Number|5|5.0||||||
3828328|NCT01717768|3654470|B2|50-64 years||Age, Customized||participants|Number|11|11.0||||||
3828329|NCT01717768|3654471|B1|50-64 years||Age, Customized||participants|Number|11|11.0||||||
3828330|NCT01717768|3654461|B11|<50 years||Age, Customized||participants|Number|38|38.0||||||
3828331|NCT01717768|3654462|B10|<50 years||Age, Customized||participants|Number|5|5.0||||||
3828332|NCT01717768|3654463|B9|<50 years||Age, Customized||participants|Number|9|9.0||||||
3828333|NCT01717768|3654464|B8|<50 years||Age, Customized||participants|Number|4|4.0||||||
3828334|NCT01717768|3654465|B7|<50 years||Age, Customized||participants|Number|4|4.0||||||
3828335|NCT01717768|3654466|B6|<50 years||Age, Customized||participants|Number|0|0.0||||||
3828336|NCT01717768|3654467|B5|<50 years||Age, Customized||participants|Number|1|1.0||||||
3828337|NCT01717768|3654468|B4|<50 years||Age, Customized||participants|Number|1|1.0||||||
3828338|NCT01717768|3654469|B3|<50 years||Age, Customized||participants|Number|8|8.0||||||
3828339|NCT01717768|3654470|B2|<50 years||Age, Customized||participants|Number|4|4.0||||||
3828340|NCT01717768|3654471|B1|<50 years||Age, Customized||participants|Number|2|2.0||||||
3828341|NCT01717638|3654520|B14||Male|Sex: Female, Male||Participants|Count of Participants|418|418.0||||||
3828342|NCT01717638|3654521|B13||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3828343|NCT01717638|3654522|B12||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3828344|NCT01717638|3654523|B11||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3828345|NCT01717638|3654524|B10||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3828346|NCT01717638|3654525|B9||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3828347|NCT01717638|3654526|B8||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3828348|NCT01717638|3654527|B7||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3828349|NCT01717638|3654528|B6||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3828350|NCT01717638|3654529|B5||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3828351|NCT01717638|3654530|B4||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3828352|NCT01717638|3654531|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3828353|NCT01717638|3654532|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3828354|NCT01717638|3654533|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3828355|NCT01717638|3654520|B14||Female|Sex: Female, Male||Participants|Count of Participants|387|387.0||||||
3828356|NCT01717638|3654521|B13||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3828357|NCT01717638|3654522|B12||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3828358|NCT01717638|3654523|B11||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3828359|NCT01717638|3654524|B10||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3828360|NCT01717638|3654525|B9||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3828361|NCT01717638|3654526|B8||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3828362|NCT01717638|3654527|B7||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3828363|NCT01717638|3654528|B6||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3828364|NCT01717638|3654529|B5||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3828365|NCT01717638|3654530|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3828366|NCT01717638|3654531|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3828367|NCT01717638|3654532|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3828368|NCT01717638|3654533|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3828369|NCT01717638|3654520|B14|||Age||Months|Mean|52.4|52.4|Standard Deviation|3.6|3.6|||
3828370|NCT01717638|3654521|B13|||Age||Months|Mean|53.7|53.7|Standard Deviation|3.6|3.6|||
3828371|NCT01717638|3654522|B12|||Age||Months|Mean|56.8|56.8|Standard Deviation|1.5|1.5|||
3828372|NCT01717638|3654523|B11|||Age||Months|Mean|53.4|53.4|Standard Deviation|4.3|4.3|||
3828373|NCT01717638|3654524|B10|||Age||Months|Mean|51.7|51.7|Standard Deviation|3.3|3.3|||
3828374|NCT01717638|3654525|B9|||Age||Months|Mean|53.1|53.1|Standard Deviation|3.5|3.5|||
3828375|NCT01717638|3654526|B8|||Age||Months|Mean|51.4|51.4|Standard Deviation|3.4|3.4|||
3828376|NCT01717638|3654527|B7|||Age||Months|Mean|51.8|51.8|Standard Deviation|3.4|3.4|||
3828377|NCT01717638|3654528|B6|||Age||Months|Mean|52.3|52.3|Standard Deviation|3.7|3.7|||
3828378|NCT01717638|3654529|B5|||Age||Months|Mean|51.3|51.3|Standard Deviation|3.7|3.7|||
3828379|NCT01717638|3654530|B4|||Age||Months|Mean|51.7|51.7|Standard Deviation|3.5|3.5|||
3828380|NCT01717638|3654531|B3|||Age||Months|Mean|51.7|51.7|Standard Deviation|3.5|3.5|||
3828381|NCT01717638|3654532|B2|||Age||Months|Mean|52.1|52.1|Standard Deviation|3.4|3.4|||
3828382|NCT01717638|3654533|B1|||Age||Months|Mean|51.8|51.8|Standard Deviation|3.4|3.4|||
3828383|NCT01717456|3654687|B3|Unknown||Source of Assistance with ADLs at Baseline|"OASIS Question M2100 has 5 discrete categories which are:~0 = No assistance needed~= Caregiver provides assistance for activities of daily living (ADLs)~= Caregiver needs training or support~= Caregiver is not likely to provide assistance~= Unclear if caregiver will provide assistance~= Assistance needed but none is available~Higher scores indicate a greater need for assistance with ADLs."|participants|Number|9|9.0||||||
3828384|NCT01717456|3654688|B2|Unknown||Source of Assistance with ADLs at Baseline|"OASIS Question M2100 has 5 discrete categories which are:~0 = No assistance needed~= Caregiver provides assistance for activities of daily living (ADLs)~= Caregiver needs training or support~= Caregiver is not likely to provide assistance~= Unclear if caregiver will provide assistance~= Assistance needed but none is available~Higher scores indicate a greater need for assistance with ADLs."|participants|Number|6|6.0||||||
3828385|NCT01717456|3654689|B1|Unknown||Source of Assistance with ADLs at Baseline|"OASIS Question M2100 has 5 discrete categories which are:~0 = No assistance needed~= Caregiver provides assistance for activities of daily living (ADLs)~= Caregiver needs training or support~= Caregiver is not likely to provide assistance~= Unclear if caregiver will provide assistance~= Assistance needed but none is available~Higher scores indicate a greater need for assistance with ADLs."|participants|Number|3|3.0||||||
3828386|NCT01717456|3654687|B3|Assistance needed but not available||Source of Assistance with ADLs at Baseline|"OASIS Question M2100 has 5 discrete categories which are:~0 = No assistance needed~= Caregiver provides assistance for activities of daily living (ADLs)~= Caregiver needs training or support~= Caregiver is not likely to provide assistance~= Unclear if caregiver will provide assistance~= Assistance needed but none is available~Higher scores indicate a greater need for assistance with ADLs."|participants|Number|0|0.0||||||
3828387|NCT01717456|3654688|B2|Assistance needed but not available||Source of Assistance with ADLs at Baseline|"OASIS Question M2100 has 5 discrete categories which are:~0 = No assistance needed~= Caregiver provides assistance for activities of daily living (ADLs)~= Caregiver needs training or support~= Caregiver is not likely to provide assistance~= Unclear if caregiver will provide assistance~= Assistance needed but none is available~Higher scores indicate a greater need for assistance with ADLs."|participants|Number|0|0.0||||||
3828388|NCT01717456|3654689|B1|Assistance needed but not available||Source of Assistance with ADLs at Baseline|"OASIS Question M2100 has 5 discrete categories which are:~0 = No assistance needed~= Caregiver provides assistance for activities of daily living (ADLs)~= Caregiver needs training or support~= Caregiver is not likely to provide assistance~= Unclear if caregiver will provide assistance~= Assistance needed but none is available~Higher scores indicate a greater need for assistance with ADLs."|participants|Number|0|0.0||||||
3828389|NCT01717456|3654687|B3|Unclear if caregiver will assist patient||Source of Assistance with ADLs at Baseline|"OASIS Question M2100 has 5 discrete categories which are:~0 = No assistance needed~= Caregiver provides assistance for activities of daily living (ADLs)~= Caregiver needs training or support~= Caregiver is not likely to provide assistance~= Unclear if caregiver will provide assistance~= Assistance needed but none is available~Higher scores indicate a greater need for assistance with ADLs."|participants|Number|0|0.0||||||
3828390|NCT01717456|3654688|B2|Unclear if caregiver will assist patient||Source of Assistance with ADLs at Baseline|"OASIS Question M2100 has 5 discrete categories which are:~0 = No assistance needed~= Caregiver provides assistance for activities of daily living (ADLs)~= Caregiver needs training or support~= Caregiver is not likely to provide assistance~= Unclear if caregiver will provide assistance~= Assistance needed but none is available~Higher scores indicate a greater need for assistance with ADLs."|participants|Number|0|0.0||||||
3828391|NCT01717456|3654689|B1|Unclear if caregiver will assist patient||Source of Assistance with ADLs at Baseline|"OASIS Question M2100 has 5 discrete categories which are:~0 = No assistance needed~= Caregiver provides assistance for activities of daily living (ADLs)~= Caregiver needs training or support~= Caregiver is not likely to provide assistance~= Unclear if caregiver will provide assistance~= Assistance needed but none is available~Higher scores indicate a greater need for assistance with ADLs."|participants|Number|0|0.0||||||
3828392|NCT01717456|3654687|B3|Caregiver unlikely to provide assistance||Source of Assistance with ADLs at Baseline|"OASIS Question M2100 has 5 discrete categories which are:~0 = No assistance needed~= Caregiver provides assistance for activities of daily living (ADLs)~= Caregiver needs training or support~= Caregiver is not likely to provide assistance~= Unclear if caregiver will provide assistance~= Assistance needed but none is available~Higher scores indicate a greater need for assistance with ADLs."|participants|Number|0|0.0||||||
3828409|NCT01717456|3654689|B1|Lives in assisted living||Living Situation at Baseline|"OASIS Question M1100 has 3 discrete categories which are:~1 = Lives alone 6 = Lives with another person 11 = Lives in assisted living~Scores are labels describing the patient's living situation."|participants|Number|2|2.0||||||
3828393|NCT01717456|3654688|B2|Caregiver unlikely to provide assistance||Source of Assistance with ADLs at Baseline|"OASIS Question M2100 has 5 discrete categories which are:~0 = No assistance needed~= Caregiver provides assistance for activities of daily living (ADLs)~= Caregiver needs training or support~= Caregiver is not likely to provide assistance~= Unclear if caregiver will provide assistance~= Assistance needed but none is available~Higher scores indicate a greater need for assistance with ADLs."|participants|Number|0|0.0||||||
3828394|NCT01717456|3654689|B1|Caregiver unlikely to provide assistance||Source of Assistance with ADLs at Baseline|"OASIS Question M2100 has 5 discrete categories which are:~0 = No assistance needed~= Caregiver provides assistance for activities of daily living (ADLs)~= Caregiver needs training or support~= Caregiver is not likely to provide assistance~= Unclear if caregiver will provide assistance~= Assistance needed but none is available~Higher scores indicate a greater need for assistance with ADLs."|participants|Number|0|0.0||||||
3828395|NCT01717456|3654687|B3|Caregiver needs training or support||Source of Assistance with ADLs at Baseline|"OASIS Question M2100 has 5 discrete categories which are:~0 = No assistance needed~= Caregiver provides assistance for activities of daily living (ADLs)~= Caregiver needs training or support~= Caregiver is not likely to provide assistance~= Unclear if caregiver will provide assistance~= Assistance needed but none is available~Higher scores indicate a greater need for assistance with ADLs."|participants|Number|0|0.0||||||
3828396|NCT01717456|3654688|B2|Caregiver needs training or support||Source of Assistance with ADLs at Baseline|"OASIS Question M2100 has 5 discrete categories which are:~0 = No assistance needed~= Caregiver provides assistance for activities of daily living (ADLs)~= Caregiver needs training or support~= Caregiver is not likely to provide assistance~= Unclear if caregiver will provide assistance~= Assistance needed but none is available~Higher scores indicate a greater need for assistance with ADLs."|participants|Number|0|0.0||||||
3828397|NCT01717456|3654689|B1|Caregiver needs training or support||Source of Assistance with ADLs at Baseline|"OASIS Question M2100 has 5 discrete categories which are:~0 = No assistance needed~= Caregiver provides assistance for activities of daily living (ADLs)~= Caregiver needs training or support~= Caregiver is not likely to provide assistance~= Unclear if caregiver will provide assistance~= Assistance needed but none is available~Higher scores indicate a greater need for assistance with ADLs."|participants|Number|0|0.0||||||
3828398|NCT01717456|3654687|B3|Caregiver provides assistance||Source of Assistance with ADLs at Baseline|"OASIS Question M2100 has 5 discrete categories which are:~0 = No assistance needed~= Caregiver provides assistance for activities of daily living (ADLs)~= Caregiver needs training or support~= Caregiver is not likely to provide assistance~= Unclear if caregiver will provide assistance~= Assistance needed but none is available~Higher scores indicate a greater need for assistance with ADLs."|participants|Number|3|3.0||||||
3828399|NCT01717456|3654688|B2|Caregiver provides assistance||Source of Assistance with ADLs at Baseline|"OASIS Question M2100 has 5 discrete categories which are:~0 = No assistance needed~= Caregiver provides assistance for activities of daily living (ADLs)~= Caregiver needs training or support~= Caregiver is not likely to provide assistance~= Unclear if caregiver will provide assistance~= Assistance needed but none is available~Higher scores indicate a greater need for assistance with ADLs."|participants|Number|0|0.0||||||
3828400|NCT01717456|3654689|B1|Caregiver provides assistance||Source of Assistance with ADLs at Baseline|"OASIS Question M2100 has 5 discrete categories which are:~0 = No assistance needed~= Caregiver provides assistance for activities of daily living (ADLs)~= Caregiver needs training or support~= Caregiver is not likely to provide assistance~= Unclear if caregiver will provide assistance~= Assistance needed but none is available~Higher scores indicate a greater need for assistance with ADLs."|participants|Number|3|3.0||||||
3828401|NCT01717456|3654687|B3|No assistance needed||Source of Assistance with ADLs at Baseline|"OASIS Question M2100 has 5 discrete categories which are:~0 = No assistance needed~= Caregiver provides assistance for activities of daily living (ADLs)~= Caregiver needs training or support~= Caregiver is not likely to provide assistance~= Unclear if caregiver will provide assistance~= Assistance needed but none is available~Higher scores indicate a greater need for assistance with ADLs."|participants|Number|7|7.0||||||
3828402|NCT01717456|3654688|B2|No assistance needed||Source of Assistance with ADLs at Baseline|"OASIS Question M2100 has 5 discrete categories which are:~0 = No assistance needed~= Caregiver provides assistance for activities of daily living (ADLs)~= Caregiver needs training or support~= Caregiver is not likely to provide assistance~= Unclear if caregiver will provide assistance~= Assistance needed but none is available~Higher scores indicate a greater need for assistance with ADLs."|participants|Number|2|2.0||||||
3828403|NCT01717456|3654689|B1|No assistance needed||Source of Assistance with ADLs at Baseline|"OASIS Question M2100 has 5 discrete categories which are:~0 = No assistance needed~= Caregiver provides assistance for activities of daily living (ADLs)~= Caregiver needs training or support~= Caregiver is not likely to provide assistance~= Unclear if caregiver will provide assistance~= Assistance needed but none is available~Higher scores indicate a greater need for assistance with ADLs."|participants|Number|5|5.0||||||
3828404|NCT01717456|3654687|B3|Unknown||Living Situation at Baseline|"OASIS Question M1100 has 3 discrete categories which are:~1 = Lives alone 6 = Lives with another person 11 = Lives in assisted living~Scores are labels describing the patient's living situation."|participants|Number|8|8.0||||||
3828405|NCT01717456|3654688|B2|Unknown||Living Situation at Baseline|"OASIS Question M1100 has 3 discrete categories which are:~1 = Lives alone 6 = Lives with another person 11 = Lives in assisted living~Scores are labels describing the patient's living situation."|participants|Number|6|6.0||||||
3828406|NCT01717456|3654689|B1|Unknown||Living Situation at Baseline|"OASIS Question M1100 has 3 discrete categories which are:~1 = Lives alone 6 = Lives with another person 11 = Lives in assisted living~Scores are labels describing the patient's living situation."|participants|Number|2|2.0||||||
3828407|NCT01717456|3654687|B3|Lives in assisted living||Living Situation at Baseline|"OASIS Question M1100 has 3 discrete categories which are:~1 = Lives alone 6 = Lives with another person 11 = Lives in assisted living~Scores are labels describing the patient's living situation."|participants|Number|2|2.0||||||
3828408|NCT01717456|3654688|B2|Lives in assisted living||Living Situation at Baseline|"OASIS Question M1100 has 3 discrete categories which are:~1 = Lives alone 6 = Lives with another person 11 = Lives in assisted living~Scores are labels describing the patient's living situation."|participants|Number|0|0.0||||||
3828488|NCT01717456|3654687|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3828489|NCT01717456|3654688|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828410|NCT01717456|3654687|B3|Lives with another adult||Living Situation at Baseline|"OASIS Question M1100 has 3 discrete categories which are:~1 = Lives alone 6 = Lives with another person 11 = Lives in assisted living~Scores are labels describing the patient's living situation."|participants|Number|6|6.0||||||
3828411|NCT01717456|3654688|B2|Lives with another adult||Living Situation at Baseline|"OASIS Question M1100 has 3 discrete categories which are:~1 = Lives alone 6 = Lives with another person 11 = Lives in assisted living~Scores are labels describing the patient's living situation."|participants|Number|2|2.0||||||
3828412|NCT01717456|3654689|B1|Lives with another adult||Living Situation at Baseline|"OASIS Question M1100 has 3 discrete categories which are:~1 = Lives alone 6 = Lives with another person 11 = Lives in assisted living~Scores are labels describing the patient's living situation."|participants|Number|4|4.0||||||
3828413|NCT01717456|3654687|B3|Lives alone||Living Situation at Baseline|"OASIS Question M1100 has 3 discrete categories which are:~1 = Lives alone 6 = Lives with another person 11 = Lives in assisted living~Scores are labels describing the patient's living situation."|participants|Number|3|3.0||||||
3828414|NCT01717456|3654688|B2|Lives alone||Living Situation at Baseline|"OASIS Question M1100 has 3 discrete categories which are:~1 = Lives alone 6 = Lives with another person 11 = Lives in assisted living~Scores are labels describing the patient's living situation."|participants|Number|0|0.0||||||
3828415|NCT01717456|3654689|B1|Lives alone||Living Situation at Baseline|"OASIS Question M1100 has 3 discrete categories which are:~1 = Lives alone 6 = Lives with another person 11 = Lives in assisted living~Scores are labels describing the patient's living situation."|participants|Number|3|3.0||||||
3828416|NCT01717456|3654687|B3|Unknown||Depression Screening at Baseline|"OASIS Question M1730 has 4 discrete categories. Possible responses are:~0 = Patient was not screened for depression~= Screened by PHQ2 depression scale~= Meets criteria for further screening for depression~= Does not meet criteria for further screening~Higher scores indicate a greater level of depression."|participants|Number|8|8.0||||||
3828417|NCT01717456|3654688|B2|Unknown||Depression Screening at Baseline|"OASIS Question M1730 has 4 discrete categories. Possible responses are:~0 = Patient was not screened for depression~= Screened by PHQ2 depression scale~= Meets criteria for further screening for depression~= Does not meet criteria for further screening~Higher scores indicate a greater level of depression."|participants|Number|6|6.0||||||
3828418|NCT01717456|3654689|B1|Unknown||Depression Screening at Baseline|"OASIS Question M1730 has 4 discrete categories. Possible responses are:~0 = Patient was not screened for depression~= Screened by PHQ2 depression scale~= Meets criteria for further screening for depression~= Does not meet criteria for further screening~Higher scores indicate a greater level of depression."|participants|Number|2|2.0||||||
3828419|NCT01717456|3654687|B3|Screened and does not need further evaluation||Depression Screening at Baseline|"OASIS Question M1730 has 4 discrete categories. Possible responses are:~0 = Patient was not screened for depression~= Screened by PHQ2 depression scale~= Meets criteria for further screening for depression~= Does not meet criteria for further screening~Higher scores indicate a greater level of depression."|participants|Number|0|0.0||||||
3828420|NCT01717456|3654688|B2|Screened and does not need further evaluation||Depression Screening at Baseline|"OASIS Question M1730 has 4 discrete categories. Possible responses are:~0 = Patient was not screened for depression~= Screened by PHQ2 depression scale~= Meets criteria for further screening for depression~= Does not meet criteria for further screening~Higher scores indicate a greater level of depression."|participants|Number|0|0.0||||||
3828421|NCT01717456|3654689|B1|Screened and does not need further evaluation||Depression Screening at Baseline|"OASIS Question M1730 has 4 discrete categories. Possible responses are:~0 = Patient was not screened for depression~= Screened by PHQ2 depression scale~= Meets criteria for further screening for depression~= Does not meet criteria for further screening~Higher scores indicate a greater level of depression."|participants|Number|0|0.0||||||
3828422|NCT01717456|3654687|B3|Requires further evaluation||Depression Screening at Baseline|"OASIS Question M1730 has 4 discrete categories. Possible responses are:~0 = Patient was not screened for depression~= Screened by PHQ2 depression scale~= Meets criteria for further screening for depression~= Does not meet criteria for further screening~Higher scores indicate a greater level of depression."|participants|Number|0|0.0||||||
3828423|NCT01717456|3654688|B2|Requires further evaluation||Depression Screening at Baseline|"OASIS Question M1730 has 4 discrete categories. Possible responses are:~0 = Patient was not screened for depression~= Screened by PHQ2 depression scale~= Meets criteria for further screening for depression~= Does not meet criteria for further screening~Higher scores indicate a greater level of depression."|participants|Number|0|0.0||||||
3828424|NCT01717456|3654689|B1|Requires further evaluation||Depression Screening at Baseline|"OASIS Question M1730 has 4 discrete categories. Possible responses are:~0 = Patient was not screened for depression~= Screened by PHQ2 depression scale~= Meets criteria for further screening for depression~= Does not meet criteria for further screening~Higher scores indicate a greater level of depression."|participants|Number|0|0.0||||||
3828425|NCT01717456|3654687|B3|Screened by Patient Health Questionnaire 2 (PHQ2)||Depression Screening at Baseline|"OASIS Question M1730 has 4 discrete categories. Possible responses are:~0 = Patient was not screened for depression~= Screened by PHQ2 depression scale~= Meets criteria for further screening for depression~= Does not meet criteria for further screening~Higher scores indicate a greater level of depression."|participants|Number|2|2.0||||||
3828426|NCT01717456|3654688|B2|Screened by Patient Health Questionnaire 2 (PHQ2)||Depression Screening at Baseline|"OASIS Question M1730 has 4 discrete categories. Possible responses are:~0 = Patient was not screened for depression~= Screened by PHQ2 depression scale~= Meets criteria for further screening for depression~= Does not meet criteria for further screening~Higher scores indicate a greater level of depression."|participants|Number|1|1.0||||||
3828427|NCT01717456|3654689|B1|Screened by Patient Health Questionnaire 2 (PHQ2)||Depression Screening at Baseline|"OASIS Question M1730 has 4 discrete categories. Possible responses are:~0 = Patient was not screened for depression~= Screened by PHQ2 depression scale~= Meets criteria for further screening for depression~= Does not meet criteria for further screening~Higher scores indicate a greater level of depression."|participants|Number|1|1.0||||||
3828428|NCT01717456|3654687|B3|Not screened for depression||Depression Screening at Baseline|"OASIS Question M1730 has 4 discrete categories. Possible responses are:~0 = Patient was not screened for depression~= Screened by PHQ2 depression scale~= Meets criteria for further screening for depression~= Does not meet criteria for further screening~Higher scores indicate a greater level of depression."|participants|Number|9|9.0||||||
3828429|NCT01717456|3654688|B2|Not screened for depression||Depression Screening at Baseline|"OASIS Question M1730 has 4 discrete categories. Possible responses are:~0 = Patient was not screened for depression~= Screened by PHQ2 depression scale~= Meets criteria for further screening for depression~= Does not meet criteria for further screening~Higher scores indicate a greater level of depression."|participants|Number|1|1.0||||||
3828430|NCT01717456|3654689|B1|Not screened for depression||Depression Screening at Baseline|"OASIS Question M1730 has 4 discrete categories. Possible responses are:~0 = Patient was not screened for depression~= Screened by PHQ2 depression scale~= Meets criteria for further screening for depression~= Does not meet criteria for further screening~Higher scores indicate a greater level of depression."|participants|Number|8|8.0||||||
3828431|NCT01717456|3654687|B3|||When is patient anxious at Baseline?|"OASIS Question M1720 is a 4-level ordinal scale. Responses are:~0 = Never~= Less than every day~= Daily but not constantly~= All the time~Higher scores indicate a greater level of anxiousness."|units on a scale|Median|0|0.0|Full Range|||0.0|0.0|
3828432|NCT01717456|3654688|B2|||When is patient anxious at Baseline?|"OASIS Question M1720 is a 4-level ordinal scale. Responses are:~0 = Never~= Less than every day~= Daily but not constantly~= All the time~Higher scores indicate a greater level of anxiousness."|units on a scale|Median|0|0.0|Full Range|||0.0|0.0|
3828433|NCT01717456|3654689|B1|||When is patient anxious at Baseline?|"OASIS Question M1720 is a 4-level ordinal scale. Responses are:~0 = Never~= Less than every day~= Daily but not constantly~= All the time~Higher scores indicate a greater level of anxiousness."|units on a scale|Median|0|0.0|Full Range|||0.0|0.0|
3828434|NCT01717456|3654687|B3|||Ability to use toilet at Baseline|"OASIS Question M1840 is a 5 level ordinal scale. Steps are:~0 = Independent self-toileting~= Uses toilet when reminded to do so~= Unable to reach toilet but can use a bedside commode~= Limited to use of a bedpan~= Totally dependent in toileting~Missing data for 2/11 in Group A and 6/8 in Group B.~Higher scores indicate a greater degree of impairment in toileting behavior."|participants|Median|0|0.0|Full Range|||0.0|0.0|
3828435|NCT01717456|3654688|B2|||Ability to use toilet at Baseline|"OASIS Question M1840 is a 5 level ordinal scale. Steps are:~0 = Independent self-toileting~= Uses toilet when reminded to do so~= Unable to reach toilet but can use a bedside commode~= Limited to use of a bedpan~= Totally dependent in toileting~Missing data for 2/11 in Group A and 6/8 in Group B.~Higher scores indicate a greater degree of impairment in toileting behavior."|participants|Median|0|0.0|Full Range|||0.0|0.0|
3828436|NCT01717456|3654689|B1|||Ability to use toilet at Baseline|"OASIS Question M1840 is a 5 level ordinal scale. Steps are:~0 = Independent self-toileting~= Uses toilet when reminded to do so~= Unable to reach toilet but can use a bedside commode~= Limited to use of a bedpan~= Totally dependent in toileting~Missing data for 2/11 in Group A and 6/8 in Group B.~Higher scores indicate a greater degree of impairment in toileting behavior."|participants|Median|0|0.0|Full Range|||0.0|0.0|
3828437|NCT01717456|3654687|B3|||Ambulation at Baseline|"OASIS Question M1860 is a 7-level ordinal scale.~0 = Walks without assistance~= Uses cane or other one-hand assistive device~= Uses walker or other two-hand assistive device~= Able to walk with assistance~= Chair-fast but can wheel self around~= Chair-fast and requires assistance~= Bedfast~Higher scores indicate a greater degree of physical impairment."|units on a scale|Median|0.2|0.2|Full Range|||0.0|2.0|
3828438|NCT01717456|3654688|B2|||Ambulation at Baseline|"OASIS Question M1860 is a 7-level ordinal scale.~0 = Walks without assistance~= Uses cane or other one-hand assistive device~= Uses walker or other two-hand assistive device~= Able to walk with assistance~= Chair-fast but can wheel self around~= Chair-fast and requires assistance~= Bedfast~Higher scores indicate a greater degree of physical impairment."|units on a scale|Median|0.5|0.5|Full Range|||0.0|1.0|
3828439|NCT01717456|3654689|B1|||Ambulation at Baseline|"OASIS Question M1860 is a 7-level ordinal scale.~0 = Walks without assistance~= Uses cane or other one-hand assistive device~= Uses walker or other two-hand assistive device~= Able to walk with assistance~= Chair-fast but can wheel self around~= Chair-fast and requires assistance~= Bedfast~Higher scores indicate a greater degree of physical impairment."|units on a scale|Median|0|0.0|Full Range|||0.0|2.0|
3828440|NCT01717456|3654687|B3|||Cognitive Function at Baseline|"OASIS Question M1700. 5-level ordinal scale:~0 = Alert and oriented~= Requires prompting for unfamiliar activities~= Requires assistance when task demands shifting attention~= Requires assistance for routine tasks~= Totally dependent~Data missing for 2/11 in Group A and 6/8 in Group B. A higher number indicates a greater degree of cognitive impairment."|units on a scale|Median|0|0.0|Full Range|||0.0|0.0|
3828441|NCT01717456|3654688|B2|||Cognitive Function at Baseline|"OASIS Question M1700. 5-level ordinal scale:~0 = Alert and oriented~= Requires prompting for unfamiliar activities~= Requires assistance when task demands shifting attention~= Requires assistance for routine tasks~= Totally dependent~Data missing for 2/11 in Group A and 6/8 in Group B. A higher number indicates a greater degree of cognitive impairment."|units on a scale|Median|0|0.0|Full Range|||0.0|0.0|
3828442|NCT01717456|3654689|B1|||Cognitive Function at Baseline|"OASIS Question M1700. 5-level ordinal scale:~0 = Alert and oriented~= Requires prompting for unfamiliar activities~= Requires assistance when task demands shifting attention~= Requires assistance for routine tasks~= Totally dependent~Data missing for 2/11 in Group A and 6/8 in Group B. A higher number indicates a greater degree of cognitive impairment."|units on a scale|Median|0|0.0|Full Range|||0.0|0.0|
3828443|NCT01717456|3654687|B3|||Urinary Continence Status at Baseline|"OASIS Question M1610 is a 3-level ordinal scale.~0 = No urinary incontinence~= Incontinence for urine~= Patient requires catheter~Data are missing for 2/11 in Group A and 6/8 in Group B. Having a catheter is equivalent to having urinary incontinence; therefore, the investigators treated a 2 as equivalent to a 1."|units on a scale|Median|1|1.0|Full Range|||0.0|1.0|
3828444|NCT01717456|3654688|B2|||Urinary Continence Status at Baseline|"OASIS Question M1610 is a 3-level ordinal scale.~0 = No urinary incontinence~= Incontinence for urine~= Patient requires catheter~Data are missing for 2/11 in Group A and 6/8 in Group B. Having a catheter is equivalent to having urinary incontinence; therefore, the investigators treated a 2 as equivalent to a 1."|units on a scale|Median|0.5|0.5|Full Range|||0.0|1.0|
3828445|NCT01717456|3654689|B1|||Urinary Continence Status at Baseline|"OASIS Question M1610 is a 3-level ordinal scale.~0 = No urinary incontinence~= Incontinence for urine~= Patient requires catheter~Data are missing for 2/11 in Group A and 6/8 in Group B. Having a catheter is equivalent to having urinary incontinence; therefore, the investigators treated a 2 as equivalent to a 1."|units on a scale|Median|1|1.0|Full Range|||0.0|1.0|
3828490|NCT01717456|3654689|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3828446|NCT01717456|3654687|B3|||Frequency of fecal incontinence at Baseline|"OASIS question M1620. 6-level ordinal scale.~0 = Never or rarely incontinent for stool~= Less than 1/week~= 1-3 days/week~= 4-6 days/week~= Daily stool leakage~= Multiple times per day~Higher scores represent worse outcomes.~Data were missing for 2/11 in Group A and for 6/8 in Group B."|units on a scale|Median|2|2.0|Full Range|||1.0|5.0|
3828447|NCT01717456|3654688|B2|||Frequency of fecal incontinence at Baseline|"OASIS question M1620. 6-level ordinal scale.~0 = Never or rarely incontinent for stool~= Less than 1/week~= 1-3 days/week~= 4-6 days/week~= Daily stool leakage~= Multiple times per day~Higher scores represent worse outcomes.~Data were missing for 2/11 in Group A and for 6/8 in Group B."|units on a scale|Median|4.5|4.5|Full Range|||4.0|5.0|
3828448|NCT01717456|3654689|B1|||Frequency of fecal incontinence at Baseline|"OASIS question M1620. 6-level ordinal scale.~0 = Never or rarely incontinent for stool~= Less than 1/week~= 1-3 days/week~= 4-6 days/week~= Daily stool leakage~= Multiple times per day~Higher scores represent worse outcomes.~Data were missing for 2/11 in Group A and for 6/8 in Group B."|units on a scale|Median|2|2.0|Full Range|||1.0|5.0|
3828449|NCT01717456|3654687|B3|||Zarit Caregiver Burden Scale at Baseline|The Zarit Caregiver Burden Interview is a 22-item questionnaire to assess the perceived burden of taking care of another ill or physically impaired person. All items are answered on a 5-step ordinal scale (from never to nearly always). Higher scores depict greater burden on the family. The total score range is from 0 to 66.|units on a scale|Mean|22.75|22.75|Standard Deviation|14.13|14.13|||
3828450|NCT01717456|3654688|B2|||Zarit Caregiver Burden Scale at Baseline|The Zarit Caregiver Burden Interview is a 22-item questionnaire to assess the perceived burden of taking care of another ill or physically impaired person. All items are answered on a 5-step ordinal scale (from never to nearly always). Higher scores depict greater burden on the family. The total score range is from 0 to 66.|units on a scale|Mean|18.33|18.33|Standard Deviation|13.50|13.5|||
3828451|NCT01717456|3654689|B1|||Zarit Caregiver Burden Scale at Baseline|The Zarit Caregiver Burden Interview is a 22-item questionnaire to assess the perceived burden of taking care of another ill or physically impaired person. All items are answered on a 5-step ordinal scale (from never to nearly always). Higher scores depict greater burden on the family. The total score range is from 0 to 66.|units on a scale|Mean|36.00|36.0|Standard Deviation|42.43|42.43|||
3828452|NCT01717456|3654687|B3|||MHQ Sleep Energy at Baseline|The MHQ (Br J Obstetrics & Gynecol 2001;108:1057-67) is a 32-item questionnaire that assesses the impact of anal incontinence on quality of life in women. Each item is answered on a 5-point ordinal scale. Eight of 9 subscales were used: incontinence impact, role, physical function, social function, personal function, emotional problems, sleep/energy, and severity. A total score was calculated by summing the subscales. This subscale has a range of 0-100, with higher scores signifying greater impairment in quality of life.|units on a scale|Mean|14.47|14.47|Standard Deviation|22.15|22.15|||
3828453|NCT01717456|3654688|B2|||MHQ Sleep Energy at Baseline|The MHQ (Br J Obstetrics & Gynecol 2001;108:1057-67) is a 32-item questionnaire that assesses the impact of anal incontinence on quality of life in women. Each item is answered on a 5-point ordinal scale. Eight of 9 subscales were used: incontinence impact, role, physical function, social function, personal function, emotional problems, sleep/energy, and severity. A total score was calculated by summing the subscales. This subscale has a range of 0-100, with higher scores signifying greater impairment in quality of life.|units on a scale|Mean|23.44|23.44|Standard Deviation|28.69|28.69|||
3828454|NCT01717456|3654689|B1|||MHQ Sleep Energy at Baseline|The MHQ (Br J Obstetrics & Gynecol 2001;108:1057-67) is a 32-item questionnaire that assesses the impact of anal incontinence on quality of life in women. Each item is answered on a 5-point ordinal scale. Eight of 9 subscales were used: incontinence impact, role, physical function, social function, personal function, emotional problems, sleep/energy, and severity. A total score was calculated by summing the subscales. This subscale has a range of 0-100, with higher scores signifying greater impairment in quality of life.|units on a scale|Mean|7.95|7.95|Standard Deviation|14.00|14.0|||
3828455|NCT01717456|3654687|B3|||MHQ Emotions at Baseline|The MHQ (Br J Obstetrics & Gynecol 2001;108:1057-67) is a 32-item questionnaire that assesses the impact of anal incontinence on quality of life in women. Each item is answered on a 5-point ordinal scale. Eight of 9 subscales were used: incontinence impact, role, physical function, social function, personal function, emotional problems, sleep/energy, and severity. A total score was calculated by summing the subscales. This subscale has a range of 0-100, with higher scores signifying greater impairment in quality of life.|units on a scale|Mean|32.89|32.89|Standard Deviation|26.57|26.57|||
3828456|NCT01717456|3654688|B2|||MHQ Emotions at Baseline|The MHQ (Br J Obstetrics & Gynecol 2001;108:1057-67) is a 32-item questionnaire that assesses the impact of anal incontinence on quality of life in women. Each item is answered on a 5-point ordinal scale. Eight of 9 subscales were used: incontinence impact, role, physical function, social function, personal function, emotional problems, sleep/energy, and severity. A total score was calculated by summing the subscales. This subscale has a range of 0-100, with higher scores signifying greater impairment in quality of life.|units on a scale|Mean|51.04|51.04|Standard Deviation|28.67|28.67|||
3828457|NCT01717456|3654689|B1|||MHQ Emotions at Baseline|The MHQ (Br J Obstetrics & Gynecol 2001;108:1057-67) is a 32-item questionnaire that assesses the impact of anal incontinence on quality of life in women. Each item is answered on a 5-point ordinal scale. Eight of 9 subscales were used: incontinence impact, role, physical function, social function, personal function, emotional problems, sleep/energy, and severity. A total score was calculated by summing the subscales. This subscale has a range of 0-100, with higher scores signifying greater impairment in quality of life.|units on a scale|Mean|19.70|19.7|Standard Deviation|15.49|15.49|||
3828458|NCT01717456|3654687|B3|||MHQ Personal Relationships at Baseline|The MHQ (Br J Obstetrics & Gynecol 2001;108:1057-67) is a 32-item questionnaire that assesses the impact of anal incontinence on quality of life in women. Each item is answered on a 5-point ordinal scale. Eight of 9 subscales were used: incontinence impact, role, physical function, social function, personal function, emotional problems, sleep/energy, and severity. A total score was calculated by summing the subscales. This subscale has a range of 0-100, with higher scores signifying greater impairment in quality of life.|units on a scale|Mean|13.64|13.64|Standard Deviation|25.89|25.89|||
3828491|NCT01717456|3654687|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828492|NCT01717456|3654688|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828459|NCT01717456|3654688|B2|||MHQ Personal Relationships at Baseline|The MHQ (Br J Obstetrics & Gynecol 2001;108:1057-67) is a 32-item questionnaire that assesses the impact of anal incontinence on quality of life in women. Each item is answered on a 5-point ordinal scale. Eight of 9 subscales were used: incontinence impact, role, physical function, social function, personal function, emotional problems, sleep/energy, and severity. A total score was calculated by summing the subscales. This subscale has a range of 0-100, with higher scores signifying greater impairment in quality of life.|units on a scale|Mean|20.00|20.0|Standard Deviation|32.60|32.6|||
3828460|NCT01717456|3654689|B1|||MHQ Personal Relationships at Baseline|The MHQ (Br J Obstetrics & Gynecol 2001;108:1057-67) is a 32-item questionnaire that assesses the impact of anal incontinence on quality of life in women. Each item is answered on a 5-point ordinal scale. Eight of 9 subscales were used: incontinence impact, role, physical function, social function, personal function, emotional problems, sleep/energy, and severity. A total score was calculated by summing the subscales. This subscale has a range of 0-100, with higher scores signifying greater impairment in quality of life.|units on a scale|Mean|8.33|8.33|Standard Deviation|20.41|20.41|||
3828461|NCT01717456|3654687|B3|||MHQ Social Limitations at Baseline|The MHQ (Br J Obstetrics & Gynecol 2001;108:1057-67) is a 32-item questionnaire that assesses the impact of anal incontinence on quality of life in women. Each item is answered on a 5-point ordinal scale. Eight of 9 subscales were used: incontinence impact, role, physical function, social function, personal function, emotional problems, sleep/energy, and severity. A total score was calculated by summing the subscales. This subscale has a range of 0-100, with higher scores signifying greater impairment in quality of life.|units on a scale|Mean|28.07|28.07|Standard Deviation|33.93|33.93|||
3828462|NCT01717456|3654688|B2|||MHQ Social Limitations at Baseline|The MHQ (Br J Obstetrics & Gynecol 2001;108:1057-67) is a 32-item questionnaire that assesses the impact of anal incontinence on quality of life in women. Each item is answered on a 5-point ordinal scale. Eight of 9 subscales were used: incontinence impact, role, physical function, social function, personal function, emotional problems, sleep/energy, and severity. A total score was calculated by summing the subscales. This subscale has a range of 0-100, with higher scores signifying greater impairment in quality of life.|units on a scale|Mean|43.75|43.75|Standard Deviation|35.57|35.57|||
3828463|NCT01717456|3654689|B1|||MHQ Social Limitations at Baseline|The MHQ (Br J Obstetrics & Gynecol 2001;108:1057-67) is a 32-item questionnaire that assesses the impact of anal incontinence on quality of life in women. Each item is answered on a 5-point ordinal scale. Eight of 9 subscales were used: incontinence impact, role, physical function, social function, personal function, emotional problems, sleep/energy, and severity. A total score was calculated by summing the subscales. This subscale has a range of 0-100, with higher scores signifying greater impairment in quality of life.|units on a scale|Mean|16.67|16.67|Standard Deviation|29.11|29.11|||
3828464|NCT01717456|3654687|B3|||MHQ Physical Limitations at Baseline|The MHQ (Br J Obstetrics & Gynecol 2001;108:1057-67) is a 32-item questionnaire that assesses the impact of anal incontinence on quality of life in women. Each item is answered on a 5-point ordinal scale. Eight of 9 subscales were used: incontinence impact, role, physical function, social function, personal function, emotional problems, sleep/energy, and severity. A total score was calculated by summing the subscales. This subscale has a range of 0-100, with higher scores signifying greater impairment in quality of life.|units on a scale|Mean|31.58|31.58|Standard Deviation|28.98|28.98|||
3828465|NCT01717456|3654688|B2|||MHQ Physical Limitations at Baseline|The MHQ (Br J Obstetrics & Gynecol 2001;108:1057-67) is a 32-item questionnaire that assesses the impact of anal incontinence on quality of life in women. Each item is answered on a 5-point ordinal scale. Eight of 9 subscales were used: incontinence impact, role, physical function, social function, personal function, emotional problems, sleep/energy, and severity. A total score was calculated by summing the subscales. This subscale has a range of 0-100, with higher scores signifying greater impairment in quality of life.|units on a scale|Mean|50.00|50.0|Standard Deviation|28.35|28.35|||
3828466|NCT01717456|3654689|B1|||MHQ Physical Limitations at Baseline|The MHQ (Br J Obstetrics & Gynecol 2001;108:1057-67) is a 32-item questionnaire that assesses the impact of anal incontinence on quality of life in women. Each item is answered on a 5-point ordinal scale. Eight of 9 subscales were used: incontinence impact, role, physical function, social function, personal function, emotional problems, sleep/energy, and severity. A total score was calculated by summing the subscales. This subscale has a range of 0-100, with higher scores signifying greater impairment in quality of life.|units on a scale|Mean|18.18|18.18|Standard Deviation|21.91|21.91|||
3828467|NCT01717456|3654687|B3|||MHQ Role Limitations at Baseline|The MHQ (Br J Obstetrics & Gynecol 2001;108:1057-67) is a 32-item questionnaire that assesses the impact of anal incontinence on quality of life in women. Each item is answered on a 5-point ordinal scale. Eight of 9 subscales were used: incontinence impact, role, physical function, social function, personal function, emotional problems, sleep/energy, and severity. A total score was calculated by summing the subscales. This subscale has a range of 0-100, with higher scores signifying greater impairment in quality of life.|units on a scale|Mean|28.95|28.95|Standard Deviation|32.56|32.56|||
3828468|NCT01717456|3654688|B2|||MHQ Role Limitations at Baseline|The MHQ (Br J Obstetrics & Gynecol 2001;108:1057-67) is a 32-item questionnaire that assesses the impact of anal incontinence on quality of life in women. Each item is answered on a 5-point ordinal scale. Eight of 9 subscales were used: incontinence impact, role, physical function, social function, personal function, emotional problems, sleep/energy, and severity. A total score was calculated by summing the subscales. This subscale has a range of 0-100, with higher scores signifying greater impairment in quality of life.|units on a scale|Mean|50.00|50.0|Standard Deviation|29.12|29.12|||
3828469|NCT01717456|3654689|B1|||MHQ Role Limitations at Baseline|The MHQ (Br J Obstetrics & Gynecol 2001;108:1057-67) is a 32-item questionnaire that assesses the impact of anal incontinence on quality of life in women. Each item is answered on a 5-point ordinal scale. Eight of 9 subscales were used: incontinence impact, role, physical function, social function, personal function, emotional problems, sleep/energy, and severity. A total score was calculated by summing the subscales. This subscale has a range of 0-100, with higher scores signifying greater impairment in quality of life.|units on a scale|Mean|13.64|13.64|Standard Deviation|26.49|26.49|||
3828493|NCT01717456|3654689|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828494|NCT01717456|3654687|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828495|NCT01717456|3654688|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828470|NCT01717456|3654687|B3|||MHQ Incontinence Impact at Baseline|The MHQ (Br J Obstetrics & Gynecol 2001;108:1057-67) is a 32-item questionnaire that assesses the impact of anal incontinence on quality of life in women. Each item is answered on a 5-point ordinal scale. Eight of 9 subscales were used: incontinence impact, role, physical function, social function, personal function, emotional problems, sleep/energy, and severity. A total score was calculated by summing the subscales. This subscale has a range of 0-100, with higher scores signifying greater impairment in quality of life.|units on a scale|Mean|57.89|57.89|Standard Deviation|25.07|25.07|||
3828471|NCT01717456|3654688|B2|||MHQ Incontinence Impact at Baseline|The MHQ (Br J Obstetrics & Gynecol 2001;108:1057-67) is a 32-item questionnaire that assesses the impact of anal incontinence on quality of life in women. Each item is answered on a 5-point ordinal scale. Eight of 9 subscales were used: incontinence impact, role, physical function, social function, personal function, emotional problems, sleep/energy, and severity. A total score was calculated by summing the subscales. This subscale has a range of 0-100, with higher scores signifying greater impairment in quality of life.|units on a scale|Mean|65.63|65.63|Standard Deviation|26.52|26.52|||
3828472|NCT01717456|3654689|B1|||MHQ Incontinence Impact at Baseline|The MHQ (Br J Obstetrics & Gynecol 2001;108:1057-67) is a 32-item questionnaire that assesses the impact of anal incontinence on quality of life in women. Each item is answered on a 5-point ordinal scale. Eight of 9 subscales were used: incontinence impact, role, physical function, social function, personal function, emotional problems, sleep/energy, and severity. A total score was calculated by summing the subscales. This subscale has a range of 0-100, with higher scores signifying greater impairment in quality of life.|units on a scale|Mean|52.27|52.27|Standard Deviation|23.60|23.6|||
3828473|NCT01717456|3654687|B3|||Manchester Health Questionnaire (MHQ) Severity Scale at Baseline|The MHQ (Br J Obstetrics & Gynecol 2001;108:1057-67) is a 32-item questionnaire that assesses the impact of anal incontinence on quality of life in women. Each item is answered on a 5-point ordinal scale. Eight of 9 subscales were used: incontinence impact, role, physical function, social function, personal function, emotional problems, sleep/energy, and severity. A total score was calculated by summing the subscales. The range of scores of each domain is 0-100, and higher scores indicate greater impairment. Means and SDs for a reference group of 154 FI patients were published.|units on a scale|Mean|49.21|49.21|Standard Deviation|17.42|17.42|||
3828474|NCT01717456|3654688|B2|||Manchester Health Questionnaire (MHQ) Severity Scale at Baseline|The MHQ (Br J Obstetrics & Gynecol 2001;108:1057-67) is a 32-item questionnaire that assesses the impact of anal incontinence on quality of life in women. Each item is answered on a 5-point ordinal scale. Eight of 9 subscales were used: incontinence impact, role, physical function, social function, personal function, emotional problems, sleep/energy, and severity. A total score was calculated by summing the subscales. The range of scores of each domain is 0-100, and higher scores indicate greater impairment. Means and SDs for a reference group of 154 FI patients were published.|units on a scale|Mean|50.00|50.0|Standard Deviation|18.13|18.13|||
3828475|NCT01717456|3654689|B1|||Manchester Health Questionnaire (MHQ) Severity Scale at Baseline|The MHQ (Br J Obstetrics & Gynecol 2001;108:1057-67) is a 32-item questionnaire that assesses the impact of anal incontinence on quality of life in women. Each item is answered on a 5-point ordinal scale. Eight of 9 subscales were used: incontinence impact, role, physical function, social function, personal function, emotional problems, sleep/energy, and severity. A total score was calculated by summing the subscales. The range of scores of each domain is 0-100, and higher scores indicate greater impairment. Means and SDs for a reference group of 154 FI patients were published.|units on a scale|Mean|48.64|48.64|Standard Deviation|17.76|17.76|||
3828476|NCT01717456|3654687|B3|||Fecal Incontinence Severity Index (FISI) at Baseline|Subjects rated the frequency of 4 types of stool leakage (gas, mucus, liquid, and solid) over the prior month on a 6-stepscale. Possible responses were never, 1-3 times/ month, once/week, 2 or more times/week, once/day, and 2 or more times/day. Based on the average quality of life impact scores assigned by a reference group of 34 subjects with fecal incontinence, weights were assigned to each of these 4 responses and added together for a sum score. Range is 0-61. No guidance on what defines mild, moderate, or severe is available. Higher scores show more severe fecal incontinence.|units on a scale|Mean|23.72|23.72|Standard Deviation|2.44|2.44|||
3828477|NCT01717456|3654688|B2|||Fecal Incontinence Severity Index (FISI) at Baseline|Subjects rated the frequency of 4 types of stool leakage (gas, mucus, liquid, and solid) over the prior month on a 6-stepscale. Possible responses were never, 1-3 times/ month, once/week, 2 or more times/week, once/day, and 2 or more times/day. Based on the average quality of life impact scores assigned by a reference group of 34 subjects with fecal incontinence, weights were assigned to each of these 4 responses and added together for a sum score. Range is 0-61. No guidance on what defines mild, moderate, or severe is available. Higher scores show more severe fecal incontinence.|units on a scale|Mean|22.75|22.75|Standard Deviation|8.14|8.14|||
3828478|NCT01717456|3654689|B1|||Fecal Incontinence Severity Index (FISI) at Baseline|Subjects rated the frequency of 4 types of stool leakage (gas, mucus, liquid, and solid) over the prior month on a 6-stepscale. Possible responses were never, 1-3 times/ month, once/week, 2 or more times/week, once/day, and 2 or more times/day. Based on the average quality of life impact scores assigned by a reference group of 34 subjects with fecal incontinence, weights were assigned to each of these 4 responses and added together for a sum score. Range is 0-61. No guidance on what defines mild, moderate, or severe is available. Higher scores show more severe fecal incontinence.|units on a scale|Mean|24.50|24.5|Standard Deviation|12.22|12.22|||
3828479|NCT01717456|3654687|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3828480|NCT01717456|3654688|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3828481|NCT01717456|3654689|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828482|NCT01717456|3654687|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828483|NCT01717456|3654688|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828484|NCT01717456|3654689|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828485|NCT01717456|3654687|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3828486|NCT01717456|3654688|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3828487|NCT01717456|3654689|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3828496|NCT01717456|3654689|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828497|NCT01717456|3654687|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828498|NCT01717456|3654688|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828499|NCT01717456|3654689|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828500|NCT01717456|3654687|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3828501|NCT01717456|3654688|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3828502|NCT01717456|3654689|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3828503|NCT01717456|3654687|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3828504|NCT01717456|3654688|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3828505|NCT01717456|3654689|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3828506|NCT01717456|3654687|B3|||Age||years|Mean|85.83|85.83|Standard Deviation|4.17|4.17|||
3828507|NCT01717456|3654688|B2|||Age||years|Mean|85.00|85.0|Standard Deviation|3.61|3.61|||
3828508|NCT01717456|3654689|B1|||Age||years|Mean|86.11|86.11|Standard Deviation|4.51|4.51|||
3828509|NCT01717391|3654758|B1|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3828510|NCT01717391|3654758|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3828511|NCT01717391|3654758|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3828512|NCT01717391|3654758|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3828513|NCT01717391|3654758|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3828514|NCT01717391|3654758|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3828515|NCT01717326|3654767|B21||Male|Sex: Female, Male||Participants|Count of Participants|321|321.0||||||
3828516|NCT01717326|3654768|B20||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3828517|NCT01717326|3654769|B19||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3828518|NCT01717326|3654770|B18||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3828519|NCT01717326|3654771|B17||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3828520|NCT01717326|3654772|B16||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3828521|NCT01717326|3654773|B15||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3828522|NCT01717326|3654774|B14||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3828523|NCT01717326|3654775|B13||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3828524|NCT01717326|3654776|B12||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3828525|NCT01717326|3654777|B11||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3828526|NCT01717326|3654778|B10||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3828527|NCT01717326|3654779|B9||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3828528|NCT01717326|3654780|B8||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3828529|NCT01717326|3654781|B7||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3828530|NCT01717326|3654782|B6||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3828531|NCT01717326|3654783|B5||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3828532|NCT01717326|3654784|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3828533|NCT01717326|3654785|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3828534|NCT01717326|3654786|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3828535|NCT01717326|3654787|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3828536|NCT01717326|3654767|B21||Female|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
3828537|NCT01717326|3654768|B20||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3828538|NCT01717326|3654769|B19||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3828539|NCT01717326|3654770|B18||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3828540|NCT01717326|3654771|B17||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3828541|NCT01717326|3654772|B16||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3828542|NCT01717326|3654773|B15||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3828543|NCT01717326|3654774|B14||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3828544|NCT01717326|3654775|B13||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3828545|NCT01717326|3654776|B12||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3828546|NCT01717326|3654777|B11||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3828547|NCT01717326|3654778|B10||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3828548|NCT01717326|3654779|B9||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3828549|NCT01717326|3654780|B8||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3828550|NCT01717326|3654781|B7||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3828551|NCT01717326|3654782|B6||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3828552|NCT01717326|3654783|B5||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3828553|NCT01717326|3654784|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3828554|NCT01717326|3654785|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3828555|NCT01717326|3654786|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3828556|NCT01717326|3654787|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3828557|NCT01717326|3654767|B21|||Age||years|Mean|51.9|51.9|Standard Deviation|11.3|11.3|||
3828558|NCT01717326|3654768|B20|||Age||years|Mean|42.4|42.4|Standard Deviation|10.8|10.8|||
3828559|NCT01717326|3654769|B19|||Age||years|Mean|49.0|49.0|Standard Deviation|11.5|11.5|||
3828560|NCT01717326|3654770|B18|||Age||years|Mean|55.3|55.3|Standard Deviation|10.3|10.3|||
3828561|NCT01717326|3654771|B17|||Age||years|Mean|50.6|50.6|Standard Deviation|10.9|10.9|||
3828562|NCT01717326|3654772|B16|||Age||years|Mean|43.5|43.5|Standard Deviation|10.4|10.4|||
3828563|NCT01717326|3654773|B15|||Age||years|Mean|46.2|46.2|Standard Deviation|8.4|8.4|||
3828564|NCT01717326|3654774|B14|||Age||years|Mean|54.3|54.3|Standard Deviation|12.3|12.3|||
3828565|NCT01717326|3654775|B13|||Age||years|Mean|56.2|56.2|Standard Deviation|10.9|10.9|||
3828566|NCT01717326|3654776|B12|||Age||years|Mean|54.4|54.4|Standard Deviation|9.1|9.1|||
3828567|NCT01717326|3654777|B11|||Age||years|Mean|52.2|52.2|Standard Deviation|8.8|8.8|||
3828568|NCT01717326|3654778|B10|||Age||years|Mean|58.9|58.9|Standard Deviation|8.0|8.0|||
3828569|NCT01717326|3654779|B9|||Age||years|Mean|58.8|58.8|Standard Deviation|8.2|8.2|||
3828570|NCT01717326|3654780|B8|||Age||years|Mean|59.0|59.0|Standard Deviation|7.8|7.8|||
3828571|NCT01717326|3654781|B7|||Age||years|Mean|57.0|57.0|Standard Deviation|7.0|7.0|||
3828572|NCT01717326|3654782|B6|||Age||years|Mean|53.6|53.6|Standard Deviation|8.4|8.4|||
3828573|NCT01717326|3654783|B5|||Age||years|Mean|49.7|49.7|Standard Deviation|11.5|11.5|||
3828574|NCT01717326|3654784|B4|||Age||years|Mean|48.4|48.4|Standard Deviation|11.9|11.9|||
3828575|NCT01717326|3654785|B3|||Age||years|Mean|43.3|43.3|Standard Deviation|13.5|13.5|||
3828576|NCT01717326|3654786|B2|||Age||years|Mean|43.9|43.9|Standard Deviation|12.6|12.6|||
3828577|NCT01717326|3654787|B1|||Age||years|Mean|48.7|48.7|Standard Deviation|12.5|12.5|||
3828578|NCT01717313|3655068|B3||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
3828579|NCT01717313|3655069|B2||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3828580|NCT01717313|3655070|B1||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3828581|NCT01717313|3655068|B3||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3828582|NCT01717313|3655069|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3828583|NCT01717313|3655070|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3828584|NCT01717313|3655068|B3|||Age||Years|Mean|57.2|57.2|Standard Deviation|9.5|9.5|||
3828585|NCT01717313|3655069|B2|||Age||Years|Mean|57.0|57.0|Standard Deviation|9.7|9.7|||
3828586|NCT01717313|3655070|B1|||Age||Years|Mean|57.4|57.4|Standard Deviation|9.2|9.2|||
3828587|NCT01717287|3655107|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3828588|NCT01717287|3655108|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3828589|NCT01717287|3655109|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3828590|NCT01717287|3655107|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3828591|NCT01717287|3655108|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3828592|NCT01717287|3655109|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3828593|NCT01717287|3655107|B3|12 to <18 years||Age, Customized||Participants|Number|2|2.0||||||
3828594|NCT01717287|3655108|B2|12 to <18 years||Age, Customized||Participants|Number|0|0.0||||||
3828595|NCT01717287|3655109|B1|12 to <18 years||Age, Customized||Participants|Number|2|2.0||||||
3828596|NCT01717287|3655107|B3|6 to <12 years||Age, Customized||Participants|Number|19|19.0||||||
3828597|NCT01717287|3655108|B2|6 to <12 years||Age, Customized||Participants|Number|17|17.0||||||
3828598|NCT01717287|3655109|B1|6 to <12 years||Age, Customized||Participants|Number|2|2.0||||||
3828599|NCT01717287|3655107|B3|2 to <6 years||Age, Customized||Participants|Number|11|11.0||||||
3828600|NCT01717287|3655108|B2|2 to <6 years||Age, Customized||Participants|Number|11|11.0||||||
3828601|NCT01717287|3655109|B1|2 to <6 years||Age, Customized||Participants|Number|0|0.0||||||
3828602|NCT01717209|3655132|B1|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3828603|NCT01717209|3655132|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3828604|NCT01717209|3655132|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3828605|NCT01717209|3655132|B1|||Age||years|Mean|57|57.0|Full Range|||29.0|68.0|
3828606|NCT01717053|3655141|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828607|NCT01717053|3655141|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828608|NCT01717053|3655141|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3828609|NCT01717053|3655141|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3828610|NCT01717053|3655141|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828611|NCT01717053|3655141|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828612|NCT01717053|3655141|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828613|NCT01717053|3655141|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828614|NCT01717053|3655141|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3828615|NCT01717053|3655141|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828616|NCT01717053|3655141|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3828617|NCT01717053|3655141|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3828618|NCT01717053|3655141|B1|||Age||years|Mean|66.0|66.0|Standard Deviation|5.3|5.3|||
3828619|NCT01717040|3655145|B3|BP NOS||Bipolar Diagnosis||Participants|Count of Participants|1|1.0||||||
3828620|NCT01717040|3655146|B2|BP NOS||Bipolar Diagnosis||Participants|Count of Participants|0|0.0||||||
3828621|NCT01717040|3655147|B1|BP NOS||Bipolar Diagnosis||Participants|Count of Participants|1|1.0||||||
3828622|NCT01717040|3655145|B3|BP 2||Bipolar Diagnosis||Participants|Count of Participants|12|12.0||||||
3828623|NCT01717040|3655146|B2|BP 2||Bipolar Diagnosis||Participants|Count of Participants|7|7.0||||||
3828624|NCT01717040|3655147|B1|BP 2||Bipolar Diagnosis||Participants|Count of Participants|5|5.0||||||
3828625|NCT01717040|3655145|B3|BP 1||Bipolar Diagnosis||Participants|Count of Participants|24|24.0||||||
3828626|NCT01717040|3655146|B2|BP 1||Bipolar Diagnosis||Participants|Count of Participants|13|13.0||||||
3828627|NCT01717040|3655147|B1|BP 1||Bipolar Diagnosis||Participants|Count of Participants|11|11.0||||||
3828628|NCT01717040|3655145|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828629|NCT01717040|3655146|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828630|NCT01717040|3655147|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828631|NCT01717040|3655145|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828632|NCT01717040|3655146|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828633|NCT01717040|3655147|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828634|NCT01717040|3655145|B3||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3828635|NCT01717040|3655146|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3828636|NCT01717040|3655147|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3828637|NCT01717040|3655145|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3828638|NCT01717040|3655146|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3828639|NCT01717040|3655147|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3828640|NCT01717040|3655145|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828641|NCT01717040|3655146|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828642|NCT01717040|3655147|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828643|NCT01717040|3655145|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828644|NCT01717040|3655146|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828645|NCT01717040|3655147|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828646|NCT01717040|3655145|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828647|NCT01717040|3655146|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828648|NCT01717040|3655147|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828649|NCT01717040|3655145|B3||Male|Gender||Participants|Count of Participants|13|13.0||||||
3828650|NCT01717040|3655146|B2||Male|Gender||Participants|Count of Participants|6|6.0||||||
3828651|NCT01717040|3655147|B1||Male|Gender||Participants|Count of Participants|7|7.0||||||
3828652|NCT01717040|3655145|B3||Female|Gender||Participants|Count of Participants|24|24.0||||||
3828653|NCT01717040|3655146|B2||Female|Gender||Participants|Count of Participants|14|14.0||||||
3828654|NCT01717040|3655147|B1||Female|Gender||Participants|Count of Participants|10|10.0||||||
3828655|NCT01717040|3655145|B3|||Age||years|Mean|45.05|45.05|Standard Deviation|12.492|12.492|||
3828656|NCT01717040|3655146|B2|||Age||years|Mean|43.65|43.65|Standard Deviation|12.979|12.979|||
3828657|NCT01717040|3655147|B1|||Age||years|Mean|46.71|46.71|Standard Deviation|12.071|12.071|||
3828658|NCT01717014|3655154|B1|||Body Mass Index (BMI)||kg/m2|Mean|29.0|29.0|Standard Deviation|6.1|6.1|||
3828659|NCT01717014|3655154|B1|||Weight||kilograms|Mean|88.7|88.7|Standard Deviation|18.0|18.0|||
3828660|NCT01717014|3655154|B1|||Height||centimeters|Mean|175.1|175.1|Standard Deviation|4.3|4.3|||
3828661|NCT01717014|3655154|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828662|NCT01717014|3655154|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3828663|NCT01717014|3655154|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828664|NCT01717014|3655154|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828665|NCT01717014|3655154|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828666|NCT01717014|3655154|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3828667|NCT01717014|3655154|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828668|NCT01717014|3655154|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828669|NCT01717014|3655154|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828670|NCT01717014|3655154|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828671|NCT01717014|3655154|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3828672|NCT01717014|3655154|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3828673|NCT01717014|3655154|B1|||Age||years|Mean|55.6|55.6|Standard Deviation|14.8|14.8|||
3828674|NCT01716754|3655162|B5||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3828675|NCT01716754|3655163|B4||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3828676|NCT01716754|3655164|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3828677|NCT01716754|3655165|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3828678|NCT01716754|3655166|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3828679|NCT01716754|3655162|B5||Female|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
3828680|NCT01716754|3655163|B4||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3828681|NCT01716754|3655164|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3828682|NCT01716754|3655165|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3828683|NCT01716754|3655166|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3828684|NCT01716754|3655162|B5|||Age||Years|Mean|47.4|47.4|Standard Deviation|13.36|13.36|||
3828685|NCT01716754|3655163|B4|||Age||Years|Mean|48.6|48.6|Standard Deviation|12.80|12.8|||
3828686|NCT01716754|3655164|B3|||Age||Years|Mean|46.8|46.8|Standard Deviation|13.35|13.35|||
3828687|NCT01716754|3655165|B2|||Age||Years|Mean|46.0|46.0|Standard Deviation|12.38|12.38|||
3828688|NCT01716754|3655166|B1|||Age||Years|Mean|47.6|47.6|Standard Deviation|13.86|13.86|||
3828689|NCT01716663|3655190|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3828690|NCT01716663|3655190|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3828691|NCT01716663|3655190|B1||White|Race (NIH/OMB)||Participants|Count of Participants|223|223.0||||||
3828692|NCT01716663|3655190|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3828693|NCT01716663|3655190|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828694|NCT01716663|3655190|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3828695|NCT01716663|3655190|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3828696|NCT01716663|3655190|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828697|NCT01716663|3655190|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|230|230.0||||||
3828698|NCT01716663|3655190|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3828699|NCT01716663|3655190|B1||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3828700|NCT01716663|3655190|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3828701|NCT01716663|3655190|B1|||Age||years|Mean|62.1|62.1|Standard Deviation|11.6|11.6|||
3828702|NCT01716663|3655190|B1||>=65 years|Age||Participants|Count of Participants|114|114.0||||||
3828703|NCT01716663|3655190|B1||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
3828704|NCT01716663|3655190|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3828705|NCT01716585|3655198|B3||Male|Sex: Female, Male||Participants|Count of Participants|344|344.0||||||
3828706|NCT01716585|3655199|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3828707|NCT01716585|3655200|B1||Male|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
3828708|NCT01716585|3655198|B3||Female|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
3828709|NCT01716585|3655199|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3828710|NCT01716585|3655200|B1||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3828711|NCT01716585|3655198|B3|||Age||years|Mean|49.9|49.9|Standard Deviation|10.82|10.82|||
3828712|NCT01716585|3655199|B2|||Age||years|Mean|51.2|51.2|Standard Deviation|10.23|10.23|||
3828713|NCT01716585|3655200|B1|||Age||years|Mean|49.4|49.4|Standard Deviation|10.98|10.98|||
3828714|NCT01716559|3655213|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3828715|NCT01716559|3655213|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3828716|NCT01716559|3655213|B1|||Age||years|Mean|63|63.0|Standard Deviation|9.97|9.97|||
3828717|NCT01716520|3655221|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|182|182.0||||||
3828718|NCT01716520|3655221|B1||Male|Gender||Participants|Count of Participants|127|127.0||||||
3828719|NCT01716520|3655221|B1||Female|Gender||Participants|Count of Participants|55|55.0||||||
3828720|NCT01716520|3655221|B1|||Age||Years|Mean|63.2|63.2|Standard Deviation|8.19|8.19|||
3828721|NCT01716468|3655242|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3828722|NCT01716468|3655242|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3828723|NCT01716468|3655242|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3828724|NCT01716468|3655242|B1|||Age||years|Mean|65|65.0|Full Range|||44.0|90.0|
3828725|NCT01716468|3655242|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3828726|NCT01716468|3655242|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3828727|NCT01716468|3655242|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3828728|NCT01716455|3655246|B7|UNITED STATES||Region of Enrollment||Participants|Number|66|66.0||||||
3828729|NCT01716455|3655247|B6|UNITED STATES||Region of Enrollment||Participants|Number|8|8.0||||||
3828730|NCT01716455|3655248|B5|UNITED STATES||Region of Enrollment||Participants|Number|26|26.0||||||
3828731|NCT01716455|3655249|B4|UNITED STATES||Region of Enrollment||Participants|Number|8|8.0||||||
3828732|NCT01716455|3655250|B3|UNITED STATES||Region of Enrollment||Participants|Number|8|8.0||||||
3828733|NCT01716455|3655251|B2|UNITED STATES||Region of Enrollment||Participants|Number|8|8.0||||||
3828734|NCT01716455|3655252|B1|UNITED STATES||Region of Enrollment||Participants|Number|8|8.0||||||
3828735|NCT01716455|3655246|B7||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3828736|NCT01716455|3655247|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3828737|NCT01716455|3655248|B5||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3828738|NCT01716455|3655249|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3828739|NCT01716455|3655250|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3828740|NCT01716455|3655251|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3828741|NCT01716455|3655252|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3828742|NCT01716455|3655246|B7||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3828743|NCT01716455|3655247|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3828744|NCT01716455|3655248|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3828745|NCT01716455|3655249|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3828746|NCT01716455|3655250|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3828747|NCT01716455|3655251|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3828748|NCT01716455|3655252|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3828749|NCT01716455|3655246|B7|Between 18 and 65 years||Age, Customized||Participants|Number|44|44.0||||||
3828750|NCT01716455|3655247|B6|Between 18 and 65 years||Age, Customized||Participants|Number|0|0.0||||||
3828751|NCT01716455|3655248|B5|Between 18 and 65 years||Age, Customized||Participants|Number|20|20.0||||||
3828752|NCT01716455|3655249|B4|Between 18 and 65 years||Age, Customized||Participants|Number|8|8.0||||||
3828753|NCT01716455|3655250|B3|Between 18 and 65 years||Age, Customized||Participants|Number|3|3.0||||||
3828754|NCT01716455|3655251|B2|Between 18 and 65 years||Age, Customized||Participants|Number|5|5.0||||||
3828755|NCT01716455|3655252|B1|Between 18 and 65 years||Age, Customized||Participants|Number|8|8.0||||||
3828756|NCT01716455|3655246|B7|>=65 years||Age, Customized||Participants|Number|22|22.0||||||
3828757|NCT01716455|3655247|B6|>=65 years||Age, Customized||Participants|Number|8|8.0||||||
3828758|NCT01716455|3655248|B5|>=65 years||Age, Customized||Participants|Number|6|6.0||||||
3828759|NCT01716455|3655249|B4|>=65 years||Age, Customized||Participants|Number|0|0.0||||||
3828760|NCT01716455|3655250|B3|>=65 years||Age, Customized||Participants|Number|5|5.0||||||
3828761|NCT01716455|3655251|B2|>=65 years||Age, Customized||Participants|Number|3|3.0||||||
3828762|NCT01716455|3655252|B1|>=65 years||Age, Customized||Participants|Number|0|0.0||||||
3828763|NCT01716455|3655246|B7|||Age||Years|Mean|58.7|58.7|Standard Deviation|11.23|11.23|||
3828764|NCT01716455|3655247|B6|||Age||Years|Mean|72.6|72.6|Standard Deviation|5.29|5.29|||
3828765|NCT01716455|3655248|B5|||Age||Years|Mean|55.6|55.6|Standard Deviation|10.81|10.81|||
3828766|NCT01716455|3655249|B4|||Age||Years|Mean|44.5|44.5|Standard Deviation|5.58|5.58|||
3828767|NCT01716455|3655250|B3|||Age||Years|Mean|64.4|64.4|Standard Deviation|8.23|8.23|||
3828768|NCT01716455|3655251|B2|||Age||Years|Mean|63.4|63.4|Standard Deviation|7.56|7.56|||
3828769|NCT01716455|3655252|B1|||Age||Years|Mean|58.6|58.6|Standard Deviation|4.47|4.47|||
3828770|NCT01716234|3655274|B8||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3828771|NCT01716234|3655275|B7||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3828772|NCT01716234|3655276|B6||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3828773|NCT01716234|3655277|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3828774|NCT01716234|3655278|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3828775|NCT01716234|3655279|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3828776|NCT01716234|3655280|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3828777|NCT01716234|3655281|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3828778|NCT01716234|3655274|B8||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3828779|NCT01716234|3655275|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3828780|NCT01716234|3655276|B6||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3828781|NCT01716234|3655277|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3828782|NCT01716234|3655278|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3828783|NCT01716234|3655279|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3828784|NCT01716234|3655280|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3828785|NCT01716234|3655281|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3828786|NCT01716234|3655274|B8|||Age||Years|Mean|8.9|8.9|Standard Deviation|4.9|4.9|1.0|18.0|
3828787|NCT01716234|3655275|B7|||Age||Years|Mean|0.9|0.9|Standard Deviation|0|0.0|1.0|1.0|
3828788|NCT01716234|3655276|B6|||Age||Years|Mean|13.1|13.1|Standard Deviation|3.0|3.0|7.0|18.0|
3828789|NCT01716234|3655277|B5|||Age||Years|Mean|4.1|4.1|Standard Deviation|1.3|1.3|3.0|7.0|
3828790|NCT01716234|3655278|B4|||Age||Years|Mean|12.2|12.2|Standard Deviation|3.2|3.2|7.0|18.0|
3828791|NCT01716234|3655279|B3|||Age||Years|Mean|4.4|4.4|Standard Deviation|1.5|1.5|2.0|7.0|
3828792|NCT01716234|3655280|B2|||Age||Years|Mean|11.9|11.9|Standard Deviation|3.5|3.5|7.0|17.0|
3828793|NCT01716234|3655281|B1|||Age||Years|Mean|4.0|4.0|Standard Deviation|1.3|1.3|2.0|7.0|
3828794|NCT01716221|3655324|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3828795|NCT01716221|3655324|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3828796|NCT01716221|3655324|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3828797|NCT01716221|3655324|B1|||Age||Years|Mean|65|65.0|Standard Deviation|0|0.0|||
3828798|NCT01716221|3655324|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3828799|NCT01716221|3655324|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3828800|NCT01716221|3655324|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3828801|NCT01716169|3655350|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3828802|NCT01716169|3655350|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3828803|NCT01716169|3655350|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3828804|NCT01716169|3655350|B1|||Age||years|Mean|15.6|15.6|Standard Deviation|5.6|5.6|||
3828805|NCT01716169|3655350|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3828806|NCT01716169|3655350|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3828807|NCT01716169|3655350|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
3828808|NCT01716156|3655356|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3828809|NCT01716156|3655357|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3828810|NCT01716156|3655358|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3828811|NCT01716156|3655359|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3828812|NCT01716156|3655356|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3828813|NCT01716156|3655357|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3828814|NCT01716156|3655358|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3828815|NCT01716156|3655359|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3828816|NCT01716156|3655356|B4|||Age||Years|Mean|43.2|43.2|Standard Deviation|13.0|13.0|||
3828817|NCT01716156|3655357|B3|||Age||Years|Mean|42.8|42.8|Standard Deviation|14.8|14.8|||
3828818|NCT01716156|3655358|B2|||Age||Years|Mean|42.3|42.3|Standard Deviation|7.4|7.4|||
3828819|NCT01716156|3655359|B1|||Age||Years|Mean|44.1|44.1|Standard Deviation|13.2|13.2|||
3828820|NCT01716104|3655385|B3|Russia||Region of Enrollment||participants|Number|232|232.0||||||
3828821|NCT01716104|3655386|B2|Russia||Region of Enrollment||participants|Number|114|114.0||||||
3828822|NCT01716104|3655387|B1|Russia||Region of Enrollment||participants|Number|118|118.0||||||
3828823|NCT01716104|3655385|B3|Ukraine||Region of Enrollment||participants|Number|4|4.0||||||
3828824|NCT01716104|3655386|B2|Ukraine||Region of Enrollment||participants|Number|3|3.0||||||
3828825|NCT01716104|3655387|B1|Ukraine||Region of Enrollment||participants|Number|1|1.0||||||
3828826|NCT01716104|3655385|B3||Male|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
3828827|NCT01716104|3655386|B2||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3828828|NCT01716104|3655387|B1||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3828829|NCT01716104|3655385|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3828830|NCT01716104|3655386|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3828831|NCT01716104|3655387|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3828832|NCT01716104|3655385|B3|||Age||years|Mean|54.4|54.4|Standard Deviation|4.3|4.3|||
3828833|NCT01716104|3655386|B2|||Age||years|Mean|54.4|54.4|Standard Deviation|4.4|4.4|||
3828834|NCT01716104|3655387|B1|||Age||years|Mean|54.3|54.3|Standard Deviation|4.2|4.2|||
3828835|NCT01716052|3655412|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3828836|NCT01716052|3655413|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3828837|NCT01716052|3655414|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3828838|NCT01716052|3655412|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3828839|NCT01716052|3655413|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3828840|NCT01716052|3655414|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3828841|NCT01716052|3655412|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3828842|NCT01716052|3655413|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3828843|NCT01716052|3655414|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3828844|NCT01716052|3655412|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3828845|NCT01716052|3655413|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3828846|NCT01716052|3655414|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3828847|NCT01716052|3655412|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3828848|NCT01716052|3655413|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3828849|NCT01716052|3655414|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3828850|NCT01716052|3655412|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3828851|NCT01716052|3655413|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3828852|NCT01716052|3655414|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3828853|NCT01716013|3655421|B3|Surgical incision||Wound type||participants|Number|119|119.0||||||
3828854|NCT01716013|3655422|B2|Surgical incision||Wound type||participants|Number|41|41.0||||||
3828855|NCT01716013|3655423|B1|Surgical incision||Wound type||participants|Number|78|78.0||||||
3828856|NCT01716013|3655421|B3|Injury (Laceration)||Wound type||participants|Number|40|40.0||||||
3828857|NCT01716013|3655422|B2|Injury (Laceration)||Wound type||participants|Number|13|13.0||||||
3828858|NCT01716013|3655423|B1|Injury (Laceration)||Wound type||participants|Number|27|27.0||||||
3828859|NCT01716013|3655421|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3828860|NCT01716013|3655422|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828861|NCT01716013|3655423|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3828862|NCT01716013|3655421|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828863|NCT01716013|3655422|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828864|NCT01716013|3655423|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828865|NCT01716013|3655421|B3||White|Race (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
3828866|NCT01716013|3655422|B2||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3828867|NCT01716013|3655423|B1||White|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3828868|NCT01716013|3655421|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3828869|NCT01716013|3655422|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3828870|NCT01716013|3655423|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3828871|NCT01716013|3655421|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828872|NCT01716013|3655422|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828873|NCT01716013|3655423|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828874|NCT01716013|3655421|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3828875|NCT01716013|3655422|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3828876|NCT01716013|3655423|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3828877|NCT01716013|3655421|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828878|NCT01716013|3655422|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828879|NCT01716013|3655423|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828880|NCT01716013|3655421|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828881|NCT01716013|3655422|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828882|NCT01716013|3655423|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828883|NCT01716013|3655421|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|133|133.0||||||
3828884|NCT01716013|3655422|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3828885|NCT01716013|3655423|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3828886|NCT01716013|3655421|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3828887|NCT01716013|3655422|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3828888|NCT01716013|3655423|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3828889|NCT01716013|3655421|B3||Male|Gender||Participants|Count of Participants|86|86.0||||||
3828890|NCT01716013|3655422|B2||Male|Gender||Participants|Count of Participants|30|30.0||||||
3828891|NCT01716013|3655423|B1||Male|Gender||Participants|Count of Participants|56|56.0||||||
3828892|NCT01716013|3655421|B3||Female|Gender||Participants|Count of Participants|73|73.0||||||
3828893|NCT01716013|3655422|B2||Female|Gender||Participants|Count of Participants|24|24.0||||||
3828894|NCT01716013|3655423|B1||Female|Gender||Participants|Count of Participants|49|49.0||||||
3828895|NCT01716013|3655421|B3|||Age||years|Mean|45.5|45.5|Standard Deviation|22.8|22.8|||
3828896|NCT01716013|3655422|B2|||Age||years|Mean|47.7|47.7|Standard Deviation|22.3|22.3|||
3828897|NCT01716013|3655423|B1|||Age||years|Mean|44.4|44.4|Standard Deviation|23.1|23.1|||
3828898|NCT01715948|3655436|B1|Canada||Region of Enrollment||participants|Number|8|8.0||||||
3828899|NCT01715948|3655436|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3828900|NCT01715948|3655436|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3828901|NCT01715948|3655436|B1|||Age||years|Mean|54|54.0|Full Range|||44.0|66.0|
3828902|NCT01715948|3655436|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3828903|NCT01715948|3655436|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3828904|NCT01715948|3655436|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3828905|NCT01715896|3655455|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3828906|NCT01715896|3655456|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3828907|NCT01715896|3655457|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3828908|NCT01715896|3655455|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3828909|NCT01715896|3655456|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3828910|NCT01715896|3655457|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3828911|NCT01715896|3655455|B3|||Age||years|Mean|50.0|50.0|Standard Deviation|12.4|12.4|||
3828912|NCT01715896|3655456|B2|||Age||years|Mean|50.2|50.2|Standard Deviation|13.3|13.3|||
3828913|NCT01715896|3655457|B1|||Age||years|Mean|49.9|49.9|Standard Deviation|11.4|11.4|||
3828914|NCT01715883|3655521|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3828915|NCT01715883|3655521|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828916|NCT01715883|3655521|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3828917|NCT01715883|3655521|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3828918|NCT01715883|3655521|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3828919|NCT01715883|3655521|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3828920|NCT01715883|3655521|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3828921|NCT01715883|3655521|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3828922|NCT01715883|3655521|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3828923|NCT01715857|3655531|B1|||Body Weight||kilograms|Mean|62.19|62.19|Standard Deviation|10.96|10.96|||
3828924|NCT01715857|3655531|B1|Orthopedic Surgery||Type of Surgery||percentage of participants|Number|16.73|16.73||||||
3828925|NCT01715857|3655531|B1|Gynecologic Surgery||Type of Surgery||percentage of participants|Number|28.17|28.17||||||
3828926|NCT01715857|3655531|B1|General Surgery||Type of Surgery||percentage of participants|Number|55.09|55.09||||||
3828927|NCT01715857|3655531|B1|ASA Physical Status V||American Society of Anesthesiologist (ASA) Physical Status|ASA Physical Status Classification System: ASA Physical Status I = A normal healthy patient; ASA Physical Status II = A patient with mild systemic disease; ASA Physical Status III = A patient with severe systemic disease; ASA Physical Status IV = A patient with severe systemic disease that is a constant threat to life; ASA Physical Status V = A moribund patient who is not expected to survive without the operation; ASA Physical Status VI = A declared brain-dead patient whose organs are being removed for donor purposes|percentage of participants|Number|0|0.0||||||
3828928|NCT01715857|3655531|B1|ASA Physical Status IV||American Society of Anesthesiologist (ASA) Physical Status|ASA Physical Status Classification System: ASA Physical Status I = A normal healthy patient; ASA Physical Status II = A patient with mild systemic disease; ASA Physical Status III = A patient with severe systemic disease; ASA Physical Status IV = A patient with severe systemic disease that is a constant threat to life; ASA Physical Status V = A moribund patient who is not expected to survive without the operation; ASA Physical Status VI = A declared brain-dead patient whose organs are being removed for donor purposes|percentage of participants|Number|0|0.0||||||
3828929|NCT01715857|3655531|B1|ASA Physical Status III||American Society of Anesthesiologist (ASA) Physical Status|ASA Physical Status Classification System: ASA Physical Status I = A normal healthy patient; ASA Physical Status II = A patient with mild systemic disease; ASA Physical Status III = A patient with severe systemic disease; ASA Physical Status IV = A patient with severe systemic disease that is a constant threat to life; ASA Physical Status V = A moribund patient who is not expected to survive without the operation; ASA Physical Status VI = A declared brain-dead patient whose organs are being removed for donor purposes|percentage of participants|Number|3.50|3.5||||||
3828930|NCT01715857|3655531|B1|ASA Physical Status II||American Society of Anesthesiologist (ASA) Physical Status|ASA Physical Status Classification System: ASA Physical Status I = A normal healthy patient; ASA Physical Status II = A patient with mild systemic disease; ASA Physical Status III = A patient with severe systemic disease; ASA Physical Status IV = A patient with severe systemic disease that is a constant threat to life; ASA Physical Status V = A moribund patient who is not expected to survive without the operation; ASA Physical Status VI = A declared brain-dead patient whose organs are being removed for donor purposes|percentage of participants|Number|49.18|49.18||||||
3828931|NCT01715857|3655531|B1|ASA Physical Status I||American Society of Anesthesiologist (ASA) Physical Status|ASA Physical Status Classification System: ASA Physical Status I = A normal healthy patient; ASA Physical Status II = A patient with mild systemic disease; ASA Physical Status III = A patient with severe systemic disease; ASA Physical Status IV = A patient with severe systemic disease that is a constant threat to life; ASA Physical Status V = A moribund patient who is not expected to survive without the operation; ASA Physical Status VI = A declared brain-dead patient whose organs are being removed for donor purposes|percentage of participants|Number|47.33|47.33||||||
3828932|NCT01715857|3655531|B1||Male|Sex: Female, Male||Participants|Count of Participants|1284|1284.0||||||
3828933|NCT01715857|3655531|B1||Female|Sex: Female, Male||Participants|Count of Participants|2720|2720.0||||||
3828934|NCT01715857|3655531|B1|||Age||years|Mean|45.54|45.54|Standard Deviation|12.57|12.57|||
3828935|NCT01715831|3655541|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3828936|NCT01715831|3655541|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3828937|NCT01715831|3655541|B1|||Age||years|Mean|56.0|56.0|Standard Deviation|12.6|12.6|||
3828938|NCT01715415|3655557|B3||Male|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
3828939|NCT01715415|3655558|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3828940|NCT01715415|3655559|B1||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3828941|NCT01715415|3655557|B3||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3828942|NCT01715415|3655558|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3828943|NCT01715415|3655559|B1||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3828944|NCT01715415|3655557|B3|||Age||years|Mean|52.5|52.5|Standard Deviation|9.93|9.93|||
3828945|NCT01715415|3655558|B2|||Age||years|Mean|54.9|54.9|Standard Deviation|8.46|8.46|||
3828946|NCT01715415|3655559|B1|||Age||years|Mean|51.7|51.7|Standard Deviation|10.26|10.26|||
3828947|NCT01715298|3655572|B3||Male|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
3828948|NCT01715298|3655573|B2||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3828949|NCT01715298|3655574|B1||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3828950|NCT01715298|3655572|B3||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
3828951|NCT01715298|3655573|B2||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3828952|NCT01715298|3655574|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3828953|NCT01715298|3655572|B3|||Age||Years|Mean|64.1|64.1|Standard Deviation|8.47|8.47|||
3828954|NCT01715298|3655573|B2|||Age||Years|Mean|64.2|64.2|Standard Deviation|8.41|8.41|||
3828955|NCT01715298|3655574|B1|||Age||Years|Mean|63.9|63.9|Standard Deviation|8.55|8.55|||
3828956|NCT01715285|3655611|B3|New Zealand||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3828957|NCT01715285|3655612|B2|New Zealand||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3828958|NCT01715285|3655613|B1|New Zealand||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3828959|NCT01715285|3655611|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3828960|NCT01715285|3655612|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3828961|NCT01715285|3655613|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3828962|NCT01715285|3655611|B3|Ukraine||Region of Enrollment||Participants|Count of Participants|79|79.0||||||
3828963|NCT01715285|3655612|B2|Ukraine||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3828964|NCT01715285|3655613|B1|Ukraine||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3828965|NCT01715285|3655611|B3|Turkey||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3828966|NCT01715285|3655612|B2|Turkey||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3828967|NCT01715285|3655613|B1|Turkey||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3828968|NCT01715285|3655611|B3|Sweden||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3828969|NCT01715285|3655612|B2|Sweden||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3828970|NCT01715285|3655613|B1|Sweden||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3828971|NCT01715285|3655611|B3|Spain||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3828972|NCT01715285|3655612|B2|Spain||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3828973|NCT01715285|3655613|B1|Spain||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3828974|NCT01715285|3655611|B3|South Korea||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3828975|NCT01715285|3655612|B2|South Korea||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3828976|NCT01715285|3655613|B1|South Korea||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3828977|NCT01715285|3655611|B3|South Africa||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3828978|NCT01715285|3655612|B2|South Africa||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3828979|NCT01715285|3655613|B1|South Africa||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3828980|NCT01715285|3655611|B3|Slovakia||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3828981|NCT01715285|3655612|B2|Slovakia||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3828982|NCT01715285|3655613|B1|Slovakia||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3828983|NCT01715285|3655611|B3|Russian Federation||Region of Enrollment||Participants|Count of Participants|184|184.0||||||
3828984|NCT01715285|3655612|B2|Russian Federation||Region of Enrollment||Participants|Count of Participants|95|95.0||||||
3828985|NCT01715285|3655613|B1|Russian Federation||Region of Enrollment||Participants|Count of Participants|89|89.0||||||
3828986|NCT01715285|3655611|B3|Romania||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
3828987|NCT01715285|3655612|B2|Romania||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3828988|NCT01715285|3655613|B1|Romania||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3828989|NCT01715285|3655611|B3|Portugal||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3828990|NCT01715285|3655612|B2|Portugal||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3828991|NCT01715285|3655613|B1|Portugal||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3828992|NCT01715285|3655611|B3|Poland||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3828993|NCT01715285|3655612|B2|Poland||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3828994|NCT01715285|3655613|B1|Poland||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3828995|NCT01715285|3655611|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3828996|NCT01715285|3655612|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3828997|NCT01715285|3655613|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3828998|NCT01715285|3655611|B3|Mexico||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
3828999|NCT01715285|3655612|B2|Mexico||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3829000|NCT01715285|3655613|B1|Mexico||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3829001|NCT01715285|3655611|B3|Malaysia||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3829002|NCT01715285|3655612|B2|Malaysia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3829003|NCT01715285|3655613|B1|Malaysia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3829004|NCT01715285|3655611|B3|Japan||Region of Enrollment||Participants|Count of Participants|70|70.0||||||
3829005|NCT01715285|3655612|B2|Japan||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3829006|NCT01715285|3655613|B1|Japan||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3829007|NCT01715285|3655611|B3|Italy||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3829008|NCT01715285|3655612|B2|Italy||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3829009|NCT01715285|3655613|B1|Italy||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3829010|NCT01715285|3655611|B3|Israel||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3829011|NCT01715285|3655612|B2|Israel||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3829012|NCT01715285|3655613|B1|Israel||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3829013|NCT01715285|3655611|B3|Hungary||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3829014|NCT01715285|3655612|B2|Hungary||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3829015|NCT01715285|3655613|B1|Hungary||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3829016|NCT01715285|3655611|B3|Germany||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3829017|NCT01715285|3655612|B2|Germany||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3829018|NCT01715285|3655613|B1|Germany||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3829019|NCT01715285|3655611|B3|France||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3829020|NCT01715285|3655612|B2|France||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3829021|NCT01715285|3655613|B1|France||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3829022|NCT01715285|3655611|B3|Finland||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3829023|NCT01715285|3655612|B2|Finland||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3829024|NCT01715285|3655613|B1|Finland||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3829025|NCT01715285|3655611|B3|Denmark||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3829026|NCT01715285|3655612|B2|Denmark||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3829027|NCT01715285|3655613|B1|Denmark||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3829028|NCT01715285|3655611|B3|Czech Republic||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3829029|NCT01715285|3655612|B2|Czech Republic||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3829030|NCT01715285|3655613|B1|Czech Republic||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3829031|NCT01715285|3655611|B3|Colombia||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3829032|NCT01715285|3655612|B2|Colombia||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3829033|NCT01715285|3655613|B1|Colombia||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3829034|NCT01715285|3655611|B3|China||Region of Enrollment||Participants|Count of Participants|137|137.0||||||
3829035|NCT01715285|3655612|B2|China||Region of Enrollment||Participants|Count of Participants|68|68.0||||||
3829036|NCT01715285|3655613|B1|China||Region of Enrollment||Participants|Count of Participants|69|69.0||||||
3829037|NCT01715285|3655611|B3|Chile||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3829038|NCT01715285|3655612|B2|Chile||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3829039|NCT01715285|3655613|B1|Chile||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3829040|NCT01715285|3655611|B3|Canada||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3829041|NCT01715285|3655612|B2|Canada||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3829042|NCT01715285|3655613|B1|Canada||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3829043|NCT01715285|3655611|B3|Bulgaria||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3829044|NCT01715285|3655612|B2|Bulgaria||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3829045|NCT01715285|3655613|B1|Bulgaria||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3829046|NCT01715285|3655611|B3|Brazil||Region of Enrollment||Participants|Count of Participants|56|56.0||||||
3829047|NCT01715285|3655612|B2|Brazil||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3829048|NCT01715285|3655613|B1|Brazil||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3829049|NCT01715285|3655611|B3|Belgium||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3829050|NCT01715285|3655612|B2|Belgium||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3829051|NCT01715285|3655613|B1|Belgium||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3829052|NCT01715285|3655611|B3|Australia||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3829053|NCT01715285|3655612|B2|Australia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3829054|NCT01715285|3655613|B1|Australia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3829055|NCT01715285|3655611|B3|Argentina||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3829056|NCT01715285|3655612|B2|Argentina||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3829057|NCT01715285|3655613|B1|Argentina||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3829058|NCT01715285|3655611|B3||Male|Sex: Female, Male||Participants|Count of Participants|1199|1199.0||||||
3829059|NCT01715285|3655612|B2||Male|Sex: Female, Male||Participants|Count of Participants|602|602.0||||||
3829060|NCT01715285|3655613|B1||Male|Sex: Female, Male||Participants|Count of Participants|597|597.0||||||
3829061|NCT01715285|3655611|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3829062|NCT01715285|3655612|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3829063|NCT01715285|3655613|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3829064|NCT01715285|3655611|B3|||Age||years|Mean|67.1|67.1|Standard Deviation|8.6|8.6|||
3829065|NCT01715285|3655612|B2|||Age||years|Mean|66.8|66.8|Standard Deviation|8.72|8.72|||
3829066|NCT01715285|3655613|B1|||Age||years|Mean|67.3|67.3|Standard Deviation|8.48|8.48|||
3829067|NCT01715285|3655611|B3||>=65 years|Age||Participants|Count of Participants|745|745.0||||||
3829068|NCT01715285|3655612|B2||>=65 years|Age||Participants|Count of Participants|369|369.0||||||
3829069|NCT01715285|3655613|B1||>=65 years|Age||Participants|Count of Participants|376|376.0||||||
3829070|NCT01715285|3655611|B3||Between 18 and 65 years|Age||Participants|Count of Participants|454|454.0||||||
3829071|NCT01715285|3655612|B2||Between 18 and 65 years|Age||Participants|Count of Participants|233|233.0||||||
3829072|NCT01715285|3655613|B1||Between 18 and 65 years|Age||Participants|Count of Participants|221|221.0||||||
3829073|NCT01715285|3655611|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3829074|NCT01715285|3655612|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3829075|NCT01715285|3655613|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3829076|NCT01715207|3655632|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3829077|NCT01715207|3655633|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3829078|NCT01715207|3655634|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3829079|NCT01715207|3655632|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3829080|NCT01715207|3655633|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3829081|NCT01715207|3655634|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3829082|NCT01715207|3655632|B3|||Age||yeaars|Mean|32.6|32.6|Standard Deviation|9.0|9.0|||
3829083|NCT01715207|3655633|B2|||Age||yeaars|Mean|33.2|33.2|Standard Deviation|12.0|12.0|||
3829084|NCT01715207|3655634|B1|||Age||yeaars|Mean|32.1|32.1|Standard Deviation|9.3|9.3|||
3829085|NCT01715129|3655643|B1|||Prostate Specific Antigen (PSA)||ng/mL|Mean|133.53|133.53|Standard Deviation|385.60|385.6|||
3829086|NCT01715129|3655643|B1|||Body Mass Index (BMI)||kg/m²|Mean|27.16|27.16|Standard Deviation|3.96|3.96|||
3829087|NCT01715129|3655643|B1|||Weight||kg|Mean|80.6|80.6|Standard Deviation|12.8|12.8|||
3829088|NCT01715129|3655643|B1|||Height||cm|Mean|172.2|172.2|Standard Deviation|6.7|6.7|||
3829089|NCT01715129|3655643|B1|Missing||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3829090|NCT01715129|3655643|B1|Caucasian / White||Race/Ethnicity, Customized||participants|Number|120|120.0||||||
3829091|NCT01715129|3655643|B1|Male||Sex/Gender, Customized||participants|Number|126|126.0||||||
3829092|NCT01715129|3655643|B1|||Age||years|Mean|70.4|70.4|Standard Deviation|7.3|7.3|||
3829093|NCT01715064|3655660|B3|Canada||Region of Enrollment||participants|Number|36|36.0||||||
3829094|NCT01715064|3655661|B2|Canada||Region of Enrollment||participants|Number|18|18.0||||||
3829095|NCT01715064|3655662|B1|Canada||Region of Enrollment||participants|Number|18|18.0||||||
3829096|NCT01715064|3655660|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3829097|NCT01715064|3655661|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3829098|NCT01715064|3655662|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3829099|NCT01715064|3655660|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3829100|NCT01715064|3655661|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3829101|NCT01715064|3655662|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3829102|NCT01715064|3655660|B3|||Age||years|Mean|64.6|64.6|Standard Deviation|8.8|8.8|||
3829103|NCT01715064|3655661|B2|||Age||years|Mean|67.7|67.7|Standard Deviation|7.6|7.6|||
3829104|NCT01715064|3655662|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|9.1|9.1|||
3829105|NCT01715064|3655660|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3829106|NCT01715064|3655661|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3829107|NCT01715064|3655662|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3829108|NCT01715064|3655660|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3829109|NCT01715064|3655661|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3829110|NCT01715064|3655662|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3829111|NCT01715064|3655660|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3829112|NCT01715064|3655661|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3829113|NCT01715064|3655662|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3829114|NCT01714947|3655669|B1|||Body Mass Index (BMI)||kg/m^2|Mean|26.91|26.91|Standard Deviation|8.346|8.346|||
3829115|NCT01714947|3655669|B1|||Weight||kg|Mean|80.27|80.27|Standard Deviation|20.760|20.76|||
3829116|NCT01714947|3655669|B1|||Height||cm|Mean|173.5|173.5|Standard Deviation|7.15|7.15|||
3829117|NCT01714947|3655669|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3829118|NCT01714947|3655669|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3829119|NCT01714947|3655669|B1|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3829120|NCT01714947|3655669|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3829121|NCT01714947|3655669|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3829122|NCT01714947|3655669|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3829123|NCT01714947|3655669|B1|||Age||years|Mean|64.0|64.0|Standard Deviation|13.11|13.11|||
3829124|NCT01714921|3655698|B1|Germany||Region of Enrollment||participants|Number|504|504.0||||||
3829125|NCT01714921|3655698|B1||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Data were not collected
3829126|NCT01714921|3655698|B1||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||data has been gathered based on information stored in the device. Data on sex is not available in this data.
3829127|NCT01714921|3655698|B1|||Age||years|Mean|65.5|65.5|Standard Deviation|12.4|12.4|||
3829128|NCT01714817|3655708|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|74|74.0||||||
3829129|NCT01714817|3655709|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
3829130|NCT01714817|3655710|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3829131|NCT01714817|3655708|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|156|156.0||||||
3829132|NCT01714817|3655709|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|71|71.0||||||
3829133|NCT01714817|3655710|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|85|85.0||||||
3829134|NCT01714817|3655708|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3829135|NCT01714817|3655709|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3829136|NCT01714817|3655710|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3829137|NCT01714817|3655708|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|145|145.0||||||
3829138|NCT01714817|3655709|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|74|74.0||||||
3829139|NCT01714817|3655710|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|71|71.0||||||
3829140|NCT01714817|3655708|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3829141|NCT01714817|3655709|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3829142|NCT01714817|3655710|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3829143|NCT01714817|3655708|B3||Female|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
3829144|NCT01714817|3655709|B2||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
3829145|NCT01714817|3655710|B1||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3829146|NCT01714817|3655708|B3|||Age||years|Mean|33.1|33.1|Standard Deviation|10.60|10.6|17.0|72.0|
3829147|NCT01714817|3655709|B2|||Age||years|Mean|33.2|33.2|Standard Deviation|10.48|10.48|18.0|72.0|
3829148|NCT01714817|3655710|B1|||Age||years|Mean|33.1|33.1|Standard Deviation|10.75|10.75|17.0|65.0|
3829149|NCT01714804|3655730|B3|United States||Region of Enrollment||participants|Number|59|59.0||||||
3829150|NCT01714804|3655731|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3829151|NCT01714804|3655732|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3829152|NCT01714804|3655730|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3829153|NCT01714804|3655730|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3829154|NCT01714804|3655731|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3829155|NCT01714804|3655732|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3829156|NCT01714804|3655730|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3829157|NCT01714804|3655731|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3829158|NCT01714804|3655732|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3829159|NCT01714804|3655730|B3|>18 years old||Age, Customized||Participants|Count of Participants|59|59.0||||||
3829160|NCT01714804|3655731|B2|>18 years old||Age, Customized||Participants|Count of Participants|30|30.0||||||
3829161|NCT01714804|3655732|B1|>18 years old||Age, Customized||Participants|Count of Participants|29|29.0||||||
3829162|NCT01714635|3655741|B4|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
3829163|NCT01714635|3655742|B3|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3829164|NCT01714635|3655743|B2|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3829165|NCT01714635|3655744|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3829166|NCT01714635|3655741|B4|United States||Region of Enrollment||participants|Number|443|443.0||||||
3829167|NCT01714635|3655742|B3|United States||Region of Enrollment||participants|Number|147|147.0||||||
3829168|NCT01714635|3655743|B2|United States||Region of Enrollment||participants|Number|150|150.0||||||
3829169|NCT01714635|3655744|B1|United States||Region of Enrollment||participants|Number|146|146.0||||||
3829170|NCT01714635|3655741|B4||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
3829171|NCT01714635|3655742|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3829172|NCT01714635|3655743|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3829173|NCT01714635|3655744|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3829174|NCT01714635|3655741|B4||Female|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
3829175|NCT01714635|3655742|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3829176|NCT01714635|3655743|B2||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3829177|NCT01714635|3655744|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3829178|NCT01714635|3655741|B4|Not reported||Age, Customized|Age was grouped by catagories as described in the table.|participants|Number|0|0.0||||||
3829179|NCT01714635|3655742|B3|Not reported||Age, Customized|Age was grouped by catagories as described in the table.|participants|Number|0|0.0||||||
3829180|NCT01714635|3655743|B2|Not reported||Age, Customized|Age was grouped by catagories as described in the table.|participants|Number|0|0.0||||||
3829181|NCT01714635|3655744|B1|Not reported||Age, Customized|Age was grouped by catagories as described in the table.|participants|Number|0|0.0||||||
3829182|NCT01714635|3655741|B4|Greater than or equal to 80 years||Age, Customized|Age was grouped by catagories as described in the table.|participants|Number|15|15.0||||||
3829183|NCT01714635|3655742|B3|Greater than or equal to 80 years||Age, Customized|Age was grouped by catagories as described in the table.|participants|Number|8|8.0||||||
3829184|NCT01714635|3655743|B2|Greater than or equal to 80 years||Age, Customized|Age was grouped by catagories as described in the table.|participants|Number|5|5.0||||||
3829185|NCT01714635|3655744|B1|Greater than or equal to 80 years||Age, Customized|Age was grouped by catagories as described in the table.|participants|Number|2|2.0||||||
3829186|NCT01714635|3655741|B4|70 - 79 years||Age, Customized|Age was grouped by catagories as described in the table.|participants|Number|185|185.0||||||
3829187|NCT01714635|3655742|B3|70 - 79 years||Age, Customized|Age was grouped by catagories as described in the table.|participants|Number|60|60.0||||||
3829188|NCT01714635|3655743|B2|70 - 79 years||Age, Customized|Age was grouped by catagories as described in the table.|participants|Number|59|59.0||||||
3829189|NCT01714635|3655744|B1|70 - 79 years||Age, Customized|Age was grouped by catagories as described in the table.|participants|Number|66|66.0||||||
3829190|NCT01714635|3655741|B4|60 - 69 years||Age, Customized|Age was grouped by catagories as described in the table.|participants|Number|193|193.0||||||
3829191|NCT01714635|3655742|B3|60 - 69 years||Age, Customized|Age was grouped by catagories as described in the table.|participants|Number|67|67.0||||||
3829192|NCT01714635|3655743|B2|60 - 69 years||Age, Customized|Age was grouped by catagories as described in the table.|participants|Number|68|68.0||||||
3829193|NCT01714635|3655744|B1|60 - 69 years||Age, Customized|Age was grouped by catagories as described in the table.|participants|Number|58|58.0||||||
3829194|NCT01714635|3655741|B4|Less than 60 years||Age, Customized|Age was grouped by catagories as described in the table.|participants|Number|52|52.0||||||
3829195|NCT01714635|3655742|B3|Less than 60 years||Age, Customized|Age was grouped by catagories as described in the table.|participants|Number|13|13.0||||||
3829196|NCT01714635|3655743|B2|Less than 60 years||Age, Customized|Age was grouped by catagories as described in the table.|participants|Number|18|18.0||||||
3829197|NCT01714635|3655744|B1|Less than 60 years||Age, Customized|Age was grouped by catagories as described in the table.|participants|Number|21|21.0||||||
3829198|NCT01714609|3655760|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
3829199|NCT01714609|3655761|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3829200|NCT01714609|3655762|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3829201|NCT01714609|3655760|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3829202|NCT01714609|3655761|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3829203|NCT01714609|3655762|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3829204|NCT01714609|3655760|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3829205|NCT01714609|3655761|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3829206|NCT01714609|3655762|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3829207|NCT01714609|3655760|B3|||Age||years|Mean|57.38|57.38|Standard Deviation|4.48|4.48|||
3829208|NCT01714609|3655761|B2|||Age||years|Mean|58.78|58.78|Standard Deviation|4.25|4.25|||
3829209|NCT01714609|3655762|B1|||Age||years|Mean|55.98|55.98|Standard Deviation|4.7|4.7|||
3829210|NCT01714544|3655769|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
3829211|NCT01714544|3655769|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3829212|NCT01714544|3655769|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829213|NCT01714544|3655769|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829214|NCT01714544|3655769|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829215|NCT01714544|3655769|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829216|NCT01714544|3655769|B1||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3829217|NCT01714544|3655769|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3829218|NCT01714544|3655769|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829219|NCT01714544|3655769|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3829220|NCT01714544|3655769|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3829221|NCT01714544|3655769|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3829222|NCT01714544|3655769|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3829223|NCT01714544|3655769|B1|||Age||years|Mean|50|50.0|Standard Deviation|12.2|12.2|||
3829224|NCT01714505|3655773|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3829225|NCT01714505|3655773|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3829226|NCT01714505|3655773|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3829227|NCT01714505|3655773|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3829228|NCT01714505|3655773|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3829229|NCT01714492|3655784|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3829230|NCT01714492|3655784|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3829231|NCT01714492|3655784|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3829232|NCT01714492|3655784|B1|||Age||years|Mean|74|74.0|Standard Deviation|8.6|8.6|||
3829233|NCT01714492|3655784|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3829234|NCT01714492|3655784|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3829235|NCT01714492|3655784|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3829236|NCT01714336|3655793|B3|United States||Region of Enrollment||participants|Number|138|138.0||||||
3829237|NCT01714336|3655794|B2|United States||Region of Enrollment||participants|Number|69|69.0||||||
3829238|NCT01714336|3655795|B1|United States||Region of Enrollment||participants|Number|69|69.0||||||
3829239|NCT01714336|3655793|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3829240|NCT01714336|3655794|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3829241|NCT01714336|3655795|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3829242|NCT01714336|3655793|B3||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3829243|NCT01714336|3655794|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3829244|NCT01714336|3655795|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3829245|NCT01714336|3655793|B3|||Age||years|Mean|81.6|81.6|Standard Deviation|10|10.0|||
3829246|NCT01714336|3655794|B2|||Age||years|Mean|81.0|81.0|Standard Deviation|10|10.0|||
3829247|NCT01714336|3655795|B1|||Age||years|Mean|82.2|82.2|Standard Deviation|10|10.0|||
3829248|NCT01714323|3655816|B3|United States||Region of Enrollment||participants|Number|1357|1357.0||||||
3829249|NCT01714323|3655817|B2|United States||Region of Enrollment||participants|Number|680|680.0||||||
3829250|NCT01714323|3655818|B1|United States||Region of Enrollment||participants|Number|677|677.0||||||
3829251|NCT01714323|3655816|B3||Male|Sex: Female, Male||Participants|Count of Participants|689|689.0||||||
3829252|NCT01714323|3655817|B2||Male|Sex: Female, Male||Participants|Count of Participants|348|348.0||||||
3829253|NCT01714323|3655818|B1||Male|Sex: Female, Male||Participants|Count of Participants|341|341.0||||||
3829254|NCT01714323|3655816|B3||Female|Sex: Female, Male||Participants|Count of Participants|668|668.0||||||
3829255|NCT01714323|3655817|B2||Female|Sex: Female, Male||Participants|Count of Participants|332|332.0||||||
3829256|NCT01714323|3655818|B1||Female|Sex: Female, Male||Participants|Count of Participants|336|336.0||||||
3829257|NCT01714323|3655816|B3|||Age||years|Mean|49.7|49.7|Standard Deviation|12.6|12.6|||
3829258|NCT01714323|3655817|B2|||Age||years|Mean|49.6|49.6|Standard Deviation|12.8|12.8|||
3829259|NCT01714323|3655818|B1|||Age||years|Mean|49.8|49.8|Standard Deviation|12.4|12.4|||
3829260|NCT01714310|3655837|B4|||Affective Reactivity Index Parent Report|A parent completed dimensional measure of irritability on a scale of 0 to 14, with 14 being most severe.|units on a scale|Mean|NA||Standard Deviation|NA||||Columns not additive as described above.
3829261|NCT01714310|3655838|B3|||Affective Reactivity Index Parent Report|A parent completed dimensional measure of irritability on a scale of 0 to 14, with 14 being most severe.|units on a scale|Mean|8.57|8.57|Standard Deviation|2.17|2.17|||
3829262|NCT01714310|3655839|B2|||Affective Reactivity Index Parent Report|A parent completed dimensional measure of irritability on a scale of 0 to 14, with 14 being most severe.|units on a scale|Mean|10.00|10.0|Standard Deviation|1.95|1.95|||
3829263|NCT01714310|3655840|B1|||Affective Reactivity Index Parent Report|A parent completed dimensional measure of irritability on a scale of 0 to 14, with 14 being most severe.|units on a scale|Mean|8.91|8.91|Standard Deviation|2.47|2.47|||
3829264|NCT01714310|3655837|B4|||Clinical Global Impression SMD Severity|A dimensional NIH measures used to quantify severity of severe mood dysregulation. Minimum score = 1. Maximum score = 7. Higher scores mean greater impairment.|units on a scale|Mean|NA||Standard Deviation|NA||||Columns not additive as described above.
3829265|NCT01714310|3655838|B3|||Clinical Global Impression SMD Severity|A dimensional NIH measures used to quantify severity of severe mood dysregulation. Minimum score = 1. Maximum score = 7. Higher scores mean greater impairment.|units on a scale|Mean|4.83|4.83|Standard Deviation|.72|0.72|||
3829266|NCT01714310|3655839|B2|||Clinical Global Impression SMD Severity|A dimensional NIH measures used to quantify severity of severe mood dysregulation. Minimum score = 1. Maximum score = 7. Higher scores mean greater impairment.|units on a scale|Mean|4.75|4.75|Standard Deviation|.46|0.46|||
3829267|NCT01714310|3655840|B1|||Clinical Global Impression SMD Severity|A dimensional NIH measures used to quantify severity of severe mood dysregulation. Minimum score = 1. Maximum score = 7. Higher scores mean greater impairment.|units on a scale|Mean|4.82|4.82|Standard Deviation|.52|0.52|||
3829268|NCT01714310|3655837|B4|||Wechsler Abbreviated Scale of Intelligence|Standard IQ measure for youth, frequently used in clinical studies, based on an administered test, with mean population score = 100.|units on a scale|Mean|NA||Standard Deviation|NA||||Columns not additive as described above.
3829269|NCT01714310|3655838|B3|||Wechsler Abbreviated Scale of Intelligence|Standard IQ measure for youth, frequently used in clinical studies, based on an administered test, with mean population score = 100.|units on a scale|Mean|101.69|101.69|Standard Deviation|14.34|14.34|||
3829270|NCT01714310|3655839|B2|||Wechsler Abbreviated Scale of Intelligence|Standard IQ measure for youth, frequently used in clinical studies, based on an administered test, with mean population score = 100.|units on a scale|Mean|105.58|105.58|Standard Deviation|15.56|15.56|||
3829271|NCT01714310|3655840|B1|||Wechsler Abbreviated Scale of Intelligence|Standard IQ measure for youth, frequently used in clinical studies, based on an administered test, with mean population score = 100.|units on a scale|Mean|103.16|103.16|Standard Deviation|14.30|14.3|||
3829272|NCT01714310|3655837|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829273|NCT01714310|3655838|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829274|NCT01714310|3655839|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829275|NCT01714310|3655840|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829276|NCT01714310|3655837|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3829277|NCT01714310|3655838|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3829278|NCT01714310|3655839|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3829279|NCT01714310|3655840|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3829280|NCT01714310|3655837|B4||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3829281|NCT01714310|3655838|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3829282|NCT01714310|3655839|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3829283|NCT01714310|3655840|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3829284|NCT01714310|3655837|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3829285|NCT01714310|3655838|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829286|NCT01714310|3655839|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829287|NCT01714310|3655840|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3829288|NCT01714310|3655837|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829289|NCT01714310|3655838|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829290|NCT01714310|3655839|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829291|NCT01714310|3655840|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829292|NCT01714310|3655837|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3829293|NCT01714310|3655838|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829294|NCT01714310|3655839|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829295|NCT01714310|3655840|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3829296|NCT01714310|3655837|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829297|NCT01714310|3655838|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829298|NCT01714310|3655839|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829299|NCT01714310|3655840|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829300|NCT01714310|3655837|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829301|NCT01714310|3655838|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829302|NCT01714310|3655839|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829303|NCT01714310|3655840|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829304|NCT01714310|3655837|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3829305|NCT01714310|3655838|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3829306|NCT01714310|3655839|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3829307|NCT01714310|3655840|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3829308|NCT01714310|3655837|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3829309|NCT01714310|3655838|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829310|NCT01714310|3655839|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3829311|NCT01714310|3655840|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3829312|NCT01714310|3655837|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3829313|NCT01714310|3655838|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3829314|NCT01714310|3655839|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3829315|NCT01714310|3655840|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3829316|NCT01714310|3655837|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3829317|NCT01714310|3655838|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3829318|NCT01714310|3655839|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3829319|NCT01714310|3655840|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3829320|NCT01714310|3655837|B4|||Age|Columns for baseline measures are not additive, as fluoxetine and placebo groups are a subset of the original 34 participants entered into phase 1.|years|Mean|NA||Standard Deviation|NA||||Columns are not additive, as described above.
3829321|NCT01714310|3655838|B3|||Age|Columns for baseline measures are not additive, as fluoxetine and placebo groups are a subset of the original 34 participants entered into phase 1.|years|Mean|10.22|10.22|Standard Deviation|2.74|2.74|||
3829322|NCT01714310|3655839|B2|||Age|Columns for baseline measures are not additive, as fluoxetine and placebo groups are a subset of the original 34 participants entered into phase 1.|years|Mean|9.97|9.97|Standard Deviation|2.30|2.3|||
3829323|NCT01714310|3655840|B1|||Age|Columns for baseline measures are not additive, as fluoxetine and placebo groups are a subset of the original 34 participants entered into phase 1.|years|Mean|10.24|10.24|Standard Deviation|2.58|2.58|||
3829324|NCT01714232|3655889|B1|United States||Region of Enrollment||participants|Number|106|106.0||||||
3829325|NCT01714232|3655889|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3829326|NCT01714232|3655889|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3829327|NCT01714232|3655889|B1|||Age, Customized||years|Median|60|60.0|Full Range|||18.0|84.0|
3829328|NCT01714024|3655895|B4|United States||Region of Enrollment||participants|Number|36|36.0||||||
3829329|NCT01714024|3655896|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3829330|NCT01714024|3655897|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3829331|NCT01714024|3655898|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3829332|NCT01714024|3655895|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3829333|NCT01714024|3655896|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3829334|NCT01714024|3655897|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3829335|NCT01714024|3655898|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3829336|NCT01714024|3655895|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3829337|NCT01714024|3655896|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3829338|NCT01714024|3655897|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3829339|NCT01714024|3655898|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3829340|NCT01714024|3655895|B4|||Age||years|Mean|64.22|64.22|Full Range|||39.0|76.0|
3829341|NCT01714024|3655896|B3|||Age||years|Mean|66.38|66.38|Full Range|||59.0|76.0|
3829342|NCT01714024|3655897|B2|||Age||years|Mean|64.33|64.33|Full Range|||54.0|71.0|
3829343|NCT01714024|3655898|B1|||Age||years|Mean|59.33|59.33|Full Range|||39.0|75.0|
3829344|NCT01714024|3655895|B4||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3829345|NCT01714024|3655896|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3829346|NCT01714024|3655897|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3829347|NCT01714024|3655898|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3829348|NCT01714024|3655895|B4||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3829349|NCT01714024|3655896|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3829350|NCT01714024|3655897|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3829351|NCT01714024|3655898|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3829352|NCT01714024|3655895|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3829353|NCT01714024|3655896|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3829354|NCT01714024|3655897|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3829355|NCT01714024|3655898|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3829356|NCT01713998|3655917|B4|Skin Type VI||Fitzpatrick Skin Type|"Skin Type I = White; very fair, red or blonde hair blue eyes; freckles; Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes; Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|0|0.0||||||
3829357|NCT01713998|3655918|B3|Skin Type VI||Fitzpatrick Skin Type|"Skin Type I = White; very fair, red or blonde hair blue eyes; freckles; Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes; Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|0|0.0||||||
3829358|NCT01713998|3655919|B2|Skin Type VI||Fitzpatrick Skin Type|"Skin Type I = White; very fair, red or blonde hair blue eyes; freckles; Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes; Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|0|0.0||||||
3829359|NCT01713998|3655920|B1|Skin Type VI||Fitzpatrick Skin Type|"Skin Type I = White; very fair, red or blonde hair blue eyes; freckles; Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes; Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|0|0.0||||||
3829360|NCT01713998|3655917|B4|Skin Type V||Fitzpatrick Skin Type|"Skin Type I = White; very fair, red or blonde hair blue eyes; freckles; Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes; Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|0|0.0||||||
3829361|NCT01713998|3655918|B3|Skin Type V||Fitzpatrick Skin Type|"Skin Type I = White; very fair, red or blonde hair blue eyes; freckles; Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes; Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|0|0.0||||||
3829362|NCT01713998|3655919|B2|Skin Type V||Fitzpatrick Skin Type|"Skin Type I = White; very fair, red or blonde hair blue eyes; freckles; Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes; Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|0|0.0||||||
3829363|NCT01713998|3655920|B1|Skin Type V||Fitzpatrick Skin Type|"Skin Type I = White; very fair, red or blonde hair blue eyes; freckles; Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes; Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|0|0.0||||||
3829364|NCT01713998|3655917|B4|Skin Type IV||Fitzpatrick Skin Type|"Skin Type I = White; very fair, red or blonde hair blue eyes; freckles; Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes; Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|3|3.0||||||
3829365|NCT01713998|3655918|B3|Skin Type IV||Fitzpatrick Skin Type|"Skin Type I = White; very fair, red or blonde hair blue eyes; freckles; Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes; Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|1|1.0||||||
3829366|NCT01713998|3655919|B2|Skin Type IV||Fitzpatrick Skin Type|"Skin Type I = White; very fair, red or blonde hair blue eyes; freckles; Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes; Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|2|2.0||||||
3829436|NCT01713946|3655940|B4|Native American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3829367|NCT01713998|3655920|B1|Skin Type IV||Fitzpatrick Skin Type|"Skin Type I = White; very fair, red or blonde hair blue eyes; freckles; Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes; Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|0|0.0||||||
3829368|NCT01713998|3655917|B4|Skin Type III||Fitzpatrick Skin Type|"Skin Type I = White; very fair, red or blonde hair blue eyes; freckles; Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes; Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|23|23.0||||||
3829369|NCT01713998|3655918|B3|Skin Type III||Fitzpatrick Skin Type|"Skin Type I = White; very fair, red or blonde hair blue eyes; freckles; Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes; Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|10|10.0||||||
3829370|NCT01713998|3655919|B2|Skin Type III||Fitzpatrick Skin Type|"Skin Type I = White; very fair, red or blonde hair blue eyes; freckles; Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes; Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|7|7.0||||||
3829371|NCT01713998|3655920|B1|Skin Type III||Fitzpatrick Skin Type|"Skin Type I = White; very fair, red or blonde hair blue eyes; freckles; Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes; Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|6|6.0||||||
3829372|NCT01713998|3655917|B4|Skin Type II||Fitzpatrick Skin Type|"Skin Type I = White; very fair, red or blonde hair blue eyes; freckles; Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes; Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|20|20.0||||||
3829373|NCT01713998|3655918|B3|Skin Type II||Fitzpatrick Skin Type|"Skin Type I = White; very fair, red or blonde hair blue eyes; freckles; Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes; Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|5|5.0||||||
3829374|NCT01713998|3655919|B2|Skin Type II||Fitzpatrick Skin Type|"Skin Type I = White; very fair, red or blonde hair blue eyes; freckles; Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes; Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|5|5.0||||||
3829375|NCT01713998|3655920|B1|Skin Type II||Fitzpatrick Skin Type|"Skin Type I = White; very fair, red or blonde hair blue eyes; freckles; Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes; Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|10|10.0||||||
3829376|NCT01713998|3655917|B4|Skin Type I||Fitzpatrick Skin Type|"Skin Type I = White; very fair, red or blonde hair blue eyes; freckles; Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes; Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|1|1.0||||||
3829377|NCT01713998|3655918|B3|Skin Type I||Fitzpatrick Skin Type|"Skin Type I = White; very fair, red or blonde hair blue eyes; freckles; Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes; Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|0|0.0||||||
3829378|NCT01713998|3655919|B2|Skin Type I||Fitzpatrick Skin Type|"Skin Type I = White; very fair, red or blonde hair blue eyes; freckles; Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes; Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|1|1.0||||||
3829558|NCT01713582|3656099|B20||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3829379|NCT01713998|3655920|B1|Skin Type I||Fitzpatrick Skin Type|"Skin Type I = White; very fair, red or blonde hair blue eyes; freckles; Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes; Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|0|0.0||||||
3829380|NCT01713998|3655917|B4|||Body Mass Index (BMI)||kg/m^2|Mean|24|24.0|Full Range|||19.0|29.0|
3829381|NCT01713998|3655918|B3|||Body Mass Index (BMI)||kg/m^2|Mean|24|24.0|Full Range|||20.0|29.0|
3829382|NCT01713998|3655919|B2|||Body Mass Index (BMI)||kg/m^2|Mean|24|24.0|Full Range|||19.0|28.0|
3829383|NCT01713998|3655920|B1|||Body Mass Index (BMI)||kg/m^2|Mean|24|24.0|Full Range|||20.0|29.0|
3829384|NCT01713998|3655917|B4|United States||Region of Enrollment||participants|Number|47|47.0||||||
3829385|NCT01713998|3655918|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
3829386|NCT01713998|3655919|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3829387|NCT01713998|3655920|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3829388|NCT01713998|3655917|B4|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3829389|NCT01713998|3655918|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3829390|NCT01713998|3655919|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3829391|NCT01713998|3655920|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3829392|NCT01713998|3655917|B4|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3829393|NCT01713998|3655918|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3829394|NCT01713998|3655919|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3829395|NCT01713998|3655920|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3829396|NCT01713998|3655917|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
3829397|NCT01713998|3655918|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3829398|NCT01713998|3655919|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3829399|NCT01713998|3655920|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3829400|NCT01713998|3655917|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3829401|NCT01713998|3655918|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3829402|NCT01713998|3655919|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3829403|NCT01713998|3655920|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3829404|NCT01713998|3655917|B4||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3829405|NCT01713998|3655918|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3829406|NCT01713998|3655919|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3829407|NCT01713998|3655920|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3829408|NCT01713998|3655917|B4|||Age||years|Mean|53|53.0|Full Range|||36.0|64.0|
3829409|NCT01713998|3655918|B3|||Age||years|Mean|51|51.0|Full Range|||36.0|64.0|
3829410|NCT01713998|3655919|B2|||Age||years|Mean|55|55.0|Full Range|||42.0|64.0|
3829411|NCT01713998|3655920|B1|||Age||years|Mean|54|54.0|Full Range|||37.0|64.0|
3829412|NCT01713946|3655940|B4|||Body mass index||kg/m^2|Mean|19.55|19.55|Standard Deviation|5.689|5.689|||
3829413|NCT01713946|3655941|B3|||Body mass index||kg/m^2|Mean|19.78|19.78|Standard Deviation|5.484|5.484|||
3829414|NCT01713946|3655942|B2|||Body mass index||kg/m^2|Mean|19.56|19.56|Standard Deviation|6.233|6.233|||
3829415|NCT01713946|3655943|B1|||Body mass index||kg/m^2|Mean|19.29|19.29|Standard Deviation|5.283|5.283|||
3829416|NCT01713946|3655940|B4|||Body surface area||m^2|Mean|1.20|1.2|Standard Deviation|0.472|0.472|||
3829417|NCT01713946|3655941|B3|||Body surface area||m^2|Mean|1.20|1.2|Standard Deviation|0.476|0.476|||
3829418|NCT01713946|3655942|B2|||Body surface area||m^2|Mean|1.20|1.2|Standard Deviation|0.501|0.501|||
3829419|NCT01713946|3655943|B1|||Body surface area||m^2|Mean|1.18|1.18|Standard Deviation|0.437|0.437|||
3829420|NCT01713946|3655940|B4|||Height||cm|Mean|135.87|135.87|Standard Deviation|27.145|27.145|||
3829421|NCT01713946|3655941|B3|||Height||cm|Mean|135.67|135.67|Standard Deviation|27.097|27.097|||
3829422|NCT01713946|3655942|B2|||Height||cm|Mean|136.25|136.25|Standard Deviation|28.234|28.234|||
3829423|NCT01713946|3655943|B1|||Height||cm|Mean|135.65|135.65|Standard Deviation|26.171|26.171|||
3829424|NCT01713946|3655940|B4|||Weight||kg|Mean|40.01|40.01|Standard Deviation|25.093|25.093|||
3829425|NCT01713946|3655941|B3|||Weight||kg|Mean|40.50|40.5|Standard Deviation|24.923|24.923|||
3829426|NCT01713946|3655942|B2|||Weight||kg|Mean|40.75|40.75|Standard Deviation|27.267|27.267|||
3829427|NCT01713946|3655943|B1|||Weight||kg|Mean|38.69|38.69|Standard Deviation|22.802|22.802|||
3829428|NCT01713946|3655940|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3829429|NCT01713946|3655941|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3829430|NCT01713946|3655942|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3829431|NCT01713946|3655943|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3829432|NCT01713946|3655940|B4|Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3829433|NCT01713946|3655941|B3|Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3829434|NCT01713946|3655942|B2|Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3829435|NCT01713946|3655943|B1|Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3829437|NCT01713946|3655941|B3|Native American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3829438|NCT01713946|3655942|B2|Native American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3829439|NCT01713946|3655943|B1|Native American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3829440|NCT01713946|3655940|B4|Black||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3829441|NCT01713946|3655941|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3829442|NCT01713946|3655942|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3829443|NCT01713946|3655943|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3829444|NCT01713946|3655940|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|87|87.0||||||
3829445|NCT01713946|3655941|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3829446|NCT01713946|3655942|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3829447|NCT01713946|3655943|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3829448|NCT01713946|3655940|B4|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|237|237.0||||||
3829449|NCT01713946|3655941|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|77|77.0||||||
3829450|NCT01713946|3655942|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|84|84.0||||||
3829451|NCT01713946|3655943|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|76|76.0||||||
3829452|NCT01713946|3655940|B4||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
3829453|NCT01713946|3655941|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3829454|NCT01713946|3655942|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3829455|NCT01713946|3655943|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3829456|NCT01713946|3655940|B4||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
3829457|NCT01713946|3655941|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3829458|NCT01713946|3655942|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3829459|NCT01713946|3655943|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3829460|NCT01713946|3655940|B4|18 to <65 years||Age, Customized||Participants|Count of Participants|67|67.0||||||
3829461|NCT01713946|3655941|B3|18 to <65 years||Age, Customized||Participants|Count of Participants|23|23.0||||||
3829462|NCT01713946|3655942|B2|18 to <65 years||Age, Customized||Participants|Count of Participants|23|23.0||||||
3829463|NCT01713946|3655943|B1|18 to <65 years||Age, Customized||Participants|Count of Participants|21|21.0||||||
3829464|NCT01713946|3655940|B4|12 to <18 years||Age, Customized||Participants|Count of Participants|82|82.0||||||
3829465|NCT01713946|3655941|B3|12 to <18 years||Age, Customized||Participants|Count of Participants|25|25.0||||||
3829466|NCT01713946|3655942|B2|12 to <18 years||Age, Customized||Participants|Count of Participants|31|31.0||||||
3829467|NCT01713946|3655943|B1|12 to <18 years||Age, Customized||Participants|Count of Participants|26|26.0||||||
3829468|NCT01713946|3655940|B4|6 to <12 years||Age, Customized||Participants|Count of Participants|113|113.0||||||
3829469|NCT01713946|3655941|B3|6 to <12 years||Age, Customized||Participants|Count of Participants|37|37.0||||||
3829470|NCT01713946|3655942|B2|6 to <12 years||Age, Customized||Participants|Count of Participants|39|39.0||||||
3829471|NCT01713946|3655943|B1|6 to <12 years||Age, Customized||Participants|Count of Participants|37|37.0||||||
3829472|NCT01713946|3655940|B4|< 6 years||Age, Customized||Participants|Count of Participants|104|104.0||||||
3829473|NCT01713946|3655941|B3|< 6 years||Age, Customized||Participants|Count of Participants|34|34.0||||||
3829474|NCT01713946|3655942|B2|< 6 years||Age, Customized||Participants|Count of Participants|37|37.0||||||
3829475|NCT01713946|3655943|B1|< 6 years||Age, Customized||Participants|Count of Participants|33|33.0||||||
3829476|NCT01713946|3655940|B4|||Age||years|Median|10.06|10.06|Full Range|||2.2|56.3|
3829477|NCT01713946|3655941|B3|||Age||years|Median|10.34|10.34|Full Range|||2.2|52.0|
3829478|NCT01713946|3655942|B2|||Age||years|Median|10.08|10.08|Full Range|||2.3|50.5|
3829479|NCT01713946|3655943|B1|||Age||years|Median|9.72|9.72|Full Range|||2.2|56.3|
3829480|NCT01713933|3656036|B1|Type VI||Fitzpatrick Skin Type|Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily Skin Type VI = Black; Never burns, tans very easily|Participants|Number|0|0.0||||||
3829481|NCT01713933|3656036|B1|Type V||Fitzpatrick Skin Type|Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily Skin Type VI = Black; Never burns, tans very easily|Participants|Number|2|2.0||||||
3829482|NCT01713933|3656036|B1|Type IV||Fitzpatrick Skin Type|Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily Skin Type VI = Black; Never burns, tans very easily|Participants|Number|16|16.0||||||
3829559|NCT01713582|3656100|B19||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3829560|NCT01713582|3656101|B18||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3829483|NCT01713933|3656036|B1|Type III||Fitzpatrick Skin Type|Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily Skin Type VI = Black; Never burns, tans very easily|Participants|Number|15|15.0||||||
3829484|NCT01713933|3656036|B1|Type II||Fitzpatrick Skin Type|Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily Skin Type VI = Black; Never burns, tans very easily|Participants|Number|0|0.0||||||
3829485|NCT01713933|3656036|B1|Type I||Fitzpatrick Skin Type|Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily Skin Type VI = Black; Never burns, tans very easily|Participants|Number|0|0.0||||||
3829486|NCT01713933|3656036|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
3829487|NCT01713933|3656036|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3829488|NCT01713933|3656036|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3829489|NCT01713933|3656036|B1|||Age||years|Mean|40|40.0|Full Range|||25.0|57.0|
3829490|NCT01713686|3656048|B1|Fabi/Bolton Score 5||Fabi/Bolton Score|"5-point photonumeric scale, with the following descriptors:~Wrinkles absent~Shallow lines, but visible~Moderately deep lines~Deep with well-defined lines~Very deep with redundant folds"|participants|Number|14|14.0||||||
3829491|NCT01713686|3656048|B1|Fabi/Bolton Score 4||Fabi/Bolton Score|"5-point photonumeric scale, with the following descriptors:~Wrinkles absent~Shallow lines, but visible~Moderately deep lines~Deep with well-defined lines~Very deep with redundant folds"|participants|Number|111|111.0||||||
3829492|NCT01713686|3656048|B1|Fabi/Bolton Score 3||Fabi/Bolton Score|"5-point photonumeric scale, with the following descriptors:~Wrinkles absent~Shallow lines, but visible~Moderately deep lines~Deep with well-defined lines~Very deep with redundant folds"|participants|Number|0|0.0||||||
3829493|NCT01713686|3656048|B1|Fabi/Bolton Score 2||Fabi/Bolton Score|"5-point photonumeric scale, with the following descriptors:~Wrinkles absent~Shallow lines, but visible~Moderately deep lines~Deep with well-defined lines~Very deep with redundant folds"|participants|Number|0|0.0||||||
3829494|NCT01713686|3656048|B1|Fabi/Bolton Score 1||Fabi/Bolton Score|"5-point photonumeric scale, with the following descriptors:~Wrinkles absent~Shallow lines, but visible~Moderately deep lines~Deep with well-defined lines~Very deep with redundant folds"|participants|Number|0|0.0||||||
3829495|NCT01713686|3656048|B1|||BMI||kg/m^2|Mean|24.7|24.7|Full Range|||18.3|38.3|
3829496|NCT01713686|3656048|B1|Type VI||Fitzpatrick’s Sun-Reactive Skin Type|"A classification for skin color:~Type I Pale white; blond or red hair; blue eyes; freckles — Always burns, never tans;~Type II White; fair; blond or red hair; blue, green or hazel eyes — Usually burns, tans minimally;~Type III Cream white; fair with any hair or eye color; quite common — Sometimes mild burn, tans uniformly;~Type IV Moderate brown; typical Mediterranean skin tone — Rarely burns, always tans well;~Type V Dark brown; Middle Eastern skin types — Very rarely burns, tans very easily;~Type VI Deeply pigmented dark brown to black — Never burns, tans very easily."|participants|Number|0|0.0||||||
3829497|NCT01713686|3656048|B1|Type V||Fitzpatrick’s Sun-Reactive Skin Type|"A classification for skin color:~Type I Pale white; blond or red hair; blue eyes; freckles — Always burns, never tans;~Type II White; fair; blond or red hair; blue, green or hazel eyes — Usually burns, tans minimally;~Type III Cream white; fair with any hair or eye color; quite common — Sometimes mild burn, tans uniformly;~Type IV Moderate brown; typical Mediterranean skin tone — Rarely burns, always tans well;~Type V Dark brown; Middle Eastern skin types — Very rarely burns, tans very easily;~Type VI Deeply pigmented dark brown to black — Never burns, tans very easily."|participants|Number|0|0.0||||||
3829498|NCT01713686|3656048|B1|Type IV||Fitzpatrick’s Sun-Reactive Skin Type|"A classification for skin color:~Type I Pale white; blond or red hair; blue eyes; freckles — Always burns, never tans;~Type II White; fair; blond or red hair; blue, green or hazel eyes — Usually burns, tans minimally;~Type III Cream white; fair with any hair or eye color; quite common — Sometimes mild burn, tans uniformly;~Type IV Moderate brown; typical Mediterranean skin tone — Rarely burns, always tans well;~Type V Dark brown; Middle Eastern skin types — Very rarely burns, tans very easily;~Type VI Deeply pigmented dark brown to black — Never burns, tans very easily."|participants|Number|12|12.0||||||
3829499|NCT01713686|3656048|B1|Type III||Fitzpatrick’s Sun-Reactive Skin Type|"A classification for skin color:~Type I Pale white; blond or red hair; blue eyes; freckles — Always burns, never tans;~Type II White; fair; blond or red hair; blue, green or hazel eyes — Usually burns, tans minimally;~Type III Cream white; fair with any hair or eye color; quite common — Sometimes mild burn, tans uniformly;~Type IV Moderate brown; typical Mediterranean skin tone — Rarely burns, always tans well;~Type V Dark brown; Middle Eastern skin types — Very rarely burns, tans very easily;~Type VI Deeply pigmented dark brown to black — Never burns, tans very easily."|participants|Number|52|52.0||||||
3829500|NCT01713686|3656048|B1|Type II||Fitzpatrick’s Sun-Reactive Skin Type|"A classification for skin color:~Type I Pale white; blond or red hair; blue eyes; freckles — Always burns, never tans;~Type II White; fair; blond or red hair; blue, green or hazel eyes — Usually burns, tans minimally;~Type III Cream white; fair with any hair or eye color; quite common — Sometimes mild burn, tans uniformly;~Type IV Moderate brown; typical Mediterranean skin tone — Rarely burns, always tans well;~Type V Dark brown; Middle Eastern skin types — Very rarely burns, tans very easily;~Type VI Deeply pigmented dark brown to black — Never burns, tans very easily."|participants|Number|60|60.0||||||
3829561|NCT01713582|3656102|B17||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3829562|NCT01713582|3656103|B16||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3829501|NCT01713686|3656048|B1|Type I||Fitzpatrick’s Sun-Reactive Skin Type|"A classification for skin color:~Type I Pale white; blond or red hair; blue eyes; freckles — Always burns, never tans;~Type II White; fair; blond or red hair; blue, green or hazel eyes — Usually burns, tans minimally;~Type III Cream white; fair with any hair or eye color; quite common — Sometimes mild burn, tans uniformly;~Type IV Moderate brown; typical Mediterranean skin tone — Rarely burns, always tans well;~Type V Dark brown; Middle Eastern skin types — Very rarely burns, tans very easily;~Type VI Deeply pigmented dark brown to black — Never burns, tans very easily."|participants|Number|1|1.0||||||
3829502|NCT01713686|3656048|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3829503|NCT01713686|3656048|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3829504|NCT01713686|3656048|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|117|117.0||||||
3829505|NCT01713686|3656048|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3829506|NCT01713686|3656048|B1||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3829507|NCT01713686|3656048|B1|||Age||years|Mean|56.7|56.7|Full Range|||37.5|70.4|
3829508|NCT01713660|3656057|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
3829509|NCT01713660|3656057|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3829510|NCT01713660|3656057|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3829511|NCT01713660|3656057|B1|||Age||years|Mean|66|66.0|Standard Deviation|6|6.0|||
3829512|NCT01713660|3656057|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3829513|NCT01713660|3656057|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3829514|NCT01713660|3656057|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3829515|NCT01713621|3656063|B3|Thailand||Region of Enrollment||participants|Number|25|25.0||||||
3829516|NCT01713621|3656064|B2|Thailand||Region of Enrollment||participants|Number|17|17.0||||||
3829517|NCT01713621|3656065|B1|Thailand||Region of Enrollment||participants|Number|8|8.0||||||
3829518|NCT01713621|3656063|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3829519|NCT01713621|3656064|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3829520|NCT01713621|3656065|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3829521|NCT01713621|3656063|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3829522|NCT01713621|3656064|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3829523|NCT01713621|3656065|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3829524|NCT01713621|3656063|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3829525|NCT01713621|3656064|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3829526|NCT01713621|3656065|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3829527|NCT01713621|3656063|B3|||Age||years|Mean|35|35.0|Standard Deviation|10.98|10.98|||
3829528|NCT01713621|3656064|B2|||Age||years|Mean|34|34.0|Standard Deviation|10.49|10.49|||
3829529|NCT01713621|3656065|B1|||Age||years|Mean|37|37.0|Standard Deviation|12.44|12.44|||
3829530|NCT01713608|3656072|B5|||Body Mass Index||kg/m2|Mean|23.7|23.7|Standard Deviation|2.97|2.97|||
3829531|NCT01713608|3656073|B4|||Body Mass Index||kg/m2|Mean|24.2|24.2|Standard Deviation|3.02|3.02|||
3829532|NCT01713608|3656074|B3|||Body Mass Index||kg/m2|Mean|24.4|24.4|Standard Deviation|2.78|2.78|||
3829533|NCT01713608|3656075|B2|||Body Mass Index||kg/m2|Mean|22.4|22.4|Standard Deviation|3.29|3.29|||
3829534|NCT01713608|3656076|B1|||Body Mass Index||kg/m2|Mean|23.1|23.1|Standard Deviation|2.99|2.99|||
3829535|NCT01713608|3656072|B5|United Kingdom||Region of Enrollment||participants|Number|34|34.0||||||
3829536|NCT01713608|3656073|B4|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
3829537|NCT01713608|3656074|B3|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3829538|NCT01713608|3656075|B2|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3829539|NCT01713608|3656076|B1|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3829540|NCT01713608|3656072|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3829541|NCT01713608|3656073|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3829542|NCT01713608|3656074|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3829543|NCT01713608|3656075|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3829544|NCT01713608|3656076|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3829545|NCT01713608|3656072|B5||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3829546|NCT01713608|3656073|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3829547|NCT01713608|3656074|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3829548|NCT01713608|3656075|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3829549|NCT01713608|3656076|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3829550|NCT01713608|3656072|B5|||Age||years|Mean|30.3|30.3|Standard Deviation|7.51|7.51|||
3829551|NCT01713608|3656073|B4|||Age||years|Mean|30.5|30.5|Standard Deviation|7.24|7.24|||
3829552|NCT01713608|3656074|B3|||Age||years|Mean|33.4|33.4|Standard Deviation|8.09|8.09|||
3829553|NCT01713608|3656075|B2|||Age||years|Mean|25.5|25.5|Standard Deviation|3.39|3.39|||
3829554|NCT01713608|3656076|B1|||Age||years|Mean|30.5|30.5|Standard Deviation|8.91|8.91|||
3829555|NCT01713582|3656097|B22|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3829556|NCT01713582|3656097|B22||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3829557|NCT01713582|3656098|B21||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3829563|NCT01713582|3656104|B15||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3829564|NCT01713582|3656105|B14||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3829565|NCT01713582|3656106|B13||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3829566|NCT01713582|3656107|B12||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3829567|NCT01713582|3656108|B11||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3829568|NCT01713582|3656109|B10||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3829569|NCT01713582|3656110|B9||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3829570|NCT01713582|3656111|B8||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3829571|NCT01713582|3656112|B7||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3829572|NCT01713582|3656113|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3829573|NCT01713582|3656114|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3829574|NCT01713582|3656115|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3829575|NCT01713582|3656116|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3829576|NCT01713582|3656117|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3829577|NCT01713582|3656118|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3829578|NCT01713582|3656097|B22||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3829579|NCT01713582|3656098|B21||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3829580|NCT01713582|3656099|B20||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3829581|NCT01713582|3656100|B19||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3829582|NCT01713582|3656101|B18||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3829583|NCT01713582|3656102|B17||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3829584|NCT01713582|3656103|B16||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3829585|NCT01713582|3656104|B15||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3829586|NCT01713582|3656105|B14||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3829587|NCT01713582|3656106|B13||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3829588|NCT01713582|3656107|B12||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3829589|NCT01713582|3656108|B11||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3829590|NCT01713582|3656109|B10||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3829591|NCT01713582|3656110|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3829592|NCT01713582|3656111|B8||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3829593|NCT01713582|3656112|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3829594|NCT01713582|3656113|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3829595|NCT01713582|3656114|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3829596|NCT01713582|3656115|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3829597|NCT01713582|3656116|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3829598|NCT01713582|3656117|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3829599|NCT01713582|3656118|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3829600|NCT01713582|3656097|B22|||Age||Years|Mean|63.7|63.7|Standard Deviation|13.6|13.6|||
3829601|NCT01713582|3656098|B21|||Age||Years|Mean|58.5|58.5|Standard Deviation|14.1|14.1|||
3829602|NCT01713582|3656099|B20|||Age||Years|Mean|66.8|66.8|Standard Deviation|8.3|8.3|||
3829603|NCT01713582|3656100|B19|||Age||Years|Mean|62.4|62.4|Standard Deviation|8.4|8.4|||
3829604|NCT01713582|3656101|B18|||Age||Years|Mean|66.0|66.0|Standard Deviation|13.2|13.2|||
3829605|NCT01713582|3656102|B17|||Age||Years|Mean|55.6|55.6|Standard Deviation|19.3|19.3|||
3829606|NCT01713582|3656103|B16|||Age||Years|Mean|54.7|54.7|Standard Deviation|13.0|13.0|||
3829607|NCT01713582|3656104|B15|||Age||Years|Mean|59.4|59.4|Standard Deviation|18.5|18.5|||
3829608|NCT01713582|3656105|B14|||Age||Years|Mean|69.0|69.0|Standard Deviation|8.4|8.4|||
3829609|NCT01713582|3656106|B13|||Age||Years|Mean|74.7|74.7|Standard Deviation|7.4|7.4|||
3829610|NCT01713582|3656107|B12|||Age||Years|Mean|65.2|65.2|Standard Deviation|15.5|15.5|||
3829611|NCT01713582|3656108|B11|||Age||Years|Mean|67.2|67.2|Standard Deviation|8.2|8.2|48.0|81.0|
3829612|NCT01713582|3656109|B10|||Age||Years|Mean|65.6|65.6|Standard Deviation|10.0|10.0|45.0|79.0|
3829613|NCT01713582|3656110|B9|||Age||Years|Mean|57.8|57.8|Standard Deviation|16.6|16.6|26.0|75.0|
3829614|NCT01713582|3656111|B8|||Age||Years|Mean|58.5|58.5|Standard Deviation|24.1|24.1|19.0|80.0|
3829615|NCT01713582|3656112|B7|||Age||Years|Mean|65.3|65.3|Standard Deviation|13.9|13.9|42.0|79.0|
3829616|NCT01713582|3656113|B6|||Age||Years|Mean|65.8|65.8|Standard Deviation|16.3|16.3|33.0|85.0|
3829617|NCT01713582|3656114|B5|||Age||Years|Mean|70.0|70.0|Standard Deviation|10.6|10.6|55.0|80.0|
3829618|NCT01713582|3656115|B4|||Age||Years|Mean|77.7|77.7|Standard Deviation|2.3|2.3|75.0|79.0|
3829619|NCT01713582|3656116|B3|||Age||Years|Mean|73.8|73.8|Standard Deviation|2.1|2.1|71.0|76.0|
3829620|NCT01713582|3656117|B2|||Age||Years|Mean|54.7|54.7|Standard Deviation|19.6|19.6|32.0|66.0|
3829621|NCT01713582|3656118|B1|||Age||Years|Mean|67.0|67.0|Standard Deviation|3.5|3.5|65.0|71.0|
3829622|NCT01713530|3656299|B3|||Fasting plasma glucose||mmol/L|Mean|8.9|8.9|Standard Deviation|3.0|3.0|||
3829623|NCT01713530|3656300|B2|||Fasting plasma glucose||mmol/L|Mean|8.8|8.8|Standard Deviation|2.9|2.9|||
3829624|NCT01713530|3656301|B1|||Fasting plasma glucose||mmol/L|Mean|9.0|9.0|Standard Deviation|3.0|3.0|||
3829686|NCT01713283|3656363|B4|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|8|8.0||||||
3829625|NCT01713530|3656299|B3|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.3|8.3|Standard Deviation|0.8|0.8|||
3829626|NCT01713530|3656300|B2|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.3|8.3|Standard Deviation|0.7|0.7|||
3829627|NCT01713530|3656301|B1|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.3|8.3|Standard Deviation|0.9|0.9|||
3829628|NCT01713530|3656299|B3||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
3829629|NCT01713530|3656300|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3829630|NCT01713530|3656301|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3829631|NCT01713530|3656299|B3||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3829632|NCT01713530|3656300|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3829633|NCT01713530|3656301|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3829634|NCT01713530|3656299|B3|Age||Age||years|Mean|59.6|59.6|Standard Deviation|8.7|8.7|||
3829635|NCT01713530|3656300|B2|Age||Age||years|Mean|59.6|59.6|Standard Deviation|9.2|9.2|||
3829636|NCT01713530|3656301|B1|Age||Age||years|Mean|59.6|59.6|Standard Deviation|8.3|8.3|||
3829637|NCT01713400|3656318|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3829638|NCT01713400|3656319|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3829639|NCT01713400|3656320|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3829640|NCT01713400|3656318|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3829641|NCT01713400|3656319|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3829642|NCT01713400|3656320|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3829643|NCT01713400|3656318|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3829644|NCT01713400|3656319|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3829645|NCT01713400|3656320|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3829646|NCT01713400|3656318|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3829647|NCT01713400|3656319|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3829648|NCT01713400|3656320|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3829649|NCT01713400|3656318|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3829650|NCT01713400|3656319|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3829651|NCT01713400|3656320|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3829652|NCT01713400|3656318|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3829653|NCT01713400|3656319|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3829654|NCT01713400|3656320|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3829655|NCT01713348|3656329|B5|||Baseline HbA1c||%|Mean|9.1|9.1|Standard Deviation|1.3|1.3|||
3829656|NCT01713348|3656330|B4|||Baseline HbA1c||%|Mean|9.2|9.2|Standard Deviation|1.3|1.3|||
3829657|NCT01713348|3656331|B3|||Baseline HbA1c||%|Mean|9.2|9.2|Standard Deviation|1.4|1.4|||
3829658|NCT01713348|3656332|B2|||Baseline HbA1c||%|Mean|9.0|9.0|Standard Deviation|1.3|1.3|||
3829659|NCT01713348|3656333|B1|||Baseline HbA1c||%|Mean|9.2|9.2|Standard Deviation|1.3|1.3|||
3829660|NCT01713348|3656329|B5|||Baseline HbA1c||mmol/mol|Mean|76.4|76.4|Standard Deviation|14.1|14.1|||
3829661|NCT01713348|3656330|B4|||Baseline HbA1c||mmol/mol|Mean|77.4|77.4|Standard Deviation|13.7|13.7|||
3829662|NCT01713348|3656331|B3|||Baseline HbA1c||mmol/mol|Mean|76.5|76.5|Standard Deviation|15.0|15.0|||
3829663|NCT01713348|3656332|B2|||Baseline HbA1c||mmol/mol|Mean|74.8|74.8|Standard Deviation|13.9|13.9|||
3829664|NCT01713348|3656333|B1|||Baseline HbA1c||mmol/mol|Mean|76.4|76.4|Standard Deviation|14.1|14.1|||
3829665|NCT01713348|3656329|B5|United Kingdom||Region of Enrollment||participants|Number|87|87.0||||||
3829666|NCT01713348|3656330|B4|United Kingdom||Region of Enrollment||participants|Number|15|15.0||||||
3829667|NCT01713348|3656331|B3|United Kingdom||Region of Enrollment||participants|Number|30|30.0||||||
3829668|NCT01713348|3656332|B2|United Kingdom||Region of Enrollment||participants|Number|13|13.0||||||
3829669|NCT01713348|3656333|B1|United Kingdom||Region of Enrollment||participants|Number|29|29.0||||||
3829670|NCT01713348|3656329|B5||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3829671|NCT01713348|3656330|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3829672|NCT01713348|3656331|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3829673|NCT01713348|3656332|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3829674|NCT01713348|3656333|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3829675|NCT01713348|3656329|B5||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3829676|NCT01713348|3656330|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3829677|NCT01713348|3656331|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3829678|NCT01713348|3656332|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3829679|NCT01713348|3656333|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3829680|NCT01713348|3656329|B5|||Age||years|Mean|49.0|49.0|Standard Deviation|13.2|13.2|||
3829681|NCT01713348|3656330|B4|||Age||years|Mean|55.5|55.5|Standard Deviation|10.9|10.9|||
3829682|NCT01713348|3656331|B3|||Age||years|Mean|57.8|57.8|Standard Deviation|8.8|8.8|||
3829683|NCT01713348|3656332|B2|||Age||years|Mean|43.7|43.7|Standard Deviation|9.9|9.9|||
3829684|NCT01713348|3656333|B1|||Age||years|Mean|39.0|39.0|Standard Deviation|11.5|11.5|||
3829685|NCT01713283|3656362|B5|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|34|34.0||||||
3829687|NCT01713283|3656364|B3|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|6|6.0||||||
3829688|NCT01713283|3656365|B2|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|13|13.0||||||
3829689|NCT01713283|3656366|B1|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|7|7.0||||||
3829690|NCT01713283|3656362|B5|< 800,000 IU/mL||HCV RNA Category||participants|Number|26|26.0||||||
3829691|NCT01713283|3656363|B4|< 800,000 IU/mL||HCV RNA Category||participants|Number|7|7.0||||||
3829692|NCT01713283|3656364|B3|< 800,000 IU/mL||HCV RNA Category||participants|Number|8|8.0||||||
3829693|NCT01713283|3656365|B2|< 800,000 IU/mL||HCV RNA Category||participants|Number|4|4.0||||||
3829694|NCT01713283|3656366|B1|< 800,000 IU/mL||HCV RNA Category||participants|Number|7|7.0||||||
3829695|NCT01713283|3656362|B5|||HCV RNA (log10 IU/mL)||log10 IU/mL|Mean|6.0|6.0|Standard Deviation|0.61|0.61|||
3829696|NCT01713283|3656363|B4|||HCV RNA (log10 IU/mL)||log10 IU/mL|Mean|6.1|6.1|Standard Deviation|0.45|0.45|||
3829697|NCT01713283|3656364|B3|||HCV RNA (log10 IU/mL)||log10 IU/mL|Mean|5.9|5.9|Standard Deviation|0.74|0.74|||
3829698|NCT01713283|3656365|B2|||HCV RNA (log10 IU/mL)||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.58|0.58|||
3829699|NCT01713283|3656366|B1|||HCV RNA (log10 IU/mL)||log10 IU/mL|Mean|5.7|5.7|Standard Deviation|0.59|0.59|||
3829700|NCT01713283|3656362|B5|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|11|11.0||||||
3829701|NCT01713283|3656363|B4|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
3829702|NCT01713283|3656364|B3|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3829703|NCT01713283|3656365|B2|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|5|5.0||||||
3829704|NCT01713283|3656366|B1|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|2|2.0||||||
3829705|NCT01713283|3656362|B5|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|39|39.0||||||
3829706|NCT01713283|3656363|B4|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|12|12.0||||||
3829707|NCT01713283|3656364|B3|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|7|7.0||||||
3829708|NCT01713283|3656365|B2|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|11|11.0||||||
3829709|NCT01713283|3656366|B1|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|9|9.0||||||
3829710|NCT01713283|3656362|B5|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|10|10.0||||||
3829711|NCT01713283|3656363|B4|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3829712|NCT01713283|3656364|B3|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|6|6.0||||||
3829713|NCT01713283|3656365|B2|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3829714|NCT01713283|3656366|B1|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
3829715|NCT01713283|3656362|B5|Yes||Liver Cirrhosis||participants|Number|14|14.0||||||
3829716|NCT01713283|3656363|B4|Yes||Liver Cirrhosis||participants|Number|4|4.0||||||
3829717|NCT01713283|3656364|B3|Yes||Liver Cirrhosis||participants|Number|3|3.0||||||
3829718|NCT01713283|3656365|B2|Yes||Liver Cirrhosis||participants|Number|4|4.0||||||
3829719|NCT01713283|3656366|B1|Yes||Liver Cirrhosis||participants|Number|3|3.0||||||
3829720|NCT01713283|3656362|B5|No||Liver Cirrhosis||participants|Number|46|46.0||||||
3829721|NCT01713283|3656363|B4|No||Liver Cirrhosis||participants|Number|11|11.0||||||
3829722|NCT01713283|3656364|B3|No||Liver Cirrhosis||participants|Number|11|11.0||||||
3829723|NCT01713283|3656365|B2|No||Liver Cirrhosis||participants|Number|13|13.0||||||
3829724|NCT01713283|3656366|B1|No||Liver Cirrhosis||participants|Number|11|11.0||||||
3829725|NCT01713283|3656362|B5|White||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
3829726|NCT01713283|3656363|B4|White||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3829727|NCT01713283|3656364|B3|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3829728|NCT01713283|3656365|B2|White||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3829729|NCT01713283|3656366|B1|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3829730|NCT01713283|3656362|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829731|NCT01713283|3656363|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829732|NCT01713283|3656364|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829733|NCT01713283|3656365|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829734|NCT01713283|3656366|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829735|NCT01713283|3656362|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3829736|NCT01713283|3656363|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3829737|NCT01713283|3656364|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3829738|NCT01713283|3656365|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3829739|NCT01713283|3656366|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3829740|NCT01713283|3656362|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829741|NCT01713283|3656363|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829742|NCT01713283|3656364|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829743|NCT01713283|3656365|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829744|NCT01713283|3656366|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829745|NCT01713283|3656362|B5||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3829746|NCT01713283|3656363|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3829747|NCT01713283|3656364|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3829748|NCT01713283|3656365|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3829749|NCT01713283|3656366|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3829750|NCT01713283|3656362|B5||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3829751|NCT01713283|3656363|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3829752|NCT01713283|3656364|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3829753|NCT01713283|3656365|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3829754|NCT01713283|3656366|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3829755|NCT01713283|3656362|B5|||Age||years|Mean|54|54.0|Standard Deviation|12.2|12.2|||
3829756|NCT01713283|3656363|B4|||Age||years|Mean|57|57.0|Standard Deviation|9.9|9.9|||
3829757|NCT01713283|3656364|B3|||Age||years|Mean|52|52.0|Standard Deviation|15.6|15.6|||
3829758|NCT01713283|3656365|B2|||Age||years|Mean|54|54.0|Standard Deviation|11.5|11.5|||
3829759|NCT01713283|3656366|B1|||Age||years|Mean|53|53.0|Standard Deviation|12.4|12.4|||
3829760|NCT01713036|3656389|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3829761|NCT01713036|3656389|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3829762|NCT01713036|3656389|B1|||Age||years|Mean|56.2|56.2|Standard Deviation|8.54|8.54|||
3829763|NCT01712984|3656426|B4|United States||Region of Enrollment||Participants|Number|3355|3355.0||||||
3829764|NCT01712984|3656427|B3|United States||Region of Enrollment||Participants|Number|846|846.0||||||
3829765|NCT01712984|3656428|B2|United States||Region of Enrollment||Participants|Number|837|837.0||||||
3829766|NCT01712984|3656429|B1|United States||Region of Enrollment||Participants|Number|1672|1672.0||||||
3829767|NCT01712984|3656426|B4||Male|Sex: Female, Male||Participants|Count of Participants|1300|1300.0||||||
3829768|NCT01712984|3656427|B3||Male|Sex: Female, Male||Participants|Count of Participants|318|318.0||||||
3829769|NCT01712984|3656428|B2||Male|Sex: Female, Male||Participants|Count of Participants|332|332.0||||||
3829770|NCT01712984|3656429|B1||Male|Sex: Female, Male||Participants|Count of Participants|650|650.0||||||
3829771|NCT01712984|3656426|B4||Female|Sex: Female, Male||Participants|Count of Participants|2055|2055.0||||||
3829772|NCT01712984|3656427|B3||Female|Sex: Female, Male||Participants|Count of Participants|528|528.0||||||
3829773|NCT01712984|3656428|B2||Female|Sex: Female, Male||Participants|Count of Participants|505|505.0||||||
3829774|NCT01712984|3656429|B1||Female|Sex: Female, Male||Participants|Count of Participants|1022|1022.0||||||
3829775|NCT01712984|3656426|B4|||Age||Years|Mean|41.6|41.6|Standard Deviation|13.3|13.3|||
3829776|NCT01712984|3656427|B3|||Age||Years|Mean|41.9|41.9|Standard Deviation|13.3|13.3|||
3829777|NCT01712984|3656428|B2|||Age||Years|Mean|41.2|41.2|Standard Deviation|13.5|13.5|||
3829778|NCT01712984|3656429|B1|||Age||Years|Mean|41.6|41.6|Standard Deviation|13.2|13.2|||
3829779|NCT01712984|3656426|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3829780|NCT01712984|3656427|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3829781|NCT01712984|3656428|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3829782|NCT01712984|3656429|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3829783|NCT01712984|3656426|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3355|3355.0||||||
3829784|NCT01712984|3656427|B3||Between 18 and 65 years|Age||Participants|Count of Participants|846|846.0||||||
3829785|NCT01712984|3656428|B2||Between 18 and 65 years|Age||Participants|Count of Participants|837|837.0||||||
3829786|NCT01712984|3656429|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1672|1672.0||||||
3829787|NCT01712984|3656426|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3829788|NCT01712984|3656427|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3829789|NCT01712984|3656428|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3829790|NCT01712984|3656429|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3829791|NCT01712854|3656451|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3829792|NCT01712854|3656451|B1|Male and Female||Sex/Gender, Customized|Gender breakdown is not available. Columbia will never have access to this data.|participants|Number|9|9.0||||||
3829793|NCT01712854|3656451|B1|Between 40 and 75 years||Age, Customized||participants|Number|9|9.0||||||
3829794|NCT01712776|3656456|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
3829795|NCT01712776|3656457|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
3829796|NCT01712776|3656458|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3829797|NCT01712776|3656456|B3||Male|Gender||Participants|Count of Participants|46|46.0||||||
3829798|NCT01712776|3656457|B2||Male|Gender||Participants|Count of Participants|27|27.0||||||
3829799|NCT01712776|3656458|B1||Male|Gender||Participants|Count of Participants|19|19.0||||||
3829800|NCT01712776|3656456|B3||Female|Gender||Participants|Count of Participants|54|54.0||||||
3829801|NCT01712776|3656457|B2||Female|Gender||Participants|Count of Participants|23|23.0||||||
3829802|NCT01712776|3656458|B1||Female|Gender||Participants|Count of Participants|31|31.0||||||
3829803|NCT01712776|3656456|B3|||Age||years|Mean|52.23|52.23|Standard Deviation|12.45|12.45|||
3829804|NCT01712776|3656457|B2|||Age||years|Mean|51.48|51.48|Standard Deviation|11.48|11.48|||
3829805|NCT01712776|3656458|B1|||Age||years|Mean|52.98|52.98|Standard Deviation|13.42|13.42|||
3829806|NCT01712711|3656465|B3|Iran, Islamic Republic of||Region of Enrollment||participants|Number|40|40.0||||||
3829807|NCT01712711|3656466|B2|Iran, Islamic Republic of||Region of Enrollment||participants|Number|20|20.0||||||
3829808|NCT01712711|3656467|B1|Iran, Islamic Republic of||Region of Enrollment||participants|Number|20|20.0||||||
3829809|NCT01712711|3656465|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3829810|NCT01712711|3656466|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3829811|NCT01712711|3656467|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3829812|NCT01712711|3656465|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3829813|NCT01712711|3656466|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3829814|NCT01712711|3656467|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3829815|NCT01712711|3656465|B3|||Age||years|Mean|42.84|42.84|Standard Deviation|11.04|11.04|||
3829816|NCT01712711|3656466|B2|||Age||years|Mean|45.73|45.73|Standard Deviation|12.54|12.54|||
3829817|NCT01712711|3656467|B1|||Age||years|Mean|39.95|39.95|Standard Deviation|9.53|9.53|||
3829818|NCT01712711|3656465|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3829819|NCT01712711|3656466|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3829820|NCT01712711|3656467|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3829821|NCT01712711|3656465|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3829822|NCT01712711|3656466|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3829823|NCT01712711|3656467|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3829824|NCT01712711|3656465|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3829825|NCT01712711|3656466|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3829826|NCT01712711|3656467|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3829827|NCT01712685|3656474|B1|9.3||Tumor Size (cm)||Participants|Count of Participants|1|1.0||||||
3829828|NCT01712685|3656474|B1|6.89||Tumor Size (cm)||Participants|Count of Participants|1|1.0||||||
3829829|NCT01712685|3656474|B1|5.8||Tumor Size (cm)||Participants|Count of Participants|1|1.0||||||
3829830|NCT01712685|3656474|B1|4.0||Tumor Size (cm)||Participants|Count of Participants|1|1.0||||||
3829831|NCT01712685|3656474|B1|3.7||Tumor Size (cm)||Participants|Count of Participants|1|1.0||||||
3829832|NCT01712685|3656474|B1|3.6||Tumor Size (cm)||Participants|Count of Participants|1|1.0||||||
3829833|NCT01712685|3656474|B1|3.5||Tumor Size (cm)||Participants|Count of Participants|1|1.0||||||
3829834|NCT01712685|3656474|B1|3.4||Tumor Size (cm)||Participants|Count of Participants|2|2.0||||||
3829835|NCT01712685|3656474|B1|3.3||Tumor Size (cm)||Participants|Count of Participants|1|1.0||||||
3829836|NCT01712685|3656474|B1|2.7||Tumor Size (cm)||Participants|Count of Participants|1|1.0||||||
3829837|NCT01712685|3656474|B1|2.0||Tumor Size (cm)||Participants|Count of Participants|1|1.0||||||
3829838|NCT01712685|3656474|B1|4||Grade|The grades range from 0-4 with higher grades indicating greater size and extent of the tumor.|Participants|Count of Participants|2|2.0||||||
3829839|NCT01712685|3656474|B1|3||Grade|The grades range from 0-4 with higher grades indicating greater size and extent of the tumor.|Participants|Count of Participants|1|1.0||||||
3829840|NCT01712685|3656474|B1|2||Grade|The grades range from 0-4 with higher grades indicating greater size and extent of the tumor.|Participants|Count of Participants|8|8.0||||||
3829841|NCT01712685|3656474|B1|Not Applicable (N/A)||Grade|The grades range from 0-4 with higher grades indicating greater size and extent of the tumor.|Participants|Count of Participants|1|1.0||||||
3829842|NCT01712685|3656474|B1|ccRCC with sarcomatoid features||Histology||Participants|Count of Participants|1|1.0||||||
3829843|NCT01712685|3656474|B1|ccRCC with sarcomatoid differentiation||Histology||Participants|Count of Participants|1|1.0||||||
3829844|NCT01712685|3656474|B1|Clear Renal Cell Carcinoma (ccRCC)||Histology||Participants|Count of Participants|9|9.0||||||
3829845|NCT01712685|3656474|B1|Renalcyst||Histology||Participants|Count of Participants|1|1.0||||||
3829846|NCT01712685|3656474|B1|T1bNOMO||Clinical Stage|The T category describes the original tumor. T0: No evidence of primary tumor; T1–T4: Size and/or extent of the primary tumor, with higher numbers indicating larger size/extent. The N category describes whether or not the cancer has reached nearby lymph nodes. N0: No regional lymph node involvement (no cancer found in the lymph nodes). The M category tells whether there are distant metastases (spread of cancer to other parts of the body). M0: No distant metastasis (cancer has not spread to other parts of the body); M1: Distant metastasis (cancer has spread to distant parts of the body).|Participants|Count of Participants|1|1.0||||||
3829847|NCT01712685|3656474|B1|T2NOMO1||Clinical Stage|The T category describes the original tumor. T0: No evidence of primary tumor; T1–T4: Size and/or extent of the primary tumor, with higher numbers indicating larger size/extent. The N category describes whether or not the cancer has reached nearby lymph nodes. N0: No regional lymph node involvement (no cancer found in the lymph nodes). The M category tells whether there are distant metastases (spread of cancer to other parts of the body). M0: No distant metastasis (cancer has not spread to other parts of the body); M1: Distant metastasis (cancer has spread to distant parts of the body).|Participants|Count of Participants|1|1.0||||||
3829848|NCT01712685|3656474|B1|T3aNOM1||Clinical Stage|The T category describes the original tumor. T0: No evidence of primary tumor; T1–T4: Size and/or extent of the primary tumor, with higher numbers indicating larger size/extent. The N category describes whether or not the cancer has reached nearby lymph nodes. N0: No regional lymph node involvement (no cancer found in the lymph nodes). The M category tells whether there are distant metastases (spread of cancer to other parts of the body). M0: No distant metastasis (cancer has not spread to other parts of the body); M1: Distant metastasis (cancer has spread to distant parts of the body).|Participants|Count of Participants|2|2.0||||||
3829896|NCT01712490|3656545|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3829849|NCT01712685|3656474|B1|T1aNOMO||Clinical Stage|The T category describes the original tumor. T0: No evidence of primary tumor; T1–T4: Size and/or extent of the primary tumor, with higher numbers indicating larger size/extent. The N category describes whether or not the cancer has reached nearby lymph nodes. N0: No regional lymph node involvement (no cancer found in the lymph nodes). The M category tells whether there are distant metastases (spread of cancer to other parts of the body). M0: No distant metastasis (cancer has not spread to other parts of the body); M1: Distant metastasis (cancer has spread to distant parts of the body).|Participants|Count of Participants|7|7.0||||||
3829850|NCT01712685|3656474|B1|TONOMO||Clinical Stage|The T category describes the original tumor. T0: No evidence of primary tumor; T1–T4: Size and/or extent of the primary tumor, with higher numbers indicating larger size/extent. The N category describes whether or not the cancer has reached nearby lymph nodes. N0: No regional lymph node involvement (no cancer found in the lymph nodes). The M category tells whether there are distant metastases (spread of cancer to other parts of the body). M0: No distant metastasis (cancer has not spread to other parts of the body); M1: Distant metastasis (cancer has spread to distant parts of the body).|Participants|Count of Participants|1|1.0||||||
3829851|NCT01712685|3656474|B1|No||Known Hereditary Renal Cell Carcinoma Mutation|Demographics information of all the accrued 12 patients; one patient did not receive 18F-VM4-037 injection and positron emission tomography (PET) computed tomography (CT) imaging.|Participants|Count of Participants|7|7.0||||||
3829852|NCT01712685|3656474|B1|Yes (Von Hippel-Lindau)||Known Hereditary Renal Cell Carcinoma Mutation|Demographics information of all the accrued 12 patients; one patient did not receive 18F-VM4-037 injection and positron emission tomography (PET) computed tomography (CT) imaging.|Participants|Count of Participants|5|5.0||||||
3829853|NCT01712685|3656474|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3829854|NCT01712685|3656474|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3829855|NCT01712685|3656474|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829856|NCT01712685|3656474|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3829857|NCT01712685|3656474|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3829858|NCT01712685|3656474|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829859|NCT01712685|3656474|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3829860|NCT01712685|3656474|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829861|NCT01712685|3656474|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3829862|NCT01712685|3656474|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3829863|NCT01712685|3656474|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3829864|NCT01712685|3656474|B1||Male|Gender||Participants|Count of Participants|9|9.0||||||
3829865|NCT01712685|3656474|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
3829866|NCT01712685|3656474|B1|||Age||years|Mean|56.62|56.62|Standard Deviation|14.26|14.26|||
3829867|NCT01712685|3656474|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3829868|NCT01712685|3656474|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3829869|NCT01712685|3656474|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3829870|NCT01712516|3656486|B5||Male|Sex: Female, Male||Participants|Count of Participants|586|586.0||||||
3829871|NCT01712516|3656487|B4||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3829872|NCT01712516|3656488|B3||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3829873|NCT01712516|3656489|B2||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3829874|NCT01712516|3656490|B1||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3829875|NCT01712516|3656486|B5||Female|Sex: Female, Male||Participants|Count of Participants|415|415.0||||||
3829876|NCT01712516|3656487|B4||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3829877|NCT01712516|3656488|B3||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3829878|NCT01712516|3656489|B2||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3829879|NCT01712516|3656490|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3829880|NCT01712516|3656486|B5|||Age||Years|Mean|63.0|63.0|Standard Deviation|8.41|8.41|||
3829881|NCT01712516|3656487|B4|||Age||Years|Mean|62.5|62.5|Standard Deviation|8.07|8.07|||
3829882|NCT01712516|3656488|B3|||Age||Years|Mean|63.1|63.1|Standard Deviation|8.53|8.53|||
3829883|NCT01712516|3656489|B2|||Age||Years|Mean|63.7|63.7|Standard Deviation|8.58|8.58|||
3829884|NCT01712516|3656490|B1|||Age||Years|Mean|62.8|62.8|Standard Deviation|8.46|8.46|||
3829885|NCT01712490|3656543|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3829886|NCT01712490|3656544|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3829887|NCT01712490|3656545|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3829888|NCT01712490|3656543|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3829889|NCT01712490|3656544|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3829890|NCT01712490|3656545|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3829891|NCT01712490|3656543|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1114|1114.0||||||
3829892|NCT01712490|3656544|B2||White|Race (NIH/OMB)||Participants|Count of Participants|554|554.0||||||
3829893|NCT01712490|3656545|B1||White|Race (NIH/OMB)||Participants|Count of Participants|560|560.0||||||
3829894|NCT01712490|3656543|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3829895|NCT01712490|3656544|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3829897|NCT01712490|3656543|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829898|NCT01712490|3656544|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829899|NCT01712490|3656545|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829900|NCT01712490|3656543|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
3829901|NCT01712490|3656544|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3829902|NCT01712490|3656545|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3829903|NCT01712490|3656543|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829904|NCT01712490|3656544|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829905|NCT01712490|3656545|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3829906|NCT01712490|3656543|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3829907|NCT01712490|3656544|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3829908|NCT01712490|3656545|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3829909|NCT01712490|3656543|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1148|1148.0||||||
3829910|NCT01712490|3656544|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|577|577.0||||||
3829911|NCT01712490|3656545|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|571|571.0||||||
3829912|NCT01712490|3656543|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
3829913|NCT01712490|3656544|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3829914|NCT01712490|3656545|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3829915|NCT01712490|3656543|B3||Male|Sex: Female, Male||Participants|Count of Participants|776|776.0||||||
3829916|NCT01712490|3656544|B2||Male|Sex: Female, Male||Participants|Count of Participants|398|398.0||||||
3829917|NCT01712490|3656545|B1||Male|Sex: Female, Male||Participants|Count of Participants|378|378.0||||||
3829918|NCT01712490|3656543|B3||Female|Sex: Female, Male||Participants|Count of Participants|558|558.0||||||
3829919|NCT01712490|3656544|B2||Female|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
3829920|NCT01712490|3656545|B1||Female|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
3829921|NCT01712490|3656543|B3|||Age||years|Mean|39.5|39.5|Standard Deviation|15.95|15.95|||
3829922|NCT01712490|3656544|B2|||Age||years|Mean|40.2|40.2|Standard Deviation|16.05|16.05|||
3829923|NCT01712490|3656545|B1|||Age||years|Mean|38.8|38.8|Standard Deviation|15.83|15.83|||
3829924|NCT01712399|3656583|B1|||Weight||Kilogram|Mean|73.25|73.25|Standard Deviation|16.40|16.4|||
3829925|NCT01712399|3656583|B1|UNITED KINGDOM||Region of Enrollment||Participants|Number|5|5.0||||||
3829926|NCT01712399|3656583|B1|UKRAINE||Region of Enrollment||Participants|Number|39|39.0||||||
3829927|NCT01712399|3656583|B1|SPAIN||Region of Enrollment||Participants|Number|4|4.0||||||
3829928|NCT01712399|3656583|B1|SOUTH AFRICA||Region of Enrollment||Participants|Number|2|2.0||||||
3829929|NCT01712399|3656583|B1|SLOVAKIA||Region of Enrollment||Participants|Number|1|1.0||||||
3829930|NCT01712399|3656583|B1|SERBIA||Region of Enrollment||Participants|Number|24|24.0||||||
3829931|NCT01712399|3656583|B1|RUSSIAN FEDERATION||Region of Enrollment||Participants|Number|53|53.0||||||
3829932|NCT01712399|3656583|B1|POLAND||Region of Enrollment||Participants|Number|34|34.0||||||
3829933|NCT01712399|3656583|B1|MEXICO||Region of Enrollment||Participants|Number|10|10.0||||||
3829934|NCT01712399|3656583|B1|ISRAEL||Region of Enrollment||Participants|Number|11|11.0||||||
3829935|NCT01712399|3656583|B1|HUNGARY||Region of Enrollment||Participants|Number|9|9.0||||||
3829936|NCT01712399|3656583|B1|GREECE||Region of Enrollment||Participants|Number|3|3.0||||||
3829937|NCT01712399|3656583|B1|GERMANY||Region of Enrollment||Participants|Number|8|8.0||||||
3829938|NCT01712399|3656583|B1|ESTONIA||Region of Enrollment||Participants|Number|21|21.0||||||
3829939|NCT01712399|3656583|B1|CZECH REPUBLIC||Region of Enrollment||Participants|Number|69|69.0||||||
3829940|NCT01712399|3656583|B1|COLOMBIA||Region of Enrollment||Participants|Number|25|25.0||||||
3829941|NCT01712399|3656583|B1|CHILE||Region of Enrollment||Participants|Number|35|35.0||||||
3829942|NCT01712399|3656583|B1|BULGARIA||Region of Enrollment||Participants|Number|3|3.0||||||
3829943|NCT01712399|3656583|B1|ARGENTINA||Region of Enrollment||Participants|Number|41|41.0||||||
3829944|NCT01712399|3656583|B1|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3829945|NCT01712399|3656583|B1|White||Race/Ethnicity, Customized||Participants|Number|364|364.0||||||
3829946|NCT01712399|3656583|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3829947|NCT01712399|3656583|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3829948|NCT01712399|3656583|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3829949|NCT01712399|3656583|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
3829950|NCT01712399|3656583|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3829951|NCT01712399|3656583|B1||Female|Sex: Female, Male||Participants|Count of Participants|339|339.0||||||
3829952|NCT01712399|3656583|B1|||Age||Years|Mean|51.1|51.1|Standard Deviation|11.2|11.2|||
3829953|NCT01712360|3656596|B5|Dominican Republic||Region of Enrollment||participants|Number|17|17.0||||||
3829954|NCT01712360|3656597|B4|Dominican Republic||Region of Enrollment||participants|Number|0|0.0||||||
3829955|NCT01712360|3656598|B3|Dominican Republic||Region of Enrollment||participants|Number|0|0.0||||||
3829956|NCT01712360|3656599|B2|Dominican Republic||Region of Enrollment||participants|Number|15|15.0||||||
3829957|NCT01712360|3656600|B1|Dominican Republic||Region of Enrollment||participants|Number|2|2.0||||||
3829958|NCT01712360|3656596|B5|Honduras||Region of Enrollment||participants|Number|20|20.0||||||
3829959|NCT01712360|3656597|B4|Honduras||Region of Enrollment||participants|Number|0|0.0||||||
3829960|NCT01712360|3656598|B3|Honduras||Region of Enrollment||participants|Number|0|0.0||||||
3829961|NCT01712360|3656599|B2|Honduras||Region of Enrollment||participants|Number|0|0.0||||||
3829962|NCT01712360|3656600|B1|Honduras||Region of Enrollment||participants|Number|20|20.0||||||
3829963|NCT01712360|3656596|B5|United States||Region of Enrollment||participants|Number|19|19.0||||||
3829964|NCT01712360|3656597|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
3829965|NCT01712360|3656598|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3829966|NCT01712360|3656599|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3829967|NCT01712360|3656600|B1|United States||Region of Enrollment||participants|Number|0|0.0||||||
3829968|NCT01712360|3656596|B5||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3829969|NCT01712360|3656597|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3829970|NCT01712360|3656598|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3829971|NCT01712360|3656599|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3829972|NCT01712360|3656600|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3829973|NCT01712360|3656596|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3829974|NCT01712360|3656597|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3829975|NCT01712360|3656598|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3829976|NCT01712360|3656599|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3829977|NCT01712360|3656600|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3829978|NCT01712360|3656596|B5|||Age||years|Mean|19.1|19.1|Standard Deviation|9.6|9.6|||
3829979|NCT01712360|3656597|B4|||Age||years|Mean|31.7|31.7|Standard Deviation|11.2|11.2|||
3829980|NCT01712360|3656598|B3|||Age||years|Mean|38.7|38.7|Standard Deviation|6.5|6.5|||
3829981|NCT01712360|3656599|B2|||Age||years|Mean|14.7|14.7|Standard Deviation|1.7|1.7|||
3829982|NCT01712360|3656600|B1|||Age||years|Mean|14.8|14.8|Standard Deviation|1.5|1.5|||
3829983|NCT01712360|3656596|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3829984|NCT01712360|3656597|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3829985|NCT01712360|3656598|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3829986|NCT01712360|3656599|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3829987|NCT01712360|3656600|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3829988|NCT01712360|3656596|B5||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3829989|NCT01712360|3656597|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3829990|NCT01712360|3656598|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3829991|NCT01712360|3656599|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3829992|NCT01712360|3656600|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3829993|NCT01712360|3656596|B5||<=18 years|Age||Participants|Count of Participants|44|44.0||||||
3829994|NCT01712360|3656597|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3829995|NCT01712360|3656598|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3829996|NCT01712360|3656599|B2||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
3829997|NCT01712360|3656600|B1||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
3829998|NCT01712334|3656629|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3829999|NCT01712334|3656629|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3830000|NCT01712334|3656629|B1|||Age||years|Mean|13.6|13.6|Standard Deviation|6.92|6.92|||
3830001|NCT01712256|3656638|B1|||Pre-ART HIV-1 viral load||copies/mL|Mean|67502.4|67502.4|Standard Deviation|150008.65|150008.65|||
3830002|NCT01712256|3656638|B1|||Currently on ART||participants|Number|30|30.0||||||
3830003|NCT01712256|3656638|B1|||Total time on ART||months|Mean|138.6|138.6|Standard Deviation|57.42|57.42|||
3830004|NCT01712256|3656638|B1|||Time since HIV diagnosis||Days|Mean|5786.8|5786.8|Standard Deviation|2043.44|2043.44|||
3830005|NCT01712256|3656638|B1|||BMI||kg/m^2|Mean|25.64|25.64|Standard Deviation|5.077|5.077|||
3830006|NCT01712256|3656638|B1|Spain||Region of Enrollment||participants|Number|10|10.0||||||
3830007|NCT01712256|3656638|B1|Germany||Region of Enrollment||participants|Number|10|10.0||||||
3830008|NCT01712256|3656638|B1|Italy||Region of Enrollment||participants|Number|2|2.0||||||
3830009|NCT01712256|3656638|B1|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3830010|NCT01712256|3656638|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3830011|NCT01712256|3656638|B1||Male|Gender||Participants|Count of Participants|27|27.0||||||
3830012|NCT01712256|3656638|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
3830013|NCT01712256|3656638|B1|||Age||years|Mean|47.0|47.0|Standard Deviation|7.12|7.12|||
3830014|NCT01712204|3656647|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3830015|NCT01712204|3656648|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3830016|NCT01712204|3656649|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3830017|NCT01712204|3656647|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3830018|NCT01712204|3656648|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3830019|NCT01712204|3656649|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3830020|NCT01712204|3656647|B3|||Age||years|Mean|43.6|43.6|Standard Deviation|12.1|12.1|||
3830021|NCT01712204|3656648|B2|||Age||years|Mean|43.7|43.7|Standard Deviation|12.6|12.6|||
3830022|NCT01712204|3656649|B1|||Age||years|Mean|43.6|43.6|Standard Deviation|11.8|11.8|||
3830023|NCT01712178|3656656|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3830024|NCT01712178|3656657|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3830025|NCT01712178|3656658|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3830026|NCT01712178|3656656|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3830027|NCT01712178|3656657|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3830028|NCT01712178|3656658|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3830029|NCT01712178|3656656|B3|||Age||years|Mean|54.3|54.3|Standard Deviation|11.6|11.6|||
3830030|NCT01712178|3656657|B2|||Age||years|Mean|53.0|53.0|Standard Deviation|12.3|12.3|||
3830031|NCT01712178|3656658|B1|||Age||years|Mean|55.5|55.5|Standard Deviation|11.0|11.0|||
3830032|NCT01712074|3656681|B4||MALE|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3830033|NCT01712074|3656682|B3||MALE|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3830034|NCT01712074|3656683|B2||MALE|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3830035|NCT01712074|3656684|B1||MALE|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3830036|NCT01712074|3656681|B4||FEMALE|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3830037|NCT01712074|3656682|B3||FEMALE|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3830038|NCT01712074|3656683|B2||FEMALE|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3830039|NCT01712074|3656684|B1||FEMALE|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3830040|NCT01712074|3656681|B4|||Age||years|Mean|76|76.0|Standard Deviation|7.7|7.7|||
3830041|NCT01712074|3656682|B3|||Age||years|Mean|75.9|75.9|Standard Deviation|7.5|7.5|||
3830042|NCT01712074|3656683|B2|||Age||years|Mean|76.0|76.0|Standard Deviation|8.0|8.0|||
3830043|NCT01712074|3656684|B1|||Age||years|Mean|73.2|73.2|Standard Deviation|8.8|8.8|||
3830044|NCT01712061|3656740|B3||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3830045|NCT01712061|3656741|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3830046|NCT01712061|3656742|B1||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3830047|NCT01712061|3656740|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3830048|NCT01712061|3656741|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3830049|NCT01712061|3656742|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3830050|NCT01712061|3656740|B3|>=65 years||Age, Customized||participants|Number|114|114.0||||||
3830051|NCT01712061|3656741|B2|>=65 years||Age, Customized||participants|Number|25|25.0||||||
3830052|NCT01712061|3656742|B1|>=65 years||Age, Customized||participants|Number|89|89.0||||||
3830053|NCT01712061|3656740|B3|45-64 years||Age, Customized||participants|Number|109|109.0||||||
3830054|NCT01712061|3656741|B2|45-64 years||Age, Customized||participants|Number|31|31.0||||||
3830055|NCT01712061|3656742|B1|45-64 years||Age, Customized||participants|Number|78|78.0||||||
3830056|NCT01712061|3656740|B3|18-44 years||Age, Customized||participants|Number|3|3.0||||||
3830057|NCT01712061|3656741|B2|18-44 years||Age, Customized||participants|Number|0|0.0||||||
3830058|NCT01712061|3656742|B1|18-44 years||Age, Customized||participants|Number|3|3.0||||||
3830059|NCT01712061|3656740|B3|Less than (<) 18 years||Age, Customized||participants|Number|0|0.0||||||
3830060|NCT01712061|3656741|B2|Less than (<) 18 years||Age, Customized||participants|Number|0|0.0||||||
3830061|NCT01712061|3656742|B1|Less than (<) 18 years||Age, Customized||participants|Number|0|0.0||||||
3830062|NCT01712009|3656781|B4|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3830063|NCT01712009|3656782|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3830064|NCT01712009|3656783|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3830065|NCT01712009|3656784|B1|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3830066|NCT01712009|3656781|B4|White||Race/Ethnicity, Customized||participants|Number|487|487.0||||||
3830067|NCT01712009|3656782|B3|White||Race/Ethnicity, Customized||participants|Number|173|173.0||||||
3830068|NCT01712009|3656783|B2|White||Race/Ethnicity, Customized||participants|Number|166|166.0||||||
3830069|NCT01712009|3656784|B1|White||Race/Ethnicity, Customized||participants|Number|148|148.0||||||
3830070|NCT01712009|3656781|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3830071|NCT01712009|3656782|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3830072|NCT01712009|3656783|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3830073|NCT01712009|3656784|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3830074|NCT01712009|3656781|B4|Multiple||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3830075|NCT01712009|3656782|B3|Multiple||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3830076|NCT01712009|3656783|B2|Multiple||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3830077|NCT01712009|3656784|B1|Multiple||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3830078|NCT01712009|3656781|B4|Black (or African American)||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
3830079|NCT01712009|3656782|B3|Black (or African American)||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3830080|NCT01712009|3656783|B2|Black (or African American)||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
3830081|NCT01712009|3656784|B1|Black (or African American)||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
3830082|NCT01712009|3656781|B4|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3830083|NCT01712009|3656782|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3830084|NCT01712009|3656783|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3830085|NCT01712009|3656784|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3830086|NCT01712009|3656781|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3830087|NCT01712009|3656782|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3830088|NCT01712009|3656783|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3830089|NCT01712009|3656784|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3830090|NCT01712009|3656781|B4|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|550|550.0||||||
3830091|NCT01712009|3656782|B3|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|191|191.0||||||
3830092|NCT01712009|3656783|B2|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|181|181.0||||||
3830093|NCT01712009|3656784|B1|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|178|178.0||||||
3830094|NCT01712009|3656781|B4|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
3830095|NCT01712009|3656782|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3830096|NCT01712009|3656783|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3830097|NCT01712009|3656784|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3830098|NCT01712009|3656781|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3830099|NCT01712009|3656782|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3830100|NCT01712009|3656783|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3830101|NCT01712009|3656784|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3830102|NCT01712009|3656781|B4||Female|Sex: Female, Male||Participants|Count of Participants|587|587.0||||||
3830103|NCT01712009|3656782|B3||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
3830104|NCT01712009|3656783|B2||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
3830105|NCT01712009|3656784|B1||Female|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
3830106|NCT01712009|3656781|B4|||Age||years|Mean|54.2|54.2|Standard Deviation|11.1|11.1|||
3830107|NCT01712009|3656782|B3|||Age||years|Mean|54.6|54.6|Standard Deviation|10.9|10.9|||
3830108|NCT01712009|3656783|B2|||Age||years|Mean|53.2|53.2|Standard Deviation|11.7|11.7|||
3830109|NCT01712009|3656784|B1|||Age||years|Mean|54.8|54.8|Standard Deviation|10.7|10.7|||
3830110|NCT01711918|3656812|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3830111|NCT01711918|3656812|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3830112|NCT01711918|3656812|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3830113|NCT01711918|3656812|B1|||Age||years|Mean|33|33.0|Standard Deviation|10.5|10.5|||
3830114|NCT01711918|3656812|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3830115|NCT01711918|3656812|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3830116|NCT01711918|3656812|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3830117|NCT01711866|3656820|B1|Korea, Republic of||Region of Enrollment||participants|Number|69|69.0||||||
3830118|NCT01711866|3656820|B1|Singapore||Region of Enrollment||participants|Number|2|2.0||||||
3830119|NCT01711866|3656820|B1|Malaysia||Region of Enrollment||participants|Number|1|1.0||||||
3830120|NCT01711866|3656820|B1|Taiwan||Region of Enrollment||participants|Number|9|9.0||||||
3830121|NCT01711866|3656820|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3830122|NCT01711866|3656820|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3830123|NCT01711866|3656820|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3830124|NCT01711866|3656820|B1||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
3830125|NCT01711866|3656820|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3830126|NCT01711866|3656820|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3830127|NCT01711866|3656820|B1|||Age||years|Mean|59.5|59.5|Standard Deviation|8.5|8.5|||
3830128|NCT01711853|3656825|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3830129|NCT01711853|3656825|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3830130|NCT01711853|3656825|B1|||Age||years|Mean|72.7|72.7|Standard Deviation|7.6|7.6|||
3830131|NCT01711736|3656830|B3||Male|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
3830132|NCT01711736|3656831|B2||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3830133|NCT01711736|3656832|B1||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3830134|NCT01711736|3656830|B3||Female|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
3830135|NCT01711736|3656831|B2||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3830136|NCT01711736|3656832|B1||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3830137|NCT01711736|3656830|B3|||Age||Months|Mean|18.15|18.15|Standard Deviation|8.25|8.25|||
3830138|NCT01711736|3656831|B2|||Age||Months|Mean|18.1|18.1|Standard Deviation|8.34|8.34|||
3830139|NCT01711736|3656832|B1|||Age||Months|Mean|18.2|18.2|Standard Deviation|8.17|8.17|||
3830140|NCT01711645|3656861|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
3830141|NCT01711645|3656861|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830142|NCT01711645|3656861|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830143|NCT01711645|3656861|B1||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3830144|NCT01711645|3656861|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3830145|NCT01711645|3656861|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830146|NCT01711645|3656861|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3830147|NCT01711645|3656861|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830148|NCT01711645|3656861|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830149|NCT01711645|3656861|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3830150|NCT01711645|3656861|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830151|NCT01711645|3656861|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3830152|NCT01711645|3656861|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3830153|NCT01711645|3656861|B1|||Age||years|Mean|30.1|30.1|Standard Deviation|4.4|4.4|||
3830154|NCT01711645|3656861|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3830155|NCT01711645|3656861|B1||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
3830156|NCT01711645|3656861|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3830157|NCT01711619|3656896|B3|Leg pain||Pain intensity at baseline|Pain intensity was measured by a 100 mm visual analog scale (VAS), with 0 representing no pain and 100 representing the worst pain imaginable.|units on a scale|Mean|7.8|7.8|Standard Deviation|11.2|11.2|||
3830158|NCT01711619|3656897|B2|Leg pain||Pain intensity at baseline|Pain intensity was measured by a 100 mm visual analog scale (VAS), with 0 representing no pain and 100 representing the worst pain imaginable.|units on a scale|Mean|6.8|6.8|Standard Deviation|11.5|11.5|||
3830159|NCT01711619|3656898|B1|Leg pain||Pain intensity at baseline|Pain intensity was measured by a 100 mm visual analog scale (VAS), with 0 representing no pain and 100 representing the worst pain imaginable.|units on a scale|Mean|8.9|8.9|Standard Deviation|10.8|10.8|||
3830160|NCT01711619|3656896|B3|Back pain||Pain intensity at baseline|Pain intensity was measured by a 100 mm visual analog scale (VAS), with 0 representing no pain and 100 representing the worst pain imaginable.|units on a scale|Mean|69.5|69.5|Standard Deviation|13.7|13.7|||
3830161|NCT01711619|3656897|B2|Back pain||Pain intensity at baseline|Pain intensity was measured by a 100 mm visual analog scale (VAS), with 0 representing no pain and 100 representing the worst pain imaginable.|units on a scale|Mean|70.1|70.1|Standard Deviation|14.0|14.0|||
3830162|NCT01711619|3656898|B1|Back pain||Pain intensity at baseline|Pain intensity was measured by a 100 mm visual analog scale (VAS), with 0 representing no pain and 100 representing the worst pain imaginable.|units on a scale|Mean|68.8|68.8|Standard Deviation|13.4|13.4|||
3830163|NCT01711619|3656896|B3||Male|Sex: Female, Male|Percentage of males and females|Participants|Count of Participants|50|50.0||||||
3830164|NCT01711619|3656897|B2||Male|Sex: Female, Male|Percentage of males and females|Participants|Count of Participants|26|26.0||||||
3830165|NCT01711619|3656898|B1||Male|Sex: Female, Male|Percentage of males and females|Participants|Count of Participants|24|24.0||||||
3830166|NCT01711619|3656896|B3||Female|Sex: Female, Male|Percentage of males and females|Participants|Count of Participants|66|66.0||||||
3830167|NCT01711619|3656897|B2||Female|Sex: Female, Male|Percentage of males and females|Participants|Count of Participants|34|34.0||||||
3830168|NCT01711619|3656898|B1||Female|Sex: Female, Male|Percentage of males and females|Participants|Count of Participants|32|32.0||||||
3830169|NCT01711619|3656896|B3|||Age|Mean age at time of enrollment (in years)|years|Mean|51.6|51.6|Standard Deviation|11.1|11.1|||
3830170|NCT01711619|3656897|B2|||Age|Mean age at time of enrollment (in years)|years|Mean|52.2|52.2|Standard Deviation|11.4|11.4|||
3830171|NCT01711619|3656898|B1|||Age|Mean age at time of enrollment (in years)|years|Mean|50.9|50.9|Standard Deviation|10.9|10.9|||
3830172|NCT01711424|3656911|B1|Missing Data||Sex/Gender, Customized||Participants|Number|6|6.0||||||
3830173|NCT01711424|3656911|B1|Female||Sex/Gender, Customized||Participants|Number|805|805.0||||||
3830174|NCT01711424|3656911|B1|Male||Sex/Gender, Customized||Participants|Number|398|398.0||||||
3830175|NCT01711424|3656911|B1|Missing data||Age, Customized||Participants|Number|16|16.0||||||
3830176|NCT01711424|3656911|B1|>= 91 Years||Age, Customized||Participants|Number|5|5.0||||||
3830177|NCT01711424|3656911|B1|81 to 90 Years||Age, Customized||Participants|Number|84|84.0||||||
3830178|NCT01711424|3656911|B1|71 to 80 Years||Age, Customized||Participants|Number|269|269.0||||||
3830179|NCT01711424|3656911|B1|61 to 70 Years||Age, Customized||Participants|Number|261|261.0||||||
3830180|NCT01711424|3656911|B1|51 to 60 Years||Age, Customized||Participants|Number|230|230.0||||||
3830181|NCT01711424|3656911|B1|41 to 50 Years||Age, Customized||Participants|Number|196|196.0||||||
3830182|NCT01711424|3656911|B1|31 to 40 Years||Age, Customized||Participants|Number|94|94.0||||||
3830183|NCT01711424|3656911|B1|18 to 30 Years||Age, Customized||Participants|Number|51|51.0||||||
3830184|NCT01711424|3656911|B1|<18 Years||Age, Customized||Participants|Number|3|3.0||15.89|15.89|||
3830185|NCT01711359|3656918|B4|||High sensitivity C-reactive protein||milligrams per liter (mg/L)|Mean|23.44|23.44|Standard Deviation|25.98|25.98|||
3830186|NCT01711359|3656919|B3|||High sensitivity C-reactive protein||milligrams per liter (mg/L)|Mean|24.27|24.27|Standard Deviation|29.42|29.42|||
3830187|NCT01711359|3656920|B2|||High sensitivity C-reactive protein||milligrams per liter (mg/L)|Mean|23.75|23.75|Standard Deviation|26.24|26.24|||
3830188|NCT01711359|3656921|B1|||High sensitivity C-reactive protein||milligrams per liter (mg/L)|Mean|22.34|22.34|Standard Deviation|21.78|21.78|||
3830189|NCT01711359|3656918|B4|||Swollen Joint Count of 66 evaluable joints||number of joints|Mean|16.3|16.3|Standard Deviation|9.8|9.8|||
3830190|NCT01711359|3656919|B3|||Swollen Joint Count of 66 evaluable joints||number of joints|Mean|16.3|16.3|Standard Deviation|9.5|9.5|||
3830191|NCT01711359|3656920|B2|||Swollen Joint Count of 66 evaluable joints||number of joints|Mean|16.1|16.1|Standard Deviation|9.2|9.2|||
3830192|NCT01711359|3656921|B1|||Swollen Joint Count of 66 evaluable joints||number of joints|Mean|16.4|16.4|Standard Deviation|10.6|10.6|||
3830193|NCT01711359|3656918|B4|||Tender Joint Count of 68 evaluable joints||number of joints|Mean|26.9|26.9|Standard Deviation|14.5|14.5|||
3830194|NCT01711359|3656919|B3|||Tender Joint Count of 68 evaluable joints||number of joints|Mean|27.7|27.7|Standard Deviation|14.5|14.5|||
3830195|NCT01711359|3656920|B2|||Tender Joint Count of 68 evaluable joints||number of joints|Mean|26.4|26.4|Standard Deviation|14.1|14.1|||
3830196|NCT01711359|3656921|B1|||Tender Joint Count of 68 evaluable joints||number of joints|Mean|26.5|26.5|Standard Deviation|14.8|14.8|||
3830197|NCT01711359|3656918|B4|||Duration of Rheumatoid Arthritis||years|Median|0.2|0.2|Inter-Quartile Range|||0.1|0.8|
3830198|NCT01711359|3656919|B3|||Duration of Rheumatoid Arthritis||years|Median|0.2|0.2|Inter-Quartile Range|||0.1|1.0|
3830199|NCT01711359|3656920|B2|||Duration of Rheumatoid Arthritis||years|Median|0.2|0.2|Inter-Quartile Range|||0.1|1.1|
3830200|NCT01711359|3656921|B1|||Duration of Rheumatoid Arthritis||years|Median|0.2|0.2|Inter-Quartile Range|||0.1|0.6|
3830201|NCT01711359|3656918|B4|United States||Region of Enrollment||Participants|Count of Participants|104|104.0||||||
3830202|NCT01711359|3656919|B3|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3830203|NCT01711359|3656920|B2|United States||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3830204|NCT01711359|3656921|B1|United States||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3830205|NCT01711359|3656918|B4|United Kingdom||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3830206|NCT01711359|3656919|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3830207|NCT01711359|3656920|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3830208|NCT01711359|3656921|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3830209|NCT01711359|3656918|B4|Sweden||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3830210|NCT01711359|3656919|B3|Sweden||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3830211|NCT01711359|3656920|B2|Sweden||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3830212|NCT01711359|3656921|B1|Sweden||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3830213|NCT01711359|3656918|B4|Korea, Republic of||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3830214|NCT01711359|3656919|B3|Korea, Republic of||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3830215|NCT01711359|3656920|B2|Korea, Republic of||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3830216|NCT01711359|3656921|B1|Korea, Republic of||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3830217|NCT01711359|3656918|B4|South Africa||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3830218|NCT01711359|3656919|B3|South Africa||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3830219|NCT01711359|3656920|B2|South Africa||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3830220|NCT01711359|3656921|B1|South Africa||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3830221|NCT01711359|3656918|B4|Russian Federation||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3830222|NCT01711359|3656919|B3|Russian Federation||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3830223|NCT01711359|3656920|B2|Russian Federation||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3830224|NCT01711359|3656921|B1|Russian Federation||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3830225|NCT01711359|3656918|B4|Portugal||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3830226|NCT01711359|3656919|B3|Portugal||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3830227|NCT01711359|3656920|B2|Portugal||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3830228|NCT01711359|3656921|B1|Portugal||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3830229|NCT01711359|3656918|B4|Mexico||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
3830230|NCT01711359|3656919|B3|Mexico||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3830231|NCT01711359|3656920|B2|Mexico||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3830232|NCT01711359|3656921|B1|Mexico||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3830233|NCT01711359|3656918|B4|Japan||Region of Enrollment||Participants|Count of Participants|104|104.0||||||
3830234|NCT01711359|3656919|B3|Japan||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3830235|NCT01711359|3656920|B2|Japan||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3830236|NCT01711359|3656921|B1|Japan||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3830237|NCT01711359|3656918|B4|Italy||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3830238|NCT01711359|3656919|B3|Italy||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3830239|NCT01711359|3656920|B2|Italy||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3830240|NCT01711359|3656921|B1|Italy||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3830241|NCT01711359|3656918|B4|India||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
3830242|NCT01711359|3656919|B3|India||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3830243|NCT01711359|3656920|B2|India||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3830244|NCT01711359|3656921|B1|India||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3830245|NCT01711359|3656918|B4|Greece||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3830246|NCT01711359|3656919|B3|Greece||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3830247|NCT01711359|3656920|B2|Greece||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3830248|NCT01711359|3656921|B1|Greece||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3830249|NCT01711359|3656918|B4|Germany||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3830250|NCT01711359|3656919|B3|Germany||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3830251|NCT01711359|3656920|B2|Germany||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3830252|NCT01711359|3656921|B1|Germany||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3830253|NCT01711359|3656918|B4|Canada||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3830254|NCT01711359|3656919|B3|Canada||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3830255|NCT01711359|3656920|B2|Canada||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3830256|NCT01711359|3656921|B1|Canada||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3830257|NCT01711359|3656918|B4|Brazil||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3830258|NCT01711359|3656919|B3|Brazil||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3830259|NCT01711359|3656920|B2|Brazil||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3830260|NCT01711359|3656921|B1|Brazil||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3830261|NCT01711359|3656918|B4|Belgium||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3830262|NCT01711359|3656919|B3|Belgium||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3830263|NCT01711359|3656920|B2|Belgium||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3830264|NCT01711359|3656921|B1|Belgium||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3830265|NCT01711359|3656918|B4|Austria||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3830266|NCT01711359|3656919|B3|Austria||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3830267|NCT01711359|3656920|B2|Austria||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3830268|NCT01711359|3656921|B1|Austria||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3830269|NCT01711359|3656918|B4|Argentina||Region of Enrollment||Participants|Count of Participants|103|103.0||||||
3830270|NCT01711359|3656919|B3|Argentina||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3830271|NCT01711359|3656920|B2|Argentina||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3830272|NCT01711359|3656921|B1|Argentina||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3830273|NCT01711359|3656918|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830274|NCT01711359|3656919|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830275|NCT01711359|3656920|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830276|NCT01711359|3656921|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830277|NCT01711359|3656918|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3830278|NCT01711359|3656919|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3830279|NCT01711359|3656920|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3830280|NCT01711359|3656921|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3830281|NCT01711359|3656918|B4||White|Race (NIH/OMB)||Participants|Count of Participants|349|349.0||||||
3830282|NCT01711359|3656919|B3||White|Race (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
3830283|NCT01711359|3656920|B2||White|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3830284|NCT01711359|3656921|B1||White|Race (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
3830285|NCT01711359|3656918|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3830286|NCT01711359|3656919|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3830287|NCT01711359|3656920|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3830288|NCT01711359|3656921|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3830289|NCT01711359|3656918|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830290|NCT01711359|3656919|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830291|NCT01711359|3656920|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830292|NCT01711359|3656921|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830293|NCT01711359|3656918|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|165|165.0||||||
3830294|NCT01711359|3656919|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3830295|NCT01711359|3656920|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3830296|NCT01711359|3656921|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3830297|NCT01711359|3656918|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3830298|NCT01711359|3656919|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3830299|NCT01711359|3656920|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3830300|NCT01711359|3656921|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3830301|NCT01711359|3656918|B4||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
3830302|NCT01711359|3656919|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3830303|NCT01711359|3656920|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3830304|NCT01711359|3656921|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3830305|NCT01711359|3656918|B4||Female|Sex: Female, Male||Participants|Count of Participants|425|425.0||||||
3830306|NCT01711359|3656919|B3||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3830307|NCT01711359|3656920|B2||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3830308|NCT01711359|3656921|B1||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3830309|NCT01711359|3656918|B4|||Age||years|Mean|49.9|49.9|Standard Deviation|13.4|13.4|||
3830310|NCT01711359|3656919|B3|||Age||years|Mean|48.5|48.5|Standard Deviation|13.5|13.5|||
3830311|NCT01711359|3656920|B2|||Age||years|Mean|50.9|50.9|Standard Deviation|13.0|13.0|||
3830312|NCT01711359|3656921|B1|||Age||years|Mean|50.5|50.5|Standard Deviation|13.4|13.4|||
3830313|NCT01711216|3656994|B1|Kazakhstan||Region of Enrollment||participants|Number|129|129.0||||||
3830314|NCT01711216|3656994|B1|Uzbekistan||Region of Enrollment||participants|Number|160|160.0||||||
3830315|NCT01711216|3656994|B1|Ukraine||Region of Enrollment||participants|Number|284|284.0||||||
3830316|NCT01711216|3656994|B1|Russian Federation||Region of Enrollment||participants|Number|382|382.0||||||
3830317|NCT01711216|3656994|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3830318|NCT01711216|3656994|B1||Female|Sex: Female, Male||Participants|Count of Participants|955|955.0||||||
3830319|NCT01711216|3656994|B1|||Age||years|Mean|28.3|28.3|Standard Deviation|5.8|5.8|||
3830320|NCT01711177|3657015|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3830321|NCT01711177|3657016|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3830322|NCT01711177|3657017|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3830323|NCT01711177|3657018|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3830324|NCT01711177|3657015|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3830325|NCT01711177|3657016|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3830326|NCT01711177|3657017|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3830327|NCT01711177|3657018|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3830328|NCT01711177|3657015|B4|||Age||years|Mean|55|55.0|Standard Deviation|10|10.0|||
3830329|NCT01711177|3657016|B3|||Age||years|Mean|60|60.0|Standard Deviation|9|9.0|||
3830330|NCT01711177|3657017|B2|||Age||years|Mean|53|53.0|Standard Deviation|8|8.0|||
3830331|NCT01711177|3657018|B1|||Age||years|Mean|50|50.0|Standard Deviation|5|5.0|||
3830332|NCT01711177|3657015|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3830333|NCT01711177|3657016|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3830334|NCT01711177|3657017|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3830335|NCT01711177|3657018|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3830336|NCT01711177|3657015|B4||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3830337|NCT01711177|3657016|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3830338|NCT01711177|3657017|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3830339|NCT01711177|3657018|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3830340|NCT01711177|3657015|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3830341|NCT01711177|3657016|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3830342|NCT01711177|3657017|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3830343|NCT01711177|3657018|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3830344|NCT01710839|3657028|B3|||Central Retinal Thickness||micrometers|Mean|514|514.0|Full Range|||224.0|1240.0|
3830345|NCT01710839|3657029|B2|||Central Retinal Thickness||micrometers|Mean|471|471.0|Full Range|||272.0|910.0|
3830346|NCT01710839|3657030|B1|||Central Retinal Thickness||micrometers|Mean|525|525.0|Full Range|||224.0|1240.0|
3830347|NCT01710839|3657028|B3|||ETDRS BCVA Letters|Visual function of the study eye was assessed using the ETDRS protocol, which is a widely accepted international standard for macular laser photocoagulation treatment. A higher score represents better functioning.|ETDRS BCVA Letters|Mean|52.4|52.4|Full Range|||7.0|77.0|
3830348|NCT01710839|3657029|B2|||ETDRS BCVA Letters|Visual function of the study eye was assessed using the ETDRS protocol, which is a widely accepted international standard for macular laser photocoagulation treatment. A higher score represents better functioning.|ETDRS BCVA Letters|Mean|55.3|55.3|Full Range|||29.0|71.0|
3830349|NCT01710839|3657030|B1|||ETDRS BCVA Letters|Visual function of the study eye was assessed using the ETDRS protocol, which is a widely accepted international standard for macular laser photocoagulation treatment. A higher score represents better functioning.|ETDRS BCVA Letters|Mean|51.7|51.7|Full Range|||7.0|77.0|
3830350|NCT01710839|3657028|B3|||Prior Anti-VEGF Injections||injections|Mean|10.1|10.1|Full Range|||2.0|41.0|
3830351|NCT01710839|3657029|B2|||Prior Anti-VEGF Injections||injections|Mean|10.0|10.0|Full Range|||2.0|41.0|
3830352|NCT01710839|3657030|B1|||Prior Anti-VEGF Injections||injections|Mean|10.2|10.2|Full Range|||2.0|34.0|
3830353|NCT01710839|3657028|B3|HRVO||RVO Subtype||Participants|Count of Participants|2|2.0||||||
3830354|NCT01710839|3657029|B2|HRVO||RVO Subtype||Participants|Count of Participants|0|0.0||||||
3830355|NCT01710839|3657030|B1|HRVO||RVO Subtype||Participants|Count of Participants|2|2.0||||||
3830356|NCT01710839|3657028|B3|BRVO||RVO Subtype||Participants|Count of Participants|11|11.0||||||
3830357|NCT01710839|3657029|B2|BRVO||RVO Subtype||Participants|Count of Participants|2|2.0||||||
3830358|NCT01710839|3657030|B1|BRVO||RVO Subtype||Participants|Count of Participants|9|9.0||||||
3830359|NCT01710839|3657028|B3|CRVO||RVO Subtype||Participants|Count of Participants|17|17.0||||||
3830360|NCT01710839|3657029|B2|CRVO||RVO Subtype||Participants|Count of Participants|4|4.0||||||
3830361|NCT01710839|3657030|B1|CRVO||RVO Subtype||Participants|Count of Participants|13|13.0||||||
3830362|NCT01710839|3657028|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3830363|NCT01710839|3657029|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3830364|NCT01710839|3657030|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3830365|NCT01710839|3657028|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3830366|NCT01710839|3657029|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3830367|NCT01710839|3657030|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3830368|NCT01710839|3657028|B3|||Age||years|Mean|64.1|64.1|Full Range|||43.0|80.0|
3830369|NCT01710839|3657029|B2|||Age||years|Mean|63.8|63.8|Full Range|||56.0|77.0|
3830370|NCT01710839|3657030|B1|||Age||years|Mean|64.1|64.1|Full Range|||43.0|80.0|
3830371|NCT01710800|3657053|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
3830372|NCT01710800|3657053|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3830373|NCT01710800|3657053|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3830374|NCT01710800|3657053|B1|||Age||years|Mean|52|52.0|Standard Deviation|12|12.0|||
3830375|NCT01710800|3657053|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3830376|NCT01710800|3657053|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3830377|NCT01710800|3657053|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3830378|NCT01710787|3657059|B4||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3830379|NCT01710787|3657060|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3830380|NCT01710787|3657061|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3830381|NCT01710787|3657062|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3830382|NCT01710787|3657059|B4||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3830383|NCT01710787|3657060|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3830384|NCT01710787|3657061|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3830385|NCT01710787|3657062|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3830386|NCT01710787|3657059|B4|||Age||years|Mean|34.5|34.5|Standard Deviation|13.82|13.82|||
3830387|NCT01710787|3657060|B3|||Age||years|Mean|35.7|35.7|Standard Deviation|14.64|14.64|||
3830388|NCT01710787|3657061|B2|||Age||years|Mean|31.3|31.3|Standard Deviation|12.01|12.01|||
3830389|NCT01710787|3657062|B1|||Age||years|Mean|37.1|37.1|Standard Deviation|14.73|14.73|||
3830390|NCT01710709|3657117|B1|France||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3830391|NCT01710709|3657117|B1|Malaysia||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3830392|NCT01710709|3657117|B1|Poland||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3830393|NCT01710709|3657117|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3830394|NCT01710709|3657117|B1|Japan||Region of Enrollment||Participants|Count of Participants|75|75.0||||||
3830395|NCT01710709|3657117|B1|United States||Region of Enrollment||Participants|Count of Participants|322|322.0||||||
3830396|NCT01710709|3657117|B1|Hungary||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3830397|NCT01710709|3657117|B1|Romania||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3830398|NCT01710709|3657117|B1|South Korea||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3830399|NCT01710709|3657117|B1|Canada||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3830400|NCT01710709|3657117|B1||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
3830401|NCT01710709|3657117|B1||Female|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
3830402|NCT01710709|3657117|B1|||Age||Years|Mean|41.1|41.1|Standard Deviation|11.8|11.8|||
3830403|NCT01710709|3657117|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3830404|NCT01710709|3657117|B1||Between 18 and 65 years|Age||Participants|Count of Participants|458|458.0||||||
3830405|NCT01710709|3657117|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3830406|NCT01710657|3657129|B4|Japanese||Race/Ethnicity, Customized||participants|Number|142|142.0||||||
3830407|NCT01710657|3657130|B3|Japanese||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
3830408|NCT01710657|3657131|B2|Japanese||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
3830409|NCT01710657|3657132|B1|Japanese||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
3830410|NCT01710657|3657129|B4|Chinese||Race/Ethnicity, Customized||participants|Number|405|405.0||||||
3830411|NCT01710657|3657130|B3|Chinese||Race/Ethnicity, Customized||participants|Number|133|133.0||||||
3830412|NCT01710657|3657131|B2|Chinese||Race/Ethnicity, Customized||participants|Number|136|136.0||||||
3830413|NCT01710657|3657132|B1|Chinese||Race/Ethnicity, Customized||participants|Number|136|136.0||||||
3830414|NCT01710657|3657129|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830415|NCT01710657|3657130|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830416|NCT01710657|3657131|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830417|NCT01710657|3657132|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830418|NCT01710657|3657129|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830419|NCT01710657|3657130|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830420|NCT01710657|3657131|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830421|NCT01710657|3657132|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830422|NCT01710657|3657129|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830423|NCT01710657|3657130|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830424|NCT01710657|3657131|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830425|NCT01710657|3657132|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830426|NCT01710657|3657129|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830427|NCT01710657|3657130|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830428|NCT01710657|3657131|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830429|NCT01710657|3657132|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830430|NCT01710657|3657129|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830431|NCT01710657|3657130|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830432|NCT01710657|3657131|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830433|NCT01710657|3657132|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830434|NCT01710657|3657129|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|547|547.0||||||
3830435|NCT01710657|3657130|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|180|180.0||||||
3830436|NCT01710657|3657131|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|183|183.0||||||
3830437|NCT01710657|3657132|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|184|184.0||||||
3830438|NCT01710657|3657129|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830439|NCT01710657|3657130|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830440|NCT01710657|3657131|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830441|NCT01710657|3657132|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830442|NCT01710657|3657129|B4||Male|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
3830443|NCT01710657|3657130|B3||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3830444|NCT01710657|3657131|B2||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3830445|NCT01710657|3657132|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3830446|NCT01710657|3657129|B4||Female|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
3830447|NCT01710657|3657130|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3830448|NCT01710657|3657131|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3830449|NCT01710657|3657132|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3830450|NCT01710657|3657129|B4|||Age||years|Mean|32.4|32.4|Standard Deviation|12.0|12.0|||
3830451|NCT01710657|3657130|B3|||Age||years|Mean|32.3|32.3|Standard Deviation|11.9|11.9|||
3830452|NCT01710657|3657131|B2|||Age||years|Mean|33.2|33.2|Standard Deviation|12.2|12.2|||
3830453|NCT01710657|3657132|B1|||Age||years|Mean|31.8|31.8|Standard Deviation|12.0|12.0|||
3830454|NCT01710657|3657129|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3830455|NCT01710657|3657130|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3830456|NCT01710657|3657131|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3830457|NCT01710657|3657132|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3830458|NCT01710657|3657129|B4||Between 18 and 65 years|Age||Participants|Count of Participants|491|491.0||||||
3830459|NCT01710657|3657130|B3||Between 18 and 65 years|Age||Participants|Count of Participants|164|164.0||||||
3830460|NCT01710657|3657131|B2||Between 18 and 65 years|Age||Participants|Count of Participants|163|163.0||||||
3830461|NCT01710657|3657132|B1||Between 18 and 65 years|Age||Participants|Count of Participants|164|164.0||||||
3830462|NCT01710657|3657129|B4||<=18 years|Age||Participants|Count of Participants|53|53.0||||||
3830463|NCT01710657|3657130|B3||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
3830464|NCT01710657|3657131|B2||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
3830465|NCT01710657|3657132|B1||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
3830466|NCT01710527|3657151|B1|India||Region of Enrollment||Participants|Number|32|32.0||||||
3830467|NCT01710527|3657151|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3830468|NCT01710527|3657151|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3830469|NCT01710527|3657151|B1|||Age||Years|Mean|26.19|26.19|Standard Deviation|4.25|4.25|||
3830470|NCT01710514|3657176|B3|Intracytoplasmic Sperm Injection (ICSI)||Method of insemination|FAS with ET (BID: 43, TID: 47, Total: 90)|participants|Number|50|50.0||||||
3830471|NCT01710514|3657177|B2|Intracytoplasmic Sperm Injection (ICSI)||Method of insemination|FAS with ET (BID: 43, TID: 47, Total: 90)|participants|Number|26|26.0||||||
3830472|NCT01710514|3657178|B1|Intracytoplasmic Sperm Injection (ICSI)||Method of insemination|FAS with ET (BID: 43, TID: 47, Total: 90)|participants|Number|24|24.0||||||
3830473|NCT01710514|3657176|B3|IVF||Method of insemination|FAS with ET (BID: 43, TID: 47, Total: 90)|participants|Number|40|40.0||||||
3830474|NCT01710514|3657177|B2|IVF||Method of insemination|FAS with ET (BID: 43, TID: 47, Total: 90)|participants|Number|21|21.0||||||
3830475|NCT01710514|3657178|B1|IVF||Method of insemination|FAS with ET (BID: 43, TID: 47, Total: 90)|participants|Number|19|19.0||||||
3830476|NCT01710514|3657176|B3|||Embryos transferred|FAS with ET (BID: 43, TID: 47, Total: 90)|embryos|Mean|1.1|1.1|Standard Deviation|0.302|0.302|||
3830477|NCT01710514|3657177|B2|||Embryos transferred|FAS with ET (BID: 43, TID: 47, Total: 90)|embryos|Mean|1.11|1.11|Standard Deviation|0.312|0.312|||
3830478|NCT01710514|3657178|B1|||Embryos transferred|FAS with ET (BID: 43, TID: 47, Total: 90)|embryos|Mean|1.09|1.09|Standard Deviation|0.294|0.294|||
3830479|NCT01710514|3657176|B3|2 embryos||Subjects with embryo transferred|FAS with ET (BID: 43, TID: 47, Total: 90)|participants|Number|9|9.0||||||
3830480|NCT01710514|3657177|B2|2 embryos||Subjects with embryo transferred|FAS with ET (BID: 43, TID: 47, Total: 90)|participants|Number|5|5.0||||||
3830481|NCT01710514|3657178|B1|2 embryos||Subjects with embryo transferred|FAS with ET (BID: 43, TID: 47, Total: 90)|participants|Number|4|4.0||||||
3830482|NCT01710514|3657176|B3|1 embryo||Subjects with embryo transferred|FAS with ET (BID: 43, TID: 47, Total: 90)|participants|Number|81|81.0||||||
3830483|NCT01710514|3657177|B2|1 embryo||Subjects with embryo transferred|FAS with ET (BID: 43, TID: 47, Total: 90)|participants|Number|42|42.0||||||
3830484|NCT01710514|3657178|B1|1 embryo||Subjects with embryo transferred|FAS with ET (BID: 43, TID: 47, Total: 90)|participants|Number|39|39.0||||||
3830485|NCT01710514|3657176|B3|Day 5||Day of transfer|FAS with embryo transfer (ET) (BID: 43, TID: 47, Total: 90)|participants|Number|7|7.0||||||
3830486|NCT01710514|3657177|B2|Day 5||Day of transfer|FAS with embryo transfer (ET) (BID: 43, TID: 47, Total: 90)|participants|Number|2|2.0||||||
3830487|NCT01710514|3657178|B1|Day 5||Day of transfer|FAS with embryo transfer (ET) (BID: 43, TID: 47, Total: 90)|participants|Number|5|5.0||||||
3830488|NCT01710514|3657176|B3|Day 3||Day of transfer|FAS with embryo transfer (ET) (BID: 43, TID: 47, Total: 90)|participants|Number|83|83.0||||||
3830489|NCT01710514|3657177|B2|Day 3||Day of transfer|FAS with embryo transfer (ET) (BID: 43, TID: 47, Total: 90)|participants|Number|45|45.0||||||
3830490|NCT01710514|3657178|B1|Day 3||Day of transfer|FAS with embryo transfer (ET) (BID: 43, TID: 47, Total: 90)|participants|Number|38|38.0||||||
3830491|NCT01710514|3657176|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830492|NCT01710514|3657177|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830493|NCT01710514|3657178|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830494|NCT01710514|3657176|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830495|NCT01710514|3657177|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830496|NCT01710514|3657178|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830497|NCT01710514|3657176|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830498|NCT01710514|3657177|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830499|NCT01710514|3657178|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830500|NCT01710514|3657176|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830501|NCT01710514|3657177|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830502|NCT01710514|3657178|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830503|NCT01710514|3657176|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830504|NCT01710514|3657177|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830505|NCT01710514|3657178|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830506|NCT01710514|3657176|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3830507|NCT01710514|3657177|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3830508|NCT01710514|3657178|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3830509|NCT01710514|3657176|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830510|NCT01710514|3657177|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830511|NCT01710514|3657178|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830512|NCT01710514|3657176|B3||Male|Sex: Female, Male|FAS population|Participants|Count of Participants|0|0.0||||||
3830513|NCT01710514|3657177|B2||Male|Sex: Female, Male|FAS population|Participants|Count of Participants|0|0.0||||||
3830514|NCT01710514|3657178|B1||Male|Sex: Female, Male|FAS population|Participants|Count of Participants|0|0.0||||||
3830515|NCT01710514|3657176|B3||Female|Sex: Female, Male|FAS population|Participants|Count of Participants|94|94.0||||||
3830516|NCT01710514|3657177|B2||Female|Sex: Female, Male|FAS population|Participants|Count of Participants|48|48.0||||||
3830517|NCT01710514|3657178|B1||Female|Sex: Female, Male|FAS population|Participants|Count of Participants|46|46.0||||||
3830518|NCT01710514|3657176|B3|41-42 years||Age, Customized|FAS population|participants|Number|6|6.0||||||
3830519|NCT01710514|3657177|B2|41-42 years||Age, Customized|FAS population|participants|Number|5|5.0||||||
3830520|NCT01710514|3657178|B1|41-42 years||Age, Customized|FAS population|participants|Number|1|1.0||||||
3830521|NCT01710514|3657176|B3|38-40 years||Age, Customized|FAS population|participants|Number|19|19.0||||||
3830522|NCT01710514|3657177|B2|38-40 years||Age, Customized|FAS population|participants|Number|8|8.0||||||
3830523|NCT01710514|3657178|B1|38-40 years||Age, Customized|FAS population|participants|Number|11|11.0||||||
3830524|NCT01710514|3657176|B3|35-37 years||Age, Customized|FAS population|participants|Number|31|31.0||||||
3830525|NCT01710514|3657177|B2|35-37 years||Age, Customized|FAS population|participants|Number|14|14.0||||||
3830526|NCT01710514|3657178|B1|35-37 years||Age, Customized|FAS population|participants|Number|17|17.0||||||
3830527|NCT01710514|3657176|B3|<35 years||Age, Customized|FAS population|participants|Number|38|38.0||||||
3830528|NCT01710514|3657177|B2|<35 years||Age, Customized|FAS population|participants|Number|21|21.0||||||
3830529|NCT01710514|3657178|B1|<35 years||Age, Customized|FAS population|participants|Number|17|17.0||||||
3830530|NCT01710514|3657176|B3|||Age|FAS population|years|Mean|34.7|34.7|Standard Deviation|3.93|3.93|||
3830531|NCT01710514|3657177|B2|||Age|FAS population|years|Mean|34.5|34.5|Standard Deviation|4.25|4.25|||
3830532|NCT01710514|3657178|B1|||Age|FAS population|years|Mean|34.9|34.9|Standard Deviation|3.6|3.6|||
3830533|NCT01710501|3657197|B4||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3830534|NCT01710501|3657198|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3830535|NCT01710501|3657199|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3830536|NCT01710501|3657200|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3830537|NCT01710501|3657197|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3830538|NCT01710501|3657198|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3830539|NCT01710501|3657199|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3830540|NCT01710501|3657200|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3830541|NCT01710501|3657197|B4|||Age||years|Mean|48.9|48.9|Standard Deviation|11.6|11.6|||
3830542|NCT01710501|3657198|B3|||Age||years|Mean|46.4|46.4|Standard Deviation|13.3|13.3|||
3830543|NCT01710501|3657199|B2|||Age||years|Mean|48.5|48.5|Standard Deviation|12.5|12.5|||
3830544|NCT01710501|3657200|B1|||Age||years|Mean|52.0|52.0|Standard Deviation|7.9|7.9|||
3830545|NCT01710358|3657231|B4|||High Sensitivity C-Reactive Protein (hsCRP)||milligrams per liter (mg/L)|Mean|21.14|21.14|Standard Deviation|21.67|21.67|||
3830546|NCT01710358|3657232|B3|||High Sensitivity C-Reactive Protein (hsCRP)||milligrams per liter (mg/L)|Mean|21.78|21.78|Standard Deviation|20.83|20.83|||
3830547|NCT01710358|3657233|B2|||High Sensitivity C-Reactive Protein (hsCRP)||milligrams per liter (mg/L)|Mean|22.20|22.2|Standard Deviation|22.85|22.85|||
3830548|NCT01710358|3657234|B1|||High Sensitivity C-Reactive Protein (hsCRP)||milligrams per liter (mg/L)|Mean|19.66|19.66|Standard Deviation|20.97|20.97|||
3830549|NCT01710358|3657231|B4|||Swollen Joint Count of 66 Evaluable Joints||Number of Joints|Mean|15.3|15.3|Standard Deviation|8.9|8.9|||
3830550|NCT01710358|3657232|B3|||Swollen Joint Count of 66 Evaluable Joints||Number of Joints|Mean|15.4|15.4|Standard Deviation|9.1|9.1|||
3830551|NCT01710358|3657233|B2|||Swollen Joint Count of 66 Evaluable Joints||Number of Joints|Mean|15.0|15.0|Standard Deviation|8.2|8.2|||
3830552|NCT01710358|3657234|B1|||Swollen Joint Count of 66 Evaluable Joints||Number of Joints|Mean|15.5|15.5|Standard Deviation|9.4|9.4|||
3830553|NCT01710358|3657231|B4|||Tender Joint Count of 68 Evaluable Joints||Number of Joints|Mean|23.4|23.4|Standard Deviation|13.3|13.3|||
3830554|NCT01710358|3657232|B3|||Tender Joint Count of 68 Evaluable Joints||Number of Joints|Mean|23.4|23.4|Standard Deviation|13.7|13.7|||
3830555|NCT01710358|3657233|B2|||Tender Joint Count of 68 Evaluable Joints||Number of Joints|Mean|23.4|23.4|Standard Deviation|13.0|13.0|||
3830556|NCT01710358|3657234|B1|||Tender Joint Count of 68 Evaluable Joints||Number of Joints|Mean|23.3|23.3|Standard Deviation|13.5|13.5|||
3830557|NCT01710358|3657231|B4|||Duration of Rheumatoid Arthritis||years|Mean|10.1|10.1|Standard Deviation|8.7|8.7|||
3830558|NCT01710358|3657232|B3|||Duration of Rheumatoid Arthritis||years|Mean|9.6|9.6|Standard Deviation|8.5|8.5|||
3830559|NCT01710358|3657233|B2|||Duration of Rheumatoid Arthritis||years|Mean|10.3|10.3|Standard Deviation|8.8|8.8|||
3830560|NCT01710358|3657234|B1|||Duration of Rheumatoid Arthritis||years|Mean|10.4|10.4|Standard Deviation|8.7|8.7|||
3830561|NCT01710358|3657231|B4|United States||Region of Enrollment||Participants|Count of Participants|94|94.0||||||
3830562|NCT01710358|3657232|B3|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3830563|NCT01710358|3657233|B2|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3830564|NCT01710358|3657234|B1|United States||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3830565|NCT01710358|3657231|B4|United Kingdom||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3830566|NCT01710358|3657232|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3830567|NCT01710358|3657233|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3830568|NCT01710358|3657234|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3830569|NCT01710358|3657231|B4|Taiwan||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3830570|NCT01710358|3657232|B3|Taiwan||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3830571|NCT01710358|3657233|B2|Taiwan||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3830572|NCT01710358|3657234|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3830573|NCT01710358|3657231|B4|Spain||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3830574|NCT01710358|3657232|B3|Spain||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3830575|NCT01710358|3657233|B2|Spain||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3830576|NCT01710358|3657234|B1|Spain||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3830577|NCT01710358|3657231|B4|South Africa||Region of Enrollment||Participants|Count of Participants|56|56.0||||||
3830578|NCT01710358|3657232|B3|South Africa||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3830579|NCT01710358|3657233|B2|South Africa||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3830580|NCT01710358|3657234|B1|South Africa||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3830581|NCT01710358|3657231|B4|Slovenia||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3830582|NCT01710358|3657232|B3|Slovenia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3830583|NCT01710358|3657233|B2|Slovenia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3830584|NCT01710358|3657234|B1|Slovenia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3830585|NCT01710358|3657231|B4|Slovakia||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3830586|NCT01710358|3657232|B3|Slovakia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3830587|NCT01710358|3657233|B2|Slovakia||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3830588|NCT01710358|3657234|B1|Slovakia||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3830589|NCT01710358|3657231|B4|Russia||Region of Enrollment||Participants|Count of Participants|78|78.0||||||
3830590|NCT01710358|3657232|B3|Russia||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3830591|NCT01710358|3657233|B2|Russia||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3830592|NCT01710358|3657234|B1|Russia||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3830593|NCT01710358|3657231|B4|Romania||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3830594|NCT01710358|3657232|B3|Romania||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3830595|NCT01710358|3657233|B2|Romania||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3830596|NCT01710358|3657234|B1|Romania||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3830597|NCT01710358|3657231|B4|Portugal||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3830598|NCT01710358|3657232|B3|Portugal||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3830599|NCT01710358|3657233|B2|Portugal||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3830600|NCT01710358|3657234|B1|Portugal||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3830601|NCT01710358|3657231|B4|Poland||Region of Enrollment||Participants|Count of Participants|80|80.0||||||
3830602|NCT01710358|3657232|B3|Poland||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3830603|NCT01710358|3657233|B2|Poland||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3830604|NCT01710358|3657234|B1|Poland||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3830605|NCT01710358|3657231|B4|Mexico||Region of Enrollment||Participants|Count of Participants|125|125.0||||||
3830606|NCT01710358|3657232|B3|Mexico||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3830607|NCT01710358|3657233|B2|Mexico||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3830608|NCT01710358|3657234|B1|Mexico||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3830609|NCT01710358|3657231|B4|Lithuania||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3830610|NCT01710358|3657232|B3|Lithuania||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3830611|NCT01710358|3657233|B2|Lithuania||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3830612|NCT01710358|3657234|B1|Lithuania||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3830613|NCT01710358|3657231|B4|Latvia||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3830614|NCT01710358|3657232|B3|Latvia||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3830615|NCT01710358|3657233|B2|Latvia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3830616|NCT01710358|3657234|B1|Latvia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3830617|NCT01710358|3657231|B4|South Korea||Region of Enrollment||Participants|Count of Participants|57|57.0||||||
3830618|NCT01710358|3657232|B3|South Korea||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3830619|NCT01710358|3657233|B2|South Korea||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3830620|NCT01710358|3657234|B1|South Korea||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3830621|NCT01710358|3657231|B4|Japan||Region of Enrollment||Participants|Count of Participants|249|249.0||||||
3830622|NCT01710358|3657232|B3|Japan||Region of Enrollment||Participants|Count of Participants|63|63.0||||||
3830623|NCT01710358|3657233|B2|Japan||Region of Enrollment||Participants|Count of Participants|93|93.0||||||
3830624|NCT01710358|3657234|B1|Japan||Region of Enrollment||Participants|Count of Participants|93|93.0||||||
3830625|NCT01710358|3657231|B4|Hungary||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3830626|NCT01710358|3657232|B3|Hungary||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3830627|NCT01710358|3657233|B2|Hungary||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3830628|NCT01710358|3657234|B1|Hungary||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3830629|NCT01710358|3657231|B4|Greece||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3830630|NCT01710358|3657232|B3|Greece||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3830631|NCT01710358|3657233|B2|Greece||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3830632|NCT01710358|3657234|B1|Greece||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3830633|NCT01710358|3657231|B4|Germany||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3830634|NCT01710358|3657232|B3|Germany||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3830635|NCT01710358|3657233|B2|Germany||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3830636|NCT01710358|3657234|B1|Germany||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3830637|NCT01710358|3657231|B4|France||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3830638|NCT01710358|3657232|B3|France||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3830639|NCT01710358|3657233|B2|France||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3830640|NCT01710358|3657234|B1|France||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3830641|NCT01710358|3657231|B4|Czechia||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3830642|NCT01710358|3657232|B3|Czechia||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3830643|NCT01710358|3657233|B2|Czechia||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3830644|NCT01710358|3657234|B1|Czechia||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3830645|NCT01710358|3657231|B4|Croatia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3830646|NCT01710358|3657232|B3|Croatia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3830647|NCT01710358|3657233|B2|Croatia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3830648|NCT01710358|3657234|B1|Croatia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3830649|NCT01710358|3657231|B4|China||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
3830650|NCT01710358|3657232|B3|China||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3830651|NCT01710358|3657233|B2|China||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3830652|NCT01710358|3657234|B1|China||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3830653|NCT01710358|3657231|B4|Canada||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3830654|NCT01710358|3657232|B3|Canada||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3830655|NCT01710358|3657233|B2|Canada||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3830656|NCT01710358|3657234|B1|Canada||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3830657|NCT01710358|3657231|B4|Belgium||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3830658|NCT01710358|3657232|B3|Belgium||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3830659|NCT01710358|3657233|B2|Belgium||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3830660|NCT01710358|3657234|B1|Belgium||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3830661|NCT01710358|3657231|B4|Argentina||Region of Enrollment||Participants|Count of Participants|255|255.0||||||
3830662|NCT01710358|3657232|B3|Argentina||Region of Enrollment||Participants|Count of Participants|57|57.0||||||
3830663|NCT01710358|3657233|B2|Argentina||Region of Enrollment||Participants|Count of Participants|107|107.0||||||
3830664|NCT01710358|3657234|B1|Argentina||Region of Enrollment||Participants|Count of Participants|91|91.0||||||
3830665|NCT01710358|3657231|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3830666|NCT01710358|3657232|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830667|NCT01710358|3657233|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830668|NCT01710358|3657234|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3830669|NCT01710358|3657231|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3830670|NCT01710358|3657232|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3830671|NCT01710358|3657233|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3830672|NCT01710358|3657234|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3830673|NCT01710358|3657231|B4||White|Race (NIH/OMB)||Participants|Count of Participants|818|818.0||||||
3830674|NCT01710358|3657232|B3||White|Race (NIH/OMB)||Participants|Count of Participants|204|204.0||||||
3830675|NCT01710358|3657233|B2||White|Race (NIH/OMB)||Participants|Count of Participants|312|312.0||||||
3830676|NCT01710358|3657234|B1||White|Race (NIH/OMB)||Participants|Count of Participants|302|302.0||||||
3830677|NCT01710358|3657231|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3830678|NCT01710358|3657232|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3830679|NCT01710358|3657233|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3830680|NCT01710358|3657234|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3830681|NCT01710358|3657231|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830682|NCT01710358|3657232|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830683|NCT01710358|3657233|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830684|NCT01710358|3657234|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830685|NCT01710358|3657231|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|392|392.0||||||
3830686|NCT01710358|3657232|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
3830687|NCT01710358|3657233|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|143|143.0||||||
3830688|NCT01710358|3657234|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|148|148.0||||||
3830689|NCT01710358|3657231|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3830690|NCT01710358|3657232|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3830691|NCT01710358|3657233|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3830692|NCT01710358|3657234|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3830693|NCT01710358|3657231|B4||Male|Sex: Female, Male||Participants|Count of Participants|297|297.0||||||
3830694|NCT01710358|3657232|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3830695|NCT01710358|3657233|B2||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3830696|NCT01710358|3657234|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3830697|NCT01710358|3657231|B4||Female|Sex: Female, Male||Participants|Count of Participants|1008|1008.0||||||
3830698|NCT01710358|3657232|B3||Female|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
3830699|NCT01710358|3657233|B2||Female|Sex: Female, Male||Participants|Count of Participants|375|375.0||||||
3830700|NCT01710358|3657234|B1||Female|Sex: Female, Male||Participants|Count of Participants|382|382.0||||||
3830701|NCT01710358|3657231|B4|||Age||years|Mean|53.3|53.3|Standard Deviation|12.1|12.1|||
3830702|NCT01710358|3657232|B3|||Age||years|Mean|52.9|52.9|Standard Deviation|12.3|12.3|||
3830703|NCT01710358|3657233|B2|||Age||years|Mean|53.5|53.5|Standard Deviation|12.2|12.2|||
3830704|NCT01710358|3657234|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|11.8|11.8|||
3830705|NCT01710345|3657304|B4|United States||Region of Enrollment||participants|Number|100|100.0||||||
3830706|NCT01710345|3657305|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3830707|NCT01710345|3657306|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
3830708|NCT01710345|3657307|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3830709|NCT01710345|3657304|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830710|NCT01710345|3657305|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830711|NCT01710345|3657306|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830712|NCT01710345|3657307|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830713|NCT01710345|3657304|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3830714|NCT01710345|3657305|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3830715|NCT01710345|3657306|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3830716|NCT01710345|3657307|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3830717|NCT01710345|3657304|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3830718|NCT01710345|3657305|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3830719|NCT01710345|3657306|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3830720|NCT01710345|3657307|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3830721|NCT01710345|3657304|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830722|NCT01710345|3657305|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830723|NCT01710345|3657306|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830724|NCT01710345|3657307|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830725|NCT01710345|3657304|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830726|NCT01710345|3657305|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830727|NCT01710345|3657306|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830728|NCT01710345|3657307|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830729|NCT01710345|3657304|B4||White|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3830730|NCT01710345|3657305|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3830731|NCT01710345|3657306|B2||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3830732|NCT01710345|3657307|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3830733|NCT01710345|3657304|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3830734|NCT01710345|3657305|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3830735|NCT01710345|3657306|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3830736|NCT01710345|3657307|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3830737|NCT01710345|3657304|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3830738|NCT01710345|3657305|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830739|NCT01710345|3657306|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3830740|NCT01710345|3657307|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830741|NCT01710345|3657304|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3830742|NCT01710345|3657305|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3830743|NCT01710345|3657306|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3830744|NCT01710345|3657307|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3830745|NCT01710345|3657304|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3830746|NCT01710345|3657305|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830747|NCT01710345|3657306|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830748|NCT01710345|3657307|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3830749|NCT01710345|3657304|B4||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3830750|NCT01710345|3657305|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3830751|NCT01710345|3657306|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3830752|NCT01710345|3657307|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3830753|NCT01710345|3657304|B4||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3830754|NCT01710345|3657305|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3830755|NCT01710345|3657306|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3830756|NCT01710345|3657307|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3830757|NCT01710345|3657304|B4||>=65 years|Age|Patients must be at least 18 and no more than 80 years of age|Participants|Count of Participants|4|4.0||||||
3830758|NCT01710345|3657305|B3||>=65 years|Age|Patients must be at least 18 and no more than 80 years of age|Participants|Count of Participants|1|1.0||||||
3830759|NCT01710345|3657306|B2||>=65 years|Age|Patients must be at least 18 and no more than 80 years of age|Participants|Count of Participants|2|2.0||||||
3830760|NCT01710345|3657307|B1||>=65 years|Age|Patients must be at least 18 and no more than 80 years of age|Participants|Count of Participants|1|1.0||||||
3830761|NCT01710345|3657304|B4||Between 18 and 65 years|Age|Patients must be at least 18 and no more than 80 years of age|Participants|Count of Participants|96|96.0||||||
3830762|NCT01710345|3657305|B3||Between 18 and 65 years|Age|Patients must be at least 18 and no more than 80 years of age|Participants|Count of Participants|19|19.0||||||
3830763|NCT01710345|3657306|B2||Between 18 and 65 years|Age|Patients must be at least 18 and no more than 80 years of age|Participants|Count of Participants|38|38.0||||||
3830764|NCT01710345|3657307|B1||Between 18 and 65 years|Age|Patients must be at least 18 and no more than 80 years of age|Participants|Count of Participants|39|39.0||||||
3830765|NCT01710345|3657304|B4||<=18 years|Age|Patients must be at least 18 and no more than 80 years of age|Participants|Count of Participants|0|0.0||||||
3830766|NCT01710345|3657305|B3||<=18 years|Age|Patients must be at least 18 and no more than 80 years of age|Participants|Count of Participants|0|0.0||||||
3830767|NCT01710345|3657306|B2||<=18 years|Age|Patients must be at least 18 and no more than 80 years of age|Participants|Count of Participants|0|0.0||||||
3830768|NCT01710345|3657307|B1||<=18 years|Age|Patients must be at least 18 and no more than 80 years of age|Participants|Count of Participants|0|0.0||||||
3830769|NCT01710332|3657317|B3|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3830770|NCT01710332|3657318|B2|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3830771|NCT01710332|3657319|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3830772|NCT01710332|3657317|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3830773|NCT01710332|3657318|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3830774|NCT01710332|3657319|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3830775|NCT01710332|3657317|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3830776|NCT01710332|3657318|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3830777|NCT01710332|3657319|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3830778|NCT01710332|3657317|B3|||Age||years|Mean|53.7|53.7|Standard Deviation|10.8|10.8|||
3830779|NCT01710332|3657318|B2|||Age||years|Mean|53.5|53.5|Standard Deviation|9.6|9.6|||
3830780|NCT01710332|3657319|B1|||Age||years|Mean|53.8|53.8|Standard Deviation|12.8|12.8|||
3830781|NCT01710332|3657317|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3830782|NCT01710332|3657318|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3830783|NCT01710332|3657319|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3830784|NCT01710332|3657317|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3830785|NCT01710332|3657318|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3830786|NCT01710332|3657319|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3830787|NCT01710332|3657317|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3830788|NCT01710332|3657318|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3830789|NCT01710332|3657319|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3830790|NCT01710254|3657328|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3830791|NCT01710254|3657328|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3830792|NCT01710254|3657328|B1|||Age||years|Mean|67|67.0|Standard Deviation|13.6|13.6|||
3830793|NCT01710254|3657328|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3830794|NCT01710254|3657328|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3830795|NCT01710254|3657328|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3830796|NCT01710046|3657334|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3830797|NCT01710046|3657335|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3830798|NCT01710046|3657336|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3830799|NCT01710046|3657334|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3830800|NCT01710046|3657335|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3830801|NCT01710046|3657336|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3830802|NCT01710046|3657334|B3|||Age||Years|Mean|45.6|45.6|Standard Deviation|13.3|13.3|||
3830803|NCT01710046|3657335|B2|||Age||Years|Mean|46.7|46.7|Standard Deviation|21.5|21.5|||
3830804|NCT01710046|3657336|B1|||Age||Years|Mean|45.2|45.2|Standard Deviation|11.3|11.3|||
3830805|NCT01710033|3657373|B5||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3830806|NCT01710033|3657374|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3830807|NCT01710033|3657375|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3830808|NCT01710033|3657376|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3830809|NCT01710033|3657377|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3830810|NCT01710033|3657373|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3830811|NCT01710033|3657374|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3830812|NCT01710033|3657375|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3830813|NCT01710033|3657376|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3830814|NCT01710033|3657377|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3830815|NCT01710033|3657373|B5|||Age||years|Mean|52.3|52.3|Standard Deviation|15.0|15.0|||
3830816|NCT01710033|3657374|B4|||Age||years|Mean|54.2|54.2|Standard Deviation|14.3|14.3|||
3830817|NCT01710033|3657375|B3|||Age||years|Mean|46.0|46.0|Standard Deviation|17.8|17.8|||
3830818|NCT01710033|3657376|B2|||Age||years|Mean|53.0|53.0|Standard Deviation|15.5|15.5|||
3830819|NCT01710033|3657377|B1|||Age||years|Mean|54.5|54.5|Standard Deviation|15.0|15.0|||
3830820|NCT01710020|3657462|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3830821|NCT01710020|3657462|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3830822|NCT01710020|3657462|B1|||Age||years|Mean|45.9|45.9|Standard Deviation|7.9|7.9|||
3830823|NCT01709903|3657479|B3||Unknown or Not Reported|Race (NIH/OMB)|Safety Set|Participants|Count of Participants|2|2.0||||||
3830824|NCT01709903|3657480|B2||Unknown or Not Reported|Race (NIH/OMB)|Safety Set|Participants|Count of Participants|0|0.0||||||
3830825|NCT01709903|3657481|B1||Unknown or Not Reported|Race (NIH/OMB)|Safety Set|Participants|Count of Participants|2|2.0||||||
3830826|NCT01709903|3657479|B3||More than one race|Race (NIH/OMB)|Safety Set|Participants|Count of Participants|0|0.0||||||
3830827|NCT01709903|3657480|B2||More than one race|Race (NIH/OMB)|Safety Set|Participants|Count of Participants|0|0.0||||||
3830828|NCT01709903|3657481|B1||More than one race|Race (NIH/OMB)|Safety Set|Participants|Count of Participants|0|0.0||||||
3830829|NCT01709903|3657479|B3||White|Race (NIH/OMB)|Safety Set|Participants|Count of Participants|113|113.0||||||
3830830|NCT01709903|3657480|B2||White|Race (NIH/OMB)|Safety Set|Participants|Count of Participants|58|58.0||||||
3830831|NCT01709903|3657481|B1||White|Race (NIH/OMB)|Safety Set|Participants|Count of Participants|55|55.0||||||
3830832|NCT01709903|3657479|B3||Black or African American|Race (NIH/OMB)|Safety Set|Participants|Count of Participants|0|0.0||||||
3830833|NCT01709903|3657480|B2||Black or African American|Race (NIH/OMB)|Safety Set|Participants|Count of Participants|0|0.0||||||
3830834|NCT01709903|3657481|B1||Black or African American|Race (NIH/OMB)|Safety Set|Participants|Count of Participants|0|0.0||||||
3830835|NCT01709903|3657479|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Safety Set|Participants|Count of Participants|0|0.0||||||
3830836|NCT01709903|3657480|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Safety Set|Participants|Count of Participants|0|0.0||||||
3830837|NCT01709903|3657481|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Safety Set|Participants|Count of Participants|0|0.0||||||
3830838|NCT01709903|3657479|B3||Asian|Race (NIH/OMB)|Safety Set|Participants|Count of Participants|623|623.0||||||
3830839|NCT01709903|3657480|B2||Asian|Race (NIH/OMB)|Safety Set|Participants|Count of Participants|309|309.0||||||
3830840|NCT01709903|3657481|B1||Asian|Race (NIH/OMB)|Safety Set|Participants|Count of Participants|314|314.0||||||
3830841|NCT01709903|3657479|B3||American Indian or Alaska Native|Race (NIH/OMB)|Safety Set|Participants|Count of Participants|3|3.0||||||
3830842|NCT01709903|3657480|B2||American Indian or Alaska Native|Race (NIH/OMB)|Safety Set|Participants|Count of Participants|2|2.0||||||
3830843|NCT01709903|3657481|B1||American Indian or Alaska Native|Race (NIH/OMB)|Safety Set|Participants|Count of Participants|1|1.0||||||
3830844|NCT01709903|3657479|B3||Male|Sex: Female, Male|Safety Set|Participants|Count of Participants|672|672.0||||||
3830845|NCT01709903|3657480|B2||Male|Sex: Female, Male|Safety Set|Participants|Count of Participants|331|331.0||||||
3830846|NCT01709903|3657481|B1||Male|Sex: Female, Male|Safety Set|Participants|Count of Participants|341|341.0||||||
3830847|NCT01709903|3657479|B3||Female|Sex: Female, Male|Safety Set|Participants|Count of Participants|69|69.0||||||
3830848|NCT01709903|3657480|B2||Female|Sex: Female, Male|Safety Set|Participants|Count of Participants|38|38.0||||||
3830849|NCT01709903|3657481|B1||Female|Sex: Female, Male|Safety Set|Participants|Count of Participants|31|31.0||||||
3830850|NCT01709903|3657479|B3|||Age|Safety Set|years|Mean|65.0|65.0|Standard Deviation|7.87|7.87|||
3830851|NCT01709903|3657480|B2|||Age|Safety Set|years|Mean|65.3|65.3|Standard Deviation|7.91|7.91|||
3830852|NCT01709903|3657481|B1|||Age|Safety Set|years|Mean|64.8|64.8|Standard Deviation|7.82|7.82|||
3830853|NCT01709864|3657504|B3||Male|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
3830854|NCT01709864|3657505|B2||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3830855|NCT01709864|3657506|B1||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3830856|NCT01709864|3657504|B3||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
3830857|NCT01709864|3657505|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3830858|NCT01709864|3657506|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3830859|NCT01709864|3657504|B3|||Age||years|Mean|62.4|62.4|Standard Deviation|8.34|8.34|||
3830860|NCT01709864|3657505|B2|||Age||years|Mean|62.1|62.1|Standard Deviation|8.34|8.34|||
3830861|NCT01709864|3657506|B1|||Age||years|Mean|62.7|62.7|Standard Deviation|8.36|8.36|||
3830862|NCT01709799|3657541|B4|United States||Region of Enrollment||participants|Number|64|64.0||||||
3830863|NCT01709799|3657542|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
3830864|NCT01709799|3657543|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
3830865|NCT01709799|3657544|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3830866|NCT01709799|3657541|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3830867|NCT01709799|3657542|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3830868|NCT01709799|3657543|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3830869|NCT01709799|3657544|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3830870|NCT01709799|3657541|B4||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3830871|NCT01709799|3657542|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3830872|NCT01709799|3657543|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3830873|NCT01709799|3657544|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3830874|NCT01709799|3657541|B4|||Age||years|Mean|78.8133|78.8133|Full Range|||60.0|93.0|
3830875|NCT01709799|3657542|B3|||Age||years|Mean|77.2778|77.2778|Full Range|||65.0|88.0|
3830876|NCT01709799|3657543|B2|||Age||years|Mean|78.1905|78.1905|Full Range|||60.0|89.0|
3830877|NCT01709799|3657544|B1|||Age||years|Mean|79.6400|79.64|Full Range|||62.0|93.0|
3830878|NCT01709799|3657541|B4||>=65 years|Age||Participants|Count of Participants|61|61.0||||||
3830879|NCT01709799|3657542|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3830880|NCT01709799|3657543|B2||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3830881|NCT01709799|3657544|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3830882|NCT01709799|3657541|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3830883|NCT01709799|3657542|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3830884|NCT01709799|3657543|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3830885|NCT01709799|3657544|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3830886|NCT01709799|3657541|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3830887|NCT01709799|3657542|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3830888|NCT01709799|3657543|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3830889|NCT01709799|3657544|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3830890|NCT01709786|3657569|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3830891|NCT01709786|3657569|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3830892|NCT01709786|3657569|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3830893|NCT01709786|3657569|B1||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
3830894|NCT01709786|3657569|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3830895|NCT01709708|3657576|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830896|NCT01709708|3657577|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830897|NCT01709708|3657578|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830898|NCT01709708|3657576|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3830899|NCT01709708|3657577|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830900|NCT01709708|3657578|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3830901|NCT01709708|3657576|B3||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3830902|NCT01709708|3657577|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3830903|NCT01709708|3657578|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3830904|NCT01709708|3657576|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3830905|NCT01709708|3657577|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830906|NCT01709708|3657578|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3830907|NCT01709708|3657576|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830908|NCT01709708|3657577|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830909|NCT01709708|3657578|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830910|NCT01709708|3657576|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830911|NCT01709708|3657577|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830912|NCT01709708|3657578|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830913|NCT01709708|3657576|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830914|NCT01709708|3657577|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830915|NCT01709708|3657578|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3830916|NCT01709708|3657576|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3830917|NCT01709708|3657577|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3830918|NCT01709708|3657578|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3830919|NCT01709708|3657576|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3830920|NCT01709708|3657577|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3830921|NCT01709708|3657578|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3830922|NCT01709708|3657576|B3|||Age||years|Mean|41.30|41.3|Standard Deviation|12.59|12.59|||
3830923|NCT01709708|3657577|B2|||Age||years|Mean|41.97|41.97|Standard Deviation|14.71|14.71|||
3830924|NCT01709708|3657578|B1|||Age||years|Mean|40.96|40.96|Standard Deviation|11.63|11.63|||
3830925|NCT01709695|3657601|B3|||Prior stimulant treatment||Participants|Count of Participants|5|5.0||||||
3830926|NCT01709695|3657602|B2|||Prior stimulant treatment||Participants|Count of Participants|2|2.0||||||
3830927|NCT01709695|3657603|B1|||Prior stimulant treatment||Participants|Count of Participants|3|3.0||||||
3830928|NCT01709695|3657601|B3|||Clinical Global Impressions – Severity scale (CGI-S)|Severity scale (CGI-S) is a 7-point scale that requires the clinician to rate the severity of the patient's symptoms at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis. Considering total clinical experience, a patient is assessed on severity of symptoms at the time of rating 1, normal, not at all ill; 2, minimally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, very servely ill.|units on a scale|Mean|5.2|5.2|Standard Deviation|0.9|0.9|||
3830969|NCT01709513|3657760|B3|||Low Density Lipoprotein Cholesterol (LDL-C) in mg/dL|Calculated LDL-C values were obtained from Friedewald formula.|mg/dL|Mean|191.1|191.1|Standard Deviation|72.7|72.7|||
3830970|NCT01709513|3657761|B2|||Low Density Lipoprotein Cholesterol (LDL-C) in mg/dL|Calculated LDL-C values were obtained from Friedewald formula.|mg/dL|Mean|193.5|193.5|Standard Deviation|70.9|70.9|||
3830929|NCT01709695|3657602|B2|||Clinical Global Impressions – Severity scale (CGI-S)|Severity scale (CGI-S) is a 7-point scale that requires the clinician to rate the severity of the patient's symptoms at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis. Considering total clinical experience, a patient is assessed on severity of symptoms at the time of rating 1, normal, not at all ill; 2, minimally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, very servely ill.|units on a scale|Mean|5.4|5.4|Standard Deviation|0.9|0.9|||
3830930|NCT01709695|3657603|B1|||Clinical Global Impressions – Severity scale (CGI-S)|Severity scale (CGI-S) is a 7-point scale that requires the clinician to rate the severity of the patient's symptoms at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis. Considering total clinical experience, a patient is assessed on severity of symptoms at the time of rating 1, normal, not at all ill; 2, minimally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, very servely ill.|units on a scale|Mean|4.9|4.9|Standard Deviation|1.0|1.0|||
3830931|NCT01709695|3657601|B3|||Comorbid Oppositional Defiant Disorder (ODD)||Participants|Count of Participants|11|11.0||||||
3830932|NCT01709695|3657602|B2|||Comorbid Oppositional Defiant Disorder (ODD)||Participants|Count of Participants|4|4.0||||||
3830933|NCT01709695|3657603|B1|||Comorbid Oppositional Defiant Disorder (ODD)||Participants|Count of Participants|7|7.0||||||
3830934|NCT01709695|3657601|B3|Inattentive||Attention-Deficit/Hyperactivity Disorder (ADHD) subtype||Participants|Count of Participants|8|8.0||||||
3830935|NCT01709695|3657602|B2|Inattentive||Attention-Deficit/Hyperactivity Disorder (ADHD) subtype||Participants|Count of Participants|4|4.0||||||
3830936|NCT01709695|3657603|B1|Inattentive||Attention-Deficit/Hyperactivity Disorder (ADHD) subtype||Participants|Count of Participants|4|4.0||||||
3830937|NCT01709695|3657601|B3|Combined||Attention-Deficit/Hyperactivity Disorder (ADHD) subtype||Participants|Count of Participants|17|17.0||||||
3830938|NCT01709695|3657602|B2|Combined||Attention-Deficit/Hyperactivity Disorder (ADHD) subtype||Participants|Count of Participants|9|9.0||||||
3830939|NCT01709695|3657603|B1|Combined||Attention-Deficit/Hyperactivity Disorder (ADHD) subtype||Participants|Count of Participants|8|8.0||||||
3830940|NCT01709695|3657601|B3|||Full Scale IQ|Full Scale IQ - People who score generally between 70 and 130 are considered to be within the normal range of IQ functioning, where 100 is the theoretical average. Those scoring 130 and above have significantly greater cognitive resources than the average population, and those scoring 70 and below population have significantly fewer cognitive resources.|units on a scale|Mean|105.7|105.7|Standard Deviation|17.75|17.75|||
3830941|NCT01709695|3657602|B2|||Full Scale IQ|Full Scale IQ - People who score generally between 70 and 130 are considered to be within the normal range of IQ functioning, where 100 is the theoretical average. Those scoring 130 and above have significantly greater cognitive resources than the average population, and those scoring 70 and below population have significantly fewer cognitive resources.|units on a scale|Mean|101.8|101.8|Standard Deviation|13.1|13.1|||
3830942|NCT01709695|3657603|B1|||Full Scale IQ|Full Scale IQ - People who score generally between 70 and 130 are considered to be within the normal range of IQ functioning, where 100 is the theoretical average. Those scoring 130 and above have significantly greater cognitive resources than the average population, and those scoring 70 and below population have significantly fewer cognitive resources.|units on a scale|Mean|110.0|110.0|Standard Deviation|21.6|21.6|||
3830943|NCT01709695|3657601|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3830944|NCT01709695|3657602|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3830945|NCT01709695|3657603|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3830946|NCT01709695|3657601|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3830947|NCT01709695|3657602|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3830948|NCT01709695|3657603|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3830949|NCT01709695|3657601|B3|||Age||years|Mean|11.1|11.1|Standard Deviation|2.2|2.2|||
3830950|NCT01709695|3657602|B2|||Age||years|Mean|11.5|11.5|Standard Deviation|2.5|2.5|||
3830951|NCT01709695|3657603|B1|||Age||years|Mean|10.6|10.6|Standard Deviation|1.7|1.7|||
3830952|NCT01709578|3657626|B4||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3830953|NCT01709578|3657627|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3830954|NCT01709578|3657628|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3830955|NCT01709578|3657629|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3830956|NCT01709578|3657626|B4||Female|Sex: Female, Male||Participants|Count of Participants|447|447.0||||||
3830957|NCT01709578|3657627|B3||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3830958|NCT01709578|3657628|B2||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3830959|NCT01709578|3657629|B1||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3830960|NCT01709578|3657626|B4|||Age||years|Mean|52.9|52.9|Standard Deviation|12.4|12.4|||
3830961|NCT01709578|3657627|B3|||Age||years|Mean|52.9|52.9|Standard Deviation|12.9|12.9|||
3830962|NCT01709578|3657628|B2|||Age||years|Mean|54.0|54.0|Standard Deviation|11.7|11.7|||
3830963|NCT01709578|3657629|B1|||Age||years|Mean|51.9|51.9|Standard Deviation|12.4|12.4|||
3830964|NCT01709513|3657759|B4|||LDL-C in mmol/L|Calculated LDL-C values were obtained from Friedewald formula.|mmol/L|Mean|4.954|4.954|Standard Deviation|1.796|1.796|||
3830965|NCT01709513|3657760|B3|||LDL-C in mmol/L|Calculated LDL-C values were obtained from Friedewald formula.|mmol/L|Mean|4.951|4.951|Standard Deviation|1.883|1.883|||
3830966|NCT01709513|3657761|B2|||LDL-C in mmol/L|Calculated LDL-C values were obtained from Friedewald formula.|mmol/L|Mean|5.011|5.011|Standard Deviation|1.837|1.837|||
3830967|NCT01709513|3657762|B1|||LDL-C in mmol/L|Calculated LDL-C values were obtained from Friedewald formula.|mmol/L|Mean|4.85|4.85|Standard Deviation|1.54|1.54|||
3830968|NCT01709513|3657759|B4|||Low Density Lipoprotein Cholesterol (LDL-C) in mg/dL|Calculated LDL-C values were obtained from Friedewald formula.|mg/dL|Mean|191.3|191.3|Standard Deviation|69.3|69.3|||
3830971|NCT01709513|3657762|B1|||Low Density Lipoprotein Cholesterol (LDL-C) in mg/dL|Calculated LDL-C values were obtained from Friedewald formula.|mg/dL|Mean|187.3|187.3|Standard Deviation|59.5|59.5|||
3830972|NCT01709513|3657759|B4||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3830973|NCT01709513|3657760|B3||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3830974|NCT01709513|3657761|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3830975|NCT01709513|3657762|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3830976|NCT01709513|3657759|B4||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3830977|NCT01709513|3657760|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3830978|NCT01709513|3657761|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3830979|NCT01709513|3657762|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3830980|NCT01709513|3657759|B4|||Age||years|Mean|63.4|63.4|Standard Deviation|9.5|9.5|||
3830981|NCT01709513|3657760|B3|||Age||years|Mean|64.1|64.1|Standard Deviation|9.0|9.0|||
3830982|NCT01709513|3657761|B2|||Age||years|Mean|62.8|62.8|Standard Deviation|10.1|10.1|||
3830983|NCT01709513|3657762|B1|||Age||years|Mean|63.4|63.4|Standard Deviation|9.5|9.5|||
3830984|NCT01709500|3657823|B3|||Calculated LDL-C in mg/dL|Calculated LDL-C values were obtained using Friedewald formula.|mg/dL|Mean|134.4|134.4|Standard Deviation|41.1|41.1|||
3830985|NCT01709500|3657824|B2|||Calculated LDL-C in mg/dL|Calculated LDL-C values were obtained using Friedewald formula.|mg/dL|Mean|134.0|134.0|Standard Deviation|41.4|41.4|||
3830986|NCT01709500|3657825|B1|||Calculated LDL-C in mg/dL|Calculated LDL-C values were obtained using Friedewald formula.|mg/dL|Mean|134.6|134.6|Standard Deviation|41.1|41.1|||
3830987|NCT01709500|3657823|B3|||Calculated LDL-C in mmol/L|Calculated LDL-C values were obtained using Friedewald formula.|mmol/L|Mean|3.480|3.48|Standard Deviation|1.065|1.065|||
3830988|NCT01709500|3657824|B2|||Calculated LDL-C in mmol/L|Calculated LDL-C values were obtained using Friedewald formula.|mmol/L|Mean|3.471|3.471|Standard Deviation|1.071|1.071|||
3830989|NCT01709500|3657825|B1|||Calculated LDL-C in mmol/L|Calculated LDL-C values were obtained using Friedewald formula.|mmol/L|Mean|3.485|3.485|Standard Deviation|1.065|1.065|||
3830990|NCT01709500|3657823|B3||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3830991|NCT01709500|3657824|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3830992|NCT01709500|3657825|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3830993|NCT01709500|3657823|B3||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3830994|NCT01709500|3657824|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3830995|NCT01709500|3657825|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3830996|NCT01709500|3657823|B3|||Age||years|Mean|53.2|53.2|Standard Deviation|12.8|12.8|||
3830997|NCT01709500|3657824|B2|||Age||years|Mean|53.2|53.2|Standard Deviation|12.55|12.55|||
3830998|NCT01709500|3657825|B1|||Age||years|Mean|53.2|53.2|Standard Deviation|12.93|12.93|||
3830999|NCT01709474|3657880|B3|||25(OH)D at Screening|25(OH)D is also called vitamin D3. Participants were required to have a screening value of less than 20 ng/mL to be eligible for the study.|ng/mL|Mean|13.2|13.2|Standard Deviation|4.6|4.6|||
3831000|NCT01709474|3657881|B2|||25(OH)D at Screening|25(OH)D is also called vitamin D3. Participants were required to have a screening value of less than 20 ng/mL to be eligible for the study.|ng/mL|Mean|16.1|16.1|Standard Deviation|2.5|2.5|||
3831001|NCT01709474|3657882|B1|||25(OH)D at Screening|25(OH)D is also called vitamin D3. Participants were required to have a screening value of less than 20 ng/mL to be eligible for the study.|ng/mL|Mean|9.3|9.3|Standard Deviation|3.9|3.9|||
3831002|NCT01709474|3657880|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
3831003|NCT01709474|3657881|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3831004|NCT01709474|3657882|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3831005|NCT01709474|3657880|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831006|NCT01709474|3657881|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831007|NCT01709474|3657882|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831008|NCT01709474|3657880|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831009|NCT01709474|3657881|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831010|NCT01709474|3657882|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831011|NCT01709474|3657880|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3831012|NCT01709474|3657881|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831013|NCT01709474|3657882|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3831014|NCT01709474|3657880|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3831015|NCT01709474|3657881|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3831016|NCT01709474|3657882|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3831017|NCT01709474|3657880|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831018|NCT01709474|3657881|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831019|NCT01709474|3657882|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831020|NCT01709474|3657880|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3831021|NCT01709474|3657881|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3831022|NCT01709474|3657882|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3831023|NCT01709474|3657880|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831024|NCT01709474|3657881|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831025|NCT01709474|3657882|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831026|NCT01709474|3657880|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831027|NCT01709474|3657881|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831028|NCT01709474|3657882|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831029|NCT01709474|3657880|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3831030|NCT01709474|3657881|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3831031|NCT01709474|3657882|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3831032|NCT01709474|3657880|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3831033|NCT01709474|3657881|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831034|NCT01709474|3657882|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3831035|NCT01709474|3657880|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3831036|NCT01709474|3657881|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3831037|NCT01709474|3657882|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3831038|NCT01709474|3657880|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3831039|NCT01709474|3657881|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3831040|NCT01709474|3657882|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3831041|NCT01709474|3657880|B3|||Age||years|Mean|14.7|14.7|Standard Deviation|2.7|2.7|||
3831042|NCT01709474|3657881|B2|||Age||years|Mean|13.5|13.5|Standard Deviation|0.6|0.6|||
3831043|NCT01709474|3657882|B1|||Age||years|Mean|16.3|16.3|Standard Deviation|3.8|3.8|||
3831044|NCT01709422|3657891|B3|Thailand||Region of Enrollment||participants|Number|140|140.0||||||
3831045|NCT01709422|3657892|B2|Thailand||Region of Enrollment||participants|Number|70|70.0||||||
3831046|NCT01709422|3657893|B1|Thailand||Region of Enrollment||participants|Number|70|70.0||||||
3831047|NCT01709422|3657891|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3831048|NCT01709422|3657892|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3831049|NCT01709422|3657893|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3831050|NCT01709422|3657891|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3831051|NCT01709422|3657892|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3831052|NCT01709422|3657893|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3831053|NCT01709422|3657891|B3|||Age||years|Mean|58.54|58.54|Standard Deviation|17.11|17.11|||
3831054|NCT01709422|3657892|B2|||Age||years|Mean|61.31|61.31|Standard Deviation|16.52|16.52|||
3831055|NCT01709422|3657893|B1|||Age||years|Mean|55.77|55.77|Standard Deviation|17.35|17.35|||
3831056|NCT01709422|3657891|B3||>=65 years|Age||Participants|Count of Participants|56|56.0||||||
3831057|NCT01709422|3657892|B2||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
3831058|NCT01709422|3657893|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3831059|NCT01709422|3657891|B3||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
3831060|NCT01709422|3657892|B2||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3831061|NCT01709422|3657893|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3831062|NCT01709422|3657891|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3831063|NCT01709422|3657892|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3831064|NCT01709422|3657893|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3831065|NCT01709409|3657902|B3|||fraction of inspired oxygen||% of inspired oxygen|Median|45|45.0|Inter-Quartile Range|||35.0|60.0|
3831066|NCT01709409|3657903|B2|||fraction of inspired oxygen||% of inspired oxygen|Median|45|45.0|Inter-Quartile Range|||35.0|50.0|
3831067|NCT01709409|3657904|B1|||fraction of inspired oxygen||% of inspired oxygen|Median|45|45.0|Inter-Quartile Range|||32.0|65.0|
3831068|NCT01709409|3657902|B3|Canada||Region of Enrollment||participants|Number|87|87.0||||||
3831069|NCT01709409|3657903|B2|Canada||Region of Enrollment||participants|Number|45|45.0||||||
3831070|NCT01709409|3657904|B1|Canada||Region of Enrollment||participants|Number|42|42.0||||||
3831071|NCT01709409|3657902|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3831072|NCT01709409|3657902|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3831073|NCT01709409|3657903|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3831074|NCT01709409|3657904|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3831075|NCT01709409|3657902|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3831076|NCT01709409|3657903|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3831077|NCT01709409|3657904|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3831078|NCT01709409|3657902|B3|||Age||weeks gestational age|Mean|26.7|26.7|Standard Deviation|1.9|1.9|||
3831079|NCT01709409|3657903|B2|||Age||weeks gestational age|Mean|26.9|26.9|Standard Deviation|2.1|2.1|||
3831080|NCT01709409|3657904|B1|||Age||weeks gestational age|Mean|26.5|26.5|Standard Deviation|1.5|1.5|||
3831081|NCT01709383|3657911|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
3831082|NCT01709383|3657912|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3831083|NCT01709383|3657913|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3831084|NCT01709383|3657911|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3831085|NCT01709383|3657912|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3831086|NCT01709383|3657913|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3831087|NCT01709383|3657911|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3831088|NCT01709383|3657912|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3831089|NCT01709383|3657913|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3831090|NCT01709383|3657911|B3|||Age||years|Mean|60.0|60.0|Standard Deviation|10.0|10.0|||
3831091|NCT01709383|3657912|B2|||Age||years|Mean|59.8|59.8|Standard Deviation|8.7|8.7|||
3831092|NCT01709383|3657913|B1|||Age||years|Mean|60.0|60.0|Standard Deviation|10.8|10.8|||
3831093|NCT01709331|3657932|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3831094|NCT01709331|3657932|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3831095|NCT01709331|3657932|B1|||Age||Years|Mean|31.5|31.5|Standard Deviation|8.8|8.8|||
3831096|NCT01709305|3657938|B1||Male|Sex: Female, Male||Participants|Count of Participants|3295|3295.0||||||
3831097|NCT01709305|3657938|B1||Female|Sex: Female, Male||Participants|Count of Participants|2240|2240.0||||||
3831098|NCT01709305|3657938|B1|||Age||Years|Mean|53.1|53.1|Standard Deviation|9.9|9.9|||
3831099|NCT01709227|3657977|B3|||Baseline Creatinine (mg/dL)||mg/dl|Median|0.4|0.4|Inter-Quartile Range|||0.34|0.5|
3831100|NCT01709227|3657978|B2|||Baseline Creatinine (mg/dL)||mg/dl|Median|0.4|0.4|Inter-Quartile Range|||0.34|0.53|
3831101|NCT01709227|3657979|B1|||Baseline Creatinine (mg/dL)||mg/dl|Median|0.4|0.4|Inter-Quartile Range|||0.36|0.5|
3831102|NCT01709227|3657977|B3|||Length (cm)||cm|Median|50|50.0|Inter-Quartile Range|||47.0|52.0|
3831103|NCT01709227|3657978|B2|||Length (cm)||cm|Median|50|50.0|Inter-Quartile Range|||47.0|52.0|
3831104|NCT01709227|3657979|B1|||Length (cm)||cm|Median|50|50.0|Inter-Quartile Range|||47.0|53.0|
3831105|NCT01709227|3657977|B3|||Weight (kg)||kg|Median|3.4|3.4|Inter-Quartile Range|||3.0|3.8|
3831106|NCT01709227|3657978|B2|||Weight (kg)||kg|Median|3.4|3.4|Inter-Quartile Range|||3.0|3.8|
3831107|NCT01709227|3657979|B1|||Weight (kg)||kg|Median|3.4|3.4|Inter-Quartile Range|||3.0|3.8|
3831108|NCT01709227|3657977|B3|United States||Region of Enrollment||participants|Number|73|73.0||||||
3831109|NCT01709227|3657978|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
3831110|NCT01709227|3657979|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
3831111|NCT01709227|3657977|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3831112|NCT01709227|3657978|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3831113|NCT01709227|3657979|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831114|NCT01709227|3657977|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831115|NCT01709227|3657978|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831116|NCT01709227|3657979|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831117|NCT01709227|3657977|B3||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3831118|NCT01709227|3657978|B2||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3831119|NCT01709227|3657979|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3831120|NCT01709227|3657977|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3831121|NCT01709227|3657978|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3831122|NCT01709227|3657979|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3831123|NCT01709227|3657977|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831124|NCT01709227|3657978|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831125|NCT01709227|3657979|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831126|NCT01709227|3657977|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3831127|NCT01709227|3657978|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831128|NCT01709227|3657979|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3831129|NCT01709227|3657977|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831130|NCT01709227|3657978|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831131|NCT01709227|3657979|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831132|NCT01709227|3657977|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831133|NCT01709227|3657978|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831134|NCT01709227|3657979|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831135|NCT01709227|3657977|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3831136|NCT01709227|3657978|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3831137|NCT01709227|3657979|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3831138|NCT01709227|3657977|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3831139|NCT01709227|3657978|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3831140|NCT01709227|3657979|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3831141|NCT01709227|3657977|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3831142|NCT01709227|3657978|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3831143|NCT01709227|3657979|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3831144|NCT01709227|3657977|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3831145|NCT01709227|3657978|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3831146|NCT01709227|3657979|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3831147|NCT01709227|3657977|B3|||Age||days|Median|8|8.0|Inter-Quartile Range|||6.0|14.0|
3831148|NCT01709227|3657978|B2|||Age||days|Median|8|8.0|Inter-Quartile Range|||6.0|15.0|
3831149|NCT01709227|3657979|B1|||Age||days|Median|9|9.0|Inter-Quartile Range|||7.0|14.0|
3831150|NCT01709162|3658004|B3|Stable disease||Objective Response to Prior Ipilimumab Treatment|Tumors assessed per Response Evaluation Criteria In Solid Tumors Criteria for target lesions: Complete response (CR)=disappearance of all target lesions. Partial response (PR)=30% or greater decrease in sum of the longest diameter (LD) of target lesions. Progressive disease (PD)=a 20% or greater increase in sum of the LD of all target lesions, taking as reference the smallest sum LD recorded at or following baseline. Stable disease=neither sufficient increase to qualify for PD nor sufficient shrinkage to qualify for PR. Objective response=number of patients with best response of CR or PR.|Participants|Number|17|17.0||||||
3831151|NCT01709162|3658005|B2|Stable disease||Objective Response to Prior Ipilimumab Treatment|Tumors assessed per Response Evaluation Criteria In Solid Tumors Criteria for target lesions: Complete response (CR)=disappearance of all target lesions. Partial response (PR)=30% or greater decrease in sum of the longest diameter (LD) of target lesions. Progressive disease (PD)=a 20% or greater increase in sum of the LD of all target lesions, taking as reference the smallest sum LD recorded at or following baseline. Stable disease=neither sufficient increase to qualify for PD nor sufficient shrinkage to qualify for PR. Objective response=number of patients with best response of CR or PR.|Participants|Number|5|5.0||||||
3831152|NCT01709162|3658006|B1|Stable disease||Objective Response to Prior Ipilimumab Treatment|Tumors assessed per Response Evaluation Criteria In Solid Tumors Criteria for target lesions: Complete response (CR)=disappearance of all target lesions. Partial response (PR)=30% or greater decrease in sum of the longest diameter (LD) of target lesions. Progressive disease (PD)=a 20% or greater increase in sum of the LD of all target lesions, taking as reference the smallest sum LD recorded at or following baseline. Stable disease=neither sufficient increase to qualify for PD nor sufficient shrinkage to qualify for PR. Objective response=number of patients with best response of CR or PR.|Participants|Number|12|12.0||||||
3831153|NCT01709162|3658004|B3|Complete response/Partial response||Objective Response to Prior Ipilimumab Treatment|Tumors assessed per Response Evaluation Criteria In Solid Tumors Criteria for target lesions: Complete response (CR)=disappearance of all target lesions. Partial response (PR)=30% or greater decrease in sum of the longest diameter (LD) of target lesions. Progressive disease (PD)=a 20% or greater increase in sum of the LD of all target lesions, taking as reference the smallest sum LD recorded at or following baseline. Stable disease=neither sufficient increase to qualify for PD nor sufficient shrinkage to qualify for PR. Objective response=number of patients with best response of CR or PR.|Participants|Number|6|6.0||||||
3831154|NCT01709162|3658005|B2|Complete response/Partial response||Objective Response to Prior Ipilimumab Treatment|Tumors assessed per Response Evaluation Criteria In Solid Tumors Criteria for target lesions: Complete response (CR)=disappearance of all target lesions. Partial response (PR)=30% or greater decrease in sum of the longest diameter (LD) of target lesions. Progressive disease (PD)=a 20% or greater increase in sum of the LD of all target lesions, taking as reference the smallest sum LD recorded at or following baseline. Stable disease=neither sufficient increase to qualify for PD nor sufficient shrinkage to qualify for PR. Objective response=number of patients with best response of CR or PR.|Participants|Number|0|0.0||||||
3831155|NCT01709162|3658006|B1|Complete response/Partial response||Objective Response to Prior Ipilimumab Treatment|Tumors assessed per Response Evaluation Criteria In Solid Tumors Criteria for target lesions: Complete response (CR)=disappearance of all target lesions. Partial response (PR)=30% or greater decrease in sum of the longest diameter (LD) of target lesions. Progressive disease (PD)=a 20% or greater increase in sum of the LD of all target lesions, taking as reference the smallest sum LD recorded at or following baseline. Stable disease=neither sufficient increase to qualify for PD nor sufficient shrinkage to qualify for PR. Objective response=number of patients with best response of CR or PR.|Participants|Number|6|6.0||||||
3831156|NCT01709162|3658004|B3|Stage IV||Disease Stage at Study Entry|By the American Joint Committee on Cancer staging: Stage 1=no spread to lymph nodes/organs, <1 mm thick and not ulcerated (1A) or <1 mm thick and ulcerated or 1–2 mm thick and not ulcerated (1B). Stage 2=no spread to lymph nodes (LN) or other organs, 1–2 mm thick and ulcerated or 2–4 mm thick and not ulcerated (2A) or 2–4 mm thick and ulcerated or >4 mm thick and not ulcerated (2B), or >4 mm thick and ulcerated (2C). Stage 3 (A,B,C)=any thickness, ulcerated or not, and spread to nearby LN or nearby tissue but not LN. Stage 4=spread to LN, other organs, or areas far from original tumor site.|Participants|Number|21|21.0||||||
3831157|NCT01709162|3658005|B2|Stage IV||Disease Stage at Study Entry|By the American Joint Committee on Cancer staging: Stage 1=no spread to lymph nodes/organs, <1 mm thick and not ulcerated (1A) or <1 mm thick and ulcerated or 1–2 mm thick and not ulcerated (1B). Stage 2=no spread to lymph nodes (LN) or other organs, 1–2 mm thick and ulcerated or 2–4 mm thick and not ulcerated (2A) or 2–4 mm thick and ulcerated or >4 mm thick and not ulcerated (2B), or >4 mm thick and ulcerated (2C). Stage 3 (A,B,C)=any thickness, ulcerated or not, and spread to nearby LN or nearby tissue but not LN. Stage 4=spread to LN, other organs, or areas far from original tumor site.|Participants|Number|4|4.0||||||
3831158|NCT01709162|3658006|B1|Stage IV||Disease Stage at Study Entry|By the American Joint Committee on Cancer staging: Stage 1=no spread to lymph nodes/organs, <1 mm thick and not ulcerated (1A) or <1 mm thick and ulcerated or 1–2 mm thick and not ulcerated (1B). Stage 2=no spread to lymph nodes (LN) or other organs, 1–2 mm thick and ulcerated or 2–4 mm thick and not ulcerated (2A) or 2–4 mm thick and ulcerated or >4 mm thick and not ulcerated (2B), or >4 mm thick and ulcerated (2C). Stage 3 (A,B,C)=any thickness, ulcerated or not, and spread to nearby LN or nearby tissue but not LN. Stage 4=spread to LN, other organs, or areas far from original tumor site.|Participants|Number|17|17.0||||||
3831237|NCT01709110|3658027|B2|Belgium||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3831159|NCT01709162|3658004|B3|Stage III||Disease Stage at Study Entry|By the American Joint Committee on Cancer staging: Stage 1=no spread to lymph nodes/organs, <1 mm thick and not ulcerated (1A) or <1 mm thick and ulcerated or 1–2 mm thick and not ulcerated (1B). Stage 2=no spread to lymph nodes (LN) or other organs, 1–2 mm thick and ulcerated or 2–4 mm thick and not ulcerated (2A) or 2–4 mm thick and ulcerated or >4 mm thick and not ulcerated (2B), or >4 mm thick and ulcerated (2C). Stage 3 (A,B,C)=any thickness, ulcerated or not, and spread to nearby LN or nearby tissue but not LN. Stage 4=spread to LN, other organs, or areas far from original tumor site.|Participants|Number|2|2.0||||||
3831160|NCT01709162|3658005|B2|Stage III||Disease Stage at Study Entry|By the American Joint Committee on Cancer staging: Stage 1=no spread to lymph nodes/organs, <1 mm thick and not ulcerated (1A) or <1 mm thick and ulcerated or 1–2 mm thick and not ulcerated (1B). Stage 2=no spread to lymph nodes (LN) or other organs, 1–2 mm thick and ulcerated or 2–4 mm thick and not ulcerated (2A) or 2–4 mm thick and ulcerated or >4 mm thick and not ulcerated (2B), or >4 mm thick and ulcerated (2C). Stage 3 (A,B,C)=any thickness, ulcerated or not, and spread to nearby LN or nearby tissue but not LN. Stage 4=spread to LN, other organs, or areas far from original tumor site.|Participants|Number|1|1.0||||||
3831161|NCT01709162|3658006|B1|Stage III||Disease Stage at Study Entry|By the American Joint Committee on Cancer staging: Stage 1=no spread to lymph nodes/organs, <1 mm thick and not ulcerated (1A) or <1 mm thick and ulcerated or 1–2 mm thick and not ulcerated (1B). Stage 2=no spread to lymph nodes (LN) or other organs, 1–2 mm thick and ulcerated or 2–4 mm thick and not ulcerated (2A) or 2–4 mm thick and ulcerated or >4 mm thick and not ulcerated (2B), or >4 mm thick and ulcerated (2C). Stage 3 (A,B,C)=any thickness, ulcerated or not, and spread to nearby LN or nearby tissue but not LN. Stage 4=spread to LN, other organs, or areas far from original tumor site.|Participants|Number|1|1.0||||||
3831162|NCT01709162|3658004|B3|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|5|5.0||||||
3831163|NCT01709162|3658005|B2|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|0|0.0||||||
3831164|NCT01709162|3658006|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|5|5.0||||||
3831165|NCT01709162|3658004|B3|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|18|18.0||||||
3831166|NCT01709162|3658005|B2|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|5|5.0||||||
3831167|NCT01709162|3658006|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|13|13.0||||||
3831168|NCT01709162|3658004|B3|White||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
3831169|NCT01709162|3658005|B2|White||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3831170|NCT01709162|3658006|B1|White||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
3831171|NCT01709162|3658004|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3831172|NCT01709162|3658005|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3831173|NCT01709162|3658006|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3831174|NCT01709162|3658004|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3831175|NCT01709162|3658005|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3831176|NCT01709162|3658006|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3831177|NCT01709162|3658004|B3|||Age||Years|Mean|62.7|62.7|Standard Deviation|10.20|10.2|||
3831178|NCT01709162|3658005|B2|||Age||Years|Mean|64.2|64.2|Standard Deviation|4.32|4.32|||
3831179|NCT01709162|3658006|B1|||Age||Years|Mean|62.3|62.3|Standard Deviation|11.38|11.38|||
3831180|NCT01709136|3658019|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3831181|NCT01709136|3658019|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3831182|NCT01709136|3658019|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3831183|NCT01709136|3658019|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3831184|NCT01709136|3658019|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3831185|NCT01709110|3658026|B3|5 or More Fractures||Vertebral Fracture Status|(according to Bioclinica spine x-ray central assessment at baseline).|Participants|Count of Participants|208|208.0||||||
3831186|NCT01709110|3658027|B2|5 or More Fractures||Vertebral Fracture Status|(according to Bioclinica spine x-ray central assessment at baseline).|Participants|Count of Participants|102|102.0||||||
3831187|NCT01709110|3658028|B1|5 or More Fractures||Vertebral Fracture Status|(according to Bioclinica spine x-ray central assessment at baseline).|Participants|Count of Participants|106|106.0||||||
3831188|NCT01709110|3658026|B3|4 Fractures||Vertebral Fracture Status|(according to Bioclinica spine x-ray central assessment at baseline).|Participants|Count of Participants|122|122.0||||||
3831189|NCT01709110|3658027|B2|4 Fractures||Vertebral Fracture Status|(according to Bioclinica spine x-ray central assessment at baseline).|Participants|Count of Participants|62|62.0||||||
3831190|NCT01709110|3658028|B1|4 Fractures||Vertebral Fracture Status|(according to Bioclinica spine x-ray central assessment at baseline).|Participants|Count of Participants|60|60.0||||||
3831191|NCT01709110|3658026|B3|3 Fractures||Vertebral Fracture Status|(according to Bioclinica spine x-ray central assessment at baseline).|Participants|Count of Participants|205|205.0||||||
3831192|NCT01709110|3658027|B2|3 Fractures||Vertebral Fracture Status|(according to Bioclinica spine x-ray central assessment at baseline).|Participants|Count of Participants|101|101.0||||||
3831193|NCT01709110|3658028|B1|3 Fractures||Vertebral Fracture Status|(according to Bioclinica spine x-ray central assessment at baseline).|Participants|Count of Participants|104|104.0||||||
3831194|NCT01709110|3658026|B3|2 Fractures||Vertebral Fracture Status|(according to Bioclinica spine x-ray central assessment at baseline).|Participants|Count of Participants|352|352.0||||||
3831195|NCT01709110|3658027|B2|2 Fractures||Vertebral Fracture Status|(according to Bioclinica spine x-ray central assessment at baseline).|Participants|Count of Participants|174|174.0||||||
3831196|NCT01709110|3658028|B1|2 Fractures||Vertebral Fracture Status|(according to Bioclinica spine x-ray central assessment at baseline).|Participants|Count of Participants|178|178.0||||||
3831197|NCT01709110|3658026|B3|1 Fracture||Vertebral Fracture Status|(according to Bioclinica spine x-ray central assessment at baseline).|Participants|Count of Participants|471|471.0||||||
3831198|NCT01709110|3658027|B2|1 Fracture||Vertebral Fracture Status|(according to Bioclinica spine x-ray central assessment at baseline).|Participants|Count of Participants|240|240.0||||||
3831199|NCT01709110|3658028|B1|1 Fracture||Vertebral Fracture Status|(according to Bioclinica spine x-ray central assessment at baseline).|Participants|Count of Participants|231|231.0||||||
3831200|NCT01709110|3658026|B3|Total Hip||Bone Mineral Density (BMD)|Low BMD is defined as an lumbar spine, total hip or femoral neck BMD ≥ 1.5 standard deviation (SD) below the average BMD for young healthy, non-Hispanic, Caucasian women. Lumbar spine, total hip and femoral neck BMD were assessed by DXA by the investigator at baseline.|Gram per square centimeter (g/cm2)|Mean|0.735|0.735|Standard Deviation|0.1116|0.1116|||
3831201|NCT01709110|3658027|B2|Total Hip||Bone Mineral Density (BMD)|Low BMD is defined as an lumbar spine, total hip or femoral neck BMD ≥ 1.5 standard deviation (SD) below the average BMD for young healthy, non-Hispanic, Caucasian women. Lumbar spine, total hip and femoral neck BMD were assessed by DXA by the investigator at baseline.|Gram per square centimeter (g/cm2)|Mean|0.735|0.735|Standard Deviation|0.1165|0.1165|||
3831202|NCT01709110|3658028|B1|Total Hip||Bone Mineral Density (BMD)|Low BMD is defined as an lumbar spine, total hip or femoral neck BMD ≥ 1.5 standard deviation (SD) below the average BMD for young healthy, non-Hispanic, Caucasian women. Lumbar spine, total hip and femoral neck BMD were assessed by DXA by the investigator at baseline.|Gram per square centimeter (g/cm2)|Mean|0.736|0.736|Standard Deviation|0.1065|0.1065|||
3831203|NCT01709110|3658026|B3|Femoral Neck||Bone Mineral Density (BMD)|Low BMD is defined as an lumbar spine, total hip or femoral neck BMD ≥ 1.5 standard deviation (SD) below the average BMD for young healthy, non-Hispanic, Caucasian women. Lumbar spine, total hip and femoral neck BMD were assessed by DXA by the investigator at baseline.|Gram per square centimeter (g/cm2)|Mean|0.664|0.664|Standard Deviation|0.1107|0.1107|||
3831204|NCT01709110|3658027|B2|Femoral Neck||Bone Mineral Density (BMD)|Low BMD is defined as an lumbar spine, total hip or femoral neck BMD ≥ 1.5 standard deviation (SD) below the average BMD for young healthy, non-Hispanic, Caucasian women. Lumbar spine, total hip and femoral neck BMD were assessed by DXA by the investigator at baseline.|Gram per square centimeter (g/cm2)|Mean|0.667|0.667|Standard Deviation|0.1129|0.1129|||
3831205|NCT01709110|3658028|B1|Femoral Neck||Bone Mineral Density (BMD)|Low BMD is defined as an lumbar spine, total hip or femoral neck BMD ≥ 1.5 standard deviation (SD) below the average BMD for young healthy, non-Hispanic, Caucasian women. Lumbar spine, total hip and femoral neck BMD were assessed by DXA by the investigator at baseline.|Gram per square centimeter (g/cm2)|Mean|0.662|0.662|Standard Deviation|0.1085|0.1085|||
3831206|NCT01709110|3658026|B3|Lumbar Spine||Bone Mineral Density (BMD)|Low BMD is defined as an lumbar spine, total hip or femoral neck BMD ≥ 1.5 standard deviation (SD) below the average BMD for young healthy, non-Hispanic, Caucasian women. Lumbar spine, total hip and femoral neck BMD were assessed by DXA by the investigator at baseline.|Gram per square centimeter (g/cm2)|Mean|0.857|0.857|Standard Deviation|0.1506|0.1506|||
3831207|NCT01709110|3658027|B2|Lumbar Spine||Bone Mineral Density (BMD)|Low BMD is defined as an lumbar spine, total hip or femoral neck BMD ≥ 1.5 standard deviation (SD) below the average BMD for young healthy, non-Hispanic, Caucasian women. Lumbar spine, total hip and femoral neck BMD were assessed by DXA by the investigator at baseline.|Gram per square centimeter (g/cm2)|Mean|0.856|0.856|Standard Deviation|0.1473|0.1473|||
3831208|NCT01709110|3658028|B1|Lumbar Spine||Bone Mineral Density (BMD)|Low BMD is defined as an lumbar spine, total hip or femoral neck BMD ≥ 1.5 standard deviation (SD) below the average BMD for young healthy, non-Hispanic, Caucasian women. Lumbar spine, total hip and femoral neck BMD were assessed by DXA by the investigator at baseline.|Gram per square centimeter (g/cm2)|Mean|0.858|0.858|Standard Deviation|0.1541|0.1541|||
3831209|NCT01709110|3658026|B3|Without Vertebral Fracture without Bisphosphonate||Distribution of Stratification Factors|A participant was considered as having a recent clinical vertebral fragility fracture if she had at least one clinical vertebral fragility fracture within the last 12 months prior to baseline. A participant was considered a recent prior bisphosphonate user if she had received a total of 6 or more months of treatment with any oral bisphosphonate within 3 years prior to baseline.|Participants|Count of Participants|491|491.0||||||
3831210|NCT01709110|3658027|B2|Without Vertebral Fracture without Bisphosphonate||Distribution of Stratification Factors|A participant was considered as having a recent clinical vertebral fragility fracture if she had at least one clinical vertebral fragility fracture within the last 12 months prior to baseline. A participant was considered a recent prior bisphosphonate user if she had received a total of 6 or more months of treatment with any oral bisphosphonate within 3 years prior to baseline.|Participants|Count of Participants|247|247.0||||||
3831238|NCT01709110|3658028|B1|Belgium||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
3831239|NCT01709110|3658026|B3|Austria||Region of Enrollment||Participants|Count of Participants|53|53.0||||||
3831240|NCT01709110|3658027|B2|Austria||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3831211|NCT01709110|3658028|B1|Without Vertebral Fracture without Bisphosphonate||Distribution of Stratification Factors|A participant was considered as having a recent clinical vertebral fragility fracture if she had at least one clinical vertebral fragility fracture within the last 12 months prior to baseline. A participant was considered a recent prior bisphosphonate user if she had received a total of 6 or more months of treatment with any oral bisphosphonate within 3 years prior to baseline.|Participants|Count of Participants|244|244.0||||||
3831212|NCT01709110|3658026|B3|Without Vertebral Fracture with Bisphosphonate Use||Distribution of Stratification Factors|A participant was considered as having a recent clinical vertebral fragility fracture if she had at least one clinical vertebral fragility fracture within the last 12 months prior to baseline. A participant was considered a recent prior bisphosphonate user if she had received a total of 6 or more months of treatment with any oral bisphosphonate within 3 years prior to baseline.|Participants|Count of Participants|373|373.0||||||
3831213|NCT01709110|3658027|B2|Without Vertebral Fracture with Bisphosphonate Use||Distribution of Stratification Factors|A participant was considered as having a recent clinical vertebral fragility fracture if she had at least one clinical vertebral fragility fracture within the last 12 months prior to baseline. A participant was considered a recent prior bisphosphonate user if she had received a total of 6 or more months of treatment with any oral bisphosphonate within 3 years prior to baseline.|Participants|Count of Participants|189|189.0||||||
3831214|NCT01709110|3658028|B1|Without Vertebral Fracture with Bisphosphonate Use||Distribution of Stratification Factors|A participant was considered as having a recent clinical vertebral fragility fracture if she had at least one clinical vertebral fragility fracture within the last 12 months prior to baseline. A participant was considered a recent prior bisphosphonate user if she had received a total of 6 or more months of treatment with any oral bisphosphonate within 3 years prior to baseline.|Participants|Count of Participants|184|184.0||||||
3831215|NCT01709110|3658026|B3|With Vertebral Fracture without Bisphosphonate Use||Distribution of Stratification Factors|A participant was considered as having a recent clinical vertebral fragility fracture if she had at least one clinical vertebral fragility fracture within the last 12 months prior to baseline. A participant was considered a recent prior bisphosphonate user if she had received a total of 6 or more months of treatment with any oral bisphosphonate within 3 years prior to baseline.|Participants|Count of Participants|335|335.0||||||
3831216|NCT01709110|3658027|B2|With Vertebral Fracture without Bisphosphonate Use||Distribution of Stratification Factors|A participant was considered as having a recent clinical vertebral fragility fracture if she had at least one clinical vertebral fragility fracture within the last 12 months prior to baseline. A participant was considered a recent prior bisphosphonate user if she had received a total of 6 or more months of treatment with any oral bisphosphonate within 3 years prior to baseline.|Participants|Count of Participants|165|165.0||||||
3831217|NCT01709110|3658028|B1|With Vertebral Fracture without Bisphosphonate Use||Distribution of Stratification Factors|A participant was considered as having a recent clinical vertebral fragility fracture if she had at least one clinical vertebral fragility fracture within the last 12 months prior to baseline. A participant was considered a recent prior bisphosphonate user if she had received a total of 6 or more months of treatment with any oral bisphosphonate within 3 years prior to baseline.|Participants|Count of Participants|170|170.0||||||
3831218|NCT01709110|3658026|B3|Vertebral Fracture with Bisphosphonate Use||Distribution of Stratification Factors|A participant was considered as having a recent clinical vertebral fragility fracture if she had at least one clinical vertebral fragility fracture within the last 12 months prior to baseline. A participant was considered a recent prior bisphosphonate user if she had received a total of 6 or more months of treatment with any oral bisphosphonate within 3 years prior to baseline.|Participants|Count of Participants|161|161.0||||||
3831219|NCT01709110|3658027|B2|Vertebral Fracture with Bisphosphonate Use||Distribution of Stratification Factors|A participant was considered as having a recent clinical vertebral fragility fracture if she had at least one clinical vertebral fragility fracture within the last 12 months prior to baseline. A participant was considered a recent prior bisphosphonate user if she had received a total of 6 or more months of treatment with any oral bisphosphonate within 3 years prior to baseline.|Participants|Count of Participants|79|79.0||||||
3831220|NCT01709110|3658028|B1|Vertebral Fracture with Bisphosphonate Use||Distribution of Stratification Factors|A participant was considered as having a recent clinical vertebral fragility fracture if she had at least one clinical vertebral fragility fracture within the last 12 months prior to baseline. A participant was considered a recent prior bisphosphonate user if she had received a total of 6 or more months of treatment with any oral bisphosphonate within 3 years prior to baseline.|Participants|Count of Participants|82|82.0||||||
3831221|NCT01709110|3658026|B3|Germany||Region of Enrollment||Participants|Count of Participants|67|67.0||||||
3831222|NCT01709110|3658027|B2|Germany||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3831223|NCT01709110|3658028|B1|Germany||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3831224|NCT01709110|3658026|B3|France||Region of Enrollment||Participants|Count of Participants|55|55.0||||||
3831225|NCT01709110|3658027|B2|France||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3831226|NCT01709110|3658028|B1|France||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3831227|NCT01709110|3658026|B3|Italy||Region of Enrollment||Participants|Count of Participants|69|69.0||||||
3831228|NCT01709110|3658027|B2|Italy||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3831229|NCT01709110|3658028|B1|Italy||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3831230|NCT01709110|3658026|B3|Brazil||Region of Enrollment||Participants|Count of Participants|144|144.0||||||
3831231|NCT01709110|3658027|B2|Brazil||Region of Enrollment||Participants|Count of Participants|81|81.0||||||
3831232|NCT01709110|3658028|B1|Brazil||Region of Enrollment||Participants|Count of Participants|63|63.0||||||
3831233|NCT01709110|3658026|B3|Poland||Region of Enrollment||Participants|Count of Participants|118|118.0||||||
3831234|NCT01709110|3658027|B2|Poland||Region of Enrollment||Participants|Count of Participants|63|63.0||||||
3831235|NCT01709110|3658028|B1|Poland||Region of Enrollment||Participants|Count of Participants|55|55.0||||||
3831236|NCT01709110|3658026|B3|Belgium||Region of Enrollment||Participants|Count of Participants|88|88.0||||||
3831241|NCT01709110|3658028|B1|Austria||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3831242|NCT01709110|3658026|B3|Canada||Region of Enrollment||Participants|Count of Participants|69|69.0||||||
3831243|NCT01709110|3658027|B2|Canada||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3831244|NCT01709110|3658028|B1|Canada||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3831245|NCT01709110|3658026|B3|Greece||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3831246|NCT01709110|3658027|B2|Greece||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3831247|NCT01709110|3658028|B1|Greece||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3831248|NCT01709110|3658026|B3|Spain||Region of Enrollment||Participants|Count of Participants|121|121.0||||||
3831249|NCT01709110|3658027|B2|Spain||Region of Enrollment||Participants|Count of Participants|55|55.0||||||
3831250|NCT01709110|3658028|B1|Spain||Region of Enrollment||Participants|Count of Participants|66|66.0||||||
3831251|NCT01709110|3658026|B3|United States||Region of Enrollment||Participants|Count of Participants|122|122.0||||||
3831252|NCT01709110|3658027|B2|United States||Region of Enrollment||Participants|Count of Participants|67|67.0||||||
3831253|NCT01709110|3658028|B1|United States||Region of Enrollment||Participants|Count of Participants|55|55.0||||||
3831254|NCT01709110|3658026|B3|Czech Republic||Region of Enrollment||Participants|Count of Participants|136|136.0||||||
3831255|NCT01709110|3658027|B2|Czech Republic||Region of Enrollment||Participants|Count of Participants|68|68.0||||||
3831256|NCT01709110|3658028|B1|Czech Republic||Region of Enrollment||Participants|Count of Participants|68|68.0||||||
3831257|NCT01709110|3658026|B3|Hungary||Region of Enrollment||Participants|Count of Participants|121|121.0||||||
3831258|NCT01709110|3658027|B2|Hungary||Region of Enrollment||Participants|Count of Participants|53|53.0||||||
3831259|NCT01709110|3658028|B1|Hungary||Region of Enrollment||Participants|Count of Participants|68|68.0||||||
3831260|NCT01709110|3658026|B3|Argentina||Region of Enrollment||Participants|Count of Participants|157|157.0||||||
3831261|NCT01709110|3658027|B2|Argentina||Region of Enrollment||Participants|Count of Participants|78|78.0||||||
3831262|NCT01709110|3658028|B1|Argentina||Region of Enrollment||Participants|Count of Participants|79|79.0||||||
3831263|NCT01709110|3658026|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831264|NCT01709110|3658027|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831265|NCT01709110|3658028|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831266|NCT01709110|3658026|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3831267|NCT01709110|3658027|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3831268|NCT01709110|3658028|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831269|NCT01709110|3658026|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1323|1323.0||||||
3831270|NCT01709110|3658027|B2||White|Race (NIH/OMB)||Participants|Count of Participants|653|653.0||||||
3831271|NCT01709110|3658028|B1||White|Race (NIH/OMB)||Participants|Count of Participants|670|670.0||||||
3831272|NCT01709110|3658026|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3831273|NCT01709110|3658027|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3831274|NCT01709110|3658028|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3831275|NCT01709110|3658026|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831276|NCT01709110|3658027|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831277|NCT01709110|3658028|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831278|NCT01709110|3658026|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3831279|NCT01709110|3658027|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3831280|NCT01709110|3658028|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3831281|NCT01709110|3658026|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3831282|NCT01709110|3658027|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3831283|NCT01709110|3658028|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3831284|NCT01709110|3658026|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|545|545.0||||||
3831285|NCT01709110|3658027|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|279|279.0||||||
3831286|NCT01709110|3658028|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|266|266.0||||||
3831287|NCT01709110|3658026|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|612|612.0||||||
3831288|NCT01709110|3658027|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|302|302.0||||||
3831289|NCT01709110|3658028|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|310|310.0||||||
3831290|NCT01709110|3658026|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|203|203.0||||||
3831291|NCT01709110|3658027|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3831292|NCT01709110|3658028|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
3831293|NCT01709110|3658026|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3831294|NCT01709110|3658027|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3831295|NCT01709110|3658028|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3831296|NCT01709110|3658026|B3||Female|Sex: Female, Male||Participants|Count of Participants|1360|1360.0||||||
3831297|NCT01709110|3658027|B2||Female|Sex: Female, Male||Participants|Count of Participants|680|680.0||||||
3831298|NCT01709110|3658028|B1||Female|Sex: Female, Male||Participants|Count of Participants|680|680.0||||||
3831299|NCT01709110|3658026|B3|||Age||years|Mean|72.1|72.1|Standard Deviation|8.68|8.68|||
3831300|NCT01709110|3658027|B2|||Age||years|Mean|71.6|71.6|Standard Deviation|8.58|8.58|||
3831301|NCT01709110|3658028|B1|||Age||years|Mean|72.6|72.6|Standard Deviation|8.77|8.77|||
3831302|NCT01709084|3658057|B3|UGANDA||Region of Enrollment||participants|Number|125|125.0||||||
3831303|NCT01709084|3658058|B2|UGANDA||Region of Enrollment||participants|Number|65|65.0||||||
3831304|NCT01709084|3658059|B1|UGANDA||Region of Enrollment||participants|Number|60|60.0||||||
3831305|NCT01709084|3658057|B3|THAILAND||Region of Enrollment||participants|Number|109|109.0||||||
3831306|NCT01709084|3658058|B2|THAILAND||Region of Enrollment||participants|Number|58|58.0||||||
3831307|NCT01709084|3658059|B1|THAILAND||Region of Enrollment||participants|Number|51|51.0||||||
3831308|NCT01709084|3658057|B3|SOUTH AFRICA||Region of Enrollment||participants|Number|63|63.0||||||
3831309|NCT01709084|3658058|B2|SOUTH AFRICA||Region of Enrollment||participants|Number|30|30.0||||||
3831310|NCT01709084|3658059|B1|SOUTH AFRICA||Region of Enrollment||participants|Number|33|33.0||||||
3831311|NCT01709084|3658057|B3|SENEGAL||Region of Enrollment||participants|Number|25|25.0||||||
3831312|NCT01709084|3658058|B2|SENEGAL||Region of Enrollment||participants|Number|8|8.0||||||
3831313|NCT01709084|3658059|B1|SENEGAL||Region of Enrollment||participants|Number|17|17.0||||||
3831314|NCT01709084|3658057|B3|KENYA||Region of Enrollment||participants|Number|73|73.0||||||
3831315|NCT01709084|3658058|B2|KENYA||Region of Enrollment||participants|Number|37|37.0||||||
3831316|NCT01709084|3658059|B1|KENYA||Region of Enrollment||participants|Number|36|36.0||||||
3831317|NCT01709084|3658057|B3|CAMEROON||Region of Enrollment||participants|Number|29|29.0||||||
3831318|NCT01709084|3658058|B2|CAMEROON||Region of Enrollment||participants|Number|13|13.0||||||
3831319|NCT01709084|3658059|B1|CAMEROON||Region of Enrollment||participants|Number|16|16.0||||||
3831320|NCT01709084|3658057|B3||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3831321|NCT01709084|3658058|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3831322|NCT01709084|3658059|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3831323|NCT01709084|3658057|B3||Female|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
3831324|NCT01709084|3658058|B2||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3831325|NCT01709084|3658059|B1||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3831326|NCT01709084|3658057|B3|||Age||years|Mean|40.6|40.6|Standard Deviation|8.34|8.34|||
3831327|NCT01709084|3658058|B2|||Age||years|Mean|40.6|40.6|Standard Deviation|8.7|8.7|||
3831328|NCT01709084|3658059|B1|||Age||years|Mean|40.6|40.6|Standard Deviation|8|8.0|||
3831329|NCT01708967|3658076|B3|Korea, Republic of||Region of Enrollment||participants|Number|100|100.0||||||
3831330|NCT01708967|3658077|B2|Korea, Republic of||Region of Enrollment||participants|Number|50|50.0||||||
3831331|NCT01708967|3658078|B1|Korea, Republic of||Region of Enrollment||participants|Number|50|50.0||||||
3831332|NCT01708967|3658076|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3831333|NCT01708967|3658077|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3831334|NCT01708967|3658078|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3831335|NCT01708967|3658076|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3831336|NCT01708967|3658077|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3831337|NCT01708967|3658078|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3831338|NCT01708967|3658076|B3|||Age||years|Mean|59.00|59.0|Standard Deviation|11.5|11.5|||
3831339|NCT01708967|3658077|B2|||Age||years|Mean|59.7|59.7|Standard Deviation|12.3|12.3|||
3831340|NCT01708967|3658078|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|10.8|10.8|||
3831341|NCT01708967|3658076|B3||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3831342|NCT01708967|3658077|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3831343|NCT01708967|3658078|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3831344|NCT01708967|3658076|B3||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
3831345|NCT01708967|3658077|B2||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3831346|NCT01708967|3658078|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3831347|NCT01708967|3658076|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3831348|NCT01708967|3658077|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3831349|NCT01708967|3658078|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3831350|NCT01708954|3658085|B4||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3831351|NCT01708954|3658086|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3831352|NCT01708954|3658087|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3831353|NCT01708954|3658088|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3831354|NCT01708954|3658085|B4||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3831355|NCT01708954|3658086|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3831356|NCT01708954|3658087|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3831357|NCT01708954|3658088|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3831358|NCT01708954|3658085|B4|||Age||years|Median|66|66.0|Full Range|||34.0|88.0|
3831359|NCT01708954|3658086|B3|||Age||years|Median|63|63.0|Full Range|||44.0|82.0|
3831360|NCT01708954|3658087|B2|||Age||years|Median|65|65.0|Full Range|||46.0|88.0|
3831361|NCT01708954|3658088|B1|||Age||years|Median|68|68.0|Full Range|||34.0|83.0|
3831362|NCT01708915|3658111|B5||Male|Sex: Female, Male||Participants|Count of Participants|417|417.0||||||
3831363|NCT01708915|3658112|B4||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3831364|NCT01708915|3658113|B3||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3831365|NCT01708915|3658114|B2||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3831366|NCT01708915|3658115|B1||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3831367|NCT01708915|3658111|B5||Female|Sex: Female, Male||Participants|Count of Participants|388|388.0||||||
3831368|NCT01708915|3658112|B4||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3831369|NCT01708915|3658113|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3831370|NCT01708915|3658114|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3831371|NCT01708915|3658115|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3831372|NCT01708915|3658111|B5|||Age||years|Mean|40.5|40.5|Standard Deviation|13.57|13.57|||
3831373|NCT01708915|3658112|B4|||Age||years|Mean|40.2|40.2|Standard Deviation|14.31|14.31|||
3831374|NCT01708915|3658113|B3|||Age||years|Mean|42.2|42.2|Standard Deviation|13.53|13.53|||
3831375|NCT01708915|3658114|B2|||Age||years|Mean|40.4|40.4|Standard Deviation|13.06|13.06|||
3831376|NCT01708915|3658115|B1|||Age||years|Mean|39.2|39.2|Standard Deviation|13.27|13.27|||
3831377|NCT01708902|3658140|B8||Male|Sex: Female, Male||Participants|Count of Participants|525|525.0||||||
3831378|NCT01708902|3658141|B7||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3831379|NCT01708902|3658142|B6||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3831380|NCT01708902|3658143|B5||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3831381|NCT01708902|3658144|B4||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3831382|NCT01708902|3658145|B3||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3831383|NCT01708902|3658146|B2||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3831384|NCT01708902|3658147|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3831385|NCT01708902|3658140|B8||Female|Sex: Female, Male||Participants|Count of Participants|348|348.0||||||
3831386|NCT01708902|3658141|B7||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3831387|NCT01708902|3658142|B6||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3831388|NCT01708902|3658143|B5||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3831389|NCT01708902|3658144|B4||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3831390|NCT01708902|3658145|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3831391|NCT01708902|3658146|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3831392|NCT01708902|3658147|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3831393|NCT01708902|3658140|B8|||Age||years|Mean|51.0|51.0|Standard Deviation|10.3|10.3|||
3831394|NCT01708902|3658141|B7|||Age||years|Mean|49.9|49.9|Standard Deviation|11.7|11.7|||
3831395|NCT01708902|3658142|B6|||Age||years|Mean|49.5|49.5|Standard Deviation|11.6|11.6|||
3831396|NCT01708902|3658143|B5|||Age||years|Mean|50.7|50.7|Standard Deviation|9.4|9.4|||
3831397|NCT01708902|3658144|B4|||Age||years|Mean|51.4|51.4|Standard Deviation|10.2|10.2|||
3831398|NCT01708902|3658145|B3|||Age||years|Mean|51.4|51.4|Standard Deviation|10.4|10.4|||
3831399|NCT01708902|3658146|B2|||Age||years|Mean|52.1|52.1|Standard Deviation|9.6|9.6|||
3831400|NCT01708902|3658147|B1|||Age||years|Mean|50.8|50.8|Standard Deviation|10.5|10.5|||
3831401|NCT01708525|3658212|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3831402|NCT01708525|3658212|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831403|NCT01708525|3658212|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831404|NCT01708525|3658212|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3831405|NCT01708525|3658212|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831406|NCT01708525|3658212|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831407|NCT01708525|3658212|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831408|NCT01708525|3658212|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831409|NCT01708525|3658212|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3831410|NCT01708525|3658212|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3831411|NCT01708525|3658212|B1|||Age||years|Mean|62|62.0|Full Range|||59.0|65.0|
3831412|NCT01708317|3658217|B1|United States||Region of Enrollment||participants|Number|8421|8421.0||||||
3831413|NCT01708317|3658217|B1||Male|Sex: Female, Male||Participants|Count of Participants|3778|3778.0||||||
3831414|NCT01708317|3658217|B1||Female|Sex: Female, Male||Participants|Count of Participants|4643|4643.0||||||
3831415|NCT01708317|3658217|B1|||Age||years|Mean|17.0|17.0|Standard Deviation|1.3|1.3|||
3831416|NCT01708317|3658217|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3831417|NCT01708317|3658217|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1379|1379.0||||||
3831418|NCT01708317|3658217|B1||<=18 years|Age||Participants|Count of Participants|7042|7042.0||||||
3831419|NCT01708291|3658224|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
3831420|NCT01708291|3658225|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
3831421|NCT01708291|3658226|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3831422|NCT01708291|3658224|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3831423|NCT01708291|3658225|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3831424|NCT01708291|3658226|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831425|NCT01708291|3658224|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831426|NCT01708291|3658225|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831427|NCT01708291|3658226|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831428|NCT01708291|3658224|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3831429|NCT01708291|3658225|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3831430|NCT01708291|3658226|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3831431|NCT01708291|3658224|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3831432|NCT01708291|3658225|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3831433|NCT01708291|3658226|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3831434|NCT01708291|3658224|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831435|NCT01708291|3658225|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831436|NCT01708291|3658226|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831437|NCT01708291|3658224|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831438|NCT01708291|3658225|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831439|NCT01708291|3658226|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831440|NCT01708291|3658224|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831441|NCT01708291|3658225|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831442|NCT01708291|3658226|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831443|NCT01708291|3658224|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3831444|NCT01708291|3658225|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3831445|NCT01708291|3658226|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3831446|NCT01708291|3658224|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3831447|NCT01708291|3658225|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3831448|NCT01708291|3658226|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3831449|NCT01708291|3658224|B3|18 to 21||Age, Customized||participants|Number|20|20.0||||||
3831450|NCT01708291|3658225|B2|18 to 21||Age, Customized||participants|Number|16|16.0||||||
3831451|NCT01708291|3658226|B1|18 to 21||Age, Customized||participants|Number|4|4.0||||||
3831452|NCT01708291|3658224|B3|14 to 17||Age, Customized||participants|Number|22|22.0||||||
3831453|NCT01708291|3658225|B2|14 to 17||Age, Customized||participants|Number|5|5.0||||||
3831454|NCT01708291|3658226|B1|14 to 17||Age, Customized||participants|Number|17|17.0||||||
3831455|NCT01708278|3658233|B7|||Lung Function|Lung Function FEV1 between 35 and 80% predicted|participants|Number|9|9.0||||||
3831456|NCT01708278|3658234|B6|||Lung Function|Lung Function FEV1 between 35 and 80% predicted|participants|Number|1|1.0||||||
3831457|NCT01708278|3658235|B5|||Lung Function|Lung Function FEV1 between 35 and 80% predicted|participants|Number|1|1.0||||||
3831458|NCT01708278|3658236|B4|||Lung Function|Lung Function FEV1 between 35 and 80% predicted|participants|Number|2|2.0||||||
3831459|NCT01708278|3658237|B3|||Lung Function|Lung Function FEV1 between 35 and 80% predicted|participants|Number|2|2.0||||||
3831460|NCT01708278|3658238|B2|||Lung Function|Lung Function FEV1 between 35 and 80% predicted|participants|Number|2|2.0||||||
3831461|NCT01708278|3658239|B1|||Lung Function|Lung Function FEV1 between 35 and 80% predicted|participants|Number|1|1.0||||||
3831462|NCT01708278|3658233|B7|United States||Region of Enrollment||participants|Number|9|9.0||||||
3831463|NCT01708278|3658234|B6|United States||Region of Enrollment||participants|Number|1|1.0||||||
3831464|NCT01708278|3658235|B5|United States||Region of Enrollment||participants|Number|1|1.0||||||
3831465|NCT01708278|3658236|B4|United States||Region of Enrollment||participants|Number|2|2.0||||||
3831466|NCT01708278|3658237|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3831467|NCT01708278|3658238|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3831468|NCT01708278|3658239|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3831469|NCT01708278|3658233|B7||Male|Gender||Participants|Count of Participants|5|5.0||||||
3831470|NCT01708278|3658234|B6||Male|Gender||Participants|Count of Participants|1|1.0||||||
3831471|NCT01708278|3658235|B5||Male|Gender||Participants|Count of Participants|0|0.0||||||
3831472|NCT01708278|3658236|B4||Male|Gender||Participants|Count of Participants|1|1.0||||||
3831473|NCT01708278|3658237|B3||Male|Gender||Participants|Count of Participants|2|2.0||||||
3831474|NCT01708278|3658238|B2||Male|Gender||Participants|Count of Participants|1|1.0||||||
3831475|NCT01708278|3658239|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3831476|NCT01708278|3658233|B7||Female|Gender||Participants|Count of Participants|4|4.0||||||
3831477|NCT01708278|3658234|B6||Female|Gender||Participants|Count of Participants|0|0.0||||||
3831478|NCT01708278|3658235|B5||Female|Gender||Participants|Count of Participants|1|1.0||||||
3831479|NCT01708278|3658236|B4||Female|Gender||Participants|Count of Participants|1|1.0||||||
3831480|NCT01708278|3658237|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
3831481|NCT01708278|3658238|B2||Female|Gender||Participants|Count of Participants|1|1.0||||||
3831482|NCT01708278|3658239|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
3831483|NCT01708278|3658233|B7|Age 40 - 80 years||Age, Customized||participants|Number|9|9.0||||||
3831484|NCT01708278|3658234|B6|Age 40 - 80 years||Age, Customized||participants|Number|1|1.0||||||
3831485|NCT01708278|3658235|B5|Age 40 - 80 years||Age, Customized||participants|Number|1|1.0||||||
3831486|NCT01708278|3658236|B4|Age 40 - 80 years||Age, Customized||participants|Number|2|2.0||||||
3831487|NCT01708278|3658237|B3|Age 40 - 80 years||Age, Customized||participants|Number|2|2.0||||||
3831488|NCT01708278|3658238|B2|Age 40 - 80 years||Age, Customized||participants|Number|2|2.0||||||
3831489|NCT01708278|3658239|B1|Age 40 - 80 years||Age, Customized||participants|Number|1|1.0||||||
3831490|NCT01708213|3658258|B1|Canada||Region of Enrollment||participants|Number|72|72.0||||||
3831491|NCT01708213|3658258|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3831492|NCT01708213|3658258|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3831493|NCT01708213|3658258|B1|||Age||years|Mean|50.5|50.5|Full Range|||34.0|70.0|
3831494|NCT01708187|3658264|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3831495|NCT01708187|3658265|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3831496|NCT01708187|3658266|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3831497|NCT01708187|3658264|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3831498|NCT01708187|3658265|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3831499|NCT01708187|3658266|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3831500|NCT01708187|3658264|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3831501|NCT01708187|3658265|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3831502|NCT01708187|3658266|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3831503|NCT01708187|3658264|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3831504|NCT01708187|3658265|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3831505|NCT01708187|3658266|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3831506|NCT01708187|3658264|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3831507|NCT01708187|3658265|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3831508|NCT01708187|3658266|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3831509|NCT01708174|3658273|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3831510|NCT01708174|3658274|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3831511|NCT01708174|3658275|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3831512|NCT01708174|3658276|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3831513|NCT01708174|3658273|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3831514|NCT01708174|3658274|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3831515|NCT01708174|3658275|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3831516|NCT01708174|3658276|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3831517|NCT01708174|3658273|B4|||Age||Years|Median|35.0|35.0|Full Range|10.73|10.73|4.0|51.0|
3831518|NCT01708174|3658274|B3|||Age||Years|Median|35.5|35.5|Full Range|3.16|3.16|31.0|38.0|
3831519|NCT01708174|3658275|B2|||Age||Years|Median|37.0|37.0|Full Range|8.17|8.17|24.0|51.0|
3831520|NCT01708174|3658276|B1|||Age||Years|Median|8.5|8.5|Full Range|6.36|6.36|4.0|13.0|
3831521|NCT01708161|3658304|B7||Native American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3831522|NCT01708161|3658305|B6||Native American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3831523|NCT01708161|3658306|B5||Native American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3831524|NCT01708161|3658307|B4||Native American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3831525|NCT01708161|3658308|B3||Native American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3831526|NCT01708161|3658309|B2||Native American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3831527|NCT01708161|3658310|B1||Native American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3831528|NCT01708161|3658304|B7||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3831529|NCT01708161|3658305|B6||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3831530|NCT01708161|3658306|B5||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3831531|NCT01708161|3658307|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3831532|NCT01708161|3658308|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3831533|NCT01708161|3658309|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3831534|NCT01708161|3658310|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3831535|NCT01708161|3658304|B7||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3831536|NCT01708161|3658305|B6||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3831537|NCT01708161|3658306|B5||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3831538|NCT01708161|3658307|B4||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3831539|NCT01708161|3658308|B3||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3831540|NCT01708161|3658309|B2||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3831541|NCT01708161|3658310|B1||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3831542|NCT01708161|3658304|B7||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3831543|NCT01708161|3658305|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3831544|NCT01708161|3658306|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3831545|NCT01708161|3658307|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3831546|NCT01708161|3658308|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3831547|NCT01708161|3658309|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3831548|NCT01708161|3658310|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3831549|NCT01708161|3658304|B7||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3831550|NCT01708161|3658305|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3831551|NCT01708161|3658306|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3831552|NCT01708161|3658307|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3831553|NCT01708161|3658308|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3831554|NCT01708161|3658309|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3831555|NCT01708161|3658310|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3831556|NCT01708161|3658304|B7|||Age||years|Mean|56.3|56.3|Standard Deviation|10.54|10.54|||
3831557|NCT01708161|3658305|B6|||Age||years|Mean|56.0|56.0|Standard Deviation|0|0.0|||
3831558|NCT01708161|3658306|B5|||Age||years|Mean|59.7|59.7|Standard Deviation|6.53|6.53|||
3831559|NCT01708161|3658307|B4|||Age||years|Mean|51.3|51.3|Standard Deviation|8.04|8.04|||
3831560|NCT01708161|3658308|B3|||Age||years|Mean|63.7|63.7|Standard Deviation|7.83|7.83|||
3831561|NCT01708161|3658309|B2|||Age||years|Mean|57.5|57.5|Standard Deviation|15.55|15.55|||
3831562|NCT01708161|3658310|B1|||Age||years|Mean|50.5|50.5|Standard Deviation|3.11|3.11|||
3831563|NCT01708122|3658355|B3|United States||Region of Enrollment||participants|Number|53|53.0||||||
3831564|NCT01708122|3658356|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
3831565|NCT01708122|3658357|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
3831566|NCT01708122|3658355|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3831567|NCT01708122|3658356|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3831568|NCT01708122|3658357|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3831569|NCT01708122|3658355|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3831570|NCT01708122|3658356|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3831571|NCT01708122|3658357|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3831572|NCT01708122|3658355|B3|||Age||years|Mean|46.2|46.2|Full Range|||21.0|74.0|
3831573|NCT01708122|3658356|B2|||Age||years|Mean|47.1|47.1|Full Range|||29.0|74.0|
3831574|NCT01708122|3658357|B1|||Age||years|Mean|45.2|45.2|Full Range|||21.0|65.0|
3831575|NCT01708057|3658366|B1|other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3831576|NCT01708057|3658366|B1|White||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3831577|NCT01708057|3658366|B1|Female||Sex/Gender, Customized||participants|Number|1|1.0||||||
3831578|NCT01708057|3658366|B1|Male||Sex/Gender, Customized||participants|Number|2|2.0||||||
3831579|NCT01708057|3658366|B1|>=65 years||Age, Customized||participants|Number|1|1.0||||||
3831580|NCT01708057|3658366|B1|Between 18 and 65 years||Age, Customized||participants|Number|2|2.0||||||
3831581|NCT01708057|3658366|B1|<=18 year||Age, Customized||participants|Number|0|0.0||||||
3831582|NCT01707667|3658424|B3|UNITED STATES||Region of Enrollment||Participants|Number|13|13.0||||||
3831583|NCT01707667|3658425|B2|UNITED STATES||Region of Enrollment||Participants|Number|6|6.0||||||
3831584|NCT01707667|3658426|B1|UNITED STATES||Region of Enrollment||Participants|Number|7|7.0||||||
3831585|NCT01707667|3658424|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3831586|NCT01707667|3658425|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3831587|NCT01707667|3658426|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3831588|NCT01707667|3658424|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3831589|NCT01707667|3658425|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3831590|NCT01707667|3658426|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3831591|NCT01707667|3658424|B3|18 - 64||Age, Customized||Participants|Number|13|13.0||||||
3831592|NCT01707667|3658425|B2|18 - 64||Age, Customized||Participants|Number|6|6.0||||||
3831593|NCT01707667|3658426|B1|18 - 64||Age, Customized||Participants|Number|7|7.0||||||
3831594|NCT01707667|3658424|B3|||Age||Years|Mean|37.9|37.9|Standard Deviation|11.85|11.85|||
3831595|NCT01707667|3658425|B2|||Age||Years|Mean|35.2|35.2|Standard Deviation|13.18|13.18|||
3831596|NCT01707667|3658426|B1|||Age||Years|Mean|40.3|40.3|Standard Deviation|11.04|11.04|||
3831597|NCT01707654|3658445|B1|China||Region of Enrollment||participants|Number|9|9.0||||||
3831598|NCT01707654|3658445|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3831599|NCT01707654|3658445|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3831600|NCT01707654|3658445|B1|||Age||years|Mean|32.6|32.6|Standard Deviation|6.6|6.6|||
3831601|NCT01707654|3658445|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3831602|NCT01707654|3658445|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3831603|NCT01707654|3658445|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3831604|NCT01707381|3658449|B1|||Treatment-Naive||Participants|Count of Participants|15|15.0||||||
3831605|NCT01707381|3658449|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831606|NCT01707381|3658449|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831607|NCT01707381|3658449|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3831608|NCT01707381|3658449|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3831609|NCT01707381|3658449|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831610|NCT01707381|3658449|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831611|NCT01707381|3658449|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3831612|NCT01707381|3658449|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831613|NCT01707381|3658449|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3831614|NCT01707381|3658449|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3831615|NCT01707381|3658449|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3831616|NCT01707381|3658449|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3831617|NCT01707381|3658449|B1|||Age||years|Mean|61.0|61.0|Standard Deviation|11.13|11.13|||
3831618|NCT01707381|3658449|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3831619|NCT01707381|3658449|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3831620|NCT01707381|3658449|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3831621|NCT01707368|3658460|B1|>10%||Affected body surface area (BSA) at admission||Participants|Count of Participants|51|51.0||||||
3831622|NCT01707368|3658460|B1|8-10%||Affected body surface area (BSA) at admission||Participants|Count of Participants|83|83.0||||||
3831623|NCT01707368|3658460|B1|6-8%||Affected body surface area (BSA) at admission||Participants|Count of Participants|125|125.0||||||
3831624|NCT01707368|3658460|B1|4-6%||Affected body surface area (BSA) at admission||Participants|Count of Participants|138|138.0||||||
3831625|NCT01707368|3658460|B1|2-4%||Affected body surface area (BSA) at admission||Participants|Count of Participants|119|119.0||||||
3831626|NCT01707368|3658460|B1|<2%||Affected body surface area (BSA) at admission||Participants|Count of Participants|45|45.0||||||
3831627|NCT01707368|3658460|B1|Germany||Region of Enrollment||Participants|Count of Participants|561|561.0||||||
3831628|NCT01707368|3658460|B1||Male|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
3831629|NCT01707368|3658460|B1||Female|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
3831630|NCT01707368|3658460|B1|||Age||years|Mean|51.05|51.05|Standard Deviation|16.10|16.1|||
3831631|NCT01707290|3658467|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3831632|NCT01707290|3658468|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3831633|NCT01707290|3658469|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3831634|NCT01707290|3658467|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3831635|NCT01707290|3658468|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3831636|NCT01707290|3658469|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3831637|NCT01707290|3658467|B3|18 years and over||Age, Customized||participants|Number|91|91.0||||||
3831638|NCT01707290|3658468|B2|18 years and over||Age, Customized||participants|Number|2|2.0||||||
3831639|NCT01707290|3658469|B1|18 years and over||Age, Customized||participants|Number|89|89.0||||||
3831640|NCT01707290|3658467|B3|12 to 17 years||Age, Customized||participants|Number|12|12.0||||||
3831641|NCT01707290|3658468|B2|12 to 17 years||Age, Customized||participants|Number|1|1.0||||||
3831642|NCT01707290|3658469|B1|12 to 17 years||Age, Customized||participants|Number|11|11.0||||||
3831643|NCT01707290|3658467|B3|6 to 11 years||Age, Customized||participants|Number|22|22.0||||||
3831644|NCT01707290|3658468|B2|6 to 11 years||Age, Customized||participants|Number|1|1.0||||||
3831645|NCT01707290|3658469|B1|6 to 11 years||Age, Customized||participants|Number|21|21.0||||||
3831646|NCT01707238|3658491|B3|United Kingdom||Region of Enrollment||participants|Number|100|100.0||||||
3831647|NCT01707238|3658492|B2|United Kingdom||Region of Enrollment||participants|Number|52|52.0||||||
3831648|NCT01707238|3658493|B1|United Kingdom||Region of Enrollment||participants|Number|48|48.0||||||
3831649|NCT01707238|3658491|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3831650|NCT01707238|3658492|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3831651|NCT01707238|3658493|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3831652|NCT01707238|3658491|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3831653|NCT01707238|3658492|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3831654|NCT01707238|3658493|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3831655|NCT01707238|3658491|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3831656|NCT01707238|3658492|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3831657|NCT01707238|3658493|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3831658|NCT01707238|3658491|B3||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
3831659|NCT01707238|3658492|B2||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3831660|NCT01707238|3658493|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3831661|NCT01707238|3658491|B3||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
3831662|NCT01707238|3658492|B2||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
3831663|NCT01707238|3658493|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3831664|NCT01707225|3658510|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3831665|NCT01707225|3658510|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831666|NCT01707225|3658510|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831667|NCT01707225|3658510|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3831668|NCT01707225|3658510|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3831669|NCT01707225|3658510|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831670|NCT01707225|3658510|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831671|NCT01707225|3658510|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831672|NCT01707225|3658510|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831673|NCT01707225|3658510|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3831674|NCT01707225|3658510|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831675|NCT01707225|3658510|B1||Male|Gender||Participants|Count of Participants|8|8.0||||||
3831676|NCT01707225|3658510|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
3831677|NCT01707225|3658510|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3831678|NCT01707225|3658510|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3831679|NCT01707225|3658510|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3831680|NCT01707095|3658515|B3|United States||Region of Enrollment||participants|Number|84|84.0||||||
3831681|NCT01707095|3658516|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
3831682|NCT01707095|3658517|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
3831683|NCT01707095|3658515|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3831684|NCT01707095|3658516|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3831685|NCT01707095|3658517|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3831686|NCT01707095|3658515|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3831687|NCT01707095|3658516|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3831688|NCT01707095|3658517|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3831689|NCT01707095|3658515|B3|||Age||years|Mean|44|44.0|Standard Deviation|17|17.0|||
3831690|NCT01707095|3658516|B2|||Age||years|Mean|44|44.0|Standard Deviation|18|18.0|||
3831691|NCT01707095|3658517|B1|||Age||years|Mean|44|44.0|Standard Deviation|15|15.0|||
3831692|NCT01707043|3658526|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3831693|NCT01707043|3658527|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3831694|NCT01707043|3658528|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3831695|NCT01707043|3658526|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831696|NCT01707043|3658527|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831697|NCT01707043|3658528|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831698|NCT01707043|3658526|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3831699|NCT01707043|3658527|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3831700|NCT01707043|3658528|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831701|NCT01707043|3658526|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3831702|NCT01707043|3658527|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3831703|NCT01707043|3658528|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3831704|NCT01707043|3658526|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3831705|NCT01707043|3658527|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3831706|NCT01707043|3658528|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831707|NCT01707043|3658526|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831708|NCT01707043|3658527|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831709|NCT01707043|3658528|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831710|NCT01707043|3658526|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831711|NCT01707043|3658527|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831712|NCT01707043|3658528|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831713|NCT01707043|3658526|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831714|NCT01707043|3658527|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831715|NCT01707043|3658528|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831716|NCT01707043|3658526|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831717|NCT01707043|3658527|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831718|NCT01707043|3658528|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831719|NCT01707043|3658526|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3831720|NCT01707043|3658527|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3831721|NCT01707043|3658528|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3831722|NCT01707043|3658526|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3831723|NCT01707043|3658527|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3831724|NCT01707043|3658528|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831725|NCT01707043|3658526|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3831726|NCT01707043|3658527|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3831727|NCT01707043|3658528|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3831728|NCT01707043|3658526|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3831729|NCT01707043|3658527|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3831730|NCT01707043|3658528|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3831731|NCT01707043|3658526|B3|||Age||years|Median|48|48.0|Full Range|||29.0|64.0|
3831732|NCT01707043|3658527|B2|||Age||years|Median|47|47.0|Full Range|||33.0|63.0|
3831733|NCT01707043|3658528|B1|||Age||years|Median|49.5|49.5|Full Range|||29.0|64.0|
3831734|NCT01706965|3658537|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831735|NCT01706965|3658538|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831736|NCT01706965|3658539|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831737|NCT01706965|3658537|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3831738|NCT01706965|3658538|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3831739|NCT01706965|3658539|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3831740|NCT01706965|3658537|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3831741|NCT01706965|3658538|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3831742|NCT01706965|3658539|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3831743|NCT01706965|3658537|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3831744|NCT01706965|3658538|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3831745|NCT01706965|3658539|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3831746|NCT01706965|3658537|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831747|NCT01706965|3658538|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831748|NCT01706965|3658539|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831749|NCT01706965|3658537|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3831750|NCT01706965|3658538|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831751|NCT01706965|3658539|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3831752|NCT01706965|3658537|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831753|NCT01706965|3658538|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831754|NCT01706965|3658539|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831755|NCT01706965|3658537|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831756|NCT01706965|3658538|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831757|NCT01706965|3658539|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831758|NCT01706965|3658537|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3831759|NCT01706965|3658538|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3831760|NCT01706965|3658539|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3831761|NCT01706965|3658537|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3831762|NCT01706965|3658538|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3831763|NCT01706965|3658539|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3831764|NCT01706965|3658537|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3831765|NCT01706965|3658538|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3831766|NCT01706965|3658539|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3831767|NCT01706965|3658537|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3831768|NCT01706965|3658538|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3831769|NCT01706965|3658539|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3831770|NCT01706965|3658537|B3|||Age||years|Mean|43.0|43.0|Standard Deviation|10.1|10.1|||
3831771|NCT01706965|3658538|B2|||Age||years|Mean|46.1|46.1|Standard Deviation|8.0|8.0|||
3831772|NCT01706965|3658539|B1|||Age||years|Mean|40.15|40.15|Standard Deviation|12.1|12.1|||
3831773|NCT01706952|3658548|B1|Canada||Region of Enrollment||participants|Number|37|37.0||||||
3831774|NCT01706952|3658548|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3831775|NCT01706952|3658548|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3831776|NCT01706952|3658548|B1|||Age||years|Mean|47.92|47.92|Standard Deviation|16.51|16.51|||
3831777|NCT01706952|3658548|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3831778|NCT01706952|3658548|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3831779|NCT01706952|3658548|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3831780|NCT01706926|3658560|B5||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3831781|NCT01706926|3658561|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3831782|NCT01706926|3658562|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3831783|NCT01706926|3658563|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3831784|NCT01706926|3658564|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3831785|NCT01706926|3658560|B5||Female|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
3831786|NCT01706926|3658561|B4||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3831787|NCT01706926|3658562|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3831788|NCT01706926|3658563|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3831789|NCT01706926|3658564|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3831790|NCT01706926|3658560|B5|||Age||years|Mean|51.8|51.8|Standard Deviation|11.1|11.1|||
3831791|NCT01706926|3658561|B4|||Age||years|Mean|52.6|52.6|Standard Deviation|10.3|10.3|||
3831792|NCT01706926|3658562|B3|||Age||years|Mean|50.8|50.8|Standard Deviation|11.9|11.9|||
3831793|NCT01706926|3658563|B2|||Age||years|Mean|51.2|51.2|Standard Deviation|11.6|11.6|||
3831794|NCT01706926|3658564|B1|||Age||years|Mean|52.8|52.8|Standard Deviation|10.6|10.6|||
3831795|NCT01706822|3658676|B1|||Body Mass Index (BMI)||kg/m2|Mean|27.0|27.0|Standard Deviation|4.5|4.5|||
3831796|NCT01706822|3658676|B1|||Weight||kilograms|Mean|73.9|73.9|Standard Deviation|16.4|16.4|||
3831797|NCT01706822|3658676|B1|||Height||centimeters|Mean|165.0|165.0|Standard Deviation|11.9|11.9|||
3831798|NCT01706822|3658676|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831799|NCT01706822|3658676|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3831800|NCT01706822|3658676|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831801|NCT01706822|3658676|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831802|NCT01706822|3658676|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831803|NCT01706822|3658676|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3831804|NCT01706822|3658676|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3831805|NCT01706822|3658676|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831806|NCT01706822|3658676|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831807|NCT01706822|3658676|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831808|NCT01706822|3658676|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3831809|NCT01706822|3658676|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3831810|NCT01706822|3658676|B1|||Age||years|Mean|66.6|66.6|Standard Deviation|10.8|10.8|||
3831811|NCT01706770|3658684|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3831812|NCT01706770|3658685|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3831813|NCT01706770|3658686|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
3831814|NCT01706770|3658684|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3831815|NCT01706770|3658685|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3831816|NCT01706770|3658686|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3831817|NCT01706770|3658684|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3831818|NCT01706770|3658685|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3831819|NCT01706770|3658686|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3831820|NCT01706770|3658684|B3|||Age||years|Mean|34.4|34.4|Standard Deviation|11.13|11.13|||
3831821|NCT01706770|3658685|B2|||Age||years|Mean|33.8|33.8|Standard Deviation|11.50|11.5|||
3831822|NCT01706770|3658686|B1|||Age||years|Mean|34.8|34.8|Standard Deviation|11.11|11.11|||
3831823|NCT01706770|3658684|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3831824|NCT01706770|3658685|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3831825|NCT01706770|3658686|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3831826|NCT01706770|3658684|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3831827|NCT01706770|3658685|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3831828|NCT01706770|3658686|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3831829|NCT01706770|3658684|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3831830|NCT01706770|3658685|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3831831|NCT01706770|3658686|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3831832|NCT01706666|3658695|B4|||Had Prior Treatment||participants|Number|3|3.0||||||
3831833|NCT01706666|3658696|B3|||Had Prior Treatment||participants|Number|1|1.0||||||
3831834|NCT01706666|3658697|B2|||Had Prior Treatment||participants|Number|1|1.0||||||
3831835|NCT01706666|3658698|B1|||Had Prior Treatment||participants|Number|1|1.0||||||
3831836|NCT01706666|3658695|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
3831837|NCT01706666|3658696|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3831838|NCT01706666|3658697|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3831839|NCT01706666|3658698|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3831840|NCT01706666|3658695|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831841|NCT01706666|3658696|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831842|NCT01706666|3658697|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831843|NCT01706666|3658698|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831844|NCT01706666|3658695|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831845|NCT01706666|3658696|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831846|NCT01706666|3658697|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831847|NCT01706666|3658698|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831848|NCT01706666|3658695|B4||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3831849|NCT01706666|3658696|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3831850|NCT01706666|3658697|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831851|NCT01706666|3658698|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3831852|NCT01706666|3658695|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3831853|NCT01706666|3658696|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831854|NCT01706666|3658697|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3831855|NCT01706666|3658698|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831856|NCT01706666|3658695|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831857|NCT01706666|3658696|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831858|NCT01706666|3658697|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831859|NCT01706666|3658698|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831860|NCT01706666|3658695|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831861|NCT01706666|3658696|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831862|NCT01706666|3658697|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831863|NCT01706666|3658698|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831864|NCT01706666|3658695|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831865|NCT01706666|3658696|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831866|NCT01706666|3658697|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831867|NCT01706666|3658698|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831868|NCT01706666|3658695|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831869|NCT01706666|3658696|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831870|NCT01706666|3658697|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831871|NCT01706666|3658698|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831872|NCT01706666|3658695|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3831873|NCT01706666|3658696|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3831874|NCT01706666|3658697|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3831875|NCT01706666|3658698|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3831876|NCT01706666|3658695|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831877|NCT01706666|3658696|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831878|NCT01706666|3658697|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831879|NCT01706666|3658698|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831880|NCT01706666|3658695|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3831881|NCT01706666|3658696|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3831882|NCT01706666|3658697|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3831883|NCT01706666|3658698|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3831884|NCT01706666|3658695|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3831885|NCT01706666|3658696|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3831886|NCT01706666|3658697|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3831887|NCT01706666|3658698|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3831888|NCT01706666|3658695|B4|||Age||Years|Median|50|50.0|Full Range|||45.0|54.0|
3831889|NCT01706666|3658696|B3|||Age||Years|Median|50|50.0|Full Range|||||
3831890|NCT01706666|3658697|B2|||Age||Years|Median|45|45.0|Full Range|||||
3831891|NCT01706666|3658698|B1|||Age||Years|Median|54|54.0|Full Range|||||
3831892|NCT01706588|3658714|B6||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3831893|NCT01706588|3658715|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3831894|NCT01706588|3658716|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3831895|NCT01706588|3658717|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3831896|NCT01706588|3658718|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3831897|NCT01706588|3658719|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3831898|NCT01706588|3658714|B6||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3831899|NCT01706588|3658715|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3831900|NCT01706588|3658716|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3831901|NCT01706588|3658717|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3831902|NCT01706588|3658718|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3831903|NCT01706588|3658719|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3831904|NCT01706588|3658714|B6|||Age||years|Mean|28.6|28.6|Standard Deviation|7.94|7.94|||
3831905|NCT01706588|3658715|B5|||Age||years|Mean|30|30.0|Standard Deviation|9.5|9.5|||
3831906|NCT01706588|3658716|B4|||Age||years|Mean|27|27.0|Standard Deviation|4.5|4.5|||
3831907|NCT01706588|3658717|B3|||Age||years|Mean|30|30.0|Standard Deviation|9|9.0|||
3831908|NCT01706588|3658718|B2|||Age||years|Mean|28|28.0|Standard Deviation|9.4|9.4|||
3831909|NCT01706588|3658719|B1|||Age||years|Mean|28|28.0|Standard Deviation|7.3|7.3|||
3831910|NCT01706575|3658735|B1||Male|Gender||Participants|Count of Participants|63|63.0||||||
3831911|NCT01706575|3658735|B1||Female|Gender||Participants|Count of Participants|13|13.0||||||
3831912|NCT01706575|3658735|B1|||Age||years|Mean|49.82|49.82|Standard Deviation|8.46|8.46|||
3831913|NCT01706549|3658746|B1|General health||Quality of life (SF-36)|All dimensions are mean of points from 0-100, where 100 is the best score. Getting 0 points equals to poor performance.|units on a scale|Mean|56.8|56.8|Standard Deviation|20.1|20.1|||
3831914|NCT01706549|3658746|B1|Bodily Pain||Quality of life (SF-36)|All dimensions are mean of points from 0-100, where 100 is the best score. Getting 0 points equals to poor performance.|units on a scale|Mean|65.5|65.5|Standard Deviation|29.2|29.2|||
3831915|NCT01706549|3658746|B1|Social Functioning||Quality of life (SF-36)|All dimensions are mean of points from 0-100, where 100 is the best score. Getting 0 points equals to poor performance.|units on a scale|Mean|70.6|70.6|Standard Deviation|26.8|26.8|||
3831916|NCT01706549|3658746|B1|Mental health||Quality of life (SF-36)|All dimensions are mean of points from 0-100, where 100 is the best score. Getting 0 points equals to poor performance.|units on a scale|Mean|70.0|70.0|Standard Deviation|18.2|18.2|||
3831917|NCT01706549|3658746|B1|Vitality||Quality of life (SF-36)|All dimensions are mean of points from 0-100, where 100 is the best score. Getting 0 points equals to poor performance.|units on a scale|Mean|55.3|55.3|Standard Deviation|24.8|24.8|||
3831918|NCT01706549|3658746|B1|Role Emotional||Quality of life (SF-36)|All dimensions are mean of points from 0-100, where 100 is the best score. Getting 0 points equals to poor performance.|units on a scale|Mean|54.1|54.1|Standard Deviation|43.9|43.9|||
3831919|NCT01706549|3658746|B1|Role Physical||Quality of life (SF-36)|All dimensions are mean of points from 0-100, where 100 is the best score. Getting 0 points equals to poor performance.|units on a scale|Mean|57.8|57.8|Standard Deviation|45.7|45.7|||
3831920|NCT01706549|3658746|B1|Physical Functioning||Quality of life (SF-36)|All dimensions are mean of points from 0-100, where 100 is the best score. Getting 0 points equals to poor performance.|units on a scale|Mean|76.9|76.9|Standard Deviation|29.2|29.2|||
3831921|NCT01706549|3658746|B1|Finland||Region of Enrollment||participants|Number|16|16.0||||||
3831922|NCT01706549|3658746|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3831923|NCT01706549|3658746|B1||Female|Gender||Participants|Count of Participants|16|16.0||||||
3831924|NCT01706549|3658746|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3831925|NCT01706549|3658746|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3831926|NCT01706549|3658746|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3831927|NCT01706549|3658746|B1|||Age||Years|Mean|51|51.0|Standard Deviation|6.6|6.6|||
3831928|NCT01706536|3658751|B6|United States||Region of Enrollment||Participants|Count of Participants|282|282.0||||||
3831929|NCT01706536|3658752|B5|United States||Region of Enrollment||Participants|Count of Participants|59|59.0||||||
3831930|NCT01706536|3658753|B4|United States||Region of Enrollment||Participants|Count of Participants|57|57.0||||||
3831931|NCT01706536|3658754|B3|United States||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
3831932|NCT01706536|3658755|B2|United States||Region of Enrollment||Participants|Count of Participants|55|55.0||||||
3831933|NCT01706536|3658756|B1|United States||Region of Enrollment||Participants|Count of Participants|57|57.0||||||
3831934|NCT01706536|3658751|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3831935|NCT01706536|3658752|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831936|NCT01706536|3658753|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831937|NCT01706536|3658754|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3831938|NCT01706536|3658755|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831939|NCT01706536|3658756|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831940|NCT01706536|3658751|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831941|NCT01706536|3658752|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831942|NCT01706536|3658753|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831943|NCT01706536|3658754|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831944|NCT01706536|3658755|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831945|NCT01706536|3658756|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831946|NCT01706536|3658751|B6||White|Race (NIH/OMB)||Participants|Count of Participants|252|252.0||||||
3831947|NCT01706536|3658752|B5||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3831948|NCT01706536|3658753|B4||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3831949|NCT01706536|3658754|B3||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3831950|NCT01706536|3658755|B2||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3831951|NCT01706536|3658756|B1||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3831952|NCT01706536|3658751|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3831953|NCT01706536|3658752|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3831954|NCT01706536|3658753|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3831955|NCT01706536|3658754|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3831956|NCT01706536|3658755|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3831957|NCT01706536|3658756|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3831958|NCT01706536|3658751|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831959|NCT01706536|3658752|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831960|NCT01706536|3658753|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831961|NCT01706536|3658754|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831962|NCT01706536|3658755|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831963|NCT01706536|3658756|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831964|NCT01706536|3658751|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831965|NCT01706536|3658752|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831966|NCT01706536|3658753|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831967|NCT01706536|3658754|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831968|NCT01706536|3658755|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831969|NCT01706536|3658756|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831970|NCT01706536|3658751|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3831971|NCT01706536|3658752|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831972|NCT01706536|3658753|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3831973|NCT01706536|3658754|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831974|NCT01706536|3658755|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831975|NCT01706536|3658756|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3831976|NCT01706536|3658751|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831977|NCT01706536|3658752|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831978|NCT01706536|3658753|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831979|NCT01706536|3658754|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831980|NCT01706536|3658755|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831981|NCT01706536|3658756|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831982|NCT01706536|3658751|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|278|278.0||||||
3831983|NCT01706536|3658752|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3831984|NCT01706536|3658753|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3831985|NCT01706536|3658754|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3831986|NCT01706536|3658755|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3831987|NCT01706536|3658756|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3831988|NCT01706536|3658751|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3831989|NCT01706536|3658752|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831990|NCT01706536|3658753|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3831991|NCT01706536|3658754|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3831992|NCT01706536|3658755|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3831993|NCT01706536|3658756|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3831994|NCT01706536|3658751|B6||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3831995|NCT01706536|3658752|B5||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3831996|NCT01706536|3658753|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3831997|NCT01706536|3658754|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3831998|NCT01706536|3658755|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3831999|NCT01706536|3658756|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3832000|NCT01706536|3658751|B6||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3832001|NCT01706536|3658752|B5||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3832002|NCT01706536|3658753|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3832003|NCT01706536|3658754|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3832004|NCT01706536|3658755|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3832005|NCT01706536|3658756|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3832006|NCT01706536|3658751|B6|||Age||years|Mean|60.5|60.5|Standard Deviation|8.16|8.16|||
3832007|NCT01706536|3658752|B5|||Age||years|Mean|59.4|59.4|Standard Deviation|7.65|7.65|||
3832008|NCT01706536|3658753|B4|||Age||years|Mean|59.4|59.4|Standard Deviation|8.70|8.7|||
3832009|NCT01706536|3658754|B3|||Age||years|Mean|59.6|59.6|Standard Deviation|8.98|8.98|||
3832010|NCT01706536|3658755|B2|||Age||years|Mean|60.9|60.9|Standard Deviation|7.79|7.79|||
3832011|NCT01706536|3658756|B1|||Age||years|Mean|63.0|63.0|Standard Deviation|7.29|7.29|||
3832012|NCT01706536|3658751|B6||>=65 years|Age||Participants|Count of Participants|98|98.0||||||
3832013|NCT01706536|3658752|B5||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3832014|NCT01706536|3658753|B4||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3832015|NCT01706536|3658754|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3832016|NCT01706536|3658755|B2||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3832017|NCT01706536|3658756|B1||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
3832018|NCT01706536|3658751|B6||Between 18 and 65 years|Age||Participants|Count of Participants|184|184.0||||||
3832019|NCT01706536|3658752|B5||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3832020|NCT01706536|3658753|B4||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3832021|NCT01706536|3658754|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3832022|NCT01706536|3658755|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3832023|NCT01706536|3658756|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3832024|NCT01706536|3658751|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3832025|NCT01706536|3658752|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3832026|NCT01706536|3658753|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3832027|NCT01706536|3658754|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3832028|NCT01706536|3658755|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3832029|NCT01706536|3658756|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3832030|NCT01706458|3658817|B3|||Baseline PSA doubling time (months)||months|Median|2.55|2.55|Full Range|||1.0|63.9|
3832031|NCT01706458|3658818|B2|||Baseline PSA doubling time (months)||months|Median|2.2|2.2|Full Range|||1.0|25.8|
3832032|NCT01706458|3658819|B1|||Baseline PSA doubling time (months)||months|Median|2.8|2.8|Full Range|||1.4|63.9|
3832033|NCT01706458|3658817|B3|||Baseline PSA (ng/mL)||ng/mL|Median|16.25|16.25|Full Range|||2.09|1090.0|
3832034|NCT01706458|3658818|B2|||Baseline PSA (ng/mL)||ng/mL|Median|11.2|11.2|Full Range|||2.09|68.4|
3832035|NCT01706458|3658819|B1|||Baseline PSA (ng/mL)||ng/mL|Median|32.6|32.6|Full Range|||4.17|1090.0|
3832036|NCT01706458|3658817|B3|Distant lymph nodes||Metastatic sites||Participants|Count of Participants|10|10.0||||||
3832037|NCT01706458|3658818|B2|Distant lymph nodes||Metastatic sites||Participants|Count of Participants|4|4.0||||||
3832038|NCT01706458|3658819|B1|Distant lymph nodes||Metastatic sites||Participants|Count of Participants|6|6.0||||||
3832039|NCT01706458|3658817|B3|Bone||Metastatic sites||Participants|Count of Participants|7|7.0||||||
3832040|NCT01706458|3658818|B2|Bone||Metastatic sites||Participants|Count of Participants|5|5.0||||||
3832041|NCT01706458|3658819|B1|Bone||Metastatic sites||Participants|Count of Participants|2|2.0||||||
3832042|NCT01706458|3658817|B3|Visceral||Metastatic sites||Participants|Count of Participants|2|2.0||||||
3832043|NCT01706458|3658818|B2|Visceral||Metastatic sites||Participants|Count of Participants|0|0.0||||||
3832044|NCT01706458|3658819|B1|Visceral||Metastatic sites||Participants|Count of Participants|2|2.0||||||
3832045|NCT01706458|3658817|B3|Unknown||Gleason score|"The Gleason Score is a grading system for prostate cancer severity. It is defined on a scale of 1-5 where 1 is low-grade tumor cells and 5 is high-grade tumor cells.~Pathologists assign two Gleason grades to a biopsy; one for the predominant pattern and another for the second most predominant pattern. The two grades are added together to determine the Gleason Score (ultimately a number between 2 and 10). Scores of 2-4 tend to indicate less aggressive cancers, and 7-10 indicate more aggressive cancers."|Participants|Count of Participants|1|1.0||||||
3832046|NCT01706458|3658818|B2|Unknown||Gleason score|"The Gleason Score is a grading system for prostate cancer severity. It is defined on a scale of 1-5 where 1 is low-grade tumor cells and 5 is high-grade tumor cells.~Pathologists assign two Gleason grades to a biopsy; one for the predominant pattern and another for the second most predominant pattern. The two grades are added together to determine the Gleason Score (ultimately a number between 2 and 10). Scores of 2-4 tend to indicate less aggressive cancers, and 7-10 indicate more aggressive cancers."|Participants|Count of Participants|1|1.0||||||
3832047|NCT01706458|3658819|B1|Unknown||Gleason score|"The Gleason Score is a grading system for prostate cancer severity. It is defined on a scale of 1-5 where 1 is low-grade tumor cells and 5 is high-grade tumor cells.~Pathologists assign two Gleason grades to a biopsy; one for the predominant pattern and another for the second most predominant pattern. The two grades are added together to determine the Gleason Score (ultimately a number between 2 and 10). Scores of 2-4 tend to indicate less aggressive cancers, and 7-10 indicate more aggressive cancers."|Participants|Count of Participants|0|0.0||||||
3832048|NCT01706458|3658817|B3|>/= 9||Gleason score|"The Gleason Score is a grading system for prostate cancer severity. It is defined on a scale of 1-5 where 1 is low-grade tumor cells and 5 is high-grade tumor cells.~Pathologists assign two Gleason grades to a biopsy; one for the predominant pattern and another for the second most predominant pattern. The two grades are added together to determine the Gleason Score (ultimately a number between 2 and 10). Scores of 2-4 tend to indicate less aggressive cancers, and 7-10 indicate more aggressive cancers."|Participants|Count of Participants|5|5.0||||||
3832049|NCT01706458|3658818|B2|>/= 9||Gleason score|"The Gleason Score is a grading system for prostate cancer severity. It is defined on a scale of 1-5 where 1 is low-grade tumor cells and 5 is high-grade tumor cells.~Pathologists assign two Gleason grades to a biopsy; one for the predominant pattern and another for the second most predominant pattern. The two grades are added together to determine the Gleason Score (ultimately a number between 2 and 10). Scores of 2-4 tend to indicate less aggressive cancers, and 7-10 indicate more aggressive cancers."|Participants|Count of Participants|0|0.0||||||
3832105|NCT01706328|3658842|B3|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|813|813.0||||||
3832168|NCT01706146|3658911|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3832050|NCT01706458|3658819|B1|>/= 9||Gleason score|"The Gleason Score is a grading system for prostate cancer severity. It is defined on a scale of 1-5 where 1 is low-grade tumor cells and 5 is high-grade tumor cells.~Pathologists assign two Gleason grades to a biopsy; one for the predominant pattern and another for the second most predominant pattern. The two grades are added together to determine the Gleason Score (ultimately a number between 2 and 10). Scores of 2-4 tend to indicate less aggressive cancers, and 7-10 indicate more aggressive cancers."|Participants|Count of Participants|5|5.0||||||
3832051|NCT01706458|3658817|B3|8||Gleason score|"The Gleason Score is a grading system for prostate cancer severity. It is defined on a scale of 1-5 where 1 is low-grade tumor cells and 5 is high-grade tumor cells.~Pathologists assign two Gleason grades to a biopsy; one for the predominant pattern and another for the second most predominant pattern. The two grades are added together to determine the Gleason Score (ultimately a number between 2 and 10). Scores of 2-4 tend to indicate less aggressive cancers, and 7-10 indicate more aggressive cancers."|Participants|Count of Participants|2|2.0||||||
3832052|NCT01706458|3658818|B2|8||Gleason score|"The Gleason Score is a grading system for prostate cancer severity. It is defined on a scale of 1-5 where 1 is low-grade tumor cells and 5 is high-grade tumor cells.~Pathologists assign two Gleason grades to a biopsy; one for the predominant pattern and another for the second most predominant pattern. The two grades are added together to determine the Gleason Score (ultimately a number between 2 and 10). Scores of 2-4 tend to indicate less aggressive cancers, and 7-10 indicate more aggressive cancers."|Participants|Count of Participants|2|2.0||||||
3832053|NCT01706458|3658819|B1|8||Gleason score|"The Gleason Score is a grading system for prostate cancer severity. It is defined on a scale of 1-5 where 1 is low-grade tumor cells and 5 is high-grade tumor cells.~Pathologists assign two Gleason grades to a biopsy; one for the predominant pattern and another for the second most predominant pattern. The two grades are added together to determine the Gleason Score (ultimately a number between 2 and 10). Scores of 2-4 tend to indicate less aggressive cancers, and 7-10 indicate more aggressive cancers."|Participants|Count of Participants|0|0.0||||||
3832054|NCT01706458|3658817|B3|7||Gleason score|"The Gleason Score is a grading system for prostate cancer severity. It is defined on a scale of 1-5 where 1 is low-grade tumor cells and 5 is high-grade tumor cells.~Pathologists assign two Gleason grades to a biopsy; one for the predominant pattern and another for the second most predominant pattern. The two grades are added together to determine the Gleason Score (ultimately a number between 2 and 10). Scores of 2-4 tend to indicate less aggressive cancers, and 7-10 indicate more aggressive cancers."|Participants|Count of Participants|7|7.0||||||
3832055|NCT01706458|3658818|B2|7||Gleason score|"The Gleason Score is a grading system for prostate cancer severity. It is defined on a scale of 1-5 where 1 is low-grade tumor cells and 5 is high-grade tumor cells.~Pathologists assign two Gleason grades to a biopsy; one for the predominant pattern and another for the second most predominant pattern. The two grades are added together to determine the Gleason Score (ultimately a number between 2 and 10). Scores of 2-4 tend to indicate less aggressive cancers, and 7-10 indicate more aggressive cancers."|Participants|Count of Participants|4|4.0||||||
3832056|NCT01706458|3658819|B1|7||Gleason score|"The Gleason Score is a grading system for prostate cancer severity. It is defined on a scale of 1-5 where 1 is low-grade tumor cells and 5 is high-grade tumor cells.~Pathologists assign two Gleason grades to a biopsy; one for the predominant pattern and another for the second most predominant pattern. The two grades are added together to determine the Gleason Score (ultimately a number between 2 and 10). Scores of 2-4 tend to indicate less aggressive cancers, and 7-10 indicate more aggressive cancers."|Participants|Count of Participants|3|3.0||||||
3832057|NCT01706458|3658817|B3|< 7||Gleason score|"The Gleason Score is a grading system for prostate cancer severity. It is defined on a scale of 1-5 where 1 is low-grade tumor cells and 5 is high-grade tumor cells.~Pathologists assign two Gleason grades to a biopsy; one for the predominant pattern and another for the second most predominant pattern. The two grades are added together to determine the Gleason Score (ultimately a number between 2 and 10). Scores of 2-4 tend to indicate less aggressive cancers, and 7-10 indicate more aggressive cancers."|Participants|Count of Participants|3|3.0||||||
3832058|NCT01706458|3658818|B2|< 7||Gleason score|"The Gleason Score is a grading system for prostate cancer severity. It is defined on a scale of 1-5 where 1 is low-grade tumor cells and 5 is high-grade tumor cells.~Pathologists assign two Gleason grades to a biopsy; one for the predominant pattern and another for the second most predominant pattern. The two grades are added together to determine the Gleason Score (ultimately a number between 2 and 10). Scores of 2-4 tend to indicate less aggressive cancers, and 7-10 indicate more aggressive cancers."|Participants|Count of Participants|2|2.0||||||
3832059|NCT01706458|3658819|B1|< 7||Gleason score|"The Gleason Score is a grading system for prostate cancer severity. It is defined on a scale of 1-5 where 1 is low-grade tumor cells and 5 is high-grade tumor cells.~Pathologists assign two Gleason grades to a biopsy; one for the predominant pattern and another for the second most predominant pattern. The two grades are added together to determine the Gleason Score (ultimately a number between 2 and 10). Scores of 2-4 tend to indicate less aggressive cancers, and 7-10 indicate more aggressive cancers."|Participants|Count of Participants|1|1.0||||||
3832060|NCT01706458|3658817|B3|1||ECOG Performance Status|"The ECOG Performance Status describes a patient's level of function:~0. is fully active, performance without restriction,~is restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work,~is ambulatory and capable of selfcare but unable to carry out work activities, up and about more that 50% of waking hours,~is capable of limited selfcare; confined to bed or chair more than 50% of waking hours,~is completely disabled; no selfcare, confined to bed or chair,~is deceased"|Participants|Count of Participants|1|1.0||||||
3832061|NCT01706458|3658818|B2|1||ECOG Performance Status|"The ECOG Performance Status describes a patient's level of function:~0. is fully active, performance without restriction,~is restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work,~is ambulatory and capable of selfcare but unable to carry out work activities, up and about more that 50% of waking hours,~is capable of limited selfcare; confined to bed or chair more than 50% of waking hours,~is completely disabled; no selfcare, confined to bed or chair,~is deceased"|Participants|Count of Participants|1|1.0||||||
3832106|NCT01706328|3658843|B2|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|410|410.0||||||
3832107|NCT01706328|3658844|B1|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|403|403.0||||||
3832108|NCT01706328|3658842|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3832062|NCT01706458|3658819|B1|1||ECOG Performance Status|"The ECOG Performance Status describes a patient's level of function:~0. is fully active, performance without restriction,~is restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work,~is ambulatory and capable of selfcare but unable to carry out work activities, up and about more that 50% of waking hours,~is capable of limited selfcare; confined to bed or chair more than 50% of waking hours,~is completely disabled; no selfcare, confined to bed or chair,~is deceased"|Participants|Count of Participants|0|0.0||||||
3832063|NCT01706458|3658817|B3|0||ECOG Performance Status|"The ECOG Performance Status describes a patient's level of function:~0. is fully active, performance without restriction,~is restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work,~is ambulatory and capable of selfcare but unable to carry out work activities, up and about more that 50% of waking hours,~is capable of limited selfcare; confined to bed or chair more than 50% of waking hours,~is completely disabled; no selfcare, confined to bed or chair,~is deceased"|Participants|Count of Participants|17|17.0||||||
3832064|NCT01706458|3658818|B2|0||ECOG Performance Status|"The ECOG Performance Status describes a patient's level of function:~0. is fully active, performance without restriction,~is restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work,~is ambulatory and capable of selfcare but unable to carry out work activities, up and about more that 50% of waking hours,~is capable of limited selfcare; confined to bed or chair more than 50% of waking hours,~is completely disabled; no selfcare, confined to bed or chair,~is deceased"|Participants|Count of Participants|8|8.0||||||
3832065|NCT01706458|3658819|B1|0||ECOG Performance Status|"The ECOG Performance Status describes a patient's level of function:~0. is fully active, performance without restriction,~is restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work,~is ambulatory and capable of selfcare but unable to carry out work activities, up and about more that 50% of waking hours,~is capable of limited selfcare; confined to bed or chair more than 50% of waking hours,~is completely disabled; no selfcare, confined to bed or chair,~is deceased"|Participants|Count of Participants|9|9.0||||||
3832066|NCT01706458|3658817|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832067|NCT01706458|3658818|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832068|NCT01706458|3658819|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832069|NCT01706458|3658817|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832070|NCT01706458|3658818|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832071|NCT01706458|3658819|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832072|NCT01706458|3658817|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3832073|NCT01706458|3658818|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3832074|NCT01706458|3658819|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3832075|NCT01706458|3658817|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832076|NCT01706458|3658818|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832077|NCT01706458|3658819|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832078|NCT01706458|3658817|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832079|NCT01706458|3658818|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832080|NCT01706458|3658819|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832081|NCT01706458|3658817|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832082|NCT01706458|3658818|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832083|NCT01706458|3658819|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832084|NCT01706458|3658817|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832085|NCT01706458|3658818|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832086|NCT01706458|3658819|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832087|NCT01706458|3658817|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832088|NCT01706458|3658818|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832089|NCT01706458|3658819|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832090|NCT01706458|3658817|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3832091|NCT01706458|3658818|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3832092|NCT01706458|3658819|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3832093|NCT01706458|3658817|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832094|NCT01706458|3658818|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832095|NCT01706458|3658819|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832096|NCT01706458|3658817|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3832097|NCT01706458|3658818|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3832098|NCT01706458|3658819|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3832099|NCT01706458|3658817|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3832100|NCT01706458|3658818|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3832101|NCT01706458|3658819|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3832102|NCT01706458|3658817|B3|||Age||years|Median|74|74.0|Full Range|||66.0|85.0|
3832103|NCT01706458|3658818|B2|||Age||years|Median|72|72.0|Full Range|||66.0|85.0|
3832104|NCT01706458|3658819|B1|||Age||years|Median|75|75.0|Full Range|||67.0|82.0|
3832109|NCT01706328|3658843|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3832110|NCT01706328|3658844|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3832111|NCT01706328|3658842|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3832112|NCT01706328|3658843|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3832113|NCT01706328|3658844|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3832114|NCT01706328|3658842|B3||Male|Sex: Female, Male||Participants|Count of Participants|595|595.0||||||
3832115|NCT01706328|3658843|B2||Male|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
3832116|NCT01706328|3658844|B1||Male|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
3832117|NCT01706328|3658842|B3||Female|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
3832118|NCT01706328|3658843|B2||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3832119|NCT01706328|3658844|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3832120|NCT01706328|3658842|B3|||Age||Years|Mean|61.1|61.1|Standard Deviation|8.27|8.27|||
3832121|NCT01706328|3658843|B2|||Age||Years|Mean|61.3|61.3|Standard Deviation|8.37|8.37|||
3832122|NCT01706328|3658844|B1|||Age||Years|Mean|61.0|61.0|Standard Deviation|8.17|8.17|||
3832123|NCT01706263|3658856|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832124|NCT01706263|3658856|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832125|NCT01706263|3658856|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3832126|NCT01706263|3658856|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3832127|NCT01706263|3658856|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832128|NCT01706263|3658856|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3832129|NCT01706263|3658856|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832130|NCT01706263|3658856|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3832131|NCT01706263|3658856|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3832132|NCT01706263|3658856|B1|||Age||Years|Mean|21.7|21.7|Standard Deviation|4.8|4.8|||
3832133|NCT01706250|3658865|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3832134|NCT01706250|3658865|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3832135|NCT01706250|3658865|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3832136|NCT01706250|3658865|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3832137|NCT01706250|3658865|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3832138|NCT01706250|3658865|B1|||Age||Years|Mean|21.5|21.5|Standard Deviation|3.6|3.6|||
3832139|NCT01706159|3658894|B3|||Body Mass Index||kg/m^2|Mean|24.8|24.8|Standard Deviation|3.9|3.9|||
3832140|NCT01706159|3658895|B2|||Body Mass Index||kg/m^2|Mean|25.6|25.6|Standard Deviation|5.8|5.8|||
3832141|NCT01706159|3658896|B1|||Body Mass Index||kg/m^2|Mean|24.5|24.5|Standard Deviation|3.2|3.2|||
3832142|NCT01706159|3658894|B3|Whites||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3832143|NCT01706159|3658895|B2|Whites||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3832144|NCT01706159|3658896|B1|Whites||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3832145|NCT01706159|3658894|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3832146|NCT01706159|3658895|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3832147|NCT01706159|3658896|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3832148|NCT01706159|3658894|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3832149|NCT01706159|3658895|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3832150|NCT01706159|3658896|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3832151|NCT01706159|3658894|B3|||Age||years|Mean|39.2|39.2|Standard Deviation|12.2|12.2|||
3832152|NCT01706159|3658895|B2|||Age||years|Mean|45.0|45.0|Standard Deviation|15.4|15.4|||
3832153|NCT01706159|3658896|B1|||Age||years|Mean|36.9|36.9|Standard Deviation|10.6|10.6|||
3832154|NCT01706146|3658911|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
3832155|NCT01706146|3658911|B1|Canada||Region of Enrollment||participants|Number|12|12.0||||||
3832156|NCT01706146|3658911|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832157|NCT01706146|3658911|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832158|NCT01706146|3658911|B1||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3832159|NCT01706146|3658911|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3832160|NCT01706146|3658911|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3832161|NCT01706146|3658911|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3832162|NCT01706146|3658911|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832163|NCT01706146|3658911|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3832164|NCT01706146|3658911|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3832165|NCT01706146|3658911|B1|||Age||year|Mean|66.8|66.8|Standard Deviation|7.7|7.7|||
3832166|NCT01706146|3658911|B1||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
3832167|NCT01706146|3658911|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3832169|NCT01705730|3658916|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3832170|NCT01705730|3658916|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3832171|NCT01705730|3658916|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|12.0|12.0|||
3832172|NCT01705717|3658954|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3832173|NCT01705717|3658955|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3832174|NCT01705717|3658956|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3832175|NCT01705717|3658954|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3832176|NCT01705717|3658955|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3832177|NCT01705717|3658956|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3832178|NCT01705717|3658954|B3|||Age||years|Mean|47.2|47.2|Standard Deviation|10.77|10.77|||
3832179|NCT01705717|3658955|B2|||Age||years|Mean|53.9|53.9|Standard Deviation|8.2|8.2|||
3832180|NCT01705717|3658956|B1|||Age||years|Mean|44.8|44.8|Standard Deviation|10.9|10.9|||
3832181|NCT01705691|3658972|B3|Unknown Ethnicity||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3832182|NCT01705691|3658973|B2|Unknown Ethnicity||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3832183|NCT01705691|3658974|B1|Unknown Ethnicity||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3832184|NCT01705691|3658972|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3832185|NCT01705691|3658973|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3832186|NCT01705691|3658974|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3832187|NCT01705691|3658972|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
3832188|NCT01705691|3658973|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3832189|NCT01705691|3658974|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3832190|NCT01705691|3658972|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3832191|NCT01705691|3658973|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3832192|NCT01705691|3658974|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3832193|NCT01705691|3658972|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3832194|NCT01705691|3658973|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3832195|NCT01705691|3658974|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3832196|NCT01705691|3658972|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3832197|NCT01705691|3658973|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3832198|NCT01705691|3658974|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3832199|NCT01705691|3658972|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
3832200|NCT01705691|3658973|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3832201|NCT01705691|3658974|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3832202|NCT01705691|3658972|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3832203|NCT01705691|3658973|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3832204|NCT01705691|3658974|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3832205|NCT01705691|3658972|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3832206|NCT01705691|3658973|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3832207|NCT01705691|3658974|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3832208|NCT01705691|3658972|B3|||Age||years|Mean|49.67|49.67|Standard Deviation|12.21|12.21|||
3832209|NCT01705691|3658973|B2|||Age||years|Mean|49.17|49.17|Standard Deviation|13.21|13.21|||
3832210|NCT01705691|3658974|B1|||Age||years|Mean|50.47|50.47|Standard Deviation|10.73|10.73|||
3832211|NCT01705652|3658993|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
3832212|NCT01705652|3658994|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3832213|NCT01705652|3658995|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3832214|NCT01705652|3658993|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832215|NCT01705652|3658994|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832216|NCT01705652|3658995|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832217|NCT01705652|3658993|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832218|NCT01705652|3658994|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832219|NCT01705652|3658995|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832220|NCT01705652|3658993|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3832221|NCT01705652|3658994|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3832222|NCT01705652|3658995|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3832223|NCT01705652|3658993|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3832224|NCT01705652|3658994|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3832225|NCT01705652|3658995|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3832226|NCT01705652|3658993|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832227|NCT01705652|3658994|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832228|NCT01705652|3658995|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832229|NCT01705652|3658993|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832230|NCT01705652|3658994|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832231|NCT01705652|3658995|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832232|NCT01705652|3658993|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832233|NCT01705652|3658994|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832234|NCT01705652|3658995|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832235|NCT01705652|3658993|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832236|NCT01705652|3658994|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832237|NCT01705652|3658995|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832238|NCT01705652|3658993|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3832239|NCT01705652|3658994|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3832240|NCT01705652|3658995|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3832241|NCT01705652|3658993|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3832242|NCT01705652|3658994|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3832243|NCT01705652|3658995|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3832244|NCT01705652|3658993|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3832245|NCT01705652|3658994|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3832246|NCT01705652|3658995|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3832247|NCT01705652|3658993|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3832248|NCT01705652|3658994|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3832249|NCT01705652|3658995|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3832250|NCT01705652|3658993|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3832251|NCT01705652|3658994|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3832252|NCT01705652|3658995|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3832253|NCT01705652|3658993|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3832254|NCT01705652|3658994|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3832255|NCT01705652|3658995|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3832256|NCT01705652|3658993|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3832257|NCT01705652|3658994|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3832258|NCT01705652|3658995|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3832259|NCT01705587|3659002|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832260|NCT01705587|3659003|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832261|NCT01705587|3659004|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832262|NCT01705587|3659002|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832263|NCT01705587|3659003|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832264|NCT01705587|3659004|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832265|NCT01705587|3659002|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3832266|NCT01705587|3659003|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3832267|NCT01705587|3659004|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3832268|NCT01705587|3659002|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3832269|NCT01705587|3659003|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3832270|NCT01705587|3659004|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832271|NCT01705587|3659002|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832272|NCT01705587|3659003|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832273|NCT01705587|3659004|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832274|NCT01705587|3659002|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3832275|NCT01705587|3659003|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3832276|NCT01705587|3659004|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832277|NCT01705587|3659002|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832278|NCT01705587|3659003|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832279|NCT01705587|3659004|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832280|NCT01705587|3659002|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3832281|NCT01705587|3659003|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3832282|NCT01705587|3659004|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3832283|NCT01705587|3659002|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3832284|NCT01705587|3659003|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3832285|NCT01705587|3659004|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3832286|NCT01705587|3659002|B3|||Age||years|Mean|74.2|74.2|Standard Deviation|9.094|9.094|||
3832287|NCT01705587|3659003|B2|||Age||years|Mean|69.8|69.8|Standard Deviation|8.085|8.085|||
3832288|NCT01705587|3659004|B1|||Age||years|Mean|78.0|78.0|Standard Deviation|8.660|8.66|||
3832289|NCT01705574|3659021|B3|||CD4 Cell Count||cells/µL|Mean|381|381.0|Standard Deviation|204.8|204.8|||
3832290|NCT01705574|3659022|B2|||CD4 Cell Count||cells/µL|Mean|385|385.0|Standard Deviation|210.2|210.2|||
3832291|NCT01705574|3659023|B1|||CD4 Cell Count||cells/µL|Mean|376|376.0|Standard Deviation|199.6|199.6|||
3832292|NCT01705574|3659021|B3|> 400,000||HIV-1 RNA Category||participants|Number|47|47.0||||||
3832293|NCT01705574|3659022|B2|> 400,000||HIV-1 RNA Category||participants|Number|22|22.0||||||
3832294|NCT01705574|3659023|B1|> 400,000||HIV-1 RNA Category||participants|Number|25|25.0||||||
3832295|NCT01705574|3659021|B3|> 100,000 to ≤400,000||HIV-1 RNA Category||participants|Number|94|94.0||||||
3832296|NCT01705574|3659022|B2|> 100,000 to ≤400,000||HIV-1 RNA Category||participants|Number|50|50.0||||||
3832297|NCT01705574|3659023|B1|> 100,000 to ≤400,000||HIV-1 RNA Category||participants|Number|44|44.0||||||
3832298|NCT01705574|3659021|B3|≤ 100,000||HIV-1 RNA Category||participants|Number|434|434.0||||||
3832299|NCT01705574|3659022|B2|≤ 100,000||HIV-1 RNA Category||participants|Number|214|214.0||||||
3832300|NCT01705574|3659023|B1|≤ 100,000||HIV-1 RNA Category||participants|Number|220|220.0||||||
3832301|NCT01705574|3659021|B3|||HIV-1 RNA||log10 copies/mL|Mean|4.51|4.51|Standard Deviation|0.753|0.753|||
3832302|NCT01705574|3659022|B2|||HIV-1 RNA||log10 copies/mL|Mean|4.52|4.52|Standard Deviation|0.781|0.781|||
3832303|NCT01705574|3659023|B1|||HIV-1 RNA||log10 copies/mL|Mean|4.51|4.51|Standard Deviation|0.724|0.724|||
3832304|NCT01705574|3659021|B3|France||Region of Enrollment||participants|Number|2|2.0||||||
3832305|NCT01705574|3659022|B2|France||Region of Enrollment||participants|Number|1|1.0||||||
3832306|NCT01705574|3659023|B1|France||Region of Enrollment||participants|Number|1|1.0||||||
3832307|NCT01705574|3659021|B3|Uganda||Region of Enrollment||participants|Number|161|161.0||||||
3832308|NCT01705574|3659022|B2|Uganda||Region of Enrollment||participants|Number|74|74.0||||||
3832309|NCT01705574|3659023|B1|Uganda||Region of Enrollment||participants|Number|87|87.0||||||
3832310|NCT01705574|3659021|B3|Mexico||Region of Enrollment||participants|Number|4|4.0||||||
3832311|NCT01705574|3659022|B2|Mexico||Region of Enrollment||participants|Number|1|1.0||||||
3832312|NCT01705574|3659023|B1|Mexico||Region of Enrollment||participants|Number|3|3.0||||||
3832313|NCT01705574|3659021|B3|Italy||Region of Enrollment||participants|Number|5|5.0||||||
3832314|NCT01705574|3659022|B2|Italy||Region of Enrollment||participants|Number|1|1.0||||||
3832315|NCT01705574|3659023|B1|Italy||Region of Enrollment||participants|Number|4|4.0||||||
3832316|NCT01705574|3659021|B3|Dominican Republic||Region of Enrollment||participants|Number|19|19.0||||||
3832317|NCT01705574|3659022|B2|Dominican Republic||Region of Enrollment||participants|Number|13|13.0||||||
3832318|NCT01705574|3659023|B1|Dominican Republic||Region of Enrollment||participants|Number|6|6.0||||||
3832319|NCT01705574|3659021|B3|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
3832320|NCT01705574|3659022|B2|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
3832321|NCT01705574|3659023|B1|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
3832322|NCT01705574|3659021|B3|Portugal||Region of Enrollment||participants|Number|21|21.0||||||
3832323|NCT01705574|3659022|B2|Portugal||Region of Enrollment||participants|Number|13|13.0||||||
3832324|NCT01705574|3659023|B1|Portugal||Region of Enrollment||participants|Number|8|8.0||||||
3832325|NCT01705574|3659021|B3|Thailand||Region of Enrollment||participants|Number|24|24.0||||||
3832326|NCT01705574|3659022|B2|Thailand||Region of Enrollment||participants|Number|15|15.0||||||
3832327|NCT01705574|3659023|B1|Thailand||Region of Enrollment||participants|Number|9|9.0||||||
3832328|NCT01705574|3659021|B3|United Kingdom||Region of Enrollment||participants|Number|20|20.0||||||
3832329|NCT01705574|3659022|B2|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
3832330|NCT01705574|3659023|B1|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3832331|NCT01705574|3659021|B3|United States||Region of Enrollment||participants|Number|119|119.0||||||
3832332|NCT01705574|3659022|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
3832333|NCT01705574|3659023|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
3832334|NCT01705574|3659021|B3|Russian Federation||Region of Enrollment||participants|Number|192|192.0||||||
3832335|NCT01705574|3659022|B2|Russian Federation||Region of Enrollment||participants|Number|91|91.0||||||
3832336|NCT01705574|3659023|B1|Russian Federation||Region of Enrollment||participants|Number|101|101.0||||||
3832337|NCT01705574|3659021|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|531|531.0||||||
3832338|NCT01705574|3659022|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|262|262.0||||||
3832339|NCT01705574|3659023|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|269|269.0||||||
3832340|NCT01705574|3659021|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
3832341|NCT01705574|3659022|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3832342|NCT01705574|3659023|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3832343|NCT01705574|3659021|B3|Not Permitted||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3832344|NCT01705574|3659022|B2|Not Permitted||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3832345|NCT01705574|3659023|B1|Not Permitted||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3832346|NCT01705574|3659021|B3|Other||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3832347|NCT01705574|3659022|B2|Other||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3832348|NCT01705574|3659023|B1|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3832349|NCT01705574|3659021|B3|White||Race/Ethnicity, Customized||participants|Number|247|247.0||||||
3832350|NCT01705574|3659022|B2|White||Race/Ethnicity, Customized||participants|Number|119|119.0||||||
3832351|NCT01705574|3659023|B1|White||Race/Ethnicity, Customized||participants|Number|128|128.0||||||
3832352|NCT01705574|3659021|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3832353|NCT01705574|3659022|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3832354|NCT01705574|3659023|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3832355|NCT01705574|3659021|B3|Black||Race/Ethnicity, Customized||participants|Number|276|276.0||||||
3832356|NCT01705574|3659022|B2|Black||Race/Ethnicity, Customized||participants|Number|133|133.0||||||
3832357|NCT01705574|3659023|B1|Black||Race/Ethnicity, Customized||participants|Number|143|143.0||||||
3832358|NCT01705574|3659021|B3|Asian||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3832359|NCT01705574|3659022|B2|Asian||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3832360|NCT01705574|3659023|B1|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3832361|NCT01705574|3659021|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3832362|NCT01705574|3659022|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3832363|NCT01705574|3659023|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3832364|NCT01705574|3659021|B3||Female|Sex: Female, Male||Participants|Count of Participants|575|575.0||||||
3832365|NCT01705574|3659022|B2||Female|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
3832366|NCT01705574|3659023|B1||Female|Sex: Female, Male||Participants|Count of Participants|289|289.0||||||
3832367|NCT01705574|3659021|B3|||Age||years|Mean|36|36.0|Standard Deviation|9.9|9.9|||
3832368|NCT01705574|3659022|B2|||Age||years|Mean|36|36.0|Standard Deviation|9.7|9.7|||
3832369|NCT01705574|3659023|B1|||Age||years|Mean|36|36.0|Standard Deviation|10.1|10.1|||
3832370|NCT01705496|3659032|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3832371|NCT01705496|3659032|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3832372|NCT01705496|3659032|B1|||Age||years|Mean|64.1|64.1|Standard Deviation|9.11|9.11|||
3832373|NCT01705145|3659042|B1|Part B (n = 34): Male||Sex/Gender, Customized|"Data was planned to be reported separately for Part A and Part B of the study. Here n signifies participants who were evaluable for specified part of the study."|participants|Number|28|28.0||||||
3832374|NCT01705145|3659042|B1|Part B (n = 34): Female||Sex/Gender, Customized|"Data was planned to be reported separately for Part A and Part B of the study. Here n signifies participants who were evaluable for specified part of the study."|participants|Number|6|6.0||||||
3832375|NCT01705145|3659042|B1|Part A (n = 9): Male||Sex/Gender, Customized|"Data was planned to be reported separately for Part A and Part B of the study. Here n signifies participants who were evaluable for specified part of the study."|participants|Number|6|6.0||||||
3832376|NCT01705145|3659042|B1|Part A (n = 9): Female||Sex/Gender, Customized|"Data was planned to be reported separately for Part A and Part B of the study. Here n signifies participants who were evaluable for specified part of the study."|participants|Number|3|3.0||||||
3832377|NCT01705145|3659042|B1|Part B (n = 34)||Age|Data was planned to be reported separately for Part A and Part B of the study. Here “n” signifies participants who were evaluable for specified part of the study.|years|Mean|3.2|3.2|Standard Deviation|0.96|0.96|||
3832378|NCT01705145|3659042|B1|Part A (n = 9)||Age|Data was planned to be reported separately for Part A and Part B of the study. Here “n” signifies participants who were evaluable for specified part of the study.|years|Mean|3.1|3.1|Standard Deviation|1.17|1.17|||
3832379|NCT01705106|3659070|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832380|NCT01705106|3659070|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832381|NCT01705106|3659070|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3832382|NCT01705106|3659070|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3832383|NCT01705106|3659070|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832384|NCT01705106|3659070|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3832385|NCT01705106|3659070|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832386|NCT01705106|3659070|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3832387|NCT01705106|3659070|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3832388|NCT01705106|3659070|B1|||Age||years|Median|57.5|57.5|Full Range|||52.0|67.0|
3832389|NCT01705080|3659078|B5|Diastolic||24-hour ambulatory blood pressure||mmHg|Mean|87.3|87.3|Standard Deviation|13.9|13.9|||
3832390|NCT01705080|3659079|B4|Diastolic||24-hour ambulatory blood pressure||mmHg|Mean|84.8|84.8|Standard Deviation|15.6|15.6|||
3832391|NCT01705080|3659080|B3|Diastolic||24-hour ambulatory blood pressure||mmHg|Mean|83.4|83.4|Standard Deviation|14.7|14.7|||
3832392|NCT01705080|3659081|B2|Diastolic||24-hour ambulatory blood pressure||mmHg|Mean|87.2|87.2|Standard Deviation|13.6|13.6|||
3832393|NCT01705080|3659082|B1|Diastolic||24-hour ambulatory blood pressure||mmHg|Mean|88.8|88.8|Standard Deviation|13.3|13.3|||
3832394|NCT01705080|3659078|B5|Systolic||24-hour ambulatory blood pressure||mmHg|Mean|153.9|153.9|Standard Deviation|17.1|17.1|||
3832395|NCT01705080|3659079|B4|Systolic||24-hour ambulatory blood pressure||mmHg|Mean|150.1|150.1|Standard Deviation|22.0|22.0|||
3832396|NCT01705080|3659080|B3|Systolic||24-hour ambulatory blood pressure||mmHg|Mean|160.6|160.6|Standard Deviation|18.6|18.6|||
3832397|NCT01705080|3659081|B2|Systolic||24-hour ambulatory blood pressure||mmHg|Mean|146.7|146.7|Standard Deviation|12.4|12.4|||
3832398|NCT01705080|3659082|B1|Systolic||24-hour ambulatory blood pressure||mmHg|Mean|158.8|158.8|Standard Deviation|16.3|16.3|||
3832399|NCT01705080|3659078|B5|Diastolic||Office Blood Pressure||mmHg|Mean|93.8|93.8|Standard Deviation|15.5|15.5|||
3832400|NCT01705080|3659079|B4|Diastolic||Office Blood Pressure||mmHg|Mean|92.2|92.2|Standard Deviation|18.1|18.1|||
3832401|NCT01705080|3659080|B3|Diastolic||Office Blood Pressure||mmHg|Mean|90.2|90.2|Standard Deviation|12.4|12.4|||
3832402|NCT01705080|3659081|B2|Diastolic||Office Blood Pressure||mmHg|Mean|91.0|91.0|Standard Deviation|13.0|13.0|||
3832403|NCT01705080|3659082|B1|Diastolic||Office Blood Pressure||mmHg|Mean|97.0|97.0|Standard Deviation|16.4|16.4|||
3832404|NCT01705080|3659078|B5|Systolic||Office Blood Pressure||mmHg|Mean|171.5|171.5|Standard Deviation|22.3|22.3|||
3832405|NCT01705080|3659079|B4|Systolic||Office Blood Pressure||mmHg|Mean|166.2|166.2|Standard Deviation|24.8|24.8|||
3832406|NCT01705080|3659080|B3|Systolic||Office Blood Pressure||mmHg|Mean|176.4|176.4|Standard Deviation|21.2|21.2|||
3832407|NCT01705080|3659081|B2|Systolic||Office Blood Pressure||mmHg|Mean|160.5|160.5|Standard Deviation|91.0|91.0|||
3832408|NCT01705080|3659082|B1|Systolic||Office Blood Pressure||mmHg|Mean|179.8|179.8|Standard Deviation|21.6|21.6|||
3832409|NCT01705080|3659078|B5|||Estimated Glomerular Filtration Rate (eGFR)||ml/min per 1.73m2|Mean|74.4|74.4|Standard Deviation|23.1|23.1|||
3832410|NCT01705080|3659079|B4|||Estimated Glomerular Filtration Rate (eGFR)||ml/min per 1.73m2|Mean|67.1|67.1|Standard Deviation|12.0|12.0|||
3832411|NCT01705080|3659080|B3|||Estimated Glomerular Filtration Rate (eGFR)||ml/min per 1.73m2|Mean|34.4|34.4|Standard Deviation|8.6|8.6|||
3832412|NCT01705080|3659081|B2|||Estimated Glomerular Filtration Rate (eGFR)||ml/min per 1.73m2|Mean|78.5|78.5|Standard Deviation|18.6|18.6|||
3832413|NCT01705080|3659082|B1|||Estimated Glomerular Filtration Rate (eGFR)||ml/min per 1.73m2|Mean|79.9|79.9|Standard Deviation|20.4|20.4|||
3832414|NCT01705080|3659078|B5|||Coronary Artery Disease||Participants|Count of Participants|84|84.0||||||
3832415|NCT01705080|3659079|B4|||Coronary Artery Disease||Participants|Count of Participants|8|8.0||||||
3832416|NCT01705080|3659080|B3|||Coronary Artery Disease||Participants|Count of Participants|14|14.0||||||
3832417|NCT01705080|3659081|B2|||Coronary Artery Disease||Participants|Count of Participants|24|24.0||||||
3832418|NCT01705080|3659082|B1|||Coronary Artery Disease||Participants|Count of Participants|38|38.0||||||
3832419|NCT01705080|3659078|B5|||Atrial Fibrillation||Participants|Count of Participants|35|35.0||||||
3832420|NCT01705080|3659079|B4|||Atrial Fibrillation||Participants|Count of Participants|1|1.0||||||
3832421|NCT01705080|3659080|B3|||Atrial Fibrillation||Participants|Count of Participants|4|4.0||||||
3832422|NCT01705080|3659081|B2|||Atrial Fibrillation||Participants|Count of Participants|15|15.0||||||
3832423|NCT01705080|3659082|B1|||Atrial Fibrillation||Participants|Count of Participants|15|15.0||||||
3832424|NCT01705080|3659078|B5|||Myocardial Infarction||Participants|Count of Participants|39|39.0||||||
3832425|NCT01705080|3659079|B4|||Myocardial Infarction||Participants|Count of Participants|4|4.0||||||
3832426|NCT01705080|3659080|B3|||Myocardial Infarction||Participants|Count of Participants|6|6.0||||||
3832427|NCT01705080|3659081|B2|||Myocardial Infarction||Participants|Count of Participants|13|13.0||||||
3832428|NCT01705080|3659082|B1|||Myocardial Infarction||Participants|Count of Participants|16|16.0||||||
3832429|NCT01705080|3659078|B5||Male|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
3832430|NCT01705080|3659079|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3832431|NCT01705080|3659080|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3832432|NCT01705080|3659081|B2||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3832433|NCT01705080|3659082|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3832434|NCT01705080|3659078|B5||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3832435|NCT01705080|3659079|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3832436|NCT01705080|3659080|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3832437|NCT01705080|3659081|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3832438|NCT01705080|3659082|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3832439|NCT01705080|3659078|B5|||Age||years|Mean|61.0|61.0|Standard Deviation|11.3|11.3|||
3832440|NCT01705080|3659079|B4|||Age||years|Mean|60.4|60.4|Standard Deviation|14.0|14.0|||
3832441|NCT01705080|3659080|B3|||Age||years|Mean|68.4|68.4|Standard Deviation|7.7|7.7|||
3832442|NCT01705080|3659081|B2|||Age||years|Mean|58.4|58.4|Standard Deviation|11.4|11.4|||
3832443|NCT01705080|3659082|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|10.4|10.4|||
3832444|NCT01704976|3659095|B3|||Total sum score of the Short Physical Performance Battery Test||sum of points|Median|3|3.0|Inter-Quartile Range|||2.0|5.0|
3832445|NCT01704976|3659096|B2|||Total sum score of the Short Physical Performance Battery Test||sum of points|Median|4|4.0|Inter-Quartile Range|||2.0|6.0|
3832446|NCT01704976|3659097|B1|||Total sum score of the Short Physical Performance Battery Test||sum of points|Median|3|3.0|Inter-Quartile Range|||2.0|4.5|
3832447|NCT01704976|3659095|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3832448|NCT01704976|3659096|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3832449|NCT01704976|3659097|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3832450|NCT01704976|3659095|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3832451|NCT01704976|3659096|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3832452|NCT01704976|3659097|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3832453|NCT01704976|3659095|B3|Age||Age||years|Mean|87.3|87.3|Standard Deviation|9.3|9.3|||
3832454|NCT01704976|3659096|B2|Age||Age||years|Mean|83.8|83.8|Standard Deviation|9.3|9.3|||
3832455|NCT01704976|3659097|B1|Age||Age||years|Mean|90.7|90.7|Standard Deviation|7.5|7.5|||
3832456|NCT01704846|3659112|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3832457|NCT01704846|3659113|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3832458|NCT01704846|3659114|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3832459|NCT01704846|3659112|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3832460|NCT01704846|3659113|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3832461|NCT01704846|3659114|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3832462|NCT01704846|3659112|B3|||Age||years|Mean|29.1|29.1|Standard Deviation|5.8|5.8|||
3832463|NCT01704846|3659113|B2|||Age||years|Mean|30.1|30.1|Standard Deviation|5.8|5.8|||
3832464|NCT01704846|3659114|B1|||Age||years|Mean|28.1|28.1|Standard Deviation|5.7|5.7|||
3832465|NCT01704781|3659133|B6|||BMI||kg/m^2|Mean|24.1|24.1|Standard Deviation|3.74|3.74|||
3832466|NCT01704781|3659134|B5|||BMI||kg/m^2|Mean|23.5|23.5|Standard Deviation|3.44|3.44|||
3832467|NCT01704781|3659135|B4|||BMI||kg/m^2|Mean|23.6|23.6|Standard Deviation|3.85|3.85|||
3832468|NCT01704781|3659136|B3|||BMI||kg/m^2|Mean|24.4|24.4|Standard Deviation|1.75|1.75|||
3832469|NCT01704781|3659137|B2|||BMI||kg/m^2|Mean|27.9|27.9|Standard Deviation|7.65|7.65|||
3832470|NCT01704781|3659138|B1|||BMI||kg/m^2|Mean|23.7|23.7|Standard Deviation|2.32|2.32|||
3832471|NCT01704781|3659133|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832472|NCT01704781|3659134|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832473|NCT01704781|3659135|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832474|NCT01704781|3659136|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832475|NCT01704781|3659137|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832476|NCT01704781|3659138|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832477|NCT01704781|3659133|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832478|NCT01704781|3659134|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832479|NCT01704781|3659135|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832480|NCT01704781|3659136|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832481|NCT01704781|3659137|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832482|NCT01704781|3659138|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832483|NCT01704781|3659133|B6||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3832484|NCT01704781|3659134|B5||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3832485|NCT01704781|3659135|B4||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3832486|NCT01704781|3659136|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3832487|NCT01704781|3659137|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3832488|NCT01704781|3659138|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3832489|NCT01704781|3659133|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3832490|NCT01704781|3659134|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832491|NCT01704781|3659135|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832492|NCT01704781|3659136|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832493|NCT01704781|3659137|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3832494|NCT01704781|3659138|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832495|NCT01704781|3659133|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832496|NCT01704781|3659134|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832497|NCT01704781|3659135|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832498|NCT01704781|3659136|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832499|NCT01704781|3659137|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832500|NCT01704781|3659138|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832501|NCT01704781|3659133|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3832502|NCT01704781|3659134|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3832503|NCT01704781|3659135|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832504|NCT01704781|3659136|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832505|NCT01704781|3659137|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3832506|NCT01704781|3659138|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832507|NCT01704781|3659133|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832508|NCT01704781|3659134|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832509|NCT01704781|3659135|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832510|NCT01704781|3659136|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832511|NCT01704781|3659137|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832512|NCT01704781|3659138|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832513|NCT01704781|3659133|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832514|NCT01704781|3659134|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832515|NCT01704781|3659135|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832516|NCT01704781|3659136|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832517|NCT01704781|3659137|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832518|NCT01704781|3659138|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832519|NCT01704781|3659133|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3832520|NCT01704781|3659134|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3832521|NCT01704781|3659135|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3832522|NCT01704781|3659136|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3832523|NCT01704781|3659137|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3832524|NCT01704781|3659138|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3832525|NCT01704781|3659133|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832526|NCT01704781|3659134|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832527|NCT01704781|3659135|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832528|NCT01704781|3659136|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832529|NCT01704781|3659137|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832530|NCT01704781|3659138|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832531|NCT01704781|3659133|B6||Male|Gender||Participants|Count of Participants|36|36.0||||||
3832532|NCT01704781|3659134|B5||Male|Gender||Participants|Count of Participants|12|12.0||||||
3832533|NCT01704781|3659135|B4||Male|Gender||Participants|Count of Participants|12|12.0||||||
3832534|NCT01704781|3659136|B3||Male|Gender||Participants|Count of Participants|6|6.0||||||
3832535|NCT01704781|3659137|B2||Male|Gender||Participants|Count of Participants|3|3.0||||||
3832536|NCT01704781|3659138|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
3832537|NCT01704781|3659133|B6||Female|Gender||Participants|Count of Participants|0|0.0||||||
3832538|NCT01704781|3659134|B5||Female|Gender||Participants|Count of Participants|0|0.0||||||
3832539|NCT01704781|3659135|B4||Female|Gender||Participants|Count of Participants|0|0.0||||||
3832540|NCT01704781|3659136|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
3832541|NCT01704781|3659137|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
3832542|NCT01704781|3659138|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3832543|NCT01704781|3659133|B6|||Age||years|Mean|42.9|42.9|Standard Deviation|7.34|7.34|||
3832544|NCT01704781|3659134|B5|||Age||years|Mean|41.5|41.5|Standard Deviation|8.04|8.04|||
3832545|NCT01704781|3659135|B4|||Age||years|Mean|44.4|44.4|Standard Deviation|7.97|7.97|||
3832546|NCT01704781|3659136|B3|||Age||years|Mean|46.2|46.2|Standard Deviation|5.42|5.42|||
3832547|NCT01704781|3659137|B2|||Age||years|Mean|35.7|35.7|Standard Deviation|3.06|3.06|||
3832548|NCT01704781|3659138|B1|||Age||years|Mean|43.7|43.7|Standard Deviation|4.16|4.16|||
3832549|NCT01704755|3659168|B3||Male|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
3832550|NCT01704755|3659169|B2||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3832551|NCT01704755|3659170|B1||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3832552|NCT01704755|3659168|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3832553|NCT01704755|3659169|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3832554|NCT01704755|3659170|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3832555|NCT01704755|3659168|B3|||Age||years|Mean|56.8|56.8|Standard Deviation|7.41|7.41|||
3832556|NCT01704755|3659169|B2|||Age||years|Mean|56.5|56.5|Standard Deviation|7.87|7.87|||
3832557|NCT01704755|3659170|B1|||Age||years|Mean|57.1|57.1|Standard Deviation|7.01|7.01|||
3832558|NCT01704651|3659183|B3|Yes, extensive (multiple sites/organs)||Residual Disease||participants|Number|11|11.0||||||
3832559|NCT01704651|3659184|B2|Yes, extensive (multiple sites/organs)||Residual Disease||participants|Number|5|5.0||||||
3832560|NCT01704651|3659185|B1|Yes, extensive (multiple sites/organs)||Residual Disease||participants|Number|6|6.0||||||
3832561|NCT01704651|3659183|B3|Yes, suboptimal (>1 cm, limited sites)||Residual Disease||participants|Number|2|2.0||||||
3832562|NCT01704651|3659184|B2|Yes, suboptimal (>1 cm, limited sites)||Residual Disease||participants|Number|2|2.0||||||
3832563|NCT01704651|3659185|B1|Yes, suboptimal (>1 cm, limited sites)||Residual Disease||participants|Number|0|0.0||||||
3832564|NCT01704651|3659183|B3|Yes, measurable (</= 1 cm)||Residual Disease||participants|Number|23|23.0||||||
3832565|NCT01704651|3659184|B2|Yes, measurable (</= 1 cm)||Residual Disease||participants|Number|11|11.0||||||
3832566|NCT01704651|3659185|B1|Yes, measurable (</= 1 cm)||Residual Disease||participants|Number|12|12.0||||||
3832567|NCT01704651|3659183|B3|No||Residual Disease||participants|Number|98|98.0||||||
3832568|NCT01704651|3659184|B2|No||Residual Disease||participants|Number|50|50.0||||||
3832569|NCT01704651|3659185|B1|No||Residual Disease||participants|Number|48|48.0||||||
3832594|NCT01704651|3659183|B3|United States||Region of Enrollment||participants|Number|134|134.0||||||
3832595|NCT01704651|3659184|B2|United States||Region of Enrollment||participants|Number|68|68.0||||||
3832570|NCT01704651|3659183|B3|Recurrent disease||Cancer Stage|Cancer Stage used the Fédération Internationale de Gynécologie et d’Obstétrique (FIGO) staging system. For ovarian cancer, there are 4 stages: stage I: confined to the organ of origin, stage II: invasion of surrounding organs or tissue, stage III: spread to distant nodes or tissue within the pelvis, stage IV: distant metastasis(es)|participants|Number|23|23.0||||||
3832571|NCT01704651|3659184|B2|Recurrent disease||Cancer Stage|Cancer Stage used the Fédération Internationale de Gynécologie et d’Obstétrique (FIGO) staging system. For ovarian cancer, there are 4 stages: stage I: confined to the organ of origin, stage II: invasion of surrounding organs or tissue, stage III: spread to distant nodes or tissue within the pelvis, stage IV: distant metastasis(es)|participants|Number|11|11.0||||||
3832572|NCT01704651|3659185|B1|Recurrent disease||Cancer Stage|Cancer Stage used the Fédération Internationale de Gynécologie et d’Obstétrique (FIGO) staging system. For ovarian cancer, there are 4 stages: stage I: confined to the organ of origin, stage II: invasion of surrounding organs or tissue, stage III: spread to distant nodes or tissue within the pelvis, stage IV: distant metastasis(es)|participants|Number|12|12.0||||||
3832573|NCT01704651|3659183|B3|Benign pelvic masses||Cancer Stage|Cancer Stage used the Fédération Internationale de Gynécologie et d’Obstétrique (FIGO) staging system. For ovarian cancer, there are 4 stages: stage I: confined to the organ of origin, stage II: invasion of surrounding organs or tissue, stage III: spread to distant nodes or tissue within the pelvis, stage IV: distant metastasis(es)|participants|Number|8|8.0||||||
3832574|NCT01704651|3659184|B2|Benign pelvic masses||Cancer Stage|Cancer Stage used the Fédération Internationale de Gynécologie et d’Obstétrique (FIGO) staging system. For ovarian cancer, there are 4 stages: stage I: confined to the organ of origin, stage II: invasion of surrounding organs or tissue, stage III: spread to distant nodes or tissue within the pelvis, stage IV: distant metastasis(es)|participants|Number|6|6.0||||||
3832575|NCT01704651|3659185|B1|Benign pelvic masses||Cancer Stage|Cancer Stage used the Fédération Internationale de Gynécologie et d’Obstétrique (FIGO) staging system. For ovarian cancer, there are 4 stages: stage I: confined to the organ of origin, stage II: invasion of surrounding organs or tissue, stage III: spread to distant nodes or tissue within the pelvis, stage IV: distant metastasis(es)|participants|Number|2|2.0||||||
3832576|NCT01704651|3659183|B3|Other non-ovarian primary cancers||Cancer Stage|Cancer Stage used the Fédération Internationale de Gynécologie et d’Obstétrique (FIGO) staging system. For ovarian cancer, there are 4 stages: stage I: confined to the organ of origin, stage II: invasion of surrounding organs or tissue, stage III: spread to distant nodes or tissue within the pelvis, stage IV: distant metastasis(es)|participants|Number|5|5.0||||||
3832577|NCT01704651|3659184|B2|Other non-ovarian primary cancers||Cancer Stage|Cancer Stage used the Fédération Internationale de Gynécologie et d’Obstétrique (FIGO) staging system. For ovarian cancer, there are 4 stages: stage I: confined to the organ of origin, stage II: invasion of surrounding organs or tissue, stage III: spread to distant nodes or tissue within the pelvis, stage IV: distant metastasis(es)|participants|Number|3|3.0||||||
3832578|NCT01704651|3659185|B1|Other non-ovarian primary cancers||Cancer Stage|Cancer Stage used the Fédération Internationale de Gynécologie et d’Obstétrique (FIGO) staging system. For ovarian cancer, there are 4 stages: stage I: confined to the organ of origin, stage II: invasion of surrounding organs or tissue, stage III: spread to distant nodes or tissue within the pelvis, stage IV: distant metastasis(es)|participants|Number|2|2.0||||||
3832579|NCT01704651|3659183|B3|III/IV||Cancer Stage|Cancer Stage used the Fédération Internationale de Gynécologie et d’Obstétrique (FIGO) staging system. For ovarian cancer, there are 4 stages: stage I: confined to the organ of origin, stage II: invasion of surrounding organs or tissue, stage III: spread to distant nodes or tissue within the pelvis, stage IV: distant metastasis(es)|participants|Number|73|73.0||||||
3832580|NCT01704651|3659184|B2|III/IV||Cancer Stage|Cancer Stage used the Fédération Internationale de Gynécologie et d’Obstétrique (FIGO) staging system. For ovarian cancer, there are 4 stages: stage I: confined to the organ of origin, stage II: invasion of surrounding organs or tissue, stage III: spread to distant nodes or tissue within the pelvis, stage IV: distant metastasis(es)|participants|Number|40|40.0||||||
3832581|NCT01704651|3659185|B1|III/IV||Cancer Stage|Cancer Stage used the Fédération Internationale de Gynécologie et d’Obstétrique (FIGO) staging system. For ovarian cancer, there are 4 stages: stage I: confined to the organ of origin, stage II: invasion of surrounding organs or tissue, stage III: spread to distant nodes or tissue within the pelvis, stage IV: distant metastasis(es)|participants|Number|33|33.0||||||
3832582|NCT01704651|3659183|B3|I/II||Cancer Stage|Cancer Stage used the Fédération Internationale de Gynécologie et d’Obstétrique (FIGO) staging system. For ovarian cancer, there are 4 stages: stage I: confined to the organ of origin, stage II: invasion of surrounding organs or tissue, stage III: spread to distant nodes or tissue within the pelvis, stage IV: distant metastasis(es)|participants|Number|25|25.0||||||
3832583|NCT01704651|3659184|B2|I/II||Cancer Stage|Cancer Stage used the Fédération Internationale de Gynécologie et d’Obstétrique (FIGO) staging system. For ovarian cancer, there are 4 stages: stage I: confined to the organ of origin, stage II: invasion of surrounding organs or tissue, stage III: spread to distant nodes or tissue within the pelvis, stage IV: distant metastasis(es)|participants|Number|8|8.0||||||
3832584|NCT01704651|3659185|B1|I/II||Cancer Stage|Cancer Stage used the Fédération Internationale de Gynécologie et d’Obstétrique (FIGO) staging system. For ovarian cancer, there are 4 stages: stage I: confined to the organ of origin, stage II: invasion of surrounding organs or tissue, stage III: spread to distant nodes or tissue within the pelvis, stage IV: distant metastasis(es)|participants|Number|17|17.0||||||
3832585|NCT01704651|3659183|B3|Secondary debulking||Surgery Type||participants|Number|23|23.0||||||
3832586|NCT01704651|3659184|B2|Secondary debulking||Surgery Type||participants|Number|11|11.0||||||
3832587|NCT01704651|3659185|B1|Secondary debulking||Surgery Type||participants|Number|12|12.0||||||
3832588|NCT01704651|3659183|B3|Interval debulking||Surgery Type||participants|Number|20|20.0||||||
3832589|NCT01704651|3659184|B2|Interval debulking||Surgery Type||participants|Number|11|11.0||||||
3832590|NCT01704651|3659185|B1|Interval debulking||Surgery Type||participants|Number|9|9.0||||||
3832591|NCT01704651|3659183|B3|Primary surgery||Surgery Type||participants|Number|91|91.0||||||
3832592|NCT01704651|3659184|B2|Primary surgery||Surgery Type||participants|Number|46|46.0||||||
3832593|NCT01704651|3659185|B1|Primary surgery||Surgery Type||participants|Number|45|45.0||||||
3832596|NCT01704651|3659185|B1|United States||Region of Enrollment||participants|Number|66|66.0||||||
3832597|NCT01704651|3659183|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3832598|NCT01704651|3659184|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3832599|NCT01704651|3659185|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3832600|NCT01704651|3659183|B3||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3832601|NCT01704651|3659184|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3832602|NCT01704651|3659185|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3832603|NCT01704651|3659183|B3|||Age||years|Mean|62.1|62.1|Standard Deviation|10.8|10.8|||
3832604|NCT01704651|3659184|B2|||Age||years|Mean|63.7|63.7|Standard Deviation|11.2|11.2|||
3832605|NCT01704651|3659185|B1|||Age||years|Mean|60.4|60.4|Standard Deviation|10.2|10.2|||
3832606|NCT01704599|3659194|B1|Female||Adult patients with plaque psoriasis >10% BSA||participants|Number|3|3.0||||||
3832607|NCT01704599|3659194|B1|Male||Adult patients with plaque psoriasis >10% BSA||participants|Number|5|5.0||||||
3832608|NCT01704599|3659194|B1|||number enrolled participants||participants 8|Number|8|8.0||||||
3832609|NCT01704599|3659194|B1||Unknown or Not Reported|Race (NIH/OMB)|"Eleven subjects went for screening: 8 were labelled 'White' though one had an Asian name(From India) and 3 were African American.~Three subjects failed screening: two Caucasian: one white, one was the 'white' person with the Asian name and one African American.~Of the 8 who were enrolled, 2 were African American and 6 were Caucasian (white).~The one enrolled subject who develeoped an SAE before entering the vitamin plus adalimumab part of the study was white.~The seven who completed the study: 5 Caucasians and 2 African Americans."|Participants|Count of Participants|0|0.0||||||
3832610|NCT01704599|3659194|B1||More than one race|Race (NIH/OMB)|"Eleven subjects went for screening: 8 were labelled 'White' though one had an Asian name(From India) and 3 were African American.~Three subjects failed screening: two Caucasian: one white, one was the 'white' person with the Asian name and one African American.~Of the 8 who were enrolled, 2 were African American and 6 were Caucasian (white).~The one enrolled subject who develeoped an SAE before entering the vitamin plus adalimumab part of the study was white.~The seven who completed the study: 5 Caucasians and 2 African Americans."|Participants|Count of Participants|0|0.0||||||
3832611|NCT01704599|3659194|B1||White|Race (NIH/OMB)|"Eleven subjects went for screening: 8 were labelled 'White' though one had an Asian name(From India) and 3 were African American.~Three subjects failed screening: two Caucasian: one white, one was the 'white' person with the Asian name and one African American.~Of the 8 who were enrolled, 2 were African American and 6 were Caucasian (white).~The one enrolled subject who develeoped an SAE before entering the vitamin plus adalimumab part of the study was white.~The seven who completed the study: 5 Caucasians and 2 African Americans."|Participants|Count of Participants|6|6.0||||||
3832612|NCT01704599|3659194|B1||Black or African American|Race (NIH/OMB)|"Eleven subjects went for screening: 8 were labelled 'White' though one had an Asian name(From India) and 3 were African American.~Three subjects failed screening: two Caucasian: one white, one was the 'white' person with the Asian name and one African American.~Of the 8 who were enrolled, 2 were African American and 6 were Caucasian (white).~The one enrolled subject who develeoped an SAE before entering the vitamin plus adalimumab part of the study was white.~The seven who completed the study: 5 Caucasians and 2 African Americans."|Participants|Count of Participants|2|2.0||||||
3832613|NCT01704599|3659194|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|"Eleven subjects went for screening: 8 were labelled 'White' though one had an Asian name(From India) and 3 were African American.~Three subjects failed screening: two Caucasian: one white, one was the 'white' person with the Asian name and one African American.~Of the 8 who were enrolled, 2 were African American and 6 were Caucasian (white).~The one enrolled subject who develeoped an SAE before entering the vitamin plus adalimumab part of the study was white.~The seven who completed the study: 5 Caucasians and 2 African Americans."|Participants|Count of Participants|0|0.0||||||
3832614|NCT01704599|3659194|B1||Asian|Race (NIH/OMB)|"Eleven subjects went for screening: 8 were labelled 'White' though one had an Asian name(From India) and 3 were African American.~Three subjects failed screening: two Caucasian: one white, one was the 'white' person with the Asian name and one African American.~Of the 8 who were enrolled, 2 were African American and 6 were Caucasian (white).~The one enrolled subject who develeoped an SAE before entering the vitamin plus adalimumab part of the study was white.~The seven who completed the study: 5 Caucasians and 2 African Americans."|Participants|Count of Participants|0|0.0||||||
3832615|NCT01704599|3659194|B1||American Indian or Alaska Native|Race (NIH/OMB)|"Eleven subjects went for screening: 8 were labelled 'White' though one had an Asian name(From India) and 3 were African American.~Three subjects failed screening: two Caucasian: one white, one was the 'white' person with the Asian name and one African American.~Of the 8 who were enrolled, 2 were African American and 6 were Caucasian (white).~The one enrolled subject who develeoped an SAE before entering the vitamin plus adalimumab part of the study was white.~The seven who completed the study: 5 Caucasians and 2 African Americans."|Participants|Count of Participants|0|0.0||||||
3832616|NCT01704599|3659194|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3832617|NCT01704599|3659194|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3832618|NCT01704599|3659194|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3832619|NCT01704599|3659194|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3832620|NCT01704599|3659194|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3832621|NCT01704521|3659221|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3832622|NCT01704521|3659222|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3832623|NCT01704521|3659223|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3832624|NCT01704521|3659221|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832625|NCT01704521|3659222|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832626|NCT01704521|3659223|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832627|NCT01704521|3659221|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832628|NCT01704521|3659222|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832629|NCT01704521|3659223|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832630|NCT01704521|3659221|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3832631|NCT01704521|3659222|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3832632|NCT01704521|3659223|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3832633|NCT01704521|3659221|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3832634|NCT01704521|3659222|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832635|NCT01704521|3659223|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3832636|NCT01704521|3659221|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832637|NCT01704521|3659222|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832638|NCT01704521|3659223|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832639|NCT01704521|3659221|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832640|NCT01704521|3659222|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832641|NCT01704521|3659223|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832642|NCT01704521|3659221|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832643|NCT01704521|3659222|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832644|NCT01704521|3659223|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832645|NCT01704521|3659221|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832646|NCT01704521|3659222|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832647|NCT01704521|3659223|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832648|NCT01704521|3659221|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3832649|NCT01704521|3659222|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3832650|NCT01704521|3659223|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3832651|NCT01704521|3659221|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832652|NCT01704521|3659222|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832653|NCT01704521|3659223|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832654|NCT01704521|3659221|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3832655|NCT01704521|3659222|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3832656|NCT01704521|3659223|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3832657|NCT01704521|3659221|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3832658|NCT01704521|3659222|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3832659|NCT01704521|3659223|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3832660|NCT01704521|3659221|B3|||Age||years|Median|47|47.0|Full Range|||27.0|54.0|
3832661|NCT01704521|3659222|B2|||Age||years|Median|37|37.0|Full Range|||27.0|47.0|
3832662|NCT01704521|3659223|B1|||Age||years|Median|53|53.0|Full Range|||38.0|54.0|
3832663|NCT01704495|3659230|B5|||Reversibility||percentage change|Mean|17.93|17.93|Standard Deviation|18.438|18.438|||
3832664|NCT01704495|3659231|B4|||Reversibility||percentage change|Mean|18.45|18.45|Standard Deviation|16.342|16.342|||
3832665|NCT01704495|3659232|B3|||Reversibility||percentage change|Mean|18.41|18.41|Standard Deviation|20.574|20.574|||
3832666|NCT01704495|3659233|B2|||Reversibility||percentage change|Mean|16.05|16.05|Standard Deviation|15.580|15.58|||
3832667|NCT01704495|3659234|B1|||Reversibility||percentage change|Mean|18.73|18.73|Standard Deviation|20.617|20.617|||
3832668|NCT01704495|3659230|B5|||FEV1 post-bronchodilator||percentage of predicted normal|Median|75.22|75.22|Full Range|||30.38|112.89|
3832669|NCT01704495|3659231|B4|||FEV1 post-bronchodilator||percentage of predicted normal|Median|72.19|72.19|Full Range|||31.26|111.88|
3832670|NCT01704495|3659232|B3|||FEV1 post-bronchodilator||percentage of predicted normal|Median|76.31|76.31|Full Range|||34.88|112.89|
3832671|NCT01704495|3659233|B2|||FEV1 post-bronchodilator||percentage of predicted normal|Median|77.95|77.95|Full Range|||30.38|112.83|
3832672|NCT01704495|3659234|B1|||FEV1 post-bronchodilator||percentage of predicted normal|Median|74.34|74.34|Full Range|||32.33|105.44|
3832673|NCT01704495|3659230|B5|||FEV1 pre-bronchodilator||percentage of predicted normal|Median|64.93|64.93|Full Range|||29.92|123.86|
3832674|NCT01704495|3659231|B4|||FEV1 pre-bronchodilator||percentage of predicted normal|Median|61.58|61.58|Full Range|||31.13|84.86|
3832675|NCT01704495|3659232|B3|||FEV1 pre-bronchodilator||percentage of predicted normal|Median|65.76|65.76|Full Range|||32.57|123.86|
3832676|NCT01704495|3659233|B2|||FEV1 pre-bronchodilator||percentage of predicted normal|Median|66.35|66.35|Full Range|||29.92|113.57|
3832677|NCT01704495|3659234|B1|||FEV1 pre-bronchodilator||percentage of predicted normal|Median|63.74|63.74|Full Range|||30.11|85.41|
3832678|NCT01704495|3659230|B5||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
3832679|NCT01704495|3659231|B4||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3832680|NCT01704495|3659232|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3832681|NCT01704495|3659233|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3832682|NCT01704495|3659234|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3832683|NCT01704495|3659230|B5||Female|Sex: Female, Male||Participants|Count of Participants|444|444.0||||||
3832684|NCT01704495|3659231|B4||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3832685|NCT01704495|3659232|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3832686|NCT01704495|3659233|B2||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3832687|NCT01704495|3659234|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3832688|NCT01704495|3659230|B5|||Age||years|Mean|52|52.0|Standard Deviation|11.8|11.8|||
3832689|NCT01704495|3659231|B4|||Age||years|Mean|54|54.0|Standard Deviation|11.1|11.1|||
3832690|NCT01704495|3659232|B3|||Age||years|Mean|53|53.0|Standard Deviation|11.5|11.5|||
3832691|NCT01704495|3659233|B2|||Age||years|Mean|52|52.0|Standard Deviation|12.7|12.7|||
3832692|NCT01704495|3659234|B1|||Age||years|Mean|51|51.0|Standard Deviation|11.6|11.6|||
3832693|NCT01704404|3659411|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3832694|NCT01704404|3659411|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3832695|NCT01704404|3659411|B1|||Age||year|Mean|64.2|64.2|Standard Deviation|6.80|6.8|||
3832696|NCT01704287|3659450|B4||Male|Sex: Female, Male||Participants|Count of Participants|327|327.0||||||
3832697|NCT01704287|3659451|B3||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3832698|NCT01704287|3659452|B2||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3832699|NCT01704287|3659453|B1||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3832700|NCT01704287|3659450|B4||Female|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
3832701|NCT01704287|3659451|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3832702|NCT01704287|3659452|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3832703|NCT01704287|3659453|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3832704|NCT01704287|3659450|B4|||Age||Years|Mean|60.1|60.1|Standard Deviation|13.6|13.6|||
3832705|NCT01704287|3659451|B3|||Age||Years|Mean|60.5|60.5|Standard Deviation|12.7|12.7|||
3832706|NCT01704287|3659452|B2|||Age||Years|Mean|60.1|60.1|Standard Deviation|13.3|13.3|||
3832707|NCT01704287|3659453|B1|||Age||Years|Mean|59.5|59.5|Standard Deviation|14.9|14.9|||
3832708|NCT01704261|3659490|B3||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3832709|NCT01704261|3659491|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3832710|NCT01704261|3659492|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3832711|NCT01704261|3659490|B3||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3832712|NCT01704261|3659491|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3832713|NCT01704261|3659492|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3832714|NCT01704261|3659490|B3|||Age||Years|Mean|57.8|57.8|Standard Deviation|8.9|8.9|||
3832715|NCT01704261|3659491|B2|||Age||Years|Mean|58.4|58.4|Standard Deviation|9.4|9.4|||
3832716|NCT01704261|3659492|B1|||Age||Years|Mean|57.2|57.2|Standard Deviation|8.4|8.4|||
3832717|NCT01704196|3659507|B3|United States||Region of Enrollment||participants|Number|179|179.0||||||
3832718|NCT01704196|3659508|B2|United States||Region of Enrollment||participants|Number|89|89.0||||||
3832719|NCT01704196|3659509|B1|United States||Region of Enrollment||participants|Number|90|90.0||||||
3832720|NCT01704196|3659507|B3||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3832721|NCT01704196|3659508|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3832722|NCT01704196|3659509|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3832723|NCT01704196|3659507|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3832724|NCT01704196|3659508|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3832725|NCT01704196|3659509|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3832726|NCT01704196|3659507|B3|||Age||years|Mean|49.9|49.9|Standard Deviation|8.2|8.2|||
3832727|NCT01704196|3659508|B2|||Age||years|Mean|49.0|49.0|Standard Deviation|8.2|8.2|||
3832728|NCT01704196|3659509|B1|||Age||years|Mean|50.8|50.8|Standard Deviation|8.2|8.2|||
3832729|NCT01704079|3659518|B3|United States||Region of Enrollment||participants|Number|216|216.0||||||
3832730|NCT01704079|3659519|B2|United States||Region of Enrollment||participants|Number|144|144.0||||||
3832731|NCT01704079|3659520|B1|United States||Region of Enrollment||participants|Number|72|72.0||||||
3832732|NCT01704079|3659518|B3||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3832733|NCT01704079|3659519|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3832734|NCT01704079|3659520|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3832735|NCT01704079|3659518|B3||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3832736|NCT01704079|3659519|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3832737|NCT01704079|3659520|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3832738|NCT01704079|3659518|B3|||Age||years|Mean|66.3|66.3|Standard Deviation|10.63|10.63|||
3832739|NCT01704079|3659519|B2|||Age||years|Mean|66.8|66.8|Standard Deviation|10.90|10.9|||
3832740|NCT01704079|3659520|B1|||Age||years|Mean|65.3|65.3|Standard Deviation|10.06|10.06|||
3832741|NCT01703988|3659533|B5||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3832742|NCT01703988|3659534|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3832743|NCT01703988|3659535|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3832744|NCT01703988|3659536|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3832745|NCT01703988|3659537|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3832746|NCT01703988|3659533|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3832747|NCT01703988|3659534|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3832748|NCT01703988|3659535|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3832749|NCT01703988|3659536|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3832750|NCT01703988|3659537|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3832751|NCT01703988|3659533|B5|||Age||years|Mean|7.4|7.4|Standard Deviation|4.6|4.6|||
3832752|NCT01703988|3659534|B4|||Age||years|Mean|6.9|6.9|Standard Deviation|4.3|4.3|||
3832753|NCT01703988|3659535|B3|||Age||years|Mean|6.0|6.0|Standard Deviation|4.0|4.0|||
3832754|NCT01703988|3659536|B2|||Age||years|Mean|8.1|8.1|Standard Deviation|5.2|5.2|||
3832755|NCT01703988|3659537|B1|||Age||years|Mean|8.6|8.6|Standard Deviation|5.4|5.4|||
3832756|NCT01703858|3659567|B4||Male|Gender||Participants|Count of Participants|15|15.0||||||
3832757|NCT01703858|3659568|B3||Male|Gender||Participants|Count of Participants|5|5.0||||||
3832758|NCT01703858|3659569|B2||Male|Gender||Participants|Count of Participants|5|5.0||||||
3832759|NCT01703858|3659570|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
3832760|NCT01703858|3659567|B4||Female|Gender||Participants|Count of Participants|0|0.0||||||
3832761|NCT01703858|3659568|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
3832762|NCT01703858|3659569|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
3832763|NCT01703858|3659570|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3832764|NCT01703858|3659567|B4|||Age||Years|Mean|40.7|40.7|Standard Deviation|7.9|7.9|||
3832765|NCT01703858|3659568|B3|||Age||Years|Mean|41.8|41.8|Standard Deviation|7.9|7.9|||
3832766|NCT01703858|3659569|B2|||Age||Years|Mean|40.8|40.8|Standard Deviation|8.6|8.6|||
3832767|NCT01703858|3659570|B1|||Age||Years|Mean|39.4|39.4|Standard Deviation|8.9|8.9|||
3832768|NCT01703845|3659595|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3832769|NCT01703845|3659596|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3832770|NCT01703845|3659597|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3832771|NCT01703845|3659595|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3832772|NCT01703845|3659596|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3832773|NCT01703845|3659597|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3832774|NCT01703845|3659595|B3|||Age||years|Mean|66.4|66.4|Standard Deviation|9.6|9.6|||
3832775|NCT01703845|3659596|B2|||Age||years|Mean|69.4|69.4|Standard Deviation|7.8|7.8|||
3832776|NCT01703845|3659597|B1|||Age||years|Mean|63.4|63.4|Standard Deviation|10.5|10.5|||
3832777|NCT01703832|3659633|B3|Germany||Region of Enrollment|33 participants were randomized to Neurexan and 32 participants to Natural Course. All randomized participants were included in the Safety Set. One premature terminator could not be evaluated for primary efficacy, so 32 participants in the Neurexan group and 32 participants in the Natural Course group formed the Full Analysis Set for analysis of efficacy.|participants|Number|65|65.0||||||
3832778|NCT01703832|3659634|B2|Germany||Region of Enrollment|33 participants were randomized to Neurexan and 32 participants to Natural Course. All randomized participants were included in the Safety Set. One premature terminator could not be evaluated for primary efficacy, so 32 participants in the Neurexan group and 32 participants in the Natural Course group formed the Full Analysis Set for analysis of efficacy.|participants|Number|32|32.0||||||
3832779|NCT01703832|3659635|B1|Germany||Region of Enrollment|33 participants were randomized to Neurexan and 32 participants to Natural Course. All randomized participants were included in the Safety Set. One premature terminator could not be evaluated for primary efficacy, so 32 participants in the Neurexan group and 32 participants in the Natural Course group formed the Full Analysis Set for analysis of efficacy.|participants|Number|33|33.0||||||
3832780|NCT01703832|3659633|B3||Male|Sex: Female, Male|33 participants were randomized to Neurexan and 32 participants to Natural Course. All randomized participants were included in the Safety Set. One premature terminator could not be evaluated for primary efficacy, so 32 participants in the Neurexan group and 32 participants in the Natural Course group formed the Full Analysis Set for analysis of efficacy.|Participants|Count of Participants|34|34.0||||||
3832781|NCT01703832|3659634|B2||Male|Sex: Female, Male|33 participants were randomized to Neurexan and 32 participants to Natural Course. All randomized participants were included in the Safety Set. One premature terminator could not be evaluated for primary efficacy, so 32 participants in the Neurexan group and 32 participants in the Natural Course group formed the Full Analysis Set for analysis of efficacy.|Participants|Count of Participants|17|17.0||||||
3832782|NCT01703832|3659635|B1||Male|Sex: Female, Male|33 participants were randomized to Neurexan and 32 participants to Natural Course. All randomized participants were included in the Safety Set. One premature terminator could not be evaluated for primary efficacy, so 32 participants in the Neurexan group and 32 participants in the Natural Course group formed the Full Analysis Set for analysis of efficacy.|Participants|Count of Participants|17|17.0||||||
3832783|NCT01703832|3659633|B3||Female|Sex: Female, Male|33 participants were randomized to Neurexan and 32 participants to Natural Course. All randomized participants were included in the Safety Set. One premature terminator could not be evaluated for primary efficacy, so 32 participants in the Neurexan group and 32 participants in the Natural Course group formed the Full Analysis Set for analysis of efficacy.|Participants|Count of Participants|31|31.0||||||
3832784|NCT01703832|3659634|B2||Female|Sex: Female, Male|33 participants were randomized to Neurexan and 32 participants to Natural Course. All randomized participants were included in the Safety Set. One premature terminator could not be evaluated for primary efficacy, so 32 participants in the Neurexan group and 32 participants in the Natural Course group formed the Full Analysis Set for analysis of efficacy.|Participants|Count of Participants|15|15.0||||||
3832803|NCT01703819|3659668|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3832804|NCT01703819|3659666|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3832805|NCT01703819|3659667|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3832785|NCT01703832|3659635|B1||Female|Sex: Female, Male|33 participants were randomized to Neurexan and 32 participants to Natural Course. All randomized participants were included in the Safety Set. One premature terminator could not be evaluated for primary efficacy, so 32 participants in the Neurexan group and 32 participants in the Natural Course group formed the Full Analysis Set for analysis of efficacy.|Participants|Count of Participants|16|16.0||||||
3832786|NCT01703832|3659633|B3||>=65 years|Age|33 participants were randomized to Neurexan and 32 participants to Natural Course. All randomized participants were included in the Safety Set. One premature terminator could not be evaluated for primary efficacy, so 32 participants in the Neurexan group and 32 participants in the Natural Course group formed the Full Analysis Set for analysis of efficacy.|Participants|Count of Participants|0|0.0||||||
3832787|NCT01703832|3659634|B2||>=65 years|Age|33 participants were randomized to Neurexan and 32 participants to Natural Course. All randomized participants were included in the Safety Set. One premature terminator could not be evaluated for primary efficacy, so 32 participants in the Neurexan group and 32 participants in the Natural Course group formed the Full Analysis Set for analysis of efficacy.|Participants|Count of Participants|0|0.0||||||
3832788|NCT01703832|3659635|B1||>=65 years|Age|33 participants were randomized to Neurexan and 32 participants to Natural Course. All randomized participants were included in the Safety Set. One premature terminator could not be evaluated for primary efficacy, so 32 participants in the Neurexan group and 32 participants in the Natural Course group formed the Full Analysis Set for analysis of efficacy.|Participants|Count of Participants|0|0.0||||||
3832789|NCT01703832|3659633|B3||Between 18 and 65 years|Age|33 participants were randomized to Neurexan and 32 participants to Natural Course. All randomized participants were included in the Safety Set. One premature terminator could not be evaluated for primary efficacy, so 32 participants in the Neurexan group and 32 participants in the Natural Course group formed the Full Analysis Set for analysis of efficacy.|Participants|Count of Participants|65|65.0||||||
3832790|NCT01703832|3659634|B2||Between 18 and 65 years|Age|33 participants were randomized to Neurexan and 32 participants to Natural Course. All randomized participants were included in the Safety Set. One premature terminator could not be evaluated for primary efficacy, so 32 participants in the Neurexan group and 32 participants in the Natural Course group formed the Full Analysis Set for analysis of efficacy.|Participants|Count of Participants|32|32.0||||||
3832791|NCT01703832|3659635|B1||Between 18 and 65 years|Age|33 participants were randomized to Neurexan and 32 participants to Natural Course. All randomized participants were included in the Safety Set. One premature terminator could not be evaluated for primary efficacy, so 32 participants in the Neurexan group and 32 participants in the Natural Course group formed the Full Analysis Set for analysis of efficacy.|Participants|Count of Participants|33|33.0||||||
3832792|NCT01703832|3659633|B3||<=18 years|Age|33 participants were randomized to Neurexan and 32 participants to Natural Course. All randomized participants were included in the Safety Set. One premature terminator could not be evaluated for primary efficacy, so 32 participants in the Neurexan group and 32 participants in the Natural Course group formed the Full Analysis Set for analysis of efficacy.|Participants|Count of Participants|0|0.0||||||
3832793|NCT01703832|3659634|B2||<=18 years|Age|33 participants were randomized to Neurexan and 32 participants to Natural Course. All randomized participants were included in the Safety Set. One premature terminator could not be evaluated for primary efficacy, so 32 participants in the Neurexan group and 32 participants in the Natural Course group formed the Full Analysis Set for analysis of efficacy.|Participants|Count of Participants|0|0.0||||||
3832794|NCT01703832|3659635|B1||<=18 years|Age|33 participants were randomized to Neurexan and 32 participants to Natural Course. All randomized participants were included in the Safety Set. One premature terminator could not be evaluated for primary efficacy, so 32 participants in the Neurexan group and 32 participants in the Natural Course group formed the Full Analysis Set for analysis of efficacy.|Participants|Count of Participants|0|0.0||||||
3832795|NCT01703832|3659633|B3|||Age|33 participants were randomized to Neurexan and 32 participants to Natural Course. All randomized participants were included in the Safety Set. One premature terminator could not be evaluated for primary efficacy, so 32 participants in the Neurexan group and 32 participants in the Natural Course group formed the Full Analysis Set for analysis of efficacy.|years|Mean|41.9|41.9|Standard Deviation|8.3|8.3|||
3832796|NCT01703832|3659634|B2|||Age|33 participants were randomized to Neurexan and 32 participants to Natural Course. All randomized participants were included in the Safety Set. One premature terminator could not be evaluated for primary efficacy, so 32 participants in the Neurexan group and 32 participants in the Natural Course group formed the Full Analysis Set for analysis of efficacy.|years|Mean|41.3|41.3|Standard Deviation|8.3|8.3|||
3832797|NCT01703832|3659635|B1|||Age|33 participants were randomized to Neurexan and 32 participants to Natural Course. All randomized participants were included in the Safety Set. One premature terminator could not be evaluated for primary efficacy, so 32 participants in the Neurexan group and 32 participants in the Natural Course group formed the Full Analysis Set for analysis of efficacy.|years|Mean|42.6|42.6|Standard Deviation|8.4|8.4|||
3832798|NCT01703819|3659666|B3|Germany||Region of Enrollment|34 participants were randomized to Neurexan and 32 participants to Placebo and all randomized participants were included in the Safety Set. Two premature terminators could not be evaluated for primary efficacy, so 34 participants in the Neurexan group and 30 participants in the Placebo group formed the Full Analysis Set for analysis of efficacy.|participants|Number|66|66.0||||||
3832799|NCT01703819|3659667|B2|Germany||Region of Enrollment|34 participants were randomized to Neurexan and 32 participants to Placebo and all randomized participants were included in the Safety Set. Two premature terminators could not be evaluated for primary efficacy, so 34 participants in the Neurexan group and 30 participants in the Placebo group formed the Full Analysis Set for analysis of efficacy.|participants|Number|32|32.0||||||
3832800|NCT01703819|3659668|B1|Germany||Region of Enrollment|34 participants were randomized to Neurexan and 32 participants to Placebo and all randomized participants were included in the Safety Set. Two premature terminators could not be evaluated for primary efficacy, so 34 participants in the Neurexan group and 30 participants in the Placebo group formed the Full Analysis Set for analysis of efficacy.|participants|Number|34|34.0||||||
3832801|NCT01703819|3659666|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3832802|NCT01703819|3659667|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3832806|NCT01703819|3659668|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3832807|NCT01703819|3659666|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3832808|NCT01703819|3659667|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3832809|NCT01703819|3659668|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3832810|NCT01703819|3659666|B3||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
3832811|NCT01703819|3659667|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3832812|NCT01703819|3659668|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3832813|NCT01703819|3659666|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3832814|NCT01703819|3659667|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3832815|NCT01703819|3659668|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3832816|NCT01703819|3659666|B3|||Age||Years|Mean|40.9|40.9|Standard Deviation|7.6|7.6|||
3832817|NCT01703819|3659667|B2|||Age||Years|Mean|40.7|40.7|Standard Deviation|8.2|8.2|||
3832818|NCT01703819|3659668|B1|||Age||Years|Mean|41.1|41.1|Standard Deviation|7.0|7.0|||
3832819|NCT01703741|3659699|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3832820|NCT01703741|3659699|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832821|NCT01703741|3659699|B1||White|Race (NIH/OMB)||Participants|Count of Participants|127|127.0||||||
3832822|NCT01703741|3659699|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3832823|NCT01703741|3659699|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832824|NCT01703741|3659699|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3832825|NCT01703741|3659699|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3832826|NCT01703741|3659699|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832827|NCT01703741|3659699|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|133|133.0||||||
3832828|NCT01703741|3659699|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3832829|NCT01703741|3659699|B1||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3832830|NCT01703741|3659699|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3832831|NCT01703741|3659699|B1|||Age||years|Mean|57.1|57.1|Standard Deviation|9.4|9.4|||
3832832|NCT01703741|3659699|B1||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
3832833|NCT01703741|3659699|B1||Between 18 and 65 years|Age||Participants|Count of Participants|116|116.0||||||
3832834|NCT01703741|3659699|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3832835|NCT01703702|3659715|B3|France||Region of Enrollment||participants|Number|174|174.0||||||
3832836|NCT01703702|3659716|B2|France||Region of Enrollment||participants|Number|87|87.0||||||
3832837|NCT01703702|3659717|B1|France||Region of Enrollment||participants|Number|87|87.0||||||
3832838|NCT01703702|3659715|B3|Italy||Region of Enrollment||participants|Number|221|221.0||||||
3832839|NCT01703702|3659716|B2|Italy||Region of Enrollment||participants|Number|112|112.0||||||
3832840|NCT01703702|3659717|B1|Italy||Region of Enrollment||participants|Number|109|109.0||||||
3832841|NCT01703702|3659715|B3|United States||Region of Enrollment||participants|Number|223|223.0||||||
3832842|NCT01703702|3659716|B2|United States||Region of Enrollment||participants|Number|111|111.0||||||
3832843|NCT01703702|3659717|B1|United States||Region of Enrollment||participants|Number|112|112.0||||||
3832844|NCT01703702|3659715|B3||Male|Sex: Female, Male||Participants|Count of Participants|316|316.0||||||
3832845|NCT01703702|3659716|B2||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3832846|NCT01703702|3659717|B1||Male|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3832847|NCT01703702|3659715|B3||Female|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
3832848|NCT01703702|3659716|B2||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3832849|NCT01703702|3659717|B1||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3832850|NCT01703702|3659715|B3|||Age||years|Mean|72.9|72.9|Standard Deviation|8.07|8.07|||
3832851|NCT01703702|3659716|B2|||Age||years|Mean|72.7|72.7|Standard Deviation|7.94|7.94|||
3832852|NCT01703702|3659717|B1|||Age||years|Mean|73.1|73.1|Standard Deviation|8.2|8.2|||
3832853|NCT01703663|3659735|B1|||NIH Stroke Scale|total (range 0-42; 0 is no findings)|units on a scale|Median|4|4.0|Inter-Quartile Range|||2.0|6.0|
3832854|NCT01703663|3659735|B1|||Body mass index, self reported||kg/m^2|Median|29.1|29.1|Inter-Quartile Range|||26.6|33.5|
3832855|NCT01703663|3659735|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3832856|NCT01703663|3659735|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3832857|NCT01703663|3659735|B1|||Age||years|Median|60|60.0|Inter-Quartile Range|||55.0|70.0|
3832858|NCT01703286|3659742|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3832859|NCT01703286|3659742|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3832860|NCT01703286|3659742|B1|||Age||years|Mean|60.3|60.3|Standard Deviation|6.0|6.0|||
3832861|NCT01703260|3659767|B4|Did Not Have Diabetes Mellitus||Type 2 Diabetes Mellitus||participants|Number|15|15.0||||||
3832862|NCT01703260|3659768|B3|Did Not Have Diabetes Mellitus||Type 2 Diabetes Mellitus||participants|Number|5|5.0||||||
3832863|NCT01703260|3659769|B2|Did Not Have Diabetes Mellitus||Type 2 Diabetes Mellitus||participants|Number|5|5.0||||||
3832864|NCT01703260|3659770|B1|Did Not Have Diabetes Mellitus||Type 2 Diabetes Mellitus||participants|Number|5|5.0||||||
3832865|NCT01703260|3659767|B4|Had Diabetes Mellitus||Type 2 Diabetes Mellitus||participants|Number|5|5.0||||||
3832866|NCT01703260|3659768|B3|Had Diabetes Mellitus||Type 2 Diabetes Mellitus||participants|Number|1|1.0||||||
3832867|NCT01703260|3659769|B2|Had Diabetes Mellitus||Type 2 Diabetes Mellitus||participants|Number|2|2.0||||||
3832868|NCT01703260|3659770|B1|Had Diabetes Mellitus||Type 2 Diabetes Mellitus||participants|Number|2|2.0||||||
3832869|NCT01703260|3659767|B4|Ex-Smoker||Smoking Classification||participants|Number|3|3.0||||||
3832870|NCT01703260|3659768|B3|Ex-Smoker||Smoking Classification||participants|Number|0|0.0||||||
3832871|NCT01703260|3659769|B2|Ex-Smoker||Smoking Classification||participants|Number|0|0.0||||||
3832872|NCT01703260|3659770|B1|Ex-Smoker||Smoking Classification||participants|Number|3|3.0||||||
3832873|NCT01703260|3659767|B4|Current Smoker||Smoking Classification||participants|Number|3|3.0||||||
3832874|NCT01703260|3659768|B3|Current Smoker||Smoking Classification||participants|Number|1|1.0||||||
3832875|NCT01703260|3659769|B2|Current Smoker||Smoking Classification||participants|Number|1|1.0||||||
3832876|NCT01703260|3659770|B1|Current Smoker||Smoking Classification||participants|Number|1|1.0||||||
3832877|NCT01703260|3659767|B4|Had Never Smoked||Smoking Classification||participants|Number|14|14.0||||||
3832878|NCT01703260|3659768|B3|Had Never Smoked||Smoking Classification||participants|Number|5|5.0||||||
3832879|NCT01703260|3659769|B2|Had Never Smoked||Smoking Classification||participants|Number|6|6.0||||||
3832880|NCT01703260|3659770|B1|Had Never Smoked||Smoking Classification||participants|Number|3|3.0||||||
3832881|NCT01703260|3659767|B4|||Body Mass Index (BMI)||kilogram per square meter(kg/m^2)|Mean|35.26|35.26|Standard Deviation|6.381|6.381|||
3832882|NCT01703260|3659768|B3|||Body Mass Index (BMI)||kilogram per square meter(kg/m^2)|Mean|36.60|36.6|Standard Deviation|7.475|7.475|||
3832883|NCT01703260|3659769|B2|||Body Mass Index (BMI)||kilogram per square meter(kg/m^2)|Mean|32.19|32.19|Standard Deviation|6.189|6.189|||
3832884|NCT01703260|3659770|B1|||Body Mass Index (BMI)||kilogram per square meter(kg/m^2)|Mean|37.18|37.18|Standard Deviation|5.192|5.192|||
3832885|NCT01703260|3659767|B4|||Weight||kilogram (kg)|Mean|101.03|101.03|Standard Deviation|19.887|19.887|||
3832886|NCT01703260|3659768|B3|||Weight||kilogram (kg)|Mean|110.15|110.15|Standard Deviation|15.456|15.456|||
3832887|NCT01703260|3659769|B2|||Weight||kilogram (kg)|Mean|92.06|92.06|Standard Deviation|20.784|20.784|||
3832888|NCT01703260|3659770|B1|||Weight||kilogram (kg)|Mean|102.19|102.19|Standard Deviation|21.041|21.041|||
3832889|NCT01703260|3659767|B4|||Height||centimeter (cm)|Mean|169.3|169.3|Standard Deviation|11.13|11.13|||
3832890|NCT01703260|3659768|B3|||Height||centimeter (cm)|Mean|174.3|174.3|Standard Deviation|7.50|7.5|||
3832891|NCT01703260|3659769|B2|||Height||centimeter (cm)|Mean|168.7|168.7|Standard Deviation|8.62|8.62|||
3832892|NCT01703260|3659770|B1|||Height||centimeter (cm)|Mean|165.6|165.6|Standard Deviation|15.13|15.13|||
3832893|NCT01703260|3659767|B4|United States||Region of Enrollment||participants|Number|20|20.0||||||
3832894|NCT01703260|3659768|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3832895|NCT01703260|3659769|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3832896|NCT01703260|3659770|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3832897|NCT01703260|3659767|B4|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3832898|NCT01703260|3659768|B3|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3832899|NCT01703260|3659769|B2|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3832900|NCT01703260|3659770|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3832901|NCT01703260|3659767|B4|White||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3832902|NCT01703260|3659768|B3|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3832903|NCT01703260|3659769|B2|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3832904|NCT01703260|3659770|B1|White||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3832905|NCT01703260|3659767|B4|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3832906|NCT01703260|3659768|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3832907|NCT01703260|3659769|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3832908|NCT01703260|3659770|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3832909|NCT01703260|3659767|B4|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3832910|NCT01703260|3659768|B3|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3832911|NCT01703260|3659769|B2|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3832912|NCT01703260|3659770|B1|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3832913|NCT01703260|3659767|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3832914|NCT01703260|3659768|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3832915|NCT01703260|3659769|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3832916|NCT01703260|3659770|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3832917|NCT01703260|3659767|B4||Male|Gender||Participants|Count of Participants|11|11.0||||||
3832918|NCT01703260|3659768|B3||Male|Gender||Participants|Count of Participants|4|4.0||||||
3832919|NCT01703260|3659769|B2||Male|Gender||Participants|Count of Participants|5|5.0||||||
3832920|NCT01703260|3659770|B1||Male|Gender||Participants|Count of Participants|2|2.0||||||
3832921|NCT01703260|3659767|B4||Female|Gender||Participants|Count of Participants|9|9.0||||||
3832922|NCT01703260|3659768|B3||Female|Gender||Participants|Count of Participants|2|2.0||||||
3832923|NCT01703260|3659769|B2||Female|Gender||Participants|Count of Participants|2|2.0||||||
3832924|NCT01703260|3659770|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
3832925|NCT01703260|3659767|B4|60 - 80 years||Age, Customized||participants|Number|1|1.0||||||
3832926|NCT01703260|3659768|B3|60 - 80 years||Age, Customized||participants|Number|0|0.0||||||
3832927|NCT01703260|3659769|B2|60 - 80 years||Age, Customized||participants|Number|1|1.0||||||
3832928|NCT01703260|3659770|B1|60 - 80 years||Age, Customized||participants|Number|0|0.0||||||
3832929|NCT01703260|3659767|B4|40 - 59 years||Age, Customized||participants|Number|11|11.0||||||
3832930|NCT01703260|3659768|B3|40 - 59 years||Age, Customized||participants|Number|3|3.0||||||
3832931|NCT01703260|3659769|B2|40 - 59 years||Age, Customized||participants|Number|4|4.0||||||
3832932|NCT01703260|3659770|B1|40 - 59 years||Age, Customized||participants|Number|4|4.0||||||
3832933|NCT01703260|3659767|B4|18 - 39 years||Age, Customized||participants|Number|8|8.0||||||
3832934|NCT01703260|3659768|B3|18 - 39 years||Age, Customized||participants|Number|3|3.0||||||
3832935|NCT01703260|3659769|B2|18 - 39 years||Age, Customized||participants|Number|2|2.0||||||
3832936|NCT01703260|3659770|B1|18 - 39 years||Age, Customized||participants|Number|3|3.0||||||
3832937|NCT01703260|3659767|B4|||Age||years|Mean|44.0|44.0|Standard Deviation|10.93|10.93|||
3832938|NCT01703260|3659768|B3|||Age||years|Mean|42.5|42.5|Standard Deviation|8.67|8.67|||
3832939|NCT01703260|3659769|B2|||Age||years|Mean|43.9|43.9|Standard Deviation|14.77|14.77|||
3832940|NCT01703260|3659770|B1|||Age||years|Mean|45.4|45.4|Standard Deviation|9.64|9.64|||
3832941|NCT01703221|3659795|B4||Male|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
3832942|NCT01703221|3659796|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3832943|NCT01703221|3659797|B2||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3832944|NCT01703221|3659798|B1||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3832945|NCT01703221|3659795|B4||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3832946|NCT01703221|3659796|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3832947|NCT01703221|3659797|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3832948|NCT01703221|3659798|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3832949|NCT01703221|3659795|B4|||Age||Years|Mean|60|60.0|Standard Deviation|10|10.0|||
3832950|NCT01703221|3659796|B3|||Age||Years|Mean|61|61.0|Standard Deviation|9|9.0|||
3832951|NCT01703221|3659797|B2|||Age||Years|Mean|60|60.0|Standard Deviation|9|9.0|||
3832952|NCT01703221|3659798|B1|||Age||Years|Mean|60|60.0|Standard Deviation|11|11.0|||
3832953|NCT01703208|3659829|B3|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|180.4|180.4|Standard Deviation|47.8|47.8|||
3832954|NCT01703208|3659830|B2|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|179.5|179.5|Standard Deviation|45.7|45.7|||
3832955|NCT01703208|3659831|B1|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|184.1|184.1|Standard Deviation|52.2|52.2|||
3832956|NCT01703208|3659829|B3|||Hemoglobin A1C %|Hemoglobin A1C is blood marker used to report average blood glucose levels over prolonged periods of time and is reported as a percentage (%).|Percent|Mean|8.01|8.01|Standard Deviation|0.87|0.87|||
3832957|NCT01703208|3659830|B2|||Hemoglobin A1C %|Hemoglobin A1C is blood marker used to report average blood glucose levels over prolonged periods of time and is reported as a percentage (%).|Percent|Mean|8.03|8.03|Standard Deviation|0.89|0.89|||
3832958|NCT01703208|3659831|B1|||Hemoglobin A1C %|Hemoglobin A1C is blood marker used to report average blood glucose levels over prolonged periods of time and is reported as a percentage (%).|Percent|Mean|7.99|7.99|Standard Deviation|0.86|0.86|||
3832959|NCT01703208|3659829|B3||Male|Sex: Female, Male||Participants|Count of Participants|2948|2948.0||||||
3832960|NCT01703208|3659830|B2||Male|Sex: Female, Male||Participants|Count of Participants|1487|1487.0||||||
3832961|NCT01703208|3659831|B1||Male|Sex: Female, Male||Participants|Count of Participants|1461|1461.0||||||
3832962|NCT01703208|3659829|B3||Female|Sex: Female, Male||Participants|Count of Participants|1254|1254.0||||||
3832963|NCT01703208|3659830|B2||Female|Sex: Female, Male||Participants|Count of Participants|615|615.0||||||
3832964|NCT01703208|3659831|B1||Female|Sex: Female, Male||Participants|Count of Participants|639|639.0||||||
3832965|NCT01703208|3659829|B3|||Age||Years|Mean|63.6|63.6|Standard Deviation|8.5|8.5|||
3832966|NCT01703208|3659830|B2|||Age||Years|Mean|63.6|63.6|Standard Deviation|8.5|8.5|||
3832967|NCT01703208|3659831|B1|||Age||Years|Mean|63.7|63.7|Standard Deviation|8.5|8.5|||
3832968|NCT01703169|3659886|B1|United States||Region of Enrollment||Count of Participants|Number|13|13.0||||||
3832969|NCT01703169|3659886|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3832970|NCT01703169|3659886|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832971|NCT01703169|3659886|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3832972|NCT01703169|3659886|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832973|NCT01703169|3659886|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832974|NCT01703169|3659886|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3832975|NCT01703169|3659886|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832976|NCT01703169|3659886|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3832977|NCT01703169|3659886|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3832978|NCT01703169|3659886|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3832979|NCT01703169|3659886|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3832980|NCT01703169|3659886|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3832981|NCT01703091|3659894|B3|Japan||Region of Enrollment||Participants|Number|192|192.0||||||
3832982|NCT01703091|3659895|B2|Japan||Region of Enrollment||Participants|Number|98|98.0||||||
3832983|NCT01703091|3659896|B1|Japan||Region of Enrollment||Participants|Number|94|94.0||||||
3833042|NCT01703065|3659913|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3832984|NCT01703091|3659894|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832985|NCT01703091|3659895|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832986|NCT01703091|3659896|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832987|NCT01703091|3659894|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832988|NCT01703091|3659895|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832989|NCT01703091|3659896|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832990|NCT01703091|3659894|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832991|NCT01703091|3659895|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832992|NCT01703091|3659896|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832993|NCT01703091|3659894|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832994|NCT01703091|3659895|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832995|NCT01703091|3659896|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832996|NCT01703091|3659894|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832997|NCT01703091|3659895|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832998|NCT01703091|3659896|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3832999|NCT01703091|3659894|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|192|192.0||||||
3833000|NCT01703091|3659895|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3833001|NCT01703091|3659896|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3833002|NCT01703091|3659894|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833003|NCT01703091|3659895|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833004|NCT01703091|3659896|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833005|NCT01703091|3659894|B3||Male|Gender||Participants|Count of Participants|137|137.0||||||
3833006|NCT01703091|3659895|B2||Male|Gender||Participants|Count of Participants|71|71.0||||||
3833007|NCT01703091|3659896|B1||Male|Gender||Participants|Count of Participants|66|66.0||||||
3833008|NCT01703091|3659894|B3||Female|Gender||Participants|Count of Participants|55|55.0||||||
3833009|NCT01703091|3659895|B2||Female|Gender||Participants|Count of Participants|27|27.0||||||
3833010|NCT01703091|3659896|B1||Female|Gender||Participants|Count of Participants|28|28.0||||||
3833011|NCT01703091|3659894|B3|||Age||Years|Median|64|64.0|Full Range|||27.0|79.0|
3833012|NCT01703091|3659895|B2|||Age||Years|Median|64.1|64.1|Full Range|||27.0|79.0|
3833013|NCT01703091|3659896|B1|||Age||Years|Median|63.9|63.9|Full Range|||29.0|78.0|
3833014|NCT01703065|3659913|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
3833015|NCT01703065|3659915|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3833016|NCT01703065|3659913|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3833017|NCT01703065|3659915|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3833018|NCT01703065|3659913|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833019|NCT01703065|3659915|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833020|NCT01703065|3659913|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3833021|NCT01703065|3659915|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3833022|NCT01703065|3659913|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3833023|NCT01703065|3659915|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3833024|NCT01703065|3659913|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833025|NCT01703065|3659915|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833026|NCT01703065|3659913|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833027|NCT01703065|3659915|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833028|NCT01703065|3659913|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833029|NCT01703065|3659915|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833030|NCT01703065|3659913|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3833031|NCT01703065|3659915|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3833032|NCT01703065|3659913|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3833033|NCT01703065|3659915|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3833034|NCT01703065|3659913|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833035|NCT01703065|3659915|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833036|NCT01703065|3659913|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3833037|NCT01703065|3659914|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3833038|NCT01703065|3659915|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3833039|NCT01703065|3659913|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3833040|NCT01703065|3659914|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3833041|NCT01703065|3659915|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3833043|NCT01703065|3659914|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3833044|NCT01703065|3659915|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3833045|NCT01703065|3659913|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3833046|NCT01703065|3659914|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3833047|NCT01703065|3659915|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3833048|NCT01703065|3659913|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3833049|NCT01703065|3659914|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3833050|NCT01703065|3659915|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3833051|NCT01703000|3659929|B1|||Lesion Characteristic: Percent Diameter Stenosis by QCA||Percent Diameter Stenosis|Mean|69.12|69.12|Standard Deviation|9.69|9.69|||
3833052|NCT01703000|3659929|B1|Lesion Length||Lesion Characteristics by Quantitative Cornary Angiography||Millimeters|Mean|16.05|16.05|Standard Deviation|7.14|7.14|||
3833053|NCT01703000|3659929|B1|Minimum Lumen Diameter||Lesion Characteristics by Quantitative Cornary Angiography||Millimeters|Mean|0.85|0.85|Standard Deviation|0.29|0.29|||
3833054|NCT01703000|3659929|B1|Reference Vessel Diameter||Lesion Characteristics by Quantitative Cornary Angiography||Millimeters|Mean|2.78|2.78|Standard Deviation|0.45|0.45|||
3833055|NCT01703000|3659929|B1|3 (complete perfusion)||Lesion Characteristic: Pre-Procedure Thrombolysis in Myocardial Infarction (TIMI) Flow|Note: A single participant could potentially experience multiple categories listed below.|Lesions|Number|108|108.0||||||
3833056|NCT01703000|3659929|B1|2 (partial perfusion)||Lesion Characteristic: Pre-Procedure Thrombolysis in Myocardial Infarction (TIMI) Flow|Note: A single participant could potentially experience multiple categories listed below.|Lesions|Number|9|9.0||||||
3833057|NCT01703000|3659929|B1|1 (penetration with minimal perfusion)||Lesion Characteristic: Pre-Procedure Thrombolysis in Myocardial Infarction (TIMI) Flow|Note: A single participant could potentially experience multiple categories listed below.|Lesions|Number|2|2.0||||||
3833058|NCT01703000|3659929|B1|0 (no perfusion)||Lesion Characteristic: Pre-Procedure Thrombolysis in Myocardial Infarction (TIMI) Flow|Note: A single participant could potentially experience multiple categories listed below.|Lesions|Number|0|0.0||||||
3833059|NCT01703000|3659929|B1|Eccentric Lesion||Lesion Characteristics|Note: A single participant could potentially experience multiple categories listed below.|Lesions|Number|86|86.0||||||
3833060|NCT01703000|3659929|B1|Total Occlusion||Lesion Characteristics|Note: A single participant could potentially experience multiple categories listed below.|Lesions|Number|2|2.0||||||
3833061|NCT01703000|3659929|B1|Bifurcation||Lesion Characteristics|Note: A single participant could potentially experience multiple categories listed below.|Lesions|Number|61|61.0||||||
3833062|NCT01703000|3659929|B1|Aneurysm||Lesion Characteristics|Note: A single participant could potentially experience multiple categories listed below.|Lesions|Number|2|2.0||||||
3833063|NCT01703000|3659929|B1|Ulcerated||Lesion Characteristics|Note: A single participant could potentially experience multiple categories listed below.|Lesions|Number|3|3.0||||||
3833064|NCT01703000|3659929|B1|Calcification, Any||Lesion Characteristics|Note: A single participant could potentially experience multiple categories listed below.|Lesions|Number|35|35.0||||||
3833065|NCT01703000|3659929|B1|Tortuosity, Any||Lesion Characteristics|Note: A single participant could potentially experience multiple categories listed below.|Lesions|Number|10|10.0||||||
3833066|NCT01703000|3659929|B1|Greater than 20 mm||Lesion Characteristic: Lesion Length|Note: A single participant could potentially experience multiple categories listed below.|Lesions|Number|28|28.0||||||
3833067|NCT01703000|3659929|B1|Less than or equal to 20 mm||Lesion Characteristic: Lesion Length|Note: A single participant could potentially experience multiple categories listed below.|Lesions|Number|91|91.0||||||
3833068|NCT01703000|3659929|B1|Distal||Lesion Characteristic: Lesion Location|Note: A single participant could potentially experience multiple categories listed below.|Lesions|Number|15|15.0||||||
3833069|NCT01703000|3659929|B1|Mid||Lesion Characteristic: Lesion Location|Note: A single participant could potentially experience multiple categories listed below.|Lesions|Number|49|49.0||||||
3833070|NCT01703000|3659929|B1|Proximal||Lesion Characteristic: Lesion Location|Note: A single participant could potentially experience multiple categories listed below.|Lesions|Number|47|47.0||||||
3833071|NCT01703000|3659929|B1|Ostial||Lesion Characteristic: Lesion Location|Note: A single participant could potentially experience multiple categories listed below.|Lesions|Number|8|8.0||||||
3833072|NCT01703000|3659929|B1|Right Coronary Artery||Lesion Characteristics: Target Lesion Vessel|Note: A single participant could potentially experience multiple categories listed below.|Lesions|Number|32|32.0||||||
3833073|NCT01703000|3659929|B1|Circumflex Artery||Lesion Characteristics: Target Lesion Vessel|Note: A single participant could potentially experience multiple categories listed below.|Lesions|Number|27|27.0||||||
3833074|NCT01703000|3659929|B1|Left Anterior Descending Artery||Lesion Characteristics: Target Lesion Vessel|Note: A single participant could potentially experience multiple categories listed below.|Lesions|Number|60|60.0||||||
3833075|NCT01703000|3659929|B1|Family History of Coronary Artery Disease||Cardiac Risk Factors|Note: A single participant could potentially experience multiple categories listed below.|participants|Number|51|51.0||||||
3833076|NCT01703000|3659929|B1|Hypertension Requiring Medication||Cardiac Risk Factors|Note: A single participant could potentially experience multiple categories listed below.|participants|Number|70|70.0||||||
3833077|NCT01703000|3659929|B1|Hyperlipidemia Requiring Medication||Cardiac Risk Factors|Note: A single participant could potentially experience multiple categories listed below.|participants|Number|78|78.0||||||
3833078|NCT01703000|3659929|B1|Medically Treated Diabetes||Cardiac Risk Factors|Note: A single participant could potentially experience multiple categories listed below.|participants|Number|16|16.0||||||
3833079|NCT01703000|3659929|B1|Smoking, Ever||Cardiac Risk Factors|Note: A single participant could potentially experience multiple categories listed below.|participants|Number|56|56.0||||||
3833080|NCT01703000|3659929|B1|Silent Ischemia||Cardiac History|Note: A single participant could potentially experience multiple categories listed below.|participants|Number|7|7.0||||||
3833139|NCT01702532|3659988|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3833081|NCT01703000|3659929|B1|Unstable Angina||Cardiac History|Note: A single participant could potentially experience multiple categories listed below.|participants|Number|25|25.0||||||
3833082|NCT01703000|3659929|B1|Stable Angina||Cardiac History|Note: A single participant could potentially experience multiple categories listed below.|participants|Number|51|51.0||||||
3833083|NCT01703000|3659929|B1|Congestive Heart Failure||Cardiac History|Note: A single participant could potentially experience multiple categories listed below.|participants|Number|2|2.0||||||
3833084|NCT01703000|3659929|B1|Previous Myocardial Infarction||Cardiac History|Note: A single participant could potentially experience multiple categories listed below.|participants|Number|16|16.0||||||
3833085|NCT01703000|3659929|B1|Previous Coronary Artery Bypass Graft||Cardiac History|Note: A single participant could potentially experience multiple categories listed below.|participants|Number|5|5.0||||||
3833086|NCT01703000|3659929|B1|Previous Percutaneous Coronary Intervention||Cardiac History|Note: A single participant could potentially experience multiple categories listed below.|participants|Number|23|23.0||||||
3833087|NCT01703000|3659929|B1|New Zealand||Region of Enrollment||participants|Number|88|88.0||||||
3833088|NCT01703000|3659929|B1|Australia||Region of Enrollment||participants|Number|2|2.0||||||
3833089|NCT01703000|3659929|B1|Singapore||Region of Enrollment||participants|Number|10|10.0||||||
3833090|NCT01703000|3659929|B1|Not disclosed||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3833091|NCT01703000|3659929|B1|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3833092|NCT01703000|3659929|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3833093|NCT01703000|3659929|B1|Black, of African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3833094|NCT01703000|3659929|B1|Asian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3833095|NCT01703000|3659929|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
3833096|NCT01703000|3659929|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3833097|NCT01703000|3659929|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3833098|NCT01703000|3659929|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3833099|NCT01703000|3659929|B1|||Age, Customized||years|Mean|61.72|61.72|Standard Deviation|9.73|9.73|||
3833100|NCT01702987|3659960|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
3833101|NCT01702987|3659961|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3833102|NCT01702987|3659962|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3833103|NCT01702987|3659960|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3833104|NCT01702987|3659961|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3833105|NCT01702987|3659962|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3833106|NCT01702987|3659960|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3833107|NCT01702987|3659961|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3833108|NCT01702987|3659962|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3833109|NCT01702987|3659960|B3|||Age||years|Mean|52|52.0|Standard Deviation|9|9.0|||
3833110|NCT01702987|3659961|B2|||Age||years|Mean|53|53.0|Standard Deviation|7|7.0|||
3833111|NCT01702987|3659962|B1|||Age||years|Mean|51|51.0|Standard Deviation|12|12.0|||
3833112|NCT01702987|3659960|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3833113|NCT01702987|3659961|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3833114|NCT01702987|3659962|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3833115|NCT01702987|3659960|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3833116|NCT01702987|3659961|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3833117|NCT01702987|3659962|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3833118|NCT01702987|3659960|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3833119|NCT01702987|3659961|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3833120|NCT01702987|3659962|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3833121|NCT01702961|3659969|B1|Non-Hodgkin’s Lymphoma||Disease at diagnosis||participants|Number|50|50.0||||||
3833122|NCT01702961|3659969|B1|Hodgkin’s Disease||Disease at diagnosis||participants|Number|25|25.0||||||
3833123|NCT01702961|3659969|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3833124|NCT01702961|3659969|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3833125|NCT01702961|3659969|B1|||Age||years|Median|53|53.0|Full Range|||14.0|69.0|
3833126|NCT01702909|3659975|B1|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3833127|NCT01702909|3659975|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3833128|NCT01702909|3659975|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3833129|NCT01702909|3659975|B1|||Age||years|Median|58|58.0|Full Range|||54.0|67.0|
3833130|NCT01702909|3659975|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3833131|NCT01702909|3659975|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3833132|NCT01702909|3659975|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3833133|NCT01702896|3659981|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3833134|NCT01702896|3659981|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3833135|NCT01702896|3659981|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3833136|NCT01702896|3659981|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3833137|NCT01702896|3659981|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3833138|NCT01702532|3659987|B3||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
3833140|NCT01702532|3659989|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3833141|NCT01702532|3659987|B3||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3833142|NCT01702532|3659988|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3833143|NCT01702532|3659989|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3833144|NCT01702532|3659987|B3|||Age||Years|Mean|39.4|39.4|Standard Deviation|12.76|12.76|||
3833145|NCT01702532|3659988|B2|||Age||Years|Mean|39.8|39.8|Standard Deviation|12.64|12.64|||
3833146|NCT01702532|3659989|B1|||Age||Years|Mean|39.0|39.0|Standard Deviation|12.91|12.91|||
3833147|NCT01702519|3659998|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3833148|NCT01702519|3659999|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3833149|NCT01702519|3660000|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3833150|NCT01702519|3659998|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3833151|NCT01702519|3659999|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3833152|NCT01702519|3660000|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3833153|NCT01702519|3659998|B3|||Age||Years|Mean|33.8|33.8|Standard Deviation|11.58|11.58|||
3833154|NCT01702519|3659999|B2|||Age||Years|Mean|31.4|31.4|Standard Deviation|11.59|11.59|||
3833155|NCT01702519|3660000|B1|||Age||Years|Mean|36.3|36.3|Standard Deviation|11.33|11.33|||
3833156|NCT01702454|3660017|B3||Male|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
3833157|NCT01702454|3660018|B2||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3833158|NCT01702454|3660019|B1||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3833159|NCT01702454|3660017|B3||Female|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
3833160|NCT01702454|3660018|B2||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3833161|NCT01702454|3660019|B1||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3833162|NCT01702454|3660017|B3|||Age||Years|Mean|32.8|32.8|Standard Deviation|7.47|7.47|||
3833163|NCT01702454|3660018|B2|||Age||Years|Mean|32.5|32.5|Standard Deviation|7.39|7.39|||
3833164|NCT01702454|3660019|B1|||Age||Years|Mean|33.2|33.2|Standard Deviation|7.54|7.54|||
3833165|NCT01702428|3660098|B5|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
3833166|NCT01702428|3660099|B4|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3833167|NCT01702428|3660100|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3833168|NCT01702428|3660101|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3833169|NCT01702428|3660102|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3833170|NCT01702428|3660098|B5|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3833171|NCT01702428|3660099|B4|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3833172|NCT01702428|3660100|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3833173|NCT01702428|3660101|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3833174|NCT01702428|3660102|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3833175|NCT01702428|3660098|B5|African Heritage / African American||Race/Ethnicity, Customized||Participants|Count of Participants|239|239.0||||||
3833176|NCT01702428|3660099|B4|African Heritage / African American||Race/Ethnicity, Customized||Participants|Count of Participants|70|70.0||||||
3833177|NCT01702428|3660100|B3|African Heritage / African American||Race/Ethnicity, Customized||Participants|Count of Participants|57|57.0||||||
3833178|NCT01702428|3660101|B2|African Heritage / African American||Race/Ethnicity, Customized||Participants|Count of Participants|52|52.0||||||
3833179|NCT01702428|3660102|B1|African Heritage / African American||Race/Ethnicity, Customized||Participants|Count of Participants|60|60.0||||||
3833180|NCT01702428|3660098|B5|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|93|93.0||||||
3833181|NCT01702428|3660099|B4|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3833182|NCT01702428|3660100|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3833183|NCT01702428|3660101|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3833184|NCT01702428|3660102|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3833185|NCT01702428|3660098|B5|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|3784|3784.0||||||
3833186|NCT01702428|3660099|B4|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|970|970.0||||||
3833187|NCT01702428|3660100|B3|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|944|944.0||||||
3833188|NCT01702428|3660101|B2|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|938|938.0||||||
3833189|NCT01702428|3660102|B1|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|932|932.0||||||
3833190|NCT01702428|3660098|B5|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|126|126.0||||||
3833191|NCT01702428|3660099|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3833192|NCT01702428|3660100|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3833193|NCT01702428|3660101|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
3833194|NCT01702428|3660102|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3833195|NCT01702428|3660098|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3833196|NCT01702428|3660099|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3833197|NCT01702428|3660100|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3833198|NCT01702428|3660101|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3833199|NCT01702428|3660102|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3833200|NCT01702428|3660098|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|650|650.0||||||
3833201|NCT01702428|3660099|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|163|163.0||||||
3833202|NCT01702428|3660100|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|162|162.0||||||
3833203|NCT01702428|3660101|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|155|155.0||||||
3833204|NCT01702428|3660102|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|170|170.0||||||
3833205|NCT01702428|3660098|B5|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3833206|NCT01702428|3660099|B4|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3833207|NCT01702428|3660100|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3833208|NCT01702428|3660101|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3833209|NCT01702428|3660102|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3833210|NCT01702428|3660098|B5|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3833211|NCT01702428|3660099|B4|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3833212|NCT01702428|3660100|B3|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3833213|NCT01702428|3660101|B2|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3833214|NCT01702428|3660102|B1|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3833215|NCT01702428|3660098|B5||Male|Sex: Female, Male||Participants|Count of Participants|2569|2569.0||||||
3833216|NCT01702428|3660099|B4||Male|Sex: Female, Male||Participants|Count of Participants|671|671.0||||||
3833217|NCT01702428|3660100|B3||Male|Sex: Female, Male||Participants|Count of Participants|628|628.0||||||
3833218|NCT01702428|3660101|B2||Male|Sex: Female, Male||Participants|Count of Participants|638|638.0||||||
3833219|NCT01702428|3660102|B1||Male|Sex: Female, Male||Participants|Count of Participants|632|632.0||||||
3833220|NCT01702428|3660098|B5||Female|Sex: Female, Male||Participants|Count of Participants|2434|2434.0||||||
3833221|NCT01702428|3660099|B4||Female|Sex: Female, Male||Participants|Count of Participants|618|618.0||||||
3833222|NCT01702428|3660100|B3||Female|Sex: Female, Male||Participants|Count of Participants|615|615.0||||||
3833223|NCT01702428|3660101|B2||Female|Sex: Female, Male||Participants|Count of Participants|594|594.0||||||
3833224|NCT01702428|3660102|B1||Female|Sex: Female, Male||Participants|Count of Participants|607|607.0||||||
3833225|NCT01702428|3660098|B5|||Age||Months|Mean|12.3|12.3|Standard Deviation|0.7|0.7|||
3833226|NCT01702428|3660099|B4|||Age||Months|Mean|12.3|12.3|Standard Deviation|0.7|0.7|||
3833227|NCT01702428|3660100|B3|||Age||Months|Mean|12.3|12.3|Standard Deviation|0.7|0.7|||
3833228|NCT01702428|3660101|B2|||Age||Months|Mean|12.3|12.3|Standard Deviation|0.7|0.7|||
3833229|NCT01702428|3660102|B1|||Age||Months|Mean|12.3|12.3|Standard Deviation|0.7|0.7|||
3833230|NCT01702363|3660192|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|131|131.0||||||
3833231|NCT01702363|3660192|B1||Male|Gender||Participants|Count of Participants|128|128.0||||||
3833232|NCT01702363|3660192|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
3833233|NCT01702363|3660192|B1|||Age||Years|Mean|69.2|69.2|Standard Deviation|7.77|7.77|||
3833234|NCT01702311|3660207|B3||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3833235|NCT01702311|3660208|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3833236|NCT01702311|3660209|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3833237|NCT01702311|3660207|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3833238|NCT01702311|3660208|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3833239|NCT01702311|3660209|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3833240|NCT01702311|3660207|B3||>=65 years|Age||Participants|Count of Participants|47|47.0||||||
3833241|NCT01702311|3660208|B2||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3833242|NCT01702311|3660209|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3833243|NCT01702311|3660207|B3||Between 18 and 65 years|Age||Participants|Count of Participants|159|159.0||||||
3833244|NCT01702311|3660208|B2||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
3833245|NCT01702311|3660209|B1||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
3833246|NCT01702311|3660207|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3833247|NCT01702311|3660208|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3833248|NCT01702311|3660209|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3833249|NCT01702311|3660207|B3|||Age||years|Mean|57|57.0|Standard Deviation|11|11.0|||
3833250|NCT01702311|3660208|B2|||Age||years|Mean|57|57.0|Standard Deviation|11|11.0|||
3833251|NCT01702311|3660209|B1|||Age||years|Mean|58|58.0|Standard Deviation|10|10.0|||
3833252|NCT01702298|3660240|B1|||High-Density Lipoprotein Cholesterol (HDL-C)||mg/dL|Mean|43.1|43.1|Standard Deviation|11.9|11.9|||
3833253|NCT01702298|3660240|B1|||Triglycerides (TG)||mg/dL|Mean|225.3|225.3|Standard Deviation|152.5|152.5|||
3833254|NCT01702298|3660240|B1|||(Non-High-Density Lipoprotein Cholesterol (non-HDL-C)||mg/dL|Mean|152.0|152.0|Standard Deviation|37.9|37.9|||
3833255|NCT01702298|3660240|B1|||Total Cholesterol (TC)||md/dL|Mean|195.2|195.2|Standard Deviation|36.4|36.4|||
3833256|NCT01702298|3660240|B1|||Low-density lipoprotein cholesterol (LDL-C)||mg/dL|Mean|109.6|109.6|Standard Deviation|27.2|27.2|||
3833257|NCT01702298|3660240|B1|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|159.3|159.3|Standard Deviation|40.9|40.9|||
3833258|NCT01702298|3660240|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3833259|NCT01702298|3660240|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3833260|NCT01702298|3660240|B1|||Age||Years|Mean|48.3|48.3|Standard Deviation|7.1|7.1|||
3833261|NCT01702259|3660251|B3|||Percent Total Body Surface Area (TBSA)|The % Total Body Surface Area (% TBSA) covered by cellulite was marked and quantified according to the Lund and Browder Chart and methodology. The Lund and Browder chart is widely considered the most accurate method of determining Body Surface Area (BSA). It consists of an anterior and posterior diagram of a patient that is divided into sections. The % TBSA is the sum of the marked areas. The % TBSA of the buttocks and bilateral thighs area, front and back combined, affected by cellulite was calculated according to the Lund and Browder Chart.|percentage of TBSA|Mean|14.87|14.87|Standard Deviation|6.54|6.54|||
3833262|NCT01702259|3660252|B2|||Percent Total Body Surface Area (TBSA)|The % Total Body Surface Area (% TBSA) covered by cellulite was marked and quantified according to the Lund and Browder Chart and methodology. The Lund and Browder chart is widely considered the most accurate method of determining Body Surface Area (BSA). It consists of an anterior and posterior diagram of a patient that is divided into sections. The % TBSA is the sum of the marked areas. The % TBSA of the buttocks and bilateral thighs area, front and back combined, affected by cellulite was calculated according to the Lund and Browder Chart.|percentage of TBSA|Mean|14.38|14.38|Standard Deviation|7.01|7.01|||
3833263|NCT01702259|3660253|B1|||Percent Total Body Surface Area (TBSA)|The % Total Body Surface Area (% TBSA) covered by cellulite was marked and quantified according to the Lund and Browder Chart and methodology. The Lund and Browder chart is widely considered the most accurate method of determining Body Surface Area (BSA). It consists of an anterior and posterior diagram of a patient that is divided into sections. The % TBSA is the sum of the marked areas. The % TBSA of the buttocks and bilateral thighs area, front and back combined, affected by cellulite was calculated according to the Lund and Browder Chart.|percentage of TBSA|Mean|15.52|15.52|Standard Deviation|6.06|6.06|||
3833264|NCT01702259|3660251|B3|||Body Mass Index (BMI)|Measured as kilograms per meter squared (kg/m2)|kg/m2|Mean|25.22|25.22|Standard Deviation|2.80|2.8|||
3833265|NCT01702259|3660252|B2|||Body Mass Index (BMI)|Measured as kilograms per meter squared (kg/m2)|kg/m2|Mean|24.98|24.98|Standard Deviation|2.77|2.77|||
3833266|NCT01702259|3660253|B1|||Body Mass Index (BMI)|Measured as kilograms per meter squared (kg/m2)|kg/m2|Mean|25.42|25.42|Standard Deviation|2.84|2.84|||
3833267|NCT01702259|3660251|B3|||Circumference measurement|Circumference of the upper right and left thighs was recorded in inches (ins) using a flexible tape measure at standardized measurement points. Results are reported as combined bilateral (right+left thigh) circumference measurements.|inches|Mean|46.55|46.55|Standard Deviation|3.92|3.92|||
3833268|NCT01702259|3660252|B2|||Circumference measurement|Circumference of the upper right and left thighs was recorded in inches (ins) using a flexible tape measure at standardized measurement points. Results are reported as combined bilateral (right+left thigh) circumference measurements.|inches|Mean|46.05|46.05|Standard Deviation|4.66|4.66|||
3833269|NCT01702259|3660253|B1|||Circumference measurement|Circumference of the upper right and left thighs was recorded in inches (ins) using a flexible tape measure at standardized measurement points. Results are reported as combined bilateral (right+left thigh) circumference measurements.|inches|Mean|47.09|47.09|Standard Deviation|3.65|3.65|||
3833270|NCT01702259|3660251|B3|Stage III||Stage on the Nurnberger-Muller Scale (NMS)|The Nurnberger-Muller Scale (NMS) is a four-stage scale to classify stage or degree of cellulite. Stage II is defined as dimpling appearing spontaneously when standing but not when lying down. Orange peel appearance of the skin is evident to the naked eye without need for manipulation. Stage III is defined as dimpling spontaneously present with standing and lying down, evident to the naked eye without manipulation. Orange peel skin surface appearance with raised areas and nodules. NMS is assessed for both legs of each participant, and the worse of the stages is reported.|participants|Number|31|31.0||||||
3833271|NCT01702259|3660252|B2|Stage III||Stage on the Nurnberger-Muller Scale (NMS)|The Nurnberger-Muller Scale (NMS) is a four-stage scale to classify stage or degree of cellulite. Stage II is defined as dimpling appearing spontaneously when standing but not when lying down. Orange peel appearance of the skin is evident to the naked eye without need for manipulation. Stage III is defined as dimpling spontaneously present with standing and lying down, evident to the naked eye without manipulation. Orange peel skin surface appearance with raised areas and nodules. NMS is assessed for both legs of each participant, and the worse of the stages is reported.|participants|Number|16|16.0||||||
3833272|NCT01702259|3660253|B1|Stage III||Stage on the Nurnberger-Muller Scale (NMS)|The Nurnberger-Muller Scale (NMS) is a four-stage scale to classify stage or degree of cellulite. Stage II is defined as dimpling appearing spontaneously when standing but not when lying down. Orange peel appearance of the skin is evident to the naked eye without need for manipulation. Stage III is defined as dimpling spontaneously present with standing and lying down, evident to the naked eye without manipulation. Orange peel skin surface appearance with raised areas and nodules. NMS is assessed for both legs of each participant, and the worse of the stages is reported.|participants|Number|15|15.0||||||
3833319|NCT01702246|3660268|B1|||Age||years|Mean|18.5|18.5|Standard Deviation|6.8|6.8|||
3833320|NCT01702246|3660268|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3833321|NCT01702246|3660268|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3833322|NCT01702246|3660268|B1||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
3833273|NCT01702259|3660251|B3|Stage II||Stage on the Nurnberger-Muller Scale (NMS)|The Nurnberger-Muller Scale (NMS) is a four-stage scale to classify stage or degree of cellulite. Stage II is defined as dimpling appearing spontaneously when standing but not when lying down. Orange peel appearance of the skin is evident to the naked eye without need for manipulation. Stage III is defined as dimpling spontaneously present with standing and lying down, evident to the naked eye without manipulation. Orange peel skin surface appearance with raised areas and nodules. NMS is assessed for both legs of each participant, and the worse of the stages is reported.|participants|Number|37|37.0||||||
3833274|NCT01702259|3660252|B2|Stage II||Stage on the Nurnberger-Muller Scale (NMS)|The Nurnberger-Muller Scale (NMS) is a four-stage scale to classify stage or degree of cellulite. Stage II is defined as dimpling appearing spontaneously when standing but not when lying down. Orange peel appearance of the skin is evident to the naked eye without need for manipulation. Stage III is defined as dimpling spontaneously present with standing and lying down, evident to the naked eye without manipulation. Orange peel skin surface appearance with raised areas and nodules. NMS is assessed for both legs of each participant, and the worse of the stages is reported.|participants|Number|18|18.0||||||
3833275|NCT01702259|3660253|B1|Stage II||Stage on the Nurnberger-Muller Scale (NMS)|The Nurnberger-Muller Scale (NMS) is a four-stage scale to classify stage or degree of cellulite. Stage II is defined as dimpling appearing spontaneously when standing but not when lying down. Orange peel appearance of the skin is evident to the naked eye without need for manipulation. Stage III is defined as dimpling spontaneously present with standing and lying down, evident to the naked eye without manipulation. Orange peel skin surface appearance with raised areas and nodules. NMS is assessed for both legs of each participant, and the worse of the stages is reported.|participants|Number|19|19.0||||||
3833276|NCT01702259|3660251|B3|United States||Region of Enrollment||participants|Number|68|68.0||||||
3833277|NCT01702259|3660252|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
3833278|NCT01702259|3660253|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
3833279|NCT01702259|3660251|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3833280|NCT01702259|3660252|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3833281|NCT01702259|3660253|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3833282|NCT01702259|3660251|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833283|NCT01702259|3660252|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833284|NCT01702259|3660253|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833285|NCT01702259|3660251|B3||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3833286|NCT01702259|3660252|B2||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3833287|NCT01702259|3660253|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3833288|NCT01702259|3660251|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3833289|NCT01702259|3660252|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3833290|NCT01702259|3660253|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3833291|NCT01702259|3660251|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833292|NCT01702259|3660252|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833293|NCT01702259|3660253|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833294|NCT01702259|3660251|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833295|NCT01702259|3660252|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833296|NCT01702259|3660253|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833297|NCT01702259|3660251|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833298|NCT01702259|3660252|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833299|NCT01702259|3660253|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833300|NCT01702259|3660251|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3833301|NCT01702259|3660252|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3833302|NCT01702259|3660253|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3833303|NCT01702259|3660251|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3833304|NCT01702259|3660252|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3833305|NCT01702259|3660253|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3833306|NCT01702259|3660251|B3|||Age||years|Mean|39.91|39.91|Standard Deviation|10.36|10.36|||
3833307|NCT01702259|3660252|B2|||Age||years|Mean|39.94|39.94|Standard Deviation|10.72|10.72|||
3833308|NCT01702259|3660253|B1|||Age||years|Mean|39.87|39.87|Standard Deviation|10.08|10.08|||
3833309|NCT01702246|3660268|B1|||Receiving hydroxyurea (HU) therapy||participants|Number|10|10.0||||||
3833310|NCT01702246|3660268|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833311|NCT01702246|3660268|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833312|NCT01702246|3660268|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3833313|NCT01702246|3660268|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3833314|NCT01702246|3660268|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833315|NCT01702246|3660268|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833316|NCT01702246|3660268|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833317|NCT01702246|3660268|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
3833318|NCT01702246|3660268|B1||Female|Gender||Participants|Count of Participants|13|13.0||||||
3833323|NCT01702233|3660277|B4|||BMI||kg/m^2|Mean|26.69|26.69|Standard Deviation|4.866|4.866|||
3833324|NCT01702233|3660278|B3|||BMI||kg/m^2|Mean|27.14|27.14|Standard Deviation|4.382|4.382|||
3833325|NCT01702233|3660279|B2|||BMI||kg/m^2|Mean|27.29|27.29|Standard Deviation|5.455|5.455|||
3833326|NCT01702233|3660280|B1|||BMI||kg/m^2|Mean|25.92|25.92|Standard Deviation|4.455|4.455|||
3833327|NCT01702233|3660277|B4|||Screening Weight||kg|Mean|78|78.0|Standard Deviation|15.98|15.98|||
3833328|NCT01702233|3660278|B3|||Screening Weight||kg|Mean|78.8|78.8|Standard Deviation|16.90|16.9|||
3833329|NCT01702233|3660279|B2|||Screening Weight||kg|Mean|79.2|79.2|Standard Deviation|14.90|14.9|||
3833330|NCT01702233|3660280|B1|||Screening Weight||kg|Mean|76.4|76.4|Standard Deviation|16.57|16.57|||
3833331|NCT01702233|3660277|B4|||Screening Height||cm|Mean|170.8|170.8|Standard Deviation|9.65|9.65|||
3833332|NCT01702233|3660278|B3|||Screening Height||cm|Mean|169.9|169.9|Standard Deviation|11.32|11.32|||
3833333|NCT01702233|3660279|B2|||Screening Height||cm|Mean|170.6|170.6|Standard Deviation|8.01|8.01|||
3833334|NCT01702233|3660280|B1|||Screening Height||cm|Mean|171.3|171.3|Standard Deviation|10.24|10.24|||
3833335|NCT01702233|3660277|B4|Spain||Region of Enrollment||participants|Number|38|38.0||||||
3833336|NCT01702233|3660278|B3|Spain||Region of Enrollment||participants|Number|9|9.0||||||
3833337|NCT01702233|3660279|B2|Spain||Region of Enrollment||participants|Number|14|14.0||||||
3833338|NCT01702233|3660280|B1|Spain||Region of Enrollment||participants|Number|15|15.0||||||
3833339|NCT01702233|3660277|B4|Germany||Region of Enrollment||participants|Number|128|128.0||||||
3833340|NCT01702233|3660278|B3|Germany||Region of Enrollment||participants|Number|25|25.0||||||
3833341|NCT01702233|3660279|B2|Germany||Region of Enrollment||participants|Number|51|51.0||||||
3833342|NCT01702233|3660280|B1|Germany||Region of Enrollment||participants|Number|52|52.0||||||
3833343|NCT01702233|3660277|B4|Belgium||Region of Enrollment||participants|Number|9|9.0||||||
3833344|NCT01702233|3660278|B3|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
3833345|NCT01702233|3660279|B2|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
3833346|NCT01702233|3660280|B1|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
3833347|NCT01702233|3660277|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833348|NCT01702233|3660278|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833349|NCT01702233|3660279|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833350|NCT01702233|3660280|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833351|NCT01702233|3660277|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|173|173.0||||||
3833352|NCT01702233|3660278|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3833353|NCT01702233|3660279|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3833354|NCT01702233|3660280|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3833355|NCT01702233|3660277|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3833356|NCT01702233|3660278|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3833357|NCT01702233|3660279|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3833358|NCT01702233|3660280|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833359|NCT01702233|3660277|B4||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3833360|NCT01702233|3660278|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3833361|NCT01702233|3660279|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3833362|NCT01702233|3660280|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3833363|NCT01702233|3660277|B4||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3833364|NCT01702233|3660278|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3833365|NCT01702233|3660279|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3833366|NCT01702233|3660280|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3833367|NCT01702233|3660277|B4|||Age||years|Mean|51.50|51.5|Standard Deviation|6.89|6.89|||
3833368|NCT01702233|3660278|B3|||Age||years|Mean|51.80|51.8|Standard Deviation|6.74|6.74|||
3833369|NCT01702233|3660279|B2|||Age||years|Mean|51.90|51.9|Standard Deviation|7.02|7.02|||
3833370|NCT01702233|3660280|B1|||Age||years|Mean|51.00|51.0|Standard Deviation|6.90|6.9|||
3833371|NCT01702233|3660277|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3833372|NCT01702233|3660278|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3833373|NCT01702233|3660279|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3833374|NCT01702233|3660280|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3833375|NCT01702233|3660277|B4||Between 18 and 65 years|Age||Participants|Count of Participants|175|175.0||||||
3833376|NCT01702233|3660278|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3833377|NCT01702233|3660279|B2||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
3833378|NCT01702233|3660280|B1||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
3833379|NCT01702233|3660277|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3833380|NCT01702233|3660278|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3833381|NCT01702233|3660279|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3833382|NCT01702233|3660280|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3833383|NCT01702025|3660318|B5|||maximal oxygen uptake (VO2max)||milliliter/kilogram/minute|Mean|48.6|48.6|Standard Deviation|8|8.0|||
3833384|NCT01702025|3660319|B4|||maximal oxygen uptake (VO2max)||milliliter/kilogram/minute|Mean|46.5|46.5|Standard Deviation|8|8.0|||
3833385|NCT01702025|3660320|B3|||maximal oxygen uptake (VO2max)||milliliter/kilogram/minute|Mean|49.8|49.8|Standard Deviation|8|8.0|||
3833386|NCT01702025|3660321|B2|||maximal oxygen uptake (VO2max)||milliliter/kilogram/minute|Mean|49.4|49.4|Standard Deviation|10|10.0|||
3833387|NCT01702025|3660322|B1|||maximal oxygen uptake (VO2max)||milliliter/kilogram/minute|Mean|48.7|48.7|Standard Deviation|8|8.0|||
3833388|NCT01702025|3660318|B5|||Fat Free Mass||kilograms|Mean|61.2|61.2|Standard Deviation|7|7.0|||
3833389|NCT01702025|3660319|B4|||Fat Free Mass||kilograms|Mean|60.9|60.9|Standard Deviation|9|9.0|||
3833390|NCT01702025|3660320|B3|||Fat Free Mass||kilograms|Mean|61.9|61.9|Standard Deviation|7|7.0|||
3833391|NCT01702025|3660321|B2|||Fat Free Mass||kilograms|Mean|60.8|60.8|Standard Deviation|8|8.0|||
3833392|NCT01702025|3660322|B1|||Fat Free Mass||kilograms|Mean|61.3|61.3|Standard Deviation|7|7.0|||
3833393|NCT01702025|3660318|B5|||Fat Mass||kilograms|Mean|16.3|16.3|Standard Deviation|3|3.0|||
3833394|NCT01702025|3660319|B4|||Fat Mass||kilograms|Mean|17.4|17.4|Standard Deviation|5|5.0|||
3833395|NCT01702025|3660320|B3|||Fat Mass||kilograms|Mean|16.0|16.0|Standard Deviation|2|2.0|||
3833396|NCT01702025|3660321|B2|||Fat Mass||kilograms|Mean|16.5|16.5|Standard Deviation|5|5.0|||
3833397|NCT01702025|3660322|B1|||Fat Mass||kilograms|Mean|15.4|15.4|Standard Deviation|2|2.0|||
3833398|NCT01702025|3660318|B5|||Body Fat %||Percentage of body fat|Mean|21.1|21.1|Standard Deviation|5|5.0|||
3833399|NCT01702025|3660319|B4|||Body Fat %||Percentage of body fat|Mean|22.4|22.4|Standard Deviation|7|7.0|||
3833400|NCT01702025|3660320|B3|||Body Fat %||Percentage of body fat|Mean|20.6|20.6|Standard Deviation|2|2.0|||
3833401|NCT01702025|3660321|B2|||Body Fat %||Percentage of body fat|Mean|21.4|21.4|Standard Deviation|7|7.0|||
3833402|NCT01702025|3660322|B1|||Body Fat %||Percentage of body fat|Mean|20.2|20.2|Standard Deviation|3|3.0|||
3833403|NCT01702025|3660318|B5|||Body Mass Index||kg/m^2|Mean|25.2|25.2|Standard Deviation|2|2.0|||
3833404|NCT01702025|3660319|B4|||Body Mass Index||kg/m^2|Mean|25.4|25.4|Standard Deviation|2|2.0|||
3833405|NCT01702025|3660320|B3|||Body Mass Index||kg/m^2|Mean|25.1|25.1|Standard Deviation|2|2.0|||
3833406|NCT01702025|3660321|B2|||Body Mass Index||kg/m^2|Mean|25.4|25.4|Standard Deviation|2|2.0|||
3833407|NCT01702025|3660322|B1|||Body Mass Index||kg/m^2|Mean|24.8|24.8|Standard Deviation|2|2.0|||
3833408|NCT01702025|3660318|B5|United States||Region of Enrollment||participants|Number|41|41.0||||||
3833409|NCT01702025|3660319|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
3833410|NCT01702025|3660320|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3833411|NCT01702025|3660321|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3833412|NCT01702025|3660322|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3833413|NCT01702025|3660318|B5||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3833414|NCT01702025|3660319|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3833415|NCT01702025|3660320|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3833416|NCT01702025|3660321|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3833417|NCT01702025|3660322|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3833418|NCT01702025|3660318|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3833419|NCT01702025|3660319|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3833420|NCT01702025|3660320|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3833421|NCT01702025|3660321|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3833422|NCT01702025|3660322|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3833423|NCT01702025|3660318|B5|||Age||years|Mean|27|27.0|Standard Deviation|5|5.0|||
3833424|NCT01702025|3660319|B4|||Age||years|Mean|27|27.0|Standard Deviation|5|5.0|||
3833425|NCT01702025|3660320|B3|||Age||years|Mean|27|27.0|Standard Deviation|6|6.0|||
3833426|NCT01702025|3660321|B2|||Age||years|Mean|26|26.0|Standard Deviation|7|7.0|||
3833427|NCT01702025|3660322|B1|||Age||years|Mean|27|27.0|Standard Deviation|5|5.0|||
3833428|NCT01702025|3660318|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3833429|NCT01702025|3660319|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3833430|NCT01702025|3660320|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3833431|NCT01702025|3660321|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3833432|NCT01702025|3660322|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3833433|NCT01702025|3660318|B5||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3833434|NCT01702025|3660319|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3833435|NCT01702025|3660320|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3833436|NCT01702025|3660321|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3833437|NCT01702025|3660322|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3833438|NCT01702025|3660318|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3833439|NCT01702025|3660319|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3833440|NCT01702025|3660320|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3833441|NCT01702025|3660321|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3833442|NCT01702025|3660322|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3833443|NCT01701999|3660339|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3833444|NCT01701999|3660340|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3833445|NCT01701999|3660341|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3833446|NCT01701999|3660339|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3833447|NCT01701999|3660340|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3833448|NCT01701999|3660341|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3833449|NCT01701999|3660339|B3|||Age||years|Mean|45.1|45.1|Standard Deviation|11.3|11.3|||
3833450|NCT01701999|3660340|B2|||Age||years|Mean|44.0|44.0|Standard Deviation|10.7|10.7|||
3833451|NCT01701999|3660341|B1|||Age||years|Mean|50.3|50.3|Standard Deviation|13.5|13.5|||
3833452|NCT01701973|3660354|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
3833453|NCT01701973|3660354|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833454|NCT01701973|3660354|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833455|NCT01701973|3660354|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3833456|NCT01701973|3660354|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3833457|NCT01701973|3660354|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833458|NCT01701973|3660354|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3833459|NCT01701973|3660354|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833460|NCT01701973|3660354|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833461|NCT01701973|3660354|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3833462|NCT01701973|3660354|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3833463|NCT01701973|3660354|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3833464|NCT01701973|3660354|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3833465|NCT01701973|3660354|B1|||Age||years|Mean|25|25.0|Standard Deviation|5|5.0|||
3833466|NCT01701674|3660408|B1|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3833467|NCT01701674|3660408|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3833468|NCT01701674|3660408|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3833469|NCT01701674|3660408|B1|||Age||years|Mean|49|49.0|Full Range|||22.0|70.0|
3833470|NCT01701674|3660408|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3833471|NCT01701674|3660408|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3833472|NCT01701674|3660408|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3833473|NCT01701622|3660415|B1|Systolic Blood Pressure||Blood pressure||mm Hg|Mean|131|131.0|Standard Deviation|||||
3833474|NCT01701622|3660415|B1|Diastolic Blood Pressure||Blood pressure||mm Hg|Mean|79|79.0|Standard Deviation|||||
3833475|NCT01701622|3660415|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3833476|NCT01701622|3660415|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3833477|NCT01701622|3660415|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3833478|NCT01701622|3660415|B1|||Age||years|Mean|60|60.0|Standard Deviation|||||
3833479|NCT01701622|3660415|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3833480|NCT01701622|3660415|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3833481|NCT01701622|3660415|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3833482|NCT01701505|3660420|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3833483|NCT01701505|3660421|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3833484|NCT01701505|3660422|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833485|NCT01701505|3660423|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3833486|NCT01701505|3660424|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3833487|NCT01701505|3660425|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3833488|NCT01701505|3660426|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833489|NCT01701505|3660420|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833490|NCT01701505|3660421|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833491|NCT01701505|3660422|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833492|NCT01701505|3660423|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833493|NCT01701505|3660424|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833494|NCT01701505|3660425|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833495|NCT01701505|3660426|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833496|NCT01701505|3660420|B7||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3833497|NCT01701505|3660421|B6||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3833498|NCT01701505|3660422|B5||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3833499|NCT01701505|3660423|B4||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3833500|NCT01701505|3660424|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3833501|NCT01701505|3660425|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3833502|NCT01701505|3660426|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3833503|NCT01701505|3660420|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833504|NCT01701505|3660421|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833505|NCT01701505|3660422|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833506|NCT01701505|3660423|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833507|NCT01701505|3660424|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833508|NCT01701505|3660425|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833509|NCT01701505|3660426|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833510|NCT01701505|3660420|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833511|NCT01701505|3660421|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833512|NCT01701505|3660422|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833513|NCT01701505|3660423|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833514|NCT01701505|3660424|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833515|NCT01701505|3660425|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833516|NCT01701505|3660426|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833517|NCT01701505|3660420|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833518|NCT01701505|3660421|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833519|NCT01701505|3660422|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833520|NCT01701505|3660423|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833521|NCT01701505|3660424|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833522|NCT01701505|3660425|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833523|NCT01701505|3660426|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833524|NCT01701505|3660420|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3833525|NCT01701505|3660421|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833526|NCT01701505|3660422|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833527|NCT01701505|3660423|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833528|NCT01701505|3660424|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833529|NCT01701505|3660425|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3833530|NCT01701505|3660426|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833531|NCT01701505|3660420|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833532|NCT01701505|3660421|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833533|NCT01701505|3660422|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833534|NCT01701505|3660423|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833535|NCT01701505|3660424|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833536|NCT01701505|3660425|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833537|NCT01701505|3660426|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833538|NCT01701505|3660420|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3833539|NCT01701505|3660421|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3833540|NCT01701505|3660422|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3833541|NCT01701505|3660423|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3833542|NCT01701505|3660424|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3833543|NCT01701505|3660425|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3833544|NCT01701505|3660426|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3833545|NCT01701505|3660420|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3833546|NCT01701505|3660421|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3833547|NCT01701505|3660422|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833548|NCT01701505|3660423|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3833549|NCT01701505|3660424|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3833550|NCT01701505|3660425|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3833551|NCT01701505|3660426|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3833552|NCT01701505|3660420|B7||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3833553|NCT01701505|3660421|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3833554|NCT01701505|3660422|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3833555|NCT01701505|3660423|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3833556|NCT01701505|3660424|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3833557|NCT01701505|3660425|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3833558|NCT01701505|3660426|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3833559|NCT01701505|3660420|B7||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3833560|NCT01701505|3660421|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3833561|NCT01701505|3660422|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3833562|NCT01701505|3660423|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3833563|NCT01701505|3660424|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3833564|NCT01701505|3660425|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3833565|NCT01701505|3660426|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3833566|NCT01701505|3660420|B7|||Age||years|Mean|10.7|10.7|Standard Deviation|3.85|3.85|||
3833567|NCT01701505|3660421|B6|||Age||years|Mean|5.3|5.3|Standard Deviation|1.04|1.04|||
3833568|NCT01701505|3660422|B5|||Age||years|Mean|7.9|7.9|Standard Deviation|0.83|0.83|||
3833569|NCT01701505|3660423|B4|||Age||years|Mean|8.9|8.9|Standard Deviation|1.64|1.64|||
3833570|NCT01701505|3660424|B3|||Age||years|Mean|13.6|13.6|Standard Deviation|1.19|1.19|||
3833571|NCT01701505|3660425|B2|||Age||years|Mean|14.4|14.4|Standard Deviation|2.00|2.0|||
3833572|NCT01701505|3660426|B1|||Age||years|Mean|14.3|14.3|Standard Deviation|1.75|1.75|||
3833573|NCT01701414|3660481|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3833574|NCT01701414|3660482|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3833575|NCT01701414|3660483|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3833576|NCT01701414|3660481|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3833577|NCT01701414|3660482|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3833578|NCT01701414|3660483|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3833579|NCT01701414|3660481|B3||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3833580|NCT01701414|3660482|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3833581|NCT01701414|3660483|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3833582|NCT01701414|3660481|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3833583|NCT01701414|3660482|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3833584|NCT01701414|3660483|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3833585|NCT01701414|3660481|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3833586|NCT01701414|3660482|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3833587|NCT01701414|3660483|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3833588|NCT01701401|3660490|B5|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|158|158.0||||||
3833589|NCT01701401|3660491|B4|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|32|32.0||||||
3833590|NCT01701401|3660492|B3|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|46|46.0||||||
3833591|NCT01701401|3660493|B2|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|34|34.0||||||
3833592|NCT01701401|3660494|B1|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|46|46.0||||||
3833593|NCT01701401|3660490|B5|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|451|451.0||||||
3833594|NCT01701401|3660491|B4|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|112|112.0||||||
3833595|NCT01701401|3660492|B3|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|119|119.0||||||
3833596|NCT01701401|3660493|B2|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|107|107.0||||||
3833597|NCT01701401|3660494|B1|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|113|113.0||||||
3833598|NCT01701401|3660490|B5|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|256|256.0||||||
3833599|NCT01701401|3660491|B4|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|73|73.0||||||
3833600|NCT01701401|3660492|B3|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|52|52.0||||||
3833601|NCT01701401|3660493|B2|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|76|76.0||||||
3833602|NCT01701401|3660494|B1|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|55|55.0||||||
3833603|NCT01701401|3660490|B5|Missing||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|5|5.0||||||
3833604|NCT01701401|3660491|B4|Missing||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|1|1.0||||||
3833605|NCT01701401|3660492|B3|Missing||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|2|2.0||||||
3833606|NCT01701401|3660493|B2|Missing||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3833607|NCT01701401|3660494|B1|Missing||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|2|2.0||||||
3833608|NCT01701401|3660490|B5|Genotype 4||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|2|2.0||||||
3833609|NCT01701401|3660491|B4|Genotype 4||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|1|1.0||||||
3833654|NCT01701401|3660491|B4|Germany||Region of Enrollment||participants|Number|18|18.0||||||
3833610|NCT01701401|3660492|B3|Genotype 4||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3833611|NCT01701401|3660493|B2|Genotype 4||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3833612|NCT01701401|3660494|B1|Genotype 4||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|1|1.0||||||
3833613|NCT01701401|3660490|B5|Genotype 1 (no confirmed subtype)||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|4|4.0||||||
3833614|NCT01701401|3660491|B4|Genotype 1 (no confirmed subtype)||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|1|1.0||||||
3833615|NCT01701401|3660492|B3|Genotype 1 (no confirmed subtype)||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|1|1.0||||||
3833616|NCT01701401|3660493|B2|Genotype 1 (no confirmed subtype)||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|1|1.0||||||
3833617|NCT01701401|3660494|B1|Genotype 1 (no confirmed subtype)||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|1|1.0||||||
3833618|NCT01701401|3660490|B5|Genotype 1b||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|273|273.0||||||
3833619|NCT01701401|3660491|B4|Genotype 1b||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|71|71.0||||||
3833620|NCT01701401|3660492|B3|Genotype 1b||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|68|68.0||||||
3833621|NCT01701401|3660493|B2|Genotype 1b||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|68|68.0||||||
3833622|NCT01701401|3660494|B1|Genotype 1b||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|66|66.0||||||
3833623|NCT01701401|3660490|B5|Genotype 1a||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|581|581.0||||||
3833624|NCT01701401|3660491|B4|Genotype 1a||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|143|143.0||||||
3833625|NCT01701401|3660492|B3|Genotype 1a||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|146|146.0||||||
3833626|NCT01701401|3660493|B2|Genotype 1a||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|148|148.0||||||
3833627|NCT01701401|3660494|B1|Genotype 1a||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|144|144.0||||||
3833628|NCT01701401|3660490|B5|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|683|683.0||||||
3833629|NCT01701401|3660491|B4|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|173|173.0||||||
3833630|NCT01701401|3660492|B3|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|168|168.0||||||
3833631|NCT01701401|3660493|B2|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|173|173.0||||||
3833632|NCT01701401|3660494|B1|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|169|169.0||||||
3833633|NCT01701401|3660490|B5|< 800,000 IU/mL||HCV RNA Category||participants|Number|182|182.0||||||
3833634|NCT01701401|3660491|B4|< 800,000 IU/mL||HCV RNA Category||participants|Number|44|44.0||||||
3833635|NCT01701401|3660492|B3|< 800,000 IU/mL||HCV RNA Category||participants|Number|49|49.0||||||
3833636|NCT01701401|3660493|B2|< 800,000 IU/mL||HCV RNA Category||participants|Number|44|44.0||||||
3833637|NCT01701401|3660494|B1|< 800,000 IU/mL||HCV RNA Category||participants|Number|45|45.0||||||
3833638|NCT01701401|3660490|B5|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.4|6.4|Standard Deviation|0.66|0.66|||
3833639|NCT01701401|3660491|B4|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.65|0.65|||
3833640|NCT01701401|3660492|B3|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.68|0.68|||
3833641|NCT01701401|3660493|B2|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.4|6.4|Standard Deviation|0.64|0.64|||
3833642|NCT01701401|3660494|B1|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.4|6.4|Standard Deviation|0.69|0.69|||
3833643|NCT01701401|3660490|B5|Italy||Region of Enrollment||participants|Number|96|96.0||||||
3833644|NCT01701401|3660491|B4|Italy||Region of Enrollment||participants|Number|23|23.0||||||
3833645|NCT01701401|3660492|B3|Italy||Region of Enrollment||participants|Number|23|23.0||||||
3833646|NCT01701401|3660493|B2|Italy||Region of Enrollment||participants|Number|23|23.0||||||
3833647|NCT01701401|3660494|B1|Italy||Region of Enrollment||participants|Number|27|27.0||||||
3833648|NCT01701401|3660490|B5|United Kingdom||Region of Enrollment||participants|Number|55|55.0||||||
3833649|NCT01701401|3660491|B4|United Kingdom||Region of Enrollment||participants|Number|15|15.0||||||
3833650|NCT01701401|3660492|B3|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
3833651|NCT01701401|3660493|B2|United Kingdom||Region of Enrollment||participants|Number|17|17.0||||||
3833652|NCT01701401|3660494|B1|United Kingdom||Region of Enrollment||participants|Number|13|13.0||||||
3833653|NCT01701401|3660490|B5|Germany||Region of Enrollment||participants|Number|84|84.0||||||
3833655|NCT01701401|3660492|B3|Germany||Region of Enrollment||participants|Number|22|22.0||||||
3833656|NCT01701401|3660493|B2|Germany||Region of Enrollment||participants|Number|20|20.0||||||
3833657|NCT01701401|3660494|B1|Germany||Region of Enrollment||participants|Number|24|24.0||||||
3833658|NCT01701401|3660490|B5|Spain||Region of Enrollment||participants|Number|55|55.0||||||
3833659|NCT01701401|3660491|B4|Spain||Region of Enrollment||participants|Number|14|14.0||||||
3833660|NCT01701401|3660492|B3|Spain||Region of Enrollment||participants|Number|12|12.0||||||
3833661|NCT01701401|3660493|B2|Spain||Region of Enrollment||participants|Number|15|15.0||||||
3833662|NCT01701401|3660494|B1|Spain||Region of Enrollment||participants|Number|14|14.0||||||
3833663|NCT01701401|3660490|B5|United States||Region of Enrollment||participants|Number|512|512.0||||||
3833664|NCT01701401|3660491|B4|United States||Region of Enrollment||participants|Number|137|137.0||||||
3833665|NCT01701401|3660492|B3|United States||Region of Enrollment||participants|Number|132|132.0||||||
3833666|NCT01701401|3660493|B2|United States||Region of Enrollment||participants|Number|118|118.0||||||
3833667|NCT01701401|3660494|B1|United States||Region of Enrollment||participants|Number|125|125.0||||||
3833668|NCT01701401|3660490|B5|France||Region of Enrollment||participants|Number|63|63.0||||||
3833669|NCT01701401|3660491|B4|France||Region of Enrollment||participants|Number|10|10.0||||||
3833670|NCT01701401|3660492|B3|France||Region of Enrollment||participants|Number|18|18.0||||||
3833671|NCT01701401|3660493|B2|France||Region of Enrollment||participants|Number|24|24.0||||||
3833672|NCT01701401|3660494|B1|France||Region of Enrollment||participants|Number|11|11.0||||||
3833673|NCT01701401|3660490|B5|Not Disclosed||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3833674|NCT01701401|3660491|B4|Not Disclosed||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3833675|NCT01701401|3660492|B3|Not Disclosed||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3833676|NCT01701401|3660493|B2|Not Disclosed||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3833677|NCT01701401|3660494|B1|Not Disclosed||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3833678|NCT01701401|3660490|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|762|762.0||||||
3833679|NCT01701401|3660491|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|190|190.0||||||
3833680|NCT01701401|3660492|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|188|188.0||||||
3833681|NCT01701401|3660493|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|197|197.0||||||
3833682|NCT01701401|3660494|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|187|187.0||||||
3833683|NCT01701401|3660490|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|101|101.0||||||
3833684|NCT01701401|3660491|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3833685|NCT01701401|3660492|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3833686|NCT01701401|3660493|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3833687|NCT01701401|3660494|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3833688|NCT01701401|3660490|B5|Not Disclosed||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3833689|NCT01701401|3660491|B4|Not Disclosed||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3833690|NCT01701401|3660492|B3|Not Disclosed||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3833691|NCT01701401|3660493|B2|Not Disclosed||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3833692|NCT01701401|3660494|B1|Not Disclosed||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3833693|NCT01701401|3660490|B5|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3833694|NCT01701401|3660491|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3833695|NCT01701401|3660492|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3833696|NCT01701401|3660493|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3833697|NCT01701401|3660494|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3833698|NCT01701401|3660490|B5|Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3833699|NCT01701401|3660491|B4|Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3833700|NCT01701401|3660492|B3|Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3833701|NCT01701401|3660493|B2|Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3833702|NCT01701401|3660494|B1|Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3833703|NCT01701401|3660490|B5|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3833704|NCT01701401|3660491|B4|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3833705|NCT01701401|3660492|B3|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3833706|NCT01701401|3660493|B2|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3833707|NCT01701401|3660494|B1|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3833708|NCT01701401|3660490|B5|Asian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3833709|NCT01701401|3660491|B4|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3833710|NCT01701401|3660492|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3833711|NCT01701401|3660493|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3833712|NCT01701401|3660494|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3833713|NCT01701401|3660490|B5|White||Race/Ethnicity, Customized||participants|Number|735|735.0||||||
3833714|NCT01701401|3660491|B4|White||Race/Ethnicity, Customized||participants|Number|183|183.0||||||
3833715|NCT01701401|3660492|B3|White||Race/Ethnicity, Customized||participants|Number|177|177.0||||||
3833716|NCT01701401|3660493|B2|White||Race/Ethnicity, Customized||participants|Number|188|188.0||||||
3833717|NCT01701401|3660494|B1|White||Race/Ethnicity, Customized||participants|Number|187|187.0||||||
3833718|NCT01701401|3660490|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|108|108.0||||||
3833719|NCT01701401|3660491|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3833720|NCT01701401|3660492|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3833721|NCT01701401|3660493|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3833722|NCT01701401|3660494|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3833723|NCT01701401|3660490|B5||Male|Sex: Female, Male||Participants|Count of Participants|513|513.0||||||
3833724|NCT01701401|3660491|B4||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3833725|NCT01701401|3660492|B3||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3833726|NCT01701401|3660493|B2||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3833727|NCT01701401|3660494|B1||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3833728|NCT01701401|3660490|B5||Female|Sex: Female, Male||Participants|Count of Participants|352|352.0||||||
3833729|NCT01701401|3660491|B4||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3833730|NCT01701401|3660492|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3833731|NCT01701401|3660493|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3833732|NCT01701401|3660494|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3833733|NCT01701401|3660490|B5|||Age||years|Mean|52|52.0|Standard Deviation|10.6|10.6|||
3833734|NCT01701401|3660491|B4|||Age||years|Mean|53|53.0|Standard Deviation|9.9|9.9|||
3833735|NCT01701401|3660492|B3|||Age||years|Mean|53|53.0|Standard Deviation|10.3|10.3|||
3833736|NCT01701401|3660493|B2|||Age||years|Mean|52|52.0|Standard Deviation|11.5|11.5|||
3833737|NCT01701401|3660494|B1|||Age||years|Mean|52|52.0|Standard Deviation|10.7|10.7|||
3833738|NCT01701375|3660543|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3833739|NCT01701375|3660543|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3833740|NCT01701375|3660543|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3833741|NCT01701375|3660543|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|27|27.0|||
3833742|NCT01701375|3660543|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3833743|NCT01701375|3660543|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3833744|NCT01701375|3660543|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3833745|NCT01701362|3660547|B3||Male|Sex: Female, Male||Participants|Count of Participants|273|273.0||||||
3833746|NCT01701362|3660548|B2||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3833747|NCT01701362|3660549|B1||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3833748|NCT01701362|3660547|B3||Female|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
3833749|NCT01701362|3660548|B2||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3833750|NCT01701362|3660549|B1||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3833751|NCT01701362|3660547|B3|>=65 years||Age, Customized||Participants|Number|102|102.0||||||
3833752|NCT01701362|3660548|B2|>=65 years||Age, Customized||Participants|Number|50|50.0||||||
3833753|NCT01701362|3660549|B1|>=65 years||Age, Customized||Participants|Number|52|52.0||||||
3833754|NCT01701362|3660547|B3|45 - 64 years||Age, Customized||Participants|Number|317|317.0||||||
3833755|NCT01701362|3660548|B2|45 - 64 years||Age, Customized||Participants|Number|154|154.0||||||
3833756|NCT01701362|3660549|B1|45 - 64 years||Age, Customized||Participants|Number|163|163.0||||||
3833757|NCT01701362|3660547|B3|18 - 44 years||Age, Customized||Participants|Number|120|120.0||||||
3833758|NCT01701362|3660548|B2|18 - 44 years||Age, Customized||Participants|Number|61|61.0||||||
3833759|NCT01701362|3660549|B1|18 - 44 years||Age, Customized||Participants|Number|59|59.0||||||
3833760|NCT01701362|3660547|B3|||Age||Years|Mean|53.1|53.1|Standard Deviation|12.8|12.8|||
3833761|NCT01701362|3660548|B2|||Age||Years|Mean|53.4|53.4|Standard Deviation|12.7|12.7|||
3833762|NCT01701362|3660549|B1|||Age||Years|Mean|52.8|52.8|Standard Deviation|12.9|12.9|||
3833763|NCT01701271|3660578|B1|Italy||Region of Enrollment||participants|Number|20|20.0||||||
3833764|NCT01701271|3660578|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3833765|NCT01701271|3660578|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3833766|NCT01701271|3660578|B1|||Age||years|Median|44|44.0|Standard Deviation|26|26.0|||
3833767|NCT01701271|3660578|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3833768|NCT01701271|3660578|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3833769|NCT01701271|3660578|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3833770|NCT01701258|3660584|B5|||MASQ total|"Measure Description: Mood and Anxiety Symptom Questionnaire (MASQ), short form. Measures the severity of anxiety and depressive symptoms.62 items, rating of how much you have experienced certain feelings, emotions, or behaviors in the past week; item responses are on a 5-point scale from 1 (not at all) to 5 (extremely).~Range: 62-310; higher scores indicates more severe symptoms."|units on a scale|Mean|135.42|135.42|Standard Deviation|44.65|44.65|||
3833771|NCT01701258|3660585|B4|||MASQ total|"Measure Description: Mood and Anxiety Symptom Questionnaire (MASQ), short form. Measures the severity of anxiety and depressive symptoms.62 items, rating of how much you have experienced certain feelings, emotions, or behaviors in the past week; item responses are on a 5-point scale from 1 (not at all) to 5 (extremely).~Range: 62-310; higher scores indicates more severe symptoms."|units on a scale|Mean|180.57|180.57|Standard Deviation|21.89|21.89|||
3833772|NCT01701258|3660586|B3|||MASQ total|"Measure Description: Mood and Anxiety Symptom Questionnaire (MASQ), short form. Measures the severity of anxiety and depressive symptoms.62 items, rating of how much you have experienced certain feelings, emotions, or behaviors in the past week; item responses are on a 5-point scale from 1 (not at all) to 5 (extremely).~Range: 62-310; higher scores indicates more severe symptoms."|units on a scale|Mean|101.82|101.82|Standard Deviation|26.19|26.19|||
3833773|NCT01701258|3660587|B2|||MASQ total|"Measure Description: Mood and Anxiety Symptom Questionnaire (MASQ), short form. Measures the severity of anxiety and depressive symptoms.62 items, rating of how much you have experienced certain feelings, emotions, or behaviors in the past week; item responses are on a 5-point scale from 1 (not at all) to 5 (extremely).~Range: 62-310; higher scores indicates more severe symptoms."|units on a scale|Mean|167.86|167.86|Standard Deviation|22.60|22.6|||
3833774|NCT01701258|3660588|B1|||MASQ total|"Measure Description: Mood and Anxiety Symptom Questionnaire (MASQ), short form. Measures the severity of anxiety and depressive symptoms.62 items, rating of how much you have experienced certain feelings, emotions, or behaviors in the past week; item responses are on a 5-point scale from 1 (not at all) to 5 (extremely).~Range: 62-310; higher scores indicates more severe symptoms."|units on a scale|Mean|93.04|93.04|Standard Deviation|16.27|16.27|||
3833775|NCT01701258|3660584|B5|||BDI II|Measure Description: Beck Depression Inventory-II (BDI-II). Measures the presence and severity of 21 depressive symptoms during the past two weeks, on a scale from 0 (none, or no change) to 3 (persistent, or worsening).Range: 0 to 63. Higher scores indicate greater symptom severity. Clinical categories for total score: 0-14: absent; 14-19: mild; 20-28: moderate; 29-63: severe.|units on a scale|Mean|15.95|15.95|Standard Deviation|15.14|15.14|||
3833776|NCT01701258|3660585|B4|||BDI II|Measure Description: Beck Depression Inventory-II (BDI-II). Measures the presence and severity of 21 depressive symptoms during the past two weeks, on a scale from 0 (none, or no change) to 3 (persistent, or worsening).Range: 0 to 63. Higher scores indicate greater symptom severity. Clinical categories for total score: 0-14: absent; 14-19: mild; 20-28: moderate; 29-63: severe.|units on a scale|Mean|31.49|31.49|Standard Deviation|9.05|9.05|||
3833777|NCT01701258|3660586|B3|||BDI II|Measure Description: Beck Depression Inventory-II (BDI-II). Measures the presence and severity of 21 depressive symptoms during the past two weeks, on a scale from 0 (none, or no change) to 3 (persistent, or worsening).Range: 0 to 63. Higher scores indicate greater symptom severity. Clinical categories for total score: 0-14: absent; 14-19: mild; 20-28: moderate; 29-63: severe.|units on a scale|Mean|3.83|3.83|Standard Deviation|5.77|5.77|||
3833778|NCT01701258|3660587|B2|||BDI II|Measure Description: Beck Depression Inventory-II (BDI-II). Measures the presence and severity of 21 depressive symptoms during the past two weeks, on a scale from 0 (none, or no change) to 3 (persistent, or worsening).Range: 0 to 63. Higher scores indicate greater symptom severity. Clinical categories for total score: 0-14: absent; 14-19: mild; 20-28: moderate; 29-63: severe.|units on a scale|Mean|27.23|27.23|Standard Deviation|8.44|8.44|||
3833779|NCT01701258|3660588|B1|||BDI II|Measure Description: Beck Depression Inventory-II (BDI-II). Measures the presence and severity of 21 depressive symptoms during the past two weeks, on a scale from 0 (none, or no change) to 3 (persistent, or worsening).Range: 0 to 63. Higher scores indicate greater symptom severity. Clinical categories for total score: 0-14: absent; 14-19: mild; 20-28: moderate; 29-63: severe.|units on a scale|Mean|1.68|1.68|Standard Deviation|2.79|2.79|||
3833780|NCT01701258|3660584|B5|United States||Region of Enrollment||Participants|Count of Participants|96|96.0||||||
3833781|NCT01701258|3660585|B4|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3833782|NCT01701258|3660586|B3|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3833783|NCT01701258|3660587|B2|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3833784|NCT01701258|3660588|B1|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3833785|NCT01701258|3660584|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3833786|NCT01701258|3660585|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3833787|NCT01701258|3660586|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833788|NCT01701258|3660587|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833789|NCT01701258|3660588|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833790|NCT01701258|3660584|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3833791|NCT01701258|3660585|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3833792|NCT01701258|3660586|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3833793|NCT01701258|3660587|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833794|NCT01701258|3660588|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3833795|NCT01701258|3660584|B5||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3833796|NCT01701258|3660585|B4||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3833797|NCT01701258|3660586|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3833798|NCT01701258|3660587|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3833799|NCT01701258|3660588|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3833800|NCT01701258|3660584|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3833801|NCT01701258|3660585|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3833802|NCT01701258|3660586|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3833803|NCT01701258|3660587|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3833804|NCT01701258|3660588|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3833805|NCT01701258|3660584|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833806|NCT01701258|3660585|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833807|NCT01701258|3660586|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833808|NCT01701258|3660587|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833809|NCT01701258|3660588|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833810|NCT01701258|3660584|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3833811|NCT01701258|3660585|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3833812|NCT01701258|3660586|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833813|NCT01701258|3660587|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3833814|NCT01701258|3660588|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3833815|NCT01701258|3660584|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3833816|NCT01701258|3660585|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833817|NCT01701258|3660586|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833818|NCT01701258|3660587|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833819|NCT01701258|3660588|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3833820|NCT01701258|3660584|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3833821|NCT01701258|3660585|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3833822|NCT01701258|3660586|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3833823|NCT01701258|3660587|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3833824|NCT01701258|3660588|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3833825|NCT01701258|3660584|B5||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3833826|NCT01701258|3660585|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3833827|NCT01701258|3660586|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3833828|NCT01701258|3660587|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3833829|NCT01701258|3660588|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3833830|NCT01701258|3660584|B5|||Age||years|Mean|26.63|26.63|Standard Deviation|6.08|6.08|||
3833831|NCT01701258|3660585|B4|||Age||years|Mean|29.95|29.95|Standard Deviation|6.91|6.91|||
3833832|NCT01701258|3660586|B3|||Age||years|Mean|25.61|25.61|Standard Deviation|4.94|4.94|||
3833833|NCT01701258|3660587|B2|||Age||years|Mean|27.19|27.19|Standard Deviation|5.99|5.99|||
3833834|NCT01701258|3660588|B1|||Age||years|Mean|22.44|22.44|Standard Deviation|6.64|6.64|||
3833835|NCT01701258|3660584|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3833836|NCT01701258|3660585|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3833837|NCT01701258|3660586|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3833838|NCT01701258|3660587|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3833839|NCT01701258|3660588|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3833840|NCT01701258|3660584|B5||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
3833841|NCT01701258|3660585|B4||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3833842|NCT01701258|3660586|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3833843|NCT01701258|3660587|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3833844|NCT01701258|3660588|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3833845|NCT01701258|3660584|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3833846|NCT01701258|3660585|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3833847|NCT01701258|3660586|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3833848|NCT01701258|3660587|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3833849|NCT01701258|3660588|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3833850|NCT01701245|3660652|B3|Italy||Region of Enrollment||participants|Number|7|7.0||||||
3833851|NCT01701245|3660653|B2|Italy||Region of Enrollment||participants|Number|4|4.0||||||
3833852|NCT01701245|3660654|B1|Italy||Region of Enrollment||participants|Number|3|3.0||||||
3833853|NCT01701245|3660652|B3|United Kingdom||Region of Enrollment||participants|Number|24|24.0||||||
3833854|NCT01701245|3660653|B2|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
3833855|NCT01701245|3660654|B1|United Kingdom||Region of Enrollment||participants|Number|13|13.0||||||
3833856|NCT01701245|3660652|B3|Germany||Region of Enrollment||participants|Number|57|57.0||||||
3833857|NCT01701245|3660653|B2|Germany||Region of Enrollment||participants|Number|29|29.0||||||
3833858|NCT01701245|3660654|B1|Germany||Region of Enrollment||participants|Number|28|28.0||||||
3833859|NCT01701245|3660652|B3|Belgium||Region of Enrollment||participants|Number|9|9.0||||||
3833860|NCT01701245|3660653|B2|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
3833861|NCT01701245|3660654|B1|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
3833862|NCT01701245|3660652|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3833863|NCT01701245|3660653|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3833864|NCT01701245|3660654|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3833865|NCT01701245|3660652|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3833866|NCT01701245|3660653|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3833867|NCT01701245|3660654|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3833868|NCT01701245|3660652|B3|||Age||years|Mean|43.8|43.8|Standard Deviation|11.1|11.1|||
3833869|NCT01701245|3660653|B2|||Age||years|Mean|45.4|45.4|Standard Deviation|11.0|11.0|||
3833870|NCT01701245|3660654|B1|||Age||years|Mean|42.3|42.3|Standard Deviation|11.0|11.0|||
3833871|NCT01701115|3660667|B3|||Body Mass Index (BMI)||kg/m^2|Mean|26.8|26.8|Standard Deviation|3.9|3.9|||
3833872|NCT01701115|3660668|B2|||Body Mass Index (BMI)||kg/m^2|Mean|26.3|26.3|Standard Deviation|3.7|3.7|||
3833873|NCT01701115|3660669|B1|||Body Mass Index (BMI)||kg/m^2|Mean|27.6|27.6|Standard Deviation|4.2|4.2|||
3833874|NCT01701115|3660667|B3|United States||Region of Enrollment||participants|Number|152|152.0||||||
3833875|NCT01701115|3660668|B2|United States||Region of Enrollment||participants|Number|77|77.0||||||
3833876|NCT01701115|3660669|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
3833877|NCT01701115|3660667|B3|Male||Sex/Gender, Customized||Percentage of participants|Number|74.3|74.3||||||
3833878|NCT01701115|3660668|B2|Male||Sex/Gender, Customized||Percentage of participants|Number|74|74.0||||||
3833879|NCT01701115|3660669|B1|Male||Sex/Gender, Customized||Percentage of participants|Number|74.7|74.7||||||
3833880|NCT01701115|3660667|B3|Female||Sex/Gender, Customized||Percentage of participants|Number|25.7|25.7||||||
3833881|NCT01701115|3660668|B2|Female||Sex/Gender, Customized||Percentage of participants|Number|26|26.0||||||
3833882|NCT01701115|3660669|B1|Female||Sex/Gender, Customized||Percentage of participants|Number|25.3|25.3||||||
3833883|NCT01701115|3660667|B3|||Age||years|Mean|50.6|50.6|Standard Deviation|14.1|14.1|||
3833884|NCT01701115|3660668|B2|||Age||years|Mean|50|50.0|Standard Deviation|14.3|14.3|||
3833885|NCT01701115|3660669|B1|||Age||years|Mean|51.1|51.1|Standard Deviation|14.5|14.5|||
3833886|NCT01701102|3660682|B5|||Body Mass Index||kg/(m^2)|Mean|27.4|27.4|Standard Deviation|4.6|4.6|||
3833887|NCT01701102|3660683|B4|||Body Mass Index||kg/(m^2)|Mean|28.7|28.7|Standard Deviation|4.8|4.8|||
3833888|NCT01701102|3660684|B3|||Body Mass Index||kg/(m^2)|Mean|28.5|28.5|Standard Deviation|5.6|5.6|||
3833889|NCT01701102|3660685|B2|||Body Mass Index||kg/(m^2)|Mean|26.0|26.0|Standard Deviation|4.3|4.3|||
3833890|NCT01701102|3660686|B1|||Body Mass Index||kg/(m^2)|Mean|26.3|26.3|Standard Deviation|3.8|3.8|||
3833891|NCT01701102|3660682|B5||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3833892|NCT01701102|3660683|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3833893|NCT01701102|3660684|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3833894|NCT01701102|3660685|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3833895|NCT01701102|3660686|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3833896|NCT01701102|3660682|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3833897|NCT01701102|3660683|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3833898|NCT01701102|3660684|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3833899|NCT01701102|3660685|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3833900|NCT01701102|3660686|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3833901|NCT01701102|3660682|B5|||Age||years|Mean|44|44.0|Full Range|||19.0|60.0|
3833902|NCT01701102|3660683|B4|||Age||years|Mean|45|45.0|Full Range|||19.0|60.0|
3833903|NCT01701102|3660684|B3|||Age||years|Mean|46|46.0|Full Range|||27.0|60.0|
3833904|NCT01701102|3660685|B2|||Age||years|Mean|50|50.0|Full Range|||42.0|57.0|
3833905|NCT01701102|3660686|B1|||Age||years|Mean|41|41.0|Full Range|||19.0|55.0|
3833906|NCT01701063|3660699|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3833907|NCT01701063|3660700|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3833908|NCT01701063|3660701|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3833909|NCT01701063|3660702|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3833910|NCT01701063|3660699|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3833911|NCT01701063|3660700|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3833912|NCT01701063|3660701|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3833913|NCT01701063|3660702|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3833914|NCT01701063|3660699|B4|||Age||years|Mean|10.4|10.4|Standard Deviation|4.05|4.05|||
3833915|NCT01701063|3660700|B3|||Age||years|Mean|4.9|4.9|Standard Deviation|0.88|0.88|||
3833916|NCT01701063|3660701|B2|||Age||years|Mean|10.2|10.2|Standard Deviation|1.57|1.57|||
3833917|NCT01701063|3660702|B1|||Age||years|Mean|14.9|14.9|Standard Deviation|2.06|2.06|||
3833918|NCT01701037|3660746|B1|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3833919|NCT01701037|3660746|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833920|NCT01701037|3660746|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833921|NCT01701037|3660746|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3833922|NCT01701037|3660746|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833923|NCT01701037|3660746|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833924|NCT01701037|3660746|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833925|NCT01701037|3660746|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833926|NCT01701037|3660746|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833927|NCT01701037|3660746|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3833928|NCT01701037|3660746|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833929|NCT01701037|3660746|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3833930|NCT01701037|3660746|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3833931|NCT01701037|3660746|B1|70-79||Age, Customized||Participants|Count of Participants|2|2.0||||||
3833932|NCT01701037|3660746|B1|60-69||Age, Customized||Participants|Count of Participants|3|3.0||||||
3833933|NCT01701037|3660746|B1|50-59||Age, Customized||Participants|Count of Participants|3|3.0||||||
3833934|NCT01701037|3660746|B1|40-49||Age, Customized||Participants|Count of Participants|2|2.0||||||
3833935|NCT01701037|3660746|B1|30-39||Age, Customized||Participants|Count of Participants|2|2.0||||||
3833936|NCT01701037|3660746|B1|20-29||Age, Customized||Participants|Count of Participants|1|1.0||||||
3833937|NCT01701024|3660755|B3|Very Severe||Evaluator's Global Severity Score (EGSS)||participants|Number|0|0.0||||||
3833938|NCT01701024|3660756|B2|Very Severe||Evaluator's Global Severity Score (EGSS)||participants|Number|0|0.0||||||
3833939|NCT01701024|3660757|B1|Very Severe||Evaluator's Global Severity Score (EGSS)||participants|Number|0|0.0||||||
3833940|NCT01701024|3660755|B3|Severe||Evaluator's Global Severity Score (EGSS)||participants|Number|86|86.0||||||
3833941|NCT01701024|3660756|B2|Severe||Evaluator's Global Severity Score (EGSS)||participants|Number|45|45.0||||||
3833942|NCT01701024|3660757|B1|Severe||Evaluator's Global Severity Score (EGSS)||participants|Number|41|41.0||||||
3833943|NCT01701024|3660755|B3|Moderate||Evaluator's Global Severity Score (EGSS)||participants|Number|412|412.0||||||
3833944|NCT01701024|3660756|B2|Moderate||Evaluator's Global Severity Score (EGSS)||participants|Number|200|200.0||||||
3833945|NCT01701024|3660757|B1|Moderate||Evaluator's Global Severity Score (EGSS)||participants|Number|212|212.0||||||
3833946|NCT01701024|3660755|B3|Mild||Evaluator's Global Severity Score (EGSS)||participants|Number|0|0.0||||||
3833947|NCT01701024|3660756|B2|Mild||Evaluator's Global Severity Score (EGSS)||participants|Number|0|0.0||||||
3833948|NCT01701024|3660757|B1|Mild||Evaluator's Global Severity Score (EGSS)||participants|Number|0|0.0||||||
3833949|NCT01701024|3660755|B3|Almost Clear||Evaluator's Global Severity Score (EGSS)||participants|Number|0|0.0||||||
3833950|NCT01701024|3660756|B2|Almost Clear||Evaluator's Global Severity Score (EGSS)||participants|Number|0|0.0||||||
3833951|NCT01701024|3660757|B1|Almost Clear||Evaluator's Global Severity Score (EGSS)||participants|Number|0|0.0||||||
3833952|NCT01701024|3660755|B3|Clear||Evaluator's Global Severity Score (EGSS)||participants|Number|0|0.0||||||
3833953|NCT01701024|3660756|B2|Clear||Evaluator's Global Severity Score (EGSS)||participants|Number|0|0.0||||||
3833954|NCT01701024|3660757|B1|Clear||Evaluator's Global Severity Score (EGSS)||participants|Number|0|0.0||||||
3833955|NCT01701024|3660755|B3|||Non-Inflammatory Lesion Count||Lesions|Mean|37.8|37.8|Standard Deviation|17.87|17.87|||
3833956|NCT01701024|3660756|B2|||Non-Inflammatory Lesion Count||Lesions|Mean|37.2|37.2|Standard Deviation|17.07|17.07|||
3833957|NCT01701024|3660757|B1|||Non-Inflammatory Lesion Count||Lesions|Mean|38.3|38.3|Standard Deviation|18.63|18.63|||
3833958|NCT01701024|3660755|B3|||Inflammatory Lesion Count||Lesions|Mean|27|27.0|Standard Deviation|6.04|6.04|||
3833959|NCT01701024|3660756|B2|||Inflammatory Lesion Count||Lesions|Mean|26.7|26.7|Standard Deviation|6.09|6.09|||
3833960|NCT01701024|3660757|B1|||Inflammatory Lesion Count||Lesions|Mean|27.2|27.2|Standard Deviation|5.99|5.99|||
3833961|NCT01701024|3660755|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833962|NCT01701024|3660756|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833963|NCT01701024|3660757|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833964|NCT01701024|3660755|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3833965|NCT01701024|3660756|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3833966|NCT01701024|3660757|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3833967|NCT01701024|3660755|B3||White|Race (NIH/OMB)||Participants|Count of Participants|418|418.0||||||
3833968|NCT01701024|3660756|B2||White|Race (NIH/OMB)||Participants|Count of Participants|210|210.0||||||
3833969|NCT01701024|3660757|B1||White|Race (NIH/OMB)||Participants|Count of Participants|208|208.0||||||
3833970|NCT01701024|3660755|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3833971|NCT01701024|3660756|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3833972|NCT01701024|3660757|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3833973|NCT01701024|3660755|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3833974|NCT01701024|3660756|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3833975|NCT01701024|3660757|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3833976|NCT01701024|3660755|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3833977|NCT01701024|3660756|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3833978|NCT01701024|3660757|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3833979|NCT01701024|3660755|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833980|NCT01701024|3660756|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833981|NCT01701024|3660757|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833982|NCT01701024|3660755|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833983|NCT01701024|3660756|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833984|NCT01701024|3660757|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3833985|NCT01701024|3660755|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|362|362.0||||||
3833986|NCT01701024|3660756|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|173|173.0||||||
3833987|NCT01701024|3660757|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|189|189.0||||||
3833988|NCT01701024|3660755|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|136|136.0||||||
3833989|NCT01701024|3660756|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3833990|NCT01701024|3660757|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3833991|NCT01701024|3660755|B3||Male|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
3833992|NCT01701024|3660756|B2||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3833993|NCT01701024|3660757|B1||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3833994|NCT01701024|3660755|B3||Female|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
3833995|NCT01701024|3660756|B2||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3833996|NCT01701024|3660757|B1||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3833997|NCT01701024|3660755|B3|||Age||years|Mean|18.7|18.7|Standard Deviation|5.82|5.82|||
3833998|NCT01701024|3660756|B2|||Age||years|Mean|19.3|19.3|Standard Deviation|6|6.0|||
3833999|NCT01701024|3660757|B1|||Age||years|Mean|18.2|18.2|Standard Deviation|5.6|5.6|||
3834000|NCT01701011|3660770|B4|Netherlands||Region of Enrollment||participants|Number|377|377.0||||||
3834001|NCT01701011|3660771|B3|Netherlands||Region of Enrollment||participants|Number|124|124.0||||||
3834002|NCT01701011|3660772|B2|Netherlands||Region of Enrollment||participants|Number|126|126.0||||||
3834003|NCT01701011|3660773|B1|Netherlands||Region of Enrollment||participants|Number|127|127.0||||||
3834004|NCT01701011|3660770|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3834005|NCT01701011|3660771|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3834006|NCT01701011|3660772|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3834007|NCT01701011|3660773|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3834008|NCT01701011|3660770|B4||Female|Sex: Female, Male||Participants|Count of Participants|377|377.0||||||
3834009|NCT01701011|3660771|B3||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3834010|NCT01701011|3660772|B2||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3834011|NCT01701011|3660773|B1||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3834012|NCT01701011|3660770|B4|||Age||years|Mean|34.8|34.8|Standard Deviation|4.8|4.8|||
3834013|NCT01701011|3660771|B3|||Age||years|Mean|34.8|34.8|Standard Deviation|5.0|5.0|||
3834014|NCT01701011|3660772|B2|||Age||years|Mean|34.6|34.6|Standard Deviation|4.7|4.7|||
3834015|NCT01701011|3660773|B1|||Age||years|Mean|34.9|34.9|Standard Deviation|4.7|4.7|||
3834016|NCT01700985|3660786|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
3834017|NCT01700985|3660787|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
3834018|NCT01700985|3660788|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
3834019|NCT01700985|3660786|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834020|NCT01700985|3660787|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834021|NCT01700985|3660788|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834022|NCT01700985|3660786|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834023|NCT01700985|3660787|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834024|NCT01700985|3660788|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834025|NCT01700985|3660786|B3||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3834026|NCT01700985|3660787|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3834027|NCT01700985|3660788|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3834028|NCT01700985|3660786|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3834029|NCT01700985|3660787|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3834030|NCT01700985|3660788|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834031|NCT01700985|3660786|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834032|NCT01700985|3660787|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834033|NCT01700985|3660788|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834034|NCT01700985|3660786|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3834035|NCT01700985|3660787|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3834036|NCT01700985|3660788|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3834037|NCT01700985|3660786|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834038|NCT01700985|3660787|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834039|NCT01700985|3660788|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834040|NCT01700985|3660786|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834041|NCT01700985|3660787|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834042|NCT01700985|3660788|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834043|NCT01700985|3660786|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3834044|NCT01700985|3660787|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3834045|NCT01700985|3660788|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3834046|NCT01700985|3660786|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3834047|NCT01700985|3660787|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3834048|NCT01700985|3660788|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3834049|NCT01700985|3660786|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3834050|NCT01700985|3660787|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3834051|NCT01700985|3660788|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3834052|NCT01700985|3660786|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3834053|NCT01700985|3660787|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3834054|NCT01700985|3660788|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3834055|NCT01700985|3660786|B3|||Age||years|Mean|50.0|50.0|Standard Deviation|14.5|14.5|||
3834056|NCT01700985|3660787|B2|||Age||years|Mean|48.6|48.6|Standard Deviation|14.9|14.9|||
3834057|NCT01700985|3660788|B1|||Age||years|Mean|51.3|51.3|Standard Deviation|14.3|14.3|||
3834058|NCT01700959|3660805|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3834059|NCT01700959|3660806|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3834060|NCT01700959|3660807|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3834061|NCT01700959|3660808|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834062|NCT01700959|3660809|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3834063|NCT01700959|3660810|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834064|NCT01700959|3660811|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834065|NCT01700959|3660805|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834066|NCT01700959|3660806|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834067|NCT01700959|3660807|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834068|NCT01700959|3660808|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834069|NCT01700959|3660809|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834070|NCT01700959|3660810|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834071|NCT01700959|3660811|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834072|NCT01700959|3660805|B7||White|Race (NIH/OMB)||Participants|Count of Participants|338|338.0||||||
3834073|NCT01700959|3660806|B6||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3834074|NCT01700959|3660807|B5||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3834075|NCT01700959|3660808|B4||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3834076|NCT01700959|3660809|B3||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3834077|NCT01700959|3660810|B2||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3834078|NCT01700959|3660811|B1||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3834079|NCT01700959|3660805|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3834080|NCT01700959|3660806|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3834081|NCT01700959|3660807|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3834082|NCT01700959|3660808|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3834083|NCT01700959|3660809|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3834084|NCT01700959|3660810|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3834085|NCT01700959|3660811|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3834086|NCT01700959|3660805|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834087|NCT01700959|3660806|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834088|NCT01700959|3660807|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834089|NCT01700959|3660808|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834090|NCT01700959|3660809|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834091|NCT01700959|3660810|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834092|NCT01700959|3660811|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834093|NCT01700959|3660805|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3834094|NCT01700959|3660806|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3834095|NCT01700959|3660807|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834096|NCT01700959|3660808|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834097|NCT01700959|3660809|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834098|NCT01700959|3660810|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834099|NCT01700959|3660811|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834100|NCT01700959|3660805|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834101|NCT01700959|3660806|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834102|NCT01700959|3660807|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834103|NCT01700959|3660808|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834104|NCT01700959|3660809|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834105|NCT01700959|3660810|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834106|NCT01700959|3660811|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834107|NCT01700959|3660805|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3834108|NCT01700959|3660806|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3834109|NCT01700959|3660807|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3834110|NCT01700959|3660808|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3834111|NCT01700959|3660809|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3834112|NCT01700959|3660810|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3834113|NCT01700959|3660811|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3834114|NCT01700959|3660805|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|347|347.0||||||
3834115|NCT01700959|3660806|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3834116|NCT01700959|3660807|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3834117|NCT01700959|3660808|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3834118|NCT01700959|3660809|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3834119|NCT01700959|3660810|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3834120|NCT01700959|3660811|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3834121|NCT01700959|3660805|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3834122|NCT01700959|3660806|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834123|NCT01700959|3660807|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3834124|NCT01700959|3660808|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3834125|NCT01700959|3660809|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3834126|NCT01700959|3660810|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834127|NCT01700959|3660811|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834128|NCT01700959|3660805|B7||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
3834129|NCT01700959|3660806|B6||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3834130|NCT01700959|3660807|B5||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3834131|NCT01700959|3660808|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3834132|NCT01700959|3660809|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3834133|NCT01700959|3660810|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3834134|NCT01700959|3660811|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3834135|NCT01700959|3660805|B7||Female|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
3834136|NCT01700959|3660806|B6||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3834137|NCT01700959|3660807|B5||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3834138|NCT01700959|3660808|B4||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3834139|NCT01700959|3660809|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3834140|NCT01700959|3660810|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3834141|NCT01700959|3660811|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3834142|NCT01700959|3660805|B7|||Age||years|Mean|34.46|34.46|Standard Deviation|8.7|8.7|||
3834143|NCT01700959|3660806|B6|||Age||years|Mean|36.5|36.5|Standard Deviation|8.2|8.2|||
3834144|NCT01700959|3660807|B5|||Age||years|Mean|35.8|35.8|Standard Deviation|9.0|9.0|||
3834145|NCT01700959|3660808|B4|||Age||years|Mean|32.4|32.4|Standard Deviation|9.3|9.3|||
3834146|NCT01700959|3660809|B3|||Age||years|Mean|32.8|32.8|Standard Deviation|7.8|7.8|||
3834147|NCT01700959|3660810|B2|||Age||years|Mean|36.4|36.4|Standard Deviation|8.1|8.1|||
3834148|NCT01700959|3660811|B1|||Age||years|Mean|32.8|32.8|Standard Deviation|9.1|9.1|||
3834149|NCT01700907|3660838|B3|Japan||Region of Enrollment||participants|Number|20|20.0||||||
3834150|NCT01700907|3660839|B2|Japan||Region of Enrollment||participants|Number|10|10.0||||||
3834151|NCT01700907|3660840|B1|Japan||Region of Enrollment||participants|Number|10|10.0||||||
3834152|NCT01700907|3660838|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3834153|NCT01700907|3660839|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3834154|NCT01700907|3660840|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3834155|NCT01700907|3660838|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3834156|NCT01700907|3660839|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3834157|NCT01700907|3660840|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3834158|NCT01700907|3660838|B3|||Age||years|Mean|74.5|74.5|Standard Deviation|6.1|6.1|||
3834159|NCT01700907|3660839|B2|||Age||years|Mean|74.1|74.1|Standard Deviation|6.5|6.5|||
3834160|NCT01700907|3660840|B1|||Age||years|Mean|74.9|74.9|Standard Deviation|6.0|6.0|||
3834161|NCT01700907|3660838|B3||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3834162|NCT01700907|3660839|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3834163|NCT01700907|3660840|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3834164|NCT01700907|3660838|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3834165|NCT01700907|3660839|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3834166|NCT01700907|3660840|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3834167|NCT01700907|3660838|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3834168|NCT01700907|3660839|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3834169|NCT01700907|3660840|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3834170|NCT01700816|3660855|B3|Completed College||Highest Education Level||Participants|Count of Participants|19|19.0||||||
3834171|NCT01700816|3660856|B2|Completed College||Highest Education Level||Participants|Count of Participants|7|7.0||||||
3834172|NCT01700816|3660857|B1|Completed College||Highest Education Level||Participants|Count of Participants|12|12.0||||||
3834173|NCT01700816|3660855|B3|Some College||Highest Education Level||Participants|Count of Participants|4|4.0||||||
3834174|NCT01700816|3660856|B2|Some College||Highest Education Level||Participants|Count of Participants|2|2.0||||||
3834175|NCT01700816|3660857|B1|Some College||Highest Education Level||Participants|Count of Participants|2|2.0||||||
3834176|NCT01700816|3660855|B3|High School degree/GED||Highest Education Level||Participants|Count of Participants|8|8.0||||||
3834177|NCT01700816|3660856|B2|High School degree/GED||Highest Education Level||Participants|Count of Participants|6|6.0||||||
3834178|NCT01700816|3660857|B1|High School degree/GED||Highest Education Level||Participants|Count of Participants|2|2.0||||||
3834179|NCT01700816|3660855|B3|11th grade or less||Highest Education Level||Participants|Count of Participants|1|1.0||||||
3834180|NCT01700816|3660856|B2|11th grade or less||Highest Education Level||Participants|Count of Participants|0|0.0||||||
3834181|NCT01700816|3660857|B1|11th grade or less||Highest Education Level||Participants|Count of Participants|1|1.0||||||
3834182|NCT01700816|3660855|B3|Single/Divorced/Widowed||Marital Status||Participants|Count of Participants|9|9.0||||||
3834183|NCT01700816|3660856|B2|Single/Divorced/Widowed||Marital Status||Participants|Count of Participants|4|4.0||||||
3834184|NCT01700816|3660857|B1|Single/Divorced/Widowed||Marital Status||Participants|Count of Participants|5|5.0||||||
3834185|NCT01700816|3660855|B3|Married/Partnered||Marital Status||Participants|Count of Participants|25|25.0||||||
3834186|NCT01700816|3660856|B2|Married/Partnered||Marital Status||Participants|Count of Participants|13|13.0||||||
3834187|NCT01700816|3660857|B1|Married/Partnered||Marital Status||Participants|Count of Participants|12|12.0||||||
3834188|NCT01700816|3660855|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3834189|NCT01700816|3660856|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3834190|NCT01700816|3660857|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3834191|NCT01700816|3660855|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3834192|NCT01700816|3660856|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3834193|NCT01700816|3660857|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3834194|NCT01700816|3660855|B3|Non Hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3834195|NCT01700816|3660856|B2|Non Hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3834196|NCT01700816|3660857|B1|Non Hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3834197|NCT01700816|3660855|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3834198|NCT01700816|3660856|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3834199|NCT01700816|3660857|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3834200|NCT01700816|3660855|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3834201|NCT01700816|3660856|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3834202|NCT01700816|3660857|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3834203|NCT01700816|3660855|B3|||Age||years|Mean|53.2|53.2|Standard Deviation|13.49|13.49|||
3834204|NCT01700816|3660856|B2|||Age||years|Mean|53.1|53.1|Standard Deviation|14.15|14.15|||
3834205|NCT01700816|3660857|B1|||Age||years|Mean|53.3|53.3|Standard Deviation|12.84|12.84|||
3834206|NCT01700530|3660884|B4|United States||Region of Enrollment||participants|Number|50|50.0||||||
3834207|NCT01700530|3660885|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3834208|NCT01700530|3660886|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
3834209|NCT01700530|3660887|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3834210|NCT01700530|3660884|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3834211|NCT01700530|3660885|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3834212|NCT01700530|3660886|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3834213|NCT01700530|3660887|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3834214|NCT01700530|3660884|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3834215|NCT01700530|3660885|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3834216|NCT01700530|3660886|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3834217|NCT01700530|3660887|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3834218|NCT01700530|3660884|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3834219|NCT01700530|3660885|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3834220|NCT01700530|3660886|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3834221|NCT01700530|3660887|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3834222|NCT01700530|3660884|B4||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3834223|NCT01700530|3660885|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3834224|NCT01700530|3660886|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3834225|NCT01700530|3660887|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3834226|NCT01700530|3660884|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3834227|NCT01700530|3660885|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3834228|NCT01700530|3660886|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3834229|NCT01700530|3660887|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3834230|NCT01700530|3660884|B4|||Age||years|Mean|44|44.0|Standard Deviation|10|10.0|||
3834231|NCT01700530|3660885|B3|||Age||years|Mean|43|43.0|Standard Deviation|9|9.0|||
3834232|NCT01700530|3660886|B2|||Age||years|Mean|44|44.0|Standard Deviation|12|12.0|||
3834233|NCT01700530|3660887|B1|||Age||years|Mean|44|44.0|Standard Deviation|10|10.0|||
3834234|NCT01700517|3660900|B4|Brazil||Region of Enrollment||participants|Number|120|120.0||||||
3834235|NCT01700517|3660901|B3|Brazil||Region of Enrollment||participants|Number|40|40.0||||||
3834236|NCT01700517|3660902|B2|Brazil||Region of Enrollment||participants|Number|40|40.0||||||
3834237|NCT01700517|3660903|B1|Brazil||Region of Enrollment||participants|Number|40|40.0||||||
3834238|NCT01700517|3660900|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3834239|NCT01700517|3660901|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3834240|NCT01700517|3660902|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3834241|NCT01700517|3660903|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3834242|NCT01700517|3660900|B4||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3834243|NCT01700517|3660901|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3834244|NCT01700517|3660902|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3834245|NCT01700517|3660903|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3834246|NCT01700517|3660900|B4|||Age||years|Mean|71.9|71.9|Standard Deviation|7.8|7.8|||
3834247|NCT01700517|3660901|B3|||Age||years|Mean|71.8|71.8|Standard Deviation|7|7.0|||
3834248|NCT01700517|3660902|B2|||Age||years|Mean|71.9|71.9|Standard Deviation|8|8.0|||
3834249|NCT01700517|3660903|B1|||Age||years|Mean|72|72.0|Standard Deviation|8.8|8.8|||
3834250|NCT01700517|3660900|B4||>=65 years|Age||Participants|Count of Participants|99|99.0||||||
3834251|NCT01700517|3660901|B3||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
3834252|NCT01700517|3660902|B2||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
3834253|NCT01700517|3660903|B1||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
3834254|NCT01700517|3660900|B4||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3834255|NCT01700517|3660901|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3834256|NCT01700517|3660902|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3834257|NCT01700517|3660903|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3834258|NCT01700517|3660900|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3834259|NCT01700517|3660901|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3834260|NCT01700517|3660902|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3834261|NCT01700517|3660903|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3834262|NCT01700439|3660913|B1|United States||Region of Enrollment||participants|Number|934|934.0||||||
3834263|NCT01700439|3660913|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3834264|NCT01700439|3660913|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|773|773.0||||||
3834265|NCT01700439|3660913|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3834266|NCT01700439|3660913|B1||Male|Sex: Female, Male||Participants|Count of Participants|541|541.0||||||
3834267|NCT01700439|3660913|B1||Female|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
3834268|NCT01700439|3660913|B1|||Age||Years|Mean|73.5|73.5|Standard Deviation|8.3|8.3|||
3834269|NCT01700387|3660936|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3834270|NCT01700387|3660937|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3834271|NCT01700387|3660938|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834272|NCT01700387|3660936|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3834273|NCT01700387|3660937|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3834274|NCT01700387|3660938|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3834275|NCT01700387|3660936|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834276|NCT01700387|3660937|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834277|NCT01700387|3660938|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834278|NCT01700387|3660936|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3834279|NCT01700387|3660937|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3834280|NCT01700387|3660938|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3834281|NCT01700387|3660936|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3834282|NCT01700387|3660937|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3834283|NCT01700387|3660938|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3834284|NCT01700387|3660936|B3|||Age||years|Mean|40.18|40.18|Standard Deviation|12.02|12.02|||
3834285|NCT01700387|3660937|B2|||Age||years|Mean|39.51|39.51|Standard Deviation|6.99|6.99|||
3834286|NCT01700387|3660938|B1|||Age||years|Mean|40.84|40.84|Standard Deviation|15.98|15.98|||
3834287|NCT01700348|3660949|B1|||Percent of Site Bleeding||percent of sites|Mean|51.6|51.6|Standard Deviation|16.70|16.7|||
3834288|NCT01700348|3660949|B1|||Number of Bleeding Sites||number of sites|Mean|54.1|54.1|Standard Deviation|17.80|17.8|||
3834289|NCT01700348|3660949|B1|||Average Modified Gingival Index Score|"The Modified Gingival Index (MGI) scale 0 = absence of inflammation;~= mild inflammation or with slight changes in color and texture but not in all portions of gingival marginal or papillary;~= mild inflammation, such as the preceding criteria, in all portions of gingival marginal or papillary;~= moderate, bright surface inflammation, erythema, edema and/or hypertrophy of gingival marginal or papillary;~= severe inflammation: erythema, edema and/or marginal gingival hypertrophy of the unit or spontaneous bleeding, papillary, congestion or ulceration."|units on a scale|Mean|1.2|1.2|Standard Deviation|.4|0.4|||
3834290|NCT01700348|3660949|B1|||Number of Missing Teeth||missing teeth|Mean|.8|0.8|Standard Deviation|1.40|1.4|||
3834291|NCT01700348|3660949|B1|United States||Region of Enrollment||participants|Number|116|116.0||||||
3834292|NCT01700348|3660949|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3834293|NCT01700348|3660949|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3834294|NCT01700348|3660949|B1|||Age||years|Mean|34.5|34.5|Standard Deviation|11.20|11.2|||
3834295|NCT01700348|3660949|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3834296|NCT01700348|3660949|B1||Between 18 and 65 years|Age||Participants|Count of Participants|116|116.0||||||
3834297|NCT01700348|3660949|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3834298|NCT01700335|3660953|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3834299|NCT01700335|3660953|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3834300|NCT01700335|3660953|B1|80- years||Age, Customized||participants|Number|1|1.0||||||
3834301|NCT01700335|3660953|B1|70-79 years||Age, Customized||participants|Number|4|4.0||||||
3834302|NCT01700335|3660953|B1|60-69 years||Age, Customized||participants|Number|4|4.0||||||
3834303|NCT01700192|3660965|B3||Male|Sex: Female, Male||Participants|Count of Participants|607|607.0||||||
3834304|NCT01700192|3660966|B2||Male|Sex: Female, Male||Participants|Count of Participants|311|311.0||||||
3834305|NCT01700192|3660967|B1||Male|Sex: Female, Male||Participants|Count of Participants|296|296.0||||||
3834306|NCT01700192|3660965|B3||Female|Sex: Female, Male||Participants|Count of Participants|875|875.0||||||
3834307|NCT01700192|3660966|B2||Female|Sex: Female, Male||Participants|Count of Participants|430|430.0||||||
3834308|NCT01700192|3660967|B1||Female|Sex: Female, Male||Participants|Count of Participants|445|445.0||||||
3834309|NCT01700192|3660965|B3|||Age||Years|Mean|35.1|35.1|Standard Deviation|13.77|13.77|12.0|85.0|
3834310|NCT01700192|3660966|B2|||Age||Years|Mean|35.2|35.2|Standard Deviation|13.74|13.74|12.0|85.0|
3834311|NCT01700192|3660967|B1|||Age||Years|Mean|34.9|34.9|Standard Deviation|13.82|13.82|12.0|77.0|
3834312|NCT01700179|3660986|B1|||BMI||kg/m^2|Mean|28.13|28.13|Standard Deviation|4.183|4.183|||
3834313|NCT01700179|3660986|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834314|NCT01700179|3660986|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834315|NCT01700179|3660986|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3834316|NCT01700179|3660986|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834317|NCT01700179|3660986|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834318|NCT01700179|3660986|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3834319|NCT01700179|3660986|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834320|NCT01700179|3660986|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3834321|NCT01700179|3660986|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3834322|NCT01700179|3660986|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3834323|NCT01700179|3660986|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3834324|NCT01700179|3660986|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3834325|NCT01700179|3660986|B1|||Age||years|Mean|50.07|50.07|Standard Deviation|11.34|11.34|||
3834326|NCT01700140|3660990|B4|Present||Nausea/emesis||Participants|Number|0|0.0||||||
3834327|NCT01700140|3660991|B3|Present||Nausea/emesis||Participants|Number|0|0.0||||||
3834328|NCT01700140|3660992|B2|Present||Nausea/emesis||Participants|Number|0|0.0||||||
3834329|NCT01700140|3660993|B1|Present||Nausea/emesis||Participants|Number|0|0.0||||||
3834330|NCT01700140|3660990|B4|Absent||Nausea/emesis||Participants|Number|175|175.0||||||
3834331|NCT01700140|3660991|B3|Absent||Nausea/emesis||Participants|Number|60|60.0||||||
3834332|NCT01700140|3660992|B2|Absent||Nausea/emesis||Participants|Number|59|59.0||||||
3834333|NCT01700140|3660993|B1|Absent||Nausea/emesis||Participants|Number|56|56.0||||||
3834334|NCT01700140|3660990|B4|2||Performance status|"The criteria of Eastern Cooperative Oncology Group (ECOG) performance status are shown below.~0: Fully active, able to carry on all pre-disease performance without restriction, 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work, 2: Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours"|Participants|Number|7|7.0||||||
3834335|NCT01700140|3660991|B3|2||Performance status|"The criteria of Eastern Cooperative Oncology Group (ECOG) performance status are shown below.~0: Fully active, able to carry on all pre-disease performance without restriction, 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work, 2: Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours"|Participants|Number|2|2.0||||||
3834336|NCT01700140|3660992|B2|2||Performance status|"The criteria of Eastern Cooperative Oncology Group (ECOG) performance status are shown below.~0: Fully active, able to carry on all pre-disease performance without restriction, 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work, 2: Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours"|Participants|Number|2|2.0||||||
3834337|NCT01700140|3660993|B1|2||Performance status|"The criteria of Eastern Cooperative Oncology Group (ECOG) performance status are shown below.~0: Fully active, able to carry on all pre-disease performance without restriction, 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work, 2: Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours"|Participants|Number|3|3.0||||||
3834338|NCT01700140|3660990|B4|1||Performance status|"The criteria of Eastern Cooperative Oncology Group (ECOG) performance status are shown below.~0: Fully active, able to carry on all pre-disease performance without restriction, 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work, 2: Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours"|Participants|Number|38|38.0||||||
3834339|NCT01700140|3660991|B3|1||Performance status|"The criteria of Eastern Cooperative Oncology Group (ECOG) performance status are shown below.~0: Fully active, able to carry on all pre-disease performance without restriction, 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work, 2: Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours"|Participants|Number|8|8.0||||||
3834340|NCT01700140|3660992|B2|1||Performance status|"The criteria of Eastern Cooperative Oncology Group (ECOG) performance status are shown below.~0: Fully active, able to carry on all pre-disease performance without restriction, 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work, 2: Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours"|Participants|Number|16|16.0||||||
3834341|NCT01700140|3660993|B1|1||Performance status|"The criteria of Eastern Cooperative Oncology Group (ECOG) performance status are shown below.~0: Fully active, able to carry on all pre-disease performance without restriction, 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work, 2: Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours"|Participants|Number|14|14.0||||||
3834342|NCT01700140|3660990|B4|0||Performance status|"The criteria of Eastern Cooperative Oncology Group (ECOG) performance status are shown below.~0: Fully active, able to carry on all pre-disease performance without restriction, 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work, 2: Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours"|Participants|Number|130|130.0||||||
3834343|NCT01700140|3660991|B3|0||Performance status|"The criteria of Eastern Cooperative Oncology Group (ECOG) performance status are shown below.~0: Fully active, able to carry on all pre-disease performance without restriction, 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work, 2: Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours"|Participants|Number|50|50.0||||||
3834344|NCT01700140|3660992|B2|0||Performance status|"The criteria of Eastern Cooperative Oncology Group (ECOG) performance status are shown below.~0: Fully active, able to carry on all pre-disease performance without restriction, 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work, 2: Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours"|Participants|Number|41|41.0||||||
3834345|NCT01700140|3660993|B1|0||Performance status|"The criteria of Eastern Cooperative Oncology Group (ECOG) performance status are shown below.~0: Fully active, able to carry on all pre-disease performance without restriction, 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work, 2: Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours"|Participants|Number|39|39.0||||||
3834346|NCT01700140|3660990|B4|Present||Motion sickness (vehicle sickness)||Participants|Number|9|9.0||||||
3834347|NCT01700140|3660991|B3|Present||Motion sickness (vehicle sickness)||Participants|Number|5|5.0||||||
3834348|NCT01700140|3660992|B2|Present||Motion sickness (vehicle sickness)||Participants|Number|2|2.0||||||
3834349|NCT01700140|3660993|B1|Present||Motion sickness (vehicle sickness)||Participants|Number|2|2.0||||||
3834350|NCT01700140|3660990|B4|Absent||Motion sickness (vehicle sickness)||Participants|Number|166|166.0||||||
3834351|NCT01700140|3660991|B3|Absent||Motion sickness (vehicle sickness)||Participants|Number|55|55.0||||||
3834352|NCT01700140|3660992|B2|Absent||Motion sickness (vehicle sickness)||Participants|Number|57|57.0||||||
3834417|NCT01700140|3660993|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3834353|NCT01700140|3660993|B1|Absent||Motion sickness (vehicle sickness)||Participants|Number|54|54.0||||||
3834354|NCT01700140|3660990|B4|Present||Alcohol consumption history||Participants|Number|67|67.0||||||
3834355|NCT01700140|3660991|B3|Present||Alcohol consumption history||Participants|Number|20|20.0||||||
3834356|NCT01700140|3660992|B2|Present||Alcohol consumption history||Participants|Number|27|27.0||||||
3834357|NCT01700140|3660993|B1|Present||Alcohol consumption history||Participants|Number|20|20.0||||||
3834358|NCT01700140|3660990|B4|Absent||Alcohol consumption history||Participants|Number|108|108.0||||||
3834359|NCT01700140|3660991|B3|Absent||Alcohol consumption history||Participants|Number|40|40.0||||||
3834360|NCT01700140|3660992|B2|Absent||Alcohol consumption history||Participants|Number|32|32.0||||||
3834361|NCT01700140|3660993|B1|Absent||Alcohol consumption history||Participants|Number|36|36.0||||||
3834362|NCT01700140|3660990|B4|Present||History of smoking habit||Participants|Number|76|76.0||||||
3834363|NCT01700140|3660991|B3|Present||History of smoking habit||Participants|Number|21|21.0||||||
3834364|NCT01700140|3660992|B2|Present||History of smoking habit||Participants|Number|28|28.0||||||
3834365|NCT01700140|3660993|B1|Present||History of smoking habit||Participants|Number|27|27.0||||||
3834366|NCT01700140|3660990|B4|Absent||History of smoking habit||Participants|Number|99|99.0||||||
3834367|NCT01700140|3660991|B3|Absent||History of smoking habit||Participants|Number|39|39.0||||||
3834368|NCT01700140|3660992|B2|Absent||History of smoking habit||Participants|Number|31|31.0||||||
3834369|NCT01700140|3660993|B1|Absent||History of smoking habit||Participants|Number|29|29.0||||||
3834370|NCT01700140|3660990|B4|Present||Diseases in the past 5 years||Participants|Number|101|101.0||||||
3834371|NCT01700140|3660991|B3|Present||Diseases in the past 5 years||Participants|Number|38|38.0||||||
3834372|NCT01700140|3660992|B2|Present||Diseases in the past 5 years||Participants|Number|30|30.0||||||
3834373|NCT01700140|3660993|B1|Present||Diseases in the past 5 years||Participants|Number|33|33.0||||||
3834374|NCT01700140|3660990|B4|Absent||Diseases in the past 5 years||Participants|Number|74|74.0||||||
3834375|NCT01700140|3660991|B3|Absent||Diseases in the past 5 years||Participants|Number|22|22.0||||||
3834376|NCT01700140|3660992|B2|Absent||Diseases in the past 5 years||Participants|Number|29|29.0||||||
3834377|NCT01700140|3660993|B1|Absent||Diseases in the past 5 years||Participants|Number|23|23.0||||||
3834378|NCT01700140|3660990|B4|Present||Complication||Participants|Number|152|152.0||||||
3834379|NCT01700140|3660991|B3|Present||Complication||Participants|Number|50|50.0||||||
3834380|NCT01700140|3660992|B2|Present||Complication||Participants|Number|48|48.0||||||
3834381|NCT01700140|3660993|B1|Present||Complication||Participants|Number|54|54.0||||||
3834382|NCT01700140|3660990|B4|Absent||Complication||Participants|Number|23|23.0||||||
3834383|NCT01700140|3660991|B3|Absent||Complication||Participants|Number|10|10.0||||||
3834384|NCT01700140|3660992|B2|Absent||Complication||Participants|Number|11|11.0||||||
3834385|NCT01700140|3660993|B1|Absent||Complication||Participants|Number|2|2.0||||||
3834386|NCT01700140|3660990|B4|Present||History of recent chemotherapy||Participants|Number|64|64.0||||||
3834387|NCT01700140|3660991|B3|Present||History of recent chemotherapy||Participants|Number|22|22.0||||||
3834388|NCT01700140|3660992|B2|Present||History of recent chemotherapy||Participants|Number|23|23.0||||||
3834389|NCT01700140|3660993|B1|Present||History of recent chemotherapy||Participants|Number|19|19.0||||||
3834390|NCT01700140|3660990|B4|Absent||History of recent chemotherapy||Participants|Number|111|111.0||||||
3834391|NCT01700140|3660991|B3|Absent||History of recent chemotherapy||Participants|Number|38|38.0||||||
3834392|NCT01700140|3660992|B2|Absent||History of recent chemotherapy||Participants|Number|36|36.0||||||
3834393|NCT01700140|3660993|B1|Absent||History of recent chemotherapy||Participants|Number|37|37.0||||||
3834394|NCT01700140|3660990|B4|Present||History of radiotherapy||Participants|Number|8|8.0||||||
3834395|NCT01700140|3660991|B3|Present||History of radiotherapy||Participants|Number|0|0.0||||||
3834396|NCT01700140|3660992|B2|Present||History of radiotherapy||Participants|Number|5|5.0||||||
3834397|NCT01700140|3660993|B1|Present||History of radiotherapy||Participants|Number|3|3.0||||||
3834398|NCT01700140|3660990|B4|Absent||History of radiotherapy||Participants|Number|167|167.0||||||
3834399|NCT01700140|3660991|B3|Absent||History of radiotherapy||Participants|Number|60|60.0||||||
3834400|NCT01700140|3660992|B2|Absent||History of radiotherapy||Participants|Number|54|54.0||||||
3834401|NCT01700140|3660993|B1|Absent||History of radiotherapy||Participants|Number|53|53.0||||||
3834402|NCT01700140|3660990|B4|Present||Metastasis||Participants|Number|83|83.0||||||
3834403|NCT01700140|3660991|B3|Present||Metastasis||Participants|Number|24|24.0||||||
3834404|NCT01700140|3660992|B2|Present||Metastasis||Participants|Number|35|35.0||||||
3834405|NCT01700140|3660993|B1|Present||Metastasis||Participants|Number|24|24.0||||||
3834406|NCT01700140|3660990|B4|Absent||Metastasis||Participants|Number|92|92.0||||||
3834407|NCT01700140|3660991|B3|Absent||Metastasis||Participants|Number|36|36.0||||||
3834408|NCT01700140|3660992|B2|Absent||Metastasis||Participants|Number|24|24.0||||||
3834409|NCT01700140|3660993|B1|Absent||Metastasis||Participants|Number|32|32.0||||||
3834410|NCT01700140|3660990|B4||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3834411|NCT01700140|3660991|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3834412|NCT01700140|3660992|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3834413|NCT01700140|3660993|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3834414|NCT01700140|3660990|B4||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3834415|NCT01700140|3660991|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3834416|NCT01700140|3660992|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3834418|NCT01700140|3660990|B4|70≤ years||Age, Customized||Participants|Number|55|55.0||||||
3834419|NCT01700140|3660991|B3|70≤ years||Age, Customized||Participants|Number|21|21.0||||||
3834420|NCT01700140|3660992|B2|70≤ years||Age, Customized||Participants|Number|17|17.0||||||
3834421|NCT01700140|3660993|B1|70≤ years||Age, Customized||Participants|Number|17|17.0||||||
3834422|NCT01700140|3660990|B4|60-70 years||Age, Customized||Participants|Number|40|40.0||||||
3834423|NCT01700140|3660991|B3|60-70 years||Age, Customized||Participants|Number|12|12.0||||||
3834424|NCT01700140|3660992|B2|60-70 years||Age, Customized||Participants|Number|14|14.0||||||
3834425|NCT01700140|3660993|B1|60-70 years||Age, Customized||Participants|Number|14|14.0||||||
3834426|NCT01700140|3660990|B4|50-60 years||Age, Customized||Participants|Number|41|41.0||||||
3834427|NCT01700140|3660991|B3|50-60 years||Age, Customized||Participants|Number|17|17.0||||||
3834428|NCT01700140|3660992|B2|50-60 years||Age, Customized||Participants|Number|13|13.0||||||
3834429|NCT01700140|3660993|B1|50-60 years||Age, Customized||Participants|Number|11|11.0||||||
3834430|NCT01700140|3660990|B4|40-50 years||Age, Customized||Participants|Number|26|26.0||||||
3834431|NCT01700140|3660991|B3|40-50 years||Age, Customized||Participants|Number|7|7.0||||||
3834432|NCT01700140|3660992|B2|40-50 years||Age, Customized||Participants|Number|8|8.0||||||
3834433|NCT01700140|3660993|B1|40-50 years||Age, Customized||Participants|Number|11|11.0||||||
3834434|NCT01700140|3660990|B4|20-40 years||Age, Customized||Participants|Number|13|13.0||||||
3834435|NCT01700140|3660991|B3|20-40 years||Age, Customized||Participants|Number|3|3.0||||||
3834436|NCT01700140|3660992|B2|20-40 years||Age, Customized||Participants|Number|7|7.0||||||
3834437|NCT01700140|3660993|B1|20-40 years||Age, Customized||Participants|Number|3|3.0||||||
3834438|NCT01700036|3661027|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3834439|NCT01700036|3661027|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3834440|NCT01700036|3661027|B1|||Age||years|Median|59|59.0|Full Range|||18.0|70.0|
3834441|NCT01699867|3661036|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3834442|NCT01699867|3661036|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3834443|NCT01699867|3661036|B1|||Age||years|Mean|62|62.0|Full Range|||27.0|81.0|
3834444|NCT01699815|3661041|B3|United States||Region of Enrollment||participants|Number|113|113.0||||||
3834445|NCT01699815|3661042|B2|United States||Region of Enrollment||participants|Number|56|56.0||||||
3834446|NCT01699815|3661043|B1|United States||Region of Enrollment||participants|Number|57|57.0||||||
3834447|NCT01699815|3661041|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3834448|NCT01699815|3661042|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3834449|NCT01699815|3661043|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3834450|NCT01699815|3661041|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3834451|NCT01699815|3661042|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3834452|NCT01699815|3661043|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3834453|NCT01699815|3661041|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3834454|NCT01699815|3661042|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3834455|NCT01699815|3661043|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3834456|NCT01699815|3661041|B3||Between 18 and 65 years|Age||Participants|Count of Participants|113|113.0||||||
3834457|NCT01699815|3661042|B2||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
3834458|NCT01699815|3661043|B1||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
3834459|NCT01699815|3661041|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3834460|NCT01699815|3661042|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3834461|NCT01699815|3661043|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3834462|NCT01699815|3661041|B3|||Age||years|Mean|61.1|61.1|Full Range|||35.0|75.0|
3834463|NCT01699815|3661042|B2|||Age||years|Mean|61.7|61.7|Full Range|||35.0|75.0|
3834464|NCT01699815|3661043|B1|||Age||years|Mean|60.5|60.5|Full Range|||37.0|74.0|
3834465|NCT01699789|3661054|B3|Had health insurance||Health Insurance Status||participants|Number|473|473.0||||||
3834466|NCT01699789|3661055|B2|Had health insurance||Health Insurance Status||participants|Number|255|255.0||||||
3834467|NCT01699789|3661056|B1|Had health insurance||Health Insurance Status||participants|Number|218|218.0||||||
3834468|NCT01699789|3661054|B3|No health insurance||Health Insurance Status||participants|Number|545|545.0||||||
3834469|NCT01699789|3661055|B2|No health insurance||Health Insurance Status||participants|Number|259|259.0||||||
3834470|NCT01699789|3661056|B1|No health insurance||Health Insurance Status||participants|Number|286|286.0||||||
3834471|NCT01699789|3661054|B3|High school or above||Education|Note that the N’s may differ slightly from published papers due to multiple imputation|participants|Number|573|573.0||||||
3834472|NCT01699789|3661055|B2|High school or above||Education|Note that the N’s may differ slightly from published papers due to multiple imputation|participants|Number|290|290.0||||||
3834473|NCT01699789|3661056|B1|High school or above||Education|Note that the N’s may differ slightly from published papers due to multiple imputation|participants|Number|283|283.0||||||
3834474|NCT01699789|3661054|B3|Less than high school education||Education|Note that the N’s may differ slightly from published papers due to multiple imputation|participants|Number|445|445.0||||||
3834475|NCT01699789|3661055|B2|Less than high school education||Education|Note that the N’s may differ slightly from published papers due to multiple imputation|participants|Number|224|224.0||||||
3834476|NCT01699789|3661056|B1|Less than high school education||Education|Note that the N’s may differ slightly from published papers due to multiple imputation|participants|Number|221|221.0||||||
3834477|NCT01699789|3661054|B3|Single, widowed, divorced or separated||Marital status||participants|Number|787|787.0||||||
3834478|NCT01699789|3661055|B2|Single, widowed, divorced or separated||Marital status||participants|Number|399|399.0||||||
3834479|NCT01699789|3661056|B1|Single, widowed, divorced or separated||Marital status||participants|Number|388|388.0||||||
3834480|NCT01699789|3661054|B3|Married or living with partner||Marital status||participants|Number|231|231.0||||||
3834481|NCT01699789|3661055|B2|Married or living with partner||Marital status||participants|Number|115|115.0||||||
3834482|NCT01699789|3661056|B1|Married or living with partner||Marital status||participants|Number|116|116.0||||||
3834483|NCT01699789|3661054|B3|Other (Asian, Native American etc)||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3834484|NCT01699789|3661055|B2|Other (Asian, Native American etc)||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3834485|NCT01699789|3661056|B1|Other (Asian, Native American etc)||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3834486|NCT01699789|3661054|B3|Non-Hispanic white||Race/Ethnicity, Customized||participants|Number|86|86.0||||||
3834487|NCT01699789|3661055|B2|Non-Hispanic white||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
3834488|NCT01699789|3661056|B1|Non-Hispanic white||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
3834489|NCT01699789|3661054|B3|African American||Race/Ethnicity, Customized||participants|Number|488|488.0||||||
3834490|NCT01699789|3661055|B2|African American||Race/Ethnicity, Customized||participants|Number|249|249.0||||||
3834491|NCT01699789|3661056|B1|African American||Race/Ethnicity, Customized||participants|Number|239|239.0||||||
3834492|NCT01699789|3661054|B3|Latino||Race/Ethnicity, Customized||participants|Number|409|409.0||||||
3834493|NCT01699789|3661055|B2|Latino||Race/Ethnicity, Customized||participants|Number|215|215.0||||||
3834494|NCT01699789|3661056|B1|Latino||Race/Ethnicity, Customized||participants|Number|194|194.0||||||
3834495|NCT01699789|3661054|B3||Male|Sex: Female, Male||Participants|Count of Participants|423|423.0||||||
3834496|NCT01699789|3661055|B2||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
3834497|NCT01699789|3661056|B1||Male|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
3834498|NCT01699789|3661054|B3||Female|Sex: Female, Male||Participants|Count of Participants|595|595.0||||||
3834499|NCT01699789|3661055|B2||Female|Sex: Female, Male||Participants|Count of Participants|309|309.0||||||
3834500|NCT01699789|3661056|B1||Female|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
3834501|NCT01699789|3661054|B3|||Age||years|Mean|45.8|45.8|Standard Deviation|12.9|12.9|||
3834502|NCT01699789|3661055|B2|||Age||years|Mean|46.6|46.6|Standard Deviation|13.2|13.2|||
3834503|NCT01699789|3661056|B1|||Age||years|Mean|44.9|44.9|Standard Deviation|12.4|12.4|||
3834504|NCT01699763|3661119|B1|United States||Region of Enrollment||participants|Number|112|112.0||||||
3834505|NCT01699763|3661119|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3834506|NCT01699763|3661119|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3834507|NCT01699763|3661119|B1|||Age||years|Median|59|59.0|Full Range|||19.0|87.0|
3834508|NCT01699750|3661125|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3834509|NCT01699750|3661126|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3834510|NCT01699750|3661127|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3834511|NCT01699750|3661125|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3834512|NCT01699750|3661126|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3834513|NCT01699750|3661127|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3834514|NCT01699750|3661125|B3|||Age||years|Mean|35.6|35.6|Standard Deviation|9.82|9.82|||
3834515|NCT01699750|3661126|B2|||Age||years|Mean|35.3|35.3|Standard Deviation|8.77|8.77|||
3834516|NCT01699750|3661127|B1|||Age||years|Mean|36.0|36.0|Standard Deviation|10.95|10.95|||
3834517|NCT01699698|3661150|B3|Japan||Region of Enrollment||participants|Number|50|50.0||||||
3834518|NCT01699698|3661151|B2|Japan||Region of Enrollment||participants|Number|28|28.0||||||
3834519|NCT01699698|3661152|B1|Japan||Region of Enrollment||participants|Number|22|22.0||||||
3834520|NCT01699698|3661150|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
3834521|NCT01699698|3661151|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
3834522|NCT01699698|3661152|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3834523|NCT01699698|3661150|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3834524|NCT01699698|3661151|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3834525|NCT01699698|3661152|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3834526|NCT01699698|3661150|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3834527|NCT01699698|3661151|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3834528|NCT01699698|3661152|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3834529|NCT01699698|3661150|B3|||Age||years|Median|64|64.0|Full Range|||23.0|88.0|
3834530|NCT01699698|3661151|B2|||Age||years|Median|60|60.0|Full Range|||23.0|81.0|
3834531|NCT01699698|3661152|B1|||Age||years|Median|70|70.0|Full Range|||49.0|88.0|
3834532|NCT01699698|3661150|B3||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
3834533|NCT01699698|3661151|B2||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3834534|NCT01699698|3661152|B1||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
3834535|NCT01699698|3661150|B3||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3834536|NCT01699698|3661151|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3834537|NCT01699698|3661152|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3834538|NCT01699698|3661150|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3834539|NCT01699698|3661151|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3834540|NCT01699698|3661152|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3834541|NCT01699685|3661161|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3834542|NCT01699685|3661162|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3834543|NCT01699685|3661163|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3834544|NCT01699685|3661161|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3834545|NCT01699685|3661162|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3834546|NCT01699685|3661163|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3834547|NCT01699685|3661161|B3|||Age||Years|Mean|64.91|64.91|Standard Deviation|8.383|8.383|||
3834548|NCT01699685|3661162|B2|||Age||Years|Mean|64.18|64.18|Standard Deviation|7.447|7.447|||
3834549|NCT01699685|3661163|B1|||Age||Years|Mean|65.62|65.62|Standard Deviation|9.247|9.247|||
3834550|NCT01699607|3661180|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3834551|NCT01699607|3661181|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3834552|NCT01699607|3661182|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3834553|NCT01699607|3661180|B3|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3834554|NCT01699607|3661181|B2|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3834555|NCT01699607|3661182|B1|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3834556|NCT01699607|3661180|B3|White, not of Hispanic origin||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3834557|NCT01699607|3661181|B2|White, not of Hispanic origin||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3834558|NCT01699607|3661182|B1|White, not of Hispanic origin||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3834559|NCT01699607|3661180|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3834560|NCT01699607|3661181|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3834561|NCT01699607|3661182|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3834562|NCT01699607|3661180|B3||Male|Gender||Participants|Count of Participants|9|9.0||||||
3834563|NCT01699607|3661181|B2||Male|Gender||Participants|Count of Participants|3|3.0||||||
3834564|NCT01699607|3661182|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
3834565|NCT01699607|3661180|B3||Female|Gender||Participants|Count of Participants|1|1.0||||||
3834566|NCT01699607|3661181|B2||Female|Gender||Participants|Count of Participants|1|1.0||||||
3834567|NCT01699607|3661182|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3834568|NCT01699607|3661180|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3834569|NCT01699607|3661181|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3834570|NCT01699607|3661182|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3834571|NCT01699607|3661180|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3834572|NCT01699607|3661181|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3834573|NCT01699607|3661182|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3834574|NCT01699607|3661180|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3834575|NCT01699607|3661181|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3834576|NCT01699607|3661182|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3834577|NCT01699373|3661188|B3|Singapore||Region of Enrollment||participants|Number|170|170.0||||||
3834578|NCT01699373|3661189|B2|Singapore||Region of Enrollment||participants|Number|85|85.0||||||
3834579|NCT01699373|3661190|B1|Singapore||Region of Enrollment||participants|Number|85|85.0||||||
3834580|NCT01699373|3661188|B3||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3834581|NCT01699373|3661189|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3834582|NCT01699373|3661190|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3834583|NCT01699373|3661188|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3834584|NCT01699373|3661189|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3834585|NCT01699373|3661190|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3834586|NCT01699373|3661188|B3|||Age||years|Mean|62.4|62.4|Standard Deviation|12.9|12.9|||
3834587|NCT01699373|3661189|B2|||Age||years|Mean|63.7|63.7|Standard Deviation|12.6|12.6|||
3834588|NCT01699373|3661190|B1|||Age||years|Mean|61.1|61.1|Standard Deviation|13.3|13.3|||
3834589|NCT01699373|3661188|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3834590|NCT01699373|3661189|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3834591|NCT01699373|3661190|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3834592|NCT01699373|3661188|B3||Between 18 and 65 years|Age||Participants|Count of Participants|170|170.0||||||
3834593|NCT01699373|3661189|B2||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
3834594|NCT01699373|3661190|B1||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
3834595|NCT01699373|3661188|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3834596|NCT01699373|3661189|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3834597|NCT01699373|3661190|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3834598|NCT01699178|3661197|B3|United States||Region of Enrollment||participants|Number|182|182.0||||||
3834599|NCT01699178|3661198|B2|United States||Region of Enrollment||participants|Number|94|94.0||||||
3834600|NCT01699178|3661199|B1|United States||Region of Enrollment||participants|Number|88|88.0||||||
3834601|NCT01699178|3661197|B3||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3834602|NCT01699178|3661198|B2||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3834603|NCT01699178|3661199|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3834604|NCT01699178|3661197|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3834605|NCT01699178|3661198|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3834606|NCT01699178|3661199|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3834607|NCT01699178|3661197|B3|||Age||years|Mean|56.5|56.5|Standard Deviation|10.64|10.64|||
3834608|NCT01699178|3661198|B2|||Age||years|Mean|56.8|56.8|Standard Deviation|11.23|11.23|||
3834609|NCT01699178|3661199|B1|||Age||years|Mean|56.2|56.2|Standard Deviation|10.04|10.04|||
3834610|NCT01699178|3661197|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3834611|NCT01699178|3661198|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3834612|NCT01699178|3661199|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3834613|NCT01699178|3661197|B3||Between 18 and 65 years|Age||Participants|Count of Participants|182|182.0||||||
3834614|NCT01699178|3661198|B2||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
3834615|NCT01699178|3661199|B1||Between 18 and 65 years|Age||Participants|Count of Participants|88|88.0||||||
3834616|NCT01699178|3661197|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3834617|NCT01699178|3661198|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3834618|NCT01699178|3661199|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3834619|NCT01699087|3661216|B1|United States||Region of Enrollment||participants|Number|161|161.0||||||
3834620|NCT01699087|3661216|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3834621|NCT01699087|3661216|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3834622|NCT01699087|3661216|B1|||Age||years|Mean|31.5|31.5|Standard Deviation|7.4|7.4|||
3834623|NCT01699022|3661230|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3834624|NCT01699022|3661230|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3834625|NCT01699022|3661230|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3834626|NCT01699022|3661230|B1|||Age||years|Mean|34.8|34.8|Standard Deviation|5.21|5.21|||
3834627|NCT01699022|3661230|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3834628|NCT01699022|3661230|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3834629|NCT01699022|3661230|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3834630|NCT01698814|3661243|B3||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3834631|NCT01698814|3661244|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3834632|NCT01698814|3661245|B1||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3834633|NCT01698814|3661243|B3||Female|Sex: Female, Male||Participants|Count of Participants|325|325.0||||||
3834634|NCT01698814|3661244|B2||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3834635|NCT01698814|3661245|B1||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
3834636|NCT01698814|3661243|B3|≥65 years||Age, Customized||participants|Number|11|11.0||||||
3834637|NCT01698814|3661244|B2|≥65 years||Age, Customized||participants|Number|4|4.0||||||
3834638|NCT01698814|3661245|B1|≥65 years||Age, Customized||participants|Number|7|7.0||||||
3834639|NCT01698814|3661243|B3|18-64 years||Age, Customized||participants|Number|413|413.0||||||
3834640|NCT01698814|3661244|B2|18-64 years||Age, Customized||participants|Number|141|141.0||||||
3834641|NCT01698814|3661245|B1|18-64 years||Age, Customized||participants|Number|272|272.0||||||
3834642|NCT01698814|3661243|B3|12-17 years||Age, Customized||participants|Number|7|7.0||||||
3834643|NCT01698814|3661244|B2|12-17 years||Age, Customized||participants|Number|3|3.0||||||
3834644|NCT01698814|3661245|B1|12-17 years||Age, Customized||participants|Number|4|4.0||||||
3834645|NCT01698814|3661243|B3|2-11 years||Age, Customized||participants|Number|68|68.0||||||
3834646|NCT01698814|3661244|B2|2-11 years||Age, Customized||participants|Number|21|21.0||||||
3834647|NCT01698814|3661245|B1|2-11 years||Age, Customized||participants|Number|47|47.0||||||
3834648|NCT01698801|3661252|B1|4 = Completely Disabled||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|0|0.0||||||
3834649|NCT01698801|3661252|B1|3 = Limited Self-Care||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|0|0.0||||||
3834683|NCT01698684|3661296|B4|Multiple Races||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3834684|NCT01698684|3661297|B3|Multiple Races||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3834685|NCT01698684|3661298|B2|Multiple Races||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3834686|NCT01698684|3661299|B1|Multiple Races||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3834650|NCT01698801|3661252|B1|2 = Ambulatory but Unable to Work||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|6|6.0||||||
3834651|NCT01698801|3661252|B1|1= Restrictive but Ambulatory||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|7|7.0||||||
3834652|NCT01698801|3661252|B1|0 = Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|13|13.0||||||
3834653|NCT01698801|3661252|B1|Stage III||Multiple Myeloma Stage before Study Entry|"The International Staging System (ISS) divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels.~Stage I: Serum beta-2 microglobulin is less than 3.5 (mg/L) and the albumin level is above 3.5 (g/L);~Stage II: Neither stage I or III, meaning that either:~The beta-2 microglobulin level is between 3.5 and 5.5 (with any albumin level), OR~The albumin is below 3.5 while the beta-2 microglobulin is less than 3.5~Stage III: Serum beta-2 microglobulin is greater than 5.5."|participants|Number|5|5.0||||||
3834654|NCT01698801|3661252|B1|Stage II||Multiple Myeloma Stage before Study Entry|"The International Staging System (ISS) divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels.~Stage I: Serum beta-2 microglobulin is less than 3.5 (mg/L) and the albumin level is above 3.5 (g/L);~Stage II: Neither stage I or III, meaning that either:~The beta-2 microglobulin level is between 3.5 and 5.5 (with any albumin level), OR~The albumin is below 3.5 while the beta-2 microglobulin is less than 3.5~Stage III: Serum beta-2 microglobulin is greater than 5.5."|participants|Number|14|14.0||||||
3834655|NCT01698801|3661252|B1|Stage I||Multiple Myeloma Stage before Study Entry|"The International Staging System (ISS) divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels.~Stage I: Serum beta-2 microglobulin is less than 3.5 (mg/L) and the albumin level is above 3.5 (g/L);~Stage II: Neither stage I or III, meaning that either:~The beta-2 microglobulin level is between 3.5 and 5.5 (with any albumin level), OR~The albumin is below 3.5 while the beta-2 microglobulin is less than 3.5~Stage III: Serum beta-2 microglobulin is greater than 5.5."|participants|Number|7|7.0||||||
3834656|NCT01698801|3661252|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3834657|NCT01698801|3661252|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3834658|NCT01698801|3661252|B1|> 75 Years Old||Age, Customized||participants|Number|12|12.0||||||
3834659|NCT01698801|3661252|B1|≤ 75 Years Old||Age, Customized||participants|Number|14|14.0||||||
3834660|NCT01698801|3661252|B1|||Age||years|Mean|74.2|74.2|Standard Deviation|7.01|7.01|||
3834661|NCT01698775|3661261|B3||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3834662|NCT01698775|3661262|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3834663|NCT01698775|3661263|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3834664|NCT01698775|3661261|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3834665|NCT01698775|3661262|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3834666|NCT01698775|3661263|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3834667|NCT01698775|3661261|B3|||Age||Years|Mean|65.2|65.2|Standard Deviation|9.6|9.6|||
3834668|NCT01698775|3661262|B2|||Age||Years|Mean|64.5|64.5|Standard Deviation|9.7|9.7|||
3834669|NCT01698775|3661263|B1|||Age||Years|Mean|65.9|65.9|Standard Deviation|9.4|9.4|||
3834670|NCT01698710|3661290|B1||Body|Location of cyst|Patients with clinically diagnosed mucinous cysts (premalignant or malignant cysts of the pancreas) including mucinous cystic neoplasms and intraductal papillary mucinous neoplasms were eligible.|Participants|Count of Participants|1|1.0||||||
3834671|NCT01698710|3661290|B1||Head|Location of cyst|Patients with clinically diagnosed mucinous cysts (premalignant or malignant cysts of the pancreas) including mucinous cystic neoplasms and intraductal papillary mucinous neoplasms were eligible.|Participants|Count of Participants|4|4.0||||||
3834672|NCT01698710|3661290|B1|||Cyst diameter|Patients with clinically diagnosed mucinous cysts (premalignant or malignant cysts of the pancreas) including mucinous cystic neoplasms and intraductal papillary mucinous neoplasms were eligible.|mm|Mean|28.4|28.4|Full Range|||23.0|35.0|
3834673|NCT01698710|3661290|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3834674|NCT01698710|3661290|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3834675|NCT01698710|3661290|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3834676|NCT01698710|3661290|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3834677|NCT01698710|3661290|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3834678|NCT01698710|3661290|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3834679|NCT01698684|3661296|B4|United States||Region of Enrollment||participants|Number|440|440.0||||||
3834680|NCT01698684|3661297|B3|United States||Region of Enrollment||participants|Number|148|148.0||||||
3834681|NCT01698684|3661298|B2|United States||Region of Enrollment||participants|Number|147|147.0||||||
3834682|NCT01698684|3661299|B1|United States||Region of Enrollment||participants|Number|145|145.0||||||
3834687|NCT01698684|3661296|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3834688|NCT01698684|3661297|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3834689|NCT01698684|3661298|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3834690|NCT01698684|3661299|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3834691|NCT01698684|3661296|B4|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3834692|NCT01698684|3661297|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3834693|NCT01698684|3661298|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3834694|NCT01698684|3661299|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3834695|NCT01698684|3661296|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|94|94.0||||||
3834696|NCT01698684|3661297|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3834697|NCT01698684|3661298|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3834698|NCT01698684|3661299|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
3834699|NCT01698684|3661296|B4|White||Race/Ethnicity, Customized||participants|Number|333|333.0||||||
3834700|NCT01698684|3661297|B3|White||Race/Ethnicity, Customized||participants|Number|124|124.0||||||
3834701|NCT01698684|3661298|B2|White||Race/Ethnicity, Customized||participants|Number|107|107.0||||||
3834702|NCT01698684|3661299|B1|White||Race/Ethnicity, Customized||participants|Number|102|102.0||||||
3834703|NCT01698684|3661296|B4||Male|Sex: Female, Male||Participants|Count of Participants|440|440.0||||||
3834704|NCT01698684|3661297|B3||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3834705|NCT01698684|3661298|B2||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3834706|NCT01698684|3661299|B1||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3834707|NCT01698684|3661296|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3834708|NCT01698684|3661297|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3834709|NCT01698684|3661298|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3834710|NCT01698684|3661299|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3834711|NCT01698684|3661296|B4|>=65 Years||Age, Customized||participants|Number|129|129.0||||||
3834712|NCT01698684|3661297|B3|>=65 Years||Age, Customized||participants|Number|43|43.0||||||
3834713|NCT01698684|3661298|B2|>=65 Years||Age, Customized||participants|Number|44|44.0||||||
3834714|NCT01698684|3661299|B1|>=65 Years||Age, Customized||participants|Number|42|42.0||||||
3834715|NCT01698684|3661296|B4|>=50 to <65 Years||Age, Customized||participants|Number|228|228.0||||||
3834716|NCT01698684|3661297|B3|>=50 to <65 Years||Age, Customized||participants|Number|76|76.0||||||
3834717|NCT01698684|3661298|B2|>=50 to <65 Years||Age, Customized||participants|Number|78|78.0||||||
3834718|NCT01698684|3661299|B1|>=50 to <65 Years||Age, Customized||participants|Number|74|74.0||||||
3834719|NCT01698684|3661296|B4|<50 Years||Age, Customized||participants|Number|83|83.0||||||
3834720|NCT01698684|3661297|B3|<50 Years||Age, Customized||participants|Number|29|29.0||||||
3834721|NCT01698684|3661298|B2|<50 Years||Age, Customized||participants|Number|25|25.0||||||
3834722|NCT01698684|3661299|B1|<50 Years||Age, Customized||participants|Number|29|29.0||||||
3834723|NCT01698684|3661296|B4|||Age||years|Mean|58.2|58.2|Standard Deviation|10.23|10.23|||
3834724|NCT01698684|3661297|B3|||Age||years|Mean|57.9|57.9|Standard Deviation|10.61|10.61|||
3834725|NCT01698684|3661298|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|10.19|10.19|||
3834726|NCT01698684|3661299|B1|||Age||years|Mean|58.3|58.3|Standard Deviation|9.92|9.92|||
3834727|NCT01698554|3661309|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3834728|NCT01698554|3661310|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3834729|NCT01698554|3661311|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3834730|NCT01698554|3661312|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3834731|NCT01698554|3661313|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3834732|NCT01698554|3661309|B5||Female|Sex: Female, Male||Participants|Count of Participants|457|457.0||||||
3834733|NCT01698554|3661310|B4||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3834734|NCT01698554|3661311|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3834735|NCT01698554|3661312|B2||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3834736|NCT01698554|3661313|B1||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3834737|NCT01698554|3661309|B5|>65 years||Age, Customized||Participants|Number|60|60.0||||||
3834738|NCT01698554|3661310|B4|>65 years||Age, Customized||Participants|Number|9|9.0||||||
3834739|NCT01698554|3661311|B3|>65 years||Age, Customized||Participants|Number|12|12.0||||||
3834740|NCT01698554|3661312|B2|>65 years||Age, Customized||Participants|Number|17|17.0||||||
3834741|NCT01698554|3661313|B1|>65 years||Age, Customized||Participants|Number|22|22.0||||||
3834742|NCT01698554|3661309|B5|45 to 65 years||Age, Customized||Participants|Number|312|312.0||||||
3834743|NCT01698554|3661310|B4|45 to 65 years||Age, Customized||Participants|Number|55|55.0||||||
3834744|NCT01698554|3661311|B3|45 to 65 years||Age, Customized||Participants|Number|47|47.0||||||
3834745|NCT01698554|3661312|B2|45 to 65 years||Age, Customized||Participants|Number|106|106.0||||||
3834746|NCT01698554|3661313|B1|45 to 65 years||Age, Customized||Participants|Number|104|104.0||||||
3834747|NCT01698554|3661309|B5|<45 years||Age, Customized||Participants|Number|92|92.0||||||
3834748|NCT01698554|3661310|B4|<45 years||Age, Customized||Participants|Number|15|15.0||||||
3834749|NCT01698554|3661311|B3|<45 years||Age, Customized||Participants|Number|16|16.0||||||
3834750|NCT01698554|3661312|B2|<45 years||Age, Customized||Participants|Number|34|34.0||||||
3834751|NCT01698554|3661313|B1|<45 years||Age, Customized||Participants|Number|27|27.0||||||
3834752|NCT01698528|3661342|B3|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3834753|NCT01698528|3661343|B2|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3834754|NCT01698528|3661344|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3834755|NCT01698528|3661342|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3834756|NCT01698528|3661343|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3834757|NCT01698528|3661344|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3834758|NCT01698528|3661342|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3834759|NCT01698528|3661343|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3834760|NCT01698528|3661344|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3834761|NCT01698528|3661342|B3|||Age||years|Mean|53.52|53.52|Standard Deviation|13.76|13.76|||
3834762|NCT01698528|3661343|B2|||Age||years|Mean|53.3|53.3|Standard Deviation|1.88|1.88|||
3834763|NCT01698528|3661344|B1|||Age||years|Mean|53.8|53.8|Standard Deviation|16.04|16.04|||
3834764|NCT01698502|3661359|B3|Denmark||Region of Enrollment||participants|Number|21|21.0||||||
3834765|NCT01698502|3661360|B2|Denmark||Region of Enrollment||participants|Number|10|10.0||||||
3834766|NCT01698502|3661361|B1|Denmark||Region of Enrollment||participants|Number|11|11.0||||||
3834767|NCT01698502|3661359|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3834768|NCT01698502|3661360|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3834769|NCT01698502|3661361|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3834770|NCT01698502|3661359|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3834771|NCT01698502|3661360|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3834772|NCT01698502|3661361|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3834773|NCT01698502|3661359|B3|||Age||years|Mean|25|25.0|Standard Deviation|3|3.0|||
3834774|NCT01698502|3661360|B2|||Age||years|Mean|25|25.0|Standard Deviation|3|3.0|||
3834775|NCT01698502|3661361|B1|||Age||years|Mean|25|25.0|Standard Deviation|3|3.0|||
3834776|NCT01698502|3661359|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3834777|NCT01698502|3661360|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3834778|NCT01698502|3661361|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3834779|NCT01698502|3661359|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3834780|NCT01698502|3661360|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3834781|NCT01698502|3661361|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3834782|NCT01698502|3661359|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3834783|NCT01698502|3661360|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3834784|NCT01698502|3661361|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3834785|NCT01698333|3661370|B1|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3834786|NCT01698333|3661370|B1|Race|Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3834787|NCT01698333|3661370|B1|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3834788|NCT01698333|3661370|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3834789|NCT01698333|3661370|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834790|NCT01698333|3661370|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3834791|NCT01698333|3661370|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3834792|NCT01698333|3661370|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3834793|NCT01698333|3661370|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3834794|NCT01698333|3661370|B1|||Age||years|Mean|50.7|50.7|Standard Deviation|11.64|11.64|||
3834795|NCT01698320|3661374|B3|||Body Mass Index||kg/m^2|Mean|28.8|28.8|Standard Deviation|6.88|6.88|||
3834796|NCT01698320|3661375|B2|||Body Mass Index||kg/m^2|Mean|28.5|28.5|Standard Deviation|6.81|6.81|||
3834797|NCT01698320|3661376|B1|||Body Mass Index||kg/m^2|Mean|29.2|29.2|Standard Deviation|6.96|6.96|||
3834798|NCT01698320|3661374|B3|||Height||cm|Mean|168.0|168.0|Standard Deviation|9.11|9.11|||
3834799|NCT01698320|3661375|B2|||Height||cm|Mean|168.6|168.6|Standard Deviation|9.52|9.52|||
3834800|NCT01698320|3661376|B1|||Height||cm|Mean|167.4|167.4|Standard Deviation|8.67|8.67|||
3834801|NCT01698320|3661374|B3|||Weight||kg|Mean|81.8|81.8|Standard Deviation|21.22|21.22|||
3834802|NCT01698320|3661375|B2|||Weight||kg|Mean|81.2|81.2|Standard Deviation|21.4|21.4|||
3834803|NCT01698320|3661376|B1|||Weight||kg|Mean|82.3|82.3|Standard Deviation|21.09|21.09|||
3834804|NCT01698320|3661374|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|284|284.0||||||
3834805|NCT01698320|3661375|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|140|140.0||||||
3834806|NCT01698320|3661376|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|144|144.0||||||
3834807|NCT01698320|3661374|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
3834808|NCT01698320|3661375|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3834809|NCT01698320|3661376|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3834810|NCT01698320|3661374|B3|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3834811|NCT01698320|3661375|B2|Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3834812|NCT01698320|3661376|B1|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3834813|NCT01698320|3661374|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3834814|NCT01698320|3661375|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3834815|NCT01698320|3661376|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3834816|NCT01698320|3661374|B3|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3834817|NCT01698320|3661375|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3834818|NCT01698320|3661376|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3834819|NCT01698320|3661374|B3|Black||Race/Ethnicity, Customized||participants|Number|73|73.0||||||
3834820|NCT01698320|3661375|B2|Black||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
3834821|NCT01698320|3661376|B1|Black||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3834822|NCT01698320|3661374|B3|White||Race/Ethnicity, Customized||participants|Number|254|254.0||||||
3834823|NCT01698320|3661375|B2|White||Race/Ethnicity, Customized||participants|Number|125|125.0||||||
3834824|NCT01698320|3661376|B1|White||Race/Ethnicity, Customized||participants|Number|129|129.0||||||
3834825|NCT01698320|3661374|B3||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3834826|NCT01698320|3661375|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3834827|NCT01698320|3661376|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3834828|NCT01698320|3661374|B3||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
3834829|NCT01698320|3661375|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3834830|NCT01698320|3661376|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3834831|NCT01698320|3661374|B3|65+ years||Age, Customized||participants|Number|15|15.0||||||
3834832|NCT01698320|3661375|B2|65+ years||Age, Customized||participants|Number|8|8.0||||||
3834833|NCT01698320|3661376|B1|65+ years||Age, Customized||participants|Number|7|7.0||||||
3834834|NCT01698320|3661374|B3|18-64 years||Age, Customized||participants|Number|278|278.0||||||
3834835|NCT01698320|3661375|B2|18-64 years||Age, Customized||participants|Number|135|135.0||||||
3834836|NCT01698320|3661376|B1|18-64 years||Age, Customized||participants|Number|143|143.0||||||
3834837|NCT01698320|3661374|B3|12-17 years||Age, Customized||participants|Number|44|44.0||||||
3834838|NCT01698320|3661375|B2|12-17 years||Age, Customized||participants|Number|25|25.0||||||
3834839|NCT01698320|3661376|B1|12-17 years||Age, Customized||participants|Number|19|19.0||||||
3834840|NCT01698320|3661374|B3|||Age||years|Mean|36.8|36.8|Standard Deviation|15.07|15.07|||
3834841|NCT01698320|3661375|B2|||Age||years|Mean|36.6|36.6|Standard Deviation|15.04|15.04|||
3834842|NCT01698320|3661376|B1|||Age||years|Mean|37.1|37.1|Standard Deviation|15.14|15.14|||
3834843|NCT01698268|3661396|B3|United States||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
3834844|NCT01698268|3661397|B2|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3834845|NCT01698268|3661398|B1|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3834846|NCT01698268|3661396|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3834847|NCT01698268|3661397|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3834848|NCT01698268|3661398|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3834849|NCT01698268|3661396|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3834850|NCT01698268|3661397|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3834851|NCT01698268|3661398|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3834852|NCT01698268|3661396|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3834853|NCT01698268|3661397|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3834854|NCT01698268|3661398|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3834855|NCT01698268|3661396|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3834856|NCT01698268|3661397|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3834857|NCT01698268|3661398|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3834858|NCT01698268|3661396|B3||<=18 years|Age||Participants|Count of Participants|47|47.0||||||
3834859|NCT01698268|3661397|B2||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
3834860|NCT01698268|3661398|B1||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
3834861|NCT01698008|3661405|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3834862|NCT01698008|3661406|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3834863|NCT01698008|3661407|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3834864|NCT01698008|3661405|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834865|NCT01698008|3661406|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834866|NCT01698008|3661407|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834867|NCT01698008|3661405|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834868|NCT01698008|3661406|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834869|NCT01698008|3661407|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834870|NCT01698008|3661405|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3834871|NCT01698008|3661406|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3834872|NCT01698008|3661407|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3834873|NCT01698008|3661405|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834874|NCT01698008|3661406|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834875|NCT01698008|3661407|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834876|NCT01698008|3661405|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834877|NCT01698008|3661406|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834878|NCT01698008|3661407|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834879|NCT01698008|3661405|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834880|NCT01698008|3661406|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834881|NCT01698008|3661407|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834882|NCT01698008|3661405|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834883|NCT01698008|3661406|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834884|NCT01698008|3661407|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3834885|NCT01698008|3661405|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3834886|NCT01698008|3661406|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3834887|NCT01698008|3661407|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3834888|NCT01698008|3661405|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3834889|NCT01698008|3661406|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3834890|NCT01698008|3661407|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3834891|NCT01698008|3661405|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3834892|NCT01698008|3661406|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3834893|NCT01698008|3661407|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3834894|NCT01698008|3661405|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3834895|NCT01698008|3661406|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3834896|NCT01698008|3661407|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3834897|NCT01698008|3661405|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3834898|NCT01698008|3661406|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3834899|NCT01698008|3661407|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3834900|NCT01697969|3661414|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3834901|NCT01697969|3661414|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3834902|NCT01697969|3661414|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3834903|NCT01697969|3661414|B1|||Age||years|Mean|37.0|37.0|Standard Deviation|12.0|12.0|||
3834904|NCT01697956|3661419|B3|||Body Mass Index||kg/m^2|Mean|18.6|18.6|Standard Deviation|3.89|3.89|||
3834905|NCT01697956|3661420|B2|||Body Mass Index||kg/m^2|Mean|18.2|18.2|Standard Deviation|3.66|3.66|||
3834906|NCT01697956|3661421|B1|||Body Mass Index||kg/m^2|Mean|18.8|18.8|Standard Deviation|4.01|4.01|||
3834907|NCT01697956|3661419|B3|||Weight||kg|Mean|36.7|36.7|Standard Deviation|12.85|12.85|||
3834908|NCT01697956|3661420|B2|||Weight||kg|Mean|34.9|34.9|Standard Deviation|12.89|12.89|||
3834909|NCT01697956|3661421|B1|||Weight||kg|Mean|37.5|37.5|Standard Deviation|12.84|12.84|||
3834910|NCT01697956|3661419|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|71|71.0||||||
3834911|NCT01697956|3661420|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3834912|NCT01697956|3661421|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
3834913|NCT01697956|3661419|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3834914|NCT01697956|3661420|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3834915|NCT01697956|3661421|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3834916|NCT01697956|3661419|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3834917|NCT01697956|3661420|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3834918|NCT01697956|3661421|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3834919|NCT01697956|3661419|B3|Black||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3834920|NCT01697956|3661420|B2|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3834921|NCT01697956|3661421|B1|Black||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3834922|NCT01697956|3661419|B3|White||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
3834923|NCT01697956|3661420|B2|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3834924|NCT01697956|3661421|B1|White||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
3834925|NCT01697956|3661419|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3834926|NCT01697956|3661420|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3834927|NCT01697956|3661421|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3834928|NCT01697956|3661419|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3834929|NCT01697956|3661420|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3834930|NCT01697956|3661421|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3834931|NCT01697956|3661419|B3|||Age||years|Mean|9.0|9.0|Standard Deviation|1.60|1.6|||
3834932|NCT01697956|3661420|B2|||Age||years|Mean|8.5|8.5|Standard Deviation|1.65|1.65|||
3834933|NCT01697956|3661421|B1|||Age||years|Mean|9.2|9.2|Standard Deviation|1.54|1.54|||
3834934|NCT01697748|3661450|B3|United States||Region of Enrollment||participants|Number|657|657.0||||||
3834935|NCT01697748|3661451|B2|United States||Region of Enrollment||participants|Number|328|328.0||||||
3834936|NCT01697748|3661452|B1|United States||Region of Enrollment||participants|Number|329|329.0||||||
3834937|NCT01697748|3661450|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3834938|NCT01697748|3661451|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3834939|NCT01697748|3661452|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3834940|NCT01697748|3661450|B3||Female|Sex: Female, Male||Participants|Count of Participants|657|657.0||||||
3834941|NCT01697748|3661451|B2||Female|Sex: Female, Male||Participants|Count of Participants|328|328.0||||||
3834942|NCT01697748|3661452|B1||Female|Sex: Female, Male||Participants|Count of Participants|329|329.0||||||
3834943|NCT01697748|3661450|B3|||Age||years|Mean|31.0|31.0|Standard Deviation|5.6|5.6|||
3834944|NCT01697748|3661451|B2|||Age||years|Mean|30.9|30.9|Standard Deviation|5.6|5.6|||
3834945|NCT01697748|3661452|B1|||Age||years|Mean|31.0|31.0|Standard Deviation|5.5|5.5|||
3834946|NCT01697748|3661450|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3834947|NCT01697748|3661451|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3834948|NCT01697748|3661452|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3834949|NCT01697748|3661450|B3||Between 18 and 65 years|Age||Participants|Count of Participants|657|657.0||||||
3834950|NCT01697748|3661451|B2||Between 18 and 65 years|Age||Participants|Count of Participants|328|328.0||||||
3834951|NCT01697748|3661452|B1||Between 18 and 65 years|Age||Participants|Count of Participants|329|329.0||||||
3834952|NCT01697748|3661450|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3834953|NCT01697748|3661451|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3834954|NCT01697748|3661452|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3834955|NCT01697696|3661461|B3||Male|Sex: Female, Male||Participants|Count of Participants|290|290.0||||||
3834956|NCT01697696|3661462|B2||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3834957|NCT01697696|3661463|B1||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3834958|NCT01697696|3661461|B3||Female|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
3834959|NCT01697696|3661462|B2||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3834960|NCT01697696|3661463|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3834961|NCT01697696|3661461|B3|||Age||Years|Mean|63.3|63.3|Standard Deviation|9.02|9.02|||
3834962|NCT01697696|3661462|B2|||Age||Years|Mean|63.2|63.2|Standard Deviation|8.91|8.91|||
3834963|NCT01697696|3661463|B1|||Age||Years|Mean|63.3|63.3|Standard Deviation|9.15|9.15|||
3834964|NCT01697592|3661486|B11||Male|Sex: Female, Male||Participants|Count of Participants|416|416.0||||||
3834965|NCT01697592|3661487|B10||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3834966|NCT01697592|3661488|B9||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3834967|NCT01697592|3661489|B8||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3834968|NCT01697592|3661490|B7||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3834969|NCT01697592|3661491|B6||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3834970|NCT01697592|3661492|B5||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3834971|NCT01697592|3661493|B4||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3834972|NCT01697592|3661494|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3834973|NCT01697592|3661495|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3834974|NCT01697592|3661496|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3834975|NCT01697592|3661486|B11||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3834976|NCT01697592|3661487|B10||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3834977|NCT01697592|3661488|B9||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3834978|NCT01697592|3661489|B8||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3834979|NCT01697592|3661490|B7||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3834980|NCT01697592|3661491|B6||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3834981|NCT01697592|3661492|B5||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3834982|NCT01697592|3661493|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3834983|NCT01697592|3661494|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3834984|NCT01697592|3661495|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3834985|NCT01697592|3661496|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3834986|NCT01697592|3661486|B11|||Age||Years|Mean|61|61.0|Standard Deviation|10|10.0|||
3834987|NCT01697592|3661487|B10|||Age||Years|Mean|61|61.0|Standard Deviation|11|11.0|||
3834988|NCT01697592|3661488|B9|||Age||Years|Mean|61|61.0|Standard Deviation|9|9.0|||
3834989|NCT01697592|3661489|B8|||Age||Years|Mean|57|57.0|Standard Deviation|9|9.0|||
3834990|NCT01697592|3661490|B7|||Age||Years|Mean|61|61.0|Standard Deviation|10|10.0|||
3834991|NCT01697592|3661491|B6|||Age||Years|Mean|63|63.0|Standard Deviation|11|11.0|||
3834992|NCT01697592|3661492|B5|||Age||Years|Mean|61|61.0|Standard Deviation|11|11.0|||
3834993|NCT01697592|3661493|B4|||Age||Years|Mean|61|61.0|Standard Deviation|10|10.0|||
3834994|NCT01697592|3661494|B3|||Age||Years|Mean|59|59.0|Standard Deviation|9|9.0|||
3834995|NCT01697592|3661495|B2|||Age||Years|Mean|59|59.0|Standard Deviation|11|11.0|||
3834996|NCT01697592|3661496|B1|||Age||Years|Mean|63|63.0|Standard Deviation|9|9.0|||
3834997|NCT01697579|3661569|B6||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3834998|NCT01697579|3661570|B5||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3834999|NCT01697579|3661571|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3835000|NCT01697579|3661572|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3835001|NCT01697579|3661573|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3835002|NCT01697579|3661574|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3835003|NCT01697579|3661569|B6||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3835004|NCT01697579|3661570|B5||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3835005|NCT01697579|3661571|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3835006|NCT01697579|3661572|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3835007|NCT01697579|3661573|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3835008|NCT01697579|3661574|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3835009|NCT01697579|3661569|B6|||Age||Months|Mean|102.4|102.4|Standard Deviation|57.0|57.0|||
3835010|NCT01697579|3661570|B5|||Age||Months|Mean|122.5|122.5|Standard Deviation|54.0|54.0|||
3835011|NCT01697579|3661571|B4|||Age||Months|Mean|119.2|119.2|Standard Deviation|54.3|54.3|||
3835012|NCT01697579|3661572|B3|||Age||Months|Mean|119.4|119.4|Standard Deviation|52.7|52.7|||
3835013|NCT01697579|3661573|B2|||Age||Months|Mean|123.8|123.8|Standard Deviation|51.3|51.3|||
3835014|NCT01697579|3661574|B1|||Age||Months|Mean|60.2|60.2|Standard Deviation|42.3|42.3|||
3835015|NCT01697501|3661692|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3835016|NCT01697501|3661692|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3835017|NCT01697501|3661692|B1|||Age||years|Mean|45.7|45.7|Standard Deviation|9.6|9.6|||
3835018|NCT01697462|3661735|B1||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3835019|NCT01697462|3661735|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3835020|NCT01697462|3661735|B1|||Age||Years|Mean|65.38|65.38|Standard Deviation|10.24|10.24|||
3835021|NCT01697449|3661742|B1||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3835022|NCT01697449|3661742|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3835023|NCT01697449|3661742|B1|||Age||years|Mean|59.31|59.31|Standard Deviation|10.23|10.23|||
3835024|NCT01697358|3661751|B3|United States||Region of Enrollment||Participants|Count of Participants|64|64.0||||||
3835025|NCT01697358|3661752|B2|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3835026|NCT01697358|3661753|B1|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3835027|NCT01697358|3661751|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3835028|NCT01697358|3661752|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3835029|NCT01697358|3661753|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3835030|NCT01697358|3661751|B3|Spain||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3835031|NCT01697358|3661752|B2|Spain||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3835032|NCT01697358|3661753|B1|Spain||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3835033|NCT01697358|3661751|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3835034|NCT01697358|3661752|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3835035|NCT01697358|3661753|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3835036|NCT01697358|3661751|B3|Germany||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3835037|NCT01697358|3661752|B2|Germany||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3835038|NCT01697358|3661753|B1|Germany||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3835039|NCT01697358|3661751|B3|France||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3835040|NCT01697358|3661752|B2|France||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3835041|NCT01697358|3661753|B1|France||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3835042|NCT01697358|3661751|B3|Colombia||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3835043|NCT01697358|3661752|B2|Colombia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3835044|NCT01697358|3661753|B1|Colombia||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3835045|NCT01697358|3661751|B3|Canada||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3835046|NCT01697358|3661752|B2|Canada||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3835047|NCT01697358|3661753|B1|Canada||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3835048|NCT01697358|3661751|B3|Belgium||Region of Enrollment||Participants|Count of Participants|49|49.0||||||
3835049|NCT01697358|3661752|B2|Belgium||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3835050|NCT01697358|3661753|B1|Belgium||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3835051|NCT01697358|3661751|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3835052|NCT01697358|3661752|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3835053|NCT01697358|3661753|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3835054|NCT01697358|3661751|B3||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3835055|NCT01697358|3661752|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3835056|NCT01697358|3661753|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3835057|NCT01697358|3661751|B3|||Age||Years|Mean|53.9|53.9|Standard Deviation|11.5|11.5|||
3835058|NCT01697358|3661752|B2|||Age||Years|Mean|55.1|55.1|Standard Deviation|10.2|10.2|||
3835059|NCT01697358|3661753|B1|||Age||Years|Mean|52.8|52.8|Standard Deviation|12.5|12.5|||
3835060|NCT01697345|3661770|B1|No||Sexually Active During Study||Participants|Number|1|1.0||||||
3835061|NCT01697345|3661770|B1|Yes||Sexually Active During Study||Participants|Number|11|11.0||||||
3835062|NCT01697345|3661770|B1|No||Sexually Active Prior to Study||Participants|Number|5|5.0||||||
3835063|NCT01697345|3661770|B1|Yes||Sexually Active Prior to Study||Participants|Number|7|7.0||||||
3835064|NCT01697345|3661770|B1|Candidiasis species||Vaginal Swab Test|A vaginal swab was obtained prior to prescribing testosterone therapy because women with suppressed estrogen levels have an increased risk of infection.|Participants|Number|0|0.0||||||
3835065|NCT01697345|3661770|B1|Gardnerella vaginalis||Vaginal Swab Test|A vaginal swab was obtained prior to prescribing testosterone therapy because women with suppressed estrogen levels have an increased risk of infection.|Participants|Number|3|3.0||||||
3835066|NCT01697345|3661770|B1|No vaginal infection||Vaginal Swab Test|A vaginal swab was obtained prior to prescribing testosterone therapy because women with suppressed estrogen levels have an increased risk of infection.|Participants|Number|9|9.0||||||
3835067|NCT01697345|3661770|B1|exemestane (Aromasin)||Aromatase Inhibitor||Participants|Number|0|0.0||||||
3835068|NCT01697345|3661770|B1|letrozole (Femara)||Aromatase Inhibitor||Participants|Number|1|1.0||||||
3835069|NCT01697345|3661770|B1|anastrozole (Arimidex)||Aromatase Inhibitor||Participants|Number|11|11.0||||||
3835070|NCT01697345|3661770|B1|HER2-||Human Epidermal Growth Factor Receptor 2 (HER2) Status||Participants|Number|11|11.0||||||
3835071|NCT01697345|3661770|B1|HER2+||Human Epidermal Growth Factor Receptor 2 (HER2) Status||Participants|Number|1|1.0||||||
3835072|NCT01697345|3661770|B1|PR-||Progesterone-receptor (PR) Status||Participants|Number|2|2.0||||||
3835073|NCT01697345|3661770|B1|PR+||Progesterone-receptor (PR) Status||Participants|Number|10|10.0||||||
3835074|NCT01697345|3661770|B1|ER-||Estrogen-receptor (ER) Status||Participants|Number|1|1.0||||||
3835075|NCT01697345|3661770|B1|ER+||Estrogen-receptor (ER) Status||Participants|Number|11|11.0||||||
3835076|NCT01697345|3661770|B1|No||Oophorectomy||Participants|Number|8|8.0||||||
3835077|NCT01697345|3661770|B1|Yes||Oophorectomy||Participants|Number|4|4.0||||||
3835078|NCT01697345|3661770|B1|Master's degree||Highest Level of Education||Participants|Number|2|2.0||||||
3835079|NCT01697345|3661770|B1|Bachelor's degree||Highest Level of Education||Participants|Number|4|4.0||||||
3835080|NCT01697345|3661770|B1|Associate's degree||Highest Level of Education||Participants|Number|3|3.0||||||
3835081|NCT01697345|3661770|B1|High school degree||Highest Level of Education||Participants|Number|3|3.0||||||
3835082|NCT01697345|3661770|B1|51-55 years||Length of Marriage||participants|Number|1|1.0||||||
3835083|NCT01697345|3661770|B1|41-50 years||Length of Marriage||participants|Number|0|0.0||||||
3835084|NCT01697345|3661770|B1|36-40 years||Length of Marriage||participants|Number|2|2.0||||||
3835085|NCT01697345|3661770|B1|31-35 years||Length of Marriage||participants|Number|2|2.0||||||
3835086|NCT01697345|3661770|B1|26-30 years||Length of Marriage||participants|Number|1|1.0||||||
3835087|NCT01697345|3661770|B1|21-25 years||Length of Marriage||participants|Number|5|5.0||||||
3835088|NCT01697345|3661770|B1|16-20 years||Length of Marriage||participants|Number|0|0.0||||||
3835089|NCT01697345|3661770|B1|11-15 years||Length of Marriage||participants|Number|0|0.0||||||
3835090|NCT01697345|3661770|B1|6-10 years||Length of Marriage||participants|Number|0|0.0||||||
3835091|NCT01697345|3661770|B1|0-5 years||Length of Marriage||participants|Number|1|1.0||||||
3835092|NCT01697345|3661770|B1|Not Married||Marital Status||Participants|Number|0|0.0||||||
3835093|NCT01697345|3661770|B1|Married||Marital Status||Participants|Number|12|12.0||||||
3835094|NCT01697345|3661770|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3835095|NCT01697345|3661770|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3835096|NCT01697345|3661770|B1|||Age||Years|Mean|59.67|59.67|Standard Deviation|6.095|6.095|||
3835097|NCT01697332|3661789|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3835098|NCT01697332|3661789|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835099|NCT01697332|3661789|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835100|NCT01697332|3661789|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3835101|NCT01697332|3661789|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835102|NCT01697332|3661789|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835103|NCT01697332|3661789|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835104|NCT01697332|3661789|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835105|NCT01697332|3661789|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835106|NCT01697332|3661789|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3835107|NCT01697332|3661789|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835108|NCT01697332|3661789|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3835109|NCT01697332|3661789|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3835110|NCT01697332|3661789|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3835111|NCT01697332|3661789|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3835112|NCT01697332|3661789|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3835113|NCT01697319|3661795|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3835114|NCT01697319|3661795|B1|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3835115|NCT01697319|3661795|B1|Germany||Region of Enrollment||participants|Number|6|6.0||||||
3835116|NCT01697319|3661795|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3835117|NCT01697319|3661795|B1|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3835118|NCT01697319|3661795|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3835119|NCT01697319|3661795|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3835120|NCT01697319|3661795|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3835121|NCT01697319|3661795|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3835122|NCT01697319|3661795|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835123|NCT01697319|3661795|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3835124|NCT01697319|3661795|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3835125|NCT01697319|3661795|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3835126|NCT01697319|3661795|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3835127|NCT01697319|3661795|B1|>=19 years||Age, Customized||participants|Number|7|7.0||||||
3835128|NCT01697319|3661795|B1|12 to 18 years||Age, Customized||participants|Number|8|8.0||||||
3835129|NCT01697319|3661795|B1|5 to 11 years||Age, Customized||participants|Number|1|1.0||||||
3835130|NCT01697319|3661795|B1|||Age||years|Mean|20.7|20.7|Standard Deviation|8.38|8.38|||
3835131|NCT01696994|3661802|B3|United States||Region of Enrollment||participants|Number|78216|78216.0||||||
3835132|NCT01696994|3661803|B2|United States||Region of Enrollment||participants|Number|39105|39105.0||||||
3835133|NCT01696994|3661804|B1|United States||Region of Enrollment||participants|Number|39111|39111.0||||||
3835134|NCT01696994|3661802|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3835135|NCT01696994|3661803|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3835136|NCT01696994|3661804|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3835137|NCT01696994|3661802|B3||Female|Sex: Female, Male||Participants|Count of Participants|78216|78216.0||||||
3835138|NCT01696994|3661803|B2||Female|Sex: Female, Male||Participants|Count of Participants|39105|39105.0||||||
3835139|NCT01696994|3661804|B1||Female|Sex: Female, Male||Participants|Count of Participants|39111|39111.0||||||
3835140|NCT01696994|3661802|B3|||Age||years|Mean|62.5|62.5|Standard Deviation|5.4|5.4|||
3835141|NCT01696994|3661803|B2|||Age||years|Mean|62.5|62.5|Standard Deviation|5.4|5.4|||
3835142|NCT01696994|3661804|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|5.4|5.4|||
3835143|NCT01696994|3661802|B3||>=65 years|Age||Participants|Count of Participants|27761|27761.0||||||
3835144|NCT01696994|3661803|B2||>=65 years|Age||Participants|Count of Participants|13872|13872.0||||||
3835145|NCT01696994|3661804|B1||>=65 years|Age||Participants|Count of Participants|13889|13889.0||||||
3835146|NCT01696994|3661802|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50455|50455.0||||||
3835147|NCT01696994|3661803|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25233|25233.0||||||
3835148|NCT01696994|3661804|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25222|25222.0||||||
3835149|NCT01696994|3661802|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3835150|NCT01696994|3661803|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3835151|NCT01696994|3661804|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3835152|NCT01696981|3661831|B3|United States||Region of Enrollment||participants|Number|154900|154900.0||||||
3835153|NCT01696981|3661832|B2|United States||Region of Enrollment||participants|Number|77445|77445.0||||||
3835154|NCT01696981|3661833|B1|United States||Region of Enrollment||participants|Number|77455|77455.0||||||
3835155|NCT01696981|3661831|B3||Male|Sex: Female, Male||Participants|Count of Participants|76684|76684.0||||||
3835156|NCT01696981|3661832|B2||Male|Sex: Female, Male||Participants|Count of Participants|38340|38340.0||||||
3835157|NCT01696981|3661833|B1||Male|Sex: Female, Male||Participants|Count of Participants|38344|38344.0||||||
3835158|NCT01696981|3661831|B3||Female|Sex: Female, Male||Participants|Count of Participants|78216|78216.0||||||
3835159|NCT01696981|3661832|B2||Female|Sex: Female, Male||Participants|Count of Participants|39105|39105.0||||||
3835160|NCT01696981|3661833|B1||Female|Sex: Female, Male||Participants|Count of Participants|39111|39111.0||||||
3835161|NCT01696981|3661831|B3|||Age||years|Mean|62.6|62.6|Standard Deviation|5.4|5.4|||
3835162|NCT01696981|3661832|B2|||Age||years|Mean|62.6|62.6|Standard Deviation|5.4|5.4|||
3835163|NCT01696981|3661833|B1|||Age||years|Mean|62.6|62.6|Standard Deviation|5.4|5.4|||
3835164|NCT01696981|3661831|B3||>=65 years|Age||Participants|Count of Participants|55656|55656.0||||||
3835165|NCT01696981|3661832|B2||>=65 years|Age||Participants|Count of Participants|27811|27811.0||||||
3835166|NCT01696981|3661833|B1||>=65 years|Age||Participants|Count of Participants|27845|27845.0||||||
3835167|NCT01696981|3661831|B3||Between 18 and 65 years|Age||Participants|Count of Participants|99244|99244.0||||||
3835168|NCT01696981|3661832|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49634|49634.0||||||
3835169|NCT01696981|3661833|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49610|49610.0||||||
3835170|NCT01696981|3661831|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3835171|NCT01696981|3661832|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3835172|NCT01696981|3661833|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3835173|NCT01696968|3661852|B3|United States||Region of Enrollment||participants|Number|154901|154901.0||||||
3835174|NCT01696968|3661853|B2|United States||Region of Enrollment||participants|Number|77445|77445.0||||||
3835175|NCT01696968|3661854|B1|United States||Region of Enrollment||participants|Number|77456|77456.0||||||
3835176|NCT01696968|3661852|B3||Male|Sex: Female, Male||Participants|Count of Participants|76685|76685.0||||||
3835177|NCT01696968|3661853|B2||Male|Sex: Female, Male||Participants|Count of Participants|38340|38340.0||||||
3835178|NCT01696968|3661854|B1||Male|Sex: Female, Male||Participants|Count of Participants|38345|38345.0||||||
3835179|NCT01696968|3661852|B3||Female|Sex: Female, Male||Participants|Count of Participants|78216|78216.0||||||
3835180|NCT01696968|3661853|B2||Female|Sex: Female, Male||Participants|Count of Participants|39105|39105.0||||||
3835181|NCT01696968|3661854|B1||Female|Sex: Female, Male||Participants|Count of Participants|39111|39111.0||||||
3835182|NCT01696968|3661852|B3|||Age||years|Mean|62.6|62.6|Standard Deviation|5.4|5.4|||
3835183|NCT01696968|3661853|B2|||Age||years|Mean|62.6|62.6|Standard Deviation|5.4|5.4|||
3835184|NCT01696968|3661854|B1|||Age||years|Mean|62.6|62.6|Standard Deviation|5.4|5.4|||
3835185|NCT01696968|3661852|B3||>=65 years|Age||Participants|Count of Participants|55655|55655.0||||||
3835186|NCT01696968|3661853|B2||>=65 years|Age||Participants|Count of Participants|27811|27811.0||||||
3835187|NCT01696968|3661854|B1||>=65 years|Age||Participants|Count of Participants|27844|27844.0||||||
3835188|NCT01696968|3661852|B3||Between 18 and 65 years|Age||Participants|Count of Participants|99246|99246.0||||||
3835189|NCT01696968|3661853|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49634|49634.0||||||
3835190|NCT01696968|3661854|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49612|49612.0||||||
3835191|NCT01696968|3661852|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3835192|NCT01696968|3661853|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3835193|NCT01696968|3661854|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3835194|NCT01696955|3661875|B3|United States||Region of Enrollment||Participants|Count of Participants|78|78.0||||||
3835195|NCT01696955|3661876|B2|United States||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
3835196|NCT01696955|3661877|B1|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3835197|NCT01696955|3661875|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3835198|NCT01696955|3661876|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835199|NCT01696955|3661877|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3835200|NCT01696955|3661875|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835201|NCT01696955|3661876|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835202|NCT01696955|3661877|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835203|NCT01696955|3661875|B3||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3835204|NCT01696955|3661876|B2||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3835205|NCT01696955|3661877|B1||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3835206|NCT01696955|3661875|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3835207|NCT01696955|3661876|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3835208|NCT01696955|3661877|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3835209|NCT01696955|3661875|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835210|NCT01696955|3661876|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835211|NCT01696955|3661877|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835212|NCT01696955|3661875|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3835213|NCT01696955|3661876|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3835214|NCT01696955|3661877|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3835215|NCT01696955|3661875|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835216|NCT01696955|3661876|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835217|NCT01696955|3661877|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835218|NCT01696955|3661875|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3835219|NCT01696955|3661876|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3835220|NCT01696955|3661877|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3835221|NCT01696955|3661875|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3835222|NCT01696955|3661876|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3835223|NCT01696955|3661877|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3835224|NCT01696955|3661875|B3|||Age||years|Mean|62.0|62.0|Full Range|||35.0|90.0|
3835225|NCT01696955|3661876|B2|||Age||years|Mean|63.6|63.6|Full Range|||35.0|87.0|
3835226|NCT01696955|3661877|B1|||Age||years|Mean|60.5|60.5|Full Range|||37.0|90.0|
3835227|NCT01696942|3661901|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835228|NCT01696942|3661902|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835229|NCT01696942|3661903|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835230|NCT01696942|3661901|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835231|NCT01696942|3661902|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835232|NCT01696942|3661903|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835233|NCT01696942|3661901|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3835234|NCT01696942|3661902|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3835235|NCT01696942|3661903|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3835236|NCT01696942|3661901|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835237|NCT01696942|3661902|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835238|NCT01696942|3661903|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835239|NCT01696942|3661901|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835240|NCT01696942|3661902|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835241|NCT01696942|3661903|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835242|NCT01696942|3661901|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835243|NCT01696942|3661902|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835244|NCT01696942|3661903|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835245|NCT01696942|3661901|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835246|NCT01696942|3661902|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835247|NCT01696942|3661903|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835248|NCT01696942|3661901|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835249|NCT01696942|3661902|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835250|NCT01696942|3661903|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835251|NCT01696942|3661901|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3835252|NCT01696942|3661902|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3835253|NCT01696942|3661903|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3835254|NCT01696942|3661901|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3835255|NCT01696942|3661902|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3835256|NCT01696942|3661903|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835257|NCT01696942|3661901|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3835258|NCT01696942|3661902|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3835259|NCT01696942|3661903|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3835260|NCT01696942|3661901|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3835261|NCT01696942|3661902|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3835262|NCT01696942|3661903|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3835263|NCT01696942|3661901|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3835264|NCT01696942|3661902|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3835265|NCT01696942|3661903|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3835266|NCT01696942|3661901|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3835267|NCT01696942|3661902|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3835268|NCT01696942|3661903|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3835269|NCT01696942|3661901|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3835270|NCT01696942|3661902|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3835271|NCT01696942|3661903|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3835272|NCT01696929|3661912|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3835273|NCT01696929|3661912|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3835274|NCT01696929|3661912|B1|||Age||years|Mean|35|35.0|Full Range|||23.0|52.0|
3835275|NCT01696877|3661917|B3|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3835276|NCT01696877|3661918|B2|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3835277|NCT01696877|3661919|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3835278|NCT01696877|3661917|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835279|NCT01696877|3661918|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835280|NCT01696877|3661919|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835281|NCT01696877|3661917|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835282|NCT01696877|3661918|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835283|NCT01696877|3661919|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835284|NCT01696877|3661917|B3||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3835285|NCT01696877|3661918|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3835286|NCT01696877|3661919|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3835287|NCT01696877|3661917|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3835288|NCT01696877|3661918|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3835289|NCT01696877|3661919|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835290|NCT01696877|3661917|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835291|NCT01696877|3661918|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835292|NCT01696877|3661919|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835293|NCT01696877|3661917|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835294|NCT01696877|3661918|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835295|NCT01696877|3661919|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835296|NCT01696877|3661917|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835297|NCT01696877|3661918|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835298|NCT01696877|3661919|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835299|NCT01696877|3661917|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3835300|NCT01696877|3661918|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3835301|NCT01696877|3661919|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3835302|NCT01696877|3661917|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3835303|NCT01696877|3661918|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3835304|NCT01696877|3661919|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3835305|NCT01696877|3661917|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3835306|NCT01696877|3661918|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3835307|NCT01696877|3661919|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3835308|NCT01696877|3661917|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3835309|NCT01696877|3661918|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3835310|NCT01696877|3661919|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3835311|NCT01696877|3661917|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3835312|NCT01696877|3661918|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3835313|NCT01696877|3661919|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3835314|NCT01696773|3661932|B3|||Hemoglobin||g/dL|Mean|14.0|14.0|Standard Deviation|1.1|1.1|||
3835315|NCT01696773|3661933|B2|||Hemoglobin||g/dL|Mean|14.1|14.1|Standard Deviation|1.1|1.1|||
3835316|NCT01696773|3661934|B1|||Hemoglobin||g/dL|Mean|13.9|13.9|Standard Deviation|0.8|0.8|||
3835317|NCT01696773|3661932|B3|||Hematocrit||Volume % of red blood cells in blood|Mean|41.9|41.9|Standard Deviation|3.2|3.2|||
3835318|NCT01696773|3661933|B2|||Hematocrit||Volume % of red blood cells in blood|Mean|42.0|42.0|Standard Deviation|3.8|3.8|||
3835319|NCT01696773|3661934|B1|||Hematocrit||Volume % of red blood cells in blood|Mean|41.8|41.8|Standard Deviation|2.8|2.8|||
3835320|NCT01696773|3661932|B3|||Plasma triglycerides (mg/dL)||mg/dL|Mean|75.8|75.8|Standard Deviation|45.0|45.0|||
3835321|NCT01696773|3661933|B2|||Plasma triglycerides (mg/dL)||mg/dL|Mean|85.8|85.8|Standard Deviation|42.3|42.3|||
3835322|NCT01696773|3661934|B1|||Plasma triglycerides (mg/dL)||mg/dL|Mean|65.8|65.8|Standard Deviation|49.3|49.3|||
3835323|NCT01696773|3661932|B3|||Plasma cholesterol (mg/dL)||mg/dL|Mean|173.8|173.8|Standard Deviation|10.6|10.6|||
3835324|NCT01696773|3661933|B2|||Plasma cholesterol (mg/dL)||mg/dL|Mean|176.2|176.2|Standard Deviation|12.5|12.5|||
3835325|NCT01696773|3661934|B1|||Plasma cholesterol (mg/dL)||mg/dL|Mean|170.6|170.6|Standard Deviation|8.9|8.9|||
3835326|NCT01696773|3661932|B3|||BMI||kg/m^2|Mean|23.3|23.3|Standard Deviation|1.4|1.4|||
3835327|NCT01696773|3661933|B2|||BMI||kg/m^2|Mean|25.5|25.5|Standard Deviation|1.6|1.6|||
3835328|NCT01696773|3661934|B1|||BMI||kg/m^2|Mean|23.1|23.1|Standard Deviation|1.4|1.4|||
3835329|NCT01696773|3661932|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3835330|NCT01696773|3661933|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3835331|NCT01696773|3661934|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3835332|NCT01696773|3661932|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3835333|NCT01696773|3661933|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3835334|NCT01696773|3661934|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3835335|NCT01696773|3661932|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3835336|NCT01696773|3661933|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3835337|NCT01696773|3661934|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3835338|NCT01696773|3661932|B3|||Age||years|Mean|25.9|25.9|Standard Deviation|9.8|9.8|||
3835339|NCT01696773|3661933|B2|||Age||years|Mean|29.0|29.0|Standard Deviation|13.4|13.4|||
3835340|NCT01696773|3661934|B1|||Age||years|Mean|22.8|22.8|Standard Deviation|2.8|2.8|||
3835341|NCT01696760|3661941|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3835342|NCT01696760|3661942|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3835343|NCT01696760|3661943|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3835344|NCT01696760|3661941|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3835345|NCT01696760|3661942|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3835346|NCT01696760|3661943|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3835347|NCT01696760|3661941|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3835348|NCT01696760|3661942|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3835349|NCT01696760|3661943|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3835350|NCT01696760|3661941|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835351|NCT01696760|3661942|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835352|NCT01696760|3661943|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835353|NCT01696760|3661941|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3835354|NCT01696760|3661942|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3835355|NCT01696760|3661943|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3835356|NCT01696760|3661941|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3835357|NCT01696760|3661942|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3835358|NCT01696760|3661943|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835359|NCT01696760|3661941|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3835360|NCT01696760|3661942|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3835361|NCT01696760|3661943|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3835362|NCT01696760|3661941|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835363|NCT01696760|3661942|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835364|NCT01696760|3661943|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835365|NCT01696760|3661941|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835366|NCT01696760|3661942|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835367|NCT01696760|3661943|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835368|NCT01696760|3661941|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3835369|NCT01696760|3661942|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835370|NCT01696760|3661943|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3835371|NCT01696760|3661941|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835372|NCT01696760|3661942|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835373|NCT01696760|3661943|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835374|NCT01696760|3661941|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3835375|NCT01696760|3661942|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3835376|NCT01696760|3661943|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3835377|NCT01696760|3661941|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3835378|NCT01696760|3661942|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3835379|NCT01696760|3661943|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3835380|NCT01696760|3661941|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3835381|NCT01696760|3661942|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3835382|NCT01696760|3661943|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3835383|NCT01696760|3661941|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3835384|NCT01696760|3661942|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3835385|NCT01696760|3661943|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3835386|NCT01696760|3661941|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3835387|NCT01696760|3661942|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3835388|NCT01696760|3661943|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3835389|NCT01696695|3661962|B1||Male|Sex: Female, Male||Participants|Count of Participants|401|401.0||||||
3835390|NCT01696695|3661962|B1||Female|Sex: Female, Male||Participants|Count of Participants|289|289.0||||||
3835391|NCT01696695|3661962|B1|||Age||years|Mean|64.9|64.9|Standard Deviation|10.51|10.51|||
3835392|NCT01696643|3661972|B3|United States||Region of Enrollment||participants|Number|1349|1349.0||||||
3835393|NCT01696643|3661973|B2|United States||Region of Enrollment||participants|Number|672|672.0||||||
3835394|NCT01696643|3661974|B1|United States||Region of Enrollment||participants|Number|677|677.0||||||
3835395|NCT01696643|3661972|B3|Canada||Region of Enrollment||participants|Number|54|54.0||||||
3835396|NCT01696643|3661973|B2|Canada||Region of Enrollment||participants|Number|28|28.0||||||
3835397|NCT01696643|3661974|B1|Canada||Region of Enrollment||participants|Number|26|26.0||||||
3835398|NCT01696643|3661972|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3835399|NCT01696643|3661973|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3835400|NCT01696643|3661974|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835401|NCT01696643|3661972|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3835402|NCT01696643|3661973|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3835403|NCT01696643|3661974|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3835404|NCT01696643|3661972|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1118|1118.0||||||
3835405|NCT01696643|3661973|B2||White|Race (NIH/OMB)||Participants|Count of Participants|555|555.0||||||
3835406|NCT01696643|3661974|B1||White|Race (NIH/OMB)||Participants|Count of Participants|563|563.0||||||
3835407|NCT01696643|3661972|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|239|239.0||||||
3835408|NCT01696643|3661973|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
3835409|NCT01696643|3661974|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|117|117.0||||||
3835410|NCT01696643|3661972|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3835411|NCT01696643|3661973|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3835412|NCT01696643|3661974|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3835413|NCT01696643|3661972|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3835414|NCT01696643|3661973|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3835415|NCT01696643|3661974|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3835416|NCT01696643|3661972|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3835417|NCT01696643|3661973|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3835418|NCT01696643|3661974|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3835419|NCT01696643|3661972|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3835420|NCT01696643|3661973|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3835421|NCT01696643|3661974|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3835422|NCT01696643|3661972|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1325|1325.0||||||
3835423|NCT01696643|3661973|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|649|649.0||||||
3835424|NCT01696643|3661974|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|676|676.0||||||
3835425|NCT01696643|3661972|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3835426|NCT01696643|3661973|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3835427|NCT01696643|3661974|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3835428|NCT01696643|3661972|B3||Male|Sex: Female, Male||Participants|Count of Participants|549|549.0||||||
3835429|NCT01696643|3661973|B2||Male|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
3835430|NCT01696643|3661974|B1||Male|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
3835431|NCT01696643|3661972|B3||Female|Sex: Female, Male||Participants|Count of Participants|854|854.0||||||
3835432|NCT01696643|3661973|B2||Female|Sex: Female, Male||Participants|Count of Participants|417|417.0||||||
3835433|NCT01696643|3661974|B1||Female|Sex: Female, Male||Participants|Count of Participants|437|437.0||||||
3835434|NCT01696643|3661972|B3|||Age||years|Mean|54.2|54.2|Standard Deviation|10.11|10.11|||
3835435|NCT01696643|3661973|B2|||Age||years|Mean|53.9|53.9|Standard Deviation|10.21|10.21|||
3835436|NCT01696643|3661974|B1|||Age||years|Mean|54.5|54.5|Standard Deviation|10.00|10.0|||
3835437|NCT01696357|3661990|B3|United States||Region of Enrollment||participants|Number|84|84.0||||||
3835438|NCT01696357|3661991|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
3835439|NCT01696357|3661992|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
3835440|NCT01696357|3661990|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3835441|NCT01696357|3661991|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3835442|NCT01696357|3661992|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3835443|NCT01696357|3661990|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3835444|NCT01696357|3661991|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3835445|NCT01696357|3661992|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3835446|NCT01696357|3661990|B3|||Age||years|Mean|15.0|15.0|Standard Deviation|1.4|1.4|||
3835447|NCT01696357|3661991|B2|||Age||years|Mean|14.8|14.8|Standard Deviation|1.3|1.3|||
3835448|NCT01696357|3661992|B1|||Age||years|Mean|15.2|15.2|Standard Deviation|1.5|1.5|||
3835449|NCT01696214|3661999|B5|United States||Region of Enrollment||participants|Number|19|19.0||||||
3835450|NCT01696214|3662000|B4|United States||Region of Enrollment||participants|Number|5|5.0||||||
3835451|NCT01696214|3662001|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3835452|NCT01696214|3662002|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3835453|NCT01696214|3662003|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3835454|NCT01696214|3661999|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3835455|NCT01696214|3662000|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3835456|NCT01696214|3662001|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3835457|NCT01696214|3662002|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3835458|NCT01696214|3662003|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3835459|NCT01696214|3661999|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3835460|NCT01696214|3662000|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3835461|NCT01696214|3662001|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3835462|NCT01696214|3662002|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3835463|NCT01696214|3662003|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3835464|NCT01696214|3661999|B5|||Age||years|Median|41|41.0|Full Range|||26.0|50.0|
3835465|NCT01696214|3662000|B4|||Age||years|Median|28|28.0|Full Range|||26.0|50.0|
3835466|NCT01696214|3662001|B3|||Age||years|Median|39|39.0|Full Range|||28.0|50.0|
3835467|NCT01696214|3662002|B2|||Age||years|Median|48|48.0|Full Range|||44.0|50.0|
3835468|NCT01696214|3662003|B1|||Age||years|Median|49|49.0|Full Range|||42.0|50.0|
3835469|NCT01696214|3661999|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3835470|NCT01696214|3662000|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3835471|NCT01696214|3662001|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3835472|NCT01696214|3662002|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3835473|NCT01696214|3662003|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3835474|NCT01696214|3661999|B5||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3835475|NCT01696214|3662000|B4||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3835476|NCT01696214|3662001|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3835477|NCT01696214|3662002|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3835478|NCT01696214|3662003|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3835479|NCT01696214|3661999|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3835480|NCT01696214|3662000|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3835481|NCT01696214|3662001|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3835482|NCT01696214|3662002|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3835483|NCT01696214|3662003|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3835484|NCT01696188|3662024|B3|United States||Region of Enrollment||participants|Number|82|82.0||||||
3835485|NCT01696188|3662025|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
3835486|NCT01696188|3662026|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3835487|NCT01696188|3662024|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3835488|NCT01696188|3662025|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3835489|NCT01696188|3662026|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3835490|NCT01696188|3662024|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3835491|NCT01696188|3662025|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3835492|NCT01696188|3662026|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3835493|NCT01696188|3662024|B3|||Age||years|Mean|65.2|65.2|Standard Deviation|11.4|11.4|||
3835494|NCT01696188|3662025|B2|||Age||years|Mean|63.8|63.8|Standard Deviation|12|12.0|||
3835495|NCT01696188|3662026|B1|||Age||years|Mean|67.1|67.1|Standard Deviation|10.7|10.7|||
3835496|NCT01696084|3662039|B3||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
3835497|NCT01696084|3662040|B2||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3835498|NCT01696084|3662041|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3835499|NCT01696084|3662039|B3||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3835500|NCT01696084|3662040|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3835501|NCT01696084|3662041|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3835502|NCT01696084|3662039|B3|||Age||years|Mean|67.7|67.7|Standard Deviation|4.14|4.14|||
3835503|NCT01696084|3662040|B2|||Age||years|Mean|67.7|67.7|Standard Deviation|4.1|4.1|||
3835504|NCT01696084|3662041|B1|||Age||years|Mean|67.8|67.8|Standard Deviation|4.19|4.19|||
3835505|NCT01696071|3662058|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3835506|NCT01696071|3662058|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3835507|NCT01696071|3662058|B1|||Age||years|Mean|43.8|43.8|Standard Deviation|12.1|12.1|||
3835508|NCT01696058|3662085|B3||Male|Sex: Female, Male||Participants|Count of Participants|608|608.0||||||
3835509|NCT01696058|3662086|B2||Male|Sex: Female, Male||Participants|Count of Participants|303|303.0||||||
3835510|NCT01696058|3662087|B1||Male|Sex: Female, Male||Participants|Count of Participants|305|305.0||||||
3835511|NCT01696058|3662085|B3||Female|Sex: Female, Male||Participants|Count of Participants|527|527.0||||||
3835512|NCT01696058|3662086|B2||Female|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
3835513|NCT01696058|3662087|B1||Female|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
3835514|NCT01696058|3662085|B3|||Age||years|Mean|64.1|64.1|Standard Deviation|9.0|9.0|||
3835515|NCT01696058|3662086|B2|||Age||years|Mean|63.6|63.6|Standard Deviation|8.9|8.9|||
3835516|NCT01696058|3662087|B1|||Age||years|Mean|64.6|64.6|Standard Deviation|9.0|9.0|||
3835517|NCT01696045|3662114|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835518|NCT01696045|3662115|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835519|NCT01696045|3662116|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835520|NCT01696045|3662114|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835521|NCT01696045|3662115|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835522|NCT01696045|3662116|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835523|NCT01696045|3662114|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3835524|NCT01696045|3662115|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3835525|NCT01696045|3662116|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3835526|NCT01696045|3662114|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3835527|NCT01696045|3662115|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835528|NCT01696045|3662116|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3835529|NCT01696045|3662114|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835530|NCT01696045|3662115|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835531|NCT01696045|3662116|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835532|NCT01696045|3662114|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835533|NCT01696045|3662115|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835534|NCT01696045|3662116|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835535|NCT01696045|3662114|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835536|NCT01696045|3662115|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835537|NCT01696045|3662116|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835538|NCT01696045|3662114|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3835539|NCT01696045|3662115|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3835540|NCT01696045|3662116|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3835541|NCT01696045|3662114|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3835542|NCT01696045|3662115|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3835543|NCT01696045|3662116|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3835544|NCT01696045|3662114|B3|||Age||years|Mean|14.3|14.3|Standard Deviation|1.37|1.37|||
3835545|NCT01696045|3662115|B2|||Age||years|Mean|14.9|14.9|Standard Deviation|0.64|0.64|||
3835546|NCT01696045|3662116|B1|||Age||years|Mean|13.3|13.3|Standard Deviation|1.89|1.89|||
3835547|NCT01695993|3662133|B4|United States||Region of Enrollment||participants|Number|226|226.0||||||
3835548|NCT01695993|3662134|B3|United States||Region of Enrollment||participants|Number|75|75.0||||||
3835549|NCT01695993|3662135|B2|United States||Region of Enrollment||participants|Number|75|75.0||||||
3835550|NCT01695993|3662136|B1|United States||Region of Enrollment||participants|Number|76|76.0||||||
3835551|NCT01695993|3662133|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3835552|NCT01695993|3662134|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3835553|NCT01695993|3662135|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3835554|NCT01695993|3662136|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835555|NCT01695993|3662133|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835556|NCT01695993|3662134|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835557|NCT01695993|3662135|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835558|NCT01695993|3662136|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835559|NCT01695993|3662133|B4||White|Race (NIH/OMB)||Participants|Count of Participants|199|199.0||||||
3835560|NCT01695993|3662134|B3||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3835561|NCT01695993|3662135|B2||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3835562|NCT01695993|3662136|B1||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3835563|NCT01695993|3662133|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3835564|NCT01695993|3662134|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3835565|NCT01695993|3662135|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3835566|NCT01695993|3662136|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3835567|NCT01695993|3662133|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835568|NCT01695993|3662134|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835569|NCT01695993|3662135|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835570|NCT01695993|3662136|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835571|NCT01695993|3662133|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3835572|NCT01695993|3662134|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3835573|NCT01695993|3662135|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3835574|NCT01695993|3662136|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3835575|NCT01695993|3662133|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3835576|NCT01695993|3662134|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3835577|NCT01695993|3662135|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3835578|NCT01695993|3662136|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835579|NCT01695993|3662133|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3835580|NCT01695993|3662134|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3835581|NCT01695993|3662135|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835582|NCT01695993|3662136|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835583|NCT01695993|3662133|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|220|220.0||||||
3835584|NCT01695993|3662134|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3835710|NCT01695239|3662206|B2|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
3835585|NCT01695993|3662135|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3835586|NCT01695993|3662136|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3835587|NCT01695993|3662133|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3835588|NCT01695993|3662134|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3835589|NCT01695993|3662135|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3835590|NCT01695993|3662136|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3835591|NCT01695993|3662133|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3835592|NCT01695993|3662134|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3835593|NCT01695993|3662135|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3835594|NCT01695993|3662136|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3835595|NCT01695993|3662133|B4||Female|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
3835596|NCT01695993|3662134|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3835597|NCT01695993|3662135|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3835598|NCT01695993|3662136|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3835599|NCT01695993|3662133|B4|||Age||years|Mean|53|53.0|Standard Deviation|11.2|11.2|||
3835600|NCT01695993|3662134|B3|||Age||years|Mean|52.6|52.6|Standard Deviation|10.5|10.5|||
3835601|NCT01695993|3662135|B2|||Age||years|Mean|53.2|53.2|Standard Deviation|11.6|11.6|||
3835602|NCT01695993|3662136|B1|||Age||years|Mean|53.2|53.2|Standard Deviation|11.5|11.5|||
3835603|NCT01695772|3662146|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3835604|NCT01695772|3662146|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3835605|NCT01695772|3662146|B1|||Age||years|Mean|56.1|56.1|Standard Deviation|9.71|9.71|||
3835606|NCT01695746|3662158|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3835607|NCT01695746|3662158|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3835608|NCT01695746|3662158|B1|||Age||years|Mean|55.5|55.5|Standard Deviation|7.178|7.178|||
3835609|NCT01695668|3662172|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3835610|NCT01695668|3662173|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3835611|NCT01695668|3662174|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3835612|NCT01695668|3662172|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3835613|NCT01695668|3662173|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3835614|NCT01695668|3662174|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3835615|NCT01695668|3662172|B3|||Age||years|Mean|52.64|52.64|Standard Deviation|14.06|14.06|||
3835616|NCT01695668|3662173|B2|||Age||years|Mean|51.21|51.21|Standard Deviation|14.44|14.44|||
3835617|NCT01695668|3662174|B1|||Age||years|Mean|54.06|54.06|Standard Deviation|13.68|13.68|||
3835618|NCT01695668|3662172|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3835619|NCT01695668|3662173|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3835620|NCT01695668|3662174|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3835621|NCT01695668|3662172|B3||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
3835622|NCT01695668|3662173|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3835623|NCT01695668|3662174|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3835624|NCT01695668|3662172|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3835625|NCT01695668|3662173|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3835626|NCT01695668|3662174|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3835627|NCT01695369|3662181|B1|United States||Region of Enrollment||participants|Number|61|61.0||||||
3835628|NCT01695369|3662181|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3835629|NCT01695369|3662181|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3835630|NCT01695369|3662181|B1|||Age||years|Mean|26|26.0|Standard Deviation|6|6.0|||
3835631|NCT01695369|3662181|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3835632|NCT01695369|3662181|B1||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
3835633|NCT01695369|3662181|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3835634|NCT01695330|3662187|B1|||The patients were required to have received a prior IV bortezomib containing combination regimen tha||participants|Number|5|5.0||||||
3835635|NCT01695330|3662187|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3835636|NCT01695330|3662187|B1||Male|Gender||Participants|Count of Participants|2|2.0||||||
3835637|NCT01695330|3662187|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
3835638|NCT01695330|3662187|B1|||Age||years|Median|62|62.0|Standard Deviation|5.1|5.1|||
3835639|NCT01695330|3662187|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3835640|NCT01695330|3662187|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3835641|NCT01695330|3662187|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3835642|NCT01695304|3662192|B3|Kenya||Region of Enrollment||participants|Number|240|240.0||||||
3835643|NCT01695304|3662193|B2|Kenya||Region of Enrollment||participants|Number|120|120.0||||||
3835644|NCT01695304|3662194|B1|Kenya||Region of Enrollment||participants|Number|120|120.0||||||
3835645|NCT01695304|3662192|B3|Luo ethnic group||Race/Ethnicity, Customized||participants|Number|240|240.0||||||
3835646|NCT01695304|3662193|B2|Luo ethnic group||Race/Ethnicity, Customized||participants|Number|120|120.0||||||
3835647|NCT01695304|3662194|B1|Luo ethnic group||Race/Ethnicity, Customized||participants|Number|120|120.0||||||
3835648|NCT01695304|3662192|B3||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3835649|NCT01695304|3662193|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3835650|NCT01695304|3662194|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3835651|NCT01695304|3662192|B3||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3835652|NCT01695304|3662193|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3835653|NCT01695304|3662194|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3835654|NCT01695304|3662192|B3|||Age||months|Median|7.5|7.5|Full Range|||4.0|10.0|
3835655|NCT01695304|3662193|B2|||Age||months|Median|8|8.0|Full Range|||4.0|10.0|
3835656|NCT01695304|3662194|B1|||Age||months|Median|7|7.0|Full Range|||4.0|10.0|
3835657|NCT01695239|3662203|B5|Estonia||Region of Enrollment||participants|Number|29|29.0||||||
3835658|NCT01695239|3662204|B4|Estonia||Region of Enrollment||participants|Number|8|8.0||||||
3835659|NCT01695239|3662205|B3|Estonia||Region of Enrollment||participants|Number|8|8.0||||||
3835660|NCT01695239|3662206|B2|Estonia||Region of Enrollment||participants|Number|7|7.0||||||
3835661|NCT01695239|3662207|B1|Estonia||Region of Enrollment||participants|Number|6|6.0||||||
3835662|NCT01695239|3662203|B5|Bulgaria||Region of Enrollment||participants|Number|16|16.0||||||
3835663|NCT01695239|3662204|B4|Bulgaria||Region of Enrollment||participants|Number|4|4.0||||||
3835664|NCT01695239|3662205|B3|Bulgaria||Region of Enrollment||participants|Number|5|5.0||||||
3835665|NCT01695239|3662206|B2|Bulgaria||Region of Enrollment||participants|Number|4|4.0||||||
3835666|NCT01695239|3662207|B1|Bulgaria||Region of Enrollment||participants|Number|3|3.0||||||
3835667|NCT01695239|3662203|B5|France||Region of Enrollment||participants|Number|3|3.0||||||
3835668|NCT01695239|3662204|B4|France||Region of Enrollment||participants|Number|1|1.0||||||
3835669|NCT01695239|3662205|B3|France||Region of Enrollment||participants|Number|1|1.0||||||
3835670|NCT01695239|3662206|B2|France||Region of Enrollment||participants|Number|0|0.0||||||
3835671|NCT01695239|3662207|B1|France||Region of Enrollment||participants|Number|1|1.0||||||
3835672|NCT01695239|3662203|B5|Mexico||Region of Enrollment||participants|Number|12|12.0||||||
3835673|NCT01695239|3662204|B4|Mexico||Region of Enrollment||participants|Number|2|2.0||||||
3835674|NCT01695239|3662205|B3|Mexico||Region of Enrollment||participants|Number|3|3.0||||||
3835675|NCT01695239|3662206|B2|Mexico||Region of Enrollment||participants|Number|4|4.0||||||
3835676|NCT01695239|3662207|B1|Mexico||Region of Enrollment||participants|Number|3|3.0||||||
3835677|NCT01695239|3662203|B5|Poland||Region of Enrollment||participants|Number|60|60.0||||||
3835678|NCT01695239|3662204|B4|Poland||Region of Enrollment||participants|Number|15|15.0||||||
3835679|NCT01695239|3662205|B3|Poland||Region of Enrollment||participants|Number|15|15.0||||||
3835680|NCT01695239|3662206|B2|Poland||Region of Enrollment||participants|Number|14|14.0||||||
3835681|NCT01695239|3662207|B1|Poland||Region of Enrollment||participants|Number|16|16.0||||||
3835682|NCT01695239|3662203|B5|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
3835683|NCT01695239|3662204|B4|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
3835684|NCT01695239|3662205|B3|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
3835685|NCT01695239|3662206|B2|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
3835686|NCT01695239|3662207|B1|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
3835687|NCT01695239|3662203|B5|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
3835688|NCT01695239|3662204|B4|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
3835689|NCT01695239|3662205|B3|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
3835690|NCT01695239|3662206|B2|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
3835691|NCT01695239|3662207|B1|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
3835692|NCT01695239|3662203|B5|Czech Republic||Region of Enrollment||participants|Number|92|92.0||||||
3835693|NCT01695239|3662204|B4|Czech Republic||Region of Enrollment||participants|Number|22|22.0||||||
3835694|NCT01695239|3662205|B3|Czech Republic||Region of Enrollment||participants|Number|23|23.0||||||
3835695|NCT01695239|3662206|B2|Czech Republic||Region of Enrollment||participants|Number|25|25.0||||||
3835696|NCT01695239|3662207|B1|Czech Republic||Region of Enrollment||participants|Number|22|22.0||||||
3835697|NCT01695239|3662203|B5|Canada||Region of Enrollment||participants|Number|4|4.0||||||
3835698|NCT01695239|3662204|B4|Canada||Region of Enrollment||participants|Number|0|0.0||||||
3835699|NCT01695239|3662205|B3|Canada||Region of Enrollment||participants|Number|2|2.0||||||
3835700|NCT01695239|3662206|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3835701|NCT01695239|3662207|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3835702|NCT01695239|3662203|B5|Spain||Region of Enrollment||participants|Number|13|13.0||||||
3835703|NCT01695239|3662204|B4|Spain||Region of Enrollment||participants|Number|4|4.0||||||
3835704|NCT01695239|3662205|B3|Spain||Region of Enrollment||participants|Number|3|3.0||||||
3835705|NCT01695239|3662206|B2|Spain||Region of Enrollment||participants|Number|2|2.0||||||
3835706|NCT01695239|3662207|B1|Spain||Region of Enrollment||participants|Number|4|4.0||||||
3835707|NCT01695239|3662203|B5|United Kingdom||Region of Enrollment||participants|Number|17|17.0||||||
3835708|NCT01695239|3662204|B4|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3835709|NCT01695239|3662205|B3|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
3835711|NCT01695239|3662207|B1|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3835712|NCT01695239|3662203|B5|Ukraine||Region of Enrollment||participants|Number|35|35.0||||||
3835713|NCT01695239|3662204|B4|Ukraine||Region of Enrollment||participants|Number|10|10.0||||||
3835714|NCT01695239|3662205|B3|Ukraine||Region of Enrollment||participants|Number|9|9.0||||||
3835715|NCT01695239|3662206|B2|Ukraine||Region of Enrollment||participants|Number|7|7.0||||||
3835716|NCT01695239|3662207|B1|Ukraine||Region of Enrollment||participants|Number|9|9.0||||||
3835717|NCT01695239|3662203|B5|Japan||Region of Enrollment||participants|Number|12|12.0||||||
3835718|NCT01695239|3662204|B4|Japan||Region of Enrollment||participants|Number|4|4.0||||||
3835719|NCT01695239|3662205|B3|Japan||Region of Enrollment||participants|Number|2|2.0||||||
3835720|NCT01695239|3662206|B2|Japan||Region of Enrollment||participants|Number|2|2.0||||||
3835721|NCT01695239|3662207|B1|Japan||Region of Enrollment||participants|Number|4|4.0||||||
3835722|NCT01695239|3662203|B5|United States||Region of Enrollment||participants|Number|83|83.0||||||
3835723|NCT01695239|3662204|B4|United States||Region of Enrollment||participants|Number|20|20.0||||||
3835724|NCT01695239|3662205|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3835725|NCT01695239|3662206|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
3835726|NCT01695239|3662207|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3835727|NCT01695239|3662203|B5|Russian Federation||Region of Enrollment||participants|Number|34|34.0||||||
3835728|NCT01695239|3662204|B4|Russian Federation||Region of Enrollment||participants|Number|8|8.0||||||
3835729|NCT01695239|3662205|B3|Russian Federation||Region of Enrollment||participants|Number|10|10.0||||||
3835730|NCT01695239|3662206|B2|Russian Federation||Region of Enrollment||participants|Number|7|7.0||||||
3835731|NCT01695239|3662207|B1|Russian Federation||Region of Enrollment||participants|Number|9|9.0||||||
3835732|NCT01695239|3662203|B5|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
3835733|NCT01695239|3662204|B4|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3835734|NCT01695239|3662205|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3835735|NCT01695239|3662206|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3835736|NCT01695239|3662207|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3835737|NCT01695239|3662203|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|356|356.0||||||
3835738|NCT01695239|3662204|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|87|87.0||||||
3835739|NCT01695239|3662205|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|94|94.0||||||
3835740|NCT01695239|3662206|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
3835741|NCT01695239|3662207|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|92|92.0||||||
3835742|NCT01695239|3662203|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3835743|NCT01695239|3662204|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3835744|NCT01695239|3662205|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3835745|NCT01695239|3662206|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3835746|NCT01695239|3662207|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3835747|NCT01695239|3662203|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835748|NCT01695239|3662204|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835749|NCT01695239|3662205|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835750|NCT01695239|3662206|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835751|NCT01695239|3662207|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835752|NCT01695239|3662203|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3835753|NCT01695239|3662204|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835754|NCT01695239|3662205|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3835755|NCT01695239|3662206|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835756|NCT01695239|3662207|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835757|NCT01695239|3662203|B5||White|Race (NIH/OMB)||Participants|Count of Participants|392|392.0||||||
3835758|NCT01695239|3662204|B4||White|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3835759|NCT01695239|3662205|B3||White|Race (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
3835760|NCT01695239|3662206|B2||White|Race (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3835761|NCT01695239|3662207|B1||White|Race (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3835762|NCT01695239|3662203|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835763|NCT01695239|3662204|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835764|NCT01695239|3662205|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835765|NCT01695239|3662206|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835766|NCT01695239|3662207|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835767|NCT01695239|3662203|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835768|NCT01695239|3662204|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835769|NCT01695239|3662205|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835770|NCT01695239|3662206|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835771|NCT01695239|3662207|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835772|NCT01695239|3662203|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3835773|NCT01695239|3662204|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3835774|NCT01695239|3662205|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3835775|NCT01695239|3662206|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3835776|NCT01695239|3662207|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3835777|NCT01695239|3662203|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3835778|NCT01695239|3662204|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3835779|NCT01695239|3662205|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3835780|NCT01695239|3662206|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3835781|NCT01695239|3662207|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3835782|NCT01695239|3662203|B5||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
3835783|NCT01695239|3662204|B4||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3835784|NCT01695239|3662205|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3835785|NCT01695239|3662206|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3835786|NCT01695239|3662207|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3835787|NCT01695239|3662203|B5||Female|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
3835788|NCT01695239|3662204|B4||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3835789|NCT01695239|3662205|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3835790|NCT01695239|3662206|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3835791|NCT01695239|3662207|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3835792|NCT01695239|3662203|B5|||Age||years|Mean|49.52|49.52|Standard Deviation|11.87|11.87|||
3835793|NCT01695239|3662204|B4|||Age||years|Mean|49.79|49.79|Standard Deviation|12.62|12.62|||
3835794|NCT01695239|3662205|B3|||Age||years|Mean|49.07|49.07|Standard Deviation|10.07|10.07|||
3835795|NCT01695239|3662206|B2|||Age||years|Mean|48.58|48.58|Standard Deviation|12.43|12.43|||
3835796|NCT01695239|3662207|B1|||Age||years|Mean|50.60|50.6|Standard Deviation|12.32|12.32|||
3835797|NCT01695044|3662299|B3|||PSA||ug/mL|Median|162.9|162.9|Full Range|||1.4|17459.6|
3835798|NCT01695044|3662300|B2|||PSA||ug/mL|Median|94.1|94.1|Full Range|||1.4|2307.8|
3835799|NCT01695044|3662301|B1|||PSA||ug/mL|Median|188.9|188.9|Full Range|||7.5|17459.6|
3835800|NCT01695044|3662299|B3|||Prostate specific antigen (PSA)||ug/mL|Mean|633.1|633.1|Standard Deviation|1857.2|1857.2|||
3835801|NCT01695044|3662300|B2|||Prostate specific antigen (PSA)||ug/mL|Mean|220.9|220.9|Standard Deviation|438.35|438.35|||
3835802|NCT01695044|3662301|B1|||Prostate specific antigen (PSA)||ug/mL|Mean|804.8|804.8|Standard Deviation|2173.38|2173.38|||
3835803|NCT01695044|3662299|B3||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3835804|NCT01695044|3662300|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3835805|NCT01695044|3662301|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3835806|NCT01695044|3662299|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3835807|NCT01695044|3662300|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3835808|NCT01695044|3662301|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3835809|NCT01695044|3662299|B3|||Age||years|Mean|71.4|71.4|Full Range|||50.0|91.0|
3835810|NCT01695044|3662300|B2|||Age||years|Mean|73.1|73.1|Full Range|||50.0|87.0|
3835811|NCT01695044|3662301|B1|||Age||years|Mean|70.7|70.7|Full Range|||50.0|91.0|
3835812|NCT01694966|3662311|B4||Male|Sex: Female, Male||Participants|Count of Participants|727|727.0||||||
3835813|NCT01694966|3662312|B3||Male|Sex: Female, Male||Participants|Count of Participants|295|295.0||||||
3835814|NCT01694966|3662313|B2||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3835815|NCT01694966|3662314|B1||Male|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
3835816|NCT01694966|3662311|B4||Female|Sex: Female, Male||Participants|Count of Participants|478|478.0||||||
3835817|NCT01694966|3662312|B3||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3835818|NCT01694966|3662313|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3835819|NCT01694966|3662314|B1||Female|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
3835820|NCT01694966|3662311|B4||>=65 years|Age||Participants|Count of Participants|431|431.0||||||
3835821|NCT01694966|3662312|B3||>=65 years|Age||Participants|Count of Participants|181|181.0||||||
3835822|NCT01694966|3662313|B2||>=65 years|Age||Participants|Count of Participants|78|78.0||||||
3835823|NCT01694966|3662314|B1||>=65 years|Age||Participants|Count of Participants|172|172.0||||||
3835824|NCT01694966|3662311|B4||Between 18 and 65 years|Age||Participants|Count of Participants|774|774.0||||||
3835825|NCT01694966|3662312|B3||Between 18 and 65 years|Age||Participants|Count of Participants|298|298.0||||||
3835826|NCT01694966|3662313|B2||Between 18 and 65 years|Age||Participants|Count of Participants|163|163.0||||||
3835827|NCT01694966|3662314|B1||Between 18 and 65 years|Age||Participants|Count of Participants|313|313.0||||||
3835828|NCT01694966|3662311|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3835829|NCT01694966|3662312|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3835830|NCT01694966|3662313|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3835831|NCT01694966|3662314|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3835832|NCT01694771|3662324|B3||Male|Sex: Female, Male||Participants|Count of Participants|564|564.0||||||
3835833|NCT01694771|3662325|B2||Male|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
3835834|NCT01694771|3662326|B1||Male|Sex: Female, Male||Participants|Count of Participants|279|279.0||||||
3835835|NCT01694771|3662324|B3||Female|Sex: Female, Male||Participants|Count of Participants|568|568.0||||||
3835836|NCT01694771|3662325|B2||Female|Sex: Female, Male||Participants|Count of Participants|280|280.0||||||
3835837|NCT01694771|3662326|B1||Female|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
3835838|NCT01694771|3662324|B3|||Age||years|Mean|64.6|64.6|Standard Deviation|9.1|9.1|||
3835839|NCT01694771|3662325|B2|||Age||years|Mean|64.8|64.8|Standard Deviation|9.1|9.1|||
3835840|NCT01694771|3662326|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|9.1|9.1|||
3835841|NCT01694706|3662351|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3835842|NCT01694706|3662351|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3835843|NCT01694706|3662351|B1|||Age||years|Mean|34.7|34.7|Standard Deviation|8.2|8.2|||
3835844|NCT01694667|3662368|B3|||ABC-Inappropriate Speech|"Aberrant Behavior Checklist – measures problem behaviors independently and commonly used in children with autism 5 subscales are included and for each higher scores are worse. Each item uses a 0 to 3 Likert scale~Hyperactivity – 16 items, score ranges from 0-48~Irritability – 15 items, score ranges from 0-45~Stereotypy – 7 questions, score ranges from 0-21~Lethargy – 16 questions, score ranges from 0-48~Inappropriate speech – 4 questions, score ranges from 0-12~Subscales were not combined to compute a total score."|units on a scale|Mean|6.4|6.4|Standard Deviation|3.2|3.2|||
3835845|NCT01694667|3662369|B2|||ABC-Inappropriate Speech|"Aberrant Behavior Checklist – measures problem behaviors independently and commonly used in children with autism 5 subscales are included and for each higher scores are worse. Each item uses a 0 to 3 Likert scale~Hyperactivity – 16 items, score ranges from 0-48~Irritability – 15 items, score ranges from 0-45~Stereotypy – 7 questions, score ranges from 0-21~Lethargy – 16 questions, score ranges from 0-48~Inappropriate speech – 4 questions, score ranges from 0-12~Subscales were not combined to compute a total score."|units on a scale|Mean|5.8|5.8|Standard Deviation|2.8|2.8|||
3835846|NCT01694667|3662370|B1|||ABC-Inappropriate Speech|"Aberrant Behavior Checklist – measures problem behaviors independently and commonly used in children with autism 5 subscales are included and for each higher scores are worse. Each item uses a 0 to 3 Likert scale~Hyperactivity – 16 items, score ranges from 0-48~Irritability – 15 items, score ranges from 0-45~Stereotypy – 7 questions, score ranges from 0-21~Lethargy – 16 questions, score ranges from 0-48~Inappropriate speech – 4 questions, score ranges from 0-12~Subscales were not combined to compute a total score."|units on a scale|Mean|7.0|7.0|Standard Deviation|3.4|3.4|||
3835847|NCT01694667|3662368|B3|||ABC-Lethargy|"Aberrant Behavior Checklist – measures problem behaviors independently and commonly used in children with autism 5 subscales are included and for each higher scores are worse. Each item uses a 0 to 3 Likert scale~Hyperactivity – 16 items, score ranges from 0-48~Irritability – 15 items, score ranges from 0-45~Stereotypy – 7 questions, score ranges from 0-21~Lethargy – 16 questions, score ranges from 0-48~Inappropriate speech – 4 questions, score ranges from 0-12~Subscales were not combined to compute a total score."|units on a scale|Mean|10.5|10.5|Standard Deviation|7.1|7.1|||
3835848|NCT01694667|3662369|B2|||ABC-Lethargy|"Aberrant Behavior Checklist – measures problem behaviors independently and commonly used in children with autism 5 subscales are included and for each higher scores are worse. Each item uses a 0 to 3 Likert scale~Hyperactivity – 16 items, score ranges from 0-48~Irritability – 15 items, score ranges from 0-45~Stereotypy – 7 questions, score ranges from 0-21~Lethargy – 16 questions, score ranges from 0-48~Inappropriate speech – 4 questions, score ranges from 0-12~Subscales were not combined to compute a total score."|units on a scale|Mean|8.8|8.8|Standard Deviation|4.2|4.2|||
3835849|NCT01694667|3662370|B1|||ABC-Lethargy|"Aberrant Behavior Checklist – measures problem behaviors independently and commonly used in children with autism 5 subscales are included and for each higher scores are worse. Each item uses a 0 to 3 Likert scale~Hyperactivity – 16 items, score ranges from 0-48~Irritability – 15 items, score ranges from 0-45~Stereotypy – 7 questions, score ranges from 0-21~Lethargy – 16 questions, score ranges from 0-48~Inappropriate speech – 4 questions, score ranges from 0-12~Subscales were not combined to compute a total score."|units on a scale|Mean|12.2|12.2|Standard Deviation|8.8|8.8|||
3835850|NCT01694667|3662368|B3|||ABC-Stereotypy|"Aberrant Behavior Checklist – measures problem behaviors independently and commonly used in children with autism 5 subscales are included and for each higher scores are worse. Each item uses a 0 to 3 Likert scale~Hyperactivity – 16 items, score ranges from 0-48~Irritability – 15 items, score ranges from 0-45~Stereotypy – 7 questions, score ranges from 0-21~Lethargy – 16 questions, score ranges from 0-48~Inappropriate speech – 4 questions, score ranges from 0-12~Subscales were not combined to compute a total score."|units on a scale|Mean|6.7|6.7|Standard Deviation|5.5|5.5|||
3835851|NCT01694667|3662369|B2|||ABC-Stereotypy|"Aberrant Behavior Checklist – measures problem behaviors independently and commonly used in children with autism 5 subscales are included and for each higher scores are worse. Each item uses a 0 to 3 Likert scale~Hyperactivity – 16 items, score ranges from 0-48~Irritability – 15 items, score ranges from 0-45~Stereotypy – 7 questions, score ranges from 0-21~Lethargy – 16 questions, score ranges from 0-48~Inappropriate speech – 4 questions, score ranges from 0-12~Subscales were not combined to compute a total score."|units on a scale|Mean|5.4|5.4|Standard Deviation|4.7|4.7|||
3835852|NCT01694667|3662370|B1|||ABC-Stereotypy|"Aberrant Behavior Checklist – measures problem behaviors independently and commonly used in children with autism 5 subscales are included and for each higher scores are worse. Each item uses a 0 to 3 Likert scale~Hyperactivity – 16 items, score ranges from 0-48~Irritability – 15 items, score ranges from 0-45~Stereotypy – 7 questions, score ranges from 0-21~Lethargy – 16 questions, score ranges from 0-48~Inappropriate speech – 4 questions, score ranges from 0-12~Subscales were not combined to compute a total score."|units on a scale|Mean|8.0|8.0|Standard Deviation|6.0|6.0|||
3835853|NCT01694667|3662368|B3|||ABC-Irritability|"Aberrant Behavior Checklist – measures problem behaviors independently and commonly used in children with autism 5 subscales are included and for each higher scores are worse. Each item uses a 0 to 3 Likert scale~Hyperactivity – 16 items, score ranges from 0-48~Irritability – 15 items, score ranges from 0-45~Stereotypy – 7 questions, score ranges from 0-21~Lethargy – 16 questions, score ranges from 0-48~Inappropriate speech – 4 questions, score ranges from 0-12~Subscales were not combined to compute a total score."|units on a scale|Mean|18.4|18.4|Standard Deviation|8.7|8.7|||
3835854|NCT01694667|3662369|B2|||ABC-Irritability|"Aberrant Behavior Checklist – measures problem behaviors independently and commonly used in children with autism 5 subscales are included and for each higher scores are worse. Each item uses a 0 to 3 Likert scale~Hyperactivity – 16 items, score ranges from 0-48~Irritability – 15 items, score ranges from 0-45~Stereotypy – 7 questions, score ranges from 0-21~Lethargy – 16 questions, score ranges from 0-48~Inappropriate speech – 4 questions, score ranges from 0-12~Subscales were not combined to compute a total score."|units on a scale|Mean|16.8|16.8|Standard Deviation|8.3|8.3|||
3835855|NCT01694667|3662370|B1|||ABC-Irritability|"Aberrant Behavior Checklist – measures problem behaviors independently and commonly used in children with autism 5 subscales are included and for each higher scores are worse. Each item uses a 0 to 3 Likert scale~Hyperactivity – 16 items, score ranges from 0-48~Irritability – 15 items, score ranges from 0-45~Stereotypy – 7 questions, score ranges from 0-21~Lethargy – 16 questions, score ranges from 0-48~Inappropriate speech – 4 questions, score ranges from 0-12~Subscales were not combined to compute a total score."|units on a scale|Mean|20.0|20.0|Standard Deviation|8.9|8.9|||
3835856|NCT01694667|3662368|B3|||ABC-Hyperactivity|"Aberrant Behavior Checklist – measures problem behaviors independently and commonly used in children with autism 5 subscales are included and for each higher scores are worse. Each item uses a 0 to 3 Likert scale~Hyperactivity – 16 items, score ranges from 0-48~Irritability – 15 items, score ranges from 0-45~Stereotypy – 7 questions, score ranges from 0-21~Lethargy – 16 questions, score ranges from 0-48~Inappropriate speech – 4 questions, score ranges from 0-12~Subscales were not combined to compute a total score."|units on a scale|Mean|28.2|28.2|Standard Deviation|8.0|8.0|||
3835857|NCT01694667|3662369|B2|||ABC-Hyperactivity|"Aberrant Behavior Checklist – measures problem behaviors independently and commonly used in children with autism 5 subscales are included and for each higher scores are worse. Each item uses a 0 to 3 Likert scale~Hyperactivity – 16 items, score ranges from 0-48~Irritability – 15 items, score ranges from 0-45~Stereotypy – 7 questions, score ranges from 0-21~Lethargy – 16 questions, score ranges from 0-48~Inappropriate speech – 4 questions, score ranges from 0-12~Subscales were not combined to compute a total score."|units on a scale|Mean|28.1|28.1|Standard Deviation|7.6|7.6|||
3835858|NCT01694667|3662370|B1|||ABC-Hyperactivity|"Aberrant Behavior Checklist – measures problem behaviors independently and commonly used in children with autism 5 subscales are included and for each higher scores are worse. Each item uses a 0 to 3 Likert scale~Hyperactivity – 16 items, score ranges from 0-48~Irritability – 15 items, score ranges from 0-45~Stereotypy – 7 questions, score ranges from 0-21~Lethargy – 16 questions, score ranges from 0-48~Inappropriate speech – 4 questions, score ranges from 0-12~Subscales were not combined to compute a total score."|units on a scale|Mean|28.4|28.4|Standard Deviation|8.4|8.4|||
3835859|NCT01694667|3662368|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3835860|NCT01694667|3662369|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3835861|NCT01694667|3662370|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3835862|NCT01694667|3662368|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835863|NCT01694667|3662369|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835864|NCT01694667|3662370|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835865|NCT01694667|3662368|B3||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3835866|NCT01694667|3662369|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3835867|NCT01694667|3662370|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3835868|NCT01694667|3662368|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3835869|NCT01694667|3662369|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3835870|NCT01694667|3662370|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3835871|NCT01694667|3662368|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835872|NCT01694667|3662369|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835873|NCT01694667|3662370|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835874|NCT01694667|3662368|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3835875|NCT01694667|3662369|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3835876|NCT01694667|3662370|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3835877|NCT01694667|3662368|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3835878|NCT01694667|3662369|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835879|NCT01694667|3662370|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3835880|NCT01694667|3662368|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3835881|NCT01694667|3662369|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3835882|NCT01694667|3662370|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3835883|NCT01694667|3662368|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3835884|NCT01694667|3662369|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3835885|NCT01694667|3662370|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3835886|NCT01694667|3662368|B3|||Age||months|Mean|86.6|86.6|Standard Deviation|12.7|12.7|||
3835887|NCT01694667|3662369|B2|||Age||months|Mean|85.0|85.0|Standard Deviation|13.2|13.2|||
3835888|NCT01694667|3662370|B1|||Age||months|Mean|88.2|88.2|Standard Deviation|12.3|12.3|||
3835889|NCT01694641|3662387|B3|Hungary||Region of Enrollment||participants|Number|161|161.0||||||
3835890|NCT01694641|3662388|B2|Hungary||Region of Enrollment||participants|Number|81|81.0||||||
3835891|NCT01694641|3662389|B1|Hungary||Region of Enrollment||participants|Number|80|80.0||||||
3835892|NCT01694641|3662387|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3835893|NCT01694641|3662388|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3835894|NCT01694641|3662389|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3835895|NCT01694641|3662387|B3||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3835896|NCT01694641|3662388|B2||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3835897|NCT01694641|3662389|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3835898|NCT01694641|3662387|B3|||Age||years|Mean|31.7|31.7|Standard Deviation|2.6|2.6|||
3835899|NCT01694641|3662388|B2|||Age||years|Mean|32.1|32.1|Standard Deviation|2.5|2.5|||
3835900|NCT01694641|3662389|B1|||Age||years|Mean|31.2|31.2|Standard Deviation|2.7|2.7|||
3835901|NCT01694641|3662387|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3835902|NCT01694641|3662388|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3835903|NCT01694641|3662389|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3835904|NCT01694641|3662387|B3||Between 18 and 65 years|Age||Participants|Count of Participants|161|161.0||||||
3835905|NCT01694641|3662388|B2||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
3835906|NCT01694641|3662389|B1||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
3835907|NCT01694641|3662387|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3835908|NCT01694641|3662388|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3835909|NCT01694641|3662389|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3835910|NCT01694420|3662398|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3835911|NCT01694420|3662398|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3835912|NCT01694420|3662398|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3835913|NCT01694420|3662398|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3835914|NCT01694420|3662398|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3835915|NCT01694199|3662407|B3|United States||Region of Enrollment||participants|Number|139|139.0||||||
3835916|NCT01694199|3662408|B2|United States||Region of Enrollment||participants|Number|68|68.0||||||
3835917|NCT01694199|3662409|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
3835918|NCT01694199|3662407|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835919|NCT01694199|3662408|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835920|NCT01694199|3662409|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835921|NCT01694199|3662407|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3835922|NCT01694199|3662408|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3835923|NCT01694199|3662409|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835924|NCT01694199|3662407|B3||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3835925|NCT01694199|3662408|B2||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3835926|NCT01694199|3662409|B1||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3835927|NCT01694199|3662407|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3835928|NCT01694199|3662408|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3835929|NCT01694199|3662409|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3835930|NCT01694199|3662407|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835931|NCT01694199|3662408|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835932|NCT01694199|3662409|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835933|NCT01694199|3662407|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3835934|NCT01694199|3662408|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3835935|NCT01694199|3662409|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3835936|NCT01694199|3662407|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835937|NCT01694199|3662408|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835938|NCT01694199|3662409|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835939|NCT01694199|3662407|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835940|NCT01694199|3662408|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835941|NCT01694199|3662409|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835942|NCT01694199|3662407|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
3835943|NCT01694199|3662408|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3835944|NCT01694199|3662409|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3835945|NCT01694199|3662407|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3835946|NCT01694199|3662408|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3835947|NCT01694199|3662409|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3835948|NCT01694199|3662407|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3835949|NCT01694199|3662408|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3835950|NCT01694199|3662409|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3835951|NCT01694199|3662407|B3||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3835952|NCT01694199|3662408|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3835953|NCT01694199|3662409|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3835954|NCT01694199|3662407|B3|||Age||years|Mean|45|45.0|Standard Deviation|13.5|13.5|||
3835955|NCT01694199|3662408|B2|||Age||years|Mean|44.7|44.7|Standard Deviation|13.35|13.35|||
3835956|NCT01694199|3662409|B1|||Age||years|Mean|46.2|46.2|Standard Deviation|13.61|13.61|||
3835957|NCT01694199|3662407|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3835958|NCT01694199|3662408|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3835959|NCT01694199|3662409|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3835960|NCT01694199|3662407|B3||Between 18 and 65 years|Age||Participants|Count of Participants|135|135.0||||||
3835961|NCT01694199|3662408|B2||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
3835962|NCT01694199|3662409|B1||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
3835963|NCT01694199|3662407|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3835964|NCT01694199|3662408|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3835965|NCT01694199|3662409|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3835966|NCT01694121|3662424|B3|||homeless in a shelter or on the streets in past 90 days||Participants|Count of Participants|220|220.0||||||
3835967|NCT01694121|3662425|B2|||homeless in a shelter or on the streets in past 90 days||Participants|Count of Participants|104|104.0||||||
3835968|NCT01694121|3662426|B1|||homeless in a shelter or on the streets in past 90 days||Participants|Count of Participants|116|116.0||||||
3835969|NCT01694121|3662424|B3|||non-Viral STI||Participants|Count of Participants|106|106.0||||||
3835970|NCT01694121|3662425|B2|||non-Viral STI||Participants|Count of Participants|51|51.0||||||
3835971|NCT01694121|3662426|B1|||non-Viral STI||Participants|Count of Participants|55|55.0||||||
3835972|NCT01694121|3662424|B3|||full time employment status||Participants|Count of Participants|53|53.0||||||
3835973|NCT01694121|3662425|B2|||full time employment status||Participants|Count of Participants|34|34.0||||||
3835974|NCT01694121|3662426|B1|||full time employment status||Participants|Count of Participants|19|19.0||||||
3835975|NCT01694121|3662424|B3|United States||Region of Enrollment||Participants|Count of Participants|454|454.0||||||
3835976|NCT01694121|3662425|B2|United States||Region of Enrollment||Participants|Count of Participants|227|227.0||||||
3835977|NCT01694121|3662426|B1|United States||Region of Enrollment||Participants|Count of Participants|227|227.0||||||
3835978|NCT01694121|3662424|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835979|NCT01694121|3662425|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835980|NCT01694121|3662426|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835981|NCT01694121|3662424|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835982|NCT01694121|3662425|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835983|NCT01694121|3662426|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835984|NCT01694121|3662424|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835985|NCT01694121|3662425|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835986|NCT01694121|3662426|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835987|NCT01694121|3662424|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|454|454.0||||||
3835988|NCT01694121|3662425|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|227|227.0||||||
3835989|NCT01694121|3662426|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|227|227.0||||||
3835990|NCT01694121|3662424|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835991|NCT01694121|3662425|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835992|NCT01694121|3662426|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835993|NCT01694121|3662424|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835994|NCT01694121|3662425|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835995|NCT01694121|3662426|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835996|NCT01694121|3662424|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835997|NCT01694121|3662425|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835998|NCT01694121|3662426|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3835999|NCT01694121|3662424|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836000|NCT01694121|3662425|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836001|NCT01694121|3662426|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836002|NCT01694121|3662424|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|454|454.0||||||
3836003|NCT01694121|3662425|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|227|227.0||||||
3836004|NCT01694121|3662426|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|227|227.0||||||
3836005|NCT01694121|3662424|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836006|NCT01694121|3662425|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836007|NCT01694121|3662426|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836008|NCT01694121|3662424|B3||Male|Sex: Female, Male||Participants|Count of Participants|454|454.0||||||
3836009|NCT01694121|3662425|B2||Male|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
3836010|NCT01694121|3662426|B1||Male|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
3836011|NCT01694121|3662424|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3836012|NCT01694121|3662425|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3836013|NCT01694121|3662426|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3836014|NCT01694121|3662424|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3836015|NCT01694121|3662425|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3836016|NCT01694121|3662426|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3836017|NCT01694121|3662424|B3||Between 18 and 65 years|Age||Participants|Count of Participants|454|454.0||||||
3836018|NCT01694121|3662425|B2||Between 18 and 65 years|Age||Participants|Count of Participants|227|227.0||||||
3836019|NCT01694121|3662426|B1||Between 18 and 65 years|Age||Participants|Count of Participants|227|227.0||||||
3836020|NCT01694121|3662424|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3836021|NCT01694121|3662425|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3836022|NCT01694121|3662426|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3836023|NCT01694108|3662439|B3|||Premature birth||participants|Number|121|121.0||||||
3836024|NCT01694108|3662440|B2|||Premature birth||participants|Number|60|60.0||||||
3836025|NCT01694108|3662441|B1|||Premature birth||participants|Number|61|61.0||||||
3836026|NCT01694108|3662439|B3|Denmark||Region of Enrollment|All three study sites are situated in Denmark.|participants|Number|4184|4184.0||||||
3836027|NCT01694108|3662440|B2|Denmark||Region of Enrollment|All three study sites are situated in Denmark.|participants|Number|2089|2089.0||||||
3836028|NCT01694108|3662441|B1|Denmark||Region of Enrollment|All three study sites are situated in Denmark.|participants|Number|2095|2095.0||||||
3836029|NCT01694108|3662439|B3||Male|Sex: Female, Male|Gender of the child. In multiple births: gender of the first born child.|Participants|Count of Participants|2196|2196.0||||||
3836030|NCT01694108|3662440|B2||Male|Sex: Female, Male|Gender of the child. In multiple births: gender of the first born child.|Participants|Count of Participants|1104|1104.0||||||
3836031|NCT01694108|3662441|B1||Male|Sex: Female, Male|Gender of the child. In multiple births: gender of the first born child.|Participants|Count of Participants|1092|1092.0||||||
3836032|NCT01694108|3662439|B3||Female|Sex: Female, Male|Gender of the child. In multiple births: gender of the first born child.|Participants|Count of Participants|1988|1988.0||||||
3836033|NCT01694108|3662440|B2||Female|Sex: Female, Male|Gender of the child. In multiple births: gender of the first born child.|Participants|Count of Participants|985|985.0||||||
3836034|NCT01694108|3662441|B1||Female|Sex: Female, Male|Gender of the child. In multiple births: gender of the first born child.|Participants|Count of Participants|1003|1003.0||||||
3836035|NCT01694108|3662439|B3|||Age|Maternal age|years|Mean|31.95|31.95|Standard Deviation|4.5|4.5|||
3836036|NCT01694108|3662440|B2|||Age|Maternal age|years|Mean|31.9|31.9|Standard Deviation|4.4|4.4|||
3836037|NCT01694108|3662441|B1|||Age|Maternal age|years|Mean|32.0|32.0|Standard Deviation|4.6|4.6|||
3836038|NCT01693900|3662496|B3|United States||Region of Enrollment||Participants|Count of Participants|49|49.0||||||
3836039|NCT01693900|3662497|B2|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3836040|NCT01693900|3662498|B1|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3836041|NCT01693900|3662496|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3836042|NCT01693900|3662497|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3836043|NCT01693900|3662498|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3836044|NCT01693900|3662496|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3836045|NCT01693900|3662497|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3836046|NCT01693900|3662498|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3836047|NCT01693900|3662496|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3836048|NCT01693900|3662497|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3836049|NCT01693900|3662498|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3836050|NCT01693900|3662496|B3||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3836051|NCT01693900|3662497|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3836052|NCT01693900|3662498|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3836053|NCT01693900|3662496|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3836054|NCT01693900|3662497|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3836055|NCT01693900|3662498|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3836056|NCT01693653|3662511|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3836057|NCT01693653|3662513|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3836058|NCT01693653|3662511|B3|||Race/Ethnicity, Customized||particpants|Number|1|1.0||||||
3836059|NCT01693653|3662513|B1|||Race/Ethnicity, Customized||particpants|Number|1|1.0||||||
3836060|NCT01693653|3662511|B3|||Sex/Gender, Customized||participants|Number|1|1.0||||||
3836061|NCT01693653|3662513|B1|||Sex/Gender, Customized||participants|Number|1|1.0||||||
3836062|NCT01693653|3662511|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3836063|NCT01693653|3662513|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3836064|NCT01693653|3662511|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3836065|NCT01693653|3662513|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3836066|NCT01693653|3662511|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3836067|NCT01693653|3662513|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3836068|NCT01693614|3662538|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3836069|NCT01693614|3662539|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3836070|NCT01693614|3662540|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3836071|NCT01693614|3662541|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3836072|NCT01693614|3662538|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3836073|NCT01693614|3662539|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3836074|NCT01693614|3662540|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3836075|NCT01693614|3662541|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3836076|NCT01693614|3662538|B4|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3836077|NCT01693614|3662539|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3836078|NCT01693614|3662540|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3836079|NCT01693614|3662541|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3836080|NCT01693614|3662538|B4|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|57|57.0||||||
3836081|NCT01693614|3662539|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3836082|NCT01693614|3662540|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3836083|NCT01693614|3662541|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3836084|NCT01693614|3662538|B4||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3836085|NCT01693614|3662539|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3836086|NCT01693614|3662540|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3836087|NCT01693614|3662541|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3836088|NCT01693614|3662538|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3836089|NCT01693614|3662539|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3836090|NCT01693614|3662540|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3836091|NCT01693614|3662541|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3836092|NCT01693614|3662538|B4|||Age||years|Mean|62.9|62.9|Standard Deviation|12.80|12.8|||
3836093|NCT01693614|3662539|B3|||Age||years|Mean|61.4|61.4|Standard Deviation|13.11|13.11|||
3836094|NCT01693614|3662540|B2|||Age||years|Mean|67.9|67.9|Standard Deviation|8.56|8.56|||
3836095|NCT01693614|3662541|B1|||Age||years|Mean|60.0|60.0|Standard Deviation|14.57|14.57|||
3836096|NCT01693484|3662565|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3836097|NCT01693484|3662565|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836098|NCT01693484|3662565|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836099|NCT01693484|3662565|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3836100|NCT01693484|3662565|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3836101|NCT01693484|3662565|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836102|NCT01693484|3662565|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836103|NCT01693484|3662565|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836104|NCT01693484|3662565|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3836105|NCT01693484|3662565|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3836106|NCT01693484|3662565|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3836107|NCT01693484|3662565|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3836108|NCT01693484|3662565|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3836109|NCT01693367|3662569|B3|Germany||Region of Enrollment||participants|Number|4|4.0||||||
3836110|NCT01693367|3662570|B2|Germany||Region of Enrollment||participants|Number|2|2.0||||||
3836111|NCT01693367|3662571|B1|Germany||Region of Enrollment||participants|Number|2|2.0||||||
3836112|NCT01693367|3662569|B3|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
3836113|NCT01693367|3662570|B2|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
3836114|NCT01693367|3662571|B1|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
3836115|NCT01693367|3662569|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3836116|NCT01693367|3662570|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3836117|NCT01693367|3662571|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3836118|NCT01693367|3662569|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3836119|NCT01693367|3662570|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3836120|NCT01693367|3662571|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3836121|NCT01693367|3662569|B3|||Age||years|Mean|60.4|60.4|Full Range|||23.0|85.0|
3836122|NCT01693367|3662570|B2|||Age||years|Mean|55|55.0|Full Range|||23.0|71.0|
3836123|NCT01693367|3662571|B1|||Age||years|Mean|68.5|68.5|Full Range|||52.0|85.0|
3836124|NCT01693367|3662569|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3836125|NCT01693367|3662570|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3836126|NCT01693367|3662571|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3836127|NCT01693367|3662569|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3836128|NCT01693367|3662570|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3836129|NCT01693367|3662571|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3836130|NCT01693367|3662569|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3836131|NCT01693367|3662570|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3836132|NCT01693367|3662571|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3836133|NCT01693185|3662588|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3836134|NCT01693185|3662589|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3836135|NCT01693185|3662590|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3836136|NCT01693185|3662588|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3836137|NCT01693185|3662589|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3836138|NCT01693185|3662590|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3836139|NCT01693185|3662588|B3|||Age||years|Mean|54.8|54.8|Standard Deviation|11.8|11.8|||
3836140|NCT01693185|3662589|B2|||Age||years|Mean|53.0|53.0|Standard Deviation|10.7|10.7|||
3836141|NCT01693185|3662590|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|12.7|12.7|||
3836142|NCT01693120|3662607|B1||long-term persistent atrial fibrillation|Atrial fibrillation type||Participants|Count of Participants|21|21.0||||||
3836143|NCT01693120|3662607|B1||persistent atrial fibrillation|Atrial fibrillation type||Participants|Count of Participants|108|108.0||||||
3836144|NCT01693120|3662607|B1|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
3836145|NCT01693120|3662607|B1|United States||Region of Enrollment||participants|Number|94|94.0||||||
3836146|NCT01693120|3662607|B1|Hungary||Region of Enrollment||participants|Number|5|5.0||||||
3836147|NCT01693120|3662607|B1|Netherlands||Region of Enrollment||participants|Number|13|13.0||||||
3836148|NCT01693120|3662607|B1|Canada||Region of Enrollment||participants|Number|10|10.0||||||
3836149|NCT01693120|3662607|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3836150|NCT01693120|3662607|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836151|NCT01693120|3662607|B1||White|Race (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
3836152|NCT01693120|3662607|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836153|NCT01693120|3662607|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836154|NCT01693120|3662607|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3836155|NCT01693120|3662607|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836156|NCT01693120|3662607|B1||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3836157|NCT01693120|3662607|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3836158|NCT01693120|3662607|B1|||Age||years|Mean|60.6|60.6|Standard Deviation|7.7|7.7|||
3836159|NCT01693068|3662614|B3||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3836160|NCT01693068|3662615|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3836161|NCT01693068|3662616|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3836162|NCT01693068|3662614|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3836163|NCT01693068|3662615|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3836164|NCT01693068|3662616|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3836165|NCT01693068|3662614|B3||>=65 years|Age||Participants|Count of Participants|93|93.0||||||
3836166|NCT01693068|3662615|B2||>=65 years|Age||Participants|Count of Participants|65|65.0||||||
3836167|NCT01693068|3662616|B1||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
3836168|NCT01693068|3662614|B3||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
3836169|NCT01693068|3662615|B2||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
3836170|NCT01693068|3662616|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3836171|NCT01693068|3662614|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3836172|NCT01693068|3662615|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3836173|NCT01693068|3662616|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3836174|NCT01693029|3662648|B3||Peritoneal dialysis|Method of dialysis at Baseline||Participants|Count of Participants|51|51.0||||||
3836175|NCT01693029|3662649|B2||Peritoneal dialysis|Method of dialysis at Baseline||Participants|Count of Participants|26|26.0||||||
3836176|NCT01693029|3662650|B1||Peritoneal dialysis|Method of dialysis at Baseline||Participants|Count of Participants|25|25.0||||||
3836177|NCT01693029|3662648|B3||Hemodialysis|Method of dialysis at Baseline||Participants|Count of Participants|384|384.0||||||
3836178|NCT01693029|3662649|B2||Hemodialysis|Method of dialysis at Baseline||Participants|Count of Participants|192|192.0||||||
3836179|NCT01693029|3662650|B1||Hemodialysis|Method of dialysis at Baseline||Participants|Count of Participants|192|192.0||||||
3836180|NCT01693029|3662648|B3|||Time since start of dialysis||months|Median|38.60|38.6|Inter-Quartile Range|||20.93|64.23|
3836181|NCT01693029|3662649|B2|||Time since start of dialysis||months|Median|41.08|41.08|Inter-Quartile Range|||22.54|63.64|
3836182|NCT01693029|3662650|B1|||Time since start of dialysis||months|Median|36.11|36.11|Inter-Quartile Range|||18.53|66.4|
3836183|NCT01693029|3662648|B3|||Time since start of ESA therapy||months|Median|32.95|32.95|Inter-Quartile Range|||14.85|59.2|
3836184|NCT01693029|3662649|B2|||Time since start of ESA therapy||months|Median|36.24|36.24|Inter-Quartile Range|||17.15|62.09|
3836185|NCT01693029|3662650|B1|||Time since start of ESA therapy||months|Median|30.59|30.59|Inter-Quartile Range|||13.01|54.01|
3836186|NCT01693029|3662648|B3||Procrit|Type of last Erythropoiesis Stimulating Agent (ESA) therapy prior||Participants|Count of Participants|3|3.0||||||
3836187|NCT01693029|3662649|B2||Procrit|Type of last Erythropoiesis Stimulating Agent (ESA) therapy prior||Participants|Count of Participants|3|3.0||||||
3836188|NCT01693029|3662650|B1||Procrit|Type of last Erythropoiesis Stimulating Agent (ESA) therapy prior||Participants|Count of Participants|0|0.0||||||
3836189|NCT01693029|3662648|B3||Epogen|Type of last Erythropoiesis Stimulating Agent (ESA) therapy prior||Participants|Count of Participants|432|432.0||||||
3836190|NCT01693029|3662649|B2||Epogen|Type of last Erythropoiesis Stimulating Agent (ESA) therapy prior||Participants|Count of Participants|215|215.0||||||
3836191|NCT01693029|3662650|B1||Epogen|Type of last Erythropoiesis Stimulating Agent (ESA) therapy prior||Participants|Count of Participants|217|217.0||||||
3836192|NCT01693029|3662648|B3||Other|Primary cause of Chronic Kidney Disease (CKD)||Participants|Count of Participants|7|7.0||||||
3836193|NCT01693029|3662649|B2||Other|Primary cause of Chronic Kidney Disease (CKD)||Participants|Count of Participants|4|4.0||||||
3836194|NCT01693029|3662650|B1||Other|Primary cause of Chronic Kidney Disease (CKD)||Participants|Count of Participants|3|3.0||||||
3836195|NCT01693029|3662648|B3||Unknown|Primary cause of Chronic Kidney Disease (CKD)||Participants|Count of Participants|12|12.0||||||
3836196|NCT01693029|3662649|B2||Unknown|Primary cause of Chronic Kidney Disease (CKD)||Participants|Count of Participants|9|9.0||||||
3836197|NCT01693029|3662650|B1||Unknown|Primary cause of Chronic Kidney Disease (CKD)||Participants|Count of Participants|3|3.0||||||
3836198|NCT01693029|3662648|B3||Amyloidosis|Primary cause of Chronic Kidney Disease (CKD)||Participants|Count of Participants|1|1.0||||||
3836199|NCT01693029|3662649|B2||Amyloidosis|Primary cause of Chronic Kidney Disease (CKD)||Participants|Count of Participants|0|0.0||||||
3836200|NCT01693029|3662650|B1||Amyloidosis|Primary cause of Chronic Kidney Disease (CKD)||Participants|Count of Participants|1|1.0||||||
3836201|NCT01693029|3662648|B3||Vasculitis|Primary cause of Chronic Kidney Disease (CKD)||Participants|Count of Participants|2|2.0||||||
3836202|NCT01693029|3662649|B2||Vasculitis|Primary cause of Chronic Kidney Disease (CKD)||Participants|Count of Participants|0|0.0||||||
3836203|NCT01693029|3662650|B1||Vasculitis|Primary cause of Chronic Kidney Disease (CKD)||Participants|Count of Participants|2|2.0||||||
3836204|NCT01693029|3662648|B3||Urinary tract obstruction|Primary cause of Chronic Kidney Disease (CKD)||Participants|Count of Participants|2|2.0||||||
3836205|NCT01693029|3662649|B2||Urinary tract obstruction|Primary cause of Chronic Kidney Disease (CKD)||Participants|Count of Participants|0|0.0||||||
3836206|NCT01693029|3662650|B1||Urinary tract obstruction|Primary cause of Chronic Kidney Disease (CKD)||Participants|Count of Participants|2|2.0||||||
3836207|NCT01693029|3662648|B3||Polycystic kidney disease|Primary cause of Chronic Kidney Disease (CKD)||Participants|Count of Participants|9|9.0||||||
3836208|NCT01693029|3662649|B2||Polycystic kidney disease|Primary cause of Chronic Kidney Disease (CKD)||Participants|Count of Participants|4|4.0||||||
3836209|NCT01693029|3662650|B1||Polycystic kidney disease|Primary cause of Chronic Kidney Disease (CKD)||Participants|Count of Participants|5|5.0||||||
3836210|NCT01693029|3662648|B3||Kidney abnormalities|Primary cause of Chronic Kidney Disease (CKD)||Participants|Count of Participants|19|19.0||||||
3836211|NCT01693029|3662649|B2||Kidney abnormalities|Primary cause of Chronic Kidney Disease (CKD)||Participants|Count of Participants|11|11.0||||||
3836212|NCT01693029|3662650|B1||Kidney abnormalities|Primary cause of Chronic Kidney Disease (CKD)||Participants|Count of Participants|8|8.0||||||
3836213|NCT01693029|3662648|B3||Chronic glomerulonephritis|Primary cause of Chronic Kidney Disease (CKD)||Participants|Count of Participants|29|29.0||||||
3836214|NCT01693029|3662649|B2||Chronic glomerulonephritis|Primary cause of Chronic Kidney Disease (CKD)||Participants|Count of Participants|16|16.0||||||
3836215|NCT01693029|3662650|B1||Chronic glomerulonephritis|Primary cause of Chronic Kidney Disease (CKD)||Participants|Count of Participants|13|13.0||||||
3836216|NCT01693029|3662648|B3||Hypertension|Primary cause of Chronic Kidney Disease (CKD)||Participants|Count of Participants|117|117.0||||||
3836217|NCT01693029|3662649|B2||Hypertension|Primary cause of Chronic Kidney Disease (CKD)||Participants|Count of Participants|52|52.0||||||
3836218|NCT01693029|3662650|B1||Hypertension|Primary cause of Chronic Kidney Disease (CKD)||Participants|Count of Participants|65|65.0||||||
3836219|NCT01693029|3662648|B3||Diabetes mellitus|Primary cause of Chronic Kidney Disease (CKD)||Participants|Count of Participants|237|237.0||||||
3836220|NCT01693029|3662649|B2||Diabetes mellitus|Primary cause of Chronic Kidney Disease (CKD)||Participants|Count of Participants|122|122.0||||||
3836221|NCT01693029|3662650|B1||Diabetes mellitus|Primary cause of Chronic Kidney Disease (CKD)||Participants|Count of Participants|115|115.0||||||
3836222|NCT01693029|3662648|B3|||BMI||kg/m^2|Mean|30.48|30.48|Standard Deviation|7.933|7.933|||
3836223|NCT01693029|3662649|B2|||BMI||kg/m^2|Mean|31.41|31.41|Standard Deviation|8.783|8.783|||
3836224|NCT01693029|3662650|B1|||BMI||kg/m^2|Mean|29.55|29.55|Standard Deviation|6.872|6.872|||
3836225|NCT01693029|3662648|B3|||Weight||kg|Mean|84.6|84.6|Standard Deviation|22.66|22.66|||
3836226|NCT01693029|3662649|B2|||Weight||kg|Mean|86.5|86.5|Standard Deviation|24.32|24.32|||
3836227|NCT01693029|3662650|B1|||Weight||kg|Mean|82.8|82.8|Standard Deviation|20.75|20.75|||
3836228|NCT01693029|3662648|B3|||Height||cm|Mean|166.6|166.6|Standard Deviation|10.26|10.26|||
3836229|NCT01693029|3662649|B2|||Height||cm|Mean|166.0|166.0|Standard Deviation|10.33|10.33|||
3836230|NCT01693029|3662650|B1|||Height||cm|Mean|167.2|167.2|Standard Deviation|10.17|10.17|||
3836231|NCT01693029|3662648|B3|United States||Region of Enrollment||participants|Number|435|435.0||||||
3836232|NCT01693029|3662649|B2|United States||Region of Enrollment||participants|Number|218|218.0||||||
3836233|NCT01693029|3662650|B1|United States||Region of Enrollment||participants|Number|217|217.0||||||
3836234|NCT01693029|3662648|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836235|NCT01693029|3662649|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836236|NCT01693029|3662650|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836237|NCT01693029|3662648|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836238|NCT01693029|3662649|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836239|NCT01693029|3662650|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836240|NCT01693029|3662648|B3||White|Race (NIH/OMB)||Participants|Count of Participants|267|267.0||||||
3836241|NCT01693029|3662649|B2||White|Race (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
3836242|NCT01693029|3662650|B1||White|Race (NIH/OMB)||Participants|Count of Participants|139|139.0||||||
3836243|NCT01693029|3662648|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
3836244|NCT01693029|3662649|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3836245|NCT01693029|3662650|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3836246|NCT01693029|3662648|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3836247|NCT01693029|3662649|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836248|NCT01693029|3662650|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3836249|NCT01693029|3662648|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3836250|NCT01693029|3662649|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3836251|NCT01693029|3662650|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3836252|NCT01693029|3662648|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3836253|NCT01693029|3662649|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3836254|NCT01693029|3662650|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3836255|NCT01693029|3662648|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836256|NCT01693029|3662649|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836257|NCT01693029|3662650|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836258|NCT01693029|3662648|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|247|247.0||||||
3836259|NCT01693029|3662649|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
3836260|NCT01693029|3662650|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
3836261|NCT01693029|3662648|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|188|188.0||||||
3836262|NCT01693029|3662649|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
3836263|NCT01693029|3662650|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3836264|NCT01693029|3662648|B3||Male|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
3836265|NCT01693029|3662649|B2||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3836266|NCT01693029|3662650|B1||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3836267|NCT01693029|3662648|B3||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
3836268|NCT01693029|3662649|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3836269|NCT01693029|3662650|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3836270|NCT01693029|3662648|B3|||Age||years|Mean|58.7|58.7|Standard Deviation|13.61|13.61|||
3836271|NCT01693029|3662649|B2|||Age||years|Mean|57.6|57.6|Standard Deviation|13.40|13.4|||
3836272|NCT01693029|3662650|B1|||Age||years|Mean|59.8|59.8|Standard Deviation|13.76|13.76|||
3836273|NCT01692951|3662663|B5|||Amount of Cigarette Smoking as Pack-year||pack-year|Median|40|40.0|Inter-Quartile Range|||25.0|56.0|
3836274|NCT01692951|3662664|B4|||Amount of Cigarette Smoking as Pack-year||pack-year|Median|39|39.0|Inter-Quartile Range|||24.0|60.0|
3836275|NCT01692951|3662665|B3|||Amount of Cigarette Smoking as Pack-year||pack-year|Median|38|38.0|Inter-Quartile Range|||25.0|50.0|
3836276|NCT01692951|3662666|B2|||Amount of Cigarette Smoking as Pack-year||pack-year|Median|40|40.0|Inter-Quartile Range|||26.0|56.0|
3836277|NCT01692951|3662667|B1|||Amount of Cigarette Smoking as Pack-year||pack-year|Median|40|40.0|Inter-Quartile Range|||25.0|56.0|
3836278|NCT01692951|3662663|B5|||COPD||Participants|Count of Participants|58|58.0||||||
3836279|NCT01692951|3662664|B4|||COPD||Participants|Count of Participants|11|11.0||||||
3836280|NCT01692951|3662665|B3|||COPD||Participants|Count of Participants|5|5.0||||||
3836281|NCT01692951|3662666|B2|||COPD||Participants|Count of Participants|32|32.0||||||
3836282|NCT01692951|3662667|B1|||COPD||Participants|Count of Participants|10|10.0||||||
3836283|NCT01692951|3662663|B5|||Family history of lung cancer||Participants|Count of Participants|48|48.0||||||
3836284|NCT01692951|3662664|B4|||Family history of lung cancer||Participants|Count of Participants|16|16.0||||||
3836285|NCT01692951|3662665|B3|||Family history of lung cancer||Participants|Count of Participants|5|5.0||||||
3836286|NCT01692951|3662666|B2|||Family history of lung cancer||Participants|Count of Participants|21|21.0||||||
3836287|NCT01692951|3662667|B1|||Family history of lung cancer||Participants|Count of Participants|6|6.0||||||
3836288|NCT01692951|3662663|B5|Current||Smoking status||participants|Number|56|56.0||||||
3836289|NCT01692951|3662664|B4|Current||Smoking status||participants|Number|12|12.0||||||
3836290|NCT01692951|3662665|B3|Current||Smoking status||participants|Number|3|3.0||||||
3836291|NCT01692951|3662666|B2|Current||Smoking status||participants|Number|32|32.0||||||
3836292|NCT01692951|3662667|B1|Current||Smoking status||participants|Number|9|9.0||||||
3836293|NCT01692951|3662663|B5|Former||Smoking status||participants|Number|157|157.0||||||
3836294|NCT01692951|3662664|B4|Former||Smoking status||participants|Number|39|39.0||||||
3836295|NCT01692951|3662665|B3|Former||Smoking status||participants|Number|15|15.0||||||
3836296|NCT01692951|3662666|B2|Former||Smoking status||participants|Number|76|76.0||||||
3836297|NCT01692951|3662667|B1|Former||Smoking status||participants|Number|27|27.0||||||
3836298|NCT01692951|3662663|B5|Never||Smoking status||participants|Number|7|7.0||||||
3836299|NCT01692951|3662664|B4|Never||Smoking status||participants|Number|3|3.0||||||
3836300|NCT01692951|3662665|B3|Never||Smoking status||participants|Number|0|0.0||||||
3836301|NCT01692951|3662666|B2|Never||Smoking status||participants|Number|3|3.0||||||
3836302|NCT01692951|3662667|B1|Never||Smoking status||participants|Number|1|1.0||||||
3836303|NCT01692951|3662663|B5||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3836304|NCT01692951|3662664|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3836305|NCT01692951|3662665|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3836306|NCT01692951|3662666|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3836307|NCT01692951|3662667|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3836308|NCT01692951|3662663|B5||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3836309|NCT01692951|3662664|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3836310|NCT01692951|3662665|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3836311|NCT01692951|3662666|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3836312|NCT01692951|3662667|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3836313|NCT01692951|3662663|B5|||Age||years|Mean|66|66.0|Standard Deviation|7|7.0|||
3836314|NCT01692951|3662664|B4|||Age||years|Mean|68|68.0|Standard Deviation|6|6.0|||
3836315|NCT01692951|3662665|B3|||Age||years|Mean|70|70.0|Standard Deviation|9|9.0|||
3836316|NCT01692951|3662666|B2|||Age||years|Mean|65|65.0|Standard Deviation|6|6.0|||
3836317|NCT01692951|3662667|B1|||Age||years|Mean|66|66.0|Standard Deviation|11|11.0|||
3836318|NCT01692938|3662680|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3836319|NCT01692938|3662681|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3836320|NCT01692938|3662682|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3836321|NCT01692938|3662680|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3836322|NCT01692938|3662681|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3836323|NCT01692938|3662682|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3836324|NCT01692938|3662680|B3|65 years or great||Age, Customized||participants|Number|4|4.0||||||
3836325|NCT01692938|3662681|B2|65 years or great||Age, Customized||participants|Number|3|3.0||||||
3836326|NCT01692938|3662682|B1|65 years or great||Age, Customized||participants|Number|1|1.0||||||
3836327|NCT01692938|3662680|B3|51-64 years||Age, Customized||participants|Number|6|6.0||||||
3836328|NCT01692938|3662681|B2|51-64 years||Age, Customized||participants|Number|3|3.0||||||
3836329|NCT01692938|3662682|B1|51-64 years||Age, Customized||participants|Number|3|3.0||||||
3836330|NCT01692938|3662680|B3|36-50 years||Age, Customized||participants|Number|7|7.0||||||
3836331|NCT01692938|3662681|B2|36-50 years||Age, Customized||participants|Number|3|3.0||||||
3836332|NCT01692938|3662682|B1|36-50 years||Age, Customized||participants|Number|4|4.0||||||
3836333|NCT01692938|3662680|B3|21-35 years||Age, Customized||participants|Number|7|7.0||||||
3836334|NCT01692938|3662681|B2|21-35 years||Age, Customized||participants|Number|3|3.0||||||
3836335|NCT01692938|3662682|B1|21-35 years||Age, Customized||participants|Number|4|4.0||||||
3836336|NCT01692782|3662691|B4|United States||Region of Enrollment||participants|Number|331|331.0||||||
3836337|NCT01692782|3662692|B3|United States||Region of Enrollment||participants|Number|110|110.0||||||
3836338|NCT01692782|3662693|B2|United States||Region of Enrollment||participants|Number|107|107.0||||||
3836339|NCT01692782|3662694|B1|United States||Region of Enrollment||participants|Number|114|114.0||||||
3836340|NCT01692782|3662691|B4||Male|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
3836341|NCT01692782|3662692|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3836342|NCT01692782|3662693|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3836343|NCT01692782|3662694|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3836344|NCT01692782|3662691|B4||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3836345|NCT01692782|3662692|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3836346|NCT01692782|3662693|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3836347|NCT01692782|3662694|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3836348|NCT01692782|3662691|B4|||Age||Years|Mean|34.2|34.2|Standard Deviation|10.71|10.71|||
3836349|NCT01692782|3662692|B3|||Age||Years|Mean|33.9|33.9|Standard Deviation|11.03|11.03|||
3836350|NCT01692782|3662693|B2|||Age||Years|Mean|34.5|34.5|Standard Deviation|11.15|11.15|||
3836351|NCT01692782|3662694|B1|||Age||Years|Mean|34.2|34.2|Standard Deviation|10.06|10.06|||
3836352|NCT01692782|3662691|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3836353|NCT01692782|3662692|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3836354|NCT01692782|3662693|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3836355|NCT01692782|3662694|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3836356|NCT01692782|3662691|B4||Between 18 and 65 years|Age||Participants|Count of Participants|331|331.0||||||
3836357|NCT01692782|3662692|B3||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
3836358|NCT01692782|3662693|B2||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
3836359|NCT01692782|3662694|B1||Between 18 and 65 years|Age||Participants|Count of Participants|114|114.0||||||
3836360|NCT01692782|3662691|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3836361|NCT01692782|3662692|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3836362|NCT01692782|3662693|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3836363|NCT01692782|3662694|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3836364|NCT01692756|3662719|B5|||Knee Injury and Osteoarthritis Scale (KOOS) Pain Subscale|KOOS consists of 5 subscales with five questions per scale; Pain, other Symptoms, Function in daily living (ADL), Function in sport and recreation (Sport/Rec) and knee related Quality of life QOL. The last week is taken into consideration when answering the questions. Standardized answer options are given (5 Likert boxes) and each question gets a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale. The baseline KOOS Pain scores are presented here.|units on a scale|Mean|51.05|51.05|Standard Deviation|21.2|21.2|||
3836365|NCT01692756|3662720|B4|||Knee Injury and Osteoarthritis Scale (KOOS) Pain Subscale|KOOS consists of 5 subscales with five questions per scale; Pain, other Symptoms, Function in daily living (ADL), Function in sport and recreation (Sport/Rec) and knee related Quality of life QOL. The last week is taken into consideration when answering the questions. Standardized answer options are given (5 Likert boxes) and each question gets a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale. The baseline KOOS Pain scores are presented here.|units on a scale|Mean|46.30|46.3|Standard Deviation|25.02|25.02|||
3836366|NCT01692756|3662721|B3|||Knee Injury and Osteoarthritis Scale (KOOS) Pain Subscale|KOOS consists of 5 subscales with five questions per scale; Pain, other Symptoms, Function in daily living (ADL), Function in sport and recreation (Sport/Rec) and knee related Quality of life QOL. The last week is taken into consideration when answering the questions. Standardized answer options are given (5 Likert boxes) and each question gets a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale. The baseline KOOS Pain scores are presented here.|units on a scale|Mean|50.25|50.25|Standard Deviation|24.61|24.61|||
3836367|NCT01692756|3662722|B2|||Knee Injury and Osteoarthritis Scale (KOOS) Pain Subscale|KOOS consists of 5 subscales with five questions per scale; Pain, other Symptoms, Function in daily living (ADL), Function in sport and recreation (Sport/Rec) and knee related Quality of life QOL. The last week is taken into consideration when answering the questions. Standardized answer options are given (5 Likert boxes) and each question gets a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale. The baseline KOOS Pain scores are presented here.|units on a scale|Mean|58.33|58.33|Standard Deviation|15.42|15.42|||
3836368|NCT01692756|3662723|B1|||Knee Injury and Osteoarthritis Scale (KOOS) Pain Subscale|KOOS consists of 5 subscales with five questions per scale; Pain, other Symptoms, Function in daily living (ADL), Function in sport and recreation (Sport/Rec) and knee related Quality of life QOL. The last week is taken into consideration when answering the questions. Standardized answer options are given (5 Likert boxes) and each question gets a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale. The baseline KOOS Pain scores are presented here.|units on a scale|Mean|49.75|49.75|Standard Deviation|19.10|19.1|||
3836369|NCT01692756|3662719|B5|United States||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3836370|NCT01692756|3662720|B4|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3836371|NCT01692756|3662721|B3|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3836372|NCT01692756|3662722|B2|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3836373|NCT01692756|3662723|B1|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3836374|NCT01692756|3662719|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836375|NCT01692756|3662720|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836376|NCT01692756|3662721|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836377|NCT01692756|3662722|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836378|NCT01692756|3662723|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836379|NCT01692756|3662719|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3836380|NCT01692756|3662720|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836381|NCT01692756|3662721|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836382|NCT01692756|3662722|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3836383|NCT01692756|3662723|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836384|NCT01692756|3662719|B5||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3836385|NCT01692756|3662720|B4||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3836386|NCT01692756|3662721|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3836387|NCT01692756|3662722|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3836388|NCT01692756|3662723|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3836389|NCT01692756|3662719|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3836390|NCT01692756|3662720|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3836391|NCT01692756|3662721|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3836392|NCT01692756|3662722|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836393|NCT01692756|3662723|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3836394|NCT01692756|3662719|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836395|NCT01692756|3662720|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836396|NCT01692756|3662721|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836397|NCT01692756|3662722|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836398|NCT01692756|3662723|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836399|NCT01692756|3662719|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836400|NCT01692756|3662720|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836401|NCT01692756|3662721|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836402|NCT01692756|3662722|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836403|NCT01692756|3662723|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836404|NCT01692756|3662719|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836405|NCT01692756|3662720|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836406|NCT01692756|3662721|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836407|NCT01692756|3662722|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836408|NCT01692756|3662723|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836409|NCT01692756|3662719|B5||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3836410|NCT01692756|3662720|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3836411|NCT01692756|3662721|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3836412|NCT01692756|3662722|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3836413|NCT01692756|3662723|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3836414|NCT01692756|3662719|B5||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3836415|NCT01692756|3662720|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3836416|NCT01692756|3662721|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3836417|NCT01692756|3662722|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3836418|NCT01692756|3662723|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3836419|NCT01692756|3662719|B5|||Age||years|Mean|19.9|19.9|Standard Deviation|4.8|4.8|||
3836420|NCT01692756|3662720|B4|||Age||years|Mean|17.80|17.8|Standard Deviation|2.14|2.14|||
3836421|NCT01692756|3662721|B3|||Age||years|Mean|24.06|24.06|Standard Deviation|6.57|6.57|||
3836422|NCT01692756|3662722|B2|||Age||years|Mean|19.60|19.6|Standard Deviation|4.12|4.12|||
3836423|NCT01692756|3662723|B1|||Age||years|Mean|18.45|18.45|Standard Deviation|2.99|2.99|||
3836424|NCT01692730|3662784|B3||Male|Sex: Female, Male||Participants|Count of Participants|933|933.0||||||
3836425|NCT01692730|3662785|B2||Male|Sex: Female, Male||Participants|Count of Participants|458|458.0||||||
3836426|NCT01692730|3662786|B1||Male|Sex: Female, Male||Participants|Count of Participants|475|475.0||||||
3836427|NCT01692730|3662784|B3||Female|Sex: Female, Male||Participants|Count of Participants|493|493.0||||||
3836428|NCT01692730|3662785|B2||Female|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
3836429|NCT01692730|3662786|B1||Female|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
3836430|NCT01692730|3662784|B3|||Age|Collected via online survey.|years|Mean|28.00482094|28.00482094|Standard Deviation|9.602390308|9.602390308|||
3836431|NCT01692730|3662785|B2|||Age|Collected via online survey.|years|Mean|28.45541838|28.45541838|Standard Deviation|9.707011106|9.707011106|||
3836432|NCT01692730|3662786|B1|||Age|Collected via online survey.|years|Mean|27.55048409|27.55048409|Standard Deviation|9.474060629|9.474060629|||
3836433|NCT01692691|3662795|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3836434|NCT01692691|3662795|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3836435|NCT01692691|3662795|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3836436|NCT01692691|3662795|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3836437|NCT01692691|3662795|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3836438|NCT01692691|3662795|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3836439|NCT01692626|3662801|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3836440|NCT01692626|3662801|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3836441|NCT01692626|3662801|B1|>= 70 years||Age, Customized||participants|Number|5|5.0||||||
3836442|NCT01692626|3662801|B1|>= 18 - 69 years||Age, Customized||participants|Number|8|8.0||||||
3836443|NCT01692626|3662801|B1|<18 years||Age, Customized||participants|Number|0|0.0||||||
3836444|NCT01692340|3662807|B4|United States||Region of Enrollment||participants|Number|12|12.0||||||
3836445|NCT01692340|3662809|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3836446|NCT01692340|3662810|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3836447|NCT01692340|3662807|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836448|NCT01692340|3662809|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836449|NCT01692340|3662810|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836450|NCT01692340|3662807|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836451|NCT01692340|3662809|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836452|NCT01692340|3662810|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836453|NCT01692340|3662807|B4||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3836454|NCT01692340|3662809|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3836455|NCT01692340|3662810|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3836456|NCT01692340|3662807|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836457|NCT01692340|3662809|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836458|NCT01692340|3662810|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836459|NCT01692340|3662807|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836460|NCT01692340|3662809|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836461|NCT01692340|3662810|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836462|NCT01692340|3662807|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3836463|NCT01692340|3662809|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3836464|NCT01692340|3662810|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3836465|NCT01692340|3662807|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836466|NCT01692340|3662809|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836467|NCT01692340|3662810|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836468|NCT01692340|3662807|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3836469|NCT01692340|3662809|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3836470|NCT01692340|3662810|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3836471|NCT01692340|3662807|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3836472|NCT01692340|3662809|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3836473|NCT01692340|3662810|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3836474|NCT01692340|3662807|B4|||Age||years old|Mean|25.3|25.3|Full Range|||21.0|32.3|
3836475|NCT01692340|3662809|B2|||Age||years old|Mean|27.7|27.7|Full Range|||21.9|32.3|
3836476|NCT01692340|3662810|B1|||Age||years old|Mean|24|24.0|Full Range|||21.0|31.0|
3836477|NCT01692340|3662807|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3836478|NCT01692340|3662809|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3836479|NCT01692340|3662810|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3836480|NCT01692340|3662807|B4||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3836481|NCT01692340|3662809|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3836482|NCT01692340|3662810|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3836483|NCT01692340|3662807|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3836484|NCT01692340|3662809|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3836485|NCT01692340|3662810|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3836486|NCT01692301|3662827|B3||Male|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
3836487|NCT01692301|3662828|B2||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3836488|NCT01692301|3662829|B1||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3836489|NCT01692301|3662827|B3||Female|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
3836490|NCT01692301|3662828|B2||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3836491|NCT01692301|3662829|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3836492|NCT01692301|3662827|B3|||Age||Years|Mean|67.7|67.7|Standard Deviation|5.87|5.87|||
3836493|NCT01692301|3662828|B2|||Age||Years|Mean|67.2|67.2|Standard Deviation|5.97|5.97|||
3836494|NCT01692301|3662829|B1|||Age||Years|Mean|68.2|68.2|Standard Deviation|5.73|5.73|||
3836495|NCT01692275|3662856|B7|Other or unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|71|71.0||||||
3836496|NCT01692275|3662857|B6|Other or unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3836497|NCT01692275|3662858|B5|Other or unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3836498|NCT01692275|3662859|B4|Other or unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3836499|NCT01692275|3662860|B3|Other or unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3836500|NCT01692275|3662861|B2|Other or unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3836501|NCT01692275|3662862|B1|Other or unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3836502|NCT01692275|3662856|B7|White||Race/Ethnicity, Customized||Participants|Count of Participants|507|507.0||||||
3836503|NCT01692275|3662857|B6|White||Race/Ethnicity, Customized||Participants|Count of Participants|87|87.0||||||
3836504|NCT01692275|3662858|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|88|88.0||||||
3836505|NCT01692275|3662859|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|106|106.0||||||
3836506|NCT01692275|3662860|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|102|102.0||||||
3836507|NCT01692275|3662861|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|62|62.0||||||
3836565|NCT01692197|3662923|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
3836508|NCT01692275|3662862|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|62|62.0||||||
3836509|NCT01692275|3662856|B7|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|149|149.0||||||
3836510|NCT01692275|3662857|B6|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3836511|NCT01692275|3662858|B5|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3836512|NCT01692275|3662859|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3836513|NCT01692275|3662860|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3836514|NCT01692275|3662861|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3836515|NCT01692275|3662862|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
3836516|NCT01692275|3662856|B7|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3836517|NCT01692275|3662857|B6|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3836518|NCT01692275|3662858|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3836519|NCT01692275|3662859|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3836520|NCT01692275|3662860|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3836521|NCT01692275|3662861|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3836522|NCT01692275|3662862|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3836523|NCT01692275|3662856|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836524|NCT01692275|3662857|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836525|NCT01692275|3662858|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836526|NCT01692275|3662859|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836527|NCT01692275|3662860|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836528|NCT01692275|3662861|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836529|NCT01692275|3662862|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836530|NCT01692275|3662856|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|632|632.0||||||
3836531|NCT01692275|3662857|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3836532|NCT01692275|3662858|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
3836533|NCT01692275|3662859|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
3836534|NCT01692275|3662860|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3836535|NCT01692275|3662861|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|116|116.0||||||
3836536|NCT01692275|3662862|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|109|109.0||||||
3836537|NCT01692275|3662856|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|118|118.0||||||
3836538|NCT01692275|3662857|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3836539|NCT01692275|3662858|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3836540|NCT01692275|3662859|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3836541|NCT01692275|3662860|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3836542|NCT01692275|3662861|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3836543|NCT01692275|3662862|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3836544|NCT01692275|3662856|B7||Male|Sex: Female, Male||Participants|Count of Participants|575|575.0||||||
3836545|NCT01692275|3662857|B6||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3836546|NCT01692275|3662858|B5||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3836547|NCT01692275|3662859|B4||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3836548|NCT01692275|3662860|B3||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3836549|NCT01692275|3662861|B2||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3836550|NCT01692275|3662862|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3836551|NCT01692275|3662856|B7||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
3836552|NCT01692275|3662857|B6||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3836553|NCT01692275|3662858|B5||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3836554|NCT01692275|3662859|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3836555|NCT01692275|3662860|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3836556|NCT01692275|3662861|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3836557|NCT01692275|3662862|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3836558|NCT01692275|3662856|B7|||Age||years|Mean|30.9|30.9|Standard Deviation|8.7|8.7|||
3836559|NCT01692275|3662857|B6|||Age||years|Mean|32.4|32.4|Standard Deviation|7.5|7.5|||
3836560|NCT01692275|3662858|B5|||Age||years|Mean|32.4|32.4|Standard Deviation|7.4|7.4|||
3836561|NCT01692275|3662859|B4|||Age||years|Mean|25.7|25.7|Standard Deviation|7.5|7.5|||
3836562|NCT01692275|3662860|B3|||Age||years|Mean|25.5|25.5|Standard Deviation|7.9|7.9|||
3836563|NCT01692275|3662861|B2|||Age||years|Mean|34.7|34.7|Standard Deviation|8.6|8.6|||
3836564|NCT01692275|3662862|B1|||Age||years|Mean|34.4|34.4|Standard Deviation|8.4|8.4|||
3836566|NCT01692197|3662923|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3836567|NCT01692197|3662923|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836568|NCT01692197|3662923|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3836569|NCT01692197|3662923|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3836570|NCT01692197|3662923|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836571|NCT01692197|3662923|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836572|NCT01692197|3662923|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836573|NCT01692197|3662923|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3836574|NCT01692197|3662923|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3836575|NCT01692197|3662923|B1|||Age||years|Median|63|63.0|Full Range|||25.0|75.0|
3836576|NCT01692197|3662923|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3836577|NCT01692197|3662923|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3836578|NCT01692197|3662923|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3836579|NCT01691898|3662930|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3836580|NCT01691898|3662931|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3836581|NCT01691898|3662932|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3836582|NCT01691898|3662933|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836583|NCT01691898|3662934|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836584|NCT01691898|3662935|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3836585|NCT01691898|3662936|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3836586|NCT01691898|3662930|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|189|189.0||||||
3836587|NCT01691898|3662931|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3836588|NCT01691898|3662932|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3836589|NCT01691898|3662933|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3836590|NCT01691898|3662934|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3836591|NCT01691898|3662935|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3836592|NCT01691898|3662936|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3836593|NCT01691898|3662930|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3836594|NCT01691898|3662931|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3836595|NCT01691898|3662932|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836596|NCT01691898|3662933|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836597|NCT01691898|3662934|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3836598|NCT01691898|3662935|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3836599|NCT01691898|3662936|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3836600|NCT01691898|3662930|B7||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3836601|NCT01691898|3662931|B6||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3836602|NCT01691898|3662932|B5||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3836603|NCT01691898|3662933|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3836604|NCT01691898|3662934|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3836605|NCT01691898|3662935|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3836606|NCT01691898|3662936|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3836607|NCT01691898|3662930|B7||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3836608|NCT01691898|3662931|B6||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3836609|NCT01691898|3662932|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3836610|NCT01691898|3662933|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3836611|NCT01691898|3662934|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3836612|NCT01691898|3662935|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3836613|NCT01691898|3662936|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3836614|NCT01691898|3662930|B7||>=65 years|Age||Participants|Count of Participants|122|122.0||||||
3836615|NCT01691898|3662931|B6||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3836616|NCT01691898|3662932|B5||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3836617|NCT01691898|3662933|B4||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3836618|NCT01691898|3662934|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3836619|NCT01691898|3662935|B2||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
3836620|NCT01691898|3662936|B1||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
3836621|NCT01691898|3662930|B7||Between 18 and 65 years|Age||Participants|Count of Participants|108|108.0||||||
3836622|NCT01691898|3662931|B6||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3836623|NCT01691898|3662932|B5||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3836624|NCT01691898|3662933|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3836625|NCT01691898|3662934|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3836626|NCT01691898|3662935|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3836627|NCT01691898|3662936|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3836628|NCT01691898|3662930|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3836629|NCT01691898|3662931|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3836630|NCT01691898|3662932|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3836631|NCT01691898|3662933|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3836632|NCT01691898|3662934|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3836633|NCT01691898|3662935|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3836634|NCT01691898|3662936|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3836635|NCT01691885|3663087|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|39|39.0||||||
3836636|NCT01691885|3663087|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3836637|NCT01691885|3663087|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3836638|NCT01691885|3663087|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3836639|NCT01691885|3663087|B1|||Age||Years|Mean|64.4|64.4|Standard Deviation|8.95|8.95|||
3836640|NCT01691859|3663094|B1|Asian & Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3836641|NCT01691859|3663094|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|311|311.0||||||
3836642|NCT01691859|3663094|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3836643|NCT01691859|3663094|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3836644|NCT01691859|3663094|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3836645|NCT01691859|3663094|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3836646|NCT01691859|3663094|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3836647|NCT01691859|3663094|B1||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3836648|NCT01691859|3663094|B1||Female|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
3836649|NCT01691859|3663094|B1|||Age||Years|Mean|52.2|52.2|Standard Deviation|10.73|10.73|||
3836650|NCT01691794|3663113|B4|United States||Country||Participants|Number|2|2.0||||||
3836651|NCT01691794|3663114|B3|United States||Country||Participants|Number|2|2.0||||||
3836652|NCT01691794|3663115|B2|United States||Country||Participants|Number|0|0.0||||||
3836653|NCT01691794|3663116|B1|United States||Country||Participants|Number|0|0.0||||||
3836654|NCT01691794|3663113|B4|South Africa||Country||Participants|Number|34|34.0||||||
3836655|NCT01691794|3663114|B3|South Africa||Country||Participants|Number|8|8.0||||||
3836656|NCT01691794|3663115|B2|South Africa||Country||Participants|Number|24|24.0||||||
3836657|NCT01691794|3663116|B1|South Africa||Country||Participants|Number|2|2.0||||||
3836658|NCT01691794|3663113|B4|Russia||Country||Participants|Number|1|1.0||||||
3836659|NCT01691794|3663114|B3|Russia||Country||Participants|Number|0|0.0||||||
3836660|NCT01691794|3663115|B2|Russia||Country||Participants|Number|1|1.0||||||
3836661|NCT01691794|3663116|B1|Russia||Country||Participants|Number|0|0.0||||||
3836662|NCT01691794|3663113|B4|Peru||Country||Participants|Number|7|7.0||||||
3836663|NCT01691794|3663114|B3|Peru||Country||Participants|Number|6|6.0||||||
3836664|NCT01691794|3663115|B2|Peru||Country||Participants|Number|1|1.0||||||
3836665|NCT01691794|3663116|B1|Peru||Country||Participants|Number|0|0.0||||||
3836666|NCT01691794|3663113|B4|Mexico||Country||Participants|Number|2|2.0||||||
3836667|NCT01691794|3663114|B3|Mexico||Country||Participants|Number|1|1.0||||||
3836668|NCT01691794|3663115|B2|Mexico||Country||Participants|Number|0|0.0||||||
3836669|NCT01691794|3663116|B1|Mexico||Country||Participants|Number|1|1.0||||||
3836670|NCT01691794|3663113|B4|Chile||Country||Participants|Number|3|3.0||||||
3836671|NCT01691794|3663114|B3|Chile||Country||Participants|Number|2|2.0||||||
3836672|NCT01691794|3663115|B2|Chile||Country||Participants|Number|1|1.0||||||
3836673|NCT01691794|3663116|B1|Chile||Country||Participants|Number|0|0.0||||||
3836674|NCT01691794|3663113|B4|Brazil||Country||Participants|Number|7|7.0||||||
3836675|NCT01691794|3663114|B3|Brazil||Country||Participants|Number|4|4.0||||||
3836676|NCT01691794|3663115|B2|Brazil||Country||Participants|Number|3|3.0||||||
3836677|NCT01691794|3663116|B1|Brazil||Country||Participants|Number|0|0.0||||||
3836678|NCT01691794|3663113|B4|Argentina||Country||Participants|Number|3|3.0||||||
3836679|NCT01691794|3663114|B3|Argentina||Country||Participants|Number|0|0.0||||||
3836680|NCT01691794|3663115|B2|Argentina||Country||Participants|Number|3|3.0||||||
3836681|NCT01691794|3663116|B1|Argentina||Country||Participants|Number|0|0.0||||||
3836682|NCT01691794|3663113|B4|South America||Region of Enrollment||Participants|Number|20|20.0||||||
3836683|NCT01691794|3663114|B3|South America||Region of Enrollment||Participants|Number|12|12.0||||||
3836684|NCT01691794|3663115|B2|South America||Region of Enrollment||Participants|Number|8|8.0||||||
3836685|NCT01691794|3663116|B1|South America||Region of Enrollment||Participants|Number|0|0.0||||||
3836686|NCT01691794|3663113|B4|North America||Region of Enrollment||Participants|Number|4|4.0||||||
3836687|NCT01691794|3663114|B3|North America||Region of Enrollment||Participants|Number|3|3.0||||||
3836688|NCT01691794|3663115|B2|North America||Region of Enrollment||Participants|Number|0|0.0||||||
3836689|NCT01691794|3663116|B1|North America||Region of Enrollment||Participants|Number|1|1.0||||||
3836690|NCT01691794|3663113|B4|Europe||Region of Enrollment||Participants|Number|1|1.0||||||
3836691|NCT01691794|3663114|B3|Europe||Region of Enrollment||Participants|Number|0|0.0||||||
3836692|NCT01691794|3663115|B2|Europe||Region of Enrollment||Participants|Number|1|1.0||||||
3836693|NCT01691794|3663116|B1|Europe||Region of Enrollment||Participants|Number|0|0.0||||||
3836694|NCT01691794|3663113|B4|Africa||Region of Enrollment||Participants|Number|34|34.0||||||
3836695|NCT01691794|3663114|B3|Africa||Region of Enrollment||Participants|Number|8|8.0||||||
3836696|NCT01691794|3663115|B2|Africa||Region of Enrollment||Participants|Number|24|24.0||||||
3836697|NCT01691794|3663116|B1|Africa||Region of Enrollment||Participants|Number|2|2.0||||||
3836698|NCT01691794|3663113|B4|Other||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3836699|NCT01691794|3663114|B3|Other||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
3836700|NCT01691794|3663115|B2|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3836701|NCT01691794|3663116|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3836702|NCT01691794|3663113|B4|Black/African American||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
3836703|NCT01691794|3663114|B3|Black/African American||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3836704|NCT01691794|3663115|B2|Black/African American||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
3836705|NCT01691794|3663116|B1|Black/African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3836706|NCT01691794|3663113|B4|White||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
3836707|NCT01691794|3663114|B3|White||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3836708|NCT01691794|3663115|B2|White||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3836709|NCT01691794|3663116|B1|White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3836710|NCT01691794|3663113|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3836711|NCT01691794|3663114|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3836712|NCT01691794|3663115|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3836713|NCT01691794|3663116|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3836714|NCT01691794|3663113|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3836715|NCT01691794|3663114|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3836716|NCT01691794|3663115|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3836717|NCT01691794|3663116|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3836718|NCT01691794|3663113|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3836719|NCT01691794|3663114|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3836720|NCT01691794|3663115|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3836721|NCT01691794|3663116|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836722|NCT01691794|3663113|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3836723|NCT01691794|3663114|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3836724|NCT01691794|3663115|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3836725|NCT01691794|3663116|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3836726|NCT01691794|3663113|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3836727|NCT01691794|3663114|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3836728|NCT01691794|3663115|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3836729|NCT01691794|3663116|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3836730|NCT01691794|3663113|B4|||Age, Customized||Years|Median|12.0|12.0|Full Range|||6.0|17.0|
3836731|NCT01691794|3663114|B3|||Age, Customized||Years|Median|15.0|15.0|Full Range|||11.0|17.0|
3836732|NCT01691794|3663115|B2|||Age, Customized||Years|Median|11.0|11.0|Full Range|||6.0|16.0|
3836733|NCT01691794|3663116|B1|||Age, Customized||Years|Median|6.0|6.0|Full Range|||6.0|6.0|
3836734|NCT01691794|3663113|B4|||Age||Years|Mean|12.0|12.0|Standard Deviation|3.26|3.26|||
3836735|NCT01691794|3663114|B3|||Age||Years|Mean|14.7|14.7|Standard Deviation|1.72|1.72|||
3836736|NCT01691794|3663115|B2|||Age||Years|Mean|10.7|10.7|Standard Deviation|2.67|2.67|||
3836737|NCT01691794|3663116|B1|||Age||Years|Mean|6.0|6.0|Standard Deviation|0.0|0.0|||
3836738|NCT01691781|3663132|B3|||Urinary Aldosterone Excretion Rate at baseline||mcg/24 hours|Mean|8.2|8.2|Standard Deviation|12.2|12.2|||
3836739|NCT01691781|3663133|B2|||Urinary Aldosterone Excretion Rate at baseline||mcg/24 hours|Mean|5.7|5.7|Standard Deviation|3.5|3.5|||
3836740|NCT01691781|3663134|B1|||Urinary Aldosterone Excretion Rate at baseline||mcg/24 hours|Mean|11.7|11.7|Standard Deviation|18.3|18.3|||
3836741|NCT01691781|3663132|B3|||Serum calcium||mg/dL|Mean|9.9|9.9|Standard Deviation|0.7|0.7|||
3836742|NCT01691781|3663133|B2|||Serum calcium||mg/dL|Mean|9.4|9.4|Standard Deviation|0.4|0.4|||
3836743|NCT01691781|3663134|B1|||Serum calcium||mg/dL|Mean|10.6|10.6|Standard Deviation|0.5|0.5|||
3836744|NCT01691781|3663132|B3|||Parathyroid Hormone at Baseline||pg/mL|Mean|53.8|53.8|Standard Deviation|33.0|33.0|||
3836745|NCT01691781|3663133|B2|||Parathyroid Hormone at Baseline||pg/mL|Mean|33.3|33.3|Standard Deviation|25.4|25.4|||
3836746|NCT01691781|3663134|B1|||Parathyroid Hormone at Baseline||pg/mL|Mean|79.5|79.5|Standard Deviation|21.6|21.6|||
3836747|NCT01691781|3663132|B3|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3836748|NCT01691781|3663133|B2|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3836749|NCT01691781|3663134|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3836750|NCT01691781|3663132|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836751|NCT01691781|3663133|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836752|NCT01691781|3663134|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836753|NCT01691781|3663132|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836754|NCT01691781|3663133|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836755|NCT01691781|3663134|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836756|NCT01691781|3663132|B3||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3836757|NCT01691781|3663133|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3836758|NCT01691781|3663134|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3836759|NCT01691781|3663132|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3836760|NCT01691781|3663133|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3836761|NCT01691781|3663134|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3836762|NCT01691781|3663132|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836763|NCT01691781|3663133|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836764|NCT01691781|3663134|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836765|NCT01691781|3663132|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3836766|NCT01691781|3663133|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3836767|NCT01691781|3663134|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3836768|NCT01691781|3663132|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836769|NCT01691781|3663133|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836770|NCT01691781|3663134|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836771|NCT01691781|3663132|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3836772|NCT01691781|3663133|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3836773|NCT01691781|3663134|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3836774|NCT01691781|3663132|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3836775|NCT01691781|3663133|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3836776|NCT01691781|3663134|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3836777|NCT01691781|3663132|B3|||Age||years|Mean|44.9|44.9|Standard Deviation|15.3|15.3|||
3836778|NCT01691781|3663133|B2|||Age||years|Mean|39.6|39.6|Standard Deviation|12.7|12.7|||
3836779|NCT01691781|3663134|B1|||Age||years|Mean|51.4|51.4|Standard Deviation|15.6|15.6|||
3836780|NCT01691690|3663145|B3|||Time to first analgesic on unit (min)||minutes|Mean|297.74|297.74|Standard Deviation|101.97|101.97|||
3836781|NCT01691690|3663146|B2|||Time to first analgesic on unit (min)||minutes|Mean|297.09|297.09|Standard Deviation|106.91|106.91|||
3836782|NCT01691690|3663147|B1|||Time to first analgesic on unit (min)||minutes|Mean|298.36|298.36|Standard Deviation|97.52|97.52|||
3836783|NCT01691690|3663145|B3|||Post-Anesthetic Care Unit time (min)||minutes|Mean|64.82|64.82|Standard Deviation|21.44|21.44|||
3836784|NCT01691690|3663146|B2|||Post-Anesthetic Care Unit time (min)||minutes|Mean|65.07|65.07|Standard Deviation|19.40|19.4|||
3836785|NCT01691690|3663147|B1|||Post-Anesthetic Care Unit time (min)||minutes|Mean|64.57|64.57|Standard Deviation|23.41|23.41|||
3836786|NCT01691690|3663145|B3|||Extubation time (min)||minutes|Mean|16.01|16.01|Standard Deviation|8.12|8.12|||
3836787|NCT01691690|3663146|B2|||Extubation time (min)||minutes|Mean|15.38|15.38|Standard Deviation|8.52|8.52|||
3836788|NCT01691690|3663147|B1|||Extubation time (min)||minutes|Mean|16.65|16.65|Standard Deviation|7.68|7.68|||
3836789|NCT01691690|3663145|B3|||Procedure time (min)||minutes|Mean|16.26|16.26|Standard Deviation|5.85|5.85|||
3836790|NCT01691690|3663146|B2|||Procedure time (min)||minutes|Mean|16.65|16.65|Standard Deviation|5.90|5.9|||
3836791|NCT01691690|3663147|B1|||Procedure time (min)||minutes|Mean|15.85|15.85|Standard Deviation|5.78|5.78|||
3836792|NCT01691690|3663145|B3|||Body Mass Index (kg/m2)||Kg/m2|Mean|15.42|15.42|Standard Deviation|1.47|1.47|||
3836793|NCT01691690|3663146|B2|||Body Mass Index (kg/m2)||Kg/m2|Mean|15.29|15.29|Standard Deviation|1.36|1.36|||
3836794|NCT01691690|3663147|B1|||Body Mass Index (kg/m2)||Kg/m2|Mean|15.56|15.56|Standard Deviation|1.58|1.58|||
3836795|NCT01691690|3663145|B3|||Weight (kg)||kilograms|Mean|18.56|18.56|Standard Deviation|4.39|4.39|||
3836796|NCT01691690|3663146|B2|||Weight (kg)||kilograms|Mean|18.27|18.27|Standard Deviation|4.02|4.02|||
3836797|NCT01691690|3663147|B1|||Weight (kg)||kilograms|Mean|18.85|18.85|Standard Deviation|4.74|4.74|||
3836798|NCT01691690|3663145|B3|||Height (cm)||centimeters|Mean|109.04|109.04|Standard Deviation|10.58|10.58|||
3836799|NCT01691690|3663146|B2|||Height (cm)||centimeters|Mean|108.78|108.78|Standard Deviation|10.37|10.37|||
3836800|NCT01691690|3663147|B1|||Height (cm)||centimeters|Mean|109.31|109.31|Standard Deviation|10.82|10.82|||
3836801|NCT01691690|3663145|B3||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3836802|NCT01691690|3663146|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3836803|NCT01691690|3663147|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3836804|NCT01691690|3663145|B3||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3836805|NCT01691690|3663146|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3836806|NCT01691690|3663147|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3836807|NCT01691690|3663145|B3|||Age||years|Mean|4.855|4.855|Standard Deviation|1.476|1.476|||
3836808|NCT01691690|3663146|B2|||Age||years|Mean|4.84|4.84|Standard Deviation|1.42|1.42|||
3836809|NCT01691690|3663147|B1|||Age||years|Mean|4.87|4.87|Standard Deviation|1.53|1.53|||
3836810|NCT01691612|3663158|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3836811|NCT01691612|3663158|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836812|NCT01691612|3663158|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3836813|NCT01691612|3663158|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3836814|NCT01691612|3663158|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3836815|NCT01691612|3663158|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836816|NCT01691612|3663158|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836817|NCT01691612|3663158|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836818|NCT01691612|3663158|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3836819|NCT01691612|3663158|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3836820|NCT01691612|3663158|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3836821|NCT01691612|3663158|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3836822|NCT01691612|3663158|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3836823|NCT01691612|3663158|B1|||Age||years|Mean|24.9|24.9|Standard Deviation|3.5|3.5|||
3836824|NCT01691612|3663158|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3836825|NCT01691612|3663158|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3836826|NCT01691612|3663158|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3836827|NCT01691560|3663165|B5||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3836828|NCT01691560|3663166|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3836829|NCT01691560|3663167|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3836830|NCT01691560|3663168|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3836831|NCT01691560|3663169|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3836832|NCT01691560|3663165|B5||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3836833|NCT01691560|3663166|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3836834|NCT01691560|3663167|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3836835|NCT01691560|3663168|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3836836|NCT01691560|3663169|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3836837|NCT01691560|3663165|B5|||Age||Years|Mean|35.8|35.8|Standard Deviation|9.85|9.85|||
3836838|NCT01691560|3663166|B4|||Age||Years|Mean|36.2|36.2|Standard Deviation|9.62|9.62|||
3836839|NCT01691560|3663167|B3|||Age||Years|Mean|38.2|38.2|Standard Deviation|8.88|8.88|||
3836840|NCT01691560|3663168|B2|||Age||Years|Mean|33.2|33.2|Standard Deviation|10.13|10.13|||
3836841|NCT01691560|3663169|B1|||Age||Years|Mean|35.4|35.4|Standard Deviation|10.45|10.45|||
3836842|NCT01691534|3663202|B8|Positive||HIV Status||participants|Number|11|11.0||||||
3836843|NCT01691534|3663203|B7|Positive||HIV Status||participants|Number|3|3.0||||||
3836844|NCT01691534|3663204|B6|Positive||HIV Status||participants|Number|1|1.0||||||
3836845|NCT01691534|3663205|B5|Positive||HIV Status||participants|Number|2|2.0||||||
3836846|NCT01691534|3663206|B4|Positive||HIV Status||participants|Number|0|0.0||||||
3836847|NCT01691534|3663207|B3|Positive||HIV Status||participants|Number|3|3.0||||||
3836848|NCT01691534|3663208|B2|Positive||HIV Status||participants|Number|1|1.0||||||
3836849|NCT01691534|3663209|B1|Positive||HIV Status||participants|Number|1|1.0||||||
3836850|NCT01691534|3663202|B8|Doubtful||HIV Status||participants|Number|1|1.0||||||
3836851|NCT01691534|3663203|B7|Doubtful||HIV Status||participants|Number|1|1.0||||||
3836852|NCT01691534|3663204|B6|Doubtful||HIV Status||participants|Number|0|0.0||||||
3836853|NCT01691534|3663205|B5|Doubtful||HIV Status||participants|Number|0|0.0||||||
3836854|NCT01691534|3663206|B4|Doubtful||HIV Status||participants|Number|0|0.0||||||
3836855|NCT01691534|3663207|B3|Doubtful||HIV Status||participants|Number|0|0.0||||||
3836856|NCT01691534|3663208|B2|Doubtful||HIV Status||participants|Number|0|0.0||||||
3836857|NCT01691534|3663209|B1|Doubtful||HIV Status||participants|Number|0|0.0||||||
3836858|NCT01691534|3663202|B8|Negative||HIV Status||participants|Number|93|93.0||||||
3836859|NCT01691534|3663203|B7|Negative||HIV Status||participants|Number|11|11.0||||||
3836860|NCT01691534|3663204|B6|Negative||HIV Status||participants|Number|14|14.0||||||
3836861|NCT01691534|3663205|B5|Negative||HIV Status||participants|Number|13|13.0||||||
3836862|NCT01691534|3663206|B4|Negative||HIV Status||participants|Number|15|15.0||||||
3836863|NCT01691534|3663207|B3|Negative||HIV Status||participants|Number|12|12.0||||||
3836864|NCT01691534|3663208|B2|Negative||HIV Status||participants|Number|14|14.0||||||
3836865|NCT01691534|3663209|B1|Negative||HIV Status||participants|Number|14|14.0||||||
3836866|NCT01691534|3663202|B8|||BMI||kg/m^2|Mean|19.9|19.9|Standard Deviation|3.23|3.23|||
3836867|NCT01691534|3663203|B7|||BMI||kg/m^2|Mean|20.8|20.8|Standard Deviation|3.29|3.29|||
3836868|NCT01691534|3663204|B6|||BMI||kg/m^2|Mean|18.8|18.8|Standard Deviation|2.15|2.15|||
3836869|NCT01691534|3663205|B5|||BMI||kg/m^2|Mean|19.2|19.2|Standard Deviation|1.86|1.86|||
3836870|NCT01691534|3663206|B4|||BMI||kg/m^2|Mean|21.3|21.3|Standard Deviation|3.34|3.34|||
3836871|NCT01691534|3663207|B3|||BMI||kg/m^2|Mean|21.0|21.0|Standard Deviation|4.64|4.64|||
3836872|NCT01691534|3663208|B2|||BMI||kg/m^2|Mean|18.4|18.4|Standard Deviation|1.98|1.98|||
3836873|NCT01691534|3663209|B1|||BMI||kg/m^2|Mean|19.9|19.9|Standard Deviation|3.66|3.66|||
3836874|NCT01691534|3663202|B8|||Weight||kilograms|Mean|55.0|55.0|Standard Deviation|9.43|9.43|||
3836875|NCT01691534|3663203|B7|||Weight||kilograms|Mean|56.1|56.1|Standard Deviation|10.80|10.8|||
3836876|NCT01691534|3663204|B6|||Weight||kilograms|Mean|53.3|53.3|Standard Deviation|9.41|9.41|||
3836877|NCT01691534|3663205|B5|||Weight||kilograms|Mean|52.4|52.4|Standard Deviation|7.21|7.21|||
3836878|NCT01691534|3663206|B4|||Weight||kilograms|Mean|58.7|58.7|Standard Deviation|9.21|9.21|||
3836879|NCT01691534|3663207|B3|||Weight||kilograms|Mean|57.4|57.4|Standard Deviation|10.58|10.58|||
3836880|NCT01691534|3663208|B2|||Weight||kilograms|Mean|50.2|50.2|Standard Deviation|7.36|7.36|||
3836881|NCT01691534|3663209|B1|||Weight||kilograms|Mean|56.4|56.4|Standard Deviation|9.49|9.49|||
3836882|NCT01691534|3663202|B8|||Height||centimeters|Mean|166.3|166.3|Standard Deviation|9.28|9.28|||
3836883|NCT01691534|3663203|B7|||Height||centimeters|Mean|164.3|164.3|Standard Deviation|8.74|8.74|||
3836884|NCT01691534|3663204|B6|||Height||centimeters|Mean|167.8|167.8|Standard Deviation|9.05|9.05|||
3836885|NCT01691534|3663205|B5|||Height||centimeters|Mean|165.1|165.1|Standard Deviation|7.58|7.58|||
3836886|NCT01691534|3663206|B4|||Height||centimeters|Mean|166.6|166.6|Standard Deviation|11.86|11.86|||
3836887|NCT01691534|3663207|B3|||Height||centimeters|Mean|166.8|166.8|Standard Deviation|11.37|11.37|||
3836888|NCT01691534|3663208|B2|||Height||centimeters|Mean|165.3|165.3|Standard Deviation|8.64|8.64|||
3836889|NCT01691534|3663209|B1|||Height||centimeters|Mean|168.6|168.6|Standard Deviation|7.98|7.98|||
3836890|NCT01691534|3663202|B8|Mixed Ethnic||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
3836891|NCT01691534|3663203|B7|Mixed Ethnic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3836892|NCT01691534|3663204|B6|Mixed Ethnic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3836893|NCT01691534|3663205|B5|Mixed Ethnic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3836894|NCT01691534|3663206|B4|Mixed Ethnic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3836895|NCT01691534|3663207|B3|Mixed Ethnic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3836896|NCT01691534|3663208|B2|Mixed Ethnic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3836897|NCT01691534|3663209|B1|Mixed Ethnic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3836898|NCT01691534|3663202|B8|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3836899|NCT01691534|3663203|B7|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3836900|NCT01691534|3663204|B6|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3836901|NCT01691534|3663205|B5|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3836902|NCT01691534|3663206|B4|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3836903|NCT01691534|3663207|B3|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3836904|NCT01691534|3663208|B2|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3836905|NCT01691534|3663209|B1|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3836906|NCT01691534|3663202|B8|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3836907|NCT01691534|3663203|B7|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3836908|NCT01691534|3663204|B6|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3836909|NCT01691534|3663205|B5|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3836910|NCT01691534|3663206|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3836911|NCT01691534|3663207|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3836912|NCT01691534|3663208|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3836913|NCT01691534|3663209|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3836914|NCT01691534|3663202|B8|Black||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
3836915|NCT01691534|3663203|B7|Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3836916|NCT01691534|3663204|B6|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3836917|NCT01691534|3663205|B5|Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3836918|NCT01691534|3663206|B4|Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3836919|NCT01691534|3663207|B3|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3836920|NCT01691534|3663208|B2|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3836921|NCT01691534|3663209|B1|Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3836922|NCT01691534|3663202|B8||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3836923|NCT01691534|3663203|B7||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3836924|NCT01691534|3663204|B6||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3836925|NCT01691534|3663205|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3836926|NCT01691534|3663206|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3836927|NCT01691534|3663207|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3836928|NCT01691534|3663208|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3836929|NCT01691534|3663209|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3836930|NCT01691534|3663202|B8||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3836931|NCT01691534|3663203|B7||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3836932|NCT01691534|3663204|B6||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3836933|NCT01691534|3663205|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3836934|NCT01691534|3663206|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3836935|NCT01691534|3663207|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3836936|NCT01691534|3663208|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3836937|NCT01691534|3663209|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3836938|NCT01691534|3663202|B8|||Age||years|Mean|32.6|32.6|Standard Deviation|11.15|11.15|||
3836939|NCT01691534|3663203|B7|||Age||years|Mean|34.3|34.3|Standard Deviation|10.25|10.25|||
3836940|NCT01691534|3663204|B6|||Age||years|Mean|28.4|28.4|Standard Deviation|8.77|8.77|||
3836941|NCT01691534|3663205|B5|||Age||years|Mean|32.4|32.4|Standard Deviation|11.44|11.44|||
3836942|NCT01691534|3663206|B4|||Age||years|Mean|30.9|30.9|Standard Deviation|13.12|13.12|||
3836943|NCT01691534|3663207|B3|||Age||years|Mean|33.3|33.3|Standard Deviation|11.15|11.15|||
3836944|NCT01691534|3663208|B2|||Age||years|Mean|33.4|33.4|Standard Deviation|14.22|14.22|||
3836945|NCT01691534|3663209|B1|||Age||years|Mean|35.5|35.5|Standard Deviation|8.74|8.74|||
3836946|NCT01691521|3663266|B4|Mixed Race||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3836947|NCT01691521|3663267|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3836948|NCT01691521|3663268|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3836949|NCT01691521|3663269|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3836950|NCT01691521|3663266|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|440|440.0||||||
3836951|NCT01691521|3663267|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|148|148.0||||||
3836952|NCT01691521|3663268|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|148|148.0||||||
3836953|NCT01691521|3663269|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|144|144.0||||||
3836954|NCT01691521|3663266|B4|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3836955|NCT01691521|3663267|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3836956|NCT01691521|3663268|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3836957|NCT01691521|3663269|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3836958|NCT01691521|3663266|B4|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3836959|NCT01691521|3663267|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3836960|NCT01691521|3663268|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3836961|NCT01691521|3663269|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3836962|NCT01691521|3663266|B4|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|52|52.0||||||
3836963|NCT01691521|3663267|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
3836964|NCT01691521|3663268|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
3836965|NCT01691521|3663269|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
3836966|NCT01691521|3663266|B4|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|45|45.0||||||
3836967|NCT01691521|3663267|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
3836968|NCT01691521|3663268|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
3836969|NCT01691521|3663269|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
3836970|NCT01691521|3663266|B4|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3836971|NCT01691521|3663267|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3836972|NCT01691521|3663268|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3836973|NCT01691521|3663269|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3836974|NCT01691521|3663266|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3836975|NCT01691521|3663267|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3836976|NCT01691521|3663268|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3836977|NCT01691521|3663269|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3836978|NCT01691521|3663266|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
3836979|NCT01691521|3663267|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3836980|NCT01691521|3663268|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3836981|NCT01691521|3663269|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3836982|NCT01691521|3663266|B4||Male|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
3836983|NCT01691521|3663267|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3836984|NCT01691521|3663268|B2||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3836985|NCT01691521|3663269|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3836986|NCT01691521|3663266|B4||Female|Sex: Female, Male||Participants|Count of Participants|329|329.0||||||
3836987|NCT01691521|3663267|B3||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3836988|NCT01691521|3663268|B2||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3836989|NCT01691521|3663269|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3836990|NCT01691521|3663266|B4|||Age||Years|Mean|50.1|50.1|Standard Deviation|14.28|14.28|||
3836991|NCT01691521|3663267|B3|||Age||Years|Mean|51.2|51.2|Standard Deviation|14.55|14.55|||
3836992|NCT01691521|3663268|B2|||Age||Years|Mean|50.0|50.0|Standard Deviation|14.03|14.03|||
3836993|NCT01691521|3663269|B1|||Age||Years|Mean|49.2|49.2|Standard Deviation|14.26|14.26|||
3836994|NCT01691508|3663291|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3836995|NCT01691508|3663292|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3836996|NCT01691508|3663293|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3836997|NCT01691508|3663291|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|125|125.0||||||
3836998|NCT01691508|3663292|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|65|65.0||||||
3836999|NCT01691508|3663293|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|60|60.0||||||
3837000|NCT01691508|3663291|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3837001|NCT01691508|3663292|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3837002|NCT01691508|3663293|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3837003|NCT01691508|3663291|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3837004|NCT01691508|3663292|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3837005|NCT01691508|3663293|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3837006|NCT01691508|3663291|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3837007|NCT01691508|3663292|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3837008|NCT01691508|3663293|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3837009|NCT01691508|3663291|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3837010|NCT01691508|3663292|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3837011|NCT01691508|3663293|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3837012|NCT01691508|3663291|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3837013|NCT01691508|3663292|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3837014|NCT01691508|3663293|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3837015|NCT01691508|3663291|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3837016|NCT01691508|3663292|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3837017|NCT01691508|3663293|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3837018|NCT01691508|3663291|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3837019|NCT01691508|3663292|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3837020|NCT01691508|3663293|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3837021|NCT01691508|3663291|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3837022|NCT01691508|3663292|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3837023|NCT01691508|3663293|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3837024|NCT01691508|3663291|B3|||Age||Years|Mean|49.9|49.9|Standard Deviation|12.34|12.34|||
3837025|NCT01691508|3663292|B2|||Age||Years|Mean|49.8|49.8|Standard Deviation|14.10|14.1|||
3837026|NCT01691508|3663293|B1|||Age||Years|Mean|49.9|49.9|Standard Deviation|10.30|10.3|||
3837027|NCT01691482|3663308|B1|White||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
3837028|NCT01691482|3663308|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3837029|NCT01691482|3663308|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3837030|NCT01691482|3663308|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3837031|NCT01691482|3663308|B1|||Age||Years|Mean|60.3|60.3|Standard Deviation|7.42|7.42|||
3837032|NCT01691430|3663325|B3|||Bacteriuria plus pyuria||participants|Number|59|59.0||||||
3837033|NCT01691430|3663326|B2|||Bacteriuria plus pyuria||participants|Number|32|32.0||||||
3837034|NCT01691430|3663327|B1|||Bacteriuria plus pyuria||participants|Number|27|27.0||||||
3837035|NCT01691430|3663325|B3|Non-White||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3837036|NCT01691430|3663326|B2|Non-White||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3837037|NCT01691430|3663327|B1|Non-White||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3837038|NCT01691430|3663325|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|167|167.0||||||
3837039|NCT01691430|3663326|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|84|84.0||||||
3837040|NCT01691430|3663327|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|83|83.0||||||
3837041|NCT01691430|3663325|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837042|NCT01691430|3663326|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837043|NCT01691430|3663327|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837044|NCT01691430|3663325|B3||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
3837045|NCT01691430|3663326|B2||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3837046|NCT01691430|3663327|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3837047|NCT01691430|3663325|B3||>=65 years|Age||Participants|Count of Participants|185|185.0||||||
3837048|NCT01691430|3663326|B2||>=65 years|Age||Participants|Count of Participants|93|93.0||||||
3837049|NCT01691430|3663327|B1||>=65 years|Age||Participants|Count of Participants|92|92.0||||||
3837050|NCT01691430|3663325|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3837051|NCT01691430|3663326|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3837052|NCT01691430|3663327|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3837053|NCT01691430|3663325|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837054|NCT01691430|3663326|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837055|NCT01691430|3663327|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837056|NCT01691339|3663352|B5|United States||Region of Enrollment||Participants|Number|200|200.0||||||
3837057|NCT01691339|3663353|B4|United States||Region of Enrollment||Participants|Number|49|49.0||||||
3837058|NCT01691339|3663354|B3|United States||Region of Enrollment||Participants|Number|51|51.0||||||
3837059|NCT01691339|3663355|B2|United States||Region of Enrollment||Participants|Number|50|50.0||||||
3837060|NCT01691339|3663356|B1|United States||Region of Enrollment||Participants|Number|50|50.0||||||
3837061|NCT01691339|3663352|B5||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3837062|NCT01691339|3663353|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3837063|NCT01691339|3663354|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3837064|NCT01691339|3663355|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3837065|NCT01691339|3663356|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3837066|NCT01691339|3663352|B5||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3837067|NCT01691339|3663353|B4||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3837068|NCT01691339|3663354|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3837069|NCT01691339|3663355|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3837070|NCT01691339|3663356|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3837071|NCT01691339|3663352|B5|||Age||Years|Mean|57.4|57.4|Standard Deviation|18.7|18.7|||
3837072|NCT01691339|3663353|B4|||Age||Years|Mean|72.2|72.2|Standard Deviation|5.2|5.2|||
3837073|NCT01691339|3663354|B3|||Age||Years|Mean|73.3|73.3|Standard Deviation|5.7|5.7|||
3837074|NCT01691339|3663355|B2|||Age||Years|Mean|40.5|40.5|Standard Deviation|14.2|14.2|||
3837075|NCT01691339|3663356|B1|||Age||Years|Mean|43.4|43.4|Standard Deviation|13.6|13.6|||
3837076|NCT01691339|3663352|B5||>=65 years|Age||Participants|Count of Participants|100|100.0||||||
3837077|NCT01691339|3663353|B4||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
3837078|NCT01691339|3663354|B3||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
3837079|NCT01691339|3663355|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3837080|NCT01691339|3663356|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3837081|NCT01691339|3663352|B5||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
3837082|NCT01691339|3663353|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3837083|NCT01691339|3663354|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3837084|NCT01691339|3663355|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3837085|NCT01691339|3663356|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3837086|NCT01691339|3663352|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837087|NCT01691339|3663353|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837088|NCT01691339|3663354|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837089|NCT01691339|3663355|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837090|NCT01691339|3663356|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837091|NCT01691326|3663385|B3|United States||Region of Enrollment||Participants|Number|60|60.0||||||
3837092|NCT01691326|3663386|B2|United States||Region of Enrollment||Participants|Number|30|30.0||||||
3837093|NCT01691326|3663387|B1|United States||Region of Enrollment||Participants|Number|30|30.0||||||
3837094|NCT01691326|3663385|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3837095|NCT01691326|3663386|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3837096|NCT01691326|3663387|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3837097|NCT01691326|3663385|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3837098|NCT01691326|3663386|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3837099|NCT01691326|3663387|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3837100|NCT01691326|3663385|B3|||Age||Years|Mean|3.5|3.5|Standard Deviation|1.2|1.2|||
3837101|NCT01691326|3663386|B2|||Age||Years|Mean|5.2|5.2|Standard Deviation|1.6|1.6|||
3837102|NCT01691326|3663387|B1|||Age||Years|Mean|1.8|1.8|Standard Deviation|0.6|0.6|||
3837103|NCT01691326|3663385|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3837104|NCT01691326|3663386|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3837105|NCT01691326|3663387|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3837106|NCT01691326|3663385|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3837107|NCT01691326|3663386|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3837108|NCT01691326|3663387|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3837109|NCT01691326|3663385|B3||<=18 years|Age||Participants|Count of Participants|60|60.0||||||
3837110|NCT01691326|3663386|B2||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
3837111|NCT01691326|3663387|B1||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
3837112|NCT01691313|3663402|B5||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3837113|NCT01691313|3663403|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3837114|NCT01691313|3663404|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3837115|NCT01691313|3663405|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3837116|NCT01691313|3663406|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3837117|NCT01691313|3663402|B5||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3837118|NCT01691313|3663403|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3837119|NCT01691313|3663404|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3837120|NCT01691313|3663405|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3837121|NCT01691313|3663406|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3837122|NCT01691313|3663402|B5|||Age||years|Mean|64|64.0|Standard Deviation|11|11.0|||
3837123|NCT01691313|3663403|B4|||Age||years|Mean|68.4|68.4|Standard Deviation|9.6|9.6|||
3837124|NCT01691313|3663404|B3|||Age||years|Mean|63.4|63.4|Standard Deviation|9.4|9.4|||
3837125|NCT01691313|3663405|B2|||Age||years|Mean|61.7|61.7|Standard Deviation|12.2|12.2|||
3837126|NCT01691313|3663406|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|12.2|12.2|||
3837127|NCT01691248|3663423|B3||Male|Sex: Female, Male||Participants|Count of Participants|372|372.0||||||
3837128|NCT01691248|3663424|B2||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
3837129|NCT01691248|3663425|B1||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
3837130|NCT01691248|3663423|B3||Female|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
3837131|NCT01691248|3663424|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3837132|NCT01691248|3663425|B1||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3837133|NCT01691248|3663423|B3|||Age||Years|Mean|55.1|55.1|Standard Deviation|12.62|12.62|||
3837134|NCT01691248|3663424|B2|||Age||Years|Mean|55.1|55.1|Standard Deviation|13.23|13.23|||
3837135|NCT01691248|3663425|B1|||Age||Years|Mean|55.1|55.1|Standard Deviation|12.00|12.0|||
3837136|NCT01691105|3663436|B3|||Heavy Smoking Index >= 4, N (%)||Participants|Count of Participants|418|418.0||||||
3837137|NCT01691105|3663437|B2|||Heavy Smoking Index >= 4, N (%)||Participants|Count of Participants|210|210.0||||||
3837138|NCT01691105|3663438|B1|||Heavy Smoking Index >= 4, N (%)||Participants|Count of Participants|208|208.0||||||
3837139|NCT01691105|3663436|B3|||Cigarettes/day||cigarettes|Median|10.0|10.0|Inter-Quartile Range|||8.0|20.0|
3837140|NCT01691105|3663437|B2|||Cigarettes/day||cigarettes|Median|10.5|10.5|Inter-Quartile Range|||8.0|20.0|
3837141|NCT01691105|3663438|B1|||Cigarettes/day||cigarettes|Median|10.0|10.0|Inter-Quartile Range|||8.0|20.0|
3837142|NCT01691105|3663436|B3|United States||Region of Enrollment||participants|Number|1044|1044.0||||||
3837143|NCT01691105|3663437|B2|United States||Region of Enrollment||participants|Number|567|567.0||||||
3837144|NCT01691105|3663438|B1|United States||Region of Enrollment||participants|Number|477|477.0||||||
3837145|NCT01691105|3663436|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3837146|NCT01691105|3663437|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3837147|NCT01691105|3663438|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837148|NCT01691105|3663436|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3837149|NCT01691105|3663437|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3837150|NCT01691105|3663438|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3837151|NCT01691105|3663436|B3||White|Race (NIH/OMB)||Participants|Count of Participants|675|675.0||||||
3837152|NCT01691105|3663437|B2||White|Race (NIH/OMB)||Participants|Count of Participants|372|372.0||||||
3837153|NCT01691105|3663438|B1||White|Race (NIH/OMB)||Participants|Count of Participants|303|303.0||||||
3837154|NCT01691105|3663436|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|327|327.0||||||
3837155|NCT01691105|3663437|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|170|170.0||||||
3837156|NCT01691105|3663438|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|157|157.0||||||
3837157|NCT01691105|3663436|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837158|NCT01691105|3663437|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837159|NCT01691105|3663438|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837160|NCT01691105|3663436|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3837161|NCT01691105|3663437|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3837162|NCT01691105|3663438|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3837163|NCT01691105|3663436|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3837164|NCT01691105|3663437|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3837165|NCT01691105|3663438|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3837166|NCT01691105|3663436|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837167|NCT01691105|3663437|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837168|NCT01691105|3663438|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837169|NCT01691105|3663436|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|932|932.0||||||
3837170|NCT01691105|3663437|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|506|506.0||||||
3837171|NCT01691105|3663438|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|426|426.0||||||
3837172|NCT01691105|3663436|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|112|112.0||||||
3837173|NCT01691105|3663437|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3837174|NCT01691105|3663438|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3837175|NCT01691105|3663436|B3||Male|Sex: Female, Male||Participants|Count of Participants|520|520.0||||||
3837176|NCT01691105|3663437|B2||Male|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
3837177|NCT01691105|3663438|B1||Male|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
3837178|NCT01691105|3663436|B3||Female|Sex: Female, Male||Participants|Count of Participants|524|524.0||||||
3837179|NCT01691105|3663437|B2||Female|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
3837180|NCT01691105|3663438|B1||Female|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
3837181|NCT01691105|3663436|B3|||Age||years|Mean|49.3|49.3|Standard Deviation|12.1|12.1|||
3837182|NCT01691105|3663437|B2|||Age||years|Mean|49.3|49.3|Standard Deviation|11.7|11.7|||
3837183|NCT01691105|3663438|B1|||Age||years|Mean|49.3|49.3|Standard Deviation|12.6|12.6|||
3837184|NCT01691092|3663459|B1||Comorbid MDD & PTSD|diagnosis||Participants|Count of Participants|4|4.0||||||
3837185|NCT01691092|3663459|B1||Post-Traumatic Stress Disorder (PTSD)|diagnosis||Participants|Count of Participants|4|4.0||||||
3837186|NCT01691092|3663459|B1||Major Depressive Disorder (MDD)|diagnosis||Participants|Count of Participants|14|14.0||||||
3837187|NCT01691092|3663459|B1||Healthy Control (HC)|diagnosis||Participants|Count of Participants|20|20.0||||||
3837188|NCT01691092|3663459|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3837189|NCT01691092|3663459|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3837190|NCT01691092|3663459|B1|||Age||years|Mean|34.07143|34.07143|Standard Deviation|12.12615|12.12615|||
3837191|NCT01691027|3663463|B1|||SLO retinal functional map||percent traced|Mean|80|80.0|Full Range|||0.0|100.0|
3837192|NCT01691027|3663463|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3837193|NCT01691027|3663463|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3837194|NCT01691027|3663463|B1|||Age||Years|Mean|84.5|84.5|Full Range|||65.0|92.0|
3837195|NCT01691014|3663468|B5||Male|Gender||Participants|Count of Participants|25|25.0||||||
3837196|NCT01691014|3663469|B4||Male|Gender||Participants|Count of Participants|3|3.0||||||
3837197|NCT01691014|3663470|B3||Male|Gender||Participants|Count of Participants|13|13.0||||||
3837198|NCT01691014|3663471|B2||Male|Gender||Participants|Count of Participants|5|5.0||||||
3837199|NCT01691014|3663472|B1||Male|Gender||Participants|Count of Participants|4|4.0||||||
3837200|NCT01691014|3663468|B5||Female|Gender||Participants|Count of Participants|54|54.0||||||
3837201|NCT01691014|3663469|B4||Female|Gender||Participants|Count of Participants|6|6.0||||||
3837202|NCT01691014|3663470|B3||Female|Gender||Participants|Count of Participants|23|23.0||||||
3837203|NCT01691014|3663471|B2||Female|Gender||Participants|Count of Participants|21|21.0||||||
3837204|NCT01691014|3663472|B1||Female|Gender||Participants|Count of Participants|4|4.0||||||
3837205|NCT01691014|3663468|B5|||Age||years|Mean|55|55.0|Standard Deviation|13|13.0|||
3837206|NCT01691014|3663469|B4|||Age||years|Mean|51|51.0|Standard Deviation|11|11.0|||
3837207|NCT01691014|3663470|B3|||Age||years|Mean|56|56.0|Standard Deviation|14|14.0|||
3837208|NCT01691014|3663471|B2|||Age||years|Mean|57|57.0|Standard Deviation|13|13.0|||
3837209|NCT01691014|3663472|B1|||Age||years|Mean|51|51.0|Standard Deviation|6|6.0|||
3837210|NCT01690988|3663517|B4|South Korea||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3837211|NCT01690988|3663518|B3|South Korea||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3837212|NCT01690988|3663519|B2|South Korea||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3837213|NCT01690988|3663520|B1|South Korea||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3837214|NCT01690988|3663517|B4|India||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3837215|NCT01690988|3663518|B3|India||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3837216|NCT01690988|3663519|B2|India||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3837217|NCT01690988|3663520|B1|India||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3837218|NCT01690988|3663517|B4|Canada||Region of Enrollment||Participants|Count of Participants|183|183.0||||||
3837219|NCT01690988|3663518|B3|Canada||Region of Enrollment||Participants|Count of Participants|59|59.0||||||
3837220|NCT01690988|3663519|B2|Canada||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
3837221|NCT01690988|3663520|B1|Canada||Region of Enrollment||Participants|Count of Participants|63|63.0||||||
3837222|NCT01690988|3663517|B4|United States||Region of Enrollment||Participants|Count of Participants|443|443.0||||||
3837223|NCT01690988|3663518|B3|United States||Region of Enrollment||Participants|Count of Participants|149|149.0||||||
3837224|NCT01690988|3663519|B2|United States||Region of Enrollment||Participants|Count of Participants|147|147.0||||||
3837225|NCT01690988|3663520|B1|United States||Region of Enrollment||Participants|Count of Participants|147|147.0||||||
3837226|NCT01690988|3663517|B4||Male|Sex: Female, Male||Participants|Count of Participants|418|418.0||||||
3837227|NCT01690988|3663518|B3||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3837228|NCT01690988|3663519|B2||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3837229|NCT01690988|3663520|B1||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3837230|NCT01690988|3663517|B4||Female|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
3837231|NCT01690988|3663518|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3837232|NCT01690988|3663519|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3837233|NCT01690988|3663520|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3837234|NCT01690988|3663517|B4|||Age||Years|Mean|70|70.0|Standard Deviation|7.1|7.1|||
3837235|NCT01690988|3663518|B3|||Age||Years|Mean|70|70.0|Standard Deviation|7.3|7.3|||
3837236|NCT01690988|3663519|B2|||Age||Years|Mean|70|70.0|Standard Deviation|6.9|6.9|||
3837237|NCT01690988|3663520|B1|||Age||Years|Mean|70|70.0|Standard Deviation|7.2|7.2|||
3837238|NCT01690988|3663517|B4||>=65 years|Age||Participants|Count of Participants|496|496.0||||||
3837239|NCT01690988|3663518|B3||>=65 years|Age||Participants|Count of Participants|162|162.0||||||
3837240|NCT01690988|3663519|B2||>=65 years|Age||Participants|Count of Participants|163|163.0||||||
3837241|NCT01690988|3663520|B1||>=65 years|Age||Participants|Count of Participants|171|171.0||||||
3837242|NCT01690988|3663517|B4||Between 18 and 65 years|Age||Participants|Count of Participants|176|176.0||||||
3837243|NCT01690988|3663518|B3||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
3837244|NCT01690988|3663519|B2||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
3837245|NCT01690988|3663520|B1||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
3837246|NCT01690988|3663517|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837247|NCT01690988|3663518|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837248|NCT01690988|3663519|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837249|NCT01690988|3663520|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837250|NCT01690923|3663547|B1|Australia||Region of Enrollment||participants|Number|20|20.0||||||
3837251|NCT01690923|3663547|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3837252|NCT01690923|3663547|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3837253|NCT01690923|3663547|B1|||Age||years|Mean|64.6|64.6|Standard Deviation|9.5|9.5|||
3837254|NCT01690923|3663547|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3837255|NCT01690923|3663547|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3837256|NCT01690923|3663547|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837257|NCT01690663|3663553|B5|||BMI||kg/m2|Mean|30.3|30.3|Standard Deviation|5.7|5.7|||
3837258|NCT01690663|3663554|B4|||BMI||kg/m2|Mean|31.0|31.0|Standard Deviation|6.3|6.3|||
3837259|NCT01690663|3663555|B3|||BMI||kg/m2|Mean|28.9|28.9|Standard Deviation|4.4|4.4|||
3837260|NCT01690663|3663556|B2|||BMI||kg/m2|Mean|29.4|29.4|Standard Deviation|4.0|4.0|||
3837261|NCT01690663|3663557|B1|||BMI||kg/m2|Mean|30.4|30.4|Standard Deviation|6.6|6.6|||
3837262|NCT01690663|3663553|B5|United States||Region of Enrollment||participants|Number|89|89.0||||||
3837263|NCT01690663|3663554|B4|United States||Region of Enrollment||participants|Number|24|24.0||||||
3837264|NCT01690663|3663555|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
3837265|NCT01690663|3663556|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3837266|NCT01690663|3663557|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
3837267|NCT01690663|3663553|B5||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3837268|NCT01690663|3663554|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3837269|NCT01690663|3663555|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3837270|NCT01690663|3663556|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3837271|NCT01690663|3663557|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3837272|NCT01690663|3663553|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3837273|NCT01690663|3663554|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3837274|NCT01690663|3663555|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3837275|NCT01690663|3663556|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3837276|NCT01690663|3663557|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3837277|NCT01690663|3663553|B5|||Age||years|Mean|48.4|48.4|Standard Deviation|12.4|12.4|||
3837278|NCT01690663|3663554|B4|||Age||years|Mean|53.0|53.0|Standard Deviation|12.5|12.5|||
3837279|NCT01690663|3663555|B3|||Age||years|Mean|48.8|48.8|Standard Deviation|14.1|14.1|||
3837280|NCT01690663|3663556|B2|||Age||years|Mean|46.2|46.2|Standard Deviation|11.8|11.8|||
3837281|NCT01690663|3663557|B1|||Age||years|Mean|47.1|47.1|Standard Deviation|11.3|11.3|||
3837282|NCT01690663|3663553|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3837283|NCT01690663|3663554|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3837284|NCT01690663|3663555|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3837285|NCT01690663|3663556|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3837286|NCT01690663|3663557|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3837287|NCT01690663|3663553|B5||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
3837288|NCT01690663|3663554|B4||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3837289|NCT01690663|3663555|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3837290|NCT01690663|3663556|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3837291|NCT01690663|3663557|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3837292|NCT01690663|3663553|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837293|NCT01690663|3663554|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837294|NCT01690663|3663555|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837295|NCT01690663|3663556|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837296|NCT01690663|3663557|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837297|NCT01690546|3663574|B1|||Years of Opioid use||years|Mean|9.7|9.7|Full Range|||7.0|18.0|
3837298|NCT01690546|3663574|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3837299|NCT01690546|3663574|B1|African American||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3837300|NCT01690546|3663574|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3837301|NCT01690546|3663574|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3837302|NCT01690546|3663574|B1|||Age||years|Mean|40.1|40.1|Full Range|||25.0|65.0|
3837303|NCT01690299|3663587|B4||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3837304|NCT01690299|3663588|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3837305|NCT01690299|3663589|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3837306|NCT01690299|3663590|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3837307|NCT01690299|3663587|B4||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3837308|NCT01690299|3663588|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3837309|NCT01690299|3663589|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3837310|NCT01690299|3663590|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3837311|NCT01690299|3663587|B4|||Age||years|Mean|45.4|45.4|Standard Deviation|14.23|14.23|||
3837312|NCT01690299|3663588|B3|||Age||years|Mean|47.0|47.0|Standard Deviation|14.07|14.07|||
3837313|NCT01690299|3663589|B2|||Age||years|Mean|46.0|46.0|Standard Deviation|13.59|13.59|||
3837314|NCT01690299|3663590|B1|||Age||years|Mean|43.4|43.4|Standard Deviation|14.91|14.91|||
3837315|NCT01690273|3663637|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837316|NCT01690273|3663638|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837317|NCT01690273|3663639|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837318|NCT01690273|3663640|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837319|NCT01690273|3663637|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3837320|NCT01690273|3663638|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3837321|NCT01690273|3663639|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3837322|NCT01690273|3663640|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3837323|NCT01690273|3663637|B4||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3837324|NCT01690273|3663638|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3837325|NCT01690273|3663639|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3837326|NCT01690273|3663640|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3837327|NCT01690273|3663637|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837328|NCT01690273|3663638|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837329|NCT01690273|3663639|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837330|NCT01690273|3663640|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837331|NCT01690273|3663637|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837332|NCT01690273|3663638|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837333|NCT01690273|3663639|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837334|NCT01690273|3663640|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837335|NCT01690273|3663637|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837336|NCT01690273|3663638|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837337|NCT01690273|3663639|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837338|NCT01690273|3663640|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837339|NCT01690273|3663637|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837340|NCT01690273|3663638|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837341|NCT01690273|3663639|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837342|NCT01690273|3663640|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837343|NCT01690273|3663637|B4||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3837344|NCT01690273|3663638|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3837345|NCT01690273|3663639|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3837346|NCT01690273|3663640|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3837347|NCT01690273|3663637|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3837348|NCT01690273|3663638|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3837349|NCT01690273|3663639|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3837350|NCT01690273|3663640|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3837351|NCT01690273|3663637|B4|||Age||years|Mean|48.2|48.2|Standard Deviation|11.7|11.7|||
3837352|NCT01690273|3663638|B3|||Age||years|Mean|48.3|48.3|Standard Deviation|11.1|11.1|||
3837353|NCT01690273|3663639|B2|||Age||years|Mean|49.2|49.2|Standard Deviation|13.1|13.1|||
3837354|NCT01690273|3663640|B1|||Age||years|Mean|47.1|47.1|Standard Deviation|10.8|10.8|||
3837355|NCT01690143|3663692|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3837356|NCT01690143|3663692|B1|Non-Hispanic Blacks||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3837357|NCT01690143|3663692|B1|Non-Hispanic Whites||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3837358|NCT01690143|3663692|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3837359|NCT01690143|3663692|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3837360|NCT01690143|3663692|B1|||Age|Time in years from birth to enrollment|years|Median|58|58.0|Full Range|||41.0|69.0|
3837361|NCT01690130|3663700|B3|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3837362|NCT01690130|3663701|B2|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3837363|NCT01690130|3663702|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3837364|NCT01690130|3663700|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837365|NCT01690130|3663701|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837366|NCT01690130|3663702|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837367|NCT01690130|3663700|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837368|NCT01690130|3663701|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837369|NCT01690130|3663702|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837370|NCT01690130|3663700|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3837371|NCT01690130|3663701|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3837372|NCT01690130|3663702|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3837373|NCT01690130|3663700|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3837374|NCT01690130|3663701|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3837375|NCT01690130|3663702|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3837376|NCT01690130|3663700|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837377|NCT01690130|3663701|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837378|NCT01690130|3663702|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837379|NCT01690130|3663700|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837380|NCT01690130|3663701|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837381|NCT01690130|3663702|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837382|NCT01690130|3663700|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837383|NCT01690130|3663701|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837384|NCT01690130|3663702|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837385|NCT01690130|3663700|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837386|NCT01690130|3663701|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837387|NCT01690130|3663702|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837388|NCT01690130|3663700|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3837389|NCT01690130|3663701|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3837390|NCT01690130|3663702|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3837391|NCT01690130|3663700|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837392|NCT01690130|3663701|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837393|NCT01690130|3663702|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837394|NCT01690130|3663700|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3837395|NCT01690130|3663701|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3837396|NCT01690130|3663702|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3837397|NCT01690130|3663700|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3837398|NCT01690130|3663701|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3837399|NCT01690130|3663702|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3837400|NCT01690130|3663700|B3|||Age||year|Mean|42|42.0|Standard Deviation|11.5|11.5|||
3837401|NCT01690130|3663701|B2|||Age||year|Mean|42|42.0|Standard Deviation|11.5|11.5|||
3837402|NCT01690130|3663702|B1|||Age||year|Mean|42|42.0|Standard Deviation|11.5|11.5|||
3837403|NCT01690130|3663700|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3837404|NCT01690130|3663701|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3837405|NCT01690130|3663702|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3837406|NCT01690130|3663700|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3837407|NCT01690130|3663701|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3837408|NCT01690130|3663702|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3837409|NCT01690130|3663700|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837410|NCT01690130|3663701|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837411|NCT01690130|3663702|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837412|NCT01690117|3663711|B3|Germany||Region of Enrollment||participants|Number|92|92.0||||||
3837413|NCT01690117|3663712|B2|Germany||Region of Enrollment||participants|Number|45|45.0||||||
3837414|NCT01690117|3663713|B1|Germany||Region of Enrollment||participants|Number|47|47.0||||||
3837415|NCT01690117|3663711|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3837416|NCT01690117|3663712|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3837417|NCT01690117|3663713|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3837418|NCT01690117|3663711|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3837419|NCT01690117|3663712|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3837420|NCT01690117|3663713|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3837421|NCT01690117|3663711|B3|||Age||years|Mean|73.1|73.1|Standard Deviation|8.1|8.1|||
3837422|NCT01690117|3663712|B2|||Age||years|Mean|73.9|73.9|Standard Deviation|8.2|8.2|||
3837423|NCT01690117|3663713|B1|||Age||years|Mean|72.3|72.3|Standard Deviation|8.1|8.1|||
3837424|NCT01690117|3663711|B3||>=65 years|Age||Participants|Count of Participants|78|78.0||||||
3837425|NCT01690117|3663712|B2||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
3837426|NCT01690117|3663713|B1||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
3837427|NCT01690117|3663711|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3837428|NCT01690117|3663712|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3837429|NCT01690117|3663713|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3837430|NCT01690117|3663711|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837431|NCT01690117|3663712|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837432|NCT01690117|3663713|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837433|NCT01690052|3663750|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3837434|NCT01690052|3663750|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3837435|NCT01690052|3663750|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3837436|NCT01690052|3663750|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3837437|NCT01690052|3663750|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3837438|NCT01690052|3663750|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837439|NCT01690000|3663757|B3|Denmark||Region of Enrollment||participants|Number|81|81.0||||||
3837440|NCT01690000|3663758|B2|Denmark||Region of Enrollment||participants|Number|41|41.0||||||
3837441|NCT01690000|3663759|B1|Denmark||Region of Enrollment||participants|Number|40|40.0||||||
3837442|NCT01690000|3663757|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837443|NCT01690000|3663758|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837444|NCT01690000|3663759|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837445|NCT01690000|3663757|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3837446|NCT01690000|3663758|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3837447|NCT01690000|3663759|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3837448|NCT01690000|3663757|B3||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3837449|NCT01690000|3663758|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3837450|NCT01690000|3663759|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3837451|NCT01690000|3663757|B3||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
3837452|NCT01690000|3663758|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3837453|NCT01690000|3663759|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3837454|NCT01690000|3663757|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837455|NCT01690000|3663758|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837456|NCT01690000|3663759|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837457|NCT01689974|3663766|B3|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3837458|NCT01689974|3663767|B2|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3837459|NCT01689974|3663768|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3837460|NCT01689974|3663766|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3837461|NCT01689974|3663767|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3837462|NCT01689974|3663768|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3837463|NCT01689974|3663766|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3837464|NCT01689974|3663767|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3837465|NCT01689974|3663768|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3837466|NCT01689974|3663766|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3837467|NCT01689974|3663767|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3837468|NCT01689974|3663768|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3837469|NCT01689974|3663766|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3837470|NCT01689974|3663767|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3837471|NCT01689974|3663768|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3837472|NCT01689974|3663766|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837473|NCT01689974|3663767|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837474|NCT01689974|3663768|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837475|NCT01689909|3663775|B3|||Insomnia Severity Index|The Insomnia Severity Index is self rated. It has 7 items, each scored 0-4. Therefore the range of scores is 0-28, with higher scores indicating worse insomnia|units on a scale|Mean|20.8|20.8|Standard Deviation|4.1|4.1|||
3837476|NCT01689909|3663776|B2|||Insomnia Severity Index|The Insomnia Severity Index is self rated. It has 7 items, each scored 0-4. Therefore the range of scores is 0-28, with higher scores indicating worse insomnia|units on a scale|Mean|21.1|21.1|Standard Deviation|4.3|4.3|||
3837477|NCT01689909|3663777|B1|||Insomnia Severity Index|The Insomnia Severity Index is self rated. It has 7 items, each scored 0-4. Therefore the range of scores is 0-28, with higher scores indicating worse insomnia|units on a scale|Mean|20.6|20.6|Standard Deviation|3.9|3.9|||
3837478|NCT01689909|3663775|B3|||Disturbing Dreams Nightmare Severity Index|This self-rated scale has 5 items, with asymmetric weighting of each item. The range of the total score is 0-37, with higher scores indicating worse nightmares|units on a scale|Mean|10.3|10.3|Standard Deviation|8.2|8.2|||
3837479|NCT01689909|3663776|B2|||Disturbing Dreams Nightmare Severity Index|This self-rated scale has 5 items, with asymmetric weighting of each item. The range of the total score is 0-37, with higher scores indicating worse nightmares|units on a scale|Mean|10.2|10.2|Standard Deviation|7.7|7.7|||
3837480|NCT01689909|3663777|B1|||Disturbing Dreams Nightmare Severity Index|This self-rated scale has 5 items, with asymmetric weighting of each item. The range of the total score is 0-37, with higher scores indicating worse nightmares|units on a scale|Mean|10.5|10.5|Standard Deviation|8.8|8.8|||
3837481|NCT01689909|3663775|B3|||Hamilton Rating Scale for Depression -24|This version of the Hamilton Rating Scale for Depression uses 24 items, with a possible total score ranging from 0-74, with higher scores indicating worse depression|units on a scale|Mean|29.1|29.1|Standard Deviation|5.9|5.9|||
3837482|NCT01689909|3663776|B2|||Hamilton Rating Scale for Depression -24|This version of the Hamilton Rating Scale for Depression uses 24 items, with a possible total score ranging from 0-74, with higher scores indicating worse depression|units on a scale|Mean|29.6|29.6|Standard Deviation|7.0|7.0|||
3837483|NCT01689909|3663777|B1|||Hamilton Rating Scale for Depression -24|This version of the Hamilton Rating Scale for Depression uses 24 items, with a possible total score ranging from 0-74, with higher scores indicating worse depression|units on a scale|Mean|28.7|28.7|Standard Deviation|4.7|4.7|||
3837484|NCT01689909|3663775|B3|||Scale for Suicide Ideation|This is the total score for the Scale for Suicide Ideation. It has 19 items, each scored 0-2, for a maximum of 38 points. Higher scores indicate worse suicidal ideation|units on a scale|Mean|12.0|12.0|Standard Deviation|5.3|5.3|||
3837485|NCT01689909|3663776|B2|||Scale for Suicide Ideation|This is the total score for the Scale for Suicide Ideation. It has 19 items, each scored 0-2, for a maximum of 38 points. Higher scores indicate worse suicidal ideation|units on a scale|Mean|11.8|11.8|Standard Deviation|5.3|5.3|||
3837486|NCT01689909|3663777|B1|||Scale for Suicide Ideation|This is the total score for the Scale for Suicide Ideation. It has 19 items, each scored 0-2, for a maximum of 38 points. Higher scores indicate worse suicidal ideation|units on a scale|Mean|12.2|12.2|Standard Deviation|5.3|5.3|||
3837487|NCT01689909|3663775|B3|United States||Region of Enrollment||participants|Number|103|103.0||||||
3837488|NCT01689909|3663776|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
3837489|NCT01689909|3663777|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
3837490|NCT01689909|3663775|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837491|NCT01689909|3663776|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837492|NCT01689909|3663777|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837493|NCT01689909|3663775|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837494|NCT01689909|3663776|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837495|NCT01689909|3663777|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837496|NCT01689909|3663775|B3||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3837497|NCT01689909|3663776|B2||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3837498|NCT01689909|3663777|B1||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3837499|NCT01689909|3663775|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3837500|NCT01689909|3663776|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3837501|NCT01689909|3663777|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3837502|NCT01689909|3663775|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837503|NCT01689909|3663776|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837504|NCT01689909|3663777|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837505|NCT01689909|3663775|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3837506|NCT01689909|3663776|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3837507|NCT01689909|3663777|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3837508|NCT01689909|3663775|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837509|NCT01689909|3663776|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837510|NCT01689909|3663777|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837511|NCT01689909|3663775|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837512|NCT01689909|3663776|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837513|NCT01689909|3663777|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837514|NCT01689909|3663775|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3837515|NCT01689909|3663776|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3837516|NCT01689909|3663777|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3837517|NCT01689909|3663775|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3837518|NCT01689909|3663776|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3837519|NCT01689909|3663777|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3837520|NCT01689909|3663775|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3837521|NCT01689909|3663776|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3837522|NCT01689909|3663777|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3837523|NCT01689909|3663775|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3837524|NCT01689909|3663776|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3837525|NCT01689909|3663777|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3837526|NCT01689909|3663775|B3|||Age||years|Mean|40.5|40.5|Standard Deviation|13.2|13.2|||
3837527|NCT01689909|3663776|B2|||Age||years|Mean|41.2|41.2|Standard Deviation|12.0|12.0|||
3837528|NCT01689909|3663777|B1|||Age||years|Mean|39.7|39.7|Standard Deviation|14.5|14.5|||
3837529|NCT01689909|3663775|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3837530|NCT01689909|3663776|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3837531|NCT01689909|3663777|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3837532|NCT01689909|3663775|B3||Between 18 and 65 years|Age||Participants|Count of Participants|103|103.0||||||
3837533|NCT01689909|3663776|B2||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3837534|NCT01689909|3663777|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3837535|NCT01689909|3663775|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837536|NCT01689909|3663776|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837537|NCT01689909|3663777|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837538|NCT01689857|3663796|B3|Korea, Republic of||Region of Enrollment||participants|Number|40|40.0||||||
3837539|NCT01689857|3663797|B2|Korea, Republic of||Region of Enrollment||participants|Number|20|20.0||||||
3837540|NCT01689857|3663798|B1|Korea, Republic of||Region of Enrollment||participants|Number|20|20.0||||||
3837541|NCT01689857|3663796|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3837542|NCT01689857|3663797|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3837543|NCT01689857|3663798|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3837544|NCT01689857|3663796|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3837545|NCT01689857|3663797|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3837546|NCT01689857|3663798|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3837547|NCT01689857|3663796|B3|||Age||years|Mean|37.95|37.95|Standard Deviation|10.26|10.26|||
3837548|NCT01689857|3663797|B2|||Age||years|Mean|36.00|36.0|Standard Deviation|9.93|9.93|||
3837549|NCT01689857|3663798|B1|||Age||years|Mean|39.90|39.9|Standard Deviation|10.47|10.47|||
3837550|NCT01689857|3663796|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3837551|NCT01689857|3663797|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3837552|NCT01689857|3663798|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3837553|NCT01689857|3663796|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3837554|NCT01689857|3663797|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3837555|NCT01689857|3663798|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3837556|NCT01689857|3663796|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837557|NCT01689857|3663797|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837558|NCT01689857|3663798|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837559|NCT01689779|3663805|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837560|NCT01689779|3663806|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837561|NCT01689779|3663807|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837562|NCT01689779|3663805|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837563|NCT01689779|3663806|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837564|NCT01689779|3663807|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837565|NCT01689779|3663805|B3||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3837566|NCT01689779|3663806|B2||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3837567|NCT01689779|3663807|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3837568|NCT01689779|3663805|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3837569|NCT01689779|3663806|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3837570|NCT01689779|3663807|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3837571|NCT01689779|3663805|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3837572|NCT01689779|3663806|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3837573|NCT01689779|3663807|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837574|NCT01689779|3663805|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3837575|NCT01689779|3663806|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3837576|NCT01689779|3663807|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3837577|NCT01689779|3663805|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837578|NCT01689779|3663806|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837579|NCT01689779|3663807|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837580|NCT01689779|3663805|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3837581|NCT01689779|3663806|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3837582|NCT01689779|3663807|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3837583|NCT01689779|3663805|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3837584|NCT01689779|3663806|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3837585|NCT01689779|3663807|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3837586|NCT01689779|3663805|B3|||Age||years|Mean|57|57.0|Standard Deviation|13|13.0|||
3837587|NCT01689779|3663806|B2|||Age||years|Mean|61|61.0|Standard Deviation|13|13.0|||
3837588|NCT01689779|3663807|B1|||Age||years|Mean|56|56.0|Standard Deviation|13|13.0|||
3837589|NCT01689649|3663824|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||48.9|48.9|||
3837590|NCT01689649|3663824|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||51.1|51.1|||
3837591|NCT01689649|3663824|B1|||Age||years|Mean|10.1|10.1|Standard Deviation|3.1|3.1|4.0|16.0|
3837592|NCT01689532|3663834|B3|JAPAN||Region of Enrollment||participants|Number|122|122.0||||||
3837593|NCT01689532|3663835|B2|JAPAN||Region of Enrollment||participants|Number|61|61.0||||||
3837594|NCT01689532|3663836|B1|JAPAN||Region of Enrollment||participants|Number|61|61.0||||||
3837595|NCT01689532|3663834|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3837596|NCT01689532|3663835|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3837597|NCT01689532|3663836|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3837598|NCT01689532|3663834|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3837599|NCT01689532|3663835|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3837600|NCT01689532|3663836|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3837601|NCT01689532|3663834|B3|||Age||years|Mean|55.1|55.1|Standard Deviation|11.41|11.41|||
3837602|NCT01689532|3663835|B2|||Age||years|Mean|54.7|54.7|Standard Deviation|12.16|12.16|||
3837603|NCT01689532|3663836|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|10.7|10.7|||
3837604|NCT01689519|3663899|B3||Male|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
3837605|NCT01689519|3663900|B2||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3837606|NCT01689519|3663901|B1||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3837607|NCT01689519|3663899|B3||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
3837608|NCT01689519|3663900|B2||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3837609|NCT01689519|3663901|B1||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3837610|NCT01689519|3663899|B3|||Age||years|Mean|55.1|55.1|Standard Deviation|13.9|13.9|||
3837611|NCT01689519|3663900|B2|||Age||years|Mean|54.9|54.9|Standard Deviation|14.0|14.0|||
3837612|NCT01689519|3663901|B1|||Age||years|Mean|55.3|55.3|Standard Deviation|13.8|13.8|||
3837613|NCT01689441|3663916|B3|United States||Region of Enrollment||participants|Number|67|67.0||||||
3837614|NCT01689441|3663917|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
3837615|NCT01689441|3663918|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
3837616|NCT01689441|3663916|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3837617|NCT01689441|3663917|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3837618|NCT01689441|3663918|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3837619|NCT01689441|3663916|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3837620|NCT01689441|3663917|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3837621|NCT01689441|3663918|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3837622|NCT01689441|3663916|B3|||Age||years|Median|64|64.0|Inter-Quartile Range|||50.0|70.0|
3837623|NCT01689441|3663917|B2|||Age||years|Median|58|58.0|Inter-Quartile Range|||49.0|69.0|
3837624|NCT01689441|3663918|B1|||Age||years|Median|68|68.0|Inter-Quartile Range|||54.0|70.0|
3837625|NCT01689363|3663929|B1|United States||Region of Enrollment||participants|Number|253|253.0||||||
3837626|NCT01689363|3663929|B1||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3837627|NCT01689363|3663929|B1||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3837628|NCT01689363|3663929|B1|||Age||years|Mean|34.9|34.9|Standard Deviation|14.0|14.0|||
3837629|NCT01689363|3663929|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3837630|NCT01689363|3663929|B1||Between 18 and 65 years|Age||Participants|Count of Participants|239|239.0||||||
3837631|NCT01689363|3663929|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
3837632|NCT01689350|3663980|B3|||SLE patients||participants|Number|92|92.0||||||
3837633|NCT01689350|3663981|B2|||SLE patients||participants|Number|47|47.0||||||
3837634|NCT01689350|3663982|B1|||SLE patients||participants|Number|45|45.0||||||
3837635|NCT01689350|3663980|B3|China||Region of Enrollment||participants|Number|92|92.0||||||
3837636|NCT01689350|3663981|B2|China||Region of Enrollment||participants|Number|47|47.0||||||
3837637|NCT01689350|3663982|B1|China||Region of Enrollment||participants|Number|45|45.0||||||
3837638|NCT01689350|3663980|B3|Chinese Han||Race/Ethnicity, Customized||participants|Number|92|92.0||||||
3837639|NCT01689350|3663981|B2|Chinese Han||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
3837640|NCT01689350|3663982|B1|Chinese Han||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
3837641|NCT01689350|3663980|B3|Male||Sex/Gender, Customized||participants|Number|14|14.0||||||
3837642|NCT01689350|3663981|B2|Male||Sex/Gender, Customized||participants|Number|7|7.0||||||
3837643|NCT01689350|3663982|B1|Male||Sex/Gender, Customized||participants|Number|7|7.0||||||
3837644|NCT01689350|3663980|B3|Female||Sex/Gender, Customized||participants|Number|78|78.0||||||
3837645|NCT01689350|3663981|B2|Female||Sex/Gender, Customized||participants|Number|40|40.0||||||
3837646|NCT01689350|3663982|B1|Female||Sex/Gender, Customized||participants|Number|38|38.0||||||
3837647|NCT01689350|3663980|B3|||Age||years|Mean|30.78|30.78|Standard Deviation|13.17|13.17|||
3837648|NCT01689350|3663981|B2|||Age||years|Mean|31.15|31.15|Standard Deviation|13.21|13.21|||
3837649|NCT01689350|3663982|B1|||Age||years|Mean|30.40|30.4|Standard Deviation|13.28|13.28|||
3837650|NCT01689337|3663991|B1||Male|Gender||Participants|Count of Participants|1|1.0||||||
3837651|NCT01689337|3663991|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3837652|NCT01689337|3663991|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3837653|NCT01689337|3663991|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3837654|NCT01689337|3663991|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837655|NCT01689324|3664006|B1|Japan||Region of Enrollment||Participants|Number|43|43.0||||||
3837656|NCT01689324|3664006|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3837657|NCT01689324|3664006|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3837658|NCT01689324|3664006|B1|||Age||Years|Mean|11.4|11.4|Standard Deviation|0.5|0.5|||
3837659|NCT01689324|3664006|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3837660|NCT01689324|3664006|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3837661|NCT01689324|3664006|B1||<=18 years|Age||Participants|Count of Participants|43|43.0||||||
3837662|NCT01689207|3664019|B12||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3837663|NCT01689207|3664020|B11||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3837664|NCT01689207|3664021|B10||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3837665|NCT01689207|3664022|B9||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3837666|NCT01689207|3664023|B8||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3837667|NCT01689207|3664024|B7||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3837668|NCT01689207|3664025|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3837669|NCT01689207|3664026|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3837670|NCT01689207|3664027|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3837671|NCT01689207|3664028|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3837672|NCT01689207|3664029|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3837673|NCT01689207|3664030|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3837674|NCT01689207|3664019|B12||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3837675|NCT01689207|3664020|B11||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3837676|NCT01689207|3664021|B10||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837677|NCT01689207|3664022|B9||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3837678|NCT01689207|3664023|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837679|NCT01689207|3664024|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837680|NCT01689207|3664025|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837681|NCT01689207|3664026|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837682|NCT01689207|3664027|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837683|NCT01689207|3664028|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837684|NCT01689207|3664029|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837685|NCT01689207|3664030|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837686|NCT01689207|3664019|B12|||Age||years|Mean|34.8|34.8|Standard Deviation|14.0|14.0|||
3837687|NCT01689207|3664020|B11|||Age||years|Mean|68.5|68.5|Standard Deviation|2.9|2.9|||
3837688|NCT01689207|3664021|B10|||Age||years|Mean|32.9|32.9|Standard Deviation|8.4|8.4|||
3837689|NCT01689207|3664022|B9|||Age||years|Mean|51.3|51.3|Standard Deviation|19.4|19.4|||
3837690|NCT01689207|3664023|B8|||Age||years|Mean|30.6|30.6|Standard Deviation|6.3|6.3|||
3837691|NCT01689207|3664024|B7|||Age||years|Mean|29.7|29.7|Standard Deviation|7.3|7.3|||
3837692|NCT01689207|3664025|B6|||Age||years|Mean|29.4|29.4|Standard Deviation|9.9|9.9|||
3837693|NCT01689207|3664026|B5|||Age||years|Mean|27.8|27.8|Standard Deviation|1.9|1.9|||
3837694|NCT01689207|3664027|B4|||Age||years|Mean|30.3|30.3|Standard Deviation|4.9|4.9|||
3837695|NCT01689207|3664028|B3|||Age||years|Mean|27.4|27.4|Standard Deviation|5.0|5.0|||
3837696|NCT01689207|3664029|B2|||Age||years|Mean|31.3|31.3|Standard Deviation|7.1|7.1|||
3837697|NCT01689207|3664030|B1|||Age||years|Mean|33.8|33.8|Standard Deviation|6.9|6.9|||
3837698|NCT01689155|3664136|B1|September - November||Seasonality|Data represent participants receiving vaccine during time period shown. Four participants received 2 doses of Menactra; each dose is accounted for in the appropriate time period.|Participants|Number|29|29.0||||||
3837699|NCT01689155|3664136|B1|June - August||Seasonality|Data represent participants receiving vaccine during time period shown. Four participants received 2 doses of Menactra; each dose is accounted for in the appropriate time period.|Participants|Number|22|22.0||||||
3837700|NCT01689155|3664136|B1|March - May||Seasonality|Data represent participants receiving vaccine during time period shown. Four participants received 2 doses of Menactra; each dose is accounted for in the appropriate time period.|Participants|Number|39|39.0||||||
3837701|NCT01689155|3664136|B1|December - February||Seasonality|Data represent participants receiving vaccine during time period shown. Four participants received 2 doses of Menactra; each dose is accounted for in the appropriate time period.|Participants|Number|30|30.0||||||
3837702|NCT01689155|3664136|B1|United States||Region of Enrollment||Participants|Number|116|116.0||||||
3837703|NCT01689155|3664136|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3837704|NCT01689155|3664136|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3837705|NCT01689155|3664136|B1|||Age||Months|Mean|15.9|15.9|Standard Deviation|5.56|5.56|||
3837706|NCT01689155|3664136|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3837707|NCT01689155|3664136|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3837708|NCT01689155|3664136|B1||<=18 years|Age||Participants|Count of Participants|116|116.0||||||
3837709|NCT01688921|3664145|B3|United States||Region of Enrollment||participants|Number|1247|1247.0||||||
3837710|NCT01688921|3664146|B2|United States||Region of Enrollment||participants|Number|623|623.0||||||
3837711|NCT01688921|3664147|B1|United States||Region of Enrollment||participants|Number|624|624.0||||||
3837712|NCT01688921|3664145|B3||Male|Sex: Female, Male||Participants|Count of Participants|366|366.0||||||
3837713|NCT01688921|3664146|B2||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
3837714|NCT01688921|3664147|B1||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
3837715|NCT01688921|3664145|B3||Female|Sex: Female, Male||Participants|Count of Participants|881|881.0||||||
3837716|NCT01688921|3664146|B2||Female|Sex: Female, Male||Participants|Count of Participants|432|432.0||||||
3837717|NCT01688921|3664147|B1||Female|Sex: Female, Male||Participants|Count of Participants|449|449.0||||||
3837718|NCT01688921|3664145|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3837719|NCT01688921|3664146|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3837720|NCT01688921|3664147|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3837721|NCT01688921|3664145|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1247|1247.0||||||
3837722|NCT01688921|3664146|B2||Between 18 and 65 years|Age||Participants|Count of Participants|623|623.0||||||
3837723|NCT01688921|3664147|B1||Between 18 and 65 years|Age||Participants|Count of Participants|624|624.0||||||
3837724|NCT01688921|3664145|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837725|NCT01688921|3664146|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837726|NCT01688921|3664147|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837727|NCT01688921|3664145|B3|||Age||Years|Mean|41.4|41.4|Standard Deviation|12.70|12.7|||
3837728|NCT01688921|3664146|B2|||Age||Years|Mean|41.5|41.5|Standard Deviation|12.49|12.49|||
3837729|NCT01688921|3664147|B1|||Age||Years|Mean|41.3|41.3|Standard Deviation|12.92|12.92|||
3837730|NCT01688882|3664171|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3837731|NCT01688882|3664172|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3837732|NCT01688882|3664173|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3837733|NCT01688882|3664171|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3837734|NCT01688882|3664172|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3837735|NCT01688882|3664173|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3837736|NCT01688882|3664171|B3|||Age||years|Mean|65.2|65.2|Standard Deviation|14.52|14.52|||
3837737|NCT01688882|3664172|B2|||Age||years|Mean|67.9|67.9|Standard Deviation|14.60|14.6|||
3837738|NCT01688882|3664173|B1|||Age||years|Mean|63.7|63.7|Standard Deviation|14.85|14.85|||
3837739|NCT01688843|3664188|B1|Germany||Region of Enrollment||participants|Number|37|37.0||||||
3837740|NCT01688843|3664188|B1|France||Region of Enrollment||participants|Number|57|57.0||||||
3837741|NCT01688843|3664188|B1|Australia||Region of Enrollment||participants|Number|8|8.0||||||
3837742|NCT01688843|3664188|B1|Italy||Region of Enrollment||participants|Number|21|21.0||||||
3837743|NCT01688843|3664188|B1|Denmark||Region of Enrollment||participants|Number|26|26.0||||||
3837744|NCT01688843|3664188|B1|Belgium||Region of Enrollment||participants|Number|22|22.0||||||
3837745|NCT01688843|3664188|B1|Sweden||Region of Enrollment||participants|Number|16|16.0||||||
3837746|NCT01688843|3664188|B1|Austria||Region of Enrollment||participants|Number|45|45.0||||||
3837747|NCT01688843|3664188|B1|Canada||Region of Enrollment||participants|Number|20|20.0||||||
3837748|NCT01688843|3664188|B1|Spain||Region of Enrollment||participants|Number|88|88.0||||||
3837749|NCT01688843|3664188|B1|Portugal||Region of Enrollment||participants|Number|32|32.0||||||
3837750|NCT01688843|3664188|B1|Thailand||Region of Enrollment||participants|Number|10|10.0||||||
3837751|NCT01688843|3664188|B1|Malaysia||Region of Enrollment||participants|Number|25|25.0||||||
3837752|NCT01688843|3664188|B1|United Kingdom||Region of Enrollment||participants|Number|39|39.0||||||
3837753|NCT01688843|3664188|B1|United States||Region of Enrollment||participants|Number|603|603.0||||||
3837754|NCT01688843|3664188|B1|Hong Kong||Region of Enrollment||participants|Number|11|11.0||||||
3837755|NCT01688843|3664188|B1||Male|Sex: Female, Male||Participants|Count of Participants|582|582.0||||||
3837756|NCT01688843|3664188|B1||Female|Sex: Female, Male||Participants|Count of Participants|478|478.0||||||
3837757|NCT01688843|3664188|B1|||Age||years|Mean|74.3|74.3|Standard Deviation|10.6|10.6|||
3837758|NCT01688830|3664198|B22||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3837759|NCT01688830|3664199|B21||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3837760|NCT01688830|3664200|B20||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3837761|NCT01688830|3664201|B19||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3837762|NCT01688830|3664202|B18||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3837763|NCT01688830|3664203|B17||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3837764|NCT01688830|3664204|B16||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3837765|NCT01688830|3664205|B15||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3837766|NCT01688830|3664206|B14||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3837767|NCT01688830|3664207|B13||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3837768|NCT01688830|3664208|B12||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3837769|NCT01688830|3664209|B11||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3837770|NCT01688830|3664210|B10||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3837771|NCT01688830|3664211|B9||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3837772|NCT01688830|3664212|B8||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3837773|NCT01688830|3664213|B7||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3837774|NCT01688830|3664214|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3837775|NCT01688830|3664215|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3837776|NCT01688830|3664216|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3837777|NCT01688830|3664217|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3837778|NCT01688830|3664218|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3837779|NCT01688830|3664219|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3837780|NCT01688830|3664198|B22||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837781|NCT01688830|3664199|B21||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837782|NCT01688830|3664200|B20||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837783|NCT01688830|3664201|B19||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837784|NCT01688830|3664202|B18||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837785|NCT01688830|3664203|B17||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837786|NCT01688830|3664204|B16||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837787|NCT01688830|3664205|B15||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837788|NCT01688830|3664206|B14||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837789|NCT01688830|3664207|B13||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837790|NCT01688830|3664208|B12||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837791|NCT01688830|3664209|B11||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837792|NCT01688830|3664210|B10||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837793|NCT01688830|3664211|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837794|NCT01688830|3664212|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837795|NCT01688830|3664213|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837796|NCT01688830|3664214|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837797|NCT01688830|3664215|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837798|NCT01688830|3664216|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837799|NCT01688830|3664217|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837800|NCT01688830|3664218|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837801|NCT01688830|3664219|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837802|NCT01688830|3664198|B22|||Age||years|Mean|32.4|32.4|Standard Deviation|7.9|7.9|||
3837803|NCT01688830|3664199|B21|||Age||years|Mean|29.9|29.9|Standard Deviation|9.0|9.0|||
3837804|NCT01688830|3664200|B20|||Age||years|Mean|30.0|30.0|Standard Deviation|2.6|2.6|||
3837805|NCT01688830|3664201|B19|||Age||years|Mean|31.9|31.9|Standard Deviation|9.1|9.1|||
3837806|NCT01688830|3664202|B18|||Age||years|Mean|31.1|31.1|Standard Deviation|8.3|8.3|||
3837807|NCT01688830|3664203|B17|||Age||years|Mean|31.3|31.3|Standard Deviation|7.0|7.0|||
3837808|NCT01688830|3664204|B16|||Age||years|Mean|30.9|30.9|Standard Deviation|8.9|8.9|||
3837809|NCT01688830|3664205|B15|||Age||years|Mean|36.0|36.0|Standard Deviation|8.3|8.3|||
3837810|NCT01688830|3664206|B14|||Age||years|Mean|31.8|31.8|Standard Deviation|5.4|5.4|||
3837811|NCT01688830|3664207|B13|||Age||years|Mean|34.7|34.7|Standard Deviation|8.5|8.5|||
3837812|NCT01688830|3664208|B12|||Age||years|Mean|34.5|34.5|Standard Deviation|11.2|11.2|||
3837813|NCT01688830|3664209|B11|||Age||years|Mean|35.2|35.2|Standard Deviation|9.1|9.1|||
3837814|NCT01688830|3664210|B10|||Age||years|Mean|34.5|34.5|Standard Deviation|8.8|8.8|||
3837815|NCT01688830|3664211|B9|||Age||years|Mean|35.3|35.3|Standard Deviation|9.5|9.5|||
3837816|NCT01688830|3664212|B8|||Age||years|Mean|32.7|32.7|Standard Deviation|4.2|4.2|||
3837817|NCT01688830|3664213|B7|||Age||years|Mean|30.3|30.3|Standard Deviation|8.5|8.5|||
3837818|NCT01688830|3664214|B6|||Age||years|Mean|32.0|32.0|Standard Deviation|8.9|8.9|||
3837819|NCT01688830|3664215|B5|||Age||years|Mean|36.6|36.6|Standard Deviation|4.5|4.5|||
3837820|NCT01688830|3664216|B4|||Age||years|Mean|36.2|36.2|Standard Deviation|8.8|8.8|||
3837821|NCT01688830|3664217|B3|||Age||years|Mean|35.2|35.2|Standard Deviation|5.5|5.5|||
3837822|NCT01688830|3664218|B2|||Age||years|Mean|29.8|29.8|Standard Deviation|6.6|6.6|||
3837823|NCT01688830|3664219|B1|||Age||years|Mean|30.3|30.3|Standard Deviation|7.8|7.8|||
3837824|NCT01688726|3664383|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3837825|NCT01688726|3664384|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3837826|NCT01688726|3664385|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3837827|NCT01688726|3664383|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3837828|NCT01688726|3664384|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3837829|NCT01688726|3664385|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3837830|NCT01688726|3664383|B3|||Age||years|Mean|45.7|45.7|Standard Deviation|15.66|15.66|||
3837831|NCT01688726|3664384|B2|||Age||years|Mean|44.6|44.6|Standard Deviation|14.84|14.84|||
3837832|NCT01688726|3664385|B1|||Age||years|Mean|46.8|46.8|Standard Deviation|16.51|16.51|||
3837833|NCT01688635|3664398|B1|Singapore||Region of Enrollment||participants|Number|91|91.0||||||
3837834|NCT01688635|3664398|B1|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3837835|NCT01688635|3664398|B1|Asian||Race/Ethnicity, Customized||participants|Number|90|90.0||||||
3837836|NCT01688635|3664398|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3837837|NCT01688635|3664398|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3837838|NCT01688635|3664398|B1|||Age||years|Mean|32.7|32.7|Standard Deviation|9.0|9.0|||
3837839|NCT01688609|3664411|B1|Japan||Region of Enrollment||participants|Number|18|18.0||||||
3837840|NCT01688609|3664411|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837841|NCT01688609|3664411|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3837842|NCT01688609|3664411|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3837843|NCT01688609|3664411|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3837844|NCT01688609|3664411|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837845|NCT01688466|3664419|B3|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3837846|NCT01688466|3664420|B2|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3837847|NCT01688466|3664421|B1|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3837848|NCT01688466|3664419|B3|Not meeting definition for Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3837849|NCT01688466|3664420|B2|Not meeting definition for Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3837850|NCT01688466|3664421|B1|Not meeting definition for Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3837851|NCT01688466|3664419|B3|Mexican, Puerto Rican, Cuban, Central/So. American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3837852|NCT01688466|3664420|B2|Mexican, Puerto Rican, Cuban, Central/So. American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3837853|NCT01688466|3664421|B1|Mexican, Puerto Rican, Cuban, Central/So. American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3837854|NCT01688466|3664419|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837855|NCT01688466|3664420|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837856|NCT01688466|3664421|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837857|NCT01688466|3664419|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3837858|NCT01688466|3664420|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837859|NCT01688466|3664421|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3837860|NCT01688466|3664419|B3||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3837861|NCT01688466|3664420|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3837862|NCT01688466|3664421|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3837863|NCT01688466|3664419|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3837864|NCT01688466|3664420|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837865|NCT01688466|3664421|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3837866|NCT01688466|3664419|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837867|NCT01688466|3664420|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837868|NCT01688466|3664421|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837869|NCT01688466|3664419|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837870|NCT01688466|3664420|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837871|NCT01688466|3664421|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837872|NCT01688466|3664419|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837873|NCT01688466|3664420|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837874|NCT01688466|3664421|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837875|NCT01688466|3664419|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3837876|NCT01688466|3664420|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3837877|NCT01688466|3664421|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3837878|NCT01688466|3664419|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3837879|NCT01688466|3664420|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3837880|NCT01688466|3664421|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3837881|NCT01688466|3664419|B3|||Age||years|Mean|47.65|47.65|Standard Deviation|14.05|14.05|||
3837882|NCT01688466|3664420|B2|||Age||years|Mean|46.8|46.8|Standard Deviation|13.9|13.9|||
3837883|NCT01688466|3664421|B1|||Age||years|Mean|48.5|48.5|Standard Deviation|14.2|14.2|||
3837884|NCT01688466|3664419|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3837885|NCT01688466|3664420|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3837886|NCT01688466|3664421|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3837887|NCT01688466|3664419|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3837888|NCT01688466|3664420|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3837889|NCT01688466|3664421|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3837890|NCT01688466|3664419|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837891|NCT01688466|3664420|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837892|NCT01688466|3664421|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3837893|NCT01688336|3664430|B1|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3837894|NCT01688336|3664430|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837895|NCT01688336|3664430|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837896|NCT01688336|3664430|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3837897|NCT01688336|3664430|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3837898|NCT01688336|3664430|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837899|NCT01688336|3664430|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837900|NCT01688336|3664430|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3837901|NCT01688336|3664430|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3837902|NCT01688336|3664430|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3837903|NCT01688336|3664430|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3837904|NCT01688336|3664430|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3837905|NCT01688336|3664430|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3837906|NCT01688336|3664430|B1|||Age||years|Mean|63.2|63.2|Full Range|||51.0|69.0|
3837907|NCT01688310|3664440|B3|Mozambique||Region of Enrollment||participants|Number|200|200.0||||||
3837908|NCT01688310|3664441|B2|Mozambique||Region of Enrollment||participants|Number|100|100.0||||||
3837909|NCT01688310|3664442|B1|Mozambique||Region of Enrollment||participants|Number|100|100.0||||||
3837910|NCT01688310|3664440|B3||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
3837911|NCT01688310|3664441|B2||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3837912|NCT01688310|3664442|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3837913|NCT01688310|3664440|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837914|NCT01688310|3664441|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837915|NCT01688310|3664442|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3837916|NCT01688310|3664440|B3|>=25 yrs||Age, Customized||participants|Number|55|55.0||||||
3837917|NCT01688310|3664441|B2|>=25 yrs||Age, Customized||participants|Number|24|24.0||||||
3837918|NCT01688310|3664442|B1|>=25 yrs||Age, Customized||participants|Number|31|31.0||||||
3837919|NCT01688310|3664440|B3|21-24 yrs||Age, Customized||participants|Number|53|53.0||||||
3837920|NCT01688310|3664441|B2|21-24 yrs||Age, Customized||participants|Number|27|27.0||||||
3837921|NCT01688310|3664442|B1|21-24 yrs||Age, Customized||participants|Number|26|26.0||||||
3837922|NCT01688310|3664440|B3|18-20 yrs||Age, Customized||participants|Number|92|92.0||||||
3837923|NCT01688310|3664441|B2|18-20 yrs||Age, Customized||participants|Number|49|49.0||||||
3837924|NCT01688310|3664442|B1|18-20 yrs||Age, Customized||participants|Number|43|43.0||||||
3837925|NCT01688310|3664440|B3|||Age||years|Mean|22.5|22.5|Standard Deviation|4.8|4.8|||
3837926|NCT01688310|3664441|B2|||Age||years|Mean|22.3|22.3|Standard Deviation|4.7|4.7|||
3837927|NCT01688310|3664442|B1|||Age||years|Mean|22.8|22.8|Standard Deviation|4.9|4.9|||
3837928|NCT01688102|3664461|B3|United States||Region of Enrollment||participants|Number|118|118.0||||||
3837929|NCT01688102|3664462|B2|United States||Region of Enrollment||participants|Number|58|58.0||||||
3837930|NCT01688102|3664463|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
3837931|NCT01688102|3664461|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3837932|NCT01688102|3664462|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3837933|NCT01688102|3664463|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3837934|NCT01688102|3664461|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3837935|NCT01688102|3664462|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3837936|NCT01688102|3664463|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3837937|NCT01688102|3664461|B3|||Age||years|Mean|42|42.0|Standard Deviation|12|12.0|||
3837938|NCT01688102|3664462|B2|||Age||years|Mean|39|39.0|Standard Deviation|12|12.0|||
3837939|NCT01688102|3664463|B1|||Age||years|Mean|45|45.0|Standard Deviation|12|12.0|||
3837940|NCT01688050|3664492|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3837941|NCT01688050|3664492|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3837942|NCT01688050|3664492|B1|||Age||years|Mean|42.7|42.7|Standard Deviation|18.7|18.7|||
3837943|NCT01688037|3664498|B4|||Baseline AIMS Total Dyskinesia Score|The AIMS Total Dyskinesia Score rates a total of 7 items, rating involuntary movement from 0 (no dyskinesia) to 4 (severe dyskinesia). Items 1 through 7 include facial and oral movements (Items 1-4), extremity movements (Items 5-6), and trunk movements (Item 7). The AIMS dyskinesia total score for Items 1-7 ranges from 0 to 28; a higher score reflects increased severity.|units on a scale|Mean|15.0|15.0|Standard Deviation|4.8|4.8|||
3837944|NCT01688037|3664499|B3|||Baseline AIMS Total Dyskinesia Score|The AIMS Total Dyskinesia Score rates a total of 7 items, rating involuntary movement from 0 (no dyskinesia) to 4 (severe dyskinesia). Items 1 through 7 include facial and oral movements (Items 1-4), extremity movements (Items 5-6), and trunk movements (Item 7). The AIMS dyskinesia total score for Items 1-7 ranges from 0 to 28; a higher score reflects increased severity.|units on a scale|Mean|14.6|14.6|Standard Deviation|4.7|4.7|||
3837945|NCT01688037|3664500|B2|||Baseline AIMS Total Dyskinesia Score|The AIMS Total Dyskinesia Score rates a total of 7 items, rating involuntary movement from 0 (no dyskinesia) to 4 (severe dyskinesia). Items 1 through 7 include facial and oral movements (Items 1-4), extremity movements (Items 5-6), and trunk movements (Item 7). The AIMS dyskinesia total score for Items 1-7 ranges from 0 to 28; a higher score reflects increased severity.|units on a scale|Mean|14.6|14.6|Standard Deviation|5.9|5.9|||
3837946|NCT01688037|3664501|B1|||Baseline AIMS Total Dyskinesia Score|The AIMS Total Dyskinesia Score rates a total of 7 items, rating involuntary movement from 0 (no dyskinesia) to 4 (severe dyskinesia). Items 1 through 7 include facial and oral movements (Items 1-4), extremity movements (Items 5-6), and trunk movements (Item 7). The AIMS dyskinesia total score for Items 1-7 ranges from 0 to 28; a higher score reflects increased severity.|units on a scale|Mean|15.3|15.3|Standard Deviation|4.4|4.4|||
3837947|NCT01688037|3664498|B4|||BPRS Total Score|The Brief Psychiatric Rating Scale (BPRS) is a clinician-rated tool designed to assess change in the severity of psychopathology in patients with schizophrenia and other psychotic disorders (Overall and Gorham, 1962, 1988). The severity of each of the 18 items of the BPRS is rated on a scale of 1 (not present) to 7 (extremely severe) (total score range: 18 to 126). Higher scores represent greater symptom severity.|units on a scale|Mean|33.3|33.3|Full Range|||20.0|49.0|
3837948|NCT01688037|3664499|B3|||BPRS Total Score|The Brief Psychiatric Rating Scale (BPRS) is a clinician-rated tool designed to assess change in the severity of psychopathology in patients with schizophrenia and other psychotic disorders (Overall and Gorham, 1962, 1988). The severity of each of the 18 items of the BPRS is rated on a scale of 1 (not present) to 7 (extremely severe) (total score range: 18 to 126). Higher scores represent greater symptom severity.|units on a scale|Mean|33.0|33.0|Full Range|||21.0|49.0|
3837949|NCT01688037|3664500|B2|||BPRS Total Score|The Brief Psychiatric Rating Scale (BPRS) is a clinician-rated tool designed to assess change in the severity of psychopathology in patients with schizophrenia and other psychotic disorders (Overall and Gorham, 1962, 1988). The severity of each of the 18 items of the BPRS is rated on a scale of 1 (not present) to 7 (extremely severe) (total score range: 18 to 126). Higher scores represent greater symptom severity.|units on a scale|Mean|32.6|32.6|Full Range|||22.0|49.0|
3837950|NCT01688037|3664501|B1|||BPRS Total Score|The Brief Psychiatric Rating Scale (BPRS) is a clinician-rated tool designed to assess change in the severity of psychopathology in patients with schizophrenia and other psychotic disorders (Overall and Gorham, 1962, 1988). The severity of each of the 18 items of the BPRS is rated on a scale of 1 (not present) to 7 (extremely severe) (total score range: 18 to 126). Higher scores represent greater symptom severity.|units on a scale|Mean|33.8|33.8|Full Range|||20.0|48.0|
3837951|NCT01688037|3664498|B4|||Age at TD Diagnosis||years|Mean|47.5|47.5|Full Range|||16.0|73.0|
3837952|NCT01688037|3664499|B3|||Age at TD Diagnosis||years|Mean|47.5|47.5|Full Range|||22.0|73.0|
3837953|NCT01688037|3664500|B2|||Age at TD Diagnosis||years|Mean|48.5|48.5|Full Range|||37.0|67.0|
3837954|NCT01688037|3664501|B1|||Age at TD Diagnosis||years|Mean|46.9|46.9|Full Range|||16.0|73.0|
3837955|NCT01688037|3664498|B4|||Age at Schizophrenia/Schizoaffective Disorder Diagnosis||years|Mean|29.7|29.7|Full Range|||10.0|68.0|
3837956|NCT01688037|3664499|B3|||Age at Schizophrenia/Schizoaffective Disorder Diagnosis||years|Mean|30.4|30.4|Full Range|||17.0|66.0|
3837957|NCT01688037|3664500|B2|||Age at Schizophrenia/Schizoaffective Disorder Diagnosis||years|Mean|29.7|29.7|Full Range|||16.0|66.0|
3837958|NCT01688037|3664501|B1|||Age at Schizophrenia/Schizoaffective Disorder Diagnosis||years|Mean|29.4|29.4|Full Range|||10.0|68.0|
3837959|NCT01688037|3664498|B4|||Body Mass Index||kg/m^2|Mean|28.17|28.17|Full Range|||14.1|44.2|
3837960|NCT01688037|3664499|B3|||Body Mass Index||kg/m^2|Mean|26.39|26.39|Full Range|||14.1|37.8|
3837961|NCT01688037|3664500|B2|||Body Mass Index||kg/m^2|Mean|28.85|28.85|Full Range|||18.5|42.6|
3837962|NCT01688037|3664501|B1|||Body Mass Index||kg/m^2|Mean|28.71|28.71|Full Range|||19.2|44.2|
3837963|NCT01688037|3664498|B4|American Indian or Alaska Native, Black||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3837964|NCT01688037|3664499|B3|American Indian or Alaska Native, Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3837965|NCT01688037|3664500|B2|American Indian or Alaska Native, Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3837966|NCT01688037|3664501|B1|American Indian or Alaska Native, Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3837967|NCT01688037|3664498|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3837968|NCT01688037|3664499|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3837969|NCT01688037|3664500|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3837970|NCT01688037|3664501|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3837971|NCT01688037|3664498|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3837972|NCT01688037|3664499|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3837973|NCT01688037|3664500|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3837974|NCT01688037|3664501|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3837975|NCT01688037|3664498|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|57|57.0||||||
3837976|NCT01688037|3664499|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3837977|NCT01688037|3664500|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3837978|NCT01688037|3664501|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3837979|NCT01688037|3664498|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
3837980|NCT01688037|3664499|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3837981|NCT01688037|3664500|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3837982|NCT01688037|3664501|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3837983|NCT01688037|3664498|B4||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3837984|NCT01688037|3664499|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3837985|NCT01688037|3664500|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3837986|NCT01688037|3664501|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3837987|NCT01688037|3664498|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3837988|NCT01688037|3664499|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3837989|NCT01688037|3664500|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3837990|NCT01688037|3664501|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3837991|NCT01688037|3664498|B4|||Age||years|Mean|55.0|55.0|Full Range|||27.0|77.0|
3837992|NCT01688037|3664499|B3|||Age||years|Mean|55.6|55.6|Full Range|||28.0|77.0|
3837993|NCT01688037|3664500|B2|||Age||years|Mean|55.5|55.5|Full Range|||42.0|72.0|
3837994|NCT01688037|3664501|B1|||Age||years|Mean|54.5|54.5|Full Range|||27.0|76.0|
3837995|NCT01687998|3664517|B3|Estonia||Region of Enrollment||Participants|Count of Participants|59|59.0||||||
3837996|NCT01687998|3664518|B2|Estonia||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3837997|NCT01687998|3664519|B1|Estonia||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3837998|NCT01687998|3664517|B3|Germany||Region of Enrollment||Participants|Count of Participants|400|400.0||||||
3837999|NCT01687998|3664518|B2|Germany||Region of Enrollment||Participants|Count of Participants|202|202.0||||||
3838000|NCT01687998|3664519|B1|Germany||Region of Enrollment||Participants|Count of Participants|198|198.0||||||
3838001|NCT01687998|3664517|B3|Australia||Region of Enrollment||Participants|Count of Participants|319|319.0||||||
3838002|NCT01687998|3664518|B2|Australia||Region of Enrollment||Participants|Count of Participants|160|160.0||||||
3838003|NCT01687998|3664519|B1|Australia||Region of Enrollment||Participants|Count of Participants|159|159.0||||||
3838004|NCT01687998|3664517|B3|Israel||Region of Enrollment||Participants|Count of Participants|146|146.0||||||
3838005|NCT01687998|3664518|B2|Israel||Region of Enrollment||Participants|Count of Participants|74|74.0||||||
3838006|NCT01687998|3664519|B1|Israel||Region of Enrollment||Participants|Count of Participants|72|72.0||||||
3838007|NCT01687998|3664517|B3|South Africa||Region of Enrollment||Participants|Count of Participants|153|153.0||||||
3838008|NCT01687998|3664518|B2|South Africa||Region of Enrollment||Participants|Count of Participants|76|76.0||||||
3838009|NCT01687998|3664519|B1|South Africa||Region of Enrollment||Participants|Count of Participants|77|77.0||||||
3838010|NCT01687998|3664517|B3|Mexico||Region of Enrollment||Participants|Count of Participants|466|466.0||||||
3838011|NCT01687998|3664518|B2|Mexico||Region of Enrollment||Participants|Count of Participants|231|231.0||||||
3838012|NCT01687998|3664519|B1|Mexico||Region of Enrollment||Participants|Count of Participants|235|235.0||||||
3838013|NCT01687998|3664517|B3|Italy||Region of Enrollment||Participants|Count of Participants|83|83.0||||||
3838014|NCT01687998|3664518|B2|Italy||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3838015|NCT01687998|3664519|B1|Italy||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
3838016|NCT01687998|3664517|B3|Denmark||Region of Enrollment||Participants|Count of Participants|195|195.0||||||
3838017|NCT01687998|3664518|B2|Denmark||Region of Enrollment||Participants|Count of Participants|100|100.0||||||
3838018|NCT01687998|3664519|B1|Denmark||Region of Enrollment||Participants|Count of Participants|95|95.0||||||
3838019|NCT01687998|3664517|B3|Taiwan||Region of Enrollment||Participants|Count of Participants|105|105.0||||||
3838020|NCT01687998|3664518|B2|Taiwan||Region of Enrollment||Participants|Count of Participants|53|53.0||||||
3838021|NCT01687998|3664519|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
3838022|NCT01687998|3664517|B3|Belgium||Region of Enrollment||Participants|Count of Participants|84|84.0||||||
3838023|NCT01687998|3664518|B2|Belgium||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3838024|NCT01687998|3664519|B1|Belgium||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3838025|NCT01687998|3664517|B3|Turkey||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3838026|NCT01687998|3664518|B2|Turkey||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3838027|NCT01687998|3664519|B1|Turkey||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3838028|NCT01687998|3664517|B3|Czechia||Region of Enrollment||Participants|Count of Participants|372|372.0||||||
3838029|NCT01687998|3664518|B2|Czechia||Region of Enrollment||Participants|Count of Participants|185|185.0||||||
3838030|NCT01687998|3664519|B1|Czechia||Region of Enrollment||Participants|Count of Participants|187|187.0||||||
3838031|NCT01687998|3664517|B3|Canada||Region of Enrollment||Participants|Count of Participants|1245|1245.0||||||
3838032|NCT01687998|3664518|B2|Canada||Region of Enrollment||Participants|Count of Participants|619|619.0||||||
3838033|NCT01687998|3664519|B1|Canada||Region of Enrollment||Participants|Count of Participants|626|626.0||||||
3838034|NCT01687998|3664517|B3|New Zealand||Region of Enrollment||Participants|Count of Participants|127|127.0||||||
3838035|NCT01687998|3664518|B2|New Zealand||Region of Enrollment||Participants|Count of Participants|64|64.0||||||
3838036|NCT01687998|3664519|B1|New Zealand||Region of Enrollment||Participants|Count of Participants|63|63.0||||||
3838037|NCT01687998|3664517|B3|Spain||Region of Enrollment||Participants|Count of Participants|131|131.0||||||
3838038|NCT01687998|3664518|B2|Spain||Region of Enrollment||Participants|Count of Participants|66|66.0||||||
3838039|NCT01687998|3664519|B1|Spain||Region of Enrollment||Participants|Count of Participants|65|65.0||||||
3838040|NCT01687998|3664517|B3|Switzerland||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3838041|NCT01687998|3664518|B2|Switzerland||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3838042|NCT01687998|3664519|B1|Switzerland||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3838043|NCT01687998|3664517|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|116|116.0||||||
3838044|NCT01687998|3664518|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|58|58.0||||||
3838045|NCT01687998|3664519|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|58|58.0||||||
3838046|NCT01687998|3664517|B3|Ukraine||Region of Enrollment||Participants|Count of Participants|133|133.0||||||
3838047|NCT01687998|3664518|B2|Ukraine||Region of Enrollment||Participants|Count of Participants|66|66.0||||||
3838048|NCT01687998|3664519|B1|Ukraine||Region of Enrollment||Participants|Count of Participants|67|67.0||||||
3838049|NCT01687998|3664517|B3|Japan||Region of Enrollment||Participants|Count of Participants|407|407.0||||||
3838050|NCT01687998|3664518|B2|Japan||Region of Enrollment||Participants|Count of Participants|202|202.0||||||
3838051|NCT01687998|3664519|B1|Japan||Region of Enrollment||Participants|Count of Participants|205|205.0||||||
3838052|NCT01687998|3664517|B3|Hungary||Region of Enrollment||Participants|Count of Participants|233|233.0||||||
3838053|NCT01687998|3664518|B2|Hungary||Region of Enrollment||Participants|Count of Participants|115|115.0||||||
3838054|NCT01687998|3664519|B1|Hungary||Region of Enrollment||Participants|Count of Participants|118|118.0||||||
3838055|NCT01687998|3664517|B3|Romania||Region of Enrollment||Participants|Count of Participants|130|130.0||||||
3838056|NCT01687998|3664518|B2|Romania||Region of Enrollment||Participants|Count of Participants|66|66.0||||||
3838057|NCT01687998|3664519|B1|Romania||Region of Enrollment||Participants|Count of Participants|64|64.0||||||
3838058|NCT01687998|3664517|B3|Argentina||Region of Enrollment||Participants|Count of Participants|180|180.0||||||
3838059|NCT01687998|3664518|B2|Argentina||Region of Enrollment||Participants|Count of Participants|91|91.0||||||
3838060|NCT01687998|3664519|B1|Argentina||Region of Enrollment||Participants|Count of Participants|89|89.0||||||
3838061|NCT01687998|3664517|B3|Lithuania||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3838062|NCT01687998|3664518|B2|Lithuania||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3838063|NCT01687998|3664519|B1|Lithuania||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3838064|NCT01687998|3664517|B3|Bulgaria||Region of Enrollment||Participants|Count of Participants|231|231.0||||||
3838065|NCT01687998|3664518|B2|Bulgaria||Region of Enrollment||Participants|Count of Participants|118|118.0||||||
3838066|NCT01687998|3664519|B1|Bulgaria||Region of Enrollment||Participants|Count of Participants|113|113.0||||||
3838067|NCT01687998|3664517|B3|France||Region of Enrollment||Participants|Count of Participants|97|97.0||||||
3838068|NCT01687998|3664518|B2|France||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
3838069|NCT01687998|3664519|B1|France||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3838070|NCT01687998|3664517|B3|Slovakia||Region of Enrollment||Participants|Count of Participants|233|233.0||||||
3838071|NCT01687998|3664518|B2|Slovakia||Region of Enrollment||Participants|Count of Participants|117|117.0||||||
3838072|NCT01687998|3664519|B1|Slovakia||Region of Enrollment||Participants|Count of Participants|116|116.0||||||
3838073|NCT01687998|3664517|B3|Brazil||Region of Enrollment||Participants|Count of Participants|110|110.0||||||
3838074|NCT01687998|3664518|B2|Brazil||Region of Enrollment||Participants|Count of Participants|56|56.0||||||
3838075|NCT01687998|3664519|B1|Brazil||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
3838076|NCT01687998|3664517|B3|Poland||Region of Enrollment||Participants|Count of Participants|483|483.0||||||
3838077|NCT01687998|3664518|B2|Poland||Region of Enrollment||Participants|Count of Participants|240|240.0||||||
3838078|NCT01687998|3664519|B1|Poland||Region of Enrollment||Participants|Count of Participants|243|243.0||||||
3838079|NCT01687998|3664517|B3|South Korea||Region of Enrollment||Participants|Count of Participants|181|181.0||||||
3838080|NCT01687998|3664518|B2|South Korea||Region of Enrollment||Participants|Count of Participants|94|94.0||||||
3838081|NCT01687998|3664519|B1|South Korea||Region of Enrollment||Participants|Count of Participants|87|87.0||||||
3838082|NCT01687998|3664517|B3|China||Region of Enrollment||Participants|Count of Participants|445|445.0||||||
3838083|NCT01687998|3664518|B2|China||Region of Enrollment||Participants|Count of Participants|221|221.0||||||
3838084|NCT01687998|3664519|B1|China||Region of Enrollment||Participants|Count of Participants|224|224.0||||||
3838085|NCT01687998|3664517|B3|Sweden||Region of Enrollment||Participants|Count of Participants|66|66.0||||||
3838086|NCT01687998|3664518|B2|Sweden||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3838087|NCT01687998|3664519|B1|Sweden||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3838088|NCT01687998|3664517|B3|Austria||Region of Enrollment||Participants|Count of Participants|68|68.0||||||
3838089|NCT01687998|3664518|B2|Austria||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3838090|NCT01687998|3664519|B1|Austria||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3838091|NCT01687998|3664517|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|340|340.0||||||
3838092|NCT01687998|3664518|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|169|169.0||||||
3838093|NCT01687998|3664519|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|171|171.0||||||
3838094|NCT01687998|3664517|B3|United States||Region of Enrollment||Participants|Count of Participants|4475|4475.0||||||
3838095|NCT01687998|3664518|B2|United States||Region of Enrollment||Participants|Count of Participants|2240|2240.0||||||
3838096|NCT01687998|3664519|B1|United States||Region of Enrollment||Participants|Count of Participants|2235|2235.0||||||
3838097|NCT01687998|3664517|B3|Hong Kong||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
3838098|NCT01687998|3664518|B2|Hong Kong||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3838099|NCT01687998|3664519|B1|Hong Kong||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3838100|NCT01687998|3664517|B3|Russia||Region of Enrollment||Participants|Count of Participants|167|167.0||||||
3838101|NCT01687998|3664518|B2|Russia||Region of Enrollment||Participants|Count of Participants|82|82.0||||||
3838102|NCT01687998|3664519|B1|Russia||Region of Enrollment||Participants|Count of Participants|85|85.0||||||
3838103|NCT01687998|3664517|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3838104|NCT01687998|3664518|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3838105|NCT01687998|3664519|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3838106|NCT01687998|3664517|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3838107|NCT01687998|3664518|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3838108|NCT01687998|3664519|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3838109|NCT01687998|3664517|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9904|9904.0||||||
3838110|NCT01687998|3664518|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4971|4971.0||||||
3838111|NCT01687998|3664519|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4933|4933.0||||||
3838112|NCT01687998|3664517|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|294|294.0||||||
3838113|NCT01687998|3664518|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|153|153.0||||||
3838114|NCT01687998|3664519|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|141|141.0||||||
3838115|NCT01687998|3664517|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3838116|NCT01687998|3664518|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3838117|NCT01687998|3664519|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3838118|NCT01687998|3664517|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1290|1290.0||||||
3838119|NCT01687998|3664518|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|640|640.0||||||
3838120|NCT01687998|3664519|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|650|650.0||||||
3838121|NCT01687998|3664517|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|469|469.0||||||
3838122|NCT01687998|3664518|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|226|226.0||||||
3838123|NCT01687998|3664519|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|243|243.0||||||
3838124|NCT01687998|3664517|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|290|290.0||||||
3838125|NCT01687998|3664518|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
3838126|NCT01687998|3664519|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
3838127|NCT01687998|3664517|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10780|10780.0||||||
3838128|NCT01687998|3664518|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5386|5386.0||||||
3838129|NCT01687998|3664519|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5394|5394.0||||||
3838130|NCT01687998|3664517|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1022|1022.0||||||
3838131|NCT01687998|3664518|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|522|522.0||||||
3838132|NCT01687998|3664519|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|500|500.0||||||
3838133|NCT01687998|3664517|B3||Male|Sex: Female, Male||Participants|Count of Participants|9308|9308.0||||||
3838134|NCT01687998|3664518|B2||Male|Sex: Female, Male||Participants|Count of Participants|4660|4660.0||||||
3838135|NCT01687998|3664519|B1||Male|Sex: Female, Male||Participants|Count of Participants|4648|4648.0||||||
3838136|NCT01687998|3664517|B3||Female|Sex: Female, Male||Participants|Count of Participants|2784|2784.0||||||
3838137|NCT01687998|3664518|B2||Female|Sex: Female, Male||Participants|Count of Participants|1394|1394.0||||||
3838138|NCT01687998|3664519|B1||Female|Sex: Female, Male||Participants|Count of Participants|1390|1390.0||||||
3838139|NCT01687998|3664517|B3|||Age||years|Mean|64.892|64.892|Standard Deviation|9.4223|9.4223|||
3838140|NCT01687998|3664518|B2|||Age||years|Mean|64.994|64.994|Standard Deviation|9.4591|9.4591|||
3838141|NCT01687998|3664519|B1|||Age||years|Mean|64.791|64.791|Standard Deviation|9.3849|9.3849|||
3838142|NCT01687972|3664536|B3|United States||Region of Enrollment||participants|Number|88|88.0||||||
3838143|NCT01687972|3664537|B2|United States||Region of Enrollment||participants|Number|44|44.0||||||
3838144|NCT01687972|3664538|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
3838145|NCT01687972|3664536|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3838146|NCT01687972|3664537|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3838147|NCT01687972|3664538|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3838148|NCT01687972|3664536|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3838149|NCT01687972|3664537|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3838150|NCT01687972|3664538|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3838151|NCT01687972|3664536|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3838152|NCT01687972|3664537|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3838153|NCT01687972|3664538|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3838154|NCT01687972|3664536|B3||Between 18 and 65 years|Age||Participants|Count of Participants|88|88.0||||||
3838155|NCT01687972|3664537|B2||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3838156|NCT01687972|3664538|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3838157|NCT01687972|3664536|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3838158|NCT01687972|3664537|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3838159|NCT01687972|3664538|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3838160|NCT01687790|3664549|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
3838161|NCT01687790|3664549|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3838162|NCT01687790|3664549|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3838163|NCT01687790|3664549|B1||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3838164|NCT01687790|3664549|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3838165|NCT01687790|3664549|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3838166|NCT01687790|3664549|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3838167|NCT01687790|3664549|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3838168|NCT01687790|3664549|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3838169|NCT01687790|3664549|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3838170|NCT01687790|3664549|B1|||Age||years|Median|56|56.0|Full Range|||33.0|78.0|
3838171|NCT01687790|3664549|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3838172|NCT01687790|3664549|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3838173|NCT01687790|3664549|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3838174|NCT01687712|3664554|B3|||LH at screening|Measure of Luteinizing Hormone (LH) at screening.|international units (IU)|Mean|5.76|5.76|Standard Deviation|2.93|2.93|||
3838175|NCT01687712|3664555|B2|||LH at screening|Measure of Luteinizing Hormone (LH) at screening.|international units (IU)|Mean|5.74|5.74|Standard Deviation|2.44|2.44|||
3838176|NCT01687712|3664556|B1|||LH at screening|Measure of Luteinizing Hormone (LH) at screening.|international units (IU)|Mean|5.77|5.77|Standard Deviation|3.36|3.36|||
3838177|NCT01687712|3664554|B3|||FSH at screening|Measure of Follicle Stimulating Hormone (FSH) at screening.|international units (IU)|Mean|7.87|7.87|Standard Deviation|3.700|3.7|||
3838178|NCT01687712|3664555|B2|||FSH at screening|Measure of Follicle Stimulating Hormone (FSH) at screening.|international units (IU)|Mean|7.76|7.76|Standard Deviation|2.433|2.433|||
3838179|NCT01687712|3664556|B1|||FSH at screening|Measure of Follicle Stimulating Hormone (FSH) at screening.|international units (IU)|Mean|7.98|7.98|Standard Deviation|4.636|4.636|||
3838180|NCT01687712|3664554|B3||≥3|Number of previous fresh ART cycles [N(%)]|Number of previous Assisted Reproductive Technology (ART) cycles a subject had prior to starting Cycle 1.|Participants|Count of Participants|11|11.0||||||
3838181|NCT01687712|3664555|B2||≥3|Number of previous fresh ART cycles [N(%)]|Number of previous Assisted Reproductive Technology (ART) cycles a subject had prior to starting Cycle 1.|Participants|Count of Participants|4|4.0||||||
3838182|NCT01687712|3664556|B1||≥3|Number of previous fresh ART cycles [N(%)]|Number of previous Assisted Reproductive Technology (ART) cycles a subject had prior to starting Cycle 1.|Participants|Count of Participants|7|7.0||||||
3838183|NCT01687712|3664554|B3||2|Number of previous fresh ART cycles [N(%)]|Number of previous Assisted Reproductive Technology (ART) cycles a subject had prior to starting Cycle 1.|Participants|Count of Participants|50|50.0||||||
3838184|NCT01687712|3664555|B2||2|Number of previous fresh ART cycles [N(%)]|Number of previous Assisted Reproductive Technology (ART) cycles a subject had prior to starting Cycle 1.|Participants|Count of Participants|30|30.0||||||
3838185|NCT01687712|3664556|B1||2|Number of previous fresh ART cycles [N(%)]|Number of previous Assisted Reproductive Technology (ART) cycles a subject had prior to starting Cycle 1.|Participants|Count of Participants|20|20.0||||||
3838186|NCT01687712|3664554|B3||1|Number of previous fresh ART cycles [N(%)]|Number of previous Assisted Reproductive Technology (ART) cycles a subject had prior to starting Cycle 1.|Participants|Count of Participants|158|158.0||||||
3838187|NCT01687712|3664555|B2||1|Number of previous fresh ART cycles [N(%)]|Number of previous Assisted Reproductive Technology (ART) cycles a subject had prior to starting Cycle 1.|Participants|Count of Participants|77|77.0||||||
3838381|NCT01687283|3664655|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3838188|NCT01687712|3664556|B1||1|Number of previous fresh ART cycles [N(%)]|Number of previous Assisted Reproductive Technology (ART) cycles a subject had prior to starting Cycle 1.|Participants|Count of Participants|81|81.0||||||
3838189|NCT01687712|3664554|B3||0|Number of previous fresh ART cycles [N(%)]|Number of previous Assisted Reproductive Technology (ART) cycles a subject had prior to starting Cycle 1.|Participants|Count of Participants|881|881.0||||||
3838190|NCT01687712|3664555|B2||0|Number of previous fresh ART cycles [N(%)]|Number of previous Assisted Reproductive Technology (ART) cycles a subject had prior to starting Cycle 1.|Participants|Count of Participants|440|440.0||||||
3838191|NCT01687712|3664556|B1||0|Number of previous fresh ART cycles [N(%)]|Number of previous Assisted Reproductive Technology (ART) cycles a subject had prior to starting Cycle 1.|Participants|Count of Participants|441|441.0||||||
3838192|NCT01687712|3664554|B3|||Infertility Duration||years|Mean|4.1|4.1|Standard Deviation|4.58|4.58|||
3838193|NCT01687712|3664555|B2|||Infertility Duration||years|Mean|4.2|4.2|Standard Deviation|4.54|4.54|||
3838194|NCT01687712|3664556|B1|||Infertility Duration||years|Mean|4.1|4.1|Standard Deviation|4.61|4.61|||
3838195|NCT01687712|3664554|B3|Other||Primary Cause of Infertility|Subjects can have more than one factor that causes infertility, therefore percentages may add up to more than 100.|Participants|Count of Participants|69|69.0||||||
3838196|NCT01687712|3664555|B2|Other||Primary Cause of Infertility|Subjects can have more than one factor that causes infertility, therefore percentages may add up to more than 100.|Participants|Count of Participants|41|41.0||||||
3838197|NCT01687712|3664556|B1|Other||Primary Cause of Infertility|Subjects can have more than one factor that causes infertility, therefore percentages may add up to more than 100.|Participants|Count of Participants|28|28.0||||||
3838198|NCT01687712|3664554|B3|Mild Endometriosis||Primary Cause of Infertility|Subjects can have more than one factor that causes infertility, therefore percentages may add up to more than 100.|Participants|Count of Participants|104|104.0||||||
3838199|NCT01687712|3664555|B2|Mild Endometriosis||Primary Cause of Infertility|Subjects can have more than one factor that causes infertility, therefore percentages may add up to more than 100.|Participants|Count of Participants|45|45.0||||||
3838200|NCT01687712|3664556|B1|Mild Endometriosis||Primary Cause of Infertility|Subjects can have more than one factor that causes infertility, therefore percentages may add up to more than 100.|Participants|Count of Participants|59|59.0||||||
3838201|NCT01687712|3664554|B3|Tubal Factor||Primary Cause of Infertility|Subjects can have more than one factor that causes infertility, therefore percentages may add up to more than 100.|Participants|Count of Participants|307|307.0||||||
3838202|NCT01687712|3664555|B2|Tubal Factor||Primary Cause of Infertility|Subjects can have more than one factor that causes infertility, therefore percentages may add up to more than 100.|Participants|Count of Participants|169|169.0||||||
3838203|NCT01687712|3664556|B1|Tubal Factor||Primary Cause of Infertility|Subjects can have more than one factor that causes infertility, therefore percentages may add up to more than 100.|Participants|Count of Participants|138|138.0||||||
3838204|NCT01687712|3664554|B3|Male Factor||Primary Cause of Infertility|Subjects can have more than one factor that causes infertility, therefore percentages may add up to more than 100.|Participants|Count of Participants|367|367.0||||||
3838205|NCT01687712|3664555|B2|Male Factor||Primary Cause of Infertility|Subjects can have more than one factor that causes infertility, therefore percentages may add up to more than 100.|Participants|Count of Participants|178|178.0||||||
3838206|NCT01687712|3664556|B1|Male Factor||Primary Cause of Infertility|Subjects can have more than one factor that causes infertility, therefore percentages may add up to more than 100.|Participants|Count of Participants|189|189.0||||||
3838207|NCT01687712|3664554|B3|Unexplained Infertility||Primary Cause of Infertility|Subjects can have more than one factor that causes infertility, therefore percentages may add up to more than 100.|Participants|Count of Participants|431|431.0||||||
3838208|NCT01687712|3664555|B2|Unexplained Infertility||Primary Cause of Infertility|Subjects can have more than one factor that causes infertility, therefore percentages may add up to more than 100.|Participants|Count of Participants|206|206.0||||||
3838209|NCT01687712|3664556|B1|Unexplained Infertility||Primary Cause of Infertility|Subjects can have more than one factor that causes infertility, therefore percentages may add up to more than 100.|Participants|Count of Participants|225|225.0||||||
3838210|NCT01687712|3664554|B3||Unknown or Not Reported|BMI Category (kg/m^2)||Participants|Count of Participants|14|14.0||||||
3838211|NCT01687712|3664555|B2||Unknown or Not Reported|BMI Category (kg/m^2)||Participants|Count of Participants|6|6.0||||||
3838212|NCT01687712|3664556|B1||Unknown or Not Reported|BMI Category (kg/m^2)||Participants|Count of Participants|8|8.0||||||
3838213|NCT01687712|3664554|B3||>38|BMI Category (kg/m^2)||Participants|Count of Participants|7|7.0||||||
3838214|NCT01687712|3664555|B2||>38|BMI Category (kg/m^2)||Participants|Count of Participants|4|4.0||||||
3838215|NCT01687712|3664556|B1||>38|BMI Category (kg/m^2)||Participants|Count of Participants|3|3.0||||||
3838216|NCT01687712|3664554|B3||>=30 to <=38|BMI Category (kg/m^2)||Participants|Count of Participants|221|221.0||||||
3838217|NCT01687712|3664555|B2||>=30 to <=38|BMI Category (kg/m^2)||Participants|Count of Participants|112|112.0||||||
3838218|NCT01687712|3664556|B1||>=30 to <=38|BMI Category (kg/m^2)||Participants|Count of Participants|109|109.0||||||
3838219|NCT01687712|3664554|B3||>=25 to <30|BMI Category (kg/m^2)||Participants|Count of Participants|334|334.0||||||
3838220|NCT01687712|3664555|B2||>=25 to <30|BMI Category (kg/m^2)||Participants|Count of Participants|184|184.0||||||
3838221|NCT01687712|3664556|B1||>=25 to <30|BMI Category (kg/m^2)||Participants|Count of Participants|150|150.0||||||
3838222|NCT01687712|3664554|B3||>=18 to <25|BMI Category (kg/m^2)||Participants|Count of Participants|524|524.0||||||
3838223|NCT01687712|3664555|B2||>=18 to <25|BMI Category (kg/m^2)||Participants|Count of Participants|245|245.0||||||
3838224|NCT01687712|3664556|B1||>=18 to <25|BMI Category (kg/m^2)||Participants|Count of Participants|279|279.0||||||
3838225|NCT01687712|3664554|B3|||BMI (kg/m^2)||kg/m^2|Mean|26.15|26.15|Standard Deviation|4.765|4.765|||
3838226|NCT01687712|3664555|B2|||BMI (kg/m^2)||kg/m^2|Mean|26.38|26.38|Standard Deviation|4.784|4.784|||
3838227|NCT01687712|3664556|B1|||BMI (kg/m^2)||kg/m^2|Mean|25.92|25.92|Standard Deviation|4.738|4.738|||
3838228|NCT01687712|3664554|B3|||Weight (kg)||kilograms|Mean|70.57|70.57|Standard Deviation|13.828|13.828|||
3838229|NCT01687712|3664555|B2|||Weight (kg)||kilograms|Mean|71.12|71.12|Standard Deviation|13.844|13.844|||
3838230|NCT01687712|3664556|B1|||Weight (kg)||kilograms|Mean|70.01|70.01|Standard Deviation|13.803|13.803|||
3838231|NCT01687712|3664554|B3|||Height (m)||meters|Mean|1.642|1.642|Standard Deviation|0.0672|0.0672|||
3838232|NCT01687712|3664555|B2|||Height (m)||meters|Mean|1.642|1.642|Standard Deviation|0.0684|0.0684|||
3838233|NCT01687712|3664556|B1|||Height (m)||meters|Mean|1.643|1.643|Standard Deviation|0.0660|0.066|||
3838234|NCT01687712|3664554|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3838235|NCT01687712|3664555|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3838236|NCT01687712|3664556|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3838237|NCT01687712|3664554|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3838238|NCT01687712|3664555|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3838239|NCT01687712|3664556|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3838240|NCT01687712|3664554|B3||White|Race (NIH/OMB)||Participants|Count of Participants|875|875.0||||||
3838241|NCT01687712|3664555|B2||White|Race (NIH/OMB)||Participants|Count of Participants|440|440.0||||||
3838242|NCT01687712|3664556|B1||White|Race (NIH/OMB)||Participants|Count of Participants|435|435.0||||||
3838243|NCT01687712|3664554|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|118|118.0||||||
3838244|NCT01687712|3664555|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3838245|NCT01687712|3664556|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3838246|NCT01687712|3664554|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3838247|NCT01687712|3664555|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3838248|NCT01687712|3664556|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3838249|NCT01687712|3664554|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3838250|NCT01687712|3664555|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3838251|NCT01687712|3664556|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3838252|NCT01687712|3664554|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3838253|NCT01687712|3664555|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3838254|NCT01687712|3664556|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3838255|NCT01687712|3664554|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3838256|NCT01687712|3664555|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3838257|NCT01687712|3664556|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3838258|NCT01687712|3664554|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|925|925.0||||||
3838259|NCT01687712|3664555|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|473|473.0||||||
3838260|NCT01687712|3664556|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|452|452.0||||||
3838261|NCT01687712|3664554|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|174|174.0||||||
3838262|NCT01687712|3664555|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3838263|NCT01687712|3664556|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3838264|NCT01687712|3664554|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3838265|NCT01687712|3664555|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3838266|NCT01687712|3664556|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3838267|NCT01687712|3664554|B3||Female|Sex: Female, Male||Participants|Count of Participants|1100|1100.0||||||
3838268|NCT01687712|3664555|B2||Female|Sex: Female, Male||Participants|Count of Participants|551|551.0||||||
3838269|NCT01687712|3664556|B1||Female|Sex: Female, Male||Participants|Count of Participants|549|549.0||||||
3838270|NCT01687712|3664554|B3||41-42|Age, Customized||Participants|Count of Participants|154|154.0||||||
3838271|NCT01687712|3664555|B2||41-42|Age, Customized||Participants|Count of Participants|81|81.0||||||
3838272|NCT01687712|3664556|B1||41-42|Age, Customized||Participants|Count of Participants|73|73.0||||||
3838273|NCT01687712|3664554|B3||38-40|Age, Customized||Participants|Count of Participants|395|395.0||||||
3838274|NCT01687712|3664555|B2||38-40|Age, Customized||Participants|Count of Participants|194|194.0||||||
3838275|NCT01687712|3664556|B1||38-40|Age, Customized||Participants|Count of Participants|201|201.0||||||
3838276|NCT01687712|3664554|B3||35-37|Age, Customized||Participants|Count of Participants|551|551.0||||||
3838277|NCT01687712|3664555|B2||35-37|Age, Customized||Participants|Count of Participants|276|276.0||||||
3838278|NCT01687712|3664556|B1||35-37|Age, Customized||Participants|Count of Participants|275|275.0||||||
3838279|NCT01687712|3664554|B3|||Age||years|Mean|37.8|37.8|Standard Deviation|2.17|2.17|||
3838280|NCT01687712|3664555|B2|||Age||years|Mean|37.8|37.8|Standard Deviation|2.18|2.18|||
3838281|NCT01687712|3664556|B1|||Age||years|Mean|37.7|37.7|Standard Deviation|2.16|2.16|||
3838282|NCT01687478|3664595|B3|||Number of Previous MDD Episodes Within the Last 36 Months||Number of MDD Episodes|Mean|0.5|0.5|Standard Deviation|0.9|0.9|||
3838283|NCT01687478|3664596|B2|||Number of Previous MDD Episodes Within the Last 36 Months||Number of MDD Episodes|Mean|0.5|0.5|Standard Deviation|1.1|1.1|||
3838321|NCT01687478|3664595|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3838284|NCT01687478|3664597|B1|||Number of Previous MDD Episodes Within the Last 36 Months||Number of MDD Episodes|Mean|0.5|0.5|Standard Deviation|0.8|0.8|||
3838285|NCT01687478|3664595|B3|||Number of Previous Lifetime MDD Episodes||Number of MDD Episodes|Mean|1.3|1.3|Standard Deviation|1.8|1.8|||
3838286|NCT01687478|3664596|B2|||Number of Previous Lifetime MDD Episodes||Number of MDD Episodes|Mean|1.3|1.3|Standard Deviation|2.1|2.1|||
3838287|NCT01687478|3664597|B1|||Number of Previous Lifetime MDD Episodes||Number of MDD Episodes|Mean|1.4|1.4|Standard Deviation|1.4|1.4|||
3838288|NCT01687478|3664595|B3|||Years Since the Most Recent MDD Episode||years|Mean|3.45|3.45|Standard Deviation|4.65|4.65|||
3838289|NCT01687478|3664596|B2|||Years Since the Most Recent MDD Episode||years|Mean|3.23|3.23|Standard Deviation|4.15|4.15|||
3838290|NCT01687478|3664597|B1|||Years Since the Most Recent MDD Episode||years|Mean|3.66|3.66|Standard Deviation|5.12|5.12|||
3838291|NCT01687478|3664595|B3|||Years Since the First MDD Episode||years|Mean|8.05|8.05|Standard Deviation|7.10|7.1|||
3838292|NCT01687478|3664596|B2|||Years Since the First MDD Episode||years|Mean|7.38|7.38|Standard Deviation|7.86|7.86|||
3838293|NCT01687478|3664597|B1|||Years Since the First MDD Episode||years|Mean|8.71|8.71|Standard Deviation|6.21|6.21|||
3838294|NCT01687478|3664595|B3|||Age of First Major Depressive Disorder (MDD) Episode||years|Mean|30.00|30.0|Standard Deviation|12.79|12.79|||
3838295|NCT01687478|3664596|B2|||Age of First Major Depressive Disorder (MDD) Episode||years|Mean|34.07|34.07|Standard Deviation|12.69|12.69|||
3838296|NCT01687478|3664597|B1|||Age of First Major Depressive Disorder (MDD) Episode||years|Mean|29.92|29.92|Standard Deviation|12.61|12.61|||
3838297|NCT01687478|3664595|B3|||Clinical Global Impressions-Severity of Depression (CGI-S)|The CGI-S measures severity of illness at the time of assessment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill participants).|units on a scale|Mean|4.9|4.9|Standard Deviation|0.7|0.7|||
3838298|NCT01687478|3664596|B2|||Clinical Global Impressions-Severity of Depression (CGI-S)|The CGI-S measures severity of illness at the time of assessment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill participants).|units on a scale|Mean|4.9|4.9|Standard Deviation|0.7|0.7|||
3838299|NCT01687478|3664597|B1|||Clinical Global Impressions-Severity of Depression (CGI-S)|The CGI-S measures severity of illness at the time of assessment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill participants).|units on a scale|Mean|4.9|4.9|Standard Deviation|0.6|0.6|||
3838300|NCT01687478|3664595|B3|||17 Item Hamilton Rating Scale for Depression (HAM-D17) Total Score|The 17-item HAMD measures depression severity. Each item was evaluated and scored using either a 5-point scale (e.g. absent, mild, moderate, severe, very severe) or a 3-point scale (e.g. absent, mild, marked). The total score of HAMD-17 may range from 0 (normal) to 52 (severe).|units on a scale|Mean|24.8|24.8|Standard Deviation|2.6|2.6|||
3838301|NCT01687478|3664596|B2|||17 Item Hamilton Rating Scale for Depression (HAM-D17) Total Score|The 17-item HAMD measures depression severity. Each item was evaluated and scored using either a 5-point scale (e.g. absent, mild, moderate, severe, very severe) or a 3-point scale (e.g. absent, mild, marked). The total score of HAMD-17 may range from 0 (normal) to 52 (severe).|units on a scale|Mean|25.0|25.0|Standard Deviation|2.6|2.6|||
3838302|NCT01687478|3664597|B1|||17 Item Hamilton Rating Scale for Depression (HAM-D17) Total Score|The 17-item HAMD measures depression severity. Each item was evaluated and scored using either a 5-point scale (e.g. absent, mild, moderate, severe, very severe) or a 3-point scale (e.g. absent, mild, marked). The total score of HAMD-17 may range from 0 (normal) to 52 (severe).|units on a scale|Mean|24.6|24.6|Standard Deviation|2.6|2.6|||
3838303|NCT01687478|3664595|B3|||Montgomery-Äsberg Depression Rating Scale (MADRS) Total Score|The MADRS is a rating scale for severity of depressive mood symptoms. The MADRS has a 10-item checklist. Items are rated on a scale of 0-6, for a total score range of 0 (low severity of depressive symptoms) to 60 (high severity of depressive symptoms).|units on a scale|Mean|32.0|32.0|Standard Deviation|5.0|5.0|||
3838304|NCT01687478|3664596|B2|||Montgomery-Äsberg Depression Rating Scale (MADRS) Total Score|The MADRS is a rating scale for severity of depressive mood symptoms. The MADRS has a 10-item checklist. Items are rated on a scale of 0-6, for a total score range of 0 (low severity of depressive symptoms) to 60 (high severity of depressive symptoms).|units on a scale|Mean|31.8|31.8|Standard Deviation|4.8|4.8|||
3838305|NCT01687478|3664597|B1|||Montgomery-Äsberg Depression Rating Scale (MADRS) Total Score|The MADRS is a rating scale for severity of depressive mood symptoms. The MADRS has a 10-item checklist. Items are rated on a scale of 0-6, for a total score range of 0 (low severity of depressive symptoms) to 60 (high severity of depressive symptoms).|units on a scale|Mean|32.1|32.1|Standard Deviation|5.3|5.3|||
3838306|NCT01687478|3664595|B3|China||Region of Enrollment||participants|Number|176|176.0||||||
3838307|NCT01687478|3664596|B2|China||Region of Enrollment||participants|Number|88|88.0||||||
3838308|NCT01687478|3664597|B1|China||Region of Enrollment||participants|Number|88|88.0||||||
3838309|NCT01687478|3664595|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3838310|NCT01687478|3664596|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3838311|NCT01687478|3664597|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3838312|NCT01687478|3664595|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3838313|NCT01687478|3664596|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3838314|NCT01687478|3664597|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3838315|NCT01687478|3664595|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3838316|NCT01687478|3664596|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3838317|NCT01687478|3664597|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3838318|NCT01687478|3664595|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3838319|NCT01687478|3664596|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3838320|NCT01687478|3664597|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3838322|NCT01687478|3664596|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3838323|NCT01687478|3664597|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3838324|NCT01687478|3664595|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|176|176.0||||||
3838325|NCT01687478|3664596|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3838326|NCT01687478|3664597|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3838327|NCT01687478|3664595|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3838328|NCT01687478|3664596|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3838329|NCT01687478|3664597|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3838330|NCT01687478|3664595|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3838331|NCT01687478|3664596|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3838332|NCT01687478|3664597|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3838333|NCT01687478|3664595|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|176|176.0||||||
3838334|NCT01687478|3664596|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3838335|NCT01687478|3664597|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3838336|NCT01687478|3664595|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3838337|NCT01687478|3664596|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3838338|NCT01687478|3664597|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3838339|NCT01687478|3664595|B3||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3838340|NCT01687478|3664596|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3838341|NCT01687478|3664597|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3838342|NCT01687478|3664595|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3838343|NCT01687478|3664596|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3838344|NCT01687478|3664597|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3838345|NCT01687478|3664595|B3|||Age||years|Mean|40.04|40.04|Standard Deviation|12.36|12.36|||
3838346|NCT01687478|3664596|B2|||Age||years|Mean|41.45|41.45|Standard Deviation|12.44|12.44|||
3838347|NCT01687478|3664597|B1|||Age||years|Mean|38.63|38.63|Standard Deviation|12.18|12.18|||
3838348|NCT01687400|3664620|B1|United States||Region of Enrollment||participants|Number|114|114.0||||||
3838349|NCT01687400|3664620|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3838350|NCT01687400|3664620|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3838351|NCT01687400|3664620|B1||White|Race (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
3838352|NCT01687400|3664620|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3838353|NCT01687400|3664620|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3838354|NCT01687400|3664620|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3838355|NCT01687400|3664620|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3838356|NCT01687400|3664620|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3838357|NCT01687400|3664620|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
3838358|NCT01687400|3664620|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3838359|NCT01687400|3664620|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3838360|NCT01687400|3664620|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3838361|NCT01687400|3664620|B1|||Age||years|Median|73|73.0|Full Range|||31.0|88.0|
3838362|NCT01687296|3664631|B3|China||Region of Enrollment||Participants|Number|251|251.0||||||
3838363|NCT01687296|3664632|B2|China||Region of Enrollment||Participants|Number|128|128.0||||||
3838364|NCT01687296|3664633|B1|China||Region of Enrollment||Participants|Number|123|123.0||||||
3838365|NCT01687296|3664631|B3||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3838366|NCT01687296|3664632|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3838367|NCT01687296|3664633|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3838368|NCT01687296|3664631|B3||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3838369|NCT01687296|3664632|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3838370|NCT01687296|3664633|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3838371|NCT01687296|3664631|B3|||Age||Years|Mean|6.5|6.5|Standard Deviation|2.36|2.36|||
3838372|NCT01687296|3664632|B2|||Age||Years|Mean|6.5|6.5|Standard Deviation|2.32|2.32|||
3838373|NCT01687296|3664633|B1|||Age||Years|Mean|6.6|6.6|Standard Deviation|2.41|2.41|||
3838374|NCT01687283|3664654|B3|China||Region of Enrollment||Participants|Number|315|315.0||||||
3838375|NCT01687283|3664655|B2|China||Region of Enrollment||Participants|Number|157|157.0||||||
3838376|NCT01687283|3664656|B1|China||Region of Enrollment||Participants|Number|158|158.0||||||
3838377|NCT01687283|3664654|B3||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3838378|NCT01687283|3664655|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3838379|NCT01687283|3664656|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3838380|NCT01687283|3664654|B3||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3838382|NCT01687283|3664656|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3838383|NCT01687283|3664654|B3|||Age||Years|Mean|51.4|51.4|Standard Deviation|9.74|9.74|||
3838384|NCT01687283|3664655|B2|||Age||Years|Mean|51.1|51.1|Standard Deviation|6.65|6.65|||
3838385|NCT01687283|3664656|B1|||Age||Years|Mean|51.7|51.7|Standard Deviation|9.84|9.84|||
3838386|NCT01687270|3664680|B1|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|11|11.0||||||
3838387|NCT01687270|3664680|B1|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|16|16.0||||||
3838388|NCT01687270|3664680|B1|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|13|13.0||||||
3838389|NCT01687270|3664680|B1|Genotype 4||HCV Genotype||participants|Number|1|1.0||||||
3838390|NCT01687270|3664680|B1|Genotype 3B||HCV Genotype||participants|Number|1|1.0||||||
3838391|NCT01687270|3664680|B1|Genotype 3A||HCV Genotype||participants|Number|5|5.0||||||
3838392|NCT01687270|3664680|B1|Genotype 1B||HCV Genotype||participants|Number|11|11.0||||||
3838393|NCT01687270|3664680|B1|Genotype 1A||HCV Genotype||participants|Number|22|22.0||||||
3838394|NCT01687270|3664680|B1|Yes||Prior HCV Treatment||participants|Number|35|35.0||||||
3838395|NCT01687270|3664680|B1|No||Prior HCV Treatment||participants|Number|5|5.0||||||
3838396|NCT01687270|3664680|B1|> 7 log10 IU/mL||HCV RNA Category||participants|Number|12|12.0||||||
3838397|NCT01687270|3664680|B1|6 to 7 log10 IU/mL||HCV RNA Category||participants|Number|20|20.0||||||
3838398|NCT01687270|3664680|B1|< 6 log10 IU/mL||HCV RNA Category||participants|Number|8|8.0||||||
3838399|NCT01687270|3664680|B1|||HCV RNA||log10 IU/mL|Mean|6.55|6.55|Standard Deviation|0.751|0.751|||
3838400|NCT01687270|3664680|B1|New Zealand||Region of Enrollment||participants|Number|3|3.0||||||
3838401|NCT01687270|3664680|B1|Germany||Region of Enrollment||participants|Number|3|3.0||||||
3838402|NCT01687270|3664680|B1|Spain||Region of Enrollment||participants|Number|3|3.0||||||
3838403|NCT01687270|3664680|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
3838404|NCT01687270|3664680|B1|France||Region of Enrollment||participants|Number|3|3.0||||||
3838405|NCT01687270|3664680|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3838406|NCT01687270|3664680|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3838407|NCT01687270|3664680|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3838408|NCT01687270|3664680|B1|White||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
3838409|NCT01687270|3664680|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3838410|NCT01687270|3664680|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3838411|NCT01687270|3664680|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3838412|NCT01687270|3664680|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3838413|NCT01687270|3664680|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3838414|NCT01687270|3664680|B1|||Age||years|Mean|59|59.0|Standard Deviation|6.3|6.3|||
3838415|NCT01687257|3664689|B3|16||Model for End-Stage Liver Disease (MELD) Score|MELD scores, used to assess prognosis and suitability for transplant, are calculated based on laboratory values only and can range from 6 to 40, with higher scores indicating greater disease severity.|participants|Number|2|2.0||||||
3838416|NCT01687257|3664690|B2|16||Model for End-Stage Liver Disease (MELD) Score|MELD scores, used to assess prognosis and suitability for transplant, are calculated based on laboratory values only and can range from 6 to 40, with higher scores indicating greater disease severity.|participants|Number|0|0.0||||||
3838417|NCT01687257|3664691|B1|16||Model for End-Stage Liver Disease (MELD) Score|MELD scores, used to assess prognosis and suitability for transplant, are calculated based on laboratory values only and can range from 6 to 40, with higher scores indicating greater disease severity.|participants|Number|2|2.0||||||
3838418|NCT01687257|3664689|B3|15||Model for End-Stage Liver Disease (MELD) Score|MELD scores, used to assess prognosis and suitability for transplant, are calculated based on laboratory values only and can range from 6 to 40, with higher scores indicating greater disease severity.|participants|Number|6|6.0||||||
3838419|NCT01687257|3664690|B2|15||Model for End-Stage Liver Disease (MELD) Score|MELD scores, used to assess prognosis and suitability for transplant, are calculated based on laboratory values only and can range from 6 to 40, with higher scores indicating greater disease severity.|participants|Number|3|3.0||||||
3838420|NCT01687257|3664691|B1|15||Model for End-Stage Liver Disease (MELD) Score|MELD scores, used to assess prognosis and suitability for transplant, are calculated based on laboratory values only and can range from 6 to 40, with higher scores indicating greater disease severity.|participants|Number|3|3.0||||||
3838421|NCT01687257|3664689|B3|13||Model for End-Stage Liver Disease (MELD) Score|MELD scores, used to assess prognosis and suitability for transplant, are calculated based on laboratory values only and can range from 6 to 40, with higher scores indicating greater disease severity.|participants|Number|3|3.0||||||
3838422|NCT01687257|3664690|B2|13||Model for End-Stage Liver Disease (MELD) Score|MELD scores, used to assess prognosis and suitability for transplant, are calculated based on laboratory values only and can range from 6 to 40, with higher scores indicating greater disease severity.|participants|Number|1|1.0||||||
3838423|NCT01687257|3664691|B1|13||Model for End-Stage Liver Disease (MELD) Score|MELD scores, used to assess prognosis and suitability for transplant, are calculated based on laboratory values only and can range from 6 to 40, with higher scores indicating greater disease severity.|participants|Number|2|2.0||||||
3838424|NCT01687257|3664689|B3|12||Model for End-Stage Liver Disease (MELD) Score|MELD scores, used to assess prognosis and suitability for transplant, are calculated based on laboratory values only and can range from 6 to 40, with higher scores indicating greater disease severity.|participants|Number|5|5.0||||||
3838425|NCT01687257|3664690|B2|12||Model for End-Stage Liver Disease (MELD) Score|MELD scores, used to assess prognosis and suitability for transplant, are calculated based on laboratory values only and can range from 6 to 40, with higher scores indicating greater disease severity.|participants|Number|1|1.0||||||
3838426|NCT01687257|3664691|B1|12||Model for End-Stage Liver Disease (MELD) Score|MELD scores, used to assess prognosis and suitability for transplant, are calculated based on laboratory values only and can range from 6 to 40, with higher scores indicating greater disease severity.|participants|Number|4|4.0||||||
3838427|NCT01687257|3664689|B3|11||Model for End-Stage Liver Disease (MELD) Score|MELD scores, used to assess prognosis and suitability for transplant, are calculated based on laboratory values only and can range from 6 to 40, with higher scores indicating greater disease severity.|participants|Number|4|4.0||||||
3838428|NCT01687257|3664690|B2|11||Model for End-Stage Liver Disease (MELD) Score|MELD scores, used to assess prognosis and suitability for transplant, are calculated based on laboratory values only and can range from 6 to 40, with higher scores indicating greater disease severity.|participants|Number|4|4.0||||||
3838429|NCT01687257|3664691|B1|11||Model for End-Stage Liver Disease (MELD) Score|MELD scores, used to assess prognosis and suitability for transplant, are calculated based on laboratory values only and can range from 6 to 40, with higher scores indicating greater disease severity.|participants|Number|0|0.0||||||
3838430|NCT01687257|3664689|B3|10||Model for End-Stage Liver Disease (MELD) Score|MELD scores, used to assess prognosis and suitability for transplant, are calculated based on laboratory values only and can range from 6 to 40, with higher scores indicating greater disease severity.|participants|Number|9|9.0||||||
3838431|NCT01687257|3664690|B2|10||Model for End-Stage Liver Disease (MELD) Score|MELD scores, used to assess prognosis and suitability for transplant, are calculated based on laboratory values only and can range from 6 to 40, with higher scores indicating greater disease severity.|participants|Number|4|4.0||||||
3838432|NCT01687257|3664691|B1|10||Model for End-Stage Liver Disease (MELD) Score|MELD scores, used to assess prognosis and suitability for transplant, are calculated based on laboratory values only and can range from 6 to 40, with higher scores indicating greater disease severity.|participants|Number|5|5.0||||||
3838433|NCT01687257|3664689|B3|9||Model for End-Stage Liver Disease (MELD) Score|MELD scores, used to assess prognosis and suitability for transplant, are calculated based on laboratory values only and can range from 6 to 40, with higher scores indicating greater disease severity.|participants|Number|4|4.0||||||
3838434|NCT01687257|3664690|B2|9||Model for End-Stage Liver Disease (MELD) Score|MELD scores, used to assess prognosis and suitability for transplant, are calculated based on laboratory values only and can range from 6 to 40, with higher scores indicating greater disease severity.|participants|Number|1|1.0||||||
3838435|NCT01687257|3664691|B1|9||Model for End-Stage Liver Disease (MELD) Score|MELD scores, used to assess prognosis and suitability for transplant, are calculated based on laboratory values only and can range from 6 to 40, with higher scores indicating greater disease severity.|participants|Number|3|3.0||||||
3838436|NCT01687257|3664689|B3|8||Model for End-Stage Liver Disease (MELD) Score|MELD scores, used to assess prognosis and suitability for transplant, are calculated based on laboratory values only and can range from 6 to 40, with higher scores indicating greater disease severity.|participants|Number|7|7.0||||||
3838437|NCT01687257|3664690|B2|8||Model for End-Stage Liver Disease (MELD) Score|MELD scores, used to assess prognosis and suitability for transplant, are calculated based on laboratory values only and can range from 6 to 40, with higher scores indicating greater disease severity.|participants|Number|2|2.0||||||
3838438|NCT01687257|3664691|B1|8||Model for End-Stage Liver Disease (MELD) Score|MELD scores, used to assess prognosis and suitability for transplant, are calculated based on laboratory values only and can range from 6 to 40, with higher scores indicating greater disease severity.|participants|Number|5|5.0||||||
3838439|NCT01687257|3664689|B3|7||Model for End-Stage Liver Disease (MELD) Score|MELD scores, used to assess prognosis and suitability for transplant, are calculated based on laboratory values only and can range from 6 to 40, with higher scores indicating greater disease severity.|participants|Number|3|3.0||||||
3838440|NCT01687257|3664690|B2|7||Model for End-Stage Liver Disease (MELD) Score|MELD scores, used to assess prognosis and suitability for transplant, are calculated based on laboratory values only and can range from 6 to 40, with higher scores indicating greater disease severity.|participants|Number|3|3.0||||||
3838441|NCT01687257|3664691|B1|7||Model for End-Stage Liver Disease (MELD) Score|MELD scores, used to assess prognosis and suitability for transplant, are calculated based on laboratory values only and can range from 6 to 40, with higher scores indicating greater disease severity.|participants|Number|0|0.0||||||
3838442|NCT01687257|3664689|B3|6||Model for End-Stage Liver Disease (MELD) Score|MELD scores, used to assess prognosis and suitability for transplant, are calculated based on laboratory values only and can range from 6 to 40, with higher scores indicating greater disease severity.|participants|Number|3|3.0||||||
3838443|NCT01687257|3664690|B2|6||Model for End-Stage Liver Disease (MELD) Score|MELD scores, used to assess prognosis and suitability for transplant, are calculated based on laboratory values only and can range from 6 to 40, with higher scores indicating greater disease severity.|participants|Number|2|2.0||||||
3838444|NCT01687257|3664691|B1|6||Model for End-Stage Liver Disease (MELD) Score|MELD scores, used to assess prognosis and suitability for transplant, are calculated based on laboratory values only and can range from 6 to 40, with higher scores indicating greater disease severity.|participants|Number|1|1.0||||||
3838445|NCT01687257|3664689|B3|CPT B (7-10)||Child-Pugh-Turcotte (CPT) Score Category|CPT scores, widely used to grade the severity of cirrhosis and to determine the need for liver transplantation, are calculated based on a combination of laboratory values and clinical features. CPT scores can range from 5 to 15, with higher scores indicating a greater severity of disease.|participants|Number|28|28.0||||||
3838446|NCT01687257|3664690|B2|CPT B (7-10)||Child-Pugh-Turcotte (CPT) Score Category|CPT scores, widely used to grade the severity of cirrhosis and to determine the need for liver transplantation, are calculated based on a combination of laboratory values and clinical features. CPT scores can range from 5 to 15, with higher scores indicating a greater severity of disease.|participants|Number|11|11.0||||||
3838447|NCT01687257|3664691|B1|CPT B (7-10)||Child-Pugh-Turcotte (CPT) Score Category|CPT scores, widely used to grade the severity of cirrhosis and to determine the need for liver transplantation, are calculated based on a combination of laboratory values and clinical features. CPT scores can range from 5 to 15, with higher scores indicating a greater severity of disease.|participants|Number|17|17.0||||||
3838499|NCT01687257|3664689|B3|France||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 50).|participants|Number|6|6.0||||||
3838448|NCT01687257|3664689|B3|CPT A (5-6)||Child-Pugh-Turcotte (CPT) Score Category|CPT scores, widely used to grade the severity of cirrhosis and to determine the need for liver transplantation, are calculated based on a combination of laboratory values and clinical features. CPT scores can range from 5 to 15, with higher scores indicating a greater severity of disease.|participants|Number|18|18.0||||||
3838449|NCT01687257|3664690|B2|CPT A (5-6)||Child-Pugh-Turcotte (CPT) Score Category|CPT scores, widely used to grade the severity of cirrhosis and to determine the need for liver transplantation, are calculated based on a combination of laboratory values and clinical features. CPT scores can range from 5 to 15, with higher scores indicating a greater severity of disease.|participants|Number|10|10.0||||||
3838450|NCT01687257|3664691|B1|CPT A (5-6)||Child-Pugh-Turcotte (CPT) Score Category|CPT scores, widely used to grade the severity of cirrhosis and to determine the need for liver transplantation, are calculated based on a combination of laboratory values and clinical features. CPT scores can range from 5 to 15, with higher scores indicating a greater severity of disease.|participants|Number|8|8.0||||||
3838451|NCT01687257|3664689|B3|||Hepatic Venous Pressure Gradient (HVPG)||mmHg|Mean|17.0|17.0|Standard Deviation|4.85|4.85|||
3838452|NCT01687257|3664690|B2|||Hepatic Venous Pressure Gradient (HVPG)||mmHg|Mean|16.4|16.4|Standard Deviation|4.88|4.88|||
3838453|NCT01687257|3664691|B1|||Hepatic Venous Pressure Gradient (HVPG)||mmHg|Mean|17.4|17.4|Standard Deviation|4.70|4.7|||
3838454|NCT01687257|3664689|B3|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|31|31.0||||||
3838455|NCT01687257|3664690|B2|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|16|16.0||||||
3838456|NCT01687257|3664691|B1|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|15|15.0||||||
3838457|NCT01687257|3664689|B3|< 800,000 IU/mL||HCV RNA Category||participants|Number|15|15.0||||||
3838458|NCT01687257|3664690|B2|< 800,000 IU/mL||HCV RNA Category||participants|Number|5|5.0||||||
3838459|NCT01687257|3664691|B1|< 800,000 IU/mL||HCV RNA Category||participants|Number|10|10.0||||||
3838460|NCT01687257|3664689|B3|||HCV RNA||log10 IU/mL|Mean|6.1|6.1|Standard Deviation|0.64|0.64|||
3838461|NCT01687257|3664690|B2|||HCV RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.79|0.79|||
3838462|NCT01687257|3664691|B1|||HCV RNA||log10 IU/mL|Mean|6.1|6.1|Standard Deviation|0.49|0.49|||
3838463|NCT01687257|3664689|B3|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|13|13.0||||||
3838464|NCT01687257|3664690|B2|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|5|5.0||||||
3838465|NCT01687257|3664691|B1|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|8|8.0||||||
3838466|NCT01687257|3664689|B3|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|24|24.0||||||
3838467|NCT01687257|3664690|B2|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|10|10.0||||||
3838468|NCT01687257|3664691|B1|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|14|14.0||||||
3838469|NCT01687257|3664689|B3|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|9|9.0||||||
3838470|NCT01687257|3664690|B2|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|6|6.0||||||
3838471|NCT01687257|3664691|B1|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
3838472|NCT01687257|3664689|B3|Genotype 4h||HCV Genotype||participants|Number|1|1.0||||||
3838473|NCT01687257|3664690|B2|Genotype 4h||HCV Genotype||participants|Number|0|0.0||||||
3838474|NCT01687257|3664691|B1|Genotype 4h||HCV Genotype||participants|Number|1|1.0||||||
3838475|NCT01687257|3664689|B3|Genotype 4||HCV Genotype||participants|Number|2|2.0||||||
3838476|NCT01687257|3664690|B2|Genotype 4||HCV Genotype||participants|Number|1|1.0||||||
3838477|NCT01687257|3664691|B1|Genotype 4||HCV Genotype||participants|Number|1|1.0||||||
3838478|NCT01687257|3664689|B3|Genotype 3a||HCV Genotype||participants|Number|8|8.0||||||
3838479|NCT01687257|3664690|B2|Genotype 3a||HCV Genotype||participants|Number|6|6.0||||||
3838480|NCT01687257|3664691|B1|Genotype 3a||HCV Genotype||participants|Number|2|2.0||||||
3838481|NCT01687257|3664689|B3|Genotype 2b||HCV Genotype||participants|Number|2|2.0||||||
3838482|NCT01687257|3664690|B2|Genotype 2b||HCV Genotype||participants|Number|1|1.0||||||
3838483|NCT01687257|3664691|B1|Genotype 2b||HCV Genotype||participants|Number|1|1.0||||||
3838484|NCT01687257|3664689|B3|Genotype 2a/2c||HCV Genotype||participants|Number|1|1.0||||||
3838485|NCT01687257|3664690|B2|Genotype 2a/2c||HCV Genotype||participants|Number|0|0.0||||||
3838486|NCT01687257|3664691|B1|Genotype 2a/2c||HCV Genotype||participants|Number|1|1.0||||||
3838487|NCT01687257|3664689|B3|Genotype 1b||HCV Genotype||participants|Number|14|14.0||||||
3838488|NCT01687257|3664690|B2|Genotype 1b||HCV Genotype||participants|Number|5|5.0||||||
3838489|NCT01687257|3664691|B1|Genotype 1b||HCV Genotype||participants|Number|9|9.0||||||
3838490|NCT01687257|3664689|B3|Genotype 1a||HCV Genotype||participants|Number|18|18.0||||||
3838491|NCT01687257|3664690|B2|Genotype 1a||HCV Genotype||participants|Number|8|8.0||||||
3838492|NCT01687257|3664691|B1|Genotype 1a||HCV Genotype||participants|Number|10|10.0||||||
3838493|NCT01687257|3664689|B3|Spain||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 50).|participants|Number|11|11.0||||||
3838494|NCT01687257|3664690|B2|Spain||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 50).|participants|Number|3|3.0||||||
3838495|NCT01687257|3664691|B1|Spain||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 50).|participants|Number|8|8.0||||||
3838496|NCT01687257|3664689|B3|Australia||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 50).|participants|Number|5|5.0||||||
3838497|NCT01687257|3664690|B2|Australia||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 50).|participants|Number|2|2.0||||||
3838498|NCT01687257|3664691|B1|Australia||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 50).|participants|Number|3|3.0||||||
3838500|NCT01687257|3664690|B2|France||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 50).|participants|Number|4|4.0||||||
3838501|NCT01687257|3664691|B1|France||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 50).|participants|Number|2|2.0||||||
3838502|NCT01687257|3664689|B3|United States||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 50).|participants|Number|22|22.0||||||
3838503|NCT01687257|3664690|B2|United States||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 50).|participants|Number|12|12.0||||||
3838504|NCT01687257|3664691|B1|United States||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 50).|participants|Number|10|10.0||||||
3838505|NCT01687257|3664689|B3|New Zealand||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 50).|participants|Number|6|6.0||||||
3838506|NCT01687257|3664690|B2|New Zealand||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 50).|participants|Number|4|4.0||||||
3838507|NCT01687257|3664691|B1|New Zealand||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 50).|participants|Number|2|2.0||||||
3838508|NCT01687257|3664689|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3838509|NCT01687257|3664690|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3838510|NCT01687257|3664691|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3838511|NCT01687257|3664689|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3838512|NCT01687257|3664690|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3838513|NCT01687257|3664691|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3838514|NCT01687257|3664689|B3|White||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
3838515|NCT01687257|3664690|B2|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3838516|NCT01687257|3664691|B1|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3838517|NCT01687257|3664689|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3838518|NCT01687257|3664690|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3838519|NCT01687257|3664691|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3838520|NCT01687257|3664689|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3838521|NCT01687257|3664690|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3838522|NCT01687257|3664691|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3838523|NCT01687257|3664689|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3838524|NCT01687257|3664690|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3838525|NCT01687257|3664691|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3838526|NCT01687257|3664689|B3|||Age||years|Mean|55|55.0|Standard Deviation|7.0|7.0|||
3838527|NCT01687257|3664690|B2|||Age||years|Mean|56|56.0|Standard Deviation|7.0|7.0|||
3838528|NCT01687257|3664691|B1|||Age||years|Mean|55|55.0|Standard Deviation|7.2|7.2|||
3838529|NCT01687244|3664719|B3|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3838530|NCT01687244|3664720|B2|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3838531|NCT01687244|3664721|B1|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3838532|NCT01687244|3664719|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3838533|NCT01687244|3664720|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3838534|NCT01687244|3664721|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3838535|NCT01687244|3664719|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3838536|NCT01687244|3664720|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3838537|NCT01687244|3664721|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3838538|NCT01687244|3664719|B3|||Age||years|Mean|71.1|71.1|Standard Deviation|9.42|9.42|||
3838539|NCT01687244|3664720|B2|||Age||years|Mean|71.1|71.1|Standard Deviation|9.42|9.42|||
3838540|NCT01687244|3664721|B1|||Age||years|Mean|71.6|71.6|Standard Deviation|8.07|8.07|||
3838541|NCT01687244|3664719|B3||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
3838542|NCT01687244|3664720|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3838543|NCT01687244|3664721|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3838544|NCT01687244|3664719|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3838545|NCT01687244|3664720|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3838546|NCT01687244|3664721|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3838547|NCT01687244|3664719|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3838548|NCT01687244|3664720|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3838549|NCT01687244|3664721|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3838550|NCT01687218|3664752|B7|Other||Race - U.S.A.||participants|Number|8|8.0||||||
3838551|NCT01687218|3664753|B6|Other||Race - U.S.A.||participants|Number|1|1.0||||||
3838552|NCT01687218|3664754|B5|Other||Race - U.S.A.||participants|Number|2|2.0||||||
3838553|NCT01687218|3664755|B4|Other||Race - U.S.A.||participants|Number|0|0.0||||||
3838554|NCT01687218|3664756|B3|Other||Race - U.S.A.||participants|Number|2|2.0||||||
3838555|NCT01687218|3664757|B2|Other||Race - U.S.A.||participants|Number|2|2.0||||||
3838556|NCT01687218|3664758|B1|Other||Race - U.S.A.||participants|Number|1|1.0||||||
3838557|NCT01687218|3664752|B7|Native-Hawaiian or other Pacific Islander||Race - U.S.A.||participants|Number|0|0.0||||||
3838558|NCT01687218|3664753|B6|Native-Hawaiian or other Pacific Islander||Race - U.S.A.||participants|Number|0|0.0||||||
3838559|NCT01687218|3664754|B5|Native-Hawaiian or other Pacific Islander||Race - U.S.A.||participants|Number|0|0.0||||||
3838560|NCT01687218|3664755|B4|Native-Hawaiian or other Pacific Islander||Race - U.S.A.||participants|Number|0|0.0||||||
3838561|NCT01687218|3664756|B3|Native-Hawaiian or other Pacific Islander||Race - U.S.A.||participants|Number|0|0.0||||||
3838562|NCT01687218|3664757|B2|Native-Hawaiian or other Pacific Islander||Race - U.S.A.||participants|Number|0|0.0||||||
3838563|NCT01687218|3664758|B1|Native-Hawaiian or other Pacific Islander||Race - U.S.A.||participants|Number|0|0.0||||||
3838564|NCT01687218|3664752|B7|American Indian/Alaska Native||Race - U.S.A.||participants|Number|0|0.0||||||
3838565|NCT01687218|3664753|B6|American Indian/Alaska Native||Race - U.S.A.||participants|Number|0|0.0||||||
3838566|NCT01687218|3664754|B5|American Indian/Alaska Native||Race - U.S.A.||participants|Number|0|0.0||||||
3838567|NCT01687218|3664755|B4|American Indian/Alaska Native||Race - U.S.A.||participants|Number|0|0.0||||||
3838568|NCT01687218|3664756|B3|American Indian/Alaska Native||Race - U.S.A.||participants|Number|0|0.0||||||
3838569|NCT01687218|3664757|B2|American Indian/Alaska Native||Race - U.S.A.||participants|Number|0|0.0||||||
3838570|NCT01687218|3664758|B1|American Indian/Alaska Native||Race - U.S.A.||participants|Number|0|0.0||||||
3838571|NCT01687218|3664752|B7|Black/African-American||Race - U.S.A.||participants|Number|3|3.0||||||
3838572|NCT01687218|3664753|B6|Black/African-American||Race - U.S.A.||participants|Number|0|0.0||||||
3838573|NCT01687218|3664754|B5|Black/African-American||Race - U.S.A.||participants|Number|0|0.0||||||
3838574|NCT01687218|3664755|B4|Black/African-American||Race - U.S.A.||participants|Number|3|3.0||||||
3838575|NCT01687218|3664756|B3|Black/African-American||Race - U.S.A.||participants|Number|0|0.0||||||
3838576|NCT01687218|3664757|B2|Black/African-American||Race - U.S.A.||participants|Number|0|0.0||||||
3838577|NCT01687218|3664758|B1|Black/African-American||Race - U.S.A.||participants|Number|0|0.0||||||
3838578|NCT01687218|3664752|B7|Mixed||Race - U.S.A.||participants|Number|2|2.0||||||
3838579|NCT01687218|3664753|B6|Mixed||Race - U.S.A.||participants|Number|0|0.0||||||
3838580|NCT01687218|3664754|B5|Mixed||Race - U.S.A.||participants|Number|2|2.0||||||
3838581|NCT01687218|3664755|B4|Mixed||Race - U.S.A.||participants|Number|0|0.0||||||
3838582|NCT01687218|3664756|B3|Mixed||Race - U.S.A.||participants|Number|0|0.0||||||
3838583|NCT01687218|3664757|B2|Mixed||Race - U.S.A.||participants|Number|0|0.0||||||
3838584|NCT01687218|3664758|B1|Mixed||Race - U.S.A.||participants|Number|0|0.0||||||
3838585|NCT01687218|3664752|B7|Asian||Race - U.S.A.||participants|Number|4|4.0||||||
3838586|NCT01687218|3664753|B6|Asian||Race - U.S.A.||participants|Number|2|2.0||||||
3838587|NCT01687218|3664754|B5|Asian||Race - U.S.A.||participants|Number|2|2.0||||||
3838588|NCT01687218|3664755|B4|Asian||Race - U.S.A.||participants|Number|0|0.0||||||
3838589|NCT01687218|3664756|B3|Asian||Race - U.S.A.||participants|Number|0|0.0||||||
3838590|NCT01687218|3664757|B2|Asian||Race - U.S.A.||participants|Number|0|0.0||||||
3838591|NCT01687218|3664758|B1|Asian||Race - U.S.A.||participants|Number|0|0.0||||||
3838592|NCT01687218|3664752|B7|White||Race - U.S.A.||participants|Number|61|61.0||||||
3838593|NCT01687218|3664753|B6|White||Race - U.S.A.||participants|Number|10|10.0||||||
3838594|NCT01687218|3664754|B5|White||Race - U.S.A.||participants|Number|6|6.0||||||
3838595|NCT01687218|3664755|B4|White||Race - U.S.A.||participants|Number|12|12.0||||||
3838596|NCT01687218|3664756|B3|White||Race - U.S.A.||participants|Number|10|10.0||||||
3838597|NCT01687218|3664757|B2|White||Race - U.S.A.||participants|Number|11|11.0||||||
3838598|NCT01687218|3664758|B1|White||Race - U.S.A.||participants|Number|12|12.0||||||
3838599|NCT01687218|3664752|B7|Other||Race - Thailand||participants|Number|0|0.0||||||
3838600|NCT01687218|3664753|B6|Other||Race - Thailand||participants|Number|0|0.0||||||
3838601|NCT01687218|3664754|B5|Other||Race - Thailand||participants|Number|0|0.0||||||
3838602|NCT01687218|3664755|B4|Other||Race - Thailand||participants|Number|0|0.0||||||
3838603|NCT01687218|3664756|B3|Other||Race - Thailand||participants|Number|0|0.0||||||
3838604|NCT01687218|3664757|B2|Other||Race - Thailand||participants|Number|0|0.0||||||
3838605|NCT01687218|3664758|B1|Other||Race - Thailand||participants|Number|0|0.0||||||
3838606|NCT01687218|3664752|B7|Chinese||Race - Thailand||participants|Number|0|0.0||||||
3838607|NCT01687218|3664753|B6|Chinese||Race - Thailand||participants|Number|0|0.0||||||
3838608|NCT01687218|3664754|B5|Chinese||Race - Thailand||participants|Number|0|0.0||||||
3838609|NCT01687218|3664755|B4|Chinese||Race - Thailand||participants|Number|0|0.0||||||
3838610|NCT01687218|3664756|B3|Chinese||Race - Thailand||participants|Number|0|0.0||||||
3838611|NCT01687218|3664757|B2|Chinese||Race - Thailand||participants|Number|0|0.0||||||
3838612|NCT01687218|3664758|B1|Chinese||Race - Thailand||participants|Number|0|0.0||||||
3838613|NCT01687218|3664752|B7|Thai||Race - Thailand||participants|Number|54|54.0||||||
3838614|NCT01687218|3664753|B6|Thai||Race - Thailand||participants|Number|9|9.0||||||
3838615|NCT01687218|3664754|B5|Thai||Race - Thailand||participants|Number|9|9.0||||||
3838616|NCT01687218|3664755|B4|Thai||Race - Thailand||participants|Number|9|9.0||||||
3838617|NCT01687218|3664756|B3|Thai||Race - Thailand||participants|Number|9|9.0||||||
3838618|NCT01687218|3664757|B2|Thai||Race - Thailand||participants|Number|9|9.0||||||
3838619|NCT01687218|3664758|B1|Thai||Race - Thailand||participants|Number|9|9.0||||||
3838620|NCT01687218|3664752|B7|Mixed||Race - Thailand||participants|Number|0|0.0||||||
3838621|NCT01687218|3664753|B6|Mixed||Race - Thailand||participants|Number|0|0.0||||||
3838622|NCT01687218|3664754|B5|Mixed||Race - Thailand||participants|Number|0|0.0||||||
3838623|NCT01687218|3664755|B4|Mixed||Race - Thailand||participants|Number|0|0.0||||||
3838624|NCT01687218|3664756|B3|Mixed||Race - Thailand||participants|Number|0|0.0||||||
3838625|NCT01687218|3664757|B2|Mixed||Race - Thailand||participants|Number|0|0.0||||||
3838626|NCT01687218|3664758|B1|Mixed||Race - Thailand||participants|Number|0|0.0||||||
3838627|NCT01687218|3664752|B7|Indian||Race - Thailand||participants|Number|0|0.0||||||
3838628|NCT01687218|3664753|B6|Indian||Race - Thailand||participants|Number|0|0.0||||||
3838629|NCT01687218|3664754|B5|Indian||Race - Thailand||participants|Number|0|0.0||||||
3838630|NCT01687218|3664755|B4|Indian||Race - Thailand||participants|Number|0|0.0||||||
3838631|NCT01687218|3664756|B3|Indian||Race - Thailand||participants|Number|0|0.0||||||
3838632|NCT01687218|3664757|B2|Indian||Race - Thailand||participants|Number|0|0.0||||||
3838633|NCT01687218|3664758|B1|Indian||Race - Thailand||participants|Number|0|0.0||||||
3838634|NCT01687218|3664752|B7|Other||Race - South Africa||participants|Number|1|1.0||||||
3838635|NCT01687218|3664753|B6|Other||Race - South Africa||participants|Number|0|0.0||||||
3838636|NCT01687218|3664754|B5|Other||Race - South Africa||participants|Number|0|0.0||||||
3838637|NCT01687218|3664755|B4|Other||Race - South Africa||participants|Number|0|0.0||||||
3838638|NCT01687218|3664756|B3|Other||Race - South Africa||participants|Number|0|0.0||||||
3838639|NCT01687218|3664757|B2|Other||Race - South Africa||participants|Number|1|1.0||||||
3838640|NCT01687218|3664758|B1|Other||Race - South Africa||participants|Number|0|0.0||||||
3838641|NCT01687218|3664752|B7|Colored||Race - South Africa||participants|Number|1|1.0||||||
3838642|NCT01687218|3664753|B6|Colored||Race - South Africa||participants|Number|1|1.0||||||
3838643|NCT01687218|3664754|B5|Colored||Race - South Africa||participants|Number|0|0.0||||||
3838644|NCT01687218|3664755|B4|Colored||Race - South Africa||participants|Number|0|0.0||||||
3838645|NCT01687218|3664756|B3|Colored||Race - South Africa||participants|Number|0|0.0||||||
3838646|NCT01687218|3664757|B2|Colored||Race - South Africa||participants|Number|0|0.0||||||
3838647|NCT01687218|3664758|B1|Colored||Race - South Africa||participants|Number|0|0.0||||||
3838648|NCT01687218|3664752|B7|Indian||Race - South Africa||participants|Number|0|0.0||||||
3838649|NCT01687218|3664753|B6|Indian||Race - South Africa||participants|Number|0|0.0||||||
3838650|NCT01687218|3664754|B5|Indian||Race - South Africa||participants|Number|0|0.0||||||
3838651|NCT01687218|3664755|B4|Indian||Race - South Africa||participants|Number|0|0.0||||||
3838652|NCT01687218|3664756|B3|Indian||Race - South Africa||participants|Number|0|0.0||||||
3838653|NCT01687218|3664757|B2|Indian||Race - South Africa||participants|Number|0|0.0||||||
3838654|NCT01687218|3664758|B1|Indian||Race - South Africa||participants|Number|0|0.0||||||
3838655|NCT01687218|3664752|B7|Xhosa||Race - South Africa||participants|Number|14|14.0||||||
3838656|NCT01687218|3664753|B6|Xhosa||Race - South Africa||participants|Number|1|1.0||||||
3838657|NCT01687218|3664754|B5|Xhosa||Race - South Africa||participants|Number|3|3.0||||||
3838658|NCT01687218|3664755|B4|Xhosa||Race - South Africa||participants|Number|2|2.0||||||
3838659|NCT01687218|3664756|B3|Xhosa||Race - South Africa||participants|Number|3|3.0||||||
3838660|NCT01687218|3664757|B2|Xhosa||Race - South Africa||participants|Number|2|2.0||||||
3838661|NCT01687218|3664758|B1|Xhosa||Race - South Africa||participants|Number|3|3.0||||||
3838662|NCT01687218|3664752|B7|Zulu||Race - South Africa||participants|Number|0|0.0||||||
3838663|NCT01687218|3664753|B6|Zulu||Race - South Africa||participants|Number|0|0.0||||||
3838664|NCT01687218|3664754|B5|Zulu||Race - South Africa||participants|Number|0|0.0||||||
3838665|NCT01687218|3664755|B4|Zulu||Race - South Africa||participants|Number|0|0.0||||||
3838666|NCT01687218|3664756|B3|Zulu||Race - South Africa||participants|Number|0|0.0||||||
3838667|NCT01687218|3664757|B2|Zulu||Race - South Africa||participants|Number|0|0.0||||||
3838668|NCT01687218|3664758|B1|Zulu||Race - South Africa||participants|Number|0|0.0||||||
3838669|NCT01687218|3664752|B7|White||Race - South Africa||participants|Number|0|0.0||||||
3838670|NCT01687218|3664753|B6|White||Race - South Africa||participants|Number|0|0.0||||||
3838671|NCT01687218|3664754|B5|White||Race - South Africa||participants|Number|0|0.0||||||
3838672|NCT01687218|3664755|B4|White||Race - South Africa||participants|Number|0|0.0||||||
3838673|NCT01687218|3664756|B3|White||Race - South Africa||participants|Number|0|0.0||||||
3838674|NCT01687218|3664757|B2|White||Race - South Africa||participants|Number|0|0.0||||||
3838675|NCT01687218|3664758|B1|White||Race - South Africa||participants|Number|0|0.0||||||
3838676|NCT01687218|3664752|B7|Other African tribe||Race - South Africa||participants|Number|2|2.0||||||
3838677|NCT01687218|3664753|B6|Other African tribe||Race - South Africa||participants|Number|1|1.0||||||
3838678|NCT01687218|3664754|B5|Other African tribe||Race - South Africa||participants|Number|0|0.0||||||
3838679|NCT01687218|3664755|B4|Other African tribe||Race - South Africa||participants|Number|1|1.0||||||
3838680|NCT01687218|3664756|B3|Other African tribe||Race - South Africa||participants|Number|0|0.0||||||
3838681|NCT01687218|3664757|B2|Other African tribe||Race - South Africa||participants|Number|0|0.0||||||
3838682|NCT01687218|3664758|B1|Other African tribe||Race - South Africa||participants|Number|0|0.0||||||
3838683|NCT01687218|3664752|B7|Other||Race - Peru||participants|Number|0|0.0||||||
3838684|NCT01687218|3664753|B6|Other||Race - Peru||participants|Number|0|0.0||||||
3838685|NCT01687218|3664754|B5|Other||Race - Peru||participants|Number|0|0.0||||||
3838686|NCT01687218|3664755|B4|Other||Race - Peru||participants|Number|0|0.0||||||
3838687|NCT01687218|3664756|B3|Other||Race - Peru||participants|Number|0|0.0||||||
3838688|NCT01687218|3664757|B2|Other||Race - Peru||participants|Number|0|0.0||||||
3838689|NCT01687218|3664758|B1|Other||Race - Peru||participants|Number|0|0.0||||||
3838690|NCT01687218|3664752|B7|Indigenous||Race - Peru||participants|Number|13|13.0||||||
3838691|NCT01687218|3664753|B6|Indigenous||Race - Peru||participants|Number|1|1.0||||||
3838692|NCT01687218|3664754|B5|Indigenous||Race - Peru||participants|Number|4|4.0||||||
3838693|NCT01687218|3664755|B4|Indigenous||Race - Peru||participants|Number|1|1.0||||||
3838694|NCT01687218|3664756|B3|Indigenous||Race - Peru||participants|Number|3|3.0||||||
3838695|NCT01687218|3664757|B2|Indigenous||Race - Peru||participants|Number|3|3.0||||||
3838696|NCT01687218|3664758|B1|Indigenous||Race - Peru||participants|Number|1|1.0||||||
3838697|NCT01687218|3664752|B7|Black||Race - Peru||participants|Number|0|0.0||||||
3838698|NCT01687218|3664753|B6|Black||Race - Peru||participants|Number|0|0.0||||||
3838699|NCT01687218|3664754|B5|Black||Race - Peru||participants|Number|0|0.0||||||
3838700|NCT01687218|3664755|B4|Black||Race - Peru||participants|Number|0|0.0||||||
3838701|NCT01687218|3664756|B3|Black||Race - Peru||participants|Number|0|0.0||||||
3838702|NCT01687218|3664757|B2|Black||Race - Peru||participants|Number|0|0.0||||||
3838703|NCT01687218|3664758|B1|Black||Race - Peru||participants|Number|0|0.0||||||
3838704|NCT01687218|3664752|B7|Mixed||Race - Peru||participants|Number|24|24.0||||||
3838705|NCT01687218|3664753|B6|Mixed||Race - Peru||participants|Number|5|5.0||||||
3838706|NCT01687218|3664754|B5|Mixed||Race - Peru||participants|Number|3|3.0||||||
3838707|NCT01687218|3664755|B4|Mixed||Race - Peru||participants|Number|4|4.0||||||
3838708|NCT01687218|3664756|B3|Mixed||Race - Peru||participants|Number|3|3.0||||||
3838709|NCT01687218|3664757|B2|Mixed||Race - Peru||participants|Number|3|3.0||||||
3838710|NCT01687218|3664758|B1|Mixed||Race - Peru||participants|Number|6|6.0||||||
3838711|NCT01687218|3664752|B7|Asian||Race - Peru||participants|Number|0|0.0||||||
3838712|NCT01687218|3664753|B6|Asian||Race - Peru||participants|Number|0|0.0||||||
3838713|NCT01687218|3664754|B5|Asian||Race - Peru||participants|Number|0|0.0||||||
3838714|NCT01687218|3664755|B4|Asian||Race - Peru||participants|Number|0|0.0||||||
3838715|NCT01687218|3664756|B3|Asian||Race - Peru||participants|Number|0|0.0||||||
3838716|NCT01687218|3664757|B2|Asian||Race - Peru||participants|Number|0|0.0||||||
3838717|NCT01687218|3664758|B1|Asian||Race - Peru||participants|Number|0|0.0||||||
3838718|NCT01687218|3664752|B7|White||Race - Peru||participants|Number|1|1.0||||||
3838719|NCT01687218|3664753|B6|White||Race - Peru||participants|Number|0|0.0||||||
3838720|NCT01687218|3664754|B5|White||Race - Peru||participants|Number|0|0.0||||||
3838721|NCT01687218|3664755|B4|White||Race - Peru||participants|Number|1|1.0||||||
3838722|NCT01687218|3664756|B3|White||Race - Peru||participants|Number|0|0.0||||||
3838723|NCT01687218|3664757|B2|White||Race - Peru||participants|Number|0|0.0||||||
3838724|NCT01687218|3664758|B1|White||Race - Peru||participants|Number|0|0.0||||||
3838725|NCT01687218|3664752|B7|Other||Race - Puerto Rico||participants|Number|1|1.0||||||
3838726|NCT01687218|3664753|B6|Other||Race - Puerto Rico||participants|Number|0|0.0||||||
3838727|NCT01687218|3664754|B5|Other||Race - Puerto Rico||participants|Number|0|0.0||||||
3838728|NCT01687218|3664755|B4|Other||Race - Puerto Rico||participants|Number|0|0.0||||||
3838729|NCT01687218|3664756|B3|Other||Race - Puerto Rico||participants|Number|0|0.0||||||
3838730|NCT01687218|3664757|B2|Other||Race - Puerto Rico||participants|Number|0|0.0||||||
3838731|NCT01687218|3664758|B1|Other||Race - Puerto Rico||participants|Number|1|1.0||||||
3838732|NCT01687218|3664752|B7|Indigenous||Race - Puerto Rico||participants|Number|0|0.0||||||
3838733|NCT01687218|3664753|B6|Indigenous||Race - Puerto Rico||participants|Number|0|0.0||||||
3838734|NCT01687218|3664754|B5|Indigenous||Race - Puerto Rico||participants|Number|0|0.0||||||
3838735|NCT01687218|3664755|B4|Indigenous||Race - Puerto Rico||participants|Number|0|0.0||||||
3838736|NCT01687218|3664756|B3|Indigenous||Race - Puerto Rico||participants|Number|0|0.0||||||
3838737|NCT01687218|3664757|B2|Indigenous||Race - Puerto Rico||participants|Number|0|0.0||||||
3838738|NCT01687218|3664758|B1|Indigenous||Race - Puerto Rico||participants|Number|0|0.0||||||
3838739|NCT01687218|3664752|B7|Black||Race - Puerto Rico||participants|Number|2|2.0||||||
3838740|NCT01687218|3664753|B6|Black||Race - Puerto Rico||participants|Number|0|0.0||||||
3838741|NCT01687218|3664754|B5|Black||Race - Puerto Rico||participants|Number|0|0.0||||||
3838742|NCT01687218|3664755|B4|Black||Race - Puerto Rico||participants|Number|1|1.0||||||
3838743|NCT01687218|3664756|B3|Black||Race - Puerto Rico||participants|Number|1|1.0||||||
3838744|NCT01687218|3664757|B2|Black||Race - Puerto Rico||participants|Number|0|0.0||||||
3838745|NCT01687218|3664758|B1|Black||Race - Puerto Rico||participants|Number|0|0.0||||||
3838746|NCT01687218|3664752|B7|Mixed||Race - Puerto Rico||participants|Number|2|2.0||||||
3838747|NCT01687218|3664753|B6|Mixed||Race - Puerto Rico||participants|Number|1|1.0||||||
3838748|NCT01687218|3664754|B5|Mixed||Race - Puerto Rico||participants|Number|0|0.0||||||
3838749|NCT01687218|3664755|B4|Mixed||Race - Puerto Rico||participants|Number|0|0.0||||||
3838750|NCT01687218|3664756|B3|Mixed||Race - Puerto Rico||participants|Number|0|0.0||||||
3838751|NCT01687218|3664757|B2|Mixed||Race - Puerto Rico||participants|Number|1|1.0||||||
3838752|NCT01687218|3664758|B1|Mixed||Race - Puerto Rico||participants|Number|0|0.0||||||
3838753|NCT01687218|3664752|B7|Asian||Race - Puerto Rico||participants|Number|0|0.0||||||
3838754|NCT01687218|3664753|B6|Asian||Race - Puerto Rico||participants|Number|0|0.0||||||
3838755|NCT01687218|3664754|B5|Asian||Race - Puerto Rico||participants|Number|0|0.0||||||
3838756|NCT01687218|3664755|B4|Asian||Race - Puerto Rico||participants|Number|0|0.0||||||
3838757|NCT01687218|3664756|B3|Asian||Race - Puerto Rico||participants|Number|0|0.0||||||
3838758|NCT01687218|3664757|B2|Asian||Race - Puerto Rico||participants|Number|0|0.0||||||
3838759|NCT01687218|3664758|B1|Asian||Race - Puerto Rico||participants|Number|0|0.0||||||
3838760|NCT01687218|3664752|B7|White||Race - Puerto Rico||participants|Number|2|2.0||||||
3838761|NCT01687218|3664753|B6|White||Race - Puerto Rico||participants|Number|0|0.0||||||
3838762|NCT01687218|3664754|B5|White||Race - Puerto Rico||participants|Number|2|2.0||||||
3838763|NCT01687218|3664755|B4|White||Race - Puerto Rico||participants|Number|0|0.0||||||
3838764|NCT01687218|3664756|B3|White||Race - Puerto Rico||participants|Number|0|0.0||||||
3838765|NCT01687218|3664757|B2|White||Race - Puerto Rico||participants|Number|0|0.0||||||
3838766|NCT01687218|3664758|B1|White||Race - Puerto Rico||participants|Number|0|0.0||||||
3838767|NCT01687218|3664752|B7|U.S.A.||Nationality|Country in which the site clinic resides.|participants|Number|78|78.0||||||
3838768|NCT01687218|3664753|B6|U.S.A.||Nationality|Country in which the site clinic resides.|participants|Number|13|13.0||||||
3838769|NCT01687218|3664754|B5|U.S.A.||Nationality|Country in which the site clinic resides.|participants|Number|12|12.0||||||
3838770|NCT01687218|3664755|B4|U.S.A.||Nationality|Country in which the site clinic resides.|participants|Number|15|15.0||||||
3838771|NCT01687218|3664756|B3|U.S.A.||Nationality|Country in which the site clinic resides.|participants|Number|12|12.0||||||
3838772|NCT01687218|3664757|B2|U.S.A.||Nationality|Country in which the site clinic resides.|participants|Number|13|13.0||||||
3838773|NCT01687218|3664758|B1|U.S.A.||Nationality|Country in which the site clinic resides.|participants|Number|13|13.0||||||
3838774|NCT01687218|3664752|B7|Thailand||Nationality|Country in which the site clinic resides.|participants|Number|54|54.0||||||
3838775|NCT01687218|3664753|B6|Thailand||Nationality|Country in which the site clinic resides.|participants|Number|9|9.0||||||
3838776|NCT01687218|3664754|B5|Thailand||Nationality|Country in which the site clinic resides.|participants|Number|9|9.0||||||
3838777|NCT01687218|3664755|B4|Thailand||Nationality|Country in which the site clinic resides.|participants|Number|9|9.0||||||
3838778|NCT01687218|3664756|B3|Thailand||Nationality|Country in which the site clinic resides.|participants|Number|9|9.0||||||
3838779|NCT01687218|3664757|B2|Thailand||Nationality|Country in which the site clinic resides.|participants|Number|9|9.0||||||
3838780|NCT01687218|3664758|B1|Thailand||Nationality|Country in which the site clinic resides.|participants|Number|9|9.0||||||
3838781|NCT01687218|3664752|B7|South Africa||Nationality|Country in which the site clinic resides.|participants|Number|18|18.0||||||
3838782|NCT01687218|3664753|B6|South Africa||Nationality|Country in which the site clinic resides.|participants|Number|3|3.0||||||
3838783|NCT01687218|3664754|B5|South Africa||Nationality|Country in which the site clinic resides.|participants|Number|3|3.0||||||
3838784|NCT01687218|3664755|B4|South Africa||Nationality|Country in which the site clinic resides.|participants|Number|3|3.0||||||
3838785|NCT01687218|3664756|B3|South Africa||Nationality|Country in which the site clinic resides.|participants|Number|3|3.0||||||
3838786|NCT01687218|3664757|B2|South Africa||Nationality|Country in which the site clinic resides.|participants|Number|3|3.0||||||
3838787|NCT01687218|3664758|B1|South Africa||Nationality|Country in which the site clinic resides.|participants|Number|3|3.0||||||
3838788|NCT01687218|3664752|B7|Peru||Nationality|Country in which the site clinic resides.|participants|Number|38|38.0||||||
3838789|NCT01687218|3664753|B6|Peru||Nationality|Country in which the site clinic resides.|participants|Number|6|6.0||||||
3838790|NCT01687218|3664754|B5|Peru||Nationality|Country in which the site clinic resides.|participants|Number|7|7.0||||||
3838791|NCT01687218|3664755|B4|Peru||Nationality|Country in which the site clinic resides.|participants|Number|6|6.0||||||
3838792|NCT01687218|3664756|B3|Peru||Nationality|Country in which the site clinic resides.|participants|Number|6|6.0||||||
3838793|NCT01687218|3664757|B2|Peru||Nationality|Country in which the site clinic resides.|participants|Number|6|6.0||||||
3838794|NCT01687218|3664758|B1|Peru||Nationality|Country in which the site clinic resides.|participants|Number|7|7.0||||||
3838795|NCT01687218|3664752|B7|Puerto Rico||Nationality|Country in which the site clinic resides.|participants|Number|7|7.0||||||
3838796|NCT01687218|3664753|B6|Puerto Rico||Nationality|Country in which the site clinic resides.|participants|Number|1|1.0||||||
3838797|NCT01687218|3664754|B5|Puerto Rico||Nationality|Country in which the site clinic resides.|participants|Number|2|2.0||||||
3838798|NCT01687218|3664755|B4|Puerto Rico||Nationality|Country in which the site clinic resides.|participants|Number|1|1.0||||||
3838799|NCT01687218|3664756|B3|Puerto Rico||Nationality|Country in which the site clinic resides.|participants|Number|1|1.0||||||
3838800|NCT01687218|3664757|B2|Puerto Rico||Nationality|Country in which the site clinic resides.|participants|Number|1|1.0||||||
3838801|NCT01687218|3664758|B1|Puerto Rico||Nationality|Country in which the site clinic resides.|participants|Number|1|1.0||||||
3838802|NCT01687218|3664752|B7|Refuse to answer||Sexual Orientation (CASI)|One participant from Peru did not complete a baseline CASI.|participants|Number|2|2.0||||||
3838803|NCT01687218|3664753|B6|Refuse to answer||Sexual Orientation (CASI)|One participant from Peru did not complete a baseline CASI.|participants|Number|0|0.0||||||
3838804|NCT01687218|3664754|B5|Refuse to answer||Sexual Orientation (CASI)|One participant from Peru did not complete a baseline CASI.|participants|Number|0|0.0||||||
3838805|NCT01687218|3664755|B4|Refuse to answer||Sexual Orientation (CASI)|One participant from Peru did not complete a baseline CASI.|participants|Number|0|0.0||||||
3838806|NCT01687218|3664756|B3|Refuse to answer||Sexual Orientation (CASI)|One participant from Peru did not complete a baseline CASI.|participants|Number|0|0.0||||||
3838807|NCT01687218|3664757|B2|Refuse to answer||Sexual Orientation (CASI)|One participant from Peru did not complete a baseline CASI.|participants|Number|1|1.0||||||
3838808|NCT01687218|3664758|B1|Refuse to answer||Sexual Orientation (CASI)|One participant from Peru did not complete a baseline CASI.|participants|Number|1|1.0||||||
3838809|NCT01687218|3664752|B7|Other||Sexual Orientation (CASI)|One participant from Peru did not complete a baseline CASI.|participants|Number|5|5.0||||||
3838810|NCT01687218|3664753|B6|Other||Sexual Orientation (CASI)|One participant from Peru did not complete a baseline CASI.|participants|Number|0|0.0||||||
3838811|NCT01687218|3664754|B5|Other||Sexual Orientation (CASI)|One participant from Peru did not complete a baseline CASI.|participants|Number|2|2.0||||||
3838812|NCT01687218|3664755|B4|Other||Sexual Orientation (CASI)|One participant from Peru did not complete a baseline CASI.|participants|Number|1|1.0||||||
3838813|NCT01687218|3664756|B3|Other||Sexual Orientation (CASI)|One participant from Peru did not complete a baseline CASI.|participants|Number|0|0.0||||||
3838814|NCT01687218|3664757|B2|Other||Sexual Orientation (CASI)|One participant from Peru did not complete a baseline CASI.|participants|Number|1|1.0||||||
3838815|NCT01687218|3664758|B1|Other||Sexual Orientation (CASI)|One participant from Peru did not complete a baseline CASI.|participants|Number|1|1.0||||||
3838816|NCT01687218|3664752|B7|Straight/Heterosexual||Sexual Orientation (CASI)|One participant from Peru did not complete a baseline CASI.|participants|Number|3|3.0||||||
3838817|NCT01687218|3664753|B6|Straight/Heterosexual||Sexual Orientation (CASI)|One participant from Peru did not complete a baseline CASI.|participants|Number|0|0.0||||||
3838818|NCT01687218|3664754|B5|Straight/Heterosexual||Sexual Orientation (CASI)|One participant from Peru did not complete a baseline CASI.|participants|Number|0|0.0||||||
3838819|NCT01687218|3664755|B4|Straight/Heterosexual||Sexual Orientation (CASI)|One participant from Peru did not complete a baseline CASI.|participants|Number|1|1.0||||||
3838820|NCT01687218|3664756|B3|Straight/Heterosexual||Sexual Orientation (CASI)|One participant from Peru did not complete a baseline CASI.|participants|Number|1|1.0||||||
3838821|NCT01687218|3664757|B2|Straight/Heterosexual||Sexual Orientation (CASI)|One participant from Peru did not complete a baseline CASI.|participants|Number|1|1.0||||||
3838822|NCT01687218|3664758|B1|Straight/Heterosexual||Sexual Orientation (CASI)|One participant from Peru did not complete a baseline CASI.|participants|Number|0|0.0||||||
3838823|NCT01687218|3664752|B7|Bisexual||Sexual Orientation (CASI)|One participant from Peru did not complete a baseline CASI.|participants|Number|13|13.0||||||
3838824|NCT01687218|3664753|B6|Bisexual||Sexual Orientation (CASI)|One participant from Peru did not complete a baseline CASI.|participants|Number|1|1.0||||||
3838825|NCT01687218|3664754|B5|Bisexual||Sexual Orientation (CASI)|One participant from Peru did not complete a baseline CASI.|participants|Number|3|3.0||||||
3838826|NCT01687218|3664755|B4|Bisexual||Sexual Orientation (CASI)|One participant from Peru did not complete a baseline CASI.|participants|Number|0|0.0||||||
3838827|NCT01687218|3664756|B3|Bisexual||Sexual Orientation (CASI)|One participant from Peru did not complete a baseline CASI.|participants|Number|3|3.0||||||
3838828|NCT01687218|3664757|B2|Bisexual||Sexual Orientation (CASI)|One participant from Peru did not complete a baseline CASI.|participants|Number|3|3.0||||||
3838829|NCT01687218|3664758|B1|Bisexual||Sexual Orientation (CASI)|One participant from Peru did not complete a baseline CASI.|participants|Number|3|3.0||||||
3838830|NCT01687218|3664752|B7|Gay/Homosexual||Sexual Orientation (CASI)|One participant from Peru did not complete a baseline CASI.|participants|Number|171|171.0||||||
3838831|NCT01687218|3664753|B6|Gay/Homosexual||Sexual Orientation (CASI)|One participant from Peru did not complete a baseline CASI.|participants|Number|31|31.0||||||
3838832|NCT01687218|3664754|B5|Gay/Homosexual||Sexual Orientation (CASI)|One participant from Peru did not complete a baseline CASI.|participants|Number|28|28.0||||||
3838833|NCT01687218|3664755|B4|Gay/Homosexual||Sexual Orientation (CASI)|One participant from Peru did not complete a baseline CASI.|participants|Number|32|32.0||||||
3838834|NCT01687218|3664756|B3|Gay/Homosexual||Sexual Orientation (CASI)|One participant from Peru did not complete a baseline CASI.|participants|Number|27|27.0||||||
3838835|NCT01687218|3664757|B2|Gay/Homosexual||Sexual Orientation (CASI)|One participant from Peru did not complete a baseline CASI.|participants|Number|26|26.0||||||
3838836|NCT01687218|3664758|B1|Gay/Homosexual||Sexual Orientation (CASI)|One participant from Peru did not complete a baseline CASI.|participants|Number|27|27.0||||||
3838837|NCT01687218|3664752|B7|attended college or university||Highest Level of Education||participants|Number|156|156.0||||||
3838838|NCT01687218|3664753|B6|attended college or university||Highest Level of Education||participants|Number|24|24.0||||||
3838839|NCT01687218|3664754|B5|attended college or university||Highest Level of Education||participants|Number|26|26.0||||||
3838840|NCT01687218|3664755|B4|attended college or university||Highest Level of Education||participants|Number|28|28.0||||||
3838841|NCT01687218|3664756|B3|attended college or university||Highest Level of Education||participants|Number|23|23.0||||||
3838842|NCT01687218|3664757|B2|attended college or university||Highest Level of Education||participants|Number|26|26.0||||||
3838843|NCT01687218|3664758|B1|attended college or university||Highest Level of Education||participants|Number|29|29.0||||||
3838844|NCT01687218|3664752|B7|secondary school, complete||Highest Level of Education||participants|Number|27|27.0||||||
3838845|NCT01687218|3664753|B6|secondary school, complete||Highest Level of Education||participants|Number|6|6.0||||||
3838846|NCT01687218|3664754|B5|secondary school, complete||Highest Level of Education||participants|Number|4|4.0||||||
3838847|NCT01687218|3664755|B4|secondary school, complete||Highest Level of Education||participants|Number|4|4.0||||||
3838848|NCT01687218|3664756|B3|secondary school, complete||Highest Level of Education||participants|Number|6|6.0||||||
3838849|NCT01687218|3664757|B2|secondary school, complete||Highest Level of Education||participants|Number|5|5.0||||||
3838850|NCT01687218|3664758|B1|secondary school, complete||Highest Level of Education||participants|Number|2|2.0||||||
3838851|NCT01687218|3664752|B7|secondary school, not complete||Highest Level of Education||participants|Number|9|9.0||||||
3838852|NCT01687218|3664753|B6|secondary school, not complete||Highest Level of Education||participants|Number|1|1.0||||||
3838853|NCT01687218|3664754|B5|secondary school, not complete||Highest Level of Education||participants|Number|3|3.0||||||
3838854|NCT01687218|3664755|B4|secondary school, not complete||Highest Level of Education||participants|Number|1|1.0||||||
3838855|NCT01687218|3664756|B3|secondary school, not complete||Highest Level of Education||participants|Number|1|1.0||||||
3838856|NCT01687218|3664757|B2|secondary school, not complete||Highest Level of Education||participants|Number|1|1.0||||||
3838857|NCT01687218|3664758|B1|secondary school, not complete||Highest Level of Education||participants|Number|2|2.0||||||
3838858|NCT01687218|3664752|B7|primary school, complete||Highest Level of Education||participants|Number|2|2.0||||||
3838859|NCT01687218|3664753|B6|primary school, complete||Highest Level of Education||participants|Number|1|1.0||||||
3838860|NCT01687218|3664754|B5|primary school, complete||Highest Level of Education||participants|Number|0|0.0||||||
3838861|NCT01687218|3664755|B4|primary school, complete||Highest Level of Education||participants|Number|0|0.0||||||
3838862|NCT01687218|3664756|B3|primary school, complete||Highest Level of Education||participants|Number|1|1.0||||||
3838863|NCT01687218|3664757|B2|primary school, complete||Highest Level of Education||participants|Number|0|0.0||||||
3838864|NCT01687218|3664758|B1|primary school, complete||Highest Level of Education||participants|Number|0|0.0||||||
3838865|NCT01687218|3664752|B7|primary school, not complete||Highest Level of Education||participants|Number|1|1.0||||||
3838866|NCT01687218|3664753|B6|primary school, not complete||Highest Level of Education||participants|Number|0|0.0||||||
3838867|NCT01687218|3664754|B5|primary school, not complete||Highest Level of Education||participants|Number|0|0.0||||||
3838868|NCT01687218|3664755|B4|primary school, not complete||Highest Level of Education||participants|Number|1|1.0||||||
3838869|NCT01687218|3664756|B3|primary school, not complete||Highest Level of Education||participants|Number|0|0.0||||||
3838870|NCT01687218|3664757|B2|primary school, not complete||Highest Level of Education||participants|Number|0|0.0||||||
3838871|NCT01687218|3664758|B1|primary school, not complete||Highest Level of Education||participants|Number|0|0.0||||||
3838872|NCT01687218|3664752|B7|no schooling||Highest Level of Education||participants|Number|0|0.0||||||
3838873|NCT01687218|3664753|B6|no schooling||Highest Level of Education||participants|Number|0|0.0||||||
3838874|NCT01687218|3664754|B5|no schooling||Highest Level of Education||participants|Number|0|0.0||||||
3838875|NCT01687218|3664755|B4|no schooling||Highest Level of Education||participants|Number|0|0.0||||||
3838876|NCT01687218|3664756|B3|no schooling||Highest Level of Education||participants|Number|0|0.0||||||
3838877|NCT01687218|3664757|B2|no schooling||Highest Level of Education||participants|Number|0|0.0||||||
3838878|NCT01687218|3664758|B1|no schooling||Highest Level of Education||participants|Number|0|0.0||||||
3838879|NCT01687218|3664752|B7|No||Hispanic Origin||participants|Number|140|140.0||||||
3838880|NCT01687218|3664753|B6|No||Hispanic Origin||participants|Number|24|24.0||||||
3838881|NCT01687218|3664754|B5|No||Hispanic Origin||participants|Number|21|21.0||||||
3838882|NCT01687218|3664755|B4|No||Hispanic Origin||participants|Number|26|26.0||||||
3838883|NCT01687218|3664756|B3|No||Hispanic Origin||participants|Number|23|23.0||||||
3838884|NCT01687218|3664757|B2|No||Hispanic Origin||participants|Number|23|23.0||||||
3838885|NCT01687218|3664758|B1|No||Hispanic Origin||participants|Number|23|23.0||||||
3838886|NCT01687218|3664752|B7|Yes||Hispanic Origin||participants|Number|55|55.0||||||
3838887|NCT01687218|3664753|B6|Yes||Hispanic Origin||participants|Number|8|8.0||||||
3838888|NCT01687218|3664754|B5|Yes||Hispanic Origin||participants|Number|12|12.0||||||
3838889|NCT01687218|3664755|B4|Yes||Hispanic Origin||participants|Number|8|8.0||||||
3838890|NCT01687218|3664756|B3|Yes||Hispanic Origin||participants|Number|8|8.0||||||
3838891|NCT01687218|3664757|B2|Yes||Hispanic Origin||participants|Number|9|9.0||||||
3838892|NCT01687218|3664758|B1|Yes||Hispanic Origin||participants|Number|10|10.0||||||
3838893|NCT01687218|3664752|B7|Refuse to answer||Sex/Gender, Customized|One participant from Peru did not complete a baseline CASI.|participants|Number|3|3.0||||||
3838894|NCT01687218|3664753|B6|Refuse to answer||Sex/Gender, Customized|One participant from Peru did not complete a baseline CASI.|participants|Number|0|0.0||||||
3838895|NCT01687218|3664754|B5|Refuse to answer||Sex/Gender, Customized|One participant from Peru did not complete a baseline CASI.|participants|Number|0|0.0||||||
3838896|NCT01687218|3664755|B4|Refuse to answer||Sex/Gender, Customized|One participant from Peru did not complete a baseline CASI.|participants|Number|0|0.0||||||
3838897|NCT01687218|3664756|B3|Refuse to answer||Sex/Gender, Customized|One participant from Peru did not complete a baseline CASI.|participants|Number|0|0.0||||||
3838898|NCT01687218|3664757|B2|Refuse to answer||Sex/Gender, Customized|One participant from Peru did not complete a baseline CASI.|participants|Number|1|1.0||||||
3838899|NCT01687218|3664758|B1|Refuse to answer||Sex/Gender, Customized|One participant from Peru did not complete a baseline CASI.|participants|Number|2|2.0||||||
3838900|NCT01687218|3664752|B7|Other||Sex/Gender, Customized|One participant from Peru did not complete a baseline CASI.|participants|Number|27|27.0||||||
3838901|NCT01687218|3664753|B6|Other||Sex/Gender, Customized|One participant from Peru did not complete a baseline CASI.|participants|Number|6|6.0||||||
3838902|NCT01687218|3664754|B5|Other||Sex/Gender, Customized|One participant from Peru did not complete a baseline CASI.|participants|Number|3|3.0||||||
3838903|NCT01687218|3664755|B4|Other||Sex/Gender, Customized|One participant from Peru did not complete a baseline CASI.|participants|Number|3|3.0||||||
3838904|NCT01687218|3664756|B3|Other||Sex/Gender, Customized|One participant from Peru did not complete a baseline CASI.|participants|Number|6|6.0||||||
3838905|NCT01687218|3664757|B2|Other||Sex/Gender, Customized|One participant from Peru did not complete a baseline CASI.|participants|Number|4|4.0||||||
3838906|NCT01687218|3664758|B1|Other||Sex/Gender, Customized|One participant from Peru did not complete a baseline CASI.|participants|Number|5|5.0||||||
3838907|NCT01687218|3664752|B7|Transgender/Transwoman||Sex/Gender, Customized|One participant from Peru did not complete a baseline CASI.|participants|Number|19|19.0||||||
3838908|NCT01687218|3664753|B6|Transgender/Transwoman||Sex/Gender, Customized|One participant from Peru did not complete a baseline CASI.|participants|Number|1|1.0||||||
3838909|NCT01687218|3664754|B5|Transgender/Transwoman||Sex/Gender, Customized|One participant from Peru did not complete a baseline CASI.|participants|Number|3|3.0||||||
3838910|NCT01687218|3664755|B4|Transgender/Transwoman||Sex/Gender, Customized|One participant from Peru did not complete a baseline CASI.|participants|Number|3|3.0||||||
3838911|NCT01687218|3664756|B3|Transgender/Transwoman||Sex/Gender, Customized|One participant from Peru did not complete a baseline CASI.|participants|Number|2|2.0||||||
3838912|NCT01687218|3664757|B2|Transgender/Transwoman||Sex/Gender, Customized|One participant from Peru did not complete a baseline CASI.|participants|Number|6|6.0||||||
3838913|NCT01687218|3664758|B1|Transgender/Transwoman||Sex/Gender, Customized|One participant from Peru did not complete a baseline CASI.|participants|Number|4|4.0||||||
3838914|NCT01687218|3664752|B7|Woman||Sex/Gender, Customized|One participant from Peru did not complete a baseline CASI.|participants|Number|4|4.0||||||
3838978|NCT01687218|3664753|B6|Under 20||Age, Customized||participants|Number|2|2.0||||||
3838915|NCT01687218|3664753|B6|Woman||Sex/Gender, Customized|One participant from Peru did not complete a baseline CASI.|participants|Number|1|1.0||||||
3838916|NCT01687218|3664754|B5|Woman||Sex/Gender, Customized|One participant from Peru did not complete a baseline CASI.|participants|Number|1|1.0||||||
3838917|NCT01687218|3664755|B4|Woman||Sex/Gender, Customized|One participant from Peru did not complete a baseline CASI.|participants|Number|1|1.0||||||
3838918|NCT01687218|3664756|B3|Woman||Sex/Gender, Customized|One participant from Peru did not complete a baseline CASI.|participants|Number|1|1.0||||||
3838919|NCT01687218|3664757|B2|Woman||Sex/Gender, Customized|One participant from Peru did not complete a baseline CASI.|participants|Number|0|0.0||||||
3838920|NCT01687218|3664758|B1|Woman||Sex/Gender, Customized|One participant from Peru did not complete a baseline CASI.|participants|Number|0|0.0||||||
3838921|NCT01687218|3664752|B7|Man||Sex/Gender, Customized|One participant from Peru did not complete a baseline CASI.|participants|Number|141|141.0||||||
3838922|NCT01687218|3664753|B6|Man||Sex/Gender, Customized|One participant from Peru did not complete a baseline CASI.|participants|Number|24|24.0||||||
3838923|NCT01687218|3664754|B5|Man||Sex/Gender, Customized|One participant from Peru did not complete a baseline CASI.|participants|Number|26|26.0||||||
3838924|NCT01687218|3664755|B4|Man||Sex/Gender, Customized|One participant from Peru did not complete a baseline CASI.|participants|Number|27|27.0||||||
3838925|NCT01687218|3664756|B3|Man||Sex/Gender, Customized|One participant from Peru did not complete a baseline CASI.|participants|Number|22|22.0||||||
3838926|NCT01687218|3664757|B2|Man||Sex/Gender, Customized|One participant from Peru did not complete a baseline CASI.|participants|Number|21|21.0||||||
3838927|NCT01687218|3664758|B1|Man||Sex/Gender, Customized|One participant from Peru did not complete a baseline CASI.|participants|Number|21|21.0||||||
3838928|NCT01687218|3664752|B7|50+||Age, Customized||participants|Number|8|8.0||||||
3838929|NCT01687218|3664753|B6|50+||Age, Customized||participants|Number|0|0.0||||||
3838930|NCT01687218|3664754|B5|50+||Age, Customized||participants|Number|3|3.0||||||
3838931|NCT01687218|3664755|B4|50+||Age, Customized||participants|Number|1|1.0||||||
3838932|NCT01687218|3664756|B3|50+||Age, Customized||participants|Number|1|1.0||||||
3838933|NCT01687218|3664757|B2|50+||Age, Customized||participants|Number|2|2.0||||||
3838934|NCT01687218|3664758|B1|50+||Age, Customized||participants|Number|1|1.0||||||
3838935|NCT01687218|3664752|B7|45-49||Age, Customized||participants|Number|11|11.0||||||
3838936|NCT01687218|3664753|B6|45-49||Age, Customized||participants|Number|3|3.0||||||
3838937|NCT01687218|3664754|B5|45-49||Age, Customized||participants|Number|2|2.0||||||
3838938|NCT01687218|3664755|B4|45-49||Age, Customized||participants|Number|2|2.0||||||
3838939|NCT01687218|3664756|B3|45-49||Age, Customized||participants|Number|4|4.0||||||
3838940|NCT01687218|3664757|B2|45-49||Age, Customized||participants|Number|0|0.0||||||
3838941|NCT01687218|3664758|B1|45-49||Age, Customized||participants|Number|0|0.0||||||
3838942|NCT01687218|3664752|B7|40-44||Age, Customized||participants|Number|19|19.0||||||
3838943|NCT01687218|3664753|B6|40-44||Age, Customized||participants|Number|2|2.0||||||
3838944|NCT01687218|3664754|B5|40-44||Age, Customized||participants|Number|3|3.0||||||
3838945|NCT01687218|3664755|B4|40-44||Age, Customized||participants|Number|3|3.0||||||
3838946|NCT01687218|3664756|B3|40-44||Age, Customized||participants|Number|4|4.0||||||
3838947|NCT01687218|3664757|B2|40-44||Age, Customized||participants|Number|3|3.0||||||
3838948|NCT01687218|3664758|B1|40-44||Age, Customized||participants|Number|4|4.0||||||
3838949|NCT01687218|3664752|B7|35-39||Age, Customized||participants|Number|20|20.0||||||
3838950|NCT01687218|3664753|B6|35-39||Age, Customized||participants|Number|4|4.0||||||
3838951|NCT01687218|3664754|B5|35-39||Age, Customized||participants|Number|2|2.0||||||
3838952|NCT01687218|3664755|B4|35-39||Age, Customized||participants|Number|2|2.0||||||
3838953|NCT01687218|3664756|B3|35-39||Age, Customized||participants|Number|2|2.0||||||
3838954|NCT01687218|3664757|B2|35-39||Age, Customized||participants|Number|4|4.0||||||
3838955|NCT01687218|3664758|B1|35-39||Age, Customized||participants|Number|6|6.0||||||
3838956|NCT01687218|3664752|B7|30-34||Age, Customized||participants|Number|40|40.0||||||
3838957|NCT01687218|3664753|B6|30-34||Age, Customized||participants|Number|10|10.0||||||
3838958|NCT01687218|3664754|B5|30-34||Age, Customized||participants|Number|7|7.0||||||
3838959|NCT01687218|3664755|B4|30-34||Age, Customized||participants|Number|7|7.0||||||
3838960|NCT01687218|3664756|B3|30-34||Age, Customized||participants|Number|6|6.0||||||
3838961|NCT01687218|3664757|B2|30-34||Age, Customized||participants|Number|4|4.0||||||
3838962|NCT01687218|3664758|B1|30-34||Age, Customized||participants|Number|6|6.0||||||
3838963|NCT01687218|3664752|B7|25-29||Age, Customized||participants|Number|43|43.0||||||
3838964|NCT01687218|3664753|B6|25-29||Age, Customized||participants|Number|6|6.0||||||
3838965|NCT01687218|3664754|B5|25-29||Age, Customized||participants|Number|7|7.0||||||
3838966|NCT01687218|3664755|B4|25-29||Age, Customized||participants|Number|6|6.0||||||
3838967|NCT01687218|3664756|B3|25-29||Age, Customized||participants|Number|6|6.0||||||
3838968|NCT01687218|3664757|B2|25-29||Age, Customized||participants|Number|11|11.0||||||
3838969|NCT01687218|3664758|B1|25-29||Age, Customized||participants|Number|7|7.0||||||
3838970|NCT01687218|3664752|B7|20-24||Age, Customized||participants|Number|44|44.0||||||
3838971|NCT01687218|3664753|B6|20-24||Age, Customized||participants|Number|5|5.0||||||
3838972|NCT01687218|3664754|B5|20-24||Age, Customized||participants|Number|7|7.0||||||
3838973|NCT01687218|3664755|B4|20-24||Age, Customized||participants|Number|12|12.0||||||
3838974|NCT01687218|3664756|B3|20-24||Age, Customized||participants|Number|6|6.0||||||
3838975|NCT01687218|3664757|B2|20-24||Age, Customized||participants|Number|7|7.0||||||
3838976|NCT01687218|3664758|B1|20-24||Age, Customized||participants|Number|7|7.0||||||
3838977|NCT01687218|3664752|B7|Under 20||Age, Customized||participants|Number|10|10.0||||||
3838979|NCT01687218|3664754|B5|Under 20||Age, Customized||participants|Number|2|2.0||||||
3838980|NCT01687218|3664755|B4|Under 20||Age, Customized||participants|Number|1|1.0||||||
3838981|NCT01687218|3664756|B3|Under 20||Age, Customized||participants|Number|2|2.0||||||
3838982|NCT01687218|3664757|B2|Under 20||Age, Customized||participants|Number|1|1.0||||||
3838983|NCT01687218|3664758|B1|Under 20||Age, Customized||participants|Number|2|2.0||||||
3838984|NCT01687218|3664752|B7|||Age||years|Mean|31.1|31.1|Standard Deviation|9.3|9.3|||
3838985|NCT01687218|3664753|B6|||Age||years|Mean|31.4|31.4|Standard Deviation|7.8|7.8|||
3838986|NCT01687218|3664754|B5|||Age||years|Mean|32.2|32.2|Standard Deviation|10.6|10.6|||
3838987|NCT01687218|3664755|B4|||Age||years|Mean|29.6|29.6|Standard Deviation|8.9|8.9|||
3838988|NCT01687218|3664756|B3|||Age||years|Mean|32.4|32.4|Standard Deviation|9.2|9.2|||
3838989|NCT01687218|3664757|B2|||Age||years|Mean|30.4|30.4|Standard Deviation|10.6|10.6|||
3838990|NCT01687218|3664758|B1|||Age||years|Mean|30.9|30.9|Standard Deviation|8.5|8.5|||
3838991|NCT01687179|3664783|B1|||DLCO (%)||percent predicted|Mean|43|43.0|Standard Deviation|15|15.0|||
3838992|NCT01687179|3664783|B1|||DLCO (ml/min/mmhg)||ml/min/mmhg|Mean|9.8|9.8|Standard Deviation|3.1|3.1|||
3838993|NCT01687179|3664783|B1|||FVC (%)||Percent predicted|Mean|81|81.0|Standard Deviation|16|16.0|||
3838994|NCT01687179|3664783|B1|||FVC (L)||Litres|Mean|2.8|2.8|Standard Deviation|0.7|0.7|||
3838995|NCT01687179|3664783|B1|||FEV1 (%)||Percent predicted|Mean|59|59.0|Standard Deviation|21|21.0|||
3838996|NCT01687179|3664783|B1|||FEV1||Litres|Mean|1.6|1.6|Standard Deviation|0.7|0.7|||
3838997|NCT01687179|3664783|B1|||Log VEGF-D (Veascular Endothelial Growth factor)||log(pg/ml)|Mean|3.11|3.11|Standard Deviation|0.33|0.33|||
3838998|NCT01687179|3664783|B1|||St. George's Respiratory Questionnaire (SGRQ)|The Saint George's Respiratory Questionnaire (SGRQ) is a disease-specific instrument designed to measure impact on overall health, daily life, and perceived well-being in patients with obstructive airways disease. Scores range from 0 to 100, with higher scores indicating more limitations.|units on a scale|Mean|43.8|43.8|Standard Deviation|19.2|19.2|||
3838999|NCT01687179|3664783|B1|||6 minute walk distance (6MWD) (m)||m|Mean|442|442.0|Standard Deviation|103|103.0|||
3839000|NCT01687179|3664783|B1|||Chylothorax||Participants|Count of Participants|1|1.0||||||
3839001|NCT01687179|3664783|B1|||Lung Biopsy||Participants|Count of Participants|8|8.0||||||
3839002|NCT01687179|3664783|B1|||Tuberous Sclerois (TSC)- Lymphangioleiomyomatosis (LAM)||Participants|Count of Participants|0|0.0||||||
3839003|NCT01687179|3664783|B1|||Angiomyolipoma||Participants|Count of Participants|2|2.0||||||
3839004|NCT01687179|3664783|B1|||Pneumothorax||Participants|Count of Participants|9|9.0||||||
3839005|NCT01687179|3664783|B1|||Post-Menopause||Participants|Count of Participants|6|6.0||||||
3839006|NCT01687179|3664783|B1|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3839007|NCT01687179|3664783|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839008|NCT01687179|3664783|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839009|NCT01687179|3664783|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3839010|NCT01687179|3664783|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839011|NCT01687179|3664783|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839012|NCT01687179|3664783|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3839013|NCT01687179|3664783|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839014|NCT01687179|3664783|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3839015|NCT01687179|3664783|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3839016|NCT01687179|3664783|B1|||Age||years|Median|49|49.0|Full Range|||40.0|65.0|
3839017|NCT01687166|3664790|B5|Not Assessed||New York Heart Assessment (NYHA) Class|"NYHA Class at enrollment based upon the following definitions:~Class I - Subjects with heart disease who are able to remain at a comfortable state while performing ordinary physical activity Class II - Subjects who are comfortable at rest or with mild exertion but experience symptoms with more strenuous activity Class III - Subjects who are comfortable at rest but experience symptoms with mild activity Class IV - Subjects who are symptomatic at rest and are unable to carry out any physical activity"|Participants|Count of Participants|12|12.0||||||
3839018|NCT01687166|3664791|B4|Not Assessed||New York Heart Assessment (NYHA) Class|"NYHA Class at enrollment based upon the following definitions:~Class I - Subjects with heart disease who are able to remain at a comfortable state while performing ordinary physical activity Class II - Subjects who are comfortable at rest or with mild exertion but experience symptoms with more strenuous activity Class III - Subjects who are comfortable at rest but experience symptoms with mild activity Class IV - Subjects who are symptomatic at rest and are unable to carry out any physical activity"|Participants|Count of Participants|0|0.0||||||
3839019|NCT01687166|3664792|B3|Not Assessed||New York Heart Assessment (NYHA) Class|"NYHA Class at enrollment based upon the following definitions:~Class I - Subjects with heart disease who are able to remain at a comfortable state while performing ordinary physical activity Class II - Subjects who are comfortable at rest or with mild exertion but experience symptoms with more strenuous activity Class III - Subjects who are comfortable at rest but experience symptoms with mild activity Class IV - Subjects who are symptomatic at rest and are unable to carry out any physical activity"|Participants|Count of Participants|2|2.0||||||
3839020|NCT01687166|3664793|B2|Not Assessed||New York Heart Assessment (NYHA) Class|"NYHA Class at enrollment based upon the following definitions:~Class I - Subjects with heart disease who are able to remain at a comfortable state while performing ordinary physical activity Class II - Subjects who are comfortable at rest or with mild exertion but experience symptoms with more strenuous activity Class III - Subjects who are comfortable at rest but experience symptoms with mild activity Class IV - Subjects who are symptomatic at rest and are unable to carry out any physical activity"|Participants|Count of Participants|3|3.0||||||
3839194|NCT01686828|3664880|B3|||Body Mass Index (BMI)||kg/m2|Mean|25|25.0|Standard Deviation|2|2.0|||
3839021|NCT01687166|3664794|B1|Not Assessed||New York Heart Assessment (NYHA) Class|"NYHA Class at enrollment based upon the following definitions:~Class I - Subjects with heart disease who are able to remain at a comfortable state while performing ordinary physical activity Class II - Subjects who are comfortable at rest or with mild exertion but experience symptoms with more strenuous activity Class III - Subjects who are comfortable at rest but experience symptoms with mild activity Class IV - Subjects who are symptomatic at rest and are unable to carry out any physical activity"|Participants|Count of Participants|7|7.0||||||
3839022|NCT01687166|3664790|B5|Non Heart Failure (HF)||New York Heart Assessment (NYHA) Class|"NYHA Class at enrollment based upon the following definitions:~Class I - Subjects with heart disease who are able to remain at a comfortable state while performing ordinary physical activity Class II - Subjects who are comfortable at rest or with mild exertion but experience symptoms with more strenuous activity Class III - Subjects who are comfortable at rest but experience symptoms with mild activity Class IV - Subjects who are symptomatic at rest and are unable to carry out any physical activity"|Participants|Count of Participants|192|192.0||||||
3839023|NCT01687166|3664791|B4|Non Heart Failure (HF)||New York Heart Assessment (NYHA) Class|"NYHA Class at enrollment based upon the following definitions:~Class I - Subjects with heart disease who are able to remain at a comfortable state while performing ordinary physical activity Class II - Subjects who are comfortable at rest or with mild exertion but experience symptoms with more strenuous activity Class III - Subjects who are comfortable at rest but experience symptoms with mild activity Class IV - Subjects who are symptomatic at rest and are unable to carry out any physical activity"|Participants|Count of Participants|0|0.0||||||
3839024|NCT01687166|3664792|B3|Non Heart Failure (HF)||New York Heart Assessment (NYHA) Class|"NYHA Class at enrollment based upon the following definitions:~Class I - Subjects with heart disease who are able to remain at a comfortable state while performing ordinary physical activity Class II - Subjects who are comfortable at rest or with mild exertion but experience symptoms with more strenuous activity Class III - Subjects who are comfortable at rest but experience symptoms with mild activity Class IV - Subjects who are symptomatic at rest and are unable to carry out any physical activity"|Participants|Count of Participants|24|24.0||||||
3839025|NCT01687166|3664793|B2|Non Heart Failure (HF)||New York Heart Assessment (NYHA) Class|"NYHA Class at enrollment based upon the following definitions:~Class I - Subjects with heart disease who are able to remain at a comfortable state while performing ordinary physical activity Class II - Subjects who are comfortable at rest or with mild exertion but experience symptoms with more strenuous activity Class III - Subjects who are comfortable at rest but experience symptoms with mild activity Class IV - Subjects who are symptomatic at rest and are unable to carry out any physical activity"|Participants|Count of Participants|92|92.0||||||
3839026|NCT01687166|3664794|B1|Non Heart Failure (HF)||New York Heart Assessment (NYHA) Class|"NYHA Class at enrollment based upon the following definitions:~Class I - Subjects with heart disease who are able to remain at a comfortable state while performing ordinary physical activity Class II - Subjects who are comfortable at rest or with mild exertion but experience symptoms with more strenuous activity Class III - Subjects who are comfortable at rest but experience symptoms with mild activity Class IV - Subjects who are symptomatic at rest and are unable to carry out any physical activity"|Participants|Count of Participants|76|76.0||||||
3839027|NCT01687166|3664790|B5|II||New York Heart Assessment (NYHA) Class|"NYHA Class at enrollment based upon the following definitions:~Class I - Subjects with heart disease who are able to remain at a comfortable state while performing ordinary physical activity Class II - Subjects who are comfortable at rest or with mild exertion but experience symptoms with more strenuous activity Class III - Subjects who are comfortable at rest but experience symptoms with mild activity Class IV - Subjects who are symptomatic at rest and are unable to carry out any physical activity"|Participants|Count of Participants|40|40.0||||||
3839028|NCT01687166|3664791|B4|II||New York Heart Assessment (NYHA) Class|"NYHA Class at enrollment based upon the following definitions:~Class I - Subjects with heart disease who are able to remain at a comfortable state while performing ordinary physical activity Class II - Subjects who are comfortable at rest or with mild exertion but experience symptoms with more strenuous activity Class III - Subjects who are comfortable at rest but experience symptoms with mild activity Class IV - Subjects who are symptomatic at rest and are unable to carry out any physical activity"|Participants|Count of Participants|0|0.0||||||
3839029|NCT01687166|3664792|B3|II||New York Heart Assessment (NYHA) Class|"NYHA Class at enrollment based upon the following definitions:~Class I - Subjects with heart disease who are able to remain at a comfortable state while performing ordinary physical activity Class II - Subjects who are comfortable at rest or with mild exertion but experience symptoms with more strenuous activity Class III - Subjects who are comfortable at rest but experience symptoms with mild activity Class IV - Subjects who are symptomatic at rest and are unable to carry out any physical activity"|Participants|Count of Participants|10|10.0||||||
3839030|NCT01687166|3664793|B2|II||New York Heart Assessment (NYHA) Class|"NYHA Class at enrollment based upon the following definitions:~Class I - Subjects with heart disease who are able to remain at a comfortable state while performing ordinary physical activity Class II - Subjects who are comfortable at rest or with mild exertion but experience symptoms with more strenuous activity Class III - Subjects who are comfortable at rest but experience symptoms with mild activity Class IV - Subjects who are symptomatic at rest and are unable to carry out any physical activity"|Participants|Count of Participants|13|13.0||||||
3839031|NCT01687166|3664794|B1|II||New York Heart Assessment (NYHA) Class|"NYHA Class at enrollment based upon the following definitions:~Class I - Subjects with heart disease who are able to remain at a comfortable state while performing ordinary physical activity Class II - Subjects who are comfortable at rest or with mild exertion but experience symptoms with more strenuous activity Class III - Subjects who are comfortable at rest but experience symptoms with mild activity Class IV - Subjects who are symptomatic at rest and are unable to carry out any physical activity"|Participants|Count of Participants|17|17.0||||||
3839032|NCT01687166|3664790|B5|I||New York Heart Assessment (NYHA) Class|"NYHA Class at enrollment based upon the following definitions:~Class I - Subjects with heart disease who are able to remain at a comfortable state while performing ordinary physical activity Class II - Subjects who are comfortable at rest or with mild exertion but experience symptoms with more strenuous activity Class III - Subjects who are comfortable at rest but experience symptoms with mild activity Class IV - Subjects who are symptomatic at rest and are unable to carry out any physical activity"|Participants|Count of Participants|154|154.0||||||
3839195|NCT01686828|3664881|B2|||Body Mass Index (BMI)||kg/m2|Mean|26|26.0|Standard Deviation|4|4.0|||
3839033|NCT01687166|3664791|B4|I||New York Heart Assessment (NYHA) Class|"NYHA Class at enrollment based upon the following definitions:~Class I - Subjects with heart disease who are able to remain at a comfortable state while performing ordinary physical activity Class II - Subjects who are comfortable at rest or with mild exertion but experience symptoms with more strenuous activity Class III - Subjects who are comfortable at rest but experience symptoms with mild activity Class IV - Subjects who are symptomatic at rest and are unable to carry out any physical activity"|Participants|Count of Participants|3|3.0||||||
3839034|NCT01687166|3664792|B3|I||New York Heart Assessment (NYHA) Class|"NYHA Class at enrollment based upon the following definitions:~Class I - Subjects with heart disease who are able to remain at a comfortable state while performing ordinary physical activity Class II - Subjects who are comfortable at rest or with mild exertion but experience symptoms with more strenuous activity Class III - Subjects who are comfortable at rest but experience symptoms with mild activity Class IV - Subjects who are symptomatic at rest and are unable to carry out any physical activity"|Participants|Count of Participants|20|20.0||||||
3839035|NCT01687166|3664793|B2|I||New York Heart Assessment (NYHA) Class|"NYHA Class at enrollment based upon the following definitions:~Class I - Subjects with heart disease who are able to remain at a comfortable state while performing ordinary physical activity Class II - Subjects who are comfortable at rest or with mild exertion but experience symptoms with more strenuous activity Class III - Subjects who are comfortable at rest but experience symptoms with mild activity Class IV - Subjects who are symptomatic at rest and are unable to carry out any physical activity"|Participants|Count of Participants|64|64.0||||||
3839036|NCT01687166|3664794|B1|I||New York Heart Assessment (NYHA) Class|"NYHA Class at enrollment based upon the following definitions:~Class I - Subjects with heart disease who are able to remain at a comfortable state while performing ordinary physical activity Class II - Subjects who are comfortable at rest or with mild exertion but experience symptoms with more strenuous activity Class III - Subjects who are comfortable at rest but experience symptoms with mild activity Class IV - Subjects who are symptomatic at rest and are unable to carry out any physical activity"|Participants|Count of Participants|67|67.0||||||
3839037|NCT01687166|3664790|B5|||Resting Heart Rate||bpm|Mean|69|69.0|Standard Deviation|17|17.0|||
3839038|NCT01687166|3664791|B4|||Resting Heart Rate||bpm|Mean|68|68.0|Standard Deviation|7|7.0|||
3839039|NCT01687166|3664792|B3|||Resting Heart Rate||bpm|Mean|68|68.0|Standard Deviation|17|17.0|||
3839040|NCT01687166|3664793|B2|||Resting Heart Rate||bpm|Mean|67|67.0|Standard Deviation|15|15.0|||
3839041|NCT01687166|3664794|B1|||Resting Heart Rate||bpm|Mean|71|71.0|Standard Deviation|19|19.0|||
3839042|NCT01687166|3664790|B5|||Weight||kg|Mean|90|90.0|Standard Deviation|21|21.0|||
3839043|NCT01687166|3664791|B4|||Weight||kg|Mean|79|79.0|Standard Deviation|15|15.0|||
3839044|NCT01687166|3664792|B3|||Weight||kg|Mean|94|94.0|Standard Deviation|21|21.0|||
3839045|NCT01687166|3664793|B2|||Weight||kg|Mean|90|90.0|Standard Deviation|22|22.0|||
3839046|NCT01687166|3664794|B1|||Weight||kg|Mean|89|89.0|Standard Deviation|19|19.0|||
3839047|NCT01687166|3664790|B5|||Height||cm|Mean|174|174.0|Standard Deviation|10|10.0|||
3839048|NCT01687166|3664791|B4|||Height||cm|Mean|175|175.0|Standard Deviation|11|11.0|||
3839049|NCT01687166|3664792|B3|||Height||cm|Mean|175|175.0|Standard Deviation|11|11.0|||
3839050|NCT01687166|3664793|B2|||Height||cm|Mean|174|174.0|Standard Deviation|9|9.0|||
3839051|NCT01687166|3664794|B1|||Height||cm|Mean|173|173.0|Standard Deviation|9|9.0|||
3839052|NCT01687166|3664790|B5|Spain||Region of Enrollment||Participants|Count of Participants|59|59.0||||||
3839053|NCT01687166|3664791|B4|Spain||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3839054|NCT01687166|3664792|B3|Spain||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3839055|NCT01687166|3664793|B2|Spain||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3839056|NCT01687166|3664794|B1|Spain||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3839057|NCT01687166|3664790|B5|Germany||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3839058|NCT01687166|3664791|B4|Germany||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3839059|NCT01687166|3664792|B3|Germany||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3839060|NCT01687166|3664793|B2|Germany||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3839061|NCT01687166|3664794|B1|Germany||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3839062|NCT01687166|3664790|B5|Portugal||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3839063|NCT01687166|3664791|B4|Portugal||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3839064|NCT01687166|3664792|B3|Portugal||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3839065|NCT01687166|3664793|B2|Portugal||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3839066|NCT01687166|3664794|B1|Portugal||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3839067|NCT01687166|3664790|B5|France||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3839068|NCT01687166|3664791|B4|France||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3839069|NCT01687166|3664792|B3|France||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3839070|NCT01687166|3664793|B2|France||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3839071|NCT01687166|3664794|B1|France||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3839072|NCT01687166|3664790|B5|Australia||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3839073|NCT01687166|3664791|B4|Australia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3839074|NCT01687166|3664792|B3|Australia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3839075|NCT01687166|3664793|B2|Australia||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3839076|NCT01687166|3664794|B1|Australia||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3839077|NCT01687166|3664790|B5|United Kingdom||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3839078|NCT01687166|3664791|B4|United Kingdom||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3839079|NCT01687166|3664792|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3839080|NCT01687166|3664793|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3839081|NCT01687166|3664794|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3839082|NCT01687166|3664790|B5|United States||Region of Enrollment||Participants|Count of Participants|267|267.0||||||
3839083|NCT01687166|3664791|B4|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3839084|NCT01687166|3664792|B3|United States||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
3839085|NCT01687166|3664793|B2|United States||Region of Enrollment||Participants|Count of Participants|112|112.0||||||
3839086|NCT01687166|3664794|B1|United States||Region of Enrollment||Participants|Count of Participants|107|107.0||||||
3839087|NCT01687166|3664790|B5|Sweden||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3839088|NCT01687166|3664791|B4|Sweden||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3839089|NCT01687166|3664792|B3|Sweden||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3839090|NCT01687166|3664793|B2|Sweden||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3839091|NCT01687166|3664794|B1|Sweden||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3839092|NCT01687166|3664790|B5||Male|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
3839093|NCT01687166|3664791|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3839094|NCT01687166|3664792|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3839095|NCT01687166|3664793|B2||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3839096|NCT01687166|3664794|B1||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3839097|NCT01687166|3664790|B5||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3839098|NCT01687166|3664791|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3839099|NCT01687166|3664792|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3839100|NCT01687166|3664793|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3839101|NCT01687166|3664794|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3839102|NCT01687166|3664790|B5|||Age||years|Mean|60|60.0|Standard Deviation|11|11.0|||
3839103|NCT01687166|3664791|B4|||Age||years|Mean|61|61.0|Standard Deviation|10|10.0|||
3839104|NCT01687166|3664792|B3|||Age||years|Mean|62|62.0|Standard Deviation|10|10.0|||
3839105|NCT01687166|3664793|B2|||Age||years|Mean|59|59.0|Standard Deviation|10|10.0|||
3839106|NCT01687166|3664794|B1|||Age||years|Mean|60|60.0|Standard Deviation|11|11.0|||
3839107|NCT01687114|3664809|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3839108|NCT01687114|3664809|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839109|NCT01687114|3664809|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839110|NCT01687114|3664809|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3839111|NCT01687114|3664809|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839112|NCT01687114|3664809|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839113|NCT01687114|3664809|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839114|NCT01687114|3664809|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839115|NCT01687114|3664809|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3839116|NCT01687114|3664809|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3839117|NCT01687114|3664809|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3839118|NCT01687114|3664809|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3839119|NCT01687114|3664809|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3839120|NCT01687114|3664809|B1|||Age||years|Mean|27.6|27.6|Standard Deviation|3.4|3.4|||
3839121|NCT01687101|3664813|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
3839122|NCT01687101|3664813|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3839123|NCT01687101|3664813|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3839124|NCT01687101|3664813|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3839125|NCT01687101|3664813|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3839126|NCT01687101|3664813|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3839127|NCT01687088|3664817|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
3839128|NCT01687088|3664818|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
3839129|NCT01687088|3664819|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3839130|NCT01687088|3664817|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3839131|NCT01687088|3664818|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3839132|NCT01687088|3664819|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3839133|NCT01687088|3664817|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3839134|NCT01687088|3664818|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3839135|NCT01687088|3664819|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3839136|NCT01687088|3664817|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3839137|NCT01687088|3664818|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3839138|NCT01687088|3664819|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3839139|NCT01687088|3664817|B3||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
3839140|NCT01687088|3664818|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3839141|NCT01687088|3664819|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3839142|NCT01687088|3664817|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3839143|NCT01687088|3664818|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3839144|NCT01687088|3664819|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3839145|NCT01687036|3664826|B1|Austria||Region of Enrollment||participants|Number|10|10.0||||||
3839146|NCT01687036|3664826|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3839147|NCT01687036|3664826|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3839148|NCT01687036|3664826|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|7.6|7.6|||
3839149|NCT01687036|3664826|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3839150|NCT01687036|3664826|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3839151|NCT01687036|3664826|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3839152|NCT01686958|3664838|B1|||Subjects with erections sufficient for penetration at Baseline|Erectile dysfunction was defined as a score of 0-1 for Question 2 of the International Index of Erectile Function (IIEF-15). Patients with erections sufficient for penetration had a score greater than or equal to 2.|Participants|Count of Participants|21|21.0||||||
3839153|NCT01686958|3664838|B1|Germany||Region of Enrollment||participants|Number|14|14.0||||||
3839154|NCT01686958|3664838|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3839155|NCT01686958|3664838|B1|Canada||Region of Enrollment||participants|Number|12|12.0||||||
3839156|NCT01686958|3664838|B1|White/Caucasian||Race/Ethnicity, Customized|"Data was collected via a questionnaire completed by the patient at the Baseline Visit. Patients were asked to describe themselves by noting a X in one box only. Available options included; White/Caucasian; Black/African-American; Latino/Hispanic' Asian/Pacific Islander; Multi-Racial; Other."|Participants|Count of Participants|29|29.0||||||
3839157|NCT01686958|3664838|B1|Multi-racial||Race/Ethnicity, Customized|"Data was collected via a questionnaire completed by the patient at the Baseline Visit. Patients were asked to describe themselves by noting a X in one box only. Available options included; White/Caucasian; Black/African-American; Latino/Hispanic' Asian/Pacific Islander; Multi-Racial; Other."|Participants|Count of Participants|1|1.0||||||
3839158|NCT01686958|3664838|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3839159|NCT01686958|3664838|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3839160|NCT01686958|3664838|B1||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
3839161|NCT01686958|3664838|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3839162|NCT01686958|3664838|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3839163|NCT01686932|3664849|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3839164|NCT01686932|3664850|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3839165|NCT01686932|3664851|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3839166|NCT01686932|3664849|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3839167|NCT01686932|3664850|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3839168|NCT01686932|3664851|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3839169|NCT01686932|3664849|B3|||Age||years|Mean|65|65.0|Standard Deviation|7.4|7.4|||
3839170|NCT01686932|3664850|B2|||Age||years|Mean|65.2|65.2|Standard Deviation|8.6|8.6|||
3839171|NCT01686932|3664851|B1|||Age||years|Mean|64.8|64.8|Standard Deviation|6.0|6.0|||
3839172|NCT01686828|3664878|B5|||Percentage Lean Mass||%total body mass|Mean|72|72.0|Standard Deviation|6|6.0|||
3839173|NCT01686828|3664879|B4|||Percentage Lean Mass||%total body mass|Mean|73|73.0|Standard Deviation|7|7.0|||
3839174|NCT01686828|3664880|B3|||Percentage Lean Mass||%total body mass|Mean|72|72.0|Standard Deviation|4|4.0|||
3839175|NCT01686828|3664881|B2|||Percentage Lean Mass||%total body mass|Mean|73|73.0|Standard Deviation|5|5.0|||
3839176|NCT01686828|3664882|B1|||Percentage Lean Mass||%total body mass|Mean|68|68.0|Standard Deviation|7|7.0|||
3839177|NCT01686828|3664878|B5|||Percentage Body Fat||%total body mass|Mean|24|24.0|Standard Deviation|6|6.0|||
3839178|NCT01686828|3664879|B4|||Percentage Body Fat||%total body mass|Mean|23|23.0|Standard Deviation|7|7.0|||
3839179|NCT01686828|3664880|B3|||Percentage Body Fat||%total body mass|Mean|24|24.0|Standard Deviation|4|4.0|||
3839180|NCT01686828|3664881|B2|||Percentage Body Fat||%total body mass|Mean|23|23.0|Standard Deviation|6|6.0|||
3839181|NCT01686828|3664882|B1|||Percentage Body Fat||%total body mass|Mean|28|28.0|Standard Deviation|7|7.0|||
3839182|NCT01686828|3664878|B5|||Fasting Glucose||mg/dL|Mean|98|98.0|Standard Deviation|9|9.0|||
3839183|NCT01686828|3664879|B4|||Fasting Glucose||mg/dL|Mean|98|98.0|Standard Deviation|9|9.0|||
3839184|NCT01686828|3664880|B3|||Fasting Glucose||mg/dL|Mean|101|101.0|Standard Deviation|7|7.0|||
3839185|NCT01686828|3664881|B2|||Fasting Glucose||mg/dL|Mean|97|97.0|Standard Deviation|13|13.0|||
3839186|NCT01686828|3664882|B1|||Fasting Glucose||mg/dL|Mean|97|97.0|Standard Deviation|6|6.0|||
3839187|NCT01686828|3664878|B5|||Weight||kg|Mean|81|81.0|Standard Deviation|12|12.0|||
3839188|NCT01686828|3664879|B4|||Weight||kg|Mean|82|82.0|Standard Deviation|11|11.0|||
3839189|NCT01686828|3664880|B3|||Weight||kg|Mean|78|78.0|Standard Deviation|8|8.0|||
3839190|NCT01686828|3664881|B2|||Weight||kg|Mean|81|81.0|Standard Deviation|15|15.0|||
3839191|NCT01686828|3664882|B1|||Weight||kg|Mean|82|82.0|Standard Deviation|14|14.0|||
3839192|NCT01686828|3664878|B5|||Body Mass Index (BMI)||kg/m2|Mean|25|25.0|Standard Deviation|3|3.0|||
3839193|NCT01686828|3664879|B4|||Body Mass Index (BMI)||kg/m2|Mean|25|25.0|Standard Deviation|4|4.0|||
3839196|NCT01686828|3664882|B1|||Body Mass Index (BMI)||kg/m2|Mean|26|26.0|Standard Deviation|4|4.0|||
3839197|NCT01686828|3664878|B5|United States||Region of Enrollment||participants|Number|53|53.0||||||
3839198|NCT01686828|3664879|B4|United States||Region of Enrollment||participants|Number|13|13.0||||||
3839199|NCT01686828|3664880|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
3839200|NCT01686828|3664881|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3839201|NCT01686828|3664882|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3839202|NCT01686828|3664878|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3839203|NCT01686828|3664879|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839204|NCT01686828|3664880|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3839205|NCT01686828|3664881|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3839206|NCT01686828|3664882|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3839207|NCT01686828|3664878|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839208|NCT01686828|3664879|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839209|NCT01686828|3664880|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839210|NCT01686828|3664881|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839211|NCT01686828|3664882|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839212|NCT01686828|3664878|B5||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3839213|NCT01686828|3664879|B4||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3839214|NCT01686828|3664880|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3839215|NCT01686828|3664881|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3839216|NCT01686828|3664882|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3839217|NCT01686828|3664878|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3839218|NCT01686828|3664879|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3839219|NCT01686828|3664880|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839220|NCT01686828|3664881|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3839221|NCT01686828|3664882|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3839222|NCT01686828|3664878|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839223|NCT01686828|3664879|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839224|NCT01686828|3664880|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839225|NCT01686828|3664881|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839226|NCT01686828|3664882|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839227|NCT01686828|3664878|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3839228|NCT01686828|3664879|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839229|NCT01686828|3664880|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839230|NCT01686828|3664881|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839231|NCT01686828|3664882|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3839232|NCT01686828|3664878|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839233|NCT01686828|3664879|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839234|NCT01686828|3664880|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839235|NCT01686828|3664881|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839236|NCT01686828|3664882|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839237|NCT01686828|3664878|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3839238|NCT01686828|3664879|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839239|NCT01686828|3664880|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3839240|NCT01686828|3664881|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3839241|NCT01686828|3664882|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3839242|NCT01686828|3664878|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3839243|NCT01686828|3664879|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3839244|NCT01686828|3664880|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3839245|NCT01686828|3664881|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3839246|NCT01686828|3664882|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3839247|NCT01686828|3664878|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3839248|NCT01686828|3664879|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839249|NCT01686828|3664880|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839250|NCT01686828|3664881|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839251|NCT01686828|3664882|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3839252|NCT01686828|3664878|B5||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3839253|NCT01686828|3664879|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3839254|NCT01686828|3664880|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3839255|NCT01686828|3664881|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3839256|NCT01686828|3664882|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3839257|NCT01686828|3664878|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3839258|NCT01686828|3664879|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3839259|NCT01686828|3664880|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3839260|NCT01686828|3664881|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3839261|NCT01686828|3664882|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3839262|NCT01686828|3664878|B5|||Age||years|Median|36|36.0|Inter-Quartile Range|||29.0|48.0|
3839263|NCT01686828|3664879|B4|||Age||years|Median|34|34.0|Inter-Quartile Range|||28.0|45.0|
3839264|NCT01686828|3664880|B3|||Age||years|Median|42|42.0|Inter-Quartile Range|||31.0|51.0|
3839265|NCT01686828|3664881|B2|||Age||years|Median|35|35.0|Inter-Quartile Range|||27.0|45.0|
3839266|NCT01686828|3664882|B1|||Age||years|Median|37|37.0|Inter-Quartile Range|||27.0|51.0|
3839267|NCT01686646|3664903|B5||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3839268|NCT01686646|3664904|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3839269|NCT01686646|3664905|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3839270|NCT01686646|3664906|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3839271|NCT01686646|3664907|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3839272|NCT01686646|3664903|B5||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3839273|NCT01686646|3664904|B4||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3839274|NCT01686646|3664905|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3839275|NCT01686646|3664906|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3839276|NCT01686646|3664907|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3839277|NCT01686646|3664903|B5|||Age||Years|Mean|20.2|20.2|Standard Deviation|2.98|2.98|||
3839278|NCT01686646|3664904|B4|||Age||Years|Mean|20.2|20.2|Standard Deviation|2.80|2.8|||
3839279|NCT01686646|3664905|B3|||Age||Years|Mean|20.6|20.6|Standard Deviation|4.19|4.19|||
3839280|NCT01686646|3664906|B2|||Age||Years|Mean|20.0|20.0|Standard Deviation|1.74|1.74|||
3839281|NCT01686646|3664907|B1|||Age||Years|Mean|20.0|20.0|Standard Deviation|1.56|1.56|||
3839282|NCT01686633|3664956|B4|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3839283|NCT01686633|3664957|B3|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3839284|NCT01686633|3664958|B2|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3839285|NCT01686633|3664959|B1|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3839286|NCT01686633|3664956|B4|Mixed Race||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
3839287|NCT01686633|3664957|B3|Mixed Race||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3839288|NCT01686633|3664958|B2|Mixed Race||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3839289|NCT01686633|3664959|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3839290|NCT01686633|3664956|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|912|912.0||||||
3839291|NCT01686633|3664957|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|300|300.0||||||
3839292|NCT01686633|3664958|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|307|307.0||||||
3839293|NCT01686633|3664959|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|305|305.0||||||
3839294|NCT01686633|3664956|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3839295|NCT01686633|3664957|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3839296|NCT01686633|3664958|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3839297|NCT01686633|3664959|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3839298|NCT01686633|3664956|B4|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3839299|NCT01686633|3664957|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3839300|NCT01686633|3664958|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3839301|NCT01686633|3664959|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3839302|NCT01686633|3664956|B4|Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3839303|NCT01686633|3664957|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3839304|NCT01686633|3664958|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3839305|NCT01686633|3664959|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3839306|NCT01686633|3664956|B4|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3839307|NCT01686633|3664957|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3839308|NCT01686633|3664958|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3839309|NCT01686633|3664959|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3839310|NCT01686633|3664956|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3839311|NCT01686633|3664957|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3839312|NCT01686633|3664958|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3839313|NCT01686633|3664959|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3839314|NCT01686633|3664956|B4|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
3839315|NCT01686633|3664957|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3839316|NCT01686633|3664958|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3839317|NCT01686633|3664959|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3839318|NCT01686633|3664956|B4||Male|Sex: Female, Male||Participants|Count of Participants|411|411.0||||||
3839319|NCT01686633|3664957|B3||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3839320|NCT01686633|3664958|B2||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3839321|NCT01686633|3664959|B1||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3839322|NCT01686633|3664956|B4||Female|Sex: Female, Male||Participants|Count of Participants|628|628.0||||||
3839323|NCT01686633|3664957|B3||Female|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
3839324|NCT01686633|3664958|B2||Female|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
3839325|NCT01686633|3664959|B1||Female|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
3839326|NCT01686633|3664956|B4|||Age||Years|Mean|45.7|45.7|Standard Deviation|15.60|15.6|||
3839327|NCT01686633|3664957|B3|||Age||Years|Mean|46.6|46.6|Standard Deviation|14.72|14.72|||
3839328|NCT01686633|3664958|B2|||Age||Years|Mean|45.9|45.9|Standard Deviation|16.14|16.14|||
3839329|NCT01686633|3664959|B1|||Age||Years|Mean|44.7|44.7|Standard Deviation|15.89|15.89|||
3839330|NCT01686581|3664984|B1||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3839331|NCT01686581|3664984|B1||Female|Sex: Female, Male||Participants|Count of Participants|540|540.0||||||
3839332|NCT01686581|3664984|B1|||Age||years|Mean|45.4|45.4|Standard Deviation|11.7|11.7|||
3839333|NCT01686568|3664995|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
3839334|NCT01686568|3664996|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3839335|NCT01686568|3664997|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3839336|NCT01686568|3664995|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3839337|NCT01686568|3664996|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3839338|NCT01686568|3664997|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3839339|NCT01686568|3664995|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3839340|NCT01686568|3664996|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3839341|NCT01686568|3664997|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3839342|NCT01686568|3664995|B3|||Age||years|Mean|34.1|34.1|Standard Deviation|9.7|9.7|||
3839343|NCT01686568|3664996|B2|||Age||years|Mean|32.6|32.6|Standard Deviation|2.5|2.5|||
3839344|NCT01686568|3664997|B1|||Age||years|Mean|35.3|35.3|Standard Deviation|2.9|2.9|||
3839345|NCT01686503|3665020|B5|||Coinfected with hepatitis B||participants|Number|13|13.0||||||
3839346|NCT01686503|3665021|B4|||Coinfected with hepatitis B||participants|Number|0|0.0||||||
3839347|NCT01686503|3665022|B3|||Coinfected with hepatitis B||participants|Number|2|2.0||||||
3839348|NCT01686503|3665023|B2|||Coinfected with hepatitis B||participants|Number|4|4.0||||||
3839349|NCT01686503|3665024|B1|||Coinfected with hepatitis B||participants|Number|7|7.0||||||
3839350|NCT01686503|3665020|B5|||Coinfected with hepatitis C||participants|Number|33|33.0||||||
3839351|NCT01686503|3665021|B4|||Coinfected with hepatitis C||participants|Number|5|5.0||||||
3839352|NCT01686503|3665022|B3|||Coinfected with hepatitis C||participants|Number|6|6.0||||||
3839353|NCT01686503|3665023|B2|||Coinfected with hepatitis C||participants|Number|10|10.0||||||
3839354|NCT01686503|3665024|B1|||Coinfected with hepatitis C||participants|Number|12|12.0||||||
3839355|NCT01686503|3665020|B5|||Current smoker||participants|Number|105|105.0||||||
3839356|NCT01686503|3665021|B4|||Current smoker||participants|Number|13|13.0||||||
3839357|NCT01686503|3665022|B3|||Current smoker||participants|Number|23|23.0||||||
3839358|NCT01686503|3665023|B2|||Current smoker||participants|Number|31|31.0||||||
3839359|NCT01686503|3665024|B1|||Current smoker||participants|Number|38|38.0||||||
3839360|NCT01686503|3665020|B5|||Reported receiving all childhood vaccines||participants|Number|219|219.0||||||
3839361|NCT01686503|3665021|B4|||Reported receiving all childhood vaccines||participants|Number|31|31.0||||||
3839362|NCT01686503|3665022|B3|||Reported receiving all childhood vaccines||participants|Number|60|60.0||||||
3839363|NCT01686503|3665023|B2|||Reported receiving all childhood vaccines||participants|Number|64|64.0||||||
3839364|NCT01686503|3665024|B1|||Reported receiving all childhood vaccines||participants|Number|64|64.0||||||
3839365|NCT01686503|3665020|B5|||Lived or traveled internationally||participants|Number|78|78.0||||||
3839366|NCT01686503|3665021|B4|||Lived or traveled internationally||participants|Number|12|12.0||||||
3839367|NCT01686503|3665022|B3|||Lived or traveled internationally||participants|Number|29|29.0||||||
3839368|NCT01686503|3665023|B2|||Lived or traveled internationally||participants|Number|19|19.0||||||
3839369|NCT01686503|3665024|B1|||Lived or traveled internationally||participants|Number|18|18.0||||||
3839370|NCT01686503|3665020|B5|||Born in the United States||participants|Number|219|219.0||||||
3839371|NCT01686503|3665021|B4|||Born in the United States||participants|Number|31|31.0||||||
3839372|NCT01686503|3665022|B3|||Born in the United States||participants|Number|60|60.0||||||
3839373|NCT01686503|3665023|B2|||Born in the United States||participants|Number|63|63.0||||||
3839374|NCT01686503|3665024|B1|||Born in the United States||participants|Number|65|65.0||||||
3839375|NCT01686503|3665020|B5|||Year diagnosed with HIV||calendar year|Mean|2002|2002.0|Standard Deviation|8|8.0|||
3839376|NCT01686503|3665021|B4|||Year diagnosed with HIV||calendar year|Mean|2001|2001.0|Standard Deviation|9|9.0|||
3839377|NCT01686503|3665022|B3|||Year diagnosed with HIV||calendar year|Mean|2001|2001.0|Standard Deviation|8|8.0|||
3839378|NCT01686503|3665023|B2|||Year diagnosed with HIV||calendar year|Mean|2002|2002.0|Standard Deviation|8|8.0|||
3839379|NCT01686503|3665024|B1|||Year diagnosed with HIV||calendar year|Mean|2001|2001.0|Standard Deviation|8|8.0|||
3839380|NCT01686503|3665020|B5|||Diagnosis of AIDS in the record||participants|Number|127|127.0||||||
3839381|NCT01686503|3665021|B4|||Diagnosis of AIDS in the record||participants|Number|17|17.0||||||
3839382|NCT01686503|3665022|B3|||Diagnosis of AIDS in the record||participants|Number|39|39.0||||||
3839383|NCT01686503|3665023|B2|||Diagnosis of AIDS in the record||participants|Number|33|33.0||||||
3839384|NCT01686503|3665024|B1|||Diagnosis of AIDS in the record||participants|Number|38|38.0||||||
3839385|NCT01686503|3665020|B5|||Currently on antiretroviral therapy||participants|Number|227|227.0||||||
3839386|NCT01686503|3665021|B4|||Currently on antiretroviral therapy||participants|Number|33|33.0||||||
3839387|NCT01686503|3665022|B3|||Currently on antiretroviral therapy||participants|Number|66|66.0||||||
3839388|NCT01686503|3665023|B2|||Currently on antiretroviral therapy||participants|Number|64|64.0||||||
3839389|NCT01686503|3665024|B1|||Currently on antiretroviral therapy||participants|Number|64|64.0||||||
3839390|NCT01686503|3665020|B5|||Most recent CD4 count||cells/mm^3|Mean|645|645.0|Standard Deviation|338|338.0|||
3839391|NCT01686503|3665021|B4|||Most recent CD4 count||cells/mm^3|Mean|569|569.0|Standard Deviation|260|260.0|||
3839392|NCT01686503|3665022|B3|||Most recent CD4 count||cells/mm^3|Mean|676|676.0|Standard Deviation|354|354.0|||
3839393|NCT01686503|3665023|B2|||Most recent CD4 count||cells/mm^3|Mean|630|630.0|Standard Deviation|331|331.0|||
3839394|NCT01686503|3665024|B1|||Most recent CD4 count||cells/mm^3|Mean|669|669.0|Standard Deviation|361|361.0|||
3839395|NCT01686503|3665020|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3839396|NCT01686503|3665021|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3839397|NCT01686503|3665022|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839398|NCT01686503|3665023|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3839399|NCT01686503|3665024|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839400|NCT01686503|3665020|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839401|NCT01686503|3665021|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839402|NCT01686503|3665022|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839403|NCT01686503|3665023|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839404|NCT01686503|3665024|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839405|NCT01686503|3665020|B5||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3839406|NCT01686503|3665021|B4||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3839407|NCT01686503|3665022|B3||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3839408|NCT01686503|3665023|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3839409|NCT01686503|3665024|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3839410|NCT01686503|3665020|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|163|163.0||||||
3839411|NCT01686503|3665021|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3839412|NCT01686503|3665022|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3839413|NCT01686503|3665023|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3839414|NCT01686503|3665024|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3839415|NCT01686503|3665020|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839416|NCT01686503|3665021|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839417|NCT01686503|3665022|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839418|NCT01686503|3665023|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839419|NCT01686503|3665024|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839420|NCT01686503|3665020|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839421|NCT01686503|3665021|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839422|NCT01686503|3665022|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839423|NCT01686503|3665023|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839424|NCT01686503|3665024|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839425|NCT01686503|3665020|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839426|NCT01686503|3665021|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839427|NCT01686503|3665022|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839428|NCT01686503|3665023|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839429|NCT01686503|3665024|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839430|NCT01686503|3665020|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3839431|NCT01686503|3665021|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839432|NCT01686503|3665022|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839433|NCT01686503|3665023|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3839434|NCT01686503|3665024|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3839435|NCT01686503|3665020|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|221|221.0||||||
3839436|NCT01686503|3665021|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3839437|NCT01686503|3665022|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3839438|NCT01686503|3665023|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3839439|NCT01686503|3665024|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3839440|NCT01686503|3665020|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3839441|NCT01686503|3665021|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839442|NCT01686503|3665022|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839443|NCT01686503|3665023|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3839444|NCT01686503|3665024|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3839445|NCT01686503|3665020|B5||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3839446|NCT01686503|3665021|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3839447|NCT01686503|3665022|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3839448|NCT01686503|3665023|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3839449|NCT01686503|3665024|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3839450|NCT01686503|3665020|B5||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3839451|NCT01686503|3665021|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3839452|NCT01686503|3665022|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3839453|NCT01686503|3665023|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3839454|NCT01686503|3665024|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3839455|NCT01686503|3665020|B5|||Age||years|Mean|46|46.0|Standard Deviation|11|11.0|||
3839456|NCT01686503|3665021|B4|||Age||years|Mean|46|46.0|Standard Deviation|11|11.0|||
3839457|NCT01686503|3665022|B3|||Age||years|Mean|46|46.0|Standard Deviation|11|11.0|||
3839458|NCT01686503|3665023|B2|||Age||years|Mean|45|45.0|Standard Deviation|11|11.0|||
3839459|NCT01686503|3665024|B1|||Age||years|Mean|45|45.0|Standard Deviation|10|10.0|||
3839460|NCT01686451|3665041|B3|High level||Physical activity level, Categorical|We estimated physical activity level by short version of international physical activity questionnaire (IPAQ) with categorical score ranged from low to high. The higher score was meaning of lower physical activity level.|participants|Number|21|21.0||||||
3839461|NCT01686451|3665042|B2|High level||Physical activity level, Categorical|We estimated physical activity level by short version of international physical activity questionnaire (IPAQ) with categorical score ranged from low to high. The higher score was meaning of lower physical activity level.|participants|Number|12|12.0||||||
3839462|NCT01686451|3665043|B1|High level||Physical activity level, Categorical|We estimated physical activity level by short version of international physical activity questionnaire (IPAQ) with categorical score ranged from low to high. The higher score was meaning of lower physical activity level.|participants|Number|9|9.0||||||
3839463|NCT01686451|3665041|B3|Moderate level||Physical activity level, Categorical|We estimated physical activity level by short version of international physical activity questionnaire (IPAQ) with categorical score ranged from low to high. The higher score was meaning of lower physical activity level.|participants|Number|22|22.0||||||
3839464|NCT01686451|3665042|B2|Moderate level||Physical activity level, Categorical|We estimated physical activity level by short version of international physical activity questionnaire (IPAQ) with categorical score ranged from low to high. The higher score was meaning of lower physical activity level.|participants|Number|12|12.0||||||
3839465|NCT01686451|3665043|B1|Moderate level||Physical activity level, Categorical|We estimated physical activity level by short version of international physical activity questionnaire (IPAQ) with categorical score ranged from low to high. The higher score was meaning of lower physical activity level.|participants|Number|10|10.0||||||
3839466|NCT01686451|3665041|B3|Low level||Physical activity level, Categorical|We estimated physical activity level by short version of international physical activity questionnaire (IPAQ) with categorical score ranged from low to high. The higher score was meaning of lower physical activity level.|participants|Number|17|17.0||||||
3839467|NCT01686451|3665042|B2|Low level||Physical activity level, Categorical|We estimated physical activity level by short version of international physical activity questionnaire (IPAQ) with categorical score ranged from low to high. The higher score was meaning of lower physical activity level.|participants|Number|3|3.0||||||
3839468|NCT01686451|3665043|B1|Low level||Physical activity level, Categorical|We estimated physical activity level by short version of international physical activity questionnaire (IPAQ) with categorical score ranged from low to high. The higher score was meaning of lower physical activity level.|participants|Number|14|14.0||||||
3839469|NCT01686451|3665041|B3|||Fatigue score, Continuous|The fatigue score was assessed by a fatigue questionnaire named as Fatigue Assessment Scale (FAS) which used 10-item fatigue measure with the fatigue score ranged from 10-50. The higher score was meaning of higher level of fatigue.|units on a scale|Mean|19.43|19.43|Standard Deviation|2.25|2.25|||
3839518|NCT01686451|3665042|B2|China||Region of Enrollment||participants|Number|27|27.0||||||
3839519|NCT01686451|3665043|B1|China||Region of Enrollment||participants|Number|33|33.0||||||
3839470|NCT01686451|3665042|B2|||Fatigue score, Continuous|The fatigue score was assessed by a fatigue questionnaire named as Fatigue Assessment Scale (FAS) which used 10-item fatigue measure with the fatigue score ranged from 10-50. The higher score was meaning of higher level of fatigue.|units on a scale|Mean|19.26|19.26|Standard Deviation|1.85|1.85|||
3839471|NCT01686451|3665043|B1|||Fatigue score, Continuous|The fatigue score was assessed by a fatigue questionnaire named as Fatigue Assessment Scale (FAS) which used 10-item fatigue measure with the fatigue score ranged from 10-50. The higher score was meaning of higher level of fatigue.|units on a scale|Mean|19.58|19.58|Standard Deviation|2.55|2.55|||
3839472|NCT01686451|3665041|B3|||Creatinine, Continuous||μmol/L|Mean|73.93|73.93|Standard Deviation|15.68|15.68|||
3839473|NCT01686451|3665042|B2|||Creatinine, Continuous||μmol/L|Mean|75.59|75.59|Standard Deviation|17.20|17.2|||
3839474|NCT01686451|3665043|B1|||Creatinine, Continuous||μmol/L|Mean|72.57|72.57|Standard Deviation|14.44|14.44|||
3839475|NCT01686451|3665041|B3|||Creatine phosphate kinase, Continuous||U/L|Mean|85.69|85.69|Standard Deviation|24.78|24.78|||
3839476|NCT01686451|3665042|B2|||Creatine phosphate kinase, Continuous||U/L|Mean|91.65|91.65|Standard Deviation|23.71|23.71|||
3839477|NCT01686451|3665043|B1|||Creatine phosphate kinase, Continuous||U/L|Mean|80.82|80.82|Standard Deviation|24.91|24.91|||
3839478|NCT01686451|3665041|B3|||Aspartate aminotransferase, Continuous||U/L|Mean|24.80|24.8|Standard Deviation|7.22|7.22|||
3839479|NCT01686451|3665042|B2|||Aspartate aminotransferase, Continuous||U/L|Mean|25.63|25.63|Standard Deviation|7.53|7.53|||
3839480|NCT01686451|3665043|B1|||Aspartate aminotransferase, Continuous||U/L|Mean|24.12|24.12|Standard Deviation|7.00|7.0|||
3839481|NCT01686451|3665041|B3|||Alanine aminotransferase, Continuous||U/L|Mean|29.37|29.37|Standard Deviation|11.79|11.79|||
3839482|NCT01686451|3665042|B2|||Alanine aminotransferase, Continuous||U/L|Mean|30.33|30.33|Standard Deviation|13.30|13.3|||
3839483|NCT01686451|3665043|B1|||Alanine aminotransferase, Continuous||U/L|Mean|28.58|28.58|Standard Deviation|10.55|10.55|||
3839484|NCT01686451|3665041|B3|||Low-density lipoprotein-cholesterol, Continuous||mmol/L|Mean|3.73|3.73|Standard Deviation|0.50|0.5|||
3839485|NCT01686451|3665042|B2|||Low-density lipoprotein-cholesterol, Continuous||mmol/L|Mean|3.74|3.74|Standard Deviation|0.55|0.55|||
3839486|NCT01686451|3665043|B1|||Low-density lipoprotein-cholesterol, Continuous||mmol/L|Mean|3.72|3.72|Standard Deviation|0.48|0.48|||
3839487|NCT01686451|3665041|B3|||High-density lipoprotein-cholesterol, Continuous||mmol/L|Mean|1.26|1.26|Standard Deviation|0.25|0.25|||
3839488|NCT01686451|3665042|B2|||High-density lipoprotein-cholesterol, Continuous||mmol/L|Mean|1.23|1.23|Standard Deviation|0.25|0.25|||
3839489|NCT01686451|3665043|B1|||High-density lipoprotein-cholesterol, Continuous||mmol/L|Mean|1.27|1.27|Standard Deviation|0.25|0.25|||
3839490|NCT01686451|3665041|B3|||Total cholesterol, Continuous||mmol/L|Mean|5.87|5.87|Standard Deviation|0.72|0.72|||
3839491|NCT01686451|3665042|B2|||Total cholesterol, Continuous||mmol/L|Mean|5.82|5.82|Standard Deviation|0.73|0.73|||
3839492|NCT01686451|3665043|B1|||Total cholesterol, Continuous||mmol/L|Mean|5.91|5.91|Standard Deviation|0.71|0.71|||
3839493|NCT01686451|3665041|B3|||Triglyceride, Continuous||mmol/L|Mean|1.69|1.69|Standard Deviation|0.86|0.86|||
3839494|NCT01686451|3665042|B2|||Triglyceride, Continuous||mmol/L|Mean|1.61|1.61|Standard Deviation|0.65|0.65|||
3839495|NCT01686451|3665043|B1|||Triglyceride, Continuous||mmol/L|Mean|1.76|1.76|Standard Deviation|1.00|1.0|||
3839496|NCT01686451|3665041|B3|||Fasting blood glucose, Continuous||mmol/L|Mean|5.20|5.2|Standard Deviation|0.45|0.45|||
3839497|NCT01686451|3665042|B2|||Fasting blood glucose, Continuous||mmol/L|Mean|5.33|5.33|Standard Deviation|0.52|0.52|||
3839498|NCT01686451|3665043|B1|||Fasting blood glucose, Continuous||mmol/L|Mean|5.10|5.1|Standard Deviation|0.36|0.36|||
3839499|NCT01686451|3665041|B3|Diastolic blood pressure||Arterial blood pressure, Continuous||mmHg|Mean|83.65|83.65|Standard Deviation|7.80|7.8|||
3839500|NCT01686451|3665042|B2|Diastolic blood pressure||Arterial blood pressure, Continuous||mmHg|Mean|83.00|83.0|Standard Deviation|8.82|8.82|||
3839501|NCT01686451|3665043|B1|Diastolic blood pressure||Arterial blood pressure, Continuous||mmHg|Mean|84.18|84.18|Standard Deviation|6.95|6.95|||
3839502|NCT01686451|3665041|B3|Systolic blood pressure||Arterial blood pressure, Continuous||mmHg|Mean|147.98|147.98|Standard Deviation|17.71|17.71|||
3839503|NCT01686451|3665042|B2|Systolic blood pressure||Arterial blood pressure, Continuous||mmHg|Mean|147.89|147.89|Standard Deviation|17.03|17.03|||
3839504|NCT01686451|3665043|B1|Systolic blood pressure||Arterial blood pressure, Continuous||mmHg|Mean|148.06|148.06|Standard Deviation|18.51|18.51|||
3839505|NCT01686451|3665041|B3|Not Arterial hypertension||Arterial hypertension, Categorical||participants|Number|18|18.0||||||
3839506|NCT01686451|3665042|B2|Not Arterial hypertension||Arterial hypertension, Categorical||participants|Number|11|11.0||||||
3839507|NCT01686451|3665043|B1|Not Arterial hypertension||Arterial hypertension, Categorical||participants|Number|7|7.0||||||
3839508|NCT01686451|3665041|B3|Arterial hypertension||Arterial hypertension, Categorical||participants|Number|42|42.0||||||
3839509|NCT01686451|3665042|B2|Arterial hypertension||Arterial hypertension, Categorical||participants|Number|16|16.0||||||
3839510|NCT01686451|3665043|B1|Arterial hypertension||Arterial hypertension, Categorical||participants|Number|26|26.0||||||
3839511|NCT01686451|3665041|B3|Not Current cigarette smoker||Current cigarette smoker, Categorical||participants|Number|55|55.0||||||
3839512|NCT01686451|3665042|B2|Not Current cigarette smoker||Current cigarette smoker, Categorical||participants|Number|25|25.0||||||
3839513|NCT01686451|3665043|B1|Not Current cigarette smoker||Current cigarette smoker, Categorical||participants|Number|30|30.0||||||
3839514|NCT01686451|3665041|B3|Current cigarette smoker||Current cigarette smoker, Categorical||participants|Number|5|5.0||||||
3839515|NCT01686451|3665042|B2|Current cigarette smoker||Current cigarette smoker, Categorical||participants|Number|2|2.0||||||
3839516|NCT01686451|3665043|B1|Current cigarette smoker||Current cigarette smoker, Categorical||participants|Number|3|3.0||||||
3839517|NCT01686451|3665041|B3|China||Region of Enrollment||participants|Number|60|60.0||||||
3839520|NCT01686451|3665041|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3839521|NCT01686451|3665042|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3839522|NCT01686451|3665043|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3839523|NCT01686451|3665041|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3839524|NCT01686451|3665042|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3839525|NCT01686451|3665043|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3839526|NCT01686451|3665041|B3|||Age||years|Mean|46.57|46.57|Standard Deviation|6.46|6.46|||
3839527|NCT01686451|3665042|B2|||Age||years|Mean|47.04|47.04|Standard Deviation|5.83|5.83|||
3839528|NCT01686451|3665043|B1|||Age||years|Mean|46.18|46.18|Standard Deviation|7.00|7.0|||
3839529|NCT01686451|3665041|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3839530|NCT01686451|3665042|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3839531|NCT01686451|3665043|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3839532|NCT01686451|3665041|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3839533|NCT01686451|3665042|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3839534|NCT01686451|3665043|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3839535|NCT01686451|3665041|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3839536|NCT01686451|3665042|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3839537|NCT01686451|3665043|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3839538|NCT01686165|3665072|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3839539|NCT01686165|3665072|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839540|NCT01686165|3665072|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839541|NCT01686165|3665072|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3839542|NCT01686165|3665072|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839543|NCT01686165|3665072|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839544|NCT01686165|3665072|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839545|NCT01686165|3665072|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839546|NCT01686165|3665072|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3839547|NCT01686165|3665072|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3839548|NCT01686165|3665072|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3839549|NCT01686165|3665072|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3839550|NCT01686165|3665072|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3839551|NCT01685996|3665079|B3|United States||Region of Enrollment||participants|Number|74|74.0||||||
3839552|NCT01685996|3665080|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
3839553|NCT01685996|3665081|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
3839554|NCT01685996|3665079|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839555|NCT01685996|3665080|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839556|NCT01685996|3665081|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839557|NCT01685996|3665079|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839558|NCT01685996|3665080|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839559|NCT01685996|3665081|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839560|NCT01685996|3665079|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3839561|NCT01685996|3665080|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3839562|NCT01685996|3665081|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3839563|NCT01685996|3665079|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3839564|NCT01685996|3665080|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3839565|NCT01685996|3665081|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3839566|NCT01685996|3665079|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839567|NCT01685996|3665080|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839568|NCT01685996|3665081|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839569|NCT01685996|3665079|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839570|NCT01685996|3665080|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839571|NCT01685996|3665081|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839572|NCT01685996|3665079|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839573|NCT01685996|3665080|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839574|NCT01685996|3665081|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839575|NCT01685996|3665079|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839576|NCT01685996|3665080|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839577|NCT01685996|3665081|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839578|NCT01685996|3665079|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3839579|NCT01685996|3665080|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3839580|NCT01685996|3665081|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3839581|NCT01685996|3665079|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3839582|NCT01685996|3665080|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3839583|NCT01685996|3665081|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839584|NCT01685996|3665079|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3839585|NCT01685996|3665080|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3839586|NCT01685996|3665081|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3839587|NCT01685996|3665079|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3839588|NCT01685996|3665080|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3839589|NCT01685996|3665081|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3839590|NCT01685996|3665079|B3|||Age||years|Mean|45.6|45.6|Standard Deviation|9.8|9.8|||
3839591|NCT01685996|3665080|B2|||Age||years|Mean|45.9|45.9|Standard Deviation|9.7|9.7|||
3839592|NCT01685996|3665081|B1|||Age||years|Mean|45.3|45.3|Standard Deviation|9.8|9.8|||
3839593|NCT01685983|3665090|B1|Taiwan||Region of Enrollment||participants|Number|30|30.0||||||
3839594|NCT01685983|3665090|B1|Korea||Region of Enrollment||participants|Number|52|52.0||||||
3839595|NCT01685983|3665090|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3839596|NCT01685983|3665090|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3839597|NCT01685983|3665090|B1|||Age||years|Mean|71|71.0|Standard Deviation|7.35|7.35|||
3839598|NCT01685840|3665100|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3839599|NCT01685840|3665101|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3839600|NCT01685840|3665102|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3839601|NCT01685840|3665100|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3839602|NCT01685840|3665101|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3839603|NCT01685840|3665102|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3839604|NCT01685840|3665100|B3||White|Race (NIH/OMB)||Participants|Count of Participants|485|485.0||||||
3839605|NCT01685840|3665101|B2||White|Race (NIH/OMB)||Participants|Count of Participants|228|228.0||||||
3839606|NCT01685840|3665102|B1||White|Race (NIH/OMB)||Participants|Count of Participants|257|257.0||||||
3839607|NCT01685840|3665100|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|322|322.0||||||
3839608|NCT01685840|3665101|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
3839609|NCT01685840|3665102|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|155|155.0||||||
3839610|NCT01685840|3665100|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3839611|NCT01685840|3665101|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3839612|NCT01685840|3665102|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3839613|NCT01685840|3665100|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3839614|NCT01685840|3665101|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3839615|NCT01685840|3665102|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3839616|NCT01685840|3665100|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3839617|NCT01685840|3665101|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3839618|NCT01685840|3665102|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3839619|NCT01685840|3665100|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839620|NCT01685840|3665101|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839621|NCT01685840|3665102|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839622|NCT01685840|3665100|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|836|836.0||||||
3839623|NCT01685840|3665101|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|416|416.0||||||
3839624|NCT01685840|3665102|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|420|420.0||||||
3839625|NCT01685840|3665100|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3839626|NCT01685840|3665101|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3839627|NCT01685840|3665102|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3839628|NCT01685840|3665100|B3||Male|Sex: Female, Male||Participants|Count of Participants|608|608.0||||||
3839629|NCT01685840|3665101|B2||Male|Sex: Female, Male||Participants|Count of Participants|307|307.0||||||
3839630|NCT01685840|3665102|B1||Male|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
3839631|NCT01685840|3665100|B3||Female|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
3839632|NCT01685840|3665101|B2||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3839633|NCT01685840|3665102|B1||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3839634|NCT01685840|3665100|B3|||Age||years|Mean|61.5|61.5|Standard Deviation|13.9|13.9|||
3839635|NCT01685840|3665101|B2|||Age||years|Mean|60.4|60.4|Standard Deviation|14.3|14.3|||
3839636|NCT01685840|3665102|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|13.4|13.4|||
3839637|NCT01685801|3665143|B5|Residual Function Mutations||Genotype|All participants were tested for cystic fibrosis transmembrane conductance regulator (CFTR) genotype. Participants with a documented medical history of either a residual function or a messenger ribonucleic acid (mRNA) splice site (Class V) CFTR mutation were reported.|participants|Number|14|14.0||||||
3839638|NCT01685801|3665144|B4|Residual Function Mutations||Genotype|All participants were tested for cystic fibrosis transmembrane conductance regulator (CFTR) genotype. Participants with a documented medical history of either a residual function or a messenger ribonucleic acid (mRNA) splice site (Class V) CFTR mutation were reported.|participants|Number|4|4.0||||||
3839639|NCT01685801|3665145|B3|Residual Function Mutations||Genotype|All participants were tested for cystic fibrosis transmembrane conductance regulator (CFTR) genotype. Participants with a documented medical history of either a residual function or a messenger ribonucleic acid (mRNA) splice site (Class V) CFTR mutation were reported.|participants|Number|5|5.0||||||
3839640|NCT01685801|3665146|B2|Residual Function Mutations||Genotype|All participants were tested for cystic fibrosis transmembrane conductance regulator (CFTR) genotype. Participants with a documented medical history of either a residual function or a messenger ribonucleic acid (mRNA) splice site (Class V) CFTR mutation were reported.|participants|Number|3|3.0||||||
3839641|NCT01685801|3665147|B1|Residual Function Mutations||Genotype|All participants were tested for cystic fibrosis transmembrane conductance regulator (CFTR) genotype. Participants with a documented medical history of either a residual function or a messenger ribonucleic acid (mRNA) splice site (Class V) CFTR mutation were reported.|participants|Number|2|2.0||||||
3839642|NCT01685801|3665143|B5|mRNA Splice Site (Class V) Mutations||Genotype|All participants were tested for cystic fibrosis transmembrane conductance regulator (CFTR) genotype. Participants with a documented medical history of either a residual function or a messenger ribonucleic acid (mRNA) splice site (Class V) CFTR mutation were reported.|participants|Number|10|10.0||||||
3839643|NCT01685801|3665144|B4|mRNA Splice Site (Class V) Mutations||Genotype|All participants were tested for cystic fibrosis transmembrane conductance regulator (CFTR) genotype. Participants with a documented medical history of either a residual function or a messenger ribonucleic acid (mRNA) splice site (Class V) CFTR mutation were reported.|participants|Number|2|2.0||||||
3839644|NCT01685801|3665145|B3|mRNA Splice Site (Class V) Mutations||Genotype|All participants were tested for cystic fibrosis transmembrane conductance regulator (CFTR) genotype. Participants with a documented medical history of either a residual function or a messenger ribonucleic acid (mRNA) splice site (Class V) CFTR mutation were reported.|participants|Number|2|2.0||||||
3839645|NCT01685801|3665146|B2|mRNA Splice Site (Class V) Mutations||Genotype|All participants were tested for cystic fibrosis transmembrane conductance regulator (CFTR) genotype. Participants with a documented medical history of either a residual function or a messenger ribonucleic acid (mRNA) splice site (Class V) CFTR mutation were reported.|participants|Number|3|3.0||||||
3839646|NCT01685801|3665147|B1|mRNA Splice Site (Class V) Mutations||Genotype|All participants were tested for cystic fibrosis transmembrane conductance regulator (CFTR) genotype. Participants with a documented medical history of either a residual function or a messenger ribonucleic acid (mRNA) splice site (Class V) CFTR mutation were reported.|participants|Number|3|3.0||||||
3839647|NCT01685801|3665143|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3839648|NCT01685801|3665144|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3839649|NCT01685801|3665145|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3839650|NCT01685801|3665146|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3839651|NCT01685801|3665147|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3839652|NCT01685801|3665143|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3839653|NCT01685801|3665144|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3839654|NCT01685801|3665145|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3839655|NCT01685801|3665146|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3839656|NCT01685801|3665147|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3839657|NCT01685801|3665143|B5|greater than (>) 40 years||Age, Customized||participants|Number|11|11.0||||||
3839658|NCT01685801|3665144|B4|greater than (>) 40 years||Age, Customized||participants|Number|2|2.0||||||
3839659|NCT01685801|3665145|B3|greater than (>) 40 years||Age, Customized||participants|Number|4|4.0||||||
3839660|NCT01685801|3665146|B2|greater than (>) 40 years||Age, Customized||participants|Number|1|1.0||||||
3839661|NCT01685801|3665147|B1|greater than (>) 40 years||Age, Customized||participants|Number|4|4.0||||||
3839662|NCT01685801|3665143|B5|20 - 40 years||Age, Customized||participants|Number|10|10.0||||||
3839663|NCT01685801|3665144|B4|20 - 40 years||Age, Customized||participants|Number|2|2.0||||||
3839664|NCT01685801|3665145|B3|20 - 40 years||Age, Customized||participants|Number|3|3.0||||||
3839665|NCT01685801|3665146|B2|20 - 40 years||Age, Customized||participants|Number|4|4.0||||||
3839666|NCT01685801|3665147|B1|20 - 40 years||Age, Customized||participants|Number|1|1.0||||||
3839667|NCT01685801|3665143|B5|less than (<) 20 years||Age, Customized||participants|Number|3|3.0||||||
3839668|NCT01685801|3665144|B4|less than (<) 20 years||Age, Customized||participants|Number|2|2.0||||||
3839669|NCT01685801|3665145|B3|less than (<) 20 years||Age, Customized||participants|Number|0|0.0||||||
3839670|NCT01685801|3665146|B2|less than (<) 20 years||Age, Customized||participants|Number|1|1.0||||||
3839671|NCT01685801|3665147|B1|less than (<) 20 years||Age, Customized||participants|Number|0|0.0||||||
3839672|NCT01685801|3665143|B5|||Age||years|Mean|37.3|37.3|Standard Deviation|13.86|13.86|||
3839673|NCT01685801|3665144|B4|||Age||years|Mean|33.8|33.8|Standard Deviation|17.26|17.26|||
3839674|NCT01685801|3665145|B3|||Age||years|Mean|41.4|41.4|Standard Deviation|13.96|13.96|||
3839675|NCT01685801|3665146|B2|||Age||years|Mean|29.7|29.7|Standard Deviation|11.66|11.66|||
3839676|NCT01685801|3665147|B1|||Age||years|Mean|44.8|44.8|Standard Deviation|8.04|8.04|||
3839677|NCT01685697|3665170|B3|Canada||Region of Enrollment||participants|Number|56|56.0||||||
3839678|NCT01685697|3665171|B2|Canada||Region of Enrollment||participants|Number|28|28.0||||||
3839679|NCT01685697|3665172|B1|Canada||Region of Enrollment||participants|Number|28|28.0||||||
3839680|NCT01685697|3665170|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3839681|NCT01685697|3665171|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3839682|NCT01685697|3665172|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3839683|NCT01685697|3665170|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3839684|NCT01685697|3665171|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3839685|NCT01685697|3665172|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3839686|NCT01685697|3665170|B3|Gestational age in weeks||Age||weeks|Mean|28|28.0|Standard Deviation|2|2.0|||
3839687|NCT01685697|3665171|B2|Gestational age in weeks||Age||weeks|Mean|28|28.0|Standard Deviation|3|3.0|||
3839688|NCT01685697|3665172|B1|Gestational age in weeks||Age||weeks|Mean|28|28.0|Standard Deviation|2|2.0|||
3839689|NCT01685697|3665170|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3839690|NCT01685697|3665171|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3839691|NCT01685697|3665172|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3839692|NCT01685697|3665170|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3839693|NCT01685697|3665171|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3839694|NCT01685697|3665172|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3839695|NCT01685697|3665170|B3||<=18 years|Age||Participants|Count of Participants|56|56.0||||||
3839696|NCT01685697|3665171|B2||<=18 years|Age||Participants|Count of Participants|28|28.0||||||
3839697|NCT01685697|3665172|B1||<=18 years|Age||Participants|Count of Participants|28|28.0||||||
3839698|NCT01685684|3665179|B3|||Pain Intensity-Numeric Rating Scale (PI-NRS)|The PI-NRS is an 11-point numerical rating scale ranging from 0 (no pain) to 10 (worst possible pain).|units on a scale|Mean|2.9|2.9|Standard Deviation|1.00|1.0|||
3839699|NCT01685684|3665180|B2|||Pain Intensity-Numeric Rating Scale (PI-NRS)|The PI-NRS is an 11-point numerical rating scale ranging from 0 (no pain) to 10 (worst possible pain).|units on a scale|Mean|2.9|2.9|Standard Deviation|0.97|0.97|||
3839700|NCT01685684|3665181|B1|||Pain Intensity-Numeric Rating Scale (PI-NRS)|The PI-NRS is an 11-point numerical rating scale ranging from 0 (no pain) to 10 (worst possible pain).|units on a scale|Mean|3.0|3.0|Standard Deviation|1.04|1.04|||
3839701|NCT01685684|3665179|B3||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3839702|NCT01685684|3665180|B2||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3839703|NCT01685684|3665181|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3839704|NCT01685684|3665179|B3||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
3839705|NCT01685684|3665180|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3839706|NCT01685684|3665181|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3839707|NCT01685684|3665179|B3|||Age||years|Mean|49.5|49.5|Standard Deviation|12.93|12.93|||
3839708|NCT01685684|3665180|B2|||Age||years|Mean|49.9|49.9|Standard Deviation|12.56|12.56|||
3839709|NCT01685684|3665181|B1|||Age||years|Mean|49.2|49.2|Standard Deviation|13.31|13.31|||
3839710|NCT01685606|3665207|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3839711|NCT01685606|3665207|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3839712|NCT01685606|3665207|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3839713|NCT01685606|3665207|B1|||Age||years|Mean|66.2|66.2|Full Range|||52.0|77.0|
3839714|NCT01685606|3665207|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3839715|NCT01685606|3665207|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3839716|NCT01685606|3665207|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3839717|NCT01685567|3665212|B1||Symptomatic|Symptomatic Status||Participants|Count of Participants|44|44.0||||||
3839718|NCT01685567|3665212|B1||Asymptomatic|Symptomatic Status||Participants|Count of Participants|175|175.0||||||
3839719|NCT01685567|3665212|B1||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3839720|NCT01685567|3665212|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3839721|NCT01685567|3665212|B1|||Age||years|Mean|72.30|72.3|Standard Deviation|8.574|8.574|||
3839722|NCT01685463|3665220|B3|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3839723|NCT01685463|3665221|B2|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3839724|NCT01685463|3665222|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3839725|NCT01685463|3665220|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839726|NCT01685463|3665221|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839727|NCT01685463|3665222|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839728|NCT01685463|3665220|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839729|NCT01685463|3665221|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839730|NCT01685463|3665222|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839731|NCT01685463|3665220|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3839732|NCT01685463|3665221|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3839733|NCT01685463|3665222|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3839734|NCT01685463|3665220|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839735|NCT01685463|3665221|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839736|NCT01685463|3665222|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839737|NCT01685463|3665220|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839738|NCT01685463|3665221|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839739|NCT01685463|3665222|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839740|NCT01685463|3665220|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839741|NCT01685463|3665221|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839742|NCT01685463|3665222|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839743|NCT01685463|3665220|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839744|NCT01685463|3665221|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839745|NCT01685463|3665222|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839746|NCT01685463|3665220|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3839747|NCT01685463|3665221|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3839748|NCT01685463|3665222|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3839749|NCT01685463|3665220|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3839750|NCT01685463|3665221|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3839751|NCT01685463|3665222|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3839752|NCT01685463|3665220|B3|||Age||years|Mean|33.7|33.7|Standard Deviation|11.2|11.2|||
3839753|NCT01685463|3665221|B2|||Age||years|Mean|32.5|32.5|Standard Deviation|14.4|14.4|||
3839754|NCT01685463|3665222|B1|||Age||years|Mean|34.7|34.7|Standard Deviation|10.6|10.6|||
3839755|NCT01685463|3665220|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3839756|NCT01685463|3665221|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3839757|NCT01685463|3665222|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3839758|NCT01685463|3665220|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3839759|NCT01685463|3665221|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3839760|NCT01685463|3665222|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3839761|NCT01685463|3665220|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3839762|NCT01685463|3665221|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3839763|NCT01685463|3665222|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3839764|NCT01685437|3665235|B1|Australia||Region of Enrollment||participants|Number|27|27.0||||||
3839765|NCT01685437|3665235|B1|United States||Region of Enrollment||participants|Number|162|162.0||||||
3839766|NCT01685437|3665235|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3839767|NCT01685437|3665235|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839768|NCT01685437|3665235|B1||White|Race (NIH/OMB)||Participants|Count of Participants|186|186.0||||||
3839769|NCT01685437|3665235|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3839770|NCT01685437|3665235|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3839771|NCT01685437|3665235|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839772|NCT01685437|3665235|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839773|NCT01685437|3665235|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839774|NCT01685437|3665235|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|184|184.0||||||
3839775|NCT01685437|3665235|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3839776|NCT01685437|3665235|B1||Male|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
3839777|NCT01685437|3665235|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3839778|NCT01685437|3665235|B1|||Age||years|Mean|60.2|60.2|Standard Deviation|7.32|7.32|||
3839779|NCT01685437|3665235|B1||>=65 years|Age||Participants|Count of Participants|55|55.0||||||
3839780|NCT01685437|3665235|B1||Between 18 and 65 years|Age||Participants|Count of Participants|134|134.0||||||
3839781|NCT01685437|3665235|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3839782|NCT01685372|3665247|B3|Rheumatoloty||Cohort||Participants|Count of Participants|1|1.0||||||
3839783|NCT01685372|3665248|B2|Rheumatoloty||Cohort||Participants|Count of Participants|1|1.0||||||
3839784|NCT01685372|3665249|B1|Rheumatoloty||Cohort||Participants|Count of Participants|0|0.0||||||
3839785|NCT01685372|3665247|B3|Solid organ transplant||Cohort||Participants|Count of Participants|8|8.0||||||
3839786|NCT01685372|3665248|B2|Solid organ transplant||Cohort||Participants|Count of Participants|4|4.0||||||
3839787|NCT01685372|3665249|B1|Solid organ transplant||Cohort||Participants|Count of Participants|4|4.0||||||
3839788|NCT01685372|3665247|B3|Dialysis||Cohort||Participants|Count of Participants|7|7.0||||||
3839789|NCT01685372|3665248|B2|Dialysis||Cohort||Participants|Count of Participants|4|4.0||||||
3839790|NCT01685372|3665249|B1|Dialysis||Cohort||Participants|Count of Participants|3|3.0||||||
3839791|NCT01685372|3665247|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839792|NCT01685372|3665248|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839793|NCT01685372|3665249|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839794|NCT01685372|3665247|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3839795|NCT01685372|3665248|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839796|NCT01685372|3665249|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3839797|NCT01685372|3665247|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3839798|NCT01685372|3665248|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3839799|NCT01685372|3665249|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3839800|NCT01685372|3665247|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839801|NCT01685372|3665248|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839802|NCT01685372|3665249|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839803|NCT01685372|3665247|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839804|NCT01685372|3665248|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839805|NCT01685372|3665249|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839806|NCT01685372|3665247|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3839807|NCT01685372|3665248|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3839808|NCT01685372|3665249|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839809|NCT01685372|3665247|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839810|NCT01685372|3665248|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839811|NCT01685372|3665249|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839812|NCT01685372|3665247|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839813|NCT01685372|3665248|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839814|NCT01685372|3665249|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839815|NCT01685372|3665247|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3839816|NCT01685372|3665248|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3839817|NCT01685372|3665249|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3839818|NCT01685372|3665247|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3839819|NCT01685372|3665248|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3839820|NCT01685372|3665249|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3839821|NCT01685372|3665247|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3839822|NCT01685372|3665248|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3839823|NCT01685372|3665249|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3839824|NCT01685372|3665247|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3839825|NCT01685372|3665248|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3839826|NCT01685372|3665249|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3839827|NCT01685372|3665247|B3|||Age||years|Median|15|15.0|Full Range|||9.0|23.0|
3839828|NCT01685372|3665248|B2|||Age||years|Median|15|15.0|Full Range|||10.0|23.0|
3839829|NCT01685372|3665249|B1|||Age||years|Median|15|15.0|Full Range|||9.0|18.0|
3839830|NCT01685320|3665270|B3|Italy||Region of Enrollment||participants|Number|30|30.0||||||
3839831|NCT01685320|3665271|B2|Italy||Region of Enrollment||participants|Number|15|15.0||||||
3839832|NCT01685320|3665272|B1|Italy||Region of Enrollment||participants|Number|15|15.0||||||
3839833|NCT01685320|3665270|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3839834|NCT01685320|3665271|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3839835|NCT01685320|3665272|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3839836|NCT01685320|3665270|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3839837|NCT01685320|3665271|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3839838|NCT01685320|3665272|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3839839|NCT01685320|3665270|B3|||Age||years|Mean|42.5|42.5|Standard Deviation|12|12.0|||
3839840|NCT01685320|3665271|B2|||Age||years|Mean|44|44.0|Standard Deviation|11|11.0|||
3839841|NCT01685320|3665272|B1|||Age||years|Mean|41|41.0|Standard Deviation|12|12.0|||
3839842|NCT01685320|3665270|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3839843|NCT01685320|3665271|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3839844|NCT01685320|3665272|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3839845|NCT01685320|3665270|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3839846|NCT01685320|3665271|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3839847|NCT01685320|3665272|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3839848|NCT01685320|3665270|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3839849|NCT01685320|3665271|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3839850|NCT01685320|3665272|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3839851|NCT01685242|3665281|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
3839852|NCT01685242|3665282|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
3839853|NCT01685242|3665283|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3839912|NCT01685203|3665354|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3839854|NCT01685242|3665281|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839855|NCT01685242|3665282|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839856|NCT01685242|3665283|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839857|NCT01685242|3665281|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839858|NCT01685242|3665282|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839859|NCT01685242|3665283|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839860|NCT01685242|3665281|B3||White|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
3839861|NCT01685242|3665282|B2||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3839862|NCT01685242|3665283|B1||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3839863|NCT01685242|3665281|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3839864|NCT01685242|3665282|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3839865|NCT01685242|3665283|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3839866|NCT01685242|3665281|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839867|NCT01685242|3665282|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839868|NCT01685242|3665283|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839869|NCT01685242|3665281|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3839870|NCT01685242|3665282|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3839871|NCT01685242|3665283|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3839872|NCT01685242|3665281|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3839873|NCT01685242|3665282|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839874|NCT01685242|3665283|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3839875|NCT01685242|3665281|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839876|NCT01685242|3665282|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839877|NCT01685242|3665283|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3839878|NCT01685242|3665281|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3839879|NCT01685242|3665282|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3839880|NCT01685242|3665283|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3839881|NCT01685242|3665281|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3839882|NCT01685242|3665282|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3839883|NCT01685242|3665283|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3839884|NCT01685242|3665281|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3839885|NCT01685242|3665282|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3839886|NCT01685242|3665283|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3839887|NCT01685242|3665281|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3839888|NCT01685242|3665282|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3839889|NCT01685242|3665283|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3839890|NCT01685242|3665281|B3|||Age||years|Mean|38.8|38.8|Standard Deviation|15.93|15.93|||
3839891|NCT01685242|3665282|B2|||Age||years|Mean|38.1|38.1|Standard Deviation|14.56|14.56|||
3839892|NCT01685242|3665283|B1|||Age||years|Mean|39.5|39.5|Standard Deviation|17.32|17.32|||
3839893|NCT01685216|3665338|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3839894|NCT01685216|3665338|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3839895|NCT01685216|3665338|B1|5 to 17 years||Age, Customized||participants|Number|2|2.0||||||
3839896|NCT01685216|3665338|B1|2 to 4 years||Age, Customized||participants|Number|4|4.0||||||
3839897|NCT01685216|3665338|B1|||Age||years|Mean|5.17|5.17|Standard Deviation|4.446|4.446|||
3839898|NCT01685203|3665348|B8||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3839899|NCT01685203|3665349|B7||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3839900|NCT01685203|3665350|B6||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3839901|NCT01685203|3665351|B5||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3839902|NCT01685203|3665352|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3839903|NCT01685203|3665353|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3839904|NCT01685203|3665354|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3839905|NCT01685203|3665355|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3839906|NCT01685203|3665348|B8||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3839907|NCT01685203|3665349|B7||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3839908|NCT01685203|3665350|B6||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3839909|NCT01685203|3665351|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3839910|NCT01685203|3665352|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3839911|NCT01685203|3665353|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3839913|NCT01685203|3665355|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3839914|NCT01685203|3665348|B8|||Age||years|Mean|52.8|52.8|Standard Deviation|10.1|10.1|||
3839915|NCT01685203|3665349|B7|||Age||years|Mean|57.1|57.1|Standard Deviation|6.0|6.0|||
3839916|NCT01685203|3665350|B6|||Age||years|Mean|57.8|57.8|Standard Deviation|7.1|7.1|||
3839917|NCT01685203|3665351|B5|||Age||years|Mean|50.9|50.9|Standard Deviation|10.1|10.1|||
3839918|NCT01685203|3665352|B4|||Age||years|Mean|44.2|44.2|Standard Deviation|12.7|12.7|||
3839919|NCT01685203|3665353|B3|||Age||years|Mean|54.2|54.2|Standard Deviation|9.6|9.6|||
3839920|NCT01685203|3665354|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|6.9|6.9|||
3839921|NCT01685203|3665355|B1|||Age||years|Mean|48.9|48.9|Standard Deviation|10.0|10.0|||
3839922|NCT01685060|3665405|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3839923|NCT01685060|3665405|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3839924|NCT01685060|3665405|B1|||Age||Years|Mean|51.2|51.2|Standard Deviation|11.62|11.62|||
3839925|NCT01685021|3665420|B1|||Body Mass Index||kg/m2|Mean|29|29.0|Standard Deviation|8.496|8.496|||
3839926|NCT01685021|3665420|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3839927|NCT01685021|3665420|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3839928|NCT01685021|3665420|B1|||Age||years|Mean|46.82|46.82|Standard Deviation|17.098|17.098|||
3839929|NCT01684930|3665429|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3839930|NCT01684930|3665430|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3839931|NCT01684930|3665431|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3839932|NCT01684930|3665429|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3839933|NCT01684930|3665430|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3839934|NCT01684930|3665431|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3839935|NCT01684930|3665429|B3|||Age||years|Mean|67.88|67.88|Standard Deviation|9.3|9.3|||
3839936|NCT01684930|3665430|B2|||Age||years|Mean|71.85|71.85|Standard Deviation|7.9|7.9|||
3839937|NCT01684930|3665431|B1|||Age||years|Mean|63.25|63.25|Standard Deviation|8.9|8.9|||
3839938|NCT01684878|3665448|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3839939|NCT01684878|3665449|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3839940|NCT01684878|3665450|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3839941|NCT01684878|3665451|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3839942|NCT01684878|3665452|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3839943|NCT01684878|3665448|B5||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
3839944|NCT01684878|3665449|B4||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3839945|NCT01684878|3665450|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3839946|NCT01684878|3665451|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3839947|NCT01684878|3665452|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3839948|NCT01684878|3665448|B5|Greater than (>)65 years||Age, Customized||participants|Number|90|90.0||||||
3839949|NCT01684878|3665449|B4|Greater than (>)65 years||Age, Customized||participants|Number|34|34.0||||||
3839950|NCT01684878|3665450|B3|Greater than (>)65 years||Age, Customized||participants|Number|38|38.0||||||
3839951|NCT01684878|3665451|B2|Greater than (>)65 years||Age, Customized||participants|Number|11|11.0||||||
3839952|NCT01684878|3665452|B1|Greater than (>)65 years||Age, Customized||participants|Number|7|7.0||||||
3839953|NCT01684878|3665448|B5|Less than or equal to (≤)65 years||Age, Customized||participants|Number|116|116.0||||||
3839954|NCT01684878|3665449|B4|Less than or equal to (≤)65 years||Age, Customized||participants|Number|44|44.0||||||
3839955|NCT01684878|3665450|B3|Less than or equal to (≤)65 years||Age, Customized||participants|Number|40|40.0||||||
3839956|NCT01684878|3665451|B2|Less than or equal to (≤)65 years||Age, Customized||participants|Number|17|17.0||||||
3839957|NCT01684878|3665452|B1|Less than or equal to (≤)65 years||Age, Customized||participants|Number|15|15.0||||||
3839958|NCT01684839|3665479|B1|China||Region of Enrollment||participants|Number|9|9.0||||||
3839959|NCT01684839|3665479|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3839960|NCT01684839|3665479|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3839961|NCT01684839|3665479|B1|||Age||years|Mean|31.4|31.4|Standard Deviation|7.3|7.3|||
3839962|NCT01684839|3665479|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3839963|NCT01684839|3665479|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3839964|NCT01684839|3665479|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3839965|NCT01684826|3665483|B1|Netherlands||Region of Enrollment||participants|Number|49|49.0||||||
3839966|NCT01684826|3665483|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3839967|NCT01684826|3665483|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3839968|NCT01684826|3665483|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|11|11.0|||
3839969|NCT01684748|3665489|B3|||Glucose||mg/dL|Mean|97.4|97.4|Standard Deviation|12.0|12.0|||
3839970|NCT01684748|3665490|B2|||Glucose||mg/dL|Mean|99.1|99.1|Standard Deviation|13.8|13.8|||
3839971|NCT01684748|3665491|B1|||Glucose||mg/dL|Mean|95.8|95.8|Standard Deviation|10.8|10.8|||
3839972|NCT01684748|3665489|B3|||LDL cholesterol||mg/dL|Mean|130.6|130.6|Standard Deviation|31.2|31.2|||
3839973|NCT01684748|3665490|B2|||LDL cholesterol||mg/dL|Mean|131.3|131.3|Standard Deviation|22.4|22.4|||
3839974|NCT01684748|3665491|B1|||LDL cholesterol||mg/dL|Mean|129.9|129.9|Standard Deviation|34.9|34.9|||
3839975|NCT01684748|3665489|B3|||HDL cholesterol||mg/dL|Mean|50.3|50.3|Standard Deviation|21.5|21.5|||
3839976|NCT01684748|3665490|B2|||HDL cholesterol||mg/dL|Mean|55.1|55.1|Standard Deviation|29.0|29.0|||
3839977|NCT01684748|3665491|B1|||HDL cholesterol||mg/dL|Mean|45.5|45.5|Standard Deviation|9.8|9.8|||
3839978|NCT01684748|3665489|B3|||Total cholesterol||mg/dL|Mean|203.7|203.7|Standard Deviation|30.1|30.1|||
3839979|NCT01684748|3665490|B2|||Total cholesterol||mg/dL|Mean|207.8|207.8|Standard Deviation|20.9|20.9|||
3839980|NCT01684748|3665491|B1|||Total cholesterol||mg/dL|Mean|199.5|199.5|Standard Deviation|38.2|38.2|||
3839981|NCT01684748|3665489|B3|||Triglycerides||mg/dL|Mean|113.7|113.7|Standard Deviation|53.6|53.6|||
3839982|NCT01684748|3665490|B2|||Triglycerides||mg/dL|Mean|106.8|106.8|Standard Deviation|50.9|50.9|||
3839983|NCT01684748|3665491|B1|||Triglycerides||mg/dL|Mean|120.6|120.6|Standard Deviation|68.5|68.5|||
3839984|NCT01684748|3665489|B3|||Diastolic blood pressure||mmHg|Mean|80.6|80.6|Standard Deviation|6.4|6.4|||
3839985|NCT01684748|3665490|B2|||Diastolic blood pressure||mmHg|Mean|80.1|80.1|Standard Deviation|7.9|7.9|||
3839986|NCT01684748|3665491|B1|||Diastolic blood pressure||mmHg|Mean|81.0|81.0|Standard Deviation|5.1|5.1|||
3839987|NCT01684748|3665489|B3|||Systolic blood pressure||mmHg|Mean|137.2|137.2|Standard Deviation|11.7|11.7|||
3839988|NCT01684748|3665490|B2|||Systolic blood pressure||mmHg|Mean|140.6|140.6|Standard Deviation|12.8|12.8|||
3839989|NCT01684748|3665491|B1|||Systolic blood pressure||mmHg|Mean|133.7|133.7|Standard Deviation|10.1|10.1|||
3839990|NCT01684748|3665489|B3|||Total fat mass||kg|Mean|38.8|38.8|Standard Deviation|15.0|15.0|||
3839991|NCT01684748|3665490|B2|||Total fat mass||kg|Mean|34.6|34.6|Standard Deviation|14.7|14.7|||
3839992|NCT01684748|3665491|B1|||Total fat mass||kg|Mean|43.1|43.1|Standard Deviation|15.1|15.1|||
3839993|NCT01684748|3665489|B3|||Body fat||Percentage of fat|Mean|41.8|41.8|Standard Deviation|12.1|12.1|||
3839994|NCT01684748|3665490|B2|||Body fat||Percentage of fat|Mean|39.8|39.8|Standard Deviation|13.5|13.5|||
3839995|NCT01684748|3665491|B1|||Body fat||Percentage of fat|Mean|43.9|43.9|Standard Deviation|10.5|10.5|||
3839996|NCT01684748|3665489|B3|||Body mass index||kg/m2|Mean|33.0|33.0|Standard Deviation|6.9|6.9|||
3839997|NCT01684748|3665490|B2|||Body mass index||kg/m2|Mean|31.5|31.5|Standard Deviation|6.8|6.8|||
3839998|NCT01684748|3665491|B1|||Body mass index||kg/m2|Mean|34.5|34.5|Standard Deviation|7.0|7.0|||
3839999|NCT01684748|3665489|B3|||Body weight||kg|Mean|96.3|96.3|Standard Deviation|19.7|19.7|||
3840000|NCT01684748|3665490|B2|||Body weight||kg|Mean|90.4|90.4|Standard Deviation|17.7|17.7|||
3840001|NCT01684748|3665491|B1|||Body weight||kg|Mean|102.3|102.3|Standard Deviation|20.9|20.9|||
3840002|NCT01684748|3665489|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
3840003|NCT01684748|3665490|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3840004|NCT01684748|3665491|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3840005|NCT01684748|3665489|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3840006|NCT01684748|3665490|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3840007|NCT01684748|3665491|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3840008|NCT01684748|3665489|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3840009|NCT01684748|3665490|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3840010|NCT01684748|3665491|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3840011|NCT01684748|3665489|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3840012|NCT01684748|3665490|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3840013|NCT01684748|3665491|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3840014|NCT01684748|3665489|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3840015|NCT01684748|3665490|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3840016|NCT01684748|3665491|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3840017|NCT01684748|3665489|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3840018|NCT01684748|3665490|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3840019|NCT01684748|3665491|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3840020|NCT01684748|3665489|B3|||Age||years|Mean|49.5|49.5|Standard Deviation|11.8|11.8|||
3840021|NCT01684748|3665490|B2|||Age||years|Mean|49.75|49.75|Standard Deviation|14.2|14.2|||
3840022|NCT01684748|3665491|B1|||Age||years|Mean|49.25|49.25|Standard Deviation|9.8|9.8|||
3840023|NCT01684592|3665499|B3|United States||Region of Enrollment||participants|Number|128|128.0||||||
3840024|NCT01684592|3665500|B2|United States||Region of Enrollment||participants|Number|64|64.0||||||
3840025|NCT01684592|3665501|B1|United States||Region of Enrollment||participants|Number|64|64.0||||||
3840026|NCT01684592|3665499|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840027|NCT01684592|3665500|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840028|NCT01684592|3665501|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840029|NCT01684592|3665499|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3840030|NCT01684592|3665500|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3840031|NCT01684592|3665501|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3840032|NCT01684592|3665499|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3840033|NCT01684592|3665500|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3840034|NCT01684592|3665501|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3840035|NCT01684592|3665499|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
3840036|NCT01684592|3665500|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3840037|NCT01684592|3665501|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3840038|NCT01684592|3665499|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840039|NCT01684592|3665500|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840040|NCT01684592|3665501|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840041|NCT01684592|3665499|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840042|NCT01684592|3665500|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840043|NCT01684592|3665501|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840044|NCT01684592|3665499|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840045|NCT01684592|3665500|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840046|NCT01684592|3665501|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840047|NCT01684592|3665499|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3840048|NCT01684592|3665500|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3840049|NCT01684592|3665501|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3840050|NCT01684592|3665499|B3||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3840051|NCT01684592|3665500|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3840052|NCT01684592|3665501|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3840053|NCT01684592|3665499|B3|||Age||years|Mean|26.0|26.0|Standard Deviation|5.0|5.0|||
3840054|NCT01684592|3665500|B2|||Age||years|Mean|26.3|26.3|Standard Deviation|5.3|5.3|||
3840055|NCT01684592|3665501|B1|||Age||years|Mean|25.6|25.6|Standard Deviation|4.7|4.7|||
3840056|NCT01684566|3665520|B3|Germany||Region of Enrollment||participants|Number|17|17.0||||||
3840057|NCT01684566|3665521|B2|Germany||Region of Enrollment||participants|Number|7|7.0||||||
3840058|NCT01684566|3665522|B1|Germany||Region of Enrollment||participants|Number|10|10.0||||||
3840059|NCT01684566|3665520|B3|Poland||Region of Enrollment||participants|Number|26|26.0||||||
3840060|NCT01684566|3665521|B2|Poland||Region of Enrollment||participants|Number|13|13.0||||||
3840061|NCT01684566|3665522|B1|Poland||Region of Enrollment||participants|Number|13|13.0||||||
3840062|NCT01684566|3665520|B3|Israel||Region of Enrollment||participants|Number|46|46.0||||||
3840063|NCT01684566|3665521|B2|Israel||Region of Enrollment||participants|Number|23|23.0||||||
3840064|NCT01684566|3665522|B1|Israel||Region of Enrollment||participants|Number|23|23.0||||||
3840065|NCT01684566|3665520|B3|Sweden||Region of Enrollment||participants|Number|20|20.0||||||
3840066|NCT01684566|3665521|B2|Sweden||Region of Enrollment||participants|Number|9|9.0||||||
3840067|NCT01684566|3665522|B1|Sweden||Region of Enrollment||participants|Number|11|11.0||||||
3840068|NCT01684566|3665520|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3840069|NCT01684566|3665521|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3840070|NCT01684566|3665522|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840071|NCT01684566|3665520|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840072|NCT01684566|3665521|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840073|NCT01684566|3665522|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840074|NCT01684566|3665520|B3||White|Race (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
3840075|NCT01684566|3665521|B2||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3840076|NCT01684566|3665522|B1||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3840077|NCT01684566|3665520|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840078|NCT01684566|3665521|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840079|NCT01684566|3665522|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840080|NCT01684566|3665520|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840081|NCT01684566|3665521|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840082|NCT01684566|3665522|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840083|NCT01684566|3665520|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3840084|NCT01684566|3665521|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840085|NCT01684566|3665522|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3840086|NCT01684566|3665520|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840087|NCT01684566|3665521|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840088|NCT01684566|3665522|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840089|NCT01684566|3665520|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3840090|NCT01684566|3665521|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3840091|NCT01684566|3665522|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3840092|NCT01684566|3665520|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3840093|NCT01684566|3665521|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3840094|NCT01684566|3665522|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3840095|NCT01684566|3665520|B3|||Age||years|Mean|47.6|47.6|Standard Deviation|15.01|15.01|||
3840096|NCT01684566|3665521|B2|||Age||years|Mean|49.0|49.0|Standard Deviation|14.82|14.82|||
3840097|NCT01684566|3665522|B1|||Age||years|Mean|46.4|46.4|Standard Deviation|15.21|15.21|||
3840098|NCT01684436|3665545|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3840099|NCT01684436|3665545|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3840100|NCT01684436|3665545|B1|||Age||Years|Mean|49.8|49.8|Standard Deviation|14.1|14.1|||
3840101|NCT01684423|3665554|B6||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3840102|NCT01684423|3665555|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3840103|NCT01684423|3665556|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3840104|NCT01684423|3665557|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3840105|NCT01684423|3665558|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3840106|NCT01684423|3665559|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3840107|NCT01684423|3665554|B6||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3840108|NCT01684423|3665555|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3840109|NCT01684423|3665556|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3840110|NCT01684423|3665557|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3840111|NCT01684423|3665558|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3840112|NCT01684423|3665559|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3840113|NCT01684423|3665554|B6|||Age||Years|Mean|11.0|11.0|Standard Deviation|3.7|3.7|||
3840114|NCT01684423|3665555|B5|||Age||Years|Mean|9.0|9.0|Standard Deviation|2.0|2.0|||
3840115|NCT01684423|3665556|B4|||Age||Years|Mean|8.3|8.3|Standard Deviation|1.9|1.9|||
3840116|NCT01684423|3665557|B3|||Age||Years|Mean|8.5|8.5|Standard Deviation|2.1|2.1|||
3840117|NCT01684423|3665558|B2|||Age||Years|Mean|14.8|14.8|Standard Deviation|1.0|1.0|||
3840118|NCT01684423|3665559|B1|||Age||Years|Mean|15.5|15.5|Standard Deviation|1.2|1.2|||
3840119|NCT01684410|3665597|B4|United States||Region of Enrollment||participants|Number|30|30.0||||||
3840120|NCT01684410|3665598|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3840121|NCT01684410|3665599|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3840122|NCT01684410|3665600|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3840123|NCT01684410|3665597|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3840124|NCT01684410|3665598|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3840125|NCT01684410|3665599|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3840126|NCT01684410|3665600|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3840127|NCT01684410|3665597|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3840128|NCT01684410|3665598|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3840129|NCT01684410|3665599|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3840130|NCT01684410|3665600|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3840131|NCT01684410|3665597|B4|||Age||years|Mean|28.5|28.5|Standard Deviation|10.32|10.32|||
3840132|NCT01684410|3665598|B3|||Age||years|Mean|29.3|29.3|Standard Deviation|9.96|9.96|||
3840133|NCT01684410|3665599|B2|||Age||years|Mean|28.1|28.1|Standard Deviation|11.43|11.43|||
3840134|NCT01684410|3665600|B1|||Age||years|Mean|28.2|28.2|Standard Deviation|10.62|10.62|||
3840135|NCT01684215|3665616|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3840136|NCT01684215|3665617|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3840137|NCT01684215|3665618|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3840138|NCT01684215|3665619|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3840139|NCT01684215|3665620|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3840140|NCT01684215|3665616|B5||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3840141|NCT01684215|3665617|B4||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3840142|NCT01684215|3665618|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3840143|NCT01684215|3665619|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3840144|NCT01684215|3665620|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3840145|NCT01684215|3665616|B5||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3840146|NCT01684215|3665617|B4||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3840147|NCT01684215|3665618|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3840148|NCT01684215|3665619|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3840149|NCT01684215|3665620|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3840150|NCT01684215|3665616|B5||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3840151|NCT01684215|3665617|B4||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3840152|NCT01684215|3665618|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3840153|NCT01684215|3665619|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3840154|NCT01684215|3665620|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3840155|NCT01684215|3665616|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3840156|NCT01684215|3665617|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3840157|NCT01684215|3665618|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3840158|NCT01684215|3665619|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3840159|NCT01684215|3665620|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3840160|NCT01684046|3665697|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3840161|NCT01684046|3665697|B1||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3840162|NCT01684046|3665697|B1|||Age||years|Mean|32.0|32.0|Standard Deviation|11.42|11.42|||
3840163|NCT01684033|3665704|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3840164|NCT01684033|3665704|B1||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3840165|NCT01684033|3665704|B1|||Age||years|Mean|31.7|31.7|Standard Deviation|11.48|11.48|||
3840166|NCT01684007|3665713|B3|Chile||Region of Enrollment||participants|Number|19|19.0||||||
3840167|NCT01684007|3665714|B2|Chile||Region of Enrollment||participants|Number|9|9.0||||||
3840168|NCT01684007|3665715|B1|Chile||Region of Enrollment||participants|Number|10|10.0||||||
3840169|NCT01684007|3665713|B3|Argentina||Region of Enrollment||participants|Number|14|14.0||||||
3840170|NCT01684007|3665714|B2|Argentina||Region of Enrollment||participants|Number|7|7.0||||||
3840171|NCT01684007|3665715|B1|Argentina||Region of Enrollment||participants|Number|7|7.0||||||
3840172|NCT01684007|3665713|B3|Spain||Region of Enrollment||participants|Number|23|23.0||||||
3840173|NCT01684007|3665714|B2|Spain||Region of Enrollment||participants|Number|12|12.0||||||
3840174|NCT01684007|3665715|B1|Spain||Region of Enrollment||participants|Number|11|11.0||||||
3840175|NCT01684007|3665713|B3|Netherlands||Region of Enrollment||participants|Number|21|21.0||||||
3840176|NCT01684007|3665714|B2|Netherlands||Region of Enrollment||participants|Number|9|9.0||||||
3840177|NCT01684007|3665715|B1|Netherlands||Region of Enrollment||participants|Number|12|12.0||||||
3840178|NCT01684007|3665713|B3|Germany||Region of Enrollment||participants|Number|26|26.0||||||
3840179|NCT01684007|3665714|B2|Germany||Region of Enrollment||participants|Number|13|13.0||||||
3840180|NCT01684007|3665715|B1|Germany||Region of Enrollment||participants|Number|13|13.0||||||
3840181|NCT01684007|3665713|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3840182|NCT01684007|3665714|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3840183|NCT01684007|3665715|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3840184|NCT01684007|3665713|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3840185|NCT01684007|3665714|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3840186|NCT01684007|3665715|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3840187|NCT01684007|3665713|B3|||Age||years|Mean|66.6|66.6|Standard Deviation|9.0|9.0|||
3840188|NCT01684007|3665714|B2|||Age||years|Mean|65.9|65.9|Standard Deviation|10.1|10.1|||
3840189|NCT01684007|3665715|B1|||Age||years|Mean|67.2|67.2|Standard Deviation|7.9|7.9|||
3840190|NCT01683864|3665725|B3||Female|Sex: Female, Male||||0|0.0||||||
3840191|NCT01683864|3665726|B2||Female|Sex: Female, Male||||0|0.0||||||
3840192|NCT01683864|3665727|B1||Female|Sex: Female, Male||||0|0.0||||||
3840193|NCT01683864|3665724|B4||>=65 years|Age||||0|0.0||||||
3840194|NCT01683864|3665724|B4||Between 18 and 65 years|Age||||0|0.0||||||
3840195|NCT01683864|3665724|B4||<=18 years|Age||||0|0.0||||||
3840196|NCT01683864|3665725|B3||<=18 years|Age||||0|0.0||||||
3840197|NCT01683864|3665726|B2||<=18 years|Age||||0|0.0||||||
3840198|NCT01683864|3665727|B1||<=18 years|Age||||0|0.0||||||
3840199|NCT01683838|3665737|B3|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3840200|NCT01683838|3665738|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3840201|NCT01683838|3665739|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3840202|NCT01683838|3665737|B3|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3840203|NCT01683838|3665738|B2|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3840204|NCT01683838|3665739|B1|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3840205|NCT01683838|3665737|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3840206|NCT01683838|3665738|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3840207|NCT01683838|3665739|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3840208|NCT01683838|3665737|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|179|179.0||||||
3840209|NCT01683838|3665738|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|87|87.0||||||
3840210|NCT01683838|3665739|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|92|92.0||||||
3840211|NCT01683838|3665737|B3||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3840212|NCT01683838|3665738|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3840213|NCT01683838|3665739|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3840214|NCT01683838|3665737|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3840215|NCT01683838|3665738|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3840216|NCT01683838|3665739|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3840217|NCT01683838|3665737|B3|||Age||Years|Mean|40.9|40.9|Standard Deviation|12.00|12.0|||
3840218|NCT01683838|3665738|B2|||Age||Years|Mean|40.5|40.5|Standard Deviation|12.25|12.25|||
3840219|NCT01683838|3665739|B1|||Age||Years|Mean|41.3|41.3|Standard Deviation|11.79|11.79|||
3840220|NCT01683812|3665762|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
3840221|NCT01683812|3665762|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3840222|NCT01683812|3665762|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3840223|NCT01683812|3665762|B1|||Age|Corrected Gestational Age at Enrollment|weeks|Median|34.6|34.6|Full Range|||30.0|44.5|
3840224|NCT01683630|3665767|B3|Canada||Region of Enrollment||participants|Number|1849|1849.0||||||
3840225|NCT01683630|3665768|B2|Canada||Region of Enrollment||participants|Number|445|445.0||||||
3840226|NCT01683630|3665769|B1|Canada||Region of Enrollment||participants|Number|1404|1404.0||||||
3840227|NCT01683630|3665767|B3||Male|Sex: Female, Male||Participants|Count of Participants|846|846.0||||||
3840228|NCT01683630|3665768|B2||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
3840229|NCT01683630|3665769|B1||Male|Sex: Female, Male||Participants|Count of Participants|646|646.0||||||
3840230|NCT01683630|3665767|B3||Female|Sex: Female, Male||Participants|Count of Participants|1003|1003.0||||||
3840231|NCT01683630|3665768|B2||Female|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
3840232|NCT01683630|3665769|B1||Female|Sex: Female, Male||Participants|Count of Participants|758|758.0||||||
3840233|NCT01683630|3665767|B3||>=65 years|Age||Participants|Count of Participants|648|648.0||||||
3840234|NCT01683630|3665768|B2||>=65 years|Age||Participants|Count of Participants|80|80.0||||||
3840235|NCT01683630|3665769|B1||>=65 years|Age||Participants|Count of Participants|568|568.0||||||
3840236|NCT01683630|3665767|B3||Between 18 and 65 years|Age||Participants|Count of Participants|454|454.0||||||
3840237|NCT01683630|3665768|B2||Between 18 and 65 years|Age||Participants|Count of Participants|129|129.0||||||
3840238|NCT01683630|3665769|B1||Between 18 and 65 years|Age||Participants|Count of Participants|325|325.0||||||
3840239|NCT01683630|3665767|B3||<=18 years|Age||Participants|Count of Participants|747|747.0||||||
3840240|NCT01683630|3665768|B2||<=18 years|Age||Participants|Count of Participants|236|236.0||||||
3840241|NCT01683630|3665769|B1||<=18 years|Age||Participants|Count of Participants|511|511.0||||||
3840242|NCT01683604|3665780|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3840243|NCT01683604|3665780|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3840244|NCT01683604|3665780|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|10.62|10.62|||
3840245|NCT01683526|3665943|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3840246|NCT01683526|3665944|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3840247|NCT01683526|3665945|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3840248|NCT01683526|3665943|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3840249|NCT01683526|3665944|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3840250|NCT01683526|3665945|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3840251|NCT01683526|3665943|B3|||Age||years|Mean|67.4|67.4|Standard Deviation|15.1|15.1|||
3840252|NCT01683526|3665944|B2|||Age||years|Mean|65.4|65.4|Standard Deviation|14.0|14.0|||
3840253|NCT01683526|3665945|B1|||Age||years|Mean|69.6|69.6|Standard Deviation|15.9|15.9|||
3840254|NCT01683409|3665960|B6|Mexico||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3840255|NCT01683409|3665961|B5|Mexico||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3840256|NCT01683409|3665962|B4|Mexico||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3840257|NCT01683409|3665963|B3|Mexico||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3840258|NCT01683409|3665964|B2|Mexico||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3840259|NCT01683409|3665965|B1|Mexico||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3840260|NCT01683409|3665960|B6|Japan||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
3840261|NCT01683409|3665961|B5|Japan||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3840262|NCT01683409|3665962|B4|Japan||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3840263|NCT01683409|3665963|B3|Japan||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3840264|NCT01683409|3665964|B2|Japan||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3840265|NCT01683409|3665965|B1|Japan||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3840266|NCT01683409|3665960|B6|United States||Region of Enrollment||Participants|Count of Participants|68|68.0||||||
3840267|NCT01683409|3665961|B5|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3840268|NCT01683409|3665962|B4|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3840269|NCT01683409|3665963|B3|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3840270|NCT01683409|3665964|B2|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3840271|NCT01683409|3665965|B1|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3840272|NCT01683409|3665960|B6|Puerto Rico||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3840273|NCT01683409|3665961|B5|Puerto Rico||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3840274|NCT01683409|3665962|B4|Puerto Rico||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3840275|NCT01683409|3665963|B3|Puerto Rico||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3840276|NCT01683409|3665964|B2|Puerto Rico||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3840277|NCT01683409|3665965|B1|Puerto Rico||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3840278|NCT01683409|3665960|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840279|NCT01683409|3665961|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840280|NCT01683409|3665962|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840281|NCT01683409|3665963|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840282|NCT01683409|3665964|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840283|NCT01683409|3665965|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840284|NCT01683409|3665960|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3840285|NCT01683409|3665961|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840286|NCT01683409|3665962|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840287|NCT01683409|3665963|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840288|NCT01683409|3665964|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840289|NCT01683409|3665965|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3840290|NCT01683409|3665960|B6||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3840291|NCT01683409|3665961|B5||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3840292|NCT01683409|3665962|B4||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3840293|NCT01683409|3665963|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3840294|NCT01683409|3665964|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3840295|NCT01683409|3665965|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3840296|NCT01683409|3665960|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3840297|NCT01683409|3665961|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3840298|NCT01683409|3665962|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840299|NCT01683409|3665963|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3840300|NCT01683409|3665964|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3840301|NCT01683409|3665965|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3840302|NCT01683409|3665960|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3840303|NCT01683409|3665961|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3840304|NCT01683409|3665962|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840305|NCT01683409|3665963|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840306|NCT01683409|3665964|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840307|NCT01683409|3665965|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840308|NCT01683409|3665960|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3840309|NCT01683409|3665961|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3840310|NCT01683409|3665962|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3840311|NCT01683409|3665963|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3840312|NCT01683409|3665964|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3840313|NCT01683409|3665965|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3840314|NCT01683409|3665960|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3840315|NCT01683409|3665961|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3840316|NCT01683409|3665962|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3840317|NCT01683409|3665963|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3840318|NCT01683409|3665964|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3840319|NCT01683409|3665965|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3840320|NCT01683409|3665960|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840321|NCT01683409|3665961|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840322|NCT01683409|3665962|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840323|NCT01683409|3665963|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840324|NCT01683409|3665964|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840325|NCT01683409|3665965|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840326|NCT01683409|3665960|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
3840327|NCT01683409|3665961|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3840328|NCT01683409|3665962|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3840329|NCT01683409|3665963|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3840330|NCT01683409|3665964|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3840331|NCT01683409|3665965|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3840332|NCT01683409|3665960|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3840333|NCT01683409|3665961|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3840334|NCT01683409|3665962|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3840335|NCT01683409|3665963|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3840336|NCT01683409|3665964|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3840337|NCT01683409|3665965|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3840338|NCT01683409|3665960|B6||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3840339|NCT01683409|3665961|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3840340|NCT01683409|3665962|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3840341|NCT01683409|3665963|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3840342|NCT01683409|3665964|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3840343|NCT01683409|3665965|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3840344|NCT01683409|3665960|B6||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3840345|NCT01683409|3665961|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3840346|NCT01683409|3665962|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3840347|NCT01683409|3665963|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3840348|NCT01683409|3665964|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3840349|NCT01683409|3665965|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3840350|NCT01683409|3665960|B6|||Age||Years|Mean|63|63.0|Standard Deviation|9.1|9.1|||
3840351|NCT01683409|3665961|B5|||Age||Years|Mean|63|63.0|Standard Deviation|7.8|7.8|||
3840352|NCT01683409|3665962|B4|||Age||Years|Mean|61|61.0|Standard Deviation|10.4|10.4|||
3840353|NCT01683409|3665963|B3|||Age||Years|Mean|64|64.0|Standard Deviation|8.3|8.3|||
3840354|NCT01683409|3665964|B2|||Age||Years|Mean|61|61.0|Standard Deviation|10.0|10.0|||
3840355|NCT01683409|3665965|B1|||Age||Years|Mean|64|64.0|Standard Deviation|9.0|9.0|||
3840356|NCT01683383|3666010|B3|||First postnatal gas: base deficit||mEq/L|Mean|17.3|17.3|Standard Deviation|6.8|6.8|||
3840357|NCT01683383|3666011|B2|||First postnatal gas: base deficit||mEq/L|Mean|17.5|17.5|Standard Deviation|6.9|6.9|||
3840358|NCT01683383|3666012|B1|||First postnatal gas: base deficit||mEq/L|Mean|17.0|17.0|Standard Deviation|6.7|6.7|||
3840359|NCT01683383|3666010|B3|||First postnatal gas: pH||pH|Mean|7.04|7.04|Standard Deviation|0.19|0.19|||
3840360|NCT01683383|3666011|B2|||First postnatal gas: pH||pH|Mean|7.02|7.02|Standard Deviation|0.19|0.19|||
3840361|NCT01683383|3666012|B1|||First postnatal gas: pH||pH|Mean|7.06|7.06|Standard Deviation|0.20|0.2|||
3840362|NCT01683383|3666010|B3|||Cord gas: base deficit||mEq/L|Mean|14.8|14.8|Standard Deviation|6.0|6.0|||
3840363|NCT01683383|3666011|B2|||Cord gas: base deficit||mEq/L|Mean|14.0|14.0|Standard Deviation|4.7|4.7|||
3840364|NCT01683383|3666012|B1|||Cord gas: base deficit||mEq/L|Mean|15.6|15.6|Standard Deviation|7.1|7.1|||
3840365|NCT01683383|3666010|B3|||Cord gas: pH||pH|Mean|6.96|6.96|Standard Deviation|0.18|0.18|||
3840366|NCT01683383|3666011|B2|||Cord gas: pH||pH|Mean|7.01|7.01|Standard Deviation|0.15|0.15|||
3840367|NCT01683383|3666012|B1|||Cord gas: pH||pH|Mean|6.91|6.91|Standard Deviation|0.20|0.2|||
3840368|NCT01683383|3666010|B3|No pressors used||Pressors at randomization||Participants|Number|93|93.0||||||
3840369|NCT01683383|3666011|B2|No pressors used||Pressors at randomization||Participants|Number|47|47.0||||||
3840370|NCT01683383|3666012|B1|No pressors used||Pressors at randomization||Participants|Number|46|46.0||||||
3840371|NCT01683383|3666010|B3|Pressors used||Pressors at randomization||Participants|Number|7|7.0||||||
3840372|NCT01683383|3666011|B2|Pressors used||Pressors at randomization||Participants|Number|4|4.0||||||
3840373|NCT01683383|3666012|B1|Pressors used||Pressors at randomization||Participants|Number|3|3.0||||||
3840374|NCT01683383|3666010|B3|Inhaled nitric oxide: No||Respiratory support @ randomization: Inhaled nitric oxide||Participants|Number|94|94.0||||||
3840375|NCT01683383|3666011|B2|Inhaled nitric oxide: No||Respiratory support @ randomization: Inhaled nitric oxide||Participants|Number|47|47.0||||||
3840376|NCT01683383|3666012|B1|Inhaled nitric oxide: No||Respiratory support @ randomization: Inhaled nitric oxide||Participants|Number|47|47.0||||||
3840377|NCT01683383|3666010|B3|Inhaled nitric oxide: Yes||Respiratory support @ randomization: Inhaled nitric oxide||Participants|Number|6|6.0||||||
3840378|NCT01683383|3666011|B2|Inhaled nitric oxide: Yes||Respiratory support @ randomization: Inhaled nitric oxide||Participants|Number|4|4.0||||||
3840379|NCT01683383|3666012|B1|Inhaled nitric oxide: Yes||Respiratory support @ randomization: Inhaled nitric oxide||Participants|Number|2|2.0||||||
3840380|NCT01683383|3666010|B3|High-frequency ventilation: No||Respiratory support @ randomization: High-frequency ventilation||Participants|Number|93|93.0||||||
3840381|NCT01683383|3666011|B2|High-frequency ventilation: No||Respiratory support @ randomization: High-frequency ventilation||Participants|Number|47|47.0||||||
3840382|NCT01683383|3666012|B1|High-frequency ventilation: No||Respiratory support @ randomization: High-frequency ventilation||Participants|Number|46|46.0||||||
3840383|NCT01683383|3666010|B3|High-frequency ventilation: Yes||Respiratory support @ randomization: High-frequency ventilation||Participants|Number|7|7.0||||||
3840384|NCT01683383|3666011|B2|High-frequency ventilation: Yes||Respiratory support @ randomization: High-frequency ventilation||Participants|Number|4|4.0||||||
3840385|NCT01683383|3666012|B1|High-frequency ventilation: Yes||Respiratory support @ randomization: High-frequency ventilation||Participants|Number|3|3.0||||||
3840386|NCT01683383|3666010|B3|Conventional mechanical ventilation: No||Respiratory support @ randomization: Conventional mechanical ventilation||Participants|Number|45|45.0||||||
3840387|NCT01683383|3666011|B2|Conventional mechanical ventilation: No||Respiratory support @ randomization: Conventional mechanical ventilation||Participants|Number|22|22.0||||||
3840388|NCT01683383|3666012|B1|Conventional mechanical ventilation: No||Respiratory support @ randomization: Conventional mechanical ventilation||Participants|Number|23|23.0||||||
3840389|NCT01683383|3666010|B3|Conventional mechanical ventilation: Yes||Respiratory support @ randomization: Conventional mechanical ventilation||Participants|Number|55|55.0||||||
3840390|NCT01683383|3666011|B2|Conventional mechanical ventilation: Yes||Respiratory support @ randomization: Conventional mechanical ventilation||Participants|Number|29|29.0||||||
3840391|NCT01683383|3666012|B1|Conventional mechanical ventilation: Yes||Respiratory support @ randomization: Conventional mechanical ventilation||Participants|Number|26|26.0||||||
3840392|NCT01683383|3666010|B3|Non-invasive ventilation: No||Respiratory support @ randomization: Non-invasive ventilation||Participants|Number|76|76.0||||||
3840393|NCT01683383|3666011|B2|Non-invasive ventilation: No||Respiratory support @ randomization: Non-invasive ventilation||Participants|Number|42|42.0||||||
3840394|NCT01683383|3666012|B1|Non-invasive ventilation: No||Respiratory support @ randomization: Non-invasive ventilation||Participants|Number|34|34.0||||||
3840395|NCT01683383|3666010|B3|Non-invasive ventilation: Yes||Respiratory support @ randomization: Non-invasive ventilation||Participants|Number|24|24.0||||||
3840396|NCT01683383|3666011|B2|Non-invasive ventilation: Yes||Respiratory support @ randomization: Non-invasive ventilation||Participants|Number|9|9.0||||||
3840397|NCT01683383|3666012|B1|Non-invasive ventilation: Yes||Respiratory support @ randomization: Non-invasive ventilation||Participants|Number|15|15.0||||||
3840398|NCT01683383|3666010|B3|No chest compressions||Delivery room resuscitation: Chest compressions||Participants|Number|58|58.0||||||
3840399|NCT01683383|3666011|B2|No chest compressions||Delivery room resuscitation: Chest compressions||Participants|Number|29|29.0||||||
3840400|NCT01683383|3666012|B1|No chest compressions||Delivery room resuscitation: Chest compressions||Participants|Number|29|29.0||||||
3840401|NCT01683383|3666010|B3|Chest compressions||Delivery room resuscitation: Chest compressions||Participants|Number|42|42.0||||||
3840402|NCT01683383|3666011|B2|Chest compressions||Delivery room resuscitation: Chest compressions||Participants|Number|22|22.0||||||
3840403|NCT01683383|3666012|B1|Chest compressions||Delivery room resuscitation: Chest compressions||Participants|Number|20|20.0||||||
3840404|NCT01683383|3666010|B3|No epinephrine||Delivery room resuscitation: Epinephrine||Participants|Number|77|77.0||||||
3840405|NCT01683383|3666011|B2|No epinephrine||Delivery room resuscitation: Epinephrine||Participants|Number|41|41.0||||||
3840406|NCT01683383|3666012|B1|No epinephrine||Delivery room resuscitation: Epinephrine||Participants|Number|36|36.0||||||
3840407|NCT01683383|3666010|B3|Epinephrine||Delivery room resuscitation: Epinephrine||Participants|Number|23|23.0||||||
3840408|NCT01683383|3666011|B2|Epinephrine||Delivery room resuscitation: Epinephrine||Participants|Number|10|10.0||||||
3840409|NCT01683383|3666012|B1|Epinephrine||Delivery room resuscitation: Epinephrine||Participants|Number|13|13.0||||||
3840410|NCT01683383|3666010|B3|No intubation with ventilation||Delivery room resuscitation: Intubation with ventilation||Participants|Number|34|34.0||||||
3840411|NCT01683383|3666011|B2|No intubation with ventilation||Delivery room resuscitation: Intubation with ventilation||Participants|Number|19|19.0||||||
3840412|NCT01683383|3666012|B1|No intubation with ventilation||Delivery room resuscitation: Intubation with ventilation||Participants|Number|15|15.0||||||
3840413|NCT01683383|3666010|B3|Intubation with ventilation||Delivery room resuscitation: Intubation with ventilation||Participants|Number|66|66.0||||||
3840414|NCT01683383|3666011|B2|Intubation with ventilation||Delivery room resuscitation: Intubation with ventilation||Participants|Number|32|32.0||||||
3840415|NCT01683383|3666012|B1|Intubation with ventilation||Delivery room resuscitation: Intubation with ventilation||Participants|Number|34|34.0||||||
3840416|NCT01683383|3666010|B3|No bag and mask||Delivery room resuscitation: Bag and mask||Participants|Number|14|14.0||||||
3840417|NCT01683383|3666011|B2|No bag and mask||Delivery room resuscitation: Bag and mask||Participants|Number|8|8.0||||||
3840418|NCT01683383|3666012|B1|No bag and mask||Delivery room resuscitation: Bag and mask||Participants|Number|6|6.0||||||
3840419|NCT01683383|3666010|B3|Bag and mask||Delivery room resuscitation: Bag and mask||Participants|Number|86|86.0||||||
3840420|NCT01683383|3666011|B2|Bag and mask||Delivery room resuscitation: Bag and mask||Participants|Number|43|43.0||||||
3840421|NCT01683383|3666012|B1|Bag and mask||Delivery room resuscitation: Bag and mask||Participants|Number|43|43.0||||||
3840422|NCT01683383|3666010|B3|No CPAP||Delivery room resuscitation: CPAP||Participants|Number|66|66.0||||||
3840423|NCT01683383|3666011|B2|No CPAP||Delivery room resuscitation: CPAP||Participants|Number|35|35.0||||||
3840424|NCT01683383|3666012|B1|No CPAP||Delivery room resuscitation: CPAP||Participants|Number|31|31.0||||||
3840425|NCT01683383|3666010|B3|CPAP||Delivery room resuscitation: CPAP||Participants|Number|34|34.0||||||
3840426|NCT01683383|3666011|B2|CPAP||Delivery room resuscitation: CPAP||Participants|Number|16|16.0||||||
3840427|NCT01683383|3666012|B1|CPAP||Delivery room resuscitation: CPAP||Participants|Number|18|18.0||||||
3840428|NCT01683383|3666010|B3|No oxygen||Delivery room resuscitation: Oxygen||Participants|Number|7|7.0||||||
3840429|NCT01683383|3666011|B2|No oxygen||Delivery room resuscitation: Oxygen||Participants|Number|4|4.0||||||
3840430|NCT01683383|3666012|B1|No oxygen||Delivery room resuscitation: Oxygen||Participants|Number|3|3.0||||||
3840431|NCT01683383|3666010|B3|Oxygen||Delivery room resuscitation: Oxygen||Participants|Number|93|93.0||||||
3840432|NCT01683383|3666011|B2|Oxygen||Delivery room resuscitation: Oxygen||Participants|Number|47|47.0||||||
3840433|NCT01683383|3666012|B1|Oxygen||Delivery room resuscitation: Oxygen||Participants|Number|46|46.0||||||
3840434|NCT01683383|3666010|B3|Apgar @ 10 min > 5||Apgar scores @ 10 minutes|Apgar scores ≤5 at either 5 or 10 minutes can be due to acute hypoxia ischemia in the intrapartum period and as such are often one of the eligibility criteria for therapeutic hypothermia to treat HIE.|Participants|Number|49|49.0||||||
3840435|NCT01683383|3666011|B2|Apgar @ 10 min > 5||Apgar scores @ 10 minutes|Apgar scores ≤5 at either 5 or 10 minutes can be due to acute hypoxia ischemia in the intrapartum period and as such are often one of the eligibility criteria for therapeutic hypothermia to treat HIE.|Participants|Number|27|27.0||||||
3840436|NCT01683383|3666012|B1|Apgar @ 10 min > 5||Apgar scores @ 10 minutes|Apgar scores ≤5 at either 5 or 10 minutes can be due to acute hypoxia ischemia in the intrapartum period and as such are often one of the eligibility criteria for therapeutic hypothermia to treat HIE.|Participants|Number|22|22.0||||||
3840437|NCT01683383|3666010|B3|Apgar @ 10 min ≤ 5||Apgar scores @ 10 minutes|Apgar scores ≤5 at either 5 or 10 minutes can be due to acute hypoxia ischemia in the intrapartum period and as such are often one of the eligibility criteria for therapeutic hypothermia to treat HIE.|Participants|Number|51|51.0||||||
3840438|NCT01683383|3666011|B2|Apgar @ 10 min ≤ 5||Apgar scores @ 10 minutes|Apgar scores ≤5 at either 5 or 10 minutes can be due to acute hypoxia ischemia in the intrapartum period and as such are often one of the eligibility criteria for therapeutic hypothermia to treat HIE.|Participants|Number|24|24.0||||||
3840439|NCT01683383|3666012|B1|Apgar @ 10 min ≤ 5||Apgar scores @ 10 minutes|Apgar scores ≤5 at either 5 or 10 minutes can be due to acute hypoxia ischemia in the intrapartum period and as such are often one of the eligibility criteria for therapeutic hypothermia to treat HIE.|Participants|Number|27|27.0||||||
3840440|NCT01683383|3666010|B3|Apgar @ 5 min > 5||Apgar scores @ 5 minutes|Apgar scores ≤5 at either 5 or 10 minutes can be due to acute hypoxia ischemia in the intrapartum period and as such are often one of the eligibility criteria for therapeutic hypothermia to treat HIE.|Participants|Number|20|20.0||||||
3840441|NCT01683383|3666011|B2|Apgar @ 5 min > 5||Apgar scores @ 5 minutes|Apgar scores ≤5 at either 5 or 10 minutes can be due to acute hypoxia ischemia in the intrapartum period and as such are often one of the eligibility criteria for therapeutic hypothermia to treat HIE.|Participants|Number|13|13.0||||||
3840442|NCT01683383|3666012|B1|Apgar @ 5 min > 5||Apgar scores @ 5 minutes|Apgar scores ≤5 at either 5 or 10 minutes can be due to acute hypoxia ischemia in the intrapartum period and as such are often one of the eligibility criteria for therapeutic hypothermia to treat HIE.|Participants|Number|7|7.0||||||
3840443|NCT01683383|3666010|B3|Apgar @ 5 min ≤ 5||Apgar scores @ 5 minutes|Apgar scores ≤5 at either 5 or 10 minutes can be due to acute hypoxia ischemia in the intrapartum period and as such are often one of the eligibility criteria for therapeutic hypothermia to treat HIE.|Participants|Number|80|80.0||||||
3840444|NCT01683383|3666011|B2|Apgar @ 5 min ≤ 5||Apgar scores @ 5 minutes|Apgar scores ≤5 at either 5 or 10 minutes can be due to acute hypoxia ischemia in the intrapartum period and as such are often one of the eligibility criteria for therapeutic hypothermia to treat HIE.|Participants|Number|38|38.0||||||
3840445|NCT01683383|3666012|B1|Apgar @ 5 min ≤ 5||Apgar scores @ 5 minutes|Apgar scores ≤5 at either 5 or 10 minutes can be due to acute hypoxia ischemia in the intrapartum period and as such are often one of the eligibility criteria for therapeutic hypothermia to treat HIE.|Participants|Number|42|42.0||||||
3840446|NCT01683383|3666010|B3|Apgar @ 1 min > 5||Apgar scores @ 1 minute|Apgar scores ≤5 at either 5 or 10 minutes can be due to acute hypoxia ischemia in the intrapartum period and as such are often one of the eligibility criteria for therapeutic hypothermia to treat HIE.|Participants|Number|11|11.0||||||
3840447|NCT01683383|3666011|B2|Apgar @ 1 min > 5||Apgar scores @ 1 minute|Apgar scores ≤5 at either 5 or 10 minutes can be due to acute hypoxia ischemia in the intrapartum period and as such are often one of the eligibility criteria for therapeutic hypothermia to treat HIE.|Participants|Number|9|9.0||||||
3840448|NCT01683383|3666012|B1|Apgar @ 1 min > 5||Apgar scores @ 1 minute|Apgar scores ≤5 at either 5 or 10 minutes can be due to acute hypoxia ischemia in the intrapartum period and as such are often one of the eligibility criteria for therapeutic hypothermia to treat HIE.|Participants|Number|2|2.0||||||
3840449|NCT01683383|3666010|B3|Apgar @ 1 min ≤ 5||Apgar scores @ 1 minute|Apgar scores ≤5 at either 5 or 10 minutes can be due to acute hypoxia ischemia in the intrapartum period and as such are often one of the eligibility criteria for therapeutic hypothermia to treat HIE.|Participants|Number|89|89.0||||||
3840450|NCT01683383|3666011|B2|Apgar @ 1 min ≤ 5||Apgar scores @ 1 minute|Apgar scores ≤5 at either 5 or 10 minutes can be due to acute hypoxia ischemia in the intrapartum period and as such are often one of the eligibility criteria for therapeutic hypothermia to treat HIE.|Participants|Number|42|42.0||||||
3840451|NCT01683383|3666012|B1|Apgar @ 1 min ≤ 5||Apgar scores @ 1 minute|Apgar scores ≤5 at either 5 or 10 minutes can be due to acute hypoxia ischemia in the intrapartum period and as such are often one of the eligibility criteria for therapeutic hypothermia to treat HIE.|Participants|Number|47|47.0||||||
3840452|NCT01683383|3666010|B3|||Gestational age||Weeks|Mean|39.1|39.1|Standard Deviation|1.7|1.7|||
3840453|NCT01683383|3666011|B2|||Gestational age||Weeks|Mean|39.1|39.1|Standard Deviation|1.7|1.7|||
3840454|NCT01683383|3666012|B1|||Gestational age||Weeks|Mean|39.1|39.1|Standard Deviation|1.7|1.7|||
3840455|NCT01683383|3666010|B3|||Birth weight||Grams|Mean|3358|3358.0|Standard Deviation|610|610.0|||
3840456|NCT01683383|3666011|B2|||Birth weight||Grams|Mean|3321|3321.0|Standard Deviation|523|523.0|||
3840457|NCT01683383|3666012|B1|||Birth weight||Grams|Mean|3397|3397.0|Standard Deviation|627|627.0|||
3840458|NCT01683383|3666010|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3840459|NCT01683383|3666011|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3840460|NCT01683383|3666012|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3840461|NCT01683383|3666010|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3840462|NCT01683383|3666011|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3840463|NCT01683383|3666012|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3840464|NCT01683383|3666010|B3|Chron. age at cooling initiation at birth hospital||Age, Customized|Chronological age at cooling initiation at birth hospital (hours)|Hours|Mean|27|27.0|Standard Deviation|6|6.0|||
3840465|NCT01683383|3666011|B2|Chron. age at cooling initiation at birth hospital||Age, Customized|Chronological age at cooling initiation at birth hospital (hours)|Hours|Mean|28|28.0|Standard Deviation|6|6.0|||
3840466|NCT01683383|3666012|B1|Chron. age at cooling initiation at birth hospital||Age, Customized|Chronological age at cooling initiation at birth hospital (hours)|Hours|Mean|26|26.0|Standard Deviation|6|6.0|||
3840467|NCT01683266|3666027|B3|||Total Insulin Daily Dose|Number of participants analyzed for this baseline characteristics = 195 and 198 for each reporting group, respectively.|U/kg|Mean|0.719|0.719|Standard Deviation|0.262|0.262|||
3840468|NCT01683266|3666028|B2|||Total Insulin Daily Dose|Number of participants analyzed for this baseline characteristics = 195 and 198 for each reporting group, respectively.|U/kg|Mean|0.724|0.724|Standard Deviation|0.245|0.245|||
3840522|NCT01683019|3666087|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3840469|NCT01683266|3666029|B1|||Total Insulin Daily Dose|Number of participants analyzed for this baseline characteristics = 195 and 198 for each reporting group, respectively.|U/kg|Mean|0.714|0.714|Standard Deviation|0.278|0.278|||
3840470|NCT01683266|3666027|B3|||Basal Insulin Daily Dose|Number of participants analyzed for this baseline characteristics = 201 and 210 for each reporting group, respectively.|units per kilogram (U/kg)|Mean|0.376|0.376|Standard Deviation|0.162|0.162|||
3840471|NCT01683266|3666028|B2|||Basal Insulin Daily Dose|Number of participants analyzed for this baseline characteristics = 201 and 210 for each reporting group, respectively.|units per kilogram (U/kg)|Mean|0.372|0.372|Standard Deviation|0.152|0.152|||
3840472|NCT01683266|3666029|B1|||Basal Insulin Daily Dose|Number of participants analyzed for this baseline characteristics = 201 and 210 for each reporting group, respectively.|units per kilogram (U/kg)|Mean|0.381|0.381|Standard Deviation|0.173|0.173|||
3840473|NCT01683266|3666027|B3|Greater Than or Equal to (>=) 8%||Glycated Hemoglobin (HbA1c)||participants|Number|339|339.0||||||
3840474|NCT01683266|3666028|B2|Greater Than or Equal to (>=) 8%||Glycated Hemoglobin (HbA1c)||participants|Number|170|170.0||||||
3840475|NCT01683266|3666029|B1|Greater Than or Equal to (>=) 8%||Glycated Hemoglobin (HbA1c)||participants|Number|169|169.0||||||
3840476|NCT01683266|3666027|B3|Less Than (<) 8%||Glycated Hemoglobin (HbA1c)||participants|Number|210|210.0||||||
3840477|NCT01683266|3666028|B2|Less Than (<) 8%||Glycated Hemoglobin (HbA1c)||participants|Number|105|105.0||||||
3840478|NCT01683266|3666029|B1|Less Than (<) 8%||Glycated Hemoglobin (HbA1c)||participants|Number|105|105.0||||||
3840479|NCT01683266|3666027|B3|||Duration of Diabetes|Number of participants analyzed for this baseline characteristics = 274 and 272 for each reporting group, respectively.|years|Mean|21.0|21.0|Standard Deviation|12.9|12.9|||
3840480|NCT01683266|3666028|B2|||Duration of Diabetes|Number of participants analyzed for this baseline characteristics = 274 and 272 for each reporting group, respectively.|years|Mean|21.4|21.4|Standard Deviation|13.1|13.1|||
3840481|NCT01683266|3666029|B1|||Duration of Diabetes|Number of participants analyzed for this baseline characteristics = 274 and 272 for each reporting group, respectively.|years|Mean|20.5|20.5|Standard Deviation|12.7|12.7|||
3840482|NCT01683266|3666027|B3|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|27.6|27.6|Standard Deviation|5.1|5.1|||
3840483|NCT01683266|3666028|B2|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|27.6|27.6|Standard Deviation|4.7|4.7|||
3840484|NCT01683266|3666029|B1|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|27.6|27.6|Standard Deviation|5.5|5.5|||
3840485|NCT01683266|3666027|B3||Male|Sex: Female, Male||Participants|Count of Participants|313|313.0||||||
3840486|NCT01683266|3666028|B2||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3840487|NCT01683266|3666029|B1||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3840488|NCT01683266|3666027|B3||Female|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
3840489|NCT01683266|3666028|B2||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3840490|NCT01683266|3666029|B1||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3840491|NCT01683266|3666027|B3|||Age||years|Mean|47.3|47.3|Standard Deviation|13.7|13.7|||
3840492|NCT01683266|3666028|B2|||Age||years|Mean|48.2|48.2|Standard Deviation|13.4|13.4|||
3840493|NCT01683266|3666029|B1|||Age||years|Mean|46.4|46.4|Standard Deviation|13.9|13.9|||
3840494|NCT01683058|3666058|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3840495|NCT01683058|3666058|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3840496|NCT01683058|3666058|B1|||Age||Years|Mean|43.0|43.0|Standard Deviation|11.7|11.7|||
3840497|NCT01683019|3666086|B4|China||Region of Enrollment||participants|Number|37|37.0||||||
3840498|NCT01683019|3666087|B3|China||Region of Enrollment||participants|Number|14|14.0||||||
3840499|NCT01683019|3666088|B2|China||Region of Enrollment||participants|Number|10|10.0||||||
3840500|NCT01683019|3666089|B1|China||Region of Enrollment||participants|Number|13|13.0||||||
3840501|NCT01683019|3666086|B4|United States||Region of Enrollment||participants|Number|15|15.0||||||
3840502|NCT01683019|3666087|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3840503|NCT01683019|3666088|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3840504|NCT01683019|3666089|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3840505|NCT01683019|3666086|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3840506|NCT01683019|3666087|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3840507|NCT01683019|3666088|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3840508|NCT01683019|3666089|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3840509|NCT01683019|3666086|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3840510|NCT01683019|3666087|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3840511|NCT01683019|3666088|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3840512|NCT01683019|3666089|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3840513|NCT01683019|3666086|B4|||Age||years|Mean|43.5|43.5|Standard Deviation|14.2|14.2|||
3840514|NCT01683019|3666087|B3|||Age||years|Mean|46.3|46.3|Standard Deviation|12.7|12.7|||
3840515|NCT01683019|3666088|B2|||Age||years|Mean|40.7|40.7|Standard Deviation|15.9|15.9|||
3840516|NCT01683019|3666089|B1|||Age||years|Mean|44.2|44.2|Standard Deviation|15.1|15.1|||
3840517|NCT01683019|3666086|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3840518|NCT01683019|3666087|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3840519|NCT01683019|3666088|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3840520|NCT01683019|3666089|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3840521|NCT01683019|3666086|B4||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3840523|NCT01683019|3666088|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3840524|NCT01683019|3666089|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3840525|NCT01683019|3666086|B4||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3840526|NCT01683019|3666087|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3840527|NCT01683019|3666088|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3840528|NCT01683019|3666089|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3840529|NCT01682954|3666099|B3|United States||Region of Enrollment||participants|Number|78|78.0||||||
3840530|NCT01682954|3666100|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
3840531|NCT01682954|3666101|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3840532|NCT01682954|3666099|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3840533|NCT01682954|3666100|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3840534|NCT01682954|3666101|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3840535|NCT01682954|3666099|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3840536|NCT01682954|3666100|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3840537|NCT01682954|3666101|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3840538|NCT01682954|3666099|B3|||Age||years|Mean|50.65|50.65|Standard Deviation|8.73|8.73|||
3840539|NCT01682954|3666100|B2|||Age||years|Mean|50.55|50.55|Standard Deviation|7.99|7.99|||
3840540|NCT01682954|3666101|B1|||Age||years|Mean|50.75|50.75|Standard Deviation|9.49|9.49|||
3840541|NCT01682876|3666110|B5||Male|Sex: Female, Male||Participants|Count of Participants|359|359.0||||||
3840542|NCT01682876|3666111|B4||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3840543|NCT01682876|3666112|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3840544|NCT01682876|3666113|B2||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3840545|NCT01682876|3666114|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3840546|NCT01682876|3666110|B5||Female|Sex: Female, Male||Participants|Count of Participants|356|356.0||||||
3840547|NCT01682876|3666111|B4||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3840548|NCT01682876|3666112|B3||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3840549|NCT01682876|3666113|B2||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3840550|NCT01682876|3666114|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3840551|NCT01682876|3666110|B5|||Age||year|Mean|5.7|5.7|Standard Deviation|2.5|2.5|||
3840552|NCT01682876|3666111|B4|||Age||year|Mean|7.8|7.8|Standard Deviation|1.4|1.4|||
3840553|NCT01682876|3666112|B3|||Age||year|Mean|7.8|7.8|Standard Deviation|1.4|1.4|||
3840554|NCT01682876|3666113|B2|||Age||year|Mean|3.6|3.6|Standard Deviation|1.2|1.2|||
3840555|NCT01682876|3666114|B1|||Age||year|Mean|3.5|3.5|Standard Deviation|1.1|1.1|||
3840556|NCT01682863|3666160|B4||Male|Sex: Female, Male||Participants|Count of Participants|403|403.0||||||
3840557|NCT01682863|3666161|B3||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3840558|NCT01682863|3666162|B2||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3840559|NCT01682863|3666163|B1||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3840560|NCT01682863|3666160|B4||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
3840561|NCT01682863|3666161|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3840562|NCT01682863|3666162|B2||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3840563|NCT01682863|3666163|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3840564|NCT01682863|3666160|B4|||Age||Years|Mean|63.6|63.6|Standard Deviation|8.32|8.32|||
3840565|NCT01682863|3666161|B3|||Age||Years|Mean|62.8|62.8|Standard Deviation|8.52|8.52|||
3840566|NCT01682863|3666162|B2|||Age||Years|Mean|63.9|63.9|Standard Deviation|8.50|8.5|||
3840567|NCT01682863|3666163|B1|||Age||Years|Mean|64.0|64.0|Standard Deviation|7.90|7.9|||
3840568|NCT01682837|3666194|B1|||Serum 1,25-Dihydroxyvitamin D||pg/ml|Mean|73|73.0|Standard Deviation|34|34.0|||
3840569|NCT01682837|3666194|B1|||Serum Parathyroid Hormone||pg/ml|Mean|59|59.0|Standard Deviation|31|31.0|||
3840570|NCT01682837|3666194|B1|||Serum Albumin||g/dl|Mean|4.2|4.2|Standard Deviation|0.6|0.6|||
3840571|NCT01682837|3666194|B1|||Serum Creatinine (mg/dl)||mg/dl|Mean|0.9|0.9|Standard Deviation|0.2|0.2|||
3840572|NCT01682837|3666194|B1|||Serum Urea Nitrogen||mg/dl|Mean|13.7|13.7|Standard Deviation|3.5|3.5|||
3840573|NCT01682837|3666194|B1|||Serum Bicarbonate||meq/L|Mean|23|23.0|Standard Deviation|2|2.0|||
3840574|NCT01682837|3666194|B1|||Serum Chloride (meq/L)||meq/L|Mean|105|105.0|Standard Deviation|2|2.0|||
3840575|NCT01682837|3666194|B1|||Serum Potassium||meq/L|Mean|4.2|4.2|Standard Deviation|0.3|0.3|||
3840576|NCT01682837|3666194|B1|||Serum Sodium||meq/L|Mean|139|139.0|Standard Deviation|2|2.0|||
3840577|NCT01682837|3666194|B1|||Serum Magnesium||mg/dl|Mean|2.2|2.2|Standard Deviation|0.3|0.3|||
3840578|NCT01682837|3666194|B1|||Serum Phosphorus||mg/dl|Mean|3.6|3.6|Standard Deviation|0.1|0.1|||
3840579|NCT01682837|3666194|B1|||Serum Calcium||mg/dl|Mean|9.5|9.5|Standard Deviation|0.5|0.5|||
3840580|NCT01682837|3666194|B1|||24-hr Nighttime Heart Rate||beats per minute|Mean|70|70.0|Standard Deviation|11|11.0|||
3840581|NCT01682837|3666194|B1|||24-hr Nighttime Diastolic Blood Pressure||mmHg|Mean|71|71.0|Standard Deviation|10|10.0|||
3840582|NCT01682837|3666194|B1|||24-hr Nighttime Systolic Blood Pressure||mmHg|Mean|117|117.0|Standard Deviation|12|12.0|||
3840583|NCT01682837|3666194|B1|||24-hr Daytime Heart Rate||beats per minute|Mean|77|77.0|Standard Deviation|11|11.0|||
3840584|NCT01682837|3666194|B1|||24-hr Daytime Diastolic Blood Pressure||mmHg|Mean|81|81.0|Standard Deviation|11|11.0|||
3840585|NCT01682837|3666194|B1|||24-hr Daytime Systolic Blood Pressure||mmHg|Mean|129|129.0|Standard Deviation|10|10.0|||
3840586|NCT01682837|3666194|B1|||24-hr Heart Rate Average||beats per minute|Mean|76|76.0|Standard Deviation|11|11.0|||
3840587|NCT01682837|3666194|B1|||24-hr Diastolic Blood Pressure Average||mmHg|Mean|79|79.0|Standard Deviation|10|10.0|||
3840588|NCT01682837|3666194|B1|||24-hr Systolic Blood Pressure Average||mmHg|Mean|126|126.0|Standard Deviation|10|10.0|||
3840589|NCT01682837|3666194|B1|||Office Heart Rate||beats per minute|Mean|72|72.0|Standard Deviation|11|11.0|||
3840590|NCT01682837|3666194|B1|||Office Diastolic Blood Pressure||mmHg|Mean|81|81.0|Standard Deviation|8|8.0|||
3840591|NCT01682837|3666194|B1|||Office Systolic Blood Pressure||mmHg|Mean|125|125.0|Standard Deviation|11|11.0|||
3840592|NCT01682837|3666194|B1|||BMI||kg/m^2|Mean|31|31.0|Standard Deviation|5|5.0|||
3840593|NCT01682837|3666194|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3840594|NCT01682837|3666194|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840595|NCT01682837|3666194|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840596|NCT01682837|3666194|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3840597|NCT01682837|3666194|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3840598|NCT01682837|3666194|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840599|NCT01682837|3666194|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840600|NCT01682837|3666194|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840601|NCT01682837|3666194|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840602|NCT01682837|3666194|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3840603|NCT01682837|3666194|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3840604|NCT01682837|3666194|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3840605|NCT01682837|3666194|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3840606|NCT01682837|3666194|B1|||Age||years|Mean|54|54.0|Standard Deviation|12|12.0|||
3840607|NCT01682759|3666236|B3|||Body Weight|For both the Omarigliptin and Glimepiride groups n=375|kg|Mean|88.1|88.1|Standard Deviation|18.4|18.4|||
3840608|NCT01682759|3666237|B2|||Body Weight|For both the Omarigliptin and Glimepiride groups n=375|kg|Mean|88.7|88.7|Standard Deviation|18.7|18.7|||
3840609|NCT01682759|3666238|B1|||Body Weight|For both the Omarigliptin and Glimepiride groups n=375|kg|Mean|87.5|87.5|Standard Deviation|18.1|18.1|||
3840610|NCT01682759|3666236|B3|||Fasting Plamsa Glucose (FPG)|For both the Omarigliptin and Glimepiride groups n=375|mg/dL|Mean|154.0|154.0|Standard Deviation|30.7|30.7|||
3840611|NCT01682759|3666237|B2|||Fasting Plamsa Glucose (FPG)|For both the Omarigliptin and Glimepiride groups n=375|mg/dL|Mean|152.7|152.7|Standard Deviation|30.0|30.0|||
3840612|NCT01682759|3666238|B1|||Fasting Plamsa Glucose (FPG)|For both the Omarigliptin and Glimepiride groups n=375|mg/dL|Mean|155.3|155.3|Standard Deviation|31.4|31.4|||
3840613|NCT01682759|3666236|B3|||Hemoglobin A1C|For both the Omarigliptin and Glimepiride groups n=375|A1C (%)|Mean|7.46|7.46|Standard Deviation|0.73|0.73|||
3840614|NCT01682759|3666237|B2|||Hemoglobin A1C|For both the Omarigliptin and Glimepiride groups n=375|A1C (%)|Mean|7.43|7.43|Standard Deviation|0.72|0.72|||
3840615|NCT01682759|3666238|B1|||Hemoglobin A1C|For both the Omarigliptin and Glimepiride groups n=375|A1C (%)|Mean|7.49|7.49|Standard Deviation|0.75|0.75|||
3840616|NCT01682759|3666236|B3||Male|Sex: Female, Male||Participants|Count of Participants|414|414.0||||||
3840617|NCT01682759|3666237|B2||Male|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
3840618|NCT01682759|3666238|B1||Male|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
3840619|NCT01682759|3666236|B3||Female|Sex: Female, Male||Participants|Count of Participants|337|337.0||||||
3840620|NCT01682759|3666237|B2||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3840621|NCT01682759|3666238|B1||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
3840622|NCT01682759|3666236|B3|||Age||years|Mean|57.7|57.7|Standard Deviation|9.5|9.5|||
3840623|NCT01682759|3666237|B2|||Age||years|Mean|57.6|57.6|Standard Deviation|9.3|9.3|||
3840624|NCT01682759|3666238|B1|||Age||years|Mean|57.9|57.9|Standard Deviation|9.6|9.6|||
3840625|NCT01682720|3666259|B5|Interferon ineligible||Interferon Eligibility|Only participants who were treatment-naive at baseline were analyzed.|participants|Number|21|21.0||||||
3840626|NCT01682720|3666260|B4|Interferon ineligible||Interferon Eligibility|Only participants who were treatment-naive at baseline were analyzed.|participants|Number|11|11.0||||||
3840627|NCT01682720|3666261|B3|Interferon ineligible||Interferon Eligibility|Only participants who were treatment-naive at baseline were analyzed.|participants|Number|0|0.0||||||
3840628|NCT01682720|3666262|B2|Interferon ineligible||Interferon Eligibility|Only participants who were treatment-naive at baseline were analyzed.|participants|Number|5|5.0||||||
3840629|NCT01682720|3666263|B1|Interferon ineligible||Interferon Eligibility|Only participants who were treatment-naive at baseline were analyzed.|participants|Number|5|5.0||||||
3840630|NCT01682720|3666259|B5|Interferon eligible||Interferon Eligibility|Only participants who were treatment-naive at baseline were analyzed.|participants|Number|153|153.0||||||
3840631|NCT01682720|3666260|B4|Interferon eligible||Interferon Eligibility|Only participants who were treatment-naive at baseline were analyzed.|participants|Number|94|94.0||||||
3840632|NCT01682720|3666261|B3|Interferon eligible||Interferon Eligibility|Only participants who were treatment-naive at baseline were analyzed.|participants|Number|2|2.0||||||
3840633|NCT01682720|3666262|B2|Interferon eligible||Interferon Eligibility|Only participants who were treatment-naive at baseline were analyzed.|participants|Number|27|27.0||||||
3840747|NCT01682720|3666261|B3|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3840634|NCT01682720|3666263|B1|Interferon eligible||Interferon Eligibility|Only participants who were treatment-naive at baseline were analyzed.|participants|Number|30|30.0||||||
3840635|NCT01682720|3666259|B5|Relapse/Breakthrough||Response to prior HCV treatment|Only participants who were treatment-experienced at baseline were analyzed.|participants|Number|159|159.0||||||
3840636|NCT01682720|3666260|B4|Relapse/Breakthrough||Response to prior HCV treatment|Only participants who were treatment-experienced at baseline were analyzed.|participants|Number|94|94.0||||||
3840637|NCT01682720|3666261|B3|Relapse/Breakthrough||Response to prior HCV treatment|Only participants who were treatment-experienced at baseline were analyzed.|participants|Number|5|5.0||||||
3840638|NCT01682720|3666262|B2|Relapse/Breakthrough||Response to prior HCV treatment|Only participants who were treatment-experienced at baseline were analyzed.|participants|Number|28|28.0||||||
3840639|NCT01682720|3666263|B1|Relapse/Breakthrough||Response to prior HCV treatment|Only participants who were treatment-experienced at baseline were analyzed.|participants|Number|32|32.0||||||
3840640|NCT01682720|3666259|B5|Nonresponse||Response to prior HCV treatment|Only participants who were treatment-experienced at baseline were analyzed.|participants|Number|73|73.0||||||
3840641|NCT01682720|3666260|B4|Nonresponse||Response to prior HCV treatment|Only participants who were treatment-experienced at baseline were analyzed.|participants|Number|41|41.0||||||
3840642|NCT01682720|3666261|B3|Nonresponse||Response to prior HCV treatment|Only participants who were treatment-experienced at baseline were analyzed.|participants|Number|4|4.0||||||
3840643|NCT01682720|3666262|B2|Nonresponse||Response to prior HCV treatment|Only participants who were treatment-experienced at baseline were analyzed.|participants|Number|10|10.0||||||
3840644|NCT01682720|3666263|B1|Nonresponse||Response to prior HCV treatment|Only participants who were treatment-experienced at baseline were analyzed.|participants|Number|18|18.0||||||
3840645|NCT01682720|3666259|B5|Interferon intolerant||Response to prior HCV treatment|Only participants who were treatment-experienced at baseline were analyzed.|participants|Number|13|13.0||||||
3840646|NCT01682720|3666260|B4|Interferon intolerant||Response to prior HCV treatment|Only participants who were treatment-experienced at baseline were analyzed.|participants|Number|10|10.0||||||
3840647|NCT01682720|3666261|B3|Interferon intolerant||Response to prior HCV treatment|Only participants who were treatment-experienced at baseline were analyzed.|participants|Number|0|0.0||||||
3840648|NCT01682720|3666262|B2|Interferon intolerant||Response to prior HCV treatment|Only participants who were treatment-experienced at baseline were analyzed.|participants|Number|3|3.0||||||
3840649|NCT01682720|3666263|B1|Interferon intolerant||Response to prior HCV treatment|Only participants who were treatment-experienced at baseline were analyzed.|participants|Number|0|0.0||||||
3840650|NCT01682720|3666259|B5|Naive||Prior HCV Treatment Experience||participants|Number|174|174.0||||||
3840651|NCT01682720|3666260|B4|Naive||Prior HCV Treatment Experience||participants|Number|105|105.0||||||
3840652|NCT01682720|3666261|B3|Naive||Prior HCV Treatment Experience||participants|Number|2|2.0||||||
3840653|NCT01682720|3666262|B2|Naive||Prior HCV Treatment Experience||participants|Number|32|32.0||||||
3840654|NCT01682720|3666263|B1|Naive||Prior HCV Treatment Experience||participants|Number|35|35.0||||||
3840655|NCT01682720|3666259|B5|Experienced||Prior HCV Treatment Experience||participants|Number|245|245.0||||||
3840656|NCT01682720|3666260|B4|Experienced||Prior HCV Treatment Experience||participants|Number|145|145.0||||||
3840657|NCT01682720|3666261|B3|Experienced||Prior HCV Treatment Experience||participants|Number|9|9.0||||||
3840658|NCT01682720|3666262|B2|Experienced||Prior HCV Treatment Experience||participants|Number|41|41.0||||||
3840659|NCT01682720|3666263|B1|Experienced||Prior HCV Treatment Experience||participants|Number|50|50.0||||||
3840660|NCT01682720|3666259|B5|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|306|306.0||||||
3840661|NCT01682720|3666260|B4|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|178|178.0||||||
3840662|NCT01682720|3666261|B3|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|7|7.0||||||
3840663|NCT01682720|3666262|B2|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|57|57.0||||||
3840664|NCT01682720|3666263|B1|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|64|64.0||||||
3840665|NCT01682720|3666259|B5|< 6 log10 IU/mL||HCV RNA Category||participants|Number|113|113.0||||||
3840666|NCT01682720|3666260|B4|< 6 log10 IU/mL||HCV RNA Category||participants|Number|72|72.0||||||
3840667|NCT01682720|3666261|B3|< 6 log10 IU/mL||HCV RNA Category||participants|Number|4|4.0||||||
3840668|NCT01682720|3666262|B2|< 6 log10 IU/mL||HCV RNA Category||participants|Number|16|16.0||||||
3840669|NCT01682720|3666263|B1|< 6 log10 IU/mL||HCV RNA Category||participants|Number|21|21.0||||||
3840670|NCT01682720|3666259|B5|||HCV RNA||log10 IU/mL|Mean|6.4|6.4|Standard Deviation|0.72|0.72|||
3840671|NCT01682720|3666260|B4|||HCV RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.74|0.74|||
3840672|NCT01682720|3666261|B3|||HCV RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.77|0.77|||
3840673|NCT01682720|3666262|B2|||HCV RNA||log10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.70|0.7|||
3840674|NCT01682720|3666263|B1|||HCV RNA||log10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.69|0.69|||
3840675|NCT01682720|3666259|B5|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|58|58.0||||||
3840676|NCT01682720|3666260|B4|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|33|33.0||||||
3840677|NCT01682720|3666261|B3|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
3840678|NCT01682720|3666262|B2|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|8|8.0||||||
3840679|NCT01682720|3666263|B1|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|14|14.0||||||
3840680|NCT01682720|3666259|B5|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|225|225.0||||||
3840681|NCT01682720|3666260|B4|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|131|131.0||||||
3840682|NCT01682720|3666261|B3|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|4|4.0||||||
3840683|NCT01682720|3666262|B2|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|41|41.0||||||
3840684|NCT01682720|3666263|B1|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|49|49.0||||||
3840685|NCT01682720|3666259|B5|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|136|136.0||||||
3840686|NCT01682720|3666260|B4|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|86|86.0||||||
3840687|NCT01682720|3666261|B3|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|4|4.0||||||
3840688|NCT01682720|3666262|B2|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|24|24.0||||||
3840689|NCT01682720|3666263|B1|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|22|22.0||||||
3840690|NCT01682720|3666259|B5|Yes||Liver Cirrhosis||participants|Number|90|90.0||||||
3840691|NCT01682720|3666260|B4|Yes||Liver Cirrhosis||participants|Number|60|60.0||||||
3840692|NCT01682720|3666261|B3|Yes||Liver Cirrhosis||participants|Number|2|2.0||||||
3840693|NCT01682720|3666262|B2|Yes||Liver Cirrhosis||participants|Number|11|11.0||||||
3840694|NCT01682720|3666263|B1|Yes||Liver Cirrhosis||participants|Number|17|17.0||||||
3840695|NCT01682720|3666259|B5|No||Liver Cirrhosis||participants|Number|329|329.0||||||
3840696|NCT01682720|3666260|B4|No||Liver Cirrhosis||participants|Number|190|190.0||||||
3840697|NCT01682720|3666261|B3|No||Liver Cirrhosis||participants|Number|9|9.0||||||
3840698|NCT01682720|3666262|B2|No||Liver Cirrhosis||participants|Number|62|62.0||||||
3840699|NCT01682720|3666263|B1|No||Liver Cirrhosis||participants|Number|68|68.0||||||
3840700|NCT01682720|3666259|B5|Genotype 3||HCV Genotype||participants|Number|328|328.0||||||
3840701|NCT01682720|3666260|B4|Genotype 3||HCV Genotype||participants|Number|250|250.0||||||
3840702|NCT01682720|3666261|B3|Genotype 3||HCV Genotype||participants|Number|11|11.0||||||
3840703|NCT01682720|3666262|B2|Genotype 3||HCV Genotype||participants|Number|0|0.0||||||
3840704|NCT01682720|3666263|B1|Genotype 3||HCV Genotype||participants|Number|67|67.0||||||
3840705|NCT01682720|3666259|B5|Genotype 2||HCV Genotype||participants|Number|91|91.0||||||
3840706|NCT01682720|3666260|B4|Genotype 2||HCV Genotype||participants|Number|0|0.0||||||
3840707|NCT01682720|3666261|B3|Genotype 2||HCV Genotype||participants|Number|0|0.0||||||
3840708|NCT01682720|3666262|B2|Genotype 2||HCV Genotype||participants|Number|73|73.0||||||
3840709|NCT01682720|3666263|B1|Genotype 2||HCV Genotype||participants|Number|18|18.0||||||
3840710|NCT01682720|3666259|B5|Sweden||Region of Enrollment||participants|Number|24|24.0||||||
3840711|NCT01682720|3666260|B4|Sweden||Region of Enrollment||participants|Number|12|12.0||||||
3840712|NCT01682720|3666261|B3|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
3840713|NCT01682720|3666262|B2|Sweden||Region of Enrollment||participants|Number|7|7.0||||||
3840714|NCT01682720|3666263|B1|Sweden||Region of Enrollment||participants|Number|5|5.0||||||
3840715|NCT01682720|3666259|B5|Italy||Region of Enrollment||participants|Number|62|62.0||||||
3840716|NCT01682720|3666260|B4|Italy||Region of Enrollment||participants|Number|27|27.0||||||
3840717|NCT01682720|3666261|B3|Italy||Region of Enrollment||participants|Number|1|1.0||||||
3840718|NCT01682720|3666262|B2|Italy||Region of Enrollment||participants|Number|25|25.0||||||
3840719|NCT01682720|3666263|B1|Italy||Region of Enrollment||participants|Number|9|9.0||||||
3840720|NCT01682720|3666259|B5|United Kingdom||Region of Enrollment||participants|Number|55|55.0||||||
3840721|NCT01682720|3666260|B4|United Kingdom||Region of Enrollment||participants|Number|31|31.0||||||
3840722|NCT01682720|3666261|B3|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3840723|NCT01682720|3666262|B2|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3840724|NCT01682720|3666263|B1|United Kingdom||Region of Enrollment||participants|Number|17|17.0||||||
3840725|NCT01682720|3666259|B5|Germany||Region of Enrollment||participants|Number|69|69.0||||||
3840726|NCT01682720|3666260|B4|Germany||Region of Enrollment||participants|Number|46|46.0||||||
3840727|NCT01682720|3666261|B3|Germany||Region of Enrollment||participants|Number|1|1.0||||||
3840728|NCT01682720|3666262|B2|Germany||Region of Enrollment||participants|Number|8|8.0||||||
3840729|NCT01682720|3666263|B1|Germany||Region of Enrollment||participants|Number|14|14.0||||||
3840730|NCT01682720|3666259|B5|Netherlands||Region of Enrollment||participants|Number|25|25.0||||||
3840731|NCT01682720|3666260|B4|Netherlands||Region of Enrollment||participants|Number|14|14.0||||||
3840732|NCT01682720|3666261|B3|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
3840733|NCT01682720|3666262|B2|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
3840734|NCT01682720|3666263|B1|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
3840735|NCT01682720|3666259|B5|Austria||Region of Enrollment||participants|Number|18|18.0||||||
3840736|NCT01682720|3666260|B4|Austria||Region of Enrollment||participants|Number|12|12.0||||||
3840737|NCT01682720|3666261|B3|Austria||Region of Enrollment||participants|Number|0|0.0||||||
3840738|NCT01682720|3666262|B2|Austria||Region of Enrollment||participants|Number|2|2.0||||||
3840739|NCT01682720|3666263|B1|Austria||Region of Enrollment||participants|Number|4|4.0||||||
3840740|NCT01682720|3666259|B5|Poland||Region of Enrollment||participants|Number|22|22.0||||||
3840741|NCT01682720|3666260|B4|Poland||Region of Enrollment||participants|Number|18|18.0||||||
3840742|NCT01682720|3666261|B3|Poland||Region of Enrollment||participants|Number|0|0.0||||||
3840743|NCT01682720|3666262|B2|Poland||Region of Enrollment||participants|Number|0|0.0||||||
3840744|NCT01682720|3666263|B1|Poland||Region of Enrollment||participants|Number|4|4.0||||||
3840745|NCT01682720|3666259|B5|Spain||Region of Enrollment||participants|Number|48|48.0||||||
3840746|NCT01682720|3666260|B4|Spain||Region of Enrollment||participants|Number|31|31.0||||||
3840748|NCT01682720|3666262|B2|Spain||Region of Enrollment||participants|Number|5|5.0||||||
3840749|NCT01682720|3666263|B1|Spain||Region of Enrollment||participants|Number|11|11.0||||||
3840750|NCT01682720|3666259|B5|Estonia||Region of Enrollment||participants|Number|15|15.0||||||
3840751|NCT01682720|3666260|B4|Estonia||Region of Enrollment||participants|Number|6|6.0||||||
3840752|NCT01682720|3666261|B3|Estonia||Region of Enrollment||participants|Number|4|4.0||||||
3840753|NCT01682720|3666262|B2|Estonia||Region of Enrollment||participants|Number|2|2.0||||||
3840754|NCT01682720|3666263|B1|Estonia||Region of Enrollment||participants|Number|3|3.0||||||
3840755|NCT01682720|3666259|B5|France||Region of Enrollment||participants|Number|81|81.0||||||
3840756|NCT01682720|3666260|B4|France||Region of Enrollment||participants|Number|53|53.0||||||
3840757|NCT01682720|3666261|B3|France||Region of Enrollment||participants|Number|0|0.0||||||
3840758|NCT01682720|3666262|B2|France||Region of Enrollment||participants|Number|15|15.0||||||
3840759|NCT01682720|3666263|B1|France||Region of Enrollment||participants|Number|13|13.0||||||
3840760|NCT01682720|3666259|B5|Not permitted||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3840761|NCT01682720|3666260|B4|Not permitted||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3840762|NCT01682720|3666261|B3|Not permitted||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3840763|NCT01682720|3666262|B2|Not permitted||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3840764|NCT01682720|3666263|B1|Not permitted||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3840765|NCT01682720|3666259|B5|Asian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3840766|NCT01682720|3666260|B4|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3840767|NCT01682720|3666261|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3840768|NCT01682720|3666262|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3840769|NCT01682720|3666263|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3840770|NCT01682720|3666259|B5|White||Race/Ethnicity, Customized||participants|Number|393|393.0||||||
3840771|NCT01682720|3666260|B4|White||Race/Ethnicity, Customized||participants|Number|236|236.0||||||
3840772|NCT01682720|3666261|B3|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3840773|NCT01682720|3666262|B2|White||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
3840774|NCT01682720|3666263|B1|White||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
3840775|NCT01682720|3666259|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3840776|NCT01682720|3666260|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3840777|NCT01682720|3666261|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3840778|NCT01682720|3666262|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3840779|NCT01682720|3666263|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3840780|NCT01682720|3666259|B5|Not Permitted||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3840781|NCT01682720|3666260|B4|Not Permitted||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3840782|NCT01682720|3666261|B3|Not Permitted||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3840783|NCT01682720|3666262|B2|Not Permitted||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3840784|NCT01682720|3666263|B1|Not Permitted||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3840785|NCT01682720|3666259|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|349|349.0||||||
3840786|NCT01682720|3666260|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|203|203.0||||||
3840787|NCT01682720|3666261|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3840788|NCT01682720|3666262|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
3840789|NCT01682720|3666263|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|71|71.0||||||
3840790|NCT01682720|3666259|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
3840791|NCT01682720|3666260|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3840792|NCT01682720|3666261|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3840793|NCT01682720|3666262|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3840794|NCT01682720|3666263|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3840795|NCT01682720|3666259|B5||Male|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
3840796|NCT01682720|3666260|B4||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3840797|NCT01682720|3666261|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3840798|NCT01682720|3666262|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3840799|NCT01682720|3666263|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3840800|NCT01682720|3666259|B5||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3840801|NCT01682720|3666260|B4||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3840802|NCT01682720|3666261|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3840803|NCT01682720|3666262|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3840804|NCT01682720|3666263|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3840805|NCT01682720|3666259|B5|||Age||years|Mean|50|50.0|Standard Deviation|10.8|10.8|||
3840806|NCT01682720|3666260|B4|||Age||years|Mean|48|48.0|Standard Deviation|10.1|10.1|||
3840807|NCT01682720|3666261|B3|||Age||years|Mean|46|46.0|Standard Deviation|8.8|8.8|||
3840808|NCT01682720|3666262|B2|||Age||years|Mean|58|58.0|Standard Deviation|10.1|10.1|||
3840809|NCT01682720|3666263|B1|||Age||years|Mean|49|49.0|Standard Deviation|10.5|10.5|||
3840810|NCT01682681|3666283|B1||Male|Sex: Female, Male||Participants|Count of Participants|670|670.0||||||
3840811|NCT01682681|3666283|B1||Female|Sex: Female, Male||Participants|Count of Participants|562|562.0||||||
3840812|NCT01682681|3666283|B1|||Age||Years|Mean|24.07|24.07|Standard Deviation|17.10|17.1|||
3840813|NCT01682642|3666291|B3|Belgium||Region of Enrollment||participants|Number|119|119.0||||||
3840814|NCT01682642|3666292|B2|Belgium||Region of Enrollment||participants|Number|58|58.0||||||
3840815|NCT01682642|3666293|B1|Belgium||Region of Enrollment||participants|Number|61|61.0||||||
3840816|NCT01682642|3666291|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3840817|NCT01682642|3666292|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3840818|NCT01682642|3666293|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3840819|NCT01682642|3666291|B3||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3840820|NCT01682642|3666292|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3840821|NCT01682642|3666293|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3840822|NCT01682642|3666291|B3|||Age||years|Mean|31.02|31.02|Standard Deviation|3.96|3.96|||
3840823|NCT01682642|3666292|B2|||Age||years|Mean|31.70|31.7|Standard Deviation|4.28|4.28|||
3840824|NCT01682642|3666293|B1|||Age||years|Mean|30.33|30.33|Standard Deviation|3.63|3.63|||
3840825|NCT01682642|3666291|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3840826|NCT01682642|3666292|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3840827|NCT01682642|3666293|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3840828|NCT01682642|3666291|B3||Between 18 and 65 years|Age||Participants|Count of Participants|119|119.0||||||
3840829|NCT01682642|3666292|B2||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3840830|NCT01682642|3666293|B1||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
3840831|NCT01682642|3666291|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3840832|NCT01682642|3666292|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3840833|NCT01682642|3666293|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3840834|NCT01682603|3666312|B1|Non-Autonomic dysreflexia||Autonomic dysreflexia||participants|Number|23|23.0||||||
3840835|NCT01682603|3666312|B1|Autonomic dysreflexia||Autonomic dysreflexia||participants|Number|11|11.0||||||
3840836|NCT01682603|3666312|B1|D||ASIA Classification|ASIA Impairment Scale A: Complete. No sensory or motor function is preserved in the sacral segments S4-S5. B: Incomplete. Sensory but not motor function is preserved below the neurological level and includes the sacral segments S4-S5. C: Incomplete. Motor function is preserved below the neurological level, and more then half of key muscles below the neurological level have a muscle grade less then 3 (Grades 0-2). D: Incomplete. Motor function is preserved below the neurological level, and at least half of key muscles below the neurological level have a muscle grade greater than or equal to 3.|participants|Number|2|2.0||||||
3840837|NCT01682603|3666312|B1|C||ASIA Classification|ASIA Impairment Scale A: Complete. No sensory or motor function is preserved in the sacral segments S4-S5. B: Incomplete. Sensory but not motor function is preserved below the neurological level and includes the sacral segments S4-S5. C: Incomplete. Motor function is preserved below the neurological level, and more then half of key muscles below the neurological level have a muscle grade less then 3 (Grades 0-2). D: Incomplete. Motor function is preserved below the neurological level, and at least half of key muscles below the neurological level have a muscle grade greater than or equal to 3.|participants|Number|2|2.0||||||
3840838|NCT01682603|3666312|B1|B||ASIA Classification|ASIA Impairment Scale A: Complete. No sensory or motor function is preserved in the sacral segments S4-S5. B: Incomplete. Sensory but not motor function is preserved below the neurological level and includes the sacral segments S4-S5. C: Incomplete. Motor function is preserved below the neurological level, and more then half of key muscles below the neurological level have a muscle grade less then 3 (Grades 0-2). D: Incomplete. Motor function is preserved below the neurological level, and at least half of key muscles below the neurological level have a muscle grade greater than or equal to 3.|participants|Number|3|3.0||||||
3840839|NCT01682603|3666312|B1|A||ASIA Classification|ASIA Impairment Scale A: Complete. No sensory or motor function is preserved in the sacral segments S4-S5. B: Incomplete. Sensory but not motor function is preserved below the neurological level and includes the sacral segments S4-S5. C: Incomplete. Motor function is preserved below the neurological level, and more then half of key muscles below the neurological level have a muscle grade less then 3 (Grades 0-2). D: Incomplete. Motor function is preserved below the neurological level, and at least half of key muscles below the neurological level have a muscle grade greater than or equal to 3.|participants|Number|27|27.0||||||
3840840|NCT01682603|3666312|B1|Thoracic||Injury Level||participants|Number|21|21.0||||||
3840841|NCT01682603|3666312|B1|Cervical||Injury Level||participants|Number|13|13.0||||||
3840842|NCT01682603|3666312|B1|Taiwan||Region of Enrollment||participants|Number|34|34.0||||||
3840843|NCT01682603|3666312|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3840844|NCT01682603|3666312|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3840845|NCT01682603|3666312|B1|||Age||years|Mean|41.5|41.5|Full Range|||22.0|74.0|
3840846|NCT01682538|3666326|B1|Netherlands||Region of Enrollment||participants|Number|12|12.0||||||
3840847|NCT01682538|3666326|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3840848|NCT01682538|3666326|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3840849|NCT01682538|3666326|B1|||Age||years|Mean|35|35.0|Standard Deviation|12|12.0|||
3840850|NCT01682538|3666326|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3840851|NCT01682538|3666326|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3840852|NCT01682538|3666326|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3840853|NCT01682512|3666354|B4||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3840854|NCT01682512|3666355|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3840855|NCT01682512|3666356|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3840856|NCT01682512|3666357|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3840857|NCT01682512|3666354|B4||Female|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
3840858|NCT01682512|3666355|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3840859|NCT01682512|3666356|B2||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3840860|NCT01682512|3666357|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3840861|NCT01682512|3666354|B4|||Age||Years|Mean|54.5|54.5|Standard Deviation|11.08|11.08|||
3840862|NCT01682512|3666355|B3|||Age||Years|Mean|54.8|54.8|Standard Deviation|12.22|12.22|||
3840863|NCT01682512|3666356|B2|||Age||Years|Mean|54.0|54.0|Standard Deviation|11.10|11.1|||
3840864|NCT01682512|3666357|B1|||Age||Years|Mean|54.7|54.7|Standard Deviation|10.46|10.46|||
3840865|NCT01682460|3666384|B1|Canada||Region of Enrollment||participants|Number|11|11.0||||||
3840866|NCT01682460|3666384|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3840867|NCT01682460|3666384|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3840868|NCT01682460|3666384|B1|||Age||years|Mean|68|68.0|Standard Deviation|5|5.0|||
3840869|NCT01682135|3666399|B4|China||Region of Enrollment||Participants|Number|28|28.0||||||
3840870|NCT01682135|3666400|B3|China||Region of Enrollment||Participants|Number|12|12.0||||||
3840871|NCT01682135|3666401|B2|China||Region of Enrollment||Participants|Number|10|10.0||||||
3840872|NCT01682135|3666402|B1|China||Region of Enrollment||Participants|Number|6|6.0||||||
3840873|NCT01682135|3666399|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840874|NCT01682135|3666400|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840875|NCT01682135|3666401|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840876|NCT01682135|3666402|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840877|NCT01682135|3666399|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840878|NCT01682135|3666400|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840879|NCT01682135|3666401|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840880|NCT01682135|3666402|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840881|NCT01682135|3666399|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840882|NCT01682135|3666400|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840883|NCT01682135|3666401|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840884|NCT01682135|3666402|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840885|NCT01682135|3666399|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840886|NCT01682135|3666400|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840887|NCT01682135|3666401|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840888|NCT01682135|3666402|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840889|NCT01682135|3666399|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840890|NCT01682135|3666400|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840891|NCT01682135|3666401|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840892|NCT01682135|3666402|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840893|NCT01682135|3666399|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3840894|NCT01682135|3666400|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3840895|NCT01682135|3666401|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3840896|NCT01682135|3666402|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3840897|NCT01682135|3666399|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840898|NCT01682135|3666400|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840899|NCT01682135|3666401|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840900|NCT01682135|3666402|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3840901|NCT01682135|3666399|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3840902|NCT01682135|3666400|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3840903|NCT01682135|3666401|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3840904|NCT01682135|3666402|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3840905|NCT01682135|3666399|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3840906|NCT01682135|3666400|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3840907|NCT01682135|3666401|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3840908|NCT01682135|3666402|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3840909|NCT01682135|3666399|B4|||Age||Years|Mean|54.80|54.8|Standard Deviation|9.536|9.536|||
3840910|NCT01682135|3666400|B3|||Age||Years|Mean|58.18|58.18|Standard Deviation|9.444|9.444|||
3840911|NCT01682135|3666401|B2|||Age||Years|Mean|52.92|52.92|Standard Deviation|9.509|9.509|||
3840912|NCT01682135|3666402|B1|||Age||Years|Mean|51.20|51.2|Standard Deviation|9.060|9.06|||
3840913|NCT01682083|3666436|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3840914|NCT01682083|3666437|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3840915|NCT01682083|3666438|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3840916|NCT01682083|3666436|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|859|859.0||||||
3840917|NCT01682083|3666437|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|427|427.0||||||
3840918|NCT01682083|3666438|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|432|432.0||||||
3840919|NCT01682083|3666436|B3||Male|Sex: Female, Male||Participants|Count of Participants|482|482.0||||||
3840920|NCT01682083|3666437|B2||Male|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
3840921|NCT01682083|3666438|B1||Male|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
3840922|NCT01682083|3666436|B3||Female|Sex: Female, Male||Participants|Count of Participants|388|388.0||||||
3840923|NCT01682083|3666437|B2||Female|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
3840924|NCT01682083|3666438|B1||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
3840925|NCT01682083|3666436|B3|||Age||Years|Mean|50.4|50.4|Standard Deviation|13.66|13.66|||
3840926|NCT01682083|3666437|B2|||Age||Years|Mean|50.5|50.5|Standard Deviation|13.14|13.14|||
3840927|NCT01682083|3666438|B1|||Age||Years|Mean|50.4|50.4|Standard Deviation|14.17|14.17|||
3840928|NCT01682044|3666451|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3840929|NCT01682044|3666451|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3840930|NCT01682044|3666451|B1|||Age||years|Mean|60.9|60.9|Standard Deviation|13.1|13.1|||
3840931|NCT01682031|3666461|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3840932|NCT01682031|3666462|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3840933|NCT01682031|3666463|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3840934|NCT01682031|3666461|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3840935|NCT01682031|3666462|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3840936|NCT01682031|3666463|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3840937|NCT01682031|3666461|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3840938|NCT01682031|3666462|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3840939|NCT01682031|3666463|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3840940|NCT01682031|3666461|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3840941|NCT01682031|3666462|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3840942|NCT01682031|3666463|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3840943|NCT01682031|3666461|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3840944|NCT01682031|3666462|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3840945|NCT01682031|3666463|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3840946|NCT01682031|3666461|B3|||Age||years|Mean|57.1|57.1|Standard Deviation|7.3|7.3|||
3840947|NCT01682031|3666462|B2|||Age||years|Mean|57.4|57.4|Standard Deviation|8.2|8.2|||
3840948|NCT01682031|3666463|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|6.6|6.6|||
3840949|NCT01681992|3666484|B4|Other||Race/Ethnicity, Customized||Participants|Number|150|150.0||||||
3840950|NCT01681992|3666485|B3|Other||Race/Ethnicity, Customized||Participants|Number|49|49.0||||||
3840951|NCT01681992|3666486|B2|Other||Race/Ethnicity, Customized||Participants|Number|46|46.0||||||
3840952|NCT01681992|3666487|B1|Other||Race/Ethnicity, Customized||Participants|Number|55|55.0||||||
3840953|NCT01681992|3666484|B4|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Number|3091|3091.0||||||
3840954|NCT01681992|3666485|B3|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Number|1052|1052.0||||||
3840955|NCT01681992|3666486|B2|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Number|1022|1022.0||||||
3840956|NCT01681992|3666487|B1|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Number|1017|1017.0||||||
3840957|NCT01681992|3666484|B4|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
3840958|NCT01681992|3666485|B3|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3840959|NCT01681992|3666486|B2|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3840960|NCT01681992|3666487|B1|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3840961|NCT01681992|3666484|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3840962|NCT01681992|3666485|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3840963|NCT01681992|3666486|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3840964|NCT01681992|3666487|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3840965|NCT01681992|3666484|B4|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1095|1095.0||||||
3840966|NCT01681992|3666485|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|367|367.0||||||
3840967|NCT01681992|3666486|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|366|366.0||||||
3840968|NCT01681992|3666487|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|362|362.0||||||
3840969|NCT01681992|3666484|B4|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3840970|NCT01681992|3666485|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3840971|NCT01681992|3666486|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3840972|NCT01681992|3666487|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3840973|NCT01681992|3666484|B4|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3840974|NCT01681992|3666485|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3840975|NCT01681992|3666486|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3840976|NCT01681992|3666487|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3840977|NCT01681992|3666484|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3840978|NCT01681992|3666485|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3840979|NCT01681992|3666486|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3840980|NCT01681992|3666487|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3840981|NCT01681992|3666484|B4|African Heritage / African American||Race/Ethnicity, Customized||Participants|Number|144|144.0||||||
3840982|NCT01681992|3666485|B3|African Heritage / African American||Race/Ethnicity, Customized||Participants|Number|46|46.0||||||
3840983|NCT01681992|3666486|B2|African Heritage / African American||Race/Ethnicity, Customized||Participants|Number|53|53.0||||||
3840984|NCT01681992|3666487|B1|African Heritage / African American||Race/Ethnicity, Customized||Participants|Number|45|45.0||||||
3840985|NCT01681992|3666484|B4||Male|Sex: Female, Male||Participants|Count of Participants|2336|2336.0||||||
3840986|NCT01681992|3666485|B3||Male|Sex: Female, Male||Participants|Count of Participants|768|768.0||||||
3840987|NCT01681992|3666486|B2||Male|Sex: Female, Male||Participants|Count of Participants|779|779.0||||||
3840988|NCT01681992|3666487|B1||Male|Sex: Female, Male||Participants|Count of Participants|789|789.0||||||
3840989|NCT01681992|3666484|B4||Female|Sex: Female, Male||Participants|Count of Participants|2180|2180.0||||||
3840990|NCT01681992|3666485|B3||Female|Sex: Female, Male||Participants|Count of Participants|758|758.0||||||
3840991|NCT01681992|3666486|B2||Female|Sex: Female, Male||Participants|Count of Participants|718|718.0||||||
3840992|NCT01681992|3666487|B1||Female|Sex: Female, Male||Participants|Count of Participants|704|704.0||||||
3840993|NCT01681992|3666484|B4|||Age||Months|Mean|12.6|12.6|Standard Deviation|0.9|0.9|||
3840994|NCT01681992|3666485|B3|||Age||Months|Mean|12.6|12.6|Standard Deviation|0.9|0.9|||
3840995|NCT01681992|3666486|B2|||Age||Months|Mean|12.6|12.6|Standard Deviation|0.9|0.9|||
3840996|NCT01681992|3666487|B1|||Age||Months|Mean|12.6|12.6|Standard Deviation|0.9|0.9|||
3840997|NCT01681849|3666575|B4|United States||Region of Enrollment||participants|Number|84|84.0||||||
3840998|NCT01681849|3666576|B3|United States||Region of Enrollment||participants|Number|56|56.0||||||
3840999|NCT01681849|3666577|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3841000|NCT01681849|3666578|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3841001|NCT01681849|3666575|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3841002|NCT01681849|3666576|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3841003|NCT01681849|3666577|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3841004|NCT01681849|3666578|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3841005|NCT01681849|3666575|B4||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3841006|NCT01681849|3666576|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3841007|NCT01681849|3666577|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3841008|NCT01681849|3666578|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3841009|NCT01681849|3666575|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3841010|NCT01681849|3666576|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3841011|NCT01681849|3666577|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3841012|NCT01681849|3666578|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3841013|NCT01681849|3666575|B4||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
3841014|NCT01681849|3666576|B3||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
3841015|NCT01681849|3666577|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3841016|NCT01681849|3666578|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3841017|NCT01681849|3666575|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3841018|NCT01681849|3666576|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3841019|NCT01681849|3666577|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3841020|NCT01681849|3666578|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3841021|NCT01681836|3666589|B1|||Methemoglobin||percentage level of methemoglobin|Mean|1.0|1.0|Standard Deviation|0.2|0.2|||
3841022|NCT01681836|3666589|B1|||Mean arterial pressure||mmHg|Mean|91|91.0|Standard Deviation|6.8|6.8|||
3841023|NCT01681836|3666589|B1|||Diastolic blood pressure||mmHg|Mean|75|75.0|Standard Deviation|9.3|9.3|||
3841024|NCT01681836|3666589|B1|||Systolic blood pressure||mmHg|Mean|122|122.0|Standard Deviation|9.2|9.2|||
3841025|NCT01681836|3666589|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841026|NCT01681836|3666589|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841027|NCT01681836|3666589|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3841028|NCT01681836|3666589|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841029|NCT01681836|3666589|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841030|NCT01681836|3666589|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3841031|NCT01681836|3666589|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841032|NCT01681836|3666589|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3841033|NCT01681836|3666589|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3841034|NCT01681836|3666589|B1|||Age||years|Mean|30.4|30.4|Full Range|||21.0|39.0|
3841035|NCT01681628|3666614|B3|||PCL-C|PCL-C (post traumatic check list for civilians) is a measure of the severity of post traumatic stress disorder (PTSD), and can also be used for screening populations, It is a self-completed questionnaire with 17 questions scoring from 1 - 5. The scores of each question are added to create the total score for each participant. The highest possible score for any individual is 85, the lowest score being 17. A diagnostic score for PTSD is accepted as being more than 50. Participants completed the PCL-C just before treatment and one week later. The wait list group received no treatment at Time 1.|units on a scale|Mean|59.6|59.6|Standard Deviation|11.3|11.3|||
3841036|NCT01681628|3666615|B2|||PCL-C|PCL-C (post traumatic check list for civilians) is a measure of the severity of post traumatic stress disorder (PTSD), and can also be used for screening populations, It is a self-completed questionnaire with 17 questions scoring from 1 - 5. The scores of each question are added to create the total score for each participant. The highest possible score for any individual is 85, the lowest score being 17. A diagnostic score for PTSD is accepted as being more than 50. Participants completed the PCL-C just before treatment and one week later. The wait list group received no treatment at Time 1.|units on a scale|Mean|61.2|61.2|Standard Deviation|10.1|10.1|||
3841037|NCT01681628|3666616|B1|||PCL-C|PCL-C (post traumatic check list for civilians) is a measure of the severity of post traumatic stress disorder (PTSD), and can also be used for screening populations, It is a self-completed questionnaire with 17 questions scoring from 1 - 5. The scores of each question are added to create the total score for each participant. The highest possible score for any individual is 85, the lowest score being 17. A diagnostic score for PTSD is accepted as being more than 50. Participants completed the PCL-C just before treatment and one week later. The wait list group received no treatment at Time 1.|units on a scale|Mean|58.0|58.0|Standard Deviation|12.6|12.6|||
3841038|NCT01681628|3666614|B3|African (Western Uganda)||Race/Ethnicity, Customized||participants|Number|236|236.0||||||
3841039|NCT01681628|3666615|B2|African (Western Uganda)||Race/Ethnicity, Customized||participants|Number|122|122.0||||||
3841040|NCT01681628|3666616|B1|African (Western Uganda)||Race/Ethnicity, Customized||participants|Number|114|114.0||||||
3841041|NCT01681628|3666614|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3841042|NCT01681628|3666615|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3841043|NCT01681628|3666616|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3841044|NCT01681628|3666614|B3||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3841045|NCT01681628|3666615|B2||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3841046|NCT01681628|3666616|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3841047|NCT01681628|3666614|B3|||Age||years|Mean|44.5|44.5|Standard Deviation|15.0|15.0|||
3841048|NCT01681628|3666615|B2|||Age||years|Mean|45.1|45.1|Standard Deviation|14.4|14.4|||
3841049|NCT01681628|3666616|B1|||Age||years|Mean|44.3|44.3|Standard Deviation|16|16.0|||
3841050|NCT01681576|3666628|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3841051|NCT01681576|3666629|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3841052|NCT01681576|3666630|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3841053|NCT01681576|3666628|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3841054|NCT01681576|3666629|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3841055|NCT01681576|3666630|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3841056|NCT01681576|3666628|B3|||Age||years|Mean|57.3|57.3|Standard Deviation|10.3|10.3|||
3841057|NCT01681576|3666629|B2|||Age||years|Mean|58.9|58.9|Standard Deviation|7.5|7.5|||
3841058|NCT01681576|3666630|B1|||Age||years|Mean|55.7|55.7|Standard Deviation|12.5|12.5|||
3841059|NCT01681511|3666645|B3|United States||Region of Enrollment||participants|Number|95|95.0||||||
3841060|NCT01681511|3666646|B2|United States||Region of Enrollment||participants|Number|49|49.0||||||
3841061|NCT01681511|3666647|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
3841062|NCT01681511|3666645|B3||Male|Sex: Female, Male|Prior to Study Termination; of 95 subjects randomized, 91 subjects were treated and therefore considered as part of Baseline Gender demographics.|Participants|Count of Participants|41|41.0||||||
3841063|NCT01681511|3666646|B2||Male|Sex: Female, Male|Prior to Study Termination; of 95 subjects randomized, 91 subjects were treated and therefore considered as part of Baseline Gender demographics.|Participants|Count of Participants|19|19.0||||||
3841064|NCT01681511|3666647|B1||Male|Sex: Female, Male|Prior to Study Termination; of 95 subjects randomized, 91 subjects were treated and therefore considered as part of Baseline Gender demographics.|Participants|Count of Participants|22|22.0||||||
3841065|NCT01681511|3666645|B3||Female|Sex: Female, Male|Prior to Study Termination; of 95 subjects randomized, 91 subjects were treated and therefore considered as part of Baseline Gender demographics.|Participants|Count of Participants|54|54.0||||||
3841066|NCT01681511|3666646|B2||Female|Sex: Female, Male|Prior to Study Termination; of 95 subjects randomized, 91 subjects were treated and therefore considered as part of Baseline Gender demographics.|Participants|Count of Participants|30|30.0||||||
3841067|NCT01681511|3666647|B1||Female|Sex: Female, Male|Prior to Study Termination; of 95 subjects randomized, 91 subjects were treated and therefore considered as part of Baseline Gender demographics.|Participants|Count of Participants|24|24.0||||||
3841068|NCT01681511|3666645|B3|||Age||years|Mean|55.6|55.6|Standard Deviation|15.4|15.4|||
3841069|NCT01681511|3666646|B2|||Age||years|Mean|52.3|52.3|Standard Deviation|16.6|16.6|||
3841070|NCT01681511|3666647|B1|||Age||years|Mean|59|59.0|Standard Deviation|13.4|13.4|||
3841071|NCT01681511|3666645|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3841072|NCT01681511|3666646|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3841073|NCT01681511|3666647|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3841074|NCT01681511|3666645|B3||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
3841075|NCT01681511|3666646|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3841076|NCT01681511|3666647|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
3841077|NCT01681511|3666645|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3841078|NCT01681511|3666646|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3841079|NCT01681511|3666647|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3841080|NCT01681472|3666662|B5|Sweden||Region of Enrollment||participants|Number|32|32.0||||||
3841081|NCT01681472|3666663|B4|Sweden||Region of Enrollment||participants|Number|8|8.0||||||
3841082|NCT01681472|3666664|B3|Sweden||Region of Enrollment||participants|Number|8|8.0||||||
3841083|NCT01681472|3666665|B2|Sweden||Region of Enrollment||participants|Number|8|8.0||||||
3841084|NCT01681472|3666666|B1|Sweden||Region of Enrollment||participants|Number|8|8.0||||||
3841085|NCT01681472|3666662|B5||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3841086|NCT01681472|3666663|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3841087|NCT01681472|3666664|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3841088|NCT01681472|3666665|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3841089|NCT01681472|3666666|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3841090|NCT01681472|3666662|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3841091|NCT01681472|3666663|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3841092|NCT01681472|3666664|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3841093|NCT01681472|3666665|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3841094|NCT01681472|3666666|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3841095|NCT01681472|3666662|B5||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3841096|NCT01681472|3666663|B4||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3841097|NCT01681472|3666664|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3841098|NCT01681472|3666665|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3841099|NCT01681472|3666666|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3841100|NCT01681472|3666662|B5||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3841101|NCT01681472|3666663|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3841102|NCT01681472|3666664|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3841103|NCT01681472|3666665|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3841104|NCT01681472|3666666|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3841105|NCT01681472|3666662|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3841106|NCT01681472|3666663|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3841107|NCT01681472|3666664|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3841108|NCT01681472|3666665|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3841109|NCT01681472|3666666|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3841110|NCT01681472|3666662|B5|||Age||years|Mean|72.74|72.74|Standard Deviation|13.07|13.07|||
3841111|NCT01681472|3666663|B4|||Age||years|Mean|71.75|71.75|Standard Deviation|11.25|11.25|||
3841112|NCT01681472|3666664|B3|||Age||years|Mean|72|72.0|Standard Deviation|15|15.0|||
3841113|NCT01681472|3666665|B2|||Age||years|Mean|66.71|66.71|Standard Deviation|16.89|16.89|||
3841114|NCT01681472|3666666|B1|||Age||years|Mean|80.5|80.5|Standard Deviation|9.15|9.15|||
3841115|NCT01681433|3666679|B3|||Median PSA||ug/L|Median|23|23.0|Full Range|||2.51|387.6|
3841116|NCT01681433|3666680|B2|||Median PSA||ug/L|Median|18.17|18.17|Full Range|||4.24|302.15|
3841117|NCT01681433|3666681|B1|||Median PSA||ug/L|Median|34.19|34.19|Full Range|||2.51|387.6|
3841118|NCT01681433|3666679|B3|ECOG 1||ECOG Status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0-5 that describes a patient's level of functioning where 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Dead:|participants|Number|40|40.0||||||
3841119|NCT01681433|3666680|B2|ECOG 1||ECOG Status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0-5 that describes a patient's level of functioning where 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Dead:|participants|Number|20|20.0||||||
3841120|NCT01681433|3666681|B1|ECOG 1||ECOG Status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0-5 that describes a patient's level of functioning where 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Dead:|participants|Number|20|20.0||||||
3841121|NCT01681433|3666679|B3|ECOG 0||ECOG Status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0-5 that describes a patient's level of functioning where 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Dead:|participants|Number|32|32.0||||||
3841122|NCT01681433|3666680|B2|ECOG 0||ECOG Status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0-5 that describes a patient's level of functioning where 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Dead:|participants|Number|16|16.0||||||
3841123|NCT01681433|3666681|B1|ECOG 0||ECOG Status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0-5 that describes a patient's level of functioning where 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Dead:|participants|Number|16|16.0||||||
3841124|NCT01681433|3666679|B3|United States||Region of Enrollment||participants|Number|43|43.0||||||
3841125|NCT01681433|3666680|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
3841126|NCT01681433|3666681|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3841127|NCT01681433|3666679|B3|Canada||Region of Enrollment||participants|Number|29|29.0||||||
3841128|NCT01681433|3666680|B2|Canada||Region of Enrollment||participants|Number|15|15.0||||||
3841129|NCT01681433|3666681|B1|Canada||Region of Enrollment||participants|Number|14|14.0||||||
3841130|NCT01681433|3666679|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3841131|NCT01681433|3666680|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3841132|NCT01681433|3666681|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3841133|NCT01681433|3666679|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841134|NCT01681433|3666680|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841135|NCT01681433|3666681|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841136|NCT01681433|3666679|B3||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3841137|NCT01681433|3666680|B2||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3841138|NCT01681433|3666681|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3841139|NCT01681433|3666679|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3841140|NCT01681433|3666680|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3841141|NCT01681433|3666681|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3841142|NCT01681433|3666679|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841143|NCT01681433|3666680|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841144|NCT01681433|3666681|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841145|NCT01681433|3666679|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3841146|NCT01681433|3666680|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3841147|NCT01681433|3666681|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841148|NCT01681433|3666679|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841149|NCT01681433|3666680|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841150|NCT01681433|3666681|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841151|NCT01681433|3666679|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3841152|NCT01681433|3666680|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3841153|NCT01681433|3666681|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3841154|NCT01681433|3666679|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3841155|NCT01681433|3666680|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3841156|NCT01681433|3666681|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3841157|NCT01681433|3666679|B3|||Age||years|Median|72|72.0|Full Range|||53.0|89.0|
3841158|NCT01681433|3666680|B2|||Age||years|Median|72|72.0|Full Range|||57.0|89.0|
3841159|NCT01681433|3666681|B1|||Age||years|Median|71|71.0|Full Range|||53.0|85.0|
3841160|NCT01681368|3666700|B1|Vaccine||Type of Prior Therapy, No.||participants|Number|1|1.0||||||
3841161|NCT01681368|3666700|B1|Hormonal||Type of Prior Therapy, No.||participants|Number|5|5.0||||||
3841162|NCT01681368|3666700|B1|Biologic||Type of Prior Therapy, No.||participants|Number|6|6.0||||||
3841163|NCT01681368|3666700|B1|Chemotherapy||Type of Prior Therapy, No.||participants|Number|11|11.0||||||
3841164|NCT01681368|3666700|B1||≥7|No. of Prior Therapies||Participants|Count of Participants|4|4.0||||||
3841165|NCT01681368|3666700|B1||4-6|No. of Prior Therapies||Participants|Count of Participants|6|6.0||||||
3841166|NCT01681368|3666700|B1||≤3|No. of Prior Therapies||Participants|Count of Participants|1|1.0||||||
3841167|NCT01681368|3666700|B1||Classified|Histologic subtype, No.||Participants|Count of Participants|3|3.0||||||
3841168|NCT01681368|3666700|B1||Clear cell|Histologic subtype, No.||Participants|Count of Participants|1|1.0||||||
3841169|NCT01681368|3666700|B1||Endometrioid|Histologic subtype, No.||Participants|Count of Participants|1|1.0||||||
3841170|NCT01681368|3666700|B1||Serous|Histologic subtype, No.||Participants|Count of Participants|6|6.0||||||
3841171|NCT01681368|3666700|B1||2|Eastern Cooperative Oncology Group (ECOG)|ECOG: 0 (Normal activity. Fully active, able to carry on all pre-disease performance without restriction.), 1 (Symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work), and 2 (In bed <50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hour.).|Participants|Count of Participants|1|1.0||||||
3841172|NCT01681368|3666700|B1||1|Eastern Cooperative Oncology Group (ECOG)|ECOG: 0 (Normal activity. Fully active, able to carry on all pre-disease performance without restriction.), 1 (Symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work), and 2 (In bed <50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hour.).|Participants|Count of Participants|10|10.0||||||
3841173|NCT01681368|3666700|B1||0|Eastern Cooperative Oncology Group (ECOG)|ECOG: 0 (Normal activity. Fully active, able to carry on all pre-disease performance without restriction.), 1 (Symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work), and 2 (In bed <50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hour.).|Participants|Count of Participants|0|0.0||||||
3841174|NCT01681368|3666700|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3841175|NCT01681368|3666700|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3841176|NCT01681368|3666700|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841177|NCT01681368|3666700|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3841178|NCT01681368|3666700|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3841179|NCT01681368|3666700|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841180|NCT01681368|3666700|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841181|NCT01681368|3666700|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841182|NCT01681368|3666700|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3841183|NCT01681368|3666700|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3841184|NCT01681368|3666700|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841185|NCT01681368|3666700|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3841186|NCT01681368|3666700|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3841187|NCT01681368|3666700|B1|||Age||years|Median|58.87|58.87|Standard Deviation|6|6.0|||
3841188|NCT01681368|3666700|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3841189|NCT01681368|3666700|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3841190|NCT01681368|3666700|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3841191|NCT01681277|3666712|B6||Male|Gender||Participants|Count of Participants|48|48.0||||||
3841192|NCT01681277|3666713|B5||Male|Gender||Participants|Count of Participants|9|9.0||||||
3841193|NCT01681277|3666714|B4||Male|Gender||Participants|Count of Participants|9|9.0||||||
3841194|NCT01681277|3666715|B3||Male|Gender||Participants|Count of Participants|9|9.0||||||
3841195|NCT01681277|3666716|B2||Male|Gender||Participants|Count of Participants|9|9.0||||||
3841196|NCT01681277|3666717|B1||Male|Gender||Participants|Count of Participants|12|12.0||||||
3841197|NCT01681277|3666712|B6||Female|Gender||Participants|Count of Participants|0|0.0||||||
3841198|NCT01681277|3666713|B5||Female|Gender||Participants|Count of Participants|0|0.0||||||
3841199|NCT01681277|3666714|B4||Female|Gender||Participants|Count of Participants|0|0.0||||||
3841200|NCT01681277|3666715|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
3841201|NCT01681277|3666716|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
3841202|NCT01681277|3666717|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3841203|NCT01681277|3666712|B6|||Age||Years|Mean|41.9|41.9|Standard Deviation|6.5|6.5|||
3841204|NCT01681277|3666713|B5|||Age||Years|Mean|40.1|40.1|Standard Deviation|8.0|8.0|||
3841205|NCT01681277|3666714|B4|||Age||Years|Mean|43.8|43.8|Standard Deviation|4.6|4.6|||
3841206|NCT01681277|3666715|B3|||Age||Years|Mean|44.2|44.2|Standard Deviation|5.7|5.7|||
3841207|NCT01681277|3666716|B2|||Age||Years|Mean|40.9|40.9|Standard Deviation|7.0|7.0|||
3841208|NCT01681277|3666717|B1|||Age||Years|Mean|40.9|40.9|Standard Deviation|7.0|7.0|||
3841209|NCT01681212|3666762|B1|50 years and older||Female age, customized|Data are provided for the 5 women in the study.|Participants|Number|2|2.0||||||
3841210|NCT01681212|3666762|B1|Younger than 50 years||Female age, customized|Data are provided for the 5 women in the study.|Participants|Number|3|3.0||||||
3841211|NCT01681212|3666762|B1|||Height||Centimeters|Mean|163.0|163.0|Standard Deviation|9.28|9.28|||
3841212|NCT01681212|3666762|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG scales are used to assess the progress of disease and the disease's effects on daily living abilities and to determine appropriate treatment. Grade 0=fully active; able to carry on all activities without restriction. Grade 1=restricted in strenuous activity but ambulatory; able to perform light work. Grade 2=ambulatory; capable of all self care but unable to work; up more than 50% of waking hours. Grade 3=capable of limited self care, confined to bed or chair more than 50% of waking hours. Grade 4=Completely disabled; cannot carry on any self care; totally confined to bed or chair.|Participants|Number|2|2.0||||||
3841213|NCT01681212|3666762|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG scales are used to assess the progress of disease and the disease's effects on daily living abilities and to determine appropriate treatment. Grade 0=fully active; able to carry on all activities without restriction. Grade 1=restricted in strenuous activity but ambulatory; able to perform light work. Grade 2=ambulatory; capable of all self care but unable to work; up more than 50% of waking hours. Grade 3=capable of limited self care, confined to bed or chair more than 50% of waking hours. Grade 4=Completely disabled; cannot carry on any self care; totally confined to bed or chair.|Participants|Number|13|13.0||||||
3841214|NCT01681212|3666762|B1|M1C||M-stage at study entry|M-stage=stage of metastases (M), based on criteria of the American Joint Committee on Cancer. M1A=metastases to skin, subcutaneous tissue, or distant lymph nodes. M1B=metastases to lung. M1C=metastases to all other visceral sites or distant metastases to any site combined with an elevated serum level of lactase dehydrogenase.|Participants|Number|7|7.0||||||
3841215|NCT01681212|3666762|B1|M1B||M-stage at study entry|M-stage=stage of metastases (M), based on criteria of the American Joint Committee on Cancer. M1A=metastases to skin, subcutaneous tissue, or distant lymph nodes. M1B=metastases to lung. M1C=metastases to all other visceral sites or distant metastases to any site combined with an elevated serum level of lactase dehydrogenase.|Participants|Number|7|7.0||||||
3841216|NCT01681212|3666762|B1|M0||M-stage at study entry|M-stage=stage of metastases (M), based on criteria of the American Joint Committee on Cancer. M1A=metastases to skin, subcutaneous tissue, or distant lymph nodes. M1B=metastases to lung. M1C=metastases to all other visceral sites or distant metastases to any site combined with an elevated serum level of lactase dehydrogenase.|Participants|Number|1|1.0||||||
3841217|NCT01681212|3666762|B1|||Female Age, Continuous|Data are provided for the 5 women in the study.|Years|Mean|47.2|47.2|Standard Deviation|13.26|13.26|||
3841218|NCT01681212|3666762|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3841219|NCT01681212|3666762|B1|Japanese||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
3841220|NCT01681212|3666762|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3841221|NCT01681212|3666762|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3841222|NCT01681212|3666762|B1|65 and older||Age, Customized||Participants|Number|5|5.0||||||
3841223|NCT01681212|3666762|B1|Younger than 65||Age, Customized||Participants|Number|10|10.0||||||
3841224|NCT01681212|3666762|B1|||Age||Years|Mean|55.0|55.0|Standard Deviation|12.66|12.66|||
3841225|NCT01681121|3666768|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3841226|NCT01681121|3666769|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3841227|NCT01681121|3666770|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3841228|NCT01681121|3666768|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3841229|NCT01681121|3666769|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3841230|NCT01681121|3666770|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3841231|NCT01681121|3666768|B3|||Age||Years|Mean|38.7|38.7|Standard Deviation|12.13|12.13|||
3841232|NCT01681121|3666769|B2|||Age||Years|Mean|36.7|36.7|Standard Deviation|11.71|11.71|||
3841233|NCT01681121|3666770|B1|||Age||Years|Mean|41|41.0|Standard Deviation|12.33|12.33|||
3841234|NCT01681095|3666777|B3|United States||Region of Enrollment||participants|Number|110|110.0||||||
3841235|NCT01681095|3666778|B2|United States||Region of Enrollment||participants|Number|55|55.0||||||
3841236|NCT01681095|3666779|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
3841237|NCT01681095|3666777|B3||Male|Gender||Participants|Count of Participants|64|64.0||||||
3841238|NCT01681095|3666778|B2||Male|Gender||Participants|Count of Participants|29|29.0||||||
3841239|NCT01681095|3666779|B1||Male|Gender||Participants|Count of Participants|35|35.0||||||
3841240|NCT01681095|3666777|B3||Female|Gender||Participants|Count of Participants|46|46.0||||||
3841241|NCT01681095|3666778|B2||Female|Gender||Participants|Count of Participants|26|26.0||||||
3841242|NCT01681095|3666779|B1||Female|Gender||Participants|Count of Participants|20|20.0||||||
3841243|NCT01681095|3666777|B3|||Age||years|Mean|66|66.0|Standard Deviation|12|12.0|||
3841244|NCT01681095|3666778|B2|||Age||years|Mean|63|63.0|Standard Deviation|13|13.0|||
3841245|NCT01681095|3666779|B1|||Age||years|Mean|70|70.0|Standard Deviation|11|11.0|||
3841246|NCT01681095|3666777|B3||>=65 years|Age||Participants|Count of Participants|64|64.0||||||
3841247|NCT01681095|3666778|B2||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
3841248|NCT01681095|3666779|B1||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
3841249|NCT01681095|3666777|B3||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
3841250|NCT01681095|3666778|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3841251|NCT01681095|3666779|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3841252|NCT01681095|3666777|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3841253|NCT01681095|3666778|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3841254|NCT01681095|3666779|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3841255|NCT01681069|3666818|B3|||Body Weight||kg|Mean|83.5|83.5|Standard Deviation|11.9|11.9|||
3841256|NCT01681069|3666819|B2|||Body Weight||kg|Mean|84.9|84.9|Standard Deviation|12.9|12.9|||
3841257|NCT01681069|3666820|B1|||Body Weight||kg|Mean|82.0|82.0|Standard Deviation|10.6|10.6|||
3841258|NCT01681069|3666818|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3841259|NCT01681069|3666819|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3841260|NCT01681069|3666820|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3841261|NCT01681069|3666818|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3841262|NCT01681069|3666819|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3841263|NCT01681069|3666820|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3841264|NCT01681069|3666818|B3|||Age||year|Mean|42.0|42.0|Standard Deviation|11.8|11.8|||
3841265|NCT01681069|3666819|B2|||Age||year|Mean|40.5|40.5|Standard Deviation|11.9|11.9|||
3841266|NCT01681069|3666820|B1|||Age||year|Mean|43.6|43.6|Standard Deviation|11.6|11.6|||
3841267|NCT01681030|3666831|B4|Morbidly obese||BMI Category|Underweight: < 18.5 kg/m^2, Normal weight: 18.5 - <25 kg/m^2 , Overweight: 25 - <30 kg/m^2, Obese: 30 - <40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participant|Number|4|4.0||||||
3841268|NCT01681030|3666832|B3|Morbidly obese||BMI Category|Underweight: < 18.5 kg/m^2, Normal weight: 18.5 - <25 kg/m^2 , Overweight: 25 - <30 kg/m^2, Obese: 30 - <40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participant|Number|1|1.0||||||
3841269|NCT01681030|3666833|B2|Morbidly obese||BMI Category|Underweight: < 18.5 kg/m^2, Normal weight: 18.5 - <25 kg/m^2 , Overweight: 25 - <30 kg/m^2, Obese: 30 - <40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participant|Number|1|1.0||||||
3841270|NCT01681030|3666834|B1|Morbidly obese||BMI Category|Underweight: < 18.5 kg/m^2, Normal weight: 18.5 - <25 kg/m^2 , Overweight: 25 - <30 kg/m^2, Obese: 30 - <40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participant|Number|2|2.0||||||
3841271|NCT01681030|3666831|B4|Obese||BMI Category|Underweight: < 18.5 kg/m^2, Normal weight: 18.5 - <25 kg/m^2 , Overweight: 25 - <30 kg/m^2, Obese: 30 - <40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participant|Number|12|12.0||||||
3841272|NCT01681030|3666832|B3|Obese||BMI Category|Underweight: < 18.5 kg/m^2, Normal weight: 18.5 - <25 kg/m^2 , Overweight: 25 - <30 kg/m^2, Obese: 30 - <40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participant|Number|4|4.0||||||
3841273|NCT01681030|3666833|B2|Obese||BMI Category|Underweight: < 18.5 kg/m^2, Normal weight: 18.5 - <25 kg/m^2 , Overweight: 25 - <30 kg/m^2, Obese: 30 - <40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participant|Number|5|5.0||||||
3841274|NCT01681030|3666834|B1|Obese||BMI Category|Underweight: < 18.5 kg/m^2, Normal weight: 18.5 - <25 kg/m^2 , Overweight: 25 - <30 kg/m^2, Obese: 30 - <40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participant|Number|3|3.0||||||
3841275|NCT01681030|3666831|B4|Overweight||BMI Category|Underweight: < 18.5 kg/m^2, Normal weight: 18.5 - <25 kg/m^2 , Overweight: 25 - <30 kg/m^2, Obese: 30 - <40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participant|Number|10|10.0||||||
3841276|NCT01681030|3666832|B3|Overweight||BMI Category|Underweight: < 18.5 kg/m^2, Normal weight: 18.5 - <25 kg/m^2 , Overweight: 25 - <30 kg/m^2, Obese: 30 - <40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participant|Number|2|2.0||||||
3841277|NCT01681030|3666833|B2|Overweight||BMI Category|Underweight: < 18.5 kg/m^2, Normal weight: 18.5 - <25 kg/m^2 , Overweight: 25 - <30 kg/m^2, Obese: 30 - <40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participant|Number|5|5.0||||||
3841278|NCT01681030|3666834|B1|Overweight||BMI Category|Underweight: < 18.5 kg/m^2, Normal weight: 18.5 - <25 kg/m^2 , Overweight: 25 - <30 kg/m^2, Obese: 30 - <40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participant|Number|3|3.0||||||
3841279|NCT01681030|3666831|B4|Normal||BMI Category|Underweight: < 18.5 kg/m^2, Normal weight: 18.5 - <25 kg/m^2 , Overweight: 25 - <30 kg/m^2, Obese: 30 - <40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participant|Number|16|16.0||||||
3841280|NCT01681030|3666832|B3|Normal||BMI Category|Underweight: < 18.5 kg/m^2, Normal weight: 18.5 - <25 kg/m^2 , Overweight: 25 - <30 kg/m^2, Obese: 30 - <40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participant|Number|4|4.0||||||
3841281|NCT01681030|3666833|B2|Normal||BMI Category|Underweight: < 18.5 kg/m^2, Normal weight: 18.5 - <25 kg/m^2 , Overweight: 25 - <30 kg/m^2, Obese: 30 - <40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participant|Number|7|7.0||||||
3841282|NCT01681030|3666834|B1|Normal||BMI Category|Underweight: < 18.5 kg/m^2, Normal weight: 18.5 - <25 kg/m^2 , Overweight: 25 - <30 kg/m^2, Obese: 30 - <40 kg/m^2, Morbidly obese: 40 kg/m^2 or more|Participant|Number|5|5.0||||||
3841283|NCT01681030|3666831|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3841284|NCT01681030|3666832|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3841285|NCT01681030|3666833|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3841286|NCT01681030|3666834|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3841287|NCT01681030|3666831|B4|White/Caucasian||Race/Ethnicity, Customized||Participants|Number|26|26.0||||||
3841288|NCT01681030|3666832|B3|White/Caucasian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3841289|NCT01681030|3666833|B2|White/Caucasian||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3841290|NCT01681030|3666834|B1|White/Caucasian||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3841291|NCT01681030|3666831|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3841292|NCT01681030|3666832|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3841293|NCT01681030|3666833|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3841294|NCT01681030|3666834|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3841295|NCT01681030|3666831|B4|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3841296|NCT01681030|3666832|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3841297|NCT01681030|3666833|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3841298|NCT01681030|3666834|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3841299|NCT01681030|3666831|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3841300|NCT01681030|3666832|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3841301|NCT01681030|3666833|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3841302|NCT01681030|3666834|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3841303|NCT01681030|3666831|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3841304|NCT01681030|3666832|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3841305|NCT01681030|3666833|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3841306|NCT01681030|3666834|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3841307|NCT01681030|3666831|B4|Age||Age||Years|Mean|58.8|58.8|Standard Deviation|14.0|14.0|||
3841308|NCT01681030|3666832|B3|Age||Age||Years|Mean|60.5|60.5|Standard Deviation|15.4|15.4|||
3841309|NCT01681030|3666833|B2|Age||Age||Years|Mean|59.8|59.8|Standard Deviation|12.9|12.9|||
3841310|NCT01681030|3666834|B1|Age||Age||Years|Mean|56.0|56.0|Standard Deviation|15.1|15.1|||
3841311|NCT01681004|3666856|B3|Health Thermometer||EQ-5D|EQ-5D is a five-question broad quality of life measure that is combined into a single index using population norm data called time trade-off (TTO) utility of current health. A score of 0 would = worst imaginable health, while a score of 1.0 would be best imaginable health. (Scores <0 are also possible, representing states worse than death.) EQ-5D also includes a 0-100 mm health thermometer, where 0 means death and 100 means perfect health.|units on a scale|Mean|54.6|54.6|Standard Deviation|23.5|23.5|||
3841312|NCT01681004|3666857|B2|Health Thermometer||EQ-5D|EQ-5D is a five-question broad quality of life measure that is combined into a single index using population norm data called time trade-off (TTO) utility of current health. A score of 0 would = worst imaginable health, while a score of 1.0 would be best imaginable health. (Scores <0 are also possible, representing states worse than death.) EQ-5D also includes a 0-100 mm health thermometer, where 0 means death and 100 means perfect health.|units on a scale|Mean|57.8|57.8|Standard Deviation|22.9|22.9|||
3841313|NCT01681004|3666858|B1|Health Thermometer||EQ-5D|EQ-5D is a five-question broad quality of life measure that is combined into a single index using population norm data called time trade-off (TTO) utility of current health. A score of 0 would = worst imaginable health, while a score of 1.0 would be best imaginable health. (Scores <0 are also possible, representing states worse than death.) EQ-5D also includes a 0-100 mm health thermometer, where 0 means death and 100 means perfect health.|units on a scale|Mean|53.2|53.2|Standard Deviation|23.8|23.8|||
3841379|NCT01681004|3666858|B1|Sacroiliac joint disruption||Underlying diagnosis||Participants|Count of Participants|14|14.0||||||
3841314|NCT01681004|3666856|B3|Time trade-off (TTO) score||EQ-5D|EQ-5D is a five-question broad quality of life measure that is combined into a single index using population norm data called time trade-off (TTO) utility of current health. A score of 0 would = worst imaginable health, while a score of 1.0 would be best imaginable health. (Scores <0 are also possible, representing states worse than death.) EQ-5D also includes a 0-100 mm health thermometer, where 0 means death and 100 means perfect health.|units on a scale|Mean|0.45|0.45|Standard Deviation|0.18|0.18|||
3841315|NCT01681004|3666857|B2|Time trade-off (TTO) score||EQ-5D|EQ-5D is a five-question broad quality of life measure that is combined into a single index using population norm data called time trade-off (TTO) utility of current health. A score of 0 would = worst imaginable health, while a score of 1.0 would be best imaginable health. (Scores <0 are also possible, representing states worse than death.) EQ-5D also includes a 0-100 mm health thermometer, where 0 means death and 100 means perfect health.|units on a scale|Mean|0.47|0.47|Standard Deviation|0.19|0.19|||
3841316|NCT01681004|3666858|B1|Time trade-off (TTO) score||EQ-5D|EQ-5D is a five-question broad quality of life measure that is combined into a single index using population norm data called time trade-off (TTO) utility of current health. A score of 0 would = worst imaginable health, while a score of 1.0 would be best imaginable health. (Scores <0 are also possible, representing states worse than death.) EQ-5D also includes a 0-100 mm health thermometer, where 0 means death and 100 means perfect health.|units on a scale|Mean|0.44|0.44|Standard Deviation|0.18|0.18|||
3841317|NCT01681004|3666856|B3|Mental component summary (MCS)||SF-36, mean|"The Short Form 36 health survey (SF-36) is a 36-item patient reported health questionnaire to measure quality of life across 8 domains.~The PCS is the Physical Component Summary score. 0% would represent the lowest or worst possible level of functioning while 100% would represent the highest / best possible level of functioning.~The MCS is the Mental Component Summary score. 0% would represent the lowest or worst possible level of functioning while 100% would represent the highest / best possible level of functioning."|units on a scale|Mean|43.1|43.1|Standard Deviation|11.6|11.6|||
3841318|NCT01681004|3666857|B2|Mental component summary (MCS)||SF-36, mean|"The Short Form 36 health survey (SF-36) is a 36-item patient reported health questionnaire to measure quality of life across 8 domains.~The PCS is the Physical Component Summary score. 0% would represent the lowest or worst possible level of functioning while 100% would represent the highest / best possible level of functioning.~The MCS is the Mental Component Summary score. 0% would represent the lowest or worst possible level of functioning while 100% would represent the highest / best possible level of functioning."|units on a scale|Mean|43.3|43.3|Standard Deviation|12.1|12.1|||
3841319|NCT01681004|3666858|B1|Mental component summary (MCS)||SF-36, mean|"The Short Form 36 health survey (SF-36) is a 36-item patient reported health questionnaire to measure quality of life across 8 domains.~The PCS is the Physical Component Summary score. 0% would represent the lowest or worst possible level of functioning while 100% would represent the highest / best possible level of functioning.~The MCS is the Mental Component Summary score. 0% would represent the lowest or worst possible level of functioning while 100% would represent the highest / best possible level of functioning."|units on a scale|Mean|43.0|43.0|Standard Deviation|11.5|11.5|||
3841320|NCT01681004|3666856|B3|Physical component summary (PCS)||SF-36, mean|"The Short Form 36 health survey (SF-36) is a 36-item patient reported health questionnaire to measure quality of life across 8 domains.~The PCS is the Physical Component Summary score. 0% would represent the lowest or worst possible level of functioning while 100% would represent the highest / best possible level of functioning.~The MCS is the Mental Component Summary score. 0% would represent the lowest or worst possible level of functioning while 100% would represent the highest / best possible level of functioning."|units on a scale|Mean|30.4|30.4|Standard Deviation|6.2|6.2|||
3841321|NCT01681004|3666857|B2|Physical component summary (PCS)||SF-36, mean|"The Short Form 36 health survey (SF-36) is a 36-item patient reported health questionnaire to measure quality of life across 8 domains.~The PCS is the Physical Component Summary score. 0% would represent the lowest or worst possible level of functioning while 100% would represent the highest / best possible level of functioning.~The MCS is the Mental Component Summary score. 0% would represent the lowest or worst possible level of functioning while 100% would represent the highest / best possible level of functioning."|units on a scale|Mean|30.8|30.8|Standard Deviation|6.2|6.2|||
3841322|NCT01681004|3666858|B1|Physical component summary (PCS)||SF-36, mean|"The Short Form 36 health survey (SF-36) is a 36-item patient reported health questionnaire to measure quality of life across 8 domains.~The PCS is the Physical Component Summary score. 0% would represent the lowest or worst possible level of functioning while 100% would represent the highest / best possible level of functioning.~The MCS is the Mental Component Summary score. 0% would represent the lowest or worst possible level of functioning while 100% would represent the highest / best possible level of functioning."|units on a scale|Mean|30.2|30.2|Standard Deviation|6.2|6.2|||
3841323|NCT01681004|3666856|B3|||ODI score, mean|Oswestry Disability Index is a validated measure of disability related to low back pain. There are 10 sections, each with a score between 0-5. If all sections are answered, the total possible score is 50/50 = 100% which is the worst disability possible on the scale. (0/50 = no disability at all.) If any section is skipped by the study participant, the total possible score for that section is removed from the denominator. Example - section 8 skipped, total possible score is 45/45 = 100%.|units on a scale|Mean|56.8|56.8|Standard Deviation|13.2|13.2|||
3841324|NCT01681004|3666857|B2|||ODI score, mean|Oswestry Disability Index is a validated measure of disability related to low back pain. There are 10 sections, each with a score between 0-5. If all sections are answered, the total possible score is 50/50 = 100% which is the worst disability possible on the scale. (0/50 = no disability at all.) If any section is skipped by the study participant, the total possible score for that section is removed from the denominator. Example - section 8 skipped, total possible score is 45/45 = 100%.|units on a scale|Mean|56.0|56.0|Standard Deviation|14.0|14.0|||
3841325|NCT01681004|3666858|B1|||ODI score, mean|Oswestry Disability Index is a validated measure of disability related to low back pain. There are 10 sections, each with a score between 0-5. If all sections are answered, the total possible score is 50/50 = 100% which is the worst disability possible on the scale. (0/50 = no disability at all.) If any section is skipped by the study participant, the total possible score for that section is removed from the denominator. Example - section 8 skipped, total possible score is 45/45 = 100%.|units on a scale|Mean|57.2|57.2|Standard Deviation|12.8|12.8|||
3841380|NCT01681004|3666856|B3|Degenerative sacroiliitis||Underlying diagnosis||Participants|Count of Participants|128|128.0||||||
3841326|NCT01681004|3666856|B3|||VAS SIJ pain score, mean|The Visual Analog Scale (VAS) is a 100 mm line on which the subjects mark their pain rating. 0= no pain and 100= worst pain imaginable.|units on a scale|Mean|82.3|82.3|Standard Deviation|11.3|11.3|||
3841327|NCT01681004|3666857|B2|||VAS SIJ pain score, mean|The Visual Analog Scale (VAS) is a 100 mm line on which the subjects mark their pain rating. 0= no pain and 100= worst pain imaginable.|units on a scale|Mean|82.2|82.2|Standard Deviation|9.9|9.9|||
3841328|NCT01681004|3666858|B1|||VAS SIJ pain score, mean|The Visual Analog Scale (VAS) is a 100 mm line on which the subjects mark their pain rating. 0= no pain and 100= worst pain imaginable.|units on a scale|Mean|82.3|82.3|Standard Deviation|11.9|11.9|||
3841329|NCT01681004|3666856|B3|||Participants with sacral trauma (n, %)||Participants|Count of Participants|11|11.0||||||
3841330|NCT01681004|3666857|B2|||Participants with sacral trauma (n, %)||Participants|Count of Participants|3|3.0||||||
3841331|NCT01681004|3666858|B1|||Participants with sacral trauma (n, %)||Participants|Count of Participants|8|8.0||||||
3841332|NCT01681004|3666856|B3|||Participants with hip diagnosis (n, %)||Participants|Count of Participants|19|19.0||||||
3841333|NCT01681004|3666857|B2|||Participants with hip diagnosis (n, %)||Participants|Count of Participants|3|3.0||||||
3841334|NCT01681004|3666858|B1|||Participants with hip diagnosis (n, %)||Participants|Count of Participants|16|16.0||||||
3841335|NCT01681004|3666856|B3|||Participants with lumbar stenosis||Participants|Count of Participants|22|22.0||||||
3841336|NCT01681004|3666857|B2|||Participants with lumbar stenosis||Participants|Count of Participants|7|7.0||||||
3841337|NCT01681004|3666858|B1|||Participants with lumbar stenosis||Participants|Count of Participants|15|15.0||||||
3841338|NCT01681004|3666856|B3|||Taking opiods||Participants|Count of Participants|99|99.0||||||
3841339|NCT01681004|3666857|B2|||Taking opiods||Participants|Count of Participants|29|29.0||||||
3841340|NCT01681004|3666858|B1|||Taking opiods||Participants|Count of Participants|70|70.0||||||
3841341|NCT01681004|3666856|B3|RF ablation||Prior treatments||Participants|Count of Participants|25|25.0||||||
3841342|NCT01681004|3666857|B2|RF ablation||Prior treatments||Participants|Count of Participants|4|4.0||||||
3841343|NCT01681004|3666858|B1|RF ablation||Prior treatments||Participants|Count of Participants|21|21.0||||||
3841344|NCT01681004|3666856|B3|Steroid SIJ injection||Prior treatments||Participants|Count of Participants|127|127.0||||||
3841345|NCT01681004|3666857|B2|Steroid SIJ injection||Prior treatments||Participants|Count of Participants|42|42.0||||||
3841346|NCT01681004|3666858|B1|Steroid SIJ injection||Prior treatments||Participants|Count of Participants|85|85.0||||||
3841347|NCT01681004|3666856|B3|Physical therapy||Prior treatments||Participants|Count of Participants|107|107.0||||||
3841348|NCT01681004|3666857|B2|Physical therapy||Prior treatments||Participants|Count of Participants|36|36.0||||||
3841349|NCT01681004|3666858|B1|Physical therapy||Prior treatments||Participants|Count of Participants|71|71.0||||||
3841350|NCT01681004|3666856|B3|Pain worse with descending stairs||Pain Syndrome||Participants|Count of Participants|119|119.0||||||
3841351|NCT01681004|3666857|B2|Pain worse with descending stairs||Pain Syndrome||Participants|Count of Participants|37|37.0||||||
3841352|NCT01681004|3666858|B1|Pain worse with descending stairs||Pain Syndrome||Participants|Count of Participants|82|82.0||||||
3841353|NCT01681004|3666856|B3|Pain worse with climbing stairs||Pain Syndrome||Participants|Count of Participants|134|134.0||||||
3841354|NCT01681004|3666857|B2|Pain worse with climbing stairs||Pain Syndrome||Participants|Count of Participants|41|41.0||||||
3841355|NCT01681004|3666858|B1|Pain worse with climbing stairs||Pain Syndrome||Participants|Count of Participants|93|93.0||||||
3841356|NCT01681004|3666856|B3|Pain worse with walking||Pain Syndrome||Participants|Count of Participants|129|129.0||||||
3841357|NCT01681004|3666857|B2|Pain worse with walking||Pain Syndrome||Participants|Count of Participants|42|42.0||||||
3841358|NCT01681004|3666858|B1|Pain worse with walking||Pain Syndrome||Participants|Count of Participants|87|87.0||||||
3841359|NCT01681004|3666856|B3|Pain worse with rising||Pain Syndrome||Participants|Count of Participants|129|129.0||||||
3841360|NCT01681004|3666857|B2|Pain worse with rising||Pain Syndrome||Participants|Count of Participants|41|41.0||||||
3841361|NCT01681004|3666858|B1|Pain worse with rising||Pain Syndrome||Participants|Count of Participants|88|88.0||||||
3841362|NCT01681004|3666856|B3|Pain worse with sitting||Pain Syndrome||Participants|Count of Participants|130|130.0||||||
3841363|NCT01681004|3666857|B2|Pain worse with sitting||Pain Syndrome||Participants|Count of Participants|41|41.0||||||
3841364|NCT01681004|3666858|B1|Pain worse with sitting||Pain Syndrome||Participants|Count of Participants|89|89.0||||||
3841365|NCT01681004|3666856|B3|Groin pain||Pain Syndrome||Participants|Count of Participants|89|89.0||||||
3841366|NCT01681004|3666857|B2|Groin pain||Pain Syndrome||Participants|Count of Participants|29|29.0||||||
3841367|NCT01681004|3666858|B1|Groin pain||Pain Syndrome||Participants|Count of Participants|60|60.0||||||
3841368|NCT01681004|3666856|B3|Pain radiates down leg||Pain Syndrome||Participants|Count of Participants|130|130.0||||||
3841369|NCT01681004|3666857|B2|Pain radiates down leg||Pain Syndrome||Participants|Count of Participants|41|41.0||||||
3841370|NCT01681004|3666858|B1|Pain radiates down leg||Pain Syndrome||Participants|Count of Participants|89|89.0||||||
3841371|NCT01681004|3666856|B3|Pain began peripartum||Pain Syndrome||Participants|Count of Participants|48|48.0||||||
3841372|NCT01681004|3666857|B2|Pain began peripartum||Pain Syndrome||Participants|Count of Participants|19|19.0||||||
3841373|NCT01681004|3666858|B1|Pain began peripartum||Pain Syndrome||Participants|Count of Participants|29|29.0||||||
3841374|NCT01681004|3666856|B3|||Years of pain, mean (range)||years|Mean|6.0|6.0|Full Range|||0.5|40.7|
3841375|NCT01681004|3666857|B2|||Years of pain, mean (range)||years|Mean|5.0|5.0|Full Range|||0.5|38.9|
3841376|NCT01681004|3666858|B1|||Years of pain, mean (range)||years|Mean|7.0|7.0|Full Range|||0.5|40.7|
3841377|NCT01681004|3666856|B3|Sacroiliac joint disruption||Underlying diagnosis||Participants|Count of Participants|20|20.0||||||
3841378|NCT01681004|3666857|B2|Sacroiliac joint disruption||Underlying diagnosis||Participants|Count of Participants|6|6.0||||||
3841381|NCT01681004|3666857|B2|Degenerative sacroiliitis||Underlying diagnosis||Participants|Count of Participants|40|40.0||||||
3841382|NCT01681004|3666858|B1|Degenerative sacroiliitis||Underlying diagnosis||Participants|Count of Participants|88|88.0||||||
3841383|NCT01681004|3666856|B3|||Prior Lumbar fusion (n, %)||Participants|Count of Participants|58|58.0||||||
3841384|NCT01681004|3666857|B2|||Prior Lumbar fusion (n, %)||Participants|Count of Participants|17|17.0||||||
3841385|NCT01681004|3666858|B1|||Prior Lumbar fusion (n, %)||Participants|Count of Participants|41|41.0||||||
3841386|NCT01681004|3666856|B3|Not working other reason||Work status (n, %)||Participants|Count of Participants|10|10.0||||||
3841387|NCT01681004|3666857|B2|Not working other reason||Work status (n, %)||Participants|Count of Participants|4|4.0||||||
3841388|NCT01681004|3666858|B1|Not working other reason||Work status (n, %)||Participants|Count of Participants|6|6.0||||||
3841389|NCT01681004|3666856|B3|Not working due to back pain||Work status (n, %)||Participants|Count of Participants|28|28.0||||||
3841390|NCT01681004|3666857|B2|Not working due to back pain||Work status (n, %)||Participants|Count of Participants|8|8.0||||||
3841391|NCT01681004|3666858|B1|Not working due to back pain||Work status (n, %)||Participants|Count of Participants|20|20.0||||||
3841392|NCT01681004|3666856|B3|Not working, retired||Work status (n, %)||Participants|Count of Participants|30|30.0||||||
3841393|NCT01681004|3666857|B2|Not working, retired||Work status (n, %)||Participants|Count of Participants|9|9.0||||||
3841394|NCT01681004|3666858|B1|Not working, retired||Work status (n, %)||Participants|Count of Participants|21|21.0||||||
3841395|NCT01681004|3666856|B3|Not working, student||Work status (n, %)||Participants|Count of Participants|1|1.0||||||
3841396|NCT01681004|3666857|B2|Not working, student||Work status (n, %)||Participants|Count of Participants|0|0.0||||||
3841397|NCT01681004|3666858|B1|Not working, student||Work status (n, %)||Participants|Count of Participants|1|1.0||||||
3841398|NCT01681004|3666856|B3|Working part time||Work status (n, %)||Participants|Count of Participants|13|13.0||||||
3841399|NCT01681004|3666857|B2|Working part time||Work status (n, %)||Participants|Count of Participants|4|4.0||||||
3841400|NCT01681004|3666858|B1|Working part time||Work status (n, %)||Participants|Count of Participants|9|9.0||||||
3841401|NCT01681004|3666856|B3|Working full time||Work status (n, %)||Participants|Count of Participants|66|66.0||||||
3841402|NCT01681004|3666857|B2|Working full time||Work status (n, %)||Participants|Count of Participants|21|21.0||||||
3841403|NCT01681004|3666858|B1|Working full time||Work status (n, %)||Participants|Count of Participants|45|45.0||||||
3841404|NCT01681004|3666856|B3|||Ambulatory without assistance||Participants|Count of Participants|130|130.0||||||
3841405|NCT01681004|3666857|B2|||Ambulatory without assistance||Participants|Count of Participants|41|41.0||||||
3841406|NCT01681004|3666858|B1|||Ambulatory without assistance||Participants|Count of Participants|89|89.0||||||
3841407|NCT01681004|3666856|B3|Never smoker||Smoking Status (n, %)||participants|Number|76|76.0||||||
3841408|NCT01681004|3666857|B2|Never smoker||Smoking Status (n, %)||participants|Number|30|30.0||||||
3841409|NCT01681004|3666858|B1|Never smoker||Smoking Status (n, %)||participants|Number|46|46.0||||||
3841410|NCT01681004|3666856|B3|Former Smoker||Smoking Status (n, %)||participants|Number|43|43.0||||||
3841411|NCT01681004|3666857|B2|Former Smoker||Smoking Status (n, %)||participants|Number|13|13.0||||||
3841412|NCT01681004|3666858|B1|Former Smoker||Smoking Status (n, %)||participants|Number|30|30.0||||||
3841413|NCT01681004|3666856|B3|Current Smoker||Smoking Status (n, %)||participants|Number|29|29.0||||||
3841414|NCT01681004|3666857|B2|Current Smoker||Smoking Status (n, %)||participants|Number|3|3.0||||||
3841415|NCT01681004|3666858|B1|Current Smoker||Smoking Status (n, %)||participants|Number|26|26.0||||||
3841416|NCT01681004|3666856|B3|||Body Mass Index, mean (range)||kg / m2|Mean|30.43|30.43|Full Range|||16.7|49.5|
3841417|NCT01681004|3666857|B2|||Body Mass Index, mean (range)||kg / m2|Mean|30.6|30.6|Full Range|||19.4|48.9|
3841418|NCT01681004|3666858|B1|||Body Mass Index, mean (range)||kg / m2|Mean|30.4|30.4|Full Range|||16.7|49.5|
3841419|NCT01681004|3666856|B3|Ethnicity: Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3841420|NCT01681004|3666857|B2|Ethnicity: Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3841421|NCT01681004|3666858|B1|Ethnicity: Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3841422|NCT01681004|3666856|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3841423|NCT01681004|3666857|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3841424|NCT01681004|3666858|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3841425|NCT01681004|3666856|B3|American Indian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3841426|NCT01681004|3666857|B2|American Indian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3841427|NCT01681004|3666858|B1|American Indian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3841428|NCT01681004|3666856|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3841429|NCT01681004|3666857|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3841430|NCT01681004|3666858|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3841431|NCT01681004|3666856|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|141|141.0||||||
3841432|NCT01681004|3666857|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
3841433|NCT01681004|3666858|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|97|97.0||||||
3841434|NCT01681004|3666856|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3841435|NCT01681004|3666857|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3841436|NCT01681004|3666858|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3841437|NCT01681004|3666856|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3841438|NCT01681004|3666857|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3841439|NCT01681004|3666858|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3841440|NCT01681004|3666856|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3841441|NCT01681004|3666857|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3841442|NCT01681004|3666858|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3841443|NCT01681004|3666856|B3||Between 18 and 65 years|Age||Participants|Count of Participants|130|130.0||||||
3841444|NCT01681004|3666857|B2||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3841445|NCT01681004|3666858|B1||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
3841446|NCT01681004|3666856|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3841447|NCT01681004|3666857|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3841448|NCT01681004|3666858|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3841449|NCT01680991|3666913|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3841450|NCT01680991|3666914|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3841451|NCT01680991|3666915|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3841452|NCT01680991|3666916|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3841453|NCT01680991|3666913|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3841454|NCT01680991|3666914|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3841455|NCT01680991|3666915|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3841456|NCT01680991|3666916|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3841457|NCT01680991|3666913|B4|||Age||years|Mean|55.6|55.6|Standard Deviation|13.4|13.4|||
3841458|NCT01680991|3666914|B3|||Age||years|Mean|55.1|55.1|Standard Deviation|8.8|8.8|||
3841459|NCT01680991|3666915|B2|||Age||years|Mean|53.3|53.3|Standard Deviation|15.8|15.8|||
3841460|NCT01680991|3666916|B1|||Age||years|Mean|60.7|60.7|Standard Deviation|12.0|12.0|||
3841461|NCT01680900|3666977|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
3841462|NCT01680900|3666978|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3841463|NCT01680900|3666979|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3841464|NCT01680900|3666977|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3841465|NCT01680900|3666978|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3841466|NCT01680900|3666979|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3841467|NCT01680900|3666977|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3841468|NCT01680900|3666978|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3841469|NCT01680900|3666979|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3841470|NCT01680900|3666977|B3|||Age|self-reported age in years|years|Mean|51.9|51.9|Standard Deviation|3.9|3.9|||
3841471|NCT01680900|3666978|B2|||Age|self-reported age in years|years|Mean|52.7|52.7|Standard Deviation|4.2|4.2|||
3841472|NCT01680900|3666979|B1|||Age|self-reported age in years|years|Mean|51.5|51.5|Standard Deviation|3.7|3.7|||
3841473|NCT01680861|3666996|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3841474|NCT01680861|3666997|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3841475|NCT01680861|3666998|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3841476|NCT01680861|3666996|B3|White/Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3841477|NCT01680861|3666997|B2|White/Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3841478|NCT01680861|3666998|B1|White/Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3841479|NCT01680861|3666996|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3841480|NCT01680861|3666997|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3841481|NCT01680861|3666998|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3841482|NCT01680861|3666996|B3|African-American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3841483|NCT01680861|3666997|B2|African-American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3841484|NCT01680861|3666998|B1|African-American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3841485|NCT01680861|3666996|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3841486|NCT01680861|3666997|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3841487|NCT01680861|3666998|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3841488|NCT01680861|3666996|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3841489|NCT01680861|3666997|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3841490|NCT01680861|3666998|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3841491|NCT01680861|3666996|B3|||Age||years|Mean|49.2|49.2|Standard Deviation|10.8|10.8|||
3841492|NCT01680861|3666997|B2|||Age||years|Mean|48.5|48.5|Standard Deviation|11.2|11.2|||
3841493|NCT01680861|3666998|B1|||Age||years|Mean|49.9|49.9|Standard Deviation|10.5|10.5|||
3841494|NCT01680848|3667017|B1|||The mean number of years elapsed since graduation from dental school||years|Mean|18.5|18.5|Standard Deviation|9.9|9.9|||
3841495|NCT01680848|3667017|B1|Japan||Region of Enrollment|Participants were recruited from the JDPBRN Web site and mailings if they indicated that they perform some measure of restorative dentistry at their practice.|participants|Number|189|189.0||||||
3841496|NCT01680848|3667017|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3841497|NCT01680848|3667017|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841498|NCT01680848|3667017|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3841499|NCT01680848|3667017|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841500|NCT01680848|3667017|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3841501|NCT01680848|3667017|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|186|186.0||||||
3841502|NCT01680848|3667017|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841503|NCT01680848|3667017|B1||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3841504|NCT01680848|3667017|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3841505|NCT01680848|3667017|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3841506|NCT01680848|3667017|B1||Between 18 and 65 years|Age||Participants|Count of Participants|189|189.0||||||
3841507|NCT01680848|3667017|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3841508|NCT01680783|3667021|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841509|NCT01680783|3667022|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841510|NCT01680783|3667023|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841511|NCT01680783|3667021|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841512|NCT01680783|3667022|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841513|NCT01680783|3667023|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841514|NCT01680783|3667021|B3||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3841515|NCT01680783|3667022|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3841516|NCT01680783|3667023|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3841517|NCT01680783|3667021|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3841518|NCT01680783|3667022|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3841519|NCT01680783|3667023|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3841520|NCT01680783|3667021|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841521|NCT01680783|3667022|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841522|NCT01680783|3667023|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841523|NCT01680783|3667021|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3841524|NCT01680783|3667022|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3841525|NCT01680783|3667023|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3841526|NCT01680783|3667021|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841527|NCT01680783|3667022|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841528|NCT01680783|3667023|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841529|NCT01680783|3667021|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3841530|NCT01680783|3667022|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3841531|NCT01680783|3667023|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3841532|NCT01680783|3667021|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3841533|NCT01680783|3667022|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3841534|NCT01680783|3667023|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3841535|NCT01680783|3667021|B3|||Age||years|Median|59|59.0|Inter-Quartile Range|||52.0|69.0|
3841536|NCT01680783|3667022|B2|||Age||years|Median|58|58.0|Inter-Quartile Range|||49.8|67.8|
3841537|NCT01680783|3667023|B1|||Age||years|Median|60.9|60.9|Inter-Quartile Range|||56.4|71.1|
3841538|NCT01680666|3667030|B3|United States||Region of Enrollment||participants|Number|150|150.0||||||
3841539|NCT01680666|3667031|B2|United States||Region of Enrollment||participants|Number|66|66.0||||||
3841540|NCT01680666|3667032|B1|United States||Region of Enrollment||participants|Number|84|84.0||||||
3841541|NCT01680666|3667030|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3841542|NCT01680666|3667031|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3841543|NCT01680666|3667032|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3841544|NCT01680666|3667030|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3841545|NCT01680666|3667031|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3841546|NCT01680666|3667032|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3841547|NCT01680666|3667030|B3|||Age||years|Mean|7|7.0|Full Range|||0.0|18.0|
3841548|NCT01680666|3667031|B2|||Age||years|Mean|5|5.0|Full Range|||0.0|18.0|
3841549|NCT01680666|3667032|B1|||Age||years|Mean|8|8.0|Full Range|||0.0|18.0|
3841550|NCT01680666|3667030|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3841551|NCT01680666|3667031|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3841552|NCT01680666|3667032|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3841553|NCT01680666|3667030|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3841554|NCT01680666|3667031|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3841555|NCT01680666|3667032|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3841556|NCT01680666|3667030|B3||<=18 years|Age||Participants|Count of Participants|150|150.0||||||
3841557|NCT01680666|3667031|B2||<=18 years|Age||Participants|Count of Participants|66|66.0||||||
3841558|NCT01680666|3667032|B1||<=18 years|Age||Participants|Count of Participants|84|84.0||||||
3841559|NCT01680653|3667047|B1|United States||Region of Enrollment||participants|Number|57|57.0||||||
3841560|NCT01680653|3667047|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3841561|NCT01680653|3667047|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841562|NCT01680653|3667047|B1||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3841563|NCT01680653|3667047|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841564|NCT01680653|3667047|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841565|NCT01680653|3667047|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841566|NCT01680653|3667047|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841567|NCT01680653|3667047|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3841568|NCT01680653|3667047|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3841569|NCT01680653|3667047|B1|17-21 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
3841570|NCT01680653|3667047|B1|12-16 years||Age, Customized||Participants|Count of Participants|39|39.0||||||
3841571|NCT01680653|3667047|B1|7-11 years||Age, Customized||Participants|Count of Participants|12|12.0||||||
3841572|NCT01680653|3667047|B1|||Age||years|Mean|13.9|13.9|Standard Deviation|3.8|3.8|||
3841573|NCT01680549|3667057|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
3841574|NCT01680549|3667058|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3841575|NCT01680549|3667059|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3841576|NCT01680549|3667057|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3841577|NCT01680549|3667058|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3841578|NCT01680549|3667059|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3841579|NCT01680549|3667057|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3841580|NCT01680549|3667058|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3841581|NCT01680549|3667059|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3841582|NCT01680549|3667057|B3|||Age||Years|Mean|62.1|62.1|Standard Deviation|10.7|10.7|||
3841583|NCT01680549|3667058|B2|||Age||Years|Mean|63.1|63.1|Standard Deviation|11.2|11.2|||
3841584|NCT01680549|3667059|B1|||Age||Years|Mean|61.3|61.3|Standard Deviation|10.1|10.1|||
3841585|NCT01680549|3667057|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3841586|NCT01680549|3667058|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3841587|NCT01680549|3667059|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3841588|NCT01680549|3667057|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3841589|NCT01680549|3667058|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3841590|NCT01680549|3667059|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3841591|NCT01680549|3667057|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3841592|NCT01680549|3667058|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3841593|NCT01680549|3667059|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3841594|NCT01680497|3667072|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3841595|NCT01680497|3667072|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3841596|NCT01680497|3667072|B1|||Age||Years|Mean|49.3|49.3|Standard Deviation|9.5|9.5|||
3841597|NCT01680458|3667082|B1|Prophylaxis||Reason for administration, Treatment/Prophylaxis||Participants|Number|25|25.0||||||
3841598|NCT01680458|3667082|B1|Treatment||Reason for administration, Treatment/Prophylaxis||Participants|Number|2|2.0||||||
3841599|NCT01680458|3667082|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3841600|NCT01680458|3667082|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3841601|NCT01680458|3667082|B1|1 to less than 7 years||Age, Customized||Participants|Number|22|22.0||||||
3841602|NCT01680458|3667082|B1|4 weeks to less than 1 year||Age, Customized||Participants|Number|4|4.0||||||
3841603|NCT01680458|3667082|B1|Less than 4 weeks||Age, Customized||Participants|Number|1|1.0||||||
3841604|NCT01680341|3667091|B3|||Fasting plasma glucose||mmol/L|Mean|8.0|8.0|Standard Deviation|2.6|2.6|||
3841605|NCT01680341|3667092|B2|||Fasting plasma glucose||mmol/L|Mean|8.1|8.1|Standard Deviation|3.0|3.0|||
3841606|NCT01680341|3667093|B1|||Fasting plasma glucose||mmol/L|Mean|7.8|7.8|Standard Deviation|2.3|2.3|||
3841607|NCT01680341|3667091|B3|||Glycosylated Haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.2|8.2|Standard Deviation|0.9|0.9|||
3841608|NCT01680341|3667092|B2|||Glycosylated Haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.2|8.2|Standard Deviation|0.9|0.9|||
3841609|NCT01680341|3667093|B1|||Glycosylated Haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.2|8.2|Standard Deviation|0.9|0.9|||
3841610|NCT01680341|3667091|B3||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
3841611|NCT01680341|3667092|B2||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3841612|NCT01680341|3667093|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3841613|NCT01680341|3667091|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3841614|NCT01680341|3667092|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3841615|NCT01680341|3667093|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3841616|NCT01680341|3667091|B3|||Age||years|Mean|58.9|58.9|Standard Deviation|9.6|9.6|||
3841617|NCT01680341|3667092|B2|||Age||years|Mean|59.1|59.1|Standard Deviation|9.4|9.4|||
3841618|NCT01680341|3667093|B1|||Age||years|Mean|58.8|58.8|Standard Deviation|9.8|9.8|||
3841619|NCT01680328|3667114|B1||Male|Gender||Participants|Count of Participants|50|50.0||||||
3841620|NCT01680328|3667114|B1||Female|Gender||Participants|Count of Participants|32|32.0||||||
3841621|NCT01680328|3667114|B1|||Age||years|Mean|54.3|54.3|Standard Deviation|11.9|11.9|||
3841622|NCT01680172|3667150|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3841623|NCT01680172|3667151|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3841624|NCT01680172|3667152|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3841625|NCT01680172|3667150|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3841626|NCT01680172|3667151|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3841627|NCT01680172|3667152|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3841628|NCT01680172|3667150|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3841629|NCT01680172|3667151|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3841630|NCT01680172|3667152|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3841631|NCT01680172|3667150|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3841632|NCT01680172|3667151|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3841633|NCT01680172|3667152|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3841634|NCT01680172|3667150|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3841635|NCT01680172|3667151|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3841636|NCT01680172|3667152|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3841637|NCT01680172|3667150|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3841638|NCT01680172|3667151|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3841639|NCT01680172|3667152|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3841640|NCT01680159|3667161|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3841641|NCT01680159|3667162|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3841642|NCT01680159|3667163|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3841643|NCT01680159|3667164|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3841644|NCT01680159|3667165|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3841645|NCT01680159|3667161|B5||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3841646|NCT01680159|3667162|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3841647|NCT01680159|3667163|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3841648|NCT01680159|3667164|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3841649|NCT01680159|3667165|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3841650|NCT01680159|3667161|B5|||Age||years|Mean|49.5|49.5|Standard Deviation|13.7|13.7|||
3841651|NCT01680159|3667162|B4|||Age||years|Mean|55.8|55.8|Standard Deviation|12.5|12.5|||
3841652|NCT01680159|3667163|B3|||Age||years|Mean|36.7|36.7|Standard Deviation|9.7|9.7|||
3841653|NCT01680159|3667164|B2|||Age||years|Mean|50.1|50.1|Standard Deviation|11.9|11.9|||
3841654|NCT01680159|3667165|B1|||Age||years|Mean|51.2|51.2|Standard Deviation|13.9|13.9|||
3841655|NCT01680016|3667190|B3|Male (≥51 Years)||Sex/Gender, Customized||Subjects|Number|160|160.0||||||
3841656|NCT01680016|3667191|B2|Male (≥51 Years)||Sex/Gender, Customized||Subjects|Number|77|77.0||||||
3841657|NCT01680016|3667192|B1|Male (≥51 Years)||Sex/Gender, Customized||Subjects|Number|83|83.0||||||
3841658|NCT01680016|3667190|B3|Female (≥51 Years)||Sex/Gender, Customized||Subjects|Number|241|241.0||||||
3841659|NCT01680016|3667191|B2|Female (≥51 Years)||Sex/Gender, Customized||Subjects|Number|123|123.0||||||
3841660|NCT01680016|3667192|B1|Female (≥51 Years)||Sex/Gender, Customized||Subjects|Number|118|118.0||||||
3841661|NCT01680016|3667190|B3|Male (≥6 to ≤17 Years)||Sex/Gender, Customized||Subjects|Number|118|118.0||||||
3841662|NCT01680016|3667191|B2|Male (≥6 to ≤17 Years)||Sex/Gender, Customized||Subjects|Number|46|46.0||||||
3841663|NCT01680016|3667192|B1|Male (≥6 to ≤17 Years)||Sex/Gender, Customized||Subjects|Number|72|72.0||||||
3841664|NCT01680016|3667190|B3|Female (≥6 to ≤17 Years)||Sex/Gender, Customized||Subjects|Number|125|125.0||||||
3841665|NCT01680016|3667191|B2|Female (≥6 to ≤17 Years)||Sex/Gender, Customized||Subjects|Number|76|76.0||||||
3841666|NCT01680016|3667192|B1|Female (≥6 to ≤17 Years)||Sex/Gender, Customized||Subjects|Number|49|49.0||||||
3841667|NCT01680016|3667190|B3|Older Adults (≥51 Years)||Age||years|Mean|62.0|62.0|Standard Deviation|6.6|6.6|||
3841668|NCT01680016|3667191|B2|Older Adults (≥51 Years)||Age||years|Mean|61.9|61.9|Standard Deviation|6.8|6.8|||
3841669|NCT01680016|3667192|B1|Older Adults (≥51 Years)||Age||years|Mean|62.1|62.1|Standard Deviation|6.5|6.5|||
3841670|NCT01680016|3667190|B3|Children (≥6 to ≤17 Years)||Age||years|Mean|10.9|10.9|Standard Deviation|3.0|3.0|||
3841671|NCT01680016|3667191|B2|Children (≥6 to ≤17 Years)||Age||years|Mean|10.8|10.8|Standard Deviation|2.9|2.9|||
3841672|NCT01680016|3667192|B1|Children (≥6 to ≤17 Years)||Age||years|Mean|11|11.0|Standard Deviation|3.0|3.0|||
3841673|NCT01679613|3667257|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3841674|NCT01679613|3667257|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3841675|NCT01679613|3667257|B1|||Age||years|Mean|35.9|35.9|Standard Deviation|10.7|10.7|||
3841676|NCT01679600|3667271|B3|||Time poststroke||days|Mean|52|52.0|Standard Deviation|31|31.0|||
3841677|NCT01679600|3667272|B2|||Time poststroke||days|Mean|45|45.0|Standard Deviation|30|30.0|||
3841678|NCT01679600|3667273|B1|||Time poststroke||days|Mean|52|52.0|Standard Deviation|42|42.0|||
3841679|NCT01679600|3667271|B3|||Functional Ambulation Classification (0-5)|Patients will be rated on the following 6 categories: 0: Patient cannot walk, or needs help from 2 or more persons. 1: Patients needs firm continuous support from 1 person who helps carrying weight and with balance. 2: Patient needs continuous or intermittent support of one person to help with balance and coordination. 3: Patient requires verbal supervision or stand-by help from one person without physical contact. 4: Patient can walk independently on level ground, but requires help on stairs, slopes or uneven surfaces. 5: Patient can walk independently anywhere.|units on a scale|Mean|1|1.0|Standard Deviation|0.8|0.8|||
3841680|NCT01679600|3667272|B2|||Functional Ambulation Classification (0-5)|Patients will be rated on the following 6 categories: 0: Patient cannot walk, or needs help from 2 or more persons. 1: Patients needs firm continuous support from 1 person who helps carrying weight and with balance. 2: Patient needs continuous or intermittent support of one person to help with balance and coordination. 3: Patient requires verbal supervision or stand-by help from one person without physical contact. 4: Patient can walk independently on level ground, but requires help on stairs, slopes or uneven surfaces. 5: Patient can walk independently anywhere.|units on a scale|Mean|0.9|0.9|Standard Deviation|1|1.0|||
3841681|NCT01679600|3667273|B1|||Functional Ambulation Classification (0-5)|Patients will be rated on the following 6 categories: 0: Patient cannot walk, or needs help from 2 or more persons. 1: Patients needs firm continuous support from 1 person who helps carrying weight and with balance. 2: Patient needs continuous or intermittent support of one person to help with balance and coordination. 3: Patient requires verbal supervision or stand-by help from one person without physical contact. 4: Patient can walk independently on level ground, but requires help on stairs, slopes or uneven surfaces. 5: Patient can walk independently anywhere.|units on a scale|Mean|1|1.0|Standard Deviation|0.8|0.8|||
3841682|NCT01679600|3667271|B3|left||Hemiparetic side: right/left||participants|Number|7|7.0||||||
3841683|NCT01679600|3667272|B2|left||Hemiparetic side: right/left||participants|Number|5|5.0||||||
3841684|NCT01679600|3667273|B1|left||Hemiparetic side: right/left||participants|Number|2|2.0||||||
3841685|NCT01679600|3667271|B3|right||Hemiparetic side: right/left||participants|Number|7|7.0||||||
3841686|NCT01679600|3667272|B2|right||Hemiparetic side: right/left||participants|Number|2|2.0||||||
3841687|NCT01679600|3667273|B1|right||Hemiparetic side: right/left||participants|Number|5|5.0||||||
3841688|NCT01679600|3667271|B3|hemorrhagic||Type of stroke: ischemic/hemorrhagic||participants|Number|2|2.0||||||
3841689|NCT01679600|3667272|B2|hemorrhagic||Type of stroke: ischemic/hemorrhagic||participants|Number|0|0.0||||||
3841690|NCT01679600|3667273|B1|hemorrhagic||Type of stroke: ischemic/hemorrhagic||participants|Number|2|2.0||||||
3841691|NCT01679600|3667271|B3|ischemic||Type of stroke: ischemic/hemorrhagic||participants|Number|12|12.0||||||
3841692|NCT01679600|3667272|B2|ischemic||Type of stroke: ischemic/hemorrhagic||participants|Number|7|7.0||||||
3841693|NCT01679600|3667273|B1|ischemic||Type of stroke: ischemic/hemorrhagic||participants|Number|5|5.0||||||
3841694|NCT01679600|3667271|B3|Switzerland||Region of Enrollment||participants|Number|14|14.0||||||
3841695|NCT01679600|3667272|B2|Switzerland||Region of Enrollment||participants|Number|7|7.0||||||
3841696|NCT01679600|3667273|B1|Switzerland||Region of Enrollment||participants|Number|7|7.0||||||
3841697|NCT01679600|3667271|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3841698|NCT01679600|3667272|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3841699|NCT01679600|3667273|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3841700|NCT01679600|3667271|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3841701|NCT01679600|3667272|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3841702|NCT01679600|3667273|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3841703|NCT01679600|3667271|B3|||Age||years|Mean|61|61.0|Standard Deviation|11|11.0|||
3841704|NCT01679600|3667272|B2|||Age||years|Mean|63|63.0|Standard Deviation|13|13.0|||
3841705|NCT01679600|3667273|B1|||Age||years|Mean|57|57.0|Standard Deviation|12|12.0|||
3841706|NCT01679314|3667280|B3|Germany||Region of Enrollment||participants|Number|54|54.0||||||
3841707|NCT01679314|3667281|B2|Germany||Region of Enrollment||participants|Number|28|28.0||||||
3841708|NCT01679314|3667282|B1|Germany||Region of Enrollment||participants|Number|26|26.0||||||
3841709|NCT01679314|3667280|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3841710|NCT01679314|3667281|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3841711|NCT01679314|3667282|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3841712|NCT01679314|3667280|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3841713|NCT01679314|3667281|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3841714|NCT01679314|3667282|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3841715|NCT01679314|3667280|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|7.5|7.5|||
3841716|NCT01679314|3667281|B2|||Age||years|Mean|58.0|58.0|Standard Deviation|7.6|7.6|||
3841717|NCT01679314|3667282|B1|||Age||years|Mean|61.2|61.2|Standard Deviation|7.2|7.2|||
3841718|NCT01679301|3667301|B1|||Body Mass Index||kg/m^2|Mean|30.25|30.25|Standard Deviation|9.8|9.8|||
3841719|NCT01679301|3667301|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3841720|NCT01679301|3667301|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841721|NCT01679301|3667301|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841722|NCT01679301|3667301|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3841723|NCT01679301|3667301|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841724|NCT01679301|3667301|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841725|NCT01679301|3667301|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841726|NCT01679301|3667301|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841727|NCT01679301|3667301|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3841728|NCT01679301|3667301|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3841729|NCT01679301|3667301|B1|||Age||years|Mean|67.76|67.76|Standard Deviation|8.76|8.76|||
3841730|NCT01679236|3667309|B3|United States||Region of Enrollment||participants|Number|55|55.0||||||
3841731|NCT01679236|3667310|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3841732|NCT01679236|3667311|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3841733|NCT01679236|3667309|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3841734|NCT01679236|3667310|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3841735|NCT01679236|3667311|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3841736|NCT01679236|3667309|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3841737|NCT01679236|3667310|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3841738|NCT01679236|3667311|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3841739|NCT01679236|3667309|B3|||Age||years|Mean|21.93|21.93|Standard Deviation|2.53|2.53|||
3841740|NCT01679236|3667310|B2|||Age||years|Mean|22.2|22.2|Standard Deviation|2.68|2.68|||
3841741|NCT01679236|3667311|B1|||Age||years|Mean|21.7|21.7|Standard Deviation|2.42|2.42|||
3841742|NCT01679197|3667318|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
3841743|NCT01679197|3667318|B1|Decline to answer||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3841744|NCT01679197|3667318|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3841745|NCT01679197|3667318|B1|Native American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3841746|NCT01679197|3667318|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3841747|NCT01679197|3667318|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3841748|NCT01679197|3667318|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3841749|NCT01679197|3667318|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3841750|NCT01679197|3667318|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3841751|NCT01679197|3667318|B1|||Age||years|Mean|42.35|42.35|Standard Deviation|15.82|15.82|||
3841752|NCT01679197|3667318|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3841753|NCT01679197|3667318|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3841754|NCT01679197|3667318|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3841755|NCT01679028|3667331|B7|United States||Region of Enrollment||participants|Number|20|20.0||||||
3841756|NCT01679028|3667332|B6|United States||Region of Enrollment||participants|Number|6|6.0||||||
3841757|NCT01679028|3667333|B5|United States||Region of Enrollment||participants|Number|2|2.0||||||
3841758|NCT01679028|3667334|B4|United States||Region of Enrollment||participants|Number|4|4.0||||||
3841759|NCT01679028|3667335|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3841760|NCT01679028|3667336|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3841761|NCT01679028|3667337|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3841762|NCT01679028|3667331|B7||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3841763|NCT01679028|3667332|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3841764|NCT01679028|3667333|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3841765|NCT01679028|3667334|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3841766|NCT01679028|3667335|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3841767|NCT01679028|3667336|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3841768|NCT01679028|3667337|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3841769|NCT01679028|3667331|B7||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3841770|NCT01679028|3667332|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3841771|NCT01679028|3667333|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3841772|NCT01679028|3667334|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3841773|NCT01679028|3667335|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3841774|NCT01679028|3667336|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3841775|NCT01679028|3667337|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3841776|NCT01679028|3667331|B7|||Age||years|Mean|32.5|32.5|Standard Deviation|11.0|11.0|||
3841777|NCT01679028|3667332|B6|||Age||years|Mean|40.6|40.6|Standard Deviation|9.9|9.9|||
3841778|NCT01679028|3667333|B5|||Age||years|Mean|47.5|47.5|Standard Deviation|6.4|6.4|||
3841779|NCT01679028|3667334|B4|||Age||years|Mean|24|24.0|Standard Deviation|2.2|2.2|||
3841780|NCT01679028|3667335|B3|||Age||years|Mean|24.5|24.5|Standard Deviation|4.9|4.9|||
3841781|NCT01679028|3667336|B2|||Age||years|Mean|24|24.0|Standard Deviation|2|2.0|||
3841782|NCT01679028|3667337|B1|||Age||years|Mean|27|27.0|Standard Deviation|3|3.0|||
3841783|NCT01679002|3667356|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3841784|NCT01679002|3667357|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3841785|NCT01679002|3667358|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3841786|NCT01679002|3667359|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3841787|NCT01679002|3667356|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3841788|NCT01679002|3667357|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3841789|NCT01679002|3667358|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3841790|NCT01679002|3667359|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3841791|NCT01679002|3667356|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3841792|NCT01679002|3667357|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3841793|NCT01679002|3667358|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3841794|NCT01679002|3667359|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3841795|NCT01679002|3667356|B4||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3841796|NCT01679002|3667357|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3841797|NCT01679002|3667358|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3841798|NCT01679002|3667359|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3841799|NCT01679002|3667356|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3841800|NCT01679002|3667357|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3841801|NCT01679002|3667358|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3841802|NCT01679002|3667359|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3841803|NCT01678976|3667375|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3841804|NCT01678976|3667376|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3841805|NCT01678976|3667377|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3841806|NCT01678976|3667375|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3841807|NCT01678976|3667376|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3841808|NCT01678976|3667377|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3841809|NCT01678976|3667375|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3841810|NCT01678976|3667376|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3841811|NCT01678976|3667377|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3841812|NCT01678976|3667375|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3841813|NCT01678976|3667376|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3841814|NCT01678976|3667377|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3841815|NCT01678976|3667375|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3841816|NCT01678976|3667376|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3841817|NCT01678976|3667377|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3841818|NCT01678911|3667388|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3841819|NCT01678911|3667388|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3841820|NCT01678911|3667388|B1|||Age||years|Mean|44.6|44.6|Standard Deviation|13.2|13.2|||
3841821|NCT01678885|3667403|B3|United States||Region of Enrollment||participants|Number|87|87.0||||||
3841822|NCT01678885|3667404|B2|United States||Region of Enrollment||participants|Number|47|47.0||||||
3841823|NCT01678885|3667405|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3841824|NCT01678885|3667403|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3841825|NCT01678885|3667404|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3841826|NCT01678885|3667405|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3841827|NCT01678885|3667403|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3841828|NCT01678885|3667404|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3841829|NCT01678885|3667405|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3841830|NCT01678885|3667403|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3841831|NCT01678885|3667404|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3841832|NCT01678885|3667405|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3841833|NCT01678885|3667403|B3||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
3841834|NCT01678885|3667404|B2||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3841835|NCT01678885|3667405|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3841836|NCT01678885|3667403|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3841837|NCT01678885|3667404|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3841838|NCT01678885|3667405|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3841839|NCT01678846|3667417|B3||Male|Sex: Female, Male||Participants|Count of Participants|1769|1769.0||||||
3841840|NCT01678846|3667418|B2||Male|Sex: Female, Male||Participants|Count of Participants|872|872.0||||||
3841841|NCT01678846|3667419|B1||Male|Sex: Female, Male||Participants|Count of Participants|897|897.0||||||
3841842|NCT01678846|3667417|B3||Female|Sex: Female, Male||Participants|Count of Participants|1937|1937.0||||||
3841843|NCT01678846|3667418|B2||Female|Sex: Female, Male||Participants|Count of Participants|1010|1010.0||||||
3841844|NCT01678846|3667419|B1||Female|Sex: Female, Male||Participants|Count of Participants|927|927.0||||||
3841845|NCT01678846|3667417|B3|||Age||years|Mean|13.0|13.0|Standard Deviation|1.5|1.5|||
3841846|NCT01678846|3667418|B2|||Age||years|Mean|13.0|13.0|Standard Deviation|1.5|1.5|||
3841847|NCT01678846|3667419|B1|||Age||years|Mean|13.1|13.1|Standard Deviation|1.5|1.5|||
3841848|NCT01678820|3667432|B4|||Very low-density lipoprotein cholesterol (VLDL-C)|Sitagliptin, n=97; Total, n=297|mg/dL|Mean|35.6|35.6|Standard Deviation|19.3|19.3|||
3841902|NCT01678807|3667481|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3841849|NCT01678820|3667433|B3|||Very low-density lipoprotein cholesterol (VLDL-C)|Sitagliptin, n=97; Total, n=297|mg/dL|Mean|35.7|35.7|Standard Deviation|18.8|18.8|||
3841850|NCT01678820|3667434|B2|||Very low-density lipoprotein cholesterol (VLDL-C)|Sitagliptin, n=97; Total, n=297|mg/dL|Mean|35.8|35.8|Standard Deviation|20.4|20.4|||
3841851|NCT01678820|3667435|B1|||Very low-density lipoprotein cholesterol (VLDL-C)|Sitagliptin, n=97; Total, n=297|mg/dL|Mean|35.4|35.4|Standard Deviation|18.8|18.8|||
3841852|NCT01678820|3667432|B4|||High-density lipoprotein cholesterol (HDL-C)||mg/dL|Mean|47.6|47.6|Standard Deviation|11.5|11.5|||
3841853|NCT01678820|3667433|B3|||High-density lipoprotein cholesterol (HDL-C)||mg/dL|Mean|47.0|47.0|Standard Deviation|11.2|11.2|||
3841854|NCT01678820|3667434|B2|||High-density lipoprotein cholesterol (HDL-C)||mg/dL|Mean|48.2|48.2|Standard Deviation|12.1|12.1|||
3841855|NCT01678820|3667435|B1|||High-density lipoprotein cholesterol (HDL-C)||mg/dL|Mean|47.6|47.6|Standard Deviation|11.3|11.3|||
3841856|NCT01678820|3667432|B4|||Triglycerides (TG)||mg/dL|Mean|180.8|180.8|Standard Deviation|112.9|112.9|||
3841857|NCT01678820|3667433|B3|||Triglycerides (TG)||mg/dL|Mean|184.2|184.2|Standard Deviation|118.6|118.6|||
3841858|NCT01678820|3667434|B2|||Triglycerides (TG)||mg/dL|Mean|180.8|180.8|Standard Deviation|119.1|119.1|||
3841859|NCT01678820|3667435|B1|||Triglycerides (TG)||mg/dL|Mean|177.4|177.4|Standard Deviation|101.2|101.2|||
3841860|NCT01678820|3667432|B4|||Non high-density lipoprotein cholesterol (non-HDL-C)|Sitagliptin, n=97; Total, n=297|mg/dL|Mean|139.2|139.2|Standard Deviation|29.3|29.3|||
3841861|NCT01678820|3667433|B3|||Non high-density lipoprotein cholesterol (non-HDL-C)|Sitagliptin, n=97; Total, n=297|mg/dL|Mean|136.5|136.5|Standard Deviation|27.1|27.1|||
3841862|NCT01678820|3667434|B2|||Non high-density lipoprotein cholesterol (non-HDL-C)|Sitagliptin, n=97; Total, n=297|mg/dL|Mean|139.5|139.5|Standard Deviation|29.9|29.9|||
3841863|NCT01678820|3667435|B1|||Non high-density lipoprotein cholesterol (non-HDL-C)|Sitagliptin, n=97; Total, n=297|mg/dL|Mean|141.7|141.7|Standard Deviation|30.9|30.9|||
3841864|NCT01678820|3667432|B4|||Apolipoprotein B (Apo B)|Sitagliptin, n=95; Total, n=295|mg/dL|Mean|95.8|95.8|Standard Deviation|18.4|18.4|||
3841865|NCT01678820|3667433|B3|||Apolipoprotein B (Apo B)|Sitagliptin, n=95; Total, n=295|mg/dL|Mean|94.1|94.1|Standard Deviation|17.2|17.2|||
3841866|NCT01678820|3667434|B2|||Apolipoprotein B (Apo B)|Sitagliptin, n=95; Total, n=295|mg/dL|Mean|95.4|95.4|Standard Deviation|19.0|19.0|||
3841867|NCT01678820|3667435|B1|||Apolipoprotein B (Apo B)|Sitagliptin, n=95; Total, n=295|mg/dL|Mean|97.8|97.8|Standard Deviation|19.0|19.0|||
3841868|NCT01678820|3667432|B4|||Total cholesterol (TC)||mg/dL|Mean|186.8|186.8|Standard Deviation|29.6|29.6|||
3841869|NCT01678820|3667433|B3|||Total cholesterol (TC)||mg/dL|Mean|183.5|183.5|Standard Deviation|28.4|28.4|||
3841870|NCT01678820|3667434|B2|||Total cholesterol (TC)||mg/dL|Mean|187.7|187.7|Standard Deviation|29.6|29.6|||
3841871|NCT01678820|3667435|B1|||Total cholesterol (TC)||mg/dL|Mean|189.3|189.3|Standard Deviation|30.9|30.9|||
3841872|NCT01678820|3667432|B4|||Low-density lipoprotein cholesterol (LDL-C)||mg/dL|Mean|103.7|103.7|Standard Deviation|24.4|24.4|||
3841873|NCT01678820|3667433|B3|||Low-density lipoprotein cholesterol (LDL-C)||mg/dL|Mean|100.9|100.9|Standard Deviation|22.0|22.0|||
3841874|NCT01678820|3667434|B2|||Low-density lipoprotein cholesterol (LDL-C)||mg/dL|Mean|103.9|103.9|Standard Deviation|24.2|24.2|||
3841875|NCT01678820|3667435|B1|||Low-density lipoprotein cholesterol (LDL-C)||mg/dL|Mean|106.5|106.5|Standard Deviation|26.7|26.7|||
3841876|NCT01678820|3667432|B4|||Fasting plasma glucose (FPG)||mg/dL|Mean|173.8|173.8|Standard Deviation|46.8|46.8|||
3841877|NCT01678820|3667433|B3|||Fasting plasma glucose (FPG)||mg/dL|Mean|175.7|175.7|Standard Deviation|49.3|49.3|||
3841878|NCT01678820|3667434|B2|||Fasting plasma glucose (FPG)||mg/dL|Mean|175.9|175.9|Standard Deviation|48.6|48.6|||
3841879|NCT01678820|3667435|B1|||Fasting plasma glucose (FPG)||mg/dL|Mean|169.9|169.9|Standard Deviation|42.3|42.3|||
3841880|NCT01678820|3667432|B4|||Hemoglobin A1c (A1C)||Percent|Mean|8.18|8.18|Standard Deviation|1.08|1.08|||
3841881|NCT01678820|3667433|B3|||Hemoglobin A1c (A1C)||Percent|Mean|8.22|8.22|Standard Deviation|1.19|1.19|||
3841882|NCT01678820|3667434|B2|||Hemoglobin A1c (A1C)||Percent|Mean|8.15|8.15|Standard Deviation|1.09|1.09|||
3841883|NCT01678820|3667435|B1|||Hemoglobin A1c (A1C)||Percent|Mean|8.16|8.16|Standard Deviation|0.94|0.94|||
3841884|NCT01678820|3667432|B4||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3841885|NCT01678820|3667433|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3841886|NCT01678820|3667434|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3841887|NCT01678820|3667435|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3841888|NCT01678820|3667432|B4||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3841889|NCT01678820|3667433|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3841890|NCT01678820|3667434|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3841891|NCT01678820|3667435|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3841892|NCT01678820|3667432|B4|||Age||Years|Mean|54.7|54.7|Standard Deviation|10.1|10.1|||
3841893|NCT01678820|3667433|B3|||Age||Years|Mean|54.9|54.9|Standard Deviation|10.0|10.0|||
3841894|NCT01678820|3667434|B2|||Age||Years|Mean|54.2|54.2|Standard Deviation|10.3|10.3|||
3841895|NCT01678820|3667435|B1|||Age||Years|Mean|54.9|54.9|Standard Deviation|10.2|10.2|||
3841896|NCT01678807|3667479|B4||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3841897|NCT01678807|3667480|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3841898|NCT01678807|3667481|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3841899|NCT01678807|3667482|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3841900|NCT01678807|3667479|B4||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3841901|NCT01678807|3667480|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3841903|NCT01678807|3667482|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3841904|NCT01678807|3667479|B4|||Age||Years|Mean|14.4|14.4|Standard Deviation|1.7|1.7|||
3841905|NCT01678807|3667480|B3|||Age||Years|Mean|14.3|14.3|Standard Deviation|1.8|1.8|||
3841906|NCT01678807|3667481|B2|||Age||Years|Mean|14.5|14.5|Standard Deviation|1.7|1.7|||
3841907|NCT01678807|3667482|B1|||Age||Years|Mean|14.5|14.5|Standard Deviation|1.6|1.6|||
3841908|NCT01678443|3667495|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3841909|NCT01678443|3667495|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841910|NCT01678443|3667495|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841911|NCT01678443|3667495|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3841912|NCT01678443|3667495|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3841913|NCT01678443|3667495|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841914|NCT01678443|3667495|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841915|NCT01678443|3667495|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841916|NCT01678443|3667495|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841917|NCT01678443|3667495|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3841918|NCT01678443|3667495|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841919|NCT01678443|3667495|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3841920|NCT01678443|3667495|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3841921|NCT01678443|3667495|B1|||Age||years|Mean|52|52.0|Standard Deviation|0|0.0|||
3841922|NCT01678313|3667500|B3|Taiwan||Region of Enrollment||participants|Number|122|122.0||||||
3841923|NCT01678313|3667501|B2|Taiwan||Region of Enrollment||participants|Number|58|58.0||||||
3841924|NCT01678313|3667502|B1|Taiwan||Region of Enrollment||participants|Number|64|64.0||||||
3841925|NCT01678313|3667500|B3||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3841926|NCT01678313|3667501|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3841927|NCT01678313|3667502|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3841928|NCT01678313|3667500|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3841929|NCT01678313|3667501|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3841930|NCT01678313|3667502|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3841931|NCT01678313|3667500|B3|||Age||years|Mean|72.1|72.1|Standard Deviation|8.75|8.75|||
3841932|NCT01678313|3667501|B2|||Age||years|Mean|73.8|73.8|Standard Deviation|8.0|8.0|||
3841933|NCT01678313|3667502|B1|||Age||years|Mean|70.4|70.4|Standard Deviation|9.5|9.5|||
3841934|NCT01678196|3667519|B3|United States||Region of Enrollment||participants|Number|66|66.0||||||
3841935|NCT01678196|3667520|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
3841936|NCT01678196|3667521|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
3841937|NCT01678196|3667519|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3841938|NCT01678196|3667520|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3841939|NCT01678196|3667521|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3841940|NCT01678196|3667519|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841941|NCT01678196|3667520|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841942|NCT01678196|3667521|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841943|NCT01678196|3667519|B3||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3841944|NCT01678196|3667520|B2||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3841945|NCT01678196|3667521|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3841946|NCT01678196|3667519|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841947|NCT01678196|3667520|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841948|NCT01678196|3667521|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841949|NCT01678196|3667519|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841950|NCT01678196|3667520|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841951|NCT01678196|3667521|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841952|NCT01678196|3667519|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841953|NCT01678196|3667520|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841954|NCT01678196|3667521|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841955|NCT01678196|3667519|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3841956|NCT01678196|3667520|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3841957|NCT01678196|3667521|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841958|NCT01678196|3667519|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3841959|NCT01678196|3667520|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3841960|NCT01678196|3667521|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3841961|NCT01678196|3667519|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3841962|NCT01678196|3667520|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3841963|NCT01678196|3667521|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3841964|NCT01678196|3667519|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3841965|NCT01678196|3667520|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3841966|NCT01678196|3667521|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3841967|NCT01678196|3667519|B3||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
3841968|NCT01678196|3667520|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3841969|NCT01678196|3667521|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3841970|NCT01678196|3667519|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3841971|NCT01678196|3667520|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3841972|NCT01678196|3667521|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3841973|NCT01678131|3667534|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3841974|NCT01678131|3667535|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3841975|NCT01678131|3667536|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3841976|NCT01678131|3667537|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3841977|NCT01678131|3667534|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3841978|NCT01678131|3667535|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3841979|NCT01678131|3667536|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3841980|NCT01678131|3667537|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3841981|NCT01678131|3667534|B4|||Age||Years|Mean|42.1|42.1|Standard Deviation|10.2|10.2|||
3841982|NCT01678131|3667535|B3|||Age||Years|Mean|38.9|38.9|Standard Deviation|8.0|8.0|||
3841983|NCT01678131|3667536|B2|||Age||Years|Mean|43.9|43.9|Standard Deviation|12.1|12.1|||
3841984|NCT01678131|3667537|B1|||Age||Years|Mean|43.7|43.7|Standard Deviation|10.6|10.6|||
3841985|NCT01677988|3667547|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841986|NCT01677988|3667547|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841987|NCT01677988|3667547|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3841988|NCT01677988|3667547|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3841989|NCT01677988|3667547|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841990|NCT01677988|3667547|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841991|NCT01677988|3667547|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841992|NCT01677988|3667547|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841993|NCT01677988|3667547|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3841994|NCT01677988|3667547|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3841995|NCT01677988|3667547|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3841996|NCT01677988|3667547|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3841997|NCT01677988|3667547|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3841998|NCT01677988|3667547|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3841999|NCT01677988|3667547|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3842000|NCT01677936|3667558|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
3842001|NCT01677936|3667559|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3842002|NCT01677936|3667560|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3842003|NCT01677936|3667558|B3|Male||Gender||participants|Number|23|23.0||||||
3842004|NCT01677936|3667559|B2|Male||Gender||participants|Number|9|9.0||||||
3842005|NCT01677936|3667560|B1|Male||Gender||participants|Number|14|14.0||||||
3842006|NCT01677936|3667558|B3|Female||Gender||participants|Number|28|28.0||||||
3842007|NCT01677936|3667559|B2|Female||Gender||participants|Number|11|11.0||||||
3842008|NCT01677936|3667560|B1|Female||Gender||participants|Number|17|17.0||||||
3842009|NCT01677936|3667558|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3842010|NCT01677936|3667559|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3842011|NCT01677936|3667560|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3842012|NCT01677936|3667558|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3842013|NCT01677936|3667559|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3842014|NCT01677936|3667560|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3842015|NCT01677936|3667558|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3842016|NCT01677936|3667559|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3842017|NCT01677936|3667560|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3842018|NCT01677936|3667558|B3|||Age||years|Mean|58|58.0|Standard Deviation|10.22|10.22|||
3842019|NCT01677936|3667559|B2|||Age||years|Mean|59|59.0|Standard Deviation|12.54|12.54|||
3842020|NCT01677936|3667560|B1|||Age||years|Mean|58|58.0|Standard Deviation|8.56|8.56|||
3842021|NCT01677910|3667569|B4|||Body Mass Index (BMI)|BMI was calculated by weight (kg) / (height (cm) *0.01)^2.|kg/m^2|Mean|24.87|24.87|Standard Deviation|4.931|4.931|||
3842022|NCT01677910|3667570|B3|||Body Mass Index (BMI)|BMI was calculated by weight (kg) / (height (cm) *0.01)^2.|kg/m^2|Mean|25.24|25.24|Standard Deviation|5.352|5.352|||
3842023|NCT01677910|3667571|B2|||Body Mass Index (BMI)|BMI was calculated by weight (kg) / (height (cm) *0.01)^2.|kg/m^2|Mean|24.26|24.26|Standard Deviation|4.702|4.702|||
3842024|NCT01677910|3667572|B1|||Body Mass Index (BMI)|BMI was calculated by weight (kg) / (height (cm) *0.01)^2.|kg/m^2|Mean|25.13|25.13|Standard Deviation|4.790|4.79|||
3842025|NCT01677910|3667569|B4|||Height||centimeter (cm)|Mean|169.35|169.35|Standard Deviation|10.175|10.175|||
3842026|NCT01677910|3667570|B3|||Height||centimeter (cm)|Mean|169.93|169.93|Standard Deviation|10.436|10.436|||
3842027|NCT01677910|3667571|B2|||Height||centimeter (cm)|Mean|169.32|169.32|Standard Deviation|9.607|9.607|||
3842028|NCT01677910|3667572|B1|||Height||centimeter (cm)|Mean|168.8|168.8|Standard Deviation|10.707|10.707|||
3842029|NCT01677910|3667569|B4|||Weight||kilogram (kg)|Mean|71.46|71.46|Standard Deviation|16.419|16.419|||
3842030|NCT01677910|3667570|B3|||Weight||kilogram (kg)|Mean|73.44|73.44|Standard Deviation|19.971|19.971|||
3842031|NCT01677910|3667571|B2|||Weight||kilogram (kg)|Mean|70.05|70.05|Standard Deviation|14.832|14.832|||
3842032|NCT01677910|3667572|B1|||Weight||kilogram (kg)|Mean|70.87|70.87|Standard Deviation|13.940|13.94|||
3842033|NCT01677910|3667569|B4||Rest of the World|Region|North America includes USA and Canada; Europe includes Belgium, France, Germany, Italy, Netherlands, Spain, Sweden, and United Kingdom; Rest of the World includes Australia and Israel.|Participants|Count of Participants|8|8.0||||||
3842034|NCT01677910|3667570|B3||Rest of the World|Region|North America includes USA and Canada; Europe includes Belgium, France, Germany, Italy, Netherlands, Spain, Sweden, and United Kingdom; Rest of the World includes Australia and Israel.|Participants|Count of Participants|3|3.0||||||
3842035|NCT01677910|3667571|B2||Rest of the World|Region|North America includes USA and Canada; Europe includes Belgium, France, Germany, Italy, Netherlands, Spain, Sweden, and United Kingdom; Rest of the World includes Australia and Israel.|Participants|Count of Participants|2|2.0||||||
3842036|NCT01677910|3667572|B1||Rest of the World|Region|North America includes USA and Canada; Europe includes Belgium, France, Germany, Italy, Netherlands, Spain, Sweden, and United Kingdom; Rest of the World includes Australia and Israel.|Participants|Count of Participants|3|3.0||||||
3842037|NCT01677910|3667569|B4||Europe|Region|North America includes USA and Canada; Europe includes Belgium, France, Germany, Italy, Netherlands, Spain, Sweden, and United Kingdom; Rest of the World includes Australia and Israel.|Participants|Count of Participants|83|83.0||||||
3842038|NCT01677910|3667570|B3||Europe|Region|North America includes USA and Canada; Europe includes Belgium, France, Germany, Italy, Netherlands, Spain, Sweden, and United Kingdom; Rest of the World includes Australia and Israel.|Participants|Count of Participants|28|28.0||||||
3842039|NCT01677910|3667571|B2||Europe|Region|North America includes USA and Canada; Europe includes Belgium, France, Germany, Italy, Netherlands, Spain, Sweden, and United Kingdom; Rest of the World includes Australia and Israel.|Participants|Count of Participants|28|28.0||||||
3842040|NCT01677910|3667572|B1||Europe|Region|North America includes USA and Canada; Europe includes Belgium, France, Germany, Italy, Netherlands, Spain, Sweden, and United Kingdom; Rest of the World includes Australia and Israel.|Participants|Count of Participants|27|27.0||||||
3842041|NCT01677910|3667569|B4||North America|Region|North America includes USA and Canada; Europe includes Belgium, France, Germany, Italy, Netherlands, Spain, Sweden, and United Kingdom; Rest of the World includes Australia and Israel.|Participants|Count of Participants|44|44.0||||||
3842042|NCT01677910|3667570|B3||North America|Region|North America includes USA and Canada; Europe includes Belgium, France, Germany, Italy, Netherlands, Spain, Sweden, and United Kingdom; Rest of the World includes Australia and Israel.|Participants|Count of Participants|14|14.0||||||
3842043|NCT01677910|3667571|B2||North America|Region|North America includes USA and Canada; Europe includes Belgium, France, Germany, Italy, Netherlands, Spain, Sweden, and United Kingdom; Rest of the World includes Australia and Israel.|Participants|Count of Participants|15|15.0||||||
3842044|NCT01677910|3667572|B1||North America|Region|North America includes USA and Canada; Europe includes Belgium, France, Germany, Italy, Netherlands, Spain, Sweden, and United Kingdom; Rest of the World includes Australia and Israel.|Participants|Count of Participants|15|15.0||||||
3842045|NCT01677910|3667569|B4||Unknown|Urinary 5-hydroxyindoleacetic acid (u5-HIAA) at Randomization|ULN=upper limit of normal|Participants|Count of Participants|21|21.0||||||
3842046|NCT01677910|3667570|B3||Unknown|Urinary 5-hydroxyindoleacetic acid (u5-HIAA) at Randomization|ULN=upper limit of normal|Participants|Count of Participants|7|7.0||||||
3842047|NCT01677910|3667571|B2||Unknown|Urinary 5-hydroxyindoleacetic acid (u5-HIAA) at Randomization|ULN=upper limit of normal|Participants|Count of Participants|7|7.0||||||
3842048|NCT01677910|3667572|B1||Unknown|Urinary 5-hydroxyindoleacetic acid (u5-HIAA) at Randomization|ULN=upper limit of normal|Participants|Count of Participants|7|7.0||||||
3842049|NCT01677910|3667569|B4||>ULN|Urinary 5-hydroxyindoleacetic acid (u5-HIAA) at Randomization|ULN=upper limit of normal|Participants|Count of Participants|78|78.0||||||
3842050|NCT01677910|3667570|B3||>ULN|Urinary 5-hydroxyindoleacetic acid (u5-HIAA) at Randomization|ULN=upper limit of normal|Participants|Count of Participants|26|26.0||||||
3842051|NCT01677910|3667571|B2||>ULN|Urinary 5-hydroxyindoleacetic acid (u5-HIAA) at Randomization|ULN=upper limit of normal|Participants|Count of Participants|26|26.0||||||
3842052|NCT01677910|3667572|B1||>ULN|Urinary 5-hydroxyindoleacetic acid (u5-HIAA) at Randomization|ULN=upper limit of normal|Participants|Count of Participants|26|26.0||||||
3842053|NCT01677910|3667569|B4||≤ULN|Urinary 5-hydroxyindoleacetic acid (u5-HIAA) at Randomization|ULN=upper limit of normal|Participants|Count of Participants|36|36.0||||||
3842054|NCT01677910|3667570|B3||≤ULN|Urinary 5-hydroxyindoleacetic acid (u5-HIAA) at Randomization|ULN=upper limit of normal|Participants|Count of Participants|12|12.0||||||
3842055|NCT01677910|3667571|B2||≤ULN|Urinary 5-hydroxyindoleacetic acid (u5-HIAA) at Randomization|ULN=upper limit of normal|Participants|Count of Participants|12|12.0||||||
3842056|NCT01677910|3667572|B1||≤ULN|Urinary 5-hydroxyindoleacetic acid (u5-HIAA) at Randomization|ULN=upper limit of normal|Participants|Count of Participants|12|12.0||||||
3842057|NCT01677910|3667569|B4||Not Applicable|Childbearing Potential||Participants|Count of Participants|70|70.0||||||
3842058|NCT01677910|3667570|B3||Not Applicable|Childbearing Potential||Participants|Count of Participants|25|25.0||||||
3842059|NCT01677910|3667571|B2||Not Applicable|Childbearing Potential||Participants|Count of Participants|21|21.0||||||
3842060|NCT01677910|3667572|B1||Not Applicable|Childbearing Potential||Participants|Count of Participants|24|24.0||||||
3842061|NCT01677910|3667569|B4||No|Childbearing Potential||Participants|Count of Participants|62|62.0||||||
3842062|NCT01677910|3667570|B3||No|Childbearing Potential||Participants|Count of Participants|20|20.0||||||
3842063|NCT01677910|3667571|B2||No|Childbearing Potential||Participants|Count of Participants|24|24.0||||||
3842064|NCT01677910|3667572|B1||No|Childbearing Potential||Participants|Count of Participants|18|18.0||||||
3842065|NCT01677910|3667569|B4||Yes|Childbearing Potential||Participants|Count of Participants|3|3.0||||||
3842066|NCT01677910|3667570|B3||Yes|Childbearing Potential||Participants|Count of Participants|0|0.0||||||
3842067|NCT01677910|3667571|B2||Yes|Childbearing Potential||Participants|Count of Participants|0|0.0||||||
3842068|NCT01677910|3667572|B1||Yes|Childbearing Potential||Participants|Count of Participants|3|3.0||||||
3842069|NCT01677910|3667569|B4||Lanreotide|SSA Therapy Name at Study Entry||Participants|Count of Participants|32|32.0||||||
3842070|NCT01677910|3667570|B3||Lanreotide|SSA Therapy Name at Study Entry||Participants|Count of Participants|12|12.0||||||
3842071|NCT01677910|3667571|B2||Lanreotide|SSA Therapy Name at Study Entry||Participants|Count of Participants|5|5.0||||||
3842072|NCT01677910|3667572|B1||Lanreotide|SSA Therapy Name at Study Entry||Participants|Count of Participants|15|15.0||||||
3842073|NCT01677910|3667569|B4||Octreotide|SSA Therapy Name at Study Entry||Participants|Count of Participants|103|103.0||||||
3842074|NCT01677910|3667570|B3||Octreotide|SSA Therapy Name at Study Entry||Participants|Count of Participants|33|33.0||||||
3842075|NCT01677910|3667571|B2||Octreotide|SSA Therapy Name at Study Entry||Participants|Count of Participants|40|40.0||||||
3842076|NCT01677910|3667572|B1||Octreotide|SSA Therapy Name at Study Entry||Participants|Count of Participants|30|30.0||||||
3842077|NCT01677910|3667569|B4||4-Week|Somatostatin Analog (SSA) Therapy Schedule at Study Entry|"Patients who were on a 2-week SSA therapy or receiving SSA therapy via a subcutaneous continuous infusion pump are included in the 4-week category."|Participants|Count of Participants|96|96.0||||||
3842078|NCT01677910|3667570|B3||4-Week|Somatostatin Analog (SSA) Therapy Schedule at Study Entry|"Patients who were on a 2-week SSA therapy or receiving SSA therapy via a subcutaneous continuous infusion pump are included in the 4-week category."|Participants|Count of Participants|28|28.0||||||
3842079|NCT01677910|3667571|B2||4-Week|Somatostatin Analog (SSA) Therapy Schedule at Study Entry|"Patients who were on a 2-week SSA therapy or receiving SSA therapy via a subcutaneous continuous infusion pump are included in the 4-week category."|Participants|Count of Participants|34|34.0||||||
3842080|NCT01677910|3667572|B1||4-Week|Somatostatin Analog (SSA) Therapy Schedule at Study Entry|"Patients who were on a 2-week SSA therapy or receiving SSA therapy via a subcutaneous continuous infusion pump are included in the 4-week category."|Participants|Count of Participants|34|34.0||||||
3842081|NCT01677910|3667569|B4||3-Week|Somatostatin Analog (SSA) Therapy Schedule at Study Entry|"Patients who were on a 2-week SSA therapy or receiving SSA therapy via a subcutaneous continuous infusion pump are included in the 4-week category."|Participants|Count of Participants|39|39.0||||||
3842082|NCT01677910|3667570|B3||3-Week|Somatostatin Analog (SSA) Therapy Schedule at Study Entry|"Patients who were on a 2-week SSA therapy or receiving SSA therapy via a subcutaneous continuous infusion pump are included in the 4-week category."|Participants|Count of Participants|17|17.0||||||
3842083|NCT01677910|3667571|B2||3-Week|Somatostatin Analog (SSA) Therapy Schedule at Study Entry|"Patients who were on a 2-week SSA therapy or receiving SSA therapy via a subcutaneous continuous infusion pump are included in the 4-week category."|Participants|Count of Participants|11|11.0||||||
3842084|NCT01677910|3667572|B1||3-Week|Somatostatin Analog (SSA) Therapy Schedule at Study Entry|"Patients who were on a 2-week SSA therapy or receiving SSA therapy via a subcutaneous continuous infusion pump are included in the 4-week category."|Participants|Count of Participants|11|11.0||||||
3842085|NCT01677910|3667569|B4|Spain||Region of Enrollment||participants|Number|8|8.0||||||
3842086|NCT01677910|3667570|B3|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3842087|NCT01677910|3667571|B2|Spain||Region of Enrollment||participants|Number|3|3.0||||||
3842088|NCT01677910|3667572|B1|Spain||Region of Enrollment||participants|Number|4|4.0||||||
3842089|NCT01677910|3667569|B4|Germany||Region of Enrollment||participants|Number|19|19.0||||||
3842090|NCT01677910|3667570|B3|Germany||Region of Enrollment||participants|Number|6|6.0||||||
3842091|NCT01677910|3667571|B2|Germany||Region of Enrollment||participants|Number|8|8.0||||||
3842092|NCT01677910|3667572|B1|Germany||Region of Enrollment||participants|Number|5|5.0||||||
3842093|NCT01677910|3667569|B4|France||Region of Enrollment||participants|Number|11|11.0||||||
3842094|NCT01677910|3667570|B3|France||Region of Enrollment||participants|Number|4|4.0||||||
3842095|NCT01677910|3667571|B2|France||Region of Enrollment||participants|Number|4|4.0||||||
3842096|NCT01677910|3667572|B1|France||Region of Enrollment||participants|Number|3|3.0||||||
3842097|NCT01677910|3667569|B4|Australia||Region of Enrollment||participants|Number|6|6.0||||||
3842098|NCT01677910|3667570|B3|Australia||Region of Enrollment||participants|Number|3|3.0||||||
3842099|NCT01677910|3667571|B2|Australia||Region of Enrollment||participants|Number|2|2.0||||||
3842100|NCT01677910|3667572|B1|Australia||Region of Enrollment||participants|Number|1|1.0||||||
3842101|NCT01677910|3667569|B4|Israel||Region of Enrollment||participants|Number|2|2.0||||||
3842102|NCT01677910|3667570|B3|Israel||Region of Enrollment||participants|Number|0|0.0||||||
3842103|NCT01677910|3667571|B2|Israel||Region of Enrollment||participants|Number|0|0.0||||||
3842104|NCT01677910|3667572|B1|Israel||Region of Enrollment||participants|Number|2|2.0||||||
3842105|NCT01677910|3667569|B4|Italy||Region of Enrollment||participants|Number|8|8.0||||||
3842106|NCT01677910|3667570|B3|Italy||Region of Enrollment||participants|Number|3|3.0||||||
3842107|NCT01677910|3667571|B2|Italy||Region of Enrollment||participants|Number|4|4.0||||||
3842108|NCT01677910|3667572|B1|Italy||Region of Enrollment||participants|Number|1|1.0||||||
3842109|NCT01677910|3667569|B4|United Kingdom||Region of Enrollment||participants|Number|19|19.0||||||
3842110|NCT01677910|3667570|B3|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3842111|NCT01677910|3667571|B2|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3842112|NCT01677910|3667572|B1|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3842113|NCT01677910|3667569|B4|United States||Region of Enrollment||participants|Number|37|37.0||||||
3842114|NCT01677910|3667570|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3842115|NCT01677910|3667571|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3842116|NCT01677910|3667572|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3842117|NCT01677910|3667569|B4|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
3842118|NCT01677910|3667570|B3|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
3842119|NCT01677910|3667571|B2|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
3842120|NCT01677910|3667572|B1|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
3842121|NCT01677910|3667569|B4|Netherlands||Region of Enrollment||participants|Number|8|8.0||||||
3842122|NCT01677910|3667570|B3|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
3842123|NCT01677910|3667571|B2|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
3842124|NCT01677910|3667572|B1|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
3842125|NCT01677910|3667569|B4|Sweden||Region of Enrollment||participants|Number|9|9.0||||||
3842126|NCT01677910|3667570|B3|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
3842127|NCT01677910|3667571|B2|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
3842128|NCT01677910|3667572|B1|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
3842129|NCT01677910|3667569|B4|Canada||Region of Enrollment||participants|Number|7|7.0||||||
3842130|NCT01677910|3667570|B3|Canada||Region of Enrollment||participants|Number|2|2.0||||||
3842131|NCT01677910|3667571|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
3842132|NCT01677910|3667572|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
3842133|NCT01677910|3667569|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3842134|NCT01677910|3667570|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3842135|NCT01677910|3667571|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3842136|NCT01677910|3667572|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3842137|NCT01677910|3667569|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3842138|NCT01677910|3667570|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3842139|NCT01677910|3667571|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842140|NCT01677910|3667572|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842141|NCT01677910|3667569|B4||White|Race (NIH/OMB)||Participants|Count of Participants|121|121.0||||||
3842142|NCT01677910|3667570|B3||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3842143|NCT01677910|3667571|B2||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3842144|NCT01677910|3667572|B1||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3842145|NCT01677910|3667569|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3842146|NCT01677910|3667570|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842147|NCT01677910|3667571|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842148|NCT01677910|3667572|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3842149|NCT01677910|3667569|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842150|NCT01677910|3667570|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842151|NCT01677910|3667571|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842152|NCT01677910|3667572|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842153|NCT01677910|3667569|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842154|NCT01677910|3667570|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842155|NCT01677910|3667571|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842156|NCT01677910|3667572|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842157|NCT01677910|3667569|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3842158|NCT01677910|3667570|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842159|NCT01677910|3667571|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842160|NCT01677910|3667572|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3842161|NCT01677910|3667569|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)|Ethnicity data was not provided for 1 participant in France.|Participants|Count of Participants|1|1.0||||||
3842162|NCT01677910|3667570|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)|Ethnicity data was not provided for 1 participant in France.|Participants|Count of Participants|0|0.0||||||
3842163|NCT01677910|3667571|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)|Ethnicity data was not provided for 1 participant in France.|Participants|Count of Participants|1|1.0||||||
3842164|NCT01677910|3667572|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|Ethnicity data was not provided for 1 participant in France.|Participants|Count of Participants|0|0.0||||||
3842165|NCT01677910|3667569|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity data was not provided for 1 participant in France.|Participants|Count of Participants|133|133.0||||||
3842166|NCT01677910|3667570|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity data was not provided for 1 participant in France.|Participants|Count of Participants|44|44.0||||||
3842167|NCT01677910|3667571|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity data was not provided for 1 participant in France.|Participants|Count of Participants|44|44.0||||||
3842168|NCT01677910|3667572|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity data was not provided for 1 participant in France.|Participants|Count of Participants|45|45.0||||||
3842169|NCT01677910|3667569|B4||Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity data was not provided for 1 participant in France.|Participants|Count of Participants|1|1.0||||||
3842170|NCT01677910|3667570|B3||Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity data was not provided for 1 participant in France.|Participants|Count of Participants|1|1.0||||||
3842171|NCT01677910|3667571|B2||Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity data was not provided for 1 participant in France.|Participants|Count of Participants|0|0.0||||||
3842172|NCT01677910|3667572|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity data was not provided for 1 participant in France.|Participants|Count of Participants|0|0.0||||||
3842173|NCT01677910|3667569|B4||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3842174|NCT01677910|3667570|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3842175|NCT01677910|3667571|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3842176|NCT01677910|3667572|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3842177|NCT01677910|3667569|B4||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3842178|NCT01677910|3667570|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3842179|NCT01677910|3667571|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3842180|NCT01677910|3667572|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3842181|NCT01677910|3667569|B4|≥ 65 years||Age, Customized||Participants|Count of Participants|62|62.0||||||
3842182|NCT01677910|3667570|B3|≥ 65 years||Age, Customized||Participants|Count of Participants|23|23.0||||||
3842183|NCT01677910|3667571|B2|≥ 65 years||Age, Customized||Participants|Count of Participants|19|19.0||||||
3842184|NCT01677910|3667572|B1|≥ 65 years||Age, Customized||Participants|Count of Participants|20|20.0||||||
3842185|NCT01677910|3667569|B4|< 65 years||Age, Customized||Participants|Count of Participants|73|73.0||||||
3842186|NCT01677910|3667570|B3|< 65 years||Age, Customized||Participants|Count of Participants|22|22.0||||||
3842187|NCT01677910|3667571|B2|< 65 years||Age, Customized||Participants|Count of Participants|26|26.0||||||
3842188|NCT01677910|3667572|B1|< 65 years||Age, Customized||Participants|Count of Participants|25|25.0||||||
3842189|NCT01677910|3667569|B4|||Age||years|Mean|63.2|63.2|Standard Deviation|9.28|9.28|||
3842190|NCT01677910|3667570|B3|||Age||years|Mean|64.9|64.9|Standard Deviation|9.06|9.06|||
3842191|NCT01677910|3667571|B2|||Age||years|Mean|62.4|62.4|Standard Deviation|9.12|9.12|||
3842192|NCT01677910|3667572|B1|||Age||years|Mean|63.3|63.3|Standard Deviation|8.67|8.67|||
3842193|NCT01677858|3667597|B6||1 (Restrictive but ambulatory)|Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|65|65.0||||||
3842194|NCT01677858|3667598|B5||1 (Restrictive but ambulatory)|Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|50|50.0||||||
3842195|NCT01677858|3667599|B4||1 (Restrictive but ambulatory)|Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|3|3.0||||||
3842196|NCT01677858|3667600|B3||1 (Restrictive but ambulatory)|Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|9|9.0||||||
3842197|NCT01677858|3667601|B2||1 (Restrictive but ambulatory)|Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|1|1.0||||||
3842226|NCT01677858|3667600|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3842227|NCT01677858|3667601|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3842198|NCT01677858|3667602|B1||1 (Restrictive but ambulatory)|Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|2|2.0||||||
3842199|NCT01677858|3667597|B6||0 (Fully active)|Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|51|51.0||||||
3842200|NCT01677858|3667598|B5||0 (Fully active)|Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|39|39.0||||||
3842201|NCT01677858|3667599|B4||0 (Fully active)|Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|3|3.0||||||
3842202|NCT01677858|3667600|B3||0 (Fully active)|Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|6|6.0||||||
3842203|NCT01677858|3667601|B2||0 (Fully active)|Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|2|2.0||||||
3842204|NCT01677858|3667602|B1||0 (Fully active)|Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|1|1.0||||||
3842205|NCT01677858|3667597|B6|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3842206|NCT01677858|3667598|B5|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3842207|NCT01677858|3667599|B4|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3842208|NCT01677858|3667600|B3|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3842209|NCT01677858|3667601|B2|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3842210|NCT01677858|3667602|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3842211|NCT01677858|3667597|B6|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3842212|NCT01677858|3667598|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3842213|NCT01677858|3667599|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3842214|NCT01677858|3667600|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3842215|NCT01677858|3667601|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3842216|NCT01677858|3667602|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3842217|NCT01677858|3667597|B6|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3842218|NCT01677858|3667598|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3842219|NCT01677858|3667599|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3842220|NCT01677858|3667600|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3842221|NCT01677858|3667601|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3842222|NCT01677858|3667602|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3842223|NCT01677858|3667597|B6|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3842224|NCT01677858|3667598|B5|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3842225|NCT01677858|3667599|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3842284|NCT01677767|3667679|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3842228|NCT01677858|3667602|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3842229|NCT01677858|3667597|B6|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3842230|NCT01677858|3667598|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3842231|NCT01677858|3667599|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3842232|NCT01677858|3667600|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3842233|NCT01677858|3667601|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3842234|NCT01677858|3667602|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3842235|NCT01677858|3667597|B6|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3842236|NCT01677858|3667598|B5|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3842237|NCT01677858|3667599|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3842238|NCT01677858|3667600|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3842239|NCT01677858|3667601|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3842240|NCT01677858|3667602|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3842241|NCT01677858|3667597|B6|White||Race/Ethnicity, Customized||Participants|Count of Participants|101|101.0||||||
3842242|NCT01677858|3667598|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|79|79.0||||||
3842243|NCT01677858|3667599|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3842244|NCT01677858|3667600|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3842245|NCT01677858|3667601|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3842246|NCT01677858|3667602|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3842247|NCT01677858|3667597|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842248|NCT01677858|3667598|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842249|NCT01677858|3667599|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842250|NCT01677858|3667600|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842251|NCT01677858|3667601|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842252|NCT01677858|3667602|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842253|NCT01677858|3667597|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
3842254|NCT01677858|3667598|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3842255|NCT01677858|3667599|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3842256|NCT01677858|3667600|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3842257|NCT01677858|3667601|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3842258|NCT01677858|3667602|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3842259|NCT01677858|3667597|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3842260|NCT01677858|3667598|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3842261|NCT01677858|3667599|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3842262|NCT01677858|3667600|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842263|NCT01677858|3667601|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842264|NCT01677858|3667602|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842265|NCT01677858|3667597|B6||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3842266|NCT01677858|3667598|B5||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3842267|NCT01677858|3667599|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3842268|NCT01677858|3667600|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3842269|NCT01677858|3667601|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3842270|NCT01677858|3667602|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3842271|NCT01677858|3667597|B6||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3842272|NCT01677858|3667598|B5||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3842273|NCT01677858|3667599|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3842274|NCT01677858|3667600|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3842275|NCT01677858|3667601|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3842276|NCT01677858|3667602|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3842277|NCT01677858|3667597|B6|||Age||years|Mean|67.5|67.5|Standard Deviation|10.1|10.1|||
3842278|NCT01677858|3667598|B5|||Age||years|Mean|68.7|68.7|Standard Deviation|9.6|9.6|||
3842279|NCT01677858|3667599|B4|||Age||years|Mean|58.2|58.2|Standard Deviation|8.8|8.8|||
3842280|NCT01677858|3667600|B3|||Age||years|Mean|62.4|62.4|Standard Deviation|10.4|10.4|||
3842281|NCT01677858|3667601|B2|||Age||years|Mean|73.7|73.7|Standard Deviation|2.1|2.1|||
3842282|NCT01677858|3667602|B1|||Age||years|Mean|69.3|69.3|Standard Deviation|15.6|15.6|||
3842283|NCT01677767|3667679|B1|||Height|For mean height of participants n = 112 as height of some participants was not captured.|Centimeters|Mean|157.83|157.83|Standard Deviation|10.056|10.056|||
3842285|NCT01677767|3667679|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3842286|NCT01677767|3667679|B1|||Age||Years|Mean|48.1|48.1|Standard Deviation|12.26|12.26|||
3842287|NCT01677624|3667693|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3842288|NCT01677624|3667693|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3842289|NCT01677624|3667693|B1|||Age||Years|Mean|54.6|54.6|Standard Deviation|12.87|12.87|||
3842290|NCT01677507|3667698|B1|Left eye||Episcleral venous pressure||mmHg|Mean|7.9|7.9|Standard Deviation|1.5|1.5|||
3842291|NCT01677507|3667698|B1|Right eye||Episcleral venous pressure||mmHg|Mean|8.3|8.3|Standard Deviation|1.7|1.7|||
3842292|NCT01677507|3667698|B1|Left eye||Aqueous humor flow||microliters/min|Mean|2.9|2.9|Standard Deviation|0.9|0.9|||
3842293|NCT01677507|3667698|B1|Right eye||Aqueous humor flow||microliters/min|Mean|3.1|3.1|Standard Deviation|1.2|1.2|||
3842294|NCT01677507|3667698|B1|Left eye||Intraocular pressure||mmHg|Mean|13.9|13.9|Standard Deviation|3.5|3.5|||
3842295|NCT01677507|3667698|B1|Right eye||Intraocular pressure||mmHg|Mean|14.4|14.4|Standard Deviation|3.5|3.5|||
3842296|NCT01677507|3667698|B1|United States||Region of Enrollment||participants|Number|125|125.0||||||
3842297|NCT01677507|3667698|B1||American Indian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3842298|NCT01677507|3667698|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3842299|NCT01677507|3667698|B1||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3842300|NCT01677507|3667698|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3842301|NCT01677507|3667698|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|107|107.0||||||
3842302|NCT01677507|3667698|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3842303|NCT01677507|3667698|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3842304|NCT01677507|3667698|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|8.8|8.8|||
3842305|NCT01677377|3667709|B4||Extensive|Cytochrome P450 2D6 (CYP-2D6)|"CYP-2D6 is an enzyme responsible for the metabolism and elimination of many drugs. Considerable variation exists in the efficiency and amount of CYP-2D6 enzyme produced between individuals. Hence, for drugs that are metabolized by CYP-2D6, certain individuals will eliminate these drugs quickly (ultrarapid metabolizers) while others slowly (poor metabolizers).~poor metabolizer – little or no CYP-2D6 function~intermediate metabolizers – metabolize drugs at a rate somewhere between the poor and extensive metabolizers~extensive metabolizer – normal CYP-2D6 function"|Participants|Count of Participants|39|39.0||||||
3842306|NCT01677377|3667710|B3||Extensive|Cytochrome P450 2D6 (CYP-2D6)|"CYP-2D6 is an enzyme responsible for the metabolism and elimination of many drugs. Considerable variation exists in the efficiency and amount of CYP-2D6 enzyme produced between individuals. Hence, for drugs that are metabolized by CYP-2D6, certain individuals will eliminate these drugs quickly (ultrarapid metabolizers) while others slowly (poor metabolizers).~poor metabolizer – little or no CYP-2D6 function~intermediate metabolizers – metabolize drugs at a rate somewhere between the poor and extensive metabolizers~extensive metabolizer – normal CYP-2D6 function"|Participants|Count of Participants|14|14.0||||||
3842307|NCT01677377|3667711|B2||Extensive|Cytochrome P450 2D6 (CYP-2D6)|"CYP-2D6 is an enzyme responsible for the metabolism and elimination of many drugs. Considerable variation exists in the efficiency and amount of CYP-2D6 enzyme produced between individuals. Hence, for drugs that are metabolized by CYP-2D6, certain individuals will eliminate these drugs quickly (ultrarapid metabolizers) while others slowly (poor metabolizers).~poor metabolizer – little or no CYP-2D6 function~intermediate metabolizers – metabolize drugs at a rate somewhere between the poor and extensive metabolizers~extensive metabolizer – normal CYP-2D6 function"|Participants|Count of Participants|14|14.0||||||
3842308|NCT01677377|3667712|B1||Extensive|Cytochrome P450 2D6 (CYP-2D6)|"CYP-2D6 is an enzyme responsible for the metabolism and elimination of many drugs. Considerable variation exists in the efficiency and amount of CYP-2D6 enzyme produced between individuals. Hence, for drugs that are metabolized by CYP-2D6, certain individuals will eliminate these drugs quickly (ultrarapid metabolizers) while others slowly (poor metabolizers).~poor metabolizer – little or no CYP-2D6 function~intermediate metabolizers – metabolize drugs at a rate somewhere between the poor and extensive metabolizers~extensive metabolizer – normal CYP-2D6 function"|Participants|Count of Participants|11|11.0||||||
3842309|NCT01677377|3667709|B4||Poor|Cytochrome P450 2D6 (CYP-2D6)|"CYP-2D6 is an enzyme responsible for the metabolism and elimination of many drugs. Considerable variation exists in the efficiency and amount of CYP-2D6 enzyme produced between individuals. Hence, for drugs that are metabolized by CYP-2D6, certain individuals will eliminate these drugs quickly (ultrarapid metabolizers) while others slowly (poor metabolizers).~poor metabolizer – little or no CYP-2D6 function~intermediate metabolizers – metabolize drugs at a rate somewhere between the poor and extensive metabolizers~extensive metabolizer – normal CYP-2D6 function"|Participants|Count of Participants|2|2.0||||||
3842310|NCT01677377|3667710|B3||Poor|Cytochrome P450 2D6 (CYP-2D6)|"CYP-2D6 is an enzyme responsible for the metabolism and elimination of many drugs. Considerable variation exists in the efficiency and amount of CYP-2D6 enzyme produced between individuals. Hence, for drugs that are metabolized by CYP-2D6, certain individuals will eliminate these drugs quickly (ultrarapid metabolizers) while others slowly (poor metabolizers).~poor metabolizer – little or no CYP-2D6 function~intermediate metabolizers – metabolize drugs at a rate somewhere between the poor and extensive metabolizers~extensive metabolizer – normal CYP-2D6 function"|Participants|Count of Participants|0|0.0||||||
3842311|NCT01677377|3667711|B2||Poor|Cytochrome P450 2D6 (CYP-2D6)|"CYP-2D6 is an enzyme responsible for the metabolism and elimination of many drugs. Considerable variation exists in the efficiency and amount of CYP-2D6 enzyme produced between individuals. Hence, for drugs that are metabolized by CYP-2D6, certain individuals will eliminate these drugs quickly (ultrarapid metabolizers) while others slowly (poor metabolizers).~poor metabolizer – little or no CYP-2D6 function~intermediate metabolizers – metabolize drugs at a rate somewhere between the poor and extensive metabolizers~extensive metabolizer – normal CYP-2D6 function"|Participants|Count of Participants|1|1.0||||||
3842348|NCT01677377|3667712|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3842312|NCT01677377|3667712|B1||Poor|Cytochrome P450 2D6 (CYP-2D6)|"CYP-2D6 is an enzyme responsible for the metabolism and elimination of many drugs. Considerable variation exists in the efficiency and amount of CYP-2D6 enzyme produced between individuals. Hence, for drugs that are metabolized by CYP-2D6, certain individuals will eliminate these drugs quickly (ultrarapid metabolizers) while others slowly (poor metabolizers).~poor metabolizer – little or no CYP-2D6 function~intermediate metabolizers – metabolize drugs at a rate somewhere between the poor and extensive metabolizers~extensive metabolizer – normal CYP-2D6 function"|Participants|Count of Participants|1|1.0||||||
3842313|NCT01677377|3667709|B4||Intermediate|Cytochrome P450 2D6 (CYP-2D6)|"CYP-2D6 is an enzyme responsible for the metabolism and elimination of many drugs. Considerable variation exists in the efficiency and amount of CYP-2D6 enzyme produced between individuals. Hence, for drugs that are metabolized by CYP-2D6, certain individuals will eliminate these drugs quickly (ultrarapid metabolizers) while others slowly (poor metabolizers).~poor metabolizer – little or no CYP-2D6 function~intermediate metabolizers – metabolize drugs at a rate somewhere between the poor and extensive metabolizers~extensive metabolizer – normal CYP-2D6 function"|Participants|Count of Participants|4|4.0||||||
3842314|NCT01677377|3667710|B3||Intermediate|Cytochrome P450 2D6 (CYP-2D6)|"CYP-2D6 is an enzyme responsible for the metabolism and elimination of many drugs. Considerable variation exists in the efficiency and amount of CYP-2D6 enzyme produced between individuals. Hence, for drugs that are metabolized by CYP-2D6, certain individuals will eliminate these drugs quickly (ultrarapid metabolizers) while others slowly (poor metabolizers).~poor metabolizer – little or no CYP-2D6 function~intermediate metabolizers – metabolize drugs at a rate somewhere between the poor and extensive metabolizers~extensive metabolizer – normal CYP-2D6 function"|Participants|Count of Participants|1|1.0||||||
3842315|NCT01677377|3667711|B2||Intermediate|Cytochrome P450 2D6 (CYP-2D6)|"CYP-2D6 is an enzyme responsible for the metabolism and elimination of many drugs. Considerable variation exists in the efficiency and amount of CYP-2D6 enzyme produced between individuals. Hence, for drugs that are metabolized by CYP-2D6, certain individuals will eliminate these drugs quickly (ultrarapid metabolizers) while others slowly (poor metabolizers).~poor metabolizer – little or no CYP-2D6 function~intermediate metabolizers – metabolize drugs at a rate somewhere between the poor and extensive metabolizers~extensive metabolizer – normal CYP-2D6 function"|Participants|Count of Participants|0|0.0||||||
3842316|NCT01677377|3667712|B1||Intermediate|Cytochrome P450 2D6 (CYP-2D6)|"CYP-2D6 is an enzyme responsible for the metabolism and elimination of many drugs. Considerable variation exists in the efficiency and amount of CYP-2D6 enzyme produced between individuals. Hence, for drugs that are metabolized by CYP-2D6, certain individuals will eliminate these drugs quickly (ultrarapid metabolizers) while others slowly (poor metabolizers).~poor metabolizer – little or no CYP-2D6 function~intermediate metabolizers – metabolize drugs at a rate somewhere between the poor and extensive metabolizers~extensive metabolizer – normal CYP-2D6 function"|Participants|Count of Participants|3|3.0||||||
3842317|NCT01677377|3667709|B4|||Body Mass Index||kg/m^2|Mean|28.64|28.64|Standard Deviation|4.309|4.309|||
3842318|NCT01677377|3667710|B3|||Body Mass Index||kg/m^2|Mean|30.43|30.43|Standard Deviation|3.911|3.911|||
3842319|NCT01677377|3667711|B2|||Body Mass Index||kg/m^2|Mean|27.35|27.35|Standard Deviation|4.176|4.176|||
3842320|NCT01677377|3667712|B1|||Body Mass Index||kg/m^2|Mean|28.13|28.13|Standard Deviation|4.487|4.487|||
3842321|NCT01677377|3667709|B4|||Height||cm|Mean|174.03|174.03|Standard Deviation|9.372|9.372|||
3842322|NCT01677377|3667710|B3|||Height||cm|Mean|174.41|174.41|Standard Deviation|8.346|8.346|||
3842323|NCT01677377|3667711|B2|||Height||cm|Mean|175.50|175.5|Standard Deviation|11.137|11.137|||
3842324|NCT01677377|3667712|B1|||Height||cm|Mean|172.19|172.19|Standard Deviation|8.731|8.731|||
3842325|NCT01677377|3667709|B4|||Weight||kg|Mean|86.82|86.82|Standard Deviation|14.980|14.98|||
3842326|NCT01677377|3667710|B3|||Weight||kg|Mean|92.63|92.63|Standard Deviation|14.075|14.075|||
3842327|NCT01677377|3667711|B2|||Weight||kg|Mean|84.07|84.07|Standard Deviation|13.707|13.707|||
3842328|NCT01677377|3667712|B1|||Weight||kg|Mean|83.76|83.76|Standard Deviation|16.279|16.279|||
3842329|NCT01677377|3667709|B4||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3842330|NCT01677377|3667710|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3842331|NCT01677377|3667711|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3842332|NCT01677377|3667712|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3842333|NCT01677377|3667709|B4||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3842334|NCT01677377|3667710|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3842335|NCT01677377|3667711|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3842336|NCT01677377|3667712|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3842337|NCT01677377|3667709|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3842338|NCT01677377|3667710|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3842339|NCT01677377|3667711|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3842340|NCT01677377|3667712|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3842341|NCT01677377|3667709|B4||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3842342|NCT01677377|3667710|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3842343|NCT01677377|3667711|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3842344|NCT01677377|3667712|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3842345|NCT01677377|3667709|B4||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3842346|NCT01677377|3667710|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3842347|NCT01677377|3667711|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3842349|NCT01677377|3667709|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3842350|NCT01677377|3667710|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3842351|NCT01677377|3667711|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3842352|NCT01677377|3667712|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3842353|NCT01677377|3667709|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842354|NCT01677377|3667710|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842355|NCT01677377|3667711|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842356|NCT01677377|3667712|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842357|NCT01677377|3667709|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3842358|NCT01677377|3667710|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3842359|NCT01677377|3667711|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3842360|NCT01677377|3667712|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3842361|NCT01677377|3667709|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3842362|NCT01677377|3667710|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842363|NCT01677377|3667711|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3842364|NCT01677377|3667712|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3842365|NCT01677377|3667709|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3842366|NCT01677377|3667710|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3842367|NCT01677377|3667711|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3842368|NCT01677377|3667712|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3842369|NCT01677377|3667709|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3842370|NCT01677377|3667710|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3842371|NCT01677377|3667711|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3842372|NCT01677377|3667712|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3842373|NCT01677377|3667709|B4|||Age||years|Mean|42.6|42.6|Standard Deviation|9.16|9.16|||
3842374|NCT01677377|3667710|B3|||Age||years|Mean|41.7|41.7|Standard Deviation|7.96|7.96|||
3842375|NCT01677377|3667711|B2|||Age||years|Mean|42.5|42.5|Standard Deviation|9.93|9.93|||
3842376|NCT01677377|3667712|B1|||Age||years|Mean|43.7|43.7|Standard Deviation|9.98|9.98|||
3842377|NCT01677299|3667911|B5|||FPG||mg/dL|Mean|161|161.0|Standard Deviation|56.34|56.34|||
3842378|NCT01677299|3667912|B4|||FPG||mg/dL|Mean|124.3|124.3|Standard Deviation|15.03|15.03|||
3842379|NCT01677299|3667913|B3|||FPG||mg/dL|Mean|179|179.0|Standard Deviation|69.59|69.59|||
3842380|NCT01677299|3667914|B2|||FPG||mg/dL|Mean|158|158.0|Standard Deviation|42.96|42.96|||
3842381|NCT01677299|3667915|B1|||FPG||mg/dL|Mean|182.5|182.5|Standard Deviation|71.55|71.55|||
3842382|NCT01677299|3667911|B5|||HbA1c||%|Mean|7.35|7.35|Standard Deviation|1.108|1.108|||
3842383|NCT01677299|3667912|B4|||HbA1c||%|Mean|6.37|6.37|Standard Deviation|.339|0.339|||
3842384|NCT01677299|3667913|B3|||HbA1c||%|Mean|8.07|8.07|Standard Deviation|1.102|1.102|||
3842385|NCT01677299|3667914|B2|||HbA1c||%|Mean|7.33|7.33|Standard Deviation|0.965|0.965|||
3842386|NCT01677299|3667915|B1|||HbA1c||%|Mean|7.62|7.62|Standard Deviation|1.234|1.234|||
3842387|NCT01677299|3667911|B5|||eGFR||mL/min/1.73 mˆ2|Mean|108.39|108.39|Standard Deviation|21.161|21.161|||
3842388|NCT01677299|3667912|B4|||eGFR||mL/min/1.73 mˆ2|Mean|93.43|93.43|Standard Deviation|20.354|20.354|||
3842389|NCT01677299|3667913|B3|||eGFR||mL/min/1.73 mˆ2|Mean|107.54|107.54|Standard Deviation|16.644|16.644|||
3842390|NCT01677299|3667914|B2|||eGFR||mL/min/1.73 mˆ2|Mean|114.65|114.65|Standard Deviation|21.348|21.348|||
3842391|NCT01677299|3667915|B1|||eGFR||mL/min/1.73 mˆ2|Mean|117.94|117.94|Standard Deviation|22.065|22.065|||
3842392|NCT01677299|3667911|B5|||BMI||kg/mˆ2|Mean|33.33|33.33|Standard Deviation|4.05|4.05|||
3842393|NCT01677299|3667912|B4|||BMI||kg/mˆ2|Mean|32.87|32.87|Standard Deviation|3.644|3.644|||
3842394|NCT01677299|3667913|B3|||BMI||kg/mˆ2|Mean|35.65|35.65|Standard Deviation|2.935|2.935|||
3842395|NCT01677299|3667914|B2|||BMI||kg/mˆ2|Mean|30.67|30.67|Standard Deviation|2.793|2.793|||
3842396|NCT01677299|3667915|B1|||BMI||kg/mˆ2|Mean|34.13|34.13|Standard Deviation|5.455|5.455|||
3842397|NCT01677299|3667911|B5|United States||Region of Enrollment||participants|Number|24|24.0||||||
3842398|NCT01677299|3667912|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
3842399|NCT01677299|3667913|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3842400|NCT01677299|3667914|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3842401|NCT01677299|3667915|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3842402|NCT01677299|3667911|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842403|NCT01677299|3667912|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842404|NCT01677299|3667913|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842405|NCT01677299|3667914|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842406|NCT01677299|3667915|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842407|NCT01677299|3667911|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3842408|NCT01677299|3667912|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3842409|NCT01677299|3667913|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3842410|NCT01677299|3667914|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3842411|NCT01677299|3667915|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3842412|NCT01677299|3667911|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3842413|NCT01677299|3667912|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3842414|NCT01677299|3667913|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3842415|NCT01677299|3667914|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3842416|NCT01677299|3667915|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3842417|NCT01677299|3667911|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842418|NCT01677299|3667912|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842419|NCT01677299|3667913|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842420|NCT01677299|3667914|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842421|NCT01677299|3667915|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842422|NCT01677299|3667911|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842423|NCT01677299|3667912|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842424|NCT01677299|3667913|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842425|NCT01677299|3667914|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842426|NCT01677299|3667915|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842427|NCT01677299|3667911|B5||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3842428|NCT01677299|3667912|B4||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3842429|NCT01677299|3667913|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3842430|NCT01677299|3667914|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3842431|NCT01677299|3667915|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3842432|NCT01677299|3667911|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3842433|NCT01677299|3667912|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3842434|NCT01677299|3667913|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842435|NCT01677299|3667914|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842436|NCT01677299|3667915|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3842437|NCT01677299|3667911|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842438|NCT01677299|3667912|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842439|NCT01677299|3667913|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842440|NCT01677299|3667914|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842441|NCT01677299|3667915|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842442|NCT01677299|3667911|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3842443|NCT01677299|3667912|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842444|NCT01677299|3667913|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842445|NCT01677299|3667914|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3842446|NCT01677299|3667915|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842447|NCT01677299|3667911|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842448|NCT01677299|3667912|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842449|NCT01677299|3667913|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842450|NCT01677299|3667914|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842451|NCT01677299|3667915|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842452|NCT01677299|3667911|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3842453|NCT01677299|3667912|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3842454|NCT01677299|3667913|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3842455|NCT01677299|3667914|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3842456|NCT01677299|3667915|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3842457|NCT01677299|3667911|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3842458|NCT01677299|3667912|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3842459|NCT01677299|3667913|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3842460|NCT01677299|3667914|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3842461|NCT01677299|3667915|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3842462|NCT01677299|3667911|B5|||Age||years|Mean|51.3|51.3|Standard Deviation|9.98|9.98|||
3842463|NCT01677299|3667912|B4|||Age||years|Mean|55.3|55.3|Standard Deviation|7.79|7.79|||
3842464|NCT01677299|3667913|B3|||Age||years|Mean|49.7|49.7|Standard Deviation|13.92|13.92|||
3842465|NCT01677299|3667914|B2|||Age||years|Mean|56.8|56.8|Standard Deviation|7.22|7.22|||
3842466|NCT01677299|3667915|B1|||Age||years|Mean|43.2|43.2|Standard Deviation|3.54|3.54|||
3842467|NCT01677286|3667940|B1|||Proteinuria (g/day)|Study participants with predominant renal amyloid involvement.|g/day|Mean|5.99|5.99|Standard Deviation|3.15|3.15|||
3842468|NCT01677286|3667940|B1|||Creatinine Clearance (mL/min)|Study participants with predominant renal amyloid involvement.|mL/min|Mean|83.3|83.3|Standard Deviation|36.5|36.5|||
3842469|NCT01677286|3667940|B1|||Troponin I|Study participants with predominant cardiac amyloid involvement.|ng/mL|Mean|0.11|0.11|Standard Deviation|0.07|0.07|||
3842470|NCT01677286|3667940|B1|||Brain Natriuretic Peptide (BNP)|Study participants with predominant cardiac amyloid involvement.|pg/mL|Mean|385|385.0|Standard Deviation|294|294.0|||
3842471|NCT01677286|3667940|B1|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3842472|NCT01677286|3667940|B1|Unknown/not reported||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3842473|NCT01677286|3667940|B1|Not hispanic or latino||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3842474|NCT01677286|3667940|B1|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3842475|NCT01677286|3667940|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3842476|NCT01677286|3667940|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3842477|NCT01677286|3667940|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3842478|NCT01677286|3667940|B1|||Age||Years|Median|65|65.0|Full Range|||36.0|82.0|
3842479|NCT01677195|3667947|B4|United States||Region of Enrollment||participants|Number|234|234.0||||||
3842480|NCT01677195|3667948|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
3842481|NCT01677195|3667949|B2|United States||Region of Enrollment||participants|Number|83|83.0||||||
3842482|NCT01677195|3667950|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
3842483|NCT01677195|3667947|B4||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3842484|NCT01677195|3667948|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3842485|NCT01677195|3667949|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3842486|NCT01677195|3667950|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3842487|NCT01677195|3667947|B4||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3842488|NCT01677195|3667948|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3842489|NCT01677195|3667949|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3842490|NCT01677195|3667950|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3842491|NCT01677195|3667947|B4|||Age||years|Mean|41.1|41.1|Standard Deviation|13.8|13.8|||
3842492|NCT01677195|3667948|B3|||Age||years|Mean|42.2|42.2|Standard Deviation|13.6|13.6|||
3842493|NCT01677195|3667949|B2|||Age||years|Mean|39.2|39.2|Standard Deviation|13.9|13.9|||
3842494|NCT01677195|3667950|B1|||Age||years|Mean|41.1|41.1|Standard Deviation|13.8|13.8|||
3842495|NCT01677195|3667947|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3842496|NCT01677195|3667948|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3842497|NCT01677195|3667949|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3842498|NCT01677195|3667950|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3842499|NCT01677195|3667947|B4||Between 18 and 65 years|Age||Participants|Count of Participants|234|234.0||||||
3842500|NCT01677195|3667948|B3||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
3842501|NCT01677195|3667949|B2||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
3842502|NCT01677195|3667950|B1||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
3842503|NCT01677195|3667947|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3842504|NCT01677195|3667948|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3842505|NCT01677195|3667949|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3842506|NCT01677195|3667950|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3842507|NCT01677182|3667960|B4|Not applicable (male participants)||Female Reproductive Status||participants|Number|210|210.0||||||
3842508|NCT01677182|3667961|B3|Not applicable (male participants)||Female Reproductive Status||participants|Number|74|74.0||||||
3842509|NCT01677182|3667962|B2|Not applicable (male participants)||Female Reproductive Status||participants|Number|71|71.0||||||
3842510|NCT01677182|3667963|B1|Not applicable (male participants)||Female Reproductive Status||participants|Number|65|65.0||||||
3842511|NCT01677182|3667960|B4|Child-Bearing Potential||Female Reproductive Status||participants|Number|171|171.0||||||
3842512|NCT01677182|3667961|B3|Child-Bearing Potential||Female Reproductive Status||participants|Number|62|62.0||||||
3842513|NCT01677182|3667962|B2|Child-Bearing Potential||Female Reproductive Status||participants|Number|54|54.0||||||
3842514|NCT01677182|3667963|B1|Child-Bearing Potential||Female Reproductive Status||participants|Number|55|55.0||||||
3842515|NCT01677182|3667960|B4|Surgically Sterile||Female Reproductive Status||participants|Number|46|46.0||||||
3842516|NCT01677182|3667961|B3|Surgically Sterile||Female Reproductive Status||participants|Number|12|12.0||||||
3842517|NCT01677182|3667962|B2|Surgically Sterile||Female Reproductive Status||participants|Number|14|14.0||||||
3842518|NCT01677182|3667963|B1|Surgically Sterile||Female Reproductive Status||participants|Number|20|20.0||||||
3842519|NCT01677182|3667960|B4|Postmenopausal||Female Reproductive Status||participants|Number|108|108.0||||||
3842520|NCT01677182|3667961|B3|Postmenopausal||Female Reproductive Status||participants|Number|34|34.0||||||
3842521|NCT01677182|3667962|B2|Postmenopausal||Female Reproductive Status||participants|Number|30|30.0||||||
3842522|NCT01677182|3667963|B1|Postmenopausal||Female Reproductive Status||participants|Number|44|44.0||||||
3842523|NCT01677182|3667960|B4|Unknown||Psychiatric History for response to Valproic Acid Treatment of Bipolar 1 Disorder||participants|Number|28|28.0||||||
3842524|NCT01677182|3667961|B3|Unknown||Psychiatric History for response to Valproic Acid Treatment of Bipolar 1 Disorder||participants|Number|10|10.0||||||
3842525|NCT01677182|3667962|B2|Unknown||Psychiatric History for response to Valproic Acid Treatment of Bipolar 1 Disorder||participants|Number|8|8.0||||||
3842526|NCT01677182|3667963|B1|Unknown||Psychiatric History for response to Valproic Acid Treatment of Bipolar 1 Disorder||participants|Number|10|10.0||||||
3842527|NCT01677182|3667960|B4|Not Applicable||Psychiatric History for response to Valproic Acid Treatment of Bipolar 1 Disorder||participants|Number|91|91.0||||||
3842528|NCT01677182|3667961|B3|Not Applicable||Psychiatric History for response to Valproic Acid Treatment of Bipolar 1 Disorder||participants|Number|27|27.0||||||
3842529|NCT01677182|3667962|B2|Not Applicable||Psychiatric History for response to Valproic Acid Treatment of Bipolar 1 Disorder||participants|Number|29|29.0||||||
3842530|NCT01677182|3667963|B1|Not Applicable||Psychiatric History for response to Valproic Acid Treatment of Bipolar 1 Disorder||participants|Number|35|35.0||||||
3842531|NCT01677182|3667960|B4|Responded||Psychiatric History for response to Valproic Acid Treatment of Bipolar 1 Disorder||participants|Number|393|393.0||||||
3842532|NCT01677182|3667961|B3|Responded||Psychiatric History for response to Valproic Acid Treatment of Bipolar 1 Disorder||participants|Number|136|136.0||||||
3842533|NCT01677182|3667962|B2|Responded||Psychiatric History for response to Valproic Acid Treatment of Bipolar 1 Disorder||participants|Number|124|124.0||||||
3842534|NCT01677182|3667963|B1|Responded||Psychiatric History for response to Valproic Acid Treatment of Bipolar 1 Disorder||participants|Number|133|133.0||||||
3842535|NCT01677182|3667960|B4|Failed to Respond||Psychiatric History for response to Valproic Acid Treatment of Bipolar 1 Disorder||participants|Number|23|23.0||||||
3842536|NCT01677182|3667961|B3|Failed to Respond||Psychiatric History for response to Valproic Acid Treatment of Bipolar 1 Disorder||participants|Number|9|9.0||||||
3842537|NCT01677182|3667962|B2|Failed to Respond||Psychiatric History for response to Valproic Acid Treatment of Bipolar 1 Disorder||participants|Number|8|8.0||||||
3842538|NCT01677182|3667963|B1|Failed to Respond||Psychiatric History for response to Valproic Acid Treatment of Bipolar 1 Disorder||participants|Number|6|6.0||||||
3842539|NCT01677182|3667960|B4|Unknown||Psychiatric History for response to Lithium treatment for Bipolar 1 Disorder||participants|Number|21|21.0||||||
3842540|NCT01677182|3667961|B3|Unknown||Psychiatric History for response to Lithium treatment for Bipolar 1 Disorder||participants|Number|7|7.0||||||
3842541|NCT01677182|3667962|B2|Unknown||Psychiatric History for response to Lithium treatment for Bipolar 1 Disorder||participants|Number|7|7.0||||||
3842542|NCT01677182|3667963|B1|Unknown||Psychiatric History for response to Lithium treatment for Bipolar 1 Disorder||participants|Number|7|7.0||||||
3842543|NCT01677182|3667960|B4|Not Applicable||Psychiatric History for response to Lithium treatment for Bipolar 1 Disorder||participants|Number|200|200.0||||||
3842544|NCT01677182|3667961|B3|Not Applicable||Psychiatric History for response to Lithium treatment for Bipolar 1 Disorder||participants|Number|68|68.0||||||
3842545|NCT01677182|3667962|B2|Not Applicable||Psychiatric History for response to Lithium treatment for Bipolar 1 Disorder||participants|Number|63|63.0||||||
3842546|NCT01677182|3667963|B1|Not Applicable||Psychiatric History for response to Lithium treatment for Bipolar 1 Disorder||participants|Number|69|69.0||||||
3842547|NCT01677182|3667960|B4|Responded||Psychiatric History for response to Lithium treatment for Bipolar 1 Disorder||participants|Number|293|293.0||||||
3842548|NCT01677182|3667961|B3|Responded||Psychiatric History for response to Lithium treatment for Bipolar 1 Disorder||participants|Number|100|100.0||||||
3842549|NCT01677182|3667962|B2|Responded||Psychiatric History for response to Lithium treatment for Bipolar 1 Disorder||participants|Number|92|92.0||||||
3842550|NCT01677182|3667963|B1|Responded||Psychiatric History for response to Lithium treatment for Bipolar 1 Disorder||participants|Number|101|101.0||||||
3842551|NCT01677182|3667960|B4|Failed to Respond||Psychiatric History for response to Lithium treatment for Bipolar 1 Disorder||participants|Number|21|21.0||||||
3842552|NCT01677182|3667961|B3|Failed to Respond||Psychiatric History for response to Lithium treatment for Bipolar 1 Disorder||participants|Number|7|7.0||||||
3842553|NCT01677182|3667962|B2|Failed to Respond||Psychiatric History for response to Lithium treatment for Bipolar 1 Disorder||participants|Number|7|7.0||||||
3842554|NCT01677182|3667963|B1|Failed to Respond||Psychiatric History for response to Lithium treatment for Bipolar 1 Disorder||participants|Number|7|7.0||||||
3842555|NCT01677182|3667960|B4|Not a consumer||Consumption of Caffeine||participants|Number|123|123.0||||||
3842556|NCT01677182|3667961|B3|Not a consumer||Consumption of Caffeine||participants|Number|38|38.0||||||
3842557|NCT01677182|3667962|B2|Not a consumer||Consumption of Caffeine||participants|Number|41|41.0||||||
3842558|NCT01677182|3667963|B1|Not a consumer||Consumption of Caffeine||participants|Number|44|44.0||||||
3842559|NCT01677182|3667960|B4|Consumer||Consumption of Caffeine||participants|Number|412|412.0||||||
3842560|NCT01677182|3667961|B3|Consumer||Consumption of Caffeine||participants|Number|144|144.0||||||
3842561|NCT01677182|3667962|B2|Consumer||Consumption of Caffeine||participants|Number|128|128.0||||||
3842562|NCT01677182|3667963|B1|Consumer||Consumption of Caffeine||participants|Number|140|140.0||||||
3842563|NCT01677182|3667960|B4|>= 4 drinks per day||Amount of Alcohol Consumed if Current Drinker|Participants evaluable for this measure included only those who were current drinkers (36, 36, and 37 for each group, respectively).|participants|Number|0|0.0||||||
3842564|NCT01677182|3667961|B3|>= 4 drinks per day||Amount of Alcohol Consumed if Current Drinker|Participants evaluable for this measure included only those who were current drinkers (36, 36, and 37 for each group, respectively).|participants|Number|0|0.0||||||
3842565|NCT01677182|3667962|B2|>= 4 drinks per day||Amount of Alcohol Consumed if Current Drinker|Participants evaluable for this measure included only those who were current drinkers (36, 36, and 37 for each group, respectively).|participants|Number|0|0.0||||||
3842620|NCT01677182|3667961|B3|Russian Federation||Region of Enrollment||participants|Number|13|13.0||||||
3842566|NCT01677182|3667963|B1|>= 4 drinks per day||Amount of Alcohol Consumed if Current Drinker|Participants evaluable for this measure included only those who were current drinkers (36, 36, and 37 for each group, respectively).|participants|Number|0|0.0||||||
3842567|NCT01677182|3667960|B4|< 4 drinks per day||Amount of Alcohol Consumed if Current Drinker|Participants evaluable for this measure included only those who were current drinkers (36, 36, and 37 for each group, respectively).|participants|Number|109|109.0||||||
3842568|NCT01677182|3667961|B3|< 4 drinks per day||Amount of Alcohol Consumed if Current Drinker|Participants evaluable for this measure included only those who were current drinkers (36, 36, and 37 for each group, respectively).|participants|Number|37|37.0||||||
3842569|NCT01677182|3667962|B2|< 4 drinks per day||Amount of Alcohol Consumed if Current Drinker|Participants evaluable for this measure included only those who were current drinkers (36, 36, and 37 for each group, respectively).|participants|Number|36|36.0||||||
3842570|NCT01677182|3667963|B1|< 4 drinks per day||Amount of Alcohol Consumed if Current Drinker|Participants evaluable for this measure included only those who were current drinkers (36, 36, and 37 for each group, respectively).|participants|Number|36|36.0||||||
3842571|NCT01677182|3667960|B4|Current Drinker||Subject Drinking Status||participants|Number|109|109.0||||||
3842572|NCT01677182|3667961|B3|Current Drinker||Subject Drinking Status||participants|Number|37|37.0||||||
3842573|NCT01677182|3667962|B2|Current Drinker||Subject Drinking Status||participants|Number|36|36.0||||||
3842574|NCT01677182|3667963|B1|Current Drinker||Subject Drinking Status||participants|Number|36|36.0||||||
3842575|NCT01677182|3667960|B4|Ex-Drinker||Subject Drinking Status||participants|Number|128|128.0||||||
3842576|NCT01677182|3667961|B3|Ex-Drinker||Subject Drinking Status||participants|Number|36|36.0||||||
3842577|NCT01677182|3667962|B2|Ex-Drinker||Subject Drinking Status||participants|Number|41|41.0||||||
3842578|NCT01677182|3667963|B1|Ex-Drinker||Subject Drinking Status||participants|Number|51|51.0||||||
3842579|NCT01677182|3667960|B4|Had Never Drunk||Subject Drinking Status||participants|Number|298|298.0||||||
3842580|NCT01677182|3667961|B3|Had Never Drunk||Subject Drinking Status||participants|Number|109|109.0||||||
3842581|NCT01677182|3667962|B2|Had Never Drunk||Subject Drinking Status||participants|Number|92|92.0||||||
3842582|NCT01677182|3667963|B1|Had Never Drunk||Subject Drinking Status||participants|Number|97|97.0||||||
3842583|NCT01677182|3667960|B4|Ex-smoker||Smoking Classification||participants|Number|70|70.0||||||
3842584|NCT01677182|3667961|B3|Ex-smoker||Smoking Classification||participants|Number|21|21.0||||||
3842585|NCT01677182|3667962|B2|Ex-smoker||Smoking Classification||participants|Number|24|24.0||||||
3842586|NCT01677182|3667963|B1|Ex-smoker||Smoking Classification||participants|Number|25|25.0||||||
3842587|NCT01677182|3667960|B4|Current Smoker||Smoking Classification||participants|Number|227|227.0||||||
3842588|NCT01677182|3667961|B3|Current Smoker||Smoking Classification||participants|Number|82|82.0||||||
3842589|NCT01677182|3667962|B2|Current Smoker||Smoking Classification||participants|Number|70|70.0||||||
3842590|NCT01677182|3667963|B1|Current Smoker||Smoking Classification||participants|Number|75|75.0||||||
3842591|NCT01677182|3667960|B4|Had Never Smoked||Smoking Classification||participants|Number|238|238.0||||||
3842592|NCT01677182|3667961|B3|Had Never Smoked||Smoking Classification||participants|Number|79|79.0||||||
3842593|NCT01677182|3667962|B2|Had Never Smoked||Smoking Classification||participants|Number|75|75.0||||||
3842594|NCT01677182|3667963|B1|Had Never Smoked||Smoking Classification||participants|Number|84|84.0||||||
3842595|NCT01677182|3667960|B4|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|28.44|28.44|Standard Deviation|6.663|6.663|||
3842596|NCT01677182|3667961|B3|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|28.52|28.52|Standard Deviation|6.156|6.156|||
3842597|NCT01677182|3667962|B2|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|28.57|28.57|Standard Deviation|6.130|6.13|||
3842598|NCT01677182|3667963|B1|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|28.25|28.25|Standard Deviation|7.583|7.583|||
3842599|NCT01677182|3667960|B4|||Weight||kilogram (kg)|Mean|82.11|82.11|Standard Deviation|20.605|20.605|||
3842600|NCT01677182|3667961|B3|||Weight||kilogram (kg)|Mean|82.38|82.38|Standard Deviation|19.202|19.202|||
3842601|NCT01677182|3667962|B2|||Weight||kilogram (kg)|Mean|83.21|83.21|Standard Deviation|18.638|18.638|||
3842602|NCT01677182|3667963|B1|||Weight||kilogram (kg)|Mean|80.82|80.82|Standard Deviation|23.503|23.503|||
3842603|NCT01677182|3667960|B4|||Height||centimeter (cm)|Mean|169.75|169.75|Standard Deviation|8.871|8.871|||
3842604|NCT01677182|3667961|B3|||Height||centimeter (cm)|Mean|169.80|169.8|Standard Deviation|8.870|8.87|||
3842605|NCT01677182|3667962|B2|||Height||centimeter (cm)|Mean|170.66|170.66|Standard Deviation|8.423|8.423|||
3842606|NCT01677182|3667963|B1|||Height||centimeter (cm)|Mean|168.86|168.86|Standard Deviation|9.227|9.227|||
3842607|NCT01677182|3667960|B4|United States||Region of Enrollment||participants|Number|219|219.0||||||
3842608|NCT01677182|3667961|B3|United States||Region of Enrollment||participants|Number|72|72.0||||||
3842609|NCT01677182|3667962|B2|United States||Region of Enrollment||participants|Number|71|71.0||||||
3842610|NCT01677182|3667963|B1|United States||Region of Enrollment||participants|Number|76|76.0||||||
3842611|NCT01677182|3667960|B4|Ukraine||Region of Enrollment||participants|Number|57|57.0||||||
3842612|NCT01677182|3667961|B3|Ukraine||Region of Enrollment||participants|Number|18|18.0||||||
3842613|NCT01677182|3667962|B2|Ukraine||Region of Enrollment||participants|Number|19|19.0||||||
3842614|NCT01677182|3667963|B1|Ukraine||Region of Enrollment||participants|Number|20|20.0||||||
3842615|NCT01677182|3667960|B4|Serbia||Region of Enrollment||participants|Number|67|67.0||||||
3842616|NCT01677182|3667961|B3|Serbia||Region of Enrollment||participants|Number|25|25.0||||||
3842617|NCT01677182|3667962|B2|Serbia||Region of Enrollment||participants|Number|20|20.0||||||
3842618|NCT01677182|3667963|B1|Serbia||Region of Enrollment||participants|Number|22|22.0||||||
3842619|NCT01677182|3667960|B4|Russian Federation||Region of Enrollment||participants|Number|34|34.0||||||
3842621|NCT01677182|3667962|B2|Russian Federation||Region of Enrollment||participants|Number|9|9.0||||||
3842622|NCT01677182|3667963|B1|Russian Federation||Region of Enrollment||participants|Number|12|12.0||||||
3842623|NCT01677182|3667960|B4|Romania||Region of Enrollment||participants|Number|24|24.0||||||
3842624|NCT01677182|3667961|B3|Romania||Region of Enrollment||participants|Number|9|9.0||||||
3842625|NCT01677182|3667962|B2|Romania||Region of Enrollment||participants|Number|7|7.0||||||
3842626|NCT01677182|3667963|B1|Romania||Region of Enrollment||participants|Number|8|8.0||||||
3842627|NCT01677182|3667960|B4|Poland||Region of Enrollment||participants|Number|10|10.0||||||
3842628|NCT01677182|3667961|B3|Poland||Region of Enrollment||participants|Number|4|4.0||||||
3842629|NCT01677182|3667962|B2|Poland||Region of Enrollment||participants|Number|4|4.0||||||
3842630|NCT01677182|3667963|B1|Poland||Region of Enrollment||participants|Number|2|2.0||||||
3842631|NCT01677182|3667960|B4|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3842632|NCT01677182|3667961|B3|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3842633|NCT01677182|3667962|B2|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3842634|NCT01677182|3667963|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3842635|NCT01677182|3667960|B4|Germany||Region of Enrollment||participants|Number|11|11.0||||||
3842636|NCT01677182|3667961|B3|Germany||Region of Enrollment||participants|Number|3|3.0||||||
3842637|NCT01677182|3667962|B2|Germany||Region of Enrollment||participants|Number|5|5.0||||||
3842638|NCT01677182|3667963|B1|Germany||Region of Enrollment||participants|Number|3|3.0||||||
3842639|NCT01677182|3667960|B4|Czech Republic||Region of Enrollment||participants|Number|24|24.0||||||
3842640|NCT01677182|3667961|B3|Czech Republic||Region of Enrollment||participants|Number|8|8.0||||||
3842641|NCT01677182|3667962|B2|Czech Republic||Region of Enrollment||participants|Number|7|7.0||||||
3842642|NCT01677182|3667963|B1|Czech Republic||Region of Enrollment||participants|Number|9|9.0||||||
3842643|NCT01677182|3667960|B4|Bulgaria||Region of Enrollment||participants|Number|88|88.0||||||
3842644|NCT01677182|3667961|B3|Bulgaria||Region of Enrollment||participants|Number|30|30.0||||||
3842645|NCT01677182|3667962|B2|Bulgaria||Region of Enrollment||participants|Number|27|27.0||||||
3842646|NCT01677182|3667963|B1|Bulgaria||Region of Enrollment||participants|Number|31|31.0||||||
3842647|NCT01677182|3667960|B4|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3842648|NCT01677182|3667961|B3|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3842649|NCT01677182|3667962|B2|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3842650|NCT01677182|3667963|B1|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3842651|NCT01677182|3667960|B4|White||Race/Ethnicity, Customized||participants|Number|491|491.0||||||
3842652|NCT01677182|3667961|B3|White||Race/Ethnicity, Customized||participants|Number|166|166.0||||||
3842653|NCT01677182|3667962|B2|White||Race/Ethnicity, Customized||participants|Number|154|154.0||||||
3842654|NCT01677182|3667963|B1|White||Race/Ethnicity, Customized||participants|Number|171|171.0||||||
3842655|NCT01677182|3667960|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3842656|NCT01677182|3667961|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3842657|NCT01677182|3667962|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3842658|NCT01677182|3667963|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3842659|NCT01677182|3667960|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3842660|NCT01677182|3667961|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3842661|NCT01677182|3667962|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3842662|NCT01677182|3667963|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3842663|NCT01677182|3667960|B4|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3842664|NCT01677182|3667961|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3842665|NCT01677182|3667962|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3842666|NCT01677182|3667963|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3842667|NCT01677182|3667960|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3842668|NCT01677182|3667961|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3842669|NCT01677182|3667962|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3842670|NCT01677182|3667963|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3842671|NCT01677182|3667960|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|317|317.0||||||
3842672|NCT01677182|3667961|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
3842673|NCT01677182|3667962|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3842674|NCT01677182|3667963|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|109|109.0||||||
3842675|NCT01677182|3667960|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|187|187.0||||||
3842676|NCT01677182|3667961|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3842677|NCT01677182|3667962|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3842678|NCT01677182|3667963|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3842679|NCT01677182|3667960|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3842680|NCT01677182|3667961|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3842681|NCT01677182|3667962|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3842682|NCT01677182|3667963|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3842683|NCT01677182|3667960|B4||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
3842684|NCT01677182|3667961|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3842685|NCT01677182|3667962|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3842686|NCT01677182|3667963|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3842687|NCT01677182|3667960|B4||Female|Sex: Female, Male||Participants|Count of Participants|325|325.0||||||
3842688|NCT01677182|3667961|B3||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3842689|NCT01677182|3667962|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3842690|NCT01677182|3667963|B1||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3842691|NCT01677182|3667960|B4|Greater than (>) 50 years||Age, Customized||participants|Number|223|223.0||||||
3842692|NCT01677182|3667961|B3|Greater than (>) 50 years||Age, Customized||participants|Number|75|75.0||||||
3842693|NCT01677182|3667962|B2|Greater than (>) 50 years||Age, Customized||participants|Number|69|69.0||||||
3842694|NCT01677182|3667963|B1|Greater than (>) 50 years||Age, Customized||participants|Number|79|79.0||||||
3842695|NCT01677182|3667960|B4|Less than or equal to (<=) 50 years||Age, Customized||participants|Number|312|312.0||||||
3842696|NCT01677182|3667961|B3|Less than or equal to (<=) 50 years||Age, Customized||participants|Number|107|107.0||||||
3842697|NCT01677182|3667962|B2|Less than or equal to (<=) 50 years||Age, Customized||participants|Number|100|100.0||||||
3842698|NCT01677182|3667963|B1|Less than or equal to (<=) 50 years||Age, Customized||participants|Number|105|105.0||||||
3842699|NCT01677182|3667960|B4|||Age||years|Mean|45.67|45.67|Standard Deviation|11.480|11.48|||
3842700|NCT01677182|3667961|B3|||Age||years|Mean|44.87|44.87|Standard Deviation|11.608|11.608|||
3842701|NCT01677182|3667962|B2|||Age||years|Mean|45.44|45.44|Standard Deviation|11.490|11.49|||
3842702|NCT01677182|3667963|B1|||Age||years|Mean|46.67|46.67|Standard Deviation|11.332|11.332|||
3842703|NCT01676961|3667997|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3842704|NCT01676961|3667997|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3842705|NCT01676961|3667997|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3842706|NCT01676961|3667997|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3842707|NCT01676961|3667997|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3842708|NCT01676961|3667997|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3842709|NCT01676896|3668002|B4|United States||Region of Enrollment||participants|Number|292|292.0||||||
3842710|NCT01676896|3668003|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
3842711|NCT01676896|3668004|B2|United States||Region of Enrollment||participants|Number|96|96.0||||||
3842712|NCT01676896|3668005|B1|United States||Region of Enrollment||participants|Number|96|96.0||||||
3842713|NCT01676896|3668002|B4||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
3842714|NCT01676896|3668003|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3842715|NCT01676896|3668004|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3842716|NCT01676896|3668005|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3842717|NCT01676896|3668002|B4||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3842718|NCT01676896|3668003|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3842719|NCT01676896|3668004|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3842720|NCT01676896|3668005|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3842721|NCT01676896|3668002|B4|||Age||years|Mean|8.82|8.82|Standard Deviation|1.25|1.25|||
3842722|NCT01676896|3668003|B3|||Age||years|Mean|8.86|8.86|Standard Deviation|1.29|1.29|||
3842723|NCT01676896|3668004|B2|||Age||years|Mean|8.83|8.83|Standard Deviation|1.21|1.21|||
3842724|NCT01676896|3668005|B1|||Age||years|Mean|8.77|8.77|Standard Deviation|1.25|1.25|||
3842725|NCT01676896|3668002|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3842726|NCT01676896|3668003|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3842727|NCT01676896|3668004|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3842728|NCT01676896|3668005|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3842729|NCT01676896|3668002|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3842730|NCT01676896|3668003|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3842731|NCT01676896|3668004|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3842732|NCT01676896|3668005|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3842733|NCT01676896|3668002|B4||<=18 years|Age||Participants|Count of Participants|292|292.0||||||
3842734|NCT01676896|3668003|B3||<=18 years|Age||Participants|Count of Participants|100|100.0||||||
3842735|NCT01676896|3668004|B2||<=18 years|Age||Participants|Count of Participants|96|96.0||||||
3842736|NCT01676896|3668005|B1||<=18 years|Age||Participants|Count of Participants|96|96.0||||||
3842737|NCT01676727|3668102|B1|Germany||Region of Enrollment||participants|Number|7|7.0||||||
3842738|NCT01676727|3668102|B1|France||Region of Enrollment||participants|Number|15|15.0||||||
3842739|NCT01676727|3668102|B1|Italy||Region of Enrollment||participants|Number|33|33.0||||||
3842740|NCT01676727|3668102|B1|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
3842741|NCT01676727|3668102|B1|Netherlands||Region of Enrollment||participants|Number|18|18.0||||||
3842742|NCT01676727|3668102|B1|Czech Republic||Region of Enrollment||participants|Number|20|20.0||||||
3842743|NCT01676727|3668102|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3842744|NCT01676727|3668102|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3842745|NCT01676727|3668102|B1|||Age||years|Mean|81.9|81.9|Standard Deviation|5.9|5.9|||
3842746|NCT01676714|3668107|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3842747|NCT01676714|3668107|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3842748|NCT01676714|3668107|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3842749|NCT01676714|3668107|B1|||Age||years|Median|63|63.0|Full Range|||48.0|77.0|
3842750|NCT01676701|3668114|B3|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3842751|NCT01676701|3668115|B2|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3842752|NCT01676701|3668116|B1|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3842753|NCT01676701|3668114|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842754|NCT01676701|3668115|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842755|NCT01676701|3668116|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842756|NCT01676701|3668114|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842757|NCT01676701|3668115|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842758|NCT01676701|3668116|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842759|NCT01676701|3668114|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3842760|NCT01676701|3668115|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3842761|NCT01676701|3668116|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3842762|NCT01676701|3668114|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3842763|NCT01676701|3668115|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3842764|NCT01676701|3668116|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842765|NCT01676701|3668114|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842766|NCT01676701|3668115|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842767|NCT01676701|3668116|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842768|NCT01676701|3668114|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842769|NCT01676701|3668115|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842770|NCT01676701|3668116|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842771|NCT01676701|3668114|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842772|NCT01676701|3668115|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842773|NCT01676701|3668116|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842774|NCT01676701|3668114|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842775|NCT01676701|3668115|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842776|NCT01676701|3668116|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842777|NCT01676701|3668114|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3842778|NCT01676701|3668115|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3842779|NCT01676701|3668116|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3842780|NCT01676701|3668114|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3842781|NCT01676701|3668115|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3842782|NCT01676701|3668116|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842783|NCT01676701|3668114|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3842784|NCT01676701|3668115|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3842785|NCT01676701|3668116|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3842786|NCT01676701|3668114|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3842787|NCT01676701|3668115|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3842788|NCT01676701|3668116|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3842789|NCT01676701|3668114|B3|43.3 to 65.4 years||Age, Customized||participants|Number|8|8.0||||||
3842790|NCT01676701|3668115|B2|43.3 to 65.4 years||Age, Customized||participants|Number|4|4.0||||||
3842791|NCT01676701|3668116|B1|43.3 to 65.4 years||Age, Customized||participants|Number|4|4.0||||||
3842792|NCT01676532|3668143|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3842793|NCT01676532|3668143|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3842794|NCT01676532|3668143|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3842795|NCT01676532|3668143|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3842796|NCT01676532|3668143|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842797|NCT01676532|3668143|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3842798|NCT01676532|3668143|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842799|NCT01676532|3668143|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842800|NCT01676532|3668143|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|127|127.0||||||
3842801|NCT01676532|3668143|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842802|NCT01676532|3668143|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3842803|NCT01676532|3668143|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3842804|NCT01676532|3668143|B1||>=65 years|Age|Retrospective chart review|Participants|Count of Participants|0|0.0||||||
3842805|NCT01676532|3668143|B1||Between 18 and 65 years|Age|Retrospective chart review|Participants|Count of Participants|0|0.0||||||
3842806|NCT01676532|3668143|B1||<=18 years|Age|Retrospective chart review|Participants|Count of Participants|127|127.0||||||
3842807|NCT01676415|3668152|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3842808|NCT01676415|3668153|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3842809|NCT01676415|3668154|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3842810|NCT01676415|3668152|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3842811|NCT01676415|3668153|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3842812|NCT01676415|3668154|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3842813|NCT01676415|3668152|B3|||Age||years|Mean|46.3|46.3|Standard Deviation|14.3|14.3|||
3842814|NCT01676415|3668153|B2|||Age||years|Mean|45.9|45.9|Standard Deviation|11.5|11.5|||
3842815|NCT01676415|3668154|B1|||Age||years|Mean|46.7|46.7|Standard Deviation|16.5|16.5|||
3842816|NCT01676298|3668167|B9|Canada||Region of Enrollment||participants|Number|8|8.0||||||
3842817|NCT01676298|3668168|B8|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3842818|NCT01676298|3668169|B7|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3842819|NCT01676298|3668170|B6|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3842820|NCT01676298|3668171|B5|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3842821|NCT01676298|3668172|B4|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3842822|NCT01676298|3668173|B3|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3842823|NCT01676298|3668174|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3842824|NCT01676298|3668175|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3842825|NCT01676298|3668167|B9||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3842826|NCT01676298|3668168|B8||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3842827|NCT01676298|3668169|B7||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3842828|NCT01676298|3668170|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3842829|NCT01676298|3668171|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3842830|NCT01676298|3668172|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3842831|NCT01676298|3668173|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3842832|NCT01676298|3668174|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3842833|NCT01676298|3668175|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3842834|NCT01676298|3668167|B9||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3842835|NCT01676298|3668168|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3842836|NCT01676298|3668169|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3842837|NCT01676298|3668170|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3842838|NCT01676298|3668171|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3842839|NCT01676298|3668172|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3842840|NCT01676298|3668173|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3842841|NCT01676298|3668174|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3842842|NCT01676298|3668175|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3842843|NCT01676298|3668167|B9||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3842844|NCT01676298|3668168|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3842845|NCT01676298|3668169|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3842846|NCT01676298|3668170|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3842847|NCT01676298|3668171|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3842848|NCT01676298|3668172|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3842849|NCT01676298|3668173|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3842850|NCT01676298|3668174|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3842851|NCT01676298|3668175|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3842852|NCT01676298|3668167|B9||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3842853|NCT01676298|3668168|B8||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3842854|NCT01676298|3668169|B7||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3842855|NCT01676298|3668170|B6||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3842856|NCT01676298|3668171|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3842857|NCT01676298|3668172|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3842858|NCT01676298|3668173|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3842859|NCT01676298|3668174|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3842860|NCT01676298|3668175|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3842861|NCT01676298|3668167|B9||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3842862|NCT01676298|3668168|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3842863|NCT01676298|3668169|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3842864|NCT01676298|3668170|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3842865|NCT01676298|3668171|B5||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3842866|NCT01676298|3668172|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3842867|NCT01676298|3668173|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3842868|NCT01676298|3668174|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3842869|NCT01676298|3668175|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3842870|NCT01676220|3668200|B3|Greater Than or Equal to (>=) 8%||Glycated Hemoglobin A1c (HbA1c)||participants|Number|595|595.0||||||
3842871|NCT01676220|3668201|B2|Greater Than or Equal to (>=) 8%||Glycated Hemoglobin A1c (HbA1c)||participants|Number|297|297.0||||||
3842872|NCT01676220|3668202|B1|Greater Than or Equal to (>=) 8%||Glycated Hemoglobin A1c (HbA1c)||participants|Number|298|298.0||||||
3842873|NCT01676220|3668200|B3|Less Than (<) 8%||Glycated Hemoglobin A1c (HbA1c)||participants|Number|283|283.0||||||
3842874|NCT01676220|3668201|B2|Less Than (<) 8%||Glycated Hemoglobin A1c (HbA1c)||participants|Number|142|142.0||||||
3842875|NCT01676220|3668202|B1|Less Than (<) 8%||Glycated Hemoglobin A1c (HbA1c)||participants|Number|141|141.0||||||
3842876|NCT01676220|3668200|B3|||Basal Insulin Daily Dose|Number of participants analyzed for this baseline characteristics = 432 and 436 in HOE901-U300 and Lantus arm, respectively.|units per kilogram (U/kg)|Mean|0.193|0.193|Standard Deviation|0.031|0.031|||
3842877|NCT01676220|3668201|B2|||Basal Insulin Daily Dose|Number of participants analyzed for this baseline characteristics = 432 and 436 in HOE901-U300 and Lantus arm, respectively.|units per kilogram (U/kg)|Mean|0.193|0.193|Standard Deviation|0.034|0.034|||
3842878|NCT01676220|3668202|B1|||Basal Insulin Daily Dose|Number of participants analyzed for this baseline characteristics = 432 and 436 in HOE901-U300 and Lantus arm, respectively.|units per kilogram (U/kg)|Mean|0.193|0.193|Standard Deviation|0.027|0.027|||
3842879|NCT01676220|3668200|B3|||Duration of Diabetes|Number of participants analyzed for this baseline characteristics = 435 and 436 in HOE901-U300 and Lantus arm, respectively.|years|Mean|9.84|9.84|Standard Deviation|6.36|6.36|||
3842880|NCT01676220|3668201|B2|||Duration of Diabetes|Number of participants analyzed for this baseline characteristics = 435 and 436 in HOE901-U300 and Lantus arm, respectively.|years|Mean|9.57|9.57|Standard Deviation|6.22|6.22|||
3842881|NCT01676220|3668202|B1|||Duration of Diabetes|Number of participants analyzed for this baseline characteristics = 435 and 436 in HOE901-U300 and Lantus arm, respectively.|years|Mean|10.11|10.11|Standard Deviation|6.49|6.49|||
3842882|NCT01676220|3668200|B3|||Body Mass Index (BMI)||kilogram per square meter|Mean|33.0|33.0|Standard Deviation|6.7|6.7|||
3842883|NCT01676220|3668201|B2|||Body Mass Index (BMI)||kilogram per square meter|Mean|33.2|33.2|Standard Deviation|6.6|6.6|||
3842884|NCT01676220|3668202|B1|||Body Mass Index (BMI)||kilogram per square meter|Mean|32.8|32.8|Standard Deviation|6.9|6.9|||
3842885|NCT01676220|3668200|B3||Male|Sex: Female, Male||Participants|Count of Participants|507|507.0||||||
3842886|NCT01676220|3668201|B2||Male|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
3842887|NCT01676220|3668202|B1||Male|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
3842888|NCT01676220|3668200|B3||Female|Sex: Female, Male||Participants|Count of Participants|371|371.0||||||
3842889|NCT01676220|3668201|B2||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
3842890|NCT01676220|3668202|B1||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
3842891|NCT01676220|3668200|B3|||Age||years|Mean|57.7|57.7|Standard Deviation|10.1|10.1|||
3842892|NCT01676220|3668201|B2|||Age||years|Mean|57.2|57.2|Standard Deviation|10.3|10.3|||
3842893|NCT01676220|3668202|B1|||Age||years|Mean|58.2|58.2|Standard Deviation|9.9|9.9|||
3842894|NCT01676116|3668233|B3|||Fasting plasma glucose||mmol/L|Mean|9.1|9.1|Standard Deviation|2.2|2.2|||
3842895|NCT01676116|3668234|B2|||Fasting plasma glucose||mmol/L|Mean|9.4|9.4|Standard Deviation|2.3|2.3|||
3842896|NCT01676116|3668235|B1|||Fasting plasma glucose||mmol/L|Mean|9|9.0|Standard Deviation|2.1|2.1|||
3842897|NCT01676116|3668233|B3|||Body weight||kg|Mean|95.5|95.5|Standard Deviation|16.8|16.8|||
3842898|NCT01676116|3668234|B2|||Body weight||kg|Mean|95.5|95.5|Standard Deviation|17.3|17.3|||
3842899|NCT01676116|3668235|B1|||Body weight||kg|Mean|95.6|95.6|Standard Deviation|16.6|16.6|||
3842900|NCT01676116|3668233|B3|||HbA1c||percentage of glycosylated haemoglobin|Mean|7.8|7.8|Standard Deviation|0.6|0.6|||
3842901|NCT01676116|3668234|B2|||HbA1c||percentage of glycosylated haemoglobin|Mean|7.7|7.7|Standard Deviation|0.6|0.6|||
3842902|NCT01676116|3668235|B1|||HbA1c||percentage of glycosylated haemoglobin|Mean|7.8|7.8|Standard Deviation|0.6|0.6|||
3842903|NCT01676116|3668233|B3||Male|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
3842904|NCT01676116|3668234|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3842905|NCT01676116|3668235|B1||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3842906|NCT01676116|3668233|B3||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
3842907|NCT01676116|3668234|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3842908|NCT01676116|3668235|B1||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3842909|NCT01676116|3668233|B3|||Age||years|Mean|58.3|58.3|Standard Deviation|9.5|9.5|||
3842910|NCT01676116|3668234|B2|||Age||years|Mean|58.4|58.4|Standard Deviation|8.8|8.8|||
3842911|NCT01676116|3668235|B1|||Age||years|Mean|58.3|58.3|Standard Deviation|9.9|9.9|||
3842912|NCT01676012|3668258|B1|Netherlands||Region of Enrollment||participants|Number|29|29.0||||||
3842913|NCT01676012|3668258|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3842914|NCT01676012|3668258|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3842915|NCT01676012|3668258|B1|||Age||years|Mean|63|63.0|Full Range|||40.0|93.0|
3842916|NCT01675830|3668262|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3842917|NCT01675830|3668262|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3842918|NCT01675830|3668262|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3842919|NCT01675830|3668262|B1|||Age||weeks|Median|17.4|17.4|Full Range|||4.3|47.8|
3842920|NCT01675830|3668262|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3842921|NCT01675830|3668262|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3842922|NCT01675830|3668262|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
3842923|NCT01675661|3668267|B3|United States||Region of Enrollment||participants|Number|302|302.0||||||
3842924|NCT01675661|3668268|B2|United States||Region of Enrollment||participants|Number|149|149.0||||||
3842925|NCT01675661|3668269|B1|United States||Region of Enrollment||participants|Number|153|153.0||||||
3842926|NCT01675661|3668267|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3842927|NCT01675661|3668268|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3842928|NCT01675661|3668269|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3842929|NCT01675661|3668267|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3842930|NCT01675661|3668268|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3842931|NCT01675661|3668269|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3842932|NCT01675661|3668267|B3||White|Race (NIH/OMB)||Participants|Count of Participants|176|176.0||||||
3842933|NCT01675661|3668268|B2||White|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
3842934|NCT01675661|3668269|B1||White|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3842935|NCT01675661|3668267|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3842936|NCT01675661|3668268|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3842937|NCT01675661|3668269|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3842938|NCT01675661|3668267|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3842939|NCT01675661|3668268|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842940|NCT01675661|3668269|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3842941|NCT01675661|3668267|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3842942|NCT01675661|3668268|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3842943|NCT01675661|3668269|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3842944|NCT01675661|3668267|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3842945|NCT01675661|3668268|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3842946|NCT01675661|3668269|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842947|NCT01675661|3668267|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842948|NCT01675661|3668268|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842949|NCT01675661|3668269|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842950|NCT01675661|3668267|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|237|237.0||||||
3842951|NCT01675661|3668268|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
3842952|NCT01675661|3668269|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
3842953|NCT01675661|3668267|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3842954|NCT01675661|3668268|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3842955|NCT01675661|3668269|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3842956|NCT01675661|3668267|B3||Male|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
3842957|NCT01675661|3668268|B2||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3842958|NCT01675661|3668269|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3842959|NCT01675661|3668267|B3||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3842960|NCT01675661|3668268|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3842961|NCT01675661|3668269|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3842962|NCT01675661|3668267|B3|||Age||years|Mean|30.3|30.3|Standard Deviation|9.03|9.03|||
3842963|NCT01675661|3668268|B2|||Age||years|Mean|30.8|30.8|Standard Deviation|9.32|9.32|||
3842964|NCT01675661|3668269|B1|||Age||years|Mean|29.8|29.8|Standard Deviation|8.74|8.74|||
3842965|NCT01675635|3668276|B3|P2(Class II)||America Society of Anesthesiologist classification|"ASA Physical Status Classification System~P1 A normal healthy patient P2 A patient with mild systemic disease P3 A patient with severe systemic disease P4 A patient with severe systemic disease that is a constant threat to life P5 A moribund patient who is not expected to survive without the operation P6 A declared brain-dead patient whose organ are being removed for donor purposes."|Participants|Count of Participants|116|116.0||||||
3842993|NCT01675635|3668277|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842994|NCT01675635|3668278|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842966|NCT01675635|3668277|B2|P2(Class II)||America Society of Anesthesiologist classification|"ASA Physical Status Classification System~P1 A normal healthy patient P2 A patient with mild systemic disease P3 A patient with severe systemic disease P4 A patient with severe systemic disease that is a constant threat to life P5 A moribund patient who is not expected to survive without the operation P6 A declared brain-dead patient whose organ are being removed for donor purposes."|Participants|Count of Participants|60|60.0||||||
3842967|NCT01675635|3668278|B1|P2(Class II)||America Society of Anesthesiologist classification|"ASA Physical Status Classification System~P1 A normal healthy patient P2 A patient with mild systemic disease P3 A patient with severe systemic disease P4 A patient with severe systemic disease that is a constant threat to life P5 A moribund patient who is not expected to survive without the operation P6 A declared brain-dead patient whose organ are being removed for donor purposes."|Participants|Count of Participants|56|56.0||||||
3842968|NCT01675635|3668276|B3|P1(Class I)||America Society of Anesthesiologist classification|"ASA Physical Status Classification System~P1 A normal healthy patient P2 A patient with mild systemic disease P3 A patient with severe systemic disease P4 A patient with severe systemic disease that is a constant threat to life P5 A moribund patient who is not expected to survive without the operation P6 A declared brain-dead patient whose organ are being removed for donor purposes."|Participants|Count of Participants|118|118.0||||||
3842969|NCT01675635|3668277|B2|P1(Class I)||America Society of Anesthesiologist classification|"ASA Physical Status Classification System~P1 A normal healthy patient P2 A patient with mild systemic disease P3 A patient with severe systemic disease P4 A patient with severe systemic disease that is a constant threat to life P5 A moribund patient who is not expected to survive without the operation P6 A declared brain-dead patient whose organ are being removed for donor purposes."|Participants|Count of Participants|57|57.0||||||
3842970|NCT01675635|3668278|B1|P1(Class I)||America Society of Anesthesiologist classification|"ASA Physical Status Classification System~P1 A normal healthy patient P2 A patient with mild systemic disease P3 A patient with severe systemic disease P4 A patient with severe systemic disease that is a constant threat to life P5 A moribund patient who is not expected to survive without the operation P6 A declared brain-dead patient whose organ are being removed for donor purposes."|Participants|Count of Participants|61|61.0||||||
3842971|NCT01675635|3668276|B3|abnormal,clinical significant||Electrocardiogram test|the judgement of result normal, abnormal non clinical significant or abnormal clinical significant was made by the doctor according to the clinical practice. the study protocol does not have additional or particular requirement.|Participants|Count of Participants|5|5.0||||||
3842972|NCT01675635|3668277|B2|abnormal,clinical significant||Electrocardiogram test|the judgement of result normal, abnormal non clinical significant or abnormal clinical significant was made by the doctor according to the clinical practice. the study protocol does not have additional or particular requirement.|Participants|Count of Participants|5|5.0||||||
3842973|NCT01675635|3668278|B1|abnormal,clinical significant||Electrocardiogram test|the judgement of result normal, abnormal non clinical significant or abnormal clinical significant was made by the doctor according to the clinical practice. the study protocol does not have additional or particular requirement.|Participants|Count of Participants|0|0.0||||||
3842974|NCT01675635|3668276|B3|abnormal, not clinical significant||Electrocardiogram test|the judgement of result normal, abnormal non clinical significant or abnormal clinical significant was made by the doctor according to the clinical practice. the study protocol does not have additional or particular requirement.|Participants|Count of Participants|63|63.0||||||
3842975|NCT01675635|3668277|B2|abnormal, not clinical significant||Electrocardiogram test|the judgement of result normal, abnormal non clinical significant or abnormal clinical significant was made by the doctor according to the clinical practice. the study protocol does not have additional or particular requirement.|Participants|Count of Participants|34|34.0||||||
3842976|NCT01675635|3668278|B1|abnormal, not clinical significant||Electrocardiogram test|the judgement of result normal, abnormal non clinical significant or abnormal clinical significant was made by the doctor according to the clinical practice. the study protocol does not have additional or particular requirement.|Participants|Count of Participants|29|29.0||||||
3842977|NCT01675635|3668276|B3|normal||Electrocardiogram test|the judgement of result normal, abnormal non clinical significant or abnormal clinical significant was made by the doctor according to the clinical practice. the study protocol does not have additional or particular requirement.|Participants|Count of Participants|164|164.0||||||
3842978|NCT01675635|3668277|B2|normal||Electrocardiogram test|the judgement of result normal, abnormal non clinical significant or abnormal clinical significant was made by the doctor according to the clinical practice. the study protocol does not have additional or particular requirement.|Participants|Count of Participants|76|76.0||||||
3842979|NCT01675635|3668278|B1|normal||Electrocardiogram test|the judgement of result normal, abnormal non clinical significant or abnormal clinical significant was made by the doctor according to the clinical practice. the study protocol does not have additional or particular requirement.|Participants|Count of Participants|88|88.0||||||
3842980|NCT01675635|3668276|B3|China||Region of Enrollment||Participants|Count of Participants|234|234.0||||||
3842981|NCT01675635|3668277|B2|China||Region of Enrollment||Participants|Count of Participants|117|117.0||||||
3842982|NCT01675635|3668278|B1|China||Region of Enrollment||Participants|Count of Participants|117|117.0||||||
3842983|NCT01675635|3668276|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3842984|NCT01675635|3668277|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842985|NCT01675635|3668278|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3842986|NCT01675635|3668276|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842987|NCT01675635|3668277|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842988|NCT01675635|3668278|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842989|NCT01675635|3668276|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842990|NCT01675635|3668277|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842991|NCT01675635|3668278|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842992|NCT01675635|3668276|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842995|NCT01675635|3668276|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842996|NCT01675635|3668277|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842997|NCT01675635|3668278|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3842998|NCT01675635|3668276|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|233|233.0||||||
3842999|NCT01675635|3668277|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|117|117.0||||||
3843000|NCT01675635|3668278|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|116|116.0||||||
3843001|NCT01675635|3668276|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843002|NCT01675635|3668277|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843003|NCT01675635|3668278|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843004|NCT01675635|3668276|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3843005|NCT01675635|3668277|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3843006|NCT01675635|3668278|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3843007|NCT01675635|3668276|B3||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
3843008|NCT01675635|3668277|B2||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3843009|NCT01675635|3668278|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3843010|NCT01675635|3668276|B3|||Age||years|Mean|43.37|43.37|Standard Deviation|10.77|10.77|||
3843011|NCT01675635|3668277|B2|||Age||years|Mean|43.29|43.29|Standard Deviation|10.53|10.53|||
3843012|NCT01675635|3668278|B1|||Age||years|Mean|43.44|43.44|Standard Deviation|11.06|11.06|||
3843013|NCT01675622|3668297|B3|||weight||kg|Mean|58.49|58.49|Standard Deviation|10.88|10.88|||
3843014|NCT01675622|3668298|B2|||weight||kg|Mean|58.34|58.34|Standard Deviation|11.01|11.01|||
3843015|NCT01675622|3668299|B1|||weight||kg|Mean|58.64|58.64|Standard Deviation|10.79|10.79|||
3843016|NCT01675622|3668297|B3|||height||centimeter|Mean|164.74|164.74|Standard Deviation|7.82|7.82|||
3843017|NCT01675622|3668298|B2|||height||centimeter|Mean|164.99|164.99|Standard Deviation|8.20|8.2|||
3843018|NCT01675622|3668299|B1|||height||centimeter|Mean|164.5|164.5|Standard Deviation|7.45|7.45|||
3843019|NCT01675622|3668297|B3|China||Region of Enrollment||Participants|Count of Participants|238|238.0||||||
3843020|NCT01675622|3668298|B2|China||Region of Enrollment||Participants|Count of Participants|118|118.0||||||
3843021|NCT01675622|3668299|B1|China||Region of Enrollment||Participants|Count of Participants|120|120.0||||||
3843022|NCT01675622|3668297|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843023|NCT01675622|3668298|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843024|NCT01675622|3668299|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843025|NCT01675622|3668297|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3843026|NCT01675622|3668298|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3843027|NCT01675622|3668299|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3843028|NCT01675622|3668297|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843029|NCT01675622|3668298|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843030|NCT01675622|3668299|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843031|NCT01675622|3668297|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843032|NCT01675622|3668298|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843033|NCT01675622|3668299|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843034|NCT01675622|3668297|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843035|NCT01675622|3668298|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843036|NCT01675622|3668299|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843037|NCT01675622|3668297|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|236|236.0||||||
3843038|NCT01675622|3668298|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|117|117.0||||||
3843039|NCT01675622|3668299|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
3843040|NCT01675622|3668297|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843041|NCT01675622|3668298|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843042|NCT01675622|3668299|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843043|NCT01675622|3668297|B3||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3843044|NCT01675622|3668298|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3843045|NCT01675622|3668299|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3843046|NCT01675622|3668297|B3||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3843047|NCT01675622|3668298|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3843048|NCT01675622|3668299|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3843049|NCT01675622|3668297|B3|||Age||years|Mean|56.83|56.83|Standard Deviation|12.50|12.5|||
3843050|NCT01675622|3668298|B2|||Age||years|Mean|57.05|57.05|Standard Deviation|12.07|12.07|||
3843051|NCT01675622|3668299|B1|||Age||years|Mean|56.62|56.62|Standard Deviation|12.96|12.96|||
3843052|NCT01675544|3668324|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
3843053|NCT01675544|3668324|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3843054|NCT01675544|3668324|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3843055|NCT01675544|3668324|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3843056|NCT01675544|3668324|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3843057|NCT01675544|3668324|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3843058|NCT01675531|3668329|B1||Male|Gender||Participants|Count of Participants|51|51.0||||||
3843059|NCT01675531|3668329|B1||Female|Gender||Participants|Count of Participants|21|21.0||||||
3843060|NCT01675531|3668329|B1|>70||Age, Customized||participants|Number|13|13.0||||||
3843061|NCT01675531|3668329|B1|60~69||Age, Customized||participants|Number|34|34.0||||||
3843062|NCT01675531|3668329|B1|50~59||Age, Customized||participants|Number|20|20.0||||||
3843063|NCT01675531|3668329|B1|40~49||Age, Customized||participants|Number|4|4.0||||||
3843064|NCT01675531|3668329|B1|30~39||Age, Customized||participants|Number|1|1.0||||||
3843065|NCT01675531|3668329|B1|18~29||Age, Customized||participants|Number|0|0.0||||||
3843066|NCT01675531|3668329|B1|||Age||years|Mean|62.97|62.97|Standard Deviation|8.99|8.99|||
3843067|NCT01675531|3668329|B1||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
3843068|NCT01675531|3668329|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3843069|NCT01675531|3668329|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3843070|NCT01675492|3668336|B1|United States||Region of Enrollment||Participants|Count of Participants|84|84.0||||||
3843071|NCT01675492|3668336|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3843072|NCT01675492|3668336|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843073|NCT01675492|3668336|B1||White|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3843074|NCT01675492|3668336|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3843075|NCT01675492|3668336|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843076|NCT01675492|3668336|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3843077|NCT01675492|3668336|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3843078|NCT01675492|3668336|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3843079|NCT01675492|3668336|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3843080|NCT01675492|3668336|B1|||Age||years|Mean|36.3|36.3|Standard Deviation|10.36|10.36|||
3843081|NCT01675479|3668341|B1|United States||Region of Enrollment||Participants|Count of Participants|69|69.0||||||
3843082|NCT01675479|3668341|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3843083|NCT01675479|3668341|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843084|NCT01675479|3668341|B1||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3843085|NCT01675479|3668341|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3843086|NCT01675479|3668341|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843087|NCT01675479|3668341|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3843088|NCT01675479|3668341|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843089|NCT01675479|3668341|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3843090|NCT01675479|3668341|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3843091|NCT01675479|3668341|B1|||Age||years|Mean|42.7|42.7|Standard Deviation|11.8|11.8|||
3843092|NCT01675453|3668346|B3|Russian Federation||Region of Enrollment||participants|Number|40|40.0||||||
3843093|NCT01675453|3668347|B2|Russian Federation||Region of Enrollment||participants|Number|20|20.0||||||
3843094|NCT01675453|3668348|B1|Russian Federation||Region of Enrollment||participants|Number|20|20.0||||||
3843095|NCT01675453|3668346|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3843096|NCT01675453|3668347|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3843097|NCT01675453|3668348|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3843098|NCT01675453|3668346|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3843099|NCT01675453|3668347|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3843100|NCT01675453|3668348|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3843101|NCT01675453|3668346|B3|||Age||years|Median|58|58.0|Inter-Quartile Range|||51.0|63.0|
3843102|NCT01675453|3668347|B2|||Age||years|Median|57|57.0|Inter-Quartile Range|||51.0|63.0|
3843103|NCT01675453|3668348|B1|||Age||years|Median|59|59.0|Inter-Quartile Range|||54.0|63.0|
3843104|NCT01675427|3668355|B1||Male|Sex: Female, Male||Participants|Count of Participants|2573|2573.0||||||
3843105|NCT01675427|3668355|B1||Female|Sex: Female, Male||Participants|Count of Participants|2043|2043.0||||||
3843106|NCT01675427|3668355|B1|||Age||years|Mean|49.1|49.1|Standard Deviation|12.87|12.87|||
3843107|NCT01675167|3668640|B3|United States||Region of Enrollment||participants|Number|491|491.0||||||
3843108|NCT01675167|3668641|B2|United States||Region of Enrollment||participants|Number|248|248.0||||||
3843109|NCT01675167|3668642|B1|United States||Region of Enrollment||participants|Number|243|243.0||||||
3843110|NCT01675167|3668640|B3||Male|Gender||Participants|Count of Participants|225|225.0||||||
3843111|NCT01675167|3668641|B2||Male|Gender||Participants|Count of Participants|112|112.0||||||
3843112|NCT01675167|3668642|B1||Male|Gender||Participants|Count of Participants|113|113.0||||||
3843113|NCT01675167|3668640|B3||Female|Gender||Participants|Count of Participants|266|266.0||||||
3843114|NCT01675167|3668641|B2||Female|Gender||Participants|Count of Participants|136|136.0||||||
3843115|NCT01675167|3668642|B1||Female|Gender||Participants|Count of Participants|130|130.0||||||
3843116|NCT01675167|3668640|B3|||Age||years|Median|54.0|54.0|Full Range|||23.0|79.0|
3843117|NCT01675167|3668641|B2|||Age||years|Median|55.0|55.0|Full Range|||23.0|79.0|
3843118|NCT01675167|3668642|B1|||Age||years|Median|53.0|53.0|Full Range|||27.0|78.0|
3843119|NCT01675167|3668640|B3||>=65 years|Age||Participants|Count of Participants|74|74.0||||||
3843120|NCT01675167|3668641|B2||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
3843121|NCT01675167|3668642|B1||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
3843122|NCT01675167|3668640|B3||Between 18 and 65 years|Age||Participants|Count of Participants|417|417.0||||||
3843123|NCT01675167|3668641|B2||Between 18 and 65 years|Age||Participants|Count of Participants|206|206.0||||||
3843124|NCT01675167|3668642|B1||Between 18 and 65 years|Age||Participants|Count of Participants|211|211.0||||||
3843125|NCT01675167|3668640|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3843126|NCT01675167|3668641|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3843127|NCT01675167|3668642|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3843128|NCT01675141|3668666|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3843129|NCT01675141|3668666|B1|Mexican, Cuban, Puerto Rican, Central/So. American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3843130|NCT01675141|3668666|B1|Not Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3843131|NCT01675141|3668666|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3843132|NCT01675141|3668666|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3843133|NCT01675141|3668666|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3843134|NCT01675141|3668666|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3843135|NCT01675141|3668666|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843136|NCT01675141|3668666|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843137|NCT01675141|3668666|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3843138|NCT01675141|3668666|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3843139|NCT01675141|3668666|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3843140|NCT01675141|3668666|B1|||Age||years|Mean|57.05|57.05|Standard Deviation|8.28|8.28|||
3843141|NCT01675141|3668666|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3843142|NCT01675141|3668666|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3843143|NCT01675141|3668666|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3843144|NCT01675128|3668676|B4|United States||Region of Enrollment||participants|Number|24|24.0||||||
3843145|NCT01675128|3668677|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3843146|NCT01675128|3668678|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3843147|NCT01675128|3668679|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3843148|NCT01675128|3668676|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843149|NCT01675128|3668677|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843150|NCT01675128|3668678|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843151|NCT01675128|3668679|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843152|NCT01675128|3668676|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843153|NCT01675128|3668677|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843154|NCT01675128|3668678|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843155|NCT01675128|3668679|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843156|NCT01675128|3668676|B4||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3843157|NCT01675128|3668677|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3843158|NCT01675128|3668678|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3843159|NCT01675128|3668679|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3843160|NCT01675128|3668676|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3843161|NCT01675128|3668677|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3843162|NCT01675128|3668678|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3843163|NCT01675128|3668679|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3843164|NCT01675128|3668676|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843165|NCT01675128|3668677|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843166|NCT01675128|3668678|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843167|NCT01675128|3668679|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843168|NCT01675128|3668676|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3843169|NCT01675128|3668677|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3843170|NCT01675128|3668678|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843171|NCT01675128|3668679|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843172|NCT01675128|3668676|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843173|NCT01675128|3668677|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843174|NCT01675128|3668678|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843175|NCT01675128|3668679|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843176|NCT01675128|3668676|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843177|NCT01675128|3668677|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843178|NCT01675128|3668678|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843179|NCT01675128|3668679|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843180|NCT01675128|3668676|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3843181|NCT01675128|3668677|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3843182|NCT01675128|3668678|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3843183|NCT01675128|3668679|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3843184|NCT01675128|3668676|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843185|NCT01675128|3668677|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843186|NCT01675128|3668678|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843187|NCT01675128|3668679|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843188|NCT01675128|3668676|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3843189|NCT01675128|3668677|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3843190|NCT01675128|3668678|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3843191|NCT01675128|3668679|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3843192|NCT01675128|3668676|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3843193|NCT01675128|3668677|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3843194|NCT01675128|3668678|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3843195|NCT01675128|3668679|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3843196|NCT01675128|3668676|B4|||Age||years|Median|62.7|62.7|Full Range|||43.4|79.6|
3843197|NCT01675128|3668677|B3|||Age||years|Median|60.6|60.6|Full Range|||50.4|72.7|
3843198|NCT01675128|3668678|B2|||Age||years|Median|65.7|65.7|Full Range|||43.37|79.64|
3843199|NCT01675128|3668679|B1|||Age||years|Median|61.6|61.6|Full Range|||54.7|73.15|
3843200|NCT01675128|3668676|B4||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3843201|NCT01675128|3668677|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3843202|NCT01675128|3668678|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3843203|NCT01675128|3668679|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3843204|NCT01675128|3668676|B4||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3843205|NCT01675128|3668677|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3843206|NCT01675128|3668678|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3843207|NCT01675128|3668679|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3843208|NCT01675128|3668676|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3843209|NCT01675128|3668677|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3843210|NCT01675128|3668678|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3843211|NCT01675128|3668679|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3843212|NCT01675063|3668703|B1|United States||Region of Enrollment||participants|Number|77|77.0||||||
3843213|NCT01675063|3668703|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3843214|NCT01675063|3668703|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3843215|NCT01675063|3668703|B1|||Age||years|Mean|69|69.0|Full Range|||35.0|90.0|
3843216|NCT01675063|3668703|B1||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
3843217|NCT01675063|3668703|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3843218|NCT01675063|3668703|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3843219|NCT01675050|3668707|B3|Baseline prior to Second Treatment||Improvement in Abdominal Pain|This is a pain scale derived from the abdominal pain Index child version, where on a scale of zero to 10, zero represents no pain, and ten represents the most pain possible|units on a scale|Mean|6.33|6.33|Standard Deviation|2.52|2.52|||
3843220|NCT01675050|3668708|B2|Baseline prior to Second Treatment||Improvement in Abdominal Pain|This is a pain scale derived from the abdominal pain Index child version, where on a scale of zero to 10, zero represents no pain, and ten represents the most pain possible|units on a scale|Mean|6.5|6.5|Standard Deviation|3.45|3.45|||
3843221|NCT01675050|3668709|B1|Baseline prior to Second Treatment||Improvement in Abdominal Pain|This is a pain scale derived from the abdominal pain Index child version, where on a scale of zero to 10, zero represents no pain, and ten represents the most pain possible|units on a scale|Mean|6|6.0|Standard Deviation|0|0.0|||
3843222|NCT01675050|3668707|B3|Baseline prior to First Treatment||Improvement in Abdominal Pain|This is a pain scale derived from the abdominal pain Index child version, where on a scale of zero to 10, zero represents no pain, and ten represents the most pain possible|units on a scale|Mean|6.25|6.25|Standard Deviation|4.35|4.35|||
3843223|NCT01675050|3668708|B2|Baseline prior to First Treatment||Improvement in Abdominal Pain|This is a pain scale derived from the abdominal pain Index child version, where on a scale of zero to 10, zero represents no pain, and ten represents the most pain possible|units on a scale|Mean|8.5|8.5|Standard Deviation|2.12|2.12|||
3843224|NCT01675050|3668709|B1|Baseline prior to First Treatment||Improvement in Abdominal Pain|This is a pain scale derived from the abdominal pain Index child version, where on a scale of zero to 10, zero represents no pain, and ten represents the most pain possible|units on a scale|Mean|4|4.0|Standard Deviation|5.66|5.66|||
3843225|NCT01675050|3668707|B3|Baseline prior to Second Treatment||Pressure Pain Threshold|Increasing pressures are applied with a pressure plunger to the participants' thumbnail. The pressure at which the participant said that s/he felt pain is noted. The pressure is measured in in kilograms divided by centimeters squared.|kg/cm^2|Mean|1.13|1.13|Standard Deviation|.16|0.16|||
3843226|NCT01675050|3668708|B2|Baseline prior to Second Treatment||Pressure Pain Threshold|Increasing pressures are applied with a pressure plunger to the participants' thumbnail. The pressure at which the participant said that s/he felt pain is noted. The pressure is measured in in kilograms divided by centimeters squared.|kg/cm^2|Mean|1.08|1.08|Standard Deviation|.18|0.18|||
3843227|NCT01675050|3668709|B1|Baseline prior to Second Treatment||Pressure Pain Threshold|Increasing pressures are applied with a pressure plunger to the participants' thumbnail. The pressure at which the participant said that s/he felt pain is noted. The pressure is measured in in kilograms divided by centimeters squared.|kg/cm^2|Mean|1.25|1.25|Standard Deviation|0|0.0|||
3843228|NCT01675050|3668707|B3|Baseline prior to First Treatment||Pressure Pain Threshold|Increasing pressures are applied with a pressure plunger to the participants' thumbnail. The pressure at which the participant said that s/he felt pain is noted. The pressure is measured in in kilograms divided by centimeters squared.|kg/cm^2|Mean|1.51|1.51|Standard Deviation|.99|0.99|||
3843229|NCT01675050|3668708|B2|Baseline prior to First Treatment||Pressure Pain Threshold|Increasing pressures are applied with a pressure plunger to the participants' thumbnail. The pressure at which the participant said that s/he felt pain is noted. The pressure is measured in in kilograms divided by centimeters squared.|kg/cm^2|Mean|1.28|1.28|Standard Deviation|.53|0.53|||
3843230|NCT01675050|3668709|B1|Baseline prior to First Treatment||Pressure Pain Threshold|Increasing pressures are applied with a pressure plunger to the participants' thumbnail. The pressure at which the participant said that s/he felt pain is noted. The pressure is measured in in kilograms divided by centimeters squared.|kg/cm^2|Mean|1.75|1.75|Standard Deviation|2|2.0|||
3843231|NCT01675050|3668707|B3|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3843232|NCT01675050|3668708|B2|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3843233|NCT01675050|3668709|B1|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3843234|NCT01675050|3668707|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3843235|NCT01675050|3668708|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3843236|NCT01675050|3668709|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3843237|NCT01675050|3668707|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3843238|NCT01675050|3668708|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3843239|NCT01675050|3668709|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3843240|NCT01675050|3668707|B3|||Age||years|Mean|11.5|11.5|Full Range|||9.0|16.0|
3843241|NCT01675050|3668708|B2|||Age||years|Mean|10.5|10.5|Full Range|||9.0|12.0|
3843242|NCT01675050|3668709|B1|||Age||years|Mean|12.5|12.5|Full Range|||9.0|16.0|
3843243|NCT01675011|3668718|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3843244|NCT01675011|3668719|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3843245|NCT01675011|3668720|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3843246|NCT01675011|3668718|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843247|NCT01675011|3668719|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843248|NCT01675011|3668720|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843249|NCT01675011|3668718|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843250|NCT01675011|3668719|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843251|NCT01675011|3668720|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843252|NCT01675011|3668718|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3843253|NCT01675011|3668719|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843254|NCT01675011|3668720|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3843255|NCT01675011|3668718|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3843256|NCT01675011|3668719|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3843257|NCT01675011|3668720|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3843258|NCT01675011|3668718|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843259|NCT01675011|3668719|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843260|NCT01675011|3668720|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843261|NCT01675011|3668718|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843262|NCT01675011|3668719|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843263|NCT01675011|3668720|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843264|NCT01675011|3668718|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843265|NCT01675011|3668719|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843266|NCT01675011|3668720|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843267|NCT01675011|3668718|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843268|NCT01675011|3668719|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843269|NCT01675011|3668720|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843270|NCT01675011|3668718|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3843271|NCT01675011|3668719|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3843272|NCT01675011|3668720|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3843273|NCT01675011|3668718|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843274|NCT01675011|3668719|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843275|NCT01675011|3668720|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843276|NCT01675011|3668718|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3843277|NCT01675011|3668719|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3843278|NCT01675011|3668720|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3843279|NCT01675011|3668718|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3843280|NCT01675011|3668719|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3843281|NCT01675011|3668720|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3843282|NCT01675011|3668718|B3|||Age||years|Mean|45|45.0|Full Range|||40.0|49.0|
3843283|NCT01675011|3668719|B2|||Age||years|Mean|45|45.0|Full Range|||45.0|45.0|
3843284|NCT01675011|3668720|B1|||Age||years|Mean|45|45.0|Full Range|||40.0|49.0|
3843285|NCT01674725|3668727|B3||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3843286|NCT01674725|3668728|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3843287|NCT01674725|3668729|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3843288|NCT01674725|3668727|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3843289|NCT01674725|3668728|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3843290|NCT01674725|3668729|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3843291|NCT01674725|3668727|B3|||Age||years|Mean|54.2|54.2|Standard Deviation|10.67|10.67|||
3843292|NCT01674725|3668728|B2|||Age||years|Mean|54.2|54.2|Standard Deviation|10.51|10.51|||
3843293|NCT01674725|3668729|B1|||Age||years|Mean|54.2|54.2|Standard Deviation|10.90|10.9|||
3843294|NCT01674712|3668744|B6|||HDL Cholesterol (mmol/L)||mmol/L|Mean|1.2|1.2|Standard Deviation|0.3|0.3|||
3843295|NCT01674712|3668745|B5|||HDL Cholesterol (mmol/L)||mmol/L|Mean|1.2|1.2|Standard Deviation|0.3|0.3|||
3843296|NCT01674712|3668746|B4|||HDL Cholesterol (mmol/L)||mmol/L|Mean|1.2|1.2|Standard Deviation|0.3|0.3|||
3843297|NCT01674712|3668747|B3|||HDL Cholesterol (mmol/L)||mmol/L|Mean|1.2|1.2|Standard Deviation|0.3|0.3|||
3843298|NCT01674712|3668748|B2|||HDL Cholesterol (mmol/L)||mmol/L|Mean|1.2|1.2|Standard Deviation|0.3|0.3|||
3843299|NCT01674712|3668749|B1|||HDL Cholesterol (mmol/L)||mmol/L|Mean|1.1|1.1|Standard Deviation|0.3|0.3|||
3843300|NCT01674712|3668744|B6|||LDL Cholesterol (mmol/L)||mmol/L|Mean|2.7|2.7|Standard Deviation|0.5|0.5|||
3843301|NCT01674712|3668745|B5|||LDL Cholesterol (mmol/L)||mmol/L|Mean|2.7|2.7|Standard Deviation|0.5|0.5|||
3843302|NCT01674712|3668746|B4|||LDL Cholesterol (mmol/L)||mmol/L|Mean|2.7|2.7|Standard Deviation|0.4|0.4|||
3843303|NCT01674712|3668747|B3|||LDL Cholesterol (mmol/L)||mmol/L|Mean|2.6|2.6|Standard Deviation|0.4|0.4|||
3843304|NCT01674712|3668748|B2|||LDL Cholesterol (mmol/L)||mmol/L|Mean|2.6|2.6|Standard Deviation|0.4|0.4|||
3843305|NCT01674712|3668749|B1|||LDL Cholesterol (mmol/L)||mmol/L|Mean|2.6|2.6|Standard Deviation|0.5|0.5|||
3843306|NCT01674712|3668744|B6|||Triglycerides (mmol/L)||mmol/L|Mean|2.7|2.7|Standard Deviation|1.1|1.1|||
3843307|NCT01674712|3668745|B5|||Triglycerides (mmol/L)||mmol/L|Mean|2.9|2.9|Standard Deviation|1.3|1.3|||
3843308|NCT01674712|3668746|B4|||Triglycerides (mmol/L)||mmol/L|Mean|2.7|2.7|Standard Deviation|1.0|1.0|||
3843309|NCT01674712|3668747|B3|||Triglycerides (mmol/L)||mmol/L|Mean|2.7|2.7|Standard Deviation|1.4|1.4|||
3843310|NCT01674712|3668748|B2|||Triglycerides (mmol/L)||mmol/L|Mean|2.5|2.5|Standard Deviation|1.0|1.0|||
3843311|NCT01674712|3668749|B1|||Triglycerides (mmol/L)||mmol/L|Mean|2.8|2.8|Standard Deviation|1.1|1.1|||
3843312|NCT01674712|3668744|B6|Germany||Region of Enrollment||participants|Number|154|154.0||||||
3843313|NCT01674712|3668745|B5|Germany||Region of Enrollment||participants|Number|33|33.0||||||
3843314|NCT01674712|3668746|B4|Germany||Region of Enrollment||participants|Number|31|31.0||||||
3843315|NCT01674712|3668747|B3|Germany||Region of Enrollment||participants|Number|31|31.0||||||
3843316|NCT01674712|3668748|B2|Germany||Region of Enrollment||participants|Number|29|29.0||||||
3843317|NCT01674712|3668749|B1|Germany||Region of Enrollment||participants|Number|30|30.0||||||
3843318|NCT01674712|3668744|B6|Russian Federation||Region of Enrollment||participants|Number|84|84.0||||||
3843319|NCT01674712|3668745|B5|Russian Federation||Region of Enrollment||participants|Number|17|17.0||||||
3843320|NCT01674712|3668746|B4|Russian Federation||Region of Enrollment||participants|Number|16|16.0||||||
3843321|NCT01674712|3668747|B3|Russian Federation||Region of Enrollment||participants|Number|16|16.0||||||
3843322|NCT01674712|3668748|B2|Russian Federation||Region of Enrollment||participants|Number|17|17.0||||||
3843323|NCT01674712|3668749|B1|Russian Federation||Region of Enrollment||participants|Number|18|18.0||||||
3843324|NCT01674712|3668744|B6|Romania||Region of Enrollment||participants|Number|27|27.0||||||
3843325|NCT01674712|3668745|B5|Romania||Region of Enrollment||participants|Number|4|4.0||||||
3843326|NCT01674712|3668746|B4|Romania||Region of Enrollment||participants|Number|5|5.0||||||
3843327|NCT01674712|3668747|B3|Romania||Region of Enrollment||participants|Number|6|6.0||||||
3843328|NCT01674712|3668748|B2|Romania||Region of Enrollment||participants|Number|6|6.0||||||
3843329|NCT01674712|3668749|B1|Romania||Region of Enrollment||participants|Number|6|6.0||||||
3843330|NCT01674712|3668744|B6|Poland||Region of Enrollment||participants|Number|41|41.0||||||
3843331|NCT01674712|3668745|B5|Poland||Region of Enrollment||participants|Number|7|7.0||||||
3843332|NCT01674712|3668746|B4|Poland||Region of Enrollment||participants|Number|10|10.0||||||
3843333|NCT01674712|3668747|B3|Poland||Region of Enrollment||participants|Number|8|8.0||||||
3843334|NCT01674712|3668748|B2|Poland||Region of Enrollment||participants|Number|9|9.0||||||
3843335|NCT01674712|3668749|B1|Poland||Region of Enrollment||participants|Number|7|7.0||||||
3843336|NCT01674712|3668744|B6|Argentina||Region of Enrollment||participants|Number|101|101.0||||||
3843337|NCT01674712|3668745|B5|Argentina||Region of Enrollment||participants|Number|21|21.0||||||
3843338|NCT01674712|3668746|B4|Argentina||Region of Enrollment||participants|Number|20|20.0||||||
3843339|NCT01674712|3668747|B3|Argentina||Region of Enrollment||participants|Number|19|19.0||||||
3843340|NCT01674712|3668748|B2|Argentina||Region of Enrollment||participants|Number|22|22.0||||||
3843341|NCT01674712|3668749|B1|Argentina||Region of Enrollment||participants|Number|19|19.0||||||
3843342|NCT01674712|3668744|B6|Mexico||Region of Enrollment||participants|Number|39|39.0||||||
3843343|NCT01674712|3668745|B5|Mexico||Region of Enrollment||participants|Number|8|8.0||||||
3843344|NCT01674712|3668746|B4|Mexico||Region of Enrollment||participants|Number|7|7.0||||||
3843345|NCT01674712|3668747|B3|Mexico||Region of Enrollment||participants|Number|8|8.0||||||
3843346|NCT01674712|3668748|B2|Mexico||Region of Enrollment||participants|Number|9|9.0||||||
3843347|NCT01674712|3668749|B1|Mexico||Region of Enrollment||participants|Number|7|7.0||||||
3843348|NCT01674712|3668744|B6|Czech Republic||Region of Enrollment||participants|Number|110|110.0||||||
3843349|NCT01674712|3668745|B5|Czech Republic||Region of Enrollment||participants|Number|21|21.0||||||
3843350|NCT01674712|3668746|B4|Czech Republic||Region of Enrollment||participants|Number|23|23.0||||||
3843351|NCT01674712|3668747|B3|Czech Republic||Region of Enrollment||participants|Number|22|22.0||||||
3843352|NCT01674712|3668748|B2|Czech Republic||Region of Enrollment||participants|Number|22|22.0||||||
3843353|NCT01674712|3668749|B1|Czech Republic||Region of Enrollment||participants|Number|22|22.0||||||
3843354|NCT01674712|3668744|B6||Male|Sex: Female, Male||Participants|Count of Participants|358|358.0||||||
3843355|NCT01674712|3668745|B5||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3843356|NCT01674712|3668746|B4||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3843357|NCT01674712|3668747|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3843358|NCT01674712|3668748|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3843359|NCT01674712|3668749|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3843360|NCT01674712|3668744|B6||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
3843361|NCT01674712|3668745|B5||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3843362|NCT01674712|3668746|B4||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3843363|NCT01674712|3668747|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3843364|NCT01674712|3668748|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3843365|NCT01674712|3668749|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3843366|NCT01674712|3668744|B6|||Age||years|Mean|60.0|60.0|Standard Deviation|9.1|9.1|||
3843367|NCT01674712|3668745|B5|||Age||years|Mean|60.4|60.4|Standard Deviation|9.0|9.0|||
3843368|NCT01674712|3668746|B4|||Age||years|Mean|59.3|59.3|Standard Deviation|9.1|9.1|||
3843369|NCT01674712|3668747|B3|||Age||years|Mean|60.4|60.4|Standard Deviation|8.1|8.1|||
3843370|NCT01674712|3668748|B2|||Age||years|Mean|60.5|60.5|Standard Deviation|9.3|9.3|||
3843371|NCT01674712|3668749|B1|||Age||years|Mean|59.6|59.6|Standard Deviation|10|10.0|||
3843372|NCT01674647|3668775|B3|||CHA 2 DS 2 VASc score|"Predicts clinical risk of stroke and thromboembolism in atrial fibrillation incorporating these risk factors: Congestive heart failure/left ventricular dysfunction, Hypertension, Age >= 75 years, Diabetes mellitus, Stroke/transient ischemic attack/thromboembolism, Vascular disease (prior myocardial infarction, peripheral artery disease, or aortic plaque), Age 65 - 74 years, Sex category (i.e., female). Total score ranged from 0 to 8, with 0 (or 1 if female only)= Low risk ; 1 (except for female gender alone)= moderate risk and >=2=high risk."|units on scale|Mean|2.3|2.3|Standard Deviation|1.6|1.6|||
3843373|NCT01674647|3668776|B2|||CHA 2 DS 2 VASc score|"Predicts clinical risk of stroke and thromboembolism in atrial fibrillation incorporating these risk factors: Congestive heart failure/left ventricular dysfunction, Hypertension, Age >= 75 years, Diabetes mellitus, Stroke/transient ischemic attack/thromboembolism, Vascular disease (prior myocardial infarction, peripheral artery disease, or aortic plaque), Age 65 - 74 years, Sex category (i.e., female). Total score ranged from 0 to 8, with 0 (or 1 if female only)= Low risk ; 1 (except for female gender alone)= moderate risk and >=2=high risk."|units on scale|Mean|2.3|2.3|Standard Deviation|1.6|1.6|||
3843374|NCT01674647|3668777|B1|||CHA 2 DS 2 VASc score|"Predicts clinical risk of stroke and thromboembolism in atrial fibrillation incorporating these risk factors: Congestive heart failure/left ventricular dysfunction, Hypertension, Age >= 75 years, Diabetes mellitus, Stroke/transient ischemic attack/thromboembolism, Vascular disease (prior myocardial infarction, peripheral artery disease, or aortic plaque), Age 65 - 74 years, Sex category (i.e., female). Total score ranged from 0 to 8, with 0 (or 1 if female only)= Low risk ; 1 (except for female gender alone)= moderate risk and >=2=high risk."|units on scale|Mean|2.3|2.3|Standard Deviation|1.6|1.6|||
3843375|NCT01674647|3668775|B3|||CHADS 2 score|"Predicts clinical risk of stroke and thromboembolism in atrial fibrillation incorporating these risk factors: Congestive heart failure, Hypertension, Age [greater than or equal to (>=)75 years], Diabetes mellitus, Stroke/transient ischemic attack. Total score ranged from 0 to 6, with 0= low risk, 1= moderate risk and >=2= high risk."|units on scale|Mean|1.4|1.4|Standard Deviation|1.1|1.1|||
3843433|NCT01674478|3668860|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3843376|NCT01674647|3668776|B2|||CHADS 2 score|"Predicts clinical risk of stroke and thromboembolism in atrial fibrillation incorporating these risk factors: Congestive heart failure, Hypertension, Age [greater than or equal to (>=)75 years], Diabetes mellitus, Stroke/transient ischemic attack. Total score ranged from 0 to 6, with 0= low risk, 1= moderate risk and >=2= high risk."|units on scale|Mean|1.4|1.4|Standard Deviation|1.1|1.1|||
3843377|NCT01674647|3668777|B1|||CHADS 2 score|"Predicts clinical risk of stroke and thromboembolism in atrial fibrillation incorporating these risk factors: Congestive heart failure, Hypertension, Age [greater than or equal to (>=)75 years], Diabetes mellitus, Stroke/transient ischemic attack. Total score ranged from 0 to 6, with 0= low risk, 1= moderate risk and >=2= high risk."|units on scale|Mean|1.3|1.3|Standard Deviation|1.1|1.1|||
3843378|NCT01674647|3668775|B3||Male|Sex: Female, Male||Participants|Count of Participants|1094|1094.0||||||
3843379|NCT01674647|3668776|B2||Male|Sex: Female, Male||Participants|Count of Participants|367|367.0||||||
3843380|NCT01674647|3668777|B1||Male|Sex: Female, Male||Participants|Count of Participants|727|727.0||||||
3843381|NCT01674647|3668775|B3||Female|Sex: Female, Male||Participants|Count of Participants|410|410.0||||||
3843382|NCT01674647|3668776|B2||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3843383|NCT01674647|3668777|B1||Female|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
3843384|NCT01674647|3668775|B3|||Age||years|Mean|64.9|64.9|Standard Deviation|10.5|10.5|||
3843385|NCT01674647|3668776|B2|||Age||years|Mean|64.7|64.7|Standard Deviation|10.5|10.5|||
3843386|NCT01674647|3668777|B1|||Age||years|Mean|64.9|64.9|Standard Deviation|10.6|10.6|||
3843387|NCT01674634|3668804|B1|United Kingdom||Region of Enrollment||participants|Number|34|34.0||||||
3843388|NCT01674634|3668804|B1|Sweden||Region of Enrollment||participants|Number|50|50.0||||||
3843389|NCT01674634|3668804|B1|Denmark||Region of Enrollment||participants|Number|87|87.0||||||
3843390|NCT01674634|3668804|B1|New Zealand||Region of Enrollment||participants|Number|70|70.0||||||
3843391|NCT01674634|3668804|B1|Australia||Region of Enrollment||participants|Number|196|196.0||||||
3843392|NCT01674634|3668804|B1|United States||Region of Enrollment||participants|Number|278|278.0||||||
3843393|NCT01674634|3668804|B1||Male|Sex: Female, Male||Participants|Count of Participants|616|616.0||||||
3843394|NCT01674634|3668804|B1||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3843395|NCT01674634|3668804|B1|||Age||years|Mean|64.0|64.0|Standard Deviation|9.26|9.26|||
3843396|NCT01674634|3668804|B1||>=65 years|Age||Participants|Count of Participants|367|367.0||||||
3843397|NCT01674634|3668804|B1||Between 18 and 65 years|Age||Participants|Count of Participants|348|348.0||||||
3843398|NCT01674634|3668804|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3843399|NCT01674621|3668819|B6||Male|Gender||Participants|Count of Participants|0|0.0||||||
3843400|NCT01674621|3668820|B5||Male|Gender||Participants|Count of Participants|0|0.0||||||
3843401|NCT01674621|3668821|B4||Male|Gender||Participants|Count of Participants|0|0.0||||||
3843402|NCT01674621|3668822|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3843403|NCT01674621|3668823|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3843404|NCT01674621|3668824|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3843405|NCT01674621|3668819|B6||Female|Gender||Participants|Count of Participants|231|231.0||||||
3843406|NCT01674621|3668820|B5||Female|Gender||Participants|Count of Participants|49|49.0||||||
3843407|NCT01674621|3668821|B4||Female|Gender||Participants|Count of Participants|43|43.0||||||
3843408|NCT01674621|3668822|B3||Female|Gender||Participants|Count of Participants|46|46.0||||||
3843409|NCT01674621|3668823|B2||Female|Gender||Participants|Count of Participants|47|47.0||||||
3843410|NCT01674621|3668824|B1||Female|Gender||Participants|Count of Participants|46|46.0||||||
3843411|NCT01674621|3668819|B6|||Age||years|Mean|66.2|66.2|Standard Deviation|5.87|5.87|||
3843412|NCT01674621|3668820|B5|||Age||years|Mean|66.4|66.4|Standard Deviation|5.48|5.48|||
3843413|NCT01674621|3668821|B4|||Age||years|Mean|66.3|66.3|Standard Deviation|6.46|6.46|||
3843414|NCT01674621|3668822|B3|||Age||years|Mean|65.7|65.7|Standard Deviation|5.26|5.26|||
3843415|NCT01674621|3668823|B2|||Age||years|Mean|65.9|65.9|Standard Deviation|4.83|4.83|||
3843416|NCT01674621|3668824|B1|||Age||years|Mean|66.5|66.5|Standard Deviation|7.27|7.27|||
3843417|NCT01674569|3668850|B1|||Best corrected visual acuity||Number of letters|Mean|62.4|62.4|Standard Deviation|12.6|12.6|||
3843418|NCT01674569|3668850|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3843419|NCT01674569|3668850|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843420|NCT01674569|3668850|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843421|NCT01674569|3668850|B1||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3843422|NCT01674569|3668850|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3843423|NCT01674569|3668850|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843424|NCT01674569|3668850|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843425|NCT01674569|3668850|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843426|NCT01674569|3668850|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3843427|NCT01674569|3668850|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3843428|NCT01674569|3668850|B1|||Age||years|Mean|76.8|76.8|Standard Deviation|8.5|8.5|||
3843429|NCT01674478|3668859|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3843430|NCT01674478|3668860|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3843431|NCT01674478|3668861|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3843432|NCT01674478|3668859|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3843434|NCT01674478|3668861|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3843435|NCT01674478|3668859|B3|||Age|values represent the gestational age|weeks|Mean|26.1|26.1|Standard Deviation|2.0|2.0|||
3843436|NCT01674478|3668860|B2|||Age|values represent the gestational age|weeks|Mean|25.9|25.9|Standard Deviation|2.0|2.0|||
3843437|NCT01674478|3668861|B1|||Age|values represent the gestational age|weeks|Mean|26.3|26.3|Standard Deviation|2.0|2.0|||
3843438|NCT01674062|3668874|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3843439|NCT01674062|3668875|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3843440|NCT01674062|3668876|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3843441|NCT01674062|3668874|B3||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3843442|NCT01674062|3668875|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3843443|NCT01674062|3668876|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3843444|NCT01674062|3668874|B3|||Age||years|Mean|54.3|54.3|Standard Deviation|11.37|11.37|||
3843445|NCT01674062|3668875|B2|||Age||years|Mean|53.0|53.0|Standard Deviation|7.95|7.95|||
3843446|NCT01674062|3668876|B1|||Age||years|Mean|54.9|54.9|Standard Deviation|12.60|12.6|||
3843447|NCT01674010|3668892|B1|Europe||Region of Enrollment||participants|Number|99|99.0||||||
3843448|NCT01674010|3668892|B1|North America||Region of Enrollment||participants|Number|210|210.0||||||
3843449|NCT01674010|3668892|B1|Unknown Phase 2 ELND005 500 BID||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3843450|NCT01674010|3668892|B1|Unknown Phase 2 Placebo||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3843451|NCT01674010|3668892|B1|Unknown Phase 1||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3843452|NCT01674010|3668892|B1|Not Hispanic or Latino Phase 2 ELND005 500 BID||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
3843453|NCT01674010|3668892|B1|Not Hispanic or Latino Phase 2 Placebo||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
3843454|NCT01674010|3668892|B1|Not Hispanic or Latino Phase 1||Race/Ethnicity, Customized||participants|Number|284|284.0||||||
3843455|NCT01674010|3668892|B1|Hispanic or Latino Phase 2 ELND005 500 BID||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3843456|NCT01674010|3668892|B1|Hispanic or Latino Phase 2 Placebo||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3843457|NCT01674010|3668892|B1|Hispanic or Latino Phase 1||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3843458|NCT01674010|3668892|B1|Phase 2 ELND005 500 BID Female||Sex/Gender, Customized||participants|Number|32|32.0||||||
3843459|NCT01674010|3668892|B1|Phase 2 ELND005 500 BID Male||Sex/Gender, Customized||participants|Number|32|32.0||||||
3843460|NCT01674010|3668892|B1|Phase 2 Placebo Female||Sex/Gender, Customized||participants|Number|31|31.0||||||
3843461|NCT01674010|3668892|B1|Phase 2 Placebo Male||Sex/Gender, Customized||participants|Number|34|34.0||||||
3843462|NCT01674010|3668892|B1|Phase 1 Female||Sex/Gender, Customized||participants|Number|163|163.0||||||
3843463|NCT01674010|3668892|B1|Phase 1 Male||Sex/Gender, Customized||participants|Number|146|146.0||||||
3843464|NCT01674010|3668892|B1|Phase 2 ELND005 500mg BID(n=64)||Age||years|Mean|44.6|44.6|Standard Deviation|10.61|10.61|||
3843465|NCT01674010|3668892|B1|Phase 2 Placebo (n=65)||Age||years|Mean|44.5|44.5|Standard Deviation|10.65|10.65|||
3843466|NCT01674010|3668892|B1|Phase 1(n=309)||Age||years|Mean|44.3|44.3|Standard Deviation|11.09|11.09|||
3843467|NCT01673984|3668911|B3|Retired||Employment status/Occupation||participants|Number|18|18.0||||||
3843468|NCT01673984|3668912|B2|Retired||Employment status/Occupation||participants|Number|6|6.0||||||
3843469|NCT01673984|3668913|B1|Retired||Employment status/Occupation||participants|Number|12|12.0||||||
3843470|NCT01673984|3668911|B3|Employed||Employment status/Occupation||participants|Number|3|3.0||||||
3843471|NCT01673984|3668912|B2|Employed||Employment status/Occupation||participants|Number|1|1.0||||||
3843472|NCT01673984|3668913|B1|Employed||Employment status/Occupation||participants|Number|2|2.0||||||
3843473|NCT01673984|3668911|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3843474|NCT01673984|3668912|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3843475|NCT01673984|3668913|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3843476|NCT01673984|3668911|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3843477|NCT01673984|3668912|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3843478|NCT01673984|3668913|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3843479|NCT01673984|3668911|B3|||Age||years|Mean|77.7|77.7|Standard Deviation|6.7|6.7|||
3843480|NCT01673984|3668912|B2|||Age||years|Mean|78.7|78.7|Standard Deviation|9.3|9.3|||
3843481|NCT01673984|3668913|B1|||Age||years|Mean|77.2|77.2|Standard Deviation|5.4|5.4|||
3843482|NCT01673919|3668932|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3843483|NCT01673919|3668932|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3843484|NCT01673919|3668932|B1|18 to 64 years||Age, Customized||participants|Number|2|2.0||||||
3843485|NCT01673919|3668932|B1|12 to 17 years||Age, Customized||participants|Number|2|2.0||||||
3843486|NCT01673919|3668932|B1|2 to 11 years||Age, Customized||participants|Number|3|3.0||||||
3843487|NCT01673893|3668954|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3843488|NCT01673893|3668955|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3843489|NCT01673893|3668956|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3843490|NCT01673893|3668954|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3843491|NCT01673893|3668955|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3843492|NCT01673893|3668956|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3843493|NCT01673893|3668954|B3|>= 75 Years||Age, Customized||years|Number|5|5.0||||||
3843494|NCT01673893|3668955|B2|>= 75 Years||Age, Customized||years|Number|1|1.0||||||
3843495|NCT01673893|3668956|B1|>= 75 Years||Age, Customized||years|Number|4|4.0||||||
3843496|NCT01673893|3668954|B3|65 to 75 years||Age, Customized||years|Number|15|15.0||||||
3843497|NCT01673893|3668955|B2|65 to 75 years||Age, Customized||years|Number|6|6.0||||||
3843498|NCT01673893|3668956|B1|65 to 75 years||Age, Customized||years|Number|9|9.0||||||
3843499|NCT01673893|3668954|B3|50 to 65 years||Age, Customized||years|Number|32|32.0||||||
3843500|NCT01673893|3668955|B2|50 to 65 years||Age, Customized||years|Number|8|8.0||||||
3843501|NCT01673893|3668956|B1|50 to 65 years||Age, Customized||years|Number|24|24.0||||||
3843502|NCT01673893|3668954|B3|<50 years||Age, Customized||years|Number|7|7.0||||||
3843503|NCT01673893|3668955|B2|<50 years||Age, Customized||years|Number|1|1.0||||||
3843504|NCT01673893|3668956|B1|<50 years||Age, Customized||years|Number|6|6.0||||||
3843505|NCT01673867|3668962|B3|PD-L1 expression >=1%||PD-L1 Expression||participants|Number|246|246.0||||||
3843506|NCT01673867|3668963|B2|PD-L1 expression >=1%||PD-L1 Expression||participants|Number|123|123.0||||||
3843507|NCT01673867|3668964|B1|PD-L1 expression >=1%||PD-L1 Expression||participants|Number|123|123.0||||||
3843508|NCT01673867|3668962|B3|PD-L1 expression <1%||PD-L1 Expression||participants|Number|209|209.0||||||
3843509|NCT01673867|3668963|B2|PD-L1 expression <1%||PD-L1 Expression||participants|Number|101|101.0||||||
3843510|NCT01673867|3668964|B1|PD-L1 expression <1%||PD-L1 Expression||participants|Number|108|108.0||||||
3843511|NCT01673867|3668962|B3|PD-L1 not quantifiable at baseline||PD-L1 Expression||participants|Number|127|127.0||||||
3843512|NCT01673867|3668963|B2|PD-L1 not quantifiable at baseline||PD-L1 Expression||participants|Number|66|66.0||||||
3843513|NCT01673867|3668964|B1|PD-L1 not quantifiable at baseline||PD-L1 Expression||participants|Number|61|61.0||||||
3843514|NCT01673867|3668962|B3||Male|Sex: Female, Male||Participants|Count of Participants|319|319.0||||||
3843515|NCT01673867|3668963|B2||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3843516|NCT01673867|3668964|B1||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3843517|NCT01673867|3668962|B3||Female|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
3843518|NCT01673867|3668963|B2||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3843519|NCT01673867|3668964|B1||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3843520|NCT01673867|3668962|B3|>= 85||Age, Customized||participants|Number|2|2.0||||||
3843521|NCT01673867|3668963|B2|>= 85||Age, Customized||participants|Number|2|2.0||||||
3843522|NCT01673867|3668964|B1|>= 85||Age, Customized||participants|Number|0|0.0||||||
3843523|NCT01673867|3668962|B3|>= 75 AND < 85||Age, Customized||participants|Number|41|41.0||||||
3843524|NCT01673867|3668963|B2|>= 75 AND < 85||Age, Customized||participants|Number|21|21.0||||||
3843525|NCT01673867|3668964|B1|>= 75 AND < 85||Age, Customized||participants|Number|20|20.0||||||
3843526|NCT01673867|3668962|B3|>= 65 AND < 75||Age, Customized||participants|Number|200|200.0||||||
3843527|NCT01673867|3668963|B2|>= 65 AND < 75||Age, Customized||participants|Number|112|112.0||||||
3843528|NCT01673867|3668964|B1|>= 65 AND < 75||Age, Customized||participants|Number|88|88.0||||||
3843529|NCT01673867|3668962|B3|< 65||Age, Customized||participants|Number|339|339.0||||||
3843530|NCT01673867|3668963|B2|< 65||Age, Customized||participants|Number|155|155.0||||||
3843531|NCT01673867|3668964|B1|< 65||Age, Customized||participants|Number|184|184.0||||||
3843532|NCT01673867|3668962|B3|||Age||years|Mean|61.6|61.6|Standard Deviation|9.53|9.53|||
3843533|NCT01673867|3668963|B2|||Age||years|Mean|62.3|62.3|Standard Deviation|9.75|9.75|||
3843534|NCT01673867|3668964|B1|||Age||years|Mean|60.9|60.9|Standard Deviation|9.27|9.27|||
3843535|NCT01673854|3668991|B1|||Time from Diagnosis of Advanced /Metastatic Melanoma to First Vem1 Phase Dose|Vem=vemurafenib|Months|Median|1.86|1.86|Full Range|||0.3|52.3|
3843536|NCT01673854|3668991|B1|||Time from Diagnosis of Advanced /Metastatic Melanoma to First Vem1 Phase Dose|Vem=vemurafenib.|Months|Mean|4.96|4.96|Standard Deviation|9.38|9.38|||
3843537|NCT01673854|3668991|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|11|11.0||||||
3843538|NCT01673854|3668991|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|35|35.0||||||
3843539|NCT01673854|3668991|B1|5 or more||Number of Disease Sites||Participants|Number|25|25.0||||||
3843540|NCT01673854|3668991|B1|4||Number of Disease Sites||Participants|Number|4|4.0||||||
3843541|NCT01673854|3668991|B1|3||Number of Disease Sites||Participants|Number|7|7.0||||||
3843542|NCT01673854|3668991|B1|2||Number of Disease Sites||Participants|Number|8|8.0||||||
3843543|NCT01673854|3668991|B1|1||Number of Disease Sites||Participants|Number|2|2.0||||||
3843544|NCT01673854|3668991|B1|IV||Disease Stage at Study Entry|Melanoma staging criteria: Stage III (A,B,C)=The tumor may be of any thickness and may or may not be ulcerated. The cancer cells have spread either to a few nearby lymph nodes or tissue just outside the tumor but not to the lymph nodes. Stage IV=The cancer cells have spread to the lymph nodes, other organs in the body, or areas far from the original site of the tumor. This is called metastatic melanoma.|Participants|Number|38|38.0||||||
3843584|NCT01673828|3669000|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843585|NCT01673828|3669001|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843586|NCT01673828|3668999|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3843545|NCT01673854|3668991|B1|III||Disease Stage at Study Entry|Melanoma staging criteria: Stage III (A,B,C)=The tumor may be of any thickness and may or may not be ulcerated. The cancer cells have spread either to a few nearby lymph nodes or tissue just outside the tumor but not to the lymph nodes. Stage IV=The cancer cells have spread to the lymph nodes, other organs in the body, or areas far from the original site of the tumor. This is called metastatic melanoma.|Participants|Number|8|8.0||||||
3843546|NCT01673854|3668991|B1|M1C||M-Stage at Study Entry|M-stage=stage of metastases (M), based on criteria of the American Joint Committee on Cancer. M0=no metastases. M1A=metastases to skin, subcutaneous tissue, or distant lymph nodes. M1B=metastases to lung. M1C=metastases to all other visceral sites or distant metastases to any site combined with an elevated serum level of lactase dehydrogenase.|Participants|Number|24|24.0||||||
3843547|NCT01673854|3668991|B1|M1B||M-Stage at Study Entry|M-stage=stage of metastases (M), based on criteria of the American Joint Committee on Cancer. M0=no metastases. M1A=metastases to skin, subcutaneous tissue, or distant lymph nodes. M1B=metastases to lung. M1C=metastases to all other visceral sites or distant metastases to any site combined with an elevated serum level of lactase dehydrogenase.|Participants|Number|8|8.0||||||
3843548|NCT01673854|3668991|B1|M1A||M-Stage at Study Entry|M-stage=stage of metastases (M), based on criteria of the American Joint Committee on Cancer. M0=no metastases. M1A=metastases to skin, subcutaneous tissue, or distant lymph nodes. M1B=metastases to lung. M1C=metastases to all other visceral sites or distant metastases to any site combined with an elevated serum level of lactase dehydrogenase.|Participants|Number|8|8.0||||||
3843549|NCT01673854|3668991|B1|M0||M-Stage at Study Entry|M-stage=stage of metastases (M), based on criteria of the American Joint Committee on Cancer. M0=no metastases. M1A=metastases to skin, subcutaneous tissue, or distant lymph nodes. M1B=metastases to lung. M1C=metastases to all other visceral sites or distant metastases to any site combined with an elevated serum level of lactase dehydrogenase.|Participants|Number|6|6.0||||||
3843550|NCT01673854|3668991|B1|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3843551|NCT01673854|3668991|B1|White||Race/Ethnicity, Customized||Participants|Number|42|42.0||||||
3843552|NCT01673854|3668991|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3843553|NCT01673854|3668991|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3843554|NCT01673854|3668991|B1|||Age||Years|Median|57.5|57.5|Full Range|||18.0|81.0|
3843555|NCT01673854|3668991|B1|||Age||Years|Mean|55.0|55.0|Standard Deviation|14.20|14.2|||
3843556|NCT01673828|3668999|B3|Severe||TBI Severity|Moderate=post-resuscitation Glasgow Coma Scale (GCS) within range of 9–12 with abnormal head CT scan. Severe=post-resuscitation GCS within range of 3-8.|Participants|Count of Participants|11|11.0||||||
3843557|NCT01673828|3669000|B2|Severe||TBI Severity|Moderate=post-resuscitation Glasgow Coma Scale (GCS) within range of 9–12 with abnormal head CT scan. Severe=post-resuscitation GCS within range of 3-8.|Participants|Count of Participants|6|6.0||||||
3843558|NCT01673828|3669001|B1|Severe||TBI Severity|Moderate=post-resuscitation Glasgow Coma Scale (GCS) within range of 9–12 with abnormal head CT scan. Severe=post-resuscitation GCS within range of 3-8.|Participants|Count of Participants|5|5.0||||||
3843559|NCT01673828|3668999|B3|Moderate||TBI Severity|Moderate=post-resuscitation Glasgow Coma Scale (GCS) within range of 9–12 with abnormal head CT scan. Severe=post-resuscitation GCS within range of 3-8.|Participants|Count of Participants|2|2.0||||||
3843560|NCT01673828|3669000|B2|Moderate||TBI Severity|Moderate=post-resuscitation Glasgow Coma Scale (GCS) within range of 9–12 with abnormal head CT scan. Severe=post-resuscitation GCS within range of 3-8.|Participants|Count of Participants|0|0.0||||||
3843561|NCT01673828|3669001|B1|Moderate||TBI Severity|Moderate=post-resuscitation Glasgow Coma Scale (GCS) within range of 9–12 with abnormal head CT scan. Severe=post-resuscitation GCS within range of 3-8.|Participants|Count of Participants|2|2.0||||||
3843562|NCT01673828|3668999|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843563|NCT01673828|3669000|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843564|NCT01673828|3669001|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843565|NCT01673828|3668999|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843566|NCT01673828|3669000|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843567|NCT01673828|3669001|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843568|NCT01673828|3668999|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3843569|NCT01673828|3669000|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3843570|NCT01673828|3669001|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3843571|NCT01673828|3668999|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3843572|NCT01673828|3669000|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3843573|NCT01673828|3669001|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843574|NCT01673828|3668999|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843575|NCT01673828|3669000|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843576|NCT01673828|3669001|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843577|NCT01673828|3668999|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843578|NCT01673828|3669000|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843579|NCT01673828|3669001|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843580|NCT01673828|3668999|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843581|NCT01673828|3669000|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843582|NCT01673828|3669001|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843583|NCT01673828|3668999|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843587|NCT01673828|3669000|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3843588|NCT01673828|3669001|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3843589|NCT01673828|3668999|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3843590|NCT01673828|3669000|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3843591|NCT01673828|3669001|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3843592|NCT01673828|3668999|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3843593|NCT01673828|3669000|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3843594|NCT01673828|3669001|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3843595|NCT01673828|3668999|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3843596|NCT01673828|3669000|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3843597|NCT01673828|3669001|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3843598|NCT01673828|3668999|B3|||Age||years|Mean|28.8|28.8|Standard Deviation|13.0|13.0|||
3843599|NCT01673828|3669000|B2|||Age||years|Mean|26.2|26.2|Standard Deviation|13.5|13.5|||
3843600|NCT01673828|3669001|B1|||Age||years|Mean|31.1|31.1|Standard Deviation|13.1|13.1|||
3843601|NCT01673802|3669008|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3843602|NCT01673802|3669008|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3843603|NCT01673802|3669008|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3843604|NCT01673802|3669008|B1|||Age||years|Mean|54.9|54.9|Full Range|||31.0|81.0|
3843605|NCT01673698|3669012|B3|||BMI||kg/m^2|Mean|35.37|35.37|Standard Deviation|2.75|2.75|||
3843606|NCT01673698|3669013|B2|||BMI||kg/m^2|Mean|35.43|35.43|Standard Deviation|2.63|2.63|||
3843607|NCT01673698|3669014|B1|||BMI||kg/m^2|Mean|35.32|35.32|Standard Deviation|2.84|2.84|||
3843608|NCT01673698|3669012|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3843609|NCT01673698|3669013|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3843610|NCT01673698|3669014|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3843611|NCT01673698|3669012|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843612|NCT01673698|3669013|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843613|NCT01673698|3669014|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843614|NCT01673698|3669012|B3||White|Race (NIH/OMB)||Participants|Count of Participants|271|271.0||||||
3843615|NCT01673698|3669013|B2||White|Race (NIH/OMB)||Participants|Count of Participants|118|118.0||||||
3843616|NCT01673698|3669014|B1||White|Race (NIH/OMB)||Participants|Count of Participants|153|153.0||||||
3843617|NCT01673698|3669012|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3843618|NCT01673698|3669013|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3843619|NCT01673698|3669014|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3843620|NCT01673698|3669012|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843621|NCT01673698|3669013|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843622|NCT01673698|3669014|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843623|NCT01673698|3669012|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3843624|NCT01673698|3669013|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843625|NCT01673698|3669014|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3843626|NCT01673698|3669012|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3843627|NCT01673698|3669013|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3843628|NCT01673698|3669014|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843629|NCT01673698|3669012|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843630|NCT01673698|3669013|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843631|NCT01673698|3669014|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843632|NCT01673698|3669012|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|303|303.0||||||
3843633|NCT01673698|3669013|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
3843634|NCT01673698|3669014|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|172|172.0||||||
3843635|NCT01673698|3669012|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3843636|NCT01673698|3669013|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3843637|NCT01673698|3669014|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3843638|NCT01673698|3669012|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3843639|NCT01673698|3669013|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3843640|NCT01673698|3669014|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3843641|NCT01673698|3669012|B3||Female|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
3843642|NCT01673698|3669013|B2||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3843643|NCT01673698|3669014|B1||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
3843644|NCT01673698|3669012|B3|||Age||years|Mean|43.88|43.88|Standard Deviation|9.78|9.78|||
3843645|NCT01673698|3669013|B2|||Age||years|Mean|44.04|44.04|Standard Deviation|10.17|10.17|||
3843646|NCT01673698|3669014|B1|||Age||years|Mean|43.77|43.77|Standard Deviation|9.51|9.51|||
3843647|NCT01673620|3669023|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3843648|NCT01673620|3669024|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3843649|NCT01673620|3669025|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3843650|NCT01673620|3669023|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3843651|NCT01673620|3669024|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3843652|NCT01673620|3669025|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3843653|NCT01673620|3669023|B3|||Age||years|Mean|30.4|30.4|Standard Deviation|11.6|11.6|||
3843654|NCT01673620|3669024|B2|||Age||years|Mean|31.9|31.9|Standard Deviation|9.3|9.3|||
3843655|NCT01673620|3669025|B1|||Age||years|Mean|29.7|29.7|Standard Deviation|12.5|12.5|||
3843656|NCT01673594|3669034|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
3843657|NCT01673594|3669035|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3843658|NCT01673594|3669036|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3843659|NCT01673594|3669034|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843660|NCT01673594|3669035|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843661|NCT01673594|3669036|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843662|NCT01673594|3669034|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3843663|NCT01673594|3669035|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843664|NCT01673594|3669036|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3843665|NCT01673594|3669034|B3||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3843666|NCT01673594|3669035|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3843667|NCT01673594|3669036|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3843668|NCT01673594|3669034|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3843669|NCT01673594|3669035|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3843670|NCT01673594|3669036|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3843671|NCT01673594|3669034|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843672|NCT01673594|3669035|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843673|NCT01673594|3669036|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843674|NCT01673594|3669034|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3843675|NCT01673594|3669035|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3843676|NCT01673594|3669036|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3843677|NCT01673594|3669034|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843678|NCT01673594|3669035|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843679|NCT01673594|3669036|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843680|NCT01673594|3669034|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843681|NCT01673594|3669035|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843682|NCT01673594|3669036|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843683|NCT01673594|3669034|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3843684|NCT01673594|3669035|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3843685|NCT01673594|3669036|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3843686|NCT01673594|3669034|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3843687|NCT01673594|3669035|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3843688|NCT01673594|3669036|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3843689|NCT01673594|3669034|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3843690|NCT01673594|3669035|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3843691|NCT01673594|3669036|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3843692|NCT01673594|3669034|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3843693|NCT01673594|3669035|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3843694|NCT01673594|3669036|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3843695|NCT01673594|3669034|B3|||Age||years|Mean|24.8|24.8|Standard Deviation|3.0|3.0|||
3843696|NCT01673594|3669035|B2|||Age||years|Mean|24.4|24.4|Standard Deviation|3.2|3.2|||
3843697|NCT01673594|3669036|B1|||Age||years|Mean|25.1|25.1|Standard Deviation|2.9|2.9|||
3843698|NCT01673594|3669034|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3843699|NCT01673594|3669035|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3843700|NCT01673594|3669036|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3843701|NCT01673594|3669034|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3843702|NCT01673594|3669035|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3843703|NCT01673594|3669036|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3843704|NCT01673594|3669034|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3843705|NCT01673594|3669035|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3843706|NCT01673594|3669036|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3843707|NCT01673568|3669045|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3843708|NCT01673568|3669046|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3843709|NCT01673568|3669047|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3843710|NCT01673568|3669045|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3843711|NCT01673568|3669046|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3843712|NCT01673568|3669047|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3843713|NCT01673568|3669045|B3|||Age||years|Median|51|51.0|Full Range|||21.0|73.0|
3843714|NCT01673568|3669046|B2|||Age||years|Median|51|51.0|Full Range|||31.0|71.0|
3843715|NCT01673568|3669047|B1|||Age||years|Median|51|51.0|Full Range|||21.0|73.0|
3843716|NCT01673490|3669056|B1|Asian||Race/Ethnicity, Customized||Participants|Number|59|59.0||||||
3843717|NCT01673490|3669056|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3843718|NCT01673490|3669056|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3843719|NCT01673490|3669056|B1|||Age||Years|Mean|66.5|66.5|Standard Deviation|8.37|8.37|||
3843720|NCT01673425|3669069|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3843721|NCT01673425|3669069|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3843722|NCT01673425|3669069|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3843723|NCT01673425|3669069|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3843724|NCT01673425|3669069|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3843725|NCT01673425|3669069|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3843726|NCT01673347|3669073|B1|||BMI||kg/m2|Mean|25.27|25.27|Standard Deviation|4.33|4.33|||
3843727|NCT01673347|3669073|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843728|NCT01673347|3669073|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843729|NCT01673347|3669073|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3843730|NCT01673347|3669073|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843731|NCT01673347|3669073|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843732|NCT01673347|3669073|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843733|NCT01673347|3669073|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843734|NCT01673347|3669073|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3843735|NCT01673347|3669073|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3843736|NCT01673347|3669073|B1|||Age||years|Mean|55|55.0|Standard Deviation|7.12|7.12|||
3843737|NCT01673282|3669080|B3||Male|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3843738|NCT01673282|3669081|B2||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3843739|NCT01673282|3669082|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3843740|NCT01673282|3669080|B3||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3843741|NCT01673282|3669081|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3843742|NCT01673282|3669082|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3843743|NCT01673282|3669080|B3|||Age||years|Mean|48.3|48.3|Standard Deviation|16.7|16.7|||
3843744|NCT01673282|3669081|B2|||Age||years|Mean|52.5|52.5|Standard Deviation|16.0|16.0|||
3843745|NCT01673282|3669082|B1|||Age||years|Mean|44.0|44.0|Standard Deviation|16.4|16.4|||
3843746|NCT01673282|3669080|B3||>=65 years|Age||Participants|Count of Participants|58|58.0||||||
3843747|NCT01673282|3669081|B2||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
3843748|NCT01673282|3669082|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3843749|NCT01673282|3669080|B3||Between 18 and 65 years|Age||Participants|Count of Participants|252|252.0||||||
3843750|NCT01673282|3669081|B2||Between 18 and 65 years|Age||Participants|Count of Participants|117|117.0||||||
3843751|NCT01673282|3669082|B1||Between 18 and 65 years|Age||Participants|Count of Participants|135|135.0||||||
3843752|NCT01673282|3669080|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3843753|NCT01673282|3669081|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3843754|NCT01673282|3669082|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3843755|NCT01673256|3669089|B1|||Weight||kg|Mean|82.4|82.4|Standard Deviation|16.4|16.4|||
3843756|NCT01673256|3669089|B1|Germany||Region of Enrollment||participants|Number|85|85.0||||||
3843757|NCT01673256|3669089|B1|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
3843758|NCT01673256|3669089|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3843759|NCT01673256|3669089|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3843760|NCT01673256|3669089|B1|||Age||years|Mean|65.7|65.7|Standard Deviation|9.6|9.6|||
3843761|NCT01673191|3669093|B3|||Intraocular Pressure||millimeters of mercury (mm Hg)|Mean|13.9|13.9|Standard Deviation|2.7|2.7|||
3843762|NCT01673191|3669094|B2|||Intraocular Pressure||millimeters of mercury (mm Hg)|Mean|14.4|14.4|Standard Deviation|2.5|2.5|||
3843763|NCT01673191|3669095|B1|||Intraocular Pressure||millimeters of mercury (mm Hg)|Mean|13.7|13.7|Standard Deviation|2.8|2.8|||
3843764|NCT01673191|3669093|B3|||Central Retinal Thickness|Based on spectral domain optical coherence tomography (SD-OCT)|micrometers|Mean|402.5|402.5|Standard Deviation|149.5|149.5|||
3843765|NCT01673191|3669094|B2|||Central Retinal Thickness|Based on spectral domain optical coherence tomography (SD-OCT)|micrometers|Mean|403.5|403.5|Standard Deviation|156.2|156.2|||
3843766|NCT01673191|3669095|B1|||Central Retinal Thickness|Based on spectral domain optical coherence tomography (SD-OCT)|micrometers|Mean|402.2|402.2|Standard Deviation|149.8|149.8|||
3843767|NCT01673191|3669093|B3|||Best Corrected Visual Acuity|logMAR|logMAR units|Mean|0.44|0.44|Standard Deviation|0.36|0.36|||
3843768|NCT01673191|3669094|B2|||Best Corrected Visual Acuity|logMAR|logMAR units|Mean|0.32|0.32|Standard Deviation|0.22|0.22|||
3843769|NCT01673191|3669095|B1|||Best Corrected Visual Acuity|logMAR|logMAR units|Mean|0.49|0.49|Standard Deviation|0.40|0.4|||
3843770|NCT01673191|3669093|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
3843771|NCT01673191|3669094|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3843772|NCT01673191|3669095|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
3843773|NCT01673191|3669093|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3843774|NCT01673191|3669093|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3843775|NCT01673191|3669094|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3843776|NCT01673191|3669095|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3843777|NCT01673191|3669093|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3843778|NCT01673191|3669094|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3843779|NCT01673191|3669095|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3843780|NCT01673191|3669093|B3|||Age||years|Mean|67.4|67.4|Standard Deviation|7.7|7.7|||
3843781|NCT01673191|3669094|B2|||Age||years|Mean|68|68.0|Standard Deviation|8.4|8.4|||
3843782|NCT01673191|3669095|B1|||Age||years|Mean|67.1|67.1|Standard Deviation|7.6|7.6|||
3843783|NCT01673191|3669093|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3843784|NCT01673191|3669094|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3843785|NCT01673191|3669095|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3843786|NCT01673191|3669093|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3843787|NCT01673191|3669094|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3843788|NCT01673191|3669095|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3843789|NCT01673191|3669093|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3843790|NCT01673191|3669094|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3843791|NCT01673191|3669095|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3843792|NCT01673178|3669114|B6||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3843793|NCT01673178|3669115|B5||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3843794|NCT01673178|3669116|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3843795|NCT01673178|3669117|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3843796|NCT01673178|3669118|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3843797|NCT01673178|3669119|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3843798|NCT01673178|3669114|B6||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3843799|NCT01673178|3669115|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3843800|NCT01673178|3669116|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3843801|NCT01673178|3669117|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3843802|NCT01673178|3669118|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3843803|NCT01673178|3669119|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3843804|NCT01673178|3669114|B6|||Age||years|Mean|53.4|53.4|Standard Deviation|8.1|8.1|||
3843805|NCT01673178|3669115|B5|||Age||years|Mean|53.2|53.2|Standard Deviation|8.0|8.0|||
3843806|NCT01673178|3669116|B4|||Age||years|Mean|53.0|53.0|Standard Deviation|7.4|7.4|||
3843807|NCT01673178|3669117|B3|||Age||years|Mean|53.4|53.4|Standard Deviation|9.5|9.5|||
3843808|NCT01673178|3669118|B2|||Age||years|Mean|54.6|54.6|Standard Deviation|8.3|8.3|||
3843809|NCT01673178|3669119|B1|||Age||years|Mean|52.8|52.8|Standard Deviation|8.0|8.0|||
3843810|NCT01673126|3669360|B3|Belgium||Region of Enrollment||participants|Number|55|55.0||||||
3843811|NCT01673126|3669361|B2|Belgium||Region of Enrollment||participants|Number|23|23.0||||||
3843812|NCT01673126|3669362|B1|Belgium||Region of Enrollment||participants|Number|32|32.0||||||
3843813|NCT01673126|3669360|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3843814|NCT01673126|3669361|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3843815|NCT01673126|3669362|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3843816|NCT01673126|3669360|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3843817|NCT01673126|3669361|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3843818|NCT01673126|3669362|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3843819|NCT01673126|3669360|B3|||Age, Customized||years|Mean|43|43.0|Standard Deviation|18|18.0|||
3843820|NCT01673126|3669361|B2|||Age, Customized||years|Mean|40|40.0|Standard Deviation|19|19.0|||
3843821|NCT01673126|3669362|B1|||Age, Customized||years|Mean|46|46.0|Standard Deviation|17|17.0|||
3843822|NCT01673113|3669369|B3|||BMI of <30||flanks|Count of Units|22|22.0||||||
3843823|NCT01673113|3669370|B2|||BMI of <30||flanks|Count of Units|11|11.0||||||
3843824|NCT01673113|3669371|B1|||BMI of <30||flanks|Count of Units|11|11.0||||||
3843825|NCT01673113|3669369|B3|United States||Region of Enrollment||flanks|Number|22|22.0||||||
3843826|NCT01673113|3669370|B2|United States||Region of Enrollment||flanks|Number|11|11.0||||||
3843827|NCT01673113|3669371|B1|United States||Region of Enrollment||flanks|Number|11|11.0||||||
3843828|NCT01673113|3669369|B3||Male|Sex: Female, Male||flanks|Count of Units|10|10.0||||||
3843829|NCT01673113|3669370|B2||Male|Sex: Female, Male||flanks|Count of Units|5|5.0||||||
3843830|NCT01673113|3669371|B1||Male|Sex: Female, Male||flanks|Count of Units|5|5.0||||||
3843831|NCT01673113|3669369|B3||Female|Sex: Female, Male||flanks|Count of Units|12|12.0||||||
3843832|NCT01673113|3669370|B2||Female|Sex: Female, Male||flanks|Count of Units|6|6.0||||||
3843833|NCT01673113|3669371|B1||Female|Sex: Female, Male||flanks|Count of Units|6|6.0||||||
3843834|NCT01673113|3669369|B3||>=65 years|Age||flanks|Count of Units|0|0.0||||||
3843835|NCT01673113|3669370|B2||>=65 years|Age||flanks|Count of Units|0|0.0||||||
3843836|NCT01673113|3669371|B1||>=65 years|Age||flanks|Count of Units|0|0.0||||||
3843837|NCT01673113|3669369|B3||Between 18 and 65 years|Age||flanks|Count of Units|22|22.0||||||
3843838|NCT01673113|3669370|B2||Between 18 and 65 years|Age||flanks|Count of Units|11|11.0||||||
3843839|NCT01673113|3669371|B1||Between 18 and 65 years|Age||flanks|Count of Units|11|11.0||||||
3843840|NCT01673113|3669369|B3||<=18 years|Age||flanks|Count of Units|0|0.0||||||
3843841|NCT01673113|3669370|B2||<=18 years|Age||flanks|Count of Units|0|0.0||||||
3843842|NCT01673113|3669371|B1||<=18 years|Age||flanks|Count of Units|0|0.0||||||
3843843|NCT01673022|3669379|B1|United States||Region of Enrollment||participants|Number|430|430.0||||||
3843844|NCT01673022|3669379|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3843845|NCT01673022|3669379|B1||Female|Sex: Female, Male||Participants|Count of Participants|430|430.0||||||
3843846|NCT01673022|3669379|B1|||Age||years|Mean|51|51.0|Standard Deviation|28|28.0|||
3843847|NCT01673022|3669379|B1||>=65 years|Age||Participants|Count of Participants|137|137.0||||||
3843848|NCT01673022|3669379|B1||Between 18 and 65 years|Age||Participants|Count of Participants|293|293.0||||||
3843849|NCT01673022|3669379|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3843850|NCT01673009|3669383|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
3843851|NCT01673009|3669383|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3843852|NCT01673009|3669383|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843853|NCT01673009|3669383|B1||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3843854|NCT01673009|3669383|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3843855|NCT01673009|3669383|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843856|NCT01673009|3669383|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3843857|NCT01673009|3669383|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843858|NCT01673009|3669383|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843859|NCT01673009|3669383|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3843860|NCT01673009|3669383|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3843861|NCT01673009|3669383|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3843862|NCT01673009|3669383|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3843863|NCT01673009|3669383|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3843864|NCT01673009|3669383|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3843865|NCT01673009|3669383|B1||<=18 years|Age||Participants|Count of Participants|25|25.0||||||
3843866|NCT01672996|3669388|B8|United States||Region of Enrollment||Participants|Number|66|66.0||||||
3843867|NCT01672996|3669389|B7|United States||Region of Enrollment||Participants|Number|6|6.0||||||
3843868|NCT01672996|3669390|B6|United States||Region of Enrollment||Participants|Number|10|10.0||||||
3843869|NCT01672996|3669391|B5|United States||Region of Enrollment||Participants|Number|10|10.0||||||
3843870|NCT01672996|3669392|B4|United States||Region of Enrollment||Participants|Number|10|10.0||||||
3843871|NCT01672996|3669393|B3|United States||Region of Enrollment||Participants|Number|10|10.0||||||
3843872|NCT01672996|3669394|B2|United States||Region of Enrollment||Participants|Number|10|10.0||||||
3843873|NCT01672996|3669395|B1|United States||Region of Enrollment||Participants|Number|10|10.0||||||
3843874|NCT01672996|3669388|B8||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3843875|NCT01672996|3669389|B7||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3843876|NCT01672996|3669390|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3843877|NCT01672996|3669391|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3843878|NCT01672996|3669392|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3843879|NCT01672996|3669393|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3843880|NCT01672996|3669394|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3843881|NCT01672996|3669395|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3843882|NCT01672996|3669388|B8||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3843883|NCT01672996|3669389|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3843884|NCT01672996|3669390|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3843885|NCT01672996|3669391|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3843886|NCT01672996|3669392|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3843887|NCT01672996|3669393|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3843888|NCT01672996|3669394|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3843889|NCT01672996|3669395|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3843890|NCT01672996|3669388|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3843891|NCT01672996|3669389|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3843892|NCT01672996|3669390|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3843893|NCT01672996|3669391|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3843894|NCT01672996|3669392|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3843895|NCT01672996|3669393|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3843896|NCT01672996|3669394|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3843897|NCT01672996|3669395|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3843898|NCT01672996|3669388|B8||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
3843899|NCT01672996|3669389|B7||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3843900|NCT01672996|3669390|B6||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3843901|NCT01672996|3669391|B5||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3843902|NCT01672996|3669392|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3843903|NCT01672996|3669393|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3843904|NCT01672996|3669394|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3843905|NCT01672996|3669395|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3843906|NCT01672996|3669388|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3843907|NCT01672996|3669389|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3843908|NCT01672996|3669390|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3843909|NCT01672996|3669391|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3843910|NCT01672996|3669392|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3843911|NCT01672996|3669393|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3843912|NCT01672996|3669394|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3843913|NCT01672996|3669395|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3843914|NCT01672983|3669427|B7||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3843915|NCT01672983|3669428|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3843916|NCT01672983|3669429|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3843917|NCT01672983|3669430|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3843918|NCT01672983|3669431|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3843919|NCT01672983|3669432|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3843920|NCT01672983|3669433|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3843921|NCT01672983|3669427|B7||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3843922|NCT01672983|3669428|B6||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3843923|NCT01672983|3669429|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3843924|NCT01672983|3669430|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3843925|NCT01672983|3669431|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3843926|NCT01672983|3669432|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3843927|NCT01672983|3669433|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3843928|NCT01672983|3669427|B7|||Age||years|Mean|59.2|59.2|Standard Deviation|10.84|10.84|||
3843929|NCT01672983|3669428|B6|||Age||years|Mean|62.8|62.8|Standard Deviation|7.89|7.89|||
3843930|NCT01672983|3669429|B5|||Age||years|Mean|62.5|62.5|Standard Deviation|8.34|8.34|||
3843931|NCT01672983|3669430|B4|||Age||years|Mean|57.5|57.5|Standard Deviation|10.15|10.15|||
3843932|NCT01672983|3669431|B3|||Age||years|Mean|61.9|61.9|Standard Deviation|8.14|8.14|||
3843933|NCT01672983|3669432|B2|||Age||years|Mean|54.8|54.8|Standard Deviation|11.96|11.96|||
3843934|NCT01672983|3669433|B1|||Age||years|Mean|55.3|55.3|Standard Deviation|15.06|15.06|||
3843935|NCT01672970|3669468|B1|Missing||Sex/Gender, Customized||participants|Number|1|1.0||||||
3843936|NCT01672970|3669468|B1|Male||Sex/Gender, Customized||participants|Number|28|28.0||||||
3843937|NCT01672970|3669468|B1|Female||Sex/Gender, Customized||participants|Number|261|261.0||||||
3843938|NCT01672970|3669468|B1|||Age|Age was missing for one participant.|years|Mean|56.14|56.14|Standard Deviation|12.26|12.26|||
3843939|NCT01672957|3669504|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3843940|NCT01672957|3669504|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3843941|NCT01672957|3669504|B1|||Age||years|Mean|49.60|49.6|Standard Deviation|13.24|13.24|||
3843942|NCT01672892|3669517|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3843943|NCT01672892|3669518|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3843944|NCT01672892|3669519|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3843945|NCT01672892|3669517|B3||Female|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
3843946|NCT01672892|3669518|B2||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3843947|NCT01672892|3669519|B1||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3843948|NCT01672892|3669517|B3|||Age||years|Median|61|61.0|Full Range|||28.0|83.0|
3843949|NCT01672892|3669518|B2|||Age||years|Median|61|61.0|Full Range|||29.0|83.0|
3843950|NCT01672892|3669519|B1|||Age||years|Median|62|62.0|Full Range|||28.0|82.0|
3843951|NCT01672827|3669534|B1|United Kingdom||Region of Enrollment||participants|Number|24|24.0||||||
3843952|NCT01672827|3669534|B1|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
3843953|NCT01672827|3669534|B1|Japan||Region of Enrollment||participants|Number|16|16.0||||||
3843954|NCT01672827|3669534|B1|Finland||Region of Enrollment||participants|Number|37|37.0||||||
3843955|NCT01672827|3669534|B1|Denmark||Region of Enrollment||participants|Number|12|12.0||||||
3843956|NCT01672827|3669534|B1|Belgium||Region of Enrollment||participants|Number|66|66.0||||||
3843957|NCT01672827|3669534|B1|United States||Region of Enrollment||participants|Number|118|118.0||||||
3843958|NCT01672827|3669534|B1||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3843959|NCT01672827|3669534|B1||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3843960|NCT01672827|3669534|B1|||Age||years|Mean|68.2|68.2|Standard Deviation|17.1|17.1|||
3843961|NCT01672827|3669534|B1||>=65 years|Age||Participants|Count of Participants|195|195.0||||||
3843962|NCT01672827|3669534|B1||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
3843963|NCT01672827|3669534|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3843964|NCT01672788|3669540|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3843965|NCT01672788|3669540|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3843966|NCT01672788|3669540|B1|||Age||years|Mean|33.6|33.6|Standard Deviation|9.2|9.2|||
3843967|NCT01672736|3669573|B1|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3843968|NCT01672736|3669573|B1|Canada||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3843969|NCT01672736|3669573|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843970|NCT01672736|3669573|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843971|NCT01672736|3669573|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3843972|NCT01672736|3669573|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3843973|NCT01672736|3669573|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843974|NCT01672736|3669573|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843975|NCT01672736|3669573|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843976|NCT01672736|3669573|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3843977|NCT01672736|3669573|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3843978|NCT01672736|3669573|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3843979|NCT01672736|3669573|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3843980|NCT01672736|3669573|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3843981|NCT01672736|3669573|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3843982|NCT01672736|3669573|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3843983|NCT01672736|3669573|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3843984|NCT01672723|3669577|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
3843985|NCT01672723|3669577|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3843986|NCT01672723|3669577|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3843987|NCT01672723|3669577|B1|||Age||years|Mean|21.55|21.55|Standard Deviation|3.34|3.34|||
3843988|NCT01672723|3669577|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3843989|NCT01672723|3669577|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3843990|NCT01672723|3669577|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3843991|NCT01672710|3669588|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3843992|NCT01672710|3669589|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3843993|NCT01672710|3669590|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3843994|NCT01672710|3669588|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3843995|NCT01672710|3669589|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3843996|NCT01672710|3669590|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3843997|NCT01672710|3669588|B3|||Age|in years|years|Mean|51.2|51.2|Standard Deviation|7.2|7.2|||
3843998|NCT01672710|3669589|B2|||Age|in years|years|Mean|50.2|50.2|Standard Deviation|5.5|5.5|||
3843999|NCT01672710|3669590|B1|||Age|in years|years|Mean|51.7|51.7|Standard Deviation|7.9|7.9|||
3844000|NCT01672658|3669601|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3844001|NCT01672658|3669602|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3844002|NCT01672658|3669603|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3844003|NCT01672658|3669601|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3844004|NCT01672658|3669602|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3844005|NCT01672658|3669603|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3844006|NCT01672658|3669601|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3844007|NCT01672658|3669602|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3844008|NCT01672658|3669603|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3844009|NCT01672658|3669601|B3|||Age||years|Mean|42.2|42.2|Standard Deviation|13.5|13.5|||
3844010|NCT01672658|3669602|B2|||Age||years|Mean|41.9|41.9|Standard Deviation|9.6|9.6|||
3844011|NCT01672658|3669603|B1|||Age||years|Mean|42.5|42.5|Standard Deviation|16.4|16.4|||
3844012|NCT01672658|3669601|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3844013|NCT01672658|3669602|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3844014|NCT01672658|3669603|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3844015|NCT01672658|3669601|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3844016|NCT01672658|3669602|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3844017|NCT01672658|3669603|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3844018|NCT01672658|3669601|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3844019|NCT01672658|3669602|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3844020|NCT01672658|3669603|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3844021|NCT01672294|3669624|B5|||Number of Hours patient requires assistance|Self-reported number of hours patient requires assistance|hours|Mean|2.3|2.3|Standard Deviation|1.26|1.26|||
3844022|NCT01672294|3669625|B4|||Number of Hours patient requires assistance|Self-reported number of hours patient requires assistance|hours|Mean|2.1|2.1|Standard Deviation|1.25|1.25|||
3844023|NCT01672294|3669626|B3|||Number of Hours patient requires assistance|Self-reported number of hours patient requires assistance|hours|Mean|2.3|2.3|Standard Deviation|1.2|1.2|||
3844024|NCT01672294|3669627|B2|||Number of Hours patient requires assistance|Self-reported number of hours patient requires assistance|hours|Mean|2.3|2.3|Standard Deviation|1.34|1.34|||
3844025|NCT01672294|3669628|B1|||Number of Hours patient requires assistance|Self-reported number of hours patient requires assistance|hours|Mean|2.4|2.4|Standard Deviation|1.24|1.24|||
3844026|NCT01672294|3669624|B5|||Years of caregiving given or received|Self-reported years spent caregiving or years received caregiving|years|Mean|4.2|4.2|Standard Deviation|5.04|5.04|||
3844027|NCT01672294|3669625|B4|||Years of caregiving given or received|Self-reported years spent caregiving or years received caregiving|years|Mean|3.4|3.4|Standard Deviation|4.2|4.2|||
3844028|NCT01672294|3669626|B3|||Years of caregiving given or received|Self-reported years spent caregiving or years received caregiving|years|Mean|3.7|3.7|Standard Deviation|4.06|4.06|||
3844029|NCT01672294|3669627|B2|||Years of caregiving given or received|Self-reported years spent caregiving or years received caregiving|years|Mean|5.2|5.2|Standard Deviation|5.95|5.95|||
3844030|NCT01672294|3669628|B1|||Years of caregiving given or received|Self-reported years spent caregiving or years received caregiving|years|Mean|4.6|4.6|Standard Deviation|5.6|5.6|||
3844031|NCT01672294|3669624|B5|Missing||Self-rated Quality of Health||Participants|Count of Participants|141|141.0||||||
3844032|NCT01672294|3669625|B4|Missing||Self-rated Quality of Health||Participants|Count of Participants|34|34.0||||||
3844033|NCT01672294|3669626|B3|Missing||Self-rated Quality of Health||Participants|Count of Participants|35|35.0||||||
3844034|NCT01672294|3669627|B2|Missing||Self-rated Quality of Health||Participants|Count of Participants|36|36.0||||||
3844035|NCT01672294|3669628|B1|Missing||Self-rated Quality of Health||Participants|Count of Participants|36|36.0||||||
3844036|NCT01672294|3669624|B5|Poor||Self-rated Quality of Health||Participants|Count of Participants|21|21.0||||||
3844037|NCT01672294|3669625|B4|Poor||Self-rated Quality of Health||Participants|Count of Participants|12|12.0||||||
3844038|NCT01672294|3669626|B3|Poor||Self-rated Quality of Health||Participants|Count of Participants|0|0.0||||||
3844039|NCT01672294|3669627|B2|Poor||Self-rated Quality of Health||Participants|Count of Participants|9|9.0||||||
3844040|NCT01672294|3669628|B1|Poor||Self-rated Quality of Health||Participants|Count of Participants|0|0.0||||||
3844041|NCT01672294|3669624|B5|Fair||Self-rated Quality of Health||Participants|Count of Participants|46|46.0||||||
3844042|NCT01672294|3669625|B4|Fair||Self-rated Quality of Health||Participants|Count of Participants|14|14.0||||||
3844043|NCT01672294|3669626|B3|Fair||Self-rated Quality of Health||Participants|Count of Participants|9|9.0||||||
3844044|NCT01672294|3669627|B2|Fair||Self-rated Quality of Health||Participants|Count of Participants|14|14.0||||||
3844045|NCT01672294|3669628|B1|Fair||Self-rated Quality of Health||Participants|Count of Participants|9|9.0||||||
3844046|NCT01672294|3669624|B5|Good||Self-rated Quality of Health||Participants|Count of Participants|49|49.0||||||
3844047|NCT01672294|3669625|B4|Good||Self-rated Quality of Health||Participants|Count of Participants|8|8.0||||||
3844048|NCT01672294|3669626|B3|Good||Self-rated Quality of Health||Participants|Count of Participants|14|14.0||||||
3844049|NCT01672294|3669627|B2|Good||Self-rated Quality of Health||Participants|Count of Participants|11|11.0||||||
3844050|NCT01672294|3669628|B1|Good||Self-rated Quality of Health||Participants|Count of Participants|16|16.0||||||
3844051|NCT01672294|3669624|B5|Very Good||Self-rated Quality of Health||Participants|Count of Participants|28|28.0||||||
3844052|NCT01672294|3669625|B4|Very Good||Self-rated Quality of Health||Participants|Count of Participants|4|4.0||||||
3844053|NCT01672294|3669626|B3|Very Good||Self-rated Quality of Health||Participants|Count of Participants|13|13.0||||||
3844054|NCT01672294|3669627|B2|Very Good||Self-rated Quality of Health||Participants|Count of Participants|1|1.0||||||
3844055|NCT01672294|3669628|B1|Very Good||Self-rated Quality of Health||Participants|Count of Participants|10|10.0||||||
3844056|NCT01672294|3669624|B5|Excellent||Self-rated Quality of Health||Participants|Count of Participants|1|1.0||||||
3844057|NCT01672294|3669625|B4|Excellent||Self-rated Quality of Health||Participants|Count of Participants|0|0.0||||||
3844058|NCT01672294|3669626|B3|Excellent||Self-rated Quality of Health||Participants|Count of Participants|1|1.0||||||
3844059|NCT01672294|3669627|B2|Excellent||Self-rated Quality of Health||Participants|Count of Participants|0|0.0||||||
3844060|NCT01672294|3669628|B1|Excellent||Self-rated Quality of Health||Participants|Count of Participants|0|0.0||||||
3844061|NCT01672294|3669624|B5|Other||Employment|Self-reported employment|Participants|Count of Participants|1|1.0||||||
3844062|NCT01672294|3669625|B4|Other||Employment|Self-reported employment|Participants|Count of Participants|0|0.0||||||
3844063|NCT01672294|3669626|B3|Other||Employment|Self-reported employment|Participants|Count of Participants|1|1.0||||||
3844064|NCT01672294|3669627|B2|Other||Employment|Self-reported employment|Participants|Count of Participants|0|0.0||||||
3844065|NCT01672294|3669628|B1|Other||Employment|Self-reported employment|Participants|Count of Participants|0|0.0||||||
3844066|NCT01672294|3669624|B5|Disabled||Employment|Self-reported employment|Participants|Count of Participants|77|77.0||||||
3844067|NCT01672294|3669625|B4|Disabled||Employment|Self-reported employment|Participants|Count of Participants|28|28.0||||||
3844068|NCT01672294|3669626|B3|Disabled||Employment|Self-reported employment|Participants|Count of Participants|10|10.0||||||
3844069|NCT01672294|3669627|B2|Disabled||Employment|Self-reported employment|Participants|Count of Participants|32|32.0||||||
3844070|NCT01672294|3669628|B1|Disabled||Employment|Self-reported employment|Participants|Count of Participants|7|7.0||||||
3844071|NCT01672294|3669624|B5|Retired/Not Working||Employment|Self-reported employment|Participants|Count of Participants|163|163.0||||||
3844072|NCT01672294|3669625|B4|Retired/Not Working||Employment|Self-reported employment|Participants|Count of Participants|40|40.0||||||
3844073|NCT01672294|3669626|B3|Retired/Not Working||Employment|Self-reported employment|Participants|Count of Participants|42|42.0||||||
3844074|NCT01672294|3669627|B2|Retired/Not Working||Employment|Self-reported employment|Participants|Count of Participants|38|38.0||||||
3844075|NCT01672294|3669628|B1|Retired/Not Working||Employment|Self-reported employment|Participants|Count of Participants|43|43.0||||||
3844076|NCT01672294|3669624|B5|Working Full or Part Time||Employment|Self-reported employment|Participants|Count of Participants|45|45.0||||||
3844077|NCT01672294|3669625|B4|Working Full or Part Time||Employment|Self-reported employment|Participants|Count of Participants|4|4.0||||||
3844078|NCT01672294|3669626|B3|Working Full or Part Time||Employment|Self-reported employment|Participants|Count of Participants|19|19.0||||||
3844079|NCT01672294|3669627|B2|Working Full or Part Time||Employment|Self-reported employment|Participants|Count of Participants|1|1.0||||||
3844080|NCT01672294|3669628|B1|Working Full or Part Time||Employment|Self-reported employment|Participants|Count of Participants|21|21.0||||||
3844081|NCT01672294|3669624|B5|Missing||Finances|Self-reported household finances by participant|Participants|Count of Participants|1|1.0||||||
3844082|NCT01672294|3669625|B4|Missing||Finances|Self-reported household finances by participant|Participants|Count of Participants|1|1.0||||||
3844083|NCT01672294|3669626|B3|Missing||Finances|Self-reported household finances by participant|Participants|Count of Participants|0|0.0||||||
3844084|NCT01672294|3669627|B2|Missing||Finances|Self-reported household finances by participant|Participants|Count of Participants|0|0.0||||||
3844085|NCT01672294|3669628|B1|Missing||Finances|Self-reported household finances by participant|Participants|Count of Participants|0|0.0||||||
3844086|NCT01672294|3669624|B5|enough to pay bills and special things||Finances|Self-reported household finances by participant|Participants|Count of Participants|87|87.0||||||
3844087|NCT01672294|3669625|B4|enough to pay bills and special things||Finances|Self-reported household finances by participant|Participants|Count of Participants|22|22.0||||||
3844088|NCT01672294|3669626|B3|enough to pay bills and special things||Finances|Self-reported household finances by participant|Participants|Count of Participants|21|21.0||||||
3844089|NCT01672294|3669627|B2|enough to pay bills and special things||Finances|Self-reported household finances by participant|Participants|Count of Participants|22|22.0||||||
3844090|NCT01672294|3669628|B1|enough to pay bills and special things||Finances|Self-reported household finances by participant|Participants|Count of Participants|22|22.0||||||
3844091|NCT01672294|3669624|B5|Enough to pay bills, little extras||Finances|Self-reported household finances by participant|Participants|Count of Participants|101|101.0||||||
3844092|NCT01672294|3669625|B4|Enough to pay bills, little extras||Finances|Self-reported household finances by participant|Participants|Count of Participants|30|30.0||||||
3844093|NCT01672294|3669626|B3|Enough to pay bills, little extras||Finances|Self-reported household finances by participant|Participants|Count of Participants|23|23.0||||||
3844094|NCT01672294|3669627|B2|Enough to pay bills, little extras||Finances|Self-reported household finances by participant|Participants|Count of Participants|22|22.0||||||
3844095|NCT01672294|3669628|B1|Enough to pay bills, little extras||Finances|Self-reported household finances by participant|Participants|Count of Participants|26|26.0||||||
3844096|NCT01672294|3669624|B5|Money to pay bills, cut back on things||Finances|Self-reported household finances by participant|Participants|Count of Participants|62|62.0||||||
3844097|NCT01672294|3669625|B4|Money to pay bills, cut back on things||Finances|Self-reported household finances by participant|Participants|Count of Participants|13|13.0||||||
3844098|NCT01672294|3669626|B3|Money to pay bills, cut back on things||Finances|Self-reported household finances by participant|Participants|Count of Participants|22|22.0||||||
3844099|NCT01672294|3669627|B2|Money to pay bills, cut back on things||Finances|Self-reported household finances by participant|Participants|Count of Participants|14|14.0||||||
3844100|NCT01672294|3669628|B1|Money to pay bills, cut back on things||Finances|Self-reported household finances by participant|Participants|Count of Participants|13|13.0||||||
3844101|NCT01672294|3669624|B5|Difficulty paying bills||Finances|Self-reported household finances by participant|Participants|Count of Participants|35|35.0||||||
3844102|NCT01672294|3669625|B4|Difficulty paying bills||Finances|Self-reported household finances by participant|Participants|Count of Participants|6|6.0||||||
3844103|NCT01672294|3669626|B3|Difficulty paying bills||Finances|Self-reported household finances by participant|Participants|Count of Participants|6|6.0||||||
3844104|NCT01672294|3669627|B2|Difficulty paying bills||Finances|Self-reported household finances by participant|Participants|Count of Participants|13|13.0||||||
3844105|NCT01672294|3669628|B1|Difficulty paying bills||Finances|Self-reported household finances by participant|Participants|Count of Participants|10|10.0||||||
3844106|NCT01672294|3669624|B5|Graduate Work or Degree||Education||Participants|Count of Participants|24|24.0||||||
3844107|NCT01672294|3669625|B4|Graduate Work or Degree||Education||Participants|Count of Participants|6|6.0||||||
3844108|NCT01672294|3669626|B3|Graduate Work or Degree||Education||Participants|Count of Participants|8|8.0||||||
3844109|NCT01672294|3669627|B2|Graduate Work or Degree||Education||Participants|Count of Participants|7|7.0||||||
3844110|NCT01672294|3669628|B1|Graduate Work or Degree||Education||Participants|Count of Participants|3|3.0||||||
3844111|NCT01672294|3669624|B5|College Degree||Education||Participants|Count of Participants|29|29.0||||||
3844112|NCT01672294|3669625|B4|College Degree||Education||Participants|Count of Participants|6|6.0||||||
3844113|NCT01672294|3669626|B3|College Degree||Education||Participants|Count of Participants|5|5.0||||||
3844114|NCT01672294|3669627|B2|College Degree||Education||Participants|Count of Participants|6|6.0||||||
3844115|NCT01672294|3669628|B1|College Degree||Education||Participants|Count of Participants|12|12.0||||||
3844116|NCT01672294|3669624|B5|Some College||Education||Participants|Count of Participants|107|107.0||||||
3844117|NCT01672294|3669625|B4|Some College||Education||Participants|Count of Participants|29|29.0||||||
3844118|NCT01672294|3669626|B3|Some College||Education||Participants|Count of Participants|31|31.0||||||
3844119|NCT01672294|3669627|B2|Some College||Education||Participants|Count of Participants|25|25.0||||||
3844120|NCT01672294|3669628|B1|Some College||Education||Participants|Count of Participants|22|22.0||||||
3844121|NCT01672294|3669624|B5|HS or less||Education||Participants|Count of Participants|126|126.0||||||
3844122|NCT01672294|3669625|B4|HS or less||Education||Participants|Count of Participants|31|31.0||||||
3844123|NCT01672294|3669626|B3|HS or less||Education||Participants|Count of Participants|28|28.0||||||
3844124|NCT01672294|3669627|B2|HS or less||Education||Participants|Count of Participants|33|33.0||||||
3844125|NCT01672294|3669628|B1|HS or less||Education||Participants|Count of Participants|34|34.0||||||
3844126|NCT01672294|3669624|B5|Multiple Qualifying Disease||Primary Diagnosis of Veteran|Primary life-limiting diagnosis of Veteran patient|Participants|Count of Participants|7|7.0||||||
3844127|NCT01672294|3669625|B4|Multiple Qualifying Disease||Primary Diagnosis of Veteran|Primary life-limiting diagnosis of Veteran patient|Participants|Count of Participants|3|3.0||||||
3844128|NCT01672294|3669627|B2|Multiple Qualifying Disease||Primary Diagnosis of Veteran|Primary life-limiting diagnosis of Veteran patient|Participants|Count of Participants|4|4.0||||||
3844129|NCT01672294|3669624|B5|End Stage Renal Disease||Primary Diagnosis of Veteran|Primary life-limiting diagnosis of Veteran patient|Participants|Count of Participants|12|12.0||||||
3844130|NCT01672294|3669625|B4|End Stage Renal Disease||Primary Diagnosis of Veteran|Primary life-limiting diagnosis of Veteran patient|Participants|Count of Participants|6|6.0||||||
3844131|NCT01672294|3669627|B2|End Stage Renal Disease||Primary Diagnosis of Veteran|Primary life-limiting diagnosis of Veteran patient|Participants|Count of Participants|6|6.0||||||
3844132|NCT01672294|3669624|B5|Chronic obstructive pulmonary disease||Primary Diagnosis of Veteran|Primary life-limiting diagnosis of Veteran patient|Participants|Count of Participants|17|17.0||||||
3844133|NCT01672294|3669625|B4|Chronic obstructive pulmonary disease||Primary Diagnosis of Veteran|Primary life-limiting diagnosis of Veteran patient|Participants|Count of Participants|5|5.0||||||
3844134|NCT01672294|3669627|B2|Chronic obstructive pulmonary disease||Primary Diagnosis of Veteran|Primary life-limiting diagnosis of Veteran patient|Participants|Count of Participants|12|12.0||||||
3844135|NCT01672294|3669624|B5|Congestive Heart Failure||Primary Diagnosis of Veteran|Primary life-limiting diagnosis of Veteran patient|Participants|Count of Participants|12|12.0||||||
3844136|NCT01672294|3669625|B4|Congestive Heart Failure||Primary Diagnosis of Veteran|Primary life-limiting diagnosis of Veteran patient|Participants|Count of Participants|6|6.0||||||
3844137|NCT01672294|3669627|B2|Congestive Heart Failure||Primary Diagnosis of Veteran|Primary life-limiting diagnosis of Veteran patient|Participants|Count of Participants|6|6.0||||||
3844138|NCT01672294|3669624|B5|Cancer||Primary Diagnosis of Veteran|Primary life-limiting diagnosis of Veteran patient|Participants|Count of Participants|95|95.0||||||
3844139|NCT01672294|3669625|B4|Cancer||Primary Diagnosis of Veteran|Primary life-limiting diagnosis of Veteran patient|Participants|Count of Participants|52|52.0||||||
3844140|NCT01672294|3669627|B2|Cancer||Primary Diagnosis of Veteran|Primary life-limiting diagnosis of Veteran patient|Participants|Count of Participants|43|43.0||||||
3844141|NCT01672294|3669624|B5|Other||Dyad Relationship|Respective relationship of participant to other dyad in pair.|Participants|Count of Participants|40|40.0||||||
3844142|NCT01672294|3669625|B4|Other||Dyad Relationship|Respective relationship of participant to other dyad in pair.|Participants|Count of Participants|12|12.0||||||
3844143|NCT01672294|3669626|B3|Other||Dyad Relationship|Respective relationship of participant to other dyad in pair.|Participants|Count of Participants|12|12.0||||||
3844144|NCT01672294|3669627|B2|Other||Dyad Relationship|Respective relationship of participant to other dyad in pair.|Participants|Count of Participants|8|8.0||||||
3844145|NCT01672294|3669628|B1|Other||Dyad Relationship|Respective relationship of participant to other dyad in pair.|Participants|Count of Participants|8|8.0||||||
3844146|NCT01672294|3669624|B5|Parent||Dyad Relationship|Respective relationship of participant to other dyad in pair.|Participants|Count of Participants|12|12.0||||||
3844147|NCT01672294|3669625|B4|Parent||Dyad Relationship|Respective relationship of participant to other dyad in pair.|Participants|Count of Participants|3|3.0||||||
3844148|NCT01672294|3669626|B3|Parent||Dyad Relationship|Respective relationship of participant to other dyad in pair.|Participants|Count of Participants|1|1.0||||||
3844149|NCT01672294|3669627|B2|Parent||Dyad Relationship|Respective relationship of participant to other dyad in pair.|Participants|Count of Participants|6|6.0||||||
3844150|NCT01672294|3669628|B1|Parent||Dyad Relationship|Respective relationship of participant to other dyad in pair.|Participants|Count of Participants|2|2.0||||||
3844151|NCT01672294|3669624|B5|Sibling||Dyad Relationship|Respective relationship of participant to other dyad in pair.|Participants|Count of Participants|12|12.0||||||
3844152|NCT01672294|3669625|B4|Sibling||Dyad Relationship|Respective relationship of participant to other dyad in pair.|Participants|Count of Participants|3|3.0||||||
3844153|NCT01672294|3669626|B3|Sibling||Dyad Relationship|Respective relationship of participant to other dyad in pair.|Participants|Count of Participants|3|3.0||||||
3844154|NCT01672294|3669627|B2|Sibling||Dyad Relationship|Respective relationship of participant to other dyad in pair.|Participants|Count of Participants|3|3.0||||||
3844155|NCT01672294|3669628|B1|Sibling||Dyad Relationship|Respective relationship of participant to other dyad in pair.|Participants|Count of Participants|3|3.0||||||
3844156|NCT01672294|3669624|B5|Adult Child||Dyad Relationship|Respective relationship of participant to other dyad in pair.|Participants|Count of Participants|12|12.0||||||
3844157|NCT01672294|3669625|B4|Adult Child||Dyad Relationship|Respective relationship of participant to other dyad in pair.|Participants|Count of Participants|1|1.0||||||
3844158|NCT01672294|3669626|B3|Adult Child||Dyad Relationship|Respective relationship of participant to other dyad in pair.|Participants|Count of Participants|3|3.0||||||
3844159|NCT01672294|3669627|B2|Adult Child||Dyad Relationship|Respective relationship of participant to other dyad in pair.|Participants|Count of Participants|2|2.0||||||
3844160|NCT01672294|3669628|B1|Adult Child||Dyad Relationship|Respective relationship of participant to other dyad in pair.|Participants|Count of Participants|6|6.0||||||
3844161|NCT01672294|3669624|B5|Spouse||Dyad Relationship|Respective relationship of participant to other dyad in pair.|Participants|Count of Participants|210|210.0||||||
3844162|NCT01672294|3669625|B4|Spouse||Dyad Relationship|Respective relationship of participant to other dyad in pair.|Participants|Count of Participants|53|53.0||||||
3844163|NCT01672294|3669626|B3|Spouse||Dyad Relationship|Respective relationship of participant to other dyad in pair.|Participants|Count of Participants|53|53.0||||||
3844164|NCT01672294|3669627|B2|Spouse||Dyad Relationship|Respective relationship of participant to other dyad in pair.|Participants|Count of Participants|52|52.0||||||
3844165|NCT01672294|3669628|B1|Spouse||Dyad Relationship|Respective relationship of participant to other dyad in pair.|Participants|Count of Participants|52|52.0||||||
3844166|NCT01672294|3669624|B5|United States||Region of Enrollment||participants|Number|286|286.0||||||
3844167|NCT01672294|3669625|B4|United States||Region of Enrollment||participants|Number|72|72.0||||||
3844168|NCT01672294|3669626|B3|United States||Region of Enrollment||participants|Number|72|72.0||||||
3844169|NCT01672294|3669627|B2|United States||Region of Enrollment||participants|Number|71|71.0||||||
3844170|NCT01672294|3669628|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
3844171|NCT01672294|3669624|B5||Unknown or Not Reported|Race (NIH/OMB)|NIH/OMB categories collapsed to: African-American\Black, Caucasian\White Other including more than 1 race, missing|Participants|Count of Participants|2|2.0||||||
3844172|NCT01672294|3669625|B4||Unknown or Not Reported|Race (NIH/OMB)|NIH/OMB categories collapsed to: African-American\Black, Caucasian\White Other including more than 1 race, missing|Participants|Count of Participants|0|0.0||||||
3844173|NCT01672294|3669626|B3||Unknown or Not Reported|Race (NIH/OMB)|NIH/OMB categories collapsed to: African-American\Black, Caucasian\White Other including more than 1 race, missing|Participants|Count of Participants|2|2.0||||||
3844174|NCT01672294|3669627|B2||Unknown or Not Reported|Race (NIH/OMB)|NIH/OMB categories collapsed to: African-American\Black, Caucasian\White Other including more than 1 race, missing|Participants|Count of Participants|0|0.0||||||
3844175|NCT01672294|3669628|B1||Unknown or Not Reported|Race (NIH/OMB)|NIH/OMB categories collapsed to: African-American\Black, Caucasian\White Other including more than 1 race, missing|Participants|Count of Participants|0|0.0||||||
3844176|NCT01672294|3669624|B5||More than one race|Race (NIH/OMB)|NIH/OMB categories collapsed to: African-American\Black, Caucasian\White Other including more than 1 race, missing|Participants|Count of Participants|17|17.0||||||
3844177|NCT01672294|3669625|B4||More than one race|Race (NIH/OMB)|NIH/OMB categories collapsed to: African-American\Black, Caucasian\White Other including more than 1 race, missing|Participants|Count of Participants|2|2.0||||||
3844178|NCT01672294|3669626|B3||More than one race|Race (NIH/OMB)|NIH/OMB categories collapsed to: African-American\Black, Caucasian\White Other including more than 1 race, missing|Participants|Count of Participants|7|7.0||||||
3844179|NCT01672294|3669627|B2||More than one race|Race (NIH/OMB)|NIH/OMB categories collapsed to: African-American\Black, Caucasian\White Other including more than 1 race, missing|Participants|Count of Participants|4|4.0||||||
3844180|NCT01672294|3669628|B1||More than one race|Race (NIH/OMB)|NIH/OMB categories collapsed to: African-American\Black, Caucasian\White Other including more than 1 race, missing|Participants|Count of Participants|4|4.0||||||
3844181|NCT01672294|3669624|B5||White|Race (NIH/OMB)|NIH/OMB categories collapsed to: African-American\Black, Caucasian\White Other including more than 1 race, missing|Participants|Count of Participants|145|145.0||||||
3844182|NCT01672294|3669625|B4||White|Race (NIH/OMB)|NIH/OMB categories collapsed to: African-American\Black, Caucasian\White Other including more than 1 race, missing|Participants|Count of Participants|38|38.0||||||
3844183|NCT01672294|3669626|B3||White|Race (NIH/OMB)|NIH/OMB categories collapsed to: African-American\Black, Caucasian\White Other including more than 1 race, missing|Participants|Count of Participants|33|33.0||||||
3844184|NCT01672294|3669627|B2||White|Race (NIH/OMB)|NIH/OMB categories collapsed to: African-American\Black, Caucasian\White Other including more than 1 race, missing|Participants|Count of Participants|38|38.0||||||
3844185|NCT01672294|3669628|B1||White|Race (NIH/OMB)|NIH/OMB categories collapsed to: African-American\Black, Caucasian\White Other including more than 1 race, missing|Participants|Count of Participants|36|36.0||||||
3844186|NCT01672294|3669624|B5||Black or African American|Race (NIH/OMB)|NIH/OMB categories collapsed to: African-American\Black, Caucasian\White Other including more than 1 race, missing|Participants|Count of Participants|122|122.0||||||
3844187|NCT01672294|3669625|B4||Black or African American|Race (NIH/OMB)|NIH/OMB categories collapsed to: African-American\Black, Caucasian\White Other including more than 1 race, missing|Participants|Count of Participants|32|32.0||||||
3844188|NCT01672294|3669626|B3||Black or African American|Race (NIH/OMB)|NIH/OMB categories collapsed to: African-American\Black, Caucasian\White Other including more than 1 race, missing|Participants|Count of Participants|30|30.0||||||
3844189|NCT01672294|3669627|B2||Black or African American|Race (NIH/OMB)|NIH/OMB categories collapsed to: African-American\Black, Caucasian\White Other including more than 1 race, missing|Participants|Count of Participants|29|29.0||||||
3844233|NCT01672294|3669626|B3|||Age||years|Mean|60.1|60.1|Standard Deviation|12.05|12.05|||
3844234|NCT01672294|3669627|B2|||Age||years|Mean|66.8|66.8|Standard Deviation|7.85|7.85|||
3844190|NCT01672294|3669628|B1||Black or African American|Race (NIH/OMB)|NIH/OMB categories collapsed to: African-American\Black, Caucasian\White Other including more than 1 race, missing|Participants|Count of Participants|31|31.0||||||
3844191|NCT01672294|3669624|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|NIH/OMB categories collapsed to: African-American\Black, Caucasian\White Other including more than 1 race, missing|Participants|Count of Participants|0|0.0||||||
3844192|NCT01672294|3669625|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|NIH/OMB categories collapsed to: African-American\Black, Caucasian\White Other including more than 1 race, missing|Participants|Count of Participants|0|0.0||||||
3844193|NCT01672294|3669626|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|NIH/OMB categories collapsed to: African-American\Black, Caucasian\White Other including more than 1 race, missing|Participants|Count of Participants|0|0.0||||||
3844194|NCT01672294|3669627|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|NIH/OMB categories collapsed to: African-American\Black, Caucasian\White Other including more than 1 race, missing|Participants|Count of Participants|0|0.0||||||
3844195|NCT01672294|3669628|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|NIH/OMB categories collapsed to: African-American\Black, Caucasian\White Other including more than 1 race, missing|Participants|Count of Participants|0|0.0||||||
3844196|NCT01672294|3669624|B5||Asian|Race (NIH/OMB)|NIH/OMB categories collapsed to: African-American\Black, Caucasian\White Other including more than 1 race, missing|Participants|Count of Participants|0|0.0||||||
3844197|NCT01672294|3669625|B4||Asian|Race (NIH/OMB)|NIH/OMB categories collapsed to: African-American\Black, Caucasian\White Other including more than 1 race, missing|Participants|Count of Participants|0|0.0||||||
3844198|NCT01672294|3669626|B3||Asian|Race (NIH/OMB)|NIH/OMB categories collapsed to: African-American\Black, Caucasian\White Other including more than 1 race, missing|Participants|Count of Participants|0|0.0||||||
3844199|NCT01672294|3669627|B2||Asian|Race (NIH/OMB)|NIH/OMB categories collapsed to: African-American\Black, Caucasian\White Other including more than 1 race, missing|Participants|Count of Participants|0|0.0||||||
3844200|NCT01672294|3669628|B1||Asian|Race (NIH/OMB)|NIH/OMB categories collapsed to: African-American\Black, Caucasian\White Other including more than 1 race, missing|Participants|Count of Participants|0|0.0||||||
3844201|NCT01672294|3669624|B5||American Indian or Alaska Native|Race (NIH/OMB)|NIH/OMB categories collapsed to: African-American\Black, Caucasian\White Other including more than 1 race, missing|Participants|Count of Participants|0|0.0||||||
3844202|NCT01672294|3669625|B4||American Indian or Alaska Native|Race (NIH/OMB)|NIH/OMB categories collapsed to: African-American\Black, Caucasian\White Other including more than 1 race, missing|Participants|Count of Participants|0|0.0||||||
3844203|NCT01672294|3669626|B3||American Indian or Alaska Native|Race (NIH/OMB)|NIH/OMB categories collapsed to: African-American\Black, Caucasian\White Other including more than 1 race, missing|Participants|Count of Participants|0|0.0||||||
3844204|NCT01672294|3669627|B2||American Indian or Alaska Native|Race (NIH/OMB)|NIH/OMB categories collapsed to: African-American\Black, Caucasian\White Other including more than 1 race, missing|Participants|Count of Participants|0|0.0||||||
3844205|NCT01672294|3669628|B1||American Indian or Alaska Native|Race (NIH/OMB)|NIH/OMB categories collapsed to: African-American\Black, Caucasian\White Other including more than 1 race, missing|Participants|Count of Participants|0|0.0||||||
3844206|NCT01672294|3669624|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3844207|NCT01672294|3669625|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844208|NCT01672294|3669626|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3844209|NCT01672294|3669627|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844210|NCT01672294|3669628|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844211|NCT01672294|3669624|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|277|277.0||||||
3844212|NCT01672294|3669625|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3844213|NCT01672294|3669626|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3844214|NCT01672294|3669627|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3844215|NCT01672294|3669628|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3844216|NCT01672294|3669624|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3844217|NCT01672294|3669625|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844218|NCT01672294|3669626|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3844219|NCT01672294|3669627|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3844220|NCT01672294|3669628|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3844221|NCT01672294|3669624|B5||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3844222|NCT01672294|3669625|B4||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3844223|NCT01672294|3669626|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3844224|NCT01672294|3669627|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3844225|NCT01672294|3669628|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3844226|NCT01672294|3669624|B5||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3844227|NCT01672294|3669625|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3844228|NCT01672294|3669626|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3844229|NCT01672294|3669627|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3844230|NCT01672294|3669628|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3844231|NCT01672294|3669624|B5|||Age||years|Mean|63.3|63.3|Standard Deviation|10.59|10.59|||
3844232|NCT01672294|3669625|B4|||Age||years|Mean|65.4|65.4|Standard Deviation|9.21|9.21|||
3844235|NCT01672294|3669628|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|11.32|11.32|||
3844236|NCT01672242|3669653|B1|||FEV1/FVC (%)||ratio|Median|102|102.0|Inter-Quartile Range|||97.0|107.0|
3844237|NCT01672242|3669653|B1|||FEV1 (% predicted)||% predicted|Median|93|93.0|Inter-Quartile Range|||90.0|102.0|
3844238|NCT01672242|3669653|B1|||predicted body weight||kg|Median|75.3|75.3|Inter-Quartile Range|||68.4|82.2|
3844239|NCT01672242|3669653|B1|||height||inches|Median|71|71.0|Inter-Quartile Range|||68.5|74.0|
3844240|NCT01672242|3669653|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3844241|NCT01672242|3669653|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844242|NCT01672242|3669653|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844243|NCT01672242|3669653|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3844244|NCT01672242|3669653|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844245|NCT01672242|3669653|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844246|NCT01672242|3669653|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844247|NCT01672242|3669653|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844248|NCT01672242|3669653|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3844249|NCT01672242|3669653|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3844250|NCT01672242|3669653|B1|||Age|Age|years|Median|35.5|35.5|Inter-Quartile Range|||32.75|56.0|
3844251|NCT01671839|3669660|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3844252|NCT01671839|3669660|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3844253|NCT01671839|3669660|B1|||Age||Years|Mean|40.7|40.7|Standard Deviation|9.1|9.1|||
3844254|NCT01671748|3669669|B3|||Change in wound size during run-in phase (%)||percentage change in wound area|Mean|-12.0|-12.0|Standard Deviation|24.3|24.3|||
3844255|NCT01671748|3669670|B2|||Change in wound size during run-in phase (%)||percentage change in wound area|Mean|-10.9|-10.9|Standard Deviation|23.9|23.9|||
3844256|NCT01671748|3669671|B1|||Change in wound size during run-in phase (%)||percentage change in wound area|Mean|-13.0|-13.0|Standard Deviation|25.2|25.2|||
3844257|NCT01671748|3669669|B3|||Wound size at enrolment (cm^2)||cm^2|Mean|17.8|17.8|Standard Deviation|12.7|12.7|||
3844258|NCT01671748|3669670|B2|||Wound size at enrolment (cm^2)||cm^2|Mean|15.9|15.9|Standard Deviation|9.9|9.9|||
3844259|NCT01671748|3669671|B1|||Wound size at enrolment (cm^2)||cm^2|Mean|19.4|19.4|Standard Deviation|14.9|14.9|||
3844260|NCT01671748|3669669|B3|||Index ulcer duration (months)||months|Mean|19|19.0|Standard Deviation|16|16.0|||
3844261|NCT01671748|3669670|B2|||Index ulcer duration (months)||months|Mean|15.7|15.7|Standard Deviation|12.0|12.0|||
3844262|NCT01671748|3669671|B1|||Index ulcer duration (months)||months|Mean|22.3|22.3|Standard Deviation|18.5|18.5|||
3844263|NCT01671748|3669669|B3|||History of leg ulceration (months)||months|Mean|101.8|101.8|Standard Deviation|96.8|96.8|||
3844264|NCT01671748|3669670|B2|||History of leg ulceration (months)||months|Mean|109.7|109.7|Standard Deviation|112.2|112.2|||
3844265|NCT01671748|3669671|B1|||History of leg ulceration (months)||months|Mean|94.7|94.7|Standard Deviation|83.2|83.2|||
3844266|NCT01671748|3669669|B3|United Kingdom||Region of Enrollment||participants|Number|36|36.0||||||
3844267|NCT01671748|3669670|B2|United Kingdom||Region of Enrollment||participants|Number|17|17.0||||||
3844268|NCT01671748|3669671|B1|United Kingdom||Region of Enrollment||participants|Number|19|19.0||||||
3844269|NCT01671748|3669669|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3844270|NCT01671748|3669670|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3844271|NCT01671748|3669671|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3844272|NCT01671748|3669669|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3844273|NCT01671748|3669670|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3844274|NCT01671748|3669671|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3844275|NCT01671748|3669669|B3|||Age||years|Mean|69|69.0|Standard Deviation|12.0|12.0|||
3844276|NCT01671748|3669670|B2|||Age||years|Mean|70.5|70.5|Standard Deviation|12.7|12.7|||
3844277|NCT01671748|3669671|B1|||Age||years|Mean|68.2|68.2|Standard Deviation|12.2|12.2|||
3844278|NCT01671605|3669690|B3|||HDL Function||Percentage|Median|23.65|23.65|Inter-Quartile Range|||16.1|28.5|
3844279|NCT01671605|3669691|B2|||HDL Function||Percentage|Median|26.5|26.5|Inter-Quartile Range|||19.6|28.5|
3844280|NCT01671605|3669692|B1|||HDL Function||Percentage|Median|20.8|20.8|Inter-Quartile Range|||16.1|23.7|
3844281|NCT01671605|3669690|B3|United States||Region of Enrollment||participants|Number|103|103.0||||||
3844282|NCT01671605|3669691|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
3844283|NCT01671605|3669692|B1|United States||Region of Enrollment||participants|Number|72|72.0||||||
3844284|NCT01671605|3669690|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844285|NCT01671605|3669691|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844286|NCT01671605|3669692|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844287|NCT01671605|3669690|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844288|NCT01671605|3669691|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844289|NCT01671605|3669692|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844290|NCT01671605|3669690|B3||White|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3844291|NCT01671605|3669691|B2||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3844292|NCT01671605|3669692|B1||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3844293|NCT01671605|3669690|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3844294|NCT01671605|3669691|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3844295|NCT01671605|3669692|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3844296|NCT01671605|3669690|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844297|NCT01671605|3669691|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844298|NCT01671605|3669692|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844299|NCT01671605|3669690|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3844300|NCT01671605|3669691|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3844301|NCT01671605|3669692|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3844302|NCT01671605|3669690|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844303|NCT01671605|3669691|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844304|NCT01671605|3669692|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844305|NCT01671605|3669690|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3844306|NCT01671605|3669691|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3844307|NCT01671605|3669692|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3844308|NCT01671605|3669690|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3844309|NCT01671605|3669691|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3844310|NCT01671605|3669692|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3844311|NCT01671605|3669690|B3|||Age||years|Mean|55.9|55.9|Standard Deviation|12.0|12.0|||
3844312|NCT01671605|3669691|B2|||Age||years|Mean|49.9|49.9|Standard Deviation|10.6|10.6|||
3844313|NCT01671605|3669692|B1|||Age||years|Mean|61.9|61.9|Standard Deviation|13.5|13.5|||
3844314|NCT01671488|3669699|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3844315|NCT01671488|3669699|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844316|NCT01671488|3669699|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3844317|NCT01671488|3669699|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844318|NCT01671488|3669699|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3844319|NCT01671488|3669699|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3844320|NCT01671488|3669699|B1|||Age||years|Mean|60.36|60.36|Full Range|||37.0|71.0|
3844321|NCT01671488|3669699|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3844322|NCT01671488|3669699|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3844323|NCT01671488|3669699|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3844324|NCT01671319|3669705|B1|Breast conservation||Final Surgery||Participants|Count of Participants|21|21.0||||||
3844325|NCT01671319|3669705|B1|Mastectomy||Final Surgery||Participants|Count of Participants|20|20.0||||||
3844326|NCT01671319|3669705|B1|Triple negative||Receptor Status||Participants|Count of Participants|11|11.0||||||
3844327|NCT01671319|3669705|B1|HER2-positive||Receptor Status||Participants|Count of Participants|1|1.0||||||
3844328|NCT01671319|3669705|B1|Hormone receptor-postive||Receptor Status||Participants|Count of Participants|29|29.0||||||
3844329|NCT01671319|3669705|B1|T2||Staging Criteria|"Participants were staged according to the American Joint Committee on Cancer (AJCC) staging manual.~Node-negative: cancer has not spread to the lymph nodes Node-positive: cancer that has spread to the lymph nodes T1 and T2 refer to the size and/or extent of the main tumor. The higher the number after the T, the larger the tumor or the more it has grown into nearby tissues."|Participants|Count of Participants|20|20.0||||||
3844330|NCT01671319|3669705|B1|T1||Staging Criteria|"Participants were staged according to the American Joint Committee on Cancer (AJCC) staging manual.~Node-negative: cancer has not spread to the lymph nodes Node-positive: cancer that has spread to the lymph nodes T1 and T2 refer to the size and/or extent of the main tumor. The higher the number after the T, the larger the tumor or the more it has grown into nearby tissues."|Participants|Count of Participants|21|21.0||||||
3844331|NCT01671319|3669705|B1|Nodes unknown||Staging Criteria|"Participants were staged according to the American Joint Committee on Cancer (AJCC) staging manual.~Node-negative: cancer has not spread to the lymph nodes Node-positive: cancer that has spread to the lymph nodes T1 and T2 refer to the size and/or extent of the main tumor. The higher the number after the T, the larger the tumor or the more it has grown into nearby tissues."|Participants|Count of Participants|1|1.0||||||
3844332|NCT01671319|3669705|B1|Node-positive||Staging Criteria|"Participants were staged according to the American Joint Committee on Cancer (AJCC) staging manual.~Node-negative: cancer has not spread to the lymph nodes Node-positive: cancer that has spread to the lymph nodes T1 and T2 refer to the size and/or extent of the main tumor. The higher the number after the T, the larger the tumor or the more it has grown into nearby tissues."|Participants|Count of Participants|10|10.0||||||
3844333|NCT01671319|3669705|B1|Node-negative||Staging Criteria|"Participants were staged according to the American Joint Committee on Cancer (AJCC) staging manual.~Node-negative: cancer has not spread to the lymph nodes Node-positive: cancer that has spread to the lymph nodes T1 and T2 refer to the size and/or extent of the main tumor. The higher the number after the T, the larger the tumor or the more it has grown into nearby tissues."|Participants|Count of Participants|30|30.0||||||
3844334|NCT01671319|3669705|B1|Postmenopausal||Pre- vs. Postmenopausal||Participants|Count of Participants|26|26.0||||||
3844335|NCT01671319|3669705|B1|Premenopausal||Pre- vs. Postmenopausal||Participants|Count of Participants|15|15.0||||||
3844336|NCT01671319|3669705|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
3844337|NCT01671319|3669705|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844338|NCT01671319|3669705|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844339|NCT01671319|3669705|B1||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3844340|NCT01671319|3669705|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3844341|NCT01671319|3669705|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844342|NCT01671319|3669705|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844343|NCT01671319|3669705|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844344|NCT01671319|3669705|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3844345|NCT01671319|3669705|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3844346|NCT01671319|3669705|B1|||Age||years|Median|54|54.0|Full Range|||28.0|73.0|
3844347|NCT01671293|3669711|B3|Chile||Region of Enrollment||participants|Number|70|70.0||||||
3844348|NCT01671293|3669712|B2|Chile||Region of Enrollment||participants|Number|34|34.0||||||
3844349|NCT01671293|3669713|B1|Chile||Region of Enrollment||participants|Number|36|36.0||||||
3844350|NCT01671293|3669711|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3844351|NCT01671293|3669712|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3844352|NCT01671293|3669713|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3844353|NCT01671293|3669711|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3844354|NCT01671293|3669712|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3844355|NCT01671293|3669713|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3844356|NCT01671293|3669711|B3|||Age||years|Mean|52.77|52.77|Standard Deviation|8.71|8.71|||
3844357|NCT01671293|3669712|B2|||Age||years|Mean|54.88|54.88|Standard Deviation|8.59|8.59|||
3844358|NCT01671293|3669713|B1|||Age||years|Mean|50.78|50.78|Standard Deviation|8.46|8.46|||
3844359|NCT01671280|3669720|B1|Other*||Disease Type|* indicates comorbidities tabulated in duplicate.|participants|Number|6|6.0||||||
3844360|NCT01671280|3669720|B1|Pelvic inflammatory disease*||Disease Type|* indicates comorbidities tabulated in duplicate.|participants|Number|98|98.0||||||
3844361|NCT01671280|3669720|B1|Pneumonia*||Disease Type|* indicates comorbidities tabulated in duplicate.|participants|Number|299|299.0||||||
3844362|NCT01671280|3669720|B1||Male|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
3844363|NCT01671280|3669720|B1||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
3844364|NCT01671280|3669720|B1|≥65 years||Age, Customized||Participants|Number|208|208.0||||||
3844365|NCT01671280|3669720|B1|≥15 and <65 years||Age, Customized||Participants|Number|191|191.0||||||
3844366|NCT01671280|3669720|B1|<15 years||Age, Customized||Participants|Number|1|1.0||||||
3844367|NCT01671176|3669726|B1|||Height||centimeters|Mean|163.79|163.79|Standard Deviation|8.89|8.89|||
3844368|NCT01671176|3669726|B1|||BMI||kilogram/M^2|Mean|28.56|28.56|Standard Deviation|7.09|7.09|||
3844369|NCT01671176|3669726|B1|||Weight||kilogram|Mean|76.72|76.72|Standard Deviation|19.61|19.61|||
3844370|NCT01671176|3669726|B1|12 mm||Abutment length||participants|Number|3|3.0||||||
3844371|NCT01671176|3669726|B1|9 mm||Abutment length||participants|Number|7|7.0||||||
3844372|NCT01671176|3669726|B1|6 mm||Abutment length||participants|Number|20|20.0||||||
3844373|NCT01671176|3669726|B1|no||Diabetes||participants|Number|27|27.0||||||
3844374|NCT01671176|3669726|B1|yes||Diabetes||participants|Number|3|3.0||||||
3844375|NCT01671176|3669726|B1|no||Smoking status||participants|Number|29|29.0||||||
3844376|NCT01671176|3669726|B1|yes||Smoking status||participants|Number|1|1.0||||||
3844377|NCT01671176|3669726|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3844378|NCT01671176|3669726|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3844379|NCT01671176|3669726|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3844380|NCT01671176|3669726|B1|||Age||years|Mean|60.83|60.83|Standard Deviation|16.07|16.07|||
3844381|NCT01671111|3669731|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3844382|NCT01671111|3669731|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3844383|NCT01671111|3669731|B1|||Age||years|Mean|25.5|25.5|Standard Deviation|11.38|11.38|||
3844384|NCT01671059|3669741|B1||Male|Gender||Participants|Count of Participants|13|13.0||||||
3844385|NCT01671059|3669741|B1||Female|Gender||Participants|Count of Participants|67|67.0||||||
3844386|NCT01671059|3669741|B1|||Age||years|Mean|50.6|50.6|Standard Deviation|11.98|11.98|||
3844387|NCT01670825|3669764|B3|Germany||Region of Enrollment||participants|Number|2|2.0||||||
3844388|NCT01670825|3669765|B2|Germany||Region of Enrollment||participants|Number|1|1.0||||||
3844389|NCT01670825|3669766|B1|Germany||Region of Enrollment||participants|Number|1|1.0||||||
3844390|NCT01670825|3669764|B3|United States||Region of Enrollment||participants|Number|79|79.0||||||
3844391|NCT01670825|3669765|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
3844392|NCT01670825|3669766|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
3844393|NCT01670825|3669764|B3||Male|Gender||Participants|Count of Participants|43|43.0||||||
3844394|NCT01670825|3669765|B2||Male|Gender||Participants|Count of Participants|21|21.0||||||
3844395|NCT01670825|3669766|B1||Male|Gender||Participants|Count of Participants|22|22.0||||||
3844396|NCT01670825|3669764|B3||Female|Gender||Participants|Count of Participants|38|38.0||||||
3844397|NCT01670825|3669765|B2||Female|Gender||Participants|Count of Participants|18|18.0||||||
3844398|NCT01670825|3669766|B1||Female|Gender||Participants|Count of Participants|20|20.0||||||
3844399|NCT01670825|3669764|B3|||Age||years|Mean|41.37|41.37|Standard Deviation|12.16|12.16|||
3844400|NCT01670825|3669765|B2|||Age||years|Mean|41.08|41.08|Standard Deviation|13.61|13.61|||
3844401|NCT01670825|3669766|B1|||Age||years|Mean|41.67|41.67|Standard Deviation|10.72|10.72|||
3844402|NCT01670825|3669764|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3844403|NCT01670825|3669765|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3844404|NCT01670825|3669766|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3844405|NCT01670825|3669764|B3||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
3844406|NCT01670825|3669765|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3844407|NCT01670825|3669766|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3844408|NCT01670825|3669764|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3844409|NCT01670825|3669765|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3844410|NCT01670825|3669766|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3844411|NCT01670721|3669833|B1||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3844412|NCT01670721|3669833|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3844413|NCT01670721|3669833|B1|||Age||years|Mean|64.5|64.5|Standard Deviation|11.0|11.0|||
3844414|NCT01670656|3669840|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3844415|NCT01670656|3669841|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3844416|NCT01670656|3669842|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3844417|NCT01670656|3669843|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3844418|NCT01670656|3669844|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3844419|NCT01670656|3669845|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3844420|NCT01670656|3669840|B6||Female|Sex: Female, Male||Participants|Count of Participants|439|439.0||||||
3844421|NCT01670656|3669841|B5||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3844422|NCT01670656|3669842|B4||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3844423|NCT01670656|3669843|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3844424|NCT01670656|3669844|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3844425|NCT01670656|3669845|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3844426|NCT01670656|3669840|B6|||Age||Years|Mean|28.6|28.6|Standard Deviation|7.8|7.8|||
3844427|NCT01670656|3669841|B5|||Age||Years|Mean|28.4|28.4|Standard Deviation|8.2|8.2|||
3844428|NCT01670656|3669842|B4|||Age||Years|Mean|28.3|28.3|Standard Deviation|7.8|7.8|||
3844429|NCT01670656|3669843|B3|||Age||Years|Mean|29.0|29.0|Standard Deviation|7.7|7.7|||
3844430|NCT01670656|3669844|B2|||Age||Years|Mean|28.7|28.7|Standard Deviation|8.1|8.1|||
3844431|NCT01670656|3669845|B1|||Age||Years|Mean|28.7|28.7|Standard Deviation|7.5|7.5|||
3844432|NCT01670526|3669876|B3|United States||Region of Enrollment||participants|Number|94|94.0||||||
3844433|NCT01670526|3669877|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
3844434|NCT01670526|3669878|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
3844435|NCT01670526|3669876|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3844436|NCT01670526|3669877|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3844437|NCT01670526|3669878|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3844438|NCT01670526|3669876|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844439|NCT01670526|3669877|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844440|NCT01670526|3669878|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844441|NCT01670526|3669876|B3||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3844442|NCT01670526|3669877|B2||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3844443|NCT01670526|3669878|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3844444|NCT01670526|3669876|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3844445|NCT01670526|3669877|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3844446|NCT01670526|3669878|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3844447|NCT01670526|3669876|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844448|NCT01670526|3669877|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844449|NCT01670526|3669878|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844450|NCT01670526|3669876|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3844451|NCT01670526|3669877|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844452|NCT01670526|3669878|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3844453|NCT01670526|3669876|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3844454|NCT01670526|3669877|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844455|NCT01670526|3669878|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3844456|NCT01670526|3669876|B3||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3844457|NCT01670526|3669877|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3844458|NCT01670526|3669878|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3844459|NCT01670526|3669876|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3844460|NCT01670526|3669877|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3844461|NCT01670526|3669878|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3844462|NCT01670526|3669876|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3844463|NCT01670526|3669877|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3844464|NCT01670526|3669878|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3844465|NCT01670526|3669876|B3||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
3844466|NCT01670526|3669877|B2||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3844467|NCT01670526|3669878|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3844468|NCT01670526|3669876|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3844469|NCT01670526|3669877|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3844470|NCT01670526|3669878|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3844471|NCT01670487|3669891|B3||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3844472|NCT01670487|3669892|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3844473|NCT01670487|3669893|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3844474|NCT01670487|3669891|B3||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3844475|NCT01670487|3669892|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3844476|NCT01670487|3669893|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3844477|NCT01670487|3669891|B3|||Age||years|Median|51|51.0|Inter-Quartile Range|||35.0|62.0|
3844478|NCT01670487|3669892|B2|||Age||years|Median|50|50.0|Inter-Quartile Range|||37.0|62.0|
3844479|NCT01670487|3669893|B1|||Age||years|Median|52|52.0|Inter-Quartile Range|||35.0|60.0|
3844480|NCT01670292|3669900|B1|RMDQ||Baseline Patient-Centered Outcome Measures|"VAS - Visual Analog Scale: The VAS is a single-item, unidimensional measure for pain. Score interpretations for the VAS include the following cut points: no pain (0 to 4 mm), mild pain (5 to 44 mm), moderate pain (45 to 74 mm), and severe pain (75 to 100 mm).~RMDQ - Roland Morris disability questionnaire: The RMDQ consists of 24 questions related to disability, with each question worth one point. Scores can range from 0 (no disability) to 24 (severe disability)."|units on a scale|Mean|9.5|9.5|Standard Deviation|4.3|4.3|||
3844481|NCT01670292|3669900|B1|VAS||Baseline Patient-Centered Outcome Measures|"VAS - Visual Analog Scale: The VAS is a single-item, unidimensional measure for pain. Score interpretations for the VAS include the following cut points: no pain (0 to 4 mm), mild pain (5 to 44 mm), moderate pain (45 to 74 mm), and severe pain (75 to 100 mm).~RMDQ - Roland Morris disability questionnaire: The RMDQ consists of 24 questions related to disability, with each question worth one point. Scores can range from 0 (no disability) to 24 (severe disability)."|units on a scale|Mean|46.1|46.1|Standard Deviation|18.1|18.1|||
3844482|NCT01670292|3669900|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3844483|NCT01670292|3669900|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3844484|NCT01670292|3669900|B1|||Age||years|Mean|44.9|44.9|Standard Deviation|10.6|10.6|||
3844485|NCT01670279|3669938|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3844486|NCT01670279|3669939|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3844487|NCT01670279|3669940|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3844488|NCT01670279|3669941|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3844489|NCT01670279|3669938|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3844490|NCT01670279|3669939|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3844491|NCT01670279|3669940|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3844492|NCT01670279|3669941|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3844493|NCT01670279|3669938|B4|||Age||Years|Mean|74.1|74.1|Standard Deviation|4.2|4.2|||
3844494|NCT01670279|3669939|B3|||Age||Years|Mean|72.6|72.6|Standard Deviation|1.5|1.5|||
3844495|NCT01670279|3669940|B2|||Age||Years|Mean|76.0|76.0|Standard Deviation|5.3|5.3|||
3844496|NCT01670279|3669941|B1|||Age||Years|Mean|73.2|73.2|Standard Deviation|4.0|4.0|||
3844497|NCT01670201|3669979|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3844498|NCT01670201|3669979|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3844499|NCT01670201|3669979|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3844500|NCT01670201|3669979|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3844501|NCT01670201|3669979|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3844502|NCT01670201|3669979|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3844503|NCT01670188|3669984|B3|United States||Region of Enrollment||participants|Number|77|77.0||||||
3844504|NCT01670188|3669985|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
3844505|NCT01670188|3669986|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
3844506|NCT01670188|3669984|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3844507|NCT01670188|3669984|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3844508|NCT01670188|3669985|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3844509|NCT01670188|3669986|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3844510|NCT01670188|3669984|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3844511|NCT01670188|3669985|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3844512|NCT01670188|3669986|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3844513|NCT01670188|3669984|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3844514|NCT01670188|3669985|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3844515|NCT01670188|3669986|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3844516|NCT01670188|3669984|B3||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
3844517|NCT01670188|3669985|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3844518|NCT01670188|3669986|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3844519|NCT01670188|3669984|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3844520|NCT01670188|3669985|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3844521|NCT01670188|3669986|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3844522|NCT01670045|3669993|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3844523|NCT01670045|3669993|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3844524|NCT01670045|3669993|B1|||Age||years|Mean|44|44.0|Full Range|||18.0|66.0|
3844525|NCT01670019|3670009|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3844526|NCT01670019|3670010|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3844527|NCT01670019|3670011|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3844528|NCT01670019|3670009|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3844529|NCT01670019|3670010|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3844530|NCT01670019|3670011|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3844531|NCT01670019|3670009|B3|||Age||years|Mean|45.13|45.13|Standard Deviation|11.59|11.59|||
3844532|NCT01670019|3670010|B2|||Age||years|Mean|45.87|45.87|Standard Deviation|12.016|12.016|||
3844533|NCT01670019|3670011|B1|||Age||years|Mean|44.39|44.39|Standard Deviation|11.34|11.34|||
3844534|NCT01669902|3670026|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3844535|NCT01669902|3670026|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3844536|NCT01669902|3670026|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|13.3|13.3|||
3844537|NCT01669863|3670053|B1|Germany||Region of Enrollment||participants|Number|6|6.0||||||
3844538|NCT01669863|3670053|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3844539|NCT01669863|3670053|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3844540|NCT01669863|3670053|B1|||Age, Customized||years|Mean|60|60.0|Standard Deviation|10|10.0|||
3844541|NCT01669811|3670059|B3|Asian||Race/Ethnicity, Customized||Participants|Number|285|285.0||||||
3844542|NCT01669811|3670060|B2|Asian||Race/Ethnicity, Customized||Participants|Number|140|140.0||||||
3844543|NCT01669811|3670061|B1|Asian||Race/Ethnicity, Customized||Participants|Number|145|145.0||||||
3844544|NCT01669811|3670059|B3||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3844545|NCT01669811|3670060|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3844546|NCT01669811|3670061|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3844547|NCT01669811|3670059|B3||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3844548|NCT01669811|3670060|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3844549|NCT01669811|3670061|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3844550|NCT01669811|3670059|B3|>=65||Age, Customized||Participants|Number|148|148.0||||||
3844551|NCT01669811|3670060|B2|>=65||Age, Customized||Participants|Number|71|71.0||||||
3844552|NCT01669811|3670061|B1|>=65||Age, Customized||Participants|Number|77|77.0||||||
3844553|NCT01669811|3670059|B3|<65||Age, Customized||Participants|Number|137|137.0||||||
3844554|NCT01669811|3670060|B2|<65||Age, Customized||Participants|Number|69|69.0||||||
3844555|NCT01669811|3670061|B1|<65||Age, Customized||Participants|Number|68|68.0||||||
3844556|NCT01669811|3670059|B3|||Age||Years|Mean|63.2|63.2|Standard Deviation|14.35|14.35|24.0|91.0|
3844557|NCT01669811|3670060|B2|||Age||Years|Mean|61.7|61.7|Standard Deviation|14.72|14.72|24.0|91.0|
3844558|NCT01669811|3670061|B1|||Age||Years|Mean|64.7|64.7|Standard Deviation|13.87|13.87|32.0|90.0|
3844559|NCT01669798|3670080|B1|Four prior regimens||Number of prior therapy regimens||Participants|Count of Participants|2|2.0||||||
3844560|NCT01669798|3670080|B1|Three prior regimens||Number of prior therapy regimens||Participants|Count of Participants|7|7.0||||||
3844561|NCT01669798|3670080|B1|Two prior regimens||Number of prior therapy regimens||Participants|Count of Participants|10|10.0||||||
3844562|NCT01669798|3670080|B1|One prior regimen||Number of prior therapy regimens||Participants|Count of Participants|8|8.0||||||
3844563|NCT01669798|3670080|B1|Third-line chemotherapy plus bevacizumab||Antecedent Bevacizumab (bev) therapy prior to starting trial||Participants|Count of Participants|1|1.0||||||
3844564|NCT01669798|3670080|B1|Second line single agent bevacizumab||Antecedent Bevacizumab (bev) therapy prior to starting trial||Participants|Count of Participants|6|6.0||||||
3844565|NCT01669798|3670080|B1|Secon-line chemo with bev, without bev maintenance||Antecedent Bevacizumab (bev) therapy prior to starting trial||Participants|Count of Participants|4|4.0||||||
3844566|NCT01669798|3670080|B1|Second-line chemo with bev, plus bev maintenance||Antecedent Bevacizumab (bev) therapy prior to starting trial||Participants|Count of Participants|5|5.0||||||
3844567|NCT01669798|3670080|B1|Front-line chemo with bev, without bev maintenance||Antecedent Bevacizumab (bev) therapy prior to starting trial||Participants|Count of Participants|2|2.0||||||
3844568|NCT01669798|3670080|B1|Front-line chemo with bev, plus bev maintenance||Antecedent Bevacizumab (bev) therapy prior to starting trial||Participants|Count of Participants|9|9.0||||||
3844569|NCT01669798|3670080|B1|Platinum Sensitive||Platinum based treatment resistant/sensitive||Participants|Count of Participants|5|5.0||||||
3844570|NCT01669798|3670080|B1|Platinum Resistant||Platinum based treatment resistant/sensitive||Participants|Count of Participants|22|22.0||||||
3844571|NCT01669798|3670080|B1|Serous Adenocarcinoma||Histologic tumor type||Participants|Count of Participants|24|24.0||||||
3844572|NCT01669798|3670080|B1|Other: Poorly Differentiated Adenocarcinoma||Histologic tumor type||Participants|Count of Participants|1|1.0||||||
3844573|NCT01669798|3670080|B1|Clear Cell Carcinoma||Histologic tumor type||Participants|Count of Participants|1|1.0||||||
3844574|NCT01669798|3670080|B1|Adenocarcinoma, Unspecified||Histologic tumor type||Participants|Count of Participants|1|1.0||||||
3844575|NCT01669798|3670080|B1|Peritoneum||Primary site of tumor||Participants|Count of Participants|1|1.0||||||
3844576|NCT01669798|3670080|B1|Ovary||Primary site of tumor||Participants|Count of Participants|26|26.0||||||
3844577|NCT01669798|3670080|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3844578|NCT01669798|3670080|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844579|NCT01669798|3670080|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3844580|NCT01669798|3670080|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3844581|NCT01669798|3670080|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844582|NCT01669798|3670080|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844583|NCT01669798|3670080|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844584|NCT01669798|3670080|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3844585|NCT01669798|3670080|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3844586|NCT01669798|3670080|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844587|NCT01669798|3670080|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3844588|NCT01669798|3670080|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3844589|NCT01669798|3670080|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3844590|NCT01669798|3670080|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3844591|NCT01669798|3670080|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3844592|NCT01669785|3670093|B4|United States||Region of Enrollment||participants|Number|139|139.0||||||
3844593|NCT01669785|3670094|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
3844594|NCT01669785|3670095|B2|United States||Region of Enrollment||participants|Number|48|48.0||||||
3844595|NCT01669785|3670096|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
3844596|NCT01669785|3670093|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3844597|NCT01669785|3670094|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3844598|NCT01669785|3670095|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3844599|NCT01669785|3670096|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3844600|NCT01669785|3670093|B4||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3844601|NCT01669785|3670094|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3844602|NCT01669785|3670095|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3844603|NCT01669785|3670096|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3844604|NCT01669785|3670093|B4|||Age, Customized||mean years of age|Mean|43|43.0|Standard Deviation|11.10967|11.10967|||
3844605|NCT01669785|3670094|B3|||Age, Customized||mean years of age|Mean|43|43.0|Standard Deviation|10.928|10.928|||
3844606|NCT01669785|3670095|B2|||Age, Customized||mean years of age|Mean|41|41.0|Standard Deviation|11.21829|11.21829|||
3844607|NCT01669785|3670096|B1|||Age, Customized||mean years of age|Mean|44|44.0|Standard Deviation|11.18274|11.18274|||
3844608|NCT01669720|3670133|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3844609|NCT01669720|3670134|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3844610|NCT01669720|3670135|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3844611|NCT01669720|3670133|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3844612|NCT01669720|3670134|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3844613|NCT01669720|3670135|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3844614|NCT01669720|3670133|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3844615|NCT01669720|3670134|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3844616|NCT01669720|3670135|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3844617|NCT01669720|3670133|B3|||Age||years|Mean|54.6|54.6|Full Range|||44.0|75.0|
3844618|NCT01669720|3670134|B2|||Age||years|Mean|57|57.0|Full Range|||44.0|75.0|
3844619|NCT01669720|3670135|B1|||Age||years|Mean|53.5|53.5|Full Range|||46.0|61.0|
3844620|NCT01669720|3670133|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3844621|NCT01669720|3670134|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3844622|NCT01669720|3670135|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3844623|NCT01669720|3670133|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3844624|NCT01669720|3670134|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3844625|NCT01669720|3670135|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3844626|NCT01669720|3670133|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3844627|NCT01669720|3670134|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3844628|NCT01669720|3670135|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3844629|NCT01669642|3670144|B6||no fracture|fracture characteristics||Participants|Count of Participants|40|40.0||||||
3844630|NCT01669642|3670145|B5||no fracture|fracture characteristics||Participants|Count of Participants|20|20.0||||||
3844631|NCT01669642|3670146|B4||no fracture|fracture characteristics||Participants|Count of Participants|20|20.0||||||
3844632|NCT01669642|3670147|B3||no fracture|fracture characteristics||Participants|Count of Participants|0|0.0||||||
3844633|NCT01669642|3670148|B2||no fracture|fracture characteristics||Participants|Count of Participants|0|0.0||||||
3844634|NCT01669642|3670149|B1||no fracture|fracture characteristics||Participants|Count of Participants|0|0.0||||||
3844635|NCT01669642|3670144|B6||displaced fracture and overriding|fracture characteristics||Participants|Count of Participants|15|15.0||||||
3844636|NCT01669642|3670145|B5||displaced fracture and overriding|fracture characteristics||Participants|Count of Participants|0|0.0||||||
3844637|NCT01669642|3670146|B4||displaced fracture and overriding|fracture characteristics||Participants|Count of Participants|0|0.0||||||
3844638|NCT01669642|3670147|B3||displaced fracture and overriding|fracture characteristics||Participants|Count of Participants|4|4.0||||||
3844639|NCT01669642|3670148|B2||displaced fracture and overriding|fracture characteristics||Participants|Count of Participants|7|7.0||||||
3844640|NCT01669642|3670149|B1||displaced fracture and overriding|fracture characteristics||Participants|Count of Participants|4|4.0||||||
3844641|NCT01669642|3670144|B6||displaced fracture but not overriding|fracture characteristics||Participants|Count of Participants|24|24.0||||||
3844642|NCT01669642|3670145|B5||displaced fracture but not overriding|fracture characteristics||Participants|Count of Participants|0|0.0||||||
3844643|NCT01669642|3670146|B4||displaced fracture but not overriding|fracture characteristics||Participants|Count of Participants|0|0.0||||||
3844644|NCT01669642|3670147|B3||displaced fracture but not overriding|fracture characteristics||Participants|Count of Participants|7|7.0||||||
3844645|NCT01669642|3670148|B2||displaced fracture but not overriding|fracture characteristics||Participants|Count of Participants|11|11.0||||||
3844646|NCT01669642|3670149|B1||displaced fracture but not overriding|fracture characteristics||Participants|Count of Participants|6|6.0||||||
3844647|NCT01669642|3670144|B6||Non displaced fracture|fracture characteristics||Participants|Count of Participants|21|21.0||||||
3844648|NCT01669642|3670145|B5||Non displaced fracture|fracture characteristics||Participants|Count of Participants|0|0.0||||||
3844649|NCT01669642|3670146|B4||Non displaced fracture|fracture characteristics||Participants|Count of Participants|0|0.0||||||
3844650|NCT01669642|3670147|B3||Non displaced fracture|fracture characteristics||Participants|Count of Participants|9|9.0||||||
3844651|NCT01669642|3670148|B2||Non displaced fracture|fracture characteristics||Participants|Count of Participants|2|2.0||||||
3844652|NCT01669642|3670149|B1||Non displaced fracture|fracture characteristics||Participants|Count of Participants|10|10.0||||||
3844653|NCT01669642|3670144|B6|||time between opioid administration and sedation start time||minutes|Median|116|116.0|Full Range|||1.0|401.0|
3844654|NCT01669642|3670145|B5|||time between opioid administration and sedation start time||minutes|Median|0|0.0|Full Range|||0.0|0.0|
3844655|NCT01669642|3670146|B4|||time between opioid administration and sedation start time||minutes|Median|0|0.0|Full Range|||0.0|0.0|
3844656|NCT01669642|3670147|B3|||time between opioid administration and sedation start time||minutes|Median|129|129.0|Full Range|||27.0|401.0|
3844657|NCT01669642|3670148|B2|||time between opioid administration and sedation start time||minutes|Median|96|96.0|Full Range|||1.0|251.0|
3844658|NCT01669642|3670149|B1|||time between opioid administration and sedation start time||minutes|Median|116|116.0|Full Range|||20.0|383.0|
3844659|NCT01669642|3670144|B6|||Patients who received Opioids prior to sedation||Participants|Count of Participants|56|56.0||||||
3844660|NCT01669642|3670145|B5|||Patients who received Opioids prior to sedation||Participants|Count of Participants|0|0.0||||||
3844661|NCT01669642|3670146|B4|||Patients who received Opioids prior to sedation||Participants|Count of Participants|0|0.0||||||
3844662|NCT01669642|3670147|B3|||Patients who received Opioids prior to sedation||Participants|Count of Participants|19|19.0||||||
3844663|NCT01669642|3670148|B2|||Patients who received Opioids prior to sedation||Participants|Count of Participants|18|18.0||||||
3844664|NCT01669642|3670149|B1|||Patients who received Opioids prior to sedation||Participants|Count of Participants|19|19.0||||||
3844665|NCT01669642|3670144|B6|other||Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3844666|NCT01669642|3670145|B5|other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3844667|NCT01669642|3670146|B4|other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3844668|NCT01669642|3670147|B3|other||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3844669|NCT01669642|3670148|B2|other||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3844670|NCT01669642|3670149|B1|other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3844671|NCT01669642|3670144|B6|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
3844672|NCT01669642|3670145|B5|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3844673|NCT01669642|3670146|B4|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3844674|NCT01669642|3670147|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3844675|NCT01669642|3670148|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3844676|NCT01669642|3670149|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3844677|NCT01669642|3670144|B6|african american||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3844678|NCT01669642|3670145|B5|african american||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3844679|NCT01669642|3670146|B4|african american||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3844680|NCT01669642|3670147|B3|african american||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3844681|NCT01669642|3670148|B2|african american||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3844682|NCT01669642|3670149|B1|african american||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3844683|NCT01669642|3670144|B6||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3844684|NCT01669642|3670145|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3844685|NCT01669642|3670146|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3844686|NCT01669642|3670147|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3844687|NCT01669642|3670148|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3844688|NCT01669642|3670149|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3844689|NCT01669642|3670144|B6||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3844690|NCT01669642|3670145|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3844691|NCT01669642|3670146|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3844692|NCT01669642|3670147|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3844693|NCT01669642|3670148|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3844694|NCT01669642|3670149|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3844695|NCT01669642|3670144|B6|||Age||years|Median|7.2|7.2|Full Range|||2.9|11.9|
3844696|NCT01669642|3670145|B5|||Age||years|Median|7.2|7.2|Full Range|||6.4|11.9|
3844697|NCT01669642|3670146|B4|||Age||years|Median|2.9|2.9|Full Range|||2.0|5.1|
3844698|NCT01669642|3670147|B3|||Age||years|Median|13.7|13.7|Full Range|||12.6|16.9|
3844699|NCT01669642|3670148|B2|||Age||years|Median|9.2|9.2|Full Range|||6.0|11.9|
3844700|NCT01669642|3670149|B1|||Age||years|Median|4.8|4.8|Full Range|||2.9|5.9|
3844701|NCT01669629|3670186|B1|United States||Region of Enrollment||participants|Number|183|183.0||||||
3844702|NCT01669629|3670186|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3844703|NCT01669629|3670186|B1||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3844704|NCT01669629|3670186|B1|||Age||years|Mean|31.61|31.61|Standard Deviation|7.061|7.061|||
3844705|NCT01669603|3670201|B3|United States||Region of Enrollment||participants|Number|190|190.0||||||
3844706|NCT01669603|3670202|B2|United States||Region of Enrollment||participants|Number|95|95.0||||||
3844707|NCT01669603|3670203|B1|United States||Region of Enrollment||participants|Number|95|95.0||||||
3844708|NCT01669603|3670201|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3844709|NCT01669603|3670202|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3844710|NCT01669603|3670203|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3844711|NCT01669603|3670201|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844712|NCT01669603|3670202|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844713|NCT01669603|3670203|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844714|NCT01669603|3670201|B3||White|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3844715|NCT01669603|3670202|B2||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3844716|NCT01669603|3670203|B1||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3844717|NCT01669603|3670201|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3844718|NCT01669603|3670202|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3844719|NCT01669603|3670203|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3844720|NCT01669603|3670201|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844721|NCT01669603|3670202|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844722|NCT01669603|3670203|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844723|NCT01669603|3670201|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3844724|NCT01669603|3670202|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3844725|NCT01669603|3670203|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3844726|NCT01669603|3670201|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844727|NCT01669603|3670202|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844728|NCT01669603|3670203|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3844729|NCT01669603|3670201|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3844730|NCT01669603|3670202|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3844731|NCT01669603|3670203|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3844732|NCT01669603|3670201|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
3844733|NCT01669603|3670202|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3844734|NCT01669603|3670203|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3844735|NCT01669603|3670201|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3844736|NCT01669603|3670202|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3844737|NCT01669603|3670203|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3844738|NCT01669603|3670201|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3844739|NCT01669603|3670202|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3844740|NCT01669603|3670203|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3844741|NCT01669603|3670201|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3844742|NCT01669603|3670202|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3844743|NCT01669603|3670203|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3844744|NCT01669603|3670201|B3|||Age||years|Mean|23|23.0|Standard Deviation|7|7.0|||
3844745|NCT01669603|3670202|B2|||Age||years|Mean|23|23.0|Standard Deviation|7|7.0|||
3844746|NCT01669603|3670203|B1|||Age||years|Mean|22|22.0|Standard Deviation|6|6.0|||
3844747|NCT01669603|3670201|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3844748|NCT01669603|3670202|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3844749|NCT01669603|3670203|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3844750|NCT01669603|3670201|B3||Between 18 and 65 years|Age||Participants|Count of Participants|115|115.0||||||
3844751|NCT01669603|3670202|B2||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
3844752|NCT01669603|3670203|B1||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3844753|NCT01669603|3670201|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3844754|NCT01669603|3670202|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3844755|NCT01669603|3670203|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3844756|NCT01669577|3670210|B1|Brazil||Region of Enrollment||participants|Number|200|200.0||||||
3844757|NCT01669577|3670210|B1||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3844758|NCT01669577|3670210|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3844759|NCT01669577|3670210|B1|Continuous||Age||years|Mean|37|37.0|Standard Deviation|14|14.0|||
3844760|NCT01669434|3670214|B3|||Additional antihypertensive|Use of at least one additional antihypertensive medication in addition to an angiotensin converting enzyme inhibitor at the time of enrollment.|Participants|Count of Participants|187|187.0||||||
3844761|NCT01669434|3670215|B2|||Additional antihypertensive|Use of at least one additional antihypertensive medication in addition to an angiotensin converting enzyme inhibitor at the time of enrollment.|Participants|Count of Participants|95|95.0||||||
3844762|NCT01669434|3670216|B1|||Additional antihypertensive|Use of at least one additional antihypertensive medication in addition to an angiotensin converting enzyme inhibitor at the time of enrollment.|Participants|Count of Participants|92|92.0||||||
3844763|NCT01669434|3670214|B3|||congestive heart failure history||Participants|Count of Participants|16|16.0||||||
3844764|NCT01669434|3670215|B2|||congestive heart failure history||Participants|Count of Participants|9|9.0||||||
3844765|NCT01669434|3670216|B1|||congestive heart failure history||Participants|Count of Participants|7|7.0||||||
3844766|NCT01669434|3670214|B3|||hypertension history||Participants|Count of Participants|228|228.0||||||
3844767|NCT01669434|3670215|B2|||hypertension history||Participants|Count of Participants|112|112.0||||||
3844768|NCT01669434|3670216|B1|||hypertension history||Participants|Count of Participants|116|116.0||||||
3844769|NCT01669434|3670214|B3|||preoperative systolic BP||mmHg|Mean|136.5|136.5|Full Range|||99.0|187.0|
3844770|NCT01669434|3670215|B2|||preoperative systolic BP||mmHg|Mean|136.3|136.3|Full Range|||102.0|184.0|
3844771|NCT01669434|3670216|B1|||preoperative systolic BP||mmHg|Mean|136.6|136.6|Full Range|||99.0|187.0|
3844772|NCT01669434|3670214|B3|||preoperative NSAID use||Participants|Count of Participants|124|124.0||||||
3844773|NCT01669434|3670215|B2|||preoperative NSAID use||Participants|Count of Participants|71|71.0||||||
3844774|NCT01669434|3670216|B1|||preoperative NSAID use||Participants|Count of Participants|53|53.0||||||
3844775|NCT01669434|3670214|B3|||American Society of Anesthesiologists classification|Scale range 1-6 I A normal healthy patient Healthy, non-smoking, no or minimal alcohol use 2 A patient with mild systemic disease 3 A patient with severe systemic disease 4 A patient with severe systemic disease that is a constant threat to life 5 A moribund patient who is not expected to survive without the operation 6 A declared brain-dead patient whose organs are being removed for donor purposes|units on a scale|Mean|2.8|2.8|Full Range|||1.0|4.0|
3844776|NCT01669434|3670215|B2|||American Society of Anesthesiologists classification|Scale range 1-6 I A normal healthy patient Healthy, non-smoking, no or minimal alcohol use 2 A patient with mild systemic disease 3 A patient with severe systemic disease 4 A patient with severe systemic disease that is a constant threat to life 5 A moribund patient who is not expected to survive without the operation 6 A declared brain-dead patient whose organs are being removed for donor purposes|units on a scale|Mean|2.8|2.8|Full Range|||2.0|4.0|
3844777|NCT01669434|3670216|B1|||American Society of Anesthesiologists classification|Scale range 1-6 I A normal healthy patient Healthy, non-smoking, no or minimal alcohol use 2 A patient with mild systemic disease 3 A patient with severe systemic disease 4 A patient with severe systemic disease that is a constant threat to life 5 A moribund patient who is not expected to survive without the operation 6 A declared brain-dead patient whose organs are being removed for donor purposes|units on a scale|Mean|2.8|2.8|Full Range|||1.0|4.0|
3844778|NCT01669434|3670214|B3||Current|smoking status||Participants|Count of Participants|39|39.0||||||
3844779|NCT01669434|3670215|B2||Current|smoking status||Participants|Count of Participants|25|25.0||||||
3844780|NCT01669434|3670216|B1||Current|smoking status||Participants|Count of Participants|14|14.0||||||
3844781|NCT01669434|3670214|B3||Former|smoking status||Participants|Count of Participants|119|119.0||||||
3844782|NCT01669434|3670215|B2||Former|smoking status||Participants|Count of Participants|59|59.0||||||
3844783|NCT01669434|3670216|B1||Former|smoking status||Participants|Count of Participants|60|60.0||||||
3844784|NCT01669434|3670214|B3||Never|smoking status||Participants|Count of Participants|117|117.0||||||
3844785|NCT01669434|3670215|B2||Never|smoking status||Participants|Count of Participants|54|54.0||||||
3844786|NCT01669434|3670216|B1||Never|smoking status||Participants|Count of Participants|63|63.0||||||
3844787|NCT01669434|3670214|B3|United States||Region of Enrollment||participants|Number|275|275.0||||||
3844788|NCT01669434|3670215|B2|United States||Region of Enrollment||participants|Number|138|138.0||||||
3844789|NCT01669434|3670216|B1|United States||Region of Enrollment||participants|Number|137|137.0||||||
3844790|NCT01669434|3670214|B3|Other/Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3844791|NCT01669434|3670215|B2|Other/Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3844792|NCT01669434|3670216|B1|Other/Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3844793|NCT01669434|3670214|B3|Am Indian/Alaska||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3844794|NCT01669434|3670215|B2|Am Indian/Alaska||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3844795|NCT01669434|3670216|B1|Am Indian/Alaska||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3844796|NCT01669434|3670214|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3844797|NCT01669434|3670215|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3844798|NCT01669434|3670216|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3844799|NCT01669434|3670214|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3844800|NCT01669434|3670215|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3844801|NCT01669434|3670216|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3844802|NCT01669434|3670214|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|240|240.0||||||
3844803|NCT01669434|3670215|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|125|125.0||||||
3844804|NCT01669434|3670216|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|115|115.0||||||
3844805|NCT01669434|3670214|B3||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3844806|NCT01669434|3670215|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3844807|NCT01669434|3670216|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3844808|NCT01669434|3670214|B3||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3844809|NCT01669434|3670215|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3844810|NCT01669434|3670216|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3844811|NCT01669434|3670214|B3|||Age||years|Mean|63.9|63.9|Full Range|||26.0|91.0|
3844812|NCT01669434|3670215|B2|||Age||years|Mean|63.7|63.7|Full Range|||31.0|86.0|
3844813|NCT01669434|3670216|B1|||Age||years|Mean|64|64.0|Full Range|||26.0|91.0|
3844814|NCT01669174|3670233|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3844815|NCT01669174|3670234|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3844816|NCT01669174|3670235|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3844817|NCT01669174|3670233|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3844818|NCT01669174|3670234|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3844819|NCT01669174|3670235|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3844820|NCT01669174|3670233|B3|||Age||Years|Mean|63.7|63.7|Standard Deviation|6.76|6.76|||
3844821|NCT01669174|3670234|B2|||Age||Years|Mean|63.1|63.1|Standard Deviation|7.51|7.51|||
3844822|NCT01669174|3670235|B1|||Age||Years|Mean|64.5|64.5|Standard Deviation|5.93|5.93|||
3844823|NCT01669148|3670247|B1|United States||Region of Enrollment||participants|Number|248|248.0||||||
3844824|NCT01669148|3670247|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3844825|NCT01669148|3670247|B1||Female|Sex: Female, Male||Participants|Count of Participants|496|496.0||||||
3844826|NCT01669148|3670247|B1||>=65 years|Age||Participants|Count of Participants|69|69.0||||||
3844827|NCT01669148|3670247|B1||Between 18 and 65 years|Age||Participants|Count of Participants|427|427.0||||||
3844828|NCT01669148|3670247|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3844829|NCT01669122|3670252|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3844830|NCT01669122|3670252|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3844831|NCT01669122|3670252|B1|||Age||Years|Mean|28.7|28.7|Standard Deviation|6.4|6.4|||
3844832|NCT01668836|3670282|B5|||Max Elasticity||Pascal|Mean|1895.88|1895.88|Standard Deviation|456.53|456.53|||
3844833|NCT01668836|3670283|B4|||Max Elasticity||Pascal|Mean|2164.64|2164.64|Standard Deviation|275.91|275.91|||
3844834|NCT01668836|3670284|B3|||Max Elasticity||Pascal|Mean|1639.82|1639.82|Standard Deviation|383.97|383.97|||
3844835|NCT01668836|3670285|B2|||Max Elasticity||Pascal|Mean|2202.98|2202.98|Standard Deviation|391.50|391.5|||
3844836|NCT01668836|3670286|B1|||Max Elasticity||Pascal|Mean|1598.50|1598.5|Standard Deviation|398.18|398.18|||
3844837|NCT01668836|3670282|B5|||Slope|Slope reflects activity of fibrinogen and platelet function. Denotes the speed at which solid clot was formed. Its value is reduced in presence of low levels of fibrinogen and platelet function. It shows the strength which the clot is formed.|Pascal/min|Mean|132.66|132.66|Standard Deviation|53.47|53.47|||
3844838|NCT01668836|3670283|B4|||Slope|Slope reflects activity of fibrinogen and platelet function. Denotes the speed at which solid clot was formed. Its value is reduced in presence of low levels of fibrinogen and platelet function. It shows the strength which the clot is formed.|Pascal/min|Mean|158.36|158.36|Standard Deviation|37.85|37.85|||
3844839|NCT01668836|3670284|B3|||Slope|Slope reflects activity of fibrinogen and platelet function. Denotes the speed at which solid clot was formed. Its value is reduced in presence of low levels of fibrinogen and platelet function. It shows the strength which the clot is formed.|Pascal/min|Mean|108.17|108.17|Standard Deviation|43.98|43.98|||
3844840|NCT01668836|3670285|B2|||Slope|Slope reflects activity of fibrinogen and platelet function. Denotes the speed at which solid clot was formed. Its value is reduced in presence of low levels of fibrinogen and platelet function. It shows the strength which the clot is formed.|Pascal/min|Mean|165.42|165.42|Standard Deviation|60.43|60.43|||
3844841|NCT01668836|3670286|B1|||Slope|Slope reflects activity of fibrinogen and platelet function. Denotes the speed at which solid clot was formed. Its value is reduced in presence of low levels of fibrinogen and platelet function. It shows the strength which the clot is formed.|Pascal/min|Mean|100.83|100.83|Standard Deviation|38.42|38.42|||
3844842|NCT01668836|3670282|B5|||Clot complete||seconds|Mean|108.45|108.45|Standard Deviation|102.45|102.45|||
3844843|NCT01668836|3670283|B4|||Clot complete||seconds|Mean|152.64|152.64|Standard Deviation|211.01|211.01|||
3844844|NCT01668836|3670284|B3|||Clot complete||seconds|Mean|100.17|100.17|Standard Deviation|14.32|14.32|||
3844845|NCT01668836|3670285|B2|||Clot complete||seconds|Mean|80.83|80.83|Standard Deviation|12.01|12.01|||
3844846|NCT01668836|3670286|B1|||Clot complete||seconds|Mean|103.83|103.83|Standard Deviation|13.67|13.67|||
3844847|NCT01668836|3670282|B5|||Clot onset time||seconds|Mean|48.83|48.83|Standard Deviation|86.58|86.58|||
3844848|NCT01668836|3670283|B4|||Clot onset time||seconds|Mean|91.64|91.64|Standard Deviation|177.95|177.95|||
3844849|NCT01668836|3670284|B3|||Clot onset time||seconds|Mean|38.25|38.25|Standard Deviation|4.00|4.0|||
3844850|NCT01668836|3670285|B2|||Clot onset time||seconds|Mean|30.75|30.75|Standard Deviation|9.58|9.58|||
3844851|NCT01668836|3670286|B1|||Clot onset time||seconds|Mean|38.25|38.25|Standard Deviation|4.16|4.16|||
3844852|NCT01668836|3670282|B5|||Nonesterified fatty acid||mmol/L|Mean|24.67|24.67|Standard Deviation|28.69|28.69|||
3844853|NCT01668836|3670283|B4|||Nonesterified fatty acid||mmol/L|Mean|24.17|24.17|Standard Deviation|20.92|20.92|||
3844854|NCT01668836|3670284|B3|||Nonesterified fatty acid||mmol/L|Mean|29.75|29.75|Standard Deviation|49.34|49.34|||
3844855|NCT01668836|3670285|B2|||Nonesterified fatty acid||mmol/L|Mean|18.64|18.64|Standard Deviation|14.12|14.12|||
3844856|NCT01668836|3670286|B1|||Nonesterified fatty acid||mmol/L|Mean|25.73|25.73|Standard Deviation|16.55|16.55|||
3844857|NCT01668836|3670282|B5|||Platelet aggregation by epinephrine|percentage of maximum amplitude aggregation|%|Mean|78.93|78.93|Standard Deviation|17.72|17.72|||
3844858|NCT01668836|3670283|B4|||Platelet aggregation by epinephrine|percentage of maximum amplitude aggregation|%|Mean|81.20|81.2|Standard Deviation|18.27|18.27|||
3844859|NCT01668836|3670284|B3|||Platelet aggregation by epinephrine|percentage of maximum amplitude aggregation|%|Mean|66.88|66.88|Standard Deviation|25.92|25.92|||
3844860|NCT01668836|3670285|B2|||Platelet aggregation by epinephrine|percentage of maximum amplitude aggregation|%|Mean|83.42|83.42|Standard Deviation|10.22|10.22|||
3844861|NCT01668836|3670286|B1|||Platelet aggregation by epinephrine|percentage of maximum amplitude aggregation|%|Mean|84.23|84.23|Standard Deviation|3.90|3.9|||
3844862|NCT01668836|3670282|B5|||Platelet aggregation by adenosine diphosphate (ADP)|percentage of maximum amplitude aggregation by adenosine diphosphate|%|Mean|86.92|86.92|Standard Deviation|5.74|5.74|||
3844863|NCT01668836|3670283|B4|||Platelet aggregation by adenosine diphosphate (ADP)|percentage of maximum amplitude aggregation by adenosine diphosphate|%|Mean|88.45|88.45|Standard Deviation|3.65|3.65|||
3844864|NCT01668836|3670284|B3|||Platelet aggregation by adenosine diphosphate (ADP)|percentage of maximum amplitude aggregation by adenosine diphosphate|%|Mean|84.20|84.2|Standard Deviation|7.80|7.8|||
3844865|NCT01668836|3670285|B2|||Platelet aggregation by adenosine diphosphate (ADP)|percentage of maximum amplitude aggregation by adenosine diphosphate|%|Mean|88.90|88.9|Standard Deviation|5.87|5.87|||
3844866|NCT01668836|3670286|B1|||Platelet aggregation by adenosine diphosphate (ADP)|percentage of maximum amplitude aggregation by adenosine diphosphate|%|Mean|86.13|86.13|Standard Deviation|4.06|4.06|||
3844867|NCT01668836|3670282|B5|||"RAGE (receptor for advanced glycation end-products) gene expression RT-PCR"||arbitrary unit|Mean|11.3|11.3|Standard Deviation|1.74|1.74|||
3844868|NCT01668836|3670283|B4|||"RAGE (receptor for advanced glycation end-products) gene expression RT-PCR"||arbitrary unit|Mean|10.5|10.5|Standard Deviation|1.76|1.76|||
3844869|NCT01668836|3670284|B3|||"RAGE (receptor for advanced glycation end-products) gene expression RT-PCR"||arbitrary unit|Mean|10.9|10.9|Standard Deviation|1.68|1.68|||
3844870|NCT01668836|3670285|B2|||"RAGE (receptor for advanced glycation end-products) gene expression RT-PCR"||arbitrary unit|Mean|12.7|12.7|Standard Deviation|1.65|1.65|||
3844871|NCT01668836|3670286|B1|||"RAGE (receptor for advanced glycation end-products) gene expression RT-PCR"||arbitrary unit|Mean|11.3|11.3|Standard Deviation|1.24|1.24|||
3844872|NCT01668836|3670282|B5|||"Sirtuin-1 gene expression by real time polimerase chain reaction RT-PCR"|Values obtained from delta CT (cycle threshold) using as normalizer GAPDH gene.|arbitrary unit|Mean|11.0|11.0|Standard Deviation|1.33|1.33|||
3844873|NCT01668836|3670283|B4|||"Sirtuin-1 gene expression by real time polimerase chain reaction RT-PCR"|Values obtained from delta CT (cycle threshold) using as normalizer GAPDH gene.|arbitrary unit|Mean|10.6|10.6|Standard Deviation|1.15|1.15|||
3844874|NCT01668836|3670284|B3|||"Sirtuin-1 gene expression by real time polimerase chain reaction RT-PCR"|Values obtained from delta CT (cycle threshold) using as normalizer GAPDH gene.|arbitrary unit|Mean|11.4|11.4|Standard Deviation|1.26|1.26|||
3844875|NCT01668836|3670285|B2|||"Sirtuin-1 gene expression by real time polimerase chain reaction RT-PCR"|Values obtained from delta CT (cycle threshold) using as normalizer GAPDH gene.|arbitrary unit|Mean|11.6|11.6|Standard Deviation|1.38|1.38|||
3844876|NCT01668836|3670286|B1|||"Sirtuin-1 gene expression by real time polimerase chain reaction RT-PCR"|Values obtained from delta CT (cycle threshold) using as normalizer GAPDH gene.|arbitrary unit|Mean|10.4|10.4|Standard Deviation|1.28|1.28|||
3844877|NCT01668836|3670282|B5|||Estrone||pg/mL|Mean|10.0|10.0|Standard Deviation|14.7|14.7|||
3844878|NCT01668836|3670283|B4|||Estrone||pg/mL|Mean|5.11|5.11|Standard Deviation|6.7|6.7|||
3844879|NCT01668836|3670284|B3|||Estrone||pg/mL|Mean|3.1|3.1|Standard Deviation|0.0|0.0|||
3844880|NCT01668836|3670285|B2|||Estrone||pg/mL|Mean|12.4|12.4|Standard Deviation|17.4|17.4|||
3844881|NCT01668836|3670286|B1|||Estrone||pg/mL|Mean|17.6|17.6|Standard Deviation|18.3|18.3|||
3844882|NCT01668836|3670282|B5|||Sirtuin||ng/mL|Mean|1.35|1.35|Standard Deviation|1.39|1.39|||
3844883|NCT01668836|3670283|B4|||Sirtuin||ng/mL|Mean|1.65|1.65|Standard Deviation|2.21|2.21|||
3844884|NCT01668836|3670284|B3|||Sirtuin||ng/mL|Mean|1.65|1.65|Standard Deviation|1.40|1.4|||
3844885|NCT01668836|3670285|B2|||Sirtuin||ng/mL|Mean|1.16|1.16|Standard Deviation|0.90|0.9|||
3844886|NCT01668836|3670286|B1|||Sirtuin||ng/mL|Mean|0.95|0.95|Standard Deviation|0.46|0.46|||
3844887|NCT01668836|3670282|B5|||Insulin||microUI/L|Mean|61.5|61.5|Standard Deviation|48.2|48.2|||
3844888|NCT01668836|3670283|B4|||Insulin||microUI/L|Mean|44.3|44.3|Standard Deviation|28.9|28.9|||
3844889|NCT01668836|3670284|B3|||Insulin||microUI/L|Mean|69.3|69.3|Standard Deviation|57.1|57.1|||
3844890|NCT01668836|3670285|B2|||Insulin||microUI/L|Mean|77.1|77.1|Standard Deviation|62.2|62.2|||
3844891|NCT01668836|3670286|B1|||Insulin||microUI/L|Mean|53.7|53.7|Standard Deviation|33.7|33.7|||
3844892|NCT01668836|3670282|B5|||norepinephrine||pg/mL|Mean|306.7|306.7|Standard Deviation|144.5|144.5|||
3844893|NCT01668836|3670283|B4|||norepinephrine||pg/mL|Mean|420.9|420.9|Standard Deviation|171.0|171.0|||
3844894|NCT01668836|3670284|B3|||norepinephrine||pg/mL|Mean|286.3|286.3|Standard Deviation|126.8|126.8|||
3844895|NCT01668836|3670285|B2|||norepinephrine||pg/mL|Mean|270.8|270.8|Standard Deviation|88.6|88.6|||
3844896|NCT01668836|3670286|B1|||norepinephrine||pg/mL|Mean|267.8|267.8|Standard Deviation|148.9|148.9|||
3844897|NCT01668836|3670282|B5|||Estradiol||pg/mL|Mean|36.0|36.0|Standard Deviation|13.5|13.5|||
3844898|NCT01668836|3670283|B4|||Estradiol||pg/mL|Mean|25.9|25.9|Standard Deviation|8.3|8.3|||
3844899|NCT01668836|3670284|B3|||Estradiol||pg/mL|Mean|43.4|43.4|Standard Deviation|12.3|12.3|||
3844900|NCT01668836|3670285|B2|||Estradiol||pg/mL|Mean|38.6|38.6|Standard Deviation|16.4|16.4|||
3844901|NCT01668836|3670286|B1|||Estradiol||pg/mL|Mean|36.4|36.4|Standard Deviation|10.5|10.5|||
3844902|NCT01668836|3670282|B5|||follicle stimulating hormone||microUI/mL|Mean|36.8|36.8|Standard Deviation|35.1|35.1|||
3844903|NCT01668836|3670283|B4|||follicle stimulating hormone||microUI/mL|Mean|75.8|75.8|Standard Deviation|18.7|18.7|||
3844904|NCT01668836|3670284|B3|||follicle stimulating hormone||microUI/mL|Mean|6.22|6.22|Standard Deviation|3.53|3.53|||
3844905|NCT01668836|3670285|B2|||follicle stimulating hormone||microUI/mL|Mean|60.8|60.8|Standard Deviation|20.4|20.4|||
3844906|NCT01668836|3670286|B1|||follicle stimulating hormone||microUI/mL|Mean|4.12|4.12|Standard Deviation|2.2|2.2|||
3844907|NCT01668836|3670282|B5|||luteinizing hormone||microUI/mL|Mean|14.7|14.7|Standard Deviation|12.7|12.7|||
3844908|NCT01668836|3670283|B4|||luteinizing hormone||microUI/mL|Mean|29.9|29.9|Standard Deviation|9.05|9.05|||
3844909|NCT01668836|3670284|B3|||luteinizing hormone||microUI/mL|Mean|4.46|4.46|Standard Deviation|1.95|1.95|||
3844910|NCT01668836|3670285|B2|||luteinizing hormone||microUI/mL|Mean|20.9|20.9|Standard Deviation|7.53|7.53|||
3844911|NCT01668836|3670286|B1|||luteinizing hormone||microUI/mL|Mean|3.34|3.34|Standard Deviation|1.67|1.67|||
3844912|NCT01668836|3670282|B5|||glucose||mg/dL|Mean|94.8|94.8|Standard Deviation|12.2|12.2|||
3844913|NCT01668836|3670283|B4|||glucose||mg/dL|Mean|95.4|95.4|Standard Deviation|8.5|8.5|||
3844914|NCT01668836|3670284|B3|||glucose||mg/dL|Mean|91.8|91.8|Standard Deviation|12.6|12.6|||
3844915|NCT01668836|3670285|B2|||glucose||mg/dL|Mean|96.3|96.3|Standard Deviation|13.8|13.8|||
3844916|NCT01668836|3670286|B1|||glucose||mg/dL|Mean|95.8|95.8|Standard Deviation|14.1|14.1|||
3844917|NCT01668836|3670282|B5|||lipoprotein (a)||mg/dL|Mean|24.0|24.0|Standard Deviation|29.5|29.5|||
3844918|NCT01668836|3670283|B4|||lipoprotein (a)||mg/dL|Mean|23.9|23.9|Standard Deviation|17.4|17.4|||
3844919|NCT01668836|3670284|B3|||lipoprotein (a)||mg/dL|Mean|31.8|31.8|Standard Deviation|44.7|44.7|||
3844920|NCT01668836|3670285|B2|||lipoprotein (a)||mg/dL|Mean|24.1|24.1|Standard Deviation|29.7|29.7|||
3844921|NCT01668836|3670286|B1|||lipoprotein (a)||mg/dL|Mean|16.2|16.2|Standard Deviation|20.1|20.1|||
3844922|NCT01668836|3670282|B5|||Apolipoprotein B||g/L|Mean|0.99|0.99|Standard Deviation|0.25|0.25|||
3844923|NCT01668836|3670283|B4|||Apolipoprotein B||g/L|Mean|1.04|1.04|Standard Deviation|0.27|0.27|||
3844924|NCT01668836|3670284|B3|||Apolipoprotein B||g/L|Mean|0.97|0.97|Standard Deviation|0.25|0.25|||
3844925|NCT01668836|3670285|B2|||Apolipoprotein B||g/L|Mean|1.04|1.04|Standard Deviation|0.28|0.28|||
3844926|NCT01668836|3670286|B1|||Apolipoprotein B||g/L|Mean|0.91|0.91|Standard Deviation|0.18|0.18|||
3844927|NCT01668836|3670282|B5|||Apolipoprotein A1||g/L|Mean|1.49|1.49|Standard Deviation|0.24|0.24|||
3844928|NCT01668836|3670283|B4|||Apolipoprotein A1||g/L|Mean|1.72|1.72|Standard Deviation|0.25|0.25|||
3844929|NCT01668836|3670284|B3|||Apolipoprotein A1||g/L|Mean|1.34|1.34|Standard Deviation|0.11|0.11|||
3844930|NCT01668836|3670285|B2|||Apolipoprotein A1||g/L|Mean|1.53|1.53|Standard Deviation|0.19|0.19|||
3844931|NCT01668836|3670286|B1|||Apolipoprotein A1||g/L|Mean|1.37|1.37|Standard Deviation|0.21|0.21|||
3844932|NCT01668836|3670282|B5|||C-reactive protein||mg/dL|Mean|2.13|2.13|Standard Deviation|1.92|1.92|||
3844933|NCT01668836|3670283|B4|||C-reactive protein||mg/dL|Mean|2.31|2.31|Standard Deviation|2.44|2.44|||
3844934|NCT01668836|3670284|B3|||C-reactive protein||mg/dL|Mean|1.63|1.63|Standard Deviation|1.01|1.01|||
3844935|NCT01668836|3670285|B2|||C-reactive protein||mg/dL|Mean|3.47|3.47|Standard Deviation|2.38|2.38|||
3844936|NCT01668836|3670286|B1|||C-reactive protein||mg/dL|Mean|1.13|1.13|Standard Deviation|0.67|0.67|||
3844937|NCT01668836|3670282|B5|||Triglycerides||mg/dL|Mean|117.6|117.6|Standard Deviation|64.4|64.4|||
3844938|NCT01668836|3670283|B4|||Triglycerides||mg/dL|Mean|91.4|91.4|Standard Deviation|37.4|37.4|||
3844939|NCT01668836|3670284|B3|||Triglycerides||mg/dL|Mean|131.0|131.0|Standard Deviation|77.9|77.9|||
3844940|NCT01668836|3670285|B2|||Triglycerides||mg/dL|Mean|121.6|121.6|Standard Deviation|72.4|72.4|||
3844941|NCT01668836|3670286|B1|||Triglycerides||mg/dL|Mean|126.5|126.5|Standard Deviation|63.0|63.0|||
3844942|NCT01668836|3670282|B5|||LDL-cholesterol||mg/dL|Mean|135.5|135.5|Standard Deviation|32.0|32.0|||
3844943|NCT01668836|3670283|B4|||LDL-cholesterol||mg/dL|Mean|149.8|149.8|Standard Deviation|37.6|37.6|||
3844944|NCT01668836|3670284|B3|||LDL-cholesterol||mg/dL|Mean|127.6|127.6|Standard Deviation|34.0|34.0|||
3844945|NCT01668836|3670285|B2|||LDL-cholesterol||mg/dL|Mean|140.8|140.8|Standard Deviation|28.7|28.7|||
3844946|NCT01668836|3670286|B1|||LDL-cholesterol||mg/dL|Mean|125.5|125.5|Standard Deviation|29.9|29.9|||
3844947|NCT01668836|3670282|B5|||HDL-cholesterol||mg/dL|Mean|52.3|52.3|Standard Deviation|16.5|16.5|||
3844948|NCT01668836|3670283|B4|||HDL-cholesterol||mg/dL|Mean|67.2|67.2|Standard Deviation|18.2|18.2|||
3844949|NCT01668836|3670284|B3|||HDL-cholesterol||mg/dL|Mean|43.5|43.5|Standard Deviation|9.0|9.0|||
3844950|NCT01668836|3670285|B2|||HDL-cholesterol||mg/dL|Mean|54.8|54.8|Standard Deviation|15.2|15.2|||
3844951|NCT01668836|3670286|B1|||HDL-cholesterol||mg/dL|Mean|43.6|43.6|Standard Deviation|10.2|10.2|||
3844952|NCT01668836|3670282|B5|||total cholesterol||mg/dL|Mean|212.0|212.0|Standard Deviation|39.1|39.1|||
3844953|NCT01668836|3670283|B4|||total cholesterol||mg/dL|Mean|235.1|235.1|Standard Deviation|44.9|44.9|||
3844954|NCT01668836|3670284|B3|||total cholesterol||mg/dL|Mean|197.3|197.3|Standard Deviation|36.2|36.2|||
3844955|NCT01668836|3670285|B2|||total cholesterol||mg/dL|Mean|222.7|222.7|Standard Deviation|32.5|32.5|||
3844956|NCT01668836|3670286|B1|||total cholesterol||mg/dL|Mean|192.8|192.8|Standard Deviation|28.1|28.1|||
3844957|NCT01668836|3670282|B5|||Diastolic blood pressure||mmHg|Mean|82|82.0|Standard Deviation|10.8|10.8|||
3844958|NCT01668836|3670283|B4|||Diastolic blood pressure||mmHg|Mean|80.6|80.6|Standard Deviation|12.3|12.3|||
3844959|NCT01668836|3670284|B3|||Diastolic blood pressure||mmHg|Mean|84.8|84.8|Standard Deviation|9.9|9.9|||
3844960|NCT01668836|3670285|B2|||Diastolic blood pressure||mmHg|Mean|78.5|78.5|Standard Deviation|9.3|9.3|||
3844961|NCT01668836|3670286|B1|||Diastolic blood pressure||mmHg|Mean|83.9|83.9|Standard Deviation|12.0|12.0|||
3844962|NCT01668836|3670282|B5|||Systolic blood pressure||mmHg|Mean|130.6|130.6|Standard Deviation|15.4|15.4|||
3844963|NCT01668836|3670283|B4|||Systolic blood pressure||mmHg|Mean|125.6|125.6|Standard Deviation|14.1|14.1|||
3844964|NCT01668836|3670284|B3|||Systolic blood pressure||mmHg|Mean|133.2|133.2|Standard Deviation|16.6|16.6|||
3844965|NCT01668836|3670285|B2|||Systolic blood pressure||mmHg|Mean|126|126.0|Standard Deviation|14.5|14.5|||
3844966|NCT01668836|3670286|B1|||Systolic blood pressure||mmHg|Mean|136.9|136.9|Standard Deviation|15.0|15.0|||
3844967|NCT01668836|3670282|B5|||heart rate||beats/minute|Mean|63.6|63.6|Standard Deviation|9.0|9.0|||
3844968|NCT01668836|3670283|B4|||heart rate||beats/minute|Mean|60.8|60.8|Standard Deviation|8.3|8.3|||
3844969|NCT01668836|3670284|B3|||heart rate||beats/minute|Mean|63.9|63.9|Standard Deviation|10.7|10.7|||
3844970|NCT01668836|3670285|B2|||heart rate||beats/minute|Mean|65.6|65.6|Standard Deviation|9.1|9.1|||
3844971|NCT01668836|3670286|B1|||heart rate||beats/minute|Mean|63.6|63.6|Standard Deviation|7.9|7.9|||
3844972|NCT01668836|3670282|B5|||abdominal circumference||cm|Mean|95.5|95.5|Standard Deviation|10|10.0|||
3844973|NCT01668836|3670283|B4|||abdominal circumference||cm|Mean|92|92.0|Standard Deviation|7|7.0|||
3844974|NCT01668836|3670284|B3|||abdominal circumference||cm|Mean|96.5|96.5|Standard Deviation|7.6|7.6|||
3844975|NCT01668836|3670285|B2|||abdominal circumference||cm|Mean|92.7|92.7|Standard Deviation|8.7|8.7|||
3844976|NCT01668836|3670286|B1|||abdominal circumference||cm|Mean|100.9|100.9|Standard Deviation|13.9|13.9|||
3844977|NCT01668836|3670282|B5|||Body mass index||Kg/m^2|Mean|26.7|26.7|Standard Deviation|3.8|3.8|||
3844978|NCT01668836|3670283|B4|||Body mass index||Kg/m^2|Mean|25.5|25.5|Standard Deviation|3.7|3.7|||
3844979|NCT01668836|3670284|B3|||Body mass index||Kg/m^2|Mean|26.2|26.2|Standard Deviation|3.5|3.5|||
3844980|NCT01668836|3670285|B2|||Body mass index||Kg/m^2|Mean|26.5|26.5|Standard Deviation|3.4|3.4|||
3844981|NCT01668836|3670286|B1|||Body mass index||Kg/m^2|Mean|28.5|28.5|Standard Deviation|4.4|4.4|||
3844982|NCT01668836|3670282|B5|Brazil||Region of Enrollment||participants|Number|48|48.0||||||
3844983|NCT01668836|3670283|B4|Brazil||Region of Enrollment||participants|Number|12|12.0||||||
3844984|NCT01668836|3670284|B3|Brazil||Region of Enrollment||participants|Number|12|12.0||||||
3844985|NCT01668836|3670285|B2|Brazil||Region of Enrollment||participants|Number|12|12.0||||||
3844986|NCT01668836|3670286|B1|Brazil||Region of Enrollment||participants|Number|12|12.0||||||
3844987|NCT01668836|3670282|B5||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3844988|NCT01668836|3670283|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3844989|NCT01668836|3670284|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3844990|NCT01668836|3670285|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3844991|NCT01668836|3670286|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3844992|NCT01668836|3670282|B5||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3844993|NCT01668836|3670283|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3844994|NCT01668836|3670284|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3844995|NCT01668836|3670285|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3844996|NCT01668836|3670286|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3844997|NCT01668836|3670282|B5|||Age||years|Mean|58.5|58.5|Standard Deviation|3.5|3.5|||
3844998|NCT01668836|3670283|B4|||Age||years|Mean|59.5|59.5|Standard Deviation|3.7|3.7|||
3844999|NCT01668836|3670284|B3|||Age||years|Mean|57.7|57.7|Standard Deviation|3.5|3.5|||
3845000|NCT01668836|3670285|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|3.4|3.4|||
3845001|NCT01668836|3670286|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|3.6|3.6|||
3845002|NCT01668797|3670343|B3||Male|Gender||Participants|Count of Participants|123|123.0||||||
3845003|NCT01668797|3670344|B2||Male|Gender||Participants|Count of Participants|65|65.0||||||
3845004|NCT01668797|3670345|B1||Male|Gender||Participants|Count of Participants|58|58.0||||||
3845005|NCT01668797|3670343|B3||Female|Gender||Participants|Count of Participants|79|79.0||||||
3845006|NCT01668797|3670344|B2||Female|Gender||Participants|Count of Participants|40|40.0||||||
3845007|NCT01668797|3670345|B1||Female|Gender||Participants|Count of Participants|39|39.0||||||
3845008|NCT01668797|3670343|B3|||Age||years|Mean|40.2|40.2|Standard Deviation|10.7|10.7|||
3845009|NCT01668797|3670344|B2|||Age||years|Mean|41.6|41.6|Standard Deviation|10.6|10.6|||
3845010|NCT01668797|3670345|B1|||Age||years|Mean|38.8|38.8|Standard Deviation|10.7|10.7|||
3845011|NCT01668784|3670411|B3|PD-L1 Indeterminate/Not Evaluable||PD-L1 Expression||participants|Number|65|65.0||||||
3845012|NCT01668784|3670412|B2|PD-L1 Indeterminate/Not Evaluable||PD-L1 Expression||participants|Number|25|25.0||||||
3845013|NCT01668784|3670413|B1|PD-L1 Indeterminate/Not Evaluable||PD-L1 Expression||participants|Number|40|40.0||||||
3845014|NCT01668784|3670411|B3|PD-L1 Quantifiable <1%||PD-L1 Expression||participants|Number|575|575.0||||||
3845015|NCT01668784|3670412|B2|PD-L1 Quantifiable <1%||PD-L1 Expression||participants|Number|299|299.0||||||
3845016|NCT01668784|3670413|B1|PD-L1 Quantifiable <1%||PD-L1 Expression||participants|Number|276|276.0||||||
3845017|NCT01668784|3670411|B3|PD-L1 Quantifiable >=1%||PD-L1 Expression||participants|Number|181|181.0||||||
3845018|NCT01668784|3670412|B2|PD-L1 Quantifiable >=1%||PD-L1 Expression||participants|Number|87|87.0||||||
3845019|NCT01668784|3670413|B1|PD-L1 Quantifiable >=1%||PD-L1 Expression||participants|Number|94|94.0||||||
3845020|NCT01668784|3670411|B3|2||Number of Prior Anti-Angiogenic Agents Received in the Advanced/Metastatic Setting||participants|Number|230|230.0||||||
3845021|NCT01668784|3670412|B2|2||Number of Prior Anti-Angiogenic Agents Received in the Advanced/Metastatic Setting||participants|Number|114|114.0||||||
3845022|NCT01668784|3670413|B1|2||Number of Prior Anti-Angiogenic Agents Received in the Advanced/Metastatic Setting||participants|Number|116|116.0||||||
3845023|NCT01668784|3670411|B3|1||Number of Prior Anti-Angiogenic Agents Received in the Advanced/Metastatic Setting||participants|Number|591|591.0||||||
3845024|NCT01668784|3670412|B2|1||Number of Prior Anti-Angiogenic Agents Received in the Advanced/Metastatic Setting||participants|Number|297|297.0||||||
3845025|NCT01668784|3670413|B1|1||Number of Prior Anti-Angiogenic Agents Received in the Advanced/Metastatic Setting||participants|Number|294|294.0||||||
3845026|NCT01668784|3670411|B3|Rest of World (ROW)||Region||participants|Number|194|194.0||||||
3845027|NCT01668784|3670412|B2|Rest of World (ROW)||Region||participants|Number|98|98.0||||||
3845028|NCT01668784|3670413|B1|Rest of World (ROW)||Region||participants|Number|96|96.0||||||
3845029|NCT01668784|3670411|B3|Western Europe||Region||participants|Number|281|281.0||||||
3845030|NCT01668784|3670412|B2|Western Europe||Region||participants|Number|141|141.0||||||
3845031|NCT01668784|3670413|B1|Western Europe||Region||participants|Number|140|140.0||||||
3845032|NCT01668784|3670411|B3|US/Canada||Region||participants|Number|346|346.0||||||
3845033|NCT01668784|3670412|B2|US/Canada||Region||participants|Number|172|172.0||||||
3845034|NCT01668784|3670413|B1|US/Canada||Region||participants|Number|174|174.0||||||
3845035|NCT01668784|3670411|B3|Poor||Baseline MSKCC Risk Group (IVRS)|A prognostic model used to assess pretreatment clinical features that are predictive of survival. The Memorial Sloan-Kettering Cancer Center (MSKCC) risk system stratifies patients into poor-, intermediate- and favorable-risk categories based on the number of adverse clinical and laboratory parameters present. An Interactive Voice Response System (IVRS) was used to record responses.|participants|Number|124|124.0||||||
3845036|NCT01668784|3670412|B2|Poor||Baseline MSKCC Risk Group (IVRS)|A prognostic model used to assess pretreatment clinical features that are predictive of survival. The Memorial Sloan-Kettering Cancer Center (MSKCC) risk system stratifies patients into poor-, intermediate- and favorable-risk categories based on the number of adverse clinical and laboratory parameters present. An Interactive Voice Response System (IVRS) was used to record responses.|participants|Number|60|60.0||||||
3845037|NCT01668784|3670413|B1|Poor||Baseline MSKCC Risk Group (IVRS)|A prognostic model used to assess pretreatment clinical features that are predictive of survival. The Memorial Sloan-Kettering Cancer Center (MSKCC) risk system stratifies patients into poor-, intermediate- and favorable-risk categories based on the number of adverse clinical and laboratory parameters present. An Interactive Voice Response System (IVRS) was used to record responses.|participants|Number|64|64.0||||||
3845038|NCT01668784|3670411|B3|Intermediate||Baseline MSKCC Risk Group (IVRS)|A prognostic model used to assess pretreatment clinical features that are predictive of survival. The Memorial Sloan-Kettering Cancer Center (MSKCC) risk system stratifies patients into poor-, intermediate- and favorable-risk categories based on the number of adverse clinical and laboratory parameters present. An Interactive Voice Response System (IVRS) was used to record responses.|participants|Number|404|404.0||||||
3845039|NCT01668784|3670412|B2|Intermediate||Baseline MSKCC Risk Group (IVRS)|A prognostic model used to assess pretreatment clinical features that are predictive of survival. The Memorial Sloan-Kettering Cancer Center (MSKCC) risk system stratifies patients into poor-, intermediate- and favorable-risk categories based on the number of adverse clinical and laboratory parameters present. An Interactive Voice Response System (IVRS) was used to record responses.|participants|Number|203|203.0||||||
3845040|NCT01668784|3670413|B1|Intermediate||Baseline MSKCC Risk Group (IVRS)|A prognostic model used to assess pretreatment clinical features that are predictive of survival. The Memorial Sloan-Kettering Cancer Center (MSKCC) risk system stratifies patients into poor-, intermediate- and favorable-risk categories based on the number of adverse clinical and laboratory parameters present. An Interactive Voice Response System (IVRS) was used to record responses.|participants|Number|201|201.0||||||
3845041|NCT01668784|3670411|B3|Favorable||Baseline MSKCC Risk Group (IVRS)|A prognostic model used to assess pretreatment clinical features that are predictive of survival. The Memorial Sloan-Kettering Cancer Center (MSKCC) risk system stratifies patients into poor-, intermediate- and favorable-risk categories based on the number of adverse clinical and laboratory parameters present. An Interactive Voice Response System (IVRS) was used to record responses.|participants|Number|293|293.0||||||
3845090|NCT01668667|3670438|B5|White & Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3845042|NCT01668784|3670412|B2|Favorable||Baseline MSKCC Risk Group (IVRS)|A prognostic model used to assess pretreatment clinical features that are predictive of survival. The Memorial Sloan-Kettering Cancer Center (MSKCC) risk system stratifies patients into poor-, intermediate- and favorable-risk categories based on the number of adverse clinical and laboratory parameters present. An Interactive Voice Response System (IVRS) was used to record responses.|participants|Number|148|148.0||||||
3845043|NCT01668784|3670413|B1|Favorable||Baseline MSKCC Risk Group (IVRS)|A prognostic model used to assess pretreatment clinical features that are predictive of survival. The Memorial Sloan-Kettering Cancer Center (MSKCC) risk system stratifies patients into poor-, intermediate- and favorable-risk categories based on the number of adverse clinical and laboratory parameters present. An Interactive Voice Response System (IVRS) was used to record responses.|participants|Number|145|145.0||||||
3845044|NCT01668784|3670411|B3|Other||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3845045|NCT01668784|3670412|B2|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3845046|NCT01668784|3670413|B1|Other||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3845047|NCT01668784|3670411|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3845048|NCT01668784|3670412|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3845049|NCT01668784|3670413|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845050|NCT01668784|3670411|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3845051|NCT01668784|3670412|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845052|NCT01668784|3670413|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3845053|NCT01668784|3670411|B3|Asian||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
3845054|NCT01668784|3670412|B2|Asian||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3845055|NCT01668784|3670413|B1|Asian||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
3845056|NCT01668784|3670411|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3845057|NCT01668784|3670412|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3845058|NCT01668784|3670413|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3845059|NCT01668784|3670411|B3|White||Race/Ethnicity, Customized||participants|Number|720|720.0||||||
3845060|NCT01668784|3670412|B2|White||Race/Ethnicity, Customized||participants|Number|367|367.0||||||
3845061|NCT01668784|3670413|B1|White||Race/Ethnicity, Customized||participants|Number|353|353.0||||||
3845062|NCT01668784|3670411|B3||Male|Sex: Female, Male||Participants|Count of Participants|619|619.0||||||
3845063|NCT01668784|3670412|B2||Male|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
3845064|NCT01668784|3670413|B1||Male|Sex: Female, Male||Participants|Count of Participants|315|315.0||||||
3845065|NCT01668784|3670411|B3||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3845066|NCT01668784|3670412|B2||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3845067|NCT01668784|3670413|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3845068|NCT01668784|3670411|B3|>= 75 years||Age, Customized||participants|Number|74|74.0||||||
3845069|NCT01668784|3670412|B2|>= 75 years||Age, Customized||participants|Number|40|40.0||||||
3845070|NCT01668784|3670413|B1|>= 75 years||Age, Customized||participants|Number|34|34.0||||||
3845071|NCT01668784|3670411|B3|>= 65 and < 75||Age, Customized||participants|Number|250|250.0||||||
3845072|NCT01668784|3670412|B2|>= 65 and < 75||Age, Customized||participants|Number|131|131.0||||||
3845073|NCT01668784|3670413|B1|>= 65 and < 75||Age, Customized||participants|Number|119|119.0||||||
3845074|NCT01668784|3670411|B3|< 65 years||Age, Customized||participants|Number|497|497.0||||||
3845075|NCT01668784|3670412|B2|< 65 years||Age, Customized||participants|Number|240|240.0||||||
3845076|NCT01668784|3670413|B1|< 65 years||Age, Customized||participants|Number|257|257.0||||||
3845077|NCT01668784|3670411|B3|||Age||years|Mean|61.3|61.3|Standard Deviation|10.66|10.66|||
3845078|NCT01668784|3670412|B2|||Age||years|Mean|61.9|61.9|Standard Deviation|10.43|10.43|||
3845079|NCT01668784|3670413|B1|||Age||years|Mean|60.6|60.6|Standard Deviation|10.87|10.87|||
3845080|NCT01668667|3670438|B5|||IRLS Rating Scale Total Score, Continuous|International Restless Legs Syndrome Rating Scale: Very severe=31-40, Severe=21-30, Moderate=11-20, Mild=1-10, None=0.|units on a scale|Mean|23.6|23.6|Standard Deviation|5.35|5.35|||
3845081|NCT01668667|3670439|B4|||IRLS Rating Scale Total Score, Continuous|International Restless Legs Syndrome Rating Scale: Very severe=31-40, Severe=21-30, Moderate=11-20, Mild=1-10, None=0.|units on a scale|Mean|23.5|23.5|Standard Deviation|5.34|5.34|||
3845082|NCT01668667|3670440|B3|||IRLS Rating Scale Total Score, Continuous|International Restless Legs Syndrome Rating Scale: Very severe=31-40, Severe=21-30, Moderate=11-20, Mild=1-10, None=0.|units on a scale|Mean|23.7|23.7|Standard Deviation|5.25|5.25|||
3845083|NCT01668667|3670441|B2|||IRLS Rating Scale Total Score, Continuous|International Restless Legs Syndrome Rating Scale: Very severe=31-40, Severe=21-30, Moderate=11-20, Mild=1-10, None=0.|units on a scale|Mean|24.0|24.0|Standard Deviation|5.23|5.23|||
3845084|NCT01668667|3670442|B1|||IRLS Rating Scale Total Score, Continuous|International Restless Legs Syndrome Rating Scale: Very severe=31-40, Severe=21-30, Moderate=11-20, Mild=1-10, None=0.|units on a scale|Mean|23.4|23.4|Standard Deviation|5.61|5.61|||
3845085|NCT01668667|3670438|B5|Unknown or not Reported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3845086|NCT01668667|3670439|B4|Unknown or not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845087|NCT01668667|3670440|B3|Unknown or not Reported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3845088|NCT01668667|3670441|B2|Unknown or not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845089|NCT01668667|3670442|B1|Unknown or not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845091|NCT01668667|3670439|B4|White & Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845092|NCT01668667|3670440|B3|White & Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3845093|NCT01668667|3670441|B2|White & Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845094|NCT01668667|3670442|B1|White & Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845095|NCT01668667|3670438|B5|White & African American/African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3845096|NCT01668667|3670439|B4|White & African American/African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845097|NCT01668667|3670440|B3|White & African American/African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845098|NCT01668667|3670441|B2|White & African American/African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845099|NCT01668667|3670442|B1|White & African American/African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3845100|NCT01668667|3670438|B5|White||Race/Ethnicity, Customized||participants|Number|413|413.0||||||
3845101|NCT01668667|3670439|B4|White||Race/Ethnicity, Customized||participants|Number|109|109.0||||||
3845102|NCT01668667|3670440|B3|White||Race/Ethnicity, Customized||participants|Number|95|95.0||||||
3845103|NCT01668667|3670441|B2|White||Race/Ethnicity, Customized||participants|Number|97|97.0||||||
3845104|NCT01668667|3670442|B1|White||Race/Ethnicity, Customized||participants|Number|112|112.0||||||
3845105|NCT01668667|3670438|B5|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845106|NCT01668667|3670439|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845107|NCT01668667|3670440|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845108|NCT01668667|3670441|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845109|NCT01668667|3670442|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845110|NCT01668667|3670438|B5|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3845111|NCT01668667|3670439|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845112|NCT01668667|3670440|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3845113|NCT01668667|3670441|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845114|NCT01668667|3670442|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845115|NCT01668667|3670438|B5|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3845116|NCT01668667|3670439|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845117|NCT01668667|3670440|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845118|NCT01668667|3670441|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3845119|NCT01668667|3670442|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845120|NCT01668667|3670438|B5|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
3845121|NCT01668667|3670439|B4|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3845122|NCT01668667|3670440|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3845123|NCT01668667|3670441|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3845124|NCT01668667|3670442|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3845125|NCT01668667|3670438|B5||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3845126|NCT01668667|3670439|B4||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3845127|NCT01668667|3670440|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3845128|NCT01668667|3670441|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3845129|NCT01668667|3670442|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3845130|NCT01668667|3670438|B5||Female|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
3845131|NCT01668667|3670439|B4||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3845132|NCT01668667|3670440|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3845133|NCT01668667|3670441|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3845134|NCT01668667|3670442|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3845135|NCT01668667|3670438|B5|||Age||years|Mean|51.3|51.3|Standard Deviation|13.20|13.2|||
3845136|NCT01668667|3670439|B4|||Age||years|Mean|52.1|52.1|Standard Deviation|13.01|13.01|||
3845137|NCT01668667|3670440|B3|||Age||years|Mean|52.0|52.0|Standard Deviation|14.51|14.51|||
3845138|NCT01668667|3670441|B2|||Age||years|Mean|52.1|52.1|Standard Deviation|12.22|12.22|||
3845139|NCT01668667|3670442|B1|||Age||years|Mean|49.2|49.2|Standard Deviation|12.92|12.92|||
3845140|NCT01668654|3670467|B1|White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3845141|NCT01668654|3670467|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3845142|NCT01668654|3670467|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3845143|NCT01668654|3670467|B1|||Age||Years|Mean|15.3|15.3|Standard Deviation|1.50|1.5|||
3845144|NCT01668628|3670507|B4||Male|Sex: Female, Male||Participants|Count of Participants|497|497.0||||||
3845145|NCT01668628|3670508|B3||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
3845146|NCT01668628|3670509|B2||Male|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
3845147|NCT01668628|3670510|B1||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3845148|NCT01668628|3670507|B4||Female|Sex: Female, Male||Participants|Count of Participants|578|578.0||||||
3845149|NCT01668628|3670508|B3||Female|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
3845150|NCT01668628|3670509|B2||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3845151|NCT01668628|3670510|B1||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
3845152|NCT01668628|3670507|B4|||Age||years|Mean|51.5|51.5|Standard Deviation|11.6|11.6|||
3845153|NCT01668628|3670508|B3|||Age||years|Mean|51.0|51.0|Standard Deviation|11.5|11.5|||
3845154|NCT01668628|3670509|B2|||Age||years|Mean|51.9|51.9|Standard Deviation|11.6|11.6|||
3845155|NCT01668628|3670510|B1|||Age||years|Mean|51.7|51.7|Standard Deviation|11.6|11.6|||
3845156|NCT01668628|3670507|B4||>=65 years|Age||Participants|Count of Participants|214|214.0||||||
3845157|NCT01668628|3670508|B3||>=65 years|Age||Participants|Count of Participants|70|70.0||||||
3845158|NCT01668628|3670509|B2||>=65 years|Age||Participants|Count of Participants|74|74.0||||||
3845159|NCT01668628|3670510|B1||>=65 years|Age||Participants|Count of Participants|70|70.0||||||
3845160|NCT01668628|3670507|B4||Between 18 and 65 years|Age||Participants|Count of Participants|861|861.0||||||
3845161|NCT01668628|3670508|B3||Between 18 and 65 years|Age||Participants|Count of Participants|297|297.0||||||
3845162|NCT01668628|3670509|B2||Between 18 and 65 years|Age||Participants|Count of Participants|285|285.0||||||
3845163|NCT01668628|3670510|B1||Between 18 and 65 years|Age||Participants|Count of Participants|279|279.0||||||
3845164|NCT01668628|3670507|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3845165|NCT01668628|3670508|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3845166|NCT01668628|3670509|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3845167|NCT01668628|3670510|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3845168|NCT01668589|3670524|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3845169|NCT01668589|3670525|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3845170|NCT01668589|3670526|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3845171|NCT01668589|3670527|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3845172|NCT01668589|3670528|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3845173|NCT01668589|3670524|B5||Female|Sex: Female, Male||Participants|Count of Participants|1479|1479.0||||||
3845174|NCT01668589|3670525|B4||Female|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
3845175|NCT01668589|3670526|B3||Female|Sex: Female, Male||Participants|Count of Participants|299|299.0||||||
3845176|NCT01668589|3670527|B2||Female|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
3845177|NCT01668589|3670528|B1||Female|Sex: Female, Male||Participants|Count of Participants|579|579.0||||||
3845178|NCT01668589|3670524|B5|||Age||years|Mean|70.7|70.7|Standard Deviation|9.6|9.6|||
3845179|NCT01668589|3670525|B4|||Age||years|Mean|71.2|71.2|Standard Deviation|10.4|10.4|||
3845180|NCT01668589|3670526|B3|||Age||years|Mean|66.3|66.3|Standard Deviation|9.2|9.2|||
3845181|NCT01668589|3670527|B2|||Age||years|Mean|71.0|71.0|Standard Deviation|9.5|9.5|||
3845182|NCT01668589|3670528|B1|||Age||years|Mean|72.5|72.5|Standard Deviation|8.7|8.7|||
3845183|NCT01668173|3670569|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3845184|NCT01668173|3670569|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3845185|NCT01668173|3670569|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3845186|NCT01668173|3670569|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3845187|NCT01668173|3670569|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3845188|NCT01668030|3670573|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3845189|NCT01668030|3670573|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845190|NCT01668030|3670573|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845191|NCT01668030|3670573|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3845192|NCT01668030|3670573|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3845193|NCT01668030|3670573|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845194|NCT01668030|3670573|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845195|NCT01668030|3670573|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845196|NCT01668030|3670573|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3845197|NCT01668030|3670573|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3845198|NCT01668030|3670573|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3845199|NCT01668030|3670573|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3845200|NCT01668030|3670573|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3845201|NCT01668017|3670579|B6||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3845202|NCT01668017|3670580|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3845203|NCT01668017|3670581|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3845204|NCT01668017|3670582|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3845205|NCT01668017|3670583|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3845206|NCT01668017|3670584|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3845207|NCT01668017|3670579|B6||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3845208|NCT01668017|3670580|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3845209|NCT01668017|3670581|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3845210|NCT01668017|3670582|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3845211|NCT01668017|3670583|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3845212|NCT01668017|3670584|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3845213|NCT01668017|3670579|B6|||Age||years|Mean|60.7|60.7|Standard Deviation|11.0|11.0|||
3845214|NCT01668017|3670580|B5|||Age||years|Mean|56.5|56.5|Standard Deviation|20.51|20.51|||
3845215|NCT01668017|3670581|B4|||Age||years|Mean|58.8|58.8|Standard Deviation|13.63|13.63|||
3845216|NCT01668017|3670582|B3|||Age||years|Mean|61.5|61.5|Standard Deviation|9.29|9.29|||
3845217|NCT01668017|3670583|B2|||Age||years|Mean|61.4|61.4|Standard Deviation|10.63|10.63|||
3845218|NCT01668017|3670584|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|12.20|12.2|||
3845219|NCT01668004|3670695|B1|||Abdominal circumference||cm|Mean|95.5|95.5|Standard Deviation|15.5|15.5|||
3845220|NCT01668004|3670695|B1|||Weight||kg|Mean|82.63|82.63|Standard Deviation|18.00|18.0|||
3845221|NCT01668004|3670695|B1|||Height||cm|Mean|175.82|175.82|Standard Deviation|9.62|9.62|||
3845222|NCT01668004|3670695|B1|||Age at onset of disease||Years|Mean|33.1|33.1|Standard Deviation|11.8|11.8|||
3845223|NCT01668004|3670695|B1|||Time since diagnosis||Years|Mean|10.8|10.8|Standard Deviation|11.8|11.8|||
3845224|NCT01668004|3670695|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3845225|NCT01668004|3670695|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3845226|NCT01668004|3670695|B1|||Age||years|Mean|44.4|44.4|Standard Deviation|12.9|12.9|||
3845227|NCT01667978|3670706|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
3845228|NCT01667978|3670707|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3845229|NCT01667978|3670708|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3845230|NCT01667978|3670706|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3845231|NCT01667978|3670707|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3845232|NCT01667978|3670708|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3845233|NCT01667978|3670706|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3845234|NCT01667978|3670707|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3845235|NCT01667978|3670708|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3845236|NCT01667978|3670706|B3|||Age||years|Median|39|39.0|Inter-Quartile Range|||34.0|41.0|
3845237|NCT01667978|3670707|B2|||Age||years|Median|38|38.0|Inter-Quartile Range|||33.4|41.3|
3845238|NCT01667978|3670708|B1|||Age||years|Median|39.9|39.9|Inter-Quartile Range|||35.9|42.3|
3845239|NCT01667978|3670706|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3845240|NCT01667978|3670707|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3845241|NCT01667978|3670708|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3845242|NCT01667978|3670706|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3845243|NCT01667978|3670707|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3845244|NCT01667978|3670708|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3845245|NCT01667978|3670706|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3845246|NCT01667978|3670707|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3845247|NCT01667978|3670708|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3845248|NCT01667926|3670715|B3|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3845249|NCT01667926|3670716|B2|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3845250|NCT01667926|3670717|B1|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3845251|NCT01667926|3670715|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3845252|NCT01667926|3670716|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3845253|NCT01667926|3670717|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3845254|NCT01667926|3670715|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3845255|NCT01667926|3670716|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3845256|NCT01667926|3670717|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3845257|NCT01667926|3670715|B3|||Age||years|Mean|45.4|45.4|Standard Deviation|12.4|12.4|||
3845258|NCT01667926|3670716|B2|||Age||years|Mean|45.3|45.3|Standard Deviation|11.7|11.7|||
3845259|NCT01667926|3670717|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|13.6|13.6|||
3845260|NCT01667926|3670715|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3845261|NCT01667926|3670716|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3845262|NCT01667926|3670717|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3845263|NCT01667926|3670715|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3845264|NCT01667926|3670716|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3845265|NCT01667926|3670717|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3845266|NCT01667926|3670715|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3845267|NCT01667926|3670716|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3845268|NCT01667926|3670717|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3845269|NCT01667900|3670727|B6|China||Region of Enrollment||participants|Number|58|58.0||||||
3845270|NCT01667900|3670728|B5|China||Region of Enrollment||participants|Number|10|10.0||||||
3845271|NCT01667900|3670729|B4|China||Region of Enrollment||participants|Number|10|10.0||||||
3845272|NCT01667900|3670730|B3|China||Region of Enrollment||participants|Number|11|11.0||||||
3845273|NCT01667900|3670731|B2|China||Region of Enrollment||participants|Number|11|11.0||||||
3845274|NCT01667900|3670732|B1|China||Region of Enrollment||participants|Number|16|16.0||||||
3845275|NCT01667900|3670727|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845276|NCT01667900|3670728|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845277|NCT01667900|3670729|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845278|NCT01667900|3670730|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845279|NCT01667900|3670731|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845280|NCT01667900|3670732|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845281|NCT01667900|3670727|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845282|NCT01667900|3670728|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845283|NCT01667900|3670729|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845284|NCT01667900|3670730|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845285|NCT01667900|3670731|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845286|NCT01667900|3670732|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845287|NCT01667900|3670727|B6||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845288|NCT01667900|3670728|B5||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845289|NCT01667900|3670729|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845290|NCT01667900|3670730|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845291|NCT01667900|3670731|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845292|NCT01667900|3670732|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845293|NCT01667900|3670727|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845294|NCT01667900|3670728|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845295|NCT01667900|3670729|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845296|NCT01667900|3670730|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845297|NCT01667900|3670731|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845298|NCT01667900|3670732|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845299|NCT01667900|3670727|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845300|NCT01667900|3670728|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845301|NCT01667900|3670729|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845302|NCT01667900|3670730|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845303|NCT01667900|3670731|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845304|NCT01667900|3670732|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845305|NCT01667900|3670727|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3845306|NCT01667900|3670728|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3845307|NCT01667900|3670729|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3845308|NCT01667900|3670730|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3845309|NCT01667900|3670731|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3845310|NCT01667900|3670732|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3845311|NCT01667900|3670727|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845312|NCT01667900|3670728|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845313|NCT01667900|3670729|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845314|NCT01667900|3670730|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845315|NCT01667900|3670731|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845316|NCT01667900|3670732|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845317|NCT01667900|3670727|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845318|NCT01667900|3670728|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845319|NCT01667900|3670729|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845320|NCT01667900|3670730|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845321|NCT01667900|3670731|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845322|NCT01667900|3670732|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845323|NCT01667900|3670727|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3845324|NCT01667900|3670728|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3845325|NCT01667900|3670729|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3845326|NCT01667900|3670730|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3845327|NCT01667900|3670731|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3845328|NCT01667900|3670732|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3845329|NCT01667900|3670727|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845330|NCT01667900|3670728|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845331|NCT01667900|3670729|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845332|NCT01667900|3670730|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845333|NCT01667900|3670731|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845334|NCT01667900|3670732|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845335|NCT01667900|3670727|B6||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3845336|NCT01667900|3670728|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3845337|NCT01667900|3670729|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3845338|NCT01667900|3670730|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3845339|NCT01667900|3670731|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3845340|NCT01667900|3670732|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3845341|NCT01667900|3670727|B6||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3845342|NCT01667900|3670728|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3845343|NCT01667900|3670729|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3845344|NCT01667900|3670730|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3845345|NCT01667900|3670731|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3845346|NCT01667900|3670732|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3845347|NCT01667900|3670727|B6|||Age||years|Mean|48.4|48.4|Standard Deviation|14.5|14.5|||
3845348|NCT01667900|3670728|B5|||Age||years|Mean|51.8|51.8|Standard Deviation|8.3|8.3|||
3845349|NCT01667900|3670729|B4|||Age||years|Mean|55.8|55.8|Standard Deviation|8.5|8.5|||
3845350|NCT01667900|3670730|B3|||Age||years|Mean|56.9|56.9|Standard Deviation|13.1|13.1|||
3845351|NCT01667900|3670731|B2|||Age||years|Mean|58.2|58.2|Standard Deviation|4.2|4.2|||
3845352|NCT01667900|3670732|B1|||Age||years|Mean|29.2|29.2|Standard Deviation|5.6|5.6|||
3845353|NCT01667848|3670789|B3|Austria||Region of Enrollment||participants|Number|148|148.0||||||
3845354|NCT01667848|3670790|B2|Austria||Region of Enrollment||participants|Number|81|81.0||||||
3845355|NCT01667848|3670791|B1|Austria||Region of Enrollment||participants|Number|67|67.0||||||
3845356|NCT01667848|3670789|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3845357|NCT01667848|3670790|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3845358|NCT01667848|3670791|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3845359|NCT01667848|3670789|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3845360|NCT01667848|3670790|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3845361|NCT01667848|3670791|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3845362|NCT01667848|3670789|B3|||Age||years|Mean|55.7|55.7|Standard Deviation|15.14|15.14|||
3845363|NCT01667848|3670790|B2|||Age||years|Mean|55.68|55.68|Standard Deviation|16.93|16.93|||
3845364|NCT01667848|3670791|B1|||Age||years|Mean|55.87|55.87|Standard Deviation|14.44|14.44|||
3845365|NCT01667796|3670800|B3|United States||Region of Enrollment||participants|Number|57|57.0||||||
3845366|NCT01667796|3670801|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3845367|NCT01667796|3670802|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3845368|NCT01667796|3670800|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845369|NCT01667796|3670801|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845370|NCT01667796|3670802|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845371|NCT01667796|3670800|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845372|NCT01667796|3670801|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845373|NCT01667796|3670802|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845374|NCT01667796|3670800|B3||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3845375|NCT01667796|3670801|B2||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3845376|NCT01667796|3670802|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3845377|NCT01667796|3670800|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845378|NCT01667796|3670801|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845379|NCT01667796|3670802|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845380|NCT01667796|3670800|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845381|NCT01667796|3670801|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845382|NCT01667796|3670802|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845383|NCT01667796|3670800|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845384|NCT01667796|3670801|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845385|NCT01667796|3670802|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845386|NCT01667796|3670800|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845387|NCT01667796|3670801|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845442|NCT01667731|3670818|B4|Yes||Liver Cirrhosis||participants|Number|6|6.0||||||
3845388|NCT01667796|3670802|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845389|NCT01667796|3670800|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3845390|NCT01667796|3670801|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3845391|NCT01667796|3670802|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3845392|NCT01667796|3670800|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3845393|NCT01667796|3670801|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3845394|NCT01667796|3670802|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3845395|NCT01667796|3670800|B3|||Age||years|Mean|38.9|38.9|Standard Deviation|10.8|10.8|||
3845396|NCT01667796|3670801|B2|||Age||years|Mean|37.9|37.9|Standard Deviation|12.1|12.1|||
3845397|NCT01667796|3670802|B1|||Age||years|Mean|40.2|40.2|Standard Deviation|9.2|9.2|||
3845398|NCT01667731|3670816|B6|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|173|173.0||||||
3845399|NCT01667731|3670817|B5|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|92|92.0||||||
3845400|NCT01667731|3670818|B4|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|15|15.0||||||
3845401|NCT01667731|3670819|B3|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|19|19.0||||||
3845402|NCT01667731|3670820|B2|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|27|27.0||||||
3845403|NCT01667731|3670821|B1|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|20|20.0||||||
3845404|NCT01667731|3670816|B6|< 6 log10 IU/mL||HCV RNA Category||participants|Number|50|50.0||||||
3845405|NCT01667731|3670817|B5|< 6 log10 IU/mL||HCV RNA Category||participants|Number|22|22.0||||||
3845406|NCT01667731|3670818|B4|< 6 log10 IU/mL||HCV RNA Category||participants|Number|2|2.0||||||
3845407|NCT01667731|3670819|B3|< 6 log10 IU/mL||HCV RNA Category||participants|Number|5|5.0||||||
3845408|NCT01667731|3670820|B2|< 6 log10 IU/mL||HCV RNA Category||participants|Number|15|15.0||||||
3845409|NCT01667731|3670821|B1|< 6 log10 IU/mL||HCV RNA Category||participants|Number|6|6.0||||||
3845410|NCT01667731|3670816|B6|||HCV RNA (log10 IU/mL)||log10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.75|0.75|||
3845411|NCT01667731|3670817|B5|||HCV RNA (log10 IU/mL)||log10 IU/mL|Mean|6.6|6.6|Standard Deviation|0.83|0.83|||
3845412|NCT01667731|3670818|B4|||HCV RNA (log10 IU/mL)||log10 IU/mL|Mean|6.4|6.4|Standard Deviation|0.47|0.47|||
3845413|NCT01667731|3670819|B3|||HCV RNA (log10 IU/mL)||log10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.82|0.82|||
3845414|NCT01667731|3670820|B2|||HCV RNA (log10 IU/mL)||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.59|0.59|||
3845415|NCT01667731|3670821|B1|||HCV RNA (log10 IU/mL)||log10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.59|0.59|||
3845416|NCT01667731|3670816|B6|Missing||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3845417|NCT01667731|3670817|B5|Missing||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3845418|NCT01667731|3670818|B4|Missing||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3845419|NCT01667731|3670819|B3|Missing||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3845420|NCT01667731|3670820|B2|Missing||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3845421|NCT01667731|3670821|B1|Missing||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3845422|NCT01667731|3670816|B6|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|36|36.0||||||
3845423|NCT01667731|3670817|B5|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|26|26.0||||||
3845424|NCT01667731|3670818|B4|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3845425|NCT01667731|3670819|B3|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|4|4.0||||||
3845426|NCT01667731|3670820|B2|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|5|5.0||||||
3845427|NCT01667731|3670821|B1|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3845428|NCT01667731|3670816|B6|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|111|111.0||||||
3845429|NCT01667731|3670817|B5|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|57|57.0||||||
3845430|NCT01667731|3670818|B4|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|7|7.0||||||
3845431|NCT01667731|3670819|B3|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|10|10.0||||||
3845432|NCT01667731|3670820|B2|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|22|22.0||||||
3845433|NCT01667731|3670821|B1|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|15|15.0||||||
3845434|NCT01667731|3670816|B6|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|75|75.0||||||
3845435|NCT01667731|3670817|B5|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|30|30.0||||||
3845436|NCT01667731|3670818|B4|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|10|10.0||||||
3845437|NCT01667731|3670819|B3|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|10|10.0||||||
3845438|NCT01667731|3670820|B2|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|15|15.0||||||
3845439|NCT01667731|3670821|B1|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|10|10.0||||||
3845440|NCT01667731|3670816|B6|Yes||Liver Cirrhosis||participants|Number|22|22.0||||||
3845441|NCT01667731|3670817|B5|Yes||Liver Cirrhosis||participants|Number|5|5.0||||||
3845443|NCT01667731|3670819|B3|Yes||Liver Cirrhosis||participants|Number|4|4.0||||||
3845444|NCT01667731|3670820|B2|Yes||Liver Cirrhosis||participants|Number|6|6.0||||||
3845445|NCT01667731|3670821|B1|Yes||Liver Cirrhosis||participants|Number|1|1.0||||||
3845446|NCT01667731|3670816|B6|No||Liver Cirrhosis||participants|Number|201|201.0||||||
3845447|NCT01667731|3670817|B5|No||Liver Cirrhosis||participants|Number|109|109.0||||||
3845448|NCT01667731|3670818|B4|No||Liver Cirrhosis||participants|Number|11|11.0||||||
3845449|NCT01667731|3670819|B3|No||Liver Cirrhosis||participants|Number|20|20.0||||||
3845450|NCT01667731|3670820|B2|No||Liver Cirrhosis||participants|Number|36|36.0||||||
3845451|NCT01667731|3670821|B1|No||Liver Cirrhosis||participants|Number|25|25.0||||||
3845452|NCT01667731|3670816|B6|Genotype 3||HCV Genotype||participants|Number|59|59.0||||||
3845453|NCT01667731|3670817|B5|Genotype 3||HCV Genotype||participants|Number|0|0.0||||||
3845454|NCT01667731|3670818|B4|Genotype 3||HCV Genotype||participants|Number|17|17.0||||||
3845455|NCT01667731|3670819|B3|Genotype 3||HCV Genotype||participants|Number|0|0.0||||||
3845456|NCT01667731|3670820|B2|Genotype 3||HCV Genotype||participants|Number|42|42.0||||||
3845457|NCT01667731|3670821|B1|Genotype 3||HCV Genotype||participants|Number|0|0.0||||||
3845458|NCT01667731|3670816|B6|Genotype 2||HCV Genotype||participants|Number|50|50.0||||||
3845459|NCT01667731|3670817|B5|Genotype 2||HCV Genotype||participants|Number|0|0.0||||||
3845460|NCT01667731|3670818|B4|Genotype 2||HCV Genotype||participants|Number|0|0.0||||||
3845461|NCT01667731|3670819|B3|Genotype 2||HCV Genotype||participants|Number|24|24.0||||||
3845462|NCT01667731|3670820|B2|Genotype 2||HCV Genotype||participants|Number|0|0.0||||||
3845463|NCT01667731|3670821|B1|Genotype 2||HCV Genotype||participants|Number|26|26.0||||||
3845464|NCT01667731|3670816|B6|Genotype 1||HCV Genotype||participants|Number|114|114.0||||||
3845465|NCT01667731|3670817|B5|Genotype 1||HCV Genotype||participants|Number|114|114.0||||||
3845466|NCT01667731|3670818|B4|Genotype 1||HCV Genotype||participants|Number|0|0.0||||||
3845467|NCT01667731|3670819|B3|Genotype 1||HCV Genotype||participants|Number|0|0.0||||||
3845468|NCT01667731|3670820|B2|Genotype 1||HCV Genotype||participants|Number|0|0.0||||||
3845469|NCT01667731|3670821|B1|Genotype 1||HCV Genotype||participants|Number|0|0.0||||||
3845470|NCT01667731|3670816|B6|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3845471|NCT01667731|3670817|B5|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3845472|NCT01667731|3670818|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845473|NCT01667731|3670819|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845474|NCT01667731|3670820|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3845475|NCT01667731|3670821|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3845476|NCT01667731|3670816|B6|Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3845477|NCT01667731|3670817|B5|Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3845478|NCT01667731|3670818|B4|Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845479|NCT01667731|3670819|B3|Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845480|NCT01667731|3670820|B2|Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845481|NCT01667731|3670821|B1|Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3845482|NCT01667731|3670816|B6|American Indian/Alaska Native/First Nations||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3845483|NCT01667731|3670817|B5|American Indian/Alaska Native/First Nations||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845484|NCT01667731|3670818|B4|American Indian/Alaska Native/First Nations||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3845485|NCT01667731|3670819|B3|American Indian/Alaska Native/First Nations||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845486|NCT01667731|3670820|B2|American Indian/Alaska Native/First Nations||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845487|NCT01667731|3670821|B1|American Indian/Alaska Native/First Nations||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845488|NCT01667731|3670816|B6|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3845489|NCT01667731|3670817|B5|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3845490|NCT01667731|3670818|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845491|NCT01667731|3670819|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3845492|NCT01667731|3670820|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3845493|NCT01667731|3670821|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845494|NCT01667731|3670816|B6|White||Race/Ethnicity, Customized||participants|Number|156|156.0||||||
3845495|NCT01667731|3670817|B5|White||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
3845496|NCT01667731|3670818|B4|White||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3845497|NCT01667731|3670819|B3|White||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3845498|NCT01667731|3670820|B2|White||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3845499|NCT01667731|3670821|B1|White||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3845500|NCT01667731|3670816|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
3845501|NCT01667731|3670817|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
3845502|NCT01667731|3670818|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3845503|NCT01667731|3670819|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3845504|NCT01667731|3670820|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3845620|NCT01667419|3670975|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3845505|NCT01667731|3670821|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3845506|NCT01667731|3670816|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845507|NCT01667731|3670817|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845508|NCT01667731|3670818|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845509|NCT01667731|3670819|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845510|NCT01667731|3670820|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845511|NCT01667731|3670821|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845512|NCT01667731|3670816|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|169|169.0||||||
3845513|NCT01667731|3670817|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
3845514|NCT01667731|3670818|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3845515|NCT01667731|3670819|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3845516|NCT01667731|3670820|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3845517|NCT01667731|3670821|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3845518|NCT01667731|3670816|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3845519|NCT01667731|3670817|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3845520|NCT01667731|3670818|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3845521|NCT01667731|3670819|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3845522|NCT01667731|3670820|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3845523|NCT01667731|3670821|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3845524|NCT01667731|3670816|B6||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
3845525|NCT01667731|3670817|B5||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3845526|NCT01667731|3670818|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3845527|NCT01667731|3670819|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3845528|NCT01667731|3670820|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3845529|NCT01667731|3670821|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3845530|NCT01667731|3670816|B6||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3845531|NCT01667731|3670817|B5||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3845532|NCT01667731|3670818|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3845533|NCT01667731|3670819|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3845534|NCT01667731|3670820|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3845535|NCT01667731|3670821|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3845536|NCT01667731|3670816|B6|||Age||years|Mean|49|49.0|Standard Deviation|8.7|8.7|||
3845537|NCT01667731|3670817|B5|||Age||years|Mean|48|48.0|Standard Deviation|8.4|8.4|||
3845538|NCT01667731|3670818|B4|||Age||years|Mean|54|54.0|Standard Deviation|7.0|7.0|||
3845539|NCT01667731|3670819|B3|||Age||years|Mean|54|54.0|Standard Deviation|4.9|4.9|||
3845540|NCT01667731|3670820|B2|||Age||years|Mean|48|48.0|Standard Deviation|9.6|9.6|||
3845541|NCT01667731|3670821|B1|||Age||years|Mean|51|51.0|Standard Deviation|9.7|9.7|||
3845542|NCT01667679|3670878|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3845543|NCT01667679|3670879|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3845544|NCT01667679|3670880|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3845545|NCT01667679|3670878|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845546|NCT01667679|3670879|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845547|NCT01667679|3670880|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845548|NCT01667679|3670878|B3||White|Race (NIH/OMB)||Participants|Count of Participants|204|204.0||||||
3845549|NCT01667679|3670879|B2||White|Race (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3845550|NCT01667679|3670880|B1||White|Race (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
3845551|NCT01667679|3670878|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3845552|NCT01667679|3670879|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3845553|NCT01667679|3670880|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3845554|NCT01667679|3670878|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845555|NCT01667679|3670879|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845556|NCT01667679|3670880|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845557|NCT01667679|3670878|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3845558|NCT01667679|3670879|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3845559|NCT01667679|3670880|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3845560|NCT01667679|3670878|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845561|NCT01667679|3670879|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845562|NCT01667679|3670880|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845563|NCT01667679|3670878|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3845564|NCT01667679|3670879|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3845565|NCT01667679|3670880|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3845566|NCT01667679|3670878|B3||Female|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
3845567|NCT01667679|3670879|B2||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3845568|NCT01667679|3670880|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3845569|NCT01667679|3670878|B3|||Age||Years|Mean|40.1|40.1|Standard Deviation|12.24|12.24|||
3845570|NCT01667679|3670879|B2|||Age||Years|Mean|40.7|40.7|Standard Deviation|11.93|11.93|||
3845571|NCT01667679|3670880|B1|||Age||Years|Mean|39.5|39.5|Standard Deviation|12.55|12.55|||
3845572|NCT01667536|3670939|B1||Male|Gender||Participants|Count of Participants|105|105.0||||||
3845573|NCT01667536|3670939|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3845574|NCT01667536|3670939|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|6.8|6.8|||
3845575|NCT01667471|3670950|B1||Male|Gender||Participants|Count of Participants|1|1.0||||||
3845576|NCT01667471|3670950|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
3845577|NCT01667471|3670950|B1|||Age||years|Mean|14.4|14.4|Standard Deviation|3.2|3.2|||
3845578|NCT01667432|3670966|B1||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3845579|NCT01667432|3670966|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3845580|NCT01667432|3670966|B1|||Age||years|Mean|40.10|40.1|Standard Deviation|10.45|10.45|||
3845581|NCT01667419|3670971|B5|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3845582|NCT01667419|3670972|B4|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3845583|NCT01667419|3670973|B3|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3845584|NCT01667419|3670974|B2|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3845585|NCT01667419|3670975|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3845586|NCT01667419|3670971|B5|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3845587|NCT01667419|3670972|B4|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3845588|NCT01667419|3670973|B3|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3845589|NCT01667419|3670974|B2|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3845590|NCT01667419|3670975|B1|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3845591|NCT01667419|3670971|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3845592|NCT01667419|3670972|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3845593|NCT01667419|3670973|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3845594|NCT01667419|3670974|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3845595|NCT01667419|3670975|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3845596|NCT01667419|3670971|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|465|465.0||||||
3845597|NCT01667419|3670972|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|81|81.0||||||
3845598|NCT01667419|3670973|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|84|84.0||||||
3845599|NCT01667419|3670974|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|150|150.0||||||
3845600|NCT01667419|3670975|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|150|150.0||||||
3845601|NCT01667419|3670971|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3845602|NCT01667419|3670972|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3845603|NCT01667419|3670973|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3845604|NCT01667419|3670974|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3845605|NCT01667419|3670975|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3845606|NCT01667419|3670971|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|445|445.0||||||
3845607|NCT01667419|3670972|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3845608|NCT01667419|3670973|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3845609|NCT01667419|3670974|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|148|148.0||||||
3845610|NCT01667419|3670975|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
3845611|NCT01667419|3670971|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3845612|NCT01667419|3670972|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3845613|NCT01667419|3670973|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3845614|NCT01667419|3670974|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3845615|NCT01667419|3670975|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3845616|NCT01667419|3670971|B5||Male|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
3845617|NCT01667419|3670972|B4||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3845618|NCT01667419|3670973|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3845619|NCT01667419|3670974|B2||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3845621|NCT01667419|3670971|B5||Female|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
3845622|NCT01667419|3670972|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3845623|NCT01667419|3670973|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3845624|NCT01667419|3670974|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3845625|NCT01667419|3670975|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3845626|NCT01667419|3670971|B5|||Age||years|Mean|50.2|50.2|Standard Deviation|12.9|12.9|||
3845627|NCT01667419|3670972|B4|||Age||years|Mean|49.1|49.1|Standard Deviation|12.9|12.9|||
3845628|NCT01667419|3670973|B3|||Age||years|Mean|51.6|51.6|Standard Deviation|14.1|14.1|||
3845629|NCT01667419|3670974|B2|||Age||years|Mean|49.6|49.6|Standard Deviation|12.7|12.7|||
3845630|NCT01667419|3670975|B1|||Age||years|Mean|50.7|50.7|Standard Deviation|12.4|12.4|||
3845631|NCT01667250|3671006|B3|United States||Region of Enrollment||Participants|Count of Participants|59|59.0||||||
3845632|NCT01667250|3671007|B2|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3845633|NCT01667250|3671008|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3845634|NCT01667250|3671006|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3845635|NCT01667250|3671007|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3845636|NCT01667250|3671008|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3845637|NCT01667250|3671006|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3845638|NCT01667250|3671007|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3845639|NCT01667250|3671008|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3845640|NCT01667250|3671006|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3845641|NCT01667250|3671007|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3845642|NCT01667250|3671008|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3845643|NCT01667250|3671006|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3845644|NCT01667250|3671007|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3845645|NCT01667250|3671008|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3845646|NCT01667250|3671006|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
3845647|NCT01667250|3671007|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3845648|NCT01667250|3671008|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3845649|NCT01667250|3671006|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3845650|NCT01667250|3671007|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3845651|NCT01667250|3671008|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3845652|NCT01667250|3671006|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3845653|NCT01667250|3671007|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3845654|NCT01667250|3671008|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3845655|NCT01667250|3671006|B3|||Age||years|Mean|40|40.0|Full Range|||18.2|65.2|
3845656|NCT01667250|3671007|B2|||Age||years|Mean|41.0|41.0|Full Range|||20.0|60.9|
3845657|NCT01667250|3671008|B1|||Age||years|Mean|39.7|39.7|Full Range|||18.2|65.2|
3845658|NCT01667224|3671024|B3|Korea, Republic of||Region of Enrollment||participants|Number|80|80.0||||||
3845659|NCT01667224|3671025|B2|Korea, Republic of||Region of Enrollment||participants|Number|40|40.0||||||
3845660|NCT01667224|3671026|B1|Korea, Republic of||Region of Enrollment||participants|Number|40|40.0||||||
3845661|NCT01667224|3671024|B3||Male|Gender||Participants|Count of Participants|32|32.0||||||
3845662|NCT01667224|3671025|B2||Male|Gender||Participants|Count of Participants|10|10.0||||||
3845663|NCT01667224|3671026|B1||Male|Gender||Participants|Count of Participants|22|22.0||||||
3845664|NCT01667224|3671024|B3||Female|Gender||Participants|Count of Participants|48|48.0||||||
3845665|NCT01667224|3671025|B2||Female|Gender||Participants|Count of Participants|30|30.0||||||
3845666|NCT01667224|3671026|B1||Female|Gender||Participants|Count of Participants|18|18.0||||||
3845667|NCT01667224|3671024|B3|||Age||years|Mean|40.08|40.08|Standard Deviation|10.60|10.6|||
3845668|NCT01667224|3671025|B2|||Age||years|Mean|40.05|40.05|Standard Deviation|11.58|11.58|||
3845669|NCT01667224|3671026|B1|||Age||years|Mean|40.10|40.1|Standard Deviation|9.67|9.67|||
3845670|NCT01667224|3671024|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3845671|NCT01667224|3671025|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3845672|NCT01667224|3671026|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3845673|NCT01667224|3671024|B3||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
3845674|NCT01667224|3671025|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3845675|NCT01667224|3671026|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3845676|NCT01667224|3671024|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3845677|NCT01667224|3671025|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3845678|NCT01667224|3671026|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3845679|NCT01667107|3671039|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3845680|NCT01667107|3671040|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3845681|NCT01667107|3671041|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3845682|NCT01667107|3671039|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3845683|NCT01667107|3671040|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3845684|NCT01667107|3671041|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3845685|NCT01667107|3671039|B3|||Age||Years|Mean|45.5|45.5|Standard Deviation|14.22|14.22|||
3845686|NCT01667107|3671040|B2|||Age||Years|Mean|52.4|52.4|Standard Deviation|10.39|10.39|||
3845687|NCT01667107|3671041|B1|||Age||Years|Mean|30.0|30.0|Standard Deviation|7.82|7.82|||
3845688|NCT01667029|3671058|B1|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3845689|NCT01667029|3671058|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845690|NCT01667029|3671058|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845691|NCT01667029|3671058|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3845692|NCT01667029|3671058|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3845693|NCT01667029|3671058|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845694|NCT01667029|3671058|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845695|NCT01667029|3671058|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845696|NCT01667029|3671058|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845697|NCT01667029|3671058|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3845698|NCT01667029|3671058|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845699|NCT01667029|3671058|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3845700|NCT01667029|3671058|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3845701|NCT01667029|3671058|B1|||Age||years|Mean|58|58.0|Standard Deviation|5.40|5.4|||
3845702|NCT01667029|3671058|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3845703|NCT01667029|3671058|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3845704|NCT01667029|3671058|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3845705|NCT01666951|3671099|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
3845706|NCT01666951|3671100|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3845707|NCT01666951|3671101|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3845708|NCT01666951|3671099|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845709|NCT01666951|3671100|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845710|NCT01666951|3671101|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845711|NCT01666951|3671099|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845712|NCT01666951|3671100|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845713|NCT01666951|3671101|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845714|NCT01666951|3671099|B3||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3845715|NCT01666951|3671100|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3845716|NCT01666951|3671101|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3845717|NCT01666951|3671099|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3845718|NCT01666951|3671100|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3845719|NCT01666951|3671101|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3845720|NCT01666951|3671099|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845721|NCT01666951|3671100|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845722|NCT01666951|3671101|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845723|NCT01666951|3671099|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3845724|NCT01666951|3671100|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845725|NCT01666951|3671101|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3845726|NCT01666951|3671099|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3845727|NCT01666951|3671100|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845728|NCT01666951|3671101|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3845729|NCT01666951|3671099|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845730|NCT01666951|3671100|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845731|NCT01666951|3671101|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845732|NCT01666951|3671099|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3845733|NCT01666951|3671100|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3845734|NCT01666951|3671101|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3845735|NCT01666951|3671099|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3845736|NCT01666951|3671100|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3845737|NCT01666951|3671101|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3845738|NCT01666951|3671099|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3845739|NCT01666951|3671100|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3845740|NCT01666951|3671101|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3845741|NCT01666951|3671099|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3845742|NCT01666951|3671100|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3845743|NCT01666951|3671101|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3845744|NCT01666951|3671099|B3|||Age||years|Mean|49.0|49.0|Standard Deviation|12.84|12.84|||
3845745|NCT01666951|3671100|B2|||Age||years|Mean|46.4|46.4|Standard Deviation|11.49|11.49|||
3845746|NCT01666951|3671101|B1|||Age||years|Mean|51.5|51.5|Standard Deviation|13.92|13.92|||
3845747|NCT01666951|3671099|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3845748|NCT01666951|3671100|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3845749|NCT01666951|3671101|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3845750|NCT01666951|3671099|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3845751|NCT01666951|3671100|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3845752|NCT01666951|3671101|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3845753|NCT01666951|3671099|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3845754|NCT01666951|3671100|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3845755|NCT01666951|3671101|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3845756|NCT01666912|3671138|B3|United States||Region of Enrollment||participants|Number|96|96.0||||||
3845757|NCT01666912|3671139|B2|United States||Region of Enrollment||participants|Number|48|48.0||||||
3845758|NCT01666912|3671140|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
3845759|NCT01666912|3671138|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3845760|NCT01666912|3671139|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3845761|NCT01666912|3671140|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3845762|NCT01666912|3671138|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845763|NCT01666912|3671139|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845764|NCT01666912|3671140|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845765|NCT01666912|3671138|B3||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3845766|NCT01666912|3671139|B2||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3845767|NCT01666912|3671140|B1||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3845768|NCT01666912|3671138|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3845769|NCT01666912|3671139|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3845770|NCT01666912|3671140|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3845771|NCT01666912|3671138|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845772|NCT01666912|3671139|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845773|NCT01666912|3671140|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845774|NCT01666912|3671138|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3845775|NCT01666912|3671139|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845776|NCT01666912|3671140|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3845777|NCT01666912|3671138|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845778|NCT01666912|3671139|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845779|NCT01666912|3671140|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845780|NCT01666912|3671138|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845781|NCT01666912|3671139|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845782|NCT01666912|3671140|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845783|NCT01666912|3671138|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3845784|NCT01666912|3671139|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3845785|NCT01666912|3671140|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3845786|NCT01666912|3671138|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3845787|NCT01666912|3671139|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3845788|NCT01666912|3671140|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3845789|NCT01666912|3671138|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3845790|NCT01666912|3671139|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3845791|NCT01666912|3671140|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3845792|NCT01666912|3671138|B3||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3845793|NCT01666912|3671139|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3845794|NCT01666912|3671140|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3845795|NCT01666912|3671138|B3|||Age||years|Mean|21|21.0|Standard Deviation|2.4|2.4|||
3845796|NCT01666912|3671139|B2|||Age||years|Mean|21|21.0|Standard Deviation|2.35|2.35|||
3845797|NCT01666912|3671140|B1|||Age||years|Mean|21|21.0|Standard Deviation|2.58|2.58|||
3845798|NCT01666782|3671151|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
3845799|NCT01666782|3671152|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
3845800|NCT01666782|3671153|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3845801|NCT01666782|3671151|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3845802|NCT01666782|3671152|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3845803|NCT01666782|3671153|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3845804|NCT01666782|3671151|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3845805|NCT01666782|3671152|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3845806|NCT01666782|3671153|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3845807|NCT01666782|3671151|B3|||Age||years|Mean|53.4|53.4|Standard Deviation|7.54|7.54|||
3845808|NCT01666782|3671152|B2|||Age||years|Mean|52.9|52.9|Standard Deviation|7.95|7.95|||
3845809|NCT01666782|3671153|B1|||Age||years|Mean|53.94|53.94|Standard Deviation|7.16|7.16|||
3845810|NCT01666314|3671170|B9|||Body Mass Index (BMI)||kg/m^2|Mean|26.96|26.96|Full Range|||16.7|40.3|
3845811|NCT01666314|3671171|B8|||Body Mass Index (BMI)||kg/m^2|Mean|29.40|29.4|Full Range|||22.9|40.2|
3845812|NCT01666314|3671172|B7|||Body Mass Index (BMI)||kg/m^2|Mean|28.37|28.37|Full Range|||18.9|39.9|
3845813|NCT01666314|3671173|B6|||Body Mass Index (BMI)||kg/m^2|Mean|29.61|29.61|Full Range|||22.1|40.3|
3845814|NCT01666314|3671174|B5|||Body Mass Index (BMI)||kg/m^2|Mean|29.85|29.85|Full Range|||23.8|37.8|
3845815|NCT01666314|3671175|B4|||Body Mass Index (BMI)||kg/m^2|Mean|23.73|23.73|Full Range|||16.7|32.0|
3845816|NCT01666314|3671176|B3|||Body Mass Index (BMI)||kg/m^2|Mean|24.43|24.43|Full Range|||21.1|28.7|
3845817|NCT01666314|3671177|B2|||Body Mass Index (BMI)||kg/m^2|Mean|25.21|25.21|Full Range|||17.8|31.2|
3845818|NCT01666314|3671178|B1|||Body Mass Index (BMI)||kg/m^2|Mean|25.05|25.05|Full Range|||20.6|30.4|
3845819|NCT01666314|3671170|B9|||Weight||kg|Mean|77.77|77.77|Full Range|||44.7|134.6|
3845820|NCT01666314|3671171|B8|||Weight||kg|Mean|89.85|89.85|Full Range|||63.0|134.6|
3845821|NCT01666314|3671172|B7|||Weight||kg|Mean|88.23|88.23|Full Range|||64.9|114.1|
3845822|NCT01666314|3671173|B6|||Weight||kg|Mean|90.39|90.39|Full Range|||64.0|130.7|
3845823|NCT01666314|3671174|B5|||Weight||kg|Mean|87.34|87.34|Full Range|||67.0|113.0|
3845824|NCT01666314|3671175|B4|||Weight||kg|Mean|64.49|64.49|Full Range|||44.7|87.1|
3845825|NCT01666314|3671176|B3|||Weight||kg|Mean|65.75|65.75|Full Range|||55.5|76.0|
3845826|NCT01666314|3671177|B2|||Weight||kg|Mean|70.32|70.32|Full Range|||47.5|85.2|
3845827|NCT01666314|3671178|B1|||Weight||kg|Mean|65.82|65.82|Full Range|||55.1|82.4|
3845828|NCT01666314|3671170|B9|||Height||cm|Mean|169.29|169.29|Full Range|||151.0|189.0|
3845829|NCT01666314|3671171|B8|||Height||cm|Mean|174.74|174.74|Full Range|||162.0|189.0|
3845830|NCT01666314|3671172|B7|||Height||cm|Mean|176.70|176.7|Full Range|||165.0|185.4|
3845831|NCT01666314|3671173|B6|||Height||cm|Mean|174.79|174.79|Full Range|||162.0|186.0|
3845832|NCT01666314|3671174|B5|||Height||cm|Mean|170.41|170.41|Full Range|||157.0|184.7|
3845833|NCT01666314|3671175|B4|||Height||cm|Mean|164.71|164.71|Full Range|||151.0|174.0|
3845834|NCT01666314|3671176|B3|||Height||cm|Mean|163.92|163.92|Full Range|||156.6|170.7|
3845835|NCT01666314|3671177|B2|||Height||cm|Mean|167.10|167.1|Full Range|||154.0|177.5|
3845836|NCT01666314|3671178|B1|||Height||cm|Mean|161.94|161.94|Full Range|||153.0|168.2|
3845837|NCT01666314|3671170|B9|United States||Region of Enrollment||participants|Number|25|25.0||||||
3845838|NCT01666314|3671171|B8|United States||Region of Enrollment||participants|Number|10|10.0||||||
3845839|NCT01666314|3671172|B7|United States||Region of Enrollment||participants|Number|4|4.0||||||
3845840|NCT01666314|3671173|B6|United States||Region of Enrollment||participants|Number|9|9.0||||||
3845841|NCT01666314|3671174|B5|United States||Region of Enrollment||participants|Number|2|2.0||||||
3845842|NCT01666314|3671175|B4|United States||Region of Enrollment||participants|Number|0|0.0||||||
3845843|NCT01666314|3671176|B3|United States||Region of Enrollment||participants|Number|0|0.0||||||
3845844|NCT01666314|3671177|B2|United States||Region of Enrollment||participants|Number|0|0.0||||||
3845845|NCT01666314|3671178|B1|United States||Region of Enrollment||participants|Number|0|0.0||||||
3845846|NCT01666314|3671170|B9|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3845847|NCT01666314|3671171|B8|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3845848|NCT01666314|3671172|B7|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3845849|NCT01666314|3671173|B6|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3845850|NCT01666314|3671174|B5|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3845851|NCT01666314|3671175|B4|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3845852|NCT01666314|3671176|B3|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3845853|NCT01666314|3671177|B2|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3845854|NCT01666314|3671178|B1|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3845855|NCT01666314|3671170|B9|Netherlands||Region of Enrollment||participants|Number|13|13.0||||||
3845856|NCT01666314|3671171|B8|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
3845857|NCT01666314|3671172|B7|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
3845858|NCT01666314|3671173|B6|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
3845859|NCT01666314|3671174|B5|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
3845860|NCT01666314|3671175|B4|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
3845861|NCT01666314|3671176|B3|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
3845862|NCT01666314|3671177|B2|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
3845863|NCT01666314|3671178|B1|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
3845864|NCT01666314|3671170|B9|Ireland||Region of Enrollment||participants|Number|13|13.0||||||
3845865|NCT01666314|3671171|B8|Ireland||Region of Enrollment||participants|Number|3|3.0||||||
3845866|NCT01666314|3671172|B7|Ireland||Region of Enrollment||participants|Number|3|3.0||||||
3845867|NCT01666314|3671173|B6|Ireland||Region of Enrollment||participants|Number|5|5.0||||||
3845868|NCT01666314|3671174|B5|Ireland||Region of Enrollment||participants|Number|2|2.0||||||
3845869|NCT01666314|3671175|B4|Ireland||Region of Enrollment||participants|Number|0|0.0||||||
3845870|NCT01666314|3671176|B3|Ireland||Region of Enrollment||participants|Number|0|0.0||||||
3845871|NCT01666314|3671177|B2|Ireland||Region of Enrollment||participants|Number|0|0.0||||||
3845872|NCT01666314|3671178|B1|Ireland||Region of Enrollment||participants|Number|0|0.0||||||
3845873|NCT01666314|3671170|B9|Greece||Region of Enrollment||participants|Number|10|10.0||||||
3845874|NCT01666314|3671171|B8|Greece||Region of Enrollment||participants|Number|3|3.0||||||
3845875|NCT01666314|3671172|B7|Greece||Region of Enrollment||participants|Number|1|1.0||||||
3845876|NCT01666314|3671173|B6|Greece||Region of Enrollment||participants|Number|4|4.0||||||
3845877|NCT01666314|3671174|B5|Greece||Region of Enrollment||participants|Number|2|2.0||||||
3845878|NCT01666314|3671175|B4|Greece||Region of Enrollment||participants|Number|0|0.0||||||
3845879|NCT01666314|3671176|B3|Greece||Region of Enrollment||participants|Number|0|0.0||||||
3845880|NCT01666314|3671177|B2|Greece||Region of Enrollment||participants|Number|0|0.0||||||
3845881|NCT01666314|3671178|B1|Greece||Region of Enrollment||participants|Number|0|0.0||||||
3845882|NCT01666314|3671170|B9|Australia||Region of Enrollment||participants|Number|8|8.0||||||
3845883|NCT01666314|3671171|B8|Australia||Region of Enrollment||participants|Number|2|2.0||||||
3845884|NCT01666314|3671172|B7|Australia||Region of Enrollment||participants|Number|2|2.0||||||
3845885|NCT01666314|3671173|B6|Australia||Region of Enrollment||participants|Number|1|1.0||||||
3845886|NCT01666314|3671174|B5|Australia||Region of Enrollment||participants|Number|3|3.0||||||
3845887|NCT01666314|3671175|B4|Australia||Region of Enrollment||participants|Number|0|0.0||||||
3845888|NCT01666314|3671176|B3|Australia||Region of Enrollment||participants|Number|0|0.0||||||
3845889|NCT01666314|3671177|B2|Australia||Region of Enrollment||participants|Number|0|0.0||||||
3845890|NCT01666314|3671178|B1|Australia||Region of Enrollment||participants|Number|0|0.0||||||
3845891|NCT01666314|3671170|B9|Japan||Region of Enrollment||participants|Number|65|65.0||||||
3845892|NCT01666314|3671171|B8|Japan||Region of Enrollment||participants|Number|0|0.0||||||
3845893|NCT01666314|3671172|B7|Japan||Region of Enrollment||participants|Number|0|0.0||||||
3845894|NCT01666314|3671173|B6|Japan||Region of Enrollment||participants|Number|0|0.0||||||
3845895|NCT01666314|3671174|B5|Japan||Region of Enrollment||participants|Number|0|0.0||||||
3845896|NCT01666314|3671175|B4|Japan||Region of Enrollment||participants|Number|22|22.0||||||
3845897|NCT01666314|3671176|B3|Japan||Region of Enrollment||participants|Number|10|10.0||||||
3845898|NCT01666314|3671177|B2|Japan||Region of Enrollment||participants|Number|22|22.0||||||
3845899|NCT01666314|3671178|B1|Japan||Region of Enrollment||participants|Number|11|11.0||||||
3845900|NCT01666314|3671170|B9|Asian - Japanese||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
3845901|NCT01666314|3671171|B8|Asian - Japanese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845902|NCT01666314|3671172|B7|Asian - Japanese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845903|NCT01666314|3671173|B6|Asian - Japanese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845904|NCT01666314|3671174|B5|Asian - Japanese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845905|NCT01666314|3671175|B4|Asian - Japanese||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3845906|NCT01666314|3671176|B3|Asian - Japanese||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3845907|NCT01666314|3671177|B2|Asian - Japanese||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3845908|NCT01666314|3671178|B1|Asian - Japanese||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3845909|NCT01666314|3671170|B9|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3845910|NCT01666314|3671171|B8|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3845911|NCT01666314|3671172|B7|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3845912|NCT01666314|3671173|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845913|NCT01666314|3671174|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845914|NCT01666314|3671175|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845915|NCT01666314|3671176|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845916|NCT01666314|3671177|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845917|NCT01666314|3671178|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845918|NCT01666314|3671170|B9|White||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
3845919|NCT01666314|3671171|B8|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3845920|NCT01666314|3671172|B7|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3845921|NCT01666314|3671173|B6|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3845922|NCT01666314|3671174|B5|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3845923|NCT01666314|3671175|B4|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845924|NCT01666314|3671176|B3|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845925|NCT01666314|3671177|B2|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845926|NCT01666314|3671178|B1|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3845927|NCT01666314|3671170|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845928|NCT01666314|3671171|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845929|NCT01666314|3671172|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845930|NCT01666314|3671173|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845931|NCT01666314|3671174|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845932|NCT01666314|3671175|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845933|NCT01666314|3671176|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845934|NCT01666314|3671177|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845935|NCT01666314|3671178|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845936|NCT01666314|3671170|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|136|136.0||||||
3845937|NCT01666314|3671171|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3845938|NCT01666314|3671172|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3845939|NCT01666314|3671173|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3845940|NCT01666314|3671174|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3845941|NCT01666314|3671175|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3845942|NCT01666314|3671176|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3845943|NCT01666314|3671177|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3845944|NCT01666314|3671178|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3845945|NCT01666314|3671170|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3845946|NCT01666314|3671171|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3845947|NCT01666314|3671172|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845948|NCT01666314|3671173|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845949|NCT01666314|3671174|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845950|NCT01666314|3671175|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845951|NCT01666314|3671176|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845952|NCT01666314|3671177|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845953|NCT01666314|3671178|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845954|NCT01666314|3671170|B9||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3845955|NCT01666314|3671171|B8||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3845956|NCT01666314|3671172|B7||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3845957|NCT01666314|3671173|B6||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3845958|NCT01666314|3671174|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3845959|NCT01666314|3671175|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3845960|NCT01666314|3671176|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3845961|NCT01666314|3671177|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3845962|NCT01666314|3671178|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3845963|NCT01666314|3671170|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3845964|NCT01666314|3671171|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3845965|NCT01666314|3671172|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3845966|NCT01666314|3671173|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3845967|NCT01666314|3671174|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3845968|NCT01666314|3671175|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3845969|NCT01666314|3671176|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3845970|NCT01666314|3671177|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3845971|NCT01666314|3671178|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3845972|NCT01666314|3671170|B9|||Age||years|Mean|70.6|70.6|Full Range|||49.0|88.0|
3845973|NCT01666314|3671171|B8|||Age||years|Mean|69.4|69.4|Full Range|||49.0|88.0|
3845974|NCT01666314|3671172|B7|||Age||years|Mean|73.3|73.3|Full Range|||60.0|84.0|
3845975|NCT01666314|3671173|B6|||Age||years|Mean|69.9|69.9|Full Range|||55.0|84.0|
3845976|NCT01666314|3671174|B5|||Age||years|Mean|69.6|69.6|Full Range|||51.0|85.0|
3845977|NCT01666314|3671175|B4|||Age||years|Mean|71.5|71.5|Full Range|||51.0|85.0|
3845978|NCT01666314|3671176|B3|||Age||years|Mean|70.1|70.1|Full Range|||59.0|76.0|
3845979|NCT01666314|3671177|B2|||Age||years|Mean|68.5|68.5|Full Range|||52.0|82.0|
3845980|NCT01666314|3671178|B1|||Age||years|Mean|72.1|72.1|Full Range|||62.0|84.0|
3845981|NCT01666210|3671290|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3845982|NCT01666210|3671291|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3845983|NCT01666210|3671292|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3845984|NCT01666210|3671290|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3845985|NCT01666210|3671291|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3845986|NCT01666210|3671292|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3845987|NCT01666210|3671290|B3|Age greater than or equal to 65||Age, Customized||Participants|Count of Participants|37|37.0||||||
3845988|NCT01666210|3671291|B2|Age greater than or equal to 65||Age, Customized||Participants|Count of Participants|21|21.0||||||
3845989|NCT01666210|3671292|B1|Age greater than or equal to 65||Age, Customized||Participants|Count of Participants|16|16.0||||||
3845990|NCT01666210|3671290|B3|Age between 21 - 65||Age, Customized||Participants|Count of Participants|23|23.0||||||
3845991|NCT01666210|3671291|B2|Age between 21 - 65||Age, Customized||Participants|Count of Participants|9|9.0||||||
3845992|NCT01666210|3671292|B1|Age between 21 - 65||Age, Customized||Participants|Count of Participants|14|14.0||||||
3845993|NCT01666197|3671303|B3|Germany||Region of Enrollment||participants|Number|100|100.0||||||
3845994|NCT01666197|3671304|B2|Germany||Region of Enrollment||participants|Number|50|50.0||||||
3845995|NCT01666197|3671305|B1|Germany||Region of Enrollment||participants|Number|50|50.0||||||
3845996|NCT01666197|3671303|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845997|NCT01666197|3671304|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845998|NCT01666197|3671305|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3845999|NCT01666197|3671303|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3846000|NCT01666197|3671304|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3846001|NCT01666197|3671305|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3846002|NCT01666197|3671303|B3||White|Race (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3846003|NCT01666197|3671304|B2||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3846004|NCT01666197|3671305|B1||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3846005|NCT01666197|3671303|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3846006|NCT01666197|3671304|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3846007|NCT01666197|3671305|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3846008|NCT01666197|3671303|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3846009|NCT01666197|3671304|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3846010|NCT01666197|3671305|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3846011|NCT01666197|3671303|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3846012|NCT01666197|3671304|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3846013|NCT01666197|3671305|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3846014|NCT01666197|3671303|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3846015|NCT01666197|3671304|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3846016|NCT01666197|3671305|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3846017|NCT01666197|3671303|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3846018|NCT01666197|3671304|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3846019|NCT01666197|3671305|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3846020|NCT01666197|3671303|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3846021|NCT01666197|3671304|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3846022|NCT01666197|3671305|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3846023|NCT01666197|3671303|B3|||Age||Years|Mean|32.0|32.0|Standard Deviation|12.9|12.9|||
3846024|NCT01666197|3671304|B2|||Age||Years|Mean|33.2|33.2|Standard Deviation|12.2|12.2|||
3846025|NCT01666197|3671305|B1|||Age||Years|Mean|30.7|30.7|Standard Deviation|13.4|13.4|||
3846026|NCT01666145|3671312|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3846027|NCT01666145|3671312|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3846028|NCT01666145|3671312|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3846029|NCT01666145|3671312|B1|||Age||years|Mean|63|63.0|Full Range|||47.0|77.0|
3846030|NCT01666119|3671317|B1|United States||Region of Enrollment||participants|Number|249|249.0||||||
3846031|NCT01666119|3671317|B1||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3846032|NCT01666119|3671317|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3846033|NCT01666119|3671317|B1|||Age||years|Mean|38.7|38.7|Standard Deviation|10.2|10.2|||
3846034|NCT01666002|3671322|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
3846035|NCT01666002|3671323|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3846036|NCT01666002|3671324|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3846037|NCT01666002|3671322|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3846038|NCT01666002|3671323|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3846039|NCT01666002|3671324|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3846040|NCT01666002|3671322|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3846041|NCT01666002|3671323|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3846042|NCT01666002|3671324|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3846043|NCT01666002|3671322|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3846044|NCT01666002|3671323|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3846045|NCT01666002|3671324|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3846046|NCT01666002|3671322|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3846047|NCT01666002|3671323|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3846048|NCT01666002|3671324|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3846049|NCT01666002|3671322|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3846050|NCT01666002|3671323|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3846051|NCT01666002|3671324|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3846052|NCT01666002|3671322|B3|||Age||years|Mean|59|59.0|Standard Deviation|13|13.0|||
3846053|NCT01666002|3671323|B2|||Age||years|Mean|65|65.0|Standard Deviation|8|8.0|||
3846054|NCT01666002|3671324|B1|||Age||years|Mean|53|53.0|Standard Deviation|14|14.0|||
3846055|NCT01665950|3671333|B4|United States||Region of Enrollment||participants|Number|4|4.0||||||
3846056|NCT01665950|3671334|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3846057|NCT01665950|3671336|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3846058|NCT01665950|3671333|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3846059|NCT01665950|3671334|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3846060|NCT01665950|3671336|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3846061|NCT01665950|3671333|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3846062|NCT01665950|3671334|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3846063|NCT01665950|3671336|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3846064|NCT01665950|3671333|B4|||Age||years|Mean|44|44.0|Full Range|||27.0|56.0|
3846065|NCT01665950|3671334|B3|||Age||years|Mean|46.5|46.5|Full Range|||44.0|49.0|
3846066|NCT01665950|3671336|B1|||Age||years|Mean|41.5|41.5|Full Range|||27.0|56.0|
3846067|NCT01665950|3671333|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3846068|NCT01665950|3671334|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3846069|NCT01665950|3671335|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3846070|NCT01665950|3671336|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3846071|NCT01665950|3671333|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3846072|NCT01665950|3671334|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3846073|NCT01665950|3671335|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3846074|NCT01665950|3671336|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3846075|NCT01665950|3671333|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3846076|NCT01665950|3671334|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3846077|NCT01665950|3671335|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3846078|NCT01665950|3671336|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3846079|NCT01665911|3671346|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
3846080|NCT01665911|3671346|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3846081|NCT01665911|3671346|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3846082|NCT01665911|3671346|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3846083|NCT01665911|3671346|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3846084|NCT01665911|3671346|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3846085|NCT01665911|3671346|B1|||Age||years|Mean|63|63.0|Standard Deviation|10|10.0|||
3846086|NCT01665807|3671352|B4|Canada||Region of Enrollment||participants|Number|871|871.0||||||
3846087|NCT01665807|3671353|B3|Canada||Region of Enrollment||participants|Number|402|402.0||||||
3846088|NCT01665807|3671354|B2|Canada||Region of Enrollment||participants|Number|58|58.0||||||
3846089|NCT01665807|3671355|B1|Canada||Region of Enrollment||participants|Number|411|411.0||||||
3846090|NCT01665807|3671352|B4|Male||Sex/Gender, Customized||participants|Number|251|251.0||||||
3846091|NCT01665807|3671353|B3|Male||Sex/Gender, Customized||participants|Number|119|119.0||||||
3846092|NCT01665807|3671354|B2|Male||Sex/Gender, Customized||participants|Number|19|19.0||||||
3846093|NCT01665807|3671355|B1|Male||Sex/Gender, Customized||participants|Number|113|113.0||||||
3846094|NCT01665807|3671352|B4|Female||Sex/Gender, Customized||participants|Number|616|616.0||||||
3846095|NCT01665807|3671353|B3|Female||Sex/Gender, Customized||participants|Number|282|282.0||||||
3846096|NCT01665807|3671354|B2|Female||Sex/Gender, Customized||participants|Number|39|39.0||||||
3846097|NCT01665807|3671355|B1|Female||Sex/Gender, Customized||participants|Number|295|295.0||||||
3846098|NCT01665807|3671352|B4|||Age||years|Mean|42.5|42.5|Standard Deviation|12.9|12.9|||
3846099|NCT01665807|3671353|B3|||Age||years|Mean|41.2|41.2|Standard Deviation|12.6|12.6|||
3846100|NCT01665807|3671354|B2|||Age||years|Mean|40.2|40.2|Standard Deviation|11.3|11.3|||
3846101|NCT01665807|3671355|B1|||Age||years|Mean|44.0|44.0|Standard Deviation|13.2|13.2|||
3846102|NCT01665807|3671352|B4||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
3846103|NCT01665807|3671353|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3846104|NCT01665807|3671354|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3846105|NCT01665807|3671355|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3846106|NCT01665807|3671352|B4||Between 18 and 65 years|Age||Participants|Count of Participants|835|835.0||||||
3846107|NCT01665807|3671353|B3||Between 18 and 65 years|Age||Participants|Count of Participants|391|391.0||||||
3846108|NCT01665807|3671354|B2||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3846109|NCT01665807|3671355|B1||Between 18 and 65 years|Age||Participants|Count of Participants|386|386.0||||||
3846110|NCT01665807|3671352|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3846111|NCT01665807|3671353|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3846112|NCT01665807|3671354|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3846113|NCT01665807|3671355|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3846114|NCT01665768|3671368|B1|Four Prior Therapies||Number of Prior Therapies||Participants|Count of Participants|1|1.0||||||
3846115|NCT01665768|3671368|B1|Three Prior Therapies||Number of Prior Therapies||Participants|Count of Participants|18|18.0||||||
3846116|NCT01665768|3671368|B1|Two Prior Therapies||Number of Prior Therapies||Participants|Count of Participants|30|30.0||||||
3846117|NCT01665768|3671368|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3846118|NCT01665768|3671368|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3846119|NCT01665768|3671368|B1||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3846120|NCT01665768|3671368|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3846121|NCT01665768|3671368|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3846122|NCT01665768|3671368|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3846123|NCT01665768|3671368|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3846124|NCT01665768|3671368|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3846125|NCT01665768|3671368|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3846126|NCT01665768|3671368|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3846127|NCT01665768|3671368|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3846128|NCT01665768|3671368|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3846129|NCT01665768|3671368|B1|||Age||years|Median|59|59.0|Full Range|||36.0|72.0|
3846130|NCT01665768|3671368|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3846131|NCT01665768|3671368|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3846132|NCT01665768|3671368|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3846133|NCT01665599|3671373|B1|Mental Component Summary||Short Form -12 (SF-12) Health survey|"Data collected from the SF-12 questionnaire, based on the norm-based scores is used to assess improvement in the psychometrically-based physical component summary (PCS) and mental component summary (MCS). Both PCS and MCS contains four subdomains (A total of 12 questions).~PCS and MCS composite scores are computed using the scores of the 12 questions and transforming these to range from 0-100, where a zero score indicates the lowest level of health and 100 indicates the highest level of health. Positive change from baseline indicates improvement in physical and mental health."|units on a scale|Mean|43.0|43.0|Standard Deviation|10.2|10.2|||
3846134|NCT01665599|3671373|B1|Physical Component Summary||Short Form -12 (SF-12) Health survey|"Data collected from the SF-12 questionnaire, based on the norm-based scores is used to assess improvement in the psychometrically-based physical component summary (PCS) and mental component summary (MCS). Both PCS and MCS contains four subdomains (A total of 12 questions).~PCS and MCS composite scores are computed using the scores of the 12 questions and transforming these to range from 0-100, where a zero score indicates the lowest level of health and 100 indicates the highest level of health. Positive change from baseline indicates improvement in physical and mental health."|units on a scale|Mean|47.5|47.5|Standard Deviation|9.6|9.6|||
3846135|NCT01665599|3671373|B1|Global Fatigue Index (GFI)||Multidimensional Assessment of Fatigue|"The MAF have 16 questions (Q) divided into 4 domains:~Severity (Q 1-2) (Score range [SR]: 2-20)~Distress (Q 3) (SR: 1-10)~Degree of interference in activities of daily living (Q 4-14) (SR: 11-110)~Timing (Q 15-16) (SR: 5-20)~First 14 Q are scored from 1-10. Questions 15-16 are scored from 1-4 and converted to 1-10 scale by multiplying each score by 2.5. Lower score in each domain indicates improvement in fatigue.~GFI was calculated by summing up scores of Q 1, 2, 3, average of 4-14, and revised score of 15. Range of GFI: 1 (no fatigue) to 50 (severe fatigue)."|units on a scale|Mean|27.2|27.2|Standard Deviation|12.6|12.6|||
3846136|NCT01665599|3671373|B1|Timing domain||Multidimensional Assessment of Fatigue|"The MAF have 16 questions (Q) divided into 4 domains:~Severity (Q 1-2) (Score range [SR]: 2-20)~Distress (Q 3) (SR: 1-10)~Degree of interference in activities of daily living (Q 4-14) (SR: 11-110)~Timing (Q 15-16) (SR: 5-20)~First 14 Q are scored from 1-10. Questions 15-16 are scored from 1-4 and converted to 1-10 scale by multiplying each score by 2.5. Lower score in each domain indicates improvement in fatigue.~GFI was calculated by summing up scores of Q 1, 2, 3, average of 4-14, and revised score of 15. Range of GFI: 1 (no fatigue) to 50 (severe fatigue)."|units on a scale|Mean|12.8|12.8|Standard Deviation|3.1|3.1|||
3846137|NCT01665599|3671373|B1|Degree of interference domain||Multidimensional Assessment of Fatigue|"The MAF have 16 questions (Q) divided into 4 domains:~Severity (Q 1-2) (Score range [SR]: 2-20)~Distress (Q 3) (SR: 1-10)~Degree of interference in activities of daily living (Q 4-14) (SR: 11-110)~Timing (Q 15-16) (SR: 5-20)~First 14 Q are scored from 1-10. Questions 15-16 are scored from 1-4 and converted to 1-10 scale by multiplying each score by 2.5. Lower score in each domain indicates improvement in fatigue.~GFI was calculated by summing up scores of Q 1, 2, 3, average of 4-14, and revised score of 15. Range of GFI: 1 (no fatigue) to 50 (severe fatigue)."|units on a scale|Mean|48.9|48.9|Standard Deviation|24.3|24.3|||
3846185|NCT01665170|3671423|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3846186|NCT01665170|3671424|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3846187|NCT01665170|3671425|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3846188|NCT01665170|3671423|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3846189|NCT01665170|3671424|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3846138|NCT01665599|3671373|B1|Distress domain||Multidimensional Assessment of Fatigue|"The MAF have 16 questions (Q) divided into 4 domains:~Severity (Q 1-2) (Score range [SR]: 2-20)~Distress (Q 3) (SR: 1-10)~Degree of interference in activities of daily living (Q 4-14) (SR: 11-110)~Timing (Q 15-16) (SR: 5-20)~First 14 Q are scored from 1-10. Questions 15-16 are scored from 1-4 and converted to 1-10 scale by multiplying each score by 2.5. Lower score in each domain indicates improvement in fatigue.~GFI was calculated by summing up scores of Q 1, 2, 3, average of 4-14, and revised score of 15. Range of GFI: 1 (no fatigue) to 50 (severe fatigue)."|units on a scale|Mean|4.9|4.9|Standard Deviation|2.8|2.8|||
3846139|NCT01665599|3671373|B1|Severity domain||Multidimensional Assessment of Fatigue|"The MAF have 16 questions (Q) divided into 4 domains:~Severity (Q 1-2) (Score range [SR]: 2-20)~Distress (Q 3) (SR: 1-10)~Degree of interference in activities of daily living (Q 4-14) (SR: 11-110)~Timing (Q 15-16) (SR: 5-20)~First 14 Q are scored from 1-10. Questions 15-16 are scored from 1-4 and converted to 1-10 scale by multiplying each score by 2.5. Lower score in each domain indicates improvement in fatigue.~GFI was calculated by summing up scores of Q 1, 2, 3, average of 4-14, and revised score of 15. Range of GFI: 1 (no fatigue) to 50 (severe fatigue)."|units on a scale|Mean|11.9|11.9|Standard Deviation|5.5|5.5|||
3846140|NCT01665599|3671373|B1|||Total International Index of Erectile Function (IIEF) Score|"IIEF questionnaire have 15 questions (Q) divided into 5 domains-~Erectile function (6 items, Q 1-5 and 15) (Score range: 1-30)~Orgasmic function (2 items, Q 9-10) (Score range: 0-10)~Sexual desire (2 items, Q 11-12) (Score range: 2-10)~Intercourse satisfaction (3 items, Q 6-8) (Score range: 0-15)~Overall satisfaction (2 items, Q 13-14) (Score range: 2-10)~Total score was calculated by summing up scores of each domain and ranged from 5-75. Low score indicates severe dysfunction and a high score indicates no dysfunction in sexual function."|units on a scale|Mean|31.9|31.9|Standard Deviation|18.4|18.4|||
3846141|NCT01665599|3671373|B1|||BMI, Continuous||kg/m^2|Mean|30|30.0|Standard Deviation|3.4|3.4|||
3846142|NCT01665599|3671373|B1|||Weight, Continuous||pounds|Mean|211.3|211.3|Standard Deviation|30.1|30.1|||
3846143|NCT01665599|3671373|B1|||Height, Continuous||Inches|Mean|70.3|70.3|Standard Deviation|2.8|2.8|||
3846144|NCT01665599|3671373|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3846145|NCT01665599|3671373|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3846146|NCT01665599|3671373|B1||White|Race (NIH/OMB)||Participants|Count of Participants|157|157.0||||||
3846147|NCT01665599|3671373|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3846148|NCT01665599|3671373|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3846149|NCT01665599|3671373|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3846150|NCT01665599|3671373|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3846151|NCT01665599|3671373|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3846152|NCT01665599|3671373|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|164|164.0||||||
3846153|NCT01665599|3671373|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3846154|NCT01665599|3671373|B1||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3846155|NCT01665599|3671373|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3846156|NCT01665599|3671373|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|9.4|9.4|||
3846157|NCT01665599|3671373|B1||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
3846158|NCT01665599|3671373|B1||Between 18 and 65 years|Age||Participants|Count of Participants|145|145.0||||||
3846159|NCT01665599|3671373|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3846160|NCT01665508|3671393|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3846161|NCT01665508|3671393|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3846162|NCT01665508|3671393|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3846163|NCT01665508|3671393|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|10|10.0|||
3846164|NCT01665508|3671393|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3846165|NCT01665508|3671393|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3846166|NCT01665508|3671393|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3846167|NCT01665430|3671409|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3846168|NCT01665430|3671409|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3846169|NCT01665430|3671409|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|12.12|12.12|||
3846170|NCT01665170|3671423|B3|Germany||Region of Enrollment||participants|Number|60|60.0||||||
3846171|NCT01665170|3671424|B2|Germany||Region of Enrollment||participants|Number|30|30.0||||||
3846172|NCT01665170|3671425|B1|Germany||Region of Enrollment||participants|Number|30|30.0||||||
3846173|NCT01665170|3671423|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3846174|NCT01665170|3671424|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3846175|NCT01665170|3671425|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3846176|NCT01665170|3671423|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3846177|NCT01665170|3671424|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3846178|NCT01665170|3671425|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3846179|NCT01665170|3671423|B3|||Age||years|Mean|28.5|28.5|Standard Deviation|5.78|5.78|||
3846180|NCT01665170|3671424|B2|||Age||years|Mean|28.47|28.47|Standard Deviation|5.81|5.81|||
3846181|NCT01665170|3671425|B1|||Age||years|Mean|28.57|28.57|Standard Deviation|5.00|5.0|||
3846182|NCT01665170|3671423|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3846183|NCT01665170|3671424|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3846184|NCT01665170|3671425|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3846190|NCT01665170|3671425|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3846191|NCT01665157|3671474|B4|Taiwan||Region of Enrollment||participants|Number|180|180.0||||||
3846192|NCT01665157|3671475|B3|Taiwan||Region of Enrollment||participants|Number|60|60.0||||||
3846193|NCT01665157|3671476|B2|Taiwan||Region of Enrollment||participants|Number|60|60.0||||||
3846194|NCT01665157|3671477|B1|Taiwan||Region of Enrollment||participants|Number|60|60.0||||||
3846195|NCT01665157|3671474|B4||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3846196|NCT01665157|3671475|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3846197|NCT01665157|3671476|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3846198|NCT01665157|3671477|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3846199|NCT01665157|3671474|B4||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3846200|NCT01665157|3671475|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3846201|NCT01665157|3671476|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3846202|NCT01665157|3671477|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3846203|NCT01665157|3671474|B4|||Age||years|Mean|52.3|52.3|Standard Deviation|11.4|11.4|||
3846204|NCT01665157|3671475|B3|||Age||years|Mean|53.0|53.0|Standard Deviation|11.0|11.0|||
3846205|NCT01665157|3671476|B2|||Age||years|Mean|51.3|51.3|Standard Deviation|12.7|12.7|||
3846206|NCT01665157|3671477|B1|||Age||years|Mean|52.5|52.5|Standard Deviation|10.6|10.6|||
3846207|NCT01665157|3671474|B4||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3846208|NCT01665157|3671475|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3846209|NCT01665157|3671476|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3846210|NCT01665157|3671477|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3846211|NCT01665157|3671474|B4||Between 18 and 65 years|Age||Participants|Count of Participants|157|157.0||||||
3846212|NCT01665157|3671475|B3||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3846213|NCT01665157|3671476|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3846214|NCT01665157|3671477|B1||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3846215|NCT01665157|3671474|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3846216|NCT01665157|3671475|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3846217|NCT01665157|3671476|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3846218|NCT01665157|3671477|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3846219|NCT01665144|3671505|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3846220|NCT01665144|3671506|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3846221|NCT01665144|3671507|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3846222|NCT01665144|3671505|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3846223|NCT01665144|3671506|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3846224|NCT01665144|3671507|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3846225|NCT01665144|3671505|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1563|1563.0||||||
3846226|NCT01665144|3671506|B2||White|Race (NIH/OMB)||Participants|Count of Participants|513|513.0||||||
3846227|NCT01665144|3671507|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1050|1050.0||||||
3846228|NCT01665144|3671505|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3846229|NCT01665144|3671506|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3846230|NCT01665144|3671507|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3846231|NCT01665144|3671505|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3846232|NCT01665144|3671506|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3846233|NCT01665144|3671507|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3846234|NCT01665144|3671505|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3846235|NCT01665144|3671506|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3846236|NCT01665144|3671507|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3846237|NCT01665144|3671505|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3846238|NCT01665144|3671506|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3846239|NCT01665144|3671507|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3846240|NCT01665144|3671505|B3||Male|Sex: Female, Male||Participants|Count of Participants|659|659.0||||||
3846241|NCT01665144|3671506|B2||Male|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
3846242|NCT01665144|3671507|B1||Male|Sex: Female, Male||Participants|Count of Participants|436|436.0||||||
3846243|NCT01665144|3671505|B3||Female|Sex: Female, Male||Participants|Count of Participants|992|992.0||||||
3846244|NCT01665144|3671506|B2||Female|Sex: Female, Male||Participants|Count of Participants|323|323.0||||||
3846245|NCT01665144|3671507|B1||Female|Sex: Female, Male||Participants|Count of Participants|669|669.0||||||
3846246|NCT01665144|3671505|B3|||Age||Years|Mean|48.0|48.0|Standard Deviation|7.87|7.87|||
3846247|NCT01665144|3671506|B2|||Age||Years|Mean|48.1|48.1|Standard Deviation|7.94|7.94|||
3846248|NCT01665144|3671507|B1|||Age||Years|Mean|48.0|48.0|Standard Deviation|7.84|7.84|||
3846268|NCT01665053|3671515|B2|No History of PVD||History of peripheral vascular disease (PVD)||participants|Number|778|778.0||||||
3846249|NCT01665053|3671514|B3|Left Main Coronary Artery (LMCA)||Baseline Lesion Characteristics as determined by the Angiographic Core Laboratory, ITT Analysis Set|"The Promus Element Plus group has 1043 lesions in 838 subjects enrolled in this treatment arm.~The Synergy group has 1059 lesions in 846 subjects enrolled in this treatment arm.~The measure type is number of lesions. The total number of lesions does not match with the total number of participants since some of the participants have more than one lesion."|Number of lesions|Number|1|1.0||||||
3846250|NCT01665053|3671515|B2|Left Main Coronary Artery (LMCA)||Baseline Lesion Characteristics as determined by the Angiographic Core Laboratory, ITT Analysis Set|"The Promus Element Plus group has 1043 lesions in 838 subjects enrolled in this treatment arm.~The Synergy group has 1059 lesions in 846 subjects enrolled in this treatment arm.~The measure type is number of lesions. The total number of lesions does not match with the total number of participants since some of the participants have more than one lesion."|Number of lesions|Number|0|0.0||||||
3846251|NCT01665053|3671516|B1|Left Main Coronary Artery (LMCA)||Baseline Lesion Characteristics as determined by the Angiographic Core Laboratory, ITT Analysis Set|"The Promus Element Plus group has 1043 lesions in 838 subjects enrolled in this treatment arm.~The Synergy group has 1059 lesions in 846 subjects enrolled in this treatment arm.~The measure type is number of lesions. The total number of lesions does not match with the total number of participants since some of the participants have more than one lesion."|Number of lesions|Number|1|1.0||||||
3846252|NCT01665053|3671514|B3|Right Coronary Artery (RCA)||Baseline Lesion Characteristics as determined by the Angiographic Core Laboratory, ITT Analysis Set|"The Promus Element Plus group has 1043 lesions in 838 subjects enrolled in this treatment arm.~The Synergy group has 1059 lesions in 846 subjects enrolled in this treatment arm.~The measure type is number of lesions. The total number of lesions does not match with the total number of participants since some of the participants have more than one lesion."|Number of lesions|Number|691|691.0||||||
3846253|NCT01665053|3671515|B2|Right Coronary Artery (RCA)||Baseline Lesion Characteristics as determined by the Angiographic Core Laboratory, ITT Analysis Set|"The Promus Element Plus group has 1043 lesions in 838 subjects enrolled in this treatment arm.~The Synergy group has 1059 lesions in 846 subjects enrolled in this treatment arm.~The measure type is number of lesions. The total number of lesions does not match with the total number of participants since some of the participants have more than one lesion."|Number of lesions|Number|357|357.0||||||
3846254|NCT01665053|3671516|B1|Right Coronary Artery (RCA)||Baseline Lesion Characteristics as determined by the Angiographic Core Laboratory, ITT Analysis Set|"The Promus Element Plus group has 1043 lesions in 838 subjects enrolled in this treatment arm.~The Synergy group has 1059 lesions in 846 subjects enrolled in this treatment arm.~The measure type is number of lesions. The total number of lesions does not match with the total number of participants since some of the participants have more than one lesion."|Number of lesions|Number|334|334.0||||||
3846255|NCT01665053|3671514|B3|Left Circumflex Artery (LCx)||Baseline Lesion Characteristics as determined by the Angiographic Core Laboratory, ITT Analysis Set|"The Promus Element Plus group has 1043 lesions in 838 subjects enrolled in this treatment arm.~The Synergy group has 1059 lesions in 846 subjects enrolled in this treatment arm.~The measure type is number of lesions. The total number of lesions does not match with the total number of participants since some of the participants have more than one lesion."|Number of lesions|Number|540|540.0||||||
3846256|NCT01665053|3671515|B2|Left Circumflex Artery (LCx)||Baseline Lesion Characteristics as determined by the Angiographic Core Laboratory, ITT Analysis Set|"The Promus Element Plus group has 1043 lesions in 838 subjects enrolled in this treatment arm.~The Synergy group has 1059 lesions in 846 subjects enrolled in this treatment arm.~The measure type is number of lesions. The total number of lesions does not match with the total number of participants since some of the participants have more than one lesion."|Number of lesions|Number|265|265.0||||||
3846257|NCT01665053|3671516|B1|Left Circumflex Artery (LCx)||Baseline Lesion Characteristics as determined by the Angiographic Core Laboratory, ITT Analysis Set|"The Promus Element Plus group has 1043 lesions in 838 subjects enrolled in this treatment arm.~The Synergy group has 1059 lesions in 846 subjects enrolled in this treatment arm.~The measure type is number of lesions. The total number of lesions does not match with the total number of participants since some of the participants have more than one lesion."|Number of lesions|Number|275|275.0||||||
3846258|NCT01665053|3671514|B3|Left Anterior Descending (LAD)||Baseline Lesion Characteristics as determined by the Angiographic Core Laboratory, ITT Analysis Set|"The Promus Element Plus group has 1043 lesions in 838 subjects enrolled in this treatment arm.~The Synergy group has 1059 lesions in 846 subjects enrolled in this treatment arm.~The measure type is number of lesions. The total number of lesions does not match with the total number of participants since some of the participants have more than one lesion."|Number of lesions|Number|870|870.0||||||
3846259|NCT01665053|3671515|B2|Left Anterior Descending (LAD)||Baseline Lesion Characteristics as determined by the Angiographic Core Laboratory, ITT Analysis Set|"The Promus Element Plus group has 1043 lesions in 838 subjects enrolled in this treatment arm.~The Synergy group has 1059 lesions in 846 subjects enrolled in this treatment arm.~The measure type is number of lesions. The total number of lesions does not match with the total number of participants since some of the participants have more than one lesion."|Number of lesions|Number|437|437.0||||||
3846260|NCT01665053|3671516|B1|Left Anterior Descending (LAD)||Baseline Lesion Characteristics as determined by the Angiographic Core Laboratory, ITT Analysis Set|"The Promus Element Plus group has 1043 lesions in 838 subjects enrolled in this treatment arm.~The Synergy group has 1059 lesions in 846 subjects enrolled in this treatment arm.~The measure type is number of lesions. The total number of lesions does not match with the total number of participants since some of the participants have more than one lesion."|Number of lesions|Number|433|433.0||||||
3846261|NCT01665053|3671514|B3|No History of renal disease||History of renal disease||participants|Number|1576|1576.0||||||
3846262|NCT01665053|3671515|B2|No History of renal disease||History of renal disease||participants|Number|790|790.0||||||
3846263|NCT01665053|3671516|B1|No History of renal disease||History of renal disease||participants|Number|786|786.0||||||
3846264|NCT01665053|3671514|B3|History of renal disease||History of renal disease||participants|Number|108|108.0||||||
3846265|NCT01665053|3671515|B2|History of renal disease||History of renal disease||participants|Number|56|56.0||||||
3846266|NCT01665053|3671516|B1|History of renal disease||History of renal disease||participants|Number|52|52.0||||||
3846267|NCT01665053|3671514|B3|No History of PVD||History of peripheral vascular disease (PVD)||participants|Number|1557|1557.0||||||
3846269|NCT01665053|3671516|B1|No History of PVD||History of peripheral vascular disease (PVD)||participants|Number|779|779.0||||||
3846270|NCT01665053|3671514|B3|History of PVD||History of peripheral vascular disease (PVD)||participants|Number|127|127.0||||||
3846271|NCT01665053|3671515|B2|History of PVD||History of peripheral vascular disease (PVD)||participants|Number|68|68.0||||||
3846272|NCT01665053|3671516|B1|History of PVD||History of peripheral vascular disease (PVD)||participants|Number|59|59.0||||||
3846273|NCT01665053|3671514|B3|No history of TIA or CVA||History of Transient Ischemic Attack (TIA) or Cerebrovasular Accident (CVA)||participants|Number|1587|1587.0||||||
3846274|NCT01665053|3671515|B2|No history of TIA or CVA||History of Transient Ischemic Attack (TIA) or Cerebrovasular Accident (CVA)||participants|Number|798|798.0||||||
3846275|NCT01665053|3671516|B1|No history of TIA or CVA||History of Transient Ischemic Attack (TIA) or Cerebrovasular Accident (CVA)||participants|Number|789|789.0||||||
3846276|NCT01665053|3671514|B3|History of TIA or CVA||History of Transient Ischemic Attack (TIA) or Cerebrovasular Accident (CVA)||participants|Number|97|97.0||||||
3846277|NCT01665053|3671515|B2|History of TIA or CVA||History of Transient Ischemic Attack (TIA) or Cerebrovasular Accident (CVA)||participants|Number|48|48.0||||||
3846278|NCT01665053|3671516|B1|History of TIA or CVA||History of Transient Ischemic Attack (TIA) or Cerebrovasular Accident (CVA)||participants|Number|49|49.0||||||
3846279|NCT01665053|3671514|B3|No History of Cerebrovascular Accident||History of cerebrovascular accident||participants|Number|1622|1622.0||||||
3846280|NCT01665053|3671515|B2|No History of Cerebrovascular Accident||History of cerebrovascular accident||participants|Number|816|816.0||||||
3846281|NCT01665053|3671516|B1|No History of Cerebrovascular Accident||History of cerebrovascular accident||participants|Number|806|806.0||||||
3846282|NCT01665053|3671514|B3|History of Cerebrovascular Accident||History of cerebrovascular accident||participants|Number|62|62.0||||||
3846283|NCT01665053|3671515|B2|History of Cerebrovascular Accident||History of cerebrovascular accident||participants|Number|30|30.0||||||
3846284|NCT01665053|3671516|B1|History of Cerebrovascular Accident||History of cerebrovascular accident||participants|Number|32|32.0||||||
3846285|NCT01665053|3671514|B3|No History of Transient Ischemic Attack||History of Transient Ischemic Attack||participants|Number|1637|1637.0||||||
3846286|NCT01665053|3671515|B2|No History of Transient Ischemic Attack||History of Transient Ischemic Attack||participants|Number|822|822.0||||||
3846287|NCT01665053|3671516|B1|No History of Transient Ischemic Attack||History of Transient Ischemic Attack||participants|Number|815|815.0||||||
3846288|NCT01665053|3671514|B3|History of Transient Ischemic Attack||History of Transient Ischemic Attack||participants|Number|47|47.0||||||
3846289|NCT01665053|3671515|B2|History of Transient Ischemic Attack||History of Transient Ischemic Attack||participants|Number|24|24.0||||||
3846290|NCT01665053|3671516|B1|History of Transient Ischemic Attack||History of Transient Ischemic Attack||participants|Number|23|23.0||||||
3846291|NCT01665053|3671514|B3|No History of GI Bleeding||History of GI bleeding||participants|Number|1682|1682.0||||||
3846292|NCT01665053|3671515|B2|No History of GI Bleeding||History of GI bleeding||participants|Number|844|844.0||||||
3846293|NCT01665053|3671516|B1|No History of GI Bleeding||History of GI bleeding||participants|Number|838|838.0||||||
3846294|NCT01665053|3671514|B3|History of GI Bleeding||History of GI bleeding||participants|Number|2|2.0||||||
3846295|NCT01665053|3671515|B2|History of GI Bleeding||History of GI bleeding||participants|Number|2|2.0||||||
3846296|NCT01665053|3671516|B1|History of GI Bleeding||History of GI bleeding||participants|Number|0|0.0||||||
3846297|NCT01665053|3671514|B3|No history of bleeding disorder||History of bleeding disorder||participants|Number|1681|1681.0||||||
3846298|NCT01665053|3671515|B2|No history of bleeding disorder||History of bleeding disorder||participants|Number|844|844.0||||||
3846299|NCT01665053|3671516|B1|No history of bleeding disorder||History of bleeding disorder||participants|Number|837|837.0||||||
3846300|NCT01665053|3671514|B3|Hystory of bleeding disorder||History of bleeding disorder||participants|Number|3|3.0||||||
3846301|NCT01665053|3671515|B2|Hystory of bleeding disorder||History of bleeding disorder||participants|Number|2|2.0||||||
3846302|NCT01665053|3671516|B1|Hystory of bleeding disorder||History of bleeding disorder||participants|Number|1|1.0||||||
3846303|NCT01665053|3671514|B3|No Hypertension requiring medication||Hypertension Requiring Medication||participants|Number|403|403.0||||||
3846304|NCT01665053|3671515|B2|No Hypertension requiring medication||Hypertension Requiring Medication||participants|Number|194|194.0||||||
3846305|NCT01665053|3671516|B1|No Hypertension requiring medication||Hypertension Requiring Medication||participants|Number|209|209.0||||||
3846306|NCT01665053|3671514|B3|Hypertension requiring medication||Hypertension Requiring Medication||participants|Number|1281|1281.0||||||
3846307|NCT01665053|3671515|B2|Hypertension requiring medication||Hypertension Requiring Medication||participants|Number|652|652.0||||||
3846308|NCT01665053|3671516|B1|Hypertension requiring medication||Hypertension Requiring Medication||participants|Number|629|629.0||||||
3846309|NCT01665053|3671514|B3|No Hyperlipidemia requiring Medication||Hyperlipidemia Requiring Medication||participants|Number|438|438.0||||||
3846310|NCT01665053|3671515|B2|No Hyperlipidemia requiring Medication||Hyperlipidemia Requiring Medication||participants|Number|221|221.0||||||
3846311|NCT01665053|3671516|B1|No Hyperlipidemia requiring Medication||Hyperlipidemia Requiring Medication||participants|Number|217|217.0||||||
3846312|NCT01665053|3671514|B3|Hyperlipidemia Requiring Medication||Hyperlipidemia Requiring Medication||participants|Number|1246|1246.0||||||
3846313|NCT01665053|3671515|B2|Hyperlipidemia Requiring Medication||Hyperlipidemia Requiring Medication||participants|Number|625|625.0||||||
3846314|NCT01665053|3671516|B1|Hyperlipidemia Requiring Medication||Hyperlipidemia Requiring Medication||participants|Number|621|621.0||||||
3846315|NCT01665053|3671514|B3|No Current Diabetes Mellitus||Current Diabetes Mellitus||participants|Number|1133|1133.0||||||
3846316|NCT01665053|3671515|B2|No Current Diabetes Mellitus||Current Diabetes Mellitus||participants|Number|571|571.0||||||
3846317|NCT01665053|3671516|B1|No Current Diabetes Mellitus||Current Diabetes Mellitus||participants|Number|562|562.0||||||
3846318|NCT01665053|3671514|B3|Current Diabetes Mellitus||Current Diabetes Mellitus||participants|Number|551|551.0||||||
3846319|NCT01665053|3671515|B2|Current Diabetes Mellitus||Current Diabetes Mellitus||participants|Number|275|275.0||||||
3846320|NCT01665053|3671516|B1|Current Diabetes Mellitus||Current Diabetes Mellitus||participants|Number|276|276.0||||||
3846321|NCT01665053|3671514|B3|Smoking, Never||Smoking||participants|Number|624|624.0||||||
3846322|NCT01665053|3671515|B2|Smoking, Never||Smoking||participants|Number|317|317.0||||||
3846323|NCT01665053|3671516|B1|Smoking, Never||Smoking||participants|Number|307|307.0||||||
3846324|NCT01665053|3671514|B3|Smoking,Unknown||Smoking||participants|Number|31|31.0||||||
3846325|NCT01665053|3671515|B2|Smoking,Unknown||Smoking||participants|Number|19|19.0||||||
3846326|NCT01665053|3671516|B1|Smoking,Unknown||Smoking||participants|Number|12|12.0||||||
3846327|NCT01665053|3671514|B3|Smoking, Ever||Smoking||participants|Number|1029|1029.0||||||
3846328|NCT01665053|3671515|B2|Smoking, Ever||Smoking||participants|Number|510|510.0||||||
3846329|NCT01665053|3671516|B1|Smoking, Ever||Smoking||participants|Number|519|519.0||||||
3846330|NCT01665053|3671514|B3|||Weight||lbs|Mean|190.69|190.69|Standard Deviation|44.18|44.18|||
3846331|NCT01665053|3671515|B2|||Weight||lbs|Mean|190.92|190.92|Standard Deviation|44.09|44.09|||
3846332|NCT01665053|3671516|B1|||Weight||lbs|Mean|190.45|190.45|Standard Deviation|44.29|44.29|||
3846333|NCT01665053|3671514|B3|||Height||inches|Mean|67.33|67.33|Standard Deviation|4.04|4.04|||
3846334|NCT01665053|3671515|B2|||Height||inches|Mean|67.23|67.23|Standard Deviation|4.00|4.0|||
3846335|NCT01665053|3671516|B1|||Height||inches|Mean|67.44|67.44|Standard Deviation|4.07|4.07|||
3846336|NCT01665053|3671514|B3|France||Region of Enrollment||participants|Number|43|43.0||||||
3846337|NCT01665053|3671515|B2|France||Region of Enrollment||participants|Number|23|23.0||||||
3846338|NCT01665053|3671516|B1|France||Region of Enrollment||participants|Number|20|20.0||||||
3846339|NCT01665053|3671514|B3|Australia||Region of Enrollment||participants|Number|33|33.0||||||
3846340|NCT01665053|3671515|B2|Australia||Region of Enrollment||participants|Number|17|17.0||||||
3846341|NCT01665053|3671516|B1|Australia||Region of Enrollment||participants|Number|16|16.0||||||
3846342|NCT01665053|3671514|B3|Italy||Region of Enrollment||participants|Number|21|21.0||||||
3846343|NCT01665053|3671515|B2|Italy||Region of Enrollment||participants|Number|11|11.0||||||
3846344|NCT01665053|3671516|B1|Italy||Region of Enrollment||participants|Number|10|10.0||||||
3846345|NCT01665053|3671514|B3|Poland||Region of Enrollment||participants|Number|9|9.0||||||
3846346|NCT01665053|3671515|B2|Poland||Region of Enrollment||participants|Number|5|5.0||||||
3846347|NCT01665053|3671516|B1|Poland||Region of Enrollment||participants|Number|4|4.0||||||
3846348|NCT01665053|3671514|B3|Denmark||Region of Enrollment||participants|Number|19|19.0||||||
3846349|NCT01665053|3671515|B2|Denmark||Region of Enrollment||participants|Number|10|10.0||||||
3846350|NCT01665053|3671516|B1|Denmark||Region of Enrollment||participants|Number|9|9.0||||||
3846351|NCT01665053|3671514|B3|Finland||Region of Enrollment||participants|Number|30|30.0||||||
3846352|NCT01665053|3671515|B2|Finland||Region of Enrollment||participants|Number|16|16.0||||||
3846353|NCT01665053|3671516|B1|Finland||Region of Enrollment||participants|Number|14|14.0||||||
3846354|NCT01665053|3671514|B3|Belgium||Region of Enrollment||participants|Number|100|100.0||||||
3846355|NCT01665053|3671515|B2|Belgium||Region of Enrollment||participants|Number|50|50.0||||||
3846356|NCT01665053|3671516|B1|Belgium||Region of Enrollment||participants|Number|50|50.0||||||
3846357|NCT01665053|3671514|B3|Austria||Region of Enrollment||participants|Number|3|3.0||||||
3846358|NCT01665053|3671515|B2|Austria||Region of Enrollment||participants|Number|1|1.0||||||
3846359|NCT01665053|3671516|B1|Austria||Region of Enrollment||participants|Number|2|2.0||||||
3846360|NCT01665053|3671514|B3|Netherlands||Region of Enrollment||participants|Number|25|25.0||||||
3846361|NCT01665053|3671515|B2|Netherlands||Region of Enrollment||participants|Number|12|12.0||||||
3846362|NCT01665053|3671516|B1|Netherlands||Region of Enrollment||participants|Number|13|13.0||||||
3846363|NCT01665053|3671514|B3|Latvia||Region of Enrollment||participants|Number|23|23.0||||||
3846364|NCT01665053|3671515|B2|Latvia||Region of Enrollment||participants|Number|11|11.0||||||
3846365|NCT01665053|3671516|B1|Latvia||Region of Enrollment||participants|Number|12|12.0||||||
3846366|NCT01665053|3671514|B3|Canada||Region of Enrollment||participants|Number|114|114.0||||||
3846367|NCT01665053|3671515|B2|Canada||Region of Enrollment||participants|Number|58|58.0||||||
3846368|NCT01665053|3671516|B1|Canada||Region of Enrollment||participants|Number|56|56.0||||||
3846369|NCT01665053|3671514|B3|New Zealand||Region of Enrollment||participants|Number|24|24.0||||||
3846370|NCT01665053|3671515|B2|New Zealand||Region of Enrollment||participants|Number|11|11.0||||||
3846371|NCT01665053|3671516|B1|New Zealand||Region of Enrollment||participants|Number|13|13.0||||||
3846372|NCT01665053|3671514|B3|Spain||Region of Enrollment||participants|Number|38|38.0||||||
3846373|NCT01665053|3671515|B2|Spain||Region of Enrollment||participants|Number|18|18.0||||||
3846374|NCT01665053|3671516|B1|Spain||Region of Enrollment||participants|Number|20|20.0||||||
3846375|NCT01665053|3671514|B3|Japan||Region of Enrollment||participants|Number|155|155.0||||||
3846376|NCT01665053|3671515|B2|Japan||Region of Enrollment||participants|Number|74|74.0||||||
3846377|NCT01665053|3671516|B1|Japan||Region of Enrollment||participants|Number|81|81.0||||||
3846378|NCT01665053|3671514|B3|United States||Region of Enrollment||participants|Number|1020|1020.0||||||
3846379|NCT01665053|3671515|B2|United States||Region of Enrollment||participants|Number|514|514.0||||||
3846380|NCT01665053|3671516|B1|United States||Region of Enrollment||participants|Number|506|506.0||||||
3846381|NCT01665053|3671514|B3|Singapore||Region of Enrollment||participants|Number|27|27.0||||||
3846382|NCT01665053|3671515|B2|Singapore||Region of Enrollment||participants|Number|15|15.0||||||
3846383|NCT01665053|3671516|B1|Singapore||Region of Enrollment||participants|Number|12|12.0||||||
3846384|NCT01665053|3671514|B3|Not Disclosed||Race/Ethnicity, Customized|"The Ethnicity and Race data are not mutually exclusive. For example: subject can check both “Asian” and “Native Hawaiian or other Pacific Islander”, or “Caucasian” and “Hispanic or Latino”.~Therefore the sum of participants in all Categories for the Measure does not equal the Overall Number of Baseline Participants in the Arm/Group"|participants|Number|33|33.0||||||
3846385|NCT01665053|3671515|B2|Not Disclosed||Race/Ethnicity, Customized|"The Ethnicity and Race data are not mutually exclusive. For example: subject can check both “Asian” and “Native Hawaiian or other Pacific Islander”, or “Caucasian” and “Hispanic or Latino”.~Therefore the sum of participants in all Categories for the Measure does not equal the Overall Number of Baseline Participants in the Arm/Group"|participants|Number|20|20.0||||||
3846386|NCT01665053|3671516|B1|Not Disclosed||Race/Ethnicity, Customized|"The Ethnicity and Race data are not mutually exclusive. For example: subject can check both “Asian” and “Native Hawaiian or other Pacific Islander”, or “Caucasian” and “Hispanic or Latino”.~Therefore the sum of participants in all Categories for the Measure does not equal the Overall Number of Baseline Participants in the Arm/Group"|participants|Number|13|13.0||||||
3846387|NCT01665053|3671514|B3|Other||Race/Ethnicity, Customized|"The Ethnicity and Race data are not mutually exclusive. For example: subject can check both “Asian” and “Native Hawaiian or other Pacific Islander”, or “Caucasian” and “Hispanic or Latino”.~Therefore the sum of participants in all Categories for the Measure does not equal the Overall Number of Baseline Participants in the Arm/Group"|participants|Number|9|9.0||||||
3846388|NCT01665053|3671515|B2|Other||Race/Ethnicity, Customized|"The Ethnicity and Race data are not mutually exclusive. For example: subject can check both “Asian” and “Native Hawaiian or other Pacific Islander”, or “Caucasian” and “Hispanic or Latino”.~Therefore the sum of participants in all Categories for the Measure does not equal the Overall Number of Baseline Participants in the Arm/Group"|participants|Number|4|4.0||||||
3846389|NCT01665053|3671516|B1|Other||Race/Ethnicity, Customized|"The Ethnicity and Race data are not mutually exclusive. For example: subject can check both “Asian” and “Native Hawaiian or other Pacific Islander”, or “Caucasian” and “Hispanic or Latino”.~Therefore the sum of participants in all Categories for the Measure does not equal the Overall Number of Baseline Participants in the Arm/Group"|participants|Number|5|5.0||||||
3846390|NCT01665053|3671514|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|"The Ethnicity and Race data are not mutually exclusive. For example: subject can check both “Asian” and “Native Hawaiian or other Pacific Islander”, or “Caucasian” and “Hispanic or Latino”.~Therefore the sum of participants in all Categories for the Measure does not equal the Overall Number of Baseline Participants in the Arm/Group"|participants|Number|5|5.0||||||
3846391|NCT01665053|3671515|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|"The Ethnicity and Race data are not mutually exclusive. For example: subject can check both “Asian” and “Native Hawaiian or other Pacific Islander”, or “Caucasian” and “Hispanic or Latino”.~Therefore the sum of participants in all Categories for the Measure does not equal the Overall Number of Baseline Participants in the Arm/Group"|participants|Number|3|3.0||||||
3846392|NCT01665053|3671516|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|"The Ethnicity and Race data are not mutually exclusive. For example: subject can check both “Asian” and “Native Hawaiian or other Pacific Islander”, or “Caucasian” and “Hispanic or Latino”.~Therefore the sum of participants in all Categories for the Measure does not equal the Overall Number of Baseline Participants in the Arm/Group"|participants|Number|2|2.0||||||
3846393|NCT01665053|3671514|B3|Hispanic or Latino||Race/Ethnicity, Customized|"The Ethnicity and Race data are not mutually exclusive. For example: subject can check both “Asian” and “Native Hawaiian or other Pacific Islander”, or “Caucasian” and “Hispanic or Latino”.~Therefore the sum of participants in all Categories for the Measure does not equal the Overall Number of Baseline Participants in the Arm/Group"|participants|Number|31|31.0||||||
3846394|NCT01665053|3671515|B2|Hispanic or Latino||Race/Ethnicity, Customized|"The Ethnicity and Race data are not mutually exclusive. For example: subject can check both “Asian” and “Native Hawaiian or other Pacific Islander”, or “Caucasian” and “Hispanic or Latino”.~Therefore the sum of participants in all Categories for the Measure does not equal the Overall Number of Baseline Participants in the Arm/Group"|participants|Number|15|15.0||||||
3846395|NCT01665053|3671516|B1|Hispanic or Latino||Race/Ethnicity, Customized|"The Ethnicity and Race data are not mutually exclusive. For example: subject can check both “Asian” and “Native Hawaiian or other Pacific Islander”, or “Caucasian” and “Hispanic or Latino”.~Therefore the sum of participants in all Categories for the Measure does not equal the Overall Number of Baseline Participants in the Arm/Group"|participants|Number|16|16.0||||||
3846396|NCT01665053|3671514|B3|Caucasian||Race/Ethnicity, Customized|"The Ethnicity and Race data are not mutually exclusive. For example: subject can check both “Asian” and “Native Hawaiian or other Pacific Islander”, or “Caucasian” and “Hispanic or Latino”.~Therefore the sum of participants in all Categories for the Measure does not equal the Overall Number of Baseline Participants in the Arm/Group"|participants|Number|1319|1319.0||||||
3846397|NCT01665053|3671515|B2|Caucasian||Race/Ethnicity, Customized|"The Ethnicity and Race data are not mutually exclusive. For example: subject can check both “Asian” and “Native Hawaiian or other Pacific Islander”, or “Caucasian” and “Hispanic or Latino”.~Therefore the sum of participants in all Categories for the Measure does not equal the Overall Number of Baseline Participants in the Arm/Group"|participants|Number|655|655.0||||||
3846398|NCT01665053|3671516|B1|Caucasian||Race/Ethnicity, Customized|"The Ethnicity and Race data are not mutually exclusive. For example: subject can check both “Asian” and “Native Hawaiian or other Pacific Islander”, or “Caucasian” and “Hispanic or Latino”.~Therefore the sum of participants in all Categories for the Measure does not equal the Overall Number of Baseline Participants in the Arm/Group"|participants|Number|664|664.0||||||
3846399|NCT01665053|3671514|B3|Black,of African heritage||Race/Ethnicity, Customized|"The Ethnicity and Race data are not mutually exclusive. For example: subject can check both “Asian” and “Native Hawaiian or other Pacific Islander”, or “Caucasian” and “Hispanic or Latino”.~Therefore the sum of participants in all Categories for the Measure does not equal the Overall Number of Baseline Participants in the Arm/Group"|participants|Number|89|89.0||||||
3846440|NCT01664949|3671566|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3846400|NCT01665053|3671515|B2|Black,of African heritage||Race/Ethnicity, Customized|"The Ethnicity and Race data are not mutually exclusive. For example: subject can check both “Asian” and “Native Hawaiian or other Pacific Islander”, or “Caucasian” and “Hispanic or Latino”.~Therefore the sum of participants in all Categories for the Measure does not equal the Overall Number of Baseline Participants in the Arm/Group"|participants|Number|52|52.0||||||
3846401|NCT01665053|3671516|B1|Black,of African heritage||Race/Ethnicity, Customized|"The Ethnicity and Race data are not mutually exclusive. For example: subject can check both “Asian” and “Native Hawaiian or other Pacific Islander”, or “Caucasian” and “Hispanic or Latino”.~Therefore the sum of participants in all Categories for the Measure does not equal the Overall Number of Baseline Participants in the Arm/Group"|participants|Number|37|37.0||||||
3846402|NCT01665053|3671514|B3|Asian||Race/Ethnicity, Customized|"The Ethnicity and Race data are not mutually exclusive. For example: subject can check both “Asian” and “Native Hawaiian or other Pacific Islander”, or “Caucasian” and “Hispanic or Latino”.~Therefore the sum of participants in all Categories for the Measure does not equal the Overall Number of Baseline Participants in the Arm/Group"|participants|Number|200|200.0||||||
3846403|NCT01665053|3671515|B2|Asian||Race/Ethnicity, Customized|"The Ethnicity and Race data are not mutually exclusive. For example: subject can check both “Asian” and “Native Hawaiian or other Pacific Islander”, or “Caucasian” and “Hispanic or Latino”.~Therefore the sum of participants in all Categories for the Measure does not equal the Overall Number of Baseline Participants in the Arm/Group"|participants|Number|100|100.0||||||
3846404|NCT01665053|3671516|B1|Asian||Race/Ethnicity, Customized|"The Ethnicity and Race data are not mutually exclusive. For example: subject can check both “Asian” and “Native Hawaiian or other Pacific Islander”, or “Caucasian” and “Hispanic or Latino”.~Therefore the sum of participants in all Categories for the Measure does not equal the Overall Number of Baseline Participants in the Arm/Group"|participants|Number|100|100.0||||||
3846405|NCT01665053|3671514|B3|American Indian or Alaska native||Race/Ethnicity, Customized|"The Ethnicity and Race data are not mutually exclusive. For example: subject can check both “Asian” and “Native Hawaiian or other Pacific Islander”, or “Caucasian” and “Hispanic or Latino”.~Therefore the sum of participants in all Categories for the Measure does not equal the Overall Number of Baseline Participants in the Arm/Group"|participants|Number|3|3.0||||||
3846406|NCT01665053|3671515|B2|American Indian or Alaska native||Race/Ethnicity, Customized|"The Ethnicity and Race data are not mutually exclusive. For example: subject can check both “Asian” and “Native Hawaiian or other Pacific Islander”, or “Caucasian” and “Hispanic or Latino”.~Therefore the sum of participants in all Categories for the Measure does not equal the Overall Number of Baseline Participants in the Arm/Group"|participants|Number|1|1.0||||||
3846407|NCT01665053|3671516|B1|American Indian or Alaska native||Race/Ethnicity, Customized|"The Ethnicity and Race data are not mutually exclusive. For example: subject can check both “Asian” and “Native Hawaiian or other Pacific Islander”, or “Caucasian” and “Hispanic or Latino”.~Therefore the sum of participants in all Categories for the Measure does not equal the Overall Number of Baseline Participants in the Arm/Group"|participants|Number|2|2.0||||||
3846408|NCT01665053|3671514|B3||Male|Sex: Female, Male||Participants|Count of Participants|1206|1206.0||||||
3846409|NCT01665053|3671515|B2||Male|Sex: Female, Male||Participants|Count of Participants|597|597.0||||||
3846410|NCT01665053|3671516|B1||Male|Sex: Female, Male||Participants|Count of Participants|609|609.0||||||
3846411|NCT01665053|3671514|B3||Female|Sex: Female, Male||Participants|Count of Participants|478|478.0||||||
3846412|NCT01665053|3671515|B2||Female|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
3846413|NCT01665053|3671516|B1||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
3846414|NCT01665053|3671514|B3|||Age||yr|Mean|63.70|63.7|Standard Deviation|10.47|10.47|||
3846415|NCT01665053|3671515|B2|||Age||yr|Mean|63.48|63.48|Standard Deviation|10.44|10.44|||
3846416|NCT01665053|3671516|B1|||Age||yr|Mean|63.92|63.92|Standard Deviation|10.50|10.5|||
3846417|NCT01664975|3671555|B3|China||Region of Enrollment||participants|Number|103|103.0||||||
3846418|NCT01664975|3671556|B2|China||Region of Enrollment||participants|Number|51|51.0||||||
3846419|NCT01664975|3671557|B1|China||Region of Enrollment||participants|Number|52|52.0||||||
3846420|NCT01664975|3671555|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3846421|NCT01664975|3671556|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3846422|NCT01664975|3671557|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3846423|NCT01664975|3671555|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3846424|NCT01664975|3671556|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3846425|NCT01664975|3671557|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3846426|NCT01664975|3671555|B3|||Age||years|Median|55|55.0|Full Range|||15.0|70.0|
3846427|NCT01664975|3671556|B2|||Age||years|Median|51|51.0|Full Range|||15.0|70.0|
3846428|NCT01664975|3671557|B1|||Age||years|Median|55|55.0|Full Range|||16.0|69.0|
3846429|NCT01664975|3671555|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3846430|NCT01664975|3671556|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3846431|NCT01664975|3671557|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3846432|NCT01664975|3671555|B3||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
3846433|NCT01664975|3671556|B2||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
3846434|NCT01664975|3671557|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
3846435|NCT01664975|3671555|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3846436|NCT01664975|3671556|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3846437|NCT01664975|3671557|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3846438|NCT01664949|3671564|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3846439|NCT01664949|3671565|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3846441|NCT01664949|3671564|B3||Female|Sex: Female, Male||Participants|Count of Participants|371|371.0||||||
3846442|NCT01664949|3671565|B2||Female|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
3846443|NCT01664949|3671566|B1||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3846444|NCT01664949|3671564|B3|> 40 years||Age, Customized||participants|Number|411|411.0||||||
3846445|NCT01664949|3671565|B2|> 40 years||Age, Customized||participants|Number|211|211.0||||||
3846446|NCT01664949|3671566|B1|> 40 years||Age, Customized||participants|Number|200|200.0||||||
3846447|NCT01664949|3671564|B3|30 to 40 years||Age, Customized||participants|Number|30|30.0||||||
3846448|NCT01664949|3671565|B2|30 to 40 years||Age, Customized||participants|Number|15|15.0||||||
3846449|NCT01664949|3671566|B1|30 to 40 years||Age, Customized||participants|Number|15|15.0||||||
3846450|NCT01664949|3671564|B3|< 30 years||Age, Customized||participants|Number|19|19.0||||||
3846451|NCT01664949|3671565|B2|< 30 years||Age, Customized||participants|Number|10|10.0||13.65|13.65|||
3846452|NCT01664949|3671566|B1|< 30 years||Age, Customized||participants|Number|9|9.0||13.77|13.77|||
3846453|NCT01664923|3671581|B3|United States||Region of Enrollment||participants|Number|396|396.0||||||
3846454|NCT01664923|3671582|B2|United States||Region of Enrollment||participants|Number|198|198.0||||||
3846455|NCT01664923|3671583|B1|United States||Region of Enrollment||participants|Number|198|198.0||||||
3846456|NCT01664923|3671581|B3|Male||Sex/Gender, Customized||participants|Number|396|396.0||||||
3846457|NCT01664923|3671582|B2|Male||Sex/Gender, Customized||participants|Number|198|198.0||||||
3846458|NCT01664923|3671583|B1|Male||Sex/Gender, Customized||participants|Number|198|198.0||||||
3846459|NCT01664923|3671581|B3|≥ 75 years||Age, Customized||participants|Number|174|174.0||||||
3846460|NCT01664923|3671582|B2|≥ 75 years||Age, Customized||participants|Number|97|97.0||||||
3846461|NCT01664923|3671583|B1|≥ 75 years||Age, Customized||participants|Number|77|77.0||||||
3846462|NCT01664923|3671581|B3|65-74 years||Age, Customized||participants|Number|158|158.0||||||
3846463|NCT01664923|3671582|B2|65-74 years||Age, Customized||participants|Number|76|76.0||||||
3846464|NCT01664923|3671583|B1|65-74 years||Age, Customized||participants|Number|82|82.0||||||
3846465|NCT01664923|3671581|B3|< 65 years||Age, Customized||participants|Number|64|64.0||||||
3846466|NCT01664923|3671582|B2|< 65 years||Age, Customized||participants|Number|25|25.0||||||
3846467|NCT01664923|3671583|B1|< 65 years||Age, Customized||participants|Number|39|39.0||||||
3846468|NCT01664858|3671602|B4||Male|Sex: Female, Male||Participants|Count of Participants|638|638.0||||||
3846469|NCT01664858|3671603|B3||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3846470|NCT01664858|3671604|B2||Male|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
3846471|NCT01664858|3671605|B1||Male|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
3846472|NCT01664858|3671602|B4||Female|Sex: Female, Male||Participants|Count of Participants|564|564.0||||||
3846473|NCT01664858|3671603|B3||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3846474|NCT01664858|3671604|B2||Female|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
3846475|NCT01664858|3671605|B1||Female|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
3846476|NCT01664858|3671602|B4|||Age||years|Mean|56.3|56.3|Standard Deviation|9.03|9.03|||
3846477|NCT01664858|3671603|B3|||Age||years|Mean|56.5|56.5|Standard Deviation|9.21|9.21|||
3846478|NCT01664858|3671604|B2|||Age||years|Mean|55.9|55.9|Standard Deviation|8.87|8.87|||
3846479|NCT01664858|3671605|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|9.10|9.1|||
3846480|NCT01664806|3671621|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3846481|NCT01664806|3671622|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3846482|NCT01664806|3671623|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3846483|NCT01664806|3671621|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3846484|NCT01664806|3671622|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3846485|NCT01664806|3671623|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3846486|NCT01664806|3671621|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3846487|NCT01664806|3671622|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3846488|NCT01664806|3671623|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3846489|NCT01664806|3671621|B3|||Age||years|Mean|44|44.0|Standard Deviation|15|15.0|||
3846490|NCT01664806|3671622|B2|||Age||years|Mean|41|41.0|Standard Deviation|12|12.0|||
3846491|NCT01664806|3671623|B1|||Age||years|Mean|47|47.0|Standard Deviation|18|18.0|||
3846492|NCT01664806|3671621|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3846493|NCT01664806|3671622|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3846494|NCT01664806|3671623|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3846495|NCT01664806|3671621|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3846496|NCT01664806|3671622|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3846497|NCT01664806|3671623|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3846498|NCT01664806|3671621|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3846499|NCT01664806|3671622|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3846500|NCT01664806|3671623|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3846501|NCT01664793|3671632|B3|United States||Region of Enrollment||children at sites|Number|81599|81599.0||||||
3846502|NCT01664793|3671633|B2|United States||Region of Enrollment||children at sites|Number|38306|38306.0||||||
3846503|NCT01664793|3671634|B1|United States||Region of Enrollment||children at sites|Number|43293|43293.0||||||
3846504|NCT01664793|3671632|B3||Male|Sex: Female, Male||Participants|Count of Participants|41499|41499.0||||||
3846505|NCT01664793|3671633|B2||Male|Sex: Female, Male||Participants|Count of Participants|19766|19766.0||||||
3846506|NCT01664793|3671634|B1||Male|Sex: Female, Male||Participants|Count of Participants|21733|21733.0||||||
3846507|NCT01664793|3671632|B3||Female|Sex: Female, Male||Participants|Count of Participants|40100|40100.0||||||
3846508|NCT01664793|3671633|B2||Female|Sex: Female, Male||Participants|Count of Participants|18540|18540.0||||||
3846509|NCT01664793|3671634|B1||Female|Sex: Female, Male||Participants|Count of Participants|21560|21560.0||||||
3846510|NCT01664793|3671632|B3|||Age|To be eligible, the practice must have had a patient population of children under 19 years old.|years|Mean|7.2|7.2|Standard Deviation|5|5.0|||
3846511|NCT01664793|3671633|B2|||Age|To be eligible, the practice must have had a patient population of children under 19 years old.|years|Mean|7.1|7.1|Standard Deviation|5.2|5.2|||
3846512|NCT01664793|3671634|B1|||Age|To be eligible, the practice must have had a patient population of children under 19 years old.|years|Mean|7.3|7.3|Standard Deviation|4.8|4.8|||
3846513|NCT01664624|3671643|B5|||Metformin Dose||mg|Mean|819.2|819.2|Standard Deviation|202.49|202.49|||
3846514|NCT01664624|3671644|B4|||Metformin Dose||mg|Mean|855.6|855.6|Standard Deviation|211.31|211.31|||
3846515|NCT01664624|3671645|B3|||Metformin Dose||mg|Mean|805.0|805.0|Standard Deviation|220.42|220.42|||
3846516|NCT01664624|3671646|B2|||Metformin Dose||mg|Mean|745.0|745.0|Standard Deviation|225.40|225.4|||
3846517|NCT01664624|3671647|B1|||Metformin Dose||mg|Mean|875.0|875.0|Standard Deviation|151.38|151.38|||
3846518|NCT01664624|3671643|B5|||Duration of Diabetes||years|Mean|7.7|7.7|Standard Deviation|5.33|5.33|||
3846519|NCT01664624|3671644|B4|||Duration of Diabetes||years|Mean|8.2|8.2|Standard Deviation|6.63|6.63|||
3846520|NCT01664624|3671645|B3|||Duration of Diabetes||years|Mean|7.0|7.0|Standard Deviation|3.86|3.86|||
3846521|NCT01664624|3671646|B2|||Duration of Diabetes||years|Mean|8.5|8.5|Standard Deviation|6.39|6.39|||
3846522|NCT01664624|3671647|B1|||Duration of Diabetes||years|Mean|6.9|6.9|Standard Deviation|4.63|4.63|||
3846523|NCT01664624|3671643|B5|Ex-smoker||Smoking Classification||participants|Number|10|10.0||||||
3846524|NCT01664624|3671644|B4|Ex-smoker||Smoking Classification||participants|Number|2|2.0||||||
3846525|NCT01664624|3671645|B3|Ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3846526|NCT01664624|3671646|B2|Ex-smoker||Smoking Classification||participants|Number|5|5.0||||||
3846527|NCT01664624|3671647|B1|Ex-smoker||Smoking Classification||participants|Number|3|3.0||||||
3846528|NCT01664624|3671643|B5|Current smoker||Smoking Classification||participants|Number|1|1.0||||||
3846529|NCT01664624|3671644|B4|Current smoker||Smoking Classification||participants|Number|0|0.0||||||
3846530|NCT01664624|3671645|B3|Current smoker||Smoking Classification||participants|Number|0|0.0||||||
3846531|NCT01664624|3671646|B2|Current smoker||Smoking Classification||participants|Number|0|0.0||||||
3846532|NCT01664624|3671647|B1|Current smoker||Smoking Classification||participants|Number|1|1.0||||||
3846533|NCT01664624|3671643|B5|Never smoked||Smoking Classification||participants|Number|29|29.0||||||
3846534|NCT01664624|3671644|B4|Never smoked||Smoking Classification||participants|Number|7|7.0||||||
3846535|NCT01664624|3671645|B3|Never smoked||Smoking Classification||participants|Number|10|10.0||||||
3846536|NCT01664624|3671646|B2|Never smoked||Smoking Classification||participants|Number|6|6.0||||||
3846537|NCT01664624|3671647|B1|Never smoked||Smoking Classification||participants|Number|6|6.0||||||
3846538|NCT01664624|3671643|B5|||Body Mass Index (BMI)||kg/m^2|Mean|32.53|32.53|Standard Deviation|4.548|4.548|||
3846539|NCT01664624|3671644|B4|||Body Mass Index (BMI)||kg/m^2|Mean|31.37|31.37|Standard Deviation|4.653|4.653|||
3846540|NCT01664624|3671645|B3|||Body Mass Index (BMI)||kg/m^2|Mean|32.03|32.03|Standard Deviation|5.311|5.311|||
3846541|NCT01664624|3671646|B2|||Body Mass Index (BMI)||kg/m^2|Mean|31.75|31.75|Standard Deviation|3.184|3.184|||
3846542|NCT01664624|3671647|B1|||Body Mass Index (BMI)||kg/m^2|Mean|34.93|34.93|Standard Deviation|4.708|4.708|||
3846543|NCT01664624|3671643|B5|||Weight||kg|Mean|93.32|93.32|Standard Deviation|17.329|17.329|||
3846544|NCT01664624|3671644|B4|||Weight||kg|Mean|86.98|86.98|Standard Deviation|14.713|14.713|||
3846545|NCT01664624|3671645|B3|||Weight||kg|Mean|89.33|89.33|Standard Deviation|17.961|17.961|||
3846546|NCT01664624|3671646|B2|||Weight||kg|Mean|93.24|93.24|Standard Deviation|11.670|11.67|||
3846547|NCT01664624|3671647|B1|||Weight||kg|Mean|103.12|103.12|Standard Deviation|21.688|21.688|||
3846548|NCT01664624|3671643|B5|||Height||cm|Mean|169.0|169.0|Standard Deviation|8.09|8.09|||
3846549|NCT01664624|3671644|B4|||Height||cm|Mean|166.4|166.4|Standard Deviation|5.90|5.9|||
3846550|NCT01664624|3671645|B3|||Height||cm|Mean|166.6|166.6|Standard Deviation|10.44|10.44|||
3846551|NCT01664624|3671646|B2|||Height||cm|Mean|171.2|171.2|Standard Deviation|6.03|6.03|||
3846552|NCT01664624|3671647|B1|||Height||cm|Mean|171.1|171.1|Standard Deviation|8.91|8.91|||
3846553|NCT01664624|3671643|B5|United States||Region of Enrollment||participants|Number|40|40.0||||||
3846554|NCT01664624|3671644|B4|United States||Region of Enrollment||participants|Number|9|9.0||||||
3846555|NCT01664624|3671645|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3846556|NCT01664624|3671646|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3846557|NCT01664624|3671647|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3846558|NCT01664624|3671643|B5|White||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3846559|NCT01664624|3671644|B4|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3846560|NCT01664624|3671645|B3|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3846561|NCT01664624|3671646|B2|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3846562|NCT01664624|3671647|B1|White||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3846563|NCT01664624|3671643|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3846564|NCT01664624|3671644|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3846565|NCT01664624|3671645|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3846566|NCT01664624|3671646|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3846567|NCT01664624|3671647|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3846568|NCT01664624|3671643|B5|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3846569|NCT01664624|3671644|B4|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3846570|NCT01664624|3671645|B3|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3846571|NCT01664624|3671646|B2|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3846572|NCT01664624|3671647|B1|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3846573|NCT01664624|3671643|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3846574|NCT01664624|3671644|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3846575|NCT01664624|3671645|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3846576|NCT01664624|3671646|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3846577|NCT01664624|3671647|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3846578|NCT01664624|3671643|B5||Male|Gender||Participants|Count of Participants|25|25.0||||||
3846579|NCT01664624|3671644|B4||Male|Gender||Participants|Count of Participants|5|5.0||||||
3846580|NCT01664624|3671645|B3||Male|Gender||Participants|Count of Participants|6|6.0||||||
3846581|NCT01664624|3671646|B2||Male|Gender||Participants|Count of Participants|8|8.0||||||
3846582|NCT01664624|3671647|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
3846583|NCT01664624|3671643|B5||Female|Gender||Participants|Count of Participants|15|15.0||||||
3846584|NCT01664624|3671644|B4||Female|Gender||Participants|Count of Participants|4|4.0||||||
3846585|NCT01664624|3671645|B3||Female|Gender||Participants|Count of Participants|4|4.0||||||
3846586|NCT01664624|3671646|B2||Female|Gender||Participants|Count of Participants|3|3.0||||||
3846587|NCT01664624|3671647|B1||Female|Gender||Participants|Count of Participants|4|4.0||||||
3846588|NCT01664624|3671643|B5|≥ 65 years||Age, Customized||participants|Number|1|1.0||||||
3846589|NCT01664624|3671644|B4|≥ 65 years||Age, Customized||participants|Number|0|0.0||||||
3846590|NCT01664624|3671645|B3|≥ 65 years||Age, Customized||participants|Number|1|1.0||||||
3846591|NCT01664624|3671646|B2|≥ 65 years||Age, Customized||participants|Number|0|0.0||||||
3846592|NCT01664624|3671647|B1|≥ 65 years||Age, Customized||participants|Number|0|0.0||||||
3846593|NCT01664624|3671643|B5|< 65 years||Age, Customized||participants|Number|39|39.0||||||
3846594|NCT01664624|3671644|B4|< 65 years||Age, Customized||participants|Number|9|9.0||||||
3846595|NCT01664624|3671645|B3|< 65 years||Age, Customized||participants|Number|9|9.0||||||
3846596|NCT01664624|3671646|B2|< 65 years||Age, Customized||participants|Number|11|11.0||||||
3846597|NCT01664624|3671647|B1|< 65 years||Age, Customized||participants|Number|10|10.0||||||
3846598|NCT01664624|3671643|B5|||Age||years|Mean|54.7|54.7|Standard Deviation|8.15|8.15|||
3846599|NCT01664624|3671644|B4|||Age||years|Mean|54.6|54.6|Standard Deviation|6.88|6.88|||
3846600|NCT01664624|3671645|B3|||Age||years|Mean|60.7|60.7|Standard Deviation|4.24|4.24|||
3846601|NCT01664624|3671646|B2|||Age||years|Mean|52.9|52.9|Standard Deviation|7.52|7.52|||
3846602|NCT01664624|3671647|B1|||Age||years|Mean|50.7|50.7|Standard Deviation|10.15|10.15|||
3846603|NCT01664559|3671680|B3|Graduate degree||Level of education|One participant in the placebo arm did not answer the question about their education status, therefore the sum of the answers for this arm is different than the overall number of baseline participants.|participants|Number|18|18.0||||||
3846604|NCT01664559|3671681|B2|Graduate degree||Level of education|One participant in the placebo arm did not answer the question about their education status, therefore the sum of the answers for this arm is different than the overall number of baseline participants.|participants|Number|11|11.0||||||
3846605|NCT01664559|3671682|B1|Graduate degree||Level of education|One participant in the placebo arm did not answer the question about their education status, therefore the sum of the answers for this arm is different than the overall number of baseline participants.|participants|Number|7|7.0||||||
3846606|NCT01664559|3671680|B3|College degree||Level of education|One participant in the placebo arm did not answer the question about their education status, therefore the sum of the answers for this arm is different than the overall number of baseline participants.|participants|Number|13|13.0||||||
3846607|NCT01664559|3671681|B2|College degree||Level of education|One participant in the placebo arm did not answer the question about their education status, therefore the sum of the answers for this arm is different than the overall number of baseline participants.|participants|Number|6|6.0||||||
3846608|NCT01664559|3671682|B1|College degree||Level of education|One participant in the placebo arm did not answer the question about their education status, therefore the sum of the answers for this arm is different than the overall number of baseline participants.|participants|Number|7|7.0||||||
3846609|NCT01664559|3671680|B3|Some college||Level of education|One participant in the placebo arm did not answer the question about their education status, therefore the sum of the answers for this arm is different than the overall number of baseline participants.|participants|Number|23|23.0||||||
3846610|NCT01664559|3671681|B2|Some college||Level of education|One participant in the placebo arm did not answer the question about their education status, therefore the sum of the answers for this arm is different than the overall number of baseline participants.|participants|Number|11|11.0||||||
3846658|NCT01664494|3671705|B1||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||The gender was not assessed in this study.
3846611|NCT01664559|3671682|B1|Some college||Level of education|One participant in the placebo arm did not answer the question about their education status, therefore the sum of the answers for this arm is different than the overall number of baseline participants.|participants|Number|12|12.0||||||
3846612|NCT01664559|3671680|B3|High school graduate||Level of education|One participant in the placebo arm did not answer the question about their education status, therefore the sum of the answers for this arm is different than the overall number of baseline participants.|participants|Number|11|11.0||||||
3846613|NCT01664559|3671681|B2|High school graduate||Level of education|One participant in the placebo arm did not answer the question about their education status, therefore the sum of the answers for this arm is different than the overall number of baseline participants.|participants|Number|4|4.0||||||
3846614|NCT01664559|3671682|B1|High school graduate||Level of education|One participant in the placebo arm did not answer the question about their education status, therefore the sum of the answers for this arm is different than the overall number of baseline participants.|participants|Number|7|7.0||||||
3846615|NCT01664559|3671680|B3|Less than high school||Level of education|One participant in the placebo arm did not answer the question about their education status, therefore the sum of the answers for this arm is different than the overall number of baseline participants.|participants|Number|1|1.0||||||
3846616|NCT01664559|3671681|B2|Less than high school||Level of education|One participant in the placebo arm did not answer the question about their education status, therefore the sum of the answers for this arm is different than the overall number of baseline participants.|participants|Number|1|1.0||||||
3846617|NCT01664559|3671682|B1|Less than high school||Level of education|One participant in the placebo arm did not answer the question about their education status, therefore the sum of the answers for this arm is different than the overall number of baseline participants.|participants|Number|0|0.0||||||
3846618|NCT01664559|3671680|B3|||History of loop electrosurgical excision procedure||participants|Number|3|3.0||||||
3846619|NCT01664559|3671681|B2|||History of loop electrosurgical excision procedure||participants|Number|3|3.0||||||
3846620|NCT01664559|3671682|B1|||History of loop electrosurgical excision procedure||participants|Number|0|0.0||||||
3846621|NCT01664559|3671680|B3|||Currently breastfeeding|Not all patients were breastfeeding so this number is not expected to add up to the overall number of baseline participants.|participants|Number|30|30.0||||||
3846622|NCT01664559|3671681|B2|||Currently breastfeeding|Not all patients were breastfeeding so this number is not expected to add up to the overall number of baseline participants.|participants|Number|15|15.0||||||
3846623|NCT01664559|3671682|B1|||Currently breastfeeding|Not all patients were breastfeeding so this number is not expected to add up to the overall number of baseline participants.|participants|Number|15|15.0||||||
3846624|NCT01664559|3671680|B3|||Parity||pregnancies|Median|1|1.0|Inter-Quartile Range|||1.0|1.0|
3846625|NCT01664559|3671681|B2|||Parity||pregnancies|Median|1|1.0|Inter-Quartile Range|||1.0|2.0|
3846626|NCT01664559|3671682|B1|||Parity||pregnancies|Median|1|1.0|Inter-Quartile Range|||1.0|1.0|
3846627|NCT01664559|3671680|B3|||Gravidity||pregnancies|Median|1|1.0|Inter-Quartile Range|||1.0|2.0|
3846628|NCT01664559|3671681|B2|||Gravidity||pregnancies|Median|1|1.0|Inter-Quartile Range|||1.0|2.0|
3846629|NCT01664559|3671682|B1|||Gravidity||pregnancies|Median|1|1.0|Inter-Quartile Range|||1.0|2.0|
3846630|NCT01664559|3671680|B3|||Body mass index||kg/m2|Mean|27.4|27.4|Standard Deviation|5.7|5.7|||
3846631|NCT01664559|3671681|B2|||Body mass index||kg/m2|Mean|27.3|27.3|Standard Deviation|5.8|5.8|||
3846632|NCT01664559|3671682|B1|||Body mass index||kg/m2|Mean|27.6|27.6|Standard Deviation|5.7|5.7|||
3846633|NCT01664559|3671680|B3|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3846634|NCT01664559|3671681|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3846635|NCT01664559|3671682|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3846636|NCT01664559|3671680|B3|Asian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3846637|NCT01664559|3671681|B2|Asian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3846638|NCT01664559|3671682|B1|Asian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3846639|NCT01664559|3671680|B3|African American||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3846640|NCT01664559|3671681|B2|African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3846641|NCT01664559|3671682|B1|African American||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3846642|NCT01664559|3671680|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3846643|NCT01664559|3671681|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3846644|NCT01664559|3671682|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3846645|NCT01664559|3671680|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3846646|NCT01664559|3671681|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3846647|NCT01664559|3671682|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3846648|NCT01664559|3671680|B3|||Sex/Gender, Customized||female participants|Number|67|67.0||||||
3846649|NCT01664559|3671681|B2|||Sex/Gender, Customized||female participants|Number|33|33.0||||||
3846650|NCT01664559|3671682|B1|||Sex/Gender, Customized||female participants|Number|34|34.0||||||
3846651|NCT01664559|3671680|B3|||Age||years|Mean|26.9|26.9|Standard Deviation|5.3|5.3|||
3846652|NCT01664559|3671681|B2|||Age||years|Mean|26.6|26.6|Standard Deviation|5.1|5.1|||
3846653|NCT01664559|3671682|B1|||Age||years|Mean|27.3|27.3|Standard Deviation|5.4|5.4|||
3846654|NCT01664533|3671697|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3846655|NCT01664533|3671697|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3846656|NCT01664533|3671697|B1|||Age||Years|Mean|64.4|64.4|Standard Deviation|8.9|8.9|||
3846657|NCT01664494|3671705|B1||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||The gender was not assessed in this study.
3846659|NCT01664494|3671705|B1|||Age||years|Mean|68.0|68.0|Standard Deviation|11.0|11.0|||
3846660|NCT01664247|3671710|B3|||Fasting plasma glucose (FPG)||mmol/L|Mean|8.9|8.9|Standard Deviation|2.2|2.2|||
3846661|NCT01664247|3671711|B2|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.1|9.1|Standard Deviation|2.2|2.2|||
3846662|NCT01664247|3671712|B1|||Fasting plasma glucose (FPG)||mmol/L|Mean|8.7|8.7|Standard Deviation|2.1|2.1|||
3846663|NCT01664247|3671710|B3|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|7.6|7.6|Standard Deviation|0.6|0.6|||
3846664|NCT01664247|3671711|B2|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|7.6|7.6|Standard Deviation|0.6|0.6|||
3846665|NCT01664247|3671712|B1|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|7.5|7.5|Standard Deviation|0.6|0.6|||
3846666|NCT01664247|3671710|B3||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3846667|NCT01664247|3671711|B2||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3846668|NCT01664247|3671712|B1||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3846669|NCT01664247|3671710|B3||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3846670|NCT01664247|3671711|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3846671|NCT01664247|3671712|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3846672|NCT01664247|3671710|B3|||Age||years|Mean|57.2|57.2|Standard Deviation|9.7|9.7|||
3846673|NCT01664247|3671711|B2|||Age||years|Mean|57.3|57.3|Standard Deviation|9.4|9.4|||
3846674|NCT01664247|3671712|B1|||Age||years|Mean|57.0|57.0|Standard Deviation|10.0|10.0|||
3846675|NCT01664117|3671735|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3846676|NCT01664117|3671735|B1||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
3846677|NCT01664117|3671735|B1|||Age||Years|Mean|57.61|57.61|Standard Deviation|13.59|13.59|||
3846678|NCT01664104|3671790|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3846679|NCT01664104|3671790|B1||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3846680|NCT01664104|3671790|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|11.0|11.0|||
3846681|NCT01664052|3671857|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3846682|NCT01664052|3671858|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3846683|NCT01664052|3671859|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3846684|NCT01664052|3671857|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3846685|NCT01664052|3671858|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3846686|NCT01664052|3671859|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3846687|NCT01664052|3671857|B3|||Age||Years|Mean|41|41.0|Full Range|||28.0|52.0|
3846688|NCT01664052|3671858|B2|||Age||Years|Mean|40|40.0|Full Range|||28.0|52.0|
3846689|NCT01664052|3671859|B1|||Age||Years|Mean|42|42.0|Full Range|||31.0|49.0|
3846690|NCT01664039|3671876|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3846691|NCT01664039|3671877|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3846692|NCT01664039|3671878|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3846693|NCT01664039|3671876|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3846694|NCT01664039|3671877|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3846695|NCT01664039|3671878|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3846696|NCT01664039|3671876|B3|60 or more years||Age, Customized||participants|Number|53|53.0||||||
3846697|NCT01664039|3671877|B2|60 or more years||Age, Customized||participants|Number|26|26.0||||||
3846698|NCT01664039|3671878|B1|60 or more years||Age, Customized||participants|Number|27|27.0||||||
3846699|NCT01664039|3671876|B3|Under 60 years||Age, Customized||participants|Number|51|51.0||||||
3846700|NCT01664039|3671877|B2|Under 60 years||Age, Customized||participants|Number|26|26.0||||||
3846701|NCT01664039|3671878|B1|Under 60 years||Age, Customized||participants|Number|25|25.0||||||
3846702|NCT01663987|3671899|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3846703|NCT01663987|3671900|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3846704|NCT01663987|3671901|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3846705|NCT01663987|3671899|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3846706|NCT01663987|3671900|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3846707|NCT01663987|3671901|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3846708|NCT01663987|3671899|B3|||Age||years|Mean|58.7|58.7|Standard Deviation|9.7|9.7|||
3846709|NCT01663987|3671900|B2|||Age||years|Mean|58.9|58.9|Standard Deviation|11.5|11.5|||
3846710|NCT01663987|3671901|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|7.5|7.5|||
3846711|NCT01663922|3671930|B1|United Kingdom||Region of Enrollment||participants|Number|17|17.0||||||
3846712|NCT01663922|3671930|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3846713|NCT01663922|3671930|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3846714|NCT01663922|3671930|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3846715|NCT01663922|3671930|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3846716|NCT01663922|3671930|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3846717|NCT01663779|3671936|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3846718|NCT01663779|3671937|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
3846719|NCT01663779|3671938|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3846720|NCT01663779|3671936|B3|unknown||Sex/Gender, Customized|Gender was not collected as a baseline variable.|participants|Number|50|50.0||||||
3846721|NCT01663779|3671937|B2|unknown||Sex/Gender, Customized|Gender was not collected as a baseline variable.|participants|Number|23|23.0||||||
3846722|NCT01663779|3671938|B1|unknown||Sex/Gender, Customized|Gender was not collected as a baseline variable.|participants|Number|27|27.0||||||
3846723|NCT01663779|3671936|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3846724|NCT01663779|3671937|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3846725|NCT01663779|3671938|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3846726|NCT01663779|3671936|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3846727|NCT01663779|3671937|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3846728|NCT01663779|3671938|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3846729|NCT01663779|3671936|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3846730|NCT01663779|3671937|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3846731|NCT01663779|3671938|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3846732|NCT01663740|3671945|B3|||Inhibin B Level||picograms per milliliter (pg/mL)|Mean|122.3|122.3|Standard Deviation|78.70|78.7|||
3846733|NCT01663740|3671946|B2|||Inhibin B Level||picograms per milliliter (pg/mL)|Mean|149.1|149.1|Standard Deviation|98.45|98.45|||
3846734|NCT01663740|3671947|B1|||Inhibin B Level||picograms per milliliter (pg/mL)|Mean|103.4|103.4|Standard Deviation|55.82|55.82|||
3846735|NCT01663740|3671945|B3|||Testosterone Level||nanomoles per liter (nmol/L)|Mean|13.0|13.0|Standard Deviation|5.84|5.84|||
3846736|NCT01663740|3671946|B2|||Testosterone Level||nanomoles per liter (nmol/L)|Mean|11.3|11.3|Standard Deviation|5.54|5.54|||
3846737|NCT01663740|3671947|B1|||Testosterone Level||nanomoles per liter (nmol/L)|Mean|14.2|14.2|Standard Deviation|5.83|5.83|||
3846738|NCT01663740|3671945|B3|||Prolactin Level||mU/mL|Mean|170.9|170.9|Standard Deviation|63.46|63.46|||
3846739|NCT01663740|3671946|B2|||Prolactin Level||mU/mL|Mean|164.5|164.5|Standard Deviation|46.22|46.22|||
3846740|NCT01663740|3671947|B1|||Prolactin Level||mU/mL|Mean|175.4|175.4|Standard Deviation|73.51|73.51|||
3846741|NCT01663740|3671945|B3|||Luteinizing Hormone (LH) Level||milliunits per milliliter (mU/mL)|Mean|6.6|6.6|Standard Deviation|4.76|4.76|||
3846742|NCT01663740|3671946|B2|||Luteinizing Hormone (LH) Level||milliunits per milliliter (mU/mL)|Mean|6.8|6.8|Standard Deviation|6.86|6.86|||
3846743|NCT01663740|3671947|B1|||Luteinizing Hormone (LH) Level||milliunits per milliliter (mU/mL)|Mean|6.4|6.4|Standard Deviation|2.61|2.61|||
3846744|NCT01663740|3671945|B3|||Follicle Stimulating Hormone (FSH) Level||units per liter (U/L)|Mean|9.9|9.9|Standard Deviation|6.72|6.72|||
3846745|NCT01663740|3671946|B2|||Follicle Stimulating Hormone (FSH) Level||units per liter (U/L)|Mean|8.6|8.6|Standard Deviation|6.61|6.61|||
3846746|NCT01663740|3671947|B1|||Follicle Stimulating Hormone (FSH) Level||units per liter (U/L)|Mean|10.8|10.8|Standard Deviation|6.77|6.77|||
3846747|NCT01663740|3671945|B3|||Terminal Uridine Nick-End Labeling (TUNEL) Score|TUNEL score represents percentage of sperm with fragmented Deoxyribonucleic acid (DNA); total score ranged from 0 percent (%) to 100%, higher score represents more fragmentation.|units on a scale|Mean|13.8|13.8|Standard Deviation|10.03|10.03|||
3846748|NCT01663740|3671946|B2|||Terminal Uridine Nick-End Labeling (TUNEL) Score|TUNEL score represents percentage of sperm with fragmented Deoxyribonucleic acid (DNA); total score ranged from 0 percent (%) to 100%, higher score represents more fragmentation.|units on a scale|Mean|12.9|12.9|Standard Deviation|10.60|10.6|||
3846749|NCT01663740|3671947|B1|||Terminal Uridine Nick-End Labeling (TUNEL) Score|TUNEL score represents percentage of sperm with fragmented Deoxyribonucleic acid (DNA); total score ranged from 0 percent (%) to 100%, higher score represents more fragmentation.|units on a scale|Mean|14.4|14.4|Standard Deviation|9.80|9.8|||
3846750|NCT01663740|3671945|B3|||Total Motility of Sperm||percent motility|Mean|30.0|30.0|Standard Deviation|22.42|22.42|||
3846751|NCT01663740|3671946|B2|||Total Motility of Sperm||percent motility|Mean|36.3|36.3|Standard Deviation|24.24|24.24|||
3846752|NCT01663740|3671947|B1|||Total Motility of Sperm||percent motility|Mean|25.8|25.8|Standard Deviation|20.46|20.46|||
3846753|NCT01663740|3671945|B3|||Percentage of Normal Sperm Cells||percentage of normal sperm cells|Mean|20.3|20.3|Standard Deviation|30.15|30.15|||
3846754|NCT01663740|3671946|B2|||Percentage of Normal Sperm Cells||percentage of normal sperm cells|Mean|33.5|33.5|Standard Deviation|39.03|39.03|||
3846755|NCT01663740|3671947|B1|||Percentage of Normal Sperm Cells||percentage of normal sperm cells|Mean|11.4|11.4|Standard Deviation|18.44|18.44|||
3846756|NCT01663740|3671945|B3|||Sperm Density||millions of sperm/milliliter (mil/mL)|Mean|21.9|21.9|Standard Deviation|26.77|26.77|||
3846757|NCT01663740|3671946|B2|||Sperm Density||millions of sperm/milliliter (mil/mL)|Mean|23.2|23.2|Standard Deviation|24.90|24.9|||
3846758|NCT01663740|3671947|B1|||Sperm Density||millions of sperm/milliliter (mil/mL)|Mean|21.0|21.0|Standard Deviation|28.33|28.33|||
3846759|NCT01663740|3671945|B3|||Seminal Volume||milliliters (mL)|Mean|2.2|2.2|Standard Deviation|1.46|1.46|||
3846760|NCT01663740|3671946|B2|||Seminal Volume||milliliters (mL)|Mean|2.0|2.0|Standard Deviation|1.37|1.37|||
3846761|NCT01663740|3671947|B1|||Seminal Volume||milliliters (mL)|Mean|2.4|2.4|Standard Deviation|1.51|1.51|||
3846762|NCT01663740|3671945|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3846763|NCT01663740|3671946|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3846764|NCT01663740|3671947|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3846765|NCT01663740|3671945|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3846766|NCT01663740|3671946|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3846767|NCT01663740|3671947|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3846768|NCT01663740|3671945|B3|||Age||years|Mean|34.5|34.5|Standard Deviation|7.36|7.36|||
3846769|NCT01663740|3671946|B2|||Age||years|Mean|32.5|32.5|Standard Deviation|5.81|5.81|||
3846770|NCT01663740|3671947|B1|||Age||years|Mean|35.6|35.6|Standard Deviation|7.96|7.96|||
3846771|NCT01663727|3672006|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3846772|NCT01663727|3672007|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3846773|NCT01663727|3672008|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3846774|NCT01663727|3672006|B3||Female|Sex: Female, Male||Participants|Count of Participants|473|473.0||||||
3846775|NCT01663727|3672007|B2||Female|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
3846776|NCT01663727|3672008|B1||Female|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
3846777|NCT01663727|3672006|B3|||Age||years|Mean|55.3|55.3|Standard Deviation|11.1|11.1|||
3846778|NCT01663727|3672007|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|11.5|11.5|||
3846779|NCT01663727|3672008|B1|||Age||years|Mean|54.7|54.7|Standard Deviation|10.7|10.7|||
3846780|NCT01663714|3672041|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3846781|NCT01663714|3672041|B1|White||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3846782|NCT01663714|3672041|B1||Male|Gender||Participants|Count of Participants|13|13.0||||||
3846783|NCT01663714|3672041|B1||Female|Gender||Participants|Count of Participants|17|17.0||||||
3846784|NCT01663714|3672041|B1|||Age||Years|Mean|50.6|50.6|Standard Deviation|9.5|9.5|||
3846785|NCT01663636|3672068|B3|Live =>16 km from the Clinic||Number of Participants who live <16 km from the Clinic||participants|Number|4|4.0||||||
3846786|NCT01663636|3672069|B2|Live =>16 km from the Clinic||Number of Participants who live <16 km from the Clinic||participants|Number|1|1.0||||||
3846787|NCT01663636|3672070|B1|Live =>16 km from the Clinic||Number of Participants who live <16 km from the Clinic||participants|Number|3|3.0||||||
3846788|NCT01663636|3672068|B3|Live <16 km from the Clinic||Number of Participants who live <16 km from the Clinic||participants|Number|317|317.0||||||
3846789|NCT01663636|3672069|B2|Live <16 km from the Clinic||Number of Participants who live <16 km from the Clinic||participants|Number|160|160.0||||||
3846790|NCT01663636|3672070|B1|Live <16 km from the Clinic||Number of Participants who live <16 km from the Clinic||participants|Number|157|157.0||||||
3846791|NCT01663636|3672068|B3|Missing value||Sex/Gender, Customized||participants|Number|1|1.0||||||
3846792|NCT01663636|3672069|B2|Missing value||Sex/Gender, Customized||participants|Number|1|1.0||||||
3846793|NCT01663636|3672070|B1|Missing value||Sex/Gender, Customized||participants|Number|0|0.0||||||
3846794|NCT01663636|3672068|B3|Female||Sex/Gender, Customized||participants|Number|155|155.0||||||
3846795|NCT01663636|3672069|B2|Female||Sex/Gender, Customized||participants|Number|71|71.0||||||
3846796|NCT01663636|3672070|B1|Female||Sex/Gender, Customized||participants|Number|84|84.0||||||
3846797|NCT01663636|3672068|B3|Male||Sex/Gender, Customized||participants|Number|165|165.0||||||
3846798|NCT01663636|3672069|B2|Male||Sex/Gender, Customized||participants|Number|89|89.0||||||
3846799|NCT01663636|3672070|B1|Male||Sex/Gender, Customized||participants|Number|76|76.0||||||
3846800|NCT01663636|3672068|B3|||Age||weeks|Mean|9.5|9.5|Standard Deviation|1.3|1.3|||
3846801|NCT01663636|3672069|B2|||Age||weeks|Mean|9.4|9.4|Standard Deviation|1.2|1.2|||
3846802|NCT01663636|3672070|B1|||Age||weeks|Mean|9.7|9.7|Standard Deviation|1.4|1.4|||
3846803|NCT01663623|3672077|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|90|90.0||||||
3846804|NCT01663623|3672078|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
3846805|NCT01663623|3672079|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
3846806|NCT01663623|3672077|B3|Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3846807|NCT01663623|3672078|B2|Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3846808|NCT01663623|3672079|B1|Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3846809|NCT01663623|3672077|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3846810|NCT01663623|3672078|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3846811|NCT01663623|3672079|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3846812|NCT01663623|3672077|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3846813|NCT01663623|3672078|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3846814|NCT01663623|3672079|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3846815|NCT01663623|3672077|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3846816|NCT01663623|3672078|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3846817|NCT01663623|3672079|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3846818|NCT01663623|3672077|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3846819|NCT01663623|3672078|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3846820|NCT01663623|3672079|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3846821|NCT01663623|3672077|B3|||Age||Years|Mean|54.8|54.8|Standard Deviation|13.58|13.58|||
3846822|NCT01663623|3672078|B2|||Age||Years|Mean|56.2|56.2|Standard Deviation|13.59|13.59|||
3846823|NCT01663623|3672079|B1|||Age||Years|Mean|53.5|53.5|Standard Deviation|13.56|13.56|||
3846824|NCT01663532|3672088|B3||Male|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
3846825|NCT01663532|3672089|B2||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3846826|NCT01663532|3672090|B1||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3846827|NCT01663532|3672088|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3846828|NCT01663532|3672089|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3846829|NCT01663532|3672090|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3846830|NCT01663532|3672088|B3|||Age||Years|Mean|42.4|42.4|Standard Deviation|11.0|11.0|||
3846831|NCT01663532|3672089|B2|||Age||Years|Mean|42.7|42.7|Standard Deviation|10.9|10.9|||
3846832|NCT01663532|3672090|B1|||Age||Years|Mean|42.1|42.1|Standard Deviation|11.0|11.0|||
3846833|NCT01663506|3672109|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3846834|NCT01663506|3672109|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3846835|NCT01663506|3672109|B1|||Age||years|Mean|52.4|52.4|Standard Deviation|12.2|12.2|||
3846836|NCT01663363|3672138|B1|United States||Region of Enrollment||participants|Number|170|170.0||||||
3846837|NCT01663363|3672138|B1||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3846838|NCT01663363|3672138|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3846839|NCT01663363|3672138|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3846840|NCT01663363|3672138|B1||Between 18 and 65 years|Age||Participants|Count of Participants|169|169.0||||||
3846841|NCT01663363|3672138|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3846842|NCT01663285|3672143|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3846843|NCT01663285|3672143|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3846844|NCT01663285|3672143|B1|||Age||years|Mean|46|46.0|Full Range|||46.0|46.0|
3846845|NCT01663272|3672149|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3846846|NCT01663272|3672149|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3846847|NCT01663272|3672149|B1|||Age||years|Median|60.5|60.5|Full Range|||41.0|75.0|
3846848|NCT01663233|3672156|B3||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3846849|NCT01663233|3672157|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3846850|NCT01663233|3672158|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3846851|NCT01663233|3672156|B3||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3846852|NCT01663233|3672157|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3846853|NCT01663233|3672158|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3846854|NCT01663233|3672156|B3|||Age||Years|Mean|55.4|55.4|Standard Deviation|9.35|9.35|||
3846855|NCT01663233|3672157|B2|||Age||Years|Mean|55.5|55.5|Standard Deviation|9.43|9.43|||
3846856|NCT01663233|3672158|B1|||Age||Years|Mean|55.4|55.4|Standard Deviation|9.31|9.31|||
3846857|NCT01663103|3672181|B3|||Estimated glomerular filtration rate||mL/min/1.73m^2|Mean|38|38.0|Standard Deviation|13|13.0|||
3846858|NCT01663103|3672182|B2|||Estimated glomerular filtration rate||mL/min/1.73m^2|Mean|38|38.0|Standard Deviation|12|12.0|||
3846859|NCT01663103|3672183|B1|||Estimated glomerular filtration rate||mL/min/1.73m^2|Mean|38|38.0|Standard Deviation|14|14.0|||
3846860|NCT01663103|3672181|B3|Focal Segmental Glomerulosclerosis||Etiology of CKD||participants|Number|1|1.0||||||
3846861|NCT01663103|3672182|B2|Focal Segmental Glomerulosclerosis||Etiology of CKD||participants|Number|0|0.0||||||
3846862|NCT01663103|3672183|B1|Focal Segmental Glomerulosclerosis||Etiology of CKD||participants|Number|1|1.0||||||
3846863|NCT01663103|3672181|B3|Renal Cell Carcinoma||Etiology of CKD||participants|Number|3|3.0||||||
3846864|NCT01663103|3672182|B2|Renal Cell Carcinoma||Etiology of CKD||participants|Number|3|3.0||||||
3846865|NCT01663103|3672183|B1|Renal Cell Carcinoma||Etiology of CKD||participants|Number|0|0.0||||||
3846866|NCT01663103|3672181|B3|Autosomal Dominant Polycystic Kidney Disease||Etiology of CKD||participants|Number|3|3.0||||||
3846867|NCT01663103|3672182|B2|Autosomal Dominant Polycystic Kidney Disease||Etiology of CKD||participants|Number|2|2.0||||||
3846868|NCT01663103|3672183|B1|Autosomal Dominant Polycystic Kidney Disease||Etiology of CKD||participants|Number|1|1.0||||||
3846869|NCT01663103|3672181|B3|Type I DIabetes||Etiology of CKD||participants|Number|3|3.0||||||
3846870|NCT01663103|3672182|B2|Type I DIabetes||Etiology of CKD||participants|Number|2|2.0||||||
3846871|NCT01663103|3672183|B1|Type I DIabetes||Etiology of CKD||participants|Number|1|1.0||||||
3846872|NCT01663103|3672181|B3|Type II Diabetes||Etiology of CKD||participants|Number|19|19.0||||||
3846873|NCT01663103|3672182|B2|Type II Diabetes||Etiology of CKD||participants|Number|9|9.0||||||
3846874|NCT01663103|3672183|B1|Type II Diabetes||Etiology of CKD||participants|Number|10|10.0||||||
3846875|NCT01663103|3672181|B3|Hypertension||Etiology of CKD||participants|Number|22|22.0||||||
3846876|NCT01663103|3672182|B2|Hypertension||Etiology of CKD||participants|Number|10|10.0||||||
3846877|NCT01663103|3672183|B1|Hypertension||Etiology of CKD||participants|Number|12|12.0||||||
3846878|NCT01663103|3672181|B3|African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3846879|NCT01663103|3672182|B2|African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3846880|NCT01663103|3672183|B1|African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3846881|NCT01663103|3672181|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3846882|NCT01663103|3672182|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3846883|NCT01663103|3672183|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3846884|NCT01663103|3672181|B3|White||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3846885|NCT01663103|3672182|B2|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3846886|NCT01663103|3672183|B1|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3846887|NCT01663103|3672181|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3846888|NCT01663103|3672182|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3846889|NCT01663103|3672183|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3846890|NCT01663103|3672181|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3846891|NCT01663103|3672182|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3846892|NCT01663103|3672183|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3846893|NCT01663103|3672181|B3|||Age||years|Mean|63|63.0|Standard Deviation|11|11.0|||
3846894|NCT01663103|3672182|B2|||Age||years|Mean|65|65.0|Standard Deviation|11|11.0|||
3846895|NCT01663103|3672183|B1|||Age||years|Mean|61|61.0|Standard Deviation|11|11.0|||
3846896|NCT01663012|3672200|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3846897|NCT01663012|3672200|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3846898|NCT01663012|3672200|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3846899|NCT01663012|3672200|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3846900|NCT01663012|3672200|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3846901|NCT01663012|3672200|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3846902|NCT01663012|3672200|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3846903|NCT01663012|3672200|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3846904|NCT01663012|3672200|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3846905|NCT01663012|3672200|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3846906|NCT01663012|3672200|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3846907|NCT01663012|3672200|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3846908|NCT01663012|3672200|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3846909|NCT01663012|3672200|B1|||Age||years|Median|49.5|49.5|Full Range|||20.0|73.0|
3846910|NCT01663012|3672200|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3846911|NCT01663012|3672200|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3846912|NCT01663012|3672200|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3846913|NCT01662999|3672206|B7|||Body Weight (kg)|Body weight was measured in kilograms (k) prior to first dose of study drug (Day -1).|kg|Mean|77.50|77.5|Standard Deviation|10.813|10.813|||
3846914|NCT01662999|3672207|B6|||Body Weight (kg)|Body weight was measured in kilograms (k) prior to first dose of study drug (Day -1).|kg|Mean|71.71|71.71|Standard Deviation|6.404|6.404|||
3846915|NCT01662999|3672208|B5|||Body Weight (kg)|Body weight was measured in kilograms (k) prior to first dose of study drug (Day -1).|kg|Mean|79.64|79.64|Standard Deviation|11.223|11.223|||
3846916|NCT01662999|3672209|B4|||Body Weight (kg)|Body weight was measured in kilograms (k) prior to first dose of study drug (Day -1).|kg|Mean|80.73|80.73|Standard Deviation|11.903|11.903|||
3846917|NCT01662999|3672210|B3|||Body Weight (kg)|Body weight was measured in kilograms (k) prior to first dose of study drug (Day -1).|kg|Mean|76.01|76.01|Standard Deviation|14.589|14.589|||
3846918|NCT01662999|3672211|B2|||Body Weight (kg)|Body weight was measured in kilograms (k) prior to first dose of study drug (Day -1).|kg|Mean|78.94|78.94|Standard Deviation|8.100|8.1|||
3846919|NCT01662999|3672212|B1|||Body Weight (kg)|Body weight was measured in kilograms (k) prior to first dose of study drug (Day -1).|kg|Mean|77.94|77.94|Standard Deviation|12.250|12.25|||
3846920|NCT01662999|3672206|B7|||Body Surface Area (m^2)|Body surface area was measured in meters squared (m^2) prior to first dose of study drug (Day -1).|m^2|Mean|1.91|1.91|Standard Deviation|0.160|0.16|||
3846921|NCT01662999|3672207|B6|||Body Surface Area (m^2)|Body surface area was measured in meters squared (m^2) prior to first dose of study drug (Day -1).|m^2|Mean|1.85|1.85|Standard Deviation|0.108|0.108|||
3846922|NCT01662999|3672208|B5|||Body Surface Area (m^2)|Body surface area was measured in meters squared (m^2) prior to first dose of study drug (Day -1).|m^2|Mean|1.94|1.94|Standard Deviation|0.166|0.166|||
3846923|NCT01662999|3672209|B4|||Body Surface Area (m^2)|Body surface area was measured in meters squared (m^2) prior to first dose of study drug (Day -1).|m^2|Mean|1.95|1.95|Standard Deviation|0.170|0.17|||
3846924|NCT01662999|3672210|B3|||Body Surface Area (m^2)|Body surface area was measured in meters squared (m^2) prior to first dose of study drug (Day -1).|m^2|Mean|1.91|1.91|Standard Deviation|0.208|0.208|||
3846925|NCT01662999|3672211|B2|||Body Surface Area (m^2)|Body surface area was measured in meters squared (m^2) prior to first dose of study drug (Day -1).|m^2|Mean|1.92|1.92|Standard Deviation|0.145|0.145|||
3846926|NCT01662999|3672212|B1|||Body Surface Area (m^2)|Body surface area was measured in meters squared (m^2) prior to first dose of study drug (Day -1).|m^2|Mean|1.90|1.9|Standard Deviation|0.187|0.187|||
3846927|NCT01662999|3672206|B7|United States||Region of Enrollment||participants|Number|42|42.0||||||
3846928|NCT01662999|3672207|B6|United States||Region of Enrollment||participants|Number|7|7.0||||||
3846929|NCT01662999|3672208|B5|United States||Region of Enrollment||participants|Number|7|7.0||||||
3846930|NCT01662999|3672209|B4|United States||Region of Enrollment||participants|Number|7|7.0||||||
3846931|NCT01662999|3672210|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
3846932|NCT01662999|3672211|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3846933|NCT01662999|3672212|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3846934|NCT01662999|3672206|B7||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3846935|NCT01662999|3672207|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3846936|NCT01662999|3672208|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3846937|NCT01662999|3672209|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3846938|NCT01662999|3672210|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3846939|NCT01662999|3672211|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3846940|NCT01662999|3672212|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3846941|NCT01662999|3672206|B7||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3846942|NCT01662999|3672207|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3846943|NCT01662999|3672208|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3846944|NCT01662999|3672209|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3846945|NCT01662999|3672210|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3846946|NCT01662999|3672211|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3846947|NCT01662999|3672212|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3846948|NCT01662999|3672206|B7|||Age||years|Mean|32.0|32.0|Standard Deviation|6.81|6.81|||
3846949|NCT01662999|3672207|B6|||Age||years|Mean|33.3|33.3|Standard Deviation|7.95|7.95|||
3846950|NCT01662999|3672208|B5|||Age||years|Mean|34.4|34.4|Standard Deviation|5.74|5.74|||
3846951|NCT01662999|3672209|B4|||Age||years|Mean|32.0|32.0|Standard Deviation|6.51|6.51|||
3846952|NCT01662999|3672210|B3|||Age||years|Mean|27.7|27.7|Standard Deviation|6.99|6.99|||
3846953|NCT01662999|3672211|B2|||Age||years|Mean|28.7|28.7|Standard Deviation|5.02|5.02|||
3846954|NCT01662999|3672212|B1|||Age||years|Mean|36.1|36.1|Standard Deviation|6.47|6.47|||
3846955|NCT01662999|3672206|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3846956|NCT01662999|3672207|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3846957|NCT01662999|3672208|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3846958|NCT01662999|3672209|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3846959|NCT01662999|3672210|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3846960|NCT01662999|3672211|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3846961|NCT01662999|3672212|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3846962|NCT01662999|3672206|B7||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3846963|NCT01662999|3672207|B6||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3846964|NCT01662999|3672208|B5||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3846965|NCT01662999|3672209|B4||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3846966|NCT01662999|3672210|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3846967|NCT01662999|3672211|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3846968|NCT01662999|3672212|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3846969|NCT01662999|3672206|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3846970|NCT01662999|3672207|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3846971|NCT01662999|3672208|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3846972|NCT01662999|3672209|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3846973|NCT01662999|3672210|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3846974|NCT01662999|3672211|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3846975|NCT01662999|3672212|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3846976|NCT01662986|3672286|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3846977|NCT01662986|3672287|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3846978|NCT01662986|3672288|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3846979|NCT01662986|3672286|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3846980|NCT01662986|3672287|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3846981|NCT01662986|3672288|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3846982|NCT01662986|3672286|B3|||Age||Years|Mean|59.2|59.2|Standard Deviation|7.8|7.8|||
3846983|NCT01662986|3672287|B2|||Age||Years|Mean|58.4|58.4|Standard Deviation|7.0|7.0|||
3846984|NCT01662986|3672288|B1|||Age||Years|Mean|60.0|60.0|Standard Deviation|8.6|8.6|||
3846985|NCT01662908|3672321|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
3846986|NCT01662908|3672322|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
3846987|NCT01662908|3672323|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3846988|NCT01662908|3672321|B3|Canada||Region of Enrollment||participants|Number|22|22.0||||||
3846989|NCT01662908|3672322|B2|Canada||Region of Enrollment||participants|Number|6|6.0||||||
3846990|NCT01662908|3672323|B1|Canada||Region of Enrollment||participants|Number|16|16.0||||||
3846991|NCT01662908|3672321|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3846992|NCT01662908|3672322|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3846993|NCT01662908|3672323|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3846994|NCT01662908|3672321|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3846995|NCT01662908|3672322|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3846996|NCT01662908|3672323|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3846997|NCT01662908|3672321|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3846998|NCT01662908|3672322|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3846999|NCT01662908|3672323|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3847000|NCT01662908|3672321|B3||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
3847001|NCT01662908|3672322|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3847002|NCT01662908|3672323|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3847003|NCT01662908|3672321|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3847004|NCT01662908|3672322|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3847005|NCT01662908|3672323|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3847006|NCT01662882|3672338|B4|Japan||Region of Enrollment||participants|Number|48|48.0||||||
3847007|NCT01662882|3672339|B3|Japan||Region of Enrollment||participants|Number|15|15.0||||||
3847008|NCT01662882|3672340|B2|Japan||Region of Enrollment||participants|Number|18|18.0||||||
3847009|NCT01662882|3672341|B1|Japan||Region of Enrollment||participants|Number|15|15.0||||||
3847010|NCT01662882|3672338|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3847011|NCT01662882|3672339|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3847012|NCT01662882|3672340|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3847013|NCT01662882|3672341|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3847014|NCT01662882|3672338|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3847015|NCT01662882|3672339|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3847016|NCT01662882|3672340|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3847017|NCT01662882|3672341|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3847018|NCT01662882|3672338|B4|||Age||participants|Mean|72.1|72.1|Standard Deviation|8.57|8.57|||
3847019|NCT01662882|3672339|B3|||Age||participants|Mean|73.3|73.3|Standard Deviation|5.09|5.09|||
3847020|NCT01662882|3672340|B2|||Age||participants|Mean|70.0|70.0|Standard Deviation|11.15|11.15|||
3847021|NCT01662882|3672341|B1|||Age||participants|Mean|73.3|73.3|Standard Deviation|7.80|7.8|||
3847022|NCT01662856|3672354|B3|Serbia||Region of Enrollment||participants|Number|47|47.0||||||
3847023|NCT01662856|3672355|B2|Serbia||Region of Enrollment||participants|Number|15|15.0||||||
3847024|NCT01662856|3672356|B1|Serbia||Region of Enrollment||participants|Number|32|32.0||||||
3847025|NCT01662856|3672354|B3|United States||Region of Enrollment||participants|Number|85|85.0||||||
3847026|NCT01662856|3672355|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3847027|NCT01662856|3672356|B1|United States||Region of Enrollment||participants|Number|69|69.0||||||
3847028|NCT01662856|3672354|B3|Hungary||Region of Enrollment||participants|Number|72|72.0||||||
3847029|NCT01662856|3672355|B2|Hungary||Region of Enrollment||participants|Number|23|23.0||||||
3847030|NCT01662856|3672356|B1|Hungary||Region of Enrollment||participants|Number|49|49.0||||||
3847031|NCT01662856|3672354|B3|Russian Federation||Region of Enrollment||participants|Number|21|21.0||||||
3847032|NCT01662856|3672355|B2|Russian Federation||Region of Enrollment||participants|Number|3|3.0||||||
3847033|NCT01662856|3672356|B1|Russian Federation||Region of Enrollment||participants|Number|18|18.0||||||
3847034|NCT01662856|3672354|B3||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3847035|NCT01662856|3672355|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3847036|NCT01662856|3672356|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3847037|NCT01662856|3672354|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3847038|NCT01662856|3672355|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3847039|NCT01662856|3672356|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3847040|NCT01662856|3672354|B3|>=65 years||Age, Customized||participants|Number|103|103.0||||||
3847041|NCT01662856|3672355|B2|>=65 years||Age, Customized||participants|Number|25|25.0||||||
3847042|NCT01662856|3672356|B1|>=65 years||Age, Customized||participants|Number|78|78.0||||||
3847043|NCT01662856|3672354|B3|Between 18 and 64 years||Age, Customized||participants|Number|122|122.0||||||
3847044|NCT01662856|3672355|B2|Between 18 and 64 years||Age, Customized||participants|Number|32|32.0||||||
3847045|NCT01662856|3672356|B1|Between 18 and 64 years||Age, Customized||participants|Number|90|90.0||||||
3847046|NCT01662856|3672354|B3|||Age||years|Mean|63.24|63.24|Standard Deviation|9.496|9.496|||
3847047|NCT01662856|3672355|B2|||Age||years|Mean|62.04|62.04|Standard Deviation|10.734|10.734|||
3847048|NCT01662856|3672356|B1|||Age||years|Mean|63.65|63.65|Standard Deviation|9.036|9.036|||
3847049|NCT01662791|3672369|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
3847050|NCT01662791|3672370|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
3847051|NCT01662791|3672371|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3847052|NCT01662791|3672369|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3847053|NCT01662791|3672370|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3847054|NCT01662791|3672371|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3847055|NCT01662791|3672369|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3847056|NCT01662791|3672370|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3847057|NCT01662791|3672371|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3847058|NCT01662791|3672369|B3||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
3847059|NCT01662791|3672370|B2||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
3847060|NCT01662791|3672371|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3847061|NCT01662791|3672369|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3847062|NCT01662791|3672370|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3847063|NCT01662791|3672371|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3847064|NCT01662791|3672369|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3847065|NCT01662791|3672370|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3847066|NCT01662791|3672371|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3847067|NCT01662765|3672394|B3|Turkey||Region of Enrollment||participants|Number|84|84.0||||||
3847068|NCT01662765|3672395|B2|Turkey||Region of Enrollment||participants|Number|42|42.0||||||
3847069|NCT01662765|3672396|B1|Turkey||Region of Enrollment||participants|Number|42|42.0||||||
3847070|NCT01662765|3672394|B3||Male|Gender||Participants|Count of Participants|79|79.0||||||
3847071|NCT01662765|3672395|B2||Male|Gender||Participants|Count of Participants|40|40.0||||||
3847072|NCT01662765|3672396|B1||Male|Gender||Participants|Count of Participants|39|39.0||||||
3847073|NCT01662765|3672394|B3||Female|Gender||Participants|Count of Participants|5|5.0||||||
3847074|NCT01662765|3672395|B2||Female|Gender||Participants|Count of Participants|2|2.0||||||
3847075|NCT01662765|3672396|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
3847076|NCT01662765|3672394|B3|||Age||years|Mean|20.83|20.83|Inter-Quartile Range|||10.0|37.0|
3847077|NCT01662765|3672395|B2|||Age||years|Mean|19.86|19.86|Inter-Quartile Range|||10.0|37.0|
3847078|NCT01662765|3672396|B1|||Age||years|Mean|21.80|21.8|Inter-Quartile Range|||12.0|34.0|
3847079|NCT01662648|3672409|B3||Male|Sex: Female, Male||Participants|Count of Participants|657|657.0||||||
3847080|NCT01662648|3672410|B2||Male|Sex: Female, Male||Participants|Count of Participants|329|329.0||||||
3847081|NCT01662648|3672411|B1||Male|Sex: Female, Male||Participants|Count of Participants|328|328.0||||||
3847082|NCT01662648|3672409|B3||Female|Sex: Female, Male||Participants|Count of Participants|460|460.0||||||
3847083|NCT01662648|3672410|B2||Female|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
3847084|NCT01662648|3672411|B1||Female|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
3847085|NCT01662648|3672409|B3|Greater than 75 years||Age, Customized||Participants|Number|2|2.0||||||
3847086|NCT01662648|3672410|B2|Greater than 75 years||Age, Customized||Participants|Number|1|1.0||||||
3847087|NCT01662648|3672411|B1|Greater than 75 years||Age, Customized||Participants|Number|1|1.0||||||
3847088|NCT01662648|3672409|B3|>= 65 to < 75 years||Age, Customized||Participants|Number|13|13.0||||||
3847089|NCT01662648|3672410|B2|>= 65 to < 75 years||Age, Customized||Participants|Number|7|7.0||||||
3847090|NCT01662648|3672411|B1|>= 65 to < 75 years||Age, Customized||Participants|Number|6|6.0||||||
3847091|NCT01662648|3672409|B3|>= 55 to < 65 years||Age, Customized||Participants|Number|67|67.0||||||
3847092|NCT01662648|3672410|B2|>= 55 to < 65 years||Age, Customized||Participants|Number|34|34.0||||||
3847093|NCT01662648|3672411|B1|>= 55 to < 65 years||Age, Customized||Participants|Number|33|33.0||||||
3847094|NCT01662648|3672409|B3|>= 45 to < 55 years||Age, Customized||Participants|Number|170|170.0||||||
3847095|NCT01662648|3672410|B2|>= 45 to < 55 years||Age, Customized||Participants|Number|87|87.0||||||
3847096|NCT01662648|3672411|B1|>= 45 to < 55 years||Age, Customized||Participants|Number|83|83.0||||||
3847097|NCT01662648|3672409|B3|>= 35 to < 45 years||Age, Customized||Participants|Number|304|304.0||||||
3847098|NCT01662648|3672410|B2|>= 35 to < 45 years||Age, Customized||Participants|Number|152|152.0||||||
3847099|NCT01662648|3672411|B1|>= 35 to < 45 years||Age, Customized||Participants|Number|152|152.0||||||
3847100|NCT01662648|3672409|B3|Greater than or equal to (>=) 25 to < 35 years||Age, Customized||Participants|Number|344|344.0||||||
3847101|NCT01662648|3672410|B2|Greater than or equal to (>=) 25 to < 35 years||Age, Customized||Participants|Number|191|191.0||||||
3847102|NCT01662648|3672411|B1|Greater than or equal to (>=) 25 to < 35 years||Age, Customized||Participants|Number|153|153.0||||||
3847103|NCT01662648|3672409|B3|Less than (<) 25 years||Age, Customized||Participants|Number|217|217.0||||||
3847104|NCT01662648|3672410|B2|Less than (<) 25 years||Age, Customized||Participants|Number|125|125.0||11.90|11.9|||
3847105|NCT01662648|3672411|B1|Less than (<) 25 years||Age, Customized||Participants|Number|92|92.0||11.63|11.63|||
3847106|NCT01662635|3672434|B1|No otherwise specified; ALK -||Histology Subtype||participants|Number|42|42.0||||||
3847107|NCT01662635|3672434|B1|Adenousquamous; ALK -||Histology Subtype||participants|Number|16|16.0||||||
3847108|NCT01662635|3672434|B1|Solid; ALK -||Histology Subtype||participants|Number|47|47.0||||||
3847109|NCT01662635|3672434|B1|Micropapilar; ALK -||Histology Subtype||participants|Number|10|10.0||||||
3847110|NCT01662635|3672434|B1|Papilar; ALK -||Histology Subtype||participants|Number|13|13.0||||||
3847111|NCT01662635|3672434|B1|Acinar; ALK -||Histology Subtype||participants|Number|39|39.0||||||
3847112|NCT01662635|3672434|B1|Lepidic; ALK -||Histology Subtype||participants|Number|14|14.0||||||
3847113|NCT01662635|3672434|B1|No otherwise specified; ALK +||Histology Subtype||participants|Number|5|5.0||||||
3847114|NCT01662635|3672434|B1|Adenousquamous; ALK +||Histology Subtype||participants|Number|0|0.0||||||
3847115|NCT01662635|3672434|B1|Solid; ALK +||Histology Subtype||participants|Number|3|3.0||||||
3847116|NCT01662635|3672434|B1|Micropapilar; ALK +||Histology Subtype||participants|Number|1|1.0||||||
3847117|NCT01662635|3672434|B1|Papilar; ALK +||Histology Subtype||participants|Number|2|2.0||||||
3847118|NCT01662635|3672434|B1|Acinar; ALK +||Histology Subtype||participants|Number|5|5.0||||||
3847119|NCT01662635|3672434|B1|Lepidic; ALK +||Histology Subtype||participants|Number|3|3.0||||||
3847120|NCT01662635|3672434|B1|Present; ALK -||Wood smoke expossure||participants|Number|64|64.0||||||
3847121|NCT01662635|3672434|B1|Absent; ALK -||Wood smoke expossure||participants|Number|117|117.0||||||
3847122|NCT01662635|3672434|B1|Present; ALK +||Wood smoke expossure||participants|Number|10|10.0||||||
3847123|NCT01662635|3672434|B1|Absent; ALK +||Wood smoke expossure||participants|Number|9|9.0||||||
3847124|NCT01662635|3672434|B1|Non-squamus; ALK -||Histology||participants|Number|5|5.0||||||
3847125|NCT01662635|3672434|B1|Squamus; ALK -||Histology||participants|Number|176|176.0||||||
3847126|NCT01662635|3672434|B1|Non-squamus; ALK +||Histology||participants|Number|2|2.0||||||
3847127|NCT01662635|3672434|B1|Squamus; ALK+||Histology||participants|Number|17|17.0||||||
3847128|NCT01662635|3672434|B1|ECOG 2-3; ALK -||ECOG Performance status|"There were two groups:~with an ECOG PS of 0-1( 0= Fully active, able to carry on all pre-disease performance without restriction, 1= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work).~ECOG PS of 2-3;( 2=Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours. 3=Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours)."|participants|Number|33|33.0||||||
3847129|NCT01662635|3672434|B1|ECOG 0-1; ALK -||ECOG Performance status|"There were two groups:~with an ECOG PS of 0-1( 0= Fully active, able to carry on all pre-disease performance without restriction, 1= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work).~ECOG PS of 2-3;( 2=Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours. 3=Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours)."|participants|Number|148|148.0||||||
3847130|NCT01662635|3672434|B1|ECOG 2-3; ALK +||ECOG Performance status|"There were two groups:~with an ECOG PS of 0-1( 0= Fully active, able to carry on all pre-disease performance without restriction, 1= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work).~ECOG PS of 2-3;( 2=Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours. 3=Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours)."|participants|Number|4|4.0||||||
3847131|NCT01662635|3672434|B1|ECOG 0-1; ALK +||ECOG Performance status|"There were two groups:~with an ECOG PS of 0-1( 0= Fully active, able to carry on all pre-disease performance without restriction, 1= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work).~ECOG PS of 2-3;( 2=Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours. 3=Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours)."|participants|Number|15|15.0||||||
3847132|NCT01662635|3672434|B1|smokers ALK-||Smoking history||participants|Number|86|86.0||||||
3847133|NCT01662635|3672434|B1|Non smokers ALK-||Smoking history||participants|Number|95|95.0||||||
3847134|NCT01662635|3672434|B1|Smokers ALK+||Smoking history||participants|Number|7|7.0||||||
3847135|NCT01662635|3672434|B1|Non smokers ALK +||Smoking history||participants|Number|12|12.0||||||
3847136|NCT01662635|3672434|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3847137|NCT01662635|3672434|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3847138|NCT01662635|3672434|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3847139|NCT01662635|3672434|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3847140|NCT01662635|3672434|B1|55 to 87 years old||Age, Customized||participants|Number|109|109.0||||||
3847141|NCT01662635|3672434|B1|< 55 years old||Age, Customized||participants|Number|91|91.0||||||
3847142|NCT01662583|3672440|B4|United States||Region of Enrollment||participants|Number|660|660.0||||||
3847143|NCT01662583|3672441|B3|United States||Region of Enrollment||participants|Number|219|219.0||||||
3847144|NCT01662583|3672442|B2|United States||Region of Enrollment||participants|Number|225|225.0||||||
3847145|NCT01662583|3672443|B1|United States||Region of Enrollment||participants|Number|216|216.0||||||
3847146|NCT01662583|3672440|B4||Male|Sex: Female, Male||Participants|Count of Participants|333|333.0||||||
3847147|NCT01662583|3672441|B3||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3847148|NCT01662583|3672442|B2||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3847149|NCT01662583|3672443|B1||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3847150|NCT01662583|3672440|B4||Female|Sex: Female, Male||Participants|Count of Participants|327|327.0||||||
3847151|NCT01662583|3672441|B3||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3847152|NCT01662583|3672442|B2||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3847153|NCT01662583|3672443|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3847154|NCT01662583|3672440|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3847155|NCT01662583|3672441|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3847156|NCT01662583|3672442|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3847157|NCT01662583|3672443|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3847158|NCT01662583|3672440|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3847159|NCT01662583|3672441|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3847160|NCT01662583|3672442|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3847161|NCT01662583|3672443|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3847162|NCT01662583|3672440|B4||<=18 years|Age||Participants|Count of Participants|660|660.0||||||
3847163|NCT01662583|3672441|B3||<=18 years|Age||Participants|Count of Participants|219|219.0||||||
3847164|NCT01662583|3672442|B2||<=18 years|Age||Participants|Count of Participants|225|225.0||||||
3847165|NCT01662583|3672443|B1||<=18 years|Age||Participants|Count of Participants|216|216.0||||||
3847166|NCT01662531|3672456|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3847167|NCT01662531|3672457|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3847168|NCT01662531|3672458|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3847169|NCT01662531|3672456|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3847170|NCT01662531|3672457|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3847171|NCT01662531|3672458|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3847172|NCT01662531|3672456|B3|||Age||years|Mean|5.9|5.9|Standard Deviation|2.93|2.93|||
3847173|NCT01662531|3672457|B2|||Age||years|Mean|8.1|8.1|Standard Deviation|1.41|1.41|||
3847174|NCT01662531|3672458|B1|||Age||years|Mean|3.2|3.2|Standard Deviation|1.70|1.7|||
3847175|NCT01662505|3672482|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3847176|NCT01662505|3672483|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3847177|NCT01662505|3672484|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3847178|NCT01662505|3672485|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3847179|NCT01662505|3672482|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3847180|NCT01662505|3672483|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3847181|NCT01662505|3672484|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3847182|NCT01662505|3672485|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3847183|NCT01662505|3672482|B4|||Age||Years|Mean|72.2|72.2|Standard Deviation|7.7|7.7|||
3847184|NCT01662505|3672483|B3|||Age||Years|Mean|69.1|69.1|Standard Deviation|8.6|8.6|||
3847185|NCT01662505|3672484|B2|||Age||Years|Mean|78.0|78.0|Standard Deviation|5.9|5.9|||
3847186|NCT01662505|3672485|B1|||Age||Years|Mean|72.4|72.4|Standard Deviation|6.0|6.0|||
3847187|NCT01662492|3672508|B4|Female||Sex/Gender, Customized||participants|Number|98|98.0||||||
3847188|NCT01662492|3672509|B3|Female||Sex/Gender, Customized||participants|Number|29|29.0||||||
3847189|NCT01662492|3672510|B2|Female||Sex/Gender, Customized||participants|Number|32|32.0||||||
3847190|NCT01662492|3672511|B1|Female||Sex/Gender, Customized||participants|Number|37|37.0||||||
3847191|NCT01662492|3672508|B4|Male||Sex/Gender, Customized||participants|Number|27|27.0||||||
3847192|NCT01662492|3672509|B3|Male||Sex/Gender, Customized||participants|Number|8|8.0||||||
3847193|NCT01662492|3672510|B2|Male||Sex/Gender, Customized||participants|Number|11|11.0||||||
3847194|NCT01662492|3672511|B1|Male||Sex/Gender, Customized||participants|Number|8|8.0||||||
3847195|NCT01662492|3672508|B4|||Age||years|Mean|15.1|15.1|Standard Deviation|1.5|1.5|||
3847196|NCT01662492|3672509|B3|||Age||years|Mean|15.2|15.2|Standard Deviation|1.5|1.5|||
3847197|NCT01662492|3672510|B2|||Age||years|Mean|15.0|15.0|Standard Deviation|1.5|1.5|||
3847198|NCT01662492|3672511|B1|||Age||years|Mean|15.1|15.1|Standard Deviation|1.4|1.4|||
3847199|NCT01662440|3672533|B5||Male|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
3847200|NCT01662440|3672534|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3847201|NCT01662440|3672535|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3847202|NCT01662440|3672536|B2||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3847203|NCT01662440|3672537|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3847204|NCT01662440|3672533|B5||Female|Sex: Female, Male||Participants|Count of Participants|359|359.0||||||
3847205|NCT01662440|3672534|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3847206|NCT01662440|3672535|B3||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3847207|NCT01662440|3672536|B2||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3847208|NCT01662440|3672537|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3847209|NCT01662440|3672533|B5|||Age||year|Mean|36.7|36.7|Standard Deviation|12.9|12.9|||
3847210|NCT01662440|3672534|B4|||Age||year|Mean|38.8|38.8|Standard Deviation|13.3|13.3|||
3847211|NCT01662440|3672535|B3|||Age||year|Mean|35.7|35.7|Standard Deviation|12.6|12.6|||
3847212|NCT01662440|3672536|B2|||Age||year|Mean|36.8|36.8|Standard Deviation|12.7|12.7|||
3847213|NCT01662440|3672537|B1|||Age||year|Mean|37.3|37.3|Standard Deviation|13.4|13.4|||
3847214|NCT01662362|3672588|B1|United States||Region of Enrollment||participants|Number|63|63.0||||||
3847215|NCT01662362|3672588|B1|Unknown||Sex/Gender, Customized||participants|Number|44|44.0||||||
3847216|NCT01662362|3672588|B1|Female||Sex/Gender, Customized||participants|Number|10|10.0||||||
3847217|NCT01662362|3672588|B1|Male||Sex/Gender, Customized||participants|Number|9|9.0||||||
3847218|NCT01662362|3672588|B1|Unknown||Age, Customized|Routine whole blood donors|participants|Number|44|44.0||||||
3847219|NCT01662362|3672588|B1|>= 18 years||Age, Customized|Routine whole blood donors|participants|Number|19|19.0||||||
3847220|NCT01662336|3672593|B1|||Coping Self-Efficacy Scale|Coping self-efficacy was measured by the Coping Self-Efficacy Scale (CSE), a 26-item questionnaire that measures perceived self-efficacy in coping with daily psychological challenges. A summative score ranging from 0 to 260 was calculated, with higher scores indicating higher coping self-efficacy.|units on a scale|Mean|187.0|187.0|Standard Deviation|42.6|42.6|||
3847221|NCT01662336|3672593|B1|||Psychological Well-being|Psychological well-being was measured by the Center for Epidemiologic Studies Depression scale (CES-D), a 20-item questionnaire assessing the presence of depressive state during the previous week. The possible range of scores is 0 to 60, with higher scores indicating the presence of more symptomatology.|units on a scale|Mean|18.4|18.4|Standard Deviation|11.6|11.6|||
3847222|NCT01662336|3672593|B1|||Patient Perception of Stress|Perception of stress was measured by the Perceived Stress Scale (PSS), a 10-item questionnaire that assesses the degree to which the participant considered situations as stressful. The PSS score ranges from 0 to 40, with higher scores indicating higher levels of perceived stress.|units on a scale|Mean|16.3|16.3|Standard Deviation|7.5|7.5|||
3847290|NCT01662102|3672704|B1|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
3847291|NCT01662102|3672702|B3|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
3847292|NCT01662102|3672704|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
3847293|NCT01662102|3672702|B3|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
3847294|NCT01662102|3672704|B1|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
3847223|NCT01662336|3672593|B1|Energy/ Fatigue||Health Status Assessment (HSA)|Quality of life (QoL) was measured by the QoL 601-2 survey, the Health Status Assessment (HSA), a brief, comprehensive measure of health-related QoL used extensively in patients with human immunodeficiency virus / acquired immune deficiency syndrome (HIV/AIDS). The survey includes 21 items assessing 8 domains of health-related QoL including physical functioning, role functioning, social functioning, cognitive functioning, pain, energy / fatigue, mental health, and general health perception. Each domain score ranges from 0 to 100 with higher scores indicating higher quality of life.|units on a scale|Mean|54.8|54.8|Standard Deviation|21.6|21.6|||
3847224|NCT01662336|3672593|B1|Mental Health||Health Status Assessment (HSA)|Quality of life (QoL) was measured by the QoL 601-2 survey, the Health Status Assessment (HSA), a brief, comprehensive measure of health-related QoL used extensively in patients with human immunodeficiency virus / acquired immune deficiency syndrome (HIV/AIDS). The survey includes 21 items assessing 8 domains of health-related QoL including physical functioning, role functioning, social functioning, cognitive functioning, pain, energy / fatigue, mental health, and general health perception. Each domain score ranges from 0 to 100 with higher scores indicating higher quality of life.|units on a scale|Mean|61.3|61.3|Standard Deviation|22.6|22.6|||
3847225|NCT01662336|3672593|B1|Pain||Health Status Assessment (HSA)|Quality of life (QoL) was measured by the QoL 601-2 survey, the Health Status Assessment (HSA), a brief, comprehensive measure of health-related QoL used extensively in patients with human immunodeficiency virus / acquired immune deficiency syndrome (HIV/AIDS). The survey includes 21 items assessing 8 domains of health-related QoL including physical functioning, role functioning, social functioning, cognitive functioning, pain, energy / fatigue, mental health, and general health perception. Each domain score ranges from 0 to 100 with higher scores indicating higher quality of life.|units on a scale|Mean|64.4|64.4|Standard Deviation|24.8|24.8|||
3847226|NCT01662336|3672593|B1|Cognitive Functioning||Health Status Assessment (HSA)|Quality of life (QoL) was measured by the QoL 601-2 survey, the Health Status Assessment (HSA), a brief, comprehensive measure of health-related QoL used extensively in patients with human immunodeficiency virus / acquired immune deficiency syndrome (HIV/AIDS). The survey includes 21 items assessing 8 domains of health-related QoL including physical functioning, role functioning, social functioning, cognitive functioning, pain, energy / fatigue, mental health, and general health perception. Each domain score ranges from 0 to 100 with higher scores indicating higher quality of life.|units on a scale|Mean|64.0|64.0|Standard Deviation|24.3|24.3|||
3847227|NCT01662336|3672593|B1|Social Functioning||Health Status Assessment (HSA)|Quality of life (QoL) was measured by the QoL 601-2 survey, the Health Status Assessment (HSA), a brief, comprehensive measure of health-related QoL used extensively in patients with human immunodeficiency virus / acquired immune deficiency syndrome (HIV/AIDS). The survey includes 21 items assessing 8 domains of health-related QoL including physical functioning, role functioning, social functioning, cognitive functioning, pain, energy / fatigue, mental health, and general health perception. Each domain score ranges from 0 to 100 with higher scores indicating higher quality of life.|units on a scale|Mean|67.8|67.8|Standard Deviation|26.4|26.4|||
3847228|NCT01662336|3672593|B1|Role Functioning||Health Status Assessment (HSA)|Quality of life (QoL) was measured by the QoL 601-2 survey, the Health Status Assessment (HSA), a brief, comprehensive measure of health-related QoL used extensively in patients with human immunodeficiency virus / acquired immune deficiency syndrome (HIV/AIDS). The survey includes 21 items assessing 8 domains of health-related QoL including physical functioning, role functioning, social functioning, cognitive functioning, pain, energy / fatigue, mental health, and general health perception. Each domain score ranges from 0 to 100 with higher scores indicating higher quality of life.|units on a scale|Mean|68.3|68.3|Standard Deviation|29.5|29.5|||
3847229|NCT01662336|3672593|B1|Physical Functioning||Health Status Assessment (HSA)|Quality of life (QoL) was measured by the QoL 601-2 survey, the Health Status Assessment (HSA), a brief, comprehensive measure of health-related QoL used extensively in patients with human immunodeficiency virus / acquired immune deficiency syndrome (HIV/AIDS). The survey includes 21 items assessing 8 domains of health-related QoL including physical functioning, role functioning, social functioning, cognitive functioning, pain, energy / fatigue, mental health, and general health perception. Each domain score ranges from 0 to 100 with higher scores indicating higher quality of life.|units on a scale|Mean|67.8|67.8|Standard Deviation|26.2|26.2|||
3847230|NCT01662336|3672593|B1|General Health Perception||Health Status Assessment (HSA)|Quality of life (QoL) was measured by the QoL 601-2 survey, the Health Status Assessment (HSA), a brief, comprehensive measure of health-related QoL used extensively in patients with human immunodeficiency virus / acquired immune deficiency syndrome (HIV/AIDS). The survey includes 21 items assessing 8 domains of health-related QoL including physical functioning, role functioning, social functioning, cognitive functioning, pain, energy / fatigue, mental health, and general health perception. Each domain score ranges from 0 to 100 with higher scores indicating higher quality of life.|units on a scale|Mean|58.2|58.2|Standard Deviation|23.2|23.2|||
3847231|NCT01662336|3672593|B1|Adherence Perseverance Subscale Score||Adherence Self-Efficacy Scale (ASES) Scores|The ASES is a 12 item tool that measures patient’s confidence to undertake treatment related activities and behaviors including medication regimen, diet and exercise. Each question is answered on a scale from 0 (cannot do at all) to 10 (certain can do). A summative score ranges from 0 to 120, with higher scores indicating higher treatment self-efficacy. The 12 items converge to two subscales measuring adherence integration and adherence perseverance. The adherence integration subscale score ranges from 0 to 90 and the adherence perseverance subscale score ranges from 0 to 30.|units on a scale|Mean|25.0|25.0|Standard Deviation|5.0|5.0|||
3847232|NCT01662336|3672593|B1|Adherence Integration Subscale Score||Adherence Self-Efficacy Scale (ASES) Scores|The ASES is a 12 item tool that measures patient’s confidence to undertake treatment related activities and behaviors including medication regimen, diet and exercise. Each question is answered on a scale from 0 (cannot do at all) to 10 (certain can do). A summative score ranges from 0 to 120, with higher scores indicating higher treatment self-efficacy. The 12 items converge to two subscales measuring adherence integration and adherence perseverance. The adherence integration subscale score ranges from 0 to 90 and the adherence perseverance subscale score ranges from 0 to 30.|units on a scale|Mean|77.1|77.1|Standard Deviation|13.2|13.2|||
3847295|NCT01662102|3672702|B3|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
3847296|NCT01662102|3672704|B1|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
3847233|NCT01662336|3672593|B1|Adherence Summative Score||Adherence Self-Efficacy Scale (ASES) Scores|The ASES is a 12 item tool that measures patient’s confidence to undertake treatment related activities and behaviors including medication regimen, diet and exercise. Each question is answered on a scale from 0 (cannot do at all) to 10 (certain can do). A summative score ranges from 0 to 120, with higher scores indicating higher treatment self-efficacy. The 12 items converge to two subscales measuring adherence integration and adherence perseverance. The adherence integration subscale score ranges from 0 to 90 and the adherence perseverance subscale score ranges from 0 to 30.|units on a scale|Mean|102.5|102.5|Standard Deviation|17.3|17.3|||
3847234|NCT01662336|3672593|B1||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3847235|NCT01662336|3672593|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|130|130.0||||||
3847236|NCT01662336|3672593|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3847237|NCT01662336|3672593|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3847238|NCT01662336|3672593|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3847239|NCT01662336|3672593|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3847240|NCT01662336|3672593|B1||American Indian/ Alaska|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3847241|NCT01662336|3672593|B1||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3847242|NCT01662336|3672593|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3847243|NCT01662336|3672593|B1|||Age||years|Mean|50.7|50.7|Standard Deviation|10.0|10.0|||
3847244|NCT01662310|3672619|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3847245|NCT01662310|3672619|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3847246|NCT01662310|3672619|B1|||Age||years|Mean|31.3|31.3|Standard Deviation|10.52|10.52|||
3847247|NCT01662297|3672655|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3847248|NCT01662297|3672656|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3847249|NCT01662297|3672655|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3847250|NCT01662297|3672656|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3847251|NCT01662297|3672655|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3847252|NCT01662297|3672656|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3847253|NCT01662297|3672655|B3|||Age||years|Mean|60|60.0|Full Range|||60.0|60.0|
3847254|NCT01662297|3672656|B2|||Age||years|Mean|60|60.0|Full Range|||60.0|60.0|
3847255|NCT01662297|3672655|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3847256|NCT01662297|3672656|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3847257|NCT01662297|3672655|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3847258|NCT01662297|3672656|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3847259|NCT01662297|3672655|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3847260|NCT01662297|3672656|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3847261|NCT01662115|3672680|B4|United States||Region of Enrollment||participants|Number|4|4.0||||||
3847262|NCT01662115|3672682|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3847263|NCT01662115|3672683|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3847264|NCT01662115|3672680|B4|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3847265|NCT01662115|3672680|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3847266|NCT01662115|3672682|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3847267|NCT01662115|3672683|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3847268|NCT01662115|3672680|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3847269|NCT01662115|3672682|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3847270|NCT01662115|3672683|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3847271|NCT01662115|3672680|B4|||Age||years|Mean|62|62.0|Full Range|||48.0|76.0|
3847272|NCT01662115|3672682|B2|||Age||years|Mean|66|66.0|Full Range|||57.0|76.0|
3847273|NCT01662115|3672683|B1|||Age||years|Mean|58|58.0|Full Range|||48.0|69.0|
3847274|NCT01662115|3672680|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3847275|NCT01662115|3672682|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3847276|NCT01662115|3672683|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3847277|NCT01662115|3672680|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3847278|NCT01662115|3672682|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3847279|NCT01662115|3672683|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3847280|NCT01662115|3672680|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3847281|NCT01662115|3672682|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3847282|NCT01662115|3672683|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3847283|NCT01662102|3672702|B3|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
3847284|NCT01662102|3672704|B1|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
3847285|NCT01662102|3672702|B3|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
3847286|NCT01662102|3672704|B1|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
3847287|NCT01662102|3672702|B3|White||Race (NIH/OMB)||participants|Number|1|1.0||||||
3847288|NCT01662102|3672704|B1|White||Race (NIH/OMB)||participants|Number|1|1.0||||||
3847289|NCT01662102|3672702|B3|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
3847297|NCT01662102|3672702|B3|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
3847298|NCT01662102|3672704|B1|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
3847299|NCT01662102|3672702|B3|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|1|1.0||||||
3847300|NCT01662102|3672704|B1|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|1|1.0||||||
3847301|NCT01662102|3672702|B3|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
3847302|NCT01662102|3672704|B1|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
3847303|NCT01662102|3672702|B3|Male||Gender||participants|Number|1|1.0||||||
3847304|NCT01662102|3672704|B1|Male||Gender||participants|Number|1|1.0||||||
3847305|NCT01662102|3672702|B3|Female||Gender||participants|Number|0|0.0||||||
3847306|NCT01662102|3672704|B1|Female||Gender||participants|Number|0|0.0||||||
3847307|NCT01662102|3672702|B3|||Age||Years|Mean|49|49.0|Full Range|||49.0|49.0|
3847308|NCT01662102|3672704|B1|||Age||Years|Mean|49|49.0|Full Range|||49.0|49.0|
3847309|NCT01662102|3672702|B3|>=65 years||Age||participants|Number|0|0.0||||||
3847310|NCT01662102|3672704|B1|>=65 years||Age||participants|Number|0|0.0||||||
3847311|NCT01662102|3672702|B3|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
3847312|NCT01662102|3672704|B1|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
3847313|NCT01662102|3672702|B3|<=18 years||Age||participants|Number|0|0.0||||||
3847314|NCT01662102|3672704|B1|<=18 years||Age||participants|Number|0|0.0||||||
3847315|NCT01662063|3672711|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3847316|NCT01662063|3672712|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3847317|NCT01662063|3672713|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3847318|NCT01662063|3672711|B3||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3847319|NCT01662063|3672712|B2||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3847320|NCT01662063|3672713|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3847321|NCT01662063|3672711|B3|||Age||years|Mean|58.4|58.4|Standard Deviation|10.33|10.33|||
3847322|NCT01662063|3672712|B2|||Age||years|Mean|58.1|58.1|Standard Deviation|10.38|10.38|||
3847323|NCT01662063|3672713|B1|||Age||years|Mean|59.7|59.7|Standard Deviation|10.18|10.18|||
3847324|NCT01662024|3672794|B1|||Initial BMI (kg/m^2)||kg/m^2|Mean|33.4|33.4|Full Range|||33.1|33.7|
3847325|NCT01662024|3672794|B1|||Initial Weight (kg)||kg|Mean|90.4|90.4|Full Range|||88.4|92.4|
3847326|NCT01662024|3672794|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3847327|NCT01662024|3672794|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3847328|NCT01662024|3672794|B1|||Age||years|Mean|36.7|36.7|Full Range|||34.4|39.0|
3847329|NCT01661972|3672804|B3|United States||Region of Enrollment||Participants|Count of Participants|63|63.0||||||
3847330|NCT01661972|3672805|B2|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3847331|NCT01661972|3672806|B1|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3847332|NCT01661972|3672804|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3847333|NCT01661972|3672805|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3847334|NCT01661972|3672806|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847335|NCT01661972|3672804|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847336|NCT01661972|3672805|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847337|NCT01661972|3672806|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847338|NCT01661972|3672804|B3||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3847339|NCT01661972|3672805|B2||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3847340|NCT01661972|3672806|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3847341|NCT01661972|3672804|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3847342|NCT01661972|3672805|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3847343|NCT01661972|3672806|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3847344|NCT01661972|3672804|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3847345|NCT01661972|3672805|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3847346|NCT01661972|3672806|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847347|NCT01661972|3672804|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3847348|NCT01661972|3672805|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3847349|NCT01661972|3672806|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847350|NCT01661972|3672804|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3847351|NCT01661972|3672805|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3847352|NCT01661972|3672806|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847353|NCT01661972|3672804|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3847354|NCT01661972|3672805|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3847355|NCT01661972|3672806|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3847356|NCT01661972|3672804|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3847357|NCT01661972|3672805|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3847358|NCT01661972|3672806|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3847359|NCT01661972|3672804|B3|||Age||years|Mean|57.8|57.8|Standard Deviation|10.3|10.3|||
3847360|NCT01661972|3672805|B2|||Age||years|Mean|57.7|57.7|Standard Deviation|9.9|9.9|||
3847361|NCT01661972|3672806|B1|||Age||years|Mean|58.1|58.1|Standard Deviation|12.3|12.3|||
3847362|NCT01661933|3672817|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3847363|NCT01661933|3672817|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3847364|NCT01661933|3672817|B1|||Age||years|Mean|53|53.0|Full Range|||39.0|67.0|
3847365|NCT01661933|3672817|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3847366|NCT01661933|3672817|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3847367|NCT01661933|3672817|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3847368|NCT01661881|3672824|B1|High||MIPI at Diagnosis|The MIPI (Mantle Cell Lymphoma international prognostic index) (Hoster et al, 2008) is a risk index based on clinical characteristics (eg, LDH, white blood count, etc). Patients with higher MIPI scores tend to have a worse prognosis with frontline therapy.|Participants|Count of Participants|2|2.0||||||
3847369|NCT01661881|3672824|B1|Intermediate||MIPI at Diagnosis|The MIPI (Mantle Cell Lymphoma international prognostic index) (Hoster et al, 2008) is a risk index based on clinical characteristics (eg, LDH, white blood count, etc). Patients with higher MIPI scores tend to have a worse prognosis with frontline therapy.|Participants|Count of Participants|5|5.0||||||
3847370|NCT01661881|3672824|B1|Low||MIPI at Diagnosis|The MIPI (Mantle Cell Lymphoma international prognostic index) (Hoster et al, 2008) is a risk index based on clinical characteristics (eg, LDH, white blood count, etc). Patients with higher MIPI scores tend to have a worse prognosis with frontline therapy.|Participants|Count of Participants|16|16.0||||||
3847371|NCT01661881|3672824|B1|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3847372|NCT01661881|3672824|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3847373|NCT01661881|3672824|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3847374|NCT01661881|3672824|B1|||Age||years|Median|57|57.0|Full Range|||42.0|69.0|
3847375|NCT01661790|3672830|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3847376|NCT01661790|3672831|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3847377|NCT01661790|3672832|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3847378|NCT01661790|3672830|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3847379|NCT01661790|3672831|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3847380|NCT01661790|3672832|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3847381|NCT01661790|3672830|B3||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
3847382|NCT01661790|3672831|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3847383|NCT01661790|3672832|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3847384|NCT01661790|3672830|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3847385|NCT01661790|3672831|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3847386|NCT01661790|3672832|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3847387|NCT01661790|3672830|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3847388|NCT01661790|3672831|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3847389|NCT01661790|3672832|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3847390|NCT01661764|3672839|B7||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3847391|NCT01661764|3672840|B6||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3847392|NCT01661764|3672841|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3847393|NCT01661764|3672842|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3847394|NCT01661764|3672843|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3847395|NCT01661764|3672844|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3847396|NCT01661764|3672845|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3847397|NCT01661764|3672839|B7||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3847398|NCT01661764|3672840|B6||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3847399|NCT01661764|3672841|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3847400|NCT01661764|3672842|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3847401|NCT01661764|3672843|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3847402|NCT01661764|3672844|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3847403|NCT01661764|3672845|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3847404|NCT01661764|3672839|B7|||Age||years|Mean|59.6|59.6|Standard Deviation|8.2|8.2|||
3847405|NCT01661764|3672840|B6|||Age||years|Mean|61.6|61.6|Standard Deviation|7.6|7.6|||
3847406|NCT01661764|3672841|B5|||Age||years|Mean|60.5|60.5|Standard Deviation|9.8|9.8|||
3847407|NCT01661764|3672842|B4|||Age||years|Mean|58.9|58.9|Standard Deviation|7.4|7.4|||
3847408|NCT01661764|3672843|B3|||Age||years|Mean|59.6|59.6|Standard Deviation|9.6|9.6|||
3847409|NCT01661764|3672844|B2|||Age||years|Mean|60|60.0|Standard Deviation|8.3|8.3|||
3847410|NCT01661764|3672845|B1|||Age||years|Mean|58.0|58.0|Standard Deviation|6.7|6.7|||
3847411|NCT01661712|3672912|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3847412|NCT01661712|3672913|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3847413|NCT01661712|3672914|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3847414|NCT01661712|3672912|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3847415|NCT01661712|3672913|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3847416|NCT01661712|3672914|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3847417|NCT01661712|3672912|B3|||Age||years|Mean|50.8|50.8|Standard Deviation|11.2|11.2|||
3847418|NCT01661712|3672913|B2|||Age||years|Mean|50.6|50.6|Standard Deviation|11|11.0|||
3847419|NCT01661712|3672914|B1|||Age||years|Mean|51.2|51.2|Standard Deviation|11.9|11.9|||
3847420|NCT01661621|3672931|B3|Taiwan||Region of Enrollment||participants|Number|395|395.0||||||
3847421|NCT01661621|3672932|B2|Taiwan||Region of Enrollment||participants|Number|279|279.0||||||
3847422|NCT01661621|3672933|B1|Taiwan||Region of Enrollment||participants|Number|116|116.0||||||
3847423|NCT01661621|3672931|B3||Male|Sex: Female, Male||Participants|Count of Participants|395|395.0||||||
3847424|NCT01661621|3672932|B2||Male|Sex: Female, Male||Participants|Count of Participants|279|279.0||||||
3847425|NCT01661621|3672933|B1||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3847426|NCT01661621|3672931|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3847427|NCT01661621|3672932|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3847428|NCT01661621|3672933|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3847429|NCT01661621|3672931|B3|||Age||years|Mean|66.4|66.4|Standard Deviation|10.8|10.8|||
3847430|NCT01661621|3672932|B2|||Age||years|Mean|65.6|65.6|Standard Deviation|10.5|10.5|||
3847431|NCT01661621|3672933|B1|||Age||years|Mean|68.4|68.4|Standard Deviation|11.3|11.3|||
3847432|NCT01661595|3672954|B5|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3847433|NCT01661595|3672955|B4|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3847434|NCT01661595|3672956|B3|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3847435|NCT01661595|3672957|B2|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3847436|NCT01661595|3672958|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3847437|NCT01661595|3672954|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3847438|NCT01661595|3672955|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3847439|NCT01661595|3672956|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3847440|NCT01661595|3672957|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3847441|NCT01661595|3672958|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3847442|NCT01661595|3672954|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3847443|NCT01661595|3672955|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3847444|NCT01661595|3672956|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3847445|NCT01661595|3672957|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3847446|NCT01661595|3672958|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3847447|NCT01661595|3672954|B5|||Age||years|Mean|54.6|54.6|Standard Deviation|3.22|3.22|||
3847448|NCT01661595|3672955|B4|||Age||years|Mean|57.25|57.25|Standard Deviation|2.99|2.99|||
3847449|NCT01661595|3672956|B3|||Age||years|Mean|52.4|52.4|Standard Deviation|1.51|1.51|||
3847450|NCT01661595|3672957|B2|||Age||years|Mean|56|56.0|Standard Deviation|1.41|1.41|||
3847451|NCT01661595|3672958|B1|||Age||years|Mean|53.6|53.6|Standard Deviation|4.16|4.16|||
3847452|NCT01661270|3673066|B3||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
3847453|NCT01661270|3673067|B2||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3847454|NCT01661270|3673068|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3847455|NCT01661270|3673066|B3||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3847456|NCT01661270|3673067|B2||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3847457|NCT01661270|3673068|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3847458|NCT01661270|3673066|B3|||Age||years|Mean|54.4|54.4|Standard Deviation|11.0|11.0|||
3847459|NCT01661270|3673067|B2|||Age||years|Mean|55.1|55.1|Standard Deviation|10.9|10.9|||
3847460|NCT01661270|3673068|B1|||Age||years|Mean|53.0|53.0|Standard Deviation|11.3|11.3|||
3847461|NCT01661205|3673080|B1|||Body Mass Index (BMI)||kg/m2|Mean|30.8|30.8|Standard Deviation|3.9|3.9|||
3847462|NCT01661205|3673080|B1|||Weight||Lbs.|Mean|220.9|220.9|Standard Deviation|35.8|35.8|||
3847463|NCT01661205|3673080|B1|||Height||inches|Mean|71.0|71.0|Standard Deviation|3.9|3.9|||
3847464|NCT01661205|3673080|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3847465|NCT01661205|3673080|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847466|NCT01661205|3673080|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3847467|NCT01661205|3673080|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3847468|NCT01661205|3673080|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847469|NCT01661205|3673080|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847470|NCT01661205|3673080|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847471|NCT01661205|3673080|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3847472|NCT01661205|3673080|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3847473|NCT01661205|3673080|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|9.5|9.5|||
3847474|NCT01661205|3673080|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3847475|NCT01661205|3673080|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3847476|NCT01661205|3673080|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3847477|NCT01661179|3673091|B1|Asian||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3847478|NCT01661179|3673091|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3847479|NCT01661179|3673091|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3847480|NCT01661179|3673091|B1|>=65 years||Age, Customized||Participants|Number|1|1.0||||||
3847481|NCT01661179|3673091|B1|>=50 - <65 years||Age, Customized||Participants|Number|7|7.0||||||
3847482|NCT01661179|3673091|B1|>=20 - <50 years||Age, Customized||Participants|Number|6|6.0||||||
3847483|NCT01661179|3673091|B1|||Age||Years|Mean|52.6|52.6|Standard Deviation|10.21|10.21|37.0|71.0|
3847484|NCT01661140|3673095|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3847485|NCT01661140|3673095|B1||Female|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
3847486|NCT01661140|3673095|B1|||Age||years|Mean|55.0|55.0|Standard Deviation|12.03|12.03|||
3847487|NCT01661114|3673138|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3847488|NCT01661114|3673138|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3847489|NCT01661114|3673138|B1|||Age||years|Mean|61|61.0|Full Range|||25.0|80.0|
3847490|NCT01661088|3673143|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847491|NCT01661088|3673143|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3847492|NCT01661088|3673143|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3847493|NCT01661088|3673143|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3847494|NCT01661088|3673143|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3847495|NCT01661088|3673143|B1|||Age||years|Median|60|60.0|Full Range|||46.0|77.0|
3847496|NCT01661062|3673149|B1|||Pre-Treatment Weight||lb|Median|203|203.0|Full Range|||105.0|308.0|
3847497|NCT01661062|3673149|B1|N3||N Stage|"The N stage represents the amount of spread to nearby lymph nodes:~NX: Regional lymph nodes cannot be evaluated N0: No regional lymph node involvement N1, N2, N3: Degree of regional lymph node involvement (number and location of lymph nodes)"|participants|Number|2|2.0||||||
3847498|NCT01661062|3673149|B1|N2c||N Stage|"The N stage represents the amount of spread to nearby lymph nodes:~NX: Regional lymph nodes cannot be evaluated N0: No regional lymph node involvement N1, N2, N3: Degree of regional lymph node involvement (number and location of lymph nodes)"|participants|Number|4|4.0||||||
3847499|NCT01661062|3673149|B1|N2b||N Stage|"The N stage represents the amount of spread to nearby lymph nodes:~NX: Regional lymph nodes cannot be evaluated N0: No regional lymph node involvement N1, N2, N3: Degree of regional lymph node involvement (number and location of lymph nodes)"|participants|Number|10|10.0||||||
3847500|NCT01661062|3673149|B1|N2a||N Stage|"The N stage represents the amount of spread to nearby lymph nodes:~NX: Regional lymph nodes cannot be evaluated N0: No regional lymph node involvement N1, N2, N3: Degree of regional lymph node involvement (number and location of lymph nodes)"|participants|Number|1|1.0||||||
3847501|NCT01661062|3673149|B1|N1||N Stage|"The N stage represents the amount of spread to nearby lymph nodes:~NX: Regional lymph nodes cannot be evaluated N0: No regional lymph node involvement N1, N2, N3: Degree of regional lymph node involvement (number and location of lymph nodes)"|participants|Number|0|0.0||||||
3847502|NCT01661062|3673149|B1|N0||N Stage|"The N stage represents the amount of spread to nearby lymph nodes:~NX: Regional lymph nodes cannot be evaluated N0: No regional lymph node involvement N1, N2, N3: Degree of regional lymph node involvement (number and location of lymph nodes)"|participants|Number|1|1.0||||||
3847503|NCT01661062|3673149|B1|T4||T Stage|"The T stage represents the size and stage of the primary tumor:~TX: Primary tumor cannot be evaluated T0: No evidence of primary tumor Tis: Carcinoma in situ (CIS; abnormal cells are present but have not spread to neighboring tissue; although not cancer, CIS may become cancer and is sometimes called preinvasive cancer) T1, T2, T3, T4: Size and/or extent of the primary tumor (higher numbers represent more extensive disease)"|participants|Number|1|1.0||||||
3847504|NCT01661062|3673149|B1|T3||T Stage|"The T stage represents the size and stage of the primary tumor:~TX: Primary tumor cannot be evaluated T0: No evidence of primary tumor Tis: Carcinoma in situ (CIS; abnormal cells are present but have not spread to neighboring tissue; although not cancer, CIS may become cancer and is sometimes called preinvasive cancer) T1, T2, T3, T4: Size and/or extent of the primary tumor (higher numbers represent more extensive disease)"|participants|Number|5|5.0||||||
3847505|NCT01661062|3673149|B1|T2||T Stage|"The T stage represents the size and stage of the primary tumor:~TX: Primary tumor cannot be evaluated T0: No evidence of primary tumor Tis: Carcinoma in situ (CIS; abnormal cells are present but have not spread to neighboring tissue; although not cancer, CIS may become cancer and is sometimes called preinvasive cancer) T1, T2, T3, T4: Size and/or extent of the primary tumor (higher numbers represent more extensive disease)"|participants|Number|10|10.0||||||
3847506|NCT01661062|3673149|B1|T1||T Stage|"The T stage represents the size and stage of the primary tumor:~TX: Primary tumor cannot be evaluated T0: No evidence of primary tumor Tis: Carcinoma in situ (CIS; abnormal cells are present but have not spread to neighboring tissue; although not cancer, CIS may become cancer and is sometimes called preinvasive cancer) T1, T2, T3, T4: Size and/or extent of the primary tumor (higher numbers represent more extensive disease)"|participants|Number|2|2.0||||||
3847507|NCT01661062|3673149|B1|Tonsil||Disease Site|Location of the disease at baseline.|participants|Number|9|9.0||||||
3847508|NCT01661062|3673149|B1|Base of Tongue||Disease Site|Location of the disease at baseline.|participants|Number|9|9.0||||||
3847509|NCT01661062|3673149|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3847510|NCT01661062|3673149|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3847511|NCT01661062|3673149|B1|||Age||years|Median|57|57.0|Full Range|||50.0|76.0|
3847548|NCT01660893|3673163|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3847549|NCT01660893|3673164|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847550|NCT01660893|3673165|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847551|NCT01660893|3673166|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3847512|NCT01660906|3673154|B1|Cytogenetic Test Not Performed||Best Baseline Response|"MR4.5, 4.5- log reduction in gene BCR-ABL transcript from the standardized baseline (0.0032% IS); MMR, Major Molecular Response = 3-log reduction in BCR-ABL gene transcripts from a standardized baseline; CCyR, complete cytogenetic response = criteria of 0% Philadelphia chromosome positive (Ph+) metaphases among cells in a bone marrow sample; PCyR, partial cytogenetic response = criteria of 1-35% Ph+ metaphases among cells in a bone marrow sample.~3 patients did not have cytogenetic testing performed at screening and thus baseline responses could not be classified to a response category"|Participants|Count of Participants|3|3.0||||||
3847513|NCT01660906|3673154|B1|PCyR||Best Baseline Response|"MR4.5, 4.5- log reduction in gene BCR-ABL transcript from the standardized baseline (0.0032% IS); MMR, Major Molecular Response = 3-log reduction in BCR-ABL gene transcripts from a standardized baseline; CCyR, complete cytogenetic response = criteria of 0% Philadelphia chromosome positive (Ph+) metaphases among cells in a bone marrow sample; PCyR, partial cytogenetic response = criteria of 1-35% Ph+ metaphases among cells in a bone marrow sample.~3 patients did not have cytogenetic testing performed at screening and thus baseline responses could not be classified to a response category"|Participants|Count of Participants|2|2.0||||||
3847514|NCT01660906|3673154|B1|CCyR||Best Baseline Response|"MR4.5, 4.5- log reduction in gene BCR-ABL transcript from the standardized baseline (0.0032% IS); MMR, Major Molecular Response = 3-log reduction in BCR-ABL gene transcripts from a standardized baseline; CCyR, complete cytogenetic response = criteria of 0% Philadelphia chromosome positive (Ph+) metaphases among cells in a bone marrow sample; PCyR, partial cytogenetic response = criteria of 1-35% Ph+ metaphases among cells in a bone marrow sample.~3 patients did not have cytogenetic testing performed at screening and thus baseline responses could not be classified to a response category"|Participants|Count of Participants|4|4.0||||||
3847515|NCT01660906|3673154|B1|MMR||Best Baseline Response|"MR4.5, 4.5- log reduction in gene BCR-ABL transcript from the standardized baseline (0.0032% IS); MMR, Major Molecular Response = 3-log reduction in BCR-ABL gene transcripts from a standardized baseline; CCyR, complete cytogenetic response = criteria of 0% Philadelphia chromosome positive (Ph+) metaphases among cells in a bone marrow sample; PCyR, partial cytogenetic response = criteria of 1-35% Ph+ metaphases among cells in a bone marrow sample.~3 patients did not have cytogenetic testing performed at screening and thus baseline responses could not be classified to a response category"|Participants|Count of Participants|20|20.0||||||
3847516|NCT01660906|3673154|B1|MR4.5||Best Baseline Response|"MR4.5, 4.5- log reduction in gene BCR-ABL transcript from the standardized baseline (0.0032% IS); MMR, Major Molecular Response = 3-log reduction in BCR-ABL gene transcripts from a standardized baseline; CCyR, complete cytogenetic response = criteria of 0% Philadelphia chromosome positive (Ph+) metaphases among cells in a bone marrow sample; PCyR, partial cytogenetic response = criteria of 1-35% Ph+ metaphases among cells in a bone marrow sample.~3 patients did not have cytogenetic testing performed at screening and thus baseline responses could not be classified to a response category"|Participants|Count of Participants|10|10.0||||||
3847517|NCT01660906|3673154|B1|400 milligrams||Imatinib Dose at Baseline||Participants|Count of Participants|20|20.0||||||
3847518|NCT01660906|3673154|B1|< 400 milligrams||Imatinib Dose at Baseline||Participants|Count of Participants|19|19.0||||||
3847519|NCT01660906|3673154|B1|||Median Duration of Imatinib Treatment||months|Median|51.2|51.2|Full Range|||3.1|160.4|
3847520|NCT01660906|3673154|B1|||Median Time Since CML-CP Diagnosis|CML-CP, chronic myeloid leukemia-chronic phase|months|Median|51.3|51.3|Full Range|||3.9|214.6|
3847521|NCT01660906|3673154|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3847522|NCT01660906|3673154|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3847523|NCT01660906|3673154|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3847524|NCT01660906|3673154|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3847525|NCT01660906|3673154|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3847526|NCT01660906|3673154|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3847527|NCT01660906|3673154|B1||Male|Gender||Participants|Count of Participants|21|21.0||||||
3847528|NCT01660906|3673154|B1||Female|Gender||Participants|Count of Participants|18|18.0||||||
3847529|NCT01660906|3673154|B1|>= 65 years||Age, Customized||Participants|Count of Participants|12|12.0||||||
3847530|NCT01660906|3673154|B1|< 65 years||Age, Customized||Participants|Count of Participants|27|27.0||||||
3847531|NCT01660906|3673154|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|15.13|15.13|||
3847532|NCT01660893|3673163|B4|United States||Region of Enrollment||participants|Number|26|26.0||||||
3847533|NCT01660893|3673164|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3847534|NCT01660893|3673165|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3847535|NCT01660893|3673166|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3847536|NCT01660893|3673163|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3847537|NCT01660893|3673164|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847538|NCT01660893|3673165|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3847539|NCT01660893|3673166|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847540|NCT01660893|3673163|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847541|NCT01660893|3673164|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847542|NCT01660893|3673165|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847543|NCT01660893|3673166|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847544|NCT01660893|3673163|B4||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3847545|NCT01660893|3673164|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3847546|NCT01660893|3673165|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3847547|NCT01660893|3673166|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3847552|NCT01660893|3673163|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847553|NCT01660893|3673164|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847554|NCT01660893|3673165|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847555|NCT01660893|3673166|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847556|NCT01660893|3673163|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847557|NCT01660893|3673164|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847558|NCT01660893|3673165|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847559|NCT01660893|3673166|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847560|NCT01660893|3673163|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3847561|NCT01660893|3673164|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847562|NCT01660893|3673165|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847563|NCT01660893|3673166|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3847564|NCT01660893|3673163|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847565|NCT01660893|3673164|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847566|NCT01660893|3673165|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847567|NCT01660893|3673166|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847568|NCT01660893|3673163|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3847569|NCT01660893|3673164|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3847570|NCT01660893|3673165|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3847571|NCT01660893|3673166|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3847572|NCT01660893|3673163|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3847573|NCT01660893|3673164|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847574|NCT01660893|3673165|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3847575|NCT01660893|3673166|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3847576|NCT01660893|3673163|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3847577|NCT01660893|3673164|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3847578|NCT01660893|3673165|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3847579|NCT01660893|3673166|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3847580|NCT01660893|3673163|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3847581|NCT01660893|3673164|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3847582|NCT01660893|3673165|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3847583|NCT01660893|3673166|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3847584|NCT01660893|3673163|B4|||Age||years|Mean|32.4|32.4|Standard Deviation|10.11|10.11|||
3847585|NCT01660893|3673164|B3|||Age||years|Mean|32.7|32.7|Standard Deviation|9.85|9.85|||
3847586|NCT01660893|3673165|B2|||Age||years|Mean|33.3|33.3|Standard Deviation|11.10|11.1|||
3847587|NCT01660893|3673166|B1|||Age||years|Mean|31.3|31.3|Standard Deviation|10.22|10.22|||
3847588|NCT01660815|3673215|B1|Japan||Region of Enrollment||participants|Number|7|7.0||||||
3847589|NCT01660815|3673215|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3847590|NCT01660815|3673215|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3847591|NCT01660815|3673215|B1|||Age||years|Mean|54.4|54.4|Standard Deviation|5.71|5.71|||
3847592|NCT01660802|3673220|B3||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3847593|NCT01660802|3673221|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3847594|NCT01660802|3673222|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3847595|NCT01660802|3673220|B3||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3847596|NCT01660802|3673221|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3847597|NCT01660802|3673222|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3847598|NCT01660802|3673220|B3|> 65 years||Age, Customized||Participants|Number|39|39.0||||||
3847599|NCT01660802|3673221|B2|> 65 years||Age, Customized||Participants|Number|21|21.0||||||
3847600|NCT01660802|3673222|B1|> 65 years||Age, Customized||Participants|Number|18|18.0||||||
3847601|NCT01660802|3673220|B3|45 to 65 years||Age, Customized||Participants|Number|180|180.0||||||
3847602|NCT01660802|3673221|B2|45 to 65 years||Age, Customized||Participants|Number|86|86.0||||||
3847603|NCT01660802|3673222|B1|45 to 65 years||Age, Customized||Participants|Number|94|94.0||||||
3847604|NCT01660802|3673220|B3|<45 years||Age, Customized||Participants|Number|43|43.0||||||
3847605|NCT01660802|3673221|B2|<45 years||Age, Customized||Participants|Number|25|25.0||||||
3847606|NCT01660802|3673222|B1|<45 years||Age, Customized||Participants|Number|18|18.0||||||
3847607|NCT01660763|3673235|B3|United States||Region of Enrollment||participants|Number|419|419.0||||||
3847608|NCT01660763|3673236|B2|United States||Region of Enrollment||participants|Number|104|104.0||||||
3847609|NCT01660763|3673237|B1|United States||Region of Enrollment||participants|Number|315|315.0||||||
3847610|NCT01660763|3673235|B3||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3847611|NCT01660763|3673236|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3847612|NCT01660763|3673237|B1||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3847613|NCT01660763|3673235|B3||Female|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
3847614|NCT01660763|3673236|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3847615|NCT01660763|3673237|B1||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3847616|NCT01660763|3673235|B3|||Age||years|Mean|66.2|66.2|Standard Deviation|10.7|10.7|||
3847617|NCT01660763|3673236|B2|||Age||years|Mean|65.0|65.0|Standard Deviation|10.5|10.5|||
3847618|NCT01660763|3673237|B1|||Age||years|Mean|66.6|66.6|Standard Deviation|10.8|10.8|||
3847619|NCT01660763|3673235|B3||>=65 years|Age||Participants|Count of Participants|240|240.0||||||
3847620|NCT01660763|3673236|B2||>=65 years|Age||Participants|Count of Participants|54|54.0||||||
3847621|NCT01660763|3673237|B1||>=65 years|Age||Participants|Count of Participants|186|186.0||||||
3847622|NCT01660763|3673235|B3||Between 18 and 65 years|Age||Participants|Count of Participants|179|179.0||||||
3847623|NCT01660763|3673236|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3847624|NCT01660763|3673237|B1||Between 18 and 65 years|Age||Participants|Count of Participants|129|129.0||||||
3847625|NCT01660763|3673235|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3847626|NCT01660763|3673236|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3847627|NCT01660763|3673237|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3847628|NCT01660737|3673244|B1|Germany||Region of Enrollment||participants|Number|123|123.0||||||
3847629|NCT01660737|3673244|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3847630|NCT01660737|3673244|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3847631|NCT01660737|3673244|B1|||Age||years|Mean|36.00|36.0|Standard Deviation|18.9|18.9|||
3847632|NCT01660737|3673244|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3847633|NCT01660737|3673244|B1||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
3847634|NCT01660737|3673244|B1||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
3847635|NCT01660698|3673259|B3|Switzerland||Region of Enrollment||participants|Number|20|20.0||||||
3847636|NCT01660698|3673260|B2|Switzerland||Region of Enrollment||participants|Number|10|10.0||||||
3847637|NCT01660698|3673261|B1|Switzerland||Region of Enrollment||participants|Number|10|10.0||||||
3847638|NCT01660698|3673259|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3847639|NCT01660698|3673260|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3847640|NCT01660698|3673261|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3847641|NCT01660698|3673259|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3847642|NCT01660698|3673260|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3847643|NCT01660698|3673261|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3847644|NCT01660698|3673259|B3|||Age||years|Mean|34.7|34.7|Inter-Quartile Range|||29.25|44.0|
3847645|NCT01660698|3673260|B2|||Age||years|Mean|35.5|35.5|Inter-Quartile Range|||31.5|38.0|
3847646|NCT01660698|3673261|B1|||Age||years|Mean|34|34.0|Inter-Quartile Range|||29.25|44.0|
3847647|NCT01660698|3673259|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3847648|NCT01660698|3673260|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3847649|NCT01660698|3673261|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3847650|NCT01660698|3673259|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3847651|NCT01660698|3673260|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3847652|NCT01660698|3673261|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3847653|NCT01660698|3673259|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3847654|NCT01660698|3673260|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3847655|NCT01660698|3673261|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3847656|NCT01660672|3673272|B1|Malawi||Region of Enrollment||participants|Number|7|7.0||||||
3847657|NCT01660672|3673272|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3847658|NCT01660672|3673272|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3847659|NCT01660672|3673272|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3847660|NCT01660672|3673272|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3847661|NCT01660672|3673272|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
3847662|NCT01660672|3673272|B1|||Age||months|Mean|40.8|40.8|Full Range|||27.0|71.0|
3847663|NCT01660451|3673283|B4||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3847664|NCT01660451|3673284|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3847665|NCT01660451|3673285|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3847666|NCT01660451|3673286|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3847667|NCT01660451|3673283|B4||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3847668|NCT01660451|3673284|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3847669|NCT01660451|3673285|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3847670|NCT01660451|3673286|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3847671|NCT01660451|3673283|B4|18 to 90 years||Age, Customized||Participants|Number|226|226.0||||||
3847672|NCT01660451|3673284|B3|18 to 90 years||Age, Customized||Participants|Number|142|142.0||||||
3847673|NCT01660451|3673285|B2|18 to 90 years||Age, Customized||Participants|Number|51|51.0||||||
3847674|NCT01660451|3673286|B1|18 to 90 years||Age, Customized||Participants|Number|33|33.0||||||
3847675|NCT01660412|3673316|B1|||Weight||lbs|Mean|159.9|159.9|Standard Deviation|46.1|46.1|||
3847676|NCT01660412|3673316|B1|United States||Region of Enrollment||Participants|Count of Participants|57|57.0||||||
3847677|NCT01660412|3673316|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3847678|NCT01660412|3673316|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3847679|NCT01660412|3673316|B1|||Age||years|Mean|57|57.0|Standard Deviation|13.6|13.6|||
3847680|NCT01660334|3673323|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3847681|NCT01660334|3673323|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3847682|NCT01660334|3673323|B1|>=65 years||Age, Customized||participants|Number|8|8.0||||||
3847683|NCT01660334|3673323|B1|<65 years||Age, Customized||participants|Number|4|4.0||||||
3847684|NCT01660321|3673328|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
3847685|NCT01660321|3673328|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3847686|NCT01660321|3673328|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3847687|NCT01660321|3673328|B1|||Age||years|Mean|2|2.0|Standard Deviation|0.9|0.9|||
3847688|NCT01660321|3673328|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3847689|NCT01660321|3673328|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3847690|NCT01660321|3673328|B1||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
3847691|NCT01660230|3673340|B13|Austria||Region of Enrollment||participants|Number|64|64.0||||||
3847692|NCT01660230|3673341|B12|Austria||Region of Enrollment||participants|Number|14|14.0||||||
3847693|NCT01660230|3673342|B11|Austria||Region of Enrollment||participants|Number|6|6.0||||||
3847694|NCT01660230|3673343|B10|Austria||Region of Enrollment||participants|Number|6|6.0||||||
3847695|NCT01660230|3673344|B9|Austria||Region of Enrollment||participants|Number|6|6.0||||||
3847696|NCT01660230|3673345|B8|Austria||Region of Enrollment||participants|Number|6|6.0||||||
3847697|NCT01660230|3673346|B7|Austria||Region of Enrollment||participants|Number|4|4.0||||||
3847698|NCT01660230|3673347|B6|Austria||Region of Enrollment||participants|Number|2|2.0||||||
3847699|NCT01660230|3673348|B5|Austria||Region of Enrollment||participants|Number|4|4.0||||||
3847700|NCT01660230|3673349|B4|Austria||Region of Enrollment||participants|Number|4|4.0||||||
3847701|NCT01660230|3673350|B3|Austria||Region of Enrollment||participants|Number|4|4.0||||||
3847702|NCT01660230|3673351|B2|Austria||Region of Enrollment||participants|Number|4|4.0||||||
3847703|NCT01660230|3673352|B1|Austria||Region of Enrollment||participants|Number|4|4.0||||||
3847704|NCT01660230|3673340|B13||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847705|NCT01660230|3673341|B12||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847706|NCT01660230|3673342|B11||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847707|NCT01660230|3673343|B10||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847708|NCT01660230|3673344|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847709|NCT01660230|3673345|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847710|NCT01660230|3673346|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847711|NCT01660230|3673347|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847712|NCT01660230|3673348|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847713|NCT01660230|3673349|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847714|NCT01660230|3673350|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847715|NCT01660230|3673351|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847716|NCT01660230|3673352|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847717|NCT01660230|3673340|B13||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847718|NCT01660230|3673341|B12||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847719|NCT01660230|3673342|B11||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847720|NCT01660230|3673343|B10||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847721|NCT01660230|3673344|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847722|NCT01660230|3673345|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847723|NCT01660230|3673346|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847724|NCT01660230|3673347|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847725|NCT01660230|3673348|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847726|NCT01660230|3673349|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847727|NCT01660230|3673350|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847728|NCT01660230|3673351|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847729|NCT01660230|3673352|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847730|NCT01660230|3673340|B13||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3847731|NCT01660230|3673341|B12||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3847732|NCT01660230|3673342|B11||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3847733|NCT01660230|3673343|B10||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3847734|NCT01660230|3673344|B9||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3847735|NCT01660230|3673345|B8||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3847736|NCT01660230|3673346|B7||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3847737|NCT01660230|3673347|B6||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3847738|NCT01660230|3673348|B5||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3847739|NCT01660230|3673349|B4||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3847740|NCT01660230|3673350|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3847741|NCT01660230|3673351|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3847742|NCT01660230|3673352|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3847743|NCT01660230|3673340|B13||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3847744|NCT01660230|3673341|B12||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847745|NCT01660230|3673342|B11||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847746|NCT01660230|3673343|B10||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847747|NCT01660230|3673344|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847748|NCT01660230|3673345|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847749|NCT01660230|3673346|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847750|NCT01660230|3673347|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3847751|NCT01660230|3673348|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847752|NCT01660230|3673349|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847753|NCT01660230|3673350|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847754|NCT01660230|3673351|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847755|NCT01660230|3673352|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847756|NCT01660230|3673340|B13||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847757|NCT01660230|3673341|B12||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847758|NCT01660230|3673342|B11||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847759|NCT01660230|3673343|B10||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847760|NCT01660230|3673344|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847761|NCT01660230|3673345|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847762|NCT01660230|3673346|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847763|NCT01660230|3673347|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847764|NCT01660230|3673348|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847765|NCT01660230|3673349|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847766|NCT01660230|3673350|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847767|NCT01660230|3673351|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847768|NCT01660230|3673352|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847769|NCT01660230|3673340|B13||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3847770|NCT01660230|3673341|B12||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3847771|NCT01660230|3673342|B11||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3847772|NCT01660230|3673343|B10||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847773|NCT01660230|3673344|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847774|NCT01660230|3673345|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847775|NCT01660230|3673346|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847776|NCT01660230|3673347|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847777|NCT01660230|3673348|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847778|NCT01660230|3673349|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847779|NCT01660230|3673350|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847780|NCT01660230|3673351|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847781|NCT01660230|3673352|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847782|NCT01660230|3673340|B13||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847783|NCT01660230|3673341|B12||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847784|NCT01660230|3673342|B11||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847785|NCT01660230|3673343|B10||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847786|NCT01660230|3673344|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847787|NCT01660230|3673345|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847788|NCT01660230|3673346|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847789|NCT01660230|3673347|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847790|NCT01660230|3673348|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847791|NCT01660230|3673349|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847792|NCT01660230|3673350|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847793|NCT01660230|3673351|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847794|NCT01660230|3673352|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847795|NCT01660230|3673340|B13||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3847796|NCT01660230|3673341|B12||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3847797|NCT01660230|3673342|B11||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3847798|NCT01660230|3673343|B10||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3847799|NCT01660230|3673344|B9||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3847800|NCT01660230|3673345|B8||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3847801|NCT01660230|3673346|B7||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3847802|NCT01660230|3673347|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3847803|NCT01660230|3673348|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3847804|NCT01660230|3673349|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3847805|NCT01660230|3673350|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3847806|NCT01660230|3673351|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3847807|NCT01660230|3673352|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3847808|NCT01660230|3673340|B13||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3847809|NCT01660230|3673341|B12||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3847810|NCT01660230|3673342|B11||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3847811|NCT01660230|3673343|B10||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3847812|NCT01660230|3673344|B9||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3847813|NCT01660230|3673345|B8||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3847814|NCT01660230|3673346|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3847815|NCT01660230|3673347|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3847816|NCT01660230|3673348|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3847817|NCT01660230|3673349|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3847818|NCT01660230|3673350|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3847819|NCT01660230|3673351|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3847820|NCT01660230|3673352|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3847821|NCT01660230|3673340|B13|||Age||years|Mean|27.03|27.03|Standard Deviation|7.39|7.39|||
3847822|NCT01660230|3673341|B12|||Age||years|Mean|29.14|29.14|Standard Deviation|8.08|8.08|||
3847823|NCT01660230|3673342|B11|||Age||years|Mean|25.67|25.67|Standard Deviation|5.28|5.28|||
3847824|NCT01660230|3673343|B10|||Age||years|Mean|27.50|27.5|Standard Deviation|13.00|13.0|||
3847825|NCT01660230|3673344|B9|||Age||years|Mean|24.50|24.5|Standard Deviation|3.78|3.78|||
3847826|NCT01660230|3673345|B8|||Age||years|Mean|27.00|27.0|Standard Deviation|3.58|3.58|||
3847827|NCT01660230|3673346|B7|||Age||years|Mean|23.75|23.75|Standard Deviation|2.75|2.75|||
3847828|NCT01660230|3673347|B6|||Age||years|Mean|36.00|36.0|Standard Deviation|9.90|9.9|||
3847829|NCT01660230|3673348|B5|||Age||years|Mean|28.25|28.25|Standard Deviation|10.11|10.11|||
3847830|NCT01660230|3673349|B4|||Age||years|Mean|24.00|24.0|Standard Deviation|2.58|2.58|||
3847831|NCT01660230|3673350|B3|||Age||years|Mean|23.75|23.75|Standard Deviation|2.36|2.36|||
3847832|NCT01660230|3673351|B2|||Age||years|Mean|28.50|28.5|Standard Deviation|9.26|9.26|||
3847833|NCT01660230|3673352|B1|||Age||years|Mean|27.25|27.25|Standard Deviation|10.59|10.59|||
3847834|NCT01660191|3673532|B4|||Waist Size||inches|Mean|36.12|36.12|Standard Deviation|5.33|5.33|||
3847835|NCT01660191|3673533|B3|||Waist Size||inches|Mean|34.54|34.54|Standard Deviation|5.60|5.6|||
3847836|NCT01660191|3673534|B2|||Waist Size||inches|Mean|37.45|37.45|Standard Deviation|4.20|4.2|||
3847837|NCT01660191|3673535|B1|||Waist Size||inches|Mean|36.41|36.41|Standard Deviation|5.76|5.76|||
3847838|NCT01660191|3673532|B4|United States||Region of Enrollment||participants|Number|134|134.0||||||
3847839|NCT01660191|3673533|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
3847840|NCT01660191|3673534|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
3847841|NCT01660191|3673535|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
3847842|NCT01660191|3673532|B4||Male|Gender||Participants|Count of Participants|40|40.0||||||
3847843|NCT01660191|3673533|B3||Male|Gender||Participants|Count of Participants|8|8.0||||||
3847844|NCT01660191|3673534|B2||Male|Gender||Participants|Count of Participants|15|15.0||||||
3847845|NCT01660191|3673535|B1||Male|Gender||Participants|Count of Participants|17|17.0||||||
3847846|NCT01660191|3673532|B4||Female|Gender||Participants|Count of Participants|94|94.0||||||
3847847|NCT01660191|3673533|B3||Female|Gender||Participants|Count of Participants|36|36.0||||||
3847848|NCT01660191|3673534|B2||Female|Gender||Participants|Count of Participants|30|30.0||||||
3847849|NCT01660191|3673535|B1||Female|Gender||Participants|Count of Participants|28|28.0||||||
3847850|NCT01660191|3673532|B4|||Age||years|Mean|55.80|55.8|Standard Deviation|11.57|11.57|||
3847851|NCT01660191|3673533|B3|||Age||years|Mean|56.08|56.08|Standard Deviation|12.28|12.28|||
3847852|NCT01660191|3673534|B2|||Age||years|Mean|56.66|56.66|Standard Deviation|9.93|9.93|||
3847853|NCT01660191|3673535|B1|||Age||years|Mean|54.68|54.68|Standard Deviation|12.52|12.52|||
3847854|NCT01660022|3673560|B7|Switzerland||Region of Enrollment||participants|Number|56|56.0||||||
3847855|NCT01660022|3673561|B6|Switzerland||Region of Enrollment||participants|Number|20|20.0||||||
3847856|NCT01660022|3673562|B5|Switzerland||Region of Enrollment||participants|Number|6|6.0||||||
3847857|NCT01660022|3673563|B4|Switzerland||Region of Enrollment||participants|Number|7|7.0||||||
3847858|NCT01660022|3673564|B3|Switzerland||Region of Enrollment||participants|Number|8|8.0||||||
3847859|NCT01660022|3673565|B2|Switzerland||Region of Enrollment||participants|Number|7|7.0||||||
3847860|NCT01660022|3673566|B1|Switzerland||Region of Enrollment||participants|Number|8|8.0||||||
3847861|NCT01660022|3673560|B7||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3847862|NCT01660022|3673561|B6||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3847863|NCT01660022|3673562|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3847864|NCT01660022|3673563|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3847865|NCT01660022|3673564|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3847866|NCT01660022|3673565|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3847867|NCT01660022|3673566|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3847868|NCT01660022|3673560|B7||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3847869|NCT01660022|3673561|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3847870|NCT01660022|3673562|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3847871|NCT01660022|3673563|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3847872|NCT01660022|3673564|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3847873|NCT01660022|3673565|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3847874|NCT01660022|3673566|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3847875|NCT01660022|3673560|B7|||Age||years|Mean|36.43|36.43|Standard Deviation|8.7|8.7|||
3847876|NCT01660022|3673561|B6|||Age||years|Mean|37.3|37.3|Standard Deviation|10.3|10.3|||
3847877|NCT01660022|3673562|B5|||Age||years|Mean|35.7|35.7|Standard Deviation|11.7|11.7|||
3847878|NCT01660022|3673563|B4|||Age||years|Mean|32.1|32.1|Standard Deviation|8.4|8.4|||
3847879|NCT01660022|3673564|B3|||Age||years|Mean|35.4|35.4|Standard Deviation|10|10.0|||
3847880|NCT01660022|3673565|B2|||Age||years|Mean|41.7|41.7|Standard Deviation|7.1|7.1|||
3847881|NCT01660022|3673566|B1|||Age||years|Mean|36.0|36.0|Standard Deviation|9.4|9.4|||
3847882|NCT01659996|3673627|B4|United States||Region of Enrollment||Participants|Number|1288|1288.0||||||
3847883|NCT01659996|3673628|B3|United States||Region of Enrollment||Participants|Number|472|472.0||||||
3847884|NCT01659996|3673629|B2|United States||Region of Enrollment||Participants|Number|395|395.0||||||
3847885|NCT01659996|3673630|B1|United States||Region of Enrollment||Participants|Number|421|421.0||||||
3847886|NCT01659996|3673627|B4||Male|Sex: Female, Male||Participants|Count of Participants|666|666.0||||||
3847887|NCT01659996|3673628|B3||Male|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
3847888|NCT01659996|3673629|B2||Male|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
3847889|NCT01659996|3673630|B1||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3847890|NCT01659996|3673627|B4||Female|Sex: Female, Male||Participants|Count of Participants|622|622.0||||||
3847891|NCT01659996|3673628|B3||Female|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
3847892|NCT01659996|3673629|B2||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3847893|NCT01659996|3673630|B1||Female|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
3847894|NCT01659996|3673627|B4|||Age||Days|Mean|353.6|353.6|Standard Deviation|96.8|96.8|||
3847895|NCT01659996|3673628|B3|||Age||Days|Mean|483.9|483.9|Standard Deviation|30.3|30.3|||
3847896|NCT01659996|3673629|B2|||Age||Days|Mean|284.6|284.6|Standard Deviation|10.6|10.6|||
3847897|NCT01659996|3673630|B1|||Age||Days|Mean|284.5|284.5|Standard Deviation|10.8|10.8|||
3847898|NCT01659996|3673627|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3847899|NCT01659996|3673628|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3847900|NCT01659996|3673629|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3847901|NCT01659996|3673630|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3847902|NCT01659996|3673627|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3847903|NCT01659996|3673628|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3847904|NCT01659996|3673629|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3847905|NCT01659996|3673630|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3847906|NCT01659996|3673627|B4||<=18 years|Age||Participants|Count of Participants|1288|1288.0||||||
3847907|NCT01659996|3673628|B3||<=18 years|Age||Participants|Count of Participants|472|472.0||||||
3847908|NCT01659996|3673629|B2||<=18 years|Age||Participants|Count of Participants|395|395.0||||||
3847909|NCT01659996|3673630|B1||<=18 years|Age||Participants|Count of Participants|421|421.0||||||
3847910|NCT01659853|3673664|B1|Combination||Skin type||participants|Number|17|17.0||||||
3847911|NCT01659853|3673664|B1|Oily||Skin type||participants|Number|6|6.0||||||
3847912|NCT01659853|3673664|B1|Normal||Skin type||participants|Number|33|33.0||||||
3847913|NCT01659853|3673664|B1|Dry||Skin type||participants|Number|14|14.0||||||
3847957|NCT01659320|3673714|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3847958|NCT01659320|3673714|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3847914|NCT01659853|3673664|B1|VI||Fitzpatrick skin type|Fitzpatrick Skin Type Classification Scale I, always burns easily; never tans II, always burns easily; tans minimally and with difficulty III, burns minimally; tans gradually and uniformly (light brown) IV, burns minimally; always tans well (moderate brown) V, rarely burns; tans very easily (dark brown) VI, never burns, tans very easily (black)|participants|Number|0|0.0||||||
3847915|NCT01659853|3673664|B1|V||Fitzpatrick skin type|Fitzpatrick Skin Type Classification Scale I, always burns easily; never tans II, always burns easily; tans minimally and with difficulty III, burns minimally; tans gradually and uniformly (light brown) IV, burns minimally; always tans well (moderate brown) V, rarely burns; tans very easily (dark brown) VI, never burns, tans very easily (black)|participants|Number|1|1.0||||||
3847916|NCT01659853|3673664|B1|IV||Fitzpatrick skin type|Fitzpatrick Skin Type Classification Scale I, always burns easily; never tans II, always burns easily; tans minimally and with difficulty III, burns minimally; tans gradually and uniformly (light brown) IV, burns minimally; always tans well (moderate brown) V, rarely burns; tans very easily (dark brown) VI, never burns, tans very easily (black)|participants|Number|4|4.0||||||
3847917|NCT01659853|3673664|B1|III||Fitzpatrick skin type|Fitzpatrick Skin Type Classification Scale I, always burns easily; never tans II, always burns easily; tans minimally and with difficulty III, burns minimally; tans gradually and uniformly (light brown) IV, burns minimally; always tans well (moderate brown) V, rarely burns; tans very easily (dark brown) VI, never burns, tans very easily (black)|participants|Number|24|24.0||||||
3847918|NCT01659853|3673664|B1|II||Fitzpatrick skin type|Fitzpatrick Skin Type Classification Scale I, always burns easily; never tans II, always burns easily; tans minimally and with difficulty III, burns minimally; tans gradually and uniformly (light brown) IV, burns minimally; always tans well (moderate brown) V, rarely burns; tans very easily (dark brown) VI, never burns, tans very easily (black)|participants|Number|35|35.0||||||
3847919|NCT01659853|3673664|B1|I||Fitzpatrick skin type|Fitzpatrick Skin Type Classification Scale I, always burns easily; never tans II, always burns easily; tans minimally and with difficulty III, burns minimally; tans gradually and uniformly (light brown) IV, burns minimally; always tans well (moderate brown) V, rarely burns; tans very easily (dark brown) VI, never burns, tans very easily (black)|participants|Number|6|6.0||||||
3847920|NCT01659853|3673664|B1|United States||Region of Enrollment||participants|Number|70|70.0||||||
3847921|NCT01659853|3673664|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847922|NCT01659853|3673664|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847923|NCT01659853|3673664|B1||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3847924|NCT01659853|3673664|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847925|NCT01659853|3673664|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847926|NCT01659853|3673664|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847927|NCT01659853|3673664|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3847928|NCT01659853|3673664|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3847929|NCT01659853|3673664|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3847930|NCT01659853|3673664|B1|||Age||years|Mean|52.4|52.4|Standard Deviation|10.9|10.9|||
3847931|NCT01659853|3673664|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3847932|NCT01659853|3673664|B1||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
3847933|NCT01659853|3673664|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3847934|NCT01659736|3673673|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
3847935|NCT01659736|3673674|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3847936|NCT01659736|3673675|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3847937|NCT01659736|3673673|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3847938|NCT01659736|3673674|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3847939|NCT01659736|3673675|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3847940|NCT01659736|3673673|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3847941|NCT01659736|3673674|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3847942|NCT01659736|3673675|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3847943|NCT01659736|3673673|B3|||Age||years|Mean|44.28|44.28|Standard Deviation|13.09|13.09|||
3847944|NCT01659736|3673674|B2|||Age||years|Mean|44.58|44.58|Standard Deviation|14.75|14.75|||
3847945|NCT01659736|3673675|B1|||Age||years|Mean|44.00|44.0|Standard Deviation|11.95|11.95|||
3847946|NCT01659567|3673690|B1||Male|Sex: Female, Male||Participants|Count of Participants|454|454.0||||||
3847947|NCT01659567|3673690|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3847948|NCT01659567|3673690|B1|||Age||years|Mean|42.12|42.12|Standard Deviation|10.01|10.01|||
3847949|NCT01659554|3673707|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3847950|NCT01659554|3673707|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3847951|NCT01659554|3673707|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3847952|NCT01659554|3673707|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3847953|NCT01659554|3673707|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3847954|NCT01659554|3673707|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3847955|NCT01659320|3673714|B1|||Mini Mental State Examination (MMSE)|MMSE total scores range from 0-30. Higher scores indicate better memory functioning (no cognitive impairment). Total scores are reported with no subscales.|units on a scale|Mean|28.13|28.13|Standard Deviation|1.72|1.72|||
3847956|NCT01659320|3673714|B1|||Montgomery Asberg Depression Rating Scale (MADRS)|The Montgomery Asberg Depression Rating Scale total scores range from 0-60. Higher scores indicate greater severity of depression. Total scores are reported with no subscales.|units on a scale|Mean|24.67|24.67|Standard Deviation|4.56|4.56|||
3847959|NCT01659320|3673714|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847960|NCT01659320|3673714|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3847961|NCT01659320|3673714|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847962|NCT01659320|3673714|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847963|NCT01659320|3673714|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3847964|NCT01659320|3673714|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847965|NCT01659320|3673714|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3847966|NCT01659320|3673714|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3847967|NCT01659320|3673714|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3847968|NCT01659320|3673714|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3847969|NCT01659320|3673714|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3847970|NCT01659320|3673714|B1|||Age||years|Mean|72.13|72.13|Standard Deviation|10.22|10.22|||
3847971|NCT01659320|3673714|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3847972|NCT01659320|3673714|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3847973|NCT01659320|3673714|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3847974|NCT01659268|3673718|B3|Brazil||Region of Enrollment||participants|Number|17|17.0||||||
3847975|NCT01659268|3673719|B2|Brazil||Region of Enrollment||participants|Number|8|8.0||||||
3847976|NCT01659268|3673720|B1|Brazil||Region of Enrollment||participants|Number|9|9.0||||||
3847977|NCT01659268|3673718|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3847978|NCT01659268|3673719|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3847979|NCT01659268|3673720|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3847980|NCT01659268|3673718|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3847981|NCT01659268|3673719|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3847982|NCT01659268|3673720|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3847983|NCT01659268|3673718|B3|||Age||years|Mean|24.4|24.4|Standard Deviation|4.2|4.2|||
3847984|NCT01659268|3673719|B2|||Age||years|Mean|22.6|22.6|Standard Deviation|1.69|1.69|||
3847985|NCT01659268|3673720|B1|||Age||years|Mean|26|26.0|Standard Deviation|5.2|5.2|||
3847986|NCT01659268|3673718|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3847987|NCT01659268|3673719|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3847988|NCT01659268|3673720|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3847989|NCT01659268|3673718|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3847990|NCT01659268|3673719|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3847991|NCT01659268|3673720|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3847992|NCT01659268|3673718|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3847993|NCT01659268|3673719|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3847994|NCT01659268|3673720|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3847995|NCT01659125|3673733|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
3847996|NCT01659125|3673733|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3847997|NCT01659125|3673733|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3847998|NCT01659125|3673733|B1|||Age||years|Mean|37.08|37.08|Standard Deviation|12.57|12.57|||
3847999|NCT01659021|3673738|B3|Relapsed||Disease Status|Refractory: CLL progression < 6 months from completion of prior therapy; Relapsed: CLL progression ≥ 6 months from completion of prior therapy.|Participants|Count of Participants|132|132.0||||||
3848000|NCT01659021|3673739|B2|Relapsed||Disease Status|Refractory: CLL progression < 6 months from completion of prior therapy; Relapsed: CLL progression ≥ 6 months from completion of prior therapy.|Participants|Count of Participants|40|40.0||||||
3848001|NCT01659021|3673740|B1|Relapsed||Disease Status|Refractory: CLL progression < 6 months from completion of prior therapy; Relapsed: CLL progression ≥ 6 months from completion of prior therapy.|Participants|Count of Participants|92|92.0||||||
3848002|NCT01659021|3673738|B3|Refractory||Disease Status|Refractory: CLL progression < 6 months from completion of prior therapy; Relapsed: CLL progression ≥ 6 months from completion of prior therapy.|Participants|Count of Participants|129|129.0||||||
3848003|NCT01659021|3673739|B2|Refractory||Disease Status|Refractory: CLL progression < 6 months from completion of prior therapy; Relapsed: CLL progression ≥ 6 months from completion of prior therapy.|Participants|Count of Participants|47|47.0||||||
3848004|NCT01659021|3673740|B1|Refractory||Disease Status|Refractory: CLL progression < 6 months from completion of prior therapy; Relapsed: CLL progression ≥ 6 months from completion of prior therapy.|Participants|Count of Participants|82|82.0||||||
3848005|NCT01659021|3673738|B3||Unmutated|Immunoglobulin heavy chain variable region (IGHV) mutation status||Participants|Count of Participants|205|205.0||||||
3848006|NCT01659021|3673739|B2||Unmutated|Immunoglobulin heavy chain variable region (IGHV) mutation status||Participants|Count of Participants|68|68.0||||||
3848007|NCT01659021|3673740|B1||Unmutated|Immunoglobulin heavy chain variable region (IGHV) mutation status||Participants|Count of Participants|137|137.0||||||
3848008|NCT01659021|3673738|B3||Mutated|Immunoglobulin heavy chain variable region (IGHV) mutation status||Participants|Count of Participants|56|56.0||||||
3848009|NCT01659021|3673739|B2||Mutated|Immunoglobulin heavy chain variable region (IGHV) mutation status||Participants|Count of Participants|19|19.0||||||
3848010|NCT01659021|3673740|B1||Mutated|Immunoglobulin heavy chain variable region (IGHV) mutation status||Participants|Count of Participants|37|37.0||||||
3848011|NCT01659021|3673738|B3|Neither||17p deletion and/or TP53 mutation||Participants|Count of Participants|158|158.0||||||
3848012|NCT01659021|3673739|B2|Neither||17p deletion and/or TP53 mutation||Participants|Count of Participants|54|54.0||||||
3848013|NCT01659021|3673740|B1|Neither||17p deletion and/or TP53 mutation||Participants|Count of Participants|104|104.0||||||
3848014|NCT01659021|3673738|B3|Either||17p deletion and/or TP53 mutation||Participants|Count of Participants|103|103.0||||||
3848015|NCT01659021|3673739|B2|Either||17p deletion and/or TP53 mutation||Participants|Count of Participants|33|33.0||||||
3848016|NCT01659021|3673740|B1|Either||17p deletion and/or TP53 mutation||Participants|Count of Participants|70|70.0||||||
3848017|NCT01659021|3673738|B3|||Time Since Diagnosis||months|Mean|98.8|98.8|Standard Deviation|57.75|57.75|||
3848018|NCT01659021|3673739|B2|||Time Since Diagnosis||months|Mean|94.3|94.3|Standard Deviation|52.51|52.51|||
3848019|NCT01659021|3673740|B1|||Time Since Diagnosis||months|Mean|101.0|101.0|Standard Deviation|60.21|60.21|||
3848020|NCT01659021|3673738|B3|Spain||Region of Enrollment||participants|Number|13|13.0||||||
3848021|NCT01659021|3673739|B2|Spain||Region of Enrollment||participants|Number|5|5.0||||||
3848022|NCT01659021|3673740|B1|Spain||Region of Enrollment||participants|Number|8|8.0||||||
3848023|NCT01659021|3673738|B3|France||Region of Enrollment||participants|Number|24|24.0||||||
3848024|NCT01659021|3673739|B2|France||Region of Enrollment||participants|Number|9|9.0||||||
3848025|NCT01659021|3673740|B1|France||Region of Enrollment||participants|Number|15|15.0||||||
3848026|NCT01659021|3673738|B3|Australia||Region of Enrollment||participants|Number|29|29.0||||||
3848027|NCT01659021|3673739|B2|Australia||Region of Enrollment||participants|Number|13|13.0||||||
3848028|NCT01659021|3673740|B1|Australia||Region of Enrollment||participants|Number|16|16.0||||||
3848029|NCT01659021|3673738|B3|United Kingdom||Region of Enrollment||participants|Number|17|17.0||||||
3848030|NCT01659021|3673739|B2|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3848031|NCT01659021|3673740|B1|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
3848032|NCT01659021|3673738|B3|Poland||Region of Enrollment||participants|Number|36|36.0||||||
3848033|NCT01659021|3673739|B2|Poland||Region of Enrollment||participants|Number|9|9.0||||||
3848034|NCT01659021|3673740|B1|Poland||Region of Enrollment||participants|Number|27|27.0||||||
3848035|NCT01659021|3673738|B3|Denmark||Region of Enrollment||participants|Number|4|4.0||||||
3848036|NCT01659021|3673739|B2|Denmark||Region of Enrollment||participants|Number|0|0.0||||||
3848037|NCT01659021|3673740|B1|Denmark||Region of Enrollment||participants|Number|4|4.0||||||
3848038|NCT01659021|3673738|B3|Ireland||Region of Enrollment||participants|Number|11|11.0||||||
3848039|NCT01659021|3673739|B2|Ireland||Region of Enrollment||participants|Number|4|4.0||||||
3848040|NCT01659021|3673740|B1|Ireland||Region of Enrollment||participants|Number|7|7.0||||||
3848041|NCT01659021|3673738|B3|United States||Region of Enrollment||participants|Number|93|93.0||||||
3848042|NCT01659021|3673739|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
3848043|NCT01659021|3673740|B1|United States||Region of Enrollment||participants|Number|64|64.0||||||
3848044|NCT01659021|3673738|B3|Belgium||Region of Enrollment||participants|Number|6|6.0||||||
3848045|NCT01659021|3673739|B2|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
3848046|NCT01659021|3673740|B1|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
3848047|NCT01659021|3673738|B3|Sweden||Region of Enrollment||participants|Number|6|6.0||||||
3848048|NCT01659021|3673739|B2|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
3848049|NCT01659021|3673740|B1|Sweden||Region of Enrollment||participants|Number|4|4.0||||||
3848050|NCT01659021|3673738|B3|Canada||Region of Enrollment||participants|Number|22|22.0||||||
3848051|NCT01659021|3673739|B2|Canada||Region of Enrollment||participants|Number|9|9.0||||||
3848052|NCT01659021|3673740|B1|Canada||Region of Enrollment||participants|Number|13|13.0||||||
3848053|NCT01659021|3673738|B3|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3848054|NCT01659021|3673739|B2|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3848055|NCT01659021|3673740|B1|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3848056|NCT01659021|3673738|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3848057|NCT01659021|3673739|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3848058|NCT01659021|3673740|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3848059|NCT01659021|3673738|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3848060|NCT01659021|3673739|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3848061|NCT01659021|3673740|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3848062|NCT01659021|3673738|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3848063|NCT01659021|3673739|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3848064|NCT01659021|3673740|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3848065|NCT01659021|3673738|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3848066|NCT01659021|3673739|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3848067|NCT01659021|3673740|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3848068|NCT01659021|3673738|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|220|220.0||||||
3848069|NCT01659021|3673739|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|71|71.0||||||
3848070|NCT01659021|3673740|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|149|149.0||||||
3848071|NCT01659021|3673738|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3848072|NCT01659021|3673739|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3848073|NCT01659021|3673740|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3848074|NCT01659021|3673738|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|215|215.0||||||
3848075|NCT01659021|3673739|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3848076|NCT01659021|3673740|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|141|141.0||||||
3848077|NCT01659021|3673738|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3848078|NCT01659021|3673739|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3848079|NCT01659021|3673740|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3848080|NCT01659021|3673738|B3||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
3848081|NCT01659021|3673739|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3848082|NCT01659021|3673740|B1||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3848083|NCT01659021|3673738|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3848084|NCT01659021|3673739|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3848085|NCT01659021|3673740|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3848086|NCT01659021|3673738|B3|||Age||years|Mean|67|67.0|Standard Deviation|9.2|9.2|||
3848087|NCT01659021|3673739|B2|||Age||years|Mean|67|67.0|Standard Deviation|9.7|9.7|||
3848088|NCT01659021|3673740|B1|||Age||years|Mean|67|67.0|Standard Deviation|9.0|9.0|||
3848089|NCT01658943|3673757|B3|No||Liver Metastasis||participants|Number|38|38.0||||||
3848090|NCT01658943|3673758|B2|No||Liver Metastasis||participants|Number|15|15.0||||||
3848091|NCT01658943|3673759|B1|No||Liver Metastasis||participants|Number|23|23.0||||||
3848092|NCT01658943|3673757|B3|Yes||Liver Metastasis||participants|Number|82|82.0||||||
3848093|NCT01658943|3673758|B2|Yes||Liver Metastasis||participants|Number|43|43.0||||||
3848094|NCT01658943|3673759|B1|Yes||Liver Metastasis||participants|Number|39|39.0||||||
3848095|NCT01658943|3673757|B3|more than 4 months||Prior Systemic Therapy||participants|Number|75|75.0||||||
3848096|NCT01658943|3673758|B2|more than 4 months||Prior Systemic Therapy||participants|Number|36|36.0||||||
3848097|NCT01658943|3673759|B1|more than 4 months||Prior Systemic Therapy||participants|Number|39|39.0||||||
3848098|NCT01658943|3673757|B3|4 months or less||Prior Systemic Therapy||participants|Number|45|45.0||||||
3848099|NCT01658943|3673758|B2|4 months or less||Prior Systemic Therapy||participants|Number|22|22.0||||||
3848100|NCT01658943|3673759|B1|4 months or less||Prior Systemic Therapy||participants|Number|23|23.0||||||
3848101|NCT01658943|3673757|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848102|NCT01658943|3673758|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848103|NCT01658943|3673759|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848104|NCT01658943|3673757|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848105|NCT01658943|3673758|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848106|NCT01658943|3673759|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848107|NCT01658943|3673757|B3||White|Race (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3848108|NCT01658943|3673758|B2||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3848109|NCT01658943|3673759|B1||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3848110|NCT01658943|3673757|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3848111|NCT01658943|3673758|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3848112|NCT01658943|3673759|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3848113|NCT01658943|3673757|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3848114|NCT01658943|3673758|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3848115|NCT01658943|3673759|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3848116|NCT01658943|3673757|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3848117|NCT01658943|3673758|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3848118|NCT01658943|3673759|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3848119|NCT01658943|3673757|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848120|NCT01658943|3673758|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848121|NCT01658943|3673759|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848122|NCT01658943|3673757|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848123|NCT01658943|3673758|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848124|NCT01658943|3673759|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848125|NCT01658943|3673757|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|116|116.0||||||
3848126|NCT01658943|3673758|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3848127|NCT01658943|3673759|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3848128|NCT01658943|3673757|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3848129|NCT01658943|3673758|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3848130|NCT01658943|3673759|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3848131|NCT01658943|3673757|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3848132|NCT01658943|3673758|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3848133|NCT01658943|3673759|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3848134|NCT01658943|3673757|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3848135|NCT01658943|3673758|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3848136|NCT01658943|3673759|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3848137|NCT01658943|3673757|B3|||Age||years|Median|67.3|67.3|Full Range|||34.2|88.0|
3848138|NCT01658943|3673758|B2|||Age||years|Median|69.4|69.4|Full Range|||54.2|88.0|
3848139|NCT01658943|3673759|B1|||Age||years|Median|65.6|65.6|Full Range|||34.2|82.8|
3848140|NCT01658904|3673772|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
3848141|NCT01658904|3673775|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3848142|NCT01658904|3673772|B4|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
3848143|NCT01658904|3673775|B1|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
3848144|NCT01658904|3673772|B4|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
3848145|NCT01658904|3673775|B1|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
3848146|NCT01658904|3673772|B4|White||Race (NIH/OMB)||participants|Number|2|2.0||||||
3848147|NCT01658904|3673775|B1|White||Race (NIH/OMB)||participants|Number|2|2.0||||||
3848148|NCT01658904|3673772|B4|Black or African American||Race (NIH/OMB)||participants|Number|1|1.0||||||
3848149|NCT01658904|3673775|B1|Black or African American||Race (NIH/OMB)||participants|Number|1|1.0||||||
3848150|NCT01658904|3673772|B4|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
3848151|NCT01658904|3673775|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
3848152|NCT01658904|3673772|B4|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
3848153|NCT01658904|3673775|B1|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
3848154|NCT01658904|3673772|B4|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
3848155|NCT01658904|3673775|B1|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
3848156|NCT01658904|3673772|B4|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
3848157|NCT01658904|3673775|B1|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
3848158|NCT01658904|3673772|B4|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|3|3.0||||||
3848159|NCT01658904|3673775|B1|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|3|3.0||||||
3848160|NCT01658904|3673772|B4|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
3848161|NCT01658904|3673775|B1|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
3848162|NCT01658904|3673772|B4|Male||Gender||participants|Number|2|2.0||||||
3848163|NCT01658904|3673775|B1|Male||Gender||participants|Number|2|2.0||||||
3848164|NCT01658904|3673772|B4|Female||Gender||participants|Number|1|1.0||||||
3848165|NCT01658904|3673775|B1|Female||Gender||participants|Number|1|1.0||||||
3848166|NCT01658904|3673772|B4|||Age||years|Mean|49.6|49.6|Standard Deviation|10.39|10.39|||
3848167|NCT01658904|3673775|B1|||Age||years|Mean|49.6|49.6|Standard Deviation|10.39|10.39|||
3848168|NCT01658904|3673772|B4|>=65 years||Age||participants|Number|0|0.0||||||
3848169|NCT01658904|3673775|B1|>=65 years||Age||participants|Number|0|0.0||||||
3848170|NCT01658904|3673772|B4|Between 18 and 65 years||Age||participants|Number|3|3.0||||||
3848171|NCT01658904|3673775|B1|Between 18 and 65 years||Age||participants|Number|3|3.0||||||
3848172|NCT01658904|3673772|B4|<=18 years||Age||participants|Number|0|0.0||||||
3848173|NCT01658904|3673775|B1|<=18 years||Age||participants|Number|0|0.0||||||
3848174|NCT01658839|3673794|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3848175|NCT01658839|3673794|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3848176|NCT01658839|3673794|B1|||Age||years|Mean|9.9|9.9|Standard Deviation|5.0|5.0|||
3848177|NCT01658813|3673803|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3848178|NCT01658813|3673803|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3848179|NCT01658813|3673803|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3848180|NCT01658813|3673803|B1|||Age||years|Median|57|57.0|Full Range|||35.0|69.0|
3848181|NCT01658735|3673811|B4|NO||Number of participants who have ever seen a physical therapist for LBP||participants|Number|56|56.0||||||
3848182|NCT01658735|3673812|B3|NO||Number of participants who have ever seen a physical therapist for LBP||participants|Number|16|16.0||||||
3848183|NCT01658735|3673813|B2|NO||Number of participants who have ever seen a physical therapist for LBP||participants|Number|18|18.0||||||
3848184|NCT01658735|3673814|B1|NO||Number of participants who have ever seen a physical therapist for LBP||participants|Number|22|22.0||||||
3848185|NCT01658735|3673811|B4|Yes||Number of participants who have ever seen a physical therapist for LBP||participants|Number|57|57.0||||||
3848186|NCT01658735|3673812|B3|Yes||Number of participants who have ever seen a physical therapist for LBP||participants|Number|22|22.0||||||
3848187|NCT01658735|3673813|B2|Yes||Number of participants who have ever seen a physical therapist for LBP||participants|Number|18|18.0||||||
3848188|NCT01658735|3673814|B1|Yes||Number of participants who have ever seen a physical therapist for LBP||participants|Number|17|17.0||||||
3848189|NCT01658735|3673811|B4|No||Number of participants that have ever smoked greater than 100 cigarettes - lifetime||participants|Number|91|91.0||||||
3848190|NCT01658735|3673812|B3|No||Number of participants that have ever smoked greater than 100 cigarettes - lifetime||participants|Number|29|29.0||||||
3848191|NCT01658735|3673813|B2|No||Number of participants that have ever smoked greater than 100 cigarettes - lifetime||participants|Number|32|32.0||||||
3848192|NCT01658735|3673814|B1|No||Number of participants that have ever smoked greater than 100 cigarettes - lifetime||participants|Number|30|30.0||||||
3848193|NCT01658735|3673811|B4|Yes||Number of participants that have ever smoked greater than 100 cigarettes - lifetime||participants|Number|22|22.0||||||
3848194|NCT01658735|3673812|B3|Yes||Number of participants that have ever smoked greater than 100 cigarettes - lifetime||participants|Number|9|9.0||||||
3848195|NCT01658735|3673813|B2|Yes||Number of participants that have ever smoked greater than 100 cigarettes - lifetime||participants|Number|4|4.0||||||
3848196|NCT01658735|3673814|B1|Yes||Number of participants that have ever smoked greater than 100 cigarettes - lifetime||participants|Number|9|9.0||||||
3848197|NCT01658735|3673811|B4|No||Participants of participants who have ever had a MRI for their current LBP||participants|Number|62|62.0||||||
3848198|NCT01658735|3673812|B3|No||Participants of participants who have ever had a MRI for their current LBP||participants|Number|21|21.0||||||
3848199|NCT01658735|3673813|B2|No||Participants of participants who have ever had a MRI for their current LBP||participants|Number|19|19.0||||||
3848200|NCT01658735|3673814|B1|No||Participants of participants who have ever had a MRI for their current LBP||participants|Number|22|22.0||||||
3848201|NCT01658735|3673811|B4|Yes||Participants of participants who have ever had a MRI for their current LBP||participants|Number|51|51.0||||||
3848202|NCT01658735|3673812|B3|Yes||Participants of participants who have ever had a MRI for their current LBP||participants|Number|17|17.0||||||
3848203|NCT01658735|3673813|B2|Yes||Participants of participants who have ever had a MRI for their current LBP||participants|Number|17|17.0||||||
3848204|NCT01658735|3673814|B1|Yes||Participants of participants who have ever had a MRI for their current LBP||participants|Number|17|17.0||||||
3848205|NCT01658735|3673811|B4|No||Number of participants who have been to a chronic pain clinic for their current LBP||participants|Number|102|102.0||||||
3848206|NCT01658735|3673812|B3|No||Number of participants who have been to a chronic pain clinic for their current LBP||participants|Number|37|37.0||||||
3848207|NCT01658735|3673813|B2|No||Number of participants who have been to a chronic pain clinic for their current LBP||participants|Number|31|31.0||||||
3848208|NCT01658735|3673814|B1|No||Number of participants who have been to a chronic pain clinic for their current LBP||participants|Number|34|34.0||||||
3848209|NCT01658735|3673811|B4|Yes||Number of participants who have been to a chronic pain clinic for their current LBP||participants|Number|11|11.0||||||
3848210|NCT01658735|3673812|B3|Yes||Number of participants who have been to a chronic pain clinic for their current LBP||participants|Number|1|1.0||||||
3848211|NCT01658735|3673813|B2|Yes||Number of participants who have been to a chronic pain clinic for their current LBP||participants|Number|5|5.0||||||
3848212|NCT01658735|3673814|B1|Yes||Number of participants who have been to a chronic pain clinic for their current LBP||participants|Number|5|5.0||||||
3848213|NCT01658735|3673811|B4|No||Number of participants who have seen a Physician for their current LBP||participants|Number|35|35.0||||||
3848214|NCT01658735|3673812|B3|No||Number of participants who have seen a Physician for their current LBP||participants|Number|11|11.0||||||
3848215|NCT01658735|3673813|B2|No||Number of participants who have seen a Physician for their current LBP||participants|Number|8|8.0||||||
3848216|NCT01658735|3673814|B1|No||Number of participants who have seen a Physician for their current LBP||participants|Number|16|16.0||||||
3848217|NCT01658735|3673811|B4|Yes||Number of participants who have seen a Physician for their current LBP||participants|Number|78|78.0||||||
3848218|NCT01658735|3673812|B3|Yes||Number of participants who have seen a Physician for their current LBP||participants|Number|27|27.0||||||
3848219|NCT01658735|3673813|B2|Yes||Number of participants who have seen a Physician for their current LBP||participants|Number|28|28.0||||||
3848220|NCT01658735|3673814|B1|Yes||Number of participants who have seen a Physician for their current LBP||participants|Number|23|23.0||||||
3848221|NCT01658735|3673811|B4|No||Number of participants who have ever seen a Chiropractor for LBP||participants|Number|42|42.0||||||
3848222|NCT01658735|3673812|B3|No||Number of participants who have ever seen a Chiropractor for LBP||participants|Number|13|13.0||||||
3848223|NCT01658735|3673813|B2|No||Number of participants who have ever seen a Chiropractor for LBP||participants|Number|13|13.0||||||
3848224|NCT01658735|3673814|B1|No||Number of participants who have ever seen a Chiropractor for LBP||participants|Number|16|16.0||||||
3848225|NCT01658735|3673811|B4|Yes||Number of participants who have ever seen a Chiropractor for LBP||participants|Number|71|71.0||||||
3848226|NCT01658735|3673812|B3|Yes||Number of participants who have ever seen a Chiropractor for LBP||participants|Number|25|25.0||||||
3848227|NCT01658735|3673813|B2|Yes||Number of participants who have ever seen a Chiropractor for LBP||participants|Number|23|23.0||||||
3848228|NCT01658735|3673814|B1|Yes||Number of participants who have ever seen a Chiropractor for LBP||participants|Number|23|23.0||||||
3848229|NCT01658735|3673811|B4|No||Number of participants currently working at enrollment||participants|Number|25|25.0||||||
3848230|NCT01658735|3673812|B3|No||Number of participants currently working at enrollment||participants|Number|7|7.0||||||
3848231|NCT01658735|3673813|B2|No||Number of participants currently working at enrollment||participants|Number|8|8.0||||||
3848232|NCT01658735|3673814|B1|No||Number of participants currently working at enrollment||participants|Number|10|10.0||||||
3848233|NCT01658735|3673811|B4|Yes||Number of participants currently working at enrollment||participants|Number|88|88.0||||||
3848234|NCT01658735|3673812|B3|Yes||Number of participants currently working at enrollment||participants|Number|31|31.0||||||
3848235|NCT01658735|3673813|B2|Yes||Number of participants currently working at enrollment||participants|Number|28|28.0||||||
3848236|NCT01658735|3673814|B1|Yes||Number of participants currently working at enrollment||participants|Number|29|29.0||||||
3848237|NCT01658735|3673811|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848238|NCT01658735|3673812|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848239|NCT01658735|3673813|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848240|NCT01658735|3673814|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848241|NCT01658735|3673811|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
3848242|NCT01658735|3673812|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3848243|NCT01658735|3673813|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3848244|NCT01658735|3673814|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3848245|NCT01658735|3673811|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3848246|NCT01658735|3673812|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3848247|NCT01658735|3673813|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848248|NCT01658735|3673814|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3848249|NCT01658735|3673811|B4||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3848250|NCT01658735|3673812|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3848251|NCT01658735|3673813|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3848252|NCT01658735|3673814|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3848253|NCT01658735|3673811|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3848254|NCT01658735|3673812|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3848255|NCT01658735|3673813|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3848256|NCT01658735|3673814|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3848257|NCT01658735|3673811|B4|||Age||years|Mean|47.6|47.6|Standard Deviation|11.9|11.9|||
3848258|NCT01658735|3673812|B3|||Age||years|Mean|45.5|45.5|Standard Deviation|12.0|12.0|||
3848259|NCT01658735|3673813|B2|||Age||years|Mean|48.5|48.5|Standard Deviation|11.5|11.5|||
3848260|NCT01658735|3673814|B1|||Age||years|Mean|48.8|48.8|Standard Deviation|12.1|12.1|||
3848261|NCT01658657|3673845|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
3848262|NCT01658657|3673846|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3848263|NCT01658657|3673847|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3848264|NCT01658657|3673845|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3848265|NCT01658657|3673846|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3848266|NCT01658657|3673847|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3848267|NCT01658657|3673845|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3848268|NCT01658657|3673846|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3848269|NCT01658657|3673847|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3848270|NCT01658657|3673845|B3|||Age||years|Mean|47|47.0|Full Range|||27.0|67.0|
3848271|NCT01658657|3673846|B2|||Age||years|Mean|46.7|46.7|Full Range|||27.0|67.0|
3848272|NCT01658657|3673847|B1|||Age||years|Mean|47.6|47.6|Full Range|||35.0|59.0|
3848273|NCT01658579|3673854|B5|||Total Insulin Daily Dose|Number of participants analyzed for this baseline characteristics = 13, 13, 13, 13 for each reporting group, respectively.|U/kg|Mean|0.603|0.603|Standard Deviation|0.193|0.193|||
3848274|NCT01658579|3673855|B4|||Total Insulin Daily Dose|Number of participants analyzed for this baseline characteristics = 13, 13, 13, 13 for each reporting group, respectively.|U/kg|Mean|0.513|0.513|Standard Deviation|0.115|0.115|||
3848275|NCT01658579|3673856|B3|||Total Insulin Daily Dose|Number of participants analyzed for this baseline characteristics = 13, 13, 13, 13 for each reporting group, respectively.|U/kg|Mean|0.677|0.677|Standard Deviation|0.204|0.204|||
3848276|NCT01658579|3673857|B2|||Total Insulin Daily Dose|Number of participants analyzed for this baseline characteristics = 13, 13, 13, 13 for each reporting group, respectively.|U/kg|Mean|0.620|0.62|Standard Deviation|0.179|0.179|||
3848277|NCT01658579|3673858|B1|||Total Insulin Daily Dose|Number of participants analyzed for this baseline characteristics = 13, 13, 13, 13 for each reporting group, respectively.|U/kg|Mean|0.600|0.6|Standard Deviation|0.237|0.237|||
3848278|NCT01658579|3673854|B5|||Basal Insulin Daily Dose|Number of participants analyzed for this baseline characteristics =15, 14, 15, and 13 for each reporting group, respectively.|units per kilogram (U/kg)|Mean|0.301|0.301|Standard Deviation|0.087|0.087|||
3848279|NCT01658579|3673855|B4|||Basal Insulin Daily Dose|Number of participants analyzed for this baseline characteristics =15, 14, 15, and 13 for each reporting group, respectively.|units per kilogram (U/kg)|Mean|0.267|0.267|Standard Deviation|0.055|0.055|||
3848280|NCT01658579|3673856|B3|||Basal Insulin Daily Dose|Number of participants analyzed for this baseline characteristics =15, 14, 15, and 13 for each reporting group, respectively.|units per kilogram (U/kg)|Mean|0.341|0.341|Standard Deviation|0.100|0.1|||
3848281|NCT01658579|3673857|B2|||Basal Insulin Daily Dose|Number of participants analyzed for this baseline characteristics =15, 14, 15, and 13 for each reporting group, respectively.|units per kilogram (U/kg)|Mean|0.283|0.283|Standard Deviation|0.088|0.088|||
3848282|NCT01658579|3673858|B1|||Basal Insulin Daily Dose|Number of participants analyzed for this baseline characteristics =15, 14, 15, and 13 for each reporting group, respectively.|units per kilogram (U/kg)|Mean|0.309|0.309|Standard Deviation|0.086|0.086|||
3848283|NCT01658579|3673854|B5|||Duration of Diabetes||years|Median|20.7|20.7|Full Range|||2.0|54.0|
3848284|NCT01658579|3673855|B4|||Duration of Diabetes||years|Median|16.7|16.7|Full Range|||6.0|44.0|
3848285|NCT01658579|3673856|B3|||Duration of Diabetes||years|Median|20.6|20.6|Full Range|||5.0|47.0|
3848286|NCT01658579|3673857|B2|||Duration of Diabetes||years|Median|23.9|23.9|Full Range|||2.0|54.0|
3848287|NCT01658579|3673858|B1|||Duration of Diabetes||years|Median|16.8|16.8|Full Range|||3.0|48.0|
3848288|NCT01658579|3673854|B5|Greater Than or Equal to (>=) 8||Glycated Hemoglobin (HbA1c)||participants|Number|10|10.0||||||
3848289|NCT01658579|3673855|B4|Greater Than or Equal to (>=) 8||Glycated Hemoglobin (HbA1c)||participants|Number|2|2.0||||||
3848290|NCT01658579|3673856|B3|Greater Than or Equal to (>=) 8||Glycated Hemoglobin (HbA1c)||participants|Number|3|3.0||||||
3848291|NCT01658579|3673857|B2|Greater Than or Equal to (>=) 8||Glycated Hemoglobin (HbA1c)||participants|Number|1|1.0||||||
3848292|NCT01658579|3673858|B1|Greater Than or Equal to (>=) 8||Glycated Hemoglobin (HbA1c)||participants|Number|4|4.0||||||
3848293|NCT01658579|3673854|B5|Less Than (<) 8||Glycated Hemoglobin (HbA1c)||participants|Number|49|49.0||||||
3848294|NCT01658579|3673855|B4|Less Than (<) 8||Glycated Hemoglobin (HbA1c)||participants|Number|12|12.0||||||
3848295|NCT01658579|3673856|B3|Less Than (<) 8||Glycated Hemoglobin (HbA1c)||participants|Number|12|12.0||||||
3848296|NCT01658579|3673857|B2|Less Than (<) 8||Glycated Hemoglobin (HbA1c)||participants|Number|14|14.0||||||
3848297|NCT01658579|3673858|B1|Less Than (<) 8||Glycated Hemoglobin (HbA1c)||participants|Number|11|11.0||||||
3848298|NCT01658579|3673854|B5|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|27.3|27.3|Standard Deviation|5.3|5.3|||
3848299|NCT01658579|3673855|B4|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|26.1|26.1|Standard Deviation|5.1|5.1|||
3848300|NCT01658579|3673856|B3|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|28.3|28.3|Standard Deviation|6.2|6.2|||
3848301|NCT01658579|3673857|B2|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|27.4|27.4|Standard Deviation|5.0|5.0|||
3848302|NCT01658579|3673858|B1|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|27.5|27.5|Standard Deviation|4.9|4.9|||
3848303|NCT01658579|3673854|B5||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3848304|NCT01658579|3673855|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3848305|NCT01658579|3673856|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3848306|NCT01658579|3673857|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3848307|NCT01658579|3673858|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3848308|NCT01658579|3673854|B5||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3848309|NCT01658579|3673855|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3848310|NCT01658579|3673856|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3848311|NCT01658579|3673857|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3848312|NCT01658579|3673858|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3848313|NCT01658579|3673854|B5|||Age||years|Mean|44.2|44.2|Standard Deviation|14.3|14.3|||
3848314|NCT01658579|3673855|B4|||Age||years|Mean|47.6|47.6|Standard Deviation|14.1|14.1|||
3848315|NCT01658579|3673856|B3|||Age||years|Mean|39.7|39.7|Standard Deviation|12.5|12.5|||
3848316|NCT01658579|3673857|B2|||Age||years|Mean|46.2|46.2|Standard Deviation|15.9|15.9|||
3848317|NCT01658579|3673858|B1|||Age||years|Mean|43.6|43.6|Standard Deviation|14.6|14.6|||
3848318|NCT01658514|3673885|B5|||BMI||kg/m²|Mean|31.9|31.9|Standard Deviation|3.75|3.75|||
3848319|NCT01658514|3673886|B4|||BMI||kg/m²|Mean|33.3|33.3|Standard Deviation|4.09|4.09|||
3848320|NCT01658514|3673887|B3|||BMI||kg/m²|Mean|30.4|30.4|Standard Deviation|3.33|3.33|||
3848321|NCT01658514|3673888|B2|||BMI||kg/m²|Mean|31.8|31.8|Standard Deviation|3.79|3.79|||
3848322|NCT01658514|3673889|B1|||BMI||kg/m²|Mean|32.8|32.8|Standard Deviation|3.81|3.81|||
3848323|NCT01658514|3673885|B5|||Body Weight||kg|Mean|95.7|95.7|Standard Deviation|13.73|13.73|||
3848324|NCT01658514|3673886|B4|||Body Weight||kg|Mean|99.8|99.8|Standard Deviation|10.69|10.69|||
3848325|NCT01658514|3673887|B3|||Body Weight||kg|Mean|94.2|94.2|Standard Deviation|14.96|14.96|||
3848326|NCT01658514|3673888|B2|||Body Weight||kg|Mean|94.9|94.9|Standard Deviation|12.06|12.06|||
3848327|NCT01658514|3673889|B1|||Body Weight||kg|Mean|94.9|94.9|Standard Deviation|18.02|18.02|||
3848328|NCT01658514|3673885|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848329|NCT01658514|3673886|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848330|NCT01658514|3673887|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848331|NCT01658514|3673888|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848332|NCT01658514|3673889|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848333|NCT01658514|3673885|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848334|NCT01658514|3673886|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848335|NCT01658514|3673887|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848336|NCT01658514|3673888|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848337|NCT01658514|3673889|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848338|NCT01658514|3673885|B5||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3848339|NCT01658514|3673886|B4||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3848340|NCT01658514|3673887|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3848341|NCT01658514|3673888|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3848342|NCT01658514|3673889|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3848343|NCT01658514|3673885|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3848344|NCT01658514|3673886|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3848345|NCT01658514|3673887|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3848346|NCT01658514|3673888|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3848347|NCT01658514|3673889|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3848348|NCT01658514|3673885|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3848349|NCT01658514|3673886|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3848350|NCT01658514|3673887|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848351|NCT01658514|3673888|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848352|NCT01658514|3673889|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848353|NCT01658514|3673885|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848354|NCT01658514|3673886|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848355|NCT01658514|3673887|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848356|NCT01658514|3673888|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848357|NCT01658514|3673889|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848358|NCT01658514|3673885|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848359|NCT01658514|3673886|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848360|NCT01658514|3673887|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848361|NCT01658514|3673888|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848362|NCT01658514|3673889|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848363|NCT01658514|3673885|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848364|NCT01658514|3673886|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848365|NCT01658514|3673887|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848366|NCT01658514|3673888|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848367|NCT01658514|3673889|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848368|NCT01658514|3673885|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3848369|NCT01658514|3673886|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3848370|NCT01658514|3673887|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3848371|NCT01658514|3673888|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3848372|NCT01658514|3673889|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3848373|NCT01658514|3673885|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3848374|NCT01658514|3673886|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848375|NCT01658514|3673887|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3848376|NCT01658514|3673888|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3848377|NCT01658514|3673889|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848378|NCT01658514|3673885|B5||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3848379|NCT01658514|3673886|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3848380|NCT01658514|3673887|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3848381|NCT01658514|3673888|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3848382|NCT01658514|3673889|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3848383|NCT01658514|3673885|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3848384|NCT01658514|3673886|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3848385|NCT01658514|3673887|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3848386|NCT01658514|3673888|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3848387|NCT01658514|3673889|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3848388|NCT01658514|3673885|B5|||Age||years|Mean|65.1|65.1|Standard Deviation|9.83|9.83|||
3848389|NCT01658514|3673886|B4|||Age||years|Mean|70.5|70.5|Standard Deviation|5.50|5.5|||
3848390|NCT01658514|3673887|B3|||Age||years|Mean|72.6|72.6|Standard Deviation|3.90|3.9|||
3848391|NCT01658514|3673888|B2|||Age||years|Mean|60.8|60.8|Standard Deviation|6.62|6.62|||
3848392|NCT01658514|3673889|B1|||Age||years|Mean|54.5|54.5|Standard Deviation|11.01|11.01|||
3848393|NCT01658436|3673902|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3848394|NCT01658436|3673902|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3848395|NCT01658436|3673902|B1|||Age||Years|Mean|60.1|60.1|Standard Deviation|11.4|11.4|||
3848396|NCT01658228|3673910|B3|United States||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
3848397|NCT01658228|3673911|B2|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3848398|NCT01658228|3673912|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3848399|NCT01658228|3673910|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3848400|NCT01658228|3673911|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3848401|NCT01658228|3673912|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3848402|NCT01658228|3673910|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3848403|NCT01658228|3673911|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3848404|NCT01658228|3673912|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3848405|NCT01658228|3673910|B3|||Age||Years|Mean|69.8|69.8|Standard Deviation|8.7|8.7|||
3848406|NCT01658228|3673911|B2|||Age||Years|Mean|72.4|72.4|Standard Deviation|8.9|8.9|||
3848407|NCT01658228|3673912|B1|||Age||Years|Mean|67.1|67.1|Standard Deviation|7.7|7.7|||
3848408|NCT01658228|3673910|B3||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
3848409|NCT01658228|3673911|B2||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3848410|NCT01658228|3673912|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3848411|NCT01658228|3673910|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3848412|NCT01658228|3673911|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3848413|NCT01658228|3673912|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3848414|NCT01658228|3673910|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3848415|NCT01658228|3673911|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3848416|NCT01658228|3673912|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3848417|NCT01658150|3673923|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848418|NCT01658150|3673923|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3848419|NCT01658150|3673923|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3848420|NCT01658150|3673923|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3848421|NCT01658150|3673923|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848422|NCT01658150|3673923|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3848423|NCT01658150|3673923|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848424|NCT01658150|3673923|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848425|NCT01658150|3673923|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3848426|NCT01658150|3673923|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3848427|NCT01658150|3673923|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3848428|NCT01658150|3673923|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3848429|NCT01658150|3673923|B1|||Age||years|Mean|37.5|37.5|Standard Deviation|12.8|12.8|||
3848430|NCT01658072|3673943|B3|||Body mass index||kg/(m^2)|Mean|28.0|28.0|Standard Deviation|5.8|5.8|||
3848431|NCT01658072|3673944|B2|||Body mass index||kg/(m^2)|Mean|27.9|27.9|Standard Deviation|6.2|6.2|||
3848432|NCT01658072|3673945|B1|||Body mass index||kg/(m^2)|Mean|28.0|28.0|Standard Deviation|5.4|5.4|||
3848433|NCT01658072|3673943|B3|United States||Region of Enrollment||participants|Number|84|84.0||||||
3848434|NCT01658072|3673944|B2|United States||Region of Enrollment||participants|Number|43|43.0||||||
3848435|NCT01658072|3673945|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
3848436|NCT01658072|3673943|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3848437|NCT01658072|3673944|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3848438|NCT01658072|3673945|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3848439|NCT01658072|3673943|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3848440|NCT01658072|3673944|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3848441|NCT01658072|3673945|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3848442|NCT01658072|3673943|B3|||Age||years|Mean|64.3|64.3|Standard Deviation|7.8|7.8|||
3848443|NCT01658072|3673944|B2|||Age||years|Mean|64.8|64.8|Standard Deviation|7.1|7.1|||
3848444|NCT01658072|3673945|B1|||Age||years|Mean|63.7|63.7|Standard Deviation|8.5|8.5|||
3848445|NCT01658020|3673952|B3|Korea, Republic of||Region of Enrollment||participants|Number|342|342.0||||||
3848446|NCT01658020|3673953|B2|Korea, Republic of||Region of Enrollment||participants|Number|167|167.0||||||
3848447|NCT01658020|3673954|B1|Korea, Republic of||Region of Enrollment||participants|Number|175|175.0||||||
3848448|NCT01658020|3673952|B3||Male|Sex: Female, Male||Participants|Count of Participants|312|312.0||||||
3848449|NCT01658020|3673953|B2||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
3848450|NCT01658020|3673954|B1||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3848451|NCT01658020|3673952|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3848452|NCT01658020|3673953|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3848453|NCT01658020|3673954|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3848454|NCT01658020|3673952|B3||>=65 years|Age||Participants|Count of Participants|152|152.0||||||
3848455|NCT01658020|3673953|B2||>=65 years|Age||Participants|Count of Participants|74|74.0||||||
3848456|NCT01658020|3673954|B1||>=65 years|Age||Participants|Count of Participants|78|78.0||||||
3848457|NCT01658020|3673952|B3||Between 18 and 65 years|Age||Participants|Count of Participants|190|190.0||||||
3848458|NCT01658020|3673953|B2||Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
3848459|NCT01658020|3673954|B1||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
3848460|NCT01658020|3673952|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3848461|NCT01658020|3673953|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3848462|NCT01658020|3673954|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3848463|NCT01658020|3673952|B3|||Age||years|Mean|68.07|68.07|Standard Deviation|7.91|7.91|||
3848464|NCT01658020|3673953|B2|||Age||years|Mean|68.40|68.4|Standard Deviation|8.04|8.04|||
3848465|NCT01658020|3673954|B1|||Age||years|Mean|67.76|67.76|Standard Deviation|7.79|7.79|||
3848466|NCT01657903|3673971|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3848467|NCT01657903|3673971|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3848468|NCT01657903|3673971|B1|||Age||Years|Mean|38.7|38.7|Standard Deviation|13.77|13.77|||
3848469|NCT01657877|3673993|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3848470|NCT01657877|3673993|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3848471|NCT01657877|3673993|B1|||Age||Years|Mean|63.5|63.5|Standard Deviation|9.60|9.6|||
3848472|NCT01657799|3674010|B4||> 2.5|Graded Prognostic Assessment (GPA)|"A participant's GPA score was the sum total of each of the following prognostic factors, scored as 0, 0.5, or 1:~Age, years > 60 years, 50 - 59 years, or < 50 years)~Karnofsky Performance Status (< 70, 70 - 80, or 90 - 100)~No. of brain metastases (> 3, 2 - 3, or 1)~Extracranial metastases (present or absent) The total GPA score could range from 0 to 4 where lower scores indicate a worse prognosis."|Participants|Count of Participants|33|33.0||||||
3848473|NCT01657799|3674011|B3||> 2.5|Graded Prognostic Assessment (GPA)|"A participant's GPA score was the sum total of each of the following prognostic factors, scored as 0, 0.5, or 1:~Age, years > 60 years, 50 - 59 years, or < 50 years)~Karnofsky Performance Status (< 70, 70 - 80, or 90 - 100)~No. of brain metastases (> 3, 2 - 3, or 1)~Extracranial metastases (present or absent) The total GPA score could range from 0 to 4 where lower scores indicate a worse prognosis."|Participants|Count of Participants|10|10.0||||||
3848474|NCT01657799|3674012|B2||> 2.5|Graded Prognostic Assessment (GPA)|"A participant's GPA score was the sum total of each of the following prognostic factors, scored as 0, 0.5, or 1:~Age, years > 60 years, 50 - 59 years, or < 50 years)~Karnofsky Performance Status (< 70, 70 - 80, or 90 - 100)~No. of brain metastases (> 3, 2 - 3, or 1)~Extracranial metastases (present or absent) The total GPA score could range from 0 to 4 where lower scores indicate a worse prognosis."|Participants|Count of Participants|12|12.0||||||
3848475|NCT01657799|3674013|B1||> 2.5|Graded Prognostic Assessment (GPA)|"A participant's GPA score was the sum total of each of the following prognostic factors, scored as 0, 0.5, or 1:~Age, years > 60 years, 50 - 59 years, or < 50 years)~Karnofsky Performance Status (< 70, 70 - 80, or 90 - 100)~No. of brain metastases (> 3, 2 - 3, or 1)~Extracranial metastases (present or absent) The total GPA score could range from 0 to 4 where lower scores indicate a worse prognosis."|Participants|Count of Participants|11|11.0||||||
3848476|NCT01657799|3674010|B4||≤ 2.5|Graded Prognostic Assessment (GPA)|"A participant's GPA score was the sum total of each of the following prognostic factors, scored as 0, 0.5, or 1:~Age, years > 60 years, 50 - 59 years, or < 50 years)~Karnofsky Performance Status (< 70, 70 - 80, or 90 - 100)~No. of brain metastases (> 3, 2 - 3, or 1)~Extracranial metastases (present or absent) The total GPA score could range from 0 to 4 where lower scores indicate a worse prognosis."|Participants|Count of Participants|274|274.0||||||
3848477|NCT01657799|3674011|B3||≤ 2.5|Graded Prognostic Assessment (GPA)|"A participant's GPA score was the sum total of each of the following prognostic factors, scored as 0, 0.5, or 1:~Age, years > 60 years, 50 - 59 years, or < 50 years)~Karnofsky Performance Status (< 70, 70 - 80, or 90 - 100)~No. of brain metastases (> 3, 2 - 3, or 1)~Extracranial metastases (present or absent) The total GPA score could range from 0 to 4 where lower scores indicate a worse prognosis."|Participants|Count of Participants|92|92.0||||||
3848478|NCT01657799|3674012|B2||≤ 2.5|Graded Prognostic Assessment (GPA)|"A participant's GPA score was the sum total of each of the following prognostic factors, scored as 0, 0.5, or 1:~Age, years > 60 years, 50 - 59 years, or < 50 years)~Karnofsky Performance Status (< 70, 70 - 80, or 90 - 100)~No. of brain metastases (> 3, 2 - 3, or 1)~Extracranial metastases (present or absent) The total GPA score could range from 0 to 4 where lower scores indicate a worse prognosis."|Participants|Count of Participants|91|91.0||||||
3848479|NCT01657799|3674013|B1||≤ 2.5|Graded Prognostic Assessment (GPA)|"A participant's GPA score was the sum total of each of the following prognostic factors, scored as 0, 0.5, or 1:~Age, years > 60 years, 50 - 59 years, or < 50 years)~Karnofsky Performance Status (< 70, 70 - 80, or 90 - 100)~No. of brain metastases (> 3, 2 - 3, or 1)~Extracranial metastases (present or absent) The total GPA score could range from 0 to 4 where lower scores indicate a worse prognosis."|Participants|Count of Participants|91|91.0||||||
3848480|NCT01657799|3674010|B4|Multirace||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3848481|NCT01657799|3674011|B3|Multirace||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3848482|NCT01657799|3674012|B2|Multirace||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3848483|NCT01657799|3674013|B1|Multirace||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3848484|NCT01657799|3674010|B4|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3848485|NCT01657799|3674011|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3848486|NCT01657799|3674012|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3848487|NCT01657799|3674013|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3848488|NCT01657799|3674010|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|66|66.0||||||
3848489|NCT01657799|3674011|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3848490|NCT01657799|3674012|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3848491|NCT01657799|3674013|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3848492|NCT01657799|3674010|B4|Black||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3848493|NCT01657799|3674011|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3848494|NCT01657799|3674012|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3848495|NCT01657799|3674013|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3848496|NCT01657799|3674010|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|230|230.0||||||
3848497|NCT01657799|3674011|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|66|66.0||||||
3848498|NCT01657799|3674012|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|85|85.0||||||
3848499|NCT01657799|3674013|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|79|79.0||||||
3848500|NCT01657799|3674010|B4||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3848501|NCT01657799|3674011|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3848502|NCT01657799|3674012|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3848503|NCT01657799|3674013|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3848504|NCT01657799|3674010|B4||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3848505|NCT01657799|3674011|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3848506|NCT01657799|3674012|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3848507|NCT01657799|3674013|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3848508|NCT01657799|3674010|B4||≥ 65 years|Age, Customized||Participants|Count of Participants|102|102.0||||||
3848509|NCT01657799|3674011|B3||≥ 65 years|Age, Customized||Participants|Count of Participants|38|38.0||||||
3848510|NCT01657799|3674012|B2||≥ 65 years|Age, Customized||Participants|Count of Participants|30|30.0||||||
3848511|NCT01657799|3674013|B1||≥ 65 years|Age, Customized||Participants|Count of Participants|34|34.0||||||
3848512|NCT01657799|3674010|B4||< 65 years|Age, Customized||Participants|Count of Participants|205|205.0||||||
3848513|NCT01657799|3674011|B3||< 65 years|Age, Customized||Participants|Count of Participants|64|64.0||||||
3848514|NCT01657799|3674012|B2||< 65 years|Age, Customized||Participants|Count of Participants|73|73.0||||||
3848515|NCT01657799|3674013|B1||< 65 years|Age, Customized||Participants|Count of Participants|68|68.0||||||
3848516|NCT01657799|3674010|B4|||Age||years|Mean|60.6|60.6|Standard Deviation|9.20|9.2|||
3848517|NCT01657799|3674011|B3|||Age||years|Mean|61.8|61.8|Standard Deviation|9.08|9.08|||
3848518|NCT01657799|3674012|B2|||Age||years|Mean|59.8|59.8|Standard Deviation|8.74|8.74|||
3848519|NCT01657799|3674013|B1|||Age||years|Mean|60.0|60.0|Standard Deviation|9.71|9.71|||
3848520|NCT01657617|3674032|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3848521|NCT01657617|3674032|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848522|NCT01657617|3674032|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3848523|NCT01657617|3674032|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3848524|NCT01657617|3674032|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3848525|NCT01657617|3674032|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848526|NCT01657617|3674032|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848527|NCT01657617|3674032|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848528|NCT01657617|3674032|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3848529|NCT01657617|3674032|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3848530|NCT01657617|3674032|B1|||Age||years|Median|63|63.0|Full Range|||42.0|78.0|
3848531|NCT01657461|3674037|B3|||NIHSS|The NIHSS is a 15-item neurologic examination stroke scale used to evaluate the effect of acute cerebral infarction on the levels of consciousness, language, neglect, visual-field loss, extraocular movement, motor strength, ataxia, dysarthria, and sensory loss. NIHSS scores range from 0 – 42. A score of 0 indicates no stroke symptoms. Higher scores indicate incremental levels of neurological impairment.|Scores on a scale|Mean|16.59|16.59|Standard Deviation|4.63|4.63|||
3848532|NCT01657461|3674038|B2|||NIHSS|The NIHSS is a 15-item neurologic examination stroke scale used to evaluate the effect of acute cerebral infarction on the levels of consciousness, language, neglect, visual-field loss, extraocular movement, motor strength, ataxia, dysarthria, and sensory loss. NIHSS scores range from 0 – 42. A score of 0 indicates no stroke symptoms. Higher scores indicate incremental levels of neurological impairment.|Scores on a scale|Mean|16.49|16.49|Standard Deviation|4.60|4.6|||
3848533|NCT01657461|3674039|B1|||NIHSS|The NIHSS is a 15-item neurologic examination stroke scale used to evaluate the effect of acute cerebral infarction on the levels of consciousness, language, neglect, visual-field loss, extraocular movement, motor strength, ataxia, dysarthria, and sensory loss. NIHSS scores range from 0 – 42. A score of 0 indicates no stroke symptoms. Higher scores indicate incremental levels of neurological impairment.|Scores on a scale|Mean|16.69|16.69|Standard Deviation|4.68|4.68|||
3848534|NCT01657461|3674037|B3|Switzerland||Region of Enrollment||participants|Number|3|3.0||||||
3848535|NCT01657461|3674038|B2|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
3848536|NCT01657461|3674039|B1|Switzerland||Region of Enrollment||participants|Number|2|2.0||||||
3848537|NCT01657461|3674037|B3|Spain||Region of Enrollment||participants|Number|2|2.0||||||
3848538|NCT01657461|3674038|B2|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3848539|NCT01657461|3674039|B1|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3848540|NCT01657461|3674037|B3|Germany||Region of Enrollment||participants|Number|42|42.0||||||
3848541|NCT01657461|3674038|B2|Germany||Region of Enrollment||participants|Number|22|22.0||||||
3848542|NCT01657461|3674039|B1|Germany||Region of Enrollment||participants|Number|20|20.0||||||
3848543|NCT01657461|3674037|B3|France||Region of Enrollment||participants|Number|12|12.0||||||
3848544|NCT01657461|3674038|B2|France||Region of Enrollment||participants|Number|4|4.0||||||
3848545|NCT01657461|3674039|B1|France||Region of Enrollment||participants|Number|8|8.0||||||
3848546|NCT01657461|3674037|B3|Denmark||Region of Enrollment||participants|Number|2|2.0||||||
3848547|NCT01657461|3674038|B2|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
3848548|NCT01657461|3674039|B1|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
3848549|NCT01657461|3674037|B3|Austria||Region of Enrollment||participants|Number|2|2.0||||||
3848550|NCT01657461|3674038|B2|Austria||Region of Enrollment||participants|Number|1|1.0||||||
3848551|NCT01657461|3674039|B1|Austria||Region of Enrollment||participants|Number|1|1.0||||||
3848552|NCT01657461|3674037|B3|United States||Region of Enrollment||participants|Number|131|131.0||||||
3848553|NCT01657461|3674038|B2|United States||Region of Enrollment||participants|Number|66|66.0||||||
3848554|NCT01657461|3674039|B1|United States||Region of Enrollment||participants|Number|65|65.0||||||
3848555|NCT01657461|3674037|B3||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3848556|NCT01657461|3674038|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3848557|NCT01657461|3674039|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3848558|NCT01657461|3674037|B3||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3848559|NCT01657461|3674038|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3848560|NCT01657461|3674039|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3848561|NCT01657461|3674037|B3|||Age||years|Mean|65.64|65.64|Standard Deviation|11.89|11.89|||
3848562|NCT01657461|3674038|B2|||Age||years|Mean|66.32|66.32|Standard Deviation|11.277|11.277|||
3848563|NCT01657461|3674039|B1|||Age||years|Mean|64.99|64.99|Standard Deviation|12.49|12.49|||
3848564|NCT01657370|3674064|B7||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3848565|NCT01657370|3674065|B6||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3848566|NCT01657370|3674066|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3848567|NCT01657370|3674067|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3848568|NCT01657370|3674068|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3848569|NCT01657370|3674069|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3848570|NCT01657370|3674070|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3848571|NCT01657370|3674064|B7||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3848572|NCT01657370|3674065|B6||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3848573|NCT01657370|3674066|B5||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3848574|NCT01657370|3674067|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3848575|NCT01657370|3674068|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3848576|NCT01657370|3674069|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3848577|NCT01657370|3674070|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3848578|NCT01657370|3674064|B7|>= 65 years||Age, Customized||participants|Number|3|3.0||||||
3848579|NCT01657370|3674065|B6|>= 65 years||Age, Customized||participants|Number|0|0.0||||||
3848580|NCT01657370|3674066|B5|>= 65 years||Age, Customized||participants|Number|1|1.0||||||
3848581|NCT01657370|3674067|B4|>= 65 years||Age, Customized||participants|Number|0|0.0||||||
3848582|NCT01657370|3674068|B3|>= 65 years||Age, Customized||participants|Number|2|2.0||||||
3848583|NCT01657370|3674069|B2|>= 65 years||Age, Customized||participants|Number|0|0.0||||||
3848584|NCT01657370|3674070|B1|>= 65 years||Age, Customized||participants|Number|0|0.0||||||
3848585|NCT01657370|3674064|B7|60 to 64 years||Age, Customized||participants|Number|3|3.0||||||
3848586|NCT01657370|3674065|B6|60 to 64 years||Age, Customized||participants|Number|1|1.0||||||
3848587|NCT01657370|3674066|B5|60 to 64 years||Age, Customized||participants|Number|0|0.0||||||
3848588|NCT01657370|3674067|B4|60 to 64 years||Age, Customized||participants|Number|2|2.0||||||
3848589|NCT01657370|3674068|B3|60 to 64 years||Age, Customized||participants|Number|0|0.0||||||
3848590|NCT01657370|3674069|B2|60 to 64 years||Age, Customized||participants|Number|0|0.0||||||
3848591|NCT01657370|3674070|B1|60 to 64 years||Age, Customized||participants|Number|0|0.0||||||
3848592|NCT01657370|3674064|B7|50 to 59 years||Age, Customized||participants|Number|22|22.0||||||
3848593|NCT01657370|3674065|B6|50 to 59 years||Age, Customized||participants|Number|3|3.0||||||
3848594|NCT01657370|3674066|B5|50 to 59 years||Age, Customized||participants|Number|4|4.0||||||
3848595|NCT01657370|3674067|B4|50 to 59 years||Age, Customized||participants|Number|3|3.0||||||
3848596|NCT01657370|3674068|B3|50 to 59 years||Age, Customized||participants|Number|4|4.0||||||
3848597|NCT01657370|3674069|B2|50 to 59 years||Age, Customized||participants|Number|3|3.0||||||
3848598|NCT01657370|3674070|B1|50 to 59 years||Age, Customized||participants|Number|5|5.0||||||
3848599|NCT01657370|3674064|B7|40 to 49 years||Age, Customized||participants|Number|44|44.0||||||
3848600|NCT01657370|3674065|B6|40 to 49 years||Age, Customized||participants|Number|6|6.0||||||
3848601|NCT01657370|3674066|B5|40 to 49 years||Age, Customized||participants|Number|6|6.0||||||
3848602|NCT01657370|3674067|B4|40 to 49 years||Age, Customized||participants|Number|7|7.0||||||
3848603|NCT01657370|3674068|B3|40 to 49 years||Age, Customized||participants|Number|7|7.0||||||
3848604|NCT01657370|3674069|B2|40 to 49 years||Age, Customized||participants|Number|9|9.0||||||
3848605|NCT01657370|3674070|B1|40 to 49 years||Age, Customized||participants|Number|9|9.0||||||
3848606|NCT01657370|3674064|B7|30 to 39 years||Age, Customized||participants|Number|42|42.0||||||
3848607|NCT01657370|3674065|B6|30 to 39 years||Age, Customized||participants|Number|6|6.0||||||
3848608|NCT01657370|3674066|B5|30 to 39 years||Age, Customized||participants|Number|6|6.0||||||
3848609|NCT01657370|3674067|B4|30 to 39 years||Age, Customized||participants|Number|7|7.0||||||
3848610|NCT01657370|3674068|B3|30 to 39 years||Age, Customized||participants|Number|7|7.0||||||
3848611|NCT01657370|3674069|B2|30 to 39 years||Age, Customized||participants|Number|7|7.0||||||
3848612|NCT01657370|3674070|B1|30 to 39 years||Age, Customized||participants|Number|9|9.0||||||
3848613|NCT01657370|3674064|B7|20 to 29 years||Age, Customized||participants|Number|47|47.0||||||
3848614|NCT01657370|3674065|B6|20 to 29 years||Age, Customized||participants|Number|9|9.0||||||
3848615|NCT01657370|3674066|B5|20 to 29 years||Age, Customized||participants|Number|11|11.0||||||
3848616|NCT01657370|3674067|B4|20 to 29 years||Age, Customized||participants|Number|9|9.0||||||
3848617|NCT01657370|3674068|B3|20 to 29 years||Age, Customized||participants|Number|6|6.0||||||
3848618|NCT01657370|3674069|B2|20 to 29 years||Age, Customized||participants|Number|8|8.0||||||
3848619|NCT01657370|3674070|B1|20 to 29 years||Age, Customized||participants|Number|4|4.0||||||
3848620|NCT01657370|3674064|B7|<20 years||Age, Customized||participants|Number|4|4.0||||||
3848621|NCT01657370|3674065|B6|<20 years||Age, Customized||participants|Number|2|2.0||||||
3848622|NCT01657370|3674066|B5|<20 years||Age, Customized||participants|Number|0|0.0||||||
3848623|NCT01657370|3674067|B4|<20 years||Age, Customized||participants|Number|0|0.0||||||
3848624|NCT01657370|3674068|B3|<20 years||Age, Customized||participants|Number|0|0.0||||||
3848625|NCT01657370|3674069|B2|<20 years||Age, Customized||participants|Number|1|1.0||||||
3848626|NCT01657370|3674070|B1|<20 years||Age, Customized||participants|Number|1|1.0||||||
3848627|NCT01657305|3674157|B1|Germany||Region of Enrollment||participants|Number|34|34.0||||||
3848628|NCT01657305|3674157|B1|Bulgaria||Region of Enrollment||participants|Number|24|24.0||||||
3848629|NCT01657305|3674157|B1|Poland||Region of Enrollment||participants|Number|2|2.0||||||
3848630|NCT01657305|3674157|B1|Finland||Region of Enrollment||participants|Number|3|3.0||||||
3848631|NCT01657305|3674157|B1|Austria||Region of Enrollment||participants|Number|4|4.0||||||
3848632|NCT01657305|3674157|B1|Czech Republic||Region of Enrollment||participants|Number|40|40.0||||||
3848633|NCT01657305|3674157|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3848634|NCT01657305|3674157|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3848635|NCT01657305|3674157|B1|||Age||years|Median|56|56.0|Full Range|||18.0|86.0|
3848636|NCT01657305|3674157|B1||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
3848637|NCT01657305|3674157|B1||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
3848638|NCT01657305|3674157|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3848639|NCT01657292|3674207|B1|Germany||Region of Enrollment||participants|Number|26|26.0||||||
3848640|NCT01657292|3674207|B1|Switzerland||Region of Enrollment||participants|Number|4|4.0||||||
3848641|NCT01657292|3674207|B1|United Kingdom||Region of Enrollment||participants|Number|28|28.0||||||
3848642|NCT01657292|3674207|B1|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
3848643|NCT01657292|3674207|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3848644|NCT01657292|3674207|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3848645|NCT01657292|3674207|B1|||Age||years|Median|41|41.0|Full Range|||18.0|79.0|
3848646|NCT01657292|3674207|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3848647|NCT01657292|3674207|B1||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3848648|NCT01657292|3674207|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3848649|NCT01657266|3674214|B3|Mexico||Region of Enrollment||participants|Number|139|139.0||||||
3848650|NCT01657266|3674215|B2|Mexico||Region of Enrollment||participants|Number|70|70.0||||||
3848651|NCT01657266|3674216|B1|Mexico||Region of Enrollment||participants|Number|69|69.0||||||
3848652|NCT01657266|3674214|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848653|NCT01657266|3674215|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848654|NCT01657266|3674216|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848655|NCT01657266|3674214|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848656|NCT01657266|3674215|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848657|NCT01657266|3674216|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848658|NCT01657266|3674214|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|139|139.0||||||
3848659|NCT01657266|3674215|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3848660|NCT01657266|3674216|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3848661|NCT01657266|3674214|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3848662|NCT01657266|3674215|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3848663|NCT01657266|3674216|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3848664|NCT01657266|3674214|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3848665|NCT01657266|3674215|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3848666|NCT01657266|3674216|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3848667|NCT01657266|3674214|B3|||Age||years|Mean|67.7|67.7|Standard Deviation|10.3|10.3|||
3848668|NCT01657266|3674215|B2|||Age||years|Mean|68.0|68.0|Standard Deviation|9.5|9.5|||
3848669|NCT01657266|3674216|B1|||Age||years|Mean|67.4|67.4|Standard Deviation|11.1|11.1|||
3848670|NCT01657253|3674237|B3|Colombia||Region of Enrollment||participants|Number|29|29.0||||||
3848671|NCT01657253|3674238|B2|Colombia||Region of Enrollment||participants|Number|12|12.0||||||
3848672|NCT01657253|3674239|B1|Colombia||Region of Enrollment||participants|Number|17|17.0||||||
3848673|NCT01657253|3674237|B3|Chile||Region of Enrollment||participants|Number|32|32.0||||||
3848674|NCT01657253|3674238|B2|Chile||Region of Enrollment||participants|Number|15|15.0||||||
3848675|NCT01657253|3674239|B1|Chile||Region of Enrollment||participants|Number|17|17.0||||||
3848676|NCT01657253|3674237|B3|Mexico||Region of Enrollment||participants|Number|122|122.0||||||
3848677|NCT01657253|3674238|B2|Mexico||Region of Enrollment||participants|Number|63|63.0||||||
3848678|NCT01657253|3674239|B1|Mexico||Region of Enrollment||participants|Number|59|59.0||||||
3848679|NCT01657253|3674237|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848680|NCT01657253|3674238|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848681|NCT01657253|3674239|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848682|NCT01657253|3674237|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848683|NCT01657253|3674238|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848684|NCT01657253|3674239|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848685|NCT01657253|3674237|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|183|183.0||||||
3848686|NCT01657253|3674238|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
3848687|NCT01657253|3674239|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
3848688|NCT01657253|3674237|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3848689|NCT01657253|3674238|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3848690|NCT01657253|3674239|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3848691|NCT01657253|3674237|B3||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3848692|NCT01657253|3674238|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3848693|NCT01657253|3674239|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3848694|NCT01657253|3674237|B3|||Age||years|Mean|46.8|46.8|Standard Deviation|14.9|14.9|||
3848695|NCT01657253|3674238|B2|||Age||years|Mean|45.3|45.3|Standard Deviation|13.8|13.8|||
3848696|NCT01657253|3674239|B1|||Age||years|Mean|48.3|48.3|Standard Deviation|16.0|16.0|||
3848697|NCT01657032|3674250|B3|Poland||Region of Enrollment||participants|Number|88|88.0||||||
3848698|NCT01657032|3674251|B2|Poland||Region of Enrollment||participants|Number|44|44.0||||||
3848699|NCT01657032|3674252|B1|Poland||Region of Enrollment||participants|Number|44|44.0||||||
3848700|NCT01657032|3674250|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3848701|NCT01657032|3674251|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3848702|NCT01657032|3674252|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3848703|NCT01657032|3674250|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3848704|NCT01657032|3674251|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3848705|NCT01657032|3674252|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3848706|NCT01657032|3674250|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3848707|NCT01657032|3674251|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3848708|NCT01657032|3674252|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3848709|NCT01657032|3674250|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3848710|NCT01657032|3674251|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3848711|NCT01657032|3674252|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3848712|NCT01657032|3674250|B3||<=18 years|Age||Participants|Count of Participants|88|88.0||||||
3848713|NCT01657032|3674251|B2||<=18 years|Age||Participants|Count of Participants|44|44.0||||||
3848714|NCT01657032|3674252|B1||<=18 years|Age||Participants|Count of Participants|44|44.0||||||
3848715|NCT01657032|3674250|B3|||Age||months|Median|18|18.0|Inter-Quartile Range|||10.0|23.0|
3848716|NCT01657032|3674251|B2|||Age||months|Median|18|18.0|Inter-Quartile Range|||11.0|30.0|
3848717|NCT01657032|3674252|B1|||Age||months|Median|17.5|17.5|Inter-Quartile Range|||10.0|22.5|
3848718|NCT01657019|3674279|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3848719|NCT01657019|3674279|B1||Female|Sex: Female, Male||Participants|Count of Participants|521|521.0||||||
3848720|NCT01657019|3674279|B1|>/= 40 years||Age, Customized||participants|Number|298|298.0||||||
3848721|NCT01657019|3674279|B1|< 40 years||Age, Customized||participants|Number|301|301.0||||||
3848722|NCT01657019|3674279|B1|||Age||years|Mean|39.0|39.0|Standard Deviation|9.98|9.98|||
3848723|NCT01656967|3674291|B3|United States||Region of Enrollment||participants|Number|65|65.0||||||
3848724|NCT01656967|3674292|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
3848725|NCT01656967|3674293|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
3848726|NCT01656967|3674291|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3848727|NCT01656967|3674292|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3848728|NCT01656967|3674293|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3848729|NCT01656967|3674291|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3848730|NCT01656967|3674292|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3848731|NCT01656967|3674293|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3848732|NCT01656967|3674291|B3|||Age||years|Mean|42.1|42.1|Standard Deviation|13.7|13.7|||
3848733|NCT01656967|3674292|B2|||Age||years|Mean|44.4|44.4|Standard Deviation|13.7|13.7|||
3848734|NCT01656967|3674293|B1|||Age||years|Mean|39.8|39.8|Standard Deviation|13.7|13.7|||
3848735|NCT01656889|3674318|B3|United States||Region of Enrollment||participants|Number|399|399.0||||||
3848736|NCT01656889|3674319|B2|United States||Region of Enrollment||participants|Number|197|197.0||||||
3848737|NCT01656889|3674320|B1|United States||Region of Enrollment||participants|Number|202|202.0||||||
3848738|NCT01656889|3674318|B3|Canada||Region of Enrollment||participants|Number|22|22.0||||||
3848739|NCT01656889|3674319|B2|Canada||Region of Enrollment||participants|Number|13|13.0||||||
3848740|NCT01656889|3674320|B1|Canada||Region of Enrollment||participants|Number|9|9.0||||||
3848741|NCT01656889|3674318|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3848742|NCT01656889|3674319|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3848743|NCT01656889|3674320|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3848744|NCT01656889|3674318|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848745|NCT01656889|3674319|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848746|NCT01656889|3674320|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848747|NCT01656889|3674318|B3||White|Race (NIH/OMB)||Participants|Count of Participants|327|327.0||||||
3848748|NCT01656889|3674319|B2||White|Race (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
3848749|NCT01656889|3674320|B1||White|Race (NIH/OMB)||Participants|Count of Participants|160|160.0||||||
3848750|NCT01656889|3674318|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3848751|NCT01656889|3674319|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3848752|NCT01656889|3674320|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3848753|NCT01656889|3674318|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3848754|NCT01656889|3674319|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3848755|NCT01656889|3674320|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3848756|NCT01656889|3674318|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3848757|NCT01656889|3674319|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3848758|NCT01656889|3674320|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3848759|NCT01656889|3674318|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3848760|NCT01656889|3674319|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848761|NCT01656889|3674320|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3848762|NCT01656889|3674318|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848763|NCT01656889|3674319|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848764|NCT01656889|3674320|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3848765|NCT01656889|3674318|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|343|343.0||||||
3848766|NCT01656889|3674319|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|168|168.0||||||
3848767|NCT01656889|3674320|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|175|175.0||||||
3848768|NCT01656889|3674318|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3848769|NCT01656889|3674319|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3848770|NCT01656889|3674320|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3848771|NCT01656889|3674318|B3||Male|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
3848772|NCT01656889|3674319|B2||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3848773|NCT01656889|3674320|B1||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3848774|NCT01656889|3674318|B3||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3848775|NCT01656889|3674319|B2||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3848776|NCT01656889|3674320|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3848777|NCT01656889|3674318|B3|||Age||years|Mean|60.7|60.7|Standard Deviation|13.7|13.7|||
3848778|NCT01656889|3674319|B2|||Age||years|Mean|61.0|61.0|Standard Deviation|12.5|12.5|||
3848779|NCT01656889|3674320|B1|||Age||years|Mean|60.5|60.5|Standard Deviation|14.8|14.8|||
3848780|NCT01656889|3674318|B3||>=65 years|Age||Participants|Count of Participants|147|147.0||||||
3848781|NCT01656889|3674319|B2||>=65 years|Age||Participants|Count of Participants|72|72.0||||||
3848782|NCT01656889|3674320|B1||>=65 years|Age||Participants|Count of Participants|75|75.0||||||
3848783|NCT01656889|3674318|B3||Between 18 and 65 years|Age||Participants|Count of Participants|274|274.0||||||
3848784|NCT01656889|3674319|B2||Between 18 and 65 years|Age||Participants|Count of Participants|138|138.0||||||
3848785|NCT01656889|3674320|B1||Between 18 and 65 years|Age||Participants|Count of Participants|136|136.0||||||
3848786|NCT01656889|3674318|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3848787|NCT01656889|3674319|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3848788|NCT01656889|3674320|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3848789|NCT01656850|3674339|B3|Taiwan||Region of Enrollment||participants|Number|33|33.0||||||
3848790|NCT01656850|3674340|B2|Taiwan||Region of Enrollment||participants|Number|16|16.0||||||
3848791|NCT01656850|3674341|B1|Taiwan||Region of Enrollment||participants|Number|17|17.0||||||
3848792|NCT01656850|3674339|B3||Male|Gender||Participants|Count of Participants|13|13.0||||||
3848793|NCT01656850|3674340|B2||Male|Gender||Participants|Count of Participants|8|8.0||||||
3848794|NCT01656850|3674341|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
3848795|NCT01656850|3674339|B3||Female|Gender||Participants|Count of Participants|20|20.0||||||
3848796|NCT01656850|3674340|B2||Female|Gender||Participants|Count of Participants|8|8.0||||||
3848797|NCT01656850|3674341|B1||Female|Gender||Participants|Count of Participants|12|12.0||||||
3848798|NCT01656850|3674339|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3848799|NCT01656850|3674340|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3848800|NCT01656850|3674341|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3848801|NCT01656850|3674339|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3848802|NCT01656850|3674340|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3848803|NCT01656850|3674341|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3848804|NCT01656850|3674339|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3848805|NCT01656850|3674340|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3848806|NCT01656850|3674341|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3848807|NCT01656772|3674420|B3|Germany||Region of Enrollment||participants|Number|33|33.0||||||
3848808|NCT01656772|3674421|B2|Germany||Region of Enrollment||participants|Number|21|21.0||||||
3848809|NCT01656772|3674422|B1|Germany||Region of Enrollment||participants|Number|12|12.0||||||
3848810|NCT01656772|3674420|B3|United States||Region of Enrollment||participants|Number|53|53.0||||||
3848811|NCT01656772|3674421|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
3848812|NCT01656772|3674422|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3848813|NCT01656772|3674420|B3|Belgium||Region of Enrollment||participants|Number|34|34.0||||||
3848814|NCT01656772|3674421|B2|Belgium||Region of Enrollment||participants|Number|23|23.0||||||
3848815|NCT01656772|3674422|B1|Belgium||Region of Enrollment||participants|Number|11|11.0||||||
3848816|NCT01656772|3674420|B3||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3848817|NCT01656772|3674421|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3848818|NCT01656772|3674422|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3848819|NCT01656772|3674420|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3848820|NCT01656772|3674421|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3848821|NCT01656772|3674422|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3848822|NCT01656772|3674420|B3|||Age||years|Mean|62.6|62.6|Standard Deviation|9.5|9.5|||
3848823|NCT01656772|3674421|B2|||Age||years|Mean|62.4|62.4|Standard Deviation|9.8|9.8|||
3848824|NCT01656772|3674422|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|9.2|9.2|||
3848825|NCT01656759|3674431|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
3848826|NCT01656759|3674432|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
3848827|NCT01656759|3674433|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3848828|NCT01656759|3674431|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3848829|NCT01656759|3674432|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3848830|NCT01656759|3674433|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3848831|NCT01656759|3674431|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3848832|NCT01656759|3674432|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3848833|NCT01656759|3674433|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3848834|NCT01656759|3674431|B3|||Age||years|Mean|66|66.0|Standard Deviation|9|9.0|||
3848835|NCT01656759|3674432|B2|||Age||years|Mean|64|64.0|Standard Deviation|10|10.0|||
3848836|NCT01656759|3674433|B1|||Age||years|Mean|67|67.0|Standard Deviation|9|9.0|||
3848837|NCT01656759|3674431|B3||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
3848838|NCT01656759|3674432|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3848839|NCT01656759|3674433|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3848840|NCT01656759|3674431|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3848841|NCT01656759|3674432|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3848842|NCT01656759|3674433|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3848843|NCT01656759|3674431|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3848844|NCT01656759|3674432|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3848845|NCT01656759|3674433|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3848846|NCT01656486|3674446|B1||Male|Sex: Female, Male|Gender, Male/Female|Participants|Count of Participants|1|1.0||||||
3848847|NCT01656486|3674446|B1||Female|Sex: Female, Male|Gender, Male/Female|Participants|Count of Participants|0|0.0||||||
3848848|NCT01656486|3674446|B1|||Age||years|Mean|43|43.0|Standard Deviation|0|0.0|||
3848849|NCT01656460|3674450|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3848850|NCT01656460|3674450|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3848851|NCT01656460|3674450|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3848852|NCT01656460|3674450|B1|||Age||years|Mean|63.9|63.9|Full Range|||32.0|76.0|
3848853|NCT01656460|3674450|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3848854|NCT01656460|3674450|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3848855|NCT01656460|3674450|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3848856|NCT01656434|3674463|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3848857|NCT01656434|3674464|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3848858|NCT01656434|3674465|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3848859|NCT01656434|3674463|B3||Female|Sex: Female, Male||Participants|Count of Participants|3070|3070.0||||||
3848860|NCT01656434|3674464|B2||Female|Sex: Female, Male||Participants|Count of Participants|604|604.0||||||
3848861|NCT01656434|3674465|B1||Female|Sex: Female, Male||Participants|Count of Participants|2466|2466.0||||||
3848862|NCT01656434|3674463|B3|||Age||Years|Mean|29.3|29.3|Standard Deviation|7.6|7.6|||
3848863|NCT01656434|3674464|B2|||Age||Years|Mean|29.5|29.5|Standard Deviation|7.7|7.7|||
3848864|NCT01656434|3674465|B1|||Age||Years|Mean|29.2|29.2|Standard Deviation|7.6|7.6|||
3848865|NCT01656408|3674482|B11|||Peripheral Diastolic Blood Pressure (pDBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|86|86.0|Standard Deviation|10|10.0|||
3848866|NCT01656408|3674483|B10|||Peripheral Diastolic Blood Pressure (pDBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|90|90.0|Standard Deviation|10|10.0|||
3848867|NCT01656408|3674484|B9|||Peripheral Diastolic Blood Pressure (pDBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|89|89.0|Standard Deviation|6|6.0|||
3848868|NCT01656408|3674485|B8|||Peripheral Diastolic Blood Pressure (pDBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|84|84.0|Standard Deviation|8|8.0|||
3848869|NCT01656408|3674486|B7|||Peripheral Diastolic Blood Pressure (pDBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|72|72.0|Standard Deviation|9|9.0|||
3848870|NCT01656408|3674487|B6|||Peripheral Diastolic Blood Pressure (pDBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|86|86.0|Standard Deviation|11|11.0|||
3848871|NCT01656408|3674488|B5|||Peripheral Diastolic Blood Pressure (pDBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|82|82.0|Standard Deviation|5|5.0|||
3848872|NCT01656408|3674489|B4|||Peripheral Diastolic Blood Pressure (pDBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|86|86.0|Standard Deviation|7|7.0|||
3848873|NCT01656408|3674490|B3|||Peripheral Diastolic Blood Pressure (pDBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|90|90.0|Standard Deviation|10|10.0|||
3848874|NCT01656408|3674491|B2|||Peripheral Diastolic Blood Pressure (pDBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|86|86.0|Standard Deviation|9|9.0|||
3848875|NCT01656408|3674492|B1|||Peripheral Diastolic Blood Pressure (pDBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|92|92.0|Standard Deviation|6|6.0|||
3848876|NCT01656408|3674482|B11|||Peripheral Systolic Blood Pressure (pSBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|142|142.0|Standard Deviation|13|13.0|||
3848877|NCT01656408|3674483|B10|||Peripheral Systolic Blood Pressure (pSBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|147|147.0|Standard Deviation|10|10.0|||
3848878|NCT01656408|3674484|B9|||Peripheral Systolic Blood Pressure (pSBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|145|145.0|Standard Deviation|9|9.0|||
3848879|NCT01656408|3674485|B8|||Peripheral Systolic Blood Pressure (pSBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|141|141.0|Standard Deviation|11|11.0|||
3848880|NCT01656408|3674486|B7|||Peripheral Systolic Blood Pressure (pSBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|117|117.0|Standard Deviation|7|7.0|||
3848881|NCT01656408|3674487|B6|||Peripheral Systolic Blood Pressure (pSBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|151|151.0|Standard Deviation|9|9.0|||
3848882|NCT01656408|3674488|B5|||Peripheral Systolic Blood Pressure (pSBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|147|147.0|Standard Deviation|10|10.0|||
3848883|NCT01656408|3674489|B4|||Peripheral Systolic Blood Pressure (pSBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|139|139.0|Standard Deviation|5|5.0|||
3848884|NCT01656408|3674490|B3|||Peripheral Systolic Blood Pressure (pSBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|142|142.0|Standard Deviation|17|17.0|||
3848885|NCT01656408|3674491|B2|||Peripheral Systolic Blood Pressure (pSBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|137|137.0|Standard Deviation|7|7.0|||
3848886|NCT01656408|3674492|B1|||Peripheral Systolic Blood Pressure (pSBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|150|150.0|Standard Deviation|12|12.0|||
3848887|NCT01656408|3674482|B11|||Central Diastolic Blood Pressure (cDBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|87|87.0|Standard Deviation|10|10.0|||
3848888|NCT01656408|3674483|B10|||Central Diastolic Blood Pressure (cDBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|90|90.0|Standard Deviation|11|11.0|||
3848889|NCT01656408|3674484|B9|||Central Diastolic Blood Pressure (cDBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|89|89.0|Standard Deviation|6|6.0|||
3848890|NCT01656408|3674485|B8|||Central Diastolic Blood Pressure (cDBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|85|85.0|Standard Deviation|8|8.0|||
3848891|NCT01656408|3674486|B7|||Central Diastolic Blood Pressure (cDBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|73|73.0|Standard Deviation|9|9.0|||
3848892|NCT01656408|3674487|B6|||Central Diastolic Blood Pressure (cDBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|86|86.0|Standard Deviation|11|11.0|||
3848893|NCT01656408|3674488|B5|||Central Diastolic Blood Pressure (cDBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|84|84.0|Standard Deviation|7|7.0|||
3848894|NCT01656408|3674489|B4|||Central Diastolic Blood Pressure (cDBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|87|87.0|Standard Deviation|7|7.0|||
3848895|NCT01656408|3674490|B3|||Central Diastolic Blood Pressure (cDBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|87|87.0|Standard Deviation|10|10.0|||
3848896|NCT01656408|3674491|B2|||Central Diastolic Blood Pressure (cDBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|87|87.0|Standard Deviation|8|8.0|||
3848897|NCT01656408|3674492|B1|||Central Diastolic Blood Pressure (cDBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|93|93.0|Standard Deviation|5|5.0|||
3848898|NCT01656408|3674482|B11|||Augmentation Index (AIx)|N for Panel H = 7; N for Total = 102|percent|Mean|19|19.0|Standard Deviation|13|13.0|||
3848899|NCT01656408|3674483|B10|||Augmentation Index (AIx)|N for Panel H = 7; N for Total = 102|percent|Mean|23|23.0|Standard Deviation|7|7.0|||
3848900|NCT01656408|3674484|B9|||Augmentation Index (AIx)|N for Panel H = 7; N for Total = 102|percent|Mean|19|19.0|Standard Deviation|9|9.0|||
3848901|NCT01656408|3674485|B8|||Augmentation Index (AIx)|N for Panel H = 7; N for Total = 102|percent|Mean|20|20.0|Standard Deviation|11|11.0|||
3848902|NCT01656408|3674486|B7|||Augmentation Index (AIx)|N for Panel H = 7; N for Total = 102|percent|Mean|5|5.0|Standard Deviation|15|15.0|||
3848903|NCT01656408|3674487|B6|||Augmentation Index (AIx)|N for Panel H = 7; N for Total = 102|percent|Mean|30|30.0|Standard Deviation|6|6.0|||
3848904|NCT01656408|3674488|B5|||Augmentation Index (AIx)|N for Panel H = 7; N for Total = 102|percent|Mean|31|31.0|Standard Deviation|7|7.0|||
3848905|NCT01656408|3674489|B4|||Augmentation Index (AIx)|N for Panel H = 7; N for Total = 102|percent|Mean|10|10.0|Standard Deviation|12|12.0|||
3848906|NCT01656408|3674490|B3|||Augmentation Index (AIx)|N for Panel H = 7; N for Total = 102|percent|Mean|11|11.0|Standard Deviation|18|18.0|||
3848907|NCT01656408|3674491|B2|||Augmentation Index (AIx)|N for Panel H = 7; N for Total = 102|percent|Mean|13|13.0|Standard Deviation|12|12.0|||
3848908|NCT01656408|3674492|B1|||Augmentation Index (AIx)|N for Panel H = 7; N for Total = 102|percent|Mean|23|23.0|Standard Deviation|8|8.0|||
3848909|NCT01656408|3674482|B11|||Heart Rate (HR)|N for Panel H = 7; N for Total = 102|beats per minute|Mean|63|63.0|Standard Deviation|10|10.0|||
3848910|NCT01656408|3674483|B10|||Heart Rate (HR)|N for Panel H = 7; N for Total = 102|beats per minute|Mean|66|66.0|Standard Deviation|9|9.0|||
3848911|NCT01656408|3674484|B9|||Heart Rate (HR)|N for Panel H = 7; N for Total = 102|beats per minute|Mean|62|62.0|Standard Deviation|10|10.0|||
3848912|NCT01656408|3674485|B8|||Heart Rate (HR)|N for Panel H = 7; N for Total = 102|beats per minute|Mean|63|63.0|Standard Deviation|9|9.0|||
3848913|NCT01656408|3674486|B7|||Heart Rate (HR)|N for Panel H = 7; N for Total = 102|beats per minute|Mean|54|54.0|Standard Deviation|7|7.0|||
3848914|NCT01656408|3674487|B6|||Heart Rate (HR)|N for Panel H = 7; N for Total = 102|beats per minute|Mean|68|68.0|Standard Deviation|9|9.0|||
3848915|NCT01656408|3674488|B5|||Heart Rate (HR)|N for Panel H = 7; N for Total = 102|beats per minute|Mean|59|59.0|Standard Deviation|11|11.0|||
3848916|NCT01656408|3674489|B4|||Heart Rate (HR)|N for Panel H = 7; N for Total = 102|beats per minute|Mean|61|61.0|Standard Deviation|10|10.0|||
3848917|NCT01656408|3674490|B3|||Heart Rate (HR)|N for Panel H = 7; N for Total = 102|beats per minute|Mean|66|66.0|Standard Deviation|12|12.0|||
3848918|NCT01656408|3674491|B2|||Heart Rate (HR)|N for Panel H = 7; N for Total = 102|beats per minute|Mean|63|63.0|Standard Deviation|7|7.0|||
3848919|NCT01656408|3674492|B1|||Heart Rate (HR)|N for Panel H = 7; N for Total = 102|beats per minute|Mean|65|65.0|Standard Deviation|14|14.0|||
3848920|NCT01656408|3674482|B11|||Central Systolic Blood Pressure (cSBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|131|131.0|Standard Deviation|16|16.0|||
3848921|NCT01656408|3674483|B10|||Central Systolic Blood Pressure (cSBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|136|136.0|Standard Deviation|12|12.0|||
3848922|NCT01656408|3674484|B9|||Central Systolic Blood Pressure (cSBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|133|133.0|Standard Deviation|10|10.0|||
3848923|NCT01656408|3674485|B8|||Central Systolic Blood Pressure (cSBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|130|130.0|Standard Deviation|12|12.0|||
3848924|NCT01656408|3674486|B7|||Central Systolic Blood Pressure (cSBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|103|103.0|Standard Deviation|11|11.0|||
3848925|NCT01656408|3674487|B6|||Central Systolic Blood Pressure (cSBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|144|144.0|Standard Deviation|11|11.0|||
3848926|NCT01656408|3674488|B5|||Central Systolic Blood Pressure (cSBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|143|143.0|Standard Deviation|11|11.0|||
3848927|NCT01656408|3674489|B4|||Central Systolic Blood Pressure (cSBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|126|126.0|Standard Deviation|7|7.0|||
3848928|NCT01656408|3674490|B3|||Central Systolic Blood Pressure (cSBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|127|127.0|Standard Deviation|16|16.0|||
3848929|NCT01656408|3674491|B2|||Central Systolic Blood Pressure (cSBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|126|126.0|Standard Deviation|10|10.0|||
3848930|NCT01656408|3674492|B1|||Central Systolic Blood Pressure (cSBP)|N for Panel H = 7; N for Total = 102|mm Hg|Mean|141|141.0|Standard Deviation|15|15.0|||
3848931|NCT01656408|3674482|B11||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3848932|NCT01656408|3674483|B10||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3848933|NCT01656408|3674484|B9||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3848934|NCT01656408|3674485|B8||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3848935|NCT01656408|3674486|B7||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3848936|NCT01656408|3674487|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3848937|NCT01656408|3674488|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3848938|NCT01656408|3674489|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3848939|NCT01656408|3674490|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3848940|NCT01656408|3674491|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3848941|NCT01656408|3674492|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3848942|NCT01656408|3674482|B11||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3848943|NCT01656408|3674483|B10||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3848944|NCT01656408|3674484|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3848945|NCT01656408|3674485|B8||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3848946|NCT01656408|3674486|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3848947|NCT01656408|3674487|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3848948|NCT01656408|3674488|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3848949|NCT01656408|3674489|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3848950|NCT01656408|3674490|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3848951|NCT01656408|3674491|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3848952|NCT01656408|3674492|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3848953|NCT01656408|3674482|B11|||Age||years|Mean|52.5|52.5|Standard Deviation|13.2|13.2|||
3848954|NCT01656408|3674483|B10|||Age||years|Mean|54.8|54.8|Standard Deviation|9.6|9.6|||
3848955|NCT01656408|3674484|B9|||Age||years|Mean|51.5|51.5|Standard Deviation|8.5|8.5|||
3848956|NCT01656408|3674485|B8|||Age||years|Mean|58.1|58.1|Standard Deviation|5.6|5.6|||
3848957|NCT01656408|3674486|B7|||Age||years|Mean|41.5|41.5|Standard Deviation|11.2|11.2|||
3848958|NCT01656408|3674487|B6|||Age||years|Mean|69.9|69.9|Standard Deviation|2.5|2.5|||
3848959|NCT01656408|3674488|B5|||Age||years|Mean|72.6|72.6|Standard Deviation|4.2|4.2|||
3848960|NCT01656408|3674489|B4|||Age||years|Mean|42.7|42.7|Standard Deviation|10.8|10.8|||
3848961|NCT01656408|3674490|B3|||Age||years|Mean|42.0|42.0|Standard Deviation|11.4|11.4|||
3848962|NCT01656408|3674491|B2|||Age||years|Mean|41.3|41.3|Standard Deviation|10.8|10.8|||
3848963|NCT01656408|3674492|B1|||Age||years|Mean|46.1|46.1|Standard Deviation|6.3|6.3|||
3848964|NCT01656395|3674690|B7|Th2-Low||Asthma Phenotype|The Asthma Phenotype in this study was defined as either “Th2-High” or “Th2-Low,” based on measurements of asthmatic inflammation. Th2-High was defined according to the following 2 criteria at Visit 1: a peripheral-blood absolute eosinophil count ≥ 0.30 X 10^9/liters(L), and/or a peripheral-blood absolute eosinophil count ≥0.14 X 10^9/L with serum total IgE ≥100 IU/mL. Th2-Low was operationally defined as meeting neither of these criteria.|Participants|Number|232|232.0||||||
3848965|NCT01656395|3674691|B6|Th2-Low||Asthma Phenotype|The Asthma Phenotype in this study was defined as either “Th2-High” or “Th2-Low,” based on measurements of asthmatic inflammation. Th2-High was defined according to the following 2 criteria at Visit 1: a peripheral-blood absolute eosinophil count ≥ 0.30 X 10^9/liters(L), and/or a peripheral-blood absolute eosinophil count ≥0.14 X 10^9/L with serum total IgE ≥100 IU/mL. Th2-Low was operationally defined as meeting neither of these criteria.|Participants|Number|68|68.0||||||
3848966|NCT01656395|3674692|B5|Th2-Low||Asthma Phenotype|The Asthma Phenotype in this study was defined as either “Th2-High” or “Th2-Low,” based on measurements of asthmatic inflammation. Th2-High was defined according to the following 2 criteria at Visit 1: a peripheral-blood absolute eosinophil count ≥ 0.30 X 10^9/liters(L), and/or a peripheral-blood absolute eosinophil count ≥0.14 X 10^9/L with serum total IgE ≥100 IU/mL. Th2-Low was operationally defined as meeting neither of these criteria.|Participants|Number|0|0.0||||||
3848967|NCT01656395|3674693|B4|Th2-Low||Asthma Phenotype|The Asthma Phenotype in this study was defined as either “Th2-High” or “Th2-Low,” based on measurements of asthmatic inflammation. Th2-High was defined according to the following 2 criteria at Visit 1: a peripheral-blood absolute eosinophil count ≥ 0.30 X 10^9/liters(L), and/or a peripheral-blood absolute eosinophil count ≥0.14 X 10^9/L with serum total IgE ≥100 IU/mL. Th2-Low was operationally defined as meeting neither of these criteria.|Participants|Number|0|0.0||||||
3848968|NCT01656395|3674694|B3|Th2-Low||Asthma Phenotype|The Asthma Phenotype in this study was defined as either “Th2-High” or “Th2-Low,” based on measurements of asthmatic inflammation. Th2-High was defined according to the following 2 criteria at Visit 1: a peripheral-blood absolute eosinophil count ≥ 0.30 X 10^9/liters(L), and/or a peripheral-blood absolute eosinophil count ≥0.14 X 10^9/L with serum total IgE ≥100 IU/mL. Th2-Low was operationally defined as meeting neither of these criteria.|Participants|Number|88|88.0||||||
3848969|NCT01656395|3674695|B2|Th2-Low||Asthma Phenotype|The Asthma Phenotype in this study was defined as either “Th2-High” or “Th2-Low,” based on measurements of asthmatic inflammation. Th2-High was defined according to the following 2 criteria at Visit 1: a peripheral-blood absolute eosinophil count ≥ 0.30 X 10^9/liters(L), and/or a peripheral-blood absolute eosinophil count ≥0.14 X 10^9/L with serum total IgE ≥100 IU/mL. Th2-Low was operationally defined as meeting neither of these criteria.|Participants|Number|76|76.0||||||
3848970|NCT01656395|3674696|B1|Th2-Low||Asthma Phenotype|The Asthma Phenotype in this study was defined as either “Th2-High” or “Th2-Low,” based on measurements of asthmatic inflammation. Th2-High was defined according to the following 2 criteria at Visit 1: a peripheral-blood absolute eosinophil count ≥ 0.30 X 10^9/liters(L), and/or a peripheral-blood absolute eosinophil count ≥0.14 X 10^9/L with serum total IgE ≥100 IU/mL. Th2-Low was operationally defined as meeting neither of these criteria.|Participants|Number|0|0.0||||||
3848971|NCT01656395|3674690|B7|Th2-High||Asthma Phenotype|The Asthma Phenotype in this study was defined as either “Th2-High” or “Th2-Low,” based on measurements of asthmatic inflammation. Th2-High was defined according to the following 2 criteria at Visit 1: a peripheral-blood absolute eosinophil count ≥ 0.30 X 10^9/liters(L), and/or a peripheral-blood absolute eosinophil count ≥0.14 X 10^9/L with serum total IgE ≥100 IU/mL. Th2-Low was operationally defined as meeting neither of these criteria.|Participants|Number|325|325.0||||||
3848972|NCT01656395|3674691|B6|Th2-High||Asthma Phenotype|The Asthma Phenotype in this study was defined as either “Th2-High” or “Th2-Low,” based on measurements of asthmatic inflammation. Th2-High was defined according to the following 2 criteria at Visit 1: a peripheral-blood absolute eosinophil count ≥ 0.30 X 10^9/liters(L), and/or a peripheral-blood absolute eosinophil count ≥0.14 X 10^9/L with serum total IgE ≥100 IU/mL. Th2-Low was operationally defined as meeting neither of these criteria.|Participants|Number|58|58.0||||||
3848973|NCT01656395|3674692|B5|Th2-High||Asthma Phenotype|The Asthma Phenotype in this study was defined as either “Th2-High” or “Th2-Low,” based on measurements of asthmatic inflammation. Th2-High was defined according to the following 2 criteria at Visit 1: a peripheral-blood absolute eosinophil count ≥ 0.30 X 10^9/liters(L), and/or a peripheral-blood absolute eosinophil count ≥0.14 X 10^9/L with serum total IgE ≥100 IU/mL. Th2-Low was operationally defined as meeting neither of these criteria.|Participants|Number|60|60.0||||||
3848974|NCT01656395|3674693|B4|Th2-High||Asthma Phenotype|The Asthma Phenotype in this study was defined as either “Th2-High” or “Th2-Low,” based on measurements of asthmatic inflammation. Th2-High was defined according to the following 2 criteria at Visit 1: a peripheral-blood absolute eosinophil count ≥ 0.30 X 10^9/liters(L), and/or a peripheral-blood absolute eosinophil count ≥0.14 X 10^9/L with serum total IgE ≥100 IU/mL. Th2-Low was operationally defined as meeting neither of these criteria.|Participants|Number|52|52.0||||||
3848975|NCT01656395|3674694|B3|Th2-High||Asthma Phenotype|The Asthma Phenotype in this study was defined as either “Th2-High” or “Th2-Low,” based on measurements of asthmatic inflammation. Th2-High was defined according to the following 2 criteria at Visit 1: a peripheral-blood absolute eosinophil count ≥ 0.30 X 10^9/liters(L), and/or a peripheral-blood absolute eosinophil count ≥0.14 X 10^9/L with serum total IgE ≥100 IU/mL. Th2-Low was operationally defined as meeting neither of these criteria.|Participants|Number|47|47.0||||||
3849031|NCT01655823|3674848|B6||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3848976|NCT01656395|3674695|B2|Th2-High||Asthma Phenotype|The Asthma Phenotype in this study was defined as either “Th2-High” or “Th2-Low,” based on measurements of asthmatic inflammation. Th2-High was defined according to the following 2 criteria at Visit 1: a peripheral-blood absolute eosinophil count ≥ 0.30 X 10^9/liters(L), and/or a peripheral-blood absolute eosinophil count ≥0.14 X 10^9/L with serum total IgE ≥100 IU/mL. Th2-Low was operationally defined as meeting neither of these criteria.|Participants|Number|50|50.0||||||
3848977|NCT01656395|3674696|B1|Th2-High||Asthma Phenotype|The Asthma Phenotype in this study was defined as either “Th2-High” or “Th2-Low,” based on measurements of asthmatic inflammation. Th2-High was defined according to the following 2 criteria at Visit 1: a peripheral-blood absolute eosinophil count ≥ 0.30 X 10^9/liters(L), and/or a peripheral-blood absolute eosinophil count ≥0.14 X 10^9/L with serum total IgE ≥100 IU/mL. Th2-Low was operationally defined as meeting neither of these criteria.|Participants|Number|58|58.0||||||
3848978|NCT01656395|3674690|B7||Male|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
3848979|NCT01656395|3674691|B6||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3848980|NCT01656395|3674692|B5||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3848981|NCT01656395|3674693|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3848982|NCT01656395|3674694|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3848983|NCT01656395|3674695|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3848984|NCT01656395|3674696|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3848985|NCT01656395|3674690|B7||Female|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
3848986|NCT01656395|3674691|B6||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3848987|NCT01656395|3674692|B5||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3848988|NCT01656395|3674693|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3848989|NCT01656395|3674694|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3848990|NCT01656395|3674695|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3848991|NCT01656395|3674696|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3848992|NCT01656395|3674690|B7|||Age||Years|Mean|42.5|42.5|Standard Deviation|12.8|12.8|||
3848993|NCT01656395|3674691|B6|||Age||Years|Mean|41.1|41.1|Standard Deviation|12.4|12.4|||
3848994|NCT01656395|3674692|B5|||Age||Years|Mean|43.7|43.7|Standard Deviation|13.3|13.3|||
3848995|NCT01656395|3674693|B4|||Age||Years|Mean|41.7|41.7|Standard Deviation|12.2|12.2|||
3848996|NCT01656395|3674694|B3|||Age||Years|Mean|43|43.0|Standard Deviation|13.2|13.2|||
3848997|NCT01656395|3674695|B2|||Age||Years|Mean|44.3|44.3|Standard Deviation|12.4|12.4|||
3848998|NCT01656395|3674696|B1|||Age||Years|Mean|39.9|39.9|Standard Deviation|13.2|13.2|||
3848999|NCT01656304|3674789|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3849000|NCT01656304|3674789|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3849001|NCT01656304|3674789|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3849002|NCT01656304|3674789|B1|||Age||years|Mean|70.53|70.53|Standard Deviation|10.38|10.38|||
3849003|NCT01656252|3674798|B1|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3849004|NCT01656252|3674798|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849005|NCT01656252|3674798|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849006|NCT01656252|3674798|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3849007|NCT01656252|3674798|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849008|NCT01656252|3674798|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849009|NCT01656252|3674798|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849010|NCT01656252|3674798|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849011|NCT01656252|3674798|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3849012|NCT01656252|3674798|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3849013|NCT01656252|3674798|B1|||Age||years|Median|54|54.0|Inter-Quartile Range|||49.0|62.0|
3849014|NCT01656161|3674830|B1|South Africa||Region of Enrollment||participants|Number|120|120.0||||||
3849015|NCT01656161|3674830|B1||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3849016|NCT01656161|3674830|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3849017|NCT01656161|3674830|B1|||Age||years|Mean|72.23|72.23|Standard Deviation|7.32|7.32|||
3849018|NCT01656031|3674844|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
3849019|NCT01656031|3674844|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3849020|NCT01656031|3674844|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3849021|NCT01656031|3674844|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|15.9|15.9|||
3849022|NCT01656031|3674844|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3849023|NCT01656031|3674844|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3849024|NCT01656031|3674844|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3849025|NCT01655823|3674848|B6|United States||Region of Enrollment||participants|Number|125|125.0||||||
3849026|NCT01655823|3674849|B5|United States||Region of Enrollment||participants|Number|26|26.0||||||
3849027|NCT01655823|3674850|B4|United States||Region of Enrollment||participants|Number|25|25.0||||||
3849028|NCT01655823|3674851|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
3849029|NCT01655823|3674852|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3849030|NCT01655823|3674853|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3849032|NCT01655823|3674849|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3849033|NCT01655823|3674850|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3849034|NCT01655823|3674851|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3849035|NCT01655823|3674852|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3849036|NCT01655823|3674853|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3849037|NCT01655823|3674848|B6||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3849038|NCT01655823|3674849|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3849039|NCT01655823|3674850|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3849040|NCT01655823|3674851|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3849041|NCT01655823|3674852|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3849042|NCT01655823|3674853|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3849043|NCT01655823|3674848|B6|||Age||years|Mean|60.1|60.1|Standard Deviation|10.28|10.28|||
3849044|NCT01655823|3674849|B5|||Age||years|Mean|60.6|60.6|Standard Deviation|11.05|11.05|||
3849045|NCT01655823|3674850|B4|||Age||years|Mean|60.4|60.4|Standard Deviation|10.28|10.28|||
3849046|NCT01655823|3674851|B3|||Age||years|Mean|61.4|61.4|Standard Deviation|10.01|10.01|||
3849047|NCT01655823|3674852|B2|||Age||years|Mean|59.1|59.1|Standard Deviation|10.29|10.29|||
3849048|NCT01655823|3674853|B1|||Age||years|Mean|59.0|59.0|Standard Deviation|10.3|10.3|||
3849049|NCT01655719|3674869|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3849050|NCT01655719|3674869|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849051|NCT01655719|3674869|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849052|NCT01655719|3674869|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3849053|NCT01655719|3674869|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849054|NCT01655719|3674869|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849055|NCT01655719|3674869|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849056|NCT01655719|3674869|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849057|NCT01655719|3674869|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3849058|NCT01655719|3674869|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3849059|NCT01655719|3674869|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3849060|NCT01655719|3674869|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3849061|NCT01655719|3674869|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3849062|NCT01655498|3674875|B1|Other [n=60]||Previous treatment for FI||participants|Number|6|6.0||||||
3849063|NCT01655498|3674875|B1|Biofeedback||Previous treatment for FI||participants|Number|11|11.0||||||
3849064|NCT01655498|3674875|B1|Surgical implant of electrical stimulator [n=60]||Previous treatment for FI||participants|Number|1|1.0||||||
3849065|NCT01655498|3674875|B1|Surgery||Previous treatment for FI||participants|Number|4|4.0||||||
3849066|NCT01655498|3674875|B1|> 5 years||FI Symptom Duration||participants|Number|26|26.0||||||
3849067|NCT01655498|3674875|B1|6 months - 5 years||FI Symptom Duration||participants|Number|35|35.0||||||
3849068|NCT01655498|3674875|B1|||Number of FI episodes in 2-week period||episodes|Mean|11.7|11.7|Standard Deviation|9.1|9.1|||
3849069|NCT01655498|3674875|B1|Not reported||Menopause Status||participants|Number|1|1.0||||||
3849070|NCT01655498|3674875|B1|Post-menopause||Menopause Status||participants|Number|51|51.0||||||
3849071|NCT01655498|3674875|B1|Peri-menopause||Menopause Status||participants|Number|2|2.0||||||
3849072|NCT01655498|3674875|B1|Pre-menopause||Menopause Status||participants|Number|7|7.0||||||
3849073|NCT01655498|3674875|B1|No. of vaginal births||Parity||events|Median|2|2.0|Full Range|||0.0|4.0|
3849074|NCT01655498|3674875|B1|No. of pregnancies||Parity||events|Median|2|2.0|Full Range|||0.0|12.0|
3849075|NCT01655498|3674875|B1|Not reported||Sexual Activity||participants|Number|1|1.0||||||
3849076|NCT01655498|3674875|B1|Less than 1 x per month||Sexual Activity||participants|Number|33|33.0||||||
3849077|NCT01655498|3674875|B1|Greater than or equal to 1 x month||Sexual Activity||participants|Number|27|27.0||||||
3849078|NCT01655498|3674875|B1|Other gynecologic surgery||Previous Gynecologic Surgeries||participants|Number|25|25.0||||||
3849079|NCT01655498|3674875|B1|Urinary incontinence surgery||Previous Gynecologic Surgeries||participants|Number|9|9.0||||||
3849080|NCT01655498|3674875|B1|Prolapse surgery||Previous Gynecologic Surgeries||participants|Number|5|5.0||||||
3849081|NCT01655498|3674875|B1|Hysterectomy||Previous Gynecologic Surgeries||participants|Number|29|29.0||||||
3849082|NCT01655498|3674875|B1|>29.9||Body Mass Index||participants|Number|18|18.0||||||
3849083|NCT01655498|3674875|B1|25.0-29.9||Body Mass Index||participants|Number|21|21.0||||||
3849084|NCT01655498|3674875|B1|18.5-24.9||Body Mass Index||participants|Number|20|20.0||||||
3849085|NCT01655498|3674875|B1|<18.5||Body Mass Index||participants|Number|2|2.0||||||
3849086|NCT01655498|3674875|B1|United States||Region of Enrollment||participants|Number|61|61.0||||||
3849087|NCT01655498|3674875|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3849088|NCT01655498|3674875|B1|Natrive Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3849089|NCT01655498|3674875|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3849090|NCT01655498|3674875|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3849091|NCT01655498|3674875|B1|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3849092|NCT01655498|3674875|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3849093|NCT01655498|3674875|B1|White||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
3849094|NCT01655498|3674875|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3849095|NCT01655498|3674875|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3849096|NCT01655498|3674875|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|9.4|9.4|||
3849097|NCT01655381|3674882|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
3849098|NCT01655381|3674882|B1||Female|Gender||Participants|Count of Participants|12|12.0||||||
3849099|NCT01655381|3674882|B1|||Age||years|Mean|54.8|54.8|Standard Deviation|9.1|9.1|||
3849100|NCT01655329|3674902|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3849101|NCT01655329|3674902|B1|male||Sex/Gender, Customized||participants|Number|7|7.0||||||
3849102|NCT01655329|3674902|B1|female||Sex/Gender, Customized||participants|Number|3|3.0||||||
3849103|NCT01655329|3674902|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3849104|NCT01655329|3674902|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3849105|NCT01655329|3674902|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3849106|NCT01655069|3674918|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3849107|NCT01655069|3674919|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849108|NCT01655069|3674920|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849109|NCT01655069|3674921|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849110|NCT01655069|3674922|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3849111|NCT01655069|3674918|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849112|NCT01655069|3674919|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849113|NCT01655069|3674920|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849114|NCT01655069|3674921|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849115|NCT01655069|3674922|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849116|NCT01655069|3674918|B5||White|Race (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
3849117|NCT01655069|3674919|B4||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3849118|NCT01655069|3674920|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3849119|NCT01655069|3674921|B2||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3849120|NCT01655069|3674922|B1||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3849121|NCT01655069|3674918|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3849122|NCT01655069|3674919|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3849123|NCT01655069|3674920|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3849124|NCT01655069|3674921|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3849125|NCT01655069|3674922|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3849126|NCT01655069|3674918|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849127|NCT01655069|3674919|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849128|NCT01655069|3674920|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849129|NCT01655069|3674921|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849130|NCT01655069|3674922|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849131|NCT01655069|3674918|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3849132|NCT01655069|3674919|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3849133|NCT01655069|3674920|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3849134|NCT01655069|3674921|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3849135|NCT01655069|3674922|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3849136|NCT01655069|3674918|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3849137|NCT01655069|3674919|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849138|NCT01655069|3674920|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3849139|NCT01655069|3674921|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3849140|NCT01655069|3674922|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3849141|NCT01655069|3674918|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849142|NCT01655069|3674919|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849143|NCT01655069|3674920|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849144|NCT01655069|3674921|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849145|NCT01655069|3674922|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849146|NCT01655069|3674918|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
3849147|NCT01655069|3674919|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3849148|NCT01655069|3674920|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3849149|NCT01655069|3674921|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3849150|NCT01655069|3674922|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3849151|NCT01655069|3674918|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3849152|NCT01655069|3674919|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3849153|NCT01655069|3674920|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3849154|NCT01655069|3674921|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3849155|NCT01655069|3674922|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3849156|NCT01655069|3674918|B5||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3849157|NCT01655069|3674919|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3849158|NCT01655069|3674920|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3849159|NCT01655069|3674921|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3849160|NCT01655069|3674922|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3849161|NCT01655069|3674918|B5||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3849162|NCT01655069|3674919|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3849163|NCT01655069|3674920|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3849164|NCT01655069|3674921|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3849165|NCT01655069|3674922|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3849166|NCT01655069|3674918|B5|Adolescents||Age||Years|Mean|14.2|14.2|Standard Deviation|1.7|1.7|||
3849167|NCT01655069|3674919|B4|Adolescents||Age||Years|Mean|14.5|14.5|Standard Deviation|1.8|1.8|||
3849168|NCT01655069|3674920|B3|Adolescents||Age||Years|Mean|13.9|13.9|Standard Deviation|1.6|1.6|||
3849169|NCT01655069|3674918|B5|Children||Age||Years|Mean|7.3|7.3|Standard Deviation|1.6|1.6|||
3849170|NCT01655069|3674921|B2|Children||Age||Years|Mean|7.5|7.5|Standard Deviation|1.5|1.5|||
3849171|NCT01655069|3674922|B1|Children||Age||Years|Mean|7.2|7.2|Standard Deviation|1.6|1.6|||
3849172|NCT01655043|3674940|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3849173|NCT01655043|3674940|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3849174|NCT01655043|3674940|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849175|NCT01655043|3674940|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3849176|NCT01655043|3674940|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3849177|NCT01655043|3674940|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849178|NCT01655043|3674940|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3849179|NCT01655043|3674940|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849180|NCT01655043|3674940|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3849181|NCT01655043|3674940|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3849182|NCT01655043|3674940|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3849183|NCT01655043|3674940|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3849184|NCT01655043|3674940|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3849185|NCT01655043|3674940|B1|||Age||years|Mean|61.8|61.8|Standard Deviation|12.2|12.2|||
3849186|NCT01654887|3674944|B3|no||History of fever||participants|Number|29|29.0||||||
3849187|NCT01654887|3674945|B2|no||History of fever||participants|Number|13|13.0||||||
3849188|NCT01654887|3674946|B1|no||History of fever||participants|Number|16|16.0||||||
3849189|NCT01654887|3674944|B3|yes||History of fever||participants|Number|162|162.0||||||
3849190|NCT01654887|3674945|B2|yes||History of fever||participants|Number|75|75.0||||||
3849191|NCT01654887|3674946|B1|yes||History of fever||participants|Number|87|87.0||||||
3849192|NCT01654887|3674944|B3|no||Abdominal pain||participants|Number|169|169.0||||||
3849193|NCT01654887|3674945|B2|no||Abdominal pain||participants|Number|78|78.0||||||
3849194|NCT01654887|3674946|B1|no||Abdominal pain||participants|Number|91|91.0||||||
3849195|NCT01654887|3674944|B3|yes||Abdominal pain||participants|Number|22|22.0||||||
3849196|NCT01654887|3674945|B2|yes||Abdominal pain||participants|Number|10|10.0||||||
3849197|NCT01654887|3674946|B1|yes||Abdominal pain||participants|Number|12|12.0||||||
3849198|NCT01654887|3674944|B3|no||Chest pain||participants|Number|164|164.0||||||
3849199|NCT01654887|3674945|B2|no||Chest pain||participants|Number|78|78.0||||||
3849200|NCT01654887|3674946|B1|no||Chest pain||participants|Number|86|86.0||||||
3849201|NCT01654887|3674944|B3|yes||Chest pain||participants|Number|27|27.0||||||
3849202|NCT01654887|3674945|B2|yes||Chest pain||participants|Number|10|10.0||||||
3849203|NCT01654887|3674946|B1|yes||Chest pain||participants|Number|17|17.0||||||
3849204|NCT01654887|3674944|B3|no||Difficulty breathing||participants|Number|87|87.0||||||
3849205|NCT01654887|3674945|B2|no||Difficulty breathing||participants|Number|40|40.0||||||
3849206|NCT01654887|3674946|B1|no||Difficulty breathing||participants|Number|47|47.0||||||
3849207|NCT01654887|3674944|B3|yes||Difficulty breathing||participants|Number|104|104.0||||||
3849208|NCT01654887|3674945|B2|yes||Difficulty breathing||participants|Number|48|48.0||||||
3849209|NCT01654887|3674946|B1|yes||Difficulty breathing||participants|Number|56|56.0||||||
3849210|NCT01654887|3674944|B3|no||Cough||participants|Number|4|4.0||||||
3849211|NCT01654887|3674945|B2|no||Cough||participants|Number|2|2.0||||||
3849212|NCT01654887|3674946|B1|no||Cough||participants|Number|2|2.0||||||
3849213|NCT01654887|3674944|B3|yes||Cough||participants|Number|187|187.0||||||
3849214|NCT01654887|3674945|B2|yes||Cough||participants|Number|86|86.0||||||
3849215|NCT01654887|3674946|B1|yes||Cough||participants|Number|101|101.0||||||
3849216|NCT01654887|3674944|B3|no||Triage Fever >= 38 degrees celsius||participants|Number|102|102.0||||||
3849217|NCT01654887|3674945|B2|no||Triage Fever >= 38 degrees celsius||participants|Number|47|47.0||||||
3849218|NCT01654887|3674946|B1|no||Triage Fever >= 38 degrees celsius||participants|Number|55|55.0||||||
3849219|NCT01654887|3674944|B3|yes||Triage Fever >= 38 degrees celsius||participants|Number|89|89.0||||||
3849220|NCT01654887|3674945|B2|yes||Triage Fever >= 38 degrees celsius||participants|Number|41|41.0||||||
3849221|NCT01654887|3674946|B1|yes||Triage Fever >= 38 degrees celsius||participants|Number|48|48.0||||||
3849222|NCT01654887|3674944|B3|no||Tachypnea for age|Tachypnea - respiratory rate >60 breaths/minute in children <2 months of age, >50 breaths/minute in children 2 to 12 months of age, and >40 breaths/minute in children ≥1 year of age.|participants|Number|139|139.0||||||
3849223|NCT01654887|3674945|B2|no||Tachypnea for age|Tachypnea - respiratory rate >60 breaths/minute in children <2 months of age, >50 breaths/minute in children 2 to 12 months of age, and >40 breaths/minute in children ≥1 year of age.|participants|Number|63|63.0||||||
3849224|NCT01654887|3674946|B1|no||Tachypnea for age|Tachypnea - respiratory rate >60 breaths/minute in children <2 months of age, >50 breaths/minute in children 2 to 12 months of age, and >40 breaths/minute in children ≥1 year of age.|participants|Number|76|76.0||||||
3849225|NCT01654887|3674944|B3|yes||Tachypnea for age|Tachypnea - respiratory rate >60 breaths/minute in children <2 months of age, >50 breaths/minute in children 2 to 12 months of age, and >40 breaths/minute in children ≥1 year of age.|participants|Number|52|52.0||||||
3849226|NCT01654887|3674945|B2|yes||Tachypnea for age|Tachypnea - respiratory rate >60 breaths/minute in children <2 months of age, >50 breaths/minute in children 2 to 12 months of age, and >40 breaths/minute in children ≥1 year of age.|participants|Number|25|25.0||||||
3849227|NCT01654887|3674946|B1|yes||Tachypnea for age|Tachypnea - respiratory rate >60 breaths/minute in children <2 months of age, >50 breaths/minute in children 2 to 12 months of age, and >40 breaths/minute in children ≥1 year of age.|participants|Number|27|27.0||||||
3849228|NCT01654887|3674944|B3||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3849229|NCT01654887|3674945|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3849230|NCT01654887|3674946|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3849231|NCT01654887|3674944|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3849232|NCT01654887|3674945|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3849233|NCT01654887|3674946|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3849234|NCT01654887|3674944|B3|||Age||years|Median|3|3.0|Inter-Quartile Range|||1.6|6.0|
3849235|NCT01654887|3674945|B2|||Age||years|Median|3|3.0|Inter-Quartile Range|||1.7|5.7|
3849236|NCT01654887|3674946|B1|||Age||years|Median|3|3.0|Inter-Quartile Range|||1.6|6.0|
3849237|NCT01654861|3674963|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3849238|NCT01654861|3674963|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3849239|NCT01654861|3674963|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3849240|NCT01654861|3674963|B1|||Age||years|Mean|55|55.0|Full Range|||52.0|59.0|
3849241|NCT01654796|3674968|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849242|NCT01654796|3674969|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849243|NCT01654796|3674970|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849244|NCT01654796|3674971|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849245|NCT01654796|3674968|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3849246|NCT01654796|3674969|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3849247|NCT01654796|3674970|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3849248|NCT01654796|3674971|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849249|NCT01654796|3674968|B4||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3849250|NCT01654796|3674969|B3||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3849251|NCT01654796|3674970|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3849252|NCT01654796|3674971|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3849253|NCT01654796|3674968|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3849254|NCT01654796|3674969|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3849255|NCT01654796|3674970|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3849256|NCT01654796|3674971|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3849257|NCT01654796|3674968|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849258|NCT01654796|3674969|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849259|NCT01654796|3674970|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849260|NCT01654796|3674971|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849261|NCT01654796|3674968|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3849262|NCT01654796|3674969|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849263|NCT01654796|3674970|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3849264|NCT01654796|3674971|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849265|NCT01654796|3674968|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849266|NCT01654796|3674969|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849267|NCT01654796|3674970|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849268|NCT01654796|3674971|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849269|NCT01654796|3674968|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849270|NCT01654796|3674969|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849271|NCT01654796|3674970|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849272|NCT01654796|3674971|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849273|NCT01654796|3674968|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3849274|NCT01654796|3674969|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3849275|NCT01654796|3674970|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3849276|NCT01654796|3674971|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3849277|NCT01654796|3674968|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3849278|NCT01654796|3674969|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849279|NCT01654796|3674970|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3849280|NCT01654796|3674971|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3849281|NCT01654796|3674968|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3849282|NCT01654796|3674969|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3849283|NCT01654796|3674970|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3849284|NCT01654796|3674971|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3849285|NCT01654796|3674968|B4||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3849286|NCT01654796|3674969|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3849287|NCT01654796|3674970|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3849288|NCT01654796|3674971|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3849289|NCT01654796|3674968|B4|||Age||years|Mean|48.3|48.3|Standard Deviation|13.3|13.3|||
3849290|NCT01654796|3674969|B3|||Age||years|Mean|46.3|46.3|Standard Deviation|14.6|14.6|||
3849291|NCT01654796|3674970|B2|||Age||years|Mean|50.7|50.7|Standard Deviation|10|10.0|||
3849292|NCT01654796|3674971|B1|||Age||years|Mean|47.9|47.9|Standard Deviation|14.8|14.8|||
3849293|NCT01654666|3674982|B4|Other||Contralateral carotid condition||participants|Number|170|170.0||||||
3849294|NCT01654666|3674983|B3|Other||Contralateral carotid condition||participants|Number|57|57.0||||||
3849295|NCT01654666|3674984|B2|Other||Contralateral carotid condition||participants|Number|57|57.0||||||
3849296|NCT01654666|3674985|B1|Other||Contralateral carotid condition||participants|Number|56|56.0||||||
3849297|NCT01654666|3674982|B4|Occlusion||Contralateral carotid condition||participants|Number|5|5.0||||||
3849298|NCT01654666|3674983|B3|Occlusion||Contralateral carotid condition||participants|Number|2|2.0||||||
3849299|NCT01654666|3674984|B2|Occlusion||Contralateral carotid condition||participants|Number|1|1.0||||||
3849300|NCT01654666|3674985|B1|Occlusion||Contralateral carotid condition||participants|Number|2|2.0||||||
3849301|NCT01654666|3674982|B4|Severe stenosis||Contralateral carotid condition||participants|Number|14|14.0||||||
3849302|NCT01654666|3674983|B3|Severe stenosis||Contralateral carotid condition||participants|Number|4|4.0||||||
3849303|NCT01654666|3674984|B2|Severe stenosis||Contralateral carotid condition||participants|Number|5|5.0||||||
3849304|NCT01654666|3674985|B1|Severe stenosis||Contralateral carotid condition||participants|Number|5|5.0||||||
3849305|NCT01654666|3674982|B4|Asymptomatic||Clinical manifestation|Clinical manifestation of the target carotid artery stenosis.|participants|Number|61|61.0||||||
3849306|NCT01654666|3674983|B3|Asymptomatic||Clinical manifestation|Clinical manifestation of the target carotid artery stenosis.|participants|Number|21|21.0||||||
3849307|NCT01654666|3674984|B2|Asymptomatic||Clinical manifestation|Clinical manifestation of the target carotid artery stenosis.|participants|Number|18|18.0||||||
3849308|NCT01654666|3674985|B1|Asymptomatic||Clinical manifestation|Clinical manifestation of the target carotid artery stenosis.|participants|Number|22|22.0||||||
3849309|NCT01654666|3674982|B4|Symptomatic||Clinical manifestation|Clinical manifestation of the target carotid artery stenosis.|participants|Number|128|128.0||||||
3849310|NCT01654666|3674983|B3|Symptomatic||Clinical manifestation|Clinical manifestation of the target carotid artery stenosis.|participants|Number|42|42.0||||||
3849311|NCT01654666|3674984|B2|Symptomatic||Clinical manifestation|Clinical manifestation of the target carotid artery stenosis.|participants|Number|45|45.0||||||
3849312|NCT01654666|3674985|B1|Symptomatic||Clinical manifestation|Clinical manifestation of the target carotid artery stenosis.|participants|Number|41|41.0||||||
3849313|NCT01654666|3674982|B4|No new DWI lesions||Pre-treatment scans||participants|Number|184|184.0||||||
3849314|NCT01654666|3674983|B3|No new DWI lesions||Pre-treatment scans||participants|Number|62|62.0||||||
3849315|NCT01654666|3674984|B2|No new DWI lesions||Pre-treatment scans||participants|Number|61|61.0||||||
3849316|NCT01654666|3674985|B1|No new DWI lesions||Pre-treatment scans||participants|Number|61|61.0||||||
3849317|NCT01654666|3674982|B4|New DWI lesions||Pre-treatment scans||participants|Number|5|5.0||||||
3849318|NCT01654666|3674983|B3|New DWI lesions||Pre-treatment scans||participants|Number|1|1.0||||||
3849319|NCT01654666|3674984|B2|New DWI lesions||Pre-treatment scans||participants|Number|2|2.0||||||
3849320|NCT01654666|3674985|B1|New DWI lesions||Pre-treatment scans||participants|Number|2|2.0||||||
3849321|NCT01654666|3674982|B4|Han race||Race/Ethnicity, Customized||participants|Number|189|189.0||||||
3849322|NCT01654666|3674983|B3|Han race||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
3849323|NCT01654666|3674984|B2|Han race||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
3849324|NCT01654666|3674985|B1|Han race||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
3849325|NCT01654666|3674982|B4||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3849326|NCT01654666|3674983|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3849327|NCT01654666|3674984|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3849328|NCT01654666|3674985|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3849329|NCT01654666|3674982|B4||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3849330|NCT01654666|3674983|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3849331|NCT01654666|3674984|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3849332|NCT01654666|3674985|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3849333|NCT01654666|3674982|B4|||Age||years|Mean|66.56|66.56|Standard Deviation|8.58|8.58|||
3849334|NCT01654666|3674983|B3|||Age||years|Mean|65.71|65.71|Standard Deviation|8.61|8.61|||
3849335|NCT01654666|3674984|B2|||Age||years|Mean|66.47|66.47|Standard Deviation|8.54|8.54|||
3849336|NCT01654666|3674985|B1|||Age||years|Mean|67.49|67.49|Standard Deviation|8.63|8.63|||
3849337|NCT01654601|3675010|B3|Korea, Republic of||Region of Enrollment||participants|Number|28|28.0||||||
3849338|NCT01654601|3675011|B2|Korea, Republic of||Region of Enrollment||participants|Number|14|14.0||||||
3849339|NCT01654601|3675012|B1|Korea, Republic of||Region of Enrollment||participants|Number|14|14.0||||||
3849340|NCT01654601|3675010|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849341|NCT01654601|3675011|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849342|NCT01654601|3675012|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849343|NCT01654601|3675010|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849344|NCT01654601|3675011|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849345|NCT01654601|3675012|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849346|NCT01654601|3675010|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849347|NCT01654601|3675011|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849348|NCT01654601|3675012|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849349|NCT01654601|3675010|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849350|NCT01654601|3675011|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849351|NCT01654601|3675012|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849352|NCT01654601|3675010|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849353|NCT01654601|3675011|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849354|NCT01654601|3675012|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849355|NCT01654601|3675010|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3849356|NCT01654601|3675011|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3849357|NCT01654601|3675012|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3849358|NCT01654601|3675010|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849359|NCT01654601|3675011|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849360|NCT01654601|3675012|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849361|NCT01654601|3675010|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3849362|NCT01654601|3675011|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3849363|NCT01654601|3675012|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3849364|NCT01654601|3675010|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3849365|NCT01654601|3675011|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3849366|NCT01654601|3675012|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3849367|NCT01654601|3675010|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3849368|NCT01654601|3675011|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3849369|NCT01654601|3675012|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3849370|NCT01654601|3675010|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3849371|NCT01654601|3675011|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3849372|NCT01654601|3675012|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3849373|NCT01654601|3675010|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3849374|NCT01654601|3675011|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3849375|NCT01654601|3675012|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3849376|NCT01654549|3675025|B3|Iran, Islamic Republic of||Region of Enrollment||participants|Number|40|40.0||||||
3849377|NCT01654549|3675026|B2|Iran, Islamic Republic of||Region of Enrollment||participants|Number|20|20.0||||||
3849378|NCT01654549|3675027|B1|Iran, Islamic Republic of||Region of Enrollment||participants|Number|20|20.0||||||
3849379|NCT01654549|3675025|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3849380|NCT01654549|3675026|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3849381|NCT01654549|3675027|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3849382|NCT01654549|3675025|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3849383|NCT01654549|3675026|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3849384|NCT01654549|3675027|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3849385|NCT01654549|3675025|B3|||Age||years|Mean|41.57|41.57|Standard Deviation|12.30|12.3|||
3849386|NCT01654549|3675026|B2|||Age||years|Mean|41.11|41.11|Standard Deviation|10.14|10.14|||
3849387|NCT01654549|3675027|B1|||Age||years|Mean|42.90|42.9|Standard Deviation|13.96|13.96|||
3849388|NCT01654549|3675025|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3849389|NCT01654549|3675026|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3849390|NCT01654549|3675027|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3849391|NCT01654549|3675025|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3849392|NCT01654549|3675026|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3849393|NCT01654549|3675027|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3849394|NCT01654549|3675025|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3849395|NCT01654549|3675026|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3849396|NCT01654549|3675027|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3849397|NCT01654536|3675038|B3|United States||Region of Enrollment||participants|Number|737|737.0||||||
3849398|NCT01654536|3675039|B2|United States||Region of Enrollment||participants|Number|369|369.0||||||
3849399|NCT01654536|3675040|B1|United States||Region of Enrollment||participants|Number|368|368.0||||||
3849400|NCT01654536|3675038|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3849401|NCT01654536|3675039|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3849402|NCT01654536|3675040|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3849403|NCT01654536|3675038|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3849404|NCT01654536|3675039|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3849405|NCT01654536|3675040|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3849406|NCT01654536|3675038|B3||White|Race (NIH/OMB)||Participants|Count of Participants|561|561.0||||||
3849407|NCT01654536|3675039|B2||White|Race (NIH/OMB)||Participants|Count of Participants|289|289.0||||||
3849408|NCT01654536|3675040|B1||White|Race (NIH/OMB)||Participants|Count of Participants|272|272.0||||||
3849409|NCT01654536|3675038|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|127|127.0||||||
3849410|NCT01654536|3675039|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3849411|NCT01654536|3675040|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3849412|NCT01654536|3675038|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3849413|NCT01654536|3675039|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3849414|NCT01654536|3675040|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3849415|NCT01654536|3675038|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3849416|NCT01654536|3675039|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3849417|NCT01654536|3675040|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3849418|NCT01654536|3675038|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3849419|NCT01654536|3675039|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3849420|NCT01654536|3675040|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3849421|NCT01654536|3675038|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3849422|NCT01654536|3675039|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3849423|NCT01654536|3675040|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3849424|NCT01654536|3675038|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|629|629.0||||||
3849425|NCT01654536|3675039|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|314|314.0||||||
3849426|NCT01654536|3675040|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|315|315.0||||||
3849427|NCT01654536|3675038|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
3849428|NCT01654536|3675039|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3849429|NCT01654536|3675040|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3849430|NCT01654536|3675038|B3||Male|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
3849431|NCT01654536|3675039|B2||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3849432|NCT01654536|3675040|B1||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3849433|NCT01654536|3675038|B3||Female|Sex: Female, Male||Participants|Count of Participants|482|482.0||||||
3849434|NCT01654536|3675039|B2||Female|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
3849435|NCT01654536|3675040|B1||Female|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
3849436|NCT01654536|3675038|B3|||Age||years|Mean|37.8|37.8|Standard Deviation|14.05|14.05|||
3849437|NCT01654536|3675039|B2|||Age||years|Mean|37.7|37.7|Standard Deviation|14.03|14.03|||
3849438|NCT01654536|3675040|B1|||Age||years|Mean|37.9|37.9|Standard Deviation|14.09|14.09|||
3849439|NCT01654536|3675038|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3849440|NCT01654536|3675039|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3849441|NCT01654536|3675040|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3849442|NCT01654536|3675038|B3||Between 18 and 65 years|Age||Participants|Count of Participants|643|643.0||||||
3849443|NCT01654536|3675039|B2||Between 18 and 65 years|Age||Participants|Count of Participants|321|321.0||||||
3849444|NCT01654536|3675040|B1||Between 18 and 65 years|Age||Participants|Count of Participants|322|322.0||||||
3849445|NCT01654536|3675038|B3||<=18 years|Age||Participants|Count of Participants|83|83.0||||||
3849446|NCT01654536|3675039|B2||<=18 years|Age||Participants|Count of Participants|43|43.0||||||
3849447|NCT01654536|3675040|B1||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
3849448|NCT01654523|3675077|B1|||Massachusetts General Hospital Hair Pulling Scale|The Massachusetts General Hospital Hair Pulling Scale was used to measure the severity and associated functional impairment related to trichotillomania. This self-report instrument yields a total severity score. It contains seven items. Each item on this scale yields a score from 0 – 4 with 4 indicating the highest severity. The lowest possible total score is zero and the highest possible score, indicating highest severity of trichotillomania is 28.|units on a scale|Mean|16.12|16.12|Standard Deviation|4.07|4.07|||
3849449|NCT01654523|3675077|B1|||NIMH Trichotillomania Severity and Impairment Scale|The NIMH Trichotillomania Severity and Impairment Scale was used to measure baseline severity and associated functional impairment of trichotillomania. This clinician-rated instrument yields a severity score that measures average time spent pulling, time spent pulling on the previous day, resistance to pulling urges, distress associated with pulling, and interference related to trichotillomania. Each item yields a score from 0 – 5 with 5 indicating the highest severity, resulting in a total of 25 possible points.|units on a scale|Mean|13.00|13.0|Standard Deviation|4.04|4.04|||
3849450|NCT01654523|3675077|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3849451|NCT01654523|3675077|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849452|NCT01654523|3675077|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849453|NCT01654523|3675077|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3849454|NCT01654523|3675077|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3849455|NCT01654523|3675077|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849456|NCT01654523|3675077|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849457|NCT01654523|3675077|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849458|NCT01654523|3675077|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3849459|NCT01654523|3675077|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3849460|NCT01654523|3675077|B1|||Age||years|Mean|32.93|32.93|Standard Deviation|9.635|9.635|||
3849461|NCT01654302|3675081|B3|||Baseline Index Knee Pain Scores|Subject average baseline index knee pain scores are reported prior to intervention for each group - Synera then Placebo and Placebo then Synera. Index knee pain was reported using the Numeric Rating Scale, a scale from 0 to 10 where 0 = no pain and 10 = the worst pain possible.|units on a scale|Mean|6.08|6.08|Standard Deviation|1.33|1.33|||
3849462|NCT01654302|3675082|B2|||Baseline Index Knee Pain Scores|Subject average baseline index knee pain scores are reported prior to intervention for each group - Synera then Placebo and Placebo then Synera. Index knee pain was reported using the Numeric Rating Scale, a scale from 0 to 10 where 0 = no pain and 10 = the worst pain possible.|units on a scale|Mean|6.26|6.26|Standard Deviation|1.37|1.37|||
3849463|NCT01654302|3675083|B1|||Baseline Index Knee Pain Scores|Subject average baseline index knee pain scores are reported prior to intervention for each group - Synera then Placebo and Placebo then Synera. Index knee pain was reported using the Numeric Rating Scale, a scale from 0 to 10 where 0 = no pain and 10 = the worst pain possible.|units on a scale|Mean|5.90|5.9|Standard Deviation|1.25|1.25|||
3849464|NCT01654302|3675081|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
3849465|NCT01654302|3675082|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3849466|NCT01654302|3675083|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3849467|NCT01654302|3675081|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849468|NCT01654302|3675082|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849469|NCT01654302|3675083|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849470|NCT01654302|3675081|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849471|NCT01654302|3675082|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849472|NCT01654302|3675083|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849473|NCT01654302|3675081|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3849474|NCT01654302|3675082|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3849475|NCT01654302|3675083|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3849476|NCT01654302|3675081|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3849477|NCT01654302|3675082|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3849478|NCT01654302|3675083|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3849479|NCT01654302|3675081|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849480|NCT01654302|3675082|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849481|NCT01654302|3675083|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849482|NCT01654302|3675081|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849483|NCT01654302|3675082|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849484|NCT01654302|3675083|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849485|NCT01654302|3675081|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849486|NCT01654302|3675082|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849487|NCT01654302|3675083|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849488|NCT01654302|3675081|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3849489|NCT01654302|3675082|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3849490|NCT01654302|3675083|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3849491|NCT01654302|3675081|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3849492|NCT01654302|3675082|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3849493|NCT01654302|3675083|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3849494|NCT01654302|3675081|B3|||Age||years|Mean|58|58.0|Standard Deviation|7.77|7.77|||
3849495|NCT01654302|3675082|B2|||Age||years|Mean|60|60.0|Standard Deviation|8.26|8.26|||
3849496|NCT01654302|3675083|B1|||Age||years|Mean|57|57.0|Standard Deviation|7.01|7.01|||
3849497|NCT01654289|3675090|B4|United States||Region of Enrollment||participants|Number|413|413.0||||||
3849498|NCT01654289|3675091|B3|United States||Region of Enrollment||participants|Number|138|138.0||||||
3849499|NCT01654289|3675092|B2|United States||Region of Enrollment||participants|Number|137|137.0||||||
3849500|NCT01654289|3675093|B1|United States||Region of Enrollment||participants|Number|138|138.0||||||
3849501|NCT01654289|3675090|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849502|NCT01654289|3675091|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849503|NCT01654289|3675092|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849504|NCT01654289|3675093|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849505|NCT01654289|3675090|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3849506|NCT01654289|3675091|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3849507|NCT01654289|3675092|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3849508|NCT01654289|3675093|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3849509|NCT01654289|3675090|B4||White|Race (NIH/OMB)||Participants|Count of Participants|349|349.0||||||
3849510|NCT01654289|3675091|B3||White|Race (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
3849511|NCT01654289|3675092|B2||White|Race (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
3849512|NCT01654289|3675093|B1||White|Race (NIH/OMB)||Participants|Count of Participants|121|121.0||||||
3849513|NCT01654289|3675090|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3849514|NCT01654289|3675091|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3849515|NCT01654289|3675092|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3849516|NCT01654289|3675093|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3849517|NCT01654289|3675090|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849518|NCT01654289|3675091|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849519|NCT01654289|3675092|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849520|NCT01654289|3675093|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849521|NCT01654289|3675090|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3849522|NCT01654289|3675091|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3849523|NCT01654289|3675092|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3849524|NCT01654289|3675093|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3849525|NCT01654289|3675090|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849526|NCT01654289|3675091|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849527|NCT01654289|3675092|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849528|NCT01654289|3675093|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849529|NCT01654289|3675090|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849530|NCT01654289|3675091|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849531|NCT01654289|3675092|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849532|NCT01654289|3675093|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849533|NCT01654289|3675090|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|389|389.0||||||
3849534|NCT01654289|3675091|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
3849535|NCT01654289|3675092|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
3849536|NCT01654289|3675093|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|127|127.0||||||
3849537|NCT01654289|3675090|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3849538|NCT01654289|3675091|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3849539|NCT01654289|3675092|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3849598|NCT01654263|3675151|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3849540|NCT01654289|3675093|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3849541|NCT01654289|3675090|B4||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3849542|NCT01654289|3675091|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3849543|NCT01654289|3675092|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3849544|NCT01654289|3675093|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3849545|NCT01654289|3675090|B4||Female|Sex: Female, Male||Participants|Count of Participants|313|313.0||||||
3849546|NCT01654289|3675091|B3||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3849547|NCT01654289|3675092|B2||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3849548|NCT01654289|3675093|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3849549|NCT01654289|3675090|B4|||Age||years|Mean|49.7|49.7|Standard Deviation|11.6|11.6|||
3849550|NCT01654289|3675091|B3|||Age||years|Mean|50.7|50.7|Standard Deviation|12.1|12.1|||
3849551|NCT01654289|3675092|B2|||Age||years|Mean|49.2|49.2|Standard Deviation|11.2|11.2|||
3849552|NCT01654289|3675093|B1|||Age||years|Mean|49.1|49.1|Standard Deviation|11.4|11.4|||
3849553|NCT01654276|3675133|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3849554|NCT01654276|3675133|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3849555|NCT01654276|3675133|B1|||Age||years|Mean|56|56.0|Standard Deviation|8|8.0|||
3849556|NCT01654263|3675151|B7|United States||Region of Enrollment||participants|Number|884|884.0||||||
3849557|NCT01654263|3675152|B6|United States||Region of Enrollment||participants|Number|149|149.0||||||
3849558|NCT01654263|3675153|B5|United States||Region of Enrollment||participants|Number|140|140.0||||||
3849559|NCT01654263|3675154|B4|United States||Region of Enrollment||participants|Number|145|145.0||||||
3849560|NCT01654263|3675155|B3|United States||Region of Enrollment||participants|Number|139|139.0||||||
3849561|NCT01654263|3675156|B2|United States||Region of Enrollment||participants|Number|147|147.0||||||
3849562|NCT01654263|3675157|B1|United States||Region of Enrollment||participants|Number|164|164.0||||||
3849563|NCT01654263|3675151|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3849564|NCT01654263|3675152|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849565|NCT01654263|3675153|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3849566|NCT01654263|3675154|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3849567|NCT01654263|3675155|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3849568|NCT01654263|3675156|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849569|NCT01654263|3675157|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849570|NCT01654263|3675151|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3849571|NCT01654263|3675152|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3849572|NCT01654263|3675153|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3849573|NCT01654263|3675154|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849574|NCT01654263|3675155|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3849575|NCT01654263|3675156|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3849576|NCT01654263|3675157|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3849577|NCT01654263|3675151|B7||White|Race (NIH/OMB)||Participants|Count of Participants|794|794.0||||||
3849578|NCT01654263|3675152|B6||White|Race (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
3849579|NCT01654263|3675153|B5||White|Race (NIH/OMB)||Participants|Count of Participants|116|116.0||||||
3849580|NCT01654263|3675154|B4||White|Race (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
3849581|NCT01654263|3675155|B3||White|Race (NIH/OMB)||Participants|Count of Participants|114|114.0||||||
3849582|NCT01654263|3675156|B2||White|Race (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
3849583|NCT01654263|3675157|B1||White|Race (NIH/OMB)||Participants|Count of Participants|154|154.0||||||
3849584|NCT01654263|3675151|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3849585|NCT01654263|3675152|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3849586|NCT01654263|3675153|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3849587|NCT01654263|3675154|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3849588|NCT01654263|3675155|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3849589|NCT01654263|3675156|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3849590|NCT01654263|3675157|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3849591|NCT01654263|3675151|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849592|NCT01654263|3675152|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849593|NCT01654263|3675153|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849594|NCT01654263|3675154|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849595|NCT01654263|3675155|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849596|NCT01654263|3675156|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849597|NCT01654263|3675157|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849599|NCT01654263|3675152|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3849600|NCT01654263|3675153|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3849601|NCT01654263|3675154|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3849602|NCT01654263|3675155|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3849603|NCT01654263|3675156|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3849604|NCT01654263|3675157|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849605|NCT01654263|3675151|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3849606|NCT01654263|3675152|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849607|NCT01654263|3675153|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849608|NCT01654263|3675154|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3849609|NCT01654263|3675155|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849610|NCT01654263|3675156|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849611|NCT01654263|3675157|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849612|NCT01654263|3675151|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3849613|NCT01654263|3675152|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849614|NCT01654263|3675153|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849615|NCT01654263|3675154|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3849616|NCT01654263|3675155|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849617|NCT01654263|3675156|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849618|NCT01654263|3675157|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849619|NCT01654263|3675151|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|863|863.0||||||
3849620|NCT01654263|3675152|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|147|147.0||||||
3849621|NCT01654263|3675153|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
3849622|NCT01654263|3675154|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|143|143.0||||||
3849623|NCT01654263|3675155|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
3849624|NCT01654263|3675156|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
3849625|NCT01654263|3675157|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|159|159.0||||||
3849626|NCT01654263|3675151|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3849627|NCT01654263|3675152|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3849628|NCT01654263|3675153|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3849629|NCT01654263|3675154|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3849630|NCT01654263|3675155|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3849631|NCT01654263|3675156|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3849632|NCT01654263|3675157|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3849633|NCT01654263|3675151|B7||Male|Sex: Female, Male||Participants|Count of Participants|372|372.0||||||
3849634|NCT01654263|3675152|B6||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3849635|NCT01654263|3675153|B5||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3849636|NCT01654263|3675154|B4||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3849637|NCT01654263|3675155|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3849638|NCT01654263|3675156|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3849639|NCT01654263|3675157|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3849640|NCT01654263|3675151|B7||Female|Sex: Female, Male||Participants|Count of Participants|512|512.0||||||
3849641|NCT01654263|3675152|B6||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3849642|NCT01654263|3675153|B5||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3849643|NCT01654263|3675154|B4||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3849644|NCT01654263|3675155|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3849645|NCT01654263|3675156|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3849646|NCT01654263|3675157|B1||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3849647|NCT01654263|3675151|B7|||Age||years|Mean|65.0|65.0|Standard Deviation|5.3|5.3|||
3849648|NCT01654263|3675152|B6|||Age||years|Mean|70.3|70.3|Standard Deviation|2.0|2.0|||
3849649|NCT01654263|3675153|B5|||Age||years|Mean|61.0|61.0|Standard Deviation|2.8|2.8|||
3849650|NCT01654263|3675154|B4|||Age||years|Mean|70.5|70.5|Standard Deviation|2.0|2.0|||
3849651|NCT01654263|3675155|B3|||Age||years|Mean|60.8|60.8|Standard Deviation|2.7|2.7|||
3849652|NCT01654263|3675156|B2|||Age||years|Mean|67.6|67.6|Standard Deviation|2.6|2.6|||
3849653|NCT01654263|3675157|B1|||Age||years|Mean|59.7|59.7|Standard Deviation|2.8|2.8|||
3849654|NCT01654263|3675151|B7||>=65 years|Age||Participants|Count of Participants|441|441.0||||||
3849655|NCT01654263|3675152|B6||>=65 years|Age||Participants|Count of Participants|149|149.0||||||
3849656|NCT01654263|3675153|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3849657|NCT01654263|3675154|B4||>=65 years|Age||Participants|Count of Participants|145|145.0||||||
3849658|NCT01654263|3675155|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3849659|NCT01654263|3675156|B2||>=65 years|Age||Participants|Count of Participants|147|147.0||||||
3849660|NCT01654263|3675157|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3849661|NCT01654263|3675151|B7||Between 18 and 65 years|Age||Participants|Count of Participants|443|443.0||||||
3849662|NCT01654263|3675152|B6||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3849663|NCT01654263|3675153|B5||Between 18 and 65 years|Age||Participants|Count of Participants|140|140.0||||||
3849664|NCT01654263|3675154|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3849665|NCT01654263|3675155|B3||Between 18 and 65 years|Age||Participants|Count of Participants|139|139.0||||||
3849666|NCT01654263|3675156|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3849667|NCT01654263|3675157|B1||Between 18 and 65 years|Age||Participants|Count of Participants|164|164.0||||||
3849668|NCT01654263|3675151|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3849669|NCT01654263|3675152|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3849670|NCT01654263|3675153|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3849671|NCT01654263|3675154|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3849672|NCT01654263|3675155|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3849673|NCT01654263|3675156|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3849674|NCT01654263|3675157|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3849675|NCT01654250|3675185|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3849676|NCT01654250|3675186|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3849677|NCT01654250|3675187|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3849678|NCT01654250|3675185|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3849679|NCT01654250|3675186|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3849680|NCT01654250|3675187|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3849681|NCT01654250|3675185|B3|||Age||years|Mean|9.6|9.6|Standard Deviation|1.69|1.69|||
3849682|NCT01654250|3675186|B2|||Age||years|Mean|9.9|9.9|Standard Deviation|1.71|1.71|||
3849683|NCT01654250|3675187|B1|||Age||years|Mean|9.3|9.3|Standard Deviation|1.62|1.62|||
3849684|NCT01654224|3675203|B3|United States||Region of Enrollment||participants|Number|187|187.0||||||
3849685|NCT01654224|3675204|B2|United States||Region of Enrollment||participants|Number|98|98.0||||||
3849686|NCT01654224|3675205|B1|United States||Region of Enrollment||participants|Number|89|89.0||||||
3849687|NCT01654224|3675203|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3849688|NCT01654224|3675204|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3849689|NCT01654224|3675205|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849690|NCT01654224|3675203|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849691|NCT01654224|3675204|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849692|NCT01654224|3675205|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849693|NCT01654224|3675203|B3||White|Race (NIH/OMB)||Participants|Count of Participants|185|185.0||||||
3849694|NCT01654224|3675204|B2||White|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3849695|NCT01654224|3675205|B1||White|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
3849696|NCT01654224|3675203|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849697|NCT01654224|3675204|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849698|NCT01654224|3675205|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849699|NCT01654224|3675203|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849700|NCT01654224|3675204|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849701|NCT01654224|3675205|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849702|NCT01654224|3675203|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849703|NCT01654224|3675204|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849704|NCT01654224|3675205|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849705|NCT01654224|3675203|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849706|NCT01654224|3675204|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849707|NCT01654224|3675205|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849708|NCT01654224|3675203|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3849709|NCT01654224|3675204|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3849710|NCT01654224|3675205|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849711|NCT01654224|3675203|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|185|185.0||||||
3849712|NCT01654224|3675204|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3849713|NCT01654224|3675205|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
3849714|NCT01654224|3675203|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849715|NCT01654224|3675204|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849716|NCT01654224|3675205|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849717|NCT01654224|3675203|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3849718|NCT01654224|3675204|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3849719|NCT01654224|3675205|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3849720|NCT01654224|3675203|B3||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3849721|NCT01654224|3675204|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3849722|NCT01654224|3675205|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3849723|NCT01654224|3675203|B3||>=65 years|Age||Participants|Count of Participants|187|187.0||||||
3849724|NCT01654224|3675204|B2||>=65 years|Age||Participants|Count of Participants|98|98.0||||||
3849725|NCT01654224|3675205|B1||>=65 years|Age||Participants|Count of Participants|89|89.0||||||
3849726|NCT01654224|3675203|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3849727|NCT01654224|3675204|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3849728|NCT01654224|3675205|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3849729|NCT01654224|3675203|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3849730|NCT01654224|3675204|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3849731|NCT01654224|3675205|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3849732|NCT01654107|3675216|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3849733|NCT01654107|3675217|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3849734|NCT01654107|3675218|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3849735|NCT01654107|3675216|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3849736|NCT01654107|3675217|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3849737|NCT01654107|3675218|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3849738|NCT01654107|3675216|B3|||Age||years|Mean|48.40|48.4|Standard Deviation|9.330|9.33|||
3849739|NCT01654107|3675217|B2|||Age||years|Mean|48.93|48.93|Standard Deviation|8.574|8.574|||
3849740|NCT01654107|3675218|B1|||Age||years|Mean|47.82|47.82|Standard Deviation|10.205|10.205|||
3849741|NCT01653964|3675225|B1|United States||Region of Enrollment||Participants|Count of Participants|82|82.0||||||
3849742|NCT01653964|3675225|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849743|NCT01653964|3675225|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849744|NCT01653964|3675225|B1||White|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3849745|NCT01653964|3675225|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849746|NCT01653964|3675225|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849747|NCT01653964|3675225|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849748|NCT01653964|3675225|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849749|NCT01653964|3675225|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3849750|NCT01653964|3675225|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3849751|NCT01653964|3675225|B1|||Age||years|Mean|57|57.0|Standard Deviation|11.3|11.3|||
3849752|NCT01653912|3675229|B3|||Weight||kg|Mean|68.74|68.74|Standard Deviation|15.721|15.721|||
3849753|NCT01653912|3675230|B2|||Weight||kg|Mean|69.45|69.45|Standard Deviation|15.836|15.836|||
3849754|NCT01653912|3675231|B1|||Weight||kg|Mean|68.01|68.01|Standard Deviation|15.847|15.847|||
3849755|NCT01653912|3675229|B3|||Height||cm|Mean|160.86|160.86|Standard Deviation|6.264|6.264|||
3849756|NCT01653912|3675230|B2|||Height||cm|Mean|160.92|160.92|Standard Deviation|6.016|6.016|||
3849757|NCT01653912|3675231|B1|||Height||cm|Mean|160.81|160.81|Standard Deviation|6.609|6.609|||
3849758|NCT01653912|3675229|B3|Russian Federation||Region of Enrollment||participants|Number|5|5.0||||||
3849759|NCT01653912|3675230|B2|Russian Federation||Region of Enrollment||participants|Number|5|5.0||||||
3849760|NCT01653912|3675231|B1|Russian Federation||Region of Enrollment||participants|Number|0|0.0||||||
3849761|NCT01653912|3675229|B3|United Kingdom||Region of Enrollment||participants|Number|26|26.0||||||
3849762|NCT01653912|3675230|B2|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
3849763|NCT01653912|3675231|B1|United Kingdom||Region of Enrollment||participants|Number|16|16.0||||||
3849764|NCT01653912|3675229|B3|Australia||Region of Enrollment||participants|Number|28|28.0||||||
3849765|NCT01653912|3675230|B2|Australia||Region of Enrollment||participants|Number|15|15.0||||||
3849766|NCT01653912|3675231|B1|Australia||Region of Enrollment||participants|Number|13|13.0||||||
3849767|NCT01653912|3675229|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849768|NCT01653912|3675230|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849769|NCT01653912|3675231|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849770|NCT01653912|3675229|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3849771|NCT01653912|3675230|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3849772|NCT01653912|3675231|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3849773|NCT01653912|3675229|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849774|NCT01653912|3675230|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849775|NCT01653912|3675231|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849776|NCT01653912|3675229|B3|Female||Sex/Gender, Customized||participants|Number|59|59.0||||||
3849777|NCT01653912|3675230|B2|Female||Sex/Gender, Customized||participants|Number|30|30.0||||||
3849778|NCT01653912|3675231|B1|Female||Sex/Gender, Customized||participants|Number|29|29.0||||||
3849779|NCT01653912|3675229|B3|65 - 84 years||Age, Customized||participants|Number|26|26.0||||||
3849780|NCT01653912|3675230|B2|65 - 84 years||Age, Customized||participants|Number|15|15.0||||||
3849781|NCT01653912|3675231|B1|65 - 84 years||Age, Customized||participants|Number|11|11.0||||||
3849782|NCT01653912|3675229|B3|18 - 64 years||Age, Customized||participants|Number|33|33.0||||||
3849783|NCT01653912|3675230|B2|18 - 64 years||Age, Customized||participants|Number|15|15.0||||||
3849784|NCT01653912|3675231|B1|18 - 64 years||Age, Customized||participants|Number|18|18.0||||||
3849785|NCT01653782|3675251|B4|Sweden||Region of Enrollment||participants|Number|159|159.0||||||
3849786|NCT01653782|3675252|B3|Sweden||Region of Enrollment||participants|Number|52|52.0||||||
3849787|NCT01653782|3675253|B2|Sweden||Region of Enrollment||participants|Number|55|55.0||||||
3849788|NCT01653782|3675254|B1|Sweden||Region of Enrollment||participants|Number|52|52.0||||||
3849789|NCT01653782|3675251|B4||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3849790|NCT01653782|3675252|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3849791|NCT01653782|3675253|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3849792|NCT01653782|3675254|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3849793|NCT01653782|3675251|B4||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3849794|NCT01653782|3675252|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3849795|NCT01653782|3675253|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3849796|NCT01653782|3675254|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3849797|NCT01653782|3675251|B4|||Age||years|Mean|45.7|45.7|Standard Deviation|10.3|10.3|||
3849798|NCT01653782|3675252|B3|||Age||years|Mean|46.9|46.9|Standard Deviation|9.6|9.6|||
3849799|NCT01653782|3675253|B2|||Age||years|Mean|43.9|43.9|Standard Deviation|11.7|11.7|||
3849800|NCT01653782|3675254|B1|||Age||years|Mean|46.3|46.3|Standard Deviation|9.3|9.3|||
3849801|NCT01653782|3675251|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3849802|NCT01653782|3675252|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3849803|NCT01653782|3675253|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3849804|NCT01653782|3675254|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3849805|NCT01653782|3675251|B4||Between 18 and 65 years|Age||Participants|Count of Participants|159|159.0||||||
3849806|NCT01653782|3675252|B3||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3849807|NCT01653782|3675253|B2||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
3849808|NCT01653782|3675254|B1||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3849809|NCT01653782|3675251|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3849810|NCT01653782|3675252|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3849811|NCT01653782|3675253|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3849812|NCT01653782|3675254|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3849813|NCT01653743|3675264|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3849814|NCT01653743|3675265|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3849815|NCT01653743|3675266|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3849816|NCT01653743|3675264|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3849817|NCT01653743|3675265|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3849818|NCT01653743|3675266|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3849819|NCT01653743|3675264|B3|||Age||years|Mean|31.96|31.96|Standard Deviation|3.506|3.506|||
3849820|NCT01653743|3675265|B2|||Age||years|Mean|30.67|30.67|Standard Deviation|3.603|3.603|||
3849821|NCT01653743|3675266|B1|||Age||years|Mean|32.61|32.61|Standard Deviation|3.303|3.303|||
3849822|NCT01653587|3675281|B3|Brazil||Region of Enrollment||participants|Number|240|240.0||||||
3849823|NCT01653587|3675282|B2|Brazil||Region of Enrollment||participants|Number|120|120.0||||||
3849824|NCT01653587|3675283|B1|Brazil||Region of Enrollment||participants|Number|120|120.0||||||
3849825|NCT01653587|3675281|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|240|240.0||||||
3849826|NCT01653587|3675282|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
3849827|NCT01653587|3675283|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
3849828|NCT01653587|3675281|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849829|NCT01653587|3675282|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849830|NCT01653587|3675283|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849831|NCT01653587|3675281|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849832|NCT01653587|3675282|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849833|NCT01653587|3675283|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849834|NCT01653587|3675281|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849835|NCT01653587|3675282|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849836|NCT01653587|3675283|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849837|NCT01653587|3675281|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849838|NCT01653587|3675282|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849839|NCT01653587|3675283|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849840|NCT01653587|3675281|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849841|NCT01653587|3675282|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849842|NCT01653587|3675283|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849843|NCT01653587|3675281|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849844|NCT01653587|3675282|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849845|NCT01653587|3675283|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849846|NCT01653587|3675281|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849847|NCT01653587|3675282|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849848|NCT01653587|3675283|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849849|NCT01653587|3675281|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849850|NCT01653587|3675282|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849851|NCT01653587|3675283|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849852|NCT01653587|3675281|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|240|240.0||||||
3849853|NCT01653587|3675282|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
3849854|NCT01653587|3675283|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
3849855|NCT01653587|3675281|B3||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
3849856|NCT01653587|3675282|B2||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3849857|NCT01653587|3675283|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3849858|NCT01653587|3675281|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3849859|NCT01653587|3675282|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3849860|NCT01653587|3675283|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3849861|NCT01653587|3675281|B3|||Age||years|Mean|63.0|63.0|Standard Deviation|10.7|10.7|||
3849862|NCT01653587|3675282|B2|||Age||years|Mean|63.6|63.6|Standard Deviation|10.2|10.2|||
3849863|NCT01653587|3675283|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|11.2|11.2|||
3849864|NCT01653587|3675281|B3||>=65 years|Age||Participants|Count of Participants|108|108.0||||||
3849865|NCT01653587|3675282|B2||>=65 years|Age||Participants|Count of Participants|53|53.0||||||
3849866|NCT01653587|3675283|B1||>=65 years|Age||Participants|Count of Participants|55|55.0||||||
3849867|NCT01653587|3675281|B3||Between 18 and 65 years|Age||Participants|Count of Participants|132|132.0||||||
3849868|NCT01653587|3675282|B2||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
3849869|NCT01653587|3675283|B1||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
3849870|NCT01653587|3675281|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3849871|NCT01653587|3675282|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3849872|NCT01653587|3675283|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3849873|NCT01653509|3675294|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3849874|NCT01653509|3675295|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3849875|NCT01653509|3675296|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3849876|NCT01653509|3675294|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3849877|NCT01653509|3675295|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3849878|NCT01653509|3675296|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3849879|NCT01653509|3675294|B3|||Age||Years|Mean|45.3|45.3|Standard Deviation|15.11|15.11|||
3849880|NCT01653509|3675295|B2|||Age||Years|Mean|43.2|43.2|Standard Deviation|15.60|15.6|||
3849881|NCT01653509|3675296|B1|||Age||Years|Mean|47.6|47.6|Standard Deviation|14.88|14.88|||
3849882|NCT01653418|3675315|B1|||Number of Prior Therapies (including prior transplant)||prior therapies|Median|4|4.0|Full Range|||3.0|6.0|
3849883|NCT01653418|3675315|B1|||Time from Diagnosis to V-BEAM transplant||months|Median|42|42.0|Full Range|||27.0|118.0|
3849884|NCT01653418|3675315|B1|||Time to Progression from First Transplant||months|Median|29|29.0|Full Range|||17.0|97.0|
3849885|NCT01653418|3675315|B1|Light chain only||Monoclonal Protein Type|"Antibodies typically consist of 2 heavy chains and 2 light chains. There are 5 kinds of heavy chains termed IgG, IgA, IgM, IgD, and IgE; and 2 distinct types of light chain, termed kappa and lambda. In myeloma, all the abnormal plasma cells make the same antibody. Therefore the myeloma can be classified by the type of light and heavy chains produced, such as IgG kappa, IgG lambda, IgA kappa, or IgA lambda, etc.~Occasionally, the malignant plasma cells make only the light chain component of the antibody. These patients are said to have “light chain myeloma.”"|participants|Number|2|2.0||||||
3849886|NCT01653418|3675315|B1|IgA||Monoclonal Protein Type|"Antibodies typically consist of 2 heavy chains and 2 light chains. There are 5 kinds of heavy chains termed IgG, IgA, IgM, IgD, and IgE; and 2 distinct types of light chain, termed kappa and lambda. In myeloma, all the abnormal plasma cells make the same antibody. Therefore the myeloma can be classified by the type of light and heavy chains produced, such as IgG kappa, IgG lambda, IgA kappa, or IgA lambda, etc.~Occasionally, the malignant plasma cells make only the light chain component of the antibody. These patients are said to have “light chain myeloma.”"|participants|Number|5|5.0||||||
3849915|NCT01653132|3675627|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3849916|NCT01653132|3675627|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3849887|NCT01653418|3675315|B1|IgG||Monoclonal Protein Type|"Antibodies typically consist of 2 heavy chains and 2 light chains. There are 5 kinds of heavy chains termed IgG, IgA, IgM, IgD, and IgE; and 2 distinct types of light chain, termed kappa and lambda. In myeloma, all the abnormal plasma cells make the same antibody. Therefore the myeloma can be classified by the type of light and heavy chains produced, such as IgG kappa, IgG lambda, IgA kappa, or IgA lambda, etc.~Occasionally, the malignant plasma cells make only the light chain component of the antibody. These patients are said to have “light chain myeloma.”"|participants|Number|3|3.0||||||
3849888|NCT01653418|3675315|B1|Unknown||International Staging System (ISS) Stage of Myeloma on Diagnosis|"STAGE I~-Serum beta-2 microglobulin is less than 3.5 (mg/L) and the albumin level is above 3.5 (g/L)~STAGE II -Neither stage I or III~STAGE III~-Serum beta-2 microglobulin is greater than 5.5"|participants|Number|1|1.0||||||
3849889|NCT01653418|3675315|B1|Stage III||International Staging System (ISS) Stage of Myeloma on Diagnosis|"STAGE I~-Serum beta-2 microglobulin is less than 3.5 (mg/L) and the albumin level is above 3.5 (g/L)~STAGE II -Neither stage I or III~STAGE III~-Serum beta-2 microglobulin is greater than 5.5"|participants|Number|2|2.0||||||
3849890|NCT01653418|3675315|B1|Stage II||International Staging System (ISS) Stage of Myeloma on Diagnosis|"STAGE I~-Serum beta-2 microglobulin is less than 3.5 (mg/L) and the albumin level is above 3.5 (g/L)~STAGE II -Neither stage I or III~STAGE III~-Serum beta-2 microglobulin is greater than 5.5"|participants|Number|5|5.0||||||
3849891|NCT01653418|3675315|B1|Stage I||International Staging System (ISS) Stage of Myeloma on Diagnosis|"STAGE I~-Serum beta-2 microglobulin is less than 3.5 (mg/L) and the albumin level is above 3.5 (g/L)~STAGE II -Neither stage I or III~STAGE III~-Serum beta-2 microglobulin is greater than 5.5"|participants|Number|2|2.0||||||
3849892|NCT01653418|3675315|B1|Stage IIIA||Durie-Salmon Stage of Myeloma on Diagnosis|"STAGE I~Hemoglobin >10g/dL~Serum calcium normal or <10.5mg/dL~Bone x-ray, normal bone structure (scale 0), or solitary bone plasmacytoma only~Low M-component production rates IgG value <5g/dL; IgA value <3g/dL~Urine light chain M-component on electrophoresis <4g/24h~STAGE II -Neither Stage I or Stage III~STAGE III~Hemoglobin <8.5g/dL~Serum calcium >12mg/dL~Advanced lytic bone lesions (scale 3) -High M-component production rates IgG value >7g/dL IgA value >5g/dL- Bence Jones protein >12g/24h~SUBCLASS~-A: relatively normal renal function (serum creatinine) <2.0 mg/dL"|participants|Number|7|7.0||||||
3849893|NCT01653418|3675315|B1|Stage IIA||Durie-Salmon Stage of Myeloma on Diagnosis|"STAGE I~Hemoglobin >10g/dL~Serum calcium normal or <10.5mg/dL~Bone x-ray, normal bone structure (scale 0), or solitary bone plasmacytoma only~Low M-component production rates IgG value <5g/dL; IgA value <3g/dL~Urine light chain M-component on electrophoresis <4g/24h~STAGE II -Neither Stage I or Stage III~STAGE III~Hemoglobin <8.5g/dL~Serum calcium >12mg/dL~Advanced lytic bone lesions (scale 3) -High M-component production rates IgG value >7g/dL IgA value >5g/dL- Bence Jones protein >12g/24h~SUBCLASS~-A: relatively normal renal function (serum creatinine) <2.0 mg/dL"|participants|Number|3|3.0||||||
3849894|NCT01653418|3675315|B1|Stage I||Durie-Salmon Stage of Myeloma on Diagnosis|"STAGE I~Hemoglobin >10g/dL~Serum calcium normal or <10.5mg/dL~Bone x-ray, normal bone structure (scale 0), or solitary bone plasmacytoma only~Low M-component production rates IgG value <5g/dL; IgA value <3g/dL~Urine light chain M-component on electrophoresis <4g/24h~STAGE II -Neither Stage I or Stage III~STAGE III~Hemoglobin <8.5g/dL~Serum calcium >12mg/dL~Advanced lytic bone lesions (scale 3) -High M-component production rates IgG value >7g/dL IgA value >5g/dL- Bence Jones protein >12g/24h~SUBCLASS~-A: relatively normal renal function (serum creatinine) <2.0 mg/dL"|participants|Number|0|0.0||||||
3849895|NCT01653418|3675315|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3849896|NCT01653418|3675315|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3849897|NCT01653418|3675315|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3849898|NCT01653418|3675315|B1|||Age||years|Median|64.5|64.5|Full Range|||48.0|69.0|
3849899|NCT01653327|3675327|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3849900|NCT01653327|3675327|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3849901|NCT01653327|3675327|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3849902|NCT01653327|3675327|B1|||Age||Years|Mean|56.45|56.45|Full Range|||41.0|76.0|
3849903|NCT01653262|3675335|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3849904|NCT01653262|3675335|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3849905|NCT01653262|3675335|B1|||Age||years|Mean|35.8|35.8|Standard Deviation|11.8|11.8|||
3849906|NCT01653262|3675335|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3849907|NCT01653262|3675335|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3849908|NCT01653262|3675335|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3849909|NCT01653158|3675348|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3849910|NCT01653158|3675348|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3849911|NCT01653158|3675348|B1|||Age||Years|Mean|59.4|59.4|Standard Deviation|11.4|11.4|||
3849912|NCT01653132|3675627|B1|||saliva weight||gms|Mean|2.13|2.13|Standard Deviation|4.19|4.19|||
3849913|NCT01653132|3675627|B1|||DFSS|"Drooling Frequency and Severity Score:~The Drooling Score equals the sum of the Severity and Frequency sub-scores.The total score ranges from 2 to 9, with higher scores indicating more severe and frequent drooling~Drooling Severity Scale~= Never drools, dry~= Mild-drooling, only lips wet~= Moderate- drool reaches the lips and chin~= Severe- drool drips off chin & onto clothing~= Profuse- drooling off the body and onto objects (furniture, books)~Drooling Frequency Scale~= No drooling~= Occasionally drools~= Frequently drools~= Constant drooling"|units on a scale|Median|6|6.0|Inter-Quartile Range|||6.0|7.0|
3849914|NCT01653132|3675627|B1|||UPDRS|Unified Parkinsons Disease Rating Scale. The UPDRS is a rating tool to follow the longitudinal course of Parkinson's Disease. It is made up of the 1) Mentation, Behavior, and Mood, 2) Activities of Daily Living and 3) Motor sections. These are evaluated by interview. We used UPDRS, Part 2 Questions 5,6,7 evaluating speech, salivation and swallowing and Part 3 questions 18 and 19 for motor examination of speech and facial expression. The scores for these sections were summed to obtain the total score. The range possible is 0- 20, with 20 reflecting worse disability|units on a scale|Median|8.4|8.4|Inter-Quartile Range|||7.0|9.0|
3849917|NCT01653132|3675627|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3849918|NCT01653132|3675627|B1|||Age||years|Mean|68.1|68.1|Standard Deviation|9.7|9.7|||
3849919|NCT01653028|3675642|B6|United States||Region of Enrollment||participants|Number|72|72.0||||||
3849920|NCT01653028|3675643|B5|United States||Region of Enrollment||participants|Number|29|29.0||||||
3849921|NCT01653028|3675644|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
3849922|NCT01653028|3675645|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3849923|NCT01653028|3675646|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3849924|NCT01653028|3675647|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3849925|NCT01653028|3675642|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3849926|NCT01653028|3675643|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3849927|NCT01653028|3675644|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849928|NCT01653028|3675645|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849929|NCT01653028|3675646|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849930|NCT01653028|3675647|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849931|NCT01653028|3675642|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849932|NCT01653028|3675643|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849933|NCT01653028|3675644|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849934|NCT01653028|3675645|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849935|NCT01653028|3675646|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849936|NCT01653028|3675647|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849937|NCT01653028|3675642|B6||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3849938|NCT01653028|3675643|B5||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3849939|NCT01653028|3675644|B4||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3849940|NCT01653028|3675645|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3849941|NCT01653028|3675646|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3849942|NCT01653028|3675647|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3849943|NCT01653028|3675642|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3849944|NCT01653028|3675643|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3849945|NCT01653028|3675644|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3849946|NCT01653028|3675645|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3849947|NCT01653028|3675646|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849948|NCT01653028|3675647|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849949|NCT01653028|3675642|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849950|NCT01653028|3675643|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849951|NCT01653028|3675644|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849952|NCT01653028|3675645|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849953|NCT01653028|3675646|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849954|NCT01653028|3675647|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849955|NCT01653028|3675642|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3849956|NCT01653028|3675643|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849957|NCT01653028|3675644|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3849958|NCT01653028|3675645|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849959|NCT01653028|3675646|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849960|NCT01653028|3675647|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3849961|NCT01653028|3675642|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3849962|NCT01653028|3675643|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3849963|NCT01653028|3675644|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849964|NCT01653028|3675645|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849965|NCT01653028|3675646|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849966|NCT01653028|3675647|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3849967|NCT01653028|3675642|B6||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3849968|NCT01653028|3675643|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3849969|NCT01653028|3675644|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3849970|NCT01653028|3675645|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3849971|NCT01653028|3675646|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3849972|NCT01653028|3675647|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3849973|NCT01653028|3675642|B6||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3849974|NCT01653028|3675643|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3849975|NCT01653028|3675644|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3849976|NCT01653028|3675645|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3849977|NCT01653028|3675646|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3849978|NCT01653028|3675647|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3849979|NCT01653028|3675642|B6|||Age||years|Median|54.5|54.5|Full Range|||20.0|84.0|
3849980|NCT01653028|3675643|B5|||Age||years|Median|49|49.0|Full Range|||20.0|83.0|
3849981|NCT01653028|3675644|B4|||Age||years|Median|52.5|52.5|Full Range|||29.0|71.0|
3849982|NCT01653028|3675645|B3|||Age||years|Median|66|66.0|Full Range|||49.0|76.0|
3849983|NCT01653028|3675646|B2|||Age||years|Median|56.5|56.5|Full Range|||39.0|84.0|
3849984|NCT01653028|3675647|B1|||Age||years|Median|61|61.0|Full Range|||40.0|72.0|
3849985|NCT01652885|3675678|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3849986|NCT01652885|3675678|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3849987|NCT01652885|3675678|B1|||Age||years|Mean|15.0|15.0|Standard Deviation|1.55|1.55|||
3849988|NCT01652872|3675703|B3||No|Previous RBC transfusions||Participants|Count of Participants|471|471.0||||||
3849989|NCT01652872|3675704|B2||No|Previous RBC transfusions||Participants|Count of Participants|239|239.0||||||
3849990|NCT01652872|3675705|B1||No|Previous RBC transfusions||Participants|Count of Participants|232|232.0||||||
3849991|NCT01652872|3675703|B3||Yes|Previous RBC transfusions||Participants|Count of Participants|285|285.0||||||
3849992|NCT01652872|3675704|B2||Yes|Previous RBC transfusions||Participants|Count of Participants|140|140.0||||||
3849993|NCT01652872|3675705|B1||Yes|Previous RBC transfusions||Participants|Count of Participants|145|145.0||||||
3849994|NCT01652872|3675703|B3||Mixed race/Other|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3849995|NCT01652872|3675704|B2||Mixed race/Other|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3849996|NCT01652872|3675705|B1||Mixed race/Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3849997|NCT01652872|3675703|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|435|435.0||||||
3849998|NCT01652872|3675704|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|215|215.0||||||
3849999|NCT01652872|3675705|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|220|220.0||||||
3850000|NCT01652872|3675703|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3850001|NCT01652872|3675704|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3850002|NCT01652872|3675705|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3850003|NCT01652872|3675703|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|259|259.0||||||
3850004|NCT01652872|3675704|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|134|134.0||||||
3850005|NCT01652872|3675705|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|125|125.0||||||
3850006|NCT01652872|3675703|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
3850007|NCT01652872|3675704|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3850008|NCT01652872|3675705|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3850009|NCT01652872|3675703|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3850010|NCT01652872|3675704|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3850011|NCT01652872|3675705|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3850012|NCT01652872|3675703|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850013|NCT01652872|3675704|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850014|NCT01652872|3675705|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850015|NCT01652872|3675703|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|569|569.0||||||
3850016|NCT01652872|3675704|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|284|284.0||||||
3850017|NCT01652872|3675705|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|285|285.0||||||
3850018|NCT01652872|3675703|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|187|187.0||||||
3850019|NCT01652872|3675704|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3850020|NCT01652872|3675705|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
3850021|NCT01652872|3675703|B3||Male|Sex: Female, Male||Participants|Count of Participants|315|315.0||||||
3850022|NCT01652872|3675704|B2||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3850023|NCT01652872|3675705|B1||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3850024|NCT01652872|3675703|B3||Female|Sex: Female, Male||Participants|Count of Participants|441|441.0||||||
3850025|NCT01652872|3675704|B2||Female|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
3850026|NCT01652872|3675705|B1||Female|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
3850027|NCT01652872|3675703|B3||>=85 years|Age, Customized||Participants|Count of Participants|98|98.0||||||
3850028|NCT01652872|3675704|B2||>=85 years|Age, Customized||Participants|Count of Participants|52|52.0||||||
3850029|NCT01652872|3675705|B1||>=85 years|Age, Customized||Participants|Count of Participants|46|46.0||||||
3850030|NCT01652872|3675703|B3||75 - 84 years|Age, Customized||Participants|Count of Participants|202|202.0||||||
3850031|NCT01652872|3675704|B2||75 - 84 years|Age, Customized||Participants|Count of Participants|97|97.0||||||
3850032|NCT01652872|3675705|B1||75 - 84 years|Age, Customized||Participants|Count of Participants|105|105.0||||||
3850033|NCT01652872|3675703|B3||65 - 74 years|Age, Customized||Participants|Count of Participants|193|193.0||||||
3850034|NCT01652872|3675704|B2||65 - 74 years|Age, Customized||Participants|Count of Participants|96|96.0||||||
3850035|NCT01652872|3675705|B1||65 - 74 years|Age, Customized||Participants|Count of Participants|97|97.0||||||
3850036|NCT01652872|3675703|B3||18 - 64 years|Age, Customized||Participants|Count of Participants|263|263.0||||||
3850037|NCT01652872|3675704|B2||18 - 64 years|Age, Customized||Participants|Count of Participants|134|134.0||||||
3850038|NCT01652872|3675705|B1||18 - 64 years|Age, Customized||Participants|Count of Participants|129|129.0||||||
3850039|NCT01652872|3675703|B3|||Age||years|Mean|69.4|69.4|Standard Deviation|13.3|13.3|||
3850040|NCT01652872|3675704|B2|||Age||years|Mean|69.5|69.5|Standard Deviation|13.1|13.1|||
3850041|NCT01652872|3675705|B1|||Age||years|Mean|69.2|69.2|Standard Deviation|13.5|13.5|||
3850042|NCT01652729|3675720|B4|||Fasting Plasma Glucose||mg/dL|Mean|176.8|176.8|Standard Deviation|44.82|44.82|||
3850043|NCT01652729|3675721|B3|||Fasting Plasma Glucose||mg/dL|Mean|172.8|172.8|Standard Deviation|44.31|44.31|||
3850044|NCT01652729|3675722|B2|||Fasting Plasma Glucose||mg/dL|Mean|176.9|176.9|Standard Deviation|42.50|42.5|||
3850045|NCT01652729|3675723|B1|||Fasting Plasma Glucose||mg/dL|Mean|178.0|178.0|Standard Deviation|46.64|46.64|||
3850046|NCT01652729|3675720|B4|>= 9.0%||HbA1c Stratum||participants|Number|114|114.0||||||
3850047|NCT01652729|3675721|B3|>= 9.0%||HbA1c Stratum||participants|Number|19|19.0||||||
3850048|NCT01652729|3675722|B2|>= 9.0%||HbA1c Stratum||participants|Number|39|39.0||||||
3850049|NCT01652729|3675723|B1|>= 9.0%||HbA1c Stratum||participants|Number|56|56.0||||||
3850050|NCT01652729|3675720|B4|< 9.0%||HbA1c Stratum||participants|Number|250|250.0||||||
3850051|NCT01652729|3675721|B3|< 9.0%||HbA1c Stratum||participants|Number|42|42.0||||||
3850052|NCT01652729|3675722|B2|< 9.0%||HbA1c Stratum||participants|Number|83|83.0||||||
3850053|NCT01652729|3675723|B1|< 9.0%||HbA1c Stratum||participants|Number|125|125.0||||||
3850054|NCT01652729|3675720|B4|||Baseline HbA1c||percentage of total hemoglobin|Mean|8.46|8.46|Standard Deviation|1.018|1.018|||
3850055|NCT01652729|3675721|B3|||Baseline HbA1c||percentage of total hemoglobin|Mean|8.50|8.5|Standard Deviation|1.043|1.043|||
3850056|NCT01652729|3675722|B2|||Baseline HbA1c||percentage of total hemoglobin|Mean|8.50|8.5|Standard Deviation|1.043|1.043|||
3850057|NCT01652729|3675723|B1|||Baseline HbA1c||percentage of total hemoglobin|Mean|8.42|8.42|Standard Deviation|0.997|0.997|||
3850058|NCT01652729|3675720|B4|||Weight||kg|Mean|88.76|88.76|Standard Deviation|20.778|20.778|||
3850059|NCT01652729|3675721|B3|||Weight||kg|Mean|88.95|88.95|Standard Deviation|20.136|20.136|||
3850060|NCT01652729|3675722|B2|||Weight||kg|Mean|88.09|88.09|Standard Deviation|20.282|20.282|||
3850061|NCT01652729|3675723|B1|||Weight||kg|Mean|89.15|89.15|Standard Deviation|21.413|21.413|||
3850062|NCT01652729|3675720|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|144|144.0||||||
3850063|NCT01652729|3675721|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
3850064|NCT01652729|3675722|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|45|45.0||||||
3850065|NCT01652729|3675723|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|70|70.0||||||
3850066|NCT01652729|3675720|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|220|220.0||||||
3850067|NCT01652729|3675721|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
3850068|NCT01652729|3675722|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|77|77.0||||||
3850069|NCT01652729|3675723|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|111|111.0||||||
3850070|NCT01652729|3675720|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3850071|NCT01652729|3675721|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3850072|NCT01652729|3675722|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3850073|NCT01652729|3675723|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3850074|NCT01652729|3675720|B4|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3850075|NCT01652729|3675721|B3|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3850076|NCT01652729|3675722|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3850077|NCT01652729|3675723|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3850078|NCT01652729|3675720|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3850079|NCT01652729|3675721|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3850080|NCT01652729|3675722|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3850081|NCT01652729|3675723|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3850082|NCT01652729|3675720|B4|Asian||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3850083|NCT01652729|3675721|B3|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3850084|NCT01652729|3675722|B2|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3850085|NCT01652729|3675723|B1|Asian||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3850086|NCT01652729|3675720|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|49|49.0||||||
3850087|NCT01652729|3675721|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3850088|NCT01652729|3675722|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
3850089|NCT01652729|3675723|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
3850090|NCT01652729|3675720|B4|White||Race/Ethnicity, Customized||Participants|Number|296|296.0||||||
3850091|NCT01652729|3675721|B3|White||Race/Ethnicity, Customized||Participants|Number|50|50.0||||||
3850092|NCT01652729|3675722|B2|White||Race/Ethnicity, Customized||Participants|Number|98|98.0||||||
3850093|NCT01652729|3675723|B1|White||Race/Ethnicity, Customized||Participants|Number|148|148.0||||||
3850094|NCT01652729|3675720|B4||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
3850095|NCT01652729|3675721|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3850096|NCT01652729|3675722|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3850097|NCT01652729|3675723|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3850098|NCT01652729|3675720|B4||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3850099|NCT01652729|3675721|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3850100|NCT01652729|3675722|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3850101|NCT01652729|3675723|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3850102|NCT01652729|3675720|B4|>=65 years||Age, Customized||Participants|Number|50|50.0||||||
3850103|NCT01652729|3675721|B3|>=65 years||Age, Customized||Participants|Number|7|7.0||||||
3850104|NCT01652729|3675722|B2|>=65 years||Age, Customized||Participants|Number|16|16.0||||||
3850105|NCT01652729|3675723|B1|>=65 years||Age, Customized||Participants|Number|27|27.0||||||
3850106|NCT01652729|3675720|B4|<65 years||Age, Customized||Participants|Number|314|314.0||||||
3850107|NCT01652729|3675721|B3|<65 years||Age, Customized||Participants|Number|54|54.0||||||
3850108|NCT01652729|3675722|B2|<65 years||Age, Customized||Participants|Number|106|106.0||||||
3850109|NCT01652729|3675723|B1|<65 years||Age, Customized||Participants|Number|154|154.0||||||
3850110|NCT01652729|3675720|B4|||Age||Years|Mean|53.7|53.7|Standard Deviation|9.49|9.49|||
3850111|NCT01652729|3675721|B3|||Age||Years|Mean|53.4|53.4|Standard Deviation|9.48|9.48|||
3850112|NCT01652729|3675722|B2|||Age||Years|Mean|54.3|54.3|Standard Deviation|9.01|9.01|||
3850113|NCT01652729|3675723|B1|||Age||Years|Mean|53.4|53.4|Standard Deviation|9.82|9.82|||
3850114|NCT01652716|3675745|B3|||Duration of diabetes||Years|Mean|8.52|8.52|Standard Deviation|6.132|6.132|||
3850115|NCT01652716|3675746|B2|||Duration of diabetes||Years|Mean|8.47|8.47|Standard Deviation|5.961|5.961|||
3850116|NCT01652716|3675747|B1|||Duration of diabetes||Years|Mean|8.55|8.55|Standard Deviation|6.249|6.249|||
3850117|NCT01652716|3675745|B3|||Fasting plasma glucose||mg/dL|Mean|182.03|182.03|Standard Deviation|45.437|45.437|||
3850118|NCT01652716|3675746|B2|||Fasting plasma glucose||mg/dL|Mean|183.77|183.77|Standard Deviation|46.904|46.904|||
3850119|NCT01652716|3675747|B1|||Fasting plasma glucose||mg/dL|Mean|180.92|180.92|Standard Deviation|44.538|44.538|||
3850120|NCT01652716|3675745|B3|Not Recorded||HbA1c Stratum||Number of subjects|Number|2|2.0||||||
3850121|NCT01652716|3675746|B2|Not Recorded||HbA1c Stratum||Number of subjects|Number|0|0.0||||||
3850122|NCT01652716|3675747|B1|Not Recorded||HbA1c Stratum||Number of subjects|Number|2|2.0||||||
3850123|NCT01652716|3675745|B3|>=9.0%||HbA1c Stratum||Number of subjects|Number|117|117.0||||||
3850124|NCT01652716|3675746|B2|>=9.0%||HbA1c Stratum||Number of subjects|Number|49|49.0||||||
3850125|NCT01652716|3675747|B1|>=9.0%||HbA1c Stratum||Number of subjects|Number|68|68.0||||||
3850126|NCT01652716|3675745|B3|<9.0%||HbA1c Stratum||Number of subjects|Number|256|256.0||||||
3850127|NCT01652716|3675746|B2|<9.0%||HbA1c Stratum||Number of subjects|Number|97|97.0||||||
3850128|NCT01652716|3675747|B1|<9.0%||HbA1c Stratum||Number of subjects|Number|159|159.0||||||
3850129|NCT01652716|3675745|B3|||Baseline HbA1c||Percentage of total hemoglobin|Mean|8.48|8.48|Standard Deviation|1.029|1.029|||
3850130|NCT01652716|3675746|B2|||Baseline HbA1c||Percentage of total hemoglobin|Mean|8.51|8.51|Standard Deviation|1.004|1.004|||
3850131|NCT01652716|3675747|B1|||Baseline HbA1c||Percentage of total hemoglobin|Mean|8.47|8.47|Standard Deviation|1.047|1.047|||
3850132|NCT01652716|3675745|B3|||Weight||lbs|Mean|214.00|214.0|Standard Deviation|46.445|46.445|||
3850133|NCT01652716|3675746|B2|||Weight||lbs|Mean|213.19|213.19|Standard Deviation|40.834|40.834|||
3850134|NCT01652716|3675747|B1|||Weight||lbs|Mean|214.52|214.52|Standard Deviation|49.788|49.788|||
3850135|NCT01652716|3675745|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3850136|NCT01652716|3675746|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3850137|NCT01652716|3675747|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3850138|NCT01652716|3675745|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3850139|NCT01652716|3675746|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3850140|NCT01652716|3675747|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3850141|NCT01652716|3675745|B3|Other||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3850142|NCT01652716|3675746|B2|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3850143|NCT01652716|3675747|B1|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3850144|NCT01652716|3675745|B3|Asian||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
3850145|NCT01652716|3675746|B2|Asian||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3850146|NCT01652716|3675747|B1|Asian||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
3850147|NCT01652716|3675745|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|61|61.0||||||
3850148|NCT01652716|3675746|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
3850149|NCT01652716|3675747|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|38|38.0||||||
3850150|NCT01652716|3675745|B3|White||Race/Ethnicity, Customized||Participants|Number|278|278.0||||||
3850151|NCT01652716|3675746|B2|White||Race/Ethnicity, Customized||Participants|Number|110|110.0||||||
3850152|NCT01652716|3675747|B1|White||Race/Ethnicity, Customized||Participants|Number|168|168.0||||||
3850153|NCT01652716|3675745|B3|Unknown||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3850154|NCT01652716|3675746|B2|Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3850155|NCT01652716|3675747|B1|Unknown||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3850156|NCT01652716|3675745|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|286|286.0||||||
3850157|NCT01652716|3675746|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|112|112.0||||||
3850158|NCT01652716|3675747|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|174|174.0||||||
3850159|NCT01652716|3675745|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|88|88.0||||||
3850160|NCT01652716|3675746|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|34|34.0||||||
3850161|NCT01652716|3675747|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|54|54.0||||||
3850162|NCT01652716|3675745|B3||Male|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
3850163|NCT01652716|3675746|B2||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3850164|NCT01652716|3675747|B1||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3850165|NCT01652716|3675745|B3||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3850166|NCT01652716|3675746|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3850167|NCT01652716|3675747|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3850168|NCT01652716|3675745|B3|>=65 years||Age, Customized||Participants|Number|75|75.0||||||
3850169|NCT01652716|3675746|B2|>=65 years||Age, Customized||Participants|Number|28|28.0||||||
3850170|NCT01652716|3675747|B1|>=65 years||Age, Customized||Participants|Number|47|47.0||||||
3850171|NCT01652716|3675745|B3|<65 years||Age, Customized||Participants|Number|300|300.0||||||
3850172|NCT01652716|3675746|B2|<65 years||Age, Customized||Participants|Number|118|118.0||||||
3850173|NCT01652716|3675747|B1|<65 years||Age, Customized||Participants|Number|182|182.0||||||
3850174|NCT01652716|3675745|B3|||Age||Years|Mean|56.0|56.0|Standard Deviation|9.62|9.62|||
3850175|NCT01652716|3675746|B2|||Age||Years|Mean|56.5|56.5|Standard Deviation|9.04|9.04|||
3850176|NCT01652716|3675747|B1|||Age||Years|Mean|55.6|55.6|Standard Deviation|9.98|9.98|||
3850177|NCT01652703|3675762|B7|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|0.732|0.732|Standard Deviation|0.162|0.162|||
3850178|NCT01652703|3675763|B6|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|0.714|0.714|Standard Deviation|0.158|0.158|||
3850179|NCT01652703|3675764|B5|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|0.725|0.725|Standard Deviation|0.151|0.151|||
3850180|NCT01652703|3675765|B4|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|0.722|0.722|Standard Deviation|0.163|0.163|||
3850181|NCT01652703|3675766|B3|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|0.743|0.743|Standard Deviation|0.177|0.177|||
3850182|NCT01652703|3675767|B2|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|0.741|0.741|Standard Deviation|0.177|0.177|||
3850183|NCT01652703|3675768|B1|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|0.750|0.75|Standard Deviation|0.150|0.15|||
3850184|NCT01652703|3675762|B7|||Total Cholesterol/HDL-C Ratio||ratio|Mean|4.300|4.3|Standard Deviation|1.026|1.026|||
3850185|NCT01652703|3675763|B6|||Total Cholesterol/HDL-C Ratio||ratio|Mean|4.210|4.21|Standard Deviation|0.955|0.955|||
3850186|NCT01652703|3675764|B5|||Total Cholesterol/HDL-C Ratio||ratio|Mean|4.228|4.228|Standard Deviation|0.993|0.993|||
3850187|NCT01652703|3675765|B4|||Total Cholesterol/HDL-C Ratio||ratio|Mean|4.302|4.302|Standard Deviation|1.039|1.039|||
3850188|NCT01652703|3675766|B3|||Total Cholesterol/HDL-C Ratio||ratio|Mean|4.366|4.366|Standard Deviation|1.177|1.177|||
3850189|NCT01652703|3675767|B2|||Total Cholesterol/HDL-C Ratio||ratio|Mean|4.317|4.317|Standard Deviation|1.075|1.075|||
3850190|NCT01652703|3675768|B1|||Total Cholesterol/HDL-C Ratio||ratio|Mean|4.380|4.38|Standard Deviation|0.949|0.949|||
3850191|NCT01652703|3675762|B7|||Very Low-Density Lipoprotein Cholesterol (VLDL-C) Concentration||mg/dL|Mean|26.4|26.4|Standard Deviation|11.3|11.3|||
3850192|NCT01652703|3675763|B6|||Very Low-Density Lipoprotein Cholesterol (VLDL-C) Concentration||mg/dL|Mean|27.0|27.0|Standard Deviation|12.0|12.0|||
3850193|NCT01652703|3675764|B5|||Very Low-Density Lipoprotein Cholesterol (VLDL-C) Concentration||mg/dL|Mean|24.6|24.6|Standard Deviation|10.5|10.5|||
3850194|NCT01652703|3675765|B4|||Very Low-Density Lipoprotein Cholesterol (VLDL-C) Concentration||mg/dL|Mean|25.6|25.6|Standard Deviation|10.8|10.8|||
3850195|NCT01652703|3675766|B3|||Very Low-Density Lipoprotein Cholesterol (VLDL-C) Concentration||mg/dL|Mean|26.9|26.9|Standard Deviation|13.3|13.3|||
3850196|NCT01652703|3675767|B2|||Very Low-Density Lipoprotein Cholesterol (VLDL-C) Concentration||mg/dL|Mean|27.1|27.1|Standard Deviation|10.7|10.7|||
3850197|NCT01652703|3675768|B1|||Very Low-Density Lipoprotein Cholesterol (VLDL-C) Concentration||mg/dL|Mean|26.9|26.9|Standard Deviation|10.5|10.5|||
3850198|NCT01652703|3675762|B7|||Apolipoprotein B Concentration||mg/dL|Mean|111.5|111.5|Standard Deviation|16.7|16.7|||
3850199|NCT01652703|3675763|B6|||Apolipoprotein B Concentration||mg/dL|Mean|109.8|109.8|Standard Deviation|15.9|15.9|||
3850200|NCT01652703|3675764|B5|||Apolipoprotein B Concentration||mg/dL|Mean|109.6|109.6|Standard Deviation|16.9|16.9|||
3850201|NCT01652703|3675765|B4|||Apolipoprotein B Concentration||mg/dL|Mean|109.4|109.4|Standard Deviation|16.0|16.0|||
3850202|NCT01652703|3675766|B3|||Apolipoprotein B Concentration||mg/dL|Mean|113.1|113.1|Standard Deviation|19.2|19.2|||
3850203|NCT01652703|3675767|B2|||Apolipoprotein B Concentration||mg/dL|Mean|112.5|112.5|Standard Deviation|16.6|16.6|||
3850204|NCT01652703|3675768|B1|||Apolipoprotein B Concentration||mg/dL|Mean|114.6|114.6|Standard Deviation|15.4|15.4|||
3850205|NCT01652703|3675762|B7|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|168.2|168.2|Standard Deviation|25.0|25.0|||
3850206|NCT01652703|3675763|B6|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|166.7|166.7|Standard Deviation|23.5|23.5|||
3850207|NCT01652703|3675764|B5|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|165.5|165.5|Standard Deviation|24.4|24.4|||
3850208|NCT01652703|3675765|B4|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|166.3|166.3|Standard Deviation|26.2|26.2|||
3850209|NCT01652703|3675766|B3|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|170.6|170.6|Standard Deviation|27.2|27.2|||
3850210|NCT01652703|3675767|B2|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|168.7|168.7|Standard Deviation|26.1|26.1|||
3850211|NCT01652703|3675768|B1|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|171.3|171.3|Standard Deviation|23.0|23.0|||
3850212|NCT01652703|3675762|B7|||LDL-C Concentration|LDL-C was measured using ultracentrifugation.|mg/dL|Mean|141.8|141.8|Standard Deviation|20.9|20.9|||
3850213|NCT01652703|3675763|B6|||LDL-C Concentration|LDL-C was measured using ultracentrifugation.|mg/dL|Mean|139.7|139.7|Standard Deviation|18.8|18.8|||
3850214|NCT01652703|3675764|B5|||LDL-C Concentration|LDL-C was measured using ultracentrifugation.|mg/dL|Mean|141.0|141.0|Standard Deviation|21.2|21.2|||
3850215|NCT01652703|3675765|B4|||LDL-C Concentration|LDL-C was measured using ultracentrifugation.|mg/dL|Mean|140.7|140.7|Standard Deviation|23.3|23.3|||
3850216|NCT01652703|3675766|B3|||LDL-C Concentration|LDL-C was measured using ultracentrifugation.|mg/dL|Mean|143.6|143.6|Standard Deviation|20.6|20.6|||
3850217|NCT01652703|3675767|B2|||LDL-C Concentration|LDL-C was measured using ultracentrifugation.|mg/dL|Mean|141.8|141.8|Standard Deviation|23.4|23.4|||
3850218|NCT01652703|3675768|B1|||LDL-C Concentration|LDL-C was measured using ultracentrifugation.|mg/dL|Mean|144.4|144.4|Standard Deviation|18.1|18.1|||
3850219|NCT01652703|3675762|B7|Yes||Stratification Factor: Diagnosis of Heterozygous Familial Hypercholesterolemia (HeFH)||participants|Number|20|20.0||||||
3850220|NCT01652703|3675763|B6|Yes||Stratification Factor: Diagnosis of Heterozygous Familial Hypercholesterolemia (HeFH)||participants|Number|4|4.0||||||
3850221|NCT01652703|3675764|B5|Yes||Stratification Factor: Diagnosis of Heterozygous Familial Hypercholesterolemia (HeFH)||participants|Number|4|4.0||||||
3850222|NCT01652703|3675765|B4|Yes||Stratification Factor: Diagnosis of Heterozygous Familial Hypercholesterolemia (HeFH)||participants|Number|3|3.0||||||
3850223|NCT01652703|3675766|B3|Yes||Stratification Factor: Diagnosis of Heterozygous Familial Hypercholesterolemia (HeFH)||participants|Number|2|2.0||||||
3850224|NCT01652703|3675767|B2|Yes||Stratification Factor: Diagnosis of Heterozygous Familial Hypercholesterolemia (HeFH)||participants|Number|3|3.0||||||
3850225|NCT01652703|3675768|B1|Yes||Stratification Factor: Diagnosis of Heterozygous Familial Hypercholesterolemia (HeFH)||participants|Number|4|4.0||||||
3850226|NCT01652703|3675762|B7|No||Stratification Factor: Diagnosis of Heterozygous Familial Hypercholesterolemia (HeFH)||participants|Number|287|287.0||||||
3850227|NCT01652703|3675763|B6|No||Stratification Factor: Diagnosis of Heterozygous Familial Hypercholesterolemia (HeFH)||participants|Number|49|49.0||||||
3850228|NCT01652703|3675764|B5|No||Stratification Factor: Diagnosis of Heterozygous Familial Hypercholesterolemia (HeFH)||participants|Number|47|47.0||||||
3850229|NCT01652703|3675765|B4|No||Stratification Factor: Diagnosis of Heterozygous Familial Hypercholesterolemia (HeFH)||participants|Number|49|49.0||||||
3850230|NCT01652703|3675766|B3|No||Stratification Factor: Diagnosis of Heterozygous Familial Hypercholesterolemia (HeFH)||participants|Number|47|47.0||||||
3850231|NCT01652703|3675767|B2|No||Stratification Factor: Diagnosis of Heterozygous Familial Hypercholesterolemia (HeFH)||participants|Number|47|47.0||||||
3850232|NCT01652703|3675768|B1|No||Stratification Factor: Diagnosis of Heterozygous Familial Hypercholesterolemia (HeFH)||participants|Number|48|48.0||||||
3850233|NCT01652703|3675762|B7|≥ 130 mg/dL||Stratification Factor: LDL Level||participants|Number|209|209.0||||||
3850234|NCT01652703|3675763|B6|≥ 130 mg/dL||Stratification Factor: LDL Level||participants|Number|36|36.0||||||
3850235|NCT01652703|3675764|B5|≥ 130 mg/dL||Stratification Factor: LDL Level||participants|Number|36|36.0||||||
3850236|NCT01652703|3675765|B4|≥ 130 mg/dL||Stratification Factor: LDL Level||participants|Number|35|35.0||||||
3850237|NCT01652703|3675766|B3|≥ 130 mg/dL||Stratification Factor: LDL Level||participants|Number|34|34.0||||||
3850238|NCT01652703|3675767|B2|≥ 130 mg/dL||Stratification Factor: LDL Level||participants|Number|33|33.0||||||
3850239|NCT01652703|3675768|B1|≥ 130 mg/dL||Stratification Factor: LDL Level||participants|Number|35|35.0||||||
3850240|NCT01652703|3675762|B7|< 130 mg/dL||Stratification Factor: LDL Level||participants|Number|98|98.0||||||
3850241|NCT01652703|3675763|B6|< 130 mg/dL||Stratification Factor: LDL Level||participants|Number|17|17.0||||||
3850242|NCT01652703|3675764|B5|< 130 mg/dL||Stratification Factor: LDL Level||participants|Number|15|15.0||||||
3850243|NCT01652703|3675765|B4|< 130 mg/dL||Stratification Factor: LDL Level||participants|Number|17|17.0||||||
3850244|NCT01652703|3675766|B3|< 130 mg/dL||Stratification Factor: LDL Level||participants|Number|15|15.0||||||
3850245|NCT01652703|3675767|B2|< 130 mg/dL||Stratification Factor: LDL Level||participants|Number|17|17.0||||||
3850246|NCT01652703|3675768|B1|< 130 mg/dL||Stratification Factor: LDL Level||participants|Number|17|17.0||||||
3850247|NCT01652703|3675762|B7|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3850248|NCT01652703|3675763|B6|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3850249|NCT01652703|3675764|B5|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3850250|NCT01652703|3675765|B4|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3850251|NCT01652703|3675766|B3|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3850252|NCT01652703|3675767|B2|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3850253|NCT01652703|3675768|B1|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3850254|NCT01652703|3675762|B7|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3850255|NCT01652703|3675763|B6|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3850256|NCT01652703|3675764|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3850257|NCT01652703|3675765|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3850258|NCT01652703|3675766|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3850259|NCT01652703|3675767|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3850260|NCT01652703|3675768|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3850261|NCT01652703|3675762|B7|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3850262|NCT01652703|3675763|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3850263|NCT01652703|3675764|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3850264|NCT01652703|3675765|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3850265|NCT01652703|3675766|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3850266|NCT01652703|3675767|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3850267|NCT01652703|3675768|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3850268|NCT01652703|3675762|B7|Asian||Race/Ethnicity, Customized||participants|Number|307|307.0||||||
3850269|NCT01652703|3675763|B6|Asian||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
3850270|NCT01652703|3675764|B5|Asian||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
3850271|NCT01652703|3675765|B4|Asian||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
3850272|NCT01652703|3675766|B3|Asian||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
3850273|NCT01652703|3675767|B2|Asian||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
3850274|NCT01652703|3675768|B1|Asian||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
3850275|NCT01652703|3675762|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3850276|NCT01652703|3675763|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3850277|NCT01652703|3675764|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3850278|NCT01652703|3675765|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3850279|NCT01652703|3675766|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3850280|NCT01652703|3675767|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3850281|NCT01652703|3675768|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3850282|NCT01652703|3675762|B7||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
3850283|NCT01652703|3675763|B6||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3850284|NCT01652703|3675764|B5||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3850285|NCT01652703|3675765|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3850286|NCT01652703|3675766|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3850287|NCT01652703|3675767|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3850288|NCT01652703|3675768|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3850289|NCT01652703|3675762|B7||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3850290|NCT01652703|3675763|B6||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3850291|NCT01652703|3675764|B5||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3850292|NCT01652703|3675765|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3850293|NCT01652703|3675766|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3850294|NCT01652703|3675767|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3850295|NCT01652703|3675768|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3850296|NCT01652703|3675762|B7|||Age||years|Mean|61.5|61.5|Standard Deviation|9.7|9.7|||
3850297|NCT01652703|3675763|B6|||Age||years|Mean|61.3|61.3|Standard Deviation|9.9|9.9|||
3850298|NCT01652703|3675764|B5|||Age||years|Mean|61.6|61.6|Standard Deviation|9.6|9.6|||
3850299|NCT01652703|3675765|B4|||Age||years|Mean|60.8|60.8|Standard Deviation|9.2|9.2|||
3850300|NCT01652703|3675766|B3|||Age||years|Mean|64.1|64.1|Standard Deviation|9.7|9.7|||
3850301|NCT01652703|3675767|B2|||Age||years|Mean|60.9|60.9|Standard Deviation|9.8|9.8|||
3850302|NCT01652703|3675768|B1|||Age||years|Mean|60.2|60.2|Standard Deviation|10.1|10.1|||
3850303|NCT01652690|3675829|B3|||Time Since Postmenopausal Osteoarthritis Diagnosis||years|Mean|4.1|4.1|Standard Deviation|4.8|4.8|||
3850304|NCT01652690|3675830|B2|||Time Since Postmenopausal Osteoarthritis Diagnosis||years|Mean|3.0|3.0|Standard Deviation|4.1|4.1|||
3850305|NCT01652690|3675831|B1|||Time Since Postmenopausal Osteoarthritis Diagnosis||years|Mean|5.3|5.3|Standard Deviation|5.2|5.2|||
3850306|NCT01652690|3675829|B3|||Age at Menopause||years|Mean|48.3|48.3|Standard Deviation|5.4|5.4|||
3850307|NCT01652690|3675830|B2|||Age at Menopause||years|Mean|48.3|48.3|Standard Deviation|5.2|5.2|||
3850308|NCT01652690|3675831|B1|||Age at Menopause||years|Mean|48.3|48.3|Standard Deviation|5.6|5.6|||
3850309|NCT01652690|3675829|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3850310|NCT01652690|3675830|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3850311|NCT01652690|3675831|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3850312|NCT01652690|3675829|B3||Female|Sex: Female, Male||Participants|Count of Participants|600|600.0||||||
3850313|NCT01652690|3675830|B2||Female|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
3850314|NCT01652690|3675831|B1||Female|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
3850315|NCT01652690|3675829|B3|||Age||years|Mean|66.7|66.7|Standard Deviation|9.0|9.0|||
3850316|NCT01652690|3675830|B2|||Age||years|Mean|64.3|64.3|Standard Deviation|8.6|8.6|||
3850317|NCT01652690|3675831|B1|||Age||years|Mean|69.0|69.0|Standard Deviation|8.7|8.7|||
3850318|NCT01652664|3675864|B3|||Intraocular Pressure||mmHg|Mean|24.4|24.4|Standard Deviation|4.32|4.32|||
3850319|NCT01652664|3675865|B2|||Intraocular Pressure||mmHg|Mean|24.2|24.2|Standard Deviation|4.01|4.01|||
3850320|NCT01652664|3675866|B1|||Intraocular Pressure||mmHg|Mean|24.7|24.7|Standard Deviation|4.62|4.62|||
3850321|NCT01652664|3675864|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3850322|NCT01652664|3675865|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3850323|NCT01652664|3675866|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3850324|NCT01652664|3675864|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3850325|NCT01652664|3675865|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3850326|NCT01652664|3675866|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3850327|NCT01652664|3675864|B3|12 to <18 years||Age, Customized||participants|Number|57|57.0||||||
3850328|NCT01652664|3675865|B2|12 to <18 years||Age, Customized||participants|Number|30|30.0||||||
3850329|NCT01652664|3675866|B1|12 to <18 years||Age, Customized||participants|Number|27|27.0||||||
3850330|NCT01652664|3675864|B3|3 to <12 years||Age, Customized||participants|Number|79|79.0||||||
3850331|NCT01652664|3675865|B2|3 to <12 years||Age, Customized||participants|Number|39|39.0||||||
3850332|NCT01652664|3675866|B1|3 to <12 years||Age, Customized||participants|Number|40|40.0||||||
3850333|NCT01652664|3675864|B3|2 months to <3 years||Age, Customized||participants|Number|16|16.0||||||
3850334|NCT01652664|3675865|B2|2 months to <3 years||Age, Customized||participants|Number|6|6.0||||||
3850335|NCT01652664|3675866|B1|2 months to <3 years||Age, Customized||participants|Number|10|10.0||||||
3850336|NCT01652573|3675874|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
3850337|NCT01652573|3675875|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3850338|NCT01652573|3675876|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3850339|NCT01652573|3675874|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3850340|NCT01652573|3675875|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3850341|NCT01652573|3675876|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3850342|NCT01652573|3675874|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3850343|NCT01652573|3675875|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3850344|NCT01652573|3675876|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3850345|NCT01652573|3675874|B3|||Age||years|Mean|47|47.0|Full Range|||26.0|66.0|
3850346|NCT01652573|3675875|B2|||Age||years|Mean|47|47.0|Full Range|||32.0|64.0|
3850347|NCT01652573|3675876|B1|||Age||years|Mean|47|47.0|Full Range|||26.0|66.0|
3850348|NCT01652495|3675917|B3|Italy||Region of Enrollment||participants|Number|40|40.0||||||
3850349|NCT01652495|3675918|B2|Italy||Region of Enrollment||participants|Number|20|20.0||||||
3850350|NCT01652495|3675919|B1|Italy||Region of Enrollment||participants|Number|20|20.0||||||
3850351|NCT01652495|3675917|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3850352|NCT01652495|3675918|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3850353|NCT01652495|3675919|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3850354|NCT01652495|3675917|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3850355|NCT01652495|3675918|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3850356|NCT01652495|3675919|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3850357|NCT01652495|3675917|B3|||Age||years|Mean|48.70|48.7|Standard Deviation|7.29|7.29|||
3850358|NCT01652495|3675918|B2|||Age||years|Mean|46.35|46.35|Standard Deviation|7.27|7.27|||
3850359|NCT01652495|3675919|B1|||Age||years|Mean|51.05|51.05|Standard Deviation|6.67|6.67|||
3850360|NCT01652495|3675917|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3850361|NCT01652495|3675918|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3850362|NCT01652495|3675919|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3850363|NCT01652495|3675917|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3850364|NCT01652495|3675918|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3850365|NCT01652495|3675919|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3850366|NCT01652495|3675917|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3850367|NCT01652495|3675918|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3850368|NCT01652495|3675919|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3850369|NCT01652287|3675930|B3|||Smoker in Household-Yes||Participants|Count of Participants|3|3.0||||||
3850370|NCT01652287|3675931|B2|||Smoker in Household-Yes||Participants|Count of Participants|3|3.0||||||
3850371|NCT01652287|3675932|B1|||Smoker in Household-Yes||Participants|Count of Participants|0|0.0||||||
3850372|NCT01652287|3675930|B3||No response|Total Household Income||Participants|Count of Participants|1|1.0||||||
3850373|NCT01652287|3675931|B2||No response|Total Household Income||Participants|Count of Participants|0|0.0||||||
3850374|NCT01652287|3675932|B1||No response|Total Household Income||Participants|Count of Participants|1|1.0||||||
3850375|NCT01652287|3675930|B3||>$150,000|Total Household Income||Participants|Count of Participants|12|12.0||||||
3850376|NCT01652287|3675931|B2||>$150,000|Total Household Income||Participants|Count of Participants|6|6.0||||||
3850377|NCT01652287|3675932|B1||>$150,000|Total Household Income||Participants|Count of Participants|6|6.0||||||
3850378|NCT01652287|3675930|B3||$100,001-$150,000|Total Household Income||Participants|Count of Participants|16|16.0||||||
3850379|NCT01652287|3675931|B2||$100,001-$150,000|Total Household Income||Participants|Count of Participants|8|8.0||||||
3850380|NCT01652287|3675932|B1||$100,001-$150,000|Total Household Income||Participants|Count of Participants|8|8.0||||||
3850381|NCT01652287|3675930|B3||$75,001-$100,000|Total Household Income||Participants|Count of Participants|12|12.0||||||
3850382|NCT01652287|3675931|B2||$75,001-$100,000|Total Household Income||Participants|Count of Participants|6|6.0||||||
3850383|NCT01652287|3675932|B1||$75,001-$100,000|Total Household Income||Participants|Count of Participants|6|6.0||||||
3850384|NCT01652287|3675930|B3||$30,001-$75,000|Total Household Income||Participants|Count of Participants|16|16.0||||||
3850385|NCT01652287|3675931|B2||$30,001-$75,000|Total Household Income||Participants|Count of Participants|10|10.0||||||
3850386|NCT01652287|3675932|B1||$30,001-$75,000|Total Household Income||Participants|Count of Participants|6|6.0||||||
3850387|NCT01652287|3675930|B3||$15,000-$30,000|Total Household Income||Participants|Count of Participants|3|3.0||||||
3850388|NCT01652287|3675931|B2||$15,000-$30,000|Total Household Income||Participants|Count of Participants|1|1.0||||||
3850389|NCT01652287|3675932|B1||$15,000-$30,000|Total Household Income||Participants|Count of Participants|2|2.0||||||
3850390|NCT01652287|3675930|B3||Divorced|Parent's Marital Status||Participants|Count of Participants|2|2.0||||||
3850391|NCT01652287|3675931|B2||Divorced|Parent's Marital Status||Participants|Count of Participants|2|2.0||||||
3850392|NCT01652287|3675932|B1||Divorced|Parent's Marital Status||Participants|Count of Participants|0|0.0||||||
3850393|NCT01652287|3675930|B3||Single|Parent's Marital Status||Participants|Count of Participants|4|4.0||||||
3850394|NCT01652287|3675931|B2||Single|Parent's Marital Status||Participants|Count of Participants|1|1.0||||||
3850395|NCT01652287|3675932|B1||Single|Parent's Marital Status||Participants|Count of Participants|3|3.0||||||
3850396|NCT01652287|3675930|B3||Married/Living with partner|Parent's Marital Status||Participants|Count of Participants|54|54.0||||||
3850397|NCT01652287|3675931|B2||Married/Living with partner|Parent's Marital Status||Participants|Count of Participants|28|28.0||||||
3850398|NCT01652287|3675932|B1||Married/Living with partner|Parent's Marital Status||Participants|Count of Participants|26|26.0||||||
3850399|NCT01652287|3675930|B3||No|Child Attends Daycare||Participants|Count of Participants|23|23.0||||||
3850400|NCT01652287|3675931|B2||No|Child Attends Daycare||Participants|Count of Participants|14|14.0||||||
3850401|NCT01652287|3675932|B1||No|Child Attends Daycare||Participants|Count of Participants|9|9.0||||||
3850402|NCT01652287|3675930|B3||Yes|Child Attends Daycare||Participants|Count of Participants|37|37.0||||||
3850403|NCT01652287|3675931|B2||Yes|Child Attends Daycare||Participants|Count of Participants|17|17.0||||||
3850404|NCT01652287|3675932|B1||Yes|Child Attends Daycare||Participants|Count of Participants|20|20.0||||||
3850405|NCT01652287|3675930|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850406|NCT01652287|3675931|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850407|NCT01652287|3675932|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850408|NCT01652287|3675930|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3850409|NCT01652287|3675931|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3850410|NCT01652287|3675932|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3850411|NCT01652287|3675930|B3||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3850412|NCT01652287|3675931|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3850413|NCT01652287|3675932|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3850414|NCT01652287|3675930|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3850415|NCT01652287|3675931|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3850416|NCT01652287|3675932|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3850417|NCT01652287|3675930|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850418|NCT01652287|3675931|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850419|NCT01652287|3675932|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850420|NCT01652287|3675930|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3850421|NCT01652287|3675931|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3850422|NCT01652287|3675932|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3850423|NCT01652287|3675930|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3850424|NCT01652287|3675931|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850425|NCT01652287|3675932|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3850426|NCT01652287|3675930|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850427|NCT01652287|3675931|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850428|NCT01652287|3675932|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850429|NCT01652287|3675930|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3850430|NCT01652287|3675931|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3850431|NCT01652287|3675932|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3850432|NCT01652287|3675930|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3850433|NCT01652287|3675931|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3850434|NCT01652287|3675932|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3850435|NCT01652287|3675930|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3850436|NCT01652287|3675931|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3850437|NCT01652287|3675932|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3850438|NCT01652287|3675930|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3850439|NCT01652287|3675931|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3850440|NCT01652287|3675932|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3850441|NCT01652287|3675930|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3850442|NCT01652287|3675931|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3850443|NCT01652287|3675932|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3850444|NCT01652287|3675930|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3850445|NCT01652287|3675931|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3850446|NCT01652287|3675932|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3850447|NCT01652287|3675930|B3||<=18 years|Age||Participants|Count of Participants|60|60.0||||||
3850448|NCT01652287|3675931|B2||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
3850449|NCT01652287|3675932|B1||<=18 years|Age||Participants|Count of Participants|29|29.0||||||
3850450|NCT01652040|3675939|B3|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3850451|NCT01652040|3675940|B2|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3850452|NCT01652040|3675941|B1|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3850453|NCT01652040|3675939|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850454|NCT01652040|3675940|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850455|NCT01652040|3675941|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850456|NCT01652040|3675939|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850457|NCT01652040|3675940|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850458|NCT01652040|3675941|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850459|NCT01652040|3675939|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3850460|NCT01652040|3675940|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3850461|NCT01652040|3675941|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3850462|NCT01652040|3675939|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3850463|NCT01652040|3675940|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3850464|NCT01652040|3675941|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3850465|NCT01652040|3675939|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850466|NCT01652040|3675940|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850467|NCT01652040|3675941|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850468|NCT01652040|3675939|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850469|NCT01652040|3675940|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850470|NCT01652040|3675941|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850471|NCT01652040|3675939|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850472|NCT01652040|3675940|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850473|NCT01652040|3675941|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850474|NCT01652040|3675939|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3850475|NCT01652040|3675940|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3850476|NCT01652040|3675941|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3850477|NCT01652040|3675939|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3850478|NCT01652040|3675940|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3850479|NCT01652040|3675941|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3850480|NCT01652040|3675939|B3|||Age||years|Mean|36|36.0|Standard Deviation|10|10.0|||
3850481|NCT01652040|3675940|B2|||Age||years|Mean|35|35.0|Standard Deviation|8|8.0|||
3850482|NCT01652040|3675941|B1|||Age||years|Mean|37|37.0|Standard Deviation|12|12.0|||
3850483|NCT01652001|3675950|B3|Spain||Region of Enrollment|Participants were reruited from University of Granada who were attended at dental school|participants|Number|185|185.0||||||
3850484|NCT01652001|3675951|B2|Spain||Region of Enrollment|Participants were reruited from University of Granada who were attended at dental school|participants|Number|85|85.0||||||
3850485|NCT01652001|3675952|B1|Spain||Region of Enrollment|Participants were reruited from University of Granada who were attended at dental school|participants|Number|100|100.0||||||
3850486|NCT01652001|3675950|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3850487|NCT01652001|3675951|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3850488|NCT01652001|3675952|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3850489|NCT01652001|3675950|B3||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3850490|NCT01652001|3675951|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3850491|NCT01652001|3675952|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3850492|NCT01652001|3675950|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3850493|NCT01652001|3675951|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3850494|NCT01652001|3675952|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3850495|NCT01652001|3675950|B3||Between 18 and 65 years|Age||Participants|Count of Participants|185|185.0||||||
3850496|NCT01652001|3675951|B2||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
3850497|NCT01652001|3675952|B1||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
3850498|NCT01652001|3675950|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3850499|NCT01652001|3675951|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3850500|NCT01652001|3675952|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3850501|NCT01651949|3675961|B4||Male|Sex: Female, Male||Participants|Count of Participants|1419|1419.0||||||
3850502|NCT01651949|3675962|B3||Male|Sex: Female, Male||Participants|Count of Participants|313|313.0||||||
3850503|NCT01651949|3675963|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3850504|NCT01651949|3675964|B1||Male|Sex: Female, Male||Participants|Count of Participants|1106|1106.0||||||
3850505|NCT01651949|3675961|B4||Female|Sex: Female, Male||Participants|Count of Participants|1101|1101.0||||||
3850506|NCT01651949|3675962|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3850507|NCT01651949|3675963|B2||Female|Sex: Female, Male||Participants|Count of Participants|1101|1101.0||||||
3850508|NCT01651949|3675964|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3850509|NCT01651949|3675961|B4|||Age||Years|Mean|21.2|21.2|Standard Deviation|2.9|2.9|||
3850510|NCT01651949|3675962|B3|||Age||Years|Mean|22.2|22.2|Standard Deviation|2.4|2.4|||
3850511|NCT01651949|3675963|B2|||Age||Years|Mean|21.3|21.3|Standard Deviation|2.9|2.9|||
3850512|NCT01651949|3675964|B1|||Age||Years|Mean|20.8|20.8|Standard Deviation|3.0|3.0|||
3850513|NCT01651936|3675984|B3||Male|Gender||Participants|Count of Participants|13|13.0||||||
3850514|NCT01651936|3675985|B2||Male|Gender||Participants|Count of Participants|5|5.0||||||
3850515|NCT01651936|3675986|B1||Male|Gender||Participants|Count of Participants|8|8.0||||||
3850516|NCT01651936|3675984|B3||Female|Gender||Participants|Count of Participants|43|43.0||||||
3850517|NCT01651936|3675985|B2||Female|Gender||Participants|Count of Participants|21|21.0||||||
3850518|NCT01651936|3675986|B1||Female|Gender||Participants|Count of Participants|22|22.0||||||
3850519|NCT01651936|3675984|B3|≥65 years||Age, Customized||Participants|Number|15|15.0||||||
3850520|NCT01651936|3675985|B2|≥65 years||Age, Customized||Participants|Number|6|6.0||||||
3850521|NCT01651936|3675986|B1|≥65 years||Age, Customized||Participants|Number|9|9.0||||||
3850522|NCT01651936|3675984|B3|<65 years||Age, Customized||Participants|Number|41|41.0||||||
3850523|NCT01651936|3675985|B2|<65 years||Age, Customized||Participants|Number|20|20.0||||||
3850524|NCT01651936|3675986|B1|<65 years||Age, Customized||Participants|Number|21|21.0||||||
3850525|NCT01651936|3675984|B3|||Age||Years|Mean|58.5|58.5|Standard Deviation|11.8|11.8|||
3850526|NCT01651936|3675985|B2|||Age||Years|Mean|59.3|59.3|Standard Deviation|10.8|10.8|||
3850527|NCT01651936|3675986|B1|||Age||Years|Mean|57.8|57.8|Standard Deviation|12.7|12.7|||
3850528|NCT01651806|3676009|B6|||ASA|"American Society of Anesthesiologists (ASA) Score is a global score that assesses the physical status of patients before surgery.~It is sometimed refereed to as ASA-PS, because it is a measure of ‘physical status’.~ASA 1 A normal healthy patient. ASA 2 A patient with mild systemic disease. ASA 3 A patient with severe systemic disease. ASA 4 A patient with severe systemic disease that is a constant threat to life. ASA 5 A moribund patient who is not expected to survive~The ASA Score is a useful global measure of health."|Scores on a Scale|Mean|2.395|2.395|Standard Deviation|0.67|0.67|||
3850529|NCT01651806|3676010|B5|||ASA|"American Society of Anesthesiologists (ASA) Score is a global score that assesses the physical status of patients before surgery.~It is sometimed refereed to as ASA-PS, because it is a measure of ‘physical status’.~ASA 1 A normal healthy patient. ASA 2 A patient with mild systemic disease. ASA 3 A patient with severe systemic disease. ASA 4 A patient with severe systemic disease that is a constant threat to life. ASA 5 A moribund patient who is not expected to survive~The ASA Score is a useful global measure of health."|Scores on a Scale|Mean|2.26|2.26|Standard Deviation|0.7|0.7|||
3850530|NCT01651806|3676011|B4|||ASA|"American Society of Anesthesiologists (ASA) Score is a global score that assesses the physical status of patients before surgery.~It is sometimed refereed to as ASA-PS, because it is a measure of ‘physical status’.~ASA 1 A normal healthy patient. ASA 2 A patient with mild systemic disease. ASA 3 A patient with severe systemic disease. ASA 4 A patient with severe systemic disease that is a constant threat to life. ASA 5 A moribund patient who is not expected to survive~The ASA Score is a useful global measure of health."|Scores on a Scale|Mean|2.53|2.53|Standard Deviation|0.6|0.6|||
3850531|NCT01651806|3676012|B3|||ASA|"American Society of Anesthesiologists (ASA) Score is a global score that assesses the physical status of patients before surgery.~It is sometimed refereed to as ASA-PS, because it is a measure of ‘physical status’.~ASA 1 A normal healthy patient. ASA 2 A patient with mild systemic disease. ASA 3 A patient with severe systemic disease. ASA 4 A patient with severe systemic disease that is a constant threat to life. ASA 5 A moribund patient who is not expected to survive~The ASA Score is a useful global measure of health."|Scores on a Scale|Mean|2.57|2.57|Standard Deviation|0.5|0.5|||
3850586|NCT01651793|3676035|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850587|NCT01651793|3676035|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3850588|NCT01651793|3676035|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3850589|NCT01651793|3676035|B1|||Age||years|Mean|20|20.0|Standard Deviation|2|2.0|||
3850532|NCT01651806|3676013|B2|||ASA|"American Society of Anesthesiologists (ASA) Score is a global score that assesses the physical status of patients before surgery.~It is sometimed refereed to as ASA-PS, because it is a measure of ‘physical status’.~ASA 1 A normal healthy patient. ASA 2 A patient with mild systemic disease. ASA 3 A patient with severe systemic disease. ASA 4 A patient with severe systemic disease that is a constant threat to life. ASA 5 A moribund patient who is not expected to survive~The ASA Score is a useful global measure of health."|Scores on a Scale|Mean|2.26|2.26|Standard Deviation|0.7|0.7|||
3850533|NCT01651806|3676014|B1|||ASA|"American Society of Anesthesiologists (ASA) Score is a global score that assesses the physical status of patients before surgery.~It is sometimed refereed to as ASA-PS, because it is a measure of ‘physical status’.~ASA 1 A normal healthy patient. ASA 2 A patient with mild systemic disease. ASA 3 A patient with severe systemic disease. ASA 4 A patient with severe systemic disease that is a constant threat to life. ASA 5 A moribund patient who is not expected to survive~The ASA Score is a useful global measure of health."|Scores on a Scale|Mean|2.53|2.53|Standard Deviation|0.6|0.6|||
3850534|NCT01651806|3676009|B6|||BMI||kg/m^2|Mean|33.75|33.75|Standard Deviation|8.436|8.436|||
3850535|NCT01651806|3676010|B5|||BMI||kg/m^2|Mean|35.40|35.4|Standard Deviation|8.50|8.5|||
3850536|NCT01651806|3676011|B4|||BMI||kg/m^2|Mean|32.10|32.1|Standard Deviation|8.04|8.04|||
3850537|NCT01651806|3676012|B3|||BMI||kg/m^2|Mean|36|36.0|Standard Deviation|11.09|11.09|||
3850538|NCT01651806|3676013|B2|||BMI||kg/m^2|Mean|35.40|35.4|Standard Deviation|8.50|8.5|||
3850539|NCT01651806|3676014|B1|||BMI||kg/m^2|Mean|32.10|32.1|Standard Deviation|8.04|8.04|||
3850540|NCT01651806|3676009|B6||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3850541|NCT01651806|3676010|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3850542|NCT01651806|3676011|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3850543|NCT01651806|3676012|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3850544|NCT01651806|3676013|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3850545|NCT01651806|3676014|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3850546|NCT01651806|3676009|B6||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3850547|NCT01651806|3676010|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3850548|NCT01651806|3676011|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3850549|NCT01651806|3676012|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3850550|NCT01651806|3676013|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3850551|NCT01651806|3676014|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3850552|NCT01651806|3676009|B6|||Age||years|Mean|64.38|64.38|Standard Deviation|8.84|8.84|||
3850553|NCT01651806|3676010|B5|||Age||years|Mean|66.50|66.5|Standard Deviation|9.65|9.65|||
3850554|NCT01651806|3676011|B4|||Age||years|Mean|62.26|62.26|Standard Deviation|7.31|7.31|||
3850555|NCT01651806|3676012|B3|||Age||years|Mean|62.40|62.4|Standard Deviation|10.1|10.1|||
3850556|NCT01651806|3676013|B2|||Age||years|Mean|66.50|66.5|Standard Deviation|9.65|9.65|||
3850557|NCT01651806|3676014|B1|||Age||years|Mean|62.26|62.26|Standard Deviation|7.31|7.31|||
3850558|NCT01651806|3676009|B6||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
3850559|NCT01651806|3676010|B5||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3850560|NCT01651806|3676011|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3850561|NCT01651806|3676012|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3850562|NCT01651806|3676013|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3850563|NCT01651806|3676014|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3850564|NCT01651806|3676009|B6||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3850565|NCT01651806|3676010|B5||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3850566|NCT01651806|3676011|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3850567|NCT01651806|3676012|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3850568|NCT01651806|3676013|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3850569|NCT01651806|3676014|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3850570|NCT01651806|3676009|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3850571|NCT01651806|3676010|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3850572|NCT01651806|3676011|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3850573|NCT01651806|3676012|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3850574|NCT01651806|3676013|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3850575|NCT01651806|3676014|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3850576|NCT01651793|3676035|B1|||Weight||kg|Mean|67.05|67.05|Standard Deviation|14.87|14.87|||
3850577|NCT01651793|3676035|B1|||Height||cm|Mean|168.28|168.28|Standard Deviation|1.19|1.19|||
3850578|NCT01651793|3676035|B1|||Amount of sleep on a typical night in the past month (hrs)||hours|Mean|7.4|7.4|Standard Deviation|1.1|1.1|||
3850579|NCT01651793|3676035|B1|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3850580|NCT01651793|3676035|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850581|NCT01651793|3676035|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3850582|NCT01651793|3676035|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3850583|NCT01651793|3676035|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3850584|NCT01651793|3676035|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850585|NCT01651793|3676035|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850590|NCT01651780|3676056|B3|Germany||Region of Enrollment||participants|Number|353|353.0||||||
3850591|NCT01651780|3676057|B2|Germany||Region of Enrollment||participants|Number|173|173.0||||||
3850592|NCT01651780|3676058|B1|Germany||Region of Enrollment||participants|Number|180|180.0||||||
3850593|NCT01651780|3676056|B3|Switzerland||Region of Enrollment||participants|Number|47|47.0||||||
3850594|NCT01651780|3676057|B2|Switzerland||Region of Enrollment||participants|Number|22|22.0||||||
3850595|NCT01651780|3676058|B1|Switzerland||Region of Enrollment||participants|Number|25|25.0||||||
3850596|NCT01651780|3676056|B3|France||Region of Enrollment||participants|Number|214|214.0||||||
3850597|NCT01651780|3676057|B2|France||Region of Enrollment||participants|Number|106|106.0||||||
3850598|NCT01651780|3676058|B1|France||Region of Enrollment||participants|Number|108|108.0||||||
3850599|NCT01651780|3676056|B3|United Kingdom||Region of Enrollment||participants|Number|18|18.0||||||
3850600|NCT01651780|3676057|B2|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
3850601|NCT01651780|3676058|B1|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3850602|NCT01651780|3676056|B3|Italy||Region of Enrollment||participants|Number|76|76.0||||||
3850603|NCT01651780|3676057|B2|Italy||Region of Enrollment||participants|Number|39|39.0||||||
3850604|NCT01651780|3676058|B1|Italy||Region of Enrollment||participants|Number|37|37.0||||||
3850605|NCT01651780|3676056|B3|Netherlands||Region of Enrollment||participants|Number|20|20.0||||||
3850606|NCT01651780|3676057|B2|Netherlands||Region of Enrollment||participants|Number|10|10.0||||||
3850607|NCT01651780|3676058|B1|Netherlands||Region of Enrollment||participants|Number|10|10.0||||||
3850608|NCT01651780|3676056|B3|Canada||Region of Enrollment||participants|Number|74|74.0||||||
3850609|NCT01651780|3676057|B2|Canada||Region of Enrollment||participants|Number|38|38.0||||||
3850610|NCT01651780|3676058|B1|Canada||Region of Enrollment||participants|Number|36|36.0||||||
3850611|NCT01651780|3676056|B3||Male|Sex: Female, Male||Participants|Count of Participants|411|411.0||||||
3850612|NCT01651780|3676057|B2||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3850613|NCT01651780|3676058|B1||Male|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
3850614|NCT01651780|3676056|B3||Female|Sex: Female, Male||Participants|Count of Participants|391|391.0||||||
3850615|NCT01651780|3676057|B2||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
3850616|NCT01651780|3676058|B1||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
3850617|NCT01651780|3676056|B3|||Age||years|Mean|82.3|82.3|Standard Deviation|6.5|6.5|||
3850618|NCT01651780|3676057|B2|||Age||years|Mean|82.3|82.3|Standard Deviation|6.5|6.5|||
3850619|NCT01651780|3676058|B1|||Age||years|Mean|82.3|82.3|Standard Deviation|6.5|6.5|||
3850620|NCT01651403|3676089|B3|||Spine Bone Mineral Density||g/cm^2|Mean|0.599|0.599|Standard Deviation|0.1332|0.1332|||
3850621|NCT01651403|3676090|B2|||Spine Bone Mineral Density||g/cm^2|Mean|0.626|0.626|Standard Deviation|0.1567|0.1567|||
3850622|NCT01651403|3676091|B1|||Spine Bone Mineral Density||g/cm^2|Mean|0.586|0.586|Standard Deviation|0.1196|0.1196|||
3850623|NCT01651403|3676089|B3||Negative or Missing|HBeAb||Participants|Count of Participants|85|85.0||||||
3850624|NCT01651403|3676090|B2||Negative or Missing|HBeAb||Participants|Count of Participants|29|29.0||||||
3850625|NCT01651403|3676091|B1||Negative or Missing|HBeAb||Participants|Count of Participants|56|56.0||||||
3850626|NCT01651403|3676089|B3||Positive|HBeAb||Participants|Count of Participants|4|4.0||||||
3850627|NCT01651403|3676090|B2||Positive|HBeAb||Participants|Count of Participants|0|0.0||||||
3850628|NCT01651403|3676091|B1||Positive|HBeAb||Participants|Count of Participants|4|4.0||||||
3850629|NCT01651403|3676089|B3||Negative|Hepatitis B e antigen (HBeAg)||Participants|Count of Participants|4|4.0||||||
3850630|NCT01651403|3676090|B2||Negative|Hepatitis B e antigen (HBeAg)||Participants|Count of Participants|0|0.0||||||
3850631|NCT01651403|3676091|B1||Negative|Hepatitis B e antigen (HBeAg)||Participants|Count of Participants|4|4.0||||||
3850632|NCT01651403|3676089|B3||Positive|Hepatitis B e antigen (HBeAg)||Participants|Count of Participants|85|85.0||||||
3850633|NCT01651403|3676090|B2||Positive|Hepatitis B e antigen (HBeAg)||Participants|Count of Participants|29|29.0||||||
3850634|NCT01651403|3676091|B1||Positive|Hepatitis B e antigen (HBeAg)||Participants|Count of Participants|56|56.0||||||
3850635|NCT01651403|3676089|B3||Negative|Hepatitis B Virus Surface Antigen (HBsAg)||Participants|Count of Participants|0|0.0||||||
3850636|NCT01651403|3676090|B2||Negative|Hepatitis B Virus Surface Antigen (HBsAg)||Participants|Count of Participants|0|0.0||||||
3850637|NCT01651403|3676091|B1||Negative|Hepatitis B Virus Surface Antigen (HBsAg)||Participants|Count of Participants|0|0.0||||||
3850638|NCT01651403|3676089|B3||Positive|Hepatitis B Virus Surface Antigen (HBsAg)||Participants|Count of Participants|89|89.0||||||
3850639|NCT01651403|3676090|B2||Positive|Hepatitis B Virus Surface Antigen (HBsAg)||Participants|Count of Participants|29|29.0||||||
3850640|NCT01651403|3676091|B1||Positive|Hepatitis B Virus Surface Antigen (HBsAg)||Participants|Count of Participants|60|60.0||||||
3850641|NCT01651403|3676089|B3|||HBV DNA||log10 IU/mL|Mean|8.103|8.103|Standard Deviation|0.9214|0.9214|||
3850642|NCT01651403|3676090|B2|||HBV DNA||log10 IU/mL|Mean|8.133|8.133|Standard Deviation|1.2538|1.2538|||
3850643|NCT01651403|3676091|B1|||HBV DNA||log10 IU/mL|Mean|8.089|8.089|Standard Deviation|0.7208|0.7208|||
3850644|NCT01651403|3676089|B3|India||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3850645|NCT01651403|3676090|B2|India||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3850646|NCT01651403|3676091|B1|India||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3850647|NCT01651403|3676089|B3|Taiwan||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3850648|NCT01651403|3676090|B2|Taiwan||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3850649|NCT01651403|3676091|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3850650|NCT01651403|3676089|B3|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3850651|NCT01651403|3676090|B2|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3850652|NCT01651403|3676091|B1|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3850653|NCT01651403|3676089|B3|Romania||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3850654|NCT01651403|3676090|B2|Romania||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3850655|NCT01651403|3676091|B1|Romania||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3850656|NCT01651403|3676089|B3|South Korea||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3850657|NCT01651403|3676090|B2|South Korea||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3850658|NCT01651403|3676091|B1|South Korea||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3850659|NCT01651403|3676089|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850660|NCT01651403|3676090|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850661|NCT01651403|3676091|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850662|NCT01651403|3676089|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850663|NCT01651403|3676090|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850664|NCT01651403|3676091|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850665|NCT01651403|3676089|B3||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3850666|NCT01651403|3676090|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3850667|NCT01651403|3676091|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3850668|NCT01651403|3676089|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3850669|NCT01651403|3676090|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3850670|NCT01651403|3676091|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3850671|NCT01651403|3676089|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850672|NCT01651403|3676090|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850673|NCT01651403|3676091|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850674|NCT01651403|3676089|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3850675|NCT01651403|3676090|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3850676|NCT01651403|3676091|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3850677|NCT01651403|3676089|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850678|NCT01651403|3676090|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850679|NCT01651403|3676091|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850680|NCT01651403|3676089|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850681|NCT01651403|3676090|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850682|NCT01651403|3676091|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850683|NCT01651403|3676089|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
3850684|NCT01651403|3676090|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3850685|NCT01651403|3676091|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3850686|NCT01651403|3676089|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850687|NCT01651403|3676090|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850688|NCT01651403|3676091|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850689|NCT01651403|3676089|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3850690|NCT01651403|3676090|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3850691|NCT01651403|3676091|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3850692|NCT01651403|3676089|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3850693|NCT01651403|3676090|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3850694|NCT01651403|3676091|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3850695|NCT01651403|3676089|B3|||Age||years|Mean|6|6.0|Standard Deviation|2.8|2.8|||
3850696|NCT01651403|3676090|B2|||Age||years|Mean|7|7.0|Standard Deviation|3.2|3.2|||
3850697|NCT01651403|3676091|B1|||Age||years|Mean|6|6.0|Standard Deviation|2.5|2.5|||
3850698|NCT01651351|3676118|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3850699|NCT01651351|3676119|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3850700|NCT01651351|3676120|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3850701|NCT01651351|3676118|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3850702|NCT01651351|3676119|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3850703|NCT01651351|3676120|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3850704|NCT01651351|3676118|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3850705|NCT01651351|3676119|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3850706|NCT01651351|3676120|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3850707|NCT01651351|3676118|B3|||Age||years|Mean|28|28.0|Standard Deviation|11|11.0|||
3850708|NCT01651351|3676119|B2|||Age||years|Mean|29|29.0|Standard Deviation|13|13.0|||
3850709|NCT01651351|3676120|B1|||Age||years|Mean|27|27.0|Standard Deviation|8|8.0|||
3850710|NCT01651260|3676138|B1|Other||Reason for intubation||participants|Number|5|5.0||||||
3850711|NCT01651260|3676138|B1|Post-operative||Reason for intubation||participants|Number|3|3.0||||||
3850712|NCT01651260|3676138|B1|Respiratory Failure||Reason for intubation||participants|Number|55|55.0||||||
3850713|NCT01651260|3676138|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3850714|NCT01651260|3676138|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3850715|NCT01651260|3676138|B1|||Age||years|Mean|57.8|57.8|Standard Deviation|15.6|15.6|||
3850716|NCT01651208|3676143|B3|Less than High School||Educational level|Achieved high school education or higher|participants|Number|352|352.0||||||
3850717|NCT01651208|3676144|B2|Less than High School||Educational level|Achieved high school education or higher|participants|Number|176|176.0||||||
3850718|NCT01651208|3676145|B1|Less than High School||Educational level|Achieved high school education or higher|participants|Number|176|176.0||||||
3850719|NCT01651208|3676143|B3|High School or Higher||Educational level|Achieved high school education or higher|participants|Number|100|100.0||||||
3850720|NCT01651208|3676144|B2|High School or Higher||Educational level|Achieved high school education or higher|participants|Number|49|49.0||||||
3850721|NCT01651208|3676145|B1|High School or Higher||Educational level|Achieved high school education or higher|participants|Number|51|51.0||||||
3850722|NCT01651208|3676143|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|201|201.0||||||
3850723|NCT01651208|3676144|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3850724|NCT01651208|3676145|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
3850725|NCT01651208|3676143|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850726|NCT01651208|3676144|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850727|NCT01651208|3676145|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850728|NCT01651208|3676143|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850729|NCT01651208|3676144|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850730|NCT01651208|3676145|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850731|NCT01651208|3676143|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|251|251.0||||||
3850732|NCT01651208|3676144|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
3850733|NCT01651208|3676145|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
3850734|NCT01651208|3676143|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850735|NCT01651208|3676144|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850736|NCT01651208|3676145|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850737|NCT01651208|3676143|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850738|NCT01651208|3676144|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850739|NCT01651208|3676145|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850740|NCT01651208|3676143|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850741|NCT01651208|3676144|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850742|NCT01651208|3676145|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850743|NCT01651208|3676143|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850744|NCT01651208|3676144|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850745|NCT01651208|3676145|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850746|NCT01651208|3676143|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|251|251.0||||||
3850747|NCT01651208|3676144|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
3850748|NCT01651208|3676145|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
3850749|NCT01651208|3676143|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|201|201.0||||||
3850750|NCT01651208|3676144|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3850751|NCT01651208|3676145|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
3850752|NCT01651208|3676143|B3||Male|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
3850753|NCT01651208|3676144|B2||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3850754|NCT01651208|3676145|B1||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3850755|NCT01651208|3676143|B3||Female|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
3850756|NCT01651208|3676144|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3850757|NCT01651208|3676145|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3850758|NCT01651208|3676143|B3|||Age||years|Mean|69.52|69.52|Standard Deviation|8.83|8.83|||
3850759|NCT01651208|3676144|B2|||Age||years|Mean|69.94|69.94|Standard Deviation|9.01|9.01|||
3850760|NCT01651208|3676145|B1|||Age||years|Mean|69.11|69.11|Standard Deviation|8.65|8.65|||
3850761|NCT01651104|3676154|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3850762|NCT01651104|3676154|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3850763|NCT01651104|3676154|B1|||Age||Years|Mean|70.5|70.5|Standard Deviation|3.9|3.9|||
3850764|NCT01651039|3676161|B1|Progressive disease||Best response at last treatment||Participants|Count of Participants|1|1.0||||||
3850765|NCT01651039|3676161|B1|Stable Disease||Best response at last treatment||Participants|Count of Participants|6|6.0||||||
3850766|NCT01651039|3676161|B1|Minimal Response||Best response at last treatment||Participants|Count of Participants|9|9.0||||||
3850767|NCT01651039|3676161|B1|Partial Response||Best response at last treatment||Participants|Count of Participants|5|5.0||||||
3850768|NCT01651039|3676161|B1|Very Good Partial Response||Best response at last treatment||Participants|Count of Participants|4|4.0||||||
3850769|NCT01651039|3676161|B1|Complete response||Best response at last treatment||Participants|Count of Participants|2|2.0||||||
3850770|NCT01651039|3676161|B1|||Dex in last len-containing regimen||Participants|Count of Participants|23|23.0||||||
3850771|NCT01651039|3676161|B1|||Dex in most recent prior regimen||Participants|Count of Participants|21|21.0||||||
3850772|NCT01651039|3676161|B1|||Pom in most recent prior regimen||Participants|Count of Participants|3|3.0||||||
3850773|NCT01651039|3676161|B1|||Len in most recent prior regimen||Participants|Count of Participants|13|13.0||||||
3850774|NCT01651039|3676161|B1|||Progressed while on last len regimen||Participants|Count of Participants|22|22.0||||||
3850775|NCT01651039|3676161|B1|Not Len Refractory Patients||Doses of lenalidomide at time of PD on len||Participants|Count of Participants|5|5.0||||||
3850776|NCT01651039|3676161|B1|unknown||Doses of lenalidomide at time of PD on len||Participants|Count of Participants|2|2.0||||||
3850777|NCT01651039|3676161|B1|5||Doses of lenalidomide at time of PD on len||Participants|Count of Participants|1|1.0||||||
3850778|NCT01651039|3676161|B1|10||Doses of lenalidomide at time of PD on len||Participants|Count of Participants|7|7.0||||||
3850779|NCT01651039|3676161|B1|15||Doses of lenalidomide at time of PD on len||Participants|Count of Participants|5|5.0||||||
3850780|NCT01651039|3676161|B1|25||Doses of lenalidomide at time of PD on len||Participants|Count of Participants|7|7.0||||||
3850781|NCT01651039|3676161|B1|||Prior len regimens||regimens|Median|1|1.0|Full Range|||1.0|2.0|
3850782|NCT01651039|3676161|B1|||Median cumulative duration of prior lenalidomide (len) months||months|Median|13|13.0|Full Range|||4.0|20.0|
3850783|NCT01651039|3676161|B1|Carfilzomib||Prior therapy, Refractory|The number of participants that received any of the following chemo drugs and relapsed from it.|Participants|Count of Participants|7|7.0||||||
3850784|NCT01651039|3676161|B1|Bortezomib||Prior therapy, Refractory|The number of participants that received any of the following chemo drugs and relapsed from it.|Participants|Count of Participants|14|14.0||||||
3850785|NCT01651039|3676161|B1|Pomalidomide||Prior therapy, Refractory|The number of participants that received any of the following chemo drugs and relapsed from it.|Participants|Count of Participants|19|19.0||||||
3850786|NCT01651039|3676161|B1|Lenalidomide||Prior therapy, Refractory|The number of participants that received any of the following chemo drugs and relapsed from it.|Participants|Count of Participants|22|22.0||||||
3850787|NCT01651039|3676161|B1|Thalidomide||Prior therapy, Refractory|The number of participants that received any of the following chemo drugs and relapsed from it.|Participants|Count of Participants|2|2.0||||||
3850788|NCT01651039|3676161|B1|Dexamethasone||Prior therapy, Refractory|The number of participants that received any of the following chemo drugs and relapsed from it.|Participants|Count of Participants|19|19.0||||||
3850789|NCT01651039|3676161|B1|Autologous stem cell transplant||Prior Therapy, Exposed|The number of participants that received any of the following chemo drugs|Participants|Count of Participants|20|20.0||||||
3850790|NCT01651039|3676161|B1|Carfilzomib||Prior Therapy, Exposed|The number of participants that received any of the following chemo drugs|Participants|Count of Participants|8|8.0||||||
3850791|NCT01651039|3676161|B1|Bortezomib||Prior Therapy, Exposed|The number of participants that received any of the following chemo drugs|Participants|Count of Participants|27|27.0||||||
3850792|NCT01651039|3676161|B1|Pomalidomide||Prior Therapy, Exposed|The number of participants that received any of the following chemo drugs|Participants|Count of Participants|10|10.0||||||
3850793|NCT01651039|3676161|B1|Lenalidomide||Prior Therapy, Exposed|The number of participants that received any of the following chemo drugs|Participants|Count of Participants|27|27.0||||||
3850794|NCT01651039|3676161|B1|Thalidomide||Prior Therapy, Exposed|The number of participants that received any of the following chemo drugs|Participants|Count of Participants|6|6.0||||||
3850795|NCT01651039|3676161|B1|Dexamethasone||Prior Therapy, Exposed|The number of participants that received any of the following chemo drugs|Participants|Count of Participants|27|27.0||||||
3850796|NCT01651039|3676161|B1|||Prior therapy|The number of prior treatments the participants had received prior to baseline visit|regimens|Median|3|3.0|Full Range|||1.0|10.0|
3850797|NCT01651039|3676161|B1|||Prior regimens|Number of years participant was on any prior regimens|years|Median|3|3.0|Full Range|||1.0|10.0|
3850798|NCT01651039|3676161|B1|||Median time since diagnosis||years|Median|4|4.0|Full Range|||1.6|12.4|
3850799|NCT01651039|3676161|B1|t(11;14)||FISH||Participants|Count of Participants|5|5.0||||||
3850800|NCT01651039|3676161|B1|del(13q)||FISH||Participants|Count of Participants|5|5.0||||||
3850801|NCT01651039|3676161|B1|t(4;14)||FISH||Participants|Count of Participants|4|4.0||||||
3850802|NCT01651039|3676161|B1|chr1 amplification||FISH||Participants|Count of Participants|12|12.0||||||
3850803|NCT01651039|3676161|B1|del(17p)||FISH||Participants|Count of Participants|5|5.0||||||
3850804|NCT01651039|3676161|B1|Any high risk abnormality||FISH||Participants|Count of Participants|17|17.0||||||
3850805|NCT01651039|3676161|B1|Any abnormality||FISH||Participants|Count of Participants|22|22.0||||||
3850806|NCT01651039|3676161|B1|Normal||FISH||Participants|Count of Participants|2|2.0||||||
3850807|NCT01651039|3676161|B1|None||Immunoglobulin subtype||Participants|Count of Participants|4|4.0||||||
3850808|NCT01651039|3676161|B1|IgM||Immunoglobulin subtype||Participants|Count of Participants|1|1.0||||||
3850809|NCT01651039|3676161|B1|IgA||Immunoglobulin subtype||Participants|Count of Participants|8|8.0||||||
3850810|NCT01651039|3676161|B1|IgG||Immunoglobulin subtype||Participants|Count of Participants|14|14.0||||||
3850855|NCT01650844|3676187|B3|||Age||years|Mean|7.8|7.8|Standard Deviation|1.7|1.7|||
3850856|NCT01650844|3676188|B2|||Age||years|Mean|7.9|7.9|Standard Deviation|1.7|1.7|||
3850811|NCT01651039|3676161|B1|missing||ISS Staging|"The International Staging System (ISS) for Multiple Myeloma~Stage 1 ß2-M < 3.5 mg/dL and albumin =3.5 g/dL~Stage 2 Neither stage 1 nor stage 3~Stage 3 ß2-M ≥ 5.5 mg/L"|Participants|Count of Participants|12|12.0||||||
3850812|NCT01651039|3676161|B1|Stage 3||ISS Staging|"The International Staging System (ISS) for Multiple Myeloma~Stage 1 ß2-M < 3.5 mg/dL and albumin =3.5 g/dL~Stage 2 Neither stage 1 nor stage 3~Stage 3 ß2-M ≥ 5.5 mg/L"|Participants|Count of Participants|5|5.0||||||
3850813|NCT01651039|3676161|B1|Stage 2||ISS Staging|"The International Staging System (ISS) for Multiple Myeloma~Stage 1 ß2-M < 3.5 mg/dL and albumin =3.5 g/dL~Stage 2 Neither stage 1 nor stage 3~Stage 3 ß2-M ≥ 5.5 mg/L"|Participants|Count of Participants|5|5.0||||||
3850814|NCT01651039|3676161|B1|Stage 1||ISS Staging|"The International Staging System (ISS) for Multiple Myeloma~Stage 1 ß2-M < 3.5 mg/dL and albumin =3.5 g/dL~Stage 2 Neither stage 1 nor stage 3~Stage 3 ß2-M ≥ 5.5 mg/L"|Participants|Count of Participants|5|5.0||||||
3850815|NCT01651039|3676161|B1|2||The Eastern Cooperative Oncology Group (ECOG) Performance|"ECOG measures level of functioning in terms of daily living abilities:~0 - Fully active, able to carry on all pre-disease performance without restriction~- Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~- Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|Participants|Count of Participants|0|0.0||||||
3850816|NCT01651039|3676161|B1|1||The Eastern Cooperative Oncology Group (ECOG) Performance|"ECOG measures level of functioning in terms of daily living abilities:~0 - Fully active, able to carry on all pre-disease performance without restriction~- Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~- Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|Participants|Count of Participants|11|11.0||||||
3850817|NCT01651039|3676161|B1|0||The Eastern Cooperative Oncology Group (ECOG) Performance|"ECOG measures level of functioning in terms of daily living abilities:~0 - Fully active, able to carry on all pre-disease performance without restriction~- Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~- Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|Participants|Count of Participants|16|16.0||||||
3850818|NCT01651039|3676161|B1|||Age >65 years||Participants|Count of Participants|14|14.0||||||
3850819|NCT01651039|3676161|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3850820|NCT01651039|3676161|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3850821|NCT01651039|3676161|B1|||Age||years|Median|64|64.0|Full Range|||51.0|75.0|
3850822|NCT01651000|3676172|B3|United States||Region of Enrollment||participants|Number|213|213.0||||||
3850823|NCT01651000|3676173|B2|United States||Region of Enrollment||participants|Number|141|141.0||||||
3850824|NCT01651000|3676174|B1|United States||Region of Enrollment||participants|Number|72|72.0||||||
3850825|NCT01651000|3676172|B3||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3850826|NCT01651000|3676173|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3850827|NCT01651000|3676174|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3850828|NCT01651000|3676172|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3850829|NCT01651000|3676173|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3850830|NCT01651000|3676174|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3850831|NCT01651000|3676172|B3|||Age||years|Mean|64.9|64.9|Standard Deviation|11.18|11.18|||
3850832|NCT01651000|3676173|B2|||Age||years|Mean|65.1|65.1|Standard Deviation|10.33|10.33|||
3850833|NCT01651000|3676174|B1|||Age||years|Mean|64.4|64.4|Standard Deviation|12.74|12.74|||
3850834|NCT01650844|3676187|B3|||Symptom-Free Days over two weeks||Days|Mean|7.2|7.2|Standard Deviation|5.1|5.1|||
3850835|NCT01650844|3676188|B2|||Symptom-Free Days over two weeks||Days|Mean|7.4|7.4|Standard Deviation|5.1|5.1|||
3850836|NCT01650844|3676189|B1|||Symptom-Free Days over two weeks||Days|Mean|7.0|7.0|Standard Deviation|5.2|5.2|||
3850837|NCT01650844|3676187|B3|United States||Region of Enrollment||participants|Number|400|400.0||||||
3850838|NCT01650844|3676188|B2|United States||Region of Enrollment||participants|Number|200|200.0||||||
3850839|NCT01650844|3676189|B1|United States||Region of Enrollment||participants|Number|200|200.0||||||
3850840|NCT01650844|3676187|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
3850841|NCT01650844|3676188|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3850842|NCT01650844|3676189|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3850843|NCT01650844|3676187|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|127|127.0||||||
3850844|NCT01650844|3676188|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|60|60.0||||||
3850845|NCT01650844|3676189|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|67|67.0||||||
3850846|NCT01650844|3676187|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|230|230.0||||||
3850847|NCT01650844|3676188|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|118|118.0||||||
3850848|NCT01650844|3676189|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|112|112.0||||||
3850849|NCT01650844|3676187|B3||Male|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
3850850|NCT01650844|3676188|B2||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3850851|NCT01650844|3676189|B1||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3850852|NCT01650844|3676187|B3||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3850853|NCT01650844|3676188|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3850854|NCT01650844|3676189|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3850857|NCT01650844|3676189|B1|||Age||years|Mean|7.7|7.7|Standard Deviation|1.7|1.7|||
3850858|NCT01650831|3676196|B1|United States||Region of Enrollment||participants|Number|113|113.0||||||
3850859|NCT01650831|3676196|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3850860|NCT01650831|3676196|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3850861|NCT01650831|3676196|B1|||Age||years|Mean|49.6|49.6|Standard Deviation|16.71|16.71|||
3850862|NCT01650831|3676196|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3850863|NCT01650831|3676196|B1||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
3850864|NCT01650831|3676196|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3850865|NCT01650805|3676204|B3|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
3850866|NCT01650805|3676205|B2|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
3850867|NCT01650805|3676206|B1|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
3850868|NCT01650805|3676204|B3|Korea, Republic of||Region of Enrollment||participants|Number|5|5.0||||||
3850869|NCT01650805|3676205|B2|Korea, Republic of||Region of Enrollment||participants|Number|2|2.0||||||
3850870|NCT01650805|3676206|B1|Korea, Republic of||Region of Enrollment||participants|Number|3|3.0||||||
3850871|NCT01650805|3676204|B3|Sweden||Region of Enrollment||participants|Number|8|8.0||||||
3850872|NCT01650805|3676205|B2|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
3850873|NCT01650805|3676206|B1|Sweden||Region of Enrollment||participants|Number|6|6.0||||||
3850874|NCT01650805|3676204|B3|New Zealand||Region of Enrollment||participants|Number|8|8.0||||||
3850875|NCT01650805|3676205|B2|New Zealand||Region of Enrollment||participants|Number|4|4.0||||||
3850876|NCT01650805|3676206|B1|New Zealand||Region of Enrollment||participants|Number|4|4.0||||||
3850877|NCT01650805|3676204|B3|Germany||Region of Enrollment||participants|Number|23|23.0||||||
3850878|NCT01650805|3676205|B2|Germany||Region of Enrollment||participants|Number|12|12.0||||||
3850879|NCT01650805|3676206|B1|Germany||Region of Enrollment||participants|Number|11|11.0||||||
3850880|NCT01650805|3676204|B3|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
3850881|NCT01650805|3676205|B2|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
3850882|NCT01650805|3676206|B1|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
3850883|NCT01650805|3676204|B3|Australia||Region of Enrollment||participants|Number|7|7.0||||||
3850884|NCT01650805|3676205|B2|Australia||Region of Enrollment||participants|Number|6|6.0||||||
3850885|NCT01650805|3676206|B1|Australia||Region of Enrollment||participants|Number|1|1.0||||||
3850886|NCT01650805|3676204|B3|Singapore||Region of Enrollment||participants|Number|12|12.0||||||
3850887|NCT01650805|3676205|B2|Singapore||Region of Enrollment||participants|Number|11|11.0||||||
3850888|NCT01650805|3676206|B1|Singapore||Region of Enrollment||participants|Number|1|1.0||||||
3850889|NCT01650805|3676204|B3|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
3850890|NCT01650805|3676205|B2|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
3850891|NCT01650805|3676206|B1|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
3850892|NCT01650805|3676204|B3|Poland||Region of Enrollment||participants|Number|1|1.0||||||
3850893|NCT01650805|3676205|B2|Poland||Region of Enrollment||participants|Number|1|1.0||||||
3850894|NCT01650805|3676206|B1|Poland||Region of Enrollment||participants|Number|0|0.0||||||
3850895|NCT01650805|3676204|B3|Canada||Region of Enrollment||participants|Number|29|29.0||||||
3850896|NCT01650805|3676205|B2|Canada||Region of Enrollment||participants|Number|13|13.0||||||
3850897|NCT01650805|3676206|B1|Canada||Region of Enrollment||participants|Number|16|16.0||||||
3850898|NCT01650805|3676204|B3|Czech Republic||Region of Enrollment||participants|Number|4|4.0||||||
3850899|NCT01650805|3676205|B2|Czech Republic||Region of Enrollment||participants|Number|3|3.0||||||
3850900|NCT01650805|3676206|B1|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
3850901|NCT01650805|3676204|B3|France||Region of Enrollment||participants|Number|35|35.0||||||
3850902|NCT01650805|3676205|B2|France||Region of Enrollment||participants|Number|21|21.0||||||
3850903|NCT01650805|3676206|B1|France||Region of Enrollment||participants|Number|14|14.0||||||
3850904|NCT01650805|3676204|B3|United Kingdom||Region of Enrollment||participants|Number|18|18.0||||||
3850905|NCT01650805|3676205|B2|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
3850906|NCT01650805|3676206|B1|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3850907|NCT01650805|3676204|B3|Italy||Region of Enrollment||participants|Number|29|29.0||||||
3850908|NCT01650805|3676205|B2|Italy||Region of Enrollment||participants|Number|14|14.0||||||
3850909|NCT01650805|3676206|B1|Italy||Region of Enrollment||participants|Number|15|15.0||||||
3850910|NCT01650805|3676204|B3|Spain||Region of Enrollment||participants|Number|25|25.0||||||
3850911|NCT01650805|3676205|B2|Spain||Region of Enrollment||participants|Number|9|9.0||||||
3850912|NCT01650805|3676206|B1|Spain||Region of Enrollment||participants|Number|16|16.0||||||
3850913|NCT01650805|3676204|B3|Finland||Region of Enrollment||participants|Number|1|1.0||||||
3850914|NCT01650805|3676205|B2|Finland||Region of Enrollment||participants|Number|0|0.0||||||
3850915|NCT01650805|3676206|B1|Finland||Region of Enrollment||participants|Number|1|1.0||||||
3850916|NCT01650805|3676204|B3|Taiwan||Region of Enrollment||participants|Number|5|5.0||||||
3850917|NCT01650805|3676205|B2|Taiwan||Region of Enrollment||participants|Number|2|2.0||||||
3850918|NCT01650805|3676206|B1|Taiwan||Region of Enrollment||participants|Number|3|3.0||||||
3850919|NCT01650805|3676204|B3|Hong Kong||Region of Enrollment||participants|Number|5|5.0||||||
3850920|NCT01650805|3676205|B2|Hong Kong||Region of Enrollment||participants|Number|1|1.0||||||
3850921|NCT01650805|3676206|B1|Hong Kong||Region of Enrollment||participants|Number|4|4.0||||||
3850922|NCT01650805|3676204|B3|United States||Region of Enrollment||participants|Number|82|82.0||||||
3850923|NCT01650805|3676205|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
3850924|NCT01650805|3676206|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
3850925|NCT01650805|3676204|B3|Portugal||Region of Enrollment||participants|Number|2|2.0||||||
3850926|NCT01650805|3676205|B2|Portugal||Region of Enrollment||participants|Number|2|2.0||||||
3850927|NCT01650805|3676206|B1|Portugal||Region of Enrollment||participants|Number|0|0.0||||||
3850928|NCT01650805|3676204|B3||Male|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
3850929|NCT01650805|3676205|B2||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3850930|NCT01650805|3676206|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3850931|NCT01650805|3676204|B3||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3850932|NCT01650805|3676205|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3850933|NCT01650805|3676206|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3850934|NCT01650805|3676204|B3|||Age||years|Mean|51.5|51.5|Standard Deviation|15.41|15.41|||
3850935|NCT01650805|3676205|B2|||Age||years|Mean|51.2|51.2|Standard Deviation|15.19|15.19|||
3850936|NCT01650805|3676206|B1|||Age||years|Mean|51.9|51.9|Standard Deviation|15.66|15.66|||
3850937|NCT01650805|3676204|B3||>=65 years|Age||Participants|Count of Participants|72|72.0||||||
3850938|NCT01650805|3676205|B2||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
3850939|NCT01650805|3676206|B1||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
3850940|NCT01650805|3676204|B3||Between 18 and 65 years|Age||Participants|Count of Participants|235|235.0||||||
3850941|NCT01650805|3676205|B2||Between 18 and 65 years|Age||Participants|Count of Participants|116|116.0||||||
3850942|NCT01650805|3676206|B1||Between 18 and 65 years|Age||Participants|Count of Participants|119|119.0||||||
3850943|NCT01650805|3676204|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3850944|NCT01650805|3676205|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3850945|NCT01650805|3676206|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3850946|NCT01650779|3676217|B1|Plasma alfa-GAL activity||Method of Diagnosis of Fabry Disease|Number of participants with each method (genotype, leukocyte alfa-galactosidase A [GAL] activity, and plasma alfa-GAL activity) are reported. Some participants were diagnosed by more than 1 method, hence reported under more than 1 category.|participants|Number|9|9.0||||||
3850947|NCT01650779|3676217|B1|Leukocyte alfa-galactosidase A (GAL) activity||Method of Diagnosis of Fabry Disease|Number of participants with each method (genotype, leukocyte alfa-galactosidase A [GAL] activity, and plasma alfa-GAL activity) are reported. Some participants were diagnosed by more than 1 method, hence reported under more than 1 category.|participants|Number|11|11.0||||||
3850948|NCT01650779|3676217|B1|Genotype||Method of Diagnosis of Fabry Disease|Number of participants with each method (genotype, leukocyte alfa-galactosidase A [GAL] activity, and plasma alfa-GAL activity) are reported. Some participants were diagnosed by more than 1 method, hence reported under more than 1 category.|participants|Number|14|14.0||||||
3850949|NCT01650779|3676217|B1|||Duration of Fabry Disease|Duration of Fabry disease was calculated from date of initial diagnosis of Fabry disease to date of the first study infusion. Number of participants analyzed for this baseline measure were 14, as one participant did not have information on date of initial diagnosis of Fabry disease.|years|Median|9.3|9.3|Full Range|4.73|4.73|2.0|19.0|
3850950|NCT01650779|3676217|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3850951|NCT01650779|3676217|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3850952|NCT01650779|3676217|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3850953|NCT01650779|3676217|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3850954|NCT01650779|3676217|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3850955|NCT01650779|3676217|B1|||Age||years|Mean|28.5|28.5|Standard Deviation|16.11|16.11|||
3850956|NCT01650636|3676224|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3850957|NCT01650636|3676225|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3850958|NCT01650636|3676226|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850959|NCT01650636|3676224|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850960|NCT01650636|3676225|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850961|NCT01650636|3676226|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850962|NCT01650636|3676224|B3||White|Race (NIH/OMB)||Participants|Count of Participants|294|294.0||||||
3850963|NCT01650636|3676225|B2||White|Race (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
3850964|NCT01650636|3676226|B1||White|Race (NIH/OMB)||Participants|Count of Participants|148|148.0||||||
3850965|NCT01650636|3676224|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3850966|NCT01650636|3676225|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3850967|NCT01650636|3676226|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3850968|NCT01650636|3676224|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850969|NCT01650636|3676225|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850970|NCT01650636|3676226|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850971|NCT01650636|3676224|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3850972|NCT01650636|3676225|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3850973|NCT01650636|3676226|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850974|NCT01650636|3676224|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850975|NCT01650636|3676225|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850976|NCT01650636|3676226|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850977|NCT01650636|3676224|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850978|NCT01650636|3676225|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850979|NCT01650636|3676226|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3850980|NCT01650636|3676224|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|214|214.0||||||
3850981|NCT01650636|3676225|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
3850982|NCT01650636|3676226|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
3850983|NCT01650636|3676224|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
3850984|NCT01650636|3676225|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3850985|NCT01650636|3676226|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3850986|NCT01650636|3676224|B3||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3850987|NCT01650636|3676225|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3850988|NCT01650636|3676226|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3850989|NCT01650636|3676224|B3||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3850990|NCT01650636|3676225|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3850991|NCT01650636|3676226|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3850992|NCT01650636|3676224|B3||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3850993|NCT01650636|3676225|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3850994|NCT01650636|3676226|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3850995|NCT01650636|3676224|B3||Between 18 and 65 years|Age||Participants|Count of Participants|278|278.0||||||
3850996|NCT01650636|3676225|B2||Between 18 and 65 years|Age||Participants|Count of Participants|140|140.0||||||
3850997|NCT01650636|3676226|B1||Between 18 and 65 years|Age||Participants|Count of Participants|138|138.0||||||
3850998|NCT01650636|3676224|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3850999|NCT01650636|3676225|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3851000|NCT01650636|3676226|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3851001|NCT01650545|3676245|B3|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3851002|NCT01650545|3676246|B2|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3851003|NCT01650545|3676247|B1|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3851004|NCT01650545|3676245|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851005|NCT01650545|3676246|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851006|NCT01650545|3676247|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851007|NCT01650545|3676245|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851008|NCT01650545|3676246|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851009|NCT01650545|3676247|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851010|NCT01650545|3676245|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3851011|NCT01650545|3676246|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3851012|NCT01650545|3676247|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3851013|NCT01650545|3676245|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3851014|NCT01650545|3676246|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3851015|NCT01650545|3676247|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3851016|NCT01650545|3676245|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851017|NCT01650545|3676246|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851018|NCT01650545|3676247|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851019|NCT01650545|3676245|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851020|NCT01650545|3676246|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851021|NCT01650545|3676247|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851022|NCT01650545|3676245|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851023|NCT01650545|3676246|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851024|NCT01650545|3676247|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851025|NCT01650545|3676245|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3851026|NCT01650545|3676246|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3851027|NCT01650545|3676247|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3851028|NCT01650545|3676245|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3851029|NCT01650545|3676246|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3851030|NCT01650545|3676247|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3851031|NCT01650545|3676245|B3|||Age||years|Mean|61.3|61.3|Full Range|||32.0|81.0|
3851032|NCT01650545|3676246|B2|||Age||years|Mean|63.8|63.8|Full Range|||32.0|75.0|
3851033|NCT01650545|3676247|B1|||Age||years|Mean|59.1|59.1|Full Range|||35.0|81.0|
3851034|NCT01650519|3676258|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
3851035|NCT01650519|3676259|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
3851036|NCT01650519|3676260|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3851037|NCT01650519|3676258|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851038|NCT01650519|3676259|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851039|NCT01650519|3676260|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851040|NCT01650519|3676258|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3851041|NCT01650519|3676259|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3851042|NCT01650519|3676260|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3851043|NCT01650519|3676258|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3851044|NCT01650519|3676259|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3851045|NCT01650519|3676260|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851046|NCT01650519|3676258|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3851047|NCT01650519|3676259|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3851048|NCT01650519|3676260|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851049|NCT01650519|3676258|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851050|NCT01650519|3676259|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851051|NCT01650519|3676260|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851052|NCT01650519|3676258|B3||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3851053|NCT01650519|3676259|B2||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3851054|NCT01650519|3676260|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3851055|NCT01650519|3676258|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3851056|NCT01650519|3676259|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3851057|NCT01650519|3676260|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3851058|NCT01650519|3676258|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851059|NCT01650519|3676259|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851060|NCT01650519|3676260|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851061|NCT01650519|3676258|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851062|NCT01650519|3676259|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851063|NCT01650519|3676260|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851064|NCT01650519|3676258|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851065|NCT01650519|3676259|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851066|NCT01650519|3676260|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851067|NCT01650519|3676258|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3851068|NCT01650519|3676259|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3851069|NCT01650519|3676260|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3851070|NCT01650519|3676258|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3851071|NCT01650519|3676259|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3851072|NCT01650519|3676260|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3851073|NCT01650519|3676258|B3|Subject greater than or equal to 18 years of age||Age, Customized|Subject greater than or equal to 18 years of age|years|Mean|44|44.0|Standard Deviation|12.8|12.8|||
3851074|NCT01650519|3676259|B2|Subject greater than or equal to 18 years of age||Age, Customized|Subject greater than or equal to 18 years of age|years|Mean|45|45.0|Standard Deviation|13|13.0|||
3851075|NCT01650519|3676260|B1|Subject greater than or equal to 18 years of age||Age, Customized|Subject greater than or equal to 18 years of age|years|Mean|43|43.0|Standard Deviation|12.6|12.6|||
3851076|NCT01650350|3676279|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3851077|NCT01650350|3676279|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3851078|NCT01650350|3676279|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3851079|NCT01650350|3676279|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3851080|NCT01650350|3676279|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3851081|NCT01650350|3676279|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3851082|NCT01650350|3676279|B1|||Age||years|Mean|79.4|79.4|Full Range|||68.0|89.0|
3851083|NCT01650324|3676284|B6||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3851084|NCT01650324|3676285|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3851085|NCT01650324|3676286|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3851086|NCT01650324|3676287|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3851087|NCT01650324|3676288|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3851088|NCT01650324|3676289|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3851089|NCT01650324|3676284|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3851090|NCT01650324|3676285|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3851091|NCT01650324|3676286|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3851092|NCT01650324|3676287|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3851093|NCT01650324|3676288|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3851094|NCT01650324|3676289|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3851095|NCT01650324|3676284|B6|||Age||years|Mean|27|27.0|Standard Deviation|6|6.0|||
3851096|NCT01650324|3676285|B5|||Age||years|Mean|26|26.0|Standard Deviation|6|6.0|||
3851097|NCT01650324|3676286|B4|||Age||years|Mean|27|27.0|Standard Deviation|5|5.0|||
3851098|NCT01650324|3676287|B3|||Age||years|Mean|24|24.0|Standard Deviation|2|2.0|||
3851099|NCT01650324|3676288|B2|||Age||years|Mean|26|26.0|Standard Deviation|2|2.0|||
3851100|NCT01650324|3676289|B1|||Age||years|Mean|31|31.0|Standard Deviation|8|8.0|||
3851101|NCT01650285|3676322|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3851102|NCT01650285|3676322|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3851103|NCT01650285|3676322|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3851104|NCT01650285|3676322|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3851105|NCT01650285|3676322|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3851106|NCT01650285|3676322|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3851107|NCT01650285|3676322|B1|||Age||years|Mean|61|61.0|Full Range|||56.0|64.0|
3851108|NCT01650246|3676327|B1|United States||Region of Enrollment||Participants|Number|101|101.0||||||
3851109|NCT01650246|3676327|B1|South Africa||Region of Enrollment||Participants|Number|16|16.0||||||
3851110|NCT01650246|3676327|B1|New Zealand||Region of Enrollment||Participants|Number|3|3.0||||||
3851111|NCT01650246|3676327|B1|Germany||Region of Enrollment||Participants|Number|6|6.0||||||
3851112|NCT01650246|3676327|B1|Canada||Region of Enrollment||Participants|Number|6|6.0||||||
3851113|NCT01650246|3676327|B1|Belgium||Region of Enrollment||Participants|Number|9|9.0||||||
3851114|NCT01650246|3676327|B1|Australia||Region of Enrollment||Participants|Number|2|2.0||||||
3851115|NCT01650246|3676327|B1||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3851116|NCT01650246|3676327|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3851117|NCT01650246|3676327|B1|>=65 Years||Age, Customized|<65 Years, >=65 Years|Participants|Number|32|32.0||||||
3851118|NCT01650246|3676327|B1|<65 Years||Age, Customized|<65 Years, >=65 Years|Participants|Number|111|111.0||||||
3851119|NCT01650246|3676327|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|12.0|12.0|||
3851120|NCT01649856|3676332|B3||Male|Sex: Female, Male||Participants|Count of Participants|307|307.0||||||
3851121|NCT01649856|3676333|B2||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3851122|NCT01649856|3676334|B1||Male|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
3851123|NCT01649856|3676332|B3||Female|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
3851124|NCT01649856|3676333|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3851125|NCT01649856|3676334|B1||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3851126|NCT01649856|3676332|B3|||Age||years|Mean|60.6|60.6|Standard Deviation|13.38|13.38|||
3851127|NCT01649856|3676333|B2|||Age||years|Mean|61.0|61.0|Standard Deviation|12.63|12.63|||
3851128|NCT01649856|3676334|B1|||Age||years|Mean|60.4|60.4|Standard Deviation|13.78|13.78|||
3851129|NCT01649804|3676367|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3851130|NCT01649804|3676367|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3851131|NCT01649804|3676367|B1|||Age||years|Mean|51.25|51.25|Standard Deviation|8.67|8.67|||
3851132|NCT01649791|3676379|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3851133|NCT01649791|3676379|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3851134|NCT01649791|3676379|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3851135|NCT01649791|3676379|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3851136|NCT01649791|3676379|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3851137|NCT01649791|3676379|B1|||Age||years|Mean|63|63.0|Standard Deviation|8.8|8.8|||
3851138|NCT01649765|3676386|B3|Race customized|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3851139|NCT01649765|3676387|B2|Race customized|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3851140|NCT01649765|3676388|B1|Race customized|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3851141|NCT01649765|3676386|B3|Race customized|African American/African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3851142|NCT01649765|3676387|B2|Race customized|African American/African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3851143|NCT01649765|3676388|B1|Race customized|African American/African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3851144|NCT01649765|3676386|B3|Race customized|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3851145|NCT01649765|3676387|B2|Race customized|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3851146|NCT01649765|3676388|B1|Race customized|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3851204|NCT01649609|3676415|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3851147|NCT01649765|3676386|B3|Race customized|White - White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
3851148|NCT01649765|3676387|B2|Race customized|White - White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3851149|NCT01649765|3676388|B1|Race customized|White - White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3851150|NCT01649765|3676386|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3851151|NCT01649765|3676387|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3851152|NCT01649765|3676388|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3851153|NCT01649765|3676386|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3851154|NCT01649765|3676387|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3851155|NCT01649765|3676388|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3851156|NCT01649765|3676386|B3|||Age||Years|Mean|14.0|14.0|Standard Deviation|2.49|2.49|||
3851157|NCT01649765|3676387|B2|||Age||Years|Mean|13.5|13.5|Standard Deviation|2.59|2.59|||
3851158|NCT01649765|3676388|B1|||Age||Years|Mean|14.8|14.8|Standard Deviation|2.17|2.17|||
3851159|NCT01649609|3676415|B3|||Delayed Graft Function||Participants|Count of Participants|16|16.0||||||
3851160|NCT01649609|3676416|B2|||Delayed Graft Function||Participants|Count of Participants|8|8.0||||||
3851161|NCT01649609|3676417|B1|||Delayed Graft Function||Participants|Count of Participants|8|8.0||||||
3851162|NCT01649609|3676415|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3851163|NCT01649609|3676416|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3851164|NCT01649609|3676417|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3851165|NCT01649609|3676415|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3851166|NCT01649609|3676416|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3851167|NCT01649609|3676417|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3851168|NCT01649609|3676415|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851169|NCT01649609|3676416|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851170|NCT01649609|3676417|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851171|NCT01649609|3676415|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3851172|NCT01649609|3676416|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3851173|NCT01649609|3676417|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3851174|NCT01649609|3676415|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3851175|NCT01649609|3676416|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3851176|NCT01649609|3676417|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3851177|NCT01649609|3676415|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3851178|NCT01649609|3676416|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3851179|NCT01649609|3676417|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851180|NCT01649609|3676415|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3851181|NCT01649609|3676416|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3851182|NCT01649609|3676417|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3851183|NCT01649609|3676415|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3851184|NCT01649609|3676416|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851185|NCT01649609|3676417|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3851186|NCT01649609|3676415|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3851187|NCT01649609|3676416|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3851188|NCT01649609|3676417|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3851189|NCT01649609|3676415|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3851190|NCT01649609|3676416|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3851191|NCT01649609|3676417|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3851192|NCT01649609|3676415|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3851193|NCT01649609|3676416|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3851194|NCT01649609|3676417|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3851195|NCT01649609|3676415|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3851196|NCT01649609|3676416|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3851197|NCT01649609|3676417|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3851198|NCT01649609|3676415|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3851199|NCT01649609|3676416|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3851200|NCT01649609|3676417|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3851201|NCT01649609|3676415|B3|||Age||Years|Mean|56.7|56.7|Standard Deviation|13.76|13.76|||
3851202|NCT01649609|3676416|B2|||Age||Years|Mean|52.39|52.39|Standard Deviation|12.69|12.69|||
3851203|NCT01649609|3676417|B1|||Age||Years|Mean|61.04|61.04|Standard Deviation|14.12|14.12|||
3851205|NCT01649609|3676416|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3851206|NCT01649609|3676417|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3851207|NCT01649609|3676415|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3851208|NCT01649609|3676416|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3851209|NCT01649609|3676417|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3851210|NCT01649609|3676415|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3851211|NCT01649609|3676416|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3851212|NCT01649609|3676417|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3851213|NCT01649596|3676426|B3|||Temperature||Celsius|Mean|36.7|36.7|Standard Deviation|0.4|0.4|||
3851214|NCT01649596|3676427|B2|||Temperature||Celsius|Mean|36.5|36.5|Standard Deviation|0.3|0.3|||
3851215|NCT01649596|3676428|B1|||Temperature||Celsius|Mean|36.8|36.8|Standard Deviation|0.4|0.4|||
3851216|NCT01649596|3676426|B3|||Pulse||bpm|Mean|75.2|75.2|Standard Deviation|13.8|13.8|||
3851217|NCT01649596|3676427|B2|||Pulse||bpm|Mean|74.2|74.2|Standard Deviation|15.2|15.2|||
3851218|NCT01649596|3676428|B1|||Pulse||bpm|Mean|76.2|76.2|Standard Deviation|12.2|12.2|||
3851219|NCT01649596|3676426|B3|||BMI||Kg/m^2|Mean|31.2|31.2|Standard Deviation|7.6|7.6|||
3851220|NCT01649596|3676427|B2|||BMI||Kg/m^2|Mean|29.8|29.8|Standard Deviation|7.1|7.1|||
3851221|NCT01649596|3676428|B1|||BMI||Kg/m^2|Mean|32.6|32.6|Standard Deviation|7.9|7.9|||
3851222|NCT01649596|3676426|B3|United States||Region of Enrollment||participants|Number|94|94.0||||||
3851223|NCT01649596|3676427|B2|United States||Region of Enrollment||participants|Number|48|48.0||||||
3851224|NCT01649596|3676428|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
3851225|NCT01649596|3676426|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3851226|NCT01649596|3676427|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851227|NCT01649596|3676428|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3851228|NCT01649596|3676426|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851229|NCT01649596|3676427|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851230|NCT01649596|3676428|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851231|NCT01649596|3676426|B3||White|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3851232|NCT01649596|3676427|B2||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3851233|NCT01649596|3676428|B1||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3851234|NCT01649596|3676426|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3851235|NCT01649596|3676427|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3851236|NCT01649596|3676428|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3851237|NCT01649596|3676426|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851238|NCT01649596|3676427|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851239|NCT01649596|3676428|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851240|NCT01649596|3676426|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851241|NCT01649596|3676427|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851242|NCT01649596|3676428|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851243|NCT01649596|3676426|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3851244|NCT01649596|3676427|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3851245|NCT01649596|3676428|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851246|NCT01649596|3676426|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3851247|NCT01649596|3676427|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3851248|NCT01649596|3676428|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3851249|NCT01649596|3676426|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3851250|NCT01649596|3676427|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3851251|NCT01649596|3676428|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3851252|NCT01649596|3676426|B3|||Age||years|Mean|50.1|50.1|Standard Deviation|15.0|15.0|||
3851253|NCT01649596|3676427|B2|||Age||years|Mean|48.5|48.5|Standard Deviation|15.1|15.1|||
3851254|NCT01649596|3676428|B1|||Age||years|Mean|51.8|51.8|Standard Deviation|14.9|14.9|||
3851255|NCT01649557|3676437|B4||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3851256|NCT01649557|3676438|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3851257|NCT01649557|3676439|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3851258|NCT01649557|3676440|B1||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3851259|NCT01649557|3676437|B4||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3851260|NCT01649557|3676438|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3851261|NCT01649557|3676439|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3851262|NCT01649557|3676440|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3851263|NCT01649557|3676437|B4|||Age||Years|Mean|39.7|39.7|Standard Deviation|10.5|10.5|||
3851264|NCT01649557|3676438|B3|||Age||Years|Mean|41.2|41.2|Standard Deviation|12|12.0|||
3851265|NCT01649557|3676439|B2|||Age||Years|Mean|41.4|41.4|Standard Deviation|11.2|11.2|||
3851266|NCT01649557|3676440|B1|||Age||Years|Mean|39.1|39.1|Standard Deviation|10.1|10.1|||
3851267|NCT01649505|3676477|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3851268|NCT01649505|3676478|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3851269|NCT01649505|3676479|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3851270|NCT01649505|3676477|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3851271|NCT01649505|3676478|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3851272|NCT01649505|3676479|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3851273|NCT01649505|3676477|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3851274|NCT01649505|3676478|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3851275|NCT01649505|3676479|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3851276|NCT01649505|3676477|B3|||Age||years|Mean|44|44.0|Standard Deviation|0|0.0|||
3851277|NCT01649505|3676478|B2|||Age||years|Mean|44|44.0|Standard Deviation|||||
3851278|NCT01649505|3676479|B1|||Age||years|Mean|44|44.0|Standard Deviation|||||
3851279|NCT01649505|3676477|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3851280|NCT01649505|3676478|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3851281|NCT01649505|3676479|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3851282|NCT01649505|3676477|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3851283|NCT01649505|3676478|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3851284|NCT01649505|3676479|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3851285|NCT01649505|3676477|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3851286|NCT01649505|3676478|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3851287|NCT01649505|3676479|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3851288|NCT01649362|3676486|B3|Luxembourg||Region of Enrollment||participants|Number|86|86.0||||||
3851289|NCT01649362|3676487|B2|Luxembourg||Region of Enrollment||participants|Number|40|40.0||||||
3851290|NCT01649362|3676488|B1|Luxembourg||Region of Enrollment||participants|Number|46|46.0||||||
3851291|NCT01649362|3676486|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3851292|NCT01649362|3676487|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3851293|NCT01649362|3676488|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3851294|NCT01649362|3676486|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3851295|NCT01649362|3676487|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3851296|NCT01649362|3676488|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3851297|NCT01649362|3676486|B3|||Age, Customized||weeks' gestational age|Mean|31.3|31.3|Standard Deviation|1.6|1.6|||
3851298|NCT01649362|3676487|B2|||Age, Customized||weeks' gestational age|Mean|31.4|31.4|Standard Deviation|1.5|1.5|||
3851299|NCT01649362|3676488|B1|||Age, Customized||weeks' gestational age|Mean|31.3|31.3|Standard Deviation|1.7|1.7|||
3851300|NCT01649362|3676486|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3851301|NCT01649362|3676487|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3851302|NCT01649362|3676488|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3851303|NCT01649362|3676486|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3851304|NCT01649362|3676487|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3851305|NCT01649362|3676488|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3851306|NCT01649362|3676486|B3||<=18 years|Age||Participants|Count of Participants|86|86.0||||||
3851307|NCT01649362|3676487|B2||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
3851308|NCT01649362|3676488|B1||<=18 years|Age||Participants|Count of Participants|46|46.0||||||
3851309|NCT01649297|3676499|B6||Male|Sex: Female, Male||Participants|Count of Participants|520|520.0||||||
3851310|NCT01649297|3676500|B5||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3851311|NCT01649297|3676501|B4||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3851312|NCT01649297|3676502|B3||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3851313|NCT01649297|3676503|B2||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3851314|NCT01649297|3676504|B1||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3851315|NCT01649297|3676499|B6||Female|Sex: Female, Male||Participants|Count of Participants|445|445.0||||||
3851316|NCT01649297|3676500|B5||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3851317|NCT01649297|3676501|B4||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3851318|NCT01649297|3676502|B3||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3851319|NCT01649297|3676503|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3851320|NCT01649297|3676504|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3851321|NCT01649297|3676499|B6|||Age||years|Mean|58.2|58.2|Standard Deviation|10.3|10.3|||
3851322|NCT01649297|3676500|B5|||Age||years|Mean|57.9|57.9|Standard Deviation|11.2|11.2|||
3851323|NCT01649297|3676501|B4|||Age||years|Mean|58.5|58.5|Standard Deviation|10.8|10.8|||
3851324|NCT01649297|3676502|B3|||Age||years|Mean|58.8|58.8|Standard Deviation|9.8|9.8|||
3851325|NCT01649297|3676503|B2|||Age||years|Mean|58.2|58.2|Standard Deviation|10.2|10.2|||
3851326|NCT01649297|3676504|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|9.9|9.9|||
3851327|NCT01649271|3676525|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3851328|NCT01649271|3676526|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3851329|NCT01649271|3676527|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3851330|NCT01649271|3676525|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3851331|NCT01649271|3676526|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3851332|NCT01649271|3676527|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3851333|NCT01649271|3676525|B3|||Age||Years|Mean|54.2|54.2|Standard Deviation|8.7|8.7|||
3851334|NCT01649271|3676526|B2|||Age||Years|Mean|48.4|48.4|Standard Deviation|7.6|7.6|||
3851335|NCT01649271|3676527|B1|||Age||Years|Mean|60.8|60.8|Standard Deviation|3.7|3.7|||
3851336|NCT01649232|3676541|B3|Spain||Region of Enrollment||participants|Number|60|60.0||||||
3851337|NCT01649232|3676542|B2|Spain||Region of Enrollment||participants|Number|30|30.0||||||
3851338|NCT01649232|3676543|B1|Spain||Region of Enrollment||participants|Number|30|30.0||||||
3851339|NCT01649232|3676541|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3851340|NCT01649232|3676542|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3851341|NCT01649232|3676543|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3851342|NCT01649232|3676541|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3851343|NCT01649232|3676542|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3851344|NCT01649232|3676543|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3851345|NCT01649232|3676541|B3|||Age||years|Mean|25.14|25.14|Standard Deviation|18.09|18.09|||
3851346|NCT01649232|3676542|B2|||Age||years|Mean|33.12|33.12|Standard Deviation|22.80|22.8|||
3851347|NCT01649232|3676543|B1|||Age||years|Mean|20.06|20.06|Standard Deviation|13.03|13.03|||
3851348|NCT01649232|3676541|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3851349|NCT01649232|3676542|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3851350|NCT01649232|3676543|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3851351|NCT01649232|3676541|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3851352|NCT01649232|3676542|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3851353|NCT01649232|3676543|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3851354|NCT01649232|3676541|B3||<=18 years|Age||Participants|Count of Participants|33|33.0||||||
3851355|NCT01649232|3676542|B2||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
3851356|NCT01649232|3676543|B1||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
3851357|NCT01649180|3676564|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3851358|NCT01649180|3676564|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851359|NCT01649180|3676564|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851360|NCT01649180|3676564|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3851361|NCT01649180|3676564|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851362|NCT01649180|3676564|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851363|NCT01649180|3676564|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851364|NCT01649180|3676564|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851365|NCT01649180|3676564|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3851366|NCT01649180|3676564|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3851367|NCT01649180|3676564|B1|||Age||years|Median|54|54.0|Full Range|||52.0|55.0|
3851368|NCT01648920|3676572|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3851369|NCT01648920|3676572|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3851370|NCT01648920|3676572|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3851371|NCT01648920|3676572|B1|||Age||years|Mean|24.7|24.7|Full Range|||7.0|61.0|
3851372|NCT01648790|3676596|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3851373|NCT01648790|3676596|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851374|NCT01648790|3676596|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851375|NCT01648790|3676596|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3851376|NCT01648790|3676596|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3851377|NCT01648790|3676596|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851378|NCT01648790|3676596|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851379|NCT01648790|3676596|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3851380|NCT01648790|3676596|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851381|NCT01648790|3676596|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3851382|NCT01648790|3676596|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3851383|NCT01648790|3676596|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3851384|NCT01648790|3676596|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3851385|NCT01648790|3676596|B1|||Age||years|Mean|39.3|39.3|Standard Deviation|10.5|10.5|||
3851386|NCT01648699|3676621|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3851387|NCT01648699|3676621|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3851388|NCT01648699|3676621|B1|||Age||Years|Mean|50.35|50.35|Standard Deviation|11.03|11.03|||
3851389|NCT01648582|3676647|B4|Russian Federation||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
3851390|NCT01648582|3676648|B3|Russian Federation||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3851391|NCT01648582|3676649|B2|Russian Federation||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3851392|NCT01648582|3676650|B1|Russian Federation||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3851393|NCT01648582|3676647|B4|Mexico||Region of Enrollment||Participants|Count of Participants|70|70.0||||||
3851394|NCT01648582|3676648|B3|Mexico||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3851395|NCT01648582|3676649|B2|Mexico||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3851396|NCT01648582|3676650|B1|Mexico||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3851397|NCT01648582|3676647|B4|Korea, Republic of||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3851398|NCT01648582|3676648|B3|Korea, Republic of||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3851399|NCT01648582|3676649|B2|Korea, Republic of||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3851400|NCT01648582|3676650|B1|Korea, Republic of||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3851401|NCT01648582|3676647|B4|China||Region of Enrollment||Participants|Count of Participants|591|591.0||||||
3851402|NCT01648582|3676648|B3|China||Region of Enrollment||Participants|Count of Participants|195|195.0||||||
3851403|NCT01648582|3676649|B2|China||Region of Enrollment||Participants|Count of Participants|196|196.0||||||
3851404|NCT01648582|3676650|B1|China||Region of Enrollment||Participants|Count of Participants|200|200.0||||||
3851405|NCT01648582|3676647|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851406|NCT01648582|3676648|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851407|NCT01648582|3676649|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851408|NCT01648582|3676650|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851409|NCT01648582|3676647|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851410|NCT01648582|3676648|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851411|NCT01648582|3676649|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851412|NCT01648582|3676650|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851413|NCT01648582|3676647|B4||White|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3851414|NCT01648582|3676648|B3||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3851415|NCT01648582|3676649|B2||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3851416|NCT01648582|3676650|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3851417|NCT01648582|3676647|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851418|NCT01648582|3676648|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851419|NCT01648582|3676649|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851420|NCT01648582|3676650|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851421|NCT01648582|3676647|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851422|NCT01648582|3676648|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851423|NCT01648582|3676649|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851424|NCT01648582|3676650|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851425|NCT01648582|3676647|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|631|631.0||||||
3851426|NCT01648582|3676648|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|209|209.0||||||
3851427|NCT01648582|3676649|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|209|209.0||||||
3851428|NCT01648582|3676650|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|213|213.0||||||
3851429|NCT01648582|3676647|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3851430|NCT01648582|3676648|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3851431|NCT01648582|3676649|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3851432|NCT01648582|3676650|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3851433|NCT01648582|3676647|B4||Male|Sex: Female, Male||Participants|Count of Participants|417|417.0||||||
3851434|NCT01648582|3676648|B3||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3851435|NCT01648582|3676649|B2||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3851436|NCT01648582|3676650|B1||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3851437|NCT01648582|3676647|B4||Female|Sex: Female, Male||Participants|Count of Participants|338|338.0||||||
3851438|NCT01648582|3676648|B3||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3851439|NCT01648582|3676649|B2||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3851440|NCT01648582|3676650|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3851441|NCT01648582|3676647|B4|||Age||years|Mean|55.00|55.0|Standard Deviation|9.593|9.593|||
3851442|NCT01648582|3676648|B3|||Age||years|Mean|55.44|55.44|Standard Deviation|9.197|9.197|||
3851443|NCT01648582|3676649|B2|||Age||years|Mean|54.54|54.54|Standard Deviation|10.006|10.006|||
3851444|NCT01648582|3676650|B1|||Age||years|Mean|55.03|55.03|Standard Deviation|9.572|9.572|||
3851445|NCT01648530|3676721|B1||Male|Sex: Female, Male||Participants|Count of Participants|4294|4294.0||||||
3851446|NCT01648530|3676721|B1||Female|Sex: Female, Male||Participants|Count of Participants|12495|12495.0||||||
3851447|NCT01648530|3676721|B1|||Age||years|Mean|40.7|40.7|Standard Deviation|14.4|14.4|||
3851448|NCT01648491|3676727|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3851449|NCT01648491|3676727|B1||Male|Gender||Participants|Count of Participants|1|1.0||||||
3851450|NCT01648491|3676727|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3851451|NCT01648491|3676727|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3851452|NCT01648491|3676727|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3851453|NCT01648491|3676727|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3851454|NCT01648452|3676734|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3851455|NCT01648452|3676734|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3851456|NCT01648452|3676734|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3851457|NCT01648452|3676734|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3851458|NCT01648452|3676734|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3851459|NCT01648452|3676734|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3851460|NCT01648452|3676734|B1|||Age||years|Mean|35.6|35.6|Standard Deviation|11.37|11.37|||
3851461|NCT01648348|3676752|B4|United States||Region of Enrollment||participants|Number|116|116.0||||||
3851462|NCT01648348|3676753|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
3851463|NCT01648348|3676754|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
3851464|NCT01648348|3676755|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3851465|NCT01648348|3676752|B4||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3851466|NCT01648348|3676753|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3851467|NCT01648348|3676754|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3851468|NCT01648348|3676755|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3851469|NCT01648348|3676752|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3851470|NCT01648348|3676753|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3851471|NCT01648348|3676754|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3851472|NCT01648348|3676755|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3851473|NCT01648348|3676752|B4|||Age||years|Mean|55.8|55.8|Standard Deviation|10.8|10.8|||
3851474|NCT01648348|3676753|B3|||Age||years|Mean|55.6|55.6|Standard Deviation|10.2|10.2|||
3851475|NCT01648348|3676754|B2|||Age||years|Mean|56.8|56.8|Standard Deviation|12.3|12.3|||
3851476|NCT01648348|3676755|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|6.6|6.6|||
3851477|NCT01648322|3676785|B5|IV||Cancer Stage at screen||participants|Number|9|9.0||||||
3851478|NCT01648322|3676786|B4|IV||Cancer Stage at screen||participants|Number|2|2.0||||||
3851479|NCT01648322|3676787|B3|IV||Cancer Stage at screen||participants|Number|3|3.0||||||
3851480|NCT01648322|3676788|B2|IV||Cancer Stage at screen||participants|Number|4|4.0||||||
3851481|NCT01648322|3676789|B1|IV||Cancer Stage at screen||participants|Number|0|0.0||||||
3851482|NCT01648322|3676785|B5|III||Cancer Stage at screen||participants|Number|73|73.0||||||
3851483|NCT01648322|3676786|B4|III||Cancer Stage at screen||participants|Number|23|23.0||||||
3851484|NCT01648322|3676787|B3|III||Cancer Stage at screen||participants|Number|18|18.0||||||
3851485|NCT01648322|3676788|B2|III||Cancer Stage at screen||participants|Number|23|23.0||||||
3851486|NCT01648322|3676789|B1|III||Cancer Stage at screen||participants|Number|9|9.0||||||
3851487|NCT01648322|3676785|B5|II||Cancer Stage at screen||participants|Number|116|116.0||||||
3851488|NCT01648322|3676786|B4|II||Cancer Stage at screen||participants|Number|31|31.0||||||
3851489|NCT01648322|3676787|B3|II||Cancer Stage at screen||participants|Number|32|32.0||||||
3851490|NCT01648322|3676788|B2|II||Cancer Stage at screen||participants|Number|28|28.0||||||
3851491|NCT01648322|3676789|B1|II||Cancer Stage at screen||participants|Number|25|25.0||||||
3851492|NCT01648322|3676785|B5|I||Cancer Stage at screen||participants|Number|34|34.0||||||
3851493|NCT01648322|3676786|B4|I||Cancer Stage at screen||participants|Number|9|9.0||||||
3851494|NCT01648322|3676787|B3|I||Cancer Stage at screen||participants|Number|12|12.0||||||
3851495|NCT01648322|3676788|B2|I||Cancer Stage at screen||participants|Number|12|12.0||||||
3851496|NCT01648322|3676789|B1|I||Cancer Stage at screen||participants|Number|1|1.0||||||
3851497|NCT01648322|3676785|B5|Grade 2||ECOG status|"The ECOG Scale of Performance Status describes a patient’s level of functioning in terms of their ability to care for themselves, daily activity, and physical ability (walking, working, etc.).~GRADE 0. Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all self care but unable to carry out any work activities~A subject's ECOG grade is determined by the study doctor based on the established criteria listed above.~Grade 0 is best. Grade 2 is worse than Grade 1."|Participants|Count of Participants|0|0.0||||||
3851498|NCT01648322|3676786|B4|Grade 2||ECOG status|"The ECOG Scale of Performance Status describes a patient’s level of functioning in terms of their ability to care for themselves, daily activity, and physical ability (walking, working, etc.).~GRADE 0. Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all self care but unable to carry out any work activities~A subject's ECOG grade is determined by the study doctor based on the established criteria listed above.~Grade 0 is best. Grade 2 is worse than Grade 1."|Participants|Count of Participants|0|0.0||||||
3851561|NCT01648140|3676845|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3851562|NCT01648140|3676846|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3851499|NCT01648322|3676787|B3|Grade 2||ECOG status|"The ECOG Scale of Performance Status describes a patient’s level of functioning in terms of their ability to care for themselves, daily activity, and physical ability (walking, working, etc.).~GRADE 0. Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all self care but unable to carry out any work activities~A subject's ECOG grade is determined by the study doctor based on the established criteria listed above.~Grade 0 is best. Grade 2 is worse than Grade 1."|Participants|Count of Participants|0|0.0||||||
3851500|NCT01648322|3676788|B2|Grade 2||ECOG status|"The ECOG Scale of Performance Status describes a patient’s level of functioning in terms of their ability to care for themselves, daily activity, and physical ability (walking, working, etc.).~GRADE 0. Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all self care but unable to carry out any work activities~A subject's ECOG grade is determined by the study doctor based on the established criteria listed above.~Grade 0 is best. Grade 2 is worse than Grade 1."|Participants|Count of Participants|0|0.0||||||
3851501|NCT01648322|3676789|B1|Grade 2||ECOG status|"The ECOG Scale of Performance Status describes a patient’s level of functioning in terms of their ability to care for themselves, daily activity, and physical ability (walking, working, etc.).~GRADE 0. Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all self care but unable to carry out any work activities~A subject's ECOG grade is determined by the study doctor based on the established criteria listed above.~Grade 0 is best. Grade 2 is worse than Grade 1."|Participants|Count of Participants|0|0.0||||||
3851502|NCT01648322|3676785|B5|Grade 1||ECOG status|"The ECOG Scale of Performance Status describes a patient’s level of functioning in terms of their ability to care for themselves, daily activity, and physical ability (walking, working, etc.).~GRADE 0. Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all self care but unable to carry out any work activities~A subject's ECOG grade is determined by the study doctor based on the established criteria listed above.~Grade 0 is best. Grade 2 is worse than Grade 1."|Participants|Count of Participants|84|84.0||||||
3851503|NCT01648322|3676786|B4|Grade 1||ECOG status|"The ECOG Scale of Performance Status describes a patient’s level of functioning in terms of their ability to care for themselves, daily activity, and physical ability (walking, working, etc.).~GRADE 0. Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all self care but unable to carry out any work activities~A subject's ECOG grade is determined by the study doctor based on the established criteria listed above.~Grade 0 is best. Grade 2 is worse than Grade 1."|Participants|Count of Participants|24|24.0||||||
3851504|NCT01648322|3676787|B3|Grade 1||ECOG status|"The ECOG Scale of Performance Status describes a patient’s level of functioning in terms of their ability to care for themselves, daily activity, and physical ability (walking, working, etc.).~GRADE 0. Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all self care but unable to carry out any work activities~A subject's ECOG grade is determined by the study doctor based on the established criteria listed above.~Grade 0 is best. Grade 2 is worse than Grade 1."|Participants|Count of Participants|23|23.0||||||
3851505|NCT01648322|3676788|B2|Grade 1||ECOG status|"The ECOG Scale of Performance Status describes a patient’s level of functioning in terms of their ability to care for themselves, daily activity, and physical ability (walking, working, etc.).~GRADE 0. Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all self care but unable to carry out any work activities~A subject's ECOG grade is determined by the study doctor based on the established criteria listed above.~Grade 0 is best. Grade 2 is worse than Grade 1."|Participants|Count of Participants|27|27.0||||||
3851506|NCT01648322|3676789|B1|Grade 1||ECOG status|"The ECOG Scale of Performance Status describes a patient’s level of functioning in terms of their ability to care for themselves, daily activity, and physical ability (walking, working, etc.).~GRADE 0. Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all self care but unable to carry out any work activities~A subject's ECOG grade is determined by the study doctor based on the established criteria listed above.~Grade 0 is best. Grade 2 is worse than Grade 1."|Participants|Count of Participants|10|10.0||||||
3851507|NCT01648322|3676785|B5|Grade 0||ECOG status|"The ECOG Scale of Performance Status describes a patient’s level of functioning in terms of their ability to care for themselves, daily activity, and physical ability (walking, working, etc.).~GRADE 0. Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all self care but unable to carry out any work activities~A subject's ECOG grade is determined by the study doctor based on the established criteria listed above.~Grade 0 is best. Grade 2 is worse than Grade 1."|Participants|Count of Participants|148|148.0||||||
3851508|NCT01648322|3676786|B4|Grade 0||ECOG status|"The ECOG Scale of Performance Status describes a patient’s level of functioning in terms of their ability to care for themselves, daily activity, and physical ability (walking, working, etc.).~GRADE 0. Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all self care but unable to carry out any work activities~A subject's ECOG grade is determined by the study doctor based on the established criteria listed above.~Grade 0 is best. Grade 2 is worse than Grade 1."|Participants|Count of Participants|41|41.0||||||
3851509|NCT01648322|3676787|B3|Grade 0||ECOG status|"The ECOG Scale of Performance Status describes a patient’s level of functioning in terms of their ability to care for themselves, daily activity, and physical ability (walking, working, etc.).~GRADE 0. Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all self care but unable to carry out any work activities~A subject's ECOG grade is determined by the study doctor based on the established criteria listed above.~Grade 0 is best. Grade 2 is worse than Grade 1."|Participants|Count of Participants|42|42.0||||||
3851563|NCT01648140|3676842|B5||White|Race (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3851564|NCT01648140|3676843|B4||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3851565|NCT01648140|3676844|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3851510|NCT01648322|3676788|B2|Grade 0||ECOG status|"The ECOG Scale of Performance Status describes a patient’s level of functioning in terms of their ability to care for themselves, daily activity, and physical ability (walking, working, etc.).~GRADE 0. Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all self care but unable to carry out any work activities~A subject's ECOG grade is determined by the study doctor based on the established criteria listed above.~Grade 0 is best. Grade 2 is worse than Grade 1."|Participants|Count of Participants|40|40.0||||||
3851511|NCT01648322|3676789|B1|Grade 0||ECOG status|"The ECOG Scale of Performance Status describes a patient’s level of functioning in terms of their ability to care for themselves, daily activity, and physical ability (walking, working, etc.).~GRADE 0. Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all self care but unable to carry out any work activities~A subject's ECOG grade is determined by the study doctor based on the established criteria listed above.~Grade 0 is best. Grade 2 is worse than Grade 1."|Participants|Count of Participants|25|25.0||||||
3851512|NCT01648322|3676785|B5|||Height||cm|Mean|163.37|163.37|Standard Deviation|6.83|6.83|||
3851513|NCT01648322|3676786|B4|||Height||cm|Mean|162.80|162.8|Standard Deviation|6.99|6.99|||
3851514|NCT01648322|3676787|B3|||Height||cm|Mean|162.90|162.9|Standard Deviation|5.66|5.66|||
3851515|NCT01648322|3676788|B2|||Height||cm|Mean|163.58|163.58|Standard Deviation|8.15|8.15|||
3851516|NCT01648322|3676789|B1|||Height||cm|Mean|164.88|164.88|Standard Deviation|5.66|5.66|||
3851517|NCT01648322|3676785|B5|||weight||kg|Mean|71.18|71.18|Standard Deviation|14.32|14.32|||
3851518|NCT01648322|3676786|B4|||weight||kg|Mean|71.28|71.28|Standard Deviation|14.09|14.09|||
3851519|NCT01648322|3676787|B3|||weight||kg|Mean|70.22|70.22|Standard Deviation|12.94|12.94|||
3851520|NCT01648322|3676788|B2|||weight||kg|Mean|70.89|70.89|Standard Deviation|14.44|14.44|||
3851521|NCT01648322|3676789|B1|||weight||kg|Mean|73.28|73.28|Standard Deviation|17.12|17.12|||
3851522|NCT01648322|3676785|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3851523|NCT01648322|3676786|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3851524|NCT01648322|3676787|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3851525|NCT01648322|3676788|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3851526|NCT01648322|3676789|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3851527|NCT01648322|3676785|B5||Female|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
3851528|NCT01648322|3676786|B4||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3851529|NCT01648322|3676787|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3851530|NCT01648322|3676788|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3851531|NCT01648322|3676789|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3851532|NCT01648322|3676785|B5|||Age||years|Mean|48.4|48.4|Standard Deviation|10.4|10.4|||
3851533|NCT01648322|3676786|B4|||Age||years|Mean|48.2|48.2|Standard Deviation|10.9|10.9|||
3851534|NCT01648322|3676787|B3|||Age||years|Mean|48.9|48.9|Standard Deviation|10.3|10.3|||
3851535|NCT01648322|3676788|B2|||Age||years|Mean|47.9|47.9|Standard Deviation|10.1|10.1|||
3851536|NCT01648322|3676789|B1|||Age||years|Mean|48.7|48.7|Standard Deviation|10.3|10.3|||
3851537|NCT01648283|3676836|B1|United States||Region of Enrollment|enrollment from greater St. Louis metropolitan area|participants|Number|64|64.0||||||
3851538|NCT01648283|3676836|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3851539|NCT01648283|3676836|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851540|NCT01648283|3676836|B1||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3851541|NCT01648283|3676836|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3851542|NCT01648283|3676836|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851543|NCT01648283|3676836|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3851544|NCT01648283|3676836|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851545|NCT01648283|3676836|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851546|NCT01648283|3676836|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3851547|NCT01648283|3676836|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3851548|NCT01648283|3676836|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3851549|NCT01648283|3676836|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3851550|NCT01648283|3676836|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3851551|NCT01648283|3676836|B1||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
3851552|NCT01648283|3676836|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3851553|NCT01648140|3676842|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851554|NCT01648140|3676843|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851555|NCT01648140|3676844|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851556|NCT01648140|3676845|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851557|NCT01648140|3676846|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851558|NCT01648140|3676842|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3851559|NCT01648140|3676843|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851560|NCT01648140|3676844|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851566|NCT01648140|3676845|B2||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3851567|NCT01648140|3676846|B1||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3851568|NCT01648140|3676842|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3851569|NCT01648140|3676843|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3851570|NCT01648140|3676844|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3851571|NCT01648140|3676845|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3851572|NCT01648140|3676846|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3851573|NCT01648140|3676842|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851574|NCT01648140|3676843|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851575|NCT01648140|3676844|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851576|NCT01648140|3676845|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851577|NCT01648140|3676846|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851578|NCT01648140|3676842|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3851579|NCT01648140|3676843|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3851580|NCT01648140|3676844|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851581|NCT01648140|3676845|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851582|NCT01648140|3676846|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851583|NCT01648140|3676842|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851584|NCT01648140|3676843|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851585|NCT01648140|3676844|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851586|NCT01648140|3676845|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851587|NCT01648140|3676846|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851588|NCT01648140|3676842|B5||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3851589|NCT01648140|3676843|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3851590|NCT01648140|3676844|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3851591|NCT01648140|3676845|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3851592|NCT01648140|3676846|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3851593|NCT01648140|3676842|B5||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3851594|NCT01648140|3676843|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3851595|NCT01648140|3676844|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3851596|NCT01648140|3676845|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3851597|NCT01648140|3676846|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3851598|NCT01648140|3676842|B5|||Age||Years|Mean|42.2|42.2|Standard Deviation|11.73|11.73|||
3851599|NCT01648140|3676843|B4|||Age||Years|Mean|45.3|45.3|Standard Deviation|11.46|11.46|||
3851600|NCT01648140|3676844|B3|||Age||Years|Mean|39.4|39.4|Standard Deviation|12.02|12.02|||
3851601|NCT01648140|3676845|B2|||Age||Years|Mean|40.8|40.8|Standard Deviation|9.87|9.87|||
3851602|NCT01648140|3676846|B1|||Age||Years|Mean|43.7|43.7|Standard Deviation|13.23|13.23|||
3851603|NCT01648101|3677011|B4|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for members of the Safety Population: all randomized participants who received at least one dose of study medication.|Participants|Number|27|27.0||||||
3851604|NCT01648101|3677012|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for members of the Safety Population: all randomized participants who received at least one dose of study medication.|Participants|Number|10|10.0||||||
3851605|NCT01648101|3677013|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for members of the Safety Population: all randomized participants who received at least one dose of study medication.|Participants|Number|10|10.0||||||
3851606|NCT01648101|3677014|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for members of the Safety Population: all randomized participants who received at least one dose of study medication.|Participants|Number|7|7.0||||||
3851607|NCT01648101|3677011|B4|Asian - East Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for members of the Safety Population: all randomized participants who received at least one dose of study medication.|Participants|Number|48|48.0||||||
3851608|NCT01648101|3677012|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for members of the Safety Population: all randomized participants who received at least one dose of study medication.|Participants|Number|15|15.0||||||
3851609|NCT01648101|3677013|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for members of the Safety Population: all randomized participants who received at least one dose of study medication.|Participants|Number|16|16.0||||||
3851610|NCT01648101|3677014|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for members of the Safety Population: all randomized participants who received at least one dose of study medication.|Participants|Number|17|17.0||||||
3851611|NCT01648101|3677011|B4||Male|Sex: Female, Male|Baseline data are reported for members of the Safety Population: all randomized participants who received at least one dose of study medication.|Participants|Count of Participants|45|45.0||||||
3851662|NCT01647737|3677090|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3851663|NCT01647737|3677091|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3851612|NCT01648101|3677012|B3||Male|Sex: Female, Male|Baseline data are reported for members of the Safety Population: all randomized participants who received at least one dose of study medication.|Participants|Count of Participants|15|15.0||||||
3851613|NCT01648101|3677013|B2||Male|Sex: Female, Male|Baseline data are reported for members of the Safety Population: all randomized participants who received at least one dose of study medication.|Participants|Count of Participants|16|16.0||||||
3851614|NCT01648101|3677014|B1||Male|Sex: Female, Male|Baseline data are reported for members of the Safety Population: all randomized participants who received at least one dose of study medication.|Participants|Count of Participants|14|14.0||||||
3851615|NCT01648101|3677011|B4||Female|Sex: Female, Male|Baseline data are reported for members of the Safety Population: all randomized participants who received at least one dose of study medication.|Participants|Count of Participants|30|30.0||||||
3851616|NCT01648101|3677012|B3||Female|Sex: Female, Male|Baseline data are reported for members of the Safety Population: all randomized participants who received at least one dose of study medication.|Participants|Count of Participants|10|10.0||||||
3851617|NCT01648101|3677013|B2||Female|Sex: Female, Male|Baseline data are reported for members of the Safety Population: all randomized participants who received at least one dose of study medication.|Participants|Count of Participants|10|10.0||||||
3851618|NCT01648101|3677014|B1||Female|Sex: Female, Male|Baseline data are reported for members of the Safety Population: all randomized participants who received at least one dose of study medication.|Participants|Count of Participants|10|10.0||||||
3851619|NCT01648101|3677011|B4|||Age|Baseline data are reported for members of the Safety Population: all randomized participants who received at least one dose of study medication.|Years|Mean|36.5|36.5|Standard Deviation|11.27|11.27|||
3851620|NCT01648101|3677012|B3|||Age|Baseline data are reported for members of the Safety Population: all randomized participants who received at least one dose of study medication.|Years|Mean|36.3|36.3|Standard Deviation|13.50|13.5|||
3851621|NCT01648101|3677013|B2|||Age|Baseline data are reported for members of the Safety Population: all randomized participants who received at least one dose of study medication.|Years|Mean|37.1|37.1|Standard Deviation|10.90|10.9|||
3851622|NCT01648101|3677014|B1|||Age|Baseline data are reported for members of the Safety Population: all randomized participants who received at least one dose of study medication.|Years|Mean|36.0|36.0|Standard Deviation|9.43|9.43|||
3851623|NCT01647945|3677064|B5|United States||Region of Enrollment||participants|Number|23|23.0||||||
3851624|NCT01647945|3677065|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
3851625|NCT01647945|3677066|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3851626|NCT01647945|3677067|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3851627|NCT01647945|3677068|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3851628|NCT01647945|3677064|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3851629|NCT01647945|3677065|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3851630|NCT01647945|3677066|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3851631|NCT01647945|3677067|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3851632|NCT01647945|3677068|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3851633|NCT01647945|3677064|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3851634|NCT01647945|3677065|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3851635|NCT01647945|3677066|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3851636|NCT01647945|3677067|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3851637|NCT01647945|3677068|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3851638|NCT01647945|3677064|B5|||Age||years|Median|41|41.0|Inter-Quartile Range|||34.0|52.0|
3851639|NCT01647945|3677065|B4|||Age||years|Median|45|45.0|Inter-Quartile Range|||42.0|48.0|
3851640|NCT01647945|3677066|B3|||Age||years|Median|39|39.0|Inter-Quartile Range|||25.0|51.0|
3851641|NCT01647945|3677067|B2|||Age||years|Median|35|35.0|Inter-Quartile Range|||24.0|45.0|
3851642|NCT01647945|3677068|B1|||Age||years|Median|46|46.0|Inter-Quartile Range|||38.0|53.0|
3851643|NCT01647945|3677064|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3851644|NCT01647945|3677065|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3851645|NCT01647945|3677066|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3851646|NCT01647945|3677067|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3851647|NCT01647945|3677068|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3851648|NCT01647945|3677064|B5||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3851649|NCT01647945|3677065|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3851650|NCT01647945|3677066|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3851651|NCT01647945|3677067|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3851652|NCT01647945|3677068|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3851653|NCT01647945|3677064|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3851654|NCT01647945|3677065|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3851655|NCT01647945|3677066|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3851656|NCT01647945|3677067|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3851657|NCT01647945|3677068|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3851658|NCT01647737|3677089|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
3851659|NCT01647737|3677090|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3851660|NCT01647737|3677091|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3851661|NCT01647737|3677089|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3851664|NCT01647737|3677089|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3851665|NCT01647737|3677090|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3851666|NCT01647737|3677091|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3851667|NCT01647737|3677089|B3||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
3851668|NCT01647737|3677090|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3851669|NCT01647737|3677091|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3851670|NCT01647737|3677089|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3851671|NCT01647737|3677090|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3851672|NCT01647737|3677091|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3851673|NCT01647737|3677089|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3851674|NCT01647737|3677090|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3851675|NCT01647737|3677091|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3851676|NCT01647711|3677098|B6||Male|Gender||Participants|Count of Participants|11|11.0||||||
3851677|NCT01647711|3677099|B5||Male|Gender||Participants|Count of Participants|1|1.0||||||
3851678|NCT01647711|3677100|B4||Male|Gender||Participants|Count of Participants|1|1.0||||||
3851679|NCT01647711|3677101|B3||Male|Gender||Participants|Count of Participants|3|3.0||||||
3851680|NCT01647711|3677102|B2||Male|Gender||Participants|Count of Participants|2|2.0||||||
3851681|NCT01647711|3677103|B1||Male|Gender||Participants|Count of Participants|4|4.0||||||
3851682|NCT01647711|3677098|B6||Female|Gender||Participants|Count of Participants|24|24.0||||||
3851683|NCT01647711|3677099|B5||Female|Gender||Participants|Count of Participants|5|5.0||||||
3851684|NCT01647711|3677100|B4||Female|Gender||Participants|Count of Participants|10|10.0||||||
3851685|NCT01647711|3677101|B3||Female|Gender||Participants|Count of Participants|6|6.0||||||
3851686|NCT01647711|3677102|B2||Female|Gender||Participants|Count of Participants|1|1.0||||||
3851687|NCT01647711|3677103|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
3851688|NCT01647711|3677098|B6|||Age||Years|Median|64.0|64.0|Full Range|||45.0|80.0|
3851689|NCT01647711|3677099|B5|||Age||Years|Median|62.5|62.5|Full Range|||54.0|75.0|
3851690|NCT01647711|3677100|B4|||Age||Years|Median|61.0|61.0|Full Range|||45.0|70.0|
3851691|NCT01647711|3677101|B3|||Age||Years|Median|65.0|65.0|Full Range|||54.0|77.0|
3851692|NCT01647711|3677102|B2|||Age||Years|Median|58.0|58.0|Full Range|||50.0|77.0|
3851693|NCT01647711|3677103|B1|||Age||Years|Median|65.0|65.0|Full Range|||64.0|80.0|
3851694|NCT01647542|3677132|B4|||Duration of Diabetes|For this measure, number of participants evaluable were 125, 122, 124 for each arm respectively.|Years|Mean|2.652|2.652|Standard Deviation|3.227|3.227|||
3851695|NCT01647542|3677133|B3|||Duration of Diabetes|For this measure, number of participants evaluable were 125, 122, 124 for each arm respectively.|Years|Mean|2.182|2.182|Standard Deviation|2.782|2.782|||
3851696|NCT01647542|3677134|B2|||Duration of Diabetes|For this measure, number of participants evaluable were 125, 122, 124 for each arm respectively.|Years|Mean|3.499|3.499|Standard Deviation|3.64|3.64|||
3851697|NCT01647542|3677135|B1|||Duration of Diabetes|For this measure, number of participants evaluable were 125, 122, 124 for each arm respectively.|Years|Mean|2.293|2.293|Standard Deviation|3.063|3.063|||
3851698|NCT01647542|3677132|B4|Taiwan, Province of China||Enrollment by Region||Participants|Number|79|79.0||||||
3851699|NCT01647542|3677133|B3|Taiwan, Province of China||Enrollment by Region||Participants|Number|26|26.0||||||
3851700|NCT01647542|3677134|B2|Taiwan, Province of China||Enrollment by Region||Participants|Number|25|25.0||||||
3851701|NCT01647542|3677135|B1|Taiwan, Province of China||Enrollment by Region||Participants|Number|28|28.0||||||
3851702|NCT01647542|3677132|B4|New Zealand||Enrollment by Region||Participants|Number|4|4.0||||||
3851703|NCT01647542|3677133|B3|New Zealand||Enrollment by Region||Participants|Number|1|1.0||||||
3851704|NCT01647542|3677134|B2|New Zealand||Enrollment by Region||Participants|Number|2|2.0||||||
3851705|NCT01647542|3677135|B1|New Zealand||Enrollment by Region||Participants|Number|1|1.0||||||
3851706|NCT01647542|3677132|B4|Korea, Republic of||Enrollment by Region||Participants|Number|83|83.0||||||
3851707|NCT01647542|3677133|B3|Korea, Republic of||Enrollment by Region||Participants|Number|28|28.0||||||
3851708|NCT01647542|3677134|B2|Korea, Republic of||Enrollment by Region||Participants|Number|29|29.0||||||
3851709|NCT01647542|3677135|B1|Korea, Republic of||Enrollment by Region||Participants|Number|26|26.0||||||
3851710|NCT01647542|3677132|B4|China||Enrollment by Region||Participants|Number|210|210.0||||||
3851711|NCT01647542|3677133|B3|China||Enrollment by Region||Participants|Number|70|70.0||||||
3851712|NCT01647542|3677134|B2|China||Enrollment by Region||Participants|Number|70|70.0||||||
3851713|NCT01647542|3677135|B1|China||Enrollment by Region||Participants|Number|70|70.0||||||
3851714|NCT01647542|3677132|B4|Australia||Enrollment by Region||Participants|Number|17|17.0||||||
3851715|NCT01647542|3677133|B3|Australia||Enrollment by Region||Participants|Number|6|6.0||||||
3851716|NCT01647542|3677134|B2|Australia||Enrollment by Region||Participants|Number|5|5.0||||||
3851717|NCT01647542|3677135|B1|Australia||Enrollment by Region||Participants|Number|6|6.0||||||
3851718|NCT01647542|3677132|B4|>= 8.5%||Glycosylated Hemoglobin (HbA1c) Category||Participants|Number|89|89.0||||||
3851719|NCT01647542|3677133|B3|>= 8.5%||Glycosylated Hemoglobin (HbA1c) Category||Participants|Number|24|24.0||||||
3851720|NCT01647542|3677134|B2|>= 8.5%||Glycosylated Hemoglobin (HbA1c) Category||Participants|Number|32|32.0||||||
3851721|NCT01647542|3677135|B1|>= 8.5%||Glycosylated Hemoglobin (HbA1c) Category||Participants|Number|33|33.0||||||
3851722|NCT01647542|3677132|B4|< 8.5 percent (%)||Glycosylated Hemoglobin (HbA1c) Category||Participants|Number|304|304.0||||||
3851723|NCT01647542|3677133|B3|< 8.5 percent (%)||Glycosylated Hemoglobin (HbA1c) Category||Participants|Number|107|107.0||||||
3851724|NCT01647542|3677134|B2|< 8.5 percent (%)||Glycosylated Hemoglobin (HbA1c) Category||Participants|Number|99|99.0||||||
3851725|NCT01647542|3677135|B1|< 8.5 percent (%)||Glycosylated Hemoglobin (HbA1c) Category||Participants|Number|98|98.0||||||
3851726|NCT01647542|3677132|B4|Ex-smoker||Smoking Classification||Participants|Number|63|63.0||||||
3851727|NCT01647542|3677133|B3|Ex-smoker||Smoking Classification||Participants|Number|27|27.0||||||
3851728|NCT01647542|3677134|B2|Ex-smoker||Smoking Classification||Participants|Number|25|25.0||||||
3851729|NCT01647542|3677135|B1|Ex-smoker||Smoking Classification||Participants|Number|11|11.0||||||
3851730|NCT01647542|3677132|B4|Current smoker||Smoking Classification||Participants|Number|80|80.0||||||
3851731|NCT01647542|3677133|B3|Current smoker||Smoking Classification||Participants|Number|33|33.0||||||
3851732|NCT01647542|3677134|B2|Current smoker||Smoking Classification||Participants|Number|16|16.0||||||
3851733|NCT01647542|3677135|B1|Current smoker||Smoking Classification||Participants|Number|31|31.0||||||
3851734|NCT01647542|3677132|B4|Never smoked||Smoking Classification||Participants|Number|250|250.0||||||
3851735|NCT01647542|3677133|B3|Never smoked||Smoking Classification||Participants|Number|71|71.0||||||
3851736|NCT01647542|3677134|B2|Never smoked||Smoking Classification||Participants|Number|90|90.0||||||
3851737|NCT01647542|3677135|B1|Never smoked||Smoking Classification||Participants|Number|89|89.0||||||
3851738|NCT01647542|3677132|B4|||Body Mass Index||Kilogram per square meter (kg/m^2)|Mean|26.03|26.03|Standard Deviation|3.956|3.956|||
3851739|NCT01647542|3677133|B3|||Body Mass Index||Kilogram per square meter (kg/m^2)|Mean|26.12|26.12|Standard Deviation|3.516|3.516|||
3851740|NCT01647542|3677134|B2|||Body Mass Index||Kilogram per square meter (kg/m^2)|Mean|25.97|25.97|Standard Deviation|3.989|3.989|||
3851741|NCT01647542|3677135|B1|||Body Mass Index||Kilogram per square meter (kg/m^2)|Mean|26.00|26.0|Standard Deviation|4.348|4.348|||
3851742|NCT01647542|3677132|B4|White||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3851743|NCT01647542|3677133|B3|White||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3851744|NCT01647542|3677134|B2|White||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3851745|NCT01647542|3677135|B1|White||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3851746|NCT01647542|3677132|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3851747|NCT01647542|3677133|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3851748|NCT01647542|3677134|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3851749|NCT01647542|3677135|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3851750|NCT01647542|3677132|B4|Asian||Race/Ethnicity, Customized||Participants|Number|381|381.0||||||
3851751|NCT01647542|3677133|B3|Asian||Race/Ethnicity, Customized||Participants|Number|127|127.0||||||
3851752|NCT01647542|3677134|B2|Asian||Race/Ethnicity, Customized||Participants|Number|126|126.0||||||
3851753|NCT01647542|3677135|B1|Asian||Race/Ethnicity, Customized||Participants|Number|128|128.0||||||
3851754|NCT01647542|3677132|B4||Male|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
3851755|NCT01647542|3677133|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3851756|NCT01647542|3677134|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3851757|NCT01647542|3677135|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3851758|NCT01647542|3677132|B4||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3851759|NCT01647542|3677133|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3851760|NCT01647542|3677134|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3851761|NCT01647542|3677135|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3851762|NCT01647542|3677132|B4|Greater than or equal to (>=) 65 years||Age, Customized||Participants|Number|73|73.0||||||
3851763|NCT01647542|3677133|B3|Greater than or equal to (>=) 65 years||Age, Customized||Participants|Number|20|20.0||||||
3851764|NCT01647542|3677134|B2|Greater than or equal to (>=) 65 years||Age, Customized||Participants|Number|29|29.0||||||
3851765|NCT01647542|3677135|B1|Greater than or equal to (>=) 65 years||Age, Customized||Participants|Number|24|24.0||||||
3851766|NCT01647542|3677132|B4|Less than (<) 65 years||Age, Customized||Participants|Number|320|320.0||||||
3851767|NCT01647542|3677133|B3|Less than (<) 65 years||Age, Customized||Participants|Number|111|111.0||||||
3851768|NCT01647542|3677134|B2|Less than (<) 65 years||Age, Customized||Participants|Number|102|102.0||||||
3851769|NCT01647542|3677135|B1|Less than (<) 65 years||Age, Customized||Participants|Number|107|107.0||||||
3851770|NCT01647542|3677132|B4|||Age||years|Mean|53.6|53.6|Standard Deviation|11.78|11.78|||
3851771|NCT01647542|3677133|B3|||Age||years|Mean|53.1|53.1|Standard Deviation|10.96|10.96|||
3851772|NCT01647542|3677134|B2|||Age||years|Mean|55.1|55.1|Standard Deviation|11.89|11.89|||
3851773|NCT01647542|3677135|B1|||Age||years|Mean|52.7|52.7|Standard Deviation|12.41|12.41|||
3851774|NCT01647464|3677154|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3851775|NCT01647464|3677154|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3851776|NCT01647464|3677154|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3851777|NCT01647464|3677154|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3851778|NCT01647464|3677154|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3851779|NCT01647464|3677154|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3851780|NCT01647438|3677158|B3|United States||Region of Enrollment||participants|Number|63|63.0||||||
3851781|NCT01647438|3677159|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
3851782|NCT01647438|3677160|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
3851783|NCT01647438|3677158|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3851784|NCT01647438|3677159|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3851785|NCT01647438|3677160|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3851786|NCT01647438|3677158|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3851787|NCT01647438|3677159|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3851788|NCT01647438|3677160|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3851789|NCT01647438|3677158|B3|||Age||years|Mean|50|50.0|Standard Deviation|8|8.0|||
3851790|NCT01647438|3677159|B2|||Age||years|Mean|50|50.0|Standard Deviation|8|8.0|||
3851791|NCT01647438|3677160|B1|||Age||years|Mean|50|50.0|Standard Deviation|7|7.0|||
3851792|NCT01647438|3677158|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3851793|NCT01647438|3677159|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3851794|NCT01647438|3677160|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3851795|NCT01647438|3677158|B3||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
3851796|NCT01647438|3677159|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3851797|NCT01647438|3677160|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3851798|NCT01647438|3677158|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3851799|NCT01647438|3677159|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3851800|NCT01647438|3677160|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3851801|NCT01647282|3677169|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
3851802|NCT01647282|3677170|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3851803|NCT01647282|3677171|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
3851804|NCT01647282|3677169|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3851805|NCT01647282|3677169|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3851806|NCT01647282|3677170|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3851807|NCT01647282|3677171|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3851808|NCT01647282|3677169|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3851809|NCT01647282|3677170|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3851810|NCT01647282|3677171|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3851811|NCT01647282|3677169|B3|||Age||years|Mean|67.1|67.1|Standard Deviation|11.0|11.0|||
3851812|NCT01647282|3677170|B2|||Age||years|Mean|66.8|66.8|Standard Deviation|12.1|12.1|||
3851813|NCT01647282|3677171|B1|||Age||years|Mean|67.3|67.3|Standard Deviation|10.5|10.5|||
3851814|NCT01647282|3677169|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3851815|NCT01647282|3677170|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3851816|NCT01647282|3677171|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3851817|NCT01647282|3677169|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
3851818|NCT01647282|3677170|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3851819|NCT01647282|3677171|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3851820|NCT01647282|3677169|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3851821|NCT01647282|3677170|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3851822|NCT01647282|3677171|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3851823|NCT01647217|3677180|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
3851824|NCT01647217|3677181|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3851825|NCT01647217|3677182|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3851826|NCT01647217|3677180|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3851827|NCT01647217|3677181|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3851828|NCT01647217|3677182|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3851829|NCT01647217|3677180|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3851830|NCT01647217|3677181|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3851831|NCT01647217|3677182|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3851832|NCT01647217|3677180|B3|||Age||Years|Mean|48.8|48.8|Standard Deviation|19.1|19.1|||
3851833|NCT01647217|3677181|B2|||Age||Years|Mean|49|49.0|Standard Deviation|18.5|18.5|||
3851834|NCT01647217|3677182|B1|||Age||Years|Mean|48.6|48.6|Standard Deviation|21.2|21.2|||
3851835|NCT01646827|3677191|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3851836|NCT01646827|3677192|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3851837|NCT01646827|3677193|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3851838|NCT01646827|3677191|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3851839|NCT01646827|3677192|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3851840|NCT01646827|3677193|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3851841|NCT01646827|3677191|B3|||Age||Years|Mean|44.5|44.5|Standard Deviation|9.3|9.3|||
3851842|NCT01646827|3677192|B2|||Age||Years|Mean|45.9|45.9|Standard Deviation|7.3|7.3|||
3851843|NCT01646827|3677193|B1|||Age||Years|Mean|43.1|43.1|Standard Deviation|11.0|11.0|||
3851844|NCT01646814|3677222|B3||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3851845|NCT01646814|3677223|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3851846|NCT01646814|3677224|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3851847|NCT01646814|3677222|B3||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3851848|NCT01646814|3677223|B2||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3851849|NCT01646814|3677224|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3851850|NCT01646814|3677222|B3|≥ 50 and ≤ 75 years||Age, Customized||participants|Number|247|247.0||||||
3851851|NCT01646814|3677223|B2|≥ 50 and ≤ 75 years||Age, Customized||participants|Number|126|126.0||||||
3851852|NCT01646814|3677224|B1|≥ 50 and ≤ 75 years||Age, Customized||participants|Number|121|121.0||||||
3851853|NCT01646762|3677231|B1|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3851854|NCT01646762|3677231|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3851855|NCT01646762|3677231|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3851856|NCT01646762|3677231|B1|||Age||years|Median|70.0|70.0|Full Range|||46.0|81.0|
3851857|NCT01646671|3677240|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3851858|NCT01646671|3677241|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3851859|NCT01646671|3677242|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3851860|NCT01646671|3677243|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3851861|NCT01646671|3677240|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3851862|NCT01646671|3677241|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3851863|NCT01646671|3677242|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3851864|NCT01646671|3677243|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3851865|NCT01646671|3677240|B4|||Age||Years|Mean|51.3|51.3|Standard Deviation|9.45|9.45|||
3851866|NCT01646671|3677241|B3|||Age||Years|Mean|49.3|49.3|Standard Deviation|7.57|7.57|||
3851867|NCT01646671|3677242|B2|||Age||Years|Mean|56.0|56.0|Standard Deviation|12.24|12.24|||
3851868|NCT01646671|3677243|B1|||Age||Years|Mean|48.0|48.0|Standard Deviation|4.0|4.0|||
3851869|NCT01646398|3677279|B3||Male|Sex: Female, Male||Participants|Count of Participants|379|379.0||||||
3851870|NCT01646398|3677280|B2||Male|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
3851871|NCT01646398|3677281|B1||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3851872|NCT01646398|3677279|B3||Female|Sex: Female, Male||Participants|Count of Participants|385|385.0||||||
3851873|NCT01646398|3677280|B2||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
3851874|NCT01646398|3677281|B1||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
3851875|NCT01646398|3677279|B3|||Age||years|Mean|69.9|69.9|Standard Deviation|3.87|3.87|||
3851876|NCT01646398|3677280|B2|||Age||years|Mean|69.7|69.7|Standard Deviation|3.66|3.66|||
3851877|NCT01646398|3677281|B1|||Age||years|Mean|70.0|70.0|Standard Deviation|4.08|4.08|||
3851878|NCT01646385|3677296|B3||Male|Sex: Female, Male||Participants|Count of Participants|1531|1531.0||||||
3851879|NCT01646385|3677297|B2||Male|Sex: Female, Male||Participants|Count of Participants|729|729.0||||||
3851880|NCT01646385|3677298|B1||Male|Sex: Female, Male||Participants|Count of Participants|802|802.0||||||
3851881|NCT01646385|3677296|B3||Female|Sex: Female, Male||Participants|Count of Participants|4862|4862.0||||||
3851882|NCT01646385|3677297|B2||Female|Sex: Female, Male||Participants|Count of Participants|2135|2135.0||||||
3851883|NCT01646385|3677298|B1||Female|Sex: Female, Male||Participants|Count of Participants|2727|2727.0||||||
3851884|NCT01646385|3677296|B3|||Age||years|Mean|57.3|57.3|Standard Deviation|12.4|12.4|||
3851885|NCT01646385|3677297|B2|||Age||years|Mean|59.8|59.8|Standard Deviation|12.4|12.4|||
3851886|NCT01646385|3677298|B1|||Age||years|Mean|55.3|55.3|Standard Deviation|12.1|12.1|||
3851887|NCT01646346|3677330|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851888|NCT01646346|3677330|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3851889|NCT01646346|3677330|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3851890|NCT01646346|3677330|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3851891|NCT01646346|3677330|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3851892|NCT01646346|3677330|B1|||Age||years|Median|64.0|64.0|Full Range|||50.0|84.0|
3851893|NCT01646320|3677340|B3|NATIVE HAWAIIAN/OTHER PACIFIC ISLANDER||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3851894|NCT01646320|3677341|B2|NATIVE HAWAIIAN/OTHER PACIFIC ISLANDER||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3851895|NCT01646320|3677342|B1|NATIVE HAWAIIAN/OTHER PACIFIC ISLANDER||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3851896|NCT01646320|3677340|B3|AMERICAN INDIAN/ALASKA NATIVE||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3851897|NCT01646320|3677341|B2|AMERICAN INDIAN/ALASKA NATIVE||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3851898|NCT01646320|3677342|B1|AMERICAN INDIAN/ALASKA NATIVE||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3851899|NCT01646320|3677340|B3|WHITE||Race/Ethnicity, Customized||Participants|Number|297|297.0||||||
3851900|NCT01646320|3677341|B2|WHITE||Race/Ethnicity, Customized||Participants|Number|147|147.0||||||
3851901|NCT01646320|3677342|B1|WHITE||Race/Ethnicity, Customized||Participants|Number|150|150.0||||||
3851902|NCT01646320|3677340|B3|OTHER||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3851903|NCT01646320|3677341|B2|OTHER||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3851904|NCT01646320|3677342|B1|OTHER||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3851905|NCT01646320|3677340|B3|BLACK/AFRICAN AMERICAN||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
3851906|NCT01646320|3677341|B2|BLACK/AFRICAN AMERICAN||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
3851907|NCT01646320|3677342|B1|BLACK/AFRICAN AMERICAN||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3851908|NCT01646320|3677340|B3|ASIAN||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3851909|NCT01646320|3677341|B2|ASIAN||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3851910|NCT01646320|3677342|B1|ASIAN||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3851911|NCT01646320|3677340|B3||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3851912|NCT01646320|3677341|B2||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3851913|NCT01646320|3677342|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3851914|NCT01646320|3677340|B3||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3851915|NCT01646320|3677341|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3851916|NCT01646320|3677342|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3851917|NCT01646320|3677340|B3|>= 65 years||Age, Customized||Participants|Number|51|51.0||||||
3851918|NCT01646320|3677341|B2|>= 65 years||Age, Customized||Participants|Number|28|28.0||||||
3851919|NCT01646320|3677342|B1|>= 65 years||Age, Customized||Participants|Number|23|23.0||||||
3851920|NCT01646320|3677340|B3|< 65 years||Age, Customized||Participants|Number|269|269.0||||||
3851921|NCT01646320|3677341|B2|< 65 years||Age, Customized||Participants|Number|132|132.0||||||
3851922|NCT01646320|3677342|B1|< 65 years||Age, Customized||Participants|Number|137|137.0||||||
3851923|NCT01646320|3677340|B3|||Age||YEARS|Mean|55.1|55.1|Standard Deviation|9.10|9.1|30.0|75.0|
3851924|NCT01646320|3677341|B2|||Age||YEARS|Mean|55.0|55.0|Standard Deviation|9.60|9.6|||
3851925|NCT01646320|3677342|B1|||Age||YEARS|Mean|55.2|55.2|Standard Deviation|8.61|8.61|||
3851926|NCT01646268|3677357|B3|||Weight||kilograms|Mean|63.6|63.6|Standard Deviation|10.2|10.2|||
3851927|NCT01646268|3677358|B2|||Weight||kilograms|Mean|64.0|64.0|Standard Deviation|9.9|9.9|||
3851928|NCT01646268|3677359|B1|||Weight||kilograms|Mean|63.2|63.2|Standard Deviation|10.5|10.5|||
3851929|NCT01646268|3677357|B3|China||Region of Enrollment||participants|Number|247|247.0||||||
3851930|NCT01646268|3677358|B2|China||Region of Enrollment||participants|Number|123|123.0||||||
3851931|NCT01646268|3677359|B1|China||Region of Enrollment||participants|Number|124|124.0||||||
3851932|NCT01646268|3677357|B3||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3851933|NCT01646268|3677358|B2||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3851934|NCT01646268|3677359|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3851935|NCT01646268|3677357|B3||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3851936|NCT01646268|3677358|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3851937|NCT01646268|3677359|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3851938|NCT01646268|3677357|B3|||Age||years|Mean|59.4|59.4|Standard Deviation|10.2|10.2|||
3851939|NCT01646268|3677358|B2|||Age||years|Mean|59.7|59.7|Standard Deviation|10.1|10.1|||
3851940|NCT01646268|3677359|B1|||Age||years|Mean|59.1|59.1|Standard Deviation|10.3|10.3|||
3851941|NCT01646268|3677357|B3||>=65 years|Age||Participants|Count of Participants|77|77.0||||||
3851942|NCT01646268|3677358|B2||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
3851943|NCT01646268|3677359|B1||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
3851944|NCT01646268|3677357|B3||Between 18 and 65 years|Age||Participants|Count of Participants|170|170.0||||||
3851945|NCT01646268|3677358|B2||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
3851946|NCT01646268|3677359|B1||Between 18 and 65 years|Age||Participants|Count of Participants|88|88.0||||||
3851947|NCT01646268|3677357|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3851948|NCT01646268|3677358|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3851949|NCT01646268|3677359|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3851950|NCT01646255|3677372|B3|||Weight||kg|Mean|61.10|61.1|Standard Deviation|10.18|10.18|||
3851951|NCT01646255|3677373|B2|||Weight||kg|Mean|60.38|60.38|Standard Deviation|10.15|10.15|||
3851952|NCT01646255|3677374|B1|||Weight||kg|Mean|61.83|61.83|Standard Deviation|10.18|10.18|||
3851953|NCT01646255|3677372|B3||Male|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
3851954|NCT01646255|3677373|B2||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3851955|NCT01646255|3677374|B1||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3851956|NCT01646255|3677372|B3||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3851957|NCT01646255|3677373|B2||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3851958|NCT01646255|3677374|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3851959|NCT01646255|3677372|B3|mean (standard deviation)||Age||years|Mean|62.2|62.2|Standard Deviation|8.9|8.9|||
3851960|NCT01646255|3677373|B2|mean (standard deviation)||Age||years|Mean|61.7|61.7|Standard Deviation|8.8|8.8|||
3851961|NCT01646255|3677374|B1|mean (standard deviation)||Age||years|Mean|62.8|62.8|Standard Deviation|9.1|9.1|||
3851962|NCT01646255|3677372|B3||>=65 years|Age||Participants|Count of Participants|139|139.0||||||
3851963|NCT01646255|3677373|B2||>=65 years|Age||Participants|Count of Participants|63|63.0||||||
3851964|NCT01646255|3677374|B1||>=65 years|Age||Participants|Count of Participants|76|76.0||||||
3851965|NCT01646255|3677372|B3||Between 18 and 65 years|Age||Participants|Count of Participants|207|207.0||||||
3851966|NCT01646255|3677373|B2||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
3851967|NCT01646255|3677374|B1||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
3851968|NCT01646255|3677372|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3851969|NCT01646255|3677373|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3851970|NCT01646255|3677374|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3851971|NCT01646216|3677405|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3851972|NCT01646216|3677406|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3851973|NCT01646216|3677407|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3851974|NCT01646216|3677405|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851975|NCT01646216|3677406|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851976|NCT01646216|3677407|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851977|NCT01646216|3677405|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851978|NCT01646216|3677406|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851979|NCT01646216|3677407|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851980|NCT01646216|3677405|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3851981|NCT01646216|3677406|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3851982|NCT01646216|3677407|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3851983|NCT01646216|3677405|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3851984|NCT01646216|3677406|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3851985|NCT01646216|3677407|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851986|NCT01646216|3677405|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851987|NCT01646216|3677406|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851988|NCT01646216|3677407|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851989|NCT01646216|3677405|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851990|NCT01646216|3677406|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851991|NCT01646216|3677407|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851992|NCT01646216|3677405|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851993|NCT01646216|3677406|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851994|NCT01646216|3677407|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851995|NCT01646216|3677405|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851996|NCT01646216|3677406|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851997|NCT01646216|3677407|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3851998|NCT01646216|3677405|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3851999|NCT01646216|3677406|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3852000|NCT01646216|3677407|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3852001|NCT01646216|3677405|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852002|NCT01646216|3677406|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852003|NCT01646216|3677407|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852004|NCT01646216|3677405|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3852005|NCT01646216|3677406|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3852006|NCT01646216|3677407|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3852007|NCT01646216|3677405|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3852008|NCT01646216|3677406|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3852009|NCT01646216|3677407|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3852010|NCT01646216|3677405|B3|||Age||years|Mean|60|60.0|Standard Deviation|13|13.0|||
3852011|NCT01646216|3677406|B2|||Age||years|Mean|59.2|59.2|Standard Deviation|14.3|14.3|||
3852012|NCT01646216|3677407|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|11.7|11.7|||
3852013|NCT01646177|3677427|B5|United States||Region of Enrollment||Participants|Number|503|503.0||||||
3852014|NCT01646177|3677428|B4|United States||Region of Enrollment||Participants|Number|141|141.0||||||
3852015|NCT01646177|3677429|B3|United States||Region of Enrollment||Participants|Number|147|147.0||||||
3852016|NCT01646177|3677430|B2|United States||Region of Enrollment||Participants|Number|146|146.0||||||
3852017|NCT01646177|3677431|B1|United States||Region of Enrollment||Participants|Number|69|69.0||||||
3852018|NCT01646177|3677427|B5|Canada||Region of Enrollment||Participants|Number|152|152.0||||||
3852019|NCT01646177|3677428|B4|Canada||Region of Enrollment||Participants|Number|42|42.0||||||
3852020|NCT01646177|3677429|B3|Canada||Region of Enrollment||Participants|Number|44|44.0||||||
3852021|NCT01646177|3677430|B2|Canada||Region of Enrollment||Participants|Number|44|44.0||||||
3852022|NCT01646177|3677431|B1|Canada||Region of Enrollment||Participants|Number|22|22.0||||||
3852023|NCT01646177|3677427|B5|Russian Federation||Region of Enrollment||Participants|Number|77|77.0||||||
3852024|NCT01646177|3677428|B4|Russian Federation||Region of Enrollment||Participants|Number|24|24.0||||||
3852025|NCT01646177|3677429|B3|Russian Federation||Region of Enrollment||Participants|Number|20|20.0||||||
3852026|NCT01646177|3677430|B2|Russian Federation||Region of Enrollment||Participants|Number|22|22.0||||||
3852027|NCT01646177|3677431|B1|Russian Federation||Region of Enrollment||Participants|Number|11|11.0||||||
3852028|NCT01646177|3677427|B5|Poland||Region of Enrollment||Participants|Number|39|39.0||||||
3852029|NCT01646177|3677428|B4|Poland||Region of Enrollment||Participants|Number|13|13.0||||||
3852030|NCT01646177|3677429|B3|Poland||Region of Enrollment||Participants|Number|11|11.0||||||
3852031|NCT01646177|3677430|B2|Poland||Region of Enrollment||Participants|Number|10|10.0||||||
3852032|NCT01646177|3677431|B1|Poland||Region of Enrollment||Participants|Number|5|5.0||||||
3852033|NCT01646177|3677427|B5|Hungary||Region of Enrollment||Participants|Number|113|113.0||||||
3852034|NCT01646177|3677428|B4|Hungary||Region of Enrollment||Participants|Number|33|33.0||||||
3852035|NCT01646177|3677429|B3|Hungary||Region of Enrollment||Participants|Number|31|31.0||||||
3852036|NCT01646177|3677430|B2|Hungary||Region of Enrollment||Participants|Number|31|31.0||||||
3852037|NCT01646177|3677431|B1|Hungary||Region of Enrollment||Participants|Number|18|18.0||||||
3852038|NCT01646177|3677427|B5|Germany||Region of Enrollment||Participants|Number|312|312.0||||||
3852039|NCT01646177|3677428|B4|Germany||Region of Enrollment||Participants|Number|90|90.0||||||
3852040|NCT01646177|3677429|B3|Germany||Region of Enrollment||Participants|Number|90|90.0||||||
3852041|NCT01646177|3677430|B2|Germany||Region of Enrollment||Participants|Number|87|87.0||||||
3852042|NCT01646177|3677431|B1|Germany||Region of Enrollment||Participants|Number|45|45.0||||||
3852043|NCT01646177|3677427|B5|Bulgaria||Region of Enrollment||Participants|Number|48|48.0||||||
3852044|NCT01646177|3677428|B4|Bulgaria||Region of Enrollment||Participants|Number|13|13.0||||||
3852045|NCT01646177|3677429|B3|Bulgaria||Region of Enrollment||Participants|Number|14|14.0||||||
3852046|NCT01646177|3677430|B2|Bulgaria||Region of Enrollment||Participants|Number|12|12.0||||||
3852047|NCT01646177|3677431|B1|Bulgaria||Region of Enrollment||Participants|Number|9|9.0||||||
3852048|NCT01646177|3677427|B5|Mexico||Region of Enrollment||Participants|Number|5|5.0||||||
3852049|NCT01646177|3677428|B4|Mexico||Region of Enrollment||Participants|Number|1|1.0||||||
3852050|NCT01646177|3677429|B3|Mexico||Region of Enrollment||Participants|Number|1|1.0||||||
3852051|NCT01646177|3677430|B2|Mexico||Region of Enrollment||Participants|Number|2|2.0||||||
3852052|NCT01646177|3677431|B1|Mexico||Region of Enrollment||Participants|Number|1|1.0||||||
3852053|NCT01646177|3677427|B5|Chile||Region of Enrollment||Participants|Number|76|76.0||||||
3852054|NCT01646177|3677428|B4|Chile||Region of Enrollment||Participants|Number|22|22.0||||||
3852055|NCT01646177|3677429|B3|Chile||Region of Enrollment||Participants|Number|22|22.0||||||
3852056|NCT01646177|3677430|B2|Chile||Region of Enrollment||Participants|Number|21|21.0||||||
3852057|NCT01646177|3677431|B1|Chile||Region of Enrollment||Participants|Number|11|11.0||||||
3852058|NCT01646177|3677427|B5|Argentina||Region of Enrollment||Participants|Number|21|21.0||||||
3852059|NCT01646177|3677428|B4|Argentina||Region of Enrollment||Participants|Number|6|6.0||||||
3852060|NCT01646177|3677429|B3|Argentina||Region of Enrollment||Participants|Number|6|6.0||||||
3852061|NCT01646177|3677430|B2|Argentina||Region of Enrollment||Participants|Number|7|7.0||||||
3852062|NCT01646177|3677431|B1|Argentina||Region of Enrollment||Participants|Number|2|2.0||||||
3852063|NCT01646177|3677427|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852064|NCT01646177|3677428|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852065|NCT01646177|3677429|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852066|NCT01646177|3677430|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852067|NCT01646177|3677431|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852068|NCT01646177|3677427|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3852069|NCT01646177|3677428|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3852070|NCT01646177|3677429|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3852071|NCT01646177|3677430|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3852072|NCT01646177|3677431|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3852073|NCT01646177|3677427|B5||White|Race (NIH/OMB)||Participants|Count of Participants|1248|1248.0||||||
3852074|NCT01646177|3677428|B4||White|Race (NIH/OMB)||Participants|Count of Participants|361|361.0||||||
3852075|NCT01646177|3677429|B3||White|Race (NIH/OMB)||Participants|Count of Participants|360|360.0||||||
3852076|NCT01646177|3677430|B2||White|Race (NIH/OMB)||Participants|Count of Participants|351|351.0||||||
3852077|NCT01646177|3677431|B1||White|Race (NIH/OMB)||Participants|Count of Participants|176|176.0||||||
3852078|NCT01646177|3677427|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3852079|NCT01646177|3677428|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3852080|NCT01646177|3677429|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3852081|NCT01646177|3677430|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3852082|NCT01646177|3677431|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3852083|NCT01646177|3677427|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3852084|NCT01646177|3677428|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3852085|NCT01646177|3677429|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3852086|NCT01646177|3677430|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3852087|NCT01646177|3677431|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852088|NCT01646177|3677427|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3852089|NCT01646177|3677428|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3852090|NCT01646177|3677429|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3852091|NCT01646177|3677430|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3852092|NCT01646177|3677431|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3852093|NCT01646177|3677427|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3852094|NCT01646177|3677428|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3852095|NCT01646177|3677429|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3852096|NCT01646177|3677430|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3852097|NCT01646177|3677431|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3852098|NCT01646177|3677427|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|238|238.0||||||
3852099|NCT01646177|3677428|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3852100|NCT01646177|3677429|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3852101|NCT01646177|3677430|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3852102|NCT01646177|3677431|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3852103|NCT01646177|3677427|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|924|924.0||||||
3852104|NCT01646177|3677428|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|259|259.0||||||
3852105|NCT01646177|3677429|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|269|269.0||||||
3852106|NCT01646177|3677430|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|263|263.0||||||
3852107|NCT01646177|3677431|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|133|133.0||||||
3852108|NCT01646177|3677427|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|184|184.0||||||
3852109|NCT01646177|3677428|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3852110|NCT01646177|3677429|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3852111|NCT01646177|3677430|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3852112|NCT01646177|3677431|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3852113|NCT01646177|3677427|B5||Male|Sex: Female, Male||Participants|Count of Participants|918|918.0||||||
3852114|NCT01646177|3677428|B4||Male|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
3852115|NCT01646177|3677429|B3||Male|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
3852116|NCT01646177|3677430|B2||Male|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
3852117|NCT01646177|3677431|B1||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3852118|NCT01646177|3677427|B5||Female|Sex: Female, Male||Participants|Count of Participants|428|428.0||||||
3852119|NCT01646177|3677428|B4||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3852120|NCT01646177|3677429|B3||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3852121|NCT01646177|3677430|B2||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3852122|NCT01646177|3677431|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3852123|NCT01646177|3677427|B5|||Age||years|Mean|45.8|45.8|Standard Deviation|13.07|13.07|||
3852124|NCT01646177|3677428|B4|||Age||years|Mean|45.6|45.6|Standard Deviation|13.10|13.1|||
3852125|NCT01646177|3677429|B3|||Age||years|Mean|45.6|45.6|Standard Deviation|12.76|12.76|||
3852126|NCT01646177|3677430|B2|||Age||years|Mean|45.8|45.8|Standard Deviation|13.84|13.84|||
3852127|NCT01646177|3677431|B1|||Age||years|Mean|46.4|46.4|Standard Deviation|12.11|12.11|||
3852128|NCT01646151|3677512|B1|Missing||Sex/Gender, Customized||Participants|Number|11|11.0||||||
3852129|NCT01646151|3677512|B1|Male||Sex/Gender, Customized||Participants|Number|1115|1115.0||||||
3852130|NCT01646151|3677512|B1|Female||Sex/Gender, Customized||Participants|Number|1454|1454.0||||||
3852131|NCT01646151|3677512|B1|Missing||Age, Customized||Participants|Number|28|28.0||||||
3852132|NCT01646151|3677512|B1|>=91 years||Age, Customized||Participants|Number|19|19.0||||||
3852133|NCT01646151|3677512|B1|81 to 90 years||Age, Customized||Participants|Number|342|342.0||||||
3852134|NCT01646151|3677512|B1|71 to 80 years||Age, Customized||Participants|Number|883|883.0||||||
3852135|NCT01646151|3677512|B1|61 to 70 years||Age, Customized||Participants|Number|695|695.0||||||
3852136|NCT01646151|3677512|B1|51 to 60 years||Age, Customized||Participants|Number|403|403.0||||||
3852137|NCT01646151|3677512|B1|41 to 50 years||Age, Customized||Participants|Number|178|178.0||||||
3852138|NCT01646151|3677512|B1|31 to 40 years||Age, Customized||Participants|Number|20|20.0||||||
3852139|NCT01646151|3677512|B1|18 to 30 years||Age, Customized||Participants|Number|12|12.0||||||
3852140|NCT01646151|3677512|B1|<18 years||Age, Customized||Participants|Number|0|0.0||||||
3852141|NCT01646138|3677523|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3852142|NCT01646138|3677524|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3852143|NCT01646138|3677525|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3852144|NCT01646138|3677526|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852145|NCT01646138|3677527|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852146|NCT01646138|3677528|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852147|NCT01646138|3677523|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3852148|NCT01646138|3677524|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852149|NCT01646138|3677525|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3852150|NCT01646138|3677526|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852151|NCT01646138|3677527|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852152|NCT01646138|3677528|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852153|NCT01646138|3677523|B6||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3852154|NCT01646138|3677524|B5||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3852155|NCT01646138|3677525|B4||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3852156|NCT01646138|3677526|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3852157|NCT01646138|3677527|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3852158|NCT01646138|3677528|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3852159|NCT01646138|3677523|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3852160|NCT01646138|3677524|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3852161|NCT01646138|3677525|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3852162|NCT01646138|3677526|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3852163|NCT01646138|3677527|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3852164|NCT01646138|3677528|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3852165|NCT01646138|3677523|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852166|NCT01646138|3677524|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852167|NCT01646138|3677525|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852168|NCT01646138|3677526|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852169|NCT01646138|3677527|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852170|NCT01646138|3677528|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852171|NCT01646138|3677523|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852172|NCT01646138|3677524|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852173|NCT01646138|3677525|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852174|NCT01646138|3677526|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852175|NCT01646138|3677527|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852176|NCT01646138|3677528|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852177|NCT01646138|3677523|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852178|NCT01646138|3677524|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852179|NCT01646138|3677525|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852180|NCT01646138|3677526|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852181|NCT01646138|3677527|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852182|NCT01646138|3677528|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852183|NCT01646138|3677523|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852184|NCT01646138|3677524|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852185|NCT01646138|3677525|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852186|NCT01646138|3677526|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852187|NCT01646138|3677527|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852188|NCT01646138|3677528|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852189|NCT01646138|3677523|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3852190|NCT01646138|3677524|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3852191|NCT01646138|3677525|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3852192|NCT01646138|3677526|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3852193|NCT01646138|3677527|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3852194|NCT01646138|3677528|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3852195|NCT01646138|3677523|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3852196|NCT01646138|3677524|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3852197|NCT01646138|3677525|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3852198|NCT01646138|3677526|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852199|NCT01646138|3677527|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852200|NCT01646138|3677528|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852201|NCT01646138|3677523|B6||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3852202|NCT01646138|3677524|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3852203|NCT01646138|3677525|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3852204|NCT01646138|3677526|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3852205|NCT01646138|3677527|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3852206|NCT01646138|3677528|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3852207|NCT01646138|3677523|B6||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3852208|NCT01646138|3677524|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3852209|NCT01646138|3677525|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3852210|NCT01646138|3677526|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3852211|NCT01646138|3677527|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3852212|NCT01646138|3677528|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3852213|NCT01646138|3677523|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3852214|NCT01646138|3677524|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3852215|NCT01646138|3677525|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3852216|NCT01646138|3677526|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3852217|NCT01646138|3677527|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3852218|NCT01646138|3677528|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3852219|NCT01646138|3677523|B6||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3852220|NCT01646138|3677524|B5||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3852221|NCT01646138|3677525|B4||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3852222|NCT01646138|3677526|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3852223|NCT01646138|3677527|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3852224|NCT01646138|3677528|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3852225|NCT01646138|3677523|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3852226|NCT01646138|3677524|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3852227|NCT01646138|3677525|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3852228|NCT01646138|3677526|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3852229|NCT01646138|3677527|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3852230|NCT01646138|3677528|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3852231|NCT01646125|3677544|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3852232|NCT01646125|3677545|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3852233|NCT01646125|3677546|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3852234|NCT01646125|3677544|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3852235|NCT01646125|3677545|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3852236|NCT01646125|3677546|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3852237|NCT01646125|3677544|B3|||Age||Years|Mean|61.9|61.9|Standard Deviation|10.13|10.13|||
3852238|NCT01646125|3677545|B2|||Age||Years|Mean|62.1|62.1|Standard Deviation|10.34|10.34|||
3852239|NCT01646125|3677546|B1|||Age||Years|Mean|61.8|61.8|Standard Deviation|10.10|10.1|||
3852240|NCT01646073|3677570|B3|Severe||Physician's Global Assessment of Psoriasis||participants|Number|16|16.0||||||
3852241|NCT01646073|3677571|B2|Severe||Physician's Global Assessment of Psoriasis||participants|Number|14|14.0||||||
3852242|NCT01646073|3677572|B1|Severe||Physician's Global Assessment of Psoriasis||participants|Number|2|2.0||||||
3852243|NCT01646073|3677570|B3|Marked||Physician's Global Assessment of Psoriasis||participants|Number|138|138.0||||||
3852244|NCT01646073|3677571|B2|Marked||Physician's Global Assessment of Psoriasis||participants|Number|110|110.0||||||
3852245|NCT01646073|3677572|B1|Marked||Physician's Global Assessment of Psoriasis||participants|Number|28|28.0||||||
3852246|NCT01646073|3677570|B3|Moderate||Physician's Global Assessment of Psoriasis||participants|Number|271|271.0||||||
3852247|NCT01646073|3677571|B2|Moderate||Physician's Global Assessment of Psoriasis||participants|Number|214|214.0||||||
3852248|NCT01646073|3677572|B1|Moderate||Physician's Global Assessment of Psoriasis||participants|Number|57|57.0||||||
3852249|NCT01646073|3677570|B3|Mild||Physician's Global Assessment of Psoriasis||participants|Number|0|0.0||||||
3852250|NCT01646073|3677571|B2|Mild||Physician's Global Assessment of Psoriasis||participants|Number|0|0.0||||||
3852251|NCT01646073|3677572|B1|Mild||Physician's Global Assessment of Psoriasis||participants|Number|0|0.0||||||
3852252|NCT01646073|3677570|B3|Minimal||Physician's Global Assessment of Psoriasis||participants|Number|0|0.0||||||
3852253|NCT01646073|3677571|B2|Minimal||Physician's Global Assessment of Psoriasis||participants|Number|0|0.0||||||
3852254|NCT01646073|3677572|B1|Minimal||Physician's Global Assessment of Psoriasis||participants|Number|0|0.0||||||
3852255|NCT01646073|3677570|B3|Clear||Physician's Global Assessment of Psoriasis||participants|Number|0|0.0||||||
3852256|NCT01646073|3677571|B2|Clear||Physician's Global Assessment of Psoriasis||participants|Number|0|0.0||||||
3852257|NCT01646073|3677572|B1|Clear||Physician's Global Assessment of Psoriasis||participants|Number|0|0.0||||||
3852258|NCT01646073|3677570|B3|||Psoriasis Area and Severity Index|Psoriasis Area and Severity Index (PASI) is a composite measure of the level of erythema (redness of the skin), induration (hardening of the skin), and desquamation (peeling of the skin) on 4 sites (head, upper extremities, trunk, and lower extremities), each of which are rated on a 5-point scale from 0 (no symptoms) to 4 (very marked). The possible range for PASI score is 0 to 72, with the highest score representing complete erythroderma of the severest possible degree; a decrease in score indicates improvement.|units on a scale|Mean|27.66|27.66|Standard Deviation|11.831|11.831|||
3852313|NCT01646021|3677613|B2|United Kingdom||Region of Enrollment||participants|Number|16|16.0||||||
3852259|NCT01646073|3677571|B2|||Psoriasis Area and Severity Index|Psoriasis Area and Severity Index (PASI) is a composite measure of the level of erythema (redness of the skin), induration (hardening of the skin), and desquamation (peeling of the skin) on 4 sites (head, upper extremities, trunk, and lower extremities), each of which are rated on a 5-point scale from 0 (no symptoms) to 4 (very marked). The possible range for PASI score is 0 to 72, with the highest score representing complete erythroderma of the severest possible degree; a decrease in score indicates improvement.|units on a scale|Mean|28.19|28.19|Standard Deviation|11.999|11.999|||
3852260|NCT01646073|3677572|B1|||Psoriasis Area and Severity Index|Psoriasis Area and Severity Index (PASI) is a composite measure of the level of erythema (redness of the skin), induration (hardening of the skin), and desquamation (peeling of the skin) on 4 sites (head, upper extremities, trunk, and lower extremities), each of which are rated on a 5-point scale from 0 (no symptoms) to 4 (very marked). The possible range for PASI score is 0 to 72, with the highest score representing complete erythroderma of the severest possible degree; a decrease in score indicates improvement.|units on a scale|Mean|25.60|25.6|Standard Deviation|10.978|10.978|||
3852261|NCT01646073|3677570|B3|||Body Surface Area with Psoriasis||Percentage of Body Surface Area|Mean|41.94|41.94|Standard Deviation|21.918|21.918|||
3852262|NCT01646073|3677571|B2|||Body Surface Area with Psoriasis||Percentage of Body Surface Area|Mean|42.62|42.62|Standard Deviation|21.748|21.748|||
3852263|NCT01646073|3677572|B1|||Body Surface Area with Psoriasis||Percentage of Body Surface Area|Mean|39.30|39.3|Standard Deviation|22.502|22.502|||
3852264|NCT01646073|3677570|B3|||Duration of Psoriasis||years|Mean|15.03|15.03|Standard Deviation|10.149|10.149|||
3852265|NCT01646073|3677571|B2|||Duration of Psoriasis||years|Mean|14.84|14.84|Standard Deviation|10.114|10.114|||
3852266|NCT01646073|3677572|B1|||Duration of Psoriasis||years|Mean|15.79|15.79|Standard Deviation|10.309|10.309|||
3852267|NCT01646073|3677570|B3||Male|Sex: Female, Male||Participants|Count of Participants|312|312.0||||||
3852268|NCT01646073|3677571|B2||Male|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
3852269|NCT01646073|3677572|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3852270|NCT01646073|3677570|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3852271|NCT01646073|3677571|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3852272|NCT01646073|3677572|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3852273|NCT01646073|3677570|B3|||Age||years|Mean|43.2|43.2|Standard Deviation|12.01|12.01|||
3852274|NCT01646073|3677571|B2|||Age||years|Mean|43.1|43.1|Standard Deviation|11.91|11.91|||
3852275|NCT01646073|3677572|B1|||Age||years|Mean|43.8|43.8|Standard Deviation|12.45|12.45|||
3852276|NCT01646021|3677612|B3|Ukraine||Region of Enrollment||participants|Number|10|10.0||||||
3852277|NCT01646021|3677613|B2|Ukraine||Region of Enrollment||participants|Number|4|4.0||||||
3852278|NCT01646021|3677614|B1|Ukraine||Region of Enrollment||participants|Number|6|6.0||||||
3852279|NCT01646021|3677612|B3|Taiwan||Region of Enrollment||participants|Number|6|6.0||||||
3852280|NCT01646021|3677613|B2|Taiwan||Region of Enrollment||participants|Number|1|1.0||||||
3852281|NCT01646021|3677614|B1|Taiwan||Region of Enrollment||participants|Number|5|5.0||||||
3852282|NCT01646021|3677612|B3|Sweden||Region of Enrollment||participants|Number|18|18.0||||||
3852283|NCT01646021|3677613|B2|Sweden||Region of Enrollment||participants|Number|8|8.0||||||
3852284|NCT01646021|3677614|B1|Sweden||Region of Enrollment||participants|Number|10|10.0||||||
3852285|NCT01646021|3677612|B3|Russian Federation||Region of Enrollment||participants|Number|29|29.0||||||
3852286|NCT01646021|3677613|B2|Russian Federation||Region of Enrollment||participants|Number|11|11.0||||||
3852287|NCT01646021|3677614|B1|Russian Federation||Region of Enrollment||participants|Number|18|18.0||||||
3852288|NCT01646021|3677612|B3|Portugal||Region of Enrollment||participants|Number|6|6.0||||||
3852289|NCT01646021|3677613|B2|Portugal||Region of Enrollment||participants|Number|3|3.0||||||
3852290|NCT01646021|3677614|B1|Portugal||Region of Enrollment||participants|Number|3|3.0||||||
3852291|NCT01646021|3677612|B3|Poland||Region of Enrollment||participants|Number|23|23.0||||||
3852292|NCT01646021|3677613|B2|Poland||Region of Enrollment||participants|Number|14|14.0||||||
3852293|NCT01646021|3677614|B1|Poland||Region of Enrollment||participants|Number|9|9.0||||||
3852294|NCT01646021|3677612|B3|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
3852295|NCT01646021|3677613|B2|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
3852296|NCT01646021|3677614|B1|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
3852297|NCT01646021|3677612|B3|Mexico||Region of Enrollment||participants|Number|2|2.0||||||
3852298|NCT01646021|3677613|B2|Mexico||Region of Enrollment||participants|Number|1|1.0||||||
3852299|NCT01646021|3677614|B1|Mexico||Region of Enrollment||participants|Number|1|1.0||||||
3852300|NCT01646021|3677612|B3|South Korea||Region of Enrollment||participants|Number|14|14.0||||||
3852301|NCT01646021|3677613|B2|South Korea||Region of Enrollment||participants|Number|3|3.0||||||
3852302|NCT01646021|3677614|B1|South Korea||Region of Enrollment||participants|Number|11|11.0||||||
3852303|NCT01646021|3677612|B3|Italy||Region of Enrollment||participants|Number|14|14.0||||||
3852304|NCT01646021|3677613|B2|Italy||Region of Enrollment||participants|Number|8|8.0||||||
3852305|NCT01646021|3677614|B1|Italy||Region of Enrollment||participants|Number|6|6.0||||||
3852306|NCT01646021|3677612|B3|Ireland||Region of Enrollment||participants|Number|3|3.0||||||
3852307|NCT01646021|3677613|B2|Ireland||Region of Enrollment||participants|Number|1|1.0||||||
3852308|NCT01646021|3677614|B1|Ireland||Region of Enrollment||participants|Number|2|2.0||||||
3852309|NCT01646021|3677612|B3|Hungary||Region of Enrollment||participants|Number|12|12.0||||||
3852310|NCT01646021|3677613|B2|Hungary||Region of Enrollment||participants|Number|7|7.0||||||
3852311|NCT01646021|3677614|B1|Hungary||Region of Enrollment||participants|Number|5|5.0||||||
3852312|NCT01646021|3677612|B3|United Kingdom||Region of Enrollment||participants|Number|27|27.0||||||
3852314|NCT01646021|3677614|B1|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
3852315|NCT01646021|3677612|B3|France||Region of Enrollment||participants|Number|10|10.0||||||
3852316|NCT01646021|3677613|B2|France||Region of Enrollment||participants|Number|5|5.0||||||
3852317|NCT01646021|3677614|B1|France||Region of Enrollment||participants|Number|5|5.0||||||
3852318|NCT01646021|3677612|B3|Spain||Region of Enrollment||participants|Number|19|19.0||||||
3852319|NCT01646021|3677613|B2|Spain||Region of Enrollment||participants|Number|14|14.0||||||
3852320|NCT01646021|3677614|B1|Spain||Region of Enrollment||participants|Number|5|5.0||||||
3852321|NCT01646021|3677612|B3|Germany||Region of Enrollment||participants|Number|23|23.0||||||
3852322|NCT01646021|3677613|B2|Germany||Region of Enrollment||participants|Number|11|11.0||||||
3852323|NCT01646021|3677614|B1|Germany||Region of Enrollment||participants|Number|12|12.0||||||
3852324|NCT01646021|3677612|B3|Czech Republic||Region of Enrollment||participants|Number|14|14.0||||||
3852325|NCT01646021|3677613|B2|Czech Republic||Region of Enrollment||participants|Number|7|7.0||||||
3852326|NCT01646021|3677614|B1|Czech Republic||Region of Enrollment||participants|Number|7|7.0||||||
3852327|NCT01646021|3677612|B3|Colombia||Region of Enrollment||participants|Number|7|7.0||||||
3852328|NCT01646021|3677613|B2|Colombia||Region of Enrollment||participants|Number|4|4.0||||||
3852329|NCT01646021|3677614|B1|Colombia||Region of Enrollment||participants|Number|3|3.0||||||
3852330|NCT01646021|3677612|B3|Canada||Region of Enrollment||participants|Number|9|9.0||||||
3852331|NCT01646021|3677613|B2|Canada||Region of Enrollment||participants|Number|3|3.0||||||
3852332|NCT01646021|3677614|B1|Canada||Region of Enrollment||participants|Number|6|6.0||||||
3852333|NCT01646021|3677612|B3|Brazil||Region of Enrollment||participants|Number|15|15.0||||||
3852334|NCT01646021|3677613|B2|Brazil||Region of Enrollment||participants|Number|10|10.0||||||
3852335|NCT01646021|3677614|B1|Brazil||Region of Enrollment||participants|Number|5|5.0||||||
3852336|NCT01646021|3677612|B3|Belgium||Region of Enrollment||participants|Number|17|17.0||||||
3852337|NCT01646021|3677613|B2|Belgium||Region of Enrollment||participants|Number|10|10.0||||||
3852338|NCT01646021|3677614|B1|Belgium||Region of Enrollment||participants|Number|7|7.0||||||
3852339|NCT01646021|3677612|B3|Male||Sex/Gender, Customized||participants|Number|208|208.0||||||
3852340|NCT01646021|3677613|B2|Male||Sex/Gender, Customized||participants|Number|108|108.0||||||
3852341|NCT01646021|3677614|B1|Male||Sex/Gender, Customized||participants|Number|100|100.0||||||
3852342|NCT01646021|3677612|B3|Female||Sex/Gender, Customized||participants|Number|72|72.0||||||
3852343|NCT01646021|3677613|B2|Female||Sex/Gender, Customized||participants|Number|33|33.0||||||
3852344|NCT01646021|3677614|B1|Female||Sex/Gender, Customized||participants|Number|39|39.0||||||
3852345|NCT01646021|3677612|B3|||Age||years|Mean|66.9|66.9|Standard Deviation|9.26|9.26|||
3852346|NCT01646021|3677613|B2|||Age||years|Mean|67.1|67.1|Standard Deviation|9.83|9.83|||
3852347|NCT01646021|3677614|B1|||Age||years|Mean|66.7|66.7|Standard Deviation|8.68|8.68|||
3852348|NCT01646021|3677612|B3||>=65 years|Age||Participants|Count of Participants|173|173.0||||||
3852349|NCT01646021|3677613|B2||>=65 years|Age||Participants|Count of Participants|87|87.0||||||
3852350|NCT01646021|3677614|B1||>=65 years|Age||Participants|Count of Participants|86|86.0||||||
3852351|NCT01646021|3677612|B3||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
3852352|NCT01646021|3677613|B2||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3852353|NCT01646021|3677614|B1||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
3852354|NCT01646021|3677612|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3852355|NCT01646021|3677613|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3852356|NCT01646021|3677614|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3852357|NCT01645930|3677652|B1|||Weight at Baseline||kg|Mean|60.6|60.6|Standard Deviation|10.47|10.47|||
3852358|NCT01645930|3677652|B1|||Height at Baseline||cm|Mean|160.2|160.2|Standard Deviation|7.80|7.8|||
3852359|NCT01645930|3677652|B1|Korea, Republic Of||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3852360|NCT01645930|3677652|B1|Hong Kong||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3852361|NCT01645930|3677652|B1|Singapore||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3852362|NCT01645930|3677652|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
3852363|NCT01645930|3677652|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
3852364|NCT01645930|3677652|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3852365|NCT01645930|3677652|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3852366|NCT01645930|3677652|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|9.84|9.84|||
3852367|NCT01645735|3677667|B3|||PORT Score|"The Pneumonia Outcomes Research Team (PORT) Score is a clinical prediction rule for medical practitioners to calculate the probability of morbidity and mortality among patients with community acquired pneumonia. Based on the patient's age, nursing home resident status, coexisting illnesses, physical examination findings, as well as laboratory and radiographic findings. The PORT score ranges from:~A low risk of~Men - Patient's age in years. Women - Patient's age in years minus 10.~To a high risk of~Men - Patient's age in years plus 285. Women - Patient's age in years plus 275."|units on a scale|Mean|99.8|99.8|Standard Deviation|34.53|34.53|||
3852417|NCT01645280|3677712|B1|Ukraine||Region of Enrollment||participants|Number|9|9.0||||||
3852418|NCT01645280|3677707|B6|USA||Region of Enrollment||participants|Number|1|1.0||||||
3852419|NCT01645280|3677708|B5|USA||Region of Enrollment||participants|Number|0|0.0||||||
3852420|NCT01645280|3677709|B4|USA||Region of Enrollment||participants|Number|0|0.0||||||
3852421|NCT01645280|3677710|B3|USA||Region of Enrollment||participants|Number|1|1.0||||||
3852368|NCT01645735|3677668|B2|||PORT Score|"The Pneumonia Outcomes Research Team (PORT) Score is a clinical prediction rule for medical practitioners to calculate the probability of morbidity and mortality among patients with community acquired pneumonia. Based on the patient's age, nursing home resident status, coexisting illnesses, physical examination findings, as well as laboratory and radiographic findings. The PORT score ranges from:~A low risk of~Men - Patient's age in years. Women - Patient's age in years minus 10.~To a high risk of~Men - Patient's age in years plus 285. Women - Patient's age in years plus 275."|units on a scale|Mean|118.6|118.6|Standard Deviation|29.47|29.47|||
3852369|NCT01645735|3677669|B1|||PORT Score|"The Pneumonia Outcomes Research Team (PORT) Score is a clinical prediction rule for medical practitioners to calculate the probability of morbidity and mortality among patients with community acquired pneumonia. Based on the patient's age, nursing home resident status, coexisting illnesses, physical examination findings, as well as laboratory and radiographic findings. The PORT score ranges from:~A low risk of~Men - Patient's age in years. Women - Patient's age in years minus 10.~To a high risk of~Men - Patient's age in years plus 285. Women - Patient's age in years plus 275."|units on a scale|Mean|89.8|89.8|Standard Deviation|33.17|33.17|||
3852370|NCT01645735|3677667|B3|||Creatinine Clearance||mL/min/1.73 m^2|Mean|83.47|83.47|Standard Deviation|45.978|45.978|||
3852371|NCT01645735|3677668|B2|||Creatinine Clearance||mL/min/1.73 m^2|Mean|66.52|66.52|Standard Deviation|24.448|24.448|||
3852372|NCT01645735|3677669|B1|||Creatinine Clearance||mL/min/1.73 m^2|Mean|92.47|92.47|Standard Deviation|52.190|52.19|||
3852373|NCT01645735|3677667|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852374|NCT01645735|3677668|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852375|NCT01645735|3677669|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852376|NCT01645735|3677667|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852377|NCT01645735|3677668|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852378|NCT01645735|3677669|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852379|NCT01645735|3677667|B3||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3852380|NCT01645735|3677668|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3852381|NCT01645735|3677669|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3852382|NCT01645735|3677667|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3852383|NCT01645735|3677668|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852384|NCT01645735|3677669|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3852385|NCT01645735|3677667|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852386|NCT01645735|3677668|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852387|NCT01645735|3677669|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852388|NCT01645735|3677667|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852389|NCT01645735|3677668|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852390|NCT01645735|3677669|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852391|NCT01645735|3677667|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852392|NCT01645735|3677668|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852393|NCT01645735|3677669|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852394|NCT01645735|3677667|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852395|NCT01645735|3677668|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852396|NCT01645735|3677669|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852397|NCT01645735|3677667|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3852398|NCT01645735|3677668|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3852399|NCT01645735|3677669|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3852400|NCT01645735|3677667|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3852401|NCT01645735|3677668|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852402|NCT01645735|3677669|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3852403|NCT01645735|3677667|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3852404|NCT01645735|3677668|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3852405|NCT01645735|3677669|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3852406|NCT01645735|3677667|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3852407|NCT01645735|3677668|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3852408|NCT01645735|3677669|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3852409|NCT01645735|3677667|B3|||Age||years|Mean|58.3|58.3|Standard Deviation|17.51|17.51|||
3852410|NCT01645735|3677668|B2|||Age||years|Mean|68.1|68.1|Standard Deviation|14.14|14.14|||
3852411|NCT01645735|3677669|B1|||Age||years|Mean|53.2|53.2|Standard Deviation|17.09|17.09|||
3852412|NCT01645280|3677707|B6|Ukraine||Region of Enrollment||participants|Number|46|46.0||||||
3852413|NCT01645280|3677708|B5|Ukraine||Region of Enrollment||participants|Number|10|10.0||||||
3852414|NCT01645280|3677709|B4|Ukraine||Region of Enrollment||participants|Number|8|8.0||||||
3852415|NCT01645280|3677710|B3|Ukraine||Region of Enrollment||participants|Number|10|10.0||||||
3852416|NCT01645280|3677711|B2|Ukraine||Region of Enrollment||participants|Number|9|9.0||||||
3852422|NCT01645280|3677711|B2|USA||Region of Enrollment||participants|Number|0|0.0||||||
3852423|NCT01645280|3677712|B1|USA||Region of Enrollment||participants|Number|0|0.0||||||
3852424|NCT01645280|3677707|B6|Singapore||Region of Enrollment||participants|Number|4|4.0||||||
3852425|NCT01645280|3677708|B5|Singapore||Region of Enrollment||participants|Number|0|0.0||||||
3852426|NCT01645280|3677709|B4|Singapore||Region of Enrollment||participants|Number|2|2.0||||||
3852427|NCT01645280|3677710|B3|Singapore||Region of Enrollment||participants|Number|0|0.0||||||
3852428|NCT01645280|3677711|B2|Singapore||Region of Enrollment||participants|Number|1|1.0||||||
3852429|NCT01645280|3677712|B1|Singapore||Region of Enrollment||participants|Number|1|1.0||||||
3852430|NCT01645280|3677707|B6|Russia||Region of Enrollment||participants|Number|86|86.0||||||
3852431|NCT01645280|3677708|B5|Russia||Region of Enrollment||participants|Number|14|14.0||||||
3852432|NCT01645280|3677709|B4|Russia||Region of Enrollment||participants|Number|19|19.0||||||
3852433|NCT01645280|3677710|B3|Russia||Region of Enrollment||participants|Number|18|18.0||||||
3852434|NCT01645280|3677711|B2|Russia||Region of Enrollment||participants|Number|15|15.0||||||
3852435|NCT01645280|3677712|B1|Russia||Region of Enrollment||participants|Number|20|20.0||||||
3852436|NCT01645280|3677707|B6|Poland||Region of Enrollment||participants|Number|35|35.0||||||
3852437|NCT01645280|3677708|B5|Poland||Region of Enrollment||participants|Number|9|9.0||||||
3852438|NCT01645280|3677709|B4|Poland||Region of Enrollment||participants|Number|7|7.0||||||
3852439|NCT01645280|3677710|B3|Poland||Region of Enrollment||participants|Number|6|6.0||||||
3852440|NCT01645280|3677711|B2|Poland||Region of Enrollment||participants|Number|8|8.0||||||
3852441|NCT01645280|3677712|B1|Poland||Region of Enrollment||participants|Number|5|5.0||||||
3852442|NCT01645280|3677707|B6|Hungary||Region of Enrollment||participants|Number|20|20.0||||||
3852443|NCT01645280|3677708|B5|Hungary||Region of Enrollment||participants|Number|3|3.0||||||
3852444|NCT01645280|3677709|B4|Hungary||Region of Enrollment||participants|Number|4|4.0||||||
3852445|NCT01645280|3677710|B3|Hungary||Region of Enrollment||participants|Number|2|2.0||||||
3852446|NCT01645280|3677711|B2|Hungary||Region of Enrollment||participants|Number|5|5.0||||||
3852447|NCT01645280|3677712|B1|Hungary||Region of Enrollment||participants|Number|6|6.0||||||
3852448|NCT01645280|3677707|B6|Colombia||Region of Enrollment||participants|Number|43|43.0||||||
3852449|NCT01645280|3677708|B5|Colombia||Region of Enrollment||participants|Number|10|10.0||||||
3852450|NCT01645280|3677709|B4|Colombia||Region of Enrollment||participants|Number|6|6.0||||||
3852451|NCT01645280|3677710|B3|Colombia||Region of Enrollment||participants|Number|8|8.0||||||
3852452|NCT01645280|3677711|B2|Colombia||Region of Enrollment||participants|Number|9|9.0||||||
3852453|NCT01645280|3677712|B1|Colombia||Region of Enrollment||participants|Number|10|10.0||||||
3852454|NCT01645280|3677707|B6|Chile||Region of Enrollment||participants|Number|6|6.0||||||
3852455|NCT01645280|3677708|B5|Chile||Region of Enrollment||participants|Number|2|2.0||||||
3852456|NCT01645280|3677709|B4|Chile||Region of Enrollment||participants|Number|1|1.0||||||
3852457|NCT01645280|3677710|B3|Chile||Region of Enrollment||participants|Number|1|1.0||||||
3852458|NCT01645280|3677711|B2|Chile||Region of Enrollment||participants|Number|1|1.0||||||
3852459|NCT01645280|3677712|B1|Chile||Region of Enrollment||participants|Number|1|1.0||||||
3852460|NCT01645280|3677707|B6|CZ Rep||Region of Enrollment||participants|Number|1|1.0||||||
3852461|NCT01645280|3677708|B5|CZ Rep||Region of Enrollment||participants|Number|0|0.0||||||
3852462|NCT01645280|3677709|B4|CZ Rep||Region of Enrollment||participants|Number|0|0.0||||||
3852463|NCT01645280|3677710|B3|CZ Rep||Region of Enrollment||participants|Number|1|1.0||||||
3852464|NCT01645280|3677711|B2|CZ Rep||Region of Enrollment||participants|Number|0|0.0||||||
3852465|NCT01645280|3677712|B1|CZ Rep||Region of Enrollment||participants|Number|0|0.0||||||
3852466|NCT01645280|3677707|B6|Bulgaria||Region of Enrollment||participants|Number|9|9.0||||||
3852467|NCT01645280|3677708|B5|Bulgaria||Region of Enrollment||participants|Number|1|1.0||||||
3852468|NCT01645280|3677709|B4|Bulgaria||Region of Enrollment||participants|Number|2|2.0||||||
3852469|NCT01645280|3677710|B3|Bulgaria||Region of Enrollment||participants|Number|2|2.0||||||
3852470|NCT01645280|3677711|B2|Bulgaria||Region of Enrollment||participants|Number|2|2.0||||||
3852471|NCT01645280|3677712|B1|Bulgaria||Region of Enrollment||participants|Number|2|2.0||||||
3852472|NCT01645280|3677707|B6|Argentina||Region of Enrollment||participants|Number|23|23.0||||||
3852473|NCT01645280|3677708|B5|Argentina||Region of Enrollment||participants|Number|6|6.0||||||
3852474|NCT01645280|3677709|B4|Argentina||Region of Enrollment||participants|Number|5|5.0||||||
3852475|NCT01645280|3677710|B3|Argentina||Region of Enrollment||participants|Number|6|6.0||||||
3852476|NCT01645280|3677711|B2|Argentina||Region of Enrollment||participants|Number|5|5.0||||||
3852477|NCT01645280|3677712|B1|Argentina||Region of Enrollment||participants|Number|1|1.0||||||
3852478|NCT01645280|3677707|B6||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3852479|NCT01645280|3677708|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3852480|NCT01645280|3677709|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3852481|NCT01645280|3677710|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3852482|NCT01645280|3677711|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3852483|NCT01645280|3677712|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3852484|NCT01645280|3677707|B6||Female|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
3852485|NCT01645280|3677708|B5||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3852486|NCT01645280|3677709|B4||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3852487|NCT01645280|3677710|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3852488|NCT01645280|3677711|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3852489|NCT01645280|3677712|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3852490|NCT01645280|3677707|B6|||Age||years|Mean|51.5|51.5|Standard Deviation|12.34|12.34|||
3852491|NCT01645280|3677708|B5|||Age||years|Mean|49.9|49.9|Standard Deviation|12.85|12.85|||
3852492|NCT01645280|3677709|B4|||Age||years|Mean|54.6|54.6|Standard Deviation|11.34|11.34|||
3852493|NCT01645280|3677710|B3|||Age||years|Mean|51.4|51.4|Standard Deviation|13.59|13.59|||
3852494|NCT01645280|3677711|B2|||Age||years|Mean|50.8|50.8|Standard Deviation|13.01|13.01|||
3852495|NCT01645280|3677712|B1|||Age||years|Mean|51.1|51.1|Standard Deviation|10.57|10.57|||
3852496|NCT01645176|3677744|B1|||WOMAC PAIN|"(WOMAC) The Western Ontario and McMaster Universities Osteoarthritis Index~Rates activities for Stiffness, Pain and Physical Function according to the following:~scale of difficulty: 0 = None, 1 = Slight, 2 = Moderate, 3 = Very, 4 = Extremely"|units on a scale|Mean|9.8|9.8|Standard Deviation|3.2|3.2|||
3852497|NCT01645176|3677744|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3852498|NCT01645176|3677744|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3852499|NCT01645176|3677744|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3852500|NCT01645176|3677744|B1|age||Age||years|Mean|64.7|64.7|Standard Deviation|6.9|6.9|||
3852501|NCT01645111|3677748|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3852502|NCT01645111|3677748|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3852503|NCT01645111|3677748|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3852504|NCT01645111|3677748|B1|||Age||years|Mean|14.6|14.6|Standard Deviation|3.2|3.2|||
3852505|NCT01645111|3677748|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3852506|NCT01645111|3677748|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3852507|NCT01645111|3677748|B1||<=18 years|Age||Participants|Count of Participants|47|47.0||||||
3852508|NCT01645098|3677752|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3852509|NCT01645098|3677753|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3852510|NCT01645098|3677754|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3852511|NCT01645098|3677752|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3852512|NCT01645098|3677753|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3852513|NCT01645098|3677754|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3852514|NCT01645098|3677752|B3|||Age||years|Mean|9.4|9.4|Standard Deviation|1.7|1.7|||
3852515|NCT01645098|3677753|B2|||Age||years|Mean|8.9|8.9|Standard Deviation|1.9|1.9|||
3852516|NCT01645098|3677754|B1|||Age||years|Mean|9.7|9.7|Standard Deviation|1.4|1.4|||
3852517|NCT01645059|3677769|B1|Spain||Region of Enrollment||participants|Number|129|129.0||||||
3852518|NCT01645059|3677769|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3852519|NCT01645059|3677769|B1||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3852520|NCT01645059|3677769|B1|||Age||years|Mean|58.1|58.1|Standard Deviation|13.9|13.9|||
3852521|NCT01645059|3677769|B1||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
3852522|NCT01645059|3677769|B1||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
3852523|NCT01645059|3677769|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3852524|NCT01644734|3677787|B1||Male|Sex: Female, Male||Participants|Count of Participants|788|788.0||||||
3852525|NCT01644734|3677787|B1||Female|Sex: Female, Male||Participants|Count of Participants|494|494.0||||||
3852526|NCT01644734|3677787|B1|||Age||years|Mean|64.2|64.2|Standard Deviation|10.8|10.8|||
3852527|NCT01644695|3677792|B1|United States||Region of Enrollment||participants|Number|85|85.0||||||
3852528|NCT01644695|3677792|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3852529|NCT01644695|3677792|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3852530|NCT01644695|3677792|B1|||Age||years|Mean|53.25|53.25|Standard Deviation|10.22|10.22|||
3852531|NCT01644695|3677792|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3852532|NCT01644695|3677792|B1||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
3852533|NCT01644695|3677792|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3852534|NCT01644643|3677797|B5|White||Race/Ethnicity, Customized||Participants|Number|287|287.0||||||
3852535|NCT01644643|3677798|B4|White||Race/Ethnicity, Customized||Participants|Number|136|136.0||||||
3852536|NCT01644643|3677799|B3|White||Race/Ethnicity, Customized||Participants|Number|131|131.0||||||
3852537|NCT01644643|3677800|B2|White||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3852538|NCT01644643|3677801|B1|White||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3852539|NCT01644643|3677797|B5|Other||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3852540|NCT01644643|3677798|B4|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3852541|NCT01644643|3677799|B3|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3852542|NCT01644643|3677800|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3852543|NCT01644643|3677801|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3852544|NCT01644643|3677797|B5|Black Or African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3852545|NCT01644643|3677798|B4|Black Or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3852546|NCT01644643|3677799|B3|Black Or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3852662|NCT01644474|3678094|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3852547|NCT01644643|3677800|B2|Black Or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3852548|NCT01644643|3677801|B1|Black Or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3852549|NCT01644643|3677797|B5|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3852550|NCT01644643|3677798|B4|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3852551|NCT01644643|3677799|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3852552|NCT01644643|3677800|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3852553|NCT01644643|3677801|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3852554|NCT01644643|3677797|B5||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3852555|NCT01644643|3677798|B4||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3852556|NCT01644643|3677799|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3852557|NCT01644643|3677800|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3852558|NCT01644643|3677801|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3852559|NCT01644643|3677797|B5||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3852560|NCT01644643|3677798|B4||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3852561|NCT01644643|3677799|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3852562|NCT01644643|3677800|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3852563|NCT01644643|3677801|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3852564|NCT01644643|3677797|B5|75-90 Years||Age, Customized||Participants|Number|69|69.0||||||
3852565|NCT01644643|3677798|B4|75-90 Years||Age, Customized||Participants|Number|38|38.0||||||
3852566|NCT01644643|3677799|B3|75-90 Years||Age, Customized||Participants|Number|27|27.0||||||
3852567|NCT01644643|3677800|B2|75-90 Years||Age, Customized||Participants|Number|0|0.0||||||
3852568|NCT01644643|3677801|B1|75-90 Years||Age, Customized||Participants|Number|4|4.0||||||
3852569|NCT01644643|3677797|B5|65-74 Years||Age, Customized||Participants|Number|92|92.0||||||
3852570|NCT01644643|3677798|B4|65-74 Years||Age, Customized||Participants|Number|46|46.0||||||
3852571|NCT01644643|3677799|B3|65-74 Years||Age, Customized||Participants|Number|40|40.0||||||
3852572|NCT01644643|3677800|B2|65-74 Years||Age, Customized||Participants|Number|2|2.0||||||
3852573|NCT01644643|3677801|B1|65-74 Years||Age, Customized||Participants|Number|4|4.0||||||
3852574|NCT01644643|3677797|B5|46-64 Years||Age, Customized||Participants|Number|98|98.0||||||
3852575|NCT01644643|3677798|B4|46-64 Years||Age, Customized||Participants|Number|41|41.0||||||
3852576|NCT01644643|3677799|B3|46-64 Years||Age, Customized||Participants|Number|49|49.0||||||
3852577|NCT01644643|3677800|B2|46-64 Years||Age, Customized||Participants|Number|5|5.0||||||
3852578|NCT01644643|3677801|B1|46-64 Years||Age, Customized||Participants|Number|3|3.0||||||
3852579|NCT01644643|3677797|B5|18-45 Years||Age, Customized||Participants|Number|43|43.0||||||
3852580|NCT01644643|3677798|B4|18-45 Years||Age, Customized||Participants|Number|19|19.0||||||
3852581|NCT01644643|3677799|B3|18-45 Years||Age, Customized||Participants|Number|21|21.0||||||
3852582|NCT01644643|3677800|B2|18-45 Years||Age, Customized||Participants|Number|3|3.0||||||
3852583|NCT01644643|3677801|B1|18-45 Years||Age, Customized||Participants|Number|0|0.0||||||
3852584|NCT01644643|3677797|B5|||Age||Years|Mean|62.6|62.6|Standard Deviation|15.12|15.12|18.0|90.0|
3852585|NCT01644643|3677798|B4|||Age||Years|Mean|64.3|64.3|Standard Deviation|14.64|14.64|18.0|88.0|
3852586|NCT01644643|3677799|B3|||Age||Years|Mean|61.3|61.3|Standard Deviation|15.33|15.33|18.0|90.0|
3852587|NCT01644643|3677800|B2|||Age||Years|Mean|49.9|49.9|Standard Deviation|16.14|16.14|26.0|73.0|
3852588|NCT01644643|3677801|B1|||Age||Years|Mean|68.4|68.4|Standard Deviation|11.12|11.12|50.0|86.0|
3852589|NCT01644617|3677966|B4||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3852590|NCT01644617|3677967|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3852591|NCT01644617|3677968|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3852592|NCT01644617|3677969|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3852593|NCT01644617|3677966|B4||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3852594|NCT01644617|3677967|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3852595|NCT01644617|3677968|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3852596|NCT01644617|3677969|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3852597|NCT01644617|3677966|B4|||Age||Years|Mean|26.9|26.9|Standard Deviation|7.5|7.5|||
3852598|NCT01644617|3677967|B3|||Age||Years|Mean|26.6|26.6|Standard Deviation|6.1|6.1|||
3852599|NCT01644617|3677968|B2|||Age||Years|Mean|26.7|26.7|Standard Deviation|7.0|7.0|||
3852600|NCT01644617|3677969|B1|||Age||Years|Mean|27.5|27.5|Standard Deviation|9.2|9.2|||
3852601|NCT01644500|3678021|B4|South Korea||Region of Enrollment||Participants|Count of Participants|78|78.0||||||
3852602|NCT01644500|3678022|B3|South Korea||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3852603|NCT01644500|3678023|B2|South Korea||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3852604|NCT01644500|3678024|B1|South Korea||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3852605|NCT01644500|3678021|B4|China||Region of Enrollment||Participants|Count of Participants|556|556.0||||||
3852606|NCT01644500|3678022|B3|China||Region of Enrollment||Participants|Count of Participants|186|186.0||||||
3852607|NCT01644500|3678023|B2|China||Region of Enrollment||Participants|Count of Participants|186|186.0||||||
3852608|NCT01644500|3678024|B1|China||Region of Enrollment||Participants|Count of Participants|184|184.0||||||
3852609|NCT01644500|3678021|B4|Taiwan||Region of Enrollment||Participants|Count of Participants|86|86.0||||||
3852610|NCT01644500|3678022|B3|Taiwan||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3852611|NCT01644500|3678023|B2|Taiwan||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3852612|NCT01644500|3678024|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3852613|NCT01644500|3678021|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852614|NCT01644500|3678022|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852615|NCT01644500|3678023|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852616|NCT01644500|3678024|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852617|NCT01644500|3678021|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852618|NCT01644500|3678022|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852619|NCT01644500|3678023|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852620|NCT01644500|3678024|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852621|NCT01644500|3678021|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852622|NCT01644500|3678022|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852623|NCT01644500|3678023|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852624|NCT01644500|3678024|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852625|NCT01644500|3678021|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852626|NCT01644500|3678022|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852627|NCT01644500|3678023|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852628|NCT01644500|3678024|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852629|NCT01644500|3678021|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852630|NCT01644500|3678022|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852631|NCT01644500|3678023|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852632|NCT01644500|3678024|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852633|NCT01644500|3678021|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|720|720.0||||||
3852634|NCT01644500|3678022|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|242|242.0||||||
3852635|NCT01644500|3678023|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|239|239.0||||||
3852636|NCT01644500|3678024|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|239|239.0||||||
3852637|NCT01644500|3678021|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852638|NCT01644500|3678022|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852639|NCT01644500|3678023|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852640|NCT01644500|3678024|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852641|NCT01644500|3678021|B4||Male|Sex: Female, Male||Participants|Count of Participants|391|391.0||||||
3852642|NCT01644500|3678022|B3||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3852643|NCT01644500|3678023|B2||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3852644|NCT01644500|3678024|B1||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3852645|NCT01644500|3678021|B4||Female|Sex: Female, Male||Participants|Count of Participants|329|329.0||||||
3852646|NCT01644500|3678022|B3||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3852647|NCT01644500|3678023|B2||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3852648|NCT01644500|3678024|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3852649|NCT01644500|3678021|B4|||Age||years|Mean|52.81|52.81|Standard Deviation|10.317|10.317|||
3852650|NCT01644500|3678022|B3|||Age||years|Mean|51.97|51.97|Standard Deviation|10.052|10.052|||
3852651|NCT01644500|3678023|B2|||Age||years|Mean|53.79|53.79|Standard Deviation|10.093|10.093|||
3852652|NCT01644500|3678024|B1|||Age||years|Mean|52.69|52.69|Standard Deviation|10.754|10.754|||
3852653|NCT01644474|3678094|B3|||Calculated LDL-C in mg/dL|Calculated LDL-C in mg/dL from Friedewald formula (LDL cholesterol = Total cholesterol - HDL cholesterol - [Triglyceride/5]).|mg/dL|Mean|139.7|139.7|Standard Deviation|25.8|25.8|||
3852654|NCT01644474|3678095|B2|||Calculated LDL-C in mg/dL|Calculated LDL-C in mg/dL from Friedewald formula (LDL cholesterol = Total cholesterol - HDL cholesterol - [Triglyceride/5]).|mg/dL|Mean|141.1|141.1|Standard Deviation|27.1|27.1|||
3852655|NCT01644474|3678096|B1|||Calculated LDL-C in mg/dL|Calculated LDL-C in mg/dL from Friedewald formula (LDL cholesterol = Total cholesterol - HDL cholesterol - [Triglyceride/5]).|mg/dL|Mean|138.3|138.3|Standard Deviation|24.5|24.5|||
3852656|NCT01644474|3678094|B3|||Calculated LDL-C in mmol/L|Calculated LDL-C in mmol/L from Friedewald formula (LDL cholesterol = Total cholesterol - HDL cholesterol - [Triglyceride/2.2]).|mmol/L|Mean|3.62|3.62|Standard Deviation|0.7|0.7|||
3852657|NCT01644474|3678095|B2|||Calculated LDL-C in mmol/L|Calculated LDL-C in mmol/L from Friedewald formula (LDL cholesterol = Total cholesterol - HDL cholesterol - [Triglyceride/2.2]).|mmol/L|Mean|3.65|3.65|Standard Deviation|0.7|0.7|||
3852658|NCT01644474|3678096|B1|||Calculated LDL-C in mmol/L|Calculated LDL-C in mmol/L from Friedewald formula (LDL cholesterol = Total cholesterol - HDL cholesterol - [Triglyceride/2.2]).|mmol/L|Mean|3.58|3.58|Standard Deviation|0.6|0.6|||
3852659|NCT01644474|3678094|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3852660|NCT01644474|3678095|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3852661|NCT01644474|3678096|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3852663|NCT01644474|3678095|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3852664|NCT01644474|3678096|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3852665|NCT01644474|3678094|B3|||Age||years|Mean|60.2|60.2|Standard Deviation|5.0|5.0|||
3852666|NCT01644474|3678095|B2|||Age||years|Mean|60.8|60.8|Standard Deviation|4.6|4.6|||
3852667|NCT01644474|3678096|B1|||Age||years|Mean|59.6|59.6|Standard Deviation|5.3|5.3|||
3852668|NCT01644396|3678137|B1|Russian Federation||Region of Enrollment||participants|Number|50|50.0||||||
3852669|NCT01644396|3678137|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3852670|NCT01644396|3678137|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3852671|NCT01644396|3678137|B1|||Age||years|Mean|41.5|41.5|Standard Deviation|9.86|9.86|||
3852672|NCT01644331|3678179|B3|United States||Region of Enrollment||Participants|Count of Participants|257|257.0||||||
3852673|NCT01644331|3678180|B2|United States||Region of Enrollment||Participants|Count of Participants|128|128.0||||||
3852674|NCT01644331|3678181|B1|United States||Region of Enrollment||Participants|Count of Participants|129|129.0||||||
3852675|NCT01644331|3678179|B3||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3852676|NCT01644331|3678180|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3852677|NCT01644331|3678181|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3852678|NCT01644331|3678179|B3||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3852679|NCT01644331|3678180|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3852680|NCT01644331|3678181|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3852681|NCT01644331|3678179|B3|||Age||years|Mean|64.70|64.7|Standard Deviation|14.4|14.4|||
3852682|NCT01644331|3678180|B2|||Age||years|Mean|62.97|62.97|Standard Deviation|15.7|15.7|||
3852683|NCT01644331|3678181|B1|||Age||years|Mean|66.42|66.42|Standard Deviation|12.9|12.9|||
3852684|NCT01644292|3678214|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
3852685|NCT01644292|3678214|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3852686|NCT01644292|3678214|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3852687|NCT01644292|3678214|B1|||Age||years|Mean|66.5|66.5|Standard Deviation|9.2|9.2|||
3852688|NCT01644292|3678214|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3852689|NCT01644292|3678214|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3852690|NCT01644292|3678214|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3852691|NCT01644240|3678218|B4|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3852692|NCT01644240|3678219|B3|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3852693|NCT01644240|3678220|B2|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3852694|NCT01644240|3678221|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3852695|NCT01644240|3678218|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3852696|NCT01644240|3678219|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3852697|NCT01644240|3678220|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3852698|NCT01644240|3678221|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3852699|NCT01644240|3678218|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3852700|NCT01644240|3678219|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3852701|NCT01644240|3678220|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3852702|NCT01644240|3678221|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3852703|NCT01644240|3678218|B4|||Age||years|Mean|32.6|32.6|Standard Deviation|5.49|5.49|||
3852704|NCT01644240|3678219|B3|||Age||years|Mean|30.2|30.2|Standard Deviation|5.98|5.98|||
3852705|NCT01644240|3678220|B2|||Age||years|Mean|37.0|37.0|Standard Deviation|3.56|3.56|||
3852706|NCT01644240|3678221|B1|||Age||years|Mean|32.2|32.2|Standard Deviation|4.92|4.92|||
3852707|NCT01644188|3678279|B3|||Calculated LDL-C in mmol/L||mmol/L|Mean|2.778|2.778|Standard Deviation|0.926|0.926|||
3852708|NCT01644188|3678280|B2|||Calculated LDL-C in mmol/L||mmol/L|Mean|2.710|2.71|Standard Deviation|0.884|0.884|||
3852709|NCT01644188|3678281|B1|||Calculated LDL-C in mmol/L||mmol/L|Mean|2.812|2.812|Standard Deviation|0.945|0.945|||
3852710|NCT01644188|3678279|B3|||Calculated LDL-C in mg/dL|Calculated LDL-C in mg/dL from Friedewald formula (LDL cholesterol = Total cholesterol - HDL cholesterol - [Triglyceride/5]).|mg/dL|Mean|107.3|107.3|Standard Deviation|35.7|35.7|||
3852711|NCT01644188|3678280|B2|||Calculated LDL-C in mg/dL|Calculated LDL-C in mg/dL from Friedewald formula (LDL cholesterol = Total cholesterol - HDL cholesterol - [Triglyceride/5]).|mg/dL|Mean|104.6|104.6|Standard Deviation|34.1|34.1|||
3852712|NCT01644188|3678281|B1|||Calculated LDL-C in mg/dL|Calculated LDL-C in mg/dL from Friedewald formula (LDL cholesterol = Total cholesterol - HDL cholesterol - [Triglyceride/5]).|mg/dL|Mean|108.6|108.6|Standard Deviation|36.5|36.5|||
3852713|NCT01644188|3678279|B3||Male|Sex: Female, Male||Participants|Count of Participants|530|530.0||||||
3852714|NCT01644188|3678280|B2||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
3852715|NCT01644188|3678281|B1||Male|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
3852716|NCT01644188|3678279|B3||Female|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
3852717|NCT01644188|3678280|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3852718|NCT01644188|3678281|B1||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3852719|NCT01644188|3678279|B3|||Age||years|Mean|61.6|61.6|Standard Deviation|9.3|9.3|||
3852720|NCT01644188|3678280|B2|||Age||years|Mean|61.3|61.3|Standard Deviation|9.2|9.2|||
3852721|NCT01644188|3678281|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|9.4|9.4|||
3852722|NCT01644175|3678338|B3|||Calculated LDL-C in mg/dL|Calculated LDL-C in mg/dL from Friedewald formula (LDL cholesterol = Total cholesterol - HDL cholesterol - [Triglyceride/5]).|mg/dL|Mean|102.2|102.2|Standard Deviation|31.6|31.6|||
3852723|NCT01644175|3678339|B2|||Calculated LDL-C in mg/dL|Calculated LDL-C in mg/dL from Friedewald formula (LDL cholesterol = Total cholesterol - HDL cholesterol - [Triglyceride/5]).|mg/dL|Mean|100.2|100.2|Standard Deviation|29.5|29.5|||
3852724|NCT01644175|3678340|B1|||Calculated LDL-C in mg/dL|Calculated LDL-C in mg/dL from Friedewald formula (LDL cholesterol = Total cholesterol - HDL cholesterol - [Triglyceride/5]).|mg/dL|Mean|106.0|106.0|Standard Deviation|35.3|35.3|||
3852725|NCT01644175|3678338|B3|||Calculated LDL-C in mmol/L|Calculated LDL-C in mmol/L from Friedewald formula (LDL cholesterol = Total cholesterol - HDL cholesterol - [Triglyceride/2.2]).|mmol/L|Mean|2.646|2.646|Standard Deviation|0.820|0.82|||
3852726|NCT01644175|3678339|B2|||Calculated LDL-C in mmol/L|Calculated LDL-C in mmol/L from Friedewald formula (LDL cholesterol = Total cholesterol - HDL cholesterol - [Triglyceride/2.2]).|mmol/L|Mean|2.595|2.595|Standard Deviation|0.764|0.764|||
3852727|NCT01644175|3678340|B1|||Calculated LDL-C in mmol/L|Calculated LDL-C in mmol/L from Friedewald formula (LDL cholesterol = Total cholesterol - HDL cholesterol - [Triglyceride/2.2]).|mmol/L|Mean|2.746|2.746|Standard Deviation|0.915|0.915|||
3852728|NCT01644175|3678338|B3||Male|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
3852729|NCT01644175|3678339|B2||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3852730|NCT01644175|3678340|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3852731|NCT01644175|3678338|B3||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3852732|NCT01644175|3678339|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3852733|NCT01644175|3678340|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3852734|NCT01644175|3678338|B3|||Age||years|Mean|63.0|63.0|Standard Deviation|9.3|9.3|||
3852735|NCT01644175|3678339|B2|||Age||years|Mean|63.0|63.0|Standard Deviation|9.5|9.5|||
3852736|NCT01644175|3678340|B1|||Age||years|Mean|63.0|63.0|Standard Deviation|8.8|8.8|||
3852737|NCT01644058|3678391|B1|Canada||Region of Enrollment||participants|Number|18|18.0||||||
3852738|NCT01644058|3678391|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3852739|NCT01644058|3678391|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3852740|NCT01644058|3678391|B1|||Age||years|Mean|62.4|62.4|Standard Deviation|7.65|7.65|||
3852741|NCT01644058|3678391|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3852742|NCT01644058|3678391|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3852743|NCT01644058|3678391|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3852744|NCT01643928|3678396|B6||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3852745|NCT01643928|3678397|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3852746|NCT01643928|3678398|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3852747|NCT01643928|3678399|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3852748|NCT01643928|3678400|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3852749|NCT01643928|3678401|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3852750|NCT01643928|3678396|B6||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3852751|NCT01643928|3678397|B5||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3852752|NCT01643928|3678398|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3852753|NCT01643928|3678399|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3852754|NCT01643928|3678400|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3852755|NCT01643928|3678401|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3852756|NCT01643928|3678396|B6|||Age||Years|Mean|55.3|55.3|Standard Deviation|11.55|11.55|||
3852757|NCT01643928|3678397|B5|||Age||Years|Mean|55.8|55.8|Standard Deviation|10.35|10.35|||
3852758|NCT01643928|3678398|B4|||Age||Years|Mean|52.6|52.6|Standard Deviation|13.73|13.73|||
3852759|NCT01643928|3678399|B3|||Age||Years|Mean|56.7|56.7|Standard Deviation|9.35|9.35|||
3852760|NCT01643928|3678400|B2|||Age||Years|Mean|56.0|56.0|Standard Deviation|11.88|11.88|||
3852761|NCT01643928|3678401|B1|||Age||Years|Mean|55.3|55.3|Standard Deviation|12.01|12.01|||
3852762|NCT01643902|3678690|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3852763|NCT01643902|3678690|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852764|NCT01643902|3678690|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852765|NCT01643902|3678690|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3852766|NCT01643902|3678690|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3852767|NCT01643902|3678690|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852768|NCT01643902|3678690|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852769|NCT01643902|3678690|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852770|NCT01643902|3678690|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852771|NCT01643902|3678690|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3852772|NCT01643902|3678690|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852773|NCT01643902|3678690|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3852774|NCT01643902|3678690|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3852775|NCT01643902|3678690|B1|||Age||years|Mean|65|65.0|Full Range|||47.0|83.0|
3852776|NCT01643902|3678690|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3852777|NCT01643902|3678690|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3852778|NCT01643902|3678690|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3852779|NCT01643876|3678695|B1|Brazil||Region of Enrollment||participants|Number|26|26.0||||||
3852780|NCT01643876|3678695|B1|Canada||Region of Enrollment||participants|Number|22|22.0||||||
3852781|NCT01643876|3678695|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3852782|NCT01643876|3678695|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3852783|NCT01643876|3678695|B1|||Age||years|Mean|66.0|66.0|Standard Deviation|11.2|11.2|||
3852784|NCT01643876|3678695|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3852785|NCT01643876|3678695|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3852786|NCT01643876|3678695|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3852787|NCT01643798|3678700|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3852788|NCT01643798|3678700|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3852789|NCT01643798|3678700|B1|||Age||years|Mean|26|26.0|Standard Deviation|4|4.0|||
3852790|NCT01643798|3678700|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3852791|NCT01643798|3678700|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3852792|NCT01643798|3678700|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3852793|NCT01643668|3678712|B1|Both negative for virus||Cytomegalovirus Serostatus||Participants|Count of Participants|12|12.0||||||
3852794|NCT01643668|3678712|B1|Either donor or host positive for virus||Cytomegalovirus Serostatus||Participants|Count of Participants|22|22.0||||||
3852795|NCT01643668|3678712|B1|Matched Unrelated||Donor Type|Matched = Human Leukocyte Antigen (HLA) matched; Related = donor and recipient are genetic relatives|Participants|Count of Participants|23|23.0||||||
3852796|NCT01643668|3678712|B1|Matched Related||Donor Type|Matched = Human Leukocyte Antigen (HLA) matched; Related = donor and recipient are genetic relatives|Participants|Count of Participants|11|11.0||||||
3852797|NCT01643668|3678712|B1|||Hematopoietic cell transplantation specific comorbidity index (HCT-CI)|The HTC-CI provides information about the overall and non-relapse mortality risk a patient is likely to experience following a hematopoietic cell transplantation. Lower scores represent lower risk and higher scores represent higher risk. The score is produced by adding up the number of specific risk factors a patient has and can range from 0 to 26. The index is usually characterized as risk categories from 0 to 4+ with patients with four or more risk factors considered high risk.|units on a scale|Median|1|1.0|Full Range|||0.0|9.0|
3852798|NCT01643668|3678712|B1|Other||ALL Cytogenics||Participants|Count of Participants|2|2.0||||||
3852799|NCT01643668|3678712|B1|Philadelphia Chromosome||ALL Cytogenics||Participants|Count of Participants|2|2.0||||||
3852800|NCT01643668|3678712|B1|Adverse||Cytogenics for patients with AML/MDS|Southwest Oncology Group Risk Stratification|Participants|Count of Participants|5|5.0||||||
3852801|NCT01643668|3678712|B1|Intermediate||Cytogenics for patients with AML/MDS|Southwest Oncology Group Risk Stratification|Participants|Count of Participants|24|24.0||||||
3852802|NCT01643668|3678712|B1|Favorable||Cytogenics for patients with AML/MDS|Southwest Oncology Group Risk Stratification|Participants|Count of Participants|1|1.0||||||
3852803|NCT01643668|3678712|B1|Partial remission/active disease/blasts >5%||Disease Stage|"Disease stage at time of treatment:~CR1: Absence of disease following initial treatment~CR2: Complete remission occurs achieved following progression of disease after initial complete remission~Partial remission/active disease/ blasts >5%: participants who are not currently in remission"|Participants|Count of Participants|3|3.0||||||
3852804|NCT01643668|3678712|B1|Second Complete Remission (CR2)||Disease Stage|"Disease stage at time of treatment:~CR1: Absence of disease following initial treatment~CR2: Complete remission occurs achieved following progression of disease after initial complete remission~Partial remission/active disease/ blasts >5%: participants who are not currently in remission"|Participants|Count of Participants|6|6.0||||||
3852805|NCT01643668|3678712|B1|First Complete Remission (CR1)||Disease Stage|"Disease stage at time of treatment:~CR1: Absence of disease following initial treatment~CR2: Complete remission occurs achieved following progression of disease after initial complete remission~Partial remission/active disease/ blasts >5%: participants who are not currently in remission"|Participants|Count of Participants|25|25.0||||||
3852806|NCT01643668|3678712|B1|High||Hematopoietic Cell Transplantation (HCT) Refined Disease Risk Index (DRI)|Categorization of disease risk determined by the Refined Disease Risk Index (DRI) for patients receiving Hematopoietic Cell Transplantation (HCT).|Participants|Count of Participants|6|6.0||||||
3852807|NCT01643668|3678712|B1|Intermediate||Hematopoietic Cell Transplantation (HCT) Refined Disease Risk Index (DRI)|Categorization of disease risk determined by the Refined Disease Risk Index (DRI) for patients receiving Hematopoietic Cell Transplantation (HCT).|Participants|Count of Participants|27|27.0||||||
3852808|NCT01643668|3678712|B1|Low||Hematopoietic Cell Transplantation (HCT) Refined Disease Risk Index (DRI)|Categorization of disease risk determined by the Refined Disease Risk Index (DRI) for patients receiving Hematopoietic Cell Transplantation (HCT).|Participants|Count of Participants|1|1.0||||||
3852809|NCT01643668|3678712|B1||Acute Lymphoblastic Leukemia (ALL)|Diagnosis||Participants|Count of Participants|4|4.0||||||
3852810|NCT01643668|3678712|B1||Myelodysplastic Syndrome (MDS)|Diagnosis||Participants|Count of Participants|5|5.0||||||
3852811|NCT01643668|3678712|B1||Acute Myeloid Leukemia (AML)|Diagnosis||Participants|Count of Participants|25|25.0||||||
3852812|NCT01643668|3678712|B1|United States||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3852813|NCT01643668|3678712|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3852814|NCT01643668|3678712|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3852815|NCT01643668|3678712|B1|||Age||years|Median|63.5|63.5|Full Range|||25.0|74.0|
3852816|NCT01643616|3678724|B3|Germany||Region of Enrollment||participants|Number|250|250.0||||||
3852817|NCT01643616|3678725|B2|Germany||Region of Enrollment||participants|Number|125|125.0||||||
3852818|NCT01643616|3678726|B1|Germany||Region of Enrollment||participants|Number|125|125.0||||||
3852819|NCT01643616|3678724|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3852820|NCT01643616|3678725|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3852821|NCT01643616|3678726|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3852822|NCT01643616|3678724|B3||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
3852823|NCT01643616|3678725|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3852824|NCT01643616|3678726|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3852825|NCT01643616|3678724|B3|||Age||years|Mean|54.9|54.9|Standard Deviation|13.2|13.2|||
3852826|NCT01643616|3678725|B2|||Age||years|Mean|56.4|56.4|Standard Deviation|11.8|11.8|||
3852827|NCT01643616|3678726|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|14.3|14.3|||
3852828|NCT01643616|3678724|B3||>=65 years|Age||Participants|Count of Participants|56|56.0||||||
3852829|NCT01643616|3678725|B2||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
3852830|NCT01643616|3678726|B1||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
3852831|NCT01643616|3678724|B3||Between 18 and 65 years|Age||Participants|Count of Participants|194|194.0||||||
3852832|NCT01643616|3678725|B2||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
3852833|NCT01643616|3678726|B1||Between 18 and 65 years|Age||Participants|Count of Participants|99|99.0||||||
3852834|NCT01643616|3678724|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3852835|NCT01643616|3678725|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3852836|NCT01643616|3678726|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3852837|NCT01643525|3678737|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3852838|NCT01643525|3678737|B1|Males Known||Sex/Gender, Customized||participants|Number|7|7.0||||||
3852839|NCT01643525|3678737|B1|Females Known||Sex/Gender, Customized||participants|Number|16|16.0||||||
3852840|NCT01643525|3678737|B1|||Age||years|Mean|55.3|55.3|Standard Deviation|16.2|16.2|||
3852841|NCT01643213|3678741|B3|||Region of Enrollment: United States||participants|Number|27|27.0||||||
3852842|NCT01643213|3678742|B2|||Region of Enrollment: United States||participants|Number|14|14.0||||||
3852843|NCT01643213|3678743|B1|||Region of Enrollment: United States||participants|Number|13|13.0||||||
3852844|NCT01643213|3678741|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3852845|NCT01643213|3678742|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3852846|NCT01643213|3678743|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3852847|NCT01643213|3678741|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3852848|NCT01643213|3678742|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3852849|NCT01643213|3678743|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3852850|NCT01643213|3678741|B3|||Age||years|Mean|56.9|56.9|Standard Deviation|11.68|11.68|||
3852851|NCT01643213|3678742|B2|||Age||years|Mean|56|56.0|Standard Deviation|12.02|12.02|||
3852852|NCT01643213|3678743|B1|||Age||years|Mean|57.9|57.9|Standard Deviation|11.71|11.71|||
3852853|NCT01643044|3678750|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
3852854|NCT01643044|3678751|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
3852855|NCT01643044|3678752|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3852856|NCT01643044|3678750|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852857|NCT01643044|3678751|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852858|NCT01643044|3678752|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852859|NCT01643044|3678750|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3852860|NCT01643044|3678751|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3852861|NCT01643044|3678752|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3852862|NCT01643044|3678750|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3852863|NCT01643044|3678751|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852864|NCT01643044|3678752|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3852865|NCT01643044|3678750|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3852866|NCT01643044|3678751|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852867|NCT01643044|3678752|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3852868|NCT01643044|3678750|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3852869|NCT01643044|3678751|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852870|NCT01643044|3678752|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3852871|NCT01643044|3678750|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3852872|NCT01643044|3678751|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3852873|NCT01643044|3678752|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3852874|NCT01643044|3678750|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3852875|NCT01643044|3678751|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3852876|NCT01643044|3678752|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3852877|NCT01643044|3678750|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852878|NCT01643044|3678751|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852879|NCT01643044|3678752|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852880|NCT01643044|3678750|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852881|NCT01643044|3678751|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852882|NCT01643044|3678752|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852883|NCT01643044|3678750|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3852884|NCT01643044|3678751|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3852885|NCT01643044|3678752|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3852886|NCT01643044|3678750|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3852887|NCT01643044|3678751|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3852888|NCT01643044|3678752|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3852889|NCT01643044|3678750|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3852890|NCT01643044|3678751|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3852891|NCT01643044|3678752|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3852892|NCT01643044|3678750|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3852893|NCT01643044|3678751|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3852894|NCT01643044|3678752|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3852895|NCT01643044|3678750|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
3852896|NCT01643044|3678751|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3852897|NCT01643044|3678752|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3852898|NCT01643044|3678750|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3852899|NCT01643044|3678751|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3852900|NCT01643044|3678752|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3852901|NCT01642914|3678759|B4|||BMI (Body Mass Index), mean||kilograms per meter squared|Mean|29.12|29.12|Standard Deviation|6.23|6.23|||
3852902|NCT01642914|3678760|B3|||BMI (Body Mass Index), mean||kilograms per meter squared|Mean|29.83|29.83|Standard Deviation|6.57|6.57|||
3852903|NCT01642914|3678761|B2|||BMI (Body Mass Index), mean||kilograms per meter squared|Mean|29.17|29.17|Standard Deviation|6.03|6.03|||
3852904|NCT01642914|3678762|B1|||BMI (Body Mass Index), mean||kilograms per meter squared|Mean|28.43|28.43|Standard Deviation|6.03|6.03|||
3852905|NCT01642914|3678759|B4|||Height, mean||cm|Mean|164.70|164.7|Standard Deviation|8.08|8.08|||
3852906|NCT01642914|3678760|B3|||Height, mean||cm|Mean|164.37|164.37|Standard Deviation|7.07|7.07|||
3852907|NCT01642914|3678761|B2|||Height, mean||cm|Mean|164.85|164.85|Standard Deviation|8.44|8.44|||
3852908|NCT01642914|3678762|B1|||Height, mean||cm|Mean|164.87|164.87|Standard Deviation|8.65|8.65|||
3852909|NCT01642914|3678759|B4|||Weight, mean||kg|Mean|79.12|79.12|Standard Deviation|18.50|18.5|||
3852910|NCT01642914|3678760|B3|||Weight, mean||kg|Mean|80.53|80.53|Standard Deviation|18.20|18.2|||
3852911|NCT01642914|3678761|B2|||Weight, mean||kg|Mean|79.39|79.39|Standard Deviation|18.01|18.01|||
3852912|NCT01642914|3678762|B1|||Weight, mean||kg|Mean|77.59|77.59|Standard Deviation|19.19|19.19|||
3852913|NCT01642914|3678759|B4|Canada||Region of Enrollment||participants|Number|22|22.0||||||
3852914|NCT01642914|3678760|B3|Canada||Region of Enrollment||participants|Number|8|8.0||||||
3852915|NCT01642914|3678761|B2|Canada||Region of Enrollment||participants|Number|6|6.0||||||
3852916|NCT01642914|3678762|B1|Canada||Region of Enrollment||participants|Number|8|8.0||||||
3852917|NCT01642914|3678759|B4|United States||Region of Enrollment||participants|Number|464|464.0||||||
3852918|NCT01642914|3678760|B3|United States||Region of Enrollment||participants|Number|152|152.0||||||
3852919|NCT01642914|3678761|B2|United States||Region of Enrollment||participants|Number|147|147.0||||||
3852920|NCT01642914|3678762|B1|United States||Region of Enrollment||participants|Number|165|165.0||||||
3852921|NCT01642914|3678759|B4|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|416|416.0||||||
3852922|NCT01642914|3678760|B3|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|135|135.0||||||
3852923|NCT01642914|3678761|B2|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|134|134.0||||||
3852924|NCT01642914|3678762|B1|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|147|147.0||||||
3852925|NCT01642914|3678759|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
3852926|NCT01642914|3678760|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3852927|NCT01642914|3678761|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3852928|NCT01642914|3678762|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3852929|NCT01642914|3678759|B4|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3852930|NCT01642914|3678760|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3852931|NCT01642914|3678761|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3852932|NCT01642914|3678762|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3852933|NCT01642914|3678759|B4|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3852934|NCT01642914|3678760|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3852935|NCT01642914|3678761|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3852936|NCT01642914|3678762|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3852937|NCT01642914|3678759|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3852938|NCT01642914|3678760|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3852939|NCT01642914|3678761|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3852940|NCT01642914|3678762|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3852941|NCT01642914|3678759|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|148|148.0||||||
3852942|NCT01642914|3678760|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
3852943|NCT01642914|3678761|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
3852944|NCT01642914|3678762|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
3852945|NCT01642914|3678759|B4|White||Race/Ethnicity, Customized||participants|Number|329|329.0||||||
3852946|NCT01642914|3678760|B3|White||Race/Ethnicity, Customized||participants|Number|112|112.0||||||
3852947|NCT01642914|3678761|B2|White||Race/Ethnicity, Customized||participants|Number|97|97.0||||||
3852948|NCT01642914|3678762|B1|White||Race/Ethnicity, Customized||participants|Number|120|120.0||||||
3852949|NCT01642914|3678759|B4|Female||Sex/Gender, Customized||participants|Number|445|445.0||||||
3852950|NCT01642914|3678760|B3|Female||Sex/Gender, Customized||participants|Number|148|148.0||||||
3852951|NCT01642914|3678761|B2|Female||Sex/Gender, Customized||participants|Number|138|138.0||||||
3852952|NCT01642914|3678762|B1|Female||Sex/Gender, Customized||participants|Number|159|159.0||||||
3852953|NCT01642914|3678759|B4|Male||Sex/Gender, Customized||participants|Number|41|41.0||||||
3852954|NCT01642914|3678760|B3|Male||Sex/Gender, Customized||participants|Number|12|12.0||||||
3852955|NCT01642914|3678761|B2|Male||Sex/Gender, Customized||participants|Number|15|15.0||||||
3852956|NCT01642914|3678762|B1|Male||Sex/Gender, Customized||participants|Number|14|14.0||||||
3852957|NCT01642914|3678759|B4|Age ≥ 65 years||Age, Customized||participants|Number|46|46.0||||||
3852958|NCT01642914|3678760|B3|Age ≥ 65 years||Age, Customized||participants|Number|18|18.0||||||
3852959|NCT01642914|3678761|B2|Age ≥ 65 years||Age, Customized||participants|Number|12|12.0||||||
3852960|NCT01642914|3678762|B1|Age ≥ 65 years||Age, Customized||participants|Number|16|16.0||||||
3852961|NCT01642914|3678759|B4|Age 40 to 64 years||Age, Customized||participants|Number|307|307.0||||||
3852962|NCT01642914|3678760|B3|Age 40 to 64 years||Age, Customized||participants|Number|99|99.0||||||
3852963|NCT01642914|3678761|B2|Age 40 to 64 years||Age, Customized||participants|Number|104|104.0||||||
3852964|NCT01642914|3678762|B1|Age 40 to 64 years||Age, Customized||participants|Number|104|104.0||||||
3852965|NCT01642914|3678759|B4|Age 18 to 39 years||Age, Customized||participants|Number|133|133.0||||||
3852966|NCT01642914|3678760|B3|Age 18 to 39 years||Age, Customized||participants|Number|43|43.0||||||
3852967|NCT01642914|3678761|B2|Age 18 to 39 years||Age, Customized||participants|Number|37|37.0||||||
3852968|NCT01642914|3678762|B1|Age 18 to 39 years||Age, Customized||participants|Number|53|53.0||||||
3852969|NCT01642914|3678759|B4|||Age||Years|Mean|47.3|47.3|Standard Deviation|13.2|13.2|||
3852970|NCT01642914|3678760|B3|||Age||Years|Mean|47.5|47.5|Standard Deviation|13.6|13.6|||
3852971|NCT01642914|3678761|B2|||Age||Years|Mean|48.3|48.3|Standard Deviation|12.6|12.6|||
3852972|NCT01642914|3678762|B1|||Age||Years|Mean|46.3|46.3|Standard Deviation|13.4|13.4|||
3852973|NCT01642732|3678839|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3852974|NCT01642732|3678839|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3852975|NCT01642732|3678839|B1|||Age||years|Median|54|54.0|Full Range|||54.0|54.0|
3852976|NCT01642615|3678844|B1|D||Baseline EE Grade (LA Classification)|A=1 (or more) mucosal break 5 mm or less that does not extend between the tops of two mucosal folds, B=1 (or more) mucosal break more than 5 mm-long that does not extend between the tops of two mucosal folds, C=1 (or more) mucosal break that is continuous between the tops of two or more mucosal folds but that involves less than 75% of the circumference and D=1 (or more) mucosal break that involves at least 75% of the esophageal circumference.|participants|Number|1|1.0||||||
3852977|NCT01642615|3678844|B1|C||Baseline EE Grade (LA Classification)|A=1 (or more) mucosal break 5 mm or less that does not extend between the tops of two mucosal folds, B=1 (or more) mucosal break more than 5 mm-long that does not extend between the tops of two mucosal folds, C=1 (or more) mucosal break that is continuous between the tops of two or more mucosal folds but that involves less than 75% of the circumference and D=1 (or more) mucosal break that involves at least 75% of the esophageal circumference.|participants|Number|1|1.0||||||
3852978|NCT01642615|3678844|B1|B||Baseline EE Grade (LA Classification)|A=1 (or more) mucosal break 5 mm or less that does not extend between the tops of two mucosal folds, B=1 (or more) mucosal break more than 5 mm-long that does not extend between the tops of two mucosal folds, C=1 (or more) mucosal break that is continuous between the tops of two or more mucosal folds but that involves less than 75% of the circumference and D=1 (or more) mucosal break that involves at least 75% of the esophageal circumference.|participants|Number|26|26.0||||||
3852979|NCT01642615|3678844|B1|A||Baseline EE Grade (LA Classification)|A=1 (or more) mucosal break 5 mm or less that does not extend between the tops of two mucosal folds, B=1 (or more) mucosal break more than 5 mm-long that does not extend between the tops of two mucosal folds, C=1 (or more) mucosal break that is continuous between the tops of two or more mucosal folds but that involves less than 75% of the circumference and D=1 (or more) mucosal break that involves at least 75% of the esophageal circumference.|participants|Number|34|34.0||||||
3852980|NCT01642615|3678844|B1|No||Erosive Esophagitis Present||participants|Number|0|0.0||||||
3852981|NCT01642615|3678844|B1|Yes||Erosive Esophagitis Present||participants|Number|62|62.0||||||
3852982|NCT01642615|3678844|B1|Unknown||Helicobacter pylori (H. pylori) Status||participants|Number|1|1.0||||||
3852983|NCT01642615|3678844|B1|Negative||Helicobacter pylori (H. pylori) Status||participants|Number|61|61.0||||||
3852984|NCT01642615|3678844|B1|Positive||Helicobacter pylori (H. pylori) Status||participants|Number|0|0.0||||||
3852985|NCT01642615|3678844|B1|Ex-smoker||Smoking Classification||participants|Number|0|0.0||||||
3852986|NCT01642615|3678844|B1|Current smoker||Smoking Classification||participants|Number|1|1.0||||||
3852987|NCT01642615|3678844|B1|Never smoked||Smoking Classification||participants|Number|61|61.0||||||
3852988|NCT01642615|3678844|B1|||Body Mass Index (BMI)|BMI is calculated using the weight and height.|kg/m^2|Mean|22.34|22.34|Standard Deviation|5.086|5.086|||
3852989|NCT01642615|3678844|B1|||Weight||kg|Mean|61.86|61.86|Standard Deviation|17.060|17.06|||
3852990|NCT01642615|3678844|B1|||Height||cm|Mean|165.5|165.5|Standard Deviation|9.68|9.68|||
3852991|NCT01642615|3678844|B1|Mexico||Region of Enrollment||participants|Number|2|2.0||||||
3852992|NCT01642615|3678844|B1|Poland||Region of Enrollment||participants|Number|34|34.0||||||
3852993|NCT01642615|3678844|B1|Portugal||Region of Enrollment||participants|Number|4|4.0||||||
3852994|NCT01642615|3678844|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3852995|NCT01642615|3678844|B1|White||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
3852996|NCT01642615|3678844|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3852997|NCT01642615|3678844|B1|Not Collected outside the United States||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
3852998|NCT01642615|3678844|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3852999|NCT01642615|3678844|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3853000|NCT01642615|3678844|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3853001|NCT01642615|3678844|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3853002|NCT01642615|3678844|B1|15 to 17 years||Age, Customized||participants|Number|38|38.0||||||
3853003|NCT01642615|3678844|B1|12 to 14 years||Age, Customized||participants|Number|24|24.0||||||
3853004|NCT01642615|3678844|B1|||Age||years|Mean|14.8|14.8|Standard Deviation|1.64|1.64|||
3853005|NCT01642602|3678860|B1|Negative||H pylori Status||participants|Number|90|90.0||||||
3853006|NCT01642602|3678860|B1|Positive||H pylori Status||participants|Number|14|14.0||||||
3853007|NCT01642602|3678860|B1|Ex-smoker||Smoking Classification||participants|Number|1|1.0||||||
3853008|NCT01642602|3678860|B1|Never Smoked||Smoking Classification||participants|Number|103|103.0||||||
3853009|NCT01642602|3678860|B1|||Body Mass Index (BMI)||kg/m^2|Mean|23.02|23.02|Standard Deviation|4.434|4.434|||
3853010|NCT01642602|3678860|B1|||Height||cm|Mean|163.1|163.1|Standard Deviation|7.58|7.58|||
3853011|NCT01642602|3678860|B1|||Weight||kg|Mean|61.60|61.6|Standard Deviation|14.393|14.393|||
3853012|NCT01642602|3678860|B1|Not Collected||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
3853013|NCT01642602|3678860|B1|Non-Hispanic and Latino||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
3853014|NCT01642602|3678860|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3853015|NCT01642602|3678860|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3853016|NCT01642602|3678860|B1|White||Race/Ethnicity, Customized||participants|Number|95|95.0||||||
3853017|NCT01642602|3678860|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3853018|NCT01642602|3678860|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3853019|NCT01642602|3678860|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3853020|NCT01642602|3678860|B1|15 to 17 years||Age, Customized||participants|Number|70|70.0||||||
3853021|NCT01642602|3678860|B1|12 to 14 years||Age, Customized||participants|Number|34|34.0||||||
3853022|NCT01642602|3678860|B1|||Age||years|Mean|15.0|15.0|Standard Deviation|1.50|1.5|||
3853023|NCT01642589|3678865|B3|Korea, Republic of||Region of Enrollment||Participants|Number|300|300.0||||||
3853024|NCT01642589|3678866|B2|Korea, Republic of||Region of Enrollment||Participants|Number|100|100.0||||||
3853025|NCT01642589|3678867|B1|Korea, Republic of||Region of Enrollment||Participants|Number|200|200.0||||||
3853026|NCT01642589|3678865|B3||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3853027|NCT01642589|3678866|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3853028|NCT01642589|3678867|B1||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3853029|NCT01642589|3678865|B3||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3853030|NCT01642589|3678866|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3853031|NCT01642589|3678867|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3853032|NCT01642589|3678865|B3|||Age||Years|Mean|24.7|24.7|Standard Deviation|11.0|11.0|||
3853033|NCT01642589|3678866|B2|||Age||Years|Mean|24.2|24.2|Standard Deviation|10.1|10.1|||
3853034|NCT01642589|3678867|B1|||Age||Years|Mean|24.9|24.9|Standard Deviation|11.5|11.5|||
3853035|NCT01642589|3678865|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3853036|NCT01642589|3678866|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3853037|NCT01642589|3678867|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3853038|NCT01642589|3678865|B3||Between 18 and 65 years|Age||Participants|Count of Participants|151|151.0||||||
3853039|NCT01642589|3678866|B2||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3853040|NCT01642589|3678867|B1||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
3853041|NCT01642589|3678865|B3||<=18 years|Age||Participants|Count of Participants|149|149.0||||||
3853042|NCT01642589|3678866|B2||<=18 years|Age||Participants|Count of Participants|49|49.0||||||
3853043|NCT01642589|3678867|B1||<=18 years|Age||Participants|Count of Participants|100|100.0||||||
3853044|NCT01642485|3678882|B1|>25 kg/m^2||Body Mass Index||participants|Number|0|0.0||||||
3853045|NCT01642485|3678882|B1|>18 kg/m^2||Body Mass Index||participants|Number|32|32.0||||||
3853046|NCT01642485|3678882|B1|United Kingdom||Region of Enrollment||participants|Number|32|32.0||||||
3853047|NCT01642485|3678882|B1|Japanese||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3853048|NCT01642485|3678882|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3853049|NCT01642485|3678882|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3853050|NCT01642485|3678882|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3853051|NCT01642485|3678882|B1|Japanese||Age||years|Mean|27.6|27.6|Standard Deviation|3.3|3.3|||
3853052|NCT01642485|3678882|B1|Caucasian||Age||years|Mean|25.6|25.6|Standard Deviation|4.7|4.7|||
3853053|NCT01642407|3678907|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3853054|NCT01642407|3678907|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3853055|NCT01642407|3678907|B1|||Age||years|Mean|6.7|6.7|Standard Deviation|5.4|5.4|||
3853056|NCT01642407|3678907|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3853057|NCT01642407|3678907|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3853058|NCT01642407|3678907|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3853059|NCT01642277|3678952|B3|Other urotypes||Sequencing Urotypes at Baseline||participants|Number|8|8.0||||||
3853060|NCT01642277|3678953|B2|Other urotypes||Sequencing Urotypes at Baseline||participants|Number|2|2.0||||||
3853061|NCT01642277|3678954|B1|Other urotypes||Sequencing Urotypes at Baseline||participants|Number|6|6.0||||||
3853062|NCT01642277|3678952|B3|Gardnerella urotype||Sequencing Urotypes at Baseline||participants|Number|12|12.0||||||
3853063|NCT01642277|3678953|B2|Gardnerella urotype||Sequencing Urotypes at Baseline||participants|Number|4|4.0||||||
3853064|NCT01642277|3678954|B1|Gardnerella urotype||Sequencing Urotypes at Baseline||participants|Number|8|8.0||||||
3853065|NCT01642277|3678952|B3|Diverse urotype||Sequencing Urotypes at Baseline||participants|Number|12|12.0||||||
3853066|NCT01642277|3678953|B2|Diverse urotype||Sequencing Urotypes at Baseline||participants|Number|4|4.0||||||
3853067|NCT01642277|3678954|B1|Diverse urotype||Sequencing Urotypes at Baseline||participants|Number|8|8.0||||||
3853068|NCT01642277|3678952|B3|Lactobacillus urotype||Sequencing Urotypes at Baseline||participants|Number|31|31.0||||||
3853069|NCT01642277|3678953|B2|Lactobacillus urotype||Sequencing Urotypes at Baseline||participants|Number|16|16.0||||||
3853070|NCT01642277|3678954|B1|Lactobacillus urotype||Sequencing Urotypes at Baseline||participants|Number|15|15.0||||||
3853071|NCT01642277|3678952|B3|Low biomass||Sequencing Urotypes at Baseline||participants|Number|71|71.0||||||
3853072|NCT01642277|3678953|B2|Low biomass||Sequencing Urotypes at Baseline||participants|Number|34|34.0||||||
3853073|NCT01642277|3678954|B1|Low biomass||Sequencing Urotypes at Baseline||participants|Number|37|37.0||||||
3853074|NCT01642277|3678952|B3|No prior treatment||Prior Treatment for OAB||participants|Number|97|97.0||||||
3853075|NCT01642277|3678953|B2|No prior treatment||Prior Treatment for OAB||participants|Number|60|60.0||||||
3853076|NCT01642277|3678954|B1|No prior treatment||Prior Treatment for OAB||participants|Number|37|37.0||||||
3853077|NCT01642277|3678952|B3|Prior Treatment||Prior Treatment for OAB||participants|Number|37|37.0||||||
3853078|NCT01642277|3678953|B2|Prior Treatment||Prior Treatment for OAB||participants|Number|0|0.0||||||
3853079|NCT01642277|3678954|B1|Prior Treatment||Prior Treatment for OAB||participants|Number|37|37.0||||||
3853080|NCT01642277|3678952|B3|Single||Marital Status||participants|Number|25|25.0||||||
3853081|NCT01642277|3678953|B2|Single||Marital Status||participants|Number|15|15.0||||||
3853082|NCT01642277|3678954|B1|Single||Marital Status||participants|Number|10|10.0||||||
3853083|NCT01642277|3678952|B3|Widowed||Marital Status||participants|Number|15|15.0||||||
3853084|NCT01642277|3678953|B2|Widowed||Marital Status||participants|Number|1|1.0||||||
3853085|NCT01642277|3678954|B1|Widowed||Marital Status||participants|Number|14|14.0||||||
3853086|NCT01642277|3678952|B3|Divorced||Marital Status||participants|Number|15|15.0||||||
3853087|NCT01642277|3678953|B2|Divorced||Marital Status||participants|Number|6|6.0||||||
3853088|NCT01642277|3678954|B1|Divorced||Marital Status||participants|Number|9|9.0||||||
3853089|NCT01642277|3678952|B3|Separated||Marital Status||participants|Number|4|4.0||||||
3853090|NCT01642277|3678953|B2|Separated||Marital Status||participants|Number|1|1.0||||||
3853091|NCT01642277|3678954|B1|Separated||Marital Status||participants|Number|3|3.0||||||
3853092|NCT01642277|3678952|B3|Married||Marital Status||participants|Number|75|75.0||||||
3853093|NCT01642277|3678953|B2|Married||Marital Status||participants|Number|37|37.0||||||
3853094|NCT01642277|3678954|B1|Married||Marital Status||participants|Number|38|38.0||||||
3853095|NCT01642277|3678952|B3|Smoker||Smoking||participants|Number|10|10.0||||||
3853096|NCT01642277|3678953|B2|Smoker||Smoking||participants|Number|4|4.0||||||
3853097|NCT01642277|3678954|B1|Smoker||Smoking||participants|Number|6|6.0||||||
3853098|NCT01642277|3678952|B3|Non-Smoker||Smoking||participants|Number|124|124.0||||||
3853099|NCT01642277|3678953|B2|Non-Smoker||Smoking||participants|Number|56|56.0||||||
3853100|NCT01642277|3678954|B1|Non-Smoker||Smoking||participants|Number|68|68.0||||||
3853101|NCT01642277|3678952|B3|Yes||Coronary Artery Disease||participants|Number|10|10.0||||||
3853102|NCT01642277|3678953|B2|Yes||Coronary Artery Disease||participants|Number|1|1.0||||||
3853103|NCT01642277|3678954|B1|Yes||Coronary Artery Disease||participants|Number|9|9.0||||||
3853104|NCT01642277|3678952|B3|No||Coronary Artery Disease||participants|Number|124|124.0||||||
3853105|NCT01642277|3678953|B2|No||Coronary Artery Disease||participants|Number|59|59.0||||||
3853106|NCT01642277|3678954|B1|No||Coronary Artery Disease||participants|Number|65|65.0||||||
3853107|NCT01642277|3678952|B3|Yes||Hypertension||participants|Number|37|37.0||||||
3853108|NCT01642277|3678953|B2|Yes||Hypertension||participants|Number|11|11.0||||||
3853109|NCT01642277|3678954|B1|Yes||Hypertension||participants|Number|26|26.0||||||
3853110|NCT01642277|3678952|B3|No||Hypertension||participants|Number|97|97.0||||||
3853111|NCT01642277|3678953|B2|No||Hypertension||participants|Number|49|49.0||||||
3853112|NCT01642277|3678954|B1|No||Hypertension||participants|Number|48|48.0||||||
3853113|NCT01642277|3678952|B3|Yes||Diabetes||participants|Number|9|9.0||||||
3853114|NCT01642277|3678953|B2|Yes||Diabetes||participants|Number|2|2.0||||||
3853115|NCT01642277|3678954|B1|Yes||Diabetes||participants|Number|7|7.0||||||
3853116|NCT01642277|3678952|B3|No||Diabetes||participants|Number|125|125.0||||||
3853117|NCT01642277|3678953|B2|No||Diabetes||participants|Number|58|58.0||||||
3853118|NCT01642277|3678954|B1|No||Diabetes||participants|Number|67|67.0||||||
3853119|NCT01642277|3678952|B3|Unknown||Estrogen Status||participants|Number|4|4.0||||||
3853120|NCT01642277|3678953|B2|Unknown||Estrogen Status||participants|Number|2|2.0||||||
3853121|NCT01642277|3678954|B1|Unknown||Estrogen Status||participants|Number|2|2.0||||||
3853122|NCT01642277|3678952|B3|Positive||Estrogen Status||participants|Number|91|91.0||||||
3853123|NCT01642277|3678953|B2|Positive||Estrogen Status||participants|Number|26|26.0||||||
3853124|NCT01642277|3678954|B1|Positive||Estrogen Status||participants|Number|65|65.0||||||
3853125|NCT01642277|3678952|B3|Negative||Estrogen Status||participants|Number|39|39.0||||||
3853126|NCT01642277|3678953|B2|Negative||Estrogen Status||participants|Number|32|32.0||||||
3853127|NCT01642277|3678954|B1|Negative||Estrogen Status||participants|Number|7|7.0||||||
3853128|NCT01642277|3678952|B3|||Vaginal Parity||Births|Median|2.00|2.0|Inter-Quartile Range|||0.0|3.0|
3853129|NCT01642277|3678953|B2|||Vaginal Parity||Births|Median|2.00|2.0|Inter-Quartile Range|||0.0|2.75|
3853130|NCT01642277|3678954|B1|||Vaginal Parity||Births|Median|2.00|2.0|Inter-Quartile Range|||1.0|3.0|
3853131|NCT01642277|3678952|B3|||Body Mass Index||kg/m2|Median|30.59|30.59|Standard Deviation|7.61|7.61|||
3853132|NCT01642277|3678953|B2|||Body Mass Index||kg/m2|Median|27.9|27.9|Standard Deviation|5.5|5.5|||
3853133|NCT01642277|3678954|B1|||Body Mass Index||kg/m2|Median|32.7|32.7|Standard Deviation|8.4|8.4|||
3853134|NCT01642277|3678952|B3|United States||Region of Enrollment||participants|Number|134|134.0||||||
3853135|NCT01642277|3678953|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
3853136|NCT01642277|3678954|B1|United States||Region of Enrollment||participants|Number|74|74.0||||||
3853137|NCT01642277|3678952|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3853138|NCT01642277|3678953|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3853139|NCT01642277|3678954|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3853140|NCT01642277|3678952|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3853141|NCT01642277|3678953|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3853142|NCT01642277|3678954|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3853143|NCT01642277|3678952|B3|Black||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3853144|NCT01642277|3678953|B2|Black||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3853145|NCT01642277|3678954|B1|Black||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3853146|NCT01642277|3678952|B3|White||Race/Ethnicity, Customized||participants|Number|99|99.0||||||
3853147|NCT01642277|3678953|B2|White||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
3853148|NCT01642277|3678954|B1|White||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
3853149|NCT01642277|3678952|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3853150|NCT01642277|3678953|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3853151|NCT01642277|3678954|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3853152|NCT01642277|3678952|B3||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3853153|NCT01642277|3678953|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3853154|NCT01642277|3678954|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3853155|NCT01642277|3678952|B3|||Age||years|Mean|56.04|56.04|Standard Deviation|14.34|14.34|||
3853156|NCT01642277|3678953|B2|||Age||years|Mean|49|49.0|Standard Deviation|14.7|14.7|||
3853157|NCT01642277|3678954|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|11.5|11.5|||
3853158|NCT01642238|3678964|B1|||Body mass index||kg/m^2|Mean|27.0|27.0|Full Range|||24.9|29.1|
3853159|NCT01642238|3678964|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3853160|NCT01642238|3678964|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3853161|NCT01642238|3678964|B1|||Age||years|Mean|31.2|31.2|Full Range|||26.8|35.6|
3853162|NCT01642212|3678985|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3853163|NCT01642212|3678986|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3853164|NCT01642212|3678987|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3853165|NCT01642212|3678985|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3853166|NCT01642212|3678986|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3853167|NCT01642212|3678987|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3853168|NCT01642212|3678985|B3|>/= 18 Years Of Age||Age, Customized||participants|Number|58|58.0||||||
3853169|NCT01642212|3678986|B2|>/= 18 Years Of Age||Age, Customized||participants|Number|33|33.0||||||
3853170|NCT01642212|3678987|B1|>/= 18 Years Of Age||Age, Customized||participants|Number|25|25.0||||||
3853171|NCT01642212|3678985|B3|<18 Years Of Age||Age, Customized||participants|Number|35|35.0||||||
3853172|NCT01642212|3678986|B2|<18 Years Of Age||Age, Customized||participants|Number|18|18.0||||||
3853173|NCT01642212|3678987|B1|<18 Years Of Age||Age, Customized||participants|Number|17|17.0||||||
3853174|NCT01642212|3678985|B3|||Age||years|Mean|21.6|21.6|Standard Deviation|7.73|7.73|||
3853175|NCT01642212|3678986|B2|||Age||years|Mean|22.3|22.3|Standard Deviation|7.92|7.92|||
3853176|NCT01642212|3678987|B1|||Age||years|Mean|20.8|20.8|Standard Deviation|7.50|7.5|||
3853177|NCT01642147|3679039|B3|||Duration of Surgery||minute|Mean|211|211.0|Standard Deviation|43|43.0|||
3853178|NCT01642147|3679040|B2|||Duration of Surgery||minute|Mean|214|214.0|Standard Deviation|38|38.0|||
3853179|NCT01642147|3679041|B1|||Duration of Surgery||minute|Mean|207|207.0|Standard Deviation|49|49.0|||
3853180|NCT01642147|3679039|B3|China||Region of Enrollment||participants|Number|60|60.0||||||
3853181|NCT01642147|3679040|B2|China||Region of Enrollment||participants|Number|30|30.0||||||
3853182|NCT01642147|3679041|B1|China||Region of Enrollment||participants|Number|30|30.0||||||
3853183|NCT01642147|3679039|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3853184|NCT01642147|3679040|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3853185|NCT01642147|3679041|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3853186|NCT01642147|3679039|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3853187|NCT01642147|3679040|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3853188|NCT01642147|3679041|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3853189|NCT01642147|3679039|B3|||Age||years|Mean|47.0|47.0|Standard Deviation|7.9|7.9|||
3853190|NCT01642147|3679040|B2|||Age||years|Mean|47.3|47.3|Standard Deviation|7.6|7.6|||
3853191|NCT01642147|3679041|B1|||Age||years|Mean|46.6|46.6|Standard Deviation|8.2|8.2|||
3853192|NCT01642147|3679039|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3853193|NCT01642147|3679040|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3853194|NCT01642147|3679041|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3853195|NCT01642147|3679039|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3853196|NCT01642147|3679040|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3853197|NCT01642147|3679041|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3853198|NCT01642147|3679039|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3853199|NCT01642147|3679040|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3853200|NCT01642147|3679041|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3853201|NCT01642082|3679070|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
3853202|NCT01642082|3679070|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3853203|NCT01642082|3679070|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3853204|NCT01642082|3679070|B1|70-79||Age, Customized||participants|Number|5|5.0||||||
3853205|NCT01642082|3679070|B1|60-69||Age, Customized||participants|Number|13|13.0||||||
3853206|NCT01642082|3679070|B1|50-59||Age, Customized||participants|Number|9|9.0||||||
3853207|NCT01642082|3679070|B1|40-49||Age, Customized||participants|Number|1|1.0||||||
3853208|NCT01642004|3679084|B3|PD-L1 not quantifiable at baseline||PD-L1 Expression Level||participants|Number|47|47.0||||||
3853209|NCT01642004|3679085|B2|PD-L1 not quantifiable at baseline||PD-L1 Expression Level||participants|Number|29|29.0||||||
3853210|NCT01642004|3679086|B1|PD-L1 not quantifiable at baseline||PD-L1 Expression Level||participants|Number|18|18.0||||||
3853211|NCT01642004|3679084|B3|PD-L1 expression < 5%||PD-L1 Expression Level||participants|Number|144|144.0||||||
3853212|NCT01642004|3679085|B2|PD-L1 expression < 5%||PD-L1 Expression Level||participants|Number|69|69.0||||||
3853213|NCT01642004|3679086|B1|PD-L1 expression < 5%||PD-L1 Expression Level||participants|Number|75|75.0||||||
3853214|NCT01642004|3679084|B3|PD-L1 expression >= 5%||PD-L1 Expression Level||participants|Number|81|81.0||||||
3853215|NCT01642004|3679085|B2|PD-L1 expression >= 5%||PD-L1 Expression Level||participants|Number|39|39.0||||||
3853216|NCT01642004|3679086|B1|PD-L1 expression >= 5%||PD-L1 Expression Level||participants|Number|42|42.0||||||
3853217|NCT01642004|3679084|B3||Male|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
3853218|NCT01642004|3679085|B2||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3853219|NCT01642004|3679086|B1||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3853220|NCT01642004|3679084|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3853221|NCT01642004|3679085|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3853222|NCT01642004|3679086|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3853223|NCT01642004|3679084|B3|>= 85 years||Age, Customized||participants|Number|1|1.0||||||
3853224|NCT01642004|3679085|B2|>= 85 years||Age, Customized||participants|Number|0|0.0||||||
3853225|NCT01642004|3679086|B1|>= 85 years||Age, Customized||participants|Number|1|1.0||||||
3853226|NCT01642004|3679084|B3|>= 75 AND < 85 years||Age, Customized||participants|Number|28|28.0||||||
3853227|NCT01642004|3679085|B2|>= 75 AND < 85 years||Age, Customized||participants|Number|18|18.0||||||
3853228|NCT01642004|3679086|B1|>= 75 AND < 85 years||Age, Customized||participants|Number|10|10.0||||||
3853229|NCT01642004|3679084|B3|>= 65 AND < 75 years||Age, Customized||participants|Number|91|91.0||||||
3853230|NCT01642004|3679085|B2|>= 65 AND < 75 years||Age, Customized||participants|Number|46|46.0||||||
3853231|NCT01642004|3679086|B1|>= 65 AND < 75 years||Age, Customized||participants|Number|45|45.0||||||
3853232|NCT01642004|3679084|B3|< 65 years||Age, Customized||participants|Number|152|152.0||||||
3853233|NCT01642004|3679085|B2|< 65 years||Age, Customized||participants|Number|73|73.0||||||
3853234|NCT01642004|3679086|B1|< 65 years||Age, Customized||participants|Number|79|79.0||||||
3853235|NCT01642004|3679084|B3|<= 18 years||Age, Customized||participants|Number|0|0.0||||||
3853236|NCT01642004|3679085|B2|<= 18 years||Age, Customized||participants|Number|0|0.0||||||
3853237|NCT01642004|3679086|B1|<= 18 years||Age, Customized||participants|Number|0|0.0||||||
3853238|NCT01642004|3679084|B3|||Age||years|Mean|63.3|63.3|Standard Deviation|8.36|8.36|||
3853239|NCT01642004|3679085|B2|||Age||years|Mean|64.4|64.4|Standard Deviation|8.28|8.28|||
3853240|NCT01642004|3679086|B1|||Age||years|Mean|62.2|62.2|Standard Deviation|8.33|8.33|||
3853241|NCT01641991|3679117|B5|United States||Region of Enrollment||participants|Number|328|328.0||||||
3853242|NCT01641991|3679118|B4|United States||Region of Enrollment||participants|Number|82|82.0||||||
3853243|NCT01641991|3679119|B3|United States||Region of Enrollment||participants|Number|82|82.0||||||
3853244|NCT01641991|3679120|B2|United States||Region of Enrollment||participants|Number|82|82.0||||||
3853245|NCT01641991|3679121|B1|United States||Region of Enrollment||participants|Number|82|82.0||||||
3853246|NCT01641991|3679117|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853247|NCT01641991|3679118|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853248|NCT01641991|3679119|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853249|NCT01641991|3679120|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853250|NCT01641991|3679121|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853251|NCT01641991|3679117|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|309|309.0||||||
3853252|NCT01641991|3679118|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
3853253|NCT01641991|3679119|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3853254|NCT01641991|3679120|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3853255|NCT01641991|3679121|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
3853256|NCT01641991|3679117|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3853257|NCT01641991|3679118|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3853258|NCT01641991|3679119|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3853259|NCT01641991|3679120|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3853260|NCT01641991|3679121|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3853261|NCT01641991|3679117|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3853262|NCT01641991|3679118|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3853263|NCT01641991|3679119|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3853264|NCT01641991|3679120|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3853265|NCT01641991|3679121|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853266|NCT01641991|3679117|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3853267|NCT01641991|3679118|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3853268|NCT01641991|3679119|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3853269|NCT01641991|3679120|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3853270|NCT01641991|3679121|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3853271|NCT01641991|3679117|B5||White|Race (NIH/OMB)||Participants|Count of Participants|245|245.0||||||
3853272|NCT01641991|3679118|B4||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3853273|NCT01641991|3679119|B3||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3853274|NCT01641991|3679120|B2||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3853275|NCT01641991|3679121|B1||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3853276|NCT01641991|3679117|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3853277|NCT01641991|3679118|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3853278|NCT01641991|3679119|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3853279|NCT01641991|3679120|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3853280|NCT01641991|3679121|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3853281|NCT01641991|3679117|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853282|NCT01641991|3679118|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853283|NCT01641991|3679119|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853284|NCT01641991|3679120|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853285|NCT01641991|3679121|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853286|NCT01641991|3679117|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3853287|NCT01641991|3679118|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3853288|NCT01641991|3679119|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3853289|NCT01641991|3679120|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3853290|NCT01641991|3679121|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3853291|NCT01641991|3679117|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853292|NCT01641991|3679118|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853293|NCT01641991|3679119|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853294|NCT01641991|3679120|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853295|NCT01641991|3679121|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853296|NCT01641991|3679117|B5||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3853297|NCT01641991|3679118|B4||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3853298|NCT01641991|3679119|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3853299|NCT01641991|3679120|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3853300|NCT01641991|3679121|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3853301|NCT01641991|3679117|B5||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3853302|NCT01641991|3679118|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3853303|NCT01641991|3679119|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3853304|NCT01641991|3679120|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3853305|NCT01641991|3679121|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3853306|NCT01641991|3679117|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3853307|NCT01641991|3679118|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3853308|NCT01641991|3679119|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3853309|NCT01641991|3679120|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3853310|NCT01641991|3679121|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3853311|NCT01641991|3679117|B5||Between 18 and 65 years|Age||Participants|Count of Participants|328|328.0||||||
3853312|NCT01641991|3679118|B4||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
3853313|NCT01641991|3679119|B3||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
3853314|NCT01641991|3679120|B2||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
3853315|NCT01641991|3679121|B1||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
3853316|NCT01641991|3679117|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3853317|NCT01641991|3679118|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3853318|NCT01641991|3679119|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3853319|NCT01641991|3679120|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3853320|NCT01641991|3679121|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3853321|NCT01641991|3679117|B5|||Age||years|Mean|35.7|35.7|Standard Deviation|11.2|11.2|||
3853322|NCT01641991|3679118|B4|||Age||years|Mean|36.5|36.5|Standard Deviation|11.1|11.1|||
3853323|NCT01641991|3679119|B3|||Age||years|Mean|34.6|34.6|Standard Deviation|11.5|11.5|||
3853324|NCT01641991|3679120|B2|||Age||years|Mean|36.7|36.7|Standard Deviation|11.7|11.7|||
3853325|NCT01641991|3679121|B1|||Age||years|Mean|35.0|35.0|Standard Deviation|10.8|10.8|||
3853326|NCT01641978|3679200|B1|Spain||Region of Enrollment||participants|Number|125|125.0||||||
3853327|NCT01641978|3679200|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3853328|NCT01641978|3679200|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3853329|NCT01641978|3679200|B1|||Age||years|Mean|62|62.0|Standard Deviation|15|15.0|||
3853330|NCT01641978|3679200|B1||>=65 years|Age||Participants|Count of Participants|58|58.0||||||
3853331|NCT01641978|3679200|B1||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
3853332|NCT01641978|3679200|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3853333|NCT01641952|3679208|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3853334|NCT01641952|3679208|B1||Female|Sex: Female, Male||Participants|Count of Participants|434|434.0||||||
3853335|NCT01641952|3679208|B1|||Age||years|Mean|56.36|56.36|Standard Deviation|10.681|10.681|||
3853336|NCT01641939|3679221|B4||Male|Sex: Female, Male||Participants|Count of Participants|325|325.0||||||
3853337|NCT01641939|3679222|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3853338|NCT01641939|3679223|B2||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
3853339|NCT01641939|3679224|B1||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3853340|NCT01641939|3679221|B4||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3853341|NCT01641939|3679222|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3853342|NCT01641939|3679223|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3853343|NCT01641939|3679224|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3853344|NCT01641939|3679221|B4|||Age||years|Mean|61.1|61.1|Standard Deviation|10.8|10.8|||
3853345|NCT01641939|3679222|B3|||Age||years|Mean|61.2|61.2|Standard Deviation|11.4|11.4|||
3853346|NCT01641939|3679223|B2|||Age||years|Mean|60.5|60.5|Standard Deviation|10.9|10.9|||
3853347|NCT01641939|3679224|B1|||Age||years|Mean|62.1|62.1|Standard Deviation|10.3|10.3|||
3853348|NCT01641926|3679265|B5|Asian||Race/Ethnicity, Customized||participants|Number|399|399.0||||||
3853349|NCT01641926|3679266|B4|Asian||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
3853350|NCT01641926|3679267|B3|Asian||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
3853351|NCT01641926|3679268|B2|Asian||Race/Ethnicity, Customized||participants|Number|144|144.0||||||
3853352|NCT01641926|3679269|B1|Asian||Race/Ethnicity, Customized||participants|Number|142|142.0||||||
3853353|NCT01641926|3679265|B5||Male|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
3853354|NCT01641926|3679266|B4||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3853355|NCT01641926|3679267|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3853356|NCT01641926|3679268|B2||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3853357|NCT01641926|3679269|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3853358|NCT01641926|3679265|B5||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3853359|NCT01641926|3679266|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3853360|NCT01641926|3679267|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3853361|NCT01641926|3679268|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3853362|NCT01641926|3679269|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3853363|NCT01641926|3679265|B5|||Age||years|Mean|35.5|35.5|Standard Deviation|9.91|9.91|||
3853364|NCT01641926|3679266|B4|||Age||years|Mean|42.0|42.0|Standard Deviation|10.50|10.5|||
3853365|NCT01641926|3679267|B3|||Age||years|Mean|41.1|41.1|Standard Deviation|10.77|10.77|||
3853366|NCT01641926|3679268|B2|||Age||years|Mean|33.6|33.6|Standard Deviation|9.23|9.23|||
3853367|NCT01641926|3679269|B1|||Age||years|Mean|32.6|32.6|Standard Deviation|7.73|7.73|||
3853368|NCT01641900|3679298|B3|United States||Region of Enrollment||participants|Number|55|55.0||||||
3853369|NCT01641900|3679299|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
3853370|NCT01641900|3679300|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
3853371|NCT01641900|3679298|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3853372|NCT01641900|3679299|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3853373|NCT01641900|3679300|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3853374|NCT01641900|3679298|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853375|NCT01641900|3679299|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853376|NCT01641900|3679300|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853377|NCT01641900|3679298|B3||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3853378|NCT01641900|3679299|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3853379|NCT01641900|3679300|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3853380|NCT01641900|3679298|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3853381|NCT01641900|3679299|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853382|NCT01641900|3679300|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3853383|NCT01641900|3679298|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853384|NCT01641900|3679299|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853385|NCT01641900|3679300|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853386|NCT01641900|3679298|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3853387|NCT01641900|3679299|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3853388|NCT01641900|3679300|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3853389|NCT01641900|3679298|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853390|NCT01641900|3679299|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853391|NCT01641900|3679300|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853392|NCT01641900|3679298|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3853393|NCT01641900|3679299|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3853394|NCT01641900|3679300|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3853395|NCT01641900|3679298|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3853396|NCT01641900|3679299|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3853397|NCT01641900|3679300|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3853398|NCT01641900|3679298|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3853399|NCT01641900|3679299|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3853400|NCT01641900|3679300|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3853401|NCT01641900|3679298|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3853402|NCT01641900|3679299|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3853403|NCT01641900|3679300|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3853404|NCT01641900|3679298|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3853405|NCT01641900|3679299|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3853406|NCT01641900|3679300|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3853407|NCT01641900|3679298|B3|||Age||years|Mean|31.13|31.13|Standard Deviation|6.91|6.91|||
3853408|NCT01641900|3679299|B2|||Age||years|Mean|30.1|30.1|Standard Deviation|6.2|6.2|||
3853409|NCT01641900|3679300|B1|||Age||years|Mean|32.3|32.3|Standard Deviation|7.5|7.5|||
3853410|NCT01641900|3679298|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3853411|NCT01641900|3679299|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3853412|NCT01641900|3679300|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3853413|NCT01641900|3679298|B3||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
3853414|NCT01641900|3679299|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3853415|NCT01641900|3679300|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3853416|NCT01641900|3679298|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3853417|NCT01641900|3679299|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3853418|NCT01641900|3679300|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3853419|NCT01641861|3679311|B3||Male|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
3853420|NCT01641861|3679312|B2||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3853421|NCT01641861|3679313|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3853422|NCT01641861|3679311|B3||Female|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
3853423|NCT01641861|3679312|B2||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3853424|NCT01641861|3679313|B1||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3853425|NCT01641861|3679311|B3|||Age||months|Mean|89.5|89.5|Standard Deviation|8.0|8.0|||
3853426|NCT01641861|3679312|B2|||Age||months|Mean|89.2|89.2|Standard Deviation|7.5|7.5|||
3853427|NCT01641861|3679313|B1|||Age||months|Mean|89.9|89.9|Standard Deviation|8.4|8.4|||
3853428|NCT01641835|3679328|B1|||Race/Ethnicity, Customized|Subjects of Caucasian descent|participants|Number|303|303.0||||||
3853429|NCT01641835|3679328|B1||Male|Gender||Participants|Count of Participants|153|153.0||||||
3853430|NCT01641835|3679328|B1||Female|Gender||Participants|Count of Participants|150|150.0||||||
3853431|NCT01641835|3679328|B1||>=65 years|Age||Participants|Count of Participants|108|108.0||||||
3853432|NCT01641835|3679328|B1||Between 18 and 65 years|Age||Participants|Count of Participants|195|195.0||||||
3853433|NCT01641835|3679328|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3853434|NCT01641822|3679333|B3|||CFQ-R Respiratory Score at Day 1|Respiratory symptoms (eg, coughing, congestion, wheezing) were assessed with the Cystic Fibrosis Questionnaire - Revised (CFQ-R) Respiratory Symptoms Scale (RSS). The range of scores (units) was 0 to 100 with higher scores indicating fewer symptoms.|units on a scale|Mean|62.11|62.11|Standard Deviation|16.773|16.773|||
3853435|NCT01641822|3679334|B2|||CFQ-R Respiratory Score at Day 1|Respiratory symptoms (eg, coughing, congestion, wheezing) were assessed with the Cystic Fibrosis Questionnaire - Revised (CFQ-R) Respiratory Symptoms Scale (RSS). The range of scores (units) was 0 to 100 with higher scores indicating fewer symptoms.|units on a scale|Mean|64.24|64.24|Standard Deviation|15.044|15.044|||
3853436|NCT01641822|3679335|B1|||CFQ-R Respiratory Score at Day 1|Respiratory symptoms (eg, coughing, congestion, wheezing) were assessed with the Cystic Fibrosis Questionnaire - Revised (CFQ-R) Respiratory Symptoms Scale (RSS). The range of scores (units) was 0 to 100 with higher scores indicating fewer symptoms.|units on a scale|Mean|59.72|59.72|Standard Deviation|18.408|18.408|||
3853437|NCT01641822|3679333|B3|||FEV1 % predicted at Day 1|Forced expiratory volume (FEV)1 is defined as the maximal volume of air that can be exhaled in 1 second. FEV1 % predicted is defined as FEV1 of the participant divided by the average FEV1 in the population for any person of similar age, sex, race, and body composition.|percentage of FEV1 % predicted|Mean|50.11|50.11|Standard Deviation|16.213|16.213|||
3853438|NCT01641822|3679334|B2|||FEV1 % predicted at Day 1|Forced expiratory volume (FEV)1 is defined as the maximal volume of air that can be exhaled in 1 second. FEV1 % predicted is defined as FEV1 of the participant divided by the average FEV1 in the population for any person of similar age, sex, race, and body composition.|percentage of FEV1 % predicted|Mean|50.25|50.25|Standard Deviation|15.131|15.131|||
3853439|NCT01641822|3679335|B1|||FEV1 % predicted at Day 1|Forced expiratory volume (FEV)1 is defined as the maximal volume of air that can be exhaled in 1 second. FEV1 % predicted is defined as FEV1 of the participant divided by the average FEV1 in the population for any person of similar age, sex, race, and body composition.|percentage of FEV1 % predicted|Mean|49.95|49.95|Standard Deviation|17.500|17.5|||
3853440|NCT01641822|3679333|B3|United States||Region of Enrollment||participants|Number|90|90.0||||||
3853441|NCT01641822|3679334|B2|United States||Region of Enrollment||participants|Number|47|47.0||||||
3853442|NCT01641822|3679335|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
3853443|NCT01641822|3679333|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3853444|NCT01641822|3679334|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3853445|NCT01641822|3679335|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3853446|NCT01641822|3679333|B3|White||Race/Ethnicity, Customized||participants|Number|86|86.0||||||
3853447|NCT01641822|3679334|B2|White||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
3853448|NCT01641822|3679335|B1|White||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
3853449|NCT01641822|3679333|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3853450|NCT01641822|3679334|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3853451|NCT01641822|3679335|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3853452|NCT01641822|3679333|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853453|NCT01641822|3679334|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853454|NCT01641822|3679335|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853455|NCT01641822|3679333|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
3853456|NCT01641822|3679334|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3853457|NCT01641822|3679335|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3853458|NCT01641822|3679333|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3853459|NCT01641822|3679334|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3853460|NCT01641822|3679335|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3853461|NCT01641822|3679333|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3853462|NCT01641822|3679334|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3853463|NCT01641822|3679335|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3853464|NCT01641822|3679333|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3853465|NCT01641822|3679334|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3853466|NCT01641822|3679335|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3853467|NCT01641822|3679333|B3|≥ 18 years||Age, Customized||participants|Number|75|75.0||||||
3853468|NCT01641822|3679334|B2|≥ 18 years||Age, Customized||participants|Number|40|40.0||||||
3853469|NCT01641822|3679335|B1|≥ 18 years||Age, Customized||participants|Number|35|35.0||||||
3853470|NCT01641822|3679333|B3|13 - 17 years||Age, Customized||participants|Number|11|11.0||||||
3853471|NCT01641822|3679334|B2|13 - 17 years||Age, Customized||participants|Number|6|6.0||||||
3853472|NCT01641822|3679335|B1|13 - 17 years||Age, Customized||participants|Number|5|5.0||||||
3853473|NCT01641822|3679333|B3|6 - 12 years||Age, Customized||participants|Number|4|4.0||||||
3853474|NCT01641822|3679334|B2|6 - 12 years||Age, Customized||participants|Number|1|1.0||||||
3853475|NCT01641822|3679335|B1|6 - 12 years||Age, Customized||participants|Number|3|3.0||||||
3853476|NCT01641822|3679333|B3|||Age||years|Mean|28.4|28.4|Standard Deviation|11.42|11.42|||
3853477|NCT01641822|3679334|B2|||Age||years|Mean|28.0|28.0|Standard Deviation|10.88|10.88|||
3853478|NCT01641822|3679335|B1|||Age||years|Mean|28.8|28.8|Standard Deviation|12.10|12.1|||
3853479|NCT01641692|3679354|B1|American Indian or Alaskan Native & White||Race/Ethnicity, Customized||Participants|Number|31|31.0||||||
3853480|NCT01641692|3679354|B1|White||Race/Ethnicity, Customized||Participants|Number|197|197.0||||||
3853481|NCT01641692|3679354|B1|Asian-Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3853482|NCT01641692|3679354|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|85|85.0||||||
3853483|NCT01641692|3679354|B1|African American/African Heritage (HER)||Race/Ethnicity, Customized||Participants|Number|33|33.0||||||
3853484|NCT01641692|3679354|B1||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3853485|NCT01641692|3679354|B1||Female|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
3853486|NCT01641692|3679354|B1|||Age||Years|Mean|42.6|42.6|Standard Deviation|14.84|14.84|||
3853487|NCT01641653|3679548|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
3853488|NCT01641653|3679549|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3853489|NCT01641653|3679550|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3853490|NCT01641653|3679548|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3853491|NCT01641653|3679549|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3853492|NCT01641653|3679550|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3853493|NCT01641653|3679548|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3853494|NCT01641653|3679549|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3853495|NCT01641653|3679550|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3853496|NCT01641653|3679548|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3853497|NCT01641653|3679549|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3853498|NCT01641653|3679550|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3853499|NCT01641653|3679548|B3||Unknown or Not Reported|Race (NIH/OMB)|participants scheduled for hernia repair were screened and consented, preoperative glucose level was then performed with Abbott Freestyle monitor to insure that fasting glucose level was below or equal to 110mg/dL.|Participants|Count of Participants|10|10.0||||||
3853500|NCT01641653|3679549|B2||Unknown or Not Reported|Race (NIH/OMB)|participants scheduled for hernia repair were screened and consented, preoperative glucose level was then performed with Abbott Freestyle monitor to insure that fasting glucose level was below or equal to 110mg/dL.|Participants|Count of Participants|4|4.0||||||
3853501|NCT01641653|3679550|B1||Unknown or Not Reported|Race (NIH/OMB)|participants scheduled for hernia repair were screened and consented, preoperative glucose level was then performed with Abbott Freestyle monitor to insure that fasting glucose level was below or equal to 110mg/dL.|Participants|Count of Participants|6|6.0||||||
3853502|NCT01641653|3679548|B3||More than one race|Race (NIH/OMB)|participants scheduled for hernia repair were screened and consented, preoperative glucose level was then performed with Abbott Freestyle monitor to insure that fasting glucose level was below or equal to 110mg/dL.|Participants|Count of Participants|5|5.0||||||
3853503|NCT01641653|3679549|B2||More than one race|Race (NIH/OMB)|participants scheduled for hernia repair were screened and consented, preoperative glucose level was then performed with Abbott Freestyle monitor to insure that fasting glucose level was below or equal to 110mg/dL.|Participants|Count of Participants|3|3.0||||||
3853504|NCT01641653|3679550|B1||More than one race|Race (NIH/OMB)|participants scheduled for hernia repair were screened and consented, preoperative glucose level was then performed with Abbott Freestyle monitor to insure that fasting glucose level was below or equal to 110mg/dL.|Participants|Count of Participants|2|2.0||||||
3853505|NCT01641653|3679548|B3||White|Race (NIH/OMB)|participants scheduled for hernia repair were screened and consented, preoperative glucose level was then performed with Abbott Freestyle monitor to insure that fasting glucose level was below or equal to 110mg/dL.|Participants|Count of Participants|21|21.0||||||
3853506|NCT01641653|3679549|B2||White|Race (NIH/OMB)|participants scheduled for hernia repair were screened and consented, preoperative glucose level was then performed with Abbott Freestyle monitor to insure that fasting glucose level was below or equal to 110mg/dL.|Participants|Count of Participants|12|12.0||||||
3853544|NCT01641640|3679561|B1|Genotype 1b||Hepatitis C Virus (HCV) genotype||participants|Number|66|66.0||||||
3853507|NCT01641653|3679550|B1||White|Race (NIH/OMB)|participants scheduled for hernia repair were screened and consented, preoperative glucose level was then performed with Abbott Freestyle monitor to insure that fasting glucose level was below or equal to 110mg/dL.|Participants|Count of Participants|9|9.0||||||
3853508|NCT01641653|3679548|B3||Black or African American|Race (NIH/OMB)|participants scheduled for hernia repair were screened and consented, preoperative glucose level was then performed with Abbott Freestyle monitor to insure that fasting glucose level was below or equal to 110mg/dL.|Participants|Count of Participants|24|24.0||||||
3853509|NCT01641653|3679549|B2||Black or African American|Race (NIH/OMB)|participants scheduled for hernia repair were screened and consented, preoperative glucose level was then performed with Abbott Freestyle monitor to insure that fasting glucose level was below or equal to 110mg/dL.|Participants|Count of Participants|11|11.0||||||
3853510|NCT01641653|3679550|B1||Black or African American|Race (NIH/OMB)|participants scheduled for hernia repair were screened and consented, preoperative glucose level was then performed with Abbott Freestyle monitor to insure that fasting glucose level was below or equal to 110mg/dL.|Participants|Count of Participants|13|13.0||||||
3853511|NCT01641653|3679548|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|participants scheduled for hernia repair were screened and consented, preoperative glucose level was then performed with Abbott Freestyle monitor to insure that fasting glucose level was below or equal to 110mg/dL.|Participants|Count of Participants|0|0.0||||||
3853512|NCT01641653|3679549|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|participants scheduled for hernia repair were screened and consented, preoperative glucose level was then performed with Abbott Freestyle monitor to insure that fasting glucose level was below or equal to 110mg/dL.|Participants|Count of Participants|0|0.0||||||
3853513|NCT01641653|3679550|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|participants scheduled for hernia repair were screened and consented, preoperative glucose level was then performed with Abbott Freestyle monitor to insure that fasting glucose level was below or equal to 110mg/dL.|Participants|Count of Participants|0|0.0||||||
3853514|NCT01641653|3679548|B3||Asian|Race (NIH/OMB)|participants scheduled for hernia repair were screened and consented, preoperative glucose level was then performed with Abbott Freestyle monitor to insure that fasting glucose level was below or equal to 110mg/dL.|Participants|Count of Participants|0|0.0||||||
3853515|NCT01641653|3679549|B2||Asian|Race (NIH/OMB)|participants scheduled for hernia repair were screened and consented, preoperative glucose level was then performed with Abbott Freestyle monitor to insure that fasting glucose level was below or equal to 110mg/dL.|Participants|Count of Participants|0|0.0||||||
3853516|NCT01641653|3679550|B1||Asian|Race (NIH/OMB)|participants scheduled for hernia repair were screened and consented, preoperative glucose level was then performed with Abbott Freestyle monitor to insure that fasting glucose level was below or equal to 110mg/dL.|Participants|Count of Participants|0|0.0||||||
3853517|NCT01641653|3679548|B3||American Indian or Alaska Native|Race (NIH/OMB)|participants scheduled for hernia repair were screened and consented, preoperative glucose level was then performed with Abbott Freestyle monitor to insure that fasting glucose level was below or equal to 110mg/dL.|Participants|Count of Participants|0|0.0||||||
3853518|NCT01641653|3679549|B2||American Indian or Alaska Native|Race (NIH/OMB)|participants scheduled for hernia repair were screened and consented, preoperative glucose level was then performed with Abbott Freestyle monitor to insure that fasting glucose level was below or equal to 110mg/dL.|Participants|Count of Participants|0|0.0||||||
3853519|NCT01641653|3679550|B1||American Indian or Alaska Native|Race (NIH/OMB)|participants scheduled for hernia repair were screened and consented, preoperative glucose level was then performed with Abbott Freestyle monitor to insure that fasting glucose level was below or equal to 110mg/dL.|Participants|Count of Participants|0|0.0||||||
3853520|NCT01641653|3679548|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3853521|NCT01641653|3679549|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3853522|NCT01641653|3679550|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3853523|NCT01641653|3679548|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3853524|NCT01641653|3679549|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3853525|NCT01641653|3679550|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3853526|NCT01641653|3679548|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3853527|NCT01641653|3679549|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3853528|NCT01641653|3679550|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3853529|NCT01641653|3679548|B3||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3853530|NCT01641653|3679549|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3853531|NCT01641653|3679550|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3853532|NCT01641653|3679548|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3853533|NCT01641653|3679549|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3853534|NCT01641653|3679550|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3853535|NCT01641640|3679561|B1|TT||IL28 Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|51|51.0||||||
3853536|NCT01641640|3679561|B1|CT||IL28 Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|181|181.0||||||
3853537|NCT01641640|3679561|B1|CC||IL28 Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|95|95.0||||||
3853538|NCT01641640|3679561|B1|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|256|256.0||||||
3853539|NCT01641640|3679561|B1|< 6 log10 IU/mL||HCV RNA Category||participants|Number|71|71.0||||||
3853540|NCT01641640|3679561|B1|||HCV RNA||log10 IU/mL|Mean|6.4|6.4|Standard Deviation|0.67|0.67|||
3853541|NCT01641640|3679561|B1|Genotype 6||Hepatitis C Virus (HCV) genotype||participants|Number|6|6.0||||||
3853542|NCT01641640|3679561|B1|Genotype 5||Hepatitis C Virus (HCV) genotype||participants|Number|1|1.0||||||
3853543|NCT01641640|3679561|B1|Genotype 4||Hepatitis C Virus (HCV) genotype||participants|Number|28|28.0||||||
3853545|NCT01641640|3679561|B1|Genotype 1a||Hepatitis C Virus (HCV) genotype||participants|Number|225|225.0||||||
3853546|NCT01641640|3679561|B1|Genotype 1a/1b||Hepatitis C Virus (HCV) genotype||participants|Number|1|1.0||||||
3853547|NCT01641640|3679561|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3853548|NCT01641640|3679561|B1|Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3853549|NCT01641640|3679561|B1|American Indian/ Alaska Native/ First Nations||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3853550|NCT01641640|3679561|B1|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3853551|NCT01641640|3679561|B1|White||Race/Ethnicity, Customized||participants|Number|257|257.0||||||
3853552|NCT01641640|3679561|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
3853553|NCT01641640|3679561|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853554|NCT01641640|3679561|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|281|281.0||||||
3853555|NCT01641640|3679561|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3853556|NCT01641640|3679561|B1||Male|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
3853557|NCT01641640|3679561|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3853558|NCT01641640|3679561|B1|||Age||years|Mean|52|52.0|Standard Deviation|10.3|10.3|||
3853559|NCT01641471|3679570|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3853560|NCT01641471|3679571|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3853561|NCT01641471|3679572|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3853562|NCT01641471|3679570|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3853563|NCT01641471|3679571|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3853564|NCT01641471|3679572|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3853565|NCT01641471|3679570|B3|||Age||years|Mean|62.8|62.8|Standard Deviation|8.6|8.6|||
3853566|NCT01641471|3679571|B2|||Age||years|Mean|60.3|60.3|Standard Deviation|7.7|7.7|||
3853567|NCT01641471|3679572|B1|||Age||years|Mean|67.3|67.3|Standard Deviation|3.7|3.7|||
3853568|NCT01641380|3679585|B3|United States||Region of Enrollment||Participants|Count of Participants|100|100.0||||||
3853569|NCT01641380|3679586|B2|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3853570|NCT01641380|3679587|B1|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3853571|NCT01641380|3679585|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3853572|NCT01641380|3679586|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3853573|NCT01641380|3679587|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3853574|NCT01641380|3679585|B3|African American/Black||Race/Ethnicity, Customized||Participants|Count of Participants|98|98.0||||||
3853575|NCT01641380|3679586|B2|African American/Black||Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
3853576|NCT01641380|3679587|B1|African American/Black||Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
3853577|NCT01641380|3679585|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3853578|NCT01641380|3679586|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3853579|NCT01641380|3679587|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3853580|NCT01641380|3679585|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3853581|NCT01641380|3679586|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3853582|NCT01641380|3679587|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3853583|NCT01641380|3679585|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3853584|NCT01641380|3679586|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3853585|NCT01641380|3679587|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3853586|NCT01641380|3679585|B3||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3853587|NCT01641380|3679586|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3853588|NCT01641380|3679587|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3853589|NCT01641380|3679585|B3||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
3853590|NCT01641380|3679586|B2||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
3853591|NCT01641380|3679587|B1||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
3853592|NCT01641367|3679594|B7||Indeterminate|Hepatitis B Surface Antigen Result, categorical||Participants|Count of Participants|1|1.0||||||
3853593|NCT01641367|3679595|B6||Indeterminate|Hepatitis B Surface Antigen Result, categorical||Participants|Count of Participants|0|0.0||||||
3853594|NCT01641367|3679596|B5||Indeterminate|Hepatitis B Surface Antigen Result, categorical||Participants|Count of Participants|1|1.0||||||
3853595|NCT01641367|3679597|B4||Indeterminate|Hepatitis B Surface Antigen Result, categorical||Participants|Count of Participants|0|0.0||||||
3853596|NCT01641367|3679598|B3||Indeterminate|Hepatitis B Surface Antigen Result, categorical||Participants|Count of Participants|0|0.0||||||
3853597|NCT01641367|3679599|B2||Indeterminate|Hepatitis B Surface Antigen Result, categorical||Participants|Count of Participants|0|0.0||||||
3853598|NCT01641367|3679600|B1||Indeterminate|Hepatitis B Surface Antigen Result, categorical||Participants|Count of Participants|0|0.0||||||
3853599|NCT01641367|3679594|B7||Negative|Hepatitis B Surface Antigen Result, categorical||Participants|Count of Participants|515|515.0||||||
3853600|NCT01641367|3679595|B6||Negative|Hepatitis B Surface Antigen Result, categorical||Participants|Count of Participants|30|30.0||||||
3853601|NCT01641367|3679596|B5||Negative|Hepatitis B Surface Antigen Result, categorical||Participants|Count of Participants|66|66.0||||||
3853602|NCT01641367|3679597|B4||Negative|Hepatitis B Surface Antigen Result, categorical||Participants|Count of Participants|0|0.0||||||
3853603|NCT01641367|3679598|B3||Negative|Hepatitis B Surface Antigen Result, categorical||Participants|Count of Participants|72|72.0||||||
3853604|NCT01641367|3679599|B2||Negative|Hepatitis B Surface Antigen Result, categorical||Participants|Count of Participants|74|74.0||||||
3853605|NCT01641367|3679600|B1||Negative|Hepatitis B Surface Antigen Result, categorical||Participants|Count of Participants|273|273.0||||||
3853606|NCT01641367|3679594|B7||Positive|Hepatitis B Surface Antigen Result, categorical||Participants|Count of Participants|29|29.0||||||
3853607|NCT01641367|3679595|B6||Positive|Hepatitis B Surface Antigen Result, categorical||Participants|Count of Participants|4|4.0||||||
3853608|NCT01641367|3679596|B5||Positive|Hepatitis B Surface Antigen Result, categorical||Participants|Count of Participants|3|3.0||||||
3853609|NCT01641367|3679597|B4||Positive|Hepatitis B Surface Antigen Result, categorical||Participants|Count of Participants|8|8.0||||||
3853610|NCT01641367|3679598|B3||Positive|Hepatitis B Surface Antigen Result, categorical||Participants|Count of Participants|0|0.0||||||
3853611|NCT01641367|3679599|B2||Positive|Hepatitis B Surface Antigen Result, categorical||Participants|Count of Participants|0|0.0||||||
3853612|NCT01641367|3679600|B1||Positive|Hepatitis B Surface Antigen Result, categorical||Participants|Count of Participants|14|14.0||||||
3853613|NCT01641367|3679594|B7||Previously|IV drug history, categorical||Participants|Count of Participants|1|1.0||||||
3853614|NCT01641367|3679595|B6||Previously|IV drug history, categorical||Participants|Count of Participants|0|0.0||||||
3853615|NCT01641367|3679596|B5||Previously|IV drug history, categorical||Participants|Count of Participants|0|0.0||||||
3853616|NCT01641367|3679597|B4||Previously|IV drug history, categorical||Participants|Count of Participants|0|0.0||||||
3853617|NCT01641367|3679598|B3||Previously|IV drug history, categorical||Participants|Count of Participants|0|0.0||||||
3853618|NCT01641367|3679599|B2||Previously|IV drug history, categorical||Participants|Count of Participants|0|0.0||||||
3853619|NCT01641367|3679600|B1||Previously|IV drug history, categorical||Participants|Count of Participants|1|1.0||||||
3853620|NCT01641367|3679594|B7||Never|IV drug history, categorical||Participants|Count of Participants|544|544.0||||||
3853621|NCT01641367|3679595|B6||Never|IV drug history, categorical||Participants|Count of Participants|34|34.0||||||
3853622|NCT01641367|3679596|B5||Never|IV drug history, categorical||Participants|Count of Participants|70|70.0||||||
3853623|NCT01641367|3679597|B4||Never|IV drug history, categorical||Participants|Count of Participants|8|8.0||||||
3853624|NCT01641367|3679598|B3||Never|IV drug history, categorical||Participants|Count of Participants|72|72.0||||||
3853625|NCT01641367|3679599|B2||Never|IV drug history, categorical||Participants|Count of Participants|74|74.0||||||
3853626|NCT01641367|3679600|B1||Never|IV drug history, categorical||Participants|Count of Participants|286|286.0||||||
3853627|NCT01641367|3679594|B7||>= 500 cells/mm^3|CD4+ T-Cell Count, categorical|Baseline CD4+ T-cell count is defined as the last available result on or before the date of study entry|Participants|Count of Participants|37|37.0||||||
3853628|NCT01641367|3679595|B6||>= 500 cells/mm^3|CD4+ T-Cell Count, categorical|Baseline CD4+ T-cell count is defined as the last available result on or before the date of study entry|Participants|Count of Participants|2|2.0||||||
3853629|NCT01641367|3679596|B5||>= 500 cells/mm^3|CD4+ T-Cell Count, categorical|Baseline CD4+ T-cell count is defined as the last available result on or before the date of study entry|Participants|Count of Participants|5|5.0||||||
3853630|NCT01641367|3679597|B4||>= 500 cells/mm^3|CD4+ T-Cell Count, categorical|Baseline CD4+ T-cell count is defined as the last available result on or before the date of study entry|Participants|Count of Participants|0|0.0||||||
3853631|NCT01641367|3679598|B3||>= 500 cells/mm^3|CD4+ T-Cell Count, categorical|Baseline CD4+ T-cell count is defined as the last available result on or before the date of study entry|Participants|Count of Participants|7|7.0||||||
3853632|NCT01641367|3679599|B2||>= 500 cells/mm^3|CD4+ T-Cell Count, categorical|Baseline CD4+ T-cell count is defined as the last available result on or before the date of study entry|Participants|Count of Participants|3|3.0||||||
3853633|NCT01641367|3679600|B1||>= 500 cells/mm^3|CD4+ T-Cell Count, categorical|Baseline CD4+ T-cell count is defined as the last available result on or before the date of study entry|Participants|Count of Participants|20|20.0||||||
3853634|NCT01641367|3679594|B7||350 - < 500 cells/mm^3|CD4+ T-Cell Count, categorical|Baseline CD4+ T-cell count is defined as the last available result on or before the date of study entry|Participants|Count of Participants|63|63.0||||||
3853635|NCT01641367|3679595|B6||350 - < 500 cells/mm^3|CD4+ T-Cell Count, categorical|Baseline CD4+ T-cell count is defined as the last available result on or before the date of study entry|Participants|Count of Participants|8|8.0||||||
3853636|NCT01641367|3679596|B5||350 - < 500 cells/mm^3|CD4+ T-Cell Count, categorical|Baseline CD4+ T-cell count is defined as the last available result on or before the date of study entry|Participants|Count of Participants|6|6.0||||||
3853637|NCT01641367|3679597|B4||350 - < 500 cells/mm^3|CD4+ T-Cell Count, categorical|Baseline CD4+ T-cell count is defined as the last available result on or before the date of study entry|Participants|Count of Participants|1|1.0||||||
3853638|NCT01641367|3679598|B3||350 - < 500 cells/mm^3|CD4+ T-Cell Count, categorical|Baseline CD4+ T-cell count is defined as the last available result on or before the date of study entry|Participants|Count of Participants|6|6.0||||||
3853639|NCT01641367|3679599|B2||350 - < 500 cells/mm^3|CD4+ T-Cell Count, categorical|Baseline CD4+ T-cell count is defined as the last available result on or before the date of study entry|Participants|Count of Participants|12|12.0||||||
3853640|NCT01641367|3679600|B1||350 - < 500 cells/mm^3|CD4+ T-Cell Count, categorical|Baseline CD4+ T-cell count is defined as the last available result on or before the date of study entry|Participants|Count of Participants|30|30.0||||||
3853641|NCT01641367|3679594|B7||200 - < 350 cells/mm^3|CD4+ T-Cell Count, categorical|Baseline CD4+ T-cell count is defined as the last available result on or before the date of study entry|Participants|Count of Participants|148|148.0||||||
3853642|NCT01641367|3679595|B6||200 - < 350 cells/mm^3|CD4+ T-Cell Count, categorical|Baseline CD4+ T-cell count is defined as the last available result on or before the date of study entry|Participants|Count of Participants|7|7.0||||||
3853643|NCT01641367|3679596|B5||200 - < 350 cells/mm^3|CD4+ T-Cell Count, categorical|Baseline CD4+ T-cell count is defined as the last available result on or before the date of study entry|Participants|Count of Participants|19|19.0||||||
3853644|NCT01641367|3679597|B4||200 - < 350 cells/mm^3|CD4+ T-Cell Count, categorical|Baseline CD4+ T-cell count is defined as the last available result on or before the date of study entry|Participants|Count of Participants|5|5.0||||||
3853645|NCT01641367|3679598|B3||200 - < 350 cells/mm^3|CD4+ T-Cell Count, categorical|Baseline CD4+ T-cell count is defined as the last available result on or before the date of study entry|Participants|Count of Participants|23|23.0||||||
3853646|NCT01641367|3679599|B2||200 - < 350 cells/mm^3|CD4+ T-Cell Count, categorical|Baseline CD4+ T-cell count is defined as the last available result on or before the date of study entry|Participants|Count of Participants|15|15.0||||||
3853647|NCT01641367|3679600|B1||200 - < 350 cells/mm^3|CD4+ T-Cell Count, categorical|Baseline CD4+ T-cell count is defined as the last available result on or before the date of study entry|Participants|Count of Participants|79|79.0||||||
3853648|NCT01641367|3679594|B7||50 - < 200 cells/mm^3|CD4+ T-Cell Count, categorical|Baseline CD4+ T-cell count is defined as the last available result on or before the date of study entry|Participants|Count of Participants|202|202.0||||||
3853649|NCT01641367|3679595|B6||50 - < 200 cells/mm^3|CD4+ T-Cell Count, categorical|Baseline CD4+ T-cell count is defined as the last available result on or before the date of study entry|Participants|Count of Participants|10|10.0||||||
3853650|NCT01641367|3679596|B5||50 - < 200 cells/mm^3|CD4+ T-Cell Count, categorical|Baseline CD4+ T-cell count is defined as the last available result on or before the date of study entry|Participants|Count of Participants|31|31.0||||||
3853651|NCT01641367|3679597|B4||50 - < 200 cells/mm^3|CD4+ T-Cell Count, categorical|Baseline CD4+ T-cell count is defined as the last available result on or before the date of study entry|Participants|Count of Participants|1|1.0||||||
3853652|NCT01641367|3679598|B3||50 - < 200 cells/mm^3|CD4+ T-Cell Count, categorical|Baseline CD4+ T-cell count is defined as the last available result on or before the date of study entry|Participants|Count of Participants|25|25.0||||||
3853653|NCT01641367|3679599|B2||50 - < 200 cells/mm^3|CD4+ T-Cell Count, categorical|Baseline CD4+ T-cell count is defined as the last available result on or before the date of study entry|Participants|Count of Participants|27|27.0||||||
3853654|NCT01641367|3679600|B1||50 - < 200 cells/mm^3|CD4+ T-Cell Count, categorical|Baseline CD4+ T-cell count is defined as the last available result on or before the date of study entry|Participants|Count of Participants|108|108.0||||||
3853655|NCT01641367|3679594|B7||< 50 cells/mm^3|CD4+ T-Cell Count, categorical|Baseline CD4+ T-cell count is defined as the last available result on or before the date of study entry|Participants|Count of Participants|95|95.0||||||
3853656|NCT01641367|3679595|B6||< 50 cells/mm^3|CD4+ T-Cell Count, categorical|Baseline CD4+ T-cell count is defined as the last available result on or before the date of study entry|Participants|Count of Participants|7|7.0||||||
3853657|NCT01641367|3679596|B5||< 50 cells/mm^3|CD4+ T-Cell Count, categorical|Baseline CD4+ T-cell count is defined as the last available result on or before the date of study entry|Participants|Count of Participants|9|9.0||||||
3853658|NCT01641367|3679597|B4||< 50 cells/mm^3|CD4+ T-Cell Count, categorical|Baseline CD4+ T-cell count is defined as the last available result on or before the date of study entry|Participants|Count of Participants|1|1.0||||||
3853659|NCT01641367|3679598|B3||< 50 cells/mm^3|CD4+ T-Cell Count, categorical|Baseline CD4+ T-cell count is defined as the last available result on or before the date of study entry|Participants|Count of Participants|11|11.0||||||
3853660|NCT01641367|3679599|B2||< 50 cells/mm^3|CD4+ T-Cell Count, categorical|Baseline CD4+ T-cell count is defined as the last available result on or before the date of study entry|Participants|Count of Participants|17|17.0||||||
3853661|NCT01641367|3679600|B1||< 50 cells/mm^3|CD4+ T-Cell Count, categorical|Baseline CD4+ T-cell count is defined as the last available result on or before the date of study entry|Participants|Count of Participants|50|50.0||||||
3853662|NCT01641367|3679594|B7||>= 10,000,000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|1|1.0||||||
3853663|NCT01641367|3679595|B6||>= 10,000,000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|0|0.0||||||
3853664|NCT01641367|3679596|B5||>= 10,000,000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|0|0.0||||||
3853665|NCT01641367|3679597|B4||>= 10,000,000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|0|0.0||||||
3853666|NCT01641367|3679598|B3||>= 10,000,000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|1|1.0||||||
3853667|NCT01641367|3679599|B2||>= 10,000,000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|0|0.0||||||
3853668|NCT01641367|3679600|B1||>= 10,000,000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|0|0.0||||||
3853669|NCT01641367|3679594|B7||1,000,000 - < 10,000,000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|20|20.0||||||
3853670|NCT01641367|3679595|B6||1,000,000 - < 10,000,000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|2|2.0||||||
3853671|NCT01641367|3679596|B5||1,000,000 - < 10,000,000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|5|5.0||||||
3853672|NCT01641367|3679597|B4||1,000,000 - < 10,000,000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|0|0.0||||||
3853748|NCT01641367|3679596|B5|Peru||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3853673|NCT01641367|3679598|B3||1,000,000 - < 10,000,000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|4|4.0||||||
3853674|NCT01641367|3679599|B2||1,000,000 - < 10,000,000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|1|1.0||||||
3853675|NCT01641367|3679600|B1||1,000,000 - < 10,000,000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|8|8.0||||||
3853676|NCT01641367|3679594|B7||100,000 - < 1,000,000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|146|146.0||||||
3853677|NCT01641367|3679595|B6||100,000 - < 1,000,000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|10|10.0||||||
3853678|NCT01641367|3679596|B5||100,000 - < 1,000,000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|22|22.0||||||
3853679|NCT01641367|3679597|B4||100,000 - < 1,000,000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|2|2.0||||||
3853680|NCT01641367|3679598|B3||100,000 - < 1,000,000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|25|25.0||||||
3853681|NCT01641367|3679599|B2||100,000 - < 1,000,000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|27|27.0||||||
3853682|NCT01641367|3679600|B1||100,000 - < 1,000,000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|60|60.0||||||
3853683|NCT01641367|3679594|B7||10,000 - < 100,000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|175|175.0||||||
3853684|NCT01641367|3679595|B6||10,000 - < 100,000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|9|9.0||||||
3853685|NCT01641367|3679596|B5||10,000 - < 100,000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|20|20.0||||||
3853686|NCT01641367|3679597|B4||10,000 - < 100,000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|1|1.0||||||
3853687|NCT01641367|3679598|B3||10,000 - < 100,000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|18|18.0||||||
3853688|NCT01641367|3679599|B2||10,000 - < 100,000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|21|21.0||||||
3853689|NCT01641367|3679600|B1||10,000 - < 100,000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|106|106.0||||||
3853690|NCT01641367|3679594|B7||1000 - < 10,000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|121|121.0||||||
3853691|NCT01641367|3679595|B6||1000 - < 10,000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|10|10.0||||||
3853692|NCT01641367|3679596|B5||1000 - < 10,000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|12|12.0||||||
3853693|NCT01641367|3679597|B4||1000 - < 10,000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|3|3.0||||||
3853694|NCT01641367|3679598|B3||1000 - < 10,000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|20|20.0||||||
3853695|NCT01641367|3679599|B2||1000 - < 10,000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|17|17.0||||||
3853696|NCT01641367|3679600|B1||1000 - < 10,000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|59|59.0||||||
3853697|NCT01641367|3679594|B7||200 - < 1000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|52|52.0||||||
3853698|NCT01641367|3679595|B6||200 - < 1000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|2|2.0||||||
3853699|NCT01641367|3679596|B5||200 - < 1000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|9|9.0||||||
3853700|NCT01641367|3679597|B4||200 - < 1000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|1|1.0||||||
3853701|NCT01641367|3679598|B3||200 - < 1000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|3|3.0||||||
3853702|NCT01641367|3679599|B2||200 - < 1000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|5|5.0||||||
3853703|NCT01641367|3679600|B1||200 - < 1000 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|32|32.0||||||
3853704|NCT01641367|3679594|B7||40 - < 200 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|18|18.0||||||
3853705|NCT01641367|3679595|B6||40 - < 200 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|1|1.0||||||
3853706|NCT01641367|3679596|B5||40 - < 200 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|2|2.0||||||
3853707|NCT01641367|3679597|B4||40 - < 200 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|1|1.0||||||
3853708|NCT01641367|3679598|B3||40 - < 200 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|1|1.0||||||
3853709|NCT01641367|3679599|B2||40 - < 200 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|2|2.0||||||
3853710|NCT01641367|3679600|B1||40 - < 200 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|11|11.0||||||
3853711|NCT01641367|3679594|B7||< 40 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|12|12.0||||||
3853712|NCT01641367|3679595|B6||< 40 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|0|0.0||||||
3853713|NCT01641367|3679596|B5||< 40 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|0|0.0||||||
3853714|NCT01641367|3679597|B4||< 40 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|0|0.0||||||
3853715|NCT01641367|3679598|B3||< 40 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|0|0.0||||||
3853716|NCT01641367|3679599|B2||< 40 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|1|1.0||||||
3853717|NCT01641367|3679600|B1||< 40 copies/mL|Plasma HIV-1 RNA, categorical|Baseline Plasma HIV-1 RNA is defined as the last available result on or before the date of study entry|Participants|Count of Participants|11|11.0||||||
3853718|NCT01641367|3679594|B7|Zimbabwe||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3853719|NCT01641367|3679595|B6|Zimbabwe||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3853720|NCT01641367|3679596|B5|Zimbabwe||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3853721|NCT01641367|3679597|B4|Zimbabwe||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3853722|NCT01641367|3679598|B3|Zimbabwe||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3853723|NCT01641367|3679599|B2|Zimbabwe||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3853724|NCT01641367|3679600|B1|Zimbabwe||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3853725|NCT01641367|3679594|B7|Uganda||Region of Enrollment||Participants|Count of Participants|81|81.0||||||
3853726|NCT01641367|3679595|B6|Uganda||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3853727|NCT01641367|3679596|B5|Uganda||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3853728|NCT01641367|3679597|B4|Uganda||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3853729|NCT01641367|3679598|B3|Uganda||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3853730|NCT01641367|3679599|B2|Uganda||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3853731|NCT01641367|3679600|B1|Uganda||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3853732|NCT01641367|3679594|B7|Thailand||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3853733|NCT01641367|3679595|B6|Thailand||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3853734|NCT01641367|3679596|B5|Thailand||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3853735|NCT01641367|3679597|B4|Thailand||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3853736|NCT01641367|3679598|B3|Thailand||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3853737|NCT01641367|3679599|B2|Thailand||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3853738|NCT01641367|3679600|B1|Thailand||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3853739|NCT01641367|3679594|B7|South Africa||Region of Enrollment||Participants|Count of Participants|84|84.0||||||
3853740|NCT01641367|3679595|B6|South Africa||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3853741|NCT01641367|3679596|B5|South Africa||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3853742|NCT01641367|3679597|B4|South Africa||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3853743|NCT01641367|3679598|B3|South Africa||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3853744|NCT01641367|3679599|B2|South Africa||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3853745|NCT01641367|3679600|B1|South Africa||Region of Enrollment||Participants|Count of Participants|58|58.0||||||
3853746|NCT01641367|3679594|B7|Peru||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3853747|NCT01641367|3679595|B6|Peru||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3853749|NCT01641367|3679597|B4|Peru||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3853750|NCT01641367|3679598|B3|Peru||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3853751|NCT01641367|3679599|B2|Peru||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3853752|NCT01641367|3679600|B1|Peru||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3853753|NCT01641367|3679594|B7|Malawi||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3853754|NCT01641367|3679595|B6|Malawi||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3853755|NCT01641367|3679596|B5|Malawi||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3853756|NCT01641367|3679597|B4|Malawi||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3853757|NCT01641367|3679598|B3|Malawi||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3853758|NCT01641367|3679599|B2|Malawi||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3853759|NCT01641367|3679600|B1|Malawi||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3853760|NCT01641367|3679594|B7|Kenya||Region of Enrollment||Participants|Count of Participants|59|59.0||||||
3853761|NCT01641367|3679595|B6|Kenya||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3853762|NCT01641367|3679596|B5|Kenya||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3853763|NCT01641367|3679597|B4|Kenya||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3853764|NCT01641367|3679598|B3|Kenya||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3853765|NCT01641367|3679599|B2|Kenya||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3853766|NCT01641367|3679600|B1|Kenya||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3853767|NCT01641367|3679594|B7|India||Region of Enrollment||Participants|Count of Participants|128|128.0||||||
3853768|NCT01641367|3679595|B6|India||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3853769|NCT01641367|3679596|B5|India||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3853770|NCT01641367|3679597|B4|India||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3853771|NCT01641367|3679598|B3|India||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3853772|NCT01641367|3679599|B2|India||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3853773|NCT01641367|3679600|B1|India||Region of Enrollment||Participants|Count of Participants|55|55.0||||||
3853774|NCT01641367|3679594|B7|Haiti||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3853775|NCT01641367|3679595|B6|Haiti||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3853776|NCT01641367|3679596|B5|Haiti||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3853777|NCT01641367|3679597|B4|Haiti||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3853778|NCT01641367|3679598|B3|Haiti||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3853779|NCT01641367|3679599|B2|Haiti||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3853780|NCT01641367|3679600|B1|Haiti||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3853781|NCT01641367|3679594|B7|Brazil||Region of Enrollment||Participants|Count of Participants|49|49.0||||||
3853782|NCT01641367|3679595|B6|Brazil||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3853783|NCT01641367|3679596|B5|Brazil||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3853784|NCT01641367|3679597|B4|Brazil||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3853785|NCT01641367|3679598|B3|Brazil||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3853786|NCT01641367|3679599|B2|Brazil||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3853787|NCT01641367|3679600|B1|Brazil||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3853788|NCT01641367|3679594|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3853789|NCT01641367|3679595|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3853790|NCT01641367|3679596|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3853791|NCT01641367|3679597|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853792|NCT01641367|3679598|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3853793|NCT01641367|3679599|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3853794|NCT01641367|3679600|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3853795|NCT01641367|3679594|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3853796|NCT01641367|3679595|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3853797|NCT01641367|3679596|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853798|NCT01641367|3679597|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853799|NCT01641367|3679598|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853800|NCT01641367|3679599|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853801|NCT01641367|3679600|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853802|NCT01641367|3679594|B7||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3853803|NCT01641367|3679595|B6||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3853804|NCT01641367|3679596|B5||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853805|NCT01641367|3679597|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853806|NCT01641367|3679598|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3853807|NCT01641367|3679599|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3853808|NCT01641367|3679600|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3853809|NCT01641367|3679594|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|353|353.0||||||
3853810|NCT01641367|3679595|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3853811|NCT01641367|3679596|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3853812|NCT01641367|3679597|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3853813|NCT01641367|3679598|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3853814|NCT01641367|3679599|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3853815|NCT01641367|3679600|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|195|195.0||||||
3853816|NCT01641367|3679594|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853817|NCT01641367|3679595|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853818|NCT01641367|3679596|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853819|NCT01641367|3679597|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853820|NCT01641367|3679598|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853821|NCT01641367|3679599|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853822|NCT01641367|3679600|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853823|NCT01641367|3679594|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
3853824|NCT01641367|3679595|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3853825|NCT01641367|3679596|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3853826|NCT01641367|3679597|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3853827|NCT01641367|3679598|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3853828|NCT01641367|3679599|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3853829|NCT01641367|3679600|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3853830|NCT01641367|3679594|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853831|NCT01641367|3679595|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853832|NCT01641367|3679596|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853833|NCT01641367|3679597|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853834|NCT01641367|3679598|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853835|NCT01641367|3679599|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853836|NCT01641367|3679600|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853837|NCT01641367|3679594|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3853838|NCT01641367|3679595|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3853839|NCT01641367|3679596|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3853840|NCT01641367|3679597|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853841|NCT01641367|3679598|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3853842|NCT01641367|3679599|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3853843|NCT01641367|3679600|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3853844|NCT01641367|3679594|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|454|454.0||||||
3853845|NCT01641367|3679595|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3853846|NCT01641367|3679596|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3853847|NCT01641367|3679597|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3853848|NCT01641367|3679598|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3853849|NCT01641367|3679599|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3853850|NCT01641367|3679600|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|241|241.0||||||
3853851|NCT01641367|3679594|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3853852|NCT01641367|3679595|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3853853|NCT01641367|3679596|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3853854|NCT01641367|3679597|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853855|NCT01641367|3679598|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3853856|NCT01641367|3679599|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3853857|NCT01641367|3679600|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3853858|NCT01641367|3679594|B7||Male|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
3853859|NCT01641367|3679595|B6||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3853860|NCT01641367|3679596|B5||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3853861|NCT01641367|3679597|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3853862|NCT01641367|3679598|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3853863|NCT01641367|3679599|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3853864|NCT01641367|3679600|B1||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3853865|NCT01641367|3679594|B7||Female|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
3853866|NCT01641367|3679595|B6||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3853867|NCT01641367|3679596|B5||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3853868|NCT01641367|3679597|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3853869|NCT01641367|3679598|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3853870|NCT01641367|3679599|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3853871|NCT01641367|3679600|B1||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3853872|NCT01641367|3679594|B7|||Age||years|Mean|41|41.0|Standard Deviation|10|10.0|||
3853873|NCT01641367|3679595|B6|||Age||years|Mean|42|42.0|Standard Deviation|10|10.0|||
3853874|NCT01641367|3679596|B5|||Age||years|Mean|42|42.0|Standard Deviation|10|10.0|||
3853875|NCT01641367|3679597|B4|||Age||years|Mean|40|40.0|Standard Deviation|10|10.0|||
3853876|NCT01641367|3679598|B3|||Age||years|Mean|42|42.0|Standard Deviation|9|9.0|||
3853877|NCT01641367|3679599|B2|||Age||years|Mean|42|42.0|Standard Deviation|10|10.0|||
3853878|NCT01641367|3679600|B1|||Age||years|Mean|40|40.0|Standard Deviation|11|11.0|||
3853879|NCT01641237|3679620|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3853880|NCT01641237|3679620|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3853881|NCT01641237|3679620|B1|||Age||Years|Mean|36.7|36.7|Standard Deviation|12.2|12.2|||
3853882|NCT01641159|3679645|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
3853883|NCT01641159|3679646|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
3853884|NCT01641159|3679647|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3853885|NCT01641159|3679645|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853886|NCT01641159|3679646|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853887|NCT01641159|3679647|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853888|NCT01641159|3679645|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3853889|NCT01641159|3679646|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3853890|NCT01641159|3679647|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3853891|NCT01641159|3679645|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3853892|NCT01641159|3679646|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3853893|NCT01641159|3679647|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3853894|NCT01641159|3679645|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3853895|NCT01641159|3679646|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3853896|NCT01641159|3679647|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3853897|NCT01641159|3679645|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853898|NCT01641159|3679646|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853899|NCT01641159|3679647|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853900|NCT01641159|3679645|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853901|NCT01641159|3679646|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853902|NCT01641159|3679647|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853903|NCT01641159|3679645|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853904|NCT01641159|3679646|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853905|NCT01641159|3679647|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853906|NCT01641159|3679645|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853907|NCT01641159|3679646|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853908|NCT01641159|3679647|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853909|NCT01641159|3679645|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3853910|NCT01641159|3679646|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3853911|NCT01641159|3679647|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3853912|NCT01641159|3679645|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853913|NCT01641159|3679646|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853914|NCT01641159|3679647|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853915|NCT01641159|3679645|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3853916|NCT01641159|3679646|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3853917|NCT01641159|3679647|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3853918|NCT01641159|3679645|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3853919|NCT01641159|3679646|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3853920|NCT01641159|3679647|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3853921|NCT01641159|3679645|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3853922|NCT01641159|3679646|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3853923|NCT01641159|3679647|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3853924|NCT01641159|3679645|B3||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
3853925|NCT01641159|3679646|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3853926|NCT01641159|3679647|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3853927|NCT01641159|3679645|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3853928|NCT01641159|3679646|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3853929|NCT01641159|3679647|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3853930|NCT01641133|3679656|B4||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3853931|NCT01641133|3679657|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3853932|NCT01641133|3679658|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3853933|NCT01641133|3679659|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3853934|NCT01641133|3679656|B4||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3853935|NCT01641133|3679657|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3853936|NCT01641133|3679658|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3853937|NCT01641133|3679659|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3853938|NCT01641133|3679656|B4|||Age||Weeks|Mean|7.4|7.4|Standard Deviation|1.47|1.47|||
3853939|NCT01641133|3679657|B3|||Age||Weeks|Mean|7.4|7.4|Standard Deviation|1.6|1.6|||
3853940|NCT01641133|3679658|B2|||Age||Weeks|Mean|7.4|7.4|Standard Deviation|1.5|1.5|||
3853941|NCT01641133|3679659|B1|||Age||Weeks|Mean|7.4|7.4|Standard Deviation|1.3|1.3|||
3853942|NCT01641120|3679699|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3853943|NCT01641120|3679699|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3853944|NCT01641120|3679699|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3853945|NCT01641120|3679699|B1|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3853946|NCT01641120|3679699|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3853947|NCT01641120|3679699|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3853948|NCT01641120|3679699|B1|||Age||years|Mean|49|49.0|Standard Deviation|10.41|10.41|||
3853949|NCT01641081|3679711|B1||Male|Gender||Participants|Count of Participants|83|83.0||||||
3853950|NCT01641081|3679711|B1||Female|Gender||Participants|Count of Participants|91|91.0||||||
3853951|NCT01641081|3679711|B1|||Age||Years|Mean|45.4|45.4|Standard Deviation|13.2|13.2|||
3853952|NCT01641042|3679737|B3|White-Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|70|70.0||||||
3853953|NCT01641042|3679738|B2|White-Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
3853954|NCT01641042|3679739|B1|White-Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3853955|NCT01641042|3679737|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3853956|NCT01641042|3679738|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3853957|NCT01641042|3679739|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3853958|NCT01641042|3679737|B3|African Heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3853959|NCT01641042|3679738|B2|African Heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3853960|NCT01641042|3679739|B1|African Heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3853961|NCT01641042|3679737|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3853962|NCT01641042|3679738|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3853963|NCT01641042|3679739|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3853964|NCT01641042|3679737|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3853965|NCT01641042|3679738|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3853966|NCT01641042|3679739|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3853967|NCT01641042|3679737|B3|||Age||Years|Mean|11.75|11.75|Standard Deviation|4.00|4.0|||
3853968|NCT01641042|3679738|B2|||Age||Years|Mean|11.5|11.5|Standard Deviation|3.6|3.6|||
3853969|NCT01641042|3679739|B1|||Age||Years|Mean|12.0|12.0|Standard Deviation|4.4|4.4|||
3853970|NCT01640964|3679786|B4||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3853971|NCT01640964|3679787|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3853972|NCT01640964|3679788|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3853973|NCT01640964|3679789|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3853974|NCT01640964|3679786|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3853975|NCT01640964|3679787|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3853976|NCT01640964|3679788|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3853977|NCT01640964|3679789|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3853978|NCT01640964|3679786|B4|>= 65 years||Age, Customized||Patients|Number|8|8.0||||||
3853979|NCT01640964|3679787|B3|>= 65 years||Age, Customized||Patients|Number|0|0.0||||||
3853980|NCT01640964|3679788|B2|>= 65 years||Age, Customized||Patients|Number|5|5.0||||||
3853981|NCT01640964|3679789|B1|>= 65 years||Age, Customized||Patients|Number|3|3.0||||||
3853982|NCT01640964|3679786|B4|< 65 years||Age, Customized||Patients|Number|38|38.0||||||
3853983|NCT01640964|3679787|B3|< 65 years||Age, Customized||Patients|Number|6|6.0||||||
3853984|NCT01640964|3679788|B2|< 65 years||Age, Customized||Patients|Number|15|15.0||||||
3853985|NCT01640964|3679789|B1|< 65 years||Age, Customized||Patients|Number|17|17.0||||||
3853986|NCT01640951|3679806|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3853987|NCT01640951|3679807|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853988|NCT01640951|3679808|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3853989|NCT01640951|3679809|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3853990|NCT01640951|3679810|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3853991|NCT01640951|3679811|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3853992|NCT01640951|3679812|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3853993|NCT01640951|3679813|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853994|NCT01640951|3679814|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853995|NCT01640951|3679806|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853996|NCT01640951|3679807|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853997|NCT01640951|3679808|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853998|NCT01640951|3679809|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3853999|NCT01640951|3679810|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854000|NCT01640951|3679811|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854001|NCT01640951|3679812|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854002|NCT01640951|3679813|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854003|NCT01640951|3679814|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854004|NCT01640951|3679806|B9||White|Race (NIH/OMB)||Participants|Count of Participants|528|528.0||||||
3854005|NCT01640951|3679807|B8||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3854006|NCT01640951|3679808|B7||White|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3854007|NCT01640951|3679809|B6||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3854008|NCT01640951|3679810|B5||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3854009|NCT01640951|3679811|B4||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3854010|NCT01640951|3679812|B3||White|Race (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
3854011|NCT01640951|3679813|B2||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3854012|NCT01640951|3679814|B1||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3854013|NCT01640951|3679806|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3854014|NCT01640951|3679807|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854015|NCT01640951|3679808|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3854016|NCT01640951|3679809|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3854017|NCT01640951|3679810|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3854018|NCT01640951|3679811|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854019|NCT01640951|3679812|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3854020|NCT01640951|3679813|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3854021|NCT01640951|3679814|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3854022|NCT01640951|3679806|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3854023|NCT01640951|3679807|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854024|NCT01640951|3679808|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854025|NCT01640951|3679809|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3854026|NCT01640951|3679810|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854027|NCT01640951|3679811|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854028|NCT01640951|3679812|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854029|NCT01640951|3679813|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854030|NCT01640951|3679814|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854031|NCT01640951|3679806|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
3854032|NCT01640951|3679807|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3854033|NCT01640951|3679808|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3854034|NCT01640951|3679809|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3854035|NCT01640951|3679810|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3854036|NCT01640951|3679811|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3854037|NCT01640951|3679812|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3854038|NCT01640951|3679813|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3854039|NCT01640951|3679814|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3854040|NCT01640951|3679806|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3854041|NCT01640951|3679807|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854042|NCT01640951|3679808|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854043|NCT01640951|3679809|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854044|NCT01640951|3679810|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854045|NCT01640951|3679811|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854046|NCT01640951|3679812|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3854047|NCT01640951|3679813|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854048|NCT01640951|3679814|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854049|NCT01640951|3679806|B9||Male|Sex: Female, Male||Participants|Count of Participants|444|444.0||||||
3854050|NCT01640951|3679807|B8||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3854051|NCT01640951|3679808|B7||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3854052|NCT01640951|3679809|B6||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3854053|NCT01640951|3679810|B5||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3854054|NCT01640951|3679811|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3854055|NCT01640951|3679812|B3||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3854056|NCT01640951|3679813|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3854057|NCT01640951|3679814|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3854058|NCT01640951|3679806|B9||Female|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
3854059|NCT01640951|3679807|B8||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3854060|NCT01640951|3679808|B7||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3854061|NCT01640951|3679809|B6||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3854062|NCT01640951|3679810|B5||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3854063|NCT01640951|3679811|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3854064|NCT01640951|3679812|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3854065|NCT01640951|3679813|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3854066|NCT01640951|3679814|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3854067|NCT01640951|3679806|B9|||Age||Years|Mean|45.9|45.9|Standard Deviation|12.74|12.74|||
3854068|NCT01640951|3679807|B8|||Age||Years|Mean|46.5|46.5|Standard Deviation|13.99|13.99|||
3854069|NCT01640951|3679808|B7|||Age||Years|Mean|44.6|44.6|Standard Deviation|13.09|13.09|||
3854070|NCT01640951|3679809|B6|||Age||Years|Mean|45.2|45.2|Standard Deviation|12.08|12.08|||
3854071|NCT01640951|3679810|B5|||Age||Years|Mean|48.0|48.0|Standard Deviation|12.13|12.13|||
3854072|NCT01640951|3679811|B4|||Age||Years|Mean|42.7|42.7|Standard Deviation|12.23|12.23|||
3854073|NCT01640951|3679812|B3|||Age||Years|Mean|48.5|48.5|Standard Deviation|12.54|12.54|||
3854074|NCT01640951|3679813|B2|||Age||Years|Mean|46.0|46.0|Standard Deviation|12.03|12.03|||
3854075|NCT01640951|3679814|B1|||Age||Years|Mean|42.3|42.3|Standard Deviation|13.24|13.24|||
3854076|NCT01640925|3679921|B3||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3854077|NCT01640925|3679922|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3854078|NCT01640925|3679923|B1||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3854079|NCT01640925|3679921|B3||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3854080|NCT01640925|3679922|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3854081|NCT01640925|3679923|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3854082|NCT01640925|3679921|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|16.2|16.2|||
3854083|NCT01640925|3679922|B2|||Age||years|Mean|60.2|60.2|Standard Deviation|16.5|16.5|||
3854084|NCT01640925|3679923|B1|||Age||years|Mean|59.4|59.4|Standard Deviation|15.9|15.9|||
3854085|NCT01640873|3679936|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3854086|NCT01640873|3679937|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3854087|NCT01640873|3679938|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3854088|NCT01640873|3679936|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3854089|NCT01640873|3679937|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3854090|NCT01640873|3679938|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3854091|NCT01640873|3679936|B3|31 to 63 years||Age, Customized||Participants|Number|33|33.0||||||
3854092|NCT01640873|3679937|B2|31 to 63 years||Age, Customized||Participants|Number|11|11.0||||||
3854093|NCT01640873|3679938|B1|31 to 63 years||Age, Customized||Participants|Number|22|22.0||||||
3854094|NCT01640834|3679955|B4|Germany||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3854095|NCT01640834|3679956|B3|Germany||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3854096|NCT01640834|3679957|B2|Germany||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3854097|NCT01640834|3679958|B1|Germany||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3854098|NCT01640834|3679955|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3854099|NCT01640834|3679956|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3854100|NCT01640834|3679957|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3854101|NCT01640834|3679958|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3854102|NCT01640834|3679955|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3854103|NCT01640834|3679956|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3854104|NCT01640834|3679957|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3854105|NCT01640834|3679958|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3854106|NCT01640834|3679955|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3854107|NCT01640834|3679956|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3854108|NCT01640834|3679957|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3854109|NCT01640834|3679958|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3854110|NCT01640834|3679955|B4|||Age||years|Mean|43.0|43.0|Standard Deviation|10.3|10.3|||
3854111|NCT01640834|3679956|B3|||Age||years|Mean|43.3|43.3|Standard Deviation|10.6|10.6|||
3854112|NCT01640834|3679957|B2|||Age||years|Mean|47.1|47.1|Standard Deviation|5.7|5.7|||
3854113|NCT01640834|3679958|B1|||Age||years|Mean|38.6|38.6|Standard Deviation|12.8|12.8|||
3854114|NCT01640548|3679987|B1||Male|Gender||Participants|Count of Participants|85|85.0||||||
3854115|NCT01640548|3679987|B1||Female|Gender||Participants|Count of Participants|224|224.0||||||
3854116|NCT01640548|3679987|B1|||Age||years|Mean|61.8|61.8|Standard Deviation|11.99|11.99|||
3854117|NCT01640379|3680001|B3|||Positive Sexually Transmitted Infection Test (GC or CT)|Positive sexually transmitted infection test for gonorrhea (GC) or chlamydia (CT)|Participants|Count of Participants|25|25.0||||||
3854118|NCT01640379|3680002|B2|||Positive Sexually Transmitted Infection Test (GC or CT)|Positive sexually transmitted infection test for gonorrhea (GC) or chlamydia (CT)|Participants|Count of Participants|9|9.0||||||
3854119|NCT01640379|3680003|B1|||Positive Sexually Transmitted Infection Test (GC or CT)|Positive sexually transmitted infection test for gonorrhea (GC) or chlamydia (CT)|Participants|Count of Participants|16|16.0||||||
3854120|NCT01640379|3680001|B3|United States||Region of Enrollment||participants|Number|286|286.0||||||
3854121|NCT01640379|3680002|B2|United States||Region of Enrollment||participants|Number|137|137.0||||||
3854122|NCT01640379|3680003|B1|United States||Region of Enrollment||participants|Number|149|149.0||||||
3854123|NCT01640379|3680001|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3854124|NCT01640379|3680002|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3854125|NCT01640379|3680003|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3854126|NCT01640379|3680001|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3854127|NCT01640379|3680002|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3854128|NCT01640379|3680003|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3854129|NCT01640379|3680001|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3854130|NCT01640379|3680002|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3854131|NCT01640379|3680003|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3854132|NCT01640379|3680001|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|262|262.0||||||
3854133|NCT01640379|3680002|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
3854134|NCT01640379|3680003|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|136|136.0||||||
3854135|NCT01640379|3680001|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854136|NCT01640379|3680002|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854137|NCT01640379|3680003|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854138|NCT01640379|3680001|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854139|NCT01640379|3680002|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854140|NCT01640379|3680003|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854141|NCT01640379|3680001|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3854142|NCT01640379|3680002|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854143|NCT01640379|3680003|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3854144|NCT01640379|3680001|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3854145|NCT01640379|3680002|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3854146|NCT01640379|3680003|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3854147|NCT01640379|3680001|B3||Female|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
3854148|NCT01640379|3680002|B2||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3854149|NCT01640379|3680003|B1||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3854150|NCT01640379|3680001|B3|||Age||years|Mean|18.7|18.7|Standard Deviation|2.4|2.4|||
3854151|NCT01640379|3680002|B2|||Age||years|Mean|18.8|18.8|Standard Deviation|2.4|2.4|||
3854152|NCT01640379|3680003|B1|||Age||years|Mean|18.6|18.6|Standard Deviation|2.4|2.4|||
3854153|NCT01640353|3680012|B1|||Duration of prior pain||Years|Mean|5.1|5.1|Full Range|||0.43|41.08|
3854203|NCT01640314|3680058|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3854154|NCT01640353|3680012|B1|||SF-36 MCS|The Short Form 36 health survey (SF-36) is a 36-item patient reported health questionnaire to measure quality of life across 8 domains. The MCS is the Mental Component Summary score. 0% would represent the lowest or worst possible level of functioning while 100% would represent the highest / best possible level of functioning.|units on a scale|Mean|38.5|38.5|Standard Deviation|11.3|11.3|||
3854155|NCT01640353|3680012|B1|||Baseline SF-36 PCS|The Short Form 36 health survey (SF-36) is a 36-item patient reported health questionnaire to measure quality of life across 8 domains. The PCS is the Physical Component Summary score. 0% would represent the lowest or worst possible level of functioning while 100% would represent the highest / best possible level of functioning.|units on a scale|Mean|31.7|31.7|Standard Deviation|5.6|5.6|||
3854156|NCT01640353|3680012|B1|||Baseline EQ-5D|EuroQoL-5D (EQ-5D) is a standardized instrument to measure health state. It is a single index value for health status. A score of 0 would = worst imaginable health state while a score of 1.0 would be best imaginable health state.|units on a scale|Mean|.43|0.43|Standard Deviation|0.18|0.18|||
3854157|NCT01640353|3680012|B1|||Baseline ODI|Oswestry Disability Index is a validated measure of disability related to low back pain. There are 10 sections, each with a score between 0-5. If all sections are answered, the total possible score is 50/50 = 100% which is the worst disability possible on the scale. (0/50 = no disability at all.) If any section is skipped by the study participant, the total possible score for that section is removed from the denominator. Example - section 8 skipped, total possible score is 45/45 = 100%.|units on a scale|Mean|55.2|55.2|Standard Deviation|11.5|11.5|||
3854158|NCT01640353|3680012|B1|||Baseline SIJ pain|The Visual Analog Scale (VAS) is a 100 mm line on which the subjects mark their pain rating. 0= no pain and 100= worst pain imaginable.|units on a scale|Mean|79.8|79.8|Standard Deviation|12.8|12.8|||
3854159|NCT01640353|3680012|B1|United States||Region of Enrollment||participants|Number|172|172.0||||||
3854160|NCT01640353|3680012|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3854161|NCT01640353|3680012|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854162|NCT01640353|3680012|B1||White|Race (NIH/OMB)||Participants|Count of Participants|166|166.0||||||
3854163|NCT01640353|3680012|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3854164|NCT01640353|3680012|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3854165|NCT01640353|3680012|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854166|NCT01640353|3680012|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854167|NCT01640353|3680012|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854168|NCT01640353|3680012|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|165|165.0||||||
3854169|NCT01640353|3680012|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3854170|NCT01640353|3680012|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3854171|NCT01640353|3680012|B1||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3854172|NCT01640353|3680012|B1|||Age||Years|Mean|50.9|50.9|Full Range|||23.5|71.6|
3854173|NCT01640340|3680022|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3854174|NCT01640340|3680023|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3854175|NCT01640340|3680024|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3854176|NCT01640340|3680022|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3854177|NCT01640340|3680023|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3854178|NCT01640340|3680024|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3854179|NCT01640340|3680022|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3854180|NCT01640340|3680023|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3854181|NCT01640340|3680024|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3854182|NCT01640340|3680022|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3854183|NCT01640340|3680023|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3854184|NCT01640340|3680024|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3854185|NCT01640340|3680022|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3854186|NCT01640340|3680023|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3854187|NCT01640340|3680024|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3854188|NCT01640340|3680022|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3854189|NCT01640340|3680023|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3854190|NCT01640340|3680024|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3854191|NCT01640327|3680043|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3854192|NCT01640327|3680044|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3854193|NCT01640327|3680045|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3854194|NCT01640327|3680043|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3854195|NCT01640327|3680044|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3854196|NCT01640327|3680045|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3854197|NCT01640327|3680043|B3|||Age||Years|Mean|50.9|50.9|Standard Deviation|19.3|19.3|||
3854198|NCT01640327|3680044|B2|||Age||Years|Mean|68.3|68.3|Standard Deviation|5.1|5.1|||
3854199|NCT01640327|3680045|B1|||Age||Years|Mean|33.5|33.5|Standard Deviation|10.6|10.6|||
3854200|NCT01640314|3680058|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3854201|NCT01640314|3680059|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3854202|NCT01640314|3680060|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3854204|NCT01640314|3680059|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3854205|NCT01640314|3680060|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3854206|NCT01640314|3680058|B3|||Age||years|Mean|52.7|52.7|Standard Deviation|17.7|17.7|||
3854207|NCT01640314|3680059|B2|||Age||years|Mean|68.0|68.0|Standard Deviation|4.7|4.7|||
3854208|NCT01640314|3680060|B1|||Age||years|Mean|37.4|37.4|Standard Deviation|11.4|11.4|||
3854209|NCT01640197|3680075|B3|United Kingdom||Region of Enrollment||participants|Number|60|60.0||||||
3854210|NCT01640197|3680076|B2|United Kingdom||Region of Enrollment||participants|Number|30|30.0||||||
3854211|NCT01640197|3680077|B1|United Kingdom||Region of Enrollment||participants|Number|30|30.0||||||
3854212|NCT01640197|3680075|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3854213|NCT01640197|3680076|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3854214|NCT01640197|3680077|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3854215|NCT01640197|3680075|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3854216|NCT01640197|3680076|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3854217|NCT01640197|3680077|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3854218|NCT01640197|3680075|B3|||Age||years|Mean|20.52|20.52|Standard Deviation|2.17|2.17|||
3854219|NCT01640197|3680076|B2|||Age||years|Mean|20.00|20.0|Standard Deviation|2.32|2.32|||
3854220|NCT01640197|3680077|B1|||Age||years|Mean|21.04|21.04|Standard Deviation|2.01|2.01|||
3854221|NCT01640197|3680075|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3854222|NCT01640197|3680076|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3854223|NCT01640197|3680077|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3854224|NCT01640197|3680075|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3854225|NCT01640197|3680076|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3854226|NCT01640197|3680077|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3854227|NCT01640197|3680075|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3854228|NCT01640197|3680076|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3854229|NCT01640197|3680077|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3854230|NCT01640184|3680096|B4|||BALP-baseline|Blood level of Bone-alkaline phosphatase (BALP) on baseline.|microgram/L|Mean|17.98|17.98|Standard Deviation|13.32|13.32|||
3854231|NCT01640184|3680097|B3|||BALP-baseline|Blood level of Bone-alkaline phosphatase (BALP) on baseline.|microgram/L|Mean|19.27|19.27|Standard Deviation|14.87|14.87|||
3854232|NCT01640184|3680098|B2|||BALP-baseline|Blood level of Bone-alkaline phosphatase (BALP) on baseline.|microgram/L|Mean|18.84|18.84|Standard Deviation|17.94|17.94|||
3854233|NCT01640184|3680099|B1|||BALP-baseline|Blood level of Bone-alkaline phosphatase (BALP) on baseline.|microgram/L|Mean|17.31|17.31|Standard Deviation|6.38|6.38|||
3854234|NCT01640184|3680096|B4|||iPTH-baseline|Blood level of intact parathyroid hormone on baseline.|ng/ml|Mean|1201.8|1201.8|Standard Deviation|498.7|498.7|||
3854235|NCT01640184|3680097|B3|||iPTH-baseline|Blood level of intact parathyroid hormone on baseline.|ng/ml|Mean|1779.9|1779.9|Standard Deviation|514.1|514.1|||
3854236|NCT01640184|3680098|B2|||iPTH-baseline|Blood level of intact parathyroid hormone on baseline.|ng/ml|Mean|1550.6|1550.6|Standard Deviation|521.7|521.7|||
3854237|NCT01640184|3680099|B1|||iPTH-baseline|Blood level of intact parathyroid hormone on baseline.|ng/ml|Mean|239.84|239.84|Standard Deviation|299.01|299.01|||
3854238|NCT01640184|3680096|B4|||P-baseline|Blood level of phosphorus on baseline.|mmol/L|Mean|2.10|2.1|Standard Deviation|0.51|0.51|||
3854239|NCT01640184|3680097|B3|||P-baseline|Blood level of phosphorus on baseline.|mmol/L|Mean|2.12|2.12|Standard Deviation|0.45|0.45|||
3854240|NCT01640184|3680098|B2|||P-baseline|Blood level of phosphorus on baseline.|mmol/L|Mean|2.14|2.14|Standard Deviation|0.66|0.66|||
3854241|NCT01640184|3680099|B1|||P-baseline|Blood level of phosphorus on baseline.|mmol/L|Mean|1.95|1.95|Standard Deviation|0.49|0.49|||
3854242|NCT01640184|3680096|B4|||Ca-baseline|Blood level of Calcium on baseline.|mmol/L|Mean|2.41|2.41|Standard Deviation|0.30|0.3|||
3854243|NCT01640184|3680097|B3|||Ca-baseline|Blood level of Calcium on baseline.|mmol/L|Mean|2.53|2.53|Standard Deviation|0.23|0.23|||
3854244|NCT01640184|3680098|B2|||Ca-baseline|Blood level of Calcium on baseline.|mmol/L|Mean|2.43|2.43|Standard Deviation|0.30|0.3|||
3854245|NCT01640184|3680099|B1|||Ca-baseline|Blood level of Calcium on baseline.|mmol/L|Mean|2.31|2.31|Standard Deviation|0.27|0.27|||
3854246|NCT01640184|3680096|B4|China||Region of Enrollment||participants|Number|79|79.0||||||
3854247|NCT01640184|3680097|B3|China||Region of Enrollment||participants|Number|22|22.0||||||
3854248|NCT01640184|3680098|B2|China||Region of Enrollment||participants|Number|23|23.0||||||
3854249|NCT01640184|3680099|B1|China||Region of Enrollment||participants|Number|34|34.0||||||
3854250|NCT01640184|3680096|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854251|NCT01640184|3680097|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854252|NCT01640184|3680098|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854253|NCT01640184|3680099|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854254|NCT01640184|3680096|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854255|NCT01640184|3680097|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854256|NCT01640184|3680098|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854257|NCT01640184|3680099|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854258|NCT01640184|3680096|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854259|NCT01640184|3680097|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854260|NCT01640184|3680098|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854261|NCT01640184|3680099|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854262|NCT01640184|3680096|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854263|NCT01640184|3680097|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854264|NCT01640184|3680098|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854265|NCT01640184|3680099|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854266|NCT01640184|3680096|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854267|NCT01640184|3680097|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854268|NCT01640184|3680098|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854269|NCT01640184|3680099|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854270|NCT01640184|3680096|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3854271|NCT01640184|3680097|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3854272|NCT01640184|3680098|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3854273|NCT01640184|3680099|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3854274|NCT01640184|3680096|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854275|NCT01640184|3680097|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854276|NCT01640184|3680098|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854277|NCT01640184|3680099|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854278|NCT01640184|3680096|B4||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3854279|NCT01640184|3680097|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3854280|NCT01640184|3680098|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3854281|NCT01640184|3680099|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3854282|NCT01640184|3680096|B4||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3854283|NCT01640184|3680097|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3854284|NCT01640184|3680098|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3854285|NCT01640184|3680099|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3854286|NCT01640184|3680096|B4|||Age||years|Mean|55.3|55.3|Full Range|||20.0|74.0|
3854287|NCT01640184|3680097|B3|||Age||years|Mean|55.2|55.2|Full Range|||26.0|69.0|
3854288|NCT01640184|3680098|B2|||Age||years|Mean|52.0|52.0|Full Range|||24.0|73.0|
3854289|NCT01640184|3680099|B1|||Age||years|Mean|56.3|56.3|Full Range|||20.0|74.0|
3854290|NCT01640171|3680123|B1|United States||Region of Enrollment||participants|Number|57|57.0||||||
3854291|NCT01640171|3680123|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3854292|NCT01640171|3680123|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3854293|NCT01640171|3680123|B1|||Age||years|Mean|82|82.0|Standard Deviation|11|11.0|||
3854294|NCT01640054|3680130|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3854295|NCT01640054|3680130|B1|Indian or Pakistani||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3854296|NCT01640054|3680130|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3854297|NCT01640054|3680130|B1|Asian||Race/Ethnicity, Customized||Participants|Number|115|115.0||||||
3854298|NCT01640054|3680130|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3854299|NCT01640054|3680130|B1|White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3854300|NCT01640054|3680130|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3854301|NCT01640054|3680130|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3854302|NCT01640054|3680130|B1|||Age||years|Mean|53|53.0|Standard Deviation|11.3|11.3|||
3854303|NCT01639833|3680138|B3|||Weight||kilograms|Mean|81.82|81.82|Standard Deviation|15.75|15.75|||
3854304|NCT01639833|3680139|B2|||Weight||kilograms|Mean|81.96|81.96|Standard Deviation|17.27|17.27|||
3854305|NCT01639833|3680140|B1|||Weight||kilograms|Mean|81.67|81.67|Standard Deviation|14.27|14.27|||
3854306|NCT01639833|3680138|B3|||Height||centimeters|Mean|171.1|171.1|Standard Deviation|9.7|9.7|||
3854307|NCT01639833|3680139|B2|||Height||centimeters|Mean|170.8|170.8|Standard Deviation|10.4|10.4|||
3854308|NCT01639833|3680140|B1|||Height||centimeters|Mean|171.3|171.3|Standard Deviation|9.1|9.1|||
3854309|NCT01639833|3680138|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854310|NCT01639833|3680139|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854311|NCT01639833|3680140|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854312|NCT01639833|3680138|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
3854313|NCT01639833|3680139|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3854314|NCT01639833|3680140|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3854315|NCT01639833|3680138|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3854316|NCT01639833|3680139|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854317|NCT01639833|3680140|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3854318|NCT01639833|3680138|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854319|NCT01639833|3680139|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854320|NCT01639833|3680140|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854321|NCT01639833|3680138|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854322|NCT01639833|3680139|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854323|NCT01639833|3680140|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854324|NCT01639833|3680138|B3||White|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
3854325|NCT01639833|3680139|B2||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3854326|NCT01639833|3680140|B1||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3854327|NCT01639833|3680138|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854328|NCT01639833|3680139|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854329|NCT01639833|3680140|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854330|NCT01639833|3680138|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854331|NCT01639833|3680139|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854332|NCT01639833|3680140|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854333|NCT01639833|3680138|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3854334|NCT01639833|3680139|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3854335|NCT01639833|3680140|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854336|NCT01639833|3680138|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854337|NCT01639833|3680139|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854338|NCT01639833|3680140|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854339|NCT01639833|3680138|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3854340|NCT01639833|3680139|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3854341|NCT01639833|3680140|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3854342|NCT01639833|3680138|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3854343|NCT01639833|3680139|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3854344|NCT01639833|3680140|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3854345|NCT01639833|3680138|B3|||Age||years|Mean|67.6|67.6|Standard Deviation|12.7|12.7|||
3854346|NCT01639833|3680139|B2|||Age||years|Mean|66.7|66.7|Standard Deviation|13.4|13.4|||
3854347|NCT01639833|3680140|B1|||Age||years|Mean|68.5|68.5|Standard Deviation|12.2|12.2|||
3854348|NCT01639755|3680149|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3854349|NCT01639755|3680149|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3854350|NCT01639755|3680149|B1|||Age||years|Mean|29.3|29.3|Standard Deviation|9.57|9.57|||
3854351|NCT01639742|3680157|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3854352|NCT01639742|3680157|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3854353|NCT01639742|3680157|B1|||Age||years|Mean|31.9|31.9|Standard Deviation|8.89|8.89|||
3854354|NCT01639729|3680165|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3854355|NCT01639729|3680165|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3854356|NCT01639729|3680165|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3854357|NCT01639729|3680165|B1|||Age||years|Mean|29.8|29.8|Standard Deviation|7.7|7.7|||
3854358|NCT01639729|3680165|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3854359|NCT01639729|3680165|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3854360|NCT01639729|3680165|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3854361|NCT01639703|3680192|B1|Class C||Severity of cirrhosis (Child-Pugh score)|"Child-Pugh classification of severity of liver disease is evaluated according to the degree of ascites, the plasma concentrations of bilirubin and albumin, the prothrombin time, and the degree of encephalopathy.~Class A: well compensated disease~Class B: significant functional compromised~Class C: decompensated disease~For 7 patients, this score was missing."|Participants|Count of Participants|2|2.0||||||
3854362|NCT01639703|3680192|B1|Class B||Severity of cirrhosis (Child-Pugh score)|"Child-Pugh classification of severity of liver disease is evaluated according to the degree of ascites, the plasma concentrations of bilirubin and albumin, the prothrombin time, and the degree of encephalopathy.~Class A: well compensated disease~Class B: significant functional compromised~Class C: decompensated disease~For 7 patients, this score was missing."|Participants|Count of Participants|8|8.0||||||
3854363|NCT01639703|3680192|B1|Class A||Severity of cirrhosis (Child-Pugh score)|"Child-Pugh classification of severity of liver disease is evaluated according to the degree of ascites, the plasma concentrations of bilirubin and albumin, the prothrombin time, and the degree of encephalopathy.~Class A: well compensated disease~Class B: significant functional compromised~Class C: decompensated disease~For 7 patients, this score was missing."|Participants|Count of Participants|79|79.0||||||
3854364|NCT01639703|3680192|B1|Germany||Region of Enrollment||participants|Number|2|2.0||||||
3854365|NCT01639703|3680192|B1|Switzerland||Region of Enrollment||participants|Number|6|6.0||||||
3854366|NCT01639703|3680192|B1|Korea, Republic of||Region of Enrollment||participants|Number|85|85.0||||||
3854367|NCT01639703|3680192|B1|Austria||Region of Enrollment||participants|Number|3|3.0||||||
3854368|NCT01639703|3680192|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3854369|NCT01639703|3680192|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3854370|NCT01639703|3680192|B1|||Age||years|Mean|56.2|56.2|Standard Deviation|11.2|11.2|||
3854371|NCT01639560|3680233|B3|||Baseline smoking rate (cigarettes per day)||cigarettes per day|Mean|7.7|7.7|Standard Deviation|1.5|1.5|||
3854372|NCT01639560|3680234|B2|||Baseline smoking rate (cigarettes per day)||cigarettes per day|Mean|7.5|7.5|Standard Deviation|1.5|1.5|||
3854373|NCT01639560|3680235|B1|||Baseline smoking rate (cigarettes per day)||cigarettes per day|Mean|7.9|7.9|Standard Deviation|1.5|1.5|||
3854374|NCT01639560|3680233|B3|United States||Region of Enrollment||participants|Number|93|93.0||||||
3854375|NCT01639560|3680234|B2|United States||Region of Enrollment||participants|Number|48|48.0||||||
3854376|NCT01639560|3680235|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
3854377|NCT01639560|3680233|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854378|NCT01639560|3680234|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854379|NCT01639560|3680235|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854380|NCT01639560|3680233|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3854381|NCT01639560|3680234|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854382|NCT01639560|3680235|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3854383|NCT01639560|3680233|B3||White|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3854384|NCT01639560|3680234|B2||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3854385|NCT01639560|3680235|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3854386|NCT01639560|3680233|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3854387|NCT01639560|3680234|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854388|NCT01639560|3680235|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3854389|NCT01639560|3680233|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3854390|NCT01639560|3680234|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854391|NCT01639560|3680235|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3854392|NCT01639560|3680233|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3854393|NCT01639560|3680234|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854394|NCT01639560|3680235|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3854395|NCT01639560|3680233|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3854396|NCT01639560|3680234|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854397|NCT01639560|3680235|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3854398|NCT01639560|3680233|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854399|NCT01639560|3680234|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854400|NCT01639560|3680235|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854401|NCT01639560|3680233|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
3854402|NCT01639560|3680234|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3854403|NCT01639560|3680235|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3854404|NCT01639560|3680233|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3854405|NCT01639560|3680234|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3854406|NCT01639560|3680235|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854407|NCT01639560|3680233|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3854408|NCT01639560|3680234|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3854409|NCT01639560|3680235|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3854410|NCT01639560|3680233|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3854411|NCT01639560|3680234|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3854412|NCT01639560|3680235|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3854413|NCT01639560|3680233|B3|||Age||years|Mean|37.2|37.2|Standard Deviation|11.4|11.4|||
3854414|NCT01639560|3680234|B2|||Age||years|Mean|37.2|37.2|Standard Deviation|11.3|11.3|||
3854415|NCT01639560|3680235|B1|||Age||years|Mean|37.1|37.1|Standard Deviation|11.7|11.7|||
3854416|NCT01639560|3680233|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3854417|NCT01639560|3680234|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3854418|NCT01639560|3680235|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3854419|NCT01639560|3680233|B3||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
3854420|NCT01639560|3680234|B2||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3854421|NCT01639560|3680235|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3854422|NCT01639560|3680233|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3854423|NCT01639560|3680234|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3854424|NCT01639560|3680235|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3854482|NCT01639443|3680265|B3||Male|Sex: Female, Male||Participants|Count of Participants|4817|4817.0||||||
3854425|NCT01639495|3680248|B1|United States||Region of Enrollment||Participants|Count of Participants|148|148.0||||||
3854426|NCT01639495|3680248|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854427|NCT01639495|3680248|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854428|NCT01639495|3680248|B1||White|Race (NIH/OMB)||Participants|Count of Participants|147|147.0||||||
3854429|NCT01639495|3680248|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3854430|NCT01639495|3680248|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854431|NCT01639495|3680248|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854432|NCT01639495|3680248|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854433|NCT01639495|3680248|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854434|NCT01639495|3680248|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
3854435|NCT01639495|3680248|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3854436|NCT01639495|3680248|B1||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3854437|NCT01639495|3680248|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3854438|NCT01639495|3680248|B1|||Age||years|Mean|61.1|61.1|Standard Deviation|10.36|10.36|||
3854439|NCT01639469|3680256|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3854440|NCT01639469|3680256|B3||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3854441|NCT01639469|3680257|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3854442|NCT01639469|3680258|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3854443|NCT01639469|3680256|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3854444|NCT01639469|3680257|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3854445|NCT01639469|3680258|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3854446|NCT01639469|3680256|B3|||Age||years|Mean|72.1|72.1|Standard Deviation|9.6|9.6|||
3854447|NCT01639469|3680257|B2|||Age||years|Mean|72.7|72.7|Standard Deviation|9.8|9.8|||
3854448|NCT01639469|3680258|B1|||Age||years|Mean|71.5|71.5|Standard Deviation|9.4|9.4|||
3854449|NCT01639443|3680265|B3|United States||Region of Enrollment||participants|Number|5035|5035.0||||||
3854450|NCT01639443|3680266|B2|United States||Region of Enrollment||participants|Number|4855|4855.0||||||
3854451|NCT01639443|3680267|B1|United States||Region of Enrollment||participants|Number|180|180.0||||||
3854452|NCT01639443|3680265|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|660|660.0||||||
3854453|NCT01639443|3680266|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|644|644.0||||||
3854454|NCT01639443|3680267|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3854455|NCT01639443|3680265|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3854456|NCT01639443|3680266|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3854457|NCT01639443|3680267|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3854458|NCT01639443|3680265|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2497|2497.0||||||
3854459|NCT01639443|3680266|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2414|2414.0||||||
3854460|NCT01639443|3680267|B1||White|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3854461|NCT01639443|3680265|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1654|1654.0||||||
3854462|NCT01639443|3680266|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1584|1584.0||||||
3854463|NCT01639443|3680267|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3854464|NCT01639443|3680265|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3854465|NCT01639443|3680266|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3854466|NCT01639443|3680267|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3854467|NCT01639443|3680265|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|114|114.0||||||
3854468|NCT01639443|3680266|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|109|109.0||||||
3854469|NCT01639443|3680267|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3854470|NCT01639443|3680265|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3854471|NCT01639443|3680266|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3854472|NCT01639443|3680267|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3854473|NCT01639443|3680265|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854474|NCT01639443|3680266|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854475|NCT01639443|3680267|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854476|NCT01639443|3680265|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4453|4453.0||||||
3854477|NCT01639443|3680266|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4290|4290.0||||||
3854478|NCT01639443|3680267|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|163|163.0||||||
3854479|NCT01639443|3680265|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|582|582.0||||||
3854480|NCT01639443|3680266|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|565|565.0||||||
3854481|NCT01639443|3680267|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3854483|NCT01639443|3680266|B2||Male|Sex: Female, Male||Participants|Count of Participants|4649|4649.0||||||
3854484|NCT01639443|3680267|B1||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3854485|NCT01639443|3680265|B3||Female|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
3854486|NCT01639443|3680266|B2||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
3854487|NCT01639443|3680267|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3854488|NCT01639443|3680265|B3|||Age||years|Mean|62.1|62.1|Standard Deviation|10.1|10.1|||
3854489|NCT01639443|3680266|B2|||Age||years|Mean|62.2|62.2|Standard Deviation|10.0|10.0|||
3854490|NCT01639443|3680267|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|13.6|13.6|||
3854491|NCT01639443|3680265|B3||>=65 years|Age||Participants|Count of Participants|2111|2111.0||||||
3854492|NCT01639443|3680266|B2||>=65 years|Age||Participants|Count of Participants|2043|2043.0||||||
3854493|NCT01639443|3680267|B1||>=65 years|Age||Participants|Count of Participants|68|68.0||||||
3854494|NCT01639443|3680265|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2924|2924.0||||||
3854495|NCT01639443|3680266|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2812|2812.0||||||
3854496|NCT01639443|3680267|B1||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
3854497|NCT01639443|3680265|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3854498|NCT01639443|3680266|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3854499|NCT01639443|3680267|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3854500|NCT01639352|3680284|B1||BCLC Stage D|BCLC Staging|"Barcelona Clinic Liver Cancer (BCLC) staging classifies hepatocellular carcinoma (HCC) into five stages, based on the extent of study disease, Child-Pugh score, and ECOG performance status as follows:~Stage 0 (Very early stage)~Stage A (Early stage)~Stage B (Intermediate Stage)~Stage C (Advanced Stage)~Stage D (Terminal Stage)"|Participants|Count of Participants|0|0.0||||||
3854501|NCT01639352|3680284|B1||BCLC Stage C|BCLC Staging|"Barcelona Clinic Liver Cancer (BCLC) staging classifies hepatocellular carcinoma (HCC) into five stages, based on the extent of study disease, Child-Pugh score, and ECOG performance status as follows:~Stage 0 (Very early stage)~Stage A (Early stage)~Stage B (Intermediate Stage)~Stage C (Advanced Stage)~Stage D (Terminal Stage)"|Participants|Count of Participants|15|15.0||||||
3854502|NCT01639352|3680284|B1||BCLC Stage B|BCLC Staging|"Barcelona Clinic Liver Cancer (BCLC) staging classifies hepatocellular carcinoma (HCC) into five stages, based on the extent of study disease, Child-Pugh score, and ECOG performance status as follows:~Stage 0 (Very early stage)~Stage A (Early stage)~Stage B (Intermediate Stage)~Stage C (Advanced Stage)~Stage D (Terminal Stage)"|Participants|Count of Participants|5|5.0||||||
3854503|NCT01639352|3680284|B1||BCLC Stage A|BCLC Staging|"Barcelona Clinic Liver Cancer (BCLC) staging classifies hepatocellular carcinoma (HCC) into five stages, based on the extent of study disease, Child-Pugh score, and ECOG performance status as follows:~Stage 0 (Very early stage)~Stage A (Early stage)~Stage B (Intermediate Stage)~Stage C (Advanced Stage)~Stage D (Terminal Stage)"|Participants|Count of Participants|0|0.0||||||
3854504|NCT01639352|3680284|B1||BCLC Stage 0|BCLC Staging|"Barcelona Clinic Liver Cancer (BCLC) staging classifies hepatocellular carcinoma (HCC) into five stages, based on the extent of study disease, Child-Pugh score, and ECOG performance status as follows:~Stage 0 (Very early stage)~Stage A (Early stage)~Stage B (Intermediate Stage)~Stage C (Advanced Stage)~Stage D (Terminal Stage)"|Participants|Count of Participants|0|0.0||||||
3854505|NCT01639352|3680284|B1|Sorafenib||Prior Therapies|The types of therapies study participants received for the study disease prior to study enrollment. Participants may have had multiple therapies.|Participants|Count of Participants|14|14.0||||||
3854506|NCT01639352|3680284|B1|Cryoablation||Prior Therapies|The types of therapies study participants received for the study disease prior to study enrollment. Participants may have had multiple therapies.|Participants|Count of Participants|1|1.0||||||
3854507|NCT01639352|3680284|B1|Ytrium 90||Prior Therapies|The types of therapies study participants received for the study disease prior to study enrollment. Participants may have had multiple therapies.|Participants|Count of Participants|2|2.0||||||
3854508|NCT01639352|3680284|B1|Ablation||Prior Therapies|The types of therapies study participants received for the study disease prior to study enrollment. Participants may have had multiple therapies.|Participants|Count of Participants|6|6.0||||||
3854509|NCT01639352|3680284|B1|Chemotherapy||Prior Therapies|The types of therapies study participants received for the study disease prior to study enrollment. Participants may have had multiple therapies.|Participants|Count of Participants|2|2.0||||||
3854510|NCT01639352|3680284|B1|Transarterial chemoembolization (TACE)||Prior Therapies|The types of therapies study participants received for the study disease prior to study enrollment. Participants may have had multiple therapies.|Participants|Count of Participants|12|12.0||||||
3854511|NCT01639352|3680284|B1|No prior therapy||Prior Therapies|The types of therapies study participants received for the study disease prior to study enrollment. Participants may have had multiple therapies.|Participants|Count of Participants|2|2.0||||||
3854512|NCT01639352|3680284|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3854513|NCT01639352|3680284|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3854514|NCT01639352|3680284|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3854515|NCT01639352|3680284|B1|||Age||years|Median|65|65.0|Full Range|||52.0|81.0|
3854516|NCT01639352|3680284|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3854517|NCT01639352|3680284|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3854518|NCT01639352|3680284|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3854519|NCT01639222|3680293|B1|||Creatinine Clearance||mL/min/1.73 m²|Mean|86.60|86.6|Standard Deviation|14.85|14.85|||
3854520|NCT01639222|3680293|B1|||Body Mass Index (BMI)||kg/m²|Mean|25.87|25.87|Standard Deviation|2.33|2.33|||
3854521|NCT01639222|3680293|B1|||Weight||kg|Mean|77.28|77.28|Standard Deviation|10.06|10.06|||
3854522|NCT01639222|3680293|B1|||Height||cm|Mean|172.71|172.71|Standard Deviation|8.97|8.97|||
3854523|NCT01639222|3680293|B1|Germany||Region of Enrollment||Participants|Number|55|55.0||||||
3854524|NCT01639222|3680293|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3854525|NCT01639222|3680293|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3854526|NCT01639222|3680293|B1|||Age||Years|Mean|57.07|57.07|Standard Deviation|7.01|7.01|||
3854527|NCT01639157|3680303|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3854528|NCT01639157|3680303|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3854529|NCT01639157|3680303|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3854530|NCT01639157|3680303|B1|||Age||years|Mean|39.4|39.4|Full Range|||26.0|48.0|
3854531|NCT01639144|3680362|B3|No known risk factors for healing||Diabetes, rheumatoid arthritis, smoking = risk factors for healing||participants|Number|418|418.0||||||
3854532|NCT01639144|3680363|B2|No known risk factors for healing||Diabetes, rheumatoid arthritis, smoking = risk factors for healing||participants|Number|208|208.0||||||
3854533|NCT01639144|3680364|B1|No known risk factors for healing||Diabetes, rheumatoid arthritis, smoking = risk factors for healing||participants|Number|210|210.0||||||
3854534|NCT01639144|3680362|B3|Diabetes, rheumatoid arthritis, smoking||Diabetes, rheumatoid arthritis, smoking = risk factors for healing||participants|Number|82|82.0||||||
3854535|NCT01639144|3680363|B2|Diabetes, rheumatoid arthritis, smoking||Diabetes, rheumatoid arthritis, smoking = risk factors for healing||participants|Number|42|42.0||||||
3854536|NCT01639144|3680364|B1|Diabetes, rheumatoid arthritis, smoking||Diabetes, rheumatoid arthritis, smoking = risk factors for healing||participants|Number|40|40.0||||||
3854537|NCT01639144|3680362|B3|United States||Region of Enrollment||participants|Number|500|500.0||||||
3854538|NCT01639144|3680363|B2|United States||Region of Enrollment||participants|Number|250|250.0||||||
3854539|NCT01639144|3680364|B1|United States||Region of Enrollment||participants|Number|250|250.0||||||
3854540|NCT01639144|3680362|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|500|500.0||||||
3854541|NCT01639144|3680363|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|250|250.0||||||
3854542|NCT01639144|3680364|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|250|250.0||||||
3854543|NCT01639144|3680362|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854544|NCT01639144|3680363|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854545|NCT01639144|3680364|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854546|NCT01639144|3680362|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854547|NCT01639144|3680363|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854548|NCT01639144|3680364|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854549|NCT01639144|3680362|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854550|NCT01639144|3680363|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854551|NCT01639144|3680364|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854552|NCT01639144|3680362|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854553|NCT01639144|3680363|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854554|NCT01639144|3680364|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854555|NCT01639144|3680362|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854556|NCT01639144|3680363|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854557|NCT01639144|3680364|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854558|NCT01639144|3680362|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854559|NCT01639144|3680363|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854560|NCT01639144|3680364|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854561|NCT01639144|3680362|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|500|500.0||||||
3854562|NCT01639144|3680363|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|250|250.0||||||
3854563|NCT01639144|3680364|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|250|250.0||||||
3854564|NCT01639144|3680362|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854565|NCT01639144|3680363|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854566|NCT01639144|3680364|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854567|NCT01639144|3680362|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854568|NCT01639144|3680363|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854569|NCT01639144|3680364|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854570|NCT01639144|3680362|B3||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
3854571|NCT01639144|3680363|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3854572|NCT01639144|3680364|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3854573|NCT01639144|3680362|B3||Female|Sex: Female, Male||Participants|Count of Participants|324|324.0||||||
3854574|NCT01639144|3680363|B2||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3854575|NCT01639144|3680364|B1||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3854576|NCT01639144|3680362|B3||>=65 years|Age||Participants|Count of Participants|136|136.0||||||
3854577|NCT01639144|3680363|B2||>=65 years|Age||Participants|Count of Participants|68|68.0||||||
3854578|NCT01639144|3680364|B1||>=65 years|Age||Participants|Count of Participants|68|68.0||||||
3854579|NCT01639144|3680362|B3||Between 18 and 65 years|Age||Participants|Count of Participants|364|364.0||||||
3854580|NCT01639144|3680363|B2||Between 18 and 65 years|Age||Participants|Count of Participants|182|182.0||||||
3854581|NCT01639144|3680364|B1||Between 18 and 65 years|Age||Participants|Count of Participants|182|182.0||||||
3854582|NCT01639144|3680362|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3854583|NCT01639144|3680363|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3854584|NCT01639144|3680364|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3854585|NCT01639040|3680371|B3|||Pruritus Numerical Rating Scale (NRS) score|Pruritus NRS was an assessment tool that was used to report intensity of subject’s pruritus (itch), both maximum and average intensity during a 24-hour recall period. Participants were asked following question: how would a subject rate his itch at worst moment during previous 24 hours (for maximum itch intensity on a scale of 0–10 [0 = no itch; 10 = worst itch imaginable]).|units on a scale|Mean|6.0|6.0|Standard Deviation|1.93|1.93|||
3854586|NCT01639040|3680372|B2|||Pruritus Numerical Rating Scale (NRS) score|Pruritus NRS was an assessment tool that was used to report intensity of subject’s pruritus (itch), both maximum and average intensity during a 24-hour recall period. Participants were asked following question: how would a subject rate his itch at worst moment during previous 24 hours (for maximum itch intensity on a scale of 0–10 [0 = no itch; 10 = worst itch imaginable]).|units on a scale|Mean|6.4|6.4|Standard Deviation|2.00|2.0|||
3854587|NCT01639040|3680373|B1|||Pruritus Numerical Rating Scale (NRS) score|Pruritus NRS was an assessment tool that was used to report intensity of subject’s pruritus (itch), both maximum and average intensity during a 24-hour recall period. Participants were asked following question: how would a subject rate his itch at worst moment during previous 24 hours (for maximum itch intensity on a scale of 0–10 [0 = no itch; 10 = worst itch imaginable]).|units on a scale|Mean|5.0|5.0|Standard Deviation|1.39|1.39|||
3854588|NCT01639040|3680371|B3|||Investigator's Global Assessment (IGA) Score|IGA was an assessment scale used to determine severity of AD and clinical response to treatment on a 6-point scale (0 = clear; 1 = almost clear; 2 = mild; 3 = moderate; 4 = severe; and 5 = very severe disease) based on erythema and papulation/infiltration. Therapeutic response was an IGA score of 0 (clear) or 1 (almost clear).|units on a scale|Mean|3.4|3.4|Standard Deviation|0.55|0.55|||
3854589|NCT01639040|3680372|B2|||Investigator's Global Assessment (IGA) Score|IGA was an assessment scale used to determine severity of AD and clinical response to treatment on a 6-point scale (0 = clear; 1 = almost clear; 2 = mild; 3 = moderate; 4 = severe; and 5 = very severe disease) based on erythema and papulation/infiltration. Therapeutic response was an IGA score of 0 (clear) or 1 (almost clear).|units on a scale|Mean|3.4|3.4|Standard Deviation|0.60|0.6|||
3854590|NCT01639040|3680373|B1|||Investigator's Global Assessment (IGA) Score|IGA was an assessment scale used to determine severity of AD and clinical response to treatment on a 6-point scale (0 = clear; 1 = almost clear; 2 = mild; 3 = moderate; 4 = severe; and 5 = very severe disease) based on erythema and papulation/infiltration. Therapeutic response was an IGA score of 0 (clear) or 1 (almost clear).|units on a scale|Mean|3.4|3.4|Standard Deviation|0.47|0.47|||
3854591|NCT01639040|3680371|B3|||Eczema Area and Severity Index (EASI) Score|The EASI score was used to measure the severity and extent of atopic dermatitis (AD) and measures erythema, infiltration, excoriation and lichenification on 4 anatomic regions of the body: head, trunk, upper and lower extremities. The total EASI score range from 0 (minimum) to 72 (maximum) points, with the higher scores reflecting the worse severity of AD.|units on a scale|Mean|23.4|23.4|Standard Deviation|12.26|12.26|||
3854592|NCT01639040|3680372|B2|||Eczema Area and Severity Index (EASI) Score|The EASI score was used to measure the severity and extent of atopic dermatitis (AD) and measures erythema, infiltration, excoriation and lichenification on 4 anatomic regions of the body: head, trunk, upper and lower extremities. The total EASI score range from 0 (minimum) to 72 (maximum) points, with the higher scores reflecting the worse severity of AD.|units on a scale|Mean|23.1|23.1|Standard Deviation|12.35|12.35|||
3854593|NCT01639040|3680373|B1|||Eczema Area and Severity Index (EASI) Score|The EASI score was used to measure the severity and extent of atopic dermatitis (AD) and measures erythema, infiltration, excoriation and lichenification on 4 anatomic regions of the body: head, trunk, upper and lower extremities. The total EASI score range from 0 (minimum) to 72 (maximum) points, with the higher scores reflecting the worse severity of AD.|units on a scale|Mean|24.1|24.1|Standard Deviation|12.70|12.7|||
3854594|NCT01639040|3680371|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3854595|NCT01639040|3680372|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3854596|NCT01639040|3680373|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3854597|NCT01639040|3680371|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3854598|NCT01639040|3680372|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3854599|NCT01639040|3680373|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3854600|NCT01639040|3680371|B3|||Age||years|Mean|36.6|36.6|Standard Deviation|13.01|13.01|||
3854601|NCT01639040|3680372|B2|||Age||years|Mean|36.0|36.0|Standard Deviation|11.26|11.26|||
3854602|NCT01639040|3680373|B1|||Age||years|Mean|37.8|37.8|Standard Deviation|16.73|16.73|||
3854603|NCT01639001|3680390|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3854604|NCT01639001|3680391|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3854605|NCT01639001|3680392|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3854606|NCT01639001|3680390|B3||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3854607|NCT01639001|3680391|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3854608|NCT01639001|3680392|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3854609|NCT01639001|3680390|B3|||Age||Years|Mean|48.5|48.5|Standard Deviation|10.9|10.9|||
3854610|NCT01639001|3680391|B2|||Age||Years|Mean|48.9|48.9|Standard Deviation|11.2|11.2|||
3854611|NCT01639001|3680392|B1|||Age||Years|Mean|48.2|48.2|Standard Deviation|10.6|10.6|||
3854612|NCT01638819|3680437|B3|||Percent viable CD34 (cluster of differentiation) – post-thaw|CD34, a protein found on the surface of stem cells, is the best known marker for blood-forming stem cells. It is used to predict the quality of white cell count yield.|Percent viable cells|Mean|47.30|47.3|Standard Deviation|36.41|36.41|||
3854613|NCT01638819|3680438|B2|||Percent viable CD34 (cluster of differentiation) – post-thaw|CD34, a protein found on the surface of stem cells, is the best known marker for blood-forming stem cells. It is used to predict the quality of white cell count yield.|Percent viable cells|Mean|45.06|45.06|Standard Deviation|37.46|37.46|||
3854614|NCT01638819|3680439|B1|||Percent viable CD34 (cluster of differentiation) – post-thaw|CD34, a protein found on the surface of stem cells, is the best known marker for blood-forming stem cells. It is used to predict the quality of white cell count yield.|Percent viable cells|Mean|49.54|49.54|Standard Deviation|36.66|36.66|||
3854615|NCT01638819|3680437|B3|||Percent viability post-thaw, (flow cytometry 7-AAD)|This measure determines the percent of stem cells that are alive.|Percent viable cells|Mean|53.73|53.73|Standard Deviation|11.37|11.37|||
3854616|NCT01638819|3680438|B2|||Percent viability post-thaw, (flow cytometry 7-AAD)|This measure determines the percent of stem cells that are alive.|Percent viable cells|Mean|55.75|55.75|Standard Deviation|11.38|11.38|||
3854617|NCT01638819|3680439|B1|||Percent viability post-thaw, (flow cytometry 7-AAD)|This measure determines the percent of stem cells that are alive.|Percent viable cells|Mean|51.36|51.36|Standard Deviation|11.36|11.36|||
3854618|NCT01638819|3680437|B3|||Viable total nucleated cell (vTNC) count infused|The viable Total Nucleated Cell count or vTNC is the count of alive cells.|number of alive cells x 10^6/kg|Mean|335.09|335.09|Standard Deviation|203.06|203.06|||
3854619|NCT01638819|3680438|B2|||Viable total nucleated cell (vTNC) count infused|The viable Total Nucleated Cell count or vTNC is the count of alive cells.|number of alive cells x 10^6/kg|Mean|359.34|359.34|Standard Deviation|163.22|163.22|||
3854620|NCT01638819|3680439|B1|||Viable total nucleated cell (vTNC) count infused|The viable Total Nucleated Cell count or vTNC is the count of alive cells.|number of alive cells x 10^6/kg|Mean|314.88|314.88|Standard Deviation|236.52|236.52|||
3854621|NCT01638819|3680437|B3|||TNC dose infused x 10^6/kg|The Total Nucleated Cell count or TNC is the total cell count after cord blood processing.|Number of cells infused x 10^6/kg|Mean|16.16|16.16|Standard Deviation|7.26|7.26|||
3854622|NCT01638819|3680438|B2|||TNC dose infused x 10^6/kg|The Total Nucleated Cell count or TNC is the total cell count after cord blood processing.|Number of cells infused x 10^6/kg|Mean|18.17|18.17|Standard Deviation|8.30|8.3|||
3854623|NCT01638819|3680439|B1|||TNC dose infused x 10^6/kg|The Total Nucleated Cell count or TNC is the total cell count after cord blood processing.|Number of cells infused x 10^6/kg|Mean|14.49|14.49|Standard Deviation|6.12|6.12|||
3854624|NCT01638819|3680437|B3|||Weight||kilograms (kg)|Mean|19.21|19.21|Standard Deviation|3.75|3.75|||
3854625|NCT01638819|3680438|B2|||Weight||kilograms (kg)|Mean|18.67|18.67|Standard Deviation|3.02|3.02|||
3854626|NCT01638819|3680439|B1|||Weight||kilograms (kg)|Mean|19.79|19.79|Standard Deviation|4.44|4.44|||
3854627|NCT01638819|3680437|B3|Small compartment (20%)||Compartment infused|Each subject's cord blood unit consists of two compartments. One contains 80% total volume and the other contains 20% total volume.|Participants|Count of Participants|8|8.0||||||
3854628|NCT01638819|3680438|B2|Small compartment (20%)||Compartment infused|Each subject's cord blood unit consists of two compartments. One contains 80% total volume and the other contains 20% total volume.|Participants|Count of Participants|3|3.0||||||
3854629|NCT01638819|3680439|B1|Small compartment (20%)||Compartment infused|Each subject's cord blood unit consists of two compartments. One contains 80% total volume and the other contains 20% total volume.|Participants|Count of Participants|5|5.0||||||
3854630|NCT01638819|3680437|B3|Large compartment (80%)||Compartment infused|Each subject's cord blood unit consists of two compartments. One contains 80% total volume and the other contains 20% total volume.|Participants|Count of Participants|21|21.0||||||
3854631|NCT01638819|3680438|B2|Large compartment (80%)||Compartment infused|Each subject's cord blood unit consists of two compartments. One contains 80% total volume and the other contains 20% total volume.|Participants|Count of Participants|12|12.0||||||
3854632|NCT01638819|3680439|B1|Large compartment (80%)||Compartment infused|Each subject's cord blood unit consists of two compartments. One contains 80% total volume and the other contains 20% total volume.|Participants|Count of Participants|9|9.0||||||
3854633|NCT01638819|3680437|B3|||Autism Diagnostic Observation Schedule (ADOS)|The Autism Diagnostic Observation Schedule (ADOS) is a semi-structured assessment of communication, social interaction, and play (or imaginative use of materials) for individuals suspected of having autism or other pervasive developmental disorders. The total score ranges from 0 to 28 with 0 representing no abnormality present. A child is suspected to have Autism if the total ADOS score is greater than 7. The mean of the total ADOS scores is listed below.|units on a scale|Mean|7.24|7.24|Standard Deviation|2.50|2.5|||
3854634|NCT01638819|3680438|B2|||Autism Diagnostic Observation Schedule (ADOS)|The Autism Diagnostic Observation Schedule (ADOS) is a semi-structured assessment of communication, social interaction, and play (or imaginative use of materials) for individuals suspected of having autism or other pervasive developmental disorders. The total score ranges from 0 to 28 with 0 representing no abnormality present. A child is suspected to have Autism if the total ADOS score is greater than 7. The mean of the total ADOS scores is listed below.|units on a scale|Mean|6.60|6.6|Standard Deviation|3.14|3.14|||
3854635|NCT01638819|3680439|B1|||Autism Diagnostic Observation Schedule (ADOS)|The Autism Diagnostic Observation Schedule (ADOS) is a semi-structured assessment of communication, social interaction, and play (or imaginative use of materials) for individuals suspected of having autism or other pervasive developmental disorders. The total score ranges from 0 to 28 with 0 representing no abnormality present. A child is suspected to have Autism if the total ADOS score is greater than 7. The mean of the total ADOS scores is listed below.|units on a scale|Mean|7.93|7.93|Standard Deviation|1.39|1.39|||
3854636|NCT01638819|3680437|B3|||Abnormal EEG at baseline||Participants|Count of Participants|9|9.0||||||
3854637|NCT01638819|3680438|B2|||Abnormal EEG at baseline||Participants|Count of Participants|4|4.0||||||
3854638|NCT01638819|3680439|B1|||Abnormal EEG at baseline||Participants|Count of Participants|5|5.0||||||
3854639|NCT01638819|3680437|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
3854640|NCT01638819|3680438|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3854641|NCT01638819|3680439|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3854642|NCT01638819|3680437|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3854643|NCT01638819|3680438|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3854644|NCT01638819|3680439|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854645|NCT01638819|3680437|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854646|NCT01638819|3680438|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854647|NCT01638819|3680439|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854648|NCT01638819|3680437|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3854649|NCT01638819|3680438|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3854650|NCT01638819|3680439|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3854651|NCT01638819|3680437|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854652|NCT01638819|3680438|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854653|NCT01638819|3680439|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854654|NCT01638819|3680437|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854655|NCT01638819|3680438|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854656|NCT01638819|3680439|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854657|NCT01638819|3680437|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3854658|NCT01638819|3680438|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3854659|NCT01638819|3680439|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3854660|NCT01638819|3680437|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854661|NCT01638819|3680438|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854662|NCT01638819|3680439|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854663|NCT01638819|3680437|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854664|NCT01638819|3680438|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854665|NCT01638819|3680439|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854666|NCT01638819|3680437|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3854667|NCT01638819|3680438|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3854668|NCT01638819|3680439|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3854669|NCT01638819|3680437|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3854670|NCT01638819|3680438|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3854671|NCT01638819|3680439|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3854672|NCT01638819|3680437|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3854673|NCT01638819|3680438|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3854674|NCT01638819|3680439|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3854675|NCT01638819|3680437|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3854676|NCT01638819|3680438|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3854677|NCT01638819|3680439|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3854678|NCT01638819|3680437|B3|||Age||years|Mean|4.53|4.53|Full Range|||2.42|6.8|
3854679|NCT01638819|3680438|B2|||Age||years|Mean|4.57|4.57|Full Range|||3.0|6.3|
3854680|NCT01638819|3680439|B1|||Age||years|Mean|4.50|4.5|Full Range|||2.42|6.8|
3854681|NCT01638559|3680449|B1|United States||Region of Enrollment||participants|Number|82|82.0||||||
3854682|NCT01638559|3680449|B1|Canada||Region of Enrollment||participants|Number|6|6.0||||||
3854683|NCT01638559|3680449|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3854684|NCT01638559|3680449|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854685|NCT01638559|3680449|B1||White|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
3854686|NCT01638559|3680449|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3854687|NCT01638559|3680449|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854688|NCT01638559|3680449|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3854689|NCT01638559|3680449|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854690|NCT01638559|3680449|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3854691|NCT01638559|3680449|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3854692|NCT01638559|3680449|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3854693|NCT01638559|3680449|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3854694|NCT01638559|3680449|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3854695|NCT01638559|3680449|B1|||Age||years|Mean|10.4|10.4|Standard Deviation|3.4|3.4|||
3854696|NCT01638559|3680449|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3854697|NCT01638559|3680449|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3854698|NCT01638559|3680449|B1||<=18 years|Age||Participants|Count of Participants|88|88.0||||||
3854699|NCT01638546|3680453|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3854700|NCT01638546|3680454|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3854701|NCT01638546|3680455|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3854702|NCT01638546|3680453|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854703|NCT01638546|3680454|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854704|NCT01638546|3680455|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854705|NCT01638546|3680453|B3||White|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
3854706|NCT01638546|3680454|B2||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3854707|NCT01638546|3680455|B1||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3854708|NCT01638546|3680453|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3854709|NCT01638546|3680454|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3854710|NCT01638546|3680455|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3854711|NCT01638546|3680453|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854712|NCT01638546|3680454|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854713|NCT01638546|3680455|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854714|NCT01638546|3680453|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854715|NCT01638546|3680454|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854716|NCT01638546|3680455|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854717|NCT01638546|3680453|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854718|NCT01638546|3680454|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854719|NCT01638546|3680455|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3854720|NCT01638546|3680453|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3854721|NCT01638546|3680454|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3854722|NCT01638546|3680455|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3854723|NCT01638546|3680453|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3854724|NCT01638546|3680454|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3854725|NCT01638546|3680455|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3854726|NCT01638546|3680453|B3||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
3854727|NCT01638546|3680454|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3854728|NCT01638546|3680455|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3854729|NCT01638546|3680453|B3||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
3854730|NCT01638546|3680454|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3854731|NCT01638546|3680455|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3854732|NCT01638546|3680453|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3854733|NCT01638546|3680454|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3854734|NCT01638546|3680455|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3854735|NCT01638507|3680464|B1||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3854736|NCT01638507|3680464|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3854737|NCT01638507|3680464|B1|||Age||years|Mean|64.4|64.4|Standard Deviation|10.5|10.5|||
3854738|NCT01638468|3680477|B1|||Weight||kg|Mean|82.6|82.6|Standard Deviation|19.5|19.5|||
3854739|NCT01638468|3680477|B1|||Height||cm|Mean|170.0|170.0|Standard Deviation|12.6|12.6|||
3854740|NCT01638468|3680477|B1|||Body Mass Index (BMI)||kg/m2|Mean|28.33|28.33|Standard Deviation|4.43|4.43|||
3854741|NCT01638468|3680477|B1|Portugal||Region of Enrollment||participants|Number|2|2.0||||||
3854742|NCT01638468|3680477|B1|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
3854743|NCT01638468|3680477|B1|Italy||Region of Enrollment||participants|Number|4|4.0||||||
3854744|NCT01638468|3680477|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3854745|NCT01638468|3680477|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3854746|NCT01638468|3680477|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|8.0|8.0|||
3854747|NCT01638312|3680491|B3|Taiwan||Region of Enrollment||participants|Number|50|50.0||||||
3854748|NCT01638312|3680492|B2|Taiwan||Region of Enrollment||participants|Number|30|30.0||||||
3854749|NCT01638312|3680493|B1|Taiwan||Region of Enrollment||participants|Number|20|20.0||||||
3854750|NCT01638312|3680491|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3854751|NCT01638312|3680492|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3854752|NCT01638312|3680493|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3854753|NCT01638312|3680491|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3854754|NCT01638312|3680492|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3854755|NCT01638312|3680493|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3854756|NCT01638312|3680491|B3|||Age||years|Mean|32.38|32.38|Standard Deviation|9.71|9.71|||
3854757|NCT01638312|3680492|B2|||Age||years|Mean|31.87|31.87|Standard Deviation|9.46|9.46|||
3854758|NCT01638312|3680493|B1|||Age||years|Mean|33.15|33.15|Standard Deviation|10.27|10.27|||
3854759|NCT01638312|3680491|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3854760|NCT01638312|3680492|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3854761|NCT01638312|3680493|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3854762|NCT01638312|3680491|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3854763|NCT01638312|3680492|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3854764|NCT01638312|3680493|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3854765|NCT01638312|3680491|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3854766|NCT01638312|3680492|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3854767|NCT01638312|3680493|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3854768|NCT01638000|3680500|B3|||Mean Number of Pads Used / 24 hours|SAF population with baseline value > 0. The number of participants are 585 and 580. The mean number of pads per 24 hours were calculated from the data recorded by the participant during the 3-day micturition diary period.|pads|Mean|3.2|3.2|Standard Deviation|3.57|3.57|||
3854769|NCT01638000|3680501|B2|||Mean Number of Pads Used / 24 hours|SAF population with baseline value > 0. The number of participants are 585 and 580. The mean number of pads per 24 hours were calculated from the data recorded by the participant during the 3-day micturition diary period.|pads|Mean|3.3|3.3|Standard Deviation|3.70|3.7|||
3854770|NCT01638000|3680502|B1|||Mean Number of Pads Used / 24 hours|SAF population with baseline value > 0. The number of participants are 585 and 580. The mean number of pads per 24 hours were calculated from the data recorded by the participant during the 3-day micturition diary period.|pads|Mean|3.1|3.1|Standard Deviation|3.43|3.43|||
3854771|NCT01638000|3680500|B3|||Mean Nocturia Episodes / 24 hours|SAF population with baseline value > 0. The number of participants are 890 and 895. A nocturia episode is defined as waking at night ≥ 1 times to void (i.e., any voiding associated with sleep disturbance between the time the patient goes to bed with the intention to sleep until the time the patient gets up in the morning with the intention to stay awake). The mean number of nocturia episodes per 24 hours were calculated from the data recorded by the participant during the 3-day micturition diary period.|nocturia episodes|Mean|2.3|2.3|Standard Deviation|1.41|1.41|||
3854772|NCT01638000|3680501|B2|||Mean Nocturia Episodes / 24 hours|SAF population with baseline value > 0. The number of participants are 890 and 895. A nocturia episode is defined as waking at night ≥ 1 times to void (i.e., any voiding associated with sleep disturbance between the time the patient goes to bed with the intention to sleep until the time the patient gets up in the morning with the intention to stay awake). The mean number of nocturia episodes per 24 hours were calculated from the data recorded by the participant during the 3-day micturition diary period.|nocturia episodes|Mean|2.3|2.3|Standard Deviation|1.42|1.42|||
3854773|NCT01638000|3680502|B1|||Mean Nocturia Episodes / 24 hours|SAF population with baseline value > 0. The number of participants are 890 and 895. A nocturia episode is defined as waking at night ≥ 1 times to void (i.e., any voiding associated with sleep disturbance between the time the patient goes to bed with the intention to sleep until the time the patient gets up in the morning with the intention to stay awake). The mean number of nocturia episodes per 24 hours were calculated from the data recorded by the participant during the 3-day micturition diary period.|nocturia episodes|Mean|2.3|2.3|Standard Deviation|1.41|1.41|||
3854774|NCT01638000|3680500|B3|||Mean Level of Urgency|SAF population. The number of participants are 933 and 932. Urgency level was rated by the participant during the 3-day micturition diary period using the PPIUS 5-point categorical scale: 0. No urgency; 1. Mild urgency; 2. Moderate urgency; 3. Severe urgency; 4. Urgency incontinence.|units on a scale|Mean|2.6|2.6|Standard Deviation|0.49|0.49|||
3854775|NCT01638000|3680501|B2|||Mean Level of Urgency|SAF population. The number of participants are 933 and 932. Urgency level was rated by the participant during the 3-day micturition diary period using the PPIUS 5-point categorical scale: 0. No urgency; 1. Mild urgency; 2. Moderate urgency; 3. Severe urgency; 4. Urgency incontinence.|units on a scale|Mean|2.6|2.6|Standard Deviation|0.49|0.49|||
3854776|NCT01638000|3680502|B1|||Mean Level of Urgency|SAF population. The number of participants are 933 and 932. Urgency level was rated by the participant during the 3-day micturition diary period using the PPIUS 5-point categorical scale: 0. No urgency; 1. Mild urgency; 2. Moderate urgency; 3. Severe urgency; 4. Urgency incontinence.|units on a scale|Mean|2.6|2.6|Standard Deviation|0.49|0.49|||
3854777|NCT01638000|3680500|B3|||Mean Urgency Episodes (grade 3 or 4) / 24 hours|SAF population with baseline value > 0. The number of participants are 931 and 931. An urgency episode is a sudden compelling desire to pass urine immediately followed by an incontinent event or the patient having to rush to the toilet and make it in time; severity recorded as 3 (severe urgency) or 4 (urgency incontinence) on the Patient Perception of the Intensity of Urgency Scale (PPIUS) validated scale. The mean number of urgency episodes per 24 hours were calculated from the data recorded by the participant during the 3-day micturition diary period.|urgency episodes|Mean|7.8|7.8|Standard Deviation|4.61|4.61|||
3854778|NCT01638000|3680501|B2|||Mean Urgency Episodes (grade 3 or 4) / 24 hours|SAF population with baseline value > 0. The number of participants are 931 and 931. An urgency episode is a sudden compelling desire to pass urine immediately followed by an incontinent event or the patient having to rush to the toilet and make it in time; severity recorded as 3 (severe urgency) or 4 (urgency incontinence) on the Patient Perception of the Intensity of Urgency Scale (PPIUS) validated scale. The mean number of urgency episodes per 24 hours were calculated from the data recorded by the participant during the 3-day micturition diary period.|urgency episodes|Mean|7.8|7.8|Standard Deviation|4.46|4.46|||
3854779|NCT01638000|3680502|B1|||Mean Urgency Episodes (grade 3 or 4) / 24 hours|SAF population with baseline value > 0. The number of participants are 931 and 931. An urgency episode is a sudden compelling desire to pass urine immediately followed by an incontinent event or the patient having to rush to the toilet and make it in time; severity recorded as 3 (severe urgency) or 4 (urgency incontinence) on the Patient Perception of the Intensity of Urgency Scale (PPIUS) validated scale. The mean number of urgency episodes per 24 hours were calculated from the data recorded by the participant during the 3-day micturition diary period.|urgency episodes|Mean|7.7|7.7|Standard Deviation|4.75|4.75|||
3854780|NCT01638000|3680500|B3|||Mean Urgency Incontinence Episodes / 24 hours|SAF population with baseline value > 0. The number of participants are 401 and 413. An urgency incontinence episode is any involuntary leakage of urine accompanied by or immediately proceeded by urgency. The mean number of urgency incontinence episodes per 24 hours were calculated from the data recorded by the participant during the 3-day micturition diary period.|urgency incontinence episodes|Mean|2.0|2.0|Standard Deviation|1.96|1.96|||
3854781|NCT01638000|3680501|B2|||Mean Urgency Incontinence Episodes / 24 hours|SAF population with baseline value > 0. The number of participants are 401 and 413. An urgency incontinence episode is any involuntary leakage of urine accompanied by or immediately proceeded by urgency. The mean number of urgency incontinence episodes per 24 hours were calculated from the data recorded by the participant during the 3-day micturition diary period.|urgency incontinence episodes|Mean|2.0|2.0|Standard Deviation|1.94|1.94|||
3854782|NCT01638000|3680502|B1|||Mean Urgency Incontinence Episodes / 24 hours|SAF population with baseline value > 0. The number of participants are 401 and 413. An urgency incontinence episode is any involuntary leakage of urine accompanied by or immediately proceeded by urgency. The mean number of urgency incontinence episodes per 24 hours were calculated from the data recorded by the participant during the 3-day micturition diary period.|urgency incontinence episodes|Mean|1.9|1.9|Standard Deviation|1.99|1.99|||
3854783|NCT01638000|3680500|B3|||Mean Incontinence Episodes / 24 hours|SAF population with baseline value > 0. The number of participants are 410 and 424. An incontinence episode is any involuntary leakage of urine. The mean number of incontinence episodes per 24 hours were calculated from the data recorded by the participant during the 3-day micturition diary period.|incontinence episodes|Mean|2.1|2.1|Standard Deviation|2.17|2.17|||
3854784|NCT01638000|3680501|B2|||Mean Incontinence Episodes / 24 hours|SAF population with baseline value > 0. The number of participants are 410 and 424. An incontinence episode is any involuntary leakage of urine. The mean number of incontinence episodes per 24 hours were calculated from the data recorded by the participant during the 3-day micturition diary period.|incontinence episodes|Mean|2.1|2.1|Standard Deviation|2.05|2.05|||
3854785|NCT01638000|3680502|B1|||Mean Incontinence Episodes / 24 hours|SAF population with baseline value > 0. The number of participants are 410 and 424. An incontinence episode is any involuntary leakage of urine. The mean number of incontinence episodes per 24 hours were calculated from the data recorded by the participant during the 3-day micturition diary period.|incontinence episodes|Mean|2.1|2.1|Standard Deviation|2.30|2.3|||
3854786|NCT01638000|3680500|B3|||Mean Micturitions / 24 hours|SAF population. The number of participants are 933 and 932. A micturition is any voluntary urination (excluding incontinence only episodes). The mean number of micturitions per 24 hours were calculated from the data recorded by the participant during the 3-day micturition diary period.|micturitions|Mean|11.5|11.5|Standard Deviation|3.08|3.08|||
3854787|NCT01638000|3680501|B2|||Mean Micturitions / 24 hours|SAF population. The number of participants are 933 and 932. A micturition is any voluntary urination (excluding incontinence only episodes). The mean number of micturitions per 24 hours were calculated from the data recorded by the participant during the 3-day micturition diary period.|micturitions|Mean|11.4|11.4|Standard Deviation|2.89|2.89|||
3854788|NCT01638000|3680502|B1|||Mean Micturitions / 24 hours|SAF population. The number of participants are 933 and 932. A micturition is any voluntary urination (excluding incontinence only episodes). The mean number of micturitions per 24 hours were calculated from the data recorded by the participant during the 3-day micturition diary period.|micturitions|Mean|11.6|11.6|Standard Deviation|3.25|3.25|||
3854789|NCT01638000|3680500|B3||Male|Sex: Female, Male||Participants|Count of Participants|449|449.0||||||
3854790|NCT01638000|3680501|B2||Male|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
3854791|NCT01638000|3680502|B1||Male|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
3854792|NCT01638000|3680500|B3||Female|Sex: Female, Male||Participants|Count of Participants|1421|1421.0||||||
3854793|NCT01638000|3680501|B2||Female|Sex: Female, Male||Participants|Count of Participants|709|709.0||||||
3854794|NCT01638000|3680502|B1||Female|Sex: Female, Male||Participants|Count of Participants|712|712.0||||||
3854795|NCT01638000|3680500|B3|||Age||years|Mean|57.0|57.0|Standard Deviation|13.93|13.93|||
3854796|NCT01638000|3680501|B2|||Age||years|Mean|57.4|57.4|Standard Deviation|13.60|13.6|||
3854797|NCT01638000|3680502|B1|||Age||years|Mean|56.7|56.7|Standard Deviation|14.25|14.25|||
3854798|NCT01637961|3680601|B1|||Histologic Type - Leiomyosarcoma||participants|Number|21|21.0||||||
3854799|NCT01637961|3680601|B1|||FIGO (International Federation of Gynecology and Obstetrics) Stage - Recurrent/Persistent||participants|Number|21|21.0||||||
3854800|NCT01637961|3680601|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3854801|NCT01637961|3680601|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3854802|NCT01637961|3680601|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3854803|NCT01637961|3680601|B1|80-89 years||Age, Customized||participants|Number|1|1.0||||||
3854804|NCT01637961|3680601|B1|70-79 years||Age, Customized||participants|Number|2|2.0||||||
3854805|NCT01637961|3680601|B1|60-69 years||Age, Customized||participants|Number|9|9.0||||||
3854806|NCT01637961|3680601|B1|50-59 years||Age, Customized||participants|Number|6|6.0||||||
3854807|NCT01637961|3680601|B1|40-49 years||Age, Customized||participants|Number|3|3.0||||||
3854808|NCT01637961|3680601|B1|||Age||years|Mean|60.9|60.9|Standard Deviation|9.0|9.0|||
3854809|NCT01637935|3680614|B3|Never treated with any diabetes medication||Other diabetes medications|Includes use of any other diabetes medications during follow-up.|percentage of participants|Number|14.3|14.3||||||
3854810|NCT01637935|3680615|B2|Never treated with any diabetes medication||Other diabetes medications|Includes use of any other diabetes medications during follow-up.|percentage of participants|Number|14.3|14.3||||||
3854811|NCT01637935|3680616|B1|Never treated with any diabetes medication||Other diabetes medications|Includes use of any other diabetes medications during follow-up.|percentage of participants|Number|0.0|0.0||||||
3854812|NCT01637935|3680614|B3|Insulin||Other diabetes medications|Includes use of any other diabetes medications during follow-up.|percentage of participants|Number|82.1|82.1||||||
3854813|NCT01637935|3680615|B2|Insulin||Other diabetes medications|Includes use of any other diabetes medications during follow-up.|percentage of participants|Number|29.4|29.4||||||
3854814|NCT01637935|3680616|B1|Insulin||Other diabetes medications|Includes use of any other diabetes medications during follow-up.|percentage of participants|Number|52.7|52.7||||||
3854815|NCT01637935|3680614|B3|Other oral hypoglycemic drugs||Other diabetes medications|Includes use of any other diabetes medications during follow-up.|percentage of participants|Number|7.8|7.8||||||
3854816|NCT01637935|3680615|B2|Other oral hypoglycemic drugs||Other diabetes medications|Includes use of any other diabetes medications during follow-up.|percentage of participants|Number|1.4|1.4||||||
3854817|NCT01637935|3680616|B1|Other oral hypoglycemic drugs||Other diabetes medications|Includes use of any other diabetes medications during follow-up.|percentage of participants|Number|6.4|6.4||||||
3854818|NCT01637935|3680614|B3|Sulfonylureas||Other diabetes medications|Includes use of any other diabetes medications during follow-up.|percentage of participants|Number|151|151.0||||||
3854819|NCT01637935|3680615|B2|Sulfonylureas||Other diabetes medications|Includes use of any other diabetes medications during follow-up.|percentage of participants|Number|61.2|61.2||||||
3854820|NCT01637935|3680616|B1|Sulfonylureas||Other diabetes medications|Includes use of any other diabetes medications during follow-up.|percentage of participants|Number|89.8|89.8||||||
3854821|NCT01637935|3680614|B3|Metformin||Other diabetes medications|Includes use of any other diabetes medications during follow-up.|percentage of participants|Number|130.7|130.7||||||
3854822|NCT01637935|3680615|B2|Metformin||Other diabetes medications|Includes use of any other diabetes medications during follow-up.|percentage of participants|Number|45.9|45.9||||||
3854823|NCT01637935|3680616|B1|Metformin||Other diabetes medications|Includes use of any other diabetes medications during follow-up.|percentage of participants|Number|84.8|84.8||||||
3854824|NCT01637935|3680614|B3|Other thiazolidinediones||Other diabetes medications|Includes use of any other diabetes medications during follow-up.|percentage of participants|Number|9.7|9.7||||||
3854825|NCT01637935|3680615|B2|Other thiazolidinediones||Other diabetes medications|Includes use of any other diabetes medications during follow-up.|percentage of participants|Number|1.5|1.5||||||
3854826|NCT01637935|3680616|B1|Other thiazolidinediones||Other diabetes medications|Includes use of any other diabetes medications during follow-up.|percentage of participants|Number|8.2|8.2||||||
3854827|NCT01637935|3680614|B3|||Other cancer prior to baseline||percentage of participants|Number|8.4|8.4||||||
3854828|NCT01637935|3680615|B2|||Other cancer prior to baseline||percentage of participants|Number|5.3|5.3||||||
3854829|NCT01637935|3680616|B1|||Other cancer prior to baseline||percentage of participants|Number|3.1|3.1||||||
3854830|NCT01637935|3680614|B3|Missing||Diabetes duration at baseline||percentage of participants|Number|42|42.0||||||
3854831|NCT01637935|3680615|B2|Missing||Diabetes duration at baseline||percentage of participants|Number|20.4|20.4||||||
3854832|NCT01637935|3680616|B1|Missing||Diabetes duration at baseline||percentage of participants|Number|21.6|21.6||||||
3854833|NCT01637935|3680614|B3|10 or more years||Diabetes duration at baseline||percentage of participants|Number|20|20.0||||||
3854834|NCT01637935|3680615|B2|10 or more years||Diabetes duration at baseline||percentage of participants|Number|10.9|10.9||||||
3854835|NCT01637935|3680616|B1|10 or more years||Diabetes duration at baseline||percentage of participants|Number|9.1|9.1||||||
3854836|NCT01637935|3680614|B3|5-9 years||Diabetes duration at baseline||percentage of participants|Number|15.2|15.2||||||
3854837|NCT01637935|3680615|B2|5-9 years||Diabetes duration at baseline||percentage of participants|Number|6.0|6.0||||||
3854838|NCT01637935|3680616|B1|5-9 years||Diabetes duration at baseline||percentage of participants|Number|9.2|9.2||||||
3854839|NCT01637935|3680614|B3|0-4 years||Diabetes duration at baseline||percentage of participants|Number|122.9|122.9||||||
3854840|NCT01637935|3680615|B2|0-4 years||Diabetes duration at baseline||percentage of participants|Number|62.8|62.8||||||
3854841|NCT01637935|3680616|B1|0-4 years||Diabetes duration at baseline||percentage of participants|Number|60.1|60.1||||||
3854842|NCT01637935|3680614|B3|||Newly diagnosed with diabetes mellitus at the start of follow-up|Includes newly diagnosed patients and patients who newly enrolled in Kaiser Permanente with an existing diagnosis of diabetes mellitus.|percentage of participants|Number|108.7|108.7||||||
3854843|NCT01637935|3680615|B2|||Newly diagnosed with diabetes mellitus at the start of follow-up|Includes newly diagnosed patients and patients who newly enrolled in Kaiser Permanente with an existing diagnosis of diabetes mellitus.|percentage of participants|Number|57.9|57.9||||||
3854844|NCT01637935|3680616|B1|||Newly diagnosed with diabetes mellitus at the start of follow-up|Includes newly diagnosed patients and patients who newly enrolled in Kaiser Permanente with an existing diagnosis of diabetes mellitus.|percentage of participants|Number|50.8|50.8||||||
3854845|NCT01637935|3680614|B3|Missing||Baseline Glycosylated Hemoglobin (HbA1c)||percentage of participants|Number|35.6|35.6||||||
3854846|NCT01637935|3680615|B2|Missing||Baseline Glycosylated Hemoglobin (HbA1c)||percentage of participants|Number|17.5|17.5||||||
3854847|NCT01637935|3680616|B1|Missing||Baseline Glycosylated Hemoglobin (HbA1c)||percentage of participants|Number|18.1|18.1||||||
3854848|NCT01637935|3680614|B3|≥10%||Baseline Glycosylated Hemoglobin (HbA1c)||percentage of participants|Number|41|41.0||||||
3854849|NCT01637935|3680615|B2|≥10%||Baseline Glycosylated Hemoglobin (HbA1c)||percentage of participants|Number|17.1|17.1||||||
3854850|NCT01637935|3680616|B1|≥10%||Baseline Glycosylated Hemoglobin (HbA1c)||percentage of participants|Number|23.9|23.9||||||
3854851|NCT01637935|3680614|B3|9-9.9%||Baseline Glycosylated Hemoglobin (HbA1c)||percentage of participants|Number|16.7|16.7||||||
3854852|NCT01637935|3680615|B2|9-9.9%||Baseline Glycosylated Hemoglobin (HbA1c)||percentage of participants|Number|7.0|7.0||||||
3854853|NCT01637935|3680616|B1|9-9.9%||Baseline Glycosylated Hemoglobin (HbA1c)||percentage of participants|Number|9.7|9.7||||||
3854854|NCT01637935|3680614|B3|8-8.9%||Baseline Glycosylated Hemoglobin (HbA1c)||percentage of participants|Number|23.2|23.2||||||
3854855|NCT01637935|3680615|B2|8-8.9%||Baseline Glycosylated Hemoglobin (HbA1c)||percentage of participants|Number|10.4|10.4||||||
3854856|NCT01637935|3680616|B1|8-8.9%||Baseline Glycosylated Hemoglobin (HbA1c)||percentage of participants|Number|12.8|12.8||||||
3854857|NCT01637935|3680614|B3|7-7.9%||Baseline Glycosylated Hemoglobin (HbA1c)||percentage of participants|Number|37.6|37.6||||||
3854858|NCT01637935|3680615|B2|7-7.9%||Baseline Glycosylated Hemoglobin (HbA1c)||percentage of participants|Number|19.3|19.3||||||
3854859|NCT01637935|3680616|B1|7-7.9%||Baseline Glycosylated Hemoglobin (HbA1c)||percentage of participants|Number|18.3|18.3||||||
3854860|NCT01637935|3680614|B3|<7%||Baseline Glycosylated Hemoglobin (HbA1c)||percentage of participants|Number|45.7|45.7||||||
3854861|NCT01637935|3680615|B2|<7%||Baseline Glycosylated Hemoglobin (HbA1c)||percentage of participants|Number|28.6|28.6||||||
3854862|NCT01637935|3680616|B1|<7%||Baseline Glycosylated Hemoglobin (HbA1c)||percentage of participants|Number|17.1|17.1||||||
3854863|NCT01637935|3680614|B3|||Congestive heart failure at baseline||percentage of participants|Number|9.9|9.9||||||
3854864|NCT01637935|3680615|B2|||Congestive heart failure at baseline||percentage of participants|Number|6.9|6.9||||||
3854865|NCT01637935|3680616|B1|||Congestive heart failure at baseline||percentage of participants|Number|3.0|3.0||||||
3854866|NCT01637935|3680614|B3|Missing||Renal function at baseline|Elevated creatinine: Creatinine >1.4 mg/dL for women and >1.5 mg/dL for men.|percentage of participants|Number|32.7|32.7||||||
3854867|NCT01637935|3680615|B2|Missing||Renal function at baseline|Elevated creatinine: Creatinine >1.4 mg/dL for women and >1.5 mg/dL for men.|percentage of participants|Number|14.1|14.1||||||
3854868|NCT01637935|3680616|B1|Missing||Renal function at baseline|Elevated creatinine: Creatinine >1.4 mg/dL for women and >1.5 mg/dL for men.|percentage of participants|Number|18.6|18.6||||||
3854869|NCT01637935|3680614|B3|Elevated creatinine||Renal function at baseline|Elevated creatinine: Creatinine >1.4 mg/dL for women and >1.5 mg/dL for men.|percentage of participants|Number|12.7|12.7||||||
3854870|NCT01637935|3680615|B2|Elevated creatinine||Renal function at baseline|Elevated creatinine: Creatinine >1.4 mg/dL for women and >1.5 mg/dL for men.|percentage of participants|Number|8.7|8.7||||||
3854871|NCT01637935|3680616|B1|Elevated creatinine||Renal function at baseline|Elevated creatinine: Creatinine >1.4 mg/dL for women and >1.5 mg/dL for men.|percentage of participants|Number|4.0|4.0||||||
3854872|NCT01637935|3680614|B3|Normal creatinine||Renal function at baseline|Elevated creatinine: Creatinine >1.4 mg/dL for women and >1.5 mg/dL for men.|percentage of participants|Number|154.5|154.5||||||
3854873|NCT01637935|3680615|B2|Normal creatinine||Renal function at baseline|Elevated creatinine: Creatinine >1.4 mg/dL for women and >1.5 mg/dL for men.|percentage of participants|Number|77.1|77.1||||||
3854874|NCT01637935|3680616|B1|Normal creatinine||Renal function at baseline|Elevated creatinine: Creatinine >1.4 mg/dL for women and >1.5 mg/dL for men.|percentage of participants|Number|77.4|77.4||||||
3854875|NCT01637935|3680614|B3|||Current smoker||percentage of participants|Number|37.8|37.8||||||
3854876|NCT01637935|3680615|B2|||Current smoker||percentage of participants|Number|17.4|17.4||||||
3854877|NCT01637935|3680616|B1|||Current smoker||percentage of participants|Number|20.4|20.4||||||
3854878|NCT01637935|3680614|B3|Missing||Race/Ethnicity, Customized||percentage of participants|Number|12.1|12.1||||||
3854879|NCT01637935|3680615|B2|Missing||Race/Ethnicity, Customized||percentage of participants|Number|7.8|7.8||||||
3854880|NCT01637935|3680616|B1|Missing||Race/Ethnicity, Customized||percentage of participants|Number|4.3|4.3||||||
3854881|NCT01637935|3680614|B3|Other||Race/Ethnicity, Customized||percentage of participants|Number|11.6|11.6||||||
3854882|NCT01637935|3680615|B2|Other||Race/Ethnicity, Customized||percentage of participants|Number|5.7|5.7||||||
3854883|NCT01637935|3680616|B1|Other||Race/Ethnicity, Customized||percentage of participants|Number|5.9|5.9||||||
3854884|NCT01637935|3680614|B3|Hispanic||Race/Ethnicity, Customized||percentage of participants|Number|24|24.0||||||
3854885|NCT01637935|3680615|B2|Hispanic||Race/Ethnicity, Customized||percentage of participants|Number|10.6|10.6||||||
3854886|NCT01637935|3680616|B1|Hispanic||Race/Ethnicity, Customized||percentage of participants|Number|13.4|13.4||||||
3854887|NCT01637935|3680614|B3|Asian||Race/Ethnicity, Customized||percentage of participants|Number|27.6|27.6||||||
3854888|NCT01637935|3680615|B2|Asian||Race/Ethnicity, Customized||percentage of participants|Number|12.8|12.8||||||
3854889|NCT01637935|3680616|B1|Asian||Race/Ethnicity, Customized||percentage of participants|Number|14.8|14.8||||||
3854890|NCT01637935|3680614|B3|Black||Race/Ethnicity, Customized||percentage of participants|Number|21|21.0||||||
3854891|NCT01637935|3680615|B2|Black||Race/Ethnicity, Customized||percentage of participants|Number|10.8|10.8||||||
3854892|NCT01637935|3680616|B1|Black||Race/Ethnicity, Customized||percentage of participants|Number|10.2|10.2||||||
3854893|NCT01637935|3680614|B3|White||Race/Ethnicity, Customized||percentage of participants|Number|103.6|103.6||||||
3854894|NCT01637935|3680615|B2|White||Race/Ethnicity, Customized||percentage of participants|Number|52.3|52.3||||||
3854895|NCT01637935|3680616|B1|White||Race/Ethnicity, Customized||percentage of participants|Number|51.3|51.3||||||
3854896|NCT01637935|3680614|B3|Male||Sex/Gender, Customized||percentage of participants|Number|107|107.0||||||
3854897|NCT01637935|3680615|B2|Male||Sex/Gender, Customized||percentage of participants|Number|53.5|53.5||||||
3854898|NCT01637935|3680616|B1|Male||Sex/Gender, Customized||percentage of participants|Number|53.5|53.5||||||
3854899|NCT01637935|3680614|B3|Female||Sex/Gender, Customized||percentage of participants|Number|93|93.0||||||
3854900|NCT01637935|3680615|B2|Female||Sex/Gender, Customized||percentage of participants|Number|46.5|46.5||||||
3854901|NCT01637935|3680616|B1|Female||Sex/Gender, Customized||percentage of participants|Number|46.5|46.5||||||
3854902|NCT01637935|3680614|B3|70 years and older||Age, Customized||percentage of participants|Number|38.1|38.1||||||
3854903|NCT01637935|3680615|B2|70 years and older||Age, Customized||percentage of participants|Number|26.1|26.1||||||
3854904|NCT01637935|3680616|B1|70 years and older||Age, Customized||percentage of participants|Number|12.0|12.0||||||
3854905|NCT01637935|3680614|B3|60-69 years||Age, Customized||percentage of participants|Number|51.9|51.9||||||
3854906|NCT01637935|3680615|B2|60-69 years||Age, Customized||percentage of participants|Number|26.2|26.2||||||
3854907|NCT01637935|3680616|B1|60-69 years||Age, Customized||percentage of participants|Number|25.7|25.7||||||
3854908|NCT01637935|3680614|B3|50-59 years||Age, Customized||percentage of participants|Number|58.6|58.6||||||
3854909|NCT01637935|3680615|B2|50-59 years||Age, Customized||percentage of participants|Number|25.6|25.6||||||
3854910|NCT01637935|3680616|B1|50-59 years||Age, Customized||percentage of participants|Number|33.0|33.0||||||
3854911|NCT01637935|3680614|B3|40-49 years||Age, Customized||percentage of participants|Number|51.3|51.3||||||
3854912|NCT01637935|3680615|B2|40-49 years||Age, Customized||percentage of participants|Number|22.1|22.1||||||
3854913|NCT01637935|3680616|B1|40-49 years||Age, Customized||percentage of participants|Number|29.2|29.2||||||
3854914|NCT01637922|3680631|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3854915|NCT01637922|3680632|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3854916|NCT01637922|3680633|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3854917|NCT01637922|3680631|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3854918|NCT01637922|3680632|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3854919|NCT01637922|3680633|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3854920|NCT01637922|3680631|B3|||Age||years|Mean|34.6|34.6|Standard Deviation|9.7|9.7|||
3854921|NCT01637922|3680632|B2|||Age||years|Mean|34.1|34.1|Standard Deviation|8.7|8.7|||
3854922|NCT01637922|3680633|B1|||Age||years|Mean|35.4|35.4|Standard Deviation|11.0|11.0|||
3854923|NCT01637870|3680657|B1|United States||Region of Enrollment||participants|Number|110|110.0||||||
3854924|NCT01637870|3680657|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3854925|NCT01637870|3680657|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3854926|NCT01637870|3680657|B1|||Age||years|Mean|30.8|30.8|Standard Deviation|6.0|6.0|||
3854927|NCT01637870|3680657|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3854928|NCT01637870|3680657|B1||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
3854929|NCT01637870|3680657|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3854930|NCT01637584|3680661|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3854931|NCT01637584|3680662|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3854932|NCT01637584|3680663|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3854933|NCT01637584|3680661|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3854934|NCT01637584|3680662|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3854935|NCT01637584|3680663|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3854936|NCT01637584|3680661|B3|||Age||years|Mean|27.7|27.7|Standard Deviation|5.14|5.14|||
3854937|NCT01637584|3680662|B2|||Age||years|Mean|27.2|27.2|Standard Deviation|6.25|6.25|||
3854938|NCT01637584|3680663|B1|||Age||years|Mean|29.7|29.7|Standard Deviation|6.55|6.55|||
3854939|NCT01637272|3680671|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3854940|NCT01637272|3680671|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3854941|NCT01637272|3680671|B1|||Age||Years|Mean|45.9|45.9|Standard Deviation|9.99|9.99|||
3854942|NCT01637246|3680733|B1|Missing Data||Sex/Gender, Customized||Participants|Number|2097|2097.0||||||
3854943|NCT01637246|3680733|B1|Male||Sex/Gender, Customized||Participants|Number|1111|1111.0||||||
3854944|NCT01637246|3680733|B1|Female||Sex/Gender, Customized||Participants|Number|1177|1177.0||||||
3854945|NCT01637246|3680733|B1|Missing Data (N=2151)||Age||Years|Mean|NA||Standard Deviation|NA||||Age missing; not obtained
3854946|NCT01637246|3680733|B1|Data Available (N=2234)||Age||Years|Mean|66.69|66.69|Standard Deviation|11.43|11.43|||
3854947|NCT01637090|3680741|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
3854948|NCT01637090|3680741|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3854949|NCT01637090|3680741|B1||>=65 years|Age|greater than or equal to 18 years|Participants|Count of Participants|2|2.0||||||
3854950|NCT01637090|3680741|B1||Between 18 and 65 years|Age|greater than or equal to 18 years|Participants|Count of Participants|1|1.0||||||
3854951|NCT01637090|3680741|B1||<=18 years|Age|greater than or equal to 18 years|Participants|Count of Participants|0|0.0||||||
3854952|NCT01637077|3680749|B3|United States||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3854953|NCT01637077|3680750|B2|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3854954|NCT01637077|3680751|B1|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3854955|NCT01637077|3680749|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3854956|NCT01637077|3680750|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3854957|NCT01637077|3680751|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3854958|NCT01637077|3680749|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3854959|NCT01637077|3680750|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3854960|NCT01637077|3680751|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3854961|NCT01637077|3680749|B3|||Age||years|Mean|53.7|53.7|Standard Deviation|13.5|13.5|||
3854962|NCT01637077|3680750|B2|||Age||years|Mean|53.2|53.2|Standard Deviation|14.3|14.3|||
3854963|NCT01637077|3680751|B1|||Age||years|Mean|54.2|54.2|Standard Deviation|12.9|12.9|||
3854964|NCT01636986|3680778|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3854965|NCT01636986|3680779|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3854966|NCT01636986|3680780|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3854967|NCT01636986|3680778|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3854968|NCT01636986|3680779|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3854969|NCT01636986|3680780|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3854970|NCT01636986|3680778|B3|||Age||years|Mean|23.89|23.89|Standard Deviation|4.56|4.56|||
3854971|NCT01636986|3680779|B2|||Age||years|Mean|24.53|24.53|Standard Deviation|4.83|4.83|||
3854972|NCT01636986|3680780|B1|||Age||years|Mean|23.26|23.26|Standard Deviation|4.28|4.28|||
3854973|NCT01636960|3680787|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3854974|NCT01636960|3680787|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3854975|NCT01636960|3680787|B1|||Age||Years|Mean|43.3|43.3|Standard Deviation|13.7|13.7|||
3854976|NCT01636947|3680793|B3||Male|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
3854977|NCT01636947|3680794|B2||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3854978|NCT01636947|3680795|B1||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3854979|NCT01636947|3680793|B3||Female|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
3854980|NCT01636947|3680794|B2||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3854981|NCT01636947|3680795|B1||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3854982|NCT01636947|3680793|B3|≥70 years||Age, Customized||Participants|Number|119|119.0||||||
3854983|NCT01636947|3680794|B2|≥70 years||Age, Customized||Participants|Number|65|65.0||||||
3854984|NCT01636947|3680795|B1|≥70 years||Age, Customized||Participants|Number|54|54.0||||||
3854985|NCT01636947|3680793|B3|60 to 69 years||Age, Customized||Participants|Number|151|151.0||||||
3854986|NCT01636947|3680794|B2|60 to 69 years||Age, Customized||Participants|Number|77|77.0||||||
3854987|NCT01636947|3680795|B1|60 to 69 years||Age, Customized||Participants|Number|74|74.0||||||
3854988|NCT01636947|3680793|B3|50 to 59 years||Age, Customized||Participants|Number|138|138.0||||||
3854989|NCT01636947|3680794|B2|50 to 59 years||Age, Customized||Participants|Number|65|65.0||||||
3854990|NCT01636947|3680795|B1|50 to 59 years||Age, Customized||Participants|Number|73|73.0||||||
3854991|NCT01636947|3680793|B3|40 to 49 years||Age, Customized||Participants|Number|60|60.0||||||
3854992|NCT01636947|3680794|B2|40 to 49 years||Age, Customized||Participants|Number|28|28.0||||||
3854993|NCT01636947|3680795|B1|40 to 49 years||Age, Customized||Participants|Number|32|32.0||||||
3854994|NCT01636947|3680793|B3|30 to 39 years||Age, Customized||Participants|Number|15|15.0||||||
3854995|NCT01636947|3680794|B2|30 to 39 years||Age, Customized||Participants|Number|10|10.0||||||
3854996|NCT01636947|3680795|B1|30 to 39 years||Age, Customized||Participants|Number|5|5.0||||||
3854997|NCT01636947|3680793|B3|20 to 29 years||Age, Customized||Participants|Number|7|7.0||||||
3854998|NCT01636947|3680794|B2|20 to 29 years||Age, Customized||Participants|Number|3|3.0||||||
3854999|NCT01636947|3680795|B1|20 to 29 years||Age, Customized||Participants|Number|4|4.0||||||
3855000|NCT01636882|3680816|B1|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3855001|NCT01636882|3680816|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3855002|NCT01636882|3680816|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3855003|NCT01636882|3680816|B1|||Age||years|Mean|68.1|68.1|Standard Deviation|12.8|12.8|||
3855004|NCT01636778|3680820|B1|>=50 Gi Platelets/L||Baseline platelet counts||Participants|Number|37|37.0||||||
3855005|NCT01636778|3680820|B1|<50 Gi Platelets/L||Baseline platelet counts||Participants|Number|8|8.0||||||
3855006|NCT01636778|3680820|B1|||Baseline Hepatitis C Virus (HCV) RNA||Log IU/mL|Mean|6.41|6.41|Standard Deviation|0.706|0.706|||
3855007|NCT01636778|3680820|B1|||Baseline alanine transaminase (ALT)||IU/L|Mean|78.2|78.2|Standard Deviation|47.82|47.82|||
3855008|NCT01636778|3680820|B1|Experienced||Number of Participants with or without previous IFN use||Participants|Number|21|21.0||||||
3855009|NCT01636778|3680820|B1|Naïve||Number of Participants with or without previous IFN use||Participants|Number|24|24.0||||||
3855010|NCT01636778|3680820|B1|C (Score > 9)||Child-Pugh Class|The Child-Pugh (CP) score (ranging from 5 to 15, with 5 being mild and 15 being severe) is calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess the severity of liver disease. A CP score of 5-6 = Class A (mild); 7-9 = Class B (moderate); >9 = Class C (severe).|Participants|Number|0|0.0||||||
3855011|NCT01636778|3680820|B1|B (Score 7 - 9)||Child-Pugh Class|The Child-Pugh (CP) score (ranging from 5 to 15, with 5 being mild and 15 being severe) is calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess the severity of liver disease. A CP score of 5-6 = Class A (mild); 7-9 = Class B (moderate); >9 = Class C (severe).|Participants|Number|1|1.0||||||
3855012|NCT01636778|3680820|B1|A (Score 5 - 6)||Child-Pugh Class|The Child-Pugh (CP) score (ranging from 5 to 15, with 5 being mild and 15 being severe) is calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess the severity of liver disease. A CP score of 5-6 = Class A (mild); 7-9 = Class B (moderate); >9 = Class C (severe).|Participants|Number|44|44.0||||||
3855013|NCT01636778|3680820|B1|Others||HCV genotype||Participants|Number|1|1.0||||||
3855014|NCT01636778|3680820|B1|2b||HCV genotype||Participants|Number|5|5.0||||||
3855015|NCT01636778|3680820|B1|2a||HCV genotype||Participants|Number|6|6.0||||||
3855016|NCT01636778|3680820|B1|1b||HCV genotype||Participants|Number|33|33.0||||||
3855017|NCT01636778|3680820|B1|1a||HCV genotype||Participants|Number|0|0.0||||||
3855018|NCT01636778|3680820|B1|Liver cirrosis||Diagnosis||Participants|Number|22|22.0||||||
3855019|NCT01636778|3680820|B1|Chronic hepatitis C||Diagnosis||Participants|Number|23|23.0||||||
3855020|NCT01636778|3680820|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|45|45.0||||||
3855021|NCT01636778|3680820|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3855022|NCT01636778|3680820|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3855023|NCT01636778|3680820|B1|||Age||Years|Mean|57.8|57.8|Standard Deviation|9.65|9.65|||
3855024|NCT01636765|3680885|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3855025|NCT01636765|3680885|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3855026|NCT01636765|3680885|B1|||Age||Years|Mean|44.2|44.2|Full Range|||19.0|76.0|
3855027|NCT01636713|3680890|B4|Asian-Mixed Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3855028|NCT01636713|3680891|B3|Asian-Mixed Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3855029|NCT01636713|3680892|B2|Asian-Mixed Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3855030|NCT01636713|3680893|B1|Asian-Mixed Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3855031|NCT01636713|3680890|B4|Asian-South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|62|62.0||||||
3855032|NCT01636713|3680891|B3|Asian-South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
3855033|NCT01636713|3680892|B2|Asian-South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
3855034|NCT01636713|3680893|B1|Asian-South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
3855035|NCT01636713|3680890|B4|Asian-East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|516|516.0||||||
3855036|NCT01636713|3680891|B3|Asian-East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|173|173.0||||||
3855037|NCT01636713|3680892|B2|Asian-East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|173|173.0||||||
3855038|NCT01636713|3680893|B1|Asian-East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|170|170.0||||||
3855039|NCT01636713|3680890|B4||Male|Gender||Participants|Count of Participants|542|542.0||||||
3855040|NCT01636713|3680891|B3||Male|Gender||Participants|Count of Participants|182|182.0||||||
3855041|NCT01636713|3680892|B2||Male|Gender||Participants|Count of Participants|183|183.0||||||
3855042|NCT01636713|3680893|B1||Male|Gender||Participants|Count of Participants|177|177.0||||||
3855043|NCT01636713|3680890|B4||Female|Gender||Participants|Count of Participants|38|38.0||||||
3855044|NCT01636713|3680891|B3||Female|Gender||Participants|Count of Participants|11|11.0||||||
3855045|NCT01636713|3680892|B2||Female|Gender||Participants|Count of Participants|11|11.0||||||
3855046|NCT01636713|3680893|B1||Female|Gender||Participants|Count of Participants|16|16.0||||||
3855047|NCT01636713|3680890|B4|||Age||Years|Mean|64.0|64.0|Standard Deviation|8.57|8.57|||
3855048|NCT01636713|3680891|B3|||Age||Years|Mean|63.7|63.7|Standard Deviation|8.26|8.26|||
3855049|NCT01636713|3680892|B2|||Age||Years|Mean|64.0|64.0|Standard Deviation|8.71|8.71|||
3855050|NCT01636713|3680893|B1|||Age||Years|Mean|64.3|64.3|Standard Deviation|8.78|8.78|||
3855051|NCT01636687|3680909|B4||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3855052|NCT01636687|3680910|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3855053|NCT01636687|3680911|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3855054|NCT01636687|3680912|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3855055|NCT01636687|3680909|B4||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3855056|NCT01636687|3680910|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3855057|NCT01636687|3680911|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3855058|NCT01636687|3680912|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3855059|NCT01636687|3680909|B4|||Age||years|Mean|44.7|44.7|Standard Deviation|13.80|13.8|||
3855060|NCT01636687|3680910|B3|||Age||years|Mean|43.7|43.7|Standard Deviation|12.74|12.74|||
3855061|NCT01636687|3680911|B2|||Age||years|Mean|46.6|46.6|Standard Deviation|14.23|14.23|||
3855062|NCT01636687|3680912|B1|||Age||years|Mean|43.9|43.9|Standard Deviation|14.41|14.41|||
3855063|NCT01636661|3681003|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3855064|NCT01636661|3681004|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3855065|NCT01636661|3681005|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3855066|NCT01636661|3681003|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3855067|NCT01636661|3681004|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3855068|NCT01636661|3681005|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3855069|NCT01636661|3681003|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3855070|NCT01636661|3681004|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3855071|NCT01636661|3681005|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3855072|NCT01636661|3681003|B3|||Age||years|Median|14.7|14.7|Standard Deviation|3.5|3.5|||
3855073|NCT01636661|3681004|B2|||Age||years|Median|16.9|16.9|Standard Deviation|2.6|2.6|||
3855074|NCT01636661|3681005|B1|||Age||years|Median|10.7|10.7|Standard Deviation|3.2|3.2|||
3855075|NCT01636661|3681003|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3855076|NCT01636661|3681004|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3855077|NCT01636661|3681005|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3855078|NCT01636661|3681003|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3855079|NCT01636661|3681004|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3855080|NCT01636661|3681005|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3855081|NCT01636661|3681003|B3||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
3855082|NCT01636661|3681004|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3855083|NCT01636661|3681005|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3855084|NCT01636466|3681014|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3855085|NCT01636466|3681016|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3855086|NCT01636466|3681014|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3855087|NCT01636466|3681016|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3855088|NCT01636466|3681014|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3855089|NCT01636466|3681016|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3855090|NCT01636466|3681014|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3855091|NCT01636466|3681016|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3855092|NCT01636466|3681014|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3855093|NCT01636466|3681016|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3855094|NCT01636453|3681025|B1|||BMI||kg/m^2|Median|26.9|26.9|Inter-Quartile Range|||23.4|32.0|
3855095|NCT01636453|3681025|B1|Japan||Region of Enrollment||participants|Number|25|25.0||||||
3855096|NCT01636453|3681025|B1|United States||Region of Enrollment||participants|Number|95|95.0||||||
3855097|NCT01636453|3681025|B1|Race|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3855098|NCT01636453|3681025|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3855099|NCT01636453|3681025|B1|Race|American Indian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3855100|NCT01636453|3681025|B1|Race|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|61|61.0||||||
3855101|NCT01636453|3681025|B1|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3855102|NCT01636453|3681025|B1|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3855103|NCT01636453|3681025|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3855104|NCT01636453|3681025|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3855105|NCT01636453|3681025|B1||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
3855106|NCT01636453|3681025|B1||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
3855107|NCT01636453|3681025|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3855108|NCT01636414|3681041|B4||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3855109|NCT01636414|3681042|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3855110|NCT01636414|3681043|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3855111|NCT01636414|3681044|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3855112|NCT01636414|3681041|B4||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3855113|NCT01636414|3681042|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3855114|NCT01636414|3681043|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3855115|NCT01636414|3681044|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3855116|NCT01636414|3681041|B4|||Age||years|Mean|62.68|62.68|Standard Deviation|10.41|10.41|||
3855117|NCT01636414|3681042|B3|||Age||years|Mean|61.07|61.07|Standard Deviation|14.31|14.31|||
3855118|NCT01636414|3681043|B2|||Age||years|Mean|63.77|63.77|Standard Deviation|7.87|7.87|||
3855119|NCT01636414|3681044|B1|||Age||years|Mean|63.03|63.03|Standard Deviation|8.21|8.21|||
3855120|NCT01636362|3681057|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
3855121|NCT01636362|3681057|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3855122|NCT01636362|3681057|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3855123|NCT01636362|3681057|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3855124|NCT01636362|3681057|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3855125|NCT01636362|3681057|B1||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
3855126|NCT01636362|3681057|B1|||Age||years|Mean|25|25.0|Full Range|||2.0|82.0|
3855127|NCT01636297|3681063|B4|United States||Region of Enrollment||Participants|Count of Participants|91|91.0||||||
3855128|NCT01636297|3681064|B3|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3855129|NCT01636297|3681065|B2|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3855130|NCT01636297|3681066|B1|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3855131|NCT01636297|3681063|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855132|NCT01636297|3681064|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855133|NCT01636297|3681065|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855134|NCT01636297|3681066|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855135|NCT01636297|3681063|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3855136|NCT01636297|3681064|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3855137|NCT01636297|3681065|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3855138|NCT01636297|3681066|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3855139|NCT01636297|3681063|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3855140|NCT01636297|3681064|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855141|NCT01636297|3681065|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855142|NCT01636297|3681066|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3855143|NCT01636297|3681063|B4||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3855144|NCT01636297|3681064|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3855145|NCT01636297|3681065|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3855146|NCT01636297|3681066|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3855147|NCT01636297|3681063|B4||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3855148|NCT01636297|3681064|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3855149|NCT01636297|3681065|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3855150|NCT01636297|3681066|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3855151|NCT01636297|3681063|B4|||Age||years|Mean|63|63.0|Standard Deviation|7|7.0|||
3855152|NCT01636297|3681064|B3|||Age||years|Mean|65|65.0|Standard Deviation|6|6.0|||
3855153|NCT01636297|3681065|B2|||Age||years|Mean|61|61.0|Standard Deviation|9|9.0|||
3855154|NCT01636297|3681066|B1|||Age||years|Mean|63|63.0|Standard Deviation|8|8.0|||
3855155|NCT01636258|3681082|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
3855156|NCT01636258|3681083|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3855157|NCT01636258|3681084|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3855158|NCT01636258|3681082|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3855159|NCT01636258|3681083|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3855160|NCT01636258|3681084|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3855161|NCT01636258|3681082|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3855162|NCT01636258|3681083|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3855163|NCT01636258|3681084|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3855164|NCT01636258|3681082|B3|||Age||years|Mean|55|55.0|Standard Deviation|10.4|10.4|||
3855165|NCT01636258|3681083|B2|||Age||years|Mean|57.7|57.7|Standard Deviation|11.4|11.4|||
3855166|NCT01636258|3681084|B1|||Age||years|Mean|54.1|54.1|Standard Deviation|9.3|9.3|||
3855167|NCT01636258|3681082|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3855168|NCT01636258|3681083|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3855169|NCT01636258|3681084|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3855170|NCT01636258|3681082|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3855171|NCT01636258|3681083|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3855172|NCT01636258|3681084|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3855173|NCT01636258|3681082|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3855174|NCT01636258|3681083|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3855175|NCT01636258|3681084|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3855176|NCT01636206|3681099|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3855177|NCT01636206|3681100|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3855178|NCT01636206|3681101|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3855179|NCT01636206|3681099|B3||Female|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
3855180|NCT01636206|3681100|B2||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3855181|NCT01636206|3681101|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3855182|NCT01636206|3681099|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|12.68|12.68|||
3855183|NCT01636206|3681100|B2|||Age||years|Mean|58.8|58.8|Standard Deviation|12.39|12.39|||
3855184|NCT01636206|3681101|B1|||Age||years|Mean|61.0|61.0|Standard Deviation|13.18|13.18|||
3855185|NCT01636102|3681108|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3855186|NCT01636102|3681109|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3855187|NCT01636102|3681110|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3855188|NCT01636102|3681108|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3855189|NCT01636102|3681109|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3855190|NCT01636102|3681110|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3855191|NCT01636102|3681108|B3|||Age||years|Mean|53.6|53.6|Standard Deviation|18.5|18.5|||
3855192|NCT01636102|3681109|B2|||Age||years|Mean|69.2|69.2|Standard Deviation|5.7|5.7|||
3855193|NCT01636102|3681110|B1|||Age||years|Mean|37.9|37.9|Standard Deviation|12.8|12.8|||
3855194|NCT01636076|3681123|B3|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3855195|NCT01636076|3681124|B2|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3855196|NCT01636076|3681125|B1|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3855197|NCT01636076|3681123|B3|Other||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
3855198|NCT01636076|3681124|B2|Other||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3855199|NCT01636076|3681125|B1|Other||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3855200|NCT01636076|3681123|B3|White||Race/Ethnicity, Customized||Participants|Number|549|549.0||||||
3855201|NCT01636076|3681124|B2|White||Race/Ethnicity, Customized||Participants|Number|276|276.0||||||
3855202|NCT01636076|3681125|B1|White||Race/Ethnicity, Customized||Participants|Number|273|273.0||||||
3855203|NCT01636076|3681123|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3855204|NCT01636076|3681124|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3855205|NCT01636076|3681125|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3855206|NCT01636076|3681123|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3855207|NCT01636076|3681124|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3855364|NCT01635764|3681230|B4||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3855208|NCT01636076|3681125|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3855209|NCT01636076|3681123|B3|Asian||Race/Ethnicity, Customized||Participants|Number|62|62.0||||||
3855210|NCT01636076|3681124|B2|Asian||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
3855211|NCT01636076|3681125|B1|Asian||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
3855212|NCT01636076|3681123|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3855213|NCT01636076|3681124|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3855214|NCT01636076|3681125|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3855215|NCT01636076|3681123|B3||Male|Sex: Female, Male||Participants|Count of Participants|460|460.0||||||
3855216|NCT01636076|3681124|B2||Male|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
3855217|NCT01636076|3681125|B1||Male|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
3855218|NCT01636076|3681123|B3||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3855219|NCT01636076|3681124|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3855220|NCT01636076|3681125|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3855221|NCT01636076|3681123|B3|||Age||years|Mean|64.5|64.5|Standard Deviation|7.82|7.82|||
3855222|NCT01636076|3681124|B2|||Age||years|Mean|64.1|64.1|Standard Deviation|7.89|7.89|||
3855223|NCT01636076|3681125|B1|||Age||years|Mean|64.8|64.8|Standard Deviation|7.74|7.74|||
3855224|NCT01636063|3681186|B3|United States||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3855225|NCT01636063|3681187|B2|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3855226|NCT01636063|3681188|B1|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3855227|NCT01636063|3681186|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855228|NCT01636063|3681187|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855229|NCT01636063|3681188|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855230|NCT01636063|3681186|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855231|NCT01636063|3681187|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855232|NCT01636063|3681188|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855233|NCT01636063|3681186|B3||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3855234|NCT01636063|3681187|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3855235|NCT01636063|3681188|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3855236|NCT01636063|3681186|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3855237|NCT01636063|3681187|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3855238|NCT01636063|3681188|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3855239|NCT01636063|3681186|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855240|NCT01636063|3681187|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855241|NCT01636063|3681188|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855242|NCT01636063|3681186|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3855243|NCT01636063|3681187|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3855244|NCT01636063|3681188|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3855245|NCT01636063|3681186|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855246|NCT01636063|3681187|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855247|NCT01636063|3681188|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855248|NCT01636063|3681186|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855249|NCT01636063|3681187|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855250|NCT01636063|3681188|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855251|NCT01636063|3681186|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3855252|NCT01636063|3681187|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3855253|NCT01636063|3681188|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3855254|NCT01636063|3681186|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3855255|NCT01636063|3681187|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3855256|NCT01636063|3681188|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3855257|NCT01636063|3681186|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3855258|NCT01636063|3681187|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3855259|NCT01636063|3681188|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3855260|NCT01636063|3681186|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3855261|NCT01636063|3681187|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3855262|NCT01636063|3681188|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3855263|NCT01636063|3681186|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3855264|NCT01636063|3681187|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3855265|NCT01636063|3681188|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3855266|NCT01636063|3681186|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3855267|NCT01636063|3681187|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3855268|NCT01636063|3681188|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3855269|NCT01636063|3681186|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3855270|NCT01636063|3681187|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3855271|NCT01636063|3681188|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3855272|NCT01635933|3681195|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3855273|NCT01635933|3681196|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3855274|NCT01635933|3681197|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3855275|NCT01635933|3681195|B3||Female|Sex: Female, Male||Participants|Count of Participants|330|330.0||||||
3855276|NCT01635933|3681196|B2||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3855277|NCT01635933|3681197|B1||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3855278|NCT01635933|3681195|B3|≥65 years||Age, Customized||participants|Number|3|3.0||||||
3855279|NCT01635933|3681196|B2|≥65 years||Age, Customized||participants|Number|1|1.0||||||
3855280|NCT01635933|3681197|B1|≥65 years||Age, Customized||participants|Number|2|2.0||||||
3855281|NCT01635933|3681195|B3|18-64 years||Age, Customized||participants|Number|341|341.0||||||
3855282|NCT01635933|3681196|B2|18-64 years||Age, Customized||participants|Number|174|174.0||||||
3855283|NCT01635933|3681197|B1|18-64 years||Age, Customized||participants|Number|167|167.0||||||
3855284|NCT01635933|3681195|B3|16-17 years||Age, Customized||participants|Number|19|19.0||||||
3855285|NCT01635933|3681196|B2|16-17 years||Age, Customized||participants|Number|10|10.0||||||
3855286|NCT01635933|3681197|B1|16-17 years||Age, Customized||participants|Number|9|9.0||||||
3855287|NCT01635920|3681208|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3855288|NCT01635920|3681209|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3855289|NCT01635920|3681210|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3855290|NCT01635920|3681208|B3||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3855291|NCT01635920|3681209|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3855292|NCT01635920|3681210|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3855293|NCT01635920|3681208|B3|≥ 65 years||Age, Customized||participants|Number|2|2.0||||||
3855294|NCT01635920|3681209|B2|≥ 65 years||Age, Customized||participants|Number|2|2.0||||||
3855295|NCT01635920|3681210|B1|≥ 65 years||Age, Customized||participants|Number|0|0.0||||||
3855296|NCT01635920|3681208|B3|18-64 years||Age, Customized||participants|Number|234|234.0||||||
3855297|NCT01635920|3681209|B2|18-64 years||Age, Customized||participants|Number|119|119.0||||||
3855298|NCT01635920|3681210|B1|18-64 years||Age, Customized||participants|Number|115|115.0||||||
3855299|NCT01635920|3681208|B3|16-17 years||Age, Customized||participants|Number|15|15.0||||||
3855300|NCT01635920|3681209|B2|16-17 years||Age, Customized||participants|Number|5|5.0||||||
3855301|NCT01635920|3681210|B1|16-17 years||Age, Customized||participants|Number|10|10.0||||||
3855302|NCT01635881|3681219|B1|||Lesion Characteristic: Percent Diameter Stenosis|Analysis is based on the number of intent-to-treat lesions (n=67).|Percent Diameter Stenosis|Mean|73.0|73.0|Standard Deviation|12.6|12.6|||
3855303|NCT01635881|3681219|B1|Lesion Length||Lesion Characteristics|Analysis is based on the number of intent-to-treat lesions (n=67).|Millimeters|Mean|15.5|15.5|Standard Deviation|14.7|14.7|||
3855304|NCT01635881|3681219|B1|Minimum Lumen Diameter||Lesion Characteristics|Analysis is based on the number of intent-to-treat lesions (n=67).|Millimeters|Mean|0.7|0.7|Standard Deviation|0.4|0.4|||
3855305|NCT01635881|3681219|B1|Reference Vessel Diameter||Lesion Characteristics|Analysis is based on the number of intent-to-treat lesions (n=67).|Millimeters|Mean|2.6|2.6|Standard Deviation|0.5|0.5|||
3855306|NCT01635881|3681219|B1|3 (complete perfusion)||Lesion Characteristic: Pre-Procedure Thrombolysis in Myocardial Infarction (TIMI) Flow|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|59|59.0||||||
3855307|NCT01635881|3681219|B1|2 (partial perfusion)||Lesion Characteristic: Pre-Procedure Thrombolysis in Myocardial Infarction (TIMI) Flow|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|1|1.0||||||
3855308|NCT01635881|3681219|B1|1 (penetration with minimal perfusion)||Lesion Characteristic: Pre-Procedure Thrombolysis in Myocardial Infarction (TIMI) Flow|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|2|2.0||||||
3855309|NCT01635881|3681219|B1|0 (no perfusion)||Lesion Characteristic: Pre-Procedure Thrombolysis in Myocardial Infarction (TIMI) Flow|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|5|5.0||||||
3855310|NCT01635881|3681219|B1|Eccentric Lesion||Lesion Characteristics|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|40|40.0||||||
3855311|NCT01635881|3681219|B1|Total Occlusion||Lesion Characteristics|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|7|7.0||||||
3855312|NCT01635881|3681219|B1|Intimal Flap||Lesion Characteristics|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|0|0.0||||||
3855313|NCT01635881|3681219|B1|Aneurysm||Lesion Characteristics|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|3|3.0||||||
3855314|NCT01635881|3681219|B1|Ulcerated||Lesion Characteristics|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|0|0.0||||||
3855315|NCT01635881|3681219|B1|Calcification, Any||Lesion Characteristics|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|30|30.0||||||
3855316|NCT01635881|3681219|B1|Tortuosity, Any||Lesion Characteristics|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|9|9.0||||||
3855317|NCT01635881|3681219|B1|Thrombus||Lesion Characteristics|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|0|0.0||||||
3855318|NCT01635881|3681219|B1|Greater or equal to 26 mm||Lesion Characteristic: Lesion Length|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|5|5.0||||||
3855319|NCT01635881|3681219|B1|From 18 and less than 26 mm||Lesion Characteristic: Lesion Length|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|11|11.0||||||
3855320|NCT01635881|3681219|B1|Less than 18 mm||Lesion Characteristic: Lesion Length|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|51|51.0||||||
3855321|NCT01635881|3681219|B1|Distal||Lesion Characteristic: Lesion Location|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|8|8.0||||||
3855322|NCT01635881|3681219|B1|Mid||Lesion Characteristic: Lesion Location|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|32|32.0||||||
3855323|NCT01635881|3681219|B1|Proximal||Lesion Characteristic: Lesion Location|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|16|16.0||||||
3855324|NCT01635881|3681219|B1|Ostial||Lesion Characteristic: Lesion Location|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|11|11.0||||||
3855325|NCT01635881|3681219|B1|Graft||Lesion Characteristic: Target Lesion Vessel|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|2|2.0||||||
3855326|NCT01635881|3681219|B1|Left Main Coronary Artery||Lesion Characteristic: Target Lesion Vessel|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|1|1.0||||||
3855327|NCT01635881|3681219|B1|Right Coronary Artery||Lesion Characteristic: Target Lesion Vessel|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|21|21.0||||||
3855328|NCT01635881|3681219|B1|Circumflex Artery||Lesion Characteristic: Target Lesion Vessel|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|14|14.0||||||
3855329|NCT01635881|3681219|B1|Left Anterior Descending Artery||Lesion Characteristic: Target Lesion Vessel|Analysis is based on the number of intent-to-treat lesions (n=67).|Lesions|Number|26|26.0||||||
3855330|NCT01635881|3681219|B1|Family History of Coronary Artery Disease||Cardiac Risk Factors|More than one Cardiac Risk Factor may be reported for each participant.|Participants|Number|37|37.0||||||
3855331|NCT01635881|3681219|B1|Hypertension Requiring Medication||Cardiac Risk Factors|More than one Cardiac Risk Factor may be reported for each participant.|Participants|Number|56|56.0||||||
3855332|NCT01635881|3681219|B1|Hyperlipidemia Requiring Medication||Cardiac Risk Factors|More than one Cardiac Risk Factor may be reported for each participant.|Participants|Number|51|51.0||||||
3855333|NCT01635881|3681219|B1|Medically Treated Diabetes||Cardiac Risk Factors|More than one Cardiac Risk Factor may be reported for each participant.|Participants|Number|21|21.0||||||
3855334|NCT01635881|3681219|B1|Smoking, Ever||Cardiac Risk Factors|More than one Cardiac Risk Factor may be reported for each participant.|Participants|Number|36|36.0||||||
3855335|NCT01635881|3681219|B1|Silent Ischemia||Cardiac History|More than one Cardiac History measure may be reported for each participant.|Participants|Number|7|7.0||||||
3855336|NCT01635881|3681219|B1|Unstable Angina||Cardiac History|More than one Cardiac History measure may be reported for each participant.|Participants|Number|25|25.0||||||
3855337|NCT01635881|3681219|B1|Stable Angina||Cardiac History|More than one Cardiac History measure may be reported for each participant.|Participants|Number|24|24.0||||||
3855338|NCT01635881|3681219|B1|Congestive Heart Failure||Cardiac History|More than one Cardiac History measure may be reported for each participant.|Participants|Number|2|2.0||||||
3855339|NCT01635881|3681219|B1|Previous Myocardial Infarction||Cardiac History|More than one Cardiac History measure may be reported for each participant.|Participants|Number|14|14.0||||||
3855340|NCT01635881|3681219|B1|Previous Coronary Artery Bypass Graft||Cardiac History|More than one Cardiac History measure may be reported for each participant.|Participants|Number|11|11.0||||||
3855341|NCT01635881|3681219|B1|Previous Percutaneous Coronary Intervention||Cardiac History|More than one Cardiac History measure may be reported for each participant.|Participants|Number|37|37.0||||||
3855342|NCT01635881|3681219|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
3855343|NCT01635881|3681219|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3855344|NCT01635881|3681219|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3855345|NCT01635881|3681219|B1|White||Race/Ethnicity, Customized||Participants|Number|57|57.0||||||
3855346|NCT01635881|3681219|B1|Black, or African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3855347|NCT01635881|3681219|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3855348|NCT01635881|3681219|B1|American Indian or Alaska native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3855349|NCT01635881|3681219|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3855350|NCT01635881|3681219|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3855351|NCT01635881|3681219|B1|||Age||years|Mean|60.9|60.9|Standard Deviation|10.5|10.5|||
3855352|NCT01635881|3681219|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3855353|NCT01635881|3681219|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3855354|NCT01635881|3681219|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3855355|NCT01635855|3681224|B1|United States||Region of Enrollment||participants|Number|117|117.0||||||
3855356|NCT01635855|3681224|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3855357|NCT01635855|3681224|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3855358|NCT01635855|3681224|B1||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
3855359|NCT01635855|3681224|B1||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
3855360|NCT01635855|3681224|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3855361|NCT01635855|3681224|B1|||Age||years|Mean|57.04|57.04|Standard Deviation|9.40|9.4|||
3855362|NCT01635764|3681228|B6||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3855363|NCT01635764|3681229|B5||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3855365|NCT01635764|3681231|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3855366|NCT01635764|3681232|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3855367|NCT01635764|3681233|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3855368|NCT01635764|3681228|B6||Female|Sex: Female, Male||Participants|Count of Participants|328|328.0||||||
3855369|NCT01635764|3681229|B5||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3855370|NCT01635764|3681230|B4||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3855371|NCT01635764|3681231|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3855372|NCT01635764|3681232|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3855373|NCT01635764|3681233|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3855374|NCT01635764|3681228|B6|||Age||years|Mean|36.8|36.8|Standard Deviation|11.35|11.35|||
3855375|NCT01635764|3681229|B5|||Age||years|Mean|37.0|37.0|Standard Deviation|12.28|12.28|||
3855376|NCT01635764|3681230|B4|||Age||years|Mean|38.5|38.5|Standard Deviation|11.92|11.92|||
3855377|NCT01635764|3681231|B3|||Age||years|Mean|36.5|36.5|Standard Deviation|11.06|11.06|||
3855378|NCT01635764|3681232|B2|||Age||years|Mean|36.1|36.1|Standard Deviation|10.50|10.5|||
3855379|NCT01635764|3681233|B1|||Age||years|Mean|35.5|35.5|Standard Deviation|10.27|10.27|||
3855380|NCT01635504|3681261|B1|||parotid gland volumes||participants|Number|5|5.0||||||
3855381|NCT01635504|3681261|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3855382|NCT01635504|3681261|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3855383|NCT01635504|3681261|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3855384|NCT01635504|3681261|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3855385|NCT01635504|3681261|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3855386|NCT01635439|3681266|B3|||Gestational age|For the purpose of pregnancy dating, Gestational age refers to the pregnancy duration in weeks calculated from the date of the last menstrual period.|weeks|Mean|40.5|40.5|Standard Deviation|1.2|1.2|||
3855387|NCT01635439|3681267|B2|||Gestational age|For the purpose of pregnancy dating, Gestational age refers to the pregnancy duration in weeks calculated from the date of the last menstrual period.|weeks|Mean|40.4|40.4|Standard Deviation|1.3|1.3|||
3855388|NCT01635439|3681268|B1|||Gestational age|For the purpose of pregnancy dating, Gestational age refers to the pregnancy duration in weeks calculated from the date of the last menstrual period.|weeks|Mean|40.6|40.6|Standard Deviation|0.9|0.9|||
3855389|NCT01635439|3681266|B3|P5||Parity|Parity is the number times a woman has given birth to a fetus with a gestational age of 24 weeks or more, regardless of whether the child was born alive or was stillborn. (e.g., P3 is 3 births), a multiple birth considered as a single parous experience|participants|Number|5|5.0||||||
3855390|NCT01635439|3681267|B2|P5||Parity|Parity is the number times a woman has given birth to a fetus with a gestational age of 24 weeks or more, regardless of whether the child was born alive or was stillborn. (e.g., P3 is 3 births), a multiple birth considered as a single parous experience|participants|Number|3|3.0||||||
3855391|NCT01635439|3681268|B1|P5||Parity|Parity is the number times a woman has given birth to a fetus with a gestational age of 24 weeks or more, regardless of whether the child was born alive or was stillborn. (e.g., P3 is 3 births), a multiple birth considered as a single parous experience|participants|Number|2|2.0||||||
3855392|NCT01635439|3681266|B3|P4||Parity|Parity is the number times a woman has given birth to a fetus with a gestational age of 24 weeks or more, regardless of whether the child was born alive or was stillborn. (e.g., P3 is 3 births), a multiple birth considered as a single parous experience|participants|Number|6|6.0||||||
3855393|NCT01635439|3681267|B2|P4||Parity|Parity is the number times a woman has given birth to a fetus with a gestational age of 24 weeks or more, regardless of whether the child was born alive or was stillborn. (e.g., P3 is 3 births), a multiple birth considered as a single parous experience|participants|Number|3|3.0||||||
3855394|NCT01635439|3681268|B1|P4||Parity|Parity is the number times a woman has given birth to a fetus with a gestational age of 24 weeks or more, regardless of whether the child was born alive or was stillborn. (e.g., P3 is 3 births), a multiple birth considered as a single parous experience|participants|Number|3|3.0||||||
3855395|NCT01635439|3681266|B3|P3||Parity|Parity is the number times a woman has given birth to a fetus with a gestational age of 24 weeks or more, regardless of whether the child was born alive or was stillborn. (e.g., P3 is 3 births), a multiple birth considered as a single parous experience|participants|Number|19|19.0||||||
3855396|NCT01635439|3681267|B2|P3||Parity|Parity is the number times a woman has given birth to a fetus with a gestational age of 24 weeks or more, regardless of whether the child was born alive or was stillborn. (e.g., P3 is 3 births), a multiple birth considered as a single parous experience|participants|Number|8|8.0||||||
3855397|NCT01635439|3681268|B1|P3||Parity|Parity is the number times a woman has given birth to a fetus with a gestational age of 24 weeks or more, regardless of whether the child was born alive or was stillborn. (e.g., P3 is 3 births), a multiple birth considered as a single parous experience|participants|Number|11|11.0||||||
3855398|NCT01635439|3681266|B3|P2||Parity|Parity is the number times a woman has given birth to a fetus with a gestational age of 24 weeks or more, regardless of whether the child was born alive or was stillborn. (e.g., P3 is 3 births), a multiple birth considered as a single parous experience|participants|Number|34|34.0||||||
3855399|NCT01635439|3681267|B2|P2||Parity|Parity is the number times a woman has given birth to a fetus with a gestational age of 24 weeks or more, regardless of whether the child was born alive or was stillborn. (e.g., P3 is 3 births), a multiple birth considered as a single parous experience|participants|Number|14|14.0||||||
3855400|NCT01635439|3681268|B1|P2||Parity|Parity is the number times a woman has given birth to a fetus with a gestational age of 24 weeks or more, regardless of whether the child was born alive or was stillborn. (e.g., P3 is 3 births), a multiple birth considered as a single parous experience|participants|Number|20|20.0||||||
3855449|NCT01635244|3681285|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855401|NCT01635439|3681266|B3|P1||Parity|Parity is the number times a woman has given birth to a fetus with a gestational age of 24 weeks or more, regardless of whether the child was born alive or was stillborn. (e.g., P3 is 3 births), a multiple birth considered as a single parous experience|participants|Number|43|43.0||||||
3855402|NCT01635439|3681267|B2|P1||Parity|Parity is the number times a woman has given birth to a fetus with a gestational age of 24 weeks or more, regardless of whether the child was born alive or was stillborn. (e.g., P3 is 3 births), a multiple birth considered as a single parous experience|participants|Number|23|23.0||||||
3855403|NCT01635439|3681268|B1|P1||Parity|Parity is the number times a woman has given birth to a fetus with a gestational age of 24 weeks or more, regardless of whether the child was born alive or was stillborn. (e.g., P3 is 3 births), a multiple birth considered as a single parous experience|participants|Number|20|20.0||||||
3855404|NCT01635439|3681266|B3|P0||Parity|Parity is the number times a woman has given birth to a fetus with a gestational age of 24 weeks or more, regardless of whether the child was born alive or was stillborn. (e.g., P3 is 3 births), a multiple birth considered as a single parous experience|participants|Number|93|93.0||||||
3855405|NCT01635439|3681267|B2|P0||Parity|Parity is the number times a woman has given birth to a fetus with a gestational age of 24 weeks or more, regardless of whether the child was born alive or was stillborn. (e.g., P3 is 3 births), a multiple birth considered as a single parous experience|participants|Number|49|49.0||||||
3855406|NCT01635439|3681268|B1|P0||Parity|Parity is the number times a woman has given birth to a fetus with a gestational age of 24 weeks or more, regardless of whether the child was born alive or was stillborn. (e.g., P3 is 3 births), a multiple birth considered as a single parous experience|participants|Number|44|44.0||||||
3855407|NCT01635439|3681266|B3|||Body mass index||kg/m^2|Mean|23.3|23.3|Standard Deviation|3.1|3.1|||
3855408|NCT01635439|3681267|B2|||Body mass index||kg/m^2|Mean|23.5|23.5|Standard Deviation|3.5|3.5|||
3855409|NCT01635439|3681268|B1|||Body mass index||kg/m^2|Mean|23|23.0|Standard Deviation|2.7|2.7|||
3855410|NCT01635439|3681266|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3855411|NCT01635439|3681267|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3855412|NCT01635439|3681268|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3855413|NCT01635439|3681266|B3||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
3855414|NCT01635439|3681267|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3855415|NCT01635439|3681268|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3855416|NCT01635439|3681266|B3|||Age||years|Mean|26.4|26.4|Standard Deviation|4.7|4.7|||
3855417|NCT01635439|3681267|B2|||Age||years|Mean|26.8|26.8|Standard Deviation|5.1|5.1|||
3855418|NCT01635439|3681268|B1|||Age||years|Mean|26|26.0|Standard Deviation|4.3|4.3|||
3855419|NCT01635244|3681283|B4|United States||Region of Enrollment||participants|Number|56|56.0||||||
3855420|NCT01635244|3681284|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
3855421|NCT01635244|3681285|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
3855422|NCT01635244|3681286|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3855423|NCT01635244|3681283|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3855424|NCT01635244|3681284|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3855425|NCT01635244|3681285|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855426|NCT01635244|3681286|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3855427|NCT01635244|3681283|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855428|NCT01635244|3681284|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855429|NCT01635244|3681285|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855430|NCT01635244|3681286|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855431|NCT01635244|3681283|B4||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3855432|NCT01635244|3681284|B3||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3855433|NCT01635244|3681285|B2||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3855434|NCT01635244|3681286|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3855435|NCT01635244|3681283|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855436|NCT01635244|3681284|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855437|NCT01635244|3681285|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855438|NCT01635244|3681286|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855439|NCT01635244|3681283|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855440|NCT01635244|3681284|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855441|NCT01635244|3681285|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855442|NCT01635244|3681286|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855443|NCT01635244|3681283|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855444|NCT01635244|3681284|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855445|NCT01635244|3681285|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855446|NCT01635244|3681286|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855447|NCT01635244|3681283|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855448|NCT01635244|3681284|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855574|NCT01634854|3681336|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3855450|NCT01635244|3681286|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855451|NCT01635244|3681283|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3855452|NCT01635244|3681284|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3855453|NCT01635244|3681285|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855454|NCT01635244|3681286|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3855455|NCT01635244|3681283|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3855456|NCT01635244|3681284|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3855457|NCT01635244|3681285|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3855458|NCT01635244|3681286|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3855459|NCT01635244|3681283|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855460|NCT01635244|3681284|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855461|NCT01635244|3681285|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855462|NCT01635244|3681286|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855463|NCT01635244|3681283|B4||Male|Gender||Participants|Count of Participants|37|37.0||||||
3855464|NCT01635244|3681284|B3||Male|Gender||Participants|Count of Participants|14|14.0||||||
3855465|NCT01635244|3681285|B2||Male|Gender||Participants|Count of Participants|12|12.0||||||
3855466|NCT01635244|3681286|B1||Male|Gender||Participants|Count of Participants|11|11.0||||||
3855467|NCT01635244|3681283|B4||Female|Gender||Participants|Count of Participants|19|19.0||||||
3855468|NCT01635244|3681284|B3||Female|Gender||Participants|Count of Participants|4|4.0||||||
3855469|NCT01635244|3681285|B2||Female|Gender||Participants|Count of Participants|9|9.0||||||
3855470|NCT01635244|3681286|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
3855471|NCT01635244|3681283|B4|||Age||years|Median|70|70.0|Inter-Quartile Range|||63.0|78.0|
3855472|NCT01635244|3681284|B3|||Age||years|Median|71|71.0|Inter-Quartile Range|||64.0|76.0|
3855473|NCT01635244|3681285|B2|||Age||years|Median|67|67.0|Inter-Quartile Range|||61.0|74.0|
3855474|NCT01635244|3681286|B1|||Age||years|Median|74|74.0|Inter-Quartile Range|||64.0|80.0|
3855475|NCT01635218|3681296|B4|||Baseline score in Greene Climacteric Scale|"Greene Climacteric Scale is intended to be a standard measure of core climacteric symptoms. For this study a total range was assessed: 0 (without climacteric symptoms) up to 63 (most severe climacteric symptoms). The scale measures four separate sub-scales (anxiety, depression, somatic symptoms and sexual function). The score of the four sub-scales was summed. A total score of 0 -10 is considered without symptoms, 11 - 29 (mild symptoms), 30 - 49 (moderate symptoms) and > 50 (severe symptoms).~The score presented here is the baseline score of Greene Climacteric Scale before treatment."|Units in Greene Climacteric Scale|Mean|35.5|35.5|Standard Deviation|10.2|10.2|||
3855476|NCT01635218|3681297|B3|||Baseline score in Greene Climacteric Scale|"Greene Climacteric Scale is intended to be a standard measure of core climacteric symptoms. For this study a total range was assessed: 0 (without climacteric symptoms) up to 63 (most severe climacteric symptoms). The scale measures four separate sub-scales (anxiety, depression, somatic symptoms and sexual function). The score of the four sub-scales was summed. A total score of 0 -10 is considered without symptoms, 11 - 29 (mild symptoms), 30 - 49 (moderate symptoms) and > 50 (severe symptoms).~The score presented here is the baseline score of Greene Climacteric Scale before treatment."|Units in Greene Climacteric Scale|Mean|37.9|37.9|Standard Deviation|11.5|11.5|||
3855477|NCT01635218|3681298|B2|||Baseline score in Greene Climacteric Scale|"Greene Climacteric Scale is intended to be a standard measure of core climacteric symptoms. For this study a total range was assessed: 0 (without climacteric symptoms) up to 63 (most severe climacteric symptoms). The scale measures four separate sub-scales (anxiety, depression, somatic symptoms and sexual function). The score of the four sub-scales was summed. A total score of 0 -10 is considered without symptoms, 11 - 29 (mild symptoms), 30 - 49 (moderate symptoms) and > 50 (severe symptoms).~The score presented here is the baseline score of Greene Climacteric Scale before treatment."|Units in Greene Climacteric Scale|Mean|33.5|33.5|Standard Deviation|10.1|10.1|||
3855478|NCT01635218|3681299|B1|||Baseline score in Greene Climacteric Scale|"Greene Climacteric Scale is intended to be a standard measure of core climacteric symptoms. For this study a total range was assessed: 0 (without climacteric symptoms) up to 63 (most severe climacteric symptoms). The scale measures four separate sub-scales (anxiety, depression, somatic symptoms and sexual function). The score of the four sub-scales was summed. A total score of 0 -10 is considered without symptoms, 11 - 29 (mild symptoms), 30 - 49 (moderate symptoms) and > 50 (severe symptoms).~The score presented here is the baseline score of Greene Climacteric Scale before treatment."|Units in Greene Climacteric Scale|Mean|35.3|35.3|Standard Deviation|8.5|8.5|||
3855479|NCT01635218|3681296|B4|||Baseline score in Beck Depression Inventory|"Beck Depression Inventory is a 21-question multiple-choice self-report inventory. For this study a total score range was assessed: 0 (without depression) up to 63 (most severe depression): 0 - 8 is considered normal, 9 - 18 (mild to moderate depression), 19 - 28 (moderate to severe depression), > 29 (severe depression). The score of the 21 questions was summed.~The score presented here is the baseline score of BDI, the final score after the 6 weeks treatment is presented in the Outcome measure data table."|Units in Beck Depression Inventory|Mean|26.1|26.1|Standard Deviation|8.0|8.0|||
3855480|NCT01635218|3681297|B3|||Baseline score in Beck Depression Inventory|"Beck Depression Inventory is a 21-question multiple-choice self-report inventory. For this study a total score range was assessed: 0 (without depression) up to 63 (most severe depression): 0 - 8 is considered normal, 9 - 18 (mild to moderate depression), 19 - 28 (moderate to severe depression), > 29 (severe depression). The score of the 21 questions was summed.~The score presented here is the baseline score of BDI, the final score after the 6 weeks treatment is presented in the Outcome measure data table."|Units in Beck Depression Inventory|Mean|27.0|27.0|Standard Deviation|9.0|9.0|||
3855481|NCT01635218|3681298|B2|||Baseline score in Beck Depression Inventory|"Beck Depression Inventory is a 21-question multiple-choice self-report inventory. For this study a total score range was assessed: 0 (without depression) up to 63 (most severe depression): 0 - 8 is considered normal, 9 - 18 (mild to moderate depression), 19 - 28 (moderate to severe depression), > 29 (severe depression). The score of the 21 questions was summed.~The score presented here is the baseline score of BDI, the final score after the 6 weeks treatment is presented in the Outcome measure data table."|Units in Beck Depression Inventory|Mean|25.0|25.0|Standard Deviation|7.8|7.8|||
3855482|NCT01635218|3681299|B1|||Baseline score in Beck Depression Inventory|"Beck Depression Inventory is a 21-question multiple-choice self-report inventory. For this study a total score range was assessed: 0 (without depression) up to 63 (most severe depression): 0 - 8 is considered normal, 9 - 18 (mild to moderate depression), 19 - 28 (moderate to severe depression), > 29 (severe depression). The score of the 21 questions was summed.~The score presented here is the baseline score of BDI, the final score after the 6 weeks treatment is presented in the Outcome measure data table."|Units in Beck Depression Inventory|Mean|26.3|26.3|Standard Deviation|7.2|7.2|||
3855483|NCT01635218|3681296|B4|||Baseline score in 17-item Hamilton Rating Scale for Depression|"A total score in 17-item Hamilton Scale for Depression was assessed for this study. It ranges from 0 (no depression) up to 52 (most severe depression). A score < or = 7 is considered normal, 7 - 13 (mild depression), 14 - 24 (moderate to severe depression), > 24 (severe depression). The score of the 17 items was summed.~The score presented here is the baseline score of Hamilton Scale, the final score after the 6 weeks treatment is presented in Outcomes measure data table."|Units in Hamilton Scale|Mean|20.8|20.8|Standard Deviation|2.9|2.9|||
3855484|NCT01635218|3681297|B3|||Baseline score in 17-item Hamilton Rating Scale for Depression|"A total score in 17-item Hamilton Scale for Depression was assessed for this study. It ranges from 0 (no depression) up to 52 (most severe depression). A score < or = 7 is considered normal, 7 - 13 (mild depression), 14 - 24 (moderate to severe depression), > 24 (severe depression). The score of the 17 items was summed.~The score presented here is the baseline score of Hamilton Scale, the final score after the 6 weeks treatment is presented in Outcomes measure data table."|Units in Hamilton Scale|Mean|20.7|20.7|Standard Deviation|3.1|3.1|||
3855485|NCT01635218|3681298|B2|||Baseline score in 17-item Hamilton Rating Scale for Depression|"A total score in 17-item Hamilton Scale for Depression was assessed for this study. It ranges from 0 (no depression) up to 52 (most severe depression). A score < or = 7 is considered normal, 7 - 13 (mild depression), 14 - 24 (moderate to severe depression), > 24 (severe depression). The score of the 17 items was summed.~The score presented here is the baseline score of Hamilton Scale, the final score after the 6 weeks treatment is presented in Outcomes measure data table."|Units in Hamilton Scale|Mean|20.6|20.6|Standard Deviation|2.9|2.9|||
3855486|NCT01635218|3681299|B1|||Baseline score in 17-item Hamilton Rating Scale for Depression|"A total score in 17-item Hamilton Scale for Depression was assessed for this study. It ranges from 0 (no depression) up to 52 (most severe depression). A score < or = 7 is considered normal, 7 - 13 (mild depression), 14 - 24 (moderate to severe depression), > 24 (severe depression). The score of the 17 items was summed.~The score presented here is the baseline score of Hamilton Scale, the final score after the 6 weeks treatment is presented in Outcomes measure data table."|Units in Hamilton Scale|Mean|21.2|21.2|Standard Deviation|2.7|2.7|||
3855487|NCT01635218|3681296|B4|Mexico||Region of Enrollment||participants|Number|133|133.0||||||
3855488|NCT01635218|3681297|B3|Mexico||Region of Enrollment||participants|Number|43|43.0||||||
3855489|NCT01635218|3681298|B2|Mexico||Region of Enrollment||participants|Number|46|46.0||||||
3855490|NCT01635218|3681299|B1|Mexico||Region of Enrollment||participants|Number|44|44.0||||||
3855491|NCT01635218|3681296|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855492|NCT01635218|3681297|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855493|NCT01635218|3681298|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855494|NCT01635218|3681299|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855495|NCT01635218|3681296|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855496|NCT01635218|3681297|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855497|NCT01635218|3681298|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855498|NCT01635218|3681299|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855499|NCT01635218|3681296|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|133|133.0||||||
3855500|NCT01635218|3681297|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3855501|NCT01635218|3681298|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3855502|NCT01635218|3681299|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3855503|NCT01635218|3681296|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3855504|NCT01635218|3681297|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3855505|NCT01635218|3681298|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3855506|NCT01635218|3681299|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3855507|NCT01635218|3681296|B4||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3855508|NCT01635218|3681297|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3855509|NCT01635218|3681298|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3855510|NCT01635218|3681299|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3855511|NCT01635218|3681296|B4|||Age||years|Mean|49|49.0|Standard Deviation|5.8|5.8|||
3855512|NCT01635218|3681297|B3|||Age||years|Mean|48.8|48.8|Standard Deviation|5.8|5.8|||
3855513|NCT01635218|3681298|B2|||Age||years|Mean|49.2|49.2|Standard Deviation|5.3|5.3|||
3855514|NCT01635218|3681299|B1|||Age||years|Mean|49|49.0|Standard Deviation|6.4|6.4|||
3855515|NCT01635062|3681321|B3|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3855516|NCT01635062|3681322|B2|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3855517|NCT01635062|3681323|B1|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3855518|NCT01635062|3681321|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3855519|NCT01635062|3681322|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3855520|NCT01635062|3681323|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3855521|NCT01635062|3681321|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3855522|NCT01635062|3681322|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3855523|NCT01635062|3681323|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3855524|NCT01635062|3681321|B3|||Age||years|Mean|50.8|50.8|Standard Deviation|7.9|7.9|||
3855525|NCT01635062|3681322|B2|||Age||years|Mean|50.7|50.7|Standard Deviation|5.0|5.0|||
3855526|NCT01635062|3681323|B1|||Age||years|Mean|51.0|51.0|Standard Deviation|10.4|10.4|||
3855527|NCT01635062|3681321|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3855528|NCT01635062|3681322|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3855529|NCT01635062|3681323|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3855530|NCT01635062|3681321|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3855531|NCT01635062|3681322|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3855532|NCT01635062|3681323|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3855533|NCT01635062|3681321|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3855534|NCT01635062|3681322|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3855535|NCT01635062|3681323|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3855536|NCT01634854|3681334|B3|United States||Region of Enrollment||Participants|Count of Participants|121|121.0||||||
3855537|NCT01634854|3681335|B2|United States||Region of Enrollment||Participants|Count of Participants|59|59.0||||||
3855538|NCT01634854|3681336|B1|United States||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
3855539|NCT01634854|3681334|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855540|NCT01634854|3681335|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855541|NCT01634854|3681336|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855542|NCT01634854|3681334|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3855543|NCT01634854|3681335|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3855544|NCT01634854|3681336|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3855545|NCT01634854|3681334|B3||White|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
3855546|NCT01634854|3681335|B2||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3855547|NCT01634854|3681336|B1||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3855548|NCT01634854|3681334|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3855549|NCT01634854|3681335|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3855550|NCT01634854|3681336|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3855551|NCT01634854|3681334|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855552|NCT01634854|3681335|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855553|NCT01634854|3681336|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855554|NCT01634854|3681334|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855555|NCT01634854|3681335|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855556|NCT01634854|3681336|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855557|NCT01634854|3681334|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855558|NCT01634854|3681335|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855559|NCT01634854|3681336|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855560|NCT01634854|3681334|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855561|NCT01634854|3681335|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855562|NCT01634854|3681336|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855563|NCT01634854|3681334|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
3855564|NCT01634854|3681335|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3855565|NCT01634854|3681336|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3855566|NCT01634854|3681334|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3855567|NCT01634854|3681335|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3855568|NCT01634854|3681336|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3855569|NCT01634854|3681334|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3855570|NCT01634854|3681335|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3855571|NCT01634854|3681336|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3855572|NCT01634854|3681334|B3||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3855573|NCT01634854|3681335|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3855575|NCT01634854|3681334|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3855576|NCT01634854|3681335|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3855577|NCT01634854|3681336|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3855578|NCT01634854|3681334|B3||Between 18 and 65 years|Age||Participants|Count of Participants|121|121.0||||||
3855579|NCT01634854|3681335|B2||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
3855580|NCT01634854|3681336|B1||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
3855581|NCT01634854|3681334|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3855582|NCT01634854|3681335|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3855583|NCT01634854|3681336|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3855584|NCT01634659|3681355|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3855585|NCT01634659|3681356|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3855586|NCT01634659|3681357|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3855587|NCT01634659|3681355|B3||Female|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
3855588|NCT01634659|3681356|B2||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3855589|NCT01634659|3681357|B1||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3855590|NCT01634659|3681355|B3|||Age||years|Mean|32.0|32.0|Standard Deviation|9.4|9.4|||
3855591|NCT01634659|3681356|B2|||Age||years|Mean|32.1|32.1|Standard Deviation|8.8|8.8|||
3855592|NCT01634659|3681357|B1|||Age||years|Mean|31.9|31.9|Standard Deviation|10.0|10.0|||
3855593|NCT01634620|3681368|B1|Corticosteroid||Current Medications used for Pulmonary and/or Allergy Conditions|Provided is a summary of medications taken by >= 5% of participants that are used for pulmonary and/or allergy conditions. The most common medications included short-acting bata-agonist bronchodilators (SABA), inhaled corticosteroid (ICS) and long-acting bata-agonist bronchodilators (LABA) combination products, long-acting antimuscarinic antagonists (LAMA), intranasal corticosteroids, leukotriene receptor antagonists, ICS, and combination SABA/SAMA (short-acting antimuscarinic antagonists)|participants|Number|10|10.0||||||
3855594|NCT01634620|3681368|B1|SAMA||Current Medications used for Pulmonary and/or Allergy Conditions|Provided is a summary of medications taken by >= 5% of participants that are used for pulmonary and/or allergy conditions. The most common medications included short-acting bata-agonist bronchodilators (SABA), inhaled corticosteroid (ICS) and long-acting bata-agonist bronchodilators (LABA) combination products, long-acting antimuscarinic antagonists (LAMA), intranasal corticosteroids, leukotriene receptor antagonists, ICS, and combination SABA/SAMA (short-acting antimuscarinic antagonists)|participants|Number|11|11.0||||||
3855595|NCT01634620|3681368|B1|LABA||Current Medications used for Pulmonary and/or Allergy Conditions|Provided is a summary of medications taken by >= 5% of participants that are used for pulmonary and/or allergy conditions. The most common medications included short-acting bata-agonist bronchodilators (SABA), inhaled corticosteroid (ICS) and long-acting bata-agonist bronchodilators (LABA) combination products, long-acting antimuscarinic antagonists (LAMA), intranasal corticosteroids, leukotriene receptor antagonists, ICS, and combination SABA/SAMA (short-acting antimuscarinic antagonists)|participants|Number|12|12.0||||||
3855596|NCT01634620|3681368|B1|Histamine H1-Receptor Antagonist||Current Medications used for Pulmonary and/or Allergy Conditions|Provided is a summary of medications taken by >= 5% of participants that are used for pulmonary and/or allergy conditions. The most common medications included short-acting bata-agonist bronchodilators (SABA), inhaled corticosteroid (ICS) and long-acting bata-agonist bronchodilators (LABA) combination products, long-acting antimuscarinic antagonists (LAMA), intranasal corticosteroids, leukotriene receptor antagonists, ICS, and combination SABA/SAMA (short-acting antimuscarinic antagonists)|participants|Number|12|12.0||||||
3855597|NCT01634620|3681368|B1|Antihistamine||Current Medications used for Pulmonary and/or Allergy Conditions|Provided is a summary of medications taken by >= 5% of participants that are used for pulmonary and/or allergy conditions. The most common medications included short-acting bata-agonist bronchodilators (SABA), inhaled corticosteroid (ICS) and long-acting bata-agonist bronchodilators (LABA) combination products, long-acting antimuscarinic antagonists (LAMA), intranasal corticosteroids, leukotriene receptor antagonists, ICS, and combination SABA/SAMA (short-acting antimuscarinic antagonists)|participants|Number|14|14.0||||||
3855598|NCT01634620|3681368|B1|H2-Receptor Antagonist||Current Medications used for Pulmonary and/or Allergy Conditions|Provided is a summary of medications taken by >= 5% of participants that are used for pulmonary and/or allergy conditions. The most common medications included short-acting bata-agonist bronchodilators (SABA), inhaled corticosteroid (ICS) and long-acting bata-agonist bronchodilators (LABA) combination products, long-acting antimuscarinic antagonists (LAMA), intranasal corticosteroids, leukotriene receptor antagonists, ICS, and combination SABA/SAMA (short-acting antimuscarinic antagonists)|participants|Number|18|18.0||||||
3855599|NCT01634620|3681368|B1|ICS||Current Medications used for Pulmonary and/or Allergy Conditions|Provided is a summary of medications taken by >= 5% of participants that are used for pulmonary and/or allergy conditions. The most common medications included short-acting bata-agonist bronchodilators (SABA), inhaled corticosteroid (ICS) and long-acting bata-agonist bronchodilators (LABA) combination products, long-acting antimuscarinic antagonists (LAMA), intranasal corticosteroids, leukotriene receptor antagonists, ICS, and combination SABA/SAMA (short-acting antimuscarinic antagonists)|participants|Number|20|20.0||||||
3855600|NCT01634620|3681368|B1|SABA/SAMA||Current Medications used for Pulmonary and/or Allergy Conditions|Provided is a summary of medications taken by >= 5% of participants that are used for pulmonary and/or allergy conditions. The most common medications included short-acting bata-agonist bronchodilators (SABA), inhaled corticosteroid (ICS) and long-acting bata-agonist bronchodilators (LABA) combination products, long-acting antimuscarinic antagonists (LAMA), intranasal corticosteroids, leukotriene receptor antagonists, ICS, and combination SABA/SAMA (short-acting antimuscarinic antagonists)|participants|Number|22|22.0||||||
3855633|NCT01634360|3681397|B2||Male|Sex: Female, Male|The participant flow information was collected from all participants who entered the study. Baseline information was collected only for the safety population (all subjects who received at least 1 dose of perampanel in this study and at least 1 dose of study medication during the double-blind phase of the core study).|Participants|Count of Participants|80|80.0||||||
3855601|NCT01634620|3681368|B1|Leukotriene Receptor Antagonist||Current Medications used for Pulmonary and/or Allergy Conditions|Provided is a summary of medications taken by >= 5% of participants that are used for pulmonary and/or allergy conditions. The most common medications included short-acting bata-agonist bronchodilators (SABA), inhaled corticosteroid (ICS) and long-acting bata-agonist bronchodilators (LABA) combination products, long-acting antimuscarinic antagonists (LAMA), intranasal corticosteroids, leukotriene receptor antagonists, ICS, and combination SABA/SAMA (short-acting antimuscarinic antagonists)|participants|Number|28|28.0||||||
3855602|NCT01634620|3681368|B1|Intranasal Corticosteroid||Current Medications used for Pulmonary and/or Allergy Conditions|Provided is a summary of medications taken by >= 5% of participants that are used for pulmonary and/or allergy conditions. The most common medications included short-acting bata-agonist bronchodilators (SABA), inhaled corticosteroid (ICS) and long-acting bata-agonist bronchodilators (LABA) combination products, long-acting antimuscarinic antagonists (LAMA), intranasal corticosteroids, leukotriene receptor antagonists, ICS, and combination SABA/SAMA (short-acting antimuscarinic antagonists)|participants|Number|40|40.0||||||
3855603|NCT01634620|3681368|B1|LAMA||Current Medications used for Pulmonary and/or Allergy Conditions|Provided is a summary of medications taken by >= 5% of participants that are used for pulmonary and/or allergy conditions. The most common medications included short-acting bata-agonist bronchodilators (SABA), inhaled corticosteroid (ICS) and long-acting bata-agonist bronchodilators (LABA) combination products, long-acting antimuscarinic antagonists (LAMA), intranasal corticosteroids, leukotriene receptor antagonists, ICS, and combination SABA/SAMA (short-acting antimuscarinic antagonists)|participants|Number|133|133.0||||||
3855604|NCT01634620|3681368|B1|ICS/LABA Combination||Current Medications used for Pulmonary and/or Allergy Conditions|Provided is a summary of medications taken by >= 5% of participants that are used for pulmonary and/or allergy conditions. The most common medications included short-acting bata-agonist bronchodilators (SABA), inhaled corticosteroid (ICS) and long-acting bata-agonist bronchodilators (LABA) combination products, long-acting antimuscarinic antagonists (LAMA), intranasal corticosteroids, leukotriene receptor antagonists, ICS, and combination SABA/SAMA (short-acting antimuscarinic antagonists)|participants|Number|144|144.0||||||
3855605|NCT01634620|3681368|B1|SABA||Current Medications used for Pulmonary and/or Allergy Conditions|Provided is a summary of medications taken by >= 5% of participants that are used for pulmonary and/or allergy conditions. The most common medications included short-acting bata-agonist bronchodilators (SABA), inhaled corticosteroid (ICS) and long-acting bata-agonist bronchodilators (LABA) combination products, long-acting antimuscarinic antagonists (LAMA), intranasal corticosteroids, leukotriene receptor antagonists, ICS, and combination SABA/SAMA (short-acting antimuscarinic antagonists)|participants|Number|160|160.0||||||
3855606|NCT01634620|3681368|B1|Past Smoker||Smoking Status|At study visit, participants responded to a questionnaire regarding their smoking history. Participants were classified as having never smoked, current smoker, or past smoker.|participants|Number|124|124.0||||||
3855607|NCT01634620|3681368|B1|Current Smoker||Smoking Status|At study visit, participants responded to a questionnaire regarding their smoking history. Participants were classified as having never smoked, current smoker, or past smoker.|participants|Number|58|58.0||||||
3855608|NCT01634620|3681368|B1|Never Smoked||Smoking Status|At study visit, participants responded to a questionnaire regarding their smoking history. Participants were classified as having never smoked, current smoker, or past smoker.|participants|Number|9|9.0||||||
3855609|NCT01634620|3681368|B1|United States||Region of Enrollment||participants|Number|191|191.0||||||
3855610|NCT01634620|3681368|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3855611|NCT01634620|3681368|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3855612|NCT01634620|3681368|B1|||Age||years|Mean|63.9|63.9|Standard Deviation|11.34|11.34|||
3855613|NCT01634555|3681388|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3855614|NCT01634555|3681388|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3855615|NCT01634555|3681388|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855616|NCT01634555|3681388|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3855617|NCT01634555|3681388|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3855618|NCT01634555|3681388|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855619|NCT01634555|3681388|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855620|NCT01634555|3681388|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855621|NCT01634555|3681388|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3855622|NCT01634555|3681388|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3855623|NCT01634555|3681388|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3855624|NCT01634555|3681388|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3855625|NCT01634555|3681388|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3855626|NCT01634555|3681388|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3855627|NCT01634555|3681388|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3855628|NCT01634555|3681388|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3855629|NCT01634360|3681396|B3|Caucasian||Race/Ethnicity, Customized|Race|Participants|Number|182|182.0||||||
3855630|NCT01634360|3681397|B2|Caucasian||Race/Ethnicity, Customized|Race|Participants|Number|134|134.0||||||
3855631|NCT01634360|3681398|B1|Caucasian||Race/Ethnicity, Customized|Race|Participants|Number|48|48.0||||||
3855632|NCT01634360|3681396|B3||Male|Sex: Female, Male|The participant flow information was collected from all participants who entered the study. Baseline information was collected only for the safety population (all subjects who received at least 1 dose of perampanel in this study and at least 1 dose of study medication during the double-blind phase of the core study).|Participants|Count of Participants|105|105.0||||||
3855669|NCT01634256|3681454|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3855634|NCT01634360|3681398|B1||Male|Sex: Female, Male|The participant flow information was collected from all participants who entered the study. Baseline information was collected only for the safety population (all subjects who received at least 1 dose of perampanel in this study and at least 1 dose of study medication during the double-blind phase of the core study).|Participants|Count of Participants|25|25.0||||||
3855635|NCT01634360|3681396|B3||Female|Sex: Female, Male|The participant flow information was collected from all participants who entered the study. Baseline information was collected only for the safety population (all subjects who received at least 1 dose of perampanel in this study and at least 1 dose of study medication during the double-blind phase of the core study).|Participants|Count of Participants|77|77.0||||||
3855636|NCT01634360|3681397|B2||Female|Sex: Female, Male|The participant flow information was collected from all participants who entered the study. Baseline information was collected only for the safety population (all subjects who received at least 1 dose of perampanel in this study and at least 1 dose of study medication during the double-blind phase of the core study).|Participants|Count of Participants|54|54.0||||||
3855637|NCT01634360|3681398|B1||Female|Sex: Female, Male|The participant flow information was collected from all participants who entered the study. Baseline information was collected only for the safety population (all subjects who received at least 1 dose of perampanel in this study and at least 1 dose of study medication during the double-blind phase of the core study).|Participants|Count of Participants|23|23.0||||||
3855638|NCT01634360|3681396|B3|>=65 years||Age, Customized|Safety population|Participants|Number|83|83.0||||||
3855639|NCT01634360|3681397|B2|>=65 years||Age, Customized|Safety population|Participants|Number|62|62.0||||||
3855640|NCT01634360|3681398|B1|>=65 years||Age, Customized|Safety population|Participants|Number|21|21.0||||||
3855641|NCT01634360|3681396|B3|<65 years||Age, Customized|Safety population|Participants|Number|99|99.0||||||
3855642|NCT01634360|3681397|B2|<65 years||Age, Customized|Safety population|Participants|Number|72|72.0||||||
3855643|NCT01634360|3681398|B1|<65 years||Age, Customized|Safety population|Participants|Number|27|27.0||||||
3855644|NCT01634269|3681409|B1|||Body Surface Area||m²|Mean|1.4|1.4|Standard Deviation|0.1|0.1|||
3855645|NCT01634269|3681409|B1|||Logistic EuroScore|The European System for Cardiac Operative Risk Evaluation (EuroSCORE) is a method of calculating predicted operative mortality for patients undergoing cardiac surgery. If a risk factor is present, a weight/number is assigned. The weights are added to give an approximate percent of predicted mortality. A higher score indicates a higher risk. A lower score indicates a lower risk.|percent|Mean|22.3|22.3|Standard Deviation|10.1|10.1|||
3855646|NCT01634269|3681409|B1|||STS Score|The Society of Thoracic Surgeons (STS) risk model predicts the risk of operative mortality and morbidity after adult cardiac surgery on the basis of patient demographic and clinical variables. After information has been entered on a given case, the online STS risk calculator provides a risk percentage for each of the outcomes. The risk percentage estimates the chance of a specific outcome for a patient with the indicated risk factors. A higher score indicates a higher risk. A lower score indicates a lower risk.|percent|Mean|7.0|7.0|Standard Deviation|3.3|3.3|||
3855647|NCT01634269|3681409|B1|NYHA IV||NYHA Class|NEW YORK HEART ASSOCIATION CLASSIFICATION (NYHA) Class I Subject with cardiac disease but without resulting limitations of physical activity. Class II Subjects with cardiac disease resulting in slight limitation of physical activity. Class III Subjects with cardiac disease resulting in marked limitation of physical activity. Class IV Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort.|participants|Number|1|1.0||||||
3855648|NCT01634269|3681409|B1|NYHA Class III||NYHA Class|NEW YORK HEART ASSOCIATION CLASSIFICATION (NYHA) Class I Subject with cardiac disease but without resulting limitations of physical activity. Class II Subjects with cardiac disease resulting in slight limitation of physical activity. Class III Subjects with cardiac disease resulting in marked limitation of physical activity. Class IV Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort.|participants|Number|19|19.0||||||
3855649|NCT01634269|3681409|B1|NYHA Class II||NYHA Class|NEW YORK HEART ASSOCIATION CLASSIFICATION (NYHA) Class I Subject with cardiac disease but without resulting limitations of physical activity. Class II Subjects with cardiac disease resulting in slight limitation of physical activity. Class III Subjects with cardiac disease resulting in marked limitation of physical activity. Class IV Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort.|participants|Number|0|0.0||||||
3855650|NCT01634269|3681409|B1|Japan||Region of Enrollment||participants|Number|20|20.0||||||
3855651|NCT01634269|3681409|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3855652|NCT01634269|3681409|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3855653|NCT01634269|3681409|B1|||Age||years|Mean|81.0|81.0|Standard Deviation|6.6|6.6|||
3855654|NCT01634256|3681454|B3|Korea, Republic of||Region of Enrollment||participants|Number|60|60.0||||||
3855655|NCT01634256|3681455|B2|Korea, Republic of||Region of Enrollment||participants|Number|30|30.0||||||
3855656|NCT01634256|3681456|B1|Korea, Republic of||Region of Enrollment||participants|Number|30|30.0||||||
3855657|NCT01634256|3681454|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3855658|NCT01634256|3681455|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3855659|NCT01634256|3681456|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3855660|NCT01634256|3681454|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3855661|NCT01634256|3681455|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3855662|NCT01634256|3681456|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3855663|NCT01634256|3681454|B3|||Age||years|Mean|37.60|37.6|Standard Deviation|8.06|8.06|||
3855664|NCT01634256|3681455|B2|||Age||years|Mean|36.17|36.17|Standard Deviation|7.42|7.42|||
3855665|NCT01634256|3681456|B1|||Age||years|Mean|39.03|39.03|Standard Deviation|8.53|8.53|||
3855666|NCT01634256|3681454|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3855667|NCT01634256|3681455|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3855668|NCT01634256|3681456|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3855670|NCT01634256|3681455|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3855671|NCT01634256|3681456|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3855672|NCT01634256|3681454|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3855673|NCT01634256|3681455|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3855674|NCT01634256|3681456|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3855675|NCT01634243|3681471|B3|Japan||Region of Enrollment||participants|Number|64|64.0||||||
3855676|NCT01634243|3681472|B2|Japan||Region of Enrollment||participants|Number|43|43.0||||||
3855677|NCT01634243|3681473|B1|Japan||Region of Enrollment||participants|Number|21|21.0||||||
3855678|NCT01634243|3681471|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3855679|NCT01634243|3681472|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3855680|NCT01634243|3681473|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3855681|NCT01634243|3681471|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3855682|NCT01634243|3681472|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3855683|NCT01634243|3681473|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3855684|NCT01634243|3681471|B3||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
3855685|NCT01634243|3681472|B2||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3855686|NCT01634243|3681473|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3855687|NCT01634243|3681471|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3855688|NCT01634243|3681472|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3855689|NCT01634243|3681473|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3855690|NCT01634243|3681471|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3855691|NCT01634243|3681472|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3855692|NCT01634243|3681473|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3855693|NCT01634243|3681471|B3|||Age||years|Mean|64.6|64.6|Standard Deviation|7.3|7.3|||
3855694|NCT01634243|3681472|B2|||Age||years|Mean|64.7|64.7|Standard Deviation|7.6|7.6|||
3855695|NCT01634243|3681473|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|6.9|6.9|||
3855696|NCT01634165|3681500|B1|Singapore||Region of Enrollment||participants|Number|24|24.0||||||
3855697|NCT01634165|3681500|B1|Asian||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3855698|NCT01634165|3681500|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3855699|NCT01634165|3681500|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3855700|NCT01634165|3681500|B1|||Age||years|Mean|32.1|32.1|Standard Deviation|7.7|7.7|||
3855701|NCT01634152|3681533|B4||Male|Sex: Female, Male||Participants|Count of Participants|279|279.0||||||
3855702|NCT01634152|3681534|B3||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3855703|NCT01634152|3681535|B2||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3855704|NCT01634152|3681536|B1||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3855705|NCT01634152|3681533|B4||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3855706|NCT01634152|3681534|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3855707|NCT01634152|3681535|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3855708|NCT01634152|3681536|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3855709|NCT01634152|3681533|B4|||Age||Years|Mean|9.0|9.0|Standard Deviation|1.6|1.6|||
3855710|NCT01634152|3681534|B3|||Age||Years|Mean|9.2|9.2|Standard Deviation|1.6|1.6|||
3855711|NCT01634152|3681535|B2|||Age||Years|Mean|8.8|8.8|Standard Deviation|1.7|1.7|||
3855712|NCT01634152|3681536|B1|||Age||Years|Mean|9.1|9.1|Standard Deviation|1.6|1.6|||
3855713|NCT01634139|3681618|B4||Male|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
3855714|NCT01634139|3681619|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3855715|NCT01634139|3681620|B2||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3855716|NCT01634139|3681621|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3855717|NCT01634139|3681618|B4||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3855718|NCT01634139|3681619|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3855719|NCT01634139|3681620|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3855720|NCT01634139|3681621|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3855721|NCT01634139|3681618|B4|||Age||Years|Mean|8.9|8.9|Standard Deviation|1.6|1.6|||
3855722|NCT01634139|3681619|B3|||Age||Years|Mean|8.9|8.9|Standard Deviation|1.7|1.7|||
3855723|NCT01634139|3681620|B2|||Age||Years|Mean|9.0|9.0|Standard Deviation|1.6|1.6|||
3855724|NCT01634139|3681621|B1|||Age||Years|Mean|9.0|9.0|Standard Deviation|1.6|1.6|||
3855725|NCT01634113|3681721|B4||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3855726|NCT01634113|3681722|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3855727|NCT01634113|3681723|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3855728|NCT01634113|3681724|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3855729|NCT01634113|3681721|B4||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3855730|NCT01634113|3681722|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3855731|NCT01634113|3681723|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3855732|NCT01634113|3681724|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3855733|NCT01634113|3681721|B4|||Age||years|Mean|3.1|3.1|Standard Deviation|1.4|1.4|||
3855734|NCT01634113|3681722|B3|||Age||years|Mean|3.1|3.1|Standard Deviation|1.3|1.3|||
3855735|NCT01634113|3681723|B2|||Age||years|Mean|3.1|3.1|Standard Deviation|1.5|1.5|||
3855736|NCT01634113|3681724|B1|||Age||years|Mean|3.2|3.2|Standard Deviation|1.4|1.4|||
3855737|NCT01634100|3681770|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3855738|NCT01634100|3681770|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3855739|NCT01634100|3681770|B1|||Age||years|Mean|32.7|32.7|Standard Deviation|11.4|11.4|||
3855740|NCT01633944|3681789|B3|United States||Region of Enrollment||participants|Number|420|420.0||||||
3855741|NCT01633944|3681790|B2|United States||Region of Enrollment||participants|Number|211|211.0||||||
3855742|NCT01633944|3681791|B1|United States||Region of Enrollment||participants|Number|209|209.0||||||
3855743|NCT01633944|3681789|B3||Male|Gender||Participants|Count of Participants|189|189.0||||||
3855744|NCT01633944|3681790|B2||Male|Gender||Participants|Count of Participants|87|87.0||||||
3855745|NCT01633944|3681791|B1||Male|Gender||Participants|Count of Participants|102|102.0||||||
3855746|NCT01633944|3681789|B3||Female|Gender||Participants|Count of Participants|231|231.0||||||
3855747|NCT01633944|3681790|B2||Female|Gender||Participants|Count of Participants|124|124.0||||||
3855748|NCT01633944|3681791|B1||Female|Gender||Participants|Count of Participants|107|107.0||||||
3855749|NCT01633944|3681789|B3|||Age||years|Median|51.0|51.0|Full Range|||19.0|82.0|
3855750|NCT01633944|3681790|B2|||Age||years|Median|49.0|49.0|Full Range|||19.0|78.0|
3855751|NCT01633944|3681791|B1|||Age||years|Median|52.0|52.0|Full Range|||22.0|82.0|
3855752|NCT01633944|3681789|B3||>=65 years|Age||Participants|Count of Participants|54|54.0||||||
3855753|NCT01633944|3681790|B2||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3855754|NCT01633944|3681791|B1||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
3855755|NCT01633944|3681789|B3||Between 18 and 65 years|Age||Participants|Count of Participants|366|366.0||||||
3855756|NCT01633944|3681790|B2||Between 18 and 65 years|Age||Participants|Count of Participants|186|186.0||||||
3855757|NCT01633944|3681791|B1||Between 18 and 65 years|Age||Participants|Count of Participants|180|180.0||||||
3855758|NCT01633944|3681789|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3855759|NCT01633944|3681790|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3855760|NCT01633944|3681791|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3855761|NCT01633892|3681813|B1|||Skin Thickness (mm)||mm|Median|5|5.0|Standard Deviation|0|0.0|||
3855762|NCT01633892|3681813|B1|||Skin Volume (cc)||cc|Median|5|5.0|Standard Deviation|0|0.0|||
3855763|NCT01633892|3681813|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3855764|NCT01633892|3681813|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3855765|NCT01633892|3681813|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3855766|NCT01633892|3681813|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3855767|NCT01633892|3681813|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3855768|NCT01633892|3681813|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3855769|NCT01633853|3681821|B3|||25(OH)Vit D||ng/ml|Mean|15.02|15.02|Standard Deviation|6.83|6.83|||
3855770|NCT01633853|3681822|B2|||25(OH)Vit D||ng/ml|Mean|14.90|14.9|Standard Deviation|6.15|6.15|||
3855771|NCT01633853|3681823|B1|||25(OH)Vit D||ng/ml|Mean|15.14|15.14|Standard Deviation|7.46|7.46|||
3855772|NCT01633853|3681821|B3|||iPTH-baseline||ng/ml|Mean|98.2|98.2|Standard Deviation|100.1|100.1|||
3855773|NCT01633853|3681822|B2|||iPTH-baseline||ng/ml|Mean|89.5|89.5|Standard Deviation|75.0|75.0|||
3855774|NCT01633853|3681823|B1|||iPTH-baseline||ng/ml|Mean|109.7|109.7|Standard Deviation|127.8|127.8|||
3855775|NCT01633853|3681821|B3|||P-baseline||mmol/L|Mean|1.14|1.14|Standard Deviation|0.22|0.22|||
3855776|NCT01633853|3681822|B2|||P-baseline||mmol/L|Mean|1.14|1.14|Standard Deviation|0.21|0.21|||
3855777|NCT01633853|3681823|B1|||P-baseline||mmol/L|Mean|1.15|1.15|Standard Deviation|0.24|0.24|||
3855778|NCT01633853|3681821|B3|||Ca-baseline||mmol/L|Mean|2.30|2.3|Standard Deviation|0.12|0.12|||
3855779|NCT01633853|3681822|B2|||Ca-baseline||mmol/L|Mean|2.31|2.31|Standard Deviation|0.11|0.11|||
3855780|NCT01633853|3681823|B1|||Ca-baseline||mmol/L|Mean|2.29|2.29|Standard Deviation|0.14|0.14|||
3855781|NCT01633853|3681821|B3|China||Region of Enrollment||participants|Number|204|204.0||||||
3855782|NCT01633853|3681822|B2|China||Region of Enrollment||participants|Number|100|100.0||||||
3855783|NCT01633853|3681823|B1|China||Region of Enrollment||participants|Number|104|104.0||||||
3855784|NCT01633853|3681821|B3||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3855785|NCT01633853|3681822|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3855786|NCT01633853|3681823|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3855787|NCT01633853|3681821|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3855788|NCT01633853|3681822|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3855789|NCT01633853|3681823|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3855790|NCT01633853|3681821|B3|||Age||years|Mean|56.89|56.89|Standard Deviation|6.76|6.76|||
3855791|NCT01633853|3681822|B2|||Age||years|Mean|56.27|56.27|Standard Deviation|5.94|5.94|||
3855792|NCT01633853|3681823|B1|||Age||years|Mean|57.35|57.35|Standard Deviation|5.64|5.64|||
3855793|NCT01633827|3681838|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3855794|NCT01633827|3681838|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855795|NCT01633827|3681838|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855796|NCT01633827|3681838|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3855797|NCT01633827|3681838|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3855798|NCT01633827|3681838|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855799|NCT01633827|3681838|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3855800|NCT01633827|3681838|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855801|NCT01633827|3681838|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855802|NCT01633827|3681838|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3855803|NCT01633827|3681838|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855804|NCT01633827|3681838|B1||Male|Gender||Participants|Count of Participants|12|12.0||||||
3855805|NCT01633827|3681838|B1||Female|Gender||Participants|Count of Participants|8|8.0||||||
3855806|NCT01633827|3681838|B1|||Age||years|Mean|50.9|50.9|Standard Deviation|11.8|11.8|||
3855807|NCT01633814|3681852|B1|50 - 80 years of age||Age, Customized||Participants|Count of Participants|0|0.0||||||
3855808|NCT01633788|3681857|B5||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3855809|NCT01633788|3681858|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3855810|NCT01633788|3681859|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3855811|NCT01633788|3681860|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3855812|NCT01633788|3681861|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3855813|NCT01633788|3681857|B5||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3855814|NCT01633788|3681858|B4||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3855815|NCT01633788|3681859|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3855816|NCT01633788|3681860|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3855817|NCT01633788|3681861|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3855818|NCT01633788|3681857|B5|over 65 years||Age, Customized||participants|Number|72|72.0||||||
3855819|NCT01633788|3681858|B4|over 65 years||Age, Customized||participants|Number|21|21.0||||||
3855820|NCT01633788|3681859|B3|over 65 years||Age, Customized||participants|Number|20|20.0||||||
3855821|NCT01633788|3681860|B2|over 65 years||Age, Customized||participants|Number|17|17.0||||||
3855822|NCT01633788|3681861|B1|over 65 years||Age, Customized||participants|Number|14|14.0||||||
3855823|NCT01633788|3681857|B5|55 years to 65 years||Age, Customized||participants|Number|87|87.0||||||
3855824|NCT01633788|3681858|B4|55 years to 65 years||Age, Customized||participants|Number|18|18.0||||||
3855825|NCT01633788|3681859|B3|55 years to 65 years||Age, Customized||participants|Number|19|19.0||||||
3855826|NCT01633788|3681860|B2|55 years to 65 years||Age, Customized||participants|Number|24|24.0||||||
3855827|NCT01633788|3681861|B1|55 years to 65 years||Age, Customized||participants|Number|26|26.0||||||
3855828|NCT01633788|3681857|B5|40 year to less than 55 years||Age, Customized||participants|Number|73|73.0||||||
3855829|NCT01633788|3681858|B4|40 year to less than 55 years||Age, Customized||participants|Number|19|19.0||||||
3855830|NCT01633788|3681859|B3|40 year to less than 55 years||Age, Customized||participants|Number|20|20.0||||||
3855831|NCT01633788|3681860|B2|40 year to less than 55 years||Age, Customized||participants|Number|17|17.0||||||
3855832|NCT01633788|3681861|B1|40 year to less than 55 years||Age, Customized||participants|Number|17|17.0||||||
3855833|NCT01633320|3681882|B3|France||Region of Enrollment||participants|Number|200|200.0||||||
3855834|NCT01633320|3681883|B2|France||Region of Enrollment||participants|Number|68|68.0||||||
3855835|NCT01633320|3681884|B1|France||Region of Enrollment||participants|Number|132|132.0||||||
3855836|NCT01633320|3681882|B3||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3855837|NCT01633320|3681883|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3855838|NCT01633320|3681884|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3855839|NCT01633320|3681882|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3855840|NCT01633320|3681883|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3855841|NCT01633320|3681884|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3855842|NCT01633320|3681882|B3|||Age||years|Mean|43|43.0|Standard Deviation|15|15.0|||
3855843|NCT01633320|3681883|B2|||Age||years|Mean|44|44.0|Standard Deviation|15|15.0|||
3855844|NCT01633320|3681884|B1|||Age||years|Mean|41|41.0|Standard Deviation|18|18.0|||
3855845|NCT01633320|3681882|B3||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3855846|NCT01633320|3681883|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3855847|NCT01633320|3681884|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3855848|NCT01633320|3681882|B3||Between 18 and 65 years|Age||Participants|Count of Participants|180|180.0||||||
3855849|NCT01633320|3681883|B2||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
3855850|NCT01633320|3681884|B1||Between 18 and 65 years|Age||Participants|Count of Participants|118|118.0||||||
3855851|NCT01633320|3681882|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3855852|NCT01633320|3681883|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3855853|NCT01633320|3681884|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3855854|NCT01632995|3681893|B1|United States||Region of Enrollment||participants|Number|557|557.0||||||
3855855|NCT01632995|3681893|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3855856|NCT01632995|3681893|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3855857|NCT01632995|3681893|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3855858|NCT01632995|3681893|B1|Latino||Race/Ethnicity, Customized||Participants|Count of Participants|192|192.0||||||
3855859|NCT01632995|3681893|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|266|266.0||||||
3855860|NCT01632995|3681893|B1||Male|Sex: Female, Male||Participants|Count of Participants|557|557.0||||||
3855861|NCT01632995|3681893|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3855862|NCT01632995|3681893|B1|||Age||years|Median|33|33.0|Inter-Quartile Range|||27.0|42.0|
3855863|NCT01632904|3681906|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3855864|NCT01632904|3681907|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3855865|NCT01632904|3681908|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3855866|NCT01632904|3681906|B3|White or Caucasian||Race/Ethnicity, Customized||participants|Number|109|109.0||||||
3855867|NCT01632904|3681907|B2|White or Caucasian||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
3855868|NCT01632904|3681908|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
3855869|NCT01632904|3681906|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3855870|NCT01632904|3681907|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3855871|NCT01632904|3681908|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3855872|NCT01632904|3681906|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3855873|NCT01632904|3681907|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3855874|NCT01632904|3681908|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3855875|NCT01632904|3681906|B3|||Age||years|Mean|63.7|63.7|Standard Deviation|12.15|12.15|||
3855876|NCT01632904|3681907|B2|||Age||years|Mean|64.2|64.2|Standard Deviation|12.68|12.68|||
3855877|NCT01632904|3681908|B1|||Age||years|Mean|63.1|63.1|Standard Deviation|11.68|11.68|||
3855878|NCT01632878|3681918|B3|unknown||Sex/Gender, Customized||participants|Number|8|8.0||||||
3855879|NCT01632878|3681919|B2|unknown||Sex/Gender, Customized||participants|Number|4|4.0||||||
3855880|NCT01632878|3681920|B1|unknown||Sex/Gender, Customized||participants|Number|4|4.0||||||
3855881|NCT01632878|3681918|B3|female||Sex/Gender, Customized||participants|Number|372|372.0||||||
3855882|NCT01632878|3681919|B2|female||Sex/Gender, Customized||participants|Number|61|61.0||||||
3855883|NCT01632878|3681920|B1|female||Sex/Gender, Customized||participants|Number|311|311.0||||||
3855884|NCT01632878|3681918|B3|male||Sex/Gender, Customized||participants|Number|1151|1151.0||||||
3855885|NCT01632878|3681919|B2|male||Sex/Gender, Customized||participants|Number|203|203.0||||||
3855886|NCT01632878|3681920|B1|male||Sex/Gender, Customized||participants|Number|948|948.0||||||
3855887|NCT01632878|3681918|B3|||Age||years|Mean|59.2|59.2|Standard Deviation|10.77|10.77|||
3855888|NCT01632878|3681919|B2|||Age||years|Mean|59.6|59.6|Standard Deviation|11.37|11.37|||
3855889|NCT01632878|3681920|B1|||Age||years|Mean|59.1|59.1|Standard Deviation|10.64|10.64|||
3855890|NCT01632800|3681924|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3855891|NCT01632800|3681924|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855892|NCT01632800|3681924|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855893|NCT01632800|3681924|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3855894|NCT01632800|3681924|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855895|NCT01632800|3681924|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855896|NCT01632800|3681924|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3855897|NCT01632800|3681924|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855898|NCT01632800|3681924|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855899|NCT01632800|3681924|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3855900|NCT01632800|3681924|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855901|NCT01632800|3681924|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3855902|NCT01632800|3681924|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3855903|NCT01632800|3681924|B1|||Age||years|Mean|40.4|40.4|Standard Deviation|16.8|16.8|||
3855904|NCT01632735|3681928|B3|||education||years|Mean|12.9|12.9|Standard Deviation|2.9|2.9|||
3855905|NCT01632735|3681929|B2|||education||years|Mean|12.0|12.0|Standard Deviation|2.0|2.0|||
3855906|NCT01632735|3681930|B1|||education||years|Mean|14.0|14.0|Standard Deviation|2.3|2.3|||
3855907|NCT01632735|3681928|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
3855908|NCT01632735|3681929|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
3855909|NCT01632735|3681930|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3855910|NCT01632735|3681928|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855911|NCT01632735|3681929|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855912|NCT01632735|3681930|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855913|NCT01632735|3681928|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3855914|NCT01632735|3681929|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3855915|NCT01632735|3681930|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3855916|NCT01632735|3681928|B3||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3855917|NCT01632735|3681929|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3855918|NCT01632735|3681930|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3855919|NCT01632735|3681928|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3855920|NCT01632735|3681929|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3855921|NCT01632735|3681930|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3855922|NCT01632735|3681928|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855923|NCT01632735|3681929|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855924|NCT01632735|3681930|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855925|NCT01632735|3681928|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3855926|NCT01632735|3681929|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3855927|NCT01632735|3681930|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3855928|NCT01632735|3681928|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3855929|NCT01632735|3681929|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855930|NCT01632735|3681930|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3855931|NCT01632735|3681928|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855932|NCT01632735|3681929|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855933|NCT01632735|3681930|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855934|NCT01632735|3681928|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3855935|NCT01632735|3681929|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3855936|NCT01632735|3681930|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3855937|NCT01632735|3681928|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3855938|NCT01632735|3681929|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3855939|NCT01632735|3681930|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3855940|NCT01632735|3681928|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3855941|NCT01632735|3681929|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3855942|NCT01632735|3681930|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3855943|NCT01632735|3681928|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3855944|NCT01632735|3681929|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3855945|NCT01632735|3681930|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3855946|NCT01632735|3681928|B3|||Age||years|Mean|20.4|20.4|Standard Deviation|3.5|3.5|||
3855947|NCT01632735|3681929|B2|||Age||years|Mean|19.0|19.0|Standard Deviation|3.1|3.1|||
3855948|NCT01632735|3681930|B1|||Age||years|Mean|22.1|22.1|Standard Deviation|3.1|3.1|||
3855949|NCT01632709|3681943|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3855950|NCT01632709|3681944|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855951|NCT01632709|3681945|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855952|NCT01632709|3681946|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855953|NCT01632709|3681947|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3855954|NCT01632709|3681943|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3855955|NCT01632709|3681944|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855956|NCT01632709|3681945|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3855957|NCT01632709|3681946|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855958|NCT01632709|3681947|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855959|NCT01632709|3681943|B5||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3855960|NCT01632709|3681944|B4||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3855961|NCT01632709|3681945|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3855962|NCT01632709|3681946|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855963|NCT01632709|3681947|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3855964|NCT01632709|3681943|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3855965|NCT01632709|3681944|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3855966|NCT01632709|3681945|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3855967|NCT01632709|3681946|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3855968|NCT01632709|3681947|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3855969|NCT01632709|3681943|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855970|NCT01632709|3681944|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855971|NCT01632709|3681945|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855972|NCT01632709|3681946|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855973|NCT01632709|3681947|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855974|NCT01632709|3681943|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855975|NCT01632709|3681944|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855976|NCT01632709|3681945|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855977|NCT01632709|3681946|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855978|NCT01632709|3681947|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855979|NCT01632709|3681943|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855980|NCT01632709|3681944|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855981|NCT01632709|3681945|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855982|NCT01632709|3681946|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855983|NCT01632709|3681947|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3855984|NCT01632709|3681943|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3855985|NCT01632709|3681944|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3855986|NCT01632709|3681945|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3855987|NCT01632709|3681946|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3855988|NCT01632709|3681947|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3855989|NCT01632709|3681943|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3855990|NCT01632709|3681944|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3855991|NCT01632709|3681945|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3855992|NCT01632709|3681946|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3855993|NCT01632709|3681947|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3855994|NCT01632709|3681943|B5|||Age||years|Mean|53.4|53.4|Standard Deviation|13.8|13.8|||
3855995|NCT01632709|3681944|B4|||Age||years|Mean|43.3|43.3|Standard Deviation|7|7.0|||
3855996|NCT01632709|3681945|B3|||Age||years|Mean|50.4|50.4|Standard Deviation|9.4|9.4|||
3855997|NCT01632709|3681946|B2|||Age||years|Mean|55|55.0|Standard Deviation|8.5|8.5|||
3855998|NCT01632709|3681947|B1|||Age||years|Mean|67.8|67.8|Standard Deviation|11.9|11.9|||
3855999|NCT01632683|3681974|B3||Male|Sex: Female, Male||Participants|Count of Participants|541|541.0||||||
3856000|NCT01632683|3681975|B2||Male|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
3856001|NCT01632683|3681976|B1||Male|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
3856002|NCT01632683|3681974|B3||Female|Sex: Female, Male||Participants|Count of Participants|559|559.0||||||
3856003|NCT01632683|3681975|B2||Female|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
3856004|NCT01632683|3681976|B1||Female|Sex: Female, Male||Participants|Count of Participants|292|292.0||||||
3856005|NCT01632683|3681974|B3|||Age||years|Mean|53.7|53.7|Standard Deviation|13.9|13.9|||
3856006|NCT01632683|3681975|B2|||Age||years|Mean|54.4|54.4|Standard Deviation|14.1|14.1|||
3856007|NCT01632683|3681976|B1|||Age||years|Mean|53|53.0|Standard Deviation|13.7|13.7|||
3856008|NCT01632579|3681991|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3856009|NCT01632579|3681991|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856010|NCT01632579|3681991|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856011|NCT01632579|3681991|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3856012|NCT01632579|3681991|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3856013|NCT01632579|3681991|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856014|NCT01632579|3681991|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856015|NCT01632579|3681991|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3856016|NCT01632579|3681991|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856017|NCT01632579|3681991|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3856018|NCT01632579|3681991|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3856019|NCT01632579|3681991|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3856020|NCT01632579|3681991|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3856021|NCT01632579|3681991|B1|||Age||years|Mean|47.0|47.0|Standard Deviation|10.9|10.9|||
3856022|NCT01632423|3682061|B1|Missing Data||Sex/Gender, Customized||Participants|Number|52|52.0||||||
3856023|NCT01632423|3682061|B1|Male||Sex/Gender, Customized||Participants|Number|4307|4307.0||||||
3856024|NCT01632423|3682061|B1|Female||Sex/Gender, Customized||Participants|Number|5978|5978.0||||||
3856025|NCT01632423|3682061|B1|||Age||Years|Mean|67.27|67.27|Standard Deviation|12.33|12.33|||
3856026|NCT01632345|3682069|B6||Male|Sex: Female, Male||Participants|Count of Participants|315|315.0||||||
3856027|NCT01632345|3682070|B5||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3856028|NCT01632345|3682071|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3856029|NCT01632345|3682072|B3||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3856030|NCT01632345|3682073|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3856031|NCT01632345|3682074|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3856032|NCT01632345|3682069|B6||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3856033|NCT01632345|3682070|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3856034|NCT01632345|3682071|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3856035|NCT01632345|3682072|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3856036|NCT01632345|3682073|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3856037|NCT01632345|3682074|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3856038|NCT01632345|3682069|B6|||Age||years|Mean|36.4|36.4|Standard Deviation|10.62|10.62|||
3856039|NCT01632345|3682070|B5|||Age||years|Mean|35.2|35.2|Standard Deviation|9.08|9.08|||
3856040|NCT01632345|3682071|B4|||Age||years|Mean|34.4|34.4|Standard Deviation|8.85|8.85|||
3856041|NCT01632345|3682072|B3|||Age||years|Mean|36.8|36.8|Standard Deviation|11.31|11.31|||
3856042|NCT01632345|3682073|B2|||Age||years|Mean|38.3|38.3|Standard Deviation|10.71|10.71|||
3856043|NCT01632345|3682074|B1|||Age||years|Mean|38.9|38.9|Standard Deviation|13.42|13.42|||
3856044|NCT01632306|3682140|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
3856045|NCT01632306|3682141|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3856046|NCT01632306|3682142|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3856047|NCT01632306|3682140|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3856048|NCT01632306|3682141|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3856049|NCT01632306|3682142|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856050|NCT01632306|3682140|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856051|NCT01632306|3682141|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856052|NCT01632306|3682142|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856053|NCT01632306|3682140|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3856054|NCT01632306|3682141|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3856055|NCT01632306|3682142|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3856056|NCT01632306|3682140|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856057|NCT01632306|3682141|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856058|NCT01632306|3682142|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856059|NCT01632306|3682140|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856060|NCT01632306|3682141|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856061|NCT01632306|3682142|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856062|NCT01632306|3682140|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856063|NCT01632306|3682141|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856064|NCT01632306|3682142|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856065|NCT01632306|3682140|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856066|NCT01632306|3682141|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856067|NCT01632306|3682142|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856068|NCT01632306|3682140|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3856069|NCT01632306|3682141|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3856070|NCT01632306|3682142|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856071|NCT01632306|3682140|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3856072|NCT01632306|3682141|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3856073|NCT01632306|3682142|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3856074|NCT01632306|3682140|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856075|NCT01632306|3682141|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856076|NCT01632306|3682142|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856077|NCT01632306|3682140|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3856078|NCT01632306|3682141|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3856079|NCT01632306|3682142|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3856080|NCT01632306|3682140|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3856081|NCT01632306|3682141|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3856082|NCT01632306|3682142|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3856083|NCT01632306|3682140|B3|||Age||years|Mean|63.2|63.2|Standard Deviation|5.7|5.7|||
3856084|NCT01632306|3682141|B2|||Age||years|Mean|64.0|64.0|Standard Deviation|4.9|4.9|||
3856085|NCT01632306|3682142|B1|||Age||years|Mean|60.7|60.7|Standard Deviation|8.5|8.5|||
3856086|NCT01632280|3682158|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3856087|NCT01632280|3682159|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3856088|NCT01632280|3682160|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3856089|NCT01632280|3682158|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3856090|NCT01632280|3682159|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3856091|NCT01632280|3682160|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3856092|NCT01632280|3682158|B3|||Age||years|Mean|43.3|43.3|Standard Deviation|7.3|7.3|||
3856093|NCT01632280|3682159|B2|||Age||years|Mean|44.3|44.3|Standard Deviation|7.1|7.1|||
3856094|NCT01632280|3682160|B1|||Age||years|Mean|42.3|42.3|Standard Deviation|8.0|8.0|||
3856095|NCT01632267|3682171|B1|United States||Region of Enrollment||participants|Number|104|104.0||||||
3856096|NCT01632267|3682171|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3856097|NCT01632267|3682171|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3856098|NCT01632267|3682171|B1|||Age||years|Mean|50.9|50.9|Standard Deviation|11.9|11.9|||
3856099|NCT01632267|3682171|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3856100|NCT01632267|3682171|B1||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
3856101|NCT01632267|3682171|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856102|NCT01632215|3682175|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3856103|NCT01632215|3682176|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3856104|NCT01632215|3682177|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3856105|NCT01632215|3682175|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3856106|NCT01632215|3682176|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3856107|NCT01632215|3682177|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3856108|NCT01632215|3682175|B3|||Age|gabapentine 51,5 (41 - 59) Sugar pill 52,1 (35 - 70)|years|Median|51.8|51.8|Full Range|||35.0|70.0|
3856109|NCT01632215|3682176|B2|||Age|gabapentine 51,5 (41 - 59) Sugar pill 52,1 (35 - 70)|years|Median|52.1|52.1|Full Range|||35.0|70.0|
3856110|NCT01632215|3682177|B1|||Age|gabapentine 51,5 (41 - 59) Sugar pill 52,1 (35 - 70)|years|Median|51.5|51.5|Full Range|||41.0|59.0|
3856111|NCT01632150|3682184|B1|Score 2||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|2|2.0||||||
3856112|NCT01632150|3682184|B1|Score 1||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|21|21.0||||||
3856113|NCT01632150|3682184|B1|Score 0||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|17|17.0||||||
3856114|NCT01632150|3682184|B1|Not reported||Myeloma type||Participants|Number|9|9.0||||||
3856115|NCT01632150|3682184|B1|Light chain disease||Myeloma type||Participants|Number|9|9.0||||||
3856116|NCT01632150|3682184|B1|IGD||Myeloma type||Participants|Number|0|0.0||||||
3856117|NCT01632150|3682184|B1|IGM||Myeloma type||Participants|Number|0|0.0||||||
3856118|NCT01632150|3682184|B1|IGA||Myeloma type||Participants|Number|7|7.0||||||
3856119|NCT01632150|3682184|B1|Immunoglobulin (Ig)G||Myeloma type||Participants|Number|15|15.0||||||
3856120|NCT01632150|3682184|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856121|NCT01632150|3682184|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856122|NCT01632150|3682184|B1||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3856123|NCT01632150|3682184|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856124|NCT01632150|3682184|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856125|NCT01632150|3682184|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856126|NCT01632150|3682184|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856127|NCT01632150|3682184|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3856128|NCT01632150|3682184|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3856129|NCT01632150|3682184|B1|75 years and older||Age, Customized||Participants|Number|6|6.0||||||
3856130|NCT01632150|3682184|B1|65 years and older to younger than 75 years||Age, Customized||Participants|Number|12|12.0||||||
3856131|NCT01632150|3682184|B1|Younger than 65 years||Age, Customized||Participants|Number|22|22.0||||||
3856132|NCT01632150|3682184|B1|||Age||Years|Mean|64.3|64.3|Standard Deviation|8.47|8.47|||
3856133|NCT01632020|3682191|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3856134|NCT01632020|3682192|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3856135|NCT01632020|3682193|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3856136|NCT01632020|3682191|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856137|NCT01632020|3682192|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856138|NCT01632020|3682193|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856139|NCT01632020|3682191|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856140|NCT01632020|3682192|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856141|NCT01632020|3682193|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856142|NCT01632020|3682191|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3856143|NCT01632020|3682192|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3856144|NCT01632020|3682193|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3856145|NCT01632020|3682191|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3856146|NCT01632020|3682192|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3856147|NCT01632020|3682193|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3856148|NCT01632020|3682191|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856149|NCT01632020|3682192|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856150|NCT01632020|3682193|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856151|NCT01632020|3682191|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856152|NCT01632020|3682192|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856153|NCT01632020|3682193|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856154|NCT01632020|3682191|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856155|NCT01632020|3682192|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856156|NCT01632020|3682193|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856157|NCT01632020|3682191|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856158|NCT01632020|3682192|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856159|NCT01632020|3682193|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856160|NCT01632020|3682191|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3856161|NCT01632020|3682192|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3856162|NCT01632020|3682193|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3856163|NCT01632020|3682191|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856164|NCT01632020|3682192|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856165|NCT01632020|3682193|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856166|NCT01632020|3682191|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3856167|NCT01632020|3682192|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3856168|NCT01632020|3682193|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3856169|NCT01632020|3682191|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3856170|NCT01632020|3682192|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3856171|NCT01632020|3682193|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3856172|NCT01632020|3682191|B3|||Age||years|Mean|49|49.0|Full Range|||37.0|61.0|
3856173|NCT01632020|3682192|B2|||Age||years|Mean|44|44.0|Full Range|||37.0|54.0|
3856174|NCT01632020|3682193|B1|||Age||years|Mean|57|57.0|Full Range|||52.0|61.0|
3856175|NCT01631929|3682202|B3|Not||Disease debuted||participants|Number|6|6.0||||||
3856176|NCT01631929|3682203|B2|Not||Disease debuted||participants|Number|4|4.0||||||
3856177|NCT01631929|3682204|B1|Not||Disease debuted||participants|Number|2|2.0||||||
3856178|NCT01631929|3682202|B3|Yes||Disease debuted||participants|Number|6|6.0||||||
3856179|NCT01631929|3682203|B2|Yes||Disease debuted||participants|Number|2|2.0||||||
3856180|NCT01631929|3682204|B1|Yes||Disease debuted||participants|Number|4|4.0||||||
3856181|NCT01631929|3682202|B3||Male|Gender||Participants|Count of Participants|2|2.0||||||
3856182|NCT01631929|3682203|B2||Male|Gender||Participants|Count of Participants|1|1.0||||||
3856183|NCT01631929|3682204|B1||Male|Gender||Participants|Count of Participants|1|1.0||||||
3856184|NCT01631929|3682202|B3||Female|Gender||Participants|Count of Participants|10|10.0||||||
3856185|NCT01631929|3682203|B2||Female|Gender||Participants|Count of Participants|5|5.0||||||
3856186|NCT01631929|3682204|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
3856187|NCT01631929|3682202|B3|||Age||years|Mean|9.2|9.2|Standard Deviation|3.4|3.4|||
3856188|NCT01631929|3682203|B2|||Age||years|Mean|9.67|9.67|Standard Deviation|2.7|2.7|||
3856189|NCT01631929|3682204|B1|||Age||years|Mean|8.83|8.83|Standard Deviation|1.7|1.7|||
3856190|NCT01631929|3682202|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3856191|NCT01631929|3682203|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3856192|NCT01631929|3682204|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3856193|NCT01631929|3682202|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3856194|NCT01631929|3682203|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3856195|NCT01631929|3682204|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3856196|NCT01631929|3682202|B3||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
3856197|NCT01631929|3682203|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3856198|NCT01631929|3682204|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3856199|NCT01631864|3682211|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3856200|NCT01631864|3682212|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3856201|NCT01631864|3682213|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3856202|NCT01631864|3682211|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3856203|NCT01631864|3682212|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3856204|NCT01631864|3682213|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3856205|NCT01631864|3682211|B3|||Age||Years|Mean|51.2|51.2|Standard Deviation|9.5|9.5|||
3856206|NCT01631864|3682212|B2|||Age||Years|Mean|50.5|50.5|Standard Deviation|9.4|9.4|||
3856207|NCT01631864|3682213|B1|||Age||Years|Mean|51.9|51.9|Standard Deviation|9.6|9.6|||
3856208|NCT01631825|3682226|B1|Japan||Region of Enrollment||participants|Number|321|321.0||||||
3856209|NCT01631825|3682226|B1||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3856210|NCT01631825|3682226|B1||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
3856211|NCT01631825|3682226|B1||>=65 years|Age||Participants|Count of Participants|206|206.0||||||
3856212|NCT01631825|3682226|B1||Between 18 and 65 years|Age||Participants|Count of Participants|115|115.0||||||
3856213|NCT01631825|3682226|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856214|NCT01631825|3682226|B1|||Age||years|Mean|65.9|65.9|Standard Deviation|8.4|8.4|||
3856215|NCT01631812|3682246|B1|Japan||Region of Enrollment||participants|Number|130|130.0||||||
3856216|NCT01631812|3682246|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3856217|NCT01631812|3682246|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3856218|NCT01631812|3682246|B1|||Age||years|Mean|66.9|66.9|Standard Deviation|7.5|7.5|||
3856219|NCT01631812|3682246|B1||>=65 years|Age||Participants|Count of Participants|96|96.0||||||
3856220|NCT01631812|3682246|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3856221|NCT01631812|3682246|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856222|NCT01631747|3682254|B3|||Pre-pregnancy BMI||kg per meters-squared|Mean|31|31.0|Standard Deviation|4|4.0|||
3856223|NCT01631747|3682255|B2|||Pre-pregnancy BMI||kg per meters-squared|Mean|31|31.0|Standard Deviation|4|4.0|||
3856224|NCT01631747|3682256|B1|||Pre-pregnancy BMI||kg per meters-squared|Mean|31|31.0|Standard Deviation|4|4.0|||
3856225|NCT01631747|3682254|B3|||Gestational Age at Randomization||weeks|Mean|13|13.0|Standard Deviation|1|1.0|||
3856226|NCT01631747|3682255|B2|||Gestational Age at Randomization||weeks|Mean|13|13.0|Standard Deviation|1|1.0|||
3856227|NCT01631747|3682256|B1|||Gestational Age at Randomization||weeks|Mean|13|13.0|Standard Deviation|1|1.0|||
3856228|NCT01631747|3682254|B3|United States||Region of Enrollment||participants|Number|281|281.0||||||
3856229|NCT01631747|3682255|B2|United States||Region of Enrollment||participants|Number|140|140.0||||||
3856230|NCT01631747|3682256|B1|United States||Region of Enrollment||participants|Number|141|141.0||||||
3856231|NCT01631747|3682254|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3856232|NCT01631747|3682255|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3856233|NCT01631747|3682256|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3856234|NCT01631747|3682254|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3856235|NCT01631747|3682255|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3856236|NCT01631747|3682256|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3856237|NCT01631747|3682254|B3||White|Race (NIH/OMB)||Participants|Count of Participants|178|178.0||||||
3856238|NCT01631747|3682255|B2||White|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3856239|NCT01631747|3682256|B1||White|Race (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3856240|NCT01631747|3682254|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3856241|NCT01631747|3682255|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3856242|NCT01631747|3682256|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3856243|NCT01631747|3682254|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3856244|NCT01631747|3682255|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856245|NCT01631747|3682256|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3856246|NCT01631747|3682254|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3856247|NCT01631747|3682255|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3856248|NCT01631747|3682256|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3856249|NCT01631747|3682254|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3856250|NCT01631747|3682255|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856251|NCT01631747|3682256|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3856252|NCT01631747|3682254|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856253|NCT01631747|3682255|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856254|NCT01631747|3682256|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856255|NCT01631747|3682254|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|221|221.0||||||
3856256|NCT01631747|3682255|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
3856257|NCT01631747|3682256|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
3856258|NCT01631747|3682254|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3856259|NCT01631747|3682255|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3856260|NCT01631747|3682256|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3856261|NCT01631747|3682254|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3856262|NCT01631747|3682255|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3856263|NCT01631747|3682256|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3856264|NCT01631747|3682254|B3||Female|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
3856265|NCT01631747|3682255|B2||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3856266|NCT01631747|3682256|B1||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3856267|NCT01631747|3682254|B3|||Age||years|Mean|33|33.0|Standard Deviation|4|4.0|||
3856268|NCT01631747|3682255|B2|||Age||years|Mean|33|33.0|Standard Deviation|4|4.0|||
3856269|NCT01631747|3682256|B1|||Age||years|Mean|34|34.0|Standard Deviation|4|4.0|||
3856270|NCT01631682|3682295|B5|||Spider Phobia Questionnaire|Range of scores = 0-15. Higher score represents greater fear of spiders.|units on a scale|Mean|7.7|7.7|Standard Deviation|2.2|2.2|||
3856271|NCT01631682|3682296|B4|||Spider Phobia Questionnaire|Range of scores = 0-15. Higher score represents greater fear of spiders.|units on a scale|Mean|7.0|7.0|Standard Deviation|2.6|2.6|||
3856272|NCT01631682|3682297|B3|||Spider Phobia Questionnaire|Range of scores = 0-15. Higher score represents greater fear of spiders.|units on a scale|Mean|8.0|8.0|Standard Deviation|2.5|2.5|||
3856273|NCT01631682|3682298|B2|||Spider Phobia Questionnaire|Range of scores = 0-15. Higher score represents greater fear of spiders.|units on a scale|Mean|7.6|7.6|Standard Deviation|2.0|2.0|||
3856274|NCT01631682|3682299|B1|||Spider Phobia Questionnaire|Range of scores = 0-15. Higher score represents greater fear of spiders.|units on a scale|Mean|8.0|8.0|Standard Deviation|1.8|1.8|||
3856275|NCT01631682|3682295|B5|United States||Region of Enrollment||participants|Number|63|63.0||||||
3856276|NCT01631682|3682296|B4|United States||Region of Enrollment||participants|Number|5|5.0||||||
3856277|NCT01631682|3682297|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
3856278|NCT01631682|3682298|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
3856279|NCT01631682|3682299|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3856280|NCT01631682|3682295|B5||Male|Gender||Participants|Count of Participants|29|29.0||||||
3856281|NCT01631682|3682296|B4||Male|Gender||Participants|Count of Participants|0|0.0||||||
3856282|NCT01631682|3682297|B3||Male|Gender||Participants|Count of Participants|6|6.0||||||
3856283|NCT01631682|3682298|B2||Male|Gender||Participants|Count of Participants|11|11.0||||||
3856284|NCT01631682|3682299|B1||Male|Gender||Participants|Count of Participants|12|12.0||||||
3856285|NCT01631682|3682295|B5||Female|Gender||Participants|Count of Participants|34|34.0||||||
3856286|NCT01631682|3682296|B4||Female|Gender||Participants|Count of Participants|5|5.0||||||
3856287|NCT01631682|3682297|B3||Female|Gender||Participants|Count of Participants|7|7.0||||||
3856288|NCT01631682|3682298|B2||Female|Gender||Participants|Count of Participants|10|10.0||||||
3856289|NCT01631682|3682299|B1||Female|Gender||Participants|Count of Participants|12|12.0||||||
3856290|NCT01631682|3682295|B5|||Age||years|Mean|22.9|22.9|Standard Deviation|3.4|3.4|||
3856291|NCT01631682|3682296|B4|||Age||years|Mean|22.8|22.8|Standard Deviation|3.3|3.3|||
3856292|NCT01631682|3682297|B3|||Age||years|Mean|23.2|23.2|Standard Deviation|4.5|4.5|||
3856293|NCT01631682|3682298|B2|||Age||years|Mean|23.1|23.1|Standard Deviation|2.6|2.6|||
3856294|NCT01631682|3682299|B1|||Age||years|Mean|22.6|22.6|Standard Deviation|3.2|3.2|||
3856295|NCT01631682|3682295|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3856296|NCT01631682|3682296|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3856297|NCT01631682|3682297|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3856298|NCT01631682|3682298|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3856299|NCT01631682|3682299|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3856300|NCT01631682|3682295|B5||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
3856301|NCT01631682|3682296|B4||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3856302|NCT01631682|3682297|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3856303|NCT01631682|3682298|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3856304|NCT01631682|3682299|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3856305|NCT01631682|3682295|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856306|NCT01631682|3682296|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856307|NCT01631682|3682297|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856308|NCT01631682|3682298|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856309|NCT01631682|3682299|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856310|NCT01631656|3682312|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3856311|NCT01631656|3682313|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3856312|NCT01631656|3682314|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3856313|NCT01631656|3682312|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3856314|NCT01631656|3682313|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3856315|NCT01631656|3682314|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3856316|NCT01631656|3682312|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3856317|NCT01631656|3682313|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3856318|NCT01631656|3682314|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3856319|NCT01631656|3682312|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3856320|NCT01631656|3682313|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3856321|NCT01631656|3682314|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3856322|NCT01631656|3682312|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856323|NCT01631656|3682313|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856324|NCT01631656|3682314|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856325|NCT01631630|3682321|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3856326|NCT01631630|3682322|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856327|NCT01631630|3682323|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3856328|NCT01631630|3682321|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856329|NCT01631630|3682322|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856330|NCT01631630|3682323|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856331|NCT01631630|3682321|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3856332|NCT01631630|3682322|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3856333|NCT01631630|3682323|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3856334|NCT01631630|3682321|B3||Black|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3856335|NCT01631630|3682322|B2||Black|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3856336|NCT01631630|3682323|B1||Black|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3856337|NCT01631630|3682321|B3||Hawaiian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856338|NCT01631630|3682322|B2||Hawaiian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856339|NCT01631630|3682323|B1||Hawaiian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856340|NCT01631630|3682321|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3856341|NCT01631630|3682322|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3856342|NCT01631630|3682323|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856343|NCT01631630|3682321|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856344|NCT01631630|3682322|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856345|NCT01631630|3682323|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856346|NCT01631630|3682321|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856347|NCT01631630|3682322|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856348|NCT01631630|3682323|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856349|NCT01631630|3682321|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3856350|NCT01631630|3682322|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3856351|NCT01631630|3682323|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3856352|NCT01631630|3682321|B3||Hispanic|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856353|NCT01631630|3682322|B2||Hispanic|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856354|NCT01631630|3682323|B1||Hispanic|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856355|NCT01631630|3682321|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3856356|NCT01631630|3682322|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3856357|NCT01631630|3682323|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3856358|NCT01631630|3682321|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3856359|NCT01631630|3682322|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3856360|NCT01631630|3682323|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3856361|NCT01631630|3682321|B3||GTE65|Age||Participants|Count of Participants|0|0.0||||||
3856362|NCT01631630|3682322|B2||GTE65|Age||Participants|Count of Participants|0|0.0||||||
3856363|NCT01631630|3682323|B1||GTE65|Age||Participants|Count of Participants|0|0.0||||||
3856364|NCT01631630|3682321|B3||BTWN|Age||Participants|Count of Participants|16|16.0||||||
3856365|NCT01631630|3682322|B2||BTWN|Age||Participants|Count of Participants|8|8.0||||||
3856366|NCT01631630|3682323|B1||BTWN|Age||Participants|Count of Participants|8|8.0||||||
3856367|NCT01631630|3682321|B3||LTE18|Age||Participants|Count of Participants|0|0.0||||||
3856368|NCT01631630|3682322|B2||LTE18|Age||Participants|Count of Participants|0|0.0||||||
3856369|NCT01631630|3682323|B1||LTE18|Age||Participants|Count of Participants|0|0.0||||||
3856370|NCT01631435|3682434|B1|Israel||Region of Enrollment||participants|Number|13|13.0||||||
3856371|NCT01631435|3682434|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
3856372|NCT01631435|3682434|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3856373|NCT01631435|3682434|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3856374|NCT01631435|3682434|B1|||Age||years|Mean|36.94|36.94|Standard Deviation|12.71|12.71|||
3856375|NCT01631435|3682434|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3856376|NCT01631435|3682434|B1||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
3856377|NCT01631435|3682434|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856378|NCT01631331|3682439|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3856379|NCT01631331|3682439|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856380|NCT01631331|3682439|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856381|NCT01631331|3682439|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3856382|NCT01631331|3682439|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856383|NCT01631331|3682439|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856384|NCT01631331|3682439|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856385|NCT01631331|3682439|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856386|NCT01631331|3682439|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3856387|NCT01631331|3682439|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3856388|NCT01631331|3682439|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3856389|NCT01631331|3682439|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3856390|NCT01631331|3682439|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856391|NCT01631227|3682446|B3|Male||Gender||participants|Number|274|274.0||||||
3856392|NCT01631227|3682447|B2|Male||Gender||participants|Number|130|130.0||||||
3856393|NCT01631227|3682448|B1|Male||Gender||participants|Number|144|144.0||||||
3856394|NCT01631227|3682446|B3|Female||Gender||participants|Number|387|387.0||||||
3856395|NCT01631227|3682447|B2|Female||Gender||participants|Number|201|201.0||||||
3856396|NCT01631227|3682448|B1|Female||Gender||participants|Number|186|186.0||||||
3856397|NCT01631227|3682446|B3|||Age||years|Mean|60|60.0|Standard Deviation|10|10.0|||
3856398|NCT01631227|3682447|B2|||Age||years|Mean|60|60.0|Standard Deviation|10|10.0|||
3856399|NCT01631227|3682448|B1|||Age||years|Mean|60|60.0|Standard Deviation|10|10.0|||
3856400|NCT01631214|3682455|B3||Missing|Total Hip Bone Mineral Density (BMD) T-score|BMD was measured using dual-energy x-ray absorptiometry (DXA). The T-score is a comparison of a person's bone density with that of a healthy 30-year-old of the same sex. Lower scores (more negative) mean lower bone density: A T-score of -2.5 or lower qualifies as osteoporosis and a T-score of -1.0 to - 2.5 signifies osteopenia, meaning below-normal bone density without full osteoporosis.|Participants|Count of Participants|1|1.0||||||
3856401|NCT01631214|3682456|B2||Missing|Total Hip Bone Mineral Density (BMD) T-score|BMD was measured using dual-energy x-ray absorptiometry (DXA). The T-score is a comparison of a person's bone density with that of a healthy 30-year-old of the same sex. Lower scores (more negative) mean lower bone density: A T-score of -2.5 or lower qualifies as osteoporosis and a T-score of -1.0 to - 2.5 signifies osteopenia, meaning below-normal bone density without full osteoporosis.|Participants|Count of Participants|0|0.0||||||
3856402|NCT01631214|3682457|B1||Missing|Total Hip Bone Mineral Density (BMD) T-score|BMD was measured using dual-energy x-ray absorptiometry (DXA). The T-score is a comparison of a person's bone density with that of a healthy 30-year-old of the same sex. Lower scores (more negative) mean lower bone density: A T-score of -2.5 or lower qualifies as osteoporosis and a T-score of -1.0 to - 2.5 signifies osteopenia, meaning below-normal bone density without full osteoporosis.|Participants|Count of Participants|1|1.0||||||
3856403|NCT01631214|3682455|B3||> -2.5|Total Hip Bone Mineral Density (BMD) T-score|BMD was measured using dual-energy x-ray absorptiometry (DXA). The T-score is a comparison of a person's bone density with that of a healthy 30-year-old of the same sex. Lower scores (more negative) mean lower bone density: A T-score of -2.5 or lower qualifies as osteoporosis and a T-score of -1.0 to - 2.5 signifies osteopenia, meaning below-normal bone density without full osteoporosis.|Participants|Count of Participants|1352|1352.0||||||
3856404|NCT01631214|3682456|B2||> -2.5|Total Hip Bone Mineral Density (BMD) T-score|BMD was measured using dual-energy x-ray absorptiometry (DXA). The T-score is a comparison of a person's bone density with that of a healthy 30-year-old of the same sex. Lower scores (more negative) mean lower bone density: A T-score of -2.5 or lower qualifies as osteoporosis and a T-score of -1.0 to - 2.5 signifies osteopenia, meaning below-normal bone density without full osteoporosis.|Participants|Count of Participants|690|690.0||||||
3856405|NCT01631214|3682457|B1||> -2.5|Total Hip Bone Mineral Density (BMD) T-score|BMD was measured using dual-energy x-ray absorptiometry (DXA). The T-score is a comparison of a person's bone density with that of a healthy 30-year-old of the same sex. Lower scores (more negative) mean lower bone density: A T-score of -2.5 or lower qualifies as osteoporosis and a T-score of -1.0 to - 2.5 signifies osteopenia, meaning below-normal bone density without full osteoporosis.|Participants|Count of Participants|662|662.0||||||
3856406|NCT01631214|3682455|B3||≤ -2.5|Total Hip Bone Mineral Density (BMD) T-score|BMD was measured using dual-energy x-ray absorptiometry (DXA). The T-score is a comparison of a person's bone density with that of a healthy 30-year-old of the same sex. Lower scores (more negative) mean lower bone density: A T-score of -2.5 or lower qualifies as osteoporosis and a T-score of -1.0 to - 2.5 signifies osteopenia, meaning below-normal bone density without full osteoporosis.|Participants|Count of Participants|2740|2740.0||||||
3856407|NCT01631214|3682456|B2||≤ -2.5|Total Hip Bone Mineral Density (BMD) T-score|BMD was measured using dual-energy x-ray absorptiometry (DXA). The T-score is a comparison of a person's bone density with that of a healthy 30-year-old of the same sex. Lower scores (more negative) mean lower bone density: A T-score of -2.5 or lower qualifies as osteoporosis and a T-score of -1.0 to - 2.5 signifies osteopenia, meaning below-normal bone density without full osteoporosis.|Participants|Count of Participants|1356|1356.0||||||
3856408|NCT01631214|3682457|B1||≤ -2.5|Total Hip Bone Mineral Density (BMD) T-score|BMD was measured using dual-energy x-ray absorptiometry (DXA). The T-score is a comparison of a person's bone density with that of a healthy 30-year-old of the same sex. Lower scores (more negative) mean lower bone density: A T-score of -2.5 or lower qualifies as osteoporosis and a T-score of -1.0 to - 2.5 signifies osteopenia, meaning below-normal bone density without full osteoporosis.|Participants|Count of Participants|1384|1384.0||||||
3856409|NCT01631214|3682455|B3||Absence|Severe Vertebral Fracture|A participant had a prevalent vertebral fracture if any vertebra from T4 to L4 had a grade of 3 at baseline based on an assessment of spinal radiographs using the Genant Semiquantitative Scoring Method. A grade 3 fracture is defined as approximately 40% or greater reduction in anterior, middle, and/or posterior height.|Participants|Count of Participants|1403|1403.0||||||
3856410|NCT01631214|3682456|B2||Absence|Severe Vertebral Fracture|A participant had a prevalent vertebral fracture if any vertebra from T4 to L4 had a grade of 3 at baseline based on an assessment of spinal radiographs using the Genant Semiquantitative Scoring Method. A grade 3 fracture is defined as approximately 40% or greater reduction in anterior, middle, and/or posterior height.|Participants|Count of Participants|677|677.0||||||
3856456|NCT01631214|3682457|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3856457|NCT01631214|3682455|B3||Female|Sex: Female, Male||Participants|Count of Participants|4093|4093.0||||||
3856411|NCT01631214|3682457|B1||Absence|Severe Vertebral Fracture|A participant had a prevalent vertebral fracture if any vertebra from T4 to L4 had a grade of 3 at baseline based on an assessment of spinal radiographs using the Genant Semiquantitative Scoring Method. A grade 3 fracture is defined as approximately 40% or greater reduction in anterior, middle, and/or posterior height.|Participants|Count of Participants|726|726.0||||||
3856412|NCT01631214|3682455|B3||Presence|Severe Vertebral Fracture|A participant had a prevalent vertebral fracture if any vertebra from T4 to L4 had a grade of 3 at baseline based on an assessment of spinal radiographs using the Genant Semiquantitative Scoring Method. A grade 3 fracture is defined as approximately 40% or greater reduction in anterior, middle, and/or posterior height.|Participants|Count of Participants|2690|2690.0||||||
3856413|NCT01631214|3682456|B2||Presence|Severe Vertebral Fracture|A participant had a prevalent vertebral fracture if any vertebra from T4 to L4 had a grade of 3 at baseline based on an assessment of spinal radiographs using the Genant Semiquantitative Scoring Method. A grade 3 fracture is defined as approximately 40% or greater reduction in anterior, middle, and/or posterior height.|Participants|Count of Participants|1369|1369.0||||||
3856414|NCT01631214|3682457|B1||Presence|Severe Vertebral Fracture|A participant had a prevalent vertebral fracture if any vertebra from T4 to L4 had a grade of 3 at baseline based on an assessment of spinal radiographs using the Genant Semiquantitative Scoring Method. A grade 3 fracture is defined as approximately 40% or greater reduction in anterior, middle, and/or posterior height.|Participants|Count of Participants|1321|1321.0||||||
3856415|NCT01631214|3682455|B3||≥ 75 years|Age Strata per Randomization||Participants|Count of Participants|2144|2144.0||||||
3856416|NCT01631214|3682456|B2||≥ 75 years|Age Strata per Randomization||Participants|Count of Participants|1073|1073.0||||||
3856417|NCT01631214|3682457|B1||≥ 75 years|Age Strata per Randomization||Participants|Count of Participants|1071|1071.0||||||
3856418|NCT01631214|3682455|B3||< 75 years|Age Strata per Randomization||Participants|Count of Participants|1949|1949.0||||||
3856419|NCT01631214|3682456|B2||< 75 years|Age Strata per Randomization||Participants|Count of Participants|973|973.0||||||
3856420|NCT01631214|3682457|B1||< 75 years|Age Strata per Randomization||Participants|Count of Participants|976|976.0||||||
3856421|NCT01631214|3682455|B3||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3856422|NCT01631214|3682456|B2||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3856423|NCT01631214|3682457|B1||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3856424|NCT01631214|3682455|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|882|882.0||||||
3856425|NCT01631214|3682456|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|436|436.0||||||
3856426|NCT01631214|3682457|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|446|446.0||||||
3856427|NCT01631214|3682455|B3||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3856428|NCT01631214|3682456|B2||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3856429|NCT01631214|3682457|B1||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3856430|NCT01631214|3682455|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|2862|2862.0||||||
3856431|NCT01631214|3682456|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|1447|1447.0||||||
3856432|NCT01631214|3682457|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|1415|1415.0||||||
3856433|NCT01631214|3682455|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3856434|NCT01631214|3682456|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3856435|NCT01631214|3682457|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3856436|NCT01631214|3682455|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3856437|NCT01631214|3682456|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3856438|NCT01631214|3682457|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3856439|NCT01631214|3682455|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|286|286.0||||||
3856440|NCT01631214|3682456|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|137|137.0||||||
3856441|NCT01631214|3682457|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|149|149.0||||||
3856442|NCT01631214|3682455|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3856443|NCT01631214|3682456|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3856444|NCT01631214|3682457|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3856445|NCT01631214|3682455|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856446|NCT01631214|3682456|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856447|NCT01631214|3682457|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856448|NCT01631214|3682455|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2800|2800.0||||||
3856449|NCT01631214|3682456|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1415|1415.0||||||
3856450|NCT01631214|3682457|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1385|1385.0||||||
3856451|NCT01631214|3682455|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1293|1293.0||||||
3856452|NCT01631214|3682456|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|631|631.0||||||
3856453|NCT01631214|3682457|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|662|662.0||||||
3856454|NCT01631214|3682455|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3856455|NCT01631214|3682456|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3856458|NCT01631214|3682456|B2||Female|Sex: Female, Male||Participants|Count of Participants|2046|2046.0||||||
3856459|NCT01631214|3682457|B1||Female|Sex: Female, Male||Participants|Count of Participants|2047|2047.0||||||
3856460|NCT01631214|3682455|B3|||Age||years|Mean|74.3|74.3|Standard Deviation|7.5|7.5|||
3856461|NCT01631214|3682456|B2|||Age||years|Mean|74.4|74.4|Standard Deviation|7.5|7.5|||
3856462|NCT01631214|3682457|B1|||Age||years|Mean|74.2|74.2|Standard Deviation|7.5|7.5|||
3856463|NCT01631149|3682520|B3|Netherlands||Region of Enrollment||participants|Number|24|24.0||||||
3856464|NCT01631149|3682521|B2|Netherlands||Region of Enrollment||participants|Number|12|12.0||||||
3856465|NCT01631149|3682522|B1|Netherlands||Region of Enrollment||participants|Number|12|12.0||||||
3856466|NCT01631149|3682520|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3856467|NCT01631149|3682521|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3856468|NCT01631149|3682522|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3856469|NCT01631149|3682520|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3856470|NCT01631149|3682521|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3856471|NCT01631149|3682522|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3856472|NCT01631149|3682520|B3|||Age||years|Mean|60|60.0|Standard Deviation|6|6.0|||
3856473|NCT01631149|3682521|B2|||Age||years|Mean|60|60.0|Standard Deviation|12|12.0|||
3856474|NCT01631149|3682522|B1|||Age||years|Mean|59|59.0|Standard Deviation|12|12.0|||
3856475|NCT01631149|3682520|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3856476|NCT01631149|3682521|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3856477|NCT01631149|3682522|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3856478|NCT01631149|3682520|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3856479|NCT01631149|3682521|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3856480|NCT01631149|3682522|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3856481|NCT01631149|3682520|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856482|NCT01631149|3682521|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856483|NCT01631149|3682522|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856484|NCT01631110|3682537|B3|Switzerland||Region of Enrollment||participants|Number|110|110.0||||||
3856485|NCT01631110|3682538|B2|Switzerland||Region of Enrollment||participants|Number|55|55.0||||||
3856486|NCT01631110|3682539|B1|Switzerland||Region of Enrollment||participants|Number|55|55.0||||||
3856487|NCT01631110|3682537|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3856488|NCT01631110|3682538|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3856489|NCT01631110|3682539|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3856490|NCT01631110|3682537|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3856491|NCT01631110|3682538|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3856492|NCT01631110|3682539|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3856493|NCT01631110|3682537|B3|||Age||years|Mean|52.8|52.8|Standard Deviation|17.26|17.26|||
3856494|NCT01631110|3682538|B2|||Age||years|Mean|38.3|38.3|Standard Deviation|11.69|11.69|||
3856495|NCT01631110|3682539|B1|||Age||years|Mean|67.3|67.3|Standard Deviation|6.01|6.01|||
3856496|NCT01631110|3682537|B3||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
3856497|NCT01631110|3682538|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3856498|NCT01631110|3682539|B1||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
3856499|NCT01631110|3682537|B3||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
3856500|NCT01631110|3682538|B2||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
3856501|NCT01631110|3682539|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3856502|NCT01631110|3682537|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856503|NCT01631110|3682538|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856504|NCT01631110|3682539|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856505|NCT01631071|3682552|B3|Switzerland||Region of Enrollment||participants|Number|110|110.0||||||
3856506|NCT01631071|3682553|B2|Switzerland||Region of Enrollment||participants|Number|55|55.0||||||
3856507|NCT01631071|3682554|B1|Switzerland||Region of Enrollment||participants|Number|55|55.0||||||
3856508|NCT01631071|3682552|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3856509|NCT01631071|3682553|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3856510|NCT01631071|3682554|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3856511|NCT01631071|3682552|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3856512|NCT01631071|3682553|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3856513|NCT01631071|3682554|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3856514|NCT01631071|3682552|B3|||Age||years|Mean|53.6|53.6|Standard Deviation|15.37|15.37|||
3856515|NCT01631071|3682553|B2|||Age||years|Mean|41.0|41.0|Standard Deviation|11.52|11.52|||
3856516|NCT01631071|3682554|B1|||Age||years|Mean|66.2|66.2|Standard Deviation|4.42|4.42|||
3856517|NCT01631071|3682552|B3||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
3856518|NCT01631071|3682553|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3856519|NCT01631071|3682554|B1||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
3856520|NCT01631071|3682552|B3||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
3856521|NCT01631071|3682553|B2||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
3856522|NCT01631071|3682554|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3856523|NCT01631071|3682552|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856524|NCT01631071|3682553|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856525|NCT01631071|3682554|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856526|NCT01630811|3682567|B1|||Autism Diagnostic Observation Schedule (ADOS)|The Autism Diagnostic Observation Schedule (ADOS) is a semi-structured assessment of communication, social interaction, and play (or imaginative use of materials) for individuals suspected of having autism or other pervasive developmental disorders. The total score ranges from 0 to 28 with 0 representing no abnormality present. A child is suspected to have Autism if the total ADOS score is greater than 7. The mean of the total ADOS scores is listed below.|units on a scale|Mean|16.31|16.31|Standard Deviation|12.04|12.04|||
3856527|NCT01630811|3682567|B1|||Body Mass Index (BMI)||kg/m^2|Mean|28.00|28.0|Standard Deviation|5.86|5.86|||
3856528|NCT01630811|3682567|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3856529|NCT01630811|3682567|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3856530|NCT01630811|3682567|B1|||Age||years|Mean|21.68|21.68|Standard Deviation|3.30|3.3|||
3856531|NCT01630694|3682578|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
3856532|NCT01630694|3682579|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3856533|NCT01630694|3682580|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3856534|NCT01630694|3682578|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3856535|NCT01630694|3682579|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3856536|NCT01630694|3682580|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3856537|NCT01630694|3682578|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3856538|NCT01630694|3682579|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3856539|NCT01630694|3682580|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3856540|NCT01630694|3682578|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3856541|NCT01630694|3682579|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3856542|NCT01630694|3682580|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3856543|NCT01630694|3682578|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3856544|NCT01630694|3682579|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3856545|NCT01630694|3682580|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3856546|NCT01630694|3682578|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856547|NCT01630694|3682579|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856548|NCT01630694|3682580|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856549|NCT01630616|3682589|B7||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3856550|NCT01630616|3682590|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3856551|NCT01630616|3682591|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3856552|NCT01630616|3682592|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3856553|NCT01630616|3682593|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3856554|NCT01630616|3682594|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3856555|NCT01630616|3682595|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3856556|NCT01630616|3682589|B7||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3856557|NCT01630616|3682590|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3856558|NCT01630616|3682591|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3856559|NCT01630616|3682592|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3856560|NCT01630616|3682593|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3856561|NCT01630616|3682594|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3856562|NCT01630616|3682595|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3856563|NCT01630616|3682589|B7|||Age||Years|Mean|20.8|20.8|Full Range|3.4|3.4|13.0|37.0|
3856564|NCT01630616|3682590|B6|||Age||Years|Mean|20|20.0|Full Range|||20.0|20.0|
3856565|NCT01630616|3682591|B5|||Age||Years|Mean|22.3|22.3|Full Range|0.0|0.0|20.0|24.0|
3856566|NCT01630616|3682592|B4|||Age||Years|Mean|26.6|26.6|Full Range|1.6|1.6|19.0|37.0|
3856567|NCT01630616|3682593|B3|||Age||Years|Mean|16.3|16.3|Full Range|0.6|0.6|16.0|17.0|
3856568|NCT01630616|3682594|B2|||Age||Years|Mean|15.7|15.7|Full Range|0.6|0.6|15.0|16.0|
3856569|NCT01630616|3682595|B1|||Age||Years|Mean|14.8|14.8|Full Range|1.6|1.6|13.0|16.0|
3856570|NCT01630135|3682673|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|261|261.0||||||
3856571|NCT01630135|3682674|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|130|130.0||||||
3856572|NCT01630135|3682675|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|131|131.0||||||
3856573|NCT01630135|3682673|B3||Male|Gender||Participants|Count of Participants|164|164.0||||||
3856574|NCT01630135|3682674|B2||Male|Gender||Participants|Count of Participants|79|79.0||||||
3856575|NCT01630135|3682675|B1||Male|Gender||Participants|Count of Participants|85|85.0||||||
3856576|NCT01630135|3682673|B3||Female|Gender||Participants|Count of Participants|97|97.0||||||
3856577|NCT01630135|3682674|B2||Female|Gender||Participants|Count of Participants|51|51.0||||||
3856578|NCT01630135|3682675|B1||Female|Gender||Participants|Count of Participants|46|46.0||||||
3856579|NCT01630135|3682673|B3|||Age||Years|Mean|10.1|10.1|Standard Deviation|2.26|2.26|||
3856580|NCT01630135|3682674|B2|||Age||Years|Mean|10.1|10.1|Standard Deviation|2.22|2.22|||
3856581|NCT01630135|3682675|B1|||Age||Years|Mean|10.0|10.0|Standard Deviation|2.32|2.32|||
3856582|NCT01630109|3682712|B4|United States||Region of Enrollment||participants|Number|5|5.0||||||
3856583|NCT01630109|3682713|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3856584|NCT01630109|3682714|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3856585|NCT01630109|3682715|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3856586|NCT01630109|3682712|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3856587|NCT01630109|3682713|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3856588|NCT01630109|3682714|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3856589|NCT01630109|3682715|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3856590|NCT01630109|3682712|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3856591|NCT01630109|3682713|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3856592|NCT01630109|3682714|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3856593|NCT01630109|3682715|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3856594|NCT01630109|3682712|B4|||Age||years|Mean|50.20|50.2|Standard Deviation|10.84|10.84|||
3856595|NCT01630109|3682713|B3|||Age||years|Mean|46|46.0|Standard Deviation|12.76|12.76|||
3856596|NCT01630109|3682714|B2|||Age||years|Mean|59|59.0|Standard Deviation|0|0.0|||
3856597|NCT01630109|3682715|B1|||Age||years|Mean|54|54.0|Standard Deviation|0|0.0|||
3856598|NCT01630109|3682712|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3856599|NCT01630109|3682713|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3856600|NCT01630109|3682714|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3856601|NCT01630109|3682715|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3856602|NCT01630109|3682712|B4||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3856603|NCT01630109|3682713|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3856604|NCT01630109|3682714|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3856605|NCT01630109|3682715|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3856606|NCT01630109|3682712|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856607|NCT01630109|3682713|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856608|NCT01630109|3682714|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856609|NCT01630109|3682715|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856610|NCT01629953|3682737|B3|United States||Region of Enrollment||participants|Number|112|112.0||||||
3856611|NCT01629953|3682738|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
3856612|NCT01629953|3682739|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
3856613|NCT01629953|3682737|B3|racial or ethnic minority||Race/Ethnicity, Customized||Participants|Count of Participants|82|82.0||||||
3856614|NCT01629953|3682738|B2|racial or ethnic minority||Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
3856615|NCT01629953|3682739|B1|racial or ethnic minority||Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
3856616|NCT01629953|3682737|B3||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3856617|NCT01629953|3682738|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3856618|NCT01629953|3682739|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3856619|NCT01629953|3682737|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3856620|NCT01629953|3682738|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3856621|NCT01629953|3682739|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3856622|NCT01629953|3682737|B3|||Age||years|Mean|52.2|52.2|Standard Deviation|5.7|5.7|||
3856623|NCT01629953|3682738|B2|||Age||years|Mean|51.5|51.5|Standard Deviation|5.8|5.8|||
3856624|NCT01629953|3682739|B1|||Age||years|Mean|53.1|53.1|Standard Deviation|5.4|5.4|||
3856625|NCT01629953|3682737|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3856626|NCT01629953|3682738|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3856627|NCT01629953|3682739|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3856628|NCT01629953|3682737|B3||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
3856629|NCT01629953|3682738|B2||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3856630|NCT01629953|3682739|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3856631|NCT01629953|3682737|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856632|NCT01629953|3682738|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856633|NCT01629953|3682739|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856634|NCT01629862|3682748|B3|United States||Region of Enrollment||Participants|Count of Participants|53|53.0||||||
3856635|NCT01629862|3682749|B2|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3856636|NCT01629862|3682750|B1|United States||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3856637|NCT01629862|3682748|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3856638|NCT01629862|3682749|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3856639|NCT01629862|3682750|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3856640|NCT01629862|3682748|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3856641|NCT01629862|3682749|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3856642|NCT01629862|3682750|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856643|NCT01629862|3682748|B3||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3856644|NCT01629862|3682749|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3856645|NCT01629862|3682750|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3856646|NCT01629862|3682748|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3856647|NCT01629862|3682749|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3856648|NCT01629862|3682750|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3856649|NCT01629862|3682748|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856650|NCT01629862|3682749|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856651|NCT01629862|3682750|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856652|NCT01629862|3682748|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3856653|NCT01629862|3682749|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856654|NCT01629862|3682750|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3856655|NCT01629862|3682748|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856656|NCT01629862|3682749|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856657|NCT01629862|3682750|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3856658|NCT01629862|3682748|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3856659|NCT01629862|3682749|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3856660|NCT01629862|3682750|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3856661|NCT01629862|3682748|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3856662|NCT01629862|3682749|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3856663|NCT01629862|3682750|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3856664|NCT01629862|3682748|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3856665|NCT01629862|3682749|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3856666|NCT01629862|3682750|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3856667|NCT01629862|3682748|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3856668|NCT01629862|3682749|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3856669|NCT01629862|3682750|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3856670|NCT01629862|3682748|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856671|NCT01629862|3682749|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856672|NCT01629862|3682750|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856673|NCT01629823|3682757|B4|||Former smoker||participants|Number|23|23.0||||||
3856674|NCT01629823|3682758|B3|||Former smoker||participants|Number|5|5.0||||||
3856675|NCT01629823|3682759|B2|||Former smoker||participants|Number|6|6.0||||||
3856676|NCT01629823|3682760|B1|||Former smoker||participants|Number|12|12.0||||||
3856677|NCT01629823|3682757|B4|||BMI||kg/m^2|Median|25.7|25.7|Inter-Quartile Range|||22.3|29.0|
3856678|NCT01629823|3682758|B3|||BMI||kg/m^2|Median|24.1|24.1|Inter-Quartile Range|||22.0|28.8|
3856679|NCT01629823|3682759|B2|||BMI||kg/m^2|Median|26.2|26.2|Inter-Quartile Range|||22.3|28.9|
3856680|NCT01629823|3682760|B1|||BMI||kg/m^2|Median|25.8|25.8|Inter-Quartile Range|||23.0|29.8|
3856681|NCT01629823|3682757|B4|||Daily use of anti-leukotriene||participants|Number|22|22.0||||||
3856682|NCT01629823|3682758|B3|||Daily use of anti-leukotriene||participants|Number|5|5.0||||||
3856683|NCT01629823|3682759|B2|||Daily use of anti-leukotriene||participants|Number|9|9.0||||||
3856684|NCT01629823|3682760|B1|||Daily use of anti-leukotriene||participants|Number|8|8.0||||||
3856685|NCT01629823|3682757|B4|||Daily use of combined inhaled corticosteroid/long acting beta agonist (ICS/LABA)||participants|Number|54|54.0||||||
3856686|NCT01629823|3682758|B3|||Daily use of combined inhaled corticosteroid/long acting beta agonist (ICS/LABA)||participants|Number|13|13.0||||||
3856687|NCT01629823|3682759|B2|||Daily use of combined inhaled corticosteroid/long acting beta agonist (ICS/LABA)||participants|Number|23|23.0||||||
3856688|NCT01629823|3682760|B1|||Daily use of combined inhaled corticosteroid/long acting beta agonist (ICS/LABA)||participants|Number|18|18.0||||||
3856689|NCT01629823|3682757|B4|||Daily use of inhaled corticosteroid (ICS)||participants|Number|31|31.0||||||
3856690|NCT01629823|3682758|B3|||Daily use of inhaled corticosteroid (ICS)||participants|Number|10|10.0||||||
3856691|NCT01629823|3682759|B2|||Daily use of inhaled corticosteroid (ICS)||participants|Number|10|10.0||||||
3856692|NCT01629823|3682760|B1|||Daily use of inhaled corticosteroid (ICS)||participants|Number|11|11.0||||||
3856693|NCT01629823|3682757|B4|||Forced vital capacity (FVC)|Forced vital capacity: the determination of the vital capacity from a maximally forced expiratory effort.|L|Median|4.1|4.1|Inter-Quartile Range|||3.4|4.7|
3856694|NCT01629823|3682758|B3|||Forced vital capacity (FVC)|Forced vital capacity: the determination of the vital capacity from a maximally forced expiratory effort.|L|Median|3.9|3.9|Inter-Quartile Range|||3.4|4.5|
3856695|NCT01629823|3682759|B2|||Forced vital capacity (FVC)|Forced vital capacity: the determination of the vital capacity from a maximally forced expiratory effort.|L|Median|4.2|4.2|Inter-Quartile Range|||3.5|4.9|
3856696|NCT01629823|3682760|B1|||Forced vital capacity (FVC)|Forced vital capacity: the determination of the vital capacity from a maximally forced expiratory effort.|L|Median|3.9|3.9|Inter-Quartile Range|||3.3|4.5|
3856697|NCT01629823|3682757|B4|||Percent-predicted FEV₁||percent|Median|90.6|90.6|Inter-Quartile Range|||82.7|97.9|
3856698|NCT01629823|3682758|B3|||Percent-predicted FEV₁||percent|Median|91.8|91.8|Inter-Quartile Range|||80.7|98.0|
3856699|NCT01629823|3682759|B2|||Percent-predicted FEV₁||percent|Median|90.9|90.9|Inter-Quartile Range|||81.9|99.9|
3856700|NCT01629823|3682760|B1|||Percent-predicted FEV₁||percent|Median|90.0|90.0|Inter-Quartile Range|||84.0|96.3|
3856701|NCT01629823|3682757|B4|||FEV₁|FEV₁ stands for forced expiratory volume in one second, the volume that has been exhaled at the end of the first second of forced expiration.|L|Median|3.1|3.1|Inter-Quartile Range|||2.6|3.6|
3856702|NCT01629823|3682758|B3|||FEV₁|FEV₁ stands for forced expiratory volume in one second, the volume that has been exhaled at the end of the first second of forced expiration.|L|Median|3.0|3.0|Inter-Quartile Range|||2.7|3.4|
3856703|NCT01629823|3682759|B2|||FEV₁|FEV₁ stands for forced expiratory volume in one second, the volume that has been exhaled at the end of the first second of forced expiration.|L|Median|3.1|3.1|Inter-Quartile Range|||2.6|3.7|
3856704|NCT01629823|3682760|B1|||FEV₁|FEV₁ stands for forced expiratory volume in one second, the volume that has been exhaled at the end of the first second of forced expiration.|L|Median|2.9|2.9|Inter-Quartile Range|||2.4|3.5|
3856705|NCT01629823|3682757|B4|||PC20|The PC20 is the concentration of methacholine needed to produce a 20% fall in forced expiratory volume in 1 second (FEV₁) from baseline.|mg/mL|Median|0.98|0.98|Inter-Quartile Range|||0.33|2.74|
3856706|NCT01629823|3682758|B3|||PC20|The PC20 is the concentration of methacholine needed to produce a 20% fall in forced expiratory volume in 1 second (FEV₁) from baseline.|mg/mL|Median|0.89|0.89|Inter-Quartile Range|||0.28|2.33|
3856707|NCT01629823|3682759|B2|||PC20|The PC20 is the concentration of methacholine needed to produce a 20% fall in forced expiratory volume in 1 second (FEV₁) from baseline.|mg/mL|Median|0.96|0.96|Inter-Quartile Range|||0.3|2.66|
3856708|NCT01629823|3682760|B1|||PC20|The PC20 is the concentration of methacholine needed to produce a 20% fall in forced expiratory volume in 1 second (FEV₁) from baseline.|mg/mL|Median|1.06|1.06|Inter-Quartile Range|||0.47|2.95|
3856709|NCT01629823|3682757|B4|||Sinonasal Questionnaire (SNQ-6)|The Sinonasal Questionnaire (SNQ-6) is a six-item questionnaire designed to diagnose chronic sinonasal disease in patients with asthma. This questionnaire asks about runny nose, postnasal drip, need to blow the nose, facial pain or pressure, and nasal obstruction. Possible answers include never (zero points), 1–4 times per month (1 point), 2–6 times per week (2 points), and daily (3 points). The number of points is then averaged. The minimum score is 0 and the maximum score is 3, with higher scores indicating higher frequency of sinonasal disease symptoms.|units on a scale|Median|0.8|0.8|Inter-Quartile Range|||0.4|1.4|
3856710|NCT01629823|3682758|B3|||Sinonasal Questionnaire (SNQ-6)|The Sinonasal Questionnaire (SNQ-6) is a six-item questionnaire designed to diagnose chronic sinonasal disease in patients with asthma. This questionnaire asks about runny nose, postnasal drip, need to blow the nose, facial pain or pressure, and nasal obstruction. Possible answers include never (zero points), 1–4 times per month (1 point), 2–6 times per week (2 points), and daily (3 points). The number of points is then averaged. The minimum score is 0 and the maximum score is 3, with higher scores indicating higher frequency of sinonasal disease symptoms.|units on a scale|Median|0.8|0.8|Inter-Quartile Range|||0.4|1.2|
3856711|NCT01629823|3682759|B2|||Sinonasal Questionnaire (SNQ-6)|The Sinonasal Questionnaire (SNQ-6) is a six-item questionnaire designed to diagnose chronic sinonasal disease in patients with asthma. This questionnaire asks about runny nose, postnasal drip, need to blow the nose, facial pain or pressure, and nasal obstruction. Possible answers include never (zero points), 1–4 times per month (1 point), 2–6 times per week (2 points), and daily (3 points). The number of points is then averaged. The minimum score is 0 and the maximum score is 3, with higher scores indicating higher frequency of sinonasal disease symptoms.|units on a scale|Median|0.8|0.8|Inter-Quartile Range|||0.4|1.4|
3856712|NCT01629823|3682760|B1|||Sinonasal Questionnaire (SNQ-6)|The Sinonasal Questionnaire (SNQ-6) is a six-item questionnaire designed to diagnose chronic sinonasal disease in patients with asthma. This questionnaire asks about runny nose, postnasal drip, need to blow the nose, facial pain or pressure, and nasal obstruction. Possible answers include never (zero points), 1–4 times per month (1 point), 2–6 times per week (2 points), and daily (3 points). The number of points is then averaged. The minimum score is 0 and the maximum score is 3, with higher scores indicating higher frequency of sinonasal disease symptoms.|units on a scale|Median|0.8|0.8|Inter-Quartile Range|||0.6|1.6|
3856713|NCT01629823|3682757|B4|||Marks Asthma Quality of Life|Marks Asthma Quality of Life Questionnaire (AQLQ) measures physical and emotional asthma specific quality of life during the past four weeks. The minimum score is 0 and the maximum score is 80, with lower scores indicating better quality of life. The scale is for use in adults only (individuals aged 18 or older).|units on a scale|Median|7|7.0|Inter-Quartile Range|||4.0|12.0|
3856714|NCT01629823|3682758|B3|||Marks Asthma Quality of Life|Marks Asthma Quality of Life Questionnaire (AQLQ) measures physical and emotional asthma specific quality of life during the past four weeks. The minimum score is 0 and the maximum score is 80, with lower scores indicating better quality of life. The scale is for use in adults only (individuals aged 18 or older).|units on a scale|Median|6|6.0|Inter-Quartile Range|||3.0|10.0|
3856715|NCT01629823|3682759|B2|||Marks Asthma Quality of Life|Marks Asthma Quality of Life Questionnaire (AQLQ) measures physical and emotional asthma specific quality of life during the past four weeks. The minimum score is 0 and the maximum score is 80, with lower scores indicating better quality of life. The scale is for use in adults only (individuals aged 18 or older).|units on a scale|Median|7|7.0|Inter-Quartile Range|||3.0|11.0|
3856716|NCT01629823|3682760|B1|||Marks Asthma Quality of Life|Marks Asthma Quality of Life Questionnaire (AQLQ) measures physical and emotional asthma specific quality of life during the past four weeks. The minimum score is 0 and the maximum score is 80, with lower scores indicating better quality of life. The scale is for use in adults only (individuals aged 18 or older).|units on a scale|Median|9|9.0|Inter-Quartile Range|||5.0|21.0|
3856754|NCT01629771|3682784|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3856755|NCT01629771|3682785|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3856756|NCT01629771|3682786|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3856717|NCT01629823|3682757|B4|||Asthma Control Test (ACT) Score|The Asthma Control Test (ACT) is a validated self-administered survey utilizing 5 questions to assess asthma control on a scale from 1 (poor control) to 5 (total control) in individuals 12 years and older. By answering all 5 questions a patient with asthma can obtain a score that may range between 5 and 25. Asthma control is considered a good characteristic for a person with asthma and therefore a higher score is considered a better outcome.|units on a scale|Median|22|22.0|Inter-Quartile Range|||20.0|23.0|
3856718|NCT01629823|3682758|B3|||Asthma Control Test (ACT) Score|The Asthma Control Test (ACT) is a validated self-administered survey utilizing 5 questions to assess asthma control on a scale from 1 (poor control) to 5 (total control) in individuals 12 years and older. By answering all 5 questions a patient with asthma can obtain a score that may range between 5 and 25. Asthma control is considered a good characteristic for a person with asthma and therefore a higher score is considered a better outcome.|units on a scale|Median|22|22.0|Inter-Quartile Range|||20.0|23.0|
3856719|NCT01629823|3682759|B2|||Asthma Control Test (ACT) Score|The Asthma Control Test (ACT) is a validated self-administered survey utilizing 5 questions to assess asthma control on a scale from 1 (poor control) to 5 (total control) in individuals 12 years and older. By answering all 5 questions a patient with asthma can obtain a score that may range between 5 and 25. Asthma control is considered a good characteristic for a person with asthma and therefore a higher score is considered a better outcome.|units on a scale|Median|22|22.0|Inter-Quartile Range|||20.0|24.0|
3856720|NCT01629823|3682760|B1|||Asthma Control Test (ACT) Score|The Asthma Control Test (ACT) is a validated self-administered survey utilizing 5 questions to assess asthma control on a scale from 1 (poor control) to 5 (total control) in individuals 12 years and older. By answering all 5 questions a patient with asthma can obtain a score that may range between 5 and 25. Asthma control is considered a good characteristic for a person with asthma and therefore a higher score is considered a better outcome.|units on a scale|Median|21|21.0|Inter-Quartile Range|||19.0|23.0|
3856721|NCT01629823|3682757|B4|||Asthma Symptom Utility Index (ASUI) Score|The Asthma Symptom Utility Index (ASUI) is a brief, interviewer-administered, patient preference-based scale assessing frequency and severity of selected asthma-related symptoms and treatment side effects. The minimum score is 0 and the maximum score is 1, with lower scores indicating more symptoms.|units on a scale|Median|0.92|0.92|Inter-Quartile Range|||0.84|0.98|
3856722|NCT01629823|3682758|B3|||Asthma Symptom Utility Index (ASUI) Score|The Asthma Symptom Utility Index (ASUI) is a brief, interviewer-administered, patient preference-based scale assessing frequency and severity of selected asthma-related symptoms and treatment side effects. The minimum score is 0 and the maximum score is 1, with lower scores indicating more symptoms.|units on a scale|Median|0.92|0.92|Inter-Quartile Range|||0.86|0.98|
3856723|NCT01629823|3682759|B2|||Asthma Symptom Utility Index (ASUI) Score|The Asthma Symptom Utility Index (ASUI) is a brief, interviewer-administered, patient preference-based scale assessing frequency and severity of selected asthma-related symptoms and treatment side effects. The minimum score is 0 and the maximum score is 1, with lower scores indicating more symptoms.|units on a scale|Median|0.94|0.94|Inter-Quartile Range|||0.85|1.0|
3856724|NCT01629823|3682760|B1|||Asthma Symptom Utility Index (ASUI) Score|The Asthma Symptom Utility Index (ASUI) is a brief, interviewer-administered, patient preference-based scale assessing frequency and severity of selected asthma-related symptoms and treatment side effects. The minimum score is 0 and the maximum score is 1, with lower scores indicating more symptoms.|units on a scale|Median|0.89|0.89|Inter-Quartile Range|||0.83|0.94|
3856725|NCT01629823|3682757|B4|United States||Region of Enrollment||participants|Number|194|194.0||||||
3856726|NCT01629823|3682758|B3|United States||Region of Enrollment||participants|Number|59|59.0||||||
3856727|NCT01629823|3682759|B2|United States||Region of Enrollment||participants|Number|69|69.0||||||
3856728|NCT01629823|3682760|B1|United States||Region of Enrollment||participants|Number|66|66.0||||||
3856729|NCT01629823|3682757|B4||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3856730|NCT01629823|3682758|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3856731|NCT01629823|3682759|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3856732|NCT01629823|3682760|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3856733|NCT01629823|3682757|B4||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3856734|NCT01629823|3682758|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3856735|NCT01629823|3682759|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3856736|NCT01629823|3682760|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3856737|NCT01629823|3682757|B4|||Age||years|Median|31|31.0|Inter-Quartile Range|||20.0|41.0|
3856738|NCT01629823|3682758|B3|||Age||years|Median|25|25.0|Inter-Quartile Range|||18.0|39.0|
3856739|NCT01629823|3682759|B2|||Age||years|Median|31|31.0|Inter-Quartile Range|||20.0|40.0|
3856740|NCT01629823|3682760|B1|||Age||years|Median|33|33.0|Inter-Quartile Range|||23.0|47.0|
3856741|NCT01629797|3682770|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
3856742|NCT01629797|3682770|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3856743|NCT01629797|3682770|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3856744|NCT01629797|3682770|B1|||Age||years|Mean|29.6|29.6|Standard Deviation|8.4|8.4|||
3856745|NCT01629784|3682777|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
3856746|NCT01629784|3682777|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3856747|NCT01629784|3682777|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3856748|NCT01629784|3682777|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3856749|NCT01629784|3682777|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3856750|NCT01629784|3682777|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856751|NCT01629771|3682784|B3|India||Region of Enrollment||participants|Number|72|72.0||||||
3856752|NCT01629771|3682785|B2|India||Region of Enrollment||participants|Number|36|36.0||||||
3856753|NCT01629771|3682786|B1|India||Region of Enrollment||participants|Number|36|36.0||||||
3856757|NCT01629771|3682784|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3856758|NCT01629771|3682785|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3856759|NCT01629771|3682786|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3856760|NCT01629771|3682784|B3|||Age||years|Mean|52.0|52.0|Standard Deviation|16.0|16.0|||
3856761|NCT01629771|3682785|B2|||Age||years|Mean|52.3|52.3|Standard Deviation|16.1|16.1|||
3856762|NCT01629771|3682786|B1|||Age||years|Mean|51.7|51.7|Standard Deviation|16.2|16.2|||
3856763|NCT01629706|3682797|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3856764|NCT01629706|3682797|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3856765|NCT01629706|3682797|B1|||Age||years|Mean|26.67|26.67|Standard Deviation|10.79|10.79|||
3856766|NCT01629693|3682823|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3856767|NCT01629693|3682824|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3856768|NCT01629693|3682825|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3856769|NCT01629693|3682823|B3||Female|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
3856770|NCT01629693|3682824|B2||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3856771|NCT01629693|3682825|B1||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3856772|NCT01629693|3682823|B3|||Age||years|Mean|32.9|32.9|Standard Deviation|9.8|9.8|||
3856773|NCT01629693|3682824|B2|||Age||years|Mean|33.1|33.1|Standard Deviation|10.5|10.5|||
3856774|NCT01629693|3682825|B1|||Age||years|Mean|32.7|32.7|Standard Deviation|9.1|9.1|||
3856775|NCT01629667|3682832|B4||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3856776|NCT01629667|3682833|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3856777|NCT01629667|3682834|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3856778|NCT01629667|3682835|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3856779|NCT01629667|3682832|B4||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3856780|NCT01629667|3682833|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3856781|NCT01629667|3682834|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3856782|NCT01629667|3682835|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3856783|NCT01629667|3682832|B4|||Age||Years|Mean|67.6|67.6|Standard Deviation|6.8|6.8|||
3856784|NCT01629667|3682833|B3|||Age||Years|Mean|67.9|67.9|Standard Deviation|6.7|6.7|||
3856785|NCT01629667|3682834|B2|||Age||Years|Mean|67.3|67.3|Standard Deviation|7.7|7.7|||
3856786|NCT01629667|3682835|B1|||Age||Years|Mean|67.5|67.5|Standard Deviation|6.1|6.1|||
3856787|NCT01629589|3682919|B3|United States||Region of Enrollment||Participants|Number|423|423.0||||||
3856788|NCT01629589|3682920|B2|United States||Region of Enrollment||Participants|Number|211|211.0||||||
3856789|NCT01629589|3682921|B1|United States||Region of Enrollment||Participants|Number|212|212.0||||||
3856790|NCT01629589|3682919|B3||Male|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
3856791|NCT01629589|3682920|B2||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3856792|NCT01629589|3682921|B1||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3856793|NCT01629589|3682919|B3||Female|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
3856794|NCT01629589|3682920|B2||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3856795|NCT01629589|3682921|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3856796|NCT01629589|3682919|B3|||Age||Years|Mean|11.6|11.6|Standard Deviation|0.5|0.5|||
3856797|NCT01629589|3682920|B2|||Age||Years|Mean|11.6|11.6|Standard Deviation|0.5|0.5|||
3856798|NCT01629589|3682921|B1|||Age||Years|Mean|11.6|11.6|Standard Deviation|0.5|0.5|||
3856799|NCT01629589|3682919|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3856800|NCT01629589|3682920|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3856801|NCT01629589|3682921|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3856802|NCT01629589|3682919|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3856803|NCT01629589|3682920|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3856804|NCT01629589|3682921|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3856805|NCT01629589|3682919|B3||<=18 years|Age||Participants|Count of Participants|423|423.0||||||
3856806|NCT01629589|3682920|B2||<=18 years|Age||Participants|Count of Participants|211|211.0||||||
3856807|NCT01629589|3682921|B1||<=18 years|Age||Participants|Count of Participants|212|212.0||||||
3856808|NCT01629290|3682938|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3856809|NCT01629290|3682938|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3856810|NCT01629290|3682938|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3856811|NCT01629290|3682938|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3856812|NCT01629290|3682938|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3856813|NCT01629290|3682938|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856814|NCT01629134|3682948|B1|Germany||Region of Enrollment||participants|Number|62|62.0||||||
3856815|NCT01629134|3682948|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3856816|NCT01629134|3682948|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3856817|NCT01629134|3682948|B1|||Age||years|Mean|39.7|39.7|Standard Deviation|12.6|12.6|||
3856818|NCT01629134|3682948|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3856819|NCT01629134|3682948|B1||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
3856820|NCT01629134|3682948|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856821|NCT01628965|3682961|B1|Japan||Region of Enrollment||participants|Number|143|143.0||||||
3856822|NCT01628965|3682961|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3856823|NCT01628965|3682961|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3856824|NCT01628965|3682961|B1|||Age||years|Mean|65.3|65.3|Standard Deviation|8.4|8.4|||
3856825|NCT01628965|3682961|B1||>=65 years|Age||Participants|Count of Participants|85|85.0||||||
3856826|NCT01628965|3682961|B1||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3856827|NCT01628965|3682961|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856828|NCT01628926|3682967|B4|Japan||Region of Enrollment||participants|Number|414|414.0||||||
3856829|NCT01628926|3682968|B3|Japan||Region of Enrollment||participants|Number|84|84.0||||||
3856830|NCT01628926|3682969|B2|Japan||Region of Enrollment||participants|Number|166|166.0||||||
3856831|NCT01628926|3682970|B1|Japan||Region of Enrollment||participants|Number|164|164.0||||||
3856832|NCT01628926|3682967|B4||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3856833|NCT01628926|3682968|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3856834|NCT01628926|3682969|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3856835|NCT01628926|3682970|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3856836|NCT01628926|3682967|B4||Female|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
3856837|NCT01628926|3682968|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3856838|NCT01628926|3682969|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3856839|NCT01628926|3682970|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3856840|NCT01628926|3682967|B4|||Age||years|Mean|65.8|65.8|Standard Deviation|8.3|8.3|||
3856841|NCT01628926|3682968|B3|||Age||years|Mean|65.3|65.3|Standard Deviation|7.9|7.9|||
3856842|NCT01628926|3682969|B2|||Age||years|Mean|67.0|67.0|Standard Deviation|7.9|7.9|||
3856843|NCT01628926|3682970|B1|||Age||years|Mean|64.8|64.8|Standard Deviation|8.8|8.8|||
3856844|NCT01628926|3682967|B4||>=65 years|Age||Participants|Count of Participants|263|263.0||||||
3856845|NCT01628926|3682968|B3||>=65 years|Age||Participants|Count of Participants|56|56.0||||||
3856846|NCT01628926|3682969|B2||>=65 years|Age||Participants|Count of Participants|114|114.0||||||
3856847|NCT01628926|3682970|B1||>=65 years|Age||Participants|Count of Participants|93|93.0||||||
3856848|NCT01628926|3682967|B4||Between 18 and 65 years|Age||Participants|Count of Participants|151|151.0||||||
3856849|NCT01628926|3682968|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3856850|NCT01628926|3682969|B2||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3856851|NCT01628926|3682970|B1||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
3856852|NCT01628926|3682967|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856853|NCT01628926|3682968|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856854|NCT01628926|3682969|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856855|NCT01628926|3682970|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856856|NCT01628913|3683019|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3856857|NCT01628913|3683020|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3856858|NCT01628913|3683021|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3856859|NCT01628913|3683019|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3856860|NCT01628913|3683020|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3856861|NCT01628913|3683021|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3856862|NCT01628913|3683019|B3|||Age||Years|Mean|57.1|57.1|Standard Deviation|12.07|12.07|32.0|81.0|
3856863|NCT01628913|3683020|B2|||Age||Years|Mean|57.8|57.8|Standard Deviation|11.85|11.85|34.0|78.0|
3856864|NCT01628913|3683021|B1|||Age||Years|Mean|56.3|56.3|Standard Deviation|12.43|12.43|32.0|81.0|
3856865|NCT01628848|3683034|B3|Japan||Region of Enrollment||participants|Number|174|174.0||||||
3856866|NCT01628848|3683035|B2|Japan||Region of Enrollment||participants|Number|87|87.0||||||
3856867|NCT01628848|3683036|B1|Japan||Region of Enrollment||participants|Number|87|87.0||||||
3856868|NCT01628848|3683034|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3856869|NCT01628848|3683035|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3856870|NCT01628848|3683036|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3856871|NCT01628848|3683034|B3||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3856872|NCT01628848|3683035|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3856873|NCT01628848|3683036|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3856874|NCT01628848|3683034|B3|||Age||years|Mean|66.9|66.9|Standard Deviation|7.5|7.5|||
3856875|NCT01628848|3683035|B2|||Age||years|Mean|66.8|66.8|Standard Deviation|8.3|8.3|||
3856876|NCT01628848|3683036|B1|||Age||years|Mean|67.0|67.0|Standard Deviation|6.8|6.8|||
3856877|NCT01628848|3683034|B3||>=65 years|Age||Participants|Count of Participants|122|122.0||||||
3856878|NCT01628848|3683035|B2||>=65 years|Age||Participants|Count of Participants|60|60.0||||||
3856879|NCT01628848|3683036|B1||>=65 years|Age||Participants|Count of Participants|62|62.0||||||
3856880|NCT01628848|3683034|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3856881|NCT01628848|3683035|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3856882|NCT01628848|3683036|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3856883|NCT01628848|3683034|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856884|NCT01628848|3683035|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856885|NCT01628848|3683036|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3856886|NCT01628692|3683065|B7|Hepatitis C Virus Genotype 1a||Randomization Stratum||participants|Number|21|21.0||||||
3856887|NCT01628692|3683066|B6|Hepatitis C Virus Genotype 1a||Randomization Stratum||participants|Number|9|9.0||||||
3856888|NCT01628692|3683067|B5|Hepatitis C Virus Genotype 1a||Randomization Stratum||participants|Number|12|12.0||||||
3856889|NCT01628692|3683068|B4|Hepatitis C Virus Genotype 1a||Randomization Stratum||participants|Number|0|0.0||||||
3856890|NCT01628692|3683069|B3|Hepatitis C Virus Genotype 1a||Randomization Stratum||participants|Number|0|0.0||||||
3856891|NCT01628692|3683070|B2|Hepatitis C Virus Genotype 1a||Randomization Stratum||participants|Number|0|0.0||||||
3856892|NCT01628692|3683071|B1|Hepatitis C Virus Genotype 1a||Randomization Stratum||participants|Number|0|0.0||||||
3856893|NCT01628692|3683065|B7|Hepatitis C Virus Genotype 1b||Randomization Stratum||participants|Number|147|147.0||||||
3856894|NCT01628692|3683066|B6|Hepatitis C Virus Genotype 1b||Randomization Stratum||participants|Number|0|0.0||||||
3856895|NCT01628692|3683067|B5|Hepatitis C Virus Genotype 1b||Randomization Stratum||participants|Number|0|0.0||||||
3856896|NCT01628692|3683068|B4|Hepatitis C Virus Genotype 1b||Randomization Stratum||participants|Number|20|20.0||||||
3856897|NCT01628692|3683069|B3|Hepatitis C Virus Genotype 1b||Randomization Stratum||participants|Number|51|51.0||||||
3856898|NCT01628692|3683070|B2|Hepatitis C Virus Genotype 1b||Randomization Stratum||participants|Number|23|23.0||||||
3856899|NCT01628692|3683071|B1|Hepatitis C Virus Genotype 1b||Randomization Stratum||participants|Number|53|53.0||||||
3856900|NCT01628692|3683065|B7|≥800,000 IU/mL||Hepatitis C Virus RNA Distribution||participants|Number|133|133.0||||||
3856901|NCT01628692|3683066|B6|≥800,000 IU/mL||Hepatitis C Virus RNA Distribution||participants|Number|9|9.0||||||
3856902|NCT01628692|3683067|B5|≥800,000 IU/mL||Hepatitis C Virus RNA Distribution||participants|Number|7|7.0||||||
3856903|NCT01628692|3683068|B4|≥800,000 IU/mL||Hepatitis C Virus RNA Distribution||participants|Number|16|16.0||||||
3856904|NCT01628692|3683069|B3|≥800,000 IU/mL||Hepatitis C Virus RNA Distribution||participants|Number|40|40.0||||||
3856905|NCT01628692|3683070|B2|≥800,000 IU/mL||Hepatitis C Virus RNA Distribution||participants|Number|20|20.0||||||
3856906|NCT01628692|3683071|B1|≥800,000 IU/mL||Hepatitis C Virus RNA Distribution||participants|Number|41|41.0||||||
3856907|NCT01628692|3683065|B7|<800,000 IU/mL||Hepatitis C Virus RNA Distribution||participants|Number|35|35.0||||||
3856908|NCT01628692|3683066|B6|<800,000 IU/mL||Hepatitis C Virus RNA Distribution||participants|Number|0|0.0||||||
3856909|NCT01628692|3683067|B5|<800,000 IU/mL||Hepatitis C Virus RNA Distribution||participants|Number|5|5.0||||||
3856910|NCT01628692|3683068|B4|<800,000 IU/mL||Hepatitis C Virus RNA Distribution||participants|Number|4|4.0||||||
3856911|NCT01628692|3683069|B3|<800,000 IU/mL||Hepatitis C Virus RNA Distribution||participants|Number|11|11.0||||||
3856912|NCT01628692|3683070|B2|<800,000 IU/mL||Hepatitis C Virus RNA Distribution||participants|Number|3|3.0||||||
3856913|NCT01628692|3683071|B1|<800,000 IU/mL||Hepatitis C Virus RNA Distribution||participants|Number|12|12.0||||||
3856914|NCT01628692|3683065|B7||Male|Gender||Participants|Count of Participants|82|82.0||||||
3856915|NCT01628692|3683066|B6||Male|Gender||Participants|Count of Participants|7|7.0||||||
3856916|NCT01628692|3683067|B5||Male|Gender||Participants|Count of Participants|7|7.0||||||
3856917|NCT01628692|3683068|B4||Male|Gender||Participants|Count of Participants|9|9.0||||||
3856918|NCT01628692|3683069|B3||Male|Gender||Participants|Count of Participants|25|25.0||||||
3856919|NCT01628692|3683070|B2||Male|Gender||Participants|Count of Participants|12|12.0||||||
3856920|NCT01628692|3683071|B1||Male|Gender||Participants|Count of Participants|22|22.0||||||
3856921|NCT01628692|3683065|B7||Female|Gender||Participants|Count of Participants|86|86.0||||||
3856922|NCT01628692|3683066|B6||Female|Gender||Participants|Count of Participants|2|2.0||||||
3856923|NCT01628692|3683067|B5||Female|Gender||Participants|Count of Participants|5|5.0||||||
3856924|NCT01628692|3683068|B4||Female|Gender||Participants|Count of Participants|11|11.0||||||
3856925|NCT01628692|3683069|B3||Female|Gender||Participants|Count of Participants|26|26.0||||||
3856926|NCT01628692|3683070|B2||Female|Gender||Participants|Count of Participants|11|11.0||||||
3856927|NCT01628692|3683071|B1||Female|Gender||Participants|Count of Participants|31|31.0||||||
3856928|NCT01628692|3683065|B7|>=65 years||Age, Customized||participants|Number|33|33.0||||||
3856929|NCT01628692|3683066|B6|>=65 years||Age, Customized||participants|Number|0|0.0||||||
3856930|NCT01628692|3683067|B5|>=65 years||Age, Customized||participants|Number|0|0.0||||||
3856931|NCT01628692|3683068|B4|>=65 years||Age, Customized||participants|Number|8|8.0||||||
3856932|NCT01628692|3683069|B3|>=65 years||Age, Customized||participants|Number|9|9.0||||||
3856933|NCT01628692|3683070|B2|>=65 years||Age, Customized||participants|Number|4|4.0||||||
3856934|NCT01628692|3683071|B1|>=65 years||Age, Customized||participants|Number|12|12.0||||||
3856935|NCT01628692|3683065|B7|21-<65 years||Age, Customized||participants|Number|133|133.0||||||
3856936|NCT01628692|3683066|B6|21-<65 years||Age, Customized||participants|Number|9|9.0||||||
3856937|NCT01628692|3683067|B5|21-<65 years||Age, Customized||participants|Number|11|11.0||||||
3856938|NCT01628692|3683068|B4|21-<65 years||Age, Customized||participants|Number|11|11.0||||||
3856939|NCT01628692|3683069|B3|21-<65 years||Age, Customized||participants|Number|42|42.0||||||
3856940|NCT01628692|3683070|B2|21-<65 years||Age, Customized||participants|Number|19|19.0||||||
3856941|NCT01628692|3683071|B1|21-<65 years||Age, Customized||participants|Number|41|41.0||||||
3856942|NCT01628692|3683065|B7|<21 years||Age, Customized||participants|Number|2|2.0||||||
3856943|NCT01628692|3683066|B6|<21 years||Age, Customized||participants|Number|0|0.0||||||
3856944|NCT01628692|3683067|B5|<21 years||Age, Customized||participants|Number|1|1.0||||||
3856945|NCT01628692|3683068|B4|<21 years||Age, Customized||participants|Number|1|1.0||||||
3856946|NCT01628692|3683069|B3|<21 years||Age, Customized||participants|Number|0|0.0||||||
3856947|NCT01628692|3683070|B2|<21 years||Age, Customized||participants|Number|0|0.0||||||
3856948|NCT01628692|3683071|B1|<21 years||Age, Customized||participants|Number|0|0.0||||||
3856949|NCT01628614|3683120|B1|Missing||Sex/Gender, Customized||Participants|Number|1781|1781.0||||||
3856950|NCT01628614|3683120|B1|Male||Sex/Gender, Customized||Participants|Number|1389|1389.0||||||
3856951|NCT01628614|3683120|B1|Female||Sex/Gender, Customized||Participants|Number|1642|1642.0||||||
3856952|NCT01628614|3683120|B1|Missing (N=2165 patients)||Age||Years|Mean|NA||Standard Deviation|NA||||Age missing; not obtained
3856953|NCT01628614|3683120|B1|Evaluable (N=2647 patients)||Age||Years|Mean|64.72|64.72|Standard Deviation|12.03|12.03|||
3856954|NCT01628601|3683126|B1|Missing Data||Sex/Gender, Customized||Participants|Number|5|5.0||||||
3856955|NCT01628601|3683126|B1|Male||Sex/Gender, Customized||Participants|Number|155|155.0||||||
3856956|NCT01628601|3683126|B1|Female||Sex/Gender, Customized||Participants|Number|232|232.0||||||
3856957|NCT01628601|3683126|B1|||Age||Years|Mean|67.22|67.22|Standard Deviation|13.14|13.14|||
3856958|NCT01628588|3683134|B1|Missing Data||Sex/Gender, Customized||Participants|Number|2|2.0||||||
3856959|NCT01628588|3683134|B1|Male||Sex/Gender, Customized||Participants|Number|394|394.0||||||
3856960|NCT01628588|3683134|B1|Female||Sex/Gender, Customized||Participants|Number|458|458.0||||||
3856961|NCT01628588|3683134|B1|||Age||Years|Mean|66.75|66.75|Standard Deviation|13.27|13.27|||
3856962|NCT01628510|3683142|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3856963|NCT01628510|3683143|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3856964|NCT01628510|3683144|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3856965|NCT01628510|3683142|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3856966|NCT01628510|3683143|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3856967|NCT01628510|3683144|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3856968|NCT01628510|3683142|B3|||Age||weeks|Mean|28.7|28.7|Standard Deviation|2.7|2.7|||
3856969|NCT01628510|3683143|B2|||Age||weeks|Mean|28|28.0|Standard Deviation|2.5|2.5|||
3856970|NCT01628510|3683144|B1|||Age||weeks|Mean|29.4|29.4|Standard Deviation|2.8|2.8|||
3856971|NCT01628367|3683153|B3|Mandibular Premolars||Teeth|Sites at which immediate implant were placed.|Teeth|Number|8|8.0||||||
3856972|NCT01628367|3683154|B2|Mandibular Premolars||Teeth|Sites at which immediate implant were placed.|Teeth|Number|6|6.0||||||
3856973|NCT01628367|3683155|B1|Mandibular Premolars||Teeth|Sites at which immediate implant were placed.|Teeth|Number|2|2.0||||||
3856974|NCT01628367|3683153|B3|Maxillary Premolars||Teeth|Sites at which immediate implant were placed.|Teeth|Number|14|14.0||||||
3856975|NCT01628367|3683154|B2|Maxillary Premolars||Teeth|Sites at which immediate implant were placed.|Teeth|Number|5|5.0||||||
3856976|NCT01628367|3683155|B1|Maxillary Premolars||Teeth|Sites at which immediate implant were placed.|Teeth|Number|9|9.0||||||
3856977|NCT01628367|3683153|B3|Maxillary Anteriors||Teeth|Sites at which immediate implant were placed.|Teeth|Number|10|10.0||||||
3856978|NCT01628367|3683154|B2|Maxillary Anteriors||Teeth|Sites at which immediate implant were placed.|Teeth|Number|5|5.0||||||
3856979|NCT01628367|3683155|B1|Maxillary Anteriors||Teeth|Sites at which immediate implant were placed.|Teeth|Number|5|5.0||||||
3856980|NCT01628367|3683153|B3|||Lingual plate thickness|Thickness of the lingual plate measured clinically at the study site|millimeters|Mean|1.0525|1.0525|Standard Deviation|.4|0.4|||
3856981|NCT01628367|3683154|B2|||Lingual plate thickness|Thickness of the lingual plate measured clinically at the study site|millimeters|Mean|.875|0.875|Standard Deviation|.34|0.34|||
3856982|NCT01628367|3683155|B1|||Lingual plate thickness|Thickness of the lingual plate measured clinically at the study site|millimeters|Mean|1.23|1.23|Standard Deviation|.46|0.46|||
3856983|NCT01628367|3683153|B3|||Buccal plate thickness|Thickness of the buccal plate measured clinically at the study site|millimeters|Mean|.84|0.84|Standard Deviation|.36|0.36|||
3856984|NCT01628367|3683154|B2|||Buccal plate thickness|Thickness of the buccal plate measured clinically at the study site|millimeters|Mean|.75|0.75|Standard Deviation|.26|0.26|||
3856985|NCT01628367|3683155|B1|||Buccal plate thickness|Thickness of the buccal plate measured clinically at the study site|millimeters|Mean|.93|0.93|Standard Deviation|.46|0.46|||
3856986|NCT01628367|3683153|B3|6mm from free gingival margin (FGM)||Soft tissue thickness||millimeters|Mean|1.08|1.08|Standard Deviation|.26|0.26|||
3856987|NCT01628367|3683154|B2|6mm from free gingival margin (FGM)||Soft tissue thickness||millimeters|Mean|1.09|1.09|Standard Deviation|.2|0.2|||
3856988|NCT01628367|3683155|B1|6mm from free gingival margin (FGM)||Soft tissue thickness||millimeters|Mean|1.07|1.07|Standard Deviation|.32|0.32|||
3856989|NCT01628367|3683153|B3|4mm from free gingival margin (FGM)||Soft tissue thickness||millimeters|Mean|.985|0.985|Standard Deviation|.59|0.59|||
3856990|NCT01628367|3683154|B2|4mm from free gingival margin (FGM)||Soft tissue thickness||millimeters|Mean|1|1.0|Standard Deviation|.18|0.18|||
3856991|NCT01628367|3683155|B1|4mm from free gingival margin (FGM)||Soft tissue thickness||millimeters|Mean|.97|0.97|Standard Deviation|.23|0.23|||
3856992|NCT01628367|3683153|B3|||Mean keratanized gingiva (KG) width|Width of the keratinized gingiva at one study site|millimeters|Mean|4.18|4.18|Standard Deviation|1.88|1.88|||
3856993|NCT01628367|3683154|B2|||Mean keratanized gingiva (KG) width|Width of the keratinized gingiva at one study site|millimeters|Mean|3.63|3.63|Standard Deviation|1.93|1.93|||
3856994|NCT01628367|3683155|B1|||Mean keratanized gingiva (KG) width|Width of the keratinized gingiva at one study site|millimeters|Mean|4.73|4.73|Standard Deviation|1.83|1.83|||
3856995|NCT01628367|3683153|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
3856996|NCT01628367|3683154|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3856997|NCT01628367|3683155|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3856998|NCT01628367|3683153|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3856999|NCT01628367|3683154|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3857000|NCT01628367|3683155|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857001|NCT01628367|3683153|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857002|NCT01628367|3683154|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857003|NCT01628367|3683155|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857004|NCT01628367|3683153|B3||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3857005|NCT01628367|3683154|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3857006|NCT01628367|3683155|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3857007|NCT01628367|3683153|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3857008|NCT01628367|3683154|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857009|NCT01628367|3683155|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3857010|NCT01628367|3683153|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857011|NCT01628367|3683154|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857012|NCT01628367|3683155|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857013|NCT01628367|3683153|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3857014|NCT01628367|3683154|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3857015|NCT01628367|3683155|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857016|NCT01628367|3683153|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857017|NCT01628367|3683154|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857018|NCT01628367|3683155|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857019|NCT01628367|3683153|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857020|NCT01628367|3683154|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857021|NCT01628367|3683155|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857022|NCT01628367|3683153|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3857023|NCT01628367|3683154|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3857024|NCT01628367|3683155|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3857025|NCT01628367|3683153|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3857026|NCT01628367|3683154|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3857027|NCT01628367|3683155|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857028|NCT01628367|3683153|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3857029|NCT01628367|3683154|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3857030|NCT01628367|3683155|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3857031|NCT01628367|3683153|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3857032|NCT01628367|3683154|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3857033|NCT01628367|3683155|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3857034|NCT01628367|3683153|B3|18 years old and older||Age, Customized||participants|Number|32|32.0||||||
3857035|NCT01628367|3683154|B2|18 years old and older||Age, Customized||participants|Number|16|16.0||||||
3857036|NCT01628367|3683155|B1|18 years old and older||Age, Customized||participants|Number|16|16.0||||||
3857037|NCT01628250|3683166|B3|China||Region of Enrollment||participants|Number|99|99.0||||||
3857038|NCT01628250|3683167|B2|China||Region of Enrollment||participants|Number|50|50.0||||||
3857039|NCT01628250|3683168|B1|China||Region of Enrollment||participants|Number|49|49.0||||||
3857040|NCT01628250|3683166|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3857041|NCT01628250|3683167|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3857042|NCT01628250|3683168|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3857043|NCT01628250|3683166|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3857044|NCT01628250|3683167|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3857045|NCT01628250|3683168|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3857046|NCT01628250|3683166|B3||>=65 years|Age||Participants|Count of Participants|57|57.0||||||
3857047|NCT01628250|3683167|B2||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
3857048|NCT01628250|3683168|B1||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
3857049|NCT01628250|3683166|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3857050|NCT01628250|3683167|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3857051|NCT01628250|3683168|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3857052|NCT01628250|3683166|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3857053|NCT01628250|3683167|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3857054|NCT01628250|3683168|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3857055|NCT01628198|3683175|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3857056|NCT01628198|3683175|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3857057|NCT01628198|3683175|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|11.65|11.65|||
3857058|NCT01628120|3683188|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3857059|NCT01628120|3683188|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3857060|NCT01628120|3683188|B1|||Age||years|Mean|56.63|56.63|Standard Deviation|12.903|12.903|||
3857061|NCT01628107|3683213|B1||Male|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
3857062|NCT01628107|3683213|B1||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3857063|NCT01628107|3683213|B1|||Age||years|Mean|57.45|57.45|Standard Deviation|12.062|12.062|||
3857064|NCT01628042|3683238|B5||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3857065|NCT01628042|3683239|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3857066|NCT01628042|3683240|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3857067|NCT01628042|3683241|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3857068|NCT01628042|3683242|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3857069|NCT01628042|3683238|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3857070|NCT01628042|3683239|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3857071|NCT01628042|3683240|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3857072|NCT01628042|3683241|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3857073|NCT01628042|3683242|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3857074|NCT01628042|3683238|B5|||Age||Years|Mean|63|63.0|Full Range|||50.0|75.0|
3857075|NCT01628042|3683239|B4|||Age||Years|Mean|57|57.0|Full Range|||51.0|70.0|
3857076|NCT01628042|3683240|B3|||Age||Years|Mean|66|66.0|Full Range|||59.0|75.0|
3857077|NCT01628042|3683241|B2|||Age||Years|Mean|64|64.0|Full Range|||50.0|74.0|
3857078|NCT01628042|3683242|B1|||Age||Years|Mean|65|65.0|Full Range|||53.0|75.0|
3857079|NCT01627899|3683263|B1||Unknown|Sex/Gender, Customized||Participants|Count of Participants|5|5.0||||||
3857080|NCT01627899|3683263|B1||Unknown|Age, Customized||Participants|Count of Participants|5|5.0||||||
3857081|NCT01627860|3683271|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3857082|NCT01627860|3683272|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3857083|NCT01627860|3683273|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3857084|NCT01627860|3683271|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3857085|NCT01627860|3683272|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3857086|NCT01627860|3683273|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3857087|NCT01627860|3683271|B3|||Age||years|Mean|43.17|43.17|Standard Deviation|11.41|11.41|||
3857088|NCT01627860|3683272|B2|||Age||years|Mean|42.4|42.4|Standard Deviation|12.21|12.21|||
3857089|NCT01627860|3683273|B1|||Age||years|Mean|44.1|44.1|Standard Deviation|11.91|11.91|||
3857090|NCT01627782|3683284|B5|USA||Region of Enrollment||participants|Number|67|67.0||||||
3857091|NCT01627782|3683285|B4|USA||Region of Enrollment||participants|Number|17|17.0||||||
3857092|NCT01627782|3683286|B3|USA||Region of Enrollment||participants|Number|16|16.0||||||
3857093|NCT01627782|3683287|B2|USA||Region of Enrollment||participants|Number|18|18.0||||||
3857094|NCT01627782|3683288|B1|USA||Region of Enrollment||participants|Number|16|16.0||||||
3857095|NCT01627782|3683284|B5||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3857096|NCT01627782|3683285|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3857097|NCT01627782|3683286|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3857098|NCT01627782|3683287|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3857099|NCT01627782|3683288|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3857100|NCT01627782|3683284|B5||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3857101|NCT01627782|3683285|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3857102|NCT01627782|3683286|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3857103|NCT01627782|3683287|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3857104|NCT01627782|3683288|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3857105|NCT01627782|3683284|B5|||Age||years|Mean|43.9|43.9|Standard Deviation|10.9|10.9|||
3857106|NCT01627782|3683285|B4|||Age||years|Mean|43.3|43.3|Standard Deviation|11.99|11.99|||
3857107|NCT01627782|3683286|B3|||Age||years|Mean|46.1|46.1|Standard Deviation|10.51|10.51|||
3857108|NCT01627782|3683287|B2|||Age||years|Mean|45.7|45.7|Standard Deviation|9.58|9.58|||
3857109|NCT01627782|3683288|B1|||Age||years|Mean|40.3|40.3|Standard Deviation|11.79|11.79|||
3857110|NCT01627561|3683347|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3857111|NCT01627561|3683348|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3857112|NCT01627561|3683349|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3857113|NCT01627561|3683347|B3||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3857114|NCT01627561|3683348|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3857115|NCT01627561|3683349|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3857116|NCT01627561|3683347|B3|||Age||Years|Mean|4.35|4.35|Standard Deviation|0.50|0.5|||
3857117|NCT01627561|3683348|B2|||Age||Years|Mean|4.4|4.4|Standard Deviation|0.52|0.52|||
3857118|NCT01627561|3683349|B1|||Age||Years|Mean|4.3|4.3|Standard Deviation|0.48|0.48|||
3857119|NCT01627340|3683396|B3||Male|Sex: Female, Male||Participants|Count of Participants|340|340.0||||||
3857120|NCT01627340|3683397|B2||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3857121|NCT01627340|3683398|B1||Male|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
3857122|NCT01627340|3683396|B3||Female|Sex: Female, Male||Participants|Count of Participants|334|334.0||||||
3857123|NCT01627340|3683397|B2||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3857124|NCT01627340|3683398|B1||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3857125|NCT01627340|3683396|B3|||Age||Years|Mean|51.8|51.8|Standard Deviation|12.98|12.98|||
3857126|NCT01627340|3683397|B2|||Age||Years|Mean|49.6|49.6|Standard Deviation|13.72|13.72|||
3857127|NCT01627340|3683398|B1|||Age||Years|Mean|53.2|53.2|Standard Deviation|12.32|12.32|||
3857128|NCT01627327|3683415|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|607|607.0||||||
3857129|NCT01627327|3683416|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|305|305.0||||||
3857130|NCT01627327|3683417|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|302|302.0||||||
3857131|NCT01627327|3683415|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3857132|NCT01627327|3683416|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3857133|NCT01627327|3683417|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3857134|NCT01627327|3683415|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
3857135|NCT01627327|3683416|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3857136|NCT01627327|3683417|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3857137|NCT01627327|3683415|B3||Male|Sex: Female, Male||Participants|Count of Participants|402|402.0||||||
3857138|NCT01627327|3683416|B2||Male|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
3857139|NCT01627327|3683417|B1||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
3857140|NCT01627327|3683415|B3||Female|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
3857141|NCT01627327|3683416|B2||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3857142|NCT01627327|3683417|B1||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3857143|NCT01627327|3683415|B3|||Age||Years|Mean|62.6|62.6|Standard Deviation|8.03|8.03|||
3857144|NCT01627327|3683416|B2|||Age||Years|Mean|62.3|62.3|Standard Deviation|7.98|7.98|||
3857145|NCT01627327|3683417|B1|||Age||Years|Mean|62.9|62.9|Standard Deviation|8.09|8.09|||
3857146|NCT01627249|3683428|B4|||Prior PRP|PRP = panretinal photocoagulation number of participants with prior panretinal photocoagulation in the study eye|participants|Number|107|107.0||||||
3857147|NCT01627249|3683429|B3|||Prior PRP|PRP = panretinal photocoagulation number of participants with prior panretinal photocoagulation in the study eye|participants|Number|35|35.0||||||
3857148|NCT01627249|3683430|B2|||Prior PRP|PRP = panretinal photocoagulation number of participants with prior panretinal photocoagulation in the study eye|participants|Number|40|40.0||||||
3857149|NCT01627249|3683431|B1|||Prior PRP|PRP = panretinal photocoagulation number of participants with prior panretinal photocoagulation in the study eye|participants|Number|32|32.0||||||
3857150|NCT01627249|3683428|B4|||Prior other treatment for DME|DME = Diabetic macular edema|participants|Number|37|37.0||||||
3857151|NCT01627249|3683429|B3|||Prior other treatment for DME|DME = Diabetic macular edema|participants|Number|11|11.0||||||
3857152|NCT01627249|3683430|B2|||Prior other treatment for DME|DME = Diabetic macular edema|participants|Number|12|12.0||||||
3857153|NCT01627249|3683431|B1|||Prior other treatment for DME|DME = Diabetic macular edema|participants|Number|14|14.0||||||
3857154|NCT01627249|3683428|B4|||Prior Anti-VEGF for DME|VEGF = anti vascular endothelial growth factor DME = diabetic macular edema|participants|Number|84|84.0||||||
3857155|NCT01627249|3683429|B3|||Prior Anti-VEGF for DME|VEGF = anti vascular endothelial growth factor DME = diabetic macular edema|participants|Number|29|29.0||||||
3857156|NCT01627249|3683430|B2|||Prior Anti-VEGF for DME|VEGF = anti vascular endothelial growth factor DME = diabetic macular edema|participants|Number|31|31.0||||||
3857157|NCT01627249|3683431|B1|||Prior Anti-VEGF for DME|VEGF = anti vascular endothelial growth factor DME = diabetic macular edema|participants|Number|24|24.0||||||
3857158|NCT01627249|3683428|B4|||Prior Focal/Grid Laser for DME|DME = Diabetic macular edema Number of participants with prior focal/grid laser for DME in the study eye|participants|Number|244|244.0||||||
3857159|NCT01627249|3683429|B3|||Prior Focal/Grid Laser for DME|DME = Diabetic macular edema Number of participants with prior focal/grid laser for DME in the study eye|participants|Number|80|80.0||||||
3857160|NCT01627249|3683430|B2|||Prior Focal/Grid Laser for DME|DME = Diabetic macular edema Number of participants with prior focal/grid laser for DME in the study eye|participants|Number|84|84.0||||||
3857161|NCT01627249|3683431|B1|||Prior Focal/Grid Laser for DME|DME = Diabetic macular edema Number of participants with prior focal/grid laser for DME in the study eye|participants|Number|80|80.0||||||
3857162|NCT01627249|3683428|B4|Missing||Diabetic Retinopathy Severity (ETDRS Level)|ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy, NPDR = non-proliferative diabetic retinopathy, PRP = panretinal photocoagulation Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|participants|Number|12|12.0||||||
3857163|NCT01627249|3683429|B3|Missing||Diabetic Retinopathy Severity (ETDRS Level)|ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy, NPDR = non-proliferative diabetic retinopathy, PRP = panretinal photocoagulation Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|participants|Number|2|2.0||||||
3857259|NCT01627249|3683429|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3857164|NCT01627249|3683430|B2|Missing||Diabetic Retinopathy Severity (ETDRS Level)|ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy, NPDR = non-proliferative diabetic retinopathy, PRP = panretinal photocoagulation Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|participants|Number|7|7.0||||||
3857165|NCT01627249|3683431|B1|Missing||Diabetic Retinopathy Severity (ETDRS Level)|ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy, NPDR = non-proliferative diabetic retinopathy, PRP = panretinal photocoagulation Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|participants|Number|3|3.0||||||
3857166|NCT01627249|3683428|B4|High risk PDR||Diabetic Retinopathy Severity (ETDRS Level)|ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy, NPDR = non-proliferative diabetic retinopathy, PRP = panretinal photocoagulation Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|participants|Number|18|18.0||||||
3857167|NCT01627249|3683429|B3|High risk PDR||Diabetic Retinopathy Severity (ETDRS Level)|ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy, NPDR = non-proliferative diabetic retinopathy, PRP = panretinal photocoagulation Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|participants|Number|9|9.0||||||
3857168|NCT01627249|3683430|B2|High risk PDR||Diabetic Retinopathy Severity (ETDRS Level)|ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy, NPDR = non-proliferative diabetic retinopathy, PRP = panretinal photocoagulation Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|participants|Number|7|7.0||||||
3857169|NCT01627249|3683431|B1|High risk PDR||Diabetic Retinopathy Severity (ETDRS Level)|ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy, NPDR = non-proliferative diabetic retinopathy, PRP = panretinal photocoagulation Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|participants|Number|2|2.0||||||
3857170|NCT01627249|3683428|B4|Mild to moderate PDR||Diabetic Retinopathy Severity (ETDRS Level)|ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy, NPDR = non-proliferative diabetic retinopathy, PRP = panretinal photocoagulation Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|participants|Number|82|82.0||||||
3857171|NCT01627249|3683429|B3|Mild to moderate PDR||Diabetic Retinopathy Severity (ETDRS Level)|ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy, NPDR = non-proliferative diabetic retinopathy, PRP = panretinal photocoagulation Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|participants|Number|23|23.0||||||
3857172|NCT01627249|3683430|B2|Mild to moderate PDR||Diabetic Retinopathy Severity (ETDRS Level)|ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy, NPDR = non-proliferative diabetic retinopathy, PRP = panretinal photocoagulation Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|participants|Number|31|31.0||||||
3857173|NCT01627249|3683431|B1|Mild to moderate PDR||Diabetic Retinopathy Severity (ETDRS Level)|ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy, NPDR = non-proliferative diabetic retinopathy, PRP = panretinal photocoagulation Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|participants|Number|28|28.0||||||
3857174|NCT01627249|3683428|B4|Prior PRP; without current PDR||Diabetic Retinopathy Severity (ETDRS Level)|ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy, NPDR = non-proliferative diabetic retinopathy, PRP = panretinal photocoagulation Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|participants|Number|54|54.0||||||
3857175|NCT01627249|3683429|B3|Prior PRP; without current PDR||Diabetic Retinopathy Severity (ETDRS Level)|ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy, NPDR = non-proliferative diabetic retinopathy, PRP = panretinal photocoagulation Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|participants|Number|16|16.0||||||
3857176|NCT01627249|3683430|B2|Prior PRP; without current PDR||Diabetic Retinopathy Severity (ETDRS Level)|ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy, NPDR = non-proliferative diabetic retinopathy, PRP = panretinal photocoagulation Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|participants|Number|21|21.0||||||
3857177|NCT01627249|3683431|B1|Prior PRP; without current PDR||Diabetic Retinopathy Severity (ETDRS Level)|ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy, NPDR = non-proliferative diabetic retinopathy, PRP = panretinal photocoagulation Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|participants|Number|17|17.0||||||
3857178|NCT01627249|3683428|B4|Severe NPDR||Diabetic Retinopathy Severity (ETDRS Level)|ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy, NPDR = non-proliferative diabetic retinopathy, PRP = panretinal photocoagulation Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|participants|Number|50|50.0||||||
3857260|NCT01627249|3683430|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3857261|NCT01627249|3683431|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
3857179|NCT01627249|3683429|B3|Severe NPDR||Diabetic Retinopathy Severity (ETDRS Level)|ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy, NPDR = non-proliferative diabetic retinopathy, PRP = panretinal photocoagulation Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|participants|Number|18|18.0||||||
3857180|NCT01627249|3683430|B2|Severe NPDR||Diabetic Retinopathy Severity (ETDRS Level)|ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy, NPDR = non-proliferative diabetic retinopathy, PRP = panretinal photocoagulation Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|participants|Number|15|15.0||||||
3857181|NCT01627249|3683431|B1|Severe NPDR||Diabetic Retinopathy Severity (ETDRS Level)|ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy, NPDR = non-proliferative diabetic retinopathy, PRP = panretinal photocoagulation Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|participants|Number|17|17.0||||||
3857182|NCT01627249|3683428|B4|Mild to moderately severe NPDR||Diabetic Retinopathy Severity (ETDRS Level)|ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy, NPDR = non-proliferative diabetic retinopathy, PRP = panretinal photocoagulation Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|participants|Number|426|426.0||||||
3857183|NCT01627249|3683429|B3|Mild to moderately severe NPDR||Diabetic Retinopathy Severity (ETDRS Level)|ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy, NPDR = non-proliferative diabetic retinopathy, PRP = panretinal photocoagulation Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|participants|Number|145|145.0||||||
3857184|NCT01627249|3683430|B2|Mild to moderately severe NPDR||Diabetic Retinopathy Severity (ETDRS Level)|ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy, NPDR = non-proliferative diabetic retinopathy, PRP = panretinal photocoagulation Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|participants|Number|131|131.0||||||
3857185|NCT01627249|3683431|B1|Mild to moderately severe NPDR||Diabetic Retinopathy Severity (ETDRS Level)|ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy, NPDR = non-proliferative diabetic retinopathy, PRP = panretinal photocoagulation Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|participants|Number|150|150.0||||||
3857186|NCT01627249|3683428|B4|Absent of minimal NPDR||Diabetic Retinopathy Severity (ETDRS Level)|ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy, NPDR = non-proliferative diabetic retinopathy, PRP = panretinal photocoagulation Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|participants|Number|18|18.0||||||
3857187|NCT01627249|3683429|B3|Absent of minimal NPDR||Diabetic Retinopathy Severity (ETDRS Level)|ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy, NPDR = non-proliferative diabetic retinopathy, PRP = panretinal photocoagulation Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|participants|Number|5|5.0||||||
3857188|NCT01627249|3683430|B2|Absent of minimal NPDR||Diabetic Retinopathy Severity (ETDRS Level)|ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy, NPDR = non-proliferative diabetic retinopathy, PRP = panretinal photocoagulation Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|participants|Number|6|6.0||||||
3857189|NCT01627249|3683431|B1|Absent of minimal NPDR||Diabetic Retinopathy Severity (ETDRS Level)|ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy, NPDR = non-proliferative diabetic retinopathy, PRP = panretinal photocoagulation Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|participants|Number|7|7.0||||||
3857190|NCT01627249|3683428|B4|Pseudophakic||Lens Status||participants|Number|161|161.0||||||
3857191|NCT01627249|3683429|B3|Pseudophakic||Lens Status||participants|Number|45|45.0||||||
3857192|NCT01627249|3683430|B2|Pseudophakic||Lens Status||participants|Number|58|58.0||||||
3857193|NCT01627249|3683431|B1|Pseudophakic||Lens Status||participants|Number|58|58.0||||||
3857194|NCT01627249|3683428|B4|Phakic||Lens Status||participants|Number|499|499.0||||||
3857195|NCT01627249|3683429|B3|Phakic||Lens Status||participants|Number|173|173.0||||||
3857196|NCT01627249|3683430|B2|Phakic||Lens Status||participants|Number|160|160.0||||||
3857197|NCT01627249|3683431|B1|Phakic||Lens Status||participants|Number|166|166.0||||||
3857198|NCT01627249|3683428|B4|||OCT Central Subfield|OCT = Optical Coherence Tomography|Microns|Median|387|387.0|Inter-Quartile Range|||308.0|479.0|
3857199|NCT01627249|3683429|B3|||OCT Central Subfield|OCT = Optical Coherence Tomography|Microns|Median|390|390.0|Inter-Quartile Range|||310.0|493.0|
3857200|NCT01627249|3683430|B2|||OCT Central Subfield|OCT = Optical Coherence Tomography|Microns|Median|376|376.0|Inter-Quartile Range|||305.0|477.0|
3857201|NCT01627249|3683431|B1|||OCT Central Subfield|OCT = Optical Coherence Tomography|Microns|Median|387|387.0|Inter-Quartile Range|||310.0|483.0|
3857202|NCT01627249|3683428|B4|||Visual Acuity Letter Score|Best corrected visual acuity letter score as measured by a certified tester using an electronic visual acuity testing machine based on the Early Treatment Diabetic Retinopathy Study (ETDRS) method. Best value on the scale 97, worst 0.|units on a scale|Median|69|69.0|Inter-Quartile Range|||59.0|73.0|
3857262|NCT01627249|3683428|B4|Black/African American||Race/Ethnicity, Customized||participants|Number|105|105.0||||||
3857263|NCT01627249|3683429|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3857203|NCT01627249|3683429|B3|||Visual Acuity Letter Score|Best corrected visual acuity letter score as measured by a certified tester using an electronic visual acuity testing machine based on the Early Treatment Diabetic Retinopathy Study (ETDRS) method. Best value on the scale 97, worst 0.|units on a scale|Median|68|68.0|Inter-Quartile Range|||58.0|73.0|
3857204|NCT01627249|3683430|B2|||Visual Acuity Letter Score|Best corrected visual acuity letter score as measured by a certified tester using an electronic visual acuity testing machine based on the Early Treatment Diabetic Retinopathy Study (ETDRS) method. Best value on the scale 97, worst 0.|units on a scale|Median|69|69.0|Inter-Quartile Range|||60.0|72.0|
3857205|NCT01627249|3683431|B1|||Visual Acuity Letter Score|Best corrected visual acuity letter score as measured by a certified tester using an electronic visual acuity testing machine based on the Early Treatment Diabetic Retinopathy Study (ETDRS) method. Best value on the scale 97, worst 0.|units on a scale|Median|69|69.0|Inter-Quartile Range|||59.0|74.0|
3857206|NCT01627249|3683428|B4|||Prior Hypertension||participants|Number|533|533.0||||||
3857207|NCT01627249|3683429|B3|||Prior Hypertension||participants|Number|175|175.0||||||
3857208|NCT01627249|3683430|B2|||Prior Hypertension||participants|Number|181|181.0||||||
3857209|NCT01627249|3683431|B1|||Prior Hypertension||participants|Number|177|177.0||||||
3857210|NCT01627249|3683428|B4|||Prior Transient Ischemic attacks||participants|Number|24|24.0||||||
3857211|NCT01627249|3683429|B3|||Prior Transient Ischemic attacks||participants|Number|10|10.0||||||
3857212|NCT01627249|3683430|B2|||Prior Transient Ischemic attacks||participants|Number|8|8.0||||||
3857213|NCT01627249|3683431|B1|||Prior Transient Ischemic attacks||participants|Number|6|6.0||||||
3857214|NCT01627249|3683428|B4|||Prior Stroke||participants|Number|31|31.0||||||
3857215|NCT01627249|3683429|B3|||Prior Stroke||participants|Number|10|10.0||||||
3857216|NCT01627249|3683430|B2|||Prior Stroke||participants|Number|13|13.0||||||
3857217|NCT01627249|3683431|B1|||Prior Stroke||participants|Number|8|8.0||||||
3857218|NCT01627249|3683428|B4|||Prior Coronary Artery Disease|Without myocardial infarction|participants|Number|83|83.0||||||
3857219|NCT01627249|3683429|B3|||Prior Coronary Artery Disease|Without myocardial infarction|participants|Number|34|34.0||||||
3857220|NCT01627249|3683430|B2|||Prior Coronary Artery Disease|Without myocardial infarction|participants|Number|27|27.0||||||
3857221|NCT01627249|3683431|B1|||Prior Coronary Artery Disease|Without myocardial infarction|participants|Number|22|22.0||||||
3857222|NCT01627249|3683428|B4|||Prior Myocardial Infarction||participants|Number|43|43.0||||||
3857223|NCT01627249|3683429|B3|||Prior Myocardial Infarction||participants|Number|16|16.0||||||
3857224|NCT01627249|3683430|B2|||Prior Myocardial Infarction||participants|Number|14|14.0||||||
3857225|NCT01627249|3683431|B1|||Prior Myocardial Infarction||participants|Number|13|13.0||||||
3857226|NCT01627249|3683428|B4|Uncertain||Diabetes Type||participants|Number|13|13.0||||||
3857227|NCT01627249|3683429|B3|Uncertain||Diabetes Type||participants|Number|6|6.0||||||
3857228|NCT01627249|3683430|B2|Uncertain||Diabetes Type||participants|Number|1|1.0||||||
3857229|NCT01627249|3683431|B1|Uncertain||Diabetes Type||participants|Number|6|6.0||||||
3857230|NCT01627249|3683428|B4|Type 2||Diabetes Type||participants|Number|597|597.0||||||
3857231|NCT01627249|3683429|B3|Type 2||Diabetes Type||participants|Number|196|196.0||||||
3857232|NCT01627249|3683430|B2|Type 2||Diabetes Type||participants|Number|205|205.0||||||
3857233|NCT01627249|3683431|B1|Type 2||Diabetes Type||participants|Number|196|196.0||||||
3857234|NCT01627249|3683428|B4|Type 1||Diabetes Type||participants|Number|50|50.0||||||
3857235|NCT01627249|3683429|B3|Type 1||Diabetes Type||participants|Number|16|16.0||||||
3857236|NCT01627249|3683430|B2|Type 1||Diabetes Type||participants|Number|12|12.0||||||
3857237|NCT01627249|3683431|B1|Type 1||Diabetes Type||participants|Number|22|22.0||||||
3857238|NCT01627249|3683428|B4|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3857239|NCT01627249|3683429|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3857240|NCT01627249|3683430|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3857241|NCT01627249|3683431|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3857242|NCT01627249|3683428|B4|Unknown/not reported||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3857243|NCT01627249|3683429|B3|Unknown/not reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3857244|NCT01627249|3683430|B2|Unknown/not reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3857245|NCT01627249|3683431|B1|Unknown/not reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3857246|NCT01627249|3683428|B4|More than one race||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3857247|NCT01627249|3683429|B3|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3857248|NCT01627249|3683430|B2|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3857249|NCT01627249|3683431|B1|More than one race||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3857250|NCT01627249|3683428|B4|American Indian/Alaskin Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3857251|NCT01627249|3683429|B3|American Indian/Alaskin Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3857252|NCT01627249|3683430|B2|American Indian/Alaskin Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3857253|NCT01627249|3683431|B1|American Indian/Alaskin Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3857254|NCT01627249|3683428|B4|Native Hawaiian/other Pacific Islander||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3857255|NCT01627249|3683429|B3|Native Hawaiian/other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3857256|NCT01627249|3683430|B2|Native Hawaiian/other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3857257|NCT01627249|3683431|B1|Native Hawaiian/other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3857258|NCT01627249|3683428|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|103|103.0||||||
3857264|NCT01627249|3683430|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
3857265|NCT01627249|3683431|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3857266|NCT01627249|3683428|B4|White||Race/Ethnicity, Customized||participants|Number|430|430.0||||||
3857267|NCT01627249|3683429|B3|White||Race/Ethnicity, Customized||participants|Number|146|146.0||||||
3857268|NCT01627249|3683430|B2|White||Race/Ethnicity, Customized||participants|Number|139|139.0||||||
3857269|NCT01627249|3683431|B1|White||Race/Ethnicity, Customized||participants|Number|145|145.0||||||
3857270|NCT01627249|3683428|B4|Men||Sex/Gender, Customized||participants|Number|353|353.0||||||
3857271|NCT01627249|3683429|B3|Men||Sex/Gender, Customized||participants|Number|124|124.0||||||
3857272|NCT01627249|3683430|B2|Men||Sex/Gender, Customized||participants|Number|115|115.0||||||
3857273|NCT01627249|3683431|B1|Men||Sex/Gender, Customized||participants|Number|114|114.0||||||
3857274|NCT01627249|3683428|B4|Women||Sex/Gender, Customized||participants|Number|307|307.0||||||
3857275|NCT01627249|3683429|B3|Women||Sex/Gender, Customized||participants|Number|94|94.0||||||
3857276|NCT01627249|3683430|B2|Women||Sex/Gender, Customized||participants|Number|103|103.0||||||
3857277|NCT01627249|3683431|B1|Women||Sex/Gender, Customized||participants|Number|110|110.0||||||
3857278|NCT01627249|3683428|B4|||Age, Customized||years|Mean|61|61.0|Standard Deviation|10|10.0|||
3857279|NCT01627249|3683429|B3|||Age, Customized||years|Mean|60|60.0|Standard Deviation|11|11.0|||
3857280|NCT01627249|3683430|B2|||Age, Customized||years|Mean|62|62.0|Standard Deviation|10|10.0|||
3857281|NCT01627249|3683431|B1|||Age, Customized||years|Mean|60|60.0|Standard Deviation|10|10.0|||
3857282|NCT01627002|3683468|B3|United Kingdom||Region of Enrollment||participants|Number|49|49.0||||||
3857283|NCT01627002|3683469|B2|United Kingdom||Region of Enrollment||participants|Number|22|22.0||||||
3857284|NCT01627002|3683470|B1|United Kingdom||Region of Enrollment||participants|Number|27|27.0||||||
3857285|NCT01627002|3683468|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3857286|NCT01627002|3683469|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3857287|NCT01627002|3683470|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3857288|NCT01627002|3683468|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3857289|NCT01627002|3683469|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3857290|NCT01627002|3683470|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3857291|NCT01627002|3683468|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3857292|NCT01627002|3683469|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3857293|NCT01627002|3683470|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3857294|NCT01627002|3683468|B3||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3857295|NCT01627002|3683469|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3857296|NCT01627002|3683470|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3857297|NCT01627002|3683468|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3857298|NCT01627002|3683469|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3857299|NCT01627002|3683470|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3857300|NCT01626820|3683529|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3857301|NCT01626820|3683530|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3857302|NCT01626820|3683531|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3857303|NCT01626820|3683529|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3857304|NCT01626820|3683530|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3857305|NCT01626820|3683531|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3857306|NCT01626820|3683529|B3|||Age||Years|Mean|54.18|54.18|Standard Deviation|17.13|17.13|||
3857307|NCT01626820|3683530|B2|||Age||Years|Mean|68.30|68.3|Standard Deviation|5.28|5.28|||
3857308|NCT01626820|3683531|B1|||Age||Years|Mean|39.80|39.8|Standard Deviation|12.32|12.32|||
3857309|NCT01626690|3683552|B3|||Baseline Temperature||Degrees Celisius|Mean|36.6|36.6|Standard Deviation|0.39|0.39|||
3857310|NCT01626690|3683553|B2|||Baseline Temperature||Degrees Celisius|Mean|36.7|36.7|Standard Deviation|0.37|0.37|||
3857311|NCT01626690|3683554|B1|||Baseline Temperature||Degrees Celisius|Mean|36.6|36.6|Standard Deviation|0.4|0.4|||
3857312|NCT01626690|3683552|B3|United States||Region of Enrollment||participants|Number|98|98.0||||||
3857313|NCT01626690|3683553|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
3857314|NCT01626690|3683554|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
3857315|NCT01626690|3683552|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3857316|NCT01626690|3683553|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3857317|NCT01626690|3683554|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3857318|NCT01626690|3683552|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3857319|NCT01626690|3683553|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3857320|NCT01626690|3683554|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3857321|NCT01626690|3683552|B3|||Age||years|Mean|66.3|66.3|Standard Deviation|6.9|6.9|||
3857322|NCT01626690|3683553|B2|||Age||years|Mean|66.5|66.5|Standard Deviation|7.41|7.41|||
3857323|NCT01626690|3683554|B1|||Age||years|Mean|66.1|66.1|Standard Deviation|6.37|6.37|||
3857324|NCT01626690|3683552|B3||>=65 years|Age||Participants|Count of Participants|54|54.0||||||
3857325|NCT01626690|3683553|B2||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
3857326|NCT01626690|3683554|B1||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
3857327|NCT01626690|3683552|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3857328|NCT01626690|3683553|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3857329|NCT01626690|3683554|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3857330|NCT01626690|3683552|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3857331|NCT01626690|3683553|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3857332|NCT01626690|3683554|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3857333|NCT01626664|3683575|B3|Peru||Region of Enrollment||participants|Number|7|7.0||||||
3857334|NCT01626664|3683576|B2|Peru||Region of Enrollment||participants|Number|3|3.0||||||
3857335|NCT01626664|3683577|B1|Peru||Region of Enrollment||participants|Number|4|4.0||||||
3857336|NCT01626664|3683575|B3|France||Region of Enrollment||participants|Number|9|9.0||||||
3857337|NCT01626664|3683576|B2|France||Region of Enrollment||participants|Number|3|3.0||||||
3857338|NCT01626664|3683577|B1|France||Region of Enrollment||participants|Number|6|6.0||||||
3857339|NCT01626664|3683575|B3|United Kingdom||Region of Enrollment||participants|Number|13|13.0||||||
3857340|NCT01626664|3683576|B2|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3857341|NCT01626664|3683577|B1|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
3857342|NCT01626664|3683575|B3|Brazil||Region of Enrollment||participants|Number|3|3.0||||||
3857343|NCT01626664|3683576|B2|Brazil||Region of Enrollment||participants|Number|0|0.0||||||
3857344|NCT01626664|3683577|B1|Brazil||Region of Enrollment||participants|Number|3|3.0||||||
3857345|NCT01626664|3683575|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
3857346|NCT01626664|3683576|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3857347|NCT01626664|3683577|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3857348|NCT01626664|3683575|B3|Race|Not Applicable|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3857349|NCT01626664|3683576|B2|Race|Not Applicable|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3857350|NCT01626664|3683577|B1|Race|Not Applicable|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3857351|NCT01626664|3683575|B3|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3857352|NCT01626664|3683576|B2|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3857353|NCT01626664|3683577|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3857354|NCT01626664|3683575|B3|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
3857355|NCT01626664|3683576|B2|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3857356|NCT01626664|3683577|B1|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3857357|NCT01626664|3683575|B3|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3857358|NCT01626664|3683576|B2|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3857359|NCT01626664|3683577|B1|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3857360|NCT01626664|3683575|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3857361|NCT01626664|3683576|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3857362|NCT01626664|3683577|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3857363|NCT01626664|3683575|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3857364|NCT01626664|3683576|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3857365|NCT01626664|3683577|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3857366|NCT01626664|3683575|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3857367|NCT01626664|3683576|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3857368|NCT01626664|3683577|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3857369|NCT01626664|3683575|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3857370|NCT01626664|3683576|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3857371|NCT01626664|3683577|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3857372|NCT01626664|3683575|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3857373|NCT01626664|3683576|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3857374|NCT01626664|3683577|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3857375|NCT01626664|3683575|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3857376|NCT01626664|3683576|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3857377|NCT01626664|3683577|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3857378|NCT01626664|3683575|B3|||Age||years|Mean|53|53.0|Full Range|||22.0|82.0|
3857379|NCT01626664|3683576|B2|||Age||years|Mean|49|49.0|Full Range|||24.0|80.0|
3857380|NCT01626664|3683577|B1|||Age||years|Mean|55|55.0|Full Range|||22.0|82.0|
3857381|NCT01626664|3683575|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3857382|NCT01626664|3683576|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3857383|NCT01626664|3683577|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3857384|NCT01626664|3683575|B3||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
3857385|NCT01626664|3683576|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3857386|NCT01626664|3683577|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3857387|NCT01626664|3683575|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3857388|NCT01626664|3683576|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3857389|NCT01626664|3683577|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3857390|NCT01626456|3683592|B3|Bulgaria||Region of Enrollment||participants|Number|62|62.0||||||
3857391|NCT01626456|3683593|B2|Bulgaria||Region of Enrollment||participants|Number|43|43.0||||||
3857392|NCT01626456|3683594|B1|Bulgaria||Region of Enrollment||participants|Number|19|19.0||||||
3857393|NCT01626456|3683592|B3|Malaysia||Region of Enrollment||participants|Number|24|24.0||||||
3857394|NCT01626456|3683593|B2|Malaysia||Region of Enrollment||participants|Number|21|21.0||||||
3857395|NCT01626456|3683594|B1|Malaysia||Region of Enrollment||participants|Number|3|3.0||||||
3857396|NCT01626456|3683592|B3|Korea, Republic of||Region of Enrollment||participants|Number|6|6.0||||||
3857397|NCT01626456|3683593|B2|Korea, Republic of||Region of Enrollment||participants|Number|6|6.0||||||
3857398|NCT01626456|3683594|B1|Korea, Republic of||Region of Enrollment||participants|Number|0|0.0||||||
3857399|NCT01626456|3683592|B3|Ukraine||Region of Enrollment||participants|Number|122|122.0||||||
3857400|NCT01626456|3683593|B2|Ukraine||Region of Enrollment||participants|Number|93|93.0||||||
3857401|NCT01626456|3683594|B1|Ukraine||Region of Enrollment||participants|Number|29|29.0||||||
3857402|NCT01626456|3683592|B3|Philippines||Region of Enrollment||participants|Number|49|49.0||||||
3857403|NCT01626456|3683593|B2|Philippines||Region of Enrollment||participants|Number|32|32.0||||||
3857404|NCT01626456|3683594|B1|Philippines||Region of Enrollment||participants|Number|17|17.0||||||
3857405|NCT01626456|3683592|B3|United States||Region of Enrollment||participants|Number|130|130.0||||||
3857406|NCT01626456|3683593|B2|United States||Region of Enrollment||participants|Number|111|111.0||||||
3857407|NCT01626456|3683594|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3857408|NCT01626456|3683592|B3|Romania||Region of Enrollment||participants|Number|5|5.0||||||
3857409|NCT01626456|3683593|B2|Romania||Region of Enrollment||participants|Number|2|2.0||||||
3857410|NCT01626456|3683594|B1|Romania||Region of Enrollment||participants|Number|3|3.0||||||
3857411|NCT01626456|3683592|B3|Russian Federation||Region of Enrollment||participants|Number|80|80.0||||||
3857412|NCT01626456|3683593|B2|Russian Federation||Region of Enrollment||participants|Number|60|60.0||||||
3857413|NCT01626456|3683594|B1|Russian Federation||Region of Enrollment||participants|Number|20|20.0||||||
3857414|NCT01626456|3683592|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857415|NCT01626456|3683593|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857416|NCT01626456|3683594|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857417|NCT01626456|3683592|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857418|NCT01626456|3683593|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857419|NCT01626456|3683594|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857420|NCT01626456|3683592|B3||White|Race (NIH/OMB)||Participants|Count of Participants|305|305.0||||||
3857421|NCT01626456|3683593|B2||White|Race (NIH/OMB)||Participants|Count of Participants|228|228.0||||||
3857422|NCT01626456|3683594|B1||White|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3857423|NCT01626456|3683592|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
3857424|NCT01626456|3683593|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3857425|NCT01626456|3683594|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3857426|NCT01626456|3683592|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3857427|NCT01626456|3683593|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3857428|NCT01626456|3683594|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857429|NCT01626456|3683592|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3857430|NCT01626456|3683593|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3857431|NCT01626456|3683594|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3857432|NCT01626456|3683592|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857433|NCT01626456|3683593|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857434|NCT01626456|3683594|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857435|NCT01626456|3683592|B3||Male|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
3857436|NCT01626456|3683593|B2||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
3857437|NCT01626456|3683594|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3857438|NCT01626456|3683592|B3||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
3857439|NCT01626456|3683593|B2||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3857440|NCT01626456|3683594|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3857441|NCT01626456|3683592|B3|||Age||years|Mean|39.4|39.4|Standard Deviation|11.57|11.57|||
3857442|NCT01626456|3683593|B2|||Age||years|Mean|39.8|39.8|Standard Deviation|11.76|11.76|||
3857443|NCT01626456|3683594|B1|||Age||years|Mean|38.1|38.1|Standard Deviation|10.88|10.88|||
3857444|NCT01626391|3683623|B3|Both||Anti-dementia Therapy||participants|Number|0|0.0||||||
3857445|NCT01626391|3683624|B2|Both||Anti-dementia Therapy||participants|Number|0|0.0||||||
3857446|NCT01626391|3683625|B1|Both||Anti-dementia Therapy||participants|Number|0|0.0||||||
3857447|NCT01626391|3683623|B3|Memantine||Anti-dementia Therapy||participants|Number|0|0.0||||||
3857448|NCT01626391|3683624|B2|Memantine||Anti-dementia Therapy||participants|Number|0|0.0||||||
3857449|NCT01626391|3683625|B1|Memantine||Anti-dementia Therapy||participants|Number|0|0.0||||||
3857450|NCT01626391|3683623|B3|AChEI||Anti-dementia Therapy||participants|Number|9|9.0||||||
3857451|NCT01626391|3683624|B2|AChEI||Anti-dementia Therapy||participants|Number|4|4.0||||||
3857452|NCT01626391|3683625|B1|AChEI||Anti-dementia Therapy||participants|Number|5|5.0||||||
3857453|NCT01626391|3683623|B3|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
3857454|NCT01626391|3683624|B2|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3857455|NCT01626391|3683625|B1|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
3857456|NCT01626391|3683623|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857457|NCT01626391|3683624|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857458|NCT01626391|3683625|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857459|NCT01626391|3683623|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3857460|NCT01626391|3683624|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3857461|NCT01626391|3683625|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3857462|NCT01626391|3683623|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857463|NCT01626391|3683624|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857464|NCT01626391|3683625|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857465|NCT01626391|3683623|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857466|NCT01626391|3683624|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857467|NCT01626391|3683625|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857468|NCT01626391|3683623|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857469|NCT01626391|3683624|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857470|NCT01626391|3683625|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857471|NCT01626391|3683623|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3857472|NCT01626391|3683624|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3857473|NCT01626391|3683625|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3857474|NCT01626391|3683623|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857475|NCT01626391|3683624|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857476|NCT01626391|3683625|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857477|NCT01626391|3683623|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857478|NCT01626391|3683624|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857479|NCT01626391|3683625|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857480|NCT01626391|3683623|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857481|NCT01626391|3683624|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857482|NCT01626391|3683625|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857483|NCT01626391|3683623|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857484|NCT01626391|3683624|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857485|NCT01626391|3683625|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857486|NCT01626391|3683623|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3857487|NCT01626391|3683624|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3857488|NCT01626391|3683625|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3857489|NCT01626391|3683623|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3857490|NCT01626391|3683624|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3857491|NCT01626391|3683625|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3857492|NCT01626391|3683623|B3|||Age||years|Mean|74.2|74.2|Standard Deviation|6.5|6.5|||
3857493|NCT01626391|3683624|B2|||Age||years|Mean|74.3|74.3|Standard Deviation|3.3|3.3|||
3857494|NCT01626391|3683625|B1|||Age||years|Mean|74.2|74.2|Standard Deviation|8.7|8.7|||
3857495|NCT01626352|3683632|B1|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3857496|NCT01626352|3683632|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857497|NCT01626352|3683632|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857498|NCT01626352|3683632|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3857499|NCT01626352|3683632|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857500|NCT01626352|3683632|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857501|NCT01626352|3683632|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857502|NCT01626352|3683632|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3857503|NCT01626352|3683632|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3857504|NCT01626352|3683632|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3857505|NCT01626352|3683632|B1|||Age||years|Median|83|83.0|Full Range|||73.0|88.0|
3857506|NCT01626352|3683632|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3857507|NCT01626352|3683632|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3857508|NCT01626352|3683632|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3857509|NCT01626118|3683642|B5|||Surgery duration, min|Surgery duration, minutes|minutes|Mean|27.7|27.7|Standard Deviation|7.67|7.67|||
3857510|NCT01626118|3683643|B4|||Surgery duration, min|Surgery duration, minutes|minutes|Mean|27.2|27.2|Standard Deviation|6.59|6.59|||
3857511|NCT01626118|3683644|B3|||Surgery duration, min|Surgery duration, minutes|minutes|Mean|28.5|28.5|Standard Deviation|8.63|8.63|||
3857512|NCT01626118|3683645|B2|||Surgery duration, min|Surgery duration, minutes|minutes|Mean|27.6|27.6|Standard Deviation|7.95|7.95|||
3857513|NCT01626118|3683646|B1|||Surgery duration, min|Surgery duration, minutes|minutes|Mean|27.7|27.7|Standard Deviation|7.45|7.45|||
3857514|NCT01626118|3683642|B5|||Baseline pain intensity, mm|"The pain intensity is assessed using a visual analogue scale (VAS), which is a horizontal line 100 mm in length. Subjects mark the VAS with a single vertical line to indicate their current pain level, with 0 mm representing No Pain and 100 mm representing Worst Possible Pain."|mm|Mean|72.1|72.1|Standard Deviation|16.21|16.21|||
3857515|NCT01626118|3683643|B4|||Baseline pain intensity, mm|"The pain intensity is assessed using a visual analogue scale (VAS), which is a horizontal line 100 mm in length. Subjects mark the VAS with a single vertical line to indicate their current pain level, with 0 mm representing No Pain and 100 mm representing Worst Possible Pain."|mm|Mean|73.9|73.9|Standard Deviation|16.6|16.6|||
3857516|NCT01626118|3683644|B3|||Baseline pain intensity, mm|"The pain intensity is assessed using a visual analogue scale (VAS), which is a horizontal line 100 mm in length. Subjects mark the VAS with a single vertical line to indicate their current pain level, with 0 mm representing No Pain and 100 mm representing Worst Possible Pain."|mm|Mean|72.3|72.3|Standard Deviation|15.90|15.9|||
3857517|NCT01626118|3683645|B2|||Baseline pain intensity, mm|"The pain intensity is assessed using a visual analogue scale (VAS), which is a horizontal line 100 mm in length. Subjects mark the VAS with a single vertical line to indicate their current pain level, with 0 mm representing No Pain and 100 mm representing Worst Possible Pain."|mm|Mean|71.2|71.2|Standard Deviation|16.11|16.11|||
3857518|NCT01626118|3683646|B1|||Baseline pain intensity, mm|"The pain intensity is assessed using a visual analogue scale (VAS), which is a horizontal line 100 mm in length. Subjects mark the VAS with a single vertical line to indicate their current pain level, with 0 mm representing No Pain and 100 mm representing Worst Possible Pain."|mm|Mean|71.0|71.0|Standard Deviation|16.33|16.33|||
3857519|NCT01626118|3683642|B5|||BMI (kg/m^2)|Body mass index measured in kilograms per meter squared.|KG/M^2|Mean|26.3|26.3|Standard Deviation|4.52|4.52|||
3857520|NCT01626118|3683643|B4|||BMI (kg/m^2)|Body mass index measured in kilograms per meter squared.|KG/M^2|Mean|25.8|25.8|Standard Deviation|4.57|4.57|||
3857521|NCT01626118|3683644|B3|||BMI (kg/m^2)|Body mass index measured in kilograms per meter squared.|KG/M^2|Mean|26.7|26.7|Standard Deviation|4.73|4.73|||
3857522|NCT01626118|3683645|B2|||BMI (kg/m^2)|Body mass index measured in kilograms per meter squared.|KG/M^2|Mean|26.3|26.3|Standard Deviation|4.34|4.34|||
3857523|NCT01626118|3683646|B1|||BMI (kg/m^2)|Body mass index measured in kilograms per meter squared.|KG/M^2|Mean|26.5|26.5|Standard Deviation|4.49|4.49|||
3857524|NCT01626118|3683642|B5|||Height (cm)|Height measured in centimeters|CM|Mean|166.01|166.01|Standard Deviation|8.621|8.621|||
3857525|NCT01626118|3683643|B4|||Height (cm)|Height measured in centimeters|CM|Mean|165.61|165.61|Standard Deviation|7.646|7.646|||
3857526|NCT01626118|3683644|B3|||Height (cm)|Height measured in centimeters|CM|Mean|166.52|166.52|Standard Deviation|9.761|9.761|||
3857527|NCT01626118|3683645|B2|||Height (cm)|Height measured in centimeters|CM|Mean|165.65|165.65|Standard Deviation|8.994|8.994|||
3857528|NCT01626118|3683646|B1|||Height (cm)|Height measured in centimeters|CM|Mean|166.28|166.28|Standard Deviation|8.059|8.059|||
3857529|NCT01626118|3683642|B5|||Weight (kg)|Weight measured in kilogram|KG|Mean|73.19|73.19|Standard Deviation|15.758|15.758|||
3857530|NCT01626118|3683643|B4|||Weight (kg)|Weight measured in kilogram|KG|Mean|71.22|71.22|Standard Deviation|14.607|14.607|||
3857531|NCT01626118|3683644|B3|||Weight (kg)|Weight measured in kilogram|KG|Mean|74.99|74.99|Standard Deviation|17.821|17.821|||
3857532|NCT01626118|3683645|B2|||Weight (kg)|Weight measured in kilogram|KG|Mean|72.77|72.77|Standard Deviation|15.761|15.761|||
3857533|NCT01626118|3683646|B1|||Weight (kg)|Weight measured in kilogram|KG|Mean|73.81|73.81|Standard Deviation|14.686|14.686|||
3857534|NCT01626118|3683642|B5|Other||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|3|3.0||||||
3857535|NCT01626118|3683643|B4|Other||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|2|2.0||||||
3857536|NCT01626118|3683644|B3|Other||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|1|1.0||||||
3857537|NCT01626118|3683645|B2|Other||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|0|0.0||||||
3857538|NCT01626118|3683646|B1|Other||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|0|0.0||||||
3857539|NCT01626118|3683642|B5|White or Caucasian||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|282|282.0||||||
3857540|NCT01626118|3683643|B4|White or Caucasian||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|70|70.0||||||
3857541|NCT01626118|3683644|B3|White or Caucasian||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|69|69.0||||||
3857542|NCT01626118|3683645|B2|White or Caucasian||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|66|66.0||||||
3857543|NCT01626118|3683646|B1|White or Caucasian||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|77|77.0||||||
3857544|NCT01626118|3683642|B5|Black or African American||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|80|80.0||||||
3857545|NCT01626118|3683643|B4|Black or African American||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|19|19.0||||||
3857546|NCT01626118|3683644|B3|Black or African American||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|21|21.0||||||
3857547|NCT01626118|3683645|B2|Black or African American||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|25|25.0||||||
3857548|NCT01626118|3683646|B1|Black or African American||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|15|15.0||||||
3857549|NCT01626118|3683642|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|3|3.0||||||
3857550|NCT01626118|3683643|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|0|0.0||||||
3857551|NCT01626118|3683644|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|2|2.0||||||
3857552|NCT01626118|3683645|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|1|1.0||||||
3857553|NCT01626118|3683646|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|0|0.0||||||
3857554|NCT01626118|3683642|B5|Asian||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|8|8.0||||||
3857555|NCT01626118|3683643|B4|Asian||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|2|2.0||||||
3857556|NCT01626118|3683644|B3|Asian||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|2|2.0||||||
3857557|NCT01626118|3683645|B2|Asian||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|2|2.0||||||
3857558|NCT01626118|3683646|B1|Asian||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|2|2.0||||||
3857559|NCT01626118|3683642|B5|American Indian or Alaska Native||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|5|5.0||||||
3857560|NCT01626118|3683643|B4|American Indian or Alaska Native||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|1|1.0||||||
3857561|NCT01626118|3683644|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|0|0.0||||||
3857562|NCT01626118|3683645|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|2|2.0||||||
3857563|NCT01626118|3683646|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|2|2.0||||||
3857564|NCT01626118|3683642|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857565|NCT01626118|3683643|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857566|NCT01626118|3683644|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857567|NCT01626118|3683645|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857568|NCT01626118|3683646|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857569|NCT01626118|3683642|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|300|300.0||||||
3857570|NCT01626118|3683643|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3857571|NCT01626118|3683644|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3857572|NCT01626118|3683645|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3857573|NCT01626118|3683646|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3857574|NCT01626118|3683642|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3857575|NCT01626118|3683643|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3857576|NCT01626118|3683644|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3857577|NCT01626118|3683645|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3857578|NCT01626118|3683646|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3857579|NCT01626118|3683642|B5||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3857580|NCT01626118|3683643|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3857581|NCT01626118|3683644|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3857582|NCT01626118|3683645|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3857583|NCT01626118|3683646|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3857584|NCT01626118|3683642|B5||Female|Sex: Female, Male||Participants|Count of Participants|317|317.0||||||
3857585|NCT01626118|3683643|B4||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3857586|NCT01626118|3683644|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3857587|NCT01626118|3683645|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3857588|NCT01626118|3683646|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3857589|NCT01626118|3683642|B5|||Age||years|Mean|40.3|40.3|Standard Deviation|12.16|12.16|||
3857590|NCT01626118|3683643|B4|||Age||years|Mean|40.7|40.7|Standard Deviation|11.32|11.32|||
3857591|NCT01626118|3683644|B3|||Age||years|Mean|41.3|41.3|Standard Deviation|12.57|12.57|||
3857592|NCT01626118|3683645|B2|||Age||years|Mean|38.9|38.9|Standard Deviation|12.5|12.5|||
3857593|NCT01626118|3683646|B1|||Age||years|Mean|40.2|40.2|Standard Deviation|12.27|12.27|||
3857594|NCT01626092|3683687|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3857595|NCT01626092|3683687|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3857596|NCT01626092|3683687|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3857597|NCT01626092|3683687|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3857598|NCT01626092|3683687|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3857599|NCT01626092|3683687|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3857600|NCT01625910|3683693|B3|||BMI- Z score|At baseline and the 3-month follow up visit, the children’s heights and weights were measured by trained RAs. The measurements at follow-up were done by an RA, blinded to group assignment. Height and weight were measured with the child in light indoor clothing, with shoes and socks removed. RAs measured height (cm), in triplicate, using a Shorr height board, and reported the mean of the three readings. Weight was measured using a Tanita scale. Age- and gender-specific BMI Z-scores were calculated using the US CDC 2000 growth charts.|z-score units|Mean|1.90|1.9|Standard Deviation|0.69|0.69|||
3857601|NCT01625910|3683694|B2|||BMI- Z score|At baseline and the 3-month follow up visit, the children’s heights and weights were measured by trained RAs. The measurements at follow-up were done by an RA, blinded to group assignment. Height and weight were measured with the child in light indoor clothing, with shoes and socks removed. RAs measured height (cm), in triplicate, using a Shorr height board, and reported the mean of the three readings. Weight was measured using a Tanita scale. Age- and gender-specific BMI Z-scores were calculated using the US CDC 2000 growth charts.|z-score units|Mean|1.89|1.89|Standard Deviation|0.82|0.82|||
3857602|NCT01625910|3683695|B1|||BMI- Z score|At baseline and the 3-month follow up visit, the children’s heights and weights were measured by trained RAs. The measurements at follow-up were done by an RA, blinded to group assignment. Height and weight were measured with the child in light indoor clothing, with shoes and socks removed. RAs measured height (cm), in triplicate, using a Shorr height board, and reported the mean of the three readings. Weight was measured using a Tanita scale. Age- and gender-specific BMI Z-scores were calculated using the US CDC 2000 growth charts.|z-score units|Mean|1.90|1.9|Standard Deviation|0.55|0.55|||
3857603|NCT01625910|3683693|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3857604|NCT01625910|3683694|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3857605|NCT01625910|3683695|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3857606|NCT01625910|3683693|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3857607|NCT01625910|3683694|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3857608|NCT01625910|3683695|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3857609|NCT01625910|3683693|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3857610|NCT01625910|3683694|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3857611|NCT01625910|3683695|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3857612|NCT01625910|3683693|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3857613|NCT01625910|3683694|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3857614|NCT01625910|3683695|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3857615|NCT01625910|3683693|B3||<=18 years|Age||Participants|Count of Participants|72|72.0||||||
3857616|NCT01625910|3683694|B2||<=18 years|Age||Participants|Count of Participants|37|37.0||||||
3857617|NCT01625910|3683695|B1||<=18 years|Age||Participants|Count of Participants|35|35.0||||||
3857618|NCT01625845|3683704|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3857619|NCT01625845|3683705|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3857620|NCT01625845|3683706|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3857621|NCT01625845|3683704|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3857622|NCT01625845|3683705|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3857623|NCT01625845|3683706|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3857624|NCT01625845|3683704|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3857625|NCT01625845|3683705|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3857626|NCT01625845|3683706|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3857627|NCT01625845|3683704|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3857628|NCT01625845|3683705|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3857629|NCT01625845|3683706|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3857630|NCT01625845|3683704|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3857631|NCT01625845|3683705|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3857632|NCT01625845|3683706|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3857633|NCT01625689|3683725|B3|Bangladesh||Region of Enrollment||participants|Number|300|300.0||||||
3857634|NCT01625689|3683726|B2|Bangladesh||Region of Enrollment||participants|Number|150|150.0||||||
3857635|NCT01625689|3683727|B1|Bangladesh||Region of Enrollment||participants|Number|150|150.0||||||
3857636|NCT01625689|3683725|B3||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3857637|NCT01625689|3683726|B2||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3857638|NCT01625689|3683727|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3857639|NCT01625689|3683725|B3||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3857640|NCT01625689|3683726|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3857641|NCT01625689|3683727|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3857642|NCT01625689|3683725|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3857643|NCT01625689|3683726|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3857644|NCT01625689|3683727|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3857645|NCT01625689|3683725|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3857646|NCT01625689|3683726|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3857647|NCT01625689|3683727|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3857648|NCT01625689|3683725|B3||<=18 years|Age||Participants|Count of Participants|300|300.0||||||
3857649|NCT01625689|3683726|B2||<=18 years|Age||Participants|Count of Participants|150|150.0||||||
3857650|NCT01625689|3683727|B1||<=18 years|Age||Participants|Count of Participants|150|150.0||||||
3857651|NCT01625507|3683738|B1|Other||Employment||participants|Number|7|7.0||||||
3857652|NCT01625507|3683738|B1|Unemployed||Employment||participants|Number|2|2.0||||||
3857653|NCT01625507|3683738|B1|Retired||Employment||participants|Number|18|18.0||||||
3857654|NCT01625507|3683738|B1|Self-employment||Employment||participants|Number|5|5.0||||||
3857655|NCT01625507|3683738|B1|Wages and salaries||Employment||participants|Number|41|41.0||||||
3857656|NCT01625507|3683738|B1|College or university degree||Education||participants|Number|40|40.0||||||
3857657|NCT01625507|3683738|B1|High school completed||Education||participants|Number|28|28.0||||||
3857658|NCT01625507|3683738|B1|Less than high school||Education||participants|Number|5|5.0||||||
3857659|NCT01625507|3683738|B1|Canada||Region of Enrollment||participants|Number|73|73.0||||||
3857660|NCT01625507|3683738|B1||Male|Gender||Participants|Count of Participants|39|39.0||||||
3857661|NCT01625507|3683738|B1||Female|Gender||Participants|Count of Participants|34|34.0||||||
3857662|NCT01625507|3683738|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|9.7|9.7|||
3857663|NCT01625455|3683751|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3857664|NCT01625455|3683752|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3857665|NCT01625455|3683753|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3857666|NCT01625455|3683751|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3857667|NCT01625455|3683752|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3857668|NCT01625455|3683753|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3857669|NCT01625455|3683751|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3857670|NCT01625455|3683752|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3857671|NCT01625455|3683753|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3857672|NCT01625455|3683751|B3|||Age||years|Mean|63.4|63.4|Full Range|||47.0|77.0|
3857673|NCT01625455|3683752|B2|||Age||years|Mean|58.3|58.3|Full Range|||47.0|77.0|
3857674|NCT01625455|3683753|B1|||Age||years|Mean|71|71.0|Full Range|||66.0|76.0|
3857675|NCT01625455|3683751|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3857676|NCT01625455|3683752|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3857677|NCT01625455|3683753|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3857678|NCT01625455|3683751|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3857679|NCT01625455|3683752|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3857680|NCT01625455|3683753|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3857681|NCT01625455|3683751|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3857682|NCT01625455|3683752|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3857683|NCT01625455|3683753|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3857684|NCT01625416|3683762|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3857685|NCT01625416|3683763|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3857686|NCT01625416|3683764|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3857687|NCT01625416|3683762|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3857688|NCT01625416|3683763|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3857689|NCT01625416|3683764|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3857690|NCT01625416|3683762|B3||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3857691|NCT01625416|3683763|B2||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3857692|NCT01625416|3683764|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3857693|NCT01625416|3683762|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3857694|NCT01625416|3683763|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3857695|NCT01625416|3683764|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3857696|NCT01625416|3683762|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3857697|NCT01625416|3683763|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3857698|NCT01625416|3683764|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857699|NCT01625416|3683762|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3857700|NCT01625416|3683763|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3857701|NCT01625416|3683764|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3857702|NCT01625416|3683762|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3857703|NCT01625416|3683763|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3857704|NCT01625416|3683764|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3857705|NCT01625416|3683762|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857706|NCT01625416|3683763|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857707|NCT01625416|3683764|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857708|NCT01625416|3683762|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
3857709|NCT01625416|3683763|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3857710|NCT01625416|3683764|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3857711|NCT01625416|3683762|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3857712|NCT01625416|3683763|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3857713|NCT01625416|3683764|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3857714|NCT01625416|3683762|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3857715|NCT01625416|3683763|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3857716|NCT01625416|3683764|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3857717|NCT01625416|3683762|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3857718|NCT01625416|3683763|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3857719|NCT01625416|3683764|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3857720|NCT01625416|3683762|B3|||Age||years|Mean|43.2|43.2|Standard Deviation|14.7|14.7|||
3857721|NCT01625416|3683763|B2|||Age||years|Mean|43.5|43.5|Standard Deviation|14.8|14.8|||
3857722|NCT01625416|3683764|B1|||Age||years|Mean|42.8|42.8|Standard Deviation|14.7|14.7|||
3857723|NCT01625416|3683762|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3857724|NCT01625416|3683763|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3857725|NCT01625416|3683764|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3857726|NCT01625416|3683762|B3||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
3857727|NCT01625416|3683763|B2||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
3857728|NCT01625416|3683764|B1||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
3857729|NCT01625416|3683762|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3857730|NCT01625416|3683763|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3857731|NCT01625416|3683764|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3857732|NCT01625377|3683781|B3||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3857733|NCT01625377|3683782|B2||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3857734|NCT01625377|3683783|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3857735|NCT01625377|3683781|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3857736|NCT01625377|3683782|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3857737|NCT01625377|3683783|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3857738|NCT01625377|3683781|B3|||Age||Years|Mean|56.0|56.0|Standard Deviation|8.41|8.41|||
3857739|NCT01625377|3683782|B2|||Age||Years|Mean|56.5|56.5|Standard Deviation|8.59|8.59|||
3857740|NCT01625377|3683783|B1|||Age||Years|Mean|55.5|55.5|Standard Deviation|8.24|8.24|||
3857741|NCT01625338|3683814|B4|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|423|423.0||||||
3857742|NCT01625338|3683815|B3|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|183|183.0||||||
3857743|NCT01625338|3683816|B2|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|156|156.0||||||
3857744|NCT01625338|3683817|B1|≥ 800,000 IU/mL||HCV RNA Category||participants|Number|84|84.0||||||
3857745|NCT01625338|3683814|B4|< 800,000 IU/mL||HCV RNA Category||participants|Number|110|110.0||||||
3857746|NCT01625338|3683815|B3|< 800,000 IU/mL||HCV RNA Category||participants|Number|36|36.0||||||
3857747|NCT01625338|3683816|B2|< 800,000 IU/mL||HCV RNA Category||participants|Number|44|44.0||||||
3857748|NCT01625338|3683817|B1|< 800,000 IU/mL||HCV RNA Category||participants|Number|30|30.0||||||
3857749|NCT01625338|3683814|B4|||HCV RNA||log10 IU/mL|Mean|6.4|6.4|Standard Deviation|0.72|0.72|||
3857750|NCT01625338|3683815|B3|||HCV RNA||log10 IU/mL|Mean|6.4|6.4|Standard Deviation|0.64|0.64|||
3857751|NCT01625338|3683816|B2|||HCV RNA||log10 IU/mL|Mean|6.4|6.4|Standard Deviation|0.70|0.7|||
3857752|NCT01625338|3683817|B1|||HCV RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.87|0.87|||
3857753|NCT01625338|3683814|B4|Missing||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|10|10.0||||||
3857754|NCT01625338|3683815|B3|Missing||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|5|5.0||||||
3857755|NCT01625338|3683816|B2|Missing||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
3857756|NCT01625338|3683817|B1|Missing||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|2|2.0||||||
3857757|NCT01625338|3683814|B4|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|88|88.0||||||
3857758|NCT01625338|3683815|B3|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|40|40.0||||||
3857759|NCT01625338|3683816|B2|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|35|35.0||||||
3857760|NCT01625338|3683817|B1|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|13|13.0||||||
3857761|NCT01625338|3683814|B4|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|291|291.0||||||
3857762|NCT01625338|3683815|B3|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|127|127.0||||||
3857763|NCT01625338|3683816|B2|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|103|103.0||||||
3857764|NCT01625338|3683817|B1|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|61|61.0||||||
3857765|NCT01625338|3683814|B4|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|144|144.0||||||
3857766|NCT01625338|3683815|B3|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|47|47.0||||||
3857767|NCT01625338|3683816|B2|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|59|59.0||||||
3857768|NCT01625338|3683817|B1|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|38|38.0||||||
3857769|NCT01625338|3683814|B4|Yes||Cirrhosis Status||participants|Number|123|123.0||||||
3857770|NCT01625338|3683815|B3|Yes||Cirrhosis Status||participants|Number|36|36.0||||||
3857771|NCT01625338|3683816|B2|Yes||Cirrhosis Status||participants|Number|62|62.0||||||
3857772|NCT01625338|3683817|B1|Yes||Cirrhosis Status||participants|Number|25|25.0||||||
3857773|NCT01625338|3683814|B4|No||Cirrhosis Status||participants|Number|410|410.0||||||
3857774|NCT01625338|3683815|B3|No||Cirrhosis Status||participants|Number|183|183.0||||||
3857775|NCT01625338|3683816|B2|No||Cirrhosis Status||participants|Number|138|138.0||||||
3857776|NCT01625338|3683817|B1|No||Cirrhosis Status||participants|Number|89|89.0||||||
3857777|NCT01625338|3683814|B4|Indeterminate||HCV Genotype||participants|Number|1|1.0||||||
3857778|NCT01625338|3683815|B3|Indeterminate||HCV Genotype||participants|Number|0|0.0||||||
3857779|NCT01625338|3683816|B2|Indeterminate||HCV Genotype||participants|Number|1|1.0||||||
3857780|NCT01625338|3683817|B1|Indeterminate||HCV Genotype||participants|Number|0|0.0||||||
3857781|NCT01625338|3683814|B4|Genotype 4||HCV Genotype||participants|Number|10|10.0||||||
3857782|NCT01625338|3683815|B3|Genotype 4||HCV Genotype||participants|Number|3|3.0||||||
3857783|NCT01625338|3683816|B2|Genotype 4||HCV Genotype||participants|Number|7|7.0||||||
3857784|NCT01625338|3683817|B1|Genotype 4||HCV Genotype||participants|Number|0|0.0||||||
3857785|NCT01625338|3683814|B4|Genotype 3||HCV Genotype||participants|Number|306|306.0||||||
3857786|NCT01625338|3683815|B3|Genotype 3||HCV Genotype||participants|Number|74|74.0||||||
3857787|NCT01625338|3683816|B2|Genotype 3||HCV Genotype||participants|Number|180|180.0||||||
3857788|NCT01625338|3683817|B1|Genotype 3||HCV Genotype||participants|Number|52|52.0||||||
3857789|NCT01625338|3683814|B4|Genotype 2||HCV Genotype||participants|Number|80|80.0||||||
3857790|NCT01625338|3683815|B3|Genotype 2||HCV Genotype||participants|Number|8|8.0||||||
3857791|NCT01625338|3683816|B2|Genotype 2||HCV Genotype||participants|Number|10|10.0||||||
3857792|NCT01625338|3683817|B1|Genotype 2||HCV Genotype||participants|Number|62|62.0||||||
3857793|NCT01625338|3683814|B4|Genotype 1||HCV Genotype||participants|Number|136|136.0||||||
3857794|NCT01625338|3683815|B3|Genotype 1||HCV Genotype||participants|Number|134|134.0||||||
3857795|NCT01625338|3683816|B2|Genotype 1||HCV Genotype||participants|Number|2|2.0||||||
3857796|NCT01625338|3683817|B1|Genotype 1||HCV Genotype||participants|Number|0|0.0||||||
3857797|NCT01625338|3683814|B4|Estonia||Region of Enrollment||participants|Number|6|6.0||||||
3857798|NCT01625338|3683815|B3|Estonia||Region of Enrollment||participants|Number|3|3.0||||||
3857799|NCT01625338|3683816|B2|Estonia||Region of Enrollment||participants|Number|2|2.0||||||
3857800|NCT01625338|3683817|B1|Estonia||Region of Enrollment||participants|Number|1|1.0||||||
3857801|NCT01625338|3683814|B4|Germany||Region of Enrollment||participants|Number|32|32.0||||||
3857802|NCT01625338|3683815|B3|Germany||Region of Enrollment||participants|Number|18|18.0||||||
3857803|NCT01625338|3683816|B2|Germany||Region of Enrollment||participants|Number|12|12.0||||||
3857804|NCT01625338|3683817|B1|Germany||Region of Enrollment||participants|Number|2|2.0||||||
3857805|NCT01625338|3683814|B4|France||Region of Enrollment||participants|Number|23|23.0||||||
3857806|NCT01625338|3683815|B3|France||Region of Enrollment||participants|Number|11|11.0||||||
3857807|NCT01625338|3683816|B2|France||Region of Enrollment||participants|Number|10|10.0||||||
3857808|NCT01625338|3683817|B1|France||Region of Enrollment||participants|Number|2|2.0||||||
3857809|NCT01625338|3683814|B4|Australia||Region of Enrollment||participants|Number|42|42.0||||||
3857810|NCT01625338|3683815|B3|Australia||Region of Enrollment||participants|Number|19|19.0||||||
3857811|NCT01625338|3683816|B2|Australia||Region of Enrollment||participants|Number|14|14.0||||||
3857812|NCT01625338|3683817|B1|Australia||Region of Enrollment||participants|Number|9|9.0||||||
3857813|NCT01625338|3683814|B4|Italy||Region of Enrollment||participants|Number|14|14.0||||||
3857814|NCT01625338|3683815|B3|Italy||Region of Enrollment||participants|Number|4|4.0||||||
3857815|NCT01625338|3683816|B2|Italy||Region of Enrollment||participants|Number|7|7.0||||||
3857816|NCT01625338|3683817|B1|Italy||Region of Enrollment||participants|Number|3|3.0||||||
3857817|NCT01625338|3683814|B4|Poland||Region of Enrollment||participants|Number|9|9.0||||||
3857818|NCT01625338|3683815|B3|Poland||Region of Enrollment||participants|Number|8|8.0||||||
3857819|NCT01625338|3683816|B2|Poland||Region of Enrollment||participants|Number|1|1.0||||||
3857820|NCT01625338|3683817|B1|Poland||Region of Enrollment||participants|Number|0|0.0||||||
3857821|NCT01625338|3683814|B4|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
3857822|NCT01625338|3683815|B3|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
3857823|NCT01625338|3683816|B2|Czech Republic||Region of Enrollment||participants|Number|0|0.0||||||
3857824|NCT01625338|3683817|B1|Czech Republic||Region of Enrollment||participants|Number|0|0.0||||||
3857825|NCT01625338|3683814|B4|Sweden||Region of Enrollment||participants|Number|10|10.0||||||
3857826|NCT01625338|3683815|B3|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
3857827|NCT01625338|3683816|B2|Sweden||Region of Enrollment||participants|Number|5|5.0||||||
3857828|NCT01625338|3683817|B1|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
3857829|NCT01625338|3683814|B4|Netherlands||Region of Enrollment||participants|Number|10|10.0||||||
3857830|NCT01625338|3683815|B3|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
3857831|NCT01625338|3683816|B2|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
3857832|NCT01625338|3683817|B1|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
3857833|NCT01625338|3683814|B4|Austria||Region of Enrollment||participants|Number|4|4.0||||||
3857834|NCT01625338|3683815|B3|Austria||Region of Enrollment||participants|Number|1|1.0||||||
3857835|NCT01625338|3683816|B2|Austria||Region of Enrollment||participants|Number|2|2.0||||||
3857836|NCT01625338|3683817|B1|Austria||Region of Enrollment||participants|Number|1|1.0||||||
3857837|NCT01625338|3683814|B4|Canada||Region of Enrollment||participants|Number|30|30.0||||||
3857838|NCT01625338|3683815|B3|Canada||Region of Enrollment||participants|Number|10|10.0||||||
3857839|NCT01625338|3683816|B2|Canada||Region of Enrollment||participants|Number|13|13.0||||||
3857840|NCT01625338|3683817|B1|Canada||Region of Enrollment||participants|Number|7|7.0||||||
3857841|NCT01625338|3683814|B4|New Zealand||Region of Enrollment||participants|Number|40|40.0||||||
3857842|NCT01625338|3683815|B3|New Zealand||Region of Enrollment||participants|Number|6|6.0||||||
3857843|NCT01625338|3683816|B2|New Zealand||Region of Enrollment||participants|Number|30|30.0||||||
3857844|NCT01625338|3683817|B1|New Zealand||Region of Enrollment||participants|Number|4|4.0||||||
3857845|NCT01625338|3683814|B4|Spain||Region of Enrollment||participants|Number|11|11.0||||||
3857846|NCT01625338|3683815|B3|Spain||Region of Enrollment||participants|Number|2|2.0||||||
3857847|NCT01625338|3683816|B2|Spain||Region of Enrollment||participants|Number|8|8.0||||||
3857848|NCT01625338|3683817|B1|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3857849|NCT01625338|3683814|B4|United Kingdom||Region of Enrollment||participants|Number|21|21.0||||||
3857850|NCT01625338|3683815|B3|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3857851|NCT01625338|3683816|B2|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
3857852|NCT01625338|3683817|B1|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3857853|NCT01625338|3683814|B4|United States||Region of Enrollment||participants|Number|280|280.0||||||
3857854|NCT01625338|3683815|B3|United States||Region of Enrollment||participants|Number|121|121.0||||||
3857855|NCT01625338|3683816|B2|United States||Region of Enrollment||participants|Number|82|82.0||||||
3857856|NCT01625338|3683817|B1|United States||Region of Enrollment||participants|Number|77|77.0||||||
3857857|NCT01625338|3683814|B4|Not Permitted||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3857858|NCT01625338|3683815|B3|Not Permitted||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3857859|NCT01625338|3683816|B2|Not Permitted||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3857860|NCT01625338|3683817|B1|Not Permitted||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3857861|NCT01625338|3683814|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|479|479.0||||||
3857862|NCT01625338|3683815|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|197|197.0||||||
3857863|NCT01625338|3683816|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|187|187.0||||||
3857864|NCT01625338|3683817|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|95|95.0||||||
3857865|NCT01625338|3683814|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
3857866|NCT01625338|3683815|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3857867|NCT01625338|3683816|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3857868|NCT01625338|3683817|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3857869|NCT01625338|3683814|B4|Native Hawaiian Or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3857870|NCT01625338|3683815|B3|Native Hawaiian Or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3857871|NCT01625338|3683816|B2|Native Hawaiian Or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3857872|NCT01625338|3683817|B1|Native Hawaiian Or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3857873|NCT01625338|3683814|B4|American Indian Or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3857874|NCT01625338|3683815|B3|American Indian Or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3857875|NCT01625338|3683816|B2|American Indian Or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3857876|NCT01625338|3683817|B1|American Indian Or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3857877|NCT01625338|3683814|B4|Not Permitted||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3857878|NCT01625338|3683815|B3|Not Permitted||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3857879|NCT01625338|3683816|B2|Not Permitted||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3857880|NCT01625338|3683817|B1|Not Permitted||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3857881|NCT01625338|3683814|B4|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3857882|NCT01625338|3683815|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3857883|NCT01625338|3683816|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3857884|NCT01625338|3683817|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3857885|NCT01625338|3683814|B4|Asian||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3857886|NCT01625338|3683815|B3|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3857887|NCT01625338|3683816|B2|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3857888|NCT01625338|3683817|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3857889|NCT01625338|3683814|B4|Black Or African American||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3857890|NCT01625338|3683815|B3|Black Or African American||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3857891|NCT01625338|3683816|B2|Black Or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3857892|NCT01625338|3683817|B1|Black Or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3857893|NCT01625338|3683814|B4|White||Race/Ethnicity, Customized||participants|Number|476|476.0||||||
3857894|NCT01625338|3683815|B3|White||Race/Ethnicity, Customized||participants|Number|187|187.0||||||
3857895|NCT01625338|3683816|B2|White||Race/Ethnicity, Customized||participants|Number|184|184.0||||||
3857896|NCT01625338|3683817|B1|White||Race/Ethnicity, Customized||participants|Number|105|105.0||||||
3857897|NCT01625338|3683814|B4||Male|Sex: Female, Male||Participants|Count of Participants|369|369.0||||||
3857898|NCT01625338|3683815|B3||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
3857899|NCT01625338|3683816|B2||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3857900|NCT01625338|3683817|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3857901|NCT01625338|3683814|B4||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3857902|NCT01625338|3683815|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3857903|NCT01625338|3683816|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3857904|NCT01625338|3683817|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3857905|NCT01625338|3683814|B4|||Age||years|Mean|53|53.0|Standard Deviation|9.1|9.1|||
3857906|NCT01625338|3683815|B3|||Age||years|Mean|53|53.0|Standard Deviation|10.0|10.0|||
3857907|NCT01625338|3683816|B2|||Age||years|Mean|52|52.0|Standard Deviation|7.6|7.6|||
3857908|NCT01625338|3683817|B1|||Age||years|Mean|53|53.0|Standard Deviation|9.6|9.6|||
3857909|NCT01625221|3683839|B1|||Fecal incontinence episodes||episodes per week|Mean|13.9|13.9|Standard Deviation|6.7|6.7|||
3857910|NCT01625221|3683839|B1|Denmark||Region of Enrollment||participants|Number|5|5.0||||||
3857911|NCT01625221|3683839|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3857912|NCT01625221|3683839|B1|France||Region of Enrollment||participants|Number|15|15.0||||||
3857913|NCT01625221|3683839|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3857914|NCT01625221|3683839|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3857915|NCT01625221|3683839|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3857916|NCT01625221|3683839|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3857917|NCT01625221|3683839|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3857918|NCT01625221|3683839|B1|||Age||years|Mean|64.1|64.1|Standard Deviation|9.7|9.7|||
3857919|NCT01625182|3683844|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3857920|NCT01625182|3683845|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3857921|NCT01625182|3683846|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3857922|NCT01625182|3683844|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3857923|NCT01625182|3683845|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3857924|NCT01625182|3683846|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3857925|NCT01625182|3683844|B3|||Age||Years|Mean|54.5|54.5|Standard Deviation|12.48|12.48|||
3857926|NCT01625182|3683845|B2|||Age||Years|Mean|54.6|54.6|Standard Deviation|11.68|11.68|||
3857927|NCT01625182|3683846|B1|||Age||Years|Mean|54.3|54.3|Standard Deviation|13.32|13.32|||
3857928|NCT01625169|3683860|B1|||Absolute CD4 at Delivery||cells/ml|Median|437|437.0|Full Range|||157.0|913.0|
3857929|NCT01625169|3683860|B1|No||Previous Breast Feeding|Data only available for 8 participants.|participants|Number|7|7.0||||||
3857930|NCT01625169|3683860|B1|Yes||Previous Breast Feeding|Data only available for 8 participants.|participants|Number|1|1.0||||||
3857931|NCT01625169|3683860|B1|Preterm||Timing of Delivery||number participants|Number|1|1.0||||||
3857932|NCT01625169|3683860|B1|Term||Timing of Delivery||number participants|Number|8|8.0||||||
3857933|NCT01625169|3683860|B1|Vaginal||Type of Delivery||participants|Number|7|7.0||||||
3857934|NCT01625169|3683860|B1|C-section||Type of Delivery||participants|Number|2|2.0||||||
3857935|NCT01625169|3683860|B1|Abortion||Previous Pregnancies||pregnancies|Median|1|1.0|Full Range|||0.0|3.0|
3858092|NCT01624948|3683922|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3857936|NCT01625169|3683860|B1|Parity||Previous Pregnancies||pregnancies|Median|2|2.0|Full Range|||0.0|6.0|
3857937|NCT01625169|3683860|B1|Gravida||Previous Pregnancies||pregnancies|Median|3|3.0|Full Range|||1.0|8.0|
3857938|NCT01625169|3683860|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3857939|NCT01625169|3683860|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3857940|NCT01625169|3683860|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3857941|NCT01625169|3683860|B1|||Age||years|Median|28.1|28.1|Full Range|||21.0|38.0|
3857942|NCT01625104|3683873|B3||Male|Sex: Female, Male||Participants|Count of Participants|612|612.0||||||
3857943|NCT01625104|3683874|B2||Male|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
3857944|NCT01625104|3683875|B1||Male|Sex: Female, Male||Participants|Count of Participants|312|312.0||||||
3857945|NCT01625104|3683873|B3||Female|Sex: Female, Male||Participants|Count of Participants|270|270.0||||||
3857946|NCT01625104|3683874|B2||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3857947|NCT01625104|3683875|B1||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3857948|NCT01625104|3683873|B3|||Age||years|Median|60.7|60.7|Standard Deviation|12.8|12.8|||
3857949|NCT01625104|3683874|B2|||Age||years|Median|60.2|60.2|Standard Deviation|12.4|12.4|||
3857950|NCT01625104|3683875|B1|||Age||years|Median|61.2|61.2|Standard Deviation|13.2|13.2|||
3857951|NCT01625091|3683882|B3|Race/Ethnicity|Not Hispanic, Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3857952|NCT01625091|3683883|B2|Race/Ethnicity|Not Hispanic, Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3857953|NCT01625091|3683884|B1|Race/Ethnicity|Not Hispanic, Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3857954|NCT01625091|3683882|B3|Race/Ethnicity|Not Hispanic, Black|Race/Ethnicity, Customized||Participants|Count of Participants|161|161.0||||||
3857955|NCT01625091|3683883|B2|Race/Ethnicity|Not Hispanic, Black|Race/Ethnicity, Customized||Participants|Count of Participants|80|80.0||||||
3857956|NCT01625091|3683884|B1|Race/Ethnicity|Not Hispanic, Black|Race/Ethnicity, Customized||Participants|Count of Participants|81|81.0||||||
3857957|NCT01625091|3683882|B3|Race/Ethnicity|Not Hispanic, White|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3857958|NCT01625091|3683883|B2|Race/Ethnicity|Not Hispanic, White|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3857959|NCT01625091|3683884|B1|Race/Ethnicity|Not Hispanic, White|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3857960|NCT01625091|3683882|B3|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3857961|NCT01625091|3683883|B2|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3857962|NCT01625091|3683884|B1|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3857963|NCT01625091|3683882|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3857964|NCT01625091|3683883|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3857965|NCT01625091|3683884|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3857966|NCT01625091|3683882|B3||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
3857967|NCT01625091|3683883|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3857968|NCT01625091|3683884|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3857969|NCT01625091|3683882|B3|Age group|≥60|Age, Customized||Participants|Count of Participants|18|18.0||||||
3857970|NCT01625091|3683883|B2|Age group|≥60|Age, Customized||Participants|Count of Participants|10|10.0||||||
3857971|NCT01625091|3683884|B1|Age group|≥60|Age, Customized||Participants|Count of Participants|8|8.0||||||
3857972|NCT01625091|3683882|B3|Age group|50-59|Age, Customized||Participants|Count of Participants|80|80.0||||||
3857973|NCT01625091|3683883|B2|Age group|50-59|Age, Customized||Participants|Count of Participants|43|43.0||||||
3857974|NCT01625091|3683884|B1|Age group|50-59|Age, Customized||Participants|Count of Participants|37|37.0||||||
3857975|NCT01625091|3683882|B3|Age group|40-49|Age, Customized||Participants|Count of Participants|67|67.0||||||
3857976|NCT01625091|3683883|B2|Age group|40-49|Age, Customized||Participants|Count of Participants|32|32.0||||||
3857977|NCT01625091|3683884|B1|Age group|40-49|Age, Customized||Participants|Count of Participants|35|35.0||||||
3857978|NCT01625091|3683882|B3|Age group|18-39|Age, Customized||Participants|Count of Participants|29|29.0||||||
3857979|NCT01625091|3683883|B2|Age group|18-39|Age, Customized||Participants|Count of Participants|13|13.0||||||
3857980|NCT01625091|3683884|B1|Age group|18-39|Age, Customized||Participants|Count of Participants|16|16.0||||||
3857981|NCT01625091|3683882|B3|||Age||years|Mean|48.3|48.3|Standard Deviation|8.7|8.7|||
3857982|NCT01625091|3683883|B2|||Age||years|Mean|48.9|48.9|Standard Deviation|8.9|8.9|||
3857983|NCT01625091|3683884|B1|||Age||years|Mean|47.7|47.7|Standard Deviation|8.5|8.5|||
3857984|NCT01624974|3683897|B3|||Forced Expiratory Volume in One Second (FEV1)||Liters|Mean|2.289|2.289|Standard Deviation|0.618|0.618|||
3857985|NCT01624974|3683898|B2|||Forced Expiratory Volume in One Second (FEV1)||Liters|Mean|2.243|2.243|Standard Deviation|0.600|0.6|||
3857986|NCT01624974|3683899|B1|||Forced Expiratory Volume in One Second (FEV1)||Liters|Mean|2.333|2.333|Standard Deviation|0.637|0.637|||
3857987|NCT01624974|3683897|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857988|NCT01624974|3683898|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857989|NCT01624974|3683899|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3857990|NCT01624974|3683897|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3857991|NCT01624974|3683898|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3858093|NCT01624948|3683923|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3857992|NCT01624974|3683899|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3857993|NCT01624974|3683897|B3||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3857994|NCT01624974|3683898|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3857995|NCT01624974|3683899|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3857996|NCT01624974|3683897|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3857997|NCT01624974|3683898|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3857998|NCT01624974|3683899|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3857999|NCT01624974|3683897|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858000|NCT01624974|3683898|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858001|NCT01624974|3683899|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858002|NCT01624974|3683897|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3858003|NCT01624974|3683898|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858004|NCT01624974|3683899|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3858005|NCT01624974|3683897|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3858006|NCT01624974|3683898|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3858007|NCT01624974|3683899|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3858008|NCT01624974|3683897|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858009|NCT01624974|3683898|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858010|NCT01624974|3683899|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858011|NCT01624974|3683897|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3858012|NCT01624974|3683898|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3858013|NCT01624974|3683899|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3858014|NCT01624974|3683897|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3858015|NCT01624974|3683898|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3858016|NCT01624974|3683899|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3858017|NCT01624974|3683897|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3858018|NCT01624974|3683898|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3858019|NCT01624974|3683899|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3858020|NCT01624974|3683897|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3858021|NCT01624974|3683898|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3858022|NCT01624974|3683899|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3858023|NCT01624974|3683897|B3|||Age||Years|Mean|40.4|40.4|Standard Deviation|12.4|12.4|||
3858024|NCT01624974|3683898|B2|||Age||Years|Mean|39.1|39.1|Standard Deviation|13.5|13.5|||
3858025|NCT01624974|3683899|B1|||Age||Years|Mean|41.6|41.6|Standard Deviation|11.2|11.2|||
3858026|NCT01624948|3683922|B3|Normal Graft Function||Renal Graft Function|Delayed Graft Function was defined as > or =1 dialysis session during the first week posttransplant|participants|Number|32|32.0||||||
3858027|NCT01624948|3683923|B2|Normal Graft Function||Renal Graft Function|Delayed Graft Function was defined as > or =1 dialysis session during the first week posttransplant|participants|Number|18|18.0||||||
3858028|NCT01624948|3683924|B1|Normal Graft Function||Renal Graft Function|Delayed Graft Function was defined as > or =1 dialysis session during the first week posttransplant|participants|Number|14|14.0||||||
3858029|NCT01624948|3683922|B3|Delayed Graft Function||Renal Graft Function|Delayed Graft Function was defined as > or =1 dialysis session during the first week posttransplant|participants|Number|8|8.0||||||
3858030|NCT01624948|3683923|B2|Delayed Graft Function||Renal Graft Function|Delayed Graft Function was defined as > or =1 dialysis session during the first week posttransplant|participants|Number|2|2.0||||||
3858031|NCT01624948|3683924|B1|Delayed Graft Function||Renal Graft Function|Delayed Graft Function was defined as > or =1 dialysis session during the first week posttransplant|participants|Number|6|6.0||||||
3858032|NCT01624948|3683922|B3|No Ureteral Stent Present||Ureteral Stent at Transplant||participants|Number|38|38.0||||||
3858033|NCT01624948|3683923|B2|No Ureteral Stent Present||Ureteral Stent at Transplant||participants|Number|18|18.0||||||
3858034|NCT01624948|3683924|B1|No Ureteral Stent Present||Ureteral Stent at Transplant||participants|Number|20|20.0||||||
3858035|NCT01624948|3683922|B3|Ureteral Stent Present||Ureteral Stent at Transplant||participants|Number|2|2.0||||||
3858036|NCT01624948|3683923|B2|Ureteral Stent Present||Ureteral Stent at Transplant||participants|Number|2|2.0||||||
3858037|NCT01624948|3683924|B1|Ureteral Stent Present||Ureteral Stent at Transplant||participants|Number|0|0.0||||||
3858038|NCT01624948|3683922|B3|||Calculated Panel Reactive Antibodies (cPRA)|The Calculated Panel Reactive Antibodies (cPRA) represents the percentage of potential donors that will be preemptively declined due to the presence of one or more unacceptable antigens. CPRA is a computer calculation based upon HLA frequencies derived from the US donor population and the risk they attribute to circulating antibodies in a candidate's serum directed against those specific HLA antigens.|Percentage of Potential Donors|Mean|19.93|19.93|Standard Deviation|32.82|32.82|||
3858094|NCT01624948|3683924|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3858095|NCT01624948|3683922|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3858096|NCT01624948|3683923|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3858039|NCT01624948|3683923|B2|||Calculated Panel Reactive Antibodies (cPRA)|The Calculated Panel Reactive Antibodies (cPRA) represents the percentage of potential donors that will be preemptively declined due to the presence of one or more unacceptable antigens. CPRA is a computer calculation based upon HLA frequencies derived from the US donor population and the risk they attribute to circulating antibodies in a candidate's serum directed against those specific HLA antigens.|Percentage of Potential Donors|Mean|25.5|25.5|Standard Deviation|36.3|36.3|||
3858040|NCT01624948|3683924|B1|||Calculated Panel Reactive Antibodies (cPRA)|The Calculated Panel Reactive Antibodies (cPRA) represents the percentage of potential donors that will be preemptively declined due to the presence of one or more unacceptable antigens. CPRA is a computer calculation based upon HLA frequencies derived from the US donor population and the risk they attribute to circulating antibodies in a candidate's serum directed against those specific HLA antigens.|Percentage of Potential Donors|Mean|14.4|14.4|Standard Deviation|28.8|28.8|||
3858041|NCT01624948|3683922|B3|Other||Etiology of End Stage Renal Disease (ESRD)||participants|Number|5|5.0||||||
3858042|NCT01624948|3683923|B2|Other||Etiology of End Stage Renal Disease (ESRD)||participants|Number|2|2.0||||||
3858043|NCT01624948|3683924|B1|Other||Etiology of End Stage Renal Disease (ESRD)||participants|Number|3|3.0||||||
3858044|NCT01624948|3683922|B3|GN||Etiology of End Stage Renal Disease (ESRD)||participants|Number|23|23.0||||||
3858045|NCT01624948|3683923|B2|GN||Etiology of End Stage Renal Disease (ESRD)||participants|Number|11|11.0||||||
3858046|NCT01624948|3683924|B1|GN||Etiology of End Stage Renal Disease (ESRD)||participants|Number|12|12.0||||||
3858047|NCT01624948|3683922|B3|Hypertension||Etiology of End Stage Renal Disease (ESRD)||participants|Number|6|6.0||||||
3858048|NCT01624948|3683923|B2|Hypertension||Etiology of End Stage Renal Disease (ESRD)||participants|Number|3|3.0||||||
3858049|NCT01624948|3683924|B1|Hypertension||Etiology of End Stage Renal Disease (ESRD)||participants|Number|3|3.0||||||
3858050|NCT01624948|3683922|B3|Diabetes||Etiology of End Stage Renal Disease (ESRD)||participants|Number|6|6.0||||||
3858051|NCT01624948|3683923|B2|Diabetes||Etiology of End Stage Renal Disease (ESRD)||participants|Number|4|4.0||||||
3858052|NCT01624948|3683924|B1|Diabetes||Etiology of End Stage Renal Disease (ESRD)||participants|Number|2|2.0||||||
3858053|NCT01624948|3683922|B3|Second||Transplant Number||participants|Number|7|7.0||||||
3858054|NCT01624948|3683923|B2|Second||Transplant Number||participants|Number|3|3.0||||||
3858055|NCT01624948|3683924|B1|Second||Transplant Number||participants|Number|4|4.0||||||
3858056|NCT01624948|3683922|B3|First||Transplant Number||participants|Number|33|33.0||||||
3858057|NCT01624948|3683923|B2|First||Transplant Number||participants|Number|17|17.0||||||
3858058|NCT01624948|3683924|B1|First||Transplant Number||participants|Number|16|16.0||||||
3858059|NCT01624948|3683922|B3|ECD||Donor Type||participants|Number|4|4.0||||||
3858060|NCT01624948|3683923|B2|ECD||Donor Type||participants|Number|2|2.0||||||
3858061|NCT01624948|3683924|B1|ECD||Donor Type||participants|Number|2|2.0||||||
3858062|NCT01624948|3683922|B3|Standard Deceased||Donor Type||participants|Number|21|21.0||||||
3858063|NCT01624948|3683923|B2|Standard Deceased||Donor Type||participants|Number|10|10.0||||||
3858064|NCT01624948|3683924|B1|Standard Deceased||Donor Type||participants|Number|11|11.0||||||
3858065|NCT01624948|3683922|B3|Living||Donor Type||participants|Number|15|15.0||||||
3858066|NCT01624948|3683923|B2|Living||Donor Type||participants|Number|8|8.0||||||
3858067|NCT01624948|3683924|B1|Living||Donor Type||participants|Number|7|7.0||||||
3858068|NCT01624948|3683922|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3858069|NCT01624948|3683923|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3858070|NCT01624948|3683924|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3858071|NCT01624948|3683922|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858072|NCT01624948|3683923|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858073|NCT01624948|3683924|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858074|NCT01624948|3683922|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858075|NCT01624948|3683923|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858076|NCT01624948|3683924|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858077|NCT01624948|3683922|B3||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3858078|NCT01624948|3683923|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3858079|NCT01624948|3683924|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3858080|NCT01624948|3683922|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3858081|NCT01624948|3683923|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3858082|NCT01624948|3683924|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3858083|NCT01624948|3683922|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858084|NCT01624948|3683923|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858085|NCT01624948|3683924|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858086|NCT01624948|3683922|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3858087|NCT01624948|3683923|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3858088|NCT01624948|3683924|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3858089|NCT01624948|3683922|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858090|NCT01624948|3683923|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858091|NCT01624948|3683924|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858097|NCT01624948|3683924|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3858098|NCT01624948|3683922|B3|||Age||years|Mean|52.18|52.18|Standard Deviation|11.47|11.47|||
3858099|NCT01624948|3683923|B2|||Age||years|Mean|49.9|49.9|Standard Deviation|12.4|12.4|||
3858100|NCT01624948|3683924|B1|||Age||years|Mean|54.5|54.5|Standard Deviation|10.3|10.3|||
3858101|NCT01624870|3683941|B1|Germany||Region of Enrollment||participants|Number|70|70.0||||||
3858102|NCT01624870|3683941|B1|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3858103|NCT01624870|3683941|B1|Italy||Region of Enrollment||participants|Number|51|51.0||||||
3858104|NCT01624870|3683941|B1|Belgium||Region of Enrollment||participants|Number|19|19.0||||||
3858105|NCT01624870|3683941|B1|Czech Republic||Region of Enrollment||participants|Number|12|12.0||||||
3858106|NCT01624870|3683941|B1|Netherlands||Region of Enrollment||participants|Number|40|40.0||||||
3858107|NCT01624870|3683941|B1||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3858108|NCT01624870|3683941|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3858109|NCT01624870|3683941|B1|||Age||years|Mean|80.2|80.2|Standard Deviation|6.7|6.7|||
3858110|NCT01624740|3683947|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3858111|NCT01624740|3683948|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3858112|NCT01624740|3683949|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3858113|NCT01624740|3683947|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3858114|NCT01624740|3683948|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3858115|NCT01624740|3683949|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3858116|NCT01624740|3683947|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3858117|NCT01624740|3683948|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3858118|NCT01624740|3683949|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3858119|NCT01624740|3683947|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3858120|NCT01624740|3683948|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3858121|NCT01624740|3683949|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3858122|NCT01624740|3683947|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3858123|NCT01624740|3683948|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3858124|NCT01624740|3683949|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3858125|NCT01624740|3683947|B3|||Age||years|Mean|56.5|56.5|Standard Deviation|11.81|11.81|||
3858126|NCT01624740|3683948|B2|||Age||years|Mean|49.4|49.4|Standard Deviation|9.49|9.49|||
3858127|NCT01624740|3683949|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|10.57|10.57|||
3858128|NCT01624662|3683957|B5|||Nasal Polyp Surgery Eligibility|"A subject was considered eligible for surgical intervention if the following conditions were met:~Subject has had moderate symptoms of congestion from nasal polyposis for ≥ 3 months.~Subject continues to suffer from at least moderate symptoms despite use of topical steroids at conventional doses for ≥ 6 weeks.~Subject continues to suffer from at least moderate symptoms despite use (or previous use) of saline lavage for ≥ 6 weeks.~Subject has endoscopically visualized bilateral nasal polyposis of at least moderate severity (nasal polyp grading score ≥ 2 in at least 1 nostril)."|Participants|Count of Participants|172|172.0||||||
3858129|NCT01624662|3683958|B4|||Nasal Polyp Surgery Eligibility|"A subject was considered eligible for surgical intervention if the following conditions were met:~Subject has had moderate symptoms of congestion from nasal polyposis for ≥ 3 months.~Subject continues to suffer from at least moderate symptoms despite use of topical steroids at conventional doses for ≥ 6 weeks.~Subject continues to suffer from at least moderate symptoms despite use (or previous use) of saline lavage for ≥ 6 weeks.~Subject has endoscopically visualized bilateral nasal polyposis of at least moderate severity (nasal polyp grading score ≥ 2 in at least 1 nostril)."|Participants|Count of Participants|45|45.0||||||
3858130|NCT01624662|3683959|B3|||Nasal Polyp Surgery Eligibility|"A subject was considered eligible for surgical intervention if the following conditions were met:~Subject has had moderate symptoms of congestion from nasal polyposis for ≥ 3 months.~Subject continues to suffer from at least moderate symptoms despite use of topical steroids at conventional doses for ≥ 6 weeks.~Subject continues to suffer from at least moderate symptoms despite use (or previous use) of saline lavage for ≥ 6 weeks.~Subject has endoscopically visualized bilateral nasal polyposis of at least moderate severity (nasal polyp grading score ≥ 2 in at least 1 nostril)."|Participants|Count of Participants|42|42.0||||||
3858131|NCT01624662|3683960|B2|||Nasal Polyp Surgery Eligibility|"A subject was considered eligible for surgical intervention if the following conditions were met:~Subject has had moderate symptoms of congestion from nasal polyposis for ≥ 3 months.~Subject continues to suffer from at least moderate symptoms despite use of topical steroids at conventional doses for ≥ 6 weeks.~Subject continues to suffer from at least moderate symptoms despite use (or previous use) of saline lavage for ≥ 6 weeks.~Subject has endoscopically visualized bilateral nasal polyposis of at least moderate severity (nasal polyp grading score ≥ 2 in at least 1 nostril)."|Participants|Count of Participants|40|40.0||||||
3858132|NCT01624662|3683961|B1|||Nasal Polyp Surgery Eligibility|"A subject was considered eligible for surgical intervention if the following conditions were met:~Subject has had moderate symptoms of congestion from nasal polyposis for ≥ 3 months.~Subject continues to suffer from at least moderate symptoms despite use of topical steroids at conventional doses for ≥ 6 weeks.~Subject continues to suffer from at least moderate symptoms despite use (or previous use) of saline lavage for ≥ 6 weeks.~Subject has endoscopically visualized bilateral nasal polyposis of at least moderate severity (nasal polyp grading score ≥ 2 in at least 1 nostril)."|Participants|Count of Participants|45|45.0||||||
3858212|NCT01624662|3683961|B1|Ukraine||Region of Enrollment||participants|Number|12|12.0||||||
3858213|NCT01624662|3683957|B5|Romania||Region of Enrollment||participants|Number|55|55.0||||||
3858214|NCT01624662|3683958|B4|Romania||Region of Enrollment||participants|Number|14|14.0||||||
3858133|NCT01624662|3683957|B5|||Peak Nasal Inspiratory Flow (PNIF)|The PNIF is an assessment of nasal passage obstruction and was measured using an In-Check portable nasal inspiratory flow meter. To measure PNIF, a mask was placed over the nose during inspiration and inspiratory flow was recorded. Each subject inhaled 3 times and each measurement was recorded. The PNIF value used was the greatest of the 3 results at each time point.|L/min|Mean|118.4|118.4|Full Range|||30.0|370.0|
3858134|NCT01624662|3683958|B4|||Peak Nasal Inspiratory Flow (PNIF)|The PNIF is an assessment of nasal passage obstruction and was measured using an In-Check portable nasal inspiratory flow meter. To measure PNIF, a mask was placed over the nose during inspiration and inspiratory flow was recorded. Each subject inhaled 3 times and each measurement was recorded. The PNIF value used was the greatest of the 3 results at each time point.|L/min|Mean|122.7|122.7|Full Range|||30.0|370.0|
3858135|NCT01624662|3683959|B3|||Peak Nasal Inspiratory Flow (PNIF)|The PNIF is an assessment of nasal passage obstruction and was measured using an In-Check portable nasal inspiratory flow meter. To measure PNIF, a mask was placed over the nose during inspiration and inspiratory flow was recorded. Each subject inhaled 3 times and each measurement was recorded. The PNIF value used was the greatest of the 3 results at each time point.|L/min|Mean|107.6|107.6|Full Range|||40.0|350.0|
3858136|NCT01624662|3683960|B2|||Peak Nasal Inspiratory Flow (PNIF)|The PNIF is an assessment of nasal passage obstruction and was measured using an In-Check portable nasal inspiratory flow meter. To measure PNIF, a mask was placed over the nose during inspiration and inspiratory flow was recorded. Each subject inhaled 3 times and each measurement was recorded. The PNIF value used was the greatest of the 3 results at each time point.|L/min|Mean|123.4|123.4|Full Range|||30.0|370.0|
3858137|NCT01624662|3683961|B1|||Peak Nasal Inspiratory Flow (PNIF)|The PNIF is an assessment of nasal passage obstruction and was measured using an In-Check portable nasal inspiratory flow meter. To measure PNIF, a mask was placed over the nose during inspiration and inspiratory flow was recorded. Each subject inhaled 3 times and each measurement was recorded. The PNIF value used was the greatest of the 3 results at each time point.|L/min|Mean|119.7|119.7|Full Range|||30.0|370.0|
3858138|NCT01624662|3683957|B5|||Short Form (36) Health Survey Version 2 (SF-36v2) - Physical Component|The SF-36v2 is a multipurpose, scaled, 36-item, subject-completed validated questionnaire that measures 8 domains of health: limitations in physical activities, limitations in social activities, limitations in usual role activities, bodily pain, general mental health, limitations in usual role activities, vitality, and general health perceptions. It yields scale scores for each of the 8 health domains, and 2 summary measures of physical and mental health. Each scale range is from 0-100. A lower score means more disability and a higher score means less disability.|units on a scale|Mean|46.2|46.2|Full Range|||22.64|60.32|
3858139|NCT01624662|3683958|B4|||Short Form (36) Health Survey Version 2 (SF-36v2) - Physical Component|The SF-36v2 is a multipurpose, scaled, 36-item, subject-completed validated questionnaire that measures 8 domains of health: limitations in physical activities, limitations in social activities, limitations in usual role activities, bodily pain, general mental health, limitations in usual role activities, vitality, and general health perceptions. It yields scale scores for each of the 8 health domains, and 2 summary measures of physical and mental health. Each scale range is from 0-100. A lower score means more disability and a higher score means less disability.|units on a scale|Mean|46.4|46.4|Full Range|||22.64|60.32|
3858140|NCT01624662|3683959|B3|||Short Form (36) Health Survey Version 2 (SF-36v2) - Physical Component|The SF-36v2 is a multipurpose, scaled, 36-item, subject-completed validated questionnaire that measures 8 domains of health: limitations in physical activities, limitations in social activities, limitations in usual role activities, bodily pain, general mental health, limitations in usual role activities, vitality, and general health perceptions. It yields scale scores for each of the 8 health domains, and 2 summary measures of physical and mental health. Each scale range is from 0-100. A lower score means more disability and a higher score means less disability.|units on a scale|Mean|46.5|46.5|Full Range|||29.56|59.43|
3858141|NCT01624662|3683960|B2|||Short Form (36) Health Survey Version 2 (SF-36v2) - Physical Component|The SF-36v2 is a multipurpose, scaled, 36-item, subject-completed validated questionnaire that measures 8 domains of health: limitations in physical activities, limitations in social activities, limitations in usual role activities, bodily pain, general mental health, limitations in usual role activities, vitality, and general health perceptions. It yields scale scores for each of the 8 health domains, and 2 summary measures of physical and mental health. Each scale range is from 0-100. A lower score means more disability and a higher score means less disability.|units on a scale|Mean|46.1|46.1|Full Range|||28.61|58.86|
3858142|NCT01624662|3683961|B1|||Short Form (36) Health Survey Version 2 (SF-36v2) - Physical Component|The SF-36v2 is a multipurpose, scaled, 36-item, subject-completed validated questionnaire that measures 8 domains of health: limitations in physical activities, limitations in social activities, limitations in usual role activities, bodily pain, general mental health, limitations in usual role activities, vitality, and general health perceptions. It yields scale scores for each of the 8 health domains, and 2 summary measures of physical and mental health. Each scale range is from 0-100. A lower score means more disability and a higher score means less disability.|units on a scale|Mean|45.8|45.8|Full Range|||26.97|60.07|
3858143|NCT01624662|3683957|B5|||Short Form (36) Health Survey Version 2 (SF-36v2) - Mental Component|The SF-36v2 is a multipurpose, scaled, 36-item, subject-completed validated questionnaire that measures 8 domains of health: limitations in physical activities, limitations in social activities, limitations in usual role activities, bodily pain, general mental health, limitations in usual role activities, vitality, and general health. It yields scale scores for each of the 8 health domains, and 2 summary measures of physical and mental health. Each scale range is from 0-100. A lower score means more disability and a higher score means less disability.|units on a scale|Mean|45.1|45.1|Full Range|||12.27|64.81|
3858144|NCT01624662|3683958|B4|||Short Form (36) Health Survey Version 2 (SF-36v2) - Mental Component|The SF-36v2 is a multipurpose, scaled, 36-item, subject-completed validated questionnaire that measures 8 domains of health: limitations in physical activities, limitations in social activities, limitations in usual role activities, bodily pain, general mental health, limitations in usual role activities, vitality, and general health. It yields scale scores for each of the 8 health domains, and 2 summary measures of physical and mental health. Each scale range is from 0-100. A lower score means more disability and a higher score means less disability.|units on a scale|Mean|47.0|47.0|Full Range|||20.6|61.63|
3858215|NCT01624662|3683959|B3|Romania||Region of Enrollment||participants|Number|13|13.0||||||
3858145|NCT01624662|3683959|B3|||Short Form (36) Health Survey Version 2 (SF-36v2) - Mental Component|The SF-36v2 is a multipurpose, scaled, 36-item, subject-completed validated questionnaire that measures 8 domains of health: limitations in physical activities, limitations in social activities, limitations in usual role activities, bodily pain, general mental health, limitations in usual role activities, vitality, and general health. It yields scale scores for each of the 8 health domains, and 2 summary measures of physical and mental health. Each scale range is from 0-100. A lower score means more disability and a higher score means less disability.|units on a scale|Mean|45.9|45.9|Full Range|||19.63|64.81|
3858146|NCT01624662|3683960|B2|||Short Form (36) Health Survey Version 2 (SF-36v2) - Mental Component|The SF-36v2 is a multipurpose, scaled, 36-item, subject-completed validated questionnaire that measures 8 domains of health: limitations in physical activities, limitations in social activities, limitations in usual role activities, bodily pain, general mental health, limitations in usual role activities, vitality, and general health. It yields scale scores for each of the 8 health domains, and 2 summary measures of physical and mental health. Each scale range is from 0-100. A lower score means more disability and a higher score means less disability.|units on a scale|Mean|44.4|44.4|Full Range|||12.27|61.03|
3858147|NCT01624662|3683961|B1|||Short Form (36) Health Survey Version 2 (SF-36v2) - Mental Component|The SF-36v2 is a multipurpose, scaled, 36-item, subject-completed validated questionnaire that measures 8 domains of health: limitations in physical activities, limitations in social activities, limitations in usual role activities, bodily pain, general mental health, limitations in usual role activities, vitality, and general health. It yields scale scores for each of the 8 health domains, and 2 summary measures of physical and mental health. Each scale range is from 0-100. A lower score means more disability and a higher score means less disability.|units on a scale|Mean|43.1|43.1|Full Range|||21.5|63.58|
3858148|NCT01624662|3683957|B5|||Rhinosinusitis Disability Index (RSDI) Total Score|The RSDI is a subject-completed instrument that evaluates the self-perceived impact of disease specific head and neck disorders. The RSDI has 30 items in 3 domains: Physical (11 items), Functional (9 items), and Emotional (10 items). The RSDI scale ranges from 0-120, 0 being better quality of life and less impact of CRS on daily function and 120 being worse quality of life and more impact of CRS on daily function.|units on a scale|Mean|42.5|42.5|Full Range|||0.0|111.0|
3858149|NCT01624662|3683958|B4|||Rhinosinusitis Disability Index (RSDI) Total Score|The RSDI is a subject-completed instrument that evaluates the self-perceived impact of disease specific head and neck disorders. The RSDI has 30 items in 3 domains: Physical (11 items), Functional (9 items), and Emotional (10 items). The RSDI scale ranges from 0-120, 0 being better quality of life and less impact of CRS on daily function and 120 being worse quality of life and more impact of CRS on daily function.|units on a scale|Mean|41.5|41.5|Full Range|||0.0|85.0|
3858150|NCT01624662|3683959|B3|||Rhinosinusitis Disability Index (RSDI) Total Score|The RSDI is a subject-completed instrument that evaluates the self-perceived impact of disease specific head and neck disorders. The RSDI has 30 items in 3 domains: Physical (11 items), Functional (9 items), and Emotional (10 items). The RSDI scale ranges from 0-120, 0 being better quality of life and less impact of CRS on daily function and 120 being worse quality of life and more impact of CRS on daily function.|units on a scale|Mean|39.7|39.7|Full Range|||2.0|89.0|
3858151|NCT01624662|3683960|B2|||Rhinosinusitis Disability Index (RSDI) Total Score|The RSDI is a subject-completed instrument that evaluates the self-perceived impact of disease specific head and neck disorders. The RSDI has 30 items in 3 domains: Physical (11 items), Functional (9 items), and Emotional (10 items). The RSDI scale ranges from 0-120, 0 being better quality of life and less impact of CRS on daily function and 120 being worse quality of life and more impact of CRS on daily function.|units on a scale|Mean|43.9|43.9|Full Range|||7.0|111.0|
3858152|NCT01624662|3683961|B1|||Rhinosinusitis Disability Index (RSDI) Total Score|The RSDI is a subject-completed instrument that evaluates the self-perceived impact of disease specific head and neck disorders. The RSDI has 30 items in 3 domains: Physical (11 items), Functional (9 items), and Emotional (10 items). The RSDI scale ranges from 0-120, 0 being better quality of life and less impact of CRS on daily function and 120 being worse quality of life and more impact of CRS on daily function.|units on a scale|Mean|44.9|44.9|Full Range|||4.0|98.0|
3858153|NCT01624662|3683957|B5|||Medical Outcomes Study Sleep Scale Revised (MOS Sleep-R)|The MOS Sleep-R is a brief, self-administered, validated questionnaire designed to measure key aspects of sleep, such as disturbance, adequacy, somnolence, and quantity. The 12-item version with a 4-week recall was used in this study. The score range for the 12-item version is 0 to 100, lower scores indicating better sleep and higher scores indicating worse sleep. The scale yields a Sleep Problem Index and scores on the following 6 subscales: Sleep Disturbance, Snoring, Shortness of Breath or Headache, Sleep Adequacy, Sleep Somnolence, and Sleep Quantity.|units on a scale|Mean|41.2|41.2|Full Range|||0.0|94.4|
3858154|NCT01624662|3683958|B4|||Medical Outcomes Study Sleep Scale Revised (MOS Sleep-R)|The MOS Sleep-R is a brief, self-administered, validated questionnaire designed to measure key aspects of sleep, such as disturbance, adequacy, somnolence, and quantity. The 12-item version with a 4-week recall was used in this study. The score range for the 12-item version is 0 to 100, lower scores indicating better sleep and higher scores indicating worse sleep. The scale yields a Sleep Problem Index and scores on the following 6 subscales: Sleep Disturbance, Snoring, Shortness of Breath or Headache, Sleep Adequacy, Sleep Somnolence, and Sleep Quantity.|units on a scale|Mean|39.1|39.1|Full Range|||0.0|77.8|
3858155|NCT01624662|3683959|B3|||Medical Outcomes Study Sleep Scale Revised (MOS Sleep-R)|The MOS Sleep-R is a brief, self-administered, validated questionnaire designed to measure key aspects of sleep, such as disturbance, adequacy, somnolence, and quantity. The 12-item version with a 4-week recall was used in this study. The score range for the 12-item version is 0 to 100, lower scores indicating better sleep and higher scores indicating worse sleep. The scale yields a Sleep Problem Index and scores on the following 6 subscales: Sleep Disturbance, Snoring, Shortness of Breath or Headache, Sleep Adequacy, Sleep Somnolence, and Sleep Quantity.|units on a scale|Mean|43.0|43.0|Full Range|||2.8|86.1|
3858168|NCT01624662|3683957|B5|||Facial Pain or Pressure Score (7-day instantaneous morning)|"Subjects used an electronic diary to record nasal symptoms each morning for the 7-day period preceding the screening visit, evaluating symptom severity immediately preceding the time of scoring (instantaneous).~Nasal Symptom Score~0: None~Mild – symptoms clearly present, but minimal awareness, and easily tolerated~Moderate – definite awareness of symptoms that is bothersome but tolerable~Severe – symptoms that are hard to tolerate, cause interference with activities or daily living"|units on a scale|Mean|1.44|1.44|Full Range|||0.0|3.0|
3858156|NCT01624662|3683960|B2|||Medical Outcomes Study Sleep Scale Revised (MOS Sleep-R)|The MOS Sleep-R is a brief, self-administered, validated questionnaire designed to measure key aspects of sleep, such as disturbance, adequacy, somnolence, and quantity. The 12-item version with a 4-week recall was used in this study. The score range for the 12-item version is 0 to 100, lower scores indicating better sleep and higher scores indicating worse sleep. The scale yields a Sleep Problem Index and scores on the following 6 subscales: Sleep Disturbance, Snoring, Shortness of Breath or Headache, Sleep Adequacy, Sleep Somnolence, and Sleep Quantity.|units on a scale|Mean|40.9|40.9|Full Range|||8.3|94.4|
3858157|NCT01624662|3683961|B1|||Medical Outcomes Study Sleep Scale Revised (MOS Sleep-R)|The MOS Sleep-R is a brief, self-administered, validated questionnaire designed to measure key aspects of sleep, such as disturbance, adequacy, somnolence, and quantity. The 12-item version with a 4-week recall was used in this study. The score range for the 12-item version is 0 to 100, lower scores indicating better sleep and higher scores indicating worse sleep. The scale yields a Sleep Problem Index and scores on the following 6 subscales: Sleep Disturbance, Snoring, Shortness of Breath or Headache, Sleep Adequacy, Sleep Somnolence, and Sleep Quantity.|units on a scale|Mean|41.7|41.7|Full Range|||5.6|86.1|
3858158|NCT01624662|3683957|B5|||Sinonasal Outcome Test 22 (SNOT-22) Total Score|"SNOT-22 is a subject-completed questionnaire that consists of 22 questions. The questions on the SNOT-22 efficacy evaluation were used to calculate a total score. 22 questions are divided among 4 subscales: Rhinologic (7 questions), Ear/Facial Symptoms (4 questions), Sleep Function (3 questions), and Psychological Issues (6 questions). Each item was rated on the 5-point scale. The total score can range from 0-110, 0 being the best and 110 being the worst.~0: No problem~Very mild problem~Mild or slight problem~Moderate problem~Severe problem~Problem as bad as it can be"|units on a scale|Mean|48.9|48.9|Full Range|||7.0|103.0|
3858159|NCT01624662|3683958|B4|||Sinonasal Outcome Test 22 (SNOT-22) Total Score|"SNOT-22 is a subject-completed questionnaire that consists of 22 questions. The questions on the SNOT-22 efficacy evaluation were used to calculate a total score. 22 questions are divided among 4 subscales: Rhinologic (7 questions), Ear/Facial Symptoms (4 questions), Sleep Function (3 questions), and Psychological Issues (6 questions). Each item was rated on the 5-point scale. The total score can range from 0-110, 0 being the best and 110 being the worst.~0: No problem~Very mild problem~Mild or slight problem~Moderate problem~Severe problem~Problem as bad as it can be"|units on a scale|Mean|47.1|47.1|Full Range|||7.0|103.0|
3858160|NCT01624662|3683959|B3|||Sinonasal Outcome Test 22 (SNOT-22) Total Score|"SNOT-22 is a subject-completed questionnaire that consists of 22 questions. The questions on the SNOT-22 efficacy evaluation were used to calculate a total score. 22 questions are divided among 4 subscales: Rhinologic (7 questions), Ear/Facial Symptoms (4 questions), Sleep Function (3 questions), and Psychological Issues (6 questions). Each item was rated on the 5-point scale. The total score can range from 0-110, 0 being the best and 110 being the worst.~0: No problem~Very mild problem~Mild or slight problem~Moderate problem~Severe problem~Problem as bad as it can be"|units on a scale|Mean|48.1|48.1|Full Range|||11.0|92.0|
3858161|NCT01624662|3683960|B2|||Sinonasal Outcome Test 22 (SNOT-22) Total Score|"SNOT-22 is a subject-completed questionnaire that consists of 22 questions. The questions on the SNOT-22 efficacy evaluation were used to calculate a total score. 22 questions are divided among 4 subscales: Rhinologic (7 questions), Ear/Facial Symptoms (4 questions), Sleep Function (3 questions), and Psychological Issues (6 questions). Each item was rated on the 5-point scale. The total score can range from 0-110, 0 being the best and 110 being the worst.~0: No problem~Very mild problem~Mild or slight problem~Moderate problem~Severe problem~Problem as bad as it can be"|units on a scale|Mean|48.5|48.5|Full Range|||9.0|97.0|
3858162|NCT01624662|3683961|B1|||Sinonasal Outcome Test 22 (SNOT-22) Total Score|"SNOT-22 is a subject-completed questionnaire that consists of 22 questions. The questions on the SNOT-22 efficacy evaluation were used to calculate a total score. 22 questions are divided among 4 subscales: Rhinologic (7 questions), Ear/Facial Symptoms (4 questions), Sleep Function (3 questions), and Psychological Issues (6 questions). Each item was rated on the 5-point scale. The total score can range from 0-110, 0 being the best and 110 being the worst.~0: No problem~Very mild problem~Mild or slight problem~Moderate problem~Severe problem~Problem as bad as it can be"|units on a scale|Mean|52.0|52.0|Full Range|||14.0|94.0|
3858163|NCT01624662|3683957|B5|||Hyposmia Score (7-day instantaneous morning)|"Subjects used an electronic diary to record nasal symptoms each morning for the 7-day period preceding the screening visit, evaluating symptom severity immediately preceding the time of scoring (instantaneous).~Hyposmia Score~0: Normal~Slightly impaired~Moderately impaired~Absent"|units on a scale|Mean|2.43|2.43|Full Range|||0.0|3.0|
3858164|NCT01624662|3683958|B4|||Hyposmia Score (7-day instantaneous morning)|"Subjects used an electronic diary to record nasal symptoms each morning for the 7-day period preceding the screening visit, evaluating symptom severity immediately preceding the time of scoring (instantaneous).~Hyposmia Score~0: Normal~Slightly impaired~Moderately impaired~Absent"|units on a scale|Mean|2.33|2.33|Full Range|||0.0|3.0|
3858165|NCT01624662|3683959|B3|||Hyposmia Score (7-day instantaneous morning)|"Subjects used an electronic diary to record nasal symptoms each morning for the 7-day period preceding the screening visit, evaluating symptom severity immediately preceding the time of scoring (instantaneous).~Hyposmia Score~0: Normal~Slightly impaired~Moderately impaired~Absent"|units on a scale|Mean|2.54|2.54|Full Range|||0.9|3.0|
3858166|NCT01624662|3683960|B2|||Hyposmia Score (7-day instantaneous morning)|"Subjects used an electronic diary to record nasal symptoms each morning for the 7-day period preceding the screening visit, evaluating symptom severity immediately preceding the time of scoring (instantaneous).~Hyposmia Score~0: Normal~Slightly impaired~Moderately impaired~Absent"|units on a scale|Mean|2.36|2.36|Full Range|||0.0|3.0|
3858167|NCT01624662|3683961|B1|||Hyposmia Score (7-day instantaneous morning)|"Subjects used an electronic diary to record nasal symptoms each morning for the 7-day period preceding the screening visit, evaluating symptom severity immediately preceding the time of scoring (instantaneous).~Hyposmia Score~0: Normal~Slightly impaired~Moderately impaired~Absent"|units on a scale|Mean|2.47|2.47|Full Range|||0.0|3.0|
3858207|NCT01624662|3683961|B1|South Africa||Region of Enrollment||participants|Number|12|12.0||||||
3858208|NCT01624662|3683957|B5|Ukraine||Region of Enrollment||participants|Number|54|54.0||||||
3858209|NCT01624662|3683958|B4|Ukraine||Region of Enrollment||participants|Number|15|15.0||||||
3858210|NCT01624662|3683959|B3|Ukraine||Region of Enrollment||participants|Number|13|13.0||||||
3858211|NCT01624662|3683960|B2|Ukraine||Region of Enrollment||participants|Number|14|14.0||||||
3858169|NCT01624662|3683958|B4|||Facial Pain or Pressure Score (7-day instantaneous morning)|"Subjects used an electronic diary to record nasal symptoms each morning for the 7-day period preceding the screening visit, evaluating symptom severity immediately preceding the time of scoring (instantaneous).~Nasal Symptom Score~0: None~Mild – symptoms clearly present, but minimal awareness, and easily tolerated~Moderate – definite awareness of symptoms that is bothersome but tolerable~Severe – symptoms that are hard to tolerate, cause interference with activities or daily living"|units on a scale|Mean|1.35|1.35|Full Range|||0.0|3.0|
3858170|NCT01624662|3683959|B3|||Facial Pain or Pressure Score (7-day instantaneous morning)|"Subjects used an electronic diary to record nasal symptoms each morning for the 7-day period preceding the screening visit, evaluating symptom severity immediately preceding the time of scoring (instantaneous).~Nasal Symptom Score~0: None~Mild – symptoms clearly present, but minimal awareness, and easily tolerated~Moderate – definite awareness of symptoms that is bothersome but tolerable~Severe – symptoms that are hard to tolerate, cause interference with activities or daily living"|units on a scale|Mean|1.48|1.48|Full Range|||0.0|3.0|
3858171|NCT01624662|3683960|B2|||Facial Pain or Pressure Score (7-day instantaneous morning)|"Subjects used an electronic diary to record nasal symptoms each morning for the 7-day period preceding the screening visit, evaluating symptom severity immediately preceding the time of scoring (instantaneous).~Nasal Symptom Score~0: None~Mild – symptoms clearly present, but minimal awareness, and easily tolerated~Moderate – definite awareness of symptoms that is bothersome but tolerable~Severe – symptoms that are hard to tolerate, cause interference with activities or daily living"|units on a scale|Mean|1.46|1.46|Full Range|||0.0|3.0|
3858172|NCT01624662|3683961|B1|||Facial Pain or Pressure Score (7-day instantaneous morning)|"Subjects used an electronic diary to record nasal symptoms each morning for the 7-day period preceding the screening visit, evaluating symptom severity immediately preceding the time of scoring (instantaneous).~Nasal Symptom Score~0: None~Mild – symptoms clearly present, but minimal awareness, and easily tolerated~Moderate – definite awareness of symptoms that is bothersome but tolerable~Severe – symptoms that are hard to tolerate, cause interference with activities or daily living"|units on a scale|Mean|1.46|1.46|Full Range|||0.0|3.0|
3858173|NCT01624662|3683957|B5|||Rhinorrhea Score (7-day instantaneous morning)|"Subjects used an electronic diary to record nasal symptoms each morning for the 7-day period preceding the screening visit, evaluating symptom severity immediately preceding the time of scoring (instantaneous).~Nasal Symptom Score~0: None~Mild – symptoms clearly present, but minimal awareness, and easily tolerated~Moderate – definite awareness of symptoms that is bothersome but tolerable~Severe – symptoms that are hard to tolerate, cause interference with activities or daily living"|units on a scale|Mean|1.83|1.83|Full Range|||0.0|3.0|
3858174|NCT01624662|3683958|B4|||Rhinorrhea Score (7-day instantaneous morning)|"Subjects used an electronic diary to record nasal symptoms each morning for the 7-day period preceding the screening visit, evaluating symptom severity immediately preceding the time of scoring (instantaneous).~Nasal Symptom Score~0: None~Mild – symptoms clearly present, but minimal awareness, and easily tolerated~Moderate – definite awareness of symptoms that is bothersome but tolerable~Severe – symptoms that are hard to tolerate, cause interference with activities or daily living"|units on a scale|Mean|1.77|1.77|Full Range|||0.0|3.0|
3858175|NCT01624662|3683959|B3|||Rhinorrhea Score (7-day instantaneous morning)|"Subjects used an electronic diary to record nasal symptoms each morning for the 7-day period preceding the screening visit, evaluating symptom severity immediately preceding the time of scoring (instantaneous).~Nasal Symptom Score~0: None~Mild – symptoms clearly present, but minimal awareness, and easily tolerated~Moderate – definite awareness of symptoms that is bothersome but tolerable~Severe – symptoms that are hard to tolerate, cause interference with activities or daily living"|units on a scale|Mean|1.86|1.86|Full Range|||0.0|3.0|
3858176|NCT01624662|3683960|B2|||Rhinorrhea Score (7-day instantaneous morning)|"Subjects used an electronic diary to record nasal symptoms each morning for the 7-day period preceding the screening visit, evaluating symptom severity immediately preceding the time of scoring (instantaneous).~Nasal Symptom Score~0: None~Mild – symptoms clearly present, but minimal awareness, and easily tolerated~Moderate – definite awareness of symptoms that is bothersome but tolerable~Severe – symptoms that are hard to tolerate, cause interference with activities or daily living"|units on a scale|Mean|1.89|1.89|Full Range|||0.0|3.0|
3858177|NCT01624662|3683961|B1|||Rhinorrhea Score (7-day instantaneous morning)|"Subjects used an electronic diary to record nasal symptoms each morning for the 7-day period preceding the screening visit, evaluating symptom severity immediately preceding the time of scoring (instantaneous).~Nasal Symptom Score~0: None~Mild – symptoms clearly present, but minimal awareness, and easily tolerated~Moderate – definite awareness of symptoms that is bothersome but tolerable~Severe – symptoms that are hard to tolerate, cause interference with activities or daily living"|units on a scale|Mean|1.8|1.8|Full Range|||0.0|3.0|
3858178|NCT01624662|3683957|B5|||Nasal Congestion/obstruction Score (7-day instantaneous morning)|"Subjects used an electronic diary to record nasal symptoms each morning for the 7-day period preceding the screening visit, evaluating symptom severity immediately preceding the time of scoring (instantaneous).~Nasal Symptom Score~0: None~Mild – symptoms clearly present, but minimal awareness, and easily tolerated~Moderate – definite awareness of symptoms that is bothersome but tolerable~Severe – symptoms that are hard to tolerate, cause interference with activities or daily living"|units on a scale|Mean|2.24|2.24|Full Range|||1.6|3.0|
3858179|NCT01624662|3683958|B4|||Nasal Congestion/obstruction Score (7-day instantaneous morning)|"Subjects used an electronic diary to record nasal symptoms each morning for the 7-day period preceding the screening visit, evaluating symptom severity immediately preceding the time of scoring (instantaneous).~Nasal Symptom Score~0: None~Mild – symptoms clearly present, but minimal awareness, and easily tolerated~Moderate – definite awareness of symptoms that is bothersome but tolerable~Severe – symptoms that are hard to tolerate, cause interference with activities or daily living"|units on a scale|Mean|2.25|2.25|Full Range|||1.6|3.0|
3858180|NCT01624662|3683959|B3|||Nasal Congestion/obstruction Score (7-day instantaneous morning)|"Subjects used an electronic diary to record nasal symptoms each morning for the 7-day period preceding the screening visit, evaluating symptom severity immediately preceding the time of scoring (instantaneous).~Nasal Symptom Score~0: None~Mild – symptoms clearly present, but minimal awareness, and easily tolerated~Moderate – definite awareness of symptoms that is bothersome but tolerable~Severe – symptoms that are hard to tolerate, cause interference with activities or daily living"|units on a scale|Mean|2.20|2.2|Full Range|||1.7|3.0|
3858181|NCT01624662|3683960|B2|||Nasal Congestion/obstruction Score (7-day instantaneous morning)|"Subjects used an electronic diary to record nasal symptoms each morning for the 7-day period preceding the screening visit, evaluating symptom severity immediately preceding the time of scoring (instantaneous).~Nasal Symptom Score~0: None~Mild – symptoms clearly present, but minimal awareness, and easily tolerated~Moderate – definite awareness of symptoms that is bothersome but tolerable~Severe – symptoms that are hard to tolerate, cause interference with activities or daily living"|units on a scale|Mean|2.23|2.23|Full Range|||1.6|3.0|
3858182|NCT01624662|3683961|B1|||Nasal Congestion/obstruction Score (7-day instantaneous morning)|"Subjects used an electronic diary to record nasal symptoms each morning for the 7-day period preceding the screening visit, evaluating symptom severity immediately preceding the time of scoring (instantaneous).~Nasal Symptom Score~0: None~Mild – symptoms clearly present, but minimal awareness, and easily tolerated~Moderate – definite awareness of symptoms that is bothersome but tolerable~Severe – symptoms that are hard to tolerate, cause interference with activities or daily living"|units on a scale|Mean|2.29|2.29|Full Range|||1.6|3.0|
3858183|NCT01624662|3683957|B5|||Previous polyp removal surgery via polypectomy only|Subjects may have had both sinus surgery and polypectomy.|Participants|Count of Participants|115|115.0||||||
3858184|NCT01624662|3683958|B4|||Previous polyp removal surgery via polypectomy only|Subjects may have had both sinus surgery and polypectomy.|Participants|Count of Participants|27|27.0||||||
3858185|NCT01624662|3683959|B3|||Previous polyp removal surgery via polypectomy only|Subjects may have had both sinus surgery and polypectomy.|Participants|Count of Participants|25|25.0||||||
3858186|NCT01624662|3683960|B2|||Previous polyp removal surgery via polypectomy only|Subjects may have had both sinus surgery and polypectomy.|Participants|Count of Participants|33|33.0||||||
3858187|NCT01624662|3683961|B1|||Previous polyp removal surgery via polypectomy only|Subjects may have had both sinus surgery and polypectomy.|Participants|Count of Participants|30|30.0||||||
3858188|NCT01624662|3683957|B5|||Previous sinus surgery for polyp removal or sinus surgery|Subjects may have had both sinus surgery and polypectomy.|Participants|Count of Participants|111|111.0||||||
3858189|NCT01624662|3683958|B4|||Previous sinus surgery for polyp removal or sinus surgery|Subjects may have had both sinus surgery and polypectomy.|Participants|Count of Participants|26|26.0||||||
3858190|NCT01624662|3683959|B3|||Previous sinus surgery for polyp removal or sinus surgery|Subjects may have had both sinus surgery and polypectomy.|Participants|Count of Participants|33|33.0||||||
3858191|NCT01624662|3683960|B2|||Previous sinus surgery for polyp removal or sinus surgery|Subjects may have had both sinus surgery and polypectomy.|Participants|Count of Participants|28|28.0||||||
3858192|NCT01624662|3683961|B1|||Previous sinus surgery for polyp removal or sinus surgery|Subjects may have had both sinus surgery and polypectomy.|Participants|Count of Participants|24|24.0||||||
3858193|NCT01624662|3683957|B5|||Use of ICS treatment for polyps in past 10 years||Participants|Count of Participants|280|280.0||||||
3858194|NCT01624662|3683958|B4|||Use of ICS treatment for polyps in past 10 years||Participants|Count of Participants|70|70.0||||||
3858195|NCT01624662|3683959|B3|||Use of ICS treatment for polyps in past 10 years||Participants|Count of Participants|70|70.0||||||
3858196|NCT01624662|3683960|B2|||Use of ICS treatment for polyps in past 10 years||Participants|Count of Participants|67|67.0||||||
3858197|NCT01624662|3683961|B1|||Use of ICS treatment for polyps in past 10 years||Participants|Count of Participants|73|73.0||||||
3858198|NCT01624662|3683957|B5|||Total Polyp Grading Score (sum of scores from both nasal cavities)|"Nasal Polyp Grading Score (sum of scores from both nasal cavities measured by nasoendoscopy)~0: No polyps~Mild polyposis – polyps not reaching below the inferior border of the middle turbinate~Moderate polyposis – polyps reaching below the inferior border of the middle concha, but not the inferior border of the inferior turbinate~Severe polyposis – large polyps reaching below the lower inferior border of the inferior turbinate"|units on a scale|Mean|3.8|3.8|Standard Deviation|1.02|1.02|||
3858199|NCT01624662|3683958|B4|||Total Polyp Grading Score (sum of scores from both nasal cavities)|"Nasal Polyp Grading Score (sum of scores from both nasal cavities measured by nasoendoscopy)~0: No polyps~Mild polyposis – polyps not reaching below the inferior border of the middle turbinate~Moderate polyposis – polyps reaching below the inferior border of the middle concha, but not the inferior border of the inferior turbinate~Severe polyposis – large polyps reaching below the lower inferior border of the inferior turbinate"|units on a scale|Mean|3.9|3.9|Standard Deviation|0.98|0.98|||
3858200|NCT01624662|3683959|B3|||Total Polyp Grading Score (sum of scores from both nasal cavities)|"Nasal Polyp Grading Score (sum of scores from both nasal cavities measured by nasoendoscopy)~0: No polyps~Mild polyposis – polyps not reaching below the inferior border of the middle turbinate~Moderate polyposis – polyps reaching below the inferior border of the middle concha, but not the inferior border of the inferior turbinate~Severe polyposis – large polyps reaching below the lower inferior border of the inferior turbinate"|units on a scale|Mean|3.9|3.9|Standard Deviation|1.05|1.05|||
3858201|NCT01624662|3683960|B2|||Total Polyp Grading Score (sum of scores from both nasal cavities)|"Nasal Polyp Grading Score (sum of scores from both nasal cavities measured by nasoendoscopy)~0: No polyps~Mild polyposis – polyps not reaching below the inferior border of the middle turbinate~Moderate polyposis – polyps reaching below the inferior border of the middle concha, but not the inferior border of the inferior turbinate~Severe polyposis – large polyps reaching below the lower inferior border of the inferior turbinate"|units on a scale|Mean|3.8|3.8|Standard Deviation|0.98|0.98|||
3858202|NCT01624662|3683961|B1|||Total Polyp Grading Score (sum of scores from both nasal cavities)|"Nasal Polyp Grading Score (sum of scores from both nasal cavities measured by nasoendoscopy)~0: No polyps~Mild polyposis – polyps not reaching below the inferior border of the middle turbinate~Moderate polyposis – polyps reaching below the inferior border of the middle concha, but not the inferior border of the inferior turbinate~Severe polyposis – large polyps reaching below the lower inferior border of the inferior turbinate"|units on a scale|Mean|3.8|3.8|Standard Deviation|1.08|1.08|||
3858203|NCT01624662|3683957|B5|South Africa||Region of Enrollment||participants|Number|44|44.0||||||
3858204|NCT01624662|3683958|B4|South Africa||Region of Enrollment||participants|Number|11|11.0||||||
3858205|NCT01624662|3683959|B3|South Africa||Region of Enrollment||participants|Number|11|11.0||||||
3858206|NCT01624662|3683960|B2|South Africa||Region of Enrollment||participants|Number|10|10.0||||||
3858216|NCT01624662|3683960|B2|Romania||Region of Enrollment||participants|Number|13|13.0||||||
3858217|NCT01624662|3683961|B1|Romania||Region of Enrollment||participants|Number|15|15.0||||||
3858218|NCT01624662|3683957|B5|Poland||Region of Enrollment||participants|Number|131|131.0||||||
3858219|NCT01624662|3683958|B4|Poland||Region of Enrollment||participants|Number|33|33.0||||||
3858220|NCT01624662|3683959|B3|Poland||Region of Enrollment||participants|Number|33|33.0||||||
3858221|NCT01624662|3683960|B2|Poland||Region of Enrollment||participants|Number|34|34.0||||||
3858222|NCT01624662|3683961|B1|Poland||Region of Enrollment||participants|Number|31|31.0||||||
3858223|NCT01624662|3683957|B5|United States||Region of Enrollment||participants|Number|39|39.0||||||
3858224|NCT01624662|3683958|B4|United States||Region of Enrollment||participants|Number|9|9.0||||||
3858225|NCT01624662|3683959|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3858226|NCT01624662|3683960|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3858227|NCT01624662|3683961|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3858228|NCT01624662|3683957|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3858229|NCT01624662|3683958|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3858230|NCT01624662|3683959|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3858231|NCT01624662|3683960|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3858232|NCT01624662|3683961|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3858233|NCT01624662|3683957|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3858234|NCT01624662|3683958|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3858235|NCT01624662|3683959|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3858236|NCT01624662|3683960|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3858237|NCT01624662|3683961|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3858238|NCT01624662|3683957|B5|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3858239|NCT01624662|3683958|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3858240|NCT01624662|3683959|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3858241|NCT01624662|3683960|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3858242|NCT01624662|3683961|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3858243|NCT01624662|3683957|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|304|304.0||||||
3858244|NCT01624662|3683958|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|76|76.0||||||
3858245|NCT01624662|3683959|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|76|76.0||||||
3858246|NCT01624662|3683960|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|76|76.0||||||
3858247|NCT01624662|3683961|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|76|76.0||||||
3858248|NCT01624662|3683957|B5||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
3858249|NCT01624662|3683958|B4||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3858250|NCT01624662|3683959|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3858251|NCT01624662|3683960|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3858252|NCT01624662|3683961|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3858253|NCT01624662|3683957|B5||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3858254|NCT01624662|3683958|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3858255|NCT01624662|3683959|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3858256|NCT01624662|3683960|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3858257|NCT01624662|3683961|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3858258|NCT01624662|3683957|B5|||Age||years|Mean|45.8|45.8|Standard Deviation|12.66|12.66|||
3858259|NCT01624662|3683958|B4|||Age||years|Mean|45.0|45.0|Standard Deviation|12.14|12.14|||
3858260|NCT01624662|3683959|B3|||Age||years|Mean|44.8|44.8|Standard Deviation|12.87|12.87|||
3858261|NCT01624662|3683960|B2|||Age||years|Mean|46.7|46.7|Standard Deviation|13.72|13.72|||
3858262|NCT01624662|3683961|B1|||Age||years|Mean|46.7|46.7|Standard Deviation|11.95|11.95|||
3858263|NCT01624467|3684035|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3858264|NCT01624467|3684035|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3858265|NCT01624467|3684035|B1||White|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3858266|NCT01624467|3684035|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3858267|NCT01624467|3684035|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3858268|NCT01624467|3684035|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3858269|NCT01624467|3684035|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3858270|NCT01624467|3684035|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858271|NCT01624467|3684035|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3858272|NCT01624467|3684035|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3858273|NCT01624467|3684035|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3858274|NCT01624467|3684035|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3858275|NCT01624467|3684035|B1|||Age||years|Mean|60.3|60.3|Standard Deviation|9.92|9.92|||
3858276|NCT01624363|3684048|B1|United States||Region of Enrollment||participants|Number|341|341.0||||||
3858277|NCT01624363|3684048|B1||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3858278|NCT01624363|3684048|B1||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
3858279|NCT01624363|3684048|B1||>=65 years|Age||Participants|Count of Participants|113|113.0||||||
3858280|NCT01624363|3684048|B1||Between 18 and 65 years|Age||Participants|Count of Participants|228|228.0||||||
3858281|NCT01624363|3684048|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3858282|NCT01624350|3684052|B1|Italy||Region of Enrollment||participants|Number|33|33.0||||||
3858283|NCT01624350|3684052|B1|United Kingdom||Region of Enrollment||participants|Number|52|52.0||||||
3858284|NCT01624350|3684052|B1|Denmark||Region of Enrollment||participants|Number|15|15.0||||||
3858285|NCT01624350|3684052|B1||Male|Gender||Participants|Count of Participants|70|70.0||||||
3858286|NCT01624350|3684052|B1||Female|Gender||Participants|Count of Participants|30|30.0||||||
3858287|NCT01624350|3684052|B1|||Age||years|Mean|45.9|45.9|Standard Deviation|13.68|13.68|||
3858288|NCT01624259|3684072|B3|||Duration of diabetes||years|Mean|7.21|7.21|Standard Deviation|5.41|5.41|||
3858289|NCT01624259|3684073|B2|||Duration of diabetes||years|Mean|7.28|7.28|Standard Deviation|5.41|5.41|||
3858290|NCT01624259|3684074|B1|||Duration of diabetes||years|Mean|7.13|7.13|Standard Deviation|5.41|5.41|||
3858291|NCT01624259|3684072|B3|||Glycosylated hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|8.05|8.05|Standard Deviation|0.80|0.8|||
3858292|NCT01624259|3684073|B2|||Glycosylated hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|8.05|8.05|Standard Deviation|0.79|0.79|||
3858293|NCT01624259|3684074|B1|||Glycosylated hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|8.06|8.06|Standard Deviation|0.81|0.81|||
3858294|NCT01624259|3684072|B3|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared|kilograms per meter squared (kg/m^2)|Mean|33.56|33.56|Standard Deviation|5.11|5.11|||
3858295|NCT01624259|3684073|B2|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared|kilograms per meter squared (kg/m^2)|Mean|33.62|33.62|Standard Deviation|5.16|5.16|||
3858296|NCT01624259|3684074|B1|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared|kilograms per meter squared (kg/m^2)|Mean|33.50|33.5|Standard Deviation|5.07|5.07|||
3858297|NCT01624259|3684072|B3|||Body Weight||kilograms (kg)|Mean|94.09|94.09|Standard Deviation|18.58|18.58|||
3858298|NCT01624259|3684073|B2|||Body Weight||kilograms (kg)|Mean|94.35|94.35|Standard Deviation|18.96|18.96|||
3858299|NCT01624259|3684074|B1|||Body Weight||kilograms (kg)|Mean|93.82|93.82|Standard Deviation|18.23|18.23|||
3858300|NCT01624259|3684072|B3|Germany||Region of Enrollment||participants|Number|54|54.0||||||
3858301|NCT01624259|3684073|B2|Germany||Region of Enrollment||participants|Number|26|26.0||||||
3858302|NCT01624259|3684074|B1|Germany||Region of Enrollment||participants|Number|28|28.0||||||
3858303|NCT01624259|3684072|B3|Romania||Region of Enrollment||participants|Number|37|37.0||||||
3858304|NCT01624259|3684073|B2|Romania||Region of Enrollment||participants|Number|17|17.0||||||
3858305|NCT01624259|3684074|B1|Romania||Region of Enrollment||participants|Number|20|20.0||||||
3858306|NCT01624259|3684072|B3|Spain||Region of Enrollment||participants|Number|48|48.0||||||
3858307|NCT01624259|3684073|B2|Spain||Region of Enrollment||participants|Number|24|24.0||||||
3858308|NCT01624259|3684074|B1|Spain||Region of Enrollment||participants|Number|24|24.0||||||
3858309|NCT01624259|3684072|B3|Poland||Region of Enrollment||participants|Number|81|81.0||||||
3858310|NCT01624259|3684073|B2|Poland||Region of Enrollment||participants|Number|42|42.0||||||
3858311|NCT01624259|3684074|B1|Poland||Region of Enrollment||participants|Number|39|39.0||||||
3858312|NCT01624259|3684072|B3|Puerto Rico||Region of Enrollment||participants|Number|7|7.0||||||
3858313|NCT01624259|3684073|B2|Puerto Rico||Region of Enrollment||participants|Number|4|4.0||||||
3858314|NCT01624259|3684074|B1|Puerto Rico||Region of Enrollment||participants|Number|3|3.0||||||
3858315|NCT01624259|3684072|B3|Slovakia||Region of Enrollment||participants|Number|42|42.0||||||
3858316|NCT01624259|3684073|B2|Slovakia||Region of Enrollment||participants|Number|22|22.0||||||
3858317|NCT01624259|3684074|B1|Slovakia||Region of Enrollment||participants|Number|20|20.0||||||
3858318|NCT01624259|3684072|B3|Mexico||Region of Enrollment||participants|Number|41|41.0||||||
3858319|NCT01624259|3684073|B2|Mexico||Region of Enrollment||participants|Number|21|21.0||||||
3858320|NCT01624259|3684074|B1|Mexico||Region of Enrollment||participants|Number|20|20.0||||||
3858321|NCT01624259|3684072|B3|Hungary||Region of Enrollment||participants|Number|40|40.0||||||
3858322|NCT01624259|3684073|B2|Hungary||Region of Enrollment||participants|Number|19|19.0||||||
3858323|NCT01624259|3684074|B1|Hungary||Region of Enrollment||participants|Number|21|21.0||||||
3858324|NCT01624259|3684072|B3|Czech Republic||Region of Enrollment||participants|Number|55|55.0||||||
3858325|NCT01624259|3684073|B2|Czech Republic||Region of Enrollment||participants|Number|28|28.0||||||
3858326|NCT01624259|3684074|B1|Czech Republic||Region of Enrollment||participants|Number|27|27.0||||||
3858327|NCT01624259|3684072|B3|United States||Region of Enrollment||participants|Number|194|194.0||||||
3858328|NCT01624259|3684073|B2|United States||Region of Enrollment||participants|Number|97|97.0||||||
3858329|NCT01624259|3684074|B1|United States||Region of Enrollment||participants|Number|97|97.0||||||
3858330|NCT01624259|3684072|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858331|NCT01624259|3684073|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858332|NCT01624259|3684074|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858333|NCT01624259|3684072|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3858334|NCT01624259|3684073|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3858335|NCT01624259|3684074|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3858336|NCT01624259|3684072|B3||White|Race (NIH/OMB)||Participants|Count of Participants|515|515.0||||||
3858337|NCT01624259|3684073|B2||White|Race (NIH/OMB)||Participants|Count of Participants|259|259.0||||||
3858338|NCT01624259|3684074|B1||White|Race (NIH/OMB)||Participants|Count of Participants|256|256.0||||||
3858339|NCT01624259|3684072|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3858340|NCT01624259|3684073|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3858341|NCT01624259|3684074|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3858342|NCT01624259|3684072|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858343|NCT01624259|3684073|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858344|NCT01624259|3684074|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858345|NCT01624259|3684072|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3858346|NCT01624259|3684073|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858347|NCT01624259|3684074|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3858348|NCT01624259|3684072|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3858349|NCT01624259|3684073|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3858350|NCT01624259|3684074|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3858351|NCT01624259|3684072|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3858352|NCT01624259|3684073|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3858353|NCT01624259|3684074|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3858354|NCT01624259|3684072|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|444|444.0||||||
3858355|NCT01624259|3684073|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|223|223.0||||||
3858356|NCT01624259|3684074|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|221|221.0||||||
3858357|NCT01624259|3684072|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|147|147.0||||||
3858358|NCT01624259|3684073|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3858359|NCT01624259|3684074|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3858360|NCT01624259|3684072|B3||Male|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
3858361|NCT01624259|3684073|B2||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3858362|NCT01624259|3684074|B1||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3858363|NCT01624259|3684072|B3||Female|Sex: Female, Male||Participants|Count of Participants|312|312.0||||||
3858364|NCT01624259|3684073|B2||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3858365|NCT01624259|3684074|B1||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3858366|NCT01624259|3684072|B3|||Age||years|Mean|56.65|56.65|Standard Deviation|9.63|9.63|||
3858367|NCT01624259|3684073|B2|||Age||years|Mean|56.81|56.81|Standard Deviation|9.91|9.91|||
3858368|NCT01624259|3684074|B1|||Age||years|Mean|56.49|56.49|Standard Deviation|9.34|9.34|||
3858369|NCT01624233|3684124|B1|||Joint Pain Visual Analog Scale (VAS)|The pain VAS is a participant-administered single-item scale designed to measure current joint pain from PsA using a 100-mm horizontal VAS. Overall severity of participant's joint pain from PsA is indicated by placing a single mark on the horizontal 100-mm scale from 0 mm (no pain) to 100 mm (pain as severe as you can imagine).|units on a scale|Mean|62.4|62.4|Standard Deviation|23.79|23.79|||
3858370|NCT01624233|3684124|B1|||Quick Inventory of Depressive Symptomatology-Self Reported (DLQI) Total Score|"DLQI is a participant-administered, 10-question, validated, quality-of-life questionnaire that covers 6 domains, including symptoms and feelings, daily activities, leisure, work and school, personal relationships, and treatment. Response categories include 0 (not at all), 1 (a little), 2 (a lot), and 3 (very much) and unanswered (not relevant) responses were scored as 0. Total scores range from 0 to 30, with higher score indicating greater quality of life impairment."|units on a scale|Mean|10.8|10.8|Standard Deviation|6.50|6.5|||
3858371|NCT01624233|3684124|B1|||Itch Numeric Rating Scale (NRS) Score|The Itch NRS is a participant-administered, 11-point horizontal scale anchored at 0 (no itch) and 10 (worst itch imaginable). Overall severity of a participant's itching from Ps is indicated by circling the number that best describes the worst level of itching in the past 24 hours.|units on a scale|Mean|6.1|6.1|Standard Deviation|2.53|2.53|||
3858372|NCT01624233|3684124|B1|||Quick Inventory of Depressive Symptomatology-Self Reported 16 Items(QIDS-SR16) Total Score|QIDS-SR16 is a participant-administered, 16-item instrument assesses the existence and severity of symptoms of depression. A participant is asked a statement relating to the way they have felt for the past 7 days and rate on a 4-point scale: 0 (best) to 3 (worst). The sum of the domains [sad mood, concentration, self-criticism, suicidal ideation, interest, energy/fatigue, sleep disturbance, decrease/increase in appetite/weight, and psychomotor agitation/retardation] to give a single total scores range from 0 to 27, with higher scores indicating greater symptom severity.|units on a scale|Mean|4.6|4.6|Standard Deviation|4.14|4.14|||
3858373|NCT01624233|3684124|B1|||Psoriasis Scalp Severity Index (PSSI) Total Score|The PSSI is a physician assessment of erythema, induration and desquamation and percent of scalp that is covered with a scores range from 0 (none) to 4 (very severe). The composite score is derived from the sum of scores for erythema, induration, and desquamation multiplied by the score recorded for the extent of the scalp area involved, 1 (<10%) to 6 (90%-100%) with a total score ranging from 0 (less severity) to 72 (more severity).|units on a scale|Mean|27.0|27.0|Standard Deviation|15.99|15.99|||
3858374|NCT01624233|3684124|B1|||Nail Psoriasis Severity Index (NAPSI) Total Score|The NAPSI scale evaluates Ps severity in the fingernail bed and fingernail matrix with each divided into quadrants. Scores range from 0 (none) to 4 (Ps in all 4 quadrants), depending on the presence (score of 1) or absence (score of 0) of Ps in each quadrant of the fingernail bed or matrix. NAPSI score of a fingernail is the sum of scores from each quadrant of the fingernail bed and fingernail matrix (maximum of 8). The total NAPSI score equals the sum of all fingernails and ranges from 0 to 80. Higher scores indicate more severe Ps.|units on a scale|Mean|31.1|31.1|Standard Deviation|22.16|22.16|||
3858375|NCT01624233|3684124|B1|||Percentage (%) of Body Surface Area (BSA)|BSA is a physician rating of the percentage of involvement of Ps for each participant. BSA is assessed on a continuous scale from 0% (no involvement) to 100% (full involvement), where 1% corresponds to the size of the participant's hand (includes the palm, fingers and thumb). Total BSA is the sum of handprints from the affected areas.|units on a scale|Mean|45.5|45.5|Standard Deviation|23.22|23.22|||
3858376|NCT01624233|3684124|B1|5: Very Severe||Static Physician Global Assessment (sPGA) Score|The sPGA is the physician's determination of the participant's Ps lesions overall at a given time point. Lesions were categorized by descriptions for induration, erythema, and scaling. Participants Ps were assessed as clear (0), minimal (1), mild (2), moderate (3), severe (4), or very severe (5).|participants|Number|11|11.0||||||
3858377|NCT01624233|3684124|B1|4: Severe||Static Physician Global Assessment (sPGA) Score|The sPGA is the physician's determination of the participant's Ps lesions overall at a given time point. Lesions were categorized by descriptions for induration, erythema, and scaling. Participants Ps were assessed as clear (0), minimal (1), mild (2), moderate (3), severe (4), or very severe (5).|participants|Number|53|53.0||||||
3858378|NCT01624233|3684124|B1|3: Moderate||Static Physician Global Assessment (sPGA) Score|The sPGA is the physician's determination of the participant's Ps lesions overall at a given time point. Lesions were categorized by descriptions for induration, erythema, and scaling. Participants Ps were assessed as clear (0), minimal (1), mild (2), moderate (3), severe (4), or very severe (5).|participants|Number|26|26.0||||||
3858379|NCT01624233|3684124|B1|2: Mild||Static Physician Global Assessment (sPGA) Score|The sPGA is the physician's determination of the participant's Ps lesions overall at a given time point. Lesions were categorized by descriptions for induration, erythema, and scaling. Participants Ps were assessed as clear (0), minimal (1), mild (2), moderate (3), severe (4), or very severe (5).|participants|Number|1|1.0||||||
3858380|NCT01624233|3684124|B1|1: Minimal||Static Physician Global Assessment (sPGA) Score|The sPGA is the physician's determination of the participant's Ps lesions overall at a given time point. Lesions were categorized by descriptions for induration, erythema, and scaling. Participants Ps were assessed as clear (0), minimal (1), mild (2), moderate (3), severe (4), or very severe (5).|participants|Number|0|0.0||||||
3858381|NCT01624233|3684124|B1|0: Clear||Static Physician Global Assessment (sPGA) Score|The sPGA is the physician's determination of the participant's Ps lesions overall at a given time point. Lesions were categorized by descriptions for induration, erythema, and scaling. Participants Ps were assessed as clear (0), minimal (1), mild (2), moderate (3), severe (4), or very severe (5).|participants|Number|0|0.0||||||
3858382|NCT01624233|3684124|B1|||Psoriasis Area and Severity Index (PASI) Total Score|The PASI combines the extent of body surface involvement in 4 anatomical regions (head, trunk, arms, and legs). For each region the percent area of skin involved was estimated from 0 (0%) to 6 (90%-100%) and severity was estimated by clinical signs of erythema, induration and scaling with a scores range from 0(no involvement) to 4 (severe involvement). Each area is scored by itself and the scores were then combined for the final PASI. Overall scores range from 0 (no Ps) to 72 (the most severe disease).|units on a scale|Mean|27.24|27.24|Standard Deviation|10.545|10.545|||
3858383|NCT01624233|3684124|B1|Japan||Region of Enrollment||participants|Number|91|91.0||||||
3858384|NCT01624233|3684124|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858385|NCT01624233|3684124|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858386|NCT01624233|3684124|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858387|NCT01624233|3684124|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858388|NCT01624233|3684124|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858389|NCT01624233|3684124|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3858390|NCT01624233|3684124|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858391|NCT01624233|3684124|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858392|NCT01624233|3684124|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3858393|NCT01624233|3684124|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858394|NCT01624233|3684124|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3858395|NCT01624233|3684124|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3858396|NCT01624233|3684124|B1|||Age||years|Mean|46.2|46.2|Standard Deviation|11.89|11.89|||
3858397|NCT01624194|3684154|B3|United States||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3858398|NCT01624194|3684155|B2|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3858399|NCT01624194|3684156|B1|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3858400|NCT01624194|3684154|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3858401|NCT01624194|3684155|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3858402|NCT01624194|3684156|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3858403|NCT01624194|3684154|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3858404|NCT01624194|3684155|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3858405|NCT01624194|3684156|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3858406|NCT01624194|3684154|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3858407|NCT01624194|3684155|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3858408|NCT01624194|3684156|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3858409|NCT01624194|3684154|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3858410|NCT01624194|3684155|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3858411|NCT01624194|3684156|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3858412|NCT01624194|3684154|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3858413|NCT01624194|3684155|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3858414|NCT01624194|3684156|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3858415|NCT01624194|3684154|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3858416|NCT01624194|3684155|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3858417|NCT01624194|3684156|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3858418|NCT01624194|3684154|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3858419|NCT01624194|3684155|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3858420|NCT01624194|3684156|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3858421|NCT01624194|3684154|B3||<=18 years|Age||Participants|Count of Participants|34|34.0||||||
3858422|NCT01624194|3684155|B2||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
3858423|NCT01624194|3684156|B1||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
3858424|NCT01624168|3684195|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3858425|NCT01624168|3684196|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3858426|NCT01624168|3684197|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3858427|NCT01624168|3684198|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3858428|NCT01624168|3684195|B4||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3858429|NCT01624168|3684196|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3858430|NCT01624168|3684197|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3858431|NCT01624168|3684198|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3858432|NCT01624168|3684195|B4|||Age||years|Mean|21.13|21.13|Standard Deviation|3.5|3.5|||
3858433|NCT01624168|3684196|B3|||Age||years|Mean|20.18|20.18|Standard Deviation|1.16|1.16|||
3858434|NCT01624168|3684197|B2|||Age||years|Mean|21.21|21.21|Standard Deviation|3.04|3.04|||
3858435|NCT01624168|3684198|B1|||Age||years|Mean|22.42|22.42|Standard Deviation|5.47|5.47|||
3858436|NCT01623869|3684223|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3858437|NCT01623869|3684223|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3858438|NCT01623869|3684223|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3858439|NCT01623869|3684223|B1|||Age||years|Median|68.5|68.5|Full Range|||24.0|91.0|
3858440|NCT01623830|3684229|B3|United States||Region of Enrollment||participants|Number|89|89.0||||||
3858441|NCT01623830|3684230|B2|United States||Region of Enrollment||participants|Number|44|44.0||||||
3858442|NCT01623830|3684231|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
3858443|NCT01623830|3684229|B3||Male|Gender||Participants|Count of Participants|18|18.0||||||
3858444|NCT01623830|3684230|B2||Male|Gender||Participants|Count of Participants|10|10.0||||||
3858445|NCT01623830|3684231|B1||Male|Gender||Participants|Count of Participants|8|8.0||||||
3858446|NCT01623830|3684229|B3||Female|Gender||Participants|Count of Participants|71|71.0||||||
3858447|NCT01623830|3684230|B2||Female|Gender||Participants|Count of Participants|34|34.0||||||
3858448|NCT01623830|3684231|B1||Female|Gender||Participants|Count of Participants|37|37.0||||||
3858449|NCT01623830|3684229|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3858450|NCT01623830|3684230|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3858451|NCT01623830|3684231|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3858452|NCT01623830|3684229|B3||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
3858453|NCT01623830|3684230|B2||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3858454|NCT01623830|3684231|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3858455|NCT01623830|3684229|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3858456|NCT01623830|3684230|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3858457|NCT01623830|3684231|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3858458|NCT01623739|3684246|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
3858459|NCT01623739|3684247|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3858460|NCT01623739|3684248|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3858461|NCT01623739|3684246|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3858462|NCT01623739|3684246|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3858463|NCT01623739|3684247|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3858464|NCT01623739|3684248|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3858465|NCT01623739|3684246|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3858466|NCT01623739|3684247|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3858467|NCT01623739|3684248|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3858468|NCT01623739|3684246|B3|||Age||years|Mean|51.8|51.8|Standard Deviation|14.9|14.9|||
3858469|NCT01623739|3684247|B2|||Age||years|Mean|50.9|50.9|Standard Deviation|14.6|14.6|||
3858470|NCT01623739|3684248|B1|||Age||years|Mean|52.5|52.5|Standard Deviation|15.6|15.6|||
3858471|NCT01623596|3684264|B3||Male|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
3858472|NCT01623596|3684265|B2||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3858473|NCT01623596|3684266|B1||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3858474|NCT01623596|3684264|B3||Female|Sex: Female, Male||Participants|Count of Participants|640|640.0||||||
3858475|NCT01623596|3684265|B2||Female|Sex: Female, Male||Participants|Count of Participants|329|329.0||||||
3858476|NCT01623596|3684266|B1||Female|Sex: Female, Male||Participants|Count of Participants|311|311.0||||||
3858477|NCT01623596|3684264|B3|||Age||years|Mean|41.7|41.7|Standard Deviation|10.61|10.61|||
3858478|NCT01623596|3684265|B2|||Age||years|Mean|41.9|41.9|Standard Deviation|10.39|10.39|||
3858479|NCT01623596|3684266|B1|||Age||years|Mean|41.5|41.5|Standard Deviation|10.84|10.84|||
3858480|NCT01623479|3684283|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3858481|NCT01623479|3684283|B1||Female|Sex: Female, Male||Participants|Count of Participants|580|580.0||||||
3858482|NCT01623479|3684283|B1|||Age||Years|Mean|50.54|50.54|Standard Deviation|9.68|9.68|||
3858483|NCT01623466|3684289|B3|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3858484|NCT01623466|3684290|B2|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3858485|NCT01623466|3684291|B1|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3858486|NCT01623466|3684289|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3858487|NCT01623466|3684290|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3858488|NCT01623466|3684291|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3858489|NCT01623466|3684289|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3858490|NCT01623466|3684290|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3858491|NCT01623466|3684291|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3858492|NCT01623466|3684289|B3|||Age||years|Mean|32.39|32.39|Standard Deviation|7.951|7.951|||
3858493|NCT01623466|3684290|B2|||Age||years|Mean|34.94|34.94|Standard Deviation|6.673|6.673|||
3858494|NCT01623466|3684291|B1|||Age||years|Mean|29.83|29.83|Standard Deviation|8.473|8.473|||
3858495|NCT01623466|3684289|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3858496|NCT01623466|3684290|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3858497|NCT01623466|3684291|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3858498|NCT01623466|3684289|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3858499|NCT01623466|3684290|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3858500|NCT01623466|3684291|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3858501|NCT01623466|3684289|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3858502|NCT01623466|3684290|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3858503|NCT01623466|3684291|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3858504|NCT01623323|3684306|B1|United States||Region of Enrollment||participants|Number|705|705.0||||||
3858505|NCT01623323|3684306|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858506|NCT01623323|3684306|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3858507|NCT01623323|3684306|B1||White|Race (NIH/OMB)||Participants|Count of Participants|552|552.0||||||
3858508|NCT01623323|3684306|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|114|114.0||||||
3858509|NCT01623323|3684306|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3858510|NCT01623323|3684306|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3858511|NCT01623323|3684306|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3858512|NCT01623323|3684306|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858513|NCT01623323|3684306|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|624|624.0||||||
3858514|NCT01623323|3684306|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
3858515|NCT01623323|3684306|B1||Male|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
3858516|NCT01623323|3684306|B1||Female|Sex: Female, Male||Participants|Count of Participants|403|403.0||||||
3858517|NCT01623323|3684306|B1|||Age||years|Mean|45.3|45.3|Standard Deviation|13.71|13.71|||
3858518|NCT01623310|3684310|B1|Pts Without Polyps||Nasal Polyp Surgery Eligibility||Participants|Count of Participants|11|11.0||||||
3858519|NCT01623310|3684310|B1|Pts With Polyps||Nasal Polyp Surgery Eligibility||Participants|Count of Participants|16|16.0||||||
3858520|NCT01623310|3684310|B1|||Summed Bilateral Nasal Polyp Grading Scale Score|"Includes Chronic Sinusitis with Nasal Polyp Patients~In subjects with nasal polyps, polyp grading of each nasal cavity was determined by a nasal polyp grading scale score measured by nasoendoscopy.~0: No polyps~Mild polyposis: polyps not reaching below the inferior of the middle turbinate~Moderate polyposis: polyps reaching below the inferior border of the middle concha, but not the inferior border of the inferior turbinate~Severe polyposis: large polyps reaching below the lower inferior border of the inferior turbinate"|units on a scale|Mean|2.8|2.8|Standard Deviation|1.17|1.17|||
3858521|NCT01623310|3684310|B1|Pts Without Polyps||Lund-Mackay total score|"Assessment of nasal cavity appearance, via nasoendoscopy, used to evaluate signs of edema, discharge, crusting, scarring/adhesions, and nasal polyps, with each sign rated on a 0 to 2 scale.~0: None 2: Worse outcome"|units on a scale|Mean|1.4|1.4|Standard Deviation|1.20|1.2|||
3858565|NCT01623050|3684392|B1|Canada||Region of Enrollment||participants|Number|12|12.0||||||
3858522|NCT01623310|3684310|B1|Pts With Polyps||Lund-Mackay total score|"Assessment of nasal cavity appearance, via nasoendoscopy, used to evaluate signs of edema, discharge, crusting, scarring/adhesions, and nasal polyps, with each sign rated on a 0 to 2 scale.~0: None 2: Worse outcome"|units on a scale|Mean|1.7|1.7|Standard Deviation|1.51|1.51|||
3858523|NCT01623310|3684310|B1|Pts Without Polyps||Sinonasal Outcome Test 22 (SNOT-22) Total Score|"SNOT-22 is validated in large populations with chronic sinusitis with and without nasal polyps. The 22 questions are used to calculate a total score (the sum of all items) and 4 subscale scores. The 22 questions are divided among 4 subscales: Rhinologic, Ear and Facial Symptoms, Sleep Function, and Psychological Issues subscales. The total score can range from 0-110, 0 being the best and 110 being the worst.~0: No problem~Very mild problem~Mild or slight problem~Moderate problem~Severe problem~Problem as bad as it can be"|units on a scale|Mean|39.7|39.7|Standard Deviation|21.72|21.72|||
3858524|NCT01623310|3684310|B1|Pts With Polyps||Sinonasal Outcome Test 22 (SNOT-22) Total Score|"SNOT-22 is validated in large populations with chronic sinusitis with and without nasal polyps. The 22 questions are used to calculate a total score (the sum of all items) and 4 subscale scores. The 22 questions are divided among 4 subscales: Rhinologic, Ear and Facial Symptoms, Sleep Function, and Psychological Issues subscales. The total score can range from 0-110, 0 being the best and 110 being the worst.~0: No problem~Very mild problem~Mild or slight problem~Moderate problem~Severe problem~Problem as bad as it can be"|units on a scale|Mean|41.9|41.9|Standard Deviation|23.27|23.27|||
3858525|NCT01623310|3684310|B1|||Previous sinus surgery for polyp removal or sinus surgery||Participants|Count of Participants|80|80.0||||||
3858526|NCT01623310|3684310|B1|||Previous polyp removal surgery via polypectomy only||Participants|Count of Participants|11|11.0||||||
3858527|NCT01623310|3684310|B1|||Use of ICS treatment for polyps in past 10 years||Participants|Count of Participants|214|214.0||||||
3858528|NCT01623310|3684310|B1|United States||Region of Enrollment||Participants|Count of Participants|223|223.0||||||
3858529|NCT01623310|3684310|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3858530|NCT01623310|3684310|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3858531|NCT01623310|3684310|B1|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|45|45.0||||||
3858532|NCT01623310|3684310|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|175|175.0||||||
3858533|NCT01623310|3684310|B1||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3858534|NCT01623310|3684310|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3858535|NCT01623310|3684310|B1|||Age||years|Mean|45.4|45.4|Standard Deviation|12.62|12.62|||
3858536|NCT01623271|3684319|B1|||Visual Analog Scale (VAS)|Pain score on a scale of 0-10|units on a scale|Mean|5.8|5.8|Full Range|||3.0|9.0|
3858537|NCT01623271|3684319|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3858538|NCT01623271|3684319|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3858539|NCT01623271|3684319|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3858540|NCT01623271|3684319|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3858541|NCT01623271|3684319|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3858542|NCT01623154|3684323|B1|United States||Region of Enrollment||Number of Participants|Number|95|95.0||||||
3858543|NCT01623154|3684323|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3858544|NCT01623154|3684323|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3858545|NCT01623154|3684323|B1|||Age||years|Mean|10.5|10.5|Full Range|||3.4|18.0|
3858546|NCT01623154|3684323|B1||>=65 years|Age|Must drink the entire content of test solution and receive initial BreathTek UBT of both the UBiT-IR300 and the POC One|Participants|Count of Participants|0|0.0||||||
3858547|NCT01623154|3684323|B1||Between 18 and 65 years|Age|Must drink the entire content of test solution and receive initial BreathTek UBT of both the UBiT-IR300 and the POC One|Participants|Count of Participants|0|0.0||||||
3858548|NCT01623154|3684323|B1||<=18 years|Age|Must drink the entire content of test solution and receive initial BreathTek UBT of both the UBiT-IR300 and the POC One|Participants|Count of Participants|95|95.0||||||
3858549|NCT01623115|3684329|B3|||Calculated LDL-C in mmol/L||mmol/L|Mean|3.746|3.746|Standard Deviation|1.287|1.287|||
3858550|NCT01623115|3684330|B2|||Calculated LDL-C in mmol/L||mmol/L|Mean|3.749|3.749|Standard Deviation|1.325|1.325|||
3858551|NCT01623115|3684331|B1|||Calculated LDL-C in mmol/L||mmol/L|Mean|3.739|3.739|Standard Deviation|1.213|1.213|||
3858552|NCT01623115|3684329|B3|||Calculated LDL-C in mg/dL|Calculated LDL-C from Friedewald formula (LDL cholesterol = Total cholesterol - HDL cholesterol - [Triglyceride/5]).|mg/dL|Mean|144.6|144.6|Standard Deviation|49.7|49.7|||
3858553|NCT01623115|3684330|B2|||Calculated LDL-C in mg/dL|Calculated LDL-C from Friedewald formula (LDL cholesterol = Total cholesterol - HDL cholesterol - [Triglyceride/5]).|mg/dL|Mean|144.8|144.8|Standard Deviation|51.1|51.1|||
3858554|NCT01623115|3684331|B1|||Calculated LDL-C in mg/dL|Calculated LDL-C from Friedewald formula (LDL cholesterol = Total cholesterol - HDL cholesterol - [Triglyceride/5]).|mg/dL|Mean|144.4|144.4|Standard Deviation|46.8|46.8|||
3858555|NCT01623115|3684329|B3||Male|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
3858556|NCT01623115|3684330|B2||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3858557|NCT01623115|3684331|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3858558|NCT01623115|3684329|B3||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
3858559|NCT01623115|3684330|B2||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3858560|NCT01623115|3684331|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3858561|NCT01623115|3684329|B3|||Age||years|Mean|51.9|51.9|Standard Deviation|12.7|12.7|||
3858562|NCT01623115|3684330|B2|||Age||years|Mean|52.1|52.1|Standard Deviation|12.9|12.9|||
3858563|NCT01623115|3684331|B1|||Age||years|Mean|51.7|51.7|Standard Deviation|12.3|12.3|||
3858564|NCT01623050|3684392|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3858566|NCT01623050|3684392|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3858567|NCT01623050|3684392|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3858568|NCT01623050|3684392|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3858569|NCT01623050|3684392|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3858570|NCT01623050|3684392|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3858571|NCT01623050|3684392|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3858572|NCT01623050|3684392|B1|||Age||years|Mean|45.1|45.1|Standard Deviation|16.1|16.1|||
3858573|NCT01622673|3684400|B7||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3858574|NCT01622673|3684401|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3858575|NCT01622673|3684402|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3858576|NCT01622673|3684403|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3858577|NCT01622673|3684404|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3858578|NCT01622673|3684405|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3858579|NCT01622673|3684406|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3858580|NCT01622673|3684400|B7||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3858581|NCT01622673|3684401|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3858582|NCT01622673|3684402|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3858583|NCT01622673|3684403|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3858584|NCT01622673|3684404|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3858585|NCT01622673|3684405|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3858586|NCT01622673|3684406|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3858587|NCT01622673|3684400|B7|||Age||years|Mean|41.3|41.3|Standard Deviation|10.7|10.7|||
3858588|NCT01622673|3684401|B6|||Age||years|Mean|40.8|40.8|Standard Deviation|11.6|11.6|||
3858589|NCT01622673|3684402|B5|||Age||years|Mean|39.8|39.8|Standard Deviation|11.8|11.8|||
3858590|NCT01622673|3684403|B4|||Age||years|Mean|40.3|40.3|Standard Deviation|10.3|10.3|||
3858591|NCT01622673|3684404|B3|||Age||years|Mean|36.8|36.8|Standard Deviation|15.4|15.4|||
3858592|NCT01622673|3684405|B2|||Age||years|Mean|46.6|46.6|Standard Deviation|9.5|9.5|||
3858593|NCT01622673|3684406|B1|||Age||years|Mean|42.5|42.5|Standard Deviation|10.4|10.4|||
3858594|NCT01622660|3684446|B1|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3858595|NCT01622660|3684446|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858596|NCT01622660|3684446|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858597|NCT01622660|3684446|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3858598|NCT01622660|3684446|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858599|NCT01622660|3684446|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858600|NCT01622660|3684446|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858601|NCT01622660|3684446|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858602|NCT01622660|3684446|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858603|NCT01622660|3684446|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3858604|NCT01622660|3684446|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3858605|NCT01622660|3684446|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3858606|NCT01622660|3684446|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3858607|NCT01622660|3684446|B1|||Age||years|Mean|70.5|70.5|Full Range|||60.0|81.0|
3858608|NCT01622660|3684446|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3858609|NCT01622660|3684446|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3858610|NCT01622660|3684446|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3858611|NCT01622569|3684450|B5|||Nasal Polyp Surgery Eligibility||Participants|Count of Participants|189|189.0||||||
3858612|NCT01622569|3684451|B4|||Nasal Polyp Surgery Eligibility||Participants|Count of Participants|47|47.0||||||
3858613|NCT01622569|3684452|B3|||Nasal Polyp Surgery Eligibility||Participants|Count of Participants|44|44.0||||||
3858614|NCT01622569|3684453|B2|||Nasal Polyp Surgery Eligibility||Participants|Count of Participants|45|45.0||||||
3858615|NCT01622569|3684454|B1|||Nasal Polyp Surgery Eligibility||Participants|Count of Participants|53|53.0||||||
3858616|NCT01622569|3684450|B5|||Peak Nasal Inspiratory Flow (PNIF)|The PNIF is an assessment of nasal passage obstruction and was measured using an In-Check portable nasal inspiratory flow meter. To measure PNIF, a mask was placed over the nose during inspiration and inspiratory flow was recorded. Each subject inhaled 3 times and each measurement was recorded. The PNIF value used was the greatest of the 3 results at each time point.|L/min|Mean|104.3|104.3|Full Range|||0.0|360.0|
3858617|NCT01622569|3684451|B4|||Peak Nasal Inspiratory Flow (PNIF)|The PNIF is an assessment of nasal passage obstruction and was measured using an In-Check portable nasal inspiratory flow meter. To measure PNIF, a mask was placed over the nose during inspiration and inspiratory flow was recorded. Each subject inhaled 3 times and each measurement was recorded. The PNIF value used was the greatest of the 3 results at each time point.|L/min|Mean|103.2|103.2|Full Range|||25.0|340.0|
3858673|NCT01622569|3684452|B3|||Previous sinus surgery for polyp removal or sinus surgery|Patients may have had both sinus surgery and polypectomy.|Participants|Count of Participants|27|27.0||||||
3858676|NCT01622569|3684450|B5|||Use of intranasal corticosteroid (ICS) treatment for polyps in past 10 years||Participants|Count of Participants|305|305.0||||||
3858618|NCT01622569|3684452|B3|||Peak Nasal Inspiratory Flow (PNIF)|The PNIF is an assessment of nasal passage obstruction and was measured using an In-Check portable nasal inspiratory flow meter. To measure PNIF, a mask was placed over the nose during inspiration and inspiratory flow was recorded. Each subject inhaled 3 times and each measurement was recorded. The PNIF value used was the greatest of the 3 results at each time point.|L/min|Mean|97.1|97.1|Full Range|||30.0|350.0|
3858619|NCT01622569|3684453|B2|||Peak Nasal Inspiratory Flow (PNIF)|The PNIF is an assessment of nasal passage obstruction and was measured using an In-Check portable nasal inspiratory flow meter. To measure PNIF, a mask was placed over the nose during inspiration and inspiratory flow was recorded. Each subject inhaled 3 times and each measurement was recorded. The PNIF value used was the greatest of the 3 results at each time point.|L/min|Mean|111.6|111.6|Full Range|||0.0|360.0|
3858620|NCT01622569|3684454|B1|||Peak Nasal Inspiratory Flow (PNIF)|The PNIF is an assessment of nasal passage obstruction and was measured using an In-Check portable nasal inspiratory flow meter. To measure PNIF, a mask was placed over the nose during inspiration and inspiratory flow was recorded. Each subject inhaled 3 times and each measurement was recorded. The PNIF value used was the greatest of the 3 results at each time point.|L/min|Mean|105.1|105.1|Full Range|||30.0|350.0|
3858621|NCT01622569|3684450|B5|||Short Form (36) Health Survey Version 2 (SF-36v2) - Physical Component|The SF-36v2 is a multipurpose, scaled, 36-item, subject-completed validated questionnaire that measures 8 domains of health: limitations in physical activities, limitations in social activities, limitations in usual role activities, bodily pain, general mental health, limitations in usual role activities, vitality, and general health perceptions. It yields scale scores for each of the 8 health domains, and 2 summary measures of physical and mental health. Each scale range is from 0-100. A lower score means more disability and a higher score means less disability.|units on a scale|Mean|44|44.0|Full Range|||22.58|60.91|
3858622|NCT01622569|3684451|B4|||Short Form (36) Health Survey Version 2 (SF-36v2) - Physical Component|The SF-36v2 is a multipurpose, scaled, 36-item, subject-completed validated questionnaire that measures 8 domains of health: limitations in physical activities, limitations in social activities, limitations in usual role activities, bodily pain, general mental health, limitations in usual role activities, vitality, and general health perceptions. It yields scale scores for each of the 8 health domains, and 2 summary measures of physical and mental health. Each scale range is from 0-100. A lower score means more disability and a higher score means less disability.|units on a scale|Mean|43.9|43.9|Full Range|||22.58|59.26|
3858623|NCT01622569|3684452|B3|||Short Form (36) Health Survey Version 2 (SF-36v2) - Physical Component|The SF-36v2 is a multipurpose, scaled, 36-item, subject-completed validated questionnaire that measures 8 domains of health: limitations in physical activities, limitations in social activities, limitations in usual role activities, bodily pain, general mental health, limitations in usual role activities, vitality, and general health perceptions. It yields scale scores for each of the 8 health domains, and 2 summary measures of physical and mental health. Each scale range is from 0-100. A lower score means more disability and a higher score means less disability.|units on a scale|Mean|43.9|43.9|Full Range|||28.36|60.91|
3858624|NCT01622569|3684453|B2|||Short Form (36) Health Survey Version 2 (SF-36v2) - Physical Component|The SF-36v2 is a multipurpose, scaled, 36-item, subject-completed validated questionnaire that measures 8 domains of health: limitations in physical activities, limitations in social activities, limitations in usual role activities, bodily pain, general mental health, limitations in usual role activities, vitality, and general health perceptions. It yields scale scores for each of the 8 health domains, and 2 summary measures of physical and mental health. Each scale range is from 0-100. A lower score means more disability and a higher score means less disability.|units on a scale|Mean|44.7|44.7|Full Range|||28.01|60.58|
3858625|NCT01622569|3684454|B1|||Short Form (36) Health Survey Version 2 (SF-36v2) - Physical Component|The SF-36v2 is a multipurpose, scaled, 36-item, subject-completed validated questionnaire that measures 8 domains of health: limitations in physical activities, limitations in social activities, limitations in usual role activities, bodily pain, general mental health, limitations in usual role activities, vitality, and general health perceptions. It yields scale scores for each of the 8 health domains, and 2 summary measures of physical and mental health. Each scale range is from 0-100. A lower score means more disability and a higher score means less disability.|units on a scale|Mean|43.5|43.5|Full Range|||27.75|57.53|
3858626|NCT01622569|3684450|B5|||Short Form (36) Health Survey Version 2 (SF-36v2) - Mental Component|The SF-36v2 is a multipurpose, scaled, 36-item, subject-completed validated questionnaire that measures 8 domains of health: limitations in physical activities, limitations in social activities, limitations in usual role activities, bodily pain, general mental health, limitations in usual role activities, vitality, and general health. It yields scale scores for each of the 8 health domains, and 2 summary measures of physical and mental health. Each scale range is from 0-100. A lower score means more disability and a higher score means less disability.|units on a scale|Mean|47.6|47.6|Full Range|||15.26|63.99|
3858627|NCT01622569|3684451|B4|||Short Form (36) Health Survey Version 2 (SF-36v2) - Mental Component|The SF-36v2 is a multipurpose, scaled, 36-item, subject-completed validated questionnaire that measures 8 domains of health: limitations in physical activities, limitations in social activities, limitations in usual role activities, bodily pain, general mental health, limitations in usual role activities, vitality, and general health. It yields scale scores for each of the 8 health domains, and 2 summary measures of physical and mental health. Each scale range is from 0-100. A lower score means more disability and a higher score means less disability.|units on a scale|Mean|47.8|47.8|Full Range|||15.26|62.61|
3858628|NCT01622569|3684452|B3|||Short Form (36) Health Survey Version 2 (SF-36v2) - Mental Component|The SF-36v2 is a multipurpose, scaled, 36-item, subject-completed validated questionnaire that measures 8 domains of health: limitations in physical activities, limitations in social activities, limitations in usual role activities, bodily pain, general mental health, limitations in usual role activities, vitality, and general health. It yields scale scores for each of the 8 health domains, and 2 summary measures of physical and mental health. Each scale range is from 0-100. A lower score means more disability and a higher score means less disability.|units on a scale|Mean|46.0|46.0|Full Range|||18.06|58.7|
3858674|NCT01622569|3684453|B2|||Previous sinus surgery for polyp removal or sinus surgery|Patients may have had both sinus surgery and polypectomy.|Participants|Count of Participants|34|34.0||||||
3858675|NCT01622569|3684454|B1|||Previous sinus surgery for polyp removal or sinus surgery|Patients may have had both sinus surgery and polypectomy.|Participants|Count of Participants|33|33.0||||||
3858629|NCT01622569|3684453|B2|||Short Form (36) Health Survey Version 2 (SF-36v2) - Mental Component|The SF-36v2 is a multipurpose, scaled, 36-item, subject-completed validated questionnaire that measures 8 domains of health: limitations in physical activities, limitations in social activities, limitations in usual role activities, bodily pain, general mental health, limitations in usual role activities, vitality, and general health. It yields scale scores for each of the 8 health domains, and 2 summary measures of physical and mental health. Each scale range is from 0-100. A lower score means more disability and a higher score means less disability.|units on a scale|Mean|49.0|49.0|Full Range|||22.18|63.08|
3858630|NCT01622569|3684454|B1|||Short Form (36) Health Survey Version 2 (SF-36v2) - Mental Component|The SF-36v2 is a multipurpose, scaled, 36-item, subject-completed validated questionnaire that measures 8 domains of health: limitations in physical activities, limitations in social activities, limitations in usual role activities, bodily pain, general mental health, limitations in usual role activities, vitality, and general health. It yields scale scores for each of the 8 health domains, and 2 summary measures of physical and mental health. Each scale range is from 0-100. A lower score means more disability and a higher score means less disability.|units on a scale|Mean|47.6|47.6|Full Range|||23.66|63.99|
3858631|NCT01622569|3684450|B5|||Rhinosinusitis Disability Index (RSDI) Total Score|The RSDI is a subject-completed instrument that evaluates the self-perceived impact of disease specific head and neck disorders. The RSDI has 30 items in 3 domains: Physical (11 items), Functional (9 items), and Emotional (10 items). The RSDI scale ranges from 0-120, 0 being better quality of life and less impact of CRS on daily function and 120 being worse quality of life and more impact of CRS on daily function.|units on a scale|Mean|44.69|44.69|Full Range|||2.0|120.0|
3858632|NCT01622569|3684451|B4|||Rhinosinusitis Disability Index (RSDI) Total Score|The RSDI is a subject-completed instrument that evaluates the self-perceived impact of disease specific head and neck disorders. The RSDI has 30 items in 3 domains: Physical (11 items), Functional (9 items), and Emotional (10 items). The RSDI scale ranges from 0-120, 0 being better quality of life and less impact of CRS on daily function and 120 being worse quality of life and more impact of CRS on daily function.|units on a scale|Mean|45.4|45.4|Full Range|||5.0|117.0|
3858633|NCT01622569|3684452|B3|||Rhinosinusitis Disability Index (RSDI) Total Score|The RSDI is a subject-completed instrument that evaluates the self-perceived impact of disease specific head and neck disorders. The RSDI has 30 items in 3 domains: Physical (11 items), Functional (9 items), and Emotional (10 items). The RSDI scale ranges from 0-120, 0 being better quality of life and less impact of CRS on daily function and 120 being worse quality of life and more impact of CRS on daily function.|units on a scale|Mean|45.2|45.2|Full Range|||3.0|91.0|
3858634|NCT01622569|3684453|B2|||Rhinosinusitis Disability Index (RSDI) Total Score|The RSDI is a subject-completed instrument that evaluates the self-perceived impact of disease specific head and neck disorders. The RSDI has 30 items in 3 domains: Physical (11 items), Functional (9 items), and Emotional (10 items). The RSDI scale ranges from 0-120, 0 being better quality of life and less impact of CRS on daily function and 120 being worse quality of life and more impact of CRS on daily function.|units on a scale|Mean|39.8|39.8|Full Range|||2.0|96.0|
3858635|NCT01622569|3684454|B1|||Rhinosinusitis Disability Index (RSDI) Total Score|The RSDI is a subject-completed instrument that evaluates the self-perceived impact of disease specific head and neck disorders. The RSDI has 30 items in 3 domains: Physical (11 items), Functional (9 items), and Emotional (10 items). The RSDI scale ranges from 0-120, 0 being better quality of life and less impact of CRS on daily function and 120 being worse quality of life and more impact of CRS on daily function.|units on a scale|Mean|48.3|48.3|Full Range|||2.0|120.0|
3858636|NCT01622569|3684450|B5|||Medical Outcomes Study Sleep Scale Revised (MOS Sleep-R)|The MOS Sleep-R is a brief, self-administered, validated questionnaire designed to measure key aspects of sleep, such as disturbance, adequacy, somnolence, and quantity. The 12-item version with a 4-week recall was used in this study. The score range for the 12-item version is 0 to 100, lower scores indicating better sleep and higher scores indicating worse sleep. The scale yields a Sleep Problem Index and scores on the following 6 subscales: Sleep Disturbance, Snoring, Shortness of Breath or Headache, Sleep Adequacy, Sleep Somnolence, and Sleep Quantity.|units on a scale|Mean|42.71|42.71|Full Range|||2.8|97.2|
3858637|NCT01622569|3684451|B4|||Medical Outcomes Study Sleep Scale Revised (MOS Sleep-R)|The MOS Sleep-R is a brief, self-administered, validated questionnaire designed to measure key aspects of sleep, such as disturbance, adequacy, somnolence, and quantity. The 12-item version with a 4-week recall was used in this study. The score range for the 12-item version is 0 to 100, lower scores indicating better sleep and higher scores indicating worse sleep. The scale yields a Sleep Problem Index and scores on the following 6 subscales: Sleep Disturbance, Snoring, Shortness of Breath or Headache, Sleep Adequacy, Sleep Somnolence, and Sleep Quantity.|units on a scale|Mean|43.7|43.7|Full Range|||11.1|88.9|
3858638|NCT01622569|3684452|B3|||Medical Outcomes Study Sleep Scale Revised (MOS Sleep-R)|The MOS Sleep-R is a brief, self-administered, validated questionnaire designed to measure key aspects of sleep, such as disturbance, adequacy, somnolence, and quantity. The 12-item version with a 4-week recall was used in this study. The score range for the 12-item version is 0 to 100, lower scores indicating better sleep and higher scores indicating worse sleep. The scale yields a Sleep Problem Index and scores on the following 6 subscales: Sleep Disturbance, Snoring, Shortness of Breath or Headache, Sleep Adequacy, Sleep Somnolence, and Sleep Quantity.|units on a scale|Mean|46.6|46.6|Full Range|||11.1|91.7|
3858639|NCT01622569|3684453|B2|||Medical Outcomes Study Sleep Scale Revised (MOS Sleep-R)|The MOS Sleep-R is a brief, self-administered, validated questionnaire designed to measure key aspects of sleep, such as disturbance, adequacy, somnolence, and quantity. The 12-item version with a 4-week recall was used in this study. The score range for the 12-item version is 0 to 100, lower scores indicating better sleep and higher scores indicating worse sleep. The scale yields a Sleep Problem Index and scores on the following 6 subscales: Sleep Disturbance, Snoring, Shortness of Breath or Headache, Sleep Adequacy, Sleep Somnolence, and Sleep Quantity.|units on a scale|Mean|37.8|37.8|Full Range|||2.8|77.8|
3858652|NCT01622569|3684451|B4|||Facial Pain or Pressure Score (7-day instantaneous morning)|"Subjects reported nasal symptoms using the electronic diary twice daily immediately before dosing.~0: None~Mild - Symptoms clearly present, but minimal awareness, and easily tolerated~Moderate - Definite awareness of symptoms that is bothersome but tolerable~Severe - Symptoms that are hard to tolerate, cause interference with activities or daily living"|units on a scale|Mean|1.62|1.62|Full Range|||0.0|3.0|
3858774|NCT01622348|3684527|B1|||Age||years|Mean|37.5|37.5|Standard Deviation|13.76|13.76|||
3858640|NCT01622569|3684454|B1|||Medical Outcomes Study Sleep Scale Revised (MOS Sleep-R)|The MOS Sleep-R is a brief, self-administered, validated questionnaire designed to measure key aspects of sleep, such as disturbance, adequacy, somnolence, and quantity. The 12-item version with a 4-week recall was used in this study. The score range for the 12-item version is 0 to 100, lower scores indicating better sleep and higher scores indicating worse sleep. The scale yields a Sleep Problem Index and scores on the following 6 subscales: Sleep Disturbance, Snoring, Shortness of Breath or Headache, Sleep Adequacy, Sleep Somnolence, and Sleep Quantity.|units on a scale|Mean|42.8|42.8|Full Range|||5.6|97.2|
3858641|NCT01622569|3684450|B5|||Sinonasal Outcome Test 22 (SNOT-22) Total Score|"SNOT-22 is a subject-completed questionnaire that consists of 22 questions. The questions on the SNOT-22 efficacy evaluation were used to calculate a total score. 22 questions are divided among 4 subscales: Rhinologic (7 questions), Ear/Facial Symptoms (4 questions), Sleep Function (3 questions), and Psychological Issues (6 questions). Each item was rated on the 5-point scale. The total score can range from 0-110, 0 being the best and 110 being the worst.~0: No problem~Very mild problem~Mild or slight problem~Moderate problem~Severe problem~Problem as bad as can be"|units on a scale|Mean|51|51.0|Full Range|||0.0|108.0|
3858642|NCT01622569|3684451|B4|||Sinonasal Outcome Test 22 (SNOT-22) Total Score|"SNOT-22 is a subject-completed questionnaire that consists of 22 questions. The questions on the SNOT-22 efficacy evaluation were used to calculate a total score. 22 questions are divided among 4 subscales: Rhinologic (7 questions), Ear/Facial Symptoms (4 questions), Sleep Function (3 questions), and Psychological Issues (6 questions). Each item was rated on the 5-point scale. The total score can range from 0-110, 0 being the best and 110 being the worst.~0: No problem~Very mild problem~Mild or slight problem~Moderate problem~Severe problem~Problem as bad as can be"|units on a scale|Mean|52.4|52.4|Full Range|||6.0|103.0|
3858643|NCT01622569|3684452|B3|||Sinonasal Outcome Test 22 (SNOT-22) Total Score|"SNOT-22 is a subject-completed questionnaire that consists of 22 questions. The questions on the SNOT-22 efficacy evaluation were used to calculate a total score. 22 questions are divided among 4 subscales: Rhinologic (7 questions), Ear/Facial Symptoms (4 questions), Sleep Function (3 questions), and Psychological Issues (6 questions). Each item was rated on the 5-point scale. The total score can range from 0-110, 0 being the best and 110 being the worst.~0: No problem~Very mild problem~Mild or slight problem~Moderate problem~Severe problem~Problem as bad as can be"|units on a scale|Mean|51.8|51.8|Full Range|||0.0|108.0|
3858644|NCT01622569|3684453|B2|||Sinonasal Outcome Test 22 (SNOT-22) Total Score|"SNOT-22 is a subject-completed questionnaire that consists of 22 questions. The questions on the SNOT-22 efficacy evaluation were used to calculate a total score. 22 questions are divided among 4 subscales: Rhinologic (7 questions), Ear/Facial Symptoms (4 questions), Sleep Function (3 questions), and Psychological Issues (6 questions). Each item was rated on the 5-point scale. The total score can range from 0-110, 0 being the best and 110 being the worst.~0: No problem~Very mild problem~Mild or slight problem~Moderate problem~Severe problem~Problem as bad as can be"|units on a scale|Mean|46.1|46.1|Full Range|||14.0|95.0|
3858645|NCT01622569|3684454|B1|||Sinonasal Outcome Test 22 (SNOT-22) Total Score|"SNOT-22 is a subject-completed questionnaire that consists of 22 questions. The questions on the SNOT-22 efficacy evaluation were used to calculate a total score. 22 questions are divided among 4 subscales: Rhinologic (7 questions), Ear/Facial Symptoms (4 questions), Sleep Function (3 questions), and Psychological Issues (6 questions). Each item was rated on the 5-point scale. The total score can range from 0-110, 0 being the best and 110 being the worst.~0: No problem~Very mild problem~Mild or slight problem~Moderate problem~Severe problem~Problem as bad as can be"|units on a scale|Mean|53.7|53.7|Full Range|||14.0|95.0|
3858646|NCT01622569|3684450|B5|||Hyposomia Score (7-day instantaneous morning)|"Subjects reported nasal symptoms using the electronic diary twice daily immediately before dosing.~0: None~Mild - Symptoms clearly present, but minimal awareness, and easily tolerated~Moderate - Definite awareness of symptoms that is bothersome but tolerable~Severe - Symptoms that are hard to tolerate, cause interference with activities or daily living"|units on a scale|Mean|2.41|2.41|Full Range|||0.0|3.0|
3858647|NCT01622569|3684451|B4|||Hyposomia Score (7-day instantaneous morning)|"Subjects reported nasal symptoms using the electronic diary twice daily immediately before dosing.~0: None~Mild - Symptoms clearly present, but minimal awareness, and easily tolerated~Moderate - Definite awareness of symptoms that is bothersome but tolerable~Severe - Symptoms that are hard to tolerate, cause interference with activities or daily living"|units on a scale|Mean|2.44|2.44|Full Range|||0.0|3.0|
3858648|NCT01622569|3684452|B3|||Hyposomia Score (7-day instantaneous morning)|"Subjects reported nasal symptoms using the electronic diary twice daily immediately before dosing.~0: None~Mild - Symptoms clearly present, but minimal awareness, and easily tolerated~Moderate - Definite awareness of symptoms that is bothersome but tolerable~Severe - Symptoms that are hard to tolerate, cause interference with activities or daily living"|units on a scale|Mean|2.49|2.49|Full Range|||0.0|3.0|
3858649|NCT01622569|3684453|B2|||Hyposomia Score (7-day instantaneous morning)|"Subjects reported nasal symptoms using the electronic diary twice daily immediately before dosing.~0: None~Mild - Symptoms clearly present, but minimal awareness, and easily tolerated~Moderate - Definite awareness of symptoms that is bothersome but tolerable~Severe - Symptoms that are hard to tolerate, cause interference with activities or daily living"|units on a scale|Mean|2.31|2.31|Full Range|||0.0|3.0|
3858650|NCT01622569|3684454|B1|||Hyposomia Score (7-day instantaneous morning)|"Subjects reported nasal symptoms using the electronic diary twice daily immediately before dosing.~0: None~Mild - Symptoms clearly present, but minimal awareness, and easily tolerated~Moderate - Definite awareness of symptoms that is bothersome but tolerable~Severe - Symptoms that are hard to tolerate, cause interference with activities or daily living"|units on a scale|Mean|2.42|2.42|Full Range|||0.0|3.0|
3858651|NCT01622569|3684450|B5|||Facial Pain or Pressure Score (7-day instantaneous morning)|"Subjects reported nasal symptoms using the electronic diary twice daily immediately before dosing.~0: None~Mild - Symptoms clearly present, but minimal awareness, and easily tolerated~Moderate - Definite awareness of symptoms that is bothersome but tolerable~Severe - Symptoms that are hard to tolerate, cause interference with activities or daily living"|units on a scale|Mean|1.57|1.57|Full Range|||0.0|3.0|
3858671|NCT01622569|3684450|B5|||Previous sinus surgery for polyp removal or sinus surgery|Patients may have had both sinus surgery and polypectomy.|Participants|Count of Participants|124|124.0||||||
3858672|NCT01622569|3684451|B4|||Previous sinus surgery for polyp removal or sinus surgery|Patients may have had both sinus surgery and polypectomy.|Participants|Count of Participants|30|30.0||||||
3858653|NCT01622569|3684452|B3|||Facial Pain or Pressure Score (7-day instantaneous morning)|"Subjects reported nasal symptoms using the electronic diary twice daily immediately before dosing.~0: None~Mild - Symptoms clearly present, but minimal awareness, and easily tolerated~Moderate - Definite awareness of symptoms that is bothersome but tolerable~Severe - Symptoms that are hard to tolerate, cause interference with activities or daily living"|units on a scale|Mean|1.48|1.48|Full Range|||0.0|3.0|
3858654|NCT01622569|3684453|B2|||Facial Pain or Pressure Score (7-day instantaneous morning)|"Subjects reported nasal symptoms using the electronic diary twice daily immediately before dosing.~0: None~Mild - Symptoms clearly present, but minimal awareness, and easily tolerated~Moderate - Definite awareness of symptoms that is bothersome but tolerable~Severe - Symptoms that are hard to tolerate, cause interference with activities or daily living"|units on a scale|Mean|1.53|1.53|Full Range|||0.0|3.0|
3858655|NCT01622569|3684454|B1|||Facial Pain or Pressure Score (7-day instantaneous morning)|"Subjects reported nasal symptoms using the electronic diary twice daily immediately before dosing.~0: None~Mild - Symptoms clearly present, but minimal awareness, and easily tolerated~Moderate - Definite awareness of symptoms that is bothersome but tolerable~Severe - Symptoms that are hard to tolerate, cause interference with activities or daily living"|units on a scale|Mean|1.65|1.65|Full Range|||0.0|3.0|
3858656|NCT01622569|3684450|B5|||Rhinorrhea Score (7-day instantaneous morning)|"Subjects reported nasal symptoms using the electronic diary twice daily immediately before dosing.~0: None~Mild - symptoms clearly present, but minimal awareness, and easily tolerated~Moderate - definite awareness of symptoms that is bothersome but tolerable~Severe - symptoms that are hard to tolerate, cause interference with activities or daily living"|units on a scale|Mean|1.76|1.76|Full Range|||0.0|3.0|
3858657|NCT01622569|3684451|B4|||Rhinorrhea Score (7-day instantaneous morning)|"Subjects reported nasal symptoms using the electronic diary twice daily immediately before dosing.~0: None~Mild - symptoms clearly present, but minimal awareness, and easily tolerated~Moderate - definite awareness of symptoms that is bothersome but tolerable~Severe - symptoms that are hard to tolerate, cause interference with activities or daily living"|units on a scale|Mean|1.83|1.83|Full Range|||0.0|3.0|
3858658|NCT01622569|3684452|B3|||Rhinorrhea Score (7-day instantaneous morning)|"Subjects reported nasal symptoms using the electronic diary twice daily immediately before dosing.~0: None~Mild - symptoms clearly present, but minimal awareness, and easily tolerated~Moderate - definite awareness of symptoms that is bothersome but tolerable~Severe - symptoms that are hard to tolerate, cause interference with activities or daily living"|units on a scale|Mean|1.75|1.75|Full Range|||0.0|3.0|
3858659|NCT01622569|3684453|B2|||Rhinorrhea Score (7-day instantaneous morning)|"Subjects reported nasal symptoms using the electronic diary twice daily immediately before dosing.~0: None~Mild - symptoms clearly present, but minimal awareness, and easily tolerated~Moderate - definite awareness of symptoms that is bothersome but tolerable~Severe - symptoms that are hard to tolerate, cause interference with activities or daily living"|units on a scale|Mean|1.67|1.67|Full Range|||0.0|3.0|
3858660|NCT01622569|3684454|B1|||Rhinorrhea Score (7-day instantaneous morning)|"Subjects reported nasal symptoms using the electronic diary twice daily immediately before dosing.~0: None~Mild - symptoms clearly present, but minimal awareness, and easily tolerated~Moderate - definite awareness of symptoms that is bothersome but tolerable~Severe - symptoms that are hard to tolerate, cause interference with activities or daily living"|units on a scale|Mean|1.81|1.81|Full Range|||0.0|3.0|
3858661|NCT01622569|3684450|B5|||Nasal Congestion/Obstruction Score (7-Day Instantaneous Morning)|"Subjects reported nasal symptoms using the electronic diary twice daily immediately before dosing.~0: None~Mild - symptoms clearly present, but minimal awareness, and easily tolerated~Moderate - definite awareness of symptoms that is bothersome but tolerable~Severe - symptoms that are hard to tolerate, cause interference with activities or daily living"|units on a scale|Mean|2.27|2.27|Full Range|||0.8|3.0|
3858662|NCT01622569|3684451|B4|||Nasal Congestion/Obstruction Score (7-Day Instantaneous Morning)|"Subjects reported nasal symptoms using the electronic diary twice daily immediately before dosing.~0: None~Mild - symptoms clearly present, but minimal awareness, and easily tolerated~Moderate - definite awareness of symptoms that is bothersome but tolerable~Severe - symptoms that are hard to tolerate, cause interference with activities or daily living"|units on a scale|Mean|2.29|2.29|Full Range|||1.7|3.0|
3858663|NCT01622569|3684452|B3|||Nasal Congestion/Obstruction Score (7-Day Instantaneous Morning)|"Subjects reported nasal symptoms using the electronic diary twice daily immediately before dosing.~0: None~Mild - symptoms clearly present, but minimal awareness, and easily tolerated~Moderate - definite awareness of symptoms that is bothersome but tolerable~Severe - symptoms that are hard to tolerate, cause interference with activities or daily living"|units on a scale|Mean|2.24|2.24|Full Range|||1.6|3.0|
3858664|NCT01622569|3684453|B2|||Nasal Congestion/Obstruction Score (7-Day Instantaneous Morning)|"Subjects reported nasal symptoms using the electronic diary twice daily immediately before dosing.~0: None~Mild - symptoms clearly present, but minimal awareness, and easily tolerated~Moderate - definite awareness of symptoms that is bothersome but tolerable~Severe - symptoms that are hard to tolerate, cause interference with activities or daily living"|units on a scale|Mean|2.22|2.22|Full Range|||0.8|3.0|
3858665|NCT01622569|3684454|B1|||Nasal Congestion/Obstruction Score (7-Day Instantaneous Morning)|"Subjects reported nasal symptoms using the electronic diary twice daily immediately before dosing.~0: None~Mild - symptoms clearly present, but minimal awareness, and easily tolerated~Moderate - definite awareness of symptoms that is bothersome but tolerable~Severe - symptoms that are hard to tolerate, cause interference with activities or daily living"|units on a scale|Mean|2.31|2.31|Full Range|||1.7|3.0|
3858666|NCT01622569|3684450|B5|||Previous polyp removal surgery via polypectomy only|Patients may have had both sinus surgery and polypectomy.|Participants|Count of Participants|120|120.0||||||
3858667|NCT01622569|3684451|B4|||Previous polyp removal surgery via polypectomy only|Patients may have had both sinus surgery and polypectomy.|Participants|Count of Participants|27|27.0||||||
3858668|NCT01622569|3684452|B3|||Previous polyp removal surgery via polypectomy only|Patients may have had both sinus surgery and polypectomy.|Participants|Count of Participants|33|33.0||||||
3858669|NCT01622569|3684453|B2|||Previous polyp removal surgery via polypectomy only|Patients may have had both sinus surgery and polypectomy.|Participants|Count of Participants|27|27.0||||||
3858670|NCT01622569|3684454|B1|||Previous polyp removal surgery via polypectomy only|Patients may have had both sinus surgery and polypectomy.|Participants|Count of Participants|33|33.0||||||
3858677|NCT01622569|3684451|B4|||Use of intranasal corticosteroid (ICS) treatment for polyps in past 10 years||Participants|Count of Participants|75|75.0||||||
3858678|NCT01622569|3684452|B3|||Use of intranasal corticosteroid (ICS) treatment for polyps in past 10 years||Participants|Count of Participants|76|76.0||||||
3858679|NCT01622569|3684453|B2|||Use of intranasal corticosteroid (ICS) treatment for polyps in past 10 years||Participants|Count of Participants|77|77.0||||||
3858680|NCT01622569|3684454|B1|||Use of intranasal corticosteroid (ICS) treatment for polyps in past 10 years||Participants|Count of Participants|77|77.0||||||
3858681|NCT01622569|3684450|B5|||Total Polyp Grading Score (sum of scores from both nasal cavities)|"Polyp grading of each nasal cavity was determined by a nasal polyp grading scale score measured by nasoendoscopy.~0: No polyps~Mild polyposis: polyps not reaching below the inferior border of the middle turbinate~Moderate polyposis: polyps reaching below the inferior border of the middle concha, but not the inferior border of the inferior turbinate~Severe polyposis large polyps reaching below the lower inferior border of the inferior turbinate"|Units on a Scale|Mean|3.75|3.75|Full Range|||2.0|6.0|
3858682|NCT01622569|3684451|B4|||Total Polyp Grading Score (sum of scores from both nasal cavities)|"Polyp grading of each nasal cavity was determined by a nasal polyp grading scale score measured by nasoendoscopy.~0: No polyps~Mild polyposis: polyps not reaching below the inferior border of the middle turbinate~Moderate polyposis: polyps reaching below the inferior border of the middle concha, but not the inferior border of the inferior turbinate~Severe polyposis large polyps reaching below the lower inferior border of the inferior turbinate"|Units on a Scale|Mean|3.7|3.7|Full Range|||2.0|6.0|
3858683|NCT01622569|3684452|B3|||Total Polyp Grading Score (sum of scores from both nasal cavities)|"Polyp grading of each nasal cavity was determined by a nasal polyp grading scale score measured by nasoendoscopy.~0: No polyps~Mild polyposis: polyps not reaching below the inferior border of the middle turbinate~Moderate polyposis: polyps reaching below the inferior border of the middle concha, but not the inferior border of the inferior turbinate~Severe polyposis large polyps reaching below the lower inferior border of the inferior turbinate"|Units on a Scale|Mean|3.9|3.9|Full Range|||2.0|6.0|
3858684|NCT01622569|3684453|B2|||Total Polyp Grading Score (sum of scores from both nasal cavities)|"Polyp grading of each nasal cavity was determined by a nasal polyp grading scale score measured by nasoendoscopy.~0: No polyps~Mild polyposis: polyps not reaching below the inferior border of the middle turbinate~Moderate polyposis: polyps reaching below the inferior border of the middle concha, but not the inferior border of the inferior turbinate~Severe polyposis large polyps reaching below the lower inferior border of the inferior turbinate"|Units on a Scale|Mean|3.6|3.6|Full Range|||2.0|6.0|
3858685|NCT01622569|3684454|B1|||Total Polyp Grading Score (sum of scores from both nasal cavities)|"Polyp grading of each nasal cavity was determined by a nasal polyp grading scale score measured by nasoendoscopy.~0: No polyps~Mild polyposis: polyps not reaching below the inferior border of the middle turbinate~Moderate polyposis: polyps reaching below the inferior border of the middle concha, but not the inferior border of the inferior turbinate~Severe polyposis large polyps reaching below the lower inferior border of the inferior turbinate"|Units on a Scale|Mean|3.8|3.8|Full Range|||2.0|6.0|
3858686|NCT01622569|3684450|B5|South Africa||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3858687|NCT01622569|3684451|B4|South Africa||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3858688|NCT01622569|3684452|B3|South Africa||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3858689|NCT01622569|3684453|B2|South Africa||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3858690|NCT01622569|3684454|B1|South Africa||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3858691|NCT01622569|3684450|B5|United States||Region of Enrollment||Participants|Count of Participants|143|143.0||||||
3858692|NCT01622569|3684451|B4|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3858693|NCT01622569|3684452|B3|United States||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3858694|NCT01622569|3684453|B2|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3858695|NCT01622569|3684454|B1|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3858696|NCT01622569|3684450|B5|Ukraine||Region of Enrollment||Participants|Count of Participants|65|65.0||||||
3858697|NCT01622569|3684451|B4|Ukraine||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3858698|NCT01622569|3684452|B3|Ukraine||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3858699|NCT01622569|3684453|B2|Ukraine||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3858700|NCT01622569|3684454|B1|Ukraine||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3858701|NCT01622569|3684450|B5|United Kingdom||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3858702|NCT01622569|3684451|B4|United Kingdom||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3858703|NCT01622569|3684452|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3858704|NCT01622569|3684453|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3858705|NCT01622569|3684454|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3858706|NCT01622569|3684450|B5|Czechia||Region of Enrollment||Participants|Count of Participants|56|56.0||||||
3858707|NCT01622569|3684451|B4|Czechia||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3858708|NCT01622569|3684452|B3|Czechia||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3858709|NCT01622569|3684453|B2|Czechia||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3858710|NCT01622569|3684454|B1|Czechia||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3858711|NCT01622569|3684450|B5|Canada||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3858712|NCT01622569|3684451|B4|Canada||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3858713|NCT01622569|3684452|B3|Canada||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3858714|NCT01622569|3684453|B2|Canada||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3858715|NCT01622569|3684454|B1|Canada||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3858716|NCT01622569|3684450|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3858717|NCT01622569|3684451|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3858718|NCT01622569|3684452|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3858719|NCT01622569|3684453|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3858720|NCT01622569|3684454|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3858721|NCT01622569|3684450|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3858722|NCT01622569|3684451|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3858723|NCT01622569|3684452|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3858724|NCT01622569|3684453|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3858725|NCT01622569|3684454|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3858726|NCT01622569|3684450|B5|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3858727|NCT01622569|3684451|B4|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3858728|NCT01622569|3684452|B3|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3858729|NCT01622569|3684453|B2|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3858730|NCT01622569|3684454|B1|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3858731|NCT01622569|3684450|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|283|283.0||||||
3858732|NCT01622569|3684451|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|69|69.0||||||
3858733|NCT01622569|3684452|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|72|72.0||||||
3858734|NCT01622569|3684453|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|74|74.0||||||
3858735|NCT01622569|3684454|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|68|68.0||||||
3858736|NCT01622569|3684450|B5||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3858737|NCT01622569|3684451|B4||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3858738|NCT01622569|3684452|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3858739|NCT01622569|3684453|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3858740|NCT01622569|3684454|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3858741|NCT01622569|3684450|B5||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3858742|NCT01622569|3684451|B4||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3858743|NCT01622569|3684452|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3858744|NCT01622569|3684453|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3858745|NCT01622569|3684454|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3858746|NCT01622569|3684450|B5|||Age||years|Mean|45.1|45.1|Standard Deviation|12.7|12.7|||
3858747|NCT01622569|3684451|B4|||Age||years|Mean|43.9|43.9|Standard Deviation|12.6|12.6|||
3858748|NCT01622569|3684452|B3|||Age||years|Mean|46.4|46.4|Standard Deviation|12.7|12.7|||
3858749|NCT01622569|3684453|B2|||Age||years|Mean|44.9|44.9|Standard Deviation|12.7|12.7|||
3858750|NCT01622569|3684454|B1|||Age||years|Mean|45.3|45.3|Standard Deviation|13.0|13.0|||
3858751|NCT01622348|3684524|B4|United States||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3858752|NCT01622348|3684525|B3|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3858753|NCT01622348|3684526|B2|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3858754|NCT01622348|3684527|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3858755|NCT01622348|3684524|B4|Black||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3858756|NCT01622348|3684525|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3858757|NCT01622348|3684526|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3858758|NCT01622348|3684527|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3858759|NCT01622348|3684524|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3858760|NCT01622348|3684525|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3858761|NCT01622348|3684526|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3858762|NCT01622348|3684527|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3858763|NCT01622348|3684524|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3858764|NCT01622348|3684525|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3858765|NCT01622348|3684526|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3858766|NCT01622348|3684527|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3858767|NCT01622348|3684524|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3858768|NCT01622348|3684525|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3858769|NCT01622348|3684526|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3858770|NCT01622348|3684527|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3858771|NCT01622348|3684524|B4|||Age||years|Mean|39.6|39.6|Standard Deviation|13.16|13.16|||
3858772|NCT01622348|3684525|B3|||Age||years|Mean|39.6|39.6|Standard Deviation|13.15|13.15|||
3858773|NCT01622348|3684526|B2|||Age||years|Mean|41.9|41.9|Standard Deviation|12.54|12.54|||
3858775|NCT01622296|3684537|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3858776|NCT01622296|3684537|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3858777|NCT01622296|3684537|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3858778|NCT01622296|3684537|B1|||Age||years|Mean|10|10.0|Full Range|||9.0|12.0|
3858779|NCT01622257|3684543|B4|||Infertility mean score|"The Infertility score consists of 4 items:~Concerned with infertility problems~Fear of not having children~Feel lack of control over the situation~Sadness because of infertility problems~For each item there are seven rating options, 1 represents the greatest possible impairment, while 7 represents the least impairment.~A 2-week time frame was chosen for patients to describe their function. PCOSQ Infertility mean score = the average of the 4 items (Range=1-7) (PCOSQ, The Polycystic Ovary Syndrome Questionnaire)"|PCOSQ Infertility Score|Mean|3.6|3.6|Standard Deviation|1|1.0|||
3858780|NCT01622257|3684544|B3|||Infertility mean score|"The Infertility score consists of 4 items:~Concerned with infertility problems~Fear of not having children~Feel lack of control over the situation~Sadness because of infertility problems~For each item there are seven rating options, 1 represents the greatest possible impairment, while 7 represents the least impairment.~A 2-week time frame was chosen for patients to describe their function. PCOSQ Infertility mean score = the average of the 4 items (Range=1-7) (PCOSQ, The Polycystic Ovary Syndrome Questionnaire)"|PCOSQ Infertility Score|Mean|3.4|3.4|Standard Deviation|1.1|1.1|||
3858781|NCT01622257|3684545|B2|||Infertility mean score|"The Infertility score consists of 4 items:~Concerned with infertility problems~Fear of not having children~Feel lack of control over the situation~Sadness because of infertility problems~For each item there are seven rating options, 1 represents the greatest possible impairment, while 7 represents the least impairment.~A 2-week time frame was chosen for patients to describe their function. PCOSQ Infertility mean score = the average of the 4 items (Range=1-7) (PCOSQ, The Polycystic Ovary Syndrome Questionnaire)"|PCOSQ Infertility Score|Mean|3.6|3.6|Standard Deviation|0.9|0.9|||
3858782|NCT01622257|3684546|B1|||Infertility mean score|"The Infertility score consists of 4 items:~Concerned with infertility problems~Fear of not having children~Feel lack of control over the situation~Sadness because of infertility problems~For each item there are seven rating options, 1 represents the greatest possible impairment, while 7 represents the least impairment.~A 2-week time frame was chosen for patients to describe their function. PCOSQ Infertility mean score = the average of the 4 items (Range=1-7) (PCOSQ, The Polycystic Ovary Syndrome Questionnaire)"|PCOSQ Infertility Score|Mean|3.7|3.7|Standard Deviation|1.02|1.02|||
3858783|NCT01622257|3684543|B4|||Menstrual problems mean score|"The Menstrual problems score consists of 4 items:~Headaches~Irregular menstrual periods~Abdominal Bloating~Menstrual cramps~For each item there are seven rating options, 1 represents the greatest possible impairment, while 7 represents the least impairment.~A 2-week time frame was chosen for patients to describe their function. PCOSQ Menstrual problems mean score = the average of the 4 items (Range=1-7) (PCOSQ, The Polycystic Ovary Syndrome Questionnaire)"|PCOSQ Menstrual problems Score|Mean|3.7|3.7|Standard Deviation|1.1|1.1|||
3858784|NCT01622257|3684544|B3|||Menstrual problems mean score|"The Menstrual problems score consists of 4 items:~Headaches~Irregular menstrual periods~Abdominal Bloating~Menstrual cramps~For each item there are seven rating options, 1 represents the greatest possible impairment, while 7 represents the least impairment.~A 2-week time frame was chosen for patients to describe their function. PCOSQ Menstrual problems mean score = the average of the 4 items (Range=1-7) (PCOSQ, The Polycystic Ovary Syndrome Questionnaire)"|PCOSQ Menstrual problems Score|Mean|3.9|3.9|Standard Deviation|1.1|1.1|||
3858785|NCT01622257|3684545|B2|||Menstrual problems mean score|"The Menstrual problems score consists of 4 items:~Headaches~Irregular menstrual periods~Abdominal Bloating~Menstrual cramps~For each item there are seven rating options, 1 represents the greatest possible impairment, while 7 represents the least impairment.~A 2-week time frame was chosen for patients to describe their function. PCOSQ Menstrual problems mean score = the average of the 4 items (Range=1-7) (PCOSQ, The Polycystic Ovary Syndrome Questionnaire)"|PCOSQ Menstrual problems Score|Mean|3.7|3.7|Standard Deviation|1.1|1.1|||
3858786|NCT01622257|3684546|B1|||Menstrual problems mean score|"The Menstrual problems score consists of 4 items:~Headaches~Irregular menstrual periods~Abdominal Bloating~Menstrual cramps~For each item there are seven rating options, 1 represents the greatest possible impairment, while 7 represents the least impairment.~A 2-week time frame was chosen for patients to describe their function. PCOSQ Menstrual problems mean score = the average of the 4 items (Range=1-7) (PCOSQ, The Polycystic Ovary Syndrome Questionnaire)"|PCOSQ Menstrual problems Score|Mean|3.6|3.6|Standard Deviation|1.1|1.1|||
3858787|NCT01622257|3684543|B4|||Weight mean score|"The Weight score consists of 5 items:~Concerned about being overweight~Trouble dealing with your weight~Frustration in losing weight~Do not feel sexy because of weight~Difficulties staying at ideal weight~For each item there are seven rating options, 1 represents the greatest possible impairment, while 7 represents the least impairment.~A 2-week time frame was chosen for patients to describe their function. PCOSQ Weight mean score = the average of the 5 items (Range=1-7) (PCOSQ, The Polycystic Ovary Syndrome Questionnaire)"|PCOSQ Weight Score|Mean|2.4|2.4|Standard Deviation|1.4|1.4|||
3858788|NCT01622257|3684544|B3|||Weight mean score|"The Weight score consists of 5 items:~Concerned about being overweight~Trouble dealing with your weight~Frustration in losing weight~Do not feel sexy because of weight~Difficulties staying at ideal weight~For each item there are seven rating options, 1 represents the greatest possible impairment, while 7 represents the least impairment.~A 2-week time frame was chosen for patients to describe their function. PCOSQ Weight mean score = the average of the 5 items (Range=1-7) (PCOSQ, The Polycystic Ovary Syndrome Questionnaire)"|PCOSQ Weight Score|Mean|2.1|2.1|Standard Deviation|1.5|1.5|||
3858789|NCT01622257|3684545|B2|||Weight mean score|"The Weight score consists of 5 items:~Concerned about being overweight~Trouble dealing with your weight~Frustration in losing weight~Do not feel sexy because of weight~Difficulties staying at ideal weight~For each item there are seven rating options, 1 represents the greatest possible impairment, while 7 represents the least impairment.~A 2-week time frame was chosen for patients to describe their function. PCOSQ Weight mean score = the average of the 5 items (Range=1-7) (PCOSQ, The Polycystic Ovary Syndrome Questionnaire)"|PCOSQ Weight Score|Mean|2.4|2.4|Standard Deviation|1.3|1.3|||
3858814|NCT01622257|3684546|B1|||Total body fat percent||Percentage|Mean|43.2|43.2|Standard Deviation|5.6|5.6|||
3858815|NCT01622257|3684543|B4|||Waist to Hip Ratio (WHR)||Ratio|Mean|0.89|0.89|Standard Deviation|0.7|0.7|||
3858790|NCT01622257|3684546|B1|||Weight mean score|"The Weight score consists of 5 items:~Concerned about being overweight~Trouble dealing with your weight~Frustration in losing weight~Do not feel sexy because of weight~Difficulties staying at ideal weight~For each item there are seven rating options, 1 represents the greatest possible impairment, while 7 represents the least impairment.~A 2-week time frame was chosen for patients to describe their function. PCOSQ Weight mean score = the average of the 5 items (Range=1-7) (PCOSQ, The Polycystic Ovary Syndrome Questionnaire)"|PCOSQ Weight Score|Mean|2.6|2.6|Standard Deviation|1.4|1.4|||
3858791|NCT01622257|3684543|B4|||Body hair mean score|"The Body Hair score consists of 5 items:~Visible hair on chin~Visible hair on upper lip~Visible hair on face~Embarrassment about excessive body hair~Visible body hair~For each item there are seven rating options, 1 represents the greatest possible impairment, while 7 represents the least impairment.~A 2-week time frame was chosen for patients to describe their function. PCOSQ Body hair mean score = the average of the 5 items (Range=1-7) (PCOSQ, The Polycystic Ovary Syndrome Questionnaire)"|PCOSQ Body hair Score|Mean|3.5|3.5|Standard Deviation|1.7|1.7|||
3858792|NCT01622257|3684544|B3|||Body hair mean score|"The Body Hair score consists of 5 items:~Visible hair on chin~Visible hair on upper lip~Visible hair on face~Embarrassment about excessive body hair~Visible body hair~For each item there are seven rating options, 1 represents the greatest possible impairment, while 7 represents the least impairment.~A 2-week time frame was chosen for patients to describe their function. PCOSQ Body hair mean score = the average of the 5 items (Range=1-7) (PCOSQ, The Polycystic Ovary Syndrome Questionnaire)"|PCOSQ Body hair Score|Mean|3.7|3.7|Standard Deviation|1.6|1.6|||
3858793|NCT01622257|3684545|B2|||Body hair mean score|"The Body Hair score consists of 5 items:~Visible hair on chin~Visible hair on upper lip~Visible hair on face~Embarrassment about excessive body hair~Visible body hair~For each item there are seven rating options, 1 represents the greatest possible impairment, while 7 represents the least impairment.~A 2-week time frame was chosen for patients to describe their function. PCOSQ Body hair mean score = the average of the 5 items (Range=1-7) (PCOSQ, The Polycystic Ovary Syndrome Questionnaire)"|PCOSQ Body hair Score|Mean|3.3|3.3|Standard Deviation|1.9|1.9|||
3858794|NCT01622257|3684546|B1|||Body hair mean score|"The Body Hair score consists of 5 items:~Visible hair on chin~Visible hair on upper lip~Visible hair on face~Embarrassment about excessive body hair~Visible body hair~For each item there are seven rating options, 1 represents the greatest possible impairment, while 7 represents the least impairment.~A 2-week time frame was chosen for patients to describe their function. PCOSQ Body hair mean score = the average of the 5 items (Range=1-7) (PCOSQ, The Polycystic Ovary Syndrome Questionnaire)"|PCOSQ Body hair Score|Mean|3.4|3.4|Standard Deviation|1.7|1.7|||
3858795|NCT01622257|3684543|B4|||Emotion mean score|"The Emotions score consists of 8 items:~Depressed~Easily tired~Moody~Had low self-esteem~Fear of getting cancer~Worried~Being self-conscious~Late menstrual period~For each item there are seven rating options, 1 represents the greatest possible impairment, while 7 represents the least impairment.~A 2-week time frame was chosen for patients to describe their function. PCOSQ Emotions mean score = the average of the 8 items (Range=1-7) (PCOSQ, The Polycystic Ovary Syndrome Questionnaire)"|PCOSQ Emotion Score|Mean|4.6|4.6|Standard Deviation|1.6|1.6|||
3858796|NCT01622257|3684544|B3|||Emotion mean score|"The Emotions score consists of 8 items:~Depressed~Easily tired~Moody~Had low self-esteem~Fear of getting cancer~Worried~Being self-conscious~Late menstrual period~For each item there are seven rating options, 1 represents the greatest possible impairment, while 7 represents the least impairment.~A 2-week time frame was chosen for patients to describe their function. PCOSQ Emotions mean score = the average of the 8 items (Range=1-7) (PCOSQ, The Polycystic Ovary Syndrome Questionnaire)"|PCOSQ Emotion Score|Mean|4.7|4.7|Standard Deviation|1.7|1.7|||
3858797|NCT01622257|3684545|B2|||Emotion mean score|"The Emotions score consists of 8 items:~Depressed~Easily tired~Moody~Had low self-esteem~Fear of getting cancer~Worried~Being self-conscious~Late menstrual period~For each item there are seven rating options, 1 represents the greatest possible impairment, while 7 represents the least impairment.~A 2-week time frame was chosen for patients to describe their function. PCOSQ Emotions mean score = the average of the 8 items (Range=1-7) (PCOSQ, The Polycystic Ovary Syndrome Questionnaire)"|PCOSQ Emotion Score|Mean|4.9|4.9|Standard Deviation|1.6|1.6|||
3858798|NCT01622257|3684546|B1|||Emotion mean score|"The Emotions score consists of 8 items:~Depressed~Easily tired~Moody~Had low self-esteem~Fear of getting cancer~Worried~Being self-conscious~Late menstrual period~For each item there are seven rating options, 1 represents the greatest possible impairment, while 7 represents the least impairment.~A 2-week time frame was chosen for patients to describe their function. PCOSQ Emotions mean score = the average of the 8 items (Range=1-7) (PCOSQ, The Polycystic Ovary Syndrome Questionnaire)"|PCOSQ Emotion Score|Mean|4.3|4.3|Standard Deviation|1.4|1.4|||
3858799|NCT01622257|3684543|B4|||Abdominal fat mass||Kilograms (kg)|Mean|6.9|6.9|Standard Deviation|2.6|2.6|||
3858800|NCT01622257|3684544|B3|||Abdominal fat mass||Kilograms (kg)|Mean|7.1|7.1|Standard Deviation|2.2|2.2|||
3858801|NCT01622257|3684545|B2|||Abdominal fat mass||Kilograms (kg)|Mean|6.9|6.9|Standard Deviation|3.2|3.2|||
3858802|NCT01622257|3684546|B1|||Abdominal fat mass||Kilograms (kg)|Mean|6.8|6.8|Standard Deviation|2.8|2.8|||
3858803|NCT01622257|3684543|B4|||Fat free mass||Kilograms (kg)|Mean|51.1|51.1|Standard Deviation|9.6|9.6|||
3858804|NCT01622257|3684544|B3|||Fat free mass||Kilograms (kg)|Mean|51.2|51.2|Standard Deviation|10.2|10.2|||
3858805|NCT01622257|3684545|B2|||Fat free mass||Kilograms (kg)|Mean|51.2|51.2|Standard Deviation|9.1|9.1|||
3858806|NCT01622257|3684546|B1|||Fat free mass||Kilograms (kg)|Mean|50.8|50.8|Standard Deviation|9.5|9.5|||
3858807|NCT01622257|3684543|B4|||Body fat mass||Kilograms (kg)|Mean|39.5|39.5|Standard Deviation|10.5|10.5|||
3858808|NCT01622257|3684544|B3|||Body fat mass||Kilograms (kg)|Mean|41.1|41.1|Standard Deviation|10.1|10.1|||
3858809|NCT01622257|3684545|B2|||Body fat mass||Kilograms (kg)|Mean|39.8|39.8|Standard Deviation|11.2|11.2|||
3858810|NCT01622257|3684546|B1|||Body fat mass||Kilograms (kg)|Mean|37.7|37.7|Standard Deviation|10.4|10.4|||
3858811|NCT01622257|3684543|B4|||Total body fat percent||Percentage|Mean|44.6|44.6|Standard Deviation|5.8|5.8|||
3858812|NCT01622257|3684544|B3|||Total body fat percent||Percentage|Mean|45.6|45.6|Standard Deviation|5.7|5.7|||
3858813|NCT01622257|3684545|B2|||Total body fat percent||Percentage|Mean|44.9|44.9|Standard Deviation|6.2|6.2|||
3858860|NCT01622257|3684544|B3|||Total testosterone||ng/ml|Mean|0.83|0.83|Standard Deviation|0.04|0.04|||
3858816|NCT01622257|3684544|B3|||Waist to Hip Ratio (WHR)||Ratio|Mean|0.91|0.91|Standard Deviation|0.8|0.8|||
3858817|NCT01622257|3684545|B2|||Waist to Hip Ratio (WHR)||Ratio|Mean|0.89|0.89|Standard Deviation|0.7|0.7|||
3858818|NCT01622257|3684546|B1|||Waist to Hip Ratio (WHR)||Ratio|Mean|0.88|0.88|Standard Deviation|0.7|0.7|||
3858819|NCT01622257|3684543|B4|||Triglycerides (TGs)||mg/dl|Mean|204.3|204.3|Standard Deviation|25.7|25.7|||
3858820|NCT01622257|3684544|B3|||Triglycerides (TGs)||mg/dl|Mean|208.4|208.4|Standard Deviation|26.8|26.8|||
3858821|NCT01622257|3684545|B2|||Triglycerides (TGs)||mg/dl|Mean|199.6|199.6|Standard Deviation|22.4|22.4|||
3858822|NCT01622257|3684546|B1|||Triglycerides (TGs)||mg/dl|Mean|204.9|204.9|Standard Deviation|28.1|28.1|||
3858823|NCT01622257|3684543|B4|||High-density lipoprotein (HDL)||mg/dl|Mean|80.4|80.4|Standard Deviation|10.6|10.6|||
3858824|NCT01622257|3684544|B3|||High-density lipoprotein (HDL)||mg/dl|Mean|82.1|82.1|Standard Deviation|10.8|10.8|||
3858825|NCT01622257|3684545|B2|||High-density lipoprotein (HDL)||mg/dl|Mean|77.8|77.8|Standard Deviation|9.9|9.9|||
3858826|NCT01622257|3684546|B1|||High-density lipoprotein (HDL)||mg/dl|Mean|80.9|80.9|Standard Deviation|11.2|11.2|||
3858827|NCT01622257|3684543|B4|||Low-density lipoprotein (LDL)||mg/dl|Mean|126.5|126.5|Standard Deviation|19.6|19.6|||
3858828|NCT01622257|3684544|B3|||Low-density lipoprotein (LDL)||mg/dl|Mean|122.6|122.6|Standard Deviation|19.1|19.1|||
3858829|NCT01622257|3684545|B2|||Low-density lipoprotein (LDL)||mg/dl|Mean|127.1|127.1|Standard Deviation|20.4|20.4|||
3858830|NCT01622257|3684546|B1|||Low-density lipoprotein (LDL)||mg/dl|Mean|129.7|129.7|Standard Deviation|19.3|19.3|||
3858831|NCT01622257|3684543|B4|||Total cholesterol||mg/dl|Mean|277.2|277.2|Standard Deviation|30.7|30.7|||
3858832|NCT01622257|3684544|B3|||Total cholesterol||mg/dl|Mean|276.8|276.8|Standard Deviation|30.5|30.5|||
3858833|NCT01622257|3684545|B2|||Total cholesterol||mg/dl|Mean|273.4|273.4|Standard Deviation|29.2|29.2|||
3858834|NCT01622257|3684546|B1|||Total cholesterol||mg/dl|Mean|282.3|282.3|Standard Deviation|32|32.0|||
3858835|NCT01622257|3684543|B4|||Quantitative Insulin sensitivity Check Index (QUICKI)|"The quantitative insulin sensitivity check index (QUICKI) is derived using the inverse of the sum of the logarithms of the fasting insulin and fasting glucose:~1 / [(log(fasting insulin µU/mL) + log(fasting glucose mg/dL)]~µU/mL, microunits/milliliter; mg/dL, milligrams/deciliter."|Index|Mean|0.33|0.33|Standard Deviation|0.04|0.04|||
3858836|NCT01622257|3684544|B3|||Quantitative Insulin sensitivity Check Index (QUICKI)|"The quantitative insulin sensitivity check index (QUICKI) is derived using the inverse of the sum of the logarithms of the fasting insulin and fasting glucose:~1 / [(log(fasting insulin µU/mL) + log(fasting glucose mg/dL)]~µU/mL, microunits/milliliter; mg/dL, milligrams/deciliter."|Index|Mean|0.34|0.34|Standard Deviation|0.04|0.04|||
3858837|NCT01622257|3684545|B2|||Quantitative Insulin sensitivity Check Index (QUICKI)|"The quantitative insulin sensitivity check index (QUICKI) is derived using the inverse of the sum of the logarithms of the fasting insulin and fasting glucose:~1 / [(log(fasting insulin µU/mL) + log(fasting glucose mg/dL)]~µU/mL, microunits/milliliter; mg/dL, milligrams/deciliter."|Index|Mean|0.33|0.33|Standard Deviation|0.04|0.04|||
3858838|NCT01622257|3684546|B1|||Quantitative Insulin sensitivity Check Index (QUICKI)|"The quantitative insulin sensitivity check index (QUICKI) is derived using the inverse of the sum of the logarithms of the fasting insulin and fasting glucose:~1 / [(log(fasting insulin µU/mL) + log(fasting glucose mg/dL)]~µU/mL, microunits/milliliter; mg/dL, milligrams/deciliter."|Index|Mean|0.33|0.33|Standard Deviation|0.03|0.03|||
3858839|NCT01622257|3684543|B4|||Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)|Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)= Fasting insulin x Fasting glucose / 22.5|HOMA score|Mean|2.46|2.46|Standard Deviation|1.01|1.01|||
3858840|NCT01622257|3684544|B3|||Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)|Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)= Fasting insulin x Fasting glucose / 22.5|HOMA score|Mean|2.27|2.27|Standard Deviation|0.99|0.99|||
3858841|NCT01622257|3684545|B2|||Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)|Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)= Fasting insulin x Fasting glucose / 22.5|HOMA score|Mean|2.45|2.45|Standard Deviation|1.06|1.06|||
3858842|NCT01622257|3684546|B1|||Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)|Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)= Fasting insulin x Fasting glucose / 22.5|HOMA score|Mean|2.65|2.65|Standard Deviation|1.01|1.01|||
3858843|NCT01622257|3684543|B4|||Fasting Glucose/Insulin Ratio (GIR)||mg/mIU|Mean|6.46|6.46|Standard Deviation|0.7|0.7|||
3858844|NCT01622257|3684544|B3|||Fasting Glucose/Insulin Ratio (GIR)||mg/mIU|Mean|6.59|6.59|Standard Deviation|0.7|0.7|||
3858845|NCT01622257|3684545|B2|||Fasting Glucose/Insulin Ratio (GIR)||mg/mIU|Mean|6.35|6.35|Standard Deviation|0.7|0.7|||
3858846|NCT01622257|3684546|B1|||Fasting Glucose/Insulin Ratio (GIR)||mg/mIU|Mean|6.44|6.44|Standard Deviation|0.8|0.8|||
3858847|NCT01622257|3684543|B4|||Fasting glucose||mg/dl|Mean|80.1|80.1|Standard Deviation|22.3|22.3|||
3858848|NCT01622257|3684544|B3|||Fasting glucose||mg/dl|Mean|77.8|77.8|Standard Deviation|22.1|22.1|||
3858849|NCT01622257|3684545|B2|||Fasting glucose||mg/dl|Mean|79.4|79.4|Standard Deviation|22.7|22.7|||
3858850|NCT01622257|3684546|B1|||Fasting glucose||mg/dl|Mean|83.1|83.1|Standard Deviation|21.4|21.4|||
3858851|NCT01622257|3684543|B4|||Fasting insulin||µIU/ml|Mean|12.4|12.4|Standard Deviation|5.1|5.1|||
3858852|NCT01622257|3684544|B3|||Fasting insulin||µIU/ml|Mean|11.8|11.8|Standard Deviation|4.1|4.1|||
3858853|NCT01622257|3684545|B2|||Fasting insulin||µIU/ml|Mean|12.5|12.5|Standard Deviation|5.3|5.3|||
3858854|NCT01622257|3684546|B1|||Fasting insulin||µIU/ml|Mean|12.9|12.9|Standard Deviation|6.4|6.4|||
3858855|NCT01622257|3684543|B4|||Free testosterone||pg/ml|Mean|3.8|3.8|Standard Deviation|1.71|1.71|||
3858856|NCT01622257|3684544|B3|||Free testosterone||pg/ml|Mean|3.7|3.7|Standard Deviation|1.72|1.72|||
3858857|NCT01622257|3684545|B2|||Free testosterone||pg/ml|Mean|3.8|3.8|Standard Deviation|1.32|1.32|||
3858858|NCT01622257|3684546|B1|||Free testosterone||pg/ml|Mean|3.9|3.9|Standard Deviation|2.07|2.07|||
3858859|NCT01622257|3684543|B4|||Total testosterone||ng/ml|Mean|0.83|0.83|Standard Deviation|0.04|0.04|||
3858861|NCT01622257|3684545|B2|||Total testosterone||ng/ml|Mean|0.83|0.83|Standard Deviation|0.04|0.04|||
3858862|NCT01622257|3684546|B1|||Total testosterone||ng/ml|Mean|0.84|0.84|Standard Deviation|0.05|0.05|||
3858863|NCT01622257|3684543|B4|||LH/FSH ratio||Ratio|Mean|1.77|1.77|Standard Deviation|0.6|0.6|||
3858864|NCT01622257|3684544|B3|||LH/FSH ratio||Ratio|Mean|1.68|1.68|Standard Deviation|0.6|0.6|||
3858865|NCT01622257|3684545|B2|||LH/FSH ratio||Ratio|Mean|1.85|1.85|Standard Deviation|0.6|0.6|||
3858866|NCT01622257|3684546|B1|||LH/FSH ratio||Ratio|Mean|1.79|1.79|Standard Deviation|0.7|0.7|||
3858867|NCT01622257|3684543|B4|||Luteinizing Hormone (LH)||mIU/ml|Mean|10.9|10.9|Standard Deviation|1.3|1.3|||
3858868|NCT01622257|3684544|B3|||Luteinizing Hormone (LH)||mIU/ml|Mean|11.1|11.1|Standard Deviation|1.8|1.8|||
3858869|NCT01622257|3684545|B2|||Luteinizing Hormone (LH)||mIU/ml|Mean|10.7|10.7|Standard Deviation|1.1|1.1|||
3858870|NCT01622257|3684546|B1|||Luteinizing Hormone (LH)||mIU/ml|Mean|10.9|10.9|Standard Deviation|1.1|1.1|||
3858871|NCT01622257|3684543|B4|||Serum Follicle-stimulating Hormone (FSH)||mIU/ml|Mean|6.2|6.2|Standard Deviation|2.1|2.1|||
3858872|NCT01622257|3684544|B3|||Serum Follicle-stimulating Hormone (FSH)||mIU/ml|Mean|6.6|6.6|Standard Deviation|2.3|2.3|||
3858873|NCT01622257|3684545|B2|||Serum Follicle-stimulating Hormone (FSH)||mIU/ml|Mean|5.8|5.8|Standard Deviation|2.2|2.2|||
3858874|NCT01622257|3684546|B1|||Serum Follicle-stimulating Hormone (FSH)||mIU/ml|Mean|6.1|6.1|Standard Deviation|1.9|1.9|||
3858875|NCT01622257|3684543|B4|||Diastolic blood pressure||millimeters of mercury (mmHg)|Mean|81.7|81.7|Standard Deviation|7.6|7.6|||
3858876|NCT01622257|3684544|B3|||Diastolic blood pressure||millimeters of mercury (mmHg)|Mean|82.9|82.9|Standard Deviation|7.8|7.8|||
3858877|NCT01622257|3684545|B2|||Diastolic blood pressure||millimeters of mercury (mmHg)|Mean|81.6|81.6|Standard Deviation|7.1|7.1|||
3858878|NCT01622257|3684546|B1|||Diastolic blood pressure||millimeters of mercury (mmHg)|Mean|80.5|80.5|Standard Deviation|8.2|8.2|||
3858879|NCT01622257|3684543|B4|||Systolic blood pressure||millimeters of mercury (mmHg)|Mean|122|122.0|Standard Deviation|11.6|11.6|||
3858880|NCT01622257|3684544|B3|||Systolic blood pressure||millimeters of mercury (mmHg)|Mean|121.8|121.8|Standard Deviation|12.3|12.3|||
3858881|NCT01622257|3684545|B2|||Systolic blood pressure||millimeters of mercury (mmHg)|Mean|121.9|121.9|Standard Deviation|12.4|12.4|||
3858882|NCT01622257|3684546|B1|||Systolic blood pressure||millimeters of mercury (mmHg)|Mean|122.4|122.4|Standard Deviation|10.1|10.1|||
3858883|NCT01622257|3684543|B4|Oligomenorrhea||Menstrual pattern||Participants|Number|57|57.0||||||
3858884|NCT01622257|3684544|B3|Oligomenorrhea||Menstrual pattern||Participants|Number|15|15.0||||||
3858885|NCT01622257|3684545|B2|Oligomenorrhea||Menstrual pattern||Participants|Number|19|19.0||||||
3858886|NCT01622257|3684546|B1|Oligomenorrhea||Menstrual pattern||Participants|Number|23|23.0||||||
3858887|NCT01622257|3684543|B4|Amenorrhea||Menstrual pattern||Participants|Number|141|141.0||||||
3858888|NCT01622257|3684544|B3|Amenorrhea||Menstrual pattern||Participants|Number|51|51.0||||||
3858889|NCT01622257|3684545|B2|Amenorrhea||Menstrual pattern||Participants|Number|47|47.0||||||
3858890|NCT01622257|3684546|B1|Amenorrhea||Menstrual pattern||Participants|Number|43|43.0||||||
3858891|NCT01622257|3684543|B4|No||Seborrheic dermatitis||Participants|Number|99|99.0||||||
3858892|NCT01622257|3684544|B3|No||Seborrheic dermatitis||Participants|Number|27|27.0||||||
3858893|NCT01622257|3684545|B2|No||Seborrheic dermatitis||Participants|Number|32|32.0||||||
3858894|NCT01622257|3684546|B1|No||Seborrheic dermatitis||Participants|Number|40|40.0||||||
3858895|NCT01622257|3684543|B4|Yes||Seborrheic dermatitis||Participants|Number|99|99.0||||||
3858896|NCT01622257|3684544|B3|Yes||Seborrheic dermatitis||Participants|Number|39|39.0||||||
3858897|NCT01622257|3684545|B2|Yes||Seborrheic dermatitis||Participants|Number|34|34.0||||||
3858898|NCT01622257|3684546|B1|Yes||Seborrheic dermatitis||Participants|Number|26|26.0||||||
3858899|NCT01622257|3684543|B4|No||Acne||Participants|Number|131|131.0||||||
3858900|NCT01622257|3684544|B3|No||Acne||Participants|Number|40|40.0||||||
3858901|NCT01622257|3684545|B2|No||Acne||Participants|Number|43|43.0||||||
3858902|NCT01622257|3684546|B1|No||Acne||Participants|Number|48|48.0||||||
3858903|NCT01622257|3684543|B4|Yes||Acne||Participants|Number|67|67.0||||||
3858904|NCT01622257|3684544|B3|Yes||Acne||Participants|Number|26|26.0||||||
3858905|NCT01622257|3684545|B2|Yes||Acne||Participants|Number|23|23.0||||||
3858906|NCT01622257|3684546|B1|Yes||Acne||Participants|Number|18|18.0||||||
3858907|NCT01622257|3684543|B4|No||Androgenic alopecia||Participants|Number|171|171.0||||||
3858908|NCT01622257|3684544|B3|No||Androgenic alopecia||Participants|Number|60|60.0||||||
3858909|NCT01622257|3684545|B2|No||Androgenic alopecia||Participants|Number|57|57.0||||||
3858910|NCT01622257|3684546|B1|No||Androgenic alopecia||Participants|Number|54|54.0||||||
3858911|NCT01622257|3684543|B4|Yes||Androgenic alopecia||Participants|Number|27|27.0||||||
3858912|NCT01622257|3684544|B3|Yes||Androgenic alopecia||Participants|Number|6|6.0||||||
3858913|NCT01622257|3684545|B2|Yes||Androgenic alopecia||Participants|Number|9|9.0||||||
3858914|NCT01622257|3684546|B1|Yes||Androgenic alopecia||Participants|Number|12|12.0||||||
3858915|NCT01622257|3684543|B4|||Body Mass Index||kg/m^2|Mean|36.9|36.9|Standard Deviation|4.7|4.7|||
3858916|NCT01622257|3684544|B3|||Body Mass Index||kg/m^2|Mean|36.1|36.1|Standard Deviation|5.2|5.2|||
3858917|NCT01622257|3684545|B2|||Body Mass Index||kg/m^2|Mean|36.7|36.7|Standard Deviation|4.2|4.2|||
3858918|NCT01622257|3684546|B1|||Body Mass Index||kg/m^2|Mean|37.9|37.9|Standard Deviation|4.9|4.9|||
3858919|NCT01622257|3684543|B4|||Duration of infertility||Years|Mean|3.3|3.3|Standard Deviation|1.4|1.4|||
3858920|NCT01622257|3684544|B3|||Duration of infertility||Years|Mean|3.2|3.2|Standard Deviation|1.3|1.3|||
3858921|NCT01622257|3684545|B2|||Duration of infertility||Years|Mean|3.4|3.4|Standard Deviation|1.3|1.3|||
3858922|NCT01622257|3684546|B1|||Duration of infertility||Years|Mean|3.3|3.3|Standard Deviation|1.5|1.5|||
3858923|NCT01622257|3684543|B4|Egypt||Region of Enrollment||Participants|Number|198|198.0||||||
3858924|NCT01622257|3684544|B3|Egypt||Region of Enrollment||Participants|Number|66|66.0||||||
3858925|NCT01622257|3684545|B2|Egypt||Region of Enrollment||Participants|Number|66|66.0||||||
3858926|NCT01622257|3684546|B1|Egypt||Region of Enrollment||Participants|Number|66|66.0||||||
3858927|NCT01622257|3684543|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3858928|NCT01622257|3684544|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3858929|NCT01622257|3684545|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3858930|NCT01622257|3684546|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3858931|NCT01622257|3684543|B4||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
3858932|NCT01622257|3684544|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3858933|NCT01622257|3684545|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3858934|NCT01622257|3684546|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3858935|NCT01622257|3684543|B4|||Age||Years|Mean|26|26.0|Standard Deviation|4.7|4.7|||
3858936|NCT01622257|3684544|B3|||Age||Years|Mean|26.3|26.3|Standard Deviation|5.2|5.2|||
3858937|NCT01622257|3684545|B2|||Age||Years|Mean|26.1|26.1|Standard Deviation|4.1|4.1|||
3858938|NCT01622257|3684546|B1|||Age||Years|Mean|25.7|25.7|Standard Deviation|4.5|4.5|||
3858939|NCT01622231|3684568|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
3858940|NCT01622231|3684568|B1||Male|Gender||Participants|Count of Participants|42|42.0||||||
3858941|NCT01622231|3684568|B1||Female|Gender||Participants|Count of Participants|19|19.0||||||
3858942|NCT01622231|3684568|B1|||Age||Years|Mean|8.0|8.0|Standard Deviation|3.59|3.59|||
3858943|NCT01621880|3684596|B3|||Dose of neck radiation||Gy|Mean|49.7|49.7|Standard Deviation|13.0|13.0|||
3858944|NCT01621880|3684597|B2|||Dose of neck radiation||Gy|Mean|40.7|40.7|Standard Deviation|10.3|10.3|||
3858945|NCT01621880|3684598|B1|||Dose of neck radiation||Gy|Mean|58.9|58.9|Standard Deviation|8.1|8.1|||
3858946|NCT01621880|3684596|B3|||Dose of nasopharyngeal radiation||Gy|Mean|70.3|70.3|Standard Deviation|4.1|4.1|||
3858947|NCT01621880|3684597|B2|||Dose of nasopharyngeal radiation||Gy|Mean|71.1|71.1|Standard Deviation|2.4|2.4|||
3858948|NCT01621880|3684598|B1|||Dose of nasopharyngeal radiation||Gy|Mean|69.4|69.4|Standard Deviation|5.2|5.2|||
3858949|NCT01621880|3684596|B3|||IMRT(intensity modulated radiation therapy)||Participants|Count of Participants|35|35.0||||||
3858950|NCT01621880|3684597|B2|||IMRT(intensity modulated radiation therapy)||Participants|Count of Participants|18|18.0||||||
3858951|NCT01621880|3684598|B1|||IMRT(intensity modulated radiation therapy)||Participants|Count of Participants|17|17.0||||||
3858952|NCT01621880|3684596|B3|||Conventional radiotherapy||Participants|Count of Participants|77|77.0||||||
3858953|NCT01621880|3684597|B2|||Conventional radiotherapy||Participants|Count of Participants|36|36.0||||||
3858954|NCT01621880|3684598|B1|||Conventional radiotherapy||Participants|Count of Participants|41|41.0||||||
3858955|NCT01621880|3684596|B3|China||Region of Enrollment||participants|Number|112|112.0||||||
3858956|NCT01621880|3684597|B2|China||Region of Enrollment||participants|Number|54|54.0||||||
3858957|NCT01621880|3684598|B1|China||Region of Enrollment||participants|Number|58|58.0||||||
3858958|NCT01621880|3684596|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3858959|NCT01621880|3684597|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3858960|NCT01621880|3684598|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3858961|NCT01621880|3684596|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3858962|NCT01621880|3684597|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3858963|NCT01621880|3684598|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3858964|NCT01621880|3684596|B3|||Age||years|Mean|50.1|50.1|Standard Deviation|8.5|8.5|||
3858965|NCT01621880|3684597|B2|||Age||years|Mean|50.5|50.5|Standard Deviation|8.6|8.6|||
3858966|NCT01621880|3684598|B1|||Age||years|Mean|49.3|49.3|Standard Deviation|7.0|7.0|||
3858967|NCT01621802|3684607|B7|Race/Ethnicity|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1699|1699.0||||||
3858968|NCT01621802|3684608|B6|Race/Ethnicity|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|218|218.0||||||
3858969|NCT01621802|3684609|B5|Race/Ethnicity|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|575|575.0||||||
3858970|NCT01621802|3684610|B4|Race/Ethnicity|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|117|117.0||||||
3858971|NCT01621802|3684611|B3|Race/Ethnicity|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|291|291.0||||||
3858972|NCT01621802|3684612|B2|Race/Ethnicity|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|135|135.0||||||
3858973|NCT01621802|3684613|B1|Race/Ethnicity|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|363|363.0||||||
3858974|NCT01621802|3684607|B7|Race/Ethnicity|White - Arabic / North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3858975|NCT01621802|3684608|B6|Race/Ethnicity|White - Arabic / North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3858976|NCT01621802|3684609|B5|Race/Ethnicity|White - Arabic / North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3858977|NCT01621802|3684610|B4|Race/Ethnicity|White - Arabic / North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3858978|NCT01621802|3684611|B3|Race/Ethnicity|White - Arabic / North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3858979|NCT01621802|3684612|B2|Race/Ethnicity|White - Arabic / North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3858980|NCT01621802|3684613|B1|Race/Ethnicity|White - Arabic / North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3858981|NCT01621802|3684607|B7|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|275|275.0||||||
3858982|NCT01621802|3684608|B6|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3858983|NCT01621802|3684609|B5|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|52|52.0||||||
3858984|NCT01621802|3684610|B4|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3858985|NCT01621802|3684611|B3|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
3858986|NCT01621802|3684612|B2|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|45|45.0||||||
3858987|NCT01621802|3684613|B1|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|112|112.0||||||
3858988|NCT01621802|3684607|B7|Race/Ethnicity|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3858989|NCT01621802|3684608|B6|Race/Ethnicity|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3858990|NCT01621802|3684609|B5|Race/Ethnicity|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3858991|NCT01621802|3684610|B4|Race/Ethnicity|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3858992|NCT01621802|3684611|B3|Race/Ethnicity|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3858993|NCT01621802|3684612|B2|Race/Ethnicity|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3858994|NCT01621802|3684613|B1|Race/Ethnicity|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3858995|NCT01621802|3684607|B7|Race/Ethnicity|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|113|113.0||||||
3858996|NCT01621802|3684608|B6|Race/Ethnicity|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3858997|NCT01621802|3684609|B5|Race/Ethnicity|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3858998|NCT01621802|3684610|B4|Race/Ethnicity|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3858999|NCT01621802|3684611|B3|Race/Ethnicity|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3859000|NCT01621802|3684612|B2|Race/Ethnicity|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3859001|NCT01621802|3684613|B1|Race/Ethnicity|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|49|49.0||||||
3859002|NCT01621802|3684607|B7|Race/Ethnicity|Asian - Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3859003|NCT01621802|3684608|B6|Race/Ethnicity|Asian - Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3859004|NCT01621802|3684609|B5|Race/Ethnicity|Asian - Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3859005|NCT01621802|3684610|B4|Race/Ethnicity|Asian - Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3859006|NCT01621802|3684611|B3|Race/Ethnicity|Asian - Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3859007|NCT01621802|3684612|B2|Race/Ethnicity|Asian - Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3859008|NCT01621802|3684613|B1|Race/Ethnicity|Asian - Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3859009|NCT01621802|3684607|B7|Race/Ethnicity|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1338|1338.0||||||
3859010|NCT01621802|3684608|B6|Race/Ethnicity|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|209|209.0||||||
3859011|NCT01621802|3684609|B5|Race/Ethnicity|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|565|565.0||||||
3859012|NCT01621802|3684610|B4|Race/Ethnicity|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|146|146.0||||||
3859013|NCT01621802|3684611|B3|Race/Ethnicity|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|384|384.0||||||
3859014|NCT01621802|3684612|B2|Race/Ethnicity|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3859015|NCT01621802|3684613|B1|Race/Ethnicity|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3859016|NCT01621802|3684607|B7|Race/Ethnicity|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3859017|NCT01621802|3684608|B6|Race/Ethnicity|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3859018|NCT01621802|3684609|B5|Race/Ethnicity|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3859019|NCT01621802|3684610|B4|Race/Ethnicity|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3859020|NCT01621802|3684611|B3|Race/Ethnicity|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3859021|NCT01621802|3684612|B2|Race/Ethnicity|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3859022|NCT01621802|3684613|B1|Race/Ethnicity|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3859023|NCT01621802|3684607|B7|Race/Ethnicity|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|190|190.0||||||
3859024|NCT01621802|3684608|B6|Race/Ethnicity|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3859025|NCT01621802|3684609|B5|Race/Ethnicity|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3859026|NCT01621802|3684610|B4|Race/Ethnicity|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3859027|NCT01621802|3684611|B3|Race/Ethnicity|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3859028|NCT01621802|3684612|B2|Race/Ethnicity|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
3859029|NCT01621802|3684613|B1|Race/Ethnicity|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|130|130.0||||||
3859030|NCT01621802|3684607|B7|Race/Ethnicity|African Heritage / African American|Race/Ethnicity, Customized||Participants|Count of Participants|328|328.0||||||
3859031|NCT01621802|3684608|B6|Race/Ethnicity|African Heritage / African American|Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3859032|NCT01621802|3684609|B5|Race/Ethnicity|African Heritage / African American|Race/Ethnicity, Customized||Participants|Count of Participants|94|94.0||||||
3859033|NCT01621802|3684610|B4|Race/Ethnicity|African Heritage / African American|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3859034|NCT01621802|3684611|B3|Race/Ethnicity|African Heritage / African American|Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
3859035|NCT01621802|3684612|B2|Race/Ethnicity|African Heritage / African American|Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
3859036|NCT01621802|3684613|B1|Race/Ethnicity|African Heritage / African American|Race/Ethnicity, Customized||Participants|Count of Participants|96|96.0||||||
3859037|NCT01621802|3684607|B7||Male|Sex: Female, Male||Participants|Count of Participants|2104|2104.0||||||
3859038|NCT01621802|3684608|B6||Male|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
3859039|NCT01621802|3684609|B5||Male|Sex: Female, Male||Participants|Count of Participants|687|687.0||||||
3859040|NCT01621802|3684610|B4||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3859041|NCT01621802|3684611|B3||Male|Sex: Female, Male||Participants|Count of Participants|435|435.0||||||
3859042|NCT01621802|3684612|B2||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3859043|NCT01621802|3684613|B1||Male|Sex: Female, Male||Participants|Count of Participants|404|404.0||||||
3859044|NCT01621802|3684607|B7||Female|Sex: Female, Male||Participants|Count of Participants|1903|1903.0||||||
3859045|NCT01621802|3684608|B6||Female|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
3859046|NCT01621802|3684609|B5||Female|Sex: Female, Male||Participants|Count of Participants|632|632.0||||||
3859047|NCT01621802|3684610|B4||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3859048|NCT01621802|3684611|B3||Female|Sex: Female, Male||Participants|Count of Participants|361|361.0||||||
3859049|NCT01621802|3684612|B2||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3859050|NCT01621802|3684613|B1||Female|Sex: Female, Male||Participants|Count of Participants|398|398.0||||||
3859051|NCT01621802|3684607|B7|||Age||Years|Mean|4.3|4.3|Standard Deviation|0.6|0.6|||
3859052|NCT01621802|3684608|B6|||Age||Years|Mean|4.4|4.4|Standard Deviation|0.6|0.6|||
3859053|NCT01621802|3684609|B5|||Age||Years|Mean|4.4|4.4|Standard Deviation|0.6|0.6|||
3859054|NCT01621802|3684610|B4|||Age||Years|Mean|4.3|4.3|Standard Deviation|0.6|0.6|||
3859055|NCT01621802|3684611|B3|||Age||Years|Mean|4.4|4.4|Standard Deviation|0.6|0.6|||
3859056|NCT01621802|3684612|B2|||Age||Years|Mean|4.1|4.1|Standard Deviation|0.3|0.3|||
3859057|NCT01621802|3684613|B1|||Age||Years|Mean|4.1|4.1|Standard Deviation|0.3|0.3|||
3859058|NCT01621776|3684722|B4|United States||Region of Enrollment||participants|Number|99|99.0||||||
3859059|NCT01621776|3684723|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
3859060|NCT01621776|3684724|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
3859061|NCT01621776|3684725|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
3859062|NCT01621776|3684722|B4||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3859063|NCT01621776|3684723|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3859064|NCT01621776|3684724|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3859065|NCT01621776|3684725|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3859066|NCT01621776|3684722|B4||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3859067|NCT01621776|3684723|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3859068|NCT01621776|3684724|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3859069|NCT01621776|3684725|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3859070|NCT01621776|3684722|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3859071|NCT01621776|3684723|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3859072|NCT01621776|3684724|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3859073|NCT01621776|3684725|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3859074|NCT01621776|3684722|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3859075|NCT01621776|3684723|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3859076|NCT01621776|3684724|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3859077|NCT01621776|3684725|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3859078|NCT01621776|3684722|B4||<=18 years|Age||Participants|Count of Participants|99|99.0||||||
3859079|NCT01621776|3684723|B3||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
3859080|NCT01621776|3684724|B2||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
3859081|NCT01621776|3684725|B1||<=18 years|Age||Participants|Count of Participants|41|41.0||||||
3859082|NCT01621672|3684741|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3859083|NCT01621672|3684742|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3859084|NCT01621672|3684743|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3859085|NCT01621672|3684741|B3|White||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
3859086|NCT01621672|3684742|B2|White||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3859087|NCT01621672|3684743|B1|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3859088|NCT01621672|3684741|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3859089|NCT01621672|3684742|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3859090|NCT01621672|3684743|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3859091|NCT01621672|3684741|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3859092|NCT01621672|3684742|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3859093|NCT01621672|3684743|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3859094|NCT01621672|3684741|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3859095|NCT01621672|3684742|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3859096|NCT01621672|3684743|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3859097|NCT01621672|3684741|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3859098|NCT01621672|3684742|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3859099|NCT01621672|3684743|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3859100|NCT01621672|3684741|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3859101|NCT01621672|3684742|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3859102|NCT01621672|3684743|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3859103|NCT01621633|3684750|B5||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3859104|NCT01621633|3684751|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3859105|NCT01621633|3684752|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3859106|NCT01621633|3684753|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3859107|NCT01621633|3684754|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3859108|NCT01621633|3684750|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3859109|NCT01621633|3684751|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3859110|NCT01621633|3684752|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3859111|NCT01621633|3684753|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3859112|NCT01621633|3684754|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3859113|NCT01621633|3684750|B5|||Age||Years|Mean|59.0|59.0|Standard Deviation|9.54|9.54|||
3859114|NCT01621633|3684751|B4|||Age||Years|Mean|60.3|60.3|Standard Deviation|11.21|11.21|||
3859115|NCT01621633|3684752|B3|||Age||Years|Mean|58.9|58.9|Standard Deviation|8.68|8.68|||
3859116|NCT01621633|3684753|B2|||Age||Years|Mean|57.9|57.9|Standard Deviation|11.67|11.67|||
3859117|NCT01621633|3684754|B1|||Age||Years|Mean|59.1|59.1|Standard Deviation|7.92|7.92|||
3859118|NCT01621477|3684779|B1||Male|Gender||Participants|Count of Participants|8|8.0||||||
3859119|NCT01621477|3684779|B1||Female|Gender||Participants|Count of Participants|9|9.0||||||
3859120|NCT01621477|3684779|B1|||Age||years|Median|6.97|6.97|Full Range|||0.89|19.68|
3859121|NCT01621477|3684779|B1|||Age||years|Mean|8.84|8.84|Standard Deviation|5.84|5.84|||
3859122|NCT01621191|3684789|B1|Japan||Region of Enrollment||participants|Number|148|148.0||||||
3859123|NCT01621191|3684789|B1|Japanese||Race/Ethnicity, Customized||participants|Number|148|148.0||||||
3859124|NCT01621191|3684789|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3859125|NCT01621191|3684789|B1||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3859126|NCT01621191|3684789|B1|||Age||years|Mean|47.3|47.3|Standard Deviation|11.9|11.9|||
3859127|NCT01621178|3684800|B4|||Estimated Glomerular Filtration Rate (eGFR)||milliliter/minute/1.73 square meter|Mean|38.3|38.3|Standard Deviation|12.83|12.83|||
3859128|NCT01621178|3684801|B3|||Estimated Glomerular Filtration Rate (eGFR)||milliliter/minute/1.73 square meter|Mean|38.1|38.1|Standard Deviation|13.24|13.24|||
3859129|NCT01621178|3684802|B2|||Estimated Glomerular Filtration Rate (eGFR)||milliliter/minute/1.73 square meter|Mean|38.3|38.3|Standard Deviation|12.31|12.31|||
3859130|NCT01621178|3684803|B1|||Estimated Glomerular Filtration Rate (eGFR)||milliliter/minute/1.73 square meter|Mean|38.5|38.5|Standard Deviation|12.99|12.99|||
3859131|NCT01621178|3684800|B4|||Duration of Chronic Kidney Disease (CKD) Stage 3 or Higher||years|Mean|3.89|3.89|Standard Deviation|4.872|4.872|||
3859132|NCT01621178|3684801|B3|||Duration of Chronic Kidney Disease (CKD) Stage 3 or Higher||years|Mean|4.18|4.18|Standard Deviation|5.632|5.632|||
3859133|NCT01621178|3684802|B2|||Duration of Chronic Kidney Disease (CKD) Stage 3 or Higher||years|Mean|4.03|4.03|Standard Deviation|4.854|4.854|||
3859134|NCT01621178|3684803|B1|||Duration of Chronic Kidney Disease (CKD) Stage 3 or Higher||years|Mean|3.47|3.47|Standard Deviation|3.998|3.998|||
3859135|NCT01621178|3684800|B4|||Duration of Diabetes||years|Mean|18.08|18.08|Standard Deviation|8.748|8.748|||
3859136|NCT01621178|3684801|B3|||Duration of Diabetes||years|Mean|17.57|17.57|Standard Deviation|8.722|8.722|||
3859137|NCT01621178|3684802|B2|||Duration of Diabetes||years|Mean|17.95|17.95|Standard Deviation|8.788|8.788|||
3859138|NCT01621178|3684803|B1|||Duration of Diabetes||years|Mean|18.71|18.71|Standard Deviation|8.742|8.742|||
3859139|NCT01621178|3684800|B4|||Hemoglobin A1C (HbA1c) at Baseline||Percentage of HbA1c|Mean|8.57|8.57|Standard Deviation|0.973|0.973|||
3859140|NCT01621178|3684801|B3|||Hemoglobin A1C (HbA1c) at Baseline||Percentage of HbA1c|Mean|8.59|8.59|Standard Deviation|0.860|0.86|||
3859141|NCT01621178|3684802|B2|||Hemoglobin A1C (HbA1c) at Baseline||Percentage of HbA1c|Mean|8.57|8.57|Standard Deviation|1.088|1.088|||
3859142|NCT01621178|3684803|B1|||Hemoglobin A1C (HbA1c) at Baseline||Percentage of HbA1c|Mean|8.56|8.56|Standard Deviation|0.966|0.966|||
3859143|NCT01621178|3684800|B4|||Body Mass Index (BMI)||kilogram/square meter (kg/m^2)|Mean|32.50|32.5|Standard Deviation|5.248|5.248|||
3859144|NCT01621178|3684801|B3|||Body Mass Index (BMI)||kilogram/square meter (kg/m^2)|Mean|32.11|32.11|Standard Deviation|4.841|4.841|||
3859145|NCT01621178|3684802|B2|||Body Mass Index (BMI)||kilogram/square meter (kg/m^2)|Mean|33.00|33.0|Standard Deviation|5.546|5.546|||
3859146|NCT01621178|3684803|B1|||Body Mass Index (BMI)||kilogram/square meter (kg/m^2)|Mean|32.39|32.39|Standard Deviation|5.324|5.324|||
3859147|NCT01621178|3684800|B4|||Body Weight||kilogram (kg)|Mean|89.06|89.06|Standard Deviation|17.653|17.653|||
3859148|NCT01621178|3684801|B3|||Body Weight||kilogram (kg)|Mean|88.14|88.14|Standard Deviation|16.015|16.015|||
3859149|NCT01621178|3684802|B2|||Body Weight||kilogram (kg)|Mean|90.88|90.88|Standard Deviation|18.301|18.301|||
3859150|NCT01621178|3684803|B1|||Body Weight||kilogram (kg)|Mean|88.20|88.2|Standard Deviation|18.488|18.488|||
3859151|NCT01621178|3684800|B4|Spain||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3859152|NCT01621178|3684801|B3|Spain||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3859153|NCT01621178|3684802|B2|Spain||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3859154|NCT01621178|3684803|B1|Spain||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3859155|NCT01621178|3684800|B4|South Africa||Region of Enrollment||Participants|Count of Participants|51|51.0||||||
3859156|NCT01621178|3684801|B3|South Africa||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3859157|NCT01621178|3684802|B2|South Africa||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3859158|NCT01621178|3684803|B1|South Africa||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3859159|NCT01621178|3684800|B4|Mexico||Region of Enrollment||Participants|Count of Participants|53|53.0||||||
3859160|NCT01621178|3684801|B3|Mexico||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3859161|NCT01621178|3684802|B2|Mexico||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3859162|NCT01621178|3684803|B1|Mexico||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3859163|NCT01621178|3684800|B4|Poland||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3859164|NCT01621178|3684801|B3|Poland||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3859165|NCT01621178|3684802|B2|Poland||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3859166|NCT01621178|3684803|B1|Poland||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3859167|NCT01621178|3684800|B4|Brazil||Region of Enrollment||Participants|Count of Participants|141|141.0||||||
3859168|NCT01621178|3684801|B3|Brazil||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3859169|NCT01621178|3684802|B2|Brazil||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
3859170|NCT01621178|3684803|B1|Brazil||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3859171|NCT01621178|3684800|B4|Ukraine||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3859172|NCT01621178|3684801|B3|Ukraine||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3859173|NCT01621178|3684802|B2|Ukraine||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3859174|NCT01621178|3684803|B1|Ukraine||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3859175|NCT01621178|3684800|B4|United States||Region of Enrollment||Participants|Count of Participants|182|182.0||||||
3859176|NCT01621178|3684801|B3|United States||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
3859177|NCT01621178|3684802|B2|United States||Region of Enrollment||Participants|Count of Participants|59|59.0||||||
3859178|NCT01621178|3684803|B1|United States||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
3859179|NCT01621178|3684800|B4|Hungary||Region of Enrollment||Participants|Count of Participants|55|55.0||||||
3859180|NCT01621178|3684801|B3|Hungary||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3859181|NCT01621178|3684802|B2|Hungary||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3859182|NCT01621178|3684803|B1|Hungary||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3859183|NCT01621178|3684800|B4|Romania||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3859184|NCT01621178|3684801|B3|Romania||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3859185|NCT01621178|3684802|B2|Romania||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3859186|NCT01621178|3684803|B1|Romania||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3859187|NCT01621178|3684800|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3859188|NCT01621178|3684801|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3859189|NCT01621178|3684802|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3859190|NCT01621178|3684803|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3859191|NCT01621178|3684800|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3859192|NCT01621178|3684801|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3859193|NCT01621178|3684802|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3859194|NCT01621178|3684803|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3859195|NCT01621178|3684800|B4||White|Race (NIH/OMB)||Participants|Count of Participants|393|393.0||||||
3859196|NCT01621178|3684801|B3||White|Race (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
3859197|NCT01621178|3684802|B2||White|Race (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
3859198|NCT01621178|3684803|B1||White|Race (NIH/OMB)||Participants|Count of Participants|137|137.0||||||
3859199|NCT01621178|3684800|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3859200|NCT01621178|3684801|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3859201|NCT01621178|3684802|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3859202|NCT01621178|3684803|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3859203|NCT01621178|3684800|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3859204|NCT01621178|3684801|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859205|NCT01621178|3684802|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859206|NCT01621178|3684803|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3859207|NCT01621178|3684800|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3859208|NCT01621178|3684801|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3859209|NCT01621178|3684802|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3859210|NCT01621178|3684803|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3859211|NCT01621178|3684800|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3859212|NCT01621178|3684801|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3859213|NCT01621178|3684802|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3859214|NCT01621178|3684803|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3859215|NCT01621178|3684800|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859216|NCT01621178|3684801|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859217|NCT01621178|3684802|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859218|NCT01621178|3684803|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859219|NCT01621178|3684800|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|344|344.0||||||
3859220|NCT01621178|3684801|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|114|114.0||||||
3859221|NCT01621178|3684802|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
3859222|NCT01621178|3684803|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
3859223|NCT01621178|3684800|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|232|232.0||||||
3859224|NCT01621178|3684801|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3859225|NCT01621178|3684802|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3859226|NCT01621178|3684803|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3859227|NCT01621178|3684800|B4||Male|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
3859228|NCT01621178|3684801|B3||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3859229|NCT01621178|3684802|B2||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3859230|NCT01621178|3684803|B1||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3859231|NCT01621178|3684800|B4||Female|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
3859232|NCT01621178|3684801|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3859233|NCT01621178|3684802|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3859234|NCT01621178|3684803|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3859235|NCT01621178|3684800|B4|||Age||years|Mean|64.6|64.6|Standard Deviation|8.60|8.6|||
3859236|NCT01621178|3684801|B3|||Age||years|Mean|64.7|64.7|Standard Deviation|8.83|8.83|||
3859237|NCT01621178|3684802|B2|||Age||years|Mean|64.7|64.7|Standard Deviation|8.61|8.61|||
3859238|NCT01621178|3684803|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|8.41|8.41|||
3859239|NCT01621126|3684897|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3859240|NCT01621126|3684897|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3859241|NCT01621126|3684897|B1|||Age||years|Mean|28.4|28.4|Full Range|||15.0|66.0|
3859242|NCT01621126|3684897|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3859243|NCT01621126|3684897|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3859244|NCT01621126|3684897|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3859245|NCT01621009|3684901|B5|Not Abstinent||7-day point prevalence abstinence|Participants provided breath samples for carbon monoxide(CO)testing at all visits and provided a blood sample to assess cotinine (the first metabolite of nicotine)levels at baseline and again at end of treatment.|participants|Number|397|397.0||||||
3859246|NCT01621009|3684902|B4|Not Abstinent||7-day point prevalence abstinence|Participants provided breath samples for carbon monoxide(CO)testing at all visits and provided a blood sample to assess cotinine (the first metabolite of nicotine)levels at baseline and again at end of treatment.|participants|Number|99|99.0||||||
3859326|NCT01620983|3684916|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859247|NCT01621009|3684903|B3|Not Abstinent||7-day point prevalence abstinence|Participants provided breath samples for carbon monoxide(CO)testing at all visits and provided a blood sample to assess cotinine (the first metabolite of nicotine)levels at baseline and again at end of treatment.|participants|Number|106|106.0||||||
3859248|NCT01621009|3684904|B2|Not Abstinent||7-day point prevalence abstinence|Participants provided breath samples for carbon monoxide(CO)testing at all visits and provided a blood sample to assess cotinine (the first metabolite of nicotine)levels at baseline and again at end of treatment.|participants|Number|100|100.0||||||
3859249|NCT01621009|3684905|B1|Not Abstinent||7-day point prevalence abstinence|Participants provided breath samples for carbon monoxide(CO)testing at all visits and provided a blood sample to assess cotinine (the first metabolite of nicotine)levels at baseline and again at end of treatment.|participants|Number|92|92.0||||||
3859250|NCT01621009|3684901|B5|Abstinent||7-day point prevalence abstinence|Participants provided breath samples for carbon monoxide(CO)testing at all visits and provided a blood sample to assess cotinine (the first metabolite of nicotine)levels at baseline and again at end of treatment.|participants|Number|66|66.0||||||
3859251|NCT01621009|3684902|B4|Abstinent||7-day point prevalence abstinence|Participants provided breath samples for carbon monoxide(CO)testing at all visits and provided a blood sample to assess cotinine (the first metabolite of nicotine)levels at baseline and again at end of treatment.|participants|Number|14|14.0||||||
3859252|NCT01621009|3684903|B3|Abstinent||7-day point prevalence abstinence|Participants provided breath samples for carbon monoxide(CO)testing at all visits and provided a blood sample to assess cotinine (the first metabolite of nicotine)levels at baseline and again at end of treatment.|participants|Number|15|15.0||||||
3859253|NCT01621009|3684904|B2|Abstinent||7-day point prevalence abstinence|Participants provided breath samples for carbon monoxide(CO)testing at all visits and provided a blood sample to assess cotinine (the first metabolite of nicotine)levels at baseline and again at end of treatment.|participants|Number|16|16.0||||||
3859254|NCT01621009|3684905|B1|Abstinent||7-day point prevalence abstinence|Participants provided breath samples for carbon monoxide(CO)testing at all visits and provided a blood sample to assess cotinine (the first metabolite of nicotine)levels at baseline and again at end of treatment.|participants|Number|21|21.0||||||
3859255|NCT01621009|3684901|B5|United States||Region of Enrollment||participants|Number|463|463.0||||||
3859256|NCT01621009|3684902|B4|United States||Region of Enrollment||participants|Number|113|113.0||||||
3859257|NCT01621009|3684903|B3|United States||Region of Enrollment||participants|Number|121|121.0||||||
3859258|NCT01621009|3684904|B2|United States||Region of Enrollment||participants|Number|116|116.0||||||
3859259|NCT01621009|3684905|B1|United States||Region of Enrollment||participants|Number|113|113.0||||||
3859260|NCT01621009|3684901|B5||Male|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
3859261|NCT01621009|3684902|B4||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3859262|NCT01621009|3684903|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3859263|NCT01621009|3684904|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3859264|NCT01621009|3684905|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3859265|NCT01621009|3684901|B5||Female|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
3859266|NCT01621009|3684902|B4||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3859267|NCT01621009|3684903|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3859268|NCT01621009|3684904|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3859269|NCT01621009|3684905|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3859270|NCT01621009|3684901|B5|||Age||years|Mean|38.76|38.76|Standard Deviation|12.16|12.16|||
3859271|NCT01621009|3684902|B4|||Age||years|Mean|39.42|39.42|Standard Deviation|11.34|11.34|||
3859272|NCT01621009|3684903|B3|||Age||years|Mean|37.82|37.82|Standard Deviation|12.82|12.82|||
3859273|NCT01621009|3684904|B2|||Age||years|Mean|41.03|41.03|Standard Deviation|12.64|12.64|||
3859274|NCT01621009|3684905|B1|||Age||years|Mean|36.76|36.76|Standard Deviation|11.39|11.39|||
3859275|NCT01621009|3684901|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3859276|NCT01621009|3684902|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3859277|NCT01621009|3684903|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3859278|NCT01621009|3684904|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3859279|NCT01621009|3684905|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3859280|NCT01621009|3684901|B5||Between 18 and 65 years|Age||Participants|Count of Participants|463|463.0||||||
3859281|NCT01621009|3684902|B4||Between 18 and 65 years|Age||Participants|Count of Participants|113|113.0||||||
3859282|NCT01621009|3684903|B3||Between 18 and 65 years|Age||Participants|Count of Participants|121|121.0||||||
3859283|NCT01621009|3684904|B2||Between 18 and 65 years|Age||Participants|Count of Participants|116|116.0||||||
3859284|NCT01621009|3684905|B1||Between 18 and 65 years|Age||Participants|Count of Participants|113|113.0||||||
3859285|NCT01621009|3684901|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3859286|NCT01621009|3684902|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3859287|NCT01621009|3684903|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3859288|NCT01621009|3684904|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3859289|NCT01621009|3684905|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3859290|NCT01620983|3684916|B4|||Short Physical Performance Battery|The Short Physical Performance Battery measures actual physical performance of four common daily physical activities including standing balance, single standing from a chair, repeated standing from a chair, and a 4 meter walk test. Scores range from 0 to 12 with higher scores indicating better physical performance.|units on scale|Mean|7.8|7.8|Standard Deviation|2.9|2.9|||
3859327|NCT01620983|3684917|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859385|NCT01620762|3684950|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3859291|NCT01620983|3684917|B3|||Short Physical Performance Battery|The Short Physical Performance Battery measures actual physical performance of four common daily physical activities including standing balance, single standing from a chair, repeated standing from a chair, and a 4 meter walk test. Scores range from 0 to 12 with higher scores indicating better physical performance.|units on scale|Mean|7.9|7.9|Standard Deviation|2.6|2.6|||
3859292|NCT01620983|3684918|B2|||Short Physical Performance Battery|The Short Physical Performance Battery measures actual physical performance of four common daily physical activities including standing balance, single standing from a chair, repeated standing from a chair, and a 4 meter walk test. Scores range from 0 to 12 with higher scores indicating better physical performance.|units on scale|Mean|7.5|7.5|Standard Deviation|2.9|2.9|||
3859293|NCT01620983|3684919|B1|||Short Physical Performance Battery|The Short Physical Performance Battery measures actual physical performance of four common daily physical activities including standing balance, single standing from a chair, repeated standing from a chair, and a 4 meter walk test. Scores range from 0 to 12 with higher scores indicating better physical performance.|units on scale|Mean|7.6|7.6|Standard Deviation|3.2|3.2|||
3859294|NCT01620983|3684916|B4|||Six minute walk test||meters|Mean|297|297.0|Standard Deviation|120|120.0|||
3859295|NCT01620983|3684917|B3|||Six minute walk test||meters|Mean|309|309.0|Standard Deviation|106|106.0|||
3859296|NCT01620983|3684918|B2|||Six minute walk test||meters|Mean|279|279.0|Standard Deviation|132|132.0|||
3859297|NCT01620983|3684919|B1|||Six minute walk test||meters|Mean|305|305.0|Standard Deviation|121|121.0|||
3859298|NCT01620983|3684916|B4|||Pain Catastrophizing Scale|A scale that quantifies the extent to which a participant catastrophizes about their pain. Score range from 0 to 52 with higher scores denoting greater pain catastrophizing|units on scale|Mean|30.0|30.0|Standard Deviation|9.3|9.3|||
3859299|NCT01620983|3684917|B3|||Pain Catastrophizing Scale|A scale that quantifies the extent to which a participant catastrophizes about their pain. Score range from 0 to 52 with higher scores denoting greater pain catastrophizing|units on scale|Mean|29.7|29.7|Standard Deviation|9.2|9.2|||
3859300|NCT01620983|3684918|B2|||Pain Catastrophizing Scale|A scale that quantifies the extent to which a participant catastrophizes about their pain. Score range from 0 to 52 with higher scores denoting greater pain catastrophizing|units on scale|Mean|30.0|30.0|Standard Deviation|9.2|9.2|||
3859301|NCT01620983|3684919|B1|||Pain Catastrophizing Scale|A scale that quantifies the extent to which a participant catastrophizes about their pain. Score range from 0 to 52 with higher scores denoting greater pain catastrophizing|units on scale|Mean|30.4|30.4|Standard Deviation|9.6|9.6|||
3859302|NCT01620983|3684916|B4|||WOMAC Function Scale|A self report scale that quantifies the extent of difficulty with daily function. The scale ranges from 0 to 68 with higher scores denoting more difficult daily function.|units on scale|Mean|37.2|37.2|Standard Deviation|11.6|11.6|||
3859303|NCT01620983|3684917|B3|||WOMAC Function Scale|A self report scale that quantifies the extent of difficulty with daily function. The scale ranges from 0 to 68 with higher scores denoting more difficult daily function.|units on scale|Mean|36.0|36.0|Standard Deviation|11.1|11.1|||
3859304|NCT01620983|3684918|B2|||WOMAC Function Scale|A self report scale that quantifies the extent of difficulty with daily function. The scale ranges from 0 to 68 with higher scores denoting more difficult daily function.|units on scale|Mean|37.1|37.1|Standard Deviation|11.8|11.8|||
3859305|NCT01620983|3684919|B1|||WOMAC Function Scale|A self report scale that quantifies the extent of difficulty with daily function. The scale ranges from 0 to 68 with higher scores denoting more difficult daily function.|units on scale|Mean|38.6|38.6|Standard Deviation|11.8|11.8|||
3859306|NCT01620983|3684916|B4|||WOMAC Pain Scale|A self report scale that quantifies the extent of function limiting pain. The scale ranges from 0 to 20 with higher scores denoting worse activity related pain.|units on scale|Mean|11.4|11.4|Standard Deviation|3.4|3.4|||
3859307|NCT01620983|3684917|B3|||WOMAC Pain Scale|A self report scale that quantifies the extent of function limiting pain. The scale ranges from 0 to 20 with higher scores denoting worse activity related pain.|units on scale|Mean|11.4|11.4|Standard Deviation|3.4|3.4|||
3859308|NCT01620983|3684918|B2|||WOMAC Pain Scale|A self report scale that quantifies the extent of function limiting pain. The scale ranges from 0 to 20 with higher scores denoting worse activity related pain.|units on scale|Mean|11.3|11.3|Standard Deviation|3.5|3.5|||
3859309|NCT01620983|3684919|B1|||WOMAC Pain Scale|A self report scale that quantifies the extent of function limiting pain. The scale ranges from 0 to 20 with higher scores denoting worse activity related pain.|units on scale|Mean|11.6|11.6|Standard Deviation|3.1|3.1|||
3859310|NCT01620983|3684916|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3859311|NCT01620983|3684917|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3859312|NCT01620983|3684918|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3859313|NCT01620983|3684919|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859314|NCT01620983|3684916|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3859315|NCT01620983|3684917|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3859316|NCT01620983|3684918|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3859317|NCT01620983|3684919|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3859318|NCT01620983|3684916|B4||White|Race (NIH/OMB)||Participants|Count of Participants|247|247.0||||||
3859319|NCT01620983|3684917|B3||White|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
3859320|NCT01620983|3684918|B2||White|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3859321|NCT01620983|3684919|B1||White|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3859322|NCT01620983|3684916|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|139|139.0||||||
3859323|NCT01620983|3684917|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3859324|NCT01620983|3684918|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3859325|NCT01620983|3684919|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3859328|NCT01620983|3684918|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859329|NCT01620983|3684919|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859330|NCT01620983|3684916|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3859331|NCT01620983|3684917|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3859332|NCT01620983|3684918|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3859333|NCT01620983|3684919|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3859334|NCT01620983|3684916|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859335|NCT01620983|3684917|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859336|NCT01620983|3684918|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859337|NCT01620983|3684919|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859338|NCT01620983|3684916|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3859339|NCT01620983|3684917|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3859340|NCT01620983|3684918|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3859341|NCT01620983|3684919|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859342|NCT01620983|3684916|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|383|383.0||||||
3859343|NCT01620983|3684917|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
3859344|NCT01620983|3684918|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
3859345|NCT01620983|3684919|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|127|127.0||||||
3859346|NCT01620983|3684916|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3859347|NCT01620983|3684917|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3859348|NCT01620983|3684918|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3859349|NCT01620983|3684919|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3859350|NCT01620983|3684916|B4||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3859351|NCT01620983|3684917|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3859352|NCT01620983|3684918|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3859353|NCT01620983|3684919|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3859354|NCT01620983|3684916|B4||Female|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
3859355|NCT01620983|3684917|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3859356|NCT01620983|3684918|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3859357|NCT01620983|3684919|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3859358|NCT01620983|3684916|B4|||Age||years|Mean|63.2|63.2|Standard Deviation|8.0|8.0|||
3859359|NCT01620983|3684917|B3|||Age||years|Mean|62.7|62.7|Standard Deviation|7.7|7.7|||
3859360|NCT01620983|3684918|B2|||Age||years|Mean|64.2|64.2|Standard Deviation|8.5|8.5|||
3859361|NCT01620983|3684919|B1|||Age||years|Mean|62.6|62.6|Standard Deviation|7.9|7.9|||
3859362|NCT01620762|3684947|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3859363|NCT01620762|3684948|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3859364|NCT01620762|3684949|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3859365|NCT01620762|3684950|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3859366|NCT01620762|3684947|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1389|1389.0||||||
3859367|NCT01620762|3684948|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|463|463.0||||||
3859368|NCT01620762|3684949|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|468|468.0||||||
3859369|NCT01620762|3684950|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|458|458.0||||||
3859370|NCT01620762|3684947|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3859371|NCT01620762|3684948|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3859372|NCT01620762|3684949|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3859373|NCT01620762|3684950|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3859374|NCT01620762|3684947|B4||Male|Sex: Female, Male||Participants|Count of Participants|473|473.0||||||
3859375|NCT01620762|3684948|B3||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3859376|NCT01620762|3684949|B2||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3859377|NCT01620762|3684950|B1||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3859378|NCT01620762|3684947|B4||Female|Sex: Female, Male||Participants|Count of Participants|935|935.0||||||
3859379|NCT01620762|3684948|B3||Female|Sex: Female, Male||Participants|Count of Participants|317|317.0||||||
3859380|NCT01620762|3684949|B2||Female|Sex: Female, Male||Participants|Count of Participants|317|317.0||||||
3859381|NCT01620762|3684950|B1||Female|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
3859382|NCT01620762|3684947|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3859383|NCT01620762|3684948|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3859384|NCT01620762|3684949|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3859386|NCT01620762|3684947|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1318|1318.0||||||
3859387|NCT01620762|3684948|B3||Between 18 and 65 years|Age||Participants|Count of Participants|438|438.0||||||
3859388|NCT01620762|3684949|B2||Between 18 and 65 years|Age||Participants|Count of Participants|441|441.0||||||
3859389|NCT01620762|3684950|B1||Between 18 and 65 years|Age||Participants|Count of Participants|439|439.0||||||
3859390|NCT01620762|3684947|B4||<=18 years|Age||Participants|Count of Participants|90|90.0||||||
3859391|NCT01620762|3684948|B3||<=18 years|Age||Participants|Count of Participants|32|32.0||||||
3859392|NCT01620762|3684949|B2||<=18 years|Age||Participants|Count of Participants|29|29.0||||||
3859393|NCT01620762|3684950|B1||<=18 years|Age||Participants|Count of Participants|29|29.0||||||
3859394|NCT01620593|3684978|B3|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3859395|NCT01620593|3684979|B2|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3859396|NCT01620593|3684980|B1|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3859397|NCT01620593|3684978|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3859398|NCT01620593|3684979|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3859399|NCT01620593|3684980|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3859400|NCT01620593|3684978|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3859401|NCT01620593|3684979|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3859402|NCT01620593|3684980|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3859403|NCT01620593|3684978|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3859404|NCT01620593|3684979|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3859405|NCT01620593|3684980|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3859406|NCT01620593|3684978|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3859407|NCT01620593|3684979|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3859408|NCT01620593|3684980|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3859409|NCT01620593|3684978|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3859410|NCT01620593|3684979|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3859411|NCT01620593|3684980|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3859412|NCT01620528|3684995|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3859413|NCT01620528|3684996|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3859414|NCT01620528|3684997|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3859415|NCT01620528|3684998|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3859416|NCT01620528|3684995|B4||Female|Sex: Female, Male||Participants|Count of Participants|871|871.0||||||
3859417|NCT01620528|3684996|B3||Female|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
3859418|NCT01620528|3684997|B2||Female|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
3859419|NCT01620528|3684998|B1||Female|Sex: Female, Male||Participants|Count of Participants|374|374.0||||||
3859420|NCT01620528|3684995|B4|||Age||years|Mean|31.5|31.5|Standard Deviation|6.24|6.24|||
3859421|NCT01620528|3684996|B3|||Age||years|Mean|31.2|31.2|Standard Deviation|6.33|6.33|||
3859422|NCT01620528|3684997|B2|||Age||years|Mean|31.5|31.5|Standard Deviation|5.99|5.99|||
3859423|NCT01620528|3684998|B1|||Age||years|Mean|31.7|31.7|Standard Deviation|6.35|6.35|||
3859424|NCT01620489|3685338|B3|||Glycosylated haemoglobin (%)(HbA1c)||Percent (%) glycosylated haemoglobin|Mean|8.04|8.04|Standard Deviation|0.823|0.823|||
3859425|NCT01620489|3685339|B2|||Glycosylated haemoglobin (%)(HbA1c)||Percent (%) glycosylated haemoglobin|Mean|8.00|8.0|Standard Deviation|0.853|0.853|||
3859426|NCT01620489|3685340|B1|||Glycosylated haemoglobin (%)(HbA1c)||Percent (%) glycosylated haemoglobin|Mean|8.08|8.08|Standard Deviation|0.792|0.792|||
3859427|NCT01620489|3685338|B3|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.38|9.38|Standard Deviation|3.061|3.061|||
3859428|NCT01620489|3685339|B2|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.27|9.27|Standard Deviation|2.842|2.842|||
3859429|NCT01620489|3685340|B1|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.48|9.48|Standard Deviation|3.270|3.27|||
3859430|NCT01620489|3685338|B3||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3859431|NCT01620489|3685339|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3859432|NCT01620489|3685340|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3859433|NCT01620489|3685338|B3||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3859434|NCT01620489|3685339|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3859435|NCT01620489|3685340|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3859436|NCT01620489|3685338|B3|||Age||years|Mean|67.2|67.2|Standard Deviation|8.2|8.2|||
3859437|NCT01620489|3685339|B2|||Age||years|Mean|66.3|66.3|Standard Deviation|8.0|8.0|||
3859438|NCT01620489|3685340|B1|||Age||years|Mean|68.0|68.0|Standard Deviation|8.3|8.3|||
3859439|NCT01620255|3685357|B6||Male|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
3859440|NCT01620255|3685358|B5||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3859441|NCT01620255|3685359|B4||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3859442|NCT01620255|3685360|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3859443|NCT01620255|3685361|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3859444|NCT01620255|3685362|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3859445|NCT01620255|3685357|B6||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3859446|NCT01620255|3685358|B5||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3859447|NCT01620255|3685359|B4||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3859448|NCT01620255|3685360|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3859449|NCT01620255|3685361|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3859450|NCT01620255|3685362|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3859451|NCT01620255|3685357|B6|||Age||years|Mean|40.2|40.2|Standard Deviation|13.2|13.2|||
3859452|NCT01620255|3685358|B5|||Age||years|Mean|41.3|41.3|Standard Deviation|13.2|13.2|||
3859453|NCT01620255|3685359|B4|||Age||years|Mean|37.7|37.7|Standard Deviation|12.4|12.4|||
3859454|NCT01620255|3685360|B3|||Age||years|Mean|42.1|42.1|Standard Deviation|14.7|14.7|||
3859455|NCT01620255|3685361|B2|||Age||years|Mean|41.3|41.3|Standard Deviation|12.5|12.5|||
3859456|NCT01620255|3685362|B1|||Age||years|Mean|38.6|38.6|Standard Deviation|12.7|12.7|||
3859457|NCT01620177|3685443|B1|United States||Region of Enrollment||participants|Number|98|98.0||||||
3859458|NCT01620177|3685443|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3859459|NCT01620177|3685443|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3859460|NCT01620177|3685443|B1||White|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3859461|NCT01620177|3685443|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3859462|NCT01620177|3685443|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859463|NCT01620177|3685443|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3859464|NCT01620177|3685443|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859465|NCT01620177|3685443|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3859466|NCT01620177|3685443|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
3859467|NCT01620177|3685443|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3859468|NCT01620177|3685443|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3859469|NCT01620177|3685443|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3859470|NCT01620177|3685443|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3859471|NCT01620177|3685443|B1||Between 18 and 65 years|Age||Participants|Count of Participants|98|98.0||||||
3859472|NCT01620177|3685443|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3859473|NCT01620138|3685466|B3|Brazil||Region of Enrollment||participants|Number|21|21.0||||||
3859474|NCT01620138|3685467|B2|Brazil||Region of Enrollment||participants|Number|9|9.0||||||
3859475|NCT01620138|3685468|B1|Brazil||Region of Enrollment||participants|Number|12|12.0||||||
3859476|NCT01620138|3685466|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3859477|NCT01620138|3685467|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3859478|NCT01620138|3685468|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3859479|NCT01620138|3685466|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3859480|NCT01620138|3685467|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3859481|NCT01620138|3685468|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3859482|NCT01620138|3685466|B3|||Age||years|Median|54|54.0|Full Range|||24.0|65.0|
3859483|NCT01620138|3685467|B2|||Age||years|Median|54|54.0|Full Range|||36.0|65.0|
3859484|NCT01620138|3685468|B1|||Age||years|Median|33|33.0|Full Range|||24.0|63.0|
3859485|NCT01620086|3685475|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
3859486|NCT01620086|3685476|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3859487|NCT01620086|3685477|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3859488|NCT01620086|3685475|B3||Male|Gender||Participants|Count of Participants|6|6.0||||||
3859489|NCT01620086|3685476|B2||Male|Gender||Participants|Count of Participants|4|4.0||||||
3859490|NCT01620086|3685477|B1||Male|Gender||Participants|Count of Participants|2|2.0||||||
3859491|NCT01620086|3685475|B3||Female|Gender||Participants|Count of Participants|8|8.0||||||
3859492|NCT01620086|3685476|B2||Female|Gender||Participants|Count of Participants|4|4.0||||||
3859493|NCT01620086|3685477|B1||Female|Gender||Participants|Count of Participants|4|4.0||||||
3859494|NCT01620086|3685475|B3|||Age||years|Mean|35.2|35.2|Standard Deviation|8.75|8.75|||
3859495|NCT01620086|3685476|B2|||Age||years|Mean|29|29.0|Standard Deviation|9.72|9.72|||
3859496|NCT01620086|3685477|B1|||Age||years|Mean|49.5|49.5|Standard Deviation|8.22|8.22|||
3859497|NCT01620086|3685475|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3859498|NCT01620086|3685476|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3859499|NCT01620086|3685477|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3859500|NCT01620086|3685475|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3859501|NCT01620086|3685476|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3859502|NCT01620086|3685477|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3859503|NCT01620086|3685475|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3859504|NCT01620086|3685476|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3859505|NCT01620086|3685477|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3859506|NCT01620060|3685498|B1|United States||Region of Enrollment||participants|Number|105|105.0||||||
3859507|NCT01620060|3685498|B1|White||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
3859508|NCT01620060|3685498|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3859509|NCT01620060|3685498|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3859510|NCT01620060|3685498|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3859511|NCT01620060|3685498|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3859512|NCT01620060|3685498|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3859513|NCT01620060|3685498|B1||<=18 years|Age||Participants|Count of Participants|105|105.0||||||
3859514|NCT01620047|3685504|B4|United States||Region of Enrollment||participants|Number|60|60.0||||||
3859515|NCT01620047|3685505|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3859516|NCT01620047|3685506|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3859517|NCT01620047|3685507|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3859518|NCT01620047|3685504|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3859519|NCT01620047|3685505|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3859520|NCT01620047|3685506|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3859521|NCT01620047|3685507|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3859522|NCT01620047|3685504|B4||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3859523|NCT01620047|3685505|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3859524|NCT01620047|3685506|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3859525|NCT01620047|3685507|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3859526|NCT01620047|3685504|B4|||Age||years|Mean|68|68.0|Standard Deviation|10|10.0|||
3859527|NCT01620047|3685505|B3|||Age||years|Mean|67|67.0|Standard Deviation|9|9.0|||
3859528|NCT01620047|3685506|B2|||Age||years|Mean|67|67.0|Standard Deviation|12|12.0|||
3859529|NCT01620047|3685507|B1|||Age||years|Mean|69|69.0|Standard Deviation|9|9.0|||
3859530|NCT01620047|3685504|B4||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
3859531|NCT01620047|3685505|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3859532|NCT01620047|3685506|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3859533|NCT01620047|3685507|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3859534|NCT01620047|3685504|B4||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3859535|NCT01620047|3685505|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3859536|NCT01620047|3685506|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3859537|NCT01620047|3685507|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3859538|NCT01620047|3685504|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3859539|NCT01620047|3685505|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3859540|NCT01620047|3685506|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3859541|NCT01620047|3685507|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3859542|NCT01619982|3685517|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3859543|NCT01619982|3685518|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3859544|NCT01619982|3685519|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3859545|NCT01619982|3685517|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3859546|NCT01619982|3685518|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3859547|NCT01619982|3685519|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3859548|NCT01619982|3685517|B3|0 day to 12 months||Age, Customized||Participants|Count of Participants|32|32.0||||||
3859549|NCT01619982|3685518|B2|0 day to 12 months||Age, Customized||Participants|Count of Participants|12|12.0||||||
3859550|NCT01619982|3685519|B1|0 day to 12 months||Age, Customized||Participants|Count of Participants|20|20.0||||||
3859551|NCT01619878|3685536|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3859552|NCT01619878|3685536|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3859553|NCT01619878|3685536|B1|||Age||days|Mean|99.1|99.1|Standard Deviation|51.75|51.75|||
3859554|NCT01619800|3685548|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3859555|NCT01619800|3685550|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3859556|NCT01619800|3685548|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3859557|NCT01619800|3685550|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3859558|NCT01619800|3685548|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3859559|NCT01619800|3685550|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3859560|NCT01619800|3685548|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3859561|NCT01619800|3685550|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3859562|NCT01619800|3685548|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3859563|NCT01619800|3685550|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3859564|NCT01619787|3685557|B3|||Delay Discounting $100 reward (DD 100)|The delay discounting task involved allowing participants to make choices between smaller immediate monetary rewards and a larger, fixed, delayed reward. Participants completed both increasing amount of the immediate reward, and decreasing amount of the immediate reward, in a randomized order, over a series of time delays (1 day, 2 days, etc). An indifference point was calculated as the amount of immediate reward that was equal to the delayed reward. From this area under the curve, or indifference proportion*delay proportion, was calculated, leading the a range of scores between 0 and 1.|indifference proportion*delay proportion|Mean|0.7|0.7|Standard Deviation|0.3|0.3|||
3859565|NCT01619787|3685558|B2|||Delay Discounting $100 reward (DD 100)|The delay discounting task involved allowing participants to make choices between smaller immediate monetary rewards and a larger, fixed, delayed reward. Participants completed both increasing amount of the immediate reward, and decreasing amount of the immediate reward, in a randomized order, over a series of time delays (1 day, 2 days, etc). An indifference point was calculated as the amount of immediate reward that was equal to the delayed reward. From this area under the curve, or indifference proportion*delay proportion, was calculated, leading the a range of scores between 0 and 1.|indifference proportion*delay proportion|Mean|0.7|0.7|Standard Deviation|0.3|0.3|||
3859566|NCT01619787|3685559|B1|||Delay Discounting $100 reward (DD 100)|The delay discounting task involved allowing participants to make choices between smaller immediate monetary rewards and a larger, fixed, delayed reward. Participants completed both increasing amount of the immediate reward, and decreasing amount of the immediate reward, in a randomized order, over a series of time delays (1 day, 2 days, etc). An indifference point was calculated as the amount of immediate reward that was equal to the delayed reward. From this area under the curve, or indifference proportion*delay proportion, was calculated, leading the a range of scores between 0 and 1.|indifference proportion*delay proportion|Mean|0.7|0.7|Standard Deviation|0.2|0.2|||
3859567|NCT01619787|3685557|B3|||Delay Discounting $10 reward (DD 10)|The delay discounting task involved allowing participants to make choices between smaller immediate monetary rewards and a larger, fixed, delayed reward. Participants completed both increasing amount of the immediate reward, and decreasing amount of the immediate reward, in a randomized order, over a series of time delays (1 day, 2 days, etc). An indifference point was calculated as the amount of immediate reward that was equal to the delayed reward. From this area under the curve, or indifference proportion*delay proportion, was calculated, leading the a range of scores between 0 and 1.|indifference proportion*delay proportion|Mean|0.6|0.6|Standard Deviation|0.3|0.3|||
3859568|NCT01619787|3685558|B2|||Delay Discounting $10 reward (DD 10)|The delay discounting task involved allowing participants to make choices between smaller immediate monetary rewards and a larger, fixed, delayed reward. Participants completed both increasing amount of the immediate reward, and decreasing amount of the immediate reward, in a randomized order, over a series of time delays (1 day, 2 days, etc). An indifference point was calculated as the amount of immediate reward that was equal to the delayed reward. From this area under the curve, or indifference proportion*delay proportion, was calculated, leading the a range of scores between 0 and 1.|indifference proportion*delay proportion|Mean|0.6|0.6|Standard Deviation|0.3|0.3|||
3859569|NCT01619787|3685559|B1|||Delay Discounting $10 reward (DD 10)|The delay discounting task involved allowing participants to make choices between smaller immediate monetary rewards and a larger, fixed, delayed reward. Participants completed both increasing amount of the immediate reward, and decreasing amount of the immediate reward, in a randomized order, over a series of time delays (1 day, 2 days, etc). An indifference point was calculated as the amount of immediate reward that was equal to the delayed reward. From this area under the curve, or indifference proportion*delay proportion, was calculated, leading the a range of scores between 0 and 1.|indifference proportion*delay proportion|Mean|0.7|0.7|Standard Deviation|0.3|0.3|||
3859570|NCT01619787|3685557|B3|||Relative Reinforcing Value Low Energy Dense Foods (RRV LED)|RRV was assessed using a computer program where subjects earned points toward food. Participants earned a point by clicking a mouse to meet schedule requirements, i.e. 20 clicks earned one portion of food on schedule one. Each subsequent schedule had double the requirements of the previous schedule. Participants were rewarded with their preferred food each time they completed the schedule requirements. The session ended when participants no longer wished to earn points towards food.|Highest response schedule completed|Mean|25.2|25.2|Standard Deviation|32.9|32.9|||
3859571|NCT01619787|3685558|B2|||Relative Reinforcing Value Low Energy Dense Foods (RRV LED)|RRV was assessed using a computer program where subjects earned points toward food. Participants earned a point by clicking a mouse to meet schedule requirements, i.e. 20 clicks earned one portion of food on schedule one. Each subsequent schedule had double the requirements of the previous schedule. Participants were rewarded with their preferred food each time they completed the schedule requirements. The session ended when participants no longer wished to earn points towards food.|Highest response schedule completed|Mean|23.9|23.9|Standard Deviation|30.4|30.4|||
3859572|NCT01619787|3685559|B1|||Relative Reinforcing Value Low Energy Dense Foods (RRV LED)|RRV was assessed using a computer program where subjects earned points toward food. Participants earned a point by clicking a mouse to meet schedule requirements, i.e. 20 clicks earned one portion of food on schedule one. Each subsequent schedule had double the requirements of the previous schedule. Participants were rewarded with their preferred food each time they completed the schedule requirements. The session ended when participants no longer wished to earn points towards food.|Highest response schedule completed|Mean|26.0|26.0|Standard Deviation|34.7|34.7|||
3859573|NCT01619787|3685557|B3|||Relative Reinforcing Value High Energy Dense Foods (RRV HED)|RRV was assessed using a computer program where subjects earned points toward food. Participants earned a point by clicking a mouse to meet schedule requirements, i.e. 20 clicks earned one portion of food on schedule one. Each subsequent schedule had double the requirements of the previous schedule. Participants were rewarded with their preferred food each time they completed the schedule requirements. The session ended when participants no longer wished to earn points towards food.|Highest Response schedule completed|Mean|14.7|14.7|Standard Deviation|38.8|38.8|||
3859574|NCT01619787|3685558|B2|||Relative Reinforcing Value High Energy Dense Foods (RRV HED)|RRV was assessed using a computer program where subjects earned points toward food. Participants earned a point by clicking a mouse to meet schedule requirements, i.e. 20 clicks earned one portion of food on schedule one. Each subsequent schedule had double the requirements of the previous schedule. Participants were rewarded with their preferred food each time they completed the schedule requirements. The session ended when participants no longer wished to earn points towards food.|Highest Response schedule completed|Mean|15.9|15.9|Standard Deviation|25.1|25.1|||
3859575|NCT01619787|3685559|B1|||Relative Reinforcing Value High Energy Dense Foods (RRV HED)|RRV was assessed using a computer program where subjects earned points toward food. Participants earned a point by clicking a mouse to meet schedule requirements, i.e. 20 clicks earned one portion of food on schedule one. Each subsequent schedule had double the requirements of the previous schedule. Participants were rewarded with their preferred food each time they completed the schedule requirements. The session ended when participants no longer wished to earn points towards food.|Highest Response schedule completed|Mean|13.8|13.8|Standard Deviation|50.4|50.4|||
3859576|NCT01619787|3685557|B3|||Body Mass Index|Body Mass Index (BMI) was measured at the end of the sixth study session; therefore, 5 participants were lost to follow up and this is measured with 212 participants.|kg/m^2|Mean|27.6|27.6|Standard Deviation|7.2|7.2|||
3859577|NCT01619787|3685558|B2|||Body Mass Index|Body Mass Index (BMI) was measured at the end of the sixth study session; therefore, 5 participants were lost to follow up and this is measured with 212 participants.|kg/m^2|Mean|22.2|22.2|Standard Deviation|2.0|2.0|||
3859578|NCT01619787|3685559|B1|||Body Mass Index|Body Mass Index (BMI) was measured at the end of the sixth study session; therefore, 5 participants were lost to follow up and this is measured with 212 participants.|kg/m^2|Mean|32.6|32.6|Standard Deviation|6.6|6.6|||
3859579|NCT01619787|3685557|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3859580|NCT01619787|3685558|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3859581|NCT01619787|3685559|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3859582|NCT01619787|3685557|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3859583|NCT01619787|3685558|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859584|NCT01619787|3685559|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3859585|NCT01619787|3685557|B3||White|Race (NIH/OMB)||Participants|Count of Participants|162|162.0||||||
3859586|NCT01619787|3685558|B2||White|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3859587|NCT01619787|3685559|B1||White|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3859588|NCT01619787|3685557|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3859589|NCT01619787|3685558|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3859590|NCT01619787|3685559|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3859591|NCT01619787|3685557|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859592|NCT01619787|3685558|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859593|NCT01619787|3685559|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859594|NCT01619787|3685557|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3859595|NCT01619787|3685558|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3859596|NCT01619787|3685559|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3859597|NCT01619787|3685557|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3859598|NCT01619787|3685558|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3859599|NCT01619787|3685559|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859600|NCT01619787|3685557|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859601|NCT01619787|3685558|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859602|NCT01619787|3685559|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859603|NCT01619787|3685557|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|210|210.0||||||
3859604|NCT01619787|3685558|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
3859605|NCT01619787|3685559|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3859606|NCT01619787|3685557|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3859607|NCT01619787|3685558|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859608|NCT01619787|3685559|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3859609|NCT01619787|3685557|B3||Male|Gender||Participants|Count of Participants|8|8.0||||||
3859610|NCT01619787|3685558|B2||Male|Gender||Participants|Count of Participants|5|5.0||||||
3859611|NCT01619787|3685559|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
3859612|NCT01619787|3685557|B3||Female|Gender||Participants|Count of Participants|204|204.0||||||
3859613|NCT01619787|3685558|B2||Female|Gender||Participants|Count of Participants|105|105.0||||||
3859614|NCT01619787|3685559|B1||Female|Gender||Participants|Count of Participants|99|99.0||||||
3859615|NCT01619787|3685557|B3|||Age||years|Mean|42.7|42.7|Standard Deviation|7.4|7.4|||
3859616|NCT01619787|3685558|B2|||Age||years|Mean|42.5|42.5|Standard Deviation|7.4|7.4|||
3859617|NCT01619787|3685559|B1|||Age||years|Mean|43.0|43.0|Standard Deviation|7.5|7.5|||
3859618|NCT01619774|3685568|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
3859619|NCT01619774|3685568|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3859620|NCT01619774|3685568|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3859621|NCT01619774|3685568|B1|||Age||years|Median|54|54.0|Full Range|||27.0|54.0|
3859622|NCT01619579|3685574|B3|||Symptom Severity (SS) Score|"BASELINE SCORE DESCRIPTION:~Symptom Severity (SS) Score Range is 0 to 12. 0 = Lowest pain score (Best Outcome). 12 = Highest pain score (Worst Outcome).~The SS scale identifies the level of severity sum of 4 categories (Fatigue, Waking Unrefreshed, Cognitive Symptoms, Somatic Symptoms) over the past week, using this scale:~0 = no problem~= slight or mild~= moderate~= severe: continuous, life-disturbing~Full Baseline Range of Group A: 5 to 12 points. Full Baseline Range of Group B: 6 to 12 points. 9.0= Baseline Average for Group A. 9.3= Baseline Average for Group B."|units on a scale|Mean|9.2|9.2|Full Range|||5.0|12.0|
3859649|NCT01619423|3685588|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859650|NCT01619423|3685589|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859651|NCT01619423|3685590|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859623|NCT01619579|3685575|B2|||Symptom Severity (SS) Score|"BASELINE SCORE DESCRIPTION:~Symptom Severity (SS) Score Range is 0 to 12. 0 = Lowest pain score (Best Outcome). 12 = Highest pain score (Worst Outcome).~The SS scale identifies the level of severity sum of 4 categories (Fatigue, Waking Unrefreshed, Cognitive Symptoms, Somatic Symptoms) over the past week, using this scale:~0 = no problem~= slight or mild~= moderate~= severe: continuous, life-disturbing~Full Baseline Range of Group A: 5 to 12 points. Full Baseline Range of Group B: 6 to 12 points. 9.0= Baseline Average for Group A. 9.3= Baseline Average for Group B."|units on a scale|Mean|9.3|9.3|Full Range|||6.0|12.0|
3859624|NCT01619579|3685576|B1|||Symptom Severity (SS) Score|"BASELINE SCORE DESCRIPTION:~Symptom Severity (SS) Score Range is 0 to 12. 0 = Lowest pain score (Best Outcome). 12 = Highest pain score (Worst Outcome).~The SS scale identifies the level of severity sum of 4 categories (Fatigue, Waking Unrefreshed, Cognitive Symptoms, Somatic Symptoms) over the past week, using this scale:~0 = no problem~= slight or mild~= moderate~= severe: continuous, life-disturbing~Full Baseline Range of Group A: 5 to 12 points. Full Baseline Range of Group B: 6 to 12 points. 9.0= Baseline Average for Group A. 9.3= Baseline Average for Group B."|units on a scale|Mean|9.0|9.0|Full Range|||5.0|12.0|
3859625|NCT01619579|3685574|B3|||Tender Point Count (TPC)|"BASELINE SCORE DESCRIPTION:~Tender Point Count (TPC) Score Range is 0 to 18. 0 = Lowest pain score (Best Outcome). 18 = Highest pain score (Worst Outcome). The criteria required confirming tenderness used 4kg of pressure applied to a total of 18 specified tender point sites.~Fibromyalgia is diagnosed with a minimum tenderness count in 11 of 18 points. Full Baseline Range of Group A Results: 12 to 18 points. Full Baseline Range of Group B Results: 6 to 18 points. 15.4 was the Baseline Average TPC Score for Group A. 14.07 was the Baseline Average TPC Score for Group B."|units on a scale|Mean|14.4|14.4|Full Range|||6.0|18.0|
3859626|NCT01619579|3685575|B2|||Tender Point Count (TPC)|"BASELINE SCORE DESCRIPTION:~Tender Point Count (TPC) Score Range is 0 to 18. 0 = Lowest pain score (Best Outcome). 18 = Highest pain score (Worst Outcome). The criteria required confirming tenderness used 4kg of pressure applied to a total of 18 specified tender point sites.~Fibromyalgia is diagnosed with a minimum tenderness count in 11 of 18 points. Full Baseline Range of Group A Results: 12 to 18 points. Full Baseline Range of Group B Results: 6 to 18 points. 15.4 was the Baseline Average TPC Score for Group A. 14.07 was the Baseline Average TPC Score for Group B."|units on a scale|Mean|14.07|14.07|Full Range|||6.0|18.0|
3859627|NCT01619579|3685576|B1|||Tender Point Count (TPC)|"BASELINE SCORE DESCRIPTION:~Tender Point Count (TPC) Score Range is 0 to 18. 0 = Lowest pain score (Best Outcome). 18 = Highest pain score (Worst Outcome). The criteria required confirming tenderness used 4kg of pressure applied to a total of 18 specified tender point sites.~Fibromyalgia is diagnosed with a minimum tenderness count in 11 of 18 points. Full Baseline Range of Group A Results: 12 to 18 points. Full Baseline Range of Group B Results: 6 to 18 points. 15.4 was the Baseline Average TPC Score for Group A. 14.07 was the Baseline Average TPC Score for Group B."|units on a scale|Mean|15.4|15.4|Full Range|||12.0|18.0|
3859628|NCT01619579|3685574|B3|||Widespread Pain Index (WPI)|"BASELINE SCORE DESCRIPTION:~Widespread Pain Index (WPI) Score Range is 0 to 19 points. 0 = Lowest pain score (Best Outcome). 19 = Highest pain score (Worst Outcome). Full Baseline Range of Group A Results: 13 to 18 points. Full Baseline Range of Group B Results: 8 to 19 points. 15.4 was the Baseline Average WPI Score for Treatment Group A. 15.0 was the Baseline Average WPI Score for Treatment Group B. Widespread pain was defined as pain occurring in at least 2 contralateral body quadrants, in addition to the axial skeleton for at least 3 consecutive months."|units on a scale|Mean|15.1|15.1|Full Range|||8.0|19.0|
3859629|NCT01619579|3685575|B2|||Widespread Pain Index (WPI)|"BASELINE SCORE DESCRIPTION:~Widespread Pain Index (WPI) Score Range is 0 to 19 points. 0 = Lowest pain score (Best Outcome). 19 = Highest pain score (Worst Outcome). Full Baseline Range of Group A Results: 13 to 18 points. Full Baseline Range of Group B Results: 8 to 19 points. 15.4 was the Baseline Average WPI Score for Treatment Group A. 15.0 was the Baseline Average WPI Score for Treatment Group B. Widespread pain was defined as pain occurring in at least 2 contralateral body quadrants, in addition to the axial skeleton for at least 3 consecutive months."|units on a scale|Mean|15.0|15.0|Full Range|||8.0|19.0|
3859630|NCT01619579|3685576|B1|||Widespread Pain Index (WPI)|"BASELINE SCORE DESCRIPTION:~Widespread Pain Index (WPI) Score Range is 0 to 19 points. 0 = Lowest pain score (Best Outcome). 19 = Highest pain score (Worst Outcome). Full Baseline Range of Group A Results: 13 to 18 points. Full Baseline Range of Group B Results: 8 to 19 points. 15.4 was the Baseline Average WPI Score for Treatment Group A. 15.0 was the Baseline Average WPI Score for Treatment Group B. Widespread pain was defined as pain occurring in at least 2 contralateral body quadrants, in addition to the axial skeleton for at least 3 consecutive months."|units on a scale|Mean|15.4|15.4|Full Range|||13.0|18.0|
3859631|NCT01619579|3685574|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
3859632|NCT01619579|3685575|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3859633|NCT01619579|3685576|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3859634|NCT01619579|3685574|B3||Male|Gender||Participants|Count of Participants|2|2.0||||||
3859635|NCT01619579|3685575|B2||Male|Gender||Participants|Count of Participants|2|2.0||||||
3859636|NCT01619579|3685576|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3859637|NCT01619579|3685574|B3||Female|Gender||Participants|Count of Participants|20|20.0||||||
3859638|NCT01619579|3685575|B2||Female|Gender||Participants|Count of Participants|15|15.0||||||
3859639|NCT01619579|3685576|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
3859640|NCT01619579|3685574|B3|Age||Age, Customized||years|Mean|48|48.0|Full Range|||21.0|76.0|
3859641|NCT01619579|3685575|B2|Age||Age, Customized||years|Mean|52|52.0|Full Range|||31.0|76.0|
3859642|NCT01619579|3685576|B1|Age||Age, Customized||years|Mean|41|41.0|Full Range|||21.0|62.0|
3859643|NCT01619423|3685587|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3859644|NCT01619423|3685588|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859645|NCT01619423|3685589|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859646|NCT01619423|3685590|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3859647|NCT01619423|3685591|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3859648|NCT01619423|3685587|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859652|NCT01619423|3685591|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859653|NCT01619423|3685587|B5||White|Race (NIH/OMB)||Participants|Count of Participants|180|180.0||||||
3859654|NCT01619423|3685588|B4||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3859655|NCT01619423|3685589|B3||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3859656|NCT01619423|3685590|B2||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3859657|NCT01619423|3685591|B1||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3859658|NCT01619423|3685587|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3859659|NCT01619423|3685588|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859660|NCT01619423|3685589|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3859661|NCT01619423|3685590|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859662|NCT01619423|3685591|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3859663|NCT01619423|3685587|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859664|NCT01619423|3685588|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859665|NCT01619423|3685589|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859666|NCT01619423|3685590|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859667|NCT01619423|3685591|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859668|NCT01619423|3685587|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3859669|NCT01619423|3685588|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859670|NCT01619423|3685589|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3859671|NCT01619423|3685590|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859672|NCT01619423|3685591|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859673|NCT01619423|3685587|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859674|NCT01619423|3685588|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859675|NCT01619423|3685589|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859676|NCT01619423|3685590|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859677|NCT01619423|3685591|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859678|NCT01619423|3685587|B5||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3859679|NCT01619423|3685588|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3859680|NCT01619423|3685589|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3859681|NCT01619423|3685590|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3859682|NCT01619423|3685591|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3859683|NCT01619423|3685587|B5||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3859684|NCT01619423|3685588|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3859685|NCT01619423|3685589|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3859686|NCT01619423|3685590|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3859687|NCT01619423|3685591|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3859688|NCT01619423|3685587|B5|||Age||years|Mean|62.6|62.6|Full Range|||35.0|83.0|
3859689|NCT01619423|3685588|B4|||Age||years|Mean|61.3|61.3|Full Range|||35.0|80.0|
3859690|NCT01619423|3685589|B3|||Age||years|Mean|62.6|62.6|Full Range|||38.0|82.0|
3859691|NCT01619423|3685590|B2|||Age||years|Mean|63.5|63.5|Full Range|||42.0|83.0|
3859692|NCT01619423|3685591|B1|||Age||years|Mean|62|62.0|Full Range|||41.0|80.0|
3859693|NCT01619085|3685605|B1||Unknown or Not Reported|Race (NIH/OMB)|Race of all patients included in the trial. Ethnicity data was not collected in the Case Report Form (CRF).|Participants|Count of Participants|86|86.0||||||
3859694|NCT01619085|3685605|B1||More than one race|Race (NIH/OMB)|Race of all patients included in the trial. Ethnicity data was not collected in the Case Report Form (CRF).|Participants|Count of Participants|0|0.0||||||
3859695|NCT01619085|3685605|B1||White|Race (NIH/OMB)|Race of all patients included in the trial. Ethnicity data was not collected in the Case Report Form (CRF).|Participants|Count of Participants|431|431.0||||||
3859696|NCT01619085|3685605|B1||Black or African American|Race (NIH/OMB)|Race of all patients included in the trial. Ethnicity data was not collected in the Case Report Form (CRF).|Participants|Count of Participants|2|2.0||||||
3859697|NCT01619085|3685605|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race of all patients included in the trial. Ethnicity data was not collected in the Case Report Form (CRF).|Participants|Count of Participants|0|0.0||||||
3859698|NCT01619085|3685605|B1||Asian|Race (NIH/OMB)|Race of all patients included in the trial. Ethnicity data was not collected in the Case Report Form (CRF).|Participants|Count of Participants|214|214.0||||||
3859699|NCT01619085|3685605|B1||American Indian or Alaska Native|Race (NIH/OMB)|Race of all patients included in the trial. Ethnicity data was not collected in the Case Report Form (CRF).|Participants|Count of Participants|1|1.0||||||
3859700|NCT01619085|3685605|B1||Male|Sex: Female, Male|Gender distribution of all patients included in the trial.|Participants|Count of Participants|587|587.0||||||
3859701|NCT01619085|3685605|B1||Female|Sex: Female, Male|Gender distribution of all patients included in the trial.|Participants|Count of Participants|147|147.0||||||
3859702|NCT01619085|3685605|B1|||Age|Age of all patients included in the trial|Years|Mean|67.2|67.2|Standard Deviation|7.8|7.8|||
3859703|NCT01619059|3685609|B3|WHITE||Race/Ethnicity, Customized||Participants|Number|277|277.0||||||
3859704|NCT01619059|3685610|B2|WHITE||Race/Ethnicity, Customized||Participants|Number|136|136.0||||||
3859705|NCT01619059|3685611|B1|WHITE||Race/Ethnicity, Customized||Participants|Number|141|141.0||||||
3859706|NCT01619059|3685609|B3|OTHER||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3859707|NCT01619059|3685610|B2|OTHER||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3859708|NCT01619059|3685611|B1|OTHER||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3859709|NCT01619059|3685609|B3|BLACK/AFRICAN AMERICAN||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
3859710|NCT01619059|3685610|B2|BLACK/AFRICAN AMERICAN||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3859711|NCT01619059|3685611|B1|BLACK/AFRICAN AMERICAN||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3859712|NCT01619059|3685609|B3|ASIAN||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
3859713|NCT01619059|3685610|B2|ASIAN||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3859714|NCT01619059|3685611|B1|ASIAN||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3859715|NCT01619059|3685609|B3|AMERICAN INDIAN/ALASKA NATIVE||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3859716|NCT01619059|3685610|B2|AMERICAN INDIAN/ALASKA NATIVE||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3859717|NCT01619059|3685611|B1|AMERICAN INDIAN/ALASKA NATIVE||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3859718|NCT01619059|3685609|B3||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3859719|NCT01619059|3685610|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3859720|NCT01619059|3685611|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3859721|NCT01619059|3685609|B3||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3859722|NCT01619059|3685610|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3859723|NCT01619059|3685611|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3859724|NCT01619059|3685609|B3|>= 65||Age, Customized||Participants|Number|43|43.0||||||
3859725|NCT01619059|3685610|B2|>= 65||Age, Customized||Participants|Number|21|21.0||||||
3859726|NCT01619059|3685611|B1|>= 65||Age, Customized||Participants|Number|22|22.0||||||
3859727|NCT01619059|3685609|B3|< 65||Age, Customized||Participants|Number|272|272.0||||||
3859728|NCT01619059|3685610|B2|< 65||Age, Customized||Participants|Number|132|132.0||||||
3859729|NCT01619059|3685611|B1|< 65||Age, Customized||Participants|Number|140|140.0||||||
3859730|NCT01619059|3685609|B3|||Age||YEARS|Mean|54.6|54.6|Standard Deviation|9.56|9.56|27.0|78.0|
3859731|NCT01619059|3685610|B2|||Age||YEARS|Mean|54.7|54.7|Standard Deviation|9.83|9.83|27.0|77.0|
3859732|NCT01619059|3685611|B1|||Age||YEARS|Mean|54.5|54.5|Standard Deviation|9.32|9.32|27.0|78.0|
3859733|NCT01618968|3685624|B5|United States||Region of Enrollment||participants|Number|49|49.0||||||
3859734|NCT01618968|3685625|B4|United States||Region of Enrollment||participants|Number|12|12.0||||||
3859735|NCT01618968|3685626|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3859736|NCT01618968|3685627|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3859737|NCT01618968|3685628|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3859738|NCT01618968|3685624|B5|African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3859739|NCT01618968|3685625|B4|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3859740|NCT01618968|3685626|B3|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3859741|NCT01618968|3685627|B2|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3859742|NCT01618968|3685628|B1|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3859743|NCT01618968|3685624|B5|White||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
3859744|NCT01618968|3685625|B4|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3859745|NCT01618968|3685626|B3|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3859746|NCT01618968|3685627|B2|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3859747|NCT01618968|3685628|B1|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3859748|NCT01618968|3685624|B5||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3859749|NCT01618968|3685625|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3859750|NCT01618968|3685626|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3859751|NCT01618968|3685627|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3859752|NCT01618968|3685628|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3859753|NCT01618968|3685624|B5||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3859754|NCT01618968|3685625|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3859755|NCT01618968|3685626|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3859756|NCT01618968|3685627|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3859757|NCT01618968|3685628|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3859758|NCT01618968|3685624|B5|||Age||years|Mean|61.4|61.4|Standard Deviation|10.53|10.53|||
3859759|NCT01618968|3685625|B4|||Age||years|Mean|59.0|59.0|Standard Deviation|11.53|11.53|||
3859760|NCT01618968|3685626|B3|||Age||years|Mean|60.0|60.0|Standard Deviation|10.40|10.4|||
3859761|NCT01618968|3685627|B2|||Age||years|Mean|63.4|63.4|Standard Deviation|7.49|7.49|||
3859762|NCT01618968|3685628|B1|||Age||years|Mean|62.9|62.9|Standard Deviation|12.51|12.51|||
3859763|NCT01618955|3685646|B5|||BMI||kg/m^2|Mean|30.9|30.9|Standard Deviation|6.64|6.64|||
3859764|NCT01618955|3685647|B4|||BMI||kg/m^2|Mean|30.3|30.3|Standard Deviation|5.28|5.28|||
3859765|NCT01618955|3685648|B3|||BMI||kg/m^2|Mean|30.5|30.5|Standard Deviation|6.46|6.46|||
3859766|NCT01618955|3685649|B2|||BMI||kg/m^2|Mean|31.3|31.3|Standard Deviation|7.26|7.26|||
3859767|NCT01618955|3685650|B1|||BMI||kg/m^2|Mean|31.4|31.4|Standard Deviation|7.54|7.54|||
3859768|NCT01618955|3685646|B5|United States||Region of Enrollment||participants|Number|101|101.0||||||
3859769|NCT01618955|3685647|B4|United States||Region of Enrollment||participants|Number|20|20.0||||||
3859770|NCT01618955|3685648|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
3859771|NCT01618955|3685649|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3859772|NCT01618955|3685650|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3859773|NCT01618955|3685646|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859774|NCT01618955|3685647|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859775|NCT01618955|3685648|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859776|NCT01618955|3685649|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859777|NCT01618955|3685650|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859778|NCT01618955|3685646|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3859779|NCT01618955|3685647|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3859780|NCT01618955|3685648|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3859781|NCT01618955|3685649|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3859782|NCT01618955|3685650|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3859783|NCT01618955|3685646|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3859784|NCT01618955|3685647|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859785|NCT01618955|3685648|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3859786|NCT01618955|3685649|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3859787|NCT01618955|3685650|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3859788|NCT01618955|3685646|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3859789|NCT01618955|3685647|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859790|NCT01618955|3685648|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3859791|NCT01618955|3685649|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859792|NCT01618955|3685650|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859793|NCT01618955|3685646|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859794|NCT01618955|3685647|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859795|NCT01618955|3685648|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859796|NCT01618955|3685649|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859797|NCT01618955|3685650|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859798|NCT01618955|3685646|B5||White|Race (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
3859799|NCT01618955|3685647|B4||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3859800|NCT01618955|3685648|B3||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3859801|NCT01618955|3685649|B2||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3859802|NCT01618955|3685650|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3859803|NCT01618955|3685646|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3859804|NCT01618955|3685647|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3859805|NCT01618955|3685648|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3859806|NCT01618955|3685649|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3859807|NCT01618955|3685650|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3859808|NCT01618955|3685646|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859809|NCT01618955|3685647|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859810|NCT01618955|3685648|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859811|NCT01618955|3685649|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859812|NCT01618955|3685650|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859813|NCT01618955|3685646|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859814|NCT01618955|3685647|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859815|NCT01618955|3685648|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859816|NCT01618955|3685649|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859817|NCT01618955|3685650|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859818|NCT01618955|3685646|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859819|NCT01618955|3685647|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859820|NCT01618955|3685648|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859821|NCT01618955|3685649|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859822|NCT01618955|3685650|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859823|NCT01618955|3685646|B5||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3859824|NCT01618955|3685647|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3859825|NCT01618955|3685648|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3859826|NCT01618955|3685649|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3859827|NCT01618955|3685650|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3859828|NCT01618955|3685646|B5||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3859829|NCT01618955|3685647|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3859830|NCT01618955|3685648|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3859831|NCT01618955|3685649|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3859832|NCT01618955|3685650|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3859833|NCT01618955|3685646|B5|||Age||years|Mean|60.9|60.9|Standard Deviation|10.14|10.14|||
3859834|NCT01618955|3685647|B4|||Age||years|Mean|59.1|59.1|Standard Deviation|9.92|9.92|||
3859835|NCT01618955|3685648|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|10.46|10.46|||
3859836|NCT01618955|3685649|B2|||Age||years|Mean|61.8|61.8|Standard Deviation|9.00|9.0|||
3859837|NCT01618955|3685650|B1|||Age||years|Mean|63.5|63.5|Standard Deviation|11.46|11.46|||
3859838|NCT01618942|3685675|B3|China||Region of Enrollment||participants|Number|100|100.0||||||
3859839|NCT01618942|3685676|B2|China||Region of Enrollment||participants|Number|50|50.0||||||
3859840|NCT01618942|3685677|B1|China||Region of Enrollment||participants|Number|50|50.0||||||
3859841|NCT01618942|3685675|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3859842|NCT01618942|3685676|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3859843|NCT01618942|3685677|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3859844|NCT01618942|3685675|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3859845|NCT01618942|3685676|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3859846|NCT01618942|3685677|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3859847|NCT01618942|3685675|B3|||Age||years|Mean|24.2|24.2|Standard Deviation|1.6|1.6|||
3859848|NCT01618942|3685676|B2|||Age||years|Mean|24.2|24.2|Standard Deviation|1.9|1.9|||
3859849|NCT01618942|3685677|B1|||Age||years|Mean|24.3|24.3|Standard Deviation|1.3|1.3|||
3859850|NCT01618942|3685675|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3859851|NCT01618942|3685676|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3859852|NCT01618942|3685677|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3859853|NCT01618942|3685675|B3||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
3859854|NCT01618942|3685676|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3859855|NCT01618942|3685677|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3859856|NCT01618942|3685675|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3859857|NCT01618942|3685676|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3859858|NCT01618942|3685677|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3859859|NCT01618864|3685698|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
3859860|NCT01618864|3685698|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3859861|NCT01618864|3685698|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3859862|NCT01618864|3685698|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3859863|NCT01618864|3685698|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3859864|NCT01618864|3685698|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3859865|NCT01618838|3685707|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3859866|NCT01618838|3685707|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859867|NCT01618838|3685707|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859868|NCT01618838|3685707|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3859869|NCT01618838|3685707|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3859870|NCT01618838|3685707|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859871|NCT01618838|3685707|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3859872|NCT01618838|3685707|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859873|NCT01618838|3685707|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3859874|NCT01618838|3685707|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3859875|NCT01618838|3685707|B1|||Age||years|Median|75.5|75.5|Full Range|||74.0|82.0|
3859876|NCT01618838|3685707|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3859877|NCT01618838|3685707|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3859878|NCT01618838|3685707|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3859879|NCT01618708|3685713|B3||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3859880|NCT01618708|3685714|B2||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3859881|NCT01618708|3685715|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3859882|NCT01618708|3685713|B3||Female|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
3859883|NCT01618708|3685714|B2||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3859884|NCT01618708|3685715|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3859885|NCT01618708|3685713|B3|||Age||years|Mean|60.3|60.3|Standard Deviation|9.4|9.4|||
3859886|NCT01618708|3685714|B2|||Age||years|Mean|60.8|60.8|Standard Deviation|10.0|10.0|||
3859887|NCT01618708|3685715|B1|||Age||years|Mean|59.8|59.8|Standard Deviation|8.8|8.8|||
3859888|NCT01618669|3685728|B3|||Maximum Metabolic Equivalents Achieved|"A metabolic unit used to quantify the intensity of physical activity, which is defined as the ratio of the metabolic rate during exercise to the metabolic rate at rest. One MET corresponds to an energy expenditure of approximately 1 kcal/kg/hour, or an oxygen uptake of 3.5 ml of O2 consumption/kg/hour.~Data are provided for the full analysis set (538 and 534 participants in each treatment group respectively)."|metabolic equivalents|Mean|5.41|5.41|Standard Deviation|2.307|2.307|||
3859889|NCT01618669|3685729|B2|||Maximum Metabolic Equivalents Achieved|"A metabolic unit used to quantify the intensity of physical activity, which is defined as the ratio of the metabolic rate during exercise to the metabolic rate at rest. One MET corresponds to an energy expenditure of approximately 1 kcal/kg/hour, or an oxygen uptake of 3.5 ml of O2 consumption/kg/hour.~Data are provided for the full analysis set (538 and 534 participants in each treatment group respectively)."|metabolic equivalents|Mean|5.37|5.37|Standard Deviation|2.331|2.331|||
3859890|NCT01618669|3685730|B1|||Maximum Metabolic Equivalents Achieved|"A metabolic unit used to quantify the intensity of physical activity, which is defined as the ratio of the metabolic rate during exercise to the metabolic rate at rest. One MET corresponds to an energy expenditure of approximately 1 kcal/kg/hour, or an oxygen uptake of 3.5 ml of O2 consumption/kg/hour.~Data are provided for the full analysis set (538 and 534 participants in each treatment group respectively)."|metabolic equivalents|Mean|5.45|5.45|Standard Deviation|2.284|2.284|||
3859891|NCT01618669|3685728|B3|Modified Bruce Exercise||Bruce Exercise Group|"The Bruce exercise test involves walking on a treadmill while the heart is monitored by an electrocardiograph. The protocol consists of several stages of progressively greater workloads.~The Modified Bruce protocol starts at a lower workload than the standard test and is typically used for elderly or sedentary patients.~Data are reported for all randomized participants with interpretable SPECT scans at all visits as determined by at least 2 of the 3 blinded independent expert readers (full analysis set; 538 and 534 participants in each treatment group respectively)."|participants|Number|183|183.0||||||
3859892|NCT01618669|3685729|B2|Modified Bruce Exercise||Bruce Exercise Group|"The Bruce exercise test involves walking on a treadmill while the heart is monitored by an electrocardiograph. The protocol consists of several stages of progressively greater workloads.~The Modified Bruce protocol starts at a lower workload than the standard test and is typically used for elderly or sedentary patients.~Data are reported for all randomized participants with interpretable SPECT scans at all visits as determined by at least 2 of the 3 blinded independent expert readers (full analysis set; 538 and 534 participants in each treatment group respectively)."|participants|Number|93|93.0||||||
3859893|NCT01618669|3685730|B1|Modified Bruce Exercise||Bruce Exercise Group|"The Bruce exercise test involves walking on a treadmill while the heart is monitored by an electrocardiograph. The protocol consists of several stages of progressively greater workloads.~The Modified Bruce protocol starts at a lower workload than the standard test and is typically used for elderly or sedentary patients.~Data are reported for all randomized participants with interpretable SPECT scans at all visits as determined by at least 2 of the 3 blinded independent expert readers (full analysis set; 538 and 534 participants in each treatment group respectively)."|participants|Number|90|90.0||||||
3859894|NCT01618669|3685728|B3|Standard Bruce Exercise||Bruce Exercise Group|"The Bruce exercise test involves walking on a treadmill while the heart is monitored by an electrocardiograph. The protocol consists of several stages of progressively greater workloads.~The Modified Bruce protocol starts at a lower workload than the standard test and is typically used for elderly or sedentary patients.~Data are reported for all randomized participants with interpretable SPECT scans at all visits as determined by at least 2 of the 3 blinded independent expert readers (full analysis set; 538 and 534 participants in each treatment group respectively)."|participants|Number|890|890.0||||||
3859895|NCT01618669|3685729|B2|Standard Bruce Exercise||Bruce Exercise Group|"The Bruce exercise test involves walking on a treadmill while the heart is monitored by an electrocardiograph. The protocol consists of several stages of progressively greater workloads.~The Modified Bruce protocol starts at a lower workload than the standard test and is typically used for elderly or sedentary patients.~Data are reported for all randomized participants with interpretable SPECT scans at all visits as determined by at least 2 of the 3 blinded independent expert readers (full analysis set; 538 and 534 participants in each treatment group respectively)."|participants|Number|442|442.0||||||
3859896|NCT01618669|3685730|B1|Standard Bruce Exercise||Bruce Exercise Group|"The Bruce exercise test involves walking on a treadmill while the heart is monitored by an electrocardiograph. The protocol consists of several stages of progressively greater workloads.~The Modified Bruce protocol starts at a lower workload than the standard test and is typically used for elderly or sedentary patients.~Data are reported for all randomized participants with interpretable SPECT scans at all visits as determined by at least 2 of the 3 blinded independent expert readers (full analysis set; 538 and 534 participants in each treatment group respectively)."|participants|Number|448|448.0||||||
3859897|NCT01618669|3685728|B3||Male|Sex: Female, Male||Participants|Count of Participants|669|669.0||||||
3859898|NCT01618669|3685729|B2||Male|Sex: Female, Male||Participants|Count of Participants|328|328.0||||||
3859899|NCT01618669|3685730|B1||Male|Sex: Female, Male||Participants|Count of Participants|341|341.0||||||
3859900|NCT01618669|3685728|B3||Female|Sex: Female, Male||Participants|Count of Participants|473|473.0||||||
3859901|NCT01618669|3685729|B2||Female|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
3859902|NCT01618669|3685730|B1||Female|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
3859903|NCT01618669|3685728|B3|||Age||years|Mean|61.9|61.9|Standard Deviation|11.32|11.32|||
3859904|NCT01618669|3685729|B2|||Age||years|Mean|61.9|61.9|Standard Deviation|11.19|11.19|||
3859905|NCT01618669|3685730|B1|||Age||years|Mean|61.9|61.9|Standard Deviation|11.45|11.45|||
3859906|NCT01618422|3685775|B3|Culture grew non-tuberculosis mycobacterium||Sputum tuberculosis culture||participants|Number|25|25.0||||||
3859907|NCT01618422|3685776|B2|Culture grew non-tuberculosis mycobacterium||Sputum tuberculosis culture||participants|Number|13|13.0||||||
3859908|NCT01618422|3685777|B1|Culture grew non-tuberculosis mycobacterium||Sputum tuberculosis culture||participants|Number|12|12.0||||||
3859909|NCT01618422|3685775|B3|Culture grew Mycobacterium tuberculosis complex||Sputum tuberculosis culture||participants|Number|156|156.0||||||
3859910|NCT01618422|3685776|B2|Culture grew Mycobacterium tuberculosis complex||Sputum tuberculosis culture||participants|Number|77|77.0||||||
3859911|NCT01618422|3685777|B1|Culture grew Mycobacterium tuberculosis complex||Sputum tuberculosis culture||participants|Number|79|79.0||||||
3859912|NCT01618422|3685775|B3|not available||Sputum tuberculosis culture||participants|Number|44|44.0||||||
3859913|NCT01618422|3685776|B2|not available||Sputum tuberculosis culture||participants|Number|21|21.0||||||
3859914|NCT01618422|3685777|B1|not available||Sputum tuberculosis culture||participants|Number|23|23.0||||||
3859915|NCT01618422|3685775|B3|Negative||X ray showing cavitation||participants|Number|112|112.0||||||
3859916|NCT01618422|3685776|B2|Negative||X ray showing cavitation||participants|Number|52|52.0||||||
3859917|NCT01618422|3685777|B1|Negative||X ray showing cavitation||participants|Number|60|60.0||||||
3859918|NCT01618422|3685775|B3|Positive||X ray showing cavitation||participants|Number|113|113.0||||||
3859919|NCT01618422|3685776|B2|Positive||X ray showing cavitation||participants|Number|59|59.0||||||
3859920|NCT01618422|3685777|B1|Positive||X ray showing cavitation||participants|Number|54|54.0||||||
3859921|NCT01618422|3685775|B3|Severe||X ray lesions severity|"Severity of chest x-ray (CXR) lesions is graded as follows:~Mild: total area of involvement involving less than the size of right upper lobe; Moderate: total area of involvement was less than the size of right lung field but equal or bigger than right upper lobe; Severe: total area of involvement was bigger than right lung field."|participants|Number|81|81.0||||||
3859922|NCT01618422|3685776|B2|Severe||X ray lesions severity|"Severity of chest x-ray (CXR) lesions is graded as follows:~Mild: total area of involvement involving less than the size of right upper lobe; Moderate: total area of involvement was less than the size of right lung field but equal or bigger than right upper lobe; Severe: total area of involvement was bigger than right lung field."|participants|Number|46|46.0||||||
3859923|NCT01618422|3685777|B1|Severe||X ray lesions severity|"Severity of chest x-ray (CXR) lesions is graded as follows:~Mild: total area of involvement involving less than the size of right upper lobe; Moderate: total area of involvement was less than the size of right lung field but equal or bigger than right upper lobe; Severe: total area of involvement was bigger than right lung field."|participants|Number|35|35.0||||||
3859924|NCT01618422|3685775|B3|Moderate||X ray lesions severity|"Severity of chest x-ray (CXR) lesions is graded as follows:~Mild: total area of involvement involving less than the size of right upper lobe; Moderate: total area of involvement was less than the size of right lung field but equal or bigger than right upper lobe; Severe: total area of involvement was bigger than right lung field."|participants|Number|92|92.0||||||
3859925|NCT01618422|3685776|B2|Moderate||X ray lesions severity|"Severity of chest x-ray (CXR) lesions is graded as follows:~Mild: total area of involvement involving less than the size of right upper lobe; Moderate: total area of involvement was less than the size of right lung field but equal or bigger than right upper lobe; Severe: total area of involvement was bigger than right lung field."|participants|Number|47|47.0||||||
3859926|NCT01618422|3685777|B1|Moderate||X ray lesions severity|"Severity of chest x-ray (CXR) lesions is graded as follows:~Mild: total area of involvement involving less than the size of right upper lobe; Moderate: total area of involvement was less than the size of right lung field but equal or bigger than right upper lobe; Severe: total area of involvement was bigger than right lung field."|participants|Number|45|45.0||||||
3859927|NCT01618422|3685775|B3|Mild||X ray lesions severity|"Severity of chest x-ray (CXR) lesions is graded as follows:~Mild: total area of involvement involving less than the size of right upper lobe; Moderate: total area of involvement was less than the size of right lung field but equal or bigger than right upper lobe; Severe: total area of involvement was bigger than right lung field."|participants|Number|52|52.0||||||
3859928|NCT01618422|3685776|B2|Mild||X ray lesions severity|"Severity of chest x-ray (CXR) lesions is graded as follows:~Mild: total area of involvement involving less than the size of right upper lobe; Moderate: total area of involvement was less than the size of right lung field but equal or bigger than right upper lobe; Severe: total area of involvement was bigger than right lung field."|participants|Number|18|18.0||||||
3859929|NCT01618422|3685777|B1|Mild||X ray lesions severity|"Severity of chest x-ray (CXR) lesions is graded as follows:~Mild: total area of involvement involving less than the size of right upper lobe; Moderate: total area of involvement was less than the size of right lung field but equal or bigger than right upper lobe; Severe: total area of involvement was bigger than right lung field."|participants|Number|34|34.0||||||
3859930|NCT01618422|3685775|B3||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
3859931|NCT01618422|3685776|B2||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3859932|NCT01618422|3685777|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3859933|NCT01618422|3685775|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3859934|NCT01618422|3685776|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3859935|NCT01618422|3685777|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3859936|NCT01618422|3685775|B3|||Age||years|Mean|48.05|48.05|Standard Deviation|15.04|15.04|||
3859937|NCT01618422|3685776|B2|||Age||years|Mean|48.83|48.83|Standard Deviation|17.07|17.07|||
3859938|NCT01618422|3685777|B1|||Age||years|Mean|47.25|47.25|Standard Deviation|14.5|14.5|||
3859939|NCT01618344|3685784|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
3859940|NCT01618344|3685784|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3859941|NCT01618344|3685784|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3859942|NCT01618344|3685784|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3859943|NCT01618344|3685784|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3859944|NCT01618344|3685784|B1||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
3859945|NCT01618266|3685788|B1||Male|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
3859946|NCT01618266|3685788|B1||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3859947|NCT01618266|3685788|B1|||Age||Years|Mean|70.31|70.31|Standard Deviation|11.19|11.19|||
3859948|NCT01618240|3685803|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3859949|NCT01618240|3685803|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3859950|NCT01618240|3685803|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3859951|NCT01618240|3685803|B1|||Age||years|Mean|55|55.0|Standard Deviation|14|14.0|||
3859952|NCT01618240|3685803|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3859953|NCT01618240|3685803|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3859954|NCT01618240|3685803|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3859955|NCT01618227|3685808|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3859956|NCT01618227|3685809|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3859957|NCT01618227|3685810|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3859958|NCT01618227|3685808|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3859959|NCT01618227|3685809|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3859960|NCT01618227|3685810|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3859961|NCT01618227|3685808|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3859962|NCT01618227|3685809|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3859963|NCT01618227|3685810|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3859964|NCT01618227|3685808|B3|||Age||years|Mean|55|55.0|Standard Deviation|3.9|3.9|||
3859965|NCT01618227|3685809|B2|||Age||years|Mean|53.5|53.5|Standard Deviation|3.9|3.9|||
3859966|NCT01618227|3685810|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|3.5|3.5|||
3859967|NCT01618227|3685808|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3859968|NCT01618227|3685809|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3859969|NCT01618227|3685810|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3859970|NCT01618227|3685808|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3859971|NCT01618227|3685809|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3859972|NCT01618227|3685810|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3859973|NCT01618227|3685808|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3859974|NCT01618227|3685809|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3859975|NCT01618227|3685810|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3859976|NCT01618214|3685823|B3|||Fasting Plasma Glucose||mmol/L|Mean|8.95|8.95|Standard Deviation|2.40|2.4|||
3859977|NCT01618214|3685824|B2|||Fasting Plasma Glucose||mmol/L|Mean|9.07|9.07|Standard Deviation|2.43|2.43|||
3859978|NCT01618214|3685825|B1|||Fasting Plasma Glucose||mmol/L|Mean|8.83|8.83|Standard Deviation|2.36|2.36|||
3859979|NCT01618214|3685823|B3|||Glycosylated Haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.12|8.12|Standard Deviation|0.65|0.65|||
3859980|NCT01618214|3685824|B2|||Glycosylated Haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.14|8.14|Standard Deviation|0.67|0.67|||
3859981|NCT01618214|3685825|B1|||Glycosylated Haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.10|8.1|Standard Deviation|0.64|0.64|||
3859982|NCT01618214|3685823|B3|||Body mass index (BMI)||kg/m^2|Mean|25.62|25.62|Standard Deviation|3.14|3.14|||
3859983|NCT01618214|3685824|B2|||Body mass index (BMI)||kg/m^2|Mean|25.47|25.47|Standard Deviation|3.01|3.01|||
3859984|NCT01618214|3685825|B1|||Body mass index (BMI)||kg/m^2|Mean|25.76|25.76|Standard Deviation|3.26|3.26|||
3859985|NCT01618214|3685823|B3|||Weight||kg|Mean|69.9|69.9|Standard Deviation|11.5|11.5|||
3859986|NCT01618214|3685824|B2|||Weight||kg|Mean|69.5|69.5|Standard Deviation|11.6|11.6|||
3859987|NCT01618214|3685825|B1|||Weight||kg|Mean|70.3|70.3|Standard Deviation|11.3|11.3|||
3859988|NCT01618214|3685823|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859989|NCT01618214|3685824|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859990|NCT01618214|3685825|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859991|NCT01618214|3685823|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859992|NCT01618214|3685824|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859993|NCT01618214|3685825|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859994|NCT01618214|3685823|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859995|NCT01618214|3685824|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859996|NCT01618214|3685825|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859997|NCT01618214|3685823|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859998|NCT01618214|3685824|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3859999|NCT01618214|3685825|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860000|NCT01618214|3685823|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860001|NCT01618214|3685824|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860002|NCT01618214|3685825|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860003|NCT01618214|3685823|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|344|344.0||||||
3860004|NCT01618214|3685824|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|172|172.0||||||
3860005|NCT01618214|3685825|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|172|172.0||||||
3860006|NCT01618214|3685823|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860007|NCT01618214|3685824|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860008|NCT01618214|3685825|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860009|NCT01618214|3685823|B3||Male|Gender||Participants|Count of Participants|164|164.0||||||
3860010|NCT01618214|3685824|B2||Male|Gender||Participants|Count of Participants|71|71.0||||||
3860011|NCT01618214|3685825|B1||Male|Gender||Participants|Count of Participants|93|93.0||||||
3860012|NCT01618214|3685823|B3||Female|Gender||Participants|Count of Participants|180|180.0||||||
3860013|NCT01618214|3685824|B2||Female|Gender||Participants|Count of Participants|101|101.0||||||
3860014|NCT01618214|3685825|B1||Female|Gender||Participants|Count of Participants|79|79.0||||||
3860015|NCT01618214|3685823|B3|||Age||years|Mean|54.1|54.1|Standard Deviation|7.4|7.4|||
3860016|NCT01618214|3685824|B2|||Age||years|Mean|53.4|53.4|Standard Deviation|7.5|7.5|||
3860017|NCT01618214|3685825|B1|||Age||years|Mean|54.8|54.8|Standard Deviation|7.3|7.3|||
3860018|NCT01618162|3685840|B3|||Body weight||kilograms|Mean|87.9|87.9|Standard Deviation|18.2|18.2|||
3860019|NCT01618162|3685841|B2|||Body weight||kilograms|Mean|89.3|89.3|Standard Deviation|17.5|17.5|||
3860020|NCT01618162|3685842|B1|||Body weight||kilograms|Mean|87.2|87.2|Standard Deviation|18.6|18.6|||
3860021|NCT01618162|3685840|B3|||Fasting plasma glucose||mmol/L|Mean|9.1|9.1|Standard Deviation|2.1|2.1|||
3860022|NCT01618162|3685841|B2|||Fasting plasma glucose||mmol/L|Mean|9.1|9.1|Standard Deviation|2.1|2.1|||
3860023|NCT01618162|3685842|B1|||Fasting plasma glucose||mmol/L|Mean|9.1|9.1|Standard Deviation|2.2|2.2|||
3860024|NCT01618162|3685840|B3|||Glycosylated haemoglobin||percentage of glycosylated haemoglobin|Mean|7.9|7.9|Standard Deviation|0.6|0.6|||
3860025|NCT01618162|3685841|B2|||Glycosylated haemoglobin||percentage of glycosylated haemoglobin|Mean|7.9|7.9|Standard Deviation|0.6|0.6|||
3860026|NCT01618162|3685842|B1|||Glycosylated haemoglobin||percentage of glycosylated haemoglobin|Mean|7.9|7.9|Standard Deviation|0.6|0.6|||
3860027|NCT01618162|3685840|B3||Male|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
3860028|NCT01618162|3685841|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3860029|NCT01618162|3685842|B1||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3860030|NCT01618162|3685840|B3||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
3860031|NCT01618162|3685841|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3860032|NCT01618162|3685842|B1||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3860033|NCT01618162|3685840|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|10.0|10.0|||
3860034|NCT01618162|3685841|B2|||Age||years|Mean|59.4|59.4|Standard Deviation|10.8|10.8|||
3860035|NCT01618162|3685842|B1|||Age||years|Mean|60|60.0|Standard Deviation|9.6|9.6|||
3860036|NCT01618019|3685861|B3|Korea, Republic of||Region of Enrollment||participants|Number|109|109.0||||||
3860037|NCT01618019|3685862|B2|Korea, Republic of||Region of Enrollment||participants|Number|54|54.0||||||
3860038|NCT01618019|3685863|B1|Korea, Republic of||Region of Enrollment||participants|Number|55|55.0||||||
3860039|NCT01618019|3685861|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3860040|NCT01618019|3685862|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3860041|NCT01618019|3685863|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3860042|NCT01618019|3685861|B3||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3860043|NCT01618019|3685862|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3860044|NCT01618019|3685863|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3860045|NCT01618019|3685861|B3|||Age||years|Mean|49.09|49.09|Standard Deviation|9.83|9.83|||
3860046|NCT01618019|3685862|B2|||Age||years|Mean|48.67|48.67|Standard Deviation|8.91|8.91|||
3860047|NCT01618019|3685863|B1|||Age||years|Mean|49.51|49.51|Standard Deviation|10.71|10.71|||
3860048|NCT01618019|3685861|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3860049|NCT01618019|3685862|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3860050|NCT01618019|3685863|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3860051|NCT01618019|3685861|B3||Between 18 and 65 years|Age||Participants|Count of Participants|103|103.0||||||
3860052|NCT01618019|3685862|B2||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3860053|NCT01618019|3685863|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3860054|NCT01618019|3685861|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3860055|NCT01618019|3685862|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3860056|NCT01618019|3685863|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3860057|NCT01617967|3685884|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860058|NCT01617967|3685885|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860059|NCT01617967|3685886|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860060|NCT01617967|3685887|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860061|NCT01617967|3685888|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860062|NCT01617967|3685889|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860063|NCT01617967|3685890|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860064|NCT01617967|3685884|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860065|NCT01617967|3685885|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860066|NCT01617967|3685886|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860067|NCT01617967|3685887|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860068|NCT01617967|3685888|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860069|NCT01617967|3685889|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860070|NCT01617967|3685890|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860071|NCT01617967|3685884|B7||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3860072|NCT01617967|3685885|B6||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3860073|NCT01617967|3685886|B5||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3860074|NCT01617967|3685887|B4||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3860075|NCT01617967|3685888|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3860076|NCT01617967|3685889|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3860077|NCT01617967|3685890|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3860078|NCT01617967|3685884|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860079|NCT01617967|3685885|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860080|NCT01617967|3685886|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860081|NCT01617967|3685887|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860082|NCT01617967|3685888|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860083|NCT01617967|3685889|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860084|NCT01617967|3685890|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860085|NCT01617967|3685884|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860086|NCT01617967|3685885|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860087|NCT01617967|3685886|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860088|NCT01617967|3685887|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860089|NCT01617967|3685888|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860090|NCT01617967|3685889|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860091|NCT01617967|3685890|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860092|NCT01617967|3685884|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860093|NCT01617967|3685885|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860094|NCT01617967|3685886|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860095|NCT01617967|3685887|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860096|NCT01617967|3685888|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860097|NCT01617967|3685889|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860098|NCT01617967|3685890|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860099|NCT01617967|3685884|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860100|NCT01617967|3685885|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860101|NCT01617967|3685886|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860102|NCT01617967|3685887|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860103|NCT01617967|3685888|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860104|NCT01617967|3685889|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860105|NCT01617967|3685890|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860106|NCT01617967|3685884|B7||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3860107|NCT01617967|3685885|B6||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3860108|NCT01617967|3685886|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3860109|NCT01617967|3685887|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3860110|NCT01617967|3685888|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3860111|NCT01617967|3685889|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3860112|NCT01617967|3685890|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3860113|NCT01617967|3685884|B7||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3860114|NCT01617967|3685885|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3860115|NCT01617967|3685886|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3860116|NCT01617967|3685887|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3860117|NCT01617967|3685888|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3860118|NCT01617967|3685889|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3860119|NCT01617967|3685890|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3860120|NCT01617967|3685884|B7|||Age||years|Mean|55.6|55.6|Standard Deviation|15.61|15.61|||
3860121|NCT01617967|3685885|B6|||Age||years|Mean|54.7|54.7|Standard Deviation|16.34|16.34|||
3860122|NCT01617967|3685886|B5|||Age||years|Mean|51.0|51.0|Standard Deviation|16.09|16.09|||
3860123|NCT01617967|3685887|B4|||Age||years|Mean|58.7|58.7|Standard Deviation|16.07|16.07|||
3860124|NCT01617967|3685888|B3|||Age||years|Mean|41.7|41.7|Standard Deviation|2.52|2.52|||
3860125|NCT01617967|3685889|B2|||Age||years|Mean|55.7|55.7|Standard Deviation|24.83|24.83|||
3860126|NCT01617967|3685890|B1|||Age||years|Mean|65.8|65.8|Standard Deviation|8.96|8.96|||
3860127|NCT01617681|3685945|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860128|NCT01617681|3685946|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860129|NCT01617681|3685947|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860130|NCT01617681|3685948|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860131|NCT01617681|3685949|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860132|NCT01617681|3685945|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3860133|NCT01617681|3685946|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3860134|NCT01617681|3685947|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3860135|NCT01617681|3685948|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3860136|NCT01617681|3685949|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3860137|NCT01617681|3685945|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3860138|NCT01617681|3685946|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3860139|NCT01617681|3685947|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3860140|NCT01617681|3685948|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3860141|NCT01617681|3685949|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3860142|NCT01617681|3685945|B5||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3860143|NCT01617681|3685946|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3860144|NCT01617681|3685947|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3860145|NCT01617681|3685948|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3860146|NCT01617681|3685949|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3860147|NCT01617681|3685945|B5||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3860148|NCT01617681|3685946|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3860149|NCT01617681|3685947|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3860150|NCT01617681|3685948|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3860151|NCT01617681|3685949|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3860152|NCT01617681|3685945|B5|||Age||years|Mean|3.26|3.26|Standard Deviation|1.466|1.466|||
3860153|NCT01617681|3685946|B4|||Age||years|Mean|3.62|3.62|Standard Deviation|1.36|1.36|||
3860154|NCT01617681|3685947|B3|||Age||years|Mean|3.7|3.7|Standard Deviation|1.51|1.51|||
3860155|NCT01617681|3685948|B2|||Age||years|Mean|2.72|2.72|Standard Deviation|1.33|1.33|||
3860156|NCT01617681|3685949|B1|||Age||years|Mean|2.99|2.99|Standard Deviation|1.47|1.47|||
3860157|NCT01617668|3685972|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3860158|NCT01617668|3685973|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3860159|NCT01617668|3685974|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3860160|NCT01617668|3685972|B3||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
3860161|NCT01617668|3685973|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3860162|NCT01617668|3685974|B1||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3860163|NCT01617668|3685972|B3|>= 65 years||Age, Customized||Participants|Number|15|15.0||||||
3860164|NCT01617668|3685973|B2|>= 65 years||Age, Customized||Participants|Number|7|7.0||||||
3860165|NCT01617668|3685974|B1|>= 65 years||Age, Customized||Participants|Number|8|8.0||||||
3860166|NCT01617668|3685972|B3|< 65 years||Age, Customized||Participants|Number|194|194.0||||||
3860167|NCT01617668|3685973|B2|< 65 years||Age, Customized||Participants|Number|96|96.0||||||
3860168|NCT01617668|3685974|B1|< 65 years||Age, Customized||Participants|Number|98|98.0||||||
3860169|NCT01617668|3685972|B3|||Age||Years|Mean|48.7|48.7|Standard Deviation|10.04|10.04|||
3860170|NCT01617668|3685973|B2|||Age||Years|Mean|48.7|48.7|Standard Deviation|9.98|9.98|||
3860171|NCT01617668|3685974|B1|||Age||Years|Mean|48.6|48.6|Standard Deviation|10.14|10.14|||
3860172|NCT01617655|3686016|B3|||Calculated low density lipoprotein cholesterol (LDL-C) in mmol/L||mmol/L|Mean|5.123|5.123|Standard Deviation|1.382|1.382|||
3860173|NCT01617655|3686017|B2|||Calculated low density lipoprotein cholesterol (LDL-C) in mmol/L||mmol/L|Mean|5.083|5.083|Standard Deviation|1.499|1.499|||
3860174|NCT01617655|3686018|B1|||Calculated low density lipoprotein cholesterol (LDL-C) in mmol/L||mmol/L|Mean|5.205|5.205|Standard Deviation|1.125|1.125|||
3860175|NCT01617655|3686016|B3|||Calculated LDL-C in mg/dL|Calculated LDL-C from Friedewald formula (LDL cholesterol = Total cholesterol - HDL cholesterol - [Triglyceride/5]).|mg/dL|Mean|197.8|197.8|Standard Deviation|53.4|53.4|||
3860176|NCT01617655|3686017|B2|||Calculated LDL-C in mg/dL|Calculated LDL-C from Friedewald formula (LDL cholesterol = Total cholesterol - HDL cholesterol - [Triglyceride/5]).|mg/dL|Mean|196.3|196.3|Standard Deviation|57.9|57.9|||
3860177|NCT01617655|3686018|B1|||Calculated LDL-C in mg/dL|Calculated LDL-C from Friedewald formula (LDL cholesterol = Total cholesterol - HDL cholesterol - [Triglyceride/5]).|mg/dL|Mean|201|201.0|Standard Deviation|43.4|43.4|||
3860178|NCT01617655|3686016|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3860179|NCT01617655|3686017|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3860180|NCT01617655|3686018|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3860181|NCT01617655|3686016|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3860182|NCT01617655|3686017|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3860183|NCT01617655|3686018|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3860184|NCT01617655|3686016|B3|||Age||years|Mean|50.6|50.6|Standard Deviation|13.3|13.3|||
3860185|NCT01617655|3686017|B2|||Age||years|Mean|49.8|49.8|Standard Deviation|14.2|14.2|||
3860186|NCT01617655|3686018|B1|||Age||years|Mean|52.1|52.1|Standard Deviation|11.2|11.2|||
3860187|NCT01617629|3686079|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3860188|NCT01617629|3686079|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3860189|NCT01617629|3686079|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3860190|NCT01617629|3686079|B1|||Age||years|Mean|55.3|55.3|Standard Deviation|7.7|7.7|||
3860191|NCT01617603|3686084|B4|||HOMA at the begining of product intake|"Baseline HOMA (Homeostatic Model Assessment)index was evaluated at V1 (visit 1) scheduled 28 days after the screening visit (V0) without any chocolate intake. HOMA reflects the resistance to insulin and is obtained from glucose and insulin plasma concentrations at a given sampling timepoint, based on the following formula:~HOMA = Glucose (in mmol/L) X Insulin ( in mU/L)/ 22.5. Insulin resistance is defined by a HOMA index > 2.4. The highest the HOMA index is, the more pronounced the resistance to insulin is."|HOMA index|Mean|5.19|5.19|Inter-Quartile Range|||2.77|10.21|
3860192|NCT01617603|3686085|B3|||HOMA at the begining of product intake|"Baseline HOMA (Homeostatic Model Assessment)index was evaluated at V1 (visit 1) scheduled 28 days after the screening visit (V0) without any chocolate intake. HOMA reflects the resistance to insulin and is obtained from glucose and insulin plasma concentrations at a given sampling timepoint, based on the following formula:~HOMA = Glucose (in mmol/L) X Insulin ( in mU/L)/ 22.5. Insulin resistance is defined by a HOMA index > 2.4. The highest the HOMA index is, the more pronounced the resistance to insulin is."|HOMA index|Mean|4.45|4.45|Inter-Quartile Range|||3.19|6.21|
3860193|NCT01617603|3686086|B2|||HOMA at the begining of product intake|"Baseline HOMA (Homeostatic Model Assessment)index was evaluated at V1 (visit 1) scheduled 28 days after the screening visit (V0) without any chocolate intake. HOMA reflects the resistance to insulin and is obtained from glucose and insulin plasma concentrations at a given sampling timepoint, based on the following formula:~HOMA = Glucose (in mmol/L) X Insulin ( in mU/L)/ 22.5. Insulin resistance is defined by a HOMA index > 2.4. The highest the HOMA index is, the more pronounced the resistance to insulin is."|HOMA index|Mean|4.63|4.63|Inter-Quartile Range|||2.77|7.74|
3860194|NCT01617603|3686087|B1|||HOMA at the begining of product intake|"Baseline HOMA (Homeostatic Model Assessment)index was evaluated at V1 (visit 1) scheduled 28 days after the screening visit (V0) without any chocolate intake. HOMA reflects the resistance to insulin and is obtained from glucose and insulin plasma concentrations at a given sampling timepoint, based on the following formula:~HOMA = Glucose (in mmol/L) X Insulin ( in mU/L)/ 22.5. Insulin resistance is defined by a HOMA index > 2.4. The highest the HOMA index is, the more pronounced the resistance to insulin is."|HOMA index|Mean|6.50|6.5|Inter-Quartile Range|||4.14|10.21|
3860195|NCT01617603|3686084|B4|United Kingdom||Region of Enrollment||participants|Number|62|62.0||||||
3860196|NCT01617603|3686085|B3|United Kingdom||Region of Enrollment||participants|Number|21|21.0||||||
3860197|NCT01617603|3686086|B2|United Kingdom||Region of Enrollment||participants|Number|21|21.0||||||
3860198|NCT01617603|3686087|B1|United Kingdom||Region of Enrollment||participants|Number|20|20.0||||||
3860199|NCT01617603|3686084|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3860200|NCT01617603|3686085|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3860201|NCT01617603|3686086|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3860202|NCT01617603|3686087|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3860203|NCT01617603|3686084|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3860204|NCT01617603|3686085|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3860205|NCT01617603|3686086|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3860206|NCT01617603|3686087|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3860207|NCT01617603|3686084|B4|>=75 years||Age, Customized||participants|Number|0|0.0||||||
3860208|NCT01617603|3686085|B3|>=75 years||Age, Customized||participants|Number|0|0.0||||||
3860209|NCT01617603|3686086|B2|>=75 years||Age, Customized||participants|Number|0|0.0||||||
3860210|NCT01617603|3686087|B1|>=75 years||Age, Customized||participants|Number|0|0.0||||||
3860211|NCT01617603|3686084|B4|Between 45 and 75 years||Age, Customized||participants|Number|62|62.0||||||
3860212|NCT01617603|3686085|B3|Between 45 and 75 years||Age, Customized||participants|Number|21|21.0||||||
3860213|NCT01617603|3686086|B2|Between 45 and 75 years||Age, Customized||participants|Number|21|21.0||||||
3860214|NCT01617603|3686087|B1|Between 45 and 75 years||Age, Customized||participants|Number|20|20.0||||||
3860215|NCT01617603|3686084|B4|<= 45 years||Age, Customized||participants|Number|0|0.0||||||
3860216|NCT01617603|3686085|B3|<= 45 years||Age, Customized||participants|Number|0|0.0||||||
3860217|NCT01617603|3686086|B2|<= 45 years||Age, Customized||participants|Number|0|0.0||||||
3860218|NCT01617603|3686087|B1|<= 45 years||Age, Customized||participants|Number|0|0.0||||||
3860219|NCT01617577|3686097|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3860220|NCT01617577|3686098|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3860221|NCT01617577|3686099|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3860222|NCT01617577|3686097|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3860223|NCT01617577|3686098|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3860224|NCT01617577|3686099|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3860225|NCT01617577|3686097|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3860226|NCT01617577|3686098|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3860227|NCT01617577|3686099|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3860228|NCT01617577|3686097|B3|||Age||years|Mean|72.3|72.3|Standard Deviation|2.9|2.9|||
3860229|NCT01617577|3686098|B2|||Age||years|Mean|75.2|75.2|Standard Deviation|3.1|3.1|||
3860230|NCT01617577|3686099|B1|||Age||years|Mean|71.6|71.6|Standard Deviation|3.8|3.8|||
3860231|NCT01617577|3686097|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3860232|NCT01617577|3686098|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3860233|NCT01617577|3686099|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3860234|NCT01617577|3686097|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3860235|NCT01617577|3686098|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3860236|NCT01617577|3686099|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3860237|NCT01617577|3686097|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3860238|NCT01617577|3686098|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3860239|NCT01617577|3686099|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3860240|NCT01617460|3686107|B1|Japan||Region of Enrollment||participants|Number|86|86.0||||||
3860241|NCT01617460|3686107|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3860242|NCT01617460|3686107|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3860243|NCT01617460|3686107|B1|||Age||years|Mean|10.0|10.0|Standard Deviation|3.0|3.0|||
3860244|NCT01617460|3686107|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3860245|NCT01617460|3686107|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3860246|NCT01617460|3686107|B1||<=18 years|Age||Participants|Count of Participants|86|86.0||||||
3860247|NCT01617447|3686111|B3|Japan||Region of Enrollment||participants|Number|92|92.0||||||
3860248|NCT01617447|3686112|B2|Japan||Region of Enrollment||participants|Number|45|45.0||||||
3860249|NCT01617447|3686113|B1|Japan||Region of Enrollment||participants|Number|47|47.0||||||
3860250|NCT01617447|3686111|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3860251|NCT01617447|3686112|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3860252|NCT01617447|3686113|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3860253|NCT01617447|3686111|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3860254|NCT01617447|3686112|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3860255|NCT01617447|3686113|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3860256|NCT01617447|3686111|B3|||Age||years|Mean|10.1|10.1|Standard Deviation|3.2|3.2|||
3860257|NCT01617447|3686112|B2|||Age||years|Mean|9.9|9.9|Standard Deviation|3.1|3.1|||
3860258|NCT01617447|3686113|B1|||Age||years|Mean|10.3|10.3|Standard Deviation|3.3|3.3|||
3860259|NCT01617447|3686111|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3860260|NCT01617447|3686112|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3860261|NCT01617447|3686113|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3860262|NCT01617447|3686111|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3860263|NCT01617447|3686112|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3860264|NCT01617447|3686113|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3860265|NCT01617447|3686111|B3||<=18 years|Age||Participants|Count of Participants|92|92.0||||||
3860266|NCT01617447|3686112|B2||<=18 years|Age||Participants|Count of Participants|45|45.0||||||
3860267|NCT01617447|3686113|B1||<=18 years|Age||Participants|Count of Participants|47|47.0||||||
3860268|NCT01617434|3686120|B3|||Glycosylated Haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.25|8.25|Standard Deviation|0.86|0.86|||
3860269|NCT01617434|3686121|B2|||Glycosylated Haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.28|8.28|Standard Deviation|0.90|0.9|||
3860270|NCT01617434|3686122|B1|||Glycosylated Haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.22|8.22|Standard Deviation|0.81|0.81|||
3860271|NCT01617434|3686120|B3|||Fasting Plasma Glucose (FPG)||mmol/L|Mean|8.27|8.27|Standard Deviation|2.89|2.89|||
3860272|NCT01617434|3686121|B2|||Fasting Plasma Glucose (FPG)||mmol/L|Mean|8.21|8.21|Standard Deviation|2.90|2.9|||
3860273|NCT01617434|3686122|B1|||Fasting Plasma Glucose (FPG)||mmol/L|Mean|8.32|8.32|Standard Deviation|2.89|2.89|||
3860274|NCT01617434|3686120|B3|||Body Weight||kg|Mean|91.04|91.04|Standard Deviation|20.66|20.66|||
3860275|NCT01617434|3686121|B2|||Body Weight||kg|Mean|91.85|91.85|Standard Deviation|21.33|21.33|||
3860276|NCT01617434|3686122|B1|||Body Weight||kg|Mean|90.23|90.23|Standard Deviation|19.98|19.98|||
3860277|NCT01617434|3686120|B3||Male|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
3860278|NCT01617434|3686121|B2||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3860279|NCT01617434|3686122|B1||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3860280|NCT01617434|3686120|B3||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
3860281|NCT01617434|3686121|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3860282|NCT01617434|3686122|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3860283|NCT01617434|3686120|B3|||Age||years|Mean|58.4|58.4|Standard Deviation|10.2|10.2|||
3860284|NCT01617434|3686121|B2|||Age||years|Mean|57.5|57.5|Standard Deviation|11.1|11.1|||
3860285|NCT01617434|3686122|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|9.2|9.2|||
3860286|NCT01617369|3686145|B1|||Current Smoker||Participants|Count of Participants|0|0.0||||||
3860287|NCT01617369|3686145|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3860288|NCT01617369|3686145|B1|Other, Specify||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3860289|NCT01617369|3686145|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3860290|NCT01617369|3686145|B1|West Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3860291|NCT01617369|3686145|B1|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3860292|NCT01617369|3686145|B1|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3860293|NCT01617369|3686145|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3860294|NCT01617369|3686145|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3860295|NCT01617369|3686145|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3860296|NCT01617369|3686145|B1|||Age||years|Mean|31.5|31.5|Full Range|||20.0|43.0|
3860297|NCT01617369|3686145|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3860298|NCT01617369|3686145|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3860299|NCT01617369|3686145|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3860300|NCT01617187|3686151|B5|||PANSS Marder factor anxiety/depression symptom score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder factor anxiety/depression symptom score (calculated from value of 4 identified PANSS items) ranged from 4 to 28 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|10.9|10.9|Standard Deviation|3.09|3.09|||
3860301|NCT01617187|3686152|B4|||PANSS Marder factor anxiety/depression symptom score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder factor anxiety/depression symptom score (calculated from value of 4 identified PANSS items) ranged from 4 to 28 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|10.7|10.7|Standard Deviation|2.96|2.96|||
3860302|NCT01617187|3686153|B3|||PANSS Marder factor anxiety/depression symptom score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder factor anxiety/depression symptom score (calculated from value of 4 identified PANSS items) ranged from 4 to 28 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|10.9|10.9|Standard Deviation|3.62|3.62|||
3860303|NCT01617187|3686154|B2|||PANSS Marder factor anxiety/depression symptom score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder factor anxiety/depression symptom score (calculated from value of 4 identified PANSS items) ranged from 4 to 28 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|10.9|10.9|Standard Deviation|3.13|3.13|||
3860304|NCT01617187|3686155|B1|||PANSS Marder factor anxiety/depression symptom score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder factor anxiety/depression symptom score (calculated from value of 4 identified PANSS items) ranged from 4 to 28 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|11.0|11.0|Standard Deviation|2.97|2.97|||
3860305|NCT01617187|3686151|B5|||PANSS Marder factor hostility/excitement symptom score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder factor hostility/excitement symptom score (calculated from value of 4 identified PANSS items) ranged from 4 to 28 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|9.0|9.0|Standard Deviation|3.23|3.23|||
3860306|NCT01617187|3686152|B4|||PANSS Marder factor hostility/excitement symptom score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder factor hostility/excitement symptom score (calculated from value of 4 identified PANSS items) ranged from 4 to 28 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|8.8|8.8|Standard Deviation|3.22|3.22|||
3860307|NCT01617187|3686153|B3|||PANSS Marder factor hostility/excitement symptom score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder factor hostility/excitement symptom score (calculated from value of 4 identified PANSS items) ranged from 4 to 28 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|8.7|8.7|Standard Deviation|3.11|3.11|||
3860426|NCT01616953|3686280|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3860427|NCT01616953|3686281|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3860308|NCT01617187|3686154|B2|||PANSS Marder factor hostility/excitement symptom score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder factor hostility/excitement symptom score (calculated from value of 4 identified PANSS items) ranged from 4 to 28 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|9.4|9.4|Standard Deviation|3.49|3.49|||
3860309|NCT01617187|3686155|B1|||PANSS Marder factor hostility/excitement symptom score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder factor hostility/excitement symptom score (calculated from value of 4 identified PANSS items) ranged from 4 to 28 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|9.0|9.0|Standard Deviation|2.99|2.99|||
3860310|NCT01617187|3686151|B5|||PANSS Marder factor disorganized thought symptom score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder factor disorganized thought symptom score (calculated from value of 7 identified PANSS items) ranged from 7 to 49 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|21.8|21.8|Standard Deviation|4.56|4.56|||
3860311|NCT01617187|3686152|B4|||PANSS Marder factor disorganized thought symptom score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder factor disorganized thought symptom score (calculated from value of 7 identified PANSS items) ranged from 7 to 49 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|21.6|21.6|Standard Deviation|4.42|4.42|||
3860312|NCT01617187|3686153|B3|||PANSS Marder factor disorganized thought symptom score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder factor disorganized thought symptom score (calculated from value of 7 identified PANSS items) ranged from 7 to 49 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|21.2|21.2|Standard Deviation|4.29|4.29|||
3860313|NCT01617187|3686154|B2|||PANSS Marder factor disorganized thought symptom score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder factor disorganized thought symptom score (calculated from value of 7 identified PANSS items) ranged from 7 to 49 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|22.6|22.6|Standard Deviation|4.93|4.93|||
3860314|NCT01617187|3686155|B1|||PANSS Marder factor disorganized thought symptom score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder factor disorganized thought symptom score (calculated from value of 7 identified PANSS items) ranged from 7 to 49 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|21.5|21.5|Standard Deviation|4.32|4.32|||
3860315|NCT01617187|3686151|B5|||PANSS Marder factor negative symptom score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder factor negative symptom score (calculated from value of 7 identified PANSS items) ranged from 7 to 49 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|22.8|22.8|Standard Deviation|4.55|4.55|||
3860316|NCT01617187|3686152|B4|||PANSS Marder factor negative symptom score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder factor negative symptom score (calculated from value of 7 identified PANSS items) ranged from 7 to 49 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|22.8|22.8|Standard Deviation|4.76|4.76|||
3860317|NCT01617187|3686153|B3|||PANSS Marder factor negative symptom score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder factor negative symptom score (calculated from value of 7 identified PANSS items) ranged from 7 to 49 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|23.0|23.0|Standard Deviation|4.44|4.44|||
3860318|NCT01617187|3686154|B2|||PANSS Marder factor negative symptom score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder factor negative symptom score (calculated from value of 7 identified PANSS items) ranged from 7 to 49 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|23.0|23.0|Standard Deviation|4.66|4.66|||
3860319|NCT01617187|3686155|B1|||PANSS Marder factor negative symptom score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder factor negative symptom score (calculated from value of 7 identified PANSS items) ranged from 7 to 49 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|22.6|22.6|Standard Deviation|4.30|4.3|||
3860320|NCT01617187|3686151|B5|||PANSS Marder factor positive symptom score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder factor positive symptom score (calculated from value of 8 identified PANSS items) ranged from 8 to 56 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|29.5|29.5|Standard Deviation|4.80|4.8|||
3860321|NCT01617187|3686152|B4|||PANSS Marder factor positive symptom score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder factor positive symptom score (calculated from value of 8 identified PANSS items) ranged from 8 to 56 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|29.4|29.4|Standard Deviation|4.36|4.36|||
3860322|NCT01617187|3686153|B3|||PANSS Marder factor positive symptom score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder factor positive symptom score (calculated from value of 8 identified PANSS items) ranged from 8 to 56 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|29.0|29.0|Standard Deviation|4.69|4.69|||
3860323|NCT01617187|3686154|B2|||PANSS Marder factor positive symptom score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder factor positive symptom score (calculated from value of 8 identified PANSS items) ranged from 8 to 56 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|30.0|30.0|Standard Deviation|5.05|5.05|||
3860324|NCT01617187|3686155|B1|||PANSS Marder factor positive symptom score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder factor positive symptom score (calculated from value of 8 identified PANSS items) ranged from 8 to 56 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|29.3|29.3|Standard Deviation|5.02|5.02|||
3860325|NCT01617187|3686151|B5|||PANSS general psychopathology subscale score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS general psychopathology subscale score (16 PANSS items) ranged from 16 to 112 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|45.5|45.5|Standard Deviation|6.34|6.34|||
3860326|NCT01617187|3686152|B4|||PANSS general psychopathology subscale score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS general psychopathology subscale score (16 PANSS items) ranged from 16 to 112 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|44.9|44.9|Standard Deviation|6.05|6.05|||
3860327|NCT01617187|3686153|B3|||PANSS general psychopathology subscale score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS general psychopathology subscale score (16 PANSS items) ranged from 16 to 112 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|44.7|44.7|Standard Deviation|6.20|6.2|||
3860328|NCT01617187|3686154|B2|||PANSS general psychopathology subscale score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS general psychopathology subscale score (16 PANSS items) ranged from 16 to 112 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|46.3|46.3|Standard Deviation|6.87|6.87|||
3860329|NCT01617187|3686155|B1|||PANSS general psychopathology subscale score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS general psychopathology subscale score (16 PANSS items) ranged from 16 to 112 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|45.5|45.5|Standard Deviation|6.05|6.05|||
3860428|NCT01616953|3686282|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3860429|NCT01616953|3686280|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860330|NCT01617187|3686151|B5|||PANSS positive subscale score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS positive subscale score (7 PANSS items) ranged from 7 to 49 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|24.8|24.8|Standard Deviation|4.19|4.19|||
3860331|NCT01617187|3686152|B4|||PANSS positive subscale score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS positive subscale score (7 PANSS items) ranged from 7 to 49 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|24.6|24.6|Standard Deviation|3.88|3.88|||
3860332|NCT01617187|3686153|B3|||PANSS positive subscale score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS positive subscale score (7 PANSS items) ranged from 7 to 49 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|24.6|24.6|Standard Deviation|3.46|3.46|||
3860333|NCT01617187|3686154|B2|||PANSS positive subscale score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS positive subscale score (7 PANSS items) ranged from 7 to 49 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|25.5|25.5|Standard Deviation|4.76|4.76|||
3860334|NCT01617187|3686155|B1|||PANSS positive subscale score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS positive subscale score (7 PANSS items) ranged from 7 to 49 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|24.4|24.4|Standard Deviation|4.05|4.05|||
3860335|NCT01617187|3686151|B5|||PANSS negative subscale score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS negative subscale score (7 PANSS items) ranged from 7 to 49 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|23.8|23.8|Standard Deviation|4.34|4.34|||
3860336|NCT01617187|3686152|B4|||PANSS negative subscale score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS negative subscale score (7 PANSS items) ranged from 7 to 49 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|23.9|23.9|Standard Deviation|4.22|4.22|||
3860337|NCT01617187|3686153|B3|||PANSS negative subscale score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS negative subscale score (7 PANSS items) ranged from 7 to 49 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|23.4|23.4|Standard Deviation|3.96|3.96|||
3860338|NCT01617187|3686154|B2|||PANSS negative subscale score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS negative subscale score (7 PANSS items) ranged from 7 to 49 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|24.1|24.1|Standard Deviation|4.50|4.5|||
3860339|NCT01617187|3686155|B1|||PANSS negative subscale score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS negative subscale score (7 PANSS items) ranged from 7 to 49 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|23.5|23.5|Standard Deviation|4.47|4.47|||
3860340|NCT01617187|3686151|B5|||Body Weight||kg|Mean|79.3|79.3|Standard Deviation|17.75|17.75|||
3860341|NCT01617187|3686152|B4|||Body Weight||kg|Mean|77.1|77.1|Standard Deviation|17.56|17.56|||
3860342|NCT01617187|3686153|B3|||Body Weight||kg|Mean|80.7|80.7|Standard Deviation|17.79|17.79|||
3860343|NCT01617187|3686154|B2|||Body Weight||kg|Mean|78.6|78.6|Standard Deviation|17.88|17.88|||
3860344|NCT01617187|3686155|B1|||Body Weight||kg|Mean|81.6|81.6|Standard Deviation|17.73|17.73|||
3860345|NCT01617187|3686151|B5|||Clinical Global Impression Scale-Severity (CGI-S) score|CGI-S is a 7-point scale for assessing the global severity of the participant’s illness, with ratings from 1=normal, not ill to 7=very severely ill. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|4.8|4.8|Standard Deviation|0.63|0.63|||
3860430|NCT01616953|3686281|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860431|NCT01616953|3686282|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860346|NCT01617187|3686152|B4|||Clinical Global Impression Scale-Severity (CGI-S) score|CGI-S is a 7-point scale for assessing the global severity of the participant’s illness, with ratings from 1=normal, not ill to 7=very severely ill. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|4.8|4.8|Standard Deviation|0.61|0.61|||
3860347|NCT01617187|3686153|B3|||Clinical Global Impression Scale-Severity (CGI-S) score|CGI-S is a 7-point scale for assessing the global severity of the participant’s illness, with ratings from 1=normal, not ill to 7=very severely ill. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|4.8|4.8|Standard Deviation|0.61|0.61|||
3860348|NCT01617187|3686154|B2|||Clinical Global Impression Scale-Severity (CGI-S) score|CGI-S is a 7-point scale for assessing the global severity of the participant’s illness, with ratings from 1=normal, not ill to 7=very severely ill. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|4.9|4.9|Standard Deviation|0.64|0.64|||
3860349|NCT01617187|3686155|B1|||Clinical Global Impression Scale-Severity (CGI-S) score|CGI-S is a 7-point scale for assessing the global severity of the participant’s illness, with ratings from 1=normal, not ill to 7=very severely ill. Summary statistics presented are for efficacy population (FAS): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|4.8|4.8|Standard Deviation|0.64|0.64|||
3860350|NCT01617187|3686151|B5|||Positive and Negative Syndrome Scale (PANSS) total score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS total score (30 items) ranged from 30 to 210 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (Full Analysis Set [FAS]): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|94.1|94.1|Standard Deviation|11.97|11.97|||
3860351|NCT01617187|3686152|B4|||Positive and Negative Syndrome Scale (PANSS) total score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS total score (30 items) ranged from 30 to 210 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (Full Analysis Set [FAS]): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|93.4|93.4|Standard Deviation|11.16|11.16|||
3860352|NCT01617187|3686153|B3|||Positive and Negative Syndrome Scale (PANSS) total score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS total score (30 items) ranged from 30 to 210 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (Full Analysis Set [FAS]): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|92.7|92.7|Standard Deviation|10.47|10.47|||
3860353|NCT01617187|3686154|B2|||Positive and Negative Syndrome Scale (PANSS) total score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS total score (30 items) ranged from 30 to 210 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (Full Analysis Set [FAS]): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|95.8|95.8|Standard Deviation|13.77|13.77|||
3860354|NCT01617187|3686155|B1|||Positive and Negative Syndrome Scale (PANSS) total score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS total score (30 items) ranged from 30 to 210 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (Full Analysis Set [FAS]): N=96, 111, 45, 99 and 351 for asenapine 2.5 mg BID, asenapine 5 mg BID, olanzapine 15 mg QD, placebo BID and Total groups, respectively.|score on a scale|Mean|93.3|93.3|Standard Deviation|11.10|11.1|||
3860355|NCT01617187|3686151|B5||Male|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
3860356|NCT01617187|3686152|B4||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3860357|NCT01617187|3686153|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3860358|NCT01617187|3686154|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3860359|NCT01617187|3686155|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3860360|NCT01617187|3686151|B5||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3860361|NCT01617187|3686152|B4||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3860362|NCT01617187|3686153|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3860363|NCT01617187|3686154|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3860364|NCT01617187|3686155|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3860365|NCT01617187|3686151|B5|||Age||years|Mean|40.6|40.6|Standard Deviation|11.18|11.18|||
3860366|NCT01617187|3686152|B4|||Age||years|Mean|41.4|41.4|Standard Deviation|12.05|12.05|||
3860367|NCT01617187|3686153|B3|||Age||years|Mean|40.8|40.8|Standard Deviation|11.15|11.15|||
3860368|NCT01617187|3686154|B2|||Age||years|Mean|39.1|39.1|Standard Deviation|10.68|10.68|||
3860369|NCT01617187|3686155|B1|||Age||years|Mean|41.5|41.5|Standard Deviation|10.79|10.79|||
3860370|NCT01617148|3686228|B1|||Central subfield thickness||µm|Mean|304.08|304.08|Standard Deviation|75.44|75.44|||
3860371|NCT01617148|3686228|B1|||Best Corrected Visual Acuity Snellen equivalent|The Snellen Equivalent is a numerical values from 90-0 with the higher value indicated better visual acuity|E-ETDRS letters|Mean|0.25|0.25|Full Range|||0.06|0.8|
3860432|NCT01616953|3686280|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3860372|NCT01617148|3686228|B1|||E-ETDRS best-corrected visual acuity (BCVA) letter score|The scale provided is the Eletronic-Early Treatment in Diabetic Retinopathy Scale (E-ETDRS) best corrected visual acuity scale. This is a very common ophthalmology measurement tool and it is quite clear from its name. Values that are higher are considered better and values that are lower are considered worse. Minimum E-ETDRS was 24 E-ETDRS letters and maximum E-ETDRS was 80 E-ETDRS letters.|E-ETDRS letters|Mean|56.42|56.42|Standard Deviation|17.04|17.04|||
3860373|NCT01617148|3686228|B1|||Average number of injections during study||injections|Mean|7.92|7.92|Standard Deviation|0.27|0.27|||
3860374|NCT01617148|3686228|B1|||Average number of treatments prior to study entry||injections|Mean|9.62|9.62|Standard Deviation|6.58|6.58|||
3860375|NCT01617148|3686228|B1|Previous treatment- Bevacizumab and Ranibizumab||Previous treatment||Participants|Count of Participants|2|2.0||||||
3860376|NCT01617148|3686228|B1|Previous treatment- Ranibizumab||Previous treatment||Participants|Count of Participants|17|17.0||||||
3860377|NCT01617148|3686228|B1|Previous treatment- Bevacizumab||Previous treatment||Participants|Count of Participants|7|7.0||||||
3860378|NCT01617148|3686228|B1|||Time since last injection prior to study enrollment||days|Mean|50|50.0|Standard Deviation|24|24.0|||
3860379|NCT01617148|3686228|B1|||Length of time since diagnosis of exudative AMD||months|Mean|14|14.0|Standard Deviation|11|11.0|||
3860380|NCT01617148|3686228|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
3860381|NCT01617148|3686228|B1|Unknown||Sex/Gender, Customized||Participants|Count of Participants|26|26.0||||||
3860382|NCT01617148|3686228|B1|||Age||years|Mean|78|78.0|Standard Deviation|8|8.0|||
3860383|NCT01617083|3686239|B4|United States||Region of Enrollment||participants|Number|47|47.0||||||
3860384|NCT01617083|3686240|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
3860385|NCT01617083|3686241|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3860386|NCT01617083|3686242|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3860387|NCT01617083|3686239|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3860388|NCT01617083|3686240|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3860389|NCT01617083|3686241|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3860390|NCT01617083|3686242|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3860391|NCT01617083|3686239|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3860392|NCT01617083|3686240|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3860393|NCT01617083|3686241|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3860394|NCT01617083|3686242|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3860395|NCT01617083|3686239|B4|||Age||years|Mean|8.25|8.25|Standard Deviation|2.74|2.74|||
3860396|NCT01617083|3686240|B3|||Age||years|Mean|7.21|7.21|Standard Deviation|2.58|2.58|||
3860397|NCT01617083|3686241|B2|||Age||years|Mean|8.86|8.86|Standard Deviation|3.11|3.11|||
3860398|NCT01617083|3686242|B1|||Age||years|Mean|7.78|7.78|Standard Deviation|2.39|2.39|||
3860399|NCT01617083|3686239|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3860400|NCT01617083|3686240|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3860401|NCT01617083|3686241|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3860402|NCT01617083|3686242|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3860403|NCT01617083|3686239|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3860404|NCT01617083|3686240|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3860405|NCT01617083|3686241|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3860406|NCT01617083|3686242|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3860407|NCT01617083|3686239|B4||<=18 years|Age||Participants|Count of Participants|47|47.0||||||
3860408|NCT01617083|3686240|B3||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
3860409|NCT01617083|3686241|B2||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
3860410|NCT01617083|3686242|B1||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
3860411|NCT01617070|3686255|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3860412|NCT01617070|3686255|B1||Male|Gender||Participants|Count of Participants|7|7.0||||||
3860413|NCT01617070|3686255|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
3860414|NCT01617070|3686255|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3860415|NCT01617070|3686255|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3860416|NCT01617070|3686255|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3860417|NCT01617005|3686273|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3860418|NCT01617005|3686273|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3860419|NCT01617005|3686273|B1|||Age||years|Mean|51.9|51.9|Standard Deviation|11.1|11.1|||
3860420|NCT01616953|3686280|B3|||Pre-operative alveolar bone width|The alveolar crest width at baseline was measured with a vernier caliper to the nearest half of a millimeter, 3mm below the crest|millimeters|Mean|3.8|3.8|Standard Deviation|1.8|1.8|||
3860421|NCT01616953|3686281|B2|||Pre-operative alveolar bone width|The alveolar crest width at baseline was measured with a vernier caliper to the nearest half of a millimeter, 3mm below the crest|millimeters|Mean|5|5.0|Standard Deviation|1.1|1.1|||
3860422|NCT01616953|3686282|B1|||Pre-operative alveolar bone width|The alveolar crest width at baseline was measured with a vernier caliper to the nearest half of a millimeter, 3mm below the crest|millimeters|Mean|2.6|2.6|Standard Deviation|1.6|1.6|||
3860423|NCT01616953|3686280|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
3860424|NCT01616953|3686281|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3860425|NCT01616953|3686282|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3860433|NCT01616953|3686281|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3860434|NCT01616953|3686282|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3860435|NCT01616953|3686280|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3860436|NCT01616953|3686281|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3860437|NCT01616953|3686282|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3860438|NCT01616953|3686280|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860439|NCT01616953|3686281|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860440|NCT01616953|3686282|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860441|NCT01616953|3686280|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860442|NCT01616953|3686281|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860443|NCT01616953|3686282|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860444|NCT01616953|3686280|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860445|NCT01616953|3686281|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860446|NCT01616953|3686282|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860447|NCT01616953|3686280|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3860448|NCT01616953|3686281|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3860449|NCT01616953|3686282|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3860450|NCT01616953|3686280|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860451|NCT01616953|3686281|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860452|NCT01616953|3686282|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860453|NCT01616953|3686280|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3860454|NCT01616953|3686281|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3860455|NCT01616953|3686282|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3860456|NCT01616953|3686280|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3860457|NCT01616953|3686281|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3860458|NCT01616953|3686282|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3860459|NCT01616953|3686280|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3860460|NCT01616953|3686281|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3860461|NCT01616953|3686282|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3860462|NCT01616953|3686280|B3|||Age||years|Mean|29|29.0|Full Range|||18.0|54.0|
3860463|NCT01616953|3686281|B2|||Age||years|Mean|31|31.0|Full Range|||19.0|54.0|
3860464|NCT01616953|3686282|B1|||Age||years|Mean|27|27.0|Full Range|||18.0|42.0|
3860465|NCT01616953|3686280|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3860466|NCT01616953|3686281|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3860467|NCT01616953|3686282|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3860468|NCT01616953|3686280|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3860469|NCT01616953|3686281|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3860470|NCT01616953|3686282|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3860471|NCT01616953|3686280|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3860472|NCT01616953|3686281|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3860473|NCT01616953|3686282|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3860474|NCT01616771|3686291|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3860475|NCT01616771|3686291|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3860476|NCT01616771|3686291|B1|||Age||years|Mean|7.9|7.9|Standard Deviation|4.8|4.8|||
3860477|NCT01616771|3686291|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3860478|NCT01616771|3686291|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3860479|NCT01616771|3686291|B1||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
3860480|NCT01616693|3686300|B5||Temporary|Type of house||Participants|Count of Participants|48|48.0||||||
3860481|NCT01616693|3686301|B4||Temporary|Type of house||Participants|Count of Participants|11|11.0||||||
3860482|NCT01616693|3686302|B3||Temporary|Type of house||Participants|Count of Participants|10|10.0||||||
3860483|NCT01616693|3686303|B2||Temporary|Type of house||Participants|Count of Participants|16|16.0||||||
3860484|NCT01616693|3686304|B1||Temporary|Type of house||Participants|Count of Participants|11|11.0||||||
3860485|NCT01616693|3686300|B5||Mixed|Type of house||Participants|Count of Participants|212|212.0||||||
3860486|NCT01616693|3686301|B4||Mixed|Type of house||Participants|Count of Participants|54|54.0||||||
3860487|NCT01616693|3686302|B3||Mixed|Type of house||Participants|Count of Participants|52|52.0||||||
3860488|NCT01616693|3686303|B2||Mixed|Type of house||Participants|Count of Participants|47|47.0||||||
3860489|NCT01616693|3686304|B1||Mixed|Type of house||Participants|Count of Participants|59|59.0||||||
3860490|NCT01616693|3686300|B5||Permanent (pucca)|Type of house||Participants|Count of Participants|360|360.0||||||
3860491|NCT01616693|3686301|B4||Permanent (pucca)|Type of house||Participants|Count of Participants|90|90.0||||||
3860492|NCT01616693|3686302|B3||Permanent (pucca)|Type of house||Participants|Count of Participants|93|93.0||||||
3860493|NCT01616693|3686303|B2||Permanent (pucca)|Type of house||Participants|Count of Participants|92|92.0||||||
3860494|NCT01616693|3686304|B1||Permanent (pucca)|Type of house||Participants|Count of Participants|85|85.0||||||
3860495|NCT01616693|3686300|B5||Muslim|Religion||Participants|Count of Participants|179|179.0||||||
3860496|NCT01616693|3686301|B4||Muslim|Religion||Participants|Count of Participants|45|45.0||||||
3860497|NCT01616693|3686302|B3||Muslim|Religion||Participants|Count of Participants|34|34.0||||||
3860498|NCT01616693|3686303|B2||Muslim|Religion||Participants|Count of Participants|49|49.0||||||
3860499|NCT01616693|3686304|B1||Muslim|Religion||Participants|Count of Participants|51|51.0||||||
3860500|NCT01616693|3686300|B5||Christian|Religion||Participants|Count of Participants|26|26.0||||||
3860501|NCT01616693|3686301|B4||Christian|Religion||Participants|Count of Participants|6|6.0||||||
3860502|NCT01616693|3686302|B3||Christian|Religion||Participants|Count of Participants|5|5.0||||||
3860503|NCT01616693|3686303|B2||Christian|Religion||Participants|Count of Participants|10|10.0||||||
3860504|NCT01616693|3686304|B1||Christian|Religion||Participants|Count of Participants|5|5.0||||||
3860505|NCT01616693|3686300|B5||Hindu|Religion||Participants|Count of Participants|415|415.0||||||
3860506|NCT01616693|3686301|B4||Hindu|Religion||Participants|Count of Participants|104|104.0||||||
3860507|NCT01616693|3686302|B3||Hindu|Religion||Participants|Count of Participants|116|116.0||||||
3860508|NCT01616693|3686303|B2||Hindu|Religion||Participants|Count of Participants|96|96.0||||||
3860509|NCT01616693|3686304|B1||Hindu|Religion||Participants|Count of Participants|99|99.0||||||
3860510|NCT01616693|3686300|B5|India||Region of Enrollment||participants|Number|620|620.0||||||
3860511|NCT01616693|3686301|B4|India||Region of Enrollment||participants|Number|155|155.0||||||
3860512|NCT01616693|3686302|B3|India||Region of Enrollment||participants|Number|155|155.0||||||
3860513|NCT01616693|3686303|B2|India||Region of Enrollment||participants|Number|155|155.0||||||
3860514|NCT01616693|3686304|B1|India||Region of Enrollment||participants|Number|155|155.0||||||
3860515|NCT01616693|3686300|B5||Male|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
3860516|NCT01616693|3686301|B4||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3860517|NCT01616693|3686302|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3860518|NCT01616693|3686303|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3860519|NCT01616693|3686304|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3860520|NCT01616693|3686300|B5||Female|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
3860521|NCT01616693|3686301|B4||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3860522|NCT01616693|3686302|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3860523|NCT01616693|3686303|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3860524|NCT01616693|3686304|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3860525|NCT01616693|3686300|B5|||Age||weeks|Mean|5.1|5.1|Standard Deviation|.3|0.3|||
3860526|NCT01616693|3686301|B4|||Age||weeks|Mean|5.2|5.2|Standard Deviation|.3|0.3|||
3860527|NCT01616693|3686302|B3|||Age||weeks|Mean|5.1|5.1|Standard Deviation|.3|0.3|||
3860528|NCT01616693|3686303|B2|||Age||weeks|Mean|5.1|5.1|Standard Deviation|.3|0.3|||
3860529|NCT01616693|3686304|B1|||Age||weeks|Mean|5.1|5.1|Standard Deviation|.3|0.3|||
3860530|NCT01616576|3686357|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
3860531|NCT01616576|3686358|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
3860532|NCT01616576|3686359|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3860533|NCT01616576|3686357|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3860534|NCT01616576|3686358|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3860535|NCT01616576|3686359|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3860536|NCT01616576|3686357|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3860537|NCT01616576|3686358|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3860538|NCT01616576|3686359|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3860539|NCT01616576|3686357|B3|||Age||years|Mean|60.4|60.4|Standard Deviation|14.22|14.22|||
3860540|NCT01616576|3686358|B2|||Age||years|Mean|58.9|58.9|Standard Deviation|13.86|13.86|||
3860541|NCT01616576|3686359|B1|||Age||years|Mean|62.0|62.0|Standard Deviation|14.81|14.81|||
3860542|NCT01616576|3686357|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3860543|NCT01616576|3686358|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3860544|NCT01616576|3686359|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3860545|NCT01616576|3686357|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3860546|NCT01616576|3686358|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3860547|NCT01616576|3686359|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3860548|NCT01616576|3686357|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3860549|NCT01616576|3686358|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3860550|NCT01616576|3686359|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3860551|NCT01616459|3686369|B5||Male|Sex: Female, Male||Participants|Count of Participants|484|484.0||||||
3860552|NCT01616459|3686370|B4||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3860553|NCT01616459|3686371|B3||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3860554|NCT01616459|3686372|B2||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3860555|NCT01616459|3686373|B1||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3860556|NCT01616459|3686369|B5||Female|Sex: Female, Male||Participants|Count of Participants|467|467.0||||||
3860557|NCT01616459|3686370|B4||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3860558|NCT01616459|3686371|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3860559|NCT01616459|3686372|B2||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3860560|NCT01616459|3686373|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3860561|NCT01616459|3686369|B5|||Age||Weeks|Mean|8.6|8.6|Standard Deviation|1.56|1.56|||
3860562|NCT01616459|3686370|B4|||Age||Weeks|Mean|8.6|8.6|Standard Deviation|1.54|1.54|||
3860563|NCT01616459|3686371|B3|||Age||Weeks|Mean|8.7|8.7|Standard Deviation|1.62|1.62|||
3860564|NCT01616459|3686372|B2|||Age||Weeks|Mean|8.7|8.7|Standard Deviation|1.61|1.61|||
3860565|NCT01616459|3686373|B1|||Age||Weeks|Mean|8.6|8.6|Standard Deviation|1.49|1.49|||
3860566|NCT01616173|3686462|B4||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3860567|NCT01616173|3686463|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3860568|NCT01616173|3686464|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3860569|NCT01616173|3686465|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3860570|NCT01616173|3686462|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3860571|NCT01616173|3686463|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3860572|NCT01616173|3686464|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3860573|NCT01616173|3686465|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3860574|NCT01616173|3686462|B4|||Age||years|Median|43|43.0|Inter-Quartile Range|||30.0|52.0|
3860575|NCT01616173|3686463|B3|||Age||years|Median|39|39.0|Inter-Quartile Range|||23.0|60.0|
3860576|NCT01616173|3686464|B2|||Age||years|Median|47|47.0|Inter-Quartile Range|||32.0|55.0|
3860577|NCT01616173|3686465|B1|||Age||years|Median|42|42.0|Inter-Quartile Range|||31.0|47.0|
3860578|NCT01616160|3686481|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3860579|NCT01616160|3686481|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860580|NCT01616160|3686481|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860581|NCT01616160|3686481|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3860582|NCT01616160|3686481|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3860583|NCT01616160|3686481|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860584|NCT01616160|3686481|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860585|NCT01616160|3686481|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860586|NCT01616160|3686481|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3860587|NCT01616160|3686481|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3860588|NCT01616160|3686481|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3860589|NCT01616160|3686481|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3860590|NCT01616160|3686481|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3860591|NCT01616056|3686486|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3860592|NCT01616056|3686486|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3860593|NCT01616056|3686486|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3860594|NCT01616056|3686486|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860595|NCT01616056|3686486|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3860596|NCT01616056|3686486|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3860597|NCT01616056|3686486|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860598|NCT01616056|3686486|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3860599|NCT01616056|3686486|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3860600|NCT01616056|3686486|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860601|NCT01616056|3686486|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3860602|NCT01616056|3686486|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3860603|NCT01616056|3686486|B1|||Age||years|Median|55|55.0|Full Range|||32.0|75.0|
3860604|NCT01615939|3686498|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3860605|NCT01615939|3686499|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3860606|NCT01615939|3686500|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3860607|NCT01615939|3686498|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3860608|NCT01615939|3686499|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3860609|NCT01615939|3686500|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3860610|NCT01615939|3686498|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3860611|NCT01615939|3686499|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3860612|NCT01615939|3686500|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3860613|NCT01615939|3686498|B3|||Age||years|Median|41|41.0|Inter-Quartile Range|||33.0|70.0|
3860614|NCT01615939|3686499|B2|||Age||years|Median|41|41.0|Inter-Quartile Range|||30.0|61.0|
3860615|NCT01615939|3686500|B1|||Age||years|Median|48|48.0|Inter-Quartile Range|||33.0|73.0|
3860616|NCT01615939|3686498|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3860617|NCT01615939|3686499|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3860618|NCT01615939|3686500|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3860619|NCT01615939|3686498|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3860620|NCT01615939|3686499|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3860621|NCT01615939|3686500|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3860622|NCT01615939|3686498|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3860623|NCT01615939|3686499|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3860624|NCT01615939|3686500|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3860625|NCT01615822|3686511|B4|South Africa||Region of Enrollment||participants|Number|24|24.0||||||
3860626|NCT01615822|3686512|B3|South Africa||Region of Enrollment||participants|Number|6|6.0||||||
3860627|NCT01615822|3686513|B2|South Africa||Region of Enrollment||participants|Number|10|10.0||||||
3860628|NCT01615822|3686514|B1|South Africa||Region of Enrollment||participants|Number|8|8.0||||||
3860629|NCT01615822|3686511|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3860630|NCT01615822|3686512|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3860631|NCT01615822|3686513|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3860632|NCT01615822|3686514|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3860633|NCT01615822|3686511|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3860634|NCT01615822|3686512|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3860635|NCT01615822|3686513|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3860636|NCT01615822|3686514|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3860637|NCT01615822|3686511|B4|||Age||years|Mean|28.6|28.6|Standard Deviation|8.06|8.06|||
3860638|NCT01615822|3686512|B3|||Age||years|Mean|26|26.0|Standard Deviation|4.45|4.45|||
3860639|NCT01615822|3686513|B2|||Age||years|Mean|30.6|30.6|Standard Deviation|9.42|9.42|||
3860640|NCT01615822|3686514|B1|||Age||years|Mean|29.1|29.1|Standard Deviation|10.3|10.3|||
3860641|NCT01615809|3686533|B1|Spain||Region of Enrollment||center|Number|32|32.0||||||
3860642|NCT01615809|3686533|B1|gypsies||Race/Ethnicity, Customized|patients ethnicity percentage : caucasian (84.4%), Amerindian (6.3%), African (3.1%) and gypsies (6.3%).|participants|Number|2|2.0||||||
3860643|NCT01615809|3686533|B1|african||Race/Ethnicity, Customized|patients ethnicity percentage : caucasian (84.4%), Amerindian (6.3%), African (3.1%) and gypsies (6.3%).|participants|Number|1|1.0||||||
3860644|NCT01615809|3686533|B1|amerindian||Race/Ethnicity, Customized|patients ethnicity percentage : caucasian (84.4%), Amerindian (6.3%), African (3.1%) and gypsies (6.3%).|participants|Number|2|2.0||||||
3860645|NCT01615809|3686533|B1|caucasian||Race/Ethnicity, Customized|patients ethnicity percentage : caucasian (84.4%), Amerindian (6.3%), African (3.1%) and gypsies (6.3%).|participants|Number|27|27.0||||||
3860646|NCT01615809|3686533|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3860647|NCT01615809|3686533|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3860648|NCT01615809|3686533|B1|>= 3 years to <=18 years||Age, Customized||participants|Number|32|32.0||||||
3860649|NCT01615731|3686539|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3860650|NCT01615731|3686540|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
3860651|NCT01615731|3686541|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3860652|NCT01615731|3686539|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3860653|NCT01615731|3686540|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3860654|NCT01615731|3686541|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3860655|NCT01615731|3686539|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3860656|NCT01615731|3686540|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3860657|NCT01615731|3686541|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3860658|NCT01615731|3686539|B3|||Age||years|Mean|27.7|27.7|Standard Deviation|6.5|6.5|||
3860659|NCT01615731|3686540|B2|||Age||years|Mean|27.7|27.7|Standard Deviation|6.7|6.7|||
3860660|NCT01615731|3686541|B1|||Age||years|Mean|27.6|27.6|Standard Deviation|6.5|6.5|||
3860661|NCT01615484|3686562|B3|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3860662|NCT01615484|3686563|B2|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3860663|NCT01615484|3686562|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860664|NCT01615484|3686563|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860665|NCT01615484|3686564|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860666|NCT01615484|3686562|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860667|NCT01615484|3686563|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860668|NCT01615484|3686564|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860669|NCT01615484|3686562|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3860670|NCT01615484|3686563|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3860671|NCT01615484|3686564|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860672|NCT01615484|3686562|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3860673|NCT01615484|3686563|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3860674|NCT01615484|3686564|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860675|NCT01615484|3686562|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860676|NCT01615484|3686563|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860677|NCT01615484|3686564|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860678|NCT01615484|3686562|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860679|NCT01615484|3686563|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860680|NCT01615484|3686564|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860681|NCT01615484|3686562|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860682|NCT01615484|3686563|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860683|NCT01615484|3686564|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860684|NCT01615484|3686562|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3860685|NCT01615484|3686563|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3860686|NCT01615484|3686564|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3860687|NCT01615484|3686562|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3860688|NCT01615484|3686563|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3860689|NCT01615484|3686564|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3860690|NCT01615484|3686562|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3860691|NCT01615484|3686563|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3860692|NCT01615484|3686564|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3860693|NCT01615484|3686562|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3860694|NCT01615484|3686563|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3860695|NCT01615484|3686564|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3860696|NCT01615484|3686562|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3860697|NCT01615484|3686563|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3860698|NCT01615484|3686564|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3860699|NCT01615367|3686581|B3|||Young Mania Rating Scale|Young Mania Rating Scale is an 11-item, clinician-rated measure that assesses the presence and severity of patient’s current symptoms of mania. The score for each item is summed for a total score that ranges from 0 to 56 with higher scores indicating more severe current manic symptoms.|units on a scale|Mean|5.68|5.68|Standard Deviation|7.25|7.25|||
3860700|NCT01615367|3686582|B2|||Young Mania Rating Scale|Young Mania Rating Scale is an 11-item, clinician-rated measure that assesses the presence and severity of patient’s current symptoms of mania. The score for each item is summed for a total score that ranges from 0 to 56 with higher scores indicating more severe current manic symptoms.|units on a scale|Mean|5.95|5.95|Standard Deviation|5.90|5.9|||
3860701|NCT01615367|3686583|B1|||Young Mania Rating Scale|Young Mania Rating Scale is an 11-item, clinician-rated measure that assesses the presence and severity of patient’s current symptoms of mania. The score for each item is summed for a total score that ranges from 0 to 56 with higher scores indicating more severe current manic symptoms.|units on a scale|Mean|5.42|5.42|Standard Deviation|8.55|8.55|||
3860702|NCT01615367|3686581|B3|||Montgomery Asberg Depression Rating Scale|Montgomery Asberg Depression Rating Scale is a 10-item clinician-rated measure of depression that assesses the presence and severity of patient’s current depressive symptoms. The score for each item is summed for a total score that ranges from 0 to 60 with higher scores indicating more severe current depressive symptoms.|units on a scale|Mean|12.86|12.86|Standard Deviation|9.03|9.03|||
3860703|NCT01615367|3686582|B2|||Montgomery Asberg Depression Rating Scale|Montgomery Asberg Depression Rating Scale is a 10-item clinician-rated measure of depression that assesses the presence and severity of patient’s current depressive symptoms. The score for each item is summed for a total score that ranges from 0 to 60 with higher scores indicating more severe current depressive symptoms.|units on a scale|Mean|12.37|12.37|Standard Deviation|9.23|9.23|||
3860704|NCT01615367|3686583|B1|||Montgomery Asberg Depression Rating Scale|Montgomery Asberg Depression Rating Scale is a 10-item clinician-rated measure of depression that assesses the presence and severity of patient’s current depressive symptoms. The score for each item is summed for a total score that ranges from 0 to 60 with higher scores indicating more severe current depressive symptoms.|units on a scale|Mean|13.39|13.39|Standard Deviation|9.06|9.06|||
3860705|NCT01615367|3686581|B3|||Weekly Exercise Duration|Weekly exercise duration reported at baseline.|minutes|Mean|45.00|45.0|Standard Deviation|60.33|60.33|||
3860706|NCT01615367|3686582|B2|||Weekly Exercise Duration|Weekly exercise duration reported at baseline.|minutes|Mean|65.00|65.0|Standard Deviation|74.99|74.99|||
3860707|NCT01615367|3686583|B1|||Weekly Exercise Duration|Weekly exercise duration reported at baseline.|minutes|Mean|26.05|26.05|Standard Deviation|34.50|34.5|||
3860708|NCT01615367|3686581|B3|||Body Mass Index (BMI)|Body mass index level at baseline.|kg/m^2|Mean|35.18|35.18|Standard Deviation|5.78|5.78|||
3860709|NCT01615367|3686582|B2|||Body Mass Index (BMI)|Body mass index level at baseline.|kg/m^2|Mean|36.37|36.37|Standard Deviation|6.75|6.75|||
3860710|NCT01615367|3686583|B1|||Body Mass Index (BMI)|Body mass index level at baseline.|kg/m^2|Mean|33.99|33.99|Standard Deviation|4.47|4.47|||
3860711|NCT01615367|3686581|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3860712|NCT01615367|3686582|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3860713|NCT01615367|3686583|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3860714|NCT01615367|3686581|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860715|NCT01615367|3686582|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860716|NCT01615367|3686583|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860717|NCT01615367|3686581|B3||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3860718|NCT01615367|3686582|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3860719|NCT01615367|3686583|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3860720|NCT01615367|3686581|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3860721|NCT01615367|3686582|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860722|NCT01615367|3686583|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3860723|NCT01615367|3686581|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860724|NCT01615367|3686582|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860725|NCT01615367|3686583|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860726|NCT01615367|3686581|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3860727|NCT01615367|3686582|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860728|NCT01615367|3686583|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3860729|NCT01615367|3686581|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860730|NCT01615367|3686582|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860731|NCT01615367|3686583|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860732|NCT01615367|3686581|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3860733|NCT01615367|3686582|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3860734|NCT01615367|3686583|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3860735|NCT01615367|3686581|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3860736|NCT01615367|3686582|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3860737|NCT01615367|3686583|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3860738|NCT01615367|3686581|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3860739|NCT01615367|3686582|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3860740|NCT01615367|3686583|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3860741|NCT01615367|3686581|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3860742|NCT01615367|3686582|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3860743|NCT01615367|3686583|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3860744|NCT01615367|3686581|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3860745|NCT01615367|3686582|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3860746|NCT01615367|3686583|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3860747|NCT01615367|3686581|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3860748|NCT01615367|3686582|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3860749|NCT01615367|3686583|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3860750|NCT01615367|3686581|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3860751|NCT01615367|3686582|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3860752|NCT01615367|3686583|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3860753|NCT01615367|3686581|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3860754|NCT01615367|3686582|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3860755|NCT01615367|3686583|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3860756|NCT01615328|3686602|B3|Korea, Republic of||Region of Enrollment||participants|Number|77|77.0||||||
3860757|NCT01615328|3686603|B2|Korea, Republic of||Region of Enrollment||participants|Number|38|38.0||||||
3860758|NCT01615328|3686604|B1|Korea, Republic of||Region of Enrollment||participants|Number|39|39.0||||||
3860759|NCT01615328|3686602|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3860760|NCT01615328|3686603|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3860761|NCT01615328|3686604|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3860762|NCT01615328|3686602|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3860763|NCT01615328|3686603|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3860764|NCT01615328|3686604|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3860765|NCT01615328|3686602|B3|||Age||years|Mean|51.6|51.6|Standard Deviation|11.7|11.7|||
3860766|NCT01615328|3686603|B2|||Age||years|Mean|51.9|51.9|Standard Deviation|11.7|11.7|||
3860767|NCT01615328|3686604|B1|||Age||years|Mean|51.3|51.3|Standard Deviation|12.4|12.4|||
3860768|NCT01615328|3686602|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3860769|NCT01615328|3686603|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3860770|NCT01615328|3686604|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3860771|NCT01615328|3686602|B3||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
3860772|NCT01615328|3686603|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3860773|NCT01615328|3686604|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3860774|NCT01615328|3686602|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3860775|NCT01615328|3686603|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3860776|NCT01615328|3686604|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3860777|NCT01615263|3686615|B3|Canada||Region of Enrollment||participants|Number|40|40.0||||||
3860778|NCT01615263|3686616|B2|Canada||Region of Enrollment||participants|Number|20|20.0||||||
3860779|NCT01615263|3686617|B1|Canada||Region of Enrollment||participants|Number|20|20.0||||||
3860780|NCT01615263|3686615|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3860781|NCT01615263|3686616|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3860782|NCT01615263|3686617|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3860783|NCT01615263|3686615|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3860784|NCT01615263|3686616|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3860785|NCT01615263|3686617|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3860786|NCT01615263|3686615|B3|||Age||years|Mean|62.4|62.4|Standard Deviation|9.2|9.2|||
3860787|NCT01615263|3686616|B2|||Age||years|Mean|61.9|61.9|Standard Deviation|7.5|7.5|||
3860788|NCT01615263|3686617|B1|||Age||years|Mean|63.0|63.0|Standard Deviation|18.2|18.2|||
3860789|NCT01615263|3686615|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3860790|NCT01615263|3686616|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3860791|NCT01615263|3686617|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3860792|NCT01615263|3686615|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3860793|NCT01615263|3686616|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3860794|NCT01615263|3686617|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3860795|NCT01615263|3686615|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3860796|NCT01615263|3686616|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3860797|NCT01615263|3686617|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3860798|NCT01615198|3686630|B3||Male|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
3860799|NCT01615198|3686631|B2||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3860800|NCT01615198|3686632|B1||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3860801|NCT01615198|3686630|B3||Female|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
3860802|NCT01615198|3686631|B2||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3860803|NCT01615198|3686632|B1||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3860804|NCT01615198|3686630|B3|||Age||Years|Mean|70.7|70.7|Standard Deviation|4.67|4.67|||
3860805|NCT01615198|3686631|B2|||Age||Years|Mean|70.9|70.9|Standard Deviation|4.67|4.67|||
3860806|NCT01615198|3686632|B1|||Age||Years|Mean|70.5|70.5|Standard Deviation|4.67|4.67|||
3860807|NCT01615029|3686661|B6|None||Refractory to Proteasome Inhibitor (PI)/Immunomodulatory drug (IMiD)||participants|Number|31|31.0||||||
3860808|NCT01615029|3686662|B5|None||Refractory to Proteasome Inhibitor (PI)/Immunomodulatory drug (IMiD)||participants|Number|26|26.0||||||
3860809|NCT01615029|3686663|B4|None||Refractory to Proteasome Inhibitor (PI)/Immunomodulatory drug (IMiD)||participants|Number|1|1.0||||||
3860810|NCT01615029|3686664|B3|None||Refractory to Proteasome Inhibitor (PI)/Immunomodulatory drug (IMiD)||participants|Number|1|1.0||||||
3860811|NCT01615029|3686665|B2|None||Refractory to Proteasome Inhibitor (PI)/Immunomodulatory drug (IMiD)||participants|Number|0|0.0||||||
3860812|NCT01615029|3686666|B1|None||Refractory to Proteasome Inhibitor (PI)/Immunomodulatory drug (IMiD)||participants|Number|3|3.0||||||
3860813|NCT01615029|3686661|B6|IMiD only||Refractory to Proteasome Inhibitor (PI)/Immunomodulatory drug (IMiD)||participants|Number|3|3.0||||||
3860814|NCT01615029|3686662|B5|IMiD only||Refractory to Proteasome Inhibitor (PI)/Immunomodulatory drug (IMiD)||participants|Number|1|1.0||||||
3860815|NCT01615029|3686663|B4|IMiD only||Refractory to Proteasome Inhibitor (PI)/Immunomodulatory drug (IMiD)||participants|Number|1|1.0||||||
3860816|NCT01615029|3686664|B3|IMiD only||Refractory to Proteasome Inhibitor (PI)/Immunomodulatory drug (IMiD)||participants|Number|0|0.0||||||
3860817|NCT01615029|3686665|B2|IMiD only||Refractory to Proteasome Inhibitor (PI)/Immunomodulatory drug (IMiD)||participants|Number|1|1.0||||||
3860818|NCT01615029|3686666|B1|IMiD only||Refractory to Proteasome Inhibitor (PI)/Immunomodulatory drug (IMiD)||participants|Number|0|0.0||||||
3860819|NCT01615029|3686661|B6|PI only||Refractory to Proteasome Inhibitor (PI)/Immunomodulatory drug (IMiD)||participants|Number|7|7.0||||||
3860820|NCT01615029|3686662|B5|PI only||Refractory to Proteasome Inhibitor (PI)/Immunomodulatory drug (IMiD)||participants|Number|5|5.0||||||
3860821|NCT01615029|3686663|B4|PI only||Refractory to Proteasome Inhibitor (PI)/Immunomodulatory drug (IMiD)||participants|Number|0|0.0||||||
3860822|NCT01615029|3686664|B3|PI only||Refractory to Proteasome Inhibitor (PI)/Immunomodulatory drug (IMiD)||participants|Number|0|0.0||||||
3860823|NCT01615029|3686665|B2|PI only||Refractory to Proteasome Inhibitor (PI)/Immunomodulatory drug (IMiD)||participants|Number|2|2.0||||||
3860824|NCT01615029|3686666|B1|PI only||Refractory to Proteasome Inhibitor (PI)/Immunomodulatory drug (IMiD)||participants|Number|0|0.0||||||
3860825|NCT01615029|3686661|B6|Both a PI and IMiD||Refractory to Proteasome Inhibitor (PI)/Immunomodulatory drug (IMiD)||participants|Number|4|4.0||||||
3860826|NCT01615029|3686662|B5|Both a PI and IMiD||Refractory to Proteasome Inhibitor (PI)/Immunomodulatory drug (IMiD)||participants|Number|0|0.0||||||
3860827|NCT01615029|3686663|B4|Both a PI and IMiD||Refractory to Proteasome Inhibitor (PI)/Immunomodulatory drug (IMiD)||participants|Number|1|1.0||||||
3860828|NCT01615029|3686664|B3|Both a PI and IMiD||Refractory to Proteasome Inhibitor (PI)/Immunomodulatory drug (IMiD)||participants|Number|3|3.0||||||
3860907|NCT01615029|3686665|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3860829|NCT01615029|3686665|B2|Both a PI and IMiD||Refractory to Proteasome Inhibitor (PI)/Immunomodulatory drug (IMiD)||participants|Number|0|0.0||||||
3860830|NCT01615029|3686666|B1|Both a PI and IMiD||Refractory to Proteasome Inhibitor (PI)/Immunomodulatory drug (IMiD)||participants|Number|0|0.0||||||
3860831|NCT01615029|3686661|B6|>3 Lines||No. of Prior Lines of Therapy||participants|Number|3|3.0||||||
3860832|NCT01615029|3686662|B5|>3 Lines||No. of Prior Lines of Therapy||participants|Number|0|0.0||||||
3860833|NCT01615029|3686663|B4|>3 Lines||No. of Prior Lines of Therapy||participants|Number|1|1.0||||||
3860834|NCT01615029|3686664|B3|>3 Lines||No. of Prior Lines of Therapy||participants|Number|1|1.0||||||
3860835|NCT01615029|3686665|B2|>3 Lines||No. of Prior Lines of Therapy||participants|Number|0|0.0||||||
3860836|NCT01615029|3686666|B1|>3 Lines||No. of Prior Lines of Therapy||participants|Number|1|1.0||||||
3860837|NCT01615029|3686661|B6|2-3 Lines||No. of Prior Lines of Therapy||participants|Number|27|27.0||||||
3860838|NCT01615029|3686662|B5|2-3 Lines||No. of Prior Lines of Therapy||participants|Number|17|17.0||||||
3860839|NCT01615029|3686663|B4|2-3 Lines||No. of Prior Lines of Therapy||participants|Number|2|2.0||||||
3860840|NCT01615029|3686664|B3|2-3 Lines||No. of Prior Lines of Therapy||participants|Number|3|3.0||||||
3860841|NCT01615029|3686665|B2|2-3 Lines||No. of Prior Lines of Therapy||participants|Number|3|3.0||||||
3860842|NCT01615029|3686666|B1|2-3 Lines||No. of Prior Lines of Therapy||participants|Number|2|2.0||||||
3860843|NCT01615029|3686661|B6|1 Line||No. of Prior Lines of Therapy||participants|Number|15|15.0||||||
3860844|NCT01615029|3686662|B5|1 Line||No. of Prior Lines of Therapy||participants|Number|15|15.0||||||
3860845|NCT01615029|3686663|B4|1 Line||No. of Prior Lines of Therapy||participants|Number|0|0.0||||||
3860846|NCT01615029|3686664|B3|1 Line||No. of Prior Lines of Therapy||participants|Number|0|0.0||||||
3860847|NCT01615029|3686665|B2|1 Line||No. of Prior Lines of Therapy||participants|Number|0|0.0||||||
3860848|NCT01615029|3686666|B1|1 Line||No. of Prior Lines of Therapy||participants|Number|0|0.0||||||
3860849|NCT01615029|3686661|B6|III||Stage of Disease [International Staging System (ISS)|The International Staging System (ISS) system consists of stage I: beta2 microglobulin less than (<)3.5 milligram per liter (mg/L) and albumin greater than or equal to (>=) 3.5 gram/ deciliter (dL) or (35 gram/L); stage II: neither stage I nor stage III and stage III: beta2 microglobulin >= 5.5 mg/L.|participants|Number|6|6.0||||||
3860850|NCT01615029|3686662|B5|III||Stage of Disease [International Staging System (ISS)|The International Staging System (ISS) system consists of stage I: beta2 microglobulin less than (<)3.5 milligram per liter (mg/L) and albumin greater than or equal to (>=) 3.5 gram/ deciliter (dL) or (35 gram/L); stage II: neither stage I nor stage III and stage III: beta2 microglobulin >= 5.5 mg/L.|participants|Number|3|3.0||||||
3860851|NCT01615029|3686663|B4|III||Stage of Disease [International Staging System (ISS)|The International Staging System (ISS) system consists of stage I: beta2 microglobulin less than (<)3.5 milligram per liter (mg/L) and albumin greater than or equal to (>=) 3.5 gram/ deciliter (dL) or (35 gram/L); stage II: neither stage I nor stage III and stage III: beta2 microglobulin >= 5.5 mg/L.|participants|Number|1|1.0||||||
3860852|NCT01615029|3686664|B3|III||Stage of Disease [International Staging System (ISS)|The International Staging System (ISS) system consists of stage I: beta2 microglobulin less than (<)3.5 milligram per liter (mg/L) and albumin greater than or equal to (>=) 3.5 gram/ deciliter (dL) or (35 gram/L); stage II: neither stage I nor stage III and stage III: beta2 microglobulin >= 5.5 mg/L.|participants|Number|0|0.0||||||
3860853|NCT01615029|3686665|B2|III||Stage of Disease [International Staging System (ISS)|The International Staging System (ISS) system consists of stage I: beta2 microglobulin less than (<)3.5 milligram per liter (mg/L) and albumin greater than or equal to (>=) 3.5 gram/ deciliter (dL) or (35 gram/L); stage II: neither stage I nor stage III and stage III: beta2 microglobulin >= 5.5 mg/L.|participants|Number|1|1.0||||||
3860854|NCT01615029|3686666|B1|III||Stage of Disease [International Staging System (ISS)|The International Staging System (ISS) system consists of stage I: beta2 microglobulin less than (<)3.5 milligram per liter (mg/L) and albumin greater than or equal to (>=) 3.5 gram/ deciliter (dL) or (35 gram/L); stage II: neither stage I nor stage III and stage III: beta2 microglobulin >= 5.5 mg/L.|participants|Number|1|1.0||||||
3860855|NCT01615029|3686661|B6|II||Stage of Disease [International Staging System (ISS)|The International Staging System (ISS) system consists of stage I: beta2 microglobulin less than (<)3.5 milligram per liter (mg/L) and albumin greater than or equal to (>=) 3.5 gram/ deciliter (dL) or (35 gram/L); stage II: neither stage I nor stage III and stage III: beta2 microglobulin >= 5.5 mg/L.|participants|Number|18|18.0||||||
3860856|NCT01615029|3686662|B5|II||Stage of Disease [International Staging System (ISS)|The International Staging System (ISS) system consists of stage I: beta2 microglobulin less than (<)3.5 milligram per liter (mg/L) and albumin greater than or equal to (>=) 3.5 gram/ deciliter (dL) or (35 gram/L); stage II: neither stage I nor stage III and stage III: beta2 microglobulin >= 5.5 mg/L.|participants|Number|14|14.0||||||
3860857|NCT01615029|3686663|B4|II||Stage of Disease [International Staging System (ISS)|The International Staging System (ISS) system consists of stage I: beta2 microglobulin less than (<)3.5 milligram per liter (mg/L) and albumin greater than or equal to (>=) 3.5 gram/ deciliter (dL) or (35 gram/L); stage II: neither stage I nor stage III and stage III: beta2 microglobulin >= 5.5 mg/L.|participants|Number|1|1.0||||||
3860858|NCT01615029|3686664|B3|II||Stage of Disease [International Staging System (ISS)|The International Staging System (ISS) system consists of stage I: beta2 microglobulin less than (<)3.5 milligram per liter (mg/L) and albumin greater than or equal to (>=) 3.5 gram/ deciliter (dL) or (35 gram/L); stage II: neither stage I nor stage III and stage III: beta2 microglobulin >= 5.5 mg/L.|participants|Number|0|0.0||||||
3860859|NCT01615029|3686665|B2|II||Stage of Disease [International Staging System (ISS)|The International Staging System (ISS) system consists of stage I: beta2 microglobulin less than (<)3.5 milligram per liter (mg/L) and albumin greater than or equal to (>=) 3.5 gram/ deciliter (dL) or (35 gram/L); stage II: neither stage I nor stage III and stage III: beta2 microglobulin >= 5.5 mg/L.|participants|Number|1|1.0||||||
3860908|NCT01615029|3686666|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3860909|NCT01615029|3686661|B6||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3860910|NCT01615029|3686662|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3860860|NCT01615029|3686666|B1|II||Stage of Disease [International Staging System (ISS)|The International Staging System (ISS) system consists of stage I: beta2 microglobulin less than (<)3.5 milligram per liter (mg/L) and albumin greater than or equal to (>=) 3.5 gram/ deciliter (dL) or (35 gram/L); stage II: neither stage I nor stage III and stage III: beta2 microglobulin >= 5.5 mg/L.|participants|Number|2|2.0||||||
3860861|NCT01615029|3686661|B6|I||Stage of Disease [International Staging System (ISS)|The International Staging System (ISS) system consists of stage I: beta2 microglobulin less than (<)3.5 milligram per liter (mg/L) and albumin greater than or equal to (>=) 3.5 gram/ deciliter (dL) or (35 gram/L); stage II: neither stage I nor stage III and stage III: beta2 microglobulin >= 5.5 mg/L.|participants|Number|21|21.0||||||
3860862|NCT01615029|3686662|B5|I||Stage of Disease [International Staging System (ISS)|The International Staging System (ISS) system consists of stage I: beta2 microglobulin less than (<)3.5 milligram per liter (mg/L) and albumin greater than or equal to (>=) 3.5 gram/ deciliter (dL) or (35 gram/L); stage II: neither stage I nor stage III and stage III: beta2 microglobulin >= 5.5 mg/L.|participants|Number|15|15.0||||||
3860863|NCT01615029|3686663|B4|I||Stage of Disease [International Staging System (ISS)|The International Staging System (ISS) system consists of stage I: beta2 microglobulin less than (<)3.5 milligram per liter (mg/L) and albumin greater than or equal to (>=) 3.5 gram/ deciliter (dL) or (35 gram/L); stage II: neither stage I nor stage III and stage III: beta2 microglobulin >= 5.5 mg/L.|participants|Number|1|1.0||||||
3860864|NCT01615029|3686664|B3|I||Stage of Disease [International Staging System (ISS)|The International Staging System (ISS) system consists of stage I: beta2 microglobulin less than (<)3.5 milligram per liter (mg/L) and albumin greater than or equal to (>=) 3.5 gram/ deciliter (dL) or (35 gram/L); stage II: neither stage I nor stage III and stage III: beta2 microglobulin >= 5.5 mg/L.|participants|Number|4|4.0||||||
3860865|NCT01615029|3686665|B2|I||Stage of Disease [International Staging System (ISS)|The International Staging System (ISS) system consists of stage I: beta2 microglobulin less than (<)3.5 milligram per liter (mg/L) and albumin greater than or equal to (>=) 3.5 gram/ deciliter (dL) or (35 gram/L); stage II: neither stage I nor stage III and stage III: beta2 microglobulin >= 5.5 mg/L.|participants|Number|1|1.0||||||
3860866|NCT01615029|3686666|B1|I||Stage of Disease [International Staging System (ISS)|The International Staging System (ISS) system consists of stage I: beta2 microglobulin less than (<)3.5 milligram per liter (mg/L) and albumin greater than or equal to (>=) 3.5 gram/ deciliter (dL) or (35 gram/L); stage II: neither stage I nor stage III and stage III: beta2 microglobulin >= 5.5 mg/L.|participants|Number|0|0.0||||||
3860867|NCT01615029|3686661|B6|United States||Region of Enrollment||participants|Number|3|3.0||||||
3860868|NCT01615029|3686662|B5|United States||Region of Enrollment||participants|Number|3|3.0||||||
3860869|NCT01615029|3686663|B4|United States||Region of Enrollment||participants|Number|0|0.0||||||
3860870|NCT01615029|3686664|B3|United States||Region of Enrollment||participants|Number|0|0.0||||||
3860871|NCT01615029|3686665|B2|United States||Region of Enrollment||participants|Number|0|0.0||||||
3860872|NCT01615029|3686666|B1|United States||Region of Enrollment||participants|Number|0|0.0||||||
3860873|NCT01615029|3686661|B6|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
3860874|NCT01615029|3686662|B5|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3860875|NCT01615029|3686663|B4|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3860876|NCT01615029|3686664|B3|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3860877|NCT01615029|3686665|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3860878|NCT01615029|3686666|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3860879|NCT01615029|3686661|B6|Netherlands||Region of Enrollment||participants|Number|9|9.0||||||
3860880|NCT01615029|3686662|B5|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
3860881|NCT01615029|3686663|B4|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
3860882|NCT01615029|3686664|B3|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
3860883|NCT01615029|3686665|B2|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
3860884|NCT01615029|3686666|B1|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
3860885|NCT01615029|3686661|B6|Italy||Region of Enrollment||participants|Number|8|8.0||||||
3860886|NCT01615029|3686662|B5|Italy||Region of Enrollment||participants|Number|8|8.0||||||
3860887|NCT01615029|3686663|B4|Italy||Region of Enrollment||participants|Number|0|0.0||||||
3860888|NCT01615029|3686664|B3|Italy||Region of Enrollment||participants|Number|0|0.0||||||
3860889|NCT01615029|3686665|B2|Italy||Region of Enrollment||participants|Number|0|0.0||||||
3860890|NCT01615029|3686666|B1|Italy||Region of Enrollment||participants|Number|0|0.0||||||
3860891|NCT01615029|3686661|B6|France||Region of Enrollment||participants|Number|7|7.0||||||
3860892|NCT01615029|3686662|B5|France||Region of Enrollment||participants|Number|6|6.0||||||
3860893|NCT01615029|3686663|B4|France||Region of Enrollment||participants|Number|1|1.0||||||
3860894|NCT01615029|3686664|B3|France||Region of Enrollment||participants|Number|0|0.0||||||
3860895|NCT01615029|3686665|B2|France||Region of Enrollment||participants|Number|0|0.0||||||
3860896|NCT01615029|3686666|B1|France||Region of Enrollment||participants|Number|0|0.0||||||
3860897|NCT01615029|3686661|B6|Denmark||Region of Enrollment||participants|Number|11|11.0||||||
3860898|NCT01615029|3686662|B5|Denmark||Region of Enrollment||participants|Number|5|5.0||||||
3860899|NCT01615029|3686663|B4|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
3860900|NCT01615029|3686664|B3|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
3860901|NCT01615029|3686665|B2|Denmark||Region of Enrollment||participants|Number|2|2.0||||||
3860902|NCT01615029|3686666|B1|Denmark||Region of Enrollment||participants|Number|2|2.0||||||
3860903|NCT01615029|3686661|B6||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3860904|NCT01615029|3686662|B5||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3860905|NCT01615029|3686663|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3860906|NCT01615029|3686664|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3860911|NCT01615029|3686663|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3860912|NCT01615029|3686664|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3860913|NCT01615029|3686665|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3860914|NCT01615029|3686666|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3860915|NCT01615029|3686661|B6|||Age||years|Mean|60.4|60.4|Standard Deviation|8.57|8.57|||
3860916|NCT01615029|3686662|B5|||Age||years|Mean|59.7|59.7|Standard Deviation|8.38|8.38|||
3860917|NCT01615029|3686663|B4|||Age||years|Mean|67.3|67.3|Standard Deviation|10.26|10.26|||
3860918|NCT01615029|3686664|B3|||Age||years|Mean|57.5|57.5|Standard Deviation|9.68|9.68|||
3860919|NCT01615029|3686665|B2|||Age||years|Mean|62.7|62.7|Standard Deviation|2.08|2.08|||
3860920|NCT01615029|3686666|B1|||Age||years|Mean|62.7|62.7|Standard Deviation|12.74|12.74|||
3860921|NCT01614912|3686691|B1|Malaysia||Region of Enrollment||participants|Number|40|40.0||||||
3860922|NCT01614912|3686691|B1|Korea, Republic of||Region of Enrollment||participants|Number|76|76.0||||||
3860923|NCT01614912|3686691|B1|Taiwan||Region of Enrollment||participants|Number|39|39.0||||||
3860924|NCT01614912|3686691|B1|Japan||Region of Enrollment||participants|Number|126|126.0||||||
3860925|NCT01614912|3686691|B1||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3860926|NCT01614912|3686691|B1||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3860927|NCT01614912|3686691|B1|||Age||years|Mean|43.2|43.2|Standard Deviation|13.8|13.8|||
3860928|NCT01614899|3686702|B4|Malaysia||Region of Enrollment||participants|Number|64|64.0||||||
3860929|NCT01614899|3686703|B3|Malaysia||Region of Enrollment||participants|Number|20|20.0||||||
3860930|NCT01614899|3686704|B2|Malaysia||Region of Enrollment||participants|Number|23|23.0||||||
3860931|NCT01614899|3686705|B1|Malaysia||Region of Enrollment||participants|Number|21|21.0||||||
3860932|NCT01614899|3686702|B4|Korea, Republic of||Region of Enrollment||participants|Number|128|128.0||||||
3860933|NCT01614899|3686703|B3|Korea, Republic of||Region of Enrollment||participants|Number|43|43.0||||||
3860934|NCT01614899|3686704|B2|Korea, Republic of||Region of Enrollment||participants|Number|42|42.0||||||
3860935|NCT01614899|3686705|B1|Korea, Republic of||Region of Enrollment||participants|Number|43|43.0||||||
3860936|NCT01614899|3686702|B4|Taiwan||Region of Enrollment||participants|Number|59|59.0||||||
3860937|NCT01614899|3686703|B3|Taiwan||Region of Enrollment||participants|Number|19|19.0||||||
3860938|NCT01614899|3686704|B2|Taiwan||Region of Enrollment||participants|Number|21|21.0||||||
3860939|NCT01614899|3686705|B1|Taiwan||Region of Enrollment||participants|Number|19|19.0||||||
3860940|NCT01614899|3686702|B4|Japan||Region of Enrollment||participants|Number|188|188.0||||||
3860941|NCT01614899|3686703|B3|Japan||Region of Enrollment||participants|Number|60|60.0||||||
3860942|NCT01614899|3686704|B2|Japan||Region of Enrollment||participants|Number|66|66.0||||||
3860943|NCT01614899|3686705|B1|Japan||Region of Enrollment||participants|Number|62|62.0||||||
3860944|NCT01614899|3686702|B4||Male|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
3860945|NCT01614899|3686703|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3860946|NCT01614899|3686704|B2||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3860947|NCT01614899|3686705|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3860948|NCT01614899|3686702|B4||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
3860949|NCT01614899|3686703|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3860950|NCT01614899|3686704|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3860951|NCT01614899|3686705|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3860952|NCT01614899|3686702|B4|||Age||years|Mean|42.9|42.9|Standard Deviation|13.5|13.5|||
3860953|NCT01614899|3686703|B3|||Age||years|Mean|42.9|42.9|Standard Deviation|13.5|13.5|||
3860954|NCT01614899|3686704|B2|||Age||years|Mean|43.6|43.6|Standard Deviation|13.9|13.9|||
3860955|NCT01614899|3686705|B1|||Age||years|Mean|42.0|42.0|Standard Deviation|13.1|13.1|||
3860956|NCT01614886|3686736|B3|Male||Sex/Gender, Customized|Baseline characteristics is based on safety analysis set therfore female number is 76.|Participants|Number|70|70.0||||||
3860957|NCT01614886|3686737|B2|Male||Sex/Gender, Customized|Baseline characteristics is based on safety analysis set therfore female number is 76.|Participants|Number|32|32.0||||||
3860958|NCT01614886|3686738|B1|Male||Sex/Gender, Customized|Baseline characteristics is based on safety analysis set therfore female number is 76.|Participants|Number|38|38.0||||||
3860959|NCT01614886|3686736|B3|Female||Sex/Gender, Customized|Baseline characteristics is based on safety analysis set therfore female number is 76.|Participants|Number|145|145.0||||||
3860960|NCT01614886|3686737|B2|Female||Sex/Gender, Customized|Baseline characteristics is based on safety analysis set therfore female number is 76.|Participants|Number|76|76.0||||||
3860961|NCT01614886|3686738|B1|Female||Sex/Gender, Customized|Baseline characteristics is based on safety analysis set therfore female number is 76.|Participants|Number|69|69.0||||||
3860962|NCT01614886|3686736|B3|||Age||Years|Mean|77.5|77.5|Standard Deviation|6.21|6.21|||
3860963|NCT01614886|3686737|B2|||Age||Years|Mean|77.6|77.6|Standard Deviation|5.89|5.89|||
3860964|NCT01614886|3686738|B1|||Age||Years|Mean|77.5|77.5|Standard Deviation|6.54|6.54|||
3860965|NCT01614795|3686753|B5|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3860966|NCT01614795|3686754|B4|Canada||Region of Enrollment||participants|Number|0|0.0||||||
3860967|NCT01614795|3686755|B3|Canada||Region of Enrollment||participants|Number|0|0.0||||||
3860968|NCT01614795|3686756|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3860969|NCT01614795|3686757|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
3860970|NCT01614795|3686753|B5|United States||Region of Enrollment||participants|Number|45|45.0||||||
3860971|NCT01614795|3686754|B4|United States||Region of Enrollment||participants|Number|12|12.0||||||
3860972|NCT01614795|3686755|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3860973|NCT01614795|3686756|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3860974|NCT01614795|3686757|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3860975|NCT01614795|3686753|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3860976|NCT01614795|3686754|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3860977|NCT01614795|3686755|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3860978|NCT01614795|3686756|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3860979|NCT01614795|3686757|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3860980|NCT01614795|3686753|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860981|NCT01614795|3686754|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860982|NCT01614795|3686755|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860983|NCT01614795|3686756|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860984|NCT01614795|3686757|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860985|NCT01614795|3686753|B5||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3860986|NCT01614795|3686754|B4||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3860987|NCT01614795|3686755|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3860988|NCT01614795|3686756|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3860989|NCT01614795|3686757|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3860990|NCT01614795|3686753|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3860991|NCT01614795|3686754|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3860992|NCT01614795|3686755|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860993|NCT01614795|3686756|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860994|NCT01614795|3686757|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3860995|NCT01614795|3686753|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3860996|NCT01614795|3686754|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860997|NCT01614795|3686755|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3860998|NCT01614795|3686756|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3860999|NCT01614795|3686757|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861000|NCT01614795|3686753|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3861001|NCT01614795|3686754|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3861002|NCT01614795|3686755|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861003|NCT01614795|3686756|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3861004|NCT01614795|3686757|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3861005|NCT01614795|3686753|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861006|NCT01614795|3686754|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861007|NCT01614795|3686755|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861008|NCT01614795|3686756|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861009|NCT01614795|3686757|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861010|NCT01614795|3686753|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3861011|NCT01614795|3686754|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3861012|NCT01614795|3686755|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861013|NCT01614795|3686756|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861014|NCT01614795|3686757|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861015|NCT01614795|3686753|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3861016|NCT01614795|3686754|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3861017|NCT01614795|3686755|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3861018|NCT01614795|3686756|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3861019|NCT01614795|3686757|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3861020|NCT01614795|3686753|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3861021|NCT01614795|3686754|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861022|NCT01614795|3686755|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3861023|NCT01614795|3686756|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861024|NCT01614795|3686757|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3861025|NCT01614795|3686753|B5||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3861026|NCT01614795|3686754|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3861027|NCT01614795|3686755|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3861028|NCT01614795|3686756|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3861029|NCT01614795|3686757|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3861030|NCT01614795|3686753|B5||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3861031|NCT01614795|3686754|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3861032|NCT01614795|3686755|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3861033|NCT01614795|3686756|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3861034|NCT01614795|3686757|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3861035|NCT01614795|3686753|B5|||Age||years|Median|17|17.0|Full Range|||1.0|27.0|
3861036|NCT01614795|3686754|B4|||Age||years|Median|17.5|17.5|Full Range|||13.0|26.0|
3861037|NCT01614795|3686755|B3|||Age||years|Median|14|14.0|Full Range|||1.0|23.0|
3861038|NCT01614795|3686756|B2|||Age||years|Median|17.5|17.5|Full Range|||9.0|27.0|
3861039|NCT01614795|3686757|B1|||Age||years|Median|18|18.0|Full Range|||7.0|25.0|
3861040|NCT01614795|3686753|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3861041|NCT01614795|3686754|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3861042|NCT01614795|3686755|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3861043|NCT01614795|3686756|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3861044|NCT01614795|3686757|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3861045|NCT01614795|3686753|B5||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3861046|NCT01614795|3686754|B4||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3861047|NCT01614795|3686755|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3861048|NCT01614795|3686756|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3861049|NCT01614795|3686757|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3861050|NCT01614795|3686753|B5||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
3861051|NCT01614795|3686754|B4||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
3861052|NCT01614795|3686755|B3||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
3861053|NCT01614795|3686756|B2||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
3861054|NCT01614795|3686757|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
3861055|NCT01614769|3686780|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3861056|NCT01614769|3686780|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3861057|NCT01614769|3686780|B1|||Age||Years|Mean|49.3|49.3|Standard Deviation|5.5|5.5|||
3861058|NCT01614613|3686799|B1|United States||Region of Enrollment||participants|Number|146|146.0||||||
3861059|NCT01614613|3686799|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3861060|NCT01614613|3686799|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3861061|NCT01614613|3686799|B1|||Age||years|Mean|53.0|53.0|Full Range|||21.0|80.0|
3861062|NCT01614600|3686807|B1|United States||Region of Enrollment||participants|Number|88|88.0||||||
3861063|NCT01614600|3686807|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3861064|NCT01614600|3686807|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3861065|NCT01614600|3686807|B1|||Age||years|Mean|32.2|32.2|Standard Deviation|9.0|9.0|||
3861066|NCT01614574|3686811|B1|||CCL18 levels||(ng/mL)|Mean|134.8|134.8|Standard Deviation|132.26|132.26|||
3861067|NCT01614574|3686811|B1|||Plasma chitotriosidase||(nmol/mL/h)|Mean|1243.7|1243.7|Standard Deviation|344.46|344.46|||
3861068|NCT01614574|3686811|B1|||Normalized spleen volume||(% of Body Weight)|Mean|0.39|0.39|Standard Deviation|0.067|0.067|||
3861069|NCT01614574|3686811|B1|||Normalized liver volume||(% of Body Weight)|Mean|1.92|1.92|Standard Deviation|0.342|0.342|||
3861070|NCT01614574|3686811|B1|||Platelet Count||(x 10`{super 9}/L)|Mean|182.9|182.9|Standard Deviation|32.05|32.05|||
3861071|NCT01614574|3686811|B1|||Hemoglobin Concentration||(g/dL)|Mean|13.77|13.77|Standard Deviation|0.954|0.954|||
3861072|NCT01614574|3686811|B1|JAPAN||Region of Enrollment||Participants|Number|6|6.0||||||
3861073|NCT01614574|3686811|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3861074|NCT01614574|3686811|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3861075|NCT01614574|3686811|B1|Between 18 and 65 years||Age, Customized||Participants|Number|2|2.0||||||
3861076|NCT01614574|3686811|B1|<=18 years||Age, Customized||Participants|Number|4|4.0||||||
3861077|NCT01614574|3686811|B1|||Age||Years|Mean|20|20.0|Standard Deviation|10.62|10.62|||
3861078|NCT01614509|3686825|B3|Korea, Republic of||Region of Enrollment||participants|Number|45|45.0||||||
3861079|NCT01614509|3686826|B2|Korea, Republic of||Region of Enrollment||participants|Number|21|21.0||||||
3861080|NCT01614509|3686827|B1|Korea, Republic of||Region of Enrollment||participants|Number|24|24.0||||||
3861081|NCT01614509|3686825|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3861082|NCT01614509|3686826|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3861083|NCT01614509|3686827|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3861084|NCT01614509|3686825|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3861085|NCT01614509|3686826|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3861086|NCT01614509|3686827|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3861087|NCT01614509|3686825|B3|||Age||years|Mean|61.20|61.2|Standard Deviation|12.668|12.668|||
3861088|NCT01614509|3686826|B2|||Age||years|Mean|60.24|60.24|Standard Deviation|14.983|14.983|||
3861089|NCT01614509|3686827|B1|||Age||years|Mean|62.04|62.04|Standard Deviation|10.498|10.498|||
3861090|NCT01614509|3686825|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3861091|NCT01614509|3686826|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3861092|NCT01614509|3686827|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3861093|NCT01614509|3686825|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3861094|NCT01614509|3686826|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3861095|NCT01614509|3686827|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3861096|NCT01614509|3686825|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3861097|NCT01614509|3686826|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3861098|NCT01614509|3686827|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3861099|NCT01614470|3686836|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3861100|NCT01614470|3686837|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3861101|NCT01614470|3686838|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3861102|NCT01614470|3686836|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3861103|NCT01614470|3686837|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3861104|NCT01614470|3686838|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3861105|NCT01614470|3686836|B3|||Age||years|Mean|22.8|22.8|Standard Deviation|12.96|12.96|||
3861106|NCT01614470|3686837|B2|||Age||years|Mean|21.7|21.7|Standard Deviation|12.92|12.92|||
3861107|NCT01614470|3686838|B1|||Age||years|Mean|23.8|23.8|Standard Deviation|13.25|13.25|||
3861108|NCT01614457|3686860|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3861109|NCT01614457|3686861|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3861110|NCT01614457|3686862|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3861111|NCT01614457|3686860|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3861112|NCT01614457|3686861|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3861113|NCT01614457|3686862|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3861114|NCT01614457|3686860|B3|||Age||years|Mean|31.0|31.0|Standard Deviation|16.98|16.98|||
3861115|NCT01614457|3686861|B2|||Age||years|Mean|32.7|32.7|Standard Deviation|17.43|17.43|||
3861116|NCT01614457|3686862|B1|||Age||years|Mean|29.2|29.2|Standard Deviation|16.57|16.57|||
3861117|NCT01614392|3686879|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3861118|NCT01614392|3686879|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3861119|NCT01614392|3686880|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3861120|NCT01614392|3686881|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3861121|NCT01614392|3686879|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3861122|NCT01614392|3686880|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3861123|NCT01614392|3686881|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3861124|NCT01614392|3686879|B3|||Age||years|Mean|77.9|77.9|Standard Deviation|4.5|4.5|||
3861125|NCT01614392|3686880|B2|||Age||years|Mean|77.6|77.6|Standard Deviation|4|4.0|||
3861126|NCT01614392|3686881|B1|||Age||years|Mean|78.3|78.3|Standard Deviation|5|5.0|||
3861127|NCT01614249|3686888|B3|At least recommended daily intake||Dietary total omega-3||participants|Number|28|28.0||||||
3861128|NCT01614249|3686889|B2|At least recommended daily intake||Dietary total omega-3||participants|Number|10|10.0||||||
3861129|NCT01614249|3686890|B1|At least recommended daily intake||Dietary total omega-3||participants|Number|18|18.0||||||
3861130|NCT01614249|3686888|B3|Below Recommended daily intake||Dietary total omega-3||participants|Number|188|188.0||||||
3861131|NCT01614249|3686889|B2|Below Recommended daily intake||Dietary total omega-3||participants|Number|99|99.0||||||
3861132|NCT01614249|3686890|B1|Below Recommended daily intake||Dietary total omega-3||participants|Number|89|89.0||||||
3861133|NCT01614249|3686888|B3|At least EAR for pregnant women||Dietary zinc||participants|Number|2|2.0||||||
3861134|NCT01614249|3686889|B2|At least EAR for pregnant women||Dietary zinc||participants|Number|0|0.0||||||
3861135|NCT01614249|3686890|B1|At least EAR for pregnant women||Dietary zinc||participants|Number|2|2.0||||||
3861136|NCT01614249|3686888|B3|Below Estimated Average Requirement (EAR)||Dietary zinc||participants|Number|214|214.0||||||
3861137|NCT01614249|3686889|B2|Below Estimated Average Requirement (EAR)||Dietary zinc||participants|Number|109|109.0||||||
3861138|NCT01614249|3686890|B1|Below Estimated Average Requirement (EAR)||Dietary zinc||participants|Number|105|105.0||||||
3861139|NCT01614249|3686888|B3|At least EAR for pregnant women||Dietary selenium||participants|Number|58|58.0||||||
3861140|NCT01614249|3686889|B2|At least EAR for pregnant women||Dietary selenium||participants|Number|27|27.0||||||
3861141|NCT01614249|3686890|B1|At least EAR for pregnant women||Dietary selenium||participants|Number|31|31.0||||||
3861142|NCT01614249|3686888|B3|Below Estimated Average Requirement (EAR)||Dietary selenium||participants|Number|158|158.0||||||
3861143|NCT01614249|3686889|B2|Below Estimated Average Requirement (EAR)||Dietary selenium||participants|Number|82|82.0||||||
3861144|NCT01614249|3686890|B1|Below Estimated Average Requirement (EAR)||Dietary selenium||participants|Number|76|76.0||||||
3861145|NCT01614249|3686888|B3|At least EAR for pregnant women||Dietary calcium||participants|Number|59|59.0||||||
3861146|NCT01614249|3686889|B2|At least EAR for pregnant women||Dietary calcium||participants|Number|31|31.0||||||
3861147|NCT01614249|3686890|B1|At least EAR for pregnant women||Dietary calcium||participants|Number|28|28.0||||||
3861148|NCT01614249|3686888|B3|Below Estimated Average Requirement (EAR)||Dietary calcium||participants|Number|157|157.0||||||
3861149|NCT01614249|3686889|B2|Below Estimated Average Requirement (EAR)||Dietary calcium||participants|Number|78|78.0||||||
3861150|NCT01614249|3686890|B1|Below Estimated Average Requirement (EAR)||Dietary calcium||participants|Number|79|79.0||||||
3861151|NCT01614249|3686888|B3|At least EAR for pregnant women||Dietary vitamin E||participants|Number|40|40.0||||||
3861152|NCT01614249|3686889|B2|At least EAR for pregnant women||Dietary vitamin E||participants|Number|20|20.0||||||
3861153|NCT01614249|3686890|B1|At least EAR for pregnant women||Dietary vitamin E||participants|Number|20|20.0||||||
3861154|NCT01614249|3686888|B3|Below Estimated Average Requirement (EAR)||Dietary vitamin E||participants|Number|176|176.0||||||
3861155|NCT01614249|3686889|B2|Below Estimated Average Requirement (EAR)||Dietary vitamin E||participants|Number|89|89.0||||||
3861156|NCT01614249|3686890|B1|Below Estimated Average Requirement (EAR)||Dietary vitamin E||participants|Number|87|87.0||||||
3861157|NCT01614249|3686888|B3|At least EAR for pregnant women||Dietary Iron||participants|Number|0|0.0||||||
3861158|NCT01614249|3686889|B2|At least EAR for pregnant women||Dietary Iron||participants|Number|0|0.0||||||
3861159|NCT01614249|3686890|B1|At least EAR for pregnant women||Dietary Iron||participants|Number|0|0.0||||||
3861160|NCT01614249|3686888|B3|Below Estimated Average Requirement (EAR)||Dietary Iron||participants|Number|216|216.0||||||
3861161|NCT01614249|3686889|B2|Below Estimated Average Requirement (EAR)||Dietary Iron||participants|Number|109|109.0||||||
3861162|NCT01614249|3686890|B1|Below Estimated Average Requirement (EAR)||Dietary Iron||participants|Number|107|107.0||||||
3861163|NCT01614249|3686888|B3|At least EAR for pregnant women||Dietary folate||participants|Number|27|27.0||||||
3861164|NCT01614249|3686889|B2|At least EAR for pregnant women||Dietary folate||participants|Number|11|11.0||||||
3861165|NCT01614249|3686890|B1|At least EAR for pregnant women||Dietary folate||participants|Number|16|16.0||||||
3861166|NCT01614249|3686888|B3|Below Estimated Average Requirement (EAR)||Dietary folate||participants|Number|189|189.0||||||
3861167|NCT01614249|3686889|B2|Below Estimated Average Requirement (EAR)||Dietary folate||participants|Number|98|98.0||||||
3861168|NCT01614249|3686890|B1|Below Estimated Average Requirement (EAR)||Dietary folate||participants|Number|91|91.0||||||
3861169|NCT01614249|3686888|B3|At least EAR for pregnant women||Dietary vitamin B12||participants|Number|25|25.0||||||
3861170|NCT01614249|3686889|B2|At least EAR for pregnant women||Dietary vitamin B12||participants|Number|12|12.0||||||
3861171|NCT01614249|3686890|B1|At least EAR for pregnant women||Dietary vitamin B12||participants|Number|13|13.0||||||
3861172|NCT01614249|3686888|B3|Below Estimated Average Requirement (EAR)||Dietary vitamin B12||participants|Number|191|191.0||||||
3861173|NCT01614249|3686889|B2|Below Estimated Average Requirement (EAR)||Dietary vitamin B12||participants|Number|97|97.0||||||
3861174|NCT01614249|3686890|B1|Below Estimated Average Requirement (EAR)||Dietary vitamin B12||participants|Number|94|94.0||||||
3861175|NCT01614249|3686888|B3|At least EAR for pregnant women||Dietary vitamin B6||participants|Number|44|44.0||||||
3861176|NCT01614249|3686889|B2|At least EAR for pregnant women||Dietary vitamin B6||participants|Number|24|24.0||||||
3861177|NCT01614249|3686890|B1|At least EAR for pregnant women||Dietary vitamin B6||participants|Number|20|20.0||||||
3861178|NCT01614249|3686888|B3|Below Estimated Average Requirement (EAR)||Dietary vitamin B6||participants|Number|172|172.0||||||
3861179|NCT01614249|3686889|B2|Below Estimated Average Requirement (EAR)||Dietary vitamin B6||participants|Number|85|85.0||||||
3861180|NCT01614249|3686890|B1|Below Estimated Average Requirement (EAR)||Dietary vitamin B6||participants|Number|87|87.0||||||
3861181|NCT01614249|3686888|B3|At least EAR for pregnant women||Dietary vitamin B1||participants|Number|76|76.0||||||
3861182|NCT01614249|3686889|B2|At least EAR for pregnant women||Dietary vitamin B1||participants|Number|36|36.0||||||
3861183|NCT01614249|3686890|B1|At least EAR for pregnant women||Dietary vitamin B1||participants|Number|40|40.0||||||
3861184|NCT01614249|3686888|B3|Below Estimated Average Requirement (EAR)||Dietary vitamin B1||participants|Number|140|140.0||||||
3861185|NCT01614249|3686889|B2|Below Estimated Average Requirement (EAR)||Dietary vitamin B1||participants|Number|73|73.0||||||
3861186|NCT01614249|3686890|B1|Below Estimated Average Requirement (EAR)||Dietary vitamin B1||participants|Number|67|67.0||||||
3861187|NCT01614249|3686888|B3|At least EAR for pregnant women||Dietary vitamin C||participants|Number|95|95.0||||||
3861188|NCT01614249|3686889|B2|At least EAR for pregnant women||Dietary vitamin C||participants|Number|47|47.0||||||
3861189|NCT01614249|3686890|B1|At least EAR for pregnant women||Dietary vitamin C||participants|Number|48|48.0||||||
3861190|NCT01614249|3686888|B3|Below Estimated Average Requirement (EAR)||Dietary vitamin C||participants|Number|121|121.0||||||
3861191|NCT01614249|3686889|B2|Below Estimated Average Requirement (EAR)||Dietary vitamin C||participants|Number|62|62.0||||||
3861192|NCT01614249|3686890|B1|Below Estimated Average Requirement (EAR)||Dietary vitamin C||participants|Number|59|59.0||||||
3861193|NCT01614249|3686888|B3|Yes, 2 weeks before study||Experienced stressful life event||participants|Number|68|68.0||||||
3861194|NCT01614249|3686889|B2|Yes, 2 weeks before study||Experienced stressful life event||participants|Number|36|36.0||||||
3861195|NCT01614249|3686890|B1|Yes, 2 weeks before study||Experienced stressful life event||participants|Number|32|32.0||||||
3861196|NCT01614249|3686888|B3|None 2 weeks before study||Experienced stressful life event||participants|Number|148|148.0||||||
3861197|NCT01614249|3686889|B2|None 2 weeks before study||Experienced stressful life event||participants|Number|73|73.0||||||
3861198|NCT01614249|3686890|B1|None 2 weeks before study||Experienced stressful life event||participants|Number|75|75.0||||||
3861199|NCT01614249|3686888|B3|Attended||prevention of mother-to-child transmission program m2m support group meeting attendance||participants|Number|100|100.0||||||
3861200|NCT01614249|3686889|B2|Attended||prevention of mother-to-child transmission program m2m support group meeting attendance||participants|Number|47|47.0||||||
3861201|NCT01614249|3686890|B1|Attended||prevention of mother-to-child transmission program m2m support group meeting attendance||participants|Number|53|53.0||||||
3861202|NCT01614249|3686888|B3|Not attended||prevention of mother-to-child transmission program m2m support group meeting attendance||participants|Number|116|116.0||||||
3861203|NCT01614249|3686889|B2|Not attended||prevention of mother-to-child transmission program m2m support group meeting attendance||participants|Number|62|62.0||||||
3861204|NCT01614249|3686890|B1|Not attended||prevention of mother-to-child transmission program m2m support group meeting attendance||participants|Number|54|54.0||||||
3861205|NCT01614249|3686888|B3|Disclosed to someone||HIV status disclosure to anyone||participants|Number|173|173.0||||||
3861206|NCT01614249|3686889|B2|Disclosed to someone||HIV status disclosure to anyone||participants|Number|91|91.0||||||
3861207|NCT01614249|3686890|B1|Disclosed to someone||HIV status disclosure to anyone||participants|Number|82|82.0||||||
3861208|NCT01614249|3686888|B3|Not disclosed||HIV status disclosure to anyone||participants|Number|43|43.0||||||
3861209|NCT01614249|3686889|B2|Not disclosed||HIV status disclosure to anyone||participants|Number|18|18.0||||||
3861210|NCT01614249|3686890|B1|Not disclosed||HIV status disclosure to anyone||participants|Number|25|25.0||||||
3861211|NCT01614249|3686888|B3|Yes, known positive, 6 months plus||HIV status knowledge before pregnancy||participants|Number|104|104.0||||||
3861212|NCT01614249|3686889|B2|Yes, known positive, 6 months plus||HIV status knowledge before pregnancy||participants|Number|53|53.0||||||
3861213|NCT01614249|3686890|B1|Yes, known positive, 6 months plus||HIV status knowledge before pregnancy||participants|Number|51|51.0||||||
3861214|NCT01614249|3686888|B3|No, newly tested less than 6 months||HIV status knowledge before pregnancy||participants|Number|112|112.0||||||
3861215|NCT01614249|3686889|B2|No, newly tested less than 6 months||HIV status knowledge before pregnancy||participants|Number|56|56.0||||||
3861216|NCT01614249|3686890|B1|No, newly tested less than 6 months||HIV status knowledge before pregnancy||participants|Number|56|56.0||||||
3861217|NCT01614249|3686888|B3|||Household income per month||Kenya Shillings (Ksh.)|Median|5050|5050.0|Inter-Quartile Range|||3000.0|8000.0|
3861218|NCT01614249|3686889|B2|||Household income per month||Kenya Shillings (Ksh.)|Median|6000|6000.0|Inter-Quartile Range|||3000.0|8000.0|
3861219|NCT01614249|3686890|B1|||Household income per month||Kenya Shillings (Ksh.)|Median|5025|5025.0|Inter-Quartile Range|||3000.0|8000.0|
3861220|NCT01614249|3686888|B3|In gainful employment with income||Employment status||participants|Number|91|91.0||||||
3861221|NCT01614249|3686889|B2|In gainful employment with income||Employment status||participants|Number|48|48.0||||||
3861222|NCT01614249|3686890|B1|In gainful employment with income||Employment status||participants|Number|43|43.0||||||
3861223|NCT01614249|3686888|B3|Not in gainful employment||Employment status||participants|Number|125|125.0||||||
3861224|NCT01614249|3686889|B2|Not in gainful employment||Employment status||participants|Number|61|61.0||||||
3861225|NCT01614249|3686890|B1|Not in gainful employment||Employment status||participants|Number|64|64.0||||||
3861226|NCT01614249|3686888|B3|At least High school education||Education status||participants|Number|106|106.0||||||
3861227|NCT01614249|3686889|B2|At least High school education||Education status||participants|Number|54|54.0||||||
3861228|NCT01614249|3686890|B1|At least High school education||Education status||participants|Number|52|52.0||||||
3861229|NCT01614249|3686888|B3|No High school education||Education status||participants|Number|110|110.0||||||
3861230|NCT01614249|3686889|B2|No High school education||Education status||participants|Number|55|55.0||||||
3861231|NCT01614249|3686890|B1|No High school education||Education status||participants|Number|55|55.0||||||
3861232|NCT01614249|3686888|B3|Not first pregnancy||Parity||participants|Number|168|168.0||||||
3861233|NCT01614249|3686889|B2|Not first pregnancy||Parity||participants|Number|85|85.0||||||
3861234|NCT01614249|3686890|B1|Not first pregnancy||Parity||participants|Number|83|83.0||||||
3861235|NCT01614249|3686888|B3|First pregnancy||Parity||participants|Number|48|48.0||||||
3861236|NCT01614249|3686889|B2|First pregnancy||Parity||participants|Number|24|24.0||||||
3861237|NCT01614249|3686890|B1|First pregnancy||Parity||participants|Number|24|24.0||||||
3861238|NCT01614249|3686888|B3|Married||Marital status||participants|Number|167|167.0||||||
3861239|NCT01614249|3686889|B2|Married||Marital status||participants|Number|82|82.0||||||
3861240|NCT01614249|3686890|B1|Married||Marital status||participants|Number|85|85.0||||||
3861241|NCT01614249|3686888|B3|Single (not married, divorced, widowed||Marital status||participants|Number|49|49.0||||||
3861242|NCT01614249|3686889|B2|Single (not married, divorced, widowed||Marital status||participants|Number|27|27.0||||||
3861243|NCT01614249|3686890|B1|Single (not married, divorced, widowed||Marital status||participants|Number|22|22.0||||||
3861244|NCT01614249|3686888|B3|||BDI-II depressive symptom scores|Beck Depression Inventory Second Edition (BDI-II) Scale is a 21-item scoring tool which measures the existence and severity of symptoms of depression. Each of the 21 items on BDI-II tool represent a depressive symptom. The symptoms are each scored on a 4-point Likert scale of 0 to 3 (0=symptom is absent; 3=symptom is severe).Scores for each symptom are added up to obtain the total scores for all 21 items, which are interpreted as follows: Scores of 0-13: minimal depression; 14-19: mild depression; 20-28: moderate depression and 29-63: severe depression.|Scores on a scale|Median|21|21.0|Inter-Quartile Range|||17.0|25.0|
3861245|NCT01614249|3686889|B2|||BDI-II depressive symptom scores|Beck Depression Inventory Second Edition (BDI-II) Scale is a 21-item scoring tool which measures the existence and severity of symptoms of depression. Each of the 21 items on BDI-II tool represent a depressive symptom. The symptoms are each scored on a 4-point Likert scale of 0 to 3 (0=symptom is absent; 3=symptom is severe).Scores for each symptom are added up to obtain the total scores for all 21 items, which are interpreted as follows: Scores of 0-13: minimal depression; 14-19: mild depression; 20-28: moderate depression and 29-63: severe depression.|Scores on a scale|Median|20|20.0|Inter-Quartile Range|||16.0|25.0|
3861300|NCT01613768|3686910|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3861301|NCT01613768|3686910|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3861302|NCT01613768|3686910|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861246|NCT01614249|3686890|B1|||BDI-II depressive symptom scores|Beck Depression Inventory Second Edition (BDI-II) Scale is a 21-item scoring tool which measures the existence and severity of symptoms of depression. Each of the 21 items on BDI-II tool represent a depressive symptom. The symptoms are each scored on a 4-point Likert scale of 0 to 3 (0=symptom is absent; 3=symptom is severe).Scores for each symptom are added up to obtain the total scores for all 21 items, which are interpreted as follows: Scores of 0-13: minimal depression; 14-19: mild depression; 20-28: moderate depression and 29-63: severe depression.|Scores on a scale|Median|21|21.0|Inter-Quartile Range|||17.0|25.0|
3861247|NCT01614249|3686888|B3|||Mid-upper-arm circumference (MUAC)||cm|Median|26.0|26.0|Inter-Quartile Range|||24.0|27.8|
3861248|NCT01614249|3686889|B2|||Mid-upper-arm circumference (MUAC)||cm|Median|26.0|26.0|Inter-Quartile Range|||23.9|27.6|
3861249|NCT01614249|3686890|B1|||Mid-upper-arm circumference (MUAC)||cm|Median|26.0|26.0|Inter-Quartile Range|||24.3|28.0|
3861250|NCT01614249|3686888|B3|||Cluster of differentiation 4 (CD4) cell count||cells/µl|Median|360|360.0|Inter-Quartile Range|||288.0|425.0|
3861251|NCT01614249|3686889|B2|||Cluster of differentiation 4 (CD4) cell count||cells/µl|Median|361|361.0|Inter-Quartile Range|||287.0|440.0|
3861252|NCT01614249|3686890|B1|||Cluster of differentiation 4 (CD4) cell count||cells/µl|Median|360|360.0|Inter-Quartile Range|||288.0|414.0|
3861253|NCT01614249|3686888|B3|||Gestation age||Weeks|Median|22|22.0|Inter-Quartile Range|||18.0|24.0|
3861254|NCT01614249|3686889|B2|||Gestation age||Weeks|Median|22|22.0|Inter-Quartile Range|||18.0|24.0|
3861255|NCT01614249|3686890|B1|||Gestation age||Weeks|Median|22|22.0|Inter-Quartile Range|||19.0|24.0|
3861256|NCT01614249|3686888|B3|Kenya||Region of Enrollment||participants|Number|216|216.0||||||
3861257|NCT01614249|3686889|B2|Kenya||Region of Enrollment||participants|Number|109|109.0||||||
3861258|NCT01614249|3686890|B1|Kenya||Region of Enrollment||participants|Number|107|107.0||||||
3861259|NCT01614249|3686888|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3861260|NCT01614249|3686889|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3861261|NCT01614249|3686890|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3861262|NCT01614249|3686888|B3||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
3861263|NCT01614249|3686889|B2||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3861264|NCT01614249|3686890|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3861265|NCT01614249|3686888|B3|||Age||Years|Median|26|26.0|Inter-Quartile Range|||22.0|30.0|
3861266|NCT01614249|3686889|B2|||Age||Years|Median|26|26.0|Inter-Quartile Range|||22.0|30.0|
3861267|NCT01614249|3686890|B1|||Age||Years|Median|26|26.0|Inter-Quartile Range|||22.0|30.0|
3861268|NCT01614249|3686888|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3861269|NCT01614249|3686889|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3861270|NCT01614249|3686890|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3861271|NCT01614249|3686888|B3||Between 18 and 65 years|Age||Participants|Count of Participants|206|206.0||||||
3861272|NCT01614249|3686889|B2||Between 18 and 65 years|Age||Participants|Count of Participants|104|104.0||||||
3861273|NCT01614249|3686890|B1||Between 18 and 65 years|Age||Participants|Count of Participants|102|102.0||||||
3861274|NCT01614249|3686888|B3||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
3861275|NCT01614249|3686889|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3861276|NCT01614249|3686890|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3861277|NCT01614210|3686897|B1|United States||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
3861278|NCT01614210|3686897|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3861279|NCT01614210|3686897|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3861280|NCT01614210|3686897|B1|||Age||years|Median|58.5|58.5|Full Range|||38.0|79.0|
3861281|NCT01614093|3686905|B1|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3861282|NCT01614093|3686905|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861283|NCT01614093|3686905|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3861284|NCT01614093|3686905|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3861285|NCT01614093|3686905|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3861286|NCT01614093|3686905|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861287|NCT01614093|3686905|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861288|NCT01614093|3686905|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861289|NCT01614093|3686905|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3861290|NCT01614093|3686905|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3861291|NCT01614093|3686905|B1|||Age||years|Mean|32|32.0|Full Range|||18.0|64.0|
3861292|NCT01613768|3686910|B1|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3861293|NCT01613768|3686910|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3861294|NCT01613768|3686910|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861295|NCT01613768|3686910|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3861296|NCT01613768|3686910|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861297|NCT01613768|3686910|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861298|NCT01613768|3686910|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3861299|NCT01613768|3686910|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861303|NCT01613768|3686910|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3861304|NCT01613768|3686910|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3861305|NCT01613768|3686910|B1|||Age||years|Median|63|63.0|Full Range|||23.0|79.0|
3861306|NCT01613768|3686910|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3861307|NCT01613768|3686910|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3861308|NCT01613768|3686910|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3861309|NCT01613716|3686918|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3861310|NCT01613716|3686918|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3861311|NCT01613716|3686918|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3861312|NCT01613716|3686918|B1|||Age||years|Median|61.63|61.63|Full Range|||37.0|83.0|
3861313|NCT01613716|3686918|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3861314|NCT01613716|3686918|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3861315|NCT01613716|3686918|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3861316|NCT01613599|3686923|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3861317|NCT01613599|3686923|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3861318|NCT01613599|3686923|B1|||Age||years|Mean|56.3|56.3|Standard Deviation|16.5|16.5|||
3861319|NCT01613417|3686936|B3|Canada||Region of Enrollment||participants|Number|16|16.0||||||
3861320|NCT01613417|3686937|B2|Canada||Region of Enrollment||participants|Number|8|8.0||||||
3861321|NCT01613417|3686938|B1|Canada||Region of Enrollment||participants|Number|8|8.0||||||
3861322|NCT01613417|3686936|B3|Europe||Region of Enrollment||participants|Number|90|90.0||||||
3861323|NCT01613417|3686937|B2|Europe||Region of Enrollment||participants|Number|51|51.0||||||
3861324|NCT01613417|3686938|B1|Europe||Region of Enrollment||participants|Number|39|39.0||||||
3861325|NCT01613417|3686936|B3|United States||Region of Enrollment||participants|Number|92|92.0||||||
3861326|NCT01613417|3686937|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
3861327|NCT01613417|3686938|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
3861328|NCT01613417|3686936|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861329|NCT01613417|3686937|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861330|NCT01613417|3686938|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861331|NCT01613417|3686936|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3861332|NCT01613417|3686937|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861333|NCT01613417|3686938|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3861334|NCT01613417|3686936|B3||White|Race (NIH/OMB)||Participants|Count of Participants|190|190.0||||||
3861335|NCT01613417|3686937|B2||White|Race (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
3861336|NCT01613417|3686938|B1||White|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3861337|NCT01613417|3686936|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3861338|NCT01613417|3686937|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3861339|NCT01613417|3686938|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861340|NCT01613417|3686936|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861341|NCT01613417|3686937|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861342|NCT01613417|3686938|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861343|NCT01613417|3686936|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3861344|NCT01613417|3686937|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3861345|NCT01613417|3686938|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3861346|NCT01613417|3686936|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861347|NCT01613417|3686937|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861348|NCT01613417|3686938|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861349|NCT01613417|3686936|B3||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3861350|NCT01613417|3686937|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3861351|NCT01613417|3686938|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3861352|NCT01613417|3686936|B3||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3861353|NCT01613417|3686937|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3861354|NCT01613417|3686938|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3861355|NCT01613417|3686936|B3|||Age||years|Mean|55.2|55.2|Standard Deviation|14.31|14.31|||
3861356|NCT01613417|3686937|B2|||Age||years|Mean|55.9|55.9|Standard Deviation|14.29|14.29|||
3861357|NCT01613417|3686938|B1|||Age||years|Mean|54.5|54.5|Standard Deviation|14.27|14.27|||
3861358|NCT01613417|3686936|B3||>=65 years|Age||Participants|Count of Participants|58|58.0||||||
3861359|NCT01613417|3686937|B2||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
3861360|NCT01613417|3686938|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3861361|NCT01613417|3686936|B3||Between 18 and 65 years|Age||Participants|Count of Participants|140|140.0||||||
3861362|NCT01613417|3686937|B2||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
3861363|NCT01613417|3686938|B1||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
3861364|NCT01613417|3686936|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3861365|NCT01613417|3686937|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3861366|NCT01613417|3686938|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3861367|NCT01613378|3686976|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3861368|NCT01613378|3686976|B1||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3861369|NCT01613378|3686976|B1|||Age||years|Mean|55.43|55.43|Standard Deviation|13.52|13.52|||
3861370|NCT01613339|3686992|B3|Sweden||Region of Enrollment||participants|Number|46|46.0||||||
3861371|NCT01613339|3686993|B2|Sweden||Region of Enrollment||participants|Number|22|22.0||||||
3861372|NCT01613339|3686994|B1|Sweden||Region of Enrollment||participants|Number|24|24.0||||||
3861373|NCT01613339|3686992|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3861374|NCT01613339|3686993|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3861375|NCT01613339|3686994|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3861376|NCT01613339|3686992|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3861377|NCT01613339|3686993|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3861378|NCT01613339|3686994|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3861379|NCT01613339|3686992|B3|||Age||years|Mean|64|64.0|Standard Deviation|10|10.0|||
3861380|NCT01613339|3686993|B2|||Age||years|Mean|66|66.0|Standard Deviation|9|9.0|||
3861381|NCT01613339|3686994|B1|||Age||years|Mean|62|62.0|Standard Deviation|11|11.0|||
3861382|NCT01613339|3686992|B3||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3861383|NCT01613339|3686993|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3861384|NCT01613339|3686994|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3861385|NCT01613339|3686992|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3861386|NCT01613339|3686993|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3861387|NCT01613339|3686994|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3861388|NCT01613339|3686992|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3861389|NCT01613339|3686993|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3861390|NCT01613339|3686994|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3861391|NCT01613326|3687004|B3||Male|Sex: Female, Male||Participants|Count of Participants|485|485.0||||||
3861392|NCT01613326|3687005|B2||Male|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
3861393|NCT01613326|3687006|B1||Male|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
3861394|NCT01613326|3687004|B3||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3861395|NCT01613326|3687005|B2||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3861396|NCT01613326|3687006|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3861397|NCT01613326|3687004|B3|||Age||Years|Mean|63.5|63.5|Standard Deviation|8.00|8.0|||
3861398|NCT01613326|3687005|B2|||Age||Years|Mean|63.7|63.7|Standard Deviation|8.02|8.02|||
3861399|NCT01613326|3687006|B1|||Age||Years|Mean|63.2|63.2|Standard Deviation|7.98|7.98|||
3861400|NCT01613313|3687037|B5|United States||Region of Enrollment||participants|Number|14|14.0||||||
3861401|NCT01613313|3687038|B4|United States||Region of Enrollment||participants|Number|4|4.0||||||
3861402|NCT01613313|3687039|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3861403|NCT01613313|3687040|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3861404|NCT01613313|3687041|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3861405|NCT01613313|3687037|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3861406|NCT01613313|3687038|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3861407|NCT01613313|3687039|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3861408|NCT01613313|3687040|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3861409|NCT01613313|3687041|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3861410|NCT01613313|3687037|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3861411|NCT01613313|3687038|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3861412|NCT01613313|3687039|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3861413|NCT01613313|3687040|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3861414|NCT01613313|3687041|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3861415|NCT01613313|3687037|B5|||Age||Years|Mean|49.6|49.6|Standard Deviation|10.60|10.6|||
3861416|NCT01613313|3687038|B4|||Age||Years|Mean|57.0|57.0|Standard Deviation|4.97|4.97|||
3861417|NCT01613313|3687039|B3|||Age||Years|Mean|41.3|41.3|Standard Deviation|11.09|11.09|||
3861418|NCT01613313|3687040|B2|||Age||Years|Mean|51.5|51.5|Standard Deviation|12.50|12.5|||
3861419|NCT01613313|3687041|B1|||Age||Years|Mean|48.0|48.0|Standard Deviation|5.66|5.66|||
3861420|NCT01613248|3687058|B7||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3861421|NCT01613248|3687059|B6||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3861422|NCT01613248|3687060|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3861423|NCT01613248|3687061|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3861424|NCT01613248|3687062|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3861425|NCT01613248|3687063|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3861426|NCT01613248|3687064|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3861427|NCT01613248|3687058|B7||Female|Sex: Female, Male||Participants|Count of Participants|559|559.0||||||
3861428|NCT01613248|3687059|B6||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3861429|NCT01613248|3687060|B5||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3861430|NCT01613248|3687061|B4||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3861431|NCT01613248|3687062|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3861432|NCT01613248|3687063|B2||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3861433|NCT01613248|3687064|B1||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3861434|NCT01613248|3687058|B7|>= 65 years||Age, Customized||participants|Number|3|3.0||||||
3861435|NCT01613248|3687059|B6|>= 65 years||Age, Customized||participants|Number|1|1.0||||||
3861436|NCT01613248|3687060|B5|>= 65 years||Age, Customized||participants|Number|0|0.0||||||
3861437|NCT01613248|3687061|B4|>= 65 years||Age, Customized||participants|Number|0|0.0||||||
3861438|NCT01613248|3687062|B3|>= 65 years||Age, Customized||participants|Number|0|0.0||||||
3861439|NCT01613248|3687063|B2|>= 65 years||Age, Customized||participants|Number|1|1.0||||||
3861440|NCT01613248|3687064|B1|>= 65 years||Age, Customized||participants|Number|1|1.0||||||
3861441|NCT01613248|3687058|B7|60 to 64 years||Age, Customized||participants|Number|37|37.0||||||
3861442|NCT01613248|3687059|B6|60 to 64 years||Age, Customized||participants|Number|3|3.0||||||
3861443|NCT01613248|3687060|B5|60 to 64 years||Age, Customized||participants|Number|9|9.0||||||
3861444|NCT01613248|3687061|B4|60 to 64 years||Age, Customized||participants|Number|8|8.0||||||
3861445|NCT01613248|3687062|B3|60 to 64 years||Age, Customized||participants|Number|5|5.0||||||
3861446|NCT01613248|3687063|B2|60 to 64 years||Age, Customized||participants|Number|2|2.0||||||
3861447|NCT01613248|3687064|B1|60 to 64 years||Age, Customized||participants|Number|10|10.0||||||
3861448|NCT01613248|3687058|B7|50 to 59 years||Age, Customized||participants|Number|110|110.0||||||
3861449|NCT01613248|3687059|B6|50 to 59 years||Age, Customized||participants|Number|23|23.0||||||
3861450|NCT01613248|3687060|B5|50 to 59 years||Age, Customized||participants|Number|21|21.0||||||
3861451|NCT01613248|3687061|B4|50 to 59 years||Age, Customized||participants|Number|16|16.0||||||
3861452|NCT01613248|3687062|B3|50 to 59 years||Age, Customized||participants|Number|14|14.0||||||
3861453|NCT01613248|3687063|B2|50 to 59 years||Age, Customized||participants|Number|17|17.0||||||
3861454|NCT01613248|3687064|B1|50 to 59 years||Age, Customized||participants|Number|19|19.0||||||
3861455|NCT01613248|3687058|B7|40 to 49 years||Age, Customized||participants|Number|189|189.0||||||
3861456|NCT01613248|3687059|B6|40 to 49 years||Age, Customized||participants|Number|33|33.0||||||
3861457|NCT01613248|3687060|B5|40 to 49 years||Age, Customized||participants|Number|23|23.0||||||
3861458|NCT01613248|3687061|B4|40 to 49 years||Age, Customized||participants|Number|33|33.0||||||
3861459|NCT01613248|3687062|B3|40 to 49 years||Age, Customized||participants|Number|42|42.0||||||
3861460|NCT01613248|3687063|B2|40 to 49 years||Age, Customized||participants|Number|36|36.0||||||
3861461|NCT01613248|3687064|B1|40 to 49 years||Age, Customized||participants|Number|22|22.0||||||
3861462|NCT01613248|3687058|B7|30 to 39 years||Age, Customized||participants|Number|189|189.0||||||
3861463|NCT01613248|3687059|B6|30 to 39 years||Age, Customized||participants|Number|26|26.0||||||
3861464|NCT01613248|3687060|B5|30 to 39 years||Age, Customized||participants|Number|32|32.0||||||
3861465|NCT01613248|3687061|B4|30 to 39 years||Age, Customized||participants|Number|32|32.0||||||
3861466|NCT01613248|3687062|B3|30 to 39 years||Age, Customized||participants|Number|28|28.0||||||
3861467|NCT01613248|3687063|B2|30 to 39 years||Age, Customized||participants|Number|29|29.0||||||
3861468|NCT01613248|3687064|B1|30 to 39 years||Age, Customized||participants|Number|42|42.0||||||
3861469|NCT01613248|3687058|B7|20 to 29 years||Age, Customized||participants|Number|106|106.0||||||
3861470|NCT01613248|3687059|B6|20 to 29 years||Age, Customized||participants|Number|16|16.0||||||
3861471|NCT01613248|3687060|B5|20 to 29 years||Age, Customized||participants|Number|19|19.0||||||
3861472|NCT01613248|3687061|B4|20 to 29 years||Age, Customized||participants|Number|13|13.0||||||
3861473|NCT01613248|3687062|B3|20 to 29 years||Age, Customized||participants|Number|19|19.0||||||
3861474|NCT01613248|3687063|B2|20 to 29 years||Age, Customized||participants|Number|21|21.0||||||
3861475|NCT01613248|3687064|B1|20 to 29 years||Age, Customized||participants|Number|18|18.0||||||
3861476|NCT01613248|3687058|B7|< 20 years||Age, Customized||participants|Number|6|6.0||||||
3861477|NCT01613248|3687059|B6|< 20 years||Age, Customized||participants|Number|0|0.0||||||
3861478|NCT01613248|3687060|B5|< 20 years||Age, Customized||participants|Number|2|2.0||||||
3861479|NCT01613248|3687061|B4|< 20 years||Age, Customized||participants|Number|2|2.0||||||
3861480|NCT01613248|3687062|B3|< 20 years||Age, Customized||participants|Number|0|0.0||||||
3861481|NCT01613248|3687063|B2|< 20 years||Age, Customized||participants|Number|1|1.0||||||
3861482|NCT01613248|3687064|B1|< 20 years||Age, Customized||participants|Number|1|1.0||||||
3861483|NCT01613248|3687058|B7|||Age||years|Mean|40.8|40.8|Standard Deviation|11.4|11.4|||
3861484|NCT01613248|3687059|B6|||Age||years|Mean|41.9|41.9|Standard Deviation|11.0|11.0|||
3861485|NCT01613248|3687060|B5|||Age||years|Mean|40.7|40.7|Standard Deviation|12.3|12.3|||
3861486|NCT01613248|3687061|B4|||Age||years|Mean|41.4|41.4|Standard Deviation|11.5|11.5|||
3861487|NCT01613248|3687062|B3|||Age||years|Mean|41.1|41.1|Standard Deviation|10.9|10.9|||
3861488|NCT01613248|3687063|B2|||Age||years|Mean|39.6|39.6|Standard Deviation|10.7|10.7|||
3861489|NCT01613248|3687064|B1|||Age||years|Mean|40.5|40.5|Standard Deviation|11.7|11.7|||
3861490|NCT01613131|3687167|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
3861491|NCT01613131|3687168|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
3861492|NCT01613131|3687169|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3861493|NCT01613131|3687167|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3861494|NCT01613131|3687168|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3861495|NCT01613131|3687169|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3861496|NCT01613131|3687167|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3861497|NCT01613131|3687168|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3861498|NCT01613131|3687169|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3861499|NCT01613131|3687167|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3861500|NCT01613131|3687168|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3861501|NCT01613131|3687169|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3861502|NCT01613131|3687167|B3||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3861503|NCT01613131|3687168|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3861504|NCT01613131|3687169|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3861505|NCT01613131|3687167|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3861506|NCT01613131|3687168|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3861507|NCT01613131|3687169|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3861508|NCT01613027|3687198|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3861509|NCT01613027|3687198|B1||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3861510|NCT01613027|3687198|B1|||Age||years|Mean|61.2|61.2|Standard Deviation|12.5|12.5|||
3861511|NCT01613014|3687217|B3|United States||Region of Enrollment||participants|Number|144|144.0||||||
3861512|NCT01613014|3687218|B2|United States||Region of Enrollment||participants|Number|73|73.0||||||
3861513|NCT01613014|3687219|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
3861514|NCT01613014|3687217|B3||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3861515|NCT01613014|3687218|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3861516|NCT01613014|3687219|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3861517|NCT01613014|3687217|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3861518|NCT01613014|3687218|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3861519|NCT01613014|3687219|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3861520|NCT01613014|3687217|B3|||Age||years|Mean|45.7|45.7|Standard Deviation|10.9|10.9|||
3861521|NCT01613014|3687218|B2|||Age||years|Mean|45.8|45.8|Standard Deviation|10.2|10.2|||
3861522|NCT01613014|3687219|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|11.6|11.6|||
3861523|NCT01613014|3687217|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3861524|NCT01613014|3687218|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3861525|NCT01613014|3687219|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3861526|NCT01613014|3687217|B3||Between 18 and 65 years|Age||Participants|Count of Participants|144|144.0||||||
3861527|NCT01613014|3687218|B2||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
3861528|NCT01613014|3687219|B1||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
3861529|NCT01613014|3687217|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3861530|NCT01613014|3687218|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3861531|NCT01613014|3687219|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3861532|NCT01612884|3687226|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
3861533|NCT01612884|3687227|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
3861534|NCT01612884|3687228|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3861535|NCT01612884|3687226|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861536|NCT01612884|3687227|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861537|NCT01612884|3687228|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861538|NCT01612884|3687226|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861539|NCT01612884|3687227|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861540|NCT01612884|3687228|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861541|NCT01612884|3687226|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3861542|NCT01612884|3687227|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3861543|NCT01612884|3687228|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3861544|NCT01612884|3687226|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3861545|NCT01612884|3687227|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3861546|NCT01612884|3687228|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3861547|NCT01612884|3687226|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861548|NCT01612884|3687227|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861549|NCT01612884|3687228|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861550|NCT01612884|3687226|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861551|NCT01612884|3687227|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861552|NCT01612884|3687228|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861553|NCT01612884|3687226|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861554|NCT01612884|3687227|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861555|NCT01612884|3687228|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861556|NCT01612884|3687226|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3861557|NCT01612884|3687227|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3861558|NCT01612884|3687228|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3861559|NCT01612884|3687226|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3861560|NCT01612884|3687227|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3861561|NCT01612884|3687228|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3861562|NCT01612884|3687226|B3|||Age||years|Mean|54.2|54.2|Standard Deviation|10|10.0|||
3861563|NCT01612884|3687227|B2|||Age||years|Mean|53.2|53.2|Standard Deviation|10.5|10.5|||
3861564|NCT01612884|3687228|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|9.8|9.8|||
3861565|NCT01612858|3687239|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3861566|NCT01612858|3687240|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3861567|NCT01612858|3687241|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3861568|NCT01612858|3687239|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3861569|NCT01612858|3687240|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3861570|NCT01612858|3687241|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3861571|NCT01612858|3687239|B3|||Age||years|Mean|54.2|54.2|Standard Deviation|7.8|7.8|||
3861572|NCT01612858|3687240|B2|||Age||years|Mean|55.7|55.7|Standard Deviation|8.6|8.6|||
3861573|NCT01612858|3687241|B1|||Age||years|Mean|53.9|53.9|Standard Deviation|7.9|7.9|||
3861574|NCT01612767|3687250|B1|3||Thrombolysis in Myocardial Infarction (TIMI) Flow|TIMI Flow is a system developed during Thrombolysis in Myocardial Infarction (TIMI) trials for grading severity of stenosis and extent of blood flow through coronary arteries; TIMI grade 0 = no perfusion; grade 1 = penetration with minimal perfusion; grade 2 = partial perfusion; grade 3 = complete perfusion. Grade 0 represents no flow beyond an occlusion, while grade 3 represents normal flow.|Participants|Number|298|298.0||||||
3861575|NCT01612767|3687250|B1|2||Thrombolysis in Myocardial Infarction (TIMI) Flow|TIMI Flow is a system developed during Thrombolysis in Myocardial Infarction (TIMI) trials for grading severity of stenosis and extent of blood flow through coronary arteries; TIMI grade 0 = no perfusion; grade 1 = penetration with minimal perfusion; grade 2 = partial perfusion; grade 3 = complete perfusion. Grade 0 represents no flow beyond an occlusion, while grade 3 represents normal flow.|Participants|Number|24|24.0||||||
3861576|NCT01612767|3687250|B1|1||Thrombolysis in Myocardial Infarction (TIMI) Flow|TIMI Flow is a system developed during Thrombolysis in Myocardial Infarction (TIMI) trials for grading severity of stenosis and extent of blood flow through coronary arteries; TIMI grade 0 = no perfusion; grade 1 = penetration with minimal perfusion; grade 2 = partial perfusion; grade 3 = complete perfusion. Grade 0 represents no flow beyond an occlusion, while grade 3 represents normal flow.|Participants|Number|6|6.0||||||
3861577|NCT01612767|3687250|B1|0||Thrombolysis in Myocardial Infarction (TIMI) Flow|TIMI Flow is a system developed during Thrombolysis in Myocardial Infarction (TIMI) trials for grading severity of stenosis and extent of blood flow through coronary arteries; TIMI grade 0 = no perfusion; grade 1 = penetration with minimal perfusion; grade 2 = partial perfusion; grade 3 = complete perfusion. Grade 0 represents no flow beyond an occlusion, while grade 3 represents normal flow.|Participants|Number|1|1.0||||||
3861578|NCT01612767|3687250|B1|Severe||Lesion Calcification||Participants|Number|26|26.0||||||
3861579|NCT01612767|3687250|B1|Moderate||Lesion Calcification||Participants|Number|58|58.0||||||
3861580|NCT01612767|3687250|B1|None||Lesion Calcification||Participants|Number|245|245.0||||||
3861581|NCT01612767|3687250|B1|Post-deployment target vessel MLD||Vessel Diameter|MLD = minimal luminal diameter|mm|Mean|3.1|3.1|Standard Deviation|0.5|0.5|||
3861582|NCT01612767|3687250|B1|Pre-deployment target vessel reference diameter||Vessel Diameter|MLD = minimal luminal diameter|mm|Mean|2.9|2.9|Standard Deviation|0.5|0.5|||
3861583|NCT01612767|3687250|B1|Pre-deployment target vessel MLD||Vessel Diameter|MLD = minimal luminal diameter|mm|Mean|0.9|0.9|Standard Deviation|0.4|0.4|||
3861584|NCT01612767|3687250|B1|||Lesion Length||mm|Mean|13.7|13.7|Standard Deviation|6.0|6.0|||
3861585|NCT01612767|3687250|B1|Right||Lesion Location||Participants|Number|125|125.0||||||
3861586|NCT01612767|3687250|B1|Circumflex||Lesion Location||Participants|Number|82|82.0||||||
3861587|NCT01612767|3687250|B1|Left Anterior Descending (LAD)||Lesion Location||Participants|Number|122|122.0||||||
3861588|NCT01612767|3687250|B1|Anti-coagulant||Concomitant Medications||Participants|Number|32|32.0||||||
3861589|NCT01612767|3687250|B1|Insulin||Concomitant Medications||Participants|Number|37|37.0||||||
3861590|NCT01612767|3687250|B1|Statins||Concomitant Medications||Participants|Number|213|213.0||||||
3861591|NCT01612767|3687250|B1|Beta blocker||Concomitant Medications||Participants|Number|203|203.0||||||
3861592|NCT01612767|3687250|B1|Angiotensin II receptor blocker||Concomitant Medications||Participants|Number|78|78.0||||||
3861593|NCT01612767|3687250|B1|Antiotensin-converting-enzyme (ACE) inhibitor||Concomitant Medications||Participants|Number|135|135.0||||||
3861594|NCT01612767|3687250|B1|Antiplatelet - Ticagrelor||Concomitant Medications||Participants|Number|15|15.0||||||
3861595|NCT01612767|3687250|B1|Antiplatelet - Prasugrel||Concomitant Medications||Participants|Number|9|9.0||||||
3861596|NCT01612767|3687250|B1|Antiplatelet - Clopidogrel||Concomitant Medications||Participants|Number|79|79.0||||||
3861597|NCT01612767|3687250|B1|Aspirin||Concomitant Medications||Participants|Number|260|260.0||||||
3861598|NCT01612767|3687250|B1|Dual Antiplatelet Therapy (DAPT)||Concomitant Medications||Participants|Number|96|96.0||||||
3861599|NCT01612767|3687250|B1|Renal insufficiency||Medical History||Participants|Number|8|8.0||||||
3861600|NCT01612767|3687250|B1|Prior percutaneous coronary revascularization||Medical History||Participants|Number|100|100.0||||||
3861601|NCT01612767|3687250|B1|Prior coronary artery bypass graft (CABG)||Medical History||Participants|Number|27|27.0||||||
3861602|NCT01612767|3687250|B1|History of myocardial infarction (MI)||Medical History||Participants|Number|67|67.0||||||
3861603|NCT01612767|3687250|B1|Never smoked or not within last 5 years||Medical History||Participants|Number|238|238.0||||||
3861604|NCT01612767|3687250|B1|Smoked within last 5 years||Medical History||Participants|Number|31|31.0||||||
3861605|NCT01612767|3687250|B1|Current smoker||Medical History||Participants|Number|60|60.0||||||
3861606|NCT01612767|3687250|B1|Hyperlipidemia||Medical History||Participants|Number|240|240.0||||||
3861607|NCT01612767|3687250|B1|Hypertension||Medical History||Participants|Number|276|276.0||||||
3861608|NCT01612767|3687250|B1|Diabetes||Medical History||Participants|Number|94|94.0||||||
3861609|NCT01612767|3687250|B1|Colombia||Region of Enrollment||Participants|Number|1|1.0||||||
3861610|NCT01612767|3687250|B1|Latvia||Region of Enrollment||Participants|Number|8|8.0||||||
3861611|NCT01612767|3687250|B1|Netherlands||Region of Enrollment||Participants|Number|17|17.0||||||
3861612|NCT01612767|3687250|B1|Germany||Region of Enrollment||Participants|Number|88|88.0||||||
3861613|NCT01612767|3687250|B1|United States||Region of Enrollment||Participants|Number|215|215.0||||||
3861614|NCT01612767|3687250|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861615|NCT01612767|3687250|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861616|NCT01612767|3687250|B1||White|Race (NIH/OMB)||Participants|Count of Participants|305|305.0||||||
3861617|NCT01612767|3687250|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3861618|NCT01612767|3687250|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861619|NCT01612767|3687250|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3861620|NCT01612767|3687250|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3861621|NCT01612767|3687250|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861622|NCT01612767|3687250|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|306|306.0||||||
3861623|NCT01612767|3687250|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3861624|NCT01612767|3687250|B1||Male|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
3861625|NCT01612767|3687250|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3861626|NCT01612767|3687250|B1|||Age||Years|Mean|69.0|69.0|Standard Deviation|9.3|9.3|||
3861627|NCT01612702|3687304|B3|Korea, Republic of||Region of Enrollment||participants|Number|291|291.0||||||
3861628|NCT01612702|3687305|B2|Korea, Republic of||Region of Enrollment||participants|Number|145|145.0||||||
3861629|NCT01612702|3687306|B1|Korea, Republic of||Region of Enrollment||participants|Number|146|146.0||||||
3861630|NCT01612702|3687304|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3861631|NCT01612702|3687305|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3861632|NCT01612702|3687306|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3861633|NCT01612702|3687304|B3||Female|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
3861634|NCT01612702|3687305|B2||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3861635|NCT01612702|3687306|B1||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3861636|NCT01612702|3687304|B3|||Age||years|Mean|72|72.0|Standard Deviation|6.4|6.4|||
3861637|NCT01612702|3687305|B2|||Age||years|Mean|72|72.0|Standard Deviation|6.2|6.2|||
3861638|NCT01612702|3687306|B1|||Age||years|Mean|72|72.0|Standard Deviation|6.7|6.7|||
3861639|NCT01612702|3687304|B3||>=65 years|Age||Participants|Count of Participants|263|263.0||||||
3861640|NCT01612702|3687305|B2||>=65 years|Age||Participants|Count of Participants|131|131.0||||||
3861641|NCT01612702|3687306|B1||>=65 years|Age||Participants|Count of Participants|132|132.0||||||
3861642|NCT01612702|3687304|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3861643|NCT01612702|3687305|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3861644|NCT01612702|3687306|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3861645|NCT01612702|3687304|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3861646|NCT01612702|3687305|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3861647|NCT01612702|3687306|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3861648|NCT01612676|3687317|B5|Unknown||Septic shock characteristic: Primary infection location||patients|Number|1|1.0||||||
3861649|NCT01612676|3687318|B4|Unknown||Septic shock characteristic: Primary infection location||patients|Number|1|1.0||||||
3861650|NCT01612676|3687319|B3|Unknown||Septic shock characteristic: Primary infection location||patients|Number|0|0.0||||||
3861651|NCT01612676|3687320|B2|Unknown||Septic shock characteristic: Primary infection location||patients|Number|0|0.0||||||
3861652|NCT01612676|3687321|B1|Unknown||Septic shock characteristic: Primary infection location||patients|Number|0|0.0||||||
3861653|NCT01612676|3687317|B5|Other||Septic shock characteristic: Primary infection location||patients|Number|5|5.0||||||
3861654|NCT01612676|3687318|B4|Other||Septic shock characteristic: Primary infection location||patients|Number|1|1.0||||||
3861655|NCT01612676|3687319|B3|Other||Septic shock characteristic: Primary infection location||patients|Number|1|1.0||||||
3861656|NCT01612676|3687320|B2|Other||Septic shock characteristic: Primary infection location||patients|Number|0|0.0||||||
3861657|NCT01612676|3687321|B1|Other||Septic shock characteristic: Primary infection location||patients|Number|3|3.0||||||
3861658|NCT01612676|3687317|B5|Urinary tract||Septic shock characteristic: Primary infection location||patients|Number|6|6.0||||||
3861659|NCT01612676|3687318|B4|Urinary tract||Septic shock characteristic: Primary infection location||patients|Number|4|4.0||||||
3861660|NCT01612676|3687319|B3|Urinary tract||Septic shock characteristic: Primary infection location||patients|Number|1|1.0||||||
3861661|NCT01612676|3687320|B2|Urinary tract||Septic shock characteristic: Primary infection location||patients|Number|1|1.0||||||
3861662|NCT01612676|3687321|B1|Urinary tract||Septic shock characteristic: Primary infection location||patients|Number|0|0.0||||||
3861663|NCT01612676|3687317|B5|Lung||Septic shock characteristic: Primary infection location||patients|Number|3|3.0||||||
3861664|NCT01612676|3687318|B4|Lung||Septic shock characteristic: Primary infection location||patients|Number|1|1.0||||||
3861665|NCT01612676|3687319|B3|Lung||Septic shock characteristic: Primary infection location||patients|Number|0|0.0||||||
3861666|NCT01612676|3687320|B2|Lung||Septic shock characteristic: Primary infection location||patients|Number|1|1.0||||||
3861667|NCT01612676|3687321|B1|Lung||Septic shock characteristic: Primary infection location||patients|Number|1|1.0||||||
3861668|NCT01612676|3687317|B5|Abdominal cavity||Septic shock characteristic: Primary infection location||patients|Number|15|15.0||||||
3861669|NCT01612676|3687318|B4|Abdominal cavity||Septic shock characteristic: Primary infection location||patients|Number|6|6.0||||||
3861670|NCT01612676|3687319|B3|Abdominal cavity||Septic shock characteristic: Primary infection location||patients|Number|3|3.0||||||
3861671|NCT01612676|3687320|B2|Abdominal cavity||Septic shock characteristic: Primary infection location||patients|Number|5|5.0||||||
3861672|NCT01612676|3687321|B1|Abdominal cavity||Septic shock characteristic: Primary infection location||patients|Number|1|1.0||||||
3861673|NCT01612676|3687317|B5|Other||Septic shock characteristic: Primary infection type||patients|Number|2|2.0||||||
3861674|NCT01612676|3687318|B4|Other||Septic shock characteristic: Primary infection type||patients|Number|0|0.0||||||
3861675|NCT01612676|3687319|B3|Other||Septic shock characteristic: Primary infection type||patients|Number|1|1.0||||||
3861676|NCT01612676|3687320|B2|Other||Septic shock characteristic: Primary infection type||patients|Number|0|0.0||||||
3861677|NCT01612676|3687321|B1|Other||Septic shock characteristic: Primary infection type||patients|Number|1|1.0||||||
3861678|NCT01612676|3687317|B5|Unknown||Septic shock characteristic: Primary infection type||patients|Number|3|3.0||||||
3861679|NCT01612676|3687318|B4|Unknown||Septic shock characteristic: Primary infection type||patients|Number|1|1.0||||||
3861680|NCT01612676|3687319|B3|Unknown||Septic shock characteristic: Primary infection type||patients|Number|1|1.0||||||
3861681|NCT01612676|3687320|B2|Unknown||Septic shock characteristic: Primary infection type||patients|Number|1|1.0||||||
3861682|NCT01612676|3687321|B1|Unknown||Septic shock characteristic: Primary infection type||patients|Number|0|0.0||||||
3861683|NCT01612676|3687317|B5|Bacterial||Septic shock characteristic: Primary infection type||patients|Number|25|25.0||||||
3861684|NCT01612676|3687318|B4|Bacterial||Septic shock characteristic: Primary infection type||patients|Number|12|12.0||||||
3861685|NCT01612676|3687319|B3|Bacterial||Septic shock characteristic: Primary infection type||patients|Number|3|3.0||||||
3861686|NCT01612676|3687320|B2|Bacterial||Septic shock characteristic: Primary infection type||patients|Number|6|6.0||||||
3861687|NCT01612676|3687321|B1|Bacterial||Septic shock characteristic: Primary infection type||patients|Number|4|4.0||||||
3861688|NCT01612676|3687317|B5|||Total Sequential Organ Failure Assessment Score|"The Sequential Organ Failure Assessment score (SOFA) score is a scoring system to determine the extent of a person's organ function or rate of failure. The score is based on six different scores, one each for the respiratory, cardiovascular, hepatic, coagulation, renal and neurological systems.~The total SOFA score is a sum of the individual scores and range from 4 to 24, 4 being the best and 24 being the worst patient status."|Score on scale|Mean|9.67|9.67|Standard Deviation|2.88|2.88|||
3861689|NCT01612676|3687318|B4|||Total Sequential Organ Failure Assessment Score|"The Sequential Organ Failure Assessment score (SOFA) score is a scoring system to determine the extent of a person's organ function or rate of failure. The score is based on six different scores, one each for the respiratory, cardiovascular, hepatic, coagulation, renal and neurological systems.~The total SOFA score is a sum of the individual scores and range from 4 to 24, 4 being the best and 24 being the worst patient status."|Score on scale|Mean|9.31|9.31|Standard Deviation|3.01|3.01|||
3861690|NCT01612676|3687319|B3|||Total Sequential Organ Failure Assessment Score|"The Sequential Organ Failure Assessment score (SOFA) score is a scoring system to determine the extent of a person's organ function or rate of failure. The score is based on six different scores, one each for the respiratory, cardiovascular, hepatic, coagulation, renal and neurological systems.~The total SOFA score is a sum of the individual scores and range from 4 to 24, 4 being the best and 24 being the worst patient status."|Score on scale|Mean|8.8|8.8|Standard Deviation|3.19|3.19|||
3861691|NCT01612676|3687320|B2|||Total Sequential Organ Failure Assessment Score|"The Sequential Organ Failure Assessment score (SOFA) score is a scoring system to determine the extent of a person's organ function or rate of failure. The score is based on six different scores, one each for the respiratory, cardiovascular, hepatic, coagulation, renal and neurological systems.~The total SOFA score is a sum of the individual scores and range from 4 to 24, 4 being the best and 24 being the worst patient status."|Score on scale|Mean|10|10.0|Standard Deviation|2.31|2.31|||
3861692|NCT01612676|3687321|B1|||Total Sequential Organ Failure Assessment Score|"The Sequential Organ Failure Assessment score (SOFA) score is a scoring system to determine the extent of a person's organ function or rate of failure. The score is based on six different scores, one each for the respiratory, cardiovascular, hepatic, coagulation, renal and neurological systems.~The total SOFA score is a sum of the individual scores and range from 4 to 24, 4 being the best and 24 being the worst patient status."|Score on scale|Mean|11|11.0|Standard Deviation|3.32|3.32|||
3861693|NCT01612676|3687317|B5|||Weight||kg|Mean|76.3|76.3|Standard Deviation|14.8|14.8|||
3861694|NCT01612676|3687318|B4|||Weight||kg|Mean|78.9|78.9|Standard Deviation|15.3|15.3|||
3861695|NCT01612676|3687319|B3|||Weight||kg|Mean|81.3|81.3|Standard Deviation|8.0|8.0|||
3861696|NCT01612676|3687320|B2|||Weight||kg|Mean|74.7|74.7|Standard Deviation|17.7|17.7|||
3861697|NCT01612676|3687321|B1|||Weight||kg|Mean|66.6|66.6|Standard Deviation|13.5|13.5|||
3861698|NCT01612676|3687317|B5||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3861699|NCT01612676|3687318|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3861700|NCT01612676|3687319|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3861701|NCT01612676|3687320|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3861702|NCT01612676|3687321|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3861703|NCT01612676|3687317|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3861704|NCT01612676|3687318|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3861705|NCT01612676|3687319|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3861706|NCT01612676|3687320|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3861707|NCT01612676|3687321|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3861708|NCT01612676|3687317|B5|||Age||years|Mean|67.4|67.4|Standard Deviation|12.2|12.2|||
3861709|NCT01612676|3687318|B4|||Age||years|Mean|67.6|67.6|Standard Deviation|13.2|13.2|||
3861710|NCT01612676|3687319|B3|||Age||years|Mean|64.8|64.8|Standard Deviation|10.1|10.1|||
3861711|NCT01612676|3687320|B2|||Age||years|Mean|67.9|67.9|Standard Deviation|13.7|13.7|||
3861712|NCT01612676|3687321|B1|||Age||years|Mean|69.0|69.0|Standard Deviation|12.7|12.7|||
3861713|NCT01612546|3687380|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3861714|NCT01612546|3687380|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3861715|NCT01612546|3687380|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3861716|NCT01612546|3687380|B1|||Age||years|Median|64|64.0|Full Range|||48.0|73.0|
3861717|NCT01612494|3687388|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
3861718|NCT01612494|3687389|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
3861719|NCT01612494|3687390|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3861720|NCT01612494|3687388|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3861721|NCT01612494|3687389|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3861722|NCT01612494|3687390|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3861723|NCT01612494|3687388|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3861724|NCT01612494|3687389|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3861725|NCT01612494|3687390|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3861726|NCT01612494|3687388|B3|||Age||years|Mean|12|12.0|Standard Deviation|3|3.0|||
3861727|NCT01612494|3687389|B2|||Age||years|Mean|12.1|12.1|Standard Deviation|2.5|2.5|||
3861728|NCT01612494|3687390|B1|||Age||years|Mean|11.9|11.9|Standard Deviation|3|3.0|||
3861729|NCT01612494|3687388|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3861730|NCT01612494|3687389|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3861731|NCT01612494|3687390|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3861732|NCT01612494|3687388|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3861733|NCT01612494|3687389|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3861734|NCT01612494|3687390|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3861735|NCT01612494|3687388|B3||<=18 years|Age||Participants|Count of Participants|44|44.0||||||
3861736|NCT01612494|3687389|B2||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
3861737|NCT01612494|3687390|B1||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
3861738|NCT01612351|3687397|B1||T4N1|Stage of disease|"Anatomic stage for NSCLC is the American Joint Committee on Cancer (AJCC) primary tumor, regional nodes, metastasis (TNM) system, which is based on:~Size of primary tumor (T) and whether it has grown into nearby areas. Spread to regional lymph nodes (N). Once the categories have been determined, this information is combined into a prognostic group. Higher numbers mean the cancer is more advanced. N1- 1 lymph node on the same side as the original tumor. N2a- Spread to 1 lymph node on the same side. N2b- spread to 2 or more lymph nodes on same side. N2c- 1 or more lymph nodes on both sides."|Participants|Count of Participants|2|2.0||||||
3861739|NCT01612351|3687397|B1||T3N2c|Stage of disease|"Anatomic stage for NSCLC is the American Joint Committee on Cancer (AJCC) primary tumor, regional nodes, metastasis (TNM) system, which is based on:~Size of primary tumor (T) and whether it has grown into nearby areas. Spread to regional lymph nodes (N). Once the categories have been determined, this information is combined into a prognostic group. Higher numbers mean the cancer is more advanced. N1- 1 lymph node on the same side as the original tumor. N2a- Spread to 1 lymph node on the same side. N2b- spread to 2 or more lymph nodes on same side. N2c- 1 or more lymph nodes on both sides."|Participants|Count of Participants|1|1.0||||||
3861740|NCT01612351|3687397|B1||T3N0|Stage of disease|"Anatomic stage for NSCLC is the American Joint Committee on Cancer (AJCC) primary tumor, regional nodes, metastasis (TNM) system, which is based on:~Size of primary tumor (T) and whether it has grown into nearby areas. Spread to regional lymph nodes (N). Once the categories have been determined, this information is combined into a prognostic group. Higher numbers mean the cancer is more advanced. N1- 1 lymph node on the same side as the original tumor. N2a- Spread to 1 lymph node on the same side. N2b- spread to 2 or more lymph nodes on same side. N2c- 1 or more lymph nodes on both sides."|Participants|Count of Participants|3|3.0||||||
3861741|NCT01612351|3687397|B1||T2N2c|Stage of disease|"Anatomic stage for NSCLC is the American Joint Committee on Cancer (AJCC) primary tumor, regional nodes, metastasis (TNM) system, which is based on:~Size of primary tumor (T) and whether it has grown into nearby areas. Spread to regional lymph nodes (N). Once the categories have been determined, this information is combined into a prognostic group. Higher numbers mean the cancer is more advanced. N1- 1 lymph node on the same side as the original tumor. N2a- Spread to 1 lymph node on the same side. N2b- spread to 2 or more lymph nodes on same side. N2c- 1 or more lymph nodes on both sides."|Participants|Count of Participants|2|2.0||||||
3861742|NCT01612351|3687397|B1||T2N2b|Stage of disease|"Anatomic stage for NSCLC is the American Joint Committee on Cancer (AJCC) primary tumor, regional nodes, metastasis (TNM) system, which is based on:~Size of primary tumor (T) and whether it has grown into nearby areas. Spread to regional lymph nodes (N). Once the categories have been determined, this information is combined into a prognostic group. Higher numbers mean the cancer is more advanced. N1- 1 lymph node on the same side as the original tumor. N2a- Spread to 1 lymph node on the same side. N2b- spread to 2 or more lymph nodes on same side. N2c- 1 or more lymph nodes on both sides."|Participants|Count of Participants|12|12.0||||||
3861743|NCT01612351|3687397|B1||T2N2a|Stage of disease|"Anatomic stage for NSCLC is the American Joint Committee on Cancer (AJCC) primary tumor, regional nodes, metastasis (TNM) system, which is based on:~Size of primary tumor (T) and whether it has grown into nearby areas. Spread to regional lymph nodes (N). Once the categories have been determined, this information is combined into a prognostic group. Higher numbers mean the cancer is more advanced. N1- 1 lymph node on the same side as the original tumor. N2a- Spread to 1 lymph node on the same side. N2b- spread to 2 or more lymph nodes on same side. N2c- 1 or more lymph nodes on both sides."|Participants|Count of Participants|5|5.0||||||
3861744|NCT01612351|3687397|B1||T2N1|Stage of disease|"Anatomic stage for NSCLC is the American Joint Committee on Cancer (AJCC) primary tumor, regional nodes, metastasis (TNM) system, which is based on:~Size of primary tumor (T) and whether it has grown into nearby areas. Spread to regional lymph nodes (N). Once the categories have been determined, this information is combined into a prognostic group. Higher numbers mean the cancer is more advanced. N1- 1 lymph node on the same side as the original tumor. N2a- Spread to 1 lymph node on the same side. N2b- spread to 2 or more lymph nodes on same side. N2c- 1 or more lymph nodes on both sides."|Participants|Count of Participants|4|4.0||||||
3861745|NCT01612351|3687397|B1||T1N2b|Stage of disease|"Anatomic stage for NSCLC is the American Joint Committee on Cancer (AJCC) primary tumor, regional nodes, metastasis (TNM) system, which is based on:~Size of primary tumor (T) and whether it has grown into nearby areas. Spread to regional lymph nodes (N). Once the categories have been determined, this information is combined into a prognostic group. Higher numbers mean the cancer is more advanced. N1- 1 lymph node on the same side as the original tumor. N2a- Spread to 1 lymph node on the same side. N2b- spread to 2 or more lymph nodes on same side. N2c- 1 or more lymph nodes on both sides."|Participants|Count of Participants|6|6.0||||||
3861746|NCT01612351|3687397|B1||T1N2a|Stage of disease|"Anatomic stage for NSCLC is the American Joint Committee on Cancer (AJCC) primary tumor, regional nodes, metastasis (TNM) system, which is based on:~Size of primary tumor (T) and whether it has grown into nearby areas. Spread to regional lymph nodes (N). Once the categories have been determined, this information is combined into a prognostic group. Higher numbers mean the cancer is more advanced. N1- 1 lymph node on the same side as the original tumor. N2a- Spread to 1 lymph node on the same side. N2b- spread to 2 or more lymph nodes on same side. N2c- 1 or more lymph nodes on both sides."|Participants|Count of Participants|4|4.0||||||
3861747|NCT01612351|3687397|B1||T1N1|Stage of disease|"Anatomic stage for NSCLC is the American Joint Committee on Cancer (AJCC) primary tumor, regional nodes, metastasis (TNM) system, which is based on:~Size of primary tumor (T) and whether it has grown into nearby areas. Spread to regional lymph nodes (N). Once the categories have been determined, this information is combined into a prognostic group. Higher numbers mean the cancer is more advanced. N1- 1 lymph node on the same side as the original tumor. N2a- Spread to 1 lymph node on the same side. N2b- spread to 2 or more lymph nodes on same side. N2c- 1 or more lymph nodes on both sides."|Participants|Count of Participants|1|1.0||||||
3861748|NCT01612351|3687397|B1||Oropharynx|Disease Location||Participants|Count of Participants|30|30.0||||||
3861749|NCT01612351|3687397|B1||Hypopharynx|Disease Location||Participants|Count of Participants|1|1.0||||||
3861750|NCT01612351|3687397|B1||Oral Cavity|Disease Location||Participants|Count of Participants|4|4.0||||||
3861751|NCT01612351|3687397|B1||Supraglottic Larynx|Disease Location||Participants|Count of Participants|5|5.0||||||
3861752|NCT01612351|3687397|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3861753|NCT01612351|3687397|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3861754|NCT01612351|3687397|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861755|NCT01612351|3687397|B1||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3861756|NCT01612351|3687397|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3861757|NCT01612351|3687397|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861758|NCT01612351|3687397|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861759|NCT01612351|3687397|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861760|NCT01612351|3687397|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861761|NCT01612351|3687397|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3861762|NCT01612351|3687397|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3861763|NCT01612351|3687397|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3861764|NCT01612351|3687397|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3861765|NCT01612351|3687397|B1|||Age||years|Mean|57.5|57.5|Full Range|||41.0|77.0|
3861766|NCT01612221|3687409|B3|United States||Region of Enrollment||Participants|Count of Participants|100|100.0||||||
3861767|NCT01612221|3687410|B2|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3861768|NCT01612221|3687411|B1|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3861769|NCT01612221|3687409|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861770|NCT01612221|3687410|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861771|NCT01612221|3687411|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861772|NCT01612221|3687409|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861773|NCT01612221|3687410|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861774|NCT01612221|3687411|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861775|NCT01612221|3687409|B3||White|Race (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3861776|NCT01612221|3687410|B2||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3861777|NCT01612221|3687411|B1||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3861778|NCT01612221|3687409|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861779|NCT01612221|3687410|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861780|NCT01612221|3687411|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861781|NCT01612221|3687409|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861782|NCT01612221|3687410|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861783|NCT01612221|3687411|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861784|NCT01612221|3687409|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861785|NCT01612221|3687410|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861786|NCT01612221|3687411|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861787|NCT01612221|3687409|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861788|NCT01612221|3687410|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861789|NCT01612221|3687411|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861790|NCT01612221|3687409|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3861791|NCT01612221|3687410|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3861792|NCT01612221|3687411|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3861793|NCT01612221|3687409|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3861794|NCT01612221|3687410|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3861795|NCT01612221|3687411|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3861796|NCT01612221|3687409|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3861797|NCT01612221|3687410|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3861798|NCT01612221|3687411|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3861799|NCT01612221|3687409|B3||Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
3861800|NCT01612221|3687410|B2||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
3861801|NCT01612221|3687411|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3861802|NCT01612221|3687409|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3861803|NCT01612221|3687410|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3861804|NCT01612221|3687411|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3861805|NCT01612156|3687420|B3|||Body mass index||kg/m2|Mean|30.6|30.6|Standard Deviation|4.6|4.6|||
3861806|NCT01612156|3687421|B2|||Body mass index||kg/m2|Mean|30.1|30.1|Standard Deviation|4.7|4.7|||
3861807|NCT01612156|3687422|B1|||Body mass index||kg/m2|Mean|31.1|31.1|Standard Deviation|4.5|4.5|||
3861808|NCT01612156|3687420|B3|||Parity||births|Median|3|3.0|Full Range|||0.0|8.0|
3861809|NCT01612156|3687421|B2|||Parity||births|Median|3|3.0|Full Range|||0.0|8.0|
3861810|NCT01612156|3687422|B1|||Parity||births|Median|3|3.0|Full Range|||0.0|6.0|
3861811|NCT01612156|3687420|B3|Spanish||Language||participants|Number|73|73.0||||||
3861812|NCT01612156|3687421|B2|Spanish||Language||participants|Number|38|38.0||||||
3861813|NCT01612156|3687422|B1|Spanish||Language||participants|Number|35|35.0||||||
3861814|NCT01612156|3687420|B3|English||Language||participants|Number|15|15.0||||||
3861815|NCT01612156|3687421|B2|English||Language||participants|Number|10|10.0||||||
3861816|NCT01612156|3687422|B1|English||Language||participants|Number|5|5.0||||||
3861817|NCT01612156|3687420|B3|Non-Hispanic Caucasian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3861818|NCT01612156|3687421|B2|Non-Hispanic Caucasian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3861819|NCT01612156|3687422|B1|Non-Hispanic Caucasian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3861820|NCT01612156|3687420|B3|African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3861821|NCT01612156|3687421|B2|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3861822|NCT01612156|3687422|B1|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3861823|NCT01612156|3687420|B3|Latina/Hispanic||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
3861824|NCT01612156|3687421|B2|Latina/Hispanic||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
3861825|NCT01612156|3687422|B1|Latina/Hispanic||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
3861826|NCT01612156|3687420|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3861827|NCT01612156|3687421|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3861828|NCT01612156|3687422|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3861829|NCT01612156|3687420|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3861830|NCT01612156|3687421|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3861831|NCT01612156|3687422|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3861832|NCT01612156|3687420|B3|||Age||years|Mean|51.4|51.4|Standard Deviation|9.3|9.3|||
3861833|NCT01612156|3687421|B2|||Age||years|Mean|50.2|50.2|Standard Deviation|9.4|9.4|||
3861834|NCT01612156|3687422|B1|||Age||years|Mean|52.8|52.8|Standard Deviation|9.1|9.1|||
3861835|NCT01612000|3687431|B5|United States||Region of Enrollment||participants|Number|341|341.0||||||
3861836|NCT01612000|3687432|B4|United States||Region of Enrollment||participants|Number|86|86.0||||||
3861837|NCT01612000|3687433|B3|United States||Region of Enrollment||participants|Number|85|85.0||||||
3861838|NCT01612000|3687434|B2|United States||Region of Enrollment||participants|Number|86|86.0||||||
3861839|NCT01612000|3687435|B1|United States||Region of Enrollment||participants|Number|84|84.0||||||
3861840|NCT01612000|3687431|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861841|NCT01612000|3687432|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861842|NCT01612000|3687433|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861843|NCT01612000|3687434|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861844|NCT01612000|3687435|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861845|NCT01612000|3687431|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|299|299.0||||||
3861846|NCT01612000|3687432|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3861847|NCT01612000|3687433|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3861848|NCT01612000|3687434|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
3861849|NCT01612000|3687435|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
3861850|NCT01612000|3687431|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3861851|NCT01612000|3687432|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3861852|NCT01612000|3687433|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3861853|NCT01612000|3687434|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3861854|NCT01612000|3687435|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3861855|NCT01612000|3687431|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3861856|NCT01612000|3687432|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861857|NCT01612000|3687433|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3861858|NCT01612000|3687434|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861859|NCT01612000|3687435|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861860|NCT01612000|3687431|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3861861|NCT01612000|3687432|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861862|NCT01612000|3687433|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3861863|NCT01612000|3687434|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861864|NCT01612000|3687435|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861865|NCT01612000|3687431|B5||White|Race (NIH/OMB)||Participants|Count of Participants|224|224.0||||||
3861866|NCT01612000|3687432|B4||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3861867|NCT01612000|3687433|B3||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3861868|NCT01612000|3687434|B2||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3861869|NCT01612000|3687435|B1||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3861870|NCT01612000|3687431|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3861871|NCT01612000|3687432|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3861872|NCT01612000|3687433|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3861873|NCT01612000|3687434|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3861874|NCT01612000|3687435|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3861875|NCT01612000|3687431|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3861876|NCT01612000|3687432|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861877|NCT01612000|3687433|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3861878|NCT01612000|3687434|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3861879|NCT01612000|3687435|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3861880|NCT01612000|3687431|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3861881|NCT01612000|3687432|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3861882|NCT01612000|3687433|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3861883|NCT01612000|3687434|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3861884|NCT01612000|3687435|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3861885|NCT01612000|3687431|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3861886|NCT01612000|3687432|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3861887|NCT01612000|3687433|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3861888|NCT01612000|3687434|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3861889|NCT01612000|3687435|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3861890|NCT01612000|3687431|B5||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3861891|NCT01612000|3687432|B4||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3861892|NCT01612000|3687433|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3861893|NCT01612000|3687434|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3861894|NCT01612000|3687435|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3861895|NCT01612000|3687431|B5||Female|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
3861896|NCT01612000|3687432|B4||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3861897|NCT01612000|3687433|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3861898|NCT01612000|3687434|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3861899|NCT01612000|3687435|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3861900|NCT01612000|3687431|B5|||Age||years|Mean|31|31.0|Full Range|||18.0|49.0|
3861901|NCT01612000|3687432|B4|||Age||years|Mean|30|30.0|Full Range|||18.0|49.0|
3861902|NCT01612000|3687433|B3|||Age||years|Mean|32|32.0|Full Range|||18.0|49.0|
3861903|NCT01612000|3687434|B2|||Age||years|Mean|31|31.0|Full Range|||18.0|49.0|
3861904|NCT01612000|3687435|B1|||Age||years|Mean|32|32.0|Full Range|||19.0|48.0|
3861905|NCT01611974|3687460|B4||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3861906|NCT01611974|3687461|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3861907|NCT01611974|3687462|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3861908|NCT01611974|3687463|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3861909|NCT01611974|3687460|B4||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3861910|NCT01611974|3687461|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3861911|NCT01611974|3687462|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3861912|NCT01611974|3687463|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3861913|NCT01611974|3687460|B4|65 to 75 years||Age, Customized||participants|Number|25|25.0||||||
3861914|NCT01611974|3687461|B3|65 to 75 years||Age, Customized||participants|Number|6|6.0||||||
3861915|NCT01611974|3687462|B2|65 to 75 years||Age, Customized||participants|Number|12|12.0||||||
3861916|NCT01611974|3687463|B1|65 to 75 years||Age, Customized||participants|Number|7|7.0||||||
3861917|NCT01611974|3687460|B4|45 to 64 years||Age, Customized||participants|Number|60|60.0||||||
3861918|NCT01611974|3687461|B3|45 to 64 years||Age, Customized||participants|Number|20|20.0||||||
3861919|NCT01611974|3687462|B2|45 to 64 years||Age, Customized||participants|Number|18|18.0||||||
3861920|NCT01611974|3687463|B1|45 to 64 years||Age, Customized||participants|Number|22|22.0||||||
3861921|NCT01611974|3687460|B4|18 to 44 years||Age, Customized||participants|Number|35|35.0||||||
3861922|NCT01611974|3687461|B3|18 to 44 years||Age, Customized||participants|Number|14|14.0||||||
3861923|NCT01611974|3687462|B2|18 to 44 years||Age, Customized||participants|Number|10|10.0||||||
3861924|NCT01611974|3687463|B1|18 to 44 years||Age, Customized||participants|Number|11|11.0||||||
3861925|NCT01611974|3687460|B4|||Age||years|Mean|52.5|52.5|Standard Deviation|13.86|13.86|||
3861926|NCT01611974|3687461|B3|||Age||years|Mean|50.0|50.0|Standard Deviation|12.96|12.96|||
3861927|NCT01611974|3687462|B2|||Age||years|Mean|55.4|55.4|Standard Deviation|14.13|14.13|||
3861928|NCT01611974|3687463|B1|||Age||years|Mean|52.1|52.1|Standard Deviation|14.25|14.25|||
3861929|NCT01611948|3687500|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3861930|NCT01611948|3687501|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3861931|NCT01611948|3687502|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3861932|NCT01611948|3687500|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3861933|NCT01611948|3687501|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3861934|NCT01611948|3687502|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3861935|NCT01611948|3687500|B3|||Age||years|Mean|31.69|31.69|Standard Deviation|11.49|11.49|||
3861936|NCT01611948|3687501|B2|||Age||years|Mean|30.50|30.5|Standard Deviation|12.19|12.19|||
3861937|NCT01611948|3687502|B1|||Age||years|Mean|33.09|33.09|Standard Deviation|10.62|10.62|||
3861938|NCT01611883|3687509|B3||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3861939|NCT01611883|3687510|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3861940|NCT01611883|3687511|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3861941|NCT01611883|3687509|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3861942|NCT01611883|3687510|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3861943|NCT01611883|3687511|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3861944|NCT01611883|3687509|B3|||Age||years|Mean|59.6|59.6|Standard Deviation|10.2|10.2|||
3861945|NCT01611883|3687510|B2|||Age||years|Mean|60.0|60.0|Standard Deviation|9.7|9.7|||
3861946|NCT01611883|3687511|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|10.8|10.8|||
3861947|NCT01611857|3687536|B3|Received Prior Radiation: No||Number of Participants with Prior Radiation Therapy||participants|Number|33|33.0||||||
3861948|NCT01611857|3687537|B2|Received Prior Radiation: No||Number of Participants with Prior Radiation Therapy||participants|Number|23|23.0||||||
3861949|NCT01611857|3687538|B1|Received Prior Radiation: No||Number of Participants with Prior Radiation Therapy||participants|Number|10|10.0||||||
3861950|NCT01611857|3687536|B3|Received Prior Radiation: Yes||Number of Participants with Prior Radiation Therapy||participants|Number|16|16.0||||||
3861951|NCT01611857|3687537|B2|Received Prior Radiation: Yes||Number of Participants with Prior Radiation Therapy||participants|Number|11|11.0||||||
3861952|NCT01611857|3687538|B1|Received Prior Radiation: Yes||Number of Participants with Prior Radiation Therapy||participants|Number|5|5.0||||||
3861953|NCT01611857|3687536|B3|Unknown||Karnofsky Performance Score|Karnofsky Score: 100 (no complaints), 90 (able to carry on normal activities, minor signs/symptoms of disease), 80 (normal activity with effort), 70 (care for self, unable to carry on normal activity or to do active work), 60 (requires occasional assistance, but able to care for most needs), 50 (requires considerable assistance and frequent medical care), 40 (disabled, requires special care and assistance), 30 (severely disabled, hospitalisation indicated though death not imminent), 20 (very sick, hospitalisation necessary, active supportive treatment necessary), 10 (moribund), 0 (dead).|participants|Number|1|1.0||||||
3861954|NCT01611857|3687537|B2|Unknown||Karnofsky Performance Score|Karnofsky Score: 100 (no complaints), 90 (able to carry on normal activities, minor signs/symptoms of disease), 80 (normal activity with effort), 70 (care for self, unable to carry on normal activity or to do active work), 60 (requires occasional assistance, but able to care for most needs), 50 (requires considerable assistance and frequent medical care), 40 (disabled, requires special care and assistance), 30 (severely disabled, hospitalisation indicated though death not imminent), 20 (very sick, hospitalisation necessary, active supportive treatment necessary), 10 (moribund), 0 (dead).|participants|Number|1|1.0||||||
3861955|NCT01611857|3687538|B1|Unknown||Karnofsky Performance Score|Karnofsky Score: 100 (no complaints), 90 (able to carry on normal activities, minor signs/symptoms of disease), 80 (normal activity with effort), 70 (care for self, unable to carry on normal activity or to do active work), 60 (requires occasional assistance, but able to care for most needs), 50 (requires considerable assistance and frequent medical care), 40 (disabled, requires special care and assistance), 30 (severely disabled, hospitalisation indicated though death not imminent), 20 (very sick, hospitalisation necessary, active supportive treatment necessary), 10 (moribund), 0 (dead).|participants|Number|0|0.0||||||
3861956|NCT01611857|3687536|B3|0||Karnofsky Performance Score|Karnofsky Score: 100 (no complaints), 90 (able to carry on normal activities, minor signs/symptoms of disease), 80 (normal activity with effort), 70 (care for self, unable to carry on normal activity or to do active work), 60 (requires occasional assistance, but able to care for most needs), 50 (requires considerable assistance and frequent medical care), 40 (disabled, requires special care and assistance), 30 (severely disabled, hospitalisation indicated though death not imminent), 20 (very sick, hospitalisation necessary, active supportive treatment necessary), 10 (moribund), 0 (dead).|participants|Number|0|0.0||||||
3861957|NCT01611857|3687537|B2|0||Karnofsky Performance Score|Karnofsky Score: 100 (no complaints), 90 (able to carry on normal activities, minor signs/symptoms of disease), 80 (normal activity with effort), 70 (care for self, unable to carry on normal activity or to do active work), 60 (requires occasional assistance, but able to care for most needs), 50 (requires considerable assistance and frequent medical care), 40 (disabled, requires special care and assistance), 30 (severely disabled, hospitalisation indicated though death not imminent), 20 (very sick, hospitalisation necessary, active supportive treatment necessary), 10 (moribund), 0 (dead).|participants|Number|0|0.0||||||
3861958|NCT01611857|3687538|B1|0||Karnofsky Performance Score|Karnofsky Score: 100 (no complaints), 90 (able to carry on normal activities, minor signs/symptoms of disease), 80 (normal activity with effort), 70 (care for self, unable to carry on normal activity or to do active work), 60 (requires occasional assistance, but able to care for most needs), 50 (requires considerable assistance and frequent medical care), 40 (disabled, requires special care and assistance), 30 (severely disabled, hospitalisation indicated though death not imminent), 20 (very sick, hospitalisation necessary, active supportive treatment necessary), 10 (moribund), 0 (dead).|participants|Number|0|0.0||||||
3861959|NCT01611857|3687536|B3|10||Karnofsky Performance Score|Karnofsky Score: 100 (no complaints), 90 (able to carry on normal activities, minor signs/symptoms of disease), 80 (normal activity with effort), 70 (care for self, unable to carry on normal activity or to do active work), 60 (requires occasional assistance, but able to care for most needs), 50 (requires considerable assistance and frequent medical care), 40 (disabled, requires special care and assistance), 30 (severely disabled, hospitalisation indicated though death not imminent), 20 (very sick, hospitalisation necessary, active supportive treatment necessary), 10 (moribund), 0 (dead).|participants|Number|0|0.0||||||
3861960|NCT01611857|3687537|B2|10||Karnofsky Performance Score|Karnofsky Score: 100 (no complaints), 90 (able to carry on normal activities, minor signs/symptoms of disease), 80 (normal activity with effort), 70 (care for self, unable to carry on normal activity or to do active work), 60 (requires occasional assistance, but able to care for most needs), 50 (requires considerable assistance and frequent medical care), 40 (disabled, requires special care and assistance), 30 (severely disabled, hospitalisation indicated though death not imminent), 20 (very sick, hospitalisation necessary, active supportive treatment necessary), 10 (moribund), 0 (dead).|participants|Number|0|0.0||||||
3861961|NCT01611857|3687538|B1|10||Karnofsky Performance Score|Karnofsky Score: 100 (no complaints), 90 (able to carry on normal activities, minor signs/symptoms of disease), 80 (normal activity with effort), 70 (care for self, unable to carry on normal activity or to do active work), 60 (requires occasional assistance, but able to care for most needs), 50 (requires considerable assistance and frequent medical care), 40 (disabled, requires special care and assistance), 30 (severely disabled, hospitalisation indicated though death not imminent), 20 (very sick, hospitalisation necessary, active supportive treatment necessary), 10 (moribund), 0 (dead).|participants|Number|0|0.0||||||
3861962|NCT01611857|3687536|B3|20||Karnofsky Performance Score|Karnofsky Score: 100 (no complaints), 90 (able to carry on normal activities, minor signs/symptoms of disease), 80 (normal activity with effort), 70 (care for self, unable to carry on normal activity or to do active work), 60 (requires occasional assistance, but able to care for most needs), 50 (requires considerable assistance and frequent medical care), 40 (disabled, requires special care and assistance), 30 (severely disabled, hospitalisation indicated though death not imminent), 20 (very sick, hospitalisation necessary, active supportive treatment necessary), 10 (moribund), 0 (dead).|participants|Number|0|0.0||||||
3861963|NCT01611857|3687537|B2|20||Karnofsky Performance Score|Karnofsky Score: 100 (no complaints), 90 (able to carry on normal activities, minor signs/symptoms of disease), 80 (normal activity with effort), 70 (care for self, unable to carry on normal activity or to do active work), 60 (requires occasional assistance, but able to care for most needs), 50 (requires considerable assistance and frequent medical care), 40 (disabled, requires special care and assistance), 30 (severely disabled, hospitalisation indicated though death not imminent), 20 (very sick, hospitalisation necessary, active supportive treatment necessary), 10 (moribund), 0 (dead).|participants|Number|0|0.0||||||
3862086|NCT01611571|3687581|B4||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3861964|NCT01611857|3687538|B1|20||Karnofsky Performance Score|Karnofsky Score: 100 (no complaints), 90 (able to carry on normal activities, minor signs/symptoms of disease), 80 (normal activity with effort), 70 (care for self, unable to carry on normal activity or to do active work), 60 (requires occasional assistance, but able to care for most needs), 50 (requires considerable assistance and frequent medical care), 40 (disabled, requires special care and assistance), 30 (severely disabled, hospitalisation indicated though death not imminent), 20 (very sick, hospitalisation necessary, active supportive treatment necessary), 10 (moribund), 0 (dead).|participants|Number|0|0.0||||||
3861965|NCT01611857|3687536|B3|30||Karnofsky Performance Score|Karnofsky Score: 100 (no complaints), 90 (able to carry on normal activities, minor signs/symptoms of disease), 80 (normal activity with effort), 70 (care for self, unable to carry on normal activity or to do active work), 60 (requires occasional assistance, but able to care for most needs), 50 (requires considerable assistance and frequent medical care), 40 (disabled, requires special care and assistance), 30 (severely disabled, hospitalisation indicated though death not imminent), 20 (very sick, hospitalisation necessary, active supportive treatment necessary), 10 (moribund), 0 (dead).|participants|Number|0|0.0||||||
3861966|NCT01611857|3687537|B2|30||Karnofsky Performance Score|Karnofsky Score: 100 (no complaints), 90 (able to carry on normal activities, minor signs/symptoms of disease), 80 (normal activity with effort), 70 (care for self, unable to carry on normal activity or to do active work), 60 (requires occasional assistance, but able to care for most needs), 50 (requires considerable assistance and frequent medical care), 40 (disabled, requires special care and assistance), 30 (severely disabled, hospitalisation indicated though death not imminent), 20 (very sick, hospitalisation necessary, active supportive treatment necessary), 10 (moribund), 0 (dead).|participants|Number|0|0.0||||||
3861967|NCT01611857|3687538|B1|30||Karnofsky Performance Score|Karnofsky Score: 100 (no complaints), 90 (able to carry on normal activities, minor signs/symptoms of disease), 80 (normal activity with effort), 70 (care for self, unable to carry on normal activity or to do active work), 60 (requires occasional assistance, but able to care for most needs), 50 (requires considerable assistance and frequent medical care), 40 (disabled, requires special care and assistance), 30 (severely disabled, hospitalisation indicated though death not imminent), 20 (very sick, hospitalisation necessary, active supportive treatment necessary), 10 (moribund), 0 (dead).|participants|Number|0|0.0||||||
3861968|NCT01611857|3687536|B3|40||Karnofsky Performance Score|Karnofsky Score: 100 (no complaints), 90 (able to carry on normal activities, minor signs/symptoms of disease), 80 (normal activity with effort), 70 (care for self, unable to carry on normal activity or to do active work), 60 (requires occasional assistance, but able to care for most needs), 50 (requires considerable assistance and frequent medical care), 40 (disabled, requires special care and assistance), 30 (severely disabled, hospitalisation indicated though death not imminent), 20 (very sick, hospitalisation necessary, active supportive treatment necessary), 10 (moribund), 0 (dead).|participants|Number|0|0.0||||||
3861969|NCT01611857|3687537|B2|40||Karnofsky Performance Score|Karnofsky Score: 100 (no complaints), 90 (able to carry on normal activities, minor signs/symptoms of disease), 80 (normal activity with effort), 70 (care for self, unable to carry on normal activity or to do active work), 60 (requires occasional assistance, but able to care for most needs), 50 (requires considerable assistance and frequent medical care), 40 (disabled, requires special care and assistance), 30 (severely disabled, hospitalisation indicated though death not imminent), 20 (very sick, hospitalisation necessary, active supportive treatment necessary), 10 (moribund), 0 (dead).|participants|Number|0|0.0||||||
3861970|NCT01611857|3687538|B1|40||Karnofsky Performance Score|Karnofsky Score: 100 (no complaints), 90 (able to carry on normal activities, minor signs/symptoms of disease), 80 (normal activity with effort), 70 (care for self, unable to carry on normal activity or to do active work), 60 (requires occasional assistance, but able to care for most needs), 50 (requires considerable assistance and frequent medical care), 40 (disabled, requires special care and assistance), 30 (severely disabled, hospitalisation indicated though death not imminent), 20 (very sick, hospitalisation necessary, active supportive treatment necessary), 10 (moribund), 0 (dead).|participants|Number|0|0.0||||||
3861971|NCT01611857|3687536|B3|50||Karnofsky Performance Score|Karnofsky Score: 100 (no complaints), 90 (able to carry on normal activities, minor signs/symptoms of disease), 80 (normal activity with effort), 70 (care for self, unable to carry on normal activity or to do active work), 60 (requires occasional assistance, but able to care for most needs), 50 (requires considerable assistance and frequent medical care), 40 (disabled, requires special care and assistance), 30 (severely disabled, hospitalisation indicated though death not imminent), 20 (very sick, hospitalisation necessary, active supportive treatment necessary), 10 (moribund), 0 (dead).|participants|Number|0|0.0||||||
3861972|NCT01611857|3687537|B2|50||Karnofsky Performance Score|Karnofsky Score: 100 (no complaints), 90 (able to carry on normal activities, minor signs/symptoms of disease), 80 (normal activity with effort), 70 (care for self, unable to carry on normal activity or to do active work), 60 (requires occasional assistance, but able to care for most needs), 50 (requires considerable assistance and frequent medical care), 40 (disabled, requires special care and assistance), 30 (severely disabled, hospitalisation indicated though death not imminent), 20 (very sick, hospitalisation necessary, active supportive treatment necessary), 10 (moribund), 0 (dead).|participants|Number|0|0.0||||||
3861973|NCT01611857|3687538|B1|50||Karnofsky Performance Score|Karnofsky Score: 100 (no complaints), 90 (able to carry on normal activities, minor signs/symptoms of disease), 80 (normal activity with effort), 70 (care for self, unable to carry on normal activity or to do active work), 60 (requires occasional assistance, but able to care for most needs), 50 (requires considerable assistance and frequent medical care), 40 (disabled, requires special care and assistance), 30 (severely disabled, hospitalisation indicated though death not imminent), 20 (very sick, hospitalisation necessary, active supportive treatment necessary), 10 (moribund), 0 (dead).|participants|Number|0|0.0||||||
3861974|NCT01611857|3687536|B3|60||Karnofsky Performance Score|Karnofsky Score: 100 (no complaints), 90 (able to carry on normal activities, minor signs/symptoms of disease), 80 (normal activity with effort), 70 (care for self, unable to carry on normal activity or to do active work), 60 (requires occasional assistance, but able to care for most needs), 50 (requires considerable assistance and frequent medical care), 40 (disabled, requires special care and assistance), 30 (severely disabled, hospitalisation indicated though death not imminent), 20 (very sick, hospitalisation necessary, active supportive treatment necessary), 10 (moribund), 0 (dead).|participants|Number|0|0.0||||||
3862087|NCT01611571|3687582|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3861975|NCT01611857|3687537|B2|60||Karnofsky Performance Score|Karnofsky Score: 100 (no complaints), 90 (able to carry on normal activities, minor signs/symptoms of disease), 80 (normal activity with effort), 70 (care for self, unable to carry on normal activity or to do active work), 60 (requires occasional assistance, but able to care for most needs), 50 (requires considerable assistance and frequent medical care), 40 (disabled, requires special care and assistance), 30 (severely disabled, hospitalisation indicated though death not imminent), 20 (very sick, hospitalisation necessary, active supportive treatment necessary), 10 (moribund), 0 (dead).|participants|Number|0|0.0||||||
3861976|NCT01611857|3687538|B1|60||Karnofsky Performance Score|Karnofsky Score: 100 (no complaints), 90 (able to carry on normal activities, minor signs/symptoms of disease), 80 (normal activity with effort), 70 (care for self, unable to carry on normal activity or to do active work), 60 (requires occasional assistance, but able to care for most needs), 50 (requires considerable assistance and frequent medical care), 40 (disabled, requires special care and assistance), 30 (severely disabled, hospitalisation indicated though death not imminent), 20 (very sick, hospitalisation necessary, active supportive treatment necessary), 10 (moribund), 0 (dead).|participants|Number|0|0.0||||||
3861977|NCT01611857|3687536|B3|70||Karnofsky Performance Score|Karnofsky Score: 100 (no complaints), 90 (able to carry on normal activities, minor signs/symptoms of disease), 80 (normal activity with effort), 70 (care for self, unable to carry on normal activity or to do active work), 60 (requires occasional assistance, but able to care for most needs), 50 (requires considerable assistance and frequent medical care), 40 (disabled, requires special care and assistance), 30 (severely disabled, hospitalisation indicated though death not imminent), 20 (very sick, hospitalisation necessary, active supportive treatment necessary), 10 (moribund), 0 (dead).|participants|Number|5|5.0||||||
3861978|NCT01611857|3687537|B2|70||Karnofsky Performance Score|Karnofsky Score: 100 (no complaints), 90 (able to carry on normal activities, minor signs/symptoms of disease), 80 (normal activity with effort), 70 (care for self, unable to carry on normal activity or to do active work), 60 (requires occasional assistance, but able to care for most needs), 50 (requires considerable assistance and frequent medical care), 40 (disabled, requires special care and assistance), 30 (severely disabled, hospitalisation indicated though death not imminent), 20 (very sick, hospitalisation necessary, active supportive treatment necessary), 10 (moribund), 0 (dead).|participants|Number|5|5.0||||||
3861979|NCT01611857|3687538|B1|70||Karnofsky Performance Score|Karnofsky Score: 100 (no complaints), 90 (able to carry on normal activities, minor signs/symptoms of disease), 80 (normal activity with effort), 70 (care for self, unable to carry on normal activity or to do active work), 60 (requires occasional assistance, but able to care for most needs), 50 (requires considerable assistance and frequent medical care), 40 (disabled, requires special care and assistance), 30 (severely disabled, hospitalisation indicated though death not imminent), 20 (very sick, hospitalisation necessary, active supportive treatment necessary), 10 (moribund), 0 (dead).|participants|Number|0|0.0||||||
3861980|NCT01611857|3687536|B3|80||Karnofsky Performance Score|Karnofsky Score: 100 (no complaints), 90 (able to carry on normal activities, minor signs/symptoms of disease), 80 (normal activity with effort), 70 (care for self, unable to carry on normal activity or to do active work), 60 (requires occasional assistance, but able to care for most needs), 50 (requires considerable assistance and frequent medical care), 40 (disabled, requires special care and assistance), 30 (severely disabled, hospitalisation indicated though death not imminent), 20 (very sick, hospitalisation necessary, active supportive treatment necessary), 10 (moribund), 0 (dead).|participants|Number|13|13.0||||||
3861981|NCT01611857|3687537|B2|80||Karnofsky Performance Score|Karnofsky Score: 100 (no complaints), 90 (able to carry on normal activities, minor signs/symptoms of disease), 80 (normal activity with effort), 70 (care for self, unable to carry on normal activity or to do active work), 60 (requires occasional assistance, but able to care for most needs), 50 (requires considerable assistance and frequent medical care), 40 (disabled, requires special care and assistance), 30 (severely disabled, hospitalisation indicated though death not imminent), 20 (very sick, hospitalisation necessary, active supportive treatment necessary), 10 (moribund), 0 (dead).|participants|Number|3|3.0||||||
3861982|NCT01611857|3687538|B1|80||Karnofsky Performance Score|Karnofsky Score: 100 (no complaints), 90 (able to carry on normal activities, minor signs/symptoms of disease), 80 (normal activity with effort), 70 (care for self, unable to carry on normal activity or to do active work), 60 (requires occasional assistance, but able to care for most needs), 50 (requires considerable assistance and frequent medical care), 40 (disabled, requires special care and assistance), 30 (severely disabled, hospitalisation indicated though death not imminent), 20 (very sick, hospitalisation necessary, active supportive treatment necessary), 10 (moribund), 0 (dead).|participants|Number|10|10.0||||||
3861983|NCT01611857|3687536|B3|90||Karnofsky Performance Score|Karnofsky Score: 100 (no complaints), 90 (able to carry on normal activities, minor signs/symptoms of disease), 80 (normal activity with effort), 70 (care for self, unable to carry on normal activity or to do active work), 60 (requires occasional assistance, but able to care for most needs), 50 (requires considerable assistance and frequent medical care), 40 (disabled, requires special care and assistance), 30 (severely disabled, hospitalisation indicated though death not imminent), 20 (very sick, hospitalisation necessary, active supportive treatment necessary), 10 (moribund), 0 (dead).|participants|Number|21|21.0||||||
3861984|NCT01611857|3687537|B2|90||Karnofsky Performance Score|Karnofsky Score: 100 (no complaints), 90 (able to carry on normal activities, minor signs/symptoms of disease), 80 (normal activity with effort), 70 (care for self, unable to carry on normal activity or to do active work), 60 (requires occasional assistance, but able to care for most needs), 50 (requires considerable assistance and frequent medical care), 40 (disabled, requires special care and assistance), 30 (severely disabled, hospitalisation indicated though death not imminent), 20 (very sick, hospitalisation necessary, active supportive treatment necessary), 10 (moribund), 0 (dead).|participants|Number|18|18.0||||||
3861985|NCT01611857|3687538|B1|90||Karnofsky Performance Score|Karnofsky Score: 100 (no complaints), 90 (able to carry on normal activities, minor signs/symptoms of disease), 80 (normal activity with effort), 70 (care for self, unable to carry on normal activity or to do active work), 60 (requires occasional assistance, but able to care for most needs), 50 (requires considerable assistance and frequent medical care), 40 (disabled, requires special care and assistance), 30 (severely disabled, hospitalisation indicated though death not imminent), 20 (very sick, hospitalisation necessary, active supportive treatment necessary), 10 (moribund), 0 (dead).|participants|Number|3|3.0||||||
3862088|NCT01611571|3687583|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3861986|NCT01611857|3687536|B3|100||Karnofsky Performance Score|Karnofsky Score: 100 (no complaints), 90 (able to carry on normal activities, minor signs/symptoms of disease), 80 (normal activity with effort), 70 (care for self, unable to carry on normal activity or to do active work), 60 (requires occasional assistance, but able to care for most needs), 50 (requires considerable assistance and frequent medical care), 40 (disabled, requires special care and assistance), 30 (severely disabled, hospitalisation indicated though death not imminent), 20 (very sick, hospitalisation necessary, active supportive treatment necessary), 10 (moribund), 0 (dead).|participants|Number|9|9.0||||||
3861987|NCT01611857|3687537|B2|100||Karnofsky Performance Score|Karnofsky Score: 100 (no complaints), 90 (able to carry on normal activities, minor signs/symptoms of disease), 80 (normal activity with effort), 70 (care for self, unable to carry on normal activity or to do active work), 60 (requires occasional assistance, but able to care for most needs), 50 (requires considerable assistance and frequent medical care), 40 (disabled, requires special care and assistance), 30 (severely disabled, hospitalisation indicated though death not imminent), 20 (very sick, hospitalisation necessary, active supportive treatment necessary), 10 (moribund), 0 (dead).|participants|Number|7|7.0||||||
3861988|NCT01611857|3687538|B1|100||Karnofsky Performance Score|Karnofsky Score: 100 (no complaints), 90 (able to carry on normal activities, minor signs/symptoms of disease), 80 (normal activity with effort), 70 (care for self, unable to carry on normal activity or to do active work), 60 (requires occasional assistance, but able to care for most needs), 50 (requires considerable assistance and frequent medical care), 40 (disabled, requires special care and assistance), 30 (severely disabled, hospitalisation indicated though death not imminent), 20 (very sick, hospitalisation necessary, active supportive treatment necessary), 10 (moribund), 0 (dead).|participants|Number|2|2.0||||||
3861989|NCT01611857|3687536|B3|Gastric||Tumor Type|Participants enrolled per tumor type.|participants|Number|11|11.0||||||
3861990|NCT01611857|3687537|B2|Gastric||Tumor Type|Participants enrolled per tumor type.|participants|Number|11|11.0||||||
3861991|NCT01611857|3687538|B1|Gastric||Tumor Type|Participants enrolled per tumor type.|participants|Number|0|0.0||||||
3861992|NCT01611857|3687536|B3|Unknown primary||Tumor Type|Participants enrolled per tumor type.|participants|Number|1|1.0||||||
3861993|NCT01611857|3687537|B2|Unknown primary||Tumor Type|Participants enrolled per tumor type.|participants|Number|0|0.0||||||
3861994|NCT01611857|3687538|B1|Unknown primary||Tumor Type|Participants enrolled per tumor type.|participants|Number|1|1.0||||||
3861995|NCT01611857|3687536|B3|Cholangiocarcinoma||Tumor Type|Participants enrolled per tumor type.|participants|Number|1|1.0||||||
3861996|NCT01611857|3687537|B2|Cholangiocarcinoma||Tumor Type|Participants enrolled per tumor type.|participants|Number|0|0.0||||||
3861997|NCT01611857|3687538|B1|Cholangiocarcinoma||Tumor Type|Participants enrolled per tumor type.|participants|Number|1|1.0||||||
3861998|NCT01611857|3687536|B3|GE Junction||Tumor Type|Participants enrolled per tumor type.|participants|Number|10|10.0||||||
3861999|NCT01611857|3687537|B2|GE Junction||Tumor Type|Participants enrolled per tumor type.|participants|Number|9|9.0||||||
3862000|NCT01611857|3687538|B1|GE Junction||Tumor Type|Participants enrolled per tumor type.|participants|Number|1|1.0||||||
3862001|NCT01611857|3687536|B3|Pancreatic||Tumor Type|Participants enrolled per tumor type.|participants|Number|1|1.0||||||
3862002|NCT01611857|3687537|B2|Pancreatic||Tumor Type|Participants enrolled per tumor type.|participants|Number|0|0.0||||||
3862003|NCT01611857|3687538|B1|Pancreatic||Tumor Type|Participants enrolled per tumor type.|participants|Number|1|1.0||||||
3862004|NCT01611857|3687536|B3|Esophageal||Tumor Type|Participants enrolled per tumor type.|participants|Number|18|18.0||||||
3862005|NCT01611857|3687537|B2|Esophageal||Tumor Type|Participants enrolled per tumor type.|participants|Number|14|14.0||||||
3862006|NCT01611857|3687538|B1|Esophageal||Tumor Type|Participants enrolled per tumor type.|participants|Number|4|4.0||||||
3862007|NCT01611857|3687536|B3|Colorectal||Tumor Type|Participants enrolled per tumor type.|participants|Number|7|7.0||||||
3862008|NCT01611857|3687537|B2|Colorectal||Tumor Type|Participants enrolled per tumor type.|participants|Number|0|0.0||||||
3862009|NCT01611857|3687538|B1|Colorectal||Tumor Type|Participants enrolled per tumor type.|participants|Number|7|7.0||||||
3862010|NCT01611857|3687536|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
3862011|NCT01611857|3687537|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
3862012|NCT01611857|3687538|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3862013|NCT01611857|3687536|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3862014|NCT01611857|3687537|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3862015|NCT01611857|3687538|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3862016|NCT01611857|3687536|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3862017|NCT01611857|3687537|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3862018|NCT01611857|3687538|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3862019|NCT01611857|3687536|B3|||Age||years|Median|63.5|63.5|Full Range|||33.0|88.0|
3862020|NCT01611857|3687537|B2|||Age||years|Median|65|65.0|Full Range|||34.0|88.0|
3862021|NCT01611857|3687538|B1|||Age||years|Median|62|62.0|Full Range|||33.0|72.0|
3862022|NCT01611792|3687549|B3|||Modified Oswestry Disability Index|Disability; Sacle 0-100%; Lower score is considered better/improve; Collected on paper; patient self-report|units on a scale|Mean|20.8|20.8|Standard Deviation|8.4|8.4|||
3862023|NCT01611792|3687550|B2|||Modified Oswestry Disability Index|Disability; Sacle 0-100%; Lower score is considered better/improve; Collected on paper; patient self-report|units on a scale|Mean|20.1|20.1|Standard Deviation|7.8|7.8|||
3862024|NCT01611792|3687551|B1|||Modified Oswestry Disability Index|Disability; Sacle 0-100%; Lower score is considered better/improve; Collected on paper; patient self-report|units on a scale|Mean|22.3|22.3|Standard Deviation|9.7|9.7|||
3862025|NCT01611792|3687549|B3|||Numeric Pain Index|Current Pain; Scale 0-10; Lower score is better/improved; Collected on paper; patient self-report|units on a scale|Mean|3.2|3.2|Standard Deviation|1.3|1.3|||
3862258|NCT01610752|3687678|B2||Some high school|Education||Participants|Count of Participants|0|0.0||||||
3862026|NCT01611792|3687550|B2|||Numeric Pain Index|Current Pain; Scale 0-10; Lower score is better/improved; Collected on paper; patient self-report|units on a scale|Mean|3.2|3.2|Standard Deviation|1.5|1.5|||
3862027|NCT01611792|3687551|B1|||Numeric Pain Index|Current Pain; Scale 0-10; Lower score is better/improved; Collected on paper; patient self-report|units on a scale|Mean|3.7|3.7|Standard Deviation|1.7|1.7|||
3862028|NCT01611792|3687549|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
3862029|NCT01611792|3687550|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3862030|NCT01611792|3687551|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3862031|NCT01611792|3687549|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3862032|NCT01611792|3687550|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3862033|NCT01611792|3687551|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3862034|NCT01611792|3687549|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3862035|NCT01611792|3687550|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3862036|NCT01611792|3687551|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3862037|NCT01611792|3687549|B3|||Age||years|Mean|40.9|40.9|Standard Deviation|8.3|8.3|||
3862038|NCT01611792|3687550|B2|||Age||years|Mean|41.2|41.2|Standard Deviation|7.9|7.9|||
3862039|NCT01611792|3687551|B1|||Age||years|Mean|40.1|40.1|Standard Deviation|8.3|8.3|||
3862040|NCT01611792|3687549|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3862041|NCT01611792|3687550|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3862042|NCT01611792|3687551|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3862043|NCT01611792|3687549|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3862044|NCT01611792|3687550|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3862045|NCT01611792|3687551|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3862046|NCT01611792|3687549|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3862047|NCT01611792|3687550|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3862048|NCT01611792|3687551|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3862049|NCT01611779|3687568|B1|||Prior OSA Surgery||Participants|Count of Participants|5|5.0||||||
3862050|NCT01611779|3687568|B1|||Body Mass Index (BMI)||kg/m^2|Mean|26.98|26.98|Standard Deviation|3.78|3.78|||
3862051|NCT01611779|3687568|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3862052|NCT01611779|3687568|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862053|NCT01611779|3687568|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3862054|NCT01611779|3687568|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3862055|NCT01611779|3687568|B1||Male|Gender||Participants|Count of Participants|4|4.0||||||
3862056|NCT01611779|3687568|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
3862057|NCT01611779|3687568|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3862058|NCT01611779|3687568|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3862059|NCT01611779|3687568|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3862060|NCT01611662|3687577|B1||T4aN0Mo/TxN1M0|Baseline clinical stage||Participants|Count of Participants|5|5.0||||||
3862061|NCT01611662|3687577|B1||T3N0M0|Baseline clinical stage||Participants|Count of Participants|15|15.0||||||
3862062|NCT01611662|3687577|B1||T2N0M0|Baseline clinical stage||Participants|Count of Participants|11|11.0||||||
3862063|NCT01611662|3687577|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3862064|NCT01611662|3687577|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3862065|NCT01611662|3687577|B1|||Age||years|Median|69|69.0|Full Range|||51.0|82.0|
3862066|NCT01611571|3687581|B4|United States||Region of Enrollment||participants|Number|31|31.0||||||
3862067|NCT01611571|3687582|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3862068|NCT01611571|3687583|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3862069|NCT01611571|3687584|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3862070|NCT01611571|3687581|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3862071|NCT01611571|3687582|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3862072|NCT01611571|3687583|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3862073|NCT01611571|3687584|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3862074|NCT01611571|3687581|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3862075|NCT01611571|3687582|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3862076|NCT01611571|3687583|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3862077|NCT01611571|3687584|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3862078|NCT01611571|3687581|B4|||Age||years|Mean|51.6|51.6|Standard Deviation|3.9|3.9|||
3862079|NCT01611571|3687582|B3|||Age||years|Mean|51.6|51.6|Standard Deviation|3.9|3.9|||
3862080|NCT01611571|3687583|B2|||Age||years|Mean|54|54.0|Standard Deviation|2|2.0|||
3862081|NCT01611571|3687584|B1|||Age||years|Mean|56.7|56.7|Standard Deviation|4.9|4.9|||
3862082|NCT01611571|3687581|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3862083|NCT01611571|3687582|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3862084|NCT01611571|3687583|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3862085|NCT01611571|3687584|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3862089|NCT01611571|3687584|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3862090|NCT01611571|3687581|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3862091|NCT01611571|3687582|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3862092|NCT01611571|3687583|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3862093|NCT01611571|3687584|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3862094|NCT01611558|3687606|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3862095|NCT01611558|3687606|B1|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3862096|NCT01611558|3687606|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3862097|NCT01611558|3687606|B1|White||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
3862098|NCT01611558|3687606|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862099|NCT01611558|3687606|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3862100|NCT01611558|3687606|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3862101|NCT01611558|3687606|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3862102|NCT01611558|3687606|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3862103|NCT01611558|3687606|B1|65 years and older||Age, Customized||Participants|Number|12|12.0||||||
3862104|NCT01611558|3687606|B1|Younger than 65 years||Age, Customized||Participants|Number|28|28.0||||||
3862105|NCT01611558|3687606|B1|||Age||Years|Median|61.5|61.5|Full Range|||42.0|74.0|
3862106|NCT01611259|3687612|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3862107|NCT01611259|3687612|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3862108|NCT01611259|3687612|B1|||Age||years|Median|65|65.0|Full Range|||33.0|85.0|
3862109|NCT01611194|3687616|B3|Physical therapy||Common Alternative Therapy Usage||participants|Number|34|34.0||||||
3862110|NCT01611194|3687617|B2|Physical therapy||Common Alternative Therapy Usage||participants|Number|20|20.0||||||
3862111|NCT01611194|3687618|B1|Physical therapy||Common Alternative Therapy Usage||participants|Number|14|14.0||||||
3862112|NCT01611194|3687616|B3|Counseling||Common Alternative Therapy Usage||participants|Number|28|28.0||||||
3862113|NCT01611194|3687617|B2|Counseling||Common Alternative Therapy Usage||participants|Number|12|12.0||||||
3862114|NCT01611194|3687618|B1|Counseling||Common Alternative Therapy Usage||participants|Number|16|16.0||||||
3862115|NCT01611194|3687616|B3|Psychotherapy||Common Alternative Therapy Usage||participants|Number|19|19.0||||||
3862116|NCT01611194|3687617|B2|Psychotherapy||Common Alternative Therapy Usage||participants|Number|7|7.0||||||
3862117|NCT01611194|3687618|B1|Psychotherapy||Common Alternative Therapy Usage||participants|Number|12|12.0||||||
3862118|NCT01611194|3687616|B3|Fish oil or omega-3 fatty acid||Common Medication Usage||participants|Number|17|17.0||||||
3862119|NCT01611194|3687617|B2|Fish oil or omega-3 fatty acid||Common Medication Usage||participants|Number|8|8.0||||||
3862120|NCT01611194|3687618|B1|Fish oil or omega-3 fatty acid||Common Medication Usage||participants|Number|9|9.0||||||
3862121|NCT01611194|3687616|B3|Episodic migraine medication||Common Medication Usage||participants|Number|30|30.0||||||
3862122|NCT01611194|3687617|B2|Episodic migraine medication||Common Medication Usage||participants|Number|14|14.0||||||
3862123|NCT01611194|3687618|B1|Episodic migraine medication||Common Medication Usage||participants|Number|16|16.0||||||
3862124|NCT01611194|3687616|B3|Daily pain medication||Common Medication Usage||participants|Number|43|43.0||||||
3862125|NCT01611194|3687617|B2|Daily pain medication||Common Medication Usage||participants|Number|21|21.0||||||
3862126|NCT01611194|3687618|B1|Daily pain medication||Common Medication Usage||participants|Number|22|22.0||||||
3862127|NCT01611194|3687616|B3|Hypnotic or sleep aid||Common Medication Usage||participants|Number|31|31.0||||||
3862128|NCT01611194|3687617|B2|Hypnotic or sleep aid||Common Medication Usage||participants|Number|15|15.0||||||
3862129|NCT01611194|3687618|B1|Hypnotic or sleep aid||Common Medication Usage||participants|Number|16|16.0||||||
3862130|NCT01611194|3687616|B3|SSRI/SNRIs||Common Medication Usage||participants|Number|22|22.0||||||
3862131|NCT01611194|3687617|B2|SSRI/SNRIs||Common Medication Usage||participants|Number|10|10.0||||||
3862132|NCT01611194|3687618|B1|SSRI/SNRIs||Common Medication Usage||participants|Number|12|12.0||||||
3862133|NCT01611194|3687616|B3|||Number of Combat Deployments||deployments|Mean|2.8|2.8|Standard Deviation|2.4|2.4|||
3862134|NCT01611194|3687617|B2|||Number of Combat Deployments||deployments|Mean|2.2|2.2|Standard Deviation|1.7|1.7|||
3862135|NCT01611194|3687618|B1|||Number of Combat Deployments||deployments|Mean|3.4|3.4|Standard Deviation|2.8|2.8|||
3862136|NCT01611194|3687616|B3||Navy, Air Force, and Coast Guard|Military Branch||Participants|Count of Participants|4|4.0||||||
3862137|NCT01611194|3687617|B2||Navy, Air Force, and Coast Guard|Military Branch||Participants|Count of Participants|2|2.0||||||
3862138|NCT01611194|3687618|B1||Navy, Air Force, and Coast Guard|Military Branch||Participants|Count of Participants|2|2.0||||||
3862139|NCT01611194|3687616|B3||Marines|Military Branch||Participants|Count of Participants|12|12.0||||||
3862140|NCT01611194|3687617|B2||Marines|Military Branch||Participants|Count of Participants|5|5.0||||||
3862141|NCT01611194|3687618|B1||Marines|Military Branch||Participants|Count of Participants|7|7.0||||||
3862142|NCT01611194|3687616|B3||Army|Military Branch||Participants|Count of Participants|55|55.0||||||
3862143|NCT01611194|3687617|B2||Army|Military Branch||Participants|Count of Participants|28|28.0||||||
3862144|NCT01611194|3687618|B1||Army|Military Branch||Participants|Count of Participants|27|27.0||||||
3862145|NCT01611194|3687616|B3||O-1 to O-10/W-1 to W-5|Military Rank||Participants|Count of Participants|5|5.0||||||
3862146|NCT01611194|3687617|B2||O-1 to O-10/W-1 to W-5|Military Rank||Participants|Count of Participants|0|0.0||||||
3862147|NCT01611194|3687618|B1||O-1 to O-10/W-1 to W-5|Military Rank||Participants|Count of Participants|5|5.0||||||
3862148|NCT01611194|3687616|B3||E1-E10|Military Rank||Participants|Count of Participants|66|66.0||||||
3862149|NCT01611194|3687617|B2||E1-E10|Military Rank||Participants|Count of Participants|35|35.0||||||
3862150|NCT01611194|3687618|B1||E1-E10|Military Rank||Participants|Count of Participants|31|31.0||||||
3862151|NCT01611194|3687616|B3||Blunt force head injury|Most Recent Qualifying Injury||Participants|Count of Participants|25|25.0||||||
3862152|NCT01611194|3687617|B2||Blunt force head injury|Most Recent Qualifying Injury||Participants|Count of Participants|12|12.0||||||
3862153|NCT01611194|3687618|B1||Blunt force head injury|Most Recent Qualifying Injury||Participants|Count of Participants|13|13.0||||||
3862154|NCT01611194|3687616|B3||Blast injury|Most Recent Qualifying Injury||Participants|Count of Participants|46|46.0||||||
3862155|NCT01611194|3687617|B2||Blast injury|Most Recent Qualifying Injury||Participants|Count of Participants|23|23.0||||||
3862156|NCT01611194|3687618|B1||Blast injury|Most Recent Qualifying Injury||Participants|Count of Participants|23|23.0||||||
3862157|NCT01611194|3687616|B3||Combination of blast and blunt force injuries|Lifetime mTBI History||Participants|Count of Participants|34|34.0||||||
3862158|NCT01611194|3687617|B2||Combination of blast and blunt force injuries|Lifetime mTBI History||Participants|Count of Participants|20|20.0||||||
3862159|NCT01611194|3687618|B1||Combination of blast and blunt force injuries|Lifetime mTBI History||Participants|Count of Participants|14|14.0||||||
3862160|NCT01611194|3687616|B3||Blunt force head injuries only|Lifetime mTBI History||Participants|Count of Participants|14|14.0||||||
3862161|NCT01611194|3687617|B2||Blunt force head injuries only|Lifetime mTBI History||Participants|Count of Participants|7|7.0||||||
3862162|NCT01611194|3687618|B1||Blunt force head injuries only|Lifetime mTBI History||Participants|Count of Participants|7|7.0||||||
3862163|NCT01611194|3687616|B3||Blast injuries|Lifetime mTBI History||Participants|Count of Participants|23|23.0||||||
3862164|NCT01611194|3687617|B2||Blast injuries|Lifetime mTBI History||Participants|Count of Participants|8|8.0||||||
3862165|NCT01611194|3687618|B1||Blast injuries|Lifetime mTBI History||Participants|Count of Participants|15|15.0||||||
3862166|NCT01611194|3687616|B3|||Number of Lifetime mTBIs||mTBIs|Mean|3.6|3.6|Standard Deviation|2.8|2.8|||
3862167|NCT01611194|3687617|B2|||Number of Lifetime mTBIs||mTBIs|Mean|3.7|3.7|Standard Deviation|2.3|2.3|||
3862168|NCT01611194|3687618|B1|||Number of Lifetime mTBIs||mTBIs|Mean|3.6|3.6|Standard Deviation|3.2|3.2|||
3862169|NCT01611194|3687616|B3|>1year to 5 years||Most Recent Qualifying mTBI 3 Months to 1 Year||Participants|Count of Participants|51|51.0||||||
3862170|NCT01611194|3687617|B2|>1year to 5 years||Most Recent Qualifying mTBI 3 Months to 1 Year||Participants|Count of Participants|27|27.0||||||
3862171|NCT01611194|3687618|B1|>1year to 5 years||Most Recent Qualifying mTBI 3 Months to 1 Year||Participants|Count of Participants|24|24.0||||||
3862172|NCT01611194|3687616|B3|3 months to 1 year||Most Recent Qualifying mTBI 3 Months to 1 Year||Participants|Count of Participants|20|20.0||||||
3862173|NCT01611194|3687617|B2|3 months to 1 year||Most Recent Qualifying mTBI 3 Months to 1 Year||Participants|Count of Participants|8|8.0||||||
3862174|NCT01611194|3687618|B1|3 months to 1 year||Most Recent Qualifying mTBI 3 Months to 1 Year||Participants|Count of Participants|12|12.0||||||
3862175|NCT01611194|3687616|B3|||Time From Most Recent Qualifying Mild Traumatic Brain Injury (mTBI)||months|Mean|25.6|25.6|Standard Deviation|16.2|16.2|||
3862176|NCT01611194|3687617|B2|||Time From Most Recent Qualifying Mild Traumatic Brain Injury (mTBI)||months|Mean|25.5|25.5|Standard Deviation|15.4|15.4|||
3862177|NCT01611194|3687618|B1|||Time From Most Recent Qualifying Mild Traumatic Brain Injury (mTBI)||months|Mean|25.6|25.6|Standard Deviation|17.1|17.1|||
3862178|NCT01611194|3687616|B3||Veteran|Military Status||Participants|Count of Participants|3|3.0||||||
3862179|NCT01611194|3687617|B2||Veteran|Military Status||Participants|Count of Participants|2|2.0||||||
3862180|NCT01611194|3687618|B1||Veteran|Military Status||Participants|Count of Participants|1|1.0||||||
3862181|NCT01611194|3687616|B3||Active duty|Military Status||Participants|Count of Participants|68|68.0||||||
3862182|NCT01611194|3687617|B2||Active duty|Military Status||Participants|Count of Participants|33|33.0||||||
3862183|NCT01611194|3687618|B1||Active duty|Military Status||Participants|Count of Participants|35|35.0||||||
3862184|NCT01611194|3687616|B3||Graduare degree|Education||Participants|Count of Participants|6|6.0||||||
3862185|NCT01611194|3687617|B2||Graduare degree|Education||Participants|Count of Participants|1|1.0||||||
3862186|NCT01611194|3687618|B1||Graduare degree|Education||Participants|Count of Participants|5|5.0||||||
3862187|NCT01611194|3687616|B3||College degree|Education||Participants|Count of Participants|16|16.0||||||
3862188|NCT01611194|3687617|B2||College degree|Education||Participants|Count of Participants|5|5.0||||||
3862189|NCT01611194|3687618|B1||College degree|Education||Participants|Count of Participants|11|11.0||||||
3862190|NCT01611194|3687616|B3||Some college|Education||Participants|Count of Participants|36|36.0||||||
3862191|NCT01611194|3687617|B2||Some college|Education||Participants|Count of Participants|23|23.0||||||
3862192|NCT01611194|3687618|B1||Some college|Education||Participants|Count of Participants|13|13.0||||||
3862193|NCT01611194|3687616|B3||High school diploma|Education||Participants|Count of Participants|13|13.0||||||
3862194|NCT01611194|3687617|B2||High school diploma|Education||Participants|Count of Participants|6|6.0||||||
3862195|NCT01611194|3687618|B1||High school diploma|Education||Participants|Count of Participants|7|7.0||||||
3862196|NCT01611194|3687616|B3||Less than high school diploma|Education||Participants|Count of Participants|0|0.0||||||
3862197|NCT01611194|3687617|B2||Less than high school diploma|Education||Participants|Count of Participants|0|0.0||||||
3862198|NCT01611194|3687618|B1||Less than high school diploma|Education||Participants|Count of Participants|0|0.0||||||
3862199|NCT01611194|3687616|B3|United States||Region of Enrollment||Participants|Count of Participants|71|71.0||||||
3862200|NCT01611194|3687617|B2|United States||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3862201|NCT01611194|3687618|B1|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3862202|NCT01611194|3687616|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3862203|NCT01611194|3687617|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3862204|NCT01611194|3687618|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3862205|NCT01611194|3687616|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3862206|NCT01611194|3687617|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3862207|NCT01611194|3687618|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862208|NCT01611194|3687616|B3||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3862209|NCT01611194|3687617|B2||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3862210|NCT01611194|3687618|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3862211|NCT01611194|3687616|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3862212|NCT01611194|3687617|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3862213|NCT01611194|3687618|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3862214|NCT01611194|3687616|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3862215|NCT01611194|3687617|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3862216|NCT01611194|3687618|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3862217|NCT01611194|3687616|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3862218|NCT01611194|3687617|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3862219|NCT01611194|3687618|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862220|NCT01611194|3687616|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862221|NCT01611194|3687617|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862222|NCT01611194|3687618|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862223|NCT01611194|3687616|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862224|NCT01611194|3687617|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862225|NCT01611194|3687618|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862226|NCT01611194|3687616|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3862227|NCT01611194|3687617|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3862228|NCT01611194|3687618|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3862229|NCT01611194|3687616|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3862230|NCT01611194|3687617|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3862231|NCT01611194|3687618|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3862232|NCT01611194|3687616|B3||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3862233|NCT01611194|3687617|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3862234|NCT01611194|3687618|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3862235|NCT01611194|3687616|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3862236|NCT01611194|3687617|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3862237|NCT01611194|3687618|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3862238|NCT01611194|3687616|B3|||Age||years|Mean|32.8|32.8|Standard Deviation|7.3|7.3|||
3862239|NCT01611194|3687617|B2|||Age||years|Mean|30.8|30.8|Standard Deviation|5.5|5.5|||
3862240|NCT01611194|3687618|B1|||Age||years|Mean|34.8|34.8|Standard Deviation|8.3|8.3|||
3862241|NCT01610791|3687655|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3862242|NCT01610791|3687655|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3862243|NCT01610791|3687655|B1|||Age||years|Mean|46.3|46.3|Standard Deviation|12.5|12.5|||
3862244|NCT01610752|3687676|B4||Postgraduate work|Education||Participants|Count of Participants|13|13.0||||||
3862245|NCT01610752|3687677|B3||Postgraduate work|Education||Participants|Count of Participants|6|6.0||||||
3862246|NCT01610752|3687678|B2||Postgraduate work|Education||Participants|Count of Participants|2|2.0||||||
3862247|NCT01610752|3687679|B1||Postgraduate work|Education||Participants|Count of Participants|5|5.0||||||
3862248|NCT01610752|3687676|B4||College degree|Education||Participants|Count of Participants|22|22.0||||||
3862249|NCT01610752|3687677|B3||College degree|Education||Participants|Count of Participants|4|4.0||||||
3862250|NCT01610752|3687678|B2||College degree|Education||Participants|Count of Participants|11|11.0||||||
3862251|NCT01610752|3687679|B1||College degree|Education||Participants|Count of Participants|7|7.0||||||
3862252|NCT01610752|3687676|B4||High school diploma/GED/1-3 years of college|Education||Participants|Count of Participants|18|18.0||||||
3862253|NCT01610752|3687677|B3||High school diploma/GED/1-3 years of college|Education||Participants|Count of Participants|7|7.0||||||
3862254|NCT01610752|3687678|B2||High school diploma/GED/1-3 years of college|Education||Participants|Count of Participants|6|6.0||||||
3862255|NCT01610752|3687679|B1||High school diploma/GED/1-3 years of college|Education||Participants|Count of Participants|5|5.0||||||
3862256|NCT01610752|3687676|B4||Some high school|Education||Participants|Count of Participants|1|1.0||||||
3862257|NCT01610752|3687677|B3||Some high school|Education||Participants|Count of Participants|0|0.0||||||
3862259|NCT01610752|3687679|B1||Some high school|Education||Participants|Count of Participants|1|1.0||||||
3862260|NCT01610752|3687676|B4||≥$100,000|Family income per year||Participants|Count of Participants|14|14.0||||||
3862261|NCT01610752|3687677|B3||≥$100,000|Family income per year||Participants|Count of Participants|5|5.0||||||
3862262|NCT01610752|3687678|B2||≥$100,000|Family income per year||Participants|Count of Participants|7|7.0||||||
3862263|NCT01610752|3687679|B1||≥$100,000|Family income per year||Participants|Count of Participants|2|2.0||||||
3862264|NCT01610752|3687676|B4||$40,000-$99,999|Family income per year||Participants|Count of Participants|17|17.0||||||
3862265|NCT01610752|3687677|B3||$40,000-$99,999|Family income per year||Participants|Count of Participants|5|5.0||||||
3862266|NCT01610752|3687678|B2||$40,000-$99,999|Family income per year||Participants|Count of Participants|5|5.0||||||
3862267|NCT01610752|3687679|B1||$40,000-$99,999|Family income per year||Participants|Count of Participants|7|7.0||||||
3862268|NCT01610752|3687676|B4||<$5000-$39,999|Family income per year||Participants|Count of Participants|23|23.0||||||
3862269|NCT01610752|3687677|B3||<$5000-$39,999|Family income per year||Participants|Count of Participants|7|7.0||||||
3862270|NCT01610752|3687678|B2||<$5000-$39,999|Family income per year||Participants|Count of Participants|7|7.0||||||
3862271|NCT01610752|3687679|B1||<$5000-$39,999|Family income per year||Participants|Count of Participants|9|9.0||||||
3862272|NCT01610752|3687676|B4||Obese (30.0-40.0 kg/m2)|Pregravid BMI||Participants|Count of Participants|29|29.0||||||
3862273|NCT01610752|3687677|B3||Obese (30.0-40.0 kg/m2)|Pregravid BMI||Participants|Count of Participants|8|8.0||||||
3862274|NCT01610752|3687678|B2||Obese (30.0-40.0 kg/m2)|Pregravid BMI||Participants|Count of Participants|11|11.0||||||
3862275|NCT01610752|3687679|B1||Obese (30.0-40.0 kg/m2)|Pregravid BMI||Participants|Count of Participants|10|10.0||||||
3862276|NCT01610752|3687676|B4||Overweight (25.0-29.9 kg/m2)|Pregravid BMI||Participants|Count of Participants|25|25.0||||||
3862277|NCT01610752|3687677|B3||Overweight (25.0-29.9 kg/m2)|Pregravid BMI||Participants|Count of Participants|9|9.0||||||
3862278|NCT01610752|3687678|B2||Overweight (25.0-29.9 kg/m2)|Pregravid BMI||Participants|Count of Participants|8|8.0||||||
3862279|NCT01610752|3687679|B1||Overweight (25.0-29.9 kg/m2)|Pregravid BMI||Participants|Count of Participants|8|8.0||||||
3862280|NCT01610752|3687676|B4|||Parity|Parity is the number of pregnancies that have reached viability. Appropriate individual scores are 0, 1, 2, etc. Means and standard deviations include decimal numbers.|viable pregnancies|Mean|0.8|0.8|Standard Deviation|0.8|0.8|||
3862281|NCT01610752|3687677|B3|||Parity|Parity is the number of pregnancies that have reached viability. Appropriate individual scores are 0, 1, 2, etc. Means and standard deviations include decimal numbers.|viable pregnancies|Mean|0.6|0.6|Standard Deviation|0.5|0.5|||
3862282|NCT01610752|3687678|B2|||Parity|Parity is the number of pregnancies that have reached viability. Appropriate individual scores are 0, 1, 2, etc. Means and standard deviations include decimal numbers.|viable pregnancies|Mean|0.9|0.9|Standard Deviation|1.1|1.1|||
3862283|NCT01610752|3687679|B1|||Parity|Parity is the number of pregnancies that have reached viability. Appropriate individual scores are 0, 1, 2, etc. Means and standard deviations include decimal numbers.|viable pregnancies|Mean|0.7|0.7|Standard Deviation|0.8|0.8|||
3862284|NCT01610752|3687676|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862285|NCT01610752|3687677|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862286|NCT01610752|3687678|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862287|NCT01610752|3687679|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862288|NCT01610752|3687676|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862289|NCT01610752|3687677|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862290|NCT01610752|3687678|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862291|NCT01610752|3687679|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862292|NCT01610752|3687676|B4||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3862293|NCT01610752|3687677|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3862294|NCT01610752|3687678|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3862295|NCT01610752|3687679|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3862296|NCT01610752|3687676|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3862297|NCT01610752|3687677|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3862298|NCT01610752|3687678|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3862299|NCT01610752|3687679|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3862300|NCT01610752|3687676|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862301|NCT01610752|3687677|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862302|NCT01610752|3687678|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862303|NCT01610752|3687679|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862304|NCT01610752|3687676|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3862305|NCT01610752|3687677|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862306|NCT01610752|3687678|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3862307|NCT01610752|3687679|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3862308|NCT01610752|3687676|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862309|NCT01610752|3687677|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862310|NCT01610752|3687678|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862311|NCT01610752|3687679|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862312|NCT01610752|3687676|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3862313|NCT01610752|3687677|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3862314|NCT01610752|3687678|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3862315|NCT01610752|3687679|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3862316|NCT01610752|3687676|B4||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3862317|NCT01610752|3687677|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3862318|NCT01610752|3687678|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3862319|NCT01610752|3687679|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3862320|NCT01610752|3687676|B4|||Age||years|Mean|29.2|29.2|Standard Deviation|4.6|4.6|||
3862321|NCT01610752|3687677|B3|||Age||years|Mean|29.5|29.5|Standard Deviation|5.1|5.1|||
3862322|NCT01610752|3687678|B2|||Age||years|Mean|29.0|29.0|Standard Deviation|4.2|4.2|||
3862323|NCT01610752|3687679|B1|||Age||years|Mean|29.2|29.2|Standard Deviation|4.8|4.8|||
3862324|NCT01610713|3687701|B3|United Kingdom||Region of Enrollment||participants|Number|154|154.0||||||
3862325|NCT01610713|3687702|B2|United Kingdom||Region of Enrollment||participants|Number|77|77.0||||||
3862326|NCT01610713|3687703|B1|United Kingdom||Region of Enrollment||participants|Number|77|77.0||||||
3862327|NCT01610713|3687701|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3862328|NCT01610713|3687702|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3862329|NCT01610713|3687703|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3862330|NCT01610713|3687701|B3||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3862331|NCT01610713|3687702|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3862332|NCT01610713|3687703|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3862333|NCT01610713|3687701|B3|||Age||years|Mean|50.8|50.8|Standard Deviation|9.26|9.26|||
3862334|NCT01610713|3687702|B2|||Age||years|Mean|50.7|50.7|Standard Deviation|9.24|9.24|||
3862335|NCT01610713|3687703|B1|||Age||years|Mean|50.9|50.9|Standard Deviation|9.34|9.34|||
3862336|NCT01610713|3687701|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3862337|NCT01610713|3687702|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3862338|NCT01610713|3687703|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3862339|NCT01610713|3687701|B3||Between 18 and 65 years|Age||Participants|Count of Participants|143|143.0||||||
3862340|NCT01610713|3687702|B2||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
3862341|NCT01610713|3687703|B1||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
3862342|NCT01610713|3687701|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3862343|NCT01610713|3687702|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3862344|NCT01610713|3687703|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3862345|NCT01610700|3687760|B3|United Kingdom||Region of Enrollment||participants|Number|160|160.0||||||
3862346|NCT01610700|3687761|B2|United Kingdom||Region of Enrollment||participants|Number|80|80.0||||||
3862347|NCT01610700|3687762|B1|United Kingdom||Region of Enrollment||participants|Number|80|80.0||||||
3862348|NCT01610700|3687760|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3862349|NCT01610700|3687761|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3862350|NCT01610700|3687762|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3862351|NCT01610700|3687760|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3862352|NCT01610700|3687761|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3862353|NCT01610700|3687762|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3862354|NCT01610700|3687760|B3|||Age||years|Mean|50.69|50.69|Standard Deviation|9.32|9.32|||
3862355|NCT01610700|3687761|B2|||Age||years|Mean|50.42|50.42|Standard Deviation|9.33|9.33|||
3862356|NCT01610700|3687762|B1|||Age||years|Mean|50.96|50.96|Standard Deviation|9.36|9.36|||
3862357|NCT01610700|3687760|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3862358|NCT01610700|3687761|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3862359|NCT01610700|3687762|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3862360|NCT01610700|3687760|B3||Between 18 and 65 years|Age||Participants|Count of Participants|148|148.0||||||
3862361|NCT01610700|3687761|B2||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
3862362|NCT01610700|3687762|B1||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
3862363|NCT01610700|3687760|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3862364|NCT01610700|3687761|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3862365|NCT01610700|3687762|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3862366|NCT01610687|3687817|B1|United Kingdom||Region of Enrollment||participants|Number|137|137.0||||||
3862367|NCT01610687|3687817|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3862368|NCT01610687|3687817|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3862369|NCT01610687|3687817|B1|||Age||years|Mean|50.69|50.69|Standard Deviation|9.531|9.531|||
3862370|NCT01610687|3687817|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3862371|NCT01610687|3687817|B1||Between 18 and 65 years|Age||Participants|Count of Participants|127|127.0||||||
3862372|NCT01610687|3687817|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3862373|NCT01610596|3687828|B3|||Percent BSA to be Treated at Baseline|The percent Body Surface Area (BSA) with active psoriasis within the designated Treatment Area was assessed at Baseline. One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|%BSA|Mean|3.8|3.8|Standard Deviation|1.88|1.88|||
3862374|NCT01610596|3687829|B2|||Percent BSA to be Treated at Baseline|The percent Body Surface Area (BSA) with active psoriasis within the designated Treatment Area was assessed at Baseline. One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|%BSA|Mean|4.0|4.0|Standard Deviation|2.04|2.04|||
3862375|NCT01610596|3687830|B1|||Percent BSA to be Treated at Baseline|The percent Body Surface Area (BSA) with active psoriasis within the designated Treatment Area was assessed at Baseline. One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|%BSA|Mean|3.7|3.7|Standard Deviation|1.74|1.74|||
3862376|NCT01610596|3687828|B3|Severe||Pruritus at Baseline|This evaluation is the participant's assessment of the itch on the active psoriasis plaques based on the 5-point Itch Evaluation Scoring Scale Form. One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|3|3.0||||||
3862377|NCT01610596|3687829|B2|Severe||Pruritus at Baseline|This evaluation is the participant's assessment of the itch on the active psoriasis plaques based on the 5-point Itch Evaluation Scoring Scale Form. One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|2|2.0||||||
3862378|NCT01610596|3687830|B1|Severe||Pruritus at Baseline|This evaluation is the participant's assessment of the itch on the active psoriasis plaques based on the 5-point Itch Evaluation Scoring Scale Form. One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|1|1.0||||||
3862379|NCT01610596|3687828|B3|Moderal to severe||Pruritus at Baseline|This evaluation is the participant's assessment of the itch on the active psoriasis plaques based on the 5-point Itch Evaluation Scoring Scale Form. One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|6|6.0||||||
3862380|NCT01610596|3687829|B2|Moderal to severe||Pruritus at Baseline|This evaluation is the participant's assessment of the itch on the active psoriasis plaques based on the 5-point Itch Evaluation Scoring Scale Form. One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|5|5.0||||||
3862381|NCT01610596|3687830|B1|Moderal to severe||Pruritus at Baseline|This evaluation is the participant's assessment of the itch on the active psoriasis plaques based on the 5-point Itch Evaluation Scoring Scale Form. One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|1|1.0||||||
3862382|NCT01610596|3687828|B3|Moderate||Pruritus at Baseline|This evaluation is the participant's assessment of the itch on the active psoriasis plaques based on the 5-point Itch Evaluation Scoring Scale Form. One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|10|10.0||||||
3862383|NCT01610596|3687829|B2|Moderate||Pruritus at Baseline|This evaluation is the participant's assessment of the itch on the active psoriasis plaques based on the 5-point Itch Evaluation Scoring Scale Form. One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|5|5.0||||||
3862384|NCT01610596|3687830|B1|Moderate||Pruritus at Baseline|This evaluation is the participant's assessment of the itch on the active psoriasis plaques based on the 5-point Itch Evaluation Scoring Scale Form. One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|5|5.0||||||
3862385|NCT01610596|3687828|B3|Mild to moderate||Pruritus at Baseline|This evaluation is the participant's assessment of the itch on the active psoriasis plaques based on the 5-point Itch Evaluation Scoring Scale Form. One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|23|23.0||||||
3862386|NCT01610596|3687829|B2|Mild to moderate||Pruritus at Baseline|This evaluation is the participant's assessment of the itch on the active psoriasis plaques based on the 5-point Itch Evaluation Scoring Scale Form. One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|11|11.0||||||
3862387|NCT01610596|3687830|B1|Mild to moderate||Pruritus at Baseline|This evaluation is the participant's assessment of the itch on the active psoriasis plaques based on the 5-point Itch Evaluation Scoring Scale Form. One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|12|12.0||||||
3862388|NCT01610596|3687828|B3|Mild||Pruritus at Baseline|This evaluation is the participant's assessment of the itch on the active psoriasis plaques based on the 5-point Itch Evaluation Scoring Scale Form. One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|19|19.0||||||
3862389|NCT01610596|3687829|B2|Mild||Pruritus at Baseline|This evaluation is the participant's assessment of the itch on the active psoriasis plaques based on the 5-point Itch Evaluation Scoring Scale Form. One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|5|5.0||||||
3862390|NCT01610596|3687830|B1|Mild||Pruritus at Baseline|This evaluation is the participant's assessment of the itch on the active psoriasis plaques based on the 5-point Itch Evaluation Scoring Scale Form. One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|14|14.0||||||
3862391|NCT01610596|3687828|B3|None||Pruritus at Baseline|This evaluation is the participant's assessment of the itch on the active psoriasis plaques based on the 5-point Itch Evaluation Scoring Scale Form. One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|11|11.0||||||
3862392|NCT01610596|3687829|B2|None||Pruritus at Baseline|This evaluation is the participant's assessment of the itch on the active psoriasis plaques based on the 5-point Itch Evaluation Scoring Scale Form. One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|8|8.0||||||
3862393|NCT01610596|3687830|B1|None||Pruritus at Baseline|This evaluation is the participant's assessment of the itch on the active psoriasis plaques based on the 5-point Itch Evaluation Scoring Scale Form. One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|3|3.0||||||
3862394|NCT01610596|3687828|B3|Severe/very severe||Signs of Psoriasis at Baseline (plaque elevation)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|9|9.0||||||
3862395|NCT01610596|3687829|B2|Severe/very severe||Signs of Psoriasis at Baseline (plaque elevation)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|5|5.0||||||
3862396|NCT01610596|3687830|B1|Severe/very severe||Signs of Psoriasis at Baseline (plaque elevation)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|4|4.0||||||
3862397|NCT01610596|3687828|B3|Moderate||Signs of Psoriasis at Baseline (plaque elevation)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|58|58.0||||||
3862398|NCT01610596|3687829|B2|Moderate||Signs of Psoriasis at Baseline (plaque elevation)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|28|28.0||||||
3862399|NCT01610596|3687830|B1|Moderate||Signs of Psoriasis at Baseline (plaque elevation)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|30|30.0||||||
3862400|NCT01610596|3687828|B3|Mild||Signs of Psoriasis at Baseline (plaque elevation)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|5|5.0||||||
3862401|NCT01610596|3687829|B2|Mild||Signs of Psoriasis at Baseline (plaque elevation)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|3|3.0||||||
3862402|NCT01610596|3687830|B1|Mild||Signs of Psoriasis at Baseline (plaque elevation)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|2|2.0||||||
3862403|NCT01610596|3687828|B3|Almost clear||Signs of Psoriasis at Baseline (plaque elevation)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|0|0.0||||||
3862404|NCT01610596|3687829|B2|Almost clear||Signs of Psoriasis at Baseline (plaque elevation)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|0|0.0||||||
3862405|NCT01610596|3687830|B1|Almost clear||Signs of Psoriasis at Baseline (plaque elevation)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|0|0.0||||||
3862406|NCT01610596|3687828|B3|Clear||Signs of Psoriasis at Baseline (plaque elevation)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|0|0.0||||||
3862407|NCT01610596|3687829|B2|Clear||Signs of Psoriasis at Baseline (plaque elevation)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|0|0.0||||||
3862408|NCT01610596|3687830|B1|Clear||Signs of Psoriasis at Baseline (plaque elevation)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|0|0.0||||||
3862409|NCT01610596|3687828|B3|Severe/very severe||Signs of Psoriasis at Baseline (erythema)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|23|23.0||||||
3862410|NCT01610596|3687829|B2|Severe/very severe||Signs of Psoriasis at Baseline (erythema)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|11|11.0||||||
3862411|NCT01610596|3687830|B1|Severe/very severe||Signs of Psoriasis at Baseline (erythema)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|12|12.0||||||
3862412|NCT01610596|3687828|B3|Moderate||Signs of Psoriasis at Baseline (erythema)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|46|46.0||||||
3862413|NCT01610596|3687829|B2|Moderate||Signs of Psoriasis at Baseline (erythema)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|24|24.0||||||
3862414|NCT01610596|3687830|B1|Moderate||Signs of Psoriasis at Baseline (erythema)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|22|22.0||||||
3862415|NCT01610596|3687828|B3|Mild||Signs of Psoriasis at Baseline (erythema)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|2|2.0||||||
3862416|NCT01610596|3687829|B2|Mild||Signs of Psoriasis at Baseline (erythema)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|1|1.0||||||
3862417|NCT01610596|3687830|B1|Mild||Signs of Psoriasis at Baseline (erythema)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|1|1.0||||||
3862418|NCT01610596|3687828|B3|Almost clear||Signs of Psoriasis at Baseline (erythema)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|1|1.0||||||
3862419|NCT01610596|3687829|B2|Almost clear||Signs of Psoriasis at Baseline (erythema)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|0|0.0||||||
3862420|NCT01610596|3687830|B1|Almost clear||Signs of Psoriasis at Baseline (erythema)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|1|1.0||||||
3862421|NCT01610596|3687828|B3|Clear||Signs of Psoriasis at Baseline (erythema)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|0|0.0||||||
3862422|NCT01610596|3687829|B2|Clear||Signs of Psoriasis at Baseline (erythema)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|0|0.0||||||
3862423|NCT01610596|3687830|B1|Clear||Signs of Psoriasis at Baseline (erythema)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|0|0.0||||||
3862424|NCT01610596|3687828|B3|Severe/very severe||Signs of Psoriasis at Baseline (scaling)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|14|14.0||||||
3862425|NCT01610596|3687829|B2|Severe/very severe||Signs of Psoriasis at Baseline (scaling)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|6|6.0||||||
3862426|NCT01610596|3687830|B1|Severe/very severe||Signs of Psoriasis at Baseline (scaling)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|8|8.0||||||
3862427|NCT01610596|3687828|B3|Moderate||Signs of Psoriasis at Baseline (scaling)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|50|50.0||||||
3862428|NCT01610596|3687829|B2|Moderate||Signs of Psoriasis at Baseline (scaling)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|28|28.0||||||
3862429|NCT01610596|3687830|B1|Moderate||Signs of Psoriasis at Baseline (scaling)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|22|22.0||||||
3862430|NCT01610596|3687828|B3|Mild||Signs of Psoriasis at Baseline (scaling)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|8|8.0||||||
3862431|NCT01610596|3687829|B2|Mild||Signs of Psoriasis at Baseline (scaling)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|2|2.0||||||
3862432|NCT01610596|3687830|B1|Mild||Signs of Psoriasis at Baseline (scaling)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|6|6.0||||||
3862433|NCT01610596|3687828|B3|Almost clear||Signs of Psoriasis at Baseline (scaling)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|0|0.0||||||
3862434|NCT01610596|3687829|B2|Almost clear||Signs of Psoriasis at Baseline (scaling)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|0|0.0||||||
3862435|NCT01610596|3687830|B1|Almost clear||Signs of Psoriasis at Baseline (scaling)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|0|0.0||||||
3862436|NCT01610596|3687828|B3|Clear||Signs of Psoriasis at Baseline (scaling)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|0|0.0||||||
3862437|NCT01610596|3687829|B2|Clear||Signs of Psoriasis at Baseline (scaling)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|0|0.0||||||
3862438|NCT01610596|3687830|B1|Clear||Signs of Psoriasis at Baseline (scaling)|One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|0|0.0||||||
3862439|NCT01610596|3687828|B3|Severe/very severe||Overall Disease Severity at Baseline|To be enrolled into the study, subjects had to have at least moderate ODS (score of at least 3). One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|11|11.0||||||
3862440|NCT01610596|3687829|B2|Severe/very severe||Overall Disease Severity at Baseline|To be enrolled into the study, subjects had to have at least moderate ODS (score of at least 3). One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|5|5.0||||||
3862441|NCT01610596|3687830|B1|Severe/very severe||Overall Disease Severity at Baseline|To be enrolled into the study, subjects had to have at least moderate ODS (score of at least 3). One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|6|6.0||||||
3862442|NCT01610596|3687828|B3|Moderate||Overall Disease Severity at Baseline|To be enrolled into the study, subjects had to have at least moderate ODS (score of at least 3). One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|61|61.0||||||
3862443|NCT01610596|3687829|B2|Moderate||Overall Disease Severity at Baseline|To be enrolled into the study, subjects had to have at least moderate ODS (score of at least 3). One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|31|31.0||||||
3862444|NCT01610596|3687830|B1|Moderate||Overall Disease Severity at Baseline|To be enrolled into the study, subjects had to have at least moderate ODS (score of at least 3). One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|30|30.0||||||
3862445|NCT01610596|3687828|B3|Mild||Overall Disease Severity at Baseline|To be enrolled into the study, subjects had to have at least moderate ODS (score of at least 3). One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|0|0.0||||||
3862446|NCT01610596|3687829|B2|Mild||Overall Disease Severity at Baseline|To be enrolled into the study, subjects had to have at least moderate ODS (score of at least 3). One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|0|0.0||||||
3862447|NCT01610596|3687830|B1|Mild||Overall Disease Severity at Baseline|To be enrolled into the study, subjects had to have at least moderate ODS (score of at least 3). One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|0|0.0||||||
3862448|NCT01610596|3687828|B3|Almost clear||Overall Disease Severity at Baseline|To be enrolled into the study, subjects had to have at least moderate ODS (score of at least 3). One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|0|0.0||||||
3862449|NCT01610596|3687829|B2|Almost clear||Overall Disease Severity at Baseline|To be enrolled into the study, subjects had to have at least moderate ODS (score of at least 3). One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|0|0.0||||||
3862450|NCT01610596|3687830|B1|Almost clear||Overall Disease Severity at Baseline|To be enrolled into the study, subjects had to have at least moderate ODS (score of at least 3). One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|0|0.0||||||
3862451|NCT01610596|3687828|B3|Clear||Overall Disease Severity at Baseline|To be enrolled into the study, subjects had to have at least moderate ODS (score of at least 3). One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|0|0.0||||||
3862452|NCT01610596|3687829|B2|Clear||Overall Disease Severity at Baseline|To be enrolled into the study, subjects had to have at least moderate ODS (score of at least 3). One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|0|0.0||||||
3862453|NCT01610596|3687830|B1|Clear||Overall Disease Severity at Baseline|To be enrolled into the study, subjects had to have at least moderate ODS (score of at least 3). One study participant (vehicle group) did not return to the clinic (lost to follow-up) following Visit 1 (baseline visit) and was therefore excluded from the Intent-to-Treat (ITT) population.|participants|Number|0|0.0||||||
3862454|NCT01610596|3687828|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862455|NCT01610596|3687829|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862456|NCT01610596|3687830|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862457|NCT01610596|3687828|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3862458|NCT01610596|3687829|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862459|NCT01610596|3687830|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3862460|NCT01610596|3687828|B3||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3862461|NCT01610596|3687829|B2||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3862462|NCT01610596|3687830|B1||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3862463|NCT01610596|3687828|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3862464|NCT01610596|3687829|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3862465|NCT01610596|3687830|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3862466|NCT01610596|3687828|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3862467|NCT01610596|3687829|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862468|NCT01610596|3687830|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3862469|NCT01610596|3687828|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3862470|NCT01610596|3687829|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3862471|NCT01610596|3687830|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862472|NCT01610596|3687828|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3862473|NCT01610596|3687829|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862474|NCT01610596|3687830|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3862475|NCT01610596|3687828|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862476|NCT01610596|3687829|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862477|NCT01610596|3687830|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862478|NCT01610596|3687828|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3862479|NCT01610596|3687829|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3862480|NCT01610596|3687830|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3862481|NCT01610596|3687828|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3862482|NCT01610596|3687829|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3862483|NCT01610596|3687830|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3862484|NCT01610596|3687828|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3862485|NCT01610596|3687829|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3862486|NCT01610596|3687830|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3862487|NCT01610596|3687828|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3862488|NCT01610596|3687829|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3862489|NCT01610596|3687830|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3862490|NCT01610596|3687828|B3|||Age||years|Mean|51.2|51.2|Standard Deviation|12.38|12.38|||
3862491|NCT01610596|3687829|B2|||Age||years|Mean|52.3|52.3|Standard Deviation|13.06|13.06|||
3862492|NCT01610596|3687830|B1|||Age||years|Mean|50.0|50.0|Standard Deviation|11.74|11.74|||
3862493|NCT01610570|3687843|B5|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3862494|NCT01610570|3687844|B4|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3862495|NCT01610570|3687846|B2|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3862496|NCT01610570|3687843|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862497|NCT01610570|3687844|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862498|NCT01610570|3687846|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862499|NCT01610570|3687843|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862500|NCT01610570|3687844|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862501|NCT01610570|3687846|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862502|NCT01610570|3687843|B5||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3862503|NCT01610570|3687844|B4||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3862504|NCT01610570|3687846|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3862505|NCT01610570|3687843|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862506|NCT01610570|3687844|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862507|NCT01610570|3687846|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862508|NCT01610570|3687843|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862509|NCT01610570|3687844|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862510|NCT01610570|3687846|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862511|NCT01610570|3687843|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862512|NCT01610570|3687844|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862513|NCT01610570|3687846|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862514|NCT01610570|3687843|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862515|NCT01610570|3687844|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862516|NCT01610570|3687846|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862517|NCT01610570|3687843|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862518|NCT01610570|3687844|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862519|NCT01610570|3687846|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862520|NCT01610570|3687843|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3862521|NCT01610570|3687844|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3862522|NCT01610570|3687846|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3862523|NCT01610570|3687843|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3862524|NCT01610570|3687844|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862525|NCT01610570|3687846|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3862526|NCT01610570|3687843|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3862527|NCT01610570|3687844|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3862528|NCT01610570|3687846|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3862529|NCT01610570|3687843|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3862530|NCT01610570|3687844|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3862531|NCT01610570|3687846|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3862532|NCT01610570|3687843|B5|||Age||years|Mean|21.0|21.0|Standard Deviation|6.9|6.9|||
3862533|NCT01610570|3687844|B4|||Age||years|Mean|23.8|23.8|Standard Deviation|5.3|5.3|||
3862534|NCT01610570|3687846|B2|||Age||years|Mean|12.5|12.5|Standard Deviation|0|0.0|||
3862535|NCT01610570|3687843|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3862536|NCT01610570|3687844|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3862537|NCT01610570|3687846|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3862538|NCT01610570|3687843|B5||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3862539|NCT01610570|3687844|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3862540|NCT01610570|3687846|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3862541|NCT01610570|3687843|B5||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3862542|NCT01610570|3687844|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3862543|NCT01610570|3687846|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3862544|NCT01610557|3687885|B5|||Optical Coherence Tomography (OCT) Central Subfield Mean Thickness|"Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes.~Optical Coherence Tomography (OCT) scans were masked and graded at an external reading center (Duke University, Durham, North Carolina)."|micrometers|Mean|477|477.0|Full Range|||334.0|720.0|
3862545|NCT01610557|3687886|B4|||Optical Coherence Tomography (OCT) Central Subfield Mean Thickness|"Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes.~Optical Coherence Tomography (OCT) scans were masked and graded at an external reading center (Duke University, Durham, North Carolina)."|micrometers|Mean|508|508.0|Full Range|||358.0|653.0|
3862546|NCT01610557|3687887|B3|||Optical Coherence Tomography (OCT) Central Subfield Mean Thickness|"Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes.~Optical Coherence Tomography (OCT) scans were masked and graded at an external reading center (Duke University, Durham, North Carolina)."|micrometers|Mean|471|471.0|Full Range|||362.0|606.0|
3862547|NCT01610557|3687888|B2|||Optical Coherence Tomography (OCT) Central Subfield Mean Thickness|"Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes.~Optical Coherence Tomography (OCT) scans were masked and graded at an external reading center (Duke University, Durham, North Carolina)."|micrometers|Mean|444|444.0|Full Range|||366.0|602.0|
3862548|NCT01610557|3687889|B1|||Optical Coherence Tomography (OCT) Central Subfield Mean Thickness|"Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes.~Optical Coherence Tomography (OCT) scans were masked and graded at an external reading center (Duke University, Durham, North Carolina)."|micrometers|Mean|484|484.0|Full Range|||334.0|720.0|
3862549|NCT01610557|3687885|B5|||Best-corrected visual acuity|"Best-corrected visual acuity was measured using the Early Treatment Diabetic Retinopathy Study (ETDRS) protocol. Acuity is measured as letters read on an ETDRS chart.~Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes."|ETDRS letters|Mean|64|64.0|Full Range|||32.0|78.0|
3862550|NCT01610557|3687886|B4|||Best-corrected visual acuity|"Best-corrected visual acuity was measured using the Early Treatment Diabetic Retinopathy Study (ETDRS) protocol. Acuity is measured as letters read on an ETDRS chart.~Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes."|ETDRS letters|Mean|65|65.0|Full Range|||50.0|78.0|
3862684|NCT01610271|3687995|B3|No||Received preoperative antibiotic prophylaxis||participants|Number|0|0.0||||||
3862685|NCT01610271|3687996|B2|No||Received preoperative antibiotic prophylaxis||participants|Number|0|0.0||||||
3862551|NCT01610557|3687887|B3|||Best-corrected visual acuity|"Best-corrected visual acuity was measured using the Early Treatment Diabetic Retinopathy Study (ETDRS) protocol. Acuity is measured as letters read on an ETDRS chart.~Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes."|ETDRS letters|Mean|65|65.0|Full Range|||44.0|75.0|
3862552|NCT01610557|3687888|B2|||Best-corrected visual acuity|"Best-corrected visual acuity was measured using the Early Treatment Diabetic Retinopathy Study (ETDRS) protocol. Acuity is measured as letters read on an ETDRS chart.~Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes."|ETDRS letters|Mean|61|61.0|Full Range|||32.0|73.0|
3862553|NCT01610557|3687889|B1|||Best-corrected visual acuity|"Best-corrected visual acuity was measured using the Early Treatment Diabetic Retinopathy Study (ETDRS) protocol. Acuity is measured as letters read on an ETDRS chart.~Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes."|ETDRS letters|Mean|65|65.0|Full Range|||38.0|78.0|
3862554|NCT01610557|3687885|B5|||Hemoglobin A1C (%)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes.|percentage of glycosylated hemoglobin|Mean|8.1|8.1|Full Range|||5.8|12.2|
3862555|NCT01610557|3687886|B4|||Hemoglobin A1C (%)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes.|percentage of glycosylated hemoglobin|Mean|7.8|7.8|Full Range|||5.8|10.3|
3862556|NCT01610557|3687887|B3|||Hemoglobin A1C (%)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes.|percentage of glycosylated hemoglobin|Mean|7.9|7.9|Full Range|||6.2|10.6|
3862557|NCT01610557|3687888|B2|||Hemoglobin A1C (%)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes.|percentage of glycosylated hemoglobin|Mean|8.4|8.4|Full Range|||5.8|12.2|
3862558|NCT01610557|3687889|B1|||Hemoglobin A1C (%)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes.|percentage of glycosylated hemoglobin|Mean|8.1|8.1|Full Range|||6.2|11.5|
3862559|NCT01610557|3687885|B5|Diabetes Type 2||Diabetes Type|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|eyes|Number|55|55.0||||||
3862560|NCT01610557|3687886|B4|Diabetes Type 2||Diabetes Type|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|eyes|Number|12|12.0||||||
3862561|NCT01610557|3687887|B3|Diabetes Type 2||Diabetes Type|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|eyes|Number|15|15.0||||||
3862562|NCT01610557|3687888|B2|Diabetes Type 2||Diabetes Type|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|eyes|Number|13|13.0||||||
3862563|NCT01610557|3687889|B1|Diabetes Type 2||Diabetes Type|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|eyes|Number|15|15.0||||||
3862564|NCT01610557|3687885|B5|Diabetes Type 1||Diabetes Type|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|eyes|Number|7|7.0||||||
3862565|NCT01610557|3687886|B4|Diabetes Type 1||Diabetes Type|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|eyes|Number|2|2.0||||||
3862566|NCT01610557|3687887|B3|Diabetes Type 1||Diabetes Type|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|eyes|Number|1|1.0||||||
3862567|NCT01610557|3687888|B2|Diabetes Type 1||Diabetes Type|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|eyes|Number|2|2.0||||||
3862568|NCT01610557|3687889|B1|Diabetes Type 1||Diabetes Type|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|eyes|Number|2|2.0||||||
3862569|NCT01610557|3687885|B5||Unknown or Not Reported|Race (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|Participants|Count of Participants|2|2.0||||||
3862570|NCT01610557|3687886|B4||Unknown or Not Reported|Race (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|Participants|Count of Participants|1|1.0||||||
3862571|NCT01610557|3687887|B3||Unknown or Not Reported|Race (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|Participants|Count of Participants|0|0.0||||||
3862572|NCT01610557|3687888|B2||Unknown or Not Reported|Race (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|Participants|Count of Participants|0|0.0||||||
3862573|NCT01610557|3687889|B1||Unknown or Not Reported|Race (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|Participants|Count of Participants|1|1.0||||||
3862574|NCT01610557|3687885|B5||More than one race|Race (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|Participants|Count of Participants|3|3.0||||||
3862575|NCT01610557|3687886|B4||More than one race|Race (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|Participants|Count of Participants|0|0.0||||||
3862576|NCT01610557|3687887|B3||More than one race|Race (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|Participants|Count of Participants|2|2.0||||||
3862577|NCT01610557|3687888|B2||More than one race|Race (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|Participants|Count of Participants|0|0.0||||||
3862578|NCT01610557|3687889|B1||More than one race|Race (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|Participants|Count of Participants|1|1.0||||||
3862579|NCT01610557|3687885|B5||White|Race (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|Participants|Count of Participants|46|46.0||||||
3862580|NCT01610557|3687886|B4||White|Race (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|Participants|Count of Participants|10|10.0||||||
3862581|NCT01610557|3687887|B3||White|Race (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|Participants|Count of Participants|11|11.0||||||
3862582|NCT01610557|3687888|B2||White|Race (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|Participants|Count of Participants|13|13.0||||||
3862583|NCT01610557|3687889|B1||White|Race (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|Participants|Count of Participants|12|12.0||||||
3862584|NCT01610557|3687885|B5||Black or African American|Race (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|Participants|Count of Participants|8|8.0||||||
3862585|NCT01610557|3687886|B4||Black or African American|Race (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|Participants|Count of Participants|2|2.0||||||
3862586|NCT01610557|3687887|B3||Black or African American|Race (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|Participants|Count of Participants|2|2.0||||||
3862587|NCT01610557|3687888|B2||Black or African American|Race (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|Participants|Count of Participants|2|2.0||||||
3862588|NCT01610557|3687889|B1||Black or African American|Race (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|Participants|Count of Participants|2|2.0||||||
3862589|NCT01610557|3687885|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|Participants|Count of Participants|0|0.0||||||
3862590|NCT01610557|3687886|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|Participants|Count of Participants|0|0.0||||||
3862632|NCT01610557|3687888|B2|||Age|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes.|years|Mean|65.9|65.9|Full Range|||39.0|87.0|
3862591|NCT01610557|3687887|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|Participants|Count of Participants|0|0.0||||||
3862592|NCT01610557|3687888|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|Participants|Count of Participants|0|0.0||||||
3862593|NCT01610557|3687889|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|Participants|Count of Participants|0|0.0||||||
3862594|NCT01610557|3687885|B5||Asian|Race (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|Participants|Count of Participants|3|3.0||||||
3862595|NCT01610557|3687886|B4||Asian|Race (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|Participants|Count of Participants|1|1.0||||||
3862596|NCT01610557|3687887|B3||Asian|Race (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|Participants|Count of Participants|1|1.0||||||
3862597|NCT01610557|3687888|B2||Asian|Race (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|Participants|Count of Participants|0|0.0||||||
3862598|NCT01610557|3687889|B1||Asian|Race (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|Participants|Count of Participants|1|1.0||||||
3862599|NCT01610557|3687885|B5||American Indian or Alaska Native|Race (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|Participants|Count of Participants|0|0.0||||||
3862600|NCT01610557|3687886|B4||American Indian or Alaska Native|Race (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|Participants|Count of Participants|0|0.0||||||
3862601|NCT01610557|3687887|B3||American Indian or Alaska Native|Race (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|Participants|Count of Participants|0|0.0||||||
3862602|NCT01610557|3687888|B2||American Indian or Alaska Native|Race (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|Participants|Count of Participants|0|0.0||||||
3862603|NCT01610557|3687889|B1||American Indian or Alaska Native|Race (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes|Participants|Count of Participants|0|0.0||||||
3862604|NCT01610557|3687885|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes.|Participants|Count of Participants|1|1.0||||||
3862605|NCT01610557|3687886|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes.|Participants|Count of Participants|0|0.0||||||
3862606|NCT01610557|3687887|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes.|Participants|Count of Participants|1|1.0||||||
3862607|NCT01610557|3687888|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes.|Participants|Count of Participants|0|0.0||||||
3862608|NCT01610557|3687889|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes.|Participants|Count of Participants|0|0.0||||||
3862609|NCT01610557|3687885|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes.|Participants|Count of Participants|58|58.0||||||
3862610|NCT01610557|3687886|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes.|Participants|Count of Participants|14|14.0||||||
3862681|NCT01610297|3687987|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3862682|NCT01610297|3687987|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3862611|NCT01610557|3687887|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes.|Participants|Count of Participants|14|14.0||||||
3862612|NCT01610557|3687888|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes.|Participants|Count of Participants|15|15.0||||||
3862613|NCT01610557|3687889|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes.|Participants|Count of Participants|15|15.0||||||
3862614|NCT01610557|3687885|B5||Hispanic or Latino|Ethnicity (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes.|Participants|Count of Participants|3|3.0||||||
3862615|NCT01610557|3687886|B4||Hispanic or Latino|Ethnicity (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes.|Participants|Count of Participants|0|0.0||||||
3862616|NCT01610557|3687887|B3||Hispanic or Latino|Ethnicity (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes.|Participants|Count of Participants|1|1.0||||||
3862617|NCT01610557|3687888|B2||Hispanic or Latino|Ethnicity (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes.|Participants|Count of Participants|0|0.0||||||
3862618|NCT01610557|3687889|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes.|Participants|Count of Participants|2|2.0||||||
3862619|NCT01610557|3687885|B5||Male|Sex: Female, Male|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes.|Participants|Count of Participants|38|38.0||||||
3862620|NCT01610557|3687886|B4||Male|Sex: Female, Male|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes.|Participants|Count of Participants|9|9.0||||||
3862621|NCT01610557|3687887|B3||Male|Sex: Female, Male|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes.|Participants|Count of Participants|9|9.0||||||
3862622|NCT01610557|3687888|B2||Male|Sex: Female, Male|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes.|Participants|Count of Participants|7|7.0||||||
3862623|NCT01610557|3687889|B1||Male|Sex: Female, Male|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes.|Participants|Count of Participants|13|13.0||||||
3862624|NCT01610557|3687885|B5||Female|Sex: Female, Male|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes.|Participants|Count of Participants|24|24.0||||||
3862625|NCT01610557|3687886|B4||Female|Sex: Female, Male|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes.|Participants|Count of Participants|5|5.0||||||
3862626|NCT01610557|3687887|B3||Female|Sex: Female, Male|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes.|Participants|Count of Participants|7|7.0||||||
3862627|NCT01610557|3687888|B2||Female|Sex: Female, Male|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes.|Participants|Count of Participants|8|8.0||||||
3862628|NCT01610557|3687889|B1||Female|Sex: Female, Male|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes.|Participants|Count of Participants|4|4.0||||||
3862629|NCT01610557|3687885|B5|||Age|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes.|years|Mean|63|63.0|Full Range|||39.0|87.0|
3862630|NCT01610557|3687886|B4|||Age|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes.|years|Mean|61.8|61.8|Full Range|||51.0|82.0|
3862631|NCT01610557|3687887|B3|||Age|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes.|years|Mean|62.3|62.3|Full Range|||39.0|83.0|
3862683|NCT01610297|3687987|B1|||Age||years|Mean|9.07|9.07|Standard Deviation|3.81|3.81|||
3862633|NCT01610557|3687889|B1|||Age|Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly. Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes.|years|Mean|62.4|62.4|Full Range|||39.0|85.0|
3862634|NCT01610492|3687906|B1|Unknown||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3862635|NCT01610492|3687906|B1|White- White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3862636|NCT01610492|3687906|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3862637|NCT01610492|3687906|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3862638|NCT01610492|3687906|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3862639|NCT01610492|3687906|B1|||Age||Years|Mean|46.1|46.1|Standard Deviation|13.30|13.3|||
3862640|NCT01610453|3687950|B1|United Kingdom||Region of Enrollment||participants|Number|63|63.0||||||
3862641|NCT01610453|3687950|B1|Norway||Region of Enrollment||participants|Number|87|87.0||||||
3862642|NCT01610453|3687950|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3862643|NCT01610453|3687950|B1||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3862644|NCT01610453|3687950|B1|||Age||years|Median|29|29.0|Full Range|||18.0|44.0|
3862645|NCT01610414|3687955|B3|Geographic ancestry|Mixed Origin|Race/Ethnicity, Customized||Participants|Count of Participants|56|56.0||||||
3862646|NCT01610414|3687956|B2|Geographic ancestry|Mixed Origin|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3862647|NCT01610414|3687957|B1|Geographic ancestry|Mixed Origin|Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3862648|NCT01610414|3687955|B3|Geographic ancestry|White - Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1427|1427.0||||||
3862649|NCT01610414|3687956|B2|Geographic ancestry|White - Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|712|712.0||||||
3862650|NCT01610414|3687957|B1|Geographic ancestry|White - Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|715|715.0||||||
3862651|NCT01610414|3687955|B3|Geographic ancestry|White - Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3862652|NCT01610414|3687956|B2|Geographic ancestry|White - Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3862653|NCT01610414|3687957|B1|Geographic ancestry|White - Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3862654|NCT01610414|3687955|B3|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3862655|NCT01610414|3687956|B2|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3862656|NCT01610414|3687957|B1|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3862657|NCT01610414|3687955|B3|Geographic ancestry|Asian - Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|81|81.0||||||
3862658|NCT01610414|3687956|B2|Geographic ancestry|Asian - Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
3862659|NCT01610414|3687957|B1|Geographic ancestry|Asian - Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
3862660|NCT01610414|3687955|B3|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|174|174.0||||||
3862661|NCT01610414|3687956|B2|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|91|91.0||||||
3862662|NCT01610414|3687957|B1|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|83|83.0||||||
3862663|NCT01610414|3687955|B3|Geographic ancestry|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3862664|NCT01610414|3687956|B2|Geographic ancestry|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3862665|NCT01610414|3687957|B1|Geographic ancestry|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3862666|NCT01610414|3687955|B3|Geographic ancestry|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3862667|NCT01610414|3687956|B2|Geographic ancestry|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3862668|NCT01610414|3687957|B1|Geographic ancestry|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3862669|NCT01610414|3687955|B3|Geographic ancestry|African Heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3862670|NCT01610414|3687956|B2|Geographic ancestry|African Heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3862671|NCT01610414|3687957|B1|Geographic ancestry|African Heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3862672|NCT01610414|3687955|B3||Male|Sex: Female, Male||Participants|Count of Participants|1158|1158.0||||||
3862673|NCT01610414|3687956|B2||Male|Sex: Female, Male||Participants|Count of Participants|578|578.0||||||
3862674|NCT01610414|3687957|B1||Male|Sex: Female, Male||Participants|Count of Participants|580|580.0||||||
3862675|NCT01610414|3687955|B3||Female|Sex: Female, Male||Participants|Count of Participants|688|688.0||||||
3862676|NCT01610414|3687956|B2||Female|Sex: Female, Male||Participants|Count of Participants|346|346.0||||||
3862677|NCT01610414|3687957|B1||Female|Sex: Female, Male||Participants|Count of Participants|342|342.0||||||
3862678|NCT01610414|3687955|B3|||Age||Years|Mean|55.0|55.0|Standard Deviation|11.6|11.6|||
3862679|NCT01610414|3687956|B2|||Age||Years|Mean|55.1|55.1|Standard Deviation|11.4|11.4|||
3862680|NCT01610414|3687957|B1|||Age||Years|Mean|54.8|54.8|Standard Deviation|11.7|11.7|||
3862686|NCT01610271|3687997|B1|No||Received preoperative antibiotic prophylaxis||participants|Number|0|0.0||||||
3862687|NCT01610271|3687995|B3|Yes||Received preoperative antibiotic prophylaxis||participants|Number|294|294.0||||||
3862688|NCT01610271|3687996|B2|Yes||Received preoperative antibiotic prophylaxis||participants|Number|148|148.0||||||
3862689|NCT01610271|3687997|B1|Yes||Received preoperative antibiotic prophylaxis||participants|Number|146|146.0||||||
3862690|NCT01610271|3687995|B3|Vascular Surgery||Surgery type||participants|Number|16|16.0||||||
3862691|NCT01610271|3687996|B2|Vascular Surgery||Surgery type||participants|Number|9|9.0||||||
3862692|NCT01610271|3687997|B1|Vascular Surgery||Surgery type||participants|Number|7|7.0||||||
3862693|NCT01610271|3687995|B3|Spine Surgery||Surgery type||participants|Number|132|132.0||||||
3862694|NCT01610271|3687996|B2|Spine Surgery||Surgery type||participants|Number|66|66.0||||||
3862695|NCT01610271|3687997|B1|Spine Surgery||Surgery type||participants|Number|66|66.0||||||
3862696|NCT01610271|3687995|B3|Total Hip Arthroplasty||Surgery type||participants|Number|146|146.0||||||
3862697|NCT01610271|3687996|B2|Total Hip Arthroplasty||Surgery type||participants|Number|73|73.0||||||
3862698|NCT01610271|3687997|B1|Total Hip Arthroplasty||Surgery type||participants|Number|73|73.0||||||
3862699|NCT01610271|3687995|B3|No||Revision surgery||participants|Number|266|266.0||||||
3862700|NCT01610271|3687996|B2|No||Revision surgery||participants|Number|133|133.0||||||
3862701|NCT01610271|3687997|B1|No||Revision surgery||participants|Number|133|133.0||||||
3862702|NCT01610271|3687995|B3|Yes||Revision surgery||participants|Number|28|28.0||||||
3862703|NCT01610271|3687996|B2|Yes||Revision surgery||participants|Number|15|15.0||||||
3862704|NCT01610271|3687997|B1|Yes||Revision surgery||participants|Number|13|13.0||||||
3862705|NCT01610271|3687995|B3|||Surgery time (minutes)||Minutes|Mean|115.0|115.0|Standard Deviation|57.8|57.8|||
3862706|NCT01610271|3687996|B2|||Surgery time (minutes)||Minutes|Mean|115.8|115.8|Standard Deviation|60.5|60.5|||
3862707|NCT01610271|3687997|B1|||Surgery time (minutes)||Minutes|Mean|114.2|114.2|Standard Deviation|55.0|55.0|||
3862708|NCT01610271|3687995|B3|||Number of people in operating room|Number of people present in operating room at the beginning of each ten-minute interval.|People in operating room|Mean|8.6|8.6|Standard Deviation|1.8|1.8|||
3862709|NCT01610271|3687996|B2|||Number of people in operating room|Number of people present in operating room at the beginning of each ten-minute interval.|People in operating room|Mean|8.6|8.6|Standard Deviation|1.8|1.8|||
3862710|NCT01610271|3687997|B1|||Number of people in operating room|Number of people present in operating room at the beginning of each ten-minute interval.|People in operating room|Mean|8.6|8.6|Standard Deviation|1.9|1.9|||
3862711|NCT01610271|3687995|B3|No||History of smoking||participants|Number|98|98.0||||||
3862712|NCT01610271|3687996|B2|No||History of smoking||participants|Number|39|39.0||||||
3862713|NCT01610271|3687997|B1|No||History of smoking||participants|Number|59|59.0||||||
3862714|NCT01610271|3687995|B3|Yes||History of smoking||participants|Number|196|196.0||||||
3862715|NCT01610271|3687996|B2|Yes||History of smoking||participants|Number|109|109.0||||||
3862716|NCT01610271|3687997|B1|Yes||History of smoking||participants|Number|87|87.0||||||
3862717|NCT01610271|3687995|B3|No||History of diabetes mellitus (type I or II)||participants|Number|241|241.0||||||
3862718|NCT01610271|3687996|B2|No||History of diabetes mellitus (type I or II)||participants|Number|120|120.0||||||
3862719|NCT01610271|3687997|B1|No||History of diabetes mellitus (type I or II)||participants|Number|121|121.0||||||
3862720|NCT01610271|3687995|B3|Yes||History of diabetes mellitus (type I or II)||participants|Number|53|53.0||||||
3862721|NCT01610271|3687996|B2|Yes||History of diabetes mellitus (type I or II)||participants|Number|28|28.0||||||
3862722|NCT01610271|3687997|B1|Yes||History of diabetes mellitus (type I or II)||participants|Number|25|25.0||||||
3862723|NCT01610271|3687995|B3|No||History of Cancer||participants|Number|255|255.0||||||
3862724|NCT01610271|3687996|B2|No||History of Cancer||participants|Number|127|127.0||||||
3862725|NCT01610271|3687997|B1|No||History of Cancer||participants|Number|128|128.0||||||
3862726|NCT01610271|3687995|B3|Yes||History of Cancer||participants|Number|39|39.0||||||
3862727|NCT01610271|3687996|B2|Yes||History of Cancer||participants|Number|21|21.0||||||
3862728|NCT01610271|3687997|B1|Yes||History of Cancer||participants|Number|18|18.0||||||
3862729|NCT01610271|3687995|B3|No||History of neurological condition||participants|Number|126|126.0||||||
3862730|NCT01610271|3687996|B2|No||History of neurological condition||participants|Number|63|63.0||||||
3862731|NCT01610271|3687997|B1|No||History of neurological condition||participants|Number|63|63.0||||||
3862732|NCT01610271|3687995|B3|Yes||History of neurological condition||participants|Number|168|168.0||||||
3862733|NCT01610271|3687996|B2|Yes||History of neurological condition||participants|Number|85|85.0||||||
3862734|NCT01610271|3687997|B1|Yes||History of neurological condition||participants|Number|83|83.0||||||
3862735|NCT01610271|3687995|B3|No||History of cardiopulmonary condition||participants|Number|21|21.0||||||
3862736|NCT01610271|3687996|B2|No||History of cardiopulmonary condition||participants|Number|9|9.0||||||
3862737|NCT01610271|3687997|B1|No||History of cardiopulmonary condition||participants|Number|12|12.0||||||
3862738|NCT01610271|3687995|B3|Yes||History of cardiopulmonary condition||participants|Number|273|273.0||||||
3862739|NCT01610271|3687996|B2|Yes||History of cardiopulmonary condition||participants|Number|139|139.0||||||
3862740|NCT01610271|3687997|B1|Yes||History of cardiopulmonary condition||participants|Number|134|134.0||||||
3862741|NCT01610271|3687995|B3|ASA Score 4||American Society of Anesthesiologists (ASA) Risk Score|"The American Society of Anesthesiologists (ASA) risk score is graded on a scale of 1 to 5 (integer), with ASA score of 1 being the least health risk and ASA score of 5 being the greatest health risk.~ASA score 1: Normal, healthy patient; ASA score 2: Patient with mild, systemic disease; ASA score 3: Patient with severe systemic disease; ASA score 4: Patient with severe systemic disease that is a constant threat to life."|Participants|Count of Participants|9|9.0||||||
3862742|NCT01610271|3687996|B2|ASA Score 4||American Society of Anesthesiologists (ASA) Risk Score|"The American Society of Anesthesiologists (ASA) risk score is graded on a scale of 1 to 5 (integer), with ASA score of 1 being the least health risk and ASA score of 5 being the greatest health risk.~ASA score 1: Normal, healthy patient; ASA score 2: Patient with mild, systemic disease; ASA score 3: Patient with severe systemic disease; ASA score 4: Patient with severe systemic disease that is a constant threat to life."|Participants|Count of Participants|4|4.0||||||
3862743|NCT01610271|3687997|B1|ASA Score 4||American Society of Anesthesiologists (ASA) Risk Score|"The American Society of Anesthesiologists (ASA) risk score is graded on a scale of 1 to 5 (integer), with ASA score of 1 being the least health risk and ASA score of 5 being the greatest health risk.~ASA score 1: Normal, healthy patient; ASA score 2: Patient with mild, systemic disease; ASA score 3: Patient with severe systemic disease; ASA score 4: Patient with severe systemic disease that is a constant threat to life."|Participants|Count of Participants|5|5.0||||||
3862744|NCT01610271|3687995|B3|ASA Score 3||American Society of Anesthesiologists (ASA) Risk Score|"The American Society of Anesthesiologists (ASA) risk score is graded on a scale of 1 to 5 (integer), with ASA score of 1 being the least health risk and ASA score of 5 being the greatest health risk.~ASA score 1: Normal, healthy patient; ASA score 2: Patient with mild, systemic disease; ASA score 3: Patient with severe systemic disease; ASA score 4: Patient with severe systemic disease that is a constant threat to life."|Participants|Count of Participants|209|209.0||||||
3862745|NCT01610271|3687996|B2|ASA Score 3||American Society of Anesthesiologists (ASA) Risk Score|"The American Society of Anesthesiologists (ASA) risk score is graded on a scale of 1 to 5 (integer), with ASA score of 1 being the least health risk and ASA score of 5 being the greatest health risk.~ASA score 1: Normal, healthy patient; ASA score 2: Patient with mild, systemic disease; ASA score 3: Patient with severe systemic disease; ASA score 4: Patient with severe systemic disease that is a constant threat to life."|Participants|Count of Participants|105|105.0||||||
3862746|NCT01610271|3687997|B1|ASA Score 3||American Society of Anesthesiologists (ASA) Risk Score|"The American Society of Anesthesiologists (ASA) risk score is graded on a scale of 1 to 5 (integer), with ASA score of 1 being the least health risk and ASA score of 5 being the greatest health risk.~ASA score 1: Normal, healthy patient; ASA score 2: Patient with mild, systemic disease; ASA score 3: Patient with severe systemic disease; ASA score 4: Patient with severe systemic disease that is a constant threat to life."|Participants|Count of Participants|104|104.0||||||
3862747|NCT01610271|3687995|B3|ASA Score 2||American Society of Anesthesiologists (ASA) Risk Score|"The American Society of Anesthesiologists (ASA) risk score is graded on a scale of 1 to 5 (integer), with ASA score of 1 being the least health risk and ASA score of 5 being the greatest health risk.~ASA score 1: Normal, healthy patient; ASA score 2: Patient with mild, systemic disease; ASA score 3: Patient with severe systemic disease; ASA score 4: Patient with severe systemic disease that is a constant threat to life."|Participants|Count of Participants|74|74.0||||||
3862748|NCT01610271|3687996|B2|ASA Score 2||American Society of Anesthesiologists (ASA) Risk Score|"The American Society of Anesthesiologists (ASA) risk score is graded on a scale of 1 to 5 (integer), with ASA score of 1 being the least health risk and ASA score of 5 being the greatest health risk.~ASA score 1: Normal, healthy patient; ASA score 2: Patient with mild, systemic disease; ASA score 3: Patient with severe systemic disease; ASA score 4: Patient with severe systemic disease that is a constant threat to life."|Participants|Count of Participants|39|39.0||||||
3862749|NCT01610271|3687997|B1|ASA Score 2||American Society of Anesthesiologists (ASA) Risk Score|"The American Society of Anesthesiologists (ASA) risk score is graded on a scale of 1 to 5 (integer), with ASA score of 1 being the least health risk and ASA score of 5 being the greatest health risk.~ASA score 1: Normal, healthy patient; ASA score 2: Patient with mild, systemic disease; ASA score 3: Patient with severe systemic disease; ASA score 4: Patient with severe systemic disease that is a constant threat to life."|Participants|Count of Participants|35|35.0||||||
3862750|NCT01610271|3687995|B3|ASA Score 1||American Society of Anesthesiologists (ASA) Risk Score|"The American Society of Anesthesiologists (ASA) risk score is graded on a scale of 1 to 5 (integer), with ASA score of 1 being the least health risk and ASA score of 5 being the greatest health risk.~ASA score 1: Normal, healthy patient; ASA score 2: Patient with mild, systemic disease; ASA score 3: Patient with severe systemic disease; ASA score 4: Patient with severe systemic disease that is a constant threat to life."|Participants|Count of Participants|2|2.0||||||
3862751|NCT01610271|3687996|B2|ASA Score 1||American Society of Anesthesiologists (ASA) Risk Score|"The American Society of Anesthesiologists (ASA) risk score is graded on a scale of 1 to 5 (integer), with ASA score of 1 being the least health risk and ASA score of 5 being the greatest health risk.~ASA score 1: Normal, healthy patient; ASA score 2: Patient with mild, systemic disease; ASA score 3: Patient with severe systemic disease; ASA score 4: Patient with severe systemic disease that is a constant threat to life."|Participants|Count of Participants|0|0.0||||||
3862752|NCT01610271|3687997|B1|ASA Score 1||American Society of Anesthesiologists (ASA) Risk Score|"The American Society of Anesthesiologists (ASA) risk score is graded on a scale of 1 to 5 (integer), with ASA score of 1 being the least health risk and ASA score of 5 being the greatest health risk.~ASA score 1: Normal, healthy patient; ASA score 2: Patient with mild, systemic disease; ASA score 3: Patient with severe systemic disease; ASA score 4: Patient with severe systemic disease that is a constant threat to life."|Participants|Count of Participants|2|2.0||||||
3862753|NCT01610271|3687995|B3|||BMI (kg/m^2)||kg/m^2|Mean|29.1|29.1|Standard Deviation|4.9|4.9|||
3862754|NCT01610271|3687996|B2|||BMI (kg/m^2)||kg/m^2|Mean|28.8|28.8|Standard Deviation|5.3|5.3|||
3862755|NCT01610271|3687997|B1|||BMI (kg/m^2)||kg/m^2|Mean|29.4|29.4|Standard Deviation|4.5|4.5|||
3862756|NCT01610271|3687995|B3|United States||Region of Enrollment||participants|Number|294|294.0||||||
3862757|NCT01610271|3687996|B2|United States||Region of Enrollment||participants|Number|148|148.0||||||
3862758|NCT01610271|3687997|B1|United States||Region of Enrollment||participants|Number|146|146.0||||||
3862759|NCT01610271|3687995|B3||Male|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
3862760|NCT01610271|3687996|B2||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3862761|NCT01610271|3687997|B1||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3862762|NCT01610271|3687995|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3862763|NCT01610271|3687996|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3862764|NCT01610271|3687997|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3862765|NCT01610271|3687995|B3|Age in Years||Age, Customized||years|Mean|61.2|61.2|Standard Deviation|10.0|10.0|||
3862766|NCT01610271|3687996|B2|Age in Years||Age, Customized||years|Mean|61.1|61.1|Standard Deviation|9.6|9.6|||
3862767|NCT01610271|3687997|B1|Age in Years||Age, Customized||years|Mean|61.3|61.3|Standard Deviation|10.4|10.4|||
3862768|NCT01610167|3688010|B4|United States||Region of Enrollment||participants|Number|151|151.0||||||
3862769|NCT01610167|3688011|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3862770|NCT01610167|3688012|B2|United States||Region of Enrollment||participants|Number|49|49.0||||||
3862771|NCT01610167|3688013|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
3862772|NCT01610167|3688010|B4||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3862773|NCT01610167|3688011|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3862774|NCT01610167|3688012|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3862775|NCT01610167|3688013|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3862776|NCT01610167|3688010|B4||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3862777|NCT01610167|3688011|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3862778|NCT01610167|3688012|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3862779|NCT01610167|3688013|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3862780|NCT01610167|3688010|B4|||Age||years|Mean|41.65|41.65|Standard Deviation|10.65|10.65|||
3862781|NCT01610167|3688011|B3|||Age||years|Mean|42.10|42.1|Standard Deviation|10.31|10.31|||
3862782|NCT01610167|3688012|B2|||Age||years|Mean|41.55|41.55|Standard Deviation|10.70|10.7|||
3862783|NCT01610167|3688013|B1|||Age||years|Mean|41.31|41.31|Standard Deviation|11.10|11.1|||
3862784|NCT01610167|3688010|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3862785|NCT01610167|3688011|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3862786|NCT01610167|3688012|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3862787|NCT01610167|3688013|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3862788|NCT01610167|3688010|B4||Between 18 and 65 years|Age||Participants|Count of Participants|150|150.0||||||
3862789|NCT01610167|3688011|B3||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3862790|NCT01610167|3688012|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3862791|NCT01610167|3688013|B1||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3862792|NCT01610167|3688010|B4||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3862793|NCT01610167|3688011|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3862794|NCT01610167|3688012|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3862795|NCT01610167|3688013|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3862796|NCT01610154|3688035|B1|||Body Mass Index (BMI)||kg/m2|Mean|25.8|25.8|Standard Deviation|3.41|3.41|||
3862797|NCT01610154|3688035|B1|China||Region of Enrollment||participants|Number|84|84.0||||||
3862798|NCT01610154|3688035|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3862799|NCT01610154|3688035|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3862800|NCT01610154|3688035|B1|||Age||years|Mean|48.8|48.8|Standard Deviation|12.2|12.2|||
3862801|NCT01610154|3688035|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3862802|NCT01610154|3688035|B1||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
3862803|NCT01610154|3688035|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3862804|NCT01610076|3688050|B3|United States||Region of Enrollment||participants|Number|208|208.0||||||
3862805|NCT01610076|3688051|B2|United States||Region of Enrollment||participants|Number|105|105.0||||||
3862806|NCT01610076|3688052|B1|United States||Region of Enrollment||participants|Number|103|103.0||||||
3862807|NCT01610076|3688050|B3||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3862808|NCT01610076|3688051|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3862809|NCT01610076|3688052|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3862810|NCT01610076|3688050|B3||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3862811|NCT01610076|3688051|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3862812|NCT01610076|3688052|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3862813|NCT01610076|3688050|B3|||Age||years|Median|60|60.0|Inter-Quartile Range|||45.0|73.0|
3862814|NCT01610076|3688051|B2|||Age||years|Median|58|58.0|Inter-Quartile Range|||44.0|73.0|
3862815|NCT01610076|3688052|B1|||Age||years|Median|62|62.0|Inter-Quartile Range|||47.0|73.0|
3862816|NCT01610063|3688062|B3|United States||Region of Enrollment||participants|Number|227|227.0||||||
3862817|NCT01610063|3688063|B2|United States||Region of Enrollment||participants|Number|113|113.0||||||
3862818|NCT01610063|3688064|B1|United States||Region of Enrollment||participants|Number|114|114.0||||||
3862819|NCT01610063|3688062|B3||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3862820|NCT01610063|3688063|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3862821|NCT01610063|3688064|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3862822|NCT01610063|3688062|B3||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3862823|NCT01610063|3688063|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3862824|NCT01610063|3688064|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3862825|NCT01610063|3688062|B3|||Age||years|Mean|42.62|42.62|Standard Deviation|12.55|12.55|||
3862826|NCT01610063|3688063|B2|||Age||years|Mean|44.0|44.0|Standard Deviation|12.1|12.1|||
3862827|NCT01610063|3688064|B1|||Age||years|Mean|41.0|41.0|Standard Deviation|12.8|12.8|||
3862828|NCT01610037|3688085|B4||Male|Sex: Female, Male||Participants|Count of Participants|898|898.0||||||
3862829|NCT01610037|3688086|B3||Male|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
3862830|NCT01610037|3688087|B2||Male|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
3862831|NCT01610037|3688088|B1||Male|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
3862832|NCT01610037|3688085|B4||Female|Sex: Female, Male||Participants|Count of Participants|318|318.0||||||
3862833|NCT01610037|3688086|B3||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3862834|NCT01610037|3688087|B2||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3862835|NCT01610037|3688088|B1||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3862836|NCT01610037|3688085|B4|||Age||Years|Mean|64.5|64.5|Standard Deviation|8.14|8.14|||
3862837|NCT01610037|3688086|B3|||Age||Years|Mean|64.9|64.9|Standard Deviation|7.95|7.95|||
3862838|NCT01610037|3688087|B2|||Age||Years|Mean|64.1|64.1|Standard Deviation|8.57|8.57|||
3862839|NCT01610037|3688088|B1|||Age||Years|Mean|64.6|64.6|Standard Deviation|7.89|7.89|||
3862840|NCT01610011|3688131|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3862841|NCT01610011|3688132|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3862842|NCT01610011|3688133|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3862843|NCT01610011|3688131|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3862844|NCT01610011|3688132|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3862845|NCT01610011|3688133|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3862846|NCT01610011|3688131|B3|||Age||years|Mean|35.9|35.9|Standard Deviation|13.4|13.4|||
3862847|NCT01610011|3688132|B2|||Age||years|Mean|48|48.0|Standard Deviation|19.8|19.8|||
3862848|NCT01610011|3688133|B1|||Age||years|Mean|33.2|33.2|Standard Deviation|11.5|11.5|||
3862849|NCT01609933|3688140|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862850|NCT01609933|3688140|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862851|NCT01609933|3688140|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3862852|NCT01609933|3688140|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3862853|NCT01609933|3688140|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862854|NCT01609933|3688140|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862855|NCT01609933|3688140|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3862856|NCT01609933|3688140|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3862857|NCT01609933|3688140|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3862858|NCT01609933|3688140|B1|||Age||years|Mean|51.4|51.4|Standard Deviation|9.77|9.77|||
3862859|NCT01609790|3688147|B4||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3862860|NCT01609790|3688148|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3862861|NCT01609790|3688149|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3862862|NCT01609790|3688150|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3862863|NCT01609790|3688147|B4||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3862864|NCT01609790|3688148|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3862865|NCT01609790|3688149|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3862866|NCT01609790|3688150|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3862867|NCT01609790|3688147|B4|||Age||years|Median|58|58.0|Full Range|||22.0|80.0|
3862868|NCT01609790|3688148|B3|||Age||years|Median|57|57.0|Full Range|||30.0|80.0|
3862869|NCT01609790|3688149|B2|||Age||years|Median|58|58.0|Full Range|||22.0|79.0|
3862870|NCT01609790|3688150|B1|||Age||years|Median|56|56.0|Full Range|||28.0|75.0|
3862871|NCT01609582|3688169|B3|United States||Region of Enrollment||participants|Number|1118|1118.0||||||
3862872|NCT01609582|3688170|B2|United States||Region of Enrollment||participants|Number|559|559.0||||||
3862873|NCT01609582|3688171|B1|United States||Region of Enrollment||participants|Number|559|559.0||||||
3862874|NCT01609582|3688169|B3|United Kingdom||Region of Enrollment||participants|Number|32|32.0||||||
3862875|NCT01609582|3688170|B2|United Kingdom||Region of Enrollment||participants|Number|16|16.0||||||
3862876|NCT01609582|3688171|B1|United Kingdom||Region of Enrollment||participants|Number|16|16.0||||||
3862877|NCT01609582|3688169|B3|Ukraine||Region of Enrollment||participants|Number|152|152.0||||||
3862878|NCT01609582|3688170|B2|Ukraine||Region of Enrollment||participants|Number|76|76.0||||||
3862879|NCT01609582|3688171|B1|Ukraine||Region of Enrollment||participants|Number|76|76.0||||||
3862880|NCT01609582|3688169|B3|Thailand||Region of Enrollment||participants|Number|61|61.0||||||
3862881|NCT01609582|3688170|B2|Thailand||Region of Enrollment||participants|Number|32|32.0||||||
3862882|NCT01609582|3688171|B1|Thailand||Region of Enrollment||participants|Number|29|29.0||||||
3862883|NCT01609582|3688169|B3|Taiwan, Province of China||Region of Enrollment||participants|Number|62|62.0||||||
3862884|NCT01609582|3688170|B2|Taiwan, Province of China||Region of Enrollment||participants|Number|31|31.0||||||
3862885|NCT01609582|3688171|B1|Taiwan, Province of China||Region of Enrollment||participants|Number|31|31.0||||||
3862886|NCT01609582|3688169|B3|South Africa||Region of Enrollment||participants|Number|20|20.0||||||
3862887|NCT01609582|3688170|B2|South Africa||Region of Enrollment||participants|Number|10|10.0||||||
3862888|NCT01609582|3688171|B1|South Africa||Region of Enrollment||participants|Number|10|10.0||||||
3862889|NCT01609582|3688169|B3|Slovakia||Region of Enrollment||participants|Number|62|62.0||||||
3862890|NCT01609582|3688170|B2|Slovakia||Region of Enrollment||participants|Number|31|31.0||||||
3862891|NCT01609582|3688171|B1|Slovakia||Region of Enrollment||participants|Number|31|31.0||||||
3862892|NCT01609582|3688169|B3|Russian Federation||Region of Enrollment||participants|Number|48|48.0||||||
3862893|NCT01609582|3688170|B2|Russian Federation||Region of Enrollment||participants|Number|23|23.0||||||
3862894|NCT01609582|3688171|B1|Russian Federation||Region of Enrollment||participants|Number|25|25.0||||||
3862895|NCT01609582|3688169|B3|Romania||Region of Enrollment||participants|Number|9|9.0||||||
3862896|NCT01609582|3688170|B2|Romania||Region of Enrollment||participants|Number|4|4.0||||||
3862897|NCT01609582|3688171|B1|Romania||Region of Enrollment||participants|Number|5|5.0||||||
3862898|NCT01609582|3688169|B3|Poland||Region of Enrollment||participants|Number|236|236.0||||||
3862899|NCT01609582|3688170|B2|Poland||Region of Enrollment||participants|Number|118|118.0||||||
3862900|NCT01609582|3688171|B1|Poland||Region of Enrollment||participants|Number|118|118.0||||||
3862901|NCT01609582|3688169|B3|Philippines||Region of Enrollment||participants|Number|49|49.0||||||
3862902|NCT01609582|3688170|B2|Philippines||Region of Enrollment||participants|Number|24|24.0||||||
3862903|NCT01609582|3688171|B1|Philippines||Region of Enrollment||participants|Number|25|25.0||||||
3862904|NCT01609582|3688169|B3|Peru||Region of Enrollment||participants|Number|35|35.0||||||
3862905|NCT01609582|3688170|B2|Peru||Region of Enrollment||participants|Number|17|17.0||||||
3862906|NCT01609582|3688171|B1|Peru||Region of Enrollment||participants|Number|18|18.0||||||
3862907|NCT01609582|3688169|B3|New Zealand||Region of Enrollment||participants|Number|40|40.0||||||
3862908|NCT01609582|3688170|B2|New Zealand||Region of Enrollment||participants|Number|20|20.0||||||
3862909|NCT01609582|3688171|B1|New Zealand||Region of Enrollment||participants|Number|20|20.0||||||
3862910|NCT01609582|3688169|B3|Mexico||Region of Enrollment||participants|Number|52|52.0||||||
3862911|NCT01609582|3688170|B2|Mexico||Region of Enrollment||participants|Number|26|26.0||||||
3862912|NCT01609582|3688171|B1|Mexico||Region of Enrollment||participants|Number|26|26.0||||||
3862913|NCT01609582|3688169|B3|Malaysia||Region of Enrollment||participants|Number|61|61.0||||||
3862914|NCT01609582|3688170|B2|Malaysia||Region of Enrollment||participants|Number|31|31.0||||||
3862915|NCT01609582|3688171|B1|Malaysia||Region of Enrollment||participants|Number|30|30.0||||||
3862916|NCT01609582|3688169|B3|Lithuania||Region of Enrollment||participants|Number|30|30.0||||||
3862917|NCT01609582|3688170|B2|Lithuania||Region of Enrollment||participants|Number|15|15.0||||||
3862918|NCT01609582|3688171|B1|Lithuania||Region of Enrollment||participants|Number|15|15.0||||||
3862919|NCT01609582|3688169|B3|Latvia||Region of Enrollment||participants|Number|22|22.0||||||
3862920|NCT01609582|3688170|B2|Latvia||Region of Enrollment||participants|Number|11|11.0||||||
3862921|NCT01609582|3688171|B1|Latvia||Region of Enrollment||participants|Number|11|11.0||||||
3862922|NCT01609582|3688169|B3|Korea, Republic of||Region of Enrollment||participants|Number|56|56.0||||||
3862923|NCT01609582|3688170|B2|Korea, Republic of||Region of Enrollment||participants|Number|27|27.0||||||
3862924|NCT01609582|3688171|B1|Korea, Republic of||Region of Enrollment||participants|Number|29|29.0||||||
3862925|NCT01609582|3688169|B3|Italy||Region of Enrollment||participants|Number|6|6.0||||||
3862926|NCT01609582|3688170|B2|Italy||Region of Enrollment||participants|Number|3|3.0||||||
3862927|NCT01609582|3688171|B1|Italy||Region of Enrollment||participants|Number|3|3.0||||||
3862928|NCT01609582|3688169|B3|Israel||Region of Enrollment||participants|Number|51|51.0||||||
3862929|NCT01609582|3688170|B2|Israel||Region of Enrollment||participants|Number|26|26.0||||||
3862930|NCT01609582|3688171|B1|Israel||Region of Enrollment||participants|Number|25|25.0||||||
3862931|NCT01609582|3688169|B3|Hungary||Region of Enrollment||participants|Number|146|146.0||||||
3862932|NCT01609582|3688170|B2|Hungary||Region of Enrollment||participants|Number|72|72.0||||||
3862933|NCT01609582|3688171|B1|Hungary||Region of Enrollment||participants|Number|74|74.0||||||
3862934|NCT01609582|3688169|B3|Hong Kong||Region of Enrollment||participants|Number|58|58.0||||||
3862935|NCT01609582|3688170|B2|Hong Kong||Region of Enrollment||participants|Number|29|29.0||||||
3862936|NCT01609582|3688171|B1|Hong Kong||Region of Enrollment||participants|Number|29|29.0||||||
3862937|NCT01609582|3688169|B3|Germany||Region of Enrollment||participants|Number|60|60.0||||||
3862938|NCT01609582|3688170|B2|Germany||Region of Enrollment||participants|Number|30|30.0||||||
3862939|NCT01609582|3688171|B1|Germany||Region of Enrollment||participants|Number|30|30.0||||||
3862940|NCT01609582|3688169|B3|France||Region of Enrollment||participants|Number|7|7.0||||||
3862941|NCT01609582|3688170|B2|France||Region of Enrollment||participants|Number|4|4.0||||||
3862942|NCT01609582|3688171|B1|France||Region of Enrollment||participants|Number|3|3.0||||||
3862943|NCT01609582|3688169|B3|Estonia||Region of Enrollment||participants|Number|24|24.0||||||
3862944|NCT01609582|3688170|B2|Estonia||Region of Enrollment||participants|Number|11|11.0||||||
3862945|NCT01609582|3688171|B1|Estonia||Region of Enrollment||participants|Number|13|13.0||||||
3862946|NCT01609582|3688169|B3|Czech Republic||Region of Enrollment||participants|Number|112|112.0||||||
3862947|NCT01609582|3688170|B2|Czech Republic||Region of Enrollment||participants|Number|56|56.0||||||
3862948|NCT01609582|3688171|B1|Czech Republic||Region of Enrollment||participants|Number|56|56.0||||||
3862949|NCT01609582|3688169|B3|Croatia||Region of Enrollment||participants|Number|33|33.0||||||
3862950|NCT01609582|3688170|B2|Croatia||Region of Enrollment||participants|Number|17|17.0||||||
3862951|NCT01609582|3688171|B1|Croatia||Region of Enrollment||participants|Number|16|16.0||||||
3862952|NCT01609582|3688169|B3|Canada||Region of Enrollment||participants|Number|211|211.0||||||
3862953|NCT01609582|3688170|B2|Canada||Region of Enrollment||participants|Number|107|107.0||||||
3862954|NCT01609582|3688171|B1|Canada||Region of Enrollment||participants|Number|104|104.0||||||
3862955|NCT01609582|3688169|B3|Bulgaria||Region of Enrollment||participants|Number|43|43.0||||||
3862956|NCT01609582|3688170|B2|Bulgaria||Region of Enrollment||participants|Number|22|22.0||||||
3862957|NCT01609582|3688171|B1|Bulgaria||Region of Enrollment||participants|Number|21|21.0||||||
3862958|NCT01609582|3688169|B3|Australia||Region of Enrollment||participants|Number|69|69.0||||||
3862959|NCT01609582|3688170|B2|Australia||Region of Enrollment||participants|Number|35|35.0||||||
3862960|NCT01609582|3688171|B1|Australia||Region of Enrollment||participants|Number|34|34.0||||||
3862961|NCT01609582|3688169|B3|Argentina||Region of Enrollment||participants|Number|242|242.0||||||
3862962|NCT01609582|3688170|B2|Argentina||Region of Enrollment||participants|Number|121|121.0||||||
3862963|NCT01609582|3688171|B1|Argentina||Region of Enrollment||participants|Number|121|121.0||||||
3862964|NCT01609582|3688169|B3|||Duration of Diabetes|For this outcome measure, number of participants evaluable were 1602 and 1602 for each arm, respectively.|years|Mean|13.458|13.458|Standard Deviation|8.365|8.365|||
3862965|NCT01609582|3688170|B2|||Duration of Diabetes|For this outcome measure, number of participants evaluable were 1602 and 1602 for each arm, respectively.|years|Mean|13.333|13.333|Standard Deviation|8.321|8.321|||
3862966|NCT01609582|3688171|B1|||Duration of Diabetes|For this outcome measure, number of participants evaluable were 1602 and 1602 for each arm, respectively.|years|Mean|13.583|13.583|Standard Deviation|8.409|8.409|||
3862967|NCT01609582|3688169|B3|Ex-smoker||Smoking Classification||participants|Number|1214|1214.0||||||
3862968|NCT01609582|3688170|B2|Ex-smoker||Smoking Classification||participants|Number|608|608.0||||||
3862969|NCT01609582|3688171|B1|Ex-smoker||Smoking Classification||participants|Number|606|606.0||||||
3862970|NCT01609582|3688169|B3|Current smoker||Smoking Classification||participants|Number|658|658.0||||||
3862971|NCT01609582|3688170|B2|Current smoker||Smoking Classification||participants|Number|328|328.0||||||
3862972|NCT01609582|3688171|B1|Current smoker||Smoking Classification||participants|Number|330|330.0||||||
3862973|NCT01609582|3688169|B3|Never smoked||Smoking Classification||participants|Number|1335|1335.0||||||
3862974|NCT01609582|3688170|B2|Never smoked||Smoking Classification||participants|Number|668|668.0||||||
3862975|NCT01609582|3688171|B1|Never smoked||Smoking Classification||participants|Number|667|667.0||||||
3862976|NCT01609582|3688169|B3|>=8.5%||Glycosylated Hemoglobin (HbA1c) Category||participants|Number|1283|1283.0||||||
3862977|NCT01609582|3688170|B2|>=8.5%||Glycosylated Hemoglobin (HbA1c) Category||participants|Number|668|668.0||||||
3862978|NCT01609582|3688171|B1|>=8.5%||Glycosylated Hemoglobin (HbA1c) Category||participants|Number|615|615.0||||||
3862979|NCT01609582|3688169|B3|<8.5 percent (%)||Glycosylated Hemoglobin (HbA1c) Category||participants|Number|1924|1924.0||||||
3862980|NCT01609582|3688170|B2|<8.5 percent (%)||Glycosylated Hemoglobin (HbA1c) Category||participants|Number|936|936.0||||||
3862981|NCT01609582|3688171|B1|<8.5 percent (%)||Glycosylated Hemoglobin (HbA1c) Category||participants|Number|988|988.0||||||
3862982|NCT01609582|3688169|B3|||Body Mass Index (BMI)|For this outcome measure, number of participants evaluable were 1598 and 1597 for each arm, respectively.|kilogram per square meter (kg/m^2)|Mean|32.30|32.3|Standard Deviation|6.838|6.838|||
3862983|NCT01609582|3688170|B2|||Body Mass Index (BMI)|For this outcome measure, number of participants evaluable were 1598 and 1597 for each arm, respectively.|kilogram per square meter (kg/m^2)|Mean|32.45|32.45|Standard Deviation|7.497|7.497|||
3862984|NCT01609582|3688171|B1|||Body Mass Index (BMI)|For this outcome measure, number of participants evaluable were 1598 and 1597 for each arm, respectively.|kilogram per square meter (kg/m^2)|Mean|32.14|32.14|Standard Deviation|6.107|6.107|||
3862985|NCT01609582|3688169|B3|||Weight||kilogram (kg)|Mean|91.27|91.27|Standard Deviation|20.586|20.586|||
3862986|NCT01609582|3688170|B2|||Weight||kilogram (kg)|Mean|91.40|91.4|Standard Deviation|21.319|21.319|||
3862987|NCT01609582|3688171|B1|||Weight||kilogram (kg)|Mean|91.14|91.14|Standard Deviation|19.832|19.832|||
3862988|NCT01609582|3688169|B3|||Height|For this outcome measure, number of participants evaluable were 1598 and 1597 for each arm, respectively.|centimeter (cm)|Mean|167.8|167.8|Standard Deviation|10.20|10.2|||
3862989|NCT01609582|3688170|B2|||Height|For this outcome measure, number of participants evaluable were 1598 and 1597 for each arm, respectively.|centimeter (cm)|Mean|167.6|167.6|Standard Deviation|10.54|10.54|||
3862990|NCT01609582|3688171|B1|||Height|For this outcome measure, number of participants evaluable were 1598 and 1597 for each arm, respectively.|centimeter (cm)|Mean|168.1|168.1|Standard Deviation|9.84|9.84|||
3862991|NCT01609582|3688169|B3|Multiracial/More than 1 race||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3862992|NCT01609582|3688170|B2|Multiracial/More than 1 race||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3862993|NCT01609582|3688171|B1|Multiracial/More than 1 race||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3862994|NCT01609582|3688169|B3|White||Race/Ethnicity, Customized||participants|Number|2511|2511.0||||||
3862995|NCT01609582|3688170|B2|White||Race/Ethnicity, Customized||participants|Number|1246|1246.0||||||
3862996|NCT01609582|3688171|B1|White||Race/Ethnicity, Customized||participants|Number|1265|1265.0||||||
3862997|NCT01609582|3688169|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|174|174.0||||||
3862998|NCT01609582|3688170|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|95|95.0||||||
3862999|NCT01609582|3688171|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
3863000|NCT01609582|3688169|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3863001|NCT01609582|3688170|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3863002|NCT01609582|3688171|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3863003|NCT01609582|3688169|B3|Asian||Race/Ethnicity, Customized||participants|Number|404|404.0||||||
3863004|NCT01609582|3688170|B2|Asian||Race/Ethnicity, Customized||participants|Number|205|205.0||||||
3863005|NCT01609582|3688171|B1|Asian||Race/Ethnicity, Customized||participants|Number|199|199.0||||||
3863006|NCT01609582|3688169|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|88|88.0||||||
3863007|NCT01609582|3688170|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
3863008|NCT01609582|3688171|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
3863009|NCT01609582|3688169|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2015|2015.0||||||
3863010|NCT01609582|3688170|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1008|1008.0||||||
3863011|NCT01609582|3688171|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1007|1007.0||||||
3863012|NCT01609582|3688169|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|923|923.0||||||
3863013|NCT01609582|3688170|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|477|477.0||||||
3863014|NCT01609582|3688171|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|446|446.0||||||
3863015|NCT01609582|3688169|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|269|269.0||||||
3863016|NCT01609582|3688170|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
3863017|NCT01609582|3688171|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|150|150.0||||||
3863018|NCT01609582|3688169|B3||Male|Sex: Female, Male||Participants|Count of Participants|2101|2101.0||||||
3863019|NCT01609582|3688170|B2||Male|Sex: Female, Male||Participants|Count of Participants|1041|1041.0||||||
3863020|NCT01609582|3688171|B1||Male|Sex: Female, Male||Participants|Count of Participants|1060|1060.0||||||
3863021|NCT01609582|3688169|B3||Female|Sex: Female, Male||Participants|Count of Participants|1106|1106.0||||||
3863022|NCT01609582|3688170|B2||Female|Sex: Female, Male||Participants|Count of Participants|563|563.0||||||
3863023|NCT01609582|3688171|B1||Female|Sex: Female, Male||Participants|Count of Participants|543|543.0||||||
3863024|NCT01609582|3688169|B3|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|1562|1562.0||||||
3863025|NCT01609582|3688170|B2|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|753|753.0||||||
3863026|NCT01609582|3688171|B1|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|809|809.0||||||
3863027|NCT01609582|3688169|B3|Less than (<) 65 years||Age, Customized||participants|Number|1645|1645.0||||||
3863028|NCT01609582|3688170|B2|Less than (<) 65 years||Age, Customized||participants|Number|851|851.0||||||
3863029|NCT01609582|3688171|B1|Less than (<) 65 years||Age, Customized||participants|Number|794|794.0||||||
3863030|NCT01609582|3688169|B3|||Age||years|Mean|63.7|63.7|Standard Deviation|9.12|9.12|||
3863031|NCT01609582|3688170|B2|||Age||years|Mean|63.4|63.4|Standard Deviation|9.20|9.2|||
3863032|NCT01609582|3688171|B1|||Age||years|Mean|63.9|63.9|Standard Deviation|9.03|9.03|||
3863033|NCT01609543|3688180|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3863034|NCT01609543|3688180|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3863035|NCT01609543|3688180|B1|||Age||Years|Mean|67.69|67.69|Standard Deviation|10.562|10.562|||
3863036|NCT01609478|3688186|B4||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3863037|NCT01609478|3688187|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3863038|NCT01609478|3688188|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3863039|NCT01609478|3688189|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3863040|NCT01609478|3688186|B4||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3863041|NCT01609478|3688187|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3863042|NCT01609478|3688188|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3863043|NCT01609478|3688189|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3863044|NCT01609478|3688186|B4|||Age||years|Mean|49.6|49.6|Standard Deviation|13.76|13.76|||
3863045|NCT01609478|3688187|B3|||Age||years|Mean|49.8|49.8|Standard Deviation|12.96|12.96|||
3863046|NCT01609478|3688188|B2|||Age||years|Mean|48.1|48.1|Standard Deviation|13.53|13.53|||
3863047|NCT01609478|3688189|B1|||Age||years|Mean|50.7|50.7|Standard Deviation|14.74|14.74|||
3863048|NCT01609348|3688255|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863049|NCT01609348|3688256|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863050|NCT01609348|3688257|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863051|NCT01609348|3688255|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863052|NCT01609348|3688256|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863053|NCT01609348|3688257|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863054|NCT01609348|3688255|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3863055|NCT01609348|3688256|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3863056|NCT01609348|3688257|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3863057|NCT01609348|3688255|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3863058|NCT01609348|3688256|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863059|NCT01609348|3688257|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3863060|NCT01609348|3688255|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863061|NCT01609348|3688256|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863062|NCT01609348|3688257|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863063|NCT01609348|3688255|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863064|NCT01609348|3688256|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863065|NCT01609348|3688257|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863066|NCT01609348|3688255|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863067|NCT01609348|3688256|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863068|NCT01609348|3688257|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863069|NCT01609348|3688255|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3863070|NCT01609348|3688256|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3863071|NCT01609348|3688257|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3863072|NCT01609348|3688255|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3863073|NCT01609348|3688256|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3863074|NCT01609348|3688257|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3863075|NCT01609348|3688255|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3863076|NCT01609348|3688256|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3863077|NCT01609348|3688257|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3863078|NCT01609348|3688255|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3863079|NCT01609348|3688256|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3863080|NCT01609348|3688257|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3863081|NCT01609348|3688255|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3863082|NCT01609348|3688256|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3863083|NCT01609348|3688257|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3863084|NCT01609257|3688264|B3|United States||Region of Enrollment||participants|Number|132|132.0||||||
3863085|NCT01609257|3688265|B2|United States||Region of Enrollment||participants|Number|65|65.0||||||
3863086|NCT01609257|3688266|B1|United States||Region of Enrollment||participants|Number|67|67.0||||||
3863087|NCT01609257|3688264|B3|Multi-Racial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3863088|NCT01609257|3688265|B2|Multi-Racial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3863089|NCT01609257|3688266|B1|Multi-Racial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3863090|NCT01609257|3688264|B3|White||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
3863091|NCT01609257|3688265|B2|White||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3863092|NCT01609257|3688266|B1|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3863093|NCT01609257|3688264|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|73|73.0||||||
3863094|NCT01609257|3688265|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3863095|NCT01609257|3688266|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
3863096|NCT01609257|3688264|B3|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3863097|NCT01609257|3688265|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3863098|NCT01609257|3688266|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3863099|NCT01609257|3688264|B3|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3863100|NCT01609257|3688265|B2|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3863101|NCT01609257|3688266|B1|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3863102|NCT01609257|3688264|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3863103|NCT01609257|3688265|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3863104|NCT01609257|3688266|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3863105|NCT01609257|3688264|B3|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|128|128.0||||||
3863106|NCT01609257|3688265|B2|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
3863107|NCT01609257|3688266|B1|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
3863108|NCT01609257|3688264|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3863109|NCT01609257|3688265|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3863110|NCT01609257|3688266|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3863111|NCT01609257|3688264|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3863112|NCT01609257|3688265|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3863113|NCT01609257|3688266|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3863114|NCT01609257|3688264|B3|||Age||years|Mean|32.4|32.4|Standard Deviation|9.7|9.7|||
3863115|NCT01609257|3688265|B2|||Age||years|Mean|32.1|32.1|Standard Deviation|9.3|9.3|||
3863116|NCT01609257|3688266|B1|||Age||years|Mean|32.8|32.8|Standard Deviation|10.2|10.2|||
3863117|NCT01609062|3688337|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
3863118|NCT01609062|3688338|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3863119|NCT01609062|3688339|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3863120|NCT01609062|3688337|B3|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
3863121|NCT01609062|3688338|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3863122|NCT01609062|3688339|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3863123|NCT01609062|3688337|B3|Germany||Region of Enrollment||participants|Number|3|3.0||||||
3863124|NCT01609062|3688338|B2|Germany||Region of Enrollment||participants|Number|3|3.0||||||
3863125|NCT01609062|3688339|B1|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3863126|NCT01609062|3688337|B3|Canada||Region of Enrollment||participants|Number|6|6.0||||||
3863127|NCT01609062|3688338|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3863128|NCT01609062|3688339|B1|Canada||Region of Enrollment||participants|Number|5|5.0||||||
3863129|NCT01609062|3688337|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3863130|NCT01609062|3688338|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3863131|NCT01609062|3688339|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3863132|NCT01609062|3688337|B3|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3863133|NCT01609062|3688338|B2|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3863134|NCT01609062|3688339|B1|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3863135|NCT01609062|3688337|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3863136|NCT01609062|3688338|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3863137|NCT01609062|3688339|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3863138|NCT01609062|3688337|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3863139|NCT01609062|3688338|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3863140|NCT01609062|3688339|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3863141|NCT01609062|3688337|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3863142|NCT01609062|3688338|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3863143|NCT01609062|3688339|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3863144|NCT01609062|3688337|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3863145|NCT01609062|3688338|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3863146|NCT01609062|3688339|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3863147|NCT01609062|3688337|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863148|NCT01609062|3688338|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863149|NCT01609062|3688339|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863150|NCT01609062|3688337|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3863151|NCT01609062|3688338|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3863152|NCT01609062|3688339|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3863153|NCT01609062|3688337|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3863154|NCT01609062|3688338|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3863155|NCT01609062|3688339|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3863156|NCT01609062|3688337|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3863157|NCT01609062|3688338|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3863158|NCT01609062|3688339|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3863159|NCT01609062|3688337|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3863160|NCT01609062|3688338|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3863161|NCT01609062|3688339|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3863162|NCT01609062|3688337|B3|>=19 years||Age, Customized||participants|Number|3|3.0||||||
3863163|NCT01609062|3688338|B2|>=19 years||Age, Customized||participants|Number|0|0.0||||||
3863164|NCT01609062|3688339|B1|>=19 years||Age, Customized||participants|Number|3|3.0||||||
3863165|NCT01609062|3688337|B3|12 to 18 years||Age, Customized||participants|Number|8|8.0||||||
3863166|NCT01609062|3688338|B2|12 to 18 years||Age, Customized||participants|Number|5|5.0||||||
3863167|NCT01609062|3688339|B1|12 to 18 years||Age, Customized||participants|Number|3|3.0||||||
3863168|NCT01609062|3688337|B3|7 to 11 years||Age, Customized||participants|Number|14|14.0||||||
3863169|NCT01609062|3688338|B2|7 to 11 years||Age, Customized||participants|Number|5|5.0||||||
3863170|NCT01609062|3688339|B1|7 to 11 years||Age, Customized||participants|Number|9|9.0||||||
3863171|NCT01609062|3688337|B3|||Age||years|Mean|13.7|13.7|Standard Deviation|7.52|7.52|||
3863172|NCT01609062|3688338|B2|||Age||years|Mean|12.0|12.0|Standard Deviation|3.16|3.16|||
3863173|NCT01609062|3688339|B1|||Age||years|Mean|14.9|14.9|Standard Deviation|9.32|9.32|||
3863174|NCT01609023|3688383|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3863175|NCT01609023|3688383|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3863176|NCT01609023|3688383|B1|||Age||years|Mean|69.12|69.12|Standard Deviation|10.08|10.08|||
3863177|NCT01609010|3688393|B3||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3863178|NCT01609010|3688394|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3863179|NCT01609010|3688395|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3863180|NCT01609010|3688393|B3||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3863181|NCT01609010|3688394|B2||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3863182|NCT01609010|3688395|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3863183|NCT01609010|3688393|B3|||Age||years|Mean|58.1|58.1|Standard Deviation|11.2|11.2|||
3863184|NCT01609010|3688394|B2|||Age||years|Mean|57.2|57.2|Standard Deviation|10.8|10.8|||
3863185|NCT01609010|3688395|B1|||Age||years|Mean|59.1|59.1|Standard Deviation|11.6|11.6|||
3863186|NCT01608971|3688420|B3|Germany||Region of Enrollment||participants|Number|30|30.0||||||
3863187|NCT01608971|3688421|B2|Germany||Region of Enrollment||participants|Number|15|15.0||||||
3863188|NCT01608971|3688422|B1|Germany||Region of Enrollment||participants|Number|15|15.0||||||
3863189|NCT01608971|3688420|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3863190|NCT01608971|3688421|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3863191|NCT01608971|3688422|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3863192|NCT01608971|3688420|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3863193|NCT01608971|3688421|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3863194|NCT01608971|3688422|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3863195|NCT01608971|3688420|B3||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3863196|NCT01608971|3688421|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3863197|NCT01608971|3688422|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3863198|NCT01608971|3688420|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3863199|NCT01608971|3688421|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3863200|NCT01608971|3688422|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3863201|NCT01608971|3688420|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3863202|NCT01608971|3688421|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3863203|NCT01608971|3688422|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3863204|NCT01608815|3688435|B4|Japan||Region of Enrollment||Participants|Number|200|200.0||||||
3863205|NCT01608815|3688436|B3|Japan||Region of Enrollment||Participants|Number|5|5.0||||||
3863206|NCT01608815|3688437|B2|Japan||Region of Enrollment||Participants|Number|7|7.0||||||
3863207|NCT01608815|3688438|B1|Japan||Region of Enrollment||Participants|Number|188|188.0||||||
3863208|NCT01608815|3688435|B4||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3863209|NCT01608815|3688436|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3863210|NCT01608815|3688437|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3863211|NCT01608815|3688438|B1||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3863212|NCT01608815|3688435|B4||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3863213|NCT01608815|3688436|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3863214|NCT01608815|3688437|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3863215|NCT01608815|3688438|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3863216|NCT01608815|3688435|B4|||Age||Years|Mean|35.7|35.7|Standard Deviation|12.7|12.7|||
3863217|NCT01608815|3688436|B3|||Age||Years|Mean|5.2|5.2|Standard Deviation|3.8|3.8|||
3863218|NCT01608815|3688437|B2|||Age||Years|Mean|15.6|15.6|Standard Deviation|2.0|2.0|||
3863219|NCT01608815|3688438|B1|||Age||Years|Mean|37.2|37.2|Standard Deviation|11.4|11.4|||
3863220|NCT01608815|3688435|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3863221|NCT01608815|3688436|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3863222|NCT01608815|3688437|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3863223|NCT01608815|3688438|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3863224|NCT01608815|3688435|B4||Between 18 and 65 years|Age||Participants|Count of Participants|188|188.0||||||
3863225|NCT01608815|3688436|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3863226|NCT01608815|3688437|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3863227|NCT01608815|3688438|B1||Between 18 and 65 years|Age||Participants|Count of Participants|188|188.0||||||
3863228|NCT01608815|3688435|B4||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
3863229|NCT01608815|3688436|B3||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3863230|NCT01608815|3688437|B2||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
3863231|NCT01608815|3688438|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3863232|NCT01608724|3688457|B1|||Baseline fasting plasma glucose (FPG)||mmol/L|Mean|9.08|9.08|Standard Deviation|2.244|2.244|||
3863233|NCT01608724|3688457|B1|||Baseline haemoglobin A1c (HbA1c)||%|Mean|8.85|8.85|Standard Deviation|0.929|0.929|||
3863234|NCT01608724|3688457|B1|Chinese||Race/Ethnicity, Customized||Participants|Number|1210|1210.0||||||
3863235|NCT01608724|3688457|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1210|1210.0||||||
3863236|NCT01608724|3688457|B1||Male|Sex: Female, Male||Participants|Count of Participants|749|749.0||||||
3863237|NCT01608724|3688457|B1||Female|Sex: Female, Male||Participants|Count of Participants|461|461.0||||||
3863238|NCT01608724|3688457|B1|>=65 years||Age, Customized||Participants|Number|147|147.0||||||
3863239|NCT01608724|3688457|B1|<65 years||Age, Customized||Participants|Number|1063|1063.0||||||
3863240|NCT01608724|3688457|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|10.99|10.99|||
3863241|NCT01608672|3688464|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3863242|NCT01608672|3688464|B1||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
3863243|NCT01608672|3688464|B1|||Age||years|Mean|55.6|55.6|Standard Deviation|10.2|10.2|||
3863244|NCT01608659|3688470|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3863245|NCT01608659|3688470|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3863246|NCT01608659|3688470|B1|Missing||Age, Customized||Participants|Number|6|6.0||||||
3863247|NCT01608659|3688470|B1|≥60 years||Age, Customized||Participants|Number|35|35.0||||||
3863248|NCT01608659|3688470|B1|≥50 and <60 years||Age, Customized||Participants|Number|33|33.0||||||
3863249|NCT01608659|3688470|B1|≥40 and <50 years||Age, Customized||Participants|Number|31|31.0||||||
3863250|NCT01608659|3688470|B1|≥30 and <40 years||Age, Customized||Participants|Number|5|5.0||||||
3863251|NCT01608490|3688476|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3863252|NCT01608490|3688477|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863253|NCT01608490|3688478|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3863254|NCT01608490|3688476|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|314|314.0||||||
3863255|NCT01608490|3688477|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|157|157.0||||||
3863256|NCT01608490|3688478|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|157|157.0||||||
3863257|NCT01608490|3688476|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863258|NCT01608490|3688477|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863259|NCT01608490|3688478|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863260|NCT01608490|3688476|B3||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3863261|NCT01608490|3688477|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3863262|NCT01608490|3688478|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3863263|NCT01608490|3688476|B3||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3863264|NCT01608490|3688477|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3863265|NCT01608490|3688478|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3863266|NCT01608490|3688476|B3|||Age||years|Mean|63.9|63.9|Standard Deviation|7.9|7.9|||
3863267|NCT01608490|3688477|B2|||Age||years|Mean|64.3|64.3|Standard Deviation|7.76|7.76|||
3863268|NCT01608490|3688478|B1|||Age||years|Mean|63.4|63.4|Standard Deviation|8.05|8.05|||
3863269|NCT01608321|3688487|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
3863270|NCT01608321|3688488|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3863271|NCT01608321|3688489|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3863272|NCT01608321|3688487|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863273|NCT01608321|3688488|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863274|NCT01608321|3688489|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863275|NCT01608321|3688487|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863276|NCT01608321|3688488|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863277|NCT01608321|3688489|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863278|NCT01608321|3688487|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3863279|NCT01608321|3688488|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3863280|NCT01608321|3688489|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3863281|NCT01608321|3688487|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3863282|NCT01608321|3688488|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3863283|NCT01608321|3688489|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3863284|NCT01608321|3688487|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863285|NCT01608321|3688488|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863286|NCT01608321|3688489|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863287|NCT01608321|3688487|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863288|NCT01608321|3688488|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863289|NCT01608321|3688489|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863290|NCT01608321|3688487|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863291|NCT01608321|3688488|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863292|NCT01608321|3688489|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863293|NCT01608321|3688487|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863294|NCT01608321|3688488|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863295|NCT01608321|3688489|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863296|NCT01608321|3688487|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3863297|NCT01608321|3688488|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3863298|NCT01608321|3688489|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3863299|NCT01608321|3688487|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3863300|NCT01608321|3688488|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863301|NCT01608321|3688489|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3863302|NCT01608321|3688487|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3863303|NCT01608321|3688488|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3863304|NCT01608321|3688489|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3863305|NCT01608321|3688487|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3863306|NCT01608321|3688488|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3863307|NCT01608321|3688489|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3863308|NCT01608321|3688487|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3863309|NCT01608321|3688488|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3863310|NCT01608321|3688489|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3863311|NCT01608321|3688487|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3863312|NCT01608321|3688488|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3863313|NCT01608321|3688489|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3863314|NCT01608321|3688487|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3863315|NCT01608321|3688488|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3863316|NCT01608321|3688489|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3863317|NCT01608308|3688496|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
3863318|NCT01608308|3688497|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
3863319|NCT01608308|3688498|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
3863320|NCT01608308|3688496|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3863321|NCT01608308|3688497|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3863322|NCT01608308|3688498|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3863323|NCT01608308|3688496|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3863324|NCT01608308|3688497|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3863325|NCT01608308|3688498|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3863326|NCT01608308|3688496|B3|||Age||years|Mean|53.95|53.95|Standard Deviation|14.5|14.5|||
3863327|NCT01608308|3688497|B2|||Age||years|Mean|54.2|54.2|Standard Deviation|14.4|14.4|||
3863328|NCT01608308|3688498|B1|||Age||years|Mean|53.7|53.7|Standard Deviation|14.6|14.6|||
3863329|NCT01608295|3688521|B3|United States||Region of Enrollment||participants|Number|56|56.0||||||
3863330|NCT01608295|3688522|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3863331|NCT01608295|3688523|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
3863332|NCT01608295|3688521|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3863333|NCT01608295|3688522|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3863334|NCT01608295|3688523|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3863335|NCT01608295|3688521|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3863336|NCT01608295|3688522|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3863337|NCT01608295|3688523|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3863338|NCT01608295|3688521|B3|||Age||years|Mean|71.5|71.5|Standard Deviation|7.4|7.4|||
3863339|NCT01608295|3688522|B2|||Age||years|Mean|71.5|71.5|Standard Deviation|7.7|7.7|||
3863340|NCT01608295|3688523|B1|||Age||years|Mean|71.5|71.5|Standard Deviation|7.2|7.2|||
3863341|NCT01608295|3688521|B3||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
3863342|NCT01608295|3688522|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3863343|NCT01608295|3688523|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3863344|NCT01608295|3688521|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3863345|NCT01608295|3688522|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3863346|NCT01608295|3688523|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3863347|NCT01608295|3688521|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3863348|NCT01608295|3688522|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3863349|NCT01608295|3688523|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3863350|NCT01608100|3688535|B1|Number Participants without Myocardial Infarction||Observed Myocardial Infarction Prevalence||participants|Number|971|971.0||||||
3863351|NCT01608100|3688535|B1|Number Participants with Myocardial Infarction||Observed Myocardial Infarction Prevalence||participants|Number|130|130.0||||||
3863352|NCT01608100|3688535|B1|Other||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3863353|NCT01608100|3688535|B1|Asian||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3863354|NCT01608100|3688535|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
3863355|NCT01608100|3688535|B1|White||Race/Ethnicity, Customized||participants|Number|692|692.0||||||
3863356|NCT01608100|3688535|B1|Black||Race/Ethnicity, Customized||participants|Number|300|300.0||||||
3863357|NCT01608100|3688535|B1||Male|Sex: Female, Male||Participants|Count of Participants|619|619.0||||||
3863358|NCT01608100|3688535|B1||Female|Sex: Female, Male||Participants|Count of Participants|482|482.0||||||
3863359|NCT01608100|3688535|B1||>=65 years|Age||Participants|Count of Participants|355|355.0||||||
3863360|NCT01608100|3688535|B1||Between 18 and 65 years|Age||Participants|Count of Participants|746|746.0||||||
3863361|NCT01608100|3688535|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3863362|NCT01607853|3688559|B1|France||Region of Enrollment||participants|Number|24|24.0||||||
3863363|NCT01607853|3688559|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3863364|NCT01607853|3688559|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3863365|NCT01607853|3688559|B1|||Age||years|Mean|46.7|46.7|Standard Deviation|14.7|14.7|||
3863366|NCT01607853|3688559|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3863367|NCT01607853|3688559|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3863368|NCT01607853|3688559|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3863369|NCT01607658|3688666|B5|Australia||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3863370|NCT01607658|3688667|B4|Australia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3863371|NCT01607658|3688668|B3|Australia||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3863372|NCT01607658|3688669|B2|Australia||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3863373|NCT01607658|3688670|B1|Australia||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3863374|NCT01607658|3688666|B5|United States||Region of Enrollment||Participants|Count of Participants|214|214.0||||||
3863375|NCT01607658|3688667|B4|United States||Region of Enrollment||Participants|Count of Participants|55|55.0||||||
3863376|NCT01607658|3688668|B3|United States||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
3863377|NCT01607658|3688669|B2|United States||Region of Enrollment||Participants|Count of Participants|58|58.0||||||
3863378|NCT01607658|3688670|B1|United States||Region of Enrollment||Participants|Count of Participants|53|53.0||||||
3863379|NCT01607658|3688666|B5|Canada||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3863380|NCT01607658|3688667|B4|Canada||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3863381|NCT01607658|3688668|B3|Canada||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3863382|NCT01607658|3688669|B2|Canada||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3863383|NCT01607658|3688670|B1|Canada||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3863384|NCT01607658|3688666|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3863385|NCT01607658|3688667|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3863386|NCT01607658|3688668|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863387|NCT01607658|3688669|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863388|NCT01607658|3688670|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863389|NCT01607658|3688666|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3863390|NCT01607658|3688667|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3863391|NCT01607658|3688668|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3863392|NCT01607658|3688669|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3863393|NCT01607658|3688670|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3863394|NCT01607658|3688666|B5||White|Race (NIH/OMB)||Participants|Count of Participants|191|191.0||||||
3863395|NCT01607658|3688667|B4||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3863396|NCT01607658|3688668|B3||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3863397|NCT01607658|3688669|B2||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3863398|NCT01607658|3688670|B1||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3863399|NCT01607658|3688666|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3863400|NCT01607658|3688667|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3863401|NCT01607658|3688668|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3863402|NCT01607658|3688669|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3863403|NCT01607658|3688670|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3863404|NCT01607658|3688666|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3863405|NCT01607658|3688667|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863406|NCT01607658|3688668|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863407|NCT01607658|3688669|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3863408|NCT01607658|3688670|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863409|NCT01607658|3688666|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3863410|NCT01607658|3688667|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3863411|NCT01607658|3688668|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863412|NCT01607658|3688669|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863413|NCT01607658|3688670|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3863414|NCT01607658|3688666|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3863415|NCT01607658|3688667|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3863416|NCT01607658|3688668|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863417|NCT01607658|3688669|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3863418|NCT01607658|3688670|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863419|NCT01607658|3688666|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863420|NCT01607658|3688667|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863421|NCT01607658|3688668|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863422|NCT01607658|3688669|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863423|NCT01607658|3688670|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863424|NCT01607658|3688666|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|225|225.0||||||
3863425|NCT01607658|3688667|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3863426|NCT01607658|3688668|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3863427|NCT01607658|3688669|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3863428|NCT01607658|3688670|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3863429|NCT01607658|3688666|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3863430|NCT01607658|3688667|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3863431|NCT01607658|3688668|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3863432|NCT01607658|3688669|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3863433|NCT01607658|3688670|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3863434|NCT01607658|3688666|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3863435|NCT01607658|3688667|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3863436|NCT01607658|3688668|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3863437|NCT01607658|3688669|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3863438|NCT01607658|3688670|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3863439|NCT01607658|3688666|B5||Female|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
3863440|NCT01607658|3688667|B4||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3863441|NCT01607658|3688668|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3863442|NCT01607658|3688669|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3863443|NCT01607658|3688670|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3863444|NCT01607658|3688666|B5|||Age||years|Mean|43.4|43.4|Standard Deviation|11.88|11.88|||
3863445|NCT01607658|3688667|B4|||Age||years|Mean|42.4|42.4|Standard Deviation|11.47|11.47|||
3863446|NCT01607658|3688668|B3|||Age||years|Mean|44.3|44.3|Standard Deviation|11.64|11.64|||
3863447|NCT01607658|3688669|B2|||Age||years|Mean|44.5|44.5|Standard Deviation|12.09|12.09|||
3863448|NCT01607658|3688670|B1|||Age||years|Mean|42.4|42.4|Standard Deviation|12.36|12.36|||
3863449|NCT01607645|3688695|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
3863450|NCT01607645|3688696|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3863451|NCT01607645|3688697|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3863452|NCT01607645|3688695|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863453|NCT01607645|3688696|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863454|NCT01607645|3688697|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863455|NCT01607645|3688695|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863456|NCT01607645|3688696|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863457|NCT01607645|3688697|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863458|NCT01607645|3688695|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3863459|NCT01607645|3688696|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3863460|NCT01607645|3688697|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3863461|NCT01607645|3688695|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863462|NCT01607645|3688696|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863463|NCT01607645|3688697|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863464|NCT01607645|3688695|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863465|NCT01607645|3688696|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863466|NCT01607645|3688697|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863467|NCT01607645|3688695|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3863468|NCT01607645|3688696|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3863469|NCT01607645|3688697|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863470|NCT01607645|3688695|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863471|NCT01607645|3688696|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863472|NCT01607645|3688697|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863473|NCT01607645|3688695|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863474|NCT01607645|3688696|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863475|NCT01607645|3688697|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863476|NCT01607645|3688695|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3863477|NCT01607645|3688696|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3863478|NCT01607645|3688697|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3863479|NCT01607645|3688695|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863480|NCT01607645|3688696|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863481|NCT01607645|3688697|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863482|NCT01607645|3688695|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3863483|NCT01607645|3688696|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3863484|NCT01607645|3688697|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3863485|NCT01607645|3688695|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3863486|NCT01607645|3688696|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3863487|NCT01607645|3688697|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3863488|NCT01607645|3688695|B3|||Age||years|Mean|43.86|43.86|Standard Deviation|16.31|16.31|||
3863489|NCT01607645|3688696|B2|||Age||years|Mean|34.67|34.67|Standard Deviation|13.01|13.01|||
3863490|NCT01607645|3688697|B1|||Age||years|Mean|50.75|50.75|Standard Deviation|16.46|16.46|||
3863491|NCT01607593|3688728|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3863492|NCT01607593|3688728|B1||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3863493|NCT01607593|3688728|B1|||Age||years|Mean|35.6|35.6|Standard Deviation|10.4|10.4|||
3863494|NCT01607554|3688734|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3863495|NCT01607554|3688734|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3863496|NCT01607554|3688734|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3863497|NCT01607554|3688734|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3863498|NCT01607554|3688734|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3863499|NCT01607554|3688734|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3863500|NCT01607476|3688744|B4|United States||Region of Enrollment||participants|Number|86|86.0||||||
3863501|NCT01607476|3688745|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
3863502|NCT01607476|3688746|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3863503|NCT01607476|3688747|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3863504|NCT01607476|3688744|B4||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3863505|NCT01607476|3688745|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3863506|NCT01607476|3688746|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3863507|NCT01607476|3688747|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3863508|NCT01607476|3688744|B4||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3863509|NCT01607476|3688745|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3863510|NCT01607476|3688746|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3863511|NCT01607476|3688747|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3863512|NCT01607476|3688744|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3863513|NCT01607476|3688745|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3863514|NCT01607476|3688746|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3863515|NCT01607476|3688747|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3863516|NCT01607476|3688744|B4||Between 18 and 65 years|Age||Participants|Count of Participants|88|88.0||||||
3863517|NCT01607476|3688745|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3863518|NCT01607476|3688746|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3863519|NCT01607476|3688747|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3863520|NCT01607476|3688744|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3863521|NCT01607476|3688745|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3863522|NCT01607476|3688746|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3863523|NCT01607476|3688747|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3863524|NCT01607450|3688760|B8|||HbA1c (%)||%|Mean|6.48|6.48|Standard Deviation|1.24|1.24|||
3863525|NCT01607450|3688763|B5|||HbA1c (%)||%|Mean|8.40|8.4|Standard Deviation|3.02|3.02|||
3863526|NCT01607450|3688764|B4|||HbA1c (%)||%|Mean|5.56|5.56|Standard Deviation|0.34|0.34|||
3863527|NCT01607450|3688765|B3|||HbA1c (%)||%|Mean|7.0|7.0|Standard Deviation|0|0.0|||
3863528|NCT01607450|3688766|B2|||HbA1c (%)||%|Mean|5.47|5.47|Standard Deviation|0.40|0.4|||
3863529|NCT01607450|3688767|B1|||HbA1c (%)||%|Mean|5.47|5.47|Standard Deviation|0.40|0.4|||
3863530|NCT01607450|3688760|B8|||Body Mass Index (kg/m2)||kg/m^2|Mean|25.7|25.7|Standard Deviation|1.7|1.7|||
3863531|NCT01607450|3688763|B5|||Body Mass Index (kg/m2)||kg/m^2|Mean|30.3|30.3|Standard Deviation|1.7|1.7|||
3863532|NCT01607450|3688764|B4|||Body Mass Index (kg/m2)||kg/m^2|Mean|22.9|22.9|Standard Deviation|1.8|1.8|||
3863533|NCT01607450|3688765|B3|||Body Mass Index (kg/m2)||kg/m^2|Mean|31.0|31.0|Standard Deviation|0|0.0|||
3863534|NCT01607450|3688766|B2|||Body Mass Index (kg/m2)||kg/m^2|Mean|23.0|23.0|Standard Deviation|1.5|1.5|||
3863535|NCT01607450|3688767|B1|||Body Mass Index (kg/m2)||kg/m^2|Mean|23.9|23.9|Standard Deviation|1.6|1.6|||
3863536|NCT01607450|3688760|B8|United States||Region of Enrollment||participants|Number|33|33.0||||||
3863537|NCT01607450|3688763|B5|United States||Region of Enrollment||participants|Number|7|7.0||||||
3863538|NCT01607450|3688764|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
3863539|NCT01607450|3688765|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3863540|NCT01607450|3688766|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3863541|NCT01607450|3688767|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3863542|NCT01607450|3688760|B8|Male||Gender||participants|Number|21|21.0||||||
3863543|NCT01607450|3688763|B5|Male||Gender||participants|Number|6|6.0||||||
3863544|NCT01607450|3688764|B4|Male||Gender||participants|Number|5|5.0||||||
3863545|NCT01607450|3688765|B3|Male||Gender||participants|Number|1|1.0||||||
3863546|NCT01607450|3688766|B2|Male||Gender||participants|Number|8|8.0||||||
3863547|NCT01607450|3688767|B1|Male||Gender||participants|Number|1|1.0||||||
3863548|NCT01607450|3688760|B8|Female||Gender||participants|Number|12|12.0||||||
3863549|NCT01607450|3688763|B5|Female||Gender||participants|Number|1|1.0||||||
3863550|NCT01607450|3688764|B4|Female||Gender||participants|Number|3|3.0||||||
3863551|NCT01607450|3688765|B3|Female||Gender||participants|Number|0|0.0||||||
3863552|NCT01607450|3688766|B2|Female||Gender||participants|Number|3|3.0||||||
3863553|NCT01607450|3688767|B1|Female||Gender||participants|Number|5|5.0||||||
3863554|NCT01607450|3688760|B8|||Age||years|Mean|42.7|42.7|Standard Deviation|7.9|7.9|||
3863555|NCT01607450|3688763|B5|||Age||years|Mean|45.1|45.1|Standard Deviation|7.9|7.9|||
3863556|NCT01607450|3688764|B4|||Age||years|Mean|46.0|46.0|Standard Deviation|5.8|5.8|||
3863557|NCT01607450|3688765|B3|||Age||years|Mean|42|42.0|Standard Deviation|0|0.0|||
3863558|NCT01607450|3688766|B2|||Age||years|Mean|38.0|38.0|Standard Deviation|6.0|6.0|||
3863559|NCT01607450|3688767|B1|||Age||years|Mean|35.5|35.5|Standard Deviation|10.6|10.6|||
3863560|NCT01607411|3688817|B1|More than one race||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3863561|NCT01607411|3688817|B1|White||Race/Ethnicity, Customized||Participants|Number|41|41.0||||||
3863562|NCT01607411|3688817|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3863563|NCT01607411|3688817|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3863564|NCT01607411|3688817|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3863565|NCT01607411|3688817|B1|||Age||Years|Mean|12.4|12.4|Standard Deviation|1.12|1.12|||
3863566|NCT01607398|3688841|B3|Asian-Japanese Heritage||Race/Ethnicity, Customized|Baseline data are reported for members of the Per Protocol Population, comprised of all participants who had an evaluable sputum sample at Baseline and at the endpoint of interest, were randomized to study treatment and received at least one dose of study medication, and had no major protocol violations.|participants|Number|52|52.0||||||
3863567|NCT01607398|3688842|B2|Asian-Japanese Heritage||Race/Ethnicity, Customized|Baseline data are reported for members of the Per Protocol Population, comprised of all participants who had an evaluable sputum sample at Baseline and at the endpoint of interest, were randomized to study treatment and received at least one dose of study medication, and had no major protocol violations.|participants|Number|26|26.0||||||
3863568|NCT01607398|3688843|B1|Asian-Japanese Heritage||Race/Ethnicity, Customized|Baseline data are reported for members of the Per Protocol Population, comprised of all participants who had an evaluable sputum sample at Baseline and at the endpoint of interest, were randomized to study treatment and received at least one dose of study medication, and had no major protocol violations.|participants|Number|26|26.0||||||
3863569|NCT01607398|3688841|B3||Male|Sex: Female, Male|Baseline data are reported for members of the Per Protocol Population, comprised of all participants who had an evaluable sputum sample at Baseline and at the endpoint of interest, were randomized to study treatment and received at least one dose of study medication, and had no major protocol violations.|Participants|Count of Participants|51|51.0||||||
3863570|NCT01607398|3688842|B2||Male|Sex: Female, Male|Baseline data are reported for members of the Per Protocol Population, comprised of all participants who had an evaluable sputum sample at Baseline and at the endpoint of interest, were randomized to study treatment and received at least one dose of study medication, and had no major protocol violations.|Participants|Count of Participants|25|25.0||||||
3863571|NCT01607398|3688843|B1||Male|Sex: Female, Male|Baseline data are reported for members of the Per Protocol Population, comprised of all participants who had an evaluable sputum sample at Baseline and at the endpoint of interest, were randomized to study treatment and received at least one dose of study medication, and had no major protocol violations.|Participants|Count of Participants|26|26.0||||||
3863572|NCT01607398|3688841|B3||Female|Sex: Female, Male|Baseline data are reported for members of the Per Protocol Population, comprised of all participants who had an evaluable sputum sample at Baseline and at the endpoint of interest, were randomized to study treatment and received at least one dose of study medication, and had no major protocol violations.|Participants|Count of Participants|1|1.0||||||
3863573|NCT01607398|3688842|B2||Female|Sex: Female, Male|Baseline data are reported for members of the Per Protocol Population, comprised of all participants who had an evaluable sputum sample at Baseline and at the endpoint of interest, were randomized to study treatment and received at least one dose of study medication, and had no major protocol violations.|Participants|Count of Participants|1|1.0||||||
3863574|NCT01607398|3688843|B1||Female|Sex: Female, Male|Baseline data are reported for members of the Per Protocol Population, comprised of all participants who had an evaluable sputum sample at Baseline and at the endpoint of interest, were randomized to study treatment and received at least one dose of study medication, and had no major protocol violations.|Participants|Count of Participants|0|0.0||||||
3863575|NCT01607398|3688841|B3|||Age|Baseline data are reported for members of the Per Protocol Population, comprised of all participants who had an evaluable sputum sample at Baseline and at the endpoint of interest, were randomized to study treatment and received at least one dose of study medication, and had no major protocol violations.|Years|Mean|63.4|63.4|Standard Deviation|8.72|8.72|||
3863576|NCT01607398|3688842|B2|||Age|Baseline data are reported for members of the Per Protocol Population, comprised of all participants who had an evaluable sputum sample at Baseline and at the endpoint of interest, were randomized to study treatment and received at least one dose of study medication, and had no major protocol violations.|Years|Mean|64.7|64.7|Standard Deviation|9.31|9.31|||
3863636|NCT01606800|3688972|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3863577|NCT01607398|3688843|B1|||Age|Baseline data are reported for members of the Per Protocol Population, comprised of all participants who had an evaluable sputum sample at Baseline and at the endpoint of interest, were randomized to study treatment and received at least one dose of study medication, and had no major protocol violations.|Years|Mean|62.2|62.2|Standard Deviation|8.06|8.06|||
3863578|NCT01607346|3688888|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3863579|NCT01607346|3688888|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3863580|NCT01607346|3688888|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3863581|NCT01607346|3688888|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3863582|NCT01607346|3688888|B1|||Age||Years|Mean|40.8|40.8|Standard Deviation|9.62|9.62|||
3863583|NCT01607320|3688904|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3863584|NCT01607320|3688904|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863585|NCT01607320|3688904|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863586|NCT01607320|3688904|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3863587|NCT01607320|3688904|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3863588|NCT01607320|3688904|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863589|NCT01607320|3688904|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863590|NCT01607320|3688904|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863591|NCT01607320|3688904|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3863592|NCT01607320|3688904|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3863593|NCT01607320|3688904|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3863594|NCT01607320|3688904|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3863595|NCT01607320|3688904|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3863596|NCT01607203|3688910|B3|||Body Mass Index||kg/m^2|Mean|23.7|23.7|Standard Deviation|4.8|4.8|||
3863597|NCT01607203|3688911|B2|||Body Mass Index||kg/m^2|Mean|23.8|23.8|Standard Deviation|4.6|4.6|||
3863598|NCT01607203|3688912|B1|||Body Mass Index||kg/m^2|Mean|23.5|23.5|Standard Deviation|5.1|5.1|||
3863599|NCT01607203|3688910|B3|Belgium||Region of Enrollment||participants|Number|120|120.0||||||
3863600|NCT01607203|3688911|B2|Belgium||Region of Enrollment||participants|Number|61|61.0||||||
3863601|NCT01607203|3688912|B1|Belgium||Region of Enrollment||participants|Number|59|59.0||||||
3863602|NCT01607203|3688910|B3||Male|Sex: Female, Male|FEMALE|Participants|Count of Participants|0|0.0||||||
3863603|NCT01607203|3688911|B2||Male|Sex: Female, Male|FEMALE|Participants|Count of Participants|0|0.0||||||
3863604|NCT01607203|3688912|B1||Male|Sex: Female, Male|FEMALE|Participants|Count of Participants|0|0.0||||||
3863605|NCT01607203|3688910|B3||Female|Sex: Female, Male|FEMALE|Participants|Count of Participants|120|120.0||||||
3863606|NCT01607203|3688911|B2||Female|Sex: Female, Male|FEMALE|Participants|Count of Participants|61|61.0||||||
3863607|NCT01607203|3688912|B1||Female|Sex: Female, Male|FEMALE|Participants|Count of Participants|59|59.0||||||
3863608|NCT01607203|3688910|B3|||Age||YEARS|Mean|30.2|30.2|Standard Deviation|3.8|3.8|||
3863609|NCT01607203|3688911|B2|||Age||YEARS|Mean|30.0|30.0|Standard Deviation|3.6|3.6|||
3863610|NCT01607203|3688912|B1|||Age||YEARS|Mean|30.5|30.5|Standard Deviation|4.1|4.1|||
3863611|NCT01607112|3688923|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3863612|NCT01607112|3688924|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3863613|NCT01607112|3688925|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3863614|NCT01607112|3688923|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3863615|NCT01607112|3688924|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3863616|NCT01607112|3688925|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3863617|NCT01607112|3688923|B3|||Age||Years|Mean|52.8|52.8|Standard Deviation|19.7|19.7|||
3863618|NCT01607112|3688924|B2|||Age||Years|Mean|70.3|70.3|Standard Deviation|5.87|5.87|||
3863619|NCT01607112|3688925|B1|||Age||Years|Mean|35.7|35.7|Standard Deviation|11.98|11.98|||
3863620|NCT01606852|3688960|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
3863621|NCT01606852|3688961|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3863622|NCT01606852|3688962|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3863623|NCT01606852|3688960|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3863624|NCT01606852|3688961|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3863625|NCT01606852|3688962|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3863626|NCT01606852|3688960|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3863627|NCT01606852|3688961|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3863628|NCT01606852|3688962|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3863629|NCT01606852|3688960|B3|||Age||years|Mean|66.5|66.5|Standard Deviation|13.2|13.2|||
3863630|NCT01606852|3688961|B2|||Age||years|Mean|66.5|66.5|Standard Deviation|13.2|13.2|||
3863631|NCT01606852|3688962|B1|||Age||years|Mean|66.5|66.5|Standard Deviation|13.2|13.2|||
3863632|NCT01606800|3688971|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3863633|NCT01606800|3688972|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3863634|NCT01606800|3688973|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3863635|NCT01606800|3688971|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3863637|NCT01606800|3688973|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3863638|NCT01606800|3688971|B3|||Age||Years|Mean|37.7|37.7|Standard Deviation|10.91|10.91|||
3863639|NCT01606800|3688972|B2|||Age||Years|Mean|37.1|37.1|Standard Deviation|11.22|11.22|||
3863640|NCT01606800|3688973|B1|||Age||Years|Mean|38.4|38.4|Standard Deviation|10.79|10.79|||
3863641|NCT01606787|3688980|B3|United States||Region of Enrollment||Participants|Count of Participants|199|199.0||||||
3863642|NCT01606787|3688981|B2|United States||Region of Enrollment||Participants|Count of Participants|98|98.0||||||
3863643|NCT01606787|3688982|B1|United States||Region of Enrollment||Participants|Count of Participants|101|101.0||||||
3863644|NCT01606787|3688980|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3863645|NCT01606787|3688981|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3863646|NCT01606787|3688982|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3863647|NCT01606787|3688980|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863648|NCT01606787|3688981|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863649|NCT01606787|3688982|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863650|NCT01606787|3688980|B3||White|Race (NIH/OMB)||Participants|Count of Participants|161|161.0||||||
3863651|NCT01606787|3688981|B2||White|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3863652|NCT01606787|3688982|B1||White|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
3863653|NCT01606787|3688980|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3863654|NCT01606787|3688981|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3863655|NCT01606787|3688982|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3863656|NCT01606787|3688980|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863657|NCT01606787|3688981|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863658|NCT01606787|3688982|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863659|NCT01606787|3688980|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3863660|NCT01606787|3688981|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3863661|NCT01606787|3688982|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3863662|NCT01606787|3688980|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863663|NCT01606787|3688981|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863664|NCT01606787|3688982|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863665|NCT01606787|3688980|B3||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3863666|NCT01606787|3688981|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3863667|NCT01606787|3688982|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3863668|NCT01606787|3688980|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3863669|NCT01606787|3688981|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3863670|NCT01606787|3688982|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3863671|NCT01606787|3688980|B3|||Age||years|Median|58|58.0|Full Range|||48.0|66.0|
3863672|NCT01606787|3688981|B2|||Age||years|Median|56|56.0|Full Range|||48.0|63.0|
3863673|NCT01606787|3688982|B1|||Age||years|Median|60|60.0|Full Range|||50.0|66.0|
3863674|NCT01606761|3688991|B4|United States||Region of Enrollment||Participants|Count of Participants|445|445.0||||||
3863675|NCT01606761|3688992|B3|United States||Region of Enrollment||Participants|Count of Participants|152|152.0||||||
3863676|NCT01606761|3688993|B2|United States||Region of Enrollment||Participants|Count of Participants|145|145.0||||||
3863677|NCT01606761|3688994|B1|United States||Region of Enrollment||Participants|Count of Participants|148|148.0||||||
3863678|NCT01606761|3688991|B4|United Kingdom||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3863679|NCT01606761|3688992|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3863680|NCT01606761|3688993|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3863681|NCT01606761|3688994|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3863682|NCT01606761|3688991|B4|Taiwan, Province of China||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3863683|NCT01606761|3688992|B3|Taiwan, Province of China||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3863684|NCT01606761|3688993|B2|Taiwan, Province of China||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3863685|NCT01606761|3688994|B1|Taiwan, Province of China||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3863686|NCT01606761|3688991|B4|Spain||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3863687|NCT01606761|3688992|B3|Spain||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3863688|NCT01606761|3688993|B2|Spain||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3863689|NCT01606761|3688994|B1|Spain||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3863690|NCT01606761|3688991|B4|Russian Federation||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3863691|NCT01606761|3688992|B3|Russian Federation||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3863692|NCT01606761|3688993|B2|Russian Federation||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3863693|NCT01606761|3688994|B1|Russian Federation||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3863694|NCT01606761|3688991|B4|Republic of Korea||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3863695|NCT01606761|3688992|B3|Republic of Korea||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3863696|NCT01606761|3688993|B2|Republic of Korea||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3863697|NCT01606761|3688994|B1|Republic of Korea||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3863698|NCT01606761|3688991|B4|Puerto Rico||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3863699|NCT01606761|3688992|B3|Puerto Rico||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3863700|NCT01606761|3688993|B2|Puerto Rico||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3863701|NCT01606761|3688994|B1|Puerto Rico||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3863702|NCT01606761|3688991|B4|Portugal||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3863703|NCT01606761|3688992|B3|Portugal||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3863704|NCT01606761|3688993|B2|Portugal||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3863705|NCT01606761|3688994|B1|Portugal||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3863706|NCT01606761|3688991|B4|Poland||Region of Enrollment||Participants|Count of Participants|76|76.0||||||
3863707|NCT01606761|3688992|B3|Poland||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3863708|NCT01606761|3688993|B2|Poland||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3863709|NCT01606761|3688994|B1|Poland||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3863710|NCT01606761|3688991|B4|Netherlands||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3863711|NCT01606761|3688992|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3863712|NCT01606761|3688993|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3863713|NCT01606761|3688994|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3863714|NCT01606761|3688991|B4|Mexico||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3863715|NCT01606761|3688992|B3|Mexico||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3863716|NCT01606761|3688993|B2|Mexico||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3863717|NCT01606761|3688994|B1|Mexico||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3863718|NCT01606761|3688991|B4|Lithuania||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3863719|NCT01606761|3688992|B3|Lithuania||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3863720|NCT01606761|3688993|B2|Lithuania||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3863721|NCT01606761|3688994|B1|Lithuania||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3863722|NCT01606761|3688991|B4|Japan||Region of Enrollment||Participants|Count of Participants|116|116.0||||||
3863723|NCT01606761|3688992|B3|Japan||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3863724|NCT01606761|3688993|B2|Japan||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3863725|NCT01606761|3688994|B1|Japan||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3863726|NCT01606761|3688991|B4|Italy||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3863727|NCT01606761|3688992|B3|Italy||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3863728|NCT01606761|3688993|B2|Italy||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3863729|NCT01606761|3688994|B1|Italy||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3863730|NCT01606761|3688991|B4|Germany||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3863731|NCT01606761|3688992|B3|Germany||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3863732|NCT01606761|3688993|B2|Germany||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3863733|NCT01606761|3688994|B1|Germany||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3863734|NCT01606761|3688991|B4|France||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3863735|NCT01606761|3688992|B3|France||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3863736|NCT01606761|3688993|B2|France||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3863737|NCT01606761|3688994|B1|France||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3863738|NCT01606761|3688991|B4|Canada||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3863739|NCT01606761|3688992|B3|Canada||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3863740|NCT01606761|3688993|B2|Canada||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3863741|NCT01606761|3688994|B1|Canada||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3863742|NCT01606761|3688991|B4|Belgium||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3863743|NCT01606761|3688992|B3|Belgium||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3863744|NCT01606761|3688993|B2|Belgium||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3863745|NCT01606761|3688994|B1|Belgium||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3863746|NCT01606761|3688991|B4|Austria||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3863747|NCT01606761|3688992|B3|Austria||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3863748|NCT01606761|3688993|B2|Austria||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3863749|NCT01606761|3688994|B1|Austria||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3863750|NCT01606761|3688991|B4|Australia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3863751|NCT01606761|3688992|B3|Australia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3863752|NCT01606761|3688993|B2|Australia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3863753|NCT01606761|3688994|B1|Australia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3863754|NCT01606761|3688991|B4|Argentina||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3863755|NCT01606761|3688992|B3|Argentina||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3863756|NCT01606761|3688993|B2|Argentina||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3863757|NCT01606761|3688994|B1|Argentina||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3863758|NCT01606761|3688991|B4||Male|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3863759|NCT01606761|3688992|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3863760|NCT01606761|3688993|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3863761|NCT01606761|3688994|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3863762|NCT01606761|3688991|B4||Female|Sex: Female, Male||Participants|Count of Participants|712|712.0||||||
3863763|NCT01606761|3688992|B3||Female|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
3863764|NCT01606761|3688993|B2||Female|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
3863765|NCT01606761|3688994|B1||Female|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
3863766|NCT01606761|3688991|B4|||Age||years|Mean|55.4|55.4|Standard Deviation|12.11|12.11|||
3863767|NCT01606761|3688992|B3|||Age||years|Mean|55|55.0|Standard Deviation|12.28|12.28|||
3863768|NCT01606761|3688993|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|11.89|11.89|||
3863769|NCT01606761|3688994|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|12.19|12.19|||
3863770|NCT01606761|3688991|B4||>=65 years|Age||Participants|Count of Participants|195|195.0||||||
3863771|NCT01606761|3688992|B3||>=65 years|Age||Participants|Count of Participants|62|62.0||||||
3863772|NCT01606761|3688993|B2||>=65 years|Age||Participants|Count of Participants|67|67.0||||||
3863773|NCT01606761|3688994|B1||>=65 years|Age||Participants|Count of Participants|66|66.0||||||
3863774|NCT01606761|3688991|B4||Between 18 and 65 years|Age||Participants|Count of Participants|683|683.0||||||
3863775|NCT01606761|3688992|B3||Between 18 and 65 years|Age||Participants|Count of Participants|230|230.0||||||
3863776|NCT01606761|3688993|B2||Between 18 and 65 years|Age||Participants|Count of Participants|225|225.0||||||
3863777|NCT01606761|3688994|B1||Between 18 and 65 years|Age||Participants|Count of Participants|228|228.0||||||
3863778|NCT01606761|3688991|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3863779|NCT01606761|3688992|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||12.28|12.28|||
3863780|NCT01606761|3688993|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||11.89|11.89|||
3863781|NCT01606761|3688994|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||12.19|12.19|||
3863782|NCT01606748|3689022|B3|Any Prior (Adjuvant/Neoadjuvant) Systemic Therapy||Prior Anti-Cancer Therapy|Not all participants received prior anti-cancer therapy.|participants|Number|33|33.0||||||
3863783|NCT01606748|3689023|B2|Any Prior (Adjuvant/Neoadjuvant) Systemic Therapy||Prior Anti-Cancer Therapy|Not all participants received prior anti-cancer therapy.|participants|Number|16|16.0||||||
3863784|NCT01606748|3689024|B1|Any Prior (Adjuvant/Neoadjuvant) Systemic Therapy||Prior Anti-Cancer Therapy|Not all participants received prior anti-cancer therapy.|participants|Number|17|17.0||||||
3863785|NCT01606748|3689022|B3|Any Prior Radiotherapy||Prior Anti-Cancer Therapy|Not all participants received prior anti-cancer therapy.|participants|Number|23|23.0||||||
3863786|NCT01606748|3689023|B2|Any Prior Radiotherapy||Prior Anti-Cancer Therapy|Not all participants received prior anti-cancer therapy.|participants|Number|10|10.0||||||
3863787|NCT01606748|3689024|B1|Any Prior Radiotherapy||Prior Anti-Cancer Therapy|Not all participants received prior anti-cancer therapy.|participants|Number|13|13.0||||||
3863788|NCT01606748|3689022|B3|Pancreatic Carcinoma||Disease Characteristics - Tumor Type||participants|Number|1|1.0||||||
3863789|NCT01606748|3689023|B2|Pancreatic Carcinoma||Disease Characteristics - Tumor Type||participants|Number|1|1.0||||||
3863790|NCT01606748|3689024|B1|Pancreatic Carcinoma||Disease Characteristics - Tumor Type||participants|Number|0|0.0||||||
3863791|NCT01606748|3689022|B3|Adenocarcinoma of the Ampula of Vater||Disease Characteristics - Tumor Type||participants|Number|1|1.0||||||
3863792|NCT01606748|3689023|B2|Adenocarcinoma of the Ampula of Vater||Disease Characteristics - Tumor Type||participants|Number|1|1.0||||||
3863793|NCT01606748|3689024|B1|Adenocarcinoma of the Ampula of Vater||Disease Characteristics - Tumor Type||participants|Number|0|0.0||||||
3863794|NCT01606748|3689022|B3|Sarcoma, soft tissue||Disease Characteristics - Tumor Type||participants|Number|1|1.0||||||
3863795|NCT01606748|3689023|B2|Sarcoma, soft tissue||Disease Characteristics - Tumor Type||participants|Number|1|1.0||||||
3863796|NCT01606748|3689024|B1|Sarcoma, soft tissue||Disease Characteristics - Tumor Type||participants|Number|0|0.0||||||
3863797|NCT01606748|3689022|B3|Colorectal Carcinoma||Disease Characteristics - Tumor Type||participants|Number|1|1.0||||||
3863798|NCT01606748|3689023|B2|Colorectal Carcinoma||Disease Characteristics - Tumor Type||participants|Number|1|1.0||||||
3863799|NCT01606748|3689024|B1|Colorectal Carcinoma||Disease Characteristics - Tumor Type||participants|Number|0|0.0||||||
3863800|NCT01606748|3689022|B3|Esophageal Carcinoma||Disease Characteristics - Tumor Type||participants|Number|1|1.0||||||
3863801|NCT01606748|3689023|B2|Esophageal Carcinoma||Disease Characteristics - Tumor Type||participants|Number|1|1.0||||||
3863802|NCT01606748|3689024|B1|Esophageal Carcinoma||Disease Characteristics - Tumor Type||participants|Number|0|0.0||||||
3863803|NCT01606748|3689022|B3|Hepatocellular Carcinoma||Disease Characteristics - Tumor Type||participants|Number|1|1.0||||||
3863804|NCT01606748|3689023|B2|Hepatocellular Carcinoma||Disease Characteristics - Tumor Type||participants|Number|1|1.0||||||
3863805|NCT01606748|3689024|B1|Hepatocellular Carcinoma||Disease Characteristics - Tumor Type||participants|Number|0|0.0||||||
3863806|NCT01606748|3689022|B3|Neuroendocrine Tumor||Disease Characteristics - Tumor Type||participants|Number|1|1.0||||||
3863807|NCT01606748|3689023|B2|Neuroendocrine Tumor||Disease Characteristics - Tumor Type||participants|Number|1|1.0||||||
3863808|NCT01606748|3689024|B1|Neuroendocrine Tumor||Disease Characteristics - Tumor Type||participants|Number|0|0.0||||||
3863809|NCT01606748|3689022|B3|Mesothelioma||Disease Characteristics - Tumor Type||participants|Number|1|1.0||||||
3863810|NCT01606748|3689023|B2|Mesothelioma||Disease Characteristics - Tumor Type||participants|Number|1|1.0||||||
3863811|NCT01606748|3689024|B1|Mesothelioma||Disease Characteristics - Tumor Type||participants|Number|0|0.0||||||
3863812|NCT01606748|3689022|B3|Granulosa Cell Tumor of the Ovary||Disease Characteristics - Tumor Type||participants|Number|1|1.0||||||
3863813|NCT01606748|3689023|B2|Granulosa Cell Tumor of the Ovary||Disease Characteristics - Tumor Type||participants|Number|0|0.0||||||
3863814|NCT01606748|3689024|B1|Granulosa Cell Tumor of the Ovary||Disease Characteristics - Tumor Type||participants|Number|1|1.0||||||
3863815|NCT01606748|3689022|B3|Liver||Disease Characteristics - Tumor Type||participants|Number|1|1.0||||||
3863816|NCT01606748|3689023|B2|Liver||Disease Characteristics - Tumor Type||participants|Number|0|0.0||||||
3863817|NCT01606748|3689024|B1|Liver||Disease Characteristics - Tumor Type||participants|Number|1|1.0||||||
3863818|NCT01606748|3689022|B3|Left Parotid||Disease Characteristics - Tumor Type||participants|Number|1|1.0||||||
3863819|NCT01606748|3689023|B2|Left Parotid||Disease Characteristics - Tumor Type||participants|Number|0|0.0||||||
3863820|NCT01606748|3689024|B1|Left Parotid||Disease Characteristics - Tumor Type||participants|Number|1|1.0||||||
3863821|NCT01606748|3689022|B3|Hepatobilliary Carcinoma||Disease Characteristics - Tumor Type||participants|Number|1|1.0||||||
3863822|NCT01606748|3689023|B2|Hepatobilliary Carcinoma||Disease Characteristics - Tumor Type||participants|Number|0|0.0||||||
3863823|NCT01606748|3689024|B1|Hepatobilliary Carcinoma||Disease Characteristics - Tumor Type||participants|Number|1|1.0||||||
3863824|NCT01606748|3689022|B3|Endometrial Carcinoma||Disease Characteristics - Tumor Type||participants|Number|2|2.0||||||
3863825|NCT01606748|3689023|B2|Endometrial Carcinoma||Disease Characteristics - Tumor Type||participants|Number|1|1.0||||||
3863826|NCT01606748|3689024|B1|Endometrial Carcinoma||Disease Characteristics - Tumor Type||participants|Number|1|1.0||||||
3863827|NCT01606748|3689022|B3|Head and Neck Carcinoma||Disease Characteristics - Tumor Type||participants|Number|2|2.0||||||
3863828|NCT01606748|3689023|B2|Head and Neck Carcinoma||Disease Characteristics - Tumor Type||participants|Number|1|1.0||||||
3863829|NCT01606748|3689024|B1|Head and Neck Carcinoma||Disease Characteristics - Tumor Type||participants|Number|1|1.0||||||
3863830|NCT01606748|3689022|B3|Melanoma||Disease Characteristics - Tumor Type||participants|Number|2|2.0||||||
3863831|NCT01606748|3689023|B2|Melanoma||Disease Characteristics - Tumor Type||participants|Number|1|1.0||||||
3863832|NCT01606748|3689024|B1|Melanoma||Disease Characteristics - Tumor Type||participants|Number|1|1.0||||||
3863833|NCT01606748|3689022|B3|Nonsmall Cell Lung Carcinoma||Disease Characteristics - Tumor Type||participants|Number|2|2.0||||||
3863834|NCT01606748|3689023|B2|Nonsmall Cell Lung Carcinoma||Disease Characteristics - Tumor Type||participants|Number|0|0.0||||||
3863835|NCT01606748|3689024|B1|Nonsmall Cell Lung Carcinoma||Disease Characteristics - Tumor Type||participants|Number|2|2.0||||||
3863836|NCT01606748|3689022|B3|Thymic Tumor||Disease Characteristics - Tumor Type||participants|Number|2|2.0||||||
3863837|NCT01606748|3689023|B2|Thymic Tumor||Disease Characteristics - Tumor Type||participants|Number|0|0.0||||||
3863838|NCT01606748|3689024|B1|Thymic Tumor||Disease Characteristics - Tumor Type||participants|Number|2|2.0||||||
3863839|NCT01606748|3689022|B3|Small Cell Lung Carcinoma||Disease Characteristics - Tumor Type||participants|Number|3|3.0||||||
3863840|NCT01606748|3689023|B2|Small Cell Lung Carcinoma||Disease Characteristics - Tumor Type||participants|Number|1|1.0||||||
3863841|NCT01606748|3689024|B1|Small Cell Lung Carcinoma||Disease Characteristics - Tumor Type||participants|Number|2|2.0||||||
3863842|NCT01606748|3689022|B3|Ovarian Carcinoma||Disease Characteristics - Tumor Type||participants|Number|3|3.0||||||
3863843|NCT01606748|3689023|B2|Ovarian Carcinoma||Disease Characteristics - Tumor Type||participants|Number|1|1.0||||||
3863844|NCT01606748|3689024|B1|Ovarian Carcinoma||Disease Characteristics - Tumor Type||participants|Number|2|2.0||||||
3863845|NCT01606748|3689022|B3|Breast Carcinoma||Disease Characteristics - Tumor Type||participants|Number|7|7.0||||||
3863846|NCT01606748|3689023|B2|Breast Carcinoma||Disease Characteristics - Tumor Type||participants|Number|4|4.0||||||
3863847|NCT01606748|3689024|B1|Breast Carcinoma||Disease Characteristics - Tumor Type||participants|Number|3|3.0||||||
3863848|NCT01606748|3689022|B3|>=2||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) at Baseline|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 0 - Fully Active. 1 - Ambulatory, Restricted Strenuous Activity. 2 - Ambulatory, No Work Activities. 3 - Partially Confined to Bed, Limited Self Care. 4 - Completely Disabled. 5 - Death.|participants|Number|0|0.0||||||
3863849|NCT01606748|3689023|B2|>=2||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) at Baseline|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 0 - Fully Active. 1 - Ambulatory, Restricted Strenuous Activity. 2 - Ambulatory, No Work Activities. 3 - Partially Confined to Bed, Limited Self Care. 4 - Completely Disabled. 5 - Death.|participants|Number|0|0.0||||||
3863850|NCT01606748|3689024|B1|>=2||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) at Baseline|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 0 - Fully Active. 1 - Ambulatory, Restricted Strenuous Activity. 2 - Ambulatory, No Work Activities. 3 - Partially Confined to Bed, Limited Self Care. 4 - Completely Disabled. 5 - Death.|participants|Number|0|0.0||||||
3863851|NCT01606748|3689022|B3|1||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) at Baseline|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 0 - Fully Active. 1 - Ambulatory, Restricted Strenuous Activity. 2 - Ambulatory, No Work Activities. 3 - Partially Confined to Bed, Limited Self Care. 4 - Completely Disabled. 5 - Death.|participants|Number|19|19.0||||||
3863897|NCT01606748|3689023|B2|||Age||years|Mean|58.2|58.2|Standard Deviation|13.84|13.84|||
3863852|NCT01606748|3689023|B2|1||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) at Baseline|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 0 - Fully Active. 1 - Ambulatory, Restricted Strenuous Activity. 2 - Ambulatory, No Work Activities. 3 - Partially Confined to Bed, Limited Self Care. 4 - Completely Disabled. 5 - Death.|participants|Number|10|10.0||||||
3863853|NCT01606748|3689024|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) at Baseline|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 0 - Fully Active. 1 - Ambulatory, Restricted Strenuous Activity. 2 - Ambulatory, No Work Activities. 3 - Partially Confined to Bed, Limited Self Care. 4 - Completely Disabled. 5 - Death.|participants|Number|9|9.0||||||
3863854|NCT01606748|3689022|B3|0||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) at Baseline|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 0 - Fully Active. 1 - Ambulatory, Restricted Strenuous Activity. 2 - Ambulatory, No Work Activities. 3 - Partially Confined to Bed, Limited Self Care. 4 - Completely Disabled. 5 - Death.|participants|Number|16|16.0||||||
3863855|NCT01606748|3689023|B2|0||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) at Baseline|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 0 - Fully Active. 1 - Ambulatory, Restricted Strenuous Activity. 2 - Ambulatory, No Work Activities. 3 - Partially Confined to Bed, Limited Self Care. 4 - Completely Disabled. 5 - Death.|participants|Number|7|7.0||||||
3863856|NCT01606748|3689024|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) at Baseline|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 0 - Fully Active. 1 - Ambulatory, Restricted Strenuous Activity. 2 - Ambulatory, No Work Activities. 3 - Partially Confined to Bed, Limited Self Care. 4 - Completely Disabled. 5 - Death.|participants|Number|9|9.0||||||
3863857|NCT01606748|3689022|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
3863858|NCT01606748|3689023|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3863859|NCT01606748|3689024|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3863860|NCT01606748|3689022|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863861|NCT01606748|3689023|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863862|NCT01606748|3689024|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863863|NCT01606748|3689022|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863864|NCT01606748|3689023|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863865|NCT01606748|3689024|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863866|NCT01606748|3689022|B3||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3863867|NCT01606748|3689023|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3863868|NCT01606748|3689024|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3863869|NCT01606748|3689022|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3863870|NCT01606748|3689023|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3863871|NCT01606748|3689024|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863872|NCT01606748|3689022|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863873|NCT01606748|3689023|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863874|NCT01606748|3689024|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863875|NCT01606748|3689022|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3863876|NCT01606748|3689023|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863877|NCT01606748|3689024|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3863878|NCT01606748|3689022|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863879|NCT01606748|3689023|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863880|NCT01606748|3689024|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863881|NCT01606748|3689022|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863882|NCT01606748|3689023|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863883|NCT01606748|3689024|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863884|NCT01606748|3689022|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3863885|NCT01606748|3689023|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3863886|NCT01606748|3689024|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3863887|NCT01606748|3689022|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3863888|NCT01606748|3689023|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3863889|NCT01606748|3689024|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3863890|NCT01606748|3689022|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3863891|NCT01606748|3689023|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3863892|NCT01606748|3689024|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3863893|NCT01606748|3689022|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3863894|NCT01606748|3689023|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3863895|NCT01606748|3689024|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3863896|NCT01606748|3689022|B3|||Age||years|Mean|56.7|56.7|Standard Deviation|14.59|14.59|||
3863898|NCT01606748|3689024|B1|||Age||years|Mean|55.3|55.3|Standard Deviation|15.54|15.54|||
3863899|NCT01606735|3689053|B4|United States||Region of Enrollment||participants|Number|172|172.0||||||
3863900|NCT01606735|3689054|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
3863901|NCT01606735|3689055|B2|United States||Region of Enrollment||participants|Number|56|56.0||||||
3863902|NCT01606735|3689056|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
3863903|NCT01606735|3689053|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3863904|NCT01606735|3689054|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3863905|NCT01606735|3689055|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3863906|NCT01606735|3689056|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3863907|NCT01606735|3689053|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863908|NCT01606735|3689054|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863909|NCT01606735|3689055|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863910|NCT01606735|3689056|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863911|NCT01606735|3689053|B4||White|Race (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
3863912|NCT01606735|3689054|B3||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3863913|NCT01606735|3689055|B2||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3863914|NCT01606735|3689056|B1||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3863915|NCT01606735|3689053|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3863916|NCT01606735|3689054|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3863917|NCT01606735|3689055|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3863918|NCT01606735|3689056|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3863919|NCT01606735|3689053|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3863920|NCT01606735|3689054|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3863921|NCT01606735|3689055|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863922|NCT01606735|3689056|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863923|NCT01606735|3689053|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3863924|NCT01606735|3689054|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3863925|NCT01606735|3689055|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3863926|NCT01606735|3689056|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3863927|NCT01606735|3689053|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3863928|NCT01606735|3689054|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863929|NCT01606735|3689055|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3863930|NCT01606735|3689056|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3863931|NCT01606735|3689053|B4||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3863932|NCT01606735|3689054|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3863933|NCT01606735|3689055|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3863934|NCT01606735|3689056|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3863935|NCT01606735|3689053|B4||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3863936|NCT01606735|3689054|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3863937|NCT01606735|3689055|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3863938|NCT01606735|3689056|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3863939|NCT01606735|3689053|B4|||Age||years|Mean|70.1|70.1|Standard Deviation|9.2|9.2|||
3863940|NCT01606735|3689054|B3|||Age||years|Mean|70.1|70.1|Standard Deviation|10|10.0|||
3863941|NCT01606735|3689055|B2|||Age||years|Mean|71.8|71.8|Standard Deviation|71.8|71.8|||
3863942|NCT01606735|3689056|B1|||Age||years|Mean|68|68.0|Standard Deviation|8.9|8.9|||
3863943|NCT01606709|3689066|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3863944|NCT01606709|3689066|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3863945|NCT01606709|3689067|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3863946|NCT01606709|3689068|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3863947|NCT01606709|3689066|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3863948|NCT01606709|3689067|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3863949|NCT01606709|3689068|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3863950|NCT01606709|3689066|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3863951|NCT01606709|3689067|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3863952|NCT01606709|3689068|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3863953|NCT01606709|3689066|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3863954|NCT01606709|3689067|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3863955|NCT01606709|3689068|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3863956|NCT01606709|3689066|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3863957|NCT01606709|3689067|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3863958|NCT01606709|3689068|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3863959|NCT01606670|3689077|B1|Germany||Region of Enrollment||participants|Number|87|87.0||||||
3863960|NCT01606670|3689077|B1|Austria||Region of Enrollment||participants|Number|6|6.0||||||
3863961|NCT01606670|3689077|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3863962|NCT01606670|3689077|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3863963|NCT01606670|3689077|B1|||Age||years|Mean|71.1|71.1|Standard Deviation|9.0|9.0|||
3863964|NCT01606670|3689077|B1||>=65 years|Age||Participants|Count of Participants|76|76.0||||||
3863965|NCT01606670|3689077|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3863966|NCT01606670|3689077|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3863967|NCT01606319|3689085|B3|Negative test||Allergen Test||participants|Number|174|174.0||||||
3863968|NCT01606319|3689086|B2|Negative test||Allergen Test||participants|Number|88|88.0||||||
3863969|NCT01606319|3689087|B1|Negative test||Allergen Test||participants|Number|86|86.0||||||
3863970|NCT01606319|3689085|B3|Positive test||Allergen Test||participants|Number|126|126.0||||||
3863971|NCT01606319|3689086|B2|Positive test||Allergen Test||participants|Number|62|62.0||||||
3863972|NCT01606319|3689087|B1|Positive test||Allergen Test||participants|Number|64|64.0||||||
3863973|NCT01606319|3689085|B3|||IgE (kU/L)||kU/L|Median|70|70.0|Inter-Quartile Range|||22.0|208.0|
3863974|NCT01606319|3689086|B2|||IgE (kU/L)||kU/L|Median|70|70.0|Inter-Quartile Range|||24.0|252.0|
3863975|NCT01606319|3689087|B1|||IgE (kU/L)||kU/L|Median|64|64.0|Inter-Quartile Range|||19.0|176.0|
3863976|NCT01606319|3689085|B3|||Number of Oral Corticosteroid (OCS) courses in the past 6 months||OCS courses per 6 months|Mean|1.1|1.1|Standard Deviation|1.1|1.1|||
3863977|NCT01606319|3689086|B2|||Number of Oral Corticosteroid (OCS) courses in the past 6 months||OCS courses per 6 months|Mean|1.2|1.2|Standard Deviation|1.0|1.0|||
3863978|NCT01606319|3689087|B1|||Number of Oral Corticosteroid (OCS) courses in the past 6 months||OCS courses per 6 months|Mean|1|1.0|Standard Deviation|1.1|1.1|||
3863979|NCT01606319|3689085|B3|||Number of urgent care and ED visits in the past year||urgent care/ED visits per year|Mean|3.1|3.1|Standard Deviation|2.4|2.4|||
3863980|NCT01606319|3689086|B2|||Number of urgent care and ED visits in the past year||urgent care/ED visits per year|Mean|3.0|3.0|Standard Deviation|2.3|2.3|||
3863981|NCT01606319|3689087|B1|||Number of urgent care and ED visits in the past year||urgent care/ED visits per year|Mean|3.1|3.1|Standard Deviation|2.5|2.5|||
3863982|NCT01606319|3689085|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863983|NCT01606319|3689086|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863984|NCT01606319|3689087|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863985|NCT01606319|3689085|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3863986|NCT01606319|3689086|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3863987|NCT01606319|3689087|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3863988|NCT01606319|3689085|B3||White|Race (NIH/OMB)||Participants|Count of Participants|148|148.0||||||
3863989|NCT01606319|3689086|B2||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3863990|NCT01606319|3689087|B1||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3863991|NCT01606319|3689085|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
3863992|NCT01606319|3689086|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3863993|NCT01606319|3689087|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3863994|NCT01606319|3689085|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3863995|NCT01606319|3689086|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3863996|NCT01606319|3689087|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3863997|NCT01606319|3689085|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3863998|NCT01606319|3689086|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3863999|NCT01606319|3689087|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3864000|NCT01606319|3689085|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3864001|NCT01606319|3689086|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3864002|NCT01606319|3689087|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3864003|NCT01606319|3689085|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864004|NCT01606319|3689086|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864005|NCT01606319|3689087|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864006|NCT01606319|3689085|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|228|228.0||||||
3864007|NCT01606319|3689086|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
3864008|NCT01606319|3689087|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
3864009|NCT01606319|3689085|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3864010|NCT01606319|3689086|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3864011|NCT01606319|3689087|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3864012|NCT01606319|3689085|B3||Male|Gender||Participants|Count of Participants|179|179.0||||||
3864013|NCT01606319|3689086|B2||Male|Gender||Participants|Count of Participants|93|93.0||||||
3864014|NCT01606319|3689087|B1||Male|Gender||Participants|Count of Participants|86|86.0||||||
3864015|NCT01606319|3689085|B3||Female|Gender||Participants|Count of Participants|121|121.0||||||
3864016|NCT01606319|3689086|B2||Female|Gender||Participants|Count of Participants|57|57.0||||||
3864017|NCT01606319|3689087|B1||Female|Gender||Participants|Count of Participants|64|64.0||||||
3864018|NCT01606319|3689085|B3|||Age||months|Mean|39.9|39.9|Standard Deviation|13.2|13.2|||
3864019|NCT01606319|3689086|B2|||Age||months|Mean|39.4|39.4|Standard Deviation|13.6|13.6|||
3864020|NCT01606319|3689087|B1|||Age||months|Mean|40.3|40.3|Standard Deviation|12.9|12.9|||
3864021|NCT01606306|3689100|B7|||Serum IgE||international units per liter|Median|70|70.0|Inter-Quartile Range|||22.0|208.0|
3864022|NCT01606306|3689101|B6|||Serum IgE||international units per liter|Median|84|84.0|Inter-Quartile Range|||19.0|348.0|
3864023|NCT01606306|3689102|B5|||Serum IgE||international units per liter|Median|87|87.0|Inter-Quartile Range|||19.0|237.0|
3864024|NCT01606306|3689103|B4|||Serum IgE||international units per liter|Median|64|64.0|Inter-Quartile Range|||31.0|143.0|
3864025|NCT01606306|3689104|B3|||Serum IgE||international units per liter|Median|64|64.0|Inter-Quartile Range|||21.0|141.0|
3864026|NCT01606306|3689105|B2|||Serum IgE||international units per liter|Median|106.5|106.5|Inter-Quartile Range|||22.0|463.0|
3864027|NCT01606306|3689106|B1|||Serum IgE||international units per liter|Median|67|67.0|Inter-Quartile Range|||25.0|212.0|
3864028|NCT01606306|3689100|B7|||Blood eosinophils||number of cells per micro-liter|Median|258|258.0|Inter-Quartile Range|||158.0|492.0|
3864029|NCT01606306|3689101|B6|||Blood eosinophils||number of cells per micro-liter|Median|310|310.0|Inter-Quartile Range|||182.0|536.0|
3864030|NCT01606306|3689102|B5|||Blood eosinophils||number of cells per micro-liter|Median|308|308.0|Inter-Quartile Range|||184.0|496.0|
3864031|NCT01606306|3689103|B4|||Blood eosinophils||number of cells per micro-liter|Median|255|255.0|Inter-Quartile Range|||175.0|457.0|
3864032|NCT01606306|3689104|B3|||Blood eosinophils||number of cells per micro-liter|Median|258|258.0|Inter-Quartile Range|||133.0|460.0|
3864033|NCT01606306|3689105|B2|||Blood eosinophils||number of cells per micro-liter|Median|234|234.0|Inter-Quartile Range|||153.0|572.0|
3864034|NCT01606306|3689106|B1|||Blood eosinophils||number of cells per micro-liter|Median|183|183.0|Inter-Quartile Range|||111.0|435.0|
3864035|NCT01606306|3689100|B7|Not Present||Eczema||participants|Number|140|140.0||||||
3864036|NCT01606306|3689101|B6|Not Present||Eczema||participants|Number|17|17.0||||||
3864037|NCT01606306|3689102|B5|Not Present||Eczema||participants|Number|26|26.0||||||
3864038|NCT01606306|3689103|B4|Not Present||Eczema||participants|Number|23|23.0||||||
3864039|NCT01606306|3689104|B3|Not Present||Eczema||participants|Number|24|24.0||||||
3864040|NCT01606306|3689105|B2|Not Present||Eczema||participants|Number|21|21.0||||||
3864041|NCT01606306|3689106|B1|Not Present||Eczema||participants|Number|29|29.0||||||
3864042|NCT01606306|3689100|B7|Present||Eczema||participants|Number|160|160.0||||||
3864043|NCT01606306|3689101|B6|Present||Eczema||participants|Number|30|30.0||||||
3864044|NCT01606306|3689102|B5|Present||Eczema||participants|Number|26|26.0||||||
3864045|NCT01606306|3689103|B4|Present||Eczema||participants|Number|28|28.0||||||
3864046|NCT01606306|3689104|B3|Present||Eczema||participants|Number|27|27.0||||||
3864047|NCT01606306|3689105|B2|Present||Eczema||participants|Number|28|28.0||||||
3864048|NCT01606306|3689106|B1|Present||Eczema||participants|Number|21|21.0||||||
3864049|NCT01606306|3689100|B7|Negative test||Allergen Test||participants|Number|179|179.0||||||
3864050|NCT01606306|3689101|B6|Negative test||Allergen Test||participants|Number|30|30.0||||||
3864051|NCT01606306|3689102|B5|Negative test||Allergen Test||participants|Number|27|27.0||||||
3864052|NCT01606306|3689103|B4|Negative test||Allergen Test||participants|Number|30|30.0||||||
3864053|NCT01606306|3689104|B3|Negative test||Allergen Test||participants|Number|31|31.0||||||
3864054|NCT01606306|3689105|B2|Negative test||Allergen Test||participants|Number|29|29.0||||||
3864055|NCT01606306|3689106|B1|Negative test||Allergen Test||participants|Number|32|32.0||||||
3864056|NCT01606306|3689100|B7|Positive test||Allergen Test||participants|Number|121|121.0||||||
3864057|NCT01606306|3689101|B6|Positive test||Allergen Test||participants|Number|17|17.0||||||
3864058|NCT01606306|3689102|B5|Positive test||Allergen Test||participants|Number|25|25.0||||||
3864059|NCT01606306|3689103|B4|Positive test||Allergen Test||participants|Number|21|21.0||||||
3864060|NCT01606306|3689104|B3|Positive test||Allergen Test||participants|Number|20|20.0||||||
3864061|NCT01606306|3689105|B2|Positive test||Allergen Test||participants|Number|20|20.0||||||
3864062|NCT01606306|3689106|B1|Positive test||Allergen Test||participants|Number|18|18.0||||||
3864063|NCT01606306|3689100|B7|Not hospitalized||Hospitalized in past 12 months||participants|Number|235|235.0||||||
3864064|NCT01606306|3689101|B6|Not hospitalized||Hospitalized in past 12 months||participants|Number|35|35.0||||||
3864065|NCT01606306|3689102|B5|Not hospitalized||Hospitalized in past 12 months||participants|Number|39|39.0||||||
3864066|NCT01606306|3689103|B4|Not hospitalized||Hospitalized in past 12 months||participants|Number|45|45.0||||||
3864067|NCT01606306|3689104|B3|Not hospitalized||Hospitalized in past 12 months||participants|Number|40|40.0||||||
3864068|NCT01606306|3689105|B2|Not hospitalized||Hospitalized in past 12 months||participants|Number|35|35.0||||||
3864069|NCT01606306|3689106|B1|Not hospitalized||Hospitalized in past 12 months||participants|Number|41|41.0||||||
3864070|NCT01606306|3689100|B7|Hospitalized||Hospitalized in past 12 months||participants|Number|65|65.0||||||
3864071|NCT01606306|3689101|B6|Hospitalized||Hospitalized in past 12 months||participants|Number|12|12.0||||||
3864072|NCT01606306|3689102|B5|Hospitalized||Hospitalized in past 12 months||participants|Number|13|13.0||||||
3864073|NCT01606306|3689103|B4|Hospitalized||Hospitalized in past 12 months||participants|Number|6|6.0||||||
3864074|NCT01606306|3689104|B3|Hospitalized||Hospitalized in past 12 months||participants|Number|11|11.0||||||
3864075|NCT01606306|3689105|B2|Hospitalized||Hospitalized in past 12 months||participants|Number|14|14.0||||||
3864076|NCT01606306|3689106|B1|Hospitalized||Hospitalized in past 12 months||participants|Number|9|9.0||||||
3864077|NCT01606306|3689100|B7|Not used||Systemic corticosteroids in past 12 monts||participants|Number|76|76.0||||||
3864078|NCT01606306|3689101|B6|Not used||Systemic corticosteroids in past 12 monts||participants|Number|11|11.0||||||
3864079|NCT01606306|3689102|B5|Not used||Systemic corticosteroids in past 12 monts||participants|Number|13|13.0||||||
3864080|NCT01606306|3689103|B4|Not used||Systemic corticosteroids in past 12 monts||participants|Number|11|11.0||||||
3864081|NCT01606306|3689104|B3|Not used||Systemic corticosteroids in past 12 monts||participants|Number|14|14.0||||||
3864082|NCT01606306|3689105|B2|Not used||Systemic corticosteroids in past 12 monts||participants|Number|14|14.0||||||
3864083|NCT01606306|3689106|B1|Not used||Systemic corticosteroids in past 12 monts||participants|Number|13|13.0||||||
3864084|NCT01606306|3689100|B7|Used||Systemic corticosteroids in past 12 monts||participants|Number|224|224.0||||||
3864085|NCT01606306|3689101|B6|Used||Systemic corticosteroids in past 12 monts||participants|Number|36|36.0||||||
3864086|NCT01606306|3689102|B5|Used||Systemic corticosteroids in past 12 monts||participants|Number|39|39.0||||||
3864087|NCT01606306|3689103|B4|Used||Systemic corticosteroids in past 12 monts||participants|Number|40|40.0||||||
3864088|NCT01606306|3689104|B3|Used||Systemic corticosteroids in past 12 monts||participants|Number|37|37.0||||||
3864089|NCT01606306|3689105|B2|Used||Systemic corticosteroids in past 12 monts||participants|Number|35|35.0||||||
3864090|NCT01606306|3689106|B1|Used||Systemic corticosteroids in past 12 monts||participants|Number|37|37.0||||||
3864091|NCT01606306|3689100|B7|Not Present||Parental Asthma||participants|Number|122|122.0||||||
3864092|NCT01606306|3689101|B6|Not Present||Parental Asthma||participants|Number|24|24.0||||||
3864093|NCT01606306|3689102|B5|Not Present||Parental Asthma||participants|Number|17|17.0||||||
3864094|NCT01606306|3689103|B4|Not Present||Parental Asthma||participants|Number|19|19.0||||||
3864095|NCT01606306|3689104|B3|Not Present||Parental Asthma||participants|Number|22|22.0||||||
3864096|NCT01606306|3689105|B2|Not Present||Parental Asthma||participants|Number|20|20.0||||||
3864097|NCT01606306|3689106|B1|Not Present||Parental Asthma||participants|Number|20|20.0||||||
3864098|NCT01606306|3689100|B7|Present||Parental Asthma||participants|Number|178|178.0||||||
3864099|NCT01606306|3689101|B6|Present||Parental Asthma||participants|Number|23|23.0||||||
3864100|NCT01606306|3689102|B5|Present||Parental Asthma||participants|Number|35|35.0||||||
3864101|NCT01606306|3689103|B4|Present||Parental Asthma||participants|Number|32|32.0||||||
3864102|NCT01606306|3689104|B3|Present||Parental Asthma||participants|Number|29|29.0||||||
3864103|NCT01606306|3689105|B2|Present||Parental Asthma||participants|Number|29|29.0||||||
3864104|NCT01606306|3689106|B1|Present||Parental Asthma||participants|Number|30|30.0||||||
3864105|NCT01606306|3689100|B7|United States||Region of Enrollment||participants|Number|300|300.0||||||
3864106|NCT01606306|3689101|B6|United States||Region of Enrollment||participants|Number|47|47.0||||||
3864107|NCT01606306|3689102|B5|United States||Region of Enrollment||participants|Number|52|52.0||||||
3864108|NCT01606306|3689103|B4|United States||Region of Enrollment||participants|Number|51|51.0||||||
3864109|NCT01606306|3689104|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
3864110|NCT01606306|3689105|B2|United States||Region of Enrollment||participants|Number|49|49.0||||||
3864111|NCT01606306|3689106|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3864112|NCT01606306|3689100|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864113|NCT01606306|3689101|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864114|NCT01606306|3689102|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864115|NCT01606306|3689103|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864116|NCT01606306|3689104|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864117|NCT01606306|3689105|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864118|NCT01606306|3689106|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864119|NCT01606306|3689100|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3864120|NCT01606306|3689101|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3864121|NCT01606306|3689102|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3864122|NCT01606306|3689103|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3864123|NCT01606306|3689104|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3864124|NCT01606306|3689105|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3864125|NCT01606306|3689106|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3864126|NCT01606306|3689100|B7||White|Race (NIH/OMB)||Participants|Count of Participants|148|148.0||||||
3864127|NCT01606306|3689101|B6||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3864128|NCT01606306|3689102|B5||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3864129|NCT01606306|3689103|B4||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3864130|NCT01606306|3689104|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3864131|NCT01606306|3689105|B2||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3864132|NCT01606306|3689106|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3864133|NCT01606306|3689100|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
3864134|NCT01606306|3689101|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3864135|NCT01606306|3689102|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3864136|NCT01606306|3689103|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3864137|NCT01606306|3689104|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3864138|NCT01606306|3689105|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3864139|NCT01606306|3689106|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3864140|NCT01606306|3689100|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3864141|NCT01606306|3689101|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864142|NCT01606306|3689102|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3864143|NCT01606306|3689103|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3864144|NCT01606306|3689104|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864145|NCT01606306|3689105|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864146|NCT01606306|3689106|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3864147|NCT01606306|3689100|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3864148|NCT01606306|3689101|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864149|NCT01606306|3689102|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864150|NCT01606306|3689103|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864151|NCT01606306|3689104|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864152|NCT01606306|3689105|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864153|NCT01606306|3689106|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3864154|NCT01606306|3689100|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3864155|NCT01606306|3689101|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3864156|NCT01606306|3689102|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864157|NCT01606306|3689103|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3864158|NCT01606306|3689104|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864159|NCT01606306|3689105|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3864160|NCT01606306|3689106|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3864161|NCT01606306|3689100|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864162|NCT01606306|3689101|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864163|NCT01606306|3689102|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864164|NCT01606306|3689103|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864165|NCT01606306|3689104|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864166|NCT01606306|3689105|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864167|NCT01606306|3689106|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864168|NCT01606306|3689100|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|228|228.0||||||
3864169|NCT01606306|3689101|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3864170|NCT01606306|3689102|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3864171|NCT01606306|3689103|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3864172|NCT01606306|3689104|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3864173|NCT01606306|3689105|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3864174|NCT01606306|3689106|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3864175|NCT01606306|3689100|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3864176|NCT01606306|3689101|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3864177|NCT01606306|3689102|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3864178|NCT01606306|3689103|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3864179|NCT01606306|3689104|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3864180|NCT01606306|3689105|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3864181|NCT01606306|3689106|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3864182|NCT01606306|3689100|B7||Male|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
3864183|NCT01606306|3689101|B6||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3864184|NCT01606306|3689102|B5||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3864185|NCT01606306|3689103|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3864186|NCT01606306|3689104|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3864187|NCT01606306|3689105|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3864188|NCT01606306|3689106|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3864189|NCT01606306|3689100|B7||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3864190|NCT01606306|3689101|B6||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3864191|NCT01606306|3689102|B5||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3864192|NCT01606306|3689103|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3864193|NCT01606306|3689104|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3864194|NCT01606306|3689105|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3864195|NCT01606306|3689106|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3864196|NCT01606306|3689100|B7|||Age||months|Mean|39.9|39.9|Standard Deviation|13.2|13.2|||
3864197|NCT01606306|3689101|B6|||Age||months|Mean|41.2|41.2|Standard Deviation|14.0|14.0|||
3864198|NCT01606306|3689102|B5|||Age||months|Mean|41.7|41.7|Standard Deviation|12.7|12.7|||
3864199|NCT01606306|3689103|B4|||Age||months|Mean|38.6|38.6|Standard Deviation|15.1|15.1|||
3864200|NCT01606306|3689104|B3|||Age||months|Mean|38.7|38.7|Standard Deviation|11.6|11.6|||
3864201|NCT01606306|3689105|B2|||Age||months|Mean|40.7|40.7|Standard Deviation|12.4|12.4|||
3864202|NCT01606306|3689106|B1|||Age||months|Mean|38.3|38.3|Standard Deviation|13.6|13.6|||
3864203|NCT01606306|3689100|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3864204|NCT01606306|3689101|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3864205|NCT01606306|3689102|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3864206|NCT01606306|3689103|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3864207|NCT01606306|3689104|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3864208|NCT01606306|3689105|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3864209|NCT01606306|3689106|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3864210|NCT01606306|3689100|B7||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3864211|NCT01606306|3689101|B6||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3864212|NCT01606306|3689102|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3864213|NCT01606306|3689103|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3864214|NCT01606306|3689104|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3864215|NCT01606306|3689105|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3864216|NCT01606306|3689106|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3864217|NCT01606306|3689100|B7||<=18 years|Age||Participants|Count of Participants|300|300.0||||||
3864218|NCT01606306|3689101|B6||<=18 years|Age||Participants|Count of Participants|47|47.0||||||
3864219|NCT01606306|3689102|B5||<=18 years|Age||Participants|Count of Participants|52|52.0||||||
3864220|NCT01606306|3689103|B4||<=18 years|Age||Participants|Count of Participants|51|51.0||||||
3864221|NCT01606306|3689104|B3||<=18 years|Age||Participants|Count of Participants|51|51.0||||||
3864222|NCT01606306|3689105|B2||<=18 years|Age||Participants|Count of Participants|49|49.0||||||
3864223|NCT01606306|3689106|B1||<=18 years|Age||Participants|Count of Participants|50|50.0||||||
3864224|NCT01606254|3689117|B5|Mild||Number of Participants with Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS) Score|Drug Induced Extra-Pyramidal Symptoms Scale (DIEPSS) is a scale used to evaluate the severity of drug induced extra-pyramidal symptoms occurring during antipsychotic drug treatment. Scale consists of 8 individual symptom scales with scores ranging from 0 (none/normal) to 4 (severe). The total score is the average of the 8 item scores, for a total range of 0 (normal) to 4 (severe). Overall severity was assessed at 5 levels (0 [none, normal]; 1 [Very Mild]; 2 [Mild]; 3 [Moderate]; 4 [severe]).|Participant|Number|1|1.0||||||
3864225|NCT01606254|3689118|B4|Mild||Number of Participants with Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS) Score|Drug Induced Extra-Pyramidal Symptoms Scale (DIEPSS) is a scale used to evaluate the severity of drug induced extra-pyramidal symptoms occurring during antipsychotic drug treatment. Scale consists of 8 individual symptom scales with scores ranging from 0 (none/normal) to 4 (severe). The total score is the average of the 8 item scores, for a total range of 0 (normal) to 4 (severe). Overall severity was assessed at 5 levels (0 [none, normal]; 1 [Very Mild]; 2 [Mild]; 3 [Moderate]; 4 [severe]).|Participant|Number|0|0.0||||||
3864226|NCT01606254|3689119|B3|Mild||Number of Participants with Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS) Score|Drug Induced Extra-Pyramidal Symptoms Scale (DIEPSS) is a scale used to evaluate the severity of drug induced extra-pyramidal symptoms occurring during antipsychotic drug treatment. Scale consists of 8 individual symptom scales with scores ranging from 0 (none/normal) to 4 (severe). The total score is the average of the 8 item scores, for a total range of 0 (normal) to 4 (severe). Overall severity was assessed at 5 levels (0 [none, normal]; 1 [Very Mild]; 2 [Mild]; 3 [Moderate]; 4 [severe]).|Participant|Number|1|1.0||||||
3864227|NCT01606254|3689120|B2|Mild||Number of Participants with Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS) Score|Drug Induced Extra-Pyramidal Symptoms Scale (DIEPSS) is a scale used to evaluate the severity of drug induced extra-pyramidal symptoms occurring during antipsychotic drug treatment. Scale consists of 8 individual symptom scales with scores ranging from 0 (none/normal) to 4 (severe). The total score is the average of the 8 item scores, for a total range of 0 (normal) to 4 (severe). Overall severity was assessed at 5 levels (0 [none, normal]; 1 [Very Mild]; 2 [Mild]; 3 [Moderate]; 4 [severe]).|Participant|Number|0|0.0||||||
3864228|NCT01606254|3689121|B1|Mild||Number of Participants with Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS) Score|Drug Induced Extra-Pyramidal Symptoms Scale (DIEPSS) is a scale used to evaluate the severity of drug induced extra-pyramidal symptoms occurring during antipsychotic drug treatment. Scale consists of 8 individual symptom scales with scores ranging from 0 (none/normal) to 4 (severe). The total score is the average of the 8 item scores, for a total range of 0 (normal) to 4 (severe). Overall severity was assessed at 5 levels (0 [none, normal]; 1 [Very Mild]; 2 [Mild]; 3 [Moderate]; 4 [severe]).|Participant|Number|0|0.0||||||
3864249|NCT01606254|3689117|B5|||Age||Years|Mean|47.4|47.4|Standard Deviation|12.0|12.0|||
3864250|NCT01606254|3689118|B4|||Age||Years|Mean|49.4|49.4|Standard Deviation|12.1|12.1|||
3864229|NCT01606254|3689117|B5|Very mild||Number of Participants with Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS) Score|Drug Induced Extra-Pyramidal Symptoms Scale (DIEPSS) is a scale used to evaluate the severity of drug induced extra-pyramidal symptoms occurring during antipsychotic drug treatment. Scale consists of 8 individual symptom scales with scores ranging from 0 (none/normal) to 4 (severe). The total score is the average of the 8 item scores, for a total range of 0 (normal) to 4 (severe). Overall severity was assessed at 5 levels (0 [none, normal]; 1 [Very Mild]; 2 [Mild]; 3 [Moderate]; 4 [severe]).|Participant|Number|29|29.0||||||
3864230|NCT01606254|3689118|B4|Very mild||Number of Participants with Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS) Score|Drug Induced Extra-Pyramidal Symptoms Scale (DIEPSS) is a scale used to evaluate the severity of drug induced extra-pyramidal symptoms occurring during antipsychotic drug treatment. Scale consists of 8 individual symptom scales with scores ranging from 0 (none/normal) to 4 (severe). The total score is the average of the 8 item scores, for a total range of 0 (normal) to 4 (severe). Overall severity was assessed at 5 levels (0 [none, normal]; 1 [Very Mild]; 2 [Mild]; 3 [Moderate]; 4 [severe]).|Participant|Number|9|9.0||||||
3864231|NCT01606254|3689119|B3|Very mild||Number of Participants with Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS) Score|Drug Induced Extra-Pyramidal Symptoms Scale (DIEPSS) is a scale used to evaluate the severity of drug induced extra-pyramidal symptoms occurring during antipsychotic drug treatment. Scale consists of 8 individual symptom scales with scores ranging from 0 (none/normal) to 4 (severe). The total score is the average of the 8 item scores, for a total range of 0 (normal) to 4 (severe). Overall severity was assessed at 5 levels (0 [none, normal]; 1 [Very Mild]; 2 [Mild]; 3 [Moderate]; 4 [severe]).|Participant|Number|8|8.0||||||
3864232|NCT01606254|3689120|B2|Very mild||Number of Participants with Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS) Score|Drug Induced Extra-Pyramidal Symptoms Scale (DIEPSS) is a scale used to evaluate the severity of drug induced extra-pyramidal symptoms occurring during antipsychotic drug treatment. Scale consists of 8 individual symptom scales with scores ranging from 0 (none/normal) to 4 (severe). The total score is the average of the 8 item scores, for a total range of 0 (normal) to 4 (severe). Overall severity was assessed at 5 levels (0 [none, normal]; 1 [Very Mild]; 2 [Mild]; 3 [Moderate]; 4 [severe]).|Participant|Number|6|6.0||||||
3864233|NCT01606254|3689121|B1|Very mild||Number of Participants with Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS) Score|Drug Induced Extra-Pyramidal Symptoms Scale (DIEPSS) is a scale used to evaluate the severity of drug induced extra-pyramidal symptoms occurring during antipsychotic drug treatment. Scale consists of 8 individual symptom scales with scores ranging from 0 (none/normal) to 4 (severe). The total score is the average of the 8 item scores, for a total range of 0 (normal) to 4 (severe). Overall severity was assessed at 5 levels (0 [none, normal]; 1 [Very Mild]; 2 [Mild]; 3 [Moderate]; 4 [severe]).|Participant|Number|6|6.0||||||
3864234|NCT01606254|3689117|B5|None||Number of Participants with Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS) Score|Drug Induced Extra-Pyramidal Symptoms Scale (DIEPSS) is a scale used to evaluate the severity of drug induced extra-pyramidal symptoms occurring during antipsychotic drug treatment. Scale consists of 8 individual symptom scales with scores ranging from 0 (none/normal) to 4 (severe). The total score is the average of the 8 item scores, for a total range of 0 (normal) to 4 (severe). Overall severity was assessed at 5 levels (0 [none, normal]; 1 [Very Mild]; 2 [Mild]; 3 [Moderate]; 4 [severe]).|Participant|Number|26|26.0||||||
3864235|NCT01606254|3689118|B4|None||Number of Participants with Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS) Score|Drug Induced Extra-Pyramidal Symptoms Scale (DIEPSS) is a scale used to evaluate the severity of drug induced extra-pyramidal symptoms occurring during antipsychotic drug treatment. Scale consists of 8 individual symptom scales with scores ranging from 0 (none/normal) to 4 (severe). The total score is the average of the 8 item scores, for a total range of 0 (normal) to 4 (severe). Overall severity was assessed at 5 levels (0 [none, normal]; 1 [Very Mild]; 2 [Mild]; 3 [Moderate]; 4 [severe]).|Participant|Number|5|5.0||||||
3864236|NCT01606254|3689119|B3|None||Number of Participants with Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS) Score|Drug Induced Extra-Pyramidal Symptoms Scale (DIEPSS) is a scale used to evaluate the severity of drug induced extra-pyramidal symptoms occurring during antipsychotic drug treatment. Scale consists of 8 individual symptom scales with scores ranging from 0 (none/normal) to 4 (severe). The total score is the average of the 8 item scores, for a total range of 0 (normal) to 4 (severe). Overall severity was assessed at 5 levels (0 [none, normal]; 1 [Very Mild]; 2 [Mild]; 3 [Moderate]; 4 [severe]).|Participant|Number|5|5.0||||||
3864237|NCT01606254|3689120|B2|None||Number of Participants with Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS) Score|Drug Induced Extra-Pyramidal Symptoms Scale (DIEPSS) is a scale used to evaluate the severity of drug induced extra-pyramidal symptoms occurring during antipsychotic drug treatment. Scale consists of 8 individual symptom scales with scores ranging from 0 (none/normal) to 4 (severe). The total score is the average of the 8 item scores, for a total range of 0 (normal) to 4 (severe). Overall severity was assessed at 5 levels (0 [none, normal]; 1 [Very Mild]; 2 [Mild]; 3 [Moderate]; 4 [severe]).|Participant|Number|8|8.0||||||
3864238|NCT01606254|3689121|B1|None||Number of Participants with Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS) Score|Drug Induced Extra-Pyramidal Symptoms Scale (DIEPSS) is a scale used to evaluate the severity of drug induced extra-pyramidal symptoms occurring during antipsychotic drug treatment. Scale consists of 8 individual symptom scales with scores ranging from 0 (none/normal) to 4 (severe). The total score is the average of the 8 item scores, for a total range of 0 (normal) to 4 (severe). Overall severity was assessed at 5 levels (0 [none, normal]; 1 [Very Mild]; 2 [Mild]; 3 [Moderate]; 4 [severe]).|Participant|Number|8|8.0||||||
3864239|NCT01606254|3689117|B5||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3864240|NCT01606254|3689118|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3864241|NCT01606254|3689119|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3864242|NCT01606254|3689120|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3864243|NCT01606254|3689121|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3864244|NCT01606254|3689117|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3864245|NCT01606254|3689118|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3864246|NCT01606254|3689119|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3864247|NCT01606254|3689120|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3864248|NCT01606254|3689121|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3864251|NCT01606254|3689119|B3|||Age||Years|Mean|48.7|48.7|Standard Deviation|11.8|11.8|||
3864252|NCT01606254|3689120|B2|||Age||Years|Mean|45.2|45.2|Standard Deviation|11.1|11.1|||
3864253|NCT01606254|3689121|B1|||Age||Years|Mean|46.4|46.4|Standard Deviation|13.8|13.8|||
3864254|NCT01606228|3689206|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3864255|NCT01606228|3689206|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3864256|NCT01606228|3689206|B1|||Age||years|Mean|33.71|33.71|Standard Deviation|9.743|9.743|||
3864257|NCT01606202|3689221|B3|Romania||Region of Enrollment||participants|Number|16|16.0||||||
3864258|NCT01606202|3689222|B2|Romania||Region of Enrollment||participants|Number|9|9.0||||||
3864259|NCT01606202|3689223|B1|Romania||Region of Enrollment||participants|Number|7|7.0||||||
3864260|NCT01606202|3689221|B3|United Kingdom||Region of Enrollment||participants|Number|100|100.0||||||
3864261|NCT01606202|3689222|B2|United Kingdom||Region of Enrollment||participants|Number|51|51.0||||||
3864262|NCT01606202|3689223|B1|United Kingdom||Region of Enrollment||participants|Number|49|49.0||||||
3864263|NCT01606202|3689221|B3||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3864264|NCT01606202|3689222|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3864265|NCT01606202|3689223|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3864266|NCT01606202|3689221|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3864267|NCT01606202|3689222|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3864268|NCT01606202|3689223|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3864269|NCT01606202|3689221|B3|||Age||years|Mean|48.1|48.1|Standard Deviation|12.69|12.69|||
3864270|NCT01606202|3689222|B2|||Age||years|Mean|47.6|47.6|Standard Deviation|12.69|12.69|||
3864271|NCT01606202|3689223|B1|||Age||years|Mean|48.7|48.7|Standard Deviation|12.97|12.97|||
3864272|NCT01606202|3689221|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3864273|NCT01606202|3689222|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3864274|NCT01606202|3689223|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3864275|NCT01606202|3689221|B3||Between 18 and 65 years|Age||Participants|Count of Participants|106|106.0||||||
3864276|NCT01606202|3689222|B2||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
3864277|NCT01606202|3689223|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3864278|NCT01606202|3689221|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3864279|NCT01606202|3689222|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3864280|NCT01606202|3689223|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3864281|NCT01606189|3689256|B1|United Kingdom||Region of Enrollment||participants|Number|48|48.0||||||
3864282|NCT01606189|3689256|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3864283|NCT01606189|3689256|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3864284|NCT01606189|3689256|B1|||Age||years|Mean|38.53|38.53|Standard Deviation|10.342|10.342|||
3864285|NCT01606189|3689256|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3864286|NCT01606189|3689256|B1||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
3864287|NCT01606189|3689256|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3864288|NCT01606176|3689293|B3|United Kingdom||Region of Enrollment||participants|Number|70|70.0||||||
3864289|NCT01606176|3689294|B2|United Kingdom||Region of Enrollment||participants|Number|34|34.0||||||
3864290|NCT01606176|3689295|B1|United Kingdom||Region of Enrollment||participants|Number|36|36.0||||||
3864291|NCT01606176|3689293|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3864292|NCT01606176|3689294|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3864293|NCT01606176|3689295|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3864294|NCT01606176|3689293|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3864295|NCT01606176|3689294|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3864296|NCT01606176|3689295|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3864297|NCT01606176|3689293|B3|||Age||years|Mean|54.58|54.58|Standard Deviation|11.57|11.57|||
3864298|NCT01606176|3689294|B2|||Age||years|Mean|57.61|57.61|Standard Deviation|10.28|10.28|||
3864299|NCT01606176|3689295|B1|||Age||years|Mean|51.72|51.72|Standard Deviation|12.11|12.11|||
3864300|NCT01606176|3689293|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3864301|NCT01606176|3689294|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3864302|NCT01606176|3689295|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3864303|NCT01606176|3689293|B3||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
3864304|NCT01606176|3689294|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3864305|NCT01606176|3689295|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3864306|NCT01606176|3689293|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3864307|NCT01606176|3689294|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3864308|NCT01606176|3689295|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3864309|NCT01606137|3689341|B1|United Kingdom||Region of Enrollment||participants|Number|507|507.0||||||
3864310|NCT01606137|3689341|B1||Male|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
3864311|NCT01606137|3689341|B1||Female|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
3864312|NCT01606137|3689341|B1|||Age||years|Mean|50|50.0|Standard Deviation|12.3|12.3|||
3864313|NCT01606137|3689341|B1||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
3864314|NCT01606137|3689341|B1||Between 18 and 65 years|Age||Participants|Count of Participants|458|458.0||||||
3864315|NCT01606137|3689341|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3864316|NCT01606124|3689361|B3|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3864317|NCT01606124|3689362|B2|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3864318|NCT01606124|3689363|B1|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3864319|NCT01606124|3689361|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3864320|NCT01606124|3689362|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3864321|NCT01606124|3689363|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3864322|NCT01606124|3689361|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3864323|NCT01606124|3689362|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3864324|NCT01606124|3689363|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3864325|NCT01606124|3689361|B3|||Age||years|Mean|59.9|59.9|Standard Deviation|13.0|13.0|||
3864326|NCT01606124|3689362|B2|||Age||years|Mean|61.4|61.4|Standard Deviation|7.9|7.9|||
3864327|NCT01606124|3689363|B1|||Age||years|Mean|58.5|58.5|Standard Deviation|17.0|17.0|||
3864328|NCT01606007|3689372|B4|||HbA1c||%|Mean|8.94|8.94|Standard Deviation|1.13|1.13|||
3864329|NCT01606007|3689373|B3|||HbA1c||%|Mean|8.92|8.92|Standard Deviation|1.18|1.18|||
3864330|NCT01606007|3689374|B2|||HbA1c||%|Mean|8.87|8.87|Standard Deviation|1.16|1.16|||
3864331|NCT01606007|3689375|B1|||HbA1c||%|Mean|9.03|9.03|Standard Deviation|1.05|1.05|||
3864332|NCT01606007|3689372|B4|||T2DM duration||years|Mean|7.6|7.6|Standard Deviation|5.33|5.33|||
3864333|NCT01606007|3689373|B3|||T2DM duration||years|Mean|7.1|7.1|Standard Deviation|5.04|5.04|||
3864334|NCT01606007|3689374|B2|||T2DM duration||years|Mean|7.4|7.4|Standard Deviation|5.40|5.4|||
3864335|NCT01606007|3689375|B1|||T2DM duration||years|Mean|8.2|8.2|Standard Deviation|5.52|5.52|||
3864336|NCT01606007|3689372|B4|||Body Mass Index (BMI)||kg/m^2|Mean|31.67|31.67|Standard Deviation|5.080|5.08|||
3864337|NCT01606007|3689373|B3|||Body Mass Index (BMI)||kg/m^2|Mean|31.76|31.76|Standard Deviation|4.787|4.787|||
3864338|NCT01606007|3689374|B2|||Body Mass Index (BMI)||kg/m^2|Mean|31.46|31.46|Standard Deviation|5.321|5.321|||
3864339|NCT01606007|3689375|B1|||Body Mass Index (BMI)||kg/m^2|Mean|31.8|31.8|Standard Deviation|5.142|5.142|||
3864340|NCT01606007|3689372|B4|Other||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
3864341|NCT01606007|3689373|B3|Other||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3864342|NCT01606007|3689374|B2|Other||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3864343|NCT01606007|3689375|B1|Other||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3864344|NCT01606007|3689372|B4|Asian||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
3864345|NCT01606007|3689373|B3|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3864346|NCT01606007|3689374|B2|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3864347|NCT01606007|3689375|B1|Asian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3864348|NCT01606007|3689372|B4|Black african/american||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
3864349|NCT01606007|3689373|B3|Black african/american||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3864350|NCT01606007|3689374|B2|Black african/american||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3864351|NCT01606007|3689375|B1|Black african/american||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3864352|NCT01606007|3689372|B4|White||Race/Ethnicity, Customized||participants|Number|372|372.0||||||
3864353|NCT01606007|3689373|B3|White||Race/Ethnicity, Customized||participants|Number|120|120.0||||||
3864354|NCT01606007|3689374|B2|White||Race/Ethnicity, Customized||participants|Number|131|131.0||||||
3864355|NCT01606007|3689375|B1|White||Race/Ethnicity, Customized||participants|Number|121|121.0||||||
3864356|NCT01606007|3689372|B4||Male|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
3864357|NCT01606007|3689373|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3864358|NCT01606007|3689374|B2||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3864359|NCT01606007|3689375|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3864360|NCT01606007|3689372|B4||Female|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
3864361|NCT01606007|3689373|B3||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3864362|NCT01606007|3689374|B2||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3864363|NCT01606007|3689375|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3864364|NCT01606007|3689372|B4|>=65 years||Age, Customized||participants|Number|68|68.0||||||
3864365|NCT01606007|3689373|B3|>=65 years||Age, Customized||participants|Number|19|19.0||||||
3864366|NCT01606007|3689374|B2|>=65 years||Age, Customized||participants|Number|21|21.0||||||
3864367|NCT01606007|3689375|B1|>=65 years||Age, Customized||participants|Number|28|28.0||||||
3864368|NCT01606007|3689372|B4|<65 years||Age, Customized||participants|Number|466|466.0||||||
3864369|NCT01606007|3689373|B3|<65 years||Age, Customized||participants|Number|160|160.0||||||
3864370|NCT01606007|3689374|B2|<65 years||Age, Customized||participants|Number|158|158.0||||||
3864371|NCT01606007|3689375|B1|<65 years||Age, Customized||participants|Number|148|148.0||||||
3864372|NCT01606007|3689372|B4|||Age||Years|Mean|53.8|53.8|Standard Deviation|9.7|9.7|||
3864373|NCT01606007|3689373|B3|||Age||Years|Mean|53.4|53.4|Standard Deviation|9.8|9.8|||
3864374|NCT01606007|3689374|B2|||Age||Years|Mean|53.5|53.5|Standard Deviation|9.7|9.7|||
3864375|NCT01606007|3689375|B1|||Age||Years|Mean|54.6|54.6|Standard Deviation|9.6|9.6|||
3864376|NCT01605942|3689397|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3864377|NCT01605942|3689398|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3864378|NCT01605942|3689399|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3864379|NCT01605942|3689397|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3864380|NCT01605942|3689398|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3864381|NCT01605942|3689399|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3864382|NCT01605942|3689397|B3|>65 years||Age, Customized||Participants|Number|7|7.0||||||
3864383|NCT01605942|3689398|B2|>65 years||Age, Customized||Participants|Number|2|2.0||||||
3864384|NCT01605942|3689399|B1|>65 years||Age, Customized||Participants|Number|5|5.0||||||
3864385|NCT01605942|3689397|B3|Between 45 and 65 years||Age, Customized||Participants|Number|1|1.0||||||
3864386|NCT01605942|3689398|B2|Between 45 and 65 years||Age, Customized||Participants|Number|0|0.0||||||
3864387|NCT01605942|3689399|B1|Between 45 and 65 years||Age, Customized||Participants|Number|1|1.0||||||
3864388|NCT01605942|3689397|B3|<45 years||Age, Customized||Participants|Number|0|0.0||||||
3864389|NCT01605942|3689398|B2|<45 years||Age, Customized||Participants|Number|0|0.0||||||
3864390|NCT01605942|3689399|B1|<45 years||Age, Customized||Participants|Number|0|0.0||||||
3864391|NCT01605916|3689407|B6||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3864392|NCT01605916|3689408|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3864393|NCT01605916|3689409|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3864394|NCT01605916|3689410|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3864395|NCT01605916|3689411|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3864396|NCT01605916|3689412|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3864397|NCT01605916|3689407|B6||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3864398|NCT01605916|3689408|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3864399|NCT01605916|3689409|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3864400|NCT01605916|3689410|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3864401|NCT01605916|3689411|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3864402|NCT01605916|3689412|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3864403|NCT01605916|3689407|B6|||Age||Years|Mean|61.0|61.0|Standard Deviation|12.15|12.15|||
3864404|NCT01605916|3689408|B5|||Age||Years|Mean|66.7|66.7|Standard Deviation|12.22|12.22|||
3864405|NCT01605916|3689409|B4|||Age||Years|Mean|60.0|60.0|Standard Deviation|11.75|11.75|||
3864406|NCT01605916|3689410|B3|||Age||Years|Mean|60.0|60.0|Standard Deviation|12.36|12.36|||
3864407|NCT01605916|3689411|B2|||Age||Years|Mean|58.8|58.8|Standard Deviation|8.50|8.5|||
3864408|NCT01605916|3689412|B1|||Age||Years|Mean|55.5|55.5|Standard Deviation|17.33|17.33|||
3864409|NCT01605903|3689489|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3864410|NCT01605903|3689489|B3||Male|Sex: Female, Male||Participants|Count of Participants|366|366.0||||||
3864411|NCT01605903|3689490|B2||Male|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
3864412|NCT01605903|3689491|B1||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
3864413|NCT01605903|3689489|B3||Female|Sex: Female, Male||Participants|Count of Participants|322|322.0||||||
3864414|NCT01605903|3689490|B2||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3864415|NCT01605903|3689491|B1||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3864416|NCT01605903|3689489|B3|||Age||years|Median|5|5.0|Inter-Quartile Range|||4.0|8.0|
3864417|NCT01605903|3689490|B2|||Age||years|Median|5|5.0|Inter-Quartile Range|||3.0|7.0|
3864418|NCT01605903|3689491|B1|||Age||years|Median|5|5.0|Inter-Quartile Range|||4.0|8.0|
3864419|NCT01605890|3689498|B1|France||Region of Enrollment||participants|Number|30|30.0||||||
3864420|NCT01605890|3689498|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3864421|NCT01605890|3689498|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3864422|NCT01605890|3689498|B1|||Age||years|Median|48.8|48.8|Inter-Quartile Range|||46.0|52.6|
3864423|NCT01605890|3689498|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3864424|NCT01605890|3689498|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3864425|NCT01605890|3689498|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3864426|NCT01605877|3689513|B1|Japan||Region of Enrollment||participants|Number|64|64.0||||||
3864427|NCT01605877|3689513|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3864428|NCT01605877|3689513|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3864429|NCT01605877|3689513|B1|≥ 80 years||Age, Customized||participants|Number|1|1.0||||||
3864430|NCT01605877|3689513|B1|70-79 years||Age, Customized||participants|Number|24|24.0||||||
3864431|NCT01605877|3689513|B1|60-69 years||Age, Customized||participants|Number|29|29.0||||||
3864432|NCT01605877|3689513|B1|<60 years||Age, Customized||participants|Number|10|10.0||||||
3864433|NCT01605877|3689513|B1|||Age||years|Mean|66.7|66.7|Standard Deviation|7.2|7.2|||
3864434|NCT01605825|3689575|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3864435|NCT01605825|3689576|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3864436|NCT01605825|3689577|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864437|NCT01605825|3689575|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864438|NCT01605825|3689576|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864439|NCT01605825|3689577|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864440|NCT01605825|3689575|B3||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3864441|NCT01605825|3689576|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3864442|NCT01605825|3689577|B1||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3864443|NCT01605825|3689575|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3864444|NCT01605825|3689576|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3864445|NCT01605825|3689577|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3864446|NCT01605825|3689575|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3864447|NCT01605825|3689576|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864448|NCT01605825|3689577|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3864449|NCT01605825|3689575|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3864450|NCT01605825|3689576|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864451|NCT01605825|3689577|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3864452|NCT01605825|3689575|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864453|NCT01605825|3689576|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864454|NCT01605825|3689577|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864455|NCT01605825|3689575|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3864456|NCT01605825|3689576|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3864457|NCT01605825|3689577|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3864458|NCT01605825|3689575|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3864459|NCT01605825|3689576|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3864460|NCT01605825|3689577|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3864461|NCT01605825|3689575|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|9.82|9.82|||
3864462|NCT01605825|3689576|B2|||Age||years|Mean|63.5|63.5|Standard Deviation|8.91|8.91|||
3864463|NCT01605825|3689577|B1|||Age||years|Mean|57.5|57.5|Standard Deviation|9.72|9.72|||
3864464|NCT01605799|3689584|B3|Multiracial||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3864465|NCT01605799|3689585|B2|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3864466|NCT01605799|3689586|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3864467|NCT01605799|3689584|B3|Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3864468|NCT01605799|3689585|B2|Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3864469|NCT01605799|3689586|B1|Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3864470|NCT01605799|3689584|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3864471|NCT01605799|3689585|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3864472|NCT01605799|3689586|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3864473|NCT01605799|3689584|B3|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3864474|NCT01605799|3689585|B2|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3864475|NCT01605799|3689586|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3864476|NCT01605799|3689584|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3864477|NCT01605799|3689585|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3864478|NCT01605799|3689586|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3864479|NCT01605799|3689584|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3864480|NCT01605799|3689585|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3864481|NCT01605799|3689586|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3864482|NCT01605799|3689584|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3864483|NCT01605799|3689585|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3864484|NCT01605799|3689586|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3864485|NCT01605799|3689584|B3|||Age||years|Mean|59.9|59.9|Standard Deviation|13.4|13.4|||
3864486|NCT01605799|3689585|B2|||Age||years|Mean|60.5|60.5|Standard Deviation|14.3|14.3|||
3864487|NCT01605799|3689586|B1|||Age||years|Mean|59.4|59.4|Standard Deviation|12.8|12.8|||
3864488|NCT01605669|3689595|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3864489|NCT01605669|3689595|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3864490|NCT01605669|3689595|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3864491|NCT01605669|3689595|B1||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
3864492|NCT01605669|3689595|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3864493|NCT01605669|3689595|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3864494|NCT01605617|3689600|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3864495|NCT01605617|3689601|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3864496|NCT01605617|3689602|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3864497|NCT01605617|3689600|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3864498|NCT01605617|3689601|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3864499|NCT01605617|3689602|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3864500|NCT01605617|3689600|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3864501|NCT01605617|3689601|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3864502|NCT01605617|3689602|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3864503|NCT01605617|3689600|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3864504|NCT01605617|3689601|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3864505|NCT01605617|3689602|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3864506|NCT01605617|3689600|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3864507|NCT01605617|3689601|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3864508|NCT01605617|3689602|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3864509|NCT01605617|3689600|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3864510|NCT01605617|3689601|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3864511|NCT01605617|3689602|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3864512|NCT01605552|3689621|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3864513|NCT01605552|3689622|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3864514|NCT01605552|3689623|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3864515|NCT01605552|3689621|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3864516|NCT01605552|3689622|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3864517|NCT01605552|3689623|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3864518|NCT01605552|3689621|B3|||Age||years|Mean|49.2|49.2|Standard Deviation|6.6|6.6|||
3864519|NCT01605552|3689622|B2|||Age||years|Mean|50.5|50.5|Standard Deviation|6.7|6.7|||
3864520|NCT01605552|3689623|B1|||Age||years|Mean|47.6|47.6|Standard Deviation|6.3|6.3|||
3864521|NCT01605539|3689636|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
3864522|NCT01605539|3689637|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3864523|NCT01605539|3689638|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3864524|NCT01605539|3689636|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3864525|NCT01605539|3689637|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3864526|NCT01605539|3689638|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3864527|NCT01605539|3689636|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3864528|NCT01605539|3689637|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3864529|NCT01605539|3689638|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3864530|NCT01605539|3689636|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3864531|NCT01605539|3689637|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3864532|NCT01605539|3689638|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3864533|NCT01605539|3689636|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3864534|NCT01605539|3689637|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3864535|NCT01605539|3689638|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3864536|NCT01605539|3689636|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3864537|NCT01605539|3689637|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3864538|NCT01605539|3689638|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3864539|NCT01605461|3689662|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3864540|NCT01605461|3689662|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3864541|NCT01605461|3689662|B1|||Age||Years|Mean|29.1|29.1|Standard Deviation|11.3|11.3|||
3864542|NCT01605435|3689671|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3864543|NCT01605435|3689671|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3864544|NCT01605435|3689671|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3864545|NCT01605435|3689671|B1|||Age||years|Mean|85|85.0|Full Range|||79.0|86.0|
3864546|NCT01605370|3689719|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3864547|NCT01605370|3689721|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3864548|NCT01605370|3689719|B3|Male||Gender||participants|Number|1|1.0||||||
3864549|NCT01605370|3689721|B1|Male||Gender||participants|Number|1|1.0||||||
3864550|NCT01605370|3689719|B3|Female||Gender||participants|Number|0|0.0||||||
3864551|NCT01605370|3689721|B1|Female||Gender||participants|Number|0|0.0||||||
3864552|NCT01605370|3689719|B3|>=65 years||Age||participants|Number|0|0.0||||||
3864553|NCT01605370|3689721|B1|>=65 years||Age||participants|Number|0|0.0||||||
3864554|NCT01605370|3689719|B3|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
3864555|NCT01605370|3689721|B1|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
3864556|NCT01605370|3689719|B3|<=18 years||Age||participants|Number|0|0.0||||||
3864557|NCT01605370|3689721|B1|<=18 years||Age||participants|Number|0|0.0||||||
3864558|NCT01605292|3689728|B3|Barbeau's Class B or C||Barbeau class B or C|Of those patients receiving Barbeau's test. Barbeau's Class A reflects no reduction of arterial waveform on pulse oximetry after radial artery occlusion, indicating robust collateral flow from the ulnar artery. Barbeau's Class B and C reflect delayed but eventual recovery of arterial waveform on pulse oximetry after radial artery occlusion, indicating the presence of some but limited collaterals from the ulnar artery. Barbeau's Class D patients (no demonstrable collaterals) were excluded from the study.|participants|Number|110|110.0||||||
3864604|NCT01605292|3689729|B2|Inpatient or admitted||Outpatient||participants|Number|208|208.0||||||
3864559|NCT01605292|3689729|B2|Barbeau's Class B or C||Barbeau class B or C|Of those patients receiving Barbeau's test. Barbeau's Class A reflects no reduction of arterial waveform on pulse oximetry after radial artery occlusion, indicating robust collateral flow from the ulnar artery. Barbeau's Class B and C reflect delayed but eventual recovery of arterial waveform on pulse oximetry after radial artery occlusion, indicating the presence of some but limited collaterals from the ulnar artery. Barbeau's Class D patients (no demonstrable collaterals) were excluded from the study.|participants|Number|56|56.0||||||
3864560|NCT01605292|3689730|B1|Barbeau's Class B or C||Barbeau class B or C|Of those patients receiving Barbeau's test. Barbeau's Class A reflects no reduction of arterial waveform on pulse oximetry after radial artery occlusion, indicating robust collateral flow from the ulnar artery. Barbeau's Class B and C reflect delayed but eventual recovery of arterial waveform on pulse oximetry after radial artery occlusion, indicating the presence of some but limited collaterals from the ulnar artery. Barbeau's Class D patients (no demonstrable collaterals) were excluded from the study.|participants|Number|54|54.0||||||
3864561|NCT01605292|3689728|B3|Barbeau's Class A||Barbeau class B or C|Of those patients receiving Barbeau's test. Barbeau's Class A reflects no reduction of arterial waveform on pulse oximetry after radial artery occlusion, indicating robust collateral flow from the ulnar artery. Barbeau's Class B and C reflect delayed but eventual recovery of arterial waveform on pulse oximetry after radial artery occlusion, indicating the presence of some but limited collaterals from the ulnar artery. Barbeau's Class D patients (no demonstrable collaterals) were excluded from the study.|participants|Number|188|188.0||||||
3864562|NCT01605292|3689729|B2|Barbeau's Class A||Barbeau class B or C|Of those patients receiving Barbeau's test. Barbeau's Class A reflects no reduction of arterial waveform on pulse oximetry after radial artery occlusion, indicating robust collateral flow from the ulnar artery. Barbeau's Class B and C reflect delayed but eventual recovery of arterial waveform on pulse oximetry after radial artery occlusion, indicating the presence of some but limited collaterals from the ulnar artery. Barbeau's Class D patients (no demonstrable collaterals) were excluded from the study.|participants|Number|93|93.0||||||
3864563|NCT01605292|3689730|B1|Barbeau's Class A||Barbeau class B or C|Of those patients receiving Barbeau's test. Barbeau's Class A reflects no reduction of arterial waveform on pulse oximetry after radial artery occlusion, indicating robust collateral flow from the ulnar artery. Barbeau's Class B and C reflect delayed but eventual recovery of arterial waveform on pulse oximetry after radial artery occlusion, indicating the presence of some but limited collaterals from the ulnar artery. Barbeau's Class D patients (no demonstrable collaterals) were excluded from the study.|participants|Number|95|95.0||||||
3864564|NCT01605292|3689728|B3|No PVD||Peripheral vascular disease||participants|Number|668|668.0||||||
3864565|NCT01605292|3689729|B2|No PVD||Peripheral vascular disease||participants|Number|333|333.0||||||
3864566|NCT01605292|3689730|B1|No PVD||Peripheral vascular disease||participants|Number|335|335.0||||||
3864567|NCT01605292|3689728|B3|PVD||Peripheral vascular disease||participants|Number|30|30.0||||||
3864568|NCT01605292|3689729|B2|PVD||Peripheral vascular disease||participants|Number|14|14.0||||||
3864569|NCT01605292|3689730|B1|PVD||Peripheral vascular disease||participants|Number|16|16.0||||||
3864570|NCT01605292|3689728|B3|No tobacco use||Tobacco||participants|Number|463|463.0||||||
3864571|NCT01605292|3689729|B2|No tobacco use||Tobacco||participants|Number|219|219.0||||||
3864572|NCT01605292|3689730|B1|No tobacco use||Tobacco||participants|Number|244|244.0||||||
3864573|NCT01605292|3689728|B3|Tobacco use||Tobacco||participants|Number|235|235.0||||||
3864574|NCT01605292|3689729|B2|Tobacco use||Tobacco||participants|Number|128|128.0||||||
3864575|NCT01605292|3689730|B1|Tobacco use||Tobacco||participants|Number|107|107.0||||||
3864576|NCT01605292|3689728|B3|No DM||Diabetes mellitus||participants|Number|398|398.0||||||
3864577|NCT01605292|3689729|B2|No DM||Diabetes mellitus||participants|Number|198|198.0||||||
3864578|NCT01605292|3689730|B1|No DM||Diabetes mellitus||participants|Number|200|200.0||||||
3864579|NCT01605292|3689728|B3|DM||Diabetes mellitus||participants|Number|300|300.0||||||
3864580|NCT01605292|3689729|B2|DM||Diabetes mellitus||participants|Number|149|149.0||||||
3864581|NCT01605292|3689730|B1|DM||Diabetes mellitus||participants|Number|151|151.0||||||
3864582|NCT01605292|3689728|B3|Normal cholesterol||Hypercholesterolemia||participants|Number|179|179.0||||||
3864583|NCT01605292|3689729|B2|Normal cholesterol||Hypercholesterolemia||participants|Number|93|93.0||||||
3864584|NCT01605292|3689730|B1|Normal cholesterol||Hypercholesterolemia||participants|Number|86|86.0||||||
3864585|NCT01605292|3689728|B3|Hypercholesterolemia||Hypercholesterolemia||participants|Number|519|519.0||||||
3864586|NCT01605292|3689729|B2|Hypercholesterolemia||Hypercholesterolemia||participants|Number|254|254.0||||||
3864587|NCT01605292|3689730|B1|Hypercholesterolemia||Hypercholesterolemia||participants|Number|265|265.0||||||
3864588|NCT01605292|3689728|B3|Non-HTN||Hypertension||participants|Number|101|101.0||||||
3864589|NCT01605292|3689729|B2|Non-HTN||Hypertension||participants|Number|55|55.0||||||
3864590|NCT01605292|3689730|B1|Non-HTN||Hypertension||participants|Number|46|46.0||||||
3864591|NCT01605292|3689728|B3|HTN||Hypertension||participants|Number|597|597.0||||||
3864592|NCT01605292|3689729|B2|HTN||Hypertension||participants|Number|292|292.0||||||
3864593|NCT01605292|3689730|B1|HTN||Hypertension||participants|Number|305|305.0||||||
3864594|NCT01605292|3689728|B3|Nonobese||Obesity, BMI >= 30||participants|Number|396|396.0||||||
3864595|NCT01605292|3689729|B2|Nonobese||Obesity, BMI >= 30||participants|Number|198|198.0||||||
3864596|NCT01605292|3689730|B1|Nonobese||Obesity, BMI >= 30||participants|Number|198|198.0||||||
3864597|NCT01605292|3689728|B3|Obese||Obesity, BMI >= 30||participants|Number|302|302.0||||||
3864598|NCT01605292|3689729|B2|Obese||Obesity, BMI >= 30||participants|Number|149|149.0||||||
3864599|NCT01605292|3689730|B1|Obese||Obesity, BMI >= 30||participants|Number|153|153.0||||||
3864600|NCT01605292|3689728|B3|||BMI||kg/m^2|Mean|30.3|30.3|Standard Deviation|7.0|7.0|||
3864601|NCT01605292|3689729|B2|||BMI||kg/m^2|Mean|30.4|30.4|Standard Deviation|6.9|6.9|||
3864602|NCT01605292|3689730|B1|||BMI||kg/m^2|Mean|30.2|30.2|Standard Deviation|7.2|7.2|||
3864603|NCT01605292|3689728|B3|Inpatient or admitted||Outpatient||participants|Number|418|418.0||||||
3864605|NCT01605292|3689730|B1|Inpatient or admitted||Outpatient||participants|Number|210|210.0||||||
3864606|NCT01605292|3689728|B3|Outpatient||Outpatient||participants|Number|280|280.0||||||
3864607|NCT01605292|3689729|B2|Outpatient||Outpatient||participants|Number|139|139.0||||||
3864608|NCT01605292|3689730|B1|Outpatient||Outpatient||participants|Number|141|141.0||||||
3864609|NCT01605292|3689728|B3||Male|Sex: Female, Male||Participants|Count of Participants|516|516.0||||||
3864610|NCT01605292|3689729|B2||Male|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
3864611|NCT01605292|3689730|B1||Male|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
3864612|NCT01605292|3689728|B3||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3864613|NCT01605292|3689729|B2||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3864614|NCT01605292|3689730|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3864615|NCT01605292|3689728|B3|||Age||years|Mean|61.9|61.9|Standard Deviation|11.1|11.1|||
3864616|NCT01605292|3689729|B2|||Age||years|Mean|61.5|61.5|Standard Deviation|11.5|11.5|||
3864617|NCT01605292|3689730|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|10.6|10.6|||
3864618|NCT01605227|3689755|B3|||Baseline serum testosterone (<50 ng/dL)||Participants|Count of Participants|1022|1022.0||||||
3864619|NCT01605227|3689756|B2|||Baseline serum testosterone (<50 ng/dL)||Participants|Count of Participants|345|345.0||||||
3864620|NCT01605227|3689757|B1|||Baseline serum testosterone (<50 ng/dL)||Participants|Count of Participants|677|677.0||||||
3864621|NCT01605227|3689755|B3|||Baseline PSA||μg/L|Median|192|192.0|Full Range|||0.0|10963.0|
3864622|NCT01605227|3689756|B2|||Baseline PSA||μg/L|Median|195|195.0|Full Range|||0.54|10963.0|
3864623|NCT01605227|3689757|B1|||Baseline PSA||μg/L|Median|192|192.0|Full Range|||0.02|10030.0|
3864624|NCT01605227|3689755|B3|||Baseline LDH||U/L|Median|230|230.0|Full Range|||59.0|6004.0|
3864625|NCT01605227|3689756|B2|||Baseline LDH||U/L|Median|230|230.0|Full Range|||87.0|3062.0|
3864626|NCT01605227|3689757|B1|||Baseline LDH||U/L|Median|230|230.0|Full Range|||59.0|6004.0|
3864627|NCT01605227|3689755|B3|≥3||No. of prior anticancer agents|Excluding agents to maintain castration status|participants|Number|940|940.0||||||
3864628|NCT01605227|3689756|B2|≥3||No. of prior anticancer agents|Excluding agents to maintain castration status|participants|Number|315|315.0||||||
3864629|NCT01605227|3689757|B1|≥3||No. of prior anticancer agents|Excluding agents to maintain castration status|participants|Number|625|625.0||||||
3864630|NCT01605227|3689755|B3|2||No. of prior anticancer agents|Excluding agents to maintain castration status|participants|Number|88|88.0||||||
3864631|NCT01605227|3689756|B2|2||No. of prior anticancer agents|Excluding agents to maintain castration status|participants|Number|31|31.0||||||
3864632|NCT01605227|3689757|B1|2||No. of prior anticancer agents|Excluding agents to maintain castration status|participants|Number|57|57.0||||||
3864633|NCT01605227|3689755|B3|Other soft tissue||Extent of metastasis||participants|Number|62|62.0||||||
3864634|NCT01605227|3689756|B2|Other soft tissue||Extent of metastasis||participants|Number|23|23.0||||||
3864635|NCT01605227|3689757|B1|Other soft tissue||Extent of metastasis||participants|Number|39|39.0||||||
3864636|NCT01605227|3689755|B3|Lung||Extent of metastasis||participants|Number|98|98.0||||||
3864637|NCT01605227|3689756|B2|Lung||Extent of metastasis||participants|Number|29|29.0||||||
3864638|NCT01605227|3689757|B1|Lung||Extent of metastasis||participants|Number|69|69.0||||||
3864639|NCT01605227|3689755|B3|Liver||Extent of metastasis||participants|Number|126|126.0||||||
3864640|NCT01605227|3689756|B2|Liver||Extent of metastasis||participants|Number|35|35.0||||||
3864641|NCT01605227|3689757|B1|Liver||Extent of metastasis||participants|Number|91|91.0||||||
3864642|NCT01605227|3689755|B3|Visceral||Extent of metastasis||participants|Number|191|191.0||||||
3864643|NCT01605227|3689756|B2|Visceral||Extent of metastasis||participants|Number|58|58.0||||||
3864644|NCT01605227|3689757|B1|Visceral||Extent of metastasis||participants|Number|133|133.0||||||
3864645|NCT01605227|3689755|B3|Lymph node||Extent of metastasis||participants|Number|453|453.0||||||
3864646|NCT01605227|3689756|B2|Lymph node||Extent of metastasis||participants|Number|140|140.0||||||
3864647|NCT01605227|3689757|B1|Lymph node||Extent of metastasis||participants|Number|313|313.0||||||
3864648|NCT01605227|3689755|B3|Bone||Extent of metastasis||participants|Number|1027|1027.0||||||
3864649|NCT01605227|3689756|B2|Bone||Extent of metastasis||participants|Number|346|346.0||||||
3864650|NCT01605227|3689757|B1|Bone||Extent of metastasis||participants|Number|681|681.0||||||
3864651|NCT01605227|3689755|B3|None||Extent of metastasis||participants|Number|0|0.0||||||
3864652|NCT01605227|3689756|B2|None||Extent of metastasis||participants|Number|0|0.0||||||
3864653|NCT01605227|3689757|B1|None||Extent of metastasis||participants|Number|0|0.0||||||
3864654|NCT01605227|3689755|B3|||Bone scan lesion area||mm^2|Median|44,782.0|44.0|Full Range|||0.0|388.0|
3864655|NCT01605227|3689756|B2|||Bone scan lesion area||mm^2|Median|41,746.0|41.0|Full Range|||0.0|283.0|
3864656|NCT01605227|3689757|B1|||Bone scan lesion area||mm^2|Median|45,635.5|45.0|Full Range|||0.0|388.0|
3864657|NCT01605227|3689755|B3|||Time from diagnosis to study entry||years|Median|6.83|6.83|Full Range|||0.04|26.6|
3864658|NCT01605227|3689756|B2|||Time from diagnosis to study entry||years|Median|6.98|6.98|Full Range|||0.04|22.2|
3864659|NCT01605227|3689757|B1|||Time from diagnosis to study entry||years|Median|6.68|6.68|Full Range|||0.09|26.6|
3864660|NCT01605227|3689755|B3|||Concomitant prednisone/prednisolone at randomization||Participants|Count of Participants|431|431.0||||||
3864661|NCT01605227|3689756|B2|||Concomitant prednisone/prednisolone at randomization||Participants|Count of Participants|142|142.0||||||
3864662|NCT01605227|3689757|B1|||Concomitant prednisone/prednisolone at randomization||Participants|Count of Participants|289|289.0||||||
3864663|NCT01605227|3689755|B3|||Opioid narcotic use within 24 hours (per solicited oploid CRF)||Participants|Count of Participants|682|682.0||||||
3864712|NCT01605227|3689756|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864664|NCT01605227|3689756|B2|||Opioid narcotic use within 24 hours (per solicited oploid CRF)||Participants|Count of Participants|228|228.0||||||
3864665|NCT01605227|3689757|B1|||Opioid narcotic use within 24 hours (per solicited oploid CRF)||Participants|Count of Participants|454|454.0||||||
3864666|NCT01605227|3689755|B3|Missing||ECOG Performance Status (per CRF)||participants|Number|1|1.0||||||
3864667|NCT01605227|3689756|B2|Missing||ECOG Performance Status (per CRF)||participants|Number|0|0.0||||||
3864668|NCT01605227|3689757|B1|Missing||ECOG Performance Status (per CRF)||participants|Number|1|1.0||||||
3864669|NCT01605227|3689755|B3|2 (ambulatory but can't carry out work activities)||ECOG Performance Status (per CRF)||participants|Number|119|119.0||||||
3864670|NCT01605227|3689756|B2|2 (ambulatory but can't carry out work activities)||ECOG Performance Status (per CRF)||participants|Number|43|43.0||||||
3864671|NCT01605227|3689757|B1|2 (ambulatory but can't carry out work activities)||ECOG Performance Status (per CRF)||participants|Number|76|76.0||||||
3864672|NCT01605227|3689755|B3|0/1 (asymptomatic or symptomatic but ambulatory)||ECOG Performance Status (per CRF)||participants|Number|908|908.0||||||
3864673|NCT01605227|3689756|B2|0/1 (asymptomatic or symptomatic but ambulatory)||ECOG Performance Status (per CRF)||participants|Number|303|303.0||||||
3864674|NCT01605227|3689757|B1|0/1 (asymptomatic or symptomatic but ambulatory)||ECOG Performance Status (per CRF)||participants|Number|605|605.0||||||
3864675|NCT01605227|3689755|B3||Missing|Brief Pain Inventory (BPI) Item 3 (per CRF)|Pain will be assessed using the BPI Items #3 (worst pain over the last 24 hours by recall).|Participants|Count of Participants|11|11.0||||||
3864676|NCT01605227|3689756|B2||Missing|Brief Pain Inventory (BPI) Item 3 (per CRF)|Pain will be assessed using the BPI Items #3 (worst pain over the last 24 hours by recall).|Participants|Count of Participants|2|2.0||||||
3864677|NCT01605227|3689757|B1||Missing|Brief Pain Inventory (BPI) Item 3 (per CRF)|Pain will be assessed using the BPI Items #3 (worst pain over the last 24 hours by recall).|Participants|Count of Participants|9|9.0||||||
3864678|NCT01605227|3689755|B3||≥4|Brief Pain Inventory (BPI) Item 3 (per CRF)|Pain will be assessed using the BPI Items #3 (worst pain over the last 24 hours by recall).|Participants|Count of Participants|432|432.0||||||
3864679|NCT01605227|3689756|B2||≥4|Brief Pain Inventory (BPI) Item 3 (per CRF)|Pain will be assessed using the BPI Items #3 (worst pain over the last 24 hours by recall).|Participants|Count of Participants|148|148.0||||||
3864680|NCT01605227|3689757|B1||≥4|Brief Pain Inventory (BPI) Item 3 (per CRF)|Pain will be assessed using the BPI Items #3 (worst pain over the last 24 hours by recall).|Participants|Count of Participants|284|284.0||||||
3864681|NCT01605227|3689755|B3||<4|Brief Pain Inventory (BPI) Item 3 (per CRF)|Pain will be assessed using the BPI Items #3 (worst pain over the last 24 hours by recall).|Participants|Count of Participants|585|585.0||||||
3864682|NCT01605227|3689756|B2||<4|Brief Pain Inventory (BPI) Item 3 (per CRF)|Pain will be assessed using the BPI Items #3 (worst pain over the last 24 hours by recall).|Participants|Count of Participants|196|196.0||||||
3864683|NCT01605227|3689757|B1||<4|Brief Pain Inventory (BPI) Item 3 (per CRF)|Pain will be assessed using the BPI Items #3 (worst pain over the last 24 hours by recall).|Participants|Count of Participants|389|389.0||||||
3864684|NCT01605227|3689755|B3||No|Prior cabazitaxel (per CRF)||Participants|Count of Participants|635|635.0||||||
3864685|NCT01605227|3689756|B2||No|Prior cabazitaxel (per CRF)||Participants|Count of Participants|214|214.0||||||
3864686|NCT01605227|3689757|B1||No|Prior cabazitaxel (per CRF)||Participants|Count of Participants|421|421.0||||||
3864687|NCT01605227|3689755|B3||Yes|Prior cabazitaxel (per CRF)||Participants|Count of Participants|393|393.0||||||
3864688|NCT01605227|3689756|B2||Yes|Prior cabazitaxel (per CRF)||Participants|Count of Participants|132|132.0||||||
3864689|NCT01605227|3689757|B1||Yes|Prior cabazitaxel (per CRF)||Participants|Count of Participants|261|261.0||||||
3864690|NCT01605227|3689755|B3|Australia||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
3864691|NCT01605227|3689756|B2|Australia||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3864692|NCT01605227|3689757|B1|Australia||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3864693|NCT01605227|3689755|B3|Europe||Region of Enrollment||Participants|Count of Participants|784|784.0||||||
3864694|NCT01605227|3689756|B2|Europe||Region of Enrollment||Participants|Count of Participants|256|256.0||||||
3864695|NCT01605227|3689757|B1|Europe||Region of Enrollment||Participants|Count of Participants|528|528.0||||||
3864696|NCT01605227|3689755|B3|North America||Region of Enrollment||Participants|Count of Participants|182|182.0||||||
3864697|NCT01605227|3689756|B2|North America||Region of Enrollment||Participants|Count of Participants|63|63.0||||||
3864698|NCT01605227|3689757|B1|North America||Region of Enrollment||Participants|Count of Participants|119|119.0||||||
3864699|NCT01605227|3689755|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|220|220.0||||||
3864700|NCT01605227|3689756|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3864701|NCT01605227|3689757|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
3864702|NCT01605227|3689755|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864703|NCT01605227|3689756|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864704|NCT01605227|3689757|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864705|NCT01605227|3689755|B3||White|Race (NIH/OMB)||Participants|Count of Participants|785|785.0||||||
3864706|NCT01605227|3689756|B2||White|Race (NIH/OMB)||Participants|Count of Participants|265|265.0||||||
3864707|NCT01605227|3689757|B1||White|Race (NIH/OMB)||Participants|Count of Participants|520|520.0||||||
3864708|NCT01605227|3689755|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3864709|NCT01605227|3689756|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3864710|NCT01605227|3689757|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3864711|NCT01605227|3689755|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864713|NCT01605227|3689757|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864714|NCT01605227|3689755|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3864715|NCT01605227|3689756|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864716|NCT01605227|3689757|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3864717|NCT01605227|3689755|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3864718|NCT01605227|3689756|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3864719|NCT01605227|3689757|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864720|NCT01605227|3689755|B3||Male|Sex: Female, Male||Participants|Count of Participants|1028|1028.0||||||
3864721|NCT01605227|3689756|B2||Male|Sex: Female, Male||Participants|Count of Participants|346|346.0||||||
3864722|NCT01605227|3689757|B1||Male|Sex: Female, Male||Participants|Count of Participants|682|682.0||||||
3864723|NCT01605227|3689755|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3864724|NCT01605227|3689756|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3864725|NCT01605227|3689757|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3864726|NCT01605227|3689755|B3||>=65 years|Age||Participants|Count of Participants|766|766.0||||||
3864727|NCT01605227|3689756|B2||>=65 years|Age||Participants|Count of Participants|249|249.0||||||
3864728|NCT01605227|3689757|B1||>=65 years|Age||Participants|Count of Participants|517|517.0||||||
3864729|NCT01605227|3689755|B3||Between 18 and 65 years|Age||Participants|Count of Participants|262|262.0||||||
3864730|NCT01605227|3689756|B2||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
3864731|NCT01605227|3689757|B1||Between 18 and 65 years|Age||Participants|Count of Participants|165|165.0||||||
3864732|NCT01605227|3689755|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3864733|NCT01605227|3689756|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3864734|NCT01605227|3689757|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3864735|NCT01604941|3689779|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3864736|NCT01604941|3689780|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3864737|NCT01604941|3689781|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3864738|NCT01604941|3689779|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3864739|NCT01604941|3689780|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3864740|NCT01604941|3689781|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3864741|NCT01604941|3689779|B3|||Age||years|Mean|26.8|26.8|Standard Deviation|5.94|5.94|||
3864742|NCT01604941|3689780|B2|||Age||years|Mean|24.4|24.4|Standard Deviation|5.80|5.8|||
3864743|NCT01604941|3689781|B1|||Age||years|Mean|28.3|28.3|Standard Deviation|5.79|5.79|||
3864744|NCT01604850|3689812|B3|Relapse/Breakthrough||Response to Prior HCV Treatment||participants|Number|151|151.0||||||
3864745|NCT01604850|3689813|B2|Relapse/Breakthrough||Response to Prior HCV Treatment||participants|Number|73|73.0||||||
3864746|NCT01604850|3689814|B1|Relapse/Breakthrough||Response to Prior HCV Treatment||participants|Number|78|78.0||||||
3864747|NCT01604850|3689812|B3|Nonresponse||Response to Prior HCV Treatment||participants|Number|50|50.0||||||
3864748|NCT01604850|3689813|B2|Nonresponse||Response to Prior HCV Treatment||participants|Number|25|25.0||||||
3864749|NCT01604850|3689814|B1|Nonresponse||Response to Prior HCV Treatment||participants|Number|25|25.0||||||
3864750|NCT01604850|3689812|B3|Missing||Cirrhosis (Y/N)||participants|Number|1|1.0||||||
3864751|NCT01604850|3689813|B2|Missing||Cirrhosis (Y/N)||participants|Number|0|0.0||||||
3864752|NCT01604850|3689814|B1|Missing||Cirrhosis (Y/N)||participants|Number|1|1.0||||||
3864753|NCT01604850|3689812|B3|Yes||Cirrhosis (Y/N)||participants|Number|68|68.0||||||
3864754|NCT01604850|3689813|B2|Yes||Cirrhosis (Y/N)||participants|Number|32|32.0||||||
3864755|NCT01604850|3689814|B1|Yes||Cirrhosis (Y/N)||participants|Number|36|36.0||||||
3864756|NCT01604850|3689812|B3|No||Cirrhosis (Y/N)||participants|Number|132|132.0||||||
3864757|NCT01604850|3689813|B2|No||Cirrhosis (Y/N)||participants|Number|66|66.0||||||
3864758|NCT01604850|3689814|B1|No||Cirrhosis (Y/N)||participants|Number|66|66.0||||||
3864759|NCT01604850|3689812|B3|TT||IL28 Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|31|31.0||||||
3864760|NCT01604850|3689813|B2|TT||IL28 Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|12|12.0||||||
3864761|NCT01604850|3689814|B1|TT||IL28 Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|19|19.0||||||
3864762|NCT01604850|3689812|B3|CT||IL28 Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|109|109.0||||||
3864763|NCT01604850|3689813|B2|CT||IL28 Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|56|56.0||||||
3864764|NCT01604850|3689814|B1|CT||IL28 Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|53|53.0||||||
3864765|NCT01604850|3689812|B3|CC||IL28 Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|61|61.0||||||
3864766|NCT01604850|3689813|B2|CC||IL28 Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|30|30.0||||||
3864767|NCT01604850|3689814|B1|CC||IL28 Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|31|31.0||||||
3864768|NCT01604850|3689812|B3|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|146|146.0||||||
3864769|NCT01604850|3689813|B2|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|69|69.0||||||
3864770|NCT01604850|3689814|B1|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|77|77.0||||||
3864771|NCT01604850|3689812|B3|< 6 log10 IU/mL||HCV RNA Category||participants|Number|55|55.0||||||
3864772|NCT01604850|3689813|B2|< 6 log10 IU/mL||HCV RNA Category||participants|Number|29|29.0||||||
3864773|NCT01604850|3689814|B1|< 6 log10 IU/mL||HCV RNA Category||participants|Number|26|26.0||||||
3864774|NCT01604850|3689812|B3|||HCV RNA||log10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.65|0.65|||
3864775|NCT01604850|3689813|B2|||HCV RNA||log10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.63|0.63|||
3864776|NCT01604850|3689814|B1|||HCV RNA||log10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.67|0.67|||
3864777|NCT01604850|3689812|B3|Genotype 3||Hepatitis C Virus (HCV) genotype||participants|Number|127|127.0||||||
3864778|NCT01604850|3689813|B2|Genotype 3||Hepatitis C Virus (HCV) genotype||participants|Number|63|63.0||||||
3864779|NCT01604850|3689814|B1|Genotype 3||Hepatitis C Virus (HCV) genotype||participants|Number|64|64.0||||||
3864780|NCT01604850|3689812|B3|Genotype 2||Hepatitis C Virus (HCV) genotype||participants|Number|68|68.0||||||
3864781|NCT01604850|3689813|B2|Genotype 2||Hepatitis C Virus (HCV) genotype||participants|Number|32|32.0||||||
3864782|NCT01604850|3689814|B1|Genotype 2||Hepatitis C Virus (HCV) genotype||participants|Number|36|36.0||||||
3864783|NCT01604850|3689812|B3|Genotype 1||Hepatitis C Virus (HCV) genotype||participants|Number|6|6.0||||||
3864784|NCT01604850|3689813|B2|Genotype 1||Hepatitis C Virus (HCV) genotype||participants|Number|3|3.0||||||
3864785|NCT01604850|3689814|B1|Genotype 1||Hepatitis C Virus (HCV) genotype||participants|Number|3|3.0||||||
3864786|NCT01604850|3689812|B3|New Zealand||Region of Enrollment||participants|Number|8|8.0||||||
3864787|NCT01604850|3689813|B2|New Zealand||Region of Enrollment||participants|Number|5|5.0||||||
3864788|NCT01604850|3689814|B1|New Zealand||Region of Enrollment||participants|Number|3|3.0||||||
3864789|NCT01604850|3689812|B3|Canada||Region of Enrollment||participants|Number|43|43.0||||||
3864790|NCT01604850|3689813|B2|Canada||Region of Enrollment||participants|Number|17|17.0||||||
3864791|NCT01604850|3689814|B1|Canada||Region of Enrollment||participants|Number|26|26.0||||||
3864792|NCT01604850|3689812|B3|United States||Region of Enrollment||participants|Number|150|150.0||||||
3864793|NCT01604850|3689813|B2|United States||Region of Enrollment||participants|Number|76|76.0||||||
3864794|NCT01604850|3689814|B1|United States||Region of Enrollment||participants|Number|74|74.0||||||
3864795|NCT01604850|3689812|B3|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3864796|NCT01604850|3689813|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3864797|NCT01604850|3689814|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3864798|NCT01604850|3689812|B3|Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3864799|NCT01604850|3689813|B2|Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3864800|NCT01604850|3689814|B1|Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3864801|NCT01604850|3689812|B3|American Indian/ Alaska Native/ First Nations||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3864802|NCT01604850|3689813|B2|American Indian/ Alaska Native/ First Nations||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3864803|NCT01604850|3689814|B1|American Indian/ Alaska Native/ First Nations||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3864804|NCT01604850|3689812|B3|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3864805|NCT01604850|3689813|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3864806|NCT01604850|3689814|B1|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3864807|NCT01604850|3689812|B3|White||Race/Ethnicity, Customized||participants|Number|174|174.0||||||
3864808|NCT01604850|3689813|B2|White||Race/Ethnicity, Customized||participants|Number|86|86.0||||||
3864809|NCT01604850|3689814|B1|White||Race/Ethnicity, Customized||participants|Number|88|88.0||||||
3864810|NCT01604850|3689812|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3864811|NCT01604850|3689813|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3864812|NCT01604850|3689814|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3864813|NCT01604850|3689812|B3||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3864814|NCT01604850|3689813|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3864815|NCT01604850|3689814|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3864816|NCT01604850|3689812|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3864817|NCT01604850|3689813|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3864818|NCT01604850|3689814|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3864819|NCT01604850|3689812|B3|||Age||years|Mean|54|54.0|Standard Deviation|7.8|7.8|||
3864820|NCT01604850|3689813|B2|||Age||years|Mean|54|54.0|Standard Deviation|7.8|7.8|||
3864821|NCT01604850|3689814|B1|||Age||years|Mean|54|54.0|Standard Deviation|7.7|7.7|||
3864822|NCT01604785|3689831|B3|United States||Region of Enrollment||Participants|Count of Participants|66|66.0||||||
3864823|NCT01604785|3689832|B2|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3864824|NCT01604785|3689833|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3864825|NCT01604785|3689831|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3864826|NCT01604785|3689831|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3864827|NCT01604785|3689832|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3864828|NCT01604785|3689833|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3864829|NCT01604785|3689831|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3864830|NCT01604785|3689832|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3864831|NCT01604785|3689833|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3864832|NCT01604785|3689831|B3|||Age||years|Mean|14.6|14.6|Standard Deviation|2.8|2.8|||
3864833|NCT01604785|3689832|B2|||Age||years|Mean|14.6|14.6|Standard Deviation|3.0|3.0|||
3864834|NCT01604785|3689833|B1|||Age||years|Mean|14.6|14.6|Standard Deviation|2.1|2.1|||
3864835|NCT01604772|3689844|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3864836|NCT01604772|3689844|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3864837|NCT01604772|3689844|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3864838|NCT01604772|3689844|B1|||Age||years|Median|63.5|63.5|Full Range|||31.0|76.0|
3864839|NCT01604408|3689850|B3|Sweden||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3864840|NCT01604408|3689851|B2|Sweden||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3864841|NCT01604408|3689852|B1|Sweden||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3864842|NCT01604408|3689850|B3|Germany||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3864843|NCT01604408|3689851|B2|Germany||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3864844|NCT01604408|3689852|B1|Germany||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3864845|NCT01604408|3689850|B3|Australia||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3864846|NCT01604408|3689851|B2|Australia||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3864847|NCT01604408|3689852|B1|Australia||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3864848|NCT01604408|3689850|B3|Argentina||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3864849|NCT01604408|3689851|B2|Argentina||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3864850|NCT01604408|3689852|B1|Argentina||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3864851|NCT01604408|3689850|B3|United States||Region of Enrollment||Participants|Count of Participants|73|73.0||||||
3864852|NCT01604408|3689851|B2|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3864853|NCT01604408|3689852|B1|United States||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3864854|NCT01604408|3689850|B3|France||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3864855|NCT01604408|3689851|B2|France||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3864856|NCT01604408|3689852|B1|France||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3864857|NCT01604408|3689850|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864858|NCT01604408|3689851|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864859|NCT01604408|3689852|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864860|NCT01604408|3689850|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3864861|NCT01604408|3689851|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864862|NCT01604408|3689852|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3864863|NCT01604408|3689850|B3||White|Race (NIH/OMB)||Participants|Count of Participants|199|199.0||||||
3864864|NCT01604408|3689851|B2||White|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3864865|NCT01604408|3689852|B1||White|Race (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
3864866|NCT01604408|3689850|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864867|NCT01604408|3689851|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864868|NCT01604408|3689852|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864869|NCT01604408|3689850|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864870|NCT01604408|3689851|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864871|NCT01604408|3689852|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864872|NCT01604408|3689850|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3864873|NCT01604408|3689851|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3864874|NCT01604408|3689852|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864875|NCT01604408|3689850|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864876|NCT01604408|3689851|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864877|NCT01604408|3689852|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3864878|NCT01604408|3689850|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3864879|NCT01604408|3689851|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3864880|NCT01604408|3689852|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3864881|NCT01604408|3689850|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
3864882|NCT01604408|3689851|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3864883|NCT01604408|3689852|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3864884|NCT01604408|3689850|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3864885|NCT01604408|3689851|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3864886|NCT01604408|3689852|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3864887|NCT01604408|3689850|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3864888|NCT01604408|3689851|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3864889|NCT01604408|3689852|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3864890|NCT01604408|3689850|B3||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3864891|NCT01604408|3689851|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3864892|NCT01604408|3689852|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3864893|NCT01604408|3689850|B3|||Age||years|Mean|82.20|82.2|Standard Deviation|4.97|4.97|||
3864894|NCT01604408|3689851|B2|||Age||years|Mean|82.57|82.57|Standard Deviation|5.20|5.2|||
3864895|NCT01604408|3689852|B1|||Age||years|Mean|81.84|81.84|Standard Deviation|4.73|4.73|||
3864896|NCT01604343|3689865|B4|United States||Region of Enrollment||Participants|Count of Participants|261|261.0||||||
3864897|NCT01604343|3689866|B3|United States||Region of Enrollment||Participants|Count of Participants|88|88.0||||||
3864898|NCT01604343|3689867|B2|United States||Region of Enrollment||Participants|Count of Participants|92|92.0||||||
3864899|NCT01604343|3689868|B1|United States||Region of Enrollment||Participants|Count of Participants|81|81.0||||||
3864900|NCT01604343|3689865|B4|Ukraine||Region of Enrollment||Participants|Count of Participants|152|152.0||||||
3864901|NCT01604343|3689866|B3|Ukraine||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
3864902|NCT01604343|3689867|B2|Ukraine||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3864903|NCT01604343|3689868|B1|Ukraine||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3864904|NCT01604343|3689865|B4|Taiwan, Province of China||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3864905|NCT01604343|3689866|B3|Taiwan, Province of China||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3864906|NCT01604343|3689867|B2|Taiwan, Province of China||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3864907|NCT01604343|3689868|B1|Taiwan, Province of China||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3864908|NCT01604343|3689865|B4|South Africa||Region of Enrollment||Participants|Count of Participants|100|100.0||||||
3864909|NCT01604343|3689866|B3|South Africa||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3864910|NCT01604343|3689867|B2|South Africa||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3864911|NCT01604343|3689868|B1|South Africa||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3864912|NCT01604343|3689865|B4|Serbia||Region of Enrollment||Participants|Count of Participants|144|144.0||||||
3864913|NCT01604343|3689866|B3|Serbia||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3864914|NCT01604343|3689867|B2|Serbia||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
3864915|NCT01604343|3689868|B1|Serbia||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
3864916|NCT01604343|3689865|B4|Russian Federation||Region of Enrollment||Participants|Count of Participants|201|201.0||||||
3864917|NCT01604343|3689866|B3|Russian Federation||Region of Enrollment||Participants|Count of Participants|73|73.0||||||
3864918|NCT01604343|3689867|B2|Russian Federation||Region of Enrollment||Participants|Count of Participants|67|67.0||||||
3864919|NCT01604343|3689868|B1|Russian Federation||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
3864920|NCT01604343|3689865|B4|Romania||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3864921|NCT01604343|3689866|B3|Romania||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3864922|NCT01604343|3689867|B2|Romania||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3864923|NCT01604343|3689868|B1|Romania||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3864924|NCT01604343|3689865|B4|Republic of Korea||Region of Enrollment||Participants|Count of Participants|68|68.0||||||
3864925|NCT01604343|3689866|B3|Republic of Korea||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3864926|NCT01604343|3689867|B2|Republic of Korea||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3864927|NCT01604343|3689868|B1|Republic of Korea||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3864928|NCT01604343|3689865|B4|Poland||Region of Enrollment||Participants|Count of Participants|169|169.0||||||
3864929|NCT01604343|3689866|B3|Poland||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
3864930|NCT01604343|3689867|B2|Poland||Region of Enrollment||Participants|Count of Participants|51|51.0||||||
3864931|NCT01604343|3689868|B1|Poland||Region of Enrollment||Participants|Count of Participants|64|64.0||||||
3864932|NCT01604343|3689865|B4|Mexico||Region of Enrollment||Participants|Count of Participants|115|115.0||||||
3864933|NCT01604343|3689866|B3|Mexico||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3864934|NCT01604343|3689867|B2|Mexico||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3864935|NCT01604343|3689868|B1|Mexico||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3864936|NCT01604343|3689865|B4|Malaysia||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3864937|NCT01604343|3689866|B3|Malaysia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3864938|NCT01604343|3689867|B2|Malaysia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3864939|NCT01604343|3689868|B1|Malaysia||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3864940|NCT01604343|3689865|B4|Lithuania||Region of Enrollment||Participants|Count of Participants|98|98.0||||||
3864941|NCT01604343|3689866|B3|Lithuania||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3864942|NCT01604343|3689867|B2|Lithuania||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3864943|NCT01604343|3689868|B1|Lithuania||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3864944|NCT01604343|3689865|B4|Japan||Region of Enrollment||Participants|Count of Participants|168|168.0||||||
3864945|NCT01604343|3689866|B3|Japan||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
3864946|NCT01604343|3689867|B2|Japan||Region of Enrollment||Participants|Count of Participants|58|58.0||||||
3864947|NCT01604343|3689868|B1|Japan||Region of Enrollment||Participants|Count of Participants|56|56.0||||||
3864948|NCT01604343|3689865|B4|Croatia||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3864949|NCT01604343|3689866|B3|Croatia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3864950|NCT01604343|3689867|B2|Croatia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3864951|NCT01604343|3689868|B1|Croatia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3864952|NCT01604343|3689865|B4|Colombia||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3864953|NCT01604343|3689866|B3|Colombia||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3864954|NCT01604343|3689867|B2|Colombia||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3864955|NCT01604343|3689868|B1|Colombia||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3864956|NCT01604343|3689865|B4|Chile||Region of Enrollment||Participants|Count of Participants|68|68.0||||||
3864957|NCT01604343|3689866|B3|Chile||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3864958|NCT01604343|3689867|B2|Chile||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3864959|NCT01604343|3689868|B1|Chile||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3864960|NCT01604343|3689865|B4|Canada||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3864961|NCT01604343|3689866|B3|Canada||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3864962|NCT01604343|3689867|B2|Canada||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3864963|NCT01604343|3689868|B1|Canada||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3864964|NCT01604343|3689865|B4|Bulgaria||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3864965|NCT01604343|3689866|B3|Bulgaria||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3864966|NCT01604343|3689867|B2|Bulgaria||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3864967|NCT01604343|3689868|B1|Bulgaria||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3864968|NCT01604343|3689865|B4||Male|Sex: Female, Male||Participants|Count of Participants|335|335.0||||||
3864969|NCT01604343|3689866|B3||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3864970|NCT01604343|3689867|B2||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3864971|NCT01604343|3689868|B1||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3864972|NCT01604343|3689865|B4||Female|Sex: Female, Male||Participants|Count of Participants|1335|1335.0||||||
3864973|NCT01604343|3689866|B3||Female|Sex: Female, Male||Participants|Count of Participants|452|452.0||||||
3864974|NCT01604343|3689867|B2||Female|Sex: Female, Male||Participants|Count of Participants|447|447.0||||||
3864975|NCT01604343|3689868|B1||Female|Sex: Female, Male||Participants|Count of Participants|436|436.0||||||
3864976|NCT01604343|3689865|B4|||Age||years|Mean|52.9|52.9|Standard Deviation|11.65|11.65|||
3864977|NCT01604343|3689866|B3|||Age||years|Mean|53|53.0|Standard Deviation|11.31|11.31|||
3864978|NCT01604343|3689867|B2|||Age||years|Mean|52.9|52.9|Standard Deviation|11.8|11.8|||
3864979|NCT01604343|3689868|B1|||Age||years|Mean|52.9|52.9|Standard Deviation|11.85|11.85|||
3864980|NCT01604278|3689981|B3||Male|Sex: Female, Male||Participants|Count of Participants|366|366.0||||||
3864981|NCT01604278|3689982|B2||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
3864982|NCT01604278|3689983|B1||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3864983|NCT01604278|3689981|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3864984|NCT01604278|3689982|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3864985|NCT01604278|3689983|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3864986|NCT01604278|3689981|B3|||Age||Years|Mean|63.7|63.7|Standard Deviation|8.07|8.07|||
3864987|NCT01604278|3689982|B2|||Age||Years|Mean|64.1|64.1|Standard Deviation|7.67|7.67|||
3864988|NCT01604278|3689983|B1|||Age||Years|Mean|63.4|63.4|Standard Deviation|8.44|8.44|||
3864989|NCT01604265|3690008|B3|United Kingdom||Region of Enrollment||participants|Number|66|66.0||||||
3864990|NCT01604265|3690009|B2|United Kingdom||Region of Enrollment||participants|Number|32|32.0||||||
3864991|NCT01604265|3690010|B1|United Kingdom||Region of Enrollment||participants|Number|34|34.0||||||
3864992|NCT01604265|3690008|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3864993|NCT01604265|3690009|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3864994|NCT01604265|3690010|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3864995|NCT01604265|3690008|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3864996|NCT01604265|3690009|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3864997|NCT01604265|3690010|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3864998|NCT01604265|3690008|B3|||Age||years|Mean|49.23|49.23|Standard Deviation|8.32|8.32|||
3864999|NCT01604265|3690009|B2|||Age||years|Mean|48.08|48.08|Standard Deviation|9.73|9.73|||
3865000|NCT01604265|3690010|B1|||Age||years|Mean|50.30|50.3|Standard Deviation|6.70|6.7|||
3865001|NCT01604265|3690008|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3865002|NCT01604265|3690009|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3865003|NCT01604265|3690010|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3865004|NCT01604265|3690008|B3||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
3865005|NCT01604265|3690009|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3865006|NCT01604265|3690010|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3865007|NCT01604265|3690008|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3865008|NCT01604265|3690009|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3865009|NCT01604265|3690010|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3865010|NCT01604122|3690045|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3865011|NCT01604122|3690046|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3865012|NCT01604122|3690047|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3865013|NCT01604122|3690045|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3865014|NCT01604122|3690046|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3865015|NCT01604122|3690047|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3865016|NCT01604122|3690045|B3|||Age||years|Mean|57.5|57.5|Standard Deviation|12.2|12.2|||
3865017|NCT01604122|3690046|B2|||Age||years|Mean|55.9|55.9|Standard Deviation|12.8|12.8|||
3865018|NCT01604122|3690047|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|12.0|12.0|||
3865019|NCT01604109|3690093|B3|Thailand||Region of Enrollment||participants|Number|296|296.0||||||
3865020|NCT01604109|3690094|B2|Thailand||Region of Enrollment||participants|Number|146|146.0||||||
3865021|NCT01604109|3690095|B1|Thailand||Region of Enrollment||participants|Number|150|150.0||||||
3865022|NCT01604109|3690093|B3||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3865023|NCT01604109|3690094|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3865024|NCT01604109|3690095|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3865025|NCT01604109|3690093|B3||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3865026|NCT01604109|3690094|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3865027|NCT01604109|3690095|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3865028|NCT01604109|3690093|B3|||Age||years|Mean|3.09|3.09|Standard Deviation|0.24|0.24|||
3865029|NCT01604109|3690094|B2|||Age||years|Mean|3.10|3.1|Standard Deviation|0.25|0.25|||
3865030|NCT01604109|3690095|B1|||Age||years|Mean|3.08|3.08|Standard Deviation|0.24|0.24|||
3865031|NCT01604109|3690093|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3865032|NCT01604109|3690094|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3865033|NCT01604109|3690095|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3865034|NCT01604109|3690093|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3865035|NCT01604109|3690094|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3865036|NCT01604109|3690095|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3865037|NCT01604109|3690093|B3||<=18 years|Age||Participants|Count of Participants|296|296.0||||||
3865038|NCT01604109|3690094|B2||<=18 years|Age||Participants|Count of Participants|146|146.0||||||
3865039|NCT01604109|3690095|B1||<=18 years|Age||Participants|Count of Participants|150|150.0||||||
3865040|NCT01603940|3690102|B3|Brazil||Region of Enrollment||participants|Number|30|30.0||||||
3865041|NCT01603940|3690103|B2|Brazil||Region of Enrollment||participants|Number|14|14.0||||||
3865042|NCT01603940|3690104|B1|Brazil||Region of Enrollment||participants|Number|16|16.0||||||
3865043|NCT01603940|3690102|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3865044|NCT01603940|3690103|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3865045|NCT01603940|3690104|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3865046|NCT01603940|3690102|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3865047|NCT01603940|3690103|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3865048|NCT01603940|3690104|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3865049|NCT01603940|3690102|B3|||Age||years|Median|57|57.0|Inter-Quartile Range|||52.0|63.0|
3865050|NCT01603940|3690103|B2|||Age||years|Median|57|57.0|Inter-Quartile Range|||52.0|62.0|
3865051|NCT01603940|3690104|B1|||Age||years|Median|57|57.0|Inter-Quartile Range|||53.0|63.0|
3865052|NCT01603875|3690119|B4|Thailand||Region of Enrollment||participants|Number|81|81.0||||||
3865053|NCT01603875|3690120|B3|Thailand||Region of Enrollment||participants|Number|26|26.0||||||
3865054|NCT01603875|3690121|B2|Thailand||Region of Enrollment||participants|Number|27|27.0||||||
3865055|NCT01603875|3690122|B1|Thailand||Region of Enrollment||participants|Number|28|28.0||||||
3865056|NCT01603875|3690119|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3865057|NCT01603875|3690120|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3865058|NCT01603875|3690121|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3865059|NCT01603875|3690122|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3865060|NCT01603875|3690119|B4||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3865061|NCT01603875|3690120|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3865062|NCT01603875|3690121|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3865063|NCT01603875|3690122|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3865064|NCT01603875|3690119|B4|||Age||years|Mean|19.31|19.31|Standard Deviation|3.345|3.345|||
3865065|NCT01603875|3690120|B3|||Age||years|Mean|18.92|18.92|Standard Deviation|0.744|0.744|||
3865066|NCT01603875|3690121|B2|||Age||years|Mean|20.04|20.04|Standard Deviation|5.633|5.633|||
3865067|NCT01603875|3690122|B1|||Age||years|Mean|18.96|18.96|Standard Deviation|1.138|1.138|||
3865151|NCT01603420|3690313|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865152|NCT01603420|3690311|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3865068|NCT01603628|3690144|B4|||Modified Ashworth Scale-Bohannon (MAS-B) Ankle Score with Knee Extended|The MAS-B evaluates spasticity, grading the resistance encountered in the principal muscle group (elbow and wrist) by passively moving a limb through its range of motion at a specified velocity. The resistance encountered to passive stretch was graded on a 6-point scale: 0=no increase in muscle tone (best) to 4=affected part(s) rigid in flexion or extension (worst). For analysis purposes, the MAS-B was recoded as follows: 0=1, 1=1, 1+=2, 2=3, 3=4, 4=5.|score on a scale|Mean|3.5|3.5|Standard Deviation|0.52|0.52|||
3865069|NCT01603628|3690145|B3|||Modified Ashworth Scale-Bohannon (MAS-B) Ankle Score with Knee Extended|The MAS-B evaluates spasticity, grading the resistance encountered in the principal muscle group (elbow and wrist) by passively moving a limb through its range of motion at a specified velocity. The resistance encountered to passive stretch was graded on a 6-point scale: 0=no increase in muscle tone (best) to 4=affected part(s) rigid in flexion or extension (worst). For analysis purposes, the MAS-B was recoded as follows: 0=1, 1=1, 1+=2, 2=3, 3=4, 4=5.|score on a scale|Mean|3.5|3.5|Standard Deviation|0.50|0.5|||
3865070|NCT01603628|3690146|B2|||Modified Ashworth Scale-Bohannon (MAS-B) Ankle Score with Knee Extended|The MAS-B evaluates spasticity, grading the resistance encountered in the principal muscle group (elbow and wrist) by passively moving a limb through its range of motion at a specified velocity. The resistance encountered to passive stretch was graded on a 6-point scale: 0=no increase in muscle tone (best) to 4=affected part(s) rigid in flexion or extension (worst). For analysis purposes, the MAS-B was recoded as follows: 0=1, 1=1, 1+=2, 2=3, 3=4, 4=5.|score on a scale|Mean|3.5|3.5|Standard Deviation|0.53|0.53|||
3865071|NCT01603628|3690147|B1|||Modified Ashworth Scale-Bohannon (MAS-B) Ankle Score with Knee Extended|The MAS-B evaluates spasticity, grading the resistance encountered in the principal muscle group (elbow and wrist) by passively moving a limb through its range of motion at a specified velocity. The resistance encountered to passive stretch was graded on a 6-point scale: 0=no increase in muscle tone (best) to 4=affected part(s) rigid in flexion or extension (worst). For analysis purposes, the MAS-B was recoded as follows: 0=1, 1=1, 1+=2, 2=3, 3=4, 4=5.|score on a scale|Mean|3.5|3.5|Standard Deviation|0.52|0.52|||
3865072|NCT01603628|3690144|B4|Other Not Specified||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3865073|NCT01603628|3690145|B3|Other Not Specified||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3865074|NCT01603628|3690146|B2|Other Not Specified||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3865075|NCT01603628|3690147|B1|Other Not Specified||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3865076|NCT01603628|3690144|B4|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3865077|NCT01603628|3690145|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3865078|NCT01603628|3690146|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3865079|NCT01603628|3690147|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3865080|NCT01603628|3690144|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|115|115.0||||||
3865081|NCT01603628|3690145|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
3865082|NCT01603628|3690146|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
3865083|NCT01603628|3690147|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3865084|NCT01603628|3690144|B4|Black||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3865085|NCT01603628|3690145|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3865086|NCT01603628|3690146|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3865087|NCT01603628|3690147|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3865088|NCT01603628|3690144|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|233|233.0||||||
3865089|NCT01603628|3690145|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|80|80.0||||||
3865090|NCT01603628|3690146|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|76|76.0||||||
3865091|NCT01603628|3690147|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|77|77.0||||||
3865092|NCT01603628|3690144|B4||Male|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
3865093|NCT01603628|3690145|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3865094|NCT01603628|3690146|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3865095|NCT01603628|3690147|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3865096|NCT01603628|3690144|B4||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
3865097|NCT01603628|3690145|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3865098|NCT01603628|3690146|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3865099|NCT01603628|3690147|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3865100|NCT01603628|3690144|B4|||Age||years|Mean|6.6|6.6|Standard Deviation|3.79|3.79|||
3865101|NCT01603628|3690145|B3|||Age||years|Mean|6.6|6.6|Standard Deviation|3.89|3.89|||
3865102|NCT01603628|3690146|B2|||Age||years|Mean|6.4|6.4|Standard Deviation|3.58|3.58|||
3865103|NCT01603628|3690147|B1|||Age||years|Mean|6.7|6.7|Standard Deviation|3.90|3.9|||
3865104|NCT01603602|3690166|B4|||Modified Ashworth Scale-Bohannon (MAS-B) Score of the Principal Muscle Group Change|The MAS-B was used to evaluate spasticity based on grading the resistance encountered in the principal muscle group (elbow and wrist) by means of passively moving a limb through its range of motion at a study specified velocity. The resistance encountered to passive stretch was graded using a 6-point scale where: 0=no increase in muscle tone (best) to 4=affected part(s) rigid in flexion or extension (worst). For analysis purposes, the MAS-B was recoded as follows: 0=1, 1=1, 1+=2, 2=3, 3=4, 4=5.|score on a scale|Mean|3.3|3.3|Standard Deviation|0.45|0.45|||
3865153|NCT01603420|3690312|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3865154|NCT01603420|3690313|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865105|NCT01603602|3690167|B3|||Modified Ashworth Scale-Bohannon (MAS-B) Score of the Principal Muscle Group Change|The MAS-B was used to evaluate spasticity based on grading the resistance encountered in the principal muscle group (elbow and wrist) by means of passively moving a limb through its range of motion at a study specified velocity. The resistance encountered to passive stretch was graded using a 6-point scale where: 0=no increase in muscle tone (best) to 4=affected part(s) rigid in flexion or extension (worst). For analysis purposes, the MAS-B was recoded as follows: 0=1, 1=1, 1+=2, 2=3, 3=4, 4=5.|score on a scale|Mean|3.3|3.3|Standard Deviation|0.44|0.44|||
3865106|NCT01603602|3690168|B2|||Modified Ashworth Scale-Bohannon (MAS-B) Score of the Principal Muscle Group Change|The MAS-B was used to evaluate spasticity based on grading the resistance encountered in the principal muscle group (elbow and wrist) by means of passively moving a limb through its range of motion at a study specified velocity. The resistance encountered to passive stretch was graded using a 6-point scale where: 0=no increase in muscle tone (best) to 4=affected part(s) rigid in flexion or extension (worst). For analysis purposes, the MAS-B was recoded as follows: 0=1, 1=1, 1+=2, 2=3, 3=4, 4=5.|score on a scale|Mean|3.3|3.3|Standard Deviation|0.45|0.45|||
3865107|NCT01603602|3690169|B1|||Modified Ashworth Scale-Bohannon (MAS-B) Score of the Principal Muscle Group Change|The MAS-B was used to evaluate spasticity based on grading the resistance encountered in the principal muscle group (elbow and wrist) by means of passively moving a limb through its range of motion at a study specified velocity. The resistance encountered to passive stretch was graded using a 6-point scale where: 0=no increase in muscle tone (best) to 4=affected part(s) rigid in flexion or extension (worst). For analysis purposes, the MAS-B was recoded as follows: 0=1, 1=1, 1+=2, 2=3, 3=4, 4=5.|score on a scale|Mean|3.3|3.3|Standard Deviation|0.45|0.45|||
3865108|NCT01603602|3690166|B4|Other Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3865109|NCT01603602|3690167|B3|Other Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3865110|NCT01603602|3690168|B2|Other Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3865111|NCT01603602|3690169|B1|Other Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3865112|NCT01603602|3690166|B4|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3865113|NCT01603602|3690167|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3865114|NCT01603602|3690168|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3865115|NCT01603602|3690169|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3865116|NCT01603602|3690166|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|64|64.0||||||
3865117|NCT01603602|3690167|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3865118|NCT01603602|3690168|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3865119|NCT01603602|3690169|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3865120|NCT01603602|3690166|B4|Black||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3865121|NCT01603602|3690167|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3865122|NCT01603602|3690168|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3865123|NCT01603602|3690169|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3865124|NCT01603602|3690166|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|144|144.0||||||
3865125|NCT01603602|3690167|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
3865126|NCT01603602|3690168|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3865127|NCT01603602|3690169|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
3865128|NCT01603602|3690166|B4||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3865129|NCT01603602|3690167|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3865130|NCT01603602|3690168|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3865131|NCT01603602|3690169|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3865132|NCT01603602|3690166|B4||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3865133|NCT01603602|3690167|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3865134|NCT01603602|3690168|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3865135|NCT01603602|3690169|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3865136|NCT01603602|3690166|B4|||Age||years|Mean|7.9|7.9|Standard Deviation|4.07|4.07|||
3865137|NCT01603602|3690167|B3|||Age||years|Mean|7.8|7.8|Standard Deviation|4.06|4.06|||
3865138|NCT01603602|3690168|B2|||Age||years|Mean|8.3|8.3|Standard Deviation|4.48|4.48|||
3865139|NCT01603602|3690169|B1|||Age||years|Mean|7.6|7.6|Standard Deviation|3.66|3.66|||
3865140|NCT01603459|3690191|B1||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3865141|NCT01603459|3690191|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3865142|NCT01603459|3690191|B1|||Age||years|Mean|53.7|53.7|Standard Deviation|13.1|13.1|||
3865143|NCT01603420|3690311|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3865144|NCT01603420|3690312|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3865145|NCT01603420|3690313|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3865146|NCT01603420|3690311|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865147|NCT01603420|3690312|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865148|NCT01603420|3690313|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865149|NCT01603420|3690311|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865150|NCT01603420|3690312|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865155|NCT01603420|3690311|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3865156|NCT01603420|3690312|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865157|NCT01603420|3690313|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3865158|NCT01603420|3690311|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865159|NCT01603420|3690312|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865160|NCT01603420|3690313|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865161|NCT01603420|3690311|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865162|NCT01603420|3690312|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865163|NCT01603420|3690313|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865164|NCT01603420|3690311|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865165|NCT01603420|3690312|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865166|NCT01603420|3690313|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865167|NCT01603420|3690311|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865168|NCT01603420|3690312|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865169|NCT01603420|3690313|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865170|NCT01603420|3690311|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3865171|NCT01603420|3690312|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3865172|NCT01603420|3690313|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3865173|NCT01603420|3690311|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865174|NCT01603420|3690312|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865175|NCT01603420|3690313|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865176|NCT01603420|3690311|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3865177|NCT01603420|3690312|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3865178|NCT01603420|3690313|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3865179|NCT01603420|3690311|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3865180|NCT01603420|3690312|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3865181|NCT01603420|3690313|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3865182|NCT01603420|3690311|B3|||Age||years|Mean|62.5|62.5|Full Range|||53.0|72.0|
3865183|NCT01603420|3690312|B2|||Age||years|Mean|72|72.0|Full Range|||72.0|72.0|
3865184|NCT01603420|3690313|B1|||Age||years|Mean|53|53.0|Full Range|||53.0|53.0|
3865185|NCT01603420|3690311|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3865186|NCT01603420|3690312|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3865187|NCT01603420|3690313|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3865188|NCT01603420|3690311|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3865189|NCT01603420|3690312|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3865190|NCT01603420|3690313|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3865191|NCT01603420|3690311|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3865192|NCT01603420|3690312|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3865193|NCT01603420|3690313|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3865194|NCT01603394|3690342|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3865195|NCT01603394|3690342|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3865196|NCT01603394|3690342|B1|||Age, Customized||Age at least 18 years|Number|9|9.0||||||
3865197|NCT01603355|3690357|B1|||Participants with control of ocular inflammation at trace or less||Participants|Count of Participants|3|3.0||||||
3865198|NCT01603355|3690357|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3865199|NCT01603355|3690357|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3865200|NCT01603355|3690357|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3865201|NCT01603355|3690357|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3865202|NCT01603355|3690357|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3865203|NCT01603355|3690357|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3865204|NCT01603277|3690361|B3|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3865205|NCT01603277|3690362|B2|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3865206|NCT01603277|3690363|B1|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3865207|NCT01603277|3690361|B3|France||Region of Enrollment||participants|Number|5|5.0||||||
3865208|NCT01603277|3690362|B2|France||Region of Enrollment||participants|Number|4|4.0||||||
3865209|NCT01603277|3690363|B1|France||Region of Enrollment||participants|Number|1|1.0||||||
3865210|NCT01603277|3690361|B3|Australia||Region of Enrollment||participants|Number|13|13.0||||||
3865211|NCT01603277|3690362|B2|Australia||Region of Enrollment||participants|Number|7|7.0||||||
3865212|NCT01603277|3690363|B1|Australia||Region of Enrollment||participants|Number|6|6.0||||||
3865213|NCT01603277|3690361|B3|Ukraine||Region of Enrollment||participants|Number|34|34.0||||||
3865214|NCT01603277|3690362|B2|Ukraine||Region of Enrollment||participants|Number|17|17.0||||||
3865215|NCT01603277|3690363|B1|Ukraine||Region of Enrollment||participants|Number|17|17.0||||||
3865216|NCT01603277|3690361|B3|Poland||Region of Enrollment||participants|Number|45|45.0||||||
3865217|NCT01603277|3690362|B2|Poland||Region of Enrollment||participants|Number|19|19.0||||||
3865218|NCT01603277|3690363|B1|Poland||Region of Enrollment||participants|Number|26|26.0||||||
3865219|NCT01603277|3690361|B3|United States||Region of Enrollment||participants|Number|59|59.0||||||
3865220|NCT01603277|3690362|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
3865221|NCT01603277|3690363|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
3865222|NCT01603277|3690361|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865223|NCT01603277|3690362|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865224|NCT01603277|3690363|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865225|NCT01603277|3690361|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|149|149.0||||||
3865226|NCT01603277|3690362|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3865227|NCT01603277|3690363|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3865228|NCT01603277|3690361|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3865229|NCT01603277|3690362|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3865230|NCT01603277|3690363|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3865231|NCT01603277|3690361|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3865232|NCT01603277|3690362|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3865233|NCT01603277|3690363|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865234|NCT01603277|3690361|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865235|NCT01603277|3690362|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865236|NCT01603277|3690363|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865237|NCT01603277|3690361|B3||White|Race (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
3865238|NCT01603277|3690362|B2||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3865239|NCT01603277|3690363|B1||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3865240|NCT01603277|3690361|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3865241|NCT01603277|3690362|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3865242|NCT01603277|3690363|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3865243|NCT01603277|3690361|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865244|NCT01603277|3690362|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865245|NCT01603277|3690363|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865246|NCT01603277|3690361|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3865247|NCT01603277|3690362|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3865248|NCT01603277|3690363|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3865249|NCT01603277|3690361|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865250|NCT01603277|3690362|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865251|NCT01603277|3690363|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865252|NCT01603277|3690361|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3865253|NCT01603277|3690362|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3865254|NCT01603277|3690363|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3865255|NCT01603277|3690361|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3865256|NCT01603277|3690362|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3865257|NCT01603277|3690363|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3865258|NCT01603277|3690361|B3||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3865259|NCT01603277|3690362|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3865260|NCT01603277|3690363|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3865261|NCT01603277|3690361|B3||Between 18 and 65 years|Age||Participants|Count of Participants|135|135.0||||||
3865262|NCT01603277|3690362|B2||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
3865263|NCT01603277|3690363|B1||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
3865264|NCT01603277|3690361|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3865265|NCT01603277|3690362|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3865266|NCT01603277|3690363|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3865267|NCT01603277|3690361|B3|||Age||Years|Mean|52.9|52.9|Standard Deviation|11.1|11.1|||
3865268|NCT01603277|3690362|B2|||Age||Years|Mean|53.1|53.1|Standard Deviation|10.30|10.3|||
3865269|NCT01603277|3690363|B1|||Age||Years|Mean|52.9|52.9|Standard Deviation|11.95|11.95|||
3865270|NCT01603121|3690370|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3865271|NCT01603121|3690370|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865272|NCT01603121|3690370|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865273|NCT01603121|3690370|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3865274|NCT01603121|3690370|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865275|NCT01603121|3690370|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865276|NCT01603121|3690370|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865277|NCT01603121|3690370|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865278|NCT01603121|3690370|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865279|NCT01603121|3690370|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865280|NCT01603121|3690370|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3865281|NCT01603121|3690370|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3865282|NCT01603121|3690370|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3865283|NCT01603121|3690370|B1|||Age||years|Mean|44|44.0|Standard Deviation|0|0.0|||
3865284|NCT01603082|3690381|B3|United States||Region of Enrollment||Participants|Number|100|100.0||||||
3865285|NCT01603082|3690382|B2|United States||Region of Enrollment||Participants|Number|49|49.0||||||
3865286|NCT01603082|3690383|B1|United States||Region of Enrollment||Participants|Number|51|51.0||||||
3865287|NCT01603082|3690381|B3|Missing values||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3865288|NCT01603082|3690382|B2|Missing values||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3865289|NCT01603082|3690383|B1|Missing values||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3865290|NCT01603082|3690381|B3|Not Reported||Race/Ethnicity, Customized||Participants|Number|55|55.0||||||
3865291|NCT01603082|3690382|B2|Not Reported||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
3865292|NCT01603082|3690383|B1|Not Reported||Race/Ethnicity, Customized||Participants|Number|28|28.0||||||
3865293|NCT01603082|3690381|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
3865294|NCT01603082|3690382|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3865295|NCT01603082|3690383|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3865296|NCT01603082|3690381|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3865297|NCT01603082|3690382|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3865298|NCT01603082|3690383|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3865299|NCT01603082|3690381|B3|Missing values||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3865300|NCT01603082|3690382|B2|Missing values||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3865301|NCT01603082|3690383|B1|Missing values||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3865302|NCT01603082|3690381|B3|White||Race/Ethnicity, Customized||Participants|Number|66|66.0||||||
3865303|NCT01603082|3690382|B2|White||Race/Ethnicity, Customized||Participants|Number|33|33.0||||||
3865304|NCT01603082|3690383|B1|White||Race/Ethnicity, Customized||Participants|Number|33|33.0||||||
3865305|NCT01603082|3690381|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
3865306|NCT01603082|3690382|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3865307|NCT01603082|3690383|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3865308|NCT01603082|3690381|B3|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3865309|NCT01603082|3690382|B2|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3865310|NCT01603082|3690383|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3865311|NCT01603082|3690381|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3865312|NCT01603082|3690382|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3865313|NCT01603082|3690383|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3865314|NCT01603082|3690381|B3||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3865315|NCT01603082|3690382|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3865316|NCT01603082|3690383|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3865317|NCT01603082|3690381|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3865318|NCT01603082|3690382|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3865319|NCT01603082|3690383|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3865320|NCT01603082|3690381|B3||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
3865321|NCT01603082|3690382|B2||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3865322|NCT01603082|3690383|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3865323|NCT01603082|3690381|B3||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
3865324|NCT01603082|3690382|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3865325|NCT01603082|3690383|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3865326|NCT01603082|3690381|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3865327|NCT01603082|3690382|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3865328|NCT01603082|3690383|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3865329|NCT01603056|3690392|B3|China||Region of Enrollment||participants|Number|600|600.0||||||
3865330|NCT01603056|3690393|B2|China||Region of Enrollment||participants|Number|200|200.0||||||
3865331|NCT01603056|3690394|B1|China||Region of Enrollment||participants|Number|400|400.0||||||
3865332|NCT01603056|3690392|B3||Male|Sex: Female, Male||Participants|Count of Participants|341|341.0||||||
3865333|NCT01603056|3690393|B2||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3865334|NCT01603056|3690394|B1||Male|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
3865335|NCT01603056|3690392|B3||Female|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
3865336|NCT01603056|3690393|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3865337|NCT01603056|3690394|B1||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3865338|NCT01603056|3690392|B3|||Age||years|Mean|20.31|20.31|Standard Deviation|12.67|12.67|||
3865339|NCT01603056|3690393|B2|||Age||years|Mean|19.47|19.47|Standard Deviation|12.01|12.01|||
3865340|NCT01603056|3690394|B1|||Age||years|Mean|20.74|20.74|Standard Deviation|12.98|12.98|||
3865341|NCT01603043|3690423|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3865342|NCT01603043|3690424|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3865343|NCT01603043|3690425|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3865344|NCT01603043|3690423|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3865345|NCT01603043|3690424|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3865346|NCT01603043|3690425|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3865347|NCT01603043|3690423|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3865348|NCT01603043|3690424|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3865349|NCT01603043|3690425|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3865350|NCT01603043|3690423|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3865351|NCT01603043|3690424|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3865352|NCT01603043|3690425|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3865353|NCT01603043|3690423|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3865354|NCT01603043|3690424|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3865355|NCT01603043|3690425|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3865356|NCT01602965|3690436|B3|||Weight||kg|Mean|94.53|94.53|Standard Deviation|11.88|11.88|||
3865357|NCT01602965|3690437|B2|||Weight||kg|Mean|92.91|92.91|Standard Deviation|9.95|9.95|||
3865358|NCT01602965|3690438|B1|||Weight||kg|Mean|96.15|96.15|Standard Deviation|13.81|13.81|||
3865359|NCT01602965|3690436|B3|||BMI||kg/m^2|Mean|32.69|32.69|Standard Deviation|2.55|2.55|||
3865360|NCT01602965|3690437|B2|||BMI||kg/m^2|Mean|32.45|32.45|Standard Deviation|2.41|2.41|||
3865361|NCT01602965|3690438|B1|||BMI||kg/m^2|Mean|32.94|32.94|Standard Deviation|2.69|2.69|||
3865362|NCT01602965|3690436|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3865363|NCT01602965|3690437|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3865364|NCT01602965|3690438|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3865365|NCT01602965|3690436|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3865366|NCT01602965|3690437|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3865367|NCT01602965|3690438|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3865368|NCT01602965|3690436|B3|||Age||years|Mean|59.0|59.0|Standard Deviation|9.87|9.87|||
3865369|NCT01602965|3690437|B2|||Age||years|Mean|56.5|56.5|Standard Deviation|10.67|10.67|||
3865370|NCT01602965|3690438|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|9.08|9.08|||
3865371|NCT01602744|3690445|B3|Israel||Region of Enrollment||participants|Number|359|359.0||||||
3865372|NCT01602744|3690446|B2|Israel||Region of Enrollment||participants|Number|183|183.0||||||
3865373|NCT01602744|3690447|B1|Israel||Region of Enrollment||participants|Number|176|176.0||||||
3865374|NCT01602744|3690445|B3||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3865375|NCT01602744|3690446|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3865376|NCT01602744|3690447|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3865377|NCT01602744|3690445|B3||Female|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
3865378|NCT01602744|3690446|B2||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3865379|NCT01602744|3690447|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3865380|NCT01602744|3690445|B3|||Age||years|Mean|82.7|82.7|Standard Deviation|8.7|8.7|||
3865381|NCT01602744|3690446|B2|||Age||years|Mean|83.1|83.1|Standard Deviation|7.99|7.99|||
3865382|NCT01602744|3690447|B1|||Age||years|Mean|82.2|82.2|Standard Deviation|9.4|9.4|||
3865383|NCT01602744|3690445|B3||>=65 years|Age||Participants|Count of Participants|359|359.0||||||
3865384|NCT01602744|3690446|B2||>=65 years|Age||Participants|Count of Participants|183|183.0||||||
3865385|NCT01602744|3690447|B1||>=65 years|Age||Participants|Count of Participants|176|176.0||||||
3865386|NCT01602744|3690445|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3865387|NCT01602744|3690446|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3865388|NCT01602744|3690447|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3865389|NCT01602744|3690445|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3865390|NCT01602744|3690446|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3865391|NCT01602744|3690447|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3865392|NCT01602731|3690464|B1|||Full Range of Saint Louis University Mental Status Scores||units on a scale|Mean|20.9|20.9|Full Range|||14.0|28.0|
3865443|NCT01602679|3690471|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3865444|NCT01602679|3690472|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3865445|NCT01602679|3690470|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3865393|NCT01602731|3690464|B1|||Medication adherence|"Medication adherence was measured by 30-day pill counts and included all prescribed medications, except the ones prescribed on an as-needed basis. To capture both overtaking and undertaking medication, a delta was determined for each medication by computing the absolute difference between the number of pills taken and the number prescribed over the 30-day period. The delta values for each medication were summed for each individual subject, divided by the total number of pills prescribed, subtracted from 1, and finally multiplied by 100 to obtain an adherence score expressed as a percentage."|Percentage|Mean|69.9|69.9|Standard Deviation|12|12.0|||
3865394|NCT01602731|3690464|B1|||Saint Louis University Mental Status score|Saint Louis University Mental Status Score is measured on the scale of 30 and contains 11 questions that incorporate cognitive tasks. It has been validated in different studies and has high sensitivity and specificity in detecting dementia, as well as mild cognitive impairment. Score of <27 is in a person with high school education or <25 in a person with less than high school education is considered abnormal and consistent with cognitive impairment. The total range for the SLUMS scale could range from 1 (severe dementia) to 30 (normal).|units on a scale|Mean|20.9|20.9|Standard Deviation|5.8|5.8|||
3865395|NCT01602731|3690464|B1|live with others||Living arrangements||participants|Number|34|34.0||||||
3865396|NCT01602731|3690464|B1|live alone||Living arrangements||participants|Number|11|11.0||||||
3865397|NCT01602731|3690464|B1|postgraduate degree||Education level||participants|Number|3|3.0||||||
3865398|NCT01602731|3690464|B1|college degree||Education level||participants|Number|7|7.0||||||
3865399|NCT01602731|3690464|B1|some college||Education level||participants|Number|23|23.0||||||
3865400|NCT01602731|3690464|B1|high school or equivalent||Education level||participants|Number|10|10.0||||||
3865401|NCT01602731|3690464|B1|no high school||Education level||participants|Number|2|2.0||||||
3865402|NCT01602731|3690464|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865403|NCT01602731|3690464|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3865404|NCT01602731|3690464|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3865405|NCT01602731|3690464|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3865406|NCT01602731|3690464|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3865407|NCT01602731|3690464|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865408|NCT01602731|3690464|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865409|NCT01602731|3690464|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3865410|NCT01602731|3690464|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3865411|NCT01602731|3690464|B1|||Age||years|Mean|67.3|67.3|Standard Deviation|8.5|8.5|||
3865412|NCT01602679|3690470|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
3865413|NCT01602679|3690471|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3865414|NCT01602679|3690472|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3865415|NCT01602679|3690470|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3865416|NCT01602679|3690471|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3865417|NCT01602679|3690472|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3865418|NCT01602679|3690470|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865419|NCT01602679|3690471|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865420|NCT01602679|3690472|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865421|NCT01602679|3690470|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865422|NCT01602679|3690471|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865423|NCT01602679|3690472|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865424|NCT01602679|3690470|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865425|NCT01602679|3690471|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865426|NCT01602679|3690472|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865427|NCT01602679|3690470|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865428|NCT01602679|3690471|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865429|NCT01602679|3690472|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865430|NCT01602679|3690470|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865431|NCT01602679|3690471|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865432|NCT01602679|3690472|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865433|NCT01602679|3690470|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865434|NCT01602679|3690471|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865435|NCT01602679|3690472|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865436|NCT01602679|3690470|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3865437|NCT01602679|3690471|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3865438|NCT01602679|3690472|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3865439|NCT01602679|3690470|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3865440|NCT01602679|3690471|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3865441|NCT01602679|3690472|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3865442|NCT01602679|3690470|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3865446|NCT01602679|3690471|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3865447|NCT01602679|3690472|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3865448|NCT01602679|3690470|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3865449|NCT01602679|3690471|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3865450|NCT01602679|3690472|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3865451|NCT01602562|3690483|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
3865452|NCT01602562|3690484|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
3865453|NCT01602562|3690485|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
3865454|NCT01602562|3690483|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3865455|NCT01602562|3690484|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3865456|NCT01602562|3690485|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3865457|NCT01602562|3690483|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3865458|NCT01602562|3690484|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3865459|NCT01602562|3690485|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3865460|NCT01602562|3690483|B3|||Age||Years|Mean|29.1|29.1|Standard Deviation|23.40|23.4|||
3865461|NCT01602562|3690484|B2|||Age||Years|Mean|7.5|7.5|Standard Deviation|4.69|4.69|||
3865462|NCT01602562|3690485|B1|||Age||Years|Mean|48.6|48.6|Standard Deviation|14.32|14.32|||
3865463|NCT01602549|3690520|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|57|57.0||||||
3865464|NCT01602549|3690521|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|38|38.0||||||
3865465|NCT01602549|3690522|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
3865466|NCT01602549|3690520|B3||Male|Gender||Participants|Count of Participants|37|37.0||||||
3865467|NCT01602549|3690521|B2||Male|Gender||Participants|Count of Participants|29|29.0||||||
3865468|NCT01602549|3690522|B1||Male|Gender||Participants|Count of Participants|8|8.0||||||
3865469|NCT01602549|3690520|B3||Female|Gender||Participants|Count of Participants|20|20.0||||||
3865470|NCT01602549|3690521|B2||Female|Gender||Participants|Count of Participants|9|9.0||||||
3865471|NCT01602549|3690522|B1||Female|Gender||Participants|Count of Participants|11|11.0||||||
3865472|NCT01602549|3690520|B3|||Age||Years|Mean|67.1|67.1|Standard Deviation|7.93|7.93|||
3865473|NCT01602549|3690521|B2|||Age||Years|Mean|67.4|67.4|Standard Deviation|7.97|7.97|||
3865474|NCT01602549|3690522|B1|||Age||Years|Mean|66.7|66.7|Standard Deviation|8.04|8.04|||
3865475|NCT01602510|3690602|B1|Not Hispanic or Latino||Race/Ethnicity, Customized|Data is presented for Open Label Phase.|Participants|Number|420|420.0||||||
3865476|NCT01602510|3690602|B1||Male|Gender|Data is presented for Open Label Phase.|Participants|Count of Participants|200|200.0||||||
3865477|NCT01602510|3690602|B1||Female|Gender|Data is presented for Open Label Phase.|Participants|Count of Participants|220|220.0||||||
3865478|NCT01602510|3690602|B1|||Age|Data is presented for Open Label Phase.|Years|Mean|35.7|35.7|Standard Deviation|11.72|11.72|||
3865479|NCT01602484|3690628|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3865480|NCT01602484|3690629|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3865481|NCT01602484|3690630|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3865482|NCT01602484|3690628|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3865483|NCT01602484|3690629|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3865484|NCT01602484|3690630|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3865485|NCT01602484|3690628|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3865486|NCT01602484|3690629|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3865487|NCT01602484|3690630|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3865488|NCT01602484|3690628|B3|||Age||years|Mean|56.37|56.37|Standard Deviation|17.46|17.46|||
3865489|NCT01602484|3690629|B2|||Age||years|Mean|56.30|56.3|Standard Deviation|16.81|16.81|||
3865490|NCT01602484|3690630|B1|||Age||years|Mean|56.45|56.45|Standard Deviation|18.41|18.41|||
3865491|NCT01602484|3690628|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3865492|NCT01602484|3690629|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3865493|NCT01602484|3690630|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3865494|NCT01602484|3690628|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3865495|NCT01602484|3690629|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3865496|NCT01602484|3690630|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3865497|NCT01602484|3690628|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3865498|NCT01602484|3690629|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3865499|NCT01602484|3690630|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3865500|NCT01602471|3690643|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3865501|NCT01602471|3690643|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3865502|NCT01602471|3690643|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3865503|NCT01602471|3690643|B1|||Age||years|Mean|70.8|70.8|Standard Deviation|10.1|10.1|||
3865504|NCT01602471|3690643|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3865505|NCT01602471|3690643|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3865506|NCT01602471|3690643|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3865507|NCT01602380|3690647|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3865508|NCT01602380|3690648|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3865509|NCT01602380|3690649|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3865510|NCT01602380|3690647|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|349|349.0||||||
3865511|NCT01602380|3690648|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|174|174.0||||||
3865512|NCT01602380|3690649|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|175|175.0||||||
3865513|NCT01602380|3690647|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3865514|NCT01602380|3690648|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3865515|NCT01602380|3690649|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3865516|NCT01602380|3690647|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|70|70.0||||||
3865517|NCT01602380|3690648|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3865518|NCT01602380|3690649|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3865519|NCT01602380|3690647|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3865520|NCT01602380|3690648|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3865521|NCT01602380|3690649|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3865522|NCT01602380|3690647|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3865523|NCT01602380|3690648|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3865524|NCT01602380|3690649|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3865525|NCT01602380|3690647|B3||Female|Sex: Female, Male||Participants|Count of Participants|462|462.0||||||
3865526|NCT01602380|3690648|B2||Female|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
3865527|NCT01602380|3690649|B1||Female|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
3865528|NCT01602380|3690647|B3|||Age||years|Mean|63.5|63.5|Standard Deviation|10.12|10.12|36.0|90.0|
3865529|NCT01602380|3690648|B2|||Age||years|Mean|63.3|63.3|Standard Deviation|10.38|10.38|36.0|90.0|
3865530|NCT01602380|3690649|B1|||Age||years|Mean|63.8|63.8|Standard Deviation|9.86|9.86|38.0|87.0|
3865531|NCT01602341|3690672|B3||Male|Gender||Participants|Count of Participants|34|34.0||||||
3865532|NCT01602341|3690673|B2||Male|Gender||Participants|Count of Participants|19|19.0||||||
3865533|NCT01602341|3690674|B1||Male|Gender||Participants|Count of Participants|15|15.0||||||
3865534|NCT01602341|3690672|B3||Female|Gender||Participants|Count of Participants|52|52.0||||||
3865535|NCT01602341|3690673|B2||Female|Gender||Participants|Count of Participants|23|23.0||||||
3865536|NCT01602341|3690674|B1||Female|Gender||Participants|Count of Participants|29|29.0||||||
3865537|NCT01602341|3690672|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3865538|NCT01602341|3690673|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3865539|NCT01602341|3690674|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3865540|NCT01602341|3690672|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3865541|NCT01602341|3690673|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3865542|NCT01602341|3690674|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3865543|NCT01602341|3690672|B3||<=18 years|Age||Participants|Count of Participants|86|86.0||||||
3865544|NCT01602341|3690673|B2||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
3865545|NCT01602341|3690674|B1||<=18 years|Age||Participants|Count of Participants|44|44.0||||||
3865546|NCT01602315|3690709|B8||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3865547|NCT01602315|3690710|B7||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3865548|NCT01602315|3690711|B6||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3865549|NCT01602315|3690712|B5||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3865550|NCT01602315|3690713|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3865551|NCT01602315|3690714|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3865552|NCT01602315|3690715|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3865553|NCT01602315|3690716|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3865554|NCT01602315|3690709|B8||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3865555|NCT01602315|3690710|B7||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3865556|NCT01602315|3690711|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3865557|NCT01602315|3690712|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3865558|NCT01602315|3690713|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3865559|NCT01602315|3690714|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3865560|NCT01602315|3690715|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3865561|NCT01602315|3690716|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3865562|NCT01602315|3690709|B8|||Age||years|Mean|57.0|57.0|Standard Deviation|10.16|10.16|||
3865563|NCT01602315|3690710|B7|||Age||years|Mean|56.9|56.9|Standard Deviation|8.25|8.25|||
3865564|NCT01602315|3690711|B6|||Age||years|Mean|57.1|57.1|Standard Deviation|10.37|10.37|||
3865565|NCT01602315|3690712|B5|||Age||years|Mean|57.2|57.2|Standard Deviation|9.66|9.66|||
3865566|NCT01602315|3690713|B4|||Age||years|Mean|60.5|60.5|Standard Deviation|14.10|14.1|||
3865567|NCT01602315|3690714|B3|||Age||years|Mean|56.7|56.7|Standard Deviation|10.20|10.2|||
3865568|NCT01602315|3690715|B2|||Age||years|Mean|62.6|62.6|Standard Deviation|7.99|7.99|||
3865569|NCT01602315|3690716|B1|||Age||years|Mean|52.8|52.8|Standard Deviation|13.40|13.4|||
3865570|NCT01602224|3690808|B4|Germany||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3865571|NCT01602224|3690809|B3|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3865572|NCT01602224|3690810|B2|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3865573|NCT01602224|3690811|B1|Germany||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3865574|NCT01602224|3690808|B4|France||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3865575|NCT01602224|3690809|B3|France||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3865576|NCT01602224|3690810|B2|France||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3865577|NCT01602224|3690811|B1|France||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3865578|NCT01602224|3690808|B4|Mexico||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3865579|NCT01602224|3690809|B3|Mexico||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3865580|NCT01602224|3690810|B2|Mexico||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3865581|NCT01602224|3690811|B1|Mexico||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3865582|NCT01602224|3690808|B4|Italy||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3865583|NCT01602224|3690809|B3|Italy||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3865584|NCT01602224|3690810|B2|Italy||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3865585|NCT01602224|3690811|B1|Italy||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3865586|NCT01602224|3690808|B4|Poland||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3865587|NCT01602224|3690809|B3|Poland||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3865588|NCT01602224|3690810|B2|Poland||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3865589|NCT01602224|3690811|B1|Poland||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3865590|NCT01602224|3690808|B4|Brazil||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3865591|NCT01602224|3690809|B3|Brazil||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3865592|NCT01602224|3690810|B2|Brazil||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3865593|NCT01602224|3690811|B1|Brazil||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3865594|NCT01602224|3690808|B4|Taiwan||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3865595|NCT01602224|3690809|B3|Taiwan||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3865596|NCT01602224|3690810|B2|Taiwan||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3865597|NCT01602224|3690811|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3865598|NCT01602224|3690808|B4|Turkey||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3865599|NCT01602224|3690809|B3|Turkey||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3865600|NCT01602224|3690810|B2|Turkey||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3865601|NCT01602224|3690811|B1|Turkey||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3865602|NCT01602224|3690808|B4|Netherlands||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3865603|NCT01602224|3690809|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3865604|NCT01602224|3690810|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3865605|NCT01602224|3690811|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3865606|NCT01602224|3690808|B4|South Korea||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3865607|NCT01602224|3690809|B3|South Korea||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3865608|NCT01602224|3690810|B2|South Korea||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3865609|NCT01602224|3690811|B1|South Korea||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3865610|NCT01602224|3690808|B4|Canada||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3865611|NCT01602224|3690809|B3|Canada||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3865612|NCT01602224|3690810|B2|Canada||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3865613|NCT01602224|3690811|B1|Canada||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3865614|NCT01602224|3690808|B4|Greece||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3865615|NCT01602224|3690809|B3|Greece||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3865616|NCT01602224|3690810|B2|Greece||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3865617|NCT01602224|3690811|B1|Greece||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3865618|NCT01602224|3690808|B4|Spain||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3865619|NCT01602224|3690809|B3|Spain||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3865620|NCT01602224|3690810|B2|Spain||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3865621|NCT01602224|3690811|B1|Spain||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3865622|NCT01602224|3690808|B4|United Kingdom||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3865623|NCT01602224|3690809|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3865624|NCT01602224|3690810|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3865625|NCT01602224|3690811|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3865626|NCT01602224|3690808|B4|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3865627|NCT01602224|3690809|B3|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3865628|NCT01602224|3690810|B2|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3865629|NCT01602224|3690811|B1|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3865630|NCT01602224|3690808|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3865631|NCT01602224|3690809|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3865632|NCT01602224|3690810|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865633|NCT01602224|3690811|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865634|NCT01602224|3690808|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865635|NCT01602224|3690809|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865636|NCT01602224|3690810|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865637|NCT01602224|3690811|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865638|NCT01602224|3690808|B4||White|Race (NIH/OMB)||Participants|Count of Participants|162|162.0||||||
3865639|NCT01602224|3690809|B3||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3865640|NCT01602224|3690810|B2||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3865641|NCT01602224|3690811|B1||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3865642|NCT01602224|3690808|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3865643|NCT01602224|3690809|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3865644|NCT01602224|3690810|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3865645|NCT01602224|3690811|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3865646|NCT01602224|3690808|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865647|NCT01602224|3690809|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865648|NCT01602224|3690810|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865649|NCT01602224|3690811|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865650|NCT01602224|3690808|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3865651|NCT01602224|3690809|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3865652|NCT01602224|3690810|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3865653|NCT01602224|3690811|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3865654|NCT01602224|3690808|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3865655|NCT01602224|3690809|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3865656|NCT01602224|3690810|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3865657|NCT01602224|3690811|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3865658|NCT01602224|3690808|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3865659|NCT01602224|3690809|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3865660|NCT01602224|3690810|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3865661|NCT01602224|3690811|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3865662|NCT01602224|3690808|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
3865663|NCT01602224|3690809|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3865664|NCT01602224|3690810|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3865665|NCT01602224|3690811|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3865666|NCT01602224|3690808|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3865667|NCT01602224|3690809|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3865668|NCT01602224|3690810|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3865669|NCT01602224|3690811|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3865670|NCT01602224|3690808|B4||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3865671|NCT01602224|3690809|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3865672|NCT01602224|3690810|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3865673|NCT01602224|3690811|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3865674|NCT01602224|3690808|B4||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3865675|NCT01602224|3690809|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3865676|NCT01602224|3690810|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3865677|NCT01602224|3690811|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3865678|NCT01602224|3690808|B4|||Age||years|Median|64.8|64.8|Standard Deviation|9.93|9.93|||
3865679|NCT01602224|3690809|B3|||Age||years|Median|65.4|65.4|Standard Deviation|9.50|9.5|||
3865680|NCT01602224|3690810|B2|||Age||years|Median|65.7|65.7|Standard Deviation|9.11|9.11|||
3865681|NCT01602224|3690811|B1|||Age||years|Median|63.2|63.2|Standard Deviation|11.01|11.01|||
3865682|NCT01602198|3690857|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3865683|NCT01602198|3690858|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3865684|NCT01602198|3690857|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865685|NCT01602198|3690858|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865686|NCT01602198|3690859|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865687|NCT01602198|3690857|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865688|NCT01602198|3690858|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865689|NCT01602198|3690859|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865690|NCT01602198|3690857|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3865691|NCT01602198|3690858|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3865692|NCT01602198|3690859|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865693|NCT01602198|3690857|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865694|NCT01602198|3690858|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865695|NCT01602198|3690859|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865696|NCT01602198|3690857|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865697|NCT01602198|3690858|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865698|NCT01602198|3690859|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865699|NCT01602198|3690857|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865700|NCT01602198|3690858|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865701|NCT01602198|3690859|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865702|NCT01602198|3690857|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865703|NCT01602198|3690858|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865704|NCT01602198|3690859|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865705|NCT01602198|3690857|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865706|NCT01602198|3690858|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865707|NCT01602198|3690859|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865708|NCT01602198|3690857|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3865709|NCT01602198|3690858|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3865710|NCT01602198|3690859|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865711|NCT01602198|3690857|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865712|NCT01602198|3690858|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865713|NCT01602198|3690859|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865714|NCT01602198|3690857|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3865715|NCT01602198|3690858|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3865716|NCT01602198|3690859|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3865717|NCT01602198|3690857|B3||Female|Gender||Participants|Count of Participants|1|1.0||||||
3865718|NCT01602198|3690858|B2||Female|Gender||Participants|Count of Participants|1|1.0||||||
3865719|NCT01602198|3690859|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3865720|NCT01602198|3690857|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3865721|NCT01602198|3690858|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3865722|NCT01602198|3690859|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3865723|NCT01602198|3690857|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3865724|NCT01602198|3690858|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3865725|NCT01602198|3690859|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3865726|NCT01602198|3690857|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3865727|NCT01602198|3690858|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3865728|NCT01602198|3690859|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3865729|NCT01602068|3690866|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
3865730|NCT01602068|3690867|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
3865731|NCT01602068|3690868|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
3865732|NCT01602068|3690866|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3865733|NCT01602068|3690867|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3865734|NCT01602068|3690868|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3865735|NCT01602068|3690866|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3865736|NCT01602068|3690867|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3865737|NCT01602068|3690868|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3865738|NCT01602068|3690866|B3|||Age||years|Mean|62|62.0|Full Range|||12.0|81.0|
3865739|NCT01602068|3690867|B2|||Age||years|Mean|65|65.0|Full Range|||50.0|80.0|
3865740|NCT01602068|3690868|B1|||Age||years|Mean|59|59.0|Full Range|||12.0|81.0|
3865741|NCT01601977|3690882|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3865742|NCT01601977|3690882|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3865743|NCT01601977|3690882|B1|||Age||years|Mean|63|63.0|Standard Deviation|8|8.0|||
3865744|NCT01601847|3690900|B3|||Total circulating 25(OH)D (ng/ml)||ng/ml|Median|20.2|20.2|Full Range|||10.0|71.0|
3865745|NCT01601847|3690901|B2|||Total circulating 25(OH)D (ng/ml)||ng/ml|Median|21.0|21.0|Full Range|||10.0|50.0|
3865746|NCT01601847|3690902|B1|||Total circulating 25(OH)D (ng/ml)||ng/ml|Median|19.1|19.1|Full Range|||10.0|71.0|
3865747|NCT01601847|3690900|B3|||Alkaline phosphatase (U/L)||U/L|Median|263|263.0|Full Range|||70.0|686.0|
3865748|NCT01601847|3690901|B2|||Alkaline phosphatase (U/L)||U/L|Median|257|257.0|Full Range|||70.0|563.0|
3865749|NCT01601847|3690902|B1|||Alkaline phosphatase (U/L)||U/L|Median|268|268.0|Full Range|||128.0|686.0|
3865750|NCT01601847|3690900|B3|||Phosphorus (mg/dl)||mg/dl|Median|7.0|7.0|Full Range|||3.5|8.9|
3865751|NCT01601847|3690901|B2|||Phosphorus (mg/dl)||mg/dl|Median|6.9|6.9|Full Range|||3.6|8.9|
3865752|NCT01601847|3690902|B1|||Phosphorus (mg/dl)||mg/dl|Median|7.0|7.0|Full Range|||3.5|8.9|
3865753|NCT01601847|3690900|B3|||Calcium (mg/dl)||mg/dl|Median|9.5|9.5|Full Range|||7.1|10.8|
3865754|NCT01601847|3690901|B2|||Calcium (mg/dl)||mg/dl|Median|9.5|9.5|Full Range|||7.1|10.7|
3865755|NCT01601847|3690902|B1|||Calcium (mg/dl)||mg/dl|Median|9.5|9.5|Full Range|||7.2|10.8|
3865756|NCT01601847|3690900|B3|||Discharge season (Oct-March)||Participants|Count of Participants|136|136.0||||||
3865757|NCT01601847|3690901|B2|||Discharge season (Oct-March)||Participants|Count of Participants|67|67.0||||||
3865758|NCT01601847|3690902|B1|||Discharge season (Oct-March)||Participants|Count of Participants|69|69.0||||||
3865759|NCT01601847|3690900|B3|||Receiving maternal breast milk at randomization||Participants|Count of Participants|211|211.0||||||
3865760|NCT01601847|3690901|B2|||Receiving maternal breast milk at randomization||Participants|Count of Participants|104|104.0||||||
3865761|NCT01601847|3690902|B1|||Receiving maternal breast milk at randomization||Participants|Count of Participants|107|107.0||||||
3865762|NCT01601847|3690900|B3|||History of oxygen administration||Participants|Count of Participants|119|119.0||||||
3865763|NCT01601847|3690901|B2|||History of oxygen administration||Participants|Count of Participants|53|53.0||||||
3865764|NCT01601847|3690902|B1|||History of oxygen administration||Participants|Count of Participants|66|66.0||||||
3865765|NCT01601847|3690900|B3|||History of ventilator support||Participants|Count of Participants|53|53.0||||||
3865766|NCT01601847|3690901|B2|||History of ventilator support||Participants|Count of Participants|26|26.0||||||
3865767|NCT01601847|3690902|B1|||History of ventilator support||Participants|Count of Participants|27|27.0||||||
3865768|NCT01601847|3690900|B3|||Antenatal steroids||Participants|Count of Participants|160|160.0||||||
3865769|NCT01601847|3690901|B2|||Antenatal steroids||Participants|Count of Participants|78|78.0||||||
3865770|NCT01601847|3690902|B1|||Antenatal steroids||Participants|Count of Participants|82|82.0||||||
3865771|NCT01601847|3690900|B3|||Multiple birth (twins and triplets)||Participants|Count of Participants|96|96.0||||||
3865772|NCT01601847|3690901|B2|||Multiple birth (twins and triplets)||Participants|Count of Participants|38|38.0||||||
3865773|NCT01601847|3690902|B1|||Multiple birth (twins and triplets)||Participants|Count of Participants|58|58.0||||||
3865774|NCT01601847|3690900|B3|||Birth weight||kg|Median|1.87|1.87|Full Range|||0.79|4.05|
3865775|NCT01601847|3690901|B2|||Birth weight||kg|Median|1.96|1.96|Full Range|||0.79|3.62|
3865776|NCT01601847|3690902|B1|||Birth weight||kg|Median|1.84|1.84|Full Range|||0.82|4.05|
3865777|NCT01601847|3690900|B3|||Gestational age at birth||weeks|Median|33.14|33.14|Full Range|||28.0|36.86|
3865778|NCT01601847|3690901|B2|||Gestational age at birth||weeks|Median|33.50|33.5|Full Range|||28.0|36.86|
3865779|NCT01601847|3690902|B1|||Gestational age at birth||weeks|Median|33.00|33.0|Full Range|||29.14|36.86|
3865780|NCT01601847|3690900|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865781|NCT01601847|3690901|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865782|NCT01601847|3690902|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865783|NCT01601847|3690900|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865784|NCT01601847|3690901|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865785|NCT01601847|3690902|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865786|NCT01601847|3690900|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865787|NCT01601847|3690901|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865788|NCT01601847|3690902|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865789|NCT01601847|3690900|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|300|300.0||||||
3865790|NCT01601847|3690901|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|147|147.0||||||
3865791|NCT01601847|3690902|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|153|153.0||||||
3865792|NCT01601847|3690900|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865793|NCT01601847|3690901|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865794|NCT01601847|3690902|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865795|NCT01601847|3690900|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865796|NCT01601847|3690901|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865797|NCT01601847|3690902|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865798|NCT01601847|3690900|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865799|NCT01601847|3690901|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865800|NCT01601847|3690902|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865801|NCT01601847|3690900|B3||Male|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3865802|NCT01601847|3690901|B2||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3865803|NCT01601847|3690902|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3865804|NCT01601847|3690900|B3||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3865805|NCT01601847|3690901|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3865806|NCT01601847|3690902|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3865807|NCT01601847|3690900|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3865808|NCT01601847|3690901|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3865809|NCT01601847|3690902|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3865810|NCT01601847|3690900|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3865811|NCT01601847|3690901|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3865812|NCT01601847|3690902|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3865813|NCT01601847|3690900|B3||<=18 years|Age||Participants|Count of Participants|300|300.0||||||
3865814|NCT01601847|3690901|B2||<=18 years|Age||Participants|Count of Participants|147|147.0||||||
3865815|NCT01601847|3690902|B1||<=18 years|Age||Participants|Count of Participants|153|153.0||||||
3865816|NCT01601821|3690913|B3||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3865817|NCT01601821|3690914|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3865818|NCT01601821|3690915|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3865819|NCT01601821|3690913|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3865820|NCT01601821|3690914|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3865821|NCT01601821|3690915|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3865822|NCT01601821|3690913|B3|||Age||years|Mean|39.9|39.9|Standard Deviation|14.3|14.3|||
3865823|NCT01601821|3690914|B2|||Age||years|Mean|41.6|41.6|Standard Deviation|15.1|15.1|||
3865824|NCT01601821|3690915|B1|||Age||years|Mean|38.2|38.2|Standard Deviation|13.4|13.4|||
3865825|NCT01601782|3690946|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3865826|NCT01601782|3690946|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3865827|NCT01601782|3690946|B1|||Age||years|Mean|25|25.0|Full Range|||18.0|65.0|
3865828|NCT01601704|3690950|B3|||Baseline Antidepressant Medication Use||Participants|Count of Participants|2057|2057.0||||||
3865829|NCT01601704|3690951|B2|||Baseline Antidepressant Medication Use||Participants|Count of Participants|1015|1015.0||||||
3865830|NCT01601704|3690952|B1|||Baseline Antidepressant Medication Use||Participants|Count of Participants|1042|1042.0||||||
3865831|NCT01601704|3690950|B3|No||History of Depression||Participants|Count of Participants|6879|6879.0||||||
3865832|NCT01601704|3690951|B2|No||History of Depression||Participants|Count of Participants|3455|3455.0||||||
3865833|NCT01601704|3690952|B1|No||History of Depression||Participants|Count of Participants|3424|3424.0||||||
3865834|NCT01601704|3690950|B3|Yes||History of Depression||Participants|Count of Participants|2026|2026.0||||||
3865835|NCT01601704|3690951|B2|Yes||History of Depression||Participants|Count of Participants|995|995.0||||||
3865836|NCT01601704|3690952|B1|Yes||History of Depression||Participants|Count of Participants|1031|1031.0||||||
3865837|NCT01601704|3690950|B3|No||Dyslipidemia||Participants|Count of Participants|735|735.0||||||
3865838|NCT01601704|3690951|B2|No||Dyslipidemia||Participants|Count of Participants|380|380.0||||||
3865839|NCT01601704|3690952|B1|No||Dyslipidemia||Participants|Count of Participants|355|355.0||||||
3865840|NCT01601704|3690950|B3|Yes||Dyslipidemia||Participants|Count of Participants|8170|8170.0||||||
3865841|NCT01601704|3690951|B2|Yes||Dyslipidemia||Participants|Count of Participants|4070|4070.0||||||
3865842|NCT01601704|3690952|B1|Yes||Dyslipidemia||Participants|Count of Participants|4100|4100.0||||||
3865843|NCT01601704|3690950|B3|No||Hypertension||Participants|Count of Participants|626|626.0||||||
3865844|NCT01601704|3690951|B2|No||Hypertension||Participants|Count of Participants|333|333.0||||||
3865845|NCT01601704|3690952|B1|No||Hypertension||Participants|Count of Participants|293|293.0||||||
3865846|NCT01601704|3690950|B3|Yes||Hypertension||Participants|Count of Participants|8279|8279.0||||||
3865847|NCT01601704|3690951|B2|Yes||Hypertension||Participants|Count of Participants|4117|4117.0||||||
3865848|NCT01601704|3690952|B1|Yes||Hypertension||Participants|Count of Participants|4162|4162.0||||||
3865849|NCT01601704|3690950|B3|T2DM without CV disease||Cardiovascular (CV) risk group||Participants|Count of Participants|6041|6041.0||||||
3865850|NCT01601704|3690951|B2|T2DM without CV disease||Cardiovascular (CV) risk group||Participants|Count of Participants|3002|3002.0||||||
3865851|NCT01601704|3690952|B1|T2DM without CV disease||Cardiovascular (CV) risk group||Participants|Count of Participants|3039|3039.0||||||
3865852|NCT01601704|3690950|B3|CV disease with T2DM||Cardiovascular (CV) risk group||Participants|Count of Participants|1546|1546.0||||||
3865853|NCT01601704|3690951|B2|CV disease with T2DM||Cardiovascular (CV) risk group||Participants|Count of Participants|801|801.0||||||
3865854|NCT01601704|3690952|B1|CV disease with T2DM||Cardiovascular (CV) risk group||Participants|Count of Participants|745|745.0||||||
3865855|NCT01601704|3690950|B3|CV disease without T2DM (type 2 diabetes mellitus)||Cardiovascular (CV) risk group||Participants|Count of Participants|1316|1316.0||||||
3865856|NCT01601704|3690951|B2|CV disease without T2DM (type 2 diabetes mellitus)||Cardiovascular (CV) risk group||Participants|Count of Participants|646|646.0||||||
3865911|NCT01601704|3690952|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2973|2973.0||||||
3865857|NCT01601704|3690952|B1|CV disease without T2DM (type 2 diabetes mellitus)||Cardiovascular (CV) risk group||Participants|Count of Participants|670|670.0||||||
3865858|NCT01601704|3690950|B3|||Body Mass Index (BMI)||kg/m^2|Mean|37.3|37.3|Standard Deviation|5.35|5.35|||
3865859|NCT01601704|3690951|B2|||Body Mass Index (BMI)||kg/m^2|Mean|37.4|37.4|Standard Deviation|5.44|5.44|||
3865860|NCT01601704|3690952|B1|||Body Mass Index (BMI)||kg/m^2|Mean|37.2|37.2|Standard Deviation|5.26|5.26|||
3865861|NCT01601704|3690950|B3|||Weight||kilogram|Mean|106.0|106.0|Standard Deviation|19.14|19.14|||
3865862|NCT01601704|3690951|B2|||Weight||kilogram|Mean|106.3|106.3|Standard Deviation|19.18|19.18|||
3865863|NCT01601704|3690952|B1|||Weight||kilogram|Mean|105.6|105.6|Standard Deviation|19.09|19.09|||
3865864|NCT01601704|3690950|B3|United States||Region of Enrollment||Participants|Count of Participants|8905|8905.0||||||
3865865|NCT01601704|3690951|B2|United States||Region of Enrollment||Participants|Count of Participants|4450|4450.0||||||
3865866|NCT01601704|3690952|B1|United States||Region of Enrollment||Participants|Count of Participants|4455|4455.0||||||
3865867|NCT01601704|3690950|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
3865868|NCT01601704|3690951|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3865869|NCT01601704|3690952|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3865870|NCT01601704|3690950|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3865871|NCT01601704|3690951|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Selection of multiple race categories was not permissible by the participants. Participants advised to select the most appropriate category.
3865872|NCT01601704|3690952|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Selection of multiple race categories was not permissible by the participants. Participants advised to select the most appropriate category.
3865873|NCT01601704|3690950|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7436|7436.0||||||
3865874|NCT01601704|3690951|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3698|3698.0||||||
3865875|NCT01601704|3690952|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3738|3738.0||||||
3865876|NCT01601704|3690950|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1304|1304.0||||||
3865877|NCT01601704|3690951|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|648|648.0||||||
3865878|NCT01601704|3690952|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|656|656.0||||||
3865879|NCT01601704|3690950|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3865880|NCT01601704|3690951|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3865881|NCT01601704|3690952|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3865882|NCT01601704|3690950|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3865883|NCT01601704|3690951|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3865884|NCT01601704|3690952|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3865885|NCT01601704|3690950|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3865886|NCT01601704|3690951|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3865887|NCT01601704|3690952|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3865888|NCT01601704|3690950|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3865889|NCT01601704|3690951|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3865890|NCT01601704|3690952|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3865891|NCT01601704|3690950|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8330|8330.0||||||
3865892|NCT01601704|3690951|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4156|4156.0||||||
3865893|NCT01601704|3690952|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4174|4174.0||||||
3865894|NCT01601704|3690950|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|570|570.0||||||
3865895|NCT01601704|3690951|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|291|291.0||||||
3865896|NCT01601704|3690952|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|279|279.0||||||
3865897|NCT01601704|3690950|B3||Male|Sex: Female, Male||Participants|Count of Participants|4049|4049.0||||||
3865898|NCT01601704|3690951|B2||Male|Sex: Female, Male||Participants|Count of Participants|2031|2031.0||||||
3865899|NCT01601704|3690952|B1||Male|Sex: Female, Male||Participants|Count of Participants|2018|2018.0||||||
3865900|NCT01601704|3690950|B3||Female|Sex: Female, Male||Participants|Count of Participants|4856|4856.0||||||
3865901|NCT01601704|3690951|B2||Female|Sex: Female, Male||Participants|Count of Participants|2419|2419.0||||||
3865902|NCT01601704|3690952|B1||Female|Sex: Female, Male||Participants|Count of Participants|2437|2437.0||||||
3865903|NCT01601704|3690950|B3|||Age||years|Mean|61.0|61.0|Standard Deviation|7.33|7.33|||
3865904|NCT01601704|3690951|B2|||Age||years|Mean|60.9|60.9|Standard Deviation|7.38|7.38|||
3865905|NCT01601704|3690952|B1|||Age||years|Mean|61.1|61.1|Standard Deviation|7.27|7.27|||
3865906|NCT01601704|3690950|B3||>=65 years|Age||Participants|Count of Participants|2879|2879.0||||||
3865907|NCT01601704|3690951|B2||>=65 years|Age||Participants|Count of Participants|1397|1397.0||||||
3865908|NCT01601704|3690952|B1||>=65 years|Age||Participants|Count of Participants|1482|1482.0||||||
3865909|NCT01601704|3690950|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6026|6026.0||||||
3865910|NCT01601704|3690951|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3053|3053.0||||||
3865912|NCT01601704|3690950|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3865913|NCT01601704|3690951|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3865914|NCT01601704|3690952|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3865915|NCT01601691|3690967|B1|Finland||Region of Enrollment||participants|Number|10|10.0||||||
3865916|NCT01601691|3690967|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865917|NCT01601691|3690967|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865918|NCT01601691|3690967|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3865919|NCT01601691|3690967|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865920|NCT01601691|3690967|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865921|NCT01601691|3690967|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865922|NCT01601691|3690967|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3865923|NCT01601691|3690967|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3865924|NCT01601691|3690967|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3865925|NCT01601691|3690967|B1|||Age||year|Mean|66|66.0|Full Range|||58.0|76.0|
3865926|NCT01601626|3690971|B4|||Body Mass Index (BMI)||kg/m^2|Median|19.6|19.6|Inter-Quartile Range|||17.9|21.5|
3865927|NCT01601626|3690972|B3|||Body Mass Index (BMI)||kg/m^2|Median|18.9|18.9|Inter-Quartile Range|||17.9|21.5|
3865928|NCT01601626|3690973|B2|||Body Mass Index (BMI)||kg/m^2|Median|20.4|20.4|Inter-Quartile Range|||17.9|21.5|
3865929|NCT01601626|3690974|B1|||Body Mass Index (BMI)||kg/m^2|Median|19.9|19.9|Inter-Quartile Range|||18.3|22.1|
3865930|NCT01601626|3690971|B4||No Results Available|Mycobacteria Tuberculosis (MTB) Culture||Participants|Count of Participants|9|9.0||||||
3865931|NCT01601626|3690972|B3||No Results Available|Mycobacteria Tuberculosis (MTB) Culture||Participants|Count of Participants|1|1.0||||||
3865932|NCT01601626|3690973|B2||No Results Available|Mycobacteria Tuberculosis (MTB) Culture||Participants|Count of Participants|3|3.0||||||
3865933|NCT01601626|3690974|B1||No Results Available|Mycobacteria Tuberculosis (MTB) Culture||Participants|Count of Participants|5|5.0||||||
3865934|NCT01601626|3690971|B4||MTB-Negative|Mycobacteria Tuberculosis (MTB) Culture||Participants|Count of Participants|32|32.0||||||
3865935|NCT01601626|3690972|B3||MTB-Negative|Mycobacteria Tuberculosis (MTB) Culture||Participants|Count of Participants|13|13.0||||||
3865936|NCT01601626|3690973|B2||MTB-Negative|Mycobacteria Tuberculosis (MTB) Culture||Participants|Count of Participants|13|13.0||||||
3865937|NCT01601626|3690974|B1||MTB-Negative|Mycobacteria Tuberculosis (MTB) Culture||Participants|Count of Participants|6|6.0||||||
3865938|NCT01601626|3690971|B4||MTB-Positive|Mycobacteria Tuberculosis (MTB) Culture||Participants|Count of Participants|30|30.0||||||
3865939|NCT01601626|3690972|B3||MTB-Positive|Mycobacteria Tuberculosis (MTB) Culture||Participants|Count of Participants|9|9.0||||||
3865940|NCT01601626|3690973|B2||MTB-Positive|Mycobacteria Tuberculosis (MTB) Culture||Participants|Count of Participants|8|8.0||||||
3865941|NCT01601626|3690974|B1||MTB-Positive|Mycobacteria Tuberculosis (MTB) Culture||Participants|Count of Participants|13|13.0||||||
3865942|NCT01601626|3690971|B4||No Results Available|Acid Fast Bacilli (AFB) Smear||Participants|Count of Participants|6|6.0||||||
3865943|NCT01601626|3690972|B3||No Results Available|Acid Fast Bacilli (AFB) Smear||Participants|Count of Participants|1|1.0||||||
3865944|NCT01601626|3690973|B2||No Results Available|Acid Fast Bacilli (AFB) Smear||Participants|Count of Participants|2|2.0||||||
3865945|NCT01601626|3690974|B1||No Results Available|Acid Fast Bacilli (AFB) Smear||Participants|Count of Participants|3|3.0||||||
3865946|NCT01601626|3690971|B4||Negative|Acid Fast Bacilli (AFB) Smear||Participants|Count of Participants|40|40.0||||||
3865947|NCT01601626|3690972|B3||Negative|Acid Fast Bacilli (AFB) Smear||Participants|Count of Participants|16|16.0||||||
3865948|NCT01601626|3690973|B2||Negative|Acid Fast Bacilli (AFB) Smear||Participants|Count of Participants|14|14.0||||||
3865949|NCT01601626|3690974|B1||Negative|Acid Fast Bacilli (AFB) Smear||Participants|Count of Participants|10|10.0||||||
3865950|NCT01601626|3690971|B4||Positive|Acid Fast Bacilli (AFB) Smear||Participants|Count of Participants|25|25.0||||||
3865951|NCT01601626|3690972|B3||Positive|Acid Fast Bacilli (AFB) Smear||Participants|Count of Participants|6|6.0||||||
3865952|NCT01601626|3690973|B2||Positive|Acid Fast Bacilli (AFB) Smear||Participants|Count of Participants|8|8.0||||||
3865953|NCT01601626|3690974|B1||Positive|Acid Fast Bacilli (AFB) Smear||Participants|Count of Participants|11|11.0||||||
3865954|NCT01601626|3690971|B4||Probable Extrapulmonary TB|Tuberculosis (TB) Diagnosis Certainty|The protocol document contains the definitions of confirmed and probable for pulmonary and extrapulmonary TB in section 4.1.3.|Participants|Count of Participants|1|1.0||||||
3865955|NCT01601626|3690972|B3||Probable Extrapulmonary TB|Tuberculosis (TB) Diagnosis Certainty|The protocol document contains the definitions of confirmed and probable for pulmonary and extrapulmonary TB in section 4.1.3.|Participants|Count of Participants|1|1.0||||||
3865956|NCT01601626|3690973|B2||Probable Extrapulmonary TB|Tuberculosis (TB) Diagnosis Certainty|The protocol document contains the definitions of confirmed and probable for pulmonary and extrapulmonary TB in section 4.1.3.|Participants|Count of Participants|0|0.0||||||
3865957|NCT01601626|3690974|B1||Probable Extrapulmonary TB|Tuberculosis (TB) Diagnosis Certainty|The protocol document contains the definitions of confirmed and probable for pulmonary and extrapulmonary TB in section 4.1.3.|Participants|Count of Participants|0|0.0||||||
3865958|NCT01601626|3690971|B4||Probable Pulmonary TB|Tuberculosis (TB) Diagnosis Certainty|The protocol document contains the definitions of confirmed and probable for pulmonary and extrapulmonary TB in section 4.1.3.|Participants|Count of Participants|37|37.0||||||
3865959|NCT01601626|3690972|B3||Probable Pulmonary TB|Tuberculosis (TB) Diagnosis Certainty|The protocol document contains the definitions of confirmed and probable for pulmonary and extrapulmonary TB in section 4.1.3.|Participants|Count of Participants|13|13.0||||||
3865960|NCT01601626|3690973|B2||Probable Pulmonary TB|Tuberculosis (TB) Diagnosis Certainty|The protocol document contains the definitions of confirmed and probable for pulmonary and extrapulmonary TB in section 4.1.3.|Participants|Count of Participants|15|15.0||||||
3865961|NCT01601626|3690974|B1||Probable Pulmonary TB|Tuberculosis (TB) Diagnosis Certainty|The protocol document contains the definitions of confirmed and probable for pulmonary and extrapulmonary TB in section 4.1.3.|Participants|Count of Participants|9|9.0||||||
3865962|NCT01601626|3690971|B4||Confirmed Pulmonary and Extrapulmonary TB|Tuberculosis (TB) Diagnosis Certainty|The protocol document contains the definitions of confirmed and probable for pulmonary and extrapulmonary TB in section 4.1.3.|Participants|Count of Participants|1|1.0||||||
3865963|NCT01601626|3690972|B3||Confirmed Pulmonary and Extrapulmonary TB|Tuberculosis (TB) Diagnosis Certainty|The protocol document contains the definitions of confirmed and probable for pulmonary and extrapulmonary TB in section 4.1.3.|Participants|Count of Participants|0|0.0||||||
3865964|NCT01601626|3690973|B2||Confirmed Pulmonary and Extrapulmonary TB|Tuberculosis (TB) Diagnosis Certainty|The protocol document contains the definitions of confirmed and probable for pulmonary and extrapulmonary TB in section 4.1.3.|Participants|Count of Participants|0|0.0||||||
3865965|NCT01601626|3690974|B1||Confirmed Pulmonary and Extrapulmonary TB|Tuberculosis (TB) Diagnosis Certainty|The protocol document contains the definitions of confirmed and probable for pulmonary and extrapulmonary TB in section 4.1.3.|Participants|Count of Participants|1|1.0||||||
3865966|NCT01601626|3690971|B4||Confirmed Extrapulmonary TB|Tuberculosis (TB) Diagnosis Certainty|The protocol document contains the definitions of confirmed and probable for pulmonary and extrapulmonary TB in section 4.1.3.|Participants|Count of Participants|5|5.0||||||
3865967|NCT01601626|3690972|B3||Confirmed Extrapulmonary TB|Tuberculosis (TB) Diagnosis Certainty|The protocol document contains the definitions of confirmed and probable for pulmonary and extrapulmonary TB in section 4.1.3.|Participants|Count of Participants|3|3.0||||||
3865968|NCT01601626|3690973|B2||Confirmed Extrapulmonary TB|Tuberculosis (TB) Diagnosis Certainty|The protocol document contains the definitions of confirmed and probable for pulmonary and extrapulmonary TB in section 4.1.3.|Participants|Count of Participants|1|1.0||||||
3865969|NCT01601626|3690974|B1||Confirmed Extrapulmonary TB|Tuberculosis (TB) Diagnosis Certainty|The protocol document contains the definitions of confirmed and probable for pulmonary and extrapulmonary TB in section 4.1.3.|Participants|Count of Participants|1|1.0||||||
3865970|NCT01601626|3690971|B4||Confirmed Pulmonary TB|Tuberculosis (TB) Diagnosis Certainty|The protocol document contains the definitions of confirmed and probable for pulmonary and extrapulmonary TB in section 4.1.3.|Participants|Count of Participants|27|27.0||||||
3865971|NCT01601626|3690972|B3||Confirmed Pulmonary TB|Tuberculosis (TB) Diagnosis Certainty|The protocol document contains the definitions of confirmed and probable for pulmonary and extrapulmonary TB in section 4.1.3.|Participants|Count of Participants|6|6.0||||||
3865972|NCT01601626|3690973|B2||Confirmed Pulmonary TB|Tuberculosis (TB) Diagnosis Certainty|The protocol document contains the definitions of confirmed and probable for pulmonary and extrapulmonary TB in section 4.1.3.|Participants|Count of Participants|8|8.0||||||
3865973|NCT01601626|3690974|B1||Confirmed Pulmonary TB|Tuberculosis (TB) Diagnosis Certainty|The protocol document contains the definitions of confirmed and probable for pulmonary and extrapulmonary TB in section 4.1.3.|Participants|Count of Participants|13|13.0||||||
3865974|NCT01601626|3690971|B4|||CD4 Cell Count||cells/mm^3|Median|130|130.0|Inter-Quartile Range|||55.0|231.0|
3865975|NCT01601626|3690972|B3|||CD4 Cell Count||cells/mm^3|Median|158|158.0|Inter-Quartile Range|||73.0|202.0|
3865976|NCT01601626|3690973|B2|||CD4 Cell Count||cells/mm^3|Median|117|117.0|Inter-Quartile Range|||51.0|246.0|
3865977|NCT01601626|3690974|B1|||CD4 Cell Count||cells/mm^3|Median|128|128.0|Inter-Quartile Range|||60.0|234.0|
3865978|NCT01601626|3690971|B4|||Quantitative HIV RNA|The lower limit of quantification of the HIV RNA assay used in the protocol was 40 copies/mL.|log10 copies/mL|Median|4.6|4.6|Inter-Quartile Range|||3.5|5.3|
3865979|NCT01601626|3690972|B3|||Quantitative HIV RNA|The lower limit of quantification of the HIV RNA assay used in the protocol was 40 copies/mL.|log10 copies/mL|Median|4.2|4.2|Inter-Quartile Range|||3.2|5.0|
3865980|NCT01601626|3690973|B2|||Quantitative HIV RNA|The lower limit of quantification of the HIV RNA assay used in the protocol was 40 copies/mL.|log10 copies/mL|Median|4.8|4.8|Inter-Quartile Range|||4.2|5.3|
3865981|NCT01601626|3690974|B1|||Quantitative HIV RNA|The lower limit of quantification of the HIV RNA assay used in the protocol was 40 copies/mL.|log10 copies/mL|Median|4.7|4.7|Inter-Quartile Range|||3.4|5.6|
3865982|NCT01601626|3690971|B4||Greater than or equal to 40 copies/mL|Qualitative HIV RNA|The lower limit of quantification of the HIV RNA assay used in the protocol was 40 copies/mL.|Participants|Count of Participants|62|62.0||||||
3865983|NCT01601626|3690972|B3||Greater than or equal to 40 copies/mL|Qualitative HIV RNA|The lower limit of quantification of the HIV RNA assay used in the protocol was 40 copies/mL.|Participants|Count of Participants|20|20.0||||||
3865984|NCT01601626|3690973|B2||Greater than or equal to 40 copies/mL|Qualitative HIV RNA|The lower limit of quantification of the HIV RNA assay used in the protocol was 40 copies/mL.|Participants|Count of Participants|22|22.0||||||
3865985|NCT01601626|3690974|B1||Greater than or equal to 40 copies/mL|Qualitative HIV RNA|The lower limit of quantification of the HIV RNA assay used in the protocol was 40 copies/mL.|Participants|Count of Participants|20|20.0||||||
3865986|NCT01601626|3690971|B4||Less than 40 copies/mL|Qualitative HIV RNA|The lower limit of quantification of the HIV RNA assay used in the protocol was 40 copies/mL.|Participants|Count of Participants|9|9.0||||||
3865987|NCT01601626|3690972|B3||Less than 40 copies/mL|Qualitative HIV RNA|The lower limit of quantification of the HIV RNA assay used in the protocol was 40 copies/mL.|Participants|Count of Participants|3|3.0||||||
3865988|NCT01601626|3690973|B2||Less than 40 copies/mL|Qualitative HIV RNA|The lower limit of quantification of the HIV RNA assay used in the protocol was 40 copies/mL.|Participants|Count of Participants|2|2.0||||||
3865989|NCT01601626|3690974|B1||Less than 40 copies/mL|Qualitative HIV RNA|The lower limit of quantification of the HIV RNA assay used in the protocol was 40 copies/mL.|Participants|Count of Participants|4|4.0||||||
3865990|NCT01601626|3690971|B4|Peru||Region of Enrollment||participants|Number|6|6.0||||||
3865991|NCT01601626|3690972|B3|Peru||Region of Enrollment||participants|Number|2|2.0||||||
3865992|NCT01601626|3690973|B2|Peru||Region of Enrollment||participants|Number|2|2.0||||||
3865993|NCT01601626|3690974|B1|Peru||Region of Enrollment||participants|Number|2|2.0||||||
3865994|NCT01601626|3690971|B4|Kenya||Region of Enrollment||participants|Number|9|9.0||||||
3865995|NCT01601626|3690972|B3|Kenya||Region of Enrollment||participants|Number|2|2.0||||||
3865996|NCT01601626|3690973|B2|Kenya||Region of Enrollment||participants|Number|3|3.0||||||
3865997|NCT01601626|3690974|B1|Kenya||Region of Enrollment||participants|Number|4|4.0||||||
3865998|NCT01601626|3690971|B4|South Africa||Region of Enrollment||participants|Number|10|10.0||||||
3865999|NCT01601626|3690972|B3|South Africa||Region of Enrollment||participants|Number|3|3.0||||||
3866000|NCT01601626|3690973|B2|South Africa||Region of Enrollment||participants|Number|3|3.0||||||
3866001|NCT01601626|3690974|B1|South Africa||Region of Enrollment||participants|Number|4|4.0||||||
3866002|NCT01601626|3690971|B4|Brazil||Region of Enrollment||participants|Number|28|28.0||||||
3866003|NCT01601626|3690972|B3|Brazil||Region of Enrollment||participants|Number|10|10.0||||||
3866004|NCT01601626|3690973|B2|Brazil||Region of Enrollment||participants|Number|10|10.0||||||
3866005|NCT01601626|3690974|B1|Brazil||Region of Enrollment||participants|Number|8|8.0||||||
3866006|NCT01601626|3690971|B4|Haiti||Region of Enrollment||participants|Number|18|18.0||||||
3866007|NCT01601626|3690972|B3|Haiti||Region of Enrollment||participants|Number|6|6.0||||||
3866008|NCT01601626|3690973|B2|Haiti||Region of Enrollment||participants|Number|6|6.0||||||
3866009|NCT01601626|3690974|B1|Haiti||Region of Enrollment||participants|Number|6|6.0||||||
3866010|NCT01601626|3690971|B4||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3866011|NCT01601626|3690972|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3866012|NCT01601626|3690973|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3866013|NCT01601626|3690974|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3866014|NCT01601626|3690971|B4||Mixed, of Predominantly African Ancestry|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3866015|NCT01601626|3690972|B3||Mixed, of Predominantly African Ancestry|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3866016|NCT01601626|3690973|B2||Mixed, of Predominantly African Ancestry|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3866017|NCT01601626|3690974|B1||Mixed, of Predominantly African Ancestry|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3866018|NCT01601626|3690971|B4||Mestizo|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3866019|NCT01601626|3690972|B3||Mestizo|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3866020|NCT01601626|3690973|B2||Mestizo|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3866021|NCT01601626|3690974|B1||Mestizo|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3866022|NCT01601626|3690971|B4||Mixed Black|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3866023|NCT01601626|3690972|B3||Mixed Black|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3866024|NCT01601626|3690973|B2||Mixed Black|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3866025|NCT01601626|3690974|B1||Mixed Black|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3866026|NCT01601626|3690971|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3866027|NCT01601626|3690972|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3866028|NCT01601626|3690973|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3866029|NCT01601626|3690974|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3866030|NCT01601626|3690971|B4||Black African|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3866031|NCT01601626|3690972|B3||Black African|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3866032|NCT01601626|3690973|B2||Black African|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3866033|NCT01601626|3690974|B1||Black African|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3866034|NCT01601626|3690971|B4||Black of African Origin|Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3866035|NCT01601626|3690972|B3||Black of African Origin|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3866036|NCT01601626|3690973|B2||Black of African Origin|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3866037|NCT01601626|3690974|B1||Black of African Origin|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3866038|NCT01601626|3690971|B4||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3866039|NCT01601626|3690972|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3866040|NCT01601626|3690973|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3866041|NCT01601626|3690974|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3866042|NCT01601626|3690971|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3866043|NCT01601626|3690972|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3866044|NCT01601626|3690973|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3866045|NCT01601626|3690974|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3866046|NCT01601626|3690971|B4|||Age||years|Median|37|37.0|Inter-Quartile Range|||32.0|46.0|
3866047|NCT01601626|3690972|B3|||Age||years|Median|38|38.0|Inter-Quartile Range|||32.0|47.0|
3866048|NCT01601626|3690973|B2|||Age||years|Median|35|35.0|Inter-Quartile Range|||29.0|41.0|
3866049|NCT01601626|3690974|B1|||Age||years|Median|42|42.0|Inter-Quartile Range|||33.0|49.0|
3866050|NCT01601470|3691059|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3866051|NCT01601470|3691059|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3866052|NCT01601470|3691059|B1|||Age||Years|Mean|51.8|51.8|Standard Deviation|8.5|8.5|||
3866053|NCT01601431|3691074|B3|||Advanced adenoma detection rate||Participants|Count of Participants|31|31.0||||||
3866054|NCT01601431|3691075|B2|||Advanced adenoma detection rate||Participants|Count of Participants|10|10.0||||||
3866055|NCT01601431|3691076|B1|||Advanced adenoma detection rate||Participants|Count of Participants|21|21.0||||||
3866056|NCT01601431|3691074|B3|||Polyp detection rate||Participants|Count of Participants|179|179.0||||||
3866057|NCT01601431|3691075|B2|||Polyp detection rate||Participants|Count of Participants|92|92.0||||||
3866058|NCT01601431|3691076|B1|||Polyp detection rate||Participants|Count of Participants|87|87.0||||||
3866059|NCT01601431|3691074|B3|||Adenoma Detection Rate||Participants|Count of Participants|135|135.0||||||
3866060|NCT01601431|3691075|B2|||Adenoma Detection Rate||Participants|Count of Participants|69|69.0||||||
3866061|NCT01601431|3691076|B1|||Adenoma Detection Rate||Participants|Count of Participants|66|66.0||||||
3866062|NCT01601431|3691074|B3||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3866063|NCT01601431|3691075|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3866064|NCT01601431|3691076|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3866065|NCT01601431|3691074|B3||Female|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
3866066|NCT01601431|3691075|B2||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3866067|NCT01601431|3691076|B1||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3866068|NCT01601431|3691074|B3|||Age||years|Mean|60|60.0|Standard Deviation|7|7.0|||
3866069|NCT01601431|3691075|B2|||Age||years|Mean|60.08|60.08|Standard Deviation|7.26|7.26|||
3866070|NCT01601431|3691076|B1|||Age||years|Mean|59.48|59.48|Standard Deviation|7.28|7.28|||
3866071|NCT01601431|3691074|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3866072|NCT01601431|3691075|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3866073|NCT01601431|3691076|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3866074|NCT01601431|3691074|B3||Between 18 and 65 years|Age||Participants|Count of Participants|432|432.0||||||
3866075|NCT01601431|3691075|B2||Between 18 and 65 years|Age||Participants|Count of Participants|212|212.0||||||
3866076|NCT01601431|3691076|B1||Between 18 and 65 years|Age||Participants|Count of Participants|220|220.0||||||
3866077|NCT01601431|3691074|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3866078|NCT01601431|3691075|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3866079|NCT01601431|3691076|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3866080|NCT01601236|3691083|B7|United States||Region of Enrollment||participants|Number|34|34.0||||||
3866081|NCT01601236|3691084|B6|United States||Region of Enrollment||participants|Number|1|1.0||||||
3866082|NCT01601236|3691085|B5|United States||Region of Enrollment||participants|Number|3|3.0||||||
3866083|NCT01601236|3691086|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
3866084|NCT01601236|3691087|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
3866085|NCT01601236|3691088|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3866086|NCT01601236|3691089|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3866087|NCT01601236|3691083|B7||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3866088|NCT01601236|3691084|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3866089|NCT01601236|3691085|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3866090|NCT01601236|3691086|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3866091|NCT01601236|3691087|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3866092|NCT01601236|3691088|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3866093|NCT01601236|3691089|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3866094|NCT01601236|3691083|B7||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3866095|NCT01601236|3691084|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3866096|NCT01601236|3691085|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3866097|NCT01601236|3691086|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3866098|NCT01601236|3691087|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3866099|NCT01601236|3691088|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3866100|NCT01601236|3691089|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3866101|NCT01601236|3691083|B7||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3866102|NCT01601236|3691084|B6||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3866103|NCT01601236|3691085|B5||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3866104|NCT01601236|3691086|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3866105|NCT01601236|3691087|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3866106|NCT01601236|3691088|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3866107|NCT01601236|3691089|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3866108|NCT01601236|3691083|B7||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3866109|NCT01601236|3691084|B6||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3866110|NCT01601236|3691085|B5||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3866111|NCT01601236|3691086|B4||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3866112|NCT01601236|3691087|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3866113|NCT01601236|3691088|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3866114|NCT01601236|3691089|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3866115|NCT01601236|3691083|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3866116|NCT01601236|3691084|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3866117|NCT01601236|3691085|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3866118|NCT01601236|3691086|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3866119|NCT01601236|3691087|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3866120|NCT01601236|3691088|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3866121|NCT01601236|3691089|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3866122|NCT01601132|3691130|B1|Past smoker or has used other forms of tobacco||Tobacco history||Participants|Number|4|4.0||||||
3866123|NCT01601132|3691130|B1|Never used tobacco||Tobacco history||Participants|Number|26|26.0||||||
3866124|NCT01601132|3691130|B1|United States||Region of Enrollment||Participants|Number|30|30.0||||||
3866125|NCT01601132|3691130|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3866126|NCT01601132|3691130|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
3866127|NCT01601132|3691130|B1|White||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
3866128|NCT01601132|3691130|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3866129|NCT01601132|3691130|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3866130|NCT01601132|3691130|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3866131|NCT01601132|3691130|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3866132|NCT01601132|3691130|B1|||Age||Years|Mean|31.8|31.8|Standard Deviation|7.8|7.8|||
3866133|NCT01600950|3691147|B1|Germany||Region of Enrollment||participants|Number|20|20.0||||||
3866134|NCT01600950|3691147|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866135|NCT01600950|3691147|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866136|NCT01600950|3691147|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3866137|NCT01600950|3691147|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866138|NCT01600950|3691147|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866139|NCT01600950|3691147|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866140|NCT01600950|3691147|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866141|NCT01600950|3691147|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3866142|NCT01600950|3691147|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3866143|NCT01600950|3691147|B1|||Age||years|Mean|41.5|41.5|Standard Deviation|9.1|9.1|||
3866144|NCT01600885|3691164|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3866145|NCT01600885|3691164|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866146|NCT01600885|3691164|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3866147|NCT01600885|3691164|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3866148|NCT01600885|3691164|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866149|NCT01600885|3691164|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3866150|NCT01600885|3691164|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866151|NCT01600885|3691164|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866152|NCT01600885|3691164|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3866153|NCT01600885|3691164|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3866154|NCT01600885|3691164|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3866155|NCT01600885|3691164|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3866156|NCT01600885|3691164|B1|||Age||years|Mean|30|30.0|Standard Deviation|6.4|6.4|||
3866157|NCT01600729|3691175|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3866158|NCT01600729|3691175|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3866159|NCT01600729|3691175|B1|||Age||Years|Median|52.5|52.5|Full Range|||20.0|64.0|
3866160|NCT01600716|3691180|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3866161|NCT01600716|3691181|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3866162|NCT01600716|3691182|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3866163|NCT01600716|3691180|B3||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3866164|NCT01600716|3691181|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3866165|NCT01600716|3691182|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3866166|NCT01600716|3691180|B3|≥65 years||Age, Customized||Participants|Number|11|11.0||||||
3866167|NCT01600716|3691181|B2|≥65 years||Age, Customized||Participants|Number|7|7.0||||||
3866168|NCT01600716|3691182|B1|≥65 years||Age, Customized||Participants|Number|4|4.0||||||
3866169|NCT01600716|3691180|B3|<65 years||Age, Customized||Participants|Number|133|133.0||||||
3866170|NCT01600716|3691181|B2|<65 years||Age, Customized||Participants|Number|71|71.0||||||
3866171|NCT01600716|3691182|B1|<65 years||Age, Customized||Participants|Number|62|62.0||||||
3866172|NCT01600703|3691199|B1|||Triglyceride Levels||mmol/l|Mean|1.2|1.2|Standard Deviation|0.2|0.2|||
3866173|NCT01600703|3691199|B1|||Glucose Levels||mmol/l|Mean|4.9|4.9|Standard Deviation|0.1|0.1|||
3866174|NCT01600703|3691199|B1|||Body mass index||kg/m^2|Mean|24.6|24.6|Standard Deviation|0.6|0.6|||
3866175|NCT01600703|3691199|B1|Canada||Region of Enrollment||participants|Number|15|15.0||||||
3866176|NCT01600703|3691199|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3866177|NCT01600703|3691199|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3866178|NCT01600703|3691199|B1|||Age||years|Mean|42.3|42.3|Standard Deviation|2.6|2.6|||
3866179|NCT01600677|3691208|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3866180|NCT01600677|3691209|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3866181|NCT01600677|3691210|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3866182|NCT01600677|3691208|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3866183|NCT01600677|3691209|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3866184|NCT01600677|3691210|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3866185|NCT01600677|3691208|B3|||Age||Years|Mean|68.0|68.0|Standard Deviation|13.2|13.2|||
3866186|NCT01600677|3691209|B2|||Age||Years|Mean|71.1|71.1|Standard Deviation|13.5|13.5|||
3866187|NCT01600677|3691210|B1|||Age||Years|Mean|62.5|62.5|Standard Deviation|12.4|12.4|||
3866188|NCT01600586|3691221|B3|||No. of oral feedings/d at study start||feedings per day|Median|2|2.0|Full Range|||1.0|8.0|
3866189|NCT01600586|3691222|B2|||No. of oral feedings/d at study start||feedings per day|Median|2|2.0|Full Range|||1.0|8.0|
3866190|NCT01600586|3691223|B1|||No. of oral feedings/d at study start||feedings per day|Median|2|2.0|Full Range|||1.0|8.0|
3866191|NCT01600586|3691221|B3|||Feeding rate at study start||ml/min|Mean|0.6|0.6|Inter-Quartile Range|||0.25|0.8|
3866192|NCT01600586|3691222|B2|||Feeding rate at study start||ml/min|Mean|0.6|0.6|Inter-Quartile Range|||0.1|0.8|
3866193|NCT01600586|3691223|B1|||Feeding rate at study start||ml/min|Mean|0.6|0.6|Inter-Quartile Range|||0.4|0.8|
3866194|NCT01600586|3691221|B3|||White matter injury|White matter injury information was derived from the medical record, as approved by the Ethics board.|number of participants|Number|16|16.0||||||
3866195|NCT01600586|3691222|B2|||White matter injury|White matter injury information was derived from the medical record, as approved by the Ethics board.|number of participants|Number|9|9.0||||||
3866196|NCT01600586|3691223|B1|||White matter injury|White matter injury information was derived from the medical record, as approved by the Ethics board.|number of participants|Number|7|7.0||||||
3866197|NCT01600586|3691221|B3|||Birth weight, g, median||grams|Median|1450|1450.0|Inter-Quartile Range|||1100.0|1712.0|
3866198|NCT01600586|3691222|B2|||Birth weight, g, median||grams|Median|1405|1405.0|Inter-Quartile Range|||1057.0|1684.0|
3866199|NCT01600586|3691223|B1|||Birth weight, g, median||grams|Median|1495|1495.0|Inter-Quartile Range|||1122.0|1742.0|
3866200|NCT01600586|3691221|B3|United States||Region of Enrollment||participants|Number|94|94.0||||||
3866201|NCT01600586|3691222|B2|United States||Region of Enrollment||participants|Number|48|48.0||||||
3866202|NCT01600586|3691223|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
3866203|NCT01600586|3691221|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3866204|NCT01600586|3691222|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3866205|NCT01600586|3691223|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3866206|NCT01600586|3691221|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3866207|NCT01600586|3691222|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3866208|NCT01600586|3691223|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3866209|NCT01600586|3691221|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3866210|NCT01600586|3691222|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3866211|NCT01600586|3691223|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3866212|NCT01600586|3691221|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3866213|NCT01600586|3691222|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3866214|NCT01600586|3691223|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3866215|NCT01600586|3691221|B3||<=18 years|Age||Participants|Count of Participants|94|94.0||||||
3866216|NCT01600586|3691222|B2||<=18 years|Age||Participants|Count of Participants|48|48.0||||||
3866217|NCT01600586|3691223|B1||<=18 years|Age||Participants|Count of Participants|46|46.0||||||
3866218|NCT01600495|3691238|B3|Brazil||Region of Enrollment||participants|Number|46|46.0||||||
3866219|NCT01600495|3691239|B2|Brazil||Region of Enrollment||participants|Number|23|23.0||||||
3866220|NCT01600495|3691240|B1|Brazil||Region of Enrollment||participants|Number|23|23.0||||||
3866221|NCT01600495|3691238|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3866222|NCT01600495|3691239|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3866223|NCT01600495|3691240|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3866224|NCT01600495|3691238|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3866225|NCT01600495|3691239|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3866226|NCT01600495|3691240|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3866227|NCT01600495|3691238|B3|||Age||years|Mean|19.8|19.8|Standard Deviation|3.8|3.8|||
3866228|NCT01600495|3691239|B2|||Age||years|Mean|19.8|19.8|Standard Deviation|3.7|3.7|||
3866229|NCT01600495|3691240|B1|||Age||years|Mean|19.8|19.8|Standard Deviation|3.9|3.9|||
3866230|NCT01600495|3691238|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3866231|NCT01600495|3691239|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3866232|NCT01600495|3691240|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3866233|NCT01600495|3691238|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3866234|NCT01600495|3691239|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3866235|NCT01600495|3691240|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3866236|NCT01600495|3691238|B3||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
3866237|NCT01600495|3691239|B2||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
3866238|NCT01600495|3691240|B1||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
3866239|NCT01600482|3691253|B3|||Right Femoral Artery Site||Participants|Count of Participants|199|199.0||||||
3866240|NCT01600482|3691254|B2|||Right Femoral Artery Site||Participants|Count of Participants|57|57.0||||||
3866241|NCT01600482|3691255|B1|||Right Femoral Artery Site||Participants|Count of Participants|142|142.0||||||
3866242|NCT01600482|3691253|B3|||BMI||kg/m^2|Mean|27.87|27.87|Standard Deviation|4.45|4.45|||
3866243|NCT01600482|3691254|B2|||BMI||kg/m^2|Mean|28.18|28.18|Standard Deviation|4.41|4.41|||
3866244|NCT01600482|3691255|B1|||BMI||kg/m^2|Mean|27.75|27.75|Standard Deviation|4.47|4.47|||
3866245|NCT01600482|3691253|B3|||Height||cm|Mean|172.50|172.5|Standard Deviation|9.12|9.12|||
3866246|NCT01600482|3691254|B2|||Height||cm|Mean|171.70|171.7|Standard Deviation|7.82|7.82|||
3866247|NCT01600482|3691255|B1|||Height||cm|Mean|172.90|172.9|Standard Deviation|9.56|9.56|||
3866248|NCT01600482|3691253|B3|||Weight||Kgs|Mean|84.65|84.65|Standard Deviation|15.80|15.8|||
3866249|NCT01600482|3691254|B2|||Weight||Kgs|Mean|82.78|82.78|Standard Deviation|40.83|40.83|||
3866250|NCT01600482|3691255|B1|||Weight||Kgs|Mean|85.38|85.38|Standard Deviation|16.22|16.22|||
3866251|NCT01600482|3691253|B3|Germany||Region of Enrollment||participants|Number|60|60.0||||||
3866252|NCT01600482|3691254|B2|Germany||Region of Enrollment||participants|Number|18|18.0||||||
3866253|NCT01600482|3691255|B1|Germany||Region of Enrollment||participants|Number|42|42.0||||||
3866254|NCT01600482|3691253|B3|Ireland||Region of Enrollment||participants|Number|90|90.0||||||
3866255|NCT01600482|3691254|B2|Ireland||Region of Enrollment||participants|Number|21|21.0||||||
3866256|NCT01600482|3691255|B1|Ireland||Region of Enrollment||participants|Number|69|69.0||||||
3866257|NCT01600482|3691253|B3|United States||Region of Enrollment||participants|Number|57|57.0||||||
3866258|NCT01600482|3691254|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3866259|NCT01600482|3691255|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
3866260|NCT01600482|3691253|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3866261|NCT01600482|3691253|B3||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
3866262|NCT01600482|3691254|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3866263|NCT01600482|3691255|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3866264|NCT01600482|3691253|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3866265|NCT01600482|3691254|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3866266|NCT01600482|3691255|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3866267|NCT01600482|3691253|B3|||Age||Years|Mean|66.95|66.95|Standard Deviation|11.00|11.0|||
3866268|NCT01600482|3691254|B2|||Age||Years|Mean|67.44|67.44|Standard Deviation|11.7|11.7|||
3866269|NCT01600482|3691255|B1|||Age||Years|Mean|66.75|66.75|Standard Deviation|10.8|10.8|||
3866270|NCT01600326|3691274|B3|||50 Point Pain and Interfence with Activity scale|50 Point Pain and Interfence with Activity scale with 0 as no pain or interference|units on a scale|Mean|31.9|31.9|Full Range|||8.0|49.0|
3866271|NCT01600326|3691275|B2|||50 Point Pain and Interfence with Activity scale|50 Point Pain and Interfence with Activity scale with 0 as no pain or interference|units on a scale|Mean|31.4|31.4|Full Range|||11.0|41.0|
3866272|NCT01600326|3691276|B1|||50 Point Pain and Interfence with Activity scale|50 Point Pain and Interfence with Activity scale with 0 as no pain or interference|units on a scale|Mean|32.4|32.4|Full Range|||8.0|49.0|
3866273|NCT01600326|3691274|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3866274|NCT01600326|3691275|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3866275|NCT01600326|3691276|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3866276|NCT01600326|3691274|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3866277|NCT01600326|3691275|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3866278|NCT01600326|3691276|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3866279|NCT01600326|3691274|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3866280|NCT01600326|3691275|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3866281|NCT01600326|3691276|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3866282|NCT01600326|3691274|B3|||Age||years|Mean|57|57.0|Full Range|||24.0|81.0|
3866283|NCT01600326|3691275|B2|||Age||years|Mean|53|53.0|Full Range|||24.0|72.0|
3866284|NCT01600326|3691276|B1|||Age||years|Mean|60|60.0|Full Range|||31.0|81.0|
3866285|NCT01600287|3691285|B3|India||Region of Enrollment||participants|Number|40|40.0||||||
3866286|NCT01600287|3691286|B2|India||Region of Enrollment||participants|Number|20|20.0||||||
3866287|NCT01600287|3691287|B1|India||Region of Enrollment||participants|Number|20|20.0||||||
3866288|NCT01600287|3691285|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3866289|NCT01600287|3691286|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3866290|NCT01600287|3691287|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3866291|NCT01600287|3691285|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3866292|NCT01600287|3691286|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3866293|NCT01600287|3691287|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3866294|NCT01600287|3691285|B3|||Age||years|Mean|11.6|11.6|Standard Deviation|4.6|4.6|||
3866295|NCT01600287|3691286|B2|||Age||years|Mean|12|12.0|Standard Deviation|4.1|4.1|||
3866296|NCT01600287|3691287|B1|||Age||years|Mean|11.1|11.1|Standard Deviation|5.1|5.1|||
3866297|NCT01600287|3691285|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3866298|NCT01600287|3691286|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3866299|NCT01600287|3691287|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3866300|NCT01600287|3691285|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3866301|NCT01600287|3691286|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3866302|NCT01600287|3691287|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3866303|NCT01600287|3691285|B3||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
3866304|NCT01600287|3691286|B2||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
3866305|NCT01600287|3691287|B1||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
3866306|NCT01600222|3691328|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3866307|NCT01600222|3691328|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3866308|NCT01600222|3691328|B1|||Age||years|Mean|48.0|48.0|Standard Deviation|14.1|14.1|||
3866309|NCT01600092|3691351|B3||Male|Sex: Female, Male||Participants|Count of Participants|548|548.0||||||
3866310|NCT01600092|3691352|B2||Male|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
3866311|NCT01600092|3691353|B1||Male|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
3866312|NCT01600092|3691351|B3||Female|Sex: Female, Male||Participants|Count of Participants|472|472.0||||||
3866313|NCT01600092|3691352|B2||Female|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
3866314|NCT01600092|3691353|B1||Female|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
3866315|NCT01600092|3691351|B3|||Age||Weeks|Mean|8.3|8.3|Standard Deviation|1.4|1.4|||
3866316|NCT01600092|3691352|B2|||Age||Weeks|Mean|8.3|8.3|Standard Deviation|1.4|1.4|||
3866317|NCT01600092|3691353|B1|||Age||Weeks|Mean|8.4|8.4|Standard Deviation|1.4|1.4|||
3866318|NCT01600053|3691368|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3866319|NCT01600053|3691368|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
3866320|NCT01600053|3691368|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
3866321|NCT01600053|3691368|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3866322|NCT01600053|3691368|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3866323|NCT01600053|3691368|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3866324|NCT01600014|3691373|B1||Male|Sex: Female, Male||Participants|Count of Participants|397|397.0||||||
3866325|NCT01600014|3691373|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3866326|NCT01600014|3691373|B1|||Age||years|Mean|71.7|71.7|Standard Deviation|8.7|8.7|||
3866327|NCT01599832|3691392|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3866328|NCT01599832|3691392|B1||Not reported|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3866329|NCT01599832|3691392|B1||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3866330|NCT01599832|3691392|B1||African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3866331|NCT01599832|3691392|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3866332|NCT01599832|3691392|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3866333|NCT01599832|3691392|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3866334|NCT01599832|3691392|B1|||Age||years|Median|63|63.0|Full Range|||50.0|82.0|
3866335|NCT01599806|3691400|B3|White||Race/Ethnicity, Customized||Participants|Number|847|847.0||||||
3866336|NCT01599806|3691401|B2|White||Race/Ethnicity, Customized||Participants|Number|426|426.0||||||
3866337|NCT01599806|3691402|B1|White||Race/Ethnicity, Customized||Participants|Number|421|421.0||||||
3866338|NCT01599806|3691400|B3|Other||Race/Ethnicity, Customized||Participants|Number|75|75.0||||||
3866339|NCT01599806|3691401|B2|Other||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
3866340|NCT01599806|3691402|B1|Other||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
3866341|NCT01599806|3691400|B3|Black Or African American||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3866342|NCT01599806|3691401|B2|Black Or African American||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3866343|NCT01599806|3691402|B1|Black Or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3866344|NCT01599806|3691400|B3|Asian||Race/Ethnicity, Customized||Participants|Number|85|85.0||||||
3866345|NCT01599806|3691401|B2|Asian||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
3866346|NCT01599806|3691402|B1|Asian||Race/Ethnicity, Customized||Participants|Number|48|48.0||||||
3866347|NCT01599806|3691400|B3|American Indian Or Alaska Native||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3866348|NCT01599806|3691401|B2|American Indian Or Alaska Native||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3866349|NCT01599806|3691402|B1|American Indian Or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3866350|NCT01599806|3691400|B3||Male|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
3866351|NCT01599806|3691401|B2||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3866352|NCT01599806|3691402|B1||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3866353|NCT01599806|3691400|B3||Female|Sex: Female, Male||Participants|Count of Participants|706|706.0||||||
3866354|NCT01599806|3691401|B2||Female|Sex: Female, Male||Participants|Count of Participants|357|357.0||||||
3866355|NCT01599806|3691402|B1||Female|Sex: Female, Male||Participants|Count of Participants|349|349.0||||||
3866356|NCT01599806|3691400|B3|75-90||Age, Customized||Participants|Number|140|140.0||||||
3866357|NCT01599806|3691401|B2|75-90||Age, Customized||Participants|Number|62|62.0||||||
3866358|NCT01599806|3691402|B1|75-90||Age, Customized||Participants|Number|78|78.0||||||
3866359|NCT01599806|3691400|B3|65-74||Age, Customized||Participants|Number|177|177.0||||||
3866360|NCT01599806|3691401|B2|65-74||Age, Customized||Participants|Number|98|98.0||||||
3866361|NCT01599806|3691402|B1|65-74||Age, Customized||Participants|Number|79|79.0||||||
3866362|NCT01599806|3691400|B3|46-64||Age, Customized||Participants|Number|339|339.0||||||
3866363|NCT01599806|3691401|B2|46-64||Age, Customized||Participants|Number|177|177.0||||||
3866364|NCT01599806|3691402|B1|46-64||Age, Customized||Participants|Number|162|162.0||||||
3866365|NCT01599806|3691400|B3|18-45||Age, Customized||Participants|Number|364|364.0||||||
3866366|NCT01599806|3691401|B2|18-45||Age, Customized||Participants|Number|172|172.0||||||
3866367|NCT01599806|3691402|B1|18-45||Age, Customized||Participants|Number|192|192.0||||||
3866368|NCT01599806|3691400|B3|||Age||Years|Mean|52.0|52.0|Standard Deviation|19.29|19.29|18.0|89.0|
3866369|NCT01599806|3691401|B2|||Age||Years|Mean|52.3|52.3|Standard Deviation|18.83|18.83|18.0|86.0|
3866370|NCT01599806|3691402|B1|||Age||Years|Mean|51.6|51.6|Standard Deviation|19.76|19.76|18.0|89.0|
3866371|NCT01599741|3691527|B1|Netherlands||Region of Enrollment||participants|Number|51|51.0||||||
3866372|NCT01599741|3691527|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3866373|NCT01599741|3691527|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3866374|NCT01599741|3691527|B1|||Age||years|Mean|66|66.0|Standard Deviation|11|11.0|||
3866375|NCT01599650|3691533|B4||Male|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
3866376|NCT01599650|3691534|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3866377|NCT01599650|3691535|B2||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3866378|NCT01599650|3691536|B1||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3866379|NCT01599650|3691533|B4||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
3866380|NCT01599650|3691534|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3866381|NCT01599650|3691535|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3866382|NCT01599650|3691536|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3866383|NCT01599650|3691533|B4|||Age||years|Mean|66.3|66.3|Standard Deviation|10.30|10.3|||
3866384|NCT01599650|3691534|B3|||Age||years|Mean|67.7|67.7|Standard Deviation|9.67|9.67|||
3866385|NCT01599650|3691535|B2|||Age||years|Mean|67.3|67.3|Standard Deviation|10.41|10.41|||
3866386|NCT01599650|3691536|B1|||Age||years|Mean|64.7|64.7|Standard Deviation|10.34|10.34|||
3866387|NCT01599637|3691574|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866388|NCT01599637|3691575|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866389|NCT01599637|3691576|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866390|NCT01599637|3691577|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866391|NCT01599637|3691574|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3866392|NCT01599637|3691575|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3866393|NCT01599637|3691576|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3866394|NCT01599637|3691577|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3866395|NCT01599637|3691574|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866396|NCT01599637|3691575|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866397|NCT01599637|3691576|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866398|NCT01599637|3691577|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866399|NCT01599637|3691574|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3866400|NCT01599637|3691575|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3866401|NCT01599637|3691576|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3866402|NCT01599637|3691577|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3866403|NCT01599637|3691574|B4||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3866404|NCT01599637|3691575|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3866405|NCT01599637|3691576|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3866406|NCT01599637|3691577|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3866407|NCT01599637|3691574|B4|||Age||years|Mean|38.7|38.7|Standard Deviation|10.11|10.11|||
3866408|NCT01599637|3691575|B3|||Age||years|Mean|36.4|36.4|Standard Deviation|9.74|9.74|||
3866409|NCT01599637|3691576|B2|||Age||years|Mean|41.1|41.1|Standard Deviation|7.96|7.96|||
3866410|NCT01599637|3691577|B1|||Age||years|Mean|37.5|37.5|Standard Deviation|11.02|11.02|||
3866411|NCT01599585|3691624|B3|United States||Region of Enrollment||participants|Number|121|121.0||||||
3866412|NCT01599585|3691625|B2|United States||Region of Enrollment||participants|Number|59|59.0||||||
3866413|NCT01599585|3691626|B1|United States||Region of Enrollment||participants|Number|62|62.0||||||
3866414|NCT01599585|3691624|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3866415|NCT01599585|3691625|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3866416|NCT01599585|3691626|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3866417|NCT01599585|3691624|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866418|NCT01599585|3691625|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866419|NCT01599585|3691626|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866420|NCT01599585|3691624|B3||White|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3866421|NCT01599585|3691625|B2||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3866422|NCT01599585|3691626|B1||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3866423|NCT01599585|3691624|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3866424|NCT01599585|3691625|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3866425|NCT01599585|3691626|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3866426|NCT01599585|3691624|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866427|NCT01599585|3691625|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866428|NCT01599585|3691626|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866429|NCT01599585|3691624|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3866430|NCT01599585|3691625|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3866431|NCT01599585|3691626|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3866432|NCT01599585|3691624|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3866433|NCT01599585|3691625|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866434|NCT01599585|3691626|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3866435|NCT01599585|3691624|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3866436|NCT01599585|3691625|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866437|NCT01599585|3691626|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3866438|NCT01599585|3691624|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
3866439|NCT01599585|3691625|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3866440|NCT01599585|3691626|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3866441|NCT01599585|3691624|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3866442|NCT01599585|3691625|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3866443|NCT01599585|3691626|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3866444|NCT01599585|3691624|B3||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3866445|NCT01599585|3691625|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3866446|NCT01599585|3691626|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3866447|NCT01599585|3691624|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3866448|NCT01599585|3691625|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3866449|NCT01599585|3691626|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3866450|NCT01599585|3691624|B3|||Age||years|Mean|35.1|35.1|Standard Deviation|12.1|12.1|||
3866451|NCT01599585|3691625|B2|||Age||years|Mean|35.6|35.6|Standard Deviation|11.8|11.8|||
3866452|NCT01599585|3691626|B1|||Age||years|Mean|34.8|34.8|Standard Deviation|12.4|12.4|||
3866453|NCT01599585|3691624|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3866454|NCT01599585|3691625|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3866455|NCT01599585|3691626|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3866456|NCT01599585|3691624|B3||Between 18 and 65 years|Age||Participants|Count of Participants|121|121.0||||||
3866457|NCT01599585|3691625|B2||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
3866458|NCT01599585|3691626|B1||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
3866459|NCT01599585|3691624|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3866460|NCT01599585|3691625|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3866461|NCT01599585|3691626|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3866462|NCT01599325|3691665|B1|MDS and myeloproliferative disease (MPD)||MDS World Health Organization (WHO) Classification|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|0|0.0||||||
3866463|NCT01599325|3691665|B1|CMML||MDS World Health Organization (WHO) Classification|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|1|1.0||||||
3866464|NCT01599325|3691665|B1|Acute Myelogenous Leukemia (AML)||MDS World Health Organization (WHO) Classification|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|7|7.0||||||
3866496|NCT01599234|3691686|B2||Between 18 and 65 years|Age||Participants|Count of Participants|168|168.0||||||
3866497|NCT01599234|3691687|B1||Between 18 and 65 years|Age||Participants|Count of Participants|162|162.0||||||
3866465|NCT01599325|3691665|B1|RAEB -2 with MPD=Myeloproliferative disease||MDS World Health Organization (WHO) Classification|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|50|50.0||||||
3866466|NCT01599325|3691665|B1|RAEB-1=Refractory anemia with excess blasts||MDS World Health Organization (WHO) Classification|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|14|14.0||||||
3866467|NCT01599325|3691665|B1|Modified CMML=Chronic myelomonocytic leukemia||French-American-British classification (FAB)|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Local Reviewer.|participants|Number|1|1.0||||||
3866468|NCT01599325|3691665|B1|RAEB in transformation||French-American-British classification (FAB)|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Local Reviewer.|participants|Number|8|8.0||||||
3866469|NCT01599325|3691665|B1|RAEB=Refractory anemia with excess blasts||French-American-British classification (FAB)|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Local Reviewer.|participants|Number|63|63.0||||||
3866470|NCT01599325|3691665|B1|High (>=2.5)||International Prognostic Scoring System (IPSS) Risk Classification|The Myelodysplastic Syndrome (MDS) IPSS score assesses the severity of MDS based on 3 prognostic factors each assigned a score: the percentage of bone marrow blasts, chromosome changes in the marrow cells (karyotype) and the presence of one or more low blood cell counts (cytopenias). The IPSS score is the sum of the bone marrow blast + karyotype + cytopenia score and ranges from 0 (low risk) to 3.5 (high risk). Prognosis is categorized as Low risk (score = 0), Intermediate-1 (score 0.5 to 1.0), Intermediate-2 (score 1.5 to 2.0) or High risk (score ≥ 2.5).|participants|Number|25|25.0||||||
3866471|NCT01599325|3691665|B1|Intermediate 2 (1.5-2.0)||International Prognostic Scoring System (IPSS) Risk Classification|The Myelodysplastic Syndrome (MDS) IPSS score assesses the severity of MDS based on 3 prognostic factors each assigned a score: the percentage of bone marrow blasts, chromosome changes in the marrow cells (karyotype) and the presence of one or more low blood cell counts (cytopenias). The IPSS score is the sum of the bone marrow blast + karyotype + cytopenia score and ranges from 0 (low risk) to 3.5 (high risk). Prognosis is categorized as Low risk (score = 0), Intermediate-1 (score 0.5 to 1.0), Intermediate-2 (score 1.5 to 2.0) or High risk (score ≥ 2.5).|participants|Number|47|47.0||||||
3866472|NCT01599325|3691665|B1|Intermediate 1 (0.5-1.0)||International Prognostic Scoring System (IPSS) Risk Classification|The Myelodysplastic Syndrome (MDS) IPSS score assesses the severity of MDS based on 3 prognostic factors each assigned a score: the percentage of bone marrow blasts, chromosome changes in the marrow cells (karyotype) and the presence of one or more low blood cell counts (cytopenias). The IPSS score is the sum of the bone marrow blast + karyotype + cytopenia score and ranges from 0 (low risk) to 3.5 (high risk). Prognosis is categorized as Low risk (score = 0), Intermediate-1 (score 0.5 to 1.0), Intermediate-2 (score 1.5 to 2.0) or High risk (score ≥ 2.5).|participants|Number|0|0.0||||||
3866473|NCT01599325|3691665|B1|Low (0)||International Prognostic Scoring System (IPSS) Risk Classification|The Myelodysplastic Syndrome (MDS) IPSS score assesses the severity of MDS based on 3 prognostic factors each assigned a score: the percentage of bone marrow blasts, chromosome changes in the marrow cells (karyotype) and the presence of one or more low blood cell counts (cytopenias). The IPSS score is the sum of the bone marrow blast + karyotype + cytopenia score and ranges from 0 (low risk) to 3.5 (high risk). Prognosis is categorized as Low risk (score = 0), Intermediate-1 (score 0.5 to 1.0), Intermediate-2 (score 1.5 to 2.0) or High risk (score ≥ 2.5).|participants|Number|0|0.0||||||
3866474|NCT01599325|3691665|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3866475|NCT01599325|3691665|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3866476|NCT01599325|3691665|B1|||Age||years|Mean|54.3|54.3|Standard Deviation|11.78|11.78|||
3866477|NCT01599234|3691685|B3|Czech Republic||Region of Enrollment||participants|Number|209|209.0||||||
3866478|NCT01599234|3691686|B2|Czech Republic||Region of Enrollment||participants|Number|107|107.0||||||
3866479|NCT01599234|3691687|B1|Czech Republic||Region of Enrollment||participants|Number|102|102.0||||||
3866480|NCT01599234|3691685|B3|United Kingdom||Region of Enrollment||participants|Number|128|128.0||||||
3866481|NCT01599234|3691686|B2|United Kingdom||Region of Enrollment||participants|Number|63|63.0||||||
3866482|NCT01599234|3691687|B1|United Kingdom||Region of Enrollment||participants|Number|65|65.0||||||
3866483|NCT01599234|3691685|B3||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3866484|NCT01599234|3691686|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3866485|NCT01599234|3691687|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3866486|NCT01599234|3691685|B3||Female|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
3866487|NCT01599234|3691686|B2||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3866488|NCT01599234|3691687|B1||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3866489|NCT01599234|3691685|B3|||Age||years|Mean|47.5|47.5|Standard Deviation|9.61|9.61|||
3866490|NCT01599234|3691686|B2|||Age||years|Mean|47.1|47.1|Standard Deviation|9.15|9.15|||
3866491|NCT01599234|3691687|B1|||Age||years|Mean|48.0|48.0|Standard Deviation|10.06|10.06|||
3866492|NCT01599234|3691685|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3866493|NCT01599234|3691686|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3866494|NCT01599234|3691687|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3866495|NCT01599234|3691685|B3||Between 18 and 65 years|Age||Participants|Count of Participants|330|330.0||||||
3866498|NCT01599234|3691685|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3866499|NCT01599234|3691686|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3866500|NCT01599234|3691687|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3866501|NCT01599104|3691710|B4||Male|Sex: Female, Male||Participants|Count of Participants|818|818.0||||||
3866502|NCT01599104|3691711|B3||Male|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
3866503|NCT01599104|3691712|B2||Male|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
3866504|NCT01599104|3691713|B1||Male|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
3866505|NCT01599104|3691710|B4||Female|Sex: Female, Male||Participants|Count of Participants|343|343.0||||||
3866506|NCT01599104|3691711|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3866507|NCT01599104|3691712|B2||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3866508|NCT01599104|3691713|B1||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3866509|NCT01599104|3691710|B4|||Age||Years|Mean|58.7|58.7|Standard Deviation|10.64|10.64|||
3866510|NCT01599104|3691711|B3|||Age||Years|Mean|59.6|59.6|Standard Deviation|10.50|10.5|||
3866511|NCT01599104|3691712|B2|||Age||Years|Mean|58.7|58.7|Standard Deviation|10.50|10.5|||
3866512|NCT01599104|3691713|B1|||Age||Years|Mean|57.9|57.9|Standard Deviation|10.87|10.87|||
3866513|NCT01598987|3691753|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3866514|NCT01598987|3691753|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3866515|NCT01598987|3691753|B1|||Age||years|Mean|4.9|4.9|Standard Deviation|4.59|4.59|||
3866516|NCT01598896|3691787|B3|||Marijuana Craving|"The baseline Marijuana Craving Questionnaire (Heishman et al. 2009) - The 4 Factor Total Score~Maximum Score = 84 Minimum Score = 12 The higher the score, the more severe marijuana craving symptoms endorsed by the subject."|Score on MCQ 4 Factor Total scale|Mean|59.57|59.57|Standard Deviation|12.2|12.2|||
3866517|NCT01598896|3691788|B2|||Marijuana Craving|"The baseline Marijuana Craving Questionnaire (Heishman et al. 2009) - The 4 Factor Total Score~Maximum Score = 84 Minimum Score = 12 The higher the score, the more severe marijuana craving symptoms endorsed by the subject."|Score on MCQ 4 Factor Total scale|Mean|55.5|55.5|Standard Deviation|13.33|13.33|||
3866518|NCT01598896|3691789|B1|||Marijuana Craving|"The baseline Marijuana Craving Questionnaire (Heishman et al. 2009) - The 4 Factor Total Score~Maximum Score = 84 Minimum Score = 12 The higher the score, the more severe marijuana craving symptoms endorsed by the subject."|Score on MCQ 4 Factor Total scale|Mean|65|65.0|Standard Deviation|10.15|10.15|||
3866519|NCT01598896|3691787|B3|||Baseline Self-Report MJ Use||hits/day|Mean|37.3|37.3|Standard Deviation|18.63|18.63|||
3866520|NCT01598896|3691788|B2|||Baseline Self-Report MJ Use||hits/day|Mean|37.4|37.4|Standard Deviation|19.32|19.32|||
3866521|NCT01598896|3691789|B1|||Baseline Self-Report MJ Use||hits/day|Mean|37.16|37.16|Standard Deviation|21.92|21.92|||
3866522|NCT01598896|3691787|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866523|NCT01598896|3691788|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866524|NCT01598896|3691789|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866525|NCT01598896|3691787|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866526|NCT01598896|3691788|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866527|NCT01598896|3691789|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866528|NCT01598896|3691787|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3866529|NCT01598896|3691788|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3866530|NCT01598896|3691789|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3866531|NCT01598896|3691787|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3866532|NCT01598896|3691788|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3866533|NCT01598896|3691789|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866534|NCT01598896|3691787|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866535|NCT01598896|3691788|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866536|NCT01598896|3691789|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866537|NCT01598896|3691787|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866538|NCT01598896|3691788|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866539|NCT01598896|3691789|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866540|NCT01598896|3691787|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866541|NCT01598896|3691788|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866542|NCT01598896|3691789|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866543|NCT01598896|3691787|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3866544|NCT01598896|3691788|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3866545|NCT01598896|3691789|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3866546|NCT01598896|3691787|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3866547|NCT01598896|3691788|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3866548|NCT01598896|3691789|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3866549|NCT01598896|3691787|B3|||Age||years|Mean|32.86|32.86|Standard Deviation|9.26|9.26|||
3866550|NCT01598896|3691788|B2|||Age||years|Mean|30.75|30.75|Standard Deviation|5.91|5.91|||
3866551|NCT01598896|3691789|B1|||Age||years|Mean|35.67|35.67|Standard Deviation|13.58|13.58|||
3866552|NCT01598779|3691802|B1|Argentina||Region of Enrollment||participants|Number|150|150.0||||||
3866553|NCT01598779|3691802|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3866554|NCT01598779|3691802|B1||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3866555|NCT01598779|3691802|B1|||Age|Women age 15–45 years, with a lesion suspected of being HPV related were eligible to enter in the study.|years|Mean|28.48|28.48|Full Range|||15.0|45.0|
3866556|NCT01598740|3691806|B3|High sodium||Diet||participants|Number|13|13.0||||||
3866557|NCT01598740|3691807|B2|High sodium||Diet||participants|Number|6|6.0||||||
3866558|NCT01598740|3691808|B1|High sodium||Diet||participants|Number|7|7.0||||||
3866559|NCT01598740|3691806|B3|Medium sodium||Diet||participants|Number|2|2.0||||||
3866560|NCT01598740|3691807|B2|Medium sodium||Diet||participants|Number|1|1.0||||||
3866561|NCT01598740|3691808|B1|Medium sodium||Diet||participants|Number|1|1.0||||||
3866562|NCT01598740|3691806|B3|Low sodium||Diet||participants|Number|3|3.0||||||
3866563|NCT01598740|3691807|B2|Low sodium||Diet||participants|Number|2|2.0||||||
3866564|NCT01598740|3691808|B1|Low sodium||Diet||participants|Number|1|1.0||||||
3866565|NCT01598740|3691806|B3|||Weight||kg|Mean|95.4|95.4|Standard Deviation|25.8|25.8|||
3866566|NCT01598740|3691807|B2|||Weight||kg|Mean|99.54|99.54|Standard Deviation|27.49|27.49|||
3866567|NCT01598740|3691808|B1|||Weight||kg|Mean|91.35|91.35|Standard Deviation|24.20|24.2|||
3866568|NCT01598740|3691806|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3866569|NCT01598740|3691807|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3866570|NCT01598740|3691808|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3866571|NCT01598740|3691806|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3866572|NCT01598740|3691807|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3866573|NCT01598740|3691808|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3866574|NCT01598740|3691806|B3|||Age||years|Mean|59.9|59.9|Standard Deviation|8.7|8.7|||
3866575|NCT01598740|3691807|B2|||Age||years|Mean|63.4|63.4|Standard Deviation|9.77|9.77|||
3866576|NCT01598740|3691808|B1|||Age||years|Mean|56.3|56.3|Standard Deviation|7.58|7.58|||
3866577|NCT01598701|3691817|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3866578|NCT01598701|3691818|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3866579|NCT01598701|3691819|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3866580|NCT01598701|3691817|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3866581|NCT01598701|3691818|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3866582|NCT01598701|3691819|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3866583|NCT01598701|3691817|B3|||Age||years|Mean|50.75|50.75|Standard Deviation|15.35|15.35|||
3866584|NCT01598701|3691818|B2|||Age||years|Mean|51.5|51.5|Standard Deviation|14.4|14.4|||
3866585|NCT01598701|3691819|B1|||Age||years|Mean|50.0|50.0|Standard Deviation|16.3|16.3|||
3866586|NCT01598662|3691834|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
3866587|NCT01598662|3691835|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
3866588|NCT01598662|3691836|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3866589|NCT01598662|3691834|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3866590|NCT01598662|3691835|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3866591|NCT01598662|3691836|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3866592|NCT01598662|3691834|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3866593|NCT01598662|3691835|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3866594|NCT01598662|3691836|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3866595|NCT01598662|3691834|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3866596|NCT01598662|3691835|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3866597|NCT01598662|3691836|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3866598|NCT01598662|3691834|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3866599|NCT01598662|3691835|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3866600|NCT01598662|3691836|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3866601|NCT01598662|3691834|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3866602|NCT01598662|3691835|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3866603|NCT01598662|3691836|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3866604|NCT01598610|3691843|B1|United States||Region of Enrollment||participants|Number|220|220.0||||||
3866605|NCT01598610|3691843|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3866606|NCT01598610|3691843|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3866607|NCT01598610|3691843|B1|||Age||years|Mean|60|60.0|Full Range|||26.0|86.0|
3866608|NCT01598545|3691852|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3866609|NCT01598545|3691852|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3866610|NCT01598545|3691852|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3866611|NCT01598545|3691852|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3866612|NCT01598545|3691852|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3866613|NCT01598545|3691852|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3866614|NCT01598532|3691860|B1|||Years of Education|Numbers of years of education|Years of Education|Mean|15.72|15.72|Standard Deviation|2.97|2.97|||
3866615|NCT01598532|3691860|B1|||Time Post TBI|This calculates the time elapsed since injury|years post TBI|Mean|3.12|3.12|Standard Deviation|2.50|2.5|||
3866616|NCT01598532|3691860|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3866617|NCT01598532|3691860|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3866618|NCT01598532|3691860|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3866619|NCT01598532|3691860|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3866620|NCT01598532|3691860|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3866621|NCT01598506|3691869|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3866622|NCT01598506|3691869|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3866623|NCT01598506|3691869|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3866624|NCT01598506|3691869|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3866625|NCT01598506|3691869|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3866626|NCT01598506|3691869|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3866627|NCT01598428|3691874|B1|China||Region of Enrollment||participants|Number|20|20.0||||||
3866628|NCT01598428|3691874|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3866629|NCT01598428|3691874|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3866630|NCT01598428|3691874|B1|||Age||years|Mean|70.5|70.5|Standard Deviation|7.6|7.6|||
3866631|NCT01598350|3691883|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3866632|NCT01598350|3691883|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3866633|NCT01598350|3691883|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3866634|NCT01598350|3691883|B1|||Age||years|Mean|4.5|4.5|Standard Deviation|.71|0.71|||
3866635|NCT01598350|3691883|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3866636|NCT01598350|3691883|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3866637|NCT01598350|3691883|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3866638|NCT01598311|3691887|B3||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
3866639|NCT01598311|3691888|B2||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3866640|NCT01598311|3691889|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3866641|NCT01598311|3691887|B3||Female|Sex: Female, Male||Participants|Count of Participants|367|367.0||||||
3866642|NCT01598311|3691888|B2||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
3866643|NCT01598311|3691889|B1||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
3866644|NCT01598311|3691887|B3|||Age||Years|Mean|57.1|57.1|Standard Deviation|18.3|18.3|||
3866645|NCT01598311|3691888|B2|||Age||Years|Mean|56.5|56.5|Standard Deviation|18.3|18.3|||
3866646|NCT01598311|3691889|B1|||Age||Years|Mean|57.6|57.6|Standard Deviation|18.3|18.3|||
3866647|NCT01598298|3691904|B3||Yes|Prior taxane use||Participants|Count of Participants|156|156.0||||||
3866648|NCT01598298|3691905|B2||Yes|Prior taxane use||Participants|Count of Participants|79|79.0||||||
3866649|NCT01598298|3691906|B1||Yes|Prior taxane use||Participants|Count of Participants|77|77.0||||||
3866650|NCT01598298|3691904|B3||No|Prior taxane use||Participants|Count of Participants|133|133.0||||||
3866651|NCT01598298|3691905|B2||No|Prior taxane use||Participants|Count of Participants|65|65.0||||||
3866652|NCT01598298|3691906|B1||No|Prior taxane use||Participants|Count of Participants|68|68.0||||||
3866653|NCT01598298|3691904|B3||7-10|Baseline pain score|"Baseline pain score is the patient's self-reported average pain at baseline as measured by the BPI-SF question, Please rate your joint pain by selecting the one number that best describes your joint pain on the AVERAGE. This score ranges from 0 to 10, with higher scores indicating more pain."|Participants|Count of Participants|69|69.0||||||
3866654|NCT01598298|3691905|B2||7-10|Baseline pain score|"Baseline pain score is the patient's self-reported average pain at baseline as measured by the BPI-SF question, Please rate your joint pain by selecting the one number that best describes your joint pain on the AVERAGE. This score ranges from 0 to 10, with higher scores indicating more pain."|Participants|Count of Participants|34|34.0||||||
3866655|NCT01598298|3691906|B1||7-10|Baseline pain score|"Baseline pain score is the patient's self-reported average pain at baseline as measured by the BPI-SF question, Please rate your joint pain by selecting the one number that best describes your joint pain on the AVERAGE. This score ranges from 0 to 10, with higher scores indicating more pain."|Participants|Count of Participants|35|35.0||||||
3866656|NCT01598298|3691904|B3||4-6|Baseline pain score|"Baseline pain score is the patient's self-reported average pain at baseline as measured by the BPI-SF question, Please rate your joint pain by selecting the one number that best describes your joint pain on the AVERAGE. This score ranges from 0 to 10, with higher scores indicating more pain."|Participants|Count of Participants|220|220.0||||||
3866657|NCT01598298|3691905|B2||4-6|Baseline pain score|"Baseline pain score is the patient's self-reported average pain at baseline as measured by the BPI-SF question, Please rate your joint pain by selecting the one number that best describes your joint pain on the AVERAGE. This score ranges from 0 to 10, with higher scores indicating more pain."|Participants|Count of Participants|110|110.0||||||
3866658|NCT01598298|3691906|B1||4-6|Baseline pain score|"Baseline pain score is the patient's self-reported average pain at baseline as measured by the BPI-SF question, Please rate your joint pain by selecting the one number that best describes your joint pain on the AVERAGE. This score ranges from 0 to 10, with higher scores indicating more pain."|Participants|Count of Participants|110|110.0||||||
3866659|NCT01598298|3691904|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3866660|NCT01598298|3691905|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3866661|NCT01598298|3691906|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866662|NCT01598298|3691904|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3866663|NCT01598298|3691905|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3866664|NCT01598298|3691906|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866665|NCT01598298|3691904|B3||White|Race (NIH/OMB)||Participants|Count of Participants|248|248.0||||||
3866666|NCT01598298|3691905|B2||White|Race (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
3866667|NCT01598298|3691906|B1||White|Race (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
3866668|NCT01598298|3691904|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3866669|NCT01598298|3691905|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3866670|NCT01598298|3691906|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3866671|NCT01598298|3691904|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3866672|NCT01598298|3691905|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866673|NCT01598298|3691906|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3866674|NCT01598298|3691904|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3866675|NCT01598298|3691905|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3866676|NCT01598298|3691906|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3866677|NCT01598298|3691904|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3866678|NCT01598298|3691905|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3866679|NCT01598298|3691906|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866680|NCT01598298|3691904|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3866681|NCT01598298|3691905|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3866682|NCT01598298|3691906|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866683|NCT01598298|3691904|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|277|277.0||||||
3866684|NCT01598298|3691905|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|137|137.0||||||
3866685|NCT01598298|3691906|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
3866686|NCT01598298|3691904|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3866687|NCT01598298|3691905|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3866688|NCT01598298|3691906|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3866689|NCT01598298|3691904|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3866690|NCT01598298|3691905|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3866691|NCT01598298|3691906|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3866692|NCT01598298|3691904|B3||Female|Sex: Female, Male||Participants|Count of Participants|289|289.0||||||
3866693|NCT01598298|3691905|B2||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3866694|NCT01598298|3691906|B1||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3866695|NCT01598298|3691904|B3|||Age||years|Median|60|60.0|Full Range|||27.0|83.0|
3866696|NCT01598298|3691905|B2|||Age||years|Median|60|60.0|Full Range|||27.0|82.0|
3866697|NCT01598298|3691906|B1|||Age||years|Median|60|60.0|Full Range|||40.0|83.0|
3866698|NCT01598207|3691917|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
3866699|NCT01598207|3691918|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3866700|NCT01598207|3691919|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3866701|NCT01598207|3691917|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3866702|NCT01598207|3691918|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3866703|NCT01598207|3691919|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3866704|NCT01598207|3691917|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3866705|NCT01598207|3691918|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3866706|NCT01598207|3691919|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3866707|NCT01598207|3691917|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3866708|NCT01598207|3691918|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3866709|NCT01598207|3691919|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3866710|NCT01598207|3691917|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3866711|NCT01598207|3691918|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3866712|NCT01598207|3691919|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3866713|NCT01598207|3691917|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3866714|NCT01598207|3691918|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3866715|NCT01598207|3691919|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3866716|NCT01598194|3691938|B3|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3866717|NCT01598194|3691939|B2|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3866718|NCT01598194|3691940|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3866719|NCT01598194|3691938|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3866720|NCT01598194|3691939|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3866721|NCT01598194|3691940|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866722|NCT01598194|3691938|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866723|NCT01598194|3691939|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866724|NCT01598194|3691940|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866725|NCT01598194|3691938|B3||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3866726|NCT01598194|3691939|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3866727|NCT01598194|3691940|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3866728|NCT01598194|3691938|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3866729|NCT01598194|3691939|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3866730|NCT01598194|3691940|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3866731|NCT01598194|3691938|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866732|NCT01598194|3691939|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866733|NCT01598194|3691940|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866734|NCT01598194|3691938|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3866735|NCT01598194|3691939|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866736|NCT01598194|3691940|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3866737|NCT01598194|3691938|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3866738|NCT01598194|3691939|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3866739|NCT01598194|3691940|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866740|NCT01598194|3691938|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3866741|NCT01598194|3691939|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3866742|NCT01598194|3691940|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3866743|NCT01598194|3691938|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3866744|NCT01598194|3691939|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3866745|NCT01598194|3691940|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3866746|NCT01598194|3691938|B3|||Age||years|Mean|63|63.0|Full Range|||24.0|85.0|
3866747|NCT01598194|3691939|B2|||Age||years|Mean|61|61.0|Full Range|||24.0|85.0|
3866748|NCT01598194|3691940|B1|||Age||years|Mean|65|65.0|Full Range|||31.0|78.0|
3866749|NCT01598194|3691938|B3||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
3866750|NCT01598194|3691939|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3866751|NCT01598194|3691940|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3866752|NCT01598194|3691938|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3866753|NCT01598194|3691939|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3866754|NCT01598194|3691940|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3866755|NCT01598194|3691938|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3866756|NCT01598194|3691939|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3866757|NCT01598194|3691940|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3866758|NCT01598129|3691951|B1|||Number of cancer indications||participants|Number|9|9.0||||||
3866759|NCT01598129|3691951|B1|Finland||Region of Enrollment||participants|Number|12|12.0||||||
3866760|NCT01598129|3691951|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3866761|NCT01598129|3691951|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3866762|NCT01598129|3691951|B1|||Age||years|Median|63|63.0|Full Range|||38.0|68.0|
3866763|NCT01598064|3691960|B3|||TNF-α (pg/mL)|Tumor necrosis factor alpha (TNF-α) is a cytokine involved in systemic inflammation and is a member of a group of cytokines that stimulate the acute phase reaction.|pg/mL|Mean|11.4|11.4|Standard Deviation|3.4|3.4|||
3866764|NCT01598064|3691961|B2|||TNF-α (pg/mL)|Tumor necrosis factor alpha (TNF-α) is a cytokine involved in systemic inflammation and is a member of a group of cytokines that stimulate the acute phase reaction.|pg/mL|Mean|10.8|10.8|Standard Deviation|2.9|2.9|||
3866765|NCT01598064|3691962|B1|||TNF-α (pg/mL)|Tumor necrosis factor alpha (TNF-α) is a cytokine involved in systemic inflammation and is a member of a group of cytokines that stimulate the acute phase reaction.|pg/mL|Mean|12.0|12.0|Standard Deviation|3.9|3.9|||
3866766|NCT01598064|3691960|B3|No re-admission||Re-admission||participants|Number|44|44.0||||||
3866767|NCT01598064|3691961|B2|No re-admission||Re-admission||participants|Number|21|21.0||||||
3866768|NCT01598064|3691962|B1|No re-admission||Re-admission||participants|Number|23|23.0||||||
3866769|NCT01598064|3691960|B3|Re-admission||Re-admission||participants|Number|5|5.0||||||
3866770|NCT01598064|3691961|B2|Re-admission||Re-admission||participants|Number|3|3.0||||||
3866771|NCT01598064|3691962|B1|Re-admission||Re-admission||participants|Number|2|2.0||||||
3866772|NCT01598064|3691960|B3|||Malondialdehyde (μM)|Malondialdehyde (MDA) is one of the most frequently used indicators of lipid peroxidation, also a biomarker of oxidative stress.|μM|Mean|0.6|0.6|Standard Deviation|0.2|0.2|||
3866773|NCT01598064|3691961|B2|||Malondialdehyde (μM)|Malondialdehyde (MDA) is one of the most frequently used indicators of lipid peroxidation, also a biomarker of oxidative stress.|μM|Mean|0.6|0.6|Standard Deviation|0.2|0.2|||
3866774|NCT01598064|3691962|B1|||Malondialdehyde (μM)|Malondialdehyde (MDA) is one of the most frequently used indicators of lipid peroxidation, also a biomarker of oxidative stress.|μM|Mean|0.6|0.6|Standard Deviation|0.2|0.2|||
3866775|NCT01598064|3691960|B3|||hsCRP (mg/L)||mg/L|Mean|7.2|7.2|Standard Deviation|0.9|0.9|||
3866776|NCT01598064|3691961|B2|||hsCRP (mg/L)||mg/L|Mean|7.4|7.4|Standard Deviation|1.3|1.3|||
3866777|NCT01598064|3691962|B1|||hsCRP (mg/L)||mg/L|Mean|7.1|7.1|Standard Deviation|0.5|0.5|||
3866778|NCT01598064|3691960|B3|||Prothrombin time (seconds)|The prothrombin time are measures of the extrinsic pathway of coagulation. It is used to determine the clotting tendency of blood. The longer prothrombin time means impairment of blood coagulation.|seconds|Mean|12.3|12.3|Standard Deviation|1.3|1.3|||
3866779|NCT01598064|3691961|B2|||Prothrombin time (seconds)|The prothrombin time are measures of the extrinsic pathway of coagulation. It is used to determine the clotting tendency of blood. The longer prothrombin time means impairment of blood coagulation.|seconds|Mean|11.8|11.8|Standard Deviation|1.5|1.5|||
3866780|NCT01598064|3691962|B1|||Prothrombin time (seconds)|The prothrombin time are measures of the extrinsic pathway of coagulation. It is used to determine the clotting tendency of blood. The longer prothrombin time means impairment of blood coagulation.|seconds|Mean|12.4|12.4|Standard Deviation|1.1|1.1|||
3866781|NCT01598064|3691960|B3|||ALT (U/L)||U/L|Mean|43.6|43.6|Standard Deviation|25.0|25.0|||
3866782|NCT01598064|3691961|B2|||ALT (U/L)||U/L|Mean|39.5|39.5|Standard Deviation|21.3|21.3|||
3866783|NCT01598064|3691962|B1|||ALT (U/L)||U/L|Mean|48.2|48.2|Standard Deviation|29.3|29.3|||
3866784|NCT01598064|3691960|B3|||AST (U/L)||U/L|Mean|54.6|54.6|Standard Deviation|22.5|22.5|||
3866785|NCT01598064|3691961|B2|||AST (U/L)||U/L|Mean|51.1|51.1|Standard Deviation|20.9|20.9|||
3866786|NCT01598064|3691962|B1|||AST (U/L)||U/L|Mean|58.4|58.4|Standard Deviation|24.8|24.8|||
3866787|NCT01598064|3691960|B3|||Total bilirubin (mg/dL)|Bilirubin is excreted in bile and urine, and elevated levels in blood may indicate liver function impairment.|mg/dL|Mean|1.2|1.2|Standard Deviation|0.6|0.6|||
3866788|NCT01598064|3691961|B2|||Total bilirubin (mg/dL)|Bilirubin is excreted in bile and urine, and elevated levels in blood may indicate liver function impairment.|mg/dL|Mean|1.2|1.2|Standard Deviation|0.6|0.6|||
3866789|NCT01598064|3691962|B1|||Total bilirubin (mg/dL)|Bilirubin is excreted in bile and urine, and elevated levels in blood may indicate liver function impairment.|mg/dL|Mean|1.2|1.2|Standard Deviation|0.6|0.6|||
3866790|NCT01598064|3691960|B3|||Cr (mg/dL)||mg/dL|Mean|0.8|0.8|Standard Deviation|0.3|0.3|||
3866791|NCT01598064|3691961|B2|||Cr (mg/dL)||mg/dL|Mean|0.9|0.9|Standard Deviation|0.2|0.2|||
3866792|NCT01598064|3691962|B1|||Cr (mg/dL)||mg/dL|Mean|0.8|0.8|Standard Deviation|0.3|0.3|||
3866793|NCT01598064|3691960|B3|||Platelet (x1000 platelets/μl)||x1000 platelets/uL|Mean|110.2|110.2|Standard Deviation|50.5|50.5|||
3866794|NCT01598064|3691961|B2|||Platelet (x1000 platelets/μl)||x1000 platelets/uL|Mean|112.3|112.3|Standard Deviation|45.9|45.9|||
3866795|NCT01598064|3691962|B1|||Platelet (x1000 platelets/μl)||x1000 platelets/uL|Mean|108.3|108.3|Standard Deviation|58.2|58.2|||
3866796|NCT01598064|3691960|B3|||Hb (g/dL)||g/dL|Mean|13.0|13.0|Standard Deviation|2.0|2.0|||
3866797|NCT01598064|3691961|B2|||Hb (g/dL)||g/dL|Mean|13.2|13.2|Standard Deviation|2.1|2.1|||
3866798|NCT01598064|3691962|B1|||Hb (g/dL)||g/dL|Mean|12.8|12.8|Standard Deviation|1.8|1.8|||
3866799|NCT01598064|3691960|B3|||WBC (cells/ml)||cells/ml|Mean|5111|5111.0|Standard Deviation|1886|1886.0|||
3866800|NCT01598064|3691961|B2|||WBC (cells/ml)||cells/ml|Mean|5116|5116.0|Standard Deviation|1815|1815.0|||
3866801|NCT01598064|3691962|B1|||WBC (cells/ml)||cells/ml|Mean|5019|5019.0|Standard Deviation|2027|2027.0|||
3866802|NCT01598064|3691960|B3|NON CVA||Cerebral vascular accident||participants|Number|49|49.0||||||
3866803|NCT01598064|3691961|B2|NON CVA||Cerebral vascular accident||participants|Number|24|24.0||||||
3866804|NCT01598064|3691962|B1|NON CVA||Cerebral vascular accident||participants|Number|25|25.0||||||
3866805|NCT01598064|3691960|B3|CVA||Cerebral vascular accident||participants|Number|0|0.0||||||
3866806|NCT01598064|3691961|B2|CVA||Cerebral vascular accident||participants|Number|0|0.0||||||
3866807|NCT01598064|3691962|B1|CVA||Cerebral vascular accident||participants|Number|0|0.0||||||
3866808|NCT01598064|3691960|B3|NON HYPERTENSION||Hypertension||participants|Number|42|42.0||||||
3866809|NCT01598064|3691961|B2|NON HYPERTENSION||Hypertension||participants|Number|21|21.0||||||
3866810|NCT01598064|3691962|B1|NON HYPERTENSION||Hypertension||participants|Number|21|21.0||||||
3866811|NCT01598064|3691960|B3|HYPERTENSION||Hypertension||participants|Number|7|7.0||||||
3866812|NCT01598064|3691961|B2|HYPERTENSION||Hypertension||participants|Number|3|3.0||||||
3866813|NCT01598064|3691962|B1|HYPERTENSION||Hypertension||participants|Number|4|4.0||||||
3866814|NCT01598064|3691960|B3|NON DIABETES||Diabetes||participants|Number|37|37.0||||||
3866815|NCT01598064|3691961|B2|NON DIABETES||Diabetes||participants|Number|18|18.0||||||
3866816|NCT01598064|3691962|B1|NON DIABETES||Diabetes||participants|Number|19|19.0||||||
3866817|NCT01598064|3691960|B3|DIABETES||Diabetes||participants|Number|12|12.0||||||
3866818|NCT01598064|3691961|B2|DIABETES||Diabetes||participants|Number|6|6.0||||||
3866819|NCT01598064|3691962|B1|DIABETES||Diabetes||participants|Number|6|6.0||||||
3866820|NCT01598064|3691960|B3|NO HEPATIC ENCEPHALOPATHY||Hepatic encephalopathy||participants|Number|43|43.0||||||
3866821|NCT01598064|3691961|B2|NO HEPATIC ENCEPHALOPATHY||Hepatic encephalopathy||participants|Number|20|20.0||||||
3866822|NCT01598064|3691962|B1|NO HEPATIC ENCEPHALOPATHY||Hepatic encephalopathy||participants|Number|23|23.0||||||
3866823|NCT01598064|3691960|B3|HEPATIC ENCEPHALOPATHY||Hepatic encephalopathy||participants|Number|6|6.0||||||
3866824|NCT01598064|3691961|B2|HEPATIC ENCEPHALOPATHY||Hepatic encephalopathy||participants|Number|4|4.0||||||
3866825|NCT01598064|3691962|B1|HEPATIC ENCEPHALOPATHY||Hepatic encephalopathy||participants|Number|2|2.0||||||
3866826|NCT01598064|3691960|B3|NO VARICEAL BLEEDING||Variceal bleeding||participants|Number|48|48.0||||||
3866827|NCT01598064|3691961|B2|NO VARICEAL BLEEDING||Variceal bleeding||participants|Number|23|23.0||||||
3866828|NCT01598064|3691962|B1|NO VARICEAL BLEEDING||Variceal bleeding||participants|Number|25|25.0||||||
3866829|NCT01598064|3691960|B3|VARICEAL BLEEDING||Variceal bleeding||participants|Number|1|1.0||||||
3866830|NCT01598064|3691961|B2|VARICEAL BLEEDING||Variceal bleeding||participants|Number|1|1.0||||||
3866831|NCT01598064|3691962|B1|VARICEAL BLEEDING||Variceal bleeding||participants|Number|0|0.0||||||
3866832|NCT01598064|3691960|B3|NO ASCITES||Ascites||participants|Number|33|33.0||||||
3866833|NCT01598064|3691961|B2|NO ASCITES||Ascites||participants|Number|17|17.0||||||
3866834|NCT01598064|3691962|B1|NO ASCITES||Ascites||participants|Number|16|16.0||||||
3866835|NCT01598064|3691960|B3|ASCITES||Ascites||participants|Number|16|16.0||||||
3866836|NCT01598064|3691961|B2|ASCITES||Ascites||participants|Number|7|7.0||||||
3866837|NCT01598064|3691962|B1|ASCITES||Ascites||participants|Number|9|9.0||||||
3866838|NCT01598064|3691960|B3|NON-HCV||HCV||participants|Number|35|35.0||||||
3866839|NCT01598064|3691961|B2|NON-HCV||HCV||participants|Number|18|18.0||||||
3866840|NCT01598064|3691962|B1|NON-HCV||HCV||participants|Number|17|17.0||||||
3866841|NCT01598064|3691960|B3|HCV||HCV||participants|Number|14|14.0||||||
3866842|NCT01598064|3691961|B2|HCV||HCV||participants|Number|6|6.0||||||
3866843|NCT01598064|3691962|B1|HCV||HCV||participants|Number|8|8.0||||||
3866844|NCT01598064|3691960|B3|NON-HBV||HBV||participants|Number|29|29.0||||||
3866845|NCT01598064|3691961|B2|NON-HBV||HBV||participants|Number|13|13.0||||||
3866846|NCT01598064|3691962|B1|NON-HBV||HBV||participants|Number|16|16.0||||||
3866847|NCT01598064|3691960|B3|HBV||HBV||participants|Number|20|20.0||||||
3866848|NCT01598064|3691961|B2|HBV||HBV||participants|Number|11|11.0||||||
3866849|NCT01598064|3691962|B1|HBV||HBV||participants|Number|9|9.0||||||
3866850|NCT01598064|3691960|B3|NON-ALCOHOLISM||Alcoholism||participants|Number|45|45.0||||||
3866851|NCT01598064|3691961|B2|NON-ALCOHOLISM||Alcoholism||participants|Number|22|22.0||||||
3866852|NCT01598064|3691962|B1|NON-ALCOHOLISM||Alcoholism||participants|Number|23|23.0||||||
3866853|NCT01598064|3691960|B3|ALCOHOLSIM||Alcoholism||participants|Number|4|4.0||||||
3866854|NCT01598064|3691961|B2|ALCOHOLSIM||Alcoholism||participants|Number|2|2.0||||||
3866855|NCT01598064|3691962|B1|ALCOHOLSIM||Alcoholism||participants|Number|2|2.0||||||
3866856|NCT01598064|3691960|B3|CIRRHOSIS WITH REASONS||Reasons of cirrhosis||participants|Number|42|42.0||||||
3866857|NCT01598064|3691961|B2|CIRRHOSIS WITH REASONS||Reasons of cirrhosis||participants|Number|21|21.0||||||
3866858|NCT01598064|3691962|B1|CIRRHOSIS WITH REASONS||Reasons of cirrhosis||participants|Number|21|21.0||||||
3866859|NCT01598064|3691960|B3|CIRRHOSIS UNKNOWN REASONS||Reasons of cirrhosis||participants|Number|7|7.0||||||
3866860|NCT01598064|3691961|B2|CIRRHOSIS UNKNOWN REASONS||Reasons of cirrhosis||participants|Number|3|3.0||||||
3866861|NCT01598064|3691962|B1|CIRRHOSIS UNKNOWN REASONS||Reasons of cirrhosis||participants|Number|4|4.0||||||
3866862|NCT01598064|3691960|B3|Taiwan||Region of Enrollment||participants|Number|49|49.0||||||
3866863|NCT01598064|3691961|B2|Taiwan||Region of Enrollment||participants|Number|24|24.0||||||
3866864|NCT01598064|3691962|B1|Taiwan||Region of Enrollment||participants|Number|25|25.0||||||
3866865|NCT01598064|3691960|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3866866|NCT01598064|3691961|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3866867|NCT01598064|3691962|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3866868|NCT01598064|3691960|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3866869|NCT01598064|3691961|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3866870|NCT01598064|3691962|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3866871|NCT01598064|3691960|B3|||Age||years|Mean|59.4|59.4|Standard Deviation|11.2|11.2|||
3866872|NCT01598064|3691961|B2|||Age||years|Mean|58.9|58.9|Standard Deviation|10.6|10.6|||
3866873|NCT01598064|3691962|B1|||Age||years|Mean|59.9|59.9|Standard Deviation|12|12.0|||
3866874|NCT01598025|3691971|B3|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3866875|NCT01598025|3691972|B2|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3866876|NCT01598025|3691973|B1|United States||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3866877|NCT01598025|3691971|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866878|NCT01598025|3691972|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866879|NCT01598025|3691973|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866880|NCT01598025|3691971|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866881|NCT01598025|3691972|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866882|NCT01598025|3691973|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866883|NCT01598025|3691971|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3866884|NCT01598025|3691972|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3866885|NCT01598025|3691973|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866886|NCT01598025|3691971|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866887|NCT01598025|3691972|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866888|NCT01598025|3691973|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866889|NCT01598025|3691971|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866890|NCT01598025|3691972|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866891|NCT01598025|3691973|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866892|NCT01598025|3691971|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3866893|NCT01598025|3691972|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3866894|NCT01598025|3691973|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866895|NCT01598025|3691971|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866896|NCT01598025|3691972|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866897|NCT01598025|3691973|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866898|NCT01598025|3691971|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866899|NCT01598025|3691972|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866900|NCT01598025|3691973|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866901|NCT01598025|3691971|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3866902|NCT01598025|3691972|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3866903|NCT01598025|3691973|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866904|NCT01598025|3691971|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866905|NCT01598025|3691972|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866906|NCT01598025|3691973|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866907|NCT01598025|3691971|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3866908|NCT01598025|3691972|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3866909|NCT01598025|3691973|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3866910|NCT01598025|3691971|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3866911|NCT01598025|3691972|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3866912|NCT01598025|3691973|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3866913|NCT01598025|3691971|B3|||Age||years|Median|12|12.0|Full Range|||11.0|17.0|
3866914|NCT01598025|3691972|B2|||Age||years|Median|12|12.0|Full Range|||11.0|17.0|
3866915|NCT01597908|3691981|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3866916|NCT01597908|3691982|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3866917|NCT01597908|3691983|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3866918|NCT01597908|3691981|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3866919|NCT01597908|3691982|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3866920|NCT01597908|3691983|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3866921|NCT01597908|3691981|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3866922|NCT01597908|3691982|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3866923|NCT01597908|3691983|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3866924|NCT01597908|3691981|B3|White - Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3866925|NCT01597908|3691982|B2|White - Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3866926|NCT01597908|3691983|B1|White - Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3866927|NCT01597908|3691981|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|678|678.0||||||
3866928|NCT01597908|3691982|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|339|339.0||||||
3866929|NCT01597908|3691983|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|339|339.0||||||
3866930|NCT01597908|3691981|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3866931|NCT01597908|3691982|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3866932|NCT01597908|3691983|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3866933|NCT01597908|3691981|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
3866934|NCT01597908|3691982|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3866935|NCT01597908|3691983|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3866936|NCT01597908|3691981|B3||Male|Sex: Female, Male||Participants|Count of Participants|388|388.0||||||
3866937|NCT01597908|3691982|B2||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3866938|NCT01597908|3691983|B1||Male|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
3866939|NCT01597908|3691981|B3||Female|Sex: Female, Male||Participants|Count of Participants|316|316.0||||||
3866940|NCT01597908|3691982|B2||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3866941|NCT01597908|3691983|B1||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3866942|NCT01597908|3691981|B3|||Age||Years|Median|54.5|54.5|Full Range|13.94|13.94|18.0|91.0|
3866943|NCT01597908|3691982|B2|||Age||Years|Median|54.0|54.0|Full Range|14.06|14.06|18.0|88.0|
3866944|NCT01597908|3691983|B1|||Age||Years|Median|55.0|55.0|Full Range|13.83|13.83|18.0|91.0|
3866945|NCT01597843|3691996|B4|Missing||Proportion at Educational level|Self report on survey. The mean presented is the mean proportion of all survey responses from each of the posts in each group. We treated all surveys as independent. Thus, the proportion of responses in each category (i.e., Less than high school; High school or GED; college or technical degree; Missing) adds up to 1.0 for each group.|Proportion of participants|Mean|0.053|0.053|Standard Deviation|0.224|0.224|||
3866961|NCT01597843|3691996|B4||Male|Sex: Female, Male|Since the vast majority (> 95%)of members are male, we did not gather gender data. We report them as 100% male, knowing this is likely incorrect.|Participants|Count of Participants|282|282.0||||||
3866946|NCT01597843|3691997|B3|Missing||Proportion at Educational level|Self report on survey. The mean presented is the mean proportion of all survey responses from each of the posts in each group. We treated all surveys as independent. Thus, the proportion of responses in each category (i.e., Less than high school; High school or GED; college or technical degree; Missing) adds up to 1.0 for each group.|Proportion of participants|Mean|0.036|0.036|Standard Deviation|0.186|0.186|||
3866947|NCT01597843|3691998|B2|Missing||Proportion at Educational level|Self report on survey. The mean presented is the mean proportion of all survey responses from each of the posts in each group. We treated all surveys as independent. Thus, the proportion of responses in each category (i.e., Less than high school; High school or GED; college or technical degree; Missing) adds up to 1.0 for each group.|Proportion of participants|Mean|0.053|0.053|Standard Deviation|0.224|0.224|||
3866948|NCT01597843|3691999|B1|Missing||Proportion at Educational level|Self report on survey. The mean presented is the mean proportion of all survey responses from each of the posts in each group. We treated all surveys as independent. Thus, the proportion of responses in each category (i.e., Less than high school; High school or GED; college or technical degree; Missing) adds up to 1.0 for each group.|Proportion of participants|Mean|0.074|0.074|Standard Deviation|0.262|0.262|||
3866949|NCT01597843|3691996|B4|College or technical degree||Proportion at Educational level|Self report on survey. The mean presented is the mean proportion of all survey responses from each of the posts in each group. We treated all surveys as independent. Thus, the proportion of responses in each category (i.e., Less than high school; High school or GED; college or technical degree; Missing) adds up to 1.0 for each group.|Proportion of participants|Mean|0.315|0.315|Standard Deviation|0.465|0.465|||
3866950|NCT01597843|3691997|B3|College or technical degree||Proportion at Educational level|Self report on survey. The mean presented is the mean proportion of all survey responses from each of the posts in each group. We treated all surveys as independent. Thus, the proportion of responses in each category (i.e., Less than high school; High school or GED; college or technical degree; Missing) adds up to 1.0 for each group.|Proportion of participants|Mean|0.233|0.233|Standard Deviation|0.423|0.423|||
3866951|NCT01597843|3691998|B2|College or technical degree||Proportion at Educational level|Self report on survey. The mean presented is the mean proportion of all survey responses from each of the posts in each group. We treated all surveys as independent. Thus, the proportion of responses in each category (i.e., Less than high school; High school or GED; college or technical degree; Missing) adds up to 1.0 for each group.|Proportion of participants|Mean|0.479|0.479|Standard Deviation|0.500|0.5|||
3866952|NCT01597843|3691999|B1|College or technical degree||Proportion at Educational level|Self report on survey. The mean presented is the mean proportion of all survey responses from each of the posts in each group. We treated all surveys as independent. Thus, the proportion of responses in each category (i.e., Less than high school; High school or GED; college or technical degree; Missing) adds up to 1.0 for each group.|Proportion of participants|Mean|0.241|0.241|Standard Deviation|0.428|0.428|||
3866953|NCT01597843|3691996|B4|High school or GED||Proportion at Educational level|Self report on survey. The mean presented is the mean proportion of all survey responses from each of the posts in each group. We treated all surveys as independent. Thus, the proportion of responses in each category (i.e., Less than high school; High school or GED; college or technical degree; Missing) adds up to 1.0 for each group.|Proportion of participants|Mean|0.580|0.58|Standard Deviation|0.494|0.494|||
3866954|NCT01597843|3691997|B3|High school or GED||Proportion at Educational level|Self report on survey. The mean presented is the mean proportion of all survey responses from each of the posts in each group. We treated all surveys as independent. Thus, the proportion of responses in each category (i.e., Less than high school; High school or GED; college or technical degree; Missing) adds up to 1.0 for each group.|Proportion of participants|Mean|0.674|0.674|Standard Deviation|0.469|0.469|||
3866955|NCT01597843|3691998|B2|High school or GED||Proportion at Educational level|Self report on survey. The mean presented is the mean proportion of all survey responses from each of the posts in each group. We treated all surveys as independent. Thus, the proportion of responses in each category (i.e., Less than high school; High school or GED; college or technical degree; Missing) adds up to 1.0 for each group.|Proportion of participants|Mean|0.438|0.438|Standard Deviation|0.50|0.5|||
3866956|NCT01597843|3691999|B1|High school or GED||Proportion at Educational level|Self report on survey. The mean presented is the mean proportion of all survey responses from each of the posts in each group. We treated all surveys as independent. Thus, the proportion of responses in each category (i.e., Less than high school; High school or GED; college or technical degree; Missing) adds up to 1.0 for each group.|Proportion of participants|Mean|0.617|0.617|Standard Deviation|0.48|0.48|||
3866957|NCT01597843|3691996|B4|Less than high school||Proportion at Educational level|Self report on survey. The mean presented is the mean proportion of all survey responses from each of the posts in each group. We treated all surveys as independent. Thus, the proportion of responses in each category (i.e., Less than high school; High school or GED; college or technical degree; Missing) adds up to 1.0 for each group.|Proportion of participants|Mean|0.052|0.052|Standard Deviation|0.22|0.22|||
3866958|NCT01597843|3691997|B3|Less than high school||Proportion at Educational level|Self report on survey. The mean presented is the mean proportion of all survey responses from each of the posts in each group. We treated all surveys as independent. Thus, the proportion of responses in each category (i.e., Less than high school; High school or GED; college or technical degree; Missing) adds up to 1.0 for each group.|Proportion of participants|Mean|0.057|0.057|Standard Deviation|0.23|0.23|||
3866959|NCT01597843|3691998|B2|Less than high school||Proportion at Educational level|Self report on survey. The mean presented is the mean proportion of all survey responses from each of the posts in each group. We treated all surveys as independent. Thus, the proportion of responses in each category (i.e., Less than high school; High school or GED; college or technical degree; Missing) adds up to 1.0 for each group.|Proportion of participants|Mean|0.030|0.03|Standard Deviation|0.17|0.17|||
3866960|NCT01597843|3691999|B1|Less than high school||Proportion at Educational level|Self report on survey. The mean presented is the mean proportion of all survey responses from each of the posts in each group. We treated all surveys as independent. Thus, the proportion of responses in each category (i.e., Less than high school; High school or GED; college or technical degree; Missing) adds up to 1.0 for each group.|Proportion of participants|Mean|0.068|0.068|Standard Deviation|0.25|0.25|||
3867004|NCT01597635|3692020|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3866962|NCT01597843|3691997|B3||Male|Sex: Female, Male|Since the vast majority (> 95%)of members are male, we did not gather gender data. We report them as 100% male, knowing this is likely incorrect.|Participants|Count of Participants|81|81.0||||||
3866963|NCT01597843|3691998|B2||Male|Sex: Female, Male|Since the vast majority (> 95%)of members are male, we did not gather gender data. We report them as 100% male, knowing this is likely incorrect.|Participants|Count of Participants|122|122.0||||||
3866964|NCT01597843|3691999|B1||Male|Sex: Female, Male|Since the vast majority (> 95%)of members are male, we did not gather gender data. We report them as 100% male, knowing this is likely incorrect.|Participants|Count of Participants|79|79.0||||||
3866965|NCT01597843|3691996|B4||Female|Sex: Female, Male|Since the vast majority (> 95%)of members are male, we did not gather gender data. We report them as 100% male, knowing this is likely incorrect.|Participants|Count of Participants|0|0.0||||||
3866966|NCT01597843|3691997|B3||Female|Sex: Female, Male|Since the vast majority (> 95%)of members are male, we did not gather gender data. We report them as 100% male, knowing this is likely incorrect.|Participants|Count of Participants|0|0.0||||||
3866967|NCT01597843|3691998|B2||Female|Sex: Female, Male|Since the vast majority (> 95%)of members are male, we did not gather gender data. We report them as 100% male, knowing this is likely incorrect.|Participants|Count of Participants|0|0.0||||||
3866968|NCT01597843|3691999|B1||Female|Sex: Female, Male|Since the vast majority (> 95%)of members are male, we did not gather gender data. We report them as 100% male, knowing this is likely incorrect.|Participants|Count of Participants|0|0.0||||||
3866969|NCT01597843|3691996|B4|||Age|Age from self reported survey. We combined data from all three survey rounds to obtain the most stable estimate of age. Note that we do not have data on all people in intervention groups, just the respondents. The mean age presented is at the person level. Thus, for each group, data from all survey respondents in the 4 posts in that group are included.|Years|Mean|67.1|67.1|Standard Deviation|11.4|11.4|||
3866970|NCT01597843|3691997|B3|||Age|Age from self reported survey. We combined data from all three survey rounds to obtain the most stable estimate of age. Note that we do not have data on all people in intervention groups, just the respondents. The mean age presented is at the person level. Thus, for each group, data from all survey respondents in the 4 posts in that group are included.|Years|Mean|66.6|66.6|Standard Deviation|12.4|12.4|||
3866971|NCT01597843|3691998|B2|||Age|Age from self reported survey. We combined data from all three survey rounds to obtain the most stable estimate of age. Note that we do not have data on all people in intervention groups, just the respondents. The mean age presented is at the person level. Thus, for each group, data from all survey respondents in the 4 posts in that group are included.|Years|Mean|65.0|65.0|Standard Deviation|10.7|10.7|||
3866972|NCT01597843|3691999|B1|||Age|Age from self reported survey. We combined data from all three survey rounds to obtain the most stable estimate of age. Note that we do not have data on all people in intervention groups, just the respondents. The mean age presented is at the person level. Thus, for each group, data from all survey respondents in the 4 posts in that group are included.|Years|Mean|69.9|69.9|Standard Deviation|10.3|10.3|||
3866973|NCT01597791|3692009|B3|United States||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
3866974|NCT01597791|3692010|B2|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3866975|NCT01597791|3692011|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3866976|NCT01597791|3692009|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3866977|NCT01597791|3692010|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3866978|NCT01597791|3692011|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3866979|NCT01597791|3692009|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3866980|NCT01597791|3692010|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3866981|NCT01597791|3692011|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3866982|NCT01597791|3692009|B3|||Age||years|Mean|33.4|33.4|Standard Deviation|5.6|5.6|||
3866983|NCT01597791|3692010|B2|||Age||years|Mean|33|33.0|Standard Deviation|3.8|3.8|||
3866984|NCT01597791|3692011|B1|||Age||years|Mean|34|34.0|Standard Deviation|6.8|6.8|||
3866985|NCT01597791|3692009|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3866986|NCT01597791|3692010|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3866987|NCT01597791|3692011|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3866988|NCT01597791|3692009|B3||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3866989|NCT01597791|3692010|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3866990|NCT01597791|3692011|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3866991|NCT01597791|3692009|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3866992|NCT01597791|3692010|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3866993|NCT01597791|3692011|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3866994|NCT01597635|3692018|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866995|NCT01597635|3692019|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866996|NCT01597635|3692020|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866997|NCT01597635|3692021|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866998|NCT01597635|3692018|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3866999|NCT01597635|3692019|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867000|NCT01597635|3692020|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867001|NCT01597635|3692021|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867002|NCT01597635|3692018|B4||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3867003|NCT01597635|3692019|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3867005|NCT01597635|3692021|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3867006|NCT01597635|3692018|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3867007|NCT01597635|3692019|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867008|NCT01597635|3692020|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3867009|NCT01597635|3692021|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867010|NCT01597635|3692018|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867011|NCT01597635|3692019|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867012|NCT01597635|3692020|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867013|NCT01597635|3692021|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867014|NCT01597635|3692018|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3867015|NCT01597635|3692019|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3867016|NCT01597635|3692020|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3867017|NCT01597635|3692021|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867018|NCT01597635|3692018|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3867019|NCT01597635|3692019|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867020|NCT01597635|3692020|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3867021|NCT01597635|3692021|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867022|NCT01597635|3692018|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3867023|NCT01597635|3692019|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3867024|NCT01597635|3692020|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3867025|NCT01597635|3692021|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3867026|NCT01597635|3692018|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3867027|NCT01597635|3692019|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3867028|NCT01597635|3692020|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3867029|NCT01597635|3692021|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3867030|NCT01597635|3692018|B4|18-80 years||Age, Customized||Participants|Count of Participants|44|44.0||||||
3867031|NCT01597635|3692019|B3|18-80 years||Age, Customized||Participants|Count of Participants|19|19.0||||||
3867032|NCT01597635|3692020|B2|18-80 years||Age, Customized||Participants|Count of Participants|20|20.0||||||
3867033|NCT01597635|3692021|B1|18-80 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
3867034|NCT01597596|3692086|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3867035|NCT01597596|3692087|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3867036|NCT01597596|3692088|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3867037|NCT01597596|3692086|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3867038|NCT01597596|3692087|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3867039|NCT01597596|3692088|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3867040|NCT01597596|3692086|B3|||Age||years|Mean|0.4|0.4|Standard Deviation|0.14|0.14|||
3867041|NCT01597596|3692087|B2|||Age||years|Mean|0.5|0.5|Standard Deviation|0.28|0.28|||
3867042|NCT01597596|3692088|B1|||Age||years|Mean|0.3|0.3|Standard Deviation|||||
3867043|NCT01597505|3692101|B3|Without BI/NAP1/027 Strain||BI/NAP1/027 Strain|Number of participants with the BI/NAP1/027 Strain|Participants|Number|375|375.0||||||
3867044|NCT01597505|3692102|B2|Without BI/NAP1/027 Strain||BI/NAP1/027 Strain|Number of participants with the BI/NAP1/027 Strain|Participants|Number|179|179.0||||||
3867045|NCT01597505|3692103|B1|Without BI/NAP1/027 Strain||BI/NAP1/027 Strain|Number of participants with the BI/NAP1/027 Strain|Participants|Number|196|196.0||||||
3867046|NCT01597505|3692101|B3|With BI/NAP1/027 Strain||BI/NAP1/027 Strain|Number of participants with the BI/NAP1/027 Strain|Participants|Number|126|126.0||||||
3867047|NCT01597505|3692102|B2|With BI/NAP1/027 Strain||BI/NAP1/027 Strain|Number of participants with the BI/NAP1/027 Strain|Participants|Number|67|67.0||||||
3867048|NCT01597505|3692103|B1|With BI/NAP1/027 Strain||BI/NAP1/027 Strain|Number of participants with the BI/NAP1/027 Strain|Participants|Number|59|59.0||||||
3867049|NCT01597505|3692101|B3|>= 1 Previous Episodes||Previous episodes of CDAD|Number of participants with previous episodes of CDAD|Participants|Number|100|100.0||||||
3867050|NCT01597505|3692102|B2|>= 1 Previous Episodes||Previous episodes of CDAD|Number of participants with previous episodes of CDAD|Participants|Number|51|51.0||||||
3867051|NCT01597505|3692103|B1|>= 1 Previous Episodes||Previous episodes of CDAD|Number of participants with previous episodes of CDAD|Participants|Number|49|49.0||||||
3867052|NCT01597505|3692101|B3|0 Previous Episodes||Previous episodes of CDAD|Number of participants with previous episodes of CDAD|Participants|Number|461|461.0||||||
3867053|NCT01597505|3692102|B2|0 Previous Episodes||Previous episodes of CDAD|Number of participants with previous episodes of CDAD|Participants|Number|224|224.0||||||
3867054|NCT01597505|3692103|B1|0 Previous Episodes||Previous episodes of CDAD|Number of participants with previous episodes of CDAD|Participants|Number|237|237.0||||||
3867055|NCT01597505|3692101|B3||Male|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
3867056|NCT01597505|3692102|B2||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3867057|NCT01597505|3692103|B1||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3867058|NCT01597505|3692101|B3||Female|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
3867059|NCT01597505|3692102|B2||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
3867060|NCT01597505|3692103|B1||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
3867061|NCT01597505|3692101|B3|>= 75 years old||Age, Customized|Number of participants <75 or >=75 years old at First Dose|Participants|Number|159|159.0||||||
3867062|NCT01597505|3692102|B2|>= 75 years old||Age, Customized|Number of participants <75 or >=75 years old at First Dose|Participants|Number|80|80.0||||||
3867063|NCT01597505|3692103|B1|>= 75 years old||Age, Customized|Number of participants <75 or >=75 years old at First Dose|Participants|Number|79|79.0||||||
3867064|NCT01597505|3692101|B3|< 75 years old||Age, Customized|Number of participants <75 or >=75 years old at First Dose|Participants|Number|411|411.0||||||
3867065|NCT01597505|3692102|B2|< 75 years old||Age, Customized|Number of participants <75 or >=75 years old at First Dose|Participants|Number|200|200.0||||||
3867066|NCT01597505|3692103|B1|< 75 years old||Age, Customized|Number of participants <75 or >=75 years old at First Dose|Participants|Number|211|211.0||||||
3867067|NCT01597505|3692101|B3|||Age||Years|Mean|61.6|61.6|Standard Deviation|17.9|17.9|||
3867068|NCT01597505|3692102|B2|||Age||Years|Mean|61.8|61.8|Standard Deviation|18.4|18.4|||
3867069|NCT01597505|3692103|B1|||Age||Years|Mean|61.5|61.5|Standard Deviation|17.5|17.5|||
3867070|NCT01597492|3692136|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3867071|NCT01597492|3692137|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3867072|NCT01597492|3692138|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3867073|NCT01597492|3692136|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3867074|NCT01597492|3692137|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3867075|NCT01597492|3692138|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3867076|NCT01597492|3692136|B3|Asian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3867077|NCT01597492|3692137|B2|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3867078|NCT01597492|3692138|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3867079|NCT01597492|3692136|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
3867080|NCT01597492|3692137|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3867081|NCT01597492|3692138|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3867082|NCT01597492|3692136|B3|White||Race/Ethnicity, Customized||Participants|Number|52|52.0||||||
3867083|NCT01597492|3692137|B2|White||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
3867084|NCT01597492|3692138|B1|White||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
3867085|NCT01597492|3692136|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3867086|NCT01597492|3692137|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3867087|NCT01597492|3692138|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3867088|NCT01597492|3692136|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3867089|NCT01597492|3692137|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3867090|NCT01597492|3692138|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3867091|NCT01597492|3692136|B3|||Age||Years|Mean|39.6|39.6|Standard Deviation|12.40|12.4|||
3867092|NCT01597492|3692137|B2|||Age||Years|Mean|38.6|38.6|Standard Deviation|12.31|12.31|||
3867093|NCT01597492|3692138|B1|||Age||Years|Mean|41.0|41.0|Standard Deviation|12.57|12.57|||
3867094|NCT01597479|3692145|B3|Spain||Region of Enrollment||participants|Number|50|50.0||||||
3867095|NCT01597479|3692146|B2|Spain||Region of Enrollment||participants|Number|26|26.0||||||
3867096|NCT01597479|3692147|B1|Spain||Region of Enrollment||participants|Number|24|24.0||||||
3867097|NCT01597479|3692145|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3867098|NCT01597479|3692146|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3867099|NCT01597479|3692147|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3867100|NCT01597479|3692145|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3867101|NCT01597479|3692146|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3867102|NCT01597479|3692147|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3867103|NCT01597479|3692145|B3|years||Age||years|Mean|65.7|65.7|Standard Deviation|7.2|7.2|||
3867104|NCT01597479|3692146|B2|years||Age||years|Mean|64.2|64.2|Standard Deviation|7.5|7.5|||
3867105|NCT01597479|3692147|B1|years||Age||years|Mean|67.4|67.4|Standard Deviation|6.5|6.5|||
3867106|NCT01597440|3692155|B3|||NH3||mcmol/L|Mean|223|223.0|Standard Deviation|0|0.0|||
3867107|NCT01597440|3692157|B1|||NH3||mcmol/L|Mean|223|223.0|Standard Deviation|0|0.0|||
3867108|NCT01597440|3692155|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3867109|NCT01597440|3692157|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3867110|NCT01597440|3692155|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3867111|NCT01597440|3692157|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3867112|NCT01597440|3692155|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3867113|NCT01597440|3692157|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3867114|NCT01597440|3692155|B3|||Age||days|Mean|4|4.0|Standard Deviation|0|0.0|||
3867115|NCT01597440|3692157|B1|||Age||days|Mean|4|4.0|Standard Deviation|0|0.0|||
3867116|NCT01597440|3692155|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3867117|NCT01597440|3692157|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3867118|NCT01597440|3692155|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3867119|NCT01597440|3692157|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3867120|NCT01597440|3692155|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3867121|NCT01597440|3692157|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3867122|NCT01597388|3692166|B10||No|Human Epidermal Growth Factor Receptor Positive (HER+)||Participants|Count of Participants|90|90.0||||||
3867123|NCT01597388|3692167|B9||No|Human Epidermal Growth Factor Receptor Positive (HER+)||Participants|Count of Participants|2|2.0||||||
3867124|NCT01597388|3692168|B8||No|Human Epidermal Growth Factor Receptor Positive (HER+)||Participants|Count of Participants|4|4.0||||||
3867125|NCT01597388|3692169|B7||No|Human Epidermal Growth Factor Receptor Positive (HER+)||Participants|Count of Participants|6|6.0||||||
3867126|NCT01597388|3692170|B6||No|Human Epidermal Growth Factor Receptor Positive (HER+)||Participants|Count of Participants|4|4.0||||||
3867127|NCT01597388|3692171|B5||No|Human Epidermal Growth Factor Receptor Positive (HER+)||Participants|Count of Participants|33|33.0||||||
3867128|NCT01597388|3692172|B4||No|Human Epidermal Growth Factor Receptor Positive (HER+)||Participants|Count of Participants|9|9.0||||||
3867129|NCT01597388|3692173|B3||No|Human Epidermal Growth Factor Receptor Positive (HER+)||Participants|Count of Participants|14|14.0||||||
3867130|NCT01597388|3692174|B2||No|Human Epidermal Growth Factor Receptor Positive (HER+)||Participants|Count of Participants|12|12.0||||||
3867131|NCT01597388|3692175|B1||No|Human Epidermal Growth Factor Receptor Positive (HER+)||Participants|Count of Participants|6|6.0||||||
3867132|NCT01597388|3692166|B10||Yes|Human Epidermal Growth Factor Receptor Positive (HER+)||Participants|Count of Participants|9|9.0||||||
3867133|NCT01597388|3692167|B9||Yes|Human Epidermal Growth Factor Receptor Positive (HER+)||Participants|Count of Participants|0|0.0||||||
3867134|NCT01597388|3692168|B8||Yes|Human Epidermal Growth Factor Receptor Positive (HER+)||Participants|Count of Participants|1|1.0||||||
3867135|NCT01597388|3692169|B7||Yes|Human Epidermal Growth Factor Receptor Positive (HER+)||Participants|Count of Participants|2|2.0||||||
3867136|NCT01597388|3692170|B6||Yes|Human Epidermal Growth Factor Receptor Positive (HER+)||Participants|Count of Participants|0|0.0||||||
3867137|NCT01597388|3692171|B5||Yes|Human Epidermal Growth Factor Receptor Positive (HER+)||Participants|Count of Participants|4|4.0||||||
3867138|NCT01597388|3692172|B4||Yes|Human Epidermal Growth Factor Receptor Positive (HER+)||Participants|Count of Participants|1|1.0||||||
3867139|NCT01597388|3692173|B3||Yes|Human Epidermal Growth Factor Receptor Positive (HER+)||Participants|Count of Participants|0|0.0||||||
3867140|NCT01597388|3692174|B2||Yes|Human Epidermal Growth Factor Receptor Positive (HER+)||Participants|Count of Participants|1|1.0||||||
3867141|NCT01597388|3692175|B1||Yes|Human Epidermal Growth Factor Receptor Positive (HER+)||Participants|Count of Participants|0|0.0||||||
3867142|NCT01597388|3692166|B10||No|Progesterone Receptor Positive (PR+)||Participants|Count of Participants|34|34.0||||||
3867143|NCT01597388|3692167|B9||No|Progesterone Receptor Positive (PR+)||Participants|Count of Participants|0|0.0||||||
3867144|NCT01597388|3692168|B8||No|Progesterone Receptor Positive (PR+)||Participants|Count of Participants|4|4.0||||||
3867145|NCT01597388|3692169|B7||No|Progesterone Receptor Positive (PR+)||Participants|Count of Participants|4|4.0||||||
3867146|NCT01597388|3692170|B6||No|Progesterone Receptor Positive (PR+)||Participants|Count of Participants|0|0.0||||||
3867147|NCT01597388|3692171|B5||No|Progesterone Receptor Positive (PR+)||Participants|Count of Participants|7|7.0||||||
3867148|NCT01597388|3692172|B4||No|Progesterone Receptor Positive (PR+)||Participants|Count of Participants|3|3.0||||||
3867149|NCT01597388|3692173|B3||No|Progesterone Receptor Positive (PR+)||Participants|Count of Participants|7|7.0||||||
3867150|NCT01597388|3692174|B2||No|Progesterone Receptor Positive (PR+)||Participants|Count of Participants|6|6.0||||||
3867151|NCT01597388|3692175|B1||No|Progesterone Receptor Positive (PR+)||Participants|Count of Participants|3|3.0||||||
3867152|NCT01597388|3692166|B10||Yes|Progesterone Receptor Positive (PR+)||Participants|Count of Participants|65|65.0||||||
3867153|NCT01597388|3692167|B9||Yes|Progesterone Receptor Positive (PR+)||Participants|Count of Participants|2|2.0||||||
3867154|NCT01597388|3692168|B8||Yes|Progesterone Receptor Positive (PR+)||Participants|Count of Participants|1|1.0||||||
3867155|NCT01597388|3692169|B7||Yes|Progesterone Receptor Positive (PR+)||Participants|Count of Participants|4|4.0||||||
3867156|NCT01597388|3692170|B6||Yes|Progesterone Receptor Positive (PR+)||Participants|Count of Participants|4|4.0||||||
3867157|NCT01597388|3692171|B5||Yes|Progesterone Receptor Positive (PR+)||Participants|Count of Participants|30|30.0||||||
3867158|NCT01597388|3692172|B4||Yes|Progesterone Receptor Positive (PR+)||Participants|Count of Participants|7|7.0||||||
3867159|NCT01597388|3692173|B3||Yes|Progesterone Receptor Positive (PR+)||Participants|Count of Participants|7|7.0||||||
3867160|NCT01597388|3692174|B2||Yes|Progesterone Receptor Positive (PR+)||Participants|Count of Participants|7|7.0||||||
3867161|NCT01597388|3692175|B1||Yes|Progesterone Receptor Positive (PR+)||Participants|Count of Participants|3|3.0||||||
3867162|NCT01597388|3692166|B10||No|Estrogen Receptor Positive (ER+)||Participants|Count of Participants|0|0.0||||||
3867163|NCT01597388|3692167|B9||No|Estrogen Receptor Positive (ER+)||Participants|Count of Participants|0|0.0||||||
3867164|NCT01597388|3692168|B8||No|Estrogen Receptor Positive (ER+)||Participants|Count of Participants|0|0.0||||||
3867165|NCT01597388|3692169|B7||No|Estrogen Receptor Positive (ER+)||Participants|Count of Participants|0|0.0||||||
3867166|NCT01597388|3692170|B6||No|Estrogen Receptor Positive (ER+)||Participants|Count of Participants|0|0.0||||||
3867167|NCT01597388|3692171|B5||No|Estrogen Receptor Positive (ER+)||Participants|Count of Participants|0|0.0||||||
3867168|NCT01597388|3692172|B4||No|Estrogen Receptor Positive (ER+)||Participants|Count of Participants|0|0.0||||||
3867169|NCT01597388|3692173|B3||No|Estrogen Receptor Positive (ER+)||Participants|Count of Participants|0|0.0||||||
3867170|NCT01597388|3692174|B2||No|Estrogen Receptor Positive (ER+)||Participants|Count of Participants|0|0.0||||||
3867171|NCT01597388|3692175|B1||No|Estrogen Receptor Positive (ER+)||Participants|Count of Participants|0|0.0||||||
3867172|NCT01597388|3692166|B10||Yes|Estrogen Receptor Positive (ER+)||Participants|Count of Participants|99|99.0||||||
3867173|NCT01597388|3692167|B9||Yes|Estrogen Receptor Positive (ER+)||Participants|Count of Participants|2|2.0||||||
3867174|NCT01597388|3692168|B8||Yes|Estrogen Receptor Positive (ER+)||Participants|Count of Participants|5|5.0||||||
3867175|NCT01597388|3692169|B7||Yes|Estrogen Receptor Positive (ER+)||Participants|Count of Participants|8|8.0||||||
3867176|NCT01597388|3692170|B6||Yes|Estrogen Receptor Positive (ER+)||Participants|Count of Participants|4|4.0||||||
3867177|NCT01597388|3692171|B5||Yes|Estrogen Receptor Positive (ER+)||Participants|Count of Participants|37|37.0||||||
3867178|NCT01597388|3692172|B4||Yes|Estrogen Receptor Positive (ER+)||Participants|Count of Participants|10|10.0||||||
3867179|NCT01597388|3692173|B3||Yes|Estrogen Receptor Positive (ER+)||Participants|Count of Participants|14|14.0||||||
3867180|NCT01597388|3692174|B2||Yes|Estrogen Receptor Positive (ER+)||Participants|Count of Participants|13|13.0||||||
3867181|NCT01597388|3692175|B1||Yes|Estrogen Receptor Positive (ER+)||Participants|Count of Participants|6|6.0||||||
3867182|NCT01597388|3692166|B10||Locally advanced|Overall disease classification||Participants|Count of Participants|1|1.0||||||
3867183|NCT01597388|3692167|B9||Locally advanced|Overall disease classification||Participants|Count of Participants|0|0.0||||||
3867184|NCT01597388|3692168|B8||Locally advanced|Overall disease classification||Participants|Count of Participants|0|0.0||||||
3867185|NCT01597388|3692169|B7||Locally advanced|Overall disease classification||Participants|Count of Participants|0|0.0||||||
3867186|NCT01597388|3692170|B6||Locally advanced|Overall disease classification||Participants|Count of Participants|0|0.0||||||
3867187|NCT01597388|3692171|B5||Locally advanced|Overall disease classification||Participants|Count of Participants|0|0.0||||||
3867188|NCT01597388|3692172|B4||Locally advanced|Overall disease classification||Participants|Count of Participants|1|1.0||||||
3867189|NCT01597388|3692173|B3||Locally advanced|Overall disease classification||Participants|Count of Participants|0|0.0||||||
3867190|NCT01597388|3692174|B2||Locally advanced|Overall disease classification||Participants|Count of Participants|0|0.0||||||
3867191|NCT01597388|3692175|B1||Locally advanced|Overall disease classification||Participants|Count of Participants|0|0.0||||||
3867192|NCT01597388|3692166|B10||Metastatic|Overall disease classification||Participants|Count of Participants|98|98.0||||||
3867193|NCT01597388|3692167|B9||Metastatic|Overall disease classification||Participants|Count of Participants|2|2.0||||||
3867194|NCT01597388|3692168|B8||Metastatic|Overall disease classification||Participants|Count of Participants|5|5.0||||||
3867195|NCT01597388|3692169|B7||Metastatic|Overall disease classification||Participants|Count of Participants|8|8.0||||||
3867196|NCT01597388|3692170|B6||Metastatic|Overall disease classification||Participants|Count of Participants|4|4.0||||||
3867197|NCT01597388|3692171|B5||Metastatic|Overall disease classification||Participants|Count of Participants|37|37.0||||||
3867198|NCT01597388|3692172|B4||Metastatic|Overall disease classification||Participants|Count of Participants|9|9.0||||||
3867199|NCT01597388|3692173|B3||Metastatic|Overall disease classification||Participants|Count of Participants|14|14.0||||||
3867200|NCT01597388|3692174|B2||Metastatic|Overall disease classification||Participants|Count of Participants|13|13.0||||||
3867201|NCT01597388|3692175|B1||Metastatic|Overall disease classification||Participants|Count of Participants|6|6.0||||||
3867202|NCT01597388|3692166|B10||> 12 months|Time from most recent progression to enrollment||Participants|Count of Participants|4|4.0||||||
3867203|NCT01597388|3692167|B9||> 12 months|Time from most recent progression to enrollment||Participants|Count of Participants|0|0.0||||||
3867204|NCT01597388|3692168|B8||> 12 months|Time from most recent progression to enrollment||Participants|Count of Participants|0|0.0||||||
3867205|NCT01597388|3692169|B7||> 12 months|Time from most recent progression to enrollment||Participants|Count of Participants|0|0.0||||||
3867206|NCT01597388|3692170|B6||> 12 months|Time from most recent progression to enrollment||Participants|Count of Participants|0|0.0||||||
3867207|NCT01597388|3692171|B5||> 12 months|Time from most recent progression to enrollment||Participants|Count of Participants|3|3.0||||||
3867208|NCT01597388|3692172|B4||> 12 months|Time from most recent progression to enrollment||Participants|Count of Participants|0|0.0||||||
3867209|NCT01597388|3692173|B3||> 12 months|Time from most recent progression to enrollment||Participants|Count of Participants|0|0.0||||||
3867210|NCT01597388|3692174|B2||> 12 months|Time from most recent progression to enrollment||Participants|Count of Participants|1|1.0||||||
3867211|NCT01597388|3692175|B1||> 12 months|Time from most recent progression to enrollment||Participants|Count of Participants|0|0.0||||||
3867212|NCT01597388|3692166|B10||> 3 to ≤ 12 months|Time from most recent progression to enrollment||Participants|Count of Participants|11|11.0||||||
3867213|NCT01597388|3692167|B9||> 3 to ≤ 12 months|Time from most recent progression to enrollment||Participants|Count of Participants|0|0.0||||||
3867214|NCT01597388|3692168|B8||> 3 to ≤ 12 months|Time from most recent progression to enrollment||Participants|Count of Participants|0|0.0||||||
3867215|NCT01597388|3692169|B7||> 3 to ≤ 12 months|Time from most recent progression to enrollment||Participants|Count of Participants|0|0.0||||||
3867216|NCT01597388|3692170|B6||> 3 to ≤ 12 months|Time from most recent progression to enrollment||Participants|Count of Participants|1|1.0||||||
3867217|NCT01597388|3692171|B5||> 3 to ≤ 12 months|Time from most recent progression to enrollment||Participants|Count of Participants|5|5.0||||||
3867218|NCT01597388|3692172|B4||> 3 to ≤ 12 months|Time from most recent progression to enrollment||Participants|Count of Participants|2|2.0||||||
3867219|NCT01597388|3692173|B3||> 3 to ≤ 12 months|Time from most recent progression to enrollment||Participants|Count of Participants|2|2.0||||||
3867220|NCT01597388|3692174|B2||> 3 to ≤ 12 months|Time from most recent progression to enrollment||Participants|Count of Participants|1|1.0||||||
3867221|NCT01597388|3692175|B1||> 3 to ≤ 12 months|Time from most recent progression to enrollment||Participants|Count of Participants|0|0.0||||||
3867222|NCT01597388|3692166|B10||During screening, after informed consent|Time from most recent progression to enrollment||Participants|Count of Participants|2|2.0||||||
3867223|NCT01597388|3692167|B9||During screening, after informed consent|Time from most recent progression to enrollment||Participants|Count of Participants|0|0.0||||||
3867224|NCT01597388|3692168|B8||During screening, after informed consent|Time from most recent progression to enrollment||Participants|Count of Participants|0|0.0||||||
3867225|NCT01597388|3692169|B7||During screening, after informed consent|Time from most recent progression to enrollment||Participants|Count of Participants|0|0.0||||||
3867226|NCT01597388|3692170|B6||During screening, after informed consent|Time from most recent progression to enrollment||Participants|Count of Participants|0|0.0||||||
3867227|NCT01597388|3692171|B5||During screening, after informed consent|Time from most recent progression to enrollment||Participants|Count of Participants|1|1.0||||||
3867228|NCT01597388|3692172|B4||During screening, after informed consent|Time from most recent progression to enrollment||Participants|Count of Participants|0|0.0||||||
3867229|NCT01597388|3692173|B3||During screening, after informed consent|Time from most recent progression to enrollment||Participants|Count of Participants|0|0.0||||||
3867230|NCT01597388|3692174|B2||During screening, after informed consent|Time from most recent progression to enrollment||Participants|Count of Participants|0|0.0||||||
3867231|NCT01597388|3692175|B1||During screening, after informed consent|Time from most recent progression to enrollment||Participants|Count of Participants|1|1.0||||||
3867232|NCT01597388|3692166|B10||≤ 3 months|Time from most recent progression to enrollment||Participants|Count of Participants|82|82.0||||||
3867233|NCT01597388|3692167|B9||≤ 3 months|Time from most recent progression to enrollment||Participants|Count of Participants|2|2.0||||||
3867234|NCT01597388|3692168|B8||≤ 3 months|Time from most recent progression to enrollment||Participants|Count of Participants|5|5.0||||||
3867235|NCT01597388|3692169|B7||≤ 3 months|Time from most recent progression to enrollment||Participants|Count of Participants|8|8.0||||||
3867236|NCT01597388|3692170|B6||≤ 3 months|Time from most recent progression to enrollment||Participants|Count of Participants|3|3.0||||||
3867237|NCT01597388|3692171|B5||≤ 3 months|Time from most recent progression to enrollment||Participants|Count of Participants|28|28.0||||||
3867238|NCT01597388|3692172|B4||≤ 3 months|Time from most recent progression to enrollment||Participants|Count of Participants|8|8.0||||||
3867239|NCT01597388|3692173|B3||≤ 3 months|Time from most recent progression to enrollment||Participants|Count of Participants|12|12.0||||||
3867240|NCT01597388|3692174|B2||≤ 3 months|Time from most recent progression to enrollment||Participants|Count of Participants|11|11.0||||||
3867241|NCT01597388|3692175|B1||≤ 3 months|Time from most recent progression to enrollment||Participants|Count of Participants|5|5.0||||||
3867242|NCT01597388|3692166|B10||> 24 months|Time from Diagnosis to Enrollment||Participants|Count of Participants|92|92.0||||||
3867243|NCT01597388|3692167|B9||> 24 months|Time from Diagnosis to Enrollment||Participants|Count of Participants|2|2.0||||||
3867244|NCT01597388|3692168|B8||> 24 months|Time from Diagnosis to Enrollment||Participants|Count of Participants|5|5.0||||||
3867245|NCT01597388|3692169|B7||> 24 months|Time from Diagnosis to Enrollment||Participants|Count of Participants|8|8.0||||||
3867246|NCT01597388|3692170|B6||> 24 months|Time from Diagnosis to Enrollment||Participants|Count of Participants|4|4.0||||||
3867247|NCT01597388|3692171|B5||> 24 months|Time from Diagnosis to Enrollment||Participants|Count of Participants|33|33.0||||||
3867248|NCT01597388|3692172|B4||> 24 months|Time from Diagnosis to Enrollment||Participants|Count of Participants|9|9.0||||||
3867249|NCT01597388|3692173|B3||> 24 months|Time from Diagnosis to Enrollment||Participants|Count of Participants|13|13.0||||||
3867250|NCT01597388|3692174|B2||> 24 months|Time from Diagnosis to Enrollment||Participants|Count of Participants|12|12.0||||||
3867251|NCT01597388|3692175|B1||> 24 months|Time from Diagnosis to Enrollment||Participants|Count of Participants|6|6.0||||||
3867252|NCT01597388|3692166|B10||> 12 to ≤ 24 months|Time from Diagnosis to Enrollment||Participants|Count of Participants|6|6.0||||||
3867253|NCT01597388|3692167|B9||> 12 to ≤ 24 months|Time from Diagnosis to Enrollment||Participants|Count of Participants|0|0.0||||||
3867254|NCT01597388|3692168|B8||> 12 to ≤ 24 months|Time from Diagnosis to Enrollment||Participants|Count of Participants|0|0.0||||||
3867255|NCT01597388|3692169|B7||> 12 to ≤ 24 months|Time from Diagnosis to Enrollment||Participants|Count of Participants|0|0.0||||||
3867256|NCT01597388|3692170|B6||> 12 to ≤ 24 months|Time from Diagnosis to Enrollment||Participants|Count of Participants|0|0.0||||||
3867257|NCT01597388|3692171|B5||> 12 to ≤ 24 months|Time from Diagnosis to Enrollment||Participants|Count of Participants|4|4.0||||||
3867258|NCT01597388|3692172|B4||> 12 to ≤ 24 months|Time from Diagnosis to Enrollment||Participants|Count of Participants|1|1.0||||||
3867259|NCT01597388|3692173|B3||> 12 to ≤ 24 months|Time from Diagnosis to Enrollment||Participants|Count of Participants|0|0.0||||||
3867260|NCT01597388|3692174|B2||> 12 to ≤ 24 months|Time from Diagnosis to Enrollment||Participants|Count of Participants|1|1.0||||||
3867261|NCT01597388|3692175|B1||> 12 to ≤ 24 months|Time from Diagnosis to Enrollment||Participants|Count of Participants|0|0.0||||||
3867262|NCT01597388|3692166|B10||> 6 to ≤ 12 months|Time from Diagnosis to Enrollment||Participants|Count of Participants|1|1.0||||||
3867263|NCT01597388|3692167|B9||> 6 to ≤ 12 months|Time from Diagnosis to Enrollment||Participants|Count of Participants|0|0.0||||||
3867264|NCT01597388|3692168|B8||> 6 to ≤ 12 months|Time from Diagnosis to Enrollment||Participants|Count of Participants|0|0.0||||||
3867265|NCT01597388|3692169|B7||> 6 to ≤ 12 months|Time from Diagnosis to Enrollment||Participants|Count of Participants|0|0.0||||||
3867266|NCT01597388|3692170|B6||> 6 to ≤ 12 months|Time from Diagnosis to Enrollment||Participants|Count of Participants|0|0.0||||||
3867267|NCT01597388|3692171|B5||> 6 to ≤ 12 months|Time from Diagnosis to Enrollment||Participants|Count of Participants|0|0.0||||||
3867268|NCT01597388|3692172|B4||> 6 to ≤ 12 months|Time from Diagnosis to Enrollment||Participants|Count of Participants|0|0.0||||||
3867269|NCT01597388|3692173|B3||> 6 to ≤ 12 months|Time from Diagnosis to Enrollment||Participants|Count of Participants|1|1.0||||||
3867270|NCT01597388|3692174|B2||> 6 to ≤ 12 months|Time from Diagnosis to Enrollment||Participants|Count of Participants|0|0.0||||||
3867271|NCT01597388|3692175|B1||> 6 to ≤ 12 months|Time from Diagnosis to Enrollment||Participants|Count of Participants|0|0.0||||||
3867272|NCT01597388|3692166|B10||≤ 6 months|Time from Diagnosis to Enrollment||Participants|Count of Participants|0|0.0||||||
3867273|NCT01597388|3692167|B9||≤ 6 months|Time from Diagnosis to Enrollment||Participants|Count of Participants|0|0.0||||||
3867274|NCT01597388|3692168|B8||≤ 6 months|Time from Diagnosis to Enrollment||Participants|Count of Participants|0|0.0||||||
3867275|NCT01597388|3692169|B7||≤ 6 months|Time from Diagnosis to Enrollment||Participants|Count of Participants|0|0.0||||||
3867276|NCT01597388|3692170|B6||≤ 6 months|Time from Diagnosis to Enrollment||Participants|Count of Participants|0|0.0||||||
3867277|NCT01597388|3692171|B5||≤ 6 months|Time from Diagnosis to Enrollment||Participants|Count of Participants|0|0.0||||||
3867278|NCT01597388|3692172|B4||≤ 6 months|Time from Diagnosis to Enrollment||Participants|Count of Participants|0|0.0||||||
3867279|NCT01597388|3692173|B3||≤ 6 months|Time from Diagnosis to Enrollment||Participants|Count of Participants|0|0.0||||||
3867280|NCT01597388|3692174|B2||≤ 6 months|Time from Diagnosis to Enrollment||Participants|Count of Participants|0|0.0||||||
3867281|NCT01597388|3692175|B1||≤ 6 months|Time from Diagnosis to Enrollment||Participants|Count of Participants|0|0.0||||||
3867282|NCT01597388|3692166|B10||Present|Malignant pleural effusion||Participants|Count of Participants|13|13.0||||||
3867283|NCT01597388|3692167|B9||Present|Malignant pleural effusion||Participants|Count of Participants|0|0.0||||||
3867284|NCT01597388|3692168|B8||Present|Malignant pleural effusion||Participants|Count of Participants|0|0.0||||||
3867285|NCT01597388|3692169|B7||Present|Malignant pleural effusion||Participants|Count of Participants|1|1.0||||||
3867286|NCT01597388|3692170|B6||Present|Malignant pleural effusion||Participants|Count of Participants|3|3.0||||||
3867287|NCT01597388|3692171|B5||Present|Malignant pleural effusion||Participants|Count of Participants|4|4.0||||||
3867288|NCT01597388|3692172|B4||Present|Malignant pleural effusion||Participants|Count of Participants|3|3.0||||||
3867289|NCT01597388|3692173|B3||Present|Malignant pleural effusion||Participants|Count of Participants|0|0.0||||||
3867290|NCT01597388|3692174|B2||Present|Malignant pleural effusion||Participants|Count of Participants|1|1.0||||||
3867291|NCT01597388|3692175|B1||Present|Malignant pleural effusion||Participants|Count of Participants|1|1.0||||||
3867292|NCT01597388|3692166|B10||Absent|Malignant pleural effusion||Participants|Count of Participants|86|86.0||||||
3867293|NCT01597388|3692167|B9||Absent|Malignant pleural effusion||Participants|Count of Participants|2|2.0||||||
3867294|NCT01597388|3692168|B8||Absent|Malignant pleural effusion||Participants|Count of Participants|5|5.0||||||
3867295|NCT01597388|3692169|B7||Absent|Malignant pleural effusion||Participants|Count of Participants|7|7.0||||||
3867296|NCT01597388|3692170|B6||Absent|Malignant pleural effusion||Participants|Count of Participants|1|1.0||||||
3867297|NCT01597388|3692171|B5||Absent|Malignant pleural effusion||Participants|Count of Participants|33|33.0||||||
3867298|NCT01597388|3692172|B4||Absent|Malignant pleural effusion||Participants|Count of Participants|7|7.0||||||
3867299|NCT01597388|3692173|B3||Absent|Malignant pleural effusion||Participants|Count of Participants|14|14.0||||||
3867300|NCT01597388|3692174|B2||Absent|Malignant pleural effusion||Participants|Count of Participants|12|12.0||||||
3867301|NCT01597388|3692175|B1||Absent|Malignant pleural effusion||Participants|Count of Participants|5|5.0||||||
3867302|NCT01597388|3692166|B10||Other|Histology Type||Participants|Count of Participants|27|27.0||||||
3867303|NCT01597388|3692167|B9||Other|Histology Type||Participants|Count of Participants|1|1.0||||||
3867304|NCT01597388|3692168|B8||Other|Histology Type||Participants|Count of Participants|1|1.0||||||
3867305|NCT01597388|3692169|B7||Other|Histology Type||Participants|Count of Participants|3|3.0||||||
3867306|NCT01597388|3692170|B6||Other|Histology Type||Participants|Count of Participants|2|2.0||||||
3867307|NCT01597388|3692171|B5||Other|Histology Type||Participants|Count of Participants|11|11.0||||||
3867308|NCT01597388|3692172|B4||Other|Histology Type||Participants|Count of Participants|2|2.0||||||
3867309|NCT01597388|3692173|B3||Other|Histology Type||Participants|Count of Participants|5|5.0||||||
3867310|NCT01597388|3692174|B2||Other|Histology Type||Participants|Count of Participants|2|2.0||||||
3867311|NCT01597388|3692175|B1||Other|Histology Type||Participants|Count of Participants|0|0.0||||||
3867312|NCT01597388|3692166|B10||Invasive lobular|Histology Type||Participants|Count of Participants|9|9.0||||||
3867313|NCT01597388|3692167|B9||Invasive lobular|Histology Type||Participants|Count of Participants|0|0.0||||||
3867314|NCT01597388|3692168|B8||Invasive lobular|Histology Type||Participants|Count of Participants|0|0.0||||||
3867315|NCT01597388|3692169|B7||Invasive lobular|Histology Type||Participants|Count of Participants|0|0.0||||||
3867316|NCT01597388|3692170|B6||Invasive lobular|Histology Type||Participants|Count of Participants|0|0.0||||||
3867317|NCT01597388|3692171|B5||Invasive lobular|Histology Type||Participants|Count of Participants|2|2.0||||||
3867318|NCT01597388|3692172|B4||Invasive lobular|Histology Type||Participants|Count of Participants|1|1.0||||||
3867319|NCT01597388|3692173|B3||Invasive lobular|Histology Type||Participants|Count of Participants|1|1.0||||||
3867320|NCT01597388|3692174|B2||Invasive lobular|Histology Type||Participants|Count of Participants|3|3.0||||||
3867321|NCT01597388|3692175|B1||Invasive lobular|Histology Type||Participants|Count of Participants|2|2.0||||||
3867322|NCT01597388|3692166|B10||Invasive ductal/extensive intraductal component|Histology Type||Participants|Count of Participants|4|4.0||||||
3867323|NCT01597388|3692167|B9||Invasive ductal/extensive intraductal component|Histology Type||Participants|Count of Participants|0|0.0||||||
3867324|NCT01597388|3692168|B8||Invasive ductal/extensive intraductal component|Histology Type||Participants|Count of Participants|0|0.0||||||
3867325|NCT01597388|3692169|B7||Invasive ductal/extensive intraductal component|Histology Type||Participants|Count of Participants|0|0.0||||||
3867326|NCT01597388|3692170|B6||Invasive ductal/extensive intraductal component|Histology Type||Participants|Count of Participants|0|0.0||||||
3867327|NCT01597388|3692171|B5||Invasive ductal/extensive intraductal component|Histology Type||Participants|Count of Participants|3|3.0||||||
3867328|NCT01597388|3692172|B4||Invasive ductal/extensive intraductal component|Histology Type||Participants|Count of Participants|1|1.0||||||
3867329|NCT01597388|3692173|B3||Invasive ductal/extensive intraductal component|Histology Type||Participants|Count of Participants|0|0.0||||||
3867330|NCT01597388|3692174|B2||Invasive ductal/extensive intraductal component|Histology Type||Participants|Count of Participants|0|0.0||||||
3867331|NCT01597388|3692175|B1||Invasive ductal/extensive intraductal component|Histology Type||Participants|Count of Participants|0|0.0||||||
3867332|NCT01597388|3692166|B10||Invasive ductal|Histology Type||Participants|Count of Participants|50|50.0||||||
3867333|NCT01597388|3692167|B9||Invasive ductal|Histology Type||Participants|Count of Participants|1|1.0||||||
3867334|NCT01597388|3692168|B8||Invasive ductal|Histology Type||Participants|Count of Participants|4|4.0||||||
3867335|NCT01597388|3692169|B7||Invasive ductal|Histology Type||Participants|Count of Participants|5|5.0||||||
3867336|NCT01597388|3692170|B6||Invasive ductal|Histology Type||Participants|Count of Participants|1|1.0||||||
3867337|NCT01597388|3692171|B5||Invasive ductal|Histology Type||Participants|Count of Participants|17|17.0||||||
3867338|NCT01597388|3692172|B4||Invasive ductal|Histology Type||Participants|Count of Participants|5|5.0||||||
3867339|NCT01597388|3692173|B3||Invasive ductal|Histology Type||Participants|Count of Participants|7|7.0||||||
3867340|NCT01597388|3692174|B2||Invasive ductal|Histology Type||Participants|Count of Participants|6|6.0||||||
3867341|NCT01597388|3692175|B1||Invasive ductal|Histology Type||Participants|Count of Participants|4|4.0||||||
3867342|NCT01597388|3692166|B10||Invasive carcinoma (NOS)|Histology Type||Participants|Count of Participants|8|8.0||||||
3867343|NCT01597388|3692167|B9||Invasive carcinoma (NOS)|Histology Type||Participants|Count of Participants|0|0.0||||||
3867344|NCT01597388|3692168|B8||Invasive carcinoma (NOS)|Histology Type||Participants|Count of Participants|0|0.0||||||
3867345|NCT01597388|3692169|B7||Invasive carcinoma (NOS)|Histology Type||Participants|Count of Participants|0|0.0||||||
3867346|NCT01597388|3692170|B6||Invasive carcinoma (NOS)|Histology Type||Participants|Count of Participants|1|1.0||||||
3867347|NCT01597388|3692171|B5||Invasive carcinoma (NOS)|Histology Type||Participants|Count of Participants|4|4.0||||||
3867348|NCT01597388|3692172|B4||Invasive carcinoma (NOS)|Histology Type||Participants|Count of Participants|1|1.0||||||
3867349|NCT01597388|3692173|B3||Invasive carcinoma (NOS)|Histology Type||Participants|Count of Participants|1|1.0||||||
3867350|NCT01597388|3692174|B2||Invasive carcinoma (NOS)|Histology Type||Participants|Count of Participants|1|1.0||||||
3867351|NCT01597388|3692175|B1||Invasive carcinoma (NOS)|Histology Type||Participants|Count of Participants|0|0.0||||||
3867352|NCT01597388|3692166|B10||Cannot be determined|Histology Type||Participants|Count of Participants|1|1.0||||||
3867353|NCT01597388|3692167|B9||Cannot be determined|Histology Type||Participants|Count of Participants|0|0.0||||||
3867354|NCT01597388|3692168|B8||Cannot be determined|Histology Type||Participants|Count of Participants|0|0.0||||||
3867355|NCT01597388|3692169|B7||Cannot be determined|Histology Type||Participants|Count of Participants|0|0.0||||||
3867356|NCT01597388|3692170|B6||Cannot be determined|Histology Type||Participants|Count of Participants|0|0.0||||||
3867357|NCT01597388|3692171|B5||Cannot be determined|Histology Type||Participants|Count of Participants|0|0.0||||||
3867358|NCT01597388|3692172|B4||Cannot be determined|Histology Type||Participants|Count of Participants|0|0.0||||||
3867359|NCT01597388|3692173|B3||Cannot be determined|Histology Type||Participants|Count of Participants|0|0.0||||||
3867360|NCT01597388|3692174|B2||Cannot be determined|Histology Type||Participants|Count of Participants|1|1.0||||||
3867361|NCT01597388|3692175|B1||Cannot be determined|Histology Type||Participants|Count of Participants|0|0.0||||||
3867362|NCT01597388|3692166|B10||Missing|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|7|7.0||||||
3867363|NCT01597388|3692167|B9||Missing|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|0|0.0||||||
3867364|NCT01597388|3692168|B8||Missing|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|1|1.0||||||
3867365|NCT01597388|3692169|B7||Missing|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|0|0.0||||||
3867366|NCT01597388|3692170|B6||Missing|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|0|0.0||||||
3867367|NCT01597388|3692171|B5||Missing|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|4|4.0||||||
3867368|NCT01597388|3692172|B4||Missing|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|0|0.0||||||
3867369|NCT01597388|3692173|B3||Missing|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|0|0.0||||||
3867370|NCT01597388|3692174|B2||Missing|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|1|1.0||||||
3867371|NCT01597388|3692175|B1||Missing|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|1|1.0||||||
3867372|NCT01597388|3692166|B10||Gx|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|25|25.0||||||
3867610|NCT01597388|3692174|B2|||Age||Years|Median|64.0|64.0|Full Range|||32.0|82.0|
3867373|NCT01597388|3692167|B9||Gx|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|0|0.0||||||
3867374|NCT01597388|3692168|B8||Gx|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|0|0.0||||||
3867375|NCT01597388|3692169|B7||Gx|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|4|4.0||||||
3867376|NCT01597388|3692170|B6||Gx|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|1|1.0||||||
3867377|NCT01597388|3692171|B5||Gx|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|10|10.0||||||
3867378|NCT01597388|3692172|B4||Gx|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|1|1.0||||||
3867379|NCT01597388|3692173|B3||Gx|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|5|5.0||||||
3867380|NCT01597388|3692174|B2||Gx|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|3|3.0||||||
3867381|NCT01597388|3692175|B1||Gx|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|1|1.0||||||
3867382|NCT01597388|3692166|B10||G4|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|1|1.0||||||
3867383|NCT01597388|3692167|B9||G4|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|0|0.0||||||
3867384|NCT01597388|3692168|B8||G4|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|0|0.0||||||
3867385|NCT01597388|3692169|B7||G4|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|1|1.0||||||
3867386|NCT01597388|3692170|B6||G4|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|0|0.0||||||
3867387|NCT01597388|3692171|B5||G4|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|0|0.0||||||
3867388|NCT01597388|3692172|B4||G4|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|0|0.0||||||
3867389|NCT01597388|3692173|B3||G4|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|0|0.0||||||
3867390|NCT01597388|3692174|B2||G4|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|0|0.0||||||
3867391|NCT01597388|3692175|B1||G4|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|0|0.0||||||
3867392|NCT01597388|3692166|B10||G3|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|23|23.0||||||
3867393|NCT01597388|3692167|B9||G3|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|1|1.0||||||
3867394|NCT01597388|3692168|B8||G3|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|2|2.0||||||
3867395|NCT01597388|3692169|B7||G3|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|1|1.0||||||
3867396|NCT01597388|3692170|B6||G3|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|1|1.0||||||
3867397|NCT01597388|3692171|B5||G3|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|8|8.0||||||
3867398|NCT01597388|3692172|B4||G3|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|2|2.0||||||
3867399|NCT01597388|3692173|B3||G3|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|3|3.0||||||
3867400|NCT01597388|3692174|B2||G3|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|4|4.0||||||
3867401|NCT01597388|3692175|B1||G3|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|1|1.0||||||
3867402|NCT01597388|3692166|B10||G2|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|39|39.0||||||
3867403|NCT01597388|3692167|B9||G2|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|1|1.0||||||
3867404|NCT01597388|3692168|B8||G2|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|1|1.0||||||
3867405|NCT01597388|3692169|B7||G2|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|2|2.0||||||
3867406|NCT01597388|3692170|B6||G2|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|1|1.0||||||
3867407|NCT01597388|3692171|B5||G2|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|14|14.0||||||
3867408|NCT01597388|3692172|B4||G2|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|6|6.0||||||
3867409|NCT01597388|3692173|B3||G2|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|6|6.0||||||
3867410|NCT01597388|3692174|B2||G2|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|5|5.0||||||
3867411|NCT01597388|3692175|B1||G2|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|3|3.0||||||
3867412|NCT01597388|3692166|B10||G1|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|4|4.0||||||
3867413|NCT01597388|3692167|B9||G1|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|0|0.0||||||
3867414|NCT01597388|3692168|B8||G1|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|1|1.0||||||
3867415|NCT01597388|3692169|B7||G1|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|0|0.0||||||
3867416|NCT01597388|3692170|B6||G1|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|1|1.0||||||
3867417|NCT01597388|3692171|B5||G1|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|1|1.0||||||
3867418|NCT01597388|3692172|B4||G1|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|1|1.0||||||
3867419|NCT01597388|3692173|B3||G1|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|0|0.0||||||
3867420|NCT01597388|3692174|B2||G1|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|0|0.0||||||
3867421|NCT01597388|3692175|B1||G1|Tumour Grade|G1 = Well differentiated; G2 = Moderately differentiated; G3 = Poorly differentiated; G4 = Undifferentiated; Gx = Not assessable|Participants|Count of Participants|0|0.0||||||
3867422|NCT01597388|3692166|B10||PS = 4|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|0|0.0||||||
3867423|NCT01597388|3692167|B9||PS = 4|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|0|0.0||||||
3867424|NCT01597388|3692168|B8||PS = 4|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|0|0.0||||||
3867425|NCT01597388|3692169|B7||PS = 4|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|0|0.0||||||
3867426|NCT01597388|3692170|B6||PS = 4|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|0|0.0||||||
3867427|NCT01597388|3692171|B5||PS = 4|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|0|0.0||||||
3867428|NCT01597388|3692172|B4||PS = 4|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|0|0.0||||||
3867429|NCT01597388|3692173|B3||PS = 4|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|0|0.0||||||
3867430|NCT01597388|3692174|B2||PS = 4|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|0|0.0||||||
3867431|NCT01597388|3692175|B1||PS = 4|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|0|0.0||||||
3867432|NCT01597388|3692166|B10||PS = 3|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|0|0.0||||||
3867494|NCT01597388|3692168|B8|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3867433|NCT01597388|3692167|B9||PS = 3|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|0|0.0||||||
3867434|NCT01597388|3692168|B8||PS = 3|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|0|0.0||||||
3867435|NCT01597388|3692169|B7||PS = 3|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|0|0.0||||||
3867436|NCT01597388|3692170|B6||PS = 3|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|0|0.0||||||
3867437|NCT01597388|3692171|B5||PS = 3|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|0|0.0||||||
3867438|NCT01597388|3692172|B4||PS = 3|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|0|0.0||||||
3867439|NCT01597388|3692173|B3||PS = 3|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|0|0.0||||||
3867440|NCT01597388|3692174|B2||PS = 3|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|0|0.0||||||
3867441|NCT01597388|3692175|B1||PS = 3|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|0|0.0||||||
3867442|NCT01597388|3692166|B10||PS = 2|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|0|0.0||||||
3867443|NCT01597388|3692167|B9||PS = 2|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|0|0.0||||||
3867444|NCT01597388|3692168|B8||PS = 2|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|0|0.0||||||
3867445|NCT01597388|3692169|B7||PS = 2|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|0|0.0||||||
3867446|NCT01597388|3692170|B6||PS = 2|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|0|0.0||||||
3867447|NCT01597388|3692171|B5||PS = 2|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|0|0.0||||||
3867448|NCT01597388|3692172|B4||PS = 2|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|0|0.0||||||
3867449|NCT01597388|3692173|B3||PS = 2|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|0|0.0||||||
3867450|NCT01597388|3692174|B2||PS = 2|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|0|0.0||||||
3867451|NCT01597388|3692175|B1||PS = 2|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|0|0.0||||||
3867452|NCT01597388|3692166|B10||PS = 1|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|47|47.0||||||
3867453|NCT01597388|3692167|B9||PS = 1|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|1|1.0||||||
3867454|NCT01597388|3692168|B8||PS = 1|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|4|4.0||||||
3867455|NCT01597388|3692169|B7||PS = 1|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|3|3.0||||||
3867456|NCT01597388|3692170|B6||PS = 1|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|2|2.0||||||
3867495|NCT01597388|3692169|B7|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3867457|NCT01597388|3692171|B5||PS = 1|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|21|21.0||||||
3867458|NCT01597388|3692172|B4||PS = 1|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|5|5.0||||||
3867459|NCT01597388|3692173|B3||PS = 1|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|6|6.0||||||
3867460|NCT01597388|3692174|B2||PS = 1|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|2|2.0||||||
3867461|NCT01597388|3692175|B1||PS = 1|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|3|3.0||||||
3867462|NCT01597388|3692166|B10||PS = 0|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|52|52.0||||||
3867463|NCT01597388|3692167|B9||PS = 0|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|1|1.0||||||
3867464|NCT01597388|3692168|B8||PS = 0|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|1|1.0||||||
3867465|NCT01597388|3692169|B7||PS = 0|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|5|5.0||||||
3867466|NCT01597388|3692170|B6||PS = 0|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|2|2.0||||||
3867467|NCT01597388|3692171|B5||PS = 0|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|16|16.0||||||
3867468|NCT01597388|3692172|B4||PS = 0|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|5|5.0||||||
3867469|NCT01597388|3692173|B3||PS = 0|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|8|8.0||||||
3867470|NCT01597388|3692174|B2||PS = 0|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|11|11.0||||||
3867471|NCT01597388|3692175|B1||PS = 0|ECOG Performance Status (PS)|ECOG PS = 0 Fully active; PS = 1 Restricted in physically strenuous activity; PS = 2 Ambulatory and capable of self-care; PS = Capable of only limited self care; PS = 4 Completely disabled|Participants|Count of Participants|3|3.0||||||
3867472|NCT01597388|3692166|B10|||Weight||kg|Mean|71.96|71.96|Standard Deviation|17.134|17.134|||
3867473|NCT01597388|3692167|B9|||Weight||kg|Mean|77.45|77.45|Standard Deviation|NA||||The standard deviation was not calculated because there were only 2 participants in this arm.
3867474|NCT01597388|3692168|B8|||Weight||kg|Mean|77.98|77.98|Standard Deviation|12.586|12.586|||
3867475|NCT01597388|3692169|B7|||Weight||kg|Mean|68.95|68.95|Standard Deviation|14.115|14.115|||
3867476|NCT01597388|3692170|B6|||Weight||kg|Mean|79.88|79.88|Standard Deviation|17.854|17.854|||
3867477|NCT01597388|3692171|B5|||Weight||kg|Mean|67.62|67.62|Standard Deviation|15.511|15.511|||
3867478|NCT01597388|3692172|B4|||Weight||kg|Mean|74.53|74.53|Standard Deviation|23.776|23.776|||
3867479|NCT01597388|3692173|B3|||Weight||kg|Mean|74.51|74.51|Standard Deviation|19.236|19.236|||
3867480|NCT01597388|3692174|B2|||Weight||kg|Mean|73.29|73.29|Standard Deviation|18.845|18.845|||
3867481|NCT01597388|3692175|B1|||Weight||kg|Mean|77.42|77.42|Standard Deviation|15.953|15.953|||
3867482|NCT01597388|3692166|B10|United States||Region of Enrollment||Participants|Count of Participants|99|99.0||||||
3867483|NCT01597388|3692167|B9|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3867484|NCT01597388|3692168|B8|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3867485|NCT01597388|3692169|B7|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3867486|NCT01597388|3692170|B6|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3867487|NCT01597388|3692171|B5|United States||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3867488|NCT01597388|3692172|B4|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3867489|NCT01597388|3692173|B3|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3867490|NCT01597388|3692174|B2|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3867491|NCT01597388|3692175|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3867492|NCT01597388|3692166|B10|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3867493|NCT01597388|3692167|B9|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3867496|NCT01597388|3692170|B6|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3867497|NCT01597388|3692171|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3867498|NCT01597388|3692172|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3867499|NCT01597388|3692173|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3867500|NCT01597388|3692174|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3867501|NCT01597388|3692175|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3867502|NCT01597388|3692166|B10|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3867503|NCT01597388|3692167|B9|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3867504|NCT01597388|3692168|B8|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3867505|NCT01597388|3692169|B7|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3867506|NCT01597388|3692170|B6|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3867507|NCT01597388|3692171|B5|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3867508|NCT01597388|3692172|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3867509|NCT01597388|3692173|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3867510|NCT01597388|3692174|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3867511|NCT01597388|3692175|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3867512|NCT01597388|3692166|B10|White||Race/Ethnicity, Customized||Participants|Count of Participants|90|90.0||||||
3867513|NCT01597388|3692167|B9|White||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3867514|NCT01597388|3692168|B8|White||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3867515|NCT01597388|3692169|B7|White||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3867516|NCT01597388|3692170|B6|White||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3867517|NCT01597388|3692171|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
3867518|NCT01597388|3692172|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3867519|NCT01597388|3692173|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3867520|NCT01597388|3692174|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3867521|NCT01597388|3692175|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3867522|NCT01597388|3692166|B10||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3867523|NCT01597388|3692167|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867524|NCT01597388|3692168|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3867525|NCT01597388|3692169|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3867526|NCT01597388|3692170|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867527|NCT01597388|3692171|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3867528|NCT01597388|3692172|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3867529|NCT01597388|3692173|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3867530|NCT01597388|3692174|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3867531|NCT01597388|3692175|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3867532|NCT01597388|3692166|B10||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3867533|NCT01597388|3692167|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3867534|NCT01597388|3692168|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3867535|NCT01597388|3692169|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3867536|NCT01597388|3692170|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3867537|NCT01597388|3692171|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3867538|NCT01597388|3692172|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867539|NCT01597388|3692173|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3867540|NCT01597388|3692174|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3867541|NCT01597388|3692175|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867542|NCT01597388|3692166|B10||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3867543|NCT01597388|3692167|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867544|NCT01597388|3692168|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867545|NCT01597388|3692169|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867546|NCT01597388|3692170|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867547|NCT01597388|3692171|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867548|NCT01597388|3692172|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3867549|NCT01597388|3692173|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867550|NCT01597388|3692174|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867551|NCT01597388|3692175|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867552|NCT01597388|3692166|B10||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3867553|NCT01597388|3692167|B9||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3867554|NCT01597388|3692168|B8||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3867555|NCT01597388|3692169|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3867556|NCT01597388|3692170|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3867557|NCT01597388|3692171|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3867558|NCT01597388|3692172|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3867559|NCT01597388|3692173|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3867560|NCT01597388|3692174|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3867561|NCT01597388|3692175|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3867562|NCT01597388|3692166|B10||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3867563|NCT01597388|3692167|B9||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3867564|NCT01597388|3692168|B8||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3867565|NCT01597388|3692169|B7||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3867566|NCT01597388|3692170|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3867567|NCT01597388|3692171|B5||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3867568|NCT01597388|3692172|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3867569|NCT01597388|3692173|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3867570|NCT01597388|3692174|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3867571|NCT01597388|3692175|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3867572|NCT01597388|3692166|B10|≥65 years||Age, Customized||Participants|Count of Participants|32|32.0||||||
3867573|NCT01597388|3692167|B9|≥65 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3867574|NCT01597388|3692168|B8|≥65 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3867575|NCT01597388|3692169|B7|≥65 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3867576|NCT01597388|3692170|B6|≥65 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3867577|NCT01597388|3692171|B5|≥65 years||Age, Customized||Participants|Count of Participants|12|12.0||||||
3867578|NCT01597388|3692172|B4|≥65 years||Age, Customized||Participants|Count of Participants|4|4.0||||||
3867579|NCT01597388|3692173|B3|≥65 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
3867580|NCT01597388|3692174|B2|≥65 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
3867581|NCT01597388|3692175|B1|≥65 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
3867582|NCT01597388|3692166|B10|≥50 to <65 years||Age, Customized||Participants|Count of Participants|54|54.0||||||
3867583|NCT01597388|3692167|B9|≥50 to <65 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3867584|NCT01597388|3692168|B8|≥50 to <65 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
3867585|NCT01597388|3692169|B7|≥50 to <65 years||Age, Customized||Participants|Count of Participants|7|7.0||||||
3867586|NCT01597388|3692170|B6|≥50 to <65 years||Age, Customized||Participants|Count of Participants|4|4.0||||||
3867587|NCT01597388|3692171|B5|≥50 to <65 years||Age, Customized||Participants|Count of Participants|18|18.0||||||
3867588|NCT01597388|3692172|B4|≥50 to <65 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
3867589|NCT01597388|3692173|B3|≥50 to <65 years||Age, Customized||Participants|Count of Participants|8|8.0||||||
3867590|NCT01597388|3692174|B2|≥50 to <65 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
3867591|NCT01597388|3692175|B1|≥50 to <65 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
3867592|NCT01597388|3692166|B10|≥18 and <50 years||Age, Customized||Participants|Count of Participants|13|13.0||||||
3867593|NCT01597388|3692167|B9|≥18 and <50 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3867594|NCT01597388|3692168|B8|≥18 and <50 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3867595|NCT01597388|3692169|B7|≥18 and <50 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3867596|NCT01597388|3692170|B6|≥18 and <50 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3867597|NCT01597388|3692171|B5|≥18 and <50 years||Age, Customized||Participants|Count of Participants|7|7.0||||||
3867598|NCT01597388|3692172|B4|≥18 and <50 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3867599|NCT01597388|3692173|B3|≥18 and <50 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3867600|NCT01597388|3692174|B2|≥18 and <50 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3867601|NCT01597388|3692175|B1|≥18 and <50 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3867602|NCT01597388|3692166|B10|||Age||Years|Median|61.0|61.0|Full Range|||32.0|82.0|
3867603|NCT01597388|3692167|B9|||Age||Years|Median|55.0|55.0|Full Range|||43.0|67.0|
3867604|NCT01597388|3692168|B8|||Age||Years|Median|59.0|59.0|Full Range|||43.0|67.0|
3867605|NCT01597388|3692169|B7|||Age||Years|Median|55.5|55.5|Full Range|||34.0|64.0|
3867606|NCT01597388|3692170|B6|||Age||Years|Median|55.0|55.0|Full Range|||50.0|63.0|
3867607|NCT01597388|3692171|B5|||Age||Years|Median|61.0|61.0|Full Range|||40.0|77.0|
3867608|NCT01597388|3692172|B4|||Age||Years|Median|62.0|62.0|Full Range|||39.0|73.0|
3867609|NCT01597388|3692173|B3|||Age||Years|Median|61.0|61.0|Full Range|||50.0|76.0|
3867611|NCT01597388|3692175|B1|||Age||Years|Median|58.5|58.5|Full Range|||48.0|72.0|
3867612|NCT01597388|3692166|B10|||Age||Years|Mean|59.9|59.9|Standard Deviation|9.88|9.88|||
3867613|NCT01597388|3692167|B9|||Age||Years|Mean|55.0|55.0|Standard Deviation|NA||||The standard deviation was not calculated because there were only 2 participants in this group.
3867614|NCT01597388|3692168|B8|||Age||Years|Mean|58.4|58.4|Standard Deviation|9.26|9.26|||
3867615|NCT01597388|3692169|B7|||Age||Years|Mean|54.4|54.4|Standard Deviation|9.44|9.44|||
3867616|NCT01597388|3692170|B6|||Age||Years|Mean|55.8|55.8|Standard Deviation|6.29|6.29|||
3867617|NCT01597388|3692171|B5|||Age||Years|Mean|60.1|60.1|Standard Deviation|10.05|10.05|||
3867618|NCT01597388|3692172|B4|||Age||Years|Mean|60.1|60.1|Standard Deviation|10.46|10.46|||
3867619|NCT01597388|3692173|B3|||Age||Years|Mean|61.1|61.1|Standard Deviation|7.46|7.46|||
3867620|NCT01597388|3692174|B2|||Age||Years|Mean|63.3|63.3|Standard Deviation|12.53|12.53|||
3867621|NCT01597388|3692175|B1|||Age||Years|Mean|60.5|60.5|Standard Deviation|9.16|9.16|||
3867622|NCT01597375|3692434|B1|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3867623|NCT01597375|3692434|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3867624|NCT01597375|3692434|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3867625|NCT01597375|3692434|B1|||Age||years|Mean|47|47.0|Standard Deviation|10|10.0|||
3867626|NCT01597375|3692434|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3867627|NCT01597375|3692434|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3867628|NCT01597375|3692434|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3867629|NCT01597245|3692452|B5|||Baseline in Patient's Global Assessment (PatGA) Total Score|"The PatGA is a single-item self-reported instrument asking the participant to rate the severity of their psoriasis today by circling a number on the numeric rating scale from 0 (Clear = no psoriasis) to 5 (Severe = the worst their psoriasis has ever been)."|units on a scale|Mean|4.0|4.0|Standard Deviation|0.92|0.92|||
3867630|NCT01597245|3692453|B4|||Baseline in Patient's Global Assessment (PatGA) Total Score|"The PatGA is a single-item self-reported instrument asking the participant to rate the severity of their psoriasis today by circling a number on the numeric rating scale from 0 (Clear = no psoriasis) to 5 (Severe = the worst their psoriasis has ever been)."|units on a scale|Mean|4.1|4.1|Standard Deviation|0.91|0.91|||
3867631|NCT01597245|3692454|B3|||Baseline in Patient's Global Assessment (PatGA) Total Score|"The PatGA is a single-item self-reported instrument asking the participant to rate the severity of their psoriasis today by circling a number on the numeric rating scale from 0 (Clear = no psoriasis) to 5 (Severe = the worst their psoriasis has ever been)."|units on a scale|Mean|4.1|4.1|Standard Deviation|0.90|0.9|||
3867632|NCT01597245|3692455|B2|||Baseline in Patient's Global Assessment (PatGA) Total Score|"The PatGA is a single-item self-reported instrument asking the participant to rate the severity of their psoriasis today by circling a number on the numeric rating scale from 0 (Clear = no psoriasis) to 5 (Severe = the worst their psoriasis has ever been)."|units on a scale|Mean|4.0|4.0|Standard Deviation|0.96|0.96|||
3867633|NCT01597245|3692456|B1|||Baseline in Patient's Global Assessment (PatGA) Total Score|"The PatGA is a single-item self-reported instrument asking the participant to rate the severity of their psoriasis today by circling a number on the numeric rating scale from 0 (Clear = no psoriasis) to 5 (Severe = the worst their psoriasis has ever been)."|units on a scale|Mean|4.0|4.0|Standard Deviation|0.92|0.92|||
3867634|NCT01597245|3692452|B5|Mental Summary Score (n=166, 354, 345, 350, 1215)||Baseline in Short form (36 Items) Health Survey SF-36 Total Score|The SF-36 is a self-reported instrument that measures the participant's health status during the previous 7 days. It comprises 36-items covering 8 domains: physical functioning, role physical, role emotional, bodily pain, vitality, social functioning, mental health, and general health. Items are answered on Likert scales of varying lengths. The 8 domains are regrouped in the Physical Component Score (PCS) and Mental Component Score (MCS) scores. Scores range from 0 to 100, with higher scores indicating better levels of function and/or better health.|units on a scale|Mean|48.3832|48.3832|Standard Deviation|11.0234|11.0234|||
3867635|NCT01597245|3692453|B4|Mental Summary Score (n=166, 354, 345, 350, 1215)||Baseline in Short form (36 Items) Health Survey SF-36 Total Score|The SF-36 is a self-reported instrument that measures the participant's health status during the previous 7 days. It comprises 36-items covering 8 domains: physical functioning, role physical, role emotional, bodily pain, vitality, social functioning, mental health, and general health. Items are answered on Likert scales of varying lengths. The 8 domains are regrouped in the Physical Component Score (PCS) and Mental Component Score (MCS) scores. Scores range from 0 to 100, with higher scores indicating better levels of function and/or better health.|units on a scale|Mean|47.7140|47.714|Standard Deviation|11.6686|11.6686|||
3867636|NCT01597245|3692454|B3|Mental Summary Score (n=166, 354, 345, 350, 1215)||Baseline in Short form (36 Items) Health Survey SF-36 Total Score|The SF-36 is a self-reported instrument that measures the participant's health status during the previous 7 days. It comprises 36-items covering 8 domains: physical functioning, role physical, role emotional, bodily pain, vitality, social functioning, mental health, and general health. Items are answered on Likert scales of varying lengths. The 8 domains are regrouped in the Physical Component Score (PCS) and Mental Component Score (MCS) scores. Scores range from 0 to 100, with higher scores indicating better levels of function and/or better health.|units on a scale|Mean|49.0131|49.0131|Standard Deviation|10.9087|10.9087|||
3867637|NCT01597245|3692455|B2|Mental Summary Score (n=166, 354, 345, 350, 1215)||Baseline in Short form (36 Items) Health Survey SF-36 Total Score|The SF-36 is a self-reported instrument that measures the participant's health status during the previous 7 days. It comprises 36-items covering 8 domains: physical functioning, role physical, role emotional, bodily pain, vitality, social functioning, mental health, and general health. Items are answered on Likert scales of varying lengths. The 8 domains are regrouped in the Physical Component Score (PCS) and Mental Component Score (MCS) scores. Scores range from 0 to 100, with higher scores indicating better levels of function and/or better health.|units on a scale|Mean|48.7097|48.7097|Standard Deviation|10.6546|10.6546|||
3867767|NCT01597245|3692455|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3867768|NCT01597245|3692456|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867638|NCT01597245|3692456|B1|Mental Summary Score (n=166, 354, 345, 350, 1215)||Baseline in Short form (36 Items) Health Survey SF-36 Total Score|The SF-36 is a self-reported instrument that measures the participant's health status during the previous 7 days. It comprises 36-items covering 8 domains: physical functioning, role physical, role emotional, bodily pain, vitality, social functioning, mental health, and general health. Items are answered on Likert scales of varying lengths. The 8 domains are regrouped in the Physical Component Score (PCS) and Mental Component Score (MCS) scores. Scores range from 0 to 100, with higher scores indicating better levels of function and/or better health.|units on a scale|Mean|47.7889|47.7889|Standard Deviation|10.6183|10.6183|||
3867639|NCT01597245|3692452|B5|Physical Summary Score (n=166,354,345,350,1215)||Baseline in Short form (36 Items) Health Survey SF-36 Total Score|The SF-36 is a self-reported instrument that measures the participant's health status during the previous 7 days. It comprises 36-items covering 8 domains: physical functioning, role physical, role emotional, bodily pain, vitality, social functioning, mental health, and general health. Items are answered on Likert scales of varying lengths. The 8 domains are regrouped in the Physical Component Score (PCS) and Mental Component Score (MCS) scores. Scores range from 0 to 100, with higher scores indicating better levels of function and/or better health.|units on a scale|Mean|47.6289|47.6289|Standard Deviation|9.0814|9.0814|||
3867640|NCT01597245|3692453|B4|Physical Summary Score (n=166,354,345,350,1215)||Baseline in Short form (36 Items) Health Survey SF-36 Total Score|The SF-36 is a self-reported instrument that measures the participant's health status during the previous 7 days. It comprises 36-items covering 8 domains: physical functioning, role physical, role emotional, bodily pain, vitality, social functioning, mental health, and general health. Items are answered on Likert scales of varying lengths. The 8 domains are regrouped in the Physical Component Score (PCS) and Mental Component Score (MCS) scores. Scores range from 0 to 100, with higher scores indicating better levels of function and/or better health.|units on a scale|Mean|47.6996|47.6996|Standard Deviation|9.0332|9.0332|||
3867641|NCT01597245|3692454|B3|Physical Summary Score (n=166,354,345,350,1215)||Baseline in Short form (36 Items) Health Survey SF-36 Total Score|The SF-36 is a self-reported instrument that measures the participant's health status during the previous 7 days. It comprises 36-items covering 8 domains: physical functioning, role physical, role emotional, bodily pain, vitality, social functioning, mental health, and general health. Items are answered on Likert scales of varying lengths. The 8 domains are regrouped in the Physical Component Score (PCS) and Mental Component Score (MCS) scores. Scores range from 0 to 100, with higher scores indicating better levels of function and/or better health.|units on a scale|Mean|47.6231|47.6231|Standard Deviation|8.9693|8.9693|||
3867642|NCT01597245|3692455|B2|Physical Summary Score (n=166,354,345,350,1215)||Baseline in Short form (36 Items) Health Survey SF-36 Total Score|The SF-36 is a self-reported instrument that measures the participant's health status during the previous 7 days. It comprises 36-items covering 8 domains: physical functioning, role physical, role emotional, bodily pain, vitality, social functioning, mental health, and general health. Items are answered on Likert scales of varying lengths. The 8 domains are regrouped in the Physical Component Score (PCS) and Mental Component Score (MCS) scores. Scores range from 0 to 100, with higher scores indicating better levels of function and/or better health.|units on a scale|Mean|47.5268|47.5268|Standard Deviation|9.0729|9.0729|||
3867643|NCT01597245|3692456|B1|Physical Summary Score (n=166,354,345,350,1215)||Baseline in Short form (36 Items) Health Survey SF-36 Total Score|The SF-36 is a self-reported instrument that measures the participant's health status during the previous 7 days. It comprises 36-items covering 8 domains: physical functioning, role physical, role emotional, bodily pain, vitality, social functioning, mental health, and general health. Items are answered on Likert scales of varying lengths. The 8 domains are regrouped in the Physical Component Score (PCS) and Mental Component Score (MCS) scores. Scores range from 0 to 100, with higher scores indicating better levels of function and/or better health.|units on a scale|Mean|47.7094|47.7094|Standard Deviation|9.5043|9.5043|||
3867644|NCT01597245|3692452|B5|Work Productivity Loss (n=105,227,231,237,800)||Baseline in Work Productivity Activity Impairment Questionnaire-Psoriasis (WPAI-PSO) Total Score|The (WPAI-PSO) is a 6-item instrument to assess the impact of psoriasis on productivity impairment within the past 7 days and has four domains: absenteeism, presenteeism (reduced productivity while at work), an overall work impairment score, and impairment in daily activities performed outside of work. Four scores are derived as percentages: absenteeism, presenteeism, overall work impairment (absenteeism and presenteeism), and impairment in activities performed outside of work. Percentage is calculated as each score * 100 and ranges from 0-100; greater scores indicate greater impairment.|units on a scale|Mean|25.0|25.0|Standard Deviation|27.82|27.82|||
3867645|NCT01597245|3692453|B4|Work Productivity Loss (n=105,227,231,237,800)||Baseline in Work Productivity Activity Impairment Questionnaire-Psoriasis (WPAI-PSO) Total Score|The (WPAI-PSO) is a 6-item instrument to assess the impact of psoriasis on productivity impairment within the past 7 days and has four domains: absenteeism, presenteeism (reduced productivity while at work), an overall work impairment score, and impairment in daily activities performed outside of work. Four scores are derived as percentages: absenteeism, presenteeism, overall work impairment (absenteeism and presenteeism), and impairment in activities performed outside of work. Percentage is calculated as each score * 100 and ranges from 0-100; greater scores indicate greater impairment.|units on a scale|Mean|27.7|27.7|Standard Deviation|29.19|29.19|||
3867646|NCT01597245|3692454|B3|Work Productivity Loss (n=105,227,231,237,800)||Baseline in Work Productivity Activity Impairment Questionnaire-Psoriasis (WPAI-PSO) Total Score|The (WPAI-PSO) is a 6-item instrument to assess the impact of psoriasis on productivity impairment within the past 7 days and has four domains: absenteeism, presenteeism (reduced productivity while at work), an overall work impairment score, and impairment in daily activities performed outside of work. Four scores are derived as percentages: absenteeism, presenteeism, overall work impairment (absenteeism and presenteeism), and impairment in activities performed outside of work. Percentage is calculated as each score * 100 and ranges from 0-100; greater scores indicate greater impairment.|units on a scale|Mean|24.6|24.6|Standard Deviation|27.41|27.41|||
3867677|NCT01597245|3692455|B2|||Baseline in Psoriasis Scalp Severity Index (PSSI) Total Score|The PSSI is a physician assessment of erythema, induration and desquamation and percent of scalp that is covered with a scores range from 0 (none) to 4 (very severe). The composite score is derived from the sum of scores for erythema, induration, and desquamation multiplied by the score recorded for the extent of the scalp area involved, 1 (<10%) to 6 (90%-100%) with a total score ranging from 0 (less severity) to 72 (more severity).|units on a scale|Mean|20.0|20.0|Standard Deviation|15.19|15.19|||
3867647|NCT01597245|3692455|B2|Work Productivity Loss (n=105,227,231,237,800)||Baseline in Work Productivity Activity Impairment Questionnaire-Psoriasis (WPAI-PSO) Total Score|The (WPAI-PSO) is a 6-item instrument to assess the impact of psoriasis on productivity impairment within the past 7 days and has four domains: absenteeism, presenteeism (reduced productivity while at work), an overall work impairment score, and impairment in daily activities performed outside of work. Four scores are derived as percentages: absenteeism, presenteeism, overall work impairment (absenteeism and presenteeism), and impairment in activities performed outside of work. Percentage is calculated as each score * 100 and ranges from 0-100; greater scores indicate greater impairment.|units on a scale|Mean|22.3|22.3|Standard Deviation|26.52|26.52|||
3867648|NCT01597245|3692456|B1|Work Productivity Loss (n=105,227,231,237,800)||Baseline in Work Productivity Activity Impairment Questionnaire-Psoriasis (WPAI-PSO) Total Score|The (WPAI-PSO) is a 6-item instrument to assess the impact of psoriasis on productivity impairment within the past 7 days and has four domains: absenteeism, presenteeism (reduced productivity while at work), an overall work impairment score, and impairment in daily activities performed outside of work. Four scores are derived as percentages: absenteeism, presenteeism, overall work impairment (absenteeism and presenteeism), and impairment in activities performed outside of work. Percentage is calculated as each score * 100 and ranges from 0-100; greater scores indicate greater impairment.|units on a scale|Mean|26.1|26.1|Standard Deviation|28.11|28.11|||
3867649|NCT01597245|3692452|B5|Presenteeism Score (n=109, 239, 243,248, 839)||Baseline in Work Productivity Activity Impairment Questionnaire-Psoriasis (WPAI-PSO) Total Score|The (WPAI-PSO) is a 6-item instrument to assess the impact of psoriasis on productivity impairment within the past 7 days and has four domains: absenteeism, presenteeism (reduced productivity while at work), an overall work impairment score, and impairment in daily activities performed outside of work. Four scores are derived as percentages: absenteeism, presenteeism, overall work impairment (absenteeism and presenteeism), and impairment in activities performed outside of work. Percentage is calculated as each score * 100 and ranges from 0-100; greater scores indicate greater impairment.|units on a scale|Mean|22.8|22.8|Standard Deviation|25.44|25.44|||
3867650|NCT01597245|3692453|B4|Presenteeism Score (n=109, 239, 243,248, 839)||Baseline in Work Productivity Activity Impairment Questionnaire-Psoriasis (WPAI-PSO) Total Score|The (WPAI-PSO) is a 6-item instrument to assess the impact of psoriasis on productivity impairment within the past 7 days and has four domains: absenteeism, presenteeism (reduced productivity while at work), an overall work impairment score, and impairment in daily activities performed outside of work. Four scores are derived as percentages: absenteeism, presenteeism, overall work impairment (absenteeism and presenteeism), and impairment in activities performed outside of work. Percentage is calculated as each score * 100 and ranges from 0-100; greater scores indicate greater impairment.|units on a scale|Mean|24.2|24.2|Standard Deviation|25.80|25.8|||
3867651|NCT01597245|3692454|B3|Presenteeism Score (n=109, 239, 243,248, 839)||Baseline in Work Productivity Activity Impairment Questionnaire-Psoriasis (WPAI-PSO) Total Score|The (WPAI-PSO) is a 6-item instrument to assess the impact of psoriasis on productivity impairment within the past 7 days and has four domains: absenteeism, presenteeism (reduced productivity while at work), an overall work impairment score, and impairment in daily activities performed outside of work. Four scores are derived as percentages: absenteeism, presenteeism, overall work impairment (absenteeism and presenteeism), and impairment in activities performed outside of work. Percentage is calculated as each score * 100 and ranges from 0-100; greater scores indicate greater impairment.|units on a scale|Mean|22.3|22.3|Standard Deviation|24.77|24.77|||
3867652|NCT01597245|3692455|B2|Presenteeism Score (n=109, 239, 243,248, 839)||Baseline in Work Productivity Activity Impairment Questionnaire-Psoriasis (WPAI-PSO) Total Score|The (WPAI-PSO) is a 6-item instrument to assess the impact of psoriasis on productivity impairment within the past 7 days and has four domains: absenteeism, presenteeism (reduced productivity while at work), an overall work impairment score, and impairment in daily activities performed outside of work. Four scores are derived as percentages: absenteeism, presenteeism, overall work impairment (absenteeism and presenteeism), and impairment in activities performed outside of work. Percentage is calculated as each score * 100 and ranges from 0-100; greater scores indicate greater impairment.|units on a scale|Mean|21.2|21.2|Standard Deviation|25.42|25.42|||
3867653|NCT01597245|3692456|B1|Presenteeism Score (n=109, 239, 243,248, 839)||Baseline in Work Productivity Activity Impairment Questionnaire-Psoriasis (WPAI-PSO) Total Score|The (WPAI-PSO) is a 6-item instrument to assess the impact of psoriasis on productivity impairment within the past 7 days and has four domains: absenteeism, presenteeism (reduced productivity while at work), an overall work impairment score, and impairment in daily activities performed outside of work. Four scores are derived as percentages: absenteeism, presenteeism, overall work impairment (absenteeism and presenteeism), and impairment in activities performed outside of work. Percentage is calculated as each score * 100 and ranges from 0-100; greater scores indicate greater impairment.|units on a scale|Mean|24.3|24.3|Standard Deviation|26.19|26.19|||
3867654|NCT01597245|3692452|B5|Active Impairment Score (n=166,356,346,347,1215)||Baseline in Work Productivity Activity Impairment Questionnaire-Psoriasis (WPAI-PSO) Total Score|The (WPAI-PSO) is a 6-item instrument to assess the impact of psoriasis on productivity impairment within the past 7 days and has four domains: absenteeism, presenteeism (reduced productivity while at work), an overall work impairment score, and impairment in daily activities performed outside of work. Four scores are derived as percentages: absenteeism, presenteeism, overall work impairment (absenteeism and presenteeism), and impairment in activities performed outside of work. Percentage is calculated as each score * 100 and ranges from 0-100; greater scores indicate greater impairment.|units on a scale|Mean|30.7|30.7|Standard Deviation|29.24|29.24|||
3867655|NCT01597245|3692453|B4|Active Impairment Score (n=166,356,346,347,1215)||Baseline in Work Productivity Activity Impairment Questionnaire-Psoriasis (WPAI-PSO) Total Score|The (WPAI-PSO) is a 6-item instrument to assess the impact of psoriasis on productivity impairment within the past 7 days and has four domains: absenteeism, presenteeism (reduced productivity while at work), an overall work impairment score, and impairment in daily activities performed outside of work. Four scores are derived as percentages: absenteeism, presenteeism, overall work impairment (absenteeism and presenteeism), and impairment in activities performed outside of work. Percentage is calculated as each score * 100 and ranges from 0-100; greater scores indicate greater impairment.|units on a scale|Mean|31.7|31.7|Standard Deviation|29.64|29.64|||
3867753|NCT01597245|3692456|B1|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
3867754|NCT01597245|3692452|B5|Austria||Region of Enrollment||participants|Number|23|23.0||||||
3867656|NCT01597245|3692454|B3|Active Impairment Score (n=166,356,346,347,1215)||Baseline in Work Productivity Activity Impairment Questionnaire-Psoriasis (WPAI-PSO) Total Score|The (WPAI-PSO) is a 6-item instrument to assess the impact of psoriasis on productivity impairment within the past 7 days and has four domains: absenteeism, presenteeism (reduced productivity while at work), an overall work impairment score, and impairment in daily activities performed outside of work. Four scores are derived as percentages: absenteeism, presenteeism, overall work impairment (absenteeism and presenteeism), and impairment in activities performed outside of work. Percentage is calculated as each score * 100 and ranges from 0-100; greater scores indicate greater impairment.|units on a scale|Mean|29.4|29.4|Standard Deviation|29.28|29.28|||
3867657|NCT01597245|3692455|B2|Active Impairment Score (n=166,356,346,347,1215)||Baseline in Work Productivity Activity Impairment Questionnaire-Psoriasis (WPAI-PSO) Total Score|The (WPAI-PSO) is a 6-item instrument to assess the impact of psoriasis on productivity impairment within the past 7 days and has four domains: absenteeism, presenteeism (reduced productivity while at work), an overall work impairment score, and impairment in daily activities performed outside of work. Four scores are derived as percentages: absenteeism, presenteeism, overall work impairment (absenteeism and presenteeism), and impairment in activities performed outside of work. Percentage is calculated as each score * 100 and ranges from 0-100; greater scores indicate greater impairment.|units on a scale|Mean|31.3|31.3|Standard Deviation|29.04|29.04|||
3867658|NCT01597245|3692456|B1|Active Impairment Score (n=166,356,346,347,1215)||Baseline in Work Productivity Activity Impairment Questionnaire-Psoriasis (WPAI-PSO) Total Score|The (WPAI-PSO) is a 6-item instrument to assess the impact of psoriasis on productivity impairment within the past 7 days and has four domains: absenteeism, presenteeism (reduced productivity while at work), an overall work impairment score, and impairment in daily activities performed outside of work. Four scores are derived as percentages: absenteeism, presenteeism, overall work impairment (absenteeism and presenteeism), and impairment in activities performed outside of work. Percentage is calculated as each score * 100 and ranges from 0-100; greater scores indicate greater impairment.|units on a scale|Mean|30.2|30.2|Standard Deviation|28.87|28.87|||
3867659|NCT01597245|3692452|B5|Absenteeism Score (n=106, 227, 232, 238, 803)||Baseline in Work Productivity Activity Impairment Questionnaire-Psoriasis (WPAI-PSO) Total Score|The (WPAI-PSO) is a 6-item instrument to assess the impact of psoriasis on productivity impairment within the past 7 days and has four domains: absenteeism, presenteeism (reduced productivity while at work), an overall work impairment score, and impairment in daily activities performed outside of work. Four scores are derived as percentages: absenteeism, presenteeism, overall work impairment (absenteeism and presenteeism), and impairment in activities performed outside of work. Percentage is calculated as each score * 100 and ranges from 0-100; greater scores indicate greater impairment.|units on a scale|Mean|5.1|5.1|Standard Deviation|18.40|18.4|||
3867660|NCT01597245|3692453|B4|Absenteeism Score (n=106, 227, 232, 238, 803)||Baseline in Work Productivity Activity Impairment Questionnaire-Psoriasis (WPAI-PSO) Total Score|The (WPAI-PSO) is a 6-item instrument to assess the impact of psoriasis on productivity impairment within the past 7 days and has four domains: absenteeism, presenteeism (reduced productivity while at work), an overall work impairment score, and impairment in daily activities performed outside of work. Four scores are derived as percentages: absenteeism, presenteeism, overall work impairment (absenteeism and presenteeism), and impairment in activities performed outside of work. Percentage is calculated as each score * 100 and ranges from 0-100; greater scores indicate greater impairment.|units on a scale|Mean|7.3|7.3|Standard Deviation|22.15|22.15|||
3867661|NCT01597245|3692454|B3|Absenteeism Score (n=106, 227, 232, 238, 803)||Baseline in Work Productivity Activity Impairment Questionnaire-Psoriasis (WPAI-PSO) Total Score|The (WPAI-PSO) is a 6-item instrument to assess the impact of psoriasis on productivity impairment within the past 7 days and has four domains: absenteeism, presenteeism (reduced productivity while at work), an overall work impairment score, and impairment in daily activities performed outside of work. Four scores are derived as percentages: absenteeism, presenteeism, overall work impairment (absenteeism and presenteeism), and impairment in activities performed outside of work. Percentage is calculated as each score * 100 and ranges from 0-100; greater scores indicate greater impairment.|units on a scale|Mean|4.6|4.6|Standard Deviation|17.65|17.65|||
3867662|NCT01597245|3692455|B2|Absenteeism Score (n=106, 227, 232, 238, 803)||Baseline in Work Productivity Activity Impairment Questionnaire-Psoriasis (WPAI-PSO) Total Score|The (WPAI-PSO) is a 6-item instrument to assess the impact of psoriasis on productivity impairment within the past 7 days and has four domains: absenteeism, presenteeism (reduced productivity while at work), an overall work impairment score, and impairment in daily activities performed outside of work. Four scores are derived as percentages: absenteeism, presenteeism, overall work impairment (absenteeism and presenteeism), and impairment in activities performed outside of work. Percentage is calculated as each score * 100 and ranges from 0-100; greater scores indicate greater impairment.|units on a scale|Mean|3.7|3.7|Standard Deviation|15.24|15.24|||
3867663|NCT01597245|3692456|B1|Absenteeism Score (n=106, 227, 232, 238, 803)||Baseline in Work Productivity Activity Impairment Questionnaire-Psoriasis (WPAI-PSO) Total Score|The (WPAI-PSO) is a 6-item instrument to assess the impact of psoriasis on productivity impairment within the past 7 days and has four domains: absenteeism, presenteeism (reduced productivity while at work), an overall work impairment score, and impairment in daily activities performed outside of work. Four scores are derived as percentages: absenteeism, presenteeism, overall work impairment (absenteeism and presenteeism), and impairment in activities performed outside of work. Percentage is calculated as each score * 100 and ranges from 0-100; greater scores indicate greater impairment.|units on a scale|Mean|4.3|4.3|Standard Deviation|16.61|16.61|||
3867664|NCT01597245|3692452|B5|||Baseline in Quick Inventory of Depressive Symptomatology Self Report 16 items (QIDS-SR16) Score|QIDS-SR16 is a participant-administered, 16-item instrument assesses the existence and severity of symptoms of depression. A participant is asked a statement relating to the way they have felt for the past 7 days and rate on a 4-point scale: 0 (best) to 3 (worst). The sum of the domains [sad mood, concentration, self-criticism, suicidal ideation, interest, energy/fatigue, sleep disturbance, decrease/increase in appetite/weight, and psychomotor agitation/retardation] to give a single total scores range from 0 to 27, with higher scores indicating greater symptom severity.|units on a scale|Mean|4.5|4.5|Standard Deviation|4.00|4.0|||
3867755|NCT01597245|3692453|B4|Austria||Region of Enrollment||participants|Number|5|5.0||||||
3867756|NCT01597245|3692454|B3|Austria||Region of Enrollment||participants|Number|6|6.0||||||
3867757|NCT01597245|3692455|B2|Austria||Region of Enrollment||participants|Number|10|10.0||||||
3867665|NCT01597245|3692453|B4|||Baseline in Quick Inventory of Depressive Symptomatology Self Report 16 items (QIDS-SR16) Score|QIDS-SR16 is a participant-administered, 16-item instrument assesses the existence and severity of symptoms of depression. A participant is asked a statement relating to the way they have felt for the past 7 days and rate on a 4-point scale: 0 (best) to 3 (worst). The sum of the domains [sad mood, concentration, self-criticism, suicidal ideation, interest, energy/fatigue, sleep disturbance, decrease/increase in appetite/weight, and psychomotor agitation/retardation] to give a single total scores range from 0 to 27, with higher scores indicating greater symptom severity.|units on a scale|Mean|4.6|4.6|Standard Deviation|3.84|3.84|||
3867666|NCT01597245|3692454|B3|||Baseline in Quick Inventory of Depressive Symptomatology Self Report 16 items (QIDS-SR16) Score|QIDS-SR16 is a participant-administered, 16-item instrument assesses the existence and severity of symptoms of depression. A participant is asked a statement relating to the way they have felt for the past 7 days and rate on a 4-point scale: 0 (best) to 3 (worst). The sum of the domains [sad mood, concentration, self-criticism, suicidal ideation, interest, energy/fatigue, sleep disturbance, decrease/increase in appetite/weight, and psychomotor agitation/retardation] to give a single total scores range from 0 to 27, with higher scores indicating greater symptom severity.|units on a scale|Mean|4.4|4.4|Standard Deviation|4.04|4.04|||
3867667|NCT01597245|3692455|B2|||Baseline in Quick Inventory of Depressive Symptomatology Self Report 16 items (QIDS-SR16) Score|QIDS-SR16 is a participant-administered, 16-item instrument assesses the existence and severity of symptoms of depression. A participant is asked a statement relating to the way they have felt for the past 7 days and rate on a 4-point scale: 0 (best) to 3 (worst). The sum of the domains [sad mood, concentration, self-criticism, suicidal ideation, interest, energy/fatigue, sleep disturbance, decrease/increase in appetite/weight, and psychomotor agitation/retardation] to give a single total scores range from 0 to 27, with higher scores indicating greater symptom severity.|units on a scale|Mean|4.5|4.5|Standard Deviation|4.07|4.07|||
3867668|NCT01597245|3692456|B1|||Baseline in Quick Inventory of Depressive Symptomatology Self Report 16 items (QIDS-SR16) Score|QIDS-SR16 is a participant-administered, 16-item instrument assesses the existence and severity of symptoms of depression. A participant is asked a statement relating to the way they have felt for the past 7 days and rate on a 4-point scale: 0 (best) to 3 (worst). The sum of the domains [sad mood, concentration, self-criticism, suicidal ideation, interest, energy/fatigue, sleep disturbance, decrease/increase in appetite/weight, and psychomotor agitation/retardation] to give a single total scores range from 0 to 27, with higher scores indicating greater symptom severity.|units on a scale|Mean|4.7|4.7|Standard Deviation|4.14|4.14|||
3867669|NCT01597245|3692452|B5|||Baseline in Body Surface Area (BSA) Total Score|BSA is a physician rating of the percentage of involvement of Ps for each participant. BSA is assessed on a continuous scale from 0% (no involvement) to 100% (full involvement), where 1% corresponds to the size of the participant's hand (includes the palm, fingers and thumb). Total BSA is the sum of handprints from the affected areas.|units on a scale|Mean|26.0|26.0|Standard Deviation|16.47|16.47|||
3867670|NCT01597245|3692453|B4|||Baseline in Body Surface Area (BSA) Total Score|BSA is a physician rating of the percentage of involvement of Ps for each participant. BSA is assessed on a continuous scale from 0% (no involvement) to 100% (full involvement), where 1% corresponds to the size of the participant's hand (includes the palm, fingers and thumb). Total BSA is the sum of handprints from the affected areas.|units on a scale|Mean|25.1|25.1|Standard Deviation|15.82|15.82|||
3867671|NCT01597245|3692454|B3|||Baseline in Body Surface Area (BSA) Total Score|BSA is a physician rating of the percentage of involvement of Ps for each participant. BSA is assessed on a continuous scale from 0% (no involvement) to 100% (full involvement), where 1% corresponds to the size of the participant's hand (includes the palm, fingers and thumb). Total BSA is the sum of handprints from the affected areas.|units on a scale|Mean|27.0|27.0|Standard Deviation|17.23|17.23|||
3867672|NCT01597245|3692455|B2|||Baseline in Body Surface Area (BSA) Total Score|BSA is a physician rating of the percentage of involvement of Ps for each participant. BSA is assessed on a continuous scale from 0% (no involvement) to 100% (full involvement), where 1% corresponds to the size of the participant's hand (includes the palm, fingers and thumb). Total BSA is the sum of handprints from the affected areas.|units on a scale|Mean|25.3|25.3|Standard Deviation|15.50|15.5|||
3867673|NCT01597245|3692456|B1|||Baseline in Body Surface Area (BSA) Total Score|BSA is a physician rating of the percentage of involvement of Ps for each participant. BSA is assessed on a continuous scale from 0% (no involvement) to 100% (full involvement), where 1% corresponds to the size of the participant's hand (includes the palm, fingers and thumb). Total BSA is the sum of handprints from the affected areas.|units on a scale|Mean|27.2|27.2|Standard Deviation|18.12|18.12|||
3867674|NCT01597245|3692452|B5|||Baseline in Psoriasis Scalp Severity Index (PSSI) Total Score|The PSSI is a physician assessment of erythema, induration and desquamation and percent of scalp that is covered with a scores range from 0 (none) to 4 (very severe). The composite score is derived from the sum of scores for erythema, induration, and desquamation multiplied by the score recorded for the extent of the scalp area involved, 1 (<10%) to 6 (90%-100%) with a total score ranging from 0 (less severity) to 72 (more severity).|units on a scale|Mean|20.2|20.2|Standard Deviation|15.22|15.22|||
3867675|NCT01597245|3692453|B4|||Baseline in Psoriasis Scalp Severity Index (PSSI) Total Score|The PSSI is a physician assessment of erythema, induration and desquamation and percent of scalp that is covered with a scores range from 0 (none) to 4 (very severe). The composite score is derived from the sum of scores for erythema, induration, and desquamation multiplied by the score recorded for the extent of the scalp area involved, 1 (<10%) to 6 (90%-100%) with a total score ranging from 0 (less severity) to 72 (more severity).|units on a scale|Mean|19.5|19.5|Standard Deviation|14.85|14.85|||
3867676|NCT01597245|3692454|B3|||Baseline in Psoriasis Scalp Severity Index (PSSI) Total Score|The PSSI is a physician assessment of erythema, induration and desquamation and percent of scalp that is covered with a scores range from 0 (none) to 4 (very severe). The composite score is derived from the sum of scores for erythema, induration, and desquamation multiplied by the score recorded for the extent of the scalp area involved, 1 (<10%) to 6 (90%-100%) with a total score ranging from 0 (less severity) to 72 (more severity).|units on a scale|Mean|20.8|20.8|Standard Deviation|15.63|15.63|||
3867758|NCT01597245|3692456|B1|Austria||Region of Enrollment||participants|Number|2|2.0||||||
3867759|NCT01597245|3692452|B5|Canada||Region of Enrollment||participants|Number|288|288.0||||||
3867760|NCT01597245|3692453|B4|Canada||Region of Enrollment||participants|Number|84|84.0||||||
3867678|NCT01597245|3692456|B1|||Baseline in Psoriasis Scalp Severity Index (PSSI) Total Score|The PSSI is a physician assessment of erythema, induration and desquamation and percent of scalp that is covered with a scores range from 0 (none) to 4 (very severe). The composite score is derived from the sum of scores for erythema, induration, and desquamation multiplied by the score recorded for the extent of the scalp area involved, 1 (<10%) to 6 (90%-100%) with a total score ranging from 0 (less severity) to 72 (more severity).|units on a scale|Mean|21.0|21.0|Standard Deviation|15.24|15.24|||
3867679|NCT01597245|3692452|B5|||Baseline in Nail Psoriasis Severity Index (NAPSI) Total Score|The NAPSI scale evaluates Ps severity in the fingernail bed and fingernail matrix with each divided into quadrants. Scores range from 0 (none) to 4 (Ps in all 4 quadrants), depending on the presence (score of 1) or absence (score of 0) of Ps in each quadrant of the fingernail bed or matrix. NAPSI score of a fingernail is the sum of scores from each quadrant of the fingernail bed and fingernail matrix (maximum of 8). The total NAPSI score equals the sum of all fingernails and ranges from 0 to 80. Higher scores indicate more severe Ps.|units on a scale|Mean|26.97|26.97|Standard Deviation|20.211|20.211|||
3867680|NCT01597245|3692453|B4|||Baseline in Nail Psoriasis Severity Index (NAPSI) Total Score|The NAPSI scale evaluates Ps severity in the fingernail bed and fingernail matrix with each divided into quadrants. Scores range from 0 (none) to 4 (Ps in all 4 quadrants), depending on the presence (score of 1) or absence (score of 0) of Ps in each quadrant of the fingernail bed or matrix. NAPSI score of a fingernail is the sum of scores from each quadrant of the fingernail bed and fingernail matrix (maximum of 8). The total NAPSI score equals the sum of all fingernails and ranges from 0 to 80. Higher scores indicate more severe Ps.|units on a scale|Mean|26.27|26.27|Standard Deviation|20.388|20.388|||
3867681|NCT01597245|3692454|B3|||Baseline in Nail Psoriasis Severity Index (NAPSI) Total Score|The NAPSI scale evaluates Ps severity in the fingernail bed and fingernail matrix with each divided into quadrants. Scores range from 0 (none) to 4 (Ps in all 4 quadrants), depending on the presence (score of 1) or absence (score of 0) of Ps in each quadrant of the fingernail bed or matrix. NAPSI score of a fingernail is the sum of scores from each quadrant of the fingernail bed and fingernail matrix (maximum of 8). The total NAPSI score equals the sum of all fingernails and ranges from 0 to 80. Higher scores indicate more severe Ps.|units on a scale|Mean|23.70|23.7|Standard Deviation|18.696|18.696|||
3867682|NCT01597245|3692455|B2|||Baseline in Nail Psoriasis Severity Index (NAPSI) Total Score|The NAPSI scale evaluates Ps severity in the fingernail bed and fingernail matrix with each divided into quadrants. Scores range from 0 (none) to 4 (Ps in all 4 quadrants), depending on the presence (score of 1) or absence (score of 0) of Ps in each quadrant of the fingernail bed or matrix. NAPSI score of a fingernail is the sum of scores from each quadrant of the fingernail bed and fingernail matrix (maximum of 8). The total NAPSI score equals the sum of all fingernails and ranges from 0 to 80. Higher scores indicate more severe Ps.|units on a scale|Mean|30.44|30.44|Standard Deviation|20.648|20.648|||
3867683|NCT01597245|3692456|B1|||Baseline in Nail Psoriasis Severity Index (NAPSI) Total Score|The NAPSI scale evaluates Ps severity in the fingernail bed and fingernail matrix with each divided into quadrants. Scores range from 0 (none) to 4 (Ps in all 4 quadrants), depending on the presence (score of 1) or absence (score of 0) of Ps in each quadrant of the fingernail bed or matrix. NAPSI score of a fingernail is the sum of scores from each quadrant of the fingernail bed and fingernail matrix (maximum of 8). The total NAPSI score equals the sum of all fingernails and ranges from 0 to 80. Higher scores indicate more severe Ps.|units on a scale|Mean|27.62|27.62|Standard Deviation|20.937|20.937|||
3867684|NCT01597245|3692452|B5|||Baseline Dermatology-Specific Quality of Life Index (DLQI) Total Score|"DLQI is a participant-administered, 10-question, validated, quality-of-life questionnaire that covers 6 domains, including symptoms and feelings, daily activities, leisure, work and school, personal relationships, and treatment. Response categories include 0 (not at all), 1 (a little), 2 (a lot), and 3 (very much) and unanswered (not relevant) responses were scored as 0. Total scores range from 0 to 30, with higher score indicating greater quality of life impairment."|units on a scale|Mean|12.3|12.3|Standard Deviation|6.91|6.91|||
3867685|NCT01597245|3692453|B4|||Baseline Dermatology-Specific Quality of Life Index (DLQI) Total Score|"DLQI is a participant-administered, 10-question, validated, quality-of-life questionnaire that covers 6 domains, including symptoms and feelings, daily activities, leisure, work and school, personal relationships, and treatment. Response categories include 0 (not at all), 1 (a little), 2 (a lot), and 3 (very much) and unanswered (not relevant) responses were scored as 0. Total scores range from 0 to 30, with higher score indicating greater quality of life impairment."|units on a scale|Mean|12.4|12.4|Standard Deviation|6.86|6.86|||
3867686|NCT01597245|3692454|B3|||Baseline Dermatology-Specific Quality of Life Index (DLQI) Total Score|"DLQI is a participant-administered, 10-question, validated, quality-of-life questionnaire that covers 6 domains, including symptoms and feelings, daily activities, leisure, work and school, personal relationships, and treatment. Response categories include 0 (not at all), 1 (a little), 2 (a lot), and 3 (very much) and unanswered (not relevant) responses were scored as 0. Total scores range from 0 to 30, with higher score indicating greater quality of life impairment."|units on a scale|Mean|11.6|11.6|Standard Deviation|6.65|6.65|||
3867687|NCT01597245|3692455|B2|||Baseline Dermatology-Specific Quality of Life Index (DLQI) Total Score|"DLQI is a participant-administered, 10-question, validated, quality-of-life questionnaire that covers 6 domains, including symptoms and feelings, daily activities, leisure, work and school, personal relationships, and treatment. Response categories include 0 (not at all), 1 (a little), 2 (a lot), and 3 (very much) and unanswered (not relevant) responses were scored as 0. Total scores range from 0 to 30, with higher score indicating greater quality of life impairment."|units on a scale|Mean|12.7|12.7|Standard Deviation|7.03|7.03|||
3867688|NCT01597245|3692456|B1|||Baseline Dermatology-Specific Quality of Life Index (DLQI) Total Score|"DLQI is a participant-administered, 10-question, validated, quality-of-life questionnaire that covers 6 domains, including symptoms and feelings, daily activities, leisure, work and school, personal relationships, and treatment. Response categories include 0 (not at all), 1 (a little), 2 (a lot), and 3 (very much) and unanswered (not relevant) responses were scored as 0. Total scores range from 0 to 30, with higher score indicating greater quality of life impairment."|units on a scale|Mean|12.8|12.8|Standard Deviation|7.24|7.24|||
3867761|NCT01597245|3692454|B3|Canada||Region of Enrollment||participants|Number|82|82.0||||||
3867762|NCT01597245|3692455|B2|Canada||Region of Enrollment||participants|Number|82|82.0||||||
3867763|NCT01597245|3692456|B1|Canada||Region of Enrollment||participants|Number|40|40.0||||||
3867689|NCT01597245|3692452|B5|||Baseline in Participants Achieving Psoriasis Area and Severity Index (PASI) Score|PASI is another accepted primary efficacy measurement for this phase of development of Ps treatments. The PASI combines assessments of the extent of body-surface involvement in 4 anatomical regions (head, trunk, arms, and legs) and the severity of desquamation, erythema, and plaque induration/infiltration (thickness) in each region, yielding an overall score of 0 or no Ps to 72 for the most severe disease.|units on a scale|Mean|19.63|19.63|Standard Deviation|7.216|7.216|||
3867690|NCT01597245|3692453|B4|||Baseline in Participants Achieving Psoriasis Area and Severity Index (PASI) Score|PASI is another accepted primary efficacy measurement for this phase of development of Ps treatments. The PASI combines assessments of the extent of body-surface involvement in 4 anatomical regions (head, trunk, arms, and legs) and the severity of desquamation, erythema, and plaque induration/infiltration (thickness) in each region, yielding an overall score of 0 or no Ps to 72 for the most severe disease.|units on a scale|Mean|19.35|19.35|Standard Deviation|7.339|7.339|||
3867691|NCT01597245|3692454|B3|||Baseline in Participants Achieving Psoriasis Area and Severity Index (PASI) Score|PASI is another accepted primary efficacy measurement for this phase of development of Ps treatments. The PASI combines assessments of the extent of body-surface involvement in 4 anatomical regions (head, trunk, arms, and legs) and the severity of desquamation, erythema, and plaque induration/infiltration (thickness) in each region, yielding an overall score of 0 or no Ps to 72 for the most severe disease.|units on a scale|Mean|20.04|20.04|Standard Deviation|6.962|6.962|||
3867692|NCT01597245|3692455|B2|||Baseline in Participants Achieving Psoriasis Area and Severity Index (PASI) Score|PASI is another accepted primary efficacy measurement for this phase of development of Ps treatments. The PASI combines assessments of the extent of body-surface involvement in 4 anatomical regions (head, trunk, arms, and legs) and the severity of desquamation, erythema, and plaque induration/infiltration (thickness) in each region, yielding an overall score of 0 or no Ps to 72 for the most severe disease.|units on a scale|Mean|19.07|19.07|Standard Deviation|6.701|6.701|||
3867693|NCT01597245|3692456|B1|||Baseline in Participants Achieving Psoriasis Area and Severity Index (PASI) Score|PASI is another accepted primary efficacy measurement for this phase of development of Ps treatments. The PASI combines assessments of the extent of body-surface involvement in 4 anatomical regions (head, trunk, arms, and legs) and the severity of desquamation, erythema, and plaque induration/infiltration (thickness) in each region, yielding an overall score of 0 or no Ps to 72 for the most severe disease.|units on a scale|Mean|20.57|20.57|Standard Deviation|8.366|8.366|||
3867694|NCT01597245|3692452|B5|sPGA = 4,5||Baseline in Static Physician Global Assessment (sPGA)|The sPGA is the physician's determination of the participant's Ps lesions overall at a given time point. The sPGA is recommended as an endpoint to use to assess efficacy in the treatment of Ps (EMEA 2004). Overall lesions are categorized by descriptions for induration, erythema, and scaling. For the analysis of responses, the participant's Ps is assessed at a given time point on a 6-point scale in which 0 = cleared, 1 = minimal, 2 = mild, 3 = moderate; 4 = severe, 5 = very severe.|participants|Number|608|608.0||||||
3867695|NCT01597245|3692453|B4|sPGA = 4,5||Baseline in Static Physician Global Assessment (sPGA)|The sPGA is the physician's determination of the participant's Ps lesions overall at a given time point. The sPGA is recommended as an endpoint to use to assess efficacy in the treatment of Ps (EMEA 2004). Overall lesions are categorized by descriptions for induration, erythema, and scaling. For the analysis of responses, the participant's Ps is assessed at a given time point on a 6-point scale in which 0 = cleared, 1 = minimal, 2 = mild, 3 = moderate; 4 = severe, 5 = very severe.|participants|Number|173|173.0||||||
3867696|NCT01597245|3692454|B3|sPGA = 4,5||Baseline in Static Physician Global Assessment (sPGA)|The sPGA is the physician's determination of the participant's Ps lesions overall at a given time point. The sPGA is recommended as an endpoint to use to assess efficacy in the treatment of Ps (EMEA 2004). Overall lesions are categorized by descriptions for induration, erythema, and scaling. For the analysis of responses, the participant's Ps is assessed at a given time point on a 6-point scale in which 0 = cleared, 1 = minimal, 2 = mild, 3 = moderate; 4 = severe, 5 = very severe.|participants|Number|181|181.0||||||
3867697|NCT01597245|3692455|B2|sPGA = 4,5||Baseline in Static Physician Global Assessment (sPGA)|The sPGA is the physician's determination of the participant's Ps lesions overall at a given time point. The sPGA is recommended as an endpoint to use to assess efficacy in the treatment of Ps (EMEA 2004). Overall lesions are categorized by descriptions for induration, erythema, and scaling. For the analysis of responses, the participant's Ps is assessed at a given time point on a 6-point scale in which 0 = cleared, 1 = minimal, 2 = mild, 3 = moderate; 4 = severe, 5 = very severe.|participants|Number|172|172.0||||||
3867698|NCT01597245|3692456|B1|sPGA = 4,5||Baseline in Static Physician Global Assessment (sPGA)|The sPGA is the physician's determination of the participant's Ps lesions overall at a given time point. The sPGA is recommended as an endpoint to use to assess efficacy in the treatment of Ps (EMEA 2004). Overall lesions are categorized by descriptions for induration, erythema, and scaling. For the analysis of responses, the participant's Ps is assessed at a given time point on a 6-point scale in which 0 = cleared, 1 = minimal, 2 = mild, 3 = moderate; 4 = severe, 5 = very severe.|participants|Number|82|82.0||||||
3867699|NCT01597245|3692452|B5|sPGA = 3||Baseline in Static Physician Global Assessment (sPGA)|The sPGA is the physician's determination of the participant's Ps lesions overall at a given time point. The sPGA is recommended as an endpoint to use to assess efficacy in the treatment of Ps (EMEA 2004). Overall lesions are categorized by descriptions for induration, erythema, and scaling. For the analysis of responses, the participant's Ps is assessed at a given time point on a 6-point scale in which 0 = cleared, 1 = minimal, 2 = mild, 3 = moderate; 4 = severe, 5 = very severe.|participants|Number|616|616.0||||||
3867700|NCT01597245|3692453|B4|sPGA = 3||Baseline in Static Physician Global Assessment (sPGA)|The sPGA is the physician's determination of the participant's Ps lesions overall at a given time point. The sPGA is recommended as an endpoint to use to assess efficacy in the treatment of Ps (EMEA 2004). Overall lesions are categorized by descriptions for induration, erythema, and scaling. For the analysis of responses, the participant's Ps is assessed at a given time point on a 6-point scale in which 0 = cleared, 1 = minimal, 2 = mild, 3 = moderate; 4 = severe, 5 = very severe.|participants|Number|178|178.0||||||
3867764|NCT01597245|3692452|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3867765|NCT01597245|3692453|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3867766|NCT01597245|3692454|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3867701|NCT01597245|3692454|B3|sPGA = 3||Baseline in Static Physician Global Assessment (sPGA)|The sPGA is the physician's determination of the participant's Ps lesions overall at a given time point. The sPGA is recommended as an endpoint to use to assess efficacy in the treatment of Ps (EMEA 2004). Overall lesions are categorized by descriptions for induration, erythema, and scaling. For the analysis of responses, the participant's Ps is assessed at a given time point on a 6-point scale in which 0 = cleared, 1 = minimal, 2 = mild, 3 = moderate; 4 = severe, 5 = very severe.|participants|Number|166|166.0||||||
3867702|NCT01597245|3692455|B2|sPGA = 3||Baseline in Static Physician Global Assessment (sPGA)|The sPGA is the physician's determination of the participant's Ps lesions overall at a given time point. The sPGA is recommended as an endpoint to use to assess efficacy in the treatment of Ps (EMEA 2004). Overall lesions are categorized by descriptions for induration, erythema, and scaling. For the analysis of responses, the participant's Ps is assessed at a given time point on a 6-point scale in which 0 = cleared, 1 = minimal, 2 = mild, 3 = moderate; 4 = severe, 5 = very severe.|participants|Number|186|186.0||||||
3867703|NCT01597245|3692456|B1|sPGA = 3||Baseline in Static Physician Global Assessment (sPGA)|The sPGA is the physician's determination of the participant's Ps lesions overall at a given time point. The sPGA is recommended as an endpoint to use to assess efficacy in the treatment of Ps (EMEA 2004). Overall lesions are categorized by descriptions for induration, erythema, and scaling. For the analysis of responses, the participant's Ps is assessed at a given time point on a 6-point scale in which 0 = cleared, 1 = minimal, 2 = mild, 3 = moderate; 4 = severe, 5 = very severe.|participants|Number|86|86.0||||||
3867704|NCT01597245|3692452|B5|Spain||Region of Enrollment||participants|Number|55|55.0||||||
3867705|NCT01597245|3692453|B4|Spain||Region of Enrollment||participants|Number|16|16.0||||||
3867706|NCT01597245|3692454|B3|Spain||Region of Enrollment||participants|Number|17|17.0||||||
3867707|NCT01597245|3692455|B2|Spain||Region of Enrollment||participants|Number|15|15.0||||||
3867708|NCT01597245|3692456|B1|Spain||Region of Enrollment||participants|Number|7|7.0||||||
3867709|NCT01597245|3692452|B5|Germany||Region of Enrollment||participants|Number|179|179.0||||||
3867710|NCT01597245|3692453|B4|Germany||Region of Enrollment||participants|Number|47|47.0||||||
3867711|NCT01597245|3692454|B3|Germany||Region of Enrollment||participants|Number|51|51.0||||||
3867712|NCT01597245|3692455|B2|Germany||Region of Enrollment||participants|Number|53|53.0||||||
3867713|NCT01597245|3692456|B1|Germany||Region of Enrollment||participants|Number|28|28.0||||||
3867714|NCT01597245|3692452|B5|France||Region of Enrollment||participants|Number|65|65.0||||||
3867715|NCT01597245|3692453|B4|France||Region of Enrollment||participants|Number|19|19.0||||||
3867716|NCT01597245|3692454|B3|France||Region of Enrollment||participants|Number|21|21.0||||||
3867717|NCT01597245|3692455|B2|France||Region of Enrollment||participants|Number|18|18.0||||||
3867718|NCT01597245|3692456|B1|France||Region of Enrollment||participants|Number|7|7.0||||||
3867719|NCT01597245|3692452|B5|Australia||Region of Enrollment||participants|Number|51|51.0||||||
3867720|NCT01597245|3692453|B4|Australia||Region of Enrollment||participants|Number|16|16.0||||||
3867721|NCT01597245|3692454|B3|Australia||Region of Enrollment||participants|Number|15|15.0||||||
3867722|NCT01597245|3692455|B2|Australia||Region of Enrollment||participants|Number|13|13.0||||||
3867723|NCT01597245|3692456|B1|Australia||Region of Enrollment||participants|Number|7|7.0||||||
3867724|NCT01597245|3692452|B5|United Kingdom||Region of Enrollment||participants|Number|33|33.0||||||
3867725|NCT01597245|3692453|B4|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
3867726|NCT01597245|3692454|B3|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
3867727|NCT01597245|3692455|B2|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
3867728|NCT01597245|3692456|B1|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3867729|NCT01597245|3692452|B5|Poland||Region of Enrollment||participants|Number|102|102.0||||||
3867730|NCT01597245|3692453|B4|Poland||Region of Enrollment||participants|Number|30|30.0||||||
3867731|NCT01597245|3692454|B3|Poland||Region of Enrollment||participants|Number|28|28.0||||||
3867732|NCT01597245|3692455|B2|Poland||Region of Enrollment||participants|Number|30|30.0||||||
3867733|NCT01597245|3692456|B1|Poland||Region of Enrollment||participants|Number|14|14.0||||||
3867734|NCT01597245|3692452|B5|United States||Region of Enrollment||participants|Number|369|369.0||||||
3867735|NCT01597245|3692453|B4|United States||Region of Enrollment||participants|Number|104|104.0||||||
3867736|NCT01597245|3692454|B3|United States||Region of Enrollment||participants|Number|105|105.0||||||
3867737|NCT01597245|3692455|B2|United States||Region of Enrollment||participants|Number|111|111.0||||||
3867738|NCT01597245|3692456|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
3867739|NCT01597245|3692452|B5|Romania||Region of Enrollment||participants|Number|35|35.0||||||
3867740|NCT01597245|3692453|B4|Romania||Region of Enrollment||participants|Number|12|12.0||||||
3867741|NCT01597245|3692454|B3|Romania||Region of Enrollment||participants|Number|8|8.0||||||
3867742|NCT01597245|3692455|B2|Romania||Region of Enrollment||participants|Number|9|9.0||||||
3867743|NCT01597245|3692456|B1|Romania||Region of Enrollment||participants|Number|6|6.0||||||
3867744|NCT01597245|3692452|B5|Czech Republic||Region of Enrollment||participants|Number|18|18.0||||||
3867745|NCT01597245|3692453|B4|Czech Republic||Region of Enrollment||participants|Number|6|6.0||||||
3867746|NCT01597245|3692454|B3|Czech Republic||Region of Enrollment||participants|Number|3|3.0||||||
3867747|NCT01597245|3692455|B2|Czech Republic||Region of Enrollment||participants|Number|6|6.0||||||
3867748|NCT01597245|3692456|B1|Czech Republic||Region of Enrollment||participants|Number|3|3.0||||||
3867749|NCT01597245|3692452|B5|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
3867750|NCT01597245|3692453|B4|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
3867751|NCT01597245|3692454|B3|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
3867752|NCT01597245|3692455|B2|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
3867769|NCT01597245|3692452|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3867770|NCT01597245|3692453|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3867771|NCT01597245|3692454|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3867772|NCT01597245|3692455|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3867773|NCT01597245|3692456|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867774|NCT01597245|3692452|B5||White|Race (NIH/OMB)||Participants|Count of Participants|1125|1125.0||||||
3867775|NCT01597245|3692453|B4||White|Race (NIH/OMB)||Participants|Count of Participants|330|330.0||||||
3867776|NCT01597245|3692454|B3||White|Race (NIH/OMB)||Participants|Count of Participants|315|315.0||||||
3867777|NCT01597245|3692455|B2||White|Race (NIH/OMB)||Participants|Count of Participants|331|331.0||||||
3867778|NCT01597245|3692456|B1||White|Race (NIH/OMB)||Participants|Count of Participants|149|149.0||||||
3867779|NCT01597245|3692452|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3867780|NCT01597245|3692453|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3867781|NCT01597245|3692454|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3867782|NCT01597245|3692455|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3867783|NCT01597245|3692456|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3867784|NCT01597245|3692452|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3867785|NCT01597245|3692453|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867786|NCT01597245|3692454|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3867787|NCT01597245|3692455|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3867788|NCT01597245|3692456|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3867789|NCT01597245|3692452|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3867790|NCT01597245|3692453|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3867791|NCT01597245|3692454|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3867792|NCT01597245|3692455|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3867793|NCT01597245|3692456|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3867794|NCT01597245|3692452|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3867795|NCT01597245|3692453|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3867796|NCT01597245|3692454|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3867797|NCT01597245|3692455|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867798|NCT01597245|3692456|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3867799|NCT01597245|3692452|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|190|190.0||||||
3867800|NCT01597245|3692453|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3867801|NCT01597245|3692454|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3867802|NCT01597245|3692455|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3867803|NCT01597245|3692456|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3867804|NCT01597245|3692452|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|954|954.0||||||
3867805|NCT01597245|3692453|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|274|274.0||||||
3867806|NCT01597245|3692454|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|271|271.0||||||
3867807|NCT01597245|3692455|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|279|279.0||||||
3867808|NCT01597245|3692456|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
3867809|NCT01597245|3692452|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3867810|NCT01597245|3692453|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3867811|NCT01597245|3692454|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3867812|NCT01597245|3692455|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3867813|NCT01597245|3692456|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3867814|NCT01597245|3692452|B5||Male|Sex: Female, Male||Participants|Count of Participants|821|821.0||||||
3867815|NCT01597245|3692453|B4||Male|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
3867816|NCT01597245|3692454|B3||Male|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
3867817|NCT01597245|3692455|B2||Male|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
3867818|NCT01597245|3692456|B1||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3867819|NCT01597245|3692452|B5||Female|Sex: Female, Male||Participants|Count of Participants|403|403.0||||||
3867820|NCT01597245|3692453|B4||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3867821|NCT01597245|3692454|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3867822|NCT01597245|3692455|B2||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3867823|NCT01597245|3692456|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3867824|NCT01597245|3692452|B5|||Age||years|Mean|45.0|45.0|Standard Deviation|13.04|13.04|||
3867825|NCT01597245|3692453|B4|||Age||years|Mean|44.5|44.5|Standard Deviation|13.27|13.27|||
3867826|NCT01597245|3692454|B3|||Age||years|Mean|45|45.0|Standard Deviation|13.53|13.53|||
3867827|NCT01597245|3692455|B2|||Age||years|Mean|45.3|45.3|Standard Deviation|12.79|12.79|||
3867828|NCT01597245|3692456|B1|||Age||years|Mean|45.3|45.3|Standard Deviation|12.13|12.13|||
3867829|NCT01597141|3692551|B3|||Global Assessment of Functioning (GAF)|The Global Assessment of Functioning is a widely used scale based on a Likert-keyed score assigned by an interviewer or clinician, based on a scale of 0-100, with 100 being the highest level of functioning and 0 the 3 lowest.|units on GAF scale|Mean|39.7|39.7|Standard Deviation|12.1|12.1|||
3867830|NCT01597141|3692552|B2|||Global Assessment of Functioning (GAF)|The Global Assessment of Functioning is a widely used scale based on a Likert-keyed score assigned by an interviewer or clinician, based on a scale of 0-100, with 100 being the highest level of functioning and 0 the 3 lowest.|units on GAF scale|Mean|36.39|36.39|Standard Deviation|10.35|10.35|||
3867831|NCT01597141|3692553|B1|||Global Assessment of Functioning (GAF)|The Global Assessment of Functioning is a widely used scale based on a Likert-keyed score assigned by an interviewer or clinician, based on a scale of 0-100, with 100 being the highest level of functioning and 0 the 3 lowest.|units on GAF scale|Mean|40.16|40.16|Standard Deviation|13.93|13.93|||
3867832|NCT01597141|3692551|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
3867833|NCT01597141|3692552|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
3867834|NCT01597141|3692553|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3867835|NCT01597141|3692551|B3|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|96|96.0||||||
3867836|NCT01597141|3692552|B2|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
3867837|NCT01597141|3692553|B1|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
3867838|NCT01597141|3692551|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3867839|NCT01597141|3692552|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3867840|NCT01597141|3692553|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3867841|NCT01597141|3692551|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3867842|NCT01597141|3692552|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3867843|NCT01597141|3692553|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3867844|NCT01597141|3692551|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3867845|NCT01597141|3692552|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3867846|NCT01597141|3692553|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3867847|NCT01597141|3692551|B3|||Age||years|Mean|16.3|16.3|Standard Deviation|2.9|2.9|||
3867848|NCT01597141|3692552|B2|||Age||years|Mean|16.12|16.12|Standard Deviation|2.75|2.75|||
3867849|NCT01597141|3692553|B1|||Age||years|Mean|16.48|16.48|Standard Deviation|3.07|3.07|||
3867850|NCT01597128|3692562|B3|||Number of Participants Who Were Employed Prior to the Hernia Repair||participants|Number|8|8.0||||||
3867851|NCT01597128|3692563|B2|||Number of Participants Who Were Employed Prior to the Hernia Repair||participants|Number|5|5.0||||||
3867852|NCT01597128|3692564|B1|||Number of Participants Who Were Employed Prior to the Hernia Repair||participants|Number|3|3.0||||||
3867853|NCT01597128|3692562|B3|||With Prior Defect||participants|Number|18|18.0||||||
3867854|NCT01597128|3692563|B2|||With Prior Defect||participants|Number|7|7.0||||||
3867855|NCT01597128|3692564|B1|||With Prior Defect||participants|Number|11|11.0||||||
3867856|NCT01597128|3692562|B3|||BMI||kg/m^2|Mean|34|34.0|Standard Deviation|6.3|6.3|||
3867857|NCT01597128|3692563|B2|||BMI||kg/m^2|Mean|34|34.0|Standard Deviation|6|6.0|||
3867858|NCT01597128|3692564|B1|||BMI||kg/m^2|Mean|34|34.0|Standard Deviation|7|7.0|||
3867859|NCT01597128|3692562|B3|||Smoker||participants|Number|22|22.0||||||
3867860|NCT01597128|3692563|B2|||Smoker||participants|Number|12|12.0||||||
3867861|NCT01597128|3692564|B1|||Smoker||participants|Number|10|10.0||||||
3867862|NCT01597128|3692562|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
3867863|NCT01597128|3692563|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3867864|NCT01597128|3692564|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3867865|NCT01597128|3692562|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3867866|NCT01597128|3692563|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3867867|NCT01597128|3692564|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867868|NCT01597128|3692562|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867869|NCT01597128|3692563|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867870|NCT01597128|3692564|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867871|NCT01597128|3692562|B3||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3867872|NCT01597128|3692563|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3867873|NCT01597128|3692564|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3867874|NCT01597128|3692562|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867875|NCT01597128|3692563|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867876|NCT01597128|3692564|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867877|NCT01597128|3692562|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867878|NCT01597128|3692563|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867879|NCT01597128|3692564|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867880|NCT01597128|3692562|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867881|NCT01597128|3692563|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867882|NCT01597128|3692564|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867883|NCT01597128|3692562|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867884|NCT01597128|3692563|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867885|NCT01597128|3692564|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3867886|NCT01597128|3692562|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3867887|NCT01597128|3692563|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3867888|NCT01597128|3692564|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3867889|NCT01597128|3692562|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3867890|NCT01597128|3692563|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3867891|NCT01597128|3692564|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3867892|NCT01597128|3692562|B3|||Age||years|Mean|58|58.0|Standard Deviation|10.8|10.8|||
3867893|NCT01597128|3692563|B2|||Age||years|Mean|58|58.0|Standard Deviation|12|12.0|||
3867894|NCT01597128|3692564|B1|||Age||years|Mean|58|58.0|Standard Deviation|10|10.0|||
3867895|NCT01597050|3692589|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
3867896|NCT01597050|3692590|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3867897|NCT01597050|3692591|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3867898|NCT01597050|3692589|B3|Canada||Region of Enrollment||participants|Number|9|9.0||||||
3867899|NCT01597050|3692590|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
3867900|NCT01597050|3692591|B1|Canada||Region of Enrollment||participants|Number|7|7.0||||||
3867901|NCT01597050|3692589|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3867902|NCT01597050|3692590|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3867903|NCT01597050|3692591|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3867904|NCT01597050|3692589|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3867905|NCT01597050|3692590|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3867906|NCT01597050|3692591|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3867907|NCT01597050|3692589|B3|||Age||years|Mean|46.8|46.8|Standard Deviation|11.69|11.69|||
3867908|NCT01597050|3692590|B2|||Age||years|Mean|48.3|48.3|Standard Deviation|12.57|12.57|||
3867909|NCT01597050|3692591|B1|||Age||years|Mean|46.1|46.1|Standard Deviation|11.3|11.3|||
3867910|NCT01596972|3692598|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
3867911|NCT01596972|3692599|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
3867912|NCT01596972|3692600|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3867913|NCT01596972|3692598|B3|Other||Race/Ethnicity, Customized|The numbers below report self-described RACE of participants. Additionally, though, 3 participants in the Serum HCG arm and 5 participants in the serum quantitative urine pregnancy test arm also self-identified as having a Hispanic Ethnicity.|participants|Number|3|3.0||||||
3867914|NCT01596972|3692599|B2|Other||Race/Ethnicity, Customized|The numbers below report self-described RACE of participants. Additionally, though, 3 participants in the Serum HCG arm and 5 participants in the serum quantitative urine pregnancy test arm also self-identified as having a Hispanic Ethnicity.|participants|Number|1|1.0||||||
3867915|NCT01596972|3692600|B1|Other||Race/Ethnicity, Customized|The numbers below report self-described RACE of participants. Additionally, though, 3 participants in the Serum HCG arm and 5 participants in the serum quantitative urine pregnancy test arm also self-identified as having a Hispanic Ethnicity.|participants|Number|2|2.0||||||
3867916|NCT01596972|3692598|B3|Multiracial||Race/Ethnicity, Customized|The numbers below report self-described RACE of participants. Additionally, though, 3 participants in the Serum HCG arm and 5 participants in the serum quantitative urine pregnancy test arm also self-identified as having a Hispanic Ethnicity.|participants|Number|6|6.0||||||
3867917|NCT01596972|3692599|B2|Multiracial||Race/Ethnicity, Customized|The numbers below report self-described RACE of participants. Additionally, though, 3 participants in the Serum HCG arm and 5 participants in the serum quantitative urine pregnancy test arm also self-identified as having a Hispanic Ethnicity.|participants|Number|4|4.0||||||
3867918|NCT01596972|3692600|B1|Multiracial||Race/Ethnicity, Customized|The numbers below report self-described RACE of participants. Additionally, though, 3 participants in the Serum HCG arm and 5 participants in the serum quantitative urine pregnancy test arm also self-identified as having a Hispanic Ethnicity.|participants|Number|2|2.0||||||
3867919|NCT01596972|3692598|B3|Asian||Race/Ethnicity, Customized|The numbers below report self-described RACE of participants. Additionally, though, 3 participants in the Serum HCG arm and 5 participants in the serum quantitative urine pregnancy test arm also self-identified as having a Hispanic Ethnicity.|participants|Number|6|6.0||||||
3867920|NCT01596972|3692599|B2|Asian||Race/Ethnicity, Customized|The numbers below report self-described RACE of participants. Additionally, though, 3 participants in the Serum HCG arm and 5 participants in the serum quantitative urine pregnancy test arm also self-identified as having a Hispanic Ethnicity.|participants|Number|4|4.0||||||
3867921|NCT01596972|3692600|B1|Asian||Race/Ethnicity, Customized|The numbers below report self-described RACE of participants. Additionally, though, 3 participants in the Serum HCG arm and 5 participants in the serum quantitative urine pregnancy test arm also self-identified as having a Hispanic Ethnicity.|participants|Number|2|2.0||||||
3867922|NCT01596972|3692598|B3|Black/African American||Race/Ethnicity, Customized|The numbers below report self-described RACE of participants. Additionally, though, 3 participants in the Serum HCG arm and 5 participants in the serum quantitative urine pregnancy test arm also self-identified as having a Hispanic Ethnicity.|participants|Number|8|8.0||||||
3867923|NCT01596972|3692599|B2|Black/African American||Race/Ethnicity, Customized|The numbers below report self-described RACE of participants. Additionally, though, 3 participants in the Serum HCG arm and 5 participants in the serum quantitative urine pregnancy test arm also self-identified as having a Hispanic Ethnicity.|participants|Number|3|3.0||||||
3867924|NCT01596972|3692600|B1|Black/African American||Race/Ethnicity, Customized|The numbers below report self-described RACE of participants. Additionally, though, 3 participants in the Serum HCG arm and 5 participants in the serum quantitative urine pregnancy test arm also self-identified as having a Hispanic Ethnicity.|participants|Number|5|5.0||||||
3867925|NCT01596972|3692598|B3|White/European American||Race/Ethnicity, Customized|The numbers below report self-described RACE of participants. Additionally, though, 3 participants in the Serum HCG arm and 5 participants in the serum quantitative urine pregnancy test arm also self-identified as having a Hispanic Ethnicity.|participants|Number|28|28.0||||||
3867926|NCT01596972|3692599|B2|White/European American||Race/Ethnicity, Customized|The numbers below report self-described RACE of participants. Additionally, though, 3 participants in the Serum HCG arm and 5 participants in the serum quantitative urine pregnancy test arm also self-identified as having a Hispanic Ethnicity.|participants|Number|14|14.0||||||
3867927|NCT01596972|3692600|B1|White/European American||Race/Ethnicity, Customized|The numbers below report self-described RACE of participants. Additionally, though, 3 participants in the Serum HCG arm and 5 participants in the serum quantitative urine pregnancy test arm also self-identified as having a Hispanic Ethnicity.|participants|Number|14|14.0||||||
3867928|NCT01596972|3692598|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3867929|NCT01596972|3692599|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3867930|NCT01596972|3692600|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3867931|NCT01596972|3692598|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3867932|NCT01596972|3692599|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3867933|NCT01596972|3692600|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3867934|NCT01596972|3692598|B3|||Age||years|Mean|25|25.0|Standard Deviation|5|5.0|||
3867935|NCT01596972|3692599|B2|||Age||years|Mean|25|25.0|Standard Deviation|5|5.0|||
3867936|NCT01596972|3692600|B1|||Age||years|Mean|25|25.0|Standard Deviation|5|5.0|||
3867937|NCT01596842|3692611|B3|Korea, Republic of||Region of Enrollment||participants|Number|15|15.0||||||
3867938|NCT01596842|3692612|B2|Korea, Republic of||Region of Enrollment||participants|Number|7|7.0||||||
3867939|NCT01596842|3692613|B1|Korea, Republic of||Region of Enrollment||participants|Number|8|8.0||||||
3867940|NCT01596842|3692611|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3867941|NCT01596842|3692612|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3867942|NCT01596842|3692613|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3867943|NCT01596842|3692611|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3867944|NCT01596842|3692612|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3867945|NCT01596842|3692613|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3867946|NCT01596842|3692611|B3|||Age||years|Mean|62.1|62.1|Standard Deviation|7.9|7.9|||
3867947|NCT01596842|3692612|B2|||Age||years|Mean|64.4|64.4|Standard Deviation|8.5|8.5|||
3867948|NCT01596842|3692613|B1|||Age||years|Mean|60.0|60.0|Standard Deviation|7.3|7.3|||
3867949|NCT01596582|3692622|B3||Mostly provider|Desired role in decision-making||Participants|Count of Participants|54|54.0||||||
3867950|NCT01596582|3692623|B2||Mostly provider|Desired role in decision-making||Participants|Count of Participants|32|32.0||||||
3867951|NCT01596582|3692624|B1||Mostly provider|Desired role in decision-making||Participants|Count of Participants|22|22.0||||||
3867952|NCT01596582|3692622|B3||Shared|Desired role in decision-making||Participants|Count of Participants|176|176.0||||||
3867953|NCT01596582|3692623|B2||Shared|Desired role in decision-making||Participants|Count of Participants|88|88.0||||||
3867954|NCT01596582|3692624|B1||Shared|Desired role in decision-making||Participants|Count of Participants|88|88.0||||||
3867955|NCT01596582|3692622|B3||Mostly patient|Desired role in decision-making||Participants|Count of Participants|111|111.0||||||
3867956|NCT01596582|3692623|B2||Mostly patient|Desired role in decision-making||Participants|Count of Participants|53|53.0||||||
3867957|NCT01596582|3692624|B1||Mostly patient|Desired role in decision-making||Participants|Count of Participants|58|58.0||||||
3867958|NCT01596582|3692622|B3||None|Insurance||Participants|Count of Participants|4|4.0||||||
3867959|NCT01596582|3692623|B2||None|Insurance||Participants|Count of Participants|1|1.0||||||
3867960|NCT01596582|3692624|B1||None|Insurance||Participants|Count of Participants|3|3.0||||||
3867961|NCT01596582|3692622|B3||Other|Insurance||Participants|Count of Participants|17|17.0||||||
3867962|NCT01596582|3692623|B2||Other|Insurance||Participants|Count of Participants|11|11.0||||||
3867963|NCT01596582|3692624|B1||Other|Insurance||Participants|Count of Participants|6|6.0||||||
3867964|NCT01596582|3692622|B3||Free care|Insurance||Participants|Count of Participants|41|41.0||||||
3867965|NCT01596582|3692623|B2||Free care|Insurance||Participants|Count of Participants|20|20.0||||||
3867966|NCT01596582|3692624|B1||Free care|Insurance||Participants|Count of Participants|21|21.0||||||
3867967|NCT01596582|3692622|B3||Medicaid|Insurance||Participants|Count of Participants|86|86.0||||||
3867968|NCT01596582|3692623|B2||Medicaid|Insurance||Participants|Count of Participants|49|49.0||||||
3867969|NCT01596582|3692624|B1||Medicaid|Insurance||Participants|Count of Participants|37|37.0||||||
3867970|NCT01596582|3692622|B3||Medicare|Insurance||Participants|Count of Participants|100|100.0||||||
3867971|NCT01596582|3692623|B2||Medicare|Insurance||Participants|Count of Participants|54|54.0||||||
3867972|NCT01596582|3692624|B1||Medicare|Insurance||Participants|Count of Participants|46|46.0||||||
3867973|NCT01596582|3692622|B3||Private/HMO|Insurance||Participants|Count of Participants|93|93.0||||||
3867974|NCT01596582|3692623|B2||Private/HMO|Insurance||Participants|Count of Participants|38|38.0||||||
3867975|NCT01596582|3692624|B1||Private/HMO|Insurance||Participants|Count of Participants|55|55.0||||||
3867976|NCT01596582|3692622|B3||Refused|Marital status||Participants|Count of Participants|1|1.0||||||
3867977|NCT01596582|3692623|B2||Refused|Marital status||Participants|Count of Participants|1|1.0||||||
3867978|NCT01596582|3692624|B1||Refused|Marital status||Participants|Count of Participants|0|0.0||||||
3867979|NCT01596582|3692622|B3||Single/separated/divorced/widowed|Marital status||Participants|Count of Participants|244|244.0||||||
3867980|NCT01596582|3692623|B2||Single/separated/divorced/widowed|Marital status||Participants|Count of Participants|125|125.0||||||
3867981|NCT01596582|3692624|B1||Single/separated/divorced/widowed|Marital status||Participants|Count of Participants|119|119.0||||||
3867982|NCT01596582|3692622|B3||Married/living with partner|Marital status||Participants|Count of Participants|96|96.0||||||
3867983|NCT01596582|3692623|B2||Married/living with partner|Marital status||Participants|Count of Participants|47|47.0||||||
3867984|NCT01596582|3692624|B1||Married/living with partner|Marital status||Participants|Count of Participants|49|49.0||||||
3867985|NCT01596582|3692622|B3||Greater than high school|Education||Participants|Count of Participants|129|129.0||||||
3867986|NCT01596582|3692623|B2||Greater than high school|Education||Participants|Count of Participants|59|59.0||||||
3867987|NCT01596582|3692624|B1||Greater than high school|Education||Participants|Count of Participants|70|70.0||||||
3867988|NCT01596582|3692622|B3||High school or less|Education||Participants|Count of Participants|212|212.0||||||
3867989|NCT01596582|3692623|B2||High school or less|Education||Participants|Count of Participants|114|114.0||||||
3867990|NCT01596582|3692624|B1||High school or less|Education||Participants|Count of Participants|98|98.0||||||
3867991|NCT01596582|3692622|B3|Race : Other||Race/Ethnicity, Customized||Participants|Count of Participants|58|58.0||||||
3867992|NCT01596582|3692623|B2|Race : Other||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3867993|NCT01596582|3692624|B1|Race : Other||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3867994|NCT01596582|3692622|B3|Race : Black||Race/Ethnicity, Customized||Participants|Count of Participants|208|208.0||||||
3867995|NCT01596582|3692623|B2|Race : Black||Race/Ethnicity, Customized||Participants|Count of Participants|104|104.0||||||
3867996|NCT01596582|3692624|B1|Race : Black||Race/Ethnicity, Customized||Participants|Count of Participants|104|104.0||||||
3867997|NCT01596582|3692622|B3|Race : White||Race/Ethnicity, Customized||Participants|Count of Participants|75|75.0||||||
3867998|NCT01596582|3692623|B2|Race : White||Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3867999|NCT01596582|3692624|B1|Race : White||Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3868000|NCT01596582|3692622|B3|Ethnicity : Refused||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3868001|NCT01596582|3692623|B2|Ethnicity : Refused||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3868002|NCT01596582|3692624|B1|Ethnicity : Refused||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3868003|NCT01596582|3692622|B3|Ethnicity : Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|317|317.0||||||
3868004|NCT01596582|3692623|B2|Ethnicity : Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|163|163.0||||||
3868005|NCT01596582|3692624|B1|Ethnicity : Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|154|154.0||||||
3868006|NCT01596582|3692622|B3|Ethnicity : Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3868007|NCT01596582|3692623|B2|Ethnicity : Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3868008|NCT01596582|3692624|B1|Ethnicity : Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3868009|NCT01596582|3692622|B3||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3868010|NCT01596582|3692623|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3868011|NCT01596582|3692624|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3868012|NCT01596582|3692622|B3||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3868013|NCT01596582|3692623|B2||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3868014|NCT01596582|3692624|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3868015|NCT01596582|3692622|B3|||Age||years|Mean|56.4|56.4|Standard Deviation|6.3|6.3|||
3868016|NCT01596582|3692623|B2|||Age||years|Mean|56.8|56.8|Standard Deviation|6.8|6.8|||
3868017|NCT01596582|3692624|B1|||Age||years|Mean|56.0|56.0|Standard Deviation|5.9|5.9|||
3868018|NCT01596504|3692649|B4|||HbA1c at Screening (Day -7)||percentage of haemoglobin|Mean|7.25|7.25|Standard Deviation|0.50|0.5|||
3868019|NCT01596504|3692650|B3|||HbA1c at Screening (Day -7)||percentage of haemoglobin|Mean|7.33|7.33|Standard Deviation|0.5|0.5|||
3868020|NCT01596504|3692651|B2|||HbA1c at Screening (Day -7)||percentage of haemoglobin|Mean|7.19|7.19|Standard Deviation|0.53|0.53|||
3868021|NCT01596504|3692652|B1|||HbA1c at Screening (Day -7)||percentage of haemoglobin|Mean|7.22|7.22|Standard Deviation|0.48|0.48|||
3868022|NCT01596504|3692649|B4|||Body Mass Index (BMI)||(kg/m²)|Mean|30.79|30.79|Standard Deviation|4.22|4.22|||
3868023|NCT01596504|3692650|B3|||Body Mass Index (BMI)||(kg/m²)|Mean|31.17|31.17|Standard Deviation|4.34|4.34|||
3868024|NCT01596504|3692651|B2|||Body Mass Index (BMI)||(kg/m²)|Mean|30.52|30.52|Standard Deviation|4.01|4.01|||
3868025|NCT01596504|3692652|B1|||Body Mass Index (BMI)||(kg/m²)|Mean|30.68|30.68|Standard Deviation|4.34|4.34|||
3868026|NCT01596504|3692649|B4|||Weight||kg|Mean|91.69|91.69|Standard Deviation|14.07|14.07|||
3868027|NCT01596504|3692650|B3|||Weight||kg|Mean|92.92|92.92|Standard Deviation|15.33|15.33|||
3868028|NCT01596504|3692651|B2|||Weight||kg|Mean|91.62|91.62|Standard Deviation|13.92|13.92|||
3868029|NCT01596504|3692652|B1|||Weight||kg|Mean|90.56|90.56|Standard Deviation|13.09|13.09|||
3868030|NCT01596504|3692649|B4|No||Metformin Use at Screening||participants|Number|17|17.0||||||
3868031|NCT01596504|3692650|B3|No||Metformin Use at Screening||participants|Number|6|6.0||||||
3868032|NCT01596504|3692651|B2|No||Metformin Use at Screening||participants|Number|6|6.0||||||
3868033|NCT01596504|3692652|B1|No||Metformin Use at Screening||participants|Number|5|5.0||||||
3868034|NCT01596504|3692649|B4|Yes||Metformin Use at Screening||participants|Number|125|125.0||||||
3868035|NCT01596504|3692650|B3|Yes||Metformin Use at Screening||participants|Number|41|41.0||||||
3868036|NCT01596504|3692651|B2|Yes||Metformin Use at Screening||participants|Number|41|41.0||||||
3868037|NCT01596504|3692652|B1|Yes||Metformin Use at Screening||participants|Number|43|43.0||||||
3868038|NCT01596504|3692649|B4|Other||Race||participants|Number|1|1.0||||||
3868039|NCT01596504|3692650|B3|Other||Race||participants|Number|0|0.0||||||
3868040|NCT01596504|3692651|B2|Other||Race||participants|Number|1|1.0||||||
3868041|NCT01596504|3692652|B1|Other||Race||participants|Number|0|0.0||||||
3868042|NCT01596504|3692649|B4|Caucasian/White||Race||participants|Number|141|141.0||||||
3868043|NCT01596504|3692650|B3|Caucasian/White||Race||participants|Number|47|47.0||||||
3868044|NCT01596504|3692651|B2|Caucasian/White||Race||participants|Number|46|46.0||||||
3868045|NCT01596504|3692652|B1|Caucasian/White||Race||participants|Number|48|48.0||||||
3868046|NCT01596504|3692649|B4||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3868047|NCT01596504|3692650|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3868048|NCT01596504|3692651|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3868049|NCT01596504|3692652|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3868050|NCT01596504|3692649|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3868051|NCT01596504|3692650|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3868052|NCT01596504|3692651|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3868053|NCT01596504|3692652|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3868054|NCT01596504|3692649|B4|||Age||years|Mean|61.9|61.9|Standard Deviation|8.3|8.3|||
3868055|NCT01596504|3692650|B3|||Age||years|Mean|62.6|62.6|Standard Deviation|9.4|9.4|||
3868056|NCT01596504|3692651|B2|||Age||years|Mean|61.4|61.4|Standard Deviation|7.9|7.9|||
3868057|NCT01596504|3692652|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|7.4|7.4|||
3868058|NCT01596335|3692710|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3868059|NCT01596335|3692711|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3868060|NCT01596335|3692712|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3868061|NCT01596335|3692710|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3868062|NCT01596335|3692711|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3868063|NCT01596335|3692712|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3868064|NCT01596335|3692710|B3|>= 2 and <= 10||Age, Customized||participants|Number|27|27.0||||||
3868065|NCT01596335|3692711|B2|>= 2 and <= 10||Age, Customized||participants|Number|13|13.0||||||
3868066|NCT01596335|3692712|B1|>= 2 and <= 10||Age, Customized||participants|Number|14|14.0||||||
3868067|NCT01596335|3692710|B3|>= 1 and < 2||Age, Customized||participants|Number|4|4.0||||||
3868068|NCT01596335|3692711|B2|>= 1 and < 2||Age, Customized||participants|Number|2|2.0||||||
3868069|NCT01596335|3692712|B1|>= 1 and < 2||Age, Customized||participants|Number|2|2.0||||||
3868070|NCT01596283|3692723|B3|United States||Region of Enrollment||Participants|Count of Participants|135|135.0||||||
3868071|NCT01596283|3692724|B2|United States||Region of Enrollment||Participants|Count of Participants|66|66.0||||||
3868072|NCT01596283|3692725|B1|United States||Region of Enrollment||Participants|Count of Participants|69|69.0||||||
3868073|NCT01596283|3692723|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3868074|NCT01596283|3692724|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3868075|NCT01596283|3692725|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3868076|NCT01596283|3692723|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3868077|NCT01596283|3692724|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3868078|NCT01596283|3692725|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3868079|NCT01596283|3692723|B3|||Age||years|Median|57|57.0|Standard Deviation|13|13.0|||
3868080|NCT01596283|3692724|B2|||Age||years|Median|58|58.0|Standard Deviation|14|14.0|||
3868081|NCT01596283|3692725|B1|||Age||years|Median|55|55.0|Standard Deviation|13|13.0|||
3868082|NCT01596231|3692740|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3868083|NCT01596231|3692741|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3868084|NCT01596231|3692742|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3868085|NCT01596231|3692740|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868086|NCT01596231|3692741|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868087|NCT01596231|3692742|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868088|NCT01596231|3692740|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3868089|NCT01596231|3692741|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3868090|NCT01596231|3692742|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3868091|NCT01596231|3692740|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3868092|NCT01596231|3692741|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868093|NCT01596231|3692742|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3868094|NCT01596231|3692740|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868095|NCT01596231|3692741|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868096|NCT01596231|3692742|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868097|NCT01596231|3692740|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3868098|NCT01596231|3692741|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3868099|NCT01596231|3692742|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3868100|NCT01596231|3692740|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3868101|NCT01596231|3692741|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3868102|NCT01596231|3692742|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3868103|NCT01596231|3692740|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868104|NCT01596231|3692741|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868105|NCT01596231|3692742|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868106|NCT01596231|3692740|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868107|NCT01596231|3692741|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868108|NCT01596231|3692742|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868109|NCT01596231|3692740|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868110|NCT01596231|3692741|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868111|NCT01596231|3692742|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868112|NCT01596231|3692740|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868113|NCT01596231|3692741|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868114|NCT01596231|3692742|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868115|NCT01596231|3692740|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3868116|NCT01596231|3692741|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3868117|NCT01596231|3692742|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3868118|NCT01596231|3692740|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3868119|NCT01596231|3692741|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3868120|NCT01596231|3692742|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3868121|NCT01596231|3692740|B3|||Age||years|Mean|23.6|23.6|Standard Deviation|6.2|6.2|||
3868122|NCT01596231|3692741|B2|||Age||years|Mean|22.6|22.6|Standard Deviation|3.7|3.7|||
3868123|NCT01596231|3692742|B1|||Age||years|Mean|24.6|24.6|Standard Deviation|3.3|3.3|||
3868124|NCT01596127|3692749|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3868125|NCT01596127|3692749|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868126|NCT01596127|3692749|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3868127|NCT01596127|3692749|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868128|NCT01596127|3692749|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868129|NCT01596127|3692749|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868130|NCT01596127|3692749|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868131|NCT01596127|3692749|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868132|NCT01596127|3692749|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3868133|NCT01596127|3692749|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3868134|NCT01596127|3692749|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3868135|NCT01596127|3692749|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3868136|NCT01596127|3692749|B1|||Age||years|Median|38|38.0|Full Range|||31.0|50.0|
3868137|NCT01596088|3692754|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3868138|NCT01596088|3692754|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3868139|NCT01596088|3692754|B1|>=65 years||Age, Customized||participants|Number|1|1.0||||||
3868140|NCT01596088|3692754|B1|>=20 and <65 years||Age, Customized||participants|Number|1|1.0||||||
3868141|NCT01596062|3692758|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3868142|NCT01596062|3692759|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3868143|NCT01596062|3692760|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3868144|NCT01596062|3692761|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3868145|NCT01596062|3692758|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3868146|NCT01596062|3692759|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3868147|NCT01596062|3692760|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3868148|NCT01596062|3692761|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3868149|NCT01596062|3692758|B4|||Age||years|Mean|44.3|44.3|Standard Deviation|11.9|11.9|||
3868150|NCT01596062|3692759|B3|||Age||years|Mean|39.7|39.7|Standard Deviation|12.2|12.2|||
3868151|NCT01596062|3692760|B2|||Age||years|Mean|45.0|45.0|Standard Deviation|11.4|11.4|||
3868152|NCT01596062|3692761|B1|||Age||years|Mean|53.7|53.7|Standard Deviation|8.7|8.7|||
3868153|NCT01595854|3692795|B6||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3868154|NCT01595854|3692796|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3868155|NCT01595854|3692797|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3868156|NCT01595854|3692798|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3868157|NCT01595854|3692799|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3868158|NCT01595854|3692800|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3868159|NCT01595854|3692795|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3868160|NCT01595854|3692796|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3868161|NCT01595854|3692797|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3868162|NCT01595854|3692798|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3868163|NCT01595854|3692799|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3868164|NCT01595854|3692800|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3868165|NCT01595854|3692795|B6|||Age||years|Mean|31.3|31.3|Standard Deviation|8.2|8.2|||
3868166|NCT01595854|3692796|B5|||Age||years|Mean|30.2|30.2|Standard Deviation|7.2|7.2|||
3868167|NCT01595854|3692797|B4|||Age||years|Mean|33.3|33.3|Standard Deviation|6.3|6.3|||
3868168|NCT01595854|3692798|B3|||Age||years|Mean|33.6|33.6|Standard Deviation|9.1|9.1|||
3868169|NCT01595854|3692799|B2|||Age||years|Mean|29.8|29.8|Standard Deviation|11.4|11.4|||
3868170|NCT01595854|3692800|B1|||Age||years|Mean|30.6|30.6|Standard Deviation|7.7|7.7|||
3868171|NCT01595646|3692824|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868172|NCT01595646|3692825|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868173|NCT01595646|3692826|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868174|NCT01595646|3692827|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868175|NCT01595646|3692824|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868176|NCT01595646|3692825|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868177|NCT01595646|3692826|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868178|NCT01595646|3692827|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868179|NCT01595646|3692824|B4||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3868180|NCT01595646|3692825|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3868181|NCT01595646|3692826|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3868182|NCT01595646|3692827|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3868183|NCT01595646|3692824|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868184|NCT01595646|3692825|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868185|NCT01595646|3692826|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868186|NCT01595646|3692827|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868187|NCT01595646|3692824|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868188|NCT01595646|3692825|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868189|NCT01595646|3692826|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868190|NCT01595646|3692827|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868191|NCT01595646|3692824|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868192|NCT01595646|3692825|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868193|NCT01595646|3692826|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868194|NCT01595646|3692827|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868195|NCT01595646|3692824|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868196|NCT01595646|3692825|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868197|NCT01595646|3692826|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868198|NCT01595646|3692827|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868199|NCT01595646|3692824|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3868200|NCT01595646|3692825|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3868201|NCT01595646|3692826|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3868202|NCT01595646|3692827|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3868203|NCT01595646|3692824|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3868204|NCT01595646|3692825|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3868205|NCT01595646|3692826|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3868206|NCT01595646|3692827|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3868207|NCT01595646|3692824|B4|||Age||years|Mean|68|68.0|Full Range|||56.0|80.0|
3868208|NCT01595646|3692825|B3|||Age||years|Mean|68|68.0|Full Range|||56.0|80.0|
3868209|NCT01595646|3692826|B2|||Age||years|Mean|66|66.0|Full Range|||62.0|70.0|
3868210|NCT01595646|3692827|B1|||Age||years|Mean|68|68.0|Full Range|||61.0|75.0|
3868211|NCT01595646|3692824|B4||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3868212|NCT01595646|3692825|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3868213|NCT01595646|3692826|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3868214|NCT01595646|3692827|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3868215|NCT01595646|3692824|B4||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3868216|NCT01595646|3692825|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3868217|NCT01595646|3692826|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3868218|NCT01595646|3692827|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3868219|NCT01595646|3692824|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3868220|NCT01595646|3692825|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3868221|NCT01595646|3692826|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3868222|NCT01595646|3692827|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3868223|NCT01595438|3692849|B3|White||Race/Ethnicity, Customized||Participants|Number|847|847.0||||||
3868224|NCT01595438|3692850|B2|White||Race/Ethnicity, Customized||Participants|Number|426|426.0||||||
3868225|NCT01595438|3692851|B1|White||Race/Ethnicity, Customized||Participants|Number|421|421.0||||||
3868226|NCT01595438|3692849|B3|Other||Race/Ethnicity, Customized||Participants|Number|75|75.0||||||
3868227|NCT01595438|3692850|B2|Other||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
3868228|NCT01595438|3692851|B1|Other||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
3868229|NCT01595438|3692849|B3|Black Or African American||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3868230|NCT01595438|3692850|B2|Black Or African American||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3868231|NCT01595438|3692851|B1|Black Or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3868232|NCT01595438|3692849|B3|Asian||Race/Ethnicity, Customized||Participants|Number|85|85.0||||||
3868233|NCT01595438|3692850|B2|Asian||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
3868234|NCT01595438|3692851|B1|Asian||Race/Ethnicity, Customized||Participants|Number|48|48.0||||||
3868235|NCT01595438|3692849|B3|American Indian Or Alaska Native||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3868236|NCT01595438|3692850|B2|American Indian Or Alaska Native||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3868237|NCT01595438|3692851|B1|American Indian Or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3868238|NCT01595438|3692849|B3||Male|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
3868239|NCT01595438|3692850|B2||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3868240|NCT01595438|3692851|B1||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3868241|NCT01595438|3692849|B3||Female|Sex: Female, Male||Participants|Count of Participants|706|706.0||||||
3868242|NCT01595438|3692850|B2||Female|Sex: Female, Male||Participants|Count of Participants|357|357.0||||||
3868243|NCT01595438|3692851|B1||Female|Sex: Female, Male||Participants|Count of Participants|349|349.0||||||
3868244|NCT01595438|3692849|B3|75-90||Age, Customized||Participants|Number|140|140.0||||||
3868245|NCT01595438|3692850|B2|75-90||Age, Customized||Participants|Number|62|62.0||||||
3868246|NCT01595438|3692851|B1|75-90||Age, Customized||Participants|Number|78|78.0||||||
3868247|NCT01595438|3692849|B3|65-74||Age, Customized||Participants|Number|177|177.0||||||
3868248|NCT01595438|3692850|B2|65-74||Age, Customized||Participants|Number|98|98.0||||||
3868249|NCT01595438|3692851|B1|65-74||Age, Customized||Participants|Number|79|79.0||||||
3868250|NCT01595438|3692849|B3|46-64||Age, Customized||Participants|Number|339|339.0||||||
3868251|NCT01595438|3692850|B2|46-64||Age, Customized||Participants|Number|177|177.0||||||
3868252|NCT01595438|3692851|B1|46-64||Age, Customized||Participants|Number|162|162.0||||||
3868253|NCT01595438|3692849|B3|18-45||Age, Customized||Participants|Number|364|364.0||||||
3868254|NCT01595438|3692850|B2|18-45||Age, Customized||Participants|Number|172|172.0||||||
3868255|NCT01595438|3692851|B1|18-45||Age, Customized||Participants|Number|192|192.0||||||
3868256|NCT01595438|3692849|B3|||Age||Years|Mean|52.0|52.0|Standard Deviation|19.29|19.29|18.0|89.0|
3868257|NCT01595438|3692850|B2|||Age||Years|Mean|52.3|52.3|Standard Deviation|18.83|18.83|18.0|86.0|
3868258|NCT01595438|3692851|B1|||Age||Years|Mean|51.6|51.6|Standard Deviation|19.76|19.76|18.0|89.0|
3868259|NCT01595386|3692976|B3|other||Surgical Procedure||number of patients|Number|3|3.0||||||
3868260|NCT01595386|3692977|B2|other||Surgical Procedure||number of patients|Number|2|2.0||||||
3868261|NCT01595386|3692978|B1|other||Surgical Procedure||number of patients|Number|1|1.0||||||
3868262|NCT01595386|3692976|B3|Truncus arteriosus repair||Surgical Procedure||number of patients|Number|3|3.0||||||
3868263|NCT01595386|3692977|B2|Truncus arteriosus repair||Surgical Procedure||number of patients|Number|0|0.0||||||
3868264|NCT01595386|3692978|B1|Truncus arteriosus repair||Surgical Procedure||number of patients|Number|3|3.0||||||
3868265|NCT01595386|3692976|B3|Aortic arch augmentation||Surgical Procedure||number of patients|Number|2|2.0||||||
3868266|NCT01595386|3692977|B2|Aortic arch augmentation||Surgical Procedure||number of patients|Number|1|1.0||||||
3868267|NCT01595386|3692978|B1|Aortic arch augmentation||Surgical Procedure||number of patients|Number|1|1.0||||||
3868268|NCT01595386|3692976|B3|Interrupted aortic arch repair||Surgical Procedure||number of patients|Number|7|7.0||||||
3868269|NCT01595386|3692977|B2|Interrupted aortic arch repair||Surgical Procedure||number of patients|Number|4|4.0||||||
3868270|NCT01595386|3692978|B1|Interrupted aortic arch repair||Surgical Procedure||number of patients|Number|3|3.0||||||
3868271|NCT01595386|3692976|B3|Arterial switch operation||Surgical Procedure||number of patients|Number|12|12.0||||||
3868272|NCT01595386|3692977|B2|Arterial switch operation||Surgical Procedure||number of patients|Number|6|6.0||||||
3868273|NCT01595386|3692978|B1|Arterial switch operation||Surgical Procedure||number of patients|Number|6|6.0||||||
3868274|NCT01595386|3692976|B3|Norwood||Surgical Procedure||number of patients|Number|13|13.0||||||
3868275|NCT01595386|3692977|B2|Norwood||Surgical Procedure||number of patients|Number|6|6.0||||||
3868276|NCT01595386|3692978|B1|Norwood||Surgical Procedure||number of patients|Number|7|7.0||||||
3868277|NCT01595386|3692976|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3868278|NCT01595386|3692977|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3868279|NCT01595386|3692978|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3868280|NCT01595386|3692976|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868281|NCT01595386|3692977|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868282|NCT01595386|3692978|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868283|NCT01595386|3692976|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868284|NCT01595386|3692977|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868285|NCT01595386|3692978|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868286|NCT01595386|3692976|B3||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3868287|NCT01595386|3692977|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3868288|NCT01595386|3692978|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3868289|NCT01595386|3692976|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3868290|NCT01595386|3692977|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3868291|NCT01595386|3692978|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3868292|NCT01595386|3692976|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868293|NCT01595386|3692977|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868294|NCT01595386|3692978|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868295|NCT01595386|3692976|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868296|NCT01595386|3692977|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868297|NCT01595386|3692978|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868298|NCT01595386|3692976|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868299|NCT01595386|3692977|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868300|NCT01595386|3692978|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868301|NCT01595386|3692976|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3868302|NCT01595386|3692977|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3868303|NCT01595386|3692978|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3868304|NCT01595386|3692976|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3868305|NCT01595386|3692977|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3868306|NCT01595386|3692978|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3868307|NCT01595386|3692976|B3|||Age||Days|Median|6|6.0|Inter-Quartile Range|||5.0|8.0|
3868308|NCT01595386|3692977|B2|||Age||Days|Median|5|5.0|Inter-Quartile Range|||4.0|7.0|
3868309|NCT01595386|3692978|B1|||Age||Days|Median|6|6.0|Inter-Quartile Range|||5.0|11.0|
3868310|NCT01595282|3693005|B3|United States||Region of Enrollment||participants|Number|94|94.0||||||
3868311|NCT01595282|3693006|B2|United States||Region of Enrollment||participants|Number|47|47.0||||||
3868312|NCT01595282|3693007|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
3868313|NCT01595282|3693005|B3|Other||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3868314|NCT01595282|3693006|B2|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3868315|NCT01595282|3693007|B1|Other||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3868316|NCT01595282|3693005|B3|Multiracial||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3868317|NCT01595282|3693006|B2|Multiracial||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3868318|NCT01595282|3693007|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3868319|NCT01595282|3693005|B3|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3868320|NCT01595282|3693006|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3868321|NCT01595282|3693007|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3868322|NCT01595282|3693005|B3|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3868323|NCT01595282|3693006|B2|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3868324|NCT01595282|3693007|B1|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3868325|NCT01595282|3693005|B3|African American/Black||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
3868326|NCT01595282|3693006|B2|African American/Black||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3868327|NCT01595282|3693007|B1|African American/Black||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3868328|NCT01595282|3693005|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3868329|NCT01595282|3693006|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3868330|NCT01595282|3693007|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3868331|NCT01595282|3693005|B3||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3868332|NCT01595282|3693006|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3868333|NCT01595282|3693007|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3868334|NCT01595282|3693005|B3|||Age||years|Mean|25.9|25.9|Standard Deviation|5.6|5.6|||
3868335|NCT01595282|3693006|B2|||Age||years|Mean|25.3|25.3|Standard Deviation|4.7|4.7|||
3868336|NCT01595282|3693007|B1|||Age||years|Mean|26.4|26.4|Standard Deviation|6.4|6.4|||
3868337|NCT01595009|3693018|B3||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3868338|NCT01595009|3693019|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3868339|NCT01595009|3693020|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3868340|NCT01595009|3693018|B3||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3868341|NCT01595009|3693019|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3868342|NCT01595009|3693020|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3868343|NCT01595009|3693018|B3|||Age||years|Mean|61.8|61.8|Standard Deviation|11.62|11.62|||
3868344|NCT01595009|3693019|B2|||Age||years|Mean|64.4|64.4|Standard Deviation|9.28|9.28|||
3868345|NCT01595009|3693020|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|13.04|13.04|||
3868346|NCT01594970|3693055|B4||Male|Sex: Female, Male||Participants|Count of Participants|420|420.0||||||
3868347|NCT01594970|3693056|B3||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3868348|NCT01594970|3693057|B2||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3868349|NCT01594970|3693058|B1||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3868350|NCT01594970|3693055|B4||Female|Sex: Female, Male||Participants|Count of Participants|380|380.0||||||
3868351|NCT01594970|3693056|B3||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3868352|NCT01594970|3693057|B2||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3868353|NCT01594970|3693058|B1||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3868354|NCT01594970|3693055|B4|||Age||Years|Mean|59.5|59.5|Standard Deviation|13.30|13.3|||
3868355|NCT01594970|3693056|B3|||Age||Years|Mean|61.2|61.2|Standard Deviation|12.59|12.59|||
3868356|NCT01594970|3693057|B2|||Age||Years|Mean|59.5|59.5|Standard Deviation|13.23|13.23|||
3868357|NCT01594970|3693058|B1|||Age||Years|Mean|58.0|58.0|Standard Deviation|13.81|13.81|||
3868358|NCT01594853|3693077|B3|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3868359|NCT01594853|3693078|B2|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3868360|NCT01594853|3693079|B1|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3868361|NCT01594853|3693077|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868362|NCT01594853|3693078|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868363|NCT01594853|3693079|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868364|NCT01594853|3693077|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868365|NCT01594853|3693078|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868366|NCT01594853|3693079|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868367|NCT01594853|3693077|B3||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3868368|NCT01594853|3693078|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3868369|NCT01594853|3693079|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3868370|NCT01594853|3693077|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3868371|NCT01594853|3693078|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3868372|NCT01594853|3693079|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3868373|NCT01594853|3693077|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868374|NCT01594853|3693078|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868375|NCT01594853|3693079|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868376|NCT01594853|3693077|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868377|NCT01594853|3693078|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868378|NCT01594853|3693079|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868379|NCT01594853|3693077|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868380|NCT01594853|3693078|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868381|NCT01594853|3693079|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868382|NCT01594853|3693077|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3868383|NCT01594853|3693078|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3868384|NCT01594853|3693079|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3868385|NCT01594853|3693077|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3868386|NCT01594853|3693078|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3868387|NCT01594853|3693079|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3868388|NCT01594853|3693077|B3|||Age||years|Mean|51.7|51.7|Standard Deviation|10.5|10.5|||
3868389|NCT01594853|3693078|B2|||Age||years|Mean|51.3|51.3|Standard Deviation|12.5|12.5|||
3868390|NCT01594853|3693079|B1|||Age||years|Mean|52.1|52.1|Standard Deviation|8.4|8.4|||
3868391|NCT01594827|3693086|B3|||MRSA positive at baseline||Participants|Count of Participants|28|28.0||||||
3868392|NCT01594827|3693087|B2|||MRSA positive at baseline||Participants|Count of Participants|14|14.0||||||
3868393|NCT01594827|3693088|B1|||MRSA positive at baseline||Participants|Count of Participants|14|14.0||||||
3868394|NCT01594827|3693086|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
3868395|NCT01594827|3693087|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3868396|NCT01594827|3693088|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3868397|NCT01594827|3693086|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868398|NCT01594827|3693087|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868399|NCT01594827|3693088|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868400|NCT01594827|3693086|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868401|NCT01594827|3693087|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868402|NCT01594827|3693088|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868403|NCT01594827|3693086|B3||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3868404|NCT01594827|3693087|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3868405|NCT01594827|3693088|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3868406|NCT01594827|3693086|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3868407|NCT01594827|3693087|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3868408|NCT01594827|3693088|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868409|NCT01594827|3693086|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868410|NCT01594827|3693087|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868411|NCT01594827|3693088|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868412|NCT01594827|3693086|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868413|NCT01594827|3693087|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868414|NCT01594827|3693088|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868415|NCT01594827|3693086|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868416|NCT01594827|3693087|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868417|NCT01594827|3693088|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868418|NCT01594827|3693086|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868419|NCT01594827|3693087|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868420|NCT01594827|3693088|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868421|NCT01594827|3693086|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3868422|NCT01594827|3693087|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3868423|NCT01594827|3693088|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3868424|NCT01594827|3693086|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868425|NCT01594827|3693087|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868426|NCT01594827|3693088|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868427|NCT01594827|3693086|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3868428|NCT01594827|3693087|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3868429|NCT01594827|3693088|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3868430|NCT01594827|3693086|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3868431|NCT01594827|3693087|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3868432|NCT01594827|3693088|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3868433|NCT01594827|3693086|B3|||Age||years|Median|25.0|25.0|Full Range|||12.0|46.0|
3868434|NCT01594827|3693087|B2|||Age||years|Median|25.0|25.0|Full Range|||14.0|38.0|
3868435|NCT01594827|3693088|B1|||Age||years|Median|25.5|25.5|Full Range|||12.0|46.0|
3868436|NCT01594762|3693099|B3||Missing|Wound surface area||Participants|Count of Participants|1|1.0||||||
3868437|NCT01594762|3693100|B2||Missing|Wound surface area||Participants|Count of Participants|1|1.0||||||
3868438|NCT01594762|3693101|B1||Missing|Wound surface area||Participants|Count of Participants|0|0.0||||||
3868439|NCT01594762|3693099|B3||>=2 sq cm|Wound surface area||Participants|Count of Participants|86|86.0||||||
3868440|NCT01594762|3693100|B2||>=2 sq cm|Wound surface area||Participants|Count of Participants|43|43.0||||||
3868441|NCT01594762|3693101|B1||>=2 sq cm|Wound surface area||Participants|Count of Participants|43|43.0||||||
3868442|NCT01594762|3693099|B3||1 - <2 sq cm|Wound surface area||Participants|Count of Participants|104|104.0||||||
3868443|NCT01594762|3693100|B2||1 - <2 sq cm|Wound surface area||Participants|Count of Participants|54|54.0||||||
3868444|NCT01594762|3693101|B1||1 - <2 sq cm|Wound surface area||Participants|Count of Participants|50|50.0||||||
3868445|NCT01594762|3693099|B3||<1 sq cm|Wound surface area||Participants|Count of Participants|9|9.0||||||
3868446|NCT01594762|3693100|B2||<1 sq cm|Wound surface area||Participants|Count of Participants|5|5.0||||||
3868447|NCT01594762|3693101|B1||<1 sq cm|Wound surface area||Participants|Count of Participants|4|4.0||||||
3868448|NCT01594762|3693099|B3|United States||Region of Enrollment||participants|Number|200|200.0||||||
3868449|NCT01594762|3693100|B2|United States||Region of Enrollment||participants|Number|103|103.0||||||
3868450|NCT01594762|3693101|B1|United States||Region of Enrollment||participants|Number|97|97.0||||||
3868451|NCT01594762|3693099|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3868452|NCT01594762|3693100|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3868453|NCT01594762|3693101|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868454|NCT01594762|3693099|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868455|NCT01594762|3693100|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868456|NCT01594762|3693101|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868457|NCT01594762|3693099|B3||White|Race (NIH/OMB)||Participants|Count of Participants|153|153.0||||||
3868458|NCT01594762|3693100|B2||White|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3868459|NCT01594762|3693101|B1||White|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3868460|NCT01594762|3693099|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3868461|NCT01594762|3693100|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3868462|NCT01594762|3693101|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3868463|NCT01594762|3693099|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868464|NCT01594762|3693100|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868465|NCT01594762|3693101|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868466|NCT01594762|3693099|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868467|NCT01594762|3693100|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868468|NCT01594762|3693101|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868469|NCT01594762|3693099|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868470|NCT01594762|3693100|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868471|NCT01594762|3693101|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868472|NCT01594762|3693099|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868473|NCT01594762|3693100|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868474|NCT01594762|3693101|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868475|NCT01594762|3693099|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
3868476|NCT01594762|3693100|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3868477|NCT01594762|3693101|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3868478|NCT01594762|3693099|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3868479|NCT01594762|3693100|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3868480|NCT01594762|3693101|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3868481|NCT01594762|3693099|B3||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3868482|NCT01594762|3693100|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3868483|NCT01594762|3693101|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3868484|NCT01594762|3693099|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3868485|NCT01594762|3693100|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3868486|NCT01594762|3693101|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3868487|NCT01594762|3693099|B3|||Age||years|Mean|57.25|57.25|Standard Deviation|11.65|11.65|||
3868488|NCT01594762|3693100|B2|||Age||years|Mean|57.14|57.14|Standard Deviation|10.61|10.61|||
3868489|NCT01594762|3693101|B1|||Age||years|Mean|57.37|57.37|Standard Deviation|12.71|12.71|||
3868490|NCT01594749|3693112|B3||Male|Sex: Female, Male||Participants|Count of Participants|409|409.0||||||
3868491|NCT01594749|3693113|B2||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
3868492|NCT01594749|3693114|B1||Male|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
3868493|NCT01594749|3693112|B3||Female|Sex: Female, Male||Participants|Count of Participants|591|591.0||||||
3868494|NCT01594749|3693113|B2||Female|Sex: Female, Male||Participants|Count of Participants|293|293.0||||||
3868495|NCT01594749|3693114|B1||Female|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
3868496|NCT01594749|3693112|B3|||Age||Years|Mean|59.6|59.6|Standard Deviation|12.1|12.1|||
3868497|NCT01594749|3693113|B2|||Age||Years|Mean|59.1|59.1|Standard Deviation|12.3|12.3|||
3868498|NCT01594749|3693114|B1|||Age||Years|Mean|60.0|60.0|Standard Deviation|11.8|11.8|||
3868499|NCT01594515|3693131|B11||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3868500|NCT01594515|3693132|B10||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3868501|NCT01594515|3693133|B9||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3868502|NCT01594515|3693134|B8||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3868503|NCT01594515|3693135|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3868504|NCT01594515|3693136|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3868505|NCT01594515|3693137|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3868506|NCT01594515|3693138|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3868507|NCT01594515|3693139|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3868508|NCT01594515|3693140|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3868509|NCT01594515|3693141|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3868510|NCT01594515|3693131|B11||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3868511|NCT01594515|3693132|B10||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3868512|NCT01594515|3693133|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3868513|NCT01594515|3693134|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3868514|NCT01594515|3693135|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3868515|NCT01594515|3693136|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3868516|NCT01594515|3693137|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3868517|NCT01594515|3693138|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3868518|NCT01594515|3693139|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3868519|NCT01594515|3693140|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3868520|NCT01594515|3693141|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3868521|NCT01594515|3693131|B11|||Age||Years|Mean|35.3|35.3|Standard Deviation|6.1|6.1|||
3868522|NCT01594515|3693132|B10|||Age||Years|Mean|36.6|36.6|Standard Deviation|5.6|5.6|||
3868523|NCT01594515|3693133|B9|||Age||Years|Mean|33.5|33.5|Standard Deviation|8.4|8.4|||
3868524|NCT01594515|3693134|B8|||Age||Years|Mean|40.5|40.5|Standard Deviation|3.3|3.3|||
3868525|NCT01594515|3693135|B7|||Age||Years|Mean|36.3|36.3|Standard Deviation|6.3|6.3|||
3868526|NCT01594515|3693136|B6|||Age||Years|Mean|32.7|32.7|Standard Deviation|5.9|5.9|||
3868527|NCT01594515|3693137|B5|||Age||Years|Mean|35.5|35.5|Standard Deviation|5.9|5.9|||
3868528|NCT01594515|3693138|B4|||Age||Years|Mean|35.0|35.0|Standard Deviation|5.5|5.5|||
3868529|NCT01594515|3693139|B3|||Age||Years|Mean|38.2|38.2|Standard Deviation|6.5|6.5|||
3868530|NCT01594515|3693140|B2|||Age||Years|Mean|29.5|29.5|Standard Deviation|4.8|4.8|||
3868531|NCT01594515|3693141|B1|||Age||Years|Mean|33.5|33.5|Standard Deviation|5.1|5.1|||
3868532|NCT01594424|3693240|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3868533|NCT01594424|3693240|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3868534|NCT01594424|3693240|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3868535|NCT01594424|3693240|B1|||Age||years|Mean|48|48.0|Standard Deviation|12|12.0|||
3868536|NCT01594424|3693240|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3868537|NCT01594424|3693240|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3868538|NCT01594424|3693240|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3868539|NCT01594411|3693244|B1|||Age/Sex/Gene Expression Score|The ASGES algorithm comprises expression values for 23 genes from peripheral blood cells in 6 terms, patient age, and sex. There are both sex-specific and common algorithm terms with sex-specific weights. The changes in gene expression are quantified using an algorithm that generates a ASGES ranging from 1 to 40. A score less than or equal to 5 indicates a low risk of underlying obstructive coronary disease.The ASGES has been shown to have a negative predictive value of 96% for ASGES less than or equal to 15 in a population referred to MPI.|unitless|Mean|16|16.0|Standard Deviation|10|10.0|||
3868540|NCT01594411|3693244|B1|||Body Mass Index (BMI)||kg/m^2|Mean|29.7|29.7|Standard Deviation|6.7|6.7|||
3868541|NCT01594411|3693244|B1|United States||Region of Enrollment||participants|Number|251|251.0||||||
3868542|NCT01594411|3693244|B1||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3868543|NCT01594411|3693244|B1||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3868544|NCT01594411|3693244|B1|||Age||years|Mean|56.2|56.2|Standard Deviation|13|13.0|||
3868545|NCT01594411|3693244|B1||>=65 years|Age||Participants|Count of Participants|69|69.0||||||
3868546|NCT01594411|3693244|B1||Between 18 and 65 years|Age||Participants|Count of Participants|182|182.0||||||
3868547|NCT01594411|3693244|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3868548|NCT01594385|3693251|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3868549|NCT01594385|3693252|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3868550|NCT01594385|3693253|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3868551|NCT01594385|3693251|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3868552|NCT01594385|3693252|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3868553|NCT01594385|3693253|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3868554|NCT01594385|3693251|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3868555|NCT01594385|3693252|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3868556|NCT01594385|3693253|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3868557|NCT01594385|3693251|B3|||Age||years|Mean|40.3|40.3|Standard Deviation|16.3|16.3|||
3868558|NCT01594385|3693252|B2|||Age||years|Mean|40.2|40.2|Standard Deviation|16.3|16.3|||
3868559|NCT01594385|3693253|B1|||Age||years|Mean|40.4|40.4|Standard Deviation|16.7|16.7|||
3868560|NCT01594294|3693276|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3868561|NCT01594294|3693277|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3868562|NCT01594294|3693278|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3868563|NCT01594294|3693276|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3868564|NCT01594294|3693277|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3868565|NCT01594294|3693278|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3868566|NCT01594294|3693276|B3|||Age||years|Mean|36.4|36.4|Standard Deviation|10.9|10.9|||
3868567|NCT01594294|3693277|B2|||Age||years|Mean|37.1|37.1|Standard Deviation|10.7|10.7|||
3868568|NCT01594294|3693278|B1|||Age||years|Mean|35.7|35.7|Standard Deviation|11.1|11.1|||
3868569|NCT01594125|3693293|B6||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3868570|NCT01594125|3693294|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3868571|NCT01594125|3693295|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3868572|NCT01594125|3693296|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3868573|NCT01594125|3693297|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3868574|NCT01594125|3693298|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3868575|NCT01594125|3693293|B6||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3868576|NCT01594125|3693294|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3868577|NCT01594125|3693295|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3868578|NCT01594125|3693296|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3868579|NCT01594125|3693297|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3868580|NCT01594125|3693298|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3868581|NCT01594125|3693293|B6|||Age||years|Mean|66.1|66.1|Standard Deviation|8.81|8.81|||
3868582|NCT01594125|3693294|B5|||Age||years|Mean|67.4|67.4|Standard Deviation|4.35|4.35|||
3868583|NCT01594125|3693295|B4|||Age||years|Mean|66.5|66.5|Standard Deviation|6.56|6.56|||
3868584|NCT01594125|3693296|B3|||Age||years|Mean|73.3|73.3|Standard Deviation|2.31|2.31|||
3868585|NCT01594125|3693297|B2|||Age||years|Mean|63.1|63.1|Standard Deviation|9.84|9.84|||
3868586|NCT01594125|3693298|B1|||Age||years|Mean|67.0|67.0|Standard Deviation|14.72|14.72|||
3868587|NCT01593852|3693334|B3|Netherlands||Region of Enrollment||participants|Number|136|136.0||||||
3868588|NCT01593852|3693335|B2|Netherlands||Region of Enrollment||participants|Number|68|68.0||||||
3868589|NCT01593852|3693336|B1|Netherlands||Region of Enrollment||participants|Number|68|68.0||||||
3868590|NCT01593852|3693334|B3||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3868591|NCT01593852|3693335|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3868592|NCT01593852|3693336|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3868593|NCT01593852|3693334|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3868594|NCT01593852|3693335|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3868595|NCT01593852|3693336|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3868596|NCT01593852|3693334|B3|||Age||years|Mean|61|61.0|Standard Deviation|12|12.0|||
3868597|NCT01593852|3693335|B2|||Age||years|Mean|65|65.0|Standard Deviation|9|9.0|||
3868598|NCT01593852|3693336|B1|||Age||years|Mean|58|58.0|Standard Deviation|14|14.0|||
3868599|NCT01593787|3693359|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3868600|NCT01593787|3693360|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3868601|NCT01593787|3693361|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3868602|NCT01593787|3693362|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3868603|NCT01593787|3693359|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3868604|NCT01593787|3693360|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3868605|NCT01593787|3693361|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3868606|NCT01593787|3693362|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3868607|NCT01593787|3693359|B4|||Age||Years|Mean|65.8|65.8|Standard Deviation|9.12|9.12|||
3868608|NCT01593787|3693360|B3|||Age||Years|Mean|62.3|62.3|Standard Deviation|9.04|9.04|||
3868609|NCT01593787|3693361|B2|||Age||Years|Mean|71.3|71.3|Standard Deviation|8.80|8.8|||
3868610|NCT01593787|3693362|B1|||Age||Years|Mean|69.0|69.0|Standard Deviation|5.10|5.1|||
3868611|NCT01593722|3693402|B3|||Loa microfilarial count||mf/ml|Geometric Mean|618|618.0|Full Range|||60.0|20380.0|
3868612|NCT01593722|3693403|B2|||Loa microfilarial count||mf/ml|Geometric Mean|355|355.0|Full Range|||60.0|2300.0|
3868613|NCT01593722|3693404|B1|||Loa microfilarial count||mf/ml|Geometric Mean|1074|1074.0|Full Range|||200.0|20380.0|
3868614|NCT01593722|3693402|B3|||Absolute eosinophil count||cells x 10^9/L|Geometric Mean|2.40|2.4|Full Range|||1.05|5.76|
3868615|NCT01593722|3693403|B2|||Absolute eosinophil count||cells x 10^9/L|Geometric Mean|1.76|1.76|Full Range|||1.05|2.35|
3868616|NCT01593722|3693404|B1|||Absolute eosinophil count||cells x 10^9/L|Geometric Mean|3.27|3.27|Full Range|||2.3|5.76|
3868617|NCT01593722|3693402|B3|Cameroon||Region of Enrollment||participants|Number|12|12.0||||||
3868618|NCT01593722|3693403|B2|Cameroon||Region of Enrollment||participants|Number|6|6.0||||||
3868619|NCT01593722|3693404|B1|Cameroon||Region of Enrollment||participants|Number|6|6.0||||||
3868620|NCT01593722|3693402|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3868621|NCT01593722|3693403|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3868622|NCT01593722|3693404|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3868623|NCT01593722|3693402|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3868624|NCT01593722|3693403|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3868625|NCT01593722|3693404|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3868626|NCT01593722|3693402|B3|||Age||years|Median|44.5|44.5|Full Range|||20.0|60.0|
3868627|NCT01593722|3693403|B2|||Age||years|Median|38.5|38.5|Full Range|||25.0|53.0|
3868628|NCT01593722|3693404|B1|||Age||years|Median|44.5|44.5|Full Range|||20.0|60.0|
3868629|NCT01593670|3693419|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3868630|NCT01593670|3693419|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3868631|NCT01593670|3693419|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3868632|NCT01593670|3693419|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3868633|NCT01593670|3693419|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3868634|NCT01593592|3693427|B3|||ِAge|It is a measure of age from 18 to 60 years old for participants|years|Mean|35.00|35.0|Standard Deviation|12.650|12.65|||
3868635|NCT01593592|3693428|B2|||ِAge|It is a measure of age from 18 to 60 years old for participants|years|Mean|36.80|36.8|Standard Deviation|11.085|11.085|||
3868636|NCT01593592|3693429|B1|||ِAge|It is a measure of age from 18 to 60 years old for participants|years|Mean|33.20|33.2|Standard Deviation|13.974|13.974|||
3868637|NCT01593592|3693427|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3868638|NCT01593592|3693428|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3868639|NCT01593592|3693429|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3868640|NCT01593592|3693427|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3868641|NCT01593592|3693428|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3868642|NCT01593592|3693429|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3868643|NCT01593592|3693427|B3|||Age||years|Mean|35.00|35.0|Full Range|||18.0|60.0|
3868644|NCT01593592|3693428|B2|||Age||years|Mean|36.80|36.8|Full Range|||22.0|60.0|
3868645|NCT01593592|3693429|B1|||Age||years|Mean|33.20|33.2|Full Range|||18.0|60.0|
3868646|NCT01593215|3693440|B3|Sweden||Region of Enrollment||participants|Number|50|50.0||||||
3868647|NCT01593215|3693441|B2|Sweden||Region of Enrollment||participants|Number|25|25.0||||||
3868648|NCT01593215|3693442|B1|Sweden||Region of Enrollment||participants|Number|25|25.0||||||
3868649|NCT01593215|3693440|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3868650|NCT01593215|3693441|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3868651|NCT01593215|3693442|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3868652|NCT01593215|3693440|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3868653|NCT01593215|3693441|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3868654|NCT01593215|3693442|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3868655|NCT01593215|3693440|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3868656|NCT01593215|3693441|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3868657|NCT01593215|3693442|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3868658|NCT01593215|3693440|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3868659|NCT01593215|3693441|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3868660|NCT01593215|3693442|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3868661|NCT01593215|3693440|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3868662|NCT01593215|3693441|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3868663|NCT01593215|3693442|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3868664|NCT01593215|3693440|B3|||Age||years|Mean|60|60.0|Standard Deviation|8|8.0|||
3868665|NCT01593215|3693441|B2|||Age||years|Mean|60|60.0|Standard Deviation|7|7.0|||
3868666|NCT01593215|3693442|B1|||Age||years|Mean|61|61.0|Standard Deviation|8|8.0|||
3868667|NCT01592864|3693449|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3868668|NCT01592864|3693450|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3868669|NCT01592864|3693451|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3868670|NCT01592864|3693449|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3868671|NCT01592864|3693450|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3868672|NCT01592864|3693451|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3868673|NCT01592864|3693449|B3|||Age||Years|Mean|36.2|36.2|Standard Deviation|10.7|10.7|||
3868674|NCT01592864|3693450|B2|||Age||Years|Mean|35.5|35.5|Standard Deviation|10.6|10.6|||
3868675|NCT01592864|3693451|B1|||Age||Years|Mean|36.9|36.9|Standard Deviation|10.9|10.9|||
3868676|NCT01592851|3693464|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3868677|NCT01592851|3693465|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3868678|NCT01592851|3693466|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3868679|NCT01592851|3693464|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3868680|NCT01592851|3693465|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3868681|NCT01592851|3693466|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3868682|NCT01592851|3693464|B3|||Age||Years|Mean|36.5|36.5|Standard Deviation|10.37|10.37|||
3868683|NCT01592851|3693465|B2|||Age||Years|Mean|34.8|34.8|Standard Deviation|9.86|9.86|||
3868684|NCT01592851|3693466|B1|||Age||Years|Mean|38.1|38.1|Standard Deviation|10.70|10.7|||
3868685|NCT01592799|3693483|B1||Male|Sex: Female, Male||Participants|Count of Participants|289|289.0||||||
3868686|NCT01592799|3693483|B1||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
3868687|NCT01592799|3693483|B1|||Age||Months|Mean|33.0|33.0|Standard Deviation|37.44|37.44|||
3868688|NCT01592786|3693513|B1|Ukraine||Region of Enrollment||participants|Number|16|16.0||||||
3868689|NCT01592786|3693513|B1|Spain||Region of Enrollment||participants|Number|17|17.0||||||
3868690|NCT01592786|3693513|B1|South Africa||Region of Enrollment||participants|Number|2|2.0||||||
3868691|NCT01592786|3693513|B1|Singapore||Region of Enrollment||participants|Number|0|0.0||||||
3868692|NCT01592786|3693513|B1|Serbia||Region of Enrollment||participants|Number|21|21.0||||||
3868693|NCT01592786|3693513|B1|Poland||Region of Enrollment||participants|Number|37|37.0||||||
3868694|NCT01592786|3693513|B1|New Zealand||Region of Enrollment||participants|Number|2|2.0||||||
3868695|NCT01592786|3693513|B1|Korea, Republic of||Region of Enrollment||participants|Number|25|25.0||||||
3868696|NCT01592786|3693513|B1|Italy||Region of Enrollment||participants|Number|6|6.0||||||
3868697|NCT01592786|3693513|B1|Iceland||Region of Enrollment||participants|Number|5|5.0||||||
3868698|NCT01592786|3693513|B1|Hungary||Region of Enrollment||participants|Number|20|20.0||||||
3868699|NCT01592786|3693513|B1|France||Region of Enrollment||participants|Number|14|14.0||||||
3868700|NCT01592786|3693513|B1|Estonia||Region of Enrollment||participants|Number|6|6.0||||||
3868701|NCT01592786|3693513|B1|Colombia||Region of Enrollment||participants|Number|8|8.0||||||
3868702|NCT01592786|3693513|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3868703|NCT01592786|3693513|B1|Belgium||Region of Enrollment||participants|Number|11|11.0||||||
3868704|NCT01592786|3693513|B1|Australia||Region of Enrollment||participants|Number|0|0.0||||||
3868705|NCT01592786|3693513|B1|United States||Region of Enrollment||participants|Number|712|712.0||||||
3868706|NCT01592786|3693513|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|801|801.0||||||
3868707|NCT01592786|3693513|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|102|102.0||||||
3868708|NCT01592786|3693513|B1|Other||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3868709|NCT01592786|3693513|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3868710|NCT01592786|3693513|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3868711|NCT01592786|3693513|B1|Asian||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
3868712|NCT01592786|3693513|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
3868713|NCT01592786|3693513|B1|White||Race/Ethnicity, Customized||participants|Number|768|768.0||||||
3868714|NCT01592786|3693513|B1|Female||Sex/Gender, Customized||participants|Number|144|144.0||||||
3868715|NCT01592786|3693513|B1|Male||Sex/Gender, Customized||participants|Number|759|759.0||||||
3868716|NCT01592786|3693513|B1|||Age||Years|Mean|9.0|9.0|Standard Deviation|1.9|1.9|||
3868717|NCT01592773|3693517|B1|Ukraine||Region of Enrollment||participants|Number|14|14.0||||||
3868718|NCT01592773|3693517|B1|Spain||Region of Enrollment||participants|Number|14|14.0||||||
3868719|NCT01592773|3693517|B1|South Africa||Region of Enrollment||participants|Number|1|1.0||||||
3868720|NCT01592773|3693517|B1|Serbia||Region of Enrollment||participants|Number|21|21.0||||||
3868721|NCT01592773|3693517|B1|Poland||Region of Enrollment||participants|Number|36|36.0||||||
3868722|NCT01592773|3693517|B1|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
3868723|NCT01592773|3693517|B1|Korea, Republic of||Region of Enrollment||participants|Number|22|22.0||||||
3868724|NCT01592773|3693517|B1|Italy||Region of Enrollment||participants|Number|6|6.0||||||
3868725|NCT01592773|3693517|B1|Iceland||Region of Enrollment||participants|Number|5|5.0||||||
3868726|NCT01592773|3693517|B1|Hungary||Region of Enrollment||participants|Number|14|14.0||||||
3868727|NCT01592773|3693517|B1|France||Region of Enrollment||participants|Number|9|9.0||||||
3868728|NCT01592773|3693517|B1|Estonia||Region of Enrollment||participants|Number|5|5.0||||||
3868729|NCT01592773|3693517|B1|Colombia||Region of Enrollment||participants|Number|8|8.0||||||
3868730|NCT01592773|3693517|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3868731|NCT01592773|3693517|B1|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
3868732|NCT01592773|3693517|B1|United States||Region of Enrollment||participants|Number|586|586.0||||||
3868733|NCT01592773|3693517|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|659|659.0||||||
3868734|NCT01592773|3693517|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|88|88.0||||||
3868735|NCT01592773|3693517|B1|Other Race||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3868736|NCT01592773|3693517|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3868737|NCT01592773|3693517|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3868738|NCT01592773|3693517|B1|Asian||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
3868739|NCT01592773|3693517|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
3868740|NCT01592773|3693517|B1|White||Race/Ethnicity, Customized||participants|Number|636|636.0||||||
3868741|NCT01592773|3693517|B1||Male|Sex: Female, Male||Participants|Count of Participants|627|627.0||||||
3868742|NCT01592773|3693517|B1||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3868743|NCT01592773|3693517|B1|||Age||years|Mean|9.0|9.0|Standard Deviation|1.9|1.9|||
3868744|NCT01592760|3693521|B4|Other||Procedure Type||participants|Number|25|25.0||||||
3868745|NCT01592760|3693522|B3|Other||Procedure Type||participants|Number|4|4.0||||||
3868746|NCT01592760|3693523|B2|Other||Procedure Type||participants|Number|10|10.0||||||
3868747|NCT01592760|3693524|B1|Other||Procedure Type||participants|Number|11|11.0||||||
3868748|NCT01592760|3693521|B4|General Surgery||Procedure Type||participants|Number|23|23.0||||||
3868749|NCT01592760|3693522|B3|General Surgery||Procedure Type||participants|Number|6|6.0||||||
3868750|NCT01592760|3693523|B2|General Surgery||Procedure Type||participants|Number|10|10.0||||||
3868751|NCT01592760|3693524|B1|General Surgery||Procedure Type||participants|Number|7|7.0||||||
3868752|NCT01592760|3693521|B4|Orthopedic||Procedure Type||participants|Number|177|177.0||||||
3868753|NCT01592760|3693522|B3|Orthopedic||Procedure Type||participants|Number|35|35.0||||||
3868754|NCT01592760|3693523|B2|Orthopedic||Procedure Type||participants|Number|70|70.0||||||
3868755|NCT01592760|3693524|B1|Orthopedic||Procedure Type||participants|Number|72|72.0||||||
3868756|NCT01592760|3693521|B4|Missing Data||Device Size||participants|Number|1|1.0||||||
3868757|NCT01592760|3693522|B3|Missing Data||Device Size||participants|Number|1|1.0||||||
3868758|NCT01592760|3693523|B2|Missing Data||Device Size||participants|Number|0|0.0||||||
3868759|NCT01592760|3693524|B1|Missing Data||Device Size||participants|Number|0|0.0||||||
3868760|NCT01592760|3693521|B4|5||Device Size||participants|Number|7|7.0||||||
3868761|NCT01592760|3693522|B3|5||Device Size||participants|Number|7|7.0||||||
3868762|NCT01592760|3693523|B2|5||Device Size||participants|Number|0|0.0||||||
3868763|NCT01592760|3693524|B1|5||Device Size||participants|Number|0|0.0||||||
3868764|NCT01592760|3693521|B4|4.5||Device Size||participants|Number|106|106.0||||||
3868765|NCT01592760|3693522|B3|4.5||Device Size||participants|Number|0|0.0||||||
3868766|NCT01592760|3693523|B2|4.5||Device Size||participants|Number|48|48.0||||||
3868767|NCT01592760|3693524|B1|4.5||Device Size||participants|Number|58|58.0||||||
3868768|NCT01592760|3693521|B4|4||Device Size||participants|Number|35|35.0||||||
3868769|NCT01592760|3693522|B3|4||Device Size||participants|Number|35|35.0||||||
3868770|NCT01592760|3693523|B2|4||Device Size||participants|Number|0|0.0||||||
3868771|NCT01592760|3693524|B1|4||Device Size||participants|Number|0|0.0||||||
3868772|NCT01592760|3693521|B4|3.5||Device Size||participants|Number|74|74.0||||||
3868773|NCT01592760|3693522|B3|3.5||Device Size||participants|Number|0|0.0||||||
3868774|NCT01592760|3693523|B2|3.5||Device Size||participants|Number|42|42.0||||||
3868775|NCT01592760|3693524|B1|3.5||Device Size||participants|Number|32|32.0||||||
3868776|NCT01592760|3693521|B4|3||Device Size||participants|Number|2|2.0||||||
3868777|NCT01592760|3693522|B3|3||Device Size||participants|Number|2|2.0||||||
3868778|NCT01592760|3693523|B2|3||Device Size||participants|Number|0|0.0||||||
3868779|NCT01592760|3693524|B1|3||Device Size||participants|Number|0|0.0||||||
3868780|NCT01592760|3693521|B4|Missing Data||Mallampati Score|Mallampati Class is used to predict the ease of endotracheal intubation. Scores go from class 1 to class 4, where class 1 is the easiest intubation and class 4 is the most difficult. In order to measure Mallampati class, the standard approach to grading Mallampati class was used. Specifically, the investigator looked into the subject's oral opening facing the subject at a 90 degree angle and observed the appearance of the soft palate and extent of the uvula, while the subject fully extended the tongue from the oral cavity.|participants|Number|5|5.0||||||
3868781|NCT01592760|3693522|B3|Missing Data||Mallampati Score|Mallampati Class is used to predict the ease of endotracheal intubation. Scores go from class 1 to class 4, where class 1 is the easiest intubation and class 4 is the most difficult. In order to measure Mallampati class, the standard approach to grading Mallampati class was used. Specifically, the investigator looked into the subject's oral opening facing the subject at a 90 degree angle and observed the appearance of the soft palate and extent of the uvula, while the subject fully extended the tongue from the oral cavity.|participants|Number|0|0.0||||||
3868782|NCT01592760|3693523|B2|Missing Data||Mallampati Score|Mallampati Class is used to predict the ease of endotracheal intubation. Scores go from class 1 to class 4, where class 1 is the easiest intubation and class 4 is the most difficult. In order to measure Mallampati class, the standard approach to grading Mallampati class was used. Specifically, the investigator looked into the subject's oral opening facing the subject at a 90 degree angle and observed the appearance of the soft palate and extent of the uvula, while the subject fully extended the tongue from the oral cavity.|participants|Number|3|3.0||||||
3868783|NCT01592760|3693524|B1|Missing Data||Mallampati Score|Mallampati Class is used to predict the ease of endotracheal intubation. Scores go from class 1 to class 4, where class 1 is the easiest intubation and class 4 is the most difficult. In order to measure Mallampati class, the standard approach to grading Mallampati class was used. Specifically, the investigator looked into the subject's oral opening facing the subject at a 90 degree angle and observed the appearance of the soft palate and extent of the uvula, while the subject fully extended the tongue from the oral cavity.|participants|Number|2|2.0||||||
3868784|NCT01592760|3693521|B4|Class 4||Mallampati Score|Mallampati Class is used to predict the ease of endotracheal intubation. Scores go from class 1 to class 4, where class 1 is the easiest intubation and class 4 is the most difficult. In order to measure Mallampati class, the standard approach to grading Mallampati class was used. Specifically, the investigator looked into the subject's oral opening facing the subject at a 90 degree angle and observed the appearance of the soft palate and extent of the uvula, while the subject fully extended the tongue from the oral cavity.|participants|Number|2|2.0||||||
3868785|NCT01592760|3693522|B3|Class 4||Mallampati Score|Mallampati Class is used to predict the ease of endotracheal intubation. Scores go from class 1 to class 4, where class 1 is the easiest intubation and class 4 is the most difficult. In order to measure Mallampati class, the standard approach to grading Mallampati class was used. Specifically, the investigator looked into the subject's oral opening facing the subject at a 90 degree angle and observed the appearance of the soft palate and extent of the uvula, while the subject fully extended the tongue from the oral cavity.|participants|Number|1|1.0||||||
3868786|NCT01592760|3693523|B2|Class 4||Mallampati Score|Mallampati Class is used to predict the ease of endotracheal intubation. Scores go from class 1 to class 4, where class 1 is the easiest intubation and class 4 is the most difficult. In order to measure Mallampati class, the standard approach to grading Mallampati class was used. Specifically, the investigator looked into the subject's oral opening facing the subject at a 90 degree angle and observed the appearance of the soft palate and extent of the uvula, while the subject fully extended the tongue from the oral cavity.|participants|Number|1|1.0||||||
3868787|NCT01592760|3693524|B1|Class 4||Mallampati Score|Mallampati Class is used to predict the ease of endotracheal intubation. Scores go from class 1 to class 4, where class 1 is the easiest intubation and class 4 is the most difficult. In order to measure Mallampati class, the standard approach to grading Mallampati class was used. Specifically, the investigator looked into the subject's oral opening facing the subject at a 90 degree angle and observed the appearance of the soft palate and extent of the uvula, while the subject fully extended the tongue from the oral cavity.|participants|Number|0|0.0||||||
3868802|NCT01592760|3693523|B2|||Body Mass Index||kg/m^2|Mean|27|27.0|Standard Deviation|5|5.0|||
3868803|NCT01592760|3693524|B1|||Body Mass Index||kg/m^2|Mean|28|28.0|Standard Deviation|6|6.0|||
3868788|NCT01592760|3693521|B4|Class 3||Mallampati Score|Mallampati Class is used to predict the ease of endotracheal intubation. Scores go from class 1 to class 4, where class 1 is the easiest intubation and class 4 is the most difficult. In order to measure Mallampati class, the standard approach to grading Mallampati class was used. Specifically, the investigator looked into the subject's oral opening facing the subject at a 90 degree angle and observed the appearance of the soft palate and extent of the uvula, while the subject fully extended the tongue from the oral cavity.|participants|Number|17|17.0||||||
3868789|NCT01592760|3693522|B3|Class 3||Mallampati Score|Mallampati Class is used to predict the ease of endotracheal intubation. Scores go from class 1 to class 4, where class 1 is the easiest intubation and class 4 is the most difficult. In order to measure Mallampati class, the standard approach to grading Mallampati class was used. Specifically, the investigator looked into the subject's oral opening facing the subject at a 90 degree angle and observed the appearance of the soft palate and extent of the uvula, while the subject fully extended the tongue from the oral cavity.|participants|Number|2|2.0||||||
3868790|NCT01592760|3693523|B2|Class 3||Mallampati Score|Mallampati Class is used to predict the ease of endotracheal intubation. Scores go from class 1 to class 4, where class 1 is the easiest intubation and class 4 is the most difficult. In order to measure Mallampati class, the standard approach to grading Mallampati class was used. Specifically, the investigator looked into the subject's oral opening facing the subject at a 90 degree angle and observed the appearance of the soft palate and extent of the uvula, while the subject fully extended the tongue from the oral cavity.|participants|Number|11|11.0||||||
3868791|NCT01592760|3693524|B1|Class 3||Mallampati Score|Mallampati Class is used to predict the ease of endotracheal intubation. Scores go from class 1 to class 4, where class 1 is the easiest intubation and class 4 is the most difficult. In order to measure Mallampati class, the standard approach to grading Mallampati class was used. Specifically, the investigator looked into the subject's oral opening facing the subject at a 90 degree angle and observed the appearance of the soft palate and extent of the uvula, while the subject fully extended the tongue from the oral cavity.|participants|Number|4|4.0||||||
3868792|NCT01592760|3693521|B4|Class 2||Mallampati Score|Mallampati Class is used to predict the ease of endotracheal intubation. Scores go from class 1 to class 4, where class 1 is the easiest intubation and class 4 is the most difficult. In order to measure Mallampati class, the standard approach to grading Mallampati class was used. Specifically, the investigator looked into the subject's oral opening facing the subject at a 90 degree angle and observed the appearance of the soft palate and extent of the uvula, while the subject fully extended the tongue from the oral cavity.|participants|Number|110|110.0||||||
3868793|NCT01592760|3693522|B3|Class 2||Mallampati Score|Mallampati Class is used to predict the ease of endotracheal intubation. Scores go from class 1 to class 4, where class 1 is the easiest intubation and class 4 is the most difficult. In order to measure Mallampati class, the standard approach to grading Mallampati class was used. Specifically, the investigator looked into the subject's oral opening facing the subject at a 90 degree angle and observed the appearance of the soft palate and extent of the uvula, while the subject fully extended the tongue from the oral cavity.|participants|Number|25|25.0||||||
3868794|NCT01592760|3693523|B2|Class 2||Mallampati Score|Mallampati Class is used to predict the ease of endotracheal intubation. Scores go from class 1 to class 4, where class 1 is the easiest intubation and class 4 is the most difficult. In order to measure Mallampati class, the standard approach to grading Mallampati class was used. Specifically, the investigator looked into the subject's oral opening facing the subject at a 90 degree angle and observed the appearance of the soft palate and extent of the uvula, while the subject fully extended the tongue from the oral cavity.|participants|Number|42|42.0||||||
3868795|NCT01592760|3693524|B1|Class 2||Mallampati Score|Mallampati Class is used to predict the ease of endotracheal intubation. Scores go from class 1 to class 4, where class 1 is the easiest intubation and class 4 is the most difficult. In order to measure Mallampati class, the standard approach to grading Mallampati class was used. Specifically, the investigator looked into the subject's oral opening facing the subject at a 90 degree angle and observed the appearance of the soft palate and extent of the uvula, while the subject fully extended the tongue from the oral cavity.|participants|Number|43|43.0||||||
3868796|NCT01592760|3693521|B4|Class 1||Mallampati Score|Mallampati Class is used to predict the ease of endotracheal intubation. Scores go from class 1 to class 4, where class 1 is the easiest intubation and class 4 is the most difficult. In order to measure Mallampati class, the standard approach to grading Mallampati class was used. Specifically, the investigator looked into the subject's oral opening facing the subject at a 90 degree angle and observed the appearance of the soft palate and extent of the uvula, while the subject fully extended the tongue from the oral cavity.|participants|Number|91|91.0||||||
3868797|NCT01592760|3693522|B3|Class 1||Mallampati Score|Mallampati Class is used to predict the ease of endotracheal intubation. Scores go from class 1 to class 4, where class 1 is the easiest intubation and class 4 is the most difficult. In order to measure Mallampati class, the standard approach to grading Mallampati class was used. Specifically, the investigator looked into the subject's oral opening facing the subject at a 90 degree angle and observed the appearance of the soft palate and extent of the uvula, while the subject fully extended the tongue from the oral cavity.|participants|Number|17|17.0||||||
3868798|NCT01592760|3693523|B2|Class 1||Mallampati Score|Mallampati Class is used to predict the ease of endotracheal intubation. Scores go from class 1 to class 4, where class 1 is the easiest intubation and class 4 is the most difficult. In order to measure Mallampati class, the standard approach to grading Mallampati class was used. Specifically, the investigator looked into the subject's oral opening facing the subject at a 90 degree angle and observed the appearance of the soft palate and extent of the uvula, while the subject fully extended the tongue from the oral cavity.|participants|Number|33|33.0||||||
3868799|NCT01592760|3693524|B1|Class 1||Mallampati Score|Mallampati Class is used to predict the ease of endotracheal intubation. Scores go from class 1 to class 4, where class 1 is the easiest intubation and class 4 is the most difficult. In order to measure Mallampati class, the standard approach to grading Mallampati class was used. Specifically, the investigator looked into the subject's oral opening facing the subject at a 90 degree angle and observed the appearance of the soft palate and extent of the uvula, while the subject fully extended the tongue from the oral cavity.|participants|Number|41|41.0||||||
3868800|NCT01592760|3693521|B4|||Body Mass Index||kg/m^2|Mean|27|27.0|Standard Deviation|5|5.0|||
3868801|NCT01592760|3693522|B3|||Body Mass Index||kg/m^2|Mean|27|27.0|Standard Deviation|5|5.0|||
3868804|NCT01592760|3693521|B4||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3868805|NCT01592760|3693522|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3868806|NCT01592760|3693523|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3868807|NCT01592760|3693524|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3868808|NCT01592760|3693521|B4||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3868809|NCT01592760|3693522|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3868810|NCT01592760|3693523|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3868811|NCT01592760|3693524|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3868812|NCT01592760|3693521|B4|||Age||years|Mean|43|43.0|Standard Deviation|15|15.0|||
3868813|NCT01592760|3693522|B3|||Age||years|Mean|40|40.0|Standard Deviation|15|15.0|||
3868814|NCT01592760|3693523|B2|||Age||years|Mean|45|45.0|Standard Deviation|16|16.0|||
3868815|NCT01592760|3693524|B1|||Age||years|Mean|42|42.0|Standard Deviation|14|14.0|||
3868816|NCT01592708|3693567|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3868817|NCT01592708|3693568|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3868818|NCT01592708|3693569|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3868819|NCT01592708|3693567|B3||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3868820|NCT01592708|3693568|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3868821|NCT01592708|3693569|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3868822|NCT01592708|3693567|B3|||Age||years|Median|19|19.0|Inter-Quartile Range|||17.0|23.0|
3868823|NCT01592708|3693568|B2|||Age||years|Median|19|19.0|Inter-Quartile Range|||17.0|23.0|
3868824|NCT01592708|3693569|B1|||Age||years|Median|20|20.0|Inter-Quartile Range|||17.0|24.0|
3868825|NCT01592695|3693584|B3|||Age of smoking initiation||years|Mean|16.2|16.2|Standard Deviation|3.1|3.1|||
3868826|NCT01592695|3693585|B2|||Age of smoking initiation||years|Mean|15.8|15.8|Standard Deviation|2.8|2.8|||
3868827|NCT01592695|3693586|B1|||Age of smoking initiation||years|Mean|16.7|16.7|Standard Deviation|3.4|3.4|||
3868828|NCT01592695|3693584|B3|||Readiness to quit smoking|Scores range from 1 to 10, with higher scores indicating greater readiness to quit smoking.|units on a scale|Mean|6.6|6.6|Standard Deviation|1.2|1.2|||
3868829|NCT01592695|3693585|B2|||Readiness to quit smoking|Scores range from 1 to 10, with higher scores indicating greater readiness to quit smoking.|units on a scale|Mean|6.5|6.5|Standard Deviation|1.3|1.3|||
3868830|NCT01592695|3693586|B1|||Readiness to quit smoking|Scores range from 1 to 10, with higher scores indicating greater readiness to quit smoking.|units on a scale|Mean|6.8|6.8|Standard Deviation|1.1|1.1|||
3868831|NCT01592695|3693584|B3|||Prior quit attempts lasting at least 24 hours||quit attempts|Mean|8.0|8.0|Standard Deviation|15.0|15.0|||
3868832|NCT01592695|3693585|B2|||Prior quit attempts lasting at least 24 hours||quit attempts|Mean|9.4|9.4|Standard Deviation|19.6|19.6|||
3868833|NCT01592695|3693586|B1|||Prior quit attempts lasting at least 24 hours||quit attempts|Mean|6.6|6.6|Standard Deviation|8.1|8.1|||
3868834|NCT01592695|3693584|B3|||Cigarettes smoked per day||cigarettes/day|Mean|24.7|24.7|Standard Deviation|19.4|19.4|||
3868835|NCT01592695|3693585|B2|||Cigarettes smoked per day||cigarettes/day|Mean|27.2|27.2|Standard Deviation|25.7|25.7|||
3868836|NCT01592695|3693586|B1|||Cigarettes smoked per day||cigarettes/day|Mean|22.3|22.3|Standard Deviation|10.3|10.3|||
3868837|NCT01592695|3693584|B3|||Nicotine dependence|Possible scores range from 0 to 11. Higher scores indicate greater levels of nicotine dependence.|units on a scale|Mean|5.7|5.7|Standard Deviation|2.2|2.2|||
3868838|NCT01592695|3693585|B2|||Nicotine dependence|Possible scores range from 0 to 11. Higher scores indicate greater levels of nicotine dependence.|units on a scale|Mean|5.7|5.7|Standard Deviation|2.1|2.1|||
3868839|NCT01592695|3693586|B1|||Nicotine dependence|Possible scores range from 0 to 11. Higher scores indicate greater levels of nicotine dependence.|units on a scale|Mean|5.6|5.6|Standard Deviation|2.3|2.3|||
3868840|NCT01592695|3693584|B3|United States||Region of Enrollment||Participants|Count of Participants|63|63.0||||||
3868841|NCT01592695|3693585|B2|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3868842|NCT01592695|3693586|B1|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3868843|NCT01592695|3693584|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3868844|NCT01592695|3693585|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3868845|NCT01592695|3693586|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3868846|NCT01592695|3693584|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3868847|NCT01592695|3693585|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3868848|NCT01592695|3693586|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3868849|NCT01592695|3693584|B3|||Age||years|Mean|56.8|56.8|Standard Deviation|10.3|10.3|||
3868850|NCT01592695|3693585|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|8.8|8.8|||
3868851|NCT01592695|3693586|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|11.5|11.5|||
3868852|NCT01592695|3693584|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3868853|NCT01592695|3693585|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3868854|NCT01592695|3693586|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3868855|NCT01592695|3693584|B3||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
3868856|NCT01592695|3693585|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3868857|NCT01592695|3693586|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3868858|NCT01592695|3693584|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3868859|NCT01592695|3693585|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3868860|NCT01592695|3693586|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3868861|NCT01592435|3693605|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3868862|NCT01592435|3693605|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3868863|NCT01592435|3693605|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3868864|NCT01592435|3693605|B1||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
3868865|NCT01592435|3693605|B1||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
3868866|NCT01592396|3693611|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3868867|NCT01592396|3693612|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3868868|NCT01592396|3693613|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3868869|NCT01592396|3693611|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3868870|NCT01592396|3693612|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3868871|NCT01592396|3693613|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3868872|NCT01592396|3693611|B3|||Age||Years|Mean|14.2|14.2|Standard Deviation|1.8|1.8|||
3868873|NCT01592396|3693612|B2|||Age||Years|Mean|15.8|15.8|Standard Deviation|0.9|0.9|||
3868874|NCT01592396|3693613|B1|||Age||Years|Mean|12.6|12.6|Standard Deviation|0.7|0.7|||
3868875|NCT01592383|3693629|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868876|NCT01592383|3693629|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3868877|NCT01592383|3693629|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868878|NCT01592383|3693629|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3868879|NCT01592383|3693629|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3868880|NCT01592383|3693629|B1|||Age||years|Mean|55|55.0|Standard Deviation|11.3|11.3|||
3868881|NCT01592344|3693638|B3|United States||Region of Enrollment||participants|Number|94|94.0||||||
3868882|NCT01592344|3693639|B2|United States||Region of Enrollment||participants|Number|49|49.0||||||
3868883|NCT01592344|3693640|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
3868884|NCT01592344|3693638|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3868885|NCT01592344|3693639|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3868886|NCT01592344|3693640|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3868887|NCT01592344|3693638|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3868888|NCT01592344|3693639|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3868889|NCT01592344|3693640|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3868890|NCT01592344|3693638|B3|||Age||years|Mean|53.0|53.0|Standard Deviation|11.1|11.1|||
3868891|NCT01592344|3693639|B2|||Age||years|Mean|53.2|53.2|Standard Deviation|12.1|12.1|||
3868892|NCT01592344|3693640|B1|||Age||years|Mean|52.8|52.8|Standard Deviation|10.0|10.0|||
3868893|NCT01592292|3693653|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3868894|NCT01592292|3693654|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3868895|NCT01592292|3693655|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3868896|NCT01592292|3693653|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3868897|NCT01592292|3693654|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3868898|NCT01592292|3693655|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3868899|NCT01592292|3693653|B3|70-79 years||Age, Customized||participants|Number|7|7.0||||||
3868900|NCT01592292|3693654|B2|70-79 years||Age, Customized||participants|Number|5|5.0||||||
3868901|NCT01592292|3693655|B1|70-79 years||Age, Customized||participants|Number|2|2.0||||||
3868902|NCT01592292|3693653|B3|60-69 years||Age, Customized||participants|Number|21|21.0||||||
3868903|NCT01592292|3693654|B2|60-69 years||Age, Customized||participants|Number|6|6.0||||||
3868904|NCT01592292|3693655|B1|60-69 years||Age, Customized||participants|Number|15|15.0||||||
3868905|NCT01592292|3693653|B3|50-59 years||Age, Customized||participants|Number|13|13.0||||||
3868906|NCT01592292|3693654|B2|50-59 years||Age, Customized||participants|Number|7|7.0||||||
3868907|NCT01592292|3693655|B1|50-59 years||Age, Customized||participants|Number|6|6.0||||||
3868908|NCT01592292|3693653|B3|40-49 years||Age, Customized||participants|Number|14|14.0||||||
3868909|NCT01592292|3693654|B2|40-49 years||Age, Customized||participants|Number|7|7.0||||||
3868910|NCT01592292|3693655|B1|40-49 years||Age, Customized||participants|Number|7|7.0||||||
3868911|NCT01592292|3693653|B3|30-39 years||Age, Customized||participants|Number|8|8.0||||||
3868912|NCT01592292|3693654|B2|30-39 years||Age, Customized||participants|Number|4|4.0||||||
3868913|NCT01592292|3693655|B1|30-39 years||Age, Customized||participants|Number|4|4.0||||||
3868914|NCT01592292|3693653|B3|20-29 years||Age, Customized||participants|Number|2|2.0||||||
3868915|NCT01592292|3693654|B2|20-29 years||Age, Customized||participants|Number|2|2.0||||||
3868916|NCT01592292|3693655|B1|20-29 years||Age, Customized||participants|Number|0|0.0||||||
3868917|NCT01592240|3693690|B8||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3868918|NCT01592240|3693691|B7||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3868919|NCT01592240|3693692|B6||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3868920|NCT01592240|3693693|B5||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3868921|NCT01592240|3693694|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3868922|NCT01592240|3693695|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3868923|NCT01592240|3693696|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3868924|NCT01592240|3693697|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3868925|NCT01592240|3693690|B8||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
3868926|NCT01592240|3693691|B7||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3868927|NCT01592240|3693692|B6||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3868928|NCT01592240|3693693|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3868929|NCT01592240|3693694|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3868930|NCT01592240|3693695|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3868931|NCT01592240|3693696|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3868932|NCT01592240|3693697|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3868933|NCT01592240|3693690|B8|||Age||Years|Mean|60.3|60.3|Standard Deviation|10.01|10.01|||
3868934|NCT01592240|3693691|B7|||Age||Years|Mean|60.2|60.2|Standard Deviation|8.17|8.17|||
3868935|NCT01592240|3693692|B6|||Age||Years|Mean|60.3|60.3|Standard Deviation|9.64|9.64|||
3868936|NCT01592240|3693693|B5|||Age||Years|Mean|58.4|58.4|Standard Deviation|11.62|11.62|||
3868937|NCT01592240|3693694|B4|||Age||Years|Mean|61.4|61.4|Standard Deviation|9.75|9.75|||
3868938|NCT01592240|3693695|B3|||Age||Years|Mean|61.9|61.9|Standard Deviation|9.58|9.58|||
3868939|NCT01592240|3693696|B2|||Age||Years|Mean|59.1|59.1|Standard Deviation|11.26|11.26|||
3868940|NCT01592240|3693697|B1|||Age||Years|Mean|60.5|60.5|Standard Deviation|9.84|9.84|||
3868941|NCT01592071|3693883|B1|United States||Region of Enrollment||participants|Number|120|120.0||||||
3868942|NCT01592071|3693883|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3868943|NCT01592071|3693883|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3868944|NCT01592071|3693883|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|12.2|12.2|||
3868945|NCT01592071|3693883|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3868946|NCT01592071|3693883|B1||Between 18 and 65 years|Age||Participants|Count of Participants|116|116.0||||||
3868947|NCT01592071|3693883|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3868948|NCT01592045|3693894|B3|Partial Response (PR)||Pre-ASCT Response|At pre-ASCT evaluation, subjects must have met the International Neuroblastoma Response Criteria (INRC) for complete response (CR), very good partial response (VGPR) or partial response (PR) for primary site, soft tissue metastases, and bone metastases. Subjects who met those criteria were also required to meet the protocol specified criteria for bone marrow response.|participants|Number|11|11.0||||||
3868949|NCT01592045|3693895|B2|Partial Response (PR)||Pre-ASCT Response|At pre-ASCT evaluation, subjects must have met the International Neuroblastoma Response Criteria (INRC) for complete response (CR), very good partial response (VGPR) or partial response (PR) for primary site, soft tissue metastases, and bone metastases. Subjects who met those criteria were also required to meet the protocol specified criteria for bone marrow response.|participants|Number|7|7.0||||||
3868950|NCT01592045|3693896|B1|Partial Response (PR)||Pre-ASCT Response|At pre-ASCT evaluation, subjects must have met the International Neuroblastoma Response Criteria (INRC) for complete response (CR), very good partial response (VGPR) or partial response (PR) for primary site, soft tissue metastases, and bone metastases. Subjects who met those criteria were also required to meet the protocol specified criteria for bone marrow response.|participants|Number|4|4.0||||||
3868951|NCT01592045|3693894|B3|Very Good Partial Response (VGPR)||Pre-ASCT Response|At pre-ASCT evaluation, subjects must have met the International Neuroblastoma Response Criteria (INRC) for complete response (CR), very good partial response (VGPR) or partial response (PR) for primary site, soft tissue metastases, and bone metastases. Subjects who met those criteria were also required to meet the protocol specified criteria for bone marrow response.|participants|Number|9|9.0||||||
3868952|NCT01592045|3693895|B2|Very Good Partial Response (VGPR)||Pre-ASCT Response|At pre-ASCT evaluation, subjects must have met the International Neuroblastoma Response Criteria (INRC) for complete response (CR), very good partial response (VGPR) or partial response (PR) for primary site, soft tissue metastases, and bone metastases. Subjects who met those criteria were also required to meet the protocol specified criteria for bone marrow response.|participants|Number|4|4.0||||||
3868953|NCT01592045|3693896|B1|Very Good Partial Response (VGPR)||Pre-ASCT Response|At pre-ASCT evaluation, subjects must have met the International Neuroblastoma Response Criteria (INRC) for complete response (CR), very good partial response (VGPR) or partial response (PR) for primary site, soft tissue metastases, and bone metastases. Subjects who met those criteria were also required to meet the protocol specified criteria for bone marrow response.|participants|Number|5|5.0||||||
3868954|NCT01592045|3693894|B3|Complete Response (CR)||Pre-ASCT Response|At pre-ASCT evaluation, subjects must have met the International Neuroblastoma Response Criteria (INRC) for complete response (CR), very good partial response (VGPR) or partial response (PR) for primary site, soft tissue metastases, and bone metastases. Subjects who met those criteria were also required to meet the protocol specified criteria for bone marrow response.|participants|Number|8|8.0||||||
3868955|NCT01592045|3693895|B2|Complete Response (CR)||Pre-ASCT Response|At pre-ASCT evaluation, subjects must have met the International Neuroblastoma Response Criteria (INRC) for complete response (CR), very good partial response (VGPR) or partial response (PR) for primary site, soft tissue metastases, and bone metastases. Subjects who met those criteria were also required to meet the protocol specified criteria for bone marrow response.|participants|Number|3|3.0||||||
3868956|NCT01592045|3693896|B1|Complete Response (CR)||Pre-ASCT Response|At pre-ASCT evaluation, subjects must have met the International Neuroblastoma Response Criteria (INRC) for complete response (CR), very good partial response (VGPR) or partial response (PR) for primary site, soft tissue metastases, and bone metastases. Subjects who met those criteria were also required to meet the protocol specified criteria for bone marrow response.|participants|Number|5|5.0||||||
3868957|NCT01592045|3693894|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
3868958|NCT01592045|3693895|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3868959|NCT01592045|3693896|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3868960|NCT01592045|3693894|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3868961|NCT01592045|3693895|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3868962|NCT01592045|3693896|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868963|NCT01592045|3693894|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868964|NCT01592045|3693895|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868965|NCT01592045|3693896|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868966|NCT01592045|3693894|B3||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3868967|NCT01592045|3693895|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3868968|NCT01592045|3693896|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3868969|NCT01592045|3693894|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3868970|NCT01592045|3693895|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3868971|NCT01592045|3693896|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3868972|NCT01592045|3693894|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868973|NCT01592045|3693895|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868974|NCT01592045|3693896|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868975|NCT01592045|3693894|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3868976|NCT01592045|3693895|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3868977|NCT01592045|3693896|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868978|NCT01592045|3693894|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868979|NCT01592045|3693895|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868980|NCT01592045|3693896|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868981|NCT01592045|3693894|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868982|NCT01592045|3693895|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868983|NCT01592045|3693896|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3868984|NCT01592045|3693894|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3868985|NCT01592045|3693895|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3868986|NCT01592045|3693896|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3868987|NCT01592045|3693894|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3868988|NCT01592045|3693895|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3868989|NCT01592045|3693896|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3868990|NCT01592045|3693894|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3868991|NCT01592045|3693895|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3868992|NCT01592045|3693896|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3868993|NCT01592045|3693894|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3868994|NCT01592045|3693895|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3868995|NCT01592045|3693896|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3868996|NCT01592045|3693894|B3|||Age||years|Mean|4|4.0|Full Range|||1.0|9.0|
3868997|NCT01592045|3693895|B2|||Age||years|Mean|4|4.0|Full Range|||1.0|9.0|
3868998|NCT01592045|3693896|B1|||Age||years|Mean|4|4.0|Full Range|||2.0|7.0|
3868999|NCT01592006|3693905|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3869000|NCT01592006|3693905|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3869001|NCT01592006|3693905|B1|||Age||years|Mean|56|56.0|Standard Deviation|4.4|4.4|||
3869002|NCT01591954|3693910|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3869003|NCT01591954|3693910|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3869004|NCT01591954|3693910|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3869005|NCT01591954|3693910|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3869006|NCT01591954|3693910|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3869007|NCT01591863|3693915|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3869008|NCT01591863|3693915|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3869009|NCT01591863|3693915|B1|||Age||months|Mean|99.4|99.4|Standard Deviation|68.9|68.9|||
3869010|NCT01591837|3693925|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3869011|NCT01591837|3693926|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3869012|NCT01591837|3693927|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3869013|NCT01591837|3693925|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3869014|NCT01591837|3693926|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3869015|NCT01591837|3693927|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3869016|NCT01591837|3693925|B3|||Age||years|Mean|52.2|52.2|Standard Deviation|19.78|19.78|||
3869017|NCT01591837|3693926|B2|||Age||years|Mean|69.2|69.2|Standard Deviation|6.69|6.69|||
3869018|NCT01591837|3693927|B1|||Age||years|Mean|35.2|35.2|Standard Deviation|12.50|12.5|||
3869019|NCT01591733|3693942|B1||None|Vessel Involvement||Participants|Count of Participants|1|1.0||||||
3869020|NCT01591733|3693942|B1||Both|Vessel Involvement||Participants|Count of Participants|12|12.0||||||
3869021|NCT01591733|3693942|B1||Arterial|Vessel Involvement||Participants|Count of Participants|7|7.0||||||
3869022|NCT01591733|3693942|B1||Venous|Vessel Involvement||Participants|Count of Participants|28|28.0||||||
3869023|NCT01591733|3693942|B1|||Tumor Size||Centimeters (cm)|Median|3.75|3.75|Full Range|||2.1|5.6|
3869024|NCT01591733|3693942|B1|Tail||Pancreatic Tumor Site||Participants|Count of Participants|2|2.0||||||
3869025|NCT01591733|3693942|B1|Body||Pancreatic Tumor Site||Participants|Count of Participants|11|11.0||||||
3869026|NCT01591733|3693942|B1|Head||Pancreatic Tumor Site||Participants|Count of Participants|35|35.0||||||
3869027|NCT01591733|3693942|B1||≥3.4 ng/ml (elevated)|CEA Level|Carcinoembryonic antigen level|Participants|Count of Participants|25|25.0||||||
3869028|NCT01591733|3693942|B1||<3.4 ng/ml (normal)|CEA Level|Carcinoembryonic antigen level|Participants|Count of Participants|23|23.0||||||
3869029|NCT01591733|3693942|B1|≥35 U/ml (elevated)||CA19-9 Level|Cancer antigen 19-9 (CA 19-9) level|Participants|Count of Participants|36|36.0||||||
3869030|NCT01591733|3693942|B1|<35 U/ml (Normal)||CA19-9 Level|Cancer antigen 19-9 (CA 19-9) level|Participants|Count of Participants|12|12.0||||||
3869031|NCT01591733|3693942|B1|United States||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
3869032|NCT01591733|3693942|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3869033|NCT01591733|3693942|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3869034|NCT01591733|3693942|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3869035|NCT01591733|3693942|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3869036|NCT01591733|3693942|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3869037|NCT01591733|3693942|B1|||Age||years|Median|62|62.0|Full Range|||46.0|74.0|
3869038|NCT01591681|3693953|B1|||Daily insulin dose||U/kg/day|Median|0.64|0.64|Inter-Quartile Range|||0.44|0.78|
3869039|NCT01591681|3693953|B1|||Daily insulin dose||U/day|Median|45|45.0|Inter-Quartile Range|||32.0|60.0|
3869040|NCT01591681|3693953|B1|||Diabetes duration||years|Median|15|15.0|Inter-Quartile Range|||12.0|26.0|
3869041|NCT01591681|3693953|B1|||Glycated hemoglobin||percent|Median|6.8|6.8|Inter-Quartile Range|||6.4|7.6|
3869042|NCT01591681|3693953|B1|||Body-mass index||kg/m^2|Median|24|24.0|Inter-Quartile Range|||22.0|27.0|
3869043|NCT01591681|3693953|B1|||Height||cm|Median|172|172.0|Inter-Quartile Range|||163.0|178.0|
3869044|NCT01591681|3693953|B1|||Weight||kg|Median|70|70.0|Inter-Quartile Range|||62.0|85.0|
3869045|NCT01591681|3693953|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3869046|NCT01591681|3693953|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3869047|NCT01591681|3693953|B1|White non-Hispanic||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
3869048|NCT01591681|3693953|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3869049|NCT01591681|3693953|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3869050|NCT01591681|3693953|B1|||Age||years|Median|30|30.0|Inter-Quartile Range|||22.0|39.0|
3869051|NCT01591616|3693979|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3869052|NCT01591616|3693979|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3869053|NCT01591616|3693979|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3869054|NCT01591616|3693979|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3869055|NCT01591616|3693979|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3869056|NCT01591616|3693979|B1||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
3869057|NCT01591499|3694118|B3|Male||Gender|Biofinity/Air Optix Combination (N=67, 3 missing values) Biofinity/Purevision Combination (N=66, 2 missing values)|participants|Number|32|32.0||||||
3869058|NCT01591499|3694119|B2|Male||Gender|Biofinity/Air Optix Combination (N=67, 3 missing values) Biofinity/Purevision Combination (N=66, 2 missing values)|participants|Number|17|17.0||||||
3869059|NCT01591499|3694120|B1|Male||Gender|Biofinity/Air Optix Combination (N=67, 3 missing values) Biofinity/Purevision Combination (N=66, 2 missing values)|participants|Number|15|15.0||||||
3869060|NCT01591499|3694118|B3|Female||Gender|Biofinity/Air Optix Combination (N=67, 3 missing values) Biofinity/Purevision Combination (N=66, 2 missing values)|participants|Number|101|101.0||||||
3869061|NCT01591499|3694119|B2|Female||Gender|Biofinity/Air Optix Combination (N=67, 3 missing values) Biofinity/Purevision Combination (N=66, 2 missing values)|participants|Number|49|49.0||||||
3869062|NCT01591499|3694120|B1|Female||Gender|Biofinity/Air Optix Combination (N=67, 3 missing values) Biofinity/Purevision Combination (N=66, 2 missing values)|participants|Number|52|52.0||||||
3869063|NCT01591499|3694118|B3|||Age|Biofinity/Air Optix Combination (N=67, 3 missing values) Biofinity/Purevision Combination (N=65, 3 missing values)|years|Mean|52.94|52.94|Standard Deviation|6.02|6.02|||
3869064|NCT01591499|3694119|B2|||Age|Biofinity/Air Optix Combination (N=67, 3 missing values) Biofinity/Purevision Combination (N=65, 3 missing values)|years|Mean|52.35|52.35|Standard Deviation|5.48|5.48|||
3869065|NCT01591499|3694120|B1|||Age|Biofinity/Air Optix Combination (N=67, 3 missing values) Biofinity/Purevision Combination (N=65, 3 missing values)|years|Mean|53.51|53.51|Standard Deviation|6.5|6.5|||
3869066|NCT01591460|3694189|B1||Male|Gender||Participants|Count of Participants|82|82.0||||||
3869067|NCT01591460|3694189|B1||Female|Gender||Participants|Count of Participants|83|83.0||||||
3869068|NCT01591460|3694189|B1|||Age||years|Mean|45.8|45.8|Standard Deviation|12.53|12.53|||
3869069|NCT01591408|3694269|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
3869070|NCT01591408|3694270|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
3869071|NCT01591408|3694271|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3869072|NCT01591408|3694269|B3||Male|Gender||Participants|Count of Participants|43|43.0||||||
3869073|NCT01591408|3694270|B2||Male|Gender||Participants|Count of Participants|21|21.0||||||
3869074|NCT01591408|3694271|B1||Male|Gender||Participants|Count of Participants|22|22.0||||||
3869075|NCT01591408|3694269|B3||Female|Gender||Participants|Count of Participants|5|5.0||||||
3869076|NCT01591408|3694270|B2||Female|Gender||Participants|Count of Participants|3|3.0||||||
3869077|NCT01591408|3694271|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
3869078|NCT01591408|3694269|B3|||Age||years|Mean|29.9|29.9|Standard Deviation|5.4|5.4|||
3869079|NCT01591408|3694270|B2|||Age||years|Mean|29.4|29.4|Standard Deviation|5.6|5.6|||
3869080|NCT01591408|3694271|B1|||Age||years|Mean|30.4|30.4|Standard Deviation|5.2|5.2|||
3869081|NCT01591382|3694278|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3869082|NCT01591382|3694279|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3869083|NCT01591382|3694280|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3869084|NCT01591382|3694278|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3869085|NCT01591382|3694279|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3869086|NCT01591382|3694280|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3869087|NCT01591382|3694278|B3|||Age||years|Mean|52.2|52.2|Standard Deviation|11.5|11.5|||
3869088|NCT01591382|3694279|B2|||Age||years|Mean|55|55.0|Standard Deviation|11.2|11.2|||
3869089|NCT01591382|3694280|B1|||Age||years|Mean|48.5|48.5|Standard Deviation|11.9|11.9|||
3869090|NCT01591317|3694295|B4|Korea, Republic of||Region of Enrollment||participants|Number|30|30.0||||||
3869091|NCT01591317|3694296|B3|Korea, Republic of||Region of Enrollment||participants|Number|10|10.0||||||
3869092|NCT01591317|3694297|B2|Korea, Republic of||Region of Enrollment||participants|Number|10|10.0||||||
3869093|NCT01591317|3694298|B1|Korea, Republic of||Region of Enrollment||participants|Number|10|10.0||||||
3869094|NCT01591317|3694295|B4|Asian||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3869095|NCT01591317|3694296|B3|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3869096|NCT01591317|3694297|B2|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3869097|NCT01591317|3694298|B1|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3869098|NCT01591317|3694295|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3869099|NCT01591317|3694296|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3869100|NCT01591317|3694297|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3869101|NCT01591317|3694298|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3869102|NCT01591317|3694295|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3869103|NCT01591317|3694296|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3869104|NCT01591317|3694297|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3869105|NCT01591317|3694298|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3869106|NCT01591317|3694295|B4|||Age||years|Mean|26.7|26.7|Standard Deviation|4.9|4.9|||
3869107|NCT01591317|3694296|B3|||Age||years|Mean|26.0|26.0|Standard Deviation|4.1|4.1|||
3869108|NCT01591317|3694297|B2|||Age||years|Mean|25.9|25.9|Standard Deviation|5.2|5.2|||
3869109|NCT01591317|3694298|B1|||Age||years|Mean|28.2|28.2|Standard Deviation|5.3|5.3|||
3869110|NCT01591096|3694326|B1|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3869111|NCT01591096|3694326|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3869112|NCT01591096|3694326|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3869113|NCT01591096|3694326|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3869114|NCT01591096|3694326|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3869115|NCT01591096|3694326|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3869116|NCT01591044|3694332|B4||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3869117|NCT01591044|3694333|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3869118|NCT01591044|3694334|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3869119|NCT01591044|3694335|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3869120|NCT01591044|3694332|B4||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3869121|NCT01591044|3694333|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3869122|NCT01591044|3694334|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3869123|NCT01591044|3694335|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3869124|NCT01591044|3694332|B4|||Age||years|Mean|39.1|39.1|Standard Deviation|13|13.0|||
3869125|NCT01591044|3694333|B3|||Age||years|Mean|39.3|39.3|Standard Deviation|12.8|12.8|||
3869126|NCT01591044|3694334|B2|||Age||years|Mean|38.3|38.3|Standard Deviation|12.6|12.6|||
3869127|NCT01591044|3694335|B1|||Age||years|Mean|39.5|39.5|Standard Deviation|13.5|13.5|||
3869128|NCT01591018|3694345|B3|Valve Surgery||Type of surgery||participants|Number|60|60.0||||||
3869129|NCT01591018|3694346|B2|Valve Surgery||Type of surgery||participants|Number|31|31.0||||||
3869130|NCT01591018|3694347|B1|Valve Surgery||Type of surgery||participants|Number|29|29.0||||||
3869131|NCT01591018|3694345|B3|Coronary Artery Bypass Graft||Type of surgery||participants|Number|60|60.0||||||
3869132|NCT01591018|3694346|B2|Coronary Artery Bypass Graft||Type of surgery||participants|Number|29|29.0||||||
3869133|NCT01591018|3694347|B1|Coronary Artery Bypass Graft||Type of surgery||participants|Number|31|31.0||||||
3869134|NCT01591018|3694345|B3|Participants without ICA Stenosis||Internal carotid artery (ICA) stenosis ≥ 50%||participants|Number|110|110.0||||||
3869135|NCT01591018|3694346|B2|Participants without ICA Stenosis||Internal carotid artery (ICA) stenosis ≥ 50%||participants|Number|56|56.0||||||
3869136|NCT01591018|3694347|B1|Participants without ICA Stenosis||Internal carotid artery (ICA) stenosis ≥ 50%||participants|Number|54|54.0||||||
3869137|NCT01591018|3694345|B3|Participants with ICA Stenosis||Internal carotid artery (ICA) stenosis ≥ 50%||participants|Number|10|10.0||||||
3869138|NCT01591018|3694346|B2|Participants with ICA Stenosis||Internal carotid artery (ICA) stenosis ≥ 50%||participants|Number|4|4.0||||||
3869139|NCT01591018|3694347|B1|Participants with ICA Stenosis||Internal carotid artery (ICA) stenosis ≥ 50%||participants|Number|6|6.0||||||
3869140|NCT01591018|3694345|B3|Abstinent or Social Drinker Participants||Alcohol abuse||participants|Number|119|119.0||||||
3869141|NCT01591018|3694346|B2|Abstinent or Social Drinker Participants||Alcohol abuse||participants|Number|60|60.0||||||
3869142|NCT01591018|3694347|B1|Abstinent or Social Drinker Participants||Alcohol abuse||participants|Number|59|59.0||||||
3869143|NCT01591018|3694345|B3|Alcohol Abuse Participants||Alcohol abuse||participants|Number|1|1.0||||||
3869144|NCT01591018|3694346|B2|Alcohol Abuse Participants||Alcohol abuse||participants|Number|0|0.0||||||
3869145|NCT01591018|3694347|B1|Alcohol Abuse Participants||Alcohol abuse||participants|Number|1|1.0||||||
3869146|NCT01591018|3694345|B3|Non-smokers||Smoking||participants|Number|108|108.0||||||
3869147|NCT01591018|3694346|B2|Non-smokers||Smoking||participants|Number|54|54.0||||||
3869148|NCT01591018|3694347|B1|Non-smokers||Smoking||participants|Number|54|54.0||||||
3869149|NCT01591018|3694345|B3|Smokers||Smoking||participants|Number|12|12.0||||||
3869150|NCT01591018|3694346|B2|Smokers||Smoking||participants|Number|6|6.0||||||
3869151|NCT01591018|3694347|B1|Smokers||Smoking||participants|Number|6|6.0||||||
3869152|NCT01591018|3694345|B3|Participants without TIA or Stroke||Transient Ischemic Attack (TIA) or Stroke||participants|Number|114|114.0||||||
3869153|NCT01591018|3694346|B2|Participants without TIA or Stroke||Transient Ischemic Attack (TIA) or Stroke||participants|Number|57|57.0||||||
3869154|NCT01591018|3694347|B1|Participants without TIA or Stroke||Transient Ischemic Attack (TIA) or Stroke||participants|Number|57|57.0||||||
3869155|NCT01591018|3694345|B3|Participants with TIA or Stroke||Transient Ischemic Attack (TIA) or Stroke||participants|Number|6|6.0||||||
3869156|NCT01591018|3694346|B2|Participants with TIA or Stroke||Transient Ischemic Attack (TIA) or Stroke||participants|Number|3|3.0||||||
3869157|NCT01591018|3694347|B1|Participants with TIA or Stroke||Transient Ischemic Attack (TIA) or Stroke||participants|Number|3|3.0||||||
3869158|NCT01591018|3694345|B3|Participants without Atrial Fibrillation||Atrial Fibrillation||participants|Number|57|57.0||||||
3869159|NCT01591018|3694346|B2|Participants without Atrial Fibrillation||Atrial Fibrillation||participants|Number|30|30.0||||||
3869160|NCT01591018|3694347|B1|Participants without Atrial Fibrillation||Atrial Fibrillation||participants|Number|27|27.0||||||
3869161|NCT01591018|3694345|B3|Participants with Atrial Fibrillation||Atrial Fibrillation||participants|Number|63|63.0||||||
3869162|NCT01591018|3694346|B2|Participants with Atrial Fibrillation||Atrial Fibrillation||participants|Number|30|30.0||||||
3869163|NCT01591018|3694347|B1|Participants with Atrial Fibrillation||Atrial Fibrillation||participants|Number|33|33.0||||||
3869164|NCT01591018|3694345|B3|Participants without Myocardial Inf.arction||Myocardial Infarction in History||participants|Number|94|94.0||||||
3869165|NCT01591018|3694346|B2|Participants without Myocardial Inf.arction||Myocardial Infarction in History||participants|Number|48|48.0||||||
3869166|NCT01591018|3694347|B1|Participants without Myocardial Inf.arction||Myocardial Infarction in History||participants|Number|46|46.0||||||
3869167|NCT01591018|3694345|B3|Participants with Myocardial Infarction||Myocardial Infarction in History||participants|Number|26|26.0||||||
3869168|NCT01591018|3694346|B2|Participants with Myocardial Infarction||Myocardial Infarction in History||participants|Number|12|12.0||||||
3869169|NCT01591018|3694347|B1|Participants with Myocardial Infarction||Myocardial Infarction in History||participants|Number|14|14.0||||||
3869170|NCT01591018|3694345|B3|Participants without Coronary Heart Disease||Coronary Heart Disease||participants|Number|38|38.0||||||
3869171|NCT01591018|3694346|B2|Participants without Coronary Heart Disease||Coronary Heart Disease||participants|Number|20|20.0||||||
3869172|NCT01591018|3694347|B1|Participants without Coronary Heart Disease||Coronary Heart Disease||participants|Number|18|18.0||||||
3869173|NCT01591018|3694345|B3|Participants with Coronary Heart Disease||Coronary Heart Disease||participants|Number|82|82.0||||||
3869174|NCT01591018|3694346|B2|Participants with Coronary Heart Disease||Coronary Heart Disease||participants|Number|40|40.0||||||
3869175|NCT01591018|3694347|B1|Participants with Coronary Heart Disease||Coronary Heart Disease||participants|Number|42|42.0||||||
3869176|NCT01591018|3694345|B3|Participants without Hyperlipidemia||Hyperlipidemia||participants|Number|49|49.0||||||
3869177|NCT01591018|3694346|B2|Participants without Hyperlipidemia||Hyperlipidemia||participants|Number|22|22.0||||||
3869178|NCT01591018|3694347|B1|Participants without Hyperlipidemia||Hyperlipidemia||participants|Number|27|27.0||||||
3869179|NCT01591018|3694345|B3|Participants with Hyperlipidemia||Hyperlipidemia||participants|Number|71|71.0||||||
3869180|NCT01591018|3694346|B2|Participants with Hyperlipidemia||Hyperlipidemia||participants|Number|38|38.0||||||
3869181|NCT01591018|3694347|B1|Participants with Hyperlipidemia||Hyperlipidemia||participants|Number|33|33.0||||||
3869182|NCT01591018|3694345|B3|Participants without Arterial Hypertension||Diabetes Mellitus||participants|Number|78|78.0||||||
3869183|NCT01591018|3694346|B2|Participants without Arterial Hypertension||Diabetes Mellitus||participants|Number|41|41.0||||||
3869184|NCT01591018|3694347|B1|Participants without Arterial Hypertension||Diabetes Mellitus||participants|Number|37|37.0||||||
3869185|NCT01591018|3694345|B3|Participants with Arterial Hypertension||Diabetes Mellitus||participants|Number|42|42.0||||||
3869186|NCT01591018|3694346|B2|Participants with Arterial Hypertension||Diabetes Mellitus||participants|Number|19|19.0||||||
3869187|NCT01591018|3694347|B1|Participants with Arterial Hypertension||Diabetes Mellitus||participants|Number|23|23.0||||||
3869188|NCT01591018|3694345|B3|Participants without Arterial Hypertension||Arterial Hypertension||participants|Number|25|25.0||||||
3869189|NCT01591018|3694346|B2|Participants without Arterial Hypertension||Arterial Hypertension||participants|Number|13|13.0||||||
3869190|NCT01591018|3694347|B1|Participants without Arterial Hypertension||Arterial Hypertension||participants|Number|12|12.0||||||
3869191|NCT01591018|3694345|B3|Participants with Arterial Hypertension||Arterial Hypertension||participants|Number|95|95.0||||||
3869192|NCT01591018|3694346|B2|Participants with Arterial Hypertension||Arterial Hypertension||participants|Number|47|47.0||||||
3869193|NCT01591018|3694347|B1|Participants with Arterial Hypertension||Arterial Hypertension||participants|Number|48|48.0||||||
3869194|NCT01591018|3694345|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3869195|NCT01591018|3694346|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3869196|NCT01591018|3694347|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3869197|NCT01591018|3694345|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3869198|NCT01591018|3694346|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3869199|NCT01591018|3694347|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3869200|NCT01591018|3694345|B3|||Age||years|Median|68|68.0|Inter-Quartile Range|||62.0|72.0|
3869201|NCT01591018|3694346|B2|||Age||years|Median|69.0|69.0|Inter-Quartile Range|||64.0|73.0|
3869202|NCT01591018|3694347|B1|||Age||years|Median|66.5|66.5|Inter-Quartile Range|||61.0|71.0|
3869203|NCT01591005|3694358|B5|Czech Republic||Region of Enrollment||participants|Number|242|242.0||||||
3869204|NCT01591005|3694359|B4|Czech Republic||Region of Enrollment||participants|Number|68|68.0||||||
3869205|NCT01591005|3694360|B3|Czech Republic||Region of Enrollment||participants|Number|68|68.0||||||
3869206|NCT01591005|3694361|B2|Czech Republic||Region of Enrollment||participants|Number|53|53.0||||||
3869207|NCT01591005|3694362|B1|Czech Republic||Region of Enrollment||participants|Number|53|53.0||||||
3869208|NCT01591005|3694358|B5||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3869209|NCT01591005|3694359|B4||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3869210|NCT01591005|3694360|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3869211|NCT01591005|3694361|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3869212|NCT01591005|3694362|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3869213|NCT01591005|3694358|B5||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3869214|NCT01591005|3694359|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3869215|NCT01591005|3694360|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3869216|NCT01591005|3694361|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3869217|NCT01591005|3694362|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3869218|NCT01591005|3694358|B5|||Age||years|Mean|65.8|65.8|Standard Deviation|7.6|7.6|||
3869219|NCT01591005|3694359|B4|||Age||years|Mean|68.5|68.5|Standard Deviation|7.7|7.7|||
3869220|NCT01591005|3694360|B3|||Age||years|Mean|66.8|66.8|Standard Deviation|6.7|6.7|||
3869221|NCT01591005|3694361|B2|||Age||years|Mean|63.0|63.0|Standard Deviation|7.5|7.5|||
3869222|NCT01591005|3694362|B1|||Age||years|Mean|64.0|64.0|Standard Deviation|7.3|7.3|||
3869223|NCT01590979|3694399|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
3869224|NCT01590979|3694400|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
3869225|NCT01590979|3694401|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3869226|NCT01590979|3694399|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3869227|NCT01590979|3694400|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3869228|NCT01590979|3694401|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3869229|NCT01590979|3694399|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3869230|NCT01590979|3694400|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3869231|NCT01590979|3694401|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3869232|NCT01590979|3694399|B3|||Age||years|Mean|64.3|64.3|Standard Deviation|11.0|11.0|||
3869233|NCT01590979|3694400|B2|||Age||years|Mean|62.9|62.9|Standard Deviation|11.1|11.1|||
3869234|NCT01590979|3694401|B1|||Age||years|Mean|65.7|65.7|Standard Deviation|11.7|11.7|||
3869235|NCT01590979|3694399|B3||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
3869236|NCT01590979|3694400|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3869237|NCT01590979|3694401|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3869238|NCT01590979|3694399|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3869239|NCT01590979|3694400|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3869240|NCT01590979|3694401|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3869241|NCT01590979|3694399|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3869242|NCT01590979|3694400|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3869243|NCT01590979|3694401|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3869244|NCT01590888|3694408|B4|||Disease Burden|Disease burden in patients with Huntington disease is calculated by (CAG repeat length - 35) x Age at Baseline, with the higher score indicating a greater Disease Burden for a patient.|CAG repeats*years|Mean|404.49|404.49|Standard Deviation|103.06|103.06|||
3869245|NCT01590888|3694409|B3|||Disease Burden|Disease burden in patients with Huntington disease is calculated by (CAG repeat length - 35) x Age at Baseline, with the higher score indicating a greater Disease Burden for a patient.|CAG repeats*years|Mean|410.07|410.07|Standard Deviation|110.02|110.02|||
3869246|NCT01590888|3694410|B2|||Disease Burden|Disease burden in patients with Huntington disease is calculated by (CAG repeat length - 35) x Age at Baseline, with the higher score indicating a greater Disease Burden for a patient.|CAG repeats*years|Mean|392.54|392.54|Standard Deviation|96.10|96.1|||
3869247|NCT01590888|3694411|B1|||Disease Burden|Disease burden in patients with Huntington disease is calculated by (CAG repeat length - 35) x Age at Baseline, with the higher score indicating a greater Disease Burden for a patient.|CAG repeats*years|Mean|411.68|411.68|Standard Deviation|104.96|104.96|||
3869248|NCT01590888|3694408|B4|||CAG Smaller Allele Repeat Length|"Huntington disease (HD) is a dominant genetic disorder. Mutations in the HTT gene cause HD. The HTT mutation involves a DNA segment known as a Cytosine, Adenine and Guanine (CAG) trinucleotide repeat, a series of three DNA building blocks. Normally, the CAG segment is repeated 10 to 35 times within the gene. In people with HD, the CAG segment is repeated more than 36 times with higher repeat numbers normally indicating earlier onset of the disease and increased severity of symptoms.~HD is a dominant genetic disorder."|CAG repeats|Mean|19.1|19.1|Standard Deviation|4.1|4.1|||
3869249|NCT01590888|3694409|B3|||CAG Smaller Allele Repeat Length|"Huntington disease (HD) is a dominant genetic disorder. Mutations in the HTT gene cause HD. The HTT mutation involves a DNA segment known as a Cytosine, Adenine and Guanine (CAG) trinucleotide repeat, a series of three DNA building blocks. Normally, the CAG segment is repeated 10 to 35 times within the gene. In people with HD, the CAG segment is repeated more than 36 times with higher repeat numbers normally indicating earlier onset of the disease and increased severity of symptoms.~HD is a dominant genetic disorder."|CAG repeats|Mean|20.0|20.0|Standard Deviation|4.8|4.8|||
3869250|NCT01590888|3694410|B2|||CAG Smaller Allele Repeat Length|"Huntington disease (HD) is a dominant genetic disorder. Mutations in the HTT gene cause HD. The HTT mutation involves a DNA segment known as a Cytosine, Adenine and Guanine (CAG) trinucleotide repeat, a series of three DNA building blocks. Normally, the CAG segment is repeated 10 to 35 times within the gene. In people with HD, the CAG segment is repeated more than 36 times with higher repeat numbers normally indicating earlier onset of the disease and increased severity of symptoms.~HD is a dominant genetic disorder."|CAG repeats|Mean|18.5|18.5|Standard Deviation|3.0|3.0|||
3869251|NCT01590888|3694411|B1|||CAG Smaller Allele Repeat Length|"Huntington disease (HD) is a dominant genetic disorder. Mutations in the HTT gene cause HD. The HTT mutation involves a DNA segment known as a Cytosine, Adenine and Guanine (CAG) trinucleotide repeat, a series of three DNA building blocks. Normally, the CAG segment is repeated 10 to 35 times within the gene. In people with HD, the CAG segment is repeated more than 36 times with higher repeat numbers normally indicating earlier onset of the disease and increased severity of symptoms.~HD is a dominant genetic disorder."|CAG repeats|Mean|18.8|18.8|Standard Deviation|4.4|4.4|||
3869252|NCT01590888|3694408|B4|||CAG Larger Allele Repeat Length|Huntington disease (HD) is a dominant genetic disorder. Mutations in the HTT gene cause HD. The HTT mutation involves a DNA segment known as a Cytosine, Adenine and Guanine (CAG) trinucleotide repeat, a series of three DNA building blocks. Normally, the CAG segment is repeated 10 to 35 times within the gene. In people with HD, the CAG segment is repeated more than 36 times with higher repeat numbers normally indicating earlier onset of the disease and increased severity of symptoms.|CAG repeats|Mean|43.9|43.9|Standard Deviation|3.8|3.8|||
3869253|NCT01590888|3694409|B3|||CAG Larger Allele Repeat Length|Huntington disease (HD) is a dominant genetic disorder. Mutations in the HTT gene cause HD. The HTT mutation involves a DNA segment known as a Cytosine, Adenine and Guanine (CAG) trinucleotide repeat, a series of three DNA building blocks. Normally, the CAG segment is repeated 10 to 35 times within the gene. In people with HD, the CAG segment is repeated more than 36 times with higher repeat numbers normally indicating earlier onset of the disease and increased severity of symptoms.|CAG repeats|Mean|44.1|44.1|Standard Deviation|3.9|3.9|||
3869254|NCT01590888|3694410|B2|||CAG Larger Allele Repeat Length|Huntington disease (HD) is a dominant genetic disorder. Mutations in the HTT gene cause HD. The HTT mutation involves a DNA segment known as a Cytosine, Adenine and Guanine (CAG) trinucleotide repeat, a series of three DNA building blocks. Normally, the CAG segment is repeated 10 to 35 times within the gene. In people with HD, the CAG segment is repeated more than 36 times with higher repeat numbers normally indicating earlier onset of the disease and increased severity of symptoms.|CAG repeats|Mean|43.2|43.2|Standard Deviation|2.8|2.8|||
3869255|NCT01590888|3694411|B1|||CAG Larger Allele Repeat Length|Huntington disease (HD) is a dominant genetic disorder. Mutations in the HTT gene cause HD. The HTT mutation involves a DNA segment known as a Cytosine, Adenine and Guanine (CAG) trinucleotide repeat, a series of three DNA building blocks. Normally, the CAG segment is repeated 10 to 35 times within the gene. In people with HD, the CAG segment is repeated more than 36 times with higher repeat numbers normally indicating earlier onset of the disease and increased severity of symptoms.|CAG repeats|Mean|44.4|44.4|Standard Deviation|4.6|4.6|||
3869256|NCT01590888|3694408|B4|||Total Function Capacity|Total function capacity (TFC) is a scale measuring the participants capacity to perform 5 areas - their capacity to work, capacity to handle financial affairs, capacity to manage domestic responsibilities, capacity to perform activities of daily living and level of care required (home or care facility). The scale used is a TOTAL of each of the 5 areas, which range from 0 (unable to perform or require full care) to either 2 or 3 (normal, no assistance required). The TFC can scored from 0 to 13. The lower the score, the more severe the disease state of Huntington disease is.|units on a scale|Mean|9.2|9.2|Standard Deviation|2.0|2.0|||
3869257|NCT01590888|3694409|B3|||Total Function Capacity|Total function capacity (TFC) is a scale measuring the participants capacity to perform 5 areas - their capacity to work, capacity to handle financial affairs, capacity to manage domestic responsibilities, capacity to perform activities of daily living and level of care required (home or care facility). The scale used is a TOTAL of each of the 5 areas, which range from 0 (unable to perform or require full care) to either 2 or 3 (normal, no assistance required). The TFC can scored from 0 to 13. The lower the score, the more severe the disease state of Huntington disease is.|units on a scale|Mean|9.3|9.3|Standard Deviation|1.6|1.6|||
3869306|NCT01590888|3694410|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3869307|NCT01590888|3694411|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3869258|NCT01590888|3694410|B2|||Total Function Capacity|Total function capacity (TFC) is a scale measuring the participants capacity to perform 5 areas - their capacity to work, capacity to handle financial affairs, capacity to manage domestic responsibilities, capacity to perform activities of daily living and level of care required (home or care facility). The scale used is a TOTAL of each of the 5 areas, which range from 0 (unable to perform or require full care) to either 2 or 3 (normal, no assistance required). The TFC can scored from 0 to 13. The lower the score, the more severe the disease state of Huntington disease is.|units on a scale|Mean|9.3|9.3|Standard Deviation|2.3|2.3|||
3869259|NCT01590888|3694411|B1|||Total Function Capacity|Total function capacity (TFC) is a scale measuring the participants capacity to perform 5 areas - their capacity to work, capacity to handle financial affairs, capacity to manage domestic responsibilities, capacity to perform activities of daily living and level of care required (home or care facility). The scale used is a TOTAL of each of the 5 areas, which range from 0 (unable to perform or require full care) to either 2 or 3 (normal, no assistance required). The TFC can scored from 0 to 13. The lower the score, the more severe the disease state of Huntington disease is.|units on a scale|Mean|9.1|9.1|Standard Deviation|2.2|2.2|||
3869260|NCT01590888|3694408|B4|||Body Mass Index||kg/m^2|Mean|25.98|25.98|Standard Deviation|5.18|5.18|||
3869261|NCT01590888|3694409|B3|||Body Mass Index||kg/m^2|Mean|27.09|27.09|Standard Deviation|6.03|6.03|||
3869262|NCT01590888|3694410|B2|||Body Mass Index||kg/m^2|Mean|25.40|25.4|Standard Deviation|4.53|4.53|||
3869263|NCT01590888|3694411|B1|||Body Mass Index||kg/m^2|Mean|25.51|25.51|Standard Deviation|4.89|4.89|||
3869264|NCT01590888|3694408|B4|Australia||Region of Enrollment||participants|Number|30|30.0||||||
3869265|NCT01590888|3694409|B3|Australia||Region of Enrollment||participants|Number|10|10.0||||||
3869266|NCT01590888|3694410|B2|Australia||Region of Enrollment||participants|Number|10|10.0||||||
3869267|NCT01590888|3694411|B1|Australia||Region of Enrollment||participants|Number|10|10.0||||||
3869268|NCT01590888|3694408|B4|United States||Region of Enrollment||participants|Number|79|79.0||||||
3869269|NCT01590888|3694409|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
3869270|NCT01590888|3694410|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
3869271|NCT01590888|3694411|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
3869272|NCT01590888|3694408|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3869273|NCT01590888|3694409|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869274|NCT01590888|3694410|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869275|NCT01590888|3694411|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3869276|NCT01590888|3694408|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869277|NCT01590888|3694409|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869278|NCT01590888|3694410|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869279|NCT01590888|3694411|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869280|NCT01590888|3694408|B4||White|Race (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
3869281|NCT01590888|3694409|B3||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3869282|NCT01590888|3694410|B2||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3869283|NCT01590888|3694411|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3869284|NCT01590888|3694408|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869285|NCT01590888|3694409|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869286|NCT01590888|3694410|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869287|NCT01590888|3694411|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869288|NCT01590888|3694408|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869289|NCT01590888|3694409|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869290|NCT01590888|3694410|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869291|NCT01590888|3694411|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869292|NCT01590888|3694408|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869293|NCT01590888|3694409|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869294|NCT01590888|3694410|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869295|NCT01590888|3694411|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869296|NCT01590888|3694408|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869297|NCT01590888|3694409|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869298|NCT01590888|3694410|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869299|NCT01590888|3694411|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869300|NCT01590888|3694408|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869301|NCT01590888|3694409|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869302|NCT01590888|3694410|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869303|NCT01590888|3694411|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869304|NCT01590888|3694408|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
3869305|NCT01590888|3694409|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3869599|NCT01589822|3694771|B4|Belgium||Region of Enrollment||participants|Number|37|37.0||||||
3869308|NCT01590888|3694408|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3869309|NCT01590888|3694409|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869310|NCT01590888|3694410|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869311|NCT01590888|3694411|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3869312|NCT01590888|3694408|B4||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3869313|NCT01590888|3694409|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3869314|NCT01590888|3694410|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3869315|NCT01590888|3694411|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3869316|NCT01590888|3694408|B4||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3869317|NCT01590888|3694409|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3869318|NCT01590888|3694410|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3869319|NCT01590888|3694411|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3869320|NCT01590888|3694408|B4|||Age||years|Mean|51.9|51.9|Standard Deviation|11.0|11.0|||
3869321|NCT01590888|3694409|B3|||Age||years|Mean|51.2|51.2|Standard Deviation|10.4|10.4|||
3869322|NCT01590888|3694410|B2|||Age||years|Mean|54.1|54.1|Standard Deviation|12.1|12.1|||
3869323|NCT01590888|3694411|B1|||Age||years|Mean|50.3|50.3|Standard Deviation|10.4|10.4|||
3869324|NCT01590875|3694457|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3869325|NCT01590875|3694458|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3869326|NCT01590875|3694459|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3869327|NCT01590875|3694457|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3869328|NCT01590875|3694458|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3869329|NCT01590875|3694459|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3869330|NCT01590875|3694457|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3869331|NCT01590875|3694458|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3869332|NCT01590875|3694459|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3869333|NCT01590875|3694457|B3|||Age||years|Mean|60|60.0|Full Range|||50.0|70.0|
3869334|NCT01590875|3694458|B2|||Age||years|Mean|60|60.0|Full Range|||55.0|70.0|
3869335|NCT01590875|3694459|B1|||Age||years|Mean|60|60.0|Full Range|||50.0|70.0|
3869336|NCT01590875|3694457|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3869337|NCT01590875|3694458|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3869338|NCT01590875|3694459|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3869339|NCT01590875|3694457|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3869340|NCT01590875|3694458|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3869341|NCT01590875|3694459|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3869342|NCT01590875|3694457|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3869343|NCT01590875|3694458|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3869344|NCT01590875|3694459|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3869345|NCT01590810|3694468|B6|||Peripheral Diastolic Blood Pressure (pDBP)||mm Hg|Mean|79|79.0|Standard Deviation|10|10.0|||
3869346|NCT01590810|3694469|B5|||Peripheral Diastolic Blood Pressure (pDBP)||mm Hg|Mean|80|80.0|Standard Deviation|7|7.0|||
3869347|NCT01590810|3694470|B4|||Peripheral Diastolic Blood Pressure (pDBP)||mm Hg|Mean|75|75.0|Standard Deviation|8|8.0|||
3869348|NCT01590810|3694471|B3|||Peripheral Diastolic Blood Pressure (pDBP)||mm Hg|Mean|94|94.0|Standard Deviation|6|6.0|||
3869349|NCT01590810|3694472|B2|||Peripheral Diastolic Blood Pressure (pDBP)||mm Hg|Mean|73|73.0|Standard Deviation|6|6.0|||
3869350|NCT01590810|3694473|B1|||Peripheral Diastolic Blood Pressure (pDBP)||mm Hg|Mean|75|75.0|Standard Deviation|6|6.0|||
3869351|NCT01590810|3694468|B6|||Peripheral Systolic Blood Pressure (pSBP)||mm Hg|Mean|128|128.0|Standard Deviation|14|14.0|||
3869352|NCT01590810|3694469|B5|||Peripheral Systolic Blood Pressure (pSBP)||mm Hg|Mean|126|126.0|Standard Deviation|12|12.0|||
3869353|NCT01590810|3694470|B4|||Peripheral Systolic Blood Pressure (pSBP)||mm Hg|Mean|125|125.0|Standard Deviation|8|8.0|||
3869354|NCT01590810|3694471|B3|||Peripheral Systolic Blood Pressure (pSBP)||mm Hg|Mean|148|148.0|Standard Deviation|7|7.0|||
3869355|NCT01590810|3694472|B2|||Peripheral Systolic Blood Pressure (pSBP)||mm Hg|Mean|119|119.0|Standard Deviation|6|6.0|||
3869356|NCT01590810|3694473|B1|||Peripheral Systolic Blood Pressure (pSBP)||mm Hg|Mean|119|119.0|Standard Deviation|5|5.0|||
3869357|NCT01590810|3694468|B6|||Central Diastolic Blood Pressure (cDBP)||mm Hg|Mean|91|91.0|Standard Deviation|11|11.0|||
3869358|NCT01590810|3694469|B5|||Central Diastolic Blood Pressure (cDBP)||mm Hg|Mean|91|91.0|Standard Deviation|6|6.0|||
3869359|NCT01590810|3694470|B4|||Central Diastolic Blood Pressure (cDBP)||mm Hg|Mean|86|86.0|Standard Deviation|8|8.0|||
3869360|NCT01590810|3694471|B3|||Central Diastolic Blood Pressure (cDBP)||mm Hg|Mean|107|107.0|Standard Deviation|6|6.0|||
3869361|NCT01590810|3694472|B2|||Central Diastolic Blood Pressure (cDBP)||mm Hg|Mean|84|84.0|Standard Deviation|6|6.0|||
3869362|NCT01590810|3694473|B1|||Central Diastolic Blood Pressure (cDBP)||mm Hg|Mean|85|85.0|Standard Deviation|6|6.0|||
3869363|NCT01590810|3694468|B6|||Heart Rate (HR)||beats per minute|Mean|59|59.0|Standard Deviation|9|9.0|||
3869364|NCT01590810|3694469|B5|||Heart Rate (HR)||beats per minute|Mean|45|45.0|Standard Deviation|1|1.0|||
3869365|NCT01590810|3694470|B4|||Heart Rate (HR)||beats per minute|Mean|61|61.0|Standard Deviation|7|7.0|||
3869366|NCT01590810|3694471|B3|||Heart Rate (HR)||beats per minute|Mean|67|67.0|Standard Deviation|9|9.0|||
3869367|NCT01590810|3694472|B2|||Heart Rate (HR)||beats per minute|Mean|54|54.0|Standard Deviation|5|5.0|||
3869368|NCT01590810|3694473|B1|||Heart Rate (HR)||beats per minute|Mean|58|58.0|Standard Deviation|7|7.0|||
3869369|NCT01590810|3694468|B6|||Augmentation Index (AIx)|AIx was measured by applanation tonometry of the radial artery, using the SphygmoCor System. The central pressure waveform was determined from the peripheral pressure waveform by a transfer function. AIx is the percentage of the central pulse pressure attributed to the reflected pulse wave, and is an indirect measure of systemic arterial stiffness.|percentage of central pulse pressure|Mean|12|12.0|Standard Deviation|9|9.0|||
3869370|NCT01590810|3694469|B5|||Augmentation Index (AIx)|AIx was measured by applanation tonometry of the radial artery, using the SphygmoCor System. The central pressure waveform was determined from the peripheral pressure waveform by a transfer function. AIx is the percentage of the central pulse pressure attributed to the reflected pulse wave, and is an indirect measure of systemic arterial stiffness.|percentage of central pulse pressure|Mean|8|8.0|Standard Deviation|12|12.0|||
3869371|NCT01590810|3694470|B4|||Augmentation Index (AIx)|AIx was measured by applanation tonometry of the radial artery, using the SphygmoCor System. The central pressure waveform was determined from the peripheral pressure waveform by a transfer function. AIx is the percentage of the central pulse pressure attributed to the reflected pulse wave, and is an indirect measure of systemic arterial stiffness.|percentage of central pulse pressure|Mean|10|10.0|Standard Deviation|11|11.0|||
3869372|NCT01590810|3694471|B3|||Augmentation Index (AIx)|AIx was measured by applanation tonometry of the radial artery, using the SphygmoCor System. The central pressure waveform was determined from the peripheral pressure waveform by a transfer function. AIx is the percentage of the central pulse pressure attributed to the reflected pulse wave, and is an indirect measure of systemic arterial stiffness.|percentage of central pulse pressure|Mean|22|22.0|Standard Deviation|8|8.0|||
3869373|NCT01590810|3694472|B2|||Augmentation Index (AIx)|AIx was measured by applanation tonometry of the radial artery, using the SphygmoCor System. The central pressure waveform was determined from the peripheral pressure waveform by a transfer function. AIx is the percentage of the central pulse pressure attributed to the reflected pulse wave, and is an indirect measure of systemic arterial stiffness.|percentage of central pulse pressure|Mean|8|8.0|Standard Deviation|4|4.0|||
3869374|NCT01590810|3694473|B1|||Augmentation Index (AIx)|AIx was measured by applanation tonometry of the radial artery, using the SphygmoCor System. The central pressure waveform was determined from the peripheral pressure waveform by a transfer function. AIx is the percentage of the central pulse pressure attributed to the reflected pulse wave, and is an indirect measure of systemic arterial stiffness.|percentage of central pulse pressure|Mean|7|7.0|Standard Deviation|3|3.0|||
3869375|NCT01590810|3694468|B6|||Central Systolic Blood Pressure (cSBP)||mm Hg|Mean|106|106.0|Standard Deviation|13|13.0|||
3869376|NCT01590810|3694469|B5|||Central Systolic Blood Pressure (cSBP)||mm Hg|Mean|105|105.0|Standard Deviation|6|6.0|||
3869377|NCT01590810|3694470|B4|||Central Systolic Blood Pressure (cSBP)||mm Hg|Mean|102|102.0|Standard Deviation|9|9.0|||
3869378|NCT01590810|3694471|B3|||Central Systolic Blood Pressure (cSBP)||mm Hg|Mean|125|125.0|Standard Deviation|8|8.0|||
3869379|NCT01590810|3694472|B2|||Central Systolic Blood Pressure (cSBP)||mm Hg|Mean|98|98.0|Standard Deviation|6|6.0|||
3869380|NCT01590810|3694473|B1|||Central Systolic Blood Pressure (cSBP)||mm Hg|Mean|98|98.0|Standard Deviation|7|7.0|||
3869381|NCT01590810|3694468|B6||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3869382|NCT01590810|3694469|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3869383|NCT01590810|3694470|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3869384|NCT01590810|3694471|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3869385|NCT01590810|3694472|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3869386|NCT01590810|3694473|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3869387|NCT01590810|3694468|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3869388|NCT01590810|3694469|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3869389|NCT01590810|3694470|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3869390|NCT01590810|3694471|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3869391|NCT01590810|3694472|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3869392|NCT01590810|3694473|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3869393|NCT01590810|3694468|B6|||Age||years|Mean|42|42.0|Standard Deviation|10|10.0|||
3869394|NCT01590810|3694469|B5|||Age||years|Mean|39.0|39.0|Standard Deviation|12.7|12.7|||
3869395|NCT01590810|3694470|B4|||Age||years|Mean|44.1|44.1|Standard Deviation|6.9|6.9|||
3869396|NCT01590810|3694471|B3|||Age||years|Mean|51.4|51.4|Standard Deviation|6.8|6.8|||
3869397|NCT01590810|3694472|B2|||Age||years|Mean|34.8|34.8|Standard Deviation|8.0|8.0|||
3869398|NCT01590810|3694473|B1|||Age||years|Mean|37.5|37.5|Standard Deviation|9.8|9.8|||
3869399|NCT01590797|3694620|B3||Male|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
3869400|NCT01590797|3694621|B2||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3869401|NCT01590797|3694622|B1||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3869402|NCT01590797|3694620|B3||Female|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
3869403|NCT01590797|3694621|B2||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3869404|NCT01590797|3694622|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3869405|NCT01590797|3694620|B3|||Age||Years|Mean|57.6|57.6|Standard Deviation|8.8|8.8|||
3869406|NCT01590797|3694621|B2|||Age||Years|Mean|56.7|56.7|Standard Deviation|9.1|9.1|||
3869407|NCT01590797|3694622|B1|||Age||Years|Mean|58.6|58.6|Standard Deviation|8.4|8.4|||
3869408|NCT01590771|3694637|B3|||Fasting plasma glucose (FPG)|Sitagliptin, n=249; placebo, n=249; total, n=498|mg/dL|Mean|180.6|180.6|Standard Deviation|40.8|40.8|||
3869464|NCT01590758|3694668|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3869409|NCT01590771|3694638|B2|||Fasting plasma glucose (FPG)|Sitagliptin, n=249; placebo, n=249; total, n=498|mg/dL|Mean|179.8|179.8|Standard Deviation|40.7|40.7|||
3869410|NCT01590771|3694639|B1|||Fasting plasma glucose (FPG)|Sitagliptin, n=249; placebo, n=249; total, n=498|mg/dL|Mean|181.5|181.5|Standard Deviation|40.9|40.9|||
3869411|NCT01590771|3694637|B3|||2-hour post meal glucose (2-hr PMG)|Sitagliptin, n=248; placebo, n=249; total, n=497|mg/dL|Mean|293.4|293.4|Standard Deviation|70.2|70.2|||
3869412|NCT01590771|3694638|B2|||2-hour post meal glucose (2-hr PMG)|Sitagliptin, n=248; placebo, n=249; total, n=497|mg/dL|Mean|290.2|290.2|Standard Deviation|72.4|72.4|||
3869413|NCT01590771|3694639|B1|||2-hour post meal glucose (2-hr PMG)|Sitagliptin, n=248; placebo, n=249; total, n=497|mg/dL|Mean|296.5|296.5|Standard Deviation|68.0|68.0|||
3869414|NCT01590771|3694637|B3|||Hemoglobin A1c (A1C)||Percent of glycosylated hemoglobin (A1C)|Mean|8.55|8.55|Standard Deviation|0.99|0.99|||
3869415|NCT01590771|3694638|B2|||Hemoglobin A1c (A1C)||Percent of glycosylated hemoglobin (A1C)|Mean|8.48|8.48|Standard Deviation|0.91|0.91|||
3869416|NCT01590771|3694639|B1|||Hemoglobin A1c (A1C)||Percent of glycosylated hemoglobin (A1C)|Mean|8.61|8.61|Standard Deviation|1.06|1.06|||
3869417|NCT01590771|3694637|B3||Male|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
3869418|NCT01590771|3694638|B2||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3869419|NCT01590771|3694639|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3869420|NCT01590771|3694637|B3||Female|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
3869421|NCT01590771|3694638|B2||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3869422|NCT01590771|3694639|B1||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3869423|NCT01590771|3694637|B3|||Age||Years|Mean|57.0|57.0|Standard Deviation|9.4|9.4|||
3869424|NCT01590771|3694638|B2|||Age||Years|Mean|56.5|56.5|Standard Deviation|9.3|9.3|||
3869425|NCT01590771|3694639|B1|||Age||Years|Mean|57.5|57.5|Standard Deviation|9.5|9.5|||
3869426|NCT01590758|3694666|B3||>=2 sq cm|Wound surface area||Participants|Count of Participants|94|94.0||||||
3869427|NCT01590758|3694667|B2||>=2 sq cm|Wound surface area||Participants|Count of Participants|51|51.0||||||
3869428|NCT01590758|3694668|B1||>=2 sq cm|Wound surface area||Participants|Count of Participants|43|43.0||||||
3869429|NCT01590758|3694666|B3||1 - <2 sq cm|Wound surface area||Participants|Count of Participants|93|93.0||||||
3869430|NCT01590758|3694667|B2||1 - <2 sq cm|Wound surface area||Participants|Count of Participants|52|52.0||||||
3869431|NCT01590758|3694668|B1||1 - <2 sq cm|Wound surface area||Participants|Count of Participants|41|41.0||||||
3869432|NCT01590758|3694666|B3||<1 sq cm|Wound surface area||Participants|Count of Participants|2|2.0||||||
3869433|NCT01590758|3694667|B2||<1 sq cm|Wound surface area||Participants|Count of Participants|1|1.0||||||
3869434|NCT01590758|3694668|B1||<1 sq cm|Wound surface area||Participants|Count of Participants|1|1.0||||||
3869435|NCT01590758|3694666|B3|United States||Region of Enrollment||participants|Number|189|189.0||||||
3869436|NCT01590758|3694667|B2|United States||Region of Enrollment||participants|Number|104|104.0||||||
3869437|NCT01590758|3694668|B1|United States||Region of Enrollment||participants|Number|85|85.0||||||
3869438|NCT01590758|3694666|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3869439|NCT01590758|3694667|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3869440|NCT01590758|3694668|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869441|NCT01590758|3694666|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869442|NCT01590758|3694667|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869443|NCT01590758|3694668|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869444|NCT01590758|3694666|B3||White|Race (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
3869445|NCT01590758|3694667|B2||White|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3869446|NCT01590758|3694668|B1||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3869447|NCT01590758|3694666|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3869448|NCT01590758|3694667|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3869449|NCT01590758|3694668|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3869450|NCT01590758|3694666|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3869451|NCT01590758|3694667|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3869452|NCT01590758|3694668|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869453|NCT01590758|3694666|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3869454|NCT01590758|3694667|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3869455|NCT01590758|3694668|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3869456|NCT01590758|3694666|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3869457|NCT01590758|3694667|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869458|NCT01590758|3694668|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3869459|NCT01590758|3694666|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869460|NCT01590758|3694667|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869461|NCT01590758|3694668|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869462|NCT01590758|3694666|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3869463|NCT01590758|3694667|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3869465|NCT01590758|3694666|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3869466|NCT01590758|3694667|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3869467|NCT01590758|3694668|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3869468|NCT01590758|3694666|B3||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3869469|NCT01590758|3694667|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3869470|NCT01590758|3694668|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3869471|NCT01590758|3694666|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3869472|NCT01590758|3694667|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3869473|NCT01590758|3694668|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3869474|NCT01590758|3694666|B3|Age||Age||years|Mean|58.78|58.78|Standard Deviation|10.58|10.58|||
3869475|NCT01590758|3694667|B2|Age||Age||years|Mean|58.42|58.42|Standard Deviation|10.97|10.97|||
3869476|NCT01590758|3694668|B1|Age||Age||years|Mean|59.22|59.22|Standard Deviation|10.14|10.14|||
3869477|NCT01590563|3694679|B1|No||Prior Contraception Use||participants|Number|7|7.0||||||
3869478|NCT01590563|3694679|B1|Yes||Prior Contraception Use||participants|Number|8|8.0||||||
3869479|NCT01590563|3694679|B1|Hungary||Region of Enrollment||participants|Number|15|15.0||||||
3869480|NCT01590563|3694679|B1|||Sex/Gender, Customized||participants|Number|15|15.0||||||
3869481|NCT01590563|3694679|B1|||Age||years|Mean|33.9|33.9|Standard Deviation|4.8|4.8|||
3869482|NCT01590563|3694679|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3869483|NCT01590563|3694679|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3869484|NCT01590563|3694679|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3869485|NCT01590550|3694685|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3869486|NCT01590550|3694685|B1||Male|Gender||Participants|Count of Participants|10|10.0||||||
3869487|NCT01590550|3694685|B1||Female|Gender||Participants|Count of Participants|8|8.0||||||
3869488|NCT01590550|3694685|B1|||Age||years|Mean|7.8|7.8|Standard Deviation|6.7|6.7|||
3869489|NCT01590394|3694691|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3869490|NCT01590394|3694691|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3869491|NCT01590394|3694691|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3869492|NCT01590394|3694691|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3869493|NCT01590394|3694691|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3869494|NCT01590394|3694691|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3869495|NCT01590264|3694695|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3869496|NCT01590264|3694695|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3869497|NCT01590264|3694695|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3869498|NCT01590264|3694695|B1|||Age||years|Mean|55|55.0|Standard Deviation|6.7|6.7|||
3869499|NCT01590264|3694695|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3869500|NCT01590264|3694695|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3869501|NCT01590264|3694695|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3869502|NCT01590238|3694700|B1|||Hair density index measured prior to intervention|Hair density as measured with proprietary hair densitometer in a 2cm x 2cm square in the midline at a predetermined distance from the nasal root (individual measurement but held constant for multiple measurements in the same subject over time).|percent of pre treatment value|Mean|100|100.0|Standard Deviation|0|0.0|||
3869503|NCT01590238|3694700|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3869504|NCT01590238|3694700|B1||Male|Gender||Participants|Count of Participants|9|9.0||||||
3869505|NCT01590238|3694700|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
3869506|NCT01590238|3694700|B1|||Age||years|Mean|43.2|43.2|Standard Deviation|18.2|18.2|||
3869507|NCT01590212|3694704|B4|||Edinburgh Postnatal Depression Scale (EPDS)|Edinburgh Postnatal Depression Scale (EPDS): is a standardised questionnaire which generates a single score. Normal score=0-9, Borderline=10-12, Probable depression=13-30.|Scores on a scale|Mean|11.19|11.19|Full Range|||0.0|21.0|
3869508|NCT01590212|3694705|B3|||Edinburgh Postnatal Depression Scale (EPDS)|Edinburgh Postnatal Depression Scale (EPDS): is a standardised questionnaire which generates a single score. Normal score=0-9, Borderline=10-12, Probable depression=13-30.|Scores on a scale|Mean|9.27|9.27|Full Range|||1.0|20.0|
3869509|NCT01590212|3694706|B2|||Edinburgh Postnatal Depression Scale (EPDS)|Edinburgh Postnatal Depression Scale (EPDS): is a standardised questionnaire which generates a single score. Normal score=0-9, Borderline=10-12, Probable depression=13-30.|Scores on a scale|Mean|11|11.0|Full Range|||0.0|20.0|
3869510|NCT01590212|3694707|B1|||Edinburgh Postnatal Depression Scale (EPDS)|Edinburgh Postnatal Depression Scale (EPDS): is a standardised questionnaire which generates a single score. Normal score=0-9, Borderline=10-12, Probable depression=13-30.|Scores on a scale|Mean|14.10|14.1|Full Range|||8.0|21.0|
3869511|NCT01590212|3694704|B4|Inward directed irritability||Adult Wellbeing Scale|The Adult Wellbeing scale (AWS): a validated questionnaire which generates scores in four domains – depression, anxiety, outward-directed irritability and inward-directed irritability. The sub-scales have different cut-off scores that indicate a possible problem in that area: Anxiety (normal=0-5, borderline=6-8, problem 9-15), Depression (normal=0-3, borderline=4-6, problem 7-15), Outward directed irritability (normal=0-4, borderline=5-7, problem 8-12), Inward directed irritability (normal=0-3, borderline=4-6, problem 7-12),|Scores on a scale|Mean|2.45|2.45|Full Range|||0.0|6.0|
3869591|NCT01589822|3694771|B4|New Zealand||Region of Enrollment||participants|Number|21|21.0||||||
3869592|NCT01589822|3694772|B3|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
3869512|NCT01590212|3694705|B3|Inward directed irritability||Adult Wellbeing Scale|The Adult Wellbeing scale (AWS): a validated questionnaire which generates scores in four domains – depression, anxiety, outward-directed irritability and inward-directed irritability. The sub-scales have different cut-off scores that indicate a possible problem in that area: Anxiety (normal=0-5, borderline=6-8, problem 9-15), Depression (normal=0-3, borderline=4-6, problem 7-15), Outward directed irritability (normal=0-4, borderline=5-7, problem 8-12), Inward directed irritability (normal=0-3, borderline=4-6, problem 7-12),|Scores on a scale|Mean|2.27|2.27|Full Range|||0.0|6.0|
3869513|NCT01590212|3694706|B2|Inward directed irritability||Adult Wellbeing Scale|The Adult Wellbeing scale (AWS): a validated questionnaire which generates scores in four domains – depression, anxiety, outward-directed irritability and inward-directed irritability. The sub-scales have different cut-off scores that indicate a possible problem in that area: Anxiety (normal=0-5, borderline=6-8, problem 9-15), Depression (normal=0-3, borderline=4-6, problem 7-15), Outward directed irritability (normal=0-4, borderline=5-7, problem 8-12), Inward directed irritability (normal=0-3, borderline=4-6, problem 7-12),|Scores on a scale|Mean|2.33|2.33|Full Range|||0.0|5.0|
3869514|NCT01590212|3694707|B1|Inward directed irritability||Adult Wellbeing Scale|The Adult Wellbeing scale (AWS): a validated questionnaire which generates scores in four domains – depression, anxiety, outward-directed irritability and inward-directed irritability. The sub-scales have different cut-off scores that indicate a possible problem in that area: Anxiety (normal=0-5, borderline=6-8, problem 9-15), Depression (normal=0-3, borderline=4-6, problem 7-15), Outward directed irritability (normal=0-4, borderline=5-7, problem 8-12), Inward directed irritability (normal=0-3, borderline=4-6, problem 7-12),|Scores on a scale|Mean|2.8|2.8|Full Range|||0.0|6.0|
3869515|NCT01590212|3694704|B4|Outward directed irritability||Adult Wellbeing Scale|The Adult Wellbeing scale (AWS): a validated questionnaire which generates scores in four domains – depression, anxiety, outward-directed irritability and inward-directed irritability. The sub-scales have different cut-off scores that indicate a possible problem in that area: Anxiety (normal=0-5, borderline=6-8, problem 9-15), Depression (normal=0-3, borderline=4-6, problem 7-15), Outward directed irritability (normal=0-4, borderline=5-7, problem 8-12), Inward directed irritability (normal=0-3, borderline=4-6, problem 7-12),|Scores on a scale|Mean|3.65|3.65|Full Range|||0.0|10.0|
3869516|NCT01590212|3694705|B3|Outward directed irritability||Adult Wellbeing Scale|The Adult Wellbeing scale (AWS): a validated questionnaire which generates scores in four domains – depression, anxiety, outward-directed irritability and inward-directed irritability. The sub-scales have different cut-off scores that indicate a possible problem in that area: Anxiety (normal=0-5, borderline=6-8, problem 9-15), Depression (normal=0-3, borderline=4-6, problem 7-15), Outward directed irritability (normal=0-4, borderline=5-7, problem 8-12), Inward directed irritability (normal=0-3, borderline=4-6, problem 7-12),|Scores on a scale|Mean|3.09|3.09|Full Range|||0.0|6.0|
3869517|NCT01590212|3694706|B2|Outward directed irritability||Adult Wellbeing Scale|The Adult Wellbeing scale (AWS): a validated questionnaire which generates scores in four domains – depression, anxiety, outward-directed irritability and inward-directed irritability. The sub-scales have different cut-off scores that indicate a possible problem in that area: Anxiety (normal=0-5, borderline=6-8, problem 9-15), Depression (normal=0-3, borderline=4-6, problem 7-15), Outward directed irritability (normal=0-4, borderline=5-7, problem 8-12), Inward directed irritability (normal=0-3, borderline=4-6, problem 7-12),|Scores on a scale|Mean|3.11|3.11|Full Range|||1.0|7.0|
3869518|NCT01590212|3694707|B1|Outward directed irritability||Adult Wellbeing Scale|The Adult Wellbeing scale (AWS): a validated questionnaire which generates scores in four domains – depression, anxiety, outward-directed irritability and inward-directed irritability. The sub-scales have different cut-off scores that indicate a possible problem in that area: Anxiety (normal=0-5, borderline=6-8, problem 9-15), Depression (normal=0-3, borderline=4-6, problem 7-15), Outward directed irritability (normal=0-4, borderline=5-7, problem 8-12), Inward directed irritability (normal=0-3, borderline=4-6, problem 7-12),|Scores on a scale|Mean|4.8|4.8|Full Range|||1.0|10.0|
3869519|NCT01590212|3694704|B4|Depression||Adult Wellbeing Scale|The Adult Wellbeing scale (AWS): a validated questionnaire which generates scores in four domains – depression, anxiety, outward-directed irritability and inward-directed irritability. The sub-scales have different cut-off scores that indicate a possible problem in that area: Anxiety (normal=0-5, borderline=6-8, problem 9-15), Depression (normal=0-3, borderline=4-6, problem 7-15), Outward directed irritability (normal=0-4, borderline=5-7, problem 8-12), Inward directed irritability (normal=0-3, borderline=4-6, problem 7-12),|Scores on a scale|Mean|5.87|5.87|Full Range|||1.0|11.0|
3869520|NCT01590212|3694705|B3|Depression||Adult Wellbeing Scale|The Adult Wellbeing scale (AWS): a validated questionnaire which generates scores in four domains – depression, anxiety, outward-directed irritability and inward-directed irritability. The sub-scales have different cut-off scores that indicate a possible problem in that area: Anxiety (normal=0-5, borderline=6-8, problem 9-15), Depression (normal=0-3, borderline=4-6, problem 7-15), Outward directed irritability (normal=0-4, borderline=5-7, problem 8-12), Inward directed irritability (normal=0-3, borderline=4-6, problem 7-12),|Scores on a scale|Mean|5.0|5.0|Full Range|||1.0|8.0|
3869521|NCT01590212|3694706|B2|Depression||Adult Wellbeing Scale|The Adult Wellbeing scale (AWS): a validated questionnaire which generates scores in four domains – depression, anxiety, outward-directed irritability and inward-directed irritability. The sub-scales have different cut-off scores that indicate a possible problem in that area: Anxiety (normal=0-5, borderline=6-8, problem 9-15), Depression (normal=0-3, borderline=4-6, problem 7-15), Outward directed irritability (normal=0-4, borderline=5-7, problem 8-12), Inward directed irritability (normal=0-3, borderline=4-6, problem 7-12),|Scores on a scale|Mean|6.0|6.0|Full Range|||2.0|10.0|
3869522|NCT01590212|3694707|B1|Depression||Adult Wellbeing Scale|The Adult Wellbeing scale (AWS): a validated questionnaire which generates scores in four domains – depression, anxiety, outward-directed irritability and inward-directed irritability. The sub-scales have different cut-off scores that indicate a possible problem in that area: Anxiety (normal=0-5, borderline=6-8, problem 9-15), Depression (normal=0-3, borderline=4-6, problem 7-15), Outward directed irritability (normal=0-4, borderline=5-7, problem 8-12), Inward directed irritability (normal=0-3, borderline=4-6, problem 7-12),|Scores on a scale|Mean|7.0|7.0|Full Range|||4.0|11.0|
3869593|NCT01589822|3694773|B2|New Zealand||Region of Enrollment||participants|Number|10|10.0||||||
3869594|NCT01589822|3694774|B1|New Zealand||Region of Enrollment||participants|Number|10|10.0||||||
3869595|NCT01589822|3694771|B4|Australia||Region of Enrollment||participants|Number|25|25.0||||||
3869523|NCT01590212|3694704|B4|Anxiety||Adult Wellbeing Scale|The Adult Wellbeing scale (AWS): a validated questionnaire which generates scores in four domains – depression, anxiety, outward-directed irritability and inward-directed irritability. The sub-scales have different cut-off scores that indicate a possible problem in that area: Anxiety (normal=0-5, borderline=6-8, problem 9-15), Depression (normal=0-3, borderline=4-6, problem 7-15), Outward directed irritability (normal=0-4, borderline=5-7, problem 8-12), Inward directed irritability (normal=0-3, borderline=4-6, problem 7-12),|Scores on a scale|Mean|5.94|5.94|Full Range|||0.0|12.0|
3869524|NCT01590212|3694705|B3|Anxiety||Adult Wellbeing Scale|The Adult Wellbeing scale (AWS): a validated questionnaire which generates scores in four domains – depression, anxiety, outward-directed irritability and inward-directed irritability. The sub-scales have different cut-off scores that indicate a possible problem in that area: Anxiety (normal=0-5, borderline=6-8, problem 9-15), Depression (normal=0-3, borderline=4-6, problem 7-15), Outward directed irritability (normal=0-4, borderline=5-7, problem 8-12), Inward directed irritability (normal=0-3, borderline=4-6, problem 7-12),|Scores on a scale|Mean|5.36|5.36|Full Range|||0.0|12.0|
3869525|NCT01590212|3694706|B2|Anxiety||Adult Wellbeing Scale|The Adult Wellbeing scale (AWS): a validated questionnaire which generates scores in four domains – depression, anxiety, outward-directed irritability and inward-directed irritability. The sub-scales have different cut-off scores that indicate a possible problem in that area: Anxiety (normal=0-5, borderline=6-8, problem 9-15), Depression (normal=0-3, borderline=4-6, problem 7-15), Outward directed irritability (normal=0-4, borderline=5-7, problem 8-12), Inward directed irritability (normal=0-3, borderline=4-6, problem 7-12),|Scores on a scale|Mean|6.78|6.78|Full Range|||0.0|12.0|
3869526|NCT01590212|3694707|B1|Anxiety||Adult Wellbeing Scale|The Adult Wellbeing scale (AWS): a validated questionnaire which generates scores in four domains – depression, anxiety, outward-directed irritability and inward-directed irritability. The sub-scales have different cut-off scores that indicate a possible problem in that area: Anxiety (normal=0-5, borderline=6-8, problem 9-15), Depression (normal=0-3, borderline=4-6, problem 7-15), Outward directed irritability (normal=0-4, borderline=5-7, problem 8-12), Inward directed irritability (normal=0-3, borderline=4-6, problem 7-12),|Scores on a scale|Mean|6.3|6.3|Full Range|||3.0|11.0|
3869527|NCT01590212|3694704|B4|United Kingdom||Region of Enrollment||participants|Number|31|31.0||||||
3869528|NCT01590212|3694705|B3|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
3869529|NCT01590212|3694706|B2|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
3869530|NCT01590212|3694707|B1|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
3869531|NCT01590212|3694704|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3869532|NCT01590212|3694705|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3869533|NCT01590212|3694706|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3869534|NCT01590212|3694707|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3869535|NCT01590212|3694704|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3869536|NCT01590212|3694705|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3869537|NCT01590212|3694706|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3869538|NCT01590212|3694707|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3869539|NCT01590212|3694704|B4|||Age||years|Mean|27.14|27.14|Standard Deviation|7.49|7.49|||
3869540|NCT01590212|3694705|B3|||Age||years|Mean|29|29.0|Standard Deviation|7.851|7.851|||
3869541|NCT01590212|3694706|B2|||Age||years|Mean|28.89|28.89|Standard Deviation|8.594|8.594|||
3869542|NCT01590212|3694707|B1|||Age||years|Mean|25.2|25.2|Standard Deviation|5.391|5.391|||
3869543|NCT01590212|3694704|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3869544|NCT01590212|3694705|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3869545|NCT01590212|3694706|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3869546|NCT01590212|3694707|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3869547|NCT01590212|3694704|B4||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3869548|NCT01590212|3694705|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3869549|NCT01590212|3694706|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3869550|NCT01590212|3694707|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3869551|NCT01590212|3694704|B4||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3869552|NCT01590212|3694705|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3869553|NCT01590212|3694706|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3869554|NCT01590212|3694707|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3869555|NCT01589978|3694726|B1|3||Lesion Characteristics: Pre-Procedure Thrombolysis in Myocardial Invarction (TIMI) Flow|"Note: A single participant could potentially experience multiple categories listed below.~Site reported information collected post-enrollment from medical records. Stages range from TIMI 0 (no perfusion) to TIMI 3 (normal flow).~TIMI: Thrombolysis in Myocardial Infarction"|lesions|Number|2539|2539.0||||||
3869556|NCT01589978|3694726|B1|2||Lesion Characteristics: Pre-Procedure Thrombolysis in Myocardial Invarction (TIMI) Flow|"Note: A single participant could potentially experience multiple categories listed below.~Site reported information collected post-enrollment from medical records. Stages range from TIMI 0 (no perfusion) to TIMI 3 (normal flow).~TIMI: Thrombolysis in Myocardial Infarction"|lesions|Number|487|487.0||||||
3869557|NCT01589978|3694726|B1|1||Lesion Characteristics: Pre-Procedure Thrombolysis in Myocardial Invarction (TIMI) Flow|"Note: A single participant could potentially experience multiple categories listed below.~Site reported information collected post-enrollment from medical records. Stages range from TIMI 0 (no perfusion) to TIMI 3 (normal flow).~TIMI: Thrombolysis in Myocardial Infarction"|lesions|Number|157|157.0||||||
3869596|NCT01589822|3694772|B3|Australia||Region of Enrollment||participants|Number|6|6.0||||||
3869597|NCT01589822|3694773|B2|Australia||Region of Enrollment||participants|Number|9|9.0||||||
3869598|NCT01589822|3694774|B1|Australia||Region of Enrollment||participants|Number|10|10.0||||||
3869558|NCT01589978|3694726|B1|0||Lesion Characteristics: Pre-Procedure Thrombolysis in Myocardial Invarction (TIMI) Flow|"Note: A single participant could potentially experience multiple categories listed below.~Site reported information collected post-enrollment from medical records. Stages range from TIMI 0 (no perfusion) to TIMI 3 (normal flow).~TIMI: Thrombolysis in Myocardial Infarction"|lesions|Number|359|359.0||||||
3869559|NCT01589978|3694726|B1|||Lesion Characteristics: Reference Vessel Diameter|Site reported information collected post-enrollment from medical records.|mm|Mean|2.94|2.94|Standard Deviation|0.51|0.51|||
3869560|NCT01589978|3694726|B1|||Lesion Characteristics: Lesion Length|Site reported information collected post-enrollment from medical records.|mm|Mean|17.0|17.0|Standard Deviation|10.3|10.3|||
3869561|NCT01589978|3694726|B1|Graft||Lesion Characteristics: Target Lesion Vessel|"Note: A single participant could potentially experience multiple categories listed below.~Site reported information collected post-enrollment from medical records."|lesions|Number|199|199.0||||||
3869562|NCT01589978|3694726|B1|Left Main||Lesion Characteristics: Target Lesion Vessel|"Note: A single participant could potentially experience multiple categories listed below.~Site reported information collected post-enrollment from medical records."|lesions|Number|54|54.0||||||
3869563|NCT01589978|3694726|B1|Right Coronary Artery||Lesion Characteristics: Target Lesion Vessel|"Note: A single participant could potentially experience multiple categories listed below.~Site reported information collected post-enrollment from medical records."|lesions|Number|1165|1165.0||||||
3869564|NCT01589978|3694726|B1|Circumflex Artery||Lesion Characteristics: Target Lesion Vessel|"Note: A single participant could potentially experience multiple categories listed below.~Site reported information collected post-enrollment from medical records."|lesions|Number|848|848.0||||||
3869565|NCT01589978|3694726|B1|Left Anterior Descending Artery||Lesion Characteristics: Target Lesion Vessel|"Note: A single participant could potentially experience multiple categories listed below.~Site reported information collected post-enrollment from medical records."|lesions|Number|1339|1339.0||||||
3869566|NCT01589978|3694726|B1|Family History of CAD||Cardiac Risk Factors|"Note: A single participant could potentially experience multiple categories listed below.~Collected as part of a medical history during subject enrollment."|participants|Number|1625|1625.0||||||
3869567|NCT01589978|3694726|B1|History of Hypertension Requiring Medication||Cardiac Risk Factors|"Note: A single participant could potentially experience multiple categories listed below.~Collected as part of a medical history during subject enrollment."|participants|Number|2077|2077.0||||||
3869568|NCT01589978|3694726|B1|Hyperlipidemia Requiring Medication||Cardiac Risk Factors|"Note: A single participant could potentially experience multiple categories listed below.~Collected as part of a medical history during subject enrollment."|participants|Number|2016|2016.0||||||
3869569|NCT01589978|3694726|B1|Current Diabetic Mellitus||Cardiac Risk Factors|"Note: A single participant could potentially experience multiple categories listed below.~Collected as part of a medical history during subject enrollment."|participants|Number|989|989.0||||||
3869570|NCT01589978|3694726|B1|Smoking, Ever||Cardiac Risk Factors|"Note: A single participant could potentially experience multiple categories listed below.~Collected as part of a medical history during subject enrollment."|participants|Number|1600|1600.0||||||
3869571|NCT01589978|3694726|B1|History of CABG||Cardiac History|"Note: A single participant could potentially experience multiple categories listed below.~Collected as part of a medical history during subject enrollment."|participants|Number|457|457.0||||||
3869572|NCT01589978|3694726|B1|History of PCI||Cardiac History|"Note: A single participant could potentially experience multiple categories listed below.~Collected as part of a medical history during subject enrollment."|participants|Number|1159|1159.0||||||
3869573|NCT01589978|3694726|B1|Silent Ischemia||Cardiac History|"Note: A single participant could potentially experience multiple categories listed below.~Collected as part of a medical history during subject enrollment."|participants|Number|149|149.0||||||
3869574|NCT01589978|3694726|B1|Unstable Angina||Cardiac History|"Note: A single participant could potentially experience multiple categories listed below.~Collected as part of a medical history during subject enrollment."|participants|Number|1347|1347.0||||||
3869575|NCT01589978|3694726|B1|Stable Angina||Cardiac History|"Note: A single participant could potentially experience multiple categories listed below.~Collected as part of a medical history during subject enrollment."|participants|Number|620|620.0||||||
3869576|NCT01589978|3694726|B1|History of CHF||Cardiac History|"Note: A single participant could potentially experience multiple categories listed below.~Collected as part of a medical history during subject enrollment."|participants|Number|275|275.0||||||
3869577|NCT01589978|3694726|B1|History of MI||Cardiac History|"Note: A single participant could potentially experience multiple categories listed below.~Collected as part of a medical history during subject enrollment."|participants|Number|1409|1409.0||||||
3869578|NCT01589978|3694726|B1|History of CAD||Cardiac History|"Note: A single participant could potentially experience multiple categories listed below.~Collected as part of a medical history during subject enrollment."|participants|Number|1625|1625.0||||||
3869579|NCT01589978|3694726|B1|United States||Region of Enrollment||participants|Number|2681|2681.0||||||
3869580|NCT01589978|3694726|B1||Male|Sex: Female, Male|Collected during subject enrollment.|Participants|Count of Participants|1874|1874.0||||||
3869581|NCT01589978|3694726|B1||Female|Sex: Female, Male|Collected during subject enrollment.|Participants|Count of Participants|807|807.0||||||
3869582|NCT01589978|3694726|B1|||Age|Collected as part of a medical history during subject enrollment.|years|Mean|63.7|63.7|Standard Deviation|11.1|11.1|||
3869583|NCT01589822|3694771|B4|Korea, Republic of||Region of Enrollment||participants|Number|47|47.0||||||
3869584|NCT01589822|3694772|B3|Korea, Republic of||Region of Enrollment||participants|Number|7|7.0||||||
3869585|NCT01589822|3694773|B2|Korea, Republic of||Region of Enrollment||participants|Number|20|20.0||||||
3869586|NCT01589822|3694774|B1|Korea, Republic of||Region of Enrollment||participants|Number|20|20.0||||||
3869587|NCT01589822|3694771|B4|United Kingdom||Region of Enrollment||participants|Number|31|31.0||||||
3869588|NCT01589822|3694772|B3|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
3869589|NCT01589822|3694773|B2|United Kingdom||Region of Enrollment||participants|Number|14|14.0||||||
3869590|NCT01589822|3694774|B1|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
3869600|NCT01589822|3694772|B3|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
3869601|NCT01589822|3694773|B2|Belgium||Region of Enrollment||participants|Number|17|17.0||||||
3869602|NCT01589822|3694774|B1|Belgium||Region of Enrollment||participants|Number|17|17.0||||||
3869603|NCT01589822|3694771|B4|Canada||Region of Enrollment||participants|Number|8|8.0||||||
3869604|NCT01589822|3694772|B3|Canada||Region of Enrollment||participants|Number|4|4.0||||||
3869605|NCT01589822|3694773|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
3869606|NCT01589822|3694774|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
3869607|NCT01589822|3694771|B4|United States||Region of Enrollment||participants|Number|45|45.0||||||
3869608|NCT01589822|3694772|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
3869609|NCT01589822|3694773|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3869610|NCT01589822|3694774|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3869611|NCT01589822|3694771|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3869612|NCT01589822|3694772|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3869613|NCT01589822|3694773|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3869614|NCT01589822|3694774|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3869615|NCT01589822|3694771|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869616|NCT01589822|3694772|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869617|NCT01589822|3694773|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869618|NCT01589822|3694774|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869619|NCT01589822|3694771|B4||White|Race (NIH/OMB)||Participants|Count of Participants|157|157.0||||||
3869620|NCT01589822|3694772|B3||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3869621|NCT01589822|3694773|B2||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3869622|NCT01589822|3694774|B1||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3869623|NCT01589822|3694771|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3869624|NCT01589822|3694772|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3869625|NCT01589822|3694773|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869626|NCT01589822|3694774|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869627|NCT01589822|3694771|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869628|NCT01589822|3694772|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869629|NCT01589822|3694773|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869630|NCT01589822|3694774|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869631|NCT01589822|3694771|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3869632|NCT01589822|3694772|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3869633|NCT01589822|3694773|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3869634|NCT01589822|3694774|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3869635|NCT01589822|3694771|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869636|NCT01589822|3694772|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869637|NCT01589822|3694773|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869638|NCT01589822|3694774|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869639|NCT01589822|3694771|B4||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3869640|NCT01589822|3694772|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3869641|NCT01589822|3694773|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3869642|NCT01589822|3694774|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3869643|NCT01589822|3694771|B4||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3869644|NCT01589822|3694772|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3869645|NCT01589822|3694773|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3869646|NCT01589822|3694774|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3869647|NCT01589822|3694771|B4|||Age||years|Mean|61.8|61.8|Standard Deviation|11.1|11.1|||
3869648|NCT01589822|3694772|B3|||Age||years|Mean|62.0|62.0|Standard Deviation|12.2|12.2|||
3869649|NCT01589822|3694773|B2|||Age||years|Mean|62.5|62.5|Standard Deviation|10.8|10.8|||
3869650|NCT01589822|3694774|B1|||Age||years|Mean|61.1|61.1|Standard Deviation|11.1|11.1|||
3869651|NCT01589653|3694793|B3|||Fasting plasma glucose (mg/dL)||mg/dL|Mean|152.6|152.6|Standard Deviation|56.64|56.64|||
3869652|NCT01589653|3694794|B2|||Fasting plasma glucose (mg/dL)||mg/dL|Mean|148.5|148.5|Standard Deviation|54.24|54.24|||
3869653|NCT01589653|3694795|B1|||Fasting plasma glucose (mg/dL)||mg/dL|Mean|156.8|156.8|Standard Deviation|59.03|59.03|||
3869654|NCT01589653|3694793|B3|||HbA1c (%)||percentage of glycosylated haemoglobin|Mean|8.6|8.6|Standard Deviation|0.83|0.83|||
3869655|NCT01589653|3694794|B2|||HbA1c (%)||percentage of glycosylated haemoglobin|Mean|8.7|8.7|Standard Deviation|0.78|0.78|||
3869656|NCT01589653|3694795|B1|||HbA1c (%)||percentage of glycosylated haemoglobin|Mean|8.5|8.5|Standard Deviation|0.88|0.88|||
3869657|NCT01589653|3694793|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3869658|NCT01589653|3694794|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3869659|NCT01589653|3694795|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3869660|NCT01589653|3694793|B3||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3869661|NCT01589653|3694794|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3869662|NCT01589653|3694795|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3869663|NCT01589653|3694793|B3|||Age||years|Mean|54.7|54.7|Standard Deviation|9.96|9.96|||
3869664|NCT01589653|3694794|B2|||Age||years|Mean|54.9|54.9|Standard Deviation|9.77|9.77|||
3869665|NCT01589653|3694795|B1|||Age||years|Mean|54.4|54.4|Standard Deviation|10.22|10.22|||
3869666|NCT01589601|3694810|B3|United States||Region of Enrollment||participants|Number|150|150.0||||||
3869667|NCT01589601|3694811|B2|United States||Region of Enrollment||participants|Number|75|75.0||||||
3869668|NCT01589601|3694812|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
3869669|NCT01589601|3694810|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3869670|NCT01589601|3694811|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3869671|NCT01589601|3694812|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3869672|NCT01589601|3694810|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3869673|NCT01589601|3694811|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3869674|NCT01589601|3694812|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3869675|NCT01589601|3694810|B3|||Age||years|Mean|70.8|70.8|Standard Deviation|12.93|12.93|||
3869676|NCT01589601|3694811|B2|||Age||years|Mean|69.8|69.8|Standard Deviation|13.43|13.43|||
3869677|NCT01589601|3694812|B1|||Age||years|Mean|71.9|71.9|Standard Deviation|12.41|12.41|||
3869678|NCT01589601|3694810|B3||>=65 years|Age||Participants|Count of Participants|104|104.0||||||
3869679|NCT01589601|3694811|B2||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
3869680|NCT01589601|3694812|B1||>=65 years|Age||Participants|Count of Participants|54|54.0||||||
3869681|NCT01589601|3694810|B3||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
3869682|NCT01589601|3694811|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3869683|NCT01589601|3694812|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3869684|NCT01589601|3694810|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3869685|NCT01589601|3694811|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3869686|NCT01589601|3694812|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3869687|NCT01589510|3694829|B1|Missing||Sex/Gender, Customized||Participants|Number|4|4.0||||||
3869688|NCT01589510|3694829|B1|Male||Sex/Gender, Customized||Participants|Number|183|183.0||||||
3869689|NCT01589510|3694829|B1|Female||Sex/Gender, Customized||Participants|Number|232|232.0||||||
3869690|NCT01589510|3694829|B1|Missing||Age, Customized||Participants|Number|4|4.0||||||
3869691|NCT01589510|3694829|B1|>=91 years||Age, Customized||Participants|Number|4|4.0||||||
3869692|NCT01589510|3694829|B1|81 to 90 years||Age, Customized||Participants|Number|51|51.0||||||
3869693|NCT01589510|3694829|B1|71 to 80 years||Age, Customized||Participants|Number|116|116.0||||||
3869694|NCT01589510|3694829|B1|61 to 70 years||Age, Customized||Participants|Number|137|137.0||||||
3869695|NCT01589510|3694829|B1|51 to 60 years||Age, Customized||Participants|Number|66|66.0||||||
3869696|NCT01589510|3694829|B1|41 to 50 years||Age, Customized||Participants|Number|33|33.0||||||
3869697|NCT01589510|3694829|B1|31 to 40 years||Age, Customized||Participants|Number|7|7.0||||||
3869698|NCT01589510|3694829|B1|18 to 30 years||Age, Customized||Participants|Number|1|1.0||||||
3869699|NCT01589510|3694829|B1|<18 years||Age, Customized||Participants|Number|0|0.0||||||
3869700|NCT01589497|3694840|B5|HIV positive||HIV status||participants|Number|4|4.0||||||
3869701|NCT01589497|3694841|B4|HIV positive||HIV status||participants|Number|0|0.0||||||
3869702|NCT01589497|3694842|B3|HIV positive||HIV status||participants|Number|1|1.0||||||
3869703|NCT01589497|3694843|B2|HIV positive||HIV status||participants|Number|1|1.0||||||
3869704|NCT01589497|3694844|B1|HIV positive||HIV status||participants|Number|2|2.0||||||
3869705|NCT01589497|3694840|B5|HIV negative||HIV status||participants|Number|65|65.0||||||
3869706|NCT01589497|3694841|B4|HIV negative||HIV status||participants|Number|18|18.0||||||
3869707|NCT01589497|3694842|B3|HIV negative||HIV status||participants|Number|15|15.0||||||
3869708|NCT01589497|3694843|B2|HIV negative||HIV status||participants|Number|16|16.0||||||
3869709|NCT01589497|3694844|B1|HIV negative||HIV status||participants|Number|16|16.0||||||
3869710|NCT01589497|3694840|B5|||BMI||kg/m^2|Median|18.9|18.9|Inter-Quartile Range|||17.5|20.8|
3869711|NCT01589497|3694841|B4|||BMI||kg/m^2|Median|18.7|18.7|Inter-Quartile Range|||16.8|20.4|
3869712|NCT01589497|3694842|B3|||BMI||kg/m^2|Median|19.8|19.8|Inter-Quartile Range|||17.7|22.7|
3869713|NCT01589497|3694843|B2|||BMI||kg/m^2|Median|19.4|19.4|Inter-Quartile Range|||17.5|20.4|
3869714|NCT01589497|3694844|B1|||BMI||kg/m^2|Median|18.5|18.5|Inter-Quartile Range|||17.5|20.9|
3869715|NCT01589497|3694840|B5|||Karnofsky score|The karnofsky score was determined according to karnofsky performance scale. The scale ranged from 0 to 100, by 10. A higher value represents a better outcome.|scores on a scale|Median|90|90.0|Full Range|||80.0|100.0|
3869716|NCT01589497|3694841|B4|||Karnofsky score|The karnofsky score was determined according to karnofsky performance scale. The scale ranged from 0 to 100, by 10. A higher value represents a better outcome.|scores on a scale|Median|90|90.0|Full Range|||80.0|90.0|
3869717|NCT01589497|3694842|B3|||Karnofsky score|The karnofsky score was determined according to karnofsky performance scale. The scale ranged from 0 to 100, by 10. A higher value represents a better outcome.|scores on a scale|Median|90|90.0|Full Range|||80.0|90.0|
3869718|NCT01589497|3694843|B2|||Karnofsky score|The karnofsky score was determined according to karnofsky performance scale. The scale ranged from 0 to 100, by 10. A higher value represents a better outcome.|scores on a scale|Median|90|90.0|Full Range|||80.0|90.0|
3869719|NCT01589497|3694844|B1|||Karnofsky score|The karnofsky score was determined according to karnofsky performance scale. The scale ranged from 0 to 100, by 10. A higher value represents a better outcome.|scores on a scale|Median|90|90.0|Full Range|||80.0|100.0|
3869720|NCT01589497|3694840|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869721|NCT01589497|3694841|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869722|NCT01589497|3694842|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869723|NCT01589497|3694843|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869724|NCT01589497|3694844|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869725|NCT01589497|3694840|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869726|NCT01589497|3694841|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869727|NCT01589497|3694842|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869728|NCT01589497|3694843|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869729|NCT01589497|3694844|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869730|NCT01589497|3694840|B5||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869731|NCT01589497|3694841|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869732|NCT01589497|3694842|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869733|NCT01589497|3694843|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869734|NCT01589497|3694844|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869735|NCT01589497|3694840|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3869736|NCT01589497|3694841|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3869737|NCT01589497|3694842|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3869738|NCT01589497|3694843|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3869739|NCT01589497|3694844|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3869740|NCT01589497|3694840|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869741|NCT01589497|3694841|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869742|NCT01589497|3694842|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869743|NCT01589497|3694843|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869744|NCT01589497|3694844|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869745|NCT01589497|3694840|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869746|NCT01589497|3694841|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869747|NCT01589497|3694842|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869748|NCT01589497|3694843|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869749|NCT01589497|3694844|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869750|NCT01589497|3694840|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869751|NCT01589497|3694841|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869752|NCT01589497|3694842|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869753|NCT01589497|3694843|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869754|NCT01589497|3694844|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869755|NCT01589497|3694840|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3869756|NCT01589497|3694841|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869757|NCT01589497|3694842|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869758|NCT01589497|3694843|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3869759|NCT01589497|3694844|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869760|NCT01589497|3694840|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3869761|NCT01589497|3694841|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3869762|NCT01589497|3694842|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3869763|NCT01589497|3694843|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3869764|NCT01589497|3694844|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3869765|NCT01589497|3694840|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3869766|NCT01589497|3694841|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869767|NCT01589497|3694842|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869768|NCT01589497|3694843|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3869769|NCT01589497|3694844|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869770|NCT01589497|3694840|B5||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3869771|NCT01589497|3694841|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3869772|NCT01589497|3694842|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3869773|NCT01589497|3694843|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3869774|NCT01589497|3694844|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3869775|NCT01589497|3694840|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3869776|NCT01589497|3694841|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3869777|NCT01589497|3694842|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3869778|NCT01589497|3694843|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3869779|NCT01589497|3694844|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3869780|NCT01589497|3694840|B5||50-59|Age, Customized||Participants|Count of Participants|7|7.0||||||
3869781|NCT01589497|3694841|B4||50-59|Age, Customized||Participants|Count of Participants|1|1.0||||||
3869782|NCT01589497|3694842|B3||50-59|Age, Customized||Participants|Count of Participants|3|3.0||||||
3869783|NCT01589497|3694843|B2||50-59|Age, Customized||Participants|Count of Participants|1|1.0||||||
3869784|NCT01589497|3694844|B1||50-59|Age, Customized||Participants|Count of Participants|2|2.0||||||
3869785|NCT01589497|3694840|B5||40-49|Age, Customized||Participants|Count of Participants|13|13.0||||||
3869786|NCT01589497|3694841|B4||40-49|Age, Customized||Participants|Count of Participants|6|6.0||||||
3869787|NCT01589497|3694842|B3||40-49|Age, Customized||Participants|Count of Participants|4|4.0||||||
3869788|NCT01589497|3694843|B2||40-49|Age, Customized||Participants|Count of Participants|1|1.0||||||
3869789|NCT01589497|3694844|B1||40-49|Age, Customized||Participants|Count of Participants|2|2.0||||||
3869790|NCT01589497|3694840|B5||30-39|Age, Customized||Participants|Count of Participants|23|23.0||||||
3869791|NCT01589497|3694841|B4||30-39|Age, Customized||Participants|Count of Participants|5|5.0||||||
3869792|NCT01589497|3694842|B3||30-39|Age, Customized||Participants|Count of Participants|2|2.0||||||
3869793|NCT01589497|3694843|B2||30-39|Age, Customized||Participants|Count of Participants|11|11.0||||||
3869794|NCT01589497|3694844|B1||30-39|Age, Customized||Participants|Count of Participants|5|5.0||||||
3869795|NCT01589497|3694840|B5||20-29|Age, Customized||Participants|Count of Participants|22|22.0||||||
3869796|NCT01589497|3694841|B4||20-29|Age, Customized||Participants|Count of Participants|5|5.0||||||
3869797|NCT01589497|3694842|B3||20-29|Age, Customized||Participants|Count of Participants|6|6.0||||||
3869798|NCT01589497|3694843|B2||20-29|Age, Customized||Participants|Count of Participants|4|4.0||||||
3869799|NCT01589497|3694844|B1||20-29|Age, Customized||Participants|Count of Participants|7|7.0||||||
3869800|NCT01589497|3694840|B5||<20|Age, Customized||Participants|Count of Participants|4|4.0||||||
3869801|NCT01589497|3694841|B4||<20|Age, Customized||Participants|Count of Participants|1|1.0||||||
3869802|NCT01589497|3694842|B3||<20|Age, Customized||Participants|Count of Participants|1|1.0||||||
3869803|NCT01589497|3694843|B2||<20|Age, Customized||Participants|Count of Participants|0|0.0||||||
3869804|NCT01589497|3694844|B1||<20|Age, Customized||Participants|Count of Participants|2|2.0||||||
3869805|NCT01589497|3694840|B5|||Age||years|Median|31|31.0|Inter-Quartile Range|||24.0|40.0|
3869806|NCT01589497|3694841|B4|||Age||years|Median|32|32.0|Inter-Quartile Range|||21.0|44.0|
3869807|NCT01589497|3694842|B3|||Age||years|Median|33.5|33.5|Inter-Quartile Range|||25.5|43.0|
3869808|NCT01589497|3694843|B2|||Age||years|Median|31|31.0|Inter-Quartile Range|||30.0|35.0|
3869809|NCT01589497|3694844|B1|||Age||years|Median|28.5|28.5|Inter-Quartile Range|||22.0|33.0|
3869810|NCT01589484|3694948|B1|||Waist abdominal circumference||cm|Mean|94.1|94.1|Standard Deviation|12.7|12.7|||
3869811|NCT01589484|3694948|B1|||BMI||Kg/m2|Mean|28.0|28.0|Standard Deviation|4.7|4.7|||
3869812|NCT01589484|3694948|B1|Brazil||Region of Enrollment||participants|Number|100|100.0||||||
3869813|NCT01589484|3694948|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3869814|NCT01589484|3694948|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3869815|NCT01589484|3694948|B1|||Age||years|Mean|47.1|47.1|Standard Deviation|12.5|12.5|||
3869816|NCT01589445|3694953|B1|Bangladesh||Region of Enrollment||participants|Number|77|77.0||||||
3869817|NCT01589445|3694953|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3869818|NCT01589445|3694953|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3869819|NCT01589445|3694953|B1|||Age||years|Mean|46|46.0|Standard Deviation|6.4|6.4|||
3869820|NCT01589445|3694953|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3869821|NCT01589445|3694953|B1||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
3869822|NCT01589445|3694953|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3869823|NCT01589237|3694969|B5||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3869824|NCT01589237|3694970|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3869825|NCT01589237|3694971|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3869826|NCT01589237|3694972|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3869827|NCT01589237|3694973|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3869828|NCT01589237|3694969|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3869829|NCT01589237|3694970|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3869830|NCT01589237|3694971|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3869831|NCT01589237|3694972|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3869832|NCT01589237|3694973|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3869833|NCT01589237|3694969|B5|||Age||Years|Mean|47.6|47.6|Standard Deviation|11.43|11.43|||
3869834|NCT01589237|3694970|B4|||Age||Years|Mean|52.2|52.2|Standard Deviation|12.72|12.72|||
3869835|NCT01589237|3694971|B3|||Age||Years|Mean|43.6|43.6|Standard Deviation|84.53|84.53|||
3869836|NCT01589237|3694972|B2|||Age||Years|Mean|44.1|44.1|Standard Deviation|14.26|14.26|||
3869837|NCT01589237|3694973|B1|||Age||Years|Mean|52.9|52.9|Standard Deviation|10.22|10.22|||
3869838|NCT01588951|3695022|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3869839|NCT01588951|3695023|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869840|NCT01588951|3695024|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869841|NCT01588951|3695025|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3869842|NCT01588951|3695022|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869843|NCT01588951|3695023|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869844|NCT01588951|3695024|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869845|NCT01588951|3695025|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869846|NCT01588951|3695022|B4||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3869847|NCT01588951|3695023|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3869848|NCT01588951|3695024|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3869849|NCT01588951|3695025|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869850|NCT01588951|3695022|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3869851|NCT01588951|3695023|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3869852|NCT01588951|3695024|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869853|NCT01588951|3695025|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869854|NCT01588951|3695022|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869855|NCT01588951|3695023|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869856|NCT01588951|3695024|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869857|NCT01588951|3695025|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869858|NCT01588951|3695022|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3869859|NCT01588951|3695023|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3869860|NCT01588951|3695024|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869861|NCT01588951|3695025|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3869862|NCT01588951|3695022|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869863|NCT01588951|3695023|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869864|NCT01588951|3695024|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869865|NCT01588951|3695025|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869866|NCT01588951|3695022|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869867|NCT01588951|3695023|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869868|NCT01588951|3695024|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869869|NCT01588951|3695025|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869870|NCT01588951|3695022|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3869871|NCT01588951|3695023|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3869872|NCT01588951|3695024|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3869873|NCT01588951|3695025|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3869874|NCT01588951|3695022|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3869875|NCT01588951|3695023|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869876|NCT01588951|3695024|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869877|NCT01588951|3695025|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3869878|NCT01588951|3695022|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3869879|NCT01588951|3695023|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3869880|NCT01588951|3695024|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3869881|NCT01588951|3695025|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3869882|NCT01588951|3695022|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3869883|NCT01588951|3695023|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3869884|NCT01588951|3695024|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3869885|NCT01588951|3695025|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3869886|NCT01588951|3695022|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3869887|NCT01588951|3695023|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3869888|NCT01588951|3695024|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3869889|NCT01588951|3695025|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3869890|NCT01588951|3695022|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3869891|NCT01588951|3695023|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3869892|NCT01588951|3695024|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3869893|NCT01588951|3695025|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3869894|NCT01588951|3695022|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3869895|NCT01588951|3695023|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3869896|NCT01588951|3695024|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3869897|NCT01588951|3695025|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3869898|NCT01588821|3695035|B1|Chordoma||Diagnosis||Participants|Count of Participants|1|1.0||||||
3869899|NCT01588821|3695035|B1|Metastatic chondroblastoma||Diagnosis||Participants|Count of Participants|1|1.0||||||
3869900|NCT01588821|3695035|B1|Adenoid Cystic Carcinoma||Diagnosis||Participants|Count of Participants|1|1.0||||||
3869901|NCT01588821|3695035|B1|Melanoma||Diagnosis||Participants|Count of Participants|2|2.0||||||
3869902|NCT01588821|3695035|B1|Thyroid Cancer||Diagnosis||Participants|Count of Participants|2|2.0||||||
3869903|NCT01588821|3695035|B1|Head and neck carcinoma||Diagnosis||Participants|Count of Participants|4|4.0||||||
3869904|NCT01588821|3695035|B1|Non-Small cell lung cancer||Diagnosis||Participants|Count of Participants|5|5.0||||||
3869905|NCT01588821|3695035|B1|Renal Cell Carcinoma||Diagnosis||Participants|Count of Participants|7|7.0||||||
3869906|NCT01588821|3695035|B1|Sarcoma||Diagnosis||Participants|Count of Participants|14|14.0||||||
3869907|NCT01588821|3695035|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
3869908|NCT01588821|3695035|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3869909|NCT01588821|3695035|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3869910|NCT01588821|3695035|B1|||Age||years|Mean|54.4|54.4|Full Range|||18.0|83.0|
3869911|NCT01588561|3695040|B1|||Fagerström score|"Fagerstrom test for nicotine dependence:~http://ndri.curtin.edu.au/btitp/documents/Fagerstrom_test.pdf Scores ranged between 1 to 10, 1-2 = low dependence, 3-4 = low to moderate dependence, 5-7 = moderate dependence, 8+ = high dependence"|units on a scale|Mean|6.0|6.0|Standard Deviation|1.3|1.3|||
3869912|NCT01588561|3695040|B1|||Pack-years|calculated by reported daily cigarettes smoked divided by 20/pack and multiplied by the number of years reported smoking|pack-years|Mean|11.2|11.2|Standard Deviation|10.5|10.5|||
3869913|NCT01588561|3695040|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3869914|NCT01588561|3695040|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3869915|NCT01588561|3695040|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869916|NCT01588561|3695040|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3869917|NCT01588561|3695040|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3869918|NCT01588561|3695040|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869919|NCT01588561|3695040|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869920|NCT01588561|3695040|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869921|NCT01588561|3695040|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3869922|NCT01588561|3695040|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3869923|NCT01588561|3695040|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3869924|NCT01588561|3695040|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3869925|NCT01588561|3695040|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3869926|NCT01588561|3695040|B1|||Age||years|Mean|26.5|26.5|Standard Deviation|7.1|7.1|||
3869927|NCT01588548|3695052|B7||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3869928|NCT01588548|3695053|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3869929|NCT01588548|3695054|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3869930|NCT01588548|3695055|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3869931|NCT01588548|3695056|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3869932|NCT01588548|3695057|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3869933|NCT01588548|3695058|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3869934|NCT01588548|3695052|B7||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3869935|NCT01588548|3695053|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3869936|NCT01588548|3695054|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3869937|NCT01588548|3695055|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3869938|NCT01588548|3695056|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3869939|NCT01588548|3695057|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3869940|NCT01588548|3695058|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3869941|NCT01588548|3695052|B7|||Age||Years|Mean|61.7|61.7|Standard Deviation|12.70|12.7|||
3869942|NCT01588548|3695053|B6|||Age||Years|Mean|60.8|60.8|Standard Deviation|12.45|12.45|||
3869943|NCT01588548|3695054|B5|||Age||Years|Mean|66.5|66.5|Standard Deviation|12.85|12.85|||
3869944|NCT01588548|3695055|B4|||Age||Years|Mean|62.3|62.3|Standard Deviation|17.01|17.01|||
3869945|NCT01588548|3695056|B3|||Age||Years|Mean|63.5|63.5|Standard Deviation|14.38|14.38|||
3869946|NCT01588548|3695057|B2|||Age||Years|Mean|59.4|59.4|Standard Deviation|9.81|9.81|||
3869947|NCT01588548|3695058|B1|||Age||Years|Mean|54.0|54.0|Standard Deviation|9.00|9.0|||
3869948|NCT01588496|3695077|B4|Part B||Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Concentration|Data are provided for the full analysis set|ng/mL|Mean|651.4|651.4|Standard Deviation|197.7|197.7|||
3869949|NCT01588496|3695078|B3|Part B||Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Concentration|Data are provided for the full analysis set|ng/mL|Mean|640.3|640.3|Standard Deviation|207.5|207.5|||
3869950|NCT01588496|3695079|B2|Part B||Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Concentration|Data are provided for the full analysis set|ng/mL|Mean|674.2|674.2|Standard Deviation|180.0|180.0|||
3869951|NCT01588496|3695080|B1|Part B||Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Concentration|Data are provided for the full analysis set|ng/mL|Mean|NA||Standard Deviation|NA||||Not applicable for Part A participants
3869952|NCT01588496|3695077|B4|Part A||Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Concentration|Data are provided for the full analysis set|ng/mL|Mean|598.6|598.6|Standard Deviation|121.1|121.1|||
3869953|NCT01588496|3695078|B3|Part A||Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Concentration|Data are provided for the full analysis set|ng/mL|Mean|NA||Standard Deviation|NA||||Not applicable for Part B participants
3869954|NCT01588496|3695079|B2|Part A||Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Concentration|Data are provided for the full analysis set|ng/mL|Mean|NA||Standard Deviation|NA||||Not applicable for Part B participants
3869955|NCT01588496|3695080|B1|Part A||Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Concentration|Data are provided for the full analysis set|ng/mL|Mean|598.6|598.6|Standard Deviation|121.1|121.1|||
3869956|NCT01588496|3695077|B4|Part B||Lipoprotein(a) Concentration||nmol/L|Median|100.5|100.5|Inter-Quartile Range|||31.0|146.0|
3869957|NCT01588496|3695078|B3|Part B||Lipoprotein(a) Concentration||nmol/L|Median|76.0|76.0|Inter-Quartile Range|||25.5|145.0|
3869958|NCT01588496|3695079|B2|Part B||Lipoprotein(a) Concentration||nmol/L|Median|127.5|127.5|Inter-Quartile Range|||79.5|200.5|
3869959|NCT01588496|3695080|B1|Part B||Lipoprotein(a) Concentration||nmol/L|Median|NA||Inter-Quartile Range|||0.0|0.0|Not applicable for Part A participants
3869960|NCT01588496|3695077|B4|Part A||Lipoprotein(a) Concentration||nmol/L|Median|246.5|246.5|Inter-Quartile Range|||61.5|276.0|
3869961|NCT01588496|3695078|B3|Part A||Lipoprotein(a) Concentration||nmol/L|Median|NA||Inter-Quartile Range|||0.0|0.0|Not applicable for Part B participants
3869962|NCT01588496|3695079|B2|Part A||Lipoprotein(a) Concentration||nmol/L|Median|NA||Inter-Quartile Range|||0.0|0.0|Not applicable for Part B participants
3869963|NCT01588496|3695080|B1|Part A||Lipoprotein(a) Concentration||nmol/L|Median|246.5|246.5|Inter-Quartile Range|||61.5|276.0|
3869964|NCT01588496|3695077|B4|Part B||Apolipoprotein B/Apolipoprotein A1 Ratio|Data are provided for the full analysis set|ratio|Mean|2.084|2.084|Standard Deviation|1.011|1.011|||
3869965|NCT01588496|3695078|B3|Part B||Apolipoprotein B/Apolipoprotein A1 Ratio|Data are provided for the full analysis set|ratio|Mean|2.098|2.098|Standard Deviation|1.046|1.046|||
3869966|NCT01588496|3695079|B2|Part B||Apolipoprotein B/Apolipoprotein A1 Ratio|Data are provided for the full analysis set|ratio|Mean|2.053|2.053|Standard Deviation|0.967|0.967|||
3869967|NCT01588496|3695080|B1|Part B||Apolipoprotein B/Apolipoprotein A1 Ratio|Data are provided for the full analysis set|ratio|Mean|NA||Standard Deviation|NA||||Not applicable for Part A participants
3869968|NCT01588496|3695077|B4|Part A||Apolipoprotein B/Apolipoprotein A1 Ratio|Data are provided for the full analysis set|ratio|Mean|2.800|2.8|Standard Deviation|0.729|0.729|||
3869969|NCT01588496|3695078|B3|Part A||Apolipoprotein B/Apolipoprotein A1 Ratio|Data are provided for the full analysis set|ratio|Mean|NA||Standard Deviation|NA||||Not applicable for Part B participants
3869970|NCT01588496|3695079|B2|Part A||Apolipoprotein B/Apolipoprotein A1 Ratio|Data are provided for the full analysis set|ratio|Mean|NA||Standard Deviation|NA||||Not applicable for Part B participants
3869971|NCT01588496|3695080|B1|Part A||Apolipoprotein B/Apolipoprotein A1 Ratio|Data are provided for the full analysis set|ratio|Mean|2.800|2.8|Standard Deviation|0.729|0.729|||
3869972|NCT01588496|3695077|B4|Part B||Total Cholesterol/HDL-C Ratio|Data are provided for the full analysis set|ratio|Mean|12.014|12.014|Standard Deviation|6.395|6.395|||
3869973|NCT01588496|3695078|B3|Part B||Total Cholesterol/HDL-C Ratio|Data are provided for the full analysis set|ratio|Mean|11.972|11.972|Standard Deviation|6.387|6.387|||
3869974|NCT01588496|3695079|B2|Part B||Total Cholesterol/HDL-C Ratio|Data are provided for the full analysis set|ratio|Mean|12.101|12.101|Standard Deviation|6.619|6.619|||
3869975|NCT01588496|3695080|B1|Part B||Total Cholesterol/HDL-C Ratio|Data are provided for the full analysis set|ratio|Mean|NA||Standard Deviation|NA||||Not applicable for Part A participants
3869976|NCT01588496|3695077|B4|Part A||Total Cholesterol/HDL-C Ratio|Data are provided for the full analysis set|ratio|Mean|15.988|15.988|Standard Deviation|5.107|5.107|||
3869977|NCT01588496|3695078|B3|Part A||Total Cholesterol/HDL-C Ratio|Data are provided for the full analysis set|ratio|Mean|NA||Standard Deviation|NA||||Not applicable for Part B participants
3869978|NCT01588496|3695079|B2|Part A||Total Cholesterol/HDL-C Ratio|Data are provided for the full analysis set|ratio|Mean|NA||Standard Deviation|NA||||Not applicable for Part B participants
3869979|NCT01588496|3695080|B1|Part A||Total Cholesterol/HDL-C Ratio|Data are provided for the full analysis set|ratio|Mean|15.988|15.988|Standard Deviation|5.107|5.107|||
3869980|NCT01588496|3695077|B4|Part B||Apolipoprotein B Concentration|Data are provided for the full analysis set|mg/dL|Mean|208.4|208.4|Standard Deviation|71.4|71.4|||
3869981|NCT01588496|3695078|B3|Part B||Apolipoprotein B Concentration|Data are provided for the full analysis set|mg/dL|Mean|208.3|208.3|Standard Deviation|68.4|68.4|||
3869982|NCT01588496|3695079|B2|Part B||Apolipoprotein B Concentration|Data are provided for the full analysis set|mg/dL|Mean|208.6|208.6|Standard Deviation|79.5|79.5|||
3869983|NCT01588496|3695080|B1|Part B||Apolipoprotein B Concentration|Data are provided for the full analysis set|mg/dL|Mean|NA||Standard Deviation|NA||||Not applicable for Part A participants
3869984|NCT01588496|3695077|B4|Part A||Apolipoprotein B Concentration|Data are provided for the full analysis set|mg/dL|Mean|269.1|269.1|Standard Deviation|53.0|53.0|||
3869985|NCT01588496|3695078|B3|Part A||Apolipoprotein B Concentration|Data are provided for the full analysis set|mg/dL|Mean|NA||Standard Deviation|NA||||Not applicable for Part B participants
3869986|NCT01588496|3695079|B2|Part A||Apolipoprotein B Concentration|Data are provided for the full analysis set|mg/dL|Mean|NA||Standard Deviation|NA||||Not applicable for Part B participants
3869987|NCT01588496|3695080|B1|Part A||Apolipoprotein B Concentration|Data are provided for the full analysis set|mg/dL|Mean|269.1|269.1|Standard Deviation|53.0|53.0|||
3869988|NCT01588496|3695077|B4|Part B||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration|Data are provided for the full analysis set|mg/dL|Mean|369.7|369.7|Standard Deviation|139.6|139.6|||
3869989|NCT01588496|3695078|B3|Part B||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration|Data are provided for the full analysis set|mg/dL|Mean|374.9|374.9|Standard Deviation|136.9|136.9|||
3869990|NCT01588496|3695079|B2|Part B||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration|Data are provided for the full analysis set|mg/dL|Mean|358.9|358.9|Standard Deviation|149.1|149.1|||
3869991|NCT01588496|3695080|B1|Part B||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration|Data are provided for the full analysis set|mg/dL|Mean|NA||Standard Deviation|NA||||Not applicable for Part A participants
3869992|NCT01588496|3695077|B4|Part A||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration|Data are provided for the full analysis set|mg/dL|Mean|470.6|470.6|Standard Deviation|117.8|117.8|||
3869993|NCT01588496|3695078|B3|Part A||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration|Data are provided for the full analysis set|mg/dL|Mean|NA||Standard Deviation|NA||||Not applicable for Part B participants
3869994|NCT01588496|3695079|B2|Part A||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration|Data are provided for the full analysis set|mg/dL|Mean|NA||Standard Deviation|NA||||Not applicable for Part B participants
3869995|NCT01588496|3695080|B1|Part A||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration|Data are provided for the full analysis set|mg/dL|Mean|470.6|470.6|Standard Deviation|117.8|117.8|||
3869996|NCT01588496|3695077|B4|Part B||LDL-C Concentration|LDL-C was quantified using the ultracentrifugation method. Data are provided for the full analysis set (all enrolled participants who received at least 1 dose of evolocumab (Part A) or all randomized participants who received at least 1 dose of investigational product (Part B).|mg/dL|Mean|349.4|349.4|Standard Deviation|137.2|137.2|||
3869997|NCT01588496|3695078|B3|Part B||LDL-C Concentration|LDL-C was quantified using the ultracentrifugation method. Data are provided for the full analysis set (all enrolled participants who received at least 1 dose of evolocumab (Part A) or all randomized participants who received at least 1 dose of investigational product (Part B).|mg/dL|Mean|356.0|356.0|Standard Deviation|134.5|134.5|||
3869998|NCT01588496|3695079|B2|Part B||LDL-C Concentration|LDL-C was quantified using the ultracentrifugation method. Data are provided for the full analysis set (all enrolled participants who received at least 1 dose of evolocumab (Part A) or all randomized participants who received at least 1 dose of investigational product (Part B).|mg/dL|Mean|335.8|335.8|Standard Deviation|146.0|146.0|||
3869999|NCT01588496|3695080|B1|Part B||LDL-C Concentration|LDL-C was quantified using the ultracentrifugation method. Data are provided for the full analysis set (all enrolled participants who received at least 1 dose of evolocumab (Part A) or all randomized participants who received at least 1 dose of investigational product (Part B).|mg/dL|Mean|NA||Standard Deviation|NA||||Not applicable for Part A participants
3870000|NCT01588496|3695077|B4|Part A||LDL-C Concentration|LDL-C was quantified using the ultracentrifugation method. Data are provided for the full analysis set (all enrolled participants who received at least 1 dose of evolocumab (Part A) or all randomized participants who received at least 1 dose of investigational product (Part B).|mg/dL|Mean|441.7|441.7|Standard Deviation|113.3|113.3|||
3870001|NCT01588496|3695078|B3|Part A||LDL-C Concentration|LDL-C was quantified using the ultracentrifugation method. Data are provided for the full analysis set (all enrolled participants who received at least 1 dose of evolocumab (Part A) or all randomized participants who received at least 1 dose of investigational product (Part B).|mg/dL|Mean|NA||Standard Deviation|NA||||Not applicable for Part B participants
3870002|NCT01588496|3695079|B2|Part A||LDL-C Concentration|LDL-C was quantified using the ultracentrifugation method. Data are provided for the full analysis set (all enrolled participants who received at least 1 dose of evolocumab (Part A) or all randomized participants who received at least 1 dose of investigational product (Part B).|mg/dL|Mean|NA||Standard Deviation|NA||||Not applicable for Part B participants
3870003|NCT01588496|3695080|B1|Part A||LDL-C Concentration|LDL-C was quantified using the ultracentrifugation method. Data are provided for the full analysis set (all enrolled participants who received at least 1 dose of evolocumab (Part A) or all randomized participants who received at least 1 dose of investigational product (Part B).|mg/dL|Mean|441.7|441.7|Standard Deviation|113.3|113.3|||
3870004|NCT01588496|3695077|B4|Missing||Stratification Factor: Low-Density Lipoprotein Cholesterol (LDL-C) Level|Participants in Part A were not stratified based on LDL-C level.|participants|Number|8|8.0||||||
3870005|NCT01588496|3695078|B3|Missing||Stratification Factor: Low-Density Lipoprotein Cholesterol (LDL-C) Level|Participants in Part A were not stratified based on LDL-C level.|participants|Number|0|0.0||||||
3870006|NCT01588496|3695079|B2|Missing||Stratification Factor: Low-Density Lipoprotein Cholesterol (LDL-C) Level|Participants in Part A were not stratified based on LDL-C level.|participants|Number|0|0.0||||||
3870007|NCT01588496|3695080|B1|Missing||Stratification Factor: Low-Density Lipoprotein Cholesterol (LDL-C) Level|Participants in Part A were not stratified based on LDL-C level.|participants|Number|8|8.0||||||
3870008|NCT01588496|3695077|B4|≥ 420 mg/dL||Stratification Factor: Low-Density Lipoprotein Cholesterol (LDL-C) Level|Participants in Part A were not stratified based on LDL-C level.|participants|Number|18|18.0||||||
3870009|NCT01588496|3695078|B3|≥ 420 mg/dL||Stratification Factor: Low-Density Lipoprotein Cholesterol (LDL-C) Level|Participants in Part A were not stratified based on LDL-C level.|participants|Number|12|12.0||||||
3870010|NCT01588496|3695079|B2|≥ 420 mg/dL||Stratification Factor: Low-Density Lipoprotein Cholesterol (LDL-C) Level|Participants in Part A were not stratified based on LDL-C level.|participants|Number|6|6.0||||||
3870011|NCT01588496|3695080|B1|≥ 420 mg/dL||Stratification Factor: Low-Density Lipoprotein Cholesterol (LDL-C) Level|Participants in Part A were not stratified based on LDL-C level.|participants|Number|0|0.0||||||
3870012|NCT01588496|3695077|B4|< 420 mg/dL||Stratification Factor: Low-Density Lipoprotein Cholesterol (LDL-C) Level|Participants in Part A were not stratified based on LDL-C level.|participants|Number|32|32.0||||||
3870013|NCT01588496|3695078|B3|< 420 mg/dL||Stratification Factor: Low-Density Lipoprotein Cholesterol (LDL-C) Level|Participants in Part A were not stratified based on LDL-C level.|participants|Number|21|21.0||||||
3870014|NCT01588496|3695079|B2|< 420 mg/dL||Stratification Factor: Low-Density Lipoprotein Cholesterol (LDL-C) Level|Participants in Part A were not stratified based on LDL-C level.|participants|Number|11|11.0||||||
3870015|NCT01588496|3695080|B1|< 420 mg/dL||Stratification Factor: Low-Density Lipoprotein Cholesterol (LDL-C) Level|Participants in Part A were not stratified based on LDL-C level.|participants|Number|0|0.0||||||
3870016|NCT01588496|3695077|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
3870017|NCT01588496|3695078|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3870018|NCT01588496|3695079|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3870019|NCT01588496|3695080|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3870020|NCT01588496|3695077|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3870021|NCT01588496|3695078|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3870022|NCT01588496|3695079|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3870023|NCT01588496|3695080|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3870024|NCT01588496|3695077|B4|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3870025|NCT01588496|3695078|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3870026|NCT01588496|3695079|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3870027|NCT01588496|3695080|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3870028|NCT01588496|3695077|B4|White||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
3870029|NCT01588496|3695078|B3|White||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3870030|NCT01588496|3695079|B2|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3870031|NCT01588496|3695080|B1|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3870032|NCT01588496|3695077|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3870033|NCT01588496|3695078|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3870034|NCT01588496|3695079|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3870035|NCT01588496|3695080|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3870036|NCT01588496|3695077|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3870037|NCT01588496|3695078|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3870038|NCT01588496|3695079|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3870039|NCT01588496|3695080|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3870040|NCT01588496|3695077|B4|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3870041|NCT01588496|3695078|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3870042|NCT01588496|3695079|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3870043|NCT01588496|3695080|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3870044|NCT01588496|3695077|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3870045|NCT01588496|3695078|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3870046|NCT01588496|3695079|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3870047|NCT01588496|3695080|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3870048|NCT01588496|3695077|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3870049|NCT01588496|3695078|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3870050|NCT01588496|3695079|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3870051|NCT01588496|3695080|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3870052|NCT01588496|3695077|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3870053|NCT01588496|3695078|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3870054|NCT01588496|3695079|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3870055|NCT01588496|3695080|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3870056|NCT01588496|3695077|B4|||Age||years|Mean|31.6|31.6|Standard Deviation|12.7|12.7|||
3870057|NCT01588496|3695078|B3|||Age||years|Mean|30.3|30.3|Standard Deviation|12.4|12.4|||
3870058|NCT01588496|3695079|B2|||Age||years|Mean|32.8|32.8|Standard Deviation|13.7|13.7|||
3870059|NCT01588496|3695080|B1|||Age||years|Mean|34.3|34.3|Standard Deviation|12.4|12.4|||
3870060|NCT01588470|3695107|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3870061|NCT01588470|3695107|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3870062|NCT01588470|3695107|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3870063|NCT01588470|3695107|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3870064|NCT01588470|3695107|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3870065|NCT01588444|3695116|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3870066|NCT01588444|3695117|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3870067|NCT01588444|3695118|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3870068|NCT01588444|3695116|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3870069|NCT01588444|3695117|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3870070|NCT01588444|3695118|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3870071|NCT01588444|3695116|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3870072|NCT01588444|3695117|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3870073|NCT01588444|3695118|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3870074|NCT01588444|3695116|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3870075|NCT01588444|3695117|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3870076|NCT01588444|3695118|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3870077|NCT01588444|3695116|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3870078|NCT01588444|3695117|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3870079|NCT01588444|3695118|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3870080|NCT01588444|3695116|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3870081|NCT01588444|3695117|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3870082|NCT01588444|3695118|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3870083|NCT01588444|3695116|B3|||Age||years|Mean|54|54.0|Full Range|||27.0|79.0|
3870084|NCT01588444|3695117|B2|||Age||years|Mean|55.6|55.6|Full Range|||31.0|69.0|
3870085|NCT01588444|3695118|B1|||Age||years|Mean|53.4|53.4|Full Range|||27.0|79.0|
3870086|NCT01588418|3695125|B1|||2 hour plasma glucose concentration|glucose concentration at 2h during screening OGTT|mg/dl|Mean|177|177.0|Standard Deviation|11|11.0|||
3870087|NCT01588418|3695125|B1|||HbA1c||% of total hemoglobin|Mean|5.6|5.6|Standard Deviation|0.1|0.1|||
3870088|NCT01588418|3695125|B1|||Fasting plasma glucose||mg/dl|Mean|114|114.0|Standard Deviation|3|3.0|||
3870089|NCT01588418|3695125|B1|||BMI (Body Mass Index)||kg/m^2|Mean|29|29.0|Standard Deviation|3|3.0|||
3870090|NCT01588418|3695125|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3870091|NCT01588418|3695125|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3870092|NCT01588418|3695125|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3870093|NCT01588418|3695125|B1|||Age||years|Mean|57|57.0|Standard Deviation|6|6.0|||
3870094|NCT01588418|3695125|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3870095|NCT01588418|3695125|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3870096|NCT01588418|3695125|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3870097|NCT01588405|3695132|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870098|NCT01588405|3695132|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870099|NCT01588405|3695132|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3870100|NCT01588405|3695132|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3870101|NCT01588405|3695132|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3870102|NCT01588405|3695132|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3870103|NCT01588405|3695132|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3870104|NCT01588405|3695132|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3870105|NCT01588405|3695132|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3870106|NCT01588405|3695132|B1|||Age||years|Median|50.0|50.0|Full Range|||18.0|80.0|
3870107|NCT01588353|3695156|B4|Japan||Region of Enrollment||participants|Number|102|102.0||||||
3870108|NCT01588353|3695157|B3|Japan||Region of Enrollment||participants|Number|25|25.0||||||
3870109|NCT01588353|3695158|B2|Japan||Region of Enrollment||participants|Number|71|71.0||||||
3870110|NCT01588353|3695159|B1|Japan||Region of Enrollment||participants|Number|6|6.0||||||
3870111|NCT01588353|3695156|B4||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3870112|NCT01588353|3695157|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3870113|NCT01588353|3695158|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3870114|NCT01588353|3695159|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3870115|NCT01588353|3695156|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3870116|NCT01588353|3695157|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3870117|NCT01588353|3695158|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3870118|NCT01588353|3695159|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3870119|NCT01588353|3695156|B4|||Age||years|Mean|68.7|68.7|Standard Deviation|8.0|8.0|||
3870120|NCT01588353|3695157|B3|||Age||years|Mean|71|71.0|Standard Deviation|5.9|5.9|||
3870121|NCT01588353|3695158|B2|||Age||years|Mean|68|68.0|Standard Deviation|8.4|8.4|||
3870122|NCT01588353|3695159|B1|||Age||years|Mean|69|69.0|Standard Deviation|8.3|8.3|||
3870123|NCT01588353|3695156|B4||>=65 years|Age||Participants|Count of Participants|76|76.0||||||
3870124|NCT01588353|3695157|B3||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3870125|NCT01588353|3695158|B2||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
3870126|NCT01588353|3695159|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3870127|NCT01588353|3695156|B4||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3870128|NCT01588353|3695157|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3870129|NCT01588353|3695158|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3870130|NCT01588353|3695159|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3870131|NCT01588353|3695156|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3870132|NCT01588353|3695157|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3870133|NCT01588353|3695158|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3870134|NCT01588353|3695159|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3870135|NCT01588158|3695177|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
3870136|NCT01588158|3695178|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3870137|NCT01588158|3695179|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3870138|NCT01588158|3695177|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3870139|NCT01588158|3695178|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3870140|NCT01588158|3695179|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3870141|NCT01588158|3695177|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3870142|NCT01588158|3695178|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3870143|NCT01588158|3695179|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3870144|NCT01588158|3695177|B3|||Age||years|Mean|57.9|57.9|Standard Deviation|11.8|11.8|||
3870145|NCT01588158|3695178|B2|||Age||years|Mean|50|50.0|Standard Deviation|13.1|13.1|||
3870146|NCT01588158|3695179|B1|||Age||years|Mean|63.8|63.8|Standard Deviation|7.5|7.5|||
3870147|NCT01588158|3695177|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3870148|NCT01588158|3695178|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3870149|NCT01588158|3695179|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3870150|NCT01588158|3695177|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3870151|NCT01588158|3695178|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3870152|NCT01588158|3695179|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3870153|NCT01588158|3695177|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3870154|NCT01588158|3695178|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3870155|NCT01588158|3695179|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3870156|NCT01588106|3695202|B3|||HbA1c value at baseline||%|Mean|8.54|8.54|Standard Deviation|0.96|0.96|||
3870157|NCT01588106|3695203|B2|||HbA1c value at baseline||%|Mean|8.47|8.47|Standard Deviation|0.97|0.97|||
3870158|NCT01588106|3695204|B1|||HbA1c value at baseline||%|Mean|8.61|8.61|Standard Deviation|0.95|0.95|||
3870159|NCT01588106|3695202|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3870160|NCT01588106|3695203|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3870161|NCT01588106|3695204|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3870162|NCT01588106|3695202|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3870163|NCT01588106|3695203|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3870164|NCT01588106|3695204|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3870165|NCT01588106|3695202|B3|||Age||Years|Mean|63.87|63.87|Standard Deviation|9.83|9.83|||
3870166|NCT01588106|3695203|B2|||Age||Years|Mean|65.66|65.66|Standard Deviation|9.08|9.08|||
3870167|NCT01588106|3695204|B1|||Age||Years|Mean|62.10|62.1|Standard Deviation|10.28|10.28|||
3870168|NCT01587989|3695211|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3870169|NCT01587989|3695212|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3870170|NCT01587989|3695213|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3870171|NCT01587989|3695211|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3870172|NCT01587989|3695212|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3870173|NCT01587989|3695213|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3870174|NCT01587989|3695211|B3|||Age||years|Mean|57.46|57.46|Standard Deviation|11.28|11.28|||
3870175|NCT01587989|3695212|B2|||Age||years|Mean|57.15|57.15|Standard Deviation|10.83|10.83|||
3870176|NCT01587989|3695213|B1|||Age||years|Mean|57.78|57.78|Standard Deviation|11.88|11.88|||
3870177|NCT01587963|3695237|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3870178|NCT01587963|3695238|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3870179|NCT01587963|3695239|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3870180|NCT01587963|3695237|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870181|NCT01587963|3695238|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870182|NCT01587963|3695239|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870183|NCT01587963|3695237|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870184|NCT01587963|3695238|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870185|NCT01587963|3695239|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870186|NCT01587963|3695237|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3870187|NCT01587963|3695238|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3870188|NCT01587963|3695239|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3870189|NCT01587963|3695237|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3870190|NCT01587963|3695238|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870191|NCT01587963|3695239|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3870192|NCT01587963|3695237|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870193|NCT01587963|3695238|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870194|NCT01587963|3695239|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870195|NCT01587963|3695237|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870196|NCT01587963|3695238|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870197|NCT01587963|3695239|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870198|NCT01587963|3695237|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870199|NCT01587963|3695238|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870200|NCT01587963|3695239|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870201|NCT01587963|3695237|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870202|NCT01587963|3695238|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870203|NCT01587963|3695239|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870204|NCT01587963|3695237|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3870205|NCT01587963|3695238|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3870206|NCT01587963|3695239|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3870207|NCT01587963|3695237|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3870208|NCT01587963|3695238|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3870209|NCT01587963|3695239|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870210|NCT01587963|3695237|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3870211|NCT01587963|3695238|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3870212|NCT01587963|3695239|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3870213|NCT01587963|3695237|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3870214|NCT01587963|3695238|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3870215|NCT01587963|3695239|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3870216|NCT01587963|3695237|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3870217|NCT01587963|3695238|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3870218|NCT01587963|3695239|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3870219|NCT01587963|3695237|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3870220|NCT01587963|3695238|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3870221|NCT01587963|3695239|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3870222|NCT01587963|3695237|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3870223|NCT01587963|3695238|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3870224|NCT01587963|3695239|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3870225|NCT01587950|3695246|B1|United States||Region of Enrollment||Participants|Number|12|12.0||||||
3870226|NCT01587950|3695246|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3870227|NCT01587950|3695246|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3870228|NCT01587950|3695246|B1|||Age||Years|Mean|39.0|39.0|Standard Deviation|13.65|13.65|||
3870229|NCT01587924|3695276|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870230|NCT01587924|3695277|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870231|NCT01587924|3695278|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870232|NCT01587924|3695279|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870233|NCT01587924|3695280|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870234|NCT01587924|3695276|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3870235|NCT01587924|3695277|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3870236|NCT01587924|3695278|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870237|NCT01587924|3695279|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870238|NCT01587924|3695280|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870239|NCT01587924|3695276|B5||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3870240|NCT01587924|3695277|B4||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3870241|NCT01587924|3695278|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3870242|NCT01587924|3695279|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3870243|NCT01587924|3695280|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3870244|NCT01587924|3695276|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3870245|NCT01587924|3695277|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3870246|NCT01587924|3695278|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3870247|NCT01587924|3695279|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3870248|NCT01587924|3695280|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3870249|NCT01587924|3695276|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870250|NCT01587924|3695277|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870251|NCT01587924|3695278|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870252|NCT01587924|3695279|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870444|NCT01587274|3695612|B1|||Age||years|Mean|39|39.0|Standard Deviation|11|11.0|||
3870253|NCT01587924|3695280|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870254|NCT01587924|3695276|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3870255|NCT01587924|3695277|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870256|NCT01587924|3695278|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3870257|NCT01587924|3695279|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3870258|NCT01587924|3695280|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870259|NCT01587924|3695276|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3870260|NCT01587924|3695277|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870261|NCT01587924|3695278|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3870262|NCT01587924|3695279|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870263|NCT01587924|3695280|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870264|NCT01587924|3695276|B5||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3870265|NCT01587924|3695277|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3870266|NCT01587924|3695278|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3870267|NCT01587924|3695279|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3870268|NCT01587924|3695280|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3870269|NCT01587924|3695276|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3870270|NCT01587924|3695277|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3870271|NCT01587924|3695278|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3870272|NCT01587924|3695279|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3870273|NCT01587924|3695280|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3870274|NCT01587924|3695276|B5|||Age||Years|Mean|57.8|57.8|Standard Deviation|16.92|16.92|||
3870275|NCT01587924|3695277|B4|||Age||Years|Mean|64.2|64.2|Standard Deviation|12.77|12.77|||
3870276|NCT01587924|3695278|B3|||Age||Years|Mean|55.9|55.9|Standard Deviation|18.37|18.37|||
3870277|NCT01587924|3695279|B2|||Age||Years|Mean|54.7|54.7|Standard Deviation|18.78|18.78|||
3870278|NCT01587924|3695280|B1|||Age||Years|Mean|56.4|56.4|Standard Deviation|16.80|16.8|||
3870279|NCT01587898|3695380|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870280|NCT01587898|3695381|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870281|NCT01587898|3695382|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870282|NCT01587898|3695383|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870283|NCT01587898|3695384|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870284|NCT01587898|3695380|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3870285|NCT01587898|3695381|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3870286|NCT01587898|3695382|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3870287|NCT01587898|3695383|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3870288|NCT01587898|3695384|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3870289|NCT01587898|3695380|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3870290|NCT01587898|3695381|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3870291|NCT01587898|3695382|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3870292|NCT01587898|3695383|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3870293|NCT01587898|3695384|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3870294|NCT01587898|3695380|B5||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3870295|NCT01587898|3695381|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3870296|NCT01587898|3695382|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3870297|NCT01587898|3695383|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3870298|NCT01587898|3695384|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3870299|NCT01587898|3695380|B5||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3870300|NCT01587898|3695381|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3870301|NCT01587898|3695382|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3870302|NCT01587898|3695383|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3870303|NCT01587898|3695384|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3870304|NCT01587898|3695380|B5|||Age||Years|Mean|68.6|68.6|Standard Deviation|11.28|11.28|||
3870305|NCT01587898|3695381|B4|||Age||Years|Mean|71.3|71.3|Standard Deviation|11.26|11.26|||
3870306|NCT01587898|3695382|B3|||Age||Years|Mean|66.9|66.9|Standard Deviation|11.45|11.45|||
3870307|NCT01587898|3695383|B2|||Age||Years|Mean|66.6|66.6|Standard Deviation|11.73|11.73|||
3870308|NCT01587898|3695384|B1|||Age||Years|Mean|69.2|69.2|Standard Deviation|11.00|11.0|||
3870309|NCT01587885|3695563|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3870310|NCT01587885|3695563|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3870311|NCT01587885|3695563|B1|||Age||years|Mean|48.3|48.3|Standard Deviation|12.57|12.57|||
3870312|NCT01587651|3695577|B4|Unknown||body mass index category|body mass index <30 kg/m^2 or >= 30 kg/m^2 sum of categories does not equal number of participants due to missing data for 1 subject|participants|Number|1|1.0||||||
3870313|NCT01587651|3695578|B3|Unknown||body mass index category|body mass index <30 kg/m^2 or >= 30 kg/m^2 sum of categories does not equal number of participants due to missing data for 1 subject|participants|Number|0|0.0||||||
3870314|NCT01587651|3695579|B2|Unknown||body mass index category|body mass index <30 kg/m^2 or >= 30 kg/m^2 sum of categories does not equal number of participants due to missing data for 1 subject|participants|Number|1|1.0||||||
3870315|NCT01587651|3695580|B1|Unknown||body mass index category|body mass index <30 kg/m^2 or >= 30 kg/m^2 sum of categories does not equal number of participants due to missing data for 1 subject|participants|Number|0|0.0||||||
3870316|NCT01587651|3695577|B4|>= 30 kg/m^2||body mass index category|body mass index <30 kg/m^2 or >= 30 kg/m^2 sum of categories does not equal number of participants due to missing data for 1 subject|participants|Number|56|56.0||||||
3870317|NCT01587651|3695578|B3|>= 30 kg/m^2||body mass index category|body mass index <30 kg/m^2 or >= 30 kg/m^2 sum of categories does not equal number of participants due to missing data for 1 subject|participants|Number|11|11.0||||||
3870318|NCT01587651|3695579|B2|>= 30 kg/m^2||body mass index category|body mass index <30 kg/m^2 or >= 30 kg/m^2 sum of categories does not equal number of participants due to missing data for 1 subject|participants|Number|24|24.0||||||
3870319|NCT01587651|3695580|B1|>= 30 kg/m^2||body mass index category|body mass index <30 kg/m^2 or >= 30 kg/m^2 sum of categories does not equal number of participants due to missing data for 1 subject|participants|Number|21|21.0||||||
3870320|NCT01587651|3695577|B4|< 30 kg/m^2||body mass index category|body mass index <30 kg/m^2 or >= 30 kg/m^2 sum of categories does not equal number of participants due to missing data for 1 subject|participants|Number|53|53.0||||||
3870321|NCT01587651|3695578|B3|< 30 kg/m^2||body mass index category|body mass index <30 kg/m^2 or >= 30 kg/m^2 sum of categories does not equal number of participants due to missing data for 1 subject|participants|Number|24|24.0||||||
3870322|NCT01587651|3695579|B2|< 30 kg/m^2||body mass index category|body mass index <30 kg/m^2 or >= 30 kg/m^2 sum of categories does not equal number of participants due to missing data for 1 subject|participants|Number|16|16.0||||||
3870323|NCT01587651|3695580|B1|< 30 kg/m^2||body mass index category|body mass index <30 kg/m^2 or >= 30 kg/m^2 sum of categories does not equal number of participants due to missing data for 1 subject|participants|Number|13|13.0||||||
3870324|NCT01587651|3695577|B4|||peripheral artery disease history|number of participants with peripheral artery disease (PAD) sum of categories does not equal number of participants due to not all participants having this specific medical condition|participants|Number|5|5.0||||||
3870325|NCT01587651|3695578|B3|||peripheral artery disease history|number of participants with peripheral artery disease (PAD) sum of categories does not equal number of participants due to not all participants having this specific medical condition|participants|Number|2|2.0||||||
3870326|NCT01587651|3695579|B2|||peripheral artery disease history|number of participants with peripheral artery disease (PAD) sum of categories does not equal number of participants due to not all participants having this specific medical condition|participants|Number|1|1.0||||||
3870327|NCT01587651|3695580|B1|||peripheral artery disease history|number of participants with peripheral artery disease (PAD) sum of categories does not equal number of participants due to not all participants having this specific medical condition|participants|Number|2|2.0||||||
3870328|NCT01587651|3695577|B4|||hyperlipidemia history|number of participants with hyperlipidemia sum of categories does not equal number of participants due to not all participants having this specific medical condition|participants|Number|98|98.0||||||
3870329|NCT01587651|3695578|B3|||hyperlipidemia history|number of participants with hyperlipidemia sum of categories does not equal number of participants due to not all participants having this specific medical condition|participants|Number|31|31.0||||||
3870330|NCT01587651|3695579|B2|||hyperlipidemia history|number of participants with hyperlipidemia sum of categories does not equal number of participants due to not all participants having this specific medical condition|participants|Number|35|35.0||||||
3870331|NCT01587651|3695580|B1|||hyperlipidemia history|number of participants with hyperlipidemia sum of categories does not equal number of participants due to not all participants having this specific medical condition|participants|Number|32|32.0||||||
3870332|NCT01587651|3695577|B4|||hypertension history|number of participants with hypertension susum of categories does not equal number of participants due to not all participants having this specific medical condition|participants|Number|79|79.0||||||
3870333|NCT01587651|3695578|B3|||hypertension history|number of participants with hypertension susum of categories does not equal number of participants due to not all participants having this specific medical condition|participants|Number|24|24.0||||||
3870334|NCT01587651|3695579|B2|||hypertension history|number of participants with hypertension susum of categories does not equal number of participants due to not all participants having this specific medical condition|participants|Number|29|29.0||||||
3870335|NCT01587651|3695580|B1|||hypertension history|number of participants with hypertension susum of categories does not equal number of participants due to not all participants having this specific medical condition|participants|Number|26|26.0||||||
3870336|NCT01587651|3695577|B4|||diabetes mellitus history|number of participants with diabetes mellitus sum of categories does not equal number of participants due to not all participants having this specific medical condition|participants|Number|31|31.0||||||
3870337|NCT01587651|3695578|B3|||diabetes mellitus history|number of participants with diabetes mellitus sum of categories does not equal number of participants due to not all participants having this specific medical condition|participants|Number|5|5.0||||||
3870338|NCT01587651|3695579|B2|||diabetes mellitus history|number of participants with diabetes mellitus sum of categories does not equal number of participants due to not all participants having this specific medical condition|participants|Number|12|12.0||||||
3870339|NCT01587651|3695580|B1|||diabetes mellitus history|number of participants with diabetes mellitus sum of categories does not equal number of participants due to not all participants having this specific medical condition|participants|Number|14|14.0||||||
3870340|NCT01587651|3695577|B4|||body mass index||kg/m^2|Mean|31.6|31.6|Standard Deviation|5.77|5.77|||
3870341|NCT01587651|3695578|B3|||body mass index||kg/m^2|Mean|29.2|29.2|Standard Deviation|4.82|4.82|||
3870342|NCT01587651|3695579|B2|||body mass index||kg/m^2|Mean|32.3|32.3|Standard Deviation|5.92|5.92|||
3870343|NCT01587651|3695580|B1|||body mass index||kg/m^2|Mean|33.2|33.2|Standard Deviation|5.88|5.88|||
3870344|NCT01587651|3695577|B4|||height||cm|Mean|172.4|172.4|Standard Deviation|9.41|9.41|||
3870345|NCT01587651|3695578|B3|||height||cm|Mean|174.3|174.3|Standard Deviation|9.14|9.14|||
3870346|NCT01587651|3695579|B2|||height||cm|Mean|171.9|171.9|Standard Deviation|10.15|10.15|||
3870347|NCT01587651|3695580|B1|||height||cm|Mean|171.2|171.2|Standard Deviation|8.74|8.74|||
3870348|NCT01587651|3695577|B4|||weight||kg|Mean|94.0|94.0|Standard Deviation|18.77|18.77|||
3870349|NCT01587651|3695578|B3|||weight||kg|Mean|89.4|89.4|Standard Deviation|19.35|19.35|||
3870350|NCT01587651|3695579|B2|||weight||kg|Mean|95.4|95.4|Standard Deviation|18.85|18.85|||
3870351|NCT01587651|3695580|B1|||weight||kg|Mean|97.0|97.0|Standard Deviation|17.70|17.7|||
3870352|NCT01587651|3695577|B4|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
3870353|NCT01587651|3695578|B3|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3870354|NCT01587651|3695579|B2|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
3870355|NCT01587651|3695580|B1|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3870356|NCT01587651|3695577|B4|United States||Region of Enrollment||participants|Number|98|98.0||||||
3870357|NCT01587651|3695578|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
3870358|NCT01587651|3695579|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
3870359|NCT01587651|3695580|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3870360|NCT01587651|3695577|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870361|NCT01587651|3695578|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870362|NCT01587651|3695579|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870363|NCT01587651|3695580|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870364|NCT01587651|3695577|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3870365|NCT01587651|3695578|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3870366|NCT01587651|3695579|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870367|NCT01587651|3695580|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870368|NCT01587651|3695577|B4||White|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
3870369|NCT01587651|3695578|B3||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3870370|NCT01587651|3695579|B2||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3870371|NCT01587651|3695580|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3870372|NCT01587651|3695577|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3870373|NCT01587651|3695578|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3870374|NCT01587651|3695579|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3870375|NCT01587651|3695580|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3870376|NCT01587651|3695577|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870377|NCT01587651|3695578|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870378|NCT01587651|3695579|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870379|NCT01587651|3695580|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870380|NCT01587651|3695577|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3870381|NCT01587651|3695578|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870382|NCT01587651|3695579|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3870383|NCT01587651|3695580|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870384|NCT01587651|3695577|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3870385|NCT01587651|3695578|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870386|NCT01587651|3695579|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870387|NCT01587651|3695580|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3870388|NCT01587651|3695577|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3870389|NCT01587651|3695578|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3870390|NCT01587651|3695579|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3870391|NCT01587651|3695580|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870392|NCT01587651|3695577|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3870393|NCT01587651|3695578|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3870394|NCT01587651|3695579|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3870395|NCT01587651|3695580|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3870396|NCT01587651|3695577|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3870397|NCT01587651|3695578|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3870398|NCT01587651|3695579|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3870399|NCT01587651|3695580|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3870400|NCT01587651|3695577|B4||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3870401|NCT01587651|3695578|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3870402|NCT01587651|3695579|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3870403|NCT01587651|3695580|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3870404|NCT01587651|3695577|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3870405|NCT01587651|3695578|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3870406|NCT01587651|3695579|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3870407|NCT01587651|3695580|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3870408|NCT01587651|3695577|B4|||Age||years|Mean|59.2|59.2|Standard Deviation|8.62|8.62|||
3870409|NCT01587651|3695578|B3|||Age||years|Mean|61.5|61.5|Standard Deviation|6.87|6.87|||
3870410|NCT01587651|3695579|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|8.84|8.84|||
3870411|NCT01587651|3695580|B1|||Age||years|Mean|57.8|57.8|Standard Deviation|9.69|9.69|||
3870412|NCT01587651|3695577|B4||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
3870413|NCT01587651|3695578|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3870414|NCT01587651|3695579|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3870415|NCT01587651|3695580|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3870416|NCT01587651|3695577|B4||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
3870417|NCT01587651|3695578|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3870418|NCT01587651|3695579|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3870419|NCT01587651|3695580|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3870420|NCT01587651|3695577|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3870421|NCT01587651|3695578|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3870422|NCT01587651|3695579|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3870423|NCT01587651|3695580|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3870424|NCT01587274|3695609|B4|||Pre-existing functional impairment as measured by the Roland Morris Disability Questionnaire|"The Roland Morris Disability Questionnaire (RMDQ) is a 24 item instrument that evaluates the impact of low back pain on one's daily life. It is most sensitive for patients with mild to moderate disability due to acute, sub-acute or chronic low back pain. Each question can be answered as either a yes or no. The score ranges from 0 to 24 where a higher score reflects greater impairment and, therefore, worsening in the quality of life."|units on a scale|Median|20|20.0|Inter-Quartile Range|||17.0|21.0|
3870425|NCT01587274|3695610|B3|||Pre-existing functional impairment as measured by the Roland Morris Disability Questionnaire|"The Roland Morris Disability Questionnaire (RMDQ) is a 24 item instrument that evaluates the impact of low back pain on one's daily life. It is most sensitive for patients with mild to moderate disability due to acute, sub-acute or chronic low back pain. Each question can be answered as either a yes or no. The score ranges from 0 to 24 where a higher score reflects greater impairment and, therefore, worsening in the quality of life."|units on a scale|Median|20|20.0|Inter-Quartile Range|||17.0|21.0|
3870426|NCT01587274|3695611|B2|||Pre-existing functional impairment as measured by the Roland Morris Disability Questionnaire|"The Roland Morris Disability Questionnaire (RMDQ) is a 24 item instrument that evaluates the impact of low back pain on one's daily life. It is most sensitive for patients with mild to moderate disability due to acute, sub-acute or chronic low back pain. Each question can be answered as either a yes or no. The score ranges from 0 to 24 where a higher score reflects greater impairment and, therefore, worsening in the quality of life."|units on a scale|Median|19|19.0|Inter-Quartile Range|||17.0|21.0|
3870427|NCT01587274|3695612|B1|||Pre-existing functional impairment as measured by the Roland Morris Disability Questionnaire|"The Roland Morris Disability Questionnaire (RMDQ) is a 24 item instrument that evaluates the impact of low back pain on one's daily life. It is most sensitive for patients with mild to moderate disability due to acute, sub-acute or chronic low back pain. Each question can be answered as either a yes or no. The score ranges from 0 to 24 where a higher score reflects greater impairment and, therefore, worsening in the quality of life."|units on a scale|Median|20|20.0|Inter-Quartile Range|||17.0|22.0|
3870428|NCT01587274|3695609|B4|United States||Region of Enrollment||participants|Number|323|323.0||||||
3870429|NCT01587274|3695610|B3|United States||Region of Enrollment||participants|Number|107|107.0||||||
3870430|NCT01587274|3695611|B2|United States||Region of Enrollment||participants|Number|108|108.0||||||
3870431|NCT01587274|3695612|B1|United States||Region of Enrollment||participants|Number|108|108.0||||||
3870432|NCT01587274|3695609|B4|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3870433|NCT01587274|3695609|B4||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3870434|NCT01587274|3695610|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3870435|NCT01587274|3695611|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3870436|NCT01587274|3695612|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3870437|NCT01587274|3695609|B4||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3870438|NCT01587274|3695610|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3870439|NCT01587274|3695611|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3870440|NCT01587274|3695612|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3870441|NCT01587274|3695609|B4|||Age||years|Mean|39|39.0|Standard Deviation|11|11.0|||
3870442|NCT01587274|3695610|B3|||Age||years|Mean|39|39.0|Standard Deviation|11|11.0|||
3870443|NCT01587274|3695611|B2|||Age||years|Mean|38|38.0|Standard Deviation|11|11.0|||
3870445|NCT01587118|3695622|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3870446|NCT01587118|3695622|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870447|NCT01587118|3695622|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3870448|NCT01587118|3695622|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3870449|NCT01587118|3695622|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3870450|NCT01587118|3695622|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870451|NCT01587118|3695622|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870452|NCT01587118|3695622|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870453|NCT01587118|3695622|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3870454|NCT01587118|3695622|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3870455|NCT01587118|3695622|B1|||Age||years|Mean|48.3|48.3|Standard Deviation|11.9|11.9|||
3870456|NCT01587105|3695627|B3|United States||Region of Enrollment||participants|Number|331|331.0||||||
3870457|NCT01587105|3695628|B2|United States||Region of Enrollment||participants|Number|181|181.0||||||
3870458|NCT01587105|3695629|B1|United States||Region of Enrollment||participants|Number|150|150.0||||||
3870459|NCT01587105|3695627|B3||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3870460|NCT01587105|3695628|B2||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3870461|NCT01587105|3695629|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3870462|NCT01587105|3695627|B3||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3870463|NCT01587105|3695628|B2||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3870464|NCT01587105|3695629|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3870465|NCT01587105|3695627|B3|||Age||years|Mean|8.2|8.2|Standard Deviation|4.9|4.9|||
3870466|NCT01587105|3695628|B2|||Age||years|Mean|7.9|7.9|Standard Deviation|5.0|5.0|||
3870467|NCT01587105|3695629|B1|||Age||years|Mean|8.4|8.4|Standard Deviation|4.8|4.8|||
3870468|NCT01587105|3695627|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3870469|NCT01587105|3695628|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3870470|NCT01587105|3695629|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3870471|NCT01587105|3695627|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3870472|NCT01587105|3695628|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3870473|NCT01587105|3695629|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3870474|NCT01587105|3695627|B3||<=18 years|Age||Participants|Count of Participants|331|331.0||||||
3870475|NCT01587105|3695628|B2||<=18 years|Age||Participants|Count of Participants|181|181.0||||||
3870476|NCT01587105|3695629|B1||<=18 years|Age||Participants|Count of Participants|150|150.0||||||
3870477|NCT01587079|3695646|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||52.2|52.2|||
3870478|NCT01587079|3695646|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||47.8|47.8|||
3870479|NCT01587079|3695646|B1|Age, years||Age||years|Mean|62.8|62.8|Standard Deviation|8.6|8.6|||
3870480|NCT01587027|3695768|B3|||BMI = <=18-30 kg/m2||Participants|Number|16|16.0||||||
3870481|NCT01587027|3695769|B2|||BMI = <=18-30 kg/m2||Participants|Number|8|8.0||||||
3870482|NCT01587027|3695770|B1|||BMI = <=18-30 kg/m2||Participants|Number|8|8.0||||||
3870483|NCT01587027|3695768|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
3870484|NCT01587027|3695769|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3870485|NCT01587027|3695770|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3870486|NCT01587027|3695768|B3||Male|Gender||Participants|Count of Participants|8|8.0||||||
3870487|NCT01587027|3695769|B2||Male|Gender||Participants|Count of Participants|6|6.0||||||
3870488|NCT01587027|3695770|B1||Male|Gender||Participants|Count of Participants|2|2.0||||||
3870489|NCT01587027|3695768|B3||Female|Gender||Participants|Count of Participants|8|8.0||||||
3870490|NCT01587027|3695769|B2||Female|Gender||Participants|Count of Participants|2|2.0||||||
3870491|NCT01587027|3695770|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
3870492|NCT01587027|3695768|B3|||Age||years|Mean|25.125|25.125|Standard Deviation|3.96443|3.96443|||
3870493|NCT01587027|3695769|B2|||Age||years|Mean|25|25.0|Standard Deviation|3.16228|3.16228|||
3870494|NCT01587027|3695770|B1|||Age||years|Mean|25.60429|25.60429|Standard Deviation|5.12602|5.12602|||
3870495|NCT01587027|3695768|B3||>=65 years|Age|Age=between 18 and 40.|Participants|Count of Participants|0|0.0||||||
3870496|NCT01587027|3695769|B2||>=65 years|Age|Age=between 18 and 40.|Participants|Count of Participants|0|0.0||||||
3870497|NCT01587027|3695770|B1||>=65 years|Age|Age=between 18 and 40.|Participants|Count of Participants|0|0.0||||||
3870498|NCT01587027|3695768|B3||Between 18 and 65 years|Age|Age=between 18 and 40.|Participants|Count of Participants|16|16.0||||||
3870499|NCT01587027|3695769|B2||Between 18 and 65 years|Age|Age=between 18 and 40.|Participants|Count of Participants|8|8.0||||||
3870500|NCT01587027|3695770|B1||Between 18 and 65 years|Age|Age=between 18 and 40.|Participants|Count of Participants|8|8.0||||||
3870501|NCT01587027|3695768|B3||<=18 years|Age|Age=between 18 and 40.|Participants|Count of Participants|0|0.0||||||
3870502|NCT01587027|3695769|B2||<=18 years|Age|Age=between 18 and 40.|Participants|Count of Participants|0|0.0||||||
3870503|NCT01587027|3695770|B1||<=18 years|Age|Age=between 18 and 40.|Participants|Count of Participants|0|0.0||||||
3870504|NCT01587014|3695777|B1||Male|Gender||Participants|Count of Participants|17|17.0||||||
3870505|NCT01587014|3695777|B1||Female|Gender||Participants|Count of Participants|9|9.0||||||
3870506|NCT01587014|3695777|B1|||Age||years|Median|56|56.0|Full Range|||23.0|80.0|
3870507|NCT01587001|3695782|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
3870508|NCT01587001|3695783|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3870509|NCT01587001|3695784|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3870510|NCT01587001|3695782|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3870511|NCT01587001|3695783|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3870512|NCT01587001|3695784|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3870513|NCT01587001|3695782|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870514|NCT01587001|3695783|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870515|NCT01587001|3695784|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870516|NCT01587001|3695782|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870517|NCT01587001|3695783|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870518|NCT01587001|3695784|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870519|NCT01587001|3695782|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3870520|NCT01587001|3695783|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3870521|NCT01587001|3695784|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3870522|NCT01587001|3695782|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3870523|NCT01587001|3695783|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3870524|NCT01587001|3695784|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3870525|NCT01587001|3695782|B3|||Age||years|Mean|53|53.0|Standard Deviation|11|11.0|||
3870526|NCT01587001|3695783|B2|||Age||years|Mean|52|52.0|Standard Deviation|13|13.0|||
3870527|NCT01587001|3695784|B1|||Age||years|Mean|56|56.0|Standard Deviation|9|9.0|||
3870528|NCT01586975|3695793|B4|United States||Region of Enrollment||participants|Number|93|93.0||||||
3870529|NCT01586975|3695794|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
3870530|NCT01586975|3695795|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
3870531|NCT01586975|3695796|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3870532|NCT01586975|3695793|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3870533|NCT01586975|3695794|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870534|NCT01586975|3695795|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3870535|NCT01586975|3695796|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870536|NCT01586975|3695793|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870537|NCT01586975|3695794|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870538|NCT01586975|3695795|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870539|NCT01586975|3695796|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870540|NCT01586975|3695793|B4||White|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3870541|NCT01586975|3695794|B3||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3870542|NCT01586975|3695795|B2||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3870543|NCT01586975|3695796|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3870544|NCT01586975|3695793|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3870545|NCT01586975|3695794|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3870546|NCT01586975|3695795|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3870547|NCT01586975|3695796|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3870548|NCT01586975|3695793|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870549|NCT01586975|3695794|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870550|NCT01586975|3695795|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870551|NCT01586975|3695796|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870552|NCT01586975|3695793|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3870553|NCT01586975|3695794|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3870554|NCT01586975|3695795|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3870555|NCT01586975|3695796|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870556|NCT01586975|3695793|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870557|NCT01586975|3695794|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870558|NCT01586975|3695795|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870559|NCT01586975|3695796|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870560|NCT01586975|3695793|B4||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3870561|NCT01586975|3695794|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3870562|NCT01586975|3695795|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3870563|NCT01586975|3695796|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3870564|NCT01586975|3695793|B4||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3870565|NCT01586975|3695794|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3870566|NCT01586975|3695795|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3870567|NCT01586975|3695796|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3870568|NCT01586975|3695793|B4|||Age, Customized||years|Mean|60.7|60.7|Full Range|||21.0|93.0|
3870569|NCT01586975|3695794|B3|||Age, Customized||years|Mean|56.2|56.2|Full Range|||21.0|87.0|
3870570|NCT01586975|3695795|B2|||Age, Customized||years|Mean|67.4|67.4|Full Range|||36.0|93.0|
3870571|NCT01586975|3695796|B1|||Age, Customized||years|Mean|60.6|60.6|Full Range|||37.0|83.0|
3870572|NCT01586962|3695806|B1|Canada||Region of Enrollment||participants|Number|56|56.0||||||
3870573|NCT01586962|3695806|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3870574|NCT01586962|3695806|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3870575|NCT01586962|3695806|B1|||Age||years|Mean|32.8|32.8|Standard Deviation|12.61|12.61|||
3870576|NCT01586962|3695806|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3870577|NCT01586962|3695806|B1||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
3870578|NCT01586962|3695806|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3870579|NCT01586897|3695812|B3||Male|Sex: Female, Male||Participants|Count of Participants|1826|1826.0||||||
3870580|NCT01586897|3695813|B2||Male|Sex: Female, Male||Participants|Count of Participants|756|756.0||||||
3870581|NCT01586897|3695814|B1||Male|Sex: Female, Male||Participants|Count of Participants|1070|1070.0||||||
3870582|NCT01586897|3695812|B3||Female|Sex: Female, Male||Participants|Count of Participants|1829|1829.0||||||
3870583|NCT01586897|3695813|B2||Female|Sex: Female, Male||Participants|Count of Participants|850|850.0||||||
3870584|NCT01586897|3695814|B1||Female|Sex: Female, Male||Participants|Count of Participants|979|979.0||||||
3870585|NCT01586897|3695812|B3|||Age||years|Mean|65.8|65.8|Standard Deviation|13.0|13.0|||
3870586|NCT01586897|3695813|B2|||Age||years|Mean|65.7|65.7|Standard Deviation|12.8|12.8|||
3870587|NCT01586897|3695814|B1|||Age||years|Mean|65.9|65.9|Standard Deviation|13.1|13.1|||
3870588|NCT01586819|3695831|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3870589|NCT01586819|3695832|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3870590|NCT01586819|3695833|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3870591|NCT01586819|3695831|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3870592|NCT01586819|3695832|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3870593|NCT01586819|3695833|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3870594|NCT01586819|3695831|B3|||Age||Years|Mean|49.8|49.8|Standard Deviation|6.5|6.5|||
3870595|NCT01586819|3695832|B2|||Age||Years|Mean|51.9|51.9|Standard Deviation|7.1|7.1|||
3870596|NCT01586819|3695833|B1|||Age||Years|Mean|47.3|47.3|Standard Deviation|4.8|4.8|||
3870597|NCT01586806|3695842|B4|||Body Mass Index||kg/(m^2)|Mean|25|25.0|Standard Deviation|4|4.0|||
3870598|NCT01586806|3695843|B3|||Body Mass Index||kg/(m^2)|Mean|25|25.0|Standard Deviation|3|3.0|||
3870599|NCT01586806|3695844|B2|||Body Mass Index||kg/(m^2)|Mean|24|24.0|Standard Deviation|4|4.0|||
3870600|NCT01586806|3695845|B1|||Body Mass Index||kg/(m^2)|Mean|24|24.0|Standard Deviation|3|3.0|||
3870601|NCT01586806|3695842|B4|United States||Region of Enrollment||participants|Number|186|186.0||||||
3870602|NCT01586806|3695843|B3|United States||Region of Enrollment||participants|Number|63|63.0||||||
3870603|NCT01586806|3695844|B2|United States||Region of Enrollment||participants|Number|61|61.0||||||
3870604|NCT01586806|3695845|B1|United States||Region of Enrollment||participants|Number|62|62.0||||||
3870605|NCT01586806|3695842|B4||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3870606|NCT01586806|3695843|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3870607|NCT01586806|3695844|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3870608|NCT01586806|3695845|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3870609|NCT01586806|3695842|B4||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3870610|NCT01586806|3695843|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3870611|NCT01586806|3695844|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3870612|NCT01586806|3695845|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3870613|NCT01586806|3695842|B4|||Age||years|Mean|26|26.0|Standard Deviation|9|9.0|||
3870614|NCT01586806|3695843|B3|||Age||years|Mean|27|27.0|Standard Deviation|10|10.0|||
3870615|NCT01586806|3695844|B2|||Age||years|Mean|26|26.0|Standard Deviation|8|8.0|||
3870616|NCT01586806|3695845|B1|||Age||years|Mean|27|27.0|Standard Deviation|10|10.0|||
3870617|NCT01586364|3695867|B1|||Body mass index (BMI)||kg/m^2|Mean|26.865|26.865|Standard Deviation|4.4106|4.4106|||
3870618|NCT01586364|3695867|B1|||Weight||kg|Mean|70.54|70.54|Standard Deviation|13.024|13.024|||
3870619|NCT01586364|3695867|B1|||Height||cm|Mean|161.90|161.9|Standard Deviation|6.026|6.026|||
3870620|NCT01586364|3695867|B1|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3870621|NCT01586364|3695867|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3870622|NCT01586364|3695867|B1|Asian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3870623|NCT01586364|3695867|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3870624|NCT01586364|3695867|B1|White||Race/Ethnicity, Customized||Participants|Number|278|278.0||||||
3870625|NCT01586364|3695867|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870626|NCT01586364|3695867|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|280|280.0||||||
3870627|NCT01586364|3695867|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3870628|NCT01586364|3695867|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3870629|NCT01586364|3695867|B1||Female|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
3870630|NCT01586364|3695867|B1|||Age||Years|Mean|59.4|59.4|Standard Deviation|6.74|6.74|||
3870631|NCT01586338|3695920|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3870632|NCT01586338|3695920|B1||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3870633|NCT01586338|3695920|B1|||Age||years|Mean|62.9|62.9|Standard Deviation|9.56|9.56|||
3870634|NCT01586312|3695930|B3|Spain||Region of Enrollment||participants|Number|30|30.0||||||
3870635|NCT01586312|3695931|B2|Spain||Region of Enrollment||participants|Number|15|15.0||||||
3870636|NCT01586312|3695932|B1|Spain||Region of Enrollment||participants|Number|15|15.0||||||
3870637|NCT01586312|3695930|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870638|NCT01586312|3695931|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870639|NCT01586312|3695932|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870640|NCT01586312|3695930|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870641|NCT01586312|3695931|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870642|NCT01586312|3695932|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870643|NCT01586312|3695930|B3||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3870644|NCT01586312|3695931|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3870645|NCT01586312|3695932|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3870646|NCT01586312|3695930|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870647|NCT01586312|3695931|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870648|NCT01586312|3695932|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870649|NCT01586312|3695930|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870650|NCT01586312|3695931|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870651|NCT01586312|3695932|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870652|NCT01586312|3695930|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870653|NCT01586312|3695931|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870654|NCT01586312|3695932|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870655|NCT01586312|3695930|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870656|NCT01586312|3695931|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870657|NCT01586312|3695932|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870658|NCT01586312|3695930|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3870659|NCT01586312|3695931|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3870660|NCT01586312|3695932|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3870661|NCT01586312|3695930|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3870662|NCT01586312|3695931|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3870663|NCT01586312|3695932|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3870664|NCT01586312|3695930|B3|||Age||years|Mean|56.97|56.97|Standard Deviation|9.33|9.33|||
3870665|NCT01586312|3695931|B2|||Age||years|Mean|57.33|57.33|Standard Deviation|9.41|9.41|||
3870666|NCT01586312|3695932|B1|||Age||years|Mean|56.60|56.6|Standard Deviation|9.57|9.57|||
3870667|NCT01586195|3695943|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3870668|NCT01586195|3695943|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3870669|NCT01586195|3695943|B1|||Age||years|Mean|60.0|60.0|Standard Deviation|11.39|11.39|||
3870670|NCT01586156|3695954|B4|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3870671|NCT01586156|3695955|B3|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3870672|NCT01586156|3695956|B2|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3870673|NCT01586156|3695957|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3870674|NCT01586156|3695954|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870675|NCT01586156|3695955|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870676|NCT01586156|3695956|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870677|NCT01586156|3695957|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870678|NCT01586156|3695954|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870679|NCT01586156|3695955|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870680|NCT01586156|3695956|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870681|NCT01586156|3695957|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870682|NCT01586156|3695954|B4||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3870683|NCT01586156|3695955|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3870684|NCT01586156|3695956|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3870685|NCT01586156|3695957|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3870686|NCT01586156|3695954|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3870687|NCT01586156|3695955|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3870688|NCT01586156|3695956|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870689|NCT01586156|3695957|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3870690|NCT01586156|3695954|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870691|NCT01586156|3695955|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870692|NCT01586156|3695956|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870693|NCT01586156|3695957|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870694|NCT01586156|3695954|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3870695|NCT01586156|3695955|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870696|NCT01586156|3695956|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870697|NCT01586156|3695957|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3870698|NCT01586156|3695954|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870699|NCT01586156|3695955|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870700|NCT01586156|3695956|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870701|NCT01586156|3695957|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870702|NCT01586156|3695954|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870703|NCT01586156|3695955|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870704|NCT01586156|3695956|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870705|NCT01586156|3695957|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870706|NCT01586156|3695954|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3870707|NCT01586156|3695955|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3870708|NCT01586156|3695956|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3870709|NCT01586156|3695957|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3870710|NCT01586156|3695954|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870711|NCT01586156|3695955|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870712|NCT01586156|3695956|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870713|NCT01586156|3695957|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870714|NCT01586156|3695954|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3870715|NCT01586156|3695955|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3870716|NCT01586156|3695956|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3870717|NCT01586156|3695957|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3870718|NCT01586156|3695954|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3870719|NCT01586156|3695955|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3870720|NCT01586156|3695956|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3870721|NCT01586156|3695957|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3870722|NCT01586156|3695954|B4|||Age||years|Mean|42|42.0|Standard Deviation|4|4.0|||
3870723|NCT01586156|3695955|B3|||Age||years|Mean|38|38.0|Standard Deviation|14|14.0|||
3870724|NCT01586156|3695956|B2|||Age||years|Mean|53|53.0|Standard Deviation|9|9.0|||
3870725|NCT01586156|3695957|B1|||Age||years|Mean|42|42.0|Standard Deviation|6|6.0|||
3870726|NCT01586156|3695954|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3870727|NCT01586156|3695955|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3870728|NCT01586156|3695956|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3870729|NCT01586156|3695957|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3870730|NCT01586156|3695954|B4||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3870731|NCT01586156|3695955|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3870732|NCT01586156|3695956|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3870733|NCT01586156|3695957|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3870734|NCT01586156|3695954|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3870735|NCT01586156|3695955|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3870736|NCT01586156|3695956|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3870737|NCT01586156|3695957|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3870738|NCT01586026|3695985|B1|Unknown||Catheter Configuration|#Fr. (French units) refers to the functional lumen/relative size of the catheter's diameter with smaller numbers indicating smaller diameters. Each increment of French sizing equals 0.33 mm.|participants|Number|160|160.0||||||
3870739|NCT01586026|3695985|B1|9.5Fr.||Catheter Configuration|#Fr. (French units) refers to the functional lumen/relative size of the catheter's diameter with smaller numbers indicating smaller diameters. Each increment of French sizing equals 0.33 mm.|participants|Number|0|0.0||||||
3870740|NCT01586026|3695985|B1|8Fr.||Catheter Configuration|#Fr. (French units) refers to the functional lumen/relative size of the catheter's diameter with smaller numbers indicating smaller diameters. Each increment of French sizing equals 0.33 mm.|participants|Number|11|11.0||||||
3870741|NCT01586026|3695985|B1|7Fr.||Catheter Configuration|#Fr. (French units) refers to the functional lumen/relative size of the catheter's diameter with smaller numbers indicating smaller diameters. Each increment of French sizing equals 0.33 mm.|participants|Number|0|0.0||||||
3870742|NCT01586026|3695985|B1|Unknown||Port Configuration||participants|Number|38|38.0||||||
3870743|NCT01586026|3695985|B1|Dual Lumen||Port Configuration||participants|Number|1|1.0||||||
3870744|NCT01586026|3695985|B1|Single Lumen||Port Configuration||participants|Number|132|132.0||||||
3870745|NCT01586026|3695985|B1|Unknown||Port Access Vein||participants|Number|4|4.0||||||
3870746|NCT01586026|3695985|B1|Subclavian||Port Access Vein||participants|Number|102|102.0||||||
3870747|NCT01586026|3695985|B1|Jugular||Port Access Vein||participants|Number|65|65.0||||||
3870748|NCT01586026|3695985|B1|Hematologic||Cancer Type||participants|Number|29|29.0||||||
3870749|NCT01586026|3695985|B1|Solid tumor||Cancer Type||participants|Number|142|142.0||||||
3870750|NCT01586026|3695985|B1|United States||Region of Enrollment||participants|Number|171|171.0||||||
3870751|NCT01586026|3695985|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3870752|NCT01586026|3695985|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|168|168.0||||||
3870753|NCT01586026|3695985|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870754|NCT01586026|3695985|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3870755|NCT01586026|3695985|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870756|NCT01586026|3695985|B1||White|Race (NIH/OMB)||Participants|Count of Participants|160|160.0||||||
3870757|NCT01586026|3695985|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3870758|NCT01586026|3695985|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870759|NCT01586026|3695985|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3870760|NCT01586026|3695985|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870761|NCT01586026|3695985|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3870762|NCT01586026|3695985|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3870763|NCT01586026|3695985|B1|||Age||years|Mean|65.7|65.7|Standard Deviation|12.3|12.3|||
3870764|NCT01585987|3695995|B3|Spain||Region of Enrollment||participants|Number|7|7.0||||||
3870765|NCT01585987|3695996|B2|Spain||Region of Enrollment||participants|Number|5|5.0||||||
3870766|NCT01585987|3695997|B1|Spain||Region of Enrollment||participants|Number|2|2.0||||||
3870767|NCT01585987|3695995|B3|Germany||Region of Enrollment||participants|Number|1|1.0||||||
3870768|NCT01585987|3695996|B2|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3870769|NCT01585987|3695997|B1|Germany||Region of Enrollment||participants|Number|1|1.0||||||
3870770|NCT01585987|3695995|B3|France||Region of Enrollment||participants|Number|8|8.0||||||
3870771|NCT01585987|3695996|B2|France||Region of Enrollment||participants|Number|5|5.0||||||
3870772|NCT01585987|3695997|B1|France||Region of Enrollment||participants|Number|3|3.0||||||
3870773|NCT01585987|3695995|B3|Italy||Region of Enrollment||participants|Number|19|19.0||||||
3870774|NCT01585987|3695996|B2|Italy||Region of Enrollment||participants|Number|8|8.0||||||
3870775|NCT01585987|3695997|B1|Italy||Region of Enrollment||participants|Number|11|11.0||||||
3870776|NCT01585987|3695995|B3|Korea, Republic of||Region of Enrollment||participants|Number|45|45.0||||||
3870777|NCT01585987|3695996|B2|Korea, Republic of||Region of Enrollment||participants|Number|24|24.0||||||
3870778|NCT01585987|3695997|B1|Korea, Republic of||Region of Enrollment||participants|Number|21|21.0||||||
3870779|NCT01585987|3695995|B3|Poland||Region of Enrollment||participants|Number|2|2.0||||||
3870780|NCT01585987|3695996|B2|Poland||Region of Enrollment||participants|Number|2|2.0||||||
3870781|NCT01585987|3695997|B1|Poland||Region of Enrollment||participants|Number|0|0.0||||||
3870782|NCT01585987|3695995|B3|Taiwan||Region of Enrollment||participants|Number|1|1.0||||||
3870783|NCT01585987|3695996|B2|Taiwan||Region of Enrollment||participants|Number|0|0.0||||||
3870784|NCT01585987|3695997|B1|Taiwan||Region of Enrollment||participants|Number|1|1.0||||||
3870785|NCT01585987|3695995|B3|Japan||Region of Enrollment||participants|Number|12|12.0||||||
3870786|NCT01585987|3695996|B2|Japan||Region of Enrollment||participants|Number|5|5.0||||||
3870787|NCT01585987|3695997|B1|Japan||Region of Enrollment||participants|Number|7|7.0||||||
3870788|NCT01585987|3695995|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
3870789|NCT01585987|3695996|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3870790|NCT01585987|3695997|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3870791|NCT01585987|3695995|B3|Hong Kong||Region of Enrollment||participants|Number|1|1.0||||||
3870792|NCT01585987|3695996|B2|Hong Kong||Region of Enrollment||participants|Number|0|0.0||||||
3870793|NCT01585987|3695997|B1|Hong Kong||Region of Enrollment||participants|Number|1|1.0||||||
3870794|NCT01585987|3695995|B3|Singapore||Region of Enrollment||participants|Number|2|2.0||||||
3870795|NCT01585987|3695996|B2|Singapore||Region of Enrollment||participants|Number|1|1.0||||||
3870796|NCT01585987|3695997|B1|Singapore||Region of Enrollment||participants|Number|1|1.0||||||
3870797|NCT01585987|3695995|B3|Russian Federation||Region of Enrollment||participants|Number|2|2.0||||||
3870798|NCT01585987|3695996|B2|Russian Federation||Region of Enrollment||participants|Number|1|1.0||||||
3870799|NCT01585987|3695997|B1|Russian Federation||Region of Enrollment||participants|Number|1|1.0||||||
3870800|NCT01585987|3695995|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3870801|NCT01585987|3695996|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3870802|NCT01585987|3695997|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3870803|NCT01585987|3695995|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3870804|NCT01585987|3695996|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3870805|NCT01585987|3695997|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3870806|NCT01585987|3695995|B3|Greater, equal to (>=) 65 years of age||Age, Customized||participants|Number|51|51.0||||||
3870807|NCT01585987|3695996|B2|Greater, equal to (>=) 65 years of age||Age, Customized||participants|Number|22|22.0||||||
3870808|NCT01585987|3695997|B1|Greater, equal to (>=) 65 years of age||Age, Customized||participants|Number|29|29.0||||||
3870809|NCT01585987|3695995|B3|Less than (<) 65 years of age||Age, Customized||participants|Number|63|63.0||||||
3870810|NCT01585987|3695996|B2|Less than (<) 65 years of age||Age, Customized||participants|Number|35|35.0||||||
3870811|NCT01585987|3695997|B1|Less than (<) 65 years of age||Age, Customized||participants|Number|28|28.0||||||
3870812|NCT01585987|3695995|B3|||Age||years|Median|64.0|64.0|Full Range|||32.0|86.0|
3870813|NCT01585987|3695996|B2|||Age||years|Median|62.0|62.0|Full Range|||32.0|80.0|
3870814|NCT01585987|3695997|B1|||Age||years|Median|65.0|65.0|Full Range|||34.0|86.0|
3870815|NCT01585961|3696013|B1|United States||Region of Enrollment||participants|Number|511|511.0||||||
3870816|NCT01585961|3696013|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3870817|NCT01585961|3696013|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3870818|NCT01585961|3696013|B1||White|Race (NIH/OMB)||Participants|Count of Participants|477|477.0||||||
3870819|NCT01585961|3696013|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3870820|NCT01585961|3696013|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3870821|NCT01585961|3696013|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3870822|NCT01585961|3696013|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3870823|NCT01585961|3696013|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3870824|NCT01585961|3696013|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|494|494.0||||||
3870825|NCT01585961|3696013|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3870826|NCT01585961|3696013|B1||Male|Sex: Female, Male||Participants|Count of Participants|317|317.0||||||
3870827|NCT01585961|3696013|B1||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
3870828|NCT01585961|3696013|B1|||Age||years|Mean|62.0|62.0|Standard Deviation|11.5|11.5|||
3870829|NCT01585961|3696013|B1||>=65 years|Age||Participants|Count of Participants|246|246.0||||||
3870830|NCT01585961|3696013|B1||Between 18 and 65 years|Age||Participants|Count of Participants|265|265.0||||||
3870831|NCT01585961|3696013|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3870832|NCT01585779|3696028|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3870833|NCT01585779|3696029|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3870834|NCT01585779|3696030|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3870835|NCT01585779|3696028|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3870836|NCT01585779|3696029|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3870837|NCT01585779|3696030|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3870838|NCT01585779|3696028|B3|||Age||years|Mean|70.7|70.7|Standard Deviation|10.6|10.6|||
3870839|NCT01585779|3696029|B2|||Age||years|Mean|73.7|73.7|Standard Deviation|8.5|8.5|||
3870840|NCT01585779|3696030|B1|||Age||years|Mean|68.4|68.4|Standard Deviation|11.6|11.6|||
3870841|NCT01585779|3696028|B3||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
3870842|NCT01585779|3696029|B2||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3870843|NCT01585779|3696030|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3870844|NCT01585779|3696028|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3870845|NCT01585779|3696029|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3870846|NCT01585779|3696030|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3870847|NCT01585779|3696028|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3870848|NCT01585779|3696029|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3870849|NCT01585779|3696030|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3870850|NCT01585766|3696085|B7||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3870851|NCT01585766|3696086|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3870852|NCT01585766|3696087|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3870853|NCT01585766|3696088|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3870854|NCT01585766|3696089|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3870855|NCT01585766|3696090|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3870856|NCT01585766|3696091|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3870857|NCT01585766|3696085|B7||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3870858|NCT01585766|3696086|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3870859|NCT01585766|3696087|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3870860|NCT01585766|3696088|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3870861|NCT01585766|3696089|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3870862|NCT01585766|3696090|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3870863|NCT01585766|3696091|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3870864|NCT01585766|3696085|B7|||Age||Years|Mean|45.4|45.4|Standard Deviation|12.0|12.0|||
3870865|NCT01585766|3696086|B6|||Age||Years|Mean|44.2|44.2|Standard Deviation|10.1|10.1|||
3870866|NCT01585766|3696087|B5|||Age||Years|Mean|56.0|56.0|Standard Deviation|6.1|6.1|||
3870867|NCT01585766|3696088|B4|||Age||Years|Mean|46.5|46.5|Standard Deviation|13.8|13.8|||
3870868|NCT01585766|3696089|B3|||Age||Years|Mean|46.7|46.7|Standard Deviation|16.3|16.3|||
3870869|NCT01585766|3696090|B2|||Age||Years|Mean|42.4|42.4|Standard Deviation|7.8|7.8|||
3870870|NCT01585766|3696091|B1|||Age||Years|Mean|43.0|43.0|Standard Deviation|15.9|15.9|||
3870871|NCT01585597|3696195|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3870872|NCT01585597|3696195|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3870873|NCT01585597|3696195|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3870874|NCT01585597|3696195|B1|||Age||years|Mean|59|59.0|Standard Deviation|14|14.0|||
3870875|NCT01585584|3696200|B1|Canada||Region of Enrollment||participants|Number|10|10.0||||||
3870876|NCT01585584|3696200|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3870877|NCT01585584|3696200|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3870878|NCT01585584|3696200|B1|||Age||years|Mean|53.3|53.3|Standard Deviation|6.945|6.945|||
3870879|NCT01585584|3696200|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3870880|NCT01585584|3696200|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3870881|NCT01585584|3696200|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3870882|NCT01585558|3696204|B4|||Body mass index (BMI)||kg/m^2|Mean|25.282|25.282|Standard Deviation|4.0762|4.0762|||
3870883|NCT01585558|3696205|B3|||Body mass index (BMI)||kg/m^2|Mean|25.045|25.045|Standard Deviation|3.8496|3.8496|||
3870884|NCT01585558|3696206|B2|||Body mass index (BMI)||kg/m^2|Mean|24.792|24.792|Standard Deviation|4.1292|4.1292|||
3870885|NCT01585558|3696207|B1|||Body mass index (BMI)||kg/m^2|Mean|26.014|26.014|Standard Deviation|4.1507|4.1507|||
3870886|NCT01585558|3696204|B4|||Weight||kg|Mean|67.02|67.02|Standard Deviation|11.252|11.252|||
3870887|NCT01585558|3696205|B3|||Weight||kg|Mean|66.71|66.71|Standard Deviation|10.482|10.482|||
3870888|NCT01585558|3696206|B2|||Weight||kg|Mean|65.52|65.52|Standard Deviation|11.626|11.626|||
3870889|NCT01585558|3696207|B1|||Weight||kg|Mean|68.92|68.92|Standard Deviation|11.316|11.316|||
3870890|NCT01585558|3696204|B4|||Height||cm|Mean|162.84|162.84|Standard Deviation|6.509|6.509|||
3870891|NCT01585558|3696205|B3|||Height||cm|Mean|163.27|163.27|Standard Deviation|6.082|6.082|||
3870892|NCT01585558|3696206|B2|||Height||cm|Mean|162.53|162.53|Standard Deviation|6.488|6.488|||
3870893|NCT01585558|3696207|B1|||Height||cm|Mean|162.83|162.83|Standard Deviation|6.930|6.93|||
3870894|NCT01585558|3696204|B4|Missing value||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3870895|NCT01585558|3696205|B3|Missing value||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3870896|NCT01585558|3696206|B2|Missing value||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3870897|NCT01585558|3696207|B1|Missing value||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3870898|NCT01585558|3696204|B4|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3870899|NCT01585558|3696205|B3|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3870900|NCT01585558|3696206|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3870901|NCT01585558|3696207|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3870902|NCT01585558|3696204|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3870903|NCT01585558|3696205|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3870904|NCT01585558|3696206|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3870905|NCT01585558|3696207|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3870906|NCT01585558|3696204|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3870907|NCT01585558|3696205|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3870908|NCT01585558|3696206|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3870909|NCT01585558|3696207|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3870910|NCT01585558|3696204|B4|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3870911|NCT01585558|3696205|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3870912|NCT01585558|3696206|B2|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3870913|NCT01585558|3696207|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3870914|NCT01585558|3696204|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
3870915|NCT01585558|3696205|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3870916|NCT01585558|3696206|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3870917|NCT01585558|3696207|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3870918|NCT01585558|3696204|B4|White||Race/Ethnicity, Customized||Participants|Number|162|162.0||||||
3870919|NCT01585558|3696205|B3|White||Race/Ethnicity, Customized||Participants|Number|43|43.0||||||
3870920|NCT01585558|3696206|B2|White||Race/Ethnicity, Customized||Participants|Number|61|61.0||||||
3870921|NCT01585558|3696207|B1|White||Race/Ethnicity, Customized||Participants|Number|58|58.0||||||
3870922|NCT01585558|3696204|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870923|NCT01585558|3696205|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870924|NCT01585558|3696206|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870925|NCT01585558|3696207|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870926|NCT01585558|3696204|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|174|174.0||||||
3870927|NCT01585558|3696205|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3870928|NCT01585558|3696206|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3870929|NCT01585558|3696207|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3870930|NCT01585558|3696204|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3870931|NCT01585558|3696205|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3870932|NCT01585558|3696206|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3870933|NCT01585558|3696207|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3870934|NCT01585558|3696204|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3870935|NCT01585558|3696205|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3870936|NCT01585558|3696206|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3870937|NCT01585558|3696207|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3870938|NCT01585558|3696204|B4||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3870939|NCT01585558|3696205|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3870940|NCT01585558|3696206|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3870941|NCT01585558|3696207|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3870942|NCT01585558|3696204|B4|||Age||Years|Mean|58.1|58.1|Standard Deviation|5.51|5.51|||
3870943|NCT01585558|3696205|B3|||Age||Years|Mean|58.2|58.2|Standard Deviation|4.02|4.02|||
3870944|NCT01585558|3696206|B2|||Age||Years|Mean|57.7|57.7|Standard Deviation|5.88|5.88|||
3870945|NCT01585558|3696207|B1|||Age||Years|Mean|58.4|58.4|Standard Deviation|6.13|6.13|||
3870946|NCT01585441|3696388|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3870947|NCT01585441|3696389|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3870948|NCT01585441|3696390|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3870949|NCT01585441|3696388|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3870950|NCT01585441|3696389|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3870951|NCT01585441|3696390|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3870952|NCT01585441|3696388|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3870953|NCT01585441|3696389|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3870954|NCT01585441|3696390|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3870955|NCT01585441|3696388|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3870956|NCT01585441|3696389|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3870957|NCT01585441|3696390|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3870958|NCT01585441|3696388|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3870959|NCT01585441|3696389|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3870960|NCT01585441|3696390|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3870961|NCT01585428|3696441|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
3870962|NCT01585428|3696442|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3870963|NCT01585428|3696443|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3870964|NCT01585428|3696441|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870965|NCT01585428|3696442|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870966|NCT01585428|3696443|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870967|NCT01585428|3696441|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870968|NCT01585428|3696442|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870969|NCT01585428|3696443|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870970|NCT01585428|3696441|B3||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3870971|NCT01585428|3696442|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3870972|NCT01585428|3696443|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3870973|NCT01585428|3696441|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870974|NCT01585428|3696442|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870975|NCT01585428|3696443|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870976|NCT01585428|3696441|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870977|NCT01585428|3696442|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870978|NCT01585428|3696443|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870979|NCT01585428|3696441|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3870980|NCT01585428|3696442|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870981|NCT01585428|3696443|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3870982|NCT01585428|3696441|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870983|NCT01585428|3696442|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870984|NCT01585428|3696443|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870985|NCT01585428|3696441|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870986|NCT01585428|3696442|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870987|NCT01585428|3696443|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870988|NCT01585428|3696441|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3870989|NCT01585428|3696442|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3870990|NCT01585428|3696443|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3870991|NCT01585428|3696441|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870992|NCT01585428|3696442|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870993|NCT01585428|3696443|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3870994|NCT01585428|3696441|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3870995|NCT01585428|3696442|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3870996|NCT01585428|3696443|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3870997|NCT01585428|3696441|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3870998|NCT01585428|3696442|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3870999|NCT01585428|3696443|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3871000|NCT01585428|3696441|B3|||Age||years|Mean|47.8|47.8|Standard Deviation|10.8|10.8|||
3871001|NCT01585428|3696442|B2|||Age||years|Mean|54.9|54.9|Standard Deviation|4.5|4.5|||
3871002|NCT01585428|3696443|B1|||Age||years|Mean|43.4|43.4|Standard Deviation|11.4|11.4|||
3871003|NCT01585428|3696441|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3871004|NCT01585428|3696442|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3871005|NCT01585428|3696443|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3871006|NCT01585428|3696441|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3871007|NCT01585428|3696442|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3871008|NCT01585428|3696443|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3871009|NCT01585428|3696441|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3871010|NCT01585428|3696442|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3871011|NCT01585428|3696443|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3871012|NCT01585324|3696452|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3871013|NCT01585324|3696452|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3871014|NCT01585324|3696452|B1|||Age||years|Mean|32.1|32.1|Standard Deviation|7.2|7.2|||
3871015|NCT01585272|3696468|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3871016|NCT01585272|3696468|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3871017|NCT01585272|3696468|B1|||Age||Years|Mean|74.8|74.8|Standard Deviation|7.93|7.93|||
3871018|NCT01585246|3696476|B6|United States||Region of Enrollment||participants|Number|48|48.0||||||
3871019|NCT01585246|3696477|B5|United States||Region of Enrollment||participants|Number|11|11.0||||||
3871020|NCT01585246|3696478|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
3871021|NCT01585246|3696479|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3871022|NCT01585246|3696480|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3871023|NCT01585246|3696481|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3871024|NCT01585246|3696476|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3871025|NCT01585246|3696477|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3871026|NCT01585246|3696478|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871027|NCT01585246|3696479|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3871028|NCT01585246|3696480|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871029|NCT01585246|3696481|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871030|NCT01585246|3696476|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871031|NCT01585246|3696477|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871032|NCT01585246|3696478|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871033|NCT01585246|3696479|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871034|NCT01585246|3696480|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871035|NCT01585246|3696481|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871036|NCT01585246|3696476|B6||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3871037|NCT01585246|3696477|B5||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3871038|NCT01585246|3696478|B4||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3871039|NCT01585246|3696479|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3871040|NCT01585246|3696480|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3871041|NCT01585246|3696481|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3871042|NCT01585246|3696476|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3871043|NCT01585246|3696477|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871044|NCT01585246|3696478|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3871045|NCT01585246|3696479|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3871046|NCT01585246|3696480|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871047|NCT01585246|3696481|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871048|NCT01585246|3696476|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871049|NCT01585246|3696477|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871050|NCT01585246|3696478|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871051|NCT01585246|3696479|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871052|NCT01585246|3696480|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871053|NCT01585246|3696481|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871054|NCT01585246|3696476|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871055|NCT01585246|3696477|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871056|NCT01585246|3696478|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871057|NCT01585246|3696479|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871058|NCT01585246|3696480|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871059|NCT01585246|3696481|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871060|NCT01585246|3696476|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871061|NCT01585246|3696477|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871062|NCT01585246|3696478|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871063|NCT01585246|3696479|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871064|NCT01585246|3696480|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871065|NCT01585246|3696481|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871066|NCT01585246|3696476|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3871067|NCT01585246|3696477|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3871068|NCT01585246|3696478|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3871069|NCT01585246|3696479|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3871070|NCT01585246|3696480|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871071|NCT01585246|3696481|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871072|NCT01585246|3696476|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3871073|NCT01585246|3696477|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3871074|NCT01585246|3696478|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3871075|NCT01585246|3696479|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3871076|NCT01585246|3696480|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3871077|NCT01585246|3696481|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3871078|NCT01585246|3696476|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3871079|NCT01585246|3696477|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871080|NCT01585246|3696478|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871081|NCT01585246|3696479|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3871082|NCT01585246|3696480|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871083|NCT01585246|3696481|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871084|NCT01585246|3696476|B6|Male||Sex/Gender, Customized||participants|Number|48|48.0||||||
3871085|NCT01585246|3696477|B5|Male||Sex/Gender, Customized||participants|Number|11|11.0||||||
3871086|NCT01585246|3696478|B4|Male||Sex/Gender, Customized||participants|Number|10|10.0||||||
3871087|NCT01585246|3696479|B3|Male||Sex/Gender, Customized||participants|Number|20|20.0||||||
3871088|NCT01585246|3696480|B2|Male||Sex/Gender, Customized||participants|Number|4|4.0||||||
3871089|NCT01585246|3696481|B1|Male||Sex/Gender, Customized||participants|Number|3|3.0||||||
3871090|NCT01585246|3696476|B6|||Age||years|Mean|67.29|67.29|Standard Deviation|9.16|9.16|||
3871091|NCT01585246|3696477|B5|||Age||years|Mean|67.82|67.82|Standard Deviation|7.22|7.22|||
3871092|NCT01585246|3696478|B4|||Age||years|Mean|66.70|66.7|Standard Deviation|11.30|11.3|||
3871093|NCT01585246|3696479|B3|||Age||years|Mean|62.1|62.1|Standard Deviation|5.3|5.3|||
3871094|NCT01585246|3696480|B2|||Age||years|Mean|62.75|62.75|Standard Deviation|12.09|12.09|||
3871095|NCT01585246|3696481|B1|||Age||years|Mean|71|71.0|Standard Deviation|3.0|3.0|||
3871096|NCT01585207|3696500|B1|||YGTSS (total tic)|Yale Global Tic Severity Scale (YGTSS) - The Total Tic Score is a summation of the Total Motor Tic (0 -25) and Total Phonic Tic (0-25) Scores, full range 0 (No impairment) to 50 (Severe impairment)|total tics|Mean|39|39.0|Standard Deviation|3.67|3.67|||
3871097|NCT01585207|3696500|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3871098|NCT01585207|3696500|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3871099|NCT01585207|3696500|B1|||Age||years|Mean|34.75|34.75|Full Range|||26.0|52.0|
3871100|NCT01585168|3696504|B3|United States||Region of Enrollment||participants|Number|65|65.0||||||
3871101|NCT01585168|3696505|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
3871102|NCT01585168|3696506|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
3871103|NCT01585168|3696504|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3871104|NCT01585168|3696505|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3871105|NCT01585168|3696506|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3871106|NCT01585168|3696504|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3871107|NCT01585168|3696505|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3871108|NCT01585168|3696506|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3871109|NCT01585168|3696504|B3|||Age||years|Mean|23.42|23.42|Full Range|||18.0|34.0|
3871110|NCT01585168|3696505|B2|||Age||years|Mean|22.09|22.09|Full Range|||19.0|27.0|
3871111|NCT01585168|3696506|B1|||Age||years|Mean|24.70|24.7|Full Range|||18.0|34.0|
3871112|NCT01585168|3696504|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3871113|NCT01585168|3696505|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3871114|NCT01585168|3696506|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3871115|NCT01585168|3696504|B3||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
3871116|NCT01585168|3696505|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3871117|NCT01585168|3696506|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3871118|NCT01585168|3696504|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3871119|NCT01585168|3696505|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3871120|NCT01585168|3696506|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3871121|NCT01585129|3696529|B3|United States||Region of Enrollment||Participants|Count of Participants|80|80.0||||||
3871122|NCT01585129|3696530|B2|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3871123|NCT01585129|3696531|B1|United States||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3871124|NCT01585129|3696529|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3871125|NCT01585129|3696530|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3871126|NCT01585129|3696531|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3871127|NCT01585129|3696529|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871128|NCT01585129|3696530|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871129|NCT01585129|3696531|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871130|NCT01585129|3696529|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3871131|NCT01585129|3696530|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3871132|NCT01585129|3696531|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3871133|NCT01585129|3696529|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3871134|NCT01585129|3696530|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3871135|NCT01585129|3696531|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3871136|NCT01585129|3696529|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871137|NCT01585129|3696530|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871138|NCT01585129|3696531|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871139|NCT01585129|3696529|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3871140|NCT01585129|3696530|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871141|NCT01585129|3696531|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3871142|NCT01585129|3696529|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871143|NCT01585129|3696530|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871144|NCT01585129|3696531|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871145|NCT01585129|3696529|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3871146|NCT01585129|3696530|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3871147|NCT01585129|3696531|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3871148|NCT01585129|3696529|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3871149|NCT01585129|3696530|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3871150|NCT01585129|3696531|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3871151|NCT01585129|3696529|B3|||Age||years|Mean|25|25.0|Standard Deviation|6|6.0|||
3871152|NCT01585129|3696530|B2|||Age||years|Mean|25.3|25.3|Standard Deviation|6.6|6.6|||
3871153|NCT01585129|3696531|B1|||Age||years|Mean|24.7|24.7|Standard Deviation|6|6.0|||
3871154|NCT01585129|3696529|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3871155|NCT01585129|3696530|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3871156|NCT01585129|3696531|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3871157|NCT01585129|3696529|B3||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
3871158|NCT01585129|3696530|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3871159|NCT01585129|3696531|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3871160|NCT01585129|3696529|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3871161|NCT01585129|3696530|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3871162|NCT01585129|3696531|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3871163|NCT01585038|3696542|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3871164|NCT01585038|3696543|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3871165|NCT01585038|3696544|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3871166|NCT01585038|3696542|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3871167|NCT01585038|3696543|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3871168|NCT01585038|3696544|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3871169|NCT01585038|3696542|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871170|NCT01585038|3696543|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871171|NCT01585038|3696544|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871172|NCT01585038|3696542|B3||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3871173|NCT01585038|3696543|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3871174|NCT01585038|3696544|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3871175|NCT01585038|3696542|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3871176|NCT01585038|3696543|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3871177|NCT01585038|3696544|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3871178|NCT01585038|3696542|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871179|NCT01585038|3696543|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871180|NCT01585038|3696544|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871181|NCT01585038|3696542|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871182|NCT01585038|3696543|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871183|NCT01585038|3696544|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871184|NCT01585038|3696542|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871185|NCT01585038|3696543|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871186|NCT01585038|3696544|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871187|NCT01585038|3696542|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871188|NCT01585038|3696543|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871189|NCT01585038|3696544|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871190|NCT01585038|3696542|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3871191|NCT01585038|3696543|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3871192|NCT01585038|3696544|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3871193|NCT01585038|3696542|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3871194|NCT01585038|3696543|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3871195|NCT01585038|3696544|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3871196|NCT01585038|3696542|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3871197|NCT01585038|3696543|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3871198|NCT01585038|3696544|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3871199|NCT01585038|3696542|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3871200|NCT01585038|3696543|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3871201|NCT01585038|3696544|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3871202|NCT01585038|3696542|B3|||Age||years|Median|31.54|31.54|Full Range|||20.33|66.33|
3871203|NCT01585038|3696543|B2|||Age||years|Median|34.5|34.5|Full Range|||20.4|66.3|
3871204|NCT01585038|3696544|B1|||Age||years|Median|30.4|30.4|Full Range|||20.3|54.5|
3871205|NCT01584843|3696557|B5|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|41|41.0||||||
3871206|NCT01584843|3696558|B4|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3871207|NCT01584843|3696559|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
3871208|NCT01584843|3696560|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3871209|NCT01584843|3696561|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
3871210|NCT01584843|3696557|B5||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3871211|NCT01584843|3696558|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3871212|NCT01584843|3696559|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3871213|NCT01584843|3696560|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3871214|NCT01584843|3696561|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3871215|NCT01584843|3696557|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3871216|NCT01584843|3696558|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3871217|NCT01584843|3696559|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3871218|NCT01584843|3696560|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3871219|NCT01584843|3696561|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3871220|NCT01584843|3696557|B5|||Age||Years|Mean|45.1|45.1|Standard Deviation|23.04|23.04|||
3871221|NCT01584843|3696558|B4|||Age||Years|Mean|49.0|49.0|Standard Deviation|21.79|21.79|||
3871222|NCT01584843|3696559|B3|||Age||Years|Mean|51.4|51.4|Standard Deviation|22.78|22.78|||
3871223|NCT01584843|3696560|B2|||Age||Years|Mean|19.8|19.8|Standard Deviation|9.07|9.07|||
3871224|NCT01584843|3696561|B1|||Age||Years|Mean|43.5|43.5|Standard Deviation|23.67|23.67|||
3871225|NCT01584648|3696675|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|422|422.0||||||
3871226|NCT01584648|3696676|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|211|211.0||||||
3871227|NCT01584648|3696677|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|211|211.0||||||
3871228|NCT01584648|3696675|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3871229|NCT01584648|3696676|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3871230|NCT01584648|3696677|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3871231|NCT01584648|3696675|B3||Male|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
3871232|NCT01584648|3696676|B2||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3871233|NCT01584648|3696677|B1||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3871234|NCT01584648|3696675|B3||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
3871235|NCT01584648|3696676|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3871236|NCT01584648|3696677|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3871237|NCT01584648|3696675|B3|||Age||Years|Mean|55.2|55.2|Standard Deviation|13.52|13.52|||
3871238|NCT01584648|3696676|B2|||Age||Years|Mean|55.3|55.3|Standard Deviation|13.75|13.75|||
3871239|NCT01584648|3696677|B1|||Age||Years|Mean|55.1|55.1|Standard Deviation|13.33|13.33|||
3871240|NCT01584609|3696716|B3|United States||Region of Enrollment||Participants|Count of Participants|198|198.0||||||
3871241|NCT01584609|3696717|B2|United States||Region of Enrollment||Participants|Count of Participants|100|100.0||||||
3871242|NCT01584609|3696718|B1|United States||Region of Enrollment||Participants|Count of Participants|98|98.0||||||
3871243|NCT01584609|3696716|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3871244|NCT01584609|3696716|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3871245|NCT01584609|3696717|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3871246|NCT01584609|3696718|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3871247|NCT01584609|3696716|B3||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3871248|NCT01584609|3696717|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3871249|NCT01584609|3696718|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3871250|NCT01584609|3696716|B3|||Age||years|Mean|66.9|66.9|Standard Deviation|13|13.0|||
3871251|NCT01584609|3696717|B2|||Age||years|Mean|66.5|66.5|Standard Deviation|12.5|12.5|||
3871252|NCT01584609|3696718|B1|||Age||years|Mean|67.3|67.3|Standard Deviation|13.6|13.6|||
3871253|NCT01584544|3696739|B6|China||Region of Enrollment||participants|Number|24|24.0||||||
3871254|NCT01584544|3696740|B5|China||Region of Enrollment||participants|Number|6|6.0||||||
3871255|NCT01584544|3696741|B4|China||Region of Enrollment||participants|Number|3|3.0||||||
3871256|NCT01584544|3696742|B3|China||Region of Enrollment||participants|Number|6|6.0||||||
3871257|NCT01584544|3696743|B2|China||Region of Enrollment||participants|Number|6|6.0||||||
3871258|NCT01584544|3696744|B1|China||Region of Enrollment||participants|Number|3|3.0||||||
3871259|NCT01584544|3696739|B6||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3871260|NCT01584544|3696740|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3871261|NCT01584544|3696741|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3871262|NCT01584544|3696742|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3871263|NCT01584544|3696743|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3871264|NCT01584544|3696744|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3871265|NCT01584544|3696739|B6||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3871266|NCT01584544|3696740|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3871267|NCT01584544|3696741|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3871268|NCT01584544|3696742|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3871269|NCT01584544|3696743|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3871270|NCT01584544|3696744|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3871271|NCT01584544|3696739|B6|||Age||years|Median|78|78.0|Full Range|||75.0|84.0|
3871272|NCT01584544|3696740|B5|||Age||years|Median|78|78.0|Full Range|||76.0|79.0|
3871273|NCT01584544|3696741|B4|||Age||years|Median|76|76.0|Full Range|||76.0|77.0|
3871274|NCT01584544|3696742|B3|||Age||years|Median|78|78.0|Full Range|||75.0|82.0|
3871275|NCT01584544|3696743|B2|||Age||years|Median|77|77.0|Full Range|||75.0|84.0|
3871276|NCT01584544|3696744|B1|||Age||years|Median|77|77.0|Full Range|||75.0|82.0|
3871277|NCT01584544|3696739|B6||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3871278|NCT01584544|3696740|B5||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3871279|NCT01584544|3696741|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3871280|NCT01584544|3696742|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3871281|NCT01584544|3696743|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3871282|NCT01584544|3696744|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3871283|NCT01584544|3696739|B6||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3871284|NCT01584544|3696740|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3871285|NCT01584544|3696741|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3871286|NCT01584544|3696742|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3871287|NCT01584544|3696743|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3871288|NCT01584544|3696744|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3871289|NCT01584544|3696739|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3871290|NCT01584544|3696740|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3871291|NCT01584544|3696741|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3871292|NCT01584544|3696742|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3871293|NCT01584544|3696743|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3871294|NCT01584544|3696744|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3871295|NCT01584518|3696760|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3871296|NCT01584518|3696761|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3871297|NCT01584518|3696762|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3871298|NCT01584518|3696760|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3871299|NCT01584518|3696761|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3871300|NCT01584518|3696762|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3871301|NCT01584518|3696760|B3|||Age||years|Mean|70|70.0|Standard Deviation|9.5|9.5|||
3871302|NCT01584518|3696761|B2|||Age||years|Mean|70|70.0|Standard Deviation|9|9.0|||
3871303|NCT01584518|3696762|B1|||Age||years|Mean|70|70.0|Standard Deviation|10|10.0|||
3871304|NCT01584479|3696769|B5|United States||Region of Enrollment||participants|Number|5117|5117.0||||||
3871305|NCT01584479|3696770|B4|United States||Region of Enrollment||participants|Number|1847|1847.0||||||
3871306|NCT01584479|3696771|B3|United States||Region of Enrollment||participants|Number|852|852.0||||||
3871307|NCT01584479|3696772|B2|United States||Region of Enrollment||participants|Number|1686|1686.0||||||
3871308|NCT01584479|3696773|B1|United States||Region of Enrollment||participants|Number|732|732.0||||||
3871309|NCT01584479|3696769|B5||Male|Sex: Female, Male||Participants|Count of Participants|1751|1751.0||||||
3871310|NCT01584479|3696770|B4||Male|Sex: Female, Male||Participants|Count of Participants|609|609.0||||||
3871311|NCT01584479|3696771|B3||Male|Sex: Female, Male||Participants|Count of Participants|315|315.0||||||
3871312|NCT01584479|3696772|B2||Male|Sex: Female, Male||Participants|Count of Participants|556|556.0||||||
3871313|NCT01584479|3696773|B1||Male|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
3871314|NCT01584479|3696769|B5||Female|Sex: Female, Male||Participants|Count of Participants|3366|3366.0||||||
3871315|NCT01584479|3696770|B4||Female|Sex: Female, Male||Participants|Count of Participants|1238|1238.0||||||
3871316|NCT01584479|3696771|B3||Female|Sex: Female, Male||Participants|Count of Participants|537|537.0||||||
3871317|NCT01584479|3696772|B2||Female|Sex: Female, Male||Participants|Count of Participants|1130|1130.0||||||
3871318|NCT01584479|3696773|B1||Female|Sex: Female, Male||Participants|Count of Participants|461|461.0||||||
3871319|NCT01584479|3696769|B5|>34 and < 55 years||Age, Customized|The participants analyzed had to be within this age range during the year 2010.|participants|Number|5117|5117.0||||||
3871320|NCT01584479|3696770|B4|>34 and < 55 years||Age, Customized|The participants analyzed had to be within this age range during the year 2010.|participants|Number|1847|1847.0||||||
3871321|NCT01584479|3696771|B3|>34 and < 55 years||Age, Customized|The participants analyzed had to be within this age range during the year 2010.|participants|Number|852|852.0||||||
3871322|NCT01584479|3696772|B2|>34 and < 55 years||Age, Customized|The participants analyzed had to be within this age range during the year 2010.|participants|Number|1686|1686.0||||||
3871323|NCT01584479|3696773|B1|>34 and < 55 years||Age, Customized|The participants analyzed had to be within this age range during the year 2010.|participants|Number|732|732.0||||||
3871324|NCT01584388|3696786|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3871325|NCT01584388|3696786|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3871326|NCT01584388|3696786|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3871327|NCT01584388|3696786|B1|||Age||Years|Mean|48|48.0|Standard Deviation|17|17.0|||
3871328|NCT01584388|3696786|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3871329|NCT01584388|3696786|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3871330|NCT01584388|3696786|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3871331|NCT01584232|3696804|B3|Japan||Region of Enrollment||participants|Number|361|361.0||||||
3871332|NCT01584232|3696805|B2|Japan||Region of Enrollment||participants|Number|180|180.0||||||
3871333|NCT01584232|3696806|B1|Japan||Region of Enrollment||participants|Number|181|181.0||||||
3871334|NCT01584232|3696804|B3|Asian||Race/Ethnicity, Customized||participants|Number|361|361.0||||||
3871335|NCT01584232|3696805|B2|Asian||Race/Ethnicity, Customized||participants|Number|180|180.0||||||
3871336|NCT01584232|3696806|B1|Asian||Race/Ethnicity, Customized||participants|Number|181|181.0||||||
3871337|NCT01584232|3696804|B3||Male|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
3871338|NCT01584232|3696805|B2||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3871339|NCT01584232|3696806|B1||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3871340|NCT01584232|3696804|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3871341|NCT01584232|3696805|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3871342|NCT01584232|3696806|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3871343|NCT01584232|3696804|B3|||Age||years|Mean|56.83|56.83|Standard Deviation|10.92|10.92|||
3871344|NCT01584232|3696805|B2|||Age||years|Mean|56.14|56.14|Standard Deviation|11.33|11.33|||
3871345|NCT01584232|3696806|B1|||Age||years|Mean|57.52|57.52|Standard Deviation|10.48|10.48|||
3871346|NCT01583894|3696823|B1|Male||Gender|Gender information available in 826 subjects|participants|Number|299|299.0||||||
3871347|NCT01583894|3696823|B1|Female||Gender|Gender information available in 826 subjects|participants|Number|527|527.0||||||
3871348|NCT01583894|3696823|B1|||Age|Age information available in 823 subjects|years|Mean|52.3|52.3|Standard Deviation|13.23|13.23|||
3871349|NCT01583647|3696827|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3871350|NCT01583647|3696827|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3871351|NCT01583647|3696827|B1|||Age||Years|Mean|15.4|15.4|Standard Deviation|0.8|0.8|||
3871352|NCT01583543|3696840|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3871353|NCT01583543|3696840|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3871354|NCT01583543|3696840|B1|||Age||years|Mean|30.5|30.5|Standard Deviation|15.38|15.38|||
3871355|NCT01583530|3696847|B7|United States||Region of Enrollment||participants|Number|118|118.0||||||
3871356|NCT01583530|3696848|B6|United States||Region of Enrollment||participants|Number|20|20.0||||||
3871357|NCT01583530|3696849|B5|United States||Region of Enrollment||participants|Number|20|20.0||||||
3871358|NCT01583530|3696850|B4|United States||Region of Enrollment||participants|Number|19|19.0||||||
3871359|NCT01583530|3696851|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3871360|NCT01583530|3696852|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3871361|NCT01583530|3696853|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3871362|NCT01583530|3696847|B7||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3871363|NCT01583530|3696848|B6||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3871364|NCT01583530|3696849|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3871365|NCT01583530|3696850|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3871366|NCT01583530|3696851|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3871367|NCT01583530|3696852|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3871368|NCT01583530|3696853|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3871369|NCT01583530|3696847|B7||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3871370|NCT01583530|3696848|B6||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3871371|NCT01583530|3696849|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3871372|NCT01583530|3696850|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3871373|NCT01583530|3696851|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3871374|NCT01583530|3696852|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3871375|NCT01583530|3696853|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3871376|NCT01583530|3696847|B7|||Age||years|Mean|35.5|35.5|Standard Deviation|10.7|10.7|||
3871377|NCT01583530|3696848|B6|||Age||years|Mean|37.4|37.4|Standard Deviation|9.7|9.7|||
3871378|NCT01583530|3696849|B5|||Age||years|Mean|33.7|33.7|Standard Deviation|9.5|9.5|||
3871379|NCT01583530|3696850|B4|||Age||years|Mean|36.1|36.1|Standard Deviation|9.4|9.4|||
3871380|NCT01583530|3696851|B3|||Age||years|Mean|35.2|35.2|Standard Deviation|12.1|12.1|||
3871381|NCT01583530|3696852|B2|||Age||years|Mean|33.4|33.4|Standard Deviation|11.4|11.4|||
3871382|NCT01583530|3696853|B1|||Age||years|Mean|37.3|37.3|Standard Deviation|12.1|12.1|||
3871383|NCT01583452|3696902|B3|Mexico||Region of Enrollment||participants|Number|41|41.0||||||
3871384|NCT01583452|3696903|B2|Mexico||Region of Enrollment||participants|Number|20|20.0||||||
3871385|NCT01583452|3696904|B1|Mexico||Region of Enrollment||participants|Number|21|21.0||||||
3871386|NCT01583452|3696902|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3871387|NCT01583452|3696903|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3871388|NCT01583452|3696904|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3871389|NCT01583452|3696902|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3871390|NCT01583452|3696903|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3871391|NCT01583452|3696904|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3871392|NCT01583452|3696902|B3|||Age||years|Mean|9.2|9.2|Inter-Quartile Range|||6.0|12.0|
3871393|NCT01583452|3696903|B2|||Age||years|Mean|8.6|8.6|Inter-Quartile Range|||6.0|11.5|
3871394|NCT01583452|3696904|B1|||Age||years|Mean|9.5|9.5|Inter-Quartile Range|||7.5|12.0|
3871395|NCT01583374|3696917|B4|> 10 years||Duration of Ankylosing Spondylitis||participants|Number|188|188.0||||||
3871396|NCT01583374|3696918|B3|> 10 years||Duration of Ankylosing Spondylitis||participants|Number|64|64.0||||||
3871397|NCT01583374|3696919|B2|> 10 years||Duration of Ankylosing Spondylitis||participants|Number|63|63.0||||||
3871398|NCT01583374|3696920|B1|> 10 years||Duration of Ankylosing Spondylitis||participants|Number|61|61.0||||||
3871399|NCT01583374|3696917|B4|> 5 to ≤ 10 years||Duration of Ankylosing Spondylitis||participants|Number|95|95.0||||||
3871400|NCT01583374|3696918|B3|> 5 to ≤ 10 years||Duration of Ankylosing Spondylitis||participants|Number|33|33.0||||||
3871401|NCT01583374|3696919|B2|> 5 to ≤ 10 years||Duration of Ankylosing Spondylitis||participants|Number|29|29.0||||||
3871402|NCT01583374|3696920|B1|> 5 to ≤ 10 years||Duration of Ankylosing Spondylitis||participants|Number|33|33.0||||||
3871403|NCT01583374|3696917|B4|> 2 to ≤ 5 years||Duration of Ankylosing Spondylitis||participants|Number|78|78.0||||||
3871404|NCT01583374|3696918|B3|> 2 to ≤ 5 years||Duration of Ankylosing Spondylitis||participants|Number|26|26.0||||||
3871405|NCT01583374|3696919|B2|> 2 to ≤ 5 years||Duration of Ankylosing Spondylitis||participants|Number|23|23.0||||||
3871406|NCT01583374|3696920|B1|> 2 to ≤ 5 years||Duration of Ankylosing Spondylitis||participants|Number|29|29.0||||||
3871407|NCT01583374|3696917|B4|≤ 2 years||Duration of Ankylosing Spondylitis||participants|Number|129|129.0||||||
3871408|NCT01583374|3696918|B3|≤ 2 years||Duration of Ankylosing Spondylitis||participants|Number|40|40.0||||||
3871409|NCT01583374|3696919|B2|≤ 2 years||Duration of Ankylosing Spondylitis||participants|Number|48|48.0||||||
3871410|NCT01583374|3696920|B1|≤ 2 years||Duration of Ankylosing Spondylitis||participants|Number|41|41.0||||||
3871411|NCT01583374|3696917|B4|||Duration of Ankylosing Spondylitis (Lower Back Pain and Stiffness)||years|Mean|10.59|10.59|Standard Deviation|10.519|10.519|||
3871412|NCT01583374|3696918|B3|||Duration of Ankylosing Spondylitis (Lower Back Pain and Stiffness)||years|Mean|10.31|10.31|Standard Deviation|9.882|9.882|||
3871413|NCT01583374|3696919|B2|||Duration of Ankylosing Spondylitis (Lower Back Pain and Stiffness)||years|Mean|11.06|11.06|Standard Deviation|11.302|11.302|||
3871414|NCT01583374|3696920|B1|||Duration of Ankylosing Spondylitis (Lower Back Pain and Stiffness)||years|Mean|10.39|10.39|Standard Deviation|10.373|10.373|||
3871415|NCT01583374|3696917|B4||Male|Sex: Female, Male||Participants|Count of Participants|352|352.0||||||
3871416|NCT01583374|3696918|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3871417|NCT01583374|3696919|B2||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3871418|NCT01583374|3696920|B1||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3871419|NCT01583374|3696917|B4||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3871420|NCT01583374|3696918|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3871421|NCT01583374|3696919|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3871422|NCT01583374|3696920|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3871423|NCT01583374|3696917|B4|||Age||years|Mean|44.7|44.7|Standard Deviation|12.18|12.18|||
3871424|NCT01583374|3696918|B3|||Age||years|Mean|44.8|44.8|Standard Deviation|11.75|11.75|||
3871425|NCT01583374|3696919|B2|||Age||years|Mean|45.2|45.2|Standard Deviation|11.90|11.9|||
3871426|NCT01583374|3696920|B1|||Age||years|Mean|44.0|44.0|Standard Deviation|12.89|12.89|||
3871427|NCT01583218|3696932|B3||Male|Sex: Female, Male||Participants|Count of Participants|3425|3425.0||||||
3871428|NCT01583218|3696933|B2||Male|Sex: Female, Male||Participants|Count of Participants|1720|1720.0||||||
3871429|NCT01583218|3696934|B1||Male|Sex: Female, Male||Participants|Count of Participants|1705|1705.0||||||
3871430|NCT01583218|3696932|B3||Female|Sex: Female, Male||Participants|Count of Participants|4088|4088.0||||||
3871431|NCT01583218|3696933|B2||Female|Sex: Female, Male||Participants|Count of Participants|2034|2034.0||||||
3871432|NCT01583218|3696934|B1||Female|Sex: Female, Male||Participants|Count of Participants|2054|2054.0||||||
3871433|NCT01583218|3696932|B3|>=75 years||Age, Customized||Participants|Count of Participants|5092|5092.0||||||
3871434|NCT01583218|3696933|B2|>=75 years||Age, Customized||Participants|Count of Participants|2517|2517.0||||||
3871435|NCT01583218|3696934|B1|>=75 years||Age, Customized||Participants|Count of Participants|2575|2575.0||||||
3871436|NCT01583218|3696932|B3|<75 years||Age, Customized||Participants|Count of Participants|2421|2421.0||||||
3871437|NCT01583218|3696933|B2|<75 years||Age, Customized||Participants|Count of Participants|1237|1237.0||||||
3871438|NCT01583218|3696934|B1|<75 years||Age, Customized||Participants|Count of Participants|1184|1184.0||||||
3871439|NCT01583218|3696932|B3|||Age||years|Mean|76.4|76.4|Standard Deviation|8.39|8.39|||
3871440|NCT01583218|3696933|B2|||Age||years|Mean|76.2|76.2|Standard Deviation|8.31|8.31|||
3871441|NCT01583218|3696934|B1|||Age||years|Mean|76.6|76.6|Standard Deviation|8.46|8.46|||
3871442|NCT01583166|3696953|B3|||Visual Analog Scale for Pain: Preoperative|Participants were asked to report on pre-operative level of pain using a Visual Analog Scale, The scale is participant reported and ranged form 0 representing no pain to 10 representing unbearable pain.|Units on a Scale|Mean|0.0|0.0|Standard Deviation|1.2|1.2|||
3871443|NCT01583166|3696954|B2|||Visual Analog Scale for Pain: Preoperative|Participants were asked to report on pre-operative level of pain using a Visual Analog Scale, The scale is participant reported and ranged form 0 representing no pain to 10 representing unbearable pain.|Units on a Scale|Mean|0.0|0.0|Standard Deviation|1.4|1.4|||
3871444|NCT01583166|3696955|B1|||Visual Analog Scale for Pain: Preoperative|Participants were asked to report on pre-operative level of pain using a Visual Analog Scale, The scale is participant reported and ranged form 0 representing no pain to 10 representing unbearable pain.|Units on a Scale|Mean|0.0|0.0|Standard Deviation|1|1.0|||
3871445|NCT01583166|3696953|B3|United States||Region of Enrollment||Participants|Count of Participants|80|80.0||||||
3871446|NCT01583166|3696954|B2|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3871447|NCT01583166|3696955|B1|United States||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3871448|NCT01583166|3696953|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3871449|NCT01583166|3696954|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3871450|NCT01583166|3696955|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3871451|NCT01583166|3696953|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3871452|NCT01583166|3696954|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3871453|NCT01583166|3696955|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3871454|NCT01583166|3696953|B3|||Age||years|Mean|48.1|48.1|Standard Deviation|11.3|11.3|||
3871455|NCT01583166|3696954|B2|||Age||years|Mean|50.5|50.5|Standard Deviation|11.1|11.1|||
3871456|NCT01583166|3696955|B1|||Age||years|Mean|46.0|46.0|Standard Deviation|11.6|11.6|||
3871457|NCT01583101|3696968|B3|Unknown||Sex/Gender, Customized|We did not record gender for this study, and so it is not known.|Participants|Count of Participants|2237|2237.0||||||
3871458|NCT01583101|3696969|B2|Unknown||Sex/Gender, Customized|We did not record gender for this study, and so it is not known.|Participants|Count of Participants|1161|1161.0||||||
3871459|NCT01583101|3696970|B1|Unknown||Sex/Gender, Customized|We did not record gender for this study, and so it is not known.|Participants|Count of Participants|1076|1076.0||||||
3871460|NCT01583101|3696968|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3871461|NCT01583101|3696969|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3871462|NCT01583101|3696970|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3871463|NCT01583101|3696968|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3871464|NCT01583101|3696969|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3871465|NCT01583101|3696970|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3871466|NCT01583101|3696968|B3||<=18 years|Age||Participants|Count of Participants|2237|2237.0||||||
3871467|NCT01583101|3696969|B2||<=18 years|Age||Participants|Count of Participants|1161|1161.0||||||
3871468|NCT01583101|3696970|B1||<=18 years|Age||Participants|Count of Participants|1076|1076.0||||||
3871469|NCT01582971|3696977|B3|United States||Region of Enrollment||Participants|Count of Participants|256|256.0||||||
3871470|NCT01582971|3696978|B2|United States||Region of Enrollment||Participants|Count of Participants|128|128.0||||||
3871471|NCT01582971|3696979|B1|United States||Region of Enrollment||Participants|Count of Participants|128|128.0||||||
3871472|NCT01582971|3696977|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3871473|NCT01582971|3696978|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3871474|NCT01582971|3696979|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3871475|NCT01582971|3696977|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871476|NCT01582971|3696978|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871477|NCT01582971|3696979|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871478|NCT01582971|3696977|B3||White|Race (NIH/OMB)||Participants|Count of Participants|212|212.0||||||
3871479|NCT01582971|3696978|B2||White|Race (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
3871480|NCT01582971|3696979|B1||White|Race (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
3871481|NCT01582971|3696977|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3871482|NCT01582971|3696978|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3871483|NCT01582971|3696979|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3871484|NCT01582971|3696977|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871485|NCT01582971|3696978|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871486|NCT01582971|3696979|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871487|NCT01582971|3696977|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871488|NCT01582971|3696978|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871489|NCT01582971|3696979|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871490|NCT01582971|3696977|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871491|NCT01582971|3696978|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871492|NCT01582971|3696979|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871493|NCT01582971|3696977|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871494|NCT01582971|3696978|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871495|NCT01582971|3696979|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871496|NCT01582971|3696977|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|245|245.0||||||
3871497|NCT01582971|3696978|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
3871498|NCT01582971|3696979|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
3871499|NCT01582971|3696977|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3871500|NCT01582971|3696978|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3871501|NCT01582971|3696979|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3871502|NCT01582971|3696977|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3871503|NCT01582971|3696978|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3871504|NCT01582971|3696979|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3871505|NCT01582971|3696977|B3||Female|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
3871506|NCT01582971|3696978|B2||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3871507|NCT01582971|3696979|B1||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3871508|NCT01582971|3696977|B3|||Age||years|Mean|56.44|56.44|Standard Deviation|11.08|11.08|||
3871509|NCT01582971|3696978|B2|||Age||years|Mean|54.80|54.8|Standard Deviation|10.30|10.3|||
3871510|NCT01582971|3696979|B1|||Age||years|Mean|58.09|58.09|Standard Deviation|11.62|11.62|||
3871511|NCT01582945|3696998|B1|||Hamilton Rating Scale for Depression|Scores may range from 0-81 with higher scores indicate greater depression severity. In order to be included in the study, participants must have had a Hamilton Depression Rating Scale–28 items (HAM-D28) score ⩾20 at screening.|units on a scale|Mean|28.6|28.6|Standard Deviation|4.8|4.8|||
3871512|NCT01582945|3696998|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3871513|NCT01582945|3696998|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3871514|NCT01582945|3696998|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3871515|NCT01582945|3696998|B1|||Age||years|Mean|50.0|50.0|Standard Deviation|7.8|7.8|||
3871516|NCT01582945|3696998|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3871517|NCT01582945|3696998|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3871518|NCT01582945|3696998|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3871519|NCT01582880|3697002|B1|||corneal thickness measured at 2mm one day post op|"corneal thickness measured at 2mm one day post op is the baseline measurement for this study. This study evaluated cross-linked cornea tissue versus standard of care cornea tissue after transplant procedure. Therefore the measurement at one day post op is the baseline measurement."|µm|Number|940|940.0||||||
3871520|NCT01582880|3697002|B1|||corneal thickness measured at 1mm one day post op|"corneal thickness measured at 1mm one day post op is the baseline measurement for this study. This study evaluated cross-linked cornea tissue versus standard of care cornea tissue after transplant procedure. Therefore the measurement at one day post op is the baseline measurement."|µm|Number|730|730.0||||||
3871521|NCT01582880|3697002|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3871522|NCT01582880|3697002|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871523|NCT01582880|3697002|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871524|NCT01582880|3697002|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3871525|NCT01582880|3697002|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871526|NCT01582880|3697002|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871527|NCT01582880|3697002|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871528|NCT01582880|3697002|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871529|NCT01582880|3697002|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871530|NCT01582880|3697002|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3871531|NCT01582880|3697002|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871532|NCT01582880|3697002|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3871533|NCT01582880|3697002|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3871534|NCT01582880|3697002|B1|||Age||years|Mean|52|52.0|Standard Deviation|NA||||Standard Deviation is not applicable for a single participant
3871535|NCT01582854|3697010|B3|Post-menopausal||Fertility Status of Female Participants|Female participants with available fertility status data only: 120 and 142 participants in each treatment arm, respectively.|participants|Number|254|254.0||||||
3871536|NCT01582854|3697011|B2|Post-menopausal||Fertility Status of Female Participants|Female participants with available fertility status data only: 120 and 142 participants in each treatment arm, respectively.|participants|Number|137|137.0||||||
3871537|NCT01582854|3697012|B1|Post-menopausal||Fertility Status of Female Participants|Female participants with available fertility status data only: 120 and 142 participants in each treatment arm, respectively.|participants|Number|117|117.0||||||
3871538|NCT01582854|3697010|B3|Surgically Sterile/Hysterectomized||Fertility Status of Female Participants|Female participants with available fertility status data only: 120 and 142 participants in each treatment arm, respectively.|participants|Number|8|8.0||||||
3871539|NCT01582854|3697011|B2|Surgically Sterile/Hysterectomized||Fertility Status of Female Participants|Female participants with available fertility status data only: 120 and 142 participants in each treatment arm, respectively.|participants|Number|5|5.0||||||
3871540|NCT01582854|3697012|B1|Surgically Sterile/Hysterectomized||Fertility Status of Female Participants|Female participants with available fertility status data only: 120 and 142 participants in each treatment arm, respectively.|participants|Number|3|3.0||||||
3871541|NCT01582854|3697010|B3|Daily drinker||Alcohol Consumption||participants|Number|1|1.0||||||
3871542|NCT01582854|3697011|B2|Daily drinker||Alcohol Consumption||participants|Number|1|1.0||||||
3871543|NCT01582854|3697012|B1|Daily drinker||Alcohol Consumption||participants|Number|0|0.0||||||
3871544|NCT01582854|3697010|B3|Occasional drinker||Alcohol Consumption||participants|Number|259|259.0||||||
3871545|NCT01582854|3697011|B2|Occasional drinker||Alcohol Consumption||participants|Number|128|128.0||||||
3871546|NCT01582854|3697012|B1|Occasional drinker||Alcohol Consumption||participants|Number|131|131.0||||||
3871547|NCT01582854|3697010|B3|Never drank||Alcohol Consumption||participants|Number|243|243.0||||||
3871548|NCT01582854|3697011|B2|Never drank||Alcohol Consumption||participants|Number|126|126.0||||||
3871549|NCT01582854|3697012|B1|Never drank||Alcohol Consumption||participants|Number|117|117.0||||||
3871550|NCT01582854|3697010|B3|Ex-smoker||Smoking Status||participants|Number|46|46.0||||||
3871551|NCT01582854|3697011|B2|Ex-smoker||Smoking Status||participants|Number|23|23.0||||||
3871552|NCT01582854|3697012|B1|Ex-smoker||Smoking Status||participants|Number|23|23.0||||||
3871553|NCT01582854|3697010|B3|Current smoker||Smoking Status||participants|Number|90|90.0||||||
3871554|NCT01582854|3697011|B2|Current smoker||Smoking Status||participants|Number|37|37.0||||||
3871555|NCT01582854|3697012|B1|Current smoker||Smoking Status||participants|Number|53|53.0||||||
3871556|NCT01582854|3697010|B3|Never smoked||Smoking Status||participants|Number|367|367.0||||||
3871557|NCT01582854|3697011|B2|Never smoked||Smoking Status||participants|Number|195|195.0||||||
3871558|NCT01582854|3697012|B1|Never smoked||Smoking Status||participants|Number|172|172.0||||||
3871559|NCT01582854|3697010|B3|No||Previous Ischaemic Stroke||participants|Number|425|425.0||||||
3871560|NCT01582854|3697011|B2|No||Previous Ischaemic Stroke||participants|Number|217|217.0||||||
3871561|NCT01582854|3697012|B1|No||Previous Ischaemic Stroke||participants|Number|208|208.0||||||
3871562|NCT01582854|3697010|B3|Yes||Previous Ischaemic Stroke||participants|Number|78|78.0||||||
3871563|NCT01582854|3697011|B2|Yes||Previous Ischaemic Stroke||participants|Number|38|38.0||||||
3871564|NCT01582854|3697012|B1|Yes||Previous Ischaemic Stroke||participants|Number|40|40.0||||||
3871565|NCT01582854|3697010|B3|No||Ischaemic Heart Disease or Peripheral Artery Disease||participants|Number|5|5.0||||||
3871566|NCT01582854|3697011|B2|No||Ischaemic Heart Disease or Peripheral Artery Disease||participants|Number|2|2.0||||||
3871567|NCT01582854|3697012|B1|No||Ischaemic Heart Disease or Peripheral Artery Disease||participants|Number|3|3.0||||||
3871568|NCT01582854|3697010|B3|Yes||Ischaemic Heart Disease or Peripheral Artery Disease||participants|Number|498|498.0||||||
3871569|NCT01582854|3697011|B2|Yes||Ischaemic Heart Disease or Peripheral Artery Disease||participants|Number|253|253.0||||||
3871570|NCT01582854|3697012|B1|Yes||Ischaemic Heart Disease or Peripheral Artery Disease||participants|Number|245|245.0||||||
3871571|NCT01582854|3697010|B3|No||Diabetes||participants|Number|406|406.0||||||
3871572|NCT01582854|3697011|B2|No||Diabetes||participants|Number|198|198.0||||||
3871573|NCT01582854|3697012|B1|No||Diabetes||participants|Number|208|208.0||||||
3871574|NCT01582854|3697010|B3|Yes||Diabetes||participants|Number|97|97.0||||||
3871575|NCT01582854|3697011|B2|Yes||Diabetes||participants|Number|57|57.0||||||
3871576|NCT01582854|3697012|B1|Yes||Diabetes||participants|Number|40|40.0||||||
3871577|NCT01582854|3697010|B3|||Number of Years of Education||years|Mean|12.3|12.3|Standard Deviation|3.40|3.4|||
3871578|NCT01582854|3697011|B2|||Number of Years of Education||years|Mean|12.3|12.3|Standard Deviation|3.40|3.4|||
3871579|NCT01582854|3697012|B1|||Number of Years of Education||years|Mean|12.2|12.2|Standard Deviation|3.41|3.41|||
3871580|NCT01582854|3697010|B3|||Weight||kg|Mean|78.1|78.1|Standard Deviation|13.73|13.73|||
3871581|NCT01582854|3697011|B2|||Weight||kg|Mean|78.0|78.0|Standard Deviation|13.73|13.73|||
3871582|NCT01582854|3697012|B1|||Weight||kg|Mean|78.3|78.3|Standard Deviation|13.76|13.76|||
3871583|NCT01582854|3697010|B3|||Height||cm|Mean|167.4|167.4|Standard Deviation|7.68|7.68|||
3871584|NCT01582854|3697011|B2|||Height||cm|Mean|167.2|167.2|Standard Deviation|7.89|7.89|||
3871585|NCT01582854|3697012|B1|||Height||cm|Mean|167.6|167.6|Standard Deviation|7.47|7.47|||
3871586|NCT01582854|3697010|B3|Belarus||Region of Enrollment||participants|Number|114|114.0||||||
3871587|NCT01582854|3697011|B2|Belarus||Region of Enrollment||participants|Number|58|58.0||||||
3871588|NCT01582854|3697012|B1|Belarus||Region of Enrollment||participants|Number|56|56.0||||||
3871589|NCT01582854|3697010|B3|Kazakhstan||Region of Enrollment||participants|Number|4|4.0||||||
3871590|NCT01582854|3697011|B2|Kazakhstan||Region of Enrollment||participants|Number|2|2.0||||||
3871591|NCT01582854|3697012|B1|Kazakhstan||Region of Enrollment||participants|Number|2|2.0||||||
3871592|NCT01582854|3697010|B3|Russia||Region of Enrollment||participants|Number|385|385.0||||||
3871593|NCT01582854|3697011|B2|Russia||Region of Enrollment||participants|Number|195|195.0||||||
3871594|NCT01582854|3697012|B1|Russia||Region of Enrollment||participants|Number|190|190.0||||||
3871595|NCT01582854|3697010|B3|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3871596|NCT01582854|3697011|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3871597|NCT01582854|3697012|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3871598|NCT01582854|3697010|B3|White||Race/Ethnicity, Customized||participants|Number|488|488.0||||||
3871599|NCT01582854|3697011|B2|White||Race/Ethnicity, Customized||participants|Number|248|248.0||||||
3871600|NCT01582854|3697012|B1|White||Race/Ethnicity, Customized||participants|Number|240|240.0||||||
3871601|NCT01582854|3697010|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3871602|NCT01582854|3697011|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3871603|NCT01582854|3697012|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3871604|NCT01582854|3697010|B3|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3871605|NCT01582854|3697011|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3871606|NCT01582854|3697012|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3871607|NCT01582854|3697010|B3||Male|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
3871608|NCT01582854|3697011|B2||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3871609|NCT01582854|3697012|B1||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3871610|NCT01582854|3697010|B3||Female|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
3871611|NCT01582854|3697011|B2||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3871612|NCT01582854|3697012|B1||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3871613|NCT01582854|3697010|B3|> 65 years||Age, Customized||participants|Number|328|328.0||||||
3871614|NCT01582854|3697011|B2|> 65 years||Age, Customized||participants|Number|158|158.0||||||
3871615|NCT01582854|3697012|B1|> 65 years||Age, Customized||participants|Number|170|170.0||||||
3871616|NCT01582854|3697010|B3|≤ 65 years||Age, Customized||participants|Number|175|175.0||||||
3871617|NCT01582854|3697011|B2|≤ 65 years||Age, Customized||participants|Number|97|97.0||||||
3871618|NCT01582854|3697012|B1|≤ 65 years||Age, Customized||participants|Number|78|78.0||||||
3871619|NCT01582854|3697010|B3|||Age||years|Mean|69.9|69.9|Standard Deviation|6.92|6.92|||
3871620|NCT01582854|3697011|B2|||Age||years|Mean|69.6|69.6|Standard Deviation|7.18|7.18|||
3871621|NCT01582854|3697012|B1|||Age||years|Mean|70.3|70.3|Standard Deviation|6.65|6.65|||
3871622|NCT01582789|3697041|B1|United States||Region of Enrollment||participants|Number|61|61.0||||||
3871623|NCT01582789|3697041|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3871624|NCT01582789|3697041|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3871625|NCT01582789|3697041|B1|||Age||years|Median|30|30.0|Full Range|||19.0|38.0|
3871626|NCT01582490|3697058|B3|ASA Class 2||ASA Classification|There were 19 subjects enrolled. 8 subjects in the Infiltration - EXPAREL group were in the safety analysis set. 10 subjects in the Instillation - EXPAREL group were in the safety analysis set. ASA Class 1 is defined as a normal healthy subject; ASA Class 2 is defined as a subject with mild systemic disease.|participants|Number|4|4.0||||||
3871627|NCT01582490|3697059|B2|ASA Class 2||ASA Classification|There were 19 subjects enrolled. 8 subjects in the Infiltration - EXPAREL group were in the safety analysis set. 10 subjects in the Instillation - EXPAREL group were in the safety analysis set. ASA Class 1 is defined as a normal healthy subject; ASA Class 2 is defined as a subject with mild systemic disease.|participants|Number|1|1.0||||||
3871628|NCT01582490|3697060|B1|ASA Class 2||ASA Classification|There were 19 subjects enrolled. 8 subjects in the Infiltration - EXPAREL group were in the safety analysis set. 10 subjects in the Instillation - EXPAREL group were in the safety analysis set. ASA Class 1 is defined as a normal healthy subject; ASA Class 2 is defined as a subject with mild systemic disease.|participants|Number|3|3.0||||||
3871629|NCT01582490|3697058|B3|ASA Class 1||ASA Classification|There were 19 subjects enrolled. 8 subjects in the Infiltration - EXPAREL group were in the safety analysis set. 10 subjects in the Instillation - EXPAREL group were in the safety analysis set. ASA Class 1 is defined as a normal healthy subject; ASA Class 2 is defined as a subject with mild systemic disease.|participants|Number|14|14.0||||||
3871630|NCT01582490|3697059|B2|ASA Class 1||ASA Classification|There were 19 subjects enrolled. 8 subjects in the Infiltration - EXPAREL group were in the safety analysis set. 10 subjects in the Instillation - EXPAREL group were in the safety analysis set. ASA Class 1 is defined as a normal healthy subject; ASA Class 2 is defined as a subject with mild systemic disease.|participants|Number|9|9.0||||||
3871631|NCT01582490|3697060|B1|ASA Class 1||ASA Classification|There were 19 subjects enrolled. 8 subjects in the Infiltration - EXPAREL group were in the safety analysis set. 10 subjects in the Instillation - EXPAREL group were in the safety analysis set. ASA Class 1 is defined as a normal healthy subject; ASA Class 2 is defined as a subject with mild systemic disease.|participants|Number|5|5.0||||||
3871632|NCT01582490|3697058|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
3871633|NCT01582490|3697059|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3871634|NCT01582490|3697060|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3871635|NCT01582490|3697058|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3871636|NCT01582490|3697059|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3871637|NCT01582490|3697060|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3871638|NCT01582490|3697058|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3871639|NCT01582490|3697059|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3871640|NCT01582490|3697060|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3871641|NCT01582490|3697058|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3871642|NCT01582490|3697059|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3871643|NCT01582490|3697060|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3871644|NCT01582490|3697058|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3871645|NCT01582490|3697059|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3871646|NCT01582490|3697060|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3871647|NCT01582490|3697058|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3871648|NCT01582490|3697059|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3871649|NCT01582490|3697060|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3871650|NCT01582490|3697058|B3|||Age||years|Mean|28.8|28.8|Standard Deviation|9.57|9.57|||
3871651|NCT01582490|3697059|B2|||Age||years|Mean|29.7|29.7|Standard Deviation|11.41|11.41|||
3871652|NCT01582490|3697060|B1|||Age||years|Mean|27.8|27.8|Standard Deviation|7.25|7.25|||
3871653|NCT01582477|3697081|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
3871654|NCT01582477|3697082|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3871655|NCT01582477|3697083|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3871656|NCT01582477|3697081|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3871657|NCT01582477|3697082|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3871658|NCT01582477|3697083|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3871659|NCT01582477|3697081|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3871660|NCT01582477|3697082|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3871661|NCT01582477|3697083|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3871662|NCT01582477|3697081|B3|||Age||years|Mean|61.2|61.2|Standard Deviation|6.99|6.99|||
3871663|NCT01582477|3697082|B2|||Age||years|Mean|61.7|61.7|Standard Deviation|7.01|7.01|||
3871664|NCT01582477|3697083|B1|||Age||years|Mean|60.7|60.7|Standard Deviation|7.24|7.24|||
3871665|NCT01582477|3697081|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3871666|NCT01582477|3697082|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3871667|NCT01582477|3697083|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3871668|NCT01582477|3697081|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3871669|NCT01582477|3697082|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3871670|NCT01582477|3697083|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3871671|NCT01582477|3697081|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3871672|NCT01582477|3697082|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3871673|NCT01582477|3697083|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3871674|NCT01582451|3697100|B3|Germany||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3871675|NCT01582451|3697101|B2|Germany||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3871676|NCT01582451|3697102|B1|Germany||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3871677|NCT01582451|3697100|B3|Russia||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3871678|NCT01582451|3697101|B2|Russia||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3871679|NCT01582451|3697102|B1|Russia||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3871680|NCT01582451|3697100|B3|Israel||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3871681|NCT01582451|3697101|B2|Israel||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3871682|NCT01582451|3697102|B1|Israel||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3871683|NCT01582451|3697100|B3|Romania||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3871684|NCT01582451|3697101|B2|Romania||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3871685|NCT01582451|3697102|B1|Romania||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3871686|NCT01582451|3697100|B3|Spain||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3871687|NCT01582451|3697101|B2|Spain||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3871688|NCT01582451|3697102|B1|Spain||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3871689|NCT01582451|3697100|B3|Greece||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3871690|NCT01582451|3697101|B2|Greece||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3871691|NCT01582451|3697102|B1|Greece||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3871692|NCT01582451|3697100|B3|Czechia||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3871693|NCT01582451|3697101|B2|Czechia||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3871694|NCT01582451|3697102|B1|Czechia||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3871695|NCT01582451|3697100|B3|United States||Region of Enrollment||Participants|Count of Participants|255|255.0||||||
3871696|NCT01582451|3697101|B2|United States||Region of Enrollment||Participants|Count of Participants|85|85.0||||||
3871697|NCT01582451|3697102|B1|United States||Region of Enrollment||Participants|Count of Participants|170|170.0||||||
3871698|NCT01582451|3697100|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3871699|NCT01582451|3697101|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871700|NCT01582451|3697102|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3871701|NCT01582451|3697100|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3871702|NCT01582451|3697101|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871703|NCT01582451|3697102|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3871704|NCT01582451|3697100|B3||White|Race (NIH/OMB)||Participants|Count of Participants|428|428.0||||||
3871705|NCT01582451|3697101|B2||White|Race (NIH/OMB)||Participants|Count of Participants|148|148.0||||||
3871706|NCT01582451|3697102|B1||White|Race (NIH/OMB)||Participants|Count of Participants|280|280.0||||||
3871707|NCT01582451|3697100|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3871708|NCT01582451|3697101|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3871709|NCT01582451|3697102|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3871710|NCT01582451|3697100|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3871711|NCT01582451|3697101|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871712|NCT01582451|3697102|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3871713|NCT01582451|3697100|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3871714|NCT01582451|3697101|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3871715|NCT01582451|3697102|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3871716|NCT01582451|3697100|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3871717|NCT01582451|3697101|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871718|NCT01582451|3697102|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3871719|NCT01582451|3697100|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3871720|NCT01582451|3697101|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3871721|NCT01582451|3697102|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3871722|NCT01582451|3697100|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|330|330.0||||||
3871723|NCT01582451|3697101|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
3871724|NCT01582451|3697102|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|215|215.0||||||
3871725|NCT01582451|3697100|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3871726|NCT01582451|3697101|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3871727|NCT01582451|3697102|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3871728|NCT01582451|3697100|B3||Male|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
3871729|NCT01582451|3697101|B2||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3871730|NCT01582451|3697102|B1||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
3871731|NCT01582451|3697100|B3||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
3871732|NCT01582451|3697101|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3871733|NCT01582451|3697102|B1||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3871734|NCT01582451|3697100|B3|||Age||years|Mean|61.34|61.34|Standard Deviation|9.11|9.11|||
3871735|NCT01582451|3697101|B2|||Age||years|Mean|60.38|60.38|Standard Deviation|10.10|10.1|||
3871736|NCT01582451|3697102|B1|||Age||years|Mean|61.84|61.84|Standard Deviation|8.52|8.52|||
3871737|NCT01582308|3697145|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3871738|NCT01582308|3697145|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3871739|NCT01582308|3697145|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3871740|NCT01582308|3697145|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3871741|NCT01582308|3697145|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3871742|NCT01582282|3697179|B4|United States||Region of Enrollment||participants|Number|37|37.0||||||
3871743|NCT01582282|3697180|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3871744|NCT01582282|3697181|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3871745|NCT01582282|3697182|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3871746|NCT01582282|3697179|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3871747|NCT01582282|3697180|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3871748|NCT01582282|3697181|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3871749|NCT01582282|3697182|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3871750|NCT01582282|3697179|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3871751|NCT01582282|3697180|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3871752|NCT01582282|3697181|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3871753|NCT01582282|3697182|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3871754|NCT01582282|3697179|B4|||Age||years|Mean|61.8|61.8|Standard Deviation|9.43|9.43|||
3871755|NCT01582282|3697180|B3|||Age||years|Mean|56.5|56.5|Standard Deviation|9.99|9.99|||
3871756|NCT01582282|3697181|B2|||Age||years|Mean|64.8|64.8|Standard Deviation|8.42|8.42|||
3871757|NCT01582282|3697182|B1|||Age||years|Mean|61.8|61.8|Standard Deviation|9.39|9.39|||
3871758|NCT01582282|3697179|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3871759|NCT01582282|3697180|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3871760|NCT01582282|3697181|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3871761|NCT01582282|3697182|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3871762|NCT01582282|3697179|B4||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3871763|NCT01582282|3697180|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3871764|NCT01582282|3697181|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3871765|NCT01582282|3697182|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3871766|NCT01582282|3697179|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3871767|NCT01582282|3697180|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3871768|NCT01582282|3697181|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3871769|NCT01582282|3697182|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3871770|NCT01582243|3697207|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3871771|NCT01582243|3697207|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3871772|NCT01582243|3697207|B1|||Age||years|Mean|53.9|53.9|Standard Deviation|11.9|11.9|||
3871773|NCT01582178|3697216|B3|Czech Republic||Region of Enrollment||participants|Number|212|212.0||||||
3871774|NCT01582178|3697217|B2|Czech Republic||Region of Enrollment||participants|Number|106|106.0||||||
3871775|NCT01582178|3697218|B1|Czech Republic||Region of Enrollment||participants|Number|106|106.0||||||
3871776|NCT01582178|3697216|B3||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3871777|NCT01582178|3697217|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3871778|NCT01582178|3697218|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3871779|NCT01582178|3697216|B3||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3871780|NCT01582178|3697217|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3871781|NCT01582178|3697218|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3871782|NCT01582178|3697216|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|13.4|13.4|||
3871783|NCT01582178|3697217|B2|||Age||years|Mean|57.8|57.8|Standard Deviation|14.2|14.2|||
3871784|NCT01582178|3697218|B1|||Age||years|Mean|61.2|61.2|Standard Deviation|12.7|12.7|||
3871785|NCT01582178|3697216|B3||>=65 years|Age||Participants|Count of Participants|122|122.0||||||
3871786|NCT01582178|3697217|B2||>=65 years|Age||Participants|Count of Participants|63|63.0||||||
3871787|NCT01582178|3697218|B1||>=65 years|Age||Participants|Count of Participants|59|59.0||||||
3871788|NCT01582178|3697216|B3||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
3871789|NCT01582178|3697217|B2||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
3871790|NCT01582178|3697218|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3871791|NCT01582178|3697216|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3871792|NCT01582178|3697217|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3871793|NCT01582178|3697218|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3871794|NCT01582139|3697225|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3871795|NCT01582139|3697226|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3871796|NCT01582139|3697227|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3871797|NCT01582139|3697225|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3871798|NCT01582139|3697226|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3871799|NCT01582139|3697227|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3871800|NCT01582139|3697225|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3871801|NCT01582139|3697226|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3871802|NCT01582139|3697227|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3871803|NCT01582139|3697225|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3871804|NCT01582139|3697226|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3871805|NCT01582139|3697227|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3871806|NCT01582139|3697225|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3871807|NCT01582139|3697226|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3871808|NCT01582139|3697227|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3871809|NCT01582100|3697240|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3871810|NCT01582100|3697240|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3871811|NCT01582100|3697240|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3871812|NCT01582100|3697240|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3871813|NCT01582100|3697240|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3871814|NCT01582061|3697244|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3871815|NCT01582061|3697245|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3871816|NCT01582061|3697246|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3871817|NCT01582061|3697244|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871818|NCT01582061|3697245|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871819|NCT01582061|3697246|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871820|NCT01582061|3697244|B3||White|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3871821|NCT01582061|3697245|B2||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3871822|NCT01582061|3697246|B1||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3871823|NCT01582061|3697244|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3871824|NCT01582061|3697245|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3871825|NCT01582061|3697246|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3871826|NCT01582061|3697244|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871827|NCT01582061|3697245|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871828|NCT01582061|3697246|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871829|NCT01582061|3697244|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3871830|NCT01582061|3697245|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3871831|NCT01582061|3697246|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3871832|NCT01582061|3697244|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871833|NCT01582061|3697245|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871834|NCT01582061|3697246|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871835|NCT01582061|3697244|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3871836|NCT01582061|3697245|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3871837|NCT01582061|3697246|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3871838|NCT01582061|3697244|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3871839|NCT01582061|3697245|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3871840|NCT01582061|3697246|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3871841|NCT01582061|3697244|B3|||Age||years|Mean|42.5|42.5|Standard Deviation|13.07|13.07|||
3871842|NCT01582061|3697245|B2|||Age||years|Mean|39.9|39.9|Standard Deviation|12.55|12.55|||
3871843|NCT01582061|3697246|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|13.14|13.14|||
3871844|NCT01582009|3697297|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3871845|NCT01582009|3697297|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871846|NCT01582009|3697297|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3871847|NCT01582009|3697297|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3871848|NCT01582009|3697297|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871849|NCT01582009|3697297|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871850|NCT01582009|3697297|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871851|NCT01582009|3697297|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3871852|NCT01582009|3697297|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3871853|NCT01582009|3697297|B1|||Age||years|Mean|62.4|62.4|Standard Deviation|10.6|10.6|||
3871854|NCT01582009|3697297|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3871855|NCT01582009|3697297|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3871856|NCT01582009|3697297|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3871857|NCT01581931|3697305|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3871858|NCT01581931|3697305|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3871859|NCT01581931|3697305|B1|||Age||years|Mean|38.8|38.8|Standard Deviation|9.9|9.9|||
3871860|NCT01581710|3697320|B1|||oscillometric lung fuction(Reactance at 5Hz, z-score)||z-score|Mean|-1.14|-1.14|Standard Deviation|0.55|0.55|||
3871861|NCT01581710|3697320|B1|||oscillometric lung function (Resistance at 5Hz, z-score)||z-score|Mean|0.36|0.36|Standard Deviation|0.25|0.25|||
3871862|NCT01581710|3697320|B1|||Lung function (Forced Expiratory Volume 1/Forced Vital Capacity, predicted %)||%|Mean|86.1|86.1|Standard Deviation|2.7|2.7|||
3871863|NCT01581710|3697320|B1|||Lung function (Forced Expiratory Volume 1, predicted %)||%|Mean|92.9|92.9|Standard Deviation|4.4|4.4|||
3871864|NCT01581710|3697320|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3871865|NCT01581710|3697320|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3871866|NCT01581710|3697320|B1|||Age||years|Mean|6.41|6.41|Standard Deviation|0.88|0.88|||
3871867|NCT01581684|3697349|B11||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3871868|NCT01581684|3697350|B10||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3871869|NCT01581684|3697351|B9||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3871870|NCT01581684|3697352|B8||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3871871|NCT01581684|3697353|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3871872|NCT01581684|3697354|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3871873|NCT01581684|3697355|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3871874|NCT01581684|3697356|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3871875|NCT01581684|3697357|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3871876|NCT01581684|3697358|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3871877|NCT01581684|3697359|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3871878|NCT01581684|3697349|B11||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3871879|NCT01581684|3697350|B10||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3871880|NCT01581684|3697351|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3871881|NCT01581684|3697352|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3871882|NCT01581684|3697353|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3871883|NCT01581684|3697354|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3871884|NCT01581684|3697355|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3871885|NCT01581684|3697356|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3871886|NCT01581684|3697357|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3871887|NCT01581684|3697358|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3871888|NCT01581684|3697359|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3871889|NCT01581684|3697349|B11|||Age||years|Mean|38.6|38.6|Standard Deviation|7.1|7.1|||
3871890|NCT01581684|3697350|B10|||Age||years|Mean|42.4|42.4|Standard Deviation|8.6|8.6|||
3871891|NCT01581684|3697351|B9|||Age||years|Mean|31.0|31.0|Standard Deviation|NA||||Measure of dispersion not possible to calculated for one participant
3871892|NCT01581684|3697352|B8|||Age||years|Mean|43.8|43.8|Standard Deviation|6.7|6.7|||
3871893|NCT01581684|3697353|B7|||Age||years|Mean|32.7|32.7|Standard Deviation|5.4|5.4|||
3871894|NCT01581684|3697354|B6|||Age||years|Mean|39.5|39.5|Standard Deviation|3.1|3.1|||
3871895|NCT01581684|3697355|B5|||Age||years|Mean|38.3|38.3|Standard Deviation|8.2|8.2|||
3871896|NCT01581684|3697356|B4|||Age||years|Mean|38.8|38.8|Standard Deviation|8.7|8.7|||
3871897|NCT01581684|3697357|B3|||Age||years|Mean|39.8|39.8|Standard Deviation|4.3|4.3|||
3871898|NCT01581684|3697358|B2|||Age||years|Mean|35.5|35.5|Standard Deviation|9.9|9.9|||
3871899|NCT01581684|3697359|B1|||Age||years|Mean|38.4|38.4|Standard Deviation|6.3|6.3|||
3871900|NCT01581658|3697439|B5||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3871901|NCT01581658|3697440|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3871902|NCT01581658|3697441|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3871903|NCT01581658|3697442|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3871904|NCT01581658|3697443|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3871905|NCT01581658|3697439|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3871906|NCT01581658|3697440|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3871907|NCT01581658|3697441|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3871908|NCT01581658|3697442|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3871909|NCT01581658|3697443|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3871910|NCT01581658|3697439|B5|||Age||years|Mean|65.5|65.5|Standard Deviation|5.6|5.6|||
3871911|NCT01581658|3697440|B4|||Age||years|Mean|62.0|62.0|Standard Deviation|7.9|7.9|||
3871912|NCT01581658|3697441|B3|||Age||years|Mean|65.9|65.9|Standard Deviation|5.5|5.5|||
3871913|NCT01581658|3697442|B2|||Age||years|Mean|67.5|67.5|Standard Deviation|4.4|4.4|||
3871914|NCT01581658|3697443|B1|||Age||years|Mean|66.8|66.8|Standard Deviation|3.1|3.1|||
3871915|NCT01581619|3697464|B1|Other||Histologic Grade|Differentiation refers to how similar cancer tissue is to normal tissue. Well differentiated cancer tissue looks more like normal tissue and tends to grow or spread more slowly than poorly differentiated cancer tissue which looks less like normal tissue.|Participants|Count of Participants|5|5.0||||||
3871916|NCT01581619|3697464|B1|Poorly Differentiated||Histologic Grade|Differentiation refers to how similar cancer tissue is to normal tissue. Well differentiated cancer tissue looks more like normal tissue and tends to grow or spread more slowly than poorly differentiated cancer tissue which looks less like normal tissue.|Participants|Count of Participants|1|1.0||||||
3871917|NCT01581619|3697464|B1|Moderately Differentiated||Histologic Grade|Differentiation refers to how similar cancer tissue is to normal tissue. Well differentiated cancer tissue looks more like normal tissue and tends to grow or spread more slowly than poorly differentiated cancer tissue which looks less like normal tissue.|Participants|Count of Participants|26|26.0||||||
3871918|NCT01581619|3697464|B1|Well Differentiated||Histologic Grade|Differentiation refers to how similar cancer tissue is to normal tissue. Well differentiated cancer tissue looks more like normal tissue and tends to grow or spread more slowly than poorly differentiated cancer tissue which looks less like normal tissue.|Participants|Count of Participants|21|21.0||||||
3871919|NCT01581619|3697464|B1|Negative||Progesterone Receptor|Test for the presence of Progesterone receptors on the cancer cells. Positive indicates that they are present, Few/ faint cells indicates a borderline result, negative indicates they were not detected.|Participants|Count of Participants|3|3.0||||||
3871920|NCT01581619|3697464|B1|Few/ Faint Cells||Progesterone Receptor|Test for the presence of Progesterone receptors on the cancer cells. Positive indicates that they are present, Few/ faint cells indicates a borderline result, negative indicates they were not detected.|Participants|Count of Participants|3|3.0||||||
3871921|NCT01581619|3697464|B1|Positive||Progesterone Receptor|Test for the presence of Progesterone receptors on the cancer cells. Positive indicates that they are present, Few/ faint cells indicates a borderline result, negative indicates they were not detected.|Participants|Count of Participants|47|47.0||||||
3871922|NCT01581619|3697464|B1|Negative||Estrogen Receptor|"Test whether the cancer cells express estrogen receptors.~Positive: Estrogen receptors detected~Negative: Estrogen receptors not detected"|Participants|Count of Participants|0|0.0||||||
3871923|NCT01581619|3697464|B1|Positive||Estrogen Receptor|"Test whether the cancer cells express estrogen receptors.~Positive: Estrogen receptors detected~Negative: Estrogen receptors not detected"|Participants|Count of Participants|53|53.0||||||
3871924|NCT01581619|3697464|B1|Not Done||Her2 IHC|Immunohistochemistry (IHC) test to show if the tumor cells have Her2 receptors on their surface. IHC test gives a score from 0 to 3+ that measures the amount of Her2 receptor protein on the surface of the cancer cells. A score of either 0 or 1+ is considered Her2 negative, a score of 2+ is considered borderline, a score of 3+ is considered positive. The positive result means that the cells are expressing the Her2 protein.|Participants|Count of Participants|14|14.0||||||
3871925|NCT01581619|3697464|B1|(0, 1+) Her2 Negative||Her2 IHC|Immunohistochemistry (IHC) test to show if the tumor cells have Her2 receptors on their surface. IHC test gives a score from 0 to 3+ that measures the amount of Her2 receptor protein on the surface of the cancer cells. A score of either 0 or 1+ is considered Her2 negative, a score of 2+ is considered borderline, a score of 3+ is considered positive. The positive result means that the cells are expressing the Her2 protein.|Participants|Count of Participants|34|34.0||||||
3871926|NCT01581619|3697464|B1|(2+) / Borderline||Her2 IHC|Immunohistochemistry (IHC) test to show if the tumor cells have Her2 receptors on their surface. IHC test gives a score from 0 to 3+ that measures the amount of Her2 receptor protein on the surface of the cancer cells. A score of either 0 or 1+ is considered Her2 negative, a score of 2+ is considered borderline, a score of 3+ is considered positive. The positive result means that the cells are expressing the Her2 protein.|Participants|Count of Participants|4|4.0||||||
3871927|NCT01581619|3697464|B1|(3+) / Her2 Positive||Her2 IHC|Immunohistochemistry (IHC) test to show if the tumor cells have Her2 receptors on their surface. IHC test gives a score from 0 to 3+ that measures the amount of Her2 receptor protein on the surface of the cancer cells. A score of either 0 or 1+ is considered Her2 negative, a score of 2+ is considered borderline, a score of 3+ is considered positive. The positive result means that the cells are expressing the Her2 protein.|Participants|Count of Participants|1|1.0||||||
3871928|NCT01581619|3697464|B1|Not Done||Her2 FISH|FISH (Fluorescence In Situ Hybridization) test for expression of Her2 (human epidermal growth factor receptor 2). Positive results indicate that Her2 is being expressed while negative indicates that Her2 is not expressed.|Participants|Count of Participants|12|12.0||||||
3871929|NCT01581619|3697464|B1|Positive||Her2 FISH|FISH (Fluorescence In Situ Hybridization) test for expression of Her2 (human epidermal growth factor receptor 2). Positive results indicate that Her2 is being expressed while negative indicates that Her2 is not expressed.|Participants|Count of Participants|1|1.0||||||
3871967|NCT01581541|3697472|B1||Adenocarcinoma, not otherwise specified|Diagnosis||Participants|Count of Participants|6|6.0||||||
3871968|NCT01581541|3697472|B1||Rectal adenocarcinoma|Diagnosis||Participants|Count of Participants|1|1.0||||||
3871930|NCT01581619|3697464|B1|Negative||Her2 FISH|FISH (Fluorescence In Situ Hybridization) test for expression of Her2 (human epidermal growth factor receptor 2). Positive results indicate that Her2 is being expressed while negative indicates that Her2 is not expressed.|Participants|Count of Participants|40|40.0||||||
3871931|NCT01581619|3697464|B1|T1c||T staging|"T staging uses T plus a number (0 to 4) to describe the size and location of the tumor~Tis: Refers to carcinoma in situ, meaning the cancer is confined within the lobules or ducts of the breast tissue and has not spread into the surrounding tissue of the breast.~T1: The invasive part of the tumor is less than or equal to 20 millimeters (mm) at its widest diameter. T1 is further broken down to 3 sub-stages by size (a-c)~T1a: Tumor is larger than 1mm, but 5 mm or smaller~T1b: Tumor is larger than 5mm, but 10 mm or smaller~T1c: Tumor is larger than 10mm, but 20 mm or smaller"|Participants|Count of Participants|6|6.0||||||
3871932|NCT01581619|3697464|B1|T1b||T staging|"T staging uses T plus a number (0 to 4) to describe the size and location of the tumor~Tis: Refers to carcinoma in situ, meaning the cancer is confined within the lobules or ducts of the breast tissue and has not spread into the surrounding tissue of the breast.~T1: The invasive part of the tumor is less than or equal to 20 millimeters (mm) at its widest diameter. T1 is further broken down to 3 sub-stages by size (a-c)~T1a: Tumor is larger than 1mm, but 5 mm or smaller~T1b: Tumor is larger than 5mm, but 10 mm or smaller~T1c: Tumor is larger than 10mm, but 20 mm or smaller"|Participants|Count of Participants|22|22.0||||||
3871933|NCT01581619|3697464|B1|T1a||T staging|"T staging uses T plus a number (0 to 4) to describe the size and location of the tumor~Tis: Refers to carcinoma in situ, meaning the cancer is confined within the lobules or ducts of the breast tissue and has not spread into the surrounding tissue of the breast.~T1: The invasive part of the tumor is less than or equal to 20 millimeters (mm) at its widest diameter. T1 is further broken down to 3 sub-stages by size (a-c)~T1a: Tumor is larger than 1mm, but 5 mm or smaller~T1b: Tumor is larger than 5mm, but 10 mm or smaller~T1c: Tumor is larger than 10mm, but 20 mm or smaller"|Participants|Count of Participants|17|17.0||||||
3871934|NCT01581619|3697464|B1|Tis||T staging|"T staging uses T plus a number (0 to 4) to describe the size and location of the tumor~Tis: Refers to carcinoma in situ, meaning the cancer is confined within the lobules or ducts of the breast tissue and has not spread into the surrounding tissue of the breast.~T1: The invasive part of the tumor is less than or equal to 20 millimeters (mm) at its widest diameter. T1 is further broken down to 3 sub-stages by size (a-c)~T1a: Tumor is larger than 1mm, but 5 mm or smaller~T1b: Tumor is larger than 5mm, but 10 mm or smaller~T1c: Tumor is larger than 10mm, but 20 mm or smaller"|Participants|Count of Participants|8|8.0||||||
3871935|NCT01581619|3697464|B1|Stage 1||Stage|"Breast Cancer Staging:~Stage 0: No tumor in lymph nodes; Carcinoma in situ: with cancer cells within lobules and ducts only (no invasion)~Stage 1: Small invasive tumor that has not spread to the lymph nodes"|Participants|Count of Participants|45|45.0||||||
3871936|NCT01581619|3697464|B1|Stage 0||Stage|"Breast Cancer Staging:~Stage 0: No tumor in lymph nodes; Carcinoma in situ: with cancer cells within lobules and ducts only (no invasion)~Stage 1: Small invasive tumor that has not spread to the lymph nodes"|Participants|Count of Participants|8|8.0||||||
3871937|NCT01581619|3697464|B1|Right Breast||Side of the breast cancer||Participants|Count of Participants|26|26.0||||||
3871938|NCT01581619|3697464|B1|Left Breast||Side of the breast cancer||Participants|Count of Participants|27|27.0||||||
3871939|NCT01581619|3697464|B1|Other||Method of Initial Diagnosis||Participants|Count of Participants|1|1.0||||||
3871940|NCT01581619|3697464|B1|MRI ( magnetic resonance imaging)||Method of Initial Diagnosis||Participants|Count of Participants|1|1.0||||||
3871941|NCT01581619|3697464|B1|Mammogram||Method of Initial Diagnosis||Participants|Count of Participants|51|51.0||||||
3871942|NCT01581619|3697464|B1|United States||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
3871943|NCT01581619|3697464|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3871944|NCT01581619|3697464|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871945|NCT01581619|3697464|B1||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3871946|NCT01581619|3697464|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3871947|NCT01581619|3697464|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871948|NCT01581619|3697464|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871949|NCT01581619|3697464|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871950|NCT01581619|3697464|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3871951|NCT01581619|3697464|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3871952|NCT01581619|3697464|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3871953|NCT01581619|3697464|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3871954|NCT01581619|3697464|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3871955|NCT01581619|3697464|B1|||Age||years|Median|62|62.0|Full Range|||47.0|84.0|
3871956|NCT01581619|3697464|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3871957|NCT01581619|3697464|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3871958|NCT01581619|3697464|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3871959|NCT01581541|3697472|B1||Non-small cell lung cancer|Diagnosis||Participants|Count of Participants|1|1.0||||||
3871960|NCT01581541|3697472|B1||Synovial sarcoma|Diagnosis||Participants|Count of Participants|2|2.0||||||
3871961|NCT01581541|3697472|B1||Squamous cell carcinoma of the esophagus|Diagnosis||Participants|Count of Participants|1|1.0||||||
3871962|NCT01581541|3697472|B1||Carcinoid tumor|Diagnosis||Participants|Count of Participants|1|1.0||||||
3871963|NCT01581541|3697472|B1||Hepatocellular carcinoma|Diagnosis||Participants|Count of Participants|1|1.0||||||
3871964|NCT01581541|3697472|B1||Metastatic adenocarcinoma|Diagnosis||Participants|Count of Participants|1|1.0||||||
3871965|NCT01581541|3697472|B1||Invasive poorly differentiated carcinoma|Diagnosis||Participants|Count of Participants|1|1.0||||||
3871966|NCT01581541|3697472|B1||Adenoid cystic carcinoma|Diagnosis||Participants|Count of Participants|1|1.0||||||
3871969|NCT01581541|3697472|B1||Malignant Hürthle cell tumor|Diagnosis||Participants|Count of Participants|1|1.0||||||
3871970|NCT01581541|3697472|B1|||Number of Prior Therapies||prior therapies|Mean|7|7.0|Full Range|||1.0|14.0|
3871971|NCT01581541|3697472|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3871972|NCT01581541|3697472|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3871973|NCT01581541|3697472|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871974|NCT01581541|3697472|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3871975|NCT01581541|3697472|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3871976|NCT01581541|3697472|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871977|NCT01581541|3697472|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3871978|NCT01581541|3697472|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871979|NCT01581541|3697472|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3871980|NCT01581541|3697472|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3871981|NCT01581541|3697472|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3871982|NCT01581541|3697472|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3871983|NCT01581541|3697472|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3871984|NCT01581541|3697472|B1|||Age||years|Median|59|59.0|Full Range|||19.0|77.0|
3871985|NCT01581437|3697606|B1|paroxysmal atrial fibrillation||Atrial Fibrillation|Measure title Atrial Fibrillation|participants|Number|23|23.0||||||
3871986|NCT01581437|3697606|B1|longstanding persisitent atrial fibrillation||Atrial Fibrillation|Measure title Atrial Fibrillation|participants|Number|7|7.0||||||
3871987|NCT01581437|3697606|B1|persisitent atrial fibrillation||Atrial Fibrillation|Measure title Atrial Fibrillation|participants|Number|48|48.0||||||
3871988|NCT01581437|3697606|B1|United States||Region of Enrollment||participants|Number|78|78.0||||||
3871989|NCT01581437|3697606|B1||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||specific numbers per gender not collected
3871990|NCT01581437|3697606|B1||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||specific numbers per gender not collected
3871991|NCT01581437|3697606|B1|||Age||years|Mean|61|61.0|Full Range|||48.0|68.0|
3871992|NCT01581437|3697606|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3871993|NCT01581437|3697606|B1||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
3871994|NCT01581437|3697606|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3871995|NCT01581307|3697617|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3871996|NCT01581307|3697617|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3871997|NCT01581307|3697617|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3871998|NCT01581307|3697617|B1|||Age||years|Median|70.44|70.44|Full Range|||57.0|83.0|
3871999|NCT01581307|3697617|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3872000|NCT01581307|3697617|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3872001|NCT01581307|3697617|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3872002|NCT01581281|3697623|B4|||Pediatric Migriane Disability Assessment Score (PedMIDAS)|Scores on the PedMIDAS range from 0 to 240, with a score of 1 to 10 indicating no disability, 11 to 30 indicating mild disability, 31 to 50 indicating moderate disability, and more than 50 indicating severe disability.|units on a scale|Mean|41.9|41.9|Standard Deviation|26.8|26.8|||
3872003|NCT01581281|3697624|B3|||Pediatric Migriane Disability Assessment Score (PedMIDAS)|Scores on the PedMIDAS range from 0 to 240, with a score of 1 to 10 indicating no disability, 11 to 30 indicating mild disability, 31 to 50 indicating moderate disability, and more than 50 indicating severe disability.|units on a scale|Mean|40.6|40.6|Standard Deviation|26.4|26.4|||
3872004|NCT01581281|3697625|B2|||Pediatric Migriane Disability Assessment Score (PedMIDAS)|Scores on the PedMIDAS range from 0 to 240, with a score of 1 to 10 indicating no disability, 11 to 30 indicating mild disability, 31 to 50 indicating moderate disability, and more than 50 indicating severe disability.|units on a scale|Mean|42.9|42.9|Standard Deviation|26.7|26.7|||
3872005|NCT01581281|3697626|B1|||Pediatric Migriane Disability Assessment Score (PedMIDAS)|Scores on the PedMIDAS range from 0 to 240, with a score of 1 to 10 indicating no disability, 11 to 30 indicating mild disability, 31 to 50 indicating moderate disability, and more than 50 indicating severe disability.|units on a scale|Mean|42.6|42.6|Standard Deviation|27.4|27.4|||
3872006|NCT01581281|3697623|B4|||Headache Days|Number of headache days during 28-day baseline period|days|Mean|11.4|11.4|Standard Deviation|6.1|6.1|||
3872007|NCT01581281|3697624|B3|||Headache Days|Number of headache days during 28-day baseline period|days|Mean|11.5|11.5|Standard Deviation|6.2|6.2|||
3872008|NCT01581281|3697625|B2|||Headache Days|Number of headache days during 28-day baseline period|days|Mean|11.0|11.0|Standard Deviation|6.3|6.3|||
3872009|NCT01581281|3697626|B1|||Headache Days|Number of headache days during 28-day baseline period|days|Mean|11.5|11.5|Standard Deviation|6.1|6.1|||
3872010|NCT01581281|3697623|B4|United States||Region of Enrollment||Participants|Count of Participants|361|361.0||||||
3872011|NCT01581281|3697624|B3|United States||Region of Enrollment||Participants|Count of Participants|144|144.0||||||
3872012|NCT01581281|3697625|B2|United States||Region of Enrollment||Participants|Count of Participants|72|72.0||||||
3872013|NCT01581281|3697626|B1|United States||Region of Enrollment||Participants|Count of Participants|145|145.0||||||
3872014|NCT01581281|3697623|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3872015|NCT01581281|3697624|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3872016|NCT01581281|3697625|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3872017|NCT01581281|3697626|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3872018|NCT01581281|3697623|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3872019|NCT01581281|3697624|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||data not collected
3872020|NCT01581281|3697625|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||data not collected
3872021|NCT01581281|3697626|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||data not collected
3872022|NCT01581281|3697623|B4||White|Race (NIH/OMB)||Participants|Count of Participants|253|253.0||||||
3872023|NCT01581281|3697624|B3||White|Race (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
3872024|NCT01581281|3697625|B2||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3872025|NCT01581281|3697626|B1||White|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3872026|NCT01581281|3697623|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3872027|NCT01581281|3697624|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3872028|NCT01581281|3697625|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3872029|NCT01581281|3697626|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3872030|NCT01581281|3697623|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3872031|NCT01581281|3697624|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872032|NCT01581281|3697625|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872033|NCT01581281|3697626|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3872034|NCT01581281|3697623|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3872035|NCT01581281|3697624|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872036|NCT01581281|3697625|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872037|NCT01581281|3697626|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3872038|NCT01581281|3697623|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3872039|NCT01581281|3697624|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3872040|NCT01581281|3697625|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3872041|NCT01581281|3697626|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3872042|NCT01581281|3697623|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3872043|NCT01581281|3697624|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3872044|NCT01581281|3697625|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3872045|NCT01581281|3697626|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3872046|NCT01581281|3697623|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|316|316.0||||||
3872047|NCT01581281|3697624|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
3872048|NCT01581281|3697625|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3872049|NCT01581281|3697626|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
3872050|NCT01581281|3697623|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3872051|NCT01581281|3697624|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3872052|NCT01581281|3697625|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3872053|NCT01581281|3697626|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3872054|NCT01581281|3697623|B4||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3872055|NCT01581281|3697624|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3872056|NCT01581281|3697625|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3872057|NCT01581281|3697626|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3872058|NCT01581281|3697623|B4||Female|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
3872059|NCT01581281|3697624|B3||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3872060|NCT01581281|3697625|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3872061|NCT01581281|3697626|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3872062|NCT01581281|3697623|B4|||Age||years|Mean|14.2|14.2|Standard Deviation|2.4|2.4|||
3872063|NCT01581281|3697624|B3|||Age||years|Mean|14.2|14.2|Standard Deviation|2.4|2.4|||
3872064|NCT01581281|3697625|B2|||Age||years|Mean|14.2|14.2|Standard Deviation|2.2|2.2|||
3872065|NCT01581281|3697626|B1|||Age||years|Mean|14.2|14.2|Standard Deviation|2.5|2.5|||
3872066|NCT01581281|3697623|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3872067|NCT01581281|3697624|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3872068|NCT01581281|3697625|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3872069|NCT01581281|3697626|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3872070|NCT01581281|3697623|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3872071|NCT01581281|3697624|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3872072|NCT01581281|3697625|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3872073|NCT01581281|3697626|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3872074|NCT01581281|3697623|B4||<=18 years|Age||Participants|Count of Participants|361|361.0||||||
3872075|NCT01581281|3697624|B3||<=18 years|Age||Participants|Count of Participants|144|144.0||||||
3872076|NCT01581281|3697625|B2||<=18 years|Age||Participants|Count of Participants|72|72.0||||||
3872077|NCT01581281|3697626|B1||<=18 years|Age||Participants|Count of Participants|145|145.0||||||
3872078|NCT01581021|3697648|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
3872079|NCT01581021|3697649|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
3872080|NCT01581021|3697650|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3872081|NCT01581021|3697648|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3872082|NCT01581021|3697649|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3872083|NCT01581021|3697650|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3872084|NCT01581021|3697648|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3872085|NCT01581021|3697649|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3872086|NCT01581021|3697650|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3872087|NCT01581021|3697648|B3|||Age||years|Mean|13.90|13.9|Standard Deviation|2.21|2.21|||
3872088|NCT01581021|3697649|B2|||Age||years|Mean|14.17|14.17|Standard Deviation|2.21|2.21|||
3872089|NCT01581021|3697650|B1|||Age||years|Mean|13.62|13.62|Standard Deviation|2.21|2.21|||
3872090|NCT01581021|3697648|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3872091|NCT01581021|3697649|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3872092|NCT01581021|3697650|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3872093|NCT01581021|3697648|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3872094|NCT01581021|3697649|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3872095|NCT01581021|3697650|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3872096|NCT01581021|3697648|B3||<=18 years|Age||Participants|Count of Participants|55|55.0||||||
3872097|NCT01581021|3697649|B2||<=18 years|Age||Participants|Count of Participants|27|27.0||||||
3872098|NCT01581021|3697650|B1||<=18 years|Age||Participants|Count of Participants|28|28.0||||||
3872099|NCT01581008|3697663|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3872100|NCT01581008|3697664|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3872101|NCT01581008|3697665|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3872102|NCT01581008|3697663|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3872103|NCT01581008|3697664|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3872104|NCT01581008|3697665|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3872105|NCT01581008|3697663|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3872106|NCT01581008|3697664|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3872107|NCT01581008|3697665|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3872108|NCT01581008|3697663|B3|||Age||years|Median|63|63.0|Inter-Quartile Range|||58.0|70.0|
3872109|NCT01581008|3697664|B2|||Age||years|Median|65|65.0|Inter-Quartile Range|||58.0|66.0|
3872110|NCT01581008|3697665|B1|||Age||years|Median|63|63.0|Inter-Quartile Range|||58.0|71.0|
3872111|NCT01580995|3697676|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
3872112|NCT01580995|3697677|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3872113|NCT01580995|3697678|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3872114|NCT01580995|3697676|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3872115|NCT01580995|3697677|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3872116|NCT01580995|3697678|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3872117|NCT01580995|3697676|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3872118|NCT01580995|3697677|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3872119|NCT01580995|3697678|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3872120|NCT01580995|3697676|B3|||Age||years|Mean|56|56.0|Standard Deviation|2|2.0|||
3872121|NCT01580995|3697677|B2|||Age||years|Mean|57|57.0|Standard Deviation|3|3.0|||
3872122|NCT01580995|3697678|B1|||Age||years|Mean|55|55.0|Standard Deviation|2|2.0|||
3872123|NCT01580995|3697676|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3872124|NCT01580995|3697677|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3872125|NCT01580995|3697678|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3872126|NCT01580995|3697676|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3872127|NCT01580995|3697677|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3872128|NCT01580995|3697678|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3872129|NCT01580995|3697676|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3872130|NCT01580995|3697677|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3872131|NCT01580995|3697678|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3872132|NCT01580904|3697685|B3|Brazil||Region of Enrollment||participants|Number|89|89.0||||||
3872133|NCT01580904|3697686|B2|Brazil||Region of Enrollment||participants|Number|42|42.0||||||
3872134|NCT01580904|3697687|B1|Brazil||Region of Enrollment||participants|Number|47|47.0||||||
3872135|NCT01580904|3697685|B3||Male|Gender||Participants|Count of Participants|40|40.0||||||
3872136|NCT01580904|3697686|B2||Male|Gender||Participants|Count of Participants|20|20.0||||||
3872137|NCT01580904|3697687|B1||Male|Gender||Participants|Count of Participants|20|20.0||||||
3872138|NCT01580904|3697685|B3||Female|Gender||Participants|Count of Participants|49|49.0||||||
3872139|NCT01580904|3697686|B2||Female|Gender||Participants|Count of Participants|22|22.0||||||
3872140|NCT01580904|3697687|B1||Female|Gender||Participants|Count of Participants|27|27.0||||||
3872141|NCT01580904|3697685|B3||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3872142|NCT01580904|3697686|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3872143|NCT01580904|3697687|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3872144|NCT01580904|3697685|B3||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
3872145|NCT01580904|3697686|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3872146|NCT01580904|3697687|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3872147|NCT01580904|3697685|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3872148|NCT01580904|3697686|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3872149|NCT01580904|3697687|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3872150|NCT01580618|3697700|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3872151|NCT01580618|3697701|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3872152|NCT01580618|3697702|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3872153|NCT01580618|3697700|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3872154|NCT01580618|3697701|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3872155|NCT01580618|3697702|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3872156|NCT01580618|3697700|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3872157|NCT01580618|3697701|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3872158|NCT01580618|3697702|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3872159|NCT01580618|3697700|B3|||Age||years|Mean|66|66.0|Standard Deviation|12|12.0|||
3872160|NCT01580618|3697701|B2|||Age||years|Mean|62|62.0|Standard Deviation|12|12.0|||
3872161|NCT01580618|3697702|B1|||Age||years|Mean|70|70.0|Standard Deviation|11|11.0|||
3872162|NCT01580618|3697700|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3872163|NCT01580618|3697701|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3872164|NCT01580618|3697702|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3872165|NCT01580618|3697700|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3872166|NCT01580618|3697701|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3872167|NCT01580618|3697702|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3872168|NCT01580618|3697700|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3872169|NCT01580618|3697701|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3872170|NCT01580618|3697702|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3872171|NCT01580592|3697716|B4|Germany||Region of Enrollment||participants|Number|31|31.0||||||
3872172|NCT01580592|3697717|B3|Germany||Region of Enrollment||participants|Number|12|12.0||||||
3872173|NCT01580592|3697718|B2|Germany||Region of Enrollment||participants|Number|9|9.0||||||
3872174|NCT01580592|3697719|B1|Germany||Region of Enrollment||participants|Number|10|10.0||||||
3872175|NCT01580592|3697716|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872176|NCT01580592|3697717|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872177|NCT01580592|3697718|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872178|NCT01580592|3697719|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872179|NCT01580592|3697716|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3872180|NCT01580592|3697717|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3872181|NCT01580592|3697718|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3872182|NCT01580592|3697719|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3872183|NCT01580592|3697716|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872184|NCT01580592|3697717|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872185|NCT01580592|3697718|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872186|NCT01580592|3697719|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872187|NCT01580592|3697716|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3872188|NCT01580592|3697717|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3872189|NCT01580592|3697718|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3872190|NCT01580592|3697719|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3872191|NCT01580592|3697716|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3872192|NCT01580592|3697717|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3872193|NCT01580592|3697718|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3872194|NCT01580592|3697719|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3872195|NCT01580592|3697716|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3872196|NCT01580592|3697717|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3872197|NCT01580592|3697718|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3872198|NCT01580592|3697719|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3872199|NCT01580592|3697716|B4||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3872200|NCT01580592|3697717|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3872201|NCT01580592|3697718|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3872202|NCT01580592|3697719|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3872203|NCT01580592|3697716|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3872204|NCT01580592|3697717|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3872205|NCT01580592|3697718|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3872206|NCT01580592|3697719|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3872207|NCT01580488|3697732|B1|France||Region of Enrollment||participants|Number|24|24.0||||||
3872208|NCT01580488|3697732|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3872209|NCT01580488|3697732|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3872210|NCT01580488|3697732|B1|||Age||years|Mean|47.8|47.8|Standard Deviation|11.1|11.1|||
3872211|NCT01580488|3697732|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3872212|NCT01580488|3697732|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3872213|NCT01580488|3697732|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3872214|NCT01580423|3697776|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3872215|NCT01580423|3697776|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3872216|NCT01580423|3697776|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3872217|NCT01580423|3697776|B1|||Age||years|Mean|70.2|70.2|Standard Deviation|6.1|6.1|||
3872218|NCT01580423|3697776|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3872219|NCT01580423|3697776|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3872220|NCT01580423|3697776|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3872221|NCT01580410|3697787|B3|United States||Region of Enrollment||participants|Number|136|136.0||||||
3872222|NCT01580410|3697788|B2|United States||Region of Enrollment||participants|Number|68|68.0||||||
3872223|NCT01580410|3697789|B1|United States||Region of Enrollment||participants|Number|68|68.0||||||
3872224|NCT01580410|3697787|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3872225|NCT01580410|3697788|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872226|NCT01580410|3697789|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3872227|NCT01580410|3697787|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872228|NCT01580410|3697788|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872229|NCT01580410|3697789|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872230|NCT01580410|3697787|B3||White|Race (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
3872231|NCT01580410|3697788|B2||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3872232|NCT01580410|3697789|B1||White|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3872233|NCT01580410|3697787|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3872234|NCT01580410|3697788|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3872235|NCT01580410|3697789|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3872236|NCT01580410|3697787|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872237|NCT01580410|3697788|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872238|NCT01580410|3697789|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872239|NCT01580410|3697787|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3872240|NCT01580410|3697788|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3872241|NCT01580410|3697789|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872242|NCT01580410|3697787|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872243|NCT01580410|3697788|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872244|NCT01580410|3697789|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872245|NCT01580410|3697787|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3872246|NCT01580410|3697788|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872247|NCT01580410|3697789|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3872248|NCT01580410|3697787|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
3872249|NCT01580410|3697788|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3872250|NCT01580410|3697789|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3872251|NCT01580410|3697787|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3872252|NCT01580410|3697788|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3872253|NCT01580410|3697789|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3872254|NCT01580410|3697787|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3872255|NCT01580410|3697788|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3872256|NCT01580410|3697789|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3872257|NCT01580410|3697787|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3872258|NCT01580410|3697788|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3872259|NCT01580410|3697789|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3872260|NCT01580410|3697787|B3|||Age||years|Mean|55.5|55.5|Standard Deviation|13.4|13.4|||
3872261|NCT01580410|3697788|B2|||Age||years|Mean|55.0|55.0|Standard Deviation|14.0|14.0|||
3872262|NCT01580410|3697789|B1|||Age||years|Mean|55.9|55.9|Standard Deviation|12.9|12.9|||
3872263|NCT01580410|3697787|B3||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
3872264|NCT01580410|3697788|B2||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3872265|NCT01580410|3697789|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3872266|NCT01580410|3697787|B3||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
3872267|NCT01580410|3697788|B2||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
3872268|NCT01580410|3697789|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
3872269|NCT01580410|3697787|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3872270|NCT01580410|3697788|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3872271|NCT01580410|3697789|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3872272|NCT01580306|3697802|B5||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3872273|NCT01580306|3697803|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3872274|NCT01580306|3697804|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3872275|NCT01580306|3697805|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3872276|NCT01580306|3697806|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3872277|NCT01580306|3697802|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3872278|NCT01580306|3697803|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3872279|NCT01580306|3697804|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3872280|NCT01580306|3697805|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3872281|NCT01580306|3697806|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3872282|NCT01580306|3697802|B5|||Age||years|Mean|61.4|61.4|Standard Deviation|8.2|8.2|||
3872283|NCT01580306|3697803|B4|||Age||years|Mean|57.6|57.6|Standard Deviation|9.5|9.5|||
3872284|NCT01580306|3697804|B3|||Age||years|Mean|67.1|67.1|Standard Deviation|7.5|7.5|||
3872285|NCT01580306|3697805|B2|||Age||years|Mean|58.8|58.8|Standard Deviation|9.3|9.3|||
3872286|NCT01580306|3697806|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|2.1|2.1|||
3872287|NCT01580293|3697831|B8||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3872288|NCT01580293|3697832|B7||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3872289|NCT01580293|3697833|B6||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3872290|NCT01580293|3697834|B5||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3872291|NCT01580293|3697835|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3872292|NCT01580293|3697836|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3872293|NCT01580293|3697837|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3872294|NCT01580293|3697838|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3872295|NCT01580293|3697831|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3872296|NCT01580293|3697832|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3872297|NCT01580293|3697833|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3872298|NCT01580293|3697834|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3872299|NCT01580293|3697835|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3872300|NCT01580293|3697836|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3872301|NCT01580293|3697837|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3872302|NCT01580293|3697838|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3872303|NCT01580293|3697831|B8|||Age||years|Mean|36.1|36.1|Standard Deviation|13.5|13.5|||
3872304|NCT01580293|3697832|B7|||Age||years|Mean|37.9|37.9|Standard Deviation|13.7|13.7|||
3872305|NCT01580293|3697833|B6|||Age||years|Mean|37.0|37.0|Standard Deviation|13.5|13.5|||
3872306|NCT01580293|3697834|B5|||Age||years|Mean|33.7|33.7|Standard Deviation|13.0|13.0|||
3872307|NCT01580293|3697835|B4|||Age||years|Mean|33.1|33.1|Standard Deviation|11.0|11.0|||
3872308|NCT01580293|3697836|B3|||Age||years|Mean|31.4|31.4|Standard Deviation|11.6|11.6|||
3872309|NCT01580293|3697837|B2|||Age||years|Mean|27.3|27.3|Standard Deviation|14.2|14.2|||
3872310|NCT01580293|3697838|B1|||Age||years|Mean|44.8|44.8|Standard Deviation|13.5|13.5|||
3872311|NCT01580098|3697923|B3|Austria||Region of Enrollment||participants|Number|193|193.0||||||
3872312|NCT01580098|3697924|B2|Austria||Region of Enrollment||participants|Number|117|117.0||||||
3872313|NCT01580098|3697925|B1|Austria||Region of Enrollment||participants|Number|76|76.0||||||
3872314|NCT01580098|3697923|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3872315|NCT01580098|3697924|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3872316|NCT01580098|3697925|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3872317|NCT01580098|3697923|B3||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3872318|NCT01580098|3697924|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3872319|NCT01580098|3697925|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3872320|NCT01580098|3697923|B3|||Age||years|Mean|61.54|61.54|Standard Deviation|11.46|11.46|||
3872321|NCT01580098|3697924|B2|||Age||years|Mean|60.35|60.35|Standard Deviation|11.68|11.68|||
3872322|NCT01580098|3697925|B1|||Age||years|Mean|63.38|63.38|Standard Deviation|11.13|11.13|||
3872323|NCT01580072|3697947|B4|Austria||Region of Enrollment||participants|Number|65|65.0||||||
3872324|NCT01580072|3697949|B2|Austria||Region of Enrollment||participants|Number|37|37.0||||||
3872325|NCT01580072|3697950|B1|Austria||Region of Enrollment||participants|Number|28|28.0||||||
3872326|NCT01580072|3697947|B4|Male||Gender||participants|Number|44|44.0||||||
3872327|NCT01580072|3697949|B2|Male||Gender||participants|Number|26|26.0||||||
3872328|NCT01580072|3697950|B1|Male||Gender||participants|Number|18|18.0||||||
3872329|NCT01580072|3697947|B4|Female||Gender||participants|Number|21|21.0||||||
3872330|NCT01580072|3697949|B2|Female||Gender||participants|Number|11|11.0||||||
3872331|NCT01580072|3697950|B1|Female||Gender||participants|Number|10|10.0||||||
3872332|NCT01580072|3697947|B4|||Age||years|Mean|68.04|68.04|Standard Deviation|8.80|8.8|||
3872333|NCT01580072|3697949|B2|||Age||years|Mean|63.83|63.83|Standard Deviation|7.69|7.69|||
3872334|NCT01580072|3697950|B1|||Age||years|Mean|73.62|73.62|Standard Deviation|10.28|10.28|||
3872335|NCT01580020|3697978|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3872336|NCT01580020|3697979|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3872337|NCT01580020|3697980|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3872338|NCT01580020|3697978|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3872339|NCT01580020|3697979|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3872340|NCT01580020|3697980|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3872341|NCT01580020|3697978|B3|||Age||Years|Mean|64.8|64.8|Standard Deviation|10.1|10.1|||
3872342|NCT01580020|3697979|B2|||Age||Years|Mean|63.3|63.3|Standard Deviation|10.3|10.3|||
3872343|NCT01580020|3697980|B1|||Age||Years|Mean|65.6|65.6|Standard Deviation|9.9|9.9|||
3872344|NCT01579916|3698025|B3||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3872345|NCT01579916|3698026|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3872346|NCT01579916|3698027|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3872347|NCT01579916|3698025|B3||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3872348|NCT01579916|3698026|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3872349|NCT01579916|3698027|B1||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3872350|NCT01579916|3698025|B3|||Age||Years|Mean|32.6|32.6|Standard Deviation|9.0|9.0|||
3872351|NCT01579916|3698026|B2|||Age||Years|Mean|32.0|32.0|Standard Deviation|8.8|8.8|||
3872352|NCT01579916|3698027|B1|||Age||Years|Mean|32.7|32.7|Standard Deviation|9.1|9.1|||
3872353|NCT01579812|3698054|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3872354|NCT01579812|3698054|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3872355|NCT01579812|3698054|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3872356|NCT01579812|3698054|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3872357|NCT01579812|3698054|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3872358|NCT01579812|3698054|B1|||Age||years|Mean|58|58.0|Full Range|||30.0|79.0|
3872359|NCT01579747|3698062|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
3872360|NCT01579747|3698063|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3872361|NCT01579747|3698064|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3872362|NCT01579747|3698062|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3872363|NCT01579747|3698063|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3872364|NCT01579747|3698064|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3872365|NCT01579747|3698062|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3872366|NCT01579747|3698063|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3872367|NCT01579747|3698064|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3872368|NCT01579747|3698062|B3|||Age||years|Mean|53.65|53.65|Standard Deviation|11.85|11.85|||
3872369|NCT01579747|3698063|B2|||Age||years|Mean|58.0|58.0|Standard Deviation|9.4|9.4|||
3872370|NCT01579747|3698064|B1|||Age||years|Mean|49.3|49.3|Standard Deviation|14.3|14.3|||
3872371|NCT01579747|3698062|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3872372|NCT01579747|3698063|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3872373|NCT01579747|3698064|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3872374|NCT01579747|3698062|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3872375|NCT01579747|3698063|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3872376|NCT01579747|3698064|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3872377|NCT01579747|3698062|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3872378|NCT01579747|3698063|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3872379|NCT01579747|3698064|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3872380|NCT01579669|3698073|B3|United States||Region of Enrollment||participants|Number|211|211.0||||||
3872381|NCT01579669|3698074|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
3872382|NCT01579669|3698075|B1|United States||Region of Enrollment||participants|Number|170|170.0||||||
3872383|NCT01579669|3698073|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3872384|NCT01579669|3698074|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3872385|NCT01579669|3698075|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3872386|NCT01579669|3698073|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3872387|NCT01579669|3698074|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3872388|NCT01579669|3698075|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3872389|NCT01579669|3698073|B3||White|Race (NIH/OMB)||Participants|Count of Participants|181|181.0||||||
3872390|NCT01579669|3698074|B2||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3872391|NCT01579669|3698075|B1||White|Race (NIH/OMB)||Participants|Count of Participants|152|152.0||||||
3872392|NCT01579669|3698073|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3872393|NCT01579669|3698074|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3872394|NCT01579669|3698075|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3872395|NCT01579669|3698073|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872396|NCT01579669|3698074|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872397|NCT01579669|3698075|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872398|NCT01579669|3698073|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3872399|NCT01579669|3698074|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3872400|NCT01579669|3698075|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3872401|NCT01579669|3698073|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3872402|NCT01579669|3698074|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872403|NCT01579669|3698075|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3872404|NCT01579669|3698073|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3872405|NCT01579669|3698074|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3872406|NCT01579669|3698075|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3872407|NCT01579669|3698073|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|194|194.0||||||
3872408|NCT01579669|3698074|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3872409|NCT01579669|3698075|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|158|158.0||||||
3872410|NCT01579669|3698073|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3872411|NCT01579669|3698074|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3872412|NCT01579669|3698075|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3872413|NCT01579669|3698073|B3|Not Reported||Sex/Gender, Customized||participants|Number|1|1.0||||||
3872414|NCT01579669|3698074|B2|Not Reported||Sex/Gender, Customized||participants|Number|1|1.0||||||
3872415|NCT01579669|3698075|B1|Not Reported||Sex/Gender, Customized||participants|Number|0|0.0||||||
3872416|NCT01579669|3698073|B3|Other||Sex/Gender, Customized||participants|Number|4|4.0||||||
3872417|NCT01579669|3698074|B2|Other||Sex/Gender, Customized||participants|Number|0|0.0||||||
3872418|NCT01579669|3698075|B1|Other||Sex/Gender, Customized||participants|Number|4|4.0||||||
3872419|NCT01579669|3698073|B3|Female||Sex/Gender, Customized||participants|Number|116|116.0||||||
3872420|NCT01579669|3698074|B2|Female||Sex/Gender, Customized||participants|Number|25|25.0||||||
3872421|NCT01579669|3698075|B1|Female||Sex/Gender, Customized||participants|Number|91|91.0||||||
3872422|NCT01579669|3698073|B3|Male||Sex/Gender, Customized||participants|Number|90|90.0||||||
3872423|NCT01579669|3698074|B2|Male||Sex/Gender, Customized||participants|Number|15|15.0||||||
3872424|NCT01579669|3698075|B1|Male||Sex/Gender, Customized||participants|Number|75|75.0||||||
3872425|NCT01579669|3698073|B3|||Age||years|Mean|36.4|36.4|Full Range|||18.0|68.0|
3872426|NCT01579669|3698074|B2|||Age||years|Mean|36.3|36.3|Full Range|||28.0|62.0|
3872427|NCT01579669|3698075|B1|||Age||years|Mean|36.5|36.5|Full Range|||18.0|68.0|
3872428|NCT01579578|3698086|B3|HER2 2+ Weak/moderate membrane staining ≥10% cells||HER2 Status: HER2/IHC (Local Assessment)|HER2 Status (Local Labs): HER2/IHC (Local Assessment)|Participants|Number|3|3.0||||||
3872429|NCT01579578|3698087|B2|HER2 2+ Weak/moderate membrane staining ≥10% cells||HER2 Status: HER2/IHC (Local Assessment)|HER2 Status (Local Labs): HER2/IHC (Local Assessment)|Participants|Number|1|1.0||||||
3872430|NCT01579578|3698088|B1|HER2 2+ Weak/moderate membrane staining ≥10% cells||HER2 Status: HER2/IHC (Local Assessment)|HER2 Status (Local Labs): HER2/IHC (Local Assessment)|Participants|Number|2|2.0||||||
3872431|NCT01579578|3698086|B3|HER2 1+ Faint membrane staining ≥10% of cells||HER2 Status: HER2/IHC (Local Assessment)|HER2 Status (Local Labs): HER2/IHC (Local Assessment)|Participants|Number|8|8.0||||||
3872432|NCT01579578|3698087|B2|HER2 1+ Faint membrane staining ≥10% of cells||HER2 Status: HER2/IHC (Local Assessment)|HER2 Status (Local Labs): HER2/IHC (Local Assessment)|Participants|Number|5|5.0||||||
3872433|NCT01579578|3698088|B1|HER2 1+ Faint membrane staining ≥10% of cells||HER2 Status: HER2/IHC (Local Assessment)|HER2 Status (Local Labs): HER2/IHC (Local Assessment)|Participants|Number|3|3.0||||||
3872434|NCT01579578|3698086|B3|HER2 0 No staining/membrane staining <10% of cells||HER2 Status: HER2/IHC (Local Assessment)|HER2 Status (Local Labs): HER2/IHC (Local Assessment)|Participants|Number|14|14.0||||||
3872435|NCT01579578|3698087|B2|HER2 0 No staining/membrane staining <10% of cells||HER2 Status: HER2/IHC (Local Assessment)|HER2 Status (Local Labs): HER2/IHC (Local Assessment)|Participants|Number|6|6.0||||||
3872436|NCT01579578|3698088|B1|HER2 0 No staining/membrane staining <10% of cells||HER2 Status: HER2/IHC (Local Assessment)|HER2 Status (Local Labs): HER2/IHC (Local Assessment)|Participants|Number|8|8.0||||||
3872437|NCT01579578|3698086|B3|Japanese||Race/Ethnicity, Customized|Ethnic Group Summary|Participants|Number|7|7.0||||||
3872438|NCT01579578|3698087|B2|Japanese||Race/Ethnicity, Customized|Ethnic Group Summary|Participants|Number|3|3.0||||||
3872439|NCT01579578|3698088|B1|Japanese||Race/Ethnicity, Customized|Ethnic Group Summary|Participants|Number|4|4.0||||||
3872440|NCT01579578|3698086|B3|Chinese||Race/Ethnicity, Customized|Ethnic Group Summary|Participants|Number|3|3.0||||||
3872441|NCT01579578|3698087|B2|Chinese||Race/Ethnicity, Customized|Ethnic Group Summary|Participants|Number|2|2.0||||||
3872442|NCT01579578|3698088|B1|Chinese||Race/Ethnicity, Customized|Ethnic Group Summary|Participants|Number|1|1.0||||||
3872443|NCT01579578|3698086|B3|Asian (Other Than Chinese or Japanese)||Race/Ethnicity, Customized|Ethnic Group Summary|Participants|Number|15|15.0||||||
3872444|NCT01579578|3698087|B2|Asian (Other Than Chinese or Japanese)||Race/Ethnicity, Customized|Ethnic Group Summary|Participants|Number|7|7.0||||||
3872445|NCT01579578|3698088|B1|Asian (Other Than Chinese or Japanese)||Race/Ethnicity, Customized|Ethnic Group Summary|Participants|Number|8|8.0||||||
3872446|NCT01579578|3698086|B3|Asian||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
3872447|NCT01579578|3698087|B2|Asian||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3872448|NCT01579578|3698088|B1|Asian||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
3872449|NCT01579578|3698086|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3872450|NCT01579578|3698087|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3872451|NCT01579578|3698088|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3872452|NCT01579578|3698086|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3872453|NCT01579578|3698087|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3872454|NCT01579578|3698088|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3872455|NCT01579578|3698086|B3|>= 75 years||Age, Customized|Age Group|Participants|Number|1|1.0||||||
3872456|NCT01579578|3698087|B2|>= 75 years||Age, Customized|Age Group|Participants|Number|1|1.0||||||
3872457|NCT01579578|3698088|B1|>= 75 years||Age, Customized|Age Group|Participants|Number|0|0.0||||||
3872458|NCT01579578|3698086|B3|65 - < 75 years||Age, Customized|Age Group|Participants|Number|8|8.0||||||
3872459|NCT01579578|3698087|B2|65 - < 75 years||Age, Customized|Age Group|Participants|Number|5|5.0||||||
3872460|NCT01579578|3698088|B1|65 - < 75 years||Age, Customized|Age Group|Participants|Number|3|3.0||||||
3872461|NCT01579578|3698086|B3|50 - < 65 years||Age, Customized|Age Group|Participants|Number|11|11.0||||||
3872462|NCT01579578|3698087|B2|50 - < 65 years||Age, Customized|Age Group|Participants|Number|4|4.0||||||
3872463|NCT01579578|3698088|B1|50 - < 65 years||Age, Customized|Age Group|Participants|Number|7|7.0||||||
3872464|NCT01579578|3698086|B3|18 - < 50 years||Age, Customized|Age Group|Participants|Number|5|5.0||||||
3872465|NCT01579578|3698087|B2|18 - < 50 years||Age, Customized|Age Group|Participants|Number|2|2.0||||||
3872466|NCT01579578|3698088|B1|18 - < 50 years||Age, Customized|Age Group|Participants|Number|3|3.0||||||
3872467|NCT01579578|3698086|B3|||Age||Years|Mean|60.2|60.2|Standard Deviation|11.34|11.34|34.0|76.0|
3872468|NCT01579578|3698087|B2|||Age||Years|Mean|62.7|62.7|Standard Deviation|13.60|13.6|34.0|76.0|
3872469|NCT01579578|3698088|B1|||Age||Years|Mean|57.9|57.9|Standard Deviation|8.71|8.71|45.0|72.0|
3872470|NCT01579565|3698099|B3||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3872471|NCT01579565|3698100|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3872472|NCT01579565|3698101|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3872473|NCT01579565|3698099|B3||Female|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
3872474|NCT01579565|3698100|B2||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3872475|NCT01579565|3698101|B1||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3872476|NCT01579565|3698099|B3|||Age||years|Mean|68.3|68.3|Standard Deviation|10.0|10.0|||
3872477|NCT01579565|3698100|B2|||Age||years|Mean|67.5|67.5|Standard Deviation|10.6|10.6|||
3872478|NCT01579565|3698101|B1|||Age||years|Mean|69.2|69.2|Standard Deviation|9.2|9.2|||
3872479|NCT01579474|3698130|B7||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3872480|NCT01579474|3698131|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3872481|NCT01579474|3698132|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3872482|NCT01579474|3698133|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3872483|NCT01579474|3698134|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3872484|NCT01579474|3698135|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3872485|NCT01579474|3698136|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3872486|NCT01579474|3698130|B7||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3872487|NCT01579474|3698131|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3872488|NCT01579474|3698132|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3872489|NCT01579474|3698133|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3872490|NCT01579474|3698134|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3872491|NCT01579474|3698135|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3872492|NCT01579474|3698136|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3872493|NCT01579474|3698130|B7|||Age||years|Mean|56.3|56.3|Standard Deviation|8.97|8.97|||
3872494|NCT01579474|3698131|B6|||Age||years|Mean|57.5|57.5|Standard Deviation|14.85|14.85|||
3872495|NCT01579474|3698132|B5|||Age||years|Mean|54.9|54.9|Standard Deviation|9.55|9.55|||
3872496|NCT01579474|3698133|B4|||Age||years|Mean|47.0|47.0|Standard Deviation|18.08|18.08|||
3872497|NCT01579474|3698134|B3|||Age||years|Mean|61.3|61.3|Standard Deviation|6.79|6.79|||
3872498|NCT01579474|3698135|B2|||Age||years|Mean|56.6|56.6|Standard Deviation|9.3|9.3|||
3872499|NCT01579474|3698136|B1|||Age||years|Mean|53.5|53.5|Standard Deviation|7.61|7.61|||
3872500|NCT01579318|3698215|B1|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3872501|NCT01579318|3698215|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3872502|NCT01579318|3698215|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3872503|NCT01579318|3698215|B1|||Age||years|Mean|71.5|71.5|Standard Deviation|10.6|10.6|||
3872504|NCT01579305|3698226|B3|United Kingdom||Region of Enrollment||participants|Number|183|183.0||||||
3872505|NCT01579305|3698227|B2|United Kingdom||Region of Enrollment||participants|Number|92|92.0||||||
3872506|NCT01579305|3698228|B1|United Kingdom||Region of Enrollment||participants|Number|91|91.0||||||
3872507|NCT01579305|3698226|B3|France||Region of Enrollment||participants|Number|97|97.0||||||
3872508|NCT01579305|3698227|B2|France||Region of Enrollment||participants|Number|49|49.0||||||
3872509|NCT01579305|3698228|B1|France||Region of Enrollment||participants|Number|48|48.0||||||
3872510|NCT01579305|3698226|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3872511|NCT01579305|3698227|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3872512|NCT01579305|3698228|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3872513|NCT01579305|3698226|B3||Female|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
3872514|NCT01579305|3698227|B2||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3872515|NCT01579305|3698228|B1||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3872516|NCT01579305|3698226|B3|||Age||years|Mean|47.7|47.7|Standard Deviation|12.28|12.28|||
3872517|NCT01579305|3698227|B2|||Age||years|Mean|48.3|48.3|Standard Deviation|12.61|12.61|||
3872518|NCT01579305|3698228|B1|||Age||years|Mean|47.1|47.1|Standard Deviation|11.94|11.94|||
3872519|NCT01579214|3698235|B3|||Days from enrollment until laboratory result||Days|Median|10|10.0|Inter-Quartile Range|||8.0|16.0|
3872520|NCT01579214|3698236|B2|||Days from enrollment until laboratory result||Days|Median|10|10.0|Inter-Quartile Range|||8.0|15.0|
3872521|NCT01579214|3698237|B1|||Days from enrollment until laboratory result||Days|Median|11|11.0|Inter-Quartile Range|||8.0|19.0|
3872522|NCT01579214|3698235|B3|||CD4 Count||cells/mm^3|Median|215|215.0|Inter-Quartile Range|||106.0|285.0|
3872523|NCT01579214|3698236|B2|||CD4 Count||cells/mm^3|Median|225|225.0|Inter-Quartile Range|||110.0|293.0|
3872524|NCT01579214|3698237|B1|||CD4 Count||cells/mm^3|Median|185|185.0|Inter-Quartile Range|||106.0|262.0|
3872525|NCT01579214|3698235|B3|Missing Information||Educational Attainment||Participants|Count of Participants|7|7.0||||||
3872526|NCT01579214|3698236|B2|Missing Information||Educational Attainment||Participants|Count of Participants|0|0.0||||||
3872527|NCT01579214|3698237|B1|Missing Information||Educational Attainment||Participants|Count of Participants|7|7.0||||||
3872528|NCT01579214|3698235|B3|>Secondary||Educational Attainment||Participants|Count of Participants|25|25.0||||||
3872529|NCT01579214|3698236|B2|>Secondary||Educational Attainment||Participants|Count of Participants|18|18.0||||||
3872530|NCT01579214|3698237|B1|>Secondary||Educational Attainment||Participants|Count of Participants|7|7.0||||||
3872531|NCT01579214|3698235|B3|Any secondary||Educational Attainment||Participants|Count of Participants|49|49.0||||||
3872532|NCT01579214|3698236|B2|Any secondary||Educational Attainment||Participants|Count of Participants|37|37.0||||||
3872533|NCT01579214|3698237|B1|Any secondary||Educational Attainment||Participants|Count of Participants|12|12.0||||||
3872534|NCT01579214|3698235|B3|Any primary||Educational Attainment||Participants|Count of Participants|87|87.0||||||
3872535|NCT01579214|3698236|B2|Any primary||Educational Attainment||Participants|Count of Participants|71|71.0||||||
3872536|NCT01579214|3698237|B1|Any primary||Educational Attainment||Participants|Count of Participants|16|16.0||||||
3872537|NCT01579214|3698235|B3|<Primary||Educational Attainment||Participants|Count of Participants|15|15.0||||||
3872538|NCT01579214|3698236|B2|<Primary||Educational Attainment||Participants|Count of Participants|12|12.0||||||
3872539|NCT01579214|3698237|B1|<Primary||Educational Attainment||Participants|Count of Participants|3|3.0||||||
3872540|NCT01579214|3698235|B3|||Number of Antiretroviral Therapy (ART) Naive Participants||Participants|Count of Participants|136|136.0||||||
3872541|NCT01579214|3698236|B2|||Number of Antiretroviral Therapy (ART) Naive Participants||Participants|Count of Participants|110|110.0||||||
3872542|NCT01579214|3698237|B1|||Number of Antiretroviral Therapy (ART) Naive Participants||Participants|Count of Participants|26|26.0||||||
3872543|NCT01579214|3698235|B3|Uganda|Non-Mbarara Resident|Region of Enrollment||Participants|Count of Participants|68|68.0||||||
3872544|NCT01579214|3698236|B2|Uganda|Non-Mbarara Resident|Region of Enrollment||Participants|Count of Participants|55|55.0||||||
3872545|NCT01579214|3698237|B1|Uganda|Non-Mbarara Resident|Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3872546|NCT01579214|3698235|B3|Uganda|Mbarara Resident|Region of Enrollment||Participants|Count of Participants|115|115.0||||||
3872547|NCT01579214|3698236|B2|Uganda|Mbarara Resident|Region of Enrollment||Participants|Count of Participants|83|83.0||||||
3872548|NCT01579214|3698237|B1|Uganda|Mbarara Resident|Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3872549|NCT01579214|3698235|B3|Male Gender||Sex/Gender, Customized||Participants|Count of Participants|89|89.0||||||
3872550|NCT01579214|3698236|B2|Male Gender||Sex/Gender, Customized||Participants|Count of Participants|63|63.0||||||
3872551|NCT01579214|3698237|B1|Male Gender||Sex/Gender, Customized||Participants|Count of Participants|26|26.0||||||
3872552|NCT01579214|3698235|B3|Female Gender||Sex/Gender, Customized||Participants|Count of Participants|94|94.0||||||
3872553|NCT01579214|3698236|B2|Female Gender||Sex/Gender, Customized||Participants|Count of Participants|75|75.0||||||
3872554|NCT01579214|3698237|B1|Female Gender||Sex/Gender, Customized||Participants|Count of Participants|19|19.0||||||
3872555|NCT01579214|3698235|B3|||Age||years|Median|32|32.0|Inter-Quartile Range|||26.0|39.0|
3872556|NCT01579214|3698236|B2|||Age||years|Median|30|30.0|Inter-Quartile Range|||25.0|38.0|
3872557|NCT01579214|3698237|B1|||Age||years|Median|38|38.0|Inter-Quartile Range|||31.0|44.0|
3872558|NCT01579084|3698246|B11||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3872559|NCT01579084|3698247|B10||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3872560|NCT01579084|3698248|B9||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3872561|NCT01579084|3698249|B8||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3872562|NCT01579084|3698250|B7||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3872563|NCT01579084|3698251|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3872564|NCT01579084|3698252|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3872565|NCT01579084|3698253|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3872566|NCT01579084|3698254|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3872567|NCT01579084|3698255|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3872568|NCT01579084|3698256|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3872569|NCT01579084|3698246|B11||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3872570|NCT01579084|3698247|B10||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3872571|NCT01579084|3698248|B9||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3872572|NCT01579084|3698249|B8||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3872573|NCT01579084|3698250|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3872574|NCT01579084|3698251|B6||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3872575|NCT01579084|3698252|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3872576|NCT01579084|3698253|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3872577|NCT01579084|3698254|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3872578|NCT01579084|3698255|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3872579|NCT01579084|3698256|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3872580|NCT01579084|3698246|B11|> 65 years||Age, Customized||Participants|Number|4|4.0||||||
3872581|NCT01579084|3698247|B10|> 65 years||Age, Customized||Participants|Number|0|0.0||||||
3872582|NCT01579084|3698248|B9|> 65 years||Age, Customized||Participants|Number|1|1.0||||||
3872583|NCT01579084|3698249|B8|> 65 years||Age, Customized||Participants|Number|0|0.0||||||
3872584|NCT01579084|3698250|B7|> 65 years||Age, Customized||Participants|Number|1|1.0||||||
3872585|NCT01579084|3698251|B6|> 65 years||Age, Customized||Participants|Number|0|0.0||||||
3872586|NCT01579084|3698252|B5|> 65 years||Age, Customized||Participants|Number|0|0.0||||||
3872587|NCT01579084|3698253|B4|> 65 years||Age, Customized||Participants|Number|0|0.0||||||
3872588|NCT01579084|3698254|B3|> 65 years||Age, Customized||Participants|Number|1|1.0||||||
3872589|NCT01579084|3698255|B2|> 65 years||Age, Customized||Participants|Number|1|1.0||||||
3872590|NCT01579084|3698256|B1|> 65 years||Age, Customized||Participants|Number|0|0.0||||||
3872591|NCT01579084|3698246|B11|45 to 65 years||Age, Customized||Participants|Number|50|50.0||||||
3872592|NCT01579084|3698247|B10|45 to 65 years||Age, Customized||Participants|Number|4|4.0||||||
3872593|NCT01579084|3698248|B9|45 to 65 years||Age, Customized||Participants|Number|2|2.0||||||
3872594|NCT01579084|3698249|B8|45 to 65 years||Age, Customized||Participants|Number|3|3.0||||||
3872595|NCT01579084|3698250|B7|45 to 65 years||Age, Customized||Participants|Number|3|3.0||||||
3872596|NCT01579084|3698251|B6|45 to 65 years||Age, Customized||Participants|Number|7|7.0||||||
3872597|NCT01579084|3698252|B5|45 to 65 years||Age, Customized||Participants|Number|8|8.0||||||
3872598|NCT01579084|3698253|B4|45 to 65 years||Age, Customized||Participants|Number|4|4.0||||||
3872599|NCT01579084|3698254|B3|45 to 65 years||Age, Customized||Participants|Number|6|6.0||||||
3872600|NCT01579084|3698255|B2|45 to 65 years||Age, Customized||Participants|Number|6|6.0||||||
3872601|NCT01579084|3698256|B1|45 to 65 years||Age, Customized||Participants|Number|7|7.0||||||
3872602|NCT01579084|3698246|B11|< 45 years||Age, Customized||Participants|Number|10|10.0||||||
3872603|NCT01579084|3698247|B10|< 45 years||Age, Customized||Participants|Number|0|0.0||||||
3872604|NCT01579084|3698248|B9|< 45 years||Age, Customized||Participants|Number|1|1.0||||||
3872605|NCT01579084|3698249|B8|< 45 years||Age, Customized||Participants|Number|1|1.0||||||
3872606|NCT01579084|3698250|B7|< 45 years||Age, Customized||Participants|Number|0|0.0||||||
3872607|NCT01579084|3698251|B6|< 45 years||Age, Customized||Participants|Number|1|1.0||||||
3872608|NCT01579084|3698252|B5|< 45 years||Age, Customized||Participants|Number|0|0.0||||||
3872609|NCT01579084|3698253|B4|< 45 years||Age, Customized||Participants|Number|4|4.0||||||
3872610|NCT01579084|3698254|B3|< 45 years||Age, Customized||Participants|Number|1|1.0||||||
3872611|NCT01579084|3698255|B2|< 45 years||Age, Customized||Participants|Number|1|1.0||||||
3872612|NCT01579084|3698256|B1|< 45 years||Age, Customized||Participants|Number|1|1.0||||||
3872613|NCT01579045|3698293|B1|United Kingdom||Region of Enrollment||participants|Number|24|24.0||||||
3872614|NCT01579045|3698293|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3872615|NCT01579045|3698293|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3872616|NCT01579045|3698293|B1|||Age||years|Mean|43.2|43.2|Standard Deviation|15.3|15.3|||
3872617|NCT01579006|3698310|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3872618|NCT01579006|3698310|B1||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3872619|NCT01579006|3698310|B1|||Age||years|Mean|54.8|54.8|Standard Deviation|13.7|13.7|||
3872620|NCT01578993|3698349|B1|United States||Region of Enrollment||participants|Number|101|101.0||||||
3872621|NCT01578993|3698349|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872622|NCT01578993|3698349|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872623|NCT01578993|3698349|B1||White|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3872624|NCT01578993|3698349|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3872625|NCT01578993|3698349|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3872626|NCT01578993|3698349|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3872627|NCT01578993|3698349|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3872628|NCT01578993|3698349|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3872629|NCT01578993|3698349|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3872630|NCT01578993|3698349|B1|||Age||Years|Median|55|55.0|Full Range|||18.0|83.0|
3872631|NCT01578980|3698353|B1|||HbA1c 6-9%||participants|Number|20|20.0||||||
3872632|NCT01578980|3698353|B1|Italy||Region of Enrollment||participants|Number|5|5.0||||||
3872633|NCT01578980|3698353|B1|France||Region of Enrollment||participants|Number|5|5.0||||||
3872634|NCT01578980|3698353|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3872635|NCT01578980|3698353|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3872636|NCT01578980|3698353|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3872637|NCT01578980|3698353|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3872638|NCT01578980|3698353|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3872639|NCT01578980|3698353|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3872640|NCT01578967|3698358|B1||UnFavorable|Risk|patients with early stage HL can be stratified into two risk groups: Favorable and unfavorable. This is based on the presence or absence of certain clinical features, such as age, B symptoms, erythrocyte sedimentation rate (ESR), large number of regions involved, and large mediastinal adenopathy.|Participants|Count of Participants|22|22.0||||||
3872641|NCT01578967|3698358|B1||Favorable|Risk|patients with early stage HL can be stratified into two risk groups: Favorable and unfavorable. This is based on the presence or absence of certain clinical features, such as age, B symptoms, erythrocyte sedimentation rate (ESR), large number of regions involved, and large mediastinal adenopathy.|Participants|Count of Participants|18|18.0||||||
3872642|NCT01578967|3698358|B1||IIB|Stage|The stage of lymphoma describes the extent of the spread of the tumor, using the terms stage I through IV (1 through 4). Each stage may also be further divided into “A” and “B” categories, based on whether or not the patient is experiencing specific symptoms. Where larger numbers indicate a worse outcome.|Participants|Count of Participants|10|10.0||||||
3872643|NCT01578967|3698358|B1||IIA|Stage|The stage of lymphoma describes the extent of the spread of the tumor, using the terms stage I through IV (1 through 4). Each stage may also be further divided into “A” and “B” categories, based on whether or not the patient is experiencing specific symptoms. Where larger numbers indicate a worse outcome.|Participants|Count of Participants|28|28.0||||||
3872644|NCT01578967|3698358|B1||I|Stage|The stage of lymphoma describes the extent of the spread of the tumor, using the terms stage I through IV (1 through 4). Each stage may also be further divided into “A” and “B” categories, based on whether or not the patient is experiencing specific symptoms. Where larger numbers indicate a worse outcome.|Participants|Count of Participants|2|2.0||||||
3872645|NCT01578967|3698358|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3872646|NCT01578967|3698358|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3872647|NCT01578967|3698358|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872648|NCT01578967|3698358|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3872649|NCT01578967|3698358|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3872650|NCT01578967|3698358|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872651|NCT01578967|3698358|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872652|NCT01578967|3698358|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872653|NCT01578967|3698358|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872654|NCT01578967|3698358|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3872655|NCT01578967|3698358|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3872656|NCT01578967|3698358|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3872657|NCT01578967|3698358|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3872658|NCT01578967|3698358|B1|||Age||years|Median|29|29.0|Full Range|||19.0|67.0|
3872659|NCT01578850|3698367|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3872660|NCT01578850|3698368|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3872661|NCT01578850|3698369|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3872662|NCT01578850|3698367|B3||Female|Sex: Female, Male||Participants|Count of Participants|290|290.0||||||
3872663|NCT01578850|3698368|B2||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3872664|NCT01578850|3698369|B1||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3872665|NCT01578850|3698367|B3|||Age||Years|Mean|46.6|46.6|Standard Deviation|12.44|12.44|||
3872666|NCT01578850|3698368|B2|||Age||Years|Mean|47.0|47.0|Standard Deviation|12.02|12.02|||
3872667|NCT01578850|3698369|B1|||Age||Years|Mean|46.2|46.2|Standard Deviation|12.88|12.88|||
3872668|NCT01578785|3698421|B3|USA||Region of Enrollment||participants|Number|2|2.0||||||
3872669|NCT01578785|3698422|B2|USA||Region of Enrollment||participants|Number|1|1.0||||||
3872670|NCT01578785|3698423|B1|USA||Region of Enrollment||participants|Number|1|1.0||||||
3872671|NCT01578785|3698421|B3|Romania||Region of Enrollment||participants|Number|28|28.0||||||
3872672|NCT01578785|3698422|B2|Romania||Region of Enrollment||participants|Number|19|19.0||||||
3872673|NCT01578785|3698423|B1|Romania||Region of Enrollment||participants|Number|9|9.0||||||
3872674|NCT01578785|3698421|B3|Poland||Region of Enrollment||participants|Number|54|54.0||||||
3872675|NCT01578785|3698422|B2|Poland||Region of Enrollment||participants|Number|35|35.0||||||
3872676|NCT01578785|3698423|B1|Poland||Region of Enrollment||participants|Number|19|19.0||||||
3872677|NCT01578785|3698421|B3|Croatia||Region of Enrollment||participants|Number|25|25.0||||||
3872678|NCT01578785|3698422|B2|Croatia||Region of Enrollment||participants|Number|18|18.0||||||
3872679|NCT01578785|3698423|B1|Croatia||Region of Enrollment||participants|Number|7|7.0||||||
3872680|NCT01578785|3698421|B3|Georgia||Region of Enrollment||participants|Number|14|14.0||||||
3872681|NCT01578785|3698422|B2|Georgia||Region of Enrollment||participants|Number|8|8.0||||||
3872682|NCT01578785|3698423|B1|Georgia||Region of Enrollment||participants|Number|6|6.0||||||
3872683|NCT01578785|3698421|B3|Estonia||Region of Enrollment||participants|Number|1|1.0||||||
3872684|NCT01578785|3698422|B2|Estonia||Region of Enrollment||participants|Number|1|1.0||||||
3872685|NCT01578785|3698423|B1|Estonia||Region of Enrollment||participants|Number|0|0.0||||||
3872686|NCT01578785|3698421|B3|Belarus||Region of Enrollment||participants|Number|8|8.0||||||
3872687|NCT01578785|3698422|B2|Belarus||Region of Enrollment||participants|Number|4|4.0||||||
3872688|NCT01578785|3698423|B1|Belarus||Region of Enrollment||participants|Number|4|4.0||||||
3872689|NCT01578785|3698421|B3|Bosnia and Herzegovina||Region of Enrollment||participants|Number|17|17.0||||||
3872690|NCT01578785|3698422|B2|Bosnia and Herzegovina||Region of Enrollment||participants|Number|11|11.0||||||
3872691|NCT01578785|3698423|B1|Bosnia and Herzegovina||Region of Enrollment||participants|Number|6|6.0||||||
3872692|NCT01578785|3698421|B3|Bulgaria||Region of Enrollment||participants|Number|29|29.0||||||
3872693|NCT01578785|3698422|B2|Bulgaria||Region of Enrollment||participants|Number|22|22.0||||||
3872694|NCT01578785|3698423|B1|Bulgaria||Region of Enrollment||participants|Number|7|7.0||||||
3872695|NCT01578785|3698421|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872696|NCT01578785|3698422|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872697|NCT01578785|3698423|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872698|NCT01578785|3698421|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872699|NCT01578785|3698422|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872700|NCT01578785|3698423|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872701|NCT01578785|3698421|B3||White|Race (NIH/OMB)||Participants|Count of Participants|176|176.0||||||
3872702|NCT01578785|3698422|B2||White|Race (NIH/OMB)||Participants|Count of Participants|118|118.0||||||
3872703|NCT01578785|3698423|B1||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3872704|NCT01578785|3698421|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3872705|NCT01578785|3698422|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3872706|NCT01578785|3698423|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3872707|NCT01578785|3698421|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872708|NCT01578785|3698422|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872709|NCT01578785|3698423|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872710|NCT01578785|3698421|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872711|NCT01578785|3698422|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872712|NCT01578785|3698423|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872713|NCT01578785|3698421|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872714|NCT01578785|3698422|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872715|NCT01578785|3698423|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872716|NCT01578785|3698421|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872717|NCT01578785|3698422|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872718|NCT01578785|3698423|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872719|NCT01578785|3698421|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|178|178.0||||||
3872720|NCT01578785|3698422|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
3872721|NCT01578785|3698423|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3872722|NCT01578785|3698421|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872723|NCT01578785|3698422|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872724|NCT01578785|3698423|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872725|NCT01578785|3698421|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3872726|NCT01578785|3698422|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3872727|NCT01578785|3698423|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3872728|NCT01578785|3698421|B3||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3872729|NCT01578785|3698422|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3872730|NCT01578785|3698423|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3872731|NCT01578785|3698421|B3|AgeContinuous||Age||years|Mean|38.5|38.5|Standard Deviation|8.62|8.62|||
3872732|NCT01578785|3698422|B2|AgeContinuous||Age||years|Mean|38.9|38.9|Standard Deviation|8.36|8.36|||
3872733|NCT01578785|3698423|B1|AgeContinuous||Age||years|Mean|37.7|37.7|Standard Deviation|9.13|9.13|||
3872734|NCT01578772|3698436|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3872735|NCT01578772|3698436|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3872736|NCT01578772|3698436|B1|||Age||years|Median|60|60.0|Inter-Quartile Range|||54.0|63.0|
3872737|NCT01578707|3698443|B3||Male|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
3872738|NCT01578707|3698444|B2||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3872739|NCT01578707|3698445|B1||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3872740|NCT01578707|3698443|B3||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3872741|NCT01578707|3698444|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3872742|NCT01578707|3698445|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3872743|NCT01578707|3698443|B3|||Age||years|Mean|66.5|66.5|Standard Deviation|9.53|9.53|||
3872744|NCT01578707|3698444|B2|||Age||years|Mean|66.1|66.1|Standard Deviation|10.15|10.15|||
3872745|NCT01578707|3698445|B1|||Age||years|Mean|66.8|66.8|Standard Deviation|8.88|8.88|||
3872746|NCT01578707|3698443|B3||>=65 years|Age||Participants|Count of Participants|239|239.0||||||
3872747|NCT01578707|3698444|B2||>=65 years|Age||Participants|Count of Participants|118|118.0||||||
3872748|NCT01578707|3698445|B1||>=65 years|Age||Participants|Count of Participants|121|121.0||||||
3872749|NCT01578707|3698443|B3||Between 18 and 65 years|Age||Participants|Count of Participants|152|152.0||||||
3872750|NCT01578707|3698444|B2||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
3872751|NCT01578707|3698445|B1||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
3872752|NCT01578707|3698443|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3872753|NCT01578707|3698444|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3872754|NCT01578707|3698445|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3872755|NCT01578551|3698454|B3|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3872756|NCT01578551|3698455|B2|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3872757|NCT01578551|3698456|B1|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3872758|NCT01578551|3698454|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3872759|NCT01578551|3698455|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3872760|NCT01578551|3698456|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3872761|NCT01578551|3698454|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3872762|NCT01578551|3698455|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3872763|NCT01578551|3698456|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3872764|NCT01578551|3698454|B3|||Age||years|Median|61|61.0|Full Range|||37.0|74.0|
3872765|NCT01578551|3698455|B2|||Age||years|Median|64|64.0|Full Range|||55.0|70.0|
3872766|NCT01578551|3698456|B1|||Age||years|Median|58|58.0|Full Range|||37.0|74.0|
3872767|NCT01578551|3698454|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3872768|NCT01578551|3698455|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3872769|NCT01578551|3698456|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3872770|NCT01578551|3698454|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3872771|NCT01578551|3698455|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3872772|NCT01578551|3698456|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3872773|NCT01578551|3698454|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3872774|NCT01578551|3698455|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3872775|NCT01578551|3698456|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3872776|NCT01578499|3698467|B3|Brazil||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3872777|NCT01578499|3698468|B2|Brazil||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3872778|NCT01578499|3698469|B1|Brazil||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3872779|NCT01578499|3698467|B3|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3872780|NCT01578499|3698468|B2|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3872781|NCT01578499|3698469|B1|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3872782|NCT01578499|3698467|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3872783|NCT01578499|3698468|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3872784|NCT01578499|3698469|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3872785|NCT01578499|3698467|B3|Switzerland||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3872786|NCT01578499|3698468|B2|Switzerland||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3872787|NCT01578499|3698469|B1|Switzerland||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3872788|NCT01578499|3698467|B3|Spain||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3872789|NCT01578499|3698468|B2|Spain||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3872790|NCT01578499|3698469|B1|Spain||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3872791|NCT01578499|3698467|B3|Poland||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3872792|NCT01578499|3698468|B2|Poland||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3872793|NCT01578499|3698469|B1|Poland||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3872794|NCT01578499|3698467|B3|Italy||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3872795|NCT01578499|3698468|B2|Italy||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3872796|NCT01578499|3698469|B1|Italy||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3872797|NCT01578499|3698467|B3|Germany||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3872798|NCT01578499|3698468|B2|Germany||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3872799|NCT01578499|3698469|B1|Germany||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3872800|NCT01578499|3698467|B3|France||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3872801|NCT01578499|3698468|B2|France||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3872802|NCT01578499|3698469|B1|France||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3872803|NCT01578499|3698467|B3|Belgium||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3872804|NCT01578499|3698468|B2|Belgium||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3872805|NCT01578499|3698469|B1|Belgium||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3872806|NCT01578499|3698467|B3|Australia||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3872807|NCT01578499|3698468|B2|Australia||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3872808|NCT01578499|3698469|B1|Australia||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3872809|NCT01578499|3698467|B3|Not reported||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3872810|NCT01578499|3698468|B2|Not reported||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3872811|NCT01578499|3698469|B1|Not reported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3872812|NCT01578499|3698467|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|110|110.0||||||
3872813|NCT01578499|3698468|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
3872814|NCT01578499|3698469|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
3872815|NCT01578499|3698467|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3872816|NCT01578499|3698468|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3872817|NCT01578499|3698469|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3872818|NCT01578499|3698467|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3872819|NCT01578499|3698468|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3872820|NCT01578499|3698469|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3872821|NCT01578499|3698467|B3|Not reported||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3872822|NCT01578499|3698468|B2|Not reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3872823|NCT01578499|3698469|B1|Not reported||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3872824|NCT01578499|3698467|B3|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3872825|NCT01578499|3698468|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3872826|NCT01578499|3698469|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3872827|NCT01578499|3698467|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3872828|NCT01578499|3698468|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3872829|NCT01578499|3698469|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3872830|NCT01578499|3698467|B3|White||Race/Ethnicity, Customized||participants|Number|109|109.0||||||
3872831|NCT01578499|3698468|B2|White||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
3872832|NCT01578499|3698469|B1|White||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
3872833|NCT01578499|3698467|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3872834|NCT01578499|3698468|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3872835|NCT01578499|3698469|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3872836|NCT01578499|3698467|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3872837|NCT01578499|3698468|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3872838|NCT01578499|3698469|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3872839|NCT01578499|3698467|B3|||Age||years|Mean|58.0|58.0|Standard Deviation|14.12|14.12|||
3872840|NCT01578499|3698468|B2|||Age||years|Mean|56.6|56.6|Standard Deviation|14.43|14.43|||
3872841|NCT01578499|3698469|B1|||Age||years|Mean|59.4|59.4|Standard Deviation|13.80|13.8|||
3872842|NCT01578486|3698504|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3872843|NCT01578486|3698504|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3872844|NCT01578486|3698504|B1|||Age||years|Mean|42.8|42.8|Standard Deviation|9.8|9.8|||
3872845|NCT01578330|3698515|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3872846|NCT01578330|3698515|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3872847|NCT01578330|3698515|B1|||Age||Years|Mean|35.7|35.7|Standard Deviation|9.4|9.4|||
3872848|NCT01578239|3698522|B3|Spain||Region of Enrollment||participants|Number|11|11.0||||||
3872849|NCT01578239|3698523|B2|Spain||Region of Enrollment||participants|Number|6|6.0||||||
3872850|NCT01578239|3698524|B1|Spain||Region of Enrollment||participants|Number|5|5.0||||||
3872851|NCT01578239|3698522|B3|Germany||Region of Enrollment||participants|Number|17|17.0||||||
3872852|NCT01578239|3698523|B2|Germany||Region of Enrollment||participants|Number|7|7.0||||||
3872853|NCT01578239|3698524|B1|Germany||Region of Enrollment||participants|Number|10|10.0||||||
3872854|NCT01578239|3698522|B3|Portugal||Region of Enrollment||participants|Number|1|1.0||||||
3872855|NCT01578239|3698523|B2|Portugal||Region of Enrollment||participants|Number|0|0.0||||||
3872856|NCT01578239|3698524|B1|Portugal||Region of Enrollment||participants|Number|1|1.0||||||
3872857|NCT01578239|3698522|B3|France||Region of Enrollment||participants|Number|21|21.0||||||
3872858|NCT01578239|3698523|B2|France||Region of Enrollment||participants|Number|9|9.0||||||
3872859|NCT01578239|3698524|B1|France||Region of Enrollment||participants|Number|12|12.0||||||
3872860|NCT01578239|3698522|B3|United Kingdom||Region of Enrollment||participants|Number|24|24.0||||||
3872861|NCT01578239|3698523|B2|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
3872862|NCT01578239|3698524|B1|United Kingdom||Region of Enrollment||participants|Number|13|13.0||||||
3872863|NCT01578239|3698522|B3|Italy||Region of Enrollment||participants|Number|14|14.0||||||
3872864|NCT01578239|3698523|B2|Italy||Region of Enrollment||participants|Number|9|9.0||||||
3872865|NCT01578239|3698524|B1|Italy||Region of Enrollment||participants|Number|5|5.0||||||
3872866|NCT01578239|3698522|B3|United States||Region of Enrollment||participants|Number|135|135.0||||||
3872867|NCT01578239|3698523|B2|United States||Region of Enrollment||participants|Number|69|69.0||||||
3872868|NCT01578239|3698524|B1|United States||Region of Enrollment||participants|Number|66|66.0||||||
3872869|NCT01578239|3698522|B3|Belgium||Region of Enrollment||participants|Number|6|6.0||||||
3872870|NCT01578239|3698523|B2|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
3872871|NCT01578239|3698524|B1|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
3872872|NCT01578239|3698522|B3||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3872873|NCT01578239|3698523|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3872874|NCT01578239|3698524|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3872875|NCT01578239|3698522|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3872876|NCT01578239|3698523|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3872877|NCT01578239|3698524|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3872878|NCT01578239|3698522|B3|||Age||years|Mean|63.7|63.7|Standard Deviation|9.53|9.53|||
3872879|NCT01578239|3698523|B2|||Age||years|Mean|64.1|64.1|Standard Deviation|9.7|9.7|||
3872880|NCT01578239|3698524|B1|||Age||years|Mean|63.3|63.3|Standard Deviation|9.4|9.4|||
3872881|NCT01578187|3698531|B1|United States||Region of Enrollment||participants|Number|63|63.0||||||
3872882|NCT01578187|3698531|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3872883|NCT01578187|3698531|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3872884|NCT01578187|3698531|B1|||Age||years|Mean|42|42.0|Standard Deviation|13|13.0|||
3872885|NCT01578187|3698531|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3872886|NCT01578187|3698531|B1||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
3872887|NCT01578187|3698531|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3872888|NCT01578044|3698537|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3872889|NCT01578044|3698538|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3872890|NCT01578044|3698539|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3872891|NCT01578044|3698537|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3872892|NCT01578044|3698538|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3872893|NCT01578044|3698539|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3872894|NCT01578044|3698537|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3872895|NCT01578044|3698538|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3872896|NCT01578044|3698539|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3872897|NCT01578044|3698537|B3|||Age||Years|Mean|69.9|69.9|Full Range|||63.0|84.0|
3872898|NCT01578044|3698538|B2|||Age||Years|Mean|69.3|69.3|Full Range|||63.0|84.0|
3872899|NCT01578044|3698539|B1|||Age||Years|Mean|70.5|70.5|Full Range|||67.0|78.0|
3872900|NCT01578044|3698537|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3872901|NCT01578044|3698538|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3872902|NCT01578044|3698539|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3872903|NCT01578044|3698537|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3872904|NCT01578044|3698538|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3872905|NCT01578044|3698539|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3872906|NCT01578044|3698537|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3872907|NCT01578044|3698538|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3872908|NCT01578044|3698539|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3872909|NCT01578031|3698546|B5|Iceland||Region of Enrollment||participants|Number|124|124.0||||||
3872910|NCT01578031|3698547|B4|Iceland||Region of Enrollment||participants|Number|15|15.0||||||
3872911|NCT01578031|3698548|B3|Iceland||Region of Enrollment||participants|Number|9|9.0||||||
3872912|NCT01578031|3698549|B2|Iceland||Region of Enrollment||participants|Number|42|42.0||||||
3872913|NCT01578031|3698550|B1|Iceland||Region of Enrollment||participants|Number|58|58.0||||||
3872914|NCT01578031|3698546|B5|United States||Region of Enrollment||participants|Number|116|116.0||||||
3872915|NCT01578031|3698547|B4|United States||Region of Enrollment||participants|Number|15|15.0||||||
3872916|NCT01578031|3698548|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3872917|NCT01578031|3698549|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
3872918|NCT01578031|3698550|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
3872919|NCT01578031|3698546|B5||Male|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
3872920|NCT01578031|3698547|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3872921|NCT01578031|3698548|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3872922|NCT01578031|3698549|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3872923|NCT01578031|3698550|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3872924|NCT01578031|3698546|B5||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3872925|NCT01578031|3698547|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3872926|NCT01578031|3698548|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3872927|NCT01578031|3698549|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3872928|NCT01578031|3698550|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3872929|NCT01578031|3698546|B5|||Age||years|Mean|53.4|53.4|Standard Deviation|6.9|6.9|||
3872930|NCT01578031|3698547|B4|||Age||years|Mean|51.8|51.8|Standard Deviation|5.8|5.8|||
3872931|NCT01578031|3698548|B3|||Age||years|Mean|54.3|54.3|Standard Deviation|7.8|7.8|||
3872932|NCT01578031|3698549|B2|||Age||years|Mean|52.7|52.7|Standard Deviation|6.5|6.5|||
3872933|NCT01578031|3698550|B1|||Age||years|Mean|54.0|54.0|Standard Deviation|7.1|7.1|||
3872934|NCT01578031|3698546|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3872935|NCT01578031|3698547|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3872936|NCT01578031|3698548|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3872937|NCT01578031|3698549|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3872938|NCT01578031|3698550|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3872939|NCT01578031|3698546|B5||Between 18 and 65 years|Age||Participants|Count of Participants|240|240.0||||||
3872940|NCT01578031|3698547|B4||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3872941|NCT01578031|3698548|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3872942|NCT01578031|3698549|B2||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
3872943|NCT01578031|3698550|B1||Between 18 and 65 years|Age||Participants|Count of Participants|129|129.0||||||
3872944|NCT01578031|3698546|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3872945|NCT01578031|3698547|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3872946|NCT01578031|3698548|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3872947|NCT01578031|3698549|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3872948|NCT01578031|3698550|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3872949|NCT01577966|3698561|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3872950|NCT01577966|3698561|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3872951|NCT01577966|3698561|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3872952|NCT01577966|3698561|B1|||Age||years|Mean|43|43.0|Full Range|||25.0|69.0|
3872953|NCT01577758|3698565|B1|||Body Surface Area|Body surface area data is only available for 39 participants.|m^2|Mean|1.929|1.929|Standard Deviation|0.2424|0.2424|||
3872954|NCT01577758|3698565|B1|||Weight||kg|Mean|78.50|78.5|Standard Deviation|18.573|18.573|||
3872955|NCT01577758|3698565|B1|||Height|Height data is only available for 39 participants.|cm|Mean|170.4|170.4|Standard Deviation|7.69|7.69|||
3872956|NCT01577758|3698565|B1|Not Reported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3872957|NCT01577758|3698565|B1|White||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
3872958|NCT01577758|3698565|B1|Not Reported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3872959|NCT01577758|3698565|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
3872960|NCT01577758|3698565|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3872961|NCT01577758|3698565|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3872962|NCT01577758|3698565|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3872963|NCT01577758|3698565|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|10.81|10.81|||
3872964|NCT01577745|3698605|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872965|NCT01577745|3698606|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872966|NCT01577745|3698607|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872967|NCT01577745|3698608|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872968|NCT01577745|3698609|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872969|NCT01577745|3698610|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872970|NCT01577745|3698611|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872971|NCT01577745|3698605|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872972|NCT01577745|3698606|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872973|NCT01577745|3698607|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872974|NCT01577745|3698608|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872975|NCT01577745|3698609|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872976|NCT01577745|3698610|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872977|NCT01577745|3698611|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872978|NCT01577745|3698605|B7||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3872979|NCT01577745|3698606|B6||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3872980|NCT01577745|3698607|B5||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3872981|NCT01577745|3698608|B4||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3872982|NCT01577745|3698609|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3872983|NCT01577745|3698610|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3872984|NCT01577745|3698611|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3872985|NCT01577745|3698605|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3872986|NCT01577745|3698606|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872987|NCT01577745|3698607|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872988|NCT01577745|3698608|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872989|NCT01577745|3698609|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872990|NCT01577745|3698610|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3872991|NCT01577745|3698611|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872992|NCT01577745|3698605|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872993|NCT01577745|3698606|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872994|NCT01577745|3698607|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872995|NCT01577745|3698608|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872996|NCT01577745|3698609|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872997|NCT01577745|3698610|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872998|NCT01577745|3698611|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3872999|NCT01577745|3698605|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873000|NCT01577745|3698606|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873001|NCT01577745|3698607|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873002|NCT01577745|3698608|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873003|NCT01577745|3698609|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873004|NCT01577745|3698610|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873005|NCT01577745|3698611|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873006|NCT01577745|3698605|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873007|NCT01577745|3698606|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873008|NCT01577745|3698607|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873009|NCT01577745|3698608|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873010|NCT01577745|3698609|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873011|NCT01577745|3698610|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873012|NCT01577745|3698611|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873013|NCT01577745|3698605|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873014|NCT01577745|3698606|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873015|NCT01577745|3698607|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873016|NCT01577745|3698608|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873017|NCT01577745|3698609|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873018|NCT01577745|3698610|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873019|NCT01577745|3698611|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873020|NCT01577745|3698605|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3873021|NCT01577745|3698606|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3873022|NCT01577745|3698607|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3873023|NCT01577745|3698608|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3873024|NCT01577745|3698609|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3873025|NCT01577745|3698610|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3873026|NCT01577745|3698611|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3873027|NCT01577745|3698605|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3873028|NCT01577745|3698606|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873029|NCT01577745|3698607|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3873030|NCT01577745|3698608|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873031|NCT01577745|3698609|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873032|NCT01577745|3698610|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3873033|NCT01577745|3698611|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3873034|NCT01577745|3698605|B7||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3873035|NCT01577745|3698606|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3873036|NCT01577745|3698607|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3873037|NCT01577745|3698608|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3873038|NCT01577745|3698609|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3873039|NCT01577745|3698610|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3873040|NCT01577745|3698611|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3873041|NCT01577745|3698605|B7||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3873042|NCT01577745|3698606|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3873043|NCT01577745|3698607|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3873044|NCT01577745|3698608|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3873045|NCT01577745|3698609|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3873046|NCT01577745|3698610|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3873047|NCT01577745|3698611|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3873048|NCT01577745|3698605|B7|||Age||Years|Mean|61.6|61.6|Standard Deviation|11.3|11.3|||
3873049|NCT01577745|3698606|B6|||Age||Years|Mean|62.6|62.6|Standard Deviation|10.8|10.8|||
3873050|NCT01577745|3698607|B5|||Age||Years|Mean|62.2|62.2|Standard Deviation|5.2|5.2|||
3873051|NCT01577745|3698608|B4|||Age||Years|Mean|62.2|62.2|Standard Deviation|9.3|9.3|||
3873052|NCT01577745|3698609|B3|||Age||Years|Mean|67.7|67.7|Standard Deviation|13.7|13.7|||
3873053|NCT01577745|3698610|B2|||Age||Years|Mean|57.3|57.3|Standard Deviation|22.5|22.5|||
3873054|NCT01577745|3698611|B1|||Age||Years|Mean|55.7|55.7|Standard Deviation|14.0|14.0|||
3873055|NCT01577732|3698733|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|300|300.0||||||
3873056|NCT01577732|3698733|B1||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3873057|NCT01577732|3698733|B1||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3873058|NCT01577732|3698733|B1|||Age||months|Mean|15.8|15.8|Standard Deviation|2.96|2.96|||
3873059|NCT01577706|3698740|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3873060|NCT01577706|3698740|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3873061|NCT01577706|3698740|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3873062|NCT01577706|3698740|B1|||Age||years|Mean|28.9|28.9|Standard Deviation|7.6|7.6|||
3873063|NCT01577706|3698740|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3873064|NCT01577706|3698740|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3873065|NCT01577706|3698740|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3873066|NCT01577381|3698796|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3873067|NCT01577381|3698797|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3873068|NCT01577381|3698798|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3873069|NCT01577381|3698799|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3873070|NCT01577381|3698800|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3873071|NCT01577381|3698796|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3873072|NCT01577381|3698797|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3873073|NCT01577381|3698798|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3873074|NCT01577381|3698799|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3873075|NCT01577381|3698800|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3873076|NCT01577381|3698796|B5|||Age||years|Mean|74.6|74.6|Standard Deviation|8.6|8.6|||
3873077|NCT01577381|3698797|B4|||Age||years|Mean|73.0|73.0|Standard Deviation|11.3|11.3|||
3873078|NCT01577381|3698798|B3|||Age||years|Mean|74.0|74.0|Standard Deviation|12.2|12.2|||
3873079|NCT01577381|3698799|B2|||Age||years|Mean|71.0|71.0|Standard Deviation|6.2|6.2|||
3873080|NCT01577381|3698800|B1|||Age||years|Mean|82.5|82.5|Standard Deviation|0.7|0.7|||
3873081|NCT01577329|3698932|B3|United States||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3873082|NCT01577329|3698933|B2|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3873083|NCT01577329|3698934|B1|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3873084|NCT01577329|3698932|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3873085|NCT01577329|3698933|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3873086|NCT01577329|3698934|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3873087|NCT01577329|3698932|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3873088|NCT01577329|3698933|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3873089|NCT01577329|3698934|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3873090|NCT01577329|3698932|B3|||Age||years|Mean|69.5|69.5|Standard Deviation|7.9|7.9|||
3873091|NCT01577329|3698933|B2|||Age||years|Mean|68.7|68.7|Standard Deviation|4.8|4.8|||
3873092|NCT01577329|3698934|B1|||Age||years|Mean|70.3|70.3|Standard Deviation|5.2|5.2|||
3873093|NCT01577329|3698932|B3||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
3873094|NCT01577329|3698933|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3873095|NCT01577329|3698934|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3873096|NCT01577329|3698932|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3873097|NCT01577329|3698933|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3873098|NCT01577329|3698934|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3873099|NCT01577329|3698932|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3873100|NCT01577329|3698933|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3873101|NCT01577329|3698934|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3873102|NCT01577186|3698941|B1||Male|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
3873103|NCT01577186|3698941|B1||Female|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
3873104|NCT01577186|3698941|B1|||Age||years|Mean|40.3|40.3|Standard Deviation|10.62|10.62|||
3873105|NCT01577160|3698949|B1||Male|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
3873106|NCT01577160|3698949|B1||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3873107|NCT01577160|3698949|B1|||Age||years|Mean|41.1|41.1|Standard Deviation|11.2|11.2|||
3873108|NCT01577108|3698957|B3|||Pregnancy, 35-37 weeks||Participants|Number|99|99.0||||||
3873109|NCT01577108|3698958|B2|||Pregnancy, 35-37 weeks||Participants|Number|50|50.0||||||
3873110|NCT01577108|3698959|B1|||Pregnancy, 35-37 weeks||Participants|Number|49|49.0||||||
3873111|NCT01577108|3698957|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3873112|NCT01577108|3698958|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3873113|NCT01577108|3698959|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3873114|NCT01577108|3698957|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3873115|NCT01577108|3698958|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3873116|NCT01577108|3698959|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3873117|NCT01577108|3698957|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3873118|NCT01577108|3698958|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3873119|NCT01577108|3698959|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3873120|NCT01577108|3698957|B3||Between 18 and 65 years|Age||Participants|Count of Participants|99|99.0||||||
3873121|NCT01577108|3698958|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3873122|NCT01577108|3698959|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3873123|NCT01577108|3698957|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3873124|NCT01577108|3698958|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3873125|NCT01577108|3698959|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3873126|NCT01576952|3698966|B3||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3873127|NCT01576952|3698967|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3873128|NCT01576952|3698968|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3873129|NCT01576952|3698966|B3||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3873130|NCT01576952|3698967|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3873131|NCT01576952|3698968|B1||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3873132|NCT01576952|3698966|B3|≥ 65 years||Age, Customized||participants|Number|181|181.0||||||
3873133|NCT01576952|3698967|B2|≥ 65 years||Age, Customized||participants|Number|60|60.0||||||
3873134|NCT01576952|3698968|B1|≥ 65 years||Age, Customized||participants|Number|121|121.0||||||
3873135|NCT01576952|3698966|B3|< 65 years||Age, Customized||participants|Number|72|72.0||||||
3873136|NCT01576952|3698967|B2|< 65 years||Age, Customized||participants|Number|25|25.0||||||
3873137|NCT01576952|3698968|B1|< 65 years||Age, Customized||participants|Number|47|47.0||||||
3873138|NCT01576952|3698966|B3|||Age||years|Mean|68.7|68.7|Standard Deviation|10.17|10.17|||
3873139|NCT01576952|3698967|B2|||Age||years|Mean|68.4|68.4|Standard Deviation|10.27|10.27|||
3873140|NCT01576952|3698968|B1|||Age||years|Mean|68.9|68.9|Standard Deviation|10.14|10.14|||
3873141|NCT01576939|3698975|B1|||Tongue dose|Measurement of the lateral tongue mucosal dose was performed using optically stimulated luminescence (OSL) dosimeters, which were taped on the lingual side of the lower mouth-bite. The OSL was placed on the first day of RT in the 2 mucosal sites: lateral oral tongue on the left (L) and right (R) sides adjacent to dental fillings. The OSL was developed and measured on the same day. The measured dose per fraction was converted to the total dose for the entire treatment.|Gy|Median|30.5|30.5|Full Range|||11.2|70.0|
3873142|NCT01576939|3698975|B1||Oral Cavity|Primary Tumor location||Participants|Count of Participants|7|7.0||||||
3873143|NCT01576939|3698975|B1||Pharynx|Primary Tumor location||Participants|Count of Participants|23|23.0||||||
3873144|NCT01576939|3698975|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3873145|NCT01576939|3698975|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3873146|NCT01576939|3698975|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3873147|NCT01576939|3698975|B1|||Age||years|Median|61.5|61.5|Full Range|||42.0|82.0|
3873148|NCT01576874|3698983|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873149|NCT01576874|3698984|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873150|NCT01576874|3698985|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873151|NCT01576874|3698983|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3873152|NCT01576874|3698984|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3873153|NCT01576874|3698985|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3873154|NCT01576874|3698983|B3||White|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
3873155|NCT01576874|3698984|B2||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3873156|NCT01576874|3698985|B1||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3873157|NCT01576874|3698983|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3873158|NCT01576874|3698984|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3873159|NCT01576874|3698985|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3873160|NCT01576874|3698983|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873161|NCT01576874|3698984|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873162|NCT01576874|3698985|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873163|NCT01576874|3698983|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3873164|NCT01576874|3698984|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873165|NCT01576874|3698985|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3873166|NCT01576874|3698983|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3873167|NCT01576874|3698984|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3873168|NCT01576874|3698985|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873169|NCT01576874|3698983|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3873170|NCT01576874|3698984|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3873171|NCT01576874|3698985|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3873172|NCT01576874|3698983|B3||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3873173|NCT01576874|3698984|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3873174|NCT01576874|3698985|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3873175|NCT01576874|3698983|B3|||Age||years|Mean|31|31.0|Standard Deviation|7.4|7.4|||
3873176|NCT01576874|3698984|B2|||Age||years|Mean|31.6|31.6|Standard Deviation|7.7|7.7|||
3873177|NCT01576874|3698985|B1|||Age||years|Mean|30.4|30.4|Standard Deviation|7.1|7.1|||
3873178|NCT01576874|3698983|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3873179|NCT01576874|3698984|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3873180|NCT01576874|3698985|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3873181|NCT01576874|3698983|B3||Between 18 and 65 years|Age||Participants|Count of Participants|144|144.0||||||
3873182|NCT01576874|3698984|B2||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
3873183|NCT01576874|3698985|B1||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
3873184|NCT01576874|3698983|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3873185|NCT01576874|3698984|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3873186|NCT01576874|3698985|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3873187|NCT01576809|3698996|B1|Canada||Region of Enrollment||participants|Number|51|51.0||||||
3873188|NCT01576809|3698996|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3873189|NCT01576809|3698996|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3873190|NCT01576809|3698996|B1|||Age||years|Mean|32.0|32.0|Standard Deviation|12.65|12.65|||
3873191|NCT01576809|3698996|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3873192|NCT01576809|3698996|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3873193|NCT01576809|3698996|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3873194|NCT01576718|3699002|B7|||Qualifying Airway Reversibility|Patients demonstrated a ≥12% reversibility of FEV1 within 30 minutes following 2-4 inhalations of albuterol/salbutamol inhalation aerosol at the screening visit. If subjects failed to demonstrate an increase in FEV1 ≥12% then subjects were not eligible for the study; however, based on investigator judgment, they were allowed to retest once within 7 days. Reversibility values of 11.50 through 11.99% were rounded to 12%. Documented historical reversibility of ≥12 % within 1 year was accepted.|percentage increase in FEV1|Mean|29.0|29.0|Standard Deviation|19.8|19.8|||
3873195|NCT01576718|3699003|B6|||Qualifying Airway Reversibility|Patients demonstrated a ≥12% reversibility of FEV1 within 30 minutes following 2-4 inhalations of albuterol/salbutamol inhalation aerosol at the screening visit. If subjects failed to demonstrate an increase in FEV1 ≥12% then subjects were not eligible for the study; however, based on investigator judgment, they were allowed to retest once within 7 days. Reversibility values of 11.50 through 11.99% were rounded to 12%. Documented historical reversibility of ≥12 % within 1 year was accepted.|percentage increase in FEV1|Mean|26.8|26.8|Standard Deviation|15.7|15.7|||
3873232|NCT01576718|3699005|B4|||Weight||kg|Mean|84.4|84.4|Standard Deviation|20.56|20.56|||
3873233|NCT01576718|3699006|B3|||Weight||kg|Mean|84.4|84.4|Standard Deviation|21.89|21.89|||
3873234|NCT01576718|3699007|B2|||Weight||kg|Mean|86.6|86.6|Standard Deviation|22.90|22.9|||
3873196|NCT01576718|3699004|B5|||Qualifying Airway Reversibility|Patients demonstrated a ≥12% reversibility of FEV1 within 30 minutes following 2-4 inhalations of albuterol/salbutamol inhalation aerosol at the screening visit. If subjects failed to demonstrate an increase in FEV1 ≥12% then subjects were not eligible for the study; however, based on investigator judgment, they were allowed to retest once within 7 days. Reversibility values of 11.50 through 11.99% were rounded to 12%. Documented historical reversibility of ≥12 % within 1 year was accepted.|percentage increase in FEV1|Mean|28.9|28.9|Standard Deviation|19.1|19.1|||
3873197|NCT01576718|3699005|B4|||Qualifying Airway Reversibility|Patients demonstrated a ≥12% reversibility of FEV1 within 30 minutes following 2-4 inhalations of albuterol/salbutamol inhalation aerosol at the screening visit. If subjects failed to demonstrate an increase in FEV1 ≥12% then subjects were not eligible for the study; however, based on investigator judgment, they were allowed to retest once within 7 days. Reversibility values of 11.50 through 11.99% were rounded to 12%. Documented historical reversibility of ≥12 % within 1 year was accepted.|percentage increase in FEV1|Mean|29.1|29.1|Standard Deviation|19.5|19.5|||
3873198|NCT01576718|3699006|B3|||Qualifying Airway Reversibility|Patients demonstrated a ≥12% reversibility of FEV1 within 30 minutes following 2-4 inhalations of albuterol/salbutamol inhalation aerosol at the screening visit. If subjects failed to demonstrate an increase in FEV1 ≥12% then subjects were not eligible for the study; however, based on investigator judgment, they were allowed to retest once within 7 days. Reversibility values of 11.50 through 11.99% were rounded to 12%. Documented historical reversibility of ≥12 % within 1 year was accepted.|percentage increase in FEV1|Mean|30.4|30.4|Standard Deviation|25.2|25.2|||
3873199|NCT01576718|3699007|B2|||Qualifying Airway Reversibility|Patients demonstrated a ≥12% reversibility of FEV1 within 30 minutes following 2-4 inhalations of albuterol/salbutamol inhalation aerosol at the screening visit. If subjects failed to demonstrate an increase in FEV1 ≥12% then subjects were not eligible for the study; however, based on investigator judgment, they were allowed to retest once within 7 days. Reversibility values of 11.50 through 11.99% were rounded to 12%. Documented historical reversibility of ≥12 % within 1 year was accepted.|percentage increase in FEV1|Mean|27.3|27.3|Standard Deviation|14.7|14.7|||
3873200|NCT01576718|3699008|B1|||Qualifying Airway Reversibility|Patients demonstrated a ≥12% reversibility of FEV1 within 30 minutes following 2-4 inhalations of albuterol/salbutamol inhalation aerosol at the screening visit. If subjects failed to demonstrate an increase in FEV1 ≥12% then subjects were not eligible for the study; however, based on investigator judgment, they were allowed to retest once within 7 days. Reversibility values of 11.50 through 11.99% were rounded to 12%. Documented historical reversibility of ≥12 % within 1 year was accepted.|percentage increase in FEV1|Mean|31.6|31.6|Standard Deviation|22.4|22.4|||
3873201|NCT01576718|3699002|B7|||% Predicted Expiratory Volume In 1 Second||percent predicted FEV1|Mean|63.5|63.5|Standard Deviation|11.0|11.0|||
3873202|NCT01576718|3699003|B6|||% Predicted Expiratory Volume In 1 Second||percent predicted FEV1|Mean|62.5|62.5|Standard Deviation|12.1|12.1|||
3873203|NCT01576718|3699004|B5|||% Predicted Expiratory Volume In 1 Second||percent predicted FEV1|Mean|63.1|63.1|Standard Deviation|10.0|10.0|||
3873204|NCT01576718|3699005|B4|||% Predicted Expiratory Volume In 1 Second||percent predicted FEV1|Mean|65.3|65.3|Standard Deviation|11.4|11.4|||
3873205|NCT01576718|3699006|B3|||% Predicted Expiratory Volume In 1 Second||percent predicted FEV1|Mean|63.4|63.4|Standard Deviation|12.1|12.1|||
3873206|NCT01576718|3699007|B2|||% Predicted Expiratory Volume In 1 Second||percent predicted FEV1|Mean|63.1|63.1|Standard Deviation|9.5|9.5|||
3873207|NCT01576718|3699008|B1|||% Predicted Expiratory Volume In 1 Second||percent predicted FEV1|Mean|63.7|63.7|Standard Deviation|10.9|10.9|||
3873208|NCT01576718|3699002|B7|||Forced Expiratory Volume in 1 Second (FEV1)||liters|Mean|2.016|2.016|Standard Deviation|0.579|0.579|||
3873209|NCT01576718|3699003|B6|||Forced Expiratory Volume in 1 Second (FEV1)||liters|Mean|1.955|1.955|Standard Deviation|0.529|0.529|||
3873210|NCT01576718|3699004|B5|||Forced Expiratory Volume in 1 Second (FEV1)||liters|Mean|1.984|1.984|Standard Deviation|0.565|0.565|||
3873211|NCT01576718|3699005|B4|||Forced Expiratory Volume in 1 Second (FEV1)||liters|Mean|2.016|2.016|Standard Deviation|0.636|0.636|||
3873212|NCT01576718|3699006|B3|||Forced Expiratory Volume in 1 Second (FEV1)||liters|Mean|1.999|1.999|Standard Deviation|0.525|0.525|||
3873213|NCT01576718|3699007|B2|||Forced Expiratory Volume in 1 Second (FEV1)||liters|Mean|2.031|2.031|Standard Deviation|0.551|0.551|||
3873214|NCT01576718|3699008|B1|||Forced Expiratory Volume in 1 Second (FEV1)||liters|Mean|2.108|2.108|Standard Deviation|0.662|0.662|||
3873215|NCT01576718|3699002|B7|||Body Mass Index||kg/m^2|Mean|30.3|30.3|Standard Deviation|10.02|10.02|||
3873216|NCT01576718|3699003|B6|||Body Mass Index||kg/m^2|Mean|29.6|29.6|Standard Deviation|6.03|6.03|||
3873217|NCT01576718|3699004|B5|||Body Mass Index||kg/m^2|Mean|30.5|30.5|Standard Deviation|8.83|8.83|||
3873218|NCT01576718|3699005|B4|||Body Mass Index||kg/m^2|Mean|30.1|30.1|Standard Deviation|6.81|6.81|||
3873219|NCT01576718|3699006|B3|||Body Mass Index||kg/m^2|Mean|29.8|29.8|Standard Deviation|8.12|8.12|||
3873220|NCT01576718|3699007|B2|||Body Mass Index||kg/m^2|Mean|30.4|30.4|Standard Deviation|7.60|7.6|||
3873221|NCT01576718|3699008|B1|||Body Mass Index||kg/m^2|Mean|31.3|31.3|Standard Deviation|17.88|17.88|||
3873222|NCT01576718|3699002|B7|||Height||cm|Mean|168.3|168.3|Standard Deviation|9.58|9.58|||
3873223|NCT01576718|3699003|B6|||Height||cm|Mean|168.0|168.0|Standard Deviation|8.33|8.33|||
3873224|NCT01576718|3699004|B5|||Height||cm|Mean|168.1|168.1|Standard Deviation|8.57|8.57|||
3873225|NCT01576718|3699005|B4|||Height||cm|Mean|167.4|167.4|Standard Deviation|9.67|9.67|||
3873226|NCT01576718|3699006|B3|||Height||cm|Mean|168.4|168.4|Standard Deviation|7.86|7.86|||
3873227|NCT01576718|3699007|B2|||Height||cm|Mean|168.7|168.7|Standard Deviation|9.14|9.14|||
3873228|NCT01576718|3699008|B1|||Height||cm|Mean|169.4|169.4|Standard Deviation|13.04|13.04|||
3873229|NCT01576718|3699002|B7|||Weight||kg|Mean|85.3|85.3|Standard Deviation|21.95|21.95|||
3873230|NCT01576718|3699003|B6|||Weight||kg|Mean|83.3|83.3|Standard Deviation|16.76|16.76|||
3873231|NCT01576718|3699004|B5|||Weight||kg|Mean|86.2|86.2|Standard Deviation|25.19|25.19|||
3873235|NCT01576718|3699008|B1|||Weight||kg|Mean|86.7|86.7|Standard Deviation|23.73|23.73|||
3873236|NCT01576718|3699002|B7|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|593|593.0||||||
3873237|NCT01576718|3699003|B6|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|98|98.0||||||
3873238|NCT01576718|3699004|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|100|100.0||||||
3873239|NCT01576718|3699005|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|95|95.0||||||
3873240|NCT01576718|3699006|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|98|98.0||||||
3873241|NCT01576718|3699007|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|100|100.0||||||
3873242|NCT01576718|3699008|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|102|102.0||||||
3873243|NCT01576718|3699002|B7|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
3873244|NCT01576718|3699003|B6|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3873245|NCT01576718|3699004|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3873246|NCT01576718|3699005|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3873247|NCT01576718|3699006|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3873248|NCT01576718|3699007|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3873249|NCT01576718|3699008|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3873250|NCT01576718|3699002|B7|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3873251|NCT01576718|3699003|B6|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3873252|NCT01576718|3699004|B5|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3873253|NCT01576718|3699005|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3873254|NCT01576718|3699006|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3873255|NCT01576718|3699007|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3873256|NCT01576718|3699008|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3873257|NCT01576718|3699002|B7|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3873258|NCT01576718|3699003|B6|Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3873259|NCT01576718|3699004|B5|Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3873260|NCT01576718|3699005|B4|Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3873261|NCT01576718|3699006|B3|Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3873262|NCT01576718|3699007|B2|Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3873263|NCT01576718|3699008|B1|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3873264|NCT01576718|3699002|B7|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3873265|NCT01576718|3699003|B6|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3873266|NCT01576718|3699004|B5|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3873267|NCT01576718|3699005|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3873268|NCT01576718|3699006|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3873269|NCT01576718|3699007|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3873270|NCT01576718|3699008|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3873271|NCT01576718|3699002|B7|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3873272|NCT01576718|3699003|B6|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3873273|NCT01576718|3699004|B5|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3873274|NCT01576718|3699005|B4|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3873275|NCT01576718|3699006|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3873276|NCT01576718|3699007|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3873277|NCT01576718|3699008|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3873278|NCT01576718|3699002|B7|Black||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
3873279|NCT01576718|3699003|B6|Black||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3873280|NCT01576718|3699004|B5|Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3873281|NCT01576718|3699005|B4|Black||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3873282|NCT01576718|3699006|B3|Black||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3873283|NCT01576718|3699007|B2|Black||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3873284|NCT01576718|3699008|B1|Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3873285|NCT01576718|3699002|B7|White||Race/Ethnicity, Customized||participants|Number|565|565.0||||||
3873286|NCT01576718|3699003|B6|White||Race/Ethnicity, Customized||participants|Number|95|95.0||||||
3873287|NCT01576718|3699004|B5|White||Race/Ethnicity, Customized||participants|Number|96|96.0||||||
3873288|NCT01576718|3699005|B4|White||Race/Ethnicity, Customized||participants|Number|91|91.0||||||
3873289|NCT01576718|3699006|B3|White||Race/Ethnicity, Customized||participants|Number|93|93.0||||||
3873290|NCT01576718|3699007|B2|White||Race/Ethnicity, Customized||participants|Number|94|94.0||||||
3873291|NCT01576718|3699008|B1|White||Race/Ethnicity, Customized||participants|Number|96|96.0||||||
3873292|NCT01576718|3699002|B7||Male|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
3873293|NCT01576718|3699003|B6||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3873294|NCT01576718|3699004|B5||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3873295|NCT01576718|3699005|B4||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3873296|NCT01576718|3699006|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3873297|NCT01576718|3699007|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3873298|NCT01576718|3699008|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3873299|NCT01576718|3699002|B7||Female|Sex: Female, Male||Participants|Count of Participants|379|379.0||||||
3873300|NCT01576718|3699003|B6||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3873301|NCT01576718|3699004|B5||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3873302|NCT01576718|3699005|B4||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3873303|NCT01576718|3699006|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3873304|NCT01576718|3699007|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3873305|NCT01576718|3699008|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3873306|NCT01576718|3699002|B7|Adults (65-84 years)||Age, Customized||participants|Number|68|68.0||||||
3873307|NCT01576718|3699003|B6|Adults (65-84 years)||Age, Customized||participants|Number|10|10.0||||||
3873308|NCT01576718|3699004|B5|Adults (65-84 years)||Age, Customized||participants|Number|11|11.0||||||
3873309|NCT01576718|3699005|B4|Adults (65-84 years)||Age, Customized||participants|Number|16|16.0||||||
3873310|NCT01576718|3699006|B3|Adults (65-84 years)||Age, Customized||participants|Number|15|15.0||||||
3873311|NCT01576718|3699007|B2|Adults (65-84 years)||Age, Customized||participants|Number|5|5.0||||||
3873312|NCT01576718|3699008|B1|Adults (65-84 years)||Age, Customized||participants|Number|11|11.0||||||
3873313|NCT01576718|3699002|B7|Adults (18-64 years)||Age, Customized||participants|Number|563|563.0||||||
3873314|NCT01576718|3699003|B6|Adults (18-64 years)||Age, Customized||participants|Number|96|96.0||||||
3873315|NCT01576718|3699004|B5|Adults (18-64 years)||Age, Customized||participants|Number|94|94.0||||||
3873316|NCT01576718|3699005|B4|Adults (18-64 years)||Age, Customized||participants|Number|90|90.0||||||
3873317|NCT01576718|3699006|B3|Adults (18-64 years)||Age, Customized||participants|Number|90|90.0||||||
3873318|NCT01576718|3699007|B2|Adults (18-64 years)||Age, Customized||participants|Number|99|99.0||||||
3873319|NCT01576718|3699008|B1|Adults (18-64 years)||Age, Customized||participants|Number|94|94.0||||||
3873320|NCT01576718|3699002|B7|Adolescents (12-17 years)||Age, Customized||participants|Number|9|9.0||||||
3873321|NCT01576718|3699003|B6|Adolescents (12-17 years)||Age, Customized||participants|Number|1|1.0||||||
3873322|NCT01576718|3699004|B5|Adolescents (12-17 years)||Age, Customized||participants|Number|1|1.0||||||
3873323|NCT01576718|3699005|B4|Adolescents (12-17 years)||Age, Customized||participants|Number|1|1.0||||||
3873324|NCT01576718|3699006|B3|Adolescents (12-17 years)||Age, Customized||participants|Number|1|1.0||||||
3873325|NCT01576718|3699007|B2|Adolescents (12-17 years)||Age, Customized||participants|Number|3|3.0||||||
3873326|NCT01576718|3699008|B1|Adolescents (12-17 years)||Age, Customized||participants|Number|2|2.0||||||
3873327|NCT01576718|3699002|B7|||Age||years|Mean|49.0|49.0|Standard Deviation|13.46|13.46|||
3873328|NCT01576718|3699003|B6|||Age||years|Mean|49.2|49.2|Standard Deviation|13.26|13.26|||
3873329|NCT01576718|3699004|B5|||Age||years|Mean|49.8|49.8|Standard Deviation|12.87|12.87|||
3873330|NCT01576718|3699005|B4|||Age||years|Mean|50.9|50.9|Standard Deviation|13.32|13.32|||
3873331|NCT01576718|3699006|B3|||Age||years|Mean|47.7|47.7|Standard Deviation|14.18|14.18|||
3873332|NCT01576718|3699007|B2|||Age||years|Mean|48.7|48.7|Standard Deviation|12.48|12.48|||
3873333|NCT01576718|3699008|B1|||Age||years|Mean|47.9|47.9|Standard Deviation|14.59|14.59|||
3873334|NCT01576549|3699106|B1|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3873335|NCT01576549|3699106|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873336|NCT01576549|3699106|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873337|NCT01576549|3699106|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3873338|NCT01576549|3699106|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873339|NCT01576549|3699106|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873340|NCT01576549|3699106|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873341|NCT01576549|3699106|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873342|NCT01576549|3699106|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873343|NCT01576549|3699106|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3873344|NCT01576549|3699106|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873345|NCT01576549|3699106|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3873346|NCT01576549|3699106|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3873347|NCT01576549|3699106|B1|||Age||years|Mean|66|66.0|Full Range|||52.0|80.0|
3873348|NCT01576471|3699114|B3|United States||Region of Enrollment||participants|Number|250|250.0||||||
3873349|NCT01576471|3699115|B2|United States||Region of Enrollment||participants|Number|125|125.0||||||
3873350|NCT01576471|3699116|B1|United States||Region of Enrollment||participants|Number|125|125.0||||||
3873351|NCT01576471|3699114|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873352|NCT01576471|3699115|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873353|NCT01576471|3699116|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873354|NCT01576471|3699114|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3873355|NCT01576471|3699115|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3873356|NCT01576471|3699116|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3873357|NCT01576471|3699114|B3||White|Race (NIH/OMB)||Participants|Count of Participants|229|229.0||||||
3873358|NCT01576471|3699115|B2||White|Race (NIH/OMB)||Participants|Count of Participants|117|117.0||||||
3873359|NCT01576471|3699116|B1||White|Race (NIH/OMB)||Participants|Count of Participants|112|112.0||||||
3873360|NCT01576471|3699114|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3873361|NCT01576471|3699115|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3873362|NCT01576471|3699116|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3873363|NCT01576471|3699114|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873364|NCT01576471|3699115|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873365|NCT01576471|3699116|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873366|NCT01576471|3699114|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3873367|NCT01576471|3699115|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3873368|NCT01576471|3699116|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3873369|NCT01576471|3699114|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3873370|NCT01576471|3699115|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873371|NCT01576471|3699116|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3873372|NCT01576471|3699114|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873373|NCT01576471|3699115|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873374|NCT01576471|3699116|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873375|NCT01576471|3699114|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|222|222.0||||||
3873376|NCT01576471|3699115|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|112|112.0||||||
3873377|NCT01576471|3699116|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
3873378|NCT01576471|3699114|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3873379|NCT01576471|3699115|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3873380|NCT01576471|3699116|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3873381|NCT01576471|3699114|B3||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3873382|NCT01576471|3699115|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3873383|NCT01576471|3699116|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3873384|NCT01576471|3699114|B3||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3873385|NCT01576471|3699115|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3873386|NCT01576471|3699116|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3873387|NCT01576471|3699114|B3|||Age||years|Mean|39.8|39.8|Standard Deviation|0.75|0.75|||
3873388|NCT01576471|3699115|B2|||Age||years|Mean|40.9|40.9|Standard Deviation|1.04|1.04|||
3873389|NCT01576471|3699116|B1|||Age||years|Mean|38.6|38.6|Standard Deviation|1.07|1.07|||
3873390|NCT01576471|3699114|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3873391|NCT01576471|3699115|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3873392|NCT01576471|3699116|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3873393|NCT01576471|3699114|B3||Between 18 and 65 years|Age||Participants|Count of Participants|250|250.0||||||
3873394|NCT01576471|3699115|B2||Between 18 and 65 years|Age||Participants|Count of Participants|125|125.0||||||
3873395|NCT01576471|3699116|B1||Between 18 and 65 years|Age||Participants|Count of Participants|125|125.0||||||
3873396|NCT01576471|3699114|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3873397|NCT01576471|3699115|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3873398|NCT01576471|3699116|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3873399|NCT01576406|3699123|B7||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3873400|NCT01576406|3699124|B6||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3873401|NCT01576406|3699125|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3873402|NCT01576406|3699126|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3873403|NCT01576406|3699127|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3873404|NCT01576406|3699128|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3873405|NCT01576406|3699129|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3873406|NCT01576406|3699123|B7||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3873407|NCT01576406|3699124|B6||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3873408|NCT01576406|3699125|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3873409|NCT01576406|3699126|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3873410|NCT01576406|3699127|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3873411|NCT01576406|3699128|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3873412|NCT01576406|3699129|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3873413|NCT01576406|3699123|B7|||Age||years|Mean|60.3|60.3|Standard Deviation|9.77|9.77|||
3873414|NCT01576406|3699124|B6|||Age||years|Mean|59.0|59.0|Standard Deviation|6.04|6.04|||
3873415|NCT01576406|3699125|B5|||Age||years|Mean|60.3|60.3|Standard Deviation|7.87|7.87|||
3873416|NCT01576406|3699126|B4|||Age||years|Mean|59.2|59.2|Standard Deviation|8.85|8.85|||
3873417|NCT01576406|3699127|B3|||Age||years|Mean|61.2|61.2|Standard Deviation|10.14|10.14|||
3873418|NCT01576406|3699128|B2|||Age||years|Mean|62.9|62.9|Standard Deviation|10.35|10.35|||
3873419|NCT01576406|3699129|B1|||Age||years|Mean|57.7|57.7|Standard Deviation|15.64|15.64|||
3873420|NCT01576367|3699382|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3873421|NCT01576367|3699382|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3873422|NCT01576367|3699382|B1|Age at start of extension study (years)||Age||Years|Mean|3.1|3.1|Standard Deviation|1.7|1.7|||
3873423|NCT01576341|3699390|B1|ESA maintenance||ESA pre-treatment|A patient is considered to be ESA naïve if the patient did not receive any ESA therapy within 2 months prior to first screening visit.|participants|Number|166|166.0||||||
3873424|NCT01576341|3699390|B1|ESA naive||ESA pre-treatment|A patient is considered to be ESA naïve if the patient did not receive any ESA therapy within 2 months prior to first screening visit.|participants|Number|250|250.0||||||
3873425|NCT01576341|3699390|B1|||Body Mass Index (BMI)||kg/m^2|Mean|25.26|25.26|Standard Deviation|5.073|5.073|||
3873426|NCT01576341|3699390|B1|||Weight||kg|Mean|70.6|70.6|Standard Deviation|15.92|15.92|||
3873427|NCT01576341|3699390|B1|||Height||cm|Mean|166.9|166.9|Standard Deviation|9.44|9.44|||
3873428|NCT01576341|3699390|B1|Germany||Region of Enrollment||participants|Number|5|5.0||||||
3873429|NCT01576341|3699390|B1|Italy||Region of Enrollment||participants|Number|5|5.0||||||
3873430|NCT01576341|3699390|B1|Poland||Region of Enrollment||participants|Number|47|47.0||||||
3873431|NCT01576341|3699390|B1|Ukraine||Region of Enrollment||participants|Number|179|179.0||||||
3873432|NCT01576341|3699390|B1|Turkey||Region of Enrollment||participants|Number|33|33.0||||||
3873433|NCT01576341|3699390|B1|Romania||Region of Enrollment||participants|Number|40|40.0||||||
3873434|NCT01576341|3699390|B1|Russian Federation||Region of Enrollment||participants|Number|107|107.0||||||
3873435|NCT01576341|3699390|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873436|NCT01576341|3699390|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873437|NCT01576341|3699390|B1||White|Race (NIH/OMB)||Participants|Count of Participants|416|416.0||||||
3873438|NCT01576341|3699390|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873439|NCT01576341|3699390|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873440|NCT01576341|3699390|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873441|NCT01576341|3699390|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873442|NCT01576341|3699390|B1||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
3873443|NCT01576341|3699390|B1||Female|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
3873444|NCT01576341|3699390|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|15.78|15.78|||
3873445|NCT01576276|3699397|B3|||Pain Ratings||scores on a scale|Mean|11.3|11.3|Standard Deviation|2.4|2.4|||
3873446|NCT01576276|3699398|B2|||Pain Ratings||scores on a scale|Mean|11.6|11.6|Standard Deviation|2.2|2.2|||
3873447|NCT01576276|3699399|B1|||Pain Ratings||scores on a scale|Mean|10.9|10.9|Standard Deviation|2.6|2.6|||
3873448|NCT01576276|3699397|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3873449|NCT01576276|3699398|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3873450|NCT01576276|3699399|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873451|NCT01576276|3699397|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3873452|NCT01576276|3699398|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3873453|NCT01576276|3699399|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873454|NCT01576276|3699397|B3||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3873455|NCT01576276|3699398|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3873456|NCT01576276|3699399|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3873457|NCT01576276|3699397|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3873458|NCT01576276|3699398|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3873459|NCT01576276|3699399|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3873460|NCT01576276|3699397|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873461|NCT01576276|3699398|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873462|NCT01576276|3699399|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873463|NCT01576276|3699397|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3873464|NCT01576276|3699398|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3873465|NCT01576276|3699399|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3873466|NCT01576276|3699397|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873467|NCT01576276|3699398|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873468|NCT01576276|3699399|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873469|NCT01576276|3699397|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3873531|NCT01576146|3699432|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|14.2|14.2|||
3873470|NCT01576276|3699398|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3873471|NCT01576276|3699399|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3873472|NCT01576276|3699397|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3873473|NCT01576276|3699398|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3873474|NCT01576276|3699399|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3873475|NCT01576276|3699397|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3873476|NCT01576276|3699398|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3873477|NCT01576276|3699399|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3873478|NCT01576276|3699397|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3873479|NCT01576276|3699398|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3873480|NCT01576276|3699399|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3873481|NCT01576276|3699397|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3873482|NCT01576276|3699398|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3873483|NCT01576276|3699399|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3873484|NCT01576276|3699397|B3|||Age||years|Mean|25.5|25.5|Standard Deviation|4.0|4.0|||
3873485|NCT01576276|3699398|B2|||Age||years|Mean|26.0|26.0|Standard Deviation|4.9|4.9|||
3873486|NCT01576276|3699399|B1|||Age||years|Mean|25.0|25.0|Standard Deviation|3.3|3.3|||
3873487|NCT01576159|3699407|B5|Turkey||Region of Enrollment||participants|Number|44|44.0||||||
3873488|NCT01576159|3699408|B4|Turkey||Region of Enrollment||participants|Number|11|11.0||||||
3873489|NCT01576159|3699409|B3|Turkey||Region of Enrollment||participants|Number|11|11.0||||||
3873490|NCT01576159|3699410|B2|Turkey||Region of Enrollment||participants|Number|11|11.0||||||
3873491|NCT01576159|3699411|B1|Turkey||Region of Enrollment||participants|Number|11|11.0||||||
3873492|NCT01576159|3699407|B5||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3873493|NCT01576159|3699408|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3873494|NCT01576159|3699409|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3873495|NCT01576159|3699410|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3873496|NCT01576159|3699411|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3873497|NCT01576159|3699407|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3873498|NCT01576159|3699408|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3873499|NCT01576159|3699409|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3873500|NCT01576159|3699410|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3873501|NCT01576159|3699411|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3873502|NCT01576159|3699407|B5|||Age||years|Mean|21.8|21.8|Standard Deviation|1.9|1.9|||
3873503|NCT01576159|3699408|B4|||Age||years|Mean|22.6|22.6|Standard Deviation|2.1|2.1|||
3873504|NCT01576159|3699409|B3|||Age||years|Mean|22.8|22.8|Standard Deviation|1.9|1.9|||
3873505|NCT01576159|3699410|B2|||Age||years|Mean|21.1|21.1|Standard Deviation|1.5|1.5|||
3873506|NCT01576159|3699411|B1|||Age||years|Mean|20.7|20.7|Standard Deviation|1.3|1.3|||
3873507|NCT01576159|3699407|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3873508|NCT01576159|3699408|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3873509|NCT01576159|3699409|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3873510|NCT01576159|3699410|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3873511|NCT01576159|3699411|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3873512|NCT01576159|3699407|B5||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3873513|NCT01576159|3699408|B4||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3873514|NCT01576159|3699409|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3873515|NCT01576159|3699410|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3873516|NCT01576159|3699411|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3873517|NCT01576159|3699407|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3873518|NCT01576159|3699408|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3873519|NCT01576159|3699409|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3873520|NCT01576159|3699410|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3873521|NCT01576159|3699411|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3873522|NCT01576146|3699432|B1|||Serum Phosphorus||mg/dL|Mean|5.77|5.77|Standard Deviation|1.50|1.5|||
3873523|NCT01576146|3699432|B1|||Serum Corrected Calcium||mg/dL|Mean|10.21|10.21|Standard Deviation|0.53|0.53|||
3873524|NCT01576146|3699432|B1|||Parathyroid Hormone||pg/mL|Mean|862.1|862.1|Standard Deviation|672.0|672.0|||
3873525|NCT01576146|3699432|B1||Not Hispanic/Latino|Ethnicity||Participants|Count of Participants|24|24.0||||||
3873526|NCT01576146|3699432|B1||Hispanic/Latino|Ethnicity||Participants|Count of Participants|6|6.0||||||
3873527|NCT01576146|3699432|B1||White|Race||Participants|Count of Participants|12|12.0||||||
3873528|NCT01576146|3699432|B1||Black (or African American)|Race||Participants|Count of Participants|18|18.0||||||
3873529|NCT01576146|3699432|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3873530|NCT01576146|3699432|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3873532|NCT01576120|3699439|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3873533|NCT01576120|3699440|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3873534|NCT01576120|3699441|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3873535|NCT01576120|3699439|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3873536|NCT01576120|3699440|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3873537|NCT01576120|3699441|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3873538|NCT01576120|3699439|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3873539|NCT01576120|3699440|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3873540|NCT01576120|3699441|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3873541|NCT01576120|3699439|B3|||Age||years|Mean|37.8|37.8|Standard Deviation|11.3|11.3|||
3873542|NCT01576120|3699440|B2|||Age||years|Mean|39.7|39.7|Standard Deviation|11.7|11.7|||
3873543|NCT01576120|3699441|B1|||Age||years|Mean|36.0|36.0|Standard Deviation|10.9|10.9|||
3873544|NCT01576055|3699448|B3|Europe||Region of Enrollment||participants|Number|71|71.0||||||
3873545|NCT01576055|3699449|B2|Europe||Region of Enrollment||participants|Number|16|16.0||||||
3873546|NCT01576055|3699450|B1|Europe||Region of Enrollment||participants|Number|55|55.0||||||
3873547|NCT01576055|3699448|B3|United States||Region of Enrollment||participants|Number|196|196.0||||||
3873548|NCT01576055|3699449|B2|United States||Region of Enrollment||participants|Number|54|54.0||||||
3873549|NCT01576055|3699450|B1|United States||Region of Enrollment||participants|Number|142|142.0||||||
3873550|NCT01576055|3699448|B3||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
3873551|NCT01576055|3699449|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3873552|NCT01576055|3699450|B1||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3873553|NCT01576055|3699448|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3873554|NCT01576055|3699449|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3873555|NCT01576055|3699450|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3873556|NCT01576055|3699448|B3|||Age||years|Mean|67.0|67.0|Standard Deviation|9.17|9.17|||
3873557|NCT01576055|3699449|B2|||Age||years|Mean|67.9|67.9|Standard Deviation|8.87|8.87|||
3873558|NCT01576055|3699450|B1|||Age||years|Mean|66.8|66.8|Standard Deviation|9.30|9.3|||
3873559|NCT01576042|3699463|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
3873560|NCT01576042|3699464|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3873561|NCT01576042|3699465|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3873562|NCT01576042|3699463|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873563|NCT01576042|3699464|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873564|NCT01576042|3699465|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873565|NCT01576042|3699463|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873566|NCT01576042|3699464|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873567|NCT01576042|3699465|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873568|NCT01576042|3699463|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3873569|NCT01576042|3699464|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3873570|NCT01576042|3699465|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3873571|NCT01576042|3699463|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3873572|NCT01576042|3699464|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3873573|NCT01576042|3699465|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3873574|NCT01576042|3699463|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873575|NCT01576042|3699464|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873576|NCT01576042|3699465|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873577|NCT01576042|3699463|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873578|NCT01576042|3699464|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873579|NCT01576042|3699465|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873580|NCT01576042|3699463|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873581|NCT01576042|3699464|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873582|NCT01576042|3699465|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873583|NCT01576042|3699463|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3873584|NCT01576042|3699464|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3873585|NCT01576042|3699465|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3873586|NCT01576042|3699463|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3873587|NCT01576042|3699464|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3873588|NCT01576042|3699465|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3873589|NCT01576042|3699463|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3873590|NCT01576042|3699464|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3873591|NCT01576042|3699465|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3873592|NCT01576042|3699463|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3873593|NCT01576042|3699464|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3873594|NCT01576042|3699465|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3873595|NCT01576042|3699463|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3873596|NCT01576042|3699464|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3873597|NCT01576042|3699465|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3873598|NCT01575912|3699486|B4|France||Region of Enrollment||participants|Number|92|92.0||||||
3873599|NCT01575912|3699487|B3|France||Region of Enrollment||participants|Number|30|30.0||||||
3873600|NCT01575912|3699488|B2|France||Region of Enrollment||participants|Number|32|32.0||||||
3873601|NCT01575912|3699489|B1|France||Region of Enrollment||participants|Number|30|30.0||||||
3873602|NCT01575912|3699486|B4||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3873603|NCT01575912|3699487|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3873604|NCT01575912|3699488|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3873605|NCT01575912|3699489|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3873606|NCT01575912|3699486|B4||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3873607|NCT01575912|3699487|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3873608|NCT01575912|3699488|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3873609|NCT01575912|3699489|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3873610|NCT01575912|3699486|B4|||Age||years|Mean|43.21|43.21|Standard Deviation|10.00|10.0|||
3873611|NCT01575912|3699487|B3|||Age||years|Mean|41.53|41.53|Standard Deviation|10.27|10.27|||
3873612|NCT01575912|3699488|B2|||Age||years|Mean|44.69|44.69|Standard Deviation|10.08|10.08|||
3873613|NCT01575912|3699489|B1|||Age||years|Mean|43.3|43.3|Standard Deviation|9.72|9.72|||
3873614|NCT01575899|3699499|B4|No follow up||Follow up method|Information about the follow up method to confirmed the post-treatment Hp status of participants.|participants|Number|9|9.0||||||
3873615|NCT01575899|3699500|B3|No follow up||Follow up method|Information about the follow up method to confirmed the post-treatment Hp status of participants.|participants|Number|2|2.0||||||
3873616|NCT01575899|3699501|B2|No follow up||Follow up method|Information about the follow up method to confirmed the post-treatment Hp status of participants.|participants|Number|4|4.0||||||
3873617|NCT01575899|3699502|B1|No follow up||Follow up method|Information about the follow up method to confirmed the post-treatment Hp status of participants.|participants|Number|3|3.0||||||
3873618|NCT01575899|3699499|B4|CLO test||Follow up method|Information about the follow up method to confirmed the post-treatment Hp status of participants.|participants|Number|14|14.0||||||
3873619|NCT01575899|3699500|B3|CLO test||Follow up method|Information about the follow up method to confirmed the post-treatment Hp status of participants.|participants|Number|5|5.0||||||
3873620|NCT01575899|3699501|B2|CLO test||Follow up method|Information about the follow up method to confirmed the post-treatment Hp status of participants.|participants|Number|4|4.0||||||
3873621|NCT01575899|3699502|B1|CLO test||Follow up method|Information about the follow up method to confirmed the post-treatment Hp status of participants.|participants|Number|5|5.0||||||
3873622|NCT01575899|3699499|B4|C13-UBT||Follow up method|Information about the follow up method to confirmed the post-treatment Hp status of participants.|participants|Number|185|185.0||||||
3873623|NCT01575899|3699500|B3|C13-UBT||Follow up method|Information about the follow up method to confirmed the post-treatment Hp status of participants.|participants|Number|55|55.0||||||
3873624|NCT01575899|3699501|B2|C13-UBT||Follow up method|Information about the follow up method to confirmed the post-treatment Hp status of participants.|participants|Number|65|65.0||||||
3873625|NCT01575899|3699502|B1|C13-UBT||Follow up method|Information about the follow up method to confirmed the post-treatment Hp status of participants.|participants|Number|65|65.0||||||
3873626|NCT01575899|3699499|B4|Without peptic ulcer||Endoscopic finding|Comparison between participant's endoscopic finding with or without peptic ulcer disease.|participants|Number|122|122.0||||||
3873627|NCT01575899|3699500|B3|Without peptic ulcer||Endoscopic finding|Comparison between participant's endoscopic finding with or without peptic ulcer disease.|participants|Number|41|41.0||||||
3873628|NCT01575899|3699501|B2|Without peptic ulcer||Endoscopic finding|Comparison between participant's endoscopic finding with or without peptic ulcer disease.|participants|Number|38|38.0||||||
3873629|NCT01575899|3699502|B1|Without peptic ulcer||Endoscopic finding|Comparison between participant's endoscopic finding with or without peptic ulcer disease.|participants|Number|43|43.0||||||
3873630|NCT01575899|3699499|B4|With peptic ulcer||Endoscopic finding|Comparison between participant's endoscopic finding with or without peptic ulcer disease.|participants|Number|86|86.0||||||
3873631|NCT01575899|3699500|B3|With peptic ulcer||Endoscopic finding|Comparison between participant's endoscopic finding with or without peptic ulcer disease.|participants|Number|21|21.0||||||
3873632|NCT01575899|3699501|B2|With peptic ulcer||Endoscopic finding|Comparison between participant's endoscopic finding with or without peptic ulcer disease.|participants|Number|35|35.0||||||
3873633|NCT01575899|3699502|B1|With peptic ulcer||Endoscopic finding|Comparison between participant's endoscopic finding with or without peptic ulcer disease.|participants|Number|30|30.0||||||
3873634|NCT01575899|3699499|B4|Rural area||Resident area|Comparison about resident area of participants, living in urban area or rural area.|participants|Number|135|135.0||||||
3873635|NCT01575899|3699500|B3|Rural area||Resident area|Comparison about resident area of participants, living in urban area or rural area.|participants|Number|43|43.0||||||
3873636|NCT01575899|3699501|B2|Rural area||Resident area|Comparison about resident area of participants, living in urban area or rural area.|participants|Number|49|49.0||||||
3873637|NCT01575899|3699502|B1|Rural area||Resident area|Comparison about resident area of participants, living in urban area or rural area.|participants|Number|43|43.0||||||
3873638|NCT01575899|3699499|B4|Urban area||Resident area|Comparison about resident area of participants, living in urban area or rural area.|participants|Number|73|73.0||||||
3873639|NCT01575899|3699500|B3|Urban area||Resident area|Comparison about resident area of participants, living in urban area or rural area.|participants|Number|19|19.0||||||
3873640|NCT01575899|3699501|B2|Urban area||Resident area|Comparison about resident area of participants, living in urban area or rural area.|participants|Number|24|24.0||||||
3873641|NCT01575899|3699502|B1|Urban area||Resident area|Comparison about resident area of participants, living in urban area or rural area.|participants|Number|30|30.0||||||
3873642|NCT01575899|3699499|B4||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3873643|NCT01575899|3699500|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3873644|NCT01575899|3699501|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3873645|NCT01575899|3699502|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3873646|NCT01575899|3699499|B4||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3873647|NCT01575899|3699500|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3873648|NCT01575899|3699501|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3873649|NCT01575899|3699502|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3873650|NCT01575899|3699499|B4|>=54 years||Age, Customized||participants|Number|111|111.0||||||
3873651|NCT01575899|3699500|B3|>=54 years||Age, Customized||participants|Number|37|37.0||||||
3873652|NCT01575899|3699501|B2|>=54 years||Age, Customized||participants|Number|39|39.0||||||
3873653|NCT01575899|3699502|B1|>=54 years||Age, Customized||participants|Number|35|35.0||||||
3873654|NCT01575899|3699499|B4|< 54 years||Age, Customized||participants|Number|97|97.0||||||
3873655|NCT01575899|3699500|B3|< 54 years||Age, Customized||participants|Number|25|25.0||||||
3873656|NCT01575899|3699501|B2|< 54 years||Age, Customized||participants|Number|34|34.0||||||
3873657|NCT01575899|3699502|B1|< 54 years||Age, Customized||participants|Number|38|38.0||||||
3873658|NCT01575899|3699499|B4|||Age||years|Mean|54.01|54.01|Standard Deviation|12.77|12.77|||
3873659|NCT01575899|3699500|B3|||Age||years|Mean|54.68|54.68|Standard Deviation|11.81|11.81|||
3873660|NCT01575899|3699501|B2|||Age||years|Mean|54.63|54.63|Standard Deviation|14.42|14.42|||
3873661|NCT01575899|3699502|B1|||Age||years|Mean|52.82|52.82|Standard Deviation|12.08|12.08|||
3873662|NCT01575873|3699514|B5|Glucocorticoid-continuing Subpopulation||Total Hip BMD T-score|The T-score is the bone mineral density (BMD) at the site when compared to that of a healthy thirty-year-old. Normal is a T-score of −1.0 or higher; Osteopenia is defined as between −1.0 and −2.5; Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a thirty-year-old man/woman.|T-score|Mean|-1.61|-1.61|Standard Deviation|0.96|0.96|||
3873663|NCT01575873|3699515|B4|Glucocorticoid-continuing Subpopulation||Total Hip BMD T-score|The T-score is the bone mineral density (BMD) at the site when compared to that of a healthy thirty-year-old. Normal is a T-score of −1.0 or higher; Osteopenia is defined as between −1.0 and −2.5; Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a thirty-year-old man/woman.|T-score|Mean|-1.66|-1.66|Standard Deviation|0.96|0.96|||
3873664|NCT01575873|3699516|B3|Glucocorticoid-continuing Subpopulation||Total Hip BMD T-score|The T-score is the bone mineral density (BMD) at the site when compared to that of a healthy thirty-year-old. Normal is a T-score of −1.0 or higher; Osteopenia is defined as between −1.0 and −2.5; Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a thirty-year-old man/woman.|T-score|Mean|-1.56|-1.56|Standard Deviation|0.96|0.96|||
3873665|NCT01575873|3699514|B5|Glucocorticoid-initiating Subpopulation||Total Hip BMD T-score|The T-score is the bone mineral density (BMD) at the site when compared to that of a healthy thirty-year-old. Normal is a T-score of −1.0 or higher; Osteopenia is defined as between −1.0 and −2.5; Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a thirty-year-old man/woman.|T-score|Mean|-1.06|-1.06|Standard Deviation|1.04|1.04|||
3873666|NCT01575873|3699517|B2|Glucocorticoid-initiating Subpopulation||Total Hip BMD T-score|The T-score is the bone mineral density (BMD) at the site when compared to that of a healthy thirty-year-old. Normal is a T-score of −1.0 or higher; Osteopenia is defined as between −1.0 and −2.5; Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a thirty-year-old man/woman.|T-score|Mean|-1.14|-1.14|Standard Deviation|1.00|1.0|||
3873667|NCT01575873|3699518|B1|Glucocorticoid-initiating Subpopulation||Total Hip BMD T-score|The T-score is the bone mineral density (BMD) at the site when compared to that of a healthy thirty-year-old. Normal is a T-score of −1.0 or higher; Osteopenia is defined as between −1.0 and −2.5; Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a thirty-year-old man/woman.|T-score|Mean|-0.98|-0.98|Standard Deviation|1.07|1.07|||
3873668|NCT01575873|3699514|B5|Glucocorticoid-continuing Subpopulation||Lumbar Spine Bone Mineral Density (BMD) T-score|The T-score is the bone mineral density (BMD) at the site when compared to that of a healthy thirty-year-old. Normal is a T-score of −1.0 or higher; Osteopenia is defined as between −1.0 and −2.5; Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a thirty-year-old man/woman.|T-score|Mean|-1.94|-1.94|Standard Deviation|1.38|1.38|||
3873669|NCT01575873|3699515|B4|Glucocorticoid-continuing Subpopulation||Lumbar Spine Bone Mineral Density (BMD) T-score|The T-score is the bone mineral density (BMD) at the site when compared to that of a healthy thirty-year-old. Normal is a T-score of −1.0 or higher; Osteopenia is defined as between −1.0 and −2.5; Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a thirty-year-old man/woman.|T-score|Mean|-1.92|-1.92|Standard Deviation|1.38|1.38|||
3873714|NCT01575873|3699514|B5||White|Race/Ethnicity, Customized||Participants|Count of Participants|698|698.0||||||
3873715|NCT01575873|3699515|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|230|230.0||||||
3873670|NCT01575873|3699516|B3|Glucocorticoid-continuing Subpopulation||Lumbar Spine Bone Mineral Density (BMD) T-score|The T-score is the bone mineral density (BMD) at the site when compared to that of a healthy thirty-year-old. Normal is a T-score of −1.0 or higher; Osteopenia is defined as between −1.0 and −2.5; Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a thirty-year-old man/woman.|T-score|Mean|-1.96|-1.96|Standard Deviation|1.38|1.38|||
3873671|NCT01575873|3699514|B5|Glucocorticoid-initiating Subpopulation||Lumbar Spine Bone Mineral Density (BMD) T-score|The T-score is the bone mineral density (BMD) at the site when compared to that of a healthy thirty-year-old. Normal is a T-score of −1.0 or higher; Osteopenia is defined as between −1.0 and −2.5; Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a thirty-year-old man/woman.|T-score|Mean|-0.99|-0.99|Standard Deviation|1.72|1.72|||
3873672|NCT01575873|3699517|B2|Glucocorticoid-initiating Subpopulation||Lumbar Spine Bone Mineral Density (BMD) T-score|The T-score is the bone mineral density (BMD) at the site when compared to that of a healthy thirty-year-old. Normal is a T-score of −1.0 or higher; Osteopenia is defined as between −1.0 and −2.5; Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a thirty-year-old man/woman.|T-score|Mean|-0.92|-0.92|Standard Deviation|1.86|1.86|||
3873673|NCT01575873|3699518|B1|Glucocorticoid-initiating Subpopulation||Lumbar Spine Bone Mineral Density (BMD) T-score|The T-score is the bone mineral density (BMD) at the site when compared to that of a healthy thirty-year-old. Normal is a T-score of −1.0 or higher; Osteopenia is defined as between −1.0 and −2.5; Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a thirty-year-old man/woman.|T-score|Mean|-1.06|-1.06|Standard Deviation|1.57|1.57|||
3873674|NCT01575873|3699514|B5||Unknown|Menopausal Status||Participants|Count of Participants|9|9.0||||||
3873675|NCT01575873|3699515|B4||Unknown|Menopausal Status||Participants|Count of Participants|2|2.0||||||
3873676|NCT01575873|3699516|B3||Unknown|Menopausal Status||Participants|Count of Participants|3|3.0||||||
3873677|NCT01575873|3699517|B2||Unknown|Menopausal Status||Participants|Count of Participants|1|1.0||||||
3873678|NCT01575873|3699518|B1||Unknown|Menopausal Status||Participants|Count of Participants|3|3.0||||||
3873679|NCT01575873|3699514|B5||Postmenopause|Menopausal Status||Participants|Count of Participants|481|481.0||||||
3873680|NCT01575873|3699515|B4||Postmenopause|Menopausal Status||Participants|Count of Participants|159|159.0||||||
3873681|NCT01575873|3699516|B3||Postmenopause|Menopausal Status||Participants|Count of Participants|157|157.0||||||
3873682|NCT01575873|3699517|B2||Postmenopause|Menopausal Status||Participants|Count of Participants|82|82.0||||||
3873683|NCT01575873|3699518|B1||Postmenopause|Menopausal Status||Participants|Count of Participants|83|83.0||||||
3873684|NCT01575873|3699514|B5||Premenopause|Menopausal Status||Participants|Count of Participants|66|66.0||||||
3873685|NCT01575873|3699515|B4||Premenopause|Menopausal Status||Participants|Count of Participants|24|24.0||||||
3873686|NCT01575873|3699516|B3||Premenopause|Menopausal Status||Participants|Count of Participants|25|25.0||||||
3873687|NCT01575873|3699517|B2||Premenopause|Menopausal Status||Participants|Count of Participants|10|10.0||||||
3873688|NCT01575873|3699518|B1||Premenopause|Menopausal Status||Participants|Count of Participants|7|7.0||||||
3873689|NCT01575873|3699514|B5||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3873690|NCT01575873|3699515|B4||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3873691|NCT01575873|3699516|B3||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3873692|NCT01575873|3699517|B2||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3873693|NCT01575873|3699518|B1||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3873694|NCT01575873|3699514|B5||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3873695|NCT01575873|3699515|B4||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3873696|NCT01575873|3699516|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3873697|NCT01575873|3699517|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3873698|NCT01575873|3699518|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3873699|NCT01575873|3699514|B5||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3873700|NCT01575873|3699515|B4||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3873701|NCT01575873|3699516|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3873702|NCT01575873|3699517|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3873703|NCT01575873|3699518|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3873704|NCT01575873|3699514|B5||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3873705|NCT01575873|3699515|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3873706|NCT01575873|3699516|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3873707|NCT01575873|3699517|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3873708|NCT01575873|3699518|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3873709|NCT01575873|3699514|B5||Other|Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
3873710|NCT01575873|3699515|B4||Other|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3873711|NCT01575873|3699516|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3873712|NCT01575873|3699517|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3873713|NCT01575873|3699518|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3873716|NCT01575873|3699516|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|223|223.0||||||
3873717|NCT01575873|3699517|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|122|122.0||||||
3873718|NCT01575873|3699518|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|123|123.0||||||
3873719|NCT01575873|3699514|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873720|NCT01575873|3699515|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873721|NCT01575873|3699516|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873722|NCT01575873|3699517|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873723|NCT01575873|3699518|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873724|NCT01575873|3699514|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|660|660.0||||||
3873725|NCT01575873|3699515|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|210|210.0||||||
3873726|NCT01575873|3699516|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|198|198.0||||||
3873727|NCT01575873|3699517|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
3873728|NCT01575873|3699518|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|127|127.0||||||
3873729|NCT01575873|3699514|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|135|135.0||||||
3873730|NCT01575873|3699515|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3873731|NCT01575873|3699516|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3873732|NCT01575873|3699517|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3873733|NCT01575873|3699518|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3873734|NCT01575873|3699514|B5||Male|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
3873735|NCT01575873|3699515|B4||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3873736|NCT01575873|3699516|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3873737|NCT01575873|3699517|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3873738|NCT01575873|3699518|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3873739|NCT01575873|3699514|B5||Female|Sex: Female, Male||Participants|Count of Participants|556|556.0||||||
3873740|NCT01575873|3699515|B4||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
3873741|NCT01575873|3699516|B3||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
3873742|NCT01575873|3699517|B2||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3873743|NCT01575873|3699518|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3873744|NCT01575873|3699514|B5||≥ 75 years|Age, Customized||Participants|Count of Participants|132|132.0||||||
3873745|NCT01575873|3699515|B4||≥ 75 years|Age, Customized||Participants|Count of Participants|33|33.0||||||
3873746|NCT01575873|3699516|B3||≥ 75 years|Age, Customized||Participants|Count of Participants|34|34.0||||||
3873747|NCT01575873|3699517|B2||≥ 75 years|Age, Customized||Participants|Count of Participants|38|38.0||||||
3873748|NCT01575873|3699518|B1||≥ 75 years|Age, Customized||Participants|Count of Participants|27|27.0||||||
3873749|NCT01575873|3699514|B5||65 - 74 years|Age, Customized||Participants|Count of Participants|223|223.0||||||
3873750|NCT01575873|3699515|B4||65 - 74 years|Age, Customized||Participants|Count of Participants|73|73.0||||||
3873751|NCT01575873|3699516|B3||65 - 74 years|Age, Customized||Participants|Count of Participants|62|62.0||||||
3873752|NCT01575873|3699517|B2||65 - 74 years|Age, Customized||Participants|Count of Participants|50|50.0||||||
3873753|NCT01575873|3699518|B1||65 - 74 years|Age, Customized||Participants|Count of Participants|38|38.0||||||
3873754|NCT01575873|3699514|B5||50 - 64 years|Age, Customized||Participants|Count of Participants|374|374.0||||||
3873755|NCT01575873|3699515|B4||50 - 64 years|Age, Customized||Participants|Count of Participants|114|114.0||||||
3873756|NCT01575873|3699516|B3||50 - 64 years|Age, Customized||Participants|Count of Participants|130|130.0||||||
3873757|NCT01575873|3699517|B2||50 - 64 years|Age, Customized||Participants|Count of Participants|55|55.0||||||
3873758|NCT01575873|3699518|B1||50 - 64 years|Age, Customized||Participants|Count of Participants|75|75.0||||||
3873759|NCT01575873|3699514|B5||< 50 years|Age, Customized||Participants|Count of Participants|66|66.0||||||
3873760|NCT01575873|3699515|B4||< 50 years|Age, Customized||Participants|Count of Participants|33|33.0||||||
3873761|NCT01575873|3699516|B3||< 50 years|Age, Customized||Participants|Count of Participants|26|26.0||||||
3873762|NCT01575873|3699517|B2||< 50 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
3873763|NCT01575873|3699518|B1||< 50 years|Age, Customized||Participants|Count of Participants|5|5.0||||||
3873764|NCT01575873|3699514|B5|||Age||years|Mean|63.1|63.1|Standard Deviation|11.1|11.1|||
3873765|NCT01575873|3699515|B4|||Age||years|Mean|61.5|61.5|Standard Deviation|11.6|11.6|||
3873766|NCT01575873|3699516|B3|||Age||years|Mean|61.3|61.3|Standard Deviation|11.1|11.1|||
3873767|NCT01575873|3699517|B2|||Age||years|Mean|67.5|67.5|Standard Deviation|10.1|10.1|||
3873768|NCT01575873|3699518|B1|||Age||years|Mean|64.4|64.4|Standard Deviation|10.0|10.0|||
3873769|NCT01575834|3699545|B3||≥ 75 years|Age Strata per Randomization||Participants|Count of Participants|2239|2239.0||||||
3873770|NCT01575834|3699546|B2||≥ 75 years|Age Strata per Randomization||Participants|Count of Participants|1119|1119.0||||||
3873771|NCT01575834|3699547|B1||≥ 75 years|Age Strata per Randomization||Participants|Count of Participants|1120|1120.0||||||
3873772|NCT01575834|3699545|B3||< 75 years|Age Strata per Randomization||Participants|Count of Participants|4941|4941.0||||||
3873773|NCT01575834|3699546|B2||< 75 years|Age Strata per Randomization||Participants|Count of Participants|2470|2470.0||||||
3873774|NCT01575834|3699547|B1||< 75 years|Age Strata per Randomization||Participants|Count of Participants|2471|2471.0||||||
3873775|NCT01575834|3699545|B3||No|Prevalent Vertebral Fracture Strata per Randomization|Strata per randomization for prevalent fracture were based on local reading of baseline spine radiographs.|Participants|Count of Participants|6771|6771.0||||||
3873776|NCT01575834|3699546|B2||No|Prevalent Vertebral Fracture Strata per Randomization|Strata per randomization for prevalent fracture were based on local reading of baseline spine radiographs.|Participants|Count of Participants|3385|3385.0||||||
3873777|NCT01575834|3699547|B1||No|Prevalent Vertebral Fracture Strata per Randomization|Strata per randomization for prevalent fracture were based on local reading of baseline spine radiographs.|Participants|Count of Participants|3386|3386.0||||||
3873778|NCT01575834|3699545|B3||Yes|Prevalent Vertebral Fracture Strata per Randomization|Strata per randomization for prevalent fracture were based on local reading of baseline spine radiographs.|Participants|Count of Participants|409|409.0||||||
3873779|NCT01575834|3699546|B2||Yes|Prevalent Vertebral Fracture Strata per Randomization|Strata per randomization for prevalent fracture were based on local reading of baseline spine radiographs.|Participants|Count of Participants|204|204.0||||||
3873780|NCT01575834|3699547|B1||Yes|Prevalent Vertebral Fracture Strata per Randomization|Strata per randomization for prevalent fracture were based on local reading of baseline spine radiographs.|Participants|Count of Participants|205|205.0||||||
3873781|NCT01575834|3699545|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1801|1801.0||||||
3873782|NCT01575834|3699546|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|900|900.0||||||
3873783|NCT01575834|3699547|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|901|901.0||||||
3873784|NCT01575834|3699545|B3||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|119|119.0||||||
3873785|NCT01575834|3699546|B2||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|60|60.0||||||
3873786|NCT01575834|3699547|B1||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|59|59.0||||||
3873787|NCT01575834|3699545|B3||Native Hawaiian/Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3873788|NCT01575834|3699546|B2||Native Hawaiian/Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3873789|NCT01575834|3699547|B1||Native Hawaiian/Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3873790|NCT01575834|3699545|B3||American Indian/Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|127|127.0||||||
3873791|NCT01575834|3699546|B2||American Indian/Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|64|64.0||||||
3873792|NCT01575834|3699547|B1||American Indian/Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|63|63.0||||||
3873793|NCT01575834|3699545|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|151|151.0||||||
3873794|NCT01575834|3699546|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|77|77.0||||||
3873795|NCT01575834|3699547|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|74|74.0||||||
3873796|NCT01575834|3699545|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|866|866.0||||||
3873797|NCT01575834|3699546|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|425|425.0||||||
3873798|NCT01575834|3699547|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|441|441.0||||||
3873799|NCT01575834|3699545|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|4115|4115.0||||||
3873800|NCT01575834|3699546|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|2063|2063.0||||||
3873801|NCT01575834|3699547|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|2052|2052.0||||||
3873802|NCT01575834|3699545|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873803|NCT01575834|3699546|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873804|NCT01575834|3699547|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873805|NCT01575834|3699545|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4337|4337.0||||||
3873806|NCT01575834|3699546|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2162|2162.0||||||
3873807|NCT01575834|3699547|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2175|2175.0||||||
3873808|NCT01575834|3699545|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2843|2843.0||||||
3873809|NCT01575834|3699546|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1427|1427.0||||||
3873810|NCT01575834|3699547|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1416|1416.0||||||
3873811|NCT01575834|3699545|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3873812|NCT01575834|3699546|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3873813|NCT01575834|3699547|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3873814|NCT01575834|3699545|B3||Female|Sex: Female, Male||Participants|Count of Participants|7180|7180.0||||||
3873815|NCT01575834|3699546|B2||Female|Sex: Female, Male||Participants|Count of Participants|3589|3589.0||||||
3873816|NCT01575834|3699547|B1||Female|Sex: Female, Male||Participants|Count of Participants|3591|3591.0||||||
3873817|NCT01575834|3699545|B3||≥ 65 years|Age, Customized||Participants|Count of Participants|5655|5655.0||||||
3873818|NCT01575834|3699546|B2||≥ 65 years|Age, Customized||Participants|Count of Participants|2821|2821.0||||||
3873819|NCT01575834|3699547|B1||≥ 65 years|Age, Customized||Participants|Count of Participants|2834|2834.0||||||
3873820|NCT01575834|3699545|B3||< 65 years|Age, Customized||Participants|Count of Participants|1525|1525.0||||||
3873821|NCT01575834|3699546|B2||< 65 years|Age, Customized||Participants|Count of Participants|768|768.0||||||
3873822|NCT01575834|3699547|B1||< 65 years|Age, Customized||Participants|Count of Participants|757|757.0||||||
3873823|NCT01575834|3699545|B3|||Age||years|Mean|70.9|70.9|Standard Deviation|7.0|7.0|||
3873824|NCT01575834|3699546|B2|||Age||years|Mean|70.9|70.9|Standard Deviation|7.0|7.0|||
3873825|NCT01575834|3699547|B1|||Age||years|Mean|70.8|70.8|Standard Deviation|6.9|6.9|||
3873826|NCT01575808|3699598|B3||Category 6- Major Tissue Loss|Rutherford Category||Participants|Count of Participants|0|0.0||||||
3873827|NCT01575808|3699599|B2||Category 6- Major Tissue Loss|Rutherford Category||Participants|Count of Participants|0|0.0||||||
3873828|NCT01575808|3699600|B1||Category 6- Major Tissue Loss|Rutherford Category||Participants|Count of Participants|0|0.0||||||
3873829|NCT01575808|3699598|B3||Category 5 - Minor Tissue Loss|Rutherford Category||Participants|Count of Participants|12|12.0||||||
3873830|NCT01575808|3699599|B2||Category 5 - Minor Tissue Loss|Rutherford Category||Participants|Count of Participants|10|10.0||||||
3873831|NCT01575808|3699600|B1||Category 5 - Minor Tissue Loss|Rutherford Category||Participants|Count of Participants|2|2.0||||||
3873832|NCT01575808|3699598|B3||Category 4 - Ischemic Rest Pain|Rutherford Category||Participants|Count of Participants|8|8.0||||||
3873833|NCT01575808|3699599|B2||Category 4 - Ischemic Rest Pain|Rutherford Category||Participants|Count of Participants|7|7.0||||||
3873834|NCT01575808|3699600|B1||Category 4 - Ischemic Rest Pain|Rutherford Category||Participants|Count of Participants|1|1.0||||||
3873835|NCT01575808|3699598|B3||Category 3 - Severe Claudication|Rutherford Category||Participants|Count of Participants|99|99.0||||||
3873836|NCT01575808|3699599|B2||Category 3 - Severe Claudication|Rutherford Category||Participants|Count of Participants|44|44.0||||||
3873837|NCT01575808|3699600|B1||Category 3 - Severe Claudication|Rutherford Category||Participants|Count of Participants|55|55.0||||||
3873838|NCT01575808|3699598|B3||Category 2 - Moderate Claudication|Rutherford Category||Participants|Count of Participants|52|52.0||||||
3873839|NCT01575808|3699599|B2||Category 2 - Moderate Claudication|Rutherford Category||Participants|Count of Participants|7|7.0||||||
3873840|NCT01575808|3699600|B1||Category 2 - Moderate Claudication|Rutherford Category||Participants|Count of Participants|45|45.0||||||
3873841|NCT01575808|3699598|B3||Category 1 - Mild Claudication|Rutherford Category||Participants|Count of Participants|0|0.0||||||
3873842|NCT01575808|3699599|B2||Category 1 - Mild Claudication|Rutherford Category||Participants|Count of Participants|0|0.0||||||
3873843|NCT01575808|3699600|B1||Category 1 - Mild Claudication|Rutherford Category||Participants|Count of Participants|0|0.0||||||
3873844|NCT01575808|3699598|B3||Category 0 - Asymptomatic|Rutherford Category||Participants|Count of Participants|0|0.0||||||
3873845|NCT01575808|3699599|B2||Category 0 - Asymptomatic|Rutherford Category||Participants|Count of Participants|0|0.0||||||
3873846|NCT01575808|3699600|B1||Category 0 - Asymptomatic|Rutherford Category||Participants|Count of Participants|0|0.0||||||
3873847|NCT01575808|3699598|B3|||Ankle Brachial Index (ABI)||Ratio|Mean|0.57|0.57|Standard Deviation|0.18|0.18|||
3873848|NCT01575808|3699599|B2|||Ankle Brachial Index (ABI)||Ratio|Mean|0.47|0.47|Standard Deviation|0.20|0.2|||
3873849|NCT01575808|3699600|B1|||Ankle Brachial Index (ABI)||Ratio|Mean|0.64|0.64|Standard Deviation|0.12|0.12|||
3873850|NCT01575808|3699598|B3||Left|Study Limb||Participants|Count of Participants|83|83.0||||||
3873851|NCT01575808|3699599|B2||Left|Study Limb||Participants|Count of Participants|36|36.0||||||
3873852|NCT01575808|3699600|B1||Left|Study Limb||Participants|Count of Participants|47|47.0||||||
3873853|NCT01575808|3699598|B3||Right|Study Limb||Participants|Count of Participants|88|88.0||||||
3873854|NCT01575808|3699599|B2||Right|Study Limb||Participants|Count of Participants|32|32.0||||||
3873855|NCT01575808|3699600|B1||Right|Study Limb||Participants|Count of Participants|56|56.0||||||
3873856|NCT01575808|3699598|B3||History of COPD = No|Chronic Obstructive Pulmonary Disease (COPD)||Participants|Count of Participants|157|157.0||||||
3873857|NCT01575808|3699599|B2||History of COPD = No|Chronic Obstructive Pulmonary Disease (COPD)||Participants|Count of Participants|64|64.0||||||
3873858|NCT01575808|3699600|B1||History of COPD = No|Chronic Obstructive Pulmonary Disease (COPD)||Participants|Count of Participants|93|93.0||||||
3873859|NCT01575808|3699598|B3||History of COPD = Yes|Chronic Obstructive Pulmonary Disease (COPD)||Participants|Count of Participants|14|14.0||||||
3873860|NCT01575808|3699599|B2||History of COPD = Yes|Chronic Obstructive Pulmonary Disease (COPD)||Participants|Count of Participants|4|4.0||||||
3873861|NCT01575808|3699600|B1||History of COPD = Yes|Chronic Obstructive Pulmonary Disease (COPD)||Participants|Count of Participants|10|10.0||||||
3873862|NCT01575808|3699598|B3||HIstory of Congestive Heart Failure = No|Congestive Heart Failure||Participants|Count of Participants|164|164.0||||||
3873863|NCT01575808|3699599|B2||HIstory of Congestive Heart Failure = No|Congestive Heart Failure||Participants|Count of Participants|65|65.0||||||
3873864|NCT01575808|3699600|B1||HIstory of Congestive Heart Failure = No|Congestive Heart Failure||Participants|Count of Participants|99|99.0||||||
3873865|NCT01575808|3699598|B3||History of Congestive Heart Failure = Yes|Congestive Heart Failure||Participants|Count of Participants|7|7.0||||||
3873866|NCT01575808|3699599|B2||History of Congestive Heart Failure = Yes|Congestive Heart Failure||Participants|Count of Participants|3|3.0||||||
3873867|NCT01575808|3699600|B1||History of Congestive Heart Failure = Yes|Congestive Heart Failure||Participants|Count of Participants|4|4.0||||||
3873868|NCT01575808|3699598|B3||History of Myocardial Infarction - No|Myocardial Infarction||Participants|Count of Participants|152|152.0||||||
3873869|NCT01575808|3699599|B2||History of Myocardial Infarction - No|Myocardial Infarction||Participants|Count of Participants|61|61.0||||||
3873870|NCT01575808|3699600|B1||History of Myocardial Infarction - No|Myocardial Infarction||Participants|Count of Participants|91|91.0||||||
3873871|NCT01575808|3699598|B3||History of Myocardial Infarction = Yes|Myocardial Infarction||Participants|Count of Participants|19|19.0||||||
3873872|NCT01575808|3699599|B2||History of Myocardial Infarction = Yes|Myocardial Infarction||Participants|Count of Participants|7|7.0||||||
3873873|NCT01575808|3699600|B1||History of Myocardial Infarction = Yes|Myocardial Infarction||Participants|Count of Participants|12|12.0||||||
3873929|NCT01575769|3699648|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3873874|NCT01575808|3699598|B3||History of Coronary Artery Disease = No|Coronary Artery Disease||Participants|Count of Participants|108|108.0||||||
3873875|NCT01575808|3699599|B2||History of Coronary Artery Disease = No|Coronary Artery Disease||Participants|Count of Participants|47|47.0||||||
3873876|NCT01575808|3699600|B1||History of Coronary Artery Disease = No|Coronary Artery Disease||Participants|Count of Participants|61|61.0||||||
3873877|NCT01575808|3699598|B3||History of Coronary Artery Disease = Yes|Coronary Artery Disease||Participants|Count of Participants|63|63.0||||||
3873878|NCT01575808|3699599|B2||History of Coronary Artery Disease = Yes|Coronary Artery Disease||Participants|Count of Participants|21|21.0||||||
3873879|NCT01575808|3699600|B1||History of Coronary Artery Disease = Yes|Coronary Artery Disease||Participants|Count of Participants|42|42.0||||||
3873880|NCT01575808|3699598|B3||History of Carotid Disease = No|Carotid Disease||Participants|Count of Participants|152|152.0||||||
3873881|NCT01575808|3699599|B2||History of Carotid Disease = No|Carotid Disease||Participants|Count of Participants|62|62.0||||||
3873882|NCT01575808|3699600|B1||History of Carotid Disease = No|Carotid Disease||Participants|Count of Participants|90|90.0||||||
3873883|NCT01575808|3699598|B3||History of Carotid Disease = Yes|Carotid Disease||Participants|Count of Participants|19|19.0||||||
3873884|NCT01575808|3699599|B2||History of Carotid Disease = Yes|Carotid Disease||Participants|Count of Participants|6|6.0||||||
3873885|NCT01575808|3699600|B1||History of Carotid Disease = Yes|Carotid Disease||Participants|Count of Participants|13|13.0||||||
3873886|NCT01575808|3699598|B3||History of Dyslipidemia = No|Dyslipidemia||Participants|Count of Participants|75|75.0||||||
3873887|NCT01575808|3699599|B2||History of Dyslipidemia = No|Dyslipidemia||Participants|Count of Participants|36|36.0||||||
3873888|NCT01575808|3699600|B1||History of Dyslipidemia = No|Dyslipidemia||Participants|Count of Participants|39|39.0||||||
3873889|NCT01575808|3699598|B3||History of Dyslipidemia = Yes|Dyslipidemia||Participants|Count of Participants|96|96.0||||||
3873890|NCT01575808|3699599|B2||History of Dyslipidemia = Yes|Dyslipidemia||Participants|Count of Participants|32|32.0||||||
3873891|NCT01575808|3699600|B1||History of Dyslipidemia = Yes|Dyslipidemia||Participants|Count of Participants|64|64.0||||||
3873892|NCT01575808|3699598|B3||History of Hypertension = No|Hypertension||Participants|Count of Participants|21|21.0||||||
3873893|NCT01575808|3699599|B2||History of Hypertension = No|Hypertension||Participants|Count of Participants|9|9.0||||||
3873894|NCT01575808|3699600|B1||History of Hypertension = No|Hypertension||Participants|Count of Participants|12|12.0||||||
3873895|NCT01575808|3699598|B3||History of Hypertension = Yes|Hypertension||Participants|Count of Participants|150|150.0||||||
3873896|NCT01575808|3699599|B2||History of Hypertension = Yes|Hypertension||Participants|Count of Participants|59|59.0||||||
3873897|NCT01575808|3699600|B1||History of Hypertension = Yes|Hypertension||Participants|Count of Participants|91|91.0||||||
3873898|NCT01575808|3699598|B3||History of Diabetes Mellitus = No|Diabetes Mellitus||Participants|Count of Participants|75|75.0||||||
3873899|NCT01575808|3699599|B2||History of Diabetes Mellitus = No|Diabetes Mellitus||Participants|Count of Participants|34|34.0||||||
3873900|NCT01575808|3699600|B1||History of Diabetes Mellitus = No|Diabetes Mellitus||Participants|Count of Participants|41|41.0||||||
3873901|NCT01575808|3699598|B3||History of Diabetes Mellitus = Yes|Diabetes Mellitus||Participants|Count of Participants|96|96.0||||||
3873902|NCT01575808|3699599|B2||History of Diabetes Mellitus = Yes|Diabetes Mellitus||Participants|Count of Participants|34|34.0||||||
3873903|NCT01575808|3699600|B1||History of Diabetes Mellitus = Yes|Diabetes Mellitus||Participants|Count of Participants|62|62.0||||||
3873904|NCT01575808|3699598|B3||Not a Current Smoker|Smoking History||Participants|Count of Participants|119|119.0||||||
3873905|NCT01575808|3699599|B2||Not a Current Smoker|Smoking History||Participants|Count of Participants|45|45.0||||||
3873906|NCT01575808|3699600|B1||Not a Current Smoker|Smoking History||Participants|Count of Participants|74|74.0||||||
3873907|NCT01575808|3699598|B3||Current Smoker|Smoking History||Participants|Count of Participants|52|52.0||||||
3873908|NCT01575808|3699599|B2||Current Smoker|Smoking History||Participants|Count of Participants|23|23.0||||||
3873909|NCT01575808|3699600|B1||Current Smoker|Smoking History||Participants|Count of Participants|29|29.0||||||
3873910|NCT01575808|3699598|B3|||BMI|Body Mass Index|kg/㎡|Mean|22.5|22.5|Standard Deviation|2.83|2.83|||
3873911|NCT01575808|3699600|B1|||BMI|Body Mass Index|kg/㎡|Mean|22.5|22.5|Standard Deviation|2.83|2.83|||
3873912|NCT01575808|3699598|B3|||Weight||kilograms|Mean|59.2|59.2|Standard Deviation|10.03|10.03|||
3873913|NCT01575808|3699600|B1|||Weight||kilograms|Mean|59.2|59.2|Standard Deviation|10.03|10.03|||
3873914|NCT01575808|3699598|B3|||Height||centimeter|Mean|161.9|161.9|Standard Deviation|8.48|8.48|||
3873915|NCT01575808|3699600|B1|||Height||centimeter|Mean|161.9|161.9|Standard Deviation|8.48|8.48|||
3873916|NCT01575808|3699598|B3|Japan||Region of Enrollment||participants|Number|171|171.0||||||
3873917|NCT01575808|3699599|B2|Japan||Region of Enrollment||participants|Number|68|68.0||||||
3873918|NCT01575808|3699600|B1|Japan||Region of Enrollment||participants|Number|103|103.0||||||
3873919|NCT01575808|3699598|B3||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3873920|NCT01575808|3699599|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3873921|NCT01575808|3699600|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3873922|NCT01575808|3699598|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3873923|NCT01575808|3699599|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3873924|NCT01575808|3699600|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3873925|NCT01575808|3699598|B3|||Age||years|Mean|73.4|73.4|Standard Deviation|7.6|7.6|||
3873926|NCT01575808|3699599|B2|||Age||years|Mean|72.3|72.3|Standard Deviation|8.3|8.3|||
3873927|NCT01575808|3699600|B1|||Age||years|Mean|74.2|74.2|Standard Deviation|7.0|7.0|||
3873928|NCT01575769|3699648|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3873930|NCT01575769|3699648|B1|||Age||years|Mean|12.0|12.0|Standard Deviation|4.45|4.45|||
3873931|NCT01575756|3699674|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3873932|NCT01575756|3699674|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3873933|NCT01575756|3699674|B1|||Age||Years|Mean|26.0|26.0|Standard Deviation|12.8|12.8|||
3873934|NCT01575561|3699706|B1|Serbia||Region of Enrollment||participants|Number|35|35.0||||||
3873935|NCT01575561|3699706|B1|Chile||Region of Enrollment||participants|Number|17|17.0||||||
3873936|NCT01575561|3699706|B1|France||Region of Enrollment||participants|Number|8|8.0||||||
3873937|NCT01575561|3699706|B1|Bulgaria||Region of Enrollment||participants|Number|34|34.0||||||
3873938|NCT01575561|3699706|B1|Slovakia||Region of Enrollment||participants|Number|5|5.0||||||
3873939|NCT01575561|3699706|B1|Poland||Region of Enrollment||participants|Number|37|37.0||||||
3873940|NCT01575561|3699706|B1|Japan||Region of Enrollment||participants|Number|13|13.0||||||
3873941|NCT01575561|3699706|B1|United States||Region of Enrollment||participants|Number|95|95.0||||||
3873942|NCT01575561|3699706|B1|Hungary||Region of Enrollment||participants|Number|21|21.0||||||
3873943|NCT01575561|3699706|B1|Argentina||Region of Enrollment||participants|Number|30|30.0||||||
3873944|NCT01575561|3699706|B1|Russian Federation||Region of Enrollment||participants|Number|42|42.0||||||
3873945|NCT01575561|3699706|B1|Czech Republic||Region of Enrollment||participants|Number|40|40.0||||||
3873946|NCT01575561|3699706|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3873947|NCT01575561|3699706|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873948|NCT01575561|3699706|B1||White|Race (NIH/OMB)||Participants|Count of Participants|327|327.0||||||
3873949|NCT01575561|3699706|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3873950|NCT01575561|3699706|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873951|NCT01575561|3699706|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3873952|NCT01575561|3699706|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3873953|NCT01575561|3699706|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3873954|NCT01575561|3699706|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|315|315.0||||||
3873955|NCT01575561|3699706|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3873956|NCT01575561|3699706|B1||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3873957|NCT01575561|3699706|B1||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
3873958|NCT01575561|3699706|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|12.27|12.27|||
3873959|NCT01575561|3699706|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3873960|NCT01575561|3699706|B1||Between 18 and 65 years|Age||Participants|Count of Participants|359|359.0||||||
3873961|NCT01575561|3699706|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3873962|NCT01575522|3699718|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3873963|NCT01575522|3699718|B1|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3873964|NCT01575522|3699718|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3873965|NCT01575522|3699718|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3873966|NCT01575522|3699718|B1|||Age||years|Mean|55|55.0|Standard Deviation|10|10.0|||
3873967|NCT01575275|3699726|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3873968|NCT01575275|3699726|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3873969|NCT01575275|3699726|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3873970|NCT01575275|3699726|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3873971|NCT01575275|3699726|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3873972|NCT01575275|3699726|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3873973|NCT01575197|3699733|B4|Ghana||Region of Enrollment||participants|Number|450|450.0||||||
3873974|NCT01575197|3699734|B3|Ghana||Region of Enrollment||participants|Number|151|151.0||||||
3873975|NCT01575197|3699735|B2|Ghana||Region of Enrollment||participants|Number|149|149.0||||||
3873976|NCT01575197|3699736|B1|Ghana||Region of Enrollment||participants|Number|150|150.0||||||
3873977|NCT01575197|3699733|B4||Male|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
3873978|NCT01575197|3699734|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3873979|NCT01575197|3699735|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3873980|NCT01575197|3699736|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3873981|NCT01575197|3699733|B4||Female|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
3873982|NCT01575197|3699734|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3873983|NCT01575197|3699735|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3873984|NCT01575197|3699736|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3873985|NCT01575197|3699733|B4|||Age||weeks|Mean|6.2|6.2|Standard Deviation|0.2|0.2|||
3873986|NCT01575197|3699734|B3|||Age||weeks|Mean|6.2|6.2|Standard Deviation|0.2|0.2|||
3873987|NCT01575197|3699735|B2|||Age||weeks|Mean|6.2|6.2|Standard Deviation|0.2|0.2|||
3873988|NCT01575197|3699736|B1|||Age||weeks|Mean|6.2|6.2|Standard Deviation|0.2|0.2|||
3873989|NCT01575106|3699751|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3873990|NCT01575106|3699751|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3873991|NCT01575106|3699751|B1|||Age||years|Mean|26.5|26.5|Standard Deviation|6.7|6.7|||
3873992|NCT01575080|3699757|B1|United States||Region of Enrollment||participants|Number|102|102.0||||||
3873993|NCT01575080|3699757|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3873994|NCT01575080|3699757|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3873995|NCT01575080|3699757|B1|||Age||years|Median|55|55.0|Full Range|||19.0|82.0|
3873996|NCT01575054|3699764|B3||Male|Sex: Female, Male||Participants|Count of Participants|303|303.0||||||
3873997|NCT01575054|3699765|B2||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3873998|NCT01575054|3699766|B1||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3873999|NCT01575054|3699764|B3||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3874000|NCT01575054|3699765|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3874001|NCT01575054|3699766|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3874002|NCT01575054|3699764|B3|||Age||Years|Mean|56.5|56.5|Standard Deviation|12.24|12.24|||
3874003|NCT01575054|3699765|B2|||Age||Years|Mean|57.0|57.0|Standard Deviation|11.88|11.88|||
3874004|NCT01575054|3699766|B1|||Age||Years|Mean|56.0|56.0|Standard Deviation|12.60|12.6|||
3874005|NCT01575028|3699781|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3874006|NCT01575028|3699782|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3874007|NCT01575028|3699783|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3874008|NCT01575028|3699781|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874009|NCT01575028|3699782|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874010|NCT01575028|3699783|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874011|NCT01575028|3699781|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874012|NCT01575028|3699782|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874013|NCT01575028|3699783|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874014|NCT01575028|3699781|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3874015|NCT01575028|3699782|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3874016|NCT01575028|3699783|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3874017|NCT01575028|3699781|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874018|NCT01575028|3699782|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874019|NCT01575028|3699783|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874020|NCT01575028|3699781|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874021|NCT01575028|3699782|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874022|NCT01575028|3699783|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874023|NCT01575028|3699781|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874024|NCT01575028|3699782|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874025|NCT01575028|3699783|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874026|NCT01575028|3699781|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874027|NCT01575028|3699782|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874028|NCT01575028|3699783|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874029|NCT01575028|3699781|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3874030|NCT01575028|3699782|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3874031|NCT01575028|3699783|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3874032|NCT01575028|3699781|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3874033|NCT01575028|3699782|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3874034|NCT01575028|3699783|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3874035|NCT01575028|3699781|B3|||Age||years|Mean|11.40|11.4|Standard Deviation|4.91|4.91|||
3874036|NCT01575028|3699782|B2|||Age||years|Mean|7.36|7.36|Standard Deviation|0|0.0|||
3874037|NCT01575028|3699783|B1|||Age||years|Mean|13.425|13.425|Standard Deviation|4.871965722|4.871965722|||
3874038|NCT01575028|3699781|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3874039|NCT01575028|3699782|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3874040|NCT01575028|3699783|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3874041|NCT01575028|3699781|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3874042|NCT01575028|3699782|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3874043|NCT01575028|3699783|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3874044|NCT01575028|3699781|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3874045|NCT01575028|3699782|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3874046|NCT01575028|3699783|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3874047|NCT01574703|3699790|B5||Male|Gender||Participants|Count of Participants|2044|2044.0||||||
3874048|NCT01574703|3699791|B4||Male|Gender||Participants|Count of Participants|500|500.0||||||
3874049|NCT01574703|3699792|B3||Male|Gender||Participants|Count of Participants|493|493.0||||||
3874050|NCT01574703|3699793|B2||Male|Gender||Participants|Count of Participants|518|518.0||||||
3874051|NCT01574703|3699794|B1||Male|Gender||Participants|Count of Participants|533|533.0||||||
3874052|NCT01574703|3699790|B5||Female|Gender||Participants|Count of Participants|2551|2551.0||||||
3874053|NCT01574703|3699791|B4||Female|Gender||Participants|Count of Participants|621|621.0||||||
3874054|NCT01574703|3699792|B3||Female|Gender||Participants|Count of Participants|623|623.0||||||
3874055|NCT01574703|3699793|B2||Female|Gender||Participants|Count of Participants|648|648.0||||||
3874056|NCT01574703|3699794|B1||Female|Gender||Participants|Count of Participants|659|659.0||||||
3874057|NCT01574703|3699790|B5|||Age||Years|Mean|47.9|47.9|Standard Deviation|12.2|12.2|||
3874058|NCT01574703|3699791|B4|||Age||Years|Mean|47.5|47.5|Standard Deviation|12.2|12.2|||
3874059|NCT01574703|3699792|B3|||Age||Years|Mean|48.3|48.3|Standard Deviation|11.9|11.9|||
3874060|NCT01574703|3699793|B2|||Age||Years|Mean|47.7|47.7|Standard Deviation|12.5|12.5|||
3874061|NCT01574703|3699794|B1|||Age||Years|Mean|48.1|48.1|Standard Deviation|12.2|12.2|||
3874062|NCT01574651|3699839|B3||Male|Sex: Female, Male||Participants|Count of Participants|615|615.0||||||
3874063|NCT01574651|3699840|B2||Male|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
3874064|NCT01574651|3699841|B1||Male|Sex: Female, Male||Participants|Count of Participants|317|317.0||||||
3874065|NCT01574651|3699839|B3||Female|Sex: Female, Male||Participants|Count of Participants|319|319.0||||||
3874066|NCT01574651|3699840|B2||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3874067|NCT01574651|3699841|B1||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
3874068|NCT01574651|3699839|B3|||Age||Years|Mean|62.9|62.9|Standard Deviation|8.29|8.29|||
3874069|NCT01574651|3699840|B2|||Age||Years|Mean|63.1|63.1|Standard Deviation|8.15|8.15|||
3874070|NCT01574651|3699841|B1|||Age||Years|Mean|62.6|62.6|Standard Deviation|8.43|8.43|||
3874071|NCT01574612|3699864|B1|age 7 to 9 years||age of subjects with prior history of herpes labialis outbreak||participants|Number|10|10.0||13.9|13.9|||
3874072|NCT01574612|3699864|B1|age 4 to 6 years||age of subjects with prior history of herpes labialis outbreak||participants|Number|17|17.0||21.5|21.5|||
3874073|NCT01574612|3699864|B1|less than or equal to 3 years||age of subjects with prior history of herpes labialis outbreak||participants|Number|27|27.0||33|33.0|||
3874074|NCT01574612|3699864|B1|United States||Region of Enrollment||participants|Number|54|54.0||||||
3874075|NCT01574612|3699864|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3874076|NCT01574612|3699864|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3874077|NCT01574612|3699864|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3874078|NCT01574612|3699864|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3874079|NCT01574612|3699864|B1||<=18 years|Age||Participants|Count of Participants|54|54.0||||||
3874080|NCT01574612|3699864|B1|||Age||years|Mean|9.1|9.1|Standard Deviation|1.7|1.7|||
3874081|NCT01574326|3699868|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3874082|NCT01574326|3699869|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3874083|NCT01574326|3699870|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3874084|NCT01574326|3699868|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3874085|NCT01574326|3699869|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3874086|NCT01574326|3699870|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3874087|NCT01574326|3699868|B3|||Age|Age continuous is reported here for safety set: N= 51 and N=49 for 'FDP-Placebo for sevelamer carbonate, DTP-Sevelamer carbonate' and 'FDP-Sevelamer carbonate, DTP-Sevelamer carbonate' arms respectively. All enrolled participants who were treated with at least 1 dose of study drug were included in the safety set.|years|Mean|14.1|14.1|Standard Deviation|2.93|2.93|||
3874088|NCT01574326|3699869|B2|||Age|Age continuous is reported here for safety set: N= 51 and N=49 for 'FDP-Placebo for sevelamer carbonate, DTP-Sevelamer carbonate' and 'FDP-Sevelamer carbonate, DTP-Sevelamer carbonate' arms respectively. All enrolled participants who were treated with at least 1 dose of study drug were included in the safety set.|years|Mean|13.9|13.9|Standard Deviation|2.75|2.75|||
3874089|NCT01574326|3699870|B1|||Age|Age continuous is reported here for safety set: N= 51 and N=49 for 'FDP-Placebo for sevelamer carbonate, DTP-Sevelamer carbonate' and 'FDP-Sevelamer carbonate, DTP-Sevelamer carbonate' arms respectively. All enrolled participants who were treated with at least 1 dose of study drug were included in the safety set.|years|Mean|14.3|14.3|Standard Deviation|3.11|3.11|||
3874090|NCT01574248|3699882|B3|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3874091|NCT01574248|3699883|B2|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3874092|NCT01574248|3699884|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3874093|NCT01574248|3699882|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874094|NCT01574248|3699883|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874095|NCT01574248|3699884|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874096|NCT01574248|3699882|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874097|NCT01574248|3699883|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874098|NCT01574248|3699884|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874099|NCT01574248|3699882|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3874100|NCT01574248|3699883|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3874101|NCT01574248|3699884|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3874102|NCT01574248|3699882|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3874103|NCT01574248|3699883|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3874104|NCT01574248|3699884|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3874167|NCT01574079|3699932|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
3874105|NCT01574248|3699882|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874106|NCT01574248|3699883|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874107|NCT01574248|3699884|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874108|NCT01574248|3699882|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874109|NCT01574248|3699883|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874110|NCT01574248|3699884|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874111|NCT01574248|3699882|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874112|NCT01574248|3699883|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874113|NCT01574248|3699884|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874114|NCT01574248|3699882|B3||Male|Gender||Participants|Count of Participants|11|11.0||||||
3874115|NCT01574248|3699883|B2||Male|Gender||Participants|Count of Participants|6|6.0||||||
3874116|NCT01574248|3699884|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
3874117|NCT01574248|3699882|B3||Female|Gender||Participants|Count of Participants|19|19.0||||||
3874118|NCT01574248|3699883|B2||Female|Gender||Participants|Count of Participants|12|12.0||||||
3874119|NCT01574248|3699884|B1||Female|Gender||Participants|Count of Participants|7|7.0||||||
3874120|NCT01574248|3699882|B3|||Age||years|Mean|58.9|58.9|Standard Deviation|11.8|11.8|||
3874121|NCT01574248|3699883|B2|||Age||years|Mean|60.7|60.7|Standard Deviation|10.8|10.8|||
3874122|NCT01574248|3699884|B1|||Age||years|Mean|56.3|56.3|Standard Deviation|13.4|13.4|||
3874123|NCT01574183|3699903|B3|United States||Region of Enrollment||participants|Number|76|76.0||||||
3874124|NCT01574183|3699904|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
3874125|NCT01574183|3699905|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
3874126|NCT01574183|3699903|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3874127|NCT01574183|3699904|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3874128|NCT01574183|3699905|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3874129|NCT01574183|3699903|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3874130|NCT01574183|3699904|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3874131|NCT01574183|3699905|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3874132|NCT01574183|3699903|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3874133|NCT01574183|3699904|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3874134|NCT01574183|3699905|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3874135|NCT01574183|3699903|B3||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
3874136|NCT01574183|3699904|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3874137|NCT01574183|3699905|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3874138|NCT01574183|3699903|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3874139|NCT01574183|3699904|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3874140|NCT01574183|3699905|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3874141|NCT01574144|3699916|B1|Australia||Region of Enrollment||participants|Number|10|10.0||||||
3874142|NCT01574144|3699916|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
3874143|NCT01574144|3699916|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3874144|NCT01574144|3699916|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3874145|NCT01574144|3699916|B1|||Age||years|Mean|65.2|65.2|Standard Deviation|13.6|13.6|||
3874146|NCT01574105|3699921|B3|Canada||Region of Enrollment||participants|Number|66|66.0||||||
3874147|NCT01574105|3699922|B2|Canada||Region of Enrollment||participants|Number|37|37.0||||||
3874148|NCT01574105|3699923|B1|Canada||Region of Enrollment||participants|Number|29|29.0||||||
3874149|NCT01574105|3699921|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3874150|NCT01574105|3699922|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3874151|NCT01574105|3699923|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3874152|NCT01574105|3699921|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3874153|NCT01574105|3699922|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3874154|NCT01574105|3699923|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3874155|NCT01574105|3699921|B3|||Age||years|Mean|67.6|67.6|Standard Deviation|9.5|9.5|||
3874156|NCT01574105|3699922|B2|||Age||years|Mean|67.8|67.8|Standard Deviation|9.4|9.4|||
3874157|NCT01574105|3699923|B1|||Age||years|Mean|67.4|67.4|Standard Deviation|9.8|9.8|||
3874158|NCT01574105|3699921|B3||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
3874159|NCT01574105|3699922|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3874160|NCT01574105|3699923|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3874161|NCT01574105|3699921|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3874162|NCT01574105|3699922|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3874163|NCT01574105|3699923|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3874164|NCT01574105|3699921|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3874165|NCT01574105|3699922|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3874166|NCT01574105|3699923|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3874168|NCT01574079|3699933|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3874169|NCT01574079|3699934|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3874170|NCT01574079|3699932|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3874171|NCT01574079|3699933|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3874172|NCT01574079|3699934|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3874173|NCT01574079|3699932|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3874174|NCT01574079|3699933|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3874175|NCT01574079|3699934|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3874176|NCT01574079|3699932|B3|||Age||years|Mean|51.47|51.47|Standard Deviation|13.56|13.56|||
3874177|NCT01574079|3699933|B2|||Age||years|Mean|48.85|48.85|Standard Deviation|15.53|15.53|||
3874178|NCT01574079|3699934|B1|||Age||years|Mean|53.47|53.47|Standard Deviation|11.94|11.94|||
3874179|NCT01574079|3699932|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3874180|NCT01574079|3699933|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3874181|NCT01574079|3699934|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3874182|NCT01574079|3699932|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3874183|NCT01574079|3699933|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3874184|NCT01574079|3699934|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3874185|NCT01574079|3699932|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3874186|NCT01574079|3699933|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3874187|NCT01574079|3699934|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3874188|NCT01573910|3699945|B3||Male|Sex: Female, Male||Participants|Count of Participants|463|463.0||||||
3874189|NCT01573910|3699946|B2||Male|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
3874190|NCT01573910|3699947|B1||Male|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
3874191|NCT01573910|3699945|B3||Female|Sex: Female, Male||Participants|Count of Participants|519|519.0||||||
3874192|NCT01573910|3699946|B2||Female|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
3874193|NCT01573910|3699947|B1||Female|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
3874194|NCT01573910|3699945|B3|||Age||years|Mean|37.9|37.9|Standard Deviation|15.69|15.69|||
3874195|NCT01573910|3699946|B2|||Age||years|Mean|38.4|38.4|Standard Deviation|15.83|15.83|||
3874196|NCT01573910|3699947|B1|||Age||years|Mean|37.4|37.4|Standard Deviation|15.54|15.54|||
3874197|NCT01573767|3699956|B5|Mixed Race||Race/Ethnicity, Customized||Participants|Number|93|93.0||||||
3874198|NCT01573767|3699957|B4|Mixed Race||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
3874199|NCT01573767|3699958|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
3874200|NCT01573767|3699959|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
3874201|NCT01573767|3699960|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
3874202|NCT01573767|3699956|B5|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|245|245.0||||||
3874203|NCT01573767|3699957|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|61|61.0||||||
3874204|NCT01573767|3699958|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|55|55.0||||||
3874205|NCT01573767|3699959|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|62|62.0||||||
3874206|NCT01573767|3699960|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|67|67.0||||||
3874207|NCT01573767|3699956|B5|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3874208|NCT01573767|3699957|B4|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3874209|NCT01573767|3699958|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3874210|NCT01573767|3699959|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3874211|NCT01573767|3699960|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3874212|NCT01573767|3699956|B5|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3874213|NCT01573767|3699957|B4|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3874214|NCT01573767|3699958|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3874215|NCT01573767|3699959|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3874216|NCT01573767|3699960|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3874217|NCT01573767|3699956|B5|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
3874218|NCT01573767|3699957|B4|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3874219|NCT01573767|3699958|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3874220|NCT01573767|3699959|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3874221|NCT01573767|3699960|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3874222|NCT01573767|3699956|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|72|72.0||||||
3874223|NCT01573767|3699957|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
3874224|NCT01573767|3699958|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
3874225|NCT01573767|3699959|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
3874226|NCT01573767|3699960|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
3874227|NCT01573767|3699956|B5|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
3874228|NCT01573767|3699957|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3874229|NCT01573767|3699958|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3874230|NCT01573767|3699959|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3874231|NCT01573767|3699960|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3874232|NCT01573767|3699956|B5||Male|Gender||Participants|Count of Participants|276|276.0||||||
3874233|NCT01573767|3699957|B4||Male|Gender||Participants|Count of Participants|69|69.0||||||
3874234|NCT01573767|3699958|B3||Male|Gender||Participants|Count of Participants|71|71.0||||||
3874235|NCT01573767|3699959|B2||Male|Gender||Participants|Count of Participants|71|71.0||||||
3874236|NCT01573767|3699960|B1||Male|Gender||Participants|Count of Participants|65|65.0||||||
3874237|NCT01573767|3699956|B5||Female|Gender||Participants|Count of Participants|180|180.0||||||
3874238|NCT01573767|3699957|B4||Female|Gender||Participants|Count of Participants|45|45.0||||||
3874239|NCT01573767|3699958|B3||Female|Gender||Participants|Count of Participants|42|42.0||||||
3874240|NCT01573767|3699959|B2||Female|Gender||Participants|Count of Participants|43|43.0||||||
3874241|NCT01573767|3699960|B1||Female|Gender||Participants|Count of Participants|50|50.0||||||
3874242|NCT01573767|3699956|B5|||Age||Years|Mean|7.9|7.9|Standard Deviation|1.80|1.8|||
3874243|NCT01573767|3699957|B4|||Age||Years|Mean|7.9|7.9|Standard Deviation|1.72|1.72|||
3874244|NCT01573767|3699958|B3|||Age||Years|Mean|7.9|7.9|Standard Deviation|1.74|1.74|||
3874245|NCT01573767|3699959|B2|||Age||Years|Mean|8.0|8.0|Standard Deviation|1.95|1.95|||
3874246|NCT01573767|3699960|B1|||Age||Years|Mean|8.0|8.0|Standard Deviation|1.81|1.81|||
3874247|NCT01573624|3699997|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874248|NCT01573624|3699997|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874249|NCT01573624|3699997|B1||White|Race (NIH/OMB)||Participants|Count of Participants|367|367.0||||||
3874250|NCT01573624|3699997|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3874251|NCT01573624|3699997|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874252|NCT01573624|3699997|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3874253|NCT01573624|3699997|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874254|NCT01573624|3699997|B1||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3874255|NCT01573624|3699997|B1||Female|Sex: Female, Male||Participants|Count of Participants|289|289.0||||||
3874256|NCT01573624|3699997|B1|||Age||Years|Mean|47.5|47.5|Standard Deviation|13.84|13.84|||
3874257|NCT01573325|3700050|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3874258|NCT01573325|3700050|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3874259|NCT01573325|3700050|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3874260|NCT01573325|3700050|B1|||Age||years|Mean|56.26|56.26|Standard Deviation|10.774|10.774|||
3874261|NCT01573325|3700050|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3874262|NCT01573325|3700050|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3874263|NCT01573325|3700050|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3874264|NCT01573260|3700055|B3|||Disease duration||years|Mean|6.5|6.5|Standard Deviation|4.49|4.49|||
3874265|NCT01573260|3700056|B2|||Disease duration||years|Mean|5.5|5.5|Standard Deviation|4.4|4.4|||
3874266|NCT01573260|3700057|B1|||Disease duration||years|Mean|7.7|7.7|Standard Deviation|4.6|4.6|||
3874267|NCT01573260|3700055|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3874268|NCT01573260|3700056|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3874269|NCT01573260|3700057|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3874270|NCT01573260|3700055|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3874271|NCT01573260|3700056|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3874272|NCT01573260|3700057|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3874273|NCT01573260|3700055|B3|||Age||years|Mean|63.7|63.7|Standard Deviation|9.08|9.08|||
3874274|NCT01573260|3700056|B2|||Age||years|Mean|63.2|63.2|Standard Deviation|9.9|9.9|||
3874275|NCT01573260|3700057|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|8.1|8.1|||
3874276|NCT01573000|3700090|B3|Other/Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3874277|NCT01573000|3700091|B2|Other/Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3874278|NCT01573000|3700092|B1|Other/Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3874279|NCT01573000|3700090|B3|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3874280|NCT01573000|3700091|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3874281|NCT01573000|3700092|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3874282|NCT01573000|3700090|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3874283|NCT01573000|3700091|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3874284|NCT01573000|3700092|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3874285|NCT01573000|3700090|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3874286|NCT01573000|3700091|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3874287|NCT01573000|3700092|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3874288|NCT01573000|3700090|B3|White||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
3874289|NCT01573000|3700091|B2|White||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
3874290|NCT01573000|3700092|B1|White||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
3874291|NCT01573000|3700090|B3|Male||Sex/Gender, Customized||Participants|Number|41|41.0||||||
3874292|NCT01573000|3700091|B2|Male||Sex/Gender, Customized||Participants|Number|18|18.0||||||
3874293|NCT01573000|3700092|B1|Male||Sex/Gender, Customized||Participants|Number|23|23.0||||||
3874294|NCT01573000|3700090|B3|Female||Sex/Gender, Customized||Participants|Number|37|37.0||||||
3874295|NCT01573000|3700091|B2|Female||Sex/Gender, Customized||Participants|Number|18|18.0||||||
3874296|NCT01573000|3700092|B1|Female||Sex/Gender, Customized||Participants|Number|19|19.0||||||
3874297|NCT01573000|3700090|B3|||Age||Years|Mean|55.8|55.8|Standard Deviation|12.1|12.1|||
3874298|NCT01573000|3700091|B2|||Age||Years|Mean|55.4|55.4|Standard Deviation|12.8|12.8|||
3874299|NCT01573000|3700092|B1|||Age||Years|Mean|56.3|56.3|Standard Deviation|11.6|11.6|||
3874300|NCT01572948|3700187|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
3874301|NCT01572948|3700188|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3874302|NCT01572948|3700189|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3874303|NCT01572948|3700187|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874304|NCT01572948|3700188|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874305|NCT01572948|3700189|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874306|NCT01572948|3700187|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874307|NCT01572948|3700188|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874308|NCT01572948|3700189|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874309|NCT01572948|3700187|B3||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3874310|NCT01572948|3700188|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3874311|NCT01572948|3700189|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3874312|NCT01572948|3700187|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3874313|NCT01572948|3700188|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3874314|NCT01572948|3700189|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3874315|NCT01572948|3700187|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874316|NCT01572948|3700188|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874317|NCT01572948|3700189|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874318|NCT01572948|3700187|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874319|NCT01572948|3700188|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874320|NCT01572948|3700189|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874321|NCT01572948|3700187|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874322|NCT01572948|3700188|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874323|NCT01572948|3700189|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874324|NCT01572948|3700187|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3874325|NCT01572948|3700188|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3874326|NCT01572948|3700189|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3874327|NCT01572948|3700187|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3874328|NCT01572948|3700188|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3874329|NCT01572948|3700189|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3874330|NCT01572948|3700187|B3|||Age||years|Mean|61|61.0|Full Range|||53.0|69.0|
3874331|NCT01572948|3700188|B2|||Age||years|Mean|62|62.0|Full Range|||55.0|69.0|
3874332|NCT01572948|3700189|B1|||Age||years|Mean|61|61.0|Full Range|||53.0|69.0|
3874333|NCT01572844|3700206|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874334|NCT01572844|3700206|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874335|NCT01572844|3700206|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3874336|NCT01572844|3700206|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3874337|NCT01572844|3700206|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874338|NCT01572844|3700206|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874339|NCT01572844|3700206|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874340|NCT01572844|3700206|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3874341|NCT01572844|3700206|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3874342|NCT01572844|3700206|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3874343|NCT01572844|3700206|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3874344|NCT01572844|3700206|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3874345|NCT01572792|3700220|B6||Male|Sex: Female, Male||Participants|Count of Participants|483|483.0||||||
3874346|NCT01572792|3700221|B5||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3874347|NCT01572792|3700222|B4||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3874348|NCT01572792|3700223|B3||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3874349|NCT01572792|3700224|B2||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3874350|NCT01572792|3700225|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3874351|NCT01572792|3700220|B6||Female|Sex: Female, Male||Participants|Count of Participants|435|435.0||||||
3874352|NCT01572792|3700221|B5||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3874353|NCT01572792|3700222|B4||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3874354|NCT01572792|3700223|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3874355|NCT01572792|3700224|B2||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3874356|NCT01572792|3700225|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3874357|NCT01572792|3700220|B6|||Age||Years|Mean|63.2|63.2|Standard Deviation|8.8|8.8|||
3874358|NCT01572792|3700221|B5|||Age||Years|Mean|62.8|62.8|Standard Deviation|8.7|8.7|||
3874359|NCT01572792|3700222|B4|||Age||Years|Mean|62.9|62.9|Standard Deviation|8.3|8.3|||
3874360|NCT01572792|3700223|B3|||Age||Years|Mean|63.6|63.6|Standard Deviation|9.2|9.2|||
3874361|NCT01572792|3700224|B2|||Age||Years|Mean|63.7|63.7|Standard Deviation|9.1|9.1|||
3874362|NCT01572792|3700225|B1|||Age||Years|Mean|63.2|63.2|Standard Deviation|8.6|8.6|||
3874363|NCT01572740|3700276|B3|||Glycosylated Haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.8|8.8|Standard Deviation|0.9|0.9|||
3874364|NCT01572740|3700277|B2|||Glycosylated Haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.8|8.8|Standard Deviation|0.9|0.9|||
3874365|NCT01572740|3700278|B1|||Glycosylated Haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.8|8.8|Standard Deviation|0.9|0.9|||
3874366|NCT01572740|3700276|B3|||Fasting Plasma Glucose (FPG)||mmol/L|Mean|8.65|8.65|Standard Deviation|2.47|2.47|||
3874367|NCT01572740|3700277|B2|||Fasting Plasma Glucose (FPG)||mmol/L|Mean|8.79|8.79|Standard Deviation|2.51|2.51|||
3874368|NCT01572740|3700278|B1|||Fasting Plasma Glucose (FPG)||mmol/L|Mean|8.51|8.51|Standard Deviation|2.42|2.42|||
3874369|NCT01572740|3700276|B3|||Body Weight||kg|Mean|66.8|66.8|Standard Deviation|14.1|14.1|||
3874370|NCT01572740|3700277|B2|||Body Weight||kg|Mean|65.9|65.9|Standard Deviation|13.0|13.0|||
3874371|NCT01572740|3700278|B1|||Body Weight||kg|Mean|67.7|67.7|Standard Deviation|15.2|15.2|||
3874372|NCT01572740|3700276|B3||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3874373|NCT01572740|3700277|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3874374|NCT01572740|3700278|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3874375|NCT01572740|3700276|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3874376|NCT01572740|3700277|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3874377|NCT01572740|3700278|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3874378|NCT01572740|3700276|B3|||Age||years|Mean|60.5|60.5|Standard Deviation|11.2|11.2|||
3874379|NCT01572740|3700277|B2|||Age||years|Mean|59.8|59.8|Standard Deviation|11.3|11.3|||
3874380|NCT01572740|3700278|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|11.0|11.0|||
3874381|NCT01572727|3700307|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3874382|NCT01572727|3700308|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3874383|NCT01572727|3700309|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3874384|NCT01572727|3700307|B3||Female|Sex: Female, Male||Participants|Count of Participants|416|416.0||||||
3874385|NCT01572727|3700308|B2||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
3874386|NCT01572727|3700309|B1||Female|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
3874387|NCT01572727|3700307|B3|||Age||Years|Mean|54.9|54.9|Standard Deviation|10.89|10.89|||
3874388|NCT01572727|3700308|B2|||Age||Years|Mean|55.6|55.6|Standard Deviation|10.48|10.48|||
3874389|NCT01572727|3700309|B1|||Age||Years|Mean|54.1|54.1|Standard Deviation|11.13|11.13|||
3874390|NCT01572675|3700330|B3||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3874391|NCT01572675|3700331|B2||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3874392|NCT01572675|3700332|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3874393|NCT01572675|3700330|B3||Female|Sex: Female, Male||Participants|Count of Participants|345|345.0||||||
3874394|NCT01572675|3700331|B2||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
3874395|NCT01572675|3700332|B1||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3874396|NCT01572675|3700330|B3|||Age||Years|Mean|61.6|61.6|Standard Deviation|14.0|14.0|||
3874397|NCT01572675|3700331|B2|||Age||Years|Mean|62.4|62.4|Standard Deviation|14.2|14.2|||
3874398|NCT01572675|3700332|B1|||Age||Years|Mean|60.8|60.8|Standard Deviation|13.8|13.8|||
3874399|NCT01572389|3700430|B3|Race|More than 1 race|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3874400|NCT01572389|3700431|B2|Race|More than 1 race|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3874401|NCT01572389|3700432|B1|Race|More than 1 race|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3874402|NCT01572389|3700430|B3|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3874403|NCT01572389|3700431|B2|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3874404|NCT01572389|3700432|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3874405|NCT01572389|3700430|B3|Race|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3874406|NCT01572389|3700431|B2|Race|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3874407|NCT01572389|3700432|B1|Race|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3874408|NCT01572389|3700430|B3|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|57|57.0||||||
3874409|NCT01572389|3700431|B2|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3874410|NCT01572389|3700432|B1|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
3874411|NCT01572389|3700430|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|124|124.0||||||
3874412|NCT01572389|3700431|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
3874413|NCT01572389|3700432|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|73|73.0||||||
3874414|NCT01572389|3700430|B3||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3874415|NCT01572389|3700431|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3874416|NCT01572389|3700432|B1||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3874417|NCT01572389|3700430|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3874418|NCT01572389|3700431|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3874419|NCT01572389|3700432|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3874420|NCT01572389|3700430|B3|||Age||years|Mean|61.9|61.9|Standard Deviation|8.3|8.3|||
3874421|NCT01572389|3700431|B2|||Age||years|Mean|60.8|60.8|Standard Deviation|8.0|8.0|||
3874422|NCT01572389|3700432|B1|||Age||years|Mean|62.6|62.6|Standard Deviation|8.4|8.4|||
3874423|NCT01572298|3700441|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3874424|NCT01572298|3700442|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3874425|NCT01572298|3700443|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3874426|NCT01572298|3700441|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3874427|NCT01572298|3700442|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3874428|NCT01572298|3700443|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3874429|NCT01572298|3700441|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3874430|NCT01572298|3700442|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3874431|NCT01572298|3700443|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3874432|NCT01572298|3700441|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3874433|NCT01572298|3700442|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3874434|NCT01572298|3700443|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3874435|NCT01572298|3700441|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3874436|NCT01572298|3700442|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3874437|NCT01572298|3700443|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3874438|NCT01572298|3700441|B3|||Age||years|Mean|48.9|48.9|Standard Deviation|12.6|12.6|||
3874439|NCT01572298|3700442|B2|||Age||years|Mean|47.5|47.5|Standard Deviation|14.5|14.5|||
3874440|NCT01572298|3700443|B1|||Age||years|Mean|49.5|49.5|Standard Deviation|11.8|11.8|||
3874441|NCT01572207|3700452|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3874442|NCT01572207|3700453|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3874443|NCT01572207|3700454|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3874444|NCT01572207|3700452|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3874445|NCT01572207|3700453|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3874446|NCT01572207|3700454|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3874447|NCT01572207|3700452|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3874448|NCT01572207|3700453|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3874449|NCT01572207|3700454|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3874450|NCT01572207|3700452|B3|||Age||years|Mean|47.5|47.5|Standard Deviation|9.5|9.5|||
3874451|NCT01572207|3700453|B2|||Age||years|Mean|48|48.0|Standard Deviation|10|10.0|||
3874452|NCT01572207|3700454|B1|||Age||years|Mean|47|47.0|Standard Deviation|9|9.0|||
3874453|NCT01572207|3700452|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3874454|NCT01572207|3700453|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3874455|NCT01572207|3700454|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3874456|NCT01572207|3700452|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3874457|NCT01572207|3700453|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3874458|NCT01572207|3700454|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3874459|NCT01572207|3700452|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3874460|NCT01572207|3700453|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3874461|NCT01572207|3700454|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3874462|NCT01571557|3700465|B1||Male|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
3874463|NCT01571557|3700465|B1||Female|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
3874464|NCT01571557|3700465|B1|91 to 100 years||Age, Customized||Participants|Number|6|6.0||||||
3874465|NCT01571557|3700465|B1|81 to 90 years||Age, Customized||Participants|Number|119|119.0||||||
3874466|NCT01571557|3700465|B1|71 to 80 years||Age, Customized||Participants|Number|235|235.0||||||
3874467|NCT01571557|3700465|B1|61 to 70 years||Age, Customized||Participants|Number|127|127.0||||||
3874468|NCT01571557|3700465|B1|51 to 60 years||Age, Customized||Participants|Number|69|69.0||||||
3874469|NCT01571557|3700465|B1|41 to 50 years||Age, Customized||Participants|Number|13|13.0||||||
3874470|NCT01571557|3700465|B1|31 to 40 years||Age, Customized||Participants|Number|4|4.0||||||
3874471|NCT01571453|3700472|B3|||CGI-S score|Clinical Global Impression Scale - Severity of Illness (CGI-S) provides the clinician's impression of the patient's current state of mental illness. The clinician uses his or her clinical experience of this patient population to rate the severity of the patient's current mental illness on a 7-point scale ranging from 1 (normal - not at all ill) to 7 (among the most extremely ill patients). Higher score indicates that the patient is more ill.|units on a scale|Mean|4.9|4.9|Standard Deviation|0.7|0.7|||
3874472|NCT01571453|3700473|B2|||CGI-S score|Clinical Global Impression Scale - Severity of Illness (CGI-S) provides the clinician's impression of the patient's current state of mental illness. The clinician uses his or her clinical experience of this patient population to rate the severity of the patient's current mental illness on a 7-point scale ranging from 1 (normal - not at all ill) to 7 (among the most extremely ill patients). Higher score indicates that the patient is more ill.|units on a scale|Mean|4.9|4.9|Standard Deviation|0.7|0.7|||
3874473|NCT01571453|3700474|B1|||CGI-S score|Clinical Global Impression Scale - Severity of Illness (CGI-S) provides the clinician's impression of the patient's current state of mental illness. The clinician uses his or her clinical experience of this patient population to rate the severity of the patient's current mental illness on a 7-point scale ranging from 1 (normal - not at all ill) to 7 (among the most extremely ill patients). Higher score indicates that the patient is more ill.|units on a scale|Mean|4.8|4.8|Standard Deviation|0.7|0.7|||
3874474|NCT01571453|3700472|B3|||HAM-A total score|Hamilton Anxiety Rating Scale (HAM-A) is a 14-item rating scale designed to assess the global anxiety. Each symptom is rated from 0 (absent) to 4 (maximum severity). The total score of the 14 items ranges from 0 to 56. Total score from 0 to 56; higher score indicates greater anxiety.|units on a scale|Mean|20.9|20.9|Standard Deviation|7.1|7.1|||
3874475|NCT01571453|3700473|B2|||HAM-A total score|Hamilton Anxiety Rating Scale (HAM-A) is a 14-item rating scale designed to assess the global anxiety. Each symptom is rated from 0 (absent) to 4 (maximum severity). The total score of the 14 items ranges from 0 to 56. Total score from 0 to 56; higher score indicates greater anxiety.|units on a scale|Mean|21.1|21.1|Standard Deviation|7.0|7.0|||
3874476|NCT01571453|3700474|B1|||HAM-A total score|Hamilton Anxiety Rating Scale (HAM-A) is a 14-item rating scale designed to assess the global anxiety. Each symptom is rated from 0 (absent) to 4 (maximum severity). The total score of the 14 items ranges from 0 to 56. Total score from 0 to 56; higher score indicates greater anxiety.|units on a scale|Mean|20.6|20.6|Standard Deviation|7.3|7.3|||
3874477|NCT01571453|3700472|B3|||MADRS total score|Montgomery and Asberg Depression Rating Scale (MADRS) is a ten-item rating scale designed to assess the severity of the symptoms in depressive illness and to be sensitive to treatment effects. Symptoms are rated on a 7-point scale from 0 (no symptom) to 6 (severe symptom). Definitions of severity are provided at two-point intervals. The total score of the ten items ranges from 0 to 60. The higher the score, the more severe.|units on a scale|Mean|32.3|32.3|Standard Deviation|4.6|4.6|||
3874478|NCT01571453|3700473|B2|||MADRS total score|Montgomery and Asberg Depression Rating Scale (MADRS) is a ten-item rating scale designed to assess the severity of the symptoms in depressive illness and to be sensitive to treatment effects. Symptoms are rated on a 7-point scale from 0 (no symptom) to 6 (severe symptom). Definitions of severity are provided at two-point intervals. The total score of the ten items ranges from 0 to 60. The higher the score, the more severe.|units on a scale|Mean|32.3|32.3|Standard Deviation|4.5|4.5|||
3874479|NCT01571453|3700474|B1|||MADRS total score|Montgomery and Asberg Depression Rating Scale (MADRS) is a ten-item rating scale designed to assess the severity of the symptoms in depressive illness and to be sensitive to treatment effects. Symptoms are rated on a 7-point scale from 0 (no symptom) to 6 (severe symptom). Definitions of severity are provided at two-point intervals. The total score of the ten items ranges from 0 to 60. The higher the score, the more severe.|units on a scale|Mean|32.3|32.3|Standard Deviation|4.6|4.6|||
3874480|NCT01571453|3700472|B3||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
3874481|NCT01571453|3700473|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3874482|NCT01571453|3700474|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3874483|NCT01571453|3700472|B3||Female|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
3874484|NCT01571453|3700473|B2||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3874485|NCT01571453|3700474|B1||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3874486|NCT01571453|3700472|B3|||Age||years|Mean|40.1|40.1|Standard Deviation|12.3|12.3|||
3874487|NCT01571453|3700473|B2|||Age||years|Mean|40.7|40.7|Standard Deviation|12.3|12.3|||
3874488|NCT01571453|3700474|B1|||Age||years|Mean|39.6|39.6|Standard Deviation|12.4|12.4|||
3874489|NCT01571362|3700491|B1||Male|Sex: Female, Male|Gender|Participants|Count of Participants|177|177.0||||||
3874490|NCT01571362|3700491|B1||Female|Sex: Female, Male|Gender|Participants|Count of Participants|233|233.0||||||
3874491|NCT01571362|3700491|B1|>=65 years||Age, Customized|Age measure using NLM-defined categories.|Participants|Number|46|46.0||||||
3874492|NCT01571362|3700491|B1|Between 18 and 65 years||Age, Customized|Age measure using NLM-defined categories.|Participants|Number|364|364.0||||||
3874493|NCT01571284|3700663|B1|Missing||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|ECOG PS is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|Participants|Count of Participants|3|3.0||||||
3874494|NCT01571284|3700663|B1|1||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|ECOG PS is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|Participants|Count of Participants|292|292.0||||||
3874550|NCT01570634|3700745|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3874551|NCT01570634|3700745|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3874495|NCT01571284|3700663|B1|0||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|ECOG PS is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|Participants|Count of Participants|484|484.0||||||
3874496|NCT01571284|3700663|B1|>1||Organs with Metastases at Baseline||Participants|Count of Participants|421|421.0||||||
3874497|NCT01571284|3700663|B1|1||Organs with Metastases at Baseline||Participants|Count of Participants|358|358.0||||||
3874498|NCT01571284|3700663|B1|Other||Histology||Participants|Count of Participants|1|1.0||||||
3874499|NCT01571284|3700663|B1|Adenocarcinoma||Histology||Participants|Count of Participants|778|778.0||||||
3874500|NCT01571284|3700663|B1|Other||Location of Primary Tumor||Participants|Count of Participants|2|2.0||||||
3874501|NCT01571284|3700663|B1|Rectum||Location of Primary Tumor||Participants|Count of Participants|200|200.0||||||
3874502|NCT01571284|3700663|B1|Recto sigmoid||Location of Primary Tumor||Participants|Count of Participants|171|171.0||||||
3874503|NCT01571284|3700663|B1|Colon||Location of Primary Tumor||Participants|Count of Participants|406|406.0||||||
3874504|NCT01571284|3700663|B1|||Time From Initial Histological Diagnosis till Baseline Visit||Months|Mean|19.1|19.1|Standard Deviation|17.2|17.2|||
3874505|NCT01571284|3700663|B1|||History of Thrombovascular Event and/or Presence of Cardiovascular Risk Factor||Participants|Count of Participants|424|424.0||||||
3874506|NCT01571284|3700663|B1|||Any Relevant Medical/Surgical History|Any relevant medical/surgical history including detailed cardiovascular risk factors and prior vascular events if any.|Participants|Count of Participants|640|640.0||||||
3874507|NCT01571284|3700663|B1|||Diastolic Blood Pressure||mmHg|Mean|76.4|76.4|Standard Deviation|9.0|9.0|||
3874508|NCT01571284|3700663|B1|||Systolic Blood Pressure||mmHg|Mean|126.4|126.4|Standard Deviation|13.4|13.4|||
3874509|NCT01571284|3700663|B1|||Body Surface Area (BSA)||m^2|Mean|1.80|1.8|Standard Deviation|0.23|0.23|||
3874510|NCT01571284|3700663|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3874511|NCT01571284|3700663|B1|American Asian||Race/Ethnicity, Customized||Participants|Count of Participants|121|121.0||||||
3874512|NCT01571284|3700663|B1|Black or African||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3874513|NCT01571284|3700663|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|631|631.0||||||
3874514|NCT01571284|3700663|B1||Male|Sex: Female, Male||Participants|Count of Participants|465|465.0||||||
3874515|NCT01571284|3700663|B1||Female|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
3874516|NCT01571284|3700663|B1|||Age||years|Mean|60.3|60.3|Standard Deviation|11.0|11.0|||
3874517|NCT01571232|3700684|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3874518|NCT01571232|3700685|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3874519|NCT01571232|3700686|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3874520|NCT01571232|3700684|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3874521|NCT01571232|3700685|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3874522|NCT01571232|3700686|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3874523|NCT01571232|3700684|B3|||Age||years|Mean|62.6|62.6|Standard Deviation|1.7|1.7|||
3874524|NCT01571232|3700685|B2|||Age||years|Mean|61.2|61.2|Standard Deviation|2.9|2.9|||
3874525|NCT01571232|3700686|B1|||Age||years|Mean|63.9|63.9|Standard Deviation|1.8|1.8|||
3874526|NCT01570751|3700697|B3|||Fasting plasma glucose (FPG)||mmol/L|Mean|8.0|8.0|Standard Deviation|3.7|3.7|||
3874527|NCT01570751|3700698|B2|||Fasting plasma glucose (FPG)||mmol/L|Mean|8.5|8.5|Standard Deviation|4.1|4.1|||
3874528|NCT01570751|3700699|B1|||Fasting plasma glucose (FPG)||mmol/L|Mean|7.5|7.5|Standard Deviation|3.3|3.3|||
3874529|NCT01570751|3700697|B3|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.2|8.2|Standard Deviation|1.3|1.3|||
3874530|NCT01570751|3700698|B2|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.3|8.3|Standard Deviation|1.4|1.4|||
3874531|NCT01570751|3700699|B1|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.0|8.0|Standard Deviation|1.1|1.1|||
3874532|NCT01570751|3700697|B3||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3874533|NCT01570751|3700698|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3874534|NCT01570751|3700699|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3874535|NCT01570751|3700697|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3874536|NCT01570751|3700698|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3874537|NCT01570751|3700699|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3874538|NCT01570751|3700697|B3|||Age||years|Mean|55.3|55.3|Standard Deviation|9.6|9.6|||
3874539|NCT01570751|3700698|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|9.0|9.0|||
3874540|NCT01570751|3700699|B1|||Age||years|Mean|54.7|54.7|Standard Deviation|10.2|10.2|||
3874541|NCT01570686|3700716|B3||Male|Sex: Female, Male||Participants|Count of Participants|312|312.0||||||
3874542|NCT01570686|3700717|B2||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3874543|NCT01570686|3700718|B1||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3874544|NCT01570686|3700716|B3||Female|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
3874545|NCT01570686|3700717|B2||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3874546|NCT01570686|3700718|B1||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3874547|NCT01570686|3700716|B3|||Age||Years|Mean|55.9|55.9|Standard Deviation|10.73|10.73|||
3874548|NCT01570686|3700717|B2|||Age||Years|Mean|56.1|56.1|Standard Deviation|11.03|11.03|||
3874549|NCT01570686|3700718|B1|||Age||Years|Mean|55.7|55.7|Standard Deviation|10.44|10.44|||
3874552|NCT01570634|3700745|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3874553|NCT01570634|3700745|B1|||Age||years|Mean|66.8|66.8|Standard Deviation|13.8|13.8|||
3874554|NCT01570634|3700745|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3874555|NCT01570634|3700745|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3874556|NCT01570634|3700745|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3874557|NCT01570309|3700753|B3|United States||Region of Enrollment||participants|Number|96|96.0||||||
3874558|NCT01570309|3700754|B2|United States||Region of Enrollment||participants|Number|48|48.0||||||
3874559|NCT01570309|3700755|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
3874560|NCT01570309|3700753|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3874561|NCT01570309|3700754|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3874562|NCT01570309|3700755|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3874563|NCT01570309|3700753|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3874564|NCT01570309|3700754|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3874565|NCT01570309|3700755|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3874566|NCT01570309|3700753|B3|||Age||years|Mean|55.6|55.6|Standard Deviation|10.6|10.6|||
3874567|NCT01570309|3700754|B2|||Age||years|Mean|56.5|56.5|Standard Deviation|11.7|11.7|||
3874568|NCT01570309|3700755|B1|||Age||years|Mean|54.6|54.6|Standard Deviation|9.5|9.5|||
3874569|NCT01570309|3700753|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3874570|NCT01570309|3700754|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3874571|NCT01570309|3700755|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3874572|NCT01570309|3700753|B3||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
3874573|NCT01570309|3700754|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3874574|NCT01570309|3700755|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
3874575|NCT01570309|3700753|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3874576|NCT01570309|3700754|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3874577|NCT01570309|3700755|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3874578|NCT01570244|3700770|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3874579|NCT01570244|3700770|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3874580|NCT01570244|3700770|B1|||Age||years|Mean|28.4|28.4|Standard Deviation|5.1|5.1|||
3874581|NCT01570192|3700790|B3|||Baseline acute physiology and chronic health evaluation II (APACHE II) score|A severity of disease classification system applied within 24 hours of patient admission to an ICU. The point score is calculated from a patient's age and physiological measurements. The range of score is between 0-71. Physiological measurements and all ages fit into that range. Note: the higher the score, the higher the probability of death.|units on a scale|Mean|21.5|21.5|Standard Deviation|5.8|5.8|||
3874582|NCT01570192|3700791|B2|||Baseline acute physiology and chronic health evaluation II (APACHE II) score|A severity of disease classification system applied within 24 hours of patient admission to an ICU. The point score is calculated from a patient's age and physiological measurements. The range of score is between 0-71. Physiological measurements and all ages fit into that range. Note: the higher the score, the higher the probability of death.|units on a scale|Mean|21.0|21.0|Standard Deviation|6.2|6.2|||
3874583|NCT01570192|3700792|B1|||Baseline acute physiology and chronic health evaluation II (APACHE II) score|A severity of disease classification system applied within 24 hours of patient admission to an ICU. The point score is calculated from a patient's age and physiological measurements. The range of score is between 0-71. Physiological measurements and all ages fit into that range. Note: the higher the score, the higher the probability of death.|units on a scale|Mean|22.6|22.6|Standard Deviation|4.6|4.6|||
3874584|NCT01570192|3700790|B3|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3874585|NCT01570192|3700791|B2|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3874586|NCT01570192|3700792|B1|Spain||Region of Enrollment||participants|Number|0|0.0||||||
3874587|NCT01570192|3700790|B3|France||Region of Enrollment||participants|Number|13|13.0||||||
3874588|NCT01570192|3700791|B2|France||Region of Enrollment||participants|Number|11|11.0||||||
3874589|NCT01570192|3700792|B1|France||Region of Enrollment||participants|Number|2|2.0||||||
3874590|NCT01570192|3700790|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
3874591|NCT01570192|3700791|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
3874592|NCT01570192|3700792|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3874593|NCT01570192|3700790|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3874594|NCT01570192|3700791|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3874595|NCT01570192|3700792|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3874596|NCT01570192|3700790|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3874597|NCT01570192|3700791|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3874598|NCT01570192|3700792|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3874599|NCT01570192|3700790|B3|||Age||years|Mean|59.2|59.2|Standard Deviation|14.4|14.4|||
3874600|NCT01570192|3700791|B2|||Age||years|Mean|58.4|58.4|Standard Deviation|12.6|12.6|||
3874601|NCT01570192|3700792|B1|||Age||years|Mean|61.2|61.2|Standard Deviation|18.3|18.3|||
3874602|NCT01570192|3700790|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3874603|NCT01570192|3700791|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3874604|NCT01570192|3700792|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3874605|NCT01570192|3700790|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3874606|NCT01570192|3700791|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3874607|NCT01570192|3700792|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3874608|NCT01570192|3700790|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3874609|NCT01570192|3700791|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3874610|NCT01570192|3700792|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3874611|NCT01569841|3700831|B1|||Glycosylated Haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|7.1|7.1|Standard Deviation|0.6|0.6|||
3874612|NCT01569841|3700831|B1|||Fasting Plasma Glucose (FPG)||mmol/L|Mean|10.7|10.7|Standard Deviation|3.4|3.4|||
3874613|NCT01569841|3700831|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3874614|NCT01569841|3700831|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3874615|NCT01569841|3700831|B1|||Age||years|Mean|45.3|45.3|Standard Deviation|14.9|14.9|||
3874616|NCT01569828|3700848|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3874617|NCT01569828|3700849|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3874618|NCT01569828|3700850|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3874619|NCT01569828|3700848|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3874620|NCT01569828|3700849|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3874621|NCT01569828|3700850|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3874622|NCT01569828|3700848|B3|||Age||years|Mean|53.2|53.2|Standard Deviation|7.07|7.07|||
3874623|NCT01569828|3700849|B2|||Age||years|Mean|52.5|52.5|Standard Deviation|6.98|6.98|||
3874624|NCT01569828|3700850|B1|||Age||years|Mean|53.8|53.8|Standard Deviation|7.76|7.76|||
3874625|NCT01569815|3700869|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874626|NCT01569815|3700870|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874627|NCT01569815|3700871|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874628|NCT01569815|3700872|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874629|NCT01569815|3700873|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874630|NCT01569815|3700869|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874631|NCT01569815|3700870|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874632|NCT01569815|3700871|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874633|NCT01569815|3700872|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874634|NCT01569815|3700873|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874635|NCT01569815|3700869|B5||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3874636|NCT01569815|3700870|B4||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3874637|NCT01569815|3700871|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3874638|NCT01569815|3700872|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3874639|NCT01569815|3700873|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3874640|NCT01569815|3700869|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874641|NCT01569815|3700870|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874642|NCT01569815|3700871|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874643|NCT01569815|3700872|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874644|NCT01569815|3700873|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874645|NCT01569815|3700869|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874646|NCT01569815|3700870|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874647|NCT01569815|3700871|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874648|NCT01569815|3700872|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874649|NCT01569815|3700873|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874650|NCT01569815|3700869|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874651|NCT01569815|3700870|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874652|NCT01569815|3700871|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874653|NCT01569815|3700872|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874654|NCT01569815|3700873|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874655|NCT01569815|3700869|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874656|NCT01569815|3700870|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874657|NCT01569815|3700871|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874658|NCT01569815|3700872|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874659|NCT01569815|3700873|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874660|NCT01569815|3700869|B5||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3874661|NCT01569815|3700870|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3874662|NCT01569815|3700871|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3874663|NCT01569815|3700872|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3874664|NCT01569815|3700873|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3874665|NCT01569815|3700869|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3874666|NCT01569815|3700870|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3874667|NCT01569815|3700871|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3874668|NCT01569815|3700872|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3874669|NCT01569815|3700873|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3874670|NCT01569815|3700869|B5|||Age||years|Mean|52.5|52.5|Standard Deviation|9.72|9.72|||
3874671|NCT01569815|3700870|B4|||Age||years|Mean|53.9|53.9|Standard Deviation|8.95|8.95|||
3874672|NCT01569815|3700871|B3|||Age||years|Mean|54.5|54.5|Standard Deviation|8.33|8.33|||
3874673|NCT01569815|3700872|B2|||Age||years|Mean|50.6|50.6|Standard Deviation|11.70|11.7|||
3874674|NCT01569815|3700873|B1|||Age||years|Mean|51.0|51.0|Standard Deviation|10.88|10.88|||
3874675|NCT01569763|3700919|B3|||Alkaline Hematin Value at Baseline|Alkaline hematin methodology is a quantitative laboratory method used to evaluate the volume of menstrual blood loss, by collecting used sanitary products (tampons and pads) and extracting alkaline hematin from the hemoglobin from menstrual fluids.|Menstrual Blood Loss (ml)|Mean|307.4|307.4|Standard Deviation|170.9|170.9|||
3874676|NCT01569763|3700920|B2|||Alkaline Hematin Value at Baseline|Alkaline hematin methodology is a quantitative laboratory method used to evaluate the volume of menstrual blood loss, by collecting used sanitary products (tampons and pads) and extracting alkaline hematin from the hemoglobin from menstrual fluids.|Menstrual Blood Loss (ml)|Mean|301.8|301.8|Standard Deviation|176.1|176.1|||
3874677|NCT01569763|3700921|B1|||Alkaline Hematin Value at Baseline|Alkaline hematin methodology is a quantitative laboratory method used to evaluate the volume of menstrual blood loss, by collecting used sanitary products (tampons and pads) and extracting alkaline hematin from the hemoglobin from menstrual fluids.|Menstrual Blood Loss (ml)|Mean|310.2|310.2|Standard Deviation|169.0|169.0|||
3874678|NCT01569763|3700919|B3|Mexico||Region of Enrollment||participants|Number|41|41.0||||||
3874679|NCT01569763|3700920|B2|Mexico||Region of Enrollment||participants|Number|13|13.0||||||
3874680|NCT01569763|3700921|B1|Mexico||Region of Enrollment||participants|Number|28|28.0||||||
3874681|NCT01569763|3700919|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
3874682|NCT01569763|3700920|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3874683|NCT01569763|3700921|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3874684|NCT01569763|3700919|B3|Canada||Region of Enrollment||participants|Number|80|80.0||||||
3874685|NCT01569763|3700920|B2|Canada||Region of Enrollment||participants|Number|26|26.0||||||
3874686|NCT01569763|3700921|B1|Canada||Region of Enrollment||participants|Number|54|54.0||||||
3874687|NCT01569763|3700919|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3874688|NCT01569763|3700920|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3874689|NCT01569763|3700921|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3874690|NCT01569763|3700919|B3||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3874691|NCT01569763|3700920|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3874692|NCT01569763|3700921|B1||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3874693|NCT01569763|3700919|B3|||Age||years|Mean|42.5|42.5|Standard Deviation|4.4|4.4|||
3874694|NCT01569763|3700920|B2|||Age||years|Mean|42.5|42.5|Standard Deviation|4.7|4.7|||
3874695|NCT01569763|3700921|B1|||Age||years|Mean|42.6|42.6|Standard Deviation|4.2|4.2|||
3874696|NCT01569607|3700932|B3|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3874697|NCT01569607|3700933|B2|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3874698|NCT01569607|3700934|B1|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3874699|NCT01569607|3700932|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3874700|NCT01569607|3700932|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3874701|NCT01569607|3700933|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3874702|NCT01569607|3700934|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3874703|NCT01569607|3700932|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3874704|NCT01569607|3700933|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3874705|NCT01569607|3700934|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3874706|NCT01569607|3700932|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3874707|NCT01569607|3700933|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3874708|NCT01569607|3700934|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3874709|NCT01569607|3700932|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3874710|NCT01569607|3700933|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3874711|NCT01569607|3700934|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3874712|NCT01569607|3700932|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3874713|NCT01569607|3700933|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3874714|NCT01569607|3700934|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3874715|NCT01569568|3700957|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3874716|NCT01569568|3700958|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3874717|NCT01569568|3700959|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3874718|NCT01569568|3700957|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3874719|NCT01569568|3700958|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3874720|NCT01569568|3700959|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3874721|NCT01569568|3700957|B3|||Age||years|Mean|28.05|28.05|Standard Deviation|17.02|17.02|||
3874722|NCT01569568|3700958|B2|||Age||years|Mean|25.8|25.8|Standard Deviation|14.6|14.6|||
3874723|NCT01569568|3700959|B1|||Age||years|Mean|30.3|30.3|Standard Deviation|19.4|19.4|||
3874724|NCT01569529|3700972|B3|United States||Region of Enrollment||participants|Number|3070|3070.0||||||
3874725|NCT01569529|3700973|B2|United States||Region of Enrollment||participants|Number|394|394.0||||||
3874726|NCT01569529|3700974|B1|United States||Region of Enrollment||participants|Number|2676|2676.0||||||
3874727|NCT01569529|3700972|B3||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3874728|NCT01569529|3700973|B2||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||This is a population internet-based study looking at overall cumulative rates of program enrollment; individual-level data were not collected.
3874729|NCT01569529|3700974|B1||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||This is a population internet-based study looking at overall cumulative rates of program enrollment; individual-level data were not collected.
3874730|NCT01569529|3700972|B3||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3874731|NCT01569529|3700973|B2||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||This is a population internet-based study looking at overall cumulative rates of program enrollment; individual-level data were not collected.
3874732|NCT01569529|3700974|B1||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||This is a population internet-based study looking at overall cumulative rates of program enrollment; individual-level data were not collected.
3874733|NCT01569529|3700972|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3874734|NCT01569529|3700973|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3874735|NCT01569529|3700974|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3874736|NCT01569529|3700972|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3070|3070.0||||||
3874737|NCT01569529|3700973|B2||Between 18 and 65 years|Age||Participants|Count of Participants|394|394.0||||||
3874738|NCT01569529|3700974|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2676|2676.0||||||
3874739|NCT01569529|3700972|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3874740|NCT01569529|3700973|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3874741|NCT01569529|3700974|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3874742|NCT01569464|3700981|B3|||Weight||Kilograms|Mean|80.69|80.69|Standard Deviation|14.40|14.4|||
3874743|NCT01569464|3700982|B2|||Weight||Kilograms|Mean|80.18|80.18|Standard Deviation|12.94|12.94|||
3874744|NCT01569464|3700983|B1|||Weight||Kilograms|Mean|80.93|80.93|Standard Deviation|15.11|15.11|||
3874745|NCT01569464|3700981|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3874746|NCT01569464|3700982|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3874747|NCT01569464|3700983|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3874748|NCT01569464|3700981|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3874749|NCT01569464|3700982|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3874750|NCT01569464|3700983|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3874751|NCT01569464|3700981|B3|||Age||years|Mean|47.9|47.9|Standard Deviation|14.0|14.0|||
3874752|NCT01569464|3700982|B2|||Age||years|Mean|47.9|47.9|Standard Deviation|13.7|13.7|||
3874753|NCT01569464|3700983|B1|||Age||years|Mean|47.9|47.9|Standard Deviation|14.2|14.2|||
3874754|NCT01569464|3700981|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3874755|NCT01569464|3700982|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3874756|NCT01569464|3700983|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3874757|NCT01569464|3700981|B3||Between 18 and 65 years|Age||Participants|Count of Participants|133|133.0||||||
3874758|NCT01569464|3700982|B2||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3874759|NCT01569464|3700983|B1||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
3874760|NCT01569464|3700981|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3874761|NCT01569464|3700982|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3874762|NCT01569464|3700983|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3874763|NCT01569451|3701020|B3|||Number with GEL at baseline||participants|Number|12|12.0||||||
3874764|NCT01569451|3701021|B2|||Number with GEL at baseline||participants|Number|8|8.0||||||
3874765|NCT01569451|3701022|B1|||Number with GEL at baseline||participants|Number|4|4.0||||||
3874766|NCT01569451|3701020|B3|||Mean number of GEL at baseline||lesions|Mean|0.81|0.81|Standard Deviation|2.35|2.35|||
3874767|NCT01569451|3701021|B2|||Mean number of GEL at baseline||lesions|Mean|1.07|1.07|Standard Deviation|2.53|2.53|||
3874768|NCT01569451|3701022|B1|||Mean number of GEL at baseline||lesions|Mean|0.54|0.54|Standard Deviation|2.16|2.16|||
3874769|NCT01569451|3701020|B3|||Expanded Disability Status Scale score at baseline|Physicians assess patients' cerebral, optic, brainstem, pyramidal, sensory, cerebellar, and bowel and bladder neurological symptoms. The physician then subjectively rates the patient on the ordinal EDSS scale. The EDSS scale emphasizes ambulatory ability. The EDSS scale ranges in half integer increments from 0.0 to 10.0. Larger numbers mean more disability, with 0.0 being everything normal and 10.0 being death due to MS.|units on a scale|Mean|2.72|2.72|Standard Deviation|1.67|1.67|||
3874815|NCT01569438|3701050|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874770|NCT01569451|3701021|B2|||Expanded Disability Status Scale score at baseline|Physicians assess patients' cerebral, optic, brainstem, pyramidal, sensory, cerebellar, and bowel and bladder neurological symptoms. The physician then subjectively rates the patient on the ordinal EDSS scale. The EDSS scale emphasizes ambulatory ability. The EDSS scale ranges in half integer increments from 0.0 to 10.0. Larger numbers mean more disability, with 0.0 being everything normal and 10.0 being death due to MS.|units on a scale|Mean|2.80|2.8|Standard Deviation|1.78|1.78|||
3874771|NCT01569451|3701022|B1|||Expanded Disability Status Scale score at baseline|Physicians assess patients' cerebral, optic, brainstem, pyramidal, sensory, cerebellar, and bowel and bladder neurological symptoms. The physician then subjectively rates the patient on the ordinal EDSS scale. The EDSS scale emphasizes ambulatory ability. The EDSS scale ranges in half integer increments from 0.0 to 10.0. Larger numbers mean more disability, with 0.0 being everything normal and 10.0 being death due to MS.|units on a scale|Mean|2.63|2.63|Standard Deviation|1.57|1.57|||
3874772|NCT01569451|3701020|B3|No||Prior treatment with Tysabri (within 6 months)||participants|Number|44|44.0||||||
3874773|NCT01569451|3701021|B2|No||Prior treatment with Tysabri (within 6 months)||participants|Number|22|22.0||||||
3874774|NCT01569451|3701022|B1|No||Prior treatment with Tysabri (within 6 months)||participants|Number|22|22.0||||||
3874775|NCT01569451|3701020|B3|Yes||Prior treatment with Tysabri (within 6 months)||participants|Number|9|9.0||||||
3874776|NCT01569451|3701021|B2|Yes||Prior treatment with Tysabri (within 6 months)||participants|Number|5|5.0||||||
3874777|NCT01569451|3701022|B1|Yes||Prior treatment with Tysabri (within 6 months)||participants|Number|4|4.0||||||
3874778|NCT01569451|3701020|B3|No||Prior treatment with Tysabri||participants|Number|41|41.0||||||
3874779|NCT01569451|3701021|B2|No||Prior treatment with Tysabri||participants|Number|20|20.0||||||
3874780|NCT01569451|3701022|B1|No||Prior treatment with Tysabri||participants|Number|21|21.0||||||
3874781|NCT01569451|3701020|B3|Yes||Prior treatment with Tysabri||participants|Number|12|12.0||||||
3874782|NCT01569451|3701021|B2|Yes||Prior treatment with Tysabri||participants|Number|7|7.0||||||
3874783|NCT01569451|3701022|B1|Yes||Prior treatment with Tysabri||participants|Number|5|5.0||||||
3874784|NCT01569451|3701020|B3|CIS||Type of relapsing MS||participants|Number|4|4.0||||||
3874785|NCT01569451|3701021|B2|CIS||Type of relapsing MS||participants|Number|2|2.0||||||
3874786|NCT01569451|3701022|B1|CIS||Type of relapsing MS||participants|Number|2|2.0||||||
3874787|NCT01569451|3701020|B3|RRMS/SPMS||Type of relapsing MS||participants|Number|49|49.0||||||
3874788|NCT01569451|3701021|B2|RRMS/SPMS||Type of relapsing MS||participants|Number|25|25.0||||||
3874789|NCT01569451|3701022|B1|RRMS/SPMS||Type of relapsing MS||participants|Number|24|24.0||||||
3874790|NCT01569451|3701020|B3|Unknown||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3874791|NCT01569451|3701021|B2|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3874792|NCT01569451|3701022|B1|Unknown||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3874793|NCT01569451|3701020|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3874794|NCT01569451|3701021|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3874795|NCT01569451|3701022|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3874796|NCT01569451|3701020|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
3874797|NCT01569451|3701021|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3874798|NCT01569451|3701022|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3874799|NCT01569451|3701020|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3874800|NCT01569451|3701021|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3874801|NCT01569451|3701022|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3874802|NCT01569451|3701020|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3874803|NCT01569451|3701021|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3874804|NCT01569451|3701022|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3874805|NCT01569451|3701020|B3|||Age||years|Mean|36.55|36.55|Standard Deviation|8.65|8.65|||
3874806|NCT01569451|3701021|B2|||Age||years|Mean|36.46|36.46|Standard Deviation|8.31|8.31|||
3874807|NCT01569451|3701022|B1|||Age||years|Mean|36.64|36.64|Standard Deviation|9.15|9.15|||
3874808|NCT01569438|3701049|B3|||Numeric Pain Rating Scale (NPRS)|Subjects were instructed to select a number between 0 and 10 where 0 is no pain and 10 is the worst pain possible. The scale was completed by telephone (an interactive voice response system [IVRS]) every evening before bedtime. In order to qualify for study entry, subjects must have had an average score of >=4 and <10 during the baseline assessment phase.|units on a scale|Mean|6.3|6.3|Standard Deviation|1.28|1.28|||
3874809|NCT01569438|3701050|B2|||Numeric Pain Rating Scale (NPRS)|Subjects were instructed to select a number between 0 and 10 where 0 is no pain and 10 is the worst pain possible. The scale was completed by telephone (an interactive voice response system [IVRS]) every evening before bedtime. In order to qualify for study entry, subjects must have had an average score of >=4 and <10 during the baseline assessment phase.|units on a scale|Mean|6.4|6.4|Standard Deviation|1.12|1.12|||
3874810|NCT01569438|3701051|B1|||Numeric Pain Rating Scale (NPRS)|Subjects were instructed to select a number between 0 and 10 where 0 is no pain and 10 is the worst pain possible. The scale was completed by telephone (an interactive voice response system [IVRS]) every evening before bedtime. In order to qualify for study entry, subjects must have had an average score of >=4 and <10 during the baseline assessment phase.|units on a scale|Mean|6.2|6.2|Standard Deviation|1.44|1.44|||
3874811|NCT01569438|3701049|B3|United States||Region of Enrollment||participants|Number|74|74.0||||||
3874812|NCT01569438|3701050|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
3874813|NCT01569438|3701051|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
3874814|NCT01569438|3701049|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3874816|NCT01569438|3701051|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3874817|NCT01569438|3701049|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874818|NCT01569438|3701050|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874819|NCT01569438|3701051|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874820|NCT01569438|3701049|B3||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3874821|NCT01569438|3701050|B2||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3874822|NCT01569438|3701051|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3874823|NCT01569438|3701049|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3874824|NCT01569438|3701050|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3874825|NCT01569438|3701051|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3874826|NCT01569438|3701049|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874827|NCT01569438|3701050|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874828|NCT01569438|3701051|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874829|NCT01569438|3701049|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874830|NCT01569438|3701050|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874831|NCT01569438|3701051|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874832|NCT01569438|3701049|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3874833|NCT01569438|3701050|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874834|NCT01569438|3701051|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3874835|NCT01569438|3701049|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874836|NCT01569438|3701050|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874837|NCT01569438|3701051|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874838|NCT01569438|3701049|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3874839|NCT01569438|3701050|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3874840|NCT01569438|3701051|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3874841|NCT01569438|3701049|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3874842|NCT01569438|3701050|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3874843|NCT01569438|3701051|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3874844|NCT01569438|3701049|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3874845|NCT01569438|3701050|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3874846|NCT01569438|3701051|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3874847|NCT01569438|3701049|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3874848|NCT01569438|3701050|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3874849|NCT01569438|3701051|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3874850|NCT01569438|3701049|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3874851|NCT01569438|3701050|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3874852|NCT01569438|3701051|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3874853|NCT01569438|3701049|B3||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
3874854|NCT01569438|3701050|B2||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3874855|NCT01569438|3701051|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3874856|NCT01569438|3701049|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3874857|NCT01569438|3701050|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3874858|NCT01569438|3701051|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3874859|NCT01569295|3701064|B3|New Zealand||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3874860|NCT01569295|3701065|B2|New Zealand||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3874861|NCT01569295|3701066|B1|New Zealand||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3874862|NCT01569295|3701064|B3|Croatia||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3874863|NCT01569295|3701065|B2|Croatia||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3874864|NCT01569295|3701066|B1|Croatia||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3874865|NCT01569295|3701064|B3|France||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3874866|NCT01569295|3701065|B2|France||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3874867|NCT01569295|3701066|B1|France||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3874868|NCT01569295|3701064|B3|Australia||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3874869|NCT01569295|3701065|B2|Australia||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3874870|NCT01569295|3701066|B1|Australia||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3874871|NCT01569295|3701064|B3|Italy||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3874872|NCT01569295|3701065|B2|Italy||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3874873|NCT01569295|3701066|B1|Italy||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3874874|NCT01569295|3701064|B3|Poland||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3874875|NCT01569295|3701065|B2|Poland||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3874876|NCT01569295|3701066|B1|Poland||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3874877|NCT01569295|3701064|B3|Ireland||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3874878|NCT01569295|3701065|B2|Ireland||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3874879|NCT01569295|3701066|B1|Ireland||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3874880|NCT01569295|3701064|B3|Belgium||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3874881|NCT01569295|3701065|B2|Belgium||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3874882|NCT01569295|3701066|B1|Belgium||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3874883|NCT01569295|3701064|B3|Turkey||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3874884|NCT01569295|3701065|B2|Turkey||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3874885|NCT01569295|3701066|B1|Turkey||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3874886|NCT01569295|3701064|B3|Canada||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3874887|NCT01569295|3701065|B2|Canada||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3874888|NCT01569295|3701066|B1|Canada||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3874889|NCT01569295|3701064|B3|Greece||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3874890|NCT01569295|3701065|B2|Greece||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3874891|NCT01569295|3701066|B1|Greece||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3874892|NCT01569295|3701064|B3|Spain||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3874893|NCT01569295|3701065|B2|Spain||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3874894|NCT01569295|3701066|B1|Spain||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3874895|NCT01569295|3701064|B3|Russia||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3874896|NCT01569295|3701065|B2|Russia||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3874897|NCT01569295|3701066|B1|Russia||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3874898|NCT01569295|3701064|B3|Portugal||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3874899|NCT01569295|3701065|B2|Portugal||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3874900|NCT01569295|3701066|B1|Portugal||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3874901|NCT01569295|3701064|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|56|56.0||||||
3874902|NCT01569295|3701065|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3874903|NCT01569295|3701066|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3874904|NCT01569295|3701064|B3|Czechia||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3874905|NCT01569295|3701065|B2|Czechia||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3874906|NCT01569295|3701066|B1|Czechia||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3874907|NCT01569295|3701064|B3|United States||Region of Enrollment||Participants|Count of Participants|70|70.0||||||
3874908|NCT01569295|3701065|B2|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3874909|NCT01569295|3701066|B1|United States||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3874910|NCT01569295|3701064|B3|Hungary||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3874911|NCT01569295|3701065|B2|Hungary||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3874912|NCT01569295|3701066|B1|Hungary||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3874913|NCT01569295|3701064|B3|Romania||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3874914|NCT01569295|3701065|B2|Romania||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3874915|NCT01569295|3701066|B1|Romania||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3874916|NCT01569295|3701064|B3|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3874917|NCT01569295|3701065|B2|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3874918|NCT01569295|3701066|B1|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3874919|NCT01569295|3701064|B3|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3874920|NCT01569295|3701065|B2|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3874921|NCT01569295|3701066|B1|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3874922|NCT01569295|3701064|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|379|379.0||||||
3874923|NCT01569295|3701065|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|188|188.0||||||
3874924|NCT01569295|3701066|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|191|191.0||||||
3874925|NCT01569295|3701064|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3874926|NCT01569295|3701065|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3874927|NCT01569295|3701066|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3874928|NCT01569295|3701064|B3|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3874929|NCT01569295|3701065|B2|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3874930|NCT01569295|3701066|B1|Not Permitted||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3874931|NCT01569295|3701064|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3874932|NCT01569295|3701065|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3874933|NCT01569295|3701066|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3874934|NCT01569295|3701064|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3874935|NCT01569295|3701065|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3874936|NCT01569295|3701066|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3874937|NCT01569295|3701064|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3874938|NCT01569295|3701065|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3874939|NCT01569295|3701066|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3874940|NCT01569295|3701064|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|377|377.0||||||
3874941|NCT01569295|3701065|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|190|190.0||||||
3874942|NCT01569295|3701066|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|187|187.0||||||
3874943|NCT01569295|3701064|B3||Male|Sex: Female, Male||Participants|Count of Participants|316|316.0||||||
3874944|NCT01569295|3701065|B2||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3874945|NCT01569295|3701066|B1||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3874946|NCT01569295|3701064|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3874947|NCT01569295|3701065|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3874948|NCT01569295|3701066|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3874949|NCT01569295|3701064|B3|||Age||years|Mean|62|62.0|Standard Deviation|9.5|9.5|||
3874950|NCT01569295|3701065|B2|||Age||years|Mean|63|63.0|Standard Deviation|9.8|9.8|||
3874951|NCT01569295|3701066|B1|||Age||years|Mean|62|62.0|Standard Deviation|9.2|9.2|||
3874952|NCT01569191|3701081|B3|United Kingdom||Region of Enrollment||participants|Number|18|18.0||||||
3874953|NCT01569191|3701082|B2|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
3874954|NCT01569191|3701083|B1|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
3874955|NCT01569191|3701081|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3874956|NCT01569191|3701082|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3874957|NCT01569191|3701083|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3874958|NCT01569191|3701081|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3874959|NCT01569191|3701082|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3874960|NCT01569191|3701083|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3874961|NCT01569191|3701081|B3|||Age||years|Mean|29.5|29.5|Standard Deviation|11.0|11.0|||
3874962|NCT01569191|3701082|B2|||Age||years|Mean|29.4|29.4|Standard Deviation|10.7|10.7|||
3874963|NCT01569191|3701083|B1|||Age||years|Mean|29.5|29.5|Standard Deviation|11.0|11.0|||
3874964|NCT01569191|3701081|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3874965|NCT01569191|3701082|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3874966|NCT01569191|3701083|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3874967|NCT01569191|3701081|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3874968|NCT01569191|3701082|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3874969|NCT01569191|3701083|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3874970|NCT01569191|3701081|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3874971|NCT01569191|3701082|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3874972|NCT01569191|3701083|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3874973|NCT01569152|3701102|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3874974|NCT01569152|3701103|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3874975|NCT01569152|3701104|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3874976|NCT01569152|3701102|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3874977|NCT01569152|3701103|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3874978|NCT01569152|3701104|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3874979|NCT01569152|3701102|B3|||Age||Years|Mean|54.9|54.9|Standard Deviation|10.4|10.4|||
3874980|NCT01569152|3701103|B2|||Age||Years|Mean|56.1|56.1|Standard Deviation|11.1|11.1|||
3874981|NCT01569152|3701104|B1|||Age||Years|Mean|53.6|53.6|Standard Deviation|9.5|9.5|||
3874982|NCT01569152|3701102|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3874983|NCT01569152|3701103|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3874984|NCT01569152|3701104|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3874985|NCT01569152|3701102|B3||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
3874986|NCT01569152|3701103|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3874987|NCT01569152|3701104|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3874988|NCT01569152|3701102|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3874989|NCT01569152|3701103|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3874990|NCT01569152|3701104|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3874991|NCT01569126|3701163|B7|CYP2D6 intermediate metabolizers||Cytochrome P450 2D6 (CYP2D6) intermediate and extensive metabolizers|Based upon a laboratory deoxyribonucleic acid (DNA) screening test, participants were identified as having either the CYP2D6 intermediate metabolizer genotype or the CYP2D6 extensive metabolizer genotype. Intermediate metabolizers were individuals who carry 1 functional (normal or decreased allele) and a null or decreased allele. Extensive metabolizers were individuals with 2 fully active enzyme alleles.|participants|Number|28|28.0||||||
3874992|NCT01569126|3701164|B6|CYP2D6 intermediate metabolizers||Cytochrome P450 2D6 (CYP2D6) intermediate and extensive metabolizers|Based upon a laboratory deoxyribonucleic acid (DNA) screening test, participants were identified as having either the CYP2D6 intermediate metabolizer genotype or the CYP2D6 extensive metabolizer genotype. Intermediate metabolizers were individuals who carry 1 functional (normal or decreased allele) and a null or decreased allele. Extensive metabolizers were individuals with 2 fully active enzyme alleles.|participants|Number|6|6.0||||||
3874993|NCT01569126|3701165|B5|CYP2D6 intermediate metabolizers||Cytochrome P450 2D6 (CYP2D6) intermediate and extensive metabolizers|Based upon a laboratory deoxyribonucleic acid (DNA) screening test, participants were identified as having either the CYP2D6 intermediate metabolizer genotype or the CYP2D6 extensive metabolizer genotype. Intermediate metabolizers were individuals who carry 1 functional (normal or decreased allele) and a null or decreased allele. Extensive metabolizers were individuals with 2 fully active enzyme alleles.|participants|Number|6|6.0||||||
3874994|NCT01569126|3701166|B4|CYP2D6 intermediate metabolizers||Cytochrome P450 2D6 (CYP2D6) intermediate and extensive metabolizers|Based upon a laboratory deoxyribonucleic acid (DNA) screening test, participants were identified as having either the CYP2D6 intermediate metabolizer genotype or the CYP2D6 extensive metabolizer genotype. Intermediate metabolizers were individuals who carry 1 functional (normal or decreased allele) and a null or decreased allele. Extensive metabolizers were individuals with 2 fully active enzyme alleles.|participants|Number|4|4.0||||||
3874995|NCT01569126|3701167|B3|CYP2D6 intermediate metabolizers||Cytochrome P450 2D6 (CYP2D6) intermediate and extensive metabolizers|Based upon a laboratory deoxyribonucleic acid (DNA) screening test, participants were identified as having either the CYP2D6 intermediate metabolizer genotype or the CYP2D6 extensive metabolizer genotype. Intermediate metabolizers were individuals who carry 1 functional (normal or decreased allele) and a null or decreased allele. Extensive metabolizers were individuals with 2 fully active enzyme alleles.|participants|Number|4|4.0||||||
3874996|NCT01569126|3701168|B2|CYP2D6 intermediate metabolizers||Cytochrome P450 2D6 (CYP2D6) intermediate and extensive metabolizers|Based upon a laboratory deoxyribonucleic acid (DNA) screening test, participants were identified as having either the CYP2D6 intermediate metabolizer genotype or the CYP2D6 extensive metabolizer genotype. Intermediate metabolizers were individuals who carry 1 functional (normal or decreased allele) and a null or decreased allele. Extensive metabolizers were individuals with 2 fully active enzyme alleles.|participants|Number|4|4.0||||||
3874997|NCT01569126|3701169|B1|CYP2D6 intermediate metabolizers||Cytochrome P450 2D6 (CYP2D6) intermediate and extensive metabolizers|Based upon a laboratory deoxyribonucleic acid (DNA) screening test, participants were identified as having either the CYP2D6 intermediate metabolizer genotype or the CYP2D6 extensive metabolizer genotype. Intermediate metabolizers were individuals who carry 1 functional (normal or decreased allele) and a null or decreased allele. Extensive metabolizers were individuals with 2 fully active enzyme alleles.|participants|Number|4|4.0||||||
3874998|NCT01569126|3701163|B7|CYP2D6 extensive metabolizers||Cytochrome P450 2D6 (CYP2D6) intermediate and extensive metabolizers|Based upon a laboratory deoxyribonucleic acid (DNA) screening test, participants were identified as having either the CYP2D6 intermediate metabolizer genotype or the CYP2D6 extensive metabolizer genotype. Intermediate metabolizers were individuals who carry 1 functional (normal or decreased allele) and a null or decreased allele. Extensive metabolizers were individuals with 2 fully active enzyme alleles.|participants|Number|28|28.0||||||
3874999|NCT01569126|3701164|B6|CYP2D6 extensive metabolizers||Cytochrome P450 2D6 (CYP2D6) intermediate and extensive metabolizers|Based upon a laboratory deoxyribonucleic acid (DNA) screening test, participants were identified as having either the CYP2D6 intermediate metabolizer genotype or the CYP2D6 extensive metabolizer genotype. Intermediate metabolizers were individuals who carry 1 functional (normal or decreased allele) and a null or decreased allele. Extensive metabolizers were individuals with 2 fully active enzyme alleles.|participants|Number|6|6.0||||||
3875000|NCT01569126|3701165|B5|CYP2D6 extensive metabolizers||Cytochrome P450 2D6 (CYP2D6) intermediate and extensive metabolizers|Based upon a laboratory deoxyribonucleic acid (DNA) screening test, participants were identified as having either the CYP2D6 intermediate metabolizer genotype or the CYP2D6 extensive metabolizer genotype. Intermediate metabolizers were individuals who carry 1 functional (normal or decreased allele) and a null or decreased allele. Extensive metabolizers were individuals with 2 fully active enzyme alleles.|participants|Number|6|6.0||||||
3875001|NCT01569126|3701166|B4|CYP2D6 extensive metabolizers||Cytochrome P450 2D6 (CYP2D6) intermediate and extensive metabolizers|Based upon a laboratory deoxyribonucleic acid (DNA) screening test, participants were identified as having either the CYP2D6 intermediate metabolizer genotype or the CYP2D6 extensive metabolizer genotype. Intermediate metabolizers were individuals who carry 1 functional (normal or decreased allele) and a null or decreased allele. Extensive metabolizers were individuals with 2 fully active enzyme alleles.|participants|Number|4|4.0||||||
3875002|NCT01569126|3701167|B3|CYP2D6 extensive metabolizers||Cytochrome P450 2D6 (CYP2D6) intermediate and extensive metabolizers|Based upon a laboratory deoxyribonucleic acid (DNA) screening test, participants were identified as having either the CYP2D6 intermediate metabolizer genotype or the CYP2D6 extensive metabolizer genotype. Intermediate metabolizers were individuals who carry 1 functional (normal or decreased allele) and a null or decreased allele. Extensive metabolizers were individuals with 2 fully active enzyme alleles.|participants|Number|4|4.0||||||
3875003|NCT01569126|3701168|B2|CYP2D6 extensive metabolizers||Cytochrome P450 2D6 (CYP2D6) intermediate and extensive metabolizers|Based upon a laboratory deoxyribonucleic acid (DNA) screening test, participants were identified as having either the CYP2D6 intermediate metabolizer genotype or the CYP2D6 extensive metabolizer genotype. Intermediate metabolizers were individuals who carry 1 functional (normal or decreased allele) and a null or decreased allele. Extensive metabolizers were individuals with 2 fully active enzyme alleles.|participants|Number|4|4.0||||||
3875063|NCT01569087|3701212|B1|2+||HER2 expression||participants|Number|3|3.0||||||
3875064|NCT01569087|3701209|B4|1+||HER2 expression||participants|Number|12|12.0||||||
3875004|NCT01569126|3701169|B1|CYP2D6 extensive metabolizers||Cytochrome P450 2D6 (CYP2D6) intermediate and extensive metabolizers|Based upon a laboratory deoxyribonucleic acid (DNA) screening test, participants were identified as having either the CYP2D6 intermediate metabolizer genotype or the CYP2D6 extensive metabolizer genotype. Intermediate metabolizers were individuals who carry 1 functional (normal or decreased allele) and a null or decreased allele. Extensive metabolizers were individuals with 2 fully active enzyme alleles.|participants|Number|4|4.0||||||
3875005|NCT01569126|3701163|B7|Japan||Region of Enrollment||participants|Number|56|56.0||||||
3875006|NCT01569126|3701164|B6|Japan||Region of Enrollment||participants|Number|12|12.0||||||
3875007|NCT01569126|3701165|B5|Japan||Region of Enrollment||participants|Number|12|12.0||||||
3875008|NCT01569126|3701166|B4|Japan||Region of Enrollment||participants|Number|8|8.0||||||
3875009|NCT01569126|3701167|B3|Japan||Region of Enrollment||participants|Number|8|8.0||||||
3875010|NCT01569126|3701168|B2|Japan||Region of Enrollment||participants|Number|8|8.0||||||
3875011|NCT01569126|3701169|B1|Japan||Region of Enrollment||participants|Number|8|8.0||||||
3875012|NCT01569126|3701163|B7|Japanese||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
3875013|NCT01569126|3701164|B6|Japanese||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3875014|NCT01569126|3701165|B5|Japanese||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3875015|NCT01569126|3701166|B4|Japanese||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3875016|NCT01569126|3701167|B3|Japanese||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3875017|NCT01569126|3701168|B2|Japanese||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3875018|NCT01569126|3701169|B1|Japanese||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3875019|NCT01569126|3701163|B7||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3875020|NCT01569126|3701164|B6||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3875021|NCT01569126|3701165|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3875022|NCT01569126|3701166|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3875023|NCT01569126|3701167|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3875024|NCT01569126|3701168|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3875025|NCT01569126|3701169|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3875026|NCT01569126|3701163|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3875027|NCT01569126|3701164|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3875028|NCT01569126|3701165|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3875029|NCT01569126|3701166|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3875030|NCT01569126|3701167|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3875031|NCT01569126|3701168|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3875032|NCT01569126|3701169|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3875033|NCT01569126|3701163|B7|||Age||years|Mean|26.6|26.6|Standard Deviation|4.9|4.9|||
3875034|NCT01569126|3701164|B6|||Age||years|Mean|28.7|28.7|Standard Deviation|6.2|6.2|||
3875035|NCT01569126|3701165|B5|||Age||years|Mean|25.8|25.8|Standard Deviation|6.3|6.3|||
3875036|NCT01569126|3701166|B4|||Age||years|Mean|27.1|27.1|Standard Deviation|4.4|4.4|||
3875037|NCT01569126|3701167|B3|||Age||years|Mean|24.6|24.6|Standard Deviation|2.4|2.4|||
3875038|NCT01569126|3701168|B2|||Age||years|Mean|25.8|25.8|Standard Deviation|2.4|2.4|||
3875039|NCT01569126|3701169|B1|||Age||years|Mean|27.1|27.1|Standard Deviation|4.4|4.4|||
3875040|NCT01569087|3701209|B4|no||History previous therapy of breast cancer||participants|Number|46|46.0||||||
3875041|NCT01569087|3701210|B3|no||History previous therapy of breast cancer||participants|Number|15|15.0||||||
3875042|NCT01569087|3701211|B2|no||History previous therapy of breast cancer||participants|Number|15|15.0||||||
3875043|NCT01569087|3701212|B1|no||History previous therapy of breast cancer||participants|Number|16|16.0||||||
3875044|NCT01569087|3701209|B4|yes||History previous therapy of breast cancer||participants|Number|14|14.0||||||
3875045|NCT01569087|3701210|B3|yes||History previous therapy of breast cancer||participants|Number|4|4.0||||||
3875046|NCT01569087|3701211|B2|yes||History previous therapy of breast cancer||participants|Number|5|5.0||||||
3875047|NCT01569087|3701212|B1|yes||History previous therapy of breast cancer||participants|Number|5|5.0||||||
3875048|NCT01569087|3701209|B4|no data||HER2 expression||participants|Number|2|2.0||||||
3875049|NCT01569087|3701210|B3|no data||HER2 expression||participants|Number|0|0.0||||||
3875050|NCT01569087|3701211|B2|no data||HER2 expression||participants|Number|1|1.0||||||
3875051|NCT01569087|3701212|B1|no data||HER2 expression||participants|Number|1|1.0||||||
3875052|NCT01569087|3701209|B4|deficiency HER2 expression||HER2 expression||participants|Number|19|19.0||||||
3875053|NCT01569087|3701210|B3|deficiency HER2 expression||HER2 expression||participants|Number|5|5.0||||||
3875054|NCT01569087|3701211|B2|deficiency HER2 expression||HER2 expression||participants|Number|9|9.0||||||
3875055|NCT01569087|3701212|B1|deficiency HER2 expression||HER2 expression||participants|Number|5|5.0||||||
3875056|NCT01569087|3701209|B4|3+||HER2 expression||participants|Number|17|17.0||||||
3875057|NCT01569087|3701210|B3|3+||HER2 expression||participants|Number|8|8.0||||||
3875058|NCT01569087|3701211|B2|3+||HER2 expression||participants|Number|3|3.0||||||
3875059|NCT01569087|3701212|B1|3+||HER2 expression||participants|Number|6|6.0||||||
3875060|NCT01569087|3701209|B4|2+||HER2 expression||participants|Number|10|10.0||||||
3875061|NCT01569087|3701210|B3|2+||HER2 expression||participants|Number|3|3.0||||||
3875062|NCT01569087|3701211|B2|2+||HER2 expression||participants|Number|4|4.0||||||
3875065|NCT01569087|3701210|B3|1+||HER2 expression||participants|Number|3|3.0||||||
3875066|NCT01569087|3701211|B2|1+||HER2 expression||participants|Number|3|3.0||||||
3875067|NCT01569087|3701212|B1|1+||HER2 expression||participants|Number|6|6.0||||||
3875068|NCT01569087|3701209|B4|no data||Expression of hormone receptors||participants|Number|3|3.0||||||
3875069|NCT01569087|3701210|B3|no data||Expression of hormone receptors||participants|Number|1|1.0||||||
3875070|NCT01569087|3701211|B2|no data||Expression of hormone receptors||participants|Number|1|1.0||||||
3875071|NCT01569087|3701212|B1|no data||Expression of hormone receptors||participants|Number|1|1.0||||||
3875072|NCT01569087|3701209|B4|deficiency estrogen and progesterone receptors||Expression of hormone receptors||participants|Number|27|27.0||||||
3875073|NCT01569087|3701210|B3|deficiency estrogen and progesterone receptors||Expression of hormone receptors||participants|Number|9|9.0||||||
3875074|NCT01569087|3701211|B2|deficiency estrogen and progesterone receptors||Expression of hormone receptors||participants|Number|9|9.0||||||
3875075|NCT01569087|3701212|B1|deficiency estrogen and progesterone receptors||Expression of hormone receptors||participants|Number|9|9.0||||||
3875076|NCT01569087|3701209|B4|estrogen and progesterone receptors||Expression of hormone receptors||participants|Number|24|24.0||||||
3875077|NCT01569087|3701210|B3|estrogen and progesterone receptors||Expression of hormone receptors||participants|Number|7|7.0||||||
3875078|NCT01569087|3701211|B2|estrogen and progesterone receptors||Expression of hormone receptors||participants|Number|10|10.0||||||
3875079|NCT01569087|3701212|B1|estrogen and progesterone receptors||Expression of hormone receptors||participants|Number|7|7.0||||||
3875080|NCT01569087|3701209|B4|estrogen receptors||Expression of hormone receptors||participants|Number|6|6.0||||||
3875081|NCT01569087|3701210|B3|estrogen receptors||Expression of hormone receptors||participants|Number|2|2.0||||||
3875082|NCT01569087|3701211|B2|estrogen receptors||Expression of hormone receptors||participants|Number|0|0.0||||||
3875083|NCT01569087|3701212|B1|estrogen receptors||Expression of hormone receptors||participants|Number|4|4.0||||||
3875084|NCT01569087|3701209|B4|no data||Histologic type of a breast cancer||participants|Number|13|13.0||||||
3875085|NCT01569087|3701210|B3|no data||Histologic type of a breast cancer||participants|Number|4|4.0||||||
3875086|NCT01569087|3701211|B2|no data||Histologic type of a breast cancer||participants|Number|6|6.0||||||
3875087|NCT01569087|3701212|B1|no data||Histologic type of a breast cancer||participants|Number|3|3.0||||||
3875088|NCT01569087|3701209|B4|medullar||Histologic type of a breast cancer||participants|Number|2|2.0||||||
3875089|NCT01569087|3701210|B3|medullar||Histologic type of a breast cancer||participants|Number|0|0.0||||||
3875090|NCT01569087|3701211|B2|medullar||Histologic type of a breast cancer||participants|Number|0|0.0||||||
3875091|NCT01569087|3701212|B1|medullar||Histologic type of a breast cancer||participants|Number|2|2.0||||||
3875092|NCT01569087|3701209|B4|ductal/lobular||Histologic type of a breast cancer||participants|Number|1|1.0||||||
3875093|NCT01569087|3701210|B3|ductal/lobular||Histologic type of a breast cancer||participants|Number|0|0.0||||||
3875094|NCT01569087|3701211|B2|ductal/lobular||Histologic type of a breast cancer||participants|Number|0|0.0||||||
3875095|NCT01569087|3701212|B1|ductal/lobular||Histologic type of a breast cancer||participants|Number|1|1.0||||||
3875096|NCT01569087|3701209|B4|lobular||Histologic type of a breast cancer||participants|Number|3|3.0||||||
3875097|NCT01569087|3701210|B3|lobular||Histologic type of a breast cancer||participants|Number|0|0.0||||||
3875098|NCT01569087|3701211|B2|lobular||Histologic type of a breast cancer||participants|Number|3|3.0||||||
3875099|NCT01569087|3701212|B1|lobular||Histologic type of a breast cancer||participants|Number|0|0.0||||||
3875100|NCT01569087|3701209|B4|ductal||Histologic type of a breast cancer||participants|Number|41|41.0||||||
3875101|NCT01569087|3701210|B3|ductal||Histologic type of a breast cancer||participants|Number|15|15.0||||||
3875102|NCT01569087|3701211|B2|ductal||Histologic type of a breast cancer||participants|Number|11|11.0||||||
3875103|NCT01569087|3701212|B1|ductal||Histologic type of a breast cancer||participants|Number|15|15.0||||||
3875104|NCT01569087|3701209|B4|||Duration of a disease||months|Median|0.65|0.65|Inter-Quartile Range|||0.33|1.58|
3875105|NCT01569087|3701210|B3|||Duration of a disease||months|Median|0.5|0.5|Inter-Quartile Range|||0.2|1.0|
3875106|NCT01569087|3701211|B2|||Duration of a disease||months|Median|0.6|0.6|Inter-Quartile Range|||0.3|2.5|
3875107|NCT01569087|3701212|B1|||Duration of a disease||months|Median|0.8|0.8|Inter-Quartile Range|||0.4|5.8|
3875108|NCT01569087|3701209|B4|Russian Federation||Region of Enrollment||participants|Number|60|60.0||||||
3875109|NCT01569087|3701210|B3|Russian Federation||Region of Enrollment||participants|Number|19|19.0||||||
3875110|NCT01569087|3701211|B2|Russian Federation||Region of Enrollment||participants|Number|20|20.0||||||
3875111|NCT01569087|3701212|B1|Russian Federation||Region of Enrollment||participants|Number|21|21.0||||||
3875112|NCT01569087|3701209|B4||Male|Gender||Participants|Count of Participants|0|0.0||||||
3875113|NCT01569087|3701210|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3875114|NCT01569087|3701211|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3875115|NCT01569087|3701212|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3875116|NCT01569087|3701209|B4||Female|Gender||Participants|Count of Participants|60|60.0||||||
3875117|NCT01569087|3701210|B3||Female|Gender||Participants|Count of Participants|19|19.0||||||
3875118|NCT01569087|3701211|B2||Female|Gender||Participants|Count of Participants|20|20.0||||||
3875119|NCT01569087|3701212|B1||Female|Gender||Participants|Count of Participants|21|21.0||||||
3875120|NCT01569087|3701209|B4|||Age||years|Median|53.5|53.5|Inter-Quartile Range|||46.5|57.1|
3875121|NCT01569087|3701210|B3|||Age||years|Median|48.7|48.7|Inter-Quartile Range|||46.3|54.8|
3875122|NCT01569087|3701211|B2|||Age||years|Median|53.5|53.5|Inter-Quartile Range|||48.6|57.7|
3875123|NCT01569087|3701212|B1|||Age||years|Median|54.0|54.0|Inter-Quartile Range|||45.9|58.8|
3875124|NCT01569087|3701209|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3875125|NCT01569087|3701210|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3875126|NCT01569087|3701211|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3875127|NCT01569087|3701212|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3875128|NCT01569087|3701209|B4||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3875129|NCT01569087|3701210|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3875130|NCT01569087|3701211|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3875131|NCT01569087|3701212|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3875132|NCT01569087|3701209|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3875133|NCT01569087|3701210|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3875134|NCT01569087|3701211|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3875135|NCT01569087|3701212|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3875136|NCT01569074|3701237|B6|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3875137|NCT01569074|3701238|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3875138|NCT01569074|3701239|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3875139|NCT01569074|3701240|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3875140|NCT01569074|3701241|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3875141|NCT01569074|3701242|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3875142|NCT01569074|3701237|B6|Indian or Pakistani||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3875143|NCT01569074|3701238|B5|Indian or Pakistani||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3875144|NCT01569074|3701239|B4|Indian or Pakistani||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3875145|NCT01569074|3701240|B3|Indian or Pakistani||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3875146|NCT01569074|3701241|B2|Indian or Pakistani||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3875147|NCT01569074|3701242|B1|Indian or Pakistani||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3875148|NCT01569074|3701237|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3875149|NCT01569074|3701238|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3875150|NCT01569074|3701239|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3875151|NCT01569074|3701240|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3875152|NCT01569074|3701241|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3875153|NCT01569074|3701242|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3875154|NCT01569074|3701237|B6|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3875155|NCT01569074|3701238|B5|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3875156|NCT01569074|3701239|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3875157|NCT01569074|3701240|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3875158|NCT01569074|3701241|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3875159|NCT01569074|3701242|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3875160|NCT01569074|3701237|B6|White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3875161|NCT01569074|3701238|B5|White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3875162|NCT01569074|3701239|B4|White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3875163|NCT01569074|3701240|B3|White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3875164|NCT01569074|3701241|B2|White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3875165|NCT01569074|3701242|B1|White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3875166|NCT01569074|3701237|B6|Asian||Race/Ethnicity, Customized||Participants|Number|163|163.0||||||
3875167|NCT01569074|3701238|B5|Asian||Race/Ethnicity, Customized||Participants|Number|33|33.0||||||
3875168|NCT01569074|3701239|B4|Asian||Race/Ethnicity, Customized||Participants|Number|33|33.0||||||
3875169|NCT01569074|3701240|B3|Asian||Race/Ethnicity, Customized||Participants|Number|33|33.0||||||
3875170|NCT01569074|3701241|B2|Asian||Race/Ethnicity, Customized||Participants|Number|33|33.0||||||
3875171|NCT01569074|3701242|B1|Asian||Race/Ethnicity, Customized||Participants|Number|31|31.0||||||
3875172|NCT01569074|3701237|B6||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3875173|NCT01569074|3701238|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3875174|NCT01569074|3701239|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3875175|NCT01569074|3701240|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3875176|NCT01569074|3701241|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3875177|NCT01569074|3701242|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3875178|NCT01569074|3701237|B6||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3875179|NCT01569074|3701238|B5||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3875180|NCT01569074|3701239|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3875181|NCT01569074|3701240|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3875182|NCT01569074|3701241|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3875183|NCT01569074|3701242|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3875184|NCT01569074|3701237|B6|||Age||years|Mean|53|53.0|Standard Deviation|11.9|11.9|||
3875185|NCT01569074|3701238|B5|||Age||years|Mean|53|53.0|Standard Deviation|11.3|11.3|||
3875186|NCT01569074|3701239|B4|||Age||years|Mean|50|50.0|Standard Deviation|11.4|11.4|||
3875187|NCT01569074|3701240|B3|||Age||years|Mean|56|56.0|Standard Deviation|11.5|11.5|||
3875188|NCT01569074|3701241|B2|||Age||years|Mean|55|55.0|Standard Deviation|10.4|10.4|||
3875189|NCT01569074|3701242|B1|||Age||years|Mean|51|51.0|Standard Deviation|14.3|14.3|||
3875190|NCT01569022|3701302|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875191|NCT01569022|3701302|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875192|NCT01569022|3701302|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3875193|NCT01569022|3701302|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3875194|NCT01569022|3701302|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875195|NCT01569022|3701302|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875196|NCT01569022|3701302|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875197|NCT01569022|3701302|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3875198|NCT01569022|3701302|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3875199|NCT01569022|3701302|B1|||Age||years|Mean|52.7|52.7|Standard Deviation|11.6|11.6|||
3875200|NCT01568905|3701315|B4|||Cigarettes per day||Cigarettes per day|Mean|17.2|17.2|Standard Deviation|4.4|4.4|||
3875201|NCT01568905|3701316|B3|||Cigarettes per day||Cigarettes per day|Mean|18.7|18.7|Standard Deviation|4.3|4.3|||
3875202|NCT01568905|3701317|B2|||Cigarettes per day||Cigarettes per day|Mean|16.1|16.1|Standard Deviation|3.5|3.5|||
3875203|NCT01568905|3701318|B1|||Cigarettes per day||Cigarettes per day|Mean|16.8|16.8|Standard Deviation|5.1|5.1|||
3875204|NCT01568905|3701315|B4|Non Menthol||Menthol||participants|Number|24|24.0||||||
3875205|NCT01568905|3701316|B3|Non Menthol||Menthol||participants|Number|8|8.0||||||
3875206|NCT01568905|3701317|B2|Non Menthol||Menthol||participants|Number|8|8.0||||||
3875207|NCT01568905|3701318|B1|Non Menthol||Menthol||participants|Number|8|8.0||||||
3875208|NCT01568905|3701315|B4|Menthol||Menthol||participants|Number|11|11.0||||||
3875209|NCT01568905|3701316|B3|Menthol||Menthol||participants|Number|4|4.0||||||
3875210|NCT01568905|3701317|B2|Menthol||Menthol||participants|Number|3|3.0||||||
3875211|NCT01568905|3701318|B1|Menthol||Menthol||participants|Number|4|4.0||||||
3875212|NCT01568905|3701315|B4|United States||Region of Enrollment||participants|Number|35|35.0||||||
3875213|NCT01568905|3701316|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3875214|NCT01568905|3701317|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3875215|NCT01568905|3701318|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3875216|NCT01568905|3701315|B4||Male|Gender||Participants|Count of Participants|15|15.0||||||
3875217|NCT01568905|3701316|B3||Male|Gender||Participants|Count of Participants|7|7.0||||||
3875218|NCT01568905|3701317|B2||Male|Gender||Participants|Count of Participants|4|4.0||||||
3875219|NCT01568905|3701318|B1||Male|Gender||Participants|Count of Participants|4|4.0||||||
3875220|NCT01568905|3701315|B4||Female|Gender||Participants|Count of Participants|20|20.0||||||
3875221|NCT01568905|3701316|B3||Female|Gender||Participants|Count of Participants|5|5.0||||||
3875222|NCT01568905|3701317|B2||Female|Gender||Participants|Count of Participants|7|7.0||||||
3875223|NCT01568905|3701318|B1||Female|Gender||Participants|Count of Participants|8|8.0||||||
3875224|NCT01568905|3701315|B4|||Age||years|Mean|37.9|37.9|Standard Deviation|11.6|11.6|||
3875225|NCT01568905|3701316|B3|||Age||years|Mean|43.6|43.6|Standard Deviation|9.6|9.6|||
3875226|NCT01568905|3701317|B2|||Age||years|Mean|32.7|32.7|Standard Deviation|10.8|10.8|||
3875227|NCT01568905|3701318|B1|||Age||years|Mean|37.0|37.0|Standard Deviation|12.4|12.4|||
3875228|NCT01568905|3701315|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3875229|NCT01568905|3701316|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3875230|NCT01568905|3701317|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3875231|NCT01568905|3701318|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3875232|NCT01568905|3701315|B4||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3875233|NCT01568905|3701316|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3875234|NCT01568905|3701317|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3875235|NCT01568905|3701318|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3875236|NCT01568905|3701315|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3875237|NCT01568905|3701316|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3875238|NCT01568905|3701317|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3875239|NCT01568905|3701318|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3875240|NCT01568892|3701337|B3||Missing: None of the Available Races Applied|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3875241|NCT01568892|3701338|B2||Missing: None of the Available Races Applied|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3875242|NCT01568892|3701339|B1||Missing: None of the Available Races Applied|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3875340|NCT01568827|3701432|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875243|NCT01568892|3701337|B3||White - White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3875244|NCT01568892|3701338|B2||White - White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3875245|NCT01568892|3701339|B1||White - White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3875246|NCT01568892|3701337|B3||White - Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3875247|NCT01568892|3701338|B2||White - Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3875248|NCT01568892|3701339|B1||White - Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3875249|NCT01568892|3701337|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3875250|NCT01568892|3701338|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3875251|NCT01568892|3701339|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3875252|NCT01568892|3701337|B3||African American/African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3875253|NCT01568892|3701338|B2||African American/African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3875254|NCT01568892|3701339|B1||African American/African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3875255|NCT01568892|3701337|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3875256|NCT01568892|3701338|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3875257|NCT01568892|3701339|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3875258|NCT01568892|3701337|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3875259|NCT01568892|3701338|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3875260|NCT01568892|3701339|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3875261|NCT01568892|3701337|B3|||Age||Years|Mean|48.1|48.1|Standard Deviation|10.04|10.04|||
3875262|NCT01568892|3701338|B2|||Age||Years|Mean|48.6|48.6|Standard Deviation|8.85|8.85|||
3875263|NCT01568892|3701339|B1|||Age||Years|Mean|47.5|47.5|Standard Deviation|11.56|11.56|||
3875264|NCT01568866|3701408|B3||Subcutaneous|Stratification Factor: Route of Bortezomib Administration|The route of bortezomib administration (IV versus SC) was made in accordance with local regulatory approved route of administration. The value for this variable was selected for all participants prior to randomization to treatment group in order to balance the baseline characteristics that led to the choice of the particular route of bortezomib administration between the 2 arms.|Participants|Count of Participants|713|713.0||||||
3875265|NCT01568866|3701409|B2||Subcutaneous|Stratification Factor: Route of Bortezomib Administration|The route of bortezomib administration (IV versus SC) was made in accordance with local regulatory approved route of administration. The value for this variable was selected for all participants prior to randomization to treatment group in order to balance the baseline characteristics that led to the choice of the particular route of bortezomib administration between the 2 arms.|Participants|Count of Participants|356|356.0||||||
3875266|NCT01568866|3701410|B1||Subcutaneous|Stratification Factor: Route of Bortezomib Administration|The route of bortezomib administration (IV versus SC) was made in accordance with local regulatory approved route of administration. The value for this variable was selected for all participants prior to randomization to treatment group in order to balance the baseline characteristics that led to the choice of the particular route of bortezomib administration between the 2 arms.|Participants|Count of Participants|357|357.0||||||
3875267|NCT01568866|3701408|B3||Intravenous|Stratification Factor: Route of Bortezomib Administration|The route of bortezomib administration (IV versus SC) was made in accordance with local regulatory approved route of administration. The value for this variable was selected for all participants prior to randomization to treatment group in order to balance the baseline characteristics that led to the choice of the particular route of bortezomib administration between the 2 arms.|Participants|Count of Participants|216|216.0||||||
3875268|NCT01568866|3701409|B2||Intravenous|Stratification Factor: Route of Bortezomib Administration|The route of bortezomib administration (IV versus SC) was made in accordance with local regulatory approved route of administration. The value for this variable was selected for all participants prior to randomization to treatment group in order to balance the baseline characteristics that led to the choice of the particular route of bortezomib administration between the 2 arms.|Participants|Count of Participants|108|108.0||||||
3875269|NCT01568866|3701410|B1||Intravenous|Stratification Factor: Route of Bortezomib Administration|The route of bortezomib administration (IV versus SC) was made in accordance with local regulatory approved route of administration. The value for this variable was selected for all participants prior to randomization to treatment group in order to balance the baseline characteristics that led to the choice of the particular route of bortezomib administration between the 2 arms.|Participants|Count of Participants|108|108.0||||||
3875270|NCT01568866|3701408|B3||Stage II or III|Stratification Factor: International Staging System (ISS) Stage|"The International Staging System (ISS) for myeloma was published by the International Myeloma Working Group:~Stage I: β2-microglobulin (β2M) < 3.5 mg/L, albumin >= 3.5 g/dL~Stage II: β2M < 3.5 mg/L and albumin < 3.5 g/dL; or β2M 3.5 mg/L - 5.5 mg/L irrespective of the serum albumin~Stage III: β2M ≥ 5.5 mg/L"|Participants|Count of Participants|520|520.0||||||
3875271|NCT01568866|3701409|B2||Stage II or III|Stratification Factor: International Staging System (ISS) Stage|"The International Staging System (ISS) for myeloma was published by the International Myeloma Working Group:~Stage I: β2-microglobulin (β2M) < 3.5 mg/L, albumin >= 3.5 g/dL~Stage II: β2M < 3.5 mg/L and albumin < 3.5 g/dL; or β2M 3.5 mg/L - 5.5 mg/L irrespective of the serum albumin~Stage III: β2M ≥ 5.5 mg/L"|Participants|Count of Participants|259|259.0||||||
3875272|NCT01568866|3701410|B1||Stage II or III|Stratification Factor: International Staging System (ISS) Stage|"The International Staging System (ISS) for myeloma was published by the International Myeloma Working Group:~Stage I: β2-microglobulin (β2M) < 3.5 mg/L, albumin >= 3.5 g/dL~Stage II: β2M < 3.5 mg/L and albumin < 3.5 g/dL; or β2M 3.5 mg/L - 5.5 mg/L irrespective of the serum albumin~Stage III: β2M ≥ 5.5 mg/L"|Participants|Count of Participants|261|261.0||||||
3875273|NCT01568866|3701408|B3||Stage I|Stratification Factor: International Staging System (ISS) Stage|"The International Staging System (ISS) for myeloma was published by the International Myeloma Working Group:~Stage I: β2-microglobulin (β2M) < 3.5 mg/L, albumin >= 3.5 g/dL~Stage II: β2M < 3.5 mg/L and albumin < 3.5 g/dL; or β2M 3.5 mg/L - 5.5 mg/L irrespective of the serum albumin~Stage III: β2M ≥ 5.5 mg/L"|Participants|Count of Participants|409|409.0||||||
3875274|NCT01568866|3701409|B2||Stage I|Stratification Factor: International Staging System (ISS) Stage|"The International Staging System (ISS) for myeloma was published by the International Myeloma Working Group:~Stage I: β2-microglobulin (β2M) < 3.5 mg/L, albumin >= 3.5 g/dL~Stage II: β2M < 3.5 mg/L and albumin < 3.5 g/dL; or β2M 3.5 mg/L - 5.5 mg/L irrespective of the serum albumin~Stage III: β2M ≥ 5.5 mg/L"|Participants|Count of Participants|205|205.0||||||
3875275|NCT01568866|3701410|B1||Stage I|Stratification Factor: International Staging System (ISS) Stage|"The International Staging System (ISS) for myeloma was published by the International Myeloma Working Group:~Stage I: β2-microglobulin (β2M) < 3.5 mg/L, albumin >= 3.5 g/dL~Stage II: β2M < 3.5 mg/L and albumin < 3.5 g/dL; or β2M 3.5 mg/L - 5.5 mg/L irrespective of the serum albumin~Stage III: β2M ≥ 5.5 mg/L"|Participants|Count of Participants|204|204.0||||||
3875276|NCT01568866|3701408|B3||2 or 3 lines|Stratification Factor: Lines of Prior Treatment||Participants|Count of Participants|469|469.0||||||
3875277|NCT01568866|3701409|B2||2 or 3 lines|Stratification Factor: Lines of Prior Treatment||Participants|Count of Participants|233|233.0||||||
3875278|NCT01568866|3701410|B1||2 or 3 lines|Stratification Factor: Lines of Prior Treatment||Participants|Count of Participants|236|236.0||||||
3875279|NCT01568866|3701408|B3||1 line|Stratification Factor: Lines of Prior Treatment||Participants|Count of Participants|460|460.0||||||
3875280|NCT01568866|3701409|B2||1 line|Stratification Factor: Lines of Prior Treatment||Participants|Count of Participants|231|231.0||||||
3875281|NCT01568866|3701410|B1||1 line|Stratification Factor: Lines of Prior Treatment||Participants|Count of Participants|229|229.0||||||
3875282|NCT01568866|3701408|B3||No prior carfilzomib or bortezomib|Stratification Factor: Prior Proteasome Inhibitor Treatment||Participants|Count of Participants|424|424.0||||||
3875283|NCT01568866|3701409|B2||No prior carfilzomib or bortezomib|Stratification Factor: Prior Proteasome Inhibitor Treatment||Participants|Count of Participants|212|212.0||||||
3875284|NCT01568866|3701410|B1||No prior carfilzomib or bortezomib|Stratification Factor: Prior Proteasome Inhibitor Treatment||Participants|Count of Participants|212|212.0||||||
3875285|NCT01568866|3701408|B3||Carfilzomib or bortezomib|Stratification Factor: Prior Proteasome Inhibitor Treatment||Participants|Count of Participants|505|505.0||||||
3875286|NCT01568866|3701409|B2||Carfilzomib or bortezomib|Stratification Factor: Prior Proteasome Inhibitor Treatment||Participants|Count of Participants|252|252.0||||||
3875287|NCT01568866|3701410|B1||Carfilzomib or bortezomib|Stratification Factor: Prior Proteasome Inhibitor Treatment||Participants|Count of Participants|253|253.0||||||
3875288|NCT01568866|3701408|B3||2 (Ambulatory but unable to work)|Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|62|62.0||||||
3875289|NCT01568866|3701409|B2||2 (Ambulatory but unable to work)|Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|32|32.0||||||
3875290|NCT01568866|3701410|B1||2 (Ambulatory but unable to work)|Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|30|30.0||||||
3875291|NCT01568866|3701408|B3||1 (Restrictive but ambulatory)|Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|414|414.0||||||
3875292|NCT01568866|3701409|B2||1 (Restrictive but ambulatory)|Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|211|211.0||||||
3875293|NCT01568866|3701410|B1||1 (Restrictive but ambulatory)|Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|203|203.0||||||
3875341|NCT01568827|3701433|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875342|NCT01568827|3701431|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3875294|NCT01568866|3701408|B3||0 (Fully active)|Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|453|453.0||||||
3875295|NCT01568866|3701409|B2||0 (Fully active)|Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|221|221.0||||||
3875296|NCT01568866|3701410|B1||0 (Fully active)|Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|232|232.0||||||
3875297|NCT01568866|3701408|B3||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3875298|NCT01568866|3701409|B2||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3875299|NCT01568866|3701410|B1||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3875300|NCT01568866|3701408|B3||Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|95|95.0||||||
3875301|NCT01568866|3701409|B2||Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
3875302|NCT01568866|3701410|B1||Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|45|45.0||||||
3875303|NCT01568866|3701408|B3||Native Hawaiian/Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3875304|NCT01568866|3701409|B2||Native Hawaiian/Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3875305|NCT01568866|3701410|B1||Native Hawaiian/Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3875306|NCT01568866|3701408|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|113|113.0||||||
3875307|NCT01568866|3701409|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|56|56.0||||||
3875308|NCT01568866|3701410|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|57|57.0||||||
3875309|NCT01568866|3701408|B3||Black|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3875310|NCT01568866|3701409|B2||Black|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3875311|NCT01568866|3701410|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3875312|NCT01568866|3701408|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|701|701.0||||||
3875313|NCT01568866|3701409|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|348|348.0||||||
3875314|NCT01568866|3701410|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|353|353.0||||||
3875315|NCT01568866|3701408|B3||Male|Sex: Female, Male||Participants|Count of Participants|469|469.0||||||
3875316|NCT01568866|3701409|B2||Male|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
3875317|NCT01568866|3701410|B1||Male|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
3875318|NCT01568866|3701408|B3||Female|Sex: Female, Male||Participants|Count of Participants|460|460.0||||||
3875319|NCT01568866|3701409|B2||Female|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
3875320|NCT01568866|3701410|B1||Female|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
3875321|NCT01568866|3701408|B3||≥ 75 years|Age, Customized||Participants|Count of Participants|143|143.0||||||
3875322|NCT01568866|3701409|B2||≥ 75 years|Age, Customized||Participants|Count of Participants|77|77.0||||||
3875323|NCT01568866|3701410|B1||≥ 75 years|Age, Customized||Participants|Count of Participants|66|66.0||||||
3875324|NCT01568866|3701408|B3||65 -74 years|Age, Customized||Participants|Count of Participants|353|353.0||||||
3875325|NCT01568866|3701409|B2||65 -74 years|Age, Customized||Participants|Count of Participants|164|164.0||||||
3875326|NCT01568866|3701410|B1||65 -74 years|Age, Customized||Participants|Count of Participants|189|189.0||||||
3875327|NCT01568866|3701408|B3||< 65 years|Age, Customized||Participants|Count of Participants|433|433.0||||||
3875328|NCT01568866|3701409|B2||< 65 years|Age, Customized||Participants|Count of Participants|223|223.0||||||
3875329|NCT01568866|3701410|B1||< 65 years|Age, Customized||Participants|Count of Participants|210|210.0||||||
3875330|NCT01568866|3701408|B3|||Age||years|Median|65.0|65.0|Full Range|||30.0|89.0|
3875331|NCT01568866|3701409|B2|||Age||years|Median|65.0|65.0|Full Range|||35.0|89.0|
3875332|NCT01568866|3701410|B1|||Age||years|Median|65.0|65.0|Full Range|||30.0|88.0|
3875333|NCT01568827|3701431|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3875334|NCT01568827|3701432|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3875335|NCT01568827|3701433|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3875336|NCT01568827|3701431|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875337|NCT01568827|3701432|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875338|NCT01568827|3701433|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875339|NCT01568827|3701431|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875343|NCT01568827|3701432|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3875344|NCT01568827|3701433|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3875345|NCT01568827|3701431|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3875346|NCT01568827|3701432|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875347|NCT01568827|3701433|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3875348|NCT01568827|3701431|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875349|NCT01568827|3701432|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875350|NCT01568827|3701433|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875351|NCT01568827|3701431|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875352|NCT01568827|3701432|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875353|NCT01568827|3701433|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875354|NCT01568827|3701431|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875355|NCT01568827|3701432|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875356|NCT01568827|3701433|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875357|NCT01568827|3701431|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3875358|NCT01568827|3701432|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3875359|NCT01568827|3701433|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3875360|NCT01568827|3701431|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3875361|NCT01568827|3701432|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3875362|NCT01568827|3701433|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3875363|NCT01568827|3701431|B3|||Age||years|Mean|64.7|64.7|Standard Deviation|6.9|6.9|||
3875364|NCT01568827|3701432|B2|||Age||years|Mean|64.7|64.7|Standard Deviation|6.9|6.9|||
3875365|NCT01568827|3701433|B1|||Age||years|Mean|64.7|64.7|Standard Deviation|6.9|6.9|||
3875366|NCT01568593|3701440|B3|||Time from the dry eye diagnosis||years|Mean|6.71|6.71|Standard Deviation|6.25|6.25|||
3875367|NCT01568593|3701441|B2|||Time from the dry eye diagnosis||years|Mean|6.2|6.2|Standard Deviation|5.41|5.41|||
3875368|NCT01568593|3701442|B1|||Time from the dry eye diagnosis||years|Mean|7.18|7.18|Standard Deviation|6.98|6.98|||
3875369|NCT01568593|3701440|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3875370|NCT01568593|3701441|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3875371|NCT01568593|3701442|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3875372|NCT01568593|3701440|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3875373|NCT01568593|3701441|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3875374|NCT01568593|3701442|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3875375|NCT01568593|3701440|B3|||Age||years|Mean|62.8|62.8|Standard Deviation|10.6|10.6|||
3875376|NCT01568593|3701441|B2|||Age||years|Mean|63.6|63.6|Standard Deviation|10|10.0|||
3875377|NCT01568593|3701442|B1|||Age||years|Mean|62|62.0|Standard Deviation|11.2|11.2|||
3875378|NCT01568424|3701449|B1|||Total Bilirubin (mg/dl)||mg/dl|Median|1.1|1.1|Full Range|||0.5|6.6|
3875379|NCT01568424|3701449|B1|||Creatinine (mg/dl)||mg/dl|Median|1.4|1.4|Full Range|||0.5|4.6|
3875380|NCT01568424|3701449|B1|||Blood Urea Nitrogen (BUN)||mg/dl|Median|27|27.0|Full Range|||7.0|73.0|
3875381|NCT01568424|3701449|B1|||Central Venous Pressure (CVP)||mmHg|Median|11|11.0|Full Range|||4.0|22.0|
3875382|NCT01568424|3701449|B1|||Mean Arterial Pressure (MAP)||mmHg|Median|72|72.0|Full Range|||59.0|106.0|
3875383|NCT01568424|3701449|B1|||Cardiac Index (CI)||L/min/m^2|Median|2.4|2.4|Full Range|||1.6|3.8|
3875384|NCT01568424|3701449|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3875385|NCT01568424|3701449|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3875386|NCT01568424|3701449|B1|||Age||Years|Mean|53|53.0|Standard Deviation|13.9|13.9|||
3875387|NCT01568112|3701459|B5||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3875388|NCT01568112|3701460|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3875389|NCT01568112|3701461|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3875390|NCT01568112|3701462|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3875391|NCT01568112|3701463|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3875392|NCT01568112|3701459|B5||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3875393|NCT01568112|3701460|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3875394|NCT01568112|3701461|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3875395|NCT01568112|3701462|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3875396|NCT01568112|3701463|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3875397|NCT01568112|3701459|B5|45 to 55 years||Age, Customized||participants|Number|50|50.0||||||
3875398|NCT01568112|3701460|B4|45 to 55 years||Age, Customized||participants|Number|11|11.0||||||
3875399|NCT01568112|3701461|B3|45 to 55 years||Age, Customized||participants|Number|13|13.0||||||
3875400|NCT01568112|3701462|B2|45 to 55 years||Age, Customized||participants|Number|17|17.0||||||
3875401|NCT01568112|3701463|B1|45 to 55 years||Age, Customized||participants|Number|9|9.0||||||
3875402|NCT01568112|3701459|B5|35 to 44 years||Age, Customized||participants|Number|43|43.0||||||
3875403|NCT01568112|3701460|B4|35 to 44 years||Age, Customized||participants|Number|10|10.0||||||
3875404|NCT01568112|3701461|B3|35 to 44 years||Age, Customized||participants|Number|13|13.0||||||
3875405|NCT01568112|3701462|B2|35 to 44 years||Age, Customized||participants|Number|7|7.0||||||
3875406|NCT01568112|3701463|B1|35 to 44 years||Age, Customized||participants|Number|13|13.0||||||
3875407|NCT01568112|3701459|B5|25 to 34 years||Age, Customized||participants|Number|79|79.0||||||
3875408|NCT01568112|3701460|B4|25 to 34 years||Age, Customized||participants|Number|21|21.0||||||
3875409|NCT01568112|3701461|B3|25 to 34 years||Age, Customized||participants|Number|17|17.0||||||
3875410|NCT01568112|3701462|B2|25 to 34 years||Age, Customized||participants|Number|19|19.0||||||
3875411|NCT01568112|3701463|B1|25 to 34 years||Age, Customized||participants|Number|22|22.0||||||
3875412|NCT01568112|3701459|B5|||Age||years|Mean|37.2|37.2|Standard Deviation|9.54|9.54|||
3875413|NCT01568112|3701460|B4|||Age||years|Mean|36.2|36.2|Standard Deviation|9.33|9.33|||
3875414|NCT01568112|3701461|B3|||Age||years|Mean|38.1|38.1|Standard Deviation|10.29|10.29|||
3875415|NCT01568112|3701462|B2|||Age||years|Mean|39.0|39.0|Standard Deviation|9.61|9.61|||
3875416|NCT01568112|3701463|B1|||Age||years|Mean|35.5|35.5|Standard Deviation|8.78|8.78|||
3875417|NCT01568073|3701584|B6||Male|Sex: Female, Male||Participants|Count of Participants|354|354.0||||||
3875418|NCT01568073|3701585|B5||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3875419|NCT01568073|3701586|B4||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3875420|NCT01568073|3701587|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3875421|NCT01568073|3701588|B2||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3875422|NCT01568073|3701589|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3875423|NCT01568073|3701584|B6||Female|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
3875424|NCT01568073|3701585|B5||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3875425|NCT01568073|3701586|B4||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3875426|NCT01568073|3701587|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3875427|NCT01568073|3701588|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3875428|NCT01568073|3701589|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3875429|NCT01568073|3701584|B6|≥70 years||Age, Customized||participants|Number|187|187.0||||||
3875430|NCT01568073|3701585|B5|≥70 years||Age, Customized||participants|Number|35|35.0||||||
3875431|NCT01568073|3701586|B4|≥70 years||Age, Customized||participants|Number|38|38.0||||||
3875432|NCT01568073|3701587|B3|≥70 years||Age, Customized||participants|Number|35|35.0||||||
3875433|NCT01568073|3701588|B2|≥70 years||Age, Customized||participants|Number|38|38.0||||||
3875434|NCT01568073|3701589|B1|≥70 years||Age, Customized||participants|Number|41|41.0||||||
3875435|NCT01568073|3701584|B6|<70 years||Age, Customized||participants|Number|413|413.0||||||
3875436|NCT01568073|3701585|B5|<70 years||Age, Customized||participants|Number|81|81.0||||||
3875437|NCT01568073|3701586|B4|<70 years||Age, Customized||participants|Number|81|81.0||||||
3875438|NCT01568073|3701587|B3|<70 years||Age, Customized||participants|Number|87|87.0||||||
3875439|NCT01568073|3701588|B2|<70 years||Age, Customized||participants|Number|84|84.0||||||
3875440|NCT01568073|3701589|B1|<70 years||Age, Customized||participants|Number|80|80.0||||||
3875441|NCT01568047|3701620|B5||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3875442|NCT01568047|3701621|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3875443|NCT01568047|3701622|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3875444|NCT01568047|3701623|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3875445|NCT01568047|3701624|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3875446|NCT01568047|3701620|B5||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3875447|NCT01568047|3701621|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3875448|NCT01568047|3701622|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3875449|NCT01568047|3701623|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3875450|NCT01568047|3701624|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3875451|NCT01568047|3701620|B5|≥ 88 years||Age, Customized||participants|Number|0|0.0||||||
3875452|NCT01568047|3701621|B4|≥ 88 years||Age, Customized||participants|Number|0|0.0||||||
3875453|NCT01568047|3701622|B3|≥ 88 years||Age, Customized||participants|Number|0|0.0||||||
3875454|NCT01568047|3701623|B2|≥ 88 years||Age, Customized||participants|Number|0|0.0||||||
3875455|NCT01568047|3701624|B1|≥ 88 years||Age, Customized||participants|Number|0|0.0||||||
3875456|NCT01568047|3701620|B5|Between 49 and 88 years||Age, Customized||participants|Number|40|40.0||||||
3875457|NCT01568047|3701621|B4|Between 49 and 88 years||Age, Customized||participants|Number|10|10.0||||||
3875458|NCT01568047|3701622|B3|Between 49 and 88 years||Age, Customized||participants|Number|10|10.0||||||
3875459|NCT01568047|3701623|B2|Between 49 and 88 years||Age, Customized||participants|Number|10|10.0||||||
3875460|NCT01568047|3701624|B1|Between 49 and 88 years||Age, Customized||participants|Number|10|10.0||||||
3875461|NCT01568047|3701620|B5|≤ 49 years||Age, Customized||participants|Number|0|0.0||||||
3875462|NCT01568047|3701621|B4|≤ 49 years||Age, Customized||participants|Number|0|0.0||||||
3875463|NCT01568047|3701622|B3|≤ 49 years||Age, Customized||participants|Number|0|0.0||||||
3875464|NCT01568047|3701623|B2|≤ 49 years||Age, Customized||participants|Number|0|0.0||||||
3875465|NCT01568047|3701624|B1|≤ 49 years||Age, Customized||participants|Number|0|0.0||||||
3875466|NCT01568034|3701645|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3875467|NCT01568034|3701645|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3875468|NCT01568034|3701645|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3875469|NCT01568034|3701645|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3875470|NCT01568034|3701645|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3875471|NCT01568021|3701666|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3875472|NCT01568021|3701666|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3875473|NCT01568021|3701666|B1|> 65 years||Age, Customized||participants|Number|74|74.0||||||
3875474|NCT01568021|3701666|B1|45 to 65 years||Age, Customized||participants|Number|24|24.0||||||
3875475|NCT01568021|3701666|B1|< 45 years||Age, Customized||participants|Number|1|1.0||||||
3875476|NCT01568008|3701672|B1|Missing data||Sex/Gender, Customized||Participants|Number|11|11.0||||||
3875477|NCT01568008|3701672|B1|Female||Sex/Gender, Customized||Participants|Number|480|480.0||||||
3875478|NCT01568008|3701672|B1|Male||Sex/Gender, Customized||Participants|Number|442|442.0||||||
3875479|NCT01568008|3701672|B1|||Age|Age data was not available for 37 patients.|Years|Mean|65.40|65.4|Standard Deviation|11.88|11.88|||
3875480|NCT01567943|3701681|B3|United States||Region of Enrollment||Participants|Count of Participants|79|79.0||||||
3875481|NCT01567943|3701682|B2|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3875482|NCT01567943|3701683|B1|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3875483|NCT01567943|3701681|B3||Male|Gender||Participants|Count of Participants|50|50.0||||||
3875484|NCT01567943|3701682|B2||Male|Gender||Participants|Count of Participants|24|24.0||||||
3875485|NCT01567943|3701683|B1||Male|Gender||Participants|Count of Participants|26|26.0||||||
3875486|NCT01567943|3701681|B3||Female|Gender||Participants|Count of Participants|29|29.0||||||
3875487|NCT01567943|3701682|B2||Female|Gender||Participants|Count of Participants|15|15.0||||||
3875488|NCT01567943|3701683|B1||Female|Gender||Participants|Count of Participants|14|14.0||||||
3875489|NCT01567943|3701681|B3|||Age||years|Mean|45.38|45.38|Standard Deviation|10.24|10.24|||
3875490|NCT01567943|3701682|B2|||Age||years|Mean|46.23|46.23|Standard Deviation|10.55|10.55|||
3875491|NCT01567943|3701683|B1|||Age||years|Mean|44.55|44.55|Standard Deviation|9.92|9.92|||
3875492|NCT01567943|3701681|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3875493|NCT01567943|3701682|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3875494|NCT01567943|3701683|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3875495|NCT01567943|3701681|B3||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
3875496|NCT01567943|3701682|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3875497|NCT01567943|3701683|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3875498|NCT01567943|3701681|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3875499|NCT01567943|3701682|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3875500|NCT01567943|3701683|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3875501|NCT01567865|3701693|B5|Bangladesh||Region of Enrollment||participants|Number|727|727.0||||||
3875502|NCT01567865|3701694|B4|Bangladesh||Region of Enrollment||participants|Number|194|194.0||||||
3875503|NCT01567865|3701695|B3|Bangladesh||Region of Enrollment||participants|Number|192|192.0||||||
3875504|NCT01567865|3701696|B2|Bangladesh||Region of Enrollment||participants|Number|195|195.0||||||
3875505|NCT01567865|3701697|B1|Bangladesh||Region of Enrollment||participants|Number|146|146.0||||||
3875506|NCT01567865|3701693|B5||Male|Sex: Female, Male||Participants|Count of Participants|361|361.0||||||
3875507|NCT01567865|3701694|B4||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3875508|NCT01567865|3701695|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3875509|NCT01567865|3701696|B2||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3875510|NCT01567865|3701697|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3875511|NCT01567865|3701693|B5||Female|Sex: Female, Male||Participants|Count of Participants|366|366.0||||||
3875512|NCT01567865|3701694|B4||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3875513|NCT01567865|3701695|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3875514|NCT01567865|3701696|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3875515|NCT01567865|3701697|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3875516|NCT01567865|3701693|B5|||Age||months|Mean|10.9|10.9|Standard Deviation|.7|0.7|||
3875517|NCT01567865|3701694|B4|||Age||months|Mean|10.9|10.9|Standard Deviation|.7|0.7|||
3875518|NCT01567865|3701695|B3|||Age||months|Mean|10.8|10.8|Standard Deviation|.65|0.65|||
3875519|NCT01567865|3701696|B2|||Age||months|Mean|10.9|10.9|Standard Deviation|.73|0.73|||
3875520|NCT01567865|3701697|B1|||Age||months|Mean|10.8|10.8|Standard Deviation|.68|0.68|||
3875521|NCT01567852|3701728|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3875522|NCT01567852|3701729|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3875523|NCT01567852|3701730|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875524|NCT01567852|3701728|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3875525|NCT01567852|3701729|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3875526|NCT01567852|3701730|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3875527|NCT01567852|3701728|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3875528|NCT01567852|3701729|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3875529|NCT01567852|3701730|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3875530|NCT01567852|3701728|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3875531|NCT01567852|3701729|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3875532|NCT01567852|3701730|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875533|NCT01567852|3701728|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875534|NCT01567852|3701729|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875535|NCT01567852|3701730|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875536|NCT01567852|3701728|B3||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3875537|NCT01567852|3701729|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3875538|NCT01567852|3701730|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3875539|NCT01567852|3701728|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875540|NCT01567852|3701729|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875541|NCT01567852|3701730|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875542|NCT01567852|3701728|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875543|NCT01567852|3701729|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875544|NCT01567852|3701730|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875545|NCT01567852|3701728|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875546|NCT01567852|3701729|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875547|NCT01567852|3701730|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875548|NCT01567852|3701728|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875549|NCT01567852|3701729|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875550|NCT01567852|3701730|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875551|NCT01567852|3701728|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3875552|NCT01567852|3701729|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3875553|NCT01567852|3701730|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3875554|NCT01567852|3701728|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3875555|NCT01567852|3701729|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3875556|NCT01567852|3701730|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3875557|NCT01567852|3701728|B3|||Age||years|Mean|52.65|52.65|Standard Deviation|17.17|17.17|||
3875558|NCT01567852|3701729|B2|||Age||years|Mean|54|54.0|Standard Deviation|22.63|22.63|||
3875559|NCT01567852|3701730|B1|||Age||years|Mean|51.75|51.75|Standard Deviation|13.46|13.46|||
3875560|NCT01567839|3701739|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
3875561|NCT01567839|3701739|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3875562|NCT01567839|3701739|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3875563|NCT01567839|3701739|B1|||Age||years|Mean|25.8|25.8|Standard Deviation|2.5|2.5|||
3875564|NCT01567839|3701739|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3875565|NCT01567839|3701739|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3875566|NCT01567839|3701739|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3875567|NCT01567826|3701747|B3|no||RCA coronary vessel|Right coronary artery (RCA)|participants|Number|64|64.0||||||
3875568|NCT01567826|3701748|B2|no||RCA coronary vessel|Right coronary artery (RCA)|participants|Number|34|34.0||||||
3875569|NCT01567826|3701749|B1|no||RCA coronary vessel|Right coronary artery (RCA)|participants|Number|30|30.0||||||
3875570|NCT01567826|3701747|B3|yes||RCA coronary vessel|Right coronary artery (RCA)|participants|Number|23|23.0||||||
3875571|NCT01567826|3701748|B2|yes||RCA coronary vessel|Right coronary artery (RCA)|participants|Number|10|10.0||||||
3875572|NCT01567826|3701749|B1|yes||RCA coronary vessel|Right coronary artery (RCA)|participants|Number|13|13.0||||||
3875573|NCT01567826|3701747|B3|no||LCx coronary vessel|Left circumflex (LCx)|participants|Number|59|59.0||||||
3875574|NCT01567826|3701748|B2|no||LCx coronary vessel|Left circumflex (LCx)|participants|Number|30|30.0||||||
3875575|NCT01567826|3701749|B1|no||LCx coronary vessel|Left circumflex (LCx)|participants|Number|29|29.0||||||
3875576|NCT01567826|3701747|B3|yes||LCx coronary vessel|Left circumflex (LCx)|participants|Number|28|28.0||||||
3875577|NCT01567826|3701748|B2|yes||LCx coronary vessel|Left circumflex (LCx)|participants|Number|14|14.0||||||
3875578|NCT01567826|3701749|B1|yes||LCx coronary vessel|Left circumflex (LCx)|participants|Number|14|14.0||||||
3875579|NCT01567826|3701747|B3|no||LAD Coronary vessel|Left anterior descending (LAD)|participants|Number|50|50.0||||||
3875580|NCT01567826|3701748|B2|no||LAD Coronary vessel|Left anterior descending (LAD)|participants|Number|24|24.0||||||
3875581|NCT01567826|3701749|B1|no||LAD Coronary vessel|Left anterior descending (LAD)|participants|Number|26|26.0||||||
3875582|NCT01567826|3701747|B3|yes||LAD Coronary vessel|Left anterior descending (LAD)|participants|Number|37|37.0||||||
3875583|NCT01567826|3701748|B2|yes||LAD Coronary vessel|Left anterior descending (LAD)|participants|Number|20|20.0||||||
3875584|NCT01567826|3701749|B1|yes||LAD Coronary vessel|Left anterior descending (LAD)|participants|Number|17|17.0||||||
3875585|NCT01567826|3701747|B3|||Creatinine||mg/dl|Mean|1.04|1.04|Standard Deviation|0.96|0.96|||
3875586|NCT01567826|3701748|B2|||Creatinine||mg/dl|Mean|1.0|1.0|Standard Deviation|0.3|0.3|||
3875587|NCT01567826|3701749|B1|||Creatinine||mg/dl|Mean|1.1|1.1|Standard Deviation|1.3|1.3|||
3875588|NCT01567826|3701747|B3|no||ACE-I/ARB use|Angiotensin-converting enzyme inhibitor (ACE-I); Angiotensin receptor blocker (ARB)|participants|Number|52|52.0||||||
3875589|NCT01567826|3701748|B2|no||ACE-I/ARB use|Angiotensin-converting enzyme inhibitor (ACE-I); Angiotensin receptor blocker (ARB)|participants|Number|28|28.0||||||
3875590|NCT01567826|3701749|B1|no||ACE-I/ARB use|Angiotensin-converting enzyme inhibitor (ACE-I); Angiotensin receptor blocker (ARB)|participants|Number|24|24.0||||||
3875591|NCT01567826|3701747|B3|yes||ACE-I/ARB use|Angiotensin-converting enzyme inhibitor (ACE-I); Angiotensin receptor blocker (ARB)|participants|Number|35|35.0||||||
3875592|NCT01567826|3701748|B2|yes||ACE-I/ARB use|Angiotensin-converting enzyme inhibitor (ACE-I); Angiotensin receptor blocker (ARB)|participants|Number|16|16.0||||||
3875593|NCT01567826|3701749|B1|yes||ACE-I/ARB use|Angiotensin-converting enzyme inhibitor (ACE-I); Angiotensin receptor blocker (ARB)|participants|Number|19|19.0||||||
3875594|NCT01567826|3701747|B3|no||Beta-blocker use||participants|Number|24|24.0||||||
3875595|NCT01567826|3701748|B2|no||Beta-blocker use||participants|Number|11|11.0||||||
3875596|NCT01567826|3701749|B1|no||Beta-blocker use||participants|Number|13|13.0||||||
3875597|NCT01567826|3701747|B3|yes||Beta-blocker use||participants|Number|63|63.0||||||
3875598|NCT01567826|3701748|B2|yes||Beta-blocker use||participants|Number|33|33.0||||||
3875599|NCT01567826|3701749|B1|yes||Beta-blocker use||participants|Number|30|30.0||||||
3875600|NCT01567826|3701747|B3|no||Statin Use||participants|Number|15|15.0||||||
3875601|NCT01567826|3701748|B2|no||Statin Use||participants|Number|7|7.0||||||
3875602|NCT01567826|3701749|B1|no||Statin Use||participants|Number|8|8.0||||||
3875603|NCT01567826|3701747|B3|yes||Statin Use||participants|Number|72|72.0||||||
3875604|NCT01567826|3701748|B2|yes||Statin Use||participants|Number|37|37.0||||||
3875605|NCT01567826|3701749|B1|yes||Statin Use||participants|Number|35|35.0||||||
3875606|NCT01567826|3701747|B3|no||Previous PCI|Percutaneous coronary intervention (PCI)|participants|Number|51|51.0||||||
3875607|NCT01567826|3701748|B2|no||Previous PCI|Percutaneous coronary intervention (PCI)|participants|Number|28|28.0||||||
3875608|NCT01567826|3701749|B1|no||Previous PCI|Percutaneous coronary intervention (PCI)|participants|Number|23|23.0||||||
3875609|NCT01567826|3701747|B3|yes||Previous PCI|Percutaneous coronary intervention (PCI)|participants|Number|36|36.0||||||
3875610|NCT01567826|3701748|B2|yes||Previous PCI|Percutaneous coronary intervention (PCI)|participants|Number|16|16.0||||||
3875611|NCT01567826|3701749|B1|yes||Previous PCI|Percutaneous coronary intervention (PCI)|participants|Number|20|20.0||||||
3875612|NCT01567826|3701747|B3|no||Previous MI|Myocardial infarction (MI)|participants|Number|71|71.0||||||
3875613|NCT01567826|3701748|B2|no||Previous MI|Myocardial infarction (MI)|participants|Number|36|36.0||||||
3875614|NCT01567826|3701749|B1|no||Previous MI|Myocardial infarction (MI)|participants|Number|35|35.0||||||
3875615|NCT01567826|3701747|B3|yes||Previous MI|Myocardial infarction (MI)|participants|Number|16|16.0||||||
3875616|NCT01567826|3701748|B2|yes||Previous MI|Myocardial infarction (MI)|participants|Number|8|8.0||||||
3875617|NCT01567826|3701749|B1|yes||Previous MI|Myocardial infarction (MI)|participants|Number|8|8.0||||||
3875618|NCT01567826|3701747|B3|no||Prior CVA/TIA|Cerebrovascular accident (CVA); Transient ischemic attack (TIA)|participants|Number|82|82.0||||||
3875619|NCT01567826|3701748|B2|no||Prior CVA/TIA|Cerebrovascular accident (CVA); Transient ischemic attack (TIA)|participants|Number|42|42.0||||||
3875620|NCT01567826|3701749|B1|no||Prior CVA/TIA|Cerebrovascular accident (CVA); Transient ischemic attack (TIA)|participants|Number|40|40.0||||||
3875621|NCT01567826|3701747|B3|yes||Prior CVA/TIA|Cerebrovascular accident (CVA); Transient ischemic attack (TIA)|participants|Number|5|5.0||||||
3875622|NCT01567826|3701748|B2|yes||Prior CVA/TIA|Cerebrovascular accident (CVA); Transient ischemic attack (TIA)|participants|Number|2|2.0||||||
3875623|NCT01567826|3701749|B1|yes||Prior CVA/TIA|Cerebrovascular accident (CVA); Transient ischemic attack (TIA)|participants|Number|3|3.0||||||
3875624|NCT01567826|3701747|B3|no||Diabetes mellitus|(treated with insulin)|participants|Number|79|79.0||||||
3875625|NCT01567826|3701748|B2|no||Diabetes mellitus|(treated with insulin)|participants|Number|39|39.0||||||
3875626|NCT01567826|3701749|B1|no||Diabetes mellitus|(treated with insulin)|participants|Number|40|40.0||||||
3875627|NCT01567826|3701747|B3|yes||Diabetes mellitus|(treated with insulin)|participants|Number|8|8.0||||||
3875628|NCT01567826|3701748|B2|yes||Diabetes mellitus|(treated with insulin)|participants|Number|5|5.0||||||
3875629|NCT01567826|3701749|B1|yes||Diabetes mellitus|(treated with insulin)|participants|Number|3|3.0||||||
3875630|NCT01567826|3701747|B3|no||Hypercholesterolemia||participants|Number|8|8.0||||||
3875631|NCT01567826|3701748|B2|no||Hypercholesterolemia||participants|Number|5|5.0||||||
3875632|NCT01567826|3701749|B1|no||Hypercholesterolemia||participants|Number|3|3.0||||||
3875633|NCT01567826|3701747|B3|yes||Hypercholesterolemia||participants|Number|79|79.0||||||
3875634|NCT01567826|3701748|B2|yes||Hypercholesterolemia||participants|Number|39|39.0||||||
3875635|NCT01567826|3701749|B1|yes||Hypercholesterolemia||participants|Number|40|40.0||||||
3875636|NCT01567826|3701747|B3|no||Hypertension||participants|Number|7|7.0||||||
3875637|NCT01567826|3701748|B2|no||Hypertension||participants|Number|4|4.0||||||
3875638|NCT01567826|3701749|B1|no||Hypertension||participants|Number|3|3.0||||||
3875639|NCT01567826|3701747|B3|yes||Hypertension||participants|Number|80|80.0||||||
3875640|NCT01567826|3701748|B2|yes||Hypertension||participants|Number|40|40.0||||||
3875641|NCT01567826|3701749|B1|yes||Hypertension||participants|Number|40|40.0||||||
3875642|NCT01567826|3701747|B3|no||Current tobacco use||participants|Number|74|74.0||||||
3875643|NCT01567826|3701748|B2|no||Current tobacco use||participants|Number|35|35.0||||||
3875644|NCT01567826|3701749|B1|no||Current tobacco use||participants|Number|39|39.0||||||
3875645|NCT01567826|3701747|B3|yes||Current tobacco use||participants|Number|13|13.0||||||
3875646|NCT01567826|3701748|B2|yes||Current tobacco use||participants|Number|9|9.0||||||
3875647|NCT01567826|3701749|B1|yes||Current tobacco use||participants|Number|4|4.0||||||
3875648|NCT01567826|3701747|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3875649|NCT01567826|3701748|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3875650|NCT01567826|3701749|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3875651|NCT01567826|3701747|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3875652|NCT01567826|3701748|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3875653|NCT01567826|3701749|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3875654|NCT01567826|3701747|B3|||Age||years|Mean|63.6|63.6|Standard Deviation|9.5|9.5|||
3875655|NCT01567826|3701748|B2|||Age||years|Mean|64.4|64.4|Standard Deviation|9.29|9.29|||
3875656|NCT01567826|3701749|B1|||Age||years|Mean|62.9|62.9|Standard Deviation|9.8|9.8|||
3875657|NCT01567527|3701774|B3|||Clinical Global Impressions - Bipolar Version Severity (CGI-BP-S) - Mania|CGI-BP-S assessed the subject’s severity of Illness (mania) based on a 7-point scale ranging from 1 (normal/ not ill at all) to 7 (very severely ill).|Scores on a scale|Mean|1.5|1.5|Standard Deviation|0.7|0.7|||
3875658|NCT01567527|3701775|B2|||Clinical Global Impressions - Bipolar Version Severity (CGI-BP-S) - Mania|CGI-BP-S assessed the subject’s severity of Illness (mania) based on a 7-point scale ranging from 1 (normal/ not ill at all) to 7 (very severely ill).|Scores on a scale|Mean|1.4|1.4|Standard Deviation|0.6|0.6|||
3875659|NCT01567527|3701776|B1|||Clinical Global Impressions - Bipolar Version Severity (CGI-BP-S) - Mania|CGI-BP-S assessed the subject’s severity of Illness (mania) based on a 7-point scale ranging from 1 (normal/ not ill at all) to 7 (very severely ill).|Scores on a scale|Mean|1.5|1.5|Standard Deviation|0.7|0.7|||
3875660|NCT01567527|3701774|B3|||Montgomery Asberg Depression Rating Scale (MADRS) Total Score|The MADRS measured the depression level of a participant. This scale consisted of 10 items (reported sadness, apparent sadness, inner tension, reduced sleep, reduced appetite, concentration difficulties, lassitude, inability to feel, pessimistic thoughts, and suicidal thoughts), each with 7 defined grades of severity graded on a scale of 0 to 6 (a higher score indicated increased severity) . The overall total score was 0 to 60; 0, no depression; 60, severely depressed. The missing score for any one item resulted in a missing MADRS total score.|Scores on a scale|Mean|2.7|2.7|Standard Deviation|3.4|3.4|||
3875661|NCT01567527|3701775|B2|||Montgomery Asberg Depression Rating Scale (MADRS) Total Score|The MADRS measured the depression level of a participant. This scale consisted of 10 items (reported sadness, apparent sadness, inner tension, reduced sleep, reduced appetite, concentration difficulties, lassitude, inability to feel, pessimistic thoughts, and suicidal thoughts), each with 7 defined grades of severity graded on a scale of 0 to 6 (a higher score indicated increased severity) . The overall total score was 0 to 60; 0, no depression; 60, severely depressed. The missing score for any one item resulted in a missing MADRS total score.|Scores on a scale|Mean|2.4|2.4|Standard Deviation|3.4|3.4|||
3875662|NCT01567527|3701776|B1|||Montgomery Asberg Depression Rating Scale (MADRS) Total Score|The MADRS measured the depression level of a participant. This scale consisted of 10 items (reported sadness, apparent sadness, inner tension, reduced sleep, reduced appetite, concentration difficulties, lassitude, inability to feel, pessimistic thoughts, and suicidal thoughts), each with 7 defined grades of severity graded on a scale of 0 to 6 (a higher score indicated increased severity) . The overall total score was 0 to 60; 0, no depression; 60, severely depressed. The missing score for any one item resulted in a missing MADRS total score.|Scores on a scale|Mean|3.0|3.0|Standard Deviation|3.4|3.4|||
3875663|NCT01567527|3701774|B3|||Young-Mania Rating Scale (YMRS) Total Score|The YMRS consisted of 11 items to assess the core symptoms of mania. Four items (irritability, speech, content, and disruptive-aggressive behavior) were graded on a scale of 0 to 8 (a higher score indicated increased severity) and 7 items (elevated mood, increased motor activity/energy, sexual interest, sleep, language-thought disorder, appearance, and insight) were graded on a scale of 0 to 4 (a higher score indicated increased severity). The scores from 11 items were summed to a total score ranging from 0 to 60 (higher score indicated greater severity of symptoms).|Scores on a scale|Mean|2.8|2.8|Standard Deviation|3.3|3.3|||
3875664|NCT01567527|3701775|B2|||Young-Mania Rating Scale (YMRS) Total Score|The YMRS consisted of 11 items to assess the core symptoms of mania. Four items (irritability, speech, content, and disruptive-aggressive behavior) were graded on a scale of 0 to 8 (a higher score indicated increased severity) and 7 items (elevated mood, increased motor activity/energy, sexual interest, sleep, language-thought disorder, appearance, and insight) were graded on a scale of 0 to 4 (a higher score indicated increased severity). The scores from 11 items were summed to a total score ranging from 0 to 60 (higher score indicated greater severity of symptoms).|Scores on a scale|Mean|2.6|2.6|Standard Deviation|3.0|3.0|||
3875665|NCT01567527|3701776|B1|||Young-Mania Rating Scale (YMRS) Total Score|The YMRS consisted of 11 items to assess the core symptoms of mania. Four items (irritability, speech, content, and disruptive-aggressive behavior) were graded on a scale of 0 to 8 (a higher score indicated increased severity) and 7 items (elevated mood, increased motor activity/energy, sexual interest, sleep, language-thought disorder, appearance, and insight) were graded on a scale of 0 to 4 (a higher score indicated increased severity). The scores from 11 items were summed to a total score ranging from 0 to 60 (higher score indicated greater severity of symptoms).|Scores on a scale|Mean|2.9|2.9|Standard Deviation|3.5|3.5|||
3875666|NCT01567527|3701774|B3|||Number of prior hospitalizations for a mood episode||Prior hospitalization for mood episode|Mean|3.5|3.5|Standard Deviation|4.0|4.0|||
3875667|NCT01567527|3701775|B2|||Number of prior hospitalizations for a mood episode||Prior hospitalization for mood episode|Mean|3.5|3.5|Standard Deviation|4.1|4.1|||
3875668|NCT01567527|3701776|B1|||Number of prior hospitalizations for a mood episode||Prior hospitalization for mood episode|Mean|3.5|3.5|Standard Deviation|3.9|3.9|||
3875669|NCT01567527|3701774|B3|||Duration of disease prior to enrollment (years)||years|Mean|12.9|12.9|Standard Deviation|9.5|9.5|||
3875670|NCT01567527|3701775|B2|||Duration of disease prior to enrollment (years)||years|Mean|13.6|13.6|Standard Deviation|9.8|9.8|||
3875671|NCT01567527|3701776|B1|||Duration of disease prior to enrollment (years)||years|Mean|12.1|12.1|Standard Deviation|9.2|9.2|||
3875672|NCT01567527|3701774|B3|||Number of mood episodes past 12 months||Mood episodes|Mean|2.2|2.2|Standard Deviation|1.2|1.2|||
3875673|NCT01567527|3701775|B2|||Number of mood episodes past 12 months||Mood episodes|Mean|2.2|2.2|Standard Deviation|1.1|1.1|||
3875674|NCT01567527|3701776|B1|||Number of mood episodes past 12 months||Mood episodes|Mean|2.2|2.2|Standard Deviation|1.2|1.2|||
3875675|NCT01567527|3701774|B3|||Age at first manic episode (years)||years|Mean|25.0|25.0|Standard Deviation|10.1|10.1|||
3875676|NCT01567527|3701775|B2|||Age at first manic episode (years)||years|Mean|24.8|24.8|Standard Deviation|9.9|9.9|||
3875677|NCT01567527|3701776|B1|||Age at first manic episode (years)||years|Mean|25.2|25.2|Standard Deviation|10.3|10.3|||
3875678|NCT01567527|3701774|B3|Poland||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3875679|NCT01567527|3701775|B2|Poland||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3875680|NCT01567527|3701776|B1|Poland||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3875681|NCT01567527|3701774|B3|Taiwan||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3875682|NCT01567527|3701775|B2|Taiwan||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3875683|NCT01567527|3701776|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3875684|NCT01567527|3701774|B3|Japan||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3875685|NCT01567527|3701775|B2|Japan||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3875686|NCT01567527|3701776|B1|Japan||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3875687|NCT01567527|3701774|B3|United States||Region of Enrollment||Participants|Count of Participants|203|203.0||||||
3875688|NCT01567527|3701775|B2|United States||Region of Enrollment||Participants|Count of Participants|102|102.0||||||
3875689|NCT01567527|3701776|B1|United States||Region of Enrollment||Participants|Count of Participants|101|101.0||||||
3875690|NCT01567527|3701774|B3|Romania||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3875691|NCT01567527|3701775|B2|Romania||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3875692|NCT01567527|3701776|B1|Romania||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3875693|NCT01567527|3701774|B3|South Korea||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3875694|NCT01567527|3701775|B2|South Korea||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3875695|NCT01567527|3701776|B1|South Korea||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3875696|NCT01567527|3701774|B3|Canada||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3875697|NCT01567527|3701775|B2|Canada||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3875698|NCT01567527|3701776|B1|Canada||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3875699|NCT01567527|3701774|B3||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3875700|NCT01567527|3701775|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3875701|NCT01567527|3701776|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3875702|NCT01567527|3701774|B3||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3875703|NCT01567527|3701775|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3875704|NCT01567527|3701776|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3875705|NCT01567527|3701774|B3|||Age||years|Mean|40.6|40.6|Standard Deviation|11.0|11.0|||
3875706|NCT01567527|3701775|B2|||Age||years|Mean|40.6|40.6|Standard Deviation|11.2|11.2|||
3875707|NCT01567527|3701776|B1|||Age||years|Mean|40.6|40.6|Standard Deviation|10.8|10.8|||
3875708|NCT01567527|3701774|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3875709|NCT01567527|3701775|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3875710|NCT01567527|3701776|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3875711|NCT01567527|3701774|B3||Between 18 and 65 years|Age||Participants|Count of Participants|265|265.0||||||
3875712|NCT01567527|3701775|B2||Between 18 and 65 years|Age||Participants|Count of Participants|132|132.0||||||
3875713|NCT01567527|3701776|B1||Between 18 and 65 years|Age||Participants|Count of Participants|133|133.0||||||
3875714|NCT01567527|3701774|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3875715|NCT01567527|3701775|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3875716|NCT01567527|3701776|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3875717|NCT01567462|3701795|B3|United States||Region of Enrollment||Participants|Count of Participants|79|79.0||||||
3875718|NCT01567462|3701796|B2|United States||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
3875719|NCT01567462|3701797|B1|United States||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3875720|NCT01567462|3701795|B3|Unreported||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3875721|NCT01567462|3701796|B2|Unreported||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3875722|NCT01567462|3701797|B1|Unreported||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3875723|NCT01567462|3701795|B3|Non-White||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3875724|NCT01567462|3701796|B2|Non-White||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3875725|NCT01567462|3701797|B1|Non-White||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3875726|NCT01567462|3701795|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
3875727|NCT01567462|3701796|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3875728|NCT01567462|3701797|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3875729|NCT01567462|3701795|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3875730|NCT01567462|3701796|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3875731|NCT01567462|3701797|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3875732|NCT01567462|3701795|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3875733|NCT01567462|3701796|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3875734|NCT01567462|3701797|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3875735|NCT01567462|3701795|B3|||Age||years|Mean|69|69.0|Standard Deviation|11.7|11.7|||
3875736|NCT01567462|3701796|B2|||Age||years|Mean|69.2|69.2|Standard Deviation|11.4|11.4|||
3875737|NCT01567462|3701797|B1|||Age||years|Mean|68.7|68.7|Standard Deviation|12.2|12.2|||
3875738|NCT01567371|3701810|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3875739|NCT01567371|3701810|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3875740|NCT01567371|3701810|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3875741|NCT01567371|3701810|B1|||Age||years|Mean|21.5|21.5|Standard Deviation|11.018|11.018|||
3875742|NCT01567371|3701810|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3875743|NCT01567371|3701810|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3875744|NCT01567371|3701810|B1||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
3875745|NCT01567163|3701815|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3875746|NCT01567163|3701815|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875747|NCT01567163|3701815|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875748|NCT01567163|3701815|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3875749|NCT01567163|3701815|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3875750|NCT01567163|3701815|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3875751|NCT01567163|3701815|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875752|NCT01567163|3701815|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875753|NCT01567163|3701815|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875754|NCT01567163|3701815|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3875755|NCT01567163|3701815|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3875756|NCT01567163|3701815|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3875757|NCT01567163|3701815|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3875758|NCT01567163|3701815|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3875759|NCT01567163|3701815|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3875760|NCT01567163|3701815|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3875761|NCT01567150|3701825|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3875762|NCT01567150|3701826|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3875763|NCT01567150|3701827|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3875764|NCT01567150|3701825|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3875765|NCT01567150|3701826|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3875766|NCT01567150|3701827|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3875767|NCT01567150|3701825|B3|||Age||years|Mean|58.1|58.1|Standard Deviation|14.0|14.0|||
3875768|NCT01567150|3701826|B2|||Age||years|Mean|60.6|60.6|Standard Deviation|12.9|12.9|||
3875769|NCT01567150|3701827|B1|||Age||years|Mean|56.1|56.1|Standard Deviation|14.9|14.9|||
3875770|NCT01567020|3701836|B5|United States||Region of Enrollment||participants|Number|90|90.0||||||
3875771|NCT01567020|3701837|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
3875772|NCT01567020|3701838|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
3875773|NCT01567020|3701839|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
3875774|NCT01567020|3701840|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3875775|NCT01567020|3701836|B5||Male|Gender||Participants|Count of Participants|76|76.0||||||
3875776|NCT01567020|3701837|B4||Male|Gender||Participants|Count of Participants|7|7.0||||||
3875777|NCT01567020|3701838|B3||Male|Gender||Participants|Count of Participants|16|16.0||||||
3875778|NCT01567020|3701839|B2||Male|Gender||Participants|Count of Participants|39|39.0||||||
3875779|NCT01567020|3701840|B1||Male|Gender||Participants|Count of Participants|14|14.0||||||
3875780|NCT01567020|3701836|B5||Female|Gender||Participants|Count of Participants|14|14.0||||||
3875781|NCT01567020|3701837|B4||Female|Gender||Participants|Count of Participants|3|3.0||||||
3875782|NCT01567020|3701838|B3||Female|Gender||Participants|Count of Participants|2|2.0||||||
3875783|NCT01567020|3701839|B2||Female|Gender||Participants|Count of Participants|2|2.0||||||
3875784|NCT01567020|3701840|B1||Female|Gender||Participants|Count of Participants|7|7.0||||||
3875785|NCT01567020|3701836|B5|||Age||years|Mean|38.82|38.82|Standard Deviation|12.3|12.3|||
3875786|NCT01567020|3701837|B4|||Age||years|Mean|56.4|56.4|Standard Deviation|5.5|5.5|||
3875787|NCT01567020|3701838|B3|||Age||years|Mean|40.4|40.4|Standard Deviation|10.9|10.9|||
3875788|NCT01567020|3701839|B2|||Age||years|Mean|38.4|38.4|Standard Deviation|11.8|11.8|||
3875789|NCT01567020|3701840|B1|||Age||years|Mean|31.4|31.4|Standard Deviation|8.5|8.5|||
3875790|NCT01567020|3701836|B5||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3875791|NCT01567020|3701837|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3875792|NCT01567020|3701838|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3875793|NCT01567020|3701839|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3875794|NCT01567020|3701840|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3875795|NCT01567020|3701836|B5||Between 18 and 65 years|Age||Participants|Count of Participants|88|88.0||||||
3875796|NCT01567020|3701837|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3875797|NCT01567020|3701838|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3875798|NCT01567020|3701839|B2||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3875799|NCT01567020|3701840|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3875800|NCT01567020|3701836|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3875801|NCT01567020|3701837|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3875802|NCT01567020|3701838|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3875803|NCT01567020|3701839|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3875804|NCT01567020|3701840|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3875805|NCT01566981|3701853|B3|||Years of DM treatment||years|Mean|5.5|5.5|Standard Deviation|5.3|5.3|||
3875806|NCT01566981|3701854|B2|||Years of DM treatment||years|Mean|5.7|5.7|Standard Deviation|4.8|4.8|||
3875807|NCT01566981|3701855|B1|||Years of DM treatment||years|Mean|5.1|5.1|Standard Deviation|5.7|5.7|||
3875808|NCT01566981|3701853|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3875809|NCT01566981|3701854|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3875810|NCT01566981|3701855|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3875811|NCT01566981|3701853|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3875812|NCT01566981|3701854|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3875813|NCT01566981|3701855|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3875814|NCT01566981|3701853|B3|||Age||years|Mean|55.5|55.5|Standard Deviation|10.7|10.7|||
3875815|NCT01566981|3701854|B2|||Age||years|Mean|54.7|54.7|Standard Deviation|11.1|11.1|||
3875816|NCT01566981|3701855|B1|||Age||years|Mean|56.3|56.3|Standard Deviation|10.5|10.5|||
3875817|NCT01566838|3701866|B3|Unspecified||Side||participants|Number|1|1.0||||||
3875818|NCT01566838|3701867|B2|Unspecified||Side||participants|Number|1|1.0||||||
3875819|NCT01566838|3701868|B1|Unspecified||Side||participants|Number|0|0.0||||||
3875820|NCT01566838|3701866|B3|Right||Side||participants|Number|59|59.0||||||
3875821|NCT01566838|3701867|B2|Right||Side||participants|Number|29|29.0||||||
3875822|NCT01566838|3701868|B1|Right||Side||participants|Number|30|30.0||||||
3875823|NCT01566838|3701866|B3|Left||Side||participants|Number|23|23.0||||||
3875824|NCT01566838|3701867|B2|Left||Side||participants|Number|12|12.0||||||
3875825|NCT01566838|3701868|B1|Left||Side||participants|Number|11|11.0||||||
3875826|NCT01566838|3701866|B3|Other||Diagnosis||participants|Number|7|7.0||||||
3875827|NCT01566838|3701867|B2|Other||Diagnosis||participants|Number|3|3.0||||||
3875828|NCT01566838|3701868|B1|Other||Diagnosis||participants|Number|4|4.0||||||
3875829|NCT01566838|3701866|B3|Interstitial Lung Disease||Diagnosis||participants|Number|19|19.0||||||
3875830|NCT01566838|3701867|B2|Interstitial Lung Disease||Diagnosis||participants|Number|12|12.0||||||
3875831|NCT01566838|3701868|B1|Interstitial Lung Disease||Diagnosis||participants|Number|7|7.0||||||
3875832|NCT01566838|3701866|B3|Cancer||Diagnosis||participants|Number|57|57.0||||||
3875833|NCT01566838|3701867|B2|Cancer||Diagnosis||participants|Number|27|27.0||||||
3875834|NCT01566838|3701868|B1|Cancer||Diagnosis||participants|Number|30|30.0||||||
3875835|NCT01566838|3701866|B3|Other||Surgical Procedure Performed||participants|Number|6|6.0||||||
3875836|NCT01566838|3701867|B2|Other||Surgical Procedure Performed||participants|Number|6|6.0||||||
3875837|NCT01566838|3701868|B1|Other||Surgical Procedure Performed||participants|Number|0|0.0||||||
3875838|NCT01566838|3701866|B3|Wedge||Surgical Procedure Performed||participants|Number|34|34.0||||||
3875839|NCT01566838|3701867|B2|Wedge||Surgical Procedure Performed||participants|Number|16|16.0||||||
3875840|NCT01566838|3701868|B1|Wedge||Surgical Procedure Performed||participants|Number|18|18.0||||||
3875841|NCT01566838|3701866|B3|Lobectomy||Surgical Procedure Performed||participants|Number|43|43.0||||||
3875842|NCT01566838|3701867|B2|Lobectomy||Surgical Procedure Performed||participants|Number|20|20.0||||||
3875843|NCT01566838|3701868|B1|Lobectomy||Surgical Procedure Performed||participants|Number|23|23.0||||||
3875844|NCT01566838|3701866|B3|United States||Region of Enrollment||participants|Number|83|83.0||||||
3875845|NCT01566838|3701867|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
3875846|NCT01566838|3701868|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
3875847|NCT01566838|3701866|B3|Other||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3875848|NCT01566838|3701867|B2|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3875849|NCT01566838|3701868|B1|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3875850|NCT01566838|3701866|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
3875851|NCT01566838|3701867|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3875852|NCT01566838|3701868|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
3875853|NCT01566838|3701866|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3875854|NCT01566838|3701867|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3875855|NCT01566838|3701868|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3875856|NCT01566838|3701866|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3875857|NCT01566838|3701867|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3875858|NCT01566838|3701868|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3875859|NCT01566838|3701866|B3|||Age||years|Mean|62.95|62.95|Standard Deviation|12.25|12.25|||
3875860|NCT01566838|3701867|B2|||Age||years|Mean|62.9|62.9|Standard Deviation|12.1|12.1|||
3875861|NCT01566838|3701868|B1|||Age||years|Mean|63.0|63.0|Standard Deviation|12.4|12.4|||
3875862|NCT01566773|3701885|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3875863|NCT01566773|3701885|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3875864|NCT01566773|3701885|B1|||Age||Years|Mean|61.3|61.3|Standard Deviation|8.4|8.4|||
3875865|NCT01566721|3702092|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3875866|NCT01566721|3702093|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3875867|NCT01566721|3702094|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3875868|NCT01566721|3702092|B3||Female|Sex: Female, Male||Participants|Count of Participants|2573|2573.0||||||
3875869|NCT01566721|3702093|B2||Female|Sex: Female, Male||Participants|Count of Participants|710|710.0||||||
3875870|NCT01566721|3702094|B1||Female|Sex: Female, Male||Participants|Count of Participants|1863|1863.0||||||
3875871|NCT01566721|3702092|B3|||Age||years|Mean|53.7|53.7|Standard Deviation|11.83|11.83|||
3875872|NCT01566721|3702093|B2|||Age||years|Mean|53.0|53.0|Standard Deviation|11.32|11.32|||
3875873|NCT01566721|3702094|B1|||Age||years|Mean|54.0|54.0|Standard Deviation|12.01|12.01|||
3875874|NCT01566630|3702118|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3875875|NCT01566630|3702119|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3875876|NCT01566630|3702120|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3875877|NCT01566630|3702118|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3875878|NCT01566630|3702119|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3875879|NCT01566630|3702120|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3875880|NCT01566630|3702118|B3|Between age 18 to 40 years||Age, Customized|Between age 18 to 40|Participants|Number|3|3.0||||||
3875881|NCT01566630|3702119|B2|Between age 18 to 40 years||Age, Customized|Between age 18 to 40|Participants|Number|1|1.0||||||
3875882|NCT01566630|3702120|B1|Between age 18 to 40 years||Age, Customized|Between age 18 to 40|Participants|Number|2|2.0||||||
3875883|NCT01566604|3702175|B3||Male|Sex: Female, Male||Participants|Count of Participants|439|439.0||||||
3875884|NCT01566604|3702176|B2||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3875885|NCT01566604|3702177|B1||Male|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
3875886|NCT01566604|3702175|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3875887|NCT01566604|3702176|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3875888|NCT01566604|3702177|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3875889|NCT01566604|3702175|B3|||Age||Years|Mean|64.7|64.7|Standard Deviation|7.98|7.98|||
3875890|NCT01566604|3702176|B2|||Age||Years|Mean|65.0|65.0|Standard Deviation|8.29|8.29|||
3875891|NCT01566604|3702177|B1|||Age||Years|Mean|64.6|64.6|Standard Deviation|7.84|7.84|||
3875892|NCT01566539|3702204|B9|United States||Region of Enrollment||participants|Number|449|449.0||||||
3875893|NCT01566539|3702205|B8|United States||Region of Enrollment||participants|Number|1|1.0||||||
3875894|NCT01566539|3702206|B7|United States||Region of Enrollment||participants|Number|30|30.0||||||
3875895|NCT01566539|3702207|B6|United States||Region of Enrollment||participants|Number|30|30.0||||||
3875896|NCT01566539|3702208|B5|United States||Region of Enrollment||participants|Number|43|43.0||||||
3875897|NCT01566539|3702209|B4|United States||Region of Enrollment||participants|Number|40|40.0||||||
3875898|NCT01566539|3702210|B3|United States||Region of Enrollment||participants|Number|104|104.0||||||
3875899|NCT01566539|3702211|B2|United States||Region of Enrollment||participants|Number|100|100.0||||||
3875900|NCT01566539|3702212|B1|United States||Region of Enrollment||participants|Number|101|101.0||||||
3875901|NCT01566539|3702204|B9||Male|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
3875902|NCT01566539|3702205|B8||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3875903|NCT01566539|3702206|B7||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3875904|NCT01566539|3702207|B6||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3875905|NCT01566539|3702208|B5||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3875906|NCT01566539|3702209|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3875907|NCT01566539|3702210|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3875908|NCT01566539|3702211|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3875909|NCT01566539|3702212|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3875910|NCT01566539|3702204|B9||Female|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
3875911|NCT01566539|3702205|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3875912|NCT01566539|3702206|B7||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3875913|NCT01566539|3702207|B6||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3875914|NCT01566539|3702208|B5||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3875915|NCT01566539|3702209|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3875916|NCT01566539|3702210|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3875917|NCT01566539|3702211|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3875918|NCT01566539|3702212|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3875919|NCT01566539|3702204|B9||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3875920|NCT01566539|3702205|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3875921|NCT01566539|3702206|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3875922|NCT01566539|3702207|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3875923|NCT01566539|3702208|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3875924|NCT01566539|3702209|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3875925|NCT01566539|3702210|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3875926|NCT01566539|3702211|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3875927|NCT01566539|3702212|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3875928|NCT01566539|3702204|B9||Between 18 and 65 years|Age||Participants|Count of Participants|449|449.0||||||
3875929|NCT01566539|3702205|B8||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3875930|NCT01566539|3702206|B7||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3875931|NCT01566539|3702207|B6||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3875932|NCT01566539|3702208|B5||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
3875933|NCT01566539|3702209|B4||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3875934|NCT01566539|3702210|B3||Between 18 and 65 years|Age||Participants|Count of Participants|104|104.0||||||
3875935|NCT01566539|3702211|B2||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
3875936|NCT01566539|3702212|B1||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
3875937|NCT01566539|3702204|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3875938|NCT01566539|3702205|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3875939|NCT01566539|3702206|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3875940|NCT01566539|3702207|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3875941|NCT01566539|3702208|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3875942|NCT01566539|3702209|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3875943|NCT01566539|3702210|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3875944|NCT01566539|3702211|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3875945|NCT01566539|3702212|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3875946|NCT01566526|3702273|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3875947|NCT01566526|3702273|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3875948|NCT01566526|3702273|B1|81 to 90 years||Age, Customized||Participants|Number|1|1.0||||||
3875949|NCT01566526|3702273|B1|71 to 80 years||Age, Customized||Participants|Number|8|8.0||||||
3875950|NCT01566526|3702273|B1|61 to 70 years||Age, Customized||Participants|Number|4|4.0||||||
3875951|NCT01566526|3702273|B1|51 to 60 years||Age, Customized||Participants|Number|10|10.0||||||
3875952|NCT01566526|3702273|B1|41 to 50 years||Age, Customized||Participants|Number|3|3.0||||||
3875953|NCT01566500|3702283|B1|United States||Region of Enrollment||participants|Number|140|140.0||||||
3875954|NCT01566500|3702283|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3875955|NCT01566500|3702283|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3875956|NCT01566500|3702283|B1|||Age||years|Mean|38.51|38.51|Standard Deviation|11.72|11.72|||
3875957|NCT01566461|3702287|B3||Male|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
3875958|NCT01566461|3702288|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3875959|NCT01566461|3702289|B1||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3875960|NCT01566461|3702287|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3875961|NCT01566461|3702288|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3875962|NCT01566461|3702289|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3875963|NCT01566461|3702287|B3|||Age||Years|Mean|67.6|67.6|Standard Deviation|9.4|9.4|||
3875964|NCT01566461|3702288|B2|||Age||Years|Mean|68.0|68.0|Standard Deviation|9.2|9.2|||
3875965|NCT01566461|3702289|B1|||Age||Years|Mean|67.5|67.5|Standard Deviation|9.5|9.5|||
3875966|NCT01566435|3702334|B1|IVB||Overall stage of disease||participants|Number|9|9.0||||||
3875967|NCT01566435|3702334|B1|IVA||Overall stage of disease||participants|Number|18|18.0||||||
3875968|NCT01566435|3702334|B1|III||Overall stage of disease||participants|Number|3|3.0||||||
3875969|NCT01566435|3702334|B1|HPV-unrelated HNSCC||HPV Status||participants|Number|13|13.0||||||
3875970|NCT01566435|3702334|B1|HPV-related OPSCC||HPV Status||participants|Number|17|17.0||||||
3875971|NCT01566435|3702334|B1|Hypopharynx||Primary tumor site||participants|Number|3|3.0||||||
3875972|NCT01566435|3702334|B1|Larynx||Primary tumor site||participants|Number|9|9.0||||||
3875973|NCT01566435|3702334|B1|Oropharynx||Primary tumor site||participants|Number|18|18.0||||||
3875974|NCT01566435|3702334|B1|T4||T Stage|"-T Stage (primary tumor)~T2 = Tumor > 2 cm but not more than 4 cm in greatest dimension~T3 = Tumor > 4 cm in greatest dimension~T4a = Lip - Tumor invades through cortical bone, inferior alveolar nerve, floor of mouth, or skin of face, Oral cavity - Tumor invades adjacent structures (eg, through cortical bone into deep extrinsic muscle of the tongue, maxillary sinus, or skin of face~T4b - Tumor invades masticator space, pterygoid plates, or skull base and/or encases internal carotid artery"|participants|Number|9|9.0||||||
3876031|NCT01566331|3702384|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3876032|NCT01566331|3702385|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3876033|NCT01566331|3702386|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3875975|NCT01566435|3702334|B1|T3||T Stage|"-T Stage (primary tumor)~T2 = Tumor > 2 cm but not more than 4 cm in greatest dimension~T3 = Tumor > 4 cm in greatest dimension~T4a = Lip - Tumor invades through cortical bone, inferior alveolar nerve, floor of mouth, or skin of face, Oral cavity - Tumor invades adjacent structures (eg, through cortical bone into deep extrinsic muscle of the tongue, maxillary sinus, or skin of face~T4b - Tumor invades masticator space, pterygoid plates, or skull base and/or encases internal carotid artery"|participants|Number|13|13.0||||||
3875976|NCT01566435|3702334|B1|T2||T Stage|"-T Stage (primary tumor)~T2 = Tumor > 2 cm but not more than 4 cm in greatest dimension~T3 = Tumor > 4 cm in greatest dimension~T4a = Lip - Tumor invades through cortical bone, inferior alveolar nerve, floor of mouth, or skin of face, Oral cavity - Tumor invades adjacent structures (eg, through cortical bone into deep extrinsic muscle of the tongue, maxillary sinus, or skin of face~T4b - Tumor invades masticator space, pterygoid plates, or skull base and/or encases internal carotid artery"|participants|Number|8|8.0||||||
3875977|NCT01566435|3702334|B1|No||Smoking history||participants|Number|7|7.0||||||
3875978|NCT01566435|3702334|B1|Yes||Smoking history||participants|Number|23|23.0||||||
3875979|NCT01566435|3702334|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3875980|NCT01566435|3702334|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3875981|NCT01566435|3702334|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3875982|NCT01566435|3702334|B1|||Age||years|Mean|58.8|58.8|Full Range|||43.0|74.0|
3875983|NCT01566409|3702348|B3|Denmark||Region of Enrollment||participants|Number|102|102.0||||||
3875984|NCT01566409|3702349|B2|Denmark||Region of Enrollment||participants|Number|53|53.0||||||
3875985|NCT01566409|3702350|B1|Denmark||Region of Enrollment||participants|Number|49|49.0||||||
3875986|NCT01566409|3702348|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3875987|NCT01566409|3702349|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3875988|NCT01566409|3702350|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3875989|NCT01566409|3702348|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3875990|NCT01566409|3702349|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3875991|NCT01566409|3702350|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3875992|NCT01566409|3702348|B3|||Age, Customized||years|Median|6.1|6.1|Full Range|||2.0|15.1|
3875993|NCT01566409|3702349|B2|||Age, Customized||years|Median|6.1|6.1|Full Range|||2.0|15.1|
3875994|NCT01566409|3702350|B1|||Age, Customized||years|Median|6.2|6.2|Full Range|||2.5|12.3|
3875995|NCT01566370|3702357|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3875996|NCT01566370|3702358|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3875997|NCT01566370|3702359|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3875998|NCT01566370|3702357|B3||Male|Gender||Participants|Count of Participants|2|2.0||||||
3875999|NCT01566370|3702358|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3876000|NCT01566370|3702359|B1||Male|Gender||Participants|Count of Participants|2|2.0||||||
3876001|NCT01566370|3702357|B3||Female|Gender||Participants|Count of Participants|1|1.0||||||
3876002|NCT01566370|3702358|B2||Female|Gender||Participants|Count of Participants|1|1.0||||||
3876003|NCT01566370|3702359|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3876004|NCT01566370|3702357|B3|||Age||years|Mean|51.75|51.75|Full Range|||45.0|60.0|
3876005|NCT01566370|3702358|B2|||Age||years|Mean|45|45.0|Full Range|||45.0|45.0|
3876006|NCT01566370|3702359|B1|||Age||years|Mean|58.5|58.5|Full Range|||57.0|60.0|
3876007|NCT01566370|3702357|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3876008|NCT01566370|3702358|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3876009|NCT01566370|3702359|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3876010|NCT01566370|3702357|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3876011|NCT01566370|3702358|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3876012|NCT01566370|3702359|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3876013|NCT01566370|3702357|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3876014|NCT01566370|3702358|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3876015|NCT01566370|3702359|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3876016|NCT01566331|3702384|B3|Italy||Region of Enrollment||participants|Number|80|80.0||||||
3876017|NCT01566331|3702385|B2|Italy||Region of Enrollment||participants|Number|40|40.0||||||
3876018|NCT01566331|3702386|B1|Italy||Region of Enrollment||participants|Number|40|40.0||||||
3876019|NCT01566331|3702384|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|80|80.0||||||
3876020|NCT01566331|3702385|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
3876021|NCT01566331|3702386|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
3876022|NCT01566331|3702384|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3876023|NCT01566331|3702385|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3876024|NCT01566331|3702386|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3876025|NCT01566331|3702384|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3876026|NCT01566331|3702385|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3876027|NCT01566331|3702386|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3876028|NCT01566331|3702384|B3|||Age||years|Mean|31.1|31.1|Standard Deviation|2.2|2.2|||
3876029|NCT01566331|3702385|B2|||Age||years|Mean|31.45|31.45|Standard Deviation|1.2|1.2|||
3876030|NCT01566331|3702386|B1|||Age||years|Mean|30.97|30.97|Standard Deviation|5.16|5.16|||
3876034|NCT01566331|3702384|B3||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
3876035|NCT01566331|3702385|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3876036|NCT01566331|3702386|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3876037|NCT01566331|3702384|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3876038|NCT01566331|3702385|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3876039|NCT01566331|3702386|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3876040|NCT01566214|3702393|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3876041|NCT01566214|3702394|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3876042|NCT01566214|3702395|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3876043|NCT01566214|3702393|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3876044|NCT01566214|3702394|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3876045|NCT01566214|3702395|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3876046|NCT01566214|3702393|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876047|NCT01566214|3702394|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876048|NCT01566214|3702395|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876049|NCT01566214|3702393|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3876050|NCT01566214|3702394|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3876051|NCT01566214|3702395|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3876052|NCT01566214|3702393|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876053|NCT01566214|3702394|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876054|NCT01566214|3702395|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876055|NCT01566214|3702393|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876056|NCT01566214|3702394|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876057|NCT01566214|3702395|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876058|NCT01566214|3702393|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876059|NCT01566214|3702394|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876060|NCT01566214|3702395|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876061|NCT01566214|3702393|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876062|NCT01566214|3702394|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876063|NCT01566214|3702395|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876064|NCT01566214|3702393|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3876065|NCT01566214|3702394|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3876066|NCT01566214|3702395|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3876067|NCT01566214|3702393|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3876068|NCT01566214|3702394|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3876069|NCT01566214|3702395|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3876070|NCT01566214|3702393|B3|||Age||Years|Mean|67.00|67.0|Standard Deviation|10.05|10.05|||
3876071|NCT01566214|3702394|B2|||Age||Years|Mean|65.67|65.67|Standard Deviation|8.64|8.64|||
3876072|NCT01566214|3702395|B1|||Age||Years|Mean|68.33|68.33|Standard Deviation|11.98|11.98|||
3876073|NCT01566162|3702426|B1|Italy||Region of Enrollment||participants|Number|0|0.0||||||
3876074|NCT01566162|3702426|B1|South Africa||Region of Enrollment||participants|Number|17|17.0||||||
3876075|NCT01566162|3702426|B1|Russian Federation||Region of Enrollment||participants|Number|19|19.0||||||
3876076|NCT01566162|3702426|B1|Slovakia||Region of Enrollment||participants|Number|15|15.0||||||
3876077|NCT01566162|3702426|B1|United States||Region of Enrollment||participants|Number|114|114.0||||||
3876078|NCT01566162|3702426|B1|France||Region of Enrollment||participants|Number|4|4.0||||||
3876079|NCT01566162|3702426|B1|Serbia||Region of Enrollment||participants|Number|22|22.0||||||
3876080|NCT01566162|3702426|B1||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3876081|NCT01566162|3702426|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3876082|NCT01566162|3702426|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3876083|NCT01566162|3702426|B1||Between 18 and 65 years|Age||Participants|Count of Participants|190|190.0||||||
3876084|NCT01566162|3702426|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3876085|NCT01566162|3702426|B1|||Age||Years|Mean|42.7|42.7|Standard Deviation|12.30|12.3|||
3876086|NCT01566149|3702438|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3876087|NCT01566149|3702439|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3876088|NCT01566149|3702440|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3876089|NCT01566149|3702438|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3876090|NCT01566149|3702439|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3876091|NCT01566149|3702440|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3876092|NCT01566149|3702438|B3|||Age||years|Mean|38.3|38.3|Standard Deviation|14.84|14.84|||
3876093|NCT01566149|3702439|B2|||Age||years|Mean|41.2|41.2|Standard Deviation|14.91|14.91|||
3876094|NCT01566149|3702440|B1|||Age||years|Mean|35.4|35.4|Standard Deviation|14.48|14.48|||
3876095|NCT01566084|3702455|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3876096|NCT01566084|3702456|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3876097|NCT01566084|3702457|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3876098|NCT01566084|3702455|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3876099|NCT01566084|3702456|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3876100|NCT01566084|3702457|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3876101|NCT01566084|3702455|B3|||Age||years|Mean|62|62.0|Standard Deviation|7|7.0|||
3876102|NCT01566084|3702456|B2|||Age||years|Mean|62|62.0|Standard Deviation|7|7.0|||
3876103|NCT01566084|3702457|B1|||Age||years|Mean|62|62.0|Standard Deviation|7|7.0|||
3876104|NCT01565993|3702472|B3|Spain||Region of Enrollment||participants|Number|108|108.0||||||
3876105|NCT01565993|3702473|B2|Spain||Region of Enrollment||participants|Number|42|42.0||||||
3876106|NCT01565993|3702474|B1|Spain||Region of Enrollment||participants|Number|66|66.0||||||
3876107|NCT01565993|3702472|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3876108|NCT01565993|3702473|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3876109|NCT01565993|3702474|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3876110|NCT01565993|3702472|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3876111|NCT01565993|3702473|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3876112|NCT01565993|3702474|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3876113|NCT01565993|3702472|B3|||Age||years|Mean|64.5|64.5|Standard Deviation|11.24|11.24|||
3876114|NCT01565993|3702473|B2|||Age||years|Mean|65.55|65.55|Standard Deviation|12.68|12.68|||
3876115|NCT01565993|3702474|B1|||Age||years|Mean|64.05|64.05|Standard Deviation|10.99|10.99|||
3876116|NCT01565993|3702472|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3876117|NCT01565993|3702473|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3876118|NCT01565993|3702474|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3876119|NCT01565993|3702472|B3||Between 18 and 65 years|Age||Participants|Count of Participants|106|106.0||||||
3876120|NCT01565993|3702473|B2||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3876121|NCT01565993|3702474|B1||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
3876122|NCT01565993|3702472|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3876123|NCT01565993|3702473|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3876124|NCT01565993|3702474|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3876125|NCT01565980|3702481|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3876126|NCT01565980|3702482|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3876127|NCT01565980|3702483|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3876128|NCT01565980|3702481|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3876129|NCT01565980|3702482|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3876130|NCT01565980|3702483|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3876131|NCT01565980|3702481|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876132|NCT01565980|3702482|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876133|NCT01565980|3702483|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876134|NCT01565980|3702481|B3||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3876135|NCT01565980|3702482|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3876136|NCT01565980|3702483|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3876137|NCT01565980|3702481|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3876138|NCT01565980|3702482|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876139|NCT01565980|3702483|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3876140|NCT01565980|3702481|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876141|NCT01565980|3702482|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876142|NCT01565980|3702483|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876143|NCT01565980|3702481|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3876144|NCT01565980|3702482|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3876145|NCT01565980|3702483|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3876146|NCT01565980|3702481|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3876147|NCT01565980|3702482|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876148|NCT01565980|3702483|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3876149|NCT01565980|3702481|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3876150|NCT01565980|3702482|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3876151|NCT01565980|3702483|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876152|NCT01565980|3702481|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3876293|NCT01565889|3702581|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3876153|NCT01565980|3702482|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3876154|NCT01565980|3702483|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3876155|NCT01565980|3702481|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3876156|NCT01565980|3702482|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876157|NCT01565980|3702483|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3876158|NCT01565980|3702481|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3876159|NCT01565980|3702482|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3876160|NCT01565980|3702483|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3876161|NCT01565980|3702481|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3876162|NCT01565980|3702482|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3876163|NCT01565980|3702483|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3876164|NCT01565980|3702481|B3|||Age||years|Mean|66.2|66.2|Standard Deviation|9.4|9.4|||
3876165|NCT01565980|3702482|B2|||Age||years|Mean|64.5|64.5|Standard Deviation|9.25|9.25|||
3876166|NCT01565980|3702483|B1|||Age||years|Mean|67.9|67.9|Standard Deviation|9.5|9.5|||
3876167|NCT01565941|3702502|B3|United States||Region of Enrollment||participants|Number|696|696.0||||||
3876168|NCT01565941|3702503|B2|United States||Region of Enrollment||participants|Number|348|348.0||||||
3876169|NCT01565941|3702504|B1|United States||Region of Enrollment||participants|Number|348|348.0||||||
3876170|NCT01565941|3702502|B3|Canada||Region of Enrollment||participants|Number|2|2.0||||||
3876171|NCT01565941|3702503|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3876172|NCT01565941|3702504|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3876173|NCT01565941|3702502|B3||Male|Sex: Female, Male||Participants|Count of Participants|365|365.0||||||
3876174|NCT01565941|3702503|B2||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3876175|NCT01565941|3702504|B1||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
3876176|NCT01565941|3702502|B3||Female|Sex: Female, Male||Participants|Count of Participants|333|333.0||||||
3876177|NCT01565941|3702503|B2||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3876178|NCT01565941|3702504|B1||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3876179|NCT01565941|3702502|B3|||Age||Years|Median|6.2|6.2|Inter-Quartile Range|||1.6|12.7|
3876180|NCT01565941|3702503|B2|||Age||Years|Median|6.7|6.7|Inter-Quartile Range|||1.7|12.8|
3876181|NCT01565941|3702504|B1|||Age||Years|Median|5.5|5.5|Inter-Quartile Range|||1.4|12.5|
3876182|NCT01565941|3702502|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3876183|NCT01565941|3702503|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3876184|NCT01565941|3702504|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3876185|NCT01565941|3702502|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3876186|NCT01565941|3702503|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3876187|NCT01565941|3702504|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3876188|NCT01565941|3702502|B3||<=18 years|Age||Participants|Count of Participants|698|698.0||||||
3876189|NCT01565941|3702503|B2||<=18 years|Age||Participants|Count of Participants|349|349.0||||||
3876190|NCT01565941|3702504|B1||<=18 years|Age||Participants|Count of Participants|349|349.0||||||
3876191|NCT01565902|3702543|B5||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3876192|NCT01565902|3702544|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3876193|NCT01565902|3702545|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3876194|NCT01565902|3702546|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3876195|NCT01565902|3702547|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3876196|NCT01565902|3702543|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3876197|NCT01565902|3702544|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3876198|NCT01565902|3702545|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3876199|NCT01565902|3702546|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3876200|NCT01565902|3702547|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3876201|NCT01565902|3702543|B5|||Age||Years|Mean|50.7|50.7|Standard Deviation|5.65|5.65|||
3876202|NCT01565902|3702544|B4|||Age||Years|Mean|50.1|50.1|Standard Deviation|5.50|5.5|||
3876203|NCT01565902|3702545|B3|||Age||Years|Mean|51.8|51.8|Standard Deviation|3.41|3.41|||
3876204|NCT01565902|3702546|B2|||Age||Years|Mean|47.8|47.8|Standard Deviation|6.30|6.3|||
3876205|NCT01565902|3702547|B1|||Age||Years|Mean|53.9|53.9|Standard Deviation|6.20|6.2|||
3876206|NCT01565889|3702578|B7|Genotype 4A/4C/4D||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|1|1.0||||||
3876207|NCT01565889|3702579|B6|Genotype 4A/4C/4D||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|1|1.0||||||
3876208|NCT01565889|3702580|B5|Genotype 4A/4C/4D||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3876209|NCT01565889|3702581|B4|Genotype 4A/4C/4D||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3876294|NCT01565889|3702582|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3876210|NCT01565889|3702582|B3|Genotype 4A/4C/4D||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3876211|NCT01565889|3702583|B2|Genotype 4A/4C/4D||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3876212|NCT01565889|3702584|B1|Genotype 4A/4C/4D||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3876213|NCT01565889|3702578|B7|Genotype 4||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|1|1.0||||||
3876214|NCT01565889|3702579|B6|Genotype 4||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3876215|NCT01565889|3702580|B5|Genotype 4||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3876216|NCT01565889|3702581|B4|Genotype 4||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3876217|NCT01565889|3702582|B3|Genotype 4||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3876218|NCT01565889|3702583|B2|Genotype 4||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3876219|NCT01565889|3702584|B1|Genotype 4||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|1|1.0||||||
3876220|NCT01565889|3702578|B7|Genotype 3A||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|6|6.0||||||
3876221|NCT01565889|3702579|B6|Genotype 3A||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|2|2.0||||||
3876222|NCT01565889|3702580|B5|Genotype 3A||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|1|1.0||||||
3876223|NCT01565889|3702581|B4|Genotype 3A||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|2|2.0||||||
3876224|NCT01565889|3702582|B3|Genotype 3A||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3876225|NCT01565889|3702583|B2|Genotype 3A||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|1|1.0||||||
3876226|NCT01565889|3702584|B1|Genotype 3A||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3876227|NCT01565889|3702578|B7|Genotype 2B||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|4|4.0||||||
3876228|NCT01565889|3702579|B6|Genotype 2B||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3876229|NCT01565889|3702580|B5|Genotype 2B||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3876230|NCT01565889|3702581|B4|Genotype 2B||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3876231|NCT01565889|3702582|B3|Genotype 2B||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|2|2.0||||||
3876232|NCT01565889|3702583|B2|Genotype 2B||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|1|1.0||||||
3876233|NCT01565889|3702584|B1|Genotype 2B||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|1|1.0||||||
3876234|NCT01565889|3702578|B7|Genotype 1B||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|9|9.0||||||
3876235|NCT01565889|3702579|B6|Genotype 1B||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|2|2.0||||||
3876236|NCT01565889|3702580|B5|Genotype 1B||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3876237|NCT01565889|3702581|B4|Genotype 1B||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3876238|NCT01565889|3702582|B3|Genotype 1B||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|1|1.0||||||
3876239|NCT01565889|3702583|B2|Genotype 1B||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|1|1.0||||||
3876240|NCT01565889|3702584|B1|Genotype 1B||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|5|5.0||||||
3876295|NCT01565889|3702583|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3876241|NCT01565889|3702578|B7|Genotype 1A||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|31|31.0||||||
3876242|NCT01565889|3702579|B6|Genotype 1A||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|9|9.0||||||
3876243|NCT01565889|3702580|B5|Genotype 1A||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|6|6.0||||||
3876244|NCT01565889|3702581|B4|Genotype 1A||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|5|5.0||||||
3876245|NCT01565889|3702582|B3|Genotype 1A||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|5|5.0||||||
3876246|NCT01565889|3702583|B2|Genotype 1A||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|1|1.0||||||
3876247|NCT01565889|3702584|B1|Genotype 1A||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|5|5.0||||||
3876248|NCT01565889|3702578|B7|Black or African American||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3876249|NCT01565889|3702579|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3876250|NCT01565889|3702580|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3876251|NCT01565889|3702581|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3876252|NCT01565889|3702582|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3876253|NCT01565889|3702583|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3876254|NCT01565889|3702584|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3876255|NCT01565889|3702578|B7|White||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3876256|NCT01565889|3702579|B6|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3876257|NCT01565889|3702580|B5|White||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3876258|NCT01565889|3702581|B4|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3876259|NCT01565889|3702582|B3|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3876260|NCT01565889|3702583|B2|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3876261|NCT01565889|3702584|B1|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3876262|NCT01565889|3702578|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876263|NCT01565889|3702579|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876264|NCT01565889|3702580|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876265|NCT01565889|3702581|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876266|NCT01565889|3702582|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876267|NCT01565889|3702583|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876268|NCT01565889|3702584|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876269|NCT01565889|3702578|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3876270|NCT01565889|3702579|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876271|NCT01565889|3702580|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876272|NCT01565889|3702581|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876273|NCT01565889|3702582|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3876274|NCT01565889|3702583|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876275|NCT01565889|3702584|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876276|NCT01565889|3702578|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3876277|NCT01565889|3702579|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3876278|NCT01565889|3702580|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3876279|NCT01565889|3702581|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3876280|NCT01565889|3702582|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3876281|NCT01565889|3702583|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3876282|NCT01565889|3702584|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3876283|NCT01565889|3702578|B7||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3876284|NCT01565889|3702579|B6||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3876285|NCT01565889|3702580|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3876286|NCT01565889|3702581|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3876287|NCT01565889|3702582|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3876288|NCT01565889|3702583|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3876289|NCT01565889|3702584|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3876290|NCT01565889|3702578|B7||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3876291|NCT01565889|3702579|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3876292|NCT01565889|3702580|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3876296|NCT01565889|3702584|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3876297|NCT01565889|3702578|B7|||Age||years|Mean|47|47.0|Standard Deviation|7.2|7.2|||
3876298|NCT01565889|3702579|B6|||Age||years|Mean|46|46.0|Standard Deviation|8.7|8.7|||
3876299|NCT01565889|3702580|B5|||Age||years|Mean|46|46.0|Standard Deviation|10.3|10.3|||
3876300|NCT01565889|3702581|B4|||Age||years|Mean|47|47.0|Standard Deviation|3.8|3.8|||
3876301|NCT01565889|3702582|B3|||Age||years|Mean|47|47.0|Standard Deviation|6.4|6.4|||
3876302|NCT01565889|3702583|B2|||Age||years|Mean|58|58.0|Standard Deviation|5.3|5.3|||
3876303|NCT01565889|3702584|B1|||Age||years|Mean|54|54.0|Standard Deviation|10.1|10.1|||
3876304|NCT01565850|3702618|B3|≥ 500 cells/μL||CD4 Cell Count Category||participants|Number|48|48.0||||||
3876305|NCT01565850|3702619|B2|≥ 500 cells/μL||CD4 Cell Count Category||participants|Number|20|20.0||||||
3876306|NCT01565850|3702620|B1|≥ 500 cells/μL||CD4 Cell Count Category||participants|Number|28|28.0||||||
3876307|NCT01565850|3702618|B3|351 to ≤ 499 cells/µL||CD4 Cell Count Category||participants|Number|39|39.0||||||
3876308|NCT01565850|3702619|B2|351 to ≤ 499 cells/µL||CD4 Cell Count Category||participants|Number|12|12.0||||||
3876309|NCT01565850|3702620|B1|351 to ≤ 499 cells/µL||CD4 Cell Count Category||participants|Number|27|27.0||||||
3876310|NCT01565850|3702618|B3|200 to ≤ 349 cells/µL||CD4 Cell Count Category||participants|Number|45|45.0||||||
3876311|NCT01565850|3702619|B2|200 to ≤ 349 cells/µL||CD4 Cell Count Category||participants|Number|8|8.0||||||
3876312|NCT01565850|3702620|B1|200 to ≤ 349 cells/µL||CD4 Cell Count Category||participants|Number|37|37.0||||||
3876313|NCT01565850|3702618|B3|50 to ≤ 199 cells/µL||CD4 Cell Count Category||participants|Number|19|19.0||||||
3876314|NCT01565850|3702619|B2|50 to ≤ 199 cells/µL||CD4 Cell Count Category||participants|Number|9|9.0||||||
3876315|NCT01565850|3702620|B1|50 to ≤ 199 cells/µL||CD4 Cell Count Category||participants|Number|10|10.0||||||
3876316|NCT01565850|3702618|B3|< 50 cells/μL||CD4 Cell Count Category||participants|Number|2|2.0||||||
3876317|NCT01565850|3702619|B2|< 50 cells/μL||CD4 Cell Count Category||participants|Number|1|1.0||||||
3876318|NCT01565850|3702620|B1|< 50 cells/μL||CD4 Cell Count Category||participants|Number|1|1.0||||||
3876319|NCT01565850|3702618|B3|||CD4 Cell Count||cells/µL|Mean|417|417.0|Standard Deviation|205.7|205.7|||
3876320|NCT01565850|3702619|B2|||CD4 Cell Count||cells/µL|Mean|464|464.0|Standard Deviation|261.6|261.6|||
3876321|NCT01565850|3702620|B1|||CD4 Cell Count||cells/µL|Mean|395|395.0|Standard Deviation|169.3|169.3|||
3876322|NCT01565850|3702618|B3|> 400,000 copies/mL||HIV-1 RNA Category||participants|Number|8|8.0||||||
3876323|NCT01565850|3702619|B2|> 400,000 copies/mL||HIV-1 RNA Category||participants|Number|2|2.0||||||
3876324|NCT01565850|3702620|B1|> 400,000 copies/mL||HIV-1 RNA Category||participants|Number|6|6.0||||||
3876325|NCT01565850|3702618|B3|> 100,000 to ≤ 400,000 copies/mL||HIV-1 RNA Category||participants|Number|22|22.0||||||
3876326|NCT01565850|3702619|B2|> 100,000 to ≤ 400,000 copies/mL||HIV-1 RNA Category||participants|Number|5|5.0||||||
3876327|NCT01565850|3702620|B1|> 100,000 to ≤ 400,000 copies/mL||HIV-1 RNA Category||participants|Number|17|17.0||||||
3876328|NCT01565850|3702618|B3|≤ 100,000 copies/mL||HIV-1 RNA Category||participants|Number|123|123.0||||||
3876329|NCT01565850|3702619|B2|≤ 100,000 copies/mL||HIV-1 RNA Category||participants|Number|43|43.0||||||
3876330|NCT01565850|3702620|B1|≤ 100,000 copies/mL||HIV-1 RNA Category||participants|Number|80|80.0||||||
3876331|NCT01565850|3702618|B3|||HIV-1 RNA||log10 copies/mL|Mean|4.68|4.68|Standard Deviation|0.515|0.515|||
3876332|NCT01565850|3702619|B2|||HIV-1 RNA||log10 copies/mL|Mean|4.65|4.65|Standard Deviation|0.514|0.514|||
3876333|NCT01565850|3702620|B1|||HIV-1 RNA||log10 copies/mL|Mean|4.70|4.7|Standard Deviation|0.516|0.516|||
3876334|NCT01565850|3702618|B3|United States||Region of Enrollment||participants|Number|153|153.0||||||
3876335|NCT01565850|3702619|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
3876336|NCT01565850|3702620|B1|United States||Region of Enrollment||participants|Number|103|103.0||||||
3876337|NCT01565850|3702618|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3876338|NCT01565850|3702619|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3876339|NCT01565850|3702620|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3876340|NCT01565850|3702618|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3876341|NCT01565850|3702619|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3876342|NCT01565850|3702620|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3876343|NCT01565850|3702618|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3876344|NCT01565850|3702619|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3876345|NCT01565850|3702620|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3876346|NCT01565850|3702618|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
3876347|NCT01565850|3702619|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3876348|NCT01565850|3702620|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3876349|NCT01565850|3702618|B3|White||Race/Ethnicity, Customized||participants|Number|92|92.0||||||
3876350|NCT01565850|3702619|B2|White||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3876351|NCT01565850|3702620|B1|White||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
3876352|NCT01565850|3702618|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876353|NCT01565850|3702619|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876354|NCT01565850|3702620|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876355|NCT01565850|3702618|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|121|121.0||||||
3876356|NCT01565850|3702619|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3876357|NCT01565850|3702620|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3876358|NCT01565850|3702618|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3876359|NCT01565850|3702619|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3876360|NCT01565850|3702620|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3876361|NCT01565850|3702618|B3||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3876362|NCT01565850|3702619|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3876363|NCT01565850|3702620|B1||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3876364|NCT01565850|3702618|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3876365|NCT01565850|3702619|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3876366|NCT01565850|3702620|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3876367|NCT01565850|3702618|B3|||Age||years|Mean|35|35.0|Standard Deviation|11.2|11.2|||
3876368|NCT01565850|3702619|B2|||Age||years|Mean|37|37.0|Standard Deviation|10.9|10.9|||
3876369|NCT01565850|3702620|B1|||Age||years|Mean|35|35.0|Standard Deviation|11.3|11.3|||
3876370|NCT01565707|3702637|B5|||Mean Number of Grade 3 or 4 Urgency Episodes per 24 Hours in Adolescents|FAS population. Adolescent participants were asked to record the degree of urgency associated with each micturition and incontinence episode according to the Patient Perception of Intensity of Urgency Scale (PPIUS) scale (0 - no urgency, 1 - mild urgency, 2 - moderate urgency, 3 - severe urgency, 4 - urge incontinence). The mean number of grade 3 or 4 urgency episodes was determined using diary data recorded by the participant in the 7 days prior to baseline visit. The number of participants was N/A; N/A; 19; 20 per treatment arm.|urgency episodes|Mean|3.03|3.03|Standard Deviation|3.29|3.29|||
3876371|NCT01565707|3702638|B4|||Mean Number of Grade 3 or 4 Urgency Episodes per 24 Hours in Adolescents|FAS population. Adolescent participants were asked to record the degree of urgency associated with each micturition and incontinence episode according to the Patient Perception of Intensity of Urgency Scale (PPIUS) scale (0 - no urgency, 1 - mild urgency, 2 - moderate urgency, 3 - severe urgency, 4 - urge incontinence). The mean number of grade 3 or 4 urgency episodes was determined using diary data recorded by the participant in the 7 days prior to baseline visit. The number of participants was N/A; N/A; 19; 20 per treatment arm.|urgency episodes|Mean|2.42|2.42|Standard Deviation|2.13|2.13|||
3876372|NCT01565707|3702639|B3|||Mean Number of Grade 3 or 4 Urgency Episodes per 24 Hours in Adolescents|FAS population. Adolescent participants were asked to record the degree of urgency associated with each micturition and incontinence episode according to the Patient Perception of Intensity of Urgency Scale (PPIUS) scale (0 - no urgency, 1 - mild urgency, 2 - moderate urgency, 3 - severe urgency, 4 - urge incontinence). The mean number of grade 3 or 4 urgency episodes was determined using diary data recorded by the participant in the 7 days prior to baseline visit. The number of participants was N/A; N/A; 19; 20 per treatment arm.|urgency episodes|Mean|3.67|3.67|Standard Deviation|4.15|4.15|||
3876373|NCT01565707|3702640|B2|||Mean Number of Grade 3 or 4 Urgency Episodes per 24 Hours in Adolescents|FAS population. Adolescent participants were asked to record the degree of urgency associated with each micturition and incontinence episode according to the Patient Perception of Intensity of Urgency Scale (PPIUS) scale (0 - no urgency, 1 - mild urgency, 2 - moderate urgency, 3 - severe urgency, 4 - urge incontinence). The mean number of grade 3 or 4 urgency episodes was determined using diary data recorded by the participant in the 7 days prior to baseline visit. The number of participants was N/A; N/A; 19; 20 per treatment arm.|urgency episodes|Mean|NA||Standard Deviation|NA||||Baseline measure not applicable to the arm.
3876374|NCT01565707|3702641|B1|||Mean Number of Grade 3 or 4 Urgency Episodes per 24 Hours in Adolescents|FAS population. Adolescent participants were asked to record the degree of urgency associated with each micturition and incontinence episode according to the Patient Perception of Intensity of Urgency Scale (PPIUS) scale (0 - no urgency, 1 - mild urgency, 2 - moderate urgency, 3 - severe urgency, 4 - urge incontinence). The mean number of grade 3 or 4 urgency episodes was determined using diary data recorded by the participant in the 7 days prior to baseline visit. The number of participants was N/A; N/A; 19; 20 per treatment arm.|urgency episodes|Mean|NA||Standard Deviation|NA||||Baseline measure not applicable to the arm.
3876375|NCT01565707|3702637|B5|Adolescents||Mean Number of Nighttime Micturitions per 24 Hours|FAS population. The mean of the number of micturitions was determined using diary data recorded by the participant in the 7 days prior to baseline visit. A micturition is any voluntary urination, excluding episodes of incontinence only. The number of participants was 70; 71; 19; 21 per treatment arm.|nighttime micturitions|Mean|0.43|0.43|Standard Deviation|0.81|0.81|||
3876376|NCT01565707|3702638|B4|Adolescents||Mean Number of Nighttime Micturitions per 24 Hours|FAS population. The mean of the number of micturitions was determined using diary data recorded by the participant in the 7 days prior to baseline visit. A micturition is any voluntary urination, excluding episodes of incontinence only. The number of participants was 70; 71; 19; 21 per treatment arm.|nighttime micturitions|Mean|0.26|0.26|Standard Deviation|0.41|0.41|||
3876377|NCT01565707|3702639|B3|Adolescents||Mean Number of Nighttime Micturitions per 24 Hours|FAS population. The mean of the number of micturitions was determined using diary data recorded by the participant in the 7 days prior to baseline visit. A micturition is any voluntary urination, excluding episodes of incontinence only. The number of participants was 70; 71; 19; 21 per treatment arm.|nighttime micturitions|Mean|0.61|0.61|Standard Deviation|1.09|1.09|||
3876378|NCT01565707|3702640|B2|Adolescents||Mean Number of Nighttime Micturitions per 24 Hours|FAS population. The mean of the number of micturitions was determined using diary data recorded by the participant in the 7 days prior to baseline visit. A micturition is any voluntary urination, excluding episodes of incontinence only. The number of participants was 70; 71; 19; 21 per treatment arm.|nighttime micturitions|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876477|NCT01565707|3702639|B3|Not Hispanic or Latino||Ethnicity|SAF population. The number of participants was 73; 73; 19; 22 per treatment arm.|Participants|Number|16|16.0||||||
3876478|NCT01565707|3702640|B2|Not Hispanic or Latino||Ethnicity|SAF population. The number of participants was 73; 73; 19; 22 per treatment arm.|Participants|Number|64|64.0||||||
3876379|NCT01565707|3702641|B1|Adolescents||Mean Number of Nighttime Micturitions per 24 Hours|FAS population. The mean of the number of micturitions was determined using diary data recorded by the participant in the 7 days prior to baseline visit. A micturition is any voluntary urination, excluding episodes of incontinence only. The number of participants was 70; 71; 19; 21 per treatment arm.|nighttime micturitions|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876380|NCT01565707|3702637|B5|Children||Mean Number of Nighttime Micturitions per 24 Hours|FAS population. The mean of the number of micturitions was determined using diary data recorded by the participant in the 7 days prior to baseline visit. A micturition is any voluntary urination, excluding episodes of incontinence only. The number of participants was 70; 71; 19; 21 per treatment arm.|nighttime micturitions|Mean|0.58|0.58|Standard Deviation|0.88|0.88|||
3876381|NCT01565707|3702638|B4|Children||Mean Number of Nighttime Micturitions per 24 Hours|FAS population. The mean of the number of micturitions was determined using diary data recorded by the participant in the 7 days prior to baseline visit. A micturition is any voluntary urination, excluding episodes of incontinence only. The number of participants was 70; 71; 19; 21 per treatment arm.|nighttime micturitions|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876382|NCT01565707|3702639|B3|Children||Mean Number of Nighttime Micturitions per 24 Hours|FAS population. The mean of the number of micturitions was determined using diary data recorded by the participant in the 7 days prior to baseline visit. A micturition is any voluntary urination, excluding episodes of incontinence only. The number of participants was 70; 71; 19; 21 per treatment arm.|nighttime micturitions|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876383|NCT01565707|3702640|B2|Children||Mean Number of Nighttime Micturitions per 24 Hours|FAS population. The mean of the number of micturitions was determined using diary data recorded by the participant in the 7 days prior to baseline visit. A micturition is any voluntary urination, excluding episodes of incontinence only. The number of participants was 70; 71; 19; 21 per treatment arm.|nighttime micturitions|Mean|0.56|0.56|Standard Deviation|0.98|0.98|||
3876384|NCT01565707|3702641|B1|Children||Mean Number of Nighttime Micturitions per 24 Hours|FAS population. The mean of the number of micturitions was determined using diary data recorded by the participant in the 7 days prior to baseline visit. A micturition is any voluntary urination, excluding episodes of incontinence only. The number of participants was 70; 71; 19; 21 per treatment arm.|nighttime micturitions|Mean|0.60|0.6|Standard Deviation|0.78|0.78|||
3876385|NCT01565707|3702637|B5|Adolescents||Mean Number of Daytime Micturitions per 24 Hours|FAS population. The mean of the number of micturitions was determined using diary data recorded by the participant in the 7 days prior to baseline visit. A micturition is any voluntary urination, excluding episodes of incontinence only. The number of participants was 70; 71; 19; 21 per treatment arm.|daytime micturitions|Mean|6.84|6.84|Standard Deviation|2.51|2.51|||
3876386|NCT01565707|3702638|B4|Adolescents||Mean Number of Daytime Micturitions per 24 Hours|FAS population. The mean of the number of micturitions was determined using diary data recorded by the participant in the 7 days prior to baseline visit. A micturition is any voluntary urination, excluding episodes of incontinence only. The number of participants was 70; 71; 19; 21 per treatment arm.|daytime micturitions|Mean|6.88|6.88|Standard Deviation|2.14|2.14|||
3876387|NCT01565707|3702639|B3|Adolescents||Mean Number of Daytime Micturitions per 24 Hours|FAS population. The mean of the number of micturitions was determined using diary data recorded by the participant in the 7 days prior to baseline visit. A micturition is any voluntary urination, excluding episodes of incontinence only. The number of participants was 70; 71; 19; 21 per treatment arm.|daytime micturitions|Mean|6.79|6.79|Standard Deviation|2.92|2.92|||
3876388|NCT01565707|3702640|B2|Adolescents||Mean Number of Daytime Micturitions per 24 Hours|FAS population. The mean of the number of micturitions was determined using diary data recorded by the participant in the 7 days prior to baseline visit. A micturition is any voluntary urination, excluding episodes of incontinence only. The number of participants was 70; 71; 19; 21 per treatment arm.|daytime micturitions|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876389|NCT01565707|3702641|B1|Adolescents||Mean Number of Daytime Micturitions per 24 Hours|FAS population. The mean of the number of micturitions was determined using diary data recorded by the participant in the 7 days prior to baseline visit. A micturition is any voluntary urination, excluding episodes of incontinence only. The number of participants was 70; 71; 19; 21 per treatment arm.|daytime micturitions|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876390|NCT01565707|3702637|B5|Children||Mean Number of Daytime Micturitions per 24 Hours|FAS population. The mean of the number of micturitions was determined using diary data recorded by the participant in the 7 days prior to baseline visit. A micturition is any voluntary urination, excluding episodes of incontinence only. The number of participants was 70; 71; 19; 21 per treatment arm.|daytime micturitions|Mean|7.77|7.77|Standard Deviation|3.27|3.27|||
3876391|NCT01565707|3702638|B4|Children||Mean Number of Daytime Micturitions per 24 Hours|FAS population. The mean of the number of micturitions was determined using diary data recorded by the participant in the 7 days prior to baseline visit. A micturition is any voluntary urination, excluding episodes of incontinence only. The number of participants was 70; 71; 19; 21 per treatment arm.|daytime micturitions|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876392|NCT01565707|3702639|B3|Children||Mean Number of Daytime Micturitions per 24 Hours|FAS population. The mean of the number of micturitions was determined using diary data recorded by the participant in the 7 days prior to baseline visit. A micturition is any voluntary urination, excluding episodes of incontinence only. The number of participants was 70; 71; 19; 21 per treatment arm.|daytime micturitions|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876393|NCT01565707|3702640|B2|Children||Mean Number of Daytime Micturitions per 24 Hours|FAS population. The mean of the number of micturitions was determined using diary data recorded by the participant in the 7 days prior to baseline visit. A micturition is any voluntary urination, excluding episodes of incontinence only. The number of participants was 70; 71; 19; 21 per treatment arm.|daytime micturitions|Mean|8.00|8.0|Standard Deviation|3.40|3.4|||
3876394|NCT01565707|3702641|B1|Children||Mean Number of Daytime Micturitions per 24 Hours|FAS population. The mean of the number of micturitions was determined using diary data recorded by the participant in the 7 days prior to baseline visit. A micturition is any voluntary urination, excluding episodes of incontinence only. The number of participants was 70; 71; 19; 21 per treatment arm.|daytime micturitions|Mean|7.54|7.54|Standard Deviation|3.14|3.14|||
3876395|NCT01565707|3702637|B5|Adolescents||Mean Number of Micturitions per 24 Hours|FAS population. The mean of the number of micturitions was determined using diary data recorded by the participant in the 7 days prior to baseline visit. A micturition is any voluntary urination, excluding episodes of incontinence only. The number of participants was 70; 73; 19; 21 per treatment arm.|micturitions|Mean|7.79|7.79|Standard Deviation|3.11|3.11|||
3876396|NCT01565707|3702638|B4|Adolescents||Mean Number of Micturitions per 24 Hours|FAS population. The mean of the number of micturitions was determined using diary data recorded by the participant in the 7 days prior to baseline visit. A micturition is any voluntary urination, excluding episodes of incontinence only. The number of participants was 70; 73; 19; 21 per treatment arm.|micturitions|Mean|7.52|7.52|Standard Deviation|2.37|2.37|||
3876397|NCT01565707|3702639|B3|Adolescents||Mean Number of Micturitions per 24 Hours|FAS population. The mean of the number of micturitions was determined using diary data recorded by the participant in the 7 days prior to baseline visit. A micturition is any voluntary urination, excluding episodes of incontinence only. The number of participants was 70; 73; 19; 21 per treatment arm.|micturitions|Mean|8.08|8.08|Standard Deviation|3.82|3.82|||
3876398|NCT01565707|3702640|B2|Adolescents||Mean Number of Micturitions per 24 Hours|FAS population. The mean of the number of micturitions was determined using diary data recorded by the participant in the 7 days prior to baseline visit. A micturition is any voluntary urination, excluding episodes of incontinence only. The number of participants was 70; 73; 19; 21 per treatment arm.|micturitions|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876399|NCT01565707|3702641|B1|Adolescents||Mean Number of Micturitions per 24 Hours|FAS population. The mean of the number of micturitions was determined using diary data recorded by the participant in the 7 days prior to baseline visit. A micturition is any voluntary urination, excluding episodes of incontinence only. The number of participants was 70; 73; 19; 21 per treatment arm.|micturitions|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876400|NCT01565707|3702637|B5|Children||Mean Number of Micturitions per 24 Hours|FAS population. The mean of the number of micturitions was determined using diary data recorded by the participant in the 7 days prior to baseline visit. A micturition is any voluntary urination, excluding episodes of incontinence only. The number of participants was 70; 73; 19; 21 per treatment arm.|micturitions|Mean|8.27|8.27|Standard Deviation|2.79|2.79|||
3876401|NCT01565707|3702638|B4|Children||Mean Number of Micturitions per 24 Hours|FAS population. The mean of the number of micturitions was determined using diary data recorded by the participant in the 7 days prior to baseline visit. A micturition is any voluntary urination, excluding episodes of incontinence only. The number of participants was 70; 73; 19; 21 per treatment arm.|micturitions|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876402|NCT01565707|3702639|B3|Children||Mean Number of Micturitions per 24 Hours|FAS population. The mean of the number of micturitions was determined using diary data recorded by the participant in the 7 days prior to baseline visit. A micturition is any voluntary urination, excluding episodes of incontinence only. The number of participants was 70; 73; 19; 21 per treatment arm.|micturitions|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876403|NCT01565707|3702640|B2|Children||Mean Number of Micturitions per 24 Hours|FAS population. The mean of the number of micturitions was determined using diary data recorded by the participant in the 7 days prior to baseline visit. A micturition is any voluntary urination, excluding episodes of incontinence only. The number of participants was 70; 73; 19; 21 per treatment arm.|micturitions|Mean|8.27|8.27|Standard Deviation|3.01|3.01|||
3876404|NCT01565707|3702641|B1|Children||Mean Number of Micturitions per 24 Hours|FAS population. The mean of the number of micturitions was determined using diary data recorded by the participant in the 7 days prior to baseline visit. A micturition is any voluntary urination, excluding episodes of incontinence only. The number of participants was 70; 73; 19; 21 per treatment arm.|micturitions|Mean|8.26|8.26|Standard Deviation|2.56|2.56|||
3876405|NCT01565707|3702637|B5|Adolescents||Number of Dry (Incontinence-free) Nights per 7 Days|FAS population. The mean of the number of dry nights was determined using diary data recorded by the participant in the 7 days prior to baseline visit. The number of participants was 70; 73; 19; 21 per treatment arm.|Dry Nights|Mean|5.5|5.5|Standard Deviation|2.2|2.2|||
3876406|NCT01565707|3702638|B4|Adolescents||Number of Dry (Incontinence-free) Nights per 7 Days|FAS population. The mean of the number of dry nights was determined using diary data recorded by the participant in the 7 days prior to baseline visit. The number of participants was 70; 73; 19; 21 per treatment arm.|Dry Nights|Mean|5.4|5.4|Standard Deviation|2.2|2.2|||
3876407|NCT01565707|3702639|B3|Adolescents||Number of Dry (Incontinence-free) Nights per 7 Days|FAS population. The mean of the number of dry nights was determined using diary data recorded by the participant in the 7 days prior to baseline visit. The number of participants was 70; 73; 19; 21 per treatment arm.|Dry Nights|Mean|5.6|5.6|Standard Deviation|2.2|2.2|||
3876408|NCT01565707|3702640|B2|Adolescents||Number of Dry (Incontinence-free) Nights per 7 Days|FAS population. The mean of the number of dry nights was determined using diary data recorded by the participant in the 7 days prior to baseline visit. The number of participants was 70; 73; 19; 21 per treatment arm.|Dry Nights|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876409|NCT01565707|3702641|B1|Adolescents||Number of Dry (Incontinence-free) Nights per 7 Days|FAS population. The mean of the number of dry nights was determined using diary data recorded by the participant in the 7 days prior to baseline visit. The number of participants was 70; 73; 19; 21 per treatment arm.|Dry Nights|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876410|NCT01565707|3702637|B5|Children||Number of Dry (Incontinence-free) Nights per 7 Days|FAS population. The mean of the number of dry nights was determined using diary data recorded by the participant in the 7 days prior to baseline visit. The number of participants was 70; 73; 19; 21 per treatment arm.|Dry Nights|Mean|3.2|3.2|Standard Deviation|3.0|3.0|||
3876411|NCT01565707|3702638|B4|Children||Number of Dry (Incontinence-free) Nights per 7 Days|FAS population. The mean of the number of dry nights was determined using diary data recorded by the participant in the 7 days prior to baseline visit. The number of participants was 70; 73; 19; 21 per treatment arm.|Dry Nights|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876479|NCT01565707|3702641|B1|Not Hispanic or Latino||Ethnicity|SAF population. The number of participants was 73; 73; 19; 22 per treatment arm.|Participants|Number|65|65.0||||||
3876730|NCT01565330|3702837|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3876412|NCT01565707|3702639|B3|Children||Number of Dry (Incontinence-free) Nights per 7 Days|FAS population. The mean of the number of dry nights was determined using diary data recorded by the participant in the 7 days prior to baseline visit. The number of participants was 70; 73; 19; 21 per treatment arm.|Dry Nights|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876413|NCT01565707|3702640|B2|Children||Number of Dry (Incontinence-free) Nights per 7 Days|FAS population. The mean of the number of dry nights was determined using diary data recorded by the participant in the 7 days prior to baseline visit. The number of participants was 70; 73; 19; 21 per treatment arm.|Dry Nights|Mean|3.1|3.1|Standard Deviation|3.0|3.0|||
3876414|NCT01565707|3702641|B1|Children||Number of Dry (Incontinence-free) Nights per 7 Days|FAS population. The mean of the number of dry nights was determined using diary data recorded by the participant in the 7 days prior to baseline visit. The number of participants was 70; 73; 19; 21 per treatment arm.|Dry Nights|Mean|3.4|3.4|Standard Deviation|3.0|3.0|||
3876415|NCT01565707|3702637|B5|Adolescents||Number of Dry (Incontinence-free) Days per 7 Days|FAS population. The mean of the number of dry days was determined using diary data recorded by the participant in the 7 days prior to baseline visit. The number of participants was 70; 73; 19; 21 per treatment arm.|Dry Days|Mean|1.3|1.3|Standard Deviation|1.2|1.2|||
3876416|NCT01565707|3702638|B4|Adolescents||Number of Dry (Incontinence-free) Days per 7 Days|FAS population. The mean of the number of dry days was determined using diary data recorded by the participant in the 7 days prior to baseline visit. The number of participants was 70; 73; 19; 21 per treatment arm.|Dry Days|Mean|1.5|1.5|Standard Deviation|1.3|1.3|||
3876417|NCT01565707|3702639|B3|Adolescents||Number of Dry (Incontinence-free) Days per 7 Days|FAS population. The mean of the number of dry days was determined using diary data recorded by the participant in the 7 days prior to baseline visit. The number of participants was 70; 73; 19; 21 per treatment arm.|Dry Days|Mean|1.0|1.0|Standard Deviation|1.0|1.0|||
3876418|NCT01565707|3702640|B2|Adolescents||Number of Dry (Incontinence-free) Days per 7 Days|FAS population. The mean of the number of dry days was determined using diary data recorded by the participant in the 7 days prior to baseline visit. The number of participants was 70; 73; 19; 21 per treatment arm.|Dry Days|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876419|NCT01565707|3702641|B1|Adolescents||Number of Dry (Incontinence-free) Days per 7 Days|FAS population. The mean of the number of dry days was determined using diary data recorded by the participant in the 7 days prior to baseline visit. The number of participants was 70; 73; 19; 21 per treatment arm.|Dry Days|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876420|NCT01565707|3702637|B5|Children||Number of Dry (Incontinence-free) Days per 7 Days|FAS population. The mean of the number of dry days was determined using diary data recorded by the participant in the 7 days prior to baseline visit. The number of participants was 70; 73; 19; 21 per treatment arm.|Dry Days|Mean|0.7|0.7|Standard Deviation|1.3|1.3|||
3876421|NCT01565707|3702638|B4|Children||Number of Dry (Incontinence-free) Days per 7 Days|FAS population. The mean of the number of dry days was determined using diary data recorded by the participant in the 7 days prior to baseline visit. The number of participants was 70; 73; 19; 21 per treatment arm.|Dry Days|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876422|NCT01565707|3702639|B3|Children||Number of Dry (Incontinence-free) Days per 7 Days|FAS population. The mean of the number of dry days was determined using diary data recorded by the participant in the 7 days prior to baseline visit. The number of participants was 70; 73; 19; 21 per treatment arm.|Dry Days|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876423|NCT01565707|3702640|B2|Children||Number of Dry (Incontinence-free) Days per 7 Days|FAS population. The mean of the number of dry days was determined using diary data recorded by the participant in the 7 days prior to baseline visit. The number of participants was 70; 73; 19; 21 per treatment arm.|Dry Days|Mean|0.9|0.9|Standard Deviation|1.6|1.6|||
3876424|NCT01565707|3702641|B1|Children||Number of Dry (Incontinence-free) Days per 7 Days|FAS population. The mean of the number of dry days was determined using diary data recorded by the participant in the 7 days prior to baseline visit. The number of participants was 70; 73; 19; 21 per treatment arm.|Dry Days|Mean|0.5|0.5|Standard Deviation|0.9|0.9|||
3876425|NCT01565707|3702637|B5|Adolescents||Mean Number of Nighttime Incontinence Episodes per 24 Hours|FAS population. The mean of the number of incontinence episodes was determined using diary data recorded by the participant in the 7 days prior to baseline visit. An incontinence episode is defined as an episode with any involuntary loss of urine. Nighttime is defined as the time between going to bed and waking up the following morning. The number of participants was 70; 71; 19; 21 per treatment arm.|nighttime incontinence episodes|Mean|0.36|0.36|Standard Deviation|0.53|0.53|||
3876426|NCT01565707|3702638|B4|Adolescents||Mean Number of Nighttime Incontinence Episodes per 24 Hours|FAS population. The mean of the number of incontinence episodes was determined using diary data recorded by the participant in the 7 days prior to baseline visit. An incontinence episode is defined as an episode with any involuntary loss of urine. Nighttime is defined as the time between going to bed and waking up the following morning. The number of participants was 70; 71; 19; 21 per treatment arm.|nighttime incontinence episodes|Mean|0.33|0.33|Standard Deviation|0.40|0.4|||
3876427|NCT01565707|3702639|B3|Adolescents||Mean Number of Nighttime Incontinence Episodes per 24 Hours|FAS population. The mean of the number of incontinence episodes was determined using diary data recorded by the participant in the 7 days prior to baseline visit. An incontinence episode is defined as an episode with any involuntary loss of urine. Nighttime is defined as the time between going to bed and waking up the following morning. The number of participants was 70; 71; 19; 21 per treatment arm.|nighttime incontinence episodes|Mean|0.39|0.39|Standard Deviation|0.66|0.66|||
3876428|NCT01565707|3702640|B2|Adolescents||Mean Number of Nighttime Incontinence Episodes per 24 Hours|FAS population. The mean of the number of incontinence episodes was determined using diary data recorded by the participant in the 7 days prior to baseline visit. An incontinence episode is defined as an episode with any involuntary loss of urine. Nighttime is defined as the time between going to bed and waking up the following morning. The number of participants was 70; 71; 19; 21 per treatment arm.|nighttime incontinence episodes|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876480|NCT01565707|3702637|B5|Hispanic or Latino||Ethnicity|SAF population. The number of participants was 73; 73; 19; 22 per treatment arm.|Participants|Number|22|22.0||||||
3876731|NCT01565330|3702833|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3876429|NCT01565707|3702641|B1|Adolescents||Mean Number of Nighttime Incontinence Episodes per 24 Hours|FAS population. The mean of the number of incontinence episodes was determined using diary data recorded by the participant in the 7 days prior to baseline visit. An incontinence episode is defined as an episode with any involuntary loss of urine. Nighttime is defined as the time between going to bed and waking up the following morning. The number of participants was 70; 71; 19; 21 per treatment arm.|nighttime incontinence episodes|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876430|NCT01565707|3702637|B5|Children||Mean Number of Nighttime Incontinence Episodes per 24 Hours|FAS population. The mean of the number of incontinence episodes was determined using diary data recorded by the participant in the 7 days prior to baseline visit. An incontinence episode is defined as an episode with any involuntary loss of urine. Nighttime is defined as the time between going to bed and waking up the following morning. The number of participants was 70; 71; 19; 21 per treatment arm.|nighttime incontinence episodes|Mean|0.64|0.64|Standard Deviation|0.67|0.67|||
3876431|NCT01565707|3702638|B4|Children||Mean Number of Nighttime Incontinence Episodes per 24 Hours|FAS population. The mean of the number of incontinence episodes was determined using diary data recorded by the participant in the 7 days prior to baseline visit. An incontinence episode is defined as an episode with any involuntary loss of urine. Nighttime is defined as the time between going to bed and waking up the following morning. The number of participants was 70; 71; 19; 21 per treatment arm.|nighttime incontinence episodes|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876432|NCT01565707|3702639|B3|Children||Mean Number of Nighttime Incontinence Episodes per 24 Hours|FAS population. The mean of the number of incontinence episodes was determined using diary data recorded by the participant in the 7 days prior to baseline visit. An incontinence episode is defined as an episode with any involuntary loss of urine. Nighttime is defined as the time between going to bed and waking up the following morning. The number of participants was 70; 71; 19; 21 per treatment arm.|nighttime incontinence episodes|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876433|NCT01565707|3702640|B2|Children||Mean Number of Nighttime Incontinence Episodes per 24 Hours|FAS population. The mean of the number of incontinence episodes was determined using diary data recorded by the participant in the 7 days prior to baseline visit. An incontinence episode is defined as an episode with any involuntary loss of urine. Nighttime is defined as the time between going to bed and waking up the following morning. The number of participants was 70; 71; 19; 21 per treatment arm.|nighttime incontinence episodes|Mean|0.70|0.7|Standard Deviation|0.82|0.82|||
3876434|NCT01565707|3702641|B1|Children||Mean Number of Nighttime Incontinence Episodes per 24 Hours|FAS population. The mean of the number of incontinence episodes was determined using diary data recorded by the participant in the 7 days prior to baseline visit. An incontinence episode is defined as an episode with any involuntary loss of urine. Nighttime is defined as the time between going to bed and waking up the following morning. The number of participants was 70; 71; 19; 21 per treatment arm.|nighttime incontinence episodes|Mean|0.59|0.59|Standard Deviation|0.47|0.47|||
3876435|NCT01565707|3702637|B5|Adolescents||Mean Number of Daytime Incontinence Episodes per 24 Hours|FAS population. The mean of the number of incontinence episodes was determined using diary data recorded by the participant in the 7 days prior to baseline visit. Daytime is defined as the time between waking up in the morning and going to bed later the same day. An incontinence episode is defined as an episode with any involuntary loss of urine. The number of participants was 70; 71; 19; 21 per treatment arm.|daytime incontinence episodes|Mean|1.75|1.75|Standard Deviation|1.83|1.83|||
3876436|NCT01565707|3702638|B4|Adolescents||Mean Number of Daytime Incontinence Episodes per 24 Hours|FAS population. The mean of the number of incontinence episodes was determined using diary data recorded by the participant in the 7 days prior to baseline visit. Daytime is defined as the time between waking up in the morning and going to bed later the same day. An incontinence episode is defined as an episode with any involuntary loss of urine. The number of participants was 70; 71; 19; 21 per treatment arm.|daytime incontinence episodes|Mean|1.50|1.5|Standard Deviation|1.44|1.44|||
3876437|NCT01565707|3702639|B3|Adolescents||Mean Number of Daytime Incontinence Episodes per 24 Hours|FAS population. The mean of the number of incontinence episodes was determined using diary data recorded by the participant in the 7 days prior to baseline visit. Daytime is defined as the time between waking up in the morning and going to bed later the same day. An incontinence episode is defined as an episode with any involuntary loss of urine. The number of participants was 70; 71; 19; 21 per treatment arm.|daytime incontinence episodes|Mean|2.03|2.03|Standard Deviation|2.18|2.18|||
3876438|NCT01565707|3702640|B2|Adolescents||Mean Number of Daytime Incontinence Episodes per 24 Hours|FAS population. The mean of the number of incontinence episodes was determined using diary data recorded by the participant in the 7 days prior to baseline visit. Daytime is defined as the time between waking up in the morning and going to bed later the same day. An incontinence episode is defined as an episode with any involuntary loss of urine. The number of participants was 70; 71; 19; 21 per treatment arm.|daytime incontinence episodes|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876439|NCT01565707|3702641|B1|Adolescents||Mean Number of Daytime Incontinence Episodes per 24 Hours|FAS population. The mean of the number of incontinence episodes was determined using diary data recorded by the participant in the 7 days prior to baseline visit. Daytime is defined as the time between waking up in the morning and going to bed later the same day. An incontinence episode is defined as an episode with any involuntary loss of urine. The number of participants was 70; 71; 19; 21 per treatment arm.|daytime incontinence episodes|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876440|NCT01565707|3702637|B5|Children||Mean Number of Daytime Incontinence Episodes per 24 Hours|FAS population. The mean of the number of incontinence episodes was determined using diary data recorded by the participant in the 7 days prior to baseline visit. Daytime is defined as the time between waking up in the morning and going to bed later the same day. An incontinence episode is defined as an episode with any involuntary loss of urine. The number of participants was 70; 71; 19; 21 per treatment arm.|daytime incontinence episodes|Mean|2.26|2.26|Standard Deviation|3.01|3.01|||
3876481|NCT01565707|3702638|B4|Hispanic or Latino||Ethnicity|SAF population. The number of participants was 73; 73; 19; 22 per treatment arm.|Participants|Number|2|2.0||||||
3876482|NCT01565707|3702639|B3|Hispanic or Latino||Ethnicity|SAF population. The number of participants was 73; 73; 19; 22 per treatment arm.|Participants|Number|3|3.0||||||
3876732|NCT01565330|3702834|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3876441|NCT01565707|3702638|B4|Children||Mean Number of Daytime Incontinence Episodes per 24 Hours|FAS population. The mean of the number of incontinence episodes was determined using diary data recorded by the participant in the 7 days prior to baseline visit. Daytime is defined as the time between waking up in the morning and going to bed later the same day. An incontinence episode is defined as an episode with any involuntary loss of urine. The number of participants was 70; 71; 19; 21 per treatment arm.|daytime incontinence episodes|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876442|NCT01565707|3702639|B3|Children||Mean Number of Daytime Incontinence Episodes per 24 Hours|FAS population. The mean of the number of incontinence episodes was determined using diary data recorded by the participant in the 7 days prior to baseline visit. Daytime is defined as the time between waking up in the morning and going to bed later the same day. An incontinence episode is defined as an episode with any involuntary loss of urine. The number of participants was 70; 71; 19; 21 per treatment arm.|daytime incontinence episodes|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876443|NCT01565707|3702640|B2|Children||Mean Number of Daytime Incontinence Episodes per 24 Hours|FAS population. The mean of the number of incontinence episodes was determined using diary data recorded by the participant in the 7 days prior to baseline visit. Daytime is defined as the time between waking up in the morning and going to bed later the same day. An incontinence episode is defined as an episode with any involuntary loss of urine. The number of participants was 70; 71; 19; 21 per treatment arm.|daytime incontinence episodes|Mean|1.98|1.98|Standard Deviation|3.24|3.24|||
3876444|NCT01565707|3702641|B1|Children||Mean Number of Daytime Incontinence Episodes per 24 Hours|FAS population. The mean of the number of incontinence episodes was determined using diary data recorded by the participant in the 7 days prior to baseline visit. Daytime is defined as the time between waking up in the morning and going to bed later the same day. An incontinence episode is defined as an episode with any involuntary loss of urine. The number of participants was 70; 71; 19; 21 per treatment arm.|daytime incontinence episodes|Mean|2.54|2.54|Standard Deviation|2.75|2.75|||
3876445|NCT01565707|3702637|B5|Adolescents||Mean Number of Incontinence Episodes per 24 Hours|FAS population. The mean of the number of incontinence episodes was determined using diary data recorded by the participant in the 7 days prior to baseline visit. An incontinence episode is defined as an episode with any involuntary loss of urine. The number of participants was 70; 73; 19; 21 per treatment arm.|incontinence episodes|Mean|2.29|2.29|Standard Deviation|2.11|2.11|||
3876446|NCT01565707|3702638|B4|Adolescents||Mean Number of Incontinence Episodes per 24 Hours|FAS population. The mean of the number of incontinence episodes was determined using diary data recorded by the participant in the 7 days prior to baseline visit. An incontinence episode is defined as an episode with any involuntary loss of urine. The number of participants was 70; 73; 19; 21 per treatment arm.|incontinence episodes|Mean|1.82|1.82|Standard Deviation|1.66|1.66|||
3876447|NCT01565707|3702639|B3|Adolescents||Mean Number of Incontinence Episodes per 24 Hours|FAS population. The mean of the number of incontinence episodes was determined using diary data recorded by the participant in the 7 days prior to baseline visit. An incontinence episode is defined as an episode with any involuntary loss of urine. The number of participants was 70; 73; 19; 21 per treatment arm.|incontinence episodes|Mean|2.81|2.81|Standard Deviation|2.45|2.45|||
3876448|NCT01565707|3702640|B2|Adolescents||Mean Number of Incontinence Episodes per 24 Hours|FAS population. The mean of the number of incontinence episodes was determined using diary data recorded by the participant in the 7 days prior to baseline visit. An incontinence episode is defined as an episode with any involuntary loss of urine. The number of participants was 70; 73; 19; 21 per treatment arm.|incontinence episodes|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876449|NCT01565707|3702641|B1|Adolescents||Mean Number of Incontinence Episodes per 24 Hours|FAS population. The mean of the number of incontinence episodes was determined using diary data recorded by the participant in the 7 days prior to baseline visit. An incontinence episode is defined as an episode with any involuntary loss of urine. The number of participants was 70; 73; 19; 21 per treatment arm.|incontinence episodes|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876450|NCT01565707|3702637|B5|Children||Mean Number of Incontinence Episodes per 24 Hours|FAS population. The mean of the number of incontinence episodes was determined using diary data recorded by the participant in the 7 days prior to baseline visit. An incontinence episode is defined as an episode with any involuntary loss of urine. The number of participants was 70; 73; 19; 21 per treatment arm.|incontinence episodes|Mean|2.71|2.71|Standard Deviation|2.60|2.6|||
3876451|NCT01565707|3702638|B4|Children||Mean Number of Incontinence Episodes per 24 Hours|FAS population. The mean of the number of incontinence episodes was determined using diary data recorded by the participant in the 7 days prior to baseline visit. An incontinence episode is defined as an episode with any involuntary loss of urine. The number of participants was 70; 73; 19; 21 per treatment arm.|incontinence episodes|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876452|NCT01565707|3702639|B3|Children||Mean Number of Incontinence Episodes per 24 Hours|FAS population. The mean of the number of incontinence episodes was determined using diary data recorded by the participant in the 7 days prior to baseline visit. An incontinence episode is defined as an episode with any involuntary loss of urine. The number of participants was 70; 73; 19; 21 per treatment arm.|incontinence episodes|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876453|NCT01565707|3702640|B2|Children||Mean Number of Incontinence Episodes per 24 Hours|FAS population. The mean of the number of incontinence episodes was determined using diary data recorded by the participant in the 7 days prior to baseline visit. An incontinence episode is defined as an episode with any involuntary loss of urine. The number of participants was 70; 73; 19; 21 per treatment arm.|incontinence episodes|Mean|2.46|2.46|Standard Deviation|2.57|2.57|||
3876454|NCT01565707|3702641|B1|Children||Mean Number of Incontinence Episodes per 24 Hours|FAS population. The mean of the number of incontinence episodes was determined using diary data recorded by the participant in the 7 days prior to baseline visit. An incontinence episode is defined as an episode with any involuntary loss of urine. The number of participants was 70; 73; 19; 21 per treatment arm.|incontinence episodes|Mean|2.98|2.98|Standard Deviation|2.63|2.63|||
3876483|NCT01565707|3702640|B2|Hispanic or Latino||Ethnicity|SAF population. The number of participants was 73; 73; 19; 22 per treatment arm.|Participants|Number|9|9.0||||||
3876484|NCT01565707|3702641|B1|Hispanic or Latino||Ethnicity|SAF population. The number of participants was 73; 73; 19; 22 per treatment arm.|Participants|Number|8|8.0||||||
3876455|NCT01565707|3702637|B5|Adolescents||Daytime Maximum Volume Voided (DMaxVV) Per Micturition|FAS population. The mean DMaxVV was determined using the patient diary data recorded during two measuring days (i.e., days when the patient recorded the volume of each micturition) in the 7 days prior to the baseline visit. The DMaxVV is the largest (non-zero) volume recorded over both of the 2 measuring days in the diary (first morning void excluded). Daytime defined as time between waking up in the morning and going to bed later the same day. A micturition is any voluntary urination, excluding episodes of incontinence only. The number of participants was 70; 73; 19; 21 per treatment arm.|mL|Mean|264.63|264.63|Standard Deviation|113.08|113.08|||
3876456|NCT01565707|3702638|B4|Adolescents||Daytime Maximum Volume Voided (DMaxVV) Per Micturition|FAS population. The mean DMaxVV was determined using the patient diary data recorded during two measuring days (i.e., days when the patient recorded the volume of each micturition) in the 7 days prior to the baseline visit. The DMaxVV is the largest (non-zero) volume recorded over both of the 2 measuring days in the diary (first morning void excluded). Daytime defined as time between waking up in the morning and going to bed later the same day. A micturition is any voluntary urination, excluding episodes of incontinence only. The number of participants was 70; 73; 19; 21 per treatment arm.|mL|Mean|252.38|252.38|Standard Deviation|108.68|108.68|||
3876457|NCT01565707|3702639|B3|Adolescents||Daytime Maximum Volume Voided (DMaxVV) Per Micturition|FAS population. The mean DMaxVV was determined using the patient diary data recorded during two measuring days (i.e., days when the patient recorded the volume of each micturition) in the 7 days prior to the baseline visit. The DMaxVV is the largest (non-zero) volume recorded over both of the 2 measuring days in the diary (first morning void excluded). Daytime defined as time between waking up in the morning and going to bed later the same day. A micturition is any voluntary urination, excluding episodes of incontinence only. The number of participants was 70; 73; 19; 21 per treatment arm.|mL|Mean|278.16|278.16|Standard Deviation|119.21|119.21|||
3876458|NCT01565707|3702640|B2|Adolescents||Daytime Maximum Volume Voided (DMaxVV) Per Micturition|FAS population. The mean DMaxVV was determined using the patient diary data recorded during two measuring days (i.e., days when the patient recorded the volume of each micturition) in the 7 days prior to the baseline visit. The DMaxVV is the largest (non-zero) volume recorded over both of the 2 measuring days in the diary (first morning void excluded). Daytime defined as time between waking up in the morning and going to bed later the same day. A micturition is any voluntary urination, excluding episodes of incontinence only. The number of participants was 70; 73; 19; 21 per treatment arm.|mL|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876459|NCT01565707|3702641|B1|Adolescents||Daytime Maximum Volume Voided (DMaxVV) Per Micturition|FAS population. The mean DMaxVV was determined using the patient diary data recorded during two measuring days (i.e., days when the patient recorded the volume of each micturition) in the 7 days prior to the baseline visit. The DMaxVV is the largest (non-zero) volume recorded over both of the 2 measuring days in the diary (first morning void excluded). Daytime defined as time between waking up in the morning and going to bed later the same day. A micturition is any voluntary urination, excluding episodes of incontinence only. The number of participants was 70; 73; 19; 21 per treatment arm.|mL|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876460|NCT01565707|3702637|B5|Children||Daytime Maximum Volume Voided (DMaxVV) Per Micturition|FAS population. The mean DMaxVV was determined using the patient diary data recorded during two measuring days (i.e., days when the patient recorded the volume of each micturition) in the 7 days prior to the baseline visit. The DMaxVV is the largest (non-zero) volume recorded over both of the 2 measuring days in the diary (first morning void excluded). Daytime defined as time between waking up in the morning and going to bed later the same day. A micturition is any voluntary urination, excluding episodes of incontinence only. The number of participants was 70; 73; 19; 21 per treatment arm.|mL|Mean|148.62|148.62|Standard Deviation|62.45|62.45|||
3876461|NCT01565707|3702638|B4|Children||Daytime Maximum Volume Voided (DMaxVV) Per Micturition|FAS population. The mean DMaxVV was determined using the patient diary data recorded during two measuring days (i.e., days when the patient recorded the volume of each micturition) in the 7 days prior to the baseline visit. The DMaxVV is the largest (non-zero) volume recorded over both of the 2 measuring days in the diary (first morning void excluded). Daytime defined as time between waking up in the morning and going to bed later the same day. A micturition is any voluntary urination, excluding episodes of incontinence only. The number of participants was 70; 73; 19; 21 per treatment arm.|mL|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876462|NCT01565707|3702639|B3|Children||Daytime Maximum Volume Voided (DMaxVV) Per Micturition|FAS population. The mean DMaxVV was determined using the patient diary data recorded during two measuring days (i.e., days when the patient recorded the volume of each micturition) in the 7 days prior to the baseline visit. The DMaxVV is the largest (non-zero) volume recorded over both of the 2 measuring days in the diary (first morning void excluded). Daytime defined as time between waking up in the morning and going to bed later the same day. A micturition is any voluntary urination, excluding episodes of incontinence only. The number of participants was 70; 73; 19; 21 per treatment arm.|mL|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876463|NCT01565707|3702640|B2|Children||Daytime Maximum Volume Voided (DMaxVV) Per Micturition|FAS population. The mean DMaxVV was determined using the patient diary data recorded during two measuring days (i.e., days when the patient recorded the volume of each micturition) in the 7 days prior to the baseline visit. The DMaxVV is the largest (non-zero) volume recorded over both of the 2 measuring days in the diary (first morning void excluded). Daytime defined as time between waking up in the morning and going to bed later the same day. A micturition is any voluntary urination, excluding episodes of incontinence only. The number of participants was 70; 73; 19; 21 per treatment arm.|mL|Mean|155.51|155.51|Standard Deviation|70.66|70.66|||
3876464|NCT01565707|3702641|B1|Children||Daytime Maximum Volume Voided (DMaxVV) Per Micturition|FAS population. The mean DMaxVV was determined using the patient diary data recorded during two measuring days (i.e., days when the patient recorded the volume of each micturition) in the 7 days prior to the baseline visit. The DMaxVV is the largest (non-zero) volume recorded over both of the 2 measuring days in the diary (first morning void excluded). Daytime defined as time between waking up in the morning and going to bed later the same day. A micturition is any voluntary urination, excluding episodes of incontinence only. The number of participants was 70; 73; 19; 21 per treatment arm.|mL|Mean|141.43|141.43|Standard Deviation|52.09|52.09|||
3876485|NCT01565707|3702637|B5|Other||Race|SAF population. The number of participants was 73; 73; 19; 22 per treatment arm.|Participants|Number|4|4.0||||||
3876465|NCT01565707|3702637|B5|Adolescents||Mean Volume Voided (MVV) per Micturition|"Values for this baseline characteristic are based on the Full Analysis Set (FAS). The FAS consisted of all randomized patients that took at least 1 dose of double-blind study medication after randomization and provided a valid baseline and post baseline value for the primary efficacy endpoint. A micturition is any voluntary urination, excluding episodes of incontinence only. Micturitions voided volumes were recorded in a patient diary for any 2 days in the 7 day period prior to the baseline visit (referred to as measuring days). The number of participants was 70; 73; 19; 21 per arm."|mL|Mean|164.07|164.07|Standard Deviation|61.76|61.76|||
3876466|NCT01565707|3702638|B4|Adolescents||Mean Volume Voided (MVV) per Micturition|"Values for this baseline characteristic are based on the Full Analysis Set (FAS). The FAS consisted of all randomized patients that took at least 1 dose of double-blind study medication after randomization and provided a valid baseline and post baseline value for the primary efficacy endpoint. A micturition is any voluntary urination, excluding episodes of incontinence only. Micturitions voided volumes were recorded in a patient diary for any 2 days in the 7 day period prior to the baseline visit (referred to as measuring days). The number of participants was 70; 73; 19; 21 per arm."|mL|Mean|159.55|159.55|Standard Deviation|61.21|61.21|||
3876467|NCT01565707|3702639|B3|Adolescents||Mean Volume Voided (MVV) per Micturition|"Values for this baseline characteristic are based on the Full Analysis Set (FAS). The FAS consisted of all randomized patients that took at least 1 dose of double-blind study medication after randomization and provided a valid baseline and post baseline value for the primary efficacy endpoint. A micturition is any voluntary urination, excluding episodes of incontinence only. Micturitions voided volumes were recorded in a patient diary for any 2 days in the 7 day period prior to the baseline visit (referred to as measuring days). The number of participants was 70; 73; 19; 21 per arm."|mL|Mean|169.06|169.06|Standard Deviation|63.65|63.65|||
3876468|NCT01565707|3702640|B2|Adolescents||Mean Volume Voided (MVV) per Micturition|"Values for this baseline characteristic are based on the Full Analysis Set (FAS). The FAS consisted of all randomized patients that took at least 1 dose of double-blind study medication after randomization and provided a valid baseline and post baseline value for the primary efficacy endpoint. A micturition is any voluntary urination, excluding episodes of incontinence only. Micturitions voided volumes were recorded in a patient diary for any 2 days in the 7 day period prior to the baseline visit (referred to as measuring days). The number of participants was 70; 73; 19; 21 per arm."|mL|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876469|NCT01565707|3702641|B1|Adolescents||Mean Volume Voided (MVV) per Micturition|"Values for this baseline characteristic are based on the Full Analysis Set (FAS). The FAS consisted of all randomized patients that took at least 1 dose of double-blind study medication after randomization and provided a valid baseline and post baseline value for the primary efficacy endpoint. A micturition is any voluntary urination, excluding episodes of incontinence only. Micturitions voided volumes were recorded in a patient diary for any 2 days in the 7 day period prior to the baseline visit (referred to as measuring days). The number of participants was 70; 73; 19; 21 per arm."|mL|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876470|NCT01565707|3702637|B5|Children||Mean Volume Voided (MVV) per Micturition|"Values for this baseline characteristic are based on the Full Analysis Set (FAS). The FAS consisted of all randomized patients that took at least 1 dose of double-blind study medication after randomization and provided a valid baseline and post baseline value for the primary efficacy endpoint. A micturition is any voluntary urination, excluding episodes of incontinence only. Micturitions voided volumes were recorded in a patient diary for any 2 days in the 7 day period prior to the baseline visit (referred to as measuring days). The number of participants was 70; 73; 19; 21 per arm."|mL|Mean|95.50|95.5|Standard Deviation|39.50|39.5|||
3876471|NCT01565707|3702638|B4|Children||Mean Volume Voided (MVV) per Micturition|"Values for this baseline characteristic are based on the Full Analysis Set (FAS). The FAS consisted of all randomized patients that took at least 1 dose of double-blind study medication after randomization and provided a valid baseline and post baseline value for the primary efficacy endpoint. A micturition is any voluntary urination, excluding episodes of incontinence only. Micturitions voided volumes were recorded in a patient diary for any 2 days in the 7 day period prior to the baseline visit (referred to as measuring days). The number of participants was 70; 73; 19; 21 per arm."|mL|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876472|NCT01565707|3702639|B3|Children||Mean Volume Voided (MVV) per Micturition|"Values for this baseline characteristic are based on the Full Analysis Set (FAS). The FAS consisted of all randomized patients that took at least 1 dose of double-blind study medication after randomization and provided a valid baseline and post baseline value for the primary efficacy endpoint. A micturition is any voluntary urination, excluding episodes of incontinence only. Micturitions voided volumes were recorded in a patient diary for any 2 days in the 7 day period prior to the baseline visit (referred to as measuring days). The number of participants was 70; 73; 19; 21 per arm."|mL|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876473|NCT01565707|3702640|B2|Children||Mean Volume Voided (MVV) per Micturition|"Values for this baseline characteristic are based on the Full Analysis Set (FAS). The FAS consisted of all randomized patients that took at least 1 dose of double-blind study medication after randomization and provided a valid baseline and post baseline value for the primary efficacy endpoint. A micturition is any voluntary urination, excluding episodes of incontinence only. Micturitions voided volumes were recorded in a patient diary for any 2 days in the 7 day period prior to the baseline visit (referred to as measuring days). The number of participants was 70; 73; 19; 21 per arm."|mL|Mean|96.88|96.88|Standard Deviation|40.98|40.98|||
3876474|NCT01565707|3702641|B1|Children||Mean Volume Voided (MVV) per Micturition|"Values for this baseline characteristic are based on the Full Analysis Set (FAS). The FAS consisted of all randomized patients that took at least 1 dose of double-blind study medication after randomization and provided a valid baseline and post baseline value for the primary efficacy endpoint. A micturition is any voluntary urination, excluding episodes of incontinence only. Micturitions voided volumes were recorded in a patient diary for any 2 days in the 7 day period prior to the baseline visit (referred to as measuring days). The number of participants was 70; 73; 19; 21 per arm."|mL|Mean|94.06|94.06|Standard Deviation|38.12|38.12|||
3876475|NCT01565707|3702637|B5|Not Hispanic or Latino||Ethnicity|SAF population. The number of participants was 73; 73; 19; 22 per treatment arm.|Participants|Number|165|165.0||||||
3876476|NCT01565707|3702638|B4|Not Hispanic or Latino||Ethnicity|SAF population. The number of participants was 73; 73; 19; 22 per treatment arm.|Participants|Number|20|20.0||||||
3876486|NCT01565707|3702638|B4|Other||Race|SAF population. The number of participants was 73; 73; 19; 22 per treatment arm.|Participants|Number|0|0.0||||||
3876487|NCT01565707|3702639|B3|Other||Race|SAF population. The number of participants was 73; 73; 19; 22 per treatment arm.|Participants|Number|0|0.0||||||
3876488|NCT01565707|3702640|B2|Other||Race|SAF population. The number of participants was 73; 73; 19; 22 per treatment arm.|Participants|Number|0|0.0||||||
3876489|NCT01565707|3702641|B1|Other||Race|SAF population. The number of participants was 73; 73; 19; 22 per treatment arm.|Participants|Number|4|4.0||||||
3876490|NCT01565707|3702637|B5|American Indian/Alaskan Native||Race|SAF population. The number of participants was 73; 73; 19; 22 per treatment arm.|Participants|Number|9|9.0||||||
3876491|NCT01565707|3702638|B4|American Indian/Alaskan Native||Race|SAF population. The number of participants was 73; 73; 19; 22 per treatment arm.|Participants|Number|0|0.0||||||
3876492|NCT01565707|3702639|B3|American Indian/Alaskan Native||Race|SAF population. The number of participants was 73; 73; 19; 22 per treatment arm.|Participants|Number|2|2.0||||||
3876493|NCT01565707|3702640|B2|American Indian/Alaskan Native||Race|SAF population. The number of participants was 73; 73; 19; 22 per treatment arm.|Participants|Number|4|4.0||||||
3876494|NCT01565707|3702641|B1|American Indian/Alaskan Native||Race|SAF population. The number of participants was 73; 73; 19; 22 per treatment arm.|Participants|Number|3|3.0||||||
3876495|NCT01565707|3702637|B5|Asian||Race|SAF population. The number of participants was 73; 73; 19; 22 per treatment arm.|Participants|Number|18|18.0||||||
3876496|NCT01565707|3702638|B4|Asian||Race|SAF population. The number of participants was 73; 73; 19; 22 per treatment arm.|Participants|Number|4|4.0||||||
3876497|NCT01565707|3702639|B3|Asian||Race|SAF population. The number of participants was 73; 73; 19; 22 per treatment arm.|Participants|Number|3|3.0||||||
3876498|NCT01565707|3702640|B2|Asian||Race|SAF population. The number of participants was 73; 73; 19; 22 per treatment arm.|Participants|Number|5|5.0||||||
3876499|NCT01565707|3702641|B1|Asian||Race|SAF population. The number of participants was 73; 73; 19; 22 per treatment arm.|Participants|Number|6|6.0||||||
3876500|NCT01565707|3702637|B5|Black/African American||Race|SAF population. The number of participants was 73; 73; 19; 22 per treatment arm.|Participants|Number|8|8.0||||||
3876501|NCT01565707|3702638|B4|Black/African American||Race|SAF population. The number of participants was 73; 73; 19; 22 per treatment arm.|Participants|Number|2|2.0||||||
3876502|NCT01565707|3702639|B3|Black/African American||Race|SAF population. The number of participants was 73; 73; 19; 22 per treatment arm.|Participants|Number|1|1.0||||||
3876503|NCT01565707|3702640|B2|Black/African American||Race|SAF population. The number of participants was 73; 73; 19; 22 per treatment arm.|Participants|Number|2|2.0||||||
3876504|NCT01565707|3702641|B1|Black/African American||Race|SAF population. The number of participants was 73; 73; 19; 22 per treatment arm.|Participants|Number|3|3.0||||||
3876505|NCT01565707|3702637|B5|White||Race|SAF population. The number of participants was 73; 73; 19; 22 per treatment arm.|Participants|Number|148|148.0||||||
3876506|NCT01565707|3702638|B4|White||Race|SAF population. The number of participants was 73; 73; 19; 22 per treatment arm.|Participants|Number|16|16.0||||||
3876507|NCT01565707|3702639|B3|White||Race|SAF population. The number of participants was 73; 73; 19; 22 per treatment arm.|Participants|Number|13|13.0||||||
3876508|NCT01565707|3702640|B2|White||Race|SAF population. The number of participants was 73; 73; 19; 22 per treatment arm.|Participants|Number|62|62.0||||||
3876509|NCT01565707|3702641|B1|White||Race|SAF population. The number of participants was 73; 73; 19; 22 per treatment arm.|Participants|Number|57|57.0||||||
3876510|NCT01565707|3702637|B5||Male|Sex: Female, Male|SAF population. The number of participants was 73; 73: 19; 22 per treatment arm.|Participants|Count of Participants|75|75.0||||||
3876511|NCT01565707|3702638|B4||Male|Sex: Female, Male|SAF population. The number of participants was 73; 73: 19; 22 per treatment arm.|Participants|Count of Participants|5|5.0||||||
3876512|NCT01565707|3702639|B3||Male|Sex: Female, Male|SAF population. The number of participants was 73; 73: 19; 22 per treatment arm.|Participants|Count of Participants|3|3.0||||||
3876513|NCT01565707|3702640|B2||Male|Sex: Female, Male|SAF population. The number of participants was 73; 73: 19; 22 per treatment arm.|Participants|Count of Participants|29|29.0||||||
3876514|NCT01565707|3702641|B1||Male|Sex: Female, Male|SAF population. The number of participants was 73; 73: 19; 22 per treatment arm.|Participants|Count of Participants|38|38.0||||||
3876515|NCT01565707|3702637|B5||Female|Sex: Female, Male|SAF population. The number of participants was 73; 73: 19; 22 per treatment arm.|Participants|Count of Participants|112|112.0||||||
3876516|NCT01565707|3702638|B4||Female|Sex: Female, Male|SAF population. The number of participants was 73; 73: 19; 22 per treatment arm.|Participants|Count of Participants|17|17.0||||||
3876517|NCT01565707|3702639|B3||Female|Sex: Female, Male|SAF population. The number of participants was 73; 73: 19; 22 per treatment arm.|Participants|Count of Participants|16|16.0||||||
3876518|NCT01565707|3702640|B2||Female|Sex: Female, Male|SAF population. The number of participants was 73; 73: 19; 22 per treatment arm.|Participants|Count of Participants|44|44.0||||||
3876519|NCT01565707|3702641|B1||Female|Sex: Female, Male|SAF population. The number of participants was 73; 73: 19; 22 per treatment arm.|Participants|Count of Participants|35|35.0||||||
3876520|NCT01565707|3702637|B5|Adolescents||Age|Age values provided are for the Safety Analysis Set (SAF) population. The SAF consisted of all participants who received at least 1 dose of double-blind study medication and for whom any safety data were reported after first dose of study drug. The number of participants was 73; 73; 19; 22 per treatment arm.|years|Mean|14.3|14.3|Standard Deviation|1.8|1.8|||
3876521|NCT01565707|3702638|B4|Adolescents||Age|Age values provided are for the Safety Analysis Set (SAF) population. The SAF consisted of all participants who received at least 1 dose of double-blind study medication and for whom any safety data were reported after first dose of study drug. The number of participants was 73; 73; 19; 22 per treatment arm.|years|Mean|14.2|14.2|Standard Deviation|1.8|1.8|||
3876522|NCT01565707|3702639|B3|Adolescents||Age|Age values provided are for the Safety Analysis Set (SAF) population. The SAF consisted of all participants who received at least 1 dose of double-blind study medication and for whom any safety data were reported after first dose of study drug. The number of participants was 73; 73; 19; 22 per treatment arm.|years|Mean|14.4|14.4|Standard Deviation|1.9|1.9|||
3876523|NCT01565707|3702640|B2|Adolescents||Age|Age values provided are for the Safety Analysis Set (SAF) population. The SAF consisted of all participants who received at least 1 dose of double-blind study medication and for whom any safety data were reported after first dose of study drug. The number of participants was 73; 73; 19; 22 per treatment arm.|years|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876524|NCT01565707|3702641|B1|Adolescents||Age|Age values provided are for the Safety Analysis Set (SAF) population. The SAF consisted of all participants who received at least 1 dose of double-blind study medication and for whom any safety data were reported after first dose of study drug. The number of participants was 73; 73; 19; 22 per treatment arm.|years|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876525|NCT01565707|3702637|B5|Children||Age|Age values provided are for the Safety Analysis Set (SAF) population. The SAF consisted of all participants who received at least 1 dose of double-blind study medication and for whom any safety data were reported after first dose of study drug. The number of participants was 73; 73; 19; 22 per treatment arm.|years|Mean|7.5|7.5|Standard Deviation|1.6|1.6|||
3876526|NCT01565707|3702638|B4|Children||Age|Age values provided are for the Safety Analysis Set (SAF) population. The SAF consisted of all participants who received at least 1 dose of double-blind study medication and for whom any safety data were reported after first dose of study drug. The number of participants was 73; 73; 19; 22 per treatment arm.|years|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876527|NCT01565707|3702639|B3|Children||Age|Age values provided are for the Safety Analysis Set (SAF) population. The SAF consisted of all participants who received at least 1 dose of double-blind study medication and for whom any safety data were reported after first dose of study drug. The number of participants was 73; 73; 19; 22 per treatment arm.|years|Mean|NA||Standard Deviation|NA||||Category not applicable to the arm.
3876528|NCT01565707|3702640|B2|Children||Age|Age values provided are for the Safety Analysis Set (SAF) population. The SAF consisted of all participants who received at least 1 dose of double-blind study medication and for whom any safety data were reported after first dose of study drug. The number of participants was 73; 73; 19; 22 per treatment arm.|years|Mean|7.6|7.6|Standard Deviation|1.6|1.6|||
3876529|NCT01565707|3702641|B1|Children||Age|Age values provided are for the Safety Analysis Set (SAF) population. The SAF consisted of all participants who received at least 1 dose of double-blind study medication and for whom any safety data were reported after first dose of study drug. The number of participants was 73; 73; 19; 22 per treatment arm.|years|Mean|7.4|7.4|Standard Deviation|1.6|1.6|||
3876530|NCT01565642|3702735|B3||GDS 7|Dementia Stage: Global Deterioration Scale (GDS)|The Global deterioration scale includes seven different diagnostic stages ranging between “no cognitive deterioration” and “very serious cognitive deterioration.” It investigates the cognitive impairment. Scores range between 1 (no cognitive deterioration) and 7 (very severe cognitive decline) with higher scores reflecting greater severity of cognitive deterioration.|Participants|Count of Participants|76|76.0||||||
3876531|NCT01565642|3702736|B2||GDS 7|Dementia Stage: Global Deterioration Scale (GDS)|The Global deterioration scale includes seven different diagnostic stages ranging between “no cognitive deterioration” and “very serious cognitive deterioration.” It investigates the cognitive impairment. Scores range between 1 (no cognitive deterioration) and 7 (very severe cognitive decline) with higher scores reflecting greater severity of cognitive deterioration.|Participants|Count of Participants|42|42.0||||||
3876532|NCT01565642|3702737|B1||GDS 7|Dementia Stage: Global Deterioration Scale (GDS)|The Global deterioration scale includes seven different diagnostic stages ranging between “no cognitive deterioration” and “very serious cognitive deterioration.” It investigates the cognitive impairment. Scores range between 1 (no cognitive deterioration) and 7 (very severe cognitive decline) with higher scores reflecting greater severity of cognitive deterioration.|Participants|Count of Participants|34|34.0||||||
3876533|NCT01565642|3702735|B3||GDS 6|Dementia Stage: Global Deterioration Scale (GDS)|The Global deterioration scale includes seven different diagnostic stages ranging between “no cognitive deterioration” and “very serious cognitive deterioration.” It investigates the cognitive impairment. Scores range between 1 (no cognitive deterioration) and 7 (very severe cognitive decline) with higher scores reflecting greater severity of cognitive deterioration.|Participants|Count of Participants|152|152.0||||||
3876534|NCT01565642|3702736|B2||GDS 6|Dementia Stage: Global Deterioration Scale (GDS)|The Global deterioration scale includes seven different diagnostic stages ranging between “no cognitive deterioration” and “very serious cognitive deterioration.” It investigates the cognitive impairment. Scores range between 1 (no cognitive deterioration) and 7 (very severe cognitive decline) with higher scores reflecting greater severity of cognitive deterioration.|Participants|Count of Participants|73|73.0||||||
3876535|NCT01565642|3702737|B1||GDS 6|Dementia Stage: Global Deterioration Scale (GDS)|The Global deterioration scale includes seven different diagnostic stages ranging between “no cognitive deterioration” and “very serious cognitive deterioration.” It investigates the cognitive impairment. Scores range between 1 (no cognitive deterioration) and 7 (very severe cognitive decline) with higher scores reflecting greater severity of cognitive deterioration.|Participants|Count of Participants|79|79.0||||||
3876536|NCT01565642|3702735|B3||GDS 5|Dementia Stage: Global Deterioration Scale (GDS)|The Global deterioration scale includes seven different diagnostic stages ranging between “no cognitive deterioration” and “very serious cognitive deterioration.” It investigates the cognitive impairment. Scores range between 1 (no cognitive deterioration) and 7 (very severe cognitive decline) with higher scores reflecting greater severity of cognitive deterioration.|Participants|Count of Participants|74|74.0||||||
3876537|NCT01565642|3702736|B2||GDS 5|Dementia Stage: Global Deterioration Scale (GDS)|The Global deterioration scale includes seven different diagnostic stages ranging between “no cognitive deterioration” and “very serious cognitive deterioration.” It investigates the cognitive impairment. Scores range between 1 (no cognitive deterioration) and 7 (very severe cognitive decline) with higher scores reflecting greater severity of cognitive deterioration.|Participants|Count of Participants|36|36.0||||||
3876538|NCT01565642|3702737|B1||GDS 5|Dementia Stage: Global Deterioration Scale (GDS)|The Global deterioration scale includes seven different diagnostic stages ranging between “no cognitive deterioration” and “very serious cognitive deterioration.” It investigates the cognitive impairment. Scores range between 1 (no cognitive deterioration) and 7 (very severe cognitive decline) with higher scores reflecting greater severity of cognitive deterioration.|Participants|Count of Participants|38|38.0||||||
3876539|NCT01565642|3702735|B3|United States||Region of Enrollment||Participants|Count of Participants|302|302.0||||||
3876540|NCT01565642|3702736|B2|United States||Region of Enrollment||Participants|Count of Participants|151|151.0||||||
3876541|NCT01565642|3702737|B1|United States||Region of Enrollment||Participants|Count of Participants|151|151.0||||||
3876542|NCT01565642|3702735|B3|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3876543|NCT01565642|3702736|B2|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3876544|NCT01565642|3702737|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3876545|NCT01565642|3702735|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|257|257.0||||||
3876546|NCT01565642|3702736|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|123|123.0||||||
3876547|NCT01565642|3702737|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|134|134.0||||||
3876548|NCT01565642|3702735|B3|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
3876549|NCT01565642|3702736|B2|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3876550|NCT01565642|3702737|B1|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3876551|NCT01565642|3702735|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3876552|NCT01565642|3702736|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3876553|NCT01565642|3702737|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3876554|NCT01565642|3702735|B3||Female|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
3876555|NCT01565642|3702736|B2||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3876556|NCT01565642|3702737|B1||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3876557|NCT01565642|3702735|B3|||Age||years|Mean|86.5|86.5|Standard Deviation|6.9|6.9|||
3876558|NCT01565642|3702736|B2|||Age||years|Mean|87.3|87.3|Standard Deviation|6.7|6.7|||
3876559|NCT01565642|3702737|B1|||Age||years|Mean|85.7|85.7|Standard Deviation|7.6|7.6|||
3876560|NCT01565616|3702760|B1|Elevated TRJ Velocity||Indication of Severe Sickle Cell Disease|"Participants were eligible for the study if they had one or more of the following:~Significant neurological event, such as a stroke or any neurological deficit lasting longer than 24 hours~History of acute chest syndrome (ACS)~History of 3 or more pain crises per year~Regular red blood cell (RBC) transfusions (8 or more per year)~Trans-thoracic echocardiographic evidence of tricuspid valve regurgitant jet (TRJ) velocity 2.7 m/sec"|Participants|Count of Participants|4|4.0||||||
3876561|NCT01565616|3702760|B1|Regular RBC transfusion therapy||Indication of Severe Sickle Cell Disease|"Participants were eligible for the study if they had one or more of the following:~Significant neurological event, such as a stroke or any neurological deficit lasting longer than 24 hours~History of acute chest syndrome (ACS)~History of 3 or more pain crises per year~Regular red blood cell (RBC) transfusions (8 or more per year)~Trans-thoracic echocardiographic evidence of tricuspid valve regurgitant jet (TRJ) velocity 2.7 m/sec"|Participants|Count of Participants|4|4.0||||||
3876562|NCT01565616|3702760|B1|Recurrent pain events||Indication of Severe Sickle Cell Disease|"Participants were eligible for the study if they had one or more of the following:~Significant neurological event, such as a stroke or any neurological deficit lasting longer than 24 hours~History of acute chest syndrome (ACS)~History of 3 or more pain crises per year~Regular red blood cell (RBC) transfusions (8 or more per year)~Trans-thoracic echocardiographic evidence of tricuspid valve regurgitant jet (TRJ) velocity 2.7 m/sec"|Participants|Count of Participants|15|15.0||||||
3876563|NCT01565616|3702760|B1|Acute chest syndrome||Indication of Severe Sickle Cell Disease|"Participants were eligible for the study if they had one or more of the following:~Significant neurological event, such as a stroke or any neurological deficit lasting longer than 24 hours~History of acute chest syndrome (ACS)~History of 3 or more pain crises per year~Regular red blood cell (RBC) transfusions (8 or more per year)~Trans-thoracic echocardiographic evidence of tricuspid valve regurgitant jet (TRJ) velocity 2.7 m/sec"|Participants|Count of Participants|2|2.0||||||
3876564|NCT01565616|3702760|B1|Significant neurological event (stroke)||Indication of Severe Sickle Cell Disease|"Participants were eligible for the study if they had one or more of the following:~Significant neurological event, such as a stroke or any neurological deficit lasting longer than 24 hours~History of acute chest syndrome (ACS)~History of 3 or more pain crises per year~Regular red blood cell (RBC) transfusions (8 or more per year)~Trans-thoracic echocardiographic evidence of tricuspid valve regurgitant jet (TRJ) velocity 2.7 m/sec"|Participants|Count of Participants|2|2.0||||||
3876565|NCT01565616|3702760|B1|Unrelated||Donor Relation||Participants|Count of Participants|5|5.0||||||
3876566|NCT01565616|3702760|B1|Related||Donor Relation||Participants|Count of Participants|17|17.0||||||
3876567|NCT01565616|3702760|B1|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3876568|NCT01565616|3702760|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876569|NCT01565616|3702760|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876570|NCT01565616|3702760|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876571|NCT01565616|3702760|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3876572|NCT01565616|3702760|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876573|NCT01565616|3702760|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876574|NCT01565616|3702760|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876575|NCT01565616|3702760|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3876576|NCT01565616|3702760|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3876577|NCT01565616|3702760|B1|30-40 years of age||Age, Customized||Participants|Count of Participants|2|2.0||||||
3876578|NCT01565616|3702760|B1|24-29 years of age||Age, Customized||Participants|Count of Participants|6|6.0||||||
3876579|NCT01565616|3702760|B1|20-24 years of age||Age, Customized||Participants|Count of Participants|8|8.0||||||
3876580|NCT01565616|3702760|B1|16-19 years of age||Age, Customized||Participants|Count of Participants|6|6.0||||||
3876581|NCT01565564|3702771|B3|China||Region of Enrollment||participants|Number|700|700.0||||||
3876582|NCT01565564|3702772|B2|China||Region of Enrollment||participants|Number|339|339.0||||||
3876583|NCT01565564|3702773|B1|China||Region of Enrollment||participants|Number|361|361.0||||||
3876584|NCT01565564|3702771|B3|Chinese||Race/Ethnicity, Customized||Participants|Number|700|700.0||||||
3876585|NCT01565564|3702772|B2|Chinese||Race/Ethnicity, Customized||Participants|Number|339|339.0||||||
3876586|NCT01565564|3702773|B1|Chinese||Race/Ethnicity, Customized||Participants|Number|361|361.0||||||
3876587|NCT01565564|3702771|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876588|NCT01565564|3702772|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876589|NCT01565564|3702773|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876590|NCT01565564|3702771|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876591|NCT01565564|3702772|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876592|NCT01565564|3702773|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876593|NCT01565564|3702771|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876594|NCT01565564|3702772|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876595|NCT01565564|3702773|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876596|NCT01565564|3702771|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876597|NCT01565564|3702772|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876598|NCT01565564|3702773|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876599|NCT01565564|3702771|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876600|NCT01565564|3702772|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876601|NCT01565564|3702773|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876602|NCT01565564|3702771|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|700|700.0||||||
3876603|NCT01565564|3702772|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|339|339.0||||||
3876604|NCT01565564|3702773|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|361|361.0||||||
3876605|NCT01565564|3702771|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876606|NCT01565564|3702772|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876607|NCT01565564|3702773|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876608|NCT01565564|3702771|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|700|700.0||||||
3876609|NCT01565564|3702772|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|339|339.0||||||
3876610|NCT01565564|3702773|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|361|361.0||||||
3876611|NCT01565564|3702771|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876612|NCT01565564|3702772|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876613|NCT01565564|3702773|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876614|NCT01565564|3702771|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876615|NCT01565564|3702772|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876616|NCT01565564|3702773|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876617|NCT01565564|3702771|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3876618|NCT01565564|3702772|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3876619|NCT01565564|3702773|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3876620|NCT01565564|3702771|B3||Female|Sex: Female, Male||Participants|Count of Participants|700|700.0||||||
3876621|NCT01565564|3702772|B2||Female|Sex: Female, Male||Participants|Count of Participants|339|339.0||||||
3876622|NCT01565564|3702773|B1||Female|Sex: Female, Male||Participants|Count of Participants|361|361.0||||||
3876623|NCT01565564|3702771|B3|||Age||years|Mean|29.8|29.8|Standard Deviation|3.3|3.3|||
3876624|NCT01565564|3702772|B2|||Age||years|Mean|29.9|29.9|Standard Deviation|3.5|3.5|||
3876625|NCT01565564|3702773|B1|||Age||years|Mean|29.7|29.7|Standard Deviation|3.2|3.2|||
3876626|NCT01565551|3702782|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3876627|NCT01565551|3702783|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3876628|NCT01565551|3702784|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3876629|NCT01565551|3702782|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|528|528.0||||||
3876630|NCT01565551|3702783|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3876631|NCT01565551|3702784|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|495|495.0||||||
3876632|NCT01565551|3702782|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
3876633|NCT01565551|3702783|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3876634|NCT01565551|3702784|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3876635|NCT01565551|3702782|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3876636|NCT01565551|3702783|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3876637|NCT01565551|3702784|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3876638|NCT01565551|3702782|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3876639|NCT01565551|3702783|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876640|NCT01565551|3702784|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3876641|NCT01565551|3702782|B3||White|Race (NIH/OMB)||Participants|Count of Participants|510|510.0||||||
3876642|NCT01565551|3702783|B2||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3876643|NCT01565551|3702784|B1||White|Race (NIH/OMB)||Participants|Count of Participants|471|471.0||||||
3876644|NCT01565551|3702782|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3876645|NCT01565551|3702783|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3876646|NCT01565551|3702784|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3876647|NCT01565551|3702782|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3876648|NCT01565551|3702783|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876649|NCT01565551|3702784|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3876650|NCT01565551|3702782|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3876651|NCT01565551|3702783|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3876652|NCT01565551|3702784|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3876653|NCT01565551|3702782|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3876654|NCT01565551|3702783|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3876655|NCT01565551|3702784|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3876656|NCT01565551|3702782|B3||Male|Sex: Female, Male||Participants|Count of Participants|456|456.0||||||
3876657|NCT01565551|3702783|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3876658|NCT01565551|3702784|B1||Male|Sex: Female, Male||Participants|Count of Participants|419|419.0||||||
3876659|NCT01565551|3702782|B3||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
3876660|NCT01565551|3702783|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3876661|NCT01565551|3702784|B1||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3876662|NCT01565551|3702782|B3|||Age||Years|Mean|43.9|43.9|Standard Deviation|18.7|18.7|||
3876663|NCT01565551|3702783|B2|||Age||Years|Mean|49.9|49.9|Standard Deviation|20.4|20.4|||
3876664|NCT01565551|3702784|B1|||Age||Years|Mean|43.3|43.3|Standard Deviation|18.5|18.5|||
3876665|NCT01565538|3702791|B3|Recurrent||Stage|Tumors were classified according to the 1997 International System for Staging Lung Cancer. Reference: Mountain CF. Revisions in the International System for Staging Lung Cancer.Chest.1997;111:1710-1717.|participants|Number|35|35.0||||||
3876666|NCT01565538|3702792|B2|Recurrent||Stage|Tumors were classified according to the 1997 International System for Staging Lung Cancer. Reference: Mountain CF. Revisions in the International System for Staging Lung Cancer.Chest.1997;111:1710-1717.|participants|Number|18|18.0||||||
3876667|NCT01565538|3702793|B1|Recurrent||Stage|Tumors were classified according to the 1997 International System for Staging Lung Cancer. Reference: Mountain CF. Revisions in the International System for Staging Lung Cancer.Chest.1997;111:1710-1717.|participants|Number|17|17.0||||||
3876668|NCT01565538|3702791|B3|IV||Stage|Tumors were classified according to the 1997 International System for Staging Lung Cancer. Reference: Mountain CF. Revisions in the International System for Staging Lung Cancer.Chest.1997;111:1710-1717.|participants|Number|78|78.0||||||
3876669|NCT01565538|3702792|B2|IV||Stage|Tumors were classified according to the 1997 International System for Staging Lung Cancer. Reference: Mountain CF. Revisions in the International System for Staging Lung Cancer.Chest.1997;111:1710-1717.|participants|Number|38|38.0||||||
3876670|NCT01565538|3702793|B1|IV||Stage|Tumors were classified according to the 1997 International System for Staging Lung Cancer. Reference: Mountain CF. Revisions in the International System for Staging Lung Cancer.Chest.1997;111:1710-1717.|participants|Number|40|40.0||||||
3876671|NCT01565538|3702791|B3|IIIB||Stage|Tumors were classified according to the 1997 International System for Staging Lung Cancer. Reference: Mountain CF. Revisions in the International System for Staging Lung Cancer.Chest.1997;111:1710-1717.|participants|Number|10|10.0||||||
3876672|NCT01565538|3702792|B2|IIIB||Stage|Tumors were classified according to the 1997 International System for Staging Lung Cancer. Reference: Mountain CF. Revisions in the International System for Staging Lung Cancer.Chest.1997;111:1710-1717.|participants|Number|6|6.0||||||
3876673|NCT01565538|3702793|B1|IIIB||Stage|Tumors were classified according to the 1997 International System for Staging Lung Cancer. Reference: Mountain CF. Revisions in the International System for Staging Lung Cancer.Chest.1997;111:1710-1717.|participants|Number|4|4.0||||||
3876674|NCT01565538|3702791|B3|Current||Smoking status||participants|Number|79|79.0||||||
3876675|NCT01565538|3702792|B2|Current||Smoking status||participants|Number|40|40.0||||||
3876676|NCT01565538|3702793|B1|Current||Smoking status||participants|Number|39|39.0||||||
3876677|NCT01565538|3702791|B3|Former||Smoking status||participants|Number|12|12.0||||||
3876678|NCT01565538|3702792|B2|Former||Smoking status||participants|Number|5|5.0||||||
3876679|NCT01565538|3702793|B1|Former||Smoking status||participants|Number|7|7.0||||||
3876680|NCT01565538|3702791|B3|Never||Smoking status||participants|Number|32|32.0||||||
3876681|NCT01565538|3702792|B2|Never||Smoking status||participants|Number|17|17.0||||||
3876682|NCT01565538|3702793|B1|Never||Smoking status||participants|Number|15|15.0||||||
3876727|NCT01565330|3702834|B4|United States||Region of Enrollment||participants|Number|7|7.0||||||
3876728|NCT01565330|3702835|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3876729|NCT01565330|3702836|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3876683|NCT01565538|3702791|B3|2||ECOG PS|Eastern Cooperative Oncology Group performance status. ECOG 0=Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2 = Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours.|participants|Number|7|7.0||||||
3876684|NCT01565538|3702792|B2|2||ECOG PS|Eastern Cooperative Oncology Group performance status. ECOG 0=Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2 = Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours.|participants|Number|3|3.0||||||
3876685|NCT01565538|3702793|B1|2||ECOG PS|Eastern Cooperative Oncology Group performance status. ECOG 0=Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2 = Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours.|participants|Number|4|4.0||||||
3876686|NCT01565538|3702791|B3|0,1||ECOG PS|Eastern Cooperative Oncology Group performance status. ECOG 0=Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2 = Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours.|participants|Number|116|116.0||||||
3876687|NCT01565538|3702792|B2|0,1||ECOG PS|Eastern Cooperative Oncology Group performance status. ECOG 0=Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2 = Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours.|participants|Number|59|59.0||||||
3876688|NCT01565538|3702793|B1|0,1||ECOG PS|Eastern Cooperative Oncology Group performance status. ECOG 0=Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2 = Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours.|participants|Number|57|57.0||||||
3876689|NCT01565538|3702791|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3876690|NCT01565538|3702792|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3876691|NCT01565538|3702793|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3876692|NCT01565538|3702791|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3876693|NCT01565538|3702792|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3876694|NCT01565538|3702793|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3876695|NCT01565538|3702791|B3|||Age||years|Median|54.7|54.7|Full Range|||30.0|75.0|
3876696|NCT01565538|3702792|B2|||Age||years|Median|55.1|55.1|Full Range|||33.0|75.0|
3876697|NCT01565538|3702793|B1|||Age||years|Median|54.3|54.3|Full Range|||30.0|74.0|
3876698|NCT01565382|3702804|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3876699|NCT01565382|3702804|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3876700|NCT01565382|3702804|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3876701|NCT01565382|3702804|B1|||Age||years|Mean|72.7|72.7|Standard Deviation|9.38|9.38|||
3876702|NCT01565369|3702810|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3876703|NCT01565369|3702810|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3876704|NCT01565369|3702810|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3876705|NCT01565369|3702810|B1|||Age||years|Mean|79.3|79.3|Standard Deviation|13.3|13.3|||
3876706|NCT01565356|3702816|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
3876707|NCT01565356|3702816|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3876708|NCT01565356|3702816|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3876709|NCT01565356|3702816|B1|||Age||years|Mean|65.49|65.49|Standard Deviation|15.302|15.302|||
3876710|NCT01565343|3702821|B4|United States||Region of Enrollment||participants|Number|25|25.0||||||
3876711|NCT01565343|3702822|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3876712|NCT01565343|3702823|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3876713|NCT01565343|3702824|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3876714|NCT01565343|3702821|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3876715|NCT01565343|3702822|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3876716|NCT01565343|3702823|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3876717|NCT01565343|3702824|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3876718|NCT01565343|3702821|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3876719|NCT01565343|3702822|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3876720|NCT01565343|3702823|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3876721|NCT01565343|3702824|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3876722|NCT01565343|3702821|B4|||Age||years|Mean|61.1|61.1|Standard Deviation|16.30|16.3|||
3876723|NCT01565343|3702822|B3|||Age||years|Mean|44.4|44.4|Standard Deviation|5.64|5.64|||
3876724|NCT01565343|3702823|B2|||Age||years|Mean|79.0|79.0|Standard Deviation|3.56|3.56|||
3876725|NCT01565343|3702824|B1|||Age||years|Mean|69.7|69.7|Standard Deviation|10.66|10.66|||
3876726|NCT01565330|3702833|B5|United States||Region of Enrollment||participants|Number|20|20.0||||||
3876733|NCT01565330|3702835|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3876734|NCT01565330|3702836|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3876735|NCT01565330|3702837|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3876736|NCT01565330|3702833|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3876737|NCT01565330|3702834|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3876738|NCT01565330|3702835|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3876739|NCT01565330|3702836|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3876740|NCT01565330|3702837|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3876741|NCT01565330|3702833|B5|||Age||years|Mean|59.4|59.4|Standard Deviation|17.14|17.14|||
3876742|NCT01565330|3702834|B4|||Age||years|Mean|45.0|45.0|Standard Deviation|6.88|6.88|||
3876743|NCT01565330|3702835|B3|||Age||years|Mean|76.8|76.8|Standard Deviation|10.24|10.24|||
3876744|NCT01565330|3702836|B2|||Age||years|Mean|48.0|48.0|Standard Deviation|6.73|6.73|||
3876745|NCT01565330|3702837|B1|||Age||years|Mean|74.8|74.8|Standard Deviation|11.01|11.01|||
3876746|NCT01565291|3702854|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
3876747|NCT01565291|3702855|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3876748|NCT01565291|3702856|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3876749|NCT01565291|3702854|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3876750|NCT01565291|3702855|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3876751|NCT01565291|3702856|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3876752|NCT01565291|3702854|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3876753|NCT01565291|3702855|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3876754|NCT01565291|3702856|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3876755|NCT01565291|3702854|B3|||Age||years|Mean|74.3|74.3|Standard Deviation|10.44|10.44|||
3876756|NCT01565291|3702855|B2|||Age||years|Mean|72.5|72.5|Standard Deviation|11.56|11.56|||
3876757|NCT01565291|3702856|B1|||Age||years|Mean|75.8|75.8|Standard Deviation|9.2|9.2|||
3876758|NCT01565148|3702865|B5|||Baseline Best Corrected Visual Acuity (BCVA)||Letters|Mean|59.3|59.3|Standard Deviation|13.15|13.15|||
3876759|NCT01565148|3702866|B4|||Baseline Best Corrected Visual Acuity (BCVA)||Letters|Mean|61.5|61.5|Standard Deviation|14.03|14.03|||
3876760|NCT01565148|3702867|B3|||Baseline Best Corrected Visual Acuity (BCVA)||Letters|Mean|59.8|59.8|Standard Deviation|13.78|13.78|||
3876761|NCT01565148|3702868|B2|||Baseline Best Corrected Visual Acuity (BCVA)||Letters|Mean|58.7|58.7|Standard Deviation|12.49|12.49|||
3876762|NCT01565148|3702869|B1|||Baseline Best Corrected Visual Acuity (BCVA)||Letters|Mean|57.9|57.9|Standard Deviation|12.3|12.3|||
3876763|NCT01565148|3702865|B5||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3876764|NCT01565148|3702866|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3876765|NCT01565148|3702867|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3876766|NCT01565148|3702868|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3876767|NCT01565148|3702869|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3876768|NCT01565148|3702865|B5||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3876769|NCT01565148|3702866|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3876770|NCT01565148|3702867|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3876771|NCT01565148|3702868|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3876772|NCT01565148|3702869|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3876773|NCT01565148|3702865|B5|||Age||years|Mean|62.2|62.2|Standard Deviation|8.95|8.95|||
3876774|NCT01565148|3702866|B4|||Age||years|Mean|61.2|61.2|Standard Deviation|7.29|7.29|||
3876775|NCT01565148|3702867|B3|||Age||years|Mean|61.4|61.4|Standard Deviation|9.72|9.72|||
3876776|NCT01565148|3702868|B2|||Age||years|Mean|62.8|62.8|Standard Deviation|9.7|9.7|||
3876777|NCT01565148|3702869|B1|||Age||years|Mean|63.4|63.4|Standard Deviation|8.91|8.91|||
3876778|NCT01565083|3702906|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3876779|NCT01565083|3702907|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3876780|NCT01565083|3702908|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3876781|NCT01565083|3702906|B3||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
3876782|NCT01565083|3702907|B2||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3876783|NCT01565083|3702908|B1||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3876784|NCT01565083|3702906|B3|||Age||years|Mean|56.2|56.2|Standard Deviation|12.50|12.5|||
3876785|NCT01565083|3702907|B2|||Age||years|Mean|55.6|55.6|Standard Deviation|13.17|13.17|||
3876786|NCT01565083|3702908|B1|||Age||years|Mean|56.9|56.9|Standard Deviation|11.80|11.8|||
3876787|NCT01564953|3702935|B1|Denmark||Region of Enrollment||participants|Number|143|143.0||||||
3876788|NCT01564953|3702935|B1||Male|Gender||Participants|Count of Participants|77|77.0||||||
3876789|NCT01564953|3702935|B1||Female|Gender||Participants|Count of Participants|66|66.0||||||
3876790|NCT01564953|3702935|B1|||Age||years|Median|70|70.0|Inter-Quartile Range|||63.0|74.0|
3876791|NCT01564953|3702935|B1||>=65 years|Age||Participants|Count of Participants|99|99.0||||||
3876792|NCT01564953|3702935|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3876793|NCT01564953|3702935|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3876794|NCT01564862|3702943|B4|Daily||Alcohol Consumption||participants|Number|10|10.0||||||
3876795|NCT01564862|3702944|B3|Daily||Alcohol Consumption||participants|Number|3|3.0||||||
3876796|NCT01564862|3702945|B2|Daily||Alcohol Consumption||participants|Number|3|3.0||||||
3876797|NCT01564862|3702946|B1|Daily||Alcohol Consumption||participants|Number|4|4.0||||||
3876798|NCT01564862|3702943|B4|2 to 6 Times per Week||Alcohol Consumption||participants|Number|58|58.0||||||
3876799|NCT01564862|3702944|B3|2 to 6 Times per Week||Alcohol Consumption||participants|Number|24|24.0||||||
3876800|NCT01564862|3702945|B2|2 to 6 Times per Week||Alcohol Consumption||participants|Number|19|19.0||||||
3876801|NCT01564862|3702946|B1|2 to 6 Times per Week||Alcohol Consumption||participants|Number|15|15.0||||||
3876802|NCT01564862|3702943|B4|Once a Week||Alcohol Consumption||participants|Number|83|83.0||||||
3876803|NCT01564862|3702944|B3|Once a Week||Alcohol Consumption||participants|Number|29|29.0||||||
3876804|NCT01564862|3702945|B2|Once a Week||Alcohol Consumption||participants|Number|31|31.0||||||
3876805|NCT01564862|3702946|B1|Once a Week||Alcohol Consumption||participants|Number|23|23.0||||||
3876806|NCT01564862|3702943|B4|Once Monthly or Less Often||Alcohol Consumption||participants|Number|191|191.0||||||
3876807|NCT01564862|3702944|B3|Once Monthly or Less Often||Alcohol Consumption||participants|Number|51|51.0||||||
3876808|NCT01564862|3702945|B2|Once Monthly or Less Often||Alcohol Consumption||participants|Number|73|73.0||||||
3876809|NCT01564862|3702946|B1|Once Monthly or Less Often||Alcohol Consumption||participants|Number|67|67.0||||||
3876810|NCT01564862|3702943|B4|Never||Alcohol Consumption||participants|Number|260|260.0||||||
3876811|NCT01564862|3702944|B3|Never||Alcohol Consumption||participants|Number|87|87.0||||||
3876812|NCT01564862|3702945|B2|Never||Alcohol Consumption||participants|Number|84|84.0||||||
3876813|NCT01564862|3702946|B1|Never||Alcohol Consumption||participants|Number|89|89.0||||||
3876814|NCT01564862|3702943|B4|Past Smoker||Smoking Classification||participants|Number|96|96.0||||||
3876815|NCT01564862|3702944|B3|Past Smoker||Smoking Classification||participants|Number|33|33.0||||||
3876816|NCT01564862|3702945|B2|Past Smoker||Smoking Classification||participants|Number|33|33.0||||||
3876817|NCT01564862|3702946|B1|Past Smoker||Smoking Classification||participants|Number|30|30.0||||||
3876818|NCT01564862|3702943|B4|Current Smoker||Smoking Classification||participants|Number|197|197.0||||||
3876819|NCT01564862|3702944|B3|Current Smoker||Smoking Classification||participants|Number|56|56.0||||||
3876820|NCT01564862|3702945|B2|Current Smoker||Smoking Classification||participants|Number|68|68.0||||||
3876821|NCT01564862|3702946|B1|Current Smoker||Smoking Classification||participants|Number|73|73.0||||||
3876822|NCT01564862|3702943|B4|Never Smoked||Smoking Classification||participants|Number|309|309.0||||||
3876823|NCT01564862|3702944|B3|Never Smoked||Smoking Classification||participants|Number|105|105.0||||||
3876824|NCT01564862|3702945|B2|Never Smoked||Smoking Classification||participants|Number|109|109.0||||||
3876825|NCT01564862|3702946|B1|Never Smoked||Smoking Classification||participants|Number|95|95.0||||||
3876826|NCT01564862|3702943|B4|||Body Mass Index (BMI)||kg/m^2|Mean|28.51|28.51|Standard Deviation|7.018|7.018|||
3876827|NCT01564862|3702944|B3|||Body Mass Index (BMI)||kg/m^2|Mean|28.27|28.27|Standard Deviation|6.354|6.354|||
3876828|NCT01564862|3702945|B2|||Body Mass Index (BMI)||kg/m^2|Mean|28.39|28.39|Standard Deviation|7.312|7.312|||
3876829|NCT01564862|3702946|B1|||Body Mass Index (BMI)||kg/m^2|Mean|28.86|28.86|Standard Deviation|7.334|7.334|||
3876830|NCT01564862|3702943|B4|||Weight||kg|Mean|81.50|81.5|Standard Deviation|21.099|21.099|||
3876831|NCT01564862|3702944|B3|||Weight||kg|Mean|80.96|80.96|Standard Deviation|20.316|20.316|||
3876832|NCT01564862|3702945|B2|||Weight||kg|Mean|81.68|81.68|Standard Deviation|20.965|20.965|||
3876833|NCT01564862|3702946|B1|||Weight||kg|Mean|81.84|81.84|Standard Deviation|22.068|22.068|||
3876834|NCT01564862|3702943|B4|||Height||cm|Mean|169.0|169.0|Standard Deviation|9.25|9.25|||
3876835|NCT01564862|3702944|B3|||Height||cm|Mean|169.0|169.0|Standard Deviation|9.43|9.43|||
3876836|NCT01564862|3702945|B2|||Height||cm|Mean|169.7|169.7|Standard Deviation|9.14|9.14|||
3876837|NCT01564862|3702946|B1|||Height||cm|Mean|168.2|168.2|Standard Deviation|9.17|9.17|||
3876838|NCT01564862|3702943|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3876839|NCT01564862|3702944|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3876840|NCT01564862|3702945|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3876841|NCT01564862|3702946|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3876842|NCT01564862|3702943|B4|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3876843|NCT01564862|3702944|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3876844|NCT01564862|3702945|B2|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3876845|NCT01564862|3702946|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3876846|NCT01564862|3702943|B4|Black||Race/Ethnicity, Customized||participants|Number|75|75.0||||||
3876847|NCT01564862|3702944|B3|Black||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3876848|NCT01564862|3702945|B2|Black||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
3876849|NCT01564862|3702946|B1|Black||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3876850|NCT01564862|3702943|B4|Caucasian (or White, including Hispanic)||Race/Ethnicity, Customized||participants|Number|516|516.0||||||
3876851|NCT01564862|3702944|B3|Caucasian (or White, including Hispanic)||Race/Ethnicity, Customized||participants|Number|171|171.0||||||
3876852|NCT01564862|3702945|B2|Caucasian (or White, including Hispanic)||Race/Ethnicity, Customized||participants|Number|176|176.0||||||
3876853|NCT01564862|3702946|B1|Caucasian (or White, including Hispanic)||Race/Ethnicity, Customized||participants|Number|169|169.0||||||
3876854|NCT01564862|3702943|B4|Not-Specified||Race/Ethnicity, Customized||participants|Number|296|296.0||||||
3876855|NCT01564862|3702944|B3|Not-Specified||Race/Ethnicity, Customized||participants|Number|97|97.0||||||
3876856|NCT01564862|3702945|B2|Not-Specified||Race/Ethnicity, Customized||participants|Number|99|99.0||||||
3876857|NCT01564862|3702946|B1|Not-Specified||Race/Ethnicity, Customized||participants|Number|100|100.0||||||
3876858|NCT01564862|3702943|B4|Non-Hispanic and Non- Latino||Race/Ethnicity, Customized||participants|Number|276|276.0||||||
3876859|NCT01564862|3702944|B3|Non-Hispanic and Non- Latino||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
3876860|NCT01564862|3702945|B2|Non-Hispanic and Non- Latino||Race/Ethnicity, Customized||participants|Number|104|104.0||||||
3876861|NCT01564862|3702946|B1|Non-Hispanic and Non- Latino||Race/Ethnicity, Customized||participants|Number|90|90.0||||||
3876862|NCT01564862|3702943|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3876863|NCT01564862|3702944|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3876864|NCT01564862|3702945|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3876865|NCT01564862|3702946|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3876866|NCT01564862|3702943|B4||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
3876867|NCT01564862|3702944|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3876868|NCT01564862|3702945|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3876869|NCT01564862|3702946|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3876870|NCT01564862|3702943|B4||Female|Sex: Female, Male||Participants|Count of Participants|392|392.0||||||
3876871|NCT01564862|3702944|B3||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3876872|NCT01564862|3702945|B2||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3876873|NCT01564862|3702946|B1||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3876874|NCT01564862|3702943|B4|> 55 years||Age, Customized||participants|Number|128|128.0||||||
3876875|NCT01564862|3702944|B3|> 55 years||Age, Customized||participants|Number|42|42.0||||||
3876876|NCT01564862|3702945|B2|> 55 years||Age, Customized||participants|Number|46|46.0||||||
3876877|NCT01564862|3702946|B1|> 55 years||Age, Customized||participants|Number|40|40.0||||||
3876878|NCT01564862|3702943|B4|≤ 55 years||Age, Customized||participants|Number|474|474.0||||||
3876879|NCT01564862|3702944|B3|≤ 55 years||Age, Customized||participants|Number|152|152.0||||||
3876880|NCT01564862|3702945|B2|≤ 55 years||Age, Customized||participants|Number|164|164.0||||||
3876881|NCT01564862|3702946|B1|≤ 55 years||Age, Customized||participants|Number|158|158.0||||||
3876882|NCT01564862|3702943|B4|||Age||years|Mean|45.0|45.0|Standard Deviation|11.90|11.9|||
3876883|NCT01564862|3702944|B3|||Age||years|Mean|45.0|45.0|Standard Deviation|12.07|12.07|||
3876884|NCT01564862|3702945|B2|||Age||years|Mean|45.7|45.7|Standard Deviation|11.46|11.46|||
3876885|NCT01564862|3702946|B1|||Age||years|Mean|44.2|44.2|Standard Deviation|12.21|12.21|||
3876886|NCT01564784|3702997|B3||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3876887|NCT01564784|3702998|B2||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3876888|NCT01564784|3702999|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3876889|NCT01564784|3702997|B3||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3876890|NCT01564784|3702998|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3876891|NCT01564784|3702999|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3876892|NCT01564784|3702997|B3|||Age||Years|Mean|45.7|45.7|Standard Deviation|16.70|16.7|||
3876893|NCT01564784|3702998|B2|||Age||Years|Mean|45.6|45.6|Standard Deviation|16.32|16.32|||
3876894|NCT01564784|3702999|B1|||Age||Years|Mean|45.9|45.9|Standard Deviation|17.07|17.07|||
3876895|NCT01564758|3703027|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3876896|NCT01564758|3703027|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3876897|NCT01564758|3703027|B1|||Age||years|Mean|59.7|59.7|Standard Deviation|18.2|18.2|||
3876898|NCT01564732|3703032|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3876899|NCT01564732|3703033|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3876900|NCT01564732|3703034|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3876901|NCT01564732|3703032|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3876902|NCT01564732|3703033|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3876903|NCT01564732|3703034|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3876904|NCT01564732|3703032|B3|≥18 to ≤60 years||Age, Customized||participants|Number|11|11.0||||||
3876905|NCT01564732|3703033|B2|≥18 to ≤60 years||Age, Customized||participants|Number|5|5.0||||||
3876906|NCT01564732|3703034|B1|≥18 to ≤60 years||Age, Customized||participants|Number|6|6.0||||||
3876907|NCT01564706|3703051|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3876908|NCT01564706|3703051|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3876909|NCT01564706|3703051|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3876910|NCT01564706|3703051|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3876911|NCT01564706|3703051|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3876912|NCT01564706|3703051|B1|||Age||years|Mean|57.9|57.9|Standard Deviation|10.31|10.31|||
3876913|NCT01564693|3703055|B4|Italy||Region of Enrollment||participants|Number|15|15.0||||||
3876914|NCT01564693|3703056|B3|Italy||Region of Enrollment||participants|Number|2|2.0||||||
3876915|NCT01564693|3703057|B2|Italy||Region of Enrollment||participants|Number|4|4.0||||||
3876916|NCT01564693|3703058|B1|Italy||Region of Enrollment||participants|Number|9|9.0||||||
3876917|NCT01564693|3703055|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3876918|NCT01564693|3703056|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3876919|NCT01564693|3703057|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3876920|NCT01564693|3703058|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3876921|NCT01564693|3703055|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3876922|NCT01564693|3703056|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3876923|NCT01564693|3703057|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3876924|NCT01564693|3703058|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3876925|NCT01564693|3703055|B4|||Age||years|Mean|71.66|71.66|Standard Deviation|8.76|8.76|||
3876926|NCT01564693|3703056|B3|||Age||years|Mean|65|65.0|Standard Deviation|7.1|7.1|||
3876927|NCT01564693|3703057|B2|||Age||years|Mean|76.25|76.25|Standard Deviation|6.95|6.95|||
3876928|NCT01564693|3703058|B1|||Age||years|Mean|71.1|71.1|Standard Deviation|9.4|9.4|||
3876929|NCT01564693|3703055|B4||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3876930|NCT01564693|3703056|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3876931|NCT01564693|3703057|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3876932|NCT01564693|3703058|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3876933|NCT01564693|3703055|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3876934|NCT01564693|3703056|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3876935|NCT01564693|3703057|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3876936|NCT01564693|3703058|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3876937|NCT01564693|3703055|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3876938|NCT01564693|3703056|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3876939|NCT01564693|3703057|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3876940|NCT01564693|3703058|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3876941|NCT01564537|3703068|B3|Stage III||Stratification Factor: International Staging System (ISS) Stag at Screening|Stage I: Serum beta2-microglobulin <3.5 mg/L and albumin ≥3.5 g/dL; Stage II: Neither Stage I or III, meaning that either: beta2-microglobulin level ≥3.5 and <5.5 mg/L (with any albumin level), OR albumin <3.5 g/dL with beta2-microglobulin <3.5 mg/L; Stage III: Serum beta2-microglobulin ≥5.5 mg/L. Normal serum beta2-microglobulin: <3.0 mg/L; normal albumin: 3.5–5.0 g/dL.|participants|Number|90|90.0||||||
3876942|NCT01564537|3703069|B2|Stage III||Stratification Factor: International Staging System (ISS) Stag at Screening|Stage I: Serum beta2-microglobulin <3.5 mg/L and albumin ≥3.5 g/dL; Stage II: Neither Stage I or III, meaning that either: beta2-microglobulin level ≥3.5 and <5.5 mg/L (with any albumin level), OR albumin <3.5 g/dL with beta2-microglobulin <3.5 mg/L; Stage III: Serum beta2-microglobulin ≥5.5 mg/L. Normal serum beta2-microglobulin: <3.0 mg/L; normal albumin: 3.5–5.0 g/dL.|participants|Number|44|44.0||||||
3876943|NCT01564537|3703070|B1|Stage III||Stratification Factor: International Staging System (ISS) Stag at Screening|Stage I: Serum beta2-microglobulin <3.5 mg/L and albumin ≥3.5 g/dL; Stage II: Neither Stage I or III, meaning that either: beta2-microglobulin level ≥3.5 and <5.5 mg/L (with any albumin level), OR albumin <3.5 g/dL with beta2-microglobulin <3.5 mg/L; Stage III: Serum beta2-microglobulin ≥5.5 mg/L. Normal serum beta2-microglobulin: <3.0 mg/L; normal albumin: 3.5–5.0 g/dL.|participants|Number|46|46.0||||||
3876944|NCT01564537|3703068|B3|Stage I or Stage II||Stratification Factor: International Staging System (ISS) Stag at Screening|Stage I: Serum beta2-microglobulin <3.5 mg/L and albumin ≥3.5 g/dL; Stage II: Neither Stage I or III, meaning that either: beta2-microglobulin level ≥3.5 and <5.5 mg/L (with any albumin level), OR albumin <3.5 g/dL with beta2-microglobulin <3.5 mg/L; Stage III: Serum beta2-microglobulin ≥5.5 mg/L. Normal serum beta2-microglobulin: <3.0 mg/L; normal albumin: 3.5–5.0 g/dL.|participants|Number|632|632.0||||||
3876945|NCT01564537|3703069|B2|Stage I or Stage II||Stratification Factor: International Staging System (ISS) Stag at Screening|Stage I: Serum beta2-microglobulin <3.5 mg/L and albumin ≥3.5 g/dL; Stage II: Neither Stage I or III, meaning that either: beta2-microglobulin level ≥3.5 and <5.5 mg/L (with any albumin level), OR albumin <3.5 g/dL with beta2-microglobulin <3.5 mg/L; Stage III: Serum beta2-microglobulin ≥5.5 mg/L. Normal serum beta2-microglobulin: <3.0 mg/L; normal albumin: 3.5–5.0 g/dL.|participants|Number|318|318.0||||||
3876946|NCT01564537|3703070|B1|Stage I or Stage II||Stratification Factor: International Staging System (ISS) Stag at Screening|Stage I: Serum beta2-microglobulin <3.5 mg/L and albumin ≥3.5 g/dL; Stage II: Neither Stage I or III, meaning that either: beta2-microglobulin level ≥3.5 and <5.5 mg/L (with any albumin level), OR albumin <3.5 g/dL with beta2-microglobulin <3.5 mg/L; Stage III: Serum beta2-microglobulin ≥5.5 mg/L. Normal serum beta2-microglobulin: <3.0 mg/L; normal albumin: 3.5–5.0 g/dL.|participants|Number|314|314.0||||||
3876947|NCT01564537|3703068|B3|Naïve||Stratification Factor: Proteasome Inhibitor||participants|Number|219|219.0||||||
3876948|NCT01564537|3703069|B2|Naïve||Stratification Factor: Proteasome Inhibitor||participants|Number|109|109.0||||||
3876949|NCT01564537|3703070|B1|Naïve||Stratification Factor: Proteasome Inhibitor||participants|Number|110|110.0||||||
3876950|NCT01564537|3703068|B3|Exposed||Stratification Factor: Proteasome Inhibitor||participants|Number|503|503.0||||||
3876951|NCT01564537|3703069|B2|Exposed||Stratification Factor: Proteasome Inhibitor||participants|Number|253|253.0||||||
3876952|NCT01564537|3703070|B1|Exposed||Stratification Factor: Proteasome Inhibitor||participants|Number|250|250.0||||||
3876953|NCT01564537|3703068|B3|2 or 3 Lines||Stratification Factor: Lines of Prior Therapy||participants|Number|297|297.0||||||
3876954|NCT01564537|3703069|B2|2 or 3 Lines||Stratification Factor: Lines of Prior Therapy||participants|Number|149|149.0||||||
3876955|NCT01564537|3703070|B1|2 or 3 Lines||Stratification Factor: Lines of Prior Therapy||participants|Number|148|148.0||||||
3876956|NCT01564537|3703068|B3|1 Line||Stratification Factor: Lines of Prior Therapy||participants|Number|425|425.0||||||
3876957|NCT01564537|3703069|B2|1 Line||Stratification Factor: Lines of Prior Therapy||participants|Number|213|213.0||||||
3876958|NCT01564537|3703070|B1|1 Line||Stratification Factor: Lines of Prior Therapy||participants|Number|212|212.0||||||
3876959|NCT01564537|3703068|B3|Japan||Region of Enrollment||participants|Number|41|41.0||||||
3876960|NCT01564537|3703069|B2|Japan||Region of Enrollment||participants|Number|21|21.0||||||
3876961|NCT01564537|3703070|B1|Japan||Region of Enrollment||participants|Number|20|20.0||||||
3876962|NCT01564537|3703068|B3|Germany||Region of Enrollment||participants|Number|15|15.0||||||
3876963|NCT01564537|3703069|B2|Germany||Region of Enrollment||participants|Number|7|7.0||||||
3876964|NCT01564537|3703070|B1|Germany||Region of Enrollment||participants|Number|8|8.0||||||
3876965|NCT01564537|3703068|B3|Australia||Region of Enrollment||participants|Number|17|17.0||||||
3876966|NCT01564537|3703069|B2|Australia||Region of Enrollment||participants|Number|8|8.0||||||
3876967|NCT01564537|3703070|B1|Australia||Region of Enrollment||participants|Number|9|9.0||||||
3876968|NCT01564537|3703068|B3|Israel||Region of Enrollment||participants|Number|33|33.0||||||
3876969|NCT01564537|3703069|B2|Israel||Region of Enrollment||participants|Number|14|14.0||||||
3876970|NCT01564537|3703070|B1|Israel||Region of Enrollment||participants|Number|19|19.0||||||
3876971|NCT01564537|3703068|B3|Italy||Region of Enrollment||participants|Number|39|39.0||||||
3876972|NCT01564537|3703069|B2|Italy||Region of Enrollment||participants|Number|15|15.0||||||
3876973|NCT01564537|3703070|B1|Italy||Region of Enrollment||participants|Number|24|24.0||||||
3876974|NCT01564537|3703068|B3|Denmark||Region of Enrollment||participants|Number|17|17.0||||||
3876975|NCT01564537|3703069|B2|Denmark||Region of Enrollment||participants|Number|7|7.0||||||
3876976|NCT01564537|3703070|B1|Denmark||Region of Enrollment||participants|Number|10|10.0||||||
3876977|NCT01564537|3703068|B3|Belgium||Region of Enrollment||participants|Number|14|14.0||||||
3876978|NCT01564537|3703069|B2|Belgium||Region of Enrollment||participants|Number|7|7.0||||||
3876979|NCT01564537|3703070|B1|Belgium||Region of Enrollment||participants|Number|7|7.0||||||
3876980|NCT01564537|3703068|B3|Turkey||Region of Enrollment||participants|Number|7|7.0||||||
3876981|NCT01564537|3703069|B2|Turkey||Region of Enrollment||participants|Number|3|3.0||||||
3876982|NCT01564537|3703070|B1|Turkey||Region of Enrollment||participants|Number|4|4.0||||||
3876983|NCT01564537|3703068|B3|Czech Republic||Region of Enrollment||participants|Number|36|36.0||||||
3876984|NCT01564537|3703069|B2|Czech Republic||Region of Enrollment||participants|Number|21|21.0||||||
3876985|NCT01564537|3703070|B1|Czech Republic||Region of Enrollment||participants|Number|15|15.0||||||
3876986|NCT01564537|3703068|B3|Canada||Region of Enrollment||participants|Number|45|45.0||||||
3876987|NCT01564537|3703069|B2|Canada||Region of Enrollment||participants|Number|26|26.0||||||
3876988|NCT01564537|3703070|B1|Canada||Region of Enrollment||participants|Number|19|19.0||||||
3876989|NCT01564537|3703068|B3|New Zealand||Region of Enrollment||participants|Number|67|67.0||||||
3876990|NCT01564537|3703069|B2|New Zealand||Region of Enrollment||participants|Number|39|39.0||||||
3876991|NCT01564537|3703070|B1|New Zealand||Region of Enrollment||participants|Number|28|28.0||||||
3876992|NCT01564537|3703068|B3|Spain||Region of Enrollment||participants|Number|30|30.0||||||
3876993|NCT01564537|3703069|B2|Spain||Region of Enrollment||participants|Number|14|14.0||||||
3876994|NCT01564537|3703070|B1|Spain||Region of Enrollment||participants|Number|16|16.0||||||
3876995|NCT01564537|3703068|B3|United Kingdom||Region of Enrollment||participants|Number|20|20.0||||||
3876996|NCT01564537|3703069|B2|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3876997|NCT01564537|3703070|B1|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
3876998|NCT01564537|3703068|B3|Hungary||Region of Enrollment||participants|Number|39|39.0||||||
3876999|NCT01564537|3703069|B2|Hungary||Region of Enrollment||participants|Number|21|21.0||||||
3877000|NCT01564537|3703070|B1|Hungary||Region of Enrollment||participants|Number|18|18.0||||||
3877001|NCT01564537|3703068|B3|Romania||Region of Enrollment||participants|Number|12|12.0||||||
3877002|NCT01564537|3703069|B2|Romania||Region of Enrollment||participants|Number|6|6.0||||||
3877003|NCT01564537|3703070|B1|Romania||Region of Enrollment||participants|Number|6|6.0||||||
3877004|NCT01564537|3703068|B3|France||Region of Enrollment||participants|Number|81|81.0||||||
3877005|NCT01564537|3703069|B2|France||Region of Enrollment||participants|Number|45|45.0||||||
3877006|NCT01564537|3703070|B1|France||Region of Enrollment||participants|Number|36|36.0||||||
3877007|NCT01564537|3703068|B3|Poland||Region of Enrollment||participants|Number|41|41.0||||||
3877008|NCT01564537|3703069|B2|Poland||Region of Enrollment||participants|Number|20|20.0||||||
3877009|NCT01564537|3703070|B1|Poland||Region of Enrollment||participants|Number|21|21.0||||||
3877010|NCT01564537|3703068|B3|Korea, Republic of||Region of Enrollment||participants|Number|6|6.0||||||
3877011|NCT01564537|3703069|B2|Korea, Republic of||Region of Enrollment||participants|Number|2|2.0||||||
3877012|NCT01564537|3703070|B1|Korea, Republic of||Region of Enrollment||participants|Number|4|4.0||||||
3877013|NCT01564537|3703068|B3|China||Region of Enrollment||participants|Number|6|6.0||||||
3877014|NCT01564537|3703069|B2|China||Region of Enrollment||participants|Number|3|3.0||||||
3877015|NCT01564537|3703070|B1|China||Region of Enrollment||participants|Number|3|3.0||||||
3877016|NCT01564537|3703068|B3|Sweden||Region of Enrollment||participants|Number|27|27.0||||||
3877017|NCT01564537|3703069|B2|Sweden||Region of Enrollment||participants|Number|12|12.0||||||
3877018|NCT01564537|3703070|B1|Sweden||Region of Enrollment||participants|Number|15|15.0||||||
3877019|NCT01564537|3703068|B3|Netherlands||Region of Enrollment||participants|Number|9|9.0||||||
3877020|NCT01564537|3703069|B2|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
3877021|NCT01564537|3703070|B1|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
3877022|NCT01564537|3703068|B3|Austria||Region of Enrollment||participants|Number|9|9.0||||||
3877023|NCT01564537|3703069|B2|Austria||Region of Enrollment||participants|Number|4|4.0||||||
3877024|NCT01564537|3703070|B1|Austria||Region of Enrollment||participants|Number|5|5.0||||||
3877025|NCT01564537|3703068|B3|Portugal||Region of Enrollment||participants|Number|15|15.0||||||
3877026|NCT01564537|3703069|B2|Portugal||Region of Enrollment||participants|Number|8|8.0||||||
3877027|NCT01564537|3703070|B1|Portugal||Region of Enrollment||participants|Number|7|7.0||||||
3877028|NCT01564537|3703068|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
3877029|NCT01564537|3703069|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
3877030|NCT01564537|3703070|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
3877031|NCT01564537|3703068|B3|Singapore||Region of Enrollment||participants|Number|6|6.0||||||
3877032|NCT01564537|3703069|B2|Singapore||Region of Enrollment||participants|Number|4|4.0||||||
3877033|NCT01564537|3703070|B1|Singapore||Region of Enrollment||participants|Number|2|2.0||||||
3877034|NCT01564537|3703068|B3|Russian Federation||Region of Enrollment||participants|Number|39|39.0||||||
3877035|NCT01564537|3703069|B2|Russian Federation||Region of Enrollment||participants|Number|18|18.0||||||
3877036|NCT01564537|3703070|B1|Russian Federation||Region of Enrollment||participants|Number|21|21.0||||||
3877037|NCT01564537|3703068|B3|Missing||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3877038|NCT01564537|3703069|B2|Missing||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3877039|NCT01564537|3703070|B1|Missing||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3877040|NCT01564537|3703068|B3|Not Reported||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3877041|NCT01564537|3703069|B2|Not Reported||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3877042|NCT01564537|3703070|B1|Not Reported||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3877043|NCT01564537|3703068|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|672|672.0||||||
3877044|NCT01564537|3703069|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|333|333.0||||||
3877045|NCT01564537|3703070|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|339|339.0||||||
3877046|NCT01564537|3703068|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3877047|NCT01564537|3703069|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3877048|NCT01564537|3703070|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3877049|NCT01564537|3703068|B3|Not reported||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3877050|NCT01564537|3703069|B2|Not reported||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3877051|NCT01564537|3703070|B1|Not reported||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3877052|NCT01564537|3703068|B3|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3877053|NCT01564537|3703069|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3877054|NCT01564537|3703070|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3877055|NCT01564537|3703068|B3|American Indian/Alaska native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3877056|NCT01564537|3703069|B2|American Indian/Alaska native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3877057|NCT01564537|3703070|B1|American Indian/Alaska native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3877058|NCT01564537|3703068|B3|Asian||Race/Ethnicity, Customized||participants|Number|64|64.0||||||
3877059|NCT01564537|3703069|B2|Asian||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
3877060|NCT01564537|3703070|B1|Asian||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3877061|NCT01564537|3703068|B3|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3877062|NCT01564537|3703069|B2|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3877063|NCT01564537|3703070|B1|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3877064|NCT01564537|3703068|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3877065|NCT01564537|3703069|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3877066|NCT01564537|3703070|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3877067|NCT01564537|3703068|B3|White||Race/Ethnicity, Customized||participants|Number|611|611.0||||||
3877068|NCT01564537|3703069|B2|White||Race/Ethnicity, Customized||participants|Number|301|301.0||||||
3877069|NCT01564537|3703070|B1|White||Race/Ethnicity, Customized||participants|Number|310|310.0||||||
3877070|NCT01564537|3703068|B3||Male|Sex: Female, Male||Participants|Count of Participants|409|409.0||||||
3877071|NCT01564537|3703069|B2||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3877072|NCT01564537|3703070|B1||Male|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
3877073|NCT01564537|3703068|B3||Female|Sex: Female, Male||Participants|Count of Participants|313|313.0||||||
3877074|NCT01564537|3703069|B2||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3877075|NCT01564537|3703070|B1||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3877076|NCT01564537|3703068|B3|>75 years||Age, Customized||participants|Number|108|108.0||||||
3877077|NCT01564537|3703069|B2|>75 years||Age, Customized||participants|Number|61|61.0||||||
3877078|NCT01564537|3703070|B1|>75 years||Age, Customized||participants|Number|47|47.0||||||
3877079|NCT01564537|3703068|B3|>65-≤75 years||Age, Customized||participants|Number|270|270.0||||||
3877080|NCT01564537|3703069|B2|>65-≤75 years||Age, Customized||participants|Number|125|125.0||||||
3877081|NCT01564537|3703070|B1|>65-≤75 years||Age, Customized||participants|Number|145|145.0||||||
3877082|NCT01564537|3703068|B3|≤65 years||Age, Customized||participants|Number|344|344.0||||||
3877083|NCT01564537|3703069|B2|≤65 years||Age, Customized||participants|Number|176|176.0||||||
3877084|NCT01564537|3703070|B1|≤65 years||Age, Customized||participants|Number|168|168.0||||||
3877085|NCT01564537|3703068|B3|||Age||years|Mean|65.7|65.7|Standard Deviation|9.41|9.41|||
3877086|NCT01564537|3703069|B2|||Age||years|Mean|65.8|65.8|Standard Deviation|9.70|9.7|||
3877087|NCT01564537|3703070|B1|||Age||years|Mean|65.5|65.5|Standard Deviation|9.13|9.13|||
3877088|NCT01564459|3703091|B4||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3877089|NCT01564459|3703092|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3877090|NCT01564459|3703093|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3877091|NCT01564459|3703094|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3877092|NCT01564459|3703091|B4||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3877093|NCT01564459|3703092|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3877094|NCT01564459|3703093|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3877095|NCT01564459|3703094|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3877096|NCT01564459|3703091|B4|||Age||years|Mean|55.5|55.5|Standard Deviation|9.5|9.5|||
3877097|NCT01564459|3703092|B3|||Age||years|Mean|55.5|55.5|Standard Deviation|10.3|10.3|||
3877098|NCT01564459|3703093|B2|||Age||years|Mean|55.6|55.6|Standard Deviation|9.2|9.2|||
3877099|NCT01564459|3703094|B1|||Age||years|Mean|54.8|54.8|Standard Deviation|6.9|6.9|||
3877100|NCT01564407|3703115|B6|United States||Region of Enrollment||participants|Number|15|15.0||||||
3877101|NCT01564407|3703117|B4|United States||Region of Enrollment||participants|Number|2|2.0||||||
3877102|NCT01564407|3703118|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3877103|NCT01564407|3703119|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3877104|NCT01564407|3703120|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3877105|NCT01564407|3703115|B6|Male||Sex/Gender, Customized||participants|Number|10|10.0||||||
3877106|NCT01564407|3703117|B4|Male||Sex/Gender, Customized||participants|Number|2|2.0||||||
3877107|NCT01564407|3703118|B3|Male||Sex/Gender, Customized||participants|Number|4|4.0||||||
3877108|NCT01564407|3703119|B2|Male||Sex/Gender, Customized||participants|Number|4|4.0||||||
3877109|NCT01564407|3703120|B1|Male||Sex/Gender, Customized||participants|Number|0|0.0||||||
3877110|NCT01564407|3703115|B6|Female||Sex/Gender, Customized||participants|Number|5|5.0||||||
3877111|NCT01564407|3703117|B4|Female||Sex/Gender, Customized||participants|Number|0|0.0||||||
3877112|NCT01564407|3703118|B3|Female||Sex/Gender, Customized||participants|Number|0|0.0||||||
3877113|NCT01564407|3703119|B2|Female||Sex/Gender, Customized||participants|Number|1|1.0||||||
3877114|NCT01564407|3703120|B1|Female||Sex/Gender, Customized||participants|Number|4|4.0||||||
3877115|NCT01564407|3703115|B6|||Age||years|Mean|45.3|45.3|Standard Deviation|12.4|12.4|||
3877116|NCT01564407|3703117|B4|||Age||years|Mean|62|62.0|Standard Deviation|0|0.0|||
3877117|NCT01564407|3703118|B3|||Age||years|Mean|45.75|45.75|Standard Deviation|14.9|14.9|||
3877118|NCT01564407|3703119|B2|||Age||years|Mean|41.25|41.25|Standard Deviation|17.0|17.0|||
3877119|NCT01564407|3703120|B1|||Age||years|Mean|32.25|32.25|Standard Deviation|12.3|12.3|||
3877120|NCT01564407|3703115|B6|>=65 years||Age, Customized||participants|Number|0|0.0||||||
3877121|NCT01564407|3703117|B4|>=65 years||Age, Customized||participants|Number|0|0.0||||||
3877122|NCT01564407|3703118|B3|>=65 years||Age, Customized||participants|Number|0|0.0||||||
3877123|NCT01564407|3703119|B2|>=65 years||Age, Customized||participants|Number|0|0.0||||||
3877124|NCT01564407|3703120|B1|>=65 years||Age, Customized||participants|Number|0|0.0||||||
3877125|NCT01564407|3703115|B6|Between 18 and 65 years||Age, Customized||participants|Number|15|15.0||||||
3877126|NCT01564407|3703117|B4|Between 18 and 65 years||Age, Customized||participants|Number|2|2.0||||||
3877127|NCT01564407|3703118|B3|Between 18 and 65 years||Age, Customized||participants|Number|4|4.0||||||
3877128|NCT01564407|3703119|B2|Between 18 and 65 years||Age, Customized||participants|Number|5|5.0||||||
3877129|NCT01564407|3703120|B1|Between 18 and 65 years||Age, Customized||participants|Number|4|4.0||||||
3877130|NCT01564407|3703115|B6|<=18 years||Age, Customized||participants|Number|0|0.0||||||
3877131|NCT01564407|3703117|B4|<=18 years||Age, Customized||participants|Number|0|0.0||||||
3877132|NCT01564407|3703118|B3|<=18 years||Age, Customized||participants|Number|0|0.0||||||
3877133|NCT01564407|3703119|B2|<=18 years||Age, Customized||participants|Number|0|0.0||||||
3877134|NCT01564407|3703120|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
3877135|NCT01564394|3703163|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
3877136|NCT01564394|3703164|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3877137|NCT01564394|3703165|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3877138|NCT01564394|3703163|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3877139|NCT01564394|3703164|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3877140|NCT01564394|3703165|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3877141|NCT01564394|3703163|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3877142|NCT01564394|3703164|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3877143|NCT01564394|3703165|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3877144|NCT01564394|3703163|B3|||Age||years|Mean|71.2|71.2|Standard Deviation|9.7|9.7|||
3877145|NCT01564394|3703164|B2|||Age||years|Mean|71.2|71.2|Standard Deviation|10.1|10.1|||
3877146|NCT01564394|3703165|B1|||Age||years|Mean|71.3|71.3|Standard Deviation|9.6|9.6|||
3877147|NCT01564394|3703163|B3||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
3877148|NCT01564394|3703164|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3877149|NCT01564394|3703165|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3877150|NCT01564394|3703163|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3877151|NCT01564394|3703164|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3877152|NCT01564394|3703165|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3877153|NCT01564394|3703163|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3877154|NCT01564394|3703164|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3877155|NCT01564394|3703165|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3877156|NCT01564277|3703178|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877157|NCT01564277|3703179|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877158|NCT01564277|3703180|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877159|NCT01564277|3703178|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877160|NCT01564277|3703179|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877161|NCT01564277|3703180|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877162|NCT01564277|3703178|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3877163|NCT01564277|3703179|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3877164|NCT01564277|3703180|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3877165|NCT01564277|3703178|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3877166|NCT01564277|3703179|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877167|NCT01564277|3703180|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3877168|NCT01564277|3703178|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877169|NCT01564277|3703179|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877170|NCT01564277|3703180|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877171|NCT01564277|3703178|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877172|NCT01564277|3703179|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877173|NCT01564277|3703180|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877174|NCT01564277|3703178|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877175|NCT01564277|3703179|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877176|NCT01564277|3703180|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877177|NCT01564277|3703178|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3877178|NCT01564277|3703179|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3877179|NCT01564277|3703180|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3877180|NCT01564277|3703178|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3877181|NCT01564277|3703179|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3877182|NCT01564277|3703180|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3877183|NCT01564277|3703178|B3|||Age||years|Mean|69.2|69.2|Standard Deviation|12.3|12.3|||
3877184|NCT01564277|3703179|B2|||Age||years|Mean|68.4|68.4|Standard Deviation|16.4|16.4|||
3877185|NCT01564277|3703180|B1|||Age||years|Mean|69.9|69.9|Standard Deviation|7.5|7.5|||
3877186|NCT01564277|3703178|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3877187|NCT01564277|3703179|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3877188|NCT01564277|3703180|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3877189|NCT01564277|3703178|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3877190|NCT01564277|3703179|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3877191|NCT01564277|3703180|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3877192|NCT01564277|3703178|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3877193|NCT01564277|3703179|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3877194|NCT01564277|3703180|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3877195|NCT01563978|3703197|B3|Indian or Pakistani||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3877196|NCT01563978|3703198|B2|Indian or Pakistani||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3877197|NCT01563978|3703199|B1|Indian or Pakistani||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3877198|NCT01563978|3703197|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3877199|NCT01563978|3703198|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3877200|NCT01563978|3703199|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3877201|NCT01563978|3703197|B3|White||Race/Ethnicity, Customized||Participants|Number|121|121.0||||||
3877202|NCT01563978|3703198|B2|White||Race/Ethnicity, Customized||Participants|Number|58|58.0||||||
3877203|NCT01563978|3703199|B1|White||Race/Ethnicity, Customized||Participants|Number|63|63.0||||||
3877204|NCT01563978|3703197|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3877205|NCT01563978|3703198|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3877206|NCT01563978|3703199|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3877207|NCT01563978|3703197|B3||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3877208|NCT01563978|3703198|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3877209|NCT01563978|3703199|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3877210|NCT01563978|3703197|B3|||Age||Years|Mean|54|54.0|Standard Deviation|12.5|12.5|||
3877211|NCT01563978|3703198|B2|||Age||Years|Mean|54|54.0|Standard Deviation|13.0|13.0|||
3877212|NCT01563978|3703199|B1|||Age||Years|Mean|54|54.0|Standard Deviation|12.0|12.0|||
3877213|NCT01563913|3703224|B3|||Levodopa Exposure (Equivalence)|Prior levodopa exposure as measured by subjective self report and medical record review for dopamine agonists (such as amantadine, apomorphine, pramipexole, ropinirole, rotigotine). Converted to levodopa equivalence using the Parkinson's UK Levodopa Equivalent Dose Calculator. This is levodopa exposure prior to starting Sinemet (carbidopa/levodopa), prior to entry into the study, through another drug like a dopamine agonist.|mg/day|Median|345.0|345.0|Full Range|||30.0|1425.0|
3877214|NCT01563913|3703225|B2|||Levodopa Exposure (Equivalence)|Prior levodopa exposure as measured by subjective self report and medical record review for dopamine agonists (such as amantadine, apomorphine, pramipexole, ropinirole, rotigotine). Converted to levodopa equivalence using the Parkinson's UK Levodopa Equivalent Dose Calculator. This is levodopa exposure prior to starting Sinemet (carbidopa/levodopa), prior to entry into the study, through another drug like a dopamine agonist.|mg/day|Median|187.5|187.5|Full Range|||30.0|1425.0|
3877215|NCT01563913|3703226|B1|||Levodopa Exposure (Equivalence)|Prior levodopa exposure as measured by subjective self report and medical record review for dopamine agonists (such as amantadine, apomorphine, pramipexole, ropinirole, rotigotine). Converted to levodopa equivalence using the Parkinson's UK Levodopa Equivalent Dose Calculator. This is levodopa exposure prior to starting Sinemet (carbidopa/levodopa), prior to entry into the study, through another drug like a dopamine agonist.|mg/day|Median|540.0|540.0|Full Range|||330.0|1440.0|
3877216|NCT01563913|3703224|B3|||Levodopa Initial Dose|Initial dose of levodopa (carbidopa/levodopa or Sinemet) as prescribed by treating physician in mg/day. This oral levodopa dose was prescribed clinically and is the first prescription of Sinemet (carbidopa/levodopa) that the participant ever received.|mg/day|Median|300.0|300.0|Full Range|||150.0|600.0|
3877217|NCT01563913|3703225|B2|||Levodopa Initial Dose|Initial dose of levodopa (carbidopa/levodopa or Sinemet) as prescribed by treating physician in mg/day. This oral levodopa dose was prescribed clinically and is the first prescription of Sinemet (carbidopa/levodopa) that the participant ever received.|mg/day|Median|300.0|300.0|Full Range|||300.0|600.0|
3877218|NCT01563913|3703226|B1|||Levodopa Initial Dose|Initial dose of levodopa (carbidopa/levodopa or Sinemet) as prescribed by treating physician in mg/day. This oral levodopa dose was prescribed clinically and is the first prescription of Sinemet (carbidopa/levodopa) that the participant ever received.|mg/day|Median|300.0|300.0|Full Range|||150.0|400.0|
3877219|NCT01563913|3703224|B3|||Hoehn & Yahr|This is an objective staging scale for rating the clinical functioning of Parkinson’s disease patients, combining functional deficits (disability) and objective signs (impairment). This staging scale is commonly used in both research settings and clinical practice. The Hoehn & Yahr is an ordinal scale ranging from 0 (no signs of disease) to 5 (wheelchair bound/bedridden). The modified version of the scale includes increments of 0.5. The HY has shown good inter-rater reliability and, although it is used worldwide, the clinimetric validity has not been established.|units on a scale|Median|2.25|2.25|Full Range|||2.0|3.0|
3877220|NCT01563913|3703225|B2|||Hoehn & Yahr|This is an objective staging scale for rating the clinical functioning of Parkinson’s disease patients, combining functional deficits (disability) and objective signs (impairment). This staging scale is commonly used in both research settings and clinical practice. The Hoehn & Yahr is an ordinal scale ranging from 0 (no signs of disease) to 5 (wheelchair bound/bedridden). The modified version of the scale includes increments of 0.5. The HY has shown good inter-rater reliability and, although it is used worldwide, the clinimetric validity has not been established.|units on a scale|Median|2.0|2.0|Full Range|||2.0|3.0|
3877221|NCT01563913|3703226|B1|||Hoehn & Yahr|This is an objective staging scale for rating the clinical functioning of Parkinson’s disease patients, combining functional deficits (disability) and objective signs (impairment). This staging scale is commonly used in both research settings and clinical practice. The Hoehn & Yahr is an ordinal scale ranging from 0 (no signs of disease) to 5 (wheelchair bound/bedridden). The modified version of the scale includes increments of 0.5. The HY has shown good inter-rater reliability and, although it is used worldwide, the clinimetric validity has not been established.|units on a scale|Median|2.5|2.5|Full Range|||2.0|3.0|
3877222|NCT01563913|3703224|B3|||Unified Parkinsons Disease Rating Scale (UPDRS-III)|This is the motor subsection of the Unified Parkinson's Disease Rating Scale (UPDRS) and is a commonly used tool to rate the symptoms of Parkinson‘s disease. Each item on the scale is rated from 0 (normal) to 4 (Can barely perform the task) several motor areas including speech, facial expression, tremor, rigidity, hand movements, agility, posture, and gait. Total score ranges from 0 to 108 with higher values on this scale represent a more severe stage of the disease.|units on a scale|Mean|31.9|31.9|Standard Deviation|10.5|10.5|||
3877223|NCT01563913|3703225|B2|||Unified Parkinsons Disease Rating Scale (UPDRS-III)|This is the motor subsection of the Unified Parkinson's Disease Rating Scale (UPDRS) and is a commonly used tool to rate the symptoms of Parkinson‘s disease. Each item on the scale is rated from 0 (normal) to 4 (Can barely perform the task) several motor areas including speech, facial expression, tremor, rigidity, hand movements, agility, posture, and gait. Total score ranges from 0 to 108 with higher values on this scale represent a more severe stage of the disease.|units on a scale|Mean|29.2|29.2|Standard Deviation|10.9|10.9|||
3877224|NCT01563913|3703226|B1|||Unified Parkinsons Disease Rating Scale (UPDRS-III)|This is the motor subsection of the Unified Parkinson's Disease Rating Scale (UPDRS) and is a commonly used tool to rate the symptoms of Parkinson‘s disease. Each item on the scale is rated from 0 (normal) to 4 (Can barely perform the task) several motor areas including speech, facial expression, tremor, rigidity, hand movements, agility, posture, and gait. Total score ranges from 0 to 108 with higher values on this scale represent a more severe stage of the disease.|units on a scale|Mean|34.6|34.6|Standard Deviation|9.7|9.7|||
3877264|NCT01563913|3703224|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3877265|NCT01563913|3703225|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3877225|NCT01563913|3703224|B3|||MoCA Score|The MoCA is a short cognitive screening test designed to assist health care professionals for the detection of mild cognitive impairment. The MoCA is scored on a 0 to 30 scale, with lower numbers indicating more cognitive impairment. A point is added to the MoCA if the subject's education high school or less (12 years or less education). Scores ranging from 26 - 30 are normal, 18 - 26 mild impairment, 10 - 17 moderate impairment, and less than 10 severe cognitive impairment.|units on a scale|Mean|24.9|24.9|Standard Deviation|3.2|3.2|||
3877226|NCT01563913|3703225|B2|||MoCA Score|The MoCA is a short cognitive screening test designed to assist health care professionals for the detection of mild cognitive impairment. The MoCA is scored on a 0 to 30 scale, with lower numbers indicating more cognitive impairment. A point is added to the MoCA if the subject's education high school or less (12 years or less education). Scores ranging from 26 - 30 are normal, 18 - 26 mild impairment, 10 - 17 moderate impairment, and less than 10 severe cognitive impairment.|units on a scale|Mean|24.7|24.7|Standard Deviation|2.6|2.6|||
3877227|NCT01563913|3703226|B1|||MoCA Score|The MoCA is a short cognitive screening test designed to assist health care professionals for the detection of mild cognitive impairment. The MoCA is scored on a 0 to 30 scale, with lower numbers indicating more cognitive impairment. A point is added to the MoCA if the subject's education high school or less (12 years or less education). Scores ranging from 26 - 30 are normal, 18 - 26 mild impairment, 10 - 17 moderate impairment, and less than 10 severe cognitive impairment.|units on a scale|Mean|25.1|25.1|Standard Deviation|3.8|3.8|||
3877228|NCT01563913|3703224|B3|||DHA Intake at Screening|DHA Food Frequency Scale Total - a one page questionnaire asking about total monthly dietary intake of items such as fish, shellfish, turkey, chicken, beef, egg yolks, and liver.|mg/day|Mean|134.8|134.8|Standard Deviation|82.9|82.9|||
3877229|NCT01563913|3703225|B2|||DHA Intake at Screening|DHA Food Frequency Scale Total - a one page questionnaire asking about total monthly dietary intake of items such as fish, shellfish, turkey, chicken, beef, egg yolks, and liver.|mg/day|Mean|148.7|148.7|Standard Deviation|88.1|88.1|||
3877230|NCT01563913|3703226|B1|||DHA Intake at Screening|DHA Food Frequency Scale Total - a one page questionnaire asking about total monthly dietary intake of items such as fish, shellfish, turkey, chicken, beef, egg yolks, and liver.|mg/day|Mean|119.9|119.9|Standard Deviation|77.4|77.4|||
3877231|NCT01563913|3703224|B3|||Education|Number of years of education (subjectively reported).|years|Mean|15.9|15.9|Standard Deviation|3.2|3.2|||
3877232|NCT01563913|3703225|B2|||Education|Number of years of education (subjectively reported).|years|Mean|15.7|15.7|Standard Deviation|3.1|3.1|||
3877233|NCT01563913|3703226|B1|||Education|Number of years of education (subjectively reported).|years|Mean|16.0|16.0|Standard Deviation|3.2|3.2|||
3877234|NCT01563913|3703224|B3|||PD Symptom Duration|Year of screening visit - Subjectively reported onset of Parkinson's symptoms year|years|Mean|3.8|3.8|Standard Deviation|2.9|2.9|||
3877235|NCT01563913|3703225|B2|||PD Symptom Duration|Year of screening visit - Subjectively reported onset of Parkinson's symptoms year|years|Mean|4.6|4.6|Standard Deviation|3.8|3.8|||
3877236|NCT01563913|3703226|B1|||PD Symptom Duration|Year of screening visit - Subjectively reported onset of Parkinson's symptoms year|years|Mean|3.2|3.2|Standard Deviation|1.9|1.9|||
3877237|NCT01563913|3703224|B3|United States||Region of Enrollment|Large Northwest American City|Participants|Count of Participants|30|30.0||||||
3877238|NCT01563913|3703225|B2|United States||Region of Enrollment|Large Northwest American City|Participants|Count of Participants|15|15.0||||||
3877239|NCT01563913|3703226|B1|United States||Region of Enrollment|Large Northwest American City|Participants|Count of Participants|15|15.0||||||
3877240|NCT01563913|3703224|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877241|NCT01563913|3703225|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877242|NCT01563913|3703226|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877243|NCT01563913|3703224|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877244|NCT01563913|3703225|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877245|NCT01563913|3703226|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877246|NCT01563913|3703224|B3||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3877247|NCT01563913|3703225|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3877248|NCT01563913|3703226|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3877249|NCT01563913|3703224|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877250|NCT01563913|3703225|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877251|NCT01563913|3703226|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877252|NCT01563913|3703224|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877253|NCT01563913|3703225|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877254|NCT01563913|3703226|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877255|NCT01563913|3703224|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877256|NCT01563913|3703225|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877257|NCT01563913|3703226|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877258|NCT01563913|3703224|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877259|NCT01563913|3703225|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877260|NCT01563913|3703226|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877261|NCT01563913|3703224|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877262|NCT01563913|3703225|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877263|NCT01563913|3703226|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877266|NCT01563913|3703226|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3877267|NCT01563913|3703224|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877268|NCT01563913|3703225|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877269|NCT01563913|3703226|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877270|NCT01563913|3703224|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3877271|NCT01563913|3703225|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3877272|NCT01563913|3703226|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3877273|NCT01563913|3703224|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3877274|NCT01563913|3703225|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3877275|NCT01563913|3703226|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3877276|NCT01563913|3703224|B3|||Age||years|Mean|68.0|68.0|Standard Deviation|7.6|7.6|||
3877277|NCT01563913|3703225|B2|||Age||years|Mean|67.0|67.0|Standard Deviation|8.5|8.5|||
3877278|NCT01563913|3703226|B1|||Age||years|Mean|68.3|68.3|Standard Deviation|7.6|7.6|||
3877279|NCT01563536|3703237|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3877280|NCT01563536|3703238|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3877281|NCT01563536|3703239|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3877282|NCT01563536|3703237|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3877283|NCT01563536|3703238|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3877284|NCT01563536|3703239|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3877285|NCT01563536|3703237|B3|||Age||years|Mean|49.2|49.2|Standard Deviation|8.94|8.94|||
3877286|NCT01563536|3703238|B2|||Age||years|Mean|46.8|46.8|Standard Deviation|11.84|11.84|||
3877287|NCT01563536|3703239|B1|||Age||years|Mean|51.5|51.5|Standard Deviation|4.76|4.76|||
3877288|NCT01563406|3703268|B5|||No. hubs per patient||hubs per patient|Median|3|3.0|Inter-Quartile Range|||2.0|4.0|
3877289|NCT01563406|3703269|B4|||No. hubs per patient||hubs per patient|Median|3|3.0|Inter-Quartile Range|||2.0|5.0|
3877290|NCT01563406|3703270|B3|||No. hubs per patient||hubs per patient|Median|3|3.0|Inter-Quartile Range|||2.0|3.0|
3877291|NCT01563406|3703271|B2|||No. hubs per patient||hubs per patient|Median|3|3.0|Inter-Quartile Range|||2.0|4.0|
3877292|NCT01563406|3703272|B1|||No. hubs per patient||hubs per patient|Median|3|3.0|Inter-Quartile Range|||2.0|3.0|
3877293|NCT01563406|3703268|B5|||Time hub in place||hours|Mean|97|97.0|Standard Deviation|31|31.0|||
3877294|NCT01563406|3703269|B4|||Time hub in place||hours|Mean|94|94.0|Standard Deviation|25|25.0|||
3877295|NCT01563406|3703270|B3|||Time hub in place||hours|Mean|100|100.0|Standard Deviation|33|33.0|||
3877296|NCT01563406|3703271|B2|||Time hub in place||hours|Mean|101|101.0|Standard Deviation|41|41.0|||
3877297|NCT01563406|3703272|B1|||Time hub in place||hours|Mean|95|95.0|Standard Deviation|27|27.0|||
3877298|NCT01563406|3703268|B5|Unknown||Anatomic location of CVC||hubs|Number|2|2.0||||||
3877299|NCT01563406|3703269|B4|Unknown||Anatomic location of CVC||hubs|Number|0|0.0||||||
3877300|NCT01563406|3703270|B3|Unknown||Anatomic location of CVC||hubs|Number|0|0.0||||||
3877301|NCT01563406|3703271|B2|Unknown||Anatomic location of CVC||hubs|Number|0|0.0||||||
3877302|NCT01563406|3703272|B1|Unknown||Anatomic location of CVC||hubs|Number|2|2.0||||||
3877303|NCT01563406|3703268|B5|Subclavian||Anatomic location of CVC||hubs|Number|31|31.0||||||
3877304|NCT01563406|3703269|B4|Subclavian||Anatomic location of CVC||hubs|Number|13|13.0||||||
3877305|NCT01563406|3703270|B3|Subclavian||Anatomic location of CVC||hubs|Number|0|0.0||||||
3877306|NCT01563406|3703271|B2|Subclavian||Anatomic location of CVC||hubs|Number|0|0.0||||||
3877307|NCT01563406|3703272|B1|Subclavian||Anatomic location of CVC||hubs|Number|18|18.0||||||
3877308|NCT01563406|3703268|B5|Femoral||Anatomic location of CVC||hubs|Number|59|59.0||||||
3877309|NCT01563406|3703269|B4|Femoral||Anatomic location of CVC||hubs|Number|21|21.0||||||
3877310|NCT01563406|3703270|B3|Femoral||Anatomic location of CVC||hubs|Number|6|6.0||||||
3877311|NCT01563406|3703271|B2|Femoral||Anatomic location of CVC||hubs|Number|11|11.0||||||
3877312|NCT01563406|3703272|B1|Femoral||Anatomic location of CVC||hubs|Number|21|21.0||||||
3877313|NCT01563406|3703268|B5|Basilic/cephalic/brachial||Anatomic location of CVC||hubs|Number|122|122.0||||||
3877314|NCT01563406|3703269|B4|Basilic/cephalic/brachial||Anatomic location of CVC||hubs|Number|20|20.0||||||
3877315|NCT01563406|3703270|B3|Basilic/cephalic/brachial||Anatomic location of CVC||hubs|Number|30|30.0||||||
3877316|NCT01563406|3703271|B2|Basilic/cephalic/brachial||Anatomic location of CVC||hubs|Number|21|21.0||||||
3877317|NCT01563406|3703272|B1|Basilic/cephalic/brachial||Anatomic location of CVC||hubs|Number|51|51.0||||||
3877318|NCT01563406|3703268|B5|Internal/external jugular||Anatomic location of CVC||hubs|Number|295|295.0||||||
3877319|NCT01563406|3703269|B4|Internal/external jugular||Anatomic location of CVC||hubs|Number|58|58.0||||||
3877320|NCT01563406|3703270|B3|Internal/external jugular||Anatomic location of CVC||hubs|Number|65|65.0||||||
3877321|NCT01563406|3703271|B2|Internal/external jugular||Anatomic location of CVC||hubs|Number|70|70.0||||||
3877322|NCT01563406|3703272|B1|Internal/external jugular||Anatomic location of CVC||hubs|Number|102|102.0||||||
3877323|NCT01563406|3703268|B5|PICC||Central venous catheter (CVC) type||hubs|Number|158|158.0||||||
3877324|NCT01563406|3703269|B4|PICC||Central venous catheter (CVC) type||hubs|Number|26|26.0||||||
3877325|NCT01563406|3703270|B3|PICC||Central venous catheter (CVC) type||hubs|Number|40|40.0||||||
3877326|NCT01563406|3703271|B2|PICC||Central venous catheter (CVC) type||hubs|Number|33|33.0||||||
3877327|NCT01563406|3703272|B1|PICC||Central venous catheter (CVC) type||hubs|Number|59|59.0||||||
3877328|NCT01563406|3703268|B5|Triple lumen||Central venous catheter (CVC) type||hubs|Number|351|351.0||||||
3877329|NCT01563406|3703269|B4|Triple lumen||Central venous catheter (CVC) type||hubs|Number|86|86.0||||||
3877330|NCT01563406|3703270|B3|Triple lumen||Central venous catheter (CVC) type||hubs|Number|61|61.0||||||
3877331|NCT01563406|3703271|B2|Triple lumen||Central venous catheter (CVC) type||hubs|Number|69|69.0||||||
3877332|NCT01563406|3703272|B1|Triple lumen||Central venous catheter (CVC) type||hubs|Number|135|135.0||||||
3877333|NCT01563406|3703268|B5|No||Liver disease||participants|Number|135|135.0||||||
3877334|NCT01563406|3703269|B4|No||Liver disease||participants|Number|26|26.0||||||
3877335|NCT01563406|3703270|B3|No||Liver disease||participants|Number|28|28.0||||||
3877336|NCT01563406|3703271|B2|No||Liver disease||participants|Number|26|26.0||||||
3877337|NCT01563406|3703272|B1|No||Liver disease||participants|Number|55|55.0||||||
3877338|NCT01563406|3703268|B5|Yes||Liver disease||participants|Number|14|14.0||||||
3877339|NCT01563406|3703269|B4|Yes||Liver disease||participants|Number|3|3.0||||||
3877340|NCT01563406|3703270|B3|Yes||Liver disease||participants|Number|2|2.0||||||
3877341|NCT01563406|3703271|B2|Yes||Liver disease||participants|Number|4|4.0||||||
3877342|NCT01563406|3703272|B1|Yes||Liver disease||participants|Number|5|5.0||||||
3877343|NCT01563406|3703268|B5|No||Pulmonary Disease||participants|Number|113|113.0||||||
3877344|NCT01563406|3703269|B4|No||Pulmonary Disease||participants|Number|21|21.0||||||
3877345|NCT01563406|3703270|B3|No||Pulmonary Disease||participants|Number|22|22.0||||||
3877346|NCT01563406|3703271|B2|No||Pulmonary Disease||participants|Number|24|24.0||||||
3877347|NCT01563406|3703272|B1|No||Pulmonary Disease||participants|Number|46|46.0||||||
3877348|NCT01563406|3703268|B5|Yes||Pulmonary Disease||participants|Number|36|36.0||||||
3877349|NCT01563406|3703269|B4|Yes||Pulmonary Disease||participants|Number|8|8.0||||||
3877350|NCT01563406|3703270|B3|Yes||Pulmonary Disease||participants|Number|8|8.0||||||
3877351|NCT01563406|3703271|B2|Yes||Pulmonary Disease||participants|Number|6|6.0||||||
3877352|NCT01563406|3703272|B1|Yes||Pulmonary Disease||participants|Number|14|14.0||||||
3877353|NCT01563406|3703268|B5|No||Heart disease||participants|Number|68|68.0||||||
3877354|NCT01563406|3703269|B4|No||Heart disease||participants|Number|8|8.0||||||
3877355|NCT01563406|3703270|B3|No||Heart disease||participants|Number|18|18.0||||||
3877356|NCT01563406|3703271|B2|No||Heart disease||participants|Number|14|14.0||||||
3877357|NCT01563406|3703272|B1|No||Heart disease||participants|Number|28|28.0||||||
3877358|NCT01563406|3703268|B5|Yes||Heart disease||participants|Number|81|81.0||||||
3877359|NCT01563406|3703269|B4|Yes||Heart disease||participants|Number|21|21.0||||||
3877360|NCT01563406|3703270|B3|Yes||Heart disease||participants|Number|12|12.0||||||
3877361|NCT01563406|3703271|B2|Yes||Heart disease||participants|Number|16|16.0||||||
3877362|NCT01563406|3703272|B1|Yes||Heart disease||participants|Number|32|32.0||||||
3877363|NCT01563406|3703268|B5|No||Diabetes||participants|Number|100|100.0||||||
3877364|NCT01563406|3703269|B4|No||Diabetes||participants|Number|22|22.0||||||
3877365|NCT01563406|3703270|B3|No||Diabetes||participants|Number|22|22.0||||||
3877366|NCT01563406|3703271|B2|No||Diabetes||participants|Number|17|17.0||||||
3877367|NCT01563406|3703272|B1|No||Diabetes||participants|Number|39|39.0||||||
3877368|NCT01563406|3703268|B5|Yes||Diabetes||participants|Number|49|49.0||||||
3877369|NCT01563406|3703269|B4|Yes||Diabetes||participants|Number|7|7.0||||||
3877370|NCT01563406|3703270|B3|Yes||Diabetes||participants|Number|8|8.0||||||
3877371|NCT01563406|3703271|B2|Yes||Diabetes||participants|Number|13|13.0||||||
3877372|NCT01563406|3703272|B1|Yes||Diabetes||participants|Number|21|21.0||||||
3877373|NCT01563406|3703268|B5|No||Diarrhea||participants|Number|88|88.0||||||
3877374|NCT01563406|3703269|B4|No||Diarrhea||participants|Number|17|17.0||||||
3877375|NCT01563406|3703270|B3|No||Diarrhea||participants|Number|17|17.0||||||
3877376|NCT01563406|3703271|B2|No||Diarrhea||participants|Number|14|14.0||||||
3877377|NCT01563406|3703272|B1|No||Diarrhea||participants|Number|40|40.0||||||
3877378|NCT01563406|3703268|B5|Yes||Diarrhea||participants|Number|61|61.0||||||
3877379|NCT01563406|3703269|B4|Yes||Diarrhea||participants|Number|12|12.0||||||
3877380|NCT01563406|3703270|B3|Yes||Diarrhea||participants|Number|13|13.0||||||
3877381|NCT01563406|3703271|B2|Yes||Diarrhea||participants|Number|16|16.0||||||
3877382|NCT01563406|3703272|B1|Yes||Diarrhea||participants|Number|20|20.0||||||
3877383|NCT01563406|3703268|B5|No||Decubitus ulcer||participants|Number|97|97.0||||||
3877384|NCT01563406|3703269|B4|No||Decubitus ulcer||participants|Number|20|20.0||||||
3877385|NCT01563406|3703270|B3|No||Decubitus ulcer||participants|Number|22|22.0||||||
3877386|NCT01563406|3703271|B2|No||Decubitus ulcer||participants|Number|19|19.0||||||
3877387|NCT01563406|3703272|B1|No||Decubitus ulcer||participants|Number|36|36.0||||||
3877388|NCT01563406|3703268|B5|Yes||Decubitus ulcer||participants|Number|52|52.0||||||
3877389|NCT01563406|3703269|B4|Yes||Decubitus ulcer||participants|Number|9|9.0||||||
3877390|NCT01563406|3703270|B3|Yes||Decubitus ulcer||participants|Number|8|8.0||||||
3877391|NCT01563406|3703271|B2|Yes||Decubitus ulcer||participants|Number|11|11.0||||||
3877392|NCT01563406|3703272|B1|Yes||Decubitus ulcer||participants|Number|24|24.0||||||
3877393|NCT01563406|3703268|B5|No||Mechanical ventilation||participants|Number|49|49.0||||||
3877394|NCT01563406|3703269|B4|No||Mechanical ventilation||participants|Number|10|10.0||||||
3877395|NCT01563406|3703270|B3|No||Mechanical ventilation||participants|Number|6|6.0||||||
3877396|NCT01563406|3703271|B2|No||Mechanical ventilation||participants|Number|10|10.0||||||
3877397|NCT01563406|3703272|B1|No||Mechanical ventilation||participants|Number|23|23.0||||||
3877398|NCT01563406|3703268|B5|Yes||Mechanical ventilation||participants|Number|100|100.0||||||
3877399|NCT01563406|3703269|B4|Yes||Mechanical ventilation||participants|Number|19|19.0||||||
3877400|NCT01563406|3703270|B3|Yes||Mechanical ventilation||participants|Number|24|24.0||||||
3877401|NCT01563406|3703271|B2|Yes||Mechanical ventilation||participants|Number|20|20.0||||||
3877402|NCT01563406|3703272|B1|Yes||Mechanical ventilation||participants|Number|37|37.0||||||
3877403|NCT01563406|3703268|B5|||BMI||kg/m^2|Mean|30|30.0|Standard Deviation|11|11.0|||
3877404|NCT01563406|3703269|B4|||BMI||kg/m^2|Mean|32|32.0|Standard Deviation|13|13.0|||
3877405|NCT01563406|3703270|B3|||BMI||kg/m^2|Mean|30|30.0|Standard Deviation|14|14.0|||
3877406|NCT01563406|3703271|B2|||BMI||kg/m^2|Mean|31|31.0|Standard Deviation|11|11.0|||
3877407|NCT01563406|3703272|B1|||BMI||kg/m^2|Mean|29|29.0|Standard Deviation|9|9.0|||
3877408|NCT01563406|3703268|B5||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3877409|NCT01563406|3703269|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3877410|NCT01563406|3703270|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3877411|NCT01563406|3703271|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3877412|NCT01563406|3703272|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3877413|NCT01563406|3703268|B5||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3877414|NCT01563406|3703269|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3877415|NCT01563406|3703270|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3877416|NCT01563406|3703271|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3877417|NCT01563406|3703272|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3877418|NCT01563406|3703268|B5|||Age||years|Mean|59|59.0|Standard Deviation|16|16.0|||
3877419|NCT01563406|3703269|B4|||Age||years|Mean|59|59.0|Standard Deviation|17|17.0|||
3877420|NCT01563406|3703270|B3|||Age||years|Mean|53|53.0|Standard Deviation|17|17.0|||
3877421|NCT01563406|3703271|B2|||Age||years|Mean|61|61.0|Standard Deviation|12|12.0|||
3877422|NCT01563406|3703272|B1|||Age||years|Mean|60|60.0|Standard Deviation|17|17.0|||
3877423|NCT01563198|3703293|B1|||Non-completion rate of all scheduled patients|Participants were from 3 MRI sites whose teams were trained in Comfort Talk®. In this analysis all patients scheduled for an MRI at baseline were included as denominator.|Percentage of all scheduled participants|Number|13.3|13.3||||||
3877424|NCT01563198|3703293|B1|||Non-completion rate of showing-up patients||Percentage of all showing-up patients|Number|2.3|2.3||||||
3877425|NCT01563198|3703293|B1|||No-show rate||Percentage of participants|Number|11.2|11.2||||||
3877426|NCT01563185|3703299|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3877427|NCT01563185|3703299|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3877428|NCT01563185|3703299|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3877429|NCT01563185|3703299|B1|||Age||years|Mean|13.8|13.8|Standard Deviation|1.71|1.71|||
3877430|NCT01563185|3703299|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3877431|NCT01563185|3703299|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3877432|NCT01563185|3703299|B1||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
3877433|NCT01563172|3703313|B1|Black||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
3877434|NCT01563172|3703313|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|28|28.0||||||
3877435|NCT01563172|3703313|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3877436|NCT01563172|3703313|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3877437|NCT01563172|3703313|B1|||Age||Years|Mean|63.6|63.6|Standard Deviation|8.56|8.56|||
3877438|NCT01563081|3703340|B3|Pruritus associated with the skin diseases||Number of participants with the indicated primary disease at Baseline||participants|Number|40|40.0||||||
3877439|NCT01563081|3703341|B2|Pruritus associated with the skin diseases||Number of participants with the indicated primary disease at Baseline||participants|Number|20|20.0||||||
3877440|NCT01563081|3703342|B1|Pruritus associated with the skin diseases||Number of participants with the indicated primary disease at Baseline||participants|Number|20|20.0||||||
3877441|NCT01563081|3703340|B3|Allergic rhinitis||Number of participants with the indicated primary disease at Baseline||participants|Number|20|20.0||||||
3877442|NCT01563081|3703341|B2|Allergic rhinitis||Number of participants with the indicated primary disease at Baseline||participants|Number|10|10.0||||||
3877443|NCT01563081|3703342|B1|Allergic rhinitis||Number of participants with the indicated primary disease at Baseline||participants|Number|10|10.0||||||
3877444|NCT01563081|3703340|B3|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3877445|NCT01563081|3703341|B2|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3877446|NCT01563081|3703342|B1|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3877447|NCT01563081|3703340|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|59|59.0||||||
3877448|NCT01563081|3703341|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
3877449|NCT01563081|3703342|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
3877450|NCT01563081|3703340|B3||Male|Gender||Participants|Count of Participants|32|32.0||||||
3877451|NCT01563081|3703341|B2||Male|Gender||Participants|Count of Participants|13|13.0||||||
3877452|NCT01563081|3703342|B1||Male|Gender||Participants|Count of Participants|19|19.0||||||
3877453|NCT01563081|3703340|B3||Female|Gender||Participants|Count of Participants|28|28.0||||||
3877454|NCT01563081|3703341|B2||Female|Gender||Participants|Count of Participants|17|17.0||||||
3877455|NCT01563081|3703342|B1||Female|Gender||Participants|Count of Participants|11|11.0||||||
3877456|NCT01563081|3703340|B3|||Age||Months|Mean|12.0|12.0|Standard Deviation|4.46|4.46|||
3877457|NCT01563081|3703341|B2|||Age||Months|Mean|15.8|15.8|Standard Deviation|2.56|2.56|||
3877458|NCT01563081|3703342|B1|||Age||Months|Mean|8.1|8.1|Standard Deviation|1.94|1.94|||
3877459|NCT01563055|3703356|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
3877460|NCT01563055|3703356|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3877461|NCT01563055|3703356|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3877462|NCT01563055|3703356|B1|>=75 years||Age, Customized||Participants|Number|4|4.0||||||
3877463|NCT01563055|3703356|B1|>=65 years||Age, Customized||Participants|Number|9|9.0||||||
3877464|NCT01563055|3703356|B1|<65 years||Age, Customized||Participants|Number|1|1.0||||||
3877465|NCT01563055|3703356|B1|||Age||Years|Mean|71.5|71.5|Standard Deviation|10.38|10.38|||
3877466|NCT01563029|3703414|B6|Mixed Race||Race/Ethnicity, Customized||Participants|Number|187|187.0||||||
3877467|NCT01563029|3703415|B5|Mixed Race||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
3877468|NCT01563029|3703416|B4|Mixed Race||Race/Ethnicity, Customized||Participants|Number|39|39.0||||||
3877469|NCT01563029|3703417|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
3877470|NCT01563029|3703418|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|33|33.0||||||
3877471|NCT01563029|3703419|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
3877472|NCT01563029|3703414|B6|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|247|247.0||||||
3877473|NCT01563029|3703415|B5|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|43|43.0||||||
3877474|NCT01563029|3703416|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|51|51.0||||||
3877475|NCT01563029|3703417|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|51|51.0||||||
3877476|NCT01563029|3703418|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|55|55.0||||||
3877477|NCT01563029|3703419|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|47|47.0||||||
3877478|NCT01563029|3703414|B6|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3877479|NCT01563029|3703415|B5|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3877480|NCT01563029|3703416|B4|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3877481|NCT01563029|3703417|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3877482|NCT01563029|3703418|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3877483|NCT01563029|3703419|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3877484|NCT01563029|3703414|B6|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|28|28.0||||||
3877485|NCT01563029|3703415|B5|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3877486|NCT01563029|3703416|B4|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3877487|NCT01563029|3703417|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3877488|NCT01563029|3703418|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3877489|NCT01563029|3703419|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3877490|NCT01563029|3703414|B6|Asian -Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3877491|NCT01563029|3703415|B5|Asian -Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3877492|NCT01563029|3703416|B4|Asian -Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3877493|NCT01563029|3703417|B3|Asian -Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3877494|NCT01563029|3703418|B2|Asian -Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3877495|NCT01563029|3703419|B1|Asian -Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3877496|NCT01563029|3703414|B6|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|95|95.0||||||
3877497|NCT01563029|3703415|B5|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
3877498|NCT01563029|3703416|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
3877499|NCT01563029|3703417|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
3877500|NCT01563029|3703418|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
3877501|NCT01563029|3703419|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
3877502|NCT01563029|3703414|B6|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
3877503|NCT01563029|3703415|B5|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3877504|NCT01563029|3703416|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3877505|NCT01563029|3703417|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3877506|NCT01563029|3703418|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3877507|NCT01563029|3703419|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3877508|NCT01563029|3703414|B6||Male|Sex: Female, Male||Participants|Count of Participants|370|370.0||||||
3877509|NCT01563029|3703415|B5||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3877510|NCT01563029|3703416|B4||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3877511|NCT01563029|3703417|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3877512|NCT01563029|3703418|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3877513|NCT01563029|3703419|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3877514|NCT01563029|3703414|B6||Female|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
3877515|NCT01563029|3703415|B5||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3877516|NCT01563029|3703416|B4||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3877517|NCT01563029|3703417|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3877518|NCT01563029|3703418|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3877519|NCT01563029|3703419|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3877520|NCT01563029|3703414|B6|||Age||Years|Mean|8.0|8.0|Standard Deviation|1.92|1.92|||
3877521|NCT01563029|3703415|B5|||Age||Years|Mean|7.9|7.9|Standard Deviation|1.87|1.87|||
3877522|NCT01563029|3703416|B4|||Age||Years|Mean|7.8|7.8|Standard Deviation|2.04|2.04|||
3877523|NCT01563029|3703417|B3|||Age||Years|Mean|8.4|8.4|Standard Deviation|1.62|1.62|||
3877524|NCT01563029|3703418|B2|||Age||Years|Mean|7.9|7.9|Standard Deviation|2.08|2.08|||
3877525|NCT01563029|3703419|B1|||Age||Years|Mean|8.0|8.0|Standard Deviation|1.91|1.91|||
3877526|NCT01563003|3703471|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
3877527|NCT01563003|3703472|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3877528|NCT01563003|3703473|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3877529|NCT01563003|3703471|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3877530|NCT01563003|3703472|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3877531|NCT01563003|3703473|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3877532|NCT01563003|3703471|B3|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3877533|NCT01563003|3703472|B2|Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3877534|NCT01563003|3703473|B1|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3877535|NCT01563003|3703471|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3877536|NCT01563003|3703472|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3877537|NCT01563003|3703473|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3877538|NCT01563003|3703471|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3877539|NCT01563003|3703472|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3877540|NCT01563003|3703473|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3877541|NCT01563003|3703471|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3877542|NCT01563003|3703472|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3877543|NCT01563003|3703473|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3877544|NCT01563003|3703471|B3|||Age||years|Mean|12.74|12.74|Standard Deviation|1.34|1.34|||
3877545|NCT01563003|3703472|B2|||Age||years|Mean|12.73|12.73|Standard Deviation|1.49|1.49|||
3877546|NCT01563003|3703473|B1|||Age||years|Mean|12.75|12.75|Standard Deviation|1.24|1.24|||
3877547|NCT01563003|3703471|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3877548|NCT01563003|3703472|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3877549|NCT01563003|3703473|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3877550|NCT01563003|3703471|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3877551|NCT01563003|3703472|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3877552|NCT01563003|3703473|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3877553|NCT01563003|3703471|B3||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
3877554|NCT01563003|3703472|B2||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
3877555|NCT01563003|3703473|B1||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
3877556|NCT01562886|3703484|B1|||Rilpivirine CSF concentration||ng/mL|Geometric Mean|0.8|0.8|Full Range|||0.54|1.57|
3877557|NCT01562886|3703484|B1|United Kingdom||Region of Enrollment||participants|Number|13|13.0||||||
3877558|NCT01562886|3703484|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877559|NCT01562886|3703484|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877560|NCT01562886|3703484|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3877561|NCT01562886|3703484|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3877562|NCT01562886|3703484|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877563|NCT01562886|3703484|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877564|NCT01562886|3703484|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877565|NCT01562886|3703484|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3877566|NCT01562886|3703484|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3877567|NCT01562886|3703484|B1|||Age||years|Mean|43.8|43.8|Standard Deviation|9.5|9.5|||
3877568|NCT01562873|3703489|B1|low positive||pStat3 Positive Status||participants|Number|0|0.0||||||
3877569|NCT01562873|3703489|B1|moderate to high positive||pStat3 Positive Status||participants|Number|21|21.0||||||
3877570|NCT01562873|3703489|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3877571|NCT01562873|3703489|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3877572|NCT01562873|3703489|B1||Female|Gender||Participants|Count of Participants|21|21.0||||||
3877573|NCT01562873|3703489|B1|||Age||years|Median|51|51.0|Full Range|||36.0|72.0|
3877574|NCT01562756|3703497|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3877575|NCT01562756|3703497|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3877576|NCT01562756|3703497|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3877577|NCT01562756|3703497|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3877578|NCT01562756|3703497|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3877579|NCT01562756|3703497|B1|||Age||years|Mean|53|53.0|Standard Deviation|10.5|10.5|||
3877580|NCT01562743|3703502|B1|Japan||Region of Enrollment||participants|Number|185|185.0||||||
3877581|NCT01562743|3703502|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3877582|NCT01562743|3703502|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3877583|NCT01562743|3703502|B1|||Age||years|Mean|49.8|49.8|Standard Deviation|13.1|13.1|||
3877584|NCT01562743|3703502|B1||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
3877585|NCT01562743|3703502|B1||Between 18 and 65 years|Age||Participants|Count of Participants|157|157.0||||||
3877586|NCT01562743|3703502|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3877587|NCT01562678|3703512|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
3877588|NCT01562678|3703513|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3877589|NCT01562678|3703514|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3877590|NCT01562678|3703512|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3877591|NCT01562678|3703513|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3877592|NCT01562678|3703514|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3877593|NCT01562678|3703512|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3877594|NCT01562678|3703513|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3877595|NCT01562678|3703514|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3877596|NCT01562678|3703512|B3|||Age||years|Mean|52.5|52.5|Standard Deviation|10.5|10.5|||
3877597|NCT01562678|3703513|B2|||Age||years|Mean|52.5|52.5|Standard Deviation|10.5|10.5|||
3877598|NCT01562678|3703514|B1|||Age||years|Mean|52.5|52.5|Standard Deviation|10.5|10.5|||
3877599|NCT01562678|3703512|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3877600|NCT01562678|3703513|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3877601|NCT01562678|3703514|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3877602|NCT01562678|3703512|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3877603|NCT01562678|3703513|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3877604|NCT01562678|3703514|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3877605|NCT01562678|3703512|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3877606|NCT01562678|3703513|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3877607|NCT01562678|3703514|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3877608|NCT01562613|3703521|B1|Greece||Region of Enrollment||participants|Number|533|533.0||||||
3877609|NCT01562613|3703521|B1||Male|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
3877610|NCT01562613|3703521|B1||Female|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
3877611|NCT01562613|3703521|B1|||Age||years|Mean|63.4|63.4|Standard Deviation|11.9|11.9|||
3877612|NCT01562548|3703527|B5||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3877613|NCT01562548|3703528|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3877614|NCT01562548|3703529|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3877615|NCT01562548|3703530|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3877616|NCT01562548|3703531|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3877617|NCT01562548|3703527|B5||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3877618|NCT01562548|3703528|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3877619|NCT01562548|3703529|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3877620|NCT01562548|3703530|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3877621|NCT01562548|3703531|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3877622|NCT01562548|3703527|B5|||Age||Years|Mean|45.9|45.9|Standard Deviation|11.47|11.47|||
3877623|NCT01562548|3703528|B4|||Age||Years|Mean|47.3|47.3|Standard Deviation|13.92|13.92|||
3877624|NCT01562548|3703529|B3|||Age||Years|Mean|45.3|45.3|Standard Deviation|10.62|10.62|||
3877625|NCT01562548|3703530|B2|||Age||Years|Mean|43.8|43.8|Standard Deviation|10.35|10.35|||
3877626|NCT01562548|3703531|B1|||Age||Years|Mean|47.2|47.2|Standard Deviation|11.87|11.87|||
3877627|NCT01562444|3703584|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|205|205.0||||||
3877628|NCT01562444|3703585|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|106|106.0||||||
3877629|NCT01562444|3703586|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
3877630|NCT01562444|3703587|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
3877631|NCT01562444|3703584|B4||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3877632|NCT01562444|3703585|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3877633|NCT01562444|3703586|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3877634|NCT01562444|3703587|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3877635|NCT01562444|3703584|B4||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3877636|NCT01562444|3703585|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3877637|NCT01562444|3703586|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3877638|NCT01562444|3703587|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3877639|NCT01562444|3703584|B4|||Age||Years|Mean|42.3|42.3|Standard Deviation|14.49|14.49|||
3877640|NCT01562444|3703585|B3|||Age||Years|Mean|42.4|42.4|Standard Deviation|14.35|14.35|||
3877641|NCT01562444|3703586|B2|||Age||Years|Mean|41.8|41.8|Standard Deviation|14.34|14.34|||
3877642|NCT01562444|3703587|B1|||Age||Years|Mean|42.7|42.7|Standard Deviation|15.25|15.25|||
3877643|NCT01562379|3703834|B6|Bangladesh||Region of Enrollment||participants|Number|5476|5476.0||||||
3877644|NCT01562379|3703835|B5|Bangladesh||Region of Enrollment||participants|Number|852|852.0||||||
3877645|NCT01562379|3703836|B4|Bangladesh||Region of Enrollment||participants|Number|843|843.0||||||
3877646|NCT01562379|3703837|B3|Bangladesh||Region of Enrollment||participants|Number|851|851.0||||||
3877647|NCT01562379|3703838|B2|Bangladesh||Region of Enrollment||participants|Number|1492|1492.0||||||
3877648|NCT01562379|3703839|B1|Bangladesh||Region of Enrollment||participants|Number|1438|1438.0||||||
3877649|NCT01562379|3703834|B6||Male|Sex: Female, Male||Participants|Count of Participants|2691|2691.0||||||
3877650|NCT01562379|3703835|B5||Male|Sex: Female, Male||Participants|Count of Participants|400|400.0||||||
3877651|NCT01562379|3703836|B4||Male|Sex: Female, Male||Participants|Count of Participants|419|419.0||||||
3877652|NCT01562379|3703837|B3||Male|Sex: Female, Male||Participants|Count of Participants|419|419.0||||||
3877653|NCT01562379|3703838|B2||Male|Sex: Female, Male||Participants|Count of Participants|767|767.0||||||
3877654|NCT01562379|3703839|B1||Male|Sex: Female, Male||Participants|Count of Participants|686|686.0||||||
3877655|NCT01562379|3703834|B6||Female|Sex: Female, Male||Participants|Count of Participants|2758|2758.0||||||
3877656|NCT01562379|3703835|B5||Female|Sex: Female, Male||Participants|Count of Participants|425|425.0||||||
3877657|NCT01562379|3703836|B4||Female|Sex: Female, Male||Participants|Count of Participants|424|424.0||||||
3877658|NCT01562379|3703837|B3||Female|Sex: Female, Male||Participants|Count of Participants|432|432.0||||||
3877659|NCT01562379|3703838|B2||Female|Sex: Female, Male||Participants|Count of Participants|725|725.0||||||
3877660|NCT01562379|3703839|B1||Female|Sex: Female, Male||Participants|Count of Participants|752|752.0||||||
3877661|NCT01562379|3703834|B6|||Age||months|Mean|6.23|6.23|Standard Deviation|0.21|0.21|||
3877662|NCT01562379|3703835|B5|||Age||months|Mean|6.25|6.25|Standard Deviation|0.25|0.25|||
3877663|NCT01562379|3703836|B4|||Age||months|Mean|6.24|6.24|Standard Deviation|0.25|0.25|||
3877664|NCT01562379|3703837|B3|||Age||months|Mean|6.26|6.26|Standard Deviation|0.27|0.27|||
3877665|NCT01562379|3703838|B2|||Age||months|Mean|6.26|6.26|Standard Deviation|0.26|0.26|||
3877666|NCT01562379|3703839|B1|||Age||months|Mean|6.13|6.13|Standard Deviation|0.0|0.0|||
3877667|NCT01562327|3703855|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3877668|NCT01562327|3703855|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3877669|NCT01562327|3703855|B1|||Age||years|Mean|53.9|53.9|Standard Deviation|12.2|12.2|||
3877670|NCT01562314|3703883|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3877671|NCT01562314|3703884|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3877672|NCT01562314|3703885|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3877673|NCT01562314|3703883|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3877674|NCT01562314|3703884|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3877675|NCT01562314|3703885|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3877676|NCT01562314|3703883|B3|||Age||years|Mean|43.77|43.77|Standard Deviation|13.903|13.903|||
3877677|NCT01562314|3703884|B2|||Age||years|Mean|42.82|42.82|Standard Deviation|12.916|12.916|||
3877678|NCT01562314|3703885|B1|||Age||years|Mean|44.78|44.78|Standard Deviation|15.050|15.05|||
3877679|NCT01562275|3703930|B14||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3877680|NCT01562275|3703931|B13||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3877681|NCT01562275|3703932|B12||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3877682|NCT01562275|3703933|B11||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3877683|NCT01562275|3703934|B10||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3877684|NCT01562275|3703935|B9||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3877685|NCT01562275|3703936|B8||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3877686|NCT01562275|3703937|B7||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3877687|NCT01562275|3703938|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3877688|NCT01562275|3703939|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3877689|NCT01562275|3703940|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3877690|NCT01562275|3703941|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3877691|NCT01562275|3703942|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3877692|NCT01562275|3703943|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3877693|NCT01562275|3703930|B14||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3877694|NCT01562275|3703931|B13||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3877695|NCT01562275|3703932|B12||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3877696|NCT01562275|3703933|B11||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3877697|NCT01562275|3703934|B10||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3877698|NCT01562275|3703935|B9||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3877699|NCT01562275|3703936|B8||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3877700|NCT01562275|3703937|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3877701|NCT01562275|3703938|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3877702|NCT01562275|3703939|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3877703|NCT01562275|3703940|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3877704|NCT01562275|3703941|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3877705|NCT01562275|3703942|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3877706|NCT01562275|3703943|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3877707|NCT01562275|3703930|B14|||Age||years|Mean|59.0|59.0|Standard Deviation|11.0|11.0|||
3877708|NCT01562275|3703931|B13|||Age||years|Mean|49.0|49.0|Standard Deviation|10.1|10.1|||
3877709|NCT01562275|3703932|B12|||Age||years|Mean|62.9|62.9|Standard Deviation|8.7|8.7|||
3877710|NCT01562275|3703933|B11|||Age||years|Mean|52.7|52.7|Standard Deviation|24.9|24.9|||
3877711|NCT01562275|3703934|B10|||Age||years|Mean|57.6|57.6|Standard Deviation|10.9|10.9|||
3877712|NCT01562275|3703935|B9|||Age||years|Mean|61.0|61.0|Standard Deviation|13.7|13.7|||
3877713|NCT01562275|3703936|B8|||Age||years|Mean|58.6|58.6|Standard Deviation|11.9|11.9|||
3877714|NCT01562275|3703937|B7|||Age||years|Mean|59.0|59.0|Standard Deviation|9.2|9.2|||
3877715|NCT01562275|3703938|B6|||Age||years|Mean|51.8|51.8|Standard Deviation|10.9|10.9|||
3877716|NCT01562275|3703939|B5|||Age||years|Mean|62.3|62.3|Standard Deviation|7.0|7.0|||
3877717|NCT01562275|3703940|B4|||Age||years|Mean|66.8|66.8|Standard Deviation|16.5|16.5|||
3877718|NCT01562275|3703941|B3|||Age||years|Mean|58.3|58.3|Standard Deviation|5.5|5.5|||
3877719|NCT01562275|3703942|B2|||Age||years|Mean|59.1|59.1|Standard Deviation|8.7|8.7|||
3877720|NCT01562275|3703943|B1|||Age||years|Mean|61.0|61.0|Standard Deviation|3.5|3.5|||
3877721|NCT01562132|3704085|B3|||CD4+ T-cell Count||cells/microliter|Median|17|17.0|Full Range|||3.0|56.0|
3877722|NCT01562132|3704086|B2|||CD4+ T-cell Count||cells/microliter|Median|13|13.0|Full Range|||3.0|16.0|
3877723|NCT01562132|3704087|B1|||CD4+ T-cell Count||cells/microliter|Median|22|22.0|Full Range|||18.0|56.0|
3877724|NCT01562132|3704085|B3|Kenya||Region of Enrollment||participants|Number|6|6.0||||||
3877725|NCT01562132|3704086|B2|Kenya||Region of Enrollment||participants|Number|3|3.0||||||
3877726|NCT01562132|3704087|B1|Kenya||Region of Enrollment||participants|Number|3|3.0||||||
3877727|NCT01562132|3704085|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3877728|NCT01562132|3704086|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3877729|NCT01562132|3704087|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3877730|NCT01562132|3704085|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3877731|NCT01562132|3704086|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3877732|NCT01562132|3704087|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3877733|NCT01562132|3704085|B3|||Age||years|Median|33.5|33.5|Full Range|||26.0|58.0|
3877734|NCT01562132|3704086|B2|||Age||years|Median|31|31.0|Full Range|||26.0|58.0|
3877735|NCT01562132|3704087|B1|||Age||years|Median|36|36.0|Full Range|||28.0|49.0|
3877736|NCT01561976|3704094|B7|India||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3877737|NCT01561976|3704095|B6|India||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3877738|NCT01561976|3704096|B5|India||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3877739|NCT01561976|3704097|B4|India||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3877740|NCT01561976|3704098|B3|India||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3877741|NCT01561976|3704099|B2|India||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3877742|NCT01561976|3704100|B1|India||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3877743|NCT01561976|3704094|B7||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3877744|NCT01561976|3704095|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3877745|NCT01561976|3704096|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3877746|NCT01561976|3704097|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3877747|NCT01561976|3704098|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3877748|NCT01561976|3704099|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3877749|NCT01561976|3704100|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3877750|NCT01561976|3704094|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3877751|NCT01561976|3704095|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3877752|NCT01561976|3704096|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3877753|NCT01561976|3704097|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3877754|NCT01561976|3704098|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3877755|NCT01561976|3704099|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3877756|NCT01561976|3704100|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3877757|NCT01561976|3704094|B7|||Age||Years|Mean|28.8|28.8|Standard Deviation|6.63|6.63|||
3877758|NCT01561976|3704095|B6|||Age||Years|Mean|25.4|25.4|Standard Deviation|3.78|3.78|||
3877759|NCT01561976|3704096|B5|||Age||Years|Mean|34.6|34.6|Standard Deviation|6.73|6.73|||
3877760|NCT01561976|3704097|B4|||Age||Years|Mean|31.8|31.8|Standard Deviation|9.31|9.31|||
3877761|NCT01561976|3704098|B3|||Age||Years|Mean|27.0|27.0|Standard Deviation|5.79|5.79|||
3877762|NCT01561976|3704099|B2|||Age||Years|Mean|25.6|25.6|Standard Deviation|4.72|4.72|||
3877763|NCT01561976|3704100|B1|||Age||Years|Mean|28.2|28.2|Standard Deviation|5.63|5.63|||
3877764|NCT01561898|3704134|B5||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3877765|NCT01561898|3704135|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3877766|NCT01561898|3704136|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3877767|NCT01561898|3704137|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3877768|NCT01561898|3704138|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3877769|NCT01561898|3704134|B5||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3877770|NCT01561898|3704135|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3877771|NCT01561898|3704136|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3877772|NCT01561898|3704137|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3877773|NCT01561898|3704138|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3877774|NCT01561898|3704134|B5|||Age||years|Mean|44.3|44.3|Standard Deviation|14.9|14.9|||
3877775|NCT01561898|3704135|B4|||Age||years|Mean|46.3|46.3|Standard Deviation|14.0|14.0|||
3877776|NCT01561898|3704136|B3|||Age||years|Mean|42.0|42.0|Standard Deviation|14.1|14.1|||
3877777|NCT01561898|3704137|B2|||Age||years|Mean|46.6|46.6|Standard Deviation|15.5|15.5|||
3877778|NCT01561898|3704138|B1|||Age||years|Mean|35.6|35.6|Standard Deviation|14.8|14.8|||
3877779|NCT01561755|3704153|B3|||mean CD4+||cells/mm^3|Mean|592|592.0|Standard Deviation|212|212.0|||
3877780|NCT01561755|3704154|B2|||mean CD4+||cells/mm^3|Mean|564|564.0|Standard Deviation|270|270.0|||
3877781|NCT01561755|3704155|B1|||mean CD4+||cells/mm^3|Mean|620|620.0|Standard Deviation|223|223.0|||
3877782|NCT01561755|3704153|B3|||Number of participant with undetectable Viral Load|Number of participants with undetectable viral load <20 copies/ml|Participants|Count of Participants|1|1.0||||||
3877783|NCT01561755|3704154|B2|||Number of participant with undetectable Viral Load|Number of participants with undetectable viral load <20 copies/ml|Participants|Count of Participants|0|0.0||||||
3877784|NCT01561755|3704155|B1|||Number of participant with undetectable Viral Load|Number of participants with undetectable viral load <20 copies/ml|Participants|Count of Participants|1|1.0||||||
3877785|NCT01561755|3704153|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3877786|NCT01561755|3704154|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3877787|NCT01561755|3704155|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3877788|NCT01561755|3704153|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3877789|NCT01561755|3704154|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3877790|NCT01561755|3704155|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3877791|NCT01561755|3704153|B3|||Age||years|Mean|48|48.0|Full Range|||29.0|68.0|
3877792|NCT01561755|3704154|B2|||Age||years|Mean|58|58.0|Full Range|||29.0|68.0|
3877793|NCT01561755|3704155|B1|||Age||years|Mean|48|48.0|Full Range|||29.0|69.0|
3877794|NCT01561716|3704174|B7|United States||Region of Enrollment||participants|Number|30|30.0||||||
3877795|NCT01561716|3704175|B6|United States||Region of Enrollment||participants|Number|5|5.0||||||
3877796|NCT01561716|3704176|B5|United States||Region of Enrollment||participants|Number|5|5.0||||||
3877797|NCT01561716|3704177|B4|United States||Region of Enrollment||participants|Number|5|5.0||||||
3877798|NCT01561716|3704178|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3877799|NCT01561716|3704179|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3877800|NCT01561716|3704180|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3877801|NCT01561716|3704174|B7||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3877802|NCT01561716|3704175|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3877803|NCT01561716|3704176|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3877804|NCT01561716|3704177|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3877805|NCT01561716|3704178|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3877806|NCT01561716|3704179|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3877807|NCT01561716|3704180|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3877808|NCT01561716|3704174|B7||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3877809|NCT01561716|3704175|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3877810|NCT01561716|3704176|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3877811|NCT01561716|3704177|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3877812|NCT01561716|3704178|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3877813|NCT01561716|3704179|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3877814|NCT01561716|3704180|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3877815|NCT01561716|3704174|B7|||Age||years|Mean|28.2|28.2|Standard Deviation|3.3|3.3|||
3877816|NCT01561716|3704175|B6|||Age||years|Mean|27.7|27.7|Standard Deviation|3.7|3.7|||
3877817|NCT01561716|3704176|B5|||Age||years|Mean|28.9|28.9|Standard Deviation|2.8|2.8|||
3877818|NCT01561716|3704177|B4|||Age||years|Mean|30.1|30.1|Standard Deviation|2.4|2.4|||
3877819|NCT01561716|3704178|B3|||Age||years|Mean|26.4|26.4|Standard Deviation|2.4|2.4|||
3877820|NCT01561716|3704179|B2|||Age||years|Mean|27.8|27.8|Standard Deviation|4.0|4.0|||
3877821|NCT01561716|3704180|B1|||Age||years|Mean|28.6|28.6|Standard Deviation|4.4|4.4|||
3877822|NCT01561716|3704174|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3877823|NCT01561716|3704175|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3877824|NCT01561716|3704176|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3877825|NCT01561716|3704177|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3877826|NCT01561716|3704178|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3877827|NCT01561716|3704179|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3877828|NCT01561716|3704180|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3877829|NCT01561716|3704174|B7||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3877830|NCT01561716|3704175|B6||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3877831|NCT01561716|3704176|B5||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3877832|NCT01561716|3704177|B4||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3877833|NCT01561716|3704178|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3877834|NCT01561716|3704179|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3877835|NCT01561716|3704180|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3877836|NCT01561716|3704174|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3877837|NCT01561716|3704175|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3877838|NCT01561716|3704176|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3877839|NCT01561716|3704177|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3877840|NCT01561716|3704178|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3877841|NCT01561716|3704179|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3877842|NCT01561716|3704180|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3877843|NCT01561703|3704199|B3||Male|Gender||Participants|Count of Participants|26|26.0||||||
3877844|NCT01561703|3704200|B2||Male|Gender||Participants|Count of Participants|12|12.0||||||
3877845|NCT01561703|3704201|B1||Male|Gender||Participants|Count of Participants|14|14.0||||||
3877846|NCT01561703|3704199|B3||Female|Gender||Participants|Count of Participants|18|18.0||||||
3877847|NCT01561703|3704200|B2||Female|Gender||Participants|Count of Participants|12|12.0||||||
3877848|NCT01561703|3704201|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
3877849|NCT01561703|3704199|B3|<18 years||Age, Customized||participants|Number|44|44.0||||||
3877850|NCT01561703|3704200|B2|<18 years||Age, Customized||participants|Number|24|24.0||||||
3877851|NCT01561703|3704201|B1|<18 years||Age, Customized||participants|Number|20|20.0||||||
3877852|NCT01561560|3704208|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3877853|NCT01561560|3704208|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3877854|NCT01561560|3704208|B1|||Age||years|Mean|34.0|34.0|Standard Deviation|10.4|10.4|||
3877855|NCT01561469|3704215|B3||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3877856|NCT01561469|3704216|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3877857|NCT01561469|3704217|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3877858|NCT01561469|3704215|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3877859|NCT01561469|3704216|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3877860|NCT01561469|3704217|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3877861|NCT01561469|3704215|B3|||Age||years|Median|57|57.0|Inter-Quartile Range|||45.75|68.0|
3877862|NCT01561469|3704216|B2|||Age||years|Median|56|56.0|Inter-Quartile Range|||40.0|66.0|
3877863|NCT01561469|3704217|B1|||Age||years|Median|59|59.0|Inter-Quartile Range|||48.0|68.0|
3877864|NCT01561430|3704236|B5|Japan||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3877865|NCT01561430|3704237|B4|Japan||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3877866|NCT01561430|3704238|B3|Japan||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3877867|NCT01561430|3704239|B2|Japan||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3877868|NCT01561430|3704240|B1|Japan||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3877869|NCT01561430|3704236|B5|Netherlands||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3877870|NCT01561430|3704237|B4|Netherlands||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3877871|NCT01561430|3704238|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3877872|NCT01561430|3704239|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3877873|NCT01561430|3704240|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3877874|NCT01561430|3704236|B5|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3877875|NCT01561430|3704237|B4|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3877876|NCT01561430|3704238|B3|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3877877|NCT01561430|3704239|B2|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3877878|NCT01561430|3704240|B1|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3877879|NCT01561430|3704236|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|64|64.0||||||
3877880|NCT01561430|3704237|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3877881|NCT01561430|3704238|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3877882|NCT01561430|3704239|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3877883|NCT01561430|3704240|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3877884|NCT01561430|3704236|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3877885|NCT01561430|3704237|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3877886|NCT01561430|3704238|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3877887|NCT01561430|3704239|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3877888|NCT01561430|3704240|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3877889|NCT01561430|3704236|B5|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3877890|NCT01561430|3704237|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3877891|NCT01561430|3704238|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3877892|NCT01561430|3704239|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3877893|NCT01561430|3704240|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3877894|NCT01561430|3704236|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3877895|NCT01561430|3704237|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3877896|NCT01561430|3704238|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3877897|NCT01561430|3704239|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3877898|NCT01561430|3704240|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3877899|NCT01561430|3704236|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3877900|NCT01561430|3704237|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3877901|NCT01561430|3704238|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3877902|NCT01561430|3704239|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3877903|NCT01561430|3704240|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3877904|NCT01561430|3704236|B5||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3877905|NCT01561430|3704237|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3877906|NCT01561430|3704238|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3877907|NCT01561430|3704239|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3877908|NCT01561430|3704240|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3877909|NCT01561430|3704236|B5||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3877910|NCT01561430|3704237|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3877911|NCT01561430|3704238|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3877912|NCT01561430|3704239|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3877913|NCT01561430|3704240|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3877914|NCT01561430|3704236|B5|||Age||years|Mean|69.66|69.66|Standard Deviation|8.201|8.201|||
3877915|NCT01561430|3704237|B4|||Age||years|Mean|67.73|67.73|Standard Deviation|7.126|7.126|||
3877916|NCT01561430|3704238|B3|||Age||years|Mean|70.23|70.23|Standard Deviation|8.603|8.603|||
3877917|NCT01561430|3704239|B2|||Age||years|Mean|72.50|72.5|Standard Deviation|8.378|8.378|||
3877918|NCT01561430|3704240|B1|||Age||years|Mean|65.59|65.59|Standard Deviation|7.569|7.569|||
3877919|NCT01561313|3704281|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3877920|NCT01561313|3704282|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3877921|NCT01561313|3704283|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3877922|NCT01561313|3704281|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3877923|NCT01561313|3704282|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3877924|NCT01561313|3704283|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3877925|NCT01561313|3704281|B3|||Age||years|Mean|54.8|54.8|Standard Deviation|13.49|13.49|||
3877926|NCT01561313|3704282|B2|||Age||years|Mean|58.6|58.6|Standard Deviation|13.53|13.53|||
3877927|NCT01561313|3704283|B1|||Age||years|Mean|51.1|51.1|Standard Deviation|12.57|12.57|||
3877928|NCT01561300|3704302|B1|||Body Mass Index||kg/m^2|Median|23.2|23.2|Full Range|||18.5|26.4|
3877929|NCT01561300|3704302|B1|India||Region of Enrollment||participants|Number|30|30.0||||||
3877930|NCT01561300|3704302|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3877931|NCT01561300|3704302|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3877932|NCT01561300|3704302|B1|Age||Age||years|Median|36|36.0|Full Range|||30.0|46.0|
3877933|NCT01561079|3704314|B1|||Positive research urine toxicology screening at delivery||percent positive urine tox. screenings|Mean|19.7|19.7|Standard Deviation|25.6|25.6|||
3877934|NCT01561079|3704314|B1|||Urine toxicology screenings during treatment||number of screenings|Mean|16.4|16.4|Standard Deviation|8.0|8.0|||
3877935|NCT01561079|3704314|B1|||Buprenorphine dose at 36 weeks if gestation||mg|Mean|12.8|12.8|Standard Deviation|6.5|6.5|||
3877936|NCT01561079|3704314|B1|||Buprenorphine dose at 32 weeks if gestation||mg|Mean|12.7|12.7|Standard Deviation|6.3|6.3|||
3877937|NCT01561079|3704314|B1|||Buprenorphine dose at 28 weeks if gestation||mg|Mean|12.3|12.3|Standard Deviation|6.0|6.0|||
3877938|NCT01561079|3704314|B1|||Buprenorphine dose at 24 weeks if gestation||mg|Mean|12.0|12.0|Standard Deviation|7.1|7.1|||
3877939|NCT01561079|3704314|B1|||Length of time in treatment prior to delivery||days|Mean|121.1|121.1|Standard Deviation|56.7|56.7|||
3877940|NCT01561079|3704314|B1|||Gestational age upon treatment entry||weeks|Mean|21.3|21.3|Standard Deviation|7.0|7.0|||
3877941|NCT01561079|3704314|B1|||Duration of regular substance use upon treatment entry||years|Mean|6.5|6.5|Standard Deviation|4.4|4.4|||
3877942|NCT01561079|3704314|B1|||Age at regular substance use||years|Mean|21.0|21.0|Standard Deviation|4.6|4.6|||
3877943|NCT01561079|3704314|B1|||Age at first substance use||years|Mean|19.8|19.8|Standard Deviation|4.8|4.8|||
3877944|NCT01561079|3704314|B1|||Education||years|Mean|11.5|11.5|Standard Deviation|1.9|1.9|||
3877945|NCT01561079|3704314|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877946|NCT01561079|3704314|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877947|NCT01561079|3704314|B1||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3877948|NCT01561079|3704314|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3877949|NCT01561079|3704314|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877950|NCT01561079|3704314|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877951|NCT01561079|3704314|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3877952|NCT01561079|3704314|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3877953|NCT01561079|3704314|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3877954|NCT01561079|3704314|B1|||Age||years|Mean|27.6|27.6|Standard Deviation|4.4|4.4|||
3877955|NCT01560988|3704357|B1|United States||Region of Enrollment||participants|Number|62|62.0||||||
3877956|NCT01560988|3704357|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3877957|NCT01560988|3704357|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3877958|NCT01560988|3704357|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3877959|NCT01560988|3704357|B1||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
3877960|NCT01560988|3704357|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3877961|NCT01560975|3704381|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3877962|NCT01560975|3704381|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3877963|NCT01560975|3704381|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3877964|NCT01560975|3704381|B1|||Age||years|Mean|65.2|65.2|Standard Deviation|8.3|8.3|||
3877965|NCT01560819|3704394|B3|65-85: Severe Disease||Disease Activity before Treatment|Disease activity: measured by pediatric ulcerative colitis activity index (PUCAI). PUCAI is a validated tool to measure disease activity in pediatric UC based on clinical symptoms: a score of <10 = remission; 10-34 = mild disease; 35-64 = moderate disease; 65-85 = severe disease.|Participants|Number|0|0.0||||||
3877966|NCT01560819|3704395|B2|65-85: Severe Disease||Disease Activity before Treatment|Disease activity: measured by pediatric ulcerative colitis activity index (PUCAI). PUCAI is a validated tool to measure disease activity in pediatric UC based on clinical symptoms: a score of <10 = remission; 10-34 = mild disease; 35-64 = moderate disease; 65-85 = severe disease.|Participants|Number|0|0.0||||||
3877967|NCT01560819|3704396|B1|65-85: Severe Disease||Disease Activity before Treatment|Disease activity: measured by pediatric ulcerative colitis activity index (PUCAI). PUCAI is a validated tool to measure disease activity in pediatric UC based on clinical symptoms: a score of <10 = remission; 10-34 = mild disease; 35-64 = moderate disease; 65-85 = severe disease.|Participants|Number|0|0.0||||||
3877968|NCT01560819|3704394|B3|35-64: Moderate Disease||Disease Activity before Treatment|Disease activity: measured by pediatric ulcerative colitis activity index (PUCAI). PUCAI is a validated tool to measure disease activity in pediatric UC based on clinical symptoms: a score of <10 = remission; 10-34 = mild disease; 35-64 = moderate disease; 65-85 = severe disease.|Participants|Number|7|7.0||||||
3877969|NCT01560819|3704395|B2|35-64: Moderate Disease||Disease Activity before Treatment|Disease activity: measured by pediatric ulcerative colitis activity index (PUCAI). PUCAI is a validated tool to measure disease activity in pediatric UC based on clinical symptoms: a score of <10 = remission; 10-34 = mild disease; 35-64 = moderate disease; 65-85 = severe disease.|Participants|Number|0|0.0||||||
3877970|NCT01560819|3704396|B1|35-64: Moderate Disease||Disease Activity before Treatment|Disease activity: measured by pediatric ulcerative colitis activity index (PUCAI). PUCAI is a validated tool to measure disease activity in pediatric UC based on clinical symptoms: a score of <10 = remission; 10-34 = mild disease; 35-64 = moderate disease; 65-85 = severe disease.|Participants|Number|7|7.0||||||
3877971|NCT01560819|3704394|B3|10-34: Mild Disease||Disease Activity before Treatment|Disease activity: measured by pediatric ulcerative colitis activity index (PUCAI). PUCAI is a validated tool to measure disease activity in pediatric UC based on clinical symptoms: a score of <10 = remission; 10-34 = mild disease; 35-64 = moderate disease; 65-85 = severe disease.|Participants|Number|3|3.0||||||
3877972|NCT01560819|3704395|B2|10-34: Mild Disease||Disease Activity before Treatment|Disease activity: measured by pediatric ulcerative colitis activity index (PUCAI). PUCAI is a validated tool to measure disease activity in pediatric UC based on clinical symptoms: a score of <10 = remission; 10-34 = mild disease; 35-64 = moderate disease; 65-85 = severe disease.|Participants|Number|0|0.0||||||
3877973|NCT01560819|3704396|B1|10-34: Mild Disease||Disease Activity before Treatment|Disease activity: measured by pediatric ulcerative colitis activity index (PUCAI). PUCAI is a validated tool to measure disease activity in pediatric UC based on clinical symptoms: a score of <10 = remission; 10-34 = mild disease; 35-64 = moderate disease; 65-85 = severe disease.|Participants|Number|3|3.0||||||
3877974|NCT01560819|3704394|B3|0-9: Remission||Disease Activity before Treatment|Disease activity: measured by pediatric ulcerative colitis activity index (PUCAI). PUCAI is a validated tool to measure disease activity in pediatric UC based on clinical symptoms: a score of <10 = remission; 10-34 = mild disease; 35-64 = moderate disease; 65-85 = severe disease.|Participants|Number|0|0.0||||||
3878015|NCT01560507|3704402|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3878016|NCT01560507|3704403|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3878017|NCT01560507|3704404|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3877975|NCT01560819|3704395|B2|0-9: Remission||Disease Activity before Treatment|Disease activity: measured by pediatric ulcerative colitis activity index (PUCAI). PUCAI is a validated tool to measure disease activity in pediatric UC based on clinical symptoms: a score of <10 = remission; 10-34 = mild disease; 35-64 = moderate disease; 65-85 = severe disease.|Participants|Number|0|0.0||||||
3877976|NCT01560819|3704396|B1|0-9: Remission||Disease Activity before Treatment|Disease activity: measured by pediatric ulcerative colitis activity index (PUCAI). PUCAI is a validated tool to measure disease activity in pediatric UC based on clinical symptoms: a score of <10 = remission; 10-34 = mild disease; 35-64 = moderate disease; 65-85 = severe disease.|Participants|Number|0|0.0||||||
3877977|NCT01560819|3704394|B3|Proctitis||Disease Extent|Disease extent: extensive = involving left and transverse colon; left-sided = involving rectum and sigmoid or descending colon; pancolitis = involving the entire colon; proctitis = involving rectum.|Participants|Number|2|2.0||||||
3877978|NCT01560819|3704395|B2|Proctitis||Disease Extent|Disease extent: extensive = involving left and transverse colon; left-sided = involving rectum and sigmoid or descending colon; pancolitis = involving the entire colon; proctitis = involving rectum.|Participants|Number|0|0.0||||||
3877979|NCT01560819|3704396|B1|Proctitis||Disease Extent|Disease extent: extensive = involving left and transverse colon; left-sided = involving rectum and sigmoid or descending colon; pancolitis = involving the entire colon; proctitis = involving rectum.|Participants|Number|2|2.0||||||
3877980|NCT01560819|3704394|B3|Pancolitis||Disease Extent|Disease extent: extensive = involving left and transverse colon; left-sided = involving rectum and sigmoid or descending colon; pancolitis = involving the entire colon; proctitis = involving rectum.|Participants|Number|6|6.0||||||
3877981|NCT01560819|3704395|B2|Pancolitis||Disease Extent|Disease extent: extensive = involving left and transverse colon; left-sided = involving rectum and sigmoid or descending colon; pancolitis = involving the entire colon; proctitis = involving rectum.|Participants|Number|0|0.0||||||
3877982|NCT01560819|3704396|B1|Pancolitis||Disease Extent|Disease extent: extensive = involving left and transverse colon; left-sided = involving rectum and sigmoid or descending colon; pancolitis = involving the entire colon; proctitis = involving rectum.|Participants|Number|6|6.0||||||
3877983|NCT01560819|3704394|B3|Left-sided||Disease Extent|Disease extent: extensive = involving left and transverse colon; left-sided = involving rectum and sigmoid or descending colon; pancolitis = involving the entire colon; proctitis = involving rectum.|Participants|Number|1|1.0||||||
3877984|NCT01560819|3704395|B2|Left-sided||Disease Extent|Disease extent: extensive = involving left and transverse colon; left-sided = involving rectum and sigmoid or descending colon; pancolitis = involving the entire colon; proctitis = involving rectum.|Participants|Number|0|0.0||||||
3877985|NCT01560819|3704396|B1|Left-sided||Disease Extent|Disease extent: extensive = involving left and transverse colon; left-sided = involving rectum and sigmoid or descending colon; pancolitis = involving the entire colon; proctitis = involving rectum.|Participants|Number|1|1.0||||||
3877986|NCT01560819|3704394|B3|Extensive||Disease Extent|Disease extent: extensive = involving left and transverse colon; left-sided = involving rectum and sigmoid or descending colon; pancolitis = involving the entire colon; proctitis = involving rectum.|Participants|Number|1|1.0||||||
3877987|NCT01560819|3704395|B2|Extensive||Disease Extent|Disease extent: extensive = involving left and transverse colon; left-sided = involving rectum and sigmoid or descending colon; pancolitis = involving the entire colon; proctitis = involving rectum.|Participants|Number|0|0.0||||||
3877988|NCT01560819|3704396|B1|Extensive||Disease Extent|Disease extent: extensive = involving left and transverse colon; left-sided = involving rectum and sigmoid or descending colon; pancolitis = involving the entire colon; proctitis = involving rectum.|Participants|Number|1|1.0||||||
3877989|NCT01560819|3704394|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3877990|NCT01560819|3704395|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3877991|NCT01560819|3704396|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3877992|NCT01560819|3704394|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3877993|NCT01560819|3704395|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3877994|NCT01560819|3704396|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3877995|NCT01560819|3704394|B3|||Age, Customized||Years|Mean|27.4|27.4|Standard Deviation|15.6|15.6|||
3877996|NCT01560819|3704395|B2|||Age, Customized||Years|Mean|39.6|39.6|Standard Deviation|12.7|12.7|||
3877997|NCT01560819|3704396|B1|||Age, Customized||Years|Mean|15.2|15.2|Standard Deviation|4.4|4.4|||
3877998|NCT01560507|3704401|B4|United States||Region of Enrollment||participants|Number|9|9.0||||||
3877999|NCT01560507|3704402|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3878000|NCT01560507|3704403|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3878001|NCT01560507|3704404|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3878002|NCT01560507|3704401|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3878003|NCT01560507|3704402|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3878004|NCT01560507|3704403|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3878005|NCT01560507|3704404|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3878006|NCT01560507|3704401|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3878007|NCT01560507|3704402|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3878008|NCT01560507|3704403|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3878009|NCT01560507|3704404|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3878010|NCT01560507|3704401|B4|||Age||years|Mean|42.36|42.36|Standard Deviation|9.75|9.75|||
3878011|NCT01560507|3704402|B3|||Age||years|Mean|39.61|39.61|Standard Deviation|3.94|3.94|||
3878012|NCT01560507|3704403|B2|||Age||years|Mean|33.47|33.47|Standard Deviation|0.43|0.43|||
3878013|NCT01560507|3704404|B1|||Age||years|Mean|47.02|47.02|Standard Deviation|10.75|10.75|||
3878014|NCT01560507|3704401|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3878018|NCT01560507|3704401|B4||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3878019|NCT01560507|3704402|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3878020|NCT01560507|3704403|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3878021|NCT01560507|3704404|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3878022|NCT01560507|3704401|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3878023|NCT01560507|3704402|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3878024|NCT01560507|3704403|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3878025|NCT01560507|3704404|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3878026|NCT01560429|3704417|B3|Canada||Region of Enrollment||participants|Number|43|43.0||||||
3878027|NCT01560429|3704418|B2|Canada||Region of Enrollment||participants|Number|20|20.0||||||
3878028|NCT01560429|3704419|B1|Canada||Region of Enrollment||participants|Number|23|23.0||||||
3878029|NCT01560429|3704417|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3878030|NCT01560429|3704418|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3878031|NCT01560429|3704419|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3878032|NCT01560429|3704417|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3878033|NCT01560429|3704418|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3878034|NCT01560429|3704419|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3878035|NCT01560429|3704417|B3|||Age||years|Mean|65.6|65.6|Standard Deviation|7.8|7.8|||
3878036|NCT01560429|3704418|B2|||Age||years|Mean|62.7|62.7|Standard Deviation|8.5|8.5|||
3878037|NCT01560429|3704419|B1|||Age||years|Mean|68.4|68.4|Standard Deviation|6.1|6.1|||
3878038|NCT01560429|3704417|B3|>=65 years||Age||years|Mean|70.8|70.8|Standard Deviation|3.6|3.6|||
3878039|NCT01560429|3704418|B2|>=65 years||Age||years|Mean|70.6|70.6|Standard Deviation|3.1|3.1|||
3878040|NCT01560429|3704419|B1|>=65 years||Age||years|Mean|70.9|70.9|Standard Deviation|4.1|4.1|||
3878041|NCT01560429|3704417|B3|Between 18 and 65 years||Age||years|Mean|58|58.0|Standard Deviation|5.9|5.9|||
3878042|NCT01560429|3704418|B2|Between 18 and 65 years||Age||years|Mean|56.7|56.7|Standard Deviation|5.9|5.9|||
3878043|NCT01560429|3704419|B1|Between 18 and 65 years||Age||years|Mean|60.8|60.8|Standard Deviation|5.2|5.2|||
3878044|NCT01560403|3704428|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3878045|NCT01560403|3704429|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3878046|NCT01560403|3704430|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3878047|NCT01560403|3704428|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3878048|NCT01560403|3704429|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3878049|NCT01560403|3704430|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3878050|NCT01560403|3704428|B3|>=65 years||Age, Customized|Age at Study CL0600-020 (NCT00798967) Informed Consent (year)|participants|Number|2|2.0||||||
3878051|NCT01560403|3704429|B2|>=65 years||Age, Customized|Age at Study CL0600-020 (NCT00798967) Informed Consent (year)|participants|Number|1|1.0||||||
3878052|NCT01560403|3704430|B1|>=65 years||Age, Customized|Age at Study CL0600-020 (NCT00798967) Informed Consent (year)|participants|Number|1|1.0||||||
3878053|NCT01560403|3704428|B3|45 - < 65 years||Age, Customized|Age at Study CL0600-020 (NCT00798967) Informed Consent (year)|participants|Number|9|9.0||||||
3878054|NCT01560403|3704429|B2|45 - < 65 years||Age, Customized|Age at Study CL0600-020 (NCT00798967) Informed Consent (year)|participants|Number|6|6.0||||||
3878055|NCT01560403|3704430|B1|45 - < 65 years||Age, Customized|Age at Study CL0600-020 (NCT00798967) Informed Consent (year)|participants|Number|3|3.0||||||
3878056|NCT01560403|3704428|B3|< 45 years||Age, Customized|Age at Study CL0600-020 (NCT00798967) Informed Consent (year)|participants|Number|3|3.0||||||
3878057|NCT01560403|3704429|B2|< 45 years||Age, Customized|Age at Study CL0600-020 (NCT00798967) Informed Consent (year)|participants|Number|2|2.0||||||
3878058|NCT01560403|3704430|B1|< 45 years||Age, Customized|Age at Study CL0600-020 (NCT00798967) Informed Consent (year)|participants|Number|1|1.0||||||
3878059|NCT01560377|3704437|B1||Sigmoid volvulus|Diagnosis||Participants|Count of Participants|1|1.0||||||
3878060|NCT01560377|3704437|B1||Radiation stricture|Diagnosis||Participants|Count of Participants|1|1.0||||||
3878061|NCT01560377|3704437|B1||Colovesical fistula|Diagnosis||Participants|Count of Participants|1|1.0||||||
3878062|NCT01560377|3704437|B1||Crohn's disease|Diagnosis||Participants|Count of Participants|1|1.0||||||
3878063|NCT01560377|3704437|B1||Procidentia|Diagnosis||Participants|Count of Participants|4|4.0||||||
3878064|NCT01560377|3704437|B1||Polyp|Diagnosis||Participants|Count of Participants|6|6.0||||||
3878065|NCT01560377|3704437|B1||Colon cancer|Diagnosis||Participants|Count of Participants|29|29.0||||||
3878066|NCT01560377|3704437|B1||Rectal cancer|Diagnosis||Participants|Count of Participants|35|35.0||||||
3878067|NCT01560377|3704437|B1||Diverticulitis|Diagnosis||Participants|Count of Participants|61|61.0||||||
3878068|NCT01560377|3704437|B1||No|Preoperative radiation therapy||Participants|Count of Participants|124|124.0||||||
3878069|NCT01560377|3704437|B1||Yes|Preoperative radiation therapy||Participants|Count of Participants|15|15.0||||||
3878070|NCT01560377|3704437|B1||No|Preoperative chemotherapy||Participants|Count of Participants|126|126.0||||||
3878071|NCT01560377|3704437|B1||Yes|Preoperative chemotherapy||Participants|Count of Participants|13|13.0||||||
3878072|NCT01560377|3704437|B1||BMI < 30 kg/m^2|BMI||Participants|Count of Participants|97|97.0||||||
3878073|NCT01560377|3704437|B1||BMI > 30 kg/m^2|BMI||Participants|Count of Participants|42|42.0||||||
3878074|NCT01560377|3704437|B1||IV (severe life threating systemic disease)|ASA Classification (American Society of Anesthesiologists)||Participants|Count of Participants|3|3.0||||||
3878075|NCT01560377|3704437|B1||III (patient with severe systemic disease)|ASA Classification (American Society of Anesthesiologists)||Participants|Count of Participants|46|46.0||||||
3878076|NCT01560377|3704437|B1||II (patient with mild systemic disease)|ASA Classification (American Society of Anesthesiologists)||Participants|Count of Participants|73|73.0||||||
3878077|NCT01560377|3704437|B1||I (normal healthy patient)|ASA Classification (American Society of Anesthesiologists)||Participants|Count of Participants|17|17.0||||||
3878078|NCT01560377|3704437|B1|United States||Region of Enrollment||participants|Number|139|139.0||||||
3878079|NCT01560377|3704437|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3878080|NCT01560377|3704437|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878081|NCT01560377|3704437|B1||White|Race (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
3878082|NCT01560377|3704437|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3878083|NCT01560377|3704437|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878084|NCT01560377|3704437|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3878085|NCT01560377|3704437|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878086|NCT01560377|3704437|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878087|NCT01560377|3704437|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
3878088|NCT01560377|3704437|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3878089|NCT01560377|3704437|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3878090|NCT01560377|3704437|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3878091|NCT01560377|3704437|B1|||Age||years|Mean|58|58.0|Full Range|||44.0|72.0|
3878092|NCT01560260|3704442|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3878093|NCT01560260|3704442|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3878094|NCT01560260|3704442|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3878095|NCT01560260|3704442|B1|||Age||years|Mean|41|41.0|Standard Deviation|13|13.0|||
3878096|NCT01560260|3704442|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3878097|NCT01560260|3704442|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3878098|NCT01560260|3704442|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3878099|NCT01560234|3704458|B9|||Subject characteristics (BMI)||kg/m²|Mean|25.01|25.01|Standard Deviation|3.00|3.0|||
3878100|NCT01560234|3704459|B8|||Subject characteristics (BMI)||kg/m²|Mean|25.40|25.4|Standard Deviation|2.37|2.37|||
3878101|NCT01560234|3704460|B7|||Subject characteristics (BMI)||kg/m²|Mean|24.41|24.41|Standard Deviation|4.87|4.87|||
3878102|NCT01560234|3704461|B6|||Subject characteristics (BMI)||kg/m²|Mean|25.31|25.31|Standard Deviation|3.47|3.47|||
3878103|NCT01560234|3704462|B5|||Subject characteristics (BMI)||kg/m²|Mean|24.48|24.48|Standard Deviation|4.46|4.46|||
3878104|NCT01560234|3704463|B4|||Subject characteristics (BMI)||kg/m²|Mean|25.63|25.63|Standard Deviation|3.16|3.16|||
3878105|NCT01560234|3704464|B3|||Subject characteristics (BMI)||kg/m²|Mean|23.41|23.41|Standard Deviation|3.50|3.5|||
3878106|NCT01560234|3704465|B2|||Subject characteristics (BMI)||kg/m²|Mean|27.02|27.02|Standard Deviation|1.94|1.94|||
3878107|NCT01560234|3704466|B1|||Subject characteristics (BMI)||kg/m²|Mean|24.81|24.81|Standard Deviation|2.71|2.71|||
3878108|NCT01560234|3704458|B9|||Subject characteristics (Weight)||kg|Mean|73.3|73.3|Standard Deviation|10.9|10.9|||
3878109|NCT01560234|3704459|B8|||Subject characteristics (Weight)||kg|Mean|79.3|79.3|Standard Deviation|8.0|8.0|||
3878110|NCT01560234|3704460|B7|||Subject characteristics (Weight)||kg|Mean|69.4|69.4|Standard Deviation|10.5|10.5|||
3878111|NCT01560234|3704461|B6|||Subject characteristics (Weight)||kg|Mean|78.1|78.1|Standard Deviation|16.3|16.3|||
3878112|NCT01560234|3704462|B5|||Subject characteristics (Weight)||kg|Mean|67.7|67.7|Standard Deviation|14.2|14.2|||
3878113|NCT01560234|3704463|B4|||Subject characteristics (Weight)||kg|Mean|71.4|71.4|Standard Deviation|5.0|5.0|||
3878114|NCT01560234|3704464|B3|||Subject characteristics (Weight)||kg|Mean|68.2|68.2|Standard Deviation|12.2|12.2|||
3878115|NCT01560234|3704465|B2|||Subject characteristics (Weight)||kg|Mean|76.9|76.9|Standard Deviation|6.7|6.7|||
3878116|NCT01560234|3704466|B1|||Subject characteristics (Weight)||kg|Mean|72.1|72.1|Standard Deviation|11.2|11.2|||
3878117|NCT01560234|3704458|B9|||Subject characteristics (Height)||cm|Mean|170.9|170.9|Standard Deviation|8.3|8.3|||
3878118|NCT01560234|3704459|B8|||Subject characteristics (Height)||cm|Mean|176.9|176.9|Standard Deviation|8.6|8.6|||
3878119|NCT01560234|3704460|B7|||Subject characteristics (Height)||cm|Mean|169.3|169.3|Standard Deviation|11.1|11.1|||
3878120|NCT01560234|3704461|B6|||Subject characteristics (Height)||cm|Mean|175.0|175.0|Standard Deviation|8.3|8.3|||
3878121|NCT01560234|3704462|B5|||Subject characteristics (Height)||cm|Mean|166.0|166.0|Standard Deviation|5.0|5.0|||
3878122|NCT01560234|3704463|B4|||Subject characteristics (Height)||cm|Mean|167.7|167.7|Standard Deviation|15.5|15.5|||
3878123|NCT01560234|3704464|B3|||Subject characteristics (Height)||cm|Mean|170.5|170.5|Standard Deviation|8.5|8.5|||
3878124|NCT01560234|3704465|B2|||Subject characteristics (Height)||cm|Mean|168.6|168.6|Standard Deviation|1.7|1.7|||
3878125|NCT01560234|3704466|B1|||Subject characteristics (Height)||cm|Mean|170.1|170.1|Standard Deviation|7.1|7.1|||
3878126|NCT01560234|3704458|B9||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3878127|NCT01560234|3704459|B8||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3878128|NCT01560234|3704460|B7||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3878129|NCT01560234|3704461|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3878130|NCT01560234|3704462|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3878131|NCT01560234|3704463|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3878132|NCT01560234|3704464|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3878133|NCT01560234|3704465|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3878134|NCT01560234|3704466|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3878135|NCT01560234|3704458|B9||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3878136|NCT01560234|3704459|B8||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3878137|NCT01560234|3704460|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3878138|NCT01560234|3704461|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3878139|NCT01560234|3704462|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3878140|NCT01560234|3704463|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3878141|NCT01560234|3704464|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3878142|NCT01560234|3704465|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3878143|NCT01560234|3704466|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3878144|NCT01560234|3704458|B9|||Age||Years|Mean|28|28.0|Standard Deviation|7|7.0|||
3878145|NCT01560234|3704459|B8|||Age||Years|Mean|31|31.0|Standard Deviation|9|9.0|||
3878146|NCT01560234|3704460|B7|||Age||Years|Mean|30|30.0|Standard Deviation|9|9.0|||
3878147|NCT01560234|3704461|B6|||Age||Years|Mean|27|27.0|Standard Deviation|6|6.0|||
3878148|NCT01560234|3704462|B5|||Age||Years|Mean|31|31.0|Standard Deviation|4|4.0|||
3878149|NCT01560234|3704463|B4|||Age||Years|Mean|24|24.0|Standard Deviation|5|5.0|||
3878150|NCT01560234|3704464|B3|||Age||Years|Mean|23|23.0|Standard Deviation|3|3.0|||
3878151|NCT01560234|3704465|B2|||Age||Years|Mean|29|29.0|Standard Deviation|10|10.0|||
3878152|NCT01560234|3704466|B1|||Age||Years|Mean|27|27.0|Standard Deviation|6|6.0|||
3878153|NCT01560143|3704547|B1|||Body Mass Index||kg/m^2|Median|43.8|43.8|Full Range|||20.8|53.8|
3878154|NCT01560143|3704547|B1||Male|Gender||Participants|Count of Participants|4|4.0||||||
3878155|NCT01560143|3704547|B1||Female|Gender||Participants|Count of Participants|8|8.0||||||
3878156|NCT01560143|3704547|B1|||Age||years|Mean|37.5|37.5|Standard Deviation|10.5|10.5|||
3878157|NCT01559935|3704551|B1|Maintenance Phase|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3878158|NCT01559935|3704551|B1|Maintenance Phase|More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3878159|NCT01559935|3704551|B1|Maintenance Phase|White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3878160|NCT01559935|3704551|B1|Maintenance Phase|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3878161|NCT01559935|3704551|B1|Maintenance Phase|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878162|NCT01559935|3704551|B1|Maintenance Phase|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878163|NCT01559935|3704551|B1|Maintenance Phase|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878164|NCT01559935|3704551|B1|BiRD Phase|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3878165|NCT01559935|3704551|B1|BiRD Phase|More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3878166|NCT01559935|3704551|B1|BiRD Phase|White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3878167|NCT01559935|3704551|B1|BiRD Phase|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3878168|NCT01559935|3704551|B1|BiRD Phase|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878169|NCT01559935|3704551|B1|BiRD Phase|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878170|NCT01559935|3704551|B1|BiRD Phase|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878171|NCT01559935|3704551|B1|Car Phase|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3878172|NCT01559935|3704551|B1|Car Phase|More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3878173|NCT01559935|3704551|B1|Car Phase|White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3878174|NCT01559935|3704551|B1|Car Phase|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3878175|NCT01559935|3704551|B1|Car Phase|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878176|NCT01559935|3704551|B1|Car Phase|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878177|NCT01559935|3704551|B1|Car Phase|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878178|NCT01559935|3704551|B1|Maintenance Phase|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3878179|NCT01559935|3704551|B1|Maintenance Phase|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3878180|NCT01559935|3704551|B1|Maintenance Phase|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3878181|NCT01559935|3704551|B1|BiRD Phase|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3878182|NCT01559935|3704551|B1|BiRD Phase|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3878183|NCT01559935|3704551|B1|BiRD Phase|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3878184|NCT01559935|3704551|B1|Car Phase|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3878185|NCT01559935|3704551|B1|Car Phase|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3878186|NCT01559935|3704551|B1|Car Phase|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3878187|NCT01559935|3704551|B1|Maintenance Phase|Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3878188|NCT01559935|3704551|B1|Maintenance Phase|Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3878189|NCT01559935|3704551|B1|BiRD Phase|Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3878190|NCT01559935|3704551|B1|BiRD Phase|Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3878191|NCT01559935|3704551|B1|Car Phase|Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3878192|NCT01559935|3704551|B1|Car Phase|Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3878193|NCT01559935|3704551|B1|Maintenance Phase||Age, Customized||years|Mean|59.2|59.2|Full Range|||42.0|79.0|
3878194|NCT01559935|3704551|B1|BiRD Phase||Age, Customized||years|Mean|59.6|59.6|Full Range|||42.0|85.0|
3878195|NCT01559935|3704551|B1|Car Phase||Age, Customized||years|Mean|60.4|60.4|Full Range|||42.0|85.0|
3878196|NCT01559922|3704559|B3|United States||Region of Enrollment||participants|Number|147|147.0||||||
3878197|NCT01559922|3704560|B2|United States||Region of Enrollment||participants|Number|97|97.0||||||
3878198|NCT01559922|3704561|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3878199|NCT01559922|3704559|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878200|NCT01559922|3704560|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878201|NCT01559922|3704561|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878202|NCT01559922|3704559|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|114|114.0||||||
3878203|NCT01559922|3704560|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3878204|NCT01559922|3704561|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3878205|NCT01559922|3704559|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3878206|NCT01559922|3704560|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3878207|NCT01559922|3704561|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3878208|NCT01559922|3704559|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878209|NCT01559922|3704560|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878210|NCT01559922|3704561|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878211|NCT01559922|3704559|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878212|NCT01559922|3704560|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878213|NCT01559922|3704561|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878214|NCT01559922|3704559|B3||White|Race (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
3878215|NCT01559922|3704560|B2||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3878216|NCT01559922|3704561|B1||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3878217|NCT01559922|3704559|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3878218|NCT01559922|3704560|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3878219|NCT01559922|3704561|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3878220|NCT01559922|3704559|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3878221|NCT01559922|3704560|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3878222|NCT01559922|3704561|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878223|NCT01559922|3704559|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3878224|NCT01559922|3704560|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3878225|NCT01559922|3704561|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3878226|NCT01559922|3704559|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3878227|NCT01559922|3704560|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3878228|NCT01559922|3704561|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878229|NCT01559922|3704559|B3||Male|Gender||Participants|Count of Participants|57|57.0||||||
3878230|NCT01559922|3704560|B2||Male|Gender||Participants|Count of Participants|37|37.0||||||
3878231|NCT01559922|3704561|B1||Male|Gender||Participants|Count of Participants|20|20.0||||||
3878232|NCT01559922|3704559|B3||Female|Gender||Participants|Count of Participants|90|90.0||||||
3878233|NCT01559922|3704560|B2||Female|Gender||Participants|Count of Participants|60|60.0||||||
3878234|NCT01559922|3704561|B1||Female|Gender||Participants|Count of Participants|30|30.0||||||
3878235|NCT01559922|3704559|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3878236|NCT01559922|3704560|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3878237|NCT01559922|3704561|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3878238|NCT01559922|3704559|B3||Between 18 and 65 years|Age||Participants|Count of Participants|147|147.0||||||
3878239|NCT01559922|3704560|B2||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
3878240|NCT01559922|3704561|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3878241|NCT01559922|3704559|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3878242|NCT01559922|3704560|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3878243|NCT01559922|3704561|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3878244|NCT01559857|3704568|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
3878245|NCT01559857|3704569|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
3878246|NCT01559857|3704570|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3878247|NCT01559857|3704568|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3878248|NCT01559857|3704569|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3878249|NCT01559857|3704570|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3878250|NCT01559857|3704568|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3878251|NCT01559857|3704569|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3878252|NCT01559857|3704570|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3878253|NCT01559857|3704568|B3|||Age||years|Mean|46.35|46.35|Standard Deviation|13.45|13.45|||
3878254|NCT01559857|3704569|B2|||Age||years|Mean|43.28|43.28|Standard Deviation|11.80|11.8|||
3878255|NCT01559857|3704570|B1|||Age||years|Mean|49.42|49.42|Standard Deviation|15.11|15.11|||
3878256|NCT01559857|3704568|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3878257|NCT01559857|3704569|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3878258|NCT01559857|3704570|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3878259|NCT01559857|3704568|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3878260|NCT01559857|3704569|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3878261|NCT01559857|3704570|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3878262|NCT01559857|3704568|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3878263|NCT01559857|3704569|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3878264|NCT01559857|3704570|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3878265|NCT01559844|3704587|B1|14||Baseline Model For End-Stage Liver Disease (MELD) Score|MELD scores, used to assess prognosis and suitability for transplant, are calculated based on laboratory values only and can range from 6 to 40, with higher scores indicating greater disease severity.|participants|Number|1|1.0||||||
3878266|NCT01559844|3704587|B1|13||Baseline Model For End-Stage Liver Disease (MELD) Score|MELD scores, used to assess prognosis and suitability for transplant, are calculated based on laboratory values only and can range from 6 to 40, with higher scores indicating greater disease severity.|participants|Number|2|2.0||||||
3878267|NCT01559844|3704587|B1|11||Baseline Model For End-Stage Liver Disease (MELD) Score|MELD scores, used to assess prognosis and suitability for transplant, are calculated based on laboratory values only and can range from 6 to 40, with higher scores indicating greater disease severity.|participants|Number|8|8.0||||||
3878268|NCT01559844|3704587|B1|10||Baseline Model For End-Stage Liver Disease (MELD) Score|MELD scores, used to assess prognosis and suitability for transplant, are calculated based on laboratory values only and can range from 6 to 40, with higher scores indicating greater disease severity.|participants|Number|6|6.0||||||
3878269|NCT01559844|3704587|B1|9||Baseline Model For End-Stage Liver Disease (MELD) Score|MELD scores, used to assess prognosis and suitability for transplant, are calculated based on laboratory values only and can range from 6 to 40, with higher scores indicating greater disease severity.|participants|Number|9|9.0||||||
3878270|NCT01559844|3704587|B1|8||Baseline Model For End-Stage Liver Disease (MELD) Score|MELD scores, used to assess prognosis and suitability for transplant, are calculated based on laboratory values only and can range from 6 to 40, with higher scores indicating greater disease severity.|participants|Number|12|12.0||||||
3878271|NCT01559844|3704587|B1|7||Baseline Model For End-Stage Liver Disease (MELD) Score|MELD scores, used to assess prognosis and suitability for transplant, are calculated based on laboratory values only and can range from 6 to 40, with higher scores indicating greater disease severity.|participants|Number|18|18.0||||||
3878272|NCT01559844|3704587|B1|6||Baseline Model For End-Stage Liver Disease (MELD) Score|MELD scores, used to assess prognosis and suitability for transplant, are calculated based on laboratory values only and can range from 6 to 40, with higher scores indicating greater disease severity.|participants|Number|5|5.0||||||
3878273|NCT01559844|3704587|B1|8||Baseline Child-Pugh Turcotte (CPT) Score|CPT scores, widely used to grade the severity of cirrhosis and to determine the need for liver transplantation, are calculated based on a combination of laboratory values and clinical features. CPT scores can range from 5 to 15, with higher scores indicating a greater severity of disease.|participants|Number|3|3.0||||||
3878274|NCT01559844|3704587|B1|7||Baseline Child-Pugh Turcotte (CPT) Score|CPT scores, widely used to grade the severity of cirrhosis and to determine the need for liver transplantation, are calculated based on a combination of laboratory values and clinical features. CPT scores can range from 5 to 15, with higher scores indicating a greater severity of disease.|participants|Number|14|14.0||||||
3878275|NCT01559844|3704587|B1|6||Baseline Child-Pugh Turcotte (CPT) Score|CPT scores, widely used to grade the severity of cirrhosis and to determine the need for liver transplantation, are calculated based on a combination of laboratory values and clinical features. CPT scores can range from 5 to 15, with higher scores indicating a greater severity of disease.|participants|Number|18|18.0||||||
3878276|NCT01559844|3704587|B1|5||Baseline Child-Pugh Turcotte (CPT) Score|CPT scores, widely used to grade the severity of cirrhosis and to determine the need for liver transplantation, are calculated based on a combination of laboratory values and clinical features. CPT scores can range from 5 to 15, with higher scores indicating a greater severity of disease.|participants|Number|26|26.0||||||
3878277|NCT01559844|3704587|B1|Missing||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3878278|NCT01559844|3704587|B1|TT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|8|8.0||||||
3878279|NCT01559844|3704587|B1|CT||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|39|39.0||||||
3878280|NCT01559844|3704587|B1|CC||IL28b Status|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|13|13.0||||||
3878281|NCT01559844|3704587|B1|Genotype 4a||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|1|1.0||||||
3878282|NCT01559844|3704587|B1|Genotype 3a||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|7|7.0||||||
3878283|NCT01559844|3704587|B1|Genotype 2b||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|7|7.0||||||
3878284|NCT01559844|3704587|B1|Genotype 2a||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|1|1.0||||||
3878285|NCT01559844|3704587|B1|Genotype 1b||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|21|21.0||||||
3878286|NCT01559844|3704587|B1|Genotype 1a||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|24|24.0||||||
3878287|NCT01559844|3704587|B1|≥ 7 log10 IU/mL||Baseline HCV RNA Category||participants|Number|3|3.0||||||
3878288|NCT01559844|3704587|B1|≥ 6 and < 7 log10 IU/mL||Baseline HCV RNA Category||participants|Number|38|38.0||||||
3878289|NCT01559844|3704587|B1|< 6 log10 IU/mL||Baseline HCV RNA Category||participants|Number|20|20.0||||||
3878290|NCT01559844|3704587|B1|||Baseline HCV RNA||log10 IU/mL|Mean|6.14|6.14|Standard Deviation|0.633|0.633|||
3878291|NCT01559844|3704587|B1|||Days on Transplant Waitlist||days|Mean|266|266.0|Standard Deviation|488.8|488.8|||
3878292|NCT01559844|3704587|B1|Had Not Received Prior Treatment||Response to Last Prior HCV Treatment Regimen||participants|Number|15|15.0||||||
3878293|NCT01559844|3704587|B1|Unknown||Response to Last Prior HCV Treatment Regimen||participants|Number|12|12.0||||||
3878294|NCT01559844|3704587|B1|Responder: Relapser||Response to Last Prior HCV Treatment Regimen||participants|Number|9|9.0||||||
3878295|NCT01559844|3704587|B1|Responder: Breakthrough||Response to Last Prior HCV Treatment Regimen||participants|Number|3|3.0||||||
3878296|NCT01559844|3704587|B1|Non-Responder: Partial||Response to Last Prior HCV Treatment Regimen||participants|Number|11|11.0||||||
3878297|NCT01559844|3704587|B1|Non-Responder: Null||Response to Last Prior HCV Treatment Regimen||participants|Number|11|11.0||||||
3878298|NCT01559844|3704587|B1|No||Prior Hepatitis C Virus (HCV) Treatment||participants|Number|15|15.0||||||
3878299|NCT01559844|3704587|B1|Yes||Prior Hepatitis C Virus (HCV) Treatment||participants|Number|46|46.0||||||
3878300|NCT01559844|3704587|B1|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
3878301|NCT01559844|3704587|B1|Spain||Region of Enrollment||participants|Number|5|5.0||||||
3878302|NCT01559844|3704587|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
3878303|NCT01559844|3704587|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3878304|NCT01559844|3704587|B1|White||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
3878305|NCT01559844|3704587|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878306|NCT01559844|3704587|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3878307|NCT01559844|3704587|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3878308|NCT01559844|3704587|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3878309|NCT01559844|3704587|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3878310|NCT01559844|3704587|B1|||Age||years|Mean|59|59.0|Standard Deviation|5.5|5.5|||
3878311|NCT01559675|3704598|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3878312|NCT01559675|3704599|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3878313|NCT01559675|3704600|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3878314|NCT01559675|3704598|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3878315|NCT01559675|3704599|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3878316|NCT01559675|3704600|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3878317|NCT01559675|3704598|B3|||Age||years|Median|40|40.0|Inter-Quartile Range|||24.0|50.0|
3878318|NCT01559675|3704599|B2|||Age||years|Median|41|41.0|Inter-Quartile Range|||29.0|50.0|
3878319|NCT01559675|3704600|B1|||Age||years|Median|38|38.0|Inter-Quartile Range|||24.0|50.0|
3878320|NCT01559649|3704607|B3|posterior circulation||Stroke Location|obtained from 140 imaging-confirmed strokes|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3878321|NCT01559649|3704608|B2|posterior circulation||Stroke Location|obtained from 140 imaging-confirmed strokes|participants|Number|NA|||||||stroke location not collected in nurses
3878322|NCT01559649|3704609|B1|posterior circulation||Stroke Location|obtained from 140 imaging-confirmed strokes|participants|Number|35|35.0||||||
3878323|NCT01559649|3704607|B3|bilateral||Stroke Location|obtained from 140 imaging-confirmed strokes|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3878324|NCT01559649|3704608|B2|bilateral||Stroke Location|obtained from 140 imaging-confirmed strokes|participants|Number|NA|||||||stroke location not collected in nurses
3878325|NCT01559649|3704609|B1|bilateral||Stroke Location|obtained from 140 imaging-confirmed strokes|participants|Number|4|4.0||||||
3878326|NCT01559649|3704607|B3|left hemispheric damage||Stroke Location|obtained from 140 imaging-confirmed strokes|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3878327|NCT01559649|3704608|B2|left hemispheric damage||Stroke Location|obtained from 140 imaging-confirmed strokes|participants|Number|NA|||||||stroke location not collected in nurses
3878328|NCT01559649|3704609|B1|left hemispheric damage||Stroke Location|obtained from 140 imaging-confirmed strokes|participants|Number|50|50.0||||||
3878329|NCT01559649|3704607|B3|right hemispheric damage||Stroke Location|obtained from 140 imaging-confirmed strokes|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3878380|NCT01559506|3704621|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3878330|NCT01559649|3704608|B2|right hemispheric damage||Stroke Location|obtained from 140 imaging-confirmed strokes|participants|Number|NA|||||||stroke location not collected in nurses
3878331|NCT01559649|3704609|B1|right hemispheric damage||Stroke Location|obtained from 140 imaging-confirmed strokes|participants|Number|51|51.0||||||
3878332|NCT01559649|3704607|B3|Hemorrhagic||Stroke Type|number obtained from the number of imaging confirmed stroke (n=140)|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3878333|NCT01559649|3704608|B2|Hemorrhagic||Stroke Type|number obtained from the number of imaging confirmed stroke (n=140)|participants|Number|NA|||||||stroke type not collected in nurses
3878334|NCT01559649|3704609|B1|Hemorrhagic||Stroke Type|number obtained from the number of imaging confirmed stroke (n=140)|participants|Number|3|3.0||||||
3878335|NCT01559649|3704607|B3|Ischemic||Stroke Type|number obtained from the number of imaging confirmed stroke (n=140)|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3878336|NCT01559649|3704608|B2|Ischemic||Stroke Type|number obtained from the number of imaging confirmed stroke (n=140)|participants|Number|NA|||||||stroke type not collected in nurses
3878337|NCT01559649|3704609|B1|Ischemic||Stroke Type|number obtained from the number of imaging confirmed stroke (n=140)|participants|Number|137|137.0||||||
3878338|NCT01559649|3704607|B3|Nonstroke/TIA||Discharge Diagnosis||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3878339|NCT01559649|3704608|B2|Nonstroke/TIA||Discharge Diagnosis||participants|Number|NA|||||||discharge diagnosis not collected for nurses
3878340|NCT01559649|3704609|B1|Nonstroke/TIA||Discharge Diagnosis||participants|Number|45|45.0||||||
3878341|NCT01559649|3704607|B3|Physician-confirmed TIA||Discharge Diagnosis||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3878342|NCT01559649|3704608|B2|Physician-confirmed TIA||Discharge Diagnosis||participants|Number|NA|||||||discharge diagnosis not collected for nurses
3878343|NCT01559649|3704609|B1|Physician-confirmed TIA||Discharge Diagnosis||participants|Number|49|49.0||||||
3878344|NCT01559649|3704607|B3|Physician-confirmed stroke||Discharge Diagnosis||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3878345|NCT01559649|3704608|B2|Physician-confirmed stroke||Discharge Diagnosis||participants|Number|NA|||||||discharge diagnosis not collected for nurses
3878346|NCT01559649|3704609|B1|Physician-confirmed stroke||Discharge Diagnosis||participants|Number|16|16.0||||||
3878347|NCT01559649|3704607|B3|Imaging-confirmed stroke||Discharge Diagnosis||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3878348|NCT01559649|3704608|B2|Imaging-confirmed stroke||Discharge Diagnosis||participants|Number|NA|||||||discharge diagnosis not collected for nurses
3878349|NCT01559649|3704609|B1|Imaging-confirmed stroke||Discharge Diagnosis||participants|Number|140|140.0||||||
3878350|NCT01559649|3704607|B3|||National Institutes of Health Stroke Scale score|Scores range is 0-30. Lower scores indicates milder stroke.|units on a scale|Mean|NA||Standard Deviation|NA||||Scores not collected for nurses
3878351|NCT01559649|3704608|B2|||National Institutes of Health Stroke Scale score|Scores range is 0-30. Lower scores indicates milder stroke.|units on a scale|Mean|NA||Standard Deviation|NA||||Scores not collected for nurses.
3878352|NCT01559649|3704609|B1|||National Institutes of Health Stroke Scale score|Scores range is 0-30. Lower scores indicates milder stroke.|units on a scale|Mean|2.6|2.6|Standard Deviation|2.9|2.9|||
3878353|NCT01559649|3704607|B3|||Previous History of Stroke||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3878354|NCT01559649|3704608|B2|||Previous History of Stroke||participants|Number|NA|||||||Number of strokes not collected in nurses.
3878355|NCT01559649|3704609|B1|||Previous History of Stroke||participants|Number|60|60.0||||||
3878356|NCT01559649|3704607|B3|United States||Region of Enrollment||participants|Number|265|265.0||||||
3878357|NCT01559649|3704608|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3878358|NCT01559649|3704609|B1|United States||Region of Enrollment||participants|Number|250|250.0||||||
3878359|NCT01559649|3704607|B3|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3878360|NCT01559649|3704608|B2|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3878361|NCT01559649|3704609|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3878362|NCT01559649|3704607|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
3878363|NCT01559649|3704608|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3878364|NCT01559649|3704609|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3878365|NCT01559649|3704607|B3|African American||Race/Ethnicity, Customized||participants|Number|123|123.0||||||
3878366|NCT01559649|3704608|B2|African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3878367|NCT01559649|3704609|B1|African American||Race/Ethnicity, Customized||participants|Number|120|120.0||||||
3878368|NCT01559649|3704607|B3|White||Race/Ethnicity, Customized||participants|Number|99|99.0||||||
3878369|NCT01559649|3704608|B2|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3878370|NCT01559649|3704609|B1|White||Race/Ethnicity, Customized||participants|Number|98|98.0||||||
3878371|NCT01559649|3704607|B3||Male|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
3878372|NCT01559649|3704608|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3878373|NCT01559649|3704609|B1||Male|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
3878374|NCT01559649|3704607|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3878375|NCT01559649|3704608|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3878376|NCT01559649|3704609|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3878377|NCT01559649|3704607|B3|||Age||years|Mean|NA||Standard Deviation|NA||||Age data were not collected for nurses.
3878378|NCT01559649|3704608|B2|||Age||years|Mean|NA||Standard Deviation|NA||||Age data were not collected for nurses.
3878379|NCT01559649|3704609|B1|||Age||years|Mean|64|64.0|Standard Deviation|9.5|9.5|||
3878381|NCT01559506|3704622|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3878382|NCT01559506|3704623|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3878383|NCT01559506|3704621|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3878384|NCT01559506|3704622|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3878385|NCT01559506|3704623|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3878386|NCT01559506|3704621|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3878387|NCT01559506|3704622|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3878388|NCT01559506|3704623|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3878389|NCT01559506|3704621|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3878390|NCT01559506|3704622|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3878391|NCT01559506|3704623|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3878392|NCT01559506|3704621|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3878393|NCT01559506|3704622|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3878394|NCT01559506|3704623|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3878395|NCT01559454|3704630|B3|high school or less||education||participants|Number|10|10.0||||||
3878396|NCT01559454|3704631|B2|high school or less||education||participants|Number|4|4.0||||||
3878397|NCT01559454|3704632|B1|high school or less||education||participants|Number|6|6.0||||||
3878398|NCT01559454|3704630|B3|some college||education||participants|Number|9|9.0||||||
3878399|NCT01559454|3704631|B2|some college||education||participants|Number|6|6.0||||||
3878400|NCT01559454|3704632|B1|some college||education||participants|Number|3|3.0||||||
3878401|NCT01559454|3704630|B3|no prior arrests||criminal history||participants|Number|14|14.0||||||
3878402|NCT01559454|3704631|B2|no prior arrests||criminal history||participants|Number|9|9.0||||||
3878403|NCT01559454|3704632|B1|no prior arrests||criminal history||participants|Number|5|5.0||||||
3878404|NCT01559454|3704630|B3|any prior arrest||criminal history||participants|Number|5|5.0||||||
3878405|NCT01559454|3704631|B2|any prior arrest||criminal history||participants|Number|1|1.0||||||
3878406|NCT01559454|3704632|B1|any prior arrest||criminal history||participants|Number|4|4.0||||||
3878407|NCT01559454|3704630|B3|no past addiction treatment||drug and alcohol treatment history||participants|Number|14|14.0||||||
3878408|NCT01559454|3704631|B2|no past addiction treatment||drug and alcohol treatment history||participants|Number|7|7.0||||||
3878409|NCT01559454|3704632|B1|no past addiction treatment||drug and alcohol treatment history||participants|Number|7|7.0||||||
3878410|NCT01559454|3704630|B3|past addiction treatment||drug and alcohol treatment history||participants|Number|5|5.0||||||
3878411|NCT01559454|3704631|B2|past addiction treatment||drug and alcohol treatment history||participants|Number|3|3.0||||||
3878412|NCT01559454|3704632|B1|past addiction treatment||drug and alcohol treatment history||participants|Number|2|2.0||||||
3878413|NCT01559454|3704630|B3|past treatment||current treatment for back pain||participants|Number|7|7.0||||||
3878414|NCT01559454|3704631|B2|past treatment||current treatment for back pain||participants|Number|4|4.0||||||
3878415|NCT01559454|3704632|B1|past treatment||current treatment for back pain||participants|Number|3|3.0||||||
3878416|NCT01559454|3704630|B3|current treatment||current treatment for back pain||participants|Number|12|12.0||||||
3878417|NCT01559454|3704631|B2|current treatment||current treatment for back pain||participants|Number|6|6.0||||||
3878418|NCT01559454|3704632|B1|current treatment||current treatment for back pain||participants|Number|6|6.0||||||
3878419|NCT01559454|3704630|B3|other spinal surgery||past lower back surgery||participants|Number|10|10.0||||||
3878420|NCT01559454|3704631|B2|other spinal surgery||past lower back surgery||participants|Number|4|4.0||||||
3878421|NCT01559454|3704632|B1|other spinal surgery||past lower back surgery||participants|Number|6|6.0||||||
3878422|NCT01559454|3704630|B3|past lower back surgery||past lower back surgery||participants|Number|9|9.0||||||
3878423|NCT01559454|3704631|B2|past lower back surgery||past lower back surgery||participants|Number|6|6.0||||||
3878424|NCT01559454|3704632|B1|past lower back surgery||past lower back surgery||participants|Number|3|3.0||||||
3878425|NCT01559454|3704630|B3|current of prior marriage||never married||participants|Number|10|10.0||||||
3878426|NCT01559454|3704631|B2|current of prior marriage||never married||participants|Number|4|4.0||||||
3878427|NCT01559454|3704632|B1|current of prior marriage||never married||participants|Number|6|6.0||||||
3878428|NCT01559454|3704630|B3|never married||never married||participants|Number|9|9.0||||||
3878429|NCT01559454|3704631|B2|never married||never married||participants|Number|6|6.0||||||
3878430|NCT01559454|3704632|B1|never married||never married||participants|Number|3|3.0||||||
3878431|NCT01559454|3704630|B3|not disabled||disabled||participants|Number|6|6.0||||||
3878432|NCT01559454|3704631|B2|not disabled||disabled||participants|Number|4|4.0||||||
3878433|NCT01559454|3704632|B1|not disabled||disabled||participants|Number|2|2.0||||||
3878434|NCT01559454|3704630|B3|disabled||disabled||participants|Number|13|13.0||||||
3878435|NCT01559454|3704631|B2|disabled||disabled||participants|Number|6|6.0||||||
3878436|NCT01559454|3704632|B1|disabled||disabled||participants|Number|7|7.0||||||
3878437|NCT01559454|3704630|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
3878438|NCT01559454|3704631|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3878439|NCT01559454|3704632|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3878440|NCT01559454|3704630|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3878441|NCT01559454|3704631|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878442|NCT01559454|3704632|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3878443|NCT01559454|3704630|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878444|NCT01559454|3704631|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878445|NCT01559454|3704632|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878446|NCT01559454|3704630|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3878447|NCT01559454|3704631|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3878448|NCT01559454|3704632|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3878449|NCT01559454|3704630|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3878450|NCT01559454|3704631|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3878451|NCT01559454|3704632|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3878452|NCT01559454|3704630|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878453|NCT01559454|3704631|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878454|NCT01559454|3704632|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878455|NCT01559454|3704630|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878456|NCT01559454|3704631|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878457|NCT01559454|3704632|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878458|NCT01559454|3704630|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878459|NCT01559454|3704631|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878460|NCT01559454|3704632|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878461|NCT01559454|3704630|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878462|NCT01559454|3704631|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878463|NCT01559454|3704632|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878464|NCT01559454|3704630|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3878465|NCT01559454|3704631|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3878466|NCT01559454|3704632|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3878467|NCT01559454|3704630|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878468|NCT01559454|3704631|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878469|NCT01559454|3704632|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878470|NCT01559454|3704630|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3878471|NCT01559454|3704631|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3878472|NCT01559454|3704632|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3878473|NCT01559454|3704630|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3878474|NCT01559454|3704631|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3878475|NCT01559454|3704632|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3878476|NCT01559454|3704630|B3|||Age||years|Mean|41.16|41.16|Standard Deviation|10.71|10.71|||
3878477|NCT01559454|3704631|B2|||Age||years|Mean|38.20|38.2|Standard Deviation|9.16|9.16|||
3878478|NCT01559454|3704632|B1|||Age||years|Mean|44.44|44.44|Standard Deviation|11.85|11.85|||
3878479|NCT01559454|3704630|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3878480|NCT01559454|3704631|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3878481|NCT01559454|3704632|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3878482|NCT01559454|3704630|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3878483|NCT01559454|3704631|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3878484|NCT01559454|3704632|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3878485|NCT01559454|3704630|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3878486|NCT01559454|3704631|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3878487|NCT01559454|3704632|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3878488|NCT01559311|3704649|B4|||Baseline Left Ventricular End Diastolic Volume (LVEDV)||ml|Mean|92.91|92.91|Standard Deviation|34.36|34.36|||
3878489|NCT01559311|3704650|B3|||Baseline Left Ventricular End Diastolic Volume (LVEDV)||ml|Mean|88.78|88.78|Standard Deviation|35.27|35.27|||
3878490|NCT01559311|3704651|B2|||Baseline Left Ventricular End Diastolic Volume (LVEDV)||ml|Mean|104.28|104.28|Standard Deviation|34.08|34.08|||
3878491|NCT01559311|3704652|B1|||Baseline Left Ventricular End Diastolic Volume (LVEDV)||ml|Mean|84.72|84.72|Standard Deviation|31.14|31.14|||
3878492|NCT01559311|3704649|B4|||Baseline Left Ventricular End Systolic Volume (LVESV)||ml|Mean|37.31|37.31|Standard Deviation|20.51|20.51|||
3878493|NCT01559311|3704650|B3|||Baseline Left Ventricular End Systolic Volume (LVESV)||ml|Mean|36.92|36.92|Standard Deviation|23.85|23.85|||
3878494|NCT01559311|3704651|B2|||Baseline Left Ventricular End Systolic Volume (LVESV)||ml|Mean|41.55|41.55|Standard Deviation|20.22|20.22|||
3878495|NCT01559311|3704652|B1|||Baseline Left Ventricular End Systolic Volume (LVESV)||ml|Mean|32.93|32.93|Standard Deviation|15.92|15.92|||
3878496|NCT01559311|3704649|B4|||Baseline Left Ventricular Ejection Fraction (LVEF)||%|Mean|64.31|64.31|Standard Deviation|8.18|8.18|||
3878497|NCT01559311|3704650|B3|||Baseline Left Ventricular Ejection Fraction (LVEF)||%|Mean|64.72|64.72|Standard Deviation|7.51|7.51|||
3878498|NCT01559311|3704651|B2|||Baseline Left Ventricular Ejection Fraction (LVEF)||%|Mean|63.14|63.14|Standard Deviation|8.70|8.7|||
3878499|NCT01559311|3704652|B1|||Baseline Left Ventricular Ejection Fraction (LVEF)||%|Mean|65.19|65.19|Standard Deviation|8.42|8.42|||
3878500|NCT01559311|3704649|B4|||QRS interval||ms|Mean|121.94|121.94|Standard Deviation|36.31|36.31|||
3878501|NCT01559311|3704650|B3|||QRS interval||ms|Mean|131.47|131.47|Standard Deviation|36.56|36.56|||
3878502|NCT01559311|3704651|B2|||QRS interval||ms|Mean|118.82|118.82|Standard Deviation|40.06|40.06|||
3878503|NCT01559311|3704652|B1|||QRS interval||ms|Mean|114.67|114.67|Standard Deviation|29.83|29.83|||
3878504|NCT01559311|3704649|B4|||PR interval||ms|Mean|227.09|227.09|Standard Deviation|72.60|72.6|||
3878505|NCT01559311|3704650|B3|||PR interval||ms|Mean|214.76|214.76|Standard Deviation|56.42|56.42|||
3878506|NCT01559311|3704651|B2|||PR interval||ms|Mean|236.27|236.27|Standard Deviation|80.99|80.99|||
3878507|NCT01559311|3704652|B1|||PR interval||ms|Mean|227.60|227.6|Standard Deviation|78.50|78.5|||
3878508|NCT01559311|3704649|B4|Heart Block||Rhythm on 12-lead ECG||participants|Number|1|1.0||||||
3878509|NCT01559311|3704650|B3|Heart Block||Rhythm on 12-lead ECG||participants|Number|0|0.0||||||
3878510|NCT01559311|3704651|B2|Heart Block||Rhythm on 12-lead ECG||participants|Number|1|1.0||||||
3878511|NCT01559311|3704652|B1|Heart Block||Rhythm on 12-lead ECG||participants|Number|0|0.0||||||
3878512|NCT01559311|3704649|B4|Wenkebach||Rhythm on 12-lead ECG||participants|Number|3|3.0||||||
3878513|NCT01559311|3704650|B3|Wenkebach||Rhythm on 12-lead ECG||participants|Number|1|1.0||||||
3878514|NCT01559311|3704651|B2|Wenkebach||Rhythm on 12-lead ECG||participants|Number|0|0.0||||||
3878515|NCT01559311|3704652|B1|Wenkebach||Rhythm on 12-lead ECG||participants|Number|2|2.0||||||
3878516|NCT01559311|3704649|B4|Sinus Bradycardia||Rhythm on 12-lead ECG||participants|Number|2|2.0||||||
3878517|NCT01559311|3704650|B3|Sinus Bradycardia||Rhythm on 12-lead ECG||participants|Number|1|1.0||||||
3878518|NCT01559311|3704651|B2|Sinus Bradycardia||Rhythm on 12-lead ECG||participants|Number|0|0.0||||||
3878519|NCT01559311|3704652|B1|Sinus Bradycardia||Rhythm on 12-lead ECG||participants|Number|1|1.0||||||
3878520|NCT01559311|3704649|B4|Ventricular Paced rhythm||Rhythm on 12-lead ECG||participants|Number|1|1.0||||||
3878521|NCT01559311|3704650|B3|Ventricular Paced rhythm||Rhythm on 12-lead ECG||participants|Number|0|0.0||||||
3878522|NCT01559311|3704651|B2|Ventricular Paced rhythm||Rhythm on 12-lead ECG||participants|Number|1|1.0||||||
3878523|NCT01559311|3704652|B1|Ventricular Paced rhythm||Rhythm on 12-lead ECG||participants|Number|0|0.0||||||
3878524|NCT01559311|3704649|B4|Complete AV block with junctional escape||Rhythm on 12-lead ECG||participants|Number|1|1.0||||||
3878525|NCT01559311|3704650|B3|Complete AV block with junctional escape||Rhythm on 12-lead ECG||participants|Number|0|0.0||||||
3878526|NCT01559311|3704651|B2|Complete AV block with junctional escape||Rhythm on 12-lead ECG||participants|Number|1|1.0||||||
3878527|NCT01559311|3704652|B1|Complete AV block with junctional escape||Rhythm on 12-lead ECG||participants|Number|0|0.0||||||
3878528|NCT01559311|3704649|B4|Complete Heart Block with Escape Rhythm||Rhythm on 12-lead ECG||participants|Number|1|1.0||||||
3878529|NCT01559311|3704650|B3|Complete Heart Block with Escape Rhythm||Rhythm on 12-lead ECG||participants|Number|0|0.0||||||
3878530|NCT01559311|3704651|B2|Complete Heart Block with Escape Rhythm||Rhythm on 12-lead ECG||participants|Number|0|0.0||||||
3878531|NCT01559311|3704652|B1|Complete Heart Block with Escape Rhythm||Rhythm on 12-lead ECG||participants|Number|1|1.0||||||
3878532|NCT01559311|3704649|B4|Intermitent Pacing||Rhythm on 12-lead ECG||participants|Number|1|1.0||||||
3878533|NCT01559311|3704650|B3|Intermitent Pacing||Rhythm on 12-lead ECG||participants|Number|1|1.0||||||
3878534|NCT01559311|3704651|B2|Intermitent Pacing||Rhythm on 12-lead ECG||participants|Number|0|0.0||||||
3878535|NCT01559311|3704652|B1|Intermitent Pacing||Rhythm on 12-lead ECG||participants|Number|0|0.0||||||
3878536|NCT01559311|3704649|B4|Atrioventricular Dissociation (AVD)||Rhythm on 12-lead ECG||participants|Number|1|1.0||||||
3878537|NCT01559311|3704650|B3|Atrioventricular Dissociation (AVD)||Rhythm on 12-lead ECG||participants|Number|1|1.0||||||
3878538|NCT01559311|3704651|B2|Atrioventricular Dissociation (AVD)||Rhythm on 12-lead ECG||participants|Number|0|0.0||||||
3878539|NCT01559311|3704652|B1|Atrioventricular Dissociation (AVD)||Rhythm on 12-lead ECG||participants|Number|0|0.0||||||
3878540|NCT01559311|3704649|B4|Complete Heart Block||Rhythm on 12-lead ECG||participants|Number|37|37.0||||||
3878541|NCT01559311|3704650|B3|Complete Heart Block||Rhythm on 12-lead ECG||participants|Number|12|12.0||||||
3878542|NCT01559311|3704651|B2|Complete Heart Block||Rhythm on 12-lead ECG||participants|Number|14|14.0||||||
3878543|NCT01559311|3704652|B1|Complete Heart Block||Rhythm on 12-lead ECG||participants|Number|11|11.0||||||
3878544|NCT01559311|3704649|B4|2nd Degree Heart Block||Rhythm on 12-lead ECG||participants|Number|6|6.0||||||
3878545|NCT01559311|3704650|B3|2nd Degree Heart Block||Rhythm on 12-lead ECG||participants|Number|1|1.0||||||
3878546|NCT01559311|3704651|B2|2nd Degree Heart Block||Rhythm on 12-lead ECG||participants|Number|2|2.0||||||
3878547|NCT01559311|3704652|B1|2nd Degree Heart Block||Rhythm on 12-lead ECG||participants|Number|3|3.0||||||
3878548|NCT01559311|3704649|B4|2:1 Heart Block||Rhythm on 12-lead ECG||participants|Number|15|15.0||||||
3878549|NCT01559311|3704650|B3|2:1 Heart Block||Rhythm on 12-lead ECG||participants|Number|6|6.0||||||
3878550|NCT01559311|3704651|B2|2:1 Heart Block||Rhythm on 12-lead ECG||participants|Number|4|4.0||||||
3878551|NCT01559311|3704652|B1|2:1 Heart Block||Rhythm on 12-lead ECG||participants|Number|5|5.0||||||
3878552|NCT01559311|3704649|B4|Atrial Fibrillation||Rhythm on 12-lead ECG||participants|Number|1|1.0||||||
3878553|NCT01559311|3704650|B3|Atrial Fibrillation||Rhythm on 12-lead ECG||participants|Number|1|1.0||||||
3878554|NCT01559311|3704651|B2|Atrial Fibrillation||Rhythm on 12-lead ECG||participants|Number|0|0.0||||||
3878555|NCT01559311|3704652|B1|Atrial Fibrillation||Rhythm on 12-lead ECG||participants|Number|0|0.0||||||
3878556|NCT01559311|3704649|B4|Sinus||Rhythm on 12-lead ECG||participants|Number|28|28.0||||||
3878557|NCT01559311|3704650|B3|Sinus||Rhythm on 12-lead ECG||participants|Number|10|10.0||||||
3878558|NCT01559311|3704651|B2|Sinus||Rhythm on 12-lead ECG||participants|Number|11|11.0||||||
3878559|NCT01559311|3704652|B1|Sinus||Rhythm on 12-lead ECG||participants|Number|7|7.0||||||
3878560|NCT01559311|3704649|B4|||Heart Rate||bpm|Mean|48.04|48.04|Standard Deviation|13.85|13.85|||
3878561|NCT01559311|3704650|B3|||Heart Rate||bpm|Mean|49|49.0|Standard Deviation|14.64|14.64|||
3878562|NCT01559311|3704651|B2|||Heart Rate||bpm|Mean|47.68|47.68|Standard Deviation|10.35|10.35|||
3878563|NCT01559311|3704652|B1|||Heart Rate||bpm|Mean|47.37|47.37|Standard Deviation|16.55|16.55|||
3878564|NCT01559311|3704649|B4|Paroxysmal||Atrial Fibrillation History||participants|Number|3|3.0||||||
3878565|NCT01559311|3704650|B3|Paroxysmal||Atrial Fibrillation History||participants|Number|1|1.0||||||
3878566|NCT01559311|3704651|B2|Paroxysmal||Atrial Fibrillation History||participants|Number|2|2.0||||||
3878567|NCT01559311|3704652|B1|Paroxysmal||Atrial Fibrillation History||participants|Number|0|0.0||||||
3878568|NCT01559311|3704649|B4|None||Atrial Fibrillation History||participants|Number|95|95.0||||||
3878569|NCT01559311|3704650|B3|None||Atrial Fibrillation History||participants|Number|33|33.0||||||
3878570|NCT01559311|3704651|B2|None||Atrial Fibrillation History||participants|Number|32|32.0||||||
3878571|NCT01559311|3704652|B1|None||Atrial Fibrillation History||participants|Number|30|30.0||||||
3878572|NCT01559311|3704649|B4||Male|Gender||Participants|Count of Participants|62|62.0||||||
3878573|NCT01559311|3704650|B3||Male|Gender||Participants|Count of Participants|22|22.0||||||
3878574|NCT01559311|3704651|B2||Male|Gender||Participants|Count of Participants|20|20.0||||||
3878575|NCT01559311|3704652|B1||Male|Gender||Participants|Count of Participants|20|20.0||||||
3878576|NCT01559311|3704649|B4||Female|Gender||Participants|Count of Participants|36|36.0||||||
3878577|NCT01559311|3704650|B3||Female|Gender||Participants|Count of Participants|12|12.0||||||
3878578|NCT01559311|3704651|B2||Female|Gender||Participants|Count of Participants|14|14.0||||||
3878579|NCT01559311|3704652|B1||Female|Gender||Participants|Count of Participants|10|10.0||||||
3878580|NCT01559311|3704649|B4|||Age||years|Mean|69.49|69.49|Standard Deviation|11.82|11.82|||
3878581|NCT01559311|3704650|B3|||Age||years|Mean|72.29|72.29|Standard Deviation|9.84|9.84|||
3878582|NCT01559311|3704651|B2|||Age||years|Mean|68.41|68.41|Standard Deviation|13.22|13.22|||
3878583|NCT01559311|3704652|B1|||Age||years|Mean|67.53|67.53|Standard Deviation|11.99|11.99|||
3878584|NCT01559116|3704665|B1||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3878585|NCT01559116|3704665|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3878586|NCT01559116|3704665|B1|||Age||Years|Mean|61.1|61.1|Standard Deviation|7.7|7.7|||
3878587|NCT01559064|3704733|B4|United Kingdom||Region of Enrollment||participants|Number|19|19.0||||||
3878588|NCT01559064|3704734|B3|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
3878589|NCT01559064|3704735|B2|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
3878590|NCT01559064|3704736|B1|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
3878591|NCT01559064|3704733|B4|Germany||Region of Enrollment||participants|Number|66|66.0||||||
3878592|NCT01559064|3704734|B3|Germany||Region of Enrollment||participants|Number|33|33.0||||||
3878593|NCT01559064|3704735|B2|Germany||Region of Enrollment||participants|Number|25|25.0||||||
3878594|NCT01559064|3704736|B1|Germany||Region of Enrollment||participants|Number|8|8.0||||||
3878595|NCT01559064|3704733|B4|Netherlands||Region of Enrollment||participants|Number|20|20.0||||||
3878596|NCT01559064|3704734|B3|Netherlands||Region of Enrollment||participants|Number|13|13.0||||||
3878597|NCT01559064|3704735|B2|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
3878598|NCT01559064|3704736|B1|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
3878599|NCT01559064|3704733|B4|Belgium||Region of Enrollment||participants|Number|10|10.0||||||
3878600|NCT01559064|3704734|B3|Belgium||Region of Enrollment||participants|Number|6|6.0||||||
3878601|NCT01559064|3704735|B2|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
3878602|NCT01559064|3704736|B1|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
3878603|NCT01559064|3704733|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3878604|NCT01559064|3704734|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3878605|NCT01559064|3704735|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3878606|NCT01559064|3704736|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3878607|NCT01559064|3704733|B4||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3878608|NCT01559064|3704734|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3878609|NCT01559064|3704735|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3878610|NCT01559064|3704736|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3878611|NCT01559064|3704733|B4|||Age||years|Mean|50.6|50.6|Standard Deviation|9.7|9.7|||
3878612|NCT01559064|3704734|B3|||Age||years|Mean|58.3|58.3|Standard Deviation|5.8|5.8|||
3878613|NCT01559064|3704735|B2|||Age||years|Mean|45.2|45.2|Standard Deviation|2.8|2.8|||
3878614|NCT01559064|3704736|B1|||Age||years|Mean|35.7|35.7|Standard Deviation|3.3|3.3|||
3878615|NCT01559064|3704733|B4||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3878616|NCT01559064|3704734|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3878617|NCT01559064|3704735|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3878618|NCT01559064|3704736|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3878619|NCT01559064|3704733|B4||Between 18 and 65 years|Age||Participants|Count of Participants|106|106.0||||||
3878620|NCT01559064|3704734|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3878621|NCT01559064|3704735|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3878622|NCT01559064|3704736|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3878623|NCT01559064|3704733|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3878624|NCT01559064|3704734|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3878625|NCT01559064|3704735|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3878626|NCT01559064|3704736|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3878627|NCT01559012|3704746|B3|Italy||Region of Enrollment||participants|Number|13|13.0||||||
3878628|NCT01559012|3704747|B2|Italy||Region of Enrollment||participants|Number|7|7.0||||||
3878629|NCT01559012|3704748|B1|Italy||Region of Enrollment||participants|Number|6|6.0||||||
3878630|NCT01559012|3704746|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3878631|NCT01559012|3704747|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3878632|NCT01559012|3704748|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3878633|NCT01559012|3704746|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3878634|NCT01559012|3704747|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3878635|NCT01559012|3704748|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3878636|NCT01559012|3704746|B3|||Age||years|Mean|32.1|32.1|Standard Deviation|5.51|5.51|||
3878637|NCT01559012|3704747|B2|||Age||years|Mean|32.3|32.3|Standard Deviation|5.99|5.99|||
3878638|NCT01559012|3704748|B1|||Age||years|Mean|31.8|31.8|Standard Deviation|5.46|5.46|||
3878639|NCT01559012|3704746|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3878640|NCT01559012|3704747|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3878641|NCT01559012|3704748|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3878642|NCT01559012|3704746|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3878643|NCT01559012|3704747|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3878644|NCT01559012|3704748|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3878645|NCT01559012|3704746|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3878646|NCT01559012|3704747|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3878647|NCT01559012|3704748|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3878648|NCT01558791|3704772|B3|Yes||Reported PTSD diagnosis|Of the total study population, 29 participants did not provide information on PTSD diagnosis.|participants|Number|298|298.0||||||
3878649|NCT01558791|3704773|B2|Yes||Reported PTSD diagnosis|Of the total study population, 29 participants did not provide information on PTSD diagnosis.|participants|Number|146|146.0||||||
3878650|NCT01558791|3704774|B1|Yes||Reported PTSD diagnosis|Of the total study population, 29 participants did not provide information on PTSD diagnosis.|participants|Number|152|152.0||||||
3878651|NCT01558791|3704772|B3|No||Reported PTSD diagnosis|Of the total study population, 29 participants did not provide information on PTSD diagnosis.|participants|Number|909|909.0||||||
3878652|NCT01558791|3704773|B2|No||Reported PTSD diagnosis|Of the total study population, 29 participants did not provide information on PTSD diagnosis.|participants|Number|469|469.0||||||
3878653|NCT01558791|3704774|B1|No||Reported PTSD diagnosis|Of the total study population, 29 participants did not provide information on PTSD diagnosis.|participants|Number|440|440.0||||||
3878654|NCT01558791|3704772|B3|Yes||Service connection|Of the total study population, 65 participants did not provide information about service connection.|participants|Number|589|589.0||||||
3878655|NCT01558791|3704773|B2|Yes||Service connection|Of the total study population, 65 participants did not provide information about service connection.|participants|Number|311|311.0||||||
3878656|NCT01558791|3704774|B1|Yes||Service connection|Of the total study population, 65 participants did not provide information about service connection.|participants|Number|278|278.0||||||
3878657|NCT01558791|3704772|B3|No||Service connection|Of the total study population, 65 participants did not provide information about service connection.|participants|Number|582|582.0||||||
3878658|NCT01558791|3704773|B2|No||Service connection|Of the total study population, 65 participants did not provide information about service connection.|participants|Number|277|277.0||||||
3878659|NCT01558791|3704774|B1|No||Service connection|Of the total study population, 65 participants did not provide information about service connection.|participants|Number|305|305.0||||||
3878660|NCT01558791|3704772|B3|Unemployed||Employment|Of the total study population, 10 participants did not provide their employment status.|participants|Number|361|361.0||||||
3878661|NCT01558791|3704773|B2|Unemployed||Employment|Of the total study population, 10 participants did not provide their employment status.|participants|Number|191|191.0||||||
3878662|NCT01558791|3704774|B1|Unemployed||Employment|Of the total study population, 10 participants did not provide their employment status.|participants|Number|170|170.0||||||
3878663|NCT01558791|3704772|B3|Student||Employment|Of the total study population, 10 participants did not provide their employment status.|participants|Number|299|299.0||||||
3878664|NCT01558791|3704773|B2|Student||Employment|Of the total study population, 10 participants did not provide their employment status.|participants|Number|149|149.0||||||
3878665|NCT01558791|3704774|B1|Student||Employment|Of the total study population, 10 participants did not provide their employment status.|participants|Number|150|150.0||||||
3878666|NCT01558791|3704772|B3|Retired||Employment|Of the total study population, 10 participants did not provide their employment status.|participants|Number|127|127.0||||||
3878667|NCT01558791|3704773|B2|Retired||Employment|Of the total study population, 10 participants did not provide their employment status.|participants|Number|58|58.0||||||
3878668|NCT01558791|3704774|B1|Retired||Employment|Of the total study population, 10 participants did not provide their employment status.|participants|Number|69|69.0||||||
3878669|NCT01558791|3704772|B3|Part-time||Employment|Of the total study population, 10 participants did not provide their employment status.|participants|Number|64|64.0||||||
3878670|NCT01558791|3704773|B2|Part-time||Employment|Of the total study population, 10 participants did not provide their employment status.|participants|Number|27|27.0||||||
3878671|NCT01558791|3704774|B1|Part-time||Employment|Of the total study population, 10 participants did not provide their employment status.|participants|Number|37|37.0||||||
3878672|NCT01558791|3704772|B3|Full-time||Employment|Of the total study population, 10 participants did not provide their employment status.|participants|Number|375|375.0||||||
3878673|NCT01558791|3704773|B2|Full-time||Employment|Of the total study population, 10 participants did not provide their employment status.|participants|Number|197|197.0||||||
3878674|NCT01558791|3704774|B1|Full-time||Employment|Of the total study population, 10 participants did not provide their employment status.|participants|Number|178|178.0||||||
3878675|NCT01558791|3704772|B3|Coast Guard||Service Branch|Participants were able to select all that apply, so there is overlap for those who have served in more than one service branch and those who were in the reserves. N=1231 provided information on service era.|participants|Number|1216|1216.0||||||
3878676|NCT01558791|3704773|B2|Coast Guard||Service Branch|Participants were able to select all that apply, so there is overlap for those who have served in more than one service branch and those who were in the reserves. N=1231 provided information on service era.|participants|Number|617|617.0||||||
3878677|NCT01558791|3704774|B1|Coast Guard||Service Branch|Participants were able to select all that apply, so there is overlap for those who have served in more than one service branch and those who were in the reserves. N=1231 provided information on service era.|participants|Number|599|599.0||||||
3878678|NCT01558791|3704772|B3|Reserves||Service Branch|Participants were able to select all that apply, so there is overlap for those who have served in more than one service branch and those who were in the reserves. N=1231 provided information on service era.|participants|Number|1151|1151.0||||||
3878679|NCT01558791|3704773|B2|Reserves||Service Branch|Participants were able to select all that apply, so there is overlap for those who have served in more than one service branch and those who were in the reserves. N=1231 provided information on service era.|participants|Number|581|581.0||||||
3878680|NCT01558791|3704774|B1|Reserves||Service Branch|Participants were able to select all that apply, so there is overlap for those who have served in more than one service branch and those who were in the reserves. N=1231 provided information on service era.|participants|Number|570|570.0||||||
3878681|NCT01558791|3704772|B3|National Guard||Service Branch|Participants were able to select all that apply, so there is overlap for those who have served in more than one service branch and those who were in the reserves. N=1231 provided information on service era.|participants|Number|1100|1100.0||||||
3878682|NCT01558791|3704773|B2|National Guard||Service Branch|Participants were able to select all that apply, so there is overlap for those who have served in more than one service branch and those who were in the reserves. N=1231 provided information on service era.|participants|Number|571|571.0||||||
3878683|NCT01558791|3704774|B1|National Guard||Service Branch|Participants were able to select all that apply, so there is overlap for those who have served in more than one service branch and those who were in the reserves. N=1231 provided information on service era.|participants|Number|529|529.0||||||
3878684|NCT01558791|3704772|B3|Air Force||Service Branch|Participants were able to select all that apply, so there is overlap for those who have served in more than one service branch and those who were in the reserves. N=1231 provided information on service era.|participants|Number|1067|1067.0||||||
3878685|NCT01558791|3704773|B2|Air Force||Service Branch|Participants were able to select all that apply, so there is overlap for those who have served in more than one service branch and those who were in the reserves. N=1231 provided information on service era.|participants|Number|543|543.0||||||
3878686|NCT01558791|3704774|B1|Air Force||Service Branch|Participants were able to select all that apply, so there is overlap for those who have served in more than one service branch and those who were in the reserves. N=1231 provided information on service era.|participants|Number|524|524.0||||||
3878687|NCT01558791|3704772|B3|Marine Corps||Service Branch|Participants were able to select all that apply, so there is overlap for those who have served in more than one service branch and those who were in the reserves. N=1231 provided information on service era.|participants|Number|1041|1041.0||||||
3878688|NCT01558791|3704773|B2|Marine Corps||Service Branch|Participants were able to select all that apply, so there is overlap for those who have served in more than one service branch and those who were in the reserves. N=1231 provided information on service era.|participants|Number|533|533.0||||||
3878689|NCT01558791|3704774|B1|Marine Corps||Service Branch|Participants were able to select all that apply, so there is overlap for those who have served in more than one service branch and those who were in the reserves. N=1231 provided information on service era.|participants|Number|508|508.0||||||
3878690|NCT01558791|3704772|B3|Navy||Service Branch|Participants were able to select all that apply, so there is overlap for those who have served in more than one service branch and those who were in the reserves. N=1231 provided information on service era.|participants|Number|940|940.0||||||
3878691|NCT01558791|3704773|B2|Navy||Service Branch|Participants were able to select all that apply, so there is overlap for those who have served in more than one service branch and those who were in the reserves. N=1231 provided information on service era.|participants|Number|477|477.0||||||
3878692|NCT01558791|3704774|B1|Navy||Service Branch|Participants were able to select all that apply, so there is overlap for those who have served in more than one service branch and those who were in the reserves. N=1231 provided information on service era.|participants|Number|463|463.0||||||
3878693|NCT01558791|3704772|B3|Army||Service Branch|Participants were able to select all that apply, so there is overlap for those who have served in more than one service branch and those who were in the reserves. N=1231 provided information on service era.|participants|Number|681|681.0||||||
3878694|NCT01558791|3704773|B2|Army||Service Branch|Participants were able to select all that apply, so there is overlap for those who have served in more than one service branch and those who were in the reserves. N=1231 provided information on service era.|participants|Number|335|335.0||||||
3878695|NCT01558791|3704774|B1|Army||Service Branch|Participants were able to select all that apply, so there is overlap for those who have served in more than one service branch and those who were in the reserves. N=1231 provided information on service era.|participants|Number|346|346.0||||||
3878738|NCT01558700|3704797|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3878696|NCT01558791|3704772|B3|Never married||Marital status|Of the total study population, 13 participants did not provide their marital status.|participants|Number|332|332.0||||||
3878697|NCT01558791|3704773|B2|Never married||Marital status|Of the total study population, 13 participants did not provide their marital status.|participants|Number|161|161.0||||||
3878698|NCT01558791|3704774|B1|Never married||Marital status|Of the total study population, 13 participants did not provide their marital status.|participants|Number|171|171.0||||||
3878699|NCT01558791|3704772|B3|Separated||Marital status|Of the total study population, 13 participants did not provide their marital status.|participants|Number|86|86.0||||||
3878700|NCT01558791|3704773|B2|Separated||Marital status|Of the total study population, 13 participants did not provide their marital status.|participants|Number|44|44.0||||||
3878701|NCT01558791|3704774|B1|Separated||Marital status|Of the total study population, 13 participants did not provide their marital status.|participants|Number|42|42.0||||||
3878702|NCT01558791|3704772|B3|Divorced||Marital status|Of the total study population, 13 participants did not provide their marital status.|participants|Number|231|231.0||||||
3878703|NCT01558791|3704773|B2|Divorced||Marital status|Of the total study population, 13 participants did not provide their marital status.|participants|Number|114|114.0||||||
3878704|NCT01558791|3704774|B1|Divorced||Marital status|Of the total study population, 13 participants did not provide their marital status.|participants|Number|117|117.0||||||
3878705|NCT01558791|3704772|B3|Widowed||Marital status|Of the total study population, 13 participants did not provide their marital status.|participants|Number|5|5.0||||||
3878706|NCT01558791|3704773|B2|Widowed||Marital status|Of the total study population, 13 participants did not provide their marital status.|participants|Number|3|3.0||||||
3878707|NCT01558791|3704774|B1|Widowed||Marital status|Of the total study population, 13 participants did not provide their marital status.|participants|Number|2|2.0||||||
3878708|NCT01558791|3704772|B3|Married||Marital status|Of the total study population, 13 participants did not provide their marital status.|participants|Number|569|569.0||||||
3878709|NCT01558791|3704773|B2|Married||Marital status|Of the total study population, 13 participants did not provide their marital status.|participants|Number|300|300.0||||||
3878710|NCT01558791|3704774|B1|Married||Marital status|Of the total study population, 13 participants did not provide their marital status.|participants|Number|269|269.0||||||
3878711|NCT01558791|3704772|B3|Male||Gender|Of the total study population, 69 participants did not provide their gender.|participants|Number|977|977.0||||||
3878712|NCT01558791|3704773|B2|Male||Gender|Of the total study population, 69 participants did not provide their gender.|participants|Number|483|483.0||||||
3878713|NCT01558791|3704774|B1|Male||Gender|Of the total study population, 69 participants did not provide their gender.|participants|Number|494|494.0||||||
3878714|NCT01558791|3704772|B3|Female||Gender|Of the total study population, 69 participants did not provide their gender.|participants|Number|190|190.0||||||
3878715|NCT01558791|3704773|B2|Female||Gender|Of the total study population, 69 participants did not provide their gender.|participants|Number|99|99.0||||||
3878716|NCT01558791|3704774|B1|Female||Gender|Of the total study population, 69 participants did not provide their gender.|participants|Number|91|91.0||||||
3878717|NCT01558791|3704772|B3|60+ years||Age, Customized|Of the total study population, 7 participants did not provide their age.|participants|Number|6|6.0||||||
3878718|NCT01558791|3704773|B2|60+ years||Age, Customized|Of the total study population, 7 participants did not provide their age.|participants|Number|1|1.0||||||
3878719|NCT01558791|3704774|B1|60+ years||Age, Customized|Of the total study population, 7 participants did not provide their age.|participants|Number|5|5.0||||||
3878720|NCT01558791|3704772|B3|50-59 years||Age, Customized|Of the total study population, 7 participants did not provide their age.|participants|Number|77|77.0||||||
3878721|NCT01558791|3704773|B2|50-59 years||Age, Customized|Of the total study population, 7 participants did not provide their age.|participants|Number|38|38.0||||||
3878722|NCT01558791|3704774|B1|50-59 years||Age, Customized|Of the total study population, 7 participants did not provide their age.|participants|Number|39|39.0||||||
3878723|NCT01558791|3704772|B3|40-49 years||Age, Customized|Of the total study population, 7 participants did not provide their age.|participants|Number|242|242.0||||||
3878724|NCT01558791|3704773|B2|40-49 years||Age, Customized|Of the total study population, 7 participants did not provide their age.|participants|Number|119|119.0||||||
3878725|NCT01558791|3704774|B1|40-49 years||Age, Customized|Of the total study population, 7 participants did not provide their age.|participants|Number|123|123.0||||||
3878726|NCT01558791|3704772|B3|30-39 years||Age, Customized|Of the total study population, 7 participants did not provide their age.|participants|Number|310|310.0||||||
3878727|NCT01558791|3704773|B2|30-39 years||Age, Customized|Of the total study population, 7 participants did not provide their age.|participants|Number|158|158.0||||||
3878728|NCT01558791|3704774|B1|30-39 years||Age, Customized|Of the total study population, 7 participants did not provide their age.|participants|Number|152|152.0||||||
3878729|NCT01558791|3704772|B3|20-29 years||Age, Customized|Of the total study population, 7 participants did not provide their age.|participants|Number|593|593.0||||||
3878730|NCT01558791|3704773|B2|20-29 years||Age, Customized|Of the total study population, 7 participants did not provide their age.|participants|Number|306|306.0||||||
3878731|NCT01558791|3704774|B1|20-29 years||Age, Customized|Of the total study population, 7 participants did not provide their age.|participants|Number|287|287.0||||||
3878732|NCT01558791|3704772|B3|<20 years||Age, Customized|Of the total study population, 7 participants did not provide their age.|participants|Number|1|1.0||||||
3878733|NCT01558791|3704773|B2|<20 years||Age, Customized|Of the total study population, 7 participants did not provide their age.|participants|Number|1|1.0||||||
3878734|NCT01558791|3704774|B1|<20 years||Age, Customized|Of the total study population, 7 participants did not provide their age.|participants|Number|0|0.0||||||
3878735|NCT01558739|3704785|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3878736|NCT01558739|3704785|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3878737|NCT01558739|3704785|B1|||Age||Years|Mean|69.12|69.12|Standard Deviation|10.419|10.419|||
3878739|NCT01558700|3704798|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
3878740|NCT01558700|3704799|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3878741|NCT01558700|3704797|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3878742|NCT01558700|3704798|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3878743|NCT01558700|3704799|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3878744|NCT01558700|3704797|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3878745|NCT01558700|3704798|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3878746|NCT01558700|3704799|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3878747|NCT01558700|3704797|B3|||Age||years|Mean|58.7|58.7|Standard Deviation|6.5|6.5|||
3878748|NCT01558700|3704798|B2|||Age||years|Mean|58.9|58.9|Standard Deviation|8.6|8.6|||
3878749|NCT01558700|3704799|B1|||Age||years|Mean|58.6|58.6|Standard Deviation|4.2|4.2|||
3878750|NCT01558700|3704797|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3878751|NCT01558700|3704798|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3878752|NCT01558700|3704799|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3878753|NCT01558700|3704797|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3878754|NCT01558700|3704798|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3878755|NCT01558700|3704799|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3878756|NCT01558700|3704797|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3878757|NCT01558700|3704798|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3878758|NCT01558700|3704799|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3878759|NCT01558674|3704808|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3878760|NCT01558674|3704810|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3878761|NCT01558674|3704808|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3878762|NCT01558674|3704810|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3878763|NCT01558674|3704808|B3|||Age||Years|Mean|61.4|61.4|Standard Deviation|16.0|16.0|||
3878764|NCT01558674|3704810|B1|||Age||Years|Mean|61.4|61.4|Standard Deviation|16.0|16.0|||
3878765|NCT01558661|3704855|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
3878766|NCT01558661|3704855|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3878767|NCT01558661|3704855|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878768|NCT01558661|3704855|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3878769|NCT01558661|3704855|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878770|NCT01558661|3704855|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878771|NCT01558661|3704855|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3878772|NCT01558661|3704855|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878773|NCT01558661|3704855|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878774|NCT01558661|3704855|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3878775|NCT01558661|3704855|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3878776|NCT01558661|3704855|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3878777|NCT01558661|3704855|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3878778|NCT01558661|3704855|B1|||Age||years|Median|56|56.0|Full Range|||39.0|78.0|
3878779|NCT01558596|3704862|B3|United States||Region of Enrollment||participants|Number|201|201.0||||||
3878780|NCT01558596|3704863|B2|United States||Region of Enrollment||participants|Number|100|100.0||||||
3878781|NCT01558596|3704864|B1|United States||Region of Enrollment||participants|Number|101|101.0||||||
3878782|NCT01558596|3704862|B3||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3878783|NCT01558596|3704863|B2||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3878784|NCT01558596|3704864|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3878785|NCT01558596|3704862|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3878786|NCT01558596|3704863|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3878787|NCT01558596|3704864|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3878788|NCT01558596|3704862|B3|||Age||years|Mean|69|69.0|Standard Deviation|7|7.0|||
3878789|NCT01558596|3704863|B2|||Age||years|Mean|69|69.0|Standard Deviation|7|7.0|||
3878790|NCT01558596|3704864|B1|||Age||years|Mean|69|69.0|Standard Deviation|7|7.0|||
3878791|NCT01558492|3704871|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3878792|NCT01558492|3704871|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3878793|NCT01558492|3704871|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3878794|NCT01558492|3704871|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3878795|NCT01558492|3704871|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3878796|NCT01558492|3704871|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3878797|NCT01558297|3704877|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878798|NCT01558297|3704878|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878799|NCT01558297|3704879|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878800|NCT01558297|3704880|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878801|NCT01558297|3704877|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3878802|NCT01558297|3704878|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3878803|NCT01558297|3704879|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3878804|NCT01558297|3704880|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3878805|NCT01558297|3704877|B4||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3878806|NCT01558297|3704878|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3878807|NCT01558297|3704879|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3878808|NCT01558297|3704880|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3878809|NCT01558297|3704877|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3878810|NCT01558297|3704878|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3878811|NCT01558297|3704879|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3878812|NCT01558297|3704880|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3878813|NCT01558297|3704877|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878814|NCT01558297|3704878|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878815|NCT01558297|3704879|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878816|NCT01558297|3704880|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878817|NCT01558297|3704877|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878818|NCT01558297|3704878|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878819|NCT01558297|3704879|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878820|NCT01558297|3704880|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878821|NCT01558297|3704877|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878822|NCT01558297|3704878|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878823|NCT01558297|3704879|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878824|NCT01558297|3704880|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878825|NCT01558297|3704877|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3878826|NCT01558297|3704878|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3878827|NCT01558297|3704879|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3878828|NCT01558297|3704880|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3878829|NCT01558297|3704877|B4||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3878830|NCT01558297|3704878|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3878831|NCT01558297|3704879|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3878832|NCT01558297|3704880|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3878833|NCT01558297|3704877|B4|||Age||years|Mean|47.9|47.9|Standard Deviation|10.5|10.5|||
3878834|NCT01558297|3704878|B3|||Age||years|Mean|47.77|47.77|Standard Deviation|10.05|10.05|||
3878835|NCT01558297|3704879|B2|||Age||years|Mean|48.93|48.93|Standard Deviation|11.59|11.59|||
3878836|NCT01558297|3704880|B1|||Age||years|Mean|47.07|47.07|Standard Deviation|9.97|9.97|||
3878837|NCT01558271|3704896|B4|Japan||Region of Enrollment||participants|Number|487|487.0||||||
3878838|NCT01558271|3704897|B3|Japan||Region of Enrollment||participants|Number|137|137.0||||||
3878839|NCT01558271|3704898|B2|Japan||Region of Enrollment||participants|Number|70|70.0||||||
3878840|NCT01558271|3704899|B1|Japan||Region of Enrollment||participants|Number|280|280.0||||||
3878841|NCT01558271|3704896|B4|Asian||Race/Ethnicity, Customized||participants|Number|487|487.0||||||
3878842|NCT01558271|3704897|B3|Asian||Race/Ethnicity, Customized||participants|Number|137|137.0||||||
3878843|NCT01558271|3704898|B2|Asian||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
3878844|NCT01558271|3704899|B1|Asian||Race/Ethnicity, Customized||participants|Number|280|280.0||||||
3878845|NCT01558271|3704896|B4||Male|Sex: Female, Male||Participants|Count of Participants|396|396.0||||||
3878846|NCT01558271|3704897|B3||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3878847|NCT01558271|3704898|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3878848|NCT01558271|3704899|B1||Male|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
3878849|NCT01558271|3704896|B4||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3878850|NCT01558271|3704897|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3878851|NCT01558271|3704898|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3878852|NCT01558271|3704899|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3878853|NCT01558271|3704896|B4|||Age||years|Mean|57.44|57.44|Standard Deviation|9.63|9.63|||
3878854|NCT01558271|3704897|B3|||Age||years|Mean|57.91|57.91|Standard Deviation|10.93|10.93|||
3878855|NCT01558271|3704898|B2|||Age||years|Mean|57.66|57.66|Standard Deviation|8.34|8.34|||
3878856|NCT01558271|3704899|B1|||Age||years|Mean|57.15|57.15|Standard Deviation|9.57|9.57|||
3878857|NCT01558128|3704963|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3878858|NCT01558128|3704963|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3878859|NCT01558128|3704963|B1|||Age||years|Mean|87|87.0|Full Range|||87.0|87.0|
3878860|NCT01558089|3704967|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3878861|NCT01558089|3704967|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3878862|NCT01558089|3704967|B1|||Age||years|Mean|55.5|55.5|Standard Deviation|14.3|14.3|||
3878863|NCT01557959|3704978|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
3878864|NCT01557959|3704978|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3878865|NCT01557959|3704978|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3878866|NCT01557959|3704978|B1|||Age||years|Mean|58.6|58.6|Standard Deviation|9.4|9.4|||
3878867|NCT01557959|3704978|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3878868|NCT01557959|3704978|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3878869|NCT01557959|3704978|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3878870|NCT01557946|3704986|B3|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3878871|NCT01557946|3704987|B2|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3878872|NCT01557946|3704988|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3878873|NCT01557946|3704986|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878874|NCT01557946|3704987|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878875|NCT01557946|3704988|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878876|NCT01557946|3704986|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878877|NCT01557946|3704987|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878878|NCT01557946|3704988|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878879|NCT01557946|3704986|B3||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3878880|NCT01557946|3704987|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3878881|NCT01557946|3704988|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3878882|NCT01557946|3704986|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3878883|NCT01557946|3704987|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3878884|NCT01557946|3704988|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3878885|NCT01557946|3704986|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878886|NCT01557946|3704987|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878887|NCT01557946|3704988|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878888|NCT01557946|3704986|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3878889|NCT01557946|3704987|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3878890|NCT01557946|3704988|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3878891|NCT01557946|3704986|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878892|NCT01557946|3704987|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878893|NCT01557946|3704988|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878894|NCT01557946|3704986|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878895|NCT01557946|3704987|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878896|NCT01557946|3704988|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878897|NCT01557946|3704986|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3878898|NCT01557946|3704987|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3878899|NCT01557946|3704988|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3878900|NCT01557946|3704986|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3878901|NCT01557946|3704987|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878902|NCT01557946|3704988|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3878903|NCT01557946|3704986|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3878904|NCT01557946|3704987|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3878905|NCT01557946|3704988|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3878906|NCT01557946|3704986|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3878907|NCT01557946|3704987|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3878908|NCT01557946|3704988|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3878909|NCT01557946|3704986|B3|||Age||years|Mean|39.0|39.0|Standard Deviation|13.0|13.0|||
3878910|NCT01557946|3704987|B2|||Age||years|Mean|38.2|38.2|Standard Deviation|14.1|14.1|||
3878911|NCT01557946|3704988|B1|||Age||years|Mean|39.5|39.5|Standard Deviation|12.7|12.7|||
3878912|NCT01557946|3704986|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3878913|NCT01557946|3704987|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3878914|NCT01557946|3704988|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3878915|NCT01557946|3704986|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3878916|NCT01557946|3704987|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3878917|NCT01557946|3704988|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3878918|NCT01557946|3704986|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3878919|NCT01557946|3704987|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3878920|NCT01557946|3704988|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3878921|NCT01557920|3704995|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3878922|NCT01557920|3704995|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3878923|NCT01557920|3704995|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3878924|NCT01557920|3704995|B1|||Age||years|Mean|24.3|24.3|Standard Deviation|3.3|3.3|||
3878925|NCT01557894|3705029|B3|Romania||Region of Enrollment||participants|Number|76|76.0||||||
3878926|NCT01557894|3705030|B2|Romania||Region of Enrollment||participants|Number|38|38.0||||||
3878927|NCT01557894|3705031|B1|Romania||Region of Enrollment||participants|Number|38|38.0||||||
3878928|NCT01557894|3705029|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3878929|NCT01557894|3705030|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3878930|NCT01557894|3705031|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3878931|NCT01557894|3705029|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3878932|NCT01557894|3705030|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3878933|NCT01557894|3705031|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3878934|NCT01557894|3705029|B3|||Age||years|Mean|28.82|28.82|Standard Deviation|8.04|8.04|||
3878935|NCT01557894|3705030|B2|||Age||years|Mean|30.57|30.57|Standard Deviation|7.96|7.96|||
3878936|NCT01557894|3705031|B1|||Age||years|Mean|27.85|27.85|Standard Deviation|7.83|7.83|||
3878937|NCT01557894|3705029|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3878938|NCT01557894|3705030|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3878939|NCT01557894|3705031|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3878940|NCT01557894|3705029|B3||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
3878941|NCT01557894|3705030|B2||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3878942|NCT01557894|3705031|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3878943|NCT01557894|3705029|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3878944|NCT01557894|3705030|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3878945|NCT01557894|3705031|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3878946|NCT01557868|3705046|B3|United States||Region of Enrollment||participants|Number|198|198.0||||||
3878947|NCT01557868|3705047|B2|United States||Region of Enrollment||participants|Number|95|95.0||||||
3878948|NCT01557868|3705048|B1|United States||Region of Enrollment||participants|Number|103|103.0||||||
3878949|NCT01557868|3705046|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3878950|NCT01557868|3705047|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3878951|NCT01557868|3705048|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3878952|NCT01557868|3705046|B3|White||Race/Ethnicity, Customized||participants|Number|124|124.0||||||
3878953|NCT01557868|3705047|B2|White||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
3878954|NCT01557868|3705048|B1|White||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
3878955|NCT01557868|3705046|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3878956|NCT01557868|3705047|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3878957|NCT01557868|3705048|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3878958|NCT01557868|3705046|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
3878959|NCT01557868|3705047|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3878960|NCT01557868|3705048|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
3878961|NCT01557868|3705046|B3|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3878962|NCT01557868|3705047|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3878963|NCT01557868|3705048|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3878964|NCT01557868|3705046|B3||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3878965|NCT01557868|3705047|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3878966|NCT01557868|3705048|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3878967|NCT01557868|3705046|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3878968|NCT01557868|3705047|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3878969|NCT01557868|3705048|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3878970|NCT01557868|3705046|B3|||Age||years|Mean|45.0|45.0|Standard Deviation|10.1|10.1|||
3878971|NCT01557868|3705047|B2|||Age||years|Mean|43.3|43.3|Standard Deviation|10.4|10.4|||
3878972|NCT01557868|3705048|B1|||Age||years|Mean|46.5|46.5|Standard Deviation|9.6|9.6|||
3878973|NCT01557842|3705057|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
3878974|NCT01557842|3705058|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3878975|NCT01557842|3705059|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3878976|NCT01557842|3705057|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878977|NCT01557842|3705058|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878978|NCT01557842|3705059|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878979|NCT01557842|3705057|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878980|NCT01557842|3705058|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878981|NCT01557842|3705059|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878982|NCT01557842|3705057|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3878983|NCT01557842|3705058|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3878984|NCT01557842|3705059|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3878985|NCT01557842|3705057|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3878986|NCT01557842|3705058|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878987|NCT01557842|3705059|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3878988|NCT01557842|3705057|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3878989|NCT01557842|3705058|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3878990|NCT01557842|3705059|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878991|NCT01557842|3705057|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878992|NCT01557842|3705058|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878993|NCT01557842|3705059|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878994|NCT01557842|3705057|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878995|NCT01557842|3705058|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878996|NCT01557842|3705059|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3878997|NCT01557842|3705057|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3878998|NCT01557842|3705058|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3878999|NCT01557842|3705059|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3879000|NCT01557842|3705057|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3879001|NCT01557842|3705058|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3879002|NCT01557842|3705059|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3879003|NCT01557842|3705057|B3|||Age||years|Mean|66.1|66.1|Standard Deviation|11.7|11.7|||
3879004|NCT01557842|3705058|B2|||Age||years|Mean|63.3|63.3|Standard Deviation|6.1|6.1|||
3879005|NCT01557842|3705059|B1|||Age||years|Mean|68.0|68.0|Standard Deviation|14.4|14.4|||
3879006|NCT01557751|3705068|B1|United States||Region of Enrollment||Participants|Count of Participants|156|156.0||||||
3879007|NCT01557751|3705068|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3879008|NCT01557751|3705068|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3879009|NCT01557751|3705068|B1|||Age||years|Mean|64.23|64.23|Full Range|||40.0|88.0|
3879010|NCT01557751|3705068|B1||>=65 years|Age||Participants|Count of Participants|64|64.0||||||
3879011|NCT01557751|3705068|B1||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
3879012|NCT01557751|3705068|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879013|NCT01557699|3705072|B4|India||Region of Enrollment||participants|Number|60|60.0||||||
3879014|NCT01557699|3705073|B3|India||Region of Enrollment||participants|Number|20|20.0||||||
3879015|NCT01557699|3705074|B2|India||Region of Enrollment||participants|Number|20|20.0||||||
3879016|NCT01557699|3705075|B1|India||Region of Enrollment||participants|Number|20|20.0||||||
3879017|NCT01557699|3705072|B4|||Sex/Gender, Customized||Male participants|Number|60|60.0||||||
3879018|NCT01557699|3705073|B3|||Sex/Gender, Customized||Male participants|Number|20|20.0||||||
3879019|NCT01557699|3705074|B2|||Sex/Gender, Customized||Male participants|Number|20|20.0||||||
3879020|NCT01557699|3705075|B1|||Sex/Gender, Customized||Male participants|Number|20|20.0||||||
3879021|NCT01557699|3705072|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3879022|NCT01557699|3705073|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3879023|NCT01557699|3705074|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3879024|NCT01557699|3705075|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3879025|NCT01557699|3705072|B4||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3879026|NCT01557699|3705073|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3879027|NCT01557699|3705074|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3879028|NCT01557699|3705075|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3879029|NCT01557699|3705072|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879030|NCT01557699|3705073|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879031|NCT01557699|3705074|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879032|NCT01557699|3705075|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879033|NCT01557699|3705072|B4|||Age||years|Mean|28.67|28.67|Standard Deviation|6.67|6.67|||
3879034|NCT01557699|3705073|B3|||Age||years|Mean|28|28.0|Standard Deviation|7|7.0|||
3879035|NCT01557699|3705074|B2|||Age||years|Mean|30|30.0|Standard Deviation|6|6.0|||
3879036|NCT01557699|3705075|B1|||Age||years|Mean|28|28.0|Standard Deviation|7|7.0|18.0|45.0|
3879037|NCT01557595|3705109|B1|||Pittsburgh Sleep Quality Index|The Pittsburgh Sleep Quality Index (PSQI) was measured at the end of the baseline assessment week and again after the intervention. The PSQI is a validated self-rating instrument assessing aspects of sleep quality. The PSQI is considered appropriate in edentifying new onset insomnia in the clinical setting.|units on a scale|Mean|11.15|11.15|Standard Deviation|3.50|3.5|||
3879038|NCT01557595|3705109|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3879039|NCT01557595|3705109|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879040|NCT01557595|3705109|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879041|NCT01557595|3705109|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3879042|NCT01557595|3705109|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879043|NCT01557595|3705109|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879044|NCT01557595|3705109|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879045|NCT01557595|3705109|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879046|NCT01557595|3705109|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3879047|NCT01557595|3705109|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3879048|NCT01557595|3705109|B1|||Age||years|Mean|43.9|43.9|Full Range|||21.0|76.0|
3879049|NCT01557582|3705113|B1|Other||Etiology||participants|Number|1|1.0||||||
3879050|NCT01557582|3705113|B1|Heritable||Etiology||participants|Number|2|2.0||||||
3879051|NCT01557582|3705113|B1|HIV Infection||Etiology||participants|Number|1|1.0||||||
3879052|NCT01557582|3705113|B1|Idiopathic||Etiology||participants|Number|46|46.0||||||
3879053|NCT01557582|3705113|B1|Drug/Toxin||Etiology||participants|Number|4|4.0||||||
3879054|NCT01557582|3705113|B1|Simple Congenital||Etiology||participants|Number|6|6.0||||||
3879055|NCT01557582|3705113|B1|PORTAL HYPERTENSION||Etiology||participants|Number|2|2.0||||||
3879056|NCT01557582|3705113|B1|CONNECTIVE TISSUE||Etiology||participants|Number|39|39.0||||||
3879057|NCT01557582|3705113|B1|Functional Class III||WHO Functional Health Class|"The World Health Organization (WHO) has developed a system to help doctors determine how limited a patient is in their ability to do the activities of daily living. In general, patients with more severe PH tend to have a higher functional class.~Class I: pulmonary hypertension without resulting limitation of physical activity; Class II: slight limitation of physical activity; Class III: marked limitation of physical activity."|participants|Number|48|48.0||||||
3879058|NCT01557582|3705113|B1|Functional Class II||WHO Functional Health Class|"The World Health Organization (WHO) has developed a system to help doctors determine how limited a patient is in their ability to do the activities of daily living. In general, patients with more severe PH tend to have a higher functional class.~Class I: pulmonary hypertension without resulting limitation of physical activity; Class II: slight limitation of physical activity; Class III: marked limitation of physical activity."|participants|Number|46|46.0||||||
3879059|NCT01557582|3705113|B1|Functional Class I||WHO Functional Health Class|"The World Health Organization (WHO) has developed a system to help doctors determine how limited a patient is in their ability to do the activities of daily living. In general, patients with more severe PH tend to have a higher functional class.~Class I: pulmonary hypertension without resulting limitation of physical activity; Class II: slight limitation of physical activity; Class III: marked limitation of physical activity."|participants|Number|7|7.0||||||
3879060|NCT01557582|3705113|B1|Canada||Region of Enrollment||participants|Number|17|17.0||||||
3879061|NCT01557582|3705113|B1|United States||Region of Enrollment||participants|Number|84|84.0||||||
3879062|NCT01557582|3705113|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3879063|NCT01557582|3705113|B1|White/Caucasian||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
3879064|NCT01557582|3705113|B1|Native Hawaii/Pac Island||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3879065|NCT01557582|3705113|B1|Native American/Nat. Alaska||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3879066|NCT01557582|3705113|B1|African American||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3879067|NCT01557582|3705113|B1|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3879068|NCT01557582|3705113|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3879069|NCT01557582|3705113|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3879070|NCT01557582|3705113|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3879071|NCT01557582|3705113|B1||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
3879072|NCT01557582|3705113|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879073|NCT01557569|3705119|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
3879074|NCT01557569|3705120|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3879075|NCT01557569|3705121|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3879076|NCT01557569|3705119|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879077|NCT01557569|3705120|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879078|NCT01557569|3705121|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879079|NCT01557569|3705119|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3879080|NCT01557569|3705120|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3879081|NCT01557569|3705121|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3879082|NCT01557569|3705119|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879083|NCT01557569|3705120|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879084|NCT01557569|3705121|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879085|NCT01557569|3705119|B3||Male|Gender||Participants|Count of Participants|8|8.0||||||
3879086|NCT01557569|3705120|B2||Male|Gender||Participants|Count of Participants|4|4.0||||||
3879087|NCT01557569|3705121|B1||Male|Gender||Participants|Count of Participants|4|4.0||||||
3879088|NCT01557569|3705119|B3||Female|Gender||Participants|Count of Participants|5|5.0||||||
3879089|NCT01557569|3705120|B2||Female|Gender||Participants|Count of Participants|3|3.0||||||
3879090|NCT01557569|3705121|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
3879091|NCT01557569|3705119|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3879092|NCT01557569|3705120|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3879093|NCT01557569|3705121|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3879094|NCT01557569|3705119|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3879095|NCT01557569|3705120|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3879096|NCT01557569|3705121|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3879097|NCT01557569|3705119|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879098|NCT01557569|3705120|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879099|NCT01557569|3705121|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879100|NCT01557504|3705128|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3879101|NCT01557504|3705129|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3879102|NCT01557504|3705130|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3879103|NCT01557504|3705128|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3879104|NCT01557504|3705129|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3879105|NCT01557504|3705130|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3879106|NCT01557504|3705128|B3|14-17 years||Age, Customized||Participants|Number|18|18.0||||||
3879107|NCT01557504|3705129|B2|14-17 years||Age, Customized||Participants|Number|9|9.0||||||
3879108|NCT01557504|3705130|B1|14-17 years||Age, Customized||Participants|Number|9|9.0||||||
3879109|NCT01557504|3705128|B3|10-13 years||Age, Customized||Participants|Number|7|7.0||||||
3879110|NCT01557504|3705129|B2|10-13 years||Age, Customized||Participants|Number|3|3.0||||||
3879111|NCT01557504|3705130|B1|10-13 years||Age, Customized||Participants|Number|4|4.0||||||
3879112|NCT01557348|3705154|B3||Male|Gender||Participants|Count of Participants|159|159.0||||||
3879113|NCT01557348|3705155|B2||Male|Gender||Participants|Count of Participants|64|64.0||||||
3879114|NCT01557348|3705156|B1||Male|Gender||Participants|Count of Participants|95|95.0||||||
3879115|NCT01557348|3705154|B3||Female|Gender||Participants|Count of Participants|569|569.0||||||
3879116|NCT01557348|3705155|B2||Female|Gender||Participants|Count of Participants|259|259.0||||||
3879117|NCT01557348|3705156|B1||Female|Gender||Participants|Count of Participants|310|310.0||||||
3879118|NCT01557348|3705154|B3|||Age||years|Mean|55.7|55.7|Standard Deviation|12.93|12.93|||
3879119|NCT01557348|3705155|B2|||Age||years|Mean|54.7|54.7|Standard Deviation|13.26|13.26|||
3879120|NCT01557348|3705156|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|12.61|12.61|||
3879121|NCT01557322|3705197|B3||Male|Sex: Female, Male||Participants|Count of Participants|493|493.0||||||
3879122|NCT01557322|3705198|B2||Male|Sex: Female, Male||Participants|Count of Participants|445|445.0||||||
3879123|NCT01557322|3705199|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3879124|NCT01557322|3705197|B3||Female|Sex: Female, Male||Participants|Count of Participants|1261|1261.0||||||
3879125|NCT01557322|3705198|B2||Female|Sex: Female, Male||Participants|Count of Participants|1098|1098.0||||||
3879126|NCT01557322|3705199|B1||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3879127|NCT01557322|3705197|B3|||Age||years|Median|61.2|61.2|Full Range|||18.2|86.7|
3879128|NCT01557322|3705198|B2|||Age||years|Median|62.1|62.1|Full Range|||18.2|86.7|
3879129|NCT01557322|3705199|B1|||Age||years|Median|55.3|55.3|Full Range|||18.9|81.0|
3879130|NCT01557283|3705274|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3879131|NCT01557283|3705274|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3879132|NCT01557283|3705274|B1|||Age||years|Mean|48.83|48.83|Standard Deviation|12.428|12.428|||
3879133|NCT01557166|3705284|B3|||Glycosylated haemoglobin (HbA1c)||Percent (%) glycosylated haemoglobin|Mean|5.7|5.7|Standard Deviation|0.4|0.4|||
3879134|NCT01557166|3705285|B2|||Glycosylated haemoglobin (HbA1c)||Percent (%) glycosylated haemoglobin|Mean|5.6|5.6|Standard Deviation|0.4|0.4|||
3879135|NCT01557166|3705286|B1|||Glycosylated haemoglobin (HbA1c)||Percent (%) glycosylated haemoglobin|Mean|5.7|5.7|Standard Deviation|0.4|0.4|||
3879136|NCT01557166|3705284|B3|||Fasting plasma glucose (FPG)||mmol/L|Mean|5.4|5.4|Standard Deviation|0.8|0.8|||
3879137|NCT01557166|3705285|B2|||Fasting plasma glucose (FPG)||mmol/L|Mean|5.4|5.4|Standard Deviation|0.9|0.9|||
3879138|NCT01557166|3705286|B1|||Fasting plasma glucose (FPG)||mmol/L|Mean|5.4|5.4|Standard Deviation|0.6|0.6|||
3879139|NCT01557166|3705284|B3|||Apnoea-hypopnoea index (AHI)||events/hour|Mean|49.2|49.2|Standard Deviation|27.4|27.4|||
3879140|NCT01557166|3705285|B2|||Apnoea-hypopnoea index (AHI)||events/hour|Mean|49.3|49.3|Standard Deviation|27.5|27.5|||
3879141|NCT01557166|3705286|B1|||Apnoea-hypopnoea index (AHI)||events/hour|Mean|49.0|49.0|Standard Deviation|27.5|27.5|||
3879142|NCT01557166|3705284|B3|||Body mass index (BMI)||kg/m^2|Mean|39.1|39.1|Standard Deviation|6.9|6.9|||
3879143|NCT01557166|3705285|B2|||Body mass index (BMI)||kg/m^2|Mean|39.4|39.4|Standard Deviation|7.4|7.4|||
3879144|NCT01557166|3705286|B1|||Body mass index (BMI)||kg/m^2|Mean|38.9|38.9|Standard Deviation|6.4|6.4|||
3879145|NCT01557166|3705284|B3|||Body weight||kg|Mean|117.6|117.6|Standard Deviation|24.2|24.2|||
3879146|NCT01557166|3705285|B2|||Body weight||kg|Mean|118.7|118.7|Standard Deviation|25.4|25.4|||
3879147|NCT01557166|3705286|B1|||Body weight||kg|Mean|116.5|116.5|Standard Deviation|23.0|23.0|||
3879148|NCT01557166|3705284|B3||Male|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
3879149|NCT01557166|3705285|B2||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3879150|NCT01557166|3705286|B1||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3879151|NCT01557166|3705284|B3||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3879152|NCT01557166|3705285|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3879153|NCT01557166|3705286|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3879154|NCT01557166|3705284|B3|||Age||years|Mean|48.5|48.5|Standard Deviation|9.7|9.7|||
3879155|NCT01557166|3705285|B2|||Age||years|Mean|48.4|48.4|Standard Deviation|9.5|9.5|||
3879156|NCT01557166|3705286|B1|||Age||years|Mean|48.6|48.6|Standard Deviation|9.9|9.9|||
3879157|NCT01556997|3705299|B4|United States||Region of Enrollment||participants|Number|837|837.0||||||
3879158|NCT01556997|3705300|B3|United States||Region of Enrollment||participants|Number|278|278.0||||||
3879159|NCT01556997|3705301|B2|United States||Region of Enrollment||participants|Number|280|280.0||||||
3879160|NCT01556997|3705302|B1|United States||Region of Enrollment||participants|Number|279|279.0||||||
3879161|NCT01556997|3705299|B4|Non-black||Race/Ethnicity, Customized||participants|Number|550|550.0||||||
3879162|NCT01556997|3705300|B3|Non-black||Race/Ethnicity, Customized||participants|Number|182|182.0||||||
3879163|NCT01556997|3705301|B2|Non-black||Race/Ethnicity, Customized||participants|Number|184|184.0||||||
3879164|NCT01556997|3705302|B1|Non-black||Race/Ethnicity, Customized||participants|Number|184|184.0||||||
3879165|NCT01556997|3705299|B4|Black||Race/Ethnicity, Customized||participants|Number|287|287.0||||||
3879166|NCT01556997|3705300|B3|Black||Race/Ethnicity, Customized||participants|Number|96|96.0||||||
3879167|NCT01556997|3705301|B2|Black||Race/Ethnicity, Customized||participants|Number|96|96.0||||||
3879168|NCT01556997|3705302|B1|Black||Race/Ethnicity, Customized||participants|Number|95|95.0||||||
3879169|NCT01556997|3705299|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3879170|NCT01556997|3705300|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879171|NCT01556997|3705301|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3879172|NCT01556997|3705302|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879173|NCT01556997|3705299|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879174|NCT01556997|3705300|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879175|NCT01556997|3705301|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879176|NCT01556997|3705302|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879177|NCT01556997|3705299|B4||White|Race (NIH/OMB)||Participants|Count of Participants|540|540.0||||||
3879178|NCT01556997|3705300|B3||White|Race (NIH/OMB)||Participants|Count of Participants|180|180.0||||||
3879179|NCT01556997|3705301|B2||White|Race (NIH/OMB)||Participants|Count of Participants|181|181.0||||||
3879180|NCT01556997|3705302|B1||White|Race (NIH/OMB)||Participants|Count of Participants|179|179.0||||||
3879181|NCT01556997|3705299|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|287|287.0||||||
3879182|NCT01556997|3705300|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3879183|NCT01556997|3705301|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3879184|NCT01556997|3705302|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3879185|NCT01556997|3705299|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3879186|NCT01556997|3705300|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3879187|NCT01556997|3705301|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879188|NCT01556997|3705302|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3879189|NCT01556997|3705299|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3879190|NCT01556997|3705300|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3879191|NCT01556997|3705301|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3879192|NCT01556997|3705302|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3879193|NCT01556997|3705299|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879194|NCT01556997|3705300|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879195|NCT01556997|3705301|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879196|NCT01556997|3705302|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879197|NCT01556997|3705299|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879198|NCT01556997|3705300|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879199|NCT01556997|3705301|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879200|NCT01556997|3705302|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879201|NCT01556997|3705299|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|695|695.0||||||
3879202|NCT01556997|3705300|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|226|226.0||||||
3879203|NCT01556997|3705301|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|237|237.0||||||
3879204|NCT01556997|3705302|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|232|232.0||||||
3879205|NCT01556997|3705299|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|142|142.0||||||
3879206|NCT01556997|3705300|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3879207|NCT01556997|3705301|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3879208|NCT01556997|3705302|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3879209|NCT01556997|3705299|B4||Male|Sex: Female, Male||Participants|Count of Participants|430|430.0||||||
3879210|NCT01556997|3705300|B3||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3879211|NCT01556997|3705301|B2||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3879212|NCT01556997|3705302|B1||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3879213|NCT01556997|3705299|B4||Female|Sex: Female, Male||Participants|Count of Participants|407|407.0||||||
3879214|NCT01556997|3705300|B3||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3879215|NCT01556997|3705301|B2||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3879216|NCT01556997|3705302|B1||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3879217|NCT01556997|3705299|B4||>=65 years|Age||Participants|Count of Participants|60|60.0||||||
3879218|NCT01556997|3705300|B3||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3879219|NCT01556997|3705301|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3879220|NCT01556997|3705302|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3879221|NCT01556997|3705299|B4||Between 18 and 65 years|Age||Participants|Count of Participants|777|777.0||||||
3879222|NCT01556997|3705300|B3||Between 18 and 65 years|Age||Participants|Count of Participants|254|254.0||||||
3879223|NCT01556997|3705301|B2||Between 18 and 65 years|Age||Participants|Count of Participants|262|262.0||||||
3879224|NCT01556997|3705302|B1||Between 18 and 65 years|Age||Participants|Count of Participants|261|261.0||||||
3879225|NCT01556997|3705299|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879226|NCT01556997|3705300|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879227|NCT01556997|3705301|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879228|NCT01556997|3705302|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879229|NCT01556932|3705315|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3879230|NCT01556932|3705315|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879231|NCT01556932|3705315|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879232|NCT01556932|3705315|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3879233|NCT01556932|3705315|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3879234|NCT01556932|3705315|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879235|NCT01556932|3705315|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879236|NCT01556932|3705315|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879237|NCT01556932|3705315|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3879238|NCT01556932|3705315|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3879239|NCT01556932|3705315|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3879240|NCT01556932|3705315|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3879241|NCT01556932|3705315|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3879242|NCT01556932|3705315|B1|||Age||years|Mean|48.1600|48.16|Standard Deviation|14.1500294|14.1500294|||
3879243|NCT01556932|3705315|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3879244|NCT01556932|3705315|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3879245|NCT01556932|3705315|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879246|NCT01556906|3705321|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3879247|NCT01556906|3705321|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3879248|NCT01556906|3705321|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879249|NCT01556906|3705321|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3879250|NCT01556906|3705321|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879251|NCT01556906|3705321|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879252|NCT01556906|3705321|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3879253|NCT01556906|3705321|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879254|NCT01556906|3705321|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3879255|NCT01556906|3705321|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3879256|NCT01556906|3705321|B1|||Age||years|Mean|25.7|25.7|Standard Deviation|9.43|9.43|||
3879257|NCT01556763|3705339|B4|United States||Region of Enrollment||participants|Number|21|21.0||||||
3879258|NCT01556763|3705340|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3879259|NCT01556763|3705341|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3879260|NCT01556763|3705342|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3879261|NCT01556763|3705339|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3879262|NCT01556763|3705340|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3879263|NCT01556763|3705341|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3879264|NCT01556763|3705342|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3879265|NCT01556763|3705339|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3879266|NCT01556763|3705340|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3879267|NCT01556763|3705341|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3879268|NCT01556763|3705342|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3879269|NCT01556763|3705339|B4|||Age||years|Mean|45.7|45.7|Standard Deviation|10.4|10.4|||
3879270|NCT01556763|3705340|B3|||Age||years|Mean|51.4|51.4|Standard Deviation|6.9|6.9|||
3879271|NCT01556763|3705341|B2|||Age||years|Mean|43.1|43.1|Standard Deviation|11.0|11.0|||
3879272|NCT01556763|3705342|B1|||Age||years|Mean|40.0|40.0|Standard Deviation|11.6|11.6|||
3879273|NCT01556763|3705339|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3879274|NCT01556763|3705340|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3879275|NCT01556763|3705341|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3879276|NCT01556763|3705342|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3879277|NCT01556763|3705339|B4||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3879278|NCT01556763|3705340|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3879279|NCT01556763|3705341|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3879280|NCT01556763|3705342|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3879281|NCT01556763|3705339|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879282|NCT01556763|3705340|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879283|NCT01556763|3705341|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879284|NCT01556763|3705342|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879285|NCT01556724|3705380|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3879286|NCT01556724|3705381|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3879287|NCT01556724|3705382|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3879288|NCT01556724|3705380|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3879289|NCT01556724|3705381|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3879290|NCT01556724|3705382|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3879291|NCT01556724|3705380|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3879292|NCT01556724|3705381|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3879293|NCT01556724|3705382|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3879294|NCT01556724|3705380|B3|||Age||years|Mean|57.5|57.5|Standard Deviation|9.8|9.8|||
3879295|NCT01556724|3705381|B2|||Age||years|Mean|56.1|56.1|Standard Deviation|10.8|10.8|||
3879296|NCT01556724|3705382|B1|||Age||years|Mean|59.0|59.0|Standard Deviation|8.8|8.8|||
3879297|NCT01556724|3705380|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3879298|NCT01556724|3705381|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3879299|NCT01556724|3705382|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3879300|NCT01556724|3705380|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3879301|NCT01556724|3705381|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3879302|NCT01556724|3705382|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3879303|NCT01556724|3705380|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879304|NCT01556724|3705381|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879305|NCT01556724|3705382|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879306|NCT01556633|3705397|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3879307|NCT01556633|3705398|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3879308|NCT01556633|3705399|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3879309|NCT01556633|3705397|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3879310|NCT01556633|3705398|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3879311|NCT01556633|3705399|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3879312|NCT01556633|3705397|B3|||Age||Years|Mean|57.9|57.9|Standard Deviation|15.64|15.64|||
3879313|NCT01556633|3705398|B2|||Age||Years|Mean|66.3|66.3|Standard Deviation|9.95|9.95|||
3879314|NCT01556633|3705399|B1|||Age||Years|Mean|52.8|52.8|Standard Deviation|16.62|16.62|||
3879315|NCT01556594|3705422|B4|Canada||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3879316|NCT01556594|3705423|B3|Canada||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3879317|NCT01556594|3705424|B2|Canada||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3879318|NCT01556594|3705425|B1|Canada||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3879319|NCT01556594|3705422|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3879320|NCT01556594|3705423|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3879321|NCT01556594|3705424|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3879322|NCT01556594|3705425|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3879323|NCT01556594|3705422|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3879324|NCT01556594|3705423|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3879325|NCT01556594|3705424|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3879326|NCT01556594|3705425|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3879327|NCT01556594|3705422|B4|||Age||years|Mean|32|32.0|Standard Deviation|12|12.0|||
3879328|NCT01556594|3705423|B3|||Age||years|Mean|25|25.0|Standard Deviation|6|6.0|||
3879329|NCT01556594|3705424|B2|||Age||years|Mean|42|42.0|Standard Deviation|2|2.0|||
3879330|NCT01556594|3705425|B1|||Age||years|Mean|34|34.0|Standard Deviation|14|14.0|||
3879331|NCT01556594|3705422|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3879332|NCT01556594|3705423|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3879333|NCT01556594|3705424|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3879334|NCT01556594|3705425|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3879335|NCT01556594|3705422|B4||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3879336|NCT01556594|3705423|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3879337|NCT01556594|3705424|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3879338|NCT01556594|3705425|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3879339|NCT01556594|3705422|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879340|NCT01556594|3705423|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879341|NCT01556594|3705424|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879342|NCT01556594|3705425|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879343|NCT01556451|3705461|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3879344|NCT01556451|3705461|B1||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3879345|NCT01556451|3705461|B1|60 years or older||Age, Customized||Participants|Number|91|91.0||||||
3879346|NCT01556451|3705461|B1|Between 50 and 59 years||Age, Customized||Participants|Number|89|89.0||||||
3879347|NCT01556425|3705468|B5|United States||Region of Enrollment||Participants|Count of Participants|84|84.0||||||
3879348|NCT01556425|3705469|B4|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3879349|NCT01556425|3705470|B3|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3879350|NCT01556425|3705471|B2|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3879351|NCT01556425|3705472|B1|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3879352|NCT01556425|3705468|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879353|NCT01556425|3705469|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879354|NCT01556425|3705470|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879355|NCT01556425|3705471|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879356|NCT01556425|3705472|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879357|NCT01556425|3705468|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879358|NCT01556425|3705469|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879359|NCT01556425|3705470|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879360|NCT01556425|3705471|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879361|NCT01556425|3705472|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879362|NCT01556425|3705468|B5||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3879363|NCT01556425|3705469|B4||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3879364|NCT01556425|3705470|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3879365|NCT01556425|3705471|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3879366|NCT01556425|3705472|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3879367|NCT01556425|3705468|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3879368|NCT01556425|3705469|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3879369|NCT01556425|3705470|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3879370|NCT01556425|3705471|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3879371|NCT01556425|3705472|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3879372|NCT01556425|3705468|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879373|NCT01556425|3705469|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879374|NCT01556425|3705470|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879375|NCT01556425|3705471|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879376|NCT01556425|3705472|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879377|NCT01556425|3705468|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3879378|NCT01556425|3705469|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879379|NCT01556425|3705470|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3879380|NCT01556425|3705471|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879381|NCT01556425|3705472|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879382|NCT01556425|3705468|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3879383|NCT01556425|3705469|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879384|NCT01556425|3705470|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879385|NCT01556425|3705471|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879386|NCT01556425|3705472|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3879387|NCT01556425|3705468|B5||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3879388|NCT01556425|3705469|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3879389|NCT01556425|3705470|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3879390|NCT01556425|3705471|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3879391|NCT01556425|3705472|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3879392|NCT01556425|3705468|B5||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3879393|NCT01556425|3705469|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3879394|NCT01556425|3705470|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3879395|NCT01556425|3705471|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3879396|NCT01556425|3705472|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3879397|NCT01556425|3705468|B5|||Age||years|Mean|42.7|42.7|Standard Deviation|10.5|10.5|||
3879398|NCT01556425|3705469|B4|||Age||years|Mean|42.2|42.2|Standard Deviation|11.4|11.4|||
3879399|NCT01556425|3705470|B3|||Age||years|Mean|41.1|41.1|Standard Deviation|11.1|11.1|||
3879400|NCT01556425|3705471|B2|||Age||years|Mean|43.1|43.1|Standard Deviation|10.0|10.0|||
3879401|NCT01556425|3705472|B1|||Age||years|Mean|43.9|43.9|Standard Deviation|10.3|10.3|||
3879402|NCT01556347|3705489|B1|United States||Region of Enrollment|Heart transplant candidates with CPRA > 50%|Participants|Count of Participants|2|2.0||||||
3879403|NCT01556347|3705489|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3879404|NCT01556347|3705489|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3879405|NCT01556347|3705489|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3879406|NCT01556347|3705489|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3879407|NCT01556347|3705489|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879408|NCT01556204|3705517|B3|United States||Region of Enrollment||participants|Number|73|73.0||||||
3879409|NCT01556204|3705518|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
3879410|NCT01556204|3705519|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3879411|NCT01556204|3705517|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3879412|NCT01556204|3705518|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3879413|NCT01556204|3705519|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3879414|NCT01556204|3705517|B3||Female|Gender||Participants|Count of Participants|73|73.0||||||
3879415|NCT01556204|3705518|B2||Female|Gender||Participants|Count of Participants|38|38.0||||||
3879416|NCT01556204|3705519|B1||Female|Gender||Participants|Count of Participants|35|35.0||||||
3879417|NCT01556204|3705517|B3|||Age||years|Mean|34.5|34.5|Standard Deviation|8.5|8.5|||
3879418|NCT01556204|3705518|B2|||Age||years|Mean|34.5|34.5|Standard Deviation|8.5|8.5|||
3879419|NCT01556204|3705519|B1|||Age||years|Mean|34.3|34.3|Standard Deviation|7.2|7.2|||
3879420|NCT01556165|3705528|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879421|NCT01556165|3705529|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879422|NCT01556165|3705530|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879423|NCT01556165|3705528|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879424|NCT01556165|3705529|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879425|NCT01556165|3705530|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879426|NCT01556165|3705528|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879427|NCT01556165|3705529|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879428|NCT01556165|3705530|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879429|NCT01556165|3705528|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879430|NCT01556165|3705529|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879431|NCT01556165|3705530|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879432|NCT01556165|3705528|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879433|NCT01556165|3705529|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879434|NCT01556165|3705530|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879435|NCT01556165|3705528|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
3879436|NCT01556165|3705529|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3879437|NCT01556165|3705530|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3879438|NCT01556165|3705528|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879439|NCT01556165|3705529|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879440|NCT01556165|3705530|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879441|NCT01556165|3705528|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3879442|NCT01556165|3705529|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3879443|NCT01556165|3705530|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3879444|NCT01556165|3705528|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3879445|NCT01556165|3705529|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3879446|NCT01556165|3705530|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3879447|NCT01556165|3705528|B3|||Age||years|Mean|59.0|59.0|Standard Deviation|8.95|8.95|||
3879448|NCT01556165|3705529|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|8.72|8.72|||
3879449|NCT01556165|3705530|B1|||Age||years|Mean|59.5|59.5|Standard Deviation|9.22|9.22|||
3879450|NCT01556100|3705543|B1|Taiwan||Region of Enrollment||participants|Number|34|34.0||||||
3879451|NCT01556100|3705543|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3879452|NCT01556100|3705543|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3879453|NCT01556100|3705543|B1|||Age||years|Mean|55.08|55.08|Full Range|||20.0|80.0|
3879454|NCT01556100|3705543|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3879455|NCT01556100|3705543|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3879456|NCT01556100|3705543|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879457|NCT01556061|3705548|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3879458|NCT01556061|3705549|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3879459|NCT01556061|3705550|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3879460|NCT01556061|3705548|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3879461|NCT01556061|3705549|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3879462|NCT01556061|3705550|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3879463|NCT01556061|3705548|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3879464|NCT01556061|3705549|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3879465|NCT01556061|3705550|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3879466|NCT01556061|3705548|B3|||Age||years|Mean|44.3|44.3|Standard Deviation|11.1|11.1|||
3879467|NCT01556061|3705549|B2|||Age||years|Mean|46.2|46.2|Standard Deviation|11.2|11.2|||
3879468|NCT01556061|3705550|B1|||Age||years|Mean|42.4|42.4|Standard Deviation|11.0|11.0|||
3879469|NCT01556061|3705548|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3879470|NCT01556061|3705549|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3879471|NCT01556061|3705550|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3879472|NCT01556061|3705548|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3879473|NCT01556061|3705549|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3879474|NCT01556061|3705550|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3879475|NCT01556061|3705548|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879476|NCT01556061|3705549|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879477|NCT01556061|3705550|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879478|NCT01555983|3705561|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
3879479|NCT01555983|3705561|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3879480|NCT01555983|3705561|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3879481|NCT01555983|3705561|B1|||Age||years|Mean|46.4|46.4|Standard Deviation|13.6|13.6|||
3879482|NCT01555931|3705574|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3879483|NCT01555931|3705575|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3879484|NCT01555931|3705576|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3879485|NCT01555931|3705574|B3|Hispanic or Latina||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3879486|NCT01555931|3705575|B2|Hispanic or Latina||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3879487|NCT01555931|3705576|B1|Hispanic or Latina||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3879488|NCT01555931|3705574|B3|Black, non-Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3879489|NCT01555931|3705575|B2|Black, non-Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3879490|NCT01555931|3705576|B1|Black, non-Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3879491|NCT01555931|3705574|B3|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3879492|NCT01555931|3705575|B2|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3879493|NCT01555931|3705576|B1|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3879494|NCT01555931|3705574|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3879495|NCT01555931|3705575|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3879496|NCT01555931|3705576|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3879497|NCT01555931|3705574|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3879498|NCT01555931|3705575|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3879499|NCT01555931|3705576|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3879500|NCT01555931|3705574|B3|||Age||years|Median|27|27.0|Inter-Quartile Range|||25.0|29.0|
3879501|NCT01555931|3705575|B2|||Age||years|Median|27|27.0|Inter-Quartile Range|||25.0|29.0|
3879502|NCT01555931|3705576|B1|||Age||years|Median|28|28.0|Inter-Quartile Range|||25.0|30.0|
3879503|NCT01555567|3705585|B5|||Central Activation Ratio (CAR)|CAR = maximal voluntary isometric contraction force / maximal voluntary isometric contractions force + stimulated force|ratio|Mean|95.9|95.9|Standard Deviation|4.1|4.1|||
3879504|NCT01555567|3705586|B4|||Central Activation Ratio (CAR)|CAR = maximal voluntary isometric contraction force / maximal voluntary isometric contractions force + stimulated force|ratio|Mean|95.7|95.7|Standard Deviation|3.5|3.5|||
3879505|NCT01555567|3705587|B3|||Central Activation Ratio (CAR)|CAR = maximal voluntary isometric contraction force / maximal voluntary isometric contractions force + stimulated force|ratio|Mean|95.9|95.9|Standard Deviation|4.5|4.5|||
3879506|NCT01555567|3705588|B2|||Central Activation Ratio (CAR)|CAR = maximal voluntary isometric contraction force / maximal voluntary isometric contractions force + stimulated force|ratio|Mean|94.9|94.9|Standard Deviation|5.3|5.3|||
3879507|NCT01555567|3705589|B1|||Central Activation Ratio (CAR)|CAR = maximal voluntary isometric contraction force / maximal voluntary isometric contractions force + stimulated force|ratio|Mean|97.4|97.4|Standard Deviation|3|3.0|||
3879508|NCT01555567|3705585|B5|||Quadriceps Strength||Nm/kg|Mean|2.67|2.67|Standard Deviation|.78|0.78|||
3879509|NCT01555567|3705586|B4|||Quadriceps Strength||Nm/kg|Mean|2.7|2.7|Standard Deviation|.8|0.8|||
3879510|NCT01555567|3705587|B3|||Quadriceps Strength||Nm/kg|Mean|2.8|2.8|Standard Deviation|1.1|1.1|||
3879511|NCT01555567|3705588|B2|||Quadriceps Strength||Nm/kg|Mean|2.6|2.6|Standard Deviation|.6|0.6|||
3879512|NCT01555567|3705589|B1|||Quadriceps Strength||Nm/kg|Mean|2.6|2.6|Standard Deviation|.6|0.6|||
3879513|NCT01555567|3705585|B5|||Mass||kg|Mean|78.2|78.2|Standard Deviation|18.4|18.4|||
3879514|NCT01555567|3705586|B4|||Mass||kg|Mean|77.8|77.8|Standard Deviation|16.5|16.5|||
3879515|NCT01555567|3705587|B3|||Mass||kg|Mean|77.7|77.7|Standard Deviation|10.4|10.4|||
3879516|NCT01555567|3705588|B2|||Mass||kg|Mean|75.5|75.5|Standard Deviation|24.1|24.1|||
3879517|NCT01555567|3705589|B1|||Mass||kg|Mean|81.65|81.65|Standard Deviation|22.6|22.6|||
3879518|NCT01555567|3705585|B5|||Height||meter|Mean|1.67|1.67|Standard Deviation|.22|0.22|||
3879519|NCT01555567|3705586|B4|||Height||meter|Mean|1.45|1.45|Standard Deviation|.6|0.6|||
3879520|NCT01555567|3705587|B3|||Height||meter|Mean|1.75|1.75|Standard Deviation|.1|0.1|||
3879521|NCT01555567|3705588|B2|||Height||meter|Mean|1.73|1.73|Standard Deviation|.1|0.1|||
3879522|NCT01555567|3705589|B1|||Height||meter|Mean|1.76|1.76|Standard Deviation|.1|0.1|||
3879523|NCT01555567|3705585|B5|United States||Region of Enrollment||participants|Number|36|36.0||||||
3879524|NCT01555567|3705586|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
3879525|NCT01555567|3705587|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3879526|NCT01555567|3705588|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3879527|NCT01555567|3705589|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3879528|NCT01555567|3705585|B5||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3879529|NCT01555567|3705586|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3879530|NCT01555567|3705587|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3879531|NCT01555567|3705588|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3879532|NCT01555567|3705589|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3879533|NCT01555567|3705585|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3879534|NCT01555567|3705586|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3879535|NCT01555567|3705587|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3879536|NCT01555567|3705588|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3879537|NCT01555567|3705589|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3879538|NCT01555567|3705585|B5|||Age||years|Mean|21.6|21.6|Standard Deviation|4.9|4.9|||
3879539|NCT01555567|3705586|B4|||Age||years|Mean|23.2|23.2|Standard Deviation|6.3|6.3|||
3879540|NCT01555567|3705587|B3|||Age||years|Mean|23.2|23.2|Standard Deviation|5.4|5.4|||
3879541|NCT01555567|3705588|B2|||Age||years|Mean|18.3|18.3|Standard Deviation|3.7|3.7|||
3879542|NCT01555567|3705589|B1|||Age||years|Mean|21.8|21.8|Standard Deviation|4.4|4.4|||
3879543|NCT01555489|3705606|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3879544|NCT01555489|3705606|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879545|NCT01555489|3705606|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879546|NCT01555489|3705606|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3879547|NCT01555489|3705606|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3879548|NCT01555489|3705606|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879549|NCT01555489|3705606|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879550|NCT01555489|3705606|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879551|NCT01555489|3705606|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879552|NCT01555489|3705606|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3879553|NCT01555489|3705606|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879554|NCT01555489|3705606|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3879555|NCT01555489|3705606|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3879556|NCT01555489|3705606|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3879557|NCT01555489|3705606|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3879558|NCT01555489|3705606|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879559|NCT01555463|3705611|B3|Severe||Erythema rating||Participants|Number|145|145.0||||||
3879560|NCT01555463|3705612|B2|Severe||Erythema rating||Participants|Number|69|69.0||||||
3879561|NCT01555463|3705613|B1|Severe||Erythema rating||Participants|Number|76|76.0||||||
3879562|NCT01555463|3705611|B3|Moderate||Erythema rating||Participants|Number|734|734.0||||||
3879563|NCT01555463|3705612|B2|Moderate||Erythema rating||Participants|Number|370|370.0||||||
3879564|NCT01555463|3705613|B1|Moderate||Erythema rating||Participants|Number|364|364.0||||||
3879565|NCT01555463|3705611|B3|Mild||Erythema rating||Participants|Number|82|82.0||||||
3879566|NCT01555463|3705612|B2|Mild||Erythema rating||Participants|Number|39|39.0||||||
3879567|NCT01555463|3705613|B1|Mild||Erythema rating||Participants|Number|43|43.0||||||
3879568|NCT01555463|3705611|B3|Clear or almost clear||Erythema rating||Participants|Number|0|0.0||||||
3879569|NCT01555463|3705612|B2|Clear or almost clear||Erythema rating||Participants|Number|0|0.0||||||
3879570|NCT01555463|3705613|B1|Clear or almost clear||Erythema rating||Participants|Number|0|0.0||||||
3879571|NCT01555463|3705611|B3|||Lesion count||Inflammatory lesions|Mean|21.4|21.4|Standard Deviation|8.9|8.9|||
3879572|NCT01555463|3705612|B2|||Lesion count||Inflammatory lesions|Mean|21.2|21.2|Standard Deviation|8.7|8.7|||
3879573|NCT01555463|3705613|B1|||Lesion count||Inflammatory lesions|Mean|21.7|21.7|Standard Deviation|9.1|9.1|||
3879574|NCT01555463|3705611|B3|Severe||Investigator’s Global Assessment (IGA)|The IGA consists of 5 scores: 1) Clear: no papules and/or pustules; no erythema; 2) Minimal: rare papules and/or pustules; faint up to but not including mild erythema; 3) Mild: few papules and/or pustules; mild erythema; 4) Moderate: pronounced number of papules and/or pustules (but less than numerous papules and/or pustules); moderate erythema; 5) Severe: numerous papules and/or pustules, occasionally with confluent areas of inflamed lesions; moderate to severe erythema.|Participants|Number|127|127.0||||||
3879575|NCT01555463|3705612|B2|Severe||Investigator’s Global Assessment (IGA)|The IGA consists of 5 scores: 1) Clear: no papules and/or pustules; no erythema; 2) Minimal: rare papules and/or pustules; faint up to but not including mild erythema; 3) Mild: few papules and/or pustules; mild erythema; 4) Moderate: pronounced number of papules and/or pustules (but less than numerous papules and/or pustules); moderate erythema; 5) Severe: numerous papules and/or pustules, occasionally with confluent areas of inflamed lesions; moderate to severe erythema.|Participants|Number|62|62.0||||||
3879576|NCT01555463|3705613|B1|Severe||Investigator’s Global Assessment (IGA)|The IGA consists of 5 scores: 1) Clear: no papules and/or pustules; no erythema; 2) Minimal: rare papules and/or pustules; faint up to but not including mild erythema; 3) Mild: few papules and/or pustules; mild erythema; 4) Moderate: pronounced number of papules and/or pustules (but less than numerous papules and/or pustules); moderate erythema; 5) Severe: numerous papules and/or pustules, occasionally with confluent areas of inflamed lesions; moderate to severe erythema.|Participants|Number|65|65.0||||||
3879577|NCT01555463|3705611|B3|Moderate||Investigator’s Global Assessment (IGA)|The IGA consists of 5 scores: 1) Clear: no papules and/or pustules; no erythema; 2) Minimal: rare papules and/or pustules; faint up to but not including mild erythema; 3) Mild: few papules and/or pustules; mild erythema; 4) Moderate: pronounced number of papules and/or pustules (but less than numerous papules and/or pustules); moderate erythema; 5) Severe: numerous papules and/or pustules, occasionally with confluent areas of inflamed lesions; moderate to severe erythema.|Participants|Number|834|834.0||||||
3879578|NCT01555463|3705612|B2|Moderate||Investigator’s Global Assessment (IGA)|The IGA consists of 5 scores: 1) Clear: no papules and/or pustules; no erythema; 2) Minimal: rare papules and/or pustules; faint up to but not including mild erythema; 3) Mild: few papules and/or pustules; mild erythema; 4) Moderate: pronounced number of papules and/or pustules (but less than numerous papules and/or pustules); moderate erythema; 5) Severe: numerous papules and/or pustules, occasionally with confluent areas of inflamed lesions; moderate to severe erythema.|Participants|Number|416|416.0||||||
3879579|NCT01555463|3705613|B1|Moderate||Investigator’s Global Assessment (IGA)|The IGA consists of 5 scores: 1) Clear: no papules and/or pustules; no erythema; 2) Minimal: rare papules and/or pustules; faint up to but not including mild erythema; 3) Mild: few papules and/or pustules; mild erythema; 4) Moderate: pronounced number of papules and/or pustules (but less than numerous papules and/or pustules); moderate erythema; 5) Severe: numerous papules and/or pustules, occasionally with confluent areas of inflamed lesions; moderate to severe erythema.|Participants|Number|418|418.0||||||
3879580|NCT01555463|3705611|B3|Mild||Investigator’s Global Assessment (IGA)|The IGA consists of 5 scores: 1) Clear: no papules and/or pustules; no erythema; 2) Minimal: rare papules and/or pustules; faint up to but not including mild erythema; 3) Mild: few papules and/or pustules; mild erythema; 4) Moderate: pronounced number of papules and/or pustules (but less than numerous papules and/or pustules); moderate erythema; 5) Severe: numerous papules and/or pustules, occasionally with confluent areas of inflamed lesions; moderate to severe erythema.|Participants|Number|0|0.0||||||
3879581|NCT01555463|3705612|B2|Mild||Investigator’s Global Assessment (IGA)|The IGA consists of 5 scores: 1) Clear: no papules and/or pustules; no erythema; 2) Minimal: rare papules and/or pustules; faint up to but not including mild erythema; 3) Mild: few papules and/or pustules; mild erythema; 4) Moderate: pronounced number of papules and/or pustules (but less than numerous papules and/or pustules); moderate erythema; 5) Severe: numerous papules and/or pustules, occasionally with confluent areas of inflamed lesions; moderate to severe erythema.|Participants|Number|0|0.0||||||
3879582|NCT01555463|3705613|B1|Mild||Investigator’s Global Assessment (IGA)|The IGA consists of 5 scores: 1) Clear: no papules and/or pustules; no erythema; 2) Minimal: rare papules and/or pustules; faint up to but not including mild erythema; 3) Mild: few papules and/or pustules; mild erythema; 4) Moderate: pronounced number of papules and/or pustules (but less than numerous papules and/or pustules); moderate erythema; 5) Severe: numerous papules and/or pustules, occasionally with confluent areas of inflamed lesions; moderate to severe erythema.|Participants|Number|0|0.0||||||
3879583|NCT01555463|3705611|B3|Minimal||Investigator’s Global Assessment (IGA)|The IGA consists of 5 scores: 1) Clear: no papules and/or pustules; no erythema; 2) Minimal: rare papules and/or pustules; faint up to but not including mild erythema; 3) Mild: few papules and/or pustules; mild erythema; 4) Moderate: pronounced number of papules and/or pustules (but less than numerous papules and/or pustules); moderate erythema; 5) Severe: numerous papules and/or pustules, occasionally with confluent areas of inflamed lesions; moderate to severe erythema.|Participants|Number|0|0.0||||||
3879584|NCT01555463|3705612|B2|Minimal||Investigator’s Global Assessment (IGA)|The IGA consists of 5 scores: 1) Clear: no papules and/or pustules; no erythema; 2) Minimal: rare papules and/or pustules; faint up to but not including mild erythema; 3) Mild: few papules and/or pustules; mild erythema; 4) Moderate: pronounced number of papules and/or pustules (but less than numerous papules and/or pustules); moderate erythema; 5) Severe: numerous papules and/or pustules, occasionally with confluent areas of inflamed lesions; moderate to severe erythema.|Participants|Number|0|0.0||||||
3879630|NCT01555164|3705656|B1|Poland||Region of Enrollment||participants|Number|0|0.0||||||
3879631|NCT01555164|3705654|B3|Canada||Region of Enrollment||participants|Number|4|4.0||||||
3879632|NCT01555164|3705655|B2|Canada||Region of Enrollment||participants|Number|3|3.0||||||
3879585|NCT01555463|3705613|B1|Minimal||Investigator’s Global Assessment (IGA)|The IGA consists of 5 scores: 1) Clear: no papules and/or pustules; no erythema; 2) Minimal: rare papules and/or pustules; faint up to but not including mild erythema; 3) Mild: few papules and/or pustules; mild erythema; 4) Moderate: pronounced number of papules and/or pustules (but less than numerous papules and/or pustules); moderate erythema; 5) Severe: numerous papules and/or pustules, occasionally with confluent areas of inflamed lesions; moderate to severe erythema.|Participants|Number|0|0.0||||||
3879586|NCT01555463|3705611|B3|Clear||Investigator’s Global Assessment (IGA)|The IGA consists of 5 scores: 1) Clear: no papules and/or pustules; no erythema; 2) Minimal: rare papules and/or pustules; faint up to but not including mild erythema; 3) Mild: few papules and/or pustules; mild erythema; 4) Moderate: pronounced number of papules and/or pustules (but less than numerous papules and/or pustules); moderate erythema; 5) Severe: numerous papules and/or pustules, occasionally with confluent areas of inflamed lesions; moderate to severe erythema.|Participants|Number|0|0.0||||||
3879587|NCT01555463|3705612|B2|Clear||Investigator’s Global Assessment (IGA)|The IGA consists of 5 scores: 1) Clear: no papules and/or pustules; no erythema; 2) Minimal: rare papules and/or pustules; faint up to but not including mild erythema; 3) Mild: few papules and/or pustules; mild erythema; 4) Moderate: pronounced number of papules and/or pustules (but less than numerous papules and/or pustules); moderate erythema; 5) Severe: numerous papules and/or pustules, occasionally with confluent areas of inflamed lesions; moderate to severe erythema.|Participants|Number|0|0.0||||||
3879588|NCT01555463|3705613|B1|Clear||Investigator’s Global Assessment (IGA)|The IGA consists of 5 scores: 1) Clear: no papules and/or pustules; no erythema; 2) Minimal: rare papules and/or pustules; faint up to but not including mild erythema; 3) Mild: few papules and/or pustules; mild erythema; 4) Moderate: pronounced number of papules and/or pustules (but less than numerous papules and/or pustules); moderate erythema; 5) Severe: numerous papules and/or pustules, occasionally with confluent areas of inflamed lesions; moderate to severe erythema.|Participants|Number|0|0.0||||||
3879589|NCT01555463|3705611|B3||Male|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
3879590|NCT01555463|3705612|B2||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3879591|NCT01555463|3705613|B1||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3879592|NCT01555463|3705611|B3||Female|Sex: Female, Male||Participants|Count of Participants|702|702.0||||||
3879593|NCT01555463|3705612|B2||Female|Sex: Female, Male||Participants|Count of Participants|348|348.0||||||
3879594|NCT01555463|3705613|B1||Female|Sex: Female, Male||Participants|Count of Participants|354|354.0||||||
3879595|NCT01555463|3705611|B3|||Age||Years|Mean|51.5|51.5|Standard Deviation|12.8|12.8|||
3879596|NCT01555463|3705612|B2|||Age||Years|Mean|51.9|51.9|Standard Deviation|13.2|13.2|||
3879597|NCT01555463|3705613|B1|||Age||Years|Mean|51.2|51.2|Standard Deviation|12.3|12.3|||
3879598|NCT01555164|3705654|B3|||Duration of Diabetes||years|Mean|6.5|6.5|Standard Deviation|5.34|5.34|||
3879599|NCT01555164|3705655|B2|||Duration of Diabetes||years|Mean|6.4|6.4|Standard Deviation|5.37|5.37|||
3879600|NCT01555164|3705656|B1|||Duration of Diabetes||years|Mean|6.7|6.7|Standard Deviation|5.31|5.31|||
3879601|NCT01555164|3705654|B3|||Fasting Serum Glucose (FSG)||mg/dL|Mean|169.4|169.4|Standard Deviation|34.42|34.42|||
3879602|NCT01555164|3705655|B2|||Fasting Serum Glucose (FSG)||mg/dL|Mean|168.8|168.8|Standard Deviation|32.86|32.86|||
3879603|NCT01555164|3705656|B1|||Fasting Serum Glucose (FSG)||mg/dL|Mean|170.0|170.0|Standard Deviation|35.97|35.97|||
3879604|NCT01555164|3705654|B3|||Glycosylated hemoglobin (HbA1c)||percent HbA1c in blood|Mean|8.09|8.09|Standard Deviation|0.710|0.71|||
3879605|NCT01555164|3705655|B2|||Glycosylated hemoglobin (HbA1c)||percent HbA1c in blood|Mean|8.10|8.1|Standard Deviation|0.692|0.692|||
3879606|NCT01555164|3705656|B1|||Glycosylated hemoglobin (HbA1c)||percent HbA1c in blood|Mean|8.09|8.09|Standard Deviation|0.729|0.729|||
3879607|NCT01555164|3705654|B3|||Estimated glomerular filtration rate (eGFR)||mL/min/1.73m^2|Mean|90.4|90.4|Standard Deviation|20.91|20.91|||
3879608|NCT01555164|3705655|B2|||Estimated glomerular filtration rate (eGFR)||mL/min/1.73m^2|Mean|89.9|89.9|Standard Deviation|21.82|21.82|||
3879609|NCT01555164|3705656|B1|||Estimated glomerular filtration rate (eGFR)||mL/min/1.73m^2|Mean|90.8|90.8|Standard Deviation|20.01|20.01|||
3879610|NCT01555164|3705654|B3|||Body Mass Index (BMI)||kg/m^2|Mean|31.4|31.4|Standard Deviation|4.71|4.71|||
3879611|NCT01555164|3705655|B2|||Body Mass Index (BMI)||kg/m^2|Mean|31.6|31.6|Standard Deviation|4.95|4.95|||
3879612|NCT01555164|3705656|B1|||Body Mass Index (BMI)||kg/m^2|Mean|31.2|31.2|Standard Deviation|4.46|4.46|||
3879613|NCT01555164|3705654|B3|India||Region of Enrollment||participants|Number|93|93.0||||||
3879614|NCT01555164|3705655|B2|India||Region of Enrollment||participants|Number|49|49.0||||||
3879615|NCT01555164|3705656|B1|India||Region of Enrollment||participants|Number|44|44.0||||||
3879616|NCT01555164|3705654|B3|Russian Federation||Region of Enrollment||participants|Number|86|86.0||||||
3879617|NCT01555164|3705655|B2|Russian Federation||Region of Enrollment||participants|Number|49|49.0||||||
3879618|NCT01555164|3705656|B1|Russian Federation||Region of Enrollment||participants|Number|37|37.0||||||
3879619|NCT01555164|3705654|B3|Israel||Region of Enrollment||participants|Number|3|3.0||||||
3879620|NCT01555164|3705655|B2|Israel||Region of Enrollment||participants|Number|1|1.0||||||
3879621|NCT01555164|3705656|B1|Israel||Region of Enrollment||participants|Number|2|2.0||||||
3879622|NCT01555164|3705654|B3|South Africa||Region of Enrollment||participants|Number|11|11.0||||||
3879623|NCT01555164|3705655|B2|South Africa||Region of Enrollment||participants|Number|4|4.0||||||
3879624|NCT01555164|3705656|B1|South Africa||Region of Enrollment||participants|Number|7|7.0||||||
3879625|NCT01555164|3705654|B3|Ukraine||Region of Enrollment||participants|Number|64|64.0||||||
3879626|NCT01555164|3705655|B2|Ukraine||Region of Enrollment||participants|Number|29|29.0||||||
3879627|NCT01555164|3705656|B1|Ukraine||Region of Enrollment||participants|Number|35|35.0||||||
3879628|NCT01555164|3705654|B3|Poland||Region of Enrollment||participants|Number|5|5.0||||||
3879629|NCT01555164|3705655|B2|Poland||Region of Enrollment||participants|Number|5|5.0||||||
3879633|NCT01555164|3705656|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3879634|NCT01555164|3705654|B3|Mexico||Region of Enrollment||participants|Number|10|10.0||||||
3879635|NCT01555164|3705655|B2|Mexico||Region of Enrollment||participants|Number|4|4.0||||||
3879636|NCT01555164|3705656|B1|Mexico||Region of Enrollment||participants|Number|6|6.0||||||
3879637|NCT01555164|3705654|B3|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
3879638|NCT01555164|3705655|B2|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
3879639|NCT01555164|3705656|B1|Czech Republic||Region of Enrollment||participants|Number|0|0.0||||||
3879640|NCT01555164|3705654|B3|Hungary||Region of Enrollment||participants|Number|16|16.0||||||
3879641|NCT01555164|3705655|B2|Hungary||Region of Enrollment||participants|Number|8|8.0||||||
3879642|NCT01555164|3705656|B1|Hungary||Region of Enrollment||participants|Number|8|8.0||||||
3879643|NCT01555164|3705654|B3|United States||Region of Enrollment||participants|Number|149|149.0||||||
3879644|NCT01555164|3705655|B2|United States||Region of Enrollment||participants|Number|67|67.0||||||
3879645|NCT01555164|3705656|B1|United States||Region of Enrollment||participants|Number|82|82.0||||||
3879646|NCT01555164|3705654|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3879647|NCT01555164|3705655|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3879648|NCT01555164|3705656|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3879649|NCT01555164|3705654|B3|White||Race/Ethnicity, Customized||participants|Number|313|313.0||||||
3879650|NCT01555164|3705655|B2|White||Race/Ethnicity, Customized||participants|Number|153|153.0||||||
3879651|NCT01555164|3705656|B1|White||Race/Ethnicity, Customized||participants|Number|160|160.0||||||
3879652|NCT01555164|3705654|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3879653|NCT01555164|3705655|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3879654|NCT01555164|3705656|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3879655|NCT01555164|3705654|B3|Asian||Race/Ethnicity, Customized||participants|Number|106|106.0||||||
3879656|NCT01555164|3705655|B2|Asian||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
3879657|NCT01555164|3705656|B1|Asian||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
3879658|NCT01555164|3705654|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3879659|NCT01555164|3705655|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3879660|NCT01555164|3705656|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3879661|NCT01555164|3705654|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3879662|NCT01555164|3705655|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3879663|NCT01555164|3705656|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3879664|NCT01555164|3705654|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|347|347.0||||||
3879665|NCT01555164|3705655|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|181|181.0||||||
3879666|NCT01555164|3705656|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|166|166.0||||||
3879667|NCT01555164|3705654|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
3879668|NCT01555164|3705655|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3879669|NCT01555164|3705656|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3879670|NCT01555164|3705654|B3||Male|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
3879671|NCT01555164|3705655|B2||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3879672|NCT01555164|3705656|B1||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3879673|NCT01555164|3705654|B3||Female|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
3879674|NCT01555164|3705655|B2||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3879675|NCT01555164|3705656|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3879676|NCT01555164|3705654|B3|||Age||years|Mean|56|56.0|Standard Deviation|9.1|9.1|||
3879677|NCT01555164|3705655|B2|||Age||years|Mean|56|56.0|Standard Deviation|9.3|9.3|||
3879678|NCT01555164|3705656|B1|||Age||years|Mean|56|56.0|Standard Deviation|8.9|8.9|||
3879679|NCT01555151|3705667|B5||Male|Sex: Female, Male||Participants|Count of Participants|337|337.0||||||
3879680|NCT01555151|3705668|B4||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3879681|NCT01555151|3705669|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3879682|NCT01555151|3705670|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3879683|NCT01555151|3705671|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3879684|NCT01555151|3705667|B5||Female|Sex: Female, Male||Participants|Count of Participants|402|402.0||||||
3879685|NCT01555151|3705668|B4||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3879686|NCT01555151|3705669|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3879687|NCT01555151|3705670|B2||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3879688|NCT01555151|3705671|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3879689|NCT01555151|3705667|B5|||Age||years|Mean|45.4|45.4|Standard Deviation|16.15|16.15|||
3879690|NCT01555151|3705668|B4|||Age||years|Mean|45.5|45.5|Standard Deviation|16.57|16.57|||
3879691|NCT01555151|3705669|B3|||Age||years|Mean|46.0|46.0|Standard Deviation|16.18|16.18|||
3879692|NCT01555151|3705670|B2|||Age||years|Mean|45.9|45.9|Standard Deviation|15.56|15.56|||
3879693|NCT01555151|3705671|B1|||Age||years|Mean|44.4|44.4|Standard Deviation|16.33|16.33|||
3879694|NCT01555138|3705725|B3||Male|Sex: Female, Male||Participants|Count of Participants|401|401.0||||||
3879695|NCT01555138|3705726|B2||Male|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
3879696|NCT01555138|3705727|B1||Male|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
3879697|NCT01555138|3705725|B3||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3879698|NCT01555138|3705726|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3879699|NCT01555138|3705727|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3879700|NCT01555138|3705725|B3|||Age||years|Mean|66.0|66.0|Standard Deviation|8.49|8.49|||
3879701|NCT01555138|3705726|B2|||Age||years|Mean|66.8|66.8|Standard Deviation|8.53|8.53|||
3879702|NCT01555138|3705727|B1|||Age||years|Mean|65.3|65.3|Standard Deviation|8.39|8.39|||
3879703|NCT01555125|3705754|B4||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3879704|NCT01555125|3705755|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3879705|NCT01555125|3705756|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3879706|NCT01555125|3705757|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3879707|NCT01555125|3705754|B4||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3879708|NCT01555125|3705755|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3879709|NCT01555125|3705756|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3879710|NCT01555125|3705757|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3879711|NCT01555125|3705754|B4|||Age||Years|Mean|45.9|45.9|Standard Deviation|13.91|13.91|||
3879712|NCT01555125|3705755|B3|||Age||Years|Mean|46.5|46.5|Standard Deviation|14.14|14.14|||
3879713|NCT01555125|3705756|B2|||Age||Years|Mean|45.1|45.1|Standard Deviation|12.57|12.57|||
3879714|NCT01555125|3705757|B1|||Age||Years|Mean|46|46.0|Standard Deviation|15.09|15.09|||
3879715|NCT01555073|3705850|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3879716|NCT01555073|3705851|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3879717|NCT01555073|3705852|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3879718|NCT01555073|3705853|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3879719|NCT01555073|3705854|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3879720|NCT01555073|3705850|B5||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3879721|NCT01555073|3705851|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3879722|NCT01555073|3705852|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3879723|NCT01555073|3705853|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3879724|NCT01555073|3705854|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3879725|NCT01555073|3705850|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3879726|NCT01555073|3705851|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3879727|NCT01555073|3705852|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3879728|NCT01555073|3705853|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3879729|NCT01555073|3705854|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3879730|NCT01555073|3705850|B5||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3879731|NCT01555073|3705851|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3879732|NCT01555073|3705852|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3879733|NCT01555073|3705853|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3879734|NCT01555073|3705854|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3879735|NCT01555073|3705850|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879736|NCT01555073|3705851|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879737|NCT01555073|3705852|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879738|NCT01555073|3705853|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879739|NCT01555073|3705854|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879740|NCT01555021|3705871|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3879741|NCT01555021|3705872|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3879742|NCT01555021|3705873|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3879743|NCT01555021|3705871|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3879744|NCT01555021|3705872|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3879745|NCT01555021|3705873|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3879746|NCT01555021|3705871|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3879747|NCT01555021|3705872|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3879748|NCT01555021|3705873|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3879749|NCT01555021|3705871|B3|||Age||years|Mean|51.25|51.25|Full Range|||25.0|62.0|
3879750|NCT01555021|3705872|B2|||Age||years|Mean|43.5|43.5|Full Range|||25.0|62.0|
3879751|NCT01555021|3705873|B1|||Age||years|Mean|59|59.0|Full Range|||57.0|61.0|
3879752|NCT01555021|3705871|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3879753|NCT01555021|3705872|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3879754|NCT01555021|3705873|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3879755|NCT01555021|3705871|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3879756|NCT01555021|3705872|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3879757|NCT01555021|3705873|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3879758|NCT01555021|3705871|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879759|NCT01555021|3705872|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879760|NCT01555021|3705873|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879761|NCT01554982|3705886|B1|United States||Region of Enrollment||participants|Number|164|164.0||||||
3879762|NCT01554982|3705886|B1|Puerto Rico||Region of Enrollment||participants|Number|2|2.0||||||
3879763|NCT01554982|3705886|B1||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3879764|NCT01554982|3705886|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3879765|NCT01554982|3705886|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|11.06|11.06|||
3879766|NCT01554982|3705886|B1||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
3879767|NCT01554982|3705886|B1||Between 18 and 65 years|Age||Participants|Count of Participants|135|135.0||||||
3879768|NCT01554982|3705886|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879769|NCT01554904|3705899|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3879770|NCT01554904|3705899|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3879771|NCT01554904|3705899|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3879772|NCT01554904|3705899|B1|||Age||years|Mean|50.1|50.1|Standard Deviation|15.4|15.4|||
3879773|NCT01554904|3705899|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3879774|NCT01554904|3705899|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3879775|NCT01554904|3705899|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879776|NCT01554891|3705904|B4|||Presence of TBI|"Cohort 1: the degree of agreement for SAFE-TBI outcome (no evidence of TBI vs. at least, weak evidence of TBI) across the two assessment time points (initial vs. 4 to 6 weeks), as well as the two rater types TRC vs. TBIC Cohort 2:the distribution of SAFE-TBI outcome (percent assigned to each evidence category of the SAFE-TBI) in a group of veterans who have screened positive on the VA TBI screen.~Cohort 3:Gold Standard comparison; the sensitivity and speciﬁcity of the SAFE-TBI to identify individuals with TBI"|participants|Number|261|261.0||||||
3879777|NCT01554891|3705905|B3|||Presence of TBI|"Cohort 1: the degree of agreement for SAFE-TBI outcome (no evidence of TBI vs. at least, weak evidence of TBI) across the two assessment time points (initial vs. 4 to 6 weeks), as well as the two rater types TRC vs. TBIC Cohort 2:the distribution of SAFE-TBI outcome (percent assigned to each evidence category of the SAFE-TBI) in a group of veterans who have screened positive on the VA TBI screen.~Cohort 3:Gold Standard comparison; the sensitivity and speciﬁcity of the SAFE-TBI to identify individuals with TBI"|participants|Number|55|55.0||||||
3879778|NCT01554891|3705906|B2|||Presence of TBI|"Cohort 1: the degree of agreement for SAFE-TBI outcome (no evidence of TBI vs. at least, weak evidence of TBI) across the two assessment time points (initial vs. 4 to 6 weeks), as well as the two rater types TRC vs. TBIC Cohort 2:the distribution of SAFE-TBI outcome (percent assigned to each evidence category of the SAFE-TBI) in a group of veterans who have screened positive on the VA TBI screen.~Cohort 3:Gold Standard comparison; the sensitivity and speciﬁcity of the SAFE-TBI to identify individuals with TBI"|participants|Number|115|115.0||||||
3879779|NCT01554891|3705907|B1|||Presence of TBI|"Cohort 1: the degree of agreement for SAFE-TBI outcome (no evidence of TBI vs. at least, weak evidence of TBI) across the two assessment time points (initial vs. 4 to 6 weeks), as well as the two rater types TRC vs. TBIC Cohort 2:the distribution of SAFE-TBI outcome (percent assigned to each evidence category of the SAFE-TBI) in a group of veterans who have screened positive on the VA TBI screen.~Cohort 3:Gold Standard comparison; the sensitivity and speciﬁcity of the SAFE-TBI to identify individuals with TBI"|participants|Number|91|91.0||||||
3879780|NCT01554891|3705904|B4||Male|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
3879781|NCT01554891|3705905|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3879782|NCT01554891|3705906|B2||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3879783|NCT01554891|3705907|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3879784|NCT01554891|3705904|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3879785|NCT01554891|3705905|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3879786|NCT01554891|3705906|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3879787|NCT01554891|3705907|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3879788|NCT01554891|3705904|B4|||Age||years|Mean|31.33|31.33|Standard Deviation|8.5|8.5|||
3879789|NCT01554891|3705905|B3|||Age||years|Mean|29.20|29.2|Standard Deviation|8.56|8.56|||
3879790|NCT01554891|3705906|B2|||Age||years|Mean|33.03|33.03|Standard Deviation|8.68|8.68|||
3879791|NCT01554891|3705907|B1|||Age||years|Mean|32.29|32.29|Standard Deviation|9.30|9.3|||
3879792|NCT01554579|3705917|B3|||Numeric Pain Rating Scale (NPRS)|Subjects were instructed to select a number between 0 and 10 where 0 is no pain and 10 is the worst possible pain. The scale was completed by telephone (an interactive voice response system [IVRS]) every evening before bedtime.|units on a scale|Mean|6.75|6.75|Full Range|||5.0|9.0|
3879793|NCT01554579|3705918|B2|||Numeric Pain Rating Scale (NPRS)|Subjects were instructed to select a number between 0 and 10 where 0 is no pain and 10 is the worst possible pain. The scale was completed by telephone (an interactive voice response system [IVRS]) every evening before bedtime.|units on a scale|Mean|6.8|6.8|Full Range|||5.0|9.0|
3879794|NCT01554579|3705919|B1|||Numeric Pain Rating Scale (NPRS)|Subjects were instructed to select a number between 0 and 10 where 0 is no pain and 10 is the worst possible pain. The scale was completed by telephone (an interactive voice response system [IVRS]) every evening before bedtime.|units on a scale|Mean|6.7|6.7|Full Range|||5.0|9.0|
3879795|NCT01554579|3705917|B3|United States||Region of Enrollment||participants|Number|171|171.0||||||
3879796|NCT01554579|3705918|B2|United States||Region of Enrollment||participants|Number|85|85.0||||||
3879797|NCT01554579|3705919|B1|United States||Region of Enrollment||participants|Number|86|86.0||||||
3879798|NCT01554579|3705917|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3879799|NCT01554579|3705918|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879800|NCT01554579|3705919|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3879801|NCT01554579|3705917|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879802|NCT01554579|3705918|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879803|NCT01554579|3705919|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879804|NCT01554579|3705917|B3||White|Race (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
3879805|NCT01554579|3705918|B2||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3879806|NCT01554579|3705919|B1||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3879807|NCT01554579|3705917|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3879808|NCT01554579|3705918|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3879809|NCT01554579|3705919|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3879810|NCT01554579|3705917|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879811|NCT01554579|3705918|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879812|NCT01554579|3705919|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879813|NCT01554579|3705917|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3879814|NCT01554579|3705918|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3879815|NCT01554579|3705919|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3879816|NCT01554579|3705917|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3879817|NCT01554579|3705918|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3879818|NCT01554579|3705919|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879819|NCT01554579|3705917|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3879820|NCT01554579|3705918|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3879821|NCT01554579|3705919|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3879822|NCT01554579|3705917|B3||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3879823|NCT01554579|3705918|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3879824|NCT01554579|3705919|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3879825|NCT01554579|3705917|B3||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
3879826|NCT01554579|3705918|B2||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3879827|NCT01554579|3705919|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3879828|NCT01554579|3705917|B3||Between 18 and 65 years|Age||Participants|Count of Participants|129|129.0||||||
3879829|NCT01554579|3705918|B2||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
3879830|NCT01554579|3705919|B1||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
3879831|NCT01554579|3705917|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879832|NCT01554579|3705918|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879833|NCT01554579|3705919|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879834|NCT01554241|3705930|B5|United States||Region of Enrollment||participants|Number|81|81.0||||||
3879835|NCT01554241|3705931|B4|United States||Region of Enrollment||participants|Number|14|14.0||||||
3879836|NCT01554241|3705932|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
3879837|NCT01554241|3705933|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3879838|NCT01554241|3705934|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
3879839|NCT01554241|3705930|B5||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3879840|NCT01554241|3705931|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3879841|NCT01554241|3705932|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3879842|NCT01554241|3705933|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3879843|NCT01554241|3705934|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3879844|NCT01554241|3705930|B5||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3879845|NCT01554241|3705931|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3879846|NCT01554241|3705932|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3879847|NCT01554241|3705933|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3879848|NCT01554241|3705934|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3879849|NCT01554241|3705930|B5|||Age||years|Mean|87.4|87.4|Standard Deviation|7.9|7.9|||
3879850|NCT01554241|3705931|B4|||Age||years|Mean|90.1|90.1|Standard Deviation|6.6|6.6|||
3879851|NCT01554241|3705932|B3|||Age||years|Mean|89.5|89.5|Standard Deviation|6.6|6.6|||
3879852|NCT01554241|3705933|B2|||Age||years|Mean|85.9|85.9|Standard Deviation|8.5|8.5|||
3879853|NCT01554241|3705934|B1|||Age||years|Mean|84.9|84.9|Standard Deviation|8.7|8.7|||
3879854|NCT01554241|3705930|B5||>=65 years|Age||Participants|Count of Participants|81|81.0||||||
3879855|NCT01554241|3705931|B4||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3879856|NCT01554241|3705932|B3||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3879857|NCT01554241|3705933|B2||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3879858|NCT01554241|3705934|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3879859|NCT01554241|3705930|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3879860|NCT01554241|3705931|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3879861|NCT01554241|3705932|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3879862|NCT01554241|3705933|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3879863|NCT01554241|3705934|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3879864|NCT01554241|3705930|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879865|NCT01554241|3705931|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879866|NCT01554241|3705932|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879867|NCT01554241|3705933|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879868|NCT01554241|3705934|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879869|NCT01554176|3705951|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3879870|NCT01554176|3705952|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3879871|NCT01554176|3705953|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3879872|NCT01554176|3705951|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3879873|NCT01554176|3705952|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3879874|NCT01554176|3705953|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3879875|NCT01554176|3705951|B3|||Age||Years|Mean|48.9|48.9|Standard Deviation|11.4|11.4|||
3879876|NCT01554176|3705952|B2|||Age||Years|Mean|50.0|50.0|Standard Deviation|10.3|10.3|||
3879877|NCT01554176|3705953|B1|||Age||Years|Mean|47.8|47.8|Standard Deviation|12.4|12.4|||
3879878|NCT01554163|3705982|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3879879|NCT01554163|3705983|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3879880|NCT01554163|3705984|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3879881|NCT01554163|3705982|B3||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
3879882|NCT01554163|3705983|B2||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3879883|NCT01554163|3705984|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3879884|NCT01554163|3705982|B3|81 to 90 years||Age, Customized||Participants|Number|6|6.0||||||
3879885|NCT01554163|3705983|B2|81 to 90 years||Age, Customized||Participants|Number|4|4.0||||||
3879886|NCT01554163|3705984|B1|81 to 90 years||Age, Customized||Participants|Number|2|2.0||||||
3879887|NCT01554163|3705982|B3|71 to 80 years||Age, Customized||Participants|Number|45|45.0||||||
3879888|NCT01554163|3705983|B2|71 to 80 years||Age, Customized||Participants|Number|18|18.0||||||
3879889|NCT01554163|3705984|B1|71 to 80 years||Age, Customized||Participants|Number|27|27.0||||||
3879890|NCT01554163|3705982|B3|61 to 70 years||Age, Customized||Participants|Number|93|93.0||||||
3879891|NCT01554163|3705983|B2|61 to 70 years||Age, Customized||Participants|Number|47|47.0||||||
3879892|NCT01554163|3705984|B1|61 to 70 years||Age, Customized||Participants|Number|46|46.0||||||
3879893|NCT01554163|3705982|B3|51 to 60 years||Age, Customized||Participants|Number|81|81.0||||||
3879894|NCT01554163|3705983|B2|51 to 60 years||Age, Customized||Participants|Number|40|40.0||||||
3879895|NCT01554163|3705984|B1|51 to 60 years||Age, Customized||Participants|Number|41|41.0||||||
3879896|NCT01554163|3705982|B3|40 to 50 years||Age, Customized||Participants|Number|14|14.0||||||
3879897|NCT01554163|3705983|B2|40 to 50 years||Age, Customized||Participants|Number|10|10.0||||||
3879898|NCT01554163|3705984|B1|40 to 50 years||Age, Customized||Participants|Number|4|4.0||||||
3879899|NCT01553916|3706003|B1|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3879900|NCT01553916|3706003|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3879901|NCT01553916|3706003|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3879902|NCT01553916|3706003|B1|||Age||years|Median|58|58.0|Full Range|||49.0|78.0|
3879903|NCT01553851|3706020|B1|||History of Smoking and/or Alcohol Abuse||participants|Number|18|18.0||||||
3879904|NCT01553851|3706020|B1|Stage IV||Clinical Stage|Cancer staging uses the TNM system where T=primary tumor, N stands for nodes (indicating cancer has spread to lymph nodes, and M for metastasis. Numbering associated with staging or letters denotes an increase in number, size, location or severity. Stage II (T2N0) Stage III (T2N1, T3N1) Stage IV(T2N2a,T2N2b,T3N2b,T4aN0,T4aN1,T4aN2b,T4aN2c)|participants|Number|14|14.0||||||
3879905|NCT01553851|3706020|B1|Stage III||Clinical Stage|Cancer staging uses the TNM system where T=primary tumor, N stands for nodes (indicating cancer has spread to lymph nodes, and M for metastasis. Numbering associated with staging or letters denotes an increase in number, size, location or severity. Stage II (T2N0) Stage III (T2N1, T3N1) Stage IV(T2N2a,T2N2b,T3N2b,T4aN0,T4aN1,T4aN2b,T4aN2c)|participants|Number|3|3.0||||||
3879906|NCT01553851|3706020|B1|Stage II||Clinical Stage|Cancer staging uses the TNM system where T=primary tumor, N stands for nodes (indicating cancer has spread to lymph nodes, and M for metastasis. Numbering associated with staging or letters denotes an increase in number, size, location or severity. Stage II (T2N0) Stage III (T2N1, T3N1) Stage IV(T2N2a,T2N2b,T3N2b,T4aN0,T4aN1,T4aN2b,T4aN2c)|participants|Number|3|3.0||||||
3879907|NCT01553851|3706020|B1|Buccal||Oral Cavity Sub-Site||participants|Number|1|1.0||||||
3879908|NCT01553851|3706020|B1|Retromolar trigone||Oral Cavity Sub-Site||participants|Number|5|5.0||||||
3879909|NCT01553851|3706020|B1|Floor of Mouth||Oral Cavity Sub-Site||participants|Number|7|7.0||||||
3879910|NCT01553851|3706020|B1|Tongue||Oral Cavity Sub-Site||participants|Number|7|7.0||||||
3879911|NCT01553851|3706020|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3879912|NCT01553851|3706020|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3879913|NCT01553851|3706020|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879914|NCT01553851|3706020|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3879915|NCT01553851|3706020|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3879916|NCT01553851|3706020|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879917|NCT01553851|3706020|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879918|NCT01553851|3706020|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3879919|NCT01553851|3706020|B1||Male|Gender||Participants|Count of Participants|19|19.0||||||
3879920|NCT01553851|3706020|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
3879921|NCT01553851|3706020|B1|Median Age (years)||Age, Customized||years|Median|59.5|59.5|Full Range|||30.0|78.0|
3879922|NCT01553747|3706032|B4||Male|Sex: Female, Male||Participants|Count of Participants|378|378.0||||||
3879923|NCT01553747|3706033|B3||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3879924|NCT01553747|3706034|B2||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3879925|NCT01553747|3706035|B1||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3879926|NCT01553747|3706032|B4||Female|Sex: Female, Male||Participants|Count of Participants|768|768.0||||||
3879927|NCT01553747|3706033|B3||Female|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
3879928|NCT01553747|3706034|B2||Female|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
3879929|NCT01553747|3706035|B1||Female|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
3879930|NCT01553747|3706032|B4|≥65 years||Age, Customized||Participants|Count of Participants|126|126.0||||||
3879931|NCT01553747|3706033|B3|≥65 years||Age, Customized||Participants|Count of Participants|51|51.0||||||
3879932|NCT01553747|3706034|B2|≥65 years||Age, Customized||Participants|Count of Participants|39|39.0||||||
3879933|NCT01553747|3706035|B1|≥65 years||Age, Customized||Participants|Count of Participants|36|36.0||||||
3879934|NCT01553747|3706032|B4|41-64 years||Age, Customized||Participants|Count of Participants|602|602.0||||||
3879935|NCT01553747|3706033|B3|41-64 years||Age, Customized||Participants|Count of Participants|198|198.0||||||
3879936|NCT01553747|3706034|B2|41-64 years||Age, Customized||Participants|Count of Participants|198|198.0||||||
3879937|NCT01553747|3706035|B1|41-64 years||Age, Customized||Participants|Count of Participants|206|206.0||||||
3879938|NCT01553747|3706032|B4|18-40 years||Age, Customized||Participants|Count of Participants|418|418.0||||||
3879939|NCT01553747|3706033|B3|18-40 years||Age, Customized||Participants|Count of Participants|133|133.0||||||
3879940|NCT01553747|3706034|B2|18-40 years||Age, Customized||Participants|Count of Participants|146|146.0||||||
3879941|NCT01553747|3706035|B1|18-40 years||Age, Customized||Participants|Count of Participants|139|139.0||||||
3879942|NCT01553747|3706032|B4|||Age||years|Mean|45.9|45.9|Standard Deviation|13.45|13.45|||
3879943|NCT01553747|3706033|B3|||Age||years|Mean|47.1|47.1|Standard Deviation|13.82|13.82|||
3879944|NCT01553747|3706034|B2|||Age||years|Mean|45.7|45.7|Standard Deviation|13.31|13.31|||
3879945|NCT01553747|3706035|B1|||Age||years|Mean|45.0|45.0|Standard Deviation|13.17|13.17|||
3879946|NCT01553708|3706087|B3|Thailand||Region of Enrollment||participants|Number|34|34.0||||||
3879947|NCT01553708|3706088|B2|Thailand||Region of Enrollment||participants|Number|17|17.0||||||
3879948|NCT01553708|3706089|B1|Thailand||Region of Enrollment||participants|Number|17|17.0||||||
3879949|NCT01553708|3706087|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3879950|NCT01553708|3706088|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3879951|NCT01553708|3706089|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3879952|NCT01553708|3706087|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3879953|NCT01553708|3706088|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3879954|NCT01553708|3706089|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3879955|NCT01553708|3706087|B3|||Age||years|Mean|37.41|37.41|Standard Deviation|12.41|12.41|||
3879956|NCT01553708|3706088|B2|||Age||years|Mean|37.71|37.71|Standard Deviation|7.91|7.91|||
3879957|NCT01553708|3706089|B1|||Age||years|Mean|37.12|37.12|Standard Deviation|13.72|13.72|||
3879958|NCT01553708|3706087|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3879959|NCT01553708|3706088|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3879960|NCT01553708|3706089|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3879961|NCT01553708|3706087|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3879962|NCT01553708|3706088|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3879963|NCT01553708|3706089|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3879964|NCT01553708|3706087|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879965|NCT01553708|3706088|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879966|NCT01553708|3706089|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3879967|NCT01553591|3706096|B4|||Body Mass Index (BMI)||kg/m^2|Mean|30.85|30.85|Standard Deviation|7.513|7.513|||
3879968|NCT01553591|3706097|B3|||Body Mass Index (BMI)||kg/m^2|Mean|30.63|30.63|Standard Deviation|7.253|7.253|||
3879969|NCT01553591|3706098|B2|||Body Mass Index (BMI)||kg/m^2|Mean|31.22|31.22|Standard Deviation|7.858|7.858|||
3879970|NCT01553591|3706099|B1|||Body Mass Index (BMI)||kg/m^2|Mean|30.70|30.7|Standard Deviation|7.421|7.421|||
3879971|NCT01553591|3706096|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|921|921.0||||||
3879972|NCT01553591|3706097|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|302|302.0||||||
3879973|NCT01553591|3706098|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|309|309.0||||||
3879974|NCT01553591|3706099|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|310|310.0||||||
3879975|NCT01553591|3706096|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|361|361.0||||||
3879976|NCT01553591|3706097|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|125|125.0||||||
3879977|NCT01553591|3706098|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|117|117.0||||||
3879978|NCT01553591|3706099|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|119|119.0||||||
3879979|NCT01553591|3706096|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3879980|NCT01553591|3706097|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3879981|NCT01553591|3706098|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3879982|NCT01553591|3706099|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3879983|NCT01553591|3706096|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3879984|NCT01553591|3706097|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3879985|NCT01553591|3706098|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3879986|NCT01553591|3706099|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3879987|NCT01553591|3706096|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3879988|NCT01553591|3706097|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3879989|NCT01553591|3706098|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3879990|NCT01553591|3706099|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3879991|NCT01553591|3706096|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3879992|NCT01553591|3706097|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3879993|NCT01553591|3706098|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3879994|NCT01553591|3706099|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3879995|NCT01553591|3706096|B4|Black||Race/Ethnicity, Customized||Participants|Count of Participants|140|140.0||||||
3879996|NCT01553591|3706097|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
3879997|NCT01553591|3706098|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
3879998|NCT01553591|3706099|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
3879999|NCT01553591|3706096|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|1112|1112.0||||||
3880000|NCT01553591|3706097|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|370|370.0||||||
3880001|NCT01553591|3706098|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|368|368.0||||||
3880002|NCT01553591|3706099|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|374|374.0||||||
3880003|NCT01553591|3706096|B4||Male|Sex: Female, Male||Participants|Count of Participants|444|444.0||||||
3880004|NCT01553591|3706097|B3||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3880005|NCT01553591|3706098|B2||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3880006|NCT01553591|3706099|B1||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3880007|NCT01553591|3706096|B4||Female|Sex: Female, Male||Participants|Count of Participants|838|838.0||||||
3880008|NCT01553591|3706097|B3||Female|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
3880009|NCT01553591|3706098|B2||Female|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
3880010|NCT01553591|3706099|B1||Female|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
3880011|NCT01553591|3706096|B4|≥65 years||Age, Customized||Participants|Count of Participants|115|115.0||||||
3880012|NCT01553591|3706097|B3|≥65 years||Age, Customized||Participants|Count of Participants|51|51.0||||||
3880013|NCT01553591|3706098|B2|≥65 years||Age, Customized||Participants|Count of Participants|35|35.0||||||
3880014|NCT01553591|3706099|B1|≥65 years||Age, Customized||Participants|Count of Participants|29|29.0||||||
3880015|NCT01553591|3706096|B4|41-64 years||Age, Customized||Participants|Count of Participants|669|669.0||||||
3880016|NCT01553591|3706097|B3|41-64 years||Age, Customized||Participants|Count of Participants|217|217.0||||||
3880017|NCT01553591|3706098|B2|41-64 years||Age, Customized||Participants|Count of Participants|225|225.0||||||
3880018|NCT01553591|3706099|B1|41-64 years||Age, Customized||Participants|Count of Participants|227|227.0||||||
3880019|NCT01553591|3706096|B4|18-40 years||Age, Customized||Participants|Count of Participants|498|498.0||||||
3880020|NCT01553591|3706097|B3|18-40 years||Age, Customized||Participants|Count of Participants|159|159.0||||||
3880021|NCT01553591|3706098|B2|18-40 years||Age, Customized||Participants|Count of Participants|166|166.0||||||
3880022|NCT01553591|3706099|B1|18-40 years||Age, Customized||Participants|Count of Participants|173|173.0||||||
3880023|NCT01553591|3706096|B4|||Age||years|Mean|44.9|44.9|Standard Deviation|13.74|13.74|||
3880024|NCT01553591|3706097|B3|||Age||years|Mean|45.8|45.8|Standard Deviation|14.10|14.1|||
3880025|NCT01553591|3706098|B2|||Age||years|Mean|44.4|44.4|Standard Deviation|13.91|13.91|||
3880026|NCT01553591|3706099|B1|||Age||years|Mean|44.5|44.5|Standard Deviation|13.18|13.18|||
3880027|NCT01553539|3706151|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3880028|NCT01553539|3706151|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3880029|NCT01553539|3706151|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3880030|NCT01553539|3706151|B1|||Age||years|Mean|51.4|51.4|Standard Deviation|14.9|14.9|||
3880031|NCT01553539|3706151|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3880032|NCT01553539|3706151|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3880033|NCT01553539|3706151|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3880034|NCT01553318|3706159|B3|||Evoked pain|Range from 0 to 20, with higher score representing greater sensitivity to pressure pain stimuli|units on a scale|Mean|10.0|10.0|Standard Deviation|0.6|0.6|||
3880035|NCT01553318|3706160|B2|||Evoked pain|Range from 0 to 20, with higher score representing greater sensitivity to pressure pain stimuli|units on a scale|Mean|9.8|9.8|Standard Deviation|0.4|0.4|||
3880036|NCT01553318|3706161|B1|||Evoked pain|Range from 0 to 20, with higher score representing greater sensitivity to pressure pain stimuli|units on a scale|Mean|10.3|10.3|Standard Deviation|0.4|0.4|||
3880037|NCT01553318|3706159|B3|||Fibromyalgia impact questionnaire|Score range from 0 to 100 with higher scores indicating worse health status|units on a scale|Mean|66.8|66.8|Standard Deviation|14.0|14.0|||
3880038|NCT01553318|3706160|B2|||Fibromyalgia impact questionnaire|Score range from 0 to 100 with higher scores indicating worse health status|units on a scale|Mean|66.6|66.6|Standard Deviation|12.0|12.0|||
3880039|NCT01553318|3706161|B1|||Fibromyalgia impact questionnaire|Score range from 0 to 100 with higher scores indicating worse health status|units on a scale|Mean|66.9|66.9|Standard Deviation|16.2|16.2|||
3880040|NCT01553318|3706159|B3|||weekly average pain score|Average of daily pain scores within a one week period (scale from 0 to 10, with 10 being the worse pain possible)|units on a scale|Mean|6.4|6.4|Standard Deviation|1.1|1.1|||
3880041|NCT01553318|3706160|B2|||weekly average pain score|Average of daily pain scores within a one week period (scale from 0 to 10, with 10 being the worse pain possible)|units on a scale|Mean|6.2|6.2|Standard Deviation|1.3|1.3|||
3880042|NCT01553318|3706161|B1|||weekly average pain score|Average of daily pain scores within a one week period (scale from 0 to 10, with 10 being the worse pain possible)|units on a scale|Mean|6.5|6.5|Standard Deviation|0.9|0.9|||
3880043|NCT01553318|3706159|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
3880044|NCT01553318|3706160|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
3880045|NCT01553318|3706161|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3880046|NCT01553318|3706159|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3880047|NCT01553318|3706160|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3880048|NCT01553318|3706161|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3880049|NCT01553318|3706159|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3880050|NCT01553318|3706160|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3880051|NCT01553318|3706161|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3880052|NCT01553318|3706159|B3|||Age||years|Mean|51.2|51.2|Standard Deviation|8.4|8.4|||
3880053|NCT01553318|3706160|B2|||Age||years|Mean|51.3|51.3|Standard Deviation|8.5|8.5|||
3880054|NCT01553318|3706161|B1|||Age||years|Mean|51.1|51.1|Standard Deviation|8.5|8.5|||
3880055|NCT01553292|3706174|B1|Canada||Region of Enrollment||participants|Number|21|21.0||||||
3880056|NCT01553292|3706174|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3880057|NCT01553292|3706174|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3880058|NCT01553292|3706174|B1|||Age||Weeks|Mean|29|29.0|Standard Deviation|3|3.0|||
3880059|NCT01553292|3706174|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3880060|NCT01553292|3706174|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3880061|NCT01553292|3706174|B1||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
3880062|NCT01553188|3706195|B5|<4.0 mg/mL||OnStudy Prostatic Specific Antigen (PSA)|Prostatic Specific Antigen (PSA) reference range is 4.0 ng/mL|Participants|Count of Participants|2|2.0||||||
3880063|NCT01553188|3706196|B4|<4.0 mg/mL||OnStudy Prostatic Specific Antigen (PSA)|Prostatic Specific Antigen (PSA) reference range is 4.0 ng/mL|Participants|Count of Participants|2|2.0||||||
3880064|NCT01553188|3706197|B3|<4.0 mg/mL||OnStudy Prostatic Specific Antigen (PSA)|Prostatic Specific Antigen (PSA) reference range is 4.0 ng/mL|Participants|Count of Participants|0|0.0||||||
3880065|NCT01553188|3706198|B2|<4.0 mg/mL||OnStudy Prostatic Specific Antigen (PSA)|Prostatic Specific Antigen (PSA) reference range is 4.0 ng/mL|Participants|Count of Participants|0|0.0||||||
3880066|NCT01553188|3706199|B1|<4.0 mg/mL||OnStudy Prostatic Specific Antigen (PSA)|Prostatic Specific Antigen (PSA) reference range is 4.0 ng/mL|Participants|Count of Participants|0|0.0||||||
3880067|NCT01553188|3706195|B5|>4.0 mg/mL||OnStudy Prostatic Specific Antigen (PSA)|Prostatic Specific Antigen (PSA) reference range is 4.0 ng/mL|Participants|Count of Participants|9|9.0||||||
3880068|NCT01553188|3706196|B4|>4.0 mg/mL||OnStudy Prostatic Specific Antigen (PSA)|Prostatic Specific Antigen (PSA) reference range is 4.0 ng/mL|Participants|Count of Participants|0|0.0||||||
3880069|NCT01553188|3706197|B3|>4.0 mg/mL||OnStudy Prostatic Specific Antigen (PSA)|Prostatic Specific Antigen (PSA) reference range is 4.0 ng/mL|Participants|Count of Participants|0|0.0||||||
3880070|NCT01553188|3706198|B2|>4.0 mg/mL||OnStudy Prostatic Specific Antigen (PSA)|Prostatic Specific Antigen (PSA) reference range is 4.0 ng/mL|Participants|Count of Participants|6|6.0||||||
3880071|NCT01553188|3706199|B1|>4.0 mg/mL||OnStudy Prostatic Specific Antigen (PSA)|Prostatic Specific Antigen (PSA) reference range is 4.0 ng/mL|Participants|Count of Participants|3|3.0||||||
3880072|NCT01553188|3706195|B5|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3880073|NCT01553188|3706196|B4|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3880074|NCT01553188|3706197|B3|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3880075|NCT01553188|3706198|B2|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3880076|NCT01553188|3706199|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3880077|NCT01553188|3706195|B5|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3880078|NCT01553188|3706196|B4|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3880079|NCT01553188|3706197|B3|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3880080|NCT01553188|3706198|B2|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3880081|NCT01553188|3706199|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3880082|NCT01553188|3706195|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3880083|NCT01553188|3706196|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3880084|NCT01553188|3706197|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3880085|NCT01553188|3706198|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3880086|NCT01553188|3706199|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3880087|NCT01553188|3706195|B5|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3880088|NCT01553188|3706196|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3880089|NCT01553188|3706197|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3880090|NCT01553188|3706198|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3880091|NCT01553188|3706199|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3880092|NCT01553188|3706195|B5|Mexican, Puerto Rican, Cuban, Central or So Amer.||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3880093|NCT01553188|3706196|B4|Mexican, Puerto Rican, Cuban, Central or So Amer.||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3880094|NCT01553188|3706197|B3|Mexican, Puerto Rican, Cuban, Central or So Amer.||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3880095|NCT01553188|3706198|B2|Mexican, Puerto Rican, Cuban, Central or So Amer.||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3880096|NCT01553188|3706199|B1|Mexican, Puerto Rican, Cuban, Central or So Amer.||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3880097|NCT01553188|3706195|B5|Not meeting definition for Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
3880098|NCT01553188|3706196|B4|Not meeting definition for Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3880099|NCT01553188|3706197|B3|Not meeting definition for Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3880100|NCT01553188|3706198|B2|Not meeting definition for Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3880101|NCT01553188|3706199|B1|Not meeting definition for Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3880102|NCT01553188|3706195|B5||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3880103|NCT01553188|3706196|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3880104|NCT01553188|3706197|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3880105|NCT01553188|3706198|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3880106|NCT01553188|3706199|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3880107|NCT01553188|3706195|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3880108|NCT01553188|3706196|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3880109|NCT01553188|3706197|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3880110|NCT01553188|3706198|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3880111|NCT01553188|3706199|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3880112|NCT01553188|3706195|B5|||Age||years|Mean|69.13|69.13|Standard Deviation|9.56|9.56|||
3880113|NCT01553188|3706196|B4|||Age||years|Mean|66.05|66.05|Standard Deviation|9.87|9.87|||
3880114|NCT01553188|3706197|B3|||Age||years|Mean|74.85|74.85|Standard Deviation|7.44|7.44|||
3880115|NCT01553188|3706198|B2|||Age||years|Mean|62.9|62.9|Standard Deviation|8.7|8.7|||
3880116|NCT01553188|3706199|B1|||Age||years|Mean|62.4|62.4|Standard Deviation|1.8|1.8|||
3880117|NCT01553188|3706195|B5||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3880118|NCT01553188|3706196|B4||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3880119|NCT01553188|3706197|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3880120|NCT01553188|3706198|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3880121|NCT01553188|3706199|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3880122|NCT01553188|3706195|B5||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3880123|NCT01553188|3706196|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3880124|NCT01553188|3706197|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3880125|NCT01553188|3706198|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3880126|NCT01553188|3706199|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3880127|NCT01553188|3706195|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3880128|NCT01553188|3706196|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3880129|NCT01553188|3706197|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3880130|NCT01553188|3706198|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3880131|NCT01553188|3706199|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3880132|NCT01553136|3706227|B3||Unknown or Not Reported|Race (NIH/OMB)|"Multiple races (Other) are reported in the 'More than 1 Race' row."|Participants|Count of Participants|0|0.0||||||
3880133|NCT01553136|3706228|B2||Unknown or Not Reported|Race (NIH/OMB)|"Multiple races (Other) are reported in the 'More than 1 Race' row."|Participants|Count of Participants|0|0.0||||||
3880134|NCT01553136|3706229|B1||Unknown or Not Reported|Race (NIH/OMB)|"Multiple races (Other) are reported in the 'More than 1 Race' row."|Participants|Count of Participants|0|0.0||||||
3880135|NCT01553136|3706227|B3||More than one race|Race (NIH/OMB)|"Multiple races (Other) are reported in the 'More than 1 Race' row."|Participants|Count of Participants|12|12.0||||||
3880136|NCT01553136|3706228|B2||More than one race|Race (NIH/OMB)|"Multiple races (Other) are reported in the 'More than 1 Race' row."|Participants|Count of Participants|4|4.0||||||
3880137|NCT01553136|3706229|B1||More than one race|Race (NIH/OMB)|"Multiple races (Other) are reported in the 'More than 1 Race' row."|Participants|Count of Participants|8|8.0||||||
3880138|NCT01553136|3706227|B3||White|Race (NIH/OMB)|"Multiple races (Other) are reported in the 'More than 1 Race' row."|Participants|Count of Participants|50|50.0||||||
3880139|NCT01553136|3706228|B2||White|Race (NIH/OMB)|"Multiple races (Other) are reported in the 'More than 1 Race' row."|Participants|Count of Participants|26|26.0||||||
3880140|NCT01553136|3706229|B1||White|Race (NIH/OMB)|"Multiple races (Other) are reported in the 'More than 1 Race' row."|Participants|Count of Participants|24|24.0||||||
3880141|NCT01553136|3706227|B3||Black or African American|Race (NIH/OMB)|"Multiple races (Other) are reported in the 'More than 1 Race' row."|Participants|Count of Participants|69|69.0||||||
3880142|NCT01553136|3706228|B2||Black or African American|Race (NIH/OMB)|"Multiple races (Other) are reported in the 'More than 1 Race' row."|Participants|Count of Participants|34|34.0||||||
3880143|NCT01553136|3706229|B1||Black or African American|Race (NIH/OMB)|"Multiple races (Other) are reported in the 'More than 1 Race' row."|Participants|Count of Participants|35|35.0||||||
3880144|NCT01553136|3706227|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|"Multiple races (Other) are reported in the 'More than 1 Race' row."|Participants|Count of Participants|0|0.0||||||
3880145|NCT01553136|3706228|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|"Multiple races (Other) are reported in the 'More than 1 Race' row."|Participants|Count of Participants|0|0.0||||||
3880146|NCT01553136|3706229|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|"Multiple races (Other) are reported in the 'More than 1 Race' row."|Participants|Count of Participants|0|0.0||||||
3880147|NCT01553136|3706227|B3||Asian|Race (NIH/OMB)|"Multiple races (Other) are reported in the 'More than 1 Race' row."|Participants|Count of Participants|0|0.0||||||
3880148|NCT01553136|3706228|B2||Asian|Race (NIH/OMB)|"Multiple races (Other) are reported in the 'More than 1 Race' row."|Participants|Count of Participants|0|0.0||||||
3880149|NCT01553136|3706229|B1||Asian|Race (NIH/OMB)|"Multiple races (Other) are reported in the 'More than 1 Race' row."|Participants|Count of Participants|0|0.0||||||
3880150|NCT01553136|3706227|B3||American Indian or Alaska Native|Race (NIH/OMB)|"Multiple races (Other) are reported in the 'More than 1 Race' row."|Participants|Count of Participants|0|0.0||||||
3880151|NCT01553136|3706228|B2||American Indian or Alaska Native|Race (NIH/OMB)|"Multiple races (Other) are reported in the 'More than 1 Race' row."|Participants|Count of Participants|0|0.0||||||
3880152|NCT01553136|3706229|B1||American Indian or Alaska Native|Race (NIH/OMB)|"Multiple races (Other) are reported in the 'More than 1 Race' row."|Participants|Count of Participants|0|0.0||||||
3880153|NCT01553136|3706227|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880154|NCT01553136|3706228|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880155|NCT01553136|3706229|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880156|NCT01553136|3706227|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|116|116.0||||||
3880157|NCT01553136|3706228|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3880158|NCT01553136|3706229|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3880159|NCT01553136|3706227|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3880160|NCT01553136|3706228|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3880161|NCT01553136|3706229|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3880162|NCT01553136|3706227|B3||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3880163|NCT01553136|3706228|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3880164|NCT01553136|3706229|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3880165|NCT01553136|3706227|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3880166|NCT01553136|3706228|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3880167|NCT01553136|3706229|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3880168|NCT01553136|3706227|B3|||Age||years|Mean|42.7|42.7|Standard Deviation|11.7|11.7|||
3880169|NCT01553136|3706228|B2|||Age||years|Mean|43.6|43.6|Standard Deviation|11.7|11.7|||
3880170|NCT01553136|3706229|B1|||Age||years|Mean|41.8|41.8|Standard Deviation|11.7|11.7|||
3880171|NCT01553058|3706244|B4|||H/O Biologics||Participants|Count of Participants|29|29.0||||||
3880172|NCT01553058|3706245|B3|||H/O Biologics||Participants|Count of Participants|8|8.0||||||
3880173|NCT01553058|3706246|B2|||H/O Biologics||Participants|Count of Participants|11|11.0||||||
3880174|NCT01553058|3706247|B1|||H/O Biologics||Participants|Count of Participants|10|10.0||||||
3880175|NCT01553058|3706244|B4|||H/O Oral Systemics||Participants|Count of Participants|31|31.0||||||
3880176|NCT01553058|3706245|B3|||H/O Oral Systemics||Participants|Count of Participants|11|11.0||||||
3880177|NCT01553058|3706246|B2|||H/O Oral Systemics||Participants|Count of Participants|10|10.0||||||
3880178|NCT01553058|3706247|B1|||H/O Oral Systemics||Participants|Count of Participants|10|10.0||||||
3880179|NCT01553058|3706244|B4|||History of Phototherapy||Participants|Count of Participants|29|29.0||||||
3880180|NCT01553058|3706245|B3|||History of Phototherapy||Participants|Count of Participants|13|13.0||||||
3880181|NCT01553058|3706246|B2|||History of Phototherapy||Participants|Count of Participants|11|11.0||||||
3880182|NCT01553058|3706247|B1|||History of Phototherapy||Participants|Count of Participants|5|5.0||||||
3880183|NCT01553058|3706244|B4|||DLQI (Dermatology Quality of Life Index)|The DLQI is calculated by summing the score of 10 questions regarding impact of skin condition on daily life resulting in a maximum of 30 and a minimum of 0. The higher the score, the more quality of life is impaired.|units on a scale|Mean|14.68|14.68|Standard Deviation|6.58|6.58|||
3880184|NCT01553058|3706245|B3|||DLQI (Dermatology Quality of Life Index)|The DLQI is calculated by summing the score of 10 questions regarding impact of skin condition on daily life resulting in a maximum of 30 and a minimum of 0. The higher the score, the more quality of life is impaired.|units on a scale|Mean|14.61|14.61|Standard Deviation|6.52|6.52|||
3880185|NCT01553058|3706246|B2|||DLQI (Dermatology Quality of Life Index)|The DLQI is calculated by summing the score of 10 questions regarding impact of skin condition on daily life resulting in a maximum of 30 and a minimum of 0. The higher the score, the more quality of life is impaired.|units on a scale|Mean|13.48|13.48|Standard Deviation|7.58|7.58|||
3880186|NCT01553058|3706247|B1|||DLQI (Dermatology Quality of Life Index)|The DLQI is calculated by summing the score of 10 questions regarding impact of skin condition on daily life resulting in a maximum of 30 and a minimum of 0. The higher the score, the more quality of life is impaired.|units on a scale|Mean|15.88|15.88|Standard Deviation|5.53|5.53|||
3880187|NCT01553058|3706244|B4|||PGA (Physician's Global Assessment)|The PGA is an average assessment of all psoriatic lesions based on erythema, scale, and induration with score ranging from 0 (no evidence of disease) to 5 (maximal disease).|units on a scale|Mean|3.28|3.28|Standard Deviation|.6|0.6|||
3880188|NCT01553058|3706245|B3|||PGA (Physician's Global Assessment)|The PGA is an average assessment of all psoriatic lesions based on erythema, scale, and induration with score ranging from 0 (no evidence of disease) to 5 (maximal disease).|units on a scale|Mean|3.27|3.27|Standard Deviation|.66|0.66|||
3880189|NCT01553058|3706246|B2|||PGA (Physician's Global Assessment)|The PGA is an average assessment of all psoriatic lesions based on erythema, scale, and induration with score ranging from 0 (no evidence of disease) to 5 (maximal disease).|units on a scale|Mean|3.22|3.22|Standard Deviation|.59|0.59|||
3880190|NCT01553058|3706247|B1|||PGA (Physician's Global Assessment)|The PGA is an average assessment of all psoriatic lesions based on erythema, scale, and induration with score ranging from 0 (no evidence of disease) to 5 (maximal disease).|units on a scale|Mean|3.36|3.36|Standard Deviation|.56|0.56|||
3880191|NCT01553058|3706244|B4|||PASI (Psoriasis Area and Severity Index)|PASI combines the assessment of the severity of lesions and the area affected into a single score in the range 0 (no disease) to 72 (maximal disease).|units on a scale|Mean|18.85|18.85|Standard Deviation|7.08|7.08|||
3880192|NCT01553058|3706245|B3|||PASI (Psoriasis Area and Severity Index)|PASI combines the assessment of the severity of lesions and the area affected into a single score in the range 0 (no disease) to 72 (maximal disease).|units on a scale|Mean|19.32|19.32|Standard Deviation|8|8.0|||
3880193|NCT01553058|3706246|B2|||PASI (Psoriasis Area and Severity Index)|PASI combines the assessment of the severity of lesions and the area affected into a single score in the range 0 (no disease) to 72 (maximal disease).|units on a scale|Mean|18.33|18.33|Standard Deviation|7.64|7.64|||
3880194|NCT01553058|3706247|B1|||PASI (Psoriasis Area and Severity Index)|PASI combines the assessment of the severity of lesions and the area affected into a single score in the range 0 (no disease) to 72 (maximal disease).|units on a scale|Mean|18.89|18.89|Standard Deviation|5.59|5.59|||
3880195|NCT01553058|3706244|B4|||Body Surface Area|"Body Surface Area (BSA) is defined by how much (percentage) of the total body surface area is affected:~Mild psoriasis: <5% of BSA Moderate psoriasis: 5-10% of BSA Severe psoriasis: >10% of BSA (Note: 1% of BSA is approximately equal to the palm of the patient’s hand, excluding fingers)"|percentage|Mean|23.98|23.98|Standard Deviation|14.19|14.19|||
3880196|NCT01553058|3706245|B3|||Body Surface Area|"Body Surface Area (BSA) is defined by how much (percentage) of the total body surface area is affected:~Mild psoriasis: <5% of BSA Moderate psoriasis: 5-10% of BSA Severe psoriasis: >10% of BSA (Note: 1% of BSA is approximately equal to the palm of the patient’s hand, excluding fingers)"|percentage|Mean|22.96|22.96|Standard Deviation|13.37|13.37|||
3880197|NCT01553058|3706246|B2|||Body Surface Area|"Body Surface Area (BSA) is defined by how much (percentage) of the total body surface area is affected:~Mild psoriasis: <5% of BSA Moderate psoriasis: 5-10% of BSA Severe psoriasis: >10% of BSA (Note: 1% of BSA is approximately equal to the palm of the patient’s hand, excluding fingers)"|percentage|Mean|25.70|25.7|Standard Deviation|15.02|15.02|||
3880198|NCT01553058|3706247|B1|||Body Surface Area|"Body Surface Area (BSA) is defined by how much (percentage) of the total body surface area is affected:~Mild psoriasis: <5% of BSA Moderate psoriasis: 5-10% of BSA Severe psoriasis: >10% of BSA (Note: 1% of BSA is approximately equal to the palm of the patient’s hand, excluding fingers)"|percentage|Mean|23.39|23.39|Standard Deviation|14.48|14.48|||
3880199|NCT01553058|3706244|B4|||10year Framingham Risk %|Absolute risk of developing a first cardiovascular disease (CVD) event (coronary death, myocardial infarction, coronary insufficiency, angina, ischemic stroke, hemorrhagic stroke, transient ischemic attack, peripheral artery disease, heart failure) within 10 years. The units are in 10-year risk percentage.|percentage|Mean|7.53|7.53|Standard Deviation|8.09|8.09|||
3880200|NCT01553058|3706245|B3|||10year Framingham Risk %|Absolute risk of developing a first cardiovascular disease (CVD) event (coronary death, myocardial infarction, coronary insufficiency, angina, ischemic stroke, hemorrhagic stroke, transient ischemic attack, peripheral artery disease, heart failure) within 10 years. The units are in 10-year risk percentage.|percentage|Mean|6.12|6.12|Standard Deviation|7.68|7.68|||
3880201|NCT01553058|3706246|B2|||10year Framingham Risk %|Absolute risk of developing a first cardiovascular disease (CVD) event (coronary death, myocardial infarction, coronary insufficiency, angina, ischemic stroke, hemorrhagic stroke, transient ischemic attack, peripheral artery disease, heart failure) within 10 years. The units are in 10-year risk percentage.|percentage|Mean|7.91|7.91|Standard Deviation|8.83|8.83|||
3880259|NCT01553058|3706244|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3880260|NCT01553058|3706245|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880202|NCT01553058|3706247|B1|||10year Framingham Risk %|Absolute risk of developing a first cardiovascular disease (CVD) event (coronary death, myocardial infarction, coronary insufficiency, angina, ischemic stroke, hemorrhagic stroke, transient ischemic attack, peripheral artery disease, heart failure) within 10 years. The units are in 10-year risk percentage.|percentage|Mean|8.43|8.43|Standard Deviation|7.75|7.75|||
3880203|NCT01553058|3706244|B4|||Statin Use||Participants|Count of Participants|8|8.0||||||
3880204|NCT01553058|3706245|B3|||Statin Use||Participants|Count of Participants|3|3.0||||||
3880205|NCT01553058|3706246|B2|||Statin Use||Participants|Count of Participants|4|4.0||||||
3880206|NCT01553058|3706247|B1|||Statin Use||Participants|Count of Participants|1|1.0||||||
3880207|NCT01553058|3706244|B4|||Hyperlipidemia||Participants|Count of Participants|14|14.0||||||
3880208|NCT01553058|3706245|B3|||Hyperlipidemia||Participants|Count of Participants|4|4.0||||||
3880209|NCT01553058|3706246|B2|||Hyperlipidemia||Participants|Count of Participants|5|5.0||||||
3880210|NCT01553058|3706247|B1|||Hyperlipidemia||Participants|Count of Participants|5|5.0||||||
3880211|NCT01553058|3706244|B4|||Hypertension||Participants|Count of Participants|18|18.0||||||
3880212|NCT01553058|3706245|B3|||Hypertension||Participants|Count of Participants|5|5.0||||||
3880213|NCT01553058|3706246|B2|||Hypertension||Participants|Count of Participants|7|7.0||||||
3880214|NCT01553058|3706247|B1|||Hypertension||Participants|Count of Participants|6|6.0||||||
3880215|NCT01553058|3706244|B4|||Diabetes||Participants|Count of Participants|4|4.0||||||
3880216|NCT01553058|3706245|B3|||Diabetes||Participants|Count of Participants|0|0.0||||||
3880217|NCT01553058|3706246|B2|||Diabetes||Participants|Count of Participants|1|1.0||||||
3880218|NCT01553058|3706247|B1|||Diabetes||Participants|Count of Participants|3|3.0||||||
3880219|NCT01553058|3706244|B4|||History of Cardiovascular Disease||Participants|Count of Participants|7|7.0||||||
3880220|NCT01553058|3706245|B3|||History of Cardiovascular Disease||Participants|Count of Participants|2|2.0||||||
3880221|NCT01553058|3706246|B2|||History of Cardiovascular Disease||Participants|Count of Participants|3|3.0||||||
3880222|NCT01553058|3706247|B1|||History of Cardiovascular Disease||Participants|Count of Participants|2|2.0||||||
3880223|NCT01553058|3706244|B4|||Body Mass Index||kg/m^2|Mean|31.83|31.83|Standard Deviation|7.91|7.91|||
3880224|NCT01553058|3706245|B3|||Body Mass Index||kg/m^2|Mean|32.61|32.61|Standard Deviation|8.66|8.66|||
3880225|NCT01553058|3706246|B2|||Body Mass Index||kg/m^2|Mean|31.95|31.95|Standard Deviation|7.74|7.74|||
3880226|NCT01553058|3706247|B1|||Body Mass Index||kg/m^2|Mean|30.93|30.93|Standard Deviation|7.42|7.42|||
3880227|NCT01553058|3706244|B4|||Psoriatic Arthritis||Participants|Count of Participants|9|9.0||||||
3880228|NCT01553058|3706245|B3|||Psoriatic Arthritis||Participants|Count of Participants|3|3.0||||||
3880229|NCT01553058|3706246|B2|||Psoriatic Arthritis||Participants|Count of Participants|2|2.0||||||
3880230|NCT01553058|3706247|B1|||Psoriatic Arthritis||Participants|Count of Participants|4|4.0||||||
3880231|NCT01553058|3706244|B4|||Psoriasis Duration||years|Mean|16.7|16.7|Standard Deviation|13.94|13.94|||
3880232|NCT01553058|3706245|B3|||Psoriasis Duration||years|Mean|15.87|15.87|Standard Deviation|13.55|13.55|||
3880233|NCT01553058|3706246|B2|||Psoriasis Duration||years|Mean|19.29|19.29|Standard Deviation|13.59|13.59|||
3880234|NCT01553058|3706247|B1|||Psoriasis Duration||years|Mean|14.94|14.94|Standard Deviation|14.73|14.73|||
3880235|NCT01553058|3706244|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3880236|NCT01553058|3706245|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3880237|NCT01553058|3706246|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3880238|NCT01553058|3706247|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3880239|NCT01553058|3706244|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880240|NCT01553058|3706245|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880241|NCT01553058|3706246|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880242|NCT01553058|3706247|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880243|NCT01553058|3706244|B4||White|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3880244|NCT01553058|3706245|B3||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3880245|NCT01553058|3706246|B2||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3880246|NCT01553058|3706247|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3880247|NCT01553058|3706244|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3880248|NCT01553058|3706245|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3880249|NCT01553058|3706246|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3880250|NCT01553058|3706247|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3880251|NCT01553058|3706244|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880252|NCT01553058|3706245|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880253|NCT01553058|3706246|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880254|NCT01553058|3706247|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880255|NCT01553058|3706244|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3880256|NCT01553058|3706245|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3880257|NCT01553058|3706246|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3880258|NCT01553058|3706247|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3880261|NCT01553058|3706246|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3880262|NCT01553058|3706247|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880263|NCT01553058|3706244|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3880264|NCT01553058|3706245|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880265|NCT01553058|3706246|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880266|NCT01553058|3706247|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3880267|NCT01553058|3706244|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
3880268|NCT01553058|3706245|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3880269|NCT01553058|3706246|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3880270|NCT01553058|3706247|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3880271|NCT01553058|3706244|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3880272|NCT01553058|3706245|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3880273|NCT01553058|3706246|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3880274|NCT01553058|3706247|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3880275|NCT01553058|3706244|B4||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3880276|NCT01553058|3706245|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3880277|NCT01553058|3706246|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3880278|NCT01553058|3706247|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3880279|NCT01553058|3706244|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3880280|NCT01553058|3706245|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3880281|NCT01553058|3706246|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3880282|NCT01553058|3706247|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3880283|NCT01553058|3706244|B4|||Age||years|Mean|43.46|43.46|Standard Deviation|14.03|14.03|||
3880284|NCT01553058|3706245|B3|||Age||years|Mean|41.97|41.97|Standard Deviation|13.97|13.97|||
3880285|NCT01553058|3706246|B2|||Age||years|Mean|44.32|44.32|Standard Deviation|14.50|14.5|||
3880286|NCT01553058|3706247|B1|||Age||years|Mean|44.15|44.15|Standard Deviation|13.97|13.97|||
3880287|NCT01552954|3706308|B3|Korea, Republic of||Region of Enrollment||participants|Number|256|256.0||||||
3880288|NCT01552954|3706309|B2|Korea, Republic of||Region of Enrollment||participants|Number|125|125.0||||||
3880289|NCT01552954|3706310|B1|Korea, Republic of||Region of Enrollment||participants|Number|131|131.0||||||
3880290|NCT01552954|3706308|B3||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3880291|NCT01552954|3706309|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3880292|NCT01552954|3706310|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3880293|NCT01552954|3706308|B3||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3880294|NCT01552954|3706309|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3880295|NCT01552954|3706310|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3880296|NCT01552954|3706308|B3|||Age||years|Mean|49.5|49.5|Standard Deviation|13.3|13.3|||
3880297|NCT01552954|3706309|B2|||Age||years|Mean|48.2|48.2|Standard Deviation|12.2|12.2|||
3880298|NCT01552954|3706310|B1|||Age||years|Mean|50.7|50.7|Standard Deviation|14.3|14.3|||
3880299|NCT01552954|3706308|B3||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
3880300|NCT01552954|3706309|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3880301|NCT01552954|3706310|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3880302|NCT01552954|3706308|B3||Between 18 and 65 years|Age||Participants|Count of Participants|223|223.0||||||
3880303|NCT01552954|3706309|B2||Between 18 and 65 years|Age||Participants|Count of Participants|116|116.0||||||
3880304|NCT01552954|3706310|B1||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
3880305|NCT01552954|3706308|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3880306|NCT01552954|3706309|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3880307|NCT01552954|3706310|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3880308|NCT01552928|3706323|B5|FRANCE||Region of Enrollment||Participants|Number|60|60.0||||||
3880309|NCT01552928|3706324|B4|FRANCE||Region of Enrollment||Participants|Number|16|16.0||||||
3880310|NCT01552928|3706325|B3|FRANCE||Region of Enrollment||Participants|Number|15|15.0||||||
3880311|NCT01552928|3706326|B2|FRANCE||Region of Enrollment||Participants|Number|15|15.0||||||
3880312|NCT01552928|3706327|B1|FRANCE||Region of Enrollment||Participants|Number|14|14.0||||||
3880313|NCT01552928|3706323|B5||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3880314|NCT01552928|3706324|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3880315|NCT01552928|3706325|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3880316|NCT01552928|3706326|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3880317|NCT01552928|3706327|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3880318|NCT01552928|3706323|B5||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3880319|NCT01552928|3706324|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3880320|NCT01552928|3706325|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3880321|NCT01552928|3706326|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3880322|NCT01552928|3706327|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3880323|NCT01552928|3706323|B5|||Age||Years|Mean|29.2|29.2|Standard Deviation|6.96|6.96|||
3880324|NCT01552928|3706324|B4|||Age||Years|Mean|30.4|30.4|Standard Deviation|8.02|8.02|||
3880325|NCT01552928|3706325|B3|||Age||Years|Mean|29.5|29.5|Standard Deviation|5.83|5.83|||
3880326|NCT01552928|3706326|B2|||Age||Years|Mean|28.4|28.4|Standard Deviation|7.7|7.7|||
3880327|NCT01552928|3706327|B1|||Age||Years|Mean|28.1|28.1|Standard Deviation|6.44|6.44|||
3880328|NCT01552928|3706323|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3880329|NCT01552928|3706324|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3880330|NCT01552928|3706325|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3880331|NCT01552928|3706326|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3880332|NCT01552928|3706327|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3880333|NCT01552928|3706323|B5||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3880334|NCT01552928|3706324|B4||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3880335|NCT01552928|3706325|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3880336|NCT01552928|3706326|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3880337|NCT01552928|3706327|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3880338|NCT01552928|3706323|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3880339|NCT01552928|3706324|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3880340|NCT01552928|3706325|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3880341|NCT01552928|3706326|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3880342|NCT01552928|3706327|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3880343|NCT01552915|3706374|B4|UNITED STATES||Region of Enrollment||Participants|Number|459|459.0||||||
3880344|NCT01552915|3706375|B3|UNITED STATES||Region of Enrollment||Participants|Number|184|184.0||||||
3880345|NCT01552915|3706376|B2|UNITED STATES||Region of Enrollment||Participants|Number|184|184.0||||||
3880346|NCT01552915|3706377|B1|UNITED STATES||Region of Enrollment||Participants|Number|91|91.0||||||
3880347|NCT01552915|3706374|B4||Male|Sex: Female, Male||Participants|Count of Participants|305|305.0||||||
3880348|NCT01552915|3706375|B3||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3880349|NCT01552915|3706376|B2||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3880350|NCT01552915|3706377|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3880351|NCT01552915|3706374|B4||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3880352|NCT01552915|3706375|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3880353|NCT01552915|3706376|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3880354|NCT01552915|3706377|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3880355|NCT01552915|3706374|B4|<=18 years||Age, Customized||Participants|Number|459|459.0||||||
3880356|NCT01552915|3706375|B3|<=18 years||Age, Customized||Participants|Number|184|184.0||||||
3880357|NCT01552915|3706376|B2|<=18 years||Age, Customized||Participants|Number|184|184.0||||||
3880358|NCT01552915|3706377|B1|<=18 years||Age, Customized||Participants|Number|91|91.0||||||
3880359|NCT01552915|3706374|B4|||Age||Years|Mean|14.7|14.7|Standard Deviation|1.37|1.37|||
3880360|NCT01552915|3706375|B3|||Age||Years|Mean|14.7|14.7|Standard Deviation|1.32|1.32|||
3880361|NCT01552915|3706376|B2|||Age||Years|Mean|14.7|14.7|Standard Deviation|1.38|1.38|||
3880362|NCT01552915|3706377|B1|||Age||Years|Mean|14.8|14.8|Standard Deviation|1.43|1.43|||
3880363|NCT01552902|3706399|B4|||Attention-deficit/Hyperactivity Disorder Rating Scale-IV (ADHD-RS-IV) Total Score|The ADHD-RS-IV was developed to measure the behaviors of children with ADHD and is commonly used in clinical studies of ADHD. The ADHD-RS-IV consisted of 18 items designed to reflect current symptomatology of ADHD based on Diagnostic and Statistical Manual of Mental Disorders, 4th Edition-Text Revision (DSM-IV-TR) criteria. Each item was scored on a 4-point scale ranging from 0 (reflecting no symptoms) to 3 (reflecting severe symptoms) with total scores ranging from 0-54, Higher score = more severe symptoms.|units on a scale|Mean|36.9|36.9|Standard Deviation|6.34|6.34|||
3880364|NCT01552902|3706400|B3|||Attention-deficit/Hyperactivity Disorder Rating Scale-IV (ADHD-RS-IV) Total Score|The ADHD-RS-IV was developed to measure the behaviors of children with ADHD and is commonly used in clinical studies of ADHD. The ADHD-RS-IV consisted of 18 items designed to reflect current symptomatology of ADHD based on Diagnostic and Statistical Manual of Mental Disorders, 4th Edition-Text Revision (DSM-IV-TR) criteria. Each item was scored on a 4-point scale ranging from 0 (reflecting no symptoms) to 3 (reflecting severe symptoms) with total scores ranging from 0-54, Higher score = more severe symptoms.|units on a scale|Mean|36.9|36.9|Standard Deviation|6.42|6.42|||
3880365|NCT01552902|3706401|B2|||Attention-deficit/Hyperactivity Disorder Rating Scale-IV (ADHD-RS-IV) Total Score|The ADHD-RS-IV was developed to measure the behaviors of children with ADHD and is commonly used in clinical studies of ADHD. The ADHD-RS-IV consisted of 18 items designed to reflect current symptomatology of ADHD based on Diagnostic and Statistical Manual of Mental Disorders, 4th Edition-Text Revision (DSM-IV-TR) criteria. Each item was scored on a 4-point scale ranging from 0 (reflecting no symptoms) to 3 (reflecting severe symptoms) with total scores ranging from 0-54, Higher score = more severe symptoms.|units on a scale|Mean|37.2|37.2|Standard Deviation|6.46|6.46|||
3880401|NCT01552902|3706401|B2||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3880402|NCT01552902|3706402|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3880403|NCT01552902|3706399|B4||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
3880404|NCT01552902|3706400|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3880366|NCT01552902|3706402|B1|||Attention-deficit/Hyperactivity Disorder Rating Scale-IV (ADHD-RS-IV) Total Score|The ADHD-RS-IV was developed to measure the behaviors of children with ADHD and is commonly used in clinical studies of ADHD. The ADHD-RS-IV consisted of 18 items designed to reflect current symptomatology of ADHD based on Diagnostic and Statistical Manual of Mental Disorders, 4th Edition-Text Revision (DSM-IV-TR) criteria. Each item was scored on a 4-point scale ranging from 0 (reflecting no symptoms) to 3 (reflecting severe symptoms) with total scores ranging from 0-54, Higher score = more severe symptoms.|units on a scale|Mean|36.1|36.1|Standard Deviation|5.91|5.91|||
3880367|NCT01552902|3706399|B4|Severely ill||Clinical Global Impressions – Severity of Illness (CGI-S)|The Clinical Global Impressions Scale permits a global evaluation of the participant's severity of illness and improvement over time. The scale includes a severity of illness item and a global improvement item. The investigator performed the CGI-S to rate the severity of a participant's condition on a 7-point scale (1=normal, not at all ill; 2=borderline mentally ill; 3=mildly ill; 4=moderately ill; 5=markedly ill; 6=severely ill; or 7=extremely ill).|participants|Number|34|34.0||||||
3880368|NCT01552902|3706400|B3|Severely ill||Clinical Global Impressions – Severity of Illness (CGI-S)|The Clinical Global Impressions Scale permits a global evaluation of the participant's severity of illness and improvement over time. The scale includes a severity of illness item and a global improvement item. The investigator performed the CGI-S to rate the severity of a participant's condition on a 7-point scale (1=normal, not at all ill; 2=borderline mentally ill; 3=mildly ill; 4=moderately ill; 5=markedly ill; 6=severely ill; or 7=extremely ill).|participants|Number|13|13.0||||||
3880369|NCT01552902|3706401|B2|Severely ill||Clinical Global Impressions – Severity of Illness (CGI-S)|The Clinical Global Impressions Scale permits a global evaluation of the participant's severity of illness and improvement over time. The scale includes a severity of illness item and a global improvement item. The investigator performed the CGI-S to rate the severity of a participant's condition on a 7-point scale (1=normal, not at all ill; 2=borderline mentally ill; 3=mildly ill; 4=moderately ill; 5=markedly ill; 6=severely ill; or 7=extremely ill).|participants|Number|15|15.0||||||
3880370|NCT01552902|3706402|B1|Severely ill||Clinical Global Impressions – Severity of Illness (CGI-S)|The Clinical Global Impressions Scale permits a global evaluation of the participant's severity of illness and improvement over time. The scale includes a severity of illness item and a global improvement item. The investigator performed the CGI-S to rate the severity of a participant's condition on a 7-point scale (1=normal, not at all ill; 2=borderline mentally ill; 3=mildly ill; 4=moderately ill; 5=markedly ill; 6=severely ill; or 7=extremely ill).|participants|Number|6|6.0||||||
3880371|NCT01552902|3706399|B4|Markedly ill||Clinical Global Impressions – Severity of Illness (CGI-S)|The Clinical Global Impressions Scale permits a global evaluation of the participant's severity of illness and improvement over time. The scale includes a severity of illness item and a global improvement item. The investigator performed the CGI-S to rate the severity of a participant's condition on a 7-point scale (1=normal, not at all ill; 2=borderline mentally ill; 3=mildly ill; 4=moderately ill; 5=markedly ill; 6=severely ill; or 7=extremely ill).|participants|Number|237|237.0||||||
3880372|NCT01552902|3706400|B3|Markedly ill||Clinical Global Impressions – Severity of Illness (CGI-S)|The Clinical Global Impressions Scale permits a global evaluation of the participant's severity of illness and improvement over time. The scale includes a severity of illness item and a global improvement item. The investigator performed the CGI-S to rate the severity of a participant's condition on a 7-point scale (1=normal, not at all ill; 2=borderline mentally ill; 3=mildly ill; 4=moderately ill; 5=markedly ill; 6=severely ill; or 7=extremely ill).|participants|Number|90|90.0||||||
3880373|NCT01552902|3706401|B2|Markedly ill||Clinical Global Impressions – Severity of Illness (CGI-S)|The Clinical Global Impressions Scale permits a global evaluation of the participant's severity of illness and improvement over time. The scale includes a severity of illness item and a global improvement item. The investigator performed the CGI-S to rate the severity of a participant's condition on a 7-point scale (1=normal, not at all ill; 2=borderline mentally ill; 3=mildly ill; 4=moderately ill; 5=markedly ill; 6=severely ill; or 7=extremely ill).|participants|Number|106|106.0||||||
3880374|NCT01552902|3706402|B1|Markedly ill||Clinical Global Impressions – Severity of Illness (CGI-S)|The Clinical Global Impressions Scale permits a global evaluation of the participant's severity of illness and improvement over time. The scale includes a severity of illness item and a global improvement item. The investigator performed the CGI-S to rate the severity of a participant's condition on a 7-point scale (1=normal, not at all ill; 2=borderline mentally ill; 3=mildly ill; 4=moderately ill; 5=markedly ill; 6=severely ill; or 7=extremely ill).|participants|Number|41|41.0||||||
3880375|NCT01552902|3706399|B4|Moderately ill||Clinical Global Impressions – Severity of Illness (CGI-S)|The Clinical Global Impressions Scale permits a global evaluation of the participant's severity of illness and improvement over time. The scale includes a severity of illness item and a global improvement item. The investigator performed the CGI-S to rate the severity of a participant's condition on a 7-point scale (1=normal, not at all ill; 2=borderline mentally ill; 3=mildly ill; 4=moderately ill; 5=markedly ill; 6=severely ill; or 7=extremely ill).|participants|Number|268|268.0||||||
3880376|NCT01552902|3706400|B3|Moderately ill||Clinical Global Impressions – Severity of Illness (CGI-S)|The Clinical Global Impressions Scale permits a global evaluation of the participant's severity of illness and improvement over time. The scale includes a severity of illness item and a global improvement item. The investigator performed the CGI-S to rate the severity of a participant's condition on a 7-point scale (1=normal, not at all ill; 2=borderline mentally ill; 3=mildly ill; 4=moderately ill; 5=markedly ill; 6=severely ill; or 7=extremely ill).|participants|Number|115|115.0||||||
3880377|NCT01552902|3706401|B2|Moderately ill||Clinical Global Impressions – Severity of Illness (CGI-S)|The Clinical Global Impressions Scale permits a global evaluation of the participant's severity of illness and improvement over time. The scale includes a severity of illness item and a global improvement item. The investigator performed the CGI-S to rate the severity of a participant's condition on a 7-point scale (1=normal, not at all ill; 2=borderline mentally ill; 3=mildly ill; 4=moderately ill; 5=markedly ill; 6=severely ill; or 7=extremely ill).|participants|Number|93|93.0||||||
3880405|NCT01552902|3706401|B2||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3880406|NCT01552902|3706402|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3880407|NCT01552902|3706399|B4|||Age|Age was calculated as the difference between date of birth and date of informed consent.|years|Mean|14.7|14.7|Standard Deviation|1.40|1.4|||
3880378|NCT01552902|3706402|B1|Moderately ill||Clinical Global Impressions – Severity of Illness (CGI-S)|The Clinical Global Impressions Scale permits a global evaluation of the participant's severity of illness and improvement over time. The scale includes a severity of illness item and a global improvement item. The investigator performed the CGI-S to rate the severity of a participant's condition on a 7-point scale (1=normal, not at all ill; 2=borderline mentally ill; 3=mildly ill; 4=moderately ill; 5=markedly ill; 6=severely ill; or 7=extremely ill).|participants|Number|60|60.0||||||
3880379|NCT01552902|3706399|B4|Mildly ill||Clinical Global Impressions – Severity of Illness (CGI-S)|The Clinical Global Impressions Scale permits a global evaluation of the participant's severity of illness and improvement over time. The scale includes a severity of illness item and a global improvement item. The investigator performed the CGI-S to rate the severity of a participant's condition on a 7-point scale (1=normal, not at all ill; 2=borderline mentally ill; 3=mildly ill; 4=moderately ill; 5=markedly ill; 6=severely ill; or 7=extremely ill).|participants|Number|7|7.0||||||
3880380|NCT01552902|3706400|B3|Mildly ill||Clinical Global Impressions – Severity of Illness (CGI-S)|The Clinical Global Impressions Scale permits a global evaluation of the participant's severity of illness and improvement over time. The scale includes a severity of illness item and a global improvement item. The investigator performed the CGI-S to rate the severity of a participant's condition on a 7-point scale (1=normal, not at all ill; 2=borderline mentally ill; 3=mildly ill; 4=moderately ill; 5=markedly ill; 6=severely ill; or 7=extremely ill).|participants|Number|1|1.0||||||
3880381|NCT01552902|3706401|B2|Mildly ill||Clinical Global Impressions – Severity of Illness (CGI-S)|The Clinical Global Impressions Scale permits a global evaluation of the participant's severity of illness and improvement over time. The scale includes a severity of illness item and a global improvement item. The investigator performed the CGI-S to rate the severity of a participant's condition on a 7-point scale (1=normal, not at all ill; 2=borderline mentally ill; 3=mildly ill; 4=moderately ill; 5=markedly ill; 6=severely ill; or 7=extremely ill).|participants|Number|4|4.0||||||
3880382|NCT01552902|3706402|B1|Mildly ill||Clinical Global Impressions – Severity of Illness (CGI-S)|The Clinical Global Impressions Scale permits a global evaluation of the participant's severity of illness and improvement over time. The scale includes a severity of illness item and a global improvement item. The investigator performed the CGI-S to rate the severity of a participant's condition on a 7-point scale (1=normal, not at all ill; 2=borderline mentally ill; 3=mildly ill; 4=moderately ill; 5=markedly ill; 6=severely ill; or 7=extremely ill).|participants|Number|2|2.0||||||
3880383|NCT01552902|3706399|B4|Borderline mentally ill||Clinical Global Impressions – Severity of Illness (CGI-S)|The Clinical Global Impressions Scale permits a global evaluation of the participant's severity of illness and improvement over time. The scale includes a severity of illness item and a global improvement item. The investigator performed the CGI-S to rate the severity of a participant's condition on a 7-point scale (1=normal, not at all ill; 2=borderline mentally ill; 3=mildly ill; 4=moderately ill; 5=markedly ill; 6=severely ill; or 7=extremely ill).|participants|Number|1|1.0||||||
3880384|NCT01552902|3706400|B3|Borderline mentally ill||Clinical Global Impressions – Severity of Illness (CGI-S)|The Clinical Global Impressions Scale permits a global evaluation of the participant's severity of illness and improvement over time. The scale includes a severity of illness item and a global improvement item. The investigator performed the CGI-S to rate the severity of a participant's condition on a 7-point scale (1=normal, not at all ill; 2=borderline mentally ill; 3=mildly ill; 4=moderately ill; 5=markedly ill; 6=severely ill; or 7=extremely ill).|participants|Number|0|0.0||||||
3880385|NCT01552902|3706401|B2|Borderline mentally ill||Clinical Global Impressions – Severity of Illness (CGI-S)|The Clinical Global Impressions Scale permits a global evaluation of the participant's severity of illness and improvement over time. The scale includes a severity of illness item and a global improvement item. The investigator performed the CGI-S to rate the severity of a participant's condition on a 7-point scale (1=normal, not at all ill; 2=borderline mentally ill; 3=mildly ill; 4=moderately ill; 5=markedly ill; 6=severely ill; or 7=extremely ill).|participants|Number|0|0.0||||||
3880386|NCT01552902|3706402|B1|Borderline mentally ill||Clinical Global Impressions – Severity of Illness (CGI-S)|The Clinical Global Impressions Scale permits a global evaluation of the participant's severity of illness and improvement over time. The scale includes a severity of illness item and a global improvement item. The investigator performed the CGI-S to rate the severity of a participant's condition on a 7-point scale (1=normal, not at all ill; 2=borderline mentally ill; 3=mildly ill; 4=moderately ill; 5=markedly ill; 6=severely ill; or 7=extremely ill).|participants|Number|1|1.0||||||
3880387|NCT01552902|3706399|B4|Combined Subtype||Attention-deficit/Hyperactivity Disorder (ADHD) Subtype||participants|Number|358|358.0||||||
3880388|NCT01552902|3706400|B3|Combined Subtype||Attention-deficit/Hyperactivity Disorder (ADHD) Subtype||participants|Number|144|144.0||||||
3880389|NCT01552902|3706401|B2|Combined Subtype||Attention-deficit/Hyperactivity Disorder (ADHD) Subtype||participants|Number|146|146.0||||||
3880390|NCT01552902|3706402|B1|Combined Subtype||Attention-deficit/Hyperactivity Disorder (ADHD) Subtype||participants|Number|68|68.0||||||
3880391|NCT01552902|3706399|B4|Predominantly Hyperactive/Impulsive||Attention-deficit/Hyperactivity Disorder (ADHD) Subtype||participants|Number|8|8.0||||||
3880392|NCT01552902|3706400|B3|Predominantly Hyperactive/Impulsive||Attention-deficit/Hyperactivity Disorder (ADHD) Subtype||participants|Number|4|4.0||||||
3880393|NCT01552902|3706401|B2|Predominantly Hyperactive/Impulsive||Attention-deficit/Hyperactivity Disorder (ADHD) Subtype||participants|Number|2|2.0||||||
3880394|NCT01552902|3706402|B1|Predominantly Hyperactive/Impulsive||Attention-deficit/Hyperactivity Disorder (ADHD) Subtype||participants|Number|2|2.0||||||
3880395|NCT01552902|3706399|B4|Predominantly Inattentive||Attention-deficit/Hyperactivity Disorder (ADHD) Subtype||participants|Number|181|181.0||||||
3880396|NCT01552902|3706400|B3|Predominantly Inattentive||Attention-deficit/Hyperactivity Disorder (ADHD) Subtype||participants|Number|71|71.0||||||
3880397|NCT01552902|3706401|B2|Predominantly Inattentive||Attention-deficit/Hyperactivity Disorder (ADHD) Subtype||participants|Number|70|70.0||||||
3880398|NCT01552902|3706402|B1|Predominantly Inattentive||Attention-deficit/Hyperactivity Disorder (ADHD) Subtype||participants|Number|40|40.0||||||
3880399|NCT01552902|3706399|B4||Male|Sex: Female, Male||Participants|Count of Participants|361|361.0||||||
3880400|NCT01552902|3706400|B3||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3880408|NCT01552902|3706400|B3|||Age|Age was calculated as the difference between date of birth and date of informed consent.|years|Mean|14.7|14.7|Standard Deviation|1.42|1.42|||
3880409|NCT01552902|3706401|B2|||Age|Age was calculated as the difference between date of birth and date of informed consent.|years|Mean|14.6|14.6|Standard Deviation|1.38|1.38|||
3880410|NCT01552902|3706402|B1|||Age|Age was calculated as the difference between date of birth and date of informed consent.|years|Mean|14.7|14.7|Standard Deviation|1.37|1.37|||
3880411|NCT01552902|3706399|B4||>=65 years|Age|Age was calculated as the difference between date of birth and date of informed consent.|Participants|Count of Participants|0|0.0||||||
3880412|NCT01552902|3706400|B3||>=65 years|Age|Age was calculated as the difference between date of birth and date of informed consent.|Participants|Count of Participants|0|0.0||||||
3880413|NCT01552902|3706401|B2||>=65 years|Age|Age was calculated as the difference between date of birth and date of informed consent.|Participants|Count of Participants|0|0.0||||||
3880414|NCT01552902|3706402|B1||>=65 years|Age|Age was calculated as the difference between date of birth and date of informed consent.|Participants|Count of Participants|0|0.0||||||
3880415|NCT01552902|3706399|B4||Between 18 and 65 years|Age|Age was calculated as the difference between date of birth and date of informed consent.|Participants|Count of Participants|0|0.0||||||
3880416|NCT01552902|3706400|B3||Between 18 and 65 years|Age|Age was calculated as the difference between date of birth and date of informed consent.|Participants|Count of Participants|0|0.0||||||
3880417|NCT01552902|3706401|B2||Between 18 and 65 years|Age|Age was calculated as the difference between date of birth and date of informed consent.|Participants|Count of Participants|0|0.0||||||
3880418|NCT01552902|3706402|B1||Between 18 and 65 years|Age|Age was calculated as the difference between date of birth and date of informed consent.|Participants|Count of Participants|0|0.0||||||
3880419|NCT01552902|3706399|B4||<=18 years|Age|Age was calculated as the difference between date of birth and date of informed consent.|Participants|Count of Participants|547|547.0||||||
3880420|NCT01552902|3706400|B3||<=18 years|Age|Age was calculated as the difference between date of birth and date of informed consent.|Participants|Count of Participants|219|219.0||||||
3880421|NCT01552902|3706401|B2||<=18 years|Age|Age was calculated as the difference between date of birth and date of informed consent.|Participants|Count of Participants|218|218.0||||||
3880422|NCT01552902|3706402|B1||<=18 years|Age|Age was calculated as the difference between date of birth and date of informed consent.|Participants|Count of Participants|110|110.0||||||
3880423|NCT01552889|3706424|B3|United States||Region of Enrollment||participants|Number|201|201.0||||||
3880424|NCT01552889|3706425|B2|United States||Region of Enrollment||participants|Number|100|100.0||||||
3880425|NCT01552889|3706426|B1|United States||Region of Enrollment||participants|Number|101|101.0||||||
3880426|NCT01552889|3706424|B3||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3880427|NCT01552889|3706425|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3880428|NCT01552889|3706426|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3880429|NCT01552889|3706424|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3880430|NCT01552889|3706425|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3880431|NCT01552889|3706426|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3880432|NCT01552889|3706424|B3|||Age||years|Mean|63.05|63.05|Standard Deviation|9.7|9.7|||
3880433|NCT01552889|3706425|B2|||Age||years|Mean|63.0|63.0|Standard Deviation|9.5|9.5|||
3880434|NCT01552889|3706426|B1|||Age||years|Mean|63.1|63.1|Standard Deviation|10.0|10.0|||
3880435|NCT01552889|3706424|B3||>=65 years|Age||Participants|Count of Participants|79|79.0||||||
3880436|NCT01552889|3706425|B2||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
3880437|NCT01552889|3706426|B1||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
3880438|NCT01552889|3706424|B3||Between 18 and 65 years|Age||Participants|Count of Participants|122|122.0||||||
3880439|NCT01552889|3706425|B2||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
3880440|NCT01552889|3706426|B1||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3880441|NCT01552889|3706424|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3880442|NCT01552889|3706425|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3880443|NCT01552889|3706426|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3880444|NCT01552876|3706437|B1|United Kingdom||Region of Enrollment||participants|Number|42|42.0||||||
3880445|NCT01552876|3706437|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3880446|NCT01552876|3706437|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3880447|NCT01552876|3706437|B1|||Age||years|Mean|51.45|51.45|Standard Deviation|12.707|12.707|||
3880448|NCT01552772|3706454|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||67.0|67.0|||
3880449|NCT01552772|3706454|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||33.0|33.0|||
3880450|NCT01552772|3706454|B1|||Age||Years|Mean|43.2|43.2|Standard Deviation|10.7|10.7|||
3880451|NCT01552694|3706468|B3|||CD8+ T-cell count||cells/µL|Mean|909|909.0|Standard Deviation|418|418.0|||
3880452|NCT01552694|3706469|B2|||CD8+ T-cell count||cells/µL|Mean|801|801.0|Standard Deviation|294|294.0|||
3880453|NCT01552694|3706470|B1|||CD8+ T-cell count||cells/µL|Mean|1017|1017.0|Standard Deviation|542|542.0|||
3880454|NCT01552694|3706468|B3|||CD4+ T-cell count||cells/µL|Mean|668|668.0|Standard Deviation|219|219.0|||
3880455|NCT01552694|3706469|B2|||CD4+ T-cell count||cells/µL|Mean|606|606.0|Standard Deviation|218|218.0|||
3880456|NCT01552694|3706470|B1|||CD4+ T-cell count||cells/µL|Mean|731|731.0|Standard Deviation|220|220.0|||
3880457|NCT01552694|3706468|B3|||HIV duration||years|Mean|14.6|14.6|Standard Deviation|6.2|6.2|||
3880458|NCT01552694|3706469|B2|||HIV duration||years|Mean|14.2|14.2|Standard Deviation|7.5|7.5|||
3880459|NCT01552694|3706470|B1|||HIV duration||years|Mean|14.9|14.9|Standard Deviation|5.8|5.8|||
3880460|NCT01552694|3706468|B3|||Diastolic blood pressure||mmHg|Mean|76|76.0|Standard Deviation|10|10.0|||
3880461|NCT01552694|3706469|B2|||Diastolic blood pressure||mmHg|Mean|78|78.0|Standard Deviation|10|10.0|||
3880462|NCT01552694|3706470|B1|||Diastolic blood pressure||mmHg|Mean|74|74.0|Standard Deviation|9|9.0|||
3880463|NCT01552694|3706468|B3|||Systolic blood pressure||mmHg|Mean|125|125.0|Standard Deviation|14|14.0|||
3880464|NCT01552694|3706469|B2|||Systolic blood pressure||mmHg|Mean|127|127.0|Standard Deviation|14|14.0|||
3880465|NCT01552694|3706470|B1|||Systolic blood pressure||mmHg|Mean|124|124.0|Standard Deviation|15|15.0|||
3880466|NCT01552694|3706468|B3|||Waist circumference||cm|Mean|109|109.0|Standard Deviation|22|22.0|||
3880467|NCT01552694|3706469|B2|||Waist circumference||cm|Mean|112|112.0|Standard Deviation|23|23.0|||
3880468|NCT01552694|3706470|B1|||Waist circumference||cm|Mean|106|106.0|Standard Deviation|19|19.0|||
3880469|NCT01552694|3706468|B3|||Body mass index||kg/m^2|Mean|32.9|32.9|Standard Deviation|8.2|8.2|||
3880470|NCT01552694|3706469|B2|||Body mass index||kg/m^2|Mean|33.1|33.1|Standard Deviation|8.2|8.2|||
3880471|NCT01552694|3706470|B1|||Body mass index||kg/m^2|Mean|32.7|32.7|Standard Deviation|8.2|8.2|||
3880472|NCT01552694|3706468|B3|||Weight||kg|Mean|100|100.0|Standard Deviation|25|25.0|||
3880473|NCT01552694|3706469|B2|||Weight||kg|Mean|102|102.0|Standard Deviation|29|29.0|||
3880474|NCT01552694|3706470|B1|||Weight||kg|Mean|97|97.0|Standard Deviation|21|21.0|||
3880475|NCT01552694|3706468|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
3880476|NCT01552694|3706469|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
3880477|NCT01552694|3706470|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3880478|NCT01552694|3706468|B3|African American||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3880479|NCT01552694|3706469|B2|African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3880480|NCT01552694|3706470|B1|African American||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3880481|NCT01552694|3706468|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3880482|NCT01552694|3706469|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3880483|NCT01552694|3706470|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3880484|NCT01552694|3706468|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3880485|NCT01552694|3706469|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3880486|NCT01552694|3706470|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3880487|NCT01552694|3706468|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3880488|NCT01552694|3706469|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3880489|NCT01552694|3706470|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3880490|NCT01552694|3706468|B3|||Age||years|Mean|51|51.0|Standard Deviation|7|7.0|||
3880491|NCT01552694|3706469|B2|||Age||years|Mean|52|52.0|Standard Deviation|6|6.0|||
3880492|NCT01552694|3706470|B1|||Age||years|Mean|49|49.0|Standard Deviation|9|9.0|||
3880493|NCT01552681|3706485|B3|||Patient's Global Assessment of Disease Activity|"A self-reported measure of perceived disease activity obtained by responding to the question Overall, how would you rate your Sjogren's Syndrome symptom activity? A vertical mark on a 100 mm line rated 0 (Not active) to 100 (Very active) determines the score. The range: 0 to 100, with 100 indicating severe symptoms."|mm|Mean|71.5|71.5|Standard Deviation|16.4|16.4|||
3880494|NCT01552681|3706486|B2|||Patient's Global Assessment of Disease Activity|"A self-reported measure of perceived disease activity obtained by responding to the question Overall, how would you rate your Sjogren's Syndrome symptom activity? A vertical mark on a 100 mm line rated 0 (Not active) to 100 (Very active) determines the score. The range: 0 to 100, with 100 indicating severe symptoms."|mm|Mean|73.5|73.5|Standard Deviation|16.4|16.4|||
3880495|NCT01552681|3706487|B1|||Patient's Global Assessment of Disease Activity|"A self-reported measure of perceived disease activity obtained by responding to the question Overall, how would you rate your Sjogren's Syndrome symptom activity? A vertical mark on a 100 mm line rated 0 (Not active) to 100 (Very active) determines the score. The range: 0 to 100, with 100 indicating severe symptoms."|mm|Mean|70.3|70.3|Standard Deviation|16.5|16.5|||
3880496|NCT01552681|3706485|B3|||Physician's Global Assessment of Disease Activity|The physician’s response to the question “Overall, how would you rate the Sjogren’s Syndrome symptom activity of the subject?” A vertical mark on a 100 mm horizontal line rated 0 (Not active) to 100 (Very active). The range: 0 to 100, with 100 indicating severe symptoms.|mm|Mean|49.2|49.2|Standard Deviation|20.4|20.4|||
3880497|NCT01552681|3706486|B2|||Physician's Global Assessment of Disease Activity|The physician’s response to the question “Overall, how would you rate the Sjogren’s Syndrome symptom activity of the subject?” A vertical mark on a 100 mm horizontal line rated 0 (Not active) to 100 (Very active). The range: 0 to 100, with 100 indicating severe symptoms.|mm|Mean|50.3|50.3|Standard Deviation|20.5|20.5|||
3880498|NCT01552681|3706487|B1|||Physician's Global Assessment of Disease Activity|The physician’s response to the question “Overall, how would you rate the Sjogren’s Syndrome symptom activity of the subject?” A vertical mark on a 100 mm horizontal line rated 0 (Not active) to 100 (Very active). The range: 0 to 100, with 100 indicating severe symptoms.|mm|Mean|48.6|48.6|Standard Deviation|20.6|20.6|||
3880499|NCT01552681|3706485|B3|||Swollen Joint Count|Swollen Joint Count (SJC) is the number of swollen joints based on swelling response of 28 joints examined. SJC possible values range from 0 to 28.|units on a scale|Mean|0.2|0.2|Standard Deviation|0.6|0.6|||
3880500|NCT01552681|3706486|B2|||Swollen Joint Count|Swollen Joint Count (SJC) is the number of swollen joints based on swelling response of 28 joints examined. SJC possible values range from 0 to 28.|units on a scale|Mean|0.2|0.2|Standard Deviation|0.7|0.7|||
3880501|NCT01552681|3706487|B1|||Swollen Joint Count|Swollen Joint Count (SJC) is the number of swollen joints based on swelling response of 28 joints examined. SJC possible values range from 0 to 28.|units on a scale|Mean|0.1|0.1|Standard Deviation|0.5|0.5|||
3880502|NCT01552681|3706485|B3|||Tender Joint Count|Tender Joint Count (TJC) is the number of tender joints based on the tenderness response of 28 joints examined. TJC possible values range from 0 to 28.|units on a scale|Mean|2.5|2.5|Standard Deviation|5.1|5.1|||
3880503|NCT01552681|3706486|B2|||Tender Joint Count|Tender Joint Count (TJC) is the number of tender joints based on the tenderness response of 28 joints examined. TJC possible values range from 0 to 28.|units on a scale|Mean|5.0|5.0|Standard Deviation|7.5|7.5|||
3880504|NCT01552681|3706487|B1|||Tender Joint Count|Tender Joint Count (TJC) is the number of tender joints based on the tenderness response of 28 joints examined. TJC possible values range from 0 to 28.|units on a scale|Mean|1.1|1.1|Standard Deviation|2.0|2.0|||
3880505|NCT01552681|3706485|B3|||European League Against Rheumatism (EULAR) Sjogren’s Syndrome Disease Activity Index (ESSDAI) Score|The ESSDAI is a clinical index that measures Sjogren’s syndrome disease activity. A physician scores the disease activity level of twelve organ-specific domains in 3 or 4 levels according to their severity. For example, for no disease activity the domain score equals 0 and for high disease activity the domain score equals 3 or 4. Each domain is assigned a weight between 1 and 6, and the domain score is multiplied by the domain weight. The sum of the weighted domain scores is the overall score, which can range from 0 to 123. A higher score indicates more disease activity.|units on a scale|Mean|3.1|3.1|Standard Deviation|3.4|3.4|||
3880506|NCT01552681|3706486|B2|||European League Against Rheumatism (EULAR) Sjogren’s Syndrome Disease Activity Index (ESSDAI) Score|The ESSDAI is a clinical index that measures Sjogren’s syndrome disease activity. A physician scores the disease activity level of twelve organ-specific domains in 3 or 4 levels according to their severity. For example, for no disease activity the domain score equals 0 and for high disease activity the domain score equals 3 or 4. Each domain is assigned a weight between 1 and 6, and the domain score is multiplied by the domain weight. The sum of the weighted domain scores is the overall score, which can range from 0 to 123. A higher score indicates more disease activity.|units on a scale|Mean|3.8|3.8|Standard Deviation|4.2|4.2|||
3880507|NCT01552681|3706487|B1|||European League Against Rheumatism (EULAR) Sjogren’s Syndrome Disease Activity Index (ESSDAI) Score|The ESSDAI is a clinical index that measures Sjogren’s syndrome disease activity. A physician scores the disease activity level of twelve organ-specific domains in 3 or 4 levels according to their severity. For example, for no disease activity the domain score equals 0 and for high disease activity the domain score equals 3 or 4. Each domain is assigned a weight between 1 and 6, and the domain score is multiplied by the domain weight. The sum of the weighted domain scores is the overall score, which can range from 0 to 123. A higher score indicates more disease activity.|units on a scale|Mean|2.7|2.7|Standard Deviation|2.8|2.8|||
3880508|NCT01552681|3706485|B3|||Stimulated Salivary Flow Rate|After an unstimulated salivary flow assessment the participant was administered a single 5-mg dose of pilocarpine to stimulate saliva production. One hour after the administration of pilocarpine the participant spit into a preweighed 50-cm centrifuge tube for 15 minutes. The sample was weighed to determine the volume (1 g = 1 mL) of saliva. The volume of saliva (mL) was divided by the duration of the test (minutes) to calculate the stimulated salivary flow rate (mL/min). A stimulated salivary flow rate of ≥ 0.1 mL/min (min) was required to enter the study.|mL/min|Mean|0.5|0.5|Standard Deviation|0.4|0.4|||
3880509|NCT01552681|3706486|B2|||Stimulated Salivary Flow Rate|After an unstimulated salivary flow assessment the participant was administered a single 5-mg dose of pilocarpine to stimulate saliva production. One hour after the administration of pilocarpine the participant spit into a preweighed 50-cm centrifuge tube for 15 minutes. The sample was weighed to determine the volume (1 g = 1 mL) of saliva. The volume of saliva (mL) was divided by the duration of the test (minutes) to calculate the stimulated salivary flow rate (mL/min). A stimulated salivary flow rate of ≥ 0.1 mL/min (min) was required to enter the study.|mL/min|Mean|0.5|0.5|Standard Deviation|0.3|0.3|||
3880510|NCT01552681|3706487|B1|||Stimulated Salivary Flow Rate|After an unstimulated salivary flow assessment the participant was administered a single 5-mg dose of pilocarpine to stimulate saliva production. One hour after the administration of pilocarpine the participant spit into a preweighed 50-cm centrifuge tube for 15 minutes. The sample was weighed to determine the volume (1 g = 1 mL) of saliva. The volume of saliva (mL) was divided by the duration of the test (minutes) to calculate the stimulated salivary flow rate (mL/min). A stimulated salivary flow rate of ≥ 0.1 mL/min (min) was required to enter the study.|mL/min|Mean|0.4|0.4|Standard Deviation|0.5|0.5|||
3880511|NCT01552681|3706485|B3|||Height|Height at the baseline visit. Data were not available for six participants who received baminercept and four participants who received placebo.|cm|Mean|164.0|164.0|Standard Deviation|7.3|7.3|||
3880512|NCT01552681|3706486|B2|||Height|Height at the baseline visit. Data were not available for six participants who received baminercept and four participants who received placebo.|cm|Mean|163.2|163.2|Standard Deviation|7.7|7.7|||
3880513|NCT01552681|3706487|B1|||Height|Height at the baseline visit. Data were not available for six participants who received baminercept and four participants who received placebo.|cm|Mean|164.4|164.4|Standard Deviation|7.1|7.1|||
3880514|NCT01552681|3706485|B3|||Body Weight|Body weight at the baseline visit. Weight of 40 kg or greater was required to enter the study.|kg|Mean|76.9|76.9|Standard Deviation|19.9|19.9|||
3880515|NCT01552681|3706486|B2|||Body Weight|Body weight at the baseline visit. Weight of 40 kg or greater was required to enter the study.|kg|Mean|79.2|79.2|Standard Deviation|19.3|19.3|||
3880516|NCT01552681|3706487|B1|||Body Weight|Body weight at the baseline visit. Weight of 40 kg or greater was required to enter the study.|kg|Mean|75.5|75.5|Standard Deviation|20.4|20.4|||
3880517|NCT01552681|3706485|B3|United States||Region of Enrollment||participants|Number|52|52.0||||||
3880518|NCT01552681|3706486|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3880519|NCT01552681|3706487|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
3880520|NCT01552681|3706485|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880521|NCT01552681|3706486|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880522|NCT01552681|3706487|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880523|NCT01552681|3706485|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880524|NCT01552681|3706486|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880525|NCT01552681|3706487|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880526|NCT01552681|3706485|B3||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3880527|NCT01552681|3706486|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3880528|NCT01552681|3706487|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3880529|NCT01552681|3706485|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3880530|NCT01552681|3706486|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3880531|NCT01552681|3706487|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3880532|NCT01552681|3706485|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880533|NCT01552681|3706486|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880534|NCT01552681|3706487|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880535|NCT01552681|3706485|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3880536|NCT01552681|3706486|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880537|NCT01552681|3706487|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3880538|NCT01552681|3706485|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3880539|NCT01552681|3706486|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880540|NCT01552681|3706487|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3880541|NCT01552681|3706485|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3880542|NCT01552681|3706486|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880543|NCT01552681|3706487|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3880544|NCT01552681|3706485|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3880545|NCT01552681|3706486|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3880546|NCT01552681|3706487|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3880547|NCT01552681|3706485|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3880548|NCT01552681|3706486|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3880549|NCT01552681|3706487|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3880550|NCT01552681|3706485|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3880551|NCT01552681|3706486|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3880552|NCT01552681|3706487|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3880553|NCT01552681|3706485|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3880554|NCT01552681|3706486|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3880555|NCT01552681|3706487|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3880556|NCT01552681|3706485|B3|||Age||years|Mean|52.0|52.0|Standard Deviation|11.0|11.0|||
3880557|NCT01552681|3706486|B2|||Age||years|Mean|54.7|54.7|Standard Deviation|11.0|11.0|||
3880558|NCT01552681|3706487|B1|||Age||years|Mean|50.4|50.4|Standard Deviation|10.9|10.9|||
3880559|NCT01552603|3706536|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3880560|NCT01552603|3706536|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3880561|NCT01552603|3706536|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3880562|NCT01552603|3706536|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3880563|NCT01552603|3706536|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3880564|NCT01552408|3706541|B3|||Central Retinal Thickness||microns|Mean|530|530.0|Full Range|||262.0|1034.0|
3880565|NCT01552408|3706542|B2|||Central Retinal Thickness||microns|Mean|488|488.0|Full Range|||273.0|946.0|
3880566|NCT01552408|3706543|B1|||Central Retinal Thickness||microns|Mean|571|571.0|Full Range|||262.0|1034.0|
3880567|NCT01552408|3706541|B3|||Early Treatment Diabetic Retinopathy Study Best-Corrected Visual Acuity||letters|Mean|59.6|59.6|Full Range|||23.0|76.0|
3880568|NCT01552408|3706542|B2|||Early Treatment Diabetic Retinopathy Study Best-Corrected Visual Acuity||letters|Mean|60.1|60.1|Full Range|||37.0|76.0|
3880569|NCT01552408|3706543|B1|||Early Treatment Diabetic Retinopathy Study Best-Corrected Visual Acuity||letters|Mean|59.1|59.1|Full Range|||23.0|75.0|
3880570|NCT01552408|3706541|B3|||Diabetic Macular Edema Diagnosis Year||year|Mean|2012|2012.0|Full Range|||2008.0|2014.0|
3880571|NCT01552408|3706542|B2|||Diabetic Macular Edema Diagnosis Year||year|Mean|2012|2012.0|Full Range|||2010.0|2014.0|
3880572|NCT01552408|3706543|B1|||Diabetic Macular Edema Diagnosis Year||year|Mean|2012|2012.0|Full Range|||2008.0|2014.0|
3880573|NCT01552408|3706541|B3|||Diabetes Mellitus Diagnosis Year||year|Median|2001|2001.0|Full Range|||1980.0|2012.0|
3880574|NCT01552408|3706542|B2|||Diabetes Mellitus Diagnosis Year||year|Median|2001|2001.0|Full Range|||1980.0|2012.0|
3880575|NCT01552408|3706543|B1|||Diabetes Mellitus Diagnosis Year||year|Median|2002|2002.0|Full Range|||1982.0|2012.0|
3880576|NCT01552408|3706541|B3|||Glycated Hemoglobin||Percentage|Mean|8.4|8.4|Full Range|||5.9|12.9|
3880577|NCT01552408|3706542|B2|||Glycated Hemoglobin||Percentage|Mean|8.0|8.0|Full Range|||5.9|12.8|
3880578|NCT01552408|3706543|B1|||Glycated Hemoglobin||Percentage|Mean|8.8|8.8|Full Range|||5.9|12.9|
3880579|NCT01552408|3706541|B3|||Number of Right Eyes Enrolled||Eyes|Number|18|18.0||||||
3880580|NCT01552408|3706542|B2|||Number of Right Eyes Enrolled||Eyes|Number|11|11.0||||||
3880581|NCT01552408|3706543|B1|||Number of Right Eyes Enrolled||Eyes|Number|7|7.0||||||
3880582|NCT01552408|3706541|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3880583|NCT01552408|3706541|B3|Gender : Male||Sex/Gender, Customized||Eyes|Number|31|31.0||||||
3880584|NCT01552408|3706542|B2|Gender : Male||Sex/Gender, Customized||Eyes|Number|15|15.0||||||
3880585|NCT01552408|3706543|B1|Gender : Male||Sex/Gender, Customized||Eyes|Number|16|16.0||||||
3880586|NCT01552408|3706541|B3|Gender : Female||Sex/Gender, Customized||Eyes|Number|9|9.0||||||
3880587|NCT01552408|3706542|B2|Gender : Female||Sex/Gender, Customized||Eyes|Number|5|5.0||||||
3880588|NCT01552408|3706543|B1|Gender : Female||Sex/Gender, Customized||Eyes|Number|4|4.0||||||
3880589|NCT01552408|3706541|B3|Age||Age, Customized||years|Mean|55|55.0|Full Range|||31.0|75.0|
3880590|NCT01552408|3706542|B2|Age||Age, Customized||years|Mean|56|56.0|Full Range|||31.0|75.0|
3880591|NCT01552408|3706543|B1|Age||Age, Customized||years|Mean|55|55.0|Full Range|||45.0|69.0|
3880592|NCT01552343|3706564|B3|Not Hispanic or Latino||Ethnic Origin||participants|Number|48|48.0||||||
3880593|NCT01552343|3706565|B2|Not Hispanic or Latino||Ethnic Origin||participants|Number|25|25.0||||||
3880594|NCT01552343|3706566|B1|Not Hispanic or Latino||Ethnic Origin||participants|Number|23|23.0||||||
3880595|NCT01552343|3706564|B3|Hispanic or Latino||Ethnic Origin||participants|Number|8|8.0||||||
3880596|NCT01552343|3706565|B2|Hispanic or Latino||Ethnic Origin||participants|Number|2|2.0||||||
3880597|NCT01552343|3706566|B1|Hispanic or Latino||Ethnic Origin||participants|Number|6|6.0||||||
3880598|NCT01552343|3706564|B3|American Indian/Alaska native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3880599|NCT01552343|3706565|B2|American Indian/Alaska native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3880600|NCT01552343|3706566|B1|American Indian/Alaska native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3880601|NCT01552343|3706564|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3880602|NCT01552343|3706565|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3880603|NCT01552343|3706566|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3880604|NCT01552343|3706564|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3880605|NCT01552343|3706565|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3880606|NCT01552343|3706566|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3880607|NCT01552343|3706564|B3|White||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
3880608|NCT01552343|3706565|B2|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3880609|NCT01552343|3706566|B1|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3880610|NCT01552343|3706564|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3880611|NCT01552343|3706565|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3880612|NCT01552343|3706566|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3880613|NCT01552343|3706564|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3880614|NCT01552343|3706565|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3880615|NCT01552343|3706566|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3880616|NCT01552343|3706564|B3|>=65 years||Age, Customized||participants|Number|32|32.0||||||
3880617|NCT01552343|3706565|B2|>=65 years||Age, Customized||participants|Number|14|14.0||||||
3880618|NCT01552343|3706566|B1|>=65 years||Age, Customized||participants|Number|18|18.0||||||
3880619|NCT01552343|3706564|B3|< 65 years||Age, Customized||participants|Number|24|24.0||||||
3880620|NCT01552343|3706565|B2|< 65 years||Age, Customized||participants|Number|13|13.0||||||
3880621|NCT01552343|3706566|B1|< 65 years||Age, Customized||participants|Number|11|11.0||||||
3880622|NCT01552057|3706588|B3|Japan||Region of Enrollment||participants|Number|386|386.0||||||
3880623|NCT01552057|3706589|B2|Japan||Region of Enrollment||participants|Number|195|195.0||||||
3880624|NCT01552057|3706590|B1|Japan||Region of Enrollment||participants|Number|191|191.0||||||
3880625|NCT01552057|3706588|B3|Japanese||Race/Ethnicity, Customized||participants|Number|386|386.0||||||
3880626|NCT01552057|3706589|B2|Japanese||Race/Ethnicity, Customized||participants|Number|195|195.0||||||
3880627|NCT01552057|3706590|B1|Japanese||Race/Ethnicity, Customized||participants|Number|191|191.0||||||
3880628|NCT01552057|3706588|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3880629|NCT01552057|3706589|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3880630|NCT01552057|3706590|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3880631|NCT01552057|3706588|B3||Female|Sex: Female, Male||Participants|Count of Participants|321|321.0||||||
3880632|NCT01552057|3706589|B2||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3880633|NCT01552057|3706590|B1||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3880634|NCT01552057|3706588|B3|||Age||years|Mean|48.7|48.7|Standard Deviation|11.9|11.9|||
3880635|NCT01552057|3706589|B2|||Age||years|Mean|49.5|49.5|Standard Deviation|11.7|11.7|||
3880636|NCT01552057|3706590|B1|||Age||years|Mean|47.8|47.8|Standard Deviation|12.0|12.0|||
3880637|NCT01551979|3706623|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
3880638|NCT01551979|3706624|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3880639|NCT01551979|3706625|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3880640|NCT01551979|3706623|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3880641|NCT01551979|3706624|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3880642|NCT01551979|3706625|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3880643|NCT01551979|3706623|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3880644|NCT01551979|3706624|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3880645|NCT01551979|3706625|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3880646|NCT01551979|3706623|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3880647|NCT01551979|3706624|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3880648|NCT01551979|3706625|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3880649|NCT01551979|3706623|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3880650|NCT01551979|3706624|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3880651|NCT01551979|3706625|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3880652|NCT01551979|3706623|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3880653|NCT01551979|3706624|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3880654|NCT01551979|3706625|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3880655|NCT01551888|3706642|B1||Male|Gender||Participants|Count of Participants|14|14.0||||||
3880656|NCT01551888|3706642|B1||Female|Gender||Participants|Count of Participants|10|10.0||||||
3880657|NCT01551888|3706642|B1|||Age||Years|Mean|60.9|60.9|Standard Deviation|7.5|7.5|||
3880658|NCT01551758|3706655|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
3880659|NCT01551758|3706656|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3880660|NCT01551758|3706657|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3880661|NCT01551758|3706655|B3|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|2763|2763.0||||||
3880662|NCT01551758|3706656|B2|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|1376|1376.0||||||
3880663|NCT01551758|3706657|B1|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|1387|1387.0||||||
3880664|NCT01551758|3706655|B3|White-Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3880665|NCT01551758|3706656|B2|White-Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3880666|NCT01551758|3706657|B1|White-Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3880667|NCT01551758|3706655|B3|Asian-South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3880668|NCT01551758|3706656|B2|Asian-South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3880669|NCT01551758|3706657|B1|Asian-South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3880670|NCT01551758|3706655|B3|Asian-East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3880671|NCT01551758|3706656|B2|Asian-East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3880672|NCT01551758|3706657|B1|Asian-East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3880673|NCT01551758|3706655|B3|Asian-Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3880674|NCT01551758|3706656|B2|Asian-Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3880675|NCT01551758|3706657|B1|Asian-Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3880676|NCT01551758|3706655|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3880677|NCT01551758|3706656|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3880678|NCT01551758|3706657|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3880679|NCT01551758|3706655|B3||Male|Sex: Female, Male||Participants|Count of Participants|1430|1430.0||||||
3880680|NCT01551758|3706656|B2||Male|Sex: Female, Male||Participants|Count of Participants|698|698.0||||||
3880681|NCT01551758|3706657|B1||Male|Sex: Female, Male||Participants|Count of Participants|732|732.0||||||
3880682|NCT01551758|3706655|B3||Female|Sex: Female, Male||Participants|Count of Participants|1369|1369.0||||||
3880683|NCT01551758|3706656|B2||Female|Sex: Female, Male||Participants|Count of Participants|698|698.0||||||
3880684|NCT01551758|3706657|B1||Female|Sex: Female, Male||Participants|Count of Participants|671|671.0||||||
3880685|NCT01551758|3706655|B3|||Age||Years|Mean|66.7|66.7|Standard Deviation|9.92|9.92|||
3880686|NCT01551758|3706656|B2|||Age||Years|Mean|66.6|66.6|Standard Deviation|9.90|9.9|||
3880687|NCT01551758|3706657|B1|||Age||Years|Mean|66.7|66.7|Standard Deviation|9.93|9.93|||
3880688|NCT01551745|3706696|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3880689|NCT01551745|3706696|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3880690|NCT01551745|3706696|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3880691|NCT01551745|3706696|B1|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3880692|NCT01551745|3706696|B1|White/Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3880693|NCT01551745|3706696|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3880694|NCT01551745|3706696|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3880695|NCT01551745|3706696|B1|Age|65 Years and Older|Age, Customized||Participants|Count of Participants|2|2.0||||||
3880696|NCT01551745|3706696|B1|Age|16-64 Years|Age, Customized||Participants|Count of Participants|3|3.0||||||
3880697|NCT01551745|3706696|B1|Age|0-15 Years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3880698|NCT01551693|3706703|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3880699|NCT01551693|3706704|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3880700|NCT01551693|3706705|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3880701|NCT01551693|3706703|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3880702|NCT01551693|3706704|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3880703|NCT01551693|3706705|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3880704|NCT01551693|3706703|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3880705|NCT01551693|3706704|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3880706|NCT01551693|3706705|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3880707|NCT01551693|3706703|B3|||Age||years|Mean|71|71.0|Full Range|||60.0|83.0|
3880708|NCT01551693|3706704|B2|||Age||years|Mean|75|75.0|Full Range|||68.0|83.0|
3880709|NCT01551693|3706705|B1|||Age||years|Mean|60|60.0|Full Range|||60.0|60.0|
3880710|NCT01551355|3706716|B7|Colombia||Region of Enrollment||participants|Number|2279|2279.0||||||
3880711|NCT01551355|3706717|B6|Colombia||Region of Enrollment||participants|Number|71|71.0||||||
3880712|NCT01551355|3706718|B5|Colombia||Region of Enrollment||participants|Number|64|64.0||||||
3880713|NCT01551355|3706719|B4|Colombia||Region of Enrollment||participants|Number|435|435.0||||||
3880714|NCT01551355|3706720|B3|Colombia||Region of Enrollment||participants|Number|493|493.0||||||
3880715|NCT01551355|3706721|B2|Colombia||Region of Enrollment||participants|Number|594|594.0||||||
3880716|NCT01551355|3706722|B1|Colombia||Region of Enrollment||participants|Number|622|622.0||||||
3880717|NCT01551355|3706716|B7||Male|Gender|Children: gender (male/female)|Participants|Count of Participants|804|804.0||||||
3880718|NCT01551355|3706717|B6||Male|Gender|Children: gender (male/female)|Participants|Count of Participants|7|7.0||||||
3880719|NCT01551355|3706718|B5||Male|Gender|Children: gender (male/female)|Participants|Count of Participants|9|9.0||||||
3880720|NCT01551355|3706719|B4||Male|Gender|Children: gender (male/female)|Participants|Count of Participants|62|62.0||||||
3880721|NCT01551355|3706720|B3||Male|Gender|Children: gender (male/female)|Participants|Count of Participants|81|81.0||||||
3880722|NCT01551355|3706721|B2||Male|Gender|Children: gender (male/female)|Participants|Count of Participants|319|319.0||||||
3880723|NCT01551355|3706722|B1||Male|Gender|Children: gender (male/female)|Participants|Count of Participants|326|326.0||||||
3880724|NCT01551355|3706716|B7||Female|Gender|Children: gender (male/female)|Participants|Count of Participants|1475|1475.0||||||
3880725|NCT01551355|3706717|B6||Female|Gender|Children: gender (male/female)|Participants|Count of Participants|64|64.0||||||
3880726|NCT01551355|3706718|B5||Female|Gender|Children: gender (male/female)|Participants|Count of Participants|55|55.0||||||
3880727|NCT01551355|3706719|B4||Female|Gender|Children: gender (male/female)|Participants|Count of Participants|373|373.0||||||
3880728|NCT01551355|3706720|B3||Female|Gender|Children: gender (male/female)|Participants|Count of Participants|412|412.0||||||
3880729|NCT01551355|3706721|B2||Female|Gender|Children: gender (male/female)|Participants|Count of Participants|275|275.0||||||
3880730|NCT01551355|3706722|B1||Female|Gender|Children: gender (male/female)|Participants|Count of Participants|296|296.0||||||
3880731|NCT01551355|3706716|B7|age 5||Age, Customized||participants|Number|29|29.0||||||
3880732|NCT01551355|3706717|B6|age 5||Age, Customized||participants|Number|NA|||||||adults
3880733|NCT01551355|3706718|B5|age 5||Age, Customized||participants|Number|NA|||||||adults
3880734|NCT01551355|3706719|B4|age 5||Age, Customized||participants|Number|NA|||||||adults
3880735|NCT01551355|3706720|B3|age 5||Age, Customized||participants|Number|NA|||||||adults
3880736|NCT01551355|3706721|B2|age 5||Age, Customized||participants|Number|19|19.0||||||
3880737|NCT01551355|3706722|B1|age 5||Age, Customized||participants|Number|10|10.0||||||
3880738|NCT01551355|3706716|B7|age 4||Age, Customized||participants|Number|536|536.0||||||
3880739|NCT01551355|3706717|B6|age 4||Age, Customized||participants|Number|NA|||||||adults
3880740|NCT01551355|3706718|B5|age 4||Age, Customized||participants|Number|NA|||||||adults
3880741|NCT01551355|3706719|B4|age 4||Age, Customized||participants|Number|NA|||||||adults
3880742|NCT01551355|3706720|B3|age 4||Age, Customized||participants|Number|NA|||||||adults
3880743|NCT01551355|3706721|B2|age 4||Age, Customized||participants|Number|266|266.0||||||
3880744|NCT01551355|3706722|B1|age 4||Age, Customized||participants|Number|270|270.0||||||
3880745|NCT01551355|3706716|B7|age 3||Age, Customized||participants|Number|651|651.0||||||
3880746|NCT01551355|3706717|B6|age 3||Age, Customized||participants|Number|NA|||||||adults
3880747|NCT01551355|3706718|B5|age 3||Age, Customized||participants|Number|NA|||||||adults
3880748|NCT01551355|3706719|B4|age 3||Age, Customized||participants|Number|NA|||||||adults
3880749|NCT01551355|3706720|B3|age 3||Age, Customized||participants|Number|NA|||||||adults
3880750|NCT01551355|3706721|B2|age 3||Age, Customized||participants|Number|309|309.0||||||
3880751|NCT01551355|3706722|B1|age 3||Age, Customized||participants|Number|342|342.0||||||
3880752|NCT01551355|3706716|B7|||Age||years|Mean|NA||Standard Deviation|NA||||not analyzed
3880753|NCT01551355|3706717|B6|||Age||years|Mean|35.05|35.05|Standard Deviation|8.9|8.9|||
3880754|NCT01551355|3706718|B5|||Age||years|Mean|39.04|39.04|Standard Deviation|10.6|10.6|||
3880755|NCT01551355|3706719|B4|||Age||years|Mean|29.94|29.94|Standard Deviation|6.8|6.8|||
3880756|NCT01551355|3706720|B3|||Age||years|Mean|31.25|31.25|Standard Deviation|8.1|8.1|||
3880757|NCT01551355|3706721|B2|||Age||years|Mean|NA||Standard Deviation|NA||||not analyzed
3880758|NCT01551355|3706722|B1|||Age||years|Mean|NA||Standard Deviation|NA||||not analyzed
3880759|NCT01551303|3706739|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
3880760|NCT01551303|3706740|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
3880761|NCT01551303|3706741|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3880762|NCT01551303|3706739|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3880763|NCT01551303|3706740|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3880764|NCT01551303|3706741|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3880765|NCT01551303|3706739|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3880766|NCT01551303|3706740|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3880767|NCT01551303|3706741|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3880768|NCT01551303|3706739|B3|||Age||years|Mean|43.30|43.3|Standard Deviation|10.67|10.67|||
3880769|NCT01551303|3706740|B2|||Age||years|Mean|44.50|44.5|Standard Deviation|9.62|9.62|||
3880770|NCT01551303|3706741|B1|||Age||years|Mean|42.24|42.24|Standard Deviation|11.61|11.61|||
3880771|NCT01551199|3706748|B1|||Beck Depression Inventory|The Beck Depression Inventory-II (BDI-II) is a measure of depression and consists of 21 items that are rated using a 4-point Likert scale ranging from 0 (little or no distress) to 3 (much distress). The BDI-II ranges from a score of 0 to 63. Interpretation guidelines for the BDI-II are: 0-13 (minimal), 14-19 (mild), 20-28 (moderate), and 29-63 (severe).|units on a scale|Mean|36.4|36.4|Standard Deviation|8.11|8.11|||
3880772|NCT01551199|3706748|B1|||Beck Anxiety Inventory|The Beck Anxiety Inventory (BAI) is a measure of general anxiety and consists of 21 items that are rated using a 4-point Likert scale ranging from 0 (not at all) to 3 (severely). The BAI ranges from a score of 0 to 63. Interpretation guidelines for the BAI are: 0-7 (minimal), 8-15 (mild), 16-25 (moderate), and 26-63 (severe).|units on a scale|Mean|40.6|40.6|Standard Deviation|9.93|9.93|||
3880773|NCT01551199|3706748|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
3880774|NCT01551199|3706748|B1||Female|Gender||Participants|Count of Participants|4|4.0||||||
3880775|NCT01551199|3706748|B1|||Age||years|Mean|37|37.0|Standard Deviation|6.9|6.9|||
3880776|NCT01551186|3706754|B3|United States||Region of Enrollment||participants|Number|70|70.0||||||
3880777|NCT01551186|3706755|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
3880778|NCT01551186|3706756|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3880779|NCT01551186|3706754|B3|Race|Non-white race|Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3880780|NCT01551186|3706755|B2|Race|Non-white race|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3880781|NCT01551186|3706756|B1|Race|Non-white race|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3880782|NCT01551186|3706754|B3|Race|White race|Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
3880783|NCT01551186|3706755|B2|Race|White race|Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3880784|NCT01551186|3706756|B1|Race|White race|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3880785|NCT01551186|3706754|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3880786|NCT01551186|3706755|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3880787|NCT01551186|3706756|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3880788|NCT01551186|3706754|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3880789|NCT01551186|3706755|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3880790|NCT01551186|3706756|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3880791|NCT01551186|3706754|B3|||Age||years|Median|60|60.0|Full Range|||29.0|82.0|
3880792|NCT01551186|3706755|B2|||Age||years|Median|59|59.0|Full Range|||32.0|82.0|
3880793|NCT01551186|3706756|B1|||Age||years|Median|65|65.0|Full Range|||29.0|82.0|
3880794|NCT01551173|3706763|B3||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3880795|NCT01551173|3706764|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3880796|NCT01551173|3706765|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3880797|NCT01551173|3706763|B3||Female|Sex: Female, Male||Participants|Count of Participants|296|296.0||||||
3880798|NCT01551173|3706764|B2||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3880799|NCT01551173|3706765|B1||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3880800|NCT01551173|3706763|B3|||Age||Years|Mean|59.6|59.6|Standard Deviation|8.88|8.88|||
3880801|NCT01551173|3706764|B2|||Age||Years|Mean|60.4|60.4|Standard Deviation|9.30|9.3|||
3880802|NCT01551173|3706765|B1|||Age||Years|Mean|58.8|58.8|Standard Deviation|8.39|8.39|||
3880803|NCT01551095|3706777|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3880804|NCT01551095|3706777|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3880805|NCT01551095|3706777|B1|||Age, Customized||years|Mean|38.3|38.3|Full Range|||24.0|51.0|
3880806|NCT01551082|3706782|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3880807|NCT01551082|3706782|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3880808|NCT01551082|3706782|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3880809|NCT01551082|3706782|B1||>=65 years|Age|All patients > 18 years or older, mixed gender, race, and age who underwent thoracic resection by one surgeon and were discharged home with air leak present and chest tube to portable drainage device|Participants|Count of Participants|8|8.0||||||
3880810|NCT01551082|3706782|B1||Between 18 and 65 years|Age|All patients > 18 years or older, mixed gender, race, and age who underwent thoracic resection by one surgeon and were discharged home with air leak present and chest tube to portable drainage device|Participants|Count of Participants|4|4.0||||||
3880811|NCT01551082|3706782|B1||<=18 years|Age|All patients > 18 years or older, mixed gender, race, and age who underwent thoracic resection by one surgeon and were discharged home with air leak present and chest tube to portable drainage device|Participants|Count of Participants|0|0.0||||||
3880812|NCT01551056|3706786|B3|United States||Region of Enrollment||participants|Number|91|91.0||||||
3880813|NCT01551056|3706787|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
3880814|NCT01551056|3706788|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
3880815|NCT01551056|3706786|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880816|NCT01551056|3706787|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880817|NCT01551056|3706788|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880818|NCT01551056|3706786|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880819|NCT01551056|3706787|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880820|NCT01551056|3706788|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880821|NCT01551056|3706786|B3||White|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3880822|NCT01551056|3706787|B2||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3880823|NCT01551056|3706788|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3880824|NCT01551056|3706786|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3880825|NCT01551056|3706787|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3880826|NCT01551056|3706788|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3880827|NCT01551056|3706786|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880828|NCT01551056|3706787|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880829|NCT01551056|3706788|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880830|NCT01551056|3706786|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880831|NCT01551056|3706787|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880832|NCT01551056|3706788|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880833|NCT01551056|3706786|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3880834|NCT01551056|3706787|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3880835|NCT01551056|3706788|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3880836|NCT01551056|3706786|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880837|NCT01551056|3706787|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880838|NCT01551056|3706788|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880839|NCT01551056|3706786|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3880840|NCT01551056|3706787|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3880841|NCT01551056|3706788|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3880842|NCT01551056|3706786|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3880843|NCT01551056|3706787|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3880844|NCT01551056|3706788|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3880845|NCT01551056|3706786|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3880846|NCT01551056|3706787|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3880847|NCT01551056|3706788|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3880848|NCT01551056|3706786|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3880849|NCT01551056|3706787|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3880850|NCT01551056|3706788|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3880851|NCT01551056|3706786|B3|||Age||years|Mean|37.4|37.4|Standard Deviation|14.47|14.47|||
3880852|NCT01551056|3706787|B2|||Age||years|Mean|38.1|38.1|Standard Deviation|14.08|14.08|||
3880853|NCT01551056|3706788|B1|||Age||years|Mean|36.6|36.6|Standard Deviation|14.95|14.95|||
3880854|NCT01550965|3706843|B1||Male|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
3880855|NCT01550965|3706843|B1||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
3880856|NCT01550965|3706843|B1|||Age||years|Mean|41.8|41.8|Standard Deviation|13.75|13.75|||
3880857|NCT01550952|3706862|B1|Obese||Body Mass Index||participants|Number|6|6.0||||||
3880858|NCT01550952|3706862|B1|Overweight||Body Mass Index||participants|Number|3|3.0||||||
3880859|NCT01550952|3706862|B1|Normal||Body Mass Index||participants|Number|1|1.0||||||
3880860|NCT01550952|3706862|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3880861|NCT01550952|3706862|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3880862|NCT01550952|3706862|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3880863|NCT01550952|3706862|B1|||Age||years|Mean|72|72.0|Standard Deviation|4|4.0|||
3880864|NCT01550809|3706870|B3|Spain||Region of Enrollment||participants|Number|12|12.0||||||
3880865|NCT01550809|3706871|B2|Spain||Region of Enrollment||participants|Number|6|6.0||||||
3880866|NCT01550809|3706872|B1|Spain||Region of Enrollment||participants|Number|6|6.0||||||
3880867|NCT01550809|3706870|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3880868|NCT01550809|3706871|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3880869|NCT01550809|3706872|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3880870|NCT01550809|3706870|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3880871|NCT01550809|3706871|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3880872|NCT01550809|3706872|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3880873|NCT01550809|3706870|B3|||Age||years|Mean|41.8|41.8|Standard Deviation|7.3|7.3|||
3880874|NCT01550809|3706871|B2|||Age||years|Mean|40.3|40.3|Standard Deviation|7.9|7.9|||
3880875|NCT01550809|3706872|B1|||Age||years|Mean|43.6|43.6|Standard Deviation|6.8|6.8|||
3880876|NCT01550809|3706870|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3880877|NCT01550809|3706871|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3880878|NCT01550809|3706872|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3880879|NCT01550809|3706870|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3880880|NCT01550809|3706871|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3880881|NCT01550809|3706872|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3880882|NCT01550809|3706870|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3880883|NCT01550809|3706871|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3880884|NCT01550809|3706872|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3880885|NCT01550757|3706883|B5|United States||Region of Enrollment||participants|Number|366|366.0||||||
3880886|NCT01550757|3706884|B4|United States||Region of Enrollment||participants|Number|138|138.0||||||
3880887|NCT01550757|3706885|B3|United States||Region of Enrollment||participants|Number|128|128.0||||||
3880888|NCT01550757|3706886|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
3880889|NCT01550757|3706887|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
3880890|NCT01550757|3706883|B5||Male|Sex: Female, Male||Participants|Count of Participants|366|366.0||||||
3880891|NCT01550757|3706884|B4||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3880892|NCT01550757|3706885|B3||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3880893|NCT01550757|3706886|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3880894|NCT01550757|3706887|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3880895|NCT01550757|3706883|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3880896|NCT01550757|3706884|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3880897|NCT01550757|3706885|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3880898|NCT01550757|3706886|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3880899|NCT01550757|3706887|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3880900|NCT01550757|3706883|B5|||Age||years|Mean|52.2|52.2|Standard Deviation|1.8|1.8|||
3880901|NCT01550757|3706884|B4|||Age||years|Mean|52.6|52.6|Standard Deviation|9.4|9.4|||
3880902|NCT01550757|3706885|B3|||Age||years|Mean|51.2|51.2|Standard Deviation|9.5|9.5|||
3880903|NCT01550757|3706886|B2|||Age||years|Mean|50.3|50.3|Standard Deviation|10.0|10.0|||
3880904|NCT01550757|3706887|B1|||Age||years|Mean|54.5|54.5|Standard Deviation|8.8|8.8|||
3880905|NCT01550757|3706883|B5||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
3880906|NCT01550757|3706884|B4||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3880907|NCT01550757|3706885|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3880908|NCT01550757|3706886|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3880909|NCT01550757|3706887|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3880910|NCT01550757|3706883|B5||Between 18 and 65 years|Age||Participants|Count of Participants|351|351.0||||||
3880911|NCT01550757|3706884|B4||Between 18 and 65 years|Age||Participants|Count of Participants|130|130.0||||||
3880912|NCT01550757|3706885|B3||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
3880913|NCT01550757|3706886|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3880914|NCT01550757|3706887|B1||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3880915|NCT01550757|3706883|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3880916|NCT01550757|3706884|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3880917|NCT01550757|3706885|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3880918|NCT01550757|3706886|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3880919|NCT01550757|3706887|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3880920|NCT01550744|3706900|B1|United States||Region of Enrollment||participants|Number|478|478.0||||||
3880921|NCT01550744|3706900|B1||Male|Gender||Participants|Count of Participants|301|301.0||||||
3880922|NCT01550744|3706900|B1||Female|Gender||Participants|Count of Participants|177|177.0||||||
3880923|NCT01550744|3706900|B1|||Age||years|Mean|45.4|45.4|Standard Deviation|14.19|14.19|||
3880924|NCT01550705|3706915|B1|||Baseline Protoporphyrin IX level||micrograms per deciliter (µg/dL)|Mean|13.3|13.3|Standard Deviation|14.4|14.4|||
3880925|NCT01550705|3706915|B1||X-linked Erythropoietic Protoporphyria (XLEPP)|Protoporphyria Type||Participants|Count of Participants|2|2.0||||||
3880926|NCT01550705|3706915|B1||Erythropoietic Protoporphyria (EPP)|Protoporphyria Type||Participants|Count of Participants|9|9.0||||||
3880927|NCT01550705|3706915|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
3880928|NCT01550705|3706915|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
3880929|NCT01550705|3706915|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3880930|NCT01550705|3706915|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3880931|NCT01550705|3706915|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3880932|NCT01550549|3706920|B1|United States||Region of Enrollment||participants|Number|151|151.0||||||
3880933|NCT01550549|3706920|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3880934|NCT01550549|3706920|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3880935|NCT01550549|3706920|B1|||Age||years|Mean|74.9|74.9|Standard Deviation|11.87|11.87|||
3880936|NCT01550510|3706932|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3880937|NCT01550510|3706932|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3880938|NCT01550510|3706932|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880939|NCT01550510|3706932|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3880940|NCT01550510|3706932|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3880941|NCT01550510|3706932|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880942|NCT01550510|3706932|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880943|NCT01550510|3706932|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880944|NCT01550510|3706932|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880945|NCT01550510|3706932|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3880946|NCT01550510|3706932|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3880947|NCT01550510|3706932|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3880948|NCT01550510|3706932|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3880949|NCT01550510|3706932|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3880950|NCT01550510|3706932|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3880951|NCT01550510|3706932|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3880952|NCT01550302|3706937|B3|||Duration of Surgery||minutes|Mean|216|216.0|Standard Deviation|96|96.0|||
3880953|NCT01550302|3706938|B2|||Duration of Surgery||minutes|Mean|251|251.0|Standard Deviation|108|108.0|||
3880954|NCT01550302|3706939|B1|||Duration of Surgery||minutes|Mean|181|181.0|Standard Deviation|70|70.0|||
3880955|NCT01550302|3706937|B3|||Weight||kg|Mean|77.9|77.9|Standard Deviation|18.2|18.2|||
3880956|NCT01550302|3706938|B2|||Weight||kg|Mean|66.2|66.2|Standard Deviation|18.7|18.7|||
3880957|NCT01550302|3706939|B1|||Weight||kg|Mean|89.7|89.7|Standard Deviation|6.0|6.0|||
3880958|NCT01550302|3706937|B3|||Height||cm|Mean|168.7|168.7|Standard Deviation|13.8|13.8|||
3880959|NCT01550302|3706938|B2|||Height||cm|Mean|156.4|156.4|Standard Deviation|4.6|4.6|||
3880960|NCT01550302|3706939|B1|||Height||cm|Mean|181.0|181.0|Standard Deviation|7.6|7.6|||
3880961|NCT01550302|3706937|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3880962|NCT01550302|3706938|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3880963|NCT01550302|3706939|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3880964|NCT01550302|3706937|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3880965|NCT01550302|3706938|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3880966|NCT01550302|3706939|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3880967|NCT01550302|3706937|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3880968|NCT01550302|3706938|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3880969|NCT01550302|3706939|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3880970|NCT01550302|3706937|B3|||Age||years|Mean|58.8|58.8|Standard Deviation|7.3|7.3|||
3880971|NCT01550302|3706938|B2|||Age||years|Mean|58.8|58.8|Standard Deviation|6.7|6.7|||
3880972|NCT01550302|3706939|B1|||Age||years|Mean|58.8|58.8|Standard Deviation|8.7|8.7|||
3880973|NCT01550289|3706958|B3|India||Region of Enrollment||Participants|Count of Participants|187|187.0||||||
3880974|NCT01550289|3706959|B2|India||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
3880975|NCT01550289|3706960|B1|India||Region of Enrollment||Participants|Count of Participants|126|126.0||||||
3880976|NCT01550289|3706958|B3||Male|Gender||Participants|Count of Participants|151|151.0||||||
3880977|NCT01550289|3706959|B2||Male|Gender||Participants|Count of Participants|52|52.0||||||
3880978|NCT01550289|3706960|B1||Male|Gender||Participants|Count of Participants|99|99.0||||||
3880979|NCT01550289|3706958|B3||Female|Gender||Participants|Count of Participants|36|36.0||||||
3880980|NCT01550289|3706959|B2||Female|Gender||Participants|Count of Participants|9|9.0||||||
3880981|NCT01550289|3706960|B1||Female|Gender||Participants|Count of Participants|27|27.0||||||
3880982|NCT01550289|3706958|B3|||Age||Years|Mean|29.5|29.5|Standard Deviation|6.91|6.91|||
3880983|NCT01550289|3706959|B2|||Age||Years|Mean|29.6|29.6|Standard Deviation|6.41|6.41|||
3880984|NCT01550289|3706960|B1|||Age||Years|Mean|29.5|29.5|Standard Deviation|7.17|7.17|||
3880985|NCT01550289|3706958|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3880986|NCT01550289|3706959|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3880987|NCT01550289|3706960|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3880988|NCT01550289|3706958|B3||Between 18 and 65 years|Age||Participants|Count of Participants|187|187.0||||||
3880989|NCT01550289|3706959|B2||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
3880990|NCT01550289|3706960|B1||Between 18 and 65 years|Age||Participants|Count of Participants|126|126.0||||||
3880991|NCT01550289|3706958|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3880992|NCT01550289|3706959|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3880993|NCT01550289|3706960|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3880994|NCT01550224|3706991|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
3880995|NCT01550224|3706992|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3880996|NCT01550224|3706993|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3880997|NCT01550224|3706991|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3880998|NCT01550224|3706992|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3880999|NCT01550224|3706993|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3881000|NCT01550224|3706991|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881001|NCT01550224|3706992|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881002|NCT01550224|3706993|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881003|NCT01550224|3706991|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3881004|NCT01550224|3706992|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3881005|NCT01550224|3706993|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3881006|NCT01550224|3706991|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881007|NCT01550224|3706992|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881008|NCT01550224|3706993|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881009|NCT01550224|3706991|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881010|NCT01550224|3706992|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881011|NCT01550224|3706993|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881012|NCT01550224|3706991|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3881013|NCT01550224|3706992|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3881014|NCT01550224|3706993|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3881015|NCT01550224|3706991|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881016|NCT01550224|3706992|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881017|NCT01550224|3706993|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881018|NCT01550224|3706991|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3881019|NCT01550224|3706992|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3881020|NCT01550224|3706993|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881021|NCT01550224|3706991|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3881022|NCT01550224|3706992|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3881023|NCT01550224|3706993|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3881024|NCT01550224|3706991|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3881025|NCT01550224|3706992|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3881026|NCT01550224|3706993|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881027|NCT01550224|3706991|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3881028|NCT01550224|3706992|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3881029|NCT01550224|3706993|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3881030|NCT01550224|3706991|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3881031|NCT01550224|3706992|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3881032|NCT01550224|3706993|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3881033|NCT01550224|3706991|B3|||Age||years|Median|82.7|82.7|Full Range|||71.0|89.3|
3881034|NCT01550224|3706992|B2|||Age||years|Median|83|83.0|Full Range|||72.4|89.3|
3881035|NCT01550224|3706993|B1|||Age||years|Median|76.3|76.3|Full Range|||71.0|85.0|
3881036|NCT01550224|3706991|B3||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3881037|NCT01550224|3706992|B2||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3881038|NCT01550224|3706993|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3881039|NCT01550224|3706991|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3881040|NCT01550224|3706992|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3881041|NCT01550224|3706993|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3881042|NCT01550224|3706991|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3881043|NCT01550224|3706992|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3881044|NCT01550224|3706993|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3881045|NCT01549977|3707016|B3|Male||Gender||participants|Number|1|1.0||||||
3881046|NCT01549977|3707018|B1|Male||Gender||participants|Number|1|1.0||||||
3881047|NCT01549977|3707016|B3|Female||Gender||participants|Number|0|0.0||||||
3881048|NCT01549977|3707018|B1|Female||Gender||participants|Number|0|0.0||||||
3881049|NCT01549977|3707016|B3|≥ 65 years||Age, Customized||participants|Number|1|1.0||||||
3881050|NCT01549977|3707018|B1|≥ 65 years||Age, Customized||participants|Number|1|1.0||||||
3881051|NCT01549977|3707016|B3|18 to 65 years||Age, Customized||participants|Number|0|0.0||||||
3881052|NCT01549977|3707018|B1|18 to 65 years||Age, Customized||participants|Number|0|0.0||||||
3881053|NCT01549964|3707033|B5|||Fasting Plasma Glucose|Data is only available for 258 and 259 participants in the sitagliptin 100 mg and fasiglifam 50 mg treatment arms, respectively.|ng/dL|Mean|NA||Standard Deviation|NA||||Not determined.
3881054|NCT01549964|3707034|B4|||Fasting Plasma Glucose|Data is only available for 258 and 259 participants in the sitagliptin 100 mg and fasiglifam 50 mg treatment arms, respectively.|ng/dL|Mean|180.0|180.0|Standard Deviation|37.98|37.98|||
3881055|NCT01549964|3707035|B3|||Fasting Plasma Glucose|Data is only available for 258 and 259 participants in the sitagliptin 100 mg and fasiglifam 50 mg treatment arms, respectively.|ng/dL|Mean|179.0|179.0|Standard Deviation|33.52|33.52|||
3881056|NCT01549964|3707036|B2|||Fasting Plasma Glucose|Data is only available for 258 and 259 participants in the sitagliptin 100 mg and fasiglifam 50 mg treatment arms, respectively.|ng/dL|Mean|175.6|175.6|Standard Deviation|37.67|37.67|||
3881057|NCT01549964|3707037|B1|||Fasting Plasma Glucose|Data is only available for 258 and 259 participants in the sitagliptin 100 mg and fasiglifam 50 mg treatment arms, respectively.|ng/dL|Mean|178.4|178.4|Standard Deviation|36.94|36.94|||
3881058|NCT01549964|3707033|B5|||Duration of Diabetes||years|Mean|6.393|6.393|Standard Deviation|5.143|5.143|||
3881059|NCT01549964|3707034|B4|||Duration of Diabetes||years|Mean|6.375|6.375|Standard Deviation|5.214|5.214|||
3881060|NCT01549964|3707035|B3|||Duration of Diabetes||years|Mean|6.726|6.726|Standard Deviation|4.615|4.615|||
3881061|NCT01549964|3707036|B2|||Duration of Diabetes||years|Mean|5.940|5.94|Standard Deviation|4.942|4.942|||
3881062|NCT01549964|3707037|B1|||Duration of Diabetes||years|Mean|6.655|6.655|Standard Deviation|6.262|6.262|||
3881063|NCT01549964|3707033|B5|Data Not Available||HbA1c Category|HbA1c data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|1|1.0||||||
3881064|NCT01549964|3707034|B4|Data Not Available||HbA1c Category|HbA1c data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|1|1.0||||||
3881065|NCT01549964|3707035|B3|Data Not Available||HbA1c Category|HbA1c data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|0|0.0||||||
3881066|NCT01549964|3707036|B2|Data Not Available||HbA1c Category|HbA1c data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|0|0.0||||||
3881067|NCT01549964|3707037|B1|Data Not Available||HbA1c Category|HbA1c data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|0|0.0||||||
3881068|NCT01549964|3707033|B5|≥ 8.5%||HbA1c Category|HbA1c data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|377|377.0||||||
3881069|NCT01549964|3707034|B4|≥ 8.5%||HbA1c Category|HbA1c data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|112|112.0||||||
3881070|NCT01549964|3707035|B3|≥ 8.5%||HbA1c Category|HbA1c data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|109|109.0||||||
3881071|NCT01549964|3707036|B2|≥ 8.5%||HbA1c Category|HbA1c data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|104|104.0||||||
3881072|NCT01549964|3707037|B1|≥ 8.5%||HbA1c Category|HbA1c data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|52|52.0||||||
3881073|NCT01549964|3707033|B5|< 8.5%||HbA1c Category|HbA1c data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|538|538.0||||||
3881074|NCT01549964|3707034|B4|< 8.5%||HbA1c Category|HbA1c data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|148|148.0||||||
3881075|NCT01549964|3707035|B3|< 8.5%||HbA1c Category|HbA1c data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|154|154.0||||||
3881076|NCT01549964|3707036|B2|< 8.5%||HbA1c Category|HbA1c data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|156|156.0||||||
3881077|NCT01549964|3707037|B1|< 8.5%||HbA1c Category|HbA1c data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|80|80.0||||||
3881078|NCT01549964|3707033|B5|||Glycosylated Hemoglobin (HbA1c)|HbA1c data is available for 258 and 260 participants in the sitagliptin 100 mg and fasiglifam 50 mg treatment arms, respectively.|percent|Mean|NA||Standard Deviation|NA||||Not determined
3881079|NCT01549964|3707034|B4|||Glycosylated Hemoglobin (HbA1c)|HbA1c data is available for 258 and 260 participants in the sitagliptin 100 mg and fasiglifam 50 mg treatment arms, respectively.|percent|Mean|8.43|8.43|Standard Deviation|0.765|0.765|||
3881080|NCT01549964|3707035|B3|||Glycosylated Hemoglobin (HbA1c)|HbA1c data is available for 258 and 260 participants in the sitagliptin 100 mg and fasiglifam 50 mg treatment arms, respectively.|percent|Mean|8.41|8.41|Standard Deviation|0.712|0.712|||
3881081|NCT01549964|3707036|B2|||Glycosylated Hemoglobin (HbA1c)|HbA1c data is available for 258 and 260 participants in the sitagliptin 100 mg and fasiglifam 50 mg treatment arms, respectively.|percent|Mean|8.35|8.35|Standard Deviation|0.694|0.694|||
3881082|NCT01549964|3707037|B1|||Glycosylated Hemoglobin (HbA1c)|HbA1c data is available for 258 and 260 participants in the sitagliptin 100 mg and fasiglifam 50 mg treatment arms, respectively.|percent|Mean|8.34|8.34|Standard Deviation|0.739|0.739|||
3881083|NCT01549964|3707033|B5|Data Not Available||BMI Category|BMI data is available for 262 and 260 participants in the fasiglifam 25 mg and fasiglifam 50 mg treatment arms, respectively.|participants|Number|2|2.0||||||
3881084|NCT01549964|3707034|B4|Data Not Available||BMI Category|BMI data is available for 262 and 260 participants in the fasiglifam 25 mg and fasiglifam 50 mg treatment arms, respectively.|participants|Number|1|1.0||||||
3881085|NCT01549964|3707035|B3|Data Not Available||BMI Category|BMI data is available for 262 and 260 participants in the fasiglifam 25 mg and fasiglifam 50 mg treatment arms, respectively.|participants|Number|1|1.0||||||
3881086|NCT01549964|3707036|B2|Data Not Available||BMI Category|BMI data is available for 262 and 260 participants in the fasiglifam 25 mg and fasiglifam 50 mg treatment arms, respectively.|participants|Number|0|0.0||||||
3881087|NCT01549964|3707037|B1|Data Not Available||BMI Category|BMI data is available for 262 and 260 participants in the fasiglifam 25 mg and fasiglifam 50 mg treatment arms, respectively.|participants|Number|0|0.0||||||
3881088|NCT01549964|3707033|B5|≥ 30 kg/m^2||BMI Category|BMI data is available for 262 and 260 participants in the fasiglifam 25 mg and fasiglifam 50 mg treatment arms, respectively.|participants|Number|562|562.0||||||
3881089|NCT01549964|3707034|B4|≥ 30 kg/m^2||BMI Category|BMI data is available for 262 and 260 participants in the fasiglifam 25 mg and fasiglifam 50 mg treatment arms, respectively.|participants|Number|159|159.0||||||
3881090|NCT01549964|3707035|B3|≥ 30 kg/m^2||BMI Category|BMI data is available for 262 and 260 participants in the fasiglifam 25 mg and fasiglifam 50 mg treatment arms, respectively.|participants|Number|170|170.0||||||
3881091|NCT01549964|3707036|B2|≥ 30 kg/m^2||BMI Category|BMI data is available for 262 and 260 participants in the fasiglifam 25 mg and fasiglifam 50 mg treatment arms, respectively.|participants|Number|154|154.0||||||
3881136|NCT01549964|3707036|B2|Korea, Republic Of||Region of Enrollment||participants|Number|4|4.0||||||
3881092|NCT01549964|3707037|B1|≥ 30 kg/m^2||BMI Category|BMI data is available for 262 and 260 participants in the fasiglifam 25 mg and fasiglifam 50 mg treatment arms, respectively.|participants|Number|79|79.0||||||
3881093|NCT01549964|3707033|B5|< 30 kg/m^2||BMI Category|BMI data is available for 262 and 260 participants in the fasiglifam 25 mg and fasiglifam 50 mg treatment arms, respectively.|participants|Number|352|352.0||||||
3881094|NCT01549964|3707034|B4|< 30 kg/m^2||BMI Category|BMI data is available for 262 and 260 participants in the fasiglifam 25 mg and fasiglifam 50 mg treatment arms, respectively.|participants|Number|101|101.0||||||
3881095|NCT01549964|3707035|B3|< 30 kg/m^2||BMI Category|BMI data is available for 262 and 260 participants in the fasiglifam 25 mg and fasiglifam 50 mg treatment arms, respectively.|participants|Number|92|92.0||||||
3881096|NCT01549964|3707036|B2|< 30 kg/m^2||BMI Category|BMI data is available for 262 and 260 participants in the fasiglifam 25 mg and fasiglifam 50 mg treatment arms, respectively.|participants|Number|106|106.0||||||
3881097|NCT01549964|3707037|B1|< 30 kg/m^2||BMI Category|BMI data is available for 262 and 260 participants in the fasiglifam 25 mg and fasiglifam 50 mg treatment arms, respectively.|participants|Number|53|53.0||||||
3881098|NCT01549964|3707033|B5|||Body Mass Index (BMI)|BMI data is available for 262 and 260 participants in the fasiglifam 25 mg and fasiglifam 50 mg treatment arms, respectively.|kg/m^2|Mean|32.00|32.0|Standard Deviation|5.312|5.312|||
3881099|NCT01549964|3707034|B4|||Body Mass Index (BMI)|BMI data is available for 262 and 260 participants in the fasiglifam 25 mg and fasiglifam 50 mg treatment arms, respectively.|kg/m^2|Mean|32.16|32.16|Standard Deviation|5.651|5.651|||
3881100|NCT01549964|3707035|B3|||Body Mass Index (BMI)|BMI data is available for 262 and 260 participants in the fasiglifam 25 mg and fasiglifam 50 mg treatment arms, respectively.|kg/m^2|Mean|32.11|32.11|Standard Deviation|5.126|5.126|||
3881101|NCT01549964|3707036|B2|||Body Mass Index (BMI)|BMI data is available for 262 and 260 participants in the fasiglifam 25 mg and fasiglifam 50 mg treatment arms, respectively.|kg/m^2|Mean|31.68|31.68|Standard Deviation|5.282|5.282|||
3881102|NCT01549964|3707037|B1|||Body Mass Index (BMI)|BMI data is available for 262 and 260 participants in the fasiglifam 25 mg and fasiglifam 50 mg treatment arms, respectively.|kg/m^2|Mean|32.06|32.06|Standard Deviation|5.070|5.07|||
3881103|NCT01549964|3707033|B5|||Height|Height data is available for 262 and 260 participants in the fasiglifam 25 mg and fasiglifam 50 mg treatment arms, respectively.|cm|Mean|168.7|168.7|Standard Deviation|10.34|10.34|||
3881104|NCT01549964|3707034|B4|||Height|Height data is available for 262 and 260 participants in the fasiglifam 25 mg and fasiglifam 50 mg treatment arms, respectively.|cm|Mean|168.4|168.4|Standard Deviation|9.85|9.85|||
3881105|NCT01549964|3707035|B3|||Height|Height data is available for 262 and 260 participants in the fasiglifam 25 mg and fasiglifam 50 mg treatment arms, respectively.|cm|Mean|168.5|168.5|Standard Deviation|10.53|10.53|||
3881106|NCT01549964|3707036|B2|||Height|Height data is available for 262 and 260 participants in the fasiglifam 25 mg and fasiglifam 50 mg treatment arms, respectively.|cm|Mean|169.4|169.4|Standard Deviation|10.74|10.74|||
3881107|NCT01549964|3707037|B1|||Height|Height data is available for 262 and 260 participants in the fasiglifam 25 mg and fasiglifam 50 mg treatment arms, respectively.|cm|Mean|168.2|168.2|Standard Deviation|10.08|10.08|||
3881108|NCT01549964|3707033|B5|||Weight|Weight data is available for 260 participants in the fasiglifam 50 mg treatment arm.|kg|Mean|91.42|91.42|Standard Deviation|18.776|18.776|||
3881109|NCT01549964|3707034|B4|||Weight|Weight data is available for 260 participants in the fasiglifam 50 mg treatment arm.|kg|Mean|91.53|91.53|Standard Deviation|18.772|18.772|||
3881110|NCT01549964|3707035|B3|||Weight|Weight data is available for 260 participants in the fasiglifam 50 mg treatment arm.|kg|Mean|91.44|91.44|Standard Deviation|17.859|17.859|||
3881111|NCT01549964|3707036|B2|||Weight|Weight data is available for 260 participants in the fasiglifam 50 mg treatment arm.|kg|Mean|91.41|91.41|Standard Deviation|19.664|19.664|||
3881112|NCT01549964|3707037|B1|||Weight|Weight data is available for 260 participants in the fasiglifam 50 mg treatment arm.|kg|Mean|91.15|91.15|Standard Deviation|18.988|18.988|||
3881113|NCT01549964|3707033|B5|United States||Region of Enrollment||participants|Number|268|268.0||||||
3881114|NCT01549964|3707034|B4|United States||Region of Enrollment||participants|Number|77|77.0||||||
3881115|NCT01549964|3707035|B3|United States||Region of Enrollment||participants|Number|76|76.0||||||
3881116|NCT01549964|3707036|B2|United States||Region of Enrollment||participants|Number|76|76.0||||||
3881117|NCT01549964|3707037|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
3881118|NCT01549964|3707033|B5|Thailand||Region of Enrollment||participants|Number|48|48.0||||||
3881119|NCT01549964|3707034|B4|Thailand||Region of Enrollment||participants|Number|14|14.0||||||
3881120|NCT01549964|3707035|B3|Thailand||Region of Enrollment||participants|Number|13|13.0||||||
3881121|NCT01549964|3707036|B2|Thailand||Region of Enrollment||participants|Number|14|14.0||||||
3881122|NCT01549964|3707037|B1|Thailand||Region of Enrollment||participants|Number|7|7.0||||||
3881123|NCT01549964|3707033|B5|Slovakia||Region of Enrollment||participants|Number|231|231.0||||||
3881124|NCT01549964|3707034|B4|Slovakia||Region of Enrollment||participants|Number|66|66.0||||||
3881125|NCT01549964|3707035|B3|Slovakia||Region of Enrollment||participants|Number|65|65.0||||||
3881126|NCT01549964|3707036|B2|Slovakia||Region of Enrollment||participants|Number|66|66.0||||||
3881127|NCT01549964|3707037|B1|Slovakia||Region of Enrollment||participants|Number|34|34.0||||||
3881128|NCT01549964|3707033|B5|Malaysia||Region of Enrollment||participants|Number|25|25.0||||||
3881129|NCT01549964|3707034|B4|Malaysia||Region of Enrollment||participants|Number|8|8.0||||||
3881130|NCT01549964|3707035|B3|Malaysia||Region of Enrollment||participants|Number|7|7.0||||||
3881131|NCT01549964|3707036|B2|Malaysia||Region of Enrollment||participants|Number|8|8.0||||||
3881132|NCT01549964|3707037|B1|Malaysia||Region of Enrollment||participants|Number|2|2.0||||||
3881133|NCT01549964|3707033|B5|Korea, Republic Of||Region of Enrollment||participants|Number|12|12.0||||||
3881134|NCT01549964|3707034|B4|Korea, Republic Of||Region of Enrollment||participants|Number|2|2.0||||||
3881135|NCT01549964|3707035|B3|Korea, Republic Of||Region of Enrollment||participants|Number|4|4.0||||||
3881137|NCT01549964|3707037|B1|Korea, Republic Of||Region of Enrollment||participants|Number|2|2.0||||||
3881138|NCT01549964|3707033|B5|Italy||Region of Enrollment||participants|Number|9|9.0||||||
3881139|NCT01549964|3707034|B4|Italy||Region of Enrollment||participants|Number|2|2.0||||||
3881140|NCT01549964|3707035|B3|Italy||Region of Enrollment||participants|Number|3|3.0||||||
3881141|NCT01549964|3707036|B2|Italy||Region of Enrollment||participants|Number|3|3.0||||||
3881142|NCT01549964|3707037|B1|Italy||Region of Enrollment||participants|Number|1|1.0||||||
3881143|NCT01549964|3707033|B5|Hungary||Region of Enrollment||participants|Number|206|206.0||||||
3881144|NCT01549964|3707034|B4|Hungary||Region of Enrollment||participants|Number|60|60.0||||||
3881145|NCT01549964|3707035|B3|Hungary||Region of Enrollment||participants|Number|61|61.0||||||
3881146|NCT01549964|3707036|B2|Hungary||Region of Enrollment||participants|Number|56|56.0||||||
3881147|NCT01549964|3707037|B1|Hungary||Region of Enrollment||participants|Number|29|29.0||||||
3881148|NCT01549964|3707033|B5|Czech Republic||Region of Enrollment||participants|Number|51|51.0||||||
3881149|NCT01549964|3707034|B4|Czech Republic||Region of Enrollment||participants|Number|14|14.0||||||
3881150|NCT01549964|3707035|B3|Czech Republic||Region of Enrollment||participants|Number|14|14.0||||||
3881151|NCT01549964|3707036|B2|Czech Republic||Region of Enrollment||participants|Number|15|15.0||||||
3881152|NCT01549964|3707037|B1|Czech Republic||Region of Enrollment||participants|Number|8|8.0||||||
3881153|NCT01549964|3707033|B5|Croatia||Region of Enrollment||participants|Number|24|24.0||||||
3881154|NCT01549964|3707034|B4|Croatia||Region of Enrollment||participants|Number|6|6.0||||||
3881155|NCT01549964|3707035|B3|Croatia||Region of Enrollment||participants|Number|8|8.0||||||
3881156|NCT01549964|3707036|B2|Croatia||Region of Enrollment||participants|Number|6|6.0||||||
3881157|NCT01549964|3707037|B1|Croatia||Region of Enrollment||participants|Number|4|4.0||||||
3881158|NCT01549964|3707033|B5|Bulgaria||Region of Enrollment||participants|Number|24|24.0||||||
3881159|NCT01549964|3707034|B4|Bulgaria||Region of Enrollment||participants|Number|7|7.0||||||
3881160|NCT01549964|3707035|B3|Bulgaria||Region of Enrollment||participants|Number|7|7.0||||||
3881161|NCT01549964|3707036|B2|Bulgaria||Region of Enrollment||participants|Number|7|7.0||||||
3881162|NCT01549964|3707037|B1|Bulgaria||Region of Enrollment||participants|Number|3|3.0||||||
3881163|NCT01549964|3707033|B5|Australia||Region of Enrollment||participants|Number|18|18.0||||||
3881164|NCT01549964|3707034|B4|Australia||Region of Enrollment||participants|Number|5|5.0||||||
3881165|NCT01549964|3707035|B3|Australia||Region of Enrollment||participants|Number|5|5.0||||||
3881166|NCT01549964|3707036|B2|Australia||Region of Enrollment||participants|Number|5|5.0||||||
3881167|NCT01549964|3707037|B1|Australia||Region of Enrollment||participants|Number|3|3.0||||||
3881168|NCT01549964|3707033|B5|Not Collected||Race/Ethnicity, Customized||participants|Number|623|623.0||||||
3881169|NCT01549964|3707034|B4|Not Collected||Race/Ethnicity, Customized||participants|Number|178|178.0||||||
3881170|NCT01549964|3707035|B3|Not Collected||Race/Ethnicity, Customized||participants|Number|182|182.0||||||
3881171|NCT01549964|3707036|B2|Not Collected||Race/Ethnicity, Customized||participants|Number|172|172.0||||||
3881172|NCT01549964|3707037|B1|Not Collected||Race/Ethnicity, Customized||participants|Number|91|91.0||||||
3881173|NCT01549964|3707033|B5|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|195|195.0||||||
3881174|NCT01549964|3707034|B4|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
3881175|NCT01549964|3707035|B3|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
3881176|NCT01549964|3707036|B2|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
3881177|NCT01549964|3707037|B1|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3881178|NCT01549964|3707033|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|98|98.0||||||
3881179|NCT01549964|3707034|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3881180|NCT01549964|3707035|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3881181|NCT01549964|3707036|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3881182|NCT01549964|3707037|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3881183|NCT01549964|3707033|B5|Data Not Available||Race/Ethnicity, Customized|Race data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|1|1.0||||||
3881184|NCT01549964|3707034|B4|Data Not Available||Race/Ethnicity, Customized|Race data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|1|1.0||||||
3881185|NCT01549964|3707035|B3|Data Not Available||Race/Ethnicity, Customized|Race data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|0|0.0||||||
3881186|NCT01549964|3707036|B2|Data Not Available||Race/Ethnicity, Customized|Race data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|0|0.0||||||
3881187|NCT01549964|3707037|B1|Data Not Available||Race/Ethnicity, Customized|Race data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|0|0.0||||||
3881188|NCT01549964|3707033|B5|Multiracial||Race/Ethnicity, Customized|Race data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|1|1.0||||||
3881189|NCT01549964|3707034|B4|Multiracial||Race/Ethnicity, Customized|Race data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|0|0.0||||||
3881190|NCT01549964|3707035|B3|Multiracial||Race/Ethnicity, Customized|Race data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|0|0.0||||||
3881191|NCT01549964|3707036|B2|Multiracial||Race/Ethnicity, Customized|Race data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|1|1.0||||||
3881235|NCT01549964|3707035|B3|< 65 years||Age, Customized||participants|Number|216|216.0||||||
3881192|NCT01549964|3707037|B1|Multiracial||Race/Ethnicity, Customized|Race data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|0|0.0||||||
3881193|NCT01549964|3707033|B5|White||Race/Ethnicity, Customized|Race data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|759|759.0||||||
3881194|NCT01549964|3707034|B4|White||Race/Ethnicity, Customized|Race data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|217|217.0||||||
3881195|NCT01549964|3707035|B3|White||Race/Ethnicity, Customized|Race data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|214|214.0||||||
3881196|NCT01549964|3707036|B2|White||Race/Ethnicity, Customized|Race data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|216|216.0||||||
3881197|NCT01549964|3707037|B1|White||Race/Ethnicity, Customized|Race data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|112|112.0||||||
3881198|NCT01549964|3707033|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Race data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|2|2.0||||||
3881199|NCT01549964|3707034|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Race data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|2|2.0||||||
3881200|NCT01549964|3707035|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Race data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|0|0.0||||||
3881201|NCT01549964|3707036|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Race data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|0|0.0||||||
3881202|NCT01549964|3707037|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Race data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|0|0.0||||||
3881203|NCT01549964|3707033|B5|Black or African American||Race/Ethnicity, Customized|Race data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|52|52.0||||||
3881204|NCT01549964|3707034|B4|Black or African American||Race/Ethnicity, Customized|Race data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|12|12.0||||||
3881205|NCT01549964|3707035|B3|Black or African American||Race/Ethnicity, Customized|Race data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|19|19.0||||||
3881206|NCT01549964|3707036|B2|Black or African American||Race/Ethnicity, Customized|Race data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|13|13.0||||||
3881207|NCT01549964|3707037|B1|Black or African American||Race/Ethnicity, Customized|Race data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|8|8.0||||||
3881208|NCT01549964|3707033|B5|Asian||Race/Ethnicity, Customized|Race data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|96|96.0||||||
3881209|NCT01549964|3707034|B4|Asian||Race/Ethnicity, Customized|Race data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|26|26.0||||||
3881210|NCT01549964|3707035|B3|Asian||Race/Ethnicity, Customized|Race data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|28|28.0||||||
3881211|NCT01549964|3707036|B2|Asian||Race/Ethnicity, Customized|Race data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|30|30.0||||||
3881212|NCT01549964|3707037|B1|Asian||Race/Ethnicity, Customized|Race data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|12|12.0||||||
3881213|NCT01549964|3707033|B5|American Indian or Alaska Native||Race/Ethnicity, Customized|Race data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|5|5.0||||||
3881214|NCT01549964|3707034|B4|American Indian or Alaska Native||Race/Ethnicity, Customized|Race data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|3|3.0||||||
3881215|NCT01549964|3707035|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|Race data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|2|2.0||||||
3881216|NCT01549964|3707036|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|Race data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|0|0.0||||||
3881217|NCT01549964|3707037|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Race data is available for 260 participants in the fasiglifam 50 mg treatment arm.|participants|Number|0|0.0||||||
3881218|NCT01549964|3707033|B5||Male|Sex: Female, Male||Participants|Count of Participants|494|494.0||||||
3881219|NCT01549964|3707034|B4||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3881220|NCT01549964|3707035|B3||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3881221|NCT01549964|3707036|B2||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3881222|NCT01549964|3707037|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3881223|NCT01549964|3707033|B5||Female|Sex: Female, Male||Participants|Count of Participants|422|422.0||||||
3881224|NCT01549964|3707034|B4||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3881225|NCT01549964|3707035|B3||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3881226|NCT01549964|3707036|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3881227|NCT01549964|3707037|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3881228|NCT01549964|3707033|B5|≥ 65 years||Age, Customized||participants|Number|159|159.0||||||
3881229|NCT01549964|3707034|B4|≥ 65 years||Age, Customized||participants|Number|41|41.0||||||
3881230|NCT01549964|3707035|B3|≥ 65 years||Age, Customized||participants|Number|47|47.0||||||
3881231|NCT01549964|3707036|B2|≥ 65 years||Age, Customized||participants|Number|46|46.0||||||
3881232|NCT01549964|3707037|B1|≥ 65 years||Age, Customized||participants|Number|25|25.0||||||
3881233|NCT01549964|3707033|B5|< 65 years||Age, Customized||participants|Number|757|757.0||||||
3881234|NCT01549964|3707034|B4|< 65 years||Age, Customized||participants|Number|220|220.0||||||
3881236|NCT01549964|3707036|B2|< 65 years||Age, Customized||participants|Number|214|214.0||||||
3881237|NCT01549964|3707037|B1|< 65 years||Age, Customized||participants|Number|107|107.0||||||
3881238|NCT01549964|3707033|B5|||Age||years|Mean|56.0|56.0|Standard Deviation|9.60|9.6|||
3881239|NCT01549964|3707034|B4|||Age||years|Mean|56.0|56.0|Standard Deviation|9.37|9.37|||
3881240|NCT01549964|3707035|B3|||Age||years|Mean|56.3|56.3|Standard Deviation|9.58|9.58|||
3881241|NCT01549964|3707036|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|9.84|9.84|||
3881242|NCT01549964|3707037|B1|||Age||years|Mean|55.6|55.6|Standard Deviation|9.72|9.72|||
3881243|NCT01549951|3707058|B1|||Time from initial prostate cancer diagnosis|Time from initial diagnosis was defined as (first dose date – initial diagnosis date + 1) / 365.25.|years|Mean|6.32|6.32|Standard Deviation|5.325|5.325|||
3881244|NCT01549951|3707058|B1|Adenocarcinoma, NOS||Histological classification|Carcinoma was classified as adenocarcinoma in situ (local), not otherwise specified (NOS) and adenocarcinoma, NOS.|participants|Number|42|42.0||||||
3881245|NCT01549951|3707058|B1|Adenocarcinoma in situ, NOS||Histological classification|Carcinoma was classified as adenocarcinoma in situ (local), not otherwise specified (NOS) and adenocarcinoma, NOS.|participants|Number|8|8.0||||||
3881246|NCT01549951|3707058|B1|1||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG assessed participant's performance status on 5point scale: 0=Fully active/able to carry on all pre-disease activities without restriction;1=restricted in physically strenuous activity,ambulatory/able to carry out light or sedentary work;2=ambulatory (greater than[>] 50 percent[%] of waking hours),capable of all self care,unable to carry out any work activities;3=capable of only limited selfcare,confined to bed/chair>50% of waking hours;4=completely disabled,cannot carry on any selfcare,totally confined to bed/chair;5=dead.Participants with performance status as 0 and 1 have been reported.|participants|Number|12|12.0||||||
3881247|NCT01549951|3707058|B1|0||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG assessed participant's performance status on 5point scale: 0=Fully active/able to carry on all pre-disease activities without restriction;1=restricted in physically strenuous activity,ambulatory/able to carry out light or sedentary work;2=ambulatory (greater than[>] 50 percent[%] of waking hours),capable of all self care,unable to carry out any work activities;3=capable of only limited selfcare,confined to bed/chair>50% of waking hours;4=completely disabled,cannot carry on any selfcare,totally confined to bed/chair;5=dead.Participants with performance status as 0 and 1 have been reported.|participants|Number|38|38.0||||||
3881248|NCT01549951|3707058|B1|||Weight||kilograms (kg)|Mean|87.63|87.63|Standard Deviation|14.797|14.797|||
3881249|NCT01549951|3707058|B1|||Height||centimeters (cm)|Mean|175.32|175.32|Standard Deviation|7.521|7.521|||
3881250|NCT01549951|3707058|B1|Not reported||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3881251|NCT01549951|3707058|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3881252|NCT01549951|3707058|B1|White||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
3881253|NCT01549951|3707058|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3881254|NCT01549951|3707058|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3881255|NCT01549951|3707058|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3881256|NCT01549951|3707058|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3881257|NCT01549951|3707058|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3881258|NCT01549951|3707058|B1|||Age||years|Mean|68.7|68.7|Standard Deviation|8.85|8.85|||
3881259|NCT01549925|3707074|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3881260|NCT01549925|3707075|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3881261|NCT01549925|3707076|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3881262|NCT01549925|3707074|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3881263|NCT01549925|3707075|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3881264|NCT01549925|3707076|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3881265|NCT01549925|3707074|B3|>70 years||Age, Customized||Participants|Number|13|13.0||||||
3881266|NCT01549925|3707075|B2|>70 years||Age, Customized||Participants|Number|5|5.0||||||
3881267|NCT01549925|3707076|B1|>70 years||Age, Customized||Participants|Number|8|8.0||||||
3881268|NCT01549925|3707074|B3|50-70 years||Age, Customized||Participants|Number|29|29.0||||||
3881269|NCT01549925|3707075|B2|50-70 years||Age, Customized||Participants|Number|13|13.0||||||
3881270|NCT01549925|3707076|B1|50-70 years||Age, Customized||Participants|Number|16|16.0||||||
3881271|NCT01549925|3707074|B3|< 50 years||Age, Customized||Participants|Number|8|8.0||||||
3881272|NCT01549925|3707075|B2|< 50 years||Age, Customized||Participants|Number|7|7.0||||||
3881273|NCT01549925|3707076|B1|< 50 years||Age, Customized||Participants|Number|1|1.0||||||
3881274|NCT01549873|3707083|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3881275|NCT01549873|3707084|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3881276|NCT01549873|3707085|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3881277|NCT01549873|3707083|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3881278|NCT01549873|3707084|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3881279|NCT01549873|3707085|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3881280|NCT01549873|3707083|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3881281|NCT01549873|3707084|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3881282|NCT01549873|3707085|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3881283|NCT01549873|3707083|B3|||Age||years|Mean|14.9|14.9|Standard Deviation|2.2|2.2|||
3881284|NCT01549873|3707084|B2|||Age||years|Mean|15.4|15.4|Standard Deviation|2.4|2.4|||
3881285|NCT01549873|3707085|B1|||Age||years|Mean|14.5|14.5|Standard Deviation|2.1|2.1|||
3881286|NCT01549873|3707083|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3881287|NCT01549873|3707084|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3881288|NCT01549873|3707085|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3881289|NCT01549873|3707083|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3881290|NCT01549873|3707084|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3881291|NCT01549873|3707085|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3881292|NCT01549873|3707083|B3||<=18 years|Age||Participants|Count of Participants|27|27.0||||||
3881293|NCT01549873|3707084|B2||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
3881294|NCT01549873|3707085|B1||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
3881295|NCT01549860|3707096|B3|||Wound Area at Randomization||centimeters squared|Median|11.0|11.0|Full Range|||2.5|53.3|
3881296|NCT01549860|3707097|B2|||Wound Area at Randomization||centimeters squared|Median|12.4|12.4|Full Range|||3.1|53.3|
3881297|NCT01549860|3707098|B1|||Wound Area at Randomization||centimeters squared|Median|9.8|9.8|Full Range|||2.5|36.9|
3881298|NCT01549860|3707096|B3|||Wound Age at Randomization||months|Median|10.3|10.3|Full Range|||1.5|204.5|
3881299|NCT01549860|3707097|B2|||Wound Age at Randomization||months|Median|10.3|10.3|Full Range|||1.5|114.0|
3881300|NCT01549860|3707098|B1|||Wound Age at Randomization||months|Median|8.9|8.9|Full Range|||1.7|204.5|
3881301|NCT01549860|3707096|B3|||BMI||kg per meter squared|Median|34.7|34.7|Full Range|||17.2|69.7|
3881302|NCT01549860|3707097|B2|||BMI||kg per meter squared|Median|37.4|37.4|Full Range|||17.2|69.7|
3881303|NCT01549860|3707098|B1|||BMI||kg per meter squared|Median|33.2|33.2|Full Range|||21.2|55.7|
3881304|NCT01549860|3707096|B3|United States||Region of Enrollment||participants|Number|81|81.0||||||
3881305|NCT01549860|3707097|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
3881306|NCT01549860|3707098|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3881307|NCT01549860|3707096|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881308|NCT01549860|3707097|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881309|NCT01549860|3707098|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881310|NCT01549860|3707096|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3881311|NCT01549860|3707097|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3881312|NCT01549860|3707098|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3881313|NCT01549860|3707096|B3||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3881314|NCT01549860|3707097|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3881315|NCT01549860|3707098|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3881316|NCT01549860|3707096|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3881317|NCT01549860|3707097|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3881318|NCT01549860|3707098|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3881319|NCT01549860|3707096|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881320|NCT01549860|3707097|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881321|NCT01549860|3707098|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881322|NCT01549860|3707096|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881323|NCT01549860|3707097|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881324|NCT01549860|3707098|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881325|NCT01549860|3707096|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881326|NCT01549860|3707097|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881327|NCT01549860|3707098|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881328|NCT01549860|3707096|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3881329|NCT01549860|3707097|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3881330|NCT01549860|3707098|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3881331|NCT01549860|3707096|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3881332|NCT01549860|3707097|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3881333|NCT01549860|3707098|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3881334|NCT01549860|3707096|B3|||Age||years|Median|59.0|59.0|Full Range|||33.0|86.0|
3881335|NCT01549860|3707097|B2|||Age||years|Median|58.0|58.0|Full Range|||33.0|86.0|
3881336|NCT01549860|3707098|B1|||Age||years|Median|60.0|60.0|Full Range|||34.0|81.0|
3881337|NCT01549613|3707109|B3|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
3881338|NCT01549613|3707110|B2|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
3881339|NCT01549613|3707111|B1|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
3881340|NCT01549613|3707109|B3|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
3881341|NCT01549613|3707110|B2|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
3881342|NCT01549613|3707111|B1|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
3881343|NCT01549613|3707109|B3|White||Race (NIH/OMB)||participants|Number|63|63.0||||||
3881344|NCT01549613|3707110|B2|White||Race (NIH/OMB)||participants|Number|34|34.0||||||
3881345|NCT01549613|3707111|B1|White||Race (NIH/OMB)||participants|Number|29|29.0||||||
3881346|NCT01549613|3707109|B3|Black or African American||Race (NIH/OMB)||participants|Number|34|34.0||||||
3881347|NCT01549613|3707110|B2|Black or African American||Race (NIH/OMB)||participants|Number|14|14.0||||||
3881348|NCT01549613|3707111|B1|Black or African American||Race (NIH/OMB)||participants|Number|20|20.0||||||
3881349|NCT01549613|3707109|B3|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
3881350|NCT01549613|3707110|B2|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
3881351|NCT01549613|3707111|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
3881352|NCT01549613|3707109|B3|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
3881353|NCT01549613|3707110|B2|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
3881354|NCT01549613|3707111|B1|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
3881355|NCT01549613|3707109|B3|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
3881356|NCT01549613|3707110|B2|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
3881357|NCT01549613|3707111|B1|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
3881358|NCT01549613|3707109|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3881359|NCT01549613|3707110|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3881360|NCT01549613|3707111|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3881361|NCT01549613|3707109|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3881362|NCT01549613|3707110|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3881363|NCT01549613|3707111|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3881364|NCT01549613|3707109|B3|||Age||years|Mean|40|40.0|Standard Deviation|12.5|12.5|||
3881365|NCT01549613|3707110|B2|||Age||years|Mean|38|38.0|Standard Deviation|13|13.0|||
3881366|NCT01549613|3707111|B1|||Age||years|Mean|42|42.0|Standard Deviation|12|12.0|||
3881367|NCT01549405|3707118|B3|Turkey||Region of Enrollment||participants|Number|40|40.0||||||
3881368|NCT01549405|3707119|B2|Turkey||Region of Enrollment||participants|Number|20|20.0||||||
3881369|NCT01549405|3707120|B1|Turkey||Region of Enrollment||participants|Number|20|20.0||||||
3881370|NCT01549405|3707118|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3881371|NCT01549405|3707119|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3881372|NCT01549405|3707120|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3881373|NCT01549405|3707118|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3881374|NCT01549405|3707119|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3881375|NCT01549405|3707120|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3881376|NCT01549405|3707118|B3|||Age||years|Mean|55.1|55.1|Standard Deviation|10.2|10.2|||
3881377|NCT01549405|3707119|B2|||Age||years|Mean|53|53.0|Standard Deviation|13.6|13.6|||
3881378|NCT01549405|3707120|B1|||Age||years|Mean|57.3|57.3|Standard Deviation|7.4|7.4|||
3881379|NCT01549405|3707118|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3881380|NCT01549405|3707119|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3881381|NCT01549405|3707120|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3881382|NCT01549405|3707118|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3881383|NCT01549405|3707119|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3881384|NCT01549405|3707120|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3881385|NCT01549405|3707118|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3881386|NCT01549405|3707119|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3881387|NCT01549405|3707120|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3881388|NCT01549392|3707129|B3|Canada||Region of Enrollment||participants|Number|3|3.0||||||
3881389|NCT01549392|3707131|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
3881390|NCT01549392|3707129|B3|Male||Gender||participants|Number|1|1.0||||||
3881391|NCT01549392|3707131|B1|Male||Gender||participants|Number|1|1.0||||||
3881392|NCT01549392|3707129|B3|Female||Gender||participants|Number|2|2.0||||||
3881393|NCT01549392|3707131|B1|Female||Gender||participants|Number|2|2.0||||||
3881394|NCT01549392|3707129|B3|>=65 years||Age||participants|Number|0|0.0||||||
3881395|NCT01549392|3707131|B1|>=65 years||Age||participants|Number|0|0.0||||||
3881396|NCT01549392|3707129|B3|Between 18 and 65 years||Age||participants|Number|3|3.0||||||
3881397|NCT01549392|3707131|B1|Between 18 and 65 years||Age||participants|Number|3|3.0||||||
3881398|NCT01549392|3707129|B3|<=18 years||Age||participants|Number|0|0.0||||||
3881399|NCT01549392|3707131|B1|<=18 years||Age||participants|Number|0|0.0||||||
3881400|NCT01549392|3707129|B3|||Age||years|Median|50|50.0|Full Range|||45.0|65.0|
3881401|NCT01549392|3707131|B1|||Age||years|Median|50|50.0|Full Range|||45.0|65.0|
3881402|NCT01549340|3707138|B1||Male|Gender||Participants|Count of Participants|4351|4351.0||||||
3881403|NCT01549340|3707138|B1||Female|Gender||Participants|Count of Participants|4439|4439.0||||||
3881404|NCT01549340|3707138|B1|||Age||years|Mean|26.8|26.8|Standard Deviation|16.1|16.1|||
3881405|NCT01549275|3707149|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3881406|NCT01549275|3707150|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3881407|NCT01549275|3707151|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3881408|NCT01549275|3707149|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3881409|NCT01549275|3707150|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3881410|NCT01549275|3707151|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3881411|NCT01549275|3707149|B3|||Age||years|Mean|63.1|63.1|Standard Deviation|12.7|12.7|||
3881412|NCT01549275|3707150|B2|||Age||years|Mean|59.6|59.6|Standard Deviation|14|14.0|||
3881413|NCT01549275|3707151|B1|||Age||years|Mean|66.4|66.4|Standard Deviation|12|12.0|||
3881414|NCT01549275|3707149|B3||>=65 years|Age||Participants|Count of Participants|56|56.0||||||
3881415|NCT01549275|3707150|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3881416|NCT01549275|3707151|B1||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
3881417|NCT01549275|3707149|B3||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3881418|NCT01549275|3707150|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3881419|NCT01549275|3707151|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3881420|NCT01549275|3707149|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3881421|NCT01549275|3707150|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3881422|NCT01549275|3707151|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3881423|NCT01549223|3707162|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
3881424|NCT01549223|3707163|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3881425|NCT01549223|3707164|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3881426|NCT01549223|3707162|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881427|NCT01549223|3707163|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881428|NCT01549223|3707164|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881429|NCT01549223|3707162|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881430|NCT01549223|3707163|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881431|NCT01549223|3707164|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881432|NCT01549223|3707162|B3||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3881433|NCT01549223|3707163|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3881434|NCT01549223|3707164|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3881435|NCT01549223|3707162|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3881436|NCT01549223|3707163|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3881437|NCT01549223|3707164|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3881438|NCT01549223|3707162|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881439|NCT01549223|3707163|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881440|NCT01549223|3707164|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881441|NCT01549223|3707162|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3881442|NCT01549223|3707163|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3881443|NCT01549223|3707164|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3881444|NCT01549223|3707162|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881445|NCT01549223|3707163|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881446|NCT01549223|3707164|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881447|NCT01549223|3707162|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3881448|NCT01549223|3707163|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3881449|NCT01549223|3707164|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3881450|NCT01549223|3707162|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3881451|NCT01549223|3707163|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3881452|NCT01549223|3707164|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3881453|NCT01549223|3707162|B3|Between 18 and 40 years of age||Age, Customized||Participants|Count of Participants|60|60.0||||||
3881454|NCT01549223|3707163|B2|Between 18 and 40 years of age||Age, Customized||Participants|Count of Participants|30|30.0||||||
3881455|NCT01549223|3707164|B1|Between 18 and 40 years of age||Age, Customized||Participants|Count of Participants|30|30.0||||||
3881456|NCT01549041|3707173|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3881457|NCT01549041|3707174|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
3881458|NCT01549041|3707175|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3881459|NCT01549041|3707173|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881460|NCT01549041|3707174|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881461|NCT01549041|3707175|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881462|NCT01549041|3707173|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881463|NCT01549041|3707174|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881464|NCT01549041|3707175|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881465|NCT01549041|3707173|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3881466|NCT01549041|3707174|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3881467|NCT01549041|3707175|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3881468|NCT01549041|3707173|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3881469|NCT01549041|3707174|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3881470|NCT01549041|3707175|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3881471|NCT01549041|3707173|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881472|NCT01549041|3707174|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881473|NCT01549041|3707175|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881474|NCT01549041|3707173|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3881475|NCT01549041|3707174|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881476|NCT01549041|3707175|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3881477|NCT01549041|3707173|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881478|NCT01549041|3707174|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881479|NCT01549041|3707175|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881480|NCT01549041|3707173|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3881481|NCT01549041|3707174|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3881482|NCT01549041|3707175|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3881483|NCT01549041|3707173|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3881484|NCT01549041|3707174|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3881485|NCT01549041|3707175|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3881486|NCT01549041|3707173|B3|age||Age||years|Mean|36.3|36.3|Full Range|||20.0|61.0|
3881487|NCT01549041|3707174|B2|age||Age||years|Mean|33.1|33.1|Full Range|||20.0|56.0|
3881488|NCT01549041|3707175|B1|age||Age||years|Mean|41.2|41.2|Full Range|||22.0|61.0|
3881489|NCT01549002|3707184|B3|||Observational Scale of Behavioral Distress - revised|An observational scale of pain and distress during procedures. Scores can range from 0 to 23.5 units for each phase. A higher score indicates a greater degree of pain and distress. The total OSBD-R score is a summation of the OSBD-R score from each phase. For example, if there are six phases, the range of scores for OSBD-R is from 0 to 141. The baseline score would be one of the phases. The baseline phase consisted of 4 15-second intervals. The measured baseline OSBD-R scores was ZERO for all patients.|units on a scale|Mean|0.05|0.05|Standard Deviation|0.1|0.1|||
3881490|NCT01549002|3707185|B2|||Observational Scale of Behavioral Distress - revised|An observational scale of pain and distress during procedures. Scores can range from 0 to 23.5 units for each phase. A higher score indicates a greater degree of pain and distress. The total OSBD-R score is a summation of the OSBD-R score from each phase. For example, if there are six phases, the range of scores for OSBD-R is from 0 to 141. The baseline score would be one of the phases. The baseline phase consisted of 4 15-second intervals. The measured baseline OSBD-R scores was ZERO for all patients.|units on a scale|Mean|0.04|0.04|Standard Deviation|0.08|0.08|||
3881491|NCT01549002|3707186|B1|||Observational Scale of Behavioral Distress - revised|An observational scale of pain and distress during procedures. Scores can range from 0 to 23.5 units for each phase. A higher score indicates a greater degree of pain and distress. The total OSBD-R score is a summation of the OSBD-R score from each phase. For example, if there are six phases, the range of scores for OSBD-R is from 0 to 141. The baseline score would be one of the phases. The baseline phase consisted of 4 15-second intervals. The measured baseline OSBD-R scores was ZERO for all patients.|units on a scale|Mean|0.06|0.06|Standard Deviation|0.13|0.13|||
3881492|NCT01549002|3707184|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3881493|NCT01549002|3707185|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3881494|NCT01549002|3707186|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3881495|NCT01549002|3707184|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3881496|NCT01549002|3707185|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3881497|NCT01549002|3707186|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3881498|NCT01549002|3707184|B3|||Age||years|Median|15.4|15.4|Inter-Quartile Range|||11.8|16.8|
3881499|NCT01549002|3707185|B2|||Age||years|Median|15.4|15.4|Inter-Quartile Range|||10.2|16.4|
3881500|NCT01549002|3707186|B1|||Age||years|Median|15.3|15.3|Inter-Quartile Range|||12.2|17.4|
3881501|NCT01548885|3707197|B1|United States||Region of Enrollment||participants|Number|146|146.0||||||
3881502|NCT01548885|3707197|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3881503|NCT01548885|3707197|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3881504|NCT01548885|3707197|B1|||Age||years|Median|62|62.0|Full Range|||19.0|87.0|
3881505|NCT01548833|3707202|B1|United Kingdom||Region of Enrollment||participants|Number|39|39.0||||||
3881506|NCT01548833|3707202|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3881507|NCT01548833|3707202|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3881508|NCT01548833|3707202|B1|||Age||years|Mean|22.1|22.1|Standard Deviation|3.5|3.5|||
3881509|NCT01548742|3707210|B3|||Number of participants receiving 8 or more therapy sessions in PTSD or mental health clinics||participants|Number|43|43.0||||||
3881510|NCT01548742|3707211|B2|||Number of participants receiving 8 or more therapy sessions in PTSD or mental health clinics||participants|Number|24|24.0||||||
3881511|NCT01548742|3707212|B1|||Number of participants receiving 8 or more therapy sessions in PTSD or mental health clinics||participants|Number|19|19.0||||||
3881512|NCT01548742|3707210|B3|||Duration of previous mental health care||months|Mean|66.5|66.5|Standard Deviation|9.2|9.2|||
3881513|NCT01548742|3707211|B2|||Duration of previous mental health care||months|Mean|63.9|63.9|Standard Deviation|45.2|45.2|||
3881514|NCT01548742|3707212|B1|||Duration of previous mental health care||months|Mean|69.0|69.0|Standard Deviation|53.3|53.3|||
3881515|NCT01548742|3707210|B3|||Total number of psychotherapy mental health visits||sessions|Mean|13.9|13.9|Standard Deviation|28.7|28.7|||
3881516|NCT01548742|3707211|B2|||Total number of psychotherapy mental health visits||sessions|Mean|14.6|14.6|Standard Deviation|29.2|29.2|||
3881517|NCT01548742|3707212|B1|||Total number of psychotherapy mental health visits||sessions|Mean|13.2|13.2|Standard Deviation|28.3|28.3|||
3881518|NCT01548742|3707210|B3|||Taking psychotropic medication||participants|Number|100|100.0||||||
3881519|NCT01548742|3707211|B2|||Taking psychotropic medication||participants|Number|49|49.0||||||
3881520|NCT01548742|3707212|B1|||Taking psychotropic medication||participants|Number|51|51.0||||||
3881521|NCT01548742|3707210|B3|||Comorbid mood disorder||participants|Number|49|49.0||||||
3881522|NCT01548742|3707211|B2|||Comorbid mood disorder||participants|Number|23|23.0||||||
3881523|NCT01548742|3707212|B1|||Comorbid mood disorder||participants|Number|26|26.0||||||
3881524|NCT01548742|3707210|B3|Subthreshold PTSD||PTSD diagnosis|Full PTSD criteria defined according to the Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) (DSM-IV). Subthreshold PTSD defined as endorsement of DSM-IV criterion A1 and at least 1 symptom each from criteria B, C, and D with significant impairment.|participants|Number|3|3.0||||||
3881525|NCT01548742|3707211|B2|Subthreshold PTSD||PTSD diagnosis|Full PTSD criteria defined according to the Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) (DSM-IV). Subthreshold PTSD defined as endorsement of DSM-IV criterion A1 and at least 1 symptom each from criteria B, C, and D with significant impairment.|participants|Number|2|2.0||||||
3881526|NCT01548742|3707212|B1|Subthreshold PTSD||PTSD diagnosis|Full PTSD criteria defined according to the Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) (DSM-IV). Subthreshold PTSD defined as endorsement of DSM-IV criterion A1 and at least 1 symptom each from criteria B, C, and D with significant impairment.|participants|Number|1|1.0||||||
3881527|NCT01548742|3707210|B3|Full PTSD criteria||PTSD diagnosis|Full PTSD criteria defined according to the Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) (DSM-IV). Subthreshold PTSD defined as endorsement of DSM-IV criterion A1 and at least 1 symptom each from criteria B, C, and D with significant impairment.|participants|Number|113|113.0||||||
3881528|NCT01548742|3707211|B2|Full PTSD criteria||PTSD diagnosis|Full PTSD criteria defined according to the Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) (DSM-IV). Subthreshold PTSD defined as endorsement of DSM-IV criterion A1 and at least 1 symptom each from criteria B, C, and D with significant impairment.|participants|Number|56|56.0||||||
3881529|NCT01548742|3707212|B1|Full PTSD criteria||PTSD diagnosis|Full PTSD criteria defined according to the Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) (DSM-IV). Subthreshold PTSD defined as endorsement of DSM-IV criterion A1 and at least 1 symptom each from criteria B, C, and D with significant impairment.|participants|Number|57|57.0||||||
3881530|NCT01548742|3707210|B3|Other traumatic event||Lifetime trauma exposure event type||participants|Number|110|110.0||||||
3881531|NCT01548742|3707211|B2|Other traumatic event||Lifetime trauma exposure event type||participants|Number|55|55.0||||||
3881532|NCT01548742|3707212|B1|Other traumatic event||Lifetime trauma exposure event type||participants|Number|55|55.0||||||
3881533|NCT01548742|3707210|B3|Life-threatening illness or injury||Lifetime trauma exposure event type||participants|Number|67|67.0||||||
3881534|NCT01548742|3707211|B2|Life-threatening illness or injury||Lifetime trauma exposure event type||participants|Number|33|33.0||||||
3881535|NCT01548742|3707212|B1|Life-threatening illness or injury||Lifetime trauma exposure event type||participants|Number|34|34.0||||||
3881536|NCT01548742|3707210|B3|Serious accident||Lifetime trauma exposure event type||participants|Number|74|74.0||||||
3881537|NCT01548742|3707211|B2|Serious accident||Lifetime trauma exposure event type||participants|Number|36|36.0||||||
3881538|NCT01548742|3707212|B1|Serious accident||Lifetime trauma exposure event type||participants|Number|38|38.0||||||
3881539|NCT01548742|3707210|B3|Disaster exposure||Lifetime trauma exposure event type||participants|Number|50|50.0||||||
3881540|NCT01548742|3707211|B2|Disaster exposure||Lifetime trauma exposure event type||participants|Number|25|25.0||||||
3881541|NCT01548742|3707212|B1|Disaster exposure||Lifetime trauma exposure event type||participants|Number|25|25.0||||||
3881542|NCT01548742|3707210|B3|Physical assault||Lifetime trauma exposure event type||participants|Number|76|76.0||||||
3881543|NCT01548742|3707211|B2|Physical assault||Lifetime trauma exposure event type||participants|Number|37|37.0||||||
3881544|NCT01548742|3707212|B1|Physical assault||Lifetime trauma exposure event type||participants|Number|39|39.0||||||
3881545|NCT01548742|3707210|B3|Sexual trauma||Lifetime trauma exposure event type||participants|Number|32|32.0||||||
3881546|NCT01548742|3707211|B2|Sexual trauma||Lifetime trauma exposure event type||participants|Number|11|11.0||||||
3881547|NCT01548742|3707212|B1|Sexual trauma||Lifetime trauma exposure event type||participants|Number|21|21.0||||||
3881548|NCT01548742|3707210|B3|Combat exposure||Lifetime trauma exposure event type||participants|Number|86|86.0||||||
3881549|NCT01548742|3707211|B2|Combat exposure||Lifetime trauma exposure event type||participants|Number|47|47.0||||||
3881550|NCT01548742|3707212|B1|Combat exposure||Lifetime trauma exposure event type||participants|Number|39|39.0||||||
3881551|NCT01548742|3707210|B3|||Lifetime trauma exposure||No. of events|Mean|7.7|7.7|Standard Deviation|3.1|3.1|||
3881552|NCT01548742|3707211|B2|||Lifetime trauma exposure||No. of events|Mean|7.5|7.5|Standard Deviation|3.0|3.0|||
3881553|NCT01548742|3707212|B1|||Lifetime trauma exposure||No. of events|Mean|7.9|7.9|Standard Deviation|3.3|3.3|||
3881554|NCT01548742|3707210|B3|Other||Service Era||participants|Number|2|2.0||||||
3881555|NCT01548742|3707211|B2|Other||Service Era||participants|Number|0|0.0||||||
3881556|NCT01548742|3707212|B1|Other||Service Era||participants|Number|2|2.0||||||
3881557|NCT01548742|3707210|B3|Vietnam War||Service Era||participants|Number|86|86.0||||||
3881558|NCT01548742|3707211|B2|Vietnam War||Service Era||participants|Number|45|45.0||||||
3881559|NCT01548742|3707212|B1|Vietnam War||Service Era||participants|Number|41|41.0||||||
3881560|NCT01548742|3707210|B3|Gulf War||Service Era||participants|Number|17|17.0||||||
3881561|NCT01548742|3707211|B2|Gulf War||Service Era||participants|Number|8|8.0||||||
3881562|NCT01548742|3707212|B1|Gulf War||Service Era||participants|Number|9|9.0||||||
3881563|NCT01548742|3707210|B3|OEF/OIF||Service Era||participants|Number|11|11.0||||||
3881564|NCT01548742|3707211|B2|OEF/OIF||Service Era||participants|Number|5|5.0||||||
3881565|NCT01548742|3707212|B1|OEF/OIF||Service Era||participants|Number|6|6.0||||||
3881566|NCT01548742|3707210|B3|Mixed||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3881567|NCT01548742|3707211|B2|Mixed||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3881568|NCT01548742|3707212|B1|Mixed||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3881569|NCT01548742|3707210|B3|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3881570|NCT01548742|3707211|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3881571|NCT01548742|3707212|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3881572|NCT01548742|3707210|B3|Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3881573|NCT01548742|3707211|B2|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3881574|NCT01548742|3707212|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3881575|NCT01548742|3707210|B3|White||Race/Ethnicity, Customized||participants|Number|97|97.0||||||
3881576|NCT01548742|3707211|B2|White||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
3881577|NCT01548742|3707212|B1|White||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
3881578|NCT01548742|3707210|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3881579|NCT01548742|3707211|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3881580|NCT01548742|3707212|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3881581|NCT01548742|3707210|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3881582|NCT01548742|3707211|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3881583|NCT01548742|3707212|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3881584|NCT01548742|3707210|B3|||Age||years|Mean|58.5|58.5|Standard Deviation|9.8|9.8|||
3881585|NCT01548742|3707211|B2|||Age||years|Mean|59.4|59.4|Standard Deviation|9.2|9.2|||
3881586|NCT01548742|3707212|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|10.4|10.4|||
3881587|NCT01548690|3707227|B5|United States||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
3881588|NCT01548690|3707228|B4|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3881589|NCT01548690|3707229|B3|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3881590|NCT01548690|3707230|B2|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3881591|NCT01548690|3707231|B1|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3881592|NCT01548690|3707227|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3881593|NCT01548690|3707228|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881594|NCT01548690|3707229|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3881595|NCT01548690|3707230|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881596|NCT01548690|3707231|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3881597|NCT01548690|3707227|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881598|NCT01548690|3707228|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881599|NCT01548690|3707229|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881600|NCT01548690|3707230|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881601|NCT01548690|3707231|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881602|NCT01548690|3707227|B5||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3881603|NCT01548690|3707228|B4||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3881604|NCT01548690|3707229|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3881605|NCT01548690|3707230|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3881606|NCT01548690|3707231|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3881607|NCT01548690|3707227|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3881608|NCT01548690|3707228|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3881609|NCT01548690|3707229|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3881610|NCT01548690|3707230|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3881611|NCT01548690|3707231|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3881612|NCT01548690|3707227|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881613|NCT01548690|3707228|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881614|NCT01548690|3707229|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881615|NCT01548690|3707230|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881616|NCT01548690|3707231|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881617|NCT01548690|3707227|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3881618|NCT01548690|3707228|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881619|NCT01548690|3707229|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3881620|NCT01548690|3707230|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881621|NCT01548690|3707231|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881622|NCT01548690|3707227|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881623|NCT01548690|3707228|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881624|NCT01548690|3707229|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881625|NCT01548690|3707230|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881626|NCT01548690|3707231|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881627|NCT01548690|3707227|B5||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3881628|NCT01548690|3707228|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3881629|NCT01548690|3707229|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3881630|NCT01548690|3707230|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3881631|NCT01548690|3707231|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3881632|NCT01548690|3707227|B5||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3881633|NCT01548690|3707228|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3881634|NCT01548690|3707229|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3881635|NCT01548690|3707230|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3881636|NCT01548690|3707231|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3881637|NCT01548690|3707227|B5|||Age||years|Median|35.0|35.0|Full Range|||18.0|64.0|
3881638|NCT01548690|3707228|B4|||Age||years|Median|35.0|35.0|Full Range|||19.0|59.0|
3881639|NCT01548690|3707229|B3|||Age||years|Median|42.0|42.0|Full Range|||26.0|64.0|
3881640|NCT01548690|3707230|B2|||Age||years|Median|30.0|30.0|Full Range|||21.1|62.0|
3881641|NCT01548690|3707231|B1|||Age||years|Median|32.0|32.0|Full Range|||18.0|45.0|
3881642|NCT01548638|3707260|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3881643|NCT01548638|3707260|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3881644|NCT01548638|3707260|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3881645|NCT01548638|3707260|B1|||Age||years|Mean|38|38.0|Standard Deviation|7.1|7.1|||
3881646|NCT01548638|3707260|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3881647|NCT01548638|3707260|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3881648|NCT01548638|3707260|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3881649|NCT01548573|3707270|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3881650|NCT01548573|3707270|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3881651|NCT01548573|3707270|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3881652|NCT01548573|3707270|B1|||Age||years|Mean|59.4|59.4|Full Range|||49.0|70.6|
3881653|NCT01548573|3707270|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3881654|NCT01548573|3707270|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3881655|NCT01548573|3707270|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3881656|NCT01548417|3707277|B3|||DSM-IV symptom count|Diagnostic and Statistical Manual, 4th edition (DSM-IV ) criteria for current Alcohol Dependence defined as three or more symptoms of dependence.|number of symptoms|Mean|4.8|4.8|Standard Deviation|1.5|1.5|||
3881657|NCT01548417|3707278|B2|||DSM-IV symptom count|Diagnostic and Statistical Manual, 4th edition (DSM-IV ) criteria for current Alcohol Dependence defined as three or more symptoms of dependence.|number of symptoms|Mean|5.1|5.1|Standard Deviation|1.5|1.5|||
3881658|NCT01548417|3707279|B1|||DSM-IV symptom count|Diagnostic and Statistical Manual, 4th edition (DSM-IV ) criteria for current Alcohol Dependence defined as three or more symptoms of dependence.|number of symptoms|Mean|4.7|4.7|Standard Deviation|1.5|1.5|||
3881659|NCT01548417|3707277|B3|||Years of heavy drinking||years|Mean|14.5|14.5|Standard Deviation|9.9|9.9|||
3881660|NCT01548417|3707278|B2|||Years of heavy drinking||years|Mean|14.0|14.0|Standard Deviation|8.9|8.9|||
3881661|NCT01548417|3707279|B1|||Years of heavy drinking||years|Mean|15.0|15.0|Standard Deviation|11|11.0|||
3881662|NCT01548417|3707277|B3|||DSM-V symptom count|Diagnostic and Statistical Manual, 5th edition (DSM-V) requires 2 of 11 symptoms for a diagnosis of Alcohol Use Disorder.|number of symptoms|Mean|6.5|6.5|Standard Deviation|2.2|2.2|||
3881663|NCT01548417|3707278|B2|||DSM-V symptom count|Diagnostic and Statistical Manual, 5th edition (DSM-V) requires 2 of 11 symptoms for a diagnosis of Alcohol Use Disorder.|number of symptoms|Mean|6.9|6.9|Standard Deviation|2.1|2.1|||
3881664|NCT01548417|3707279|B1|||DSM-V symptom count|Diagnostic and Statistical Manual, 5th edition (DSM-V) requires 2 of 11 symptoms for a diagnosis of Alcohol Use Disorder.|number of symptoms|Mean|6.2|6.2|Standard Deviation|2.3|2.3|||
3881665|NCT01548417|3707277|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881666|NCT01548417|3707278|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881667|NCT01548417|3707279|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881668|NCT01548417|3707277|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3881669|NCT01548417|3707278|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3881670|NCT01548417|3707279|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3881671|NCT01548417|3707277|B3||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3881672|NCT01548417|3707278|B2||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3881673|NCT01548417|3707279|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3881674|NCT01548417|3707277|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3881675|NCT01548417|3707278|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3881676|NCT01548417|3707279|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3881677|NCT01548417|3707277|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881678|NCT01548417|3707278|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881679|NCT01548417|3707279|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881680|NCT01548417|3707277|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881681|NCT01548417|3707278|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881682|NCT01548417|3707279|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881683|NCT01548417|3707277|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881684|NCT01548417|3707278|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881685|NCT01548417|3707279|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881686|NCT01548417|3707277|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3881687|NCT01548417|3707278|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3881688|NCT01548417|3707279|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3881689|NCT01548417|3707277|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3881690|NCT01548417|3707278|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3881691|NCT01548417|3707279|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3881692|NCT01548417|3707277|B3|||Age||years|Mean|39.1|39.1|Standard Deviation|11.4|11.4|||
3881693|NCT01548417|3707278|B2|||Age||years|Mean|36.9|36.9|Standard Deviation|11.2|11.2|||
3881694|NCT01548417|3707279|B1|||Age||years|Mean|41.2|41.2|Standard Deviation|11.4|11.4|||
3881695|NCT01548404|3707288|B3|||Pruritus Numerical Rating Scale (NRS) Score|Pruritus NRS scale is an assessment tool that is used to report the intensity of participant’s pruritus (itch), both maximum and average intensity, during a 24-hour recall period. Participants were asked the following question: how would a participant rate his itch at the worst moment during the previous 24 hours (for maximum itch intensity on a scale of 0 – 10 [0= no itch; 10= worst itch imaginable]).|units on a scale|Mean|5.9|5.9|Standard Deviation|1.66|1.66|||
3881696|NCT01548404|3707289|B2|||Pruritus Numerical Rating Scale (NRS) Score|Pruritus NRS scale is an assessment tool that is used to report the intensity of participant’s pruritus (itch), both maximum and average intensity, during a 24-hour recall period. Participants were asked the following question: how would a participant rate his itch at the worst moment during the previous 24 hours (for maximum itch intensity on a scale of 0 – 10 [0= no itch; 10= worst itch imaginable]).|units on a scale|Mean|6.1|6.1|Standard Deviation|1.34|1.34|||
3881697|NCT01548404|3707290|B1|||Pruritus Numerical Rating Scale (NRS) Score|Pruritus NRS scale is an assessment tool that is used to report the intensity of participant’s pruritus (itch), both maximum and average intensity, during a 24-hour recall period. Participants were asked the following question: how would a participant rate his itch at the worst moment during the previous 24 hours (for maximum itch intensity on a scale of 0 – 10 [0= no itch; 10= worst itch imaginable]).|units on a scale|Mean|5.8|5.8|Standard Deviation|1.93|1.93|||
3881698|NCT01548404|3707288|B3|||5-D Pruritus Scale|The 5-D Pruritus Scale is a 1-page, 5-question tool used in clinical trials to assess 5 dimensions of background itch: degree, duration, direction, disability, and distribution. Each question corresponds to 1 of the 5 dimensions of itch; participants were to rate their symptoms over the preceding 2-week period on a 1 to 5 scale, with 5 being the most affected. After the summation of individual score, the total score ranges from 5 (least affected) to 25 (most affected).|units on a scale|Mean|18.5|18.5|Standard Deviation|3.26|3.26|||
3881699|NCT01548404|3707289|B2|||5-D Pruritus Scale|The 5-D Pruritus Scale is a 1-page, 5-question tool used in clinical trials to assess 5 dimensions of background itch: degree, duration, direction, disability, and distribution. Each question corresponds to 1 of the 5 dimensions of itch; participants were to rate their symptoms over the preceding 2-week period on a 1 to 5 scale, with 5 being the most affected. After the summation of individual score, the total score ranges from 5 (least affected) to 25 (most affected).|units on a scale|Mean|18.4|18.4|Standard Deviation|3.04|3.04|||
3881700|NCT01548404|3707290|B1|||5-D Pruritus Scale|The 5-D Pruritus Scale is a 1-page, 5-question tool used in clinical trials to assess 5 dimensions of background itch: degree, duration, direction, disability, and distribution. Each question corresponds to 1 of the 5 dimensions of itch; participants were to rate their symptoms over the preceding 2-week period on a 1 to 5 scale, with 5 being the most affected. After the summation of individual score, the total score ranges from 5 (least affected) to 25 (most affected).|units on a scale|Mean|18.7|18.7|Standard Deviation|3.50|3.5|||
3881701|NCT01548404|3707288|B3|||Body Surface Area (BSA)|Body surface area affected by AD was assessed for each section of the body (the possible highest score for each region was: head and neck [9%], anterior trunk [18%], back [18%], upper limbs [18%], lower limbs [36%], and genitals [1%]). It was reported as a percentage of all major body sections combined.|percentage of BSA|Mean|48.8|48.8|Standard Deviation|24.32|24.32|||
3881702|NCT01548404|3707289|B2|||Body Surface Area (BSA)|Body surface area affected by AD was assessed for each section of the body (the possible highest score for each region was: head and neck [9%], anterior trunk [18%], back [18%], upper limbs [18%], lower limbs [36%], and genitals [1%]). It was reported as a percentage of all major body sections combined.|percentage of BSA|Mean|46.8|46.8|Standard Deviation|24.55|24.55|||
3881703|NCT01548404|3707290|B1|||Body Surface Area (BSA)|Body surface area affected by AD was assessed for each section of the body (the possible highest score for each region was: head and neck [9%], anterior trunk [18%], back [18%], upper limbs [18%], lower limbs [36%], and genitals [1%]). It was reported as a percentage of all major body sections combined.|percentage of BSA|Mean|50.8|50.8|Standard Deviation|24.13|24.13|||
3881736|NCT01548287|3707317|B1|MCI||Alzheimers disease (AD)/Mild cognitive impairment (MCI)||Participants|Number|16|16.0||||||
3881704|NCT01548404|3707288|B3|||Scoring Atopic Dermatitis (SCORAD) Score|SCORAD is a clinical tool for assessing the severity of atopic dermatitis developed by the European Task Force on Atopic Dermatitis (Severity scoring of atopic dermatitis: the SCORAD index). Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology (Basel) 186 (1): 23–31. 1993. Extent and intensity of eczema as well as subjective signs (insomnia, etc.) are assessed and scored. Total score ranges from 0 (absent disease) to 103 (severe disease).|units on a scale|Mean|67.9|67.9|Standard Deviation|13.59|13.59|||
3881705|NCT01548404|3707289|B2|||Scoring Atopic Dermatitis (SCORAD) Score|SCORAD is a clinical tool for assessing the severity of atopic dermatitis developed by the European Task Force on Atopic Dermatitis (Severity scoring of atopic dermatitis: the SCORAD index). Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology (Basel) 186 (1): 23–31. 1993. Extent and intensity of eczema as well as subjective signs (insomnia, etc.) are assessed and scored. Total score ranges from 0 (absent disease) to 103 (severe disease).|units on a scale|Mean|66.7|66.7|Standard Deviation|13.82|13.82|||
3881706|NCT01548404|3707290|B1|||Scoring Atopic Dermatitis (SCORAD) Score|SCORAD is a clinical tool for assessing the severity of atopic dermatitis developed by the European Task Force on Atopic Dermatitis (Severity scoring of atopic dermatitis: the SCORAD index). Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology (Basel) 186 (1): 23–31. 1993. Extent and intensity of eczema as well as subjective signs (insomnia, etc.) are assessed and scored. Total score ranges from 0 (absent disease) to 103 (severe disease).|units on a scale|Mean|69.1|69.1|Standard Deviation|13.38|13.38|||
3881707|NCT01548404|3707288|B3|||Investigator’s Global Assessment (IGA) Score|IGA is an assessment scale used to determine severity of AD and clinical response to treatment on a 5-point scale (0 = clear; 1 = almost clear; 2 = mild; 3 = moderate; 4 = severe) based on erythema and papulation/infiltration. Therapeutic response was an IGA score of 0 (clear) or 1 (almost clear).|units on a scale|Mean|3.9|3.9|Standard Deviation|0.68|0.68|||
3881708|NCT01548404|3707289|B2|||Investigator’s Global Assessment (IGA) Score|IGA is an assessment scale used to determine severity of AD and clinical response to treatment on a 5-point scale (0 = clear; 1 = almost clear; 2 = mild; 3 = moderate; 4 = severe) based on erythema and papulation/infiltration. Therapeutic response was an IGA score of 0 (clear) or 1 (almost clear).|units on a scale|Mean|3.9|3.9|Standard Deviation|0.67|0.67|||
3881709|NCT01548404|3707290|B1|||Investigator’s Global Assessment (IGA) Score|IGA is an assessment scale used to determine severity of AD and clinical response to treatment on a 5-point scale (0 = clear; 1 = almost clear; 2 = mild; 3 = moderate; 4 = severe) based on erythema and papulation/infiltration. Therapeutic response was an IGA score of 0 (clear) or 1 (almost clear).|units on a scale|Mean|4.0|4.0|Standard Deviation|0.69|0.69|||
3881710|NCT01548404|3707288|B3|||Eczema Area and Severity Index (EASI) Score|The EASI score is used to measure the severity and extent of atopic dermatitis (AD) and measures erythema, infiltration, excoriation and lichenification on 4 anatomic regions of the body: head, trunk, upper and lower extremities. The total EASI score ranges from 0 (minimum) to 72 (maximum) points, with the higher scores reflecting the worse severity of AD.|units on a scale|Mean|29.6|29.6|Standard Deviation|13.59|13.59|||
3881711|NCT01548404|3707289|B2|||Eczema Area and Severity Index (EASI) Score|The EASI score is used to measure the severity and extent of atopic dermatitis (AD) and measures erythema, infiltration, excoriation and lichenification on 4 anatomic regions of the body: head, trunk, upper and lower extremities. The total EASI score ranges from 0 (minimum) to 72 (maximum) points, with the higher scores reflecting the worse severity of AD.|units on a scale|Mean|28.4|28.4|Standard Deviation|13.57|13.57|||
3881712|NCT01548404|3707290|B1|||Eczema Area and Severity Index (EASI) Score|The EASI score is used to measure the severity and extent of atopic dermatitis (AD) and measures erythema, infiltration, excoriation and lichenification on 4 anatomic regions of the body: head, trunk, upper and lower extremities. The total EASI score ranges from 0 (minimum) to 72 (maximum) points, with the higher scores reflecting the worse severity of AD.|units on a scale|Mean|30.8|30.8|Standard Deviation|13.63|13.63|||
3881713|NCT01548404|3707288|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3881714|NCT01548404|3707289|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3881715|NCT01548404|3707290|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3881716|NCT01548404|3707288|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3881717|NCT01548404|3707289|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3881718|NCT01548404|3707290|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3881719|NCT01548404|3707288|B3|||Age||years|Mean|36.5|36.5|Standard Deviation|11.69|11.69|||
3881720|NCT01548404|3707289|B2|||Age||years|Mean|33.7|33.7|Standard Deviation|10.41|10.41|||
3881721|NCT01548404|3707290|B1|||Age||years|Mean|39.4|39.4|Standard Deviation|12.29|12.29|||
3881722|NCT01548287|3707313|B5|No||Concomitant donepezil administration||Participants|Number|72|72.0||||||
3881723|NCT01548287|3707314|B4|No||Concomitant donepezil administration||Participants|Number|17|17.0||||||
3881724|NCT01548287|3707315|B3|No||Concomitant donepezil administration||Participants|Number|17|17.0||||||
3881725|NCT01548287|3707316|B2|No||Concomitant donepezil administration||Participants|Number|21|21.0||||||
3881726|NCT01548287|3707317|B1|No||Concomitant donepezil administration||Participants|Number|17|17.0||||||
3881727|NCT01548287|3707313|B5|Yes||Concomitant donepezil administration||Participants|Number|9|9.0||||||
3881728|NCT01548287|3707314|B4|Yes||Concomitant donepezil administration||Participants|Number|3|3.0||||||
3881729|NCT01548287|3707315|B3|Yes||Concomitant donepezil administration||Participants|Number|3|3.0||||||
3881730|NCT01548287|3707316|B2|Yes||Concomitant donepezil administration||Participants|Number|1|1.0||||||
3881731|NCT01548287|3707317|B1|Yes||Concomitant donepezil administration||Participants|Number|2|2.0||||||
3881732|NCT01548287|3707313|B5|MCI||Alzheimers disease (AD)/Mild cognitive impairment (MCI)||Participants|Number|62|62.0||||||
3881733|NCT01548287|3707314|B4|MCI||Alzheimers disease (AD)/Mild cognitive impairment (MCI)||Participants|Number|15|15.0||||||
3881734|NCT01548287|3707315|B3|MCI||Alzheimers disease (AD)/Mild cognitive impairment (MCI)||Participants|Number|15|15.0||||||
3881735|NCT01548287|3707316|B2|MCI||Alzheimers disease (AD)/Mild cognitive impairment (MCI)||Participants|Number|16|16.0||||||
3881737|NCT01548287|3707313|B5|AD||Alzheimers disease (AD)/Mild cognitive impairment (MCI)||Participants|Number|19|19.0||||||
3881738|NCT01548287|3707314|B4|AD||Alzheimers disease (AD)/Mild cognitive impairment (MCI)||Participants|Number|5|5.0||||||
3881739|NCT01548287|3707315|B3|AD||Alzheimers disease (AD)/Mild cognitive impairment (MCI)||Participants|Number|5|5.0||||||
3881740|NCT01548287|3707316|B2|AD||Alzheimers disease (AD)/Mild cognitive impairment (MCI)||Participants|Number|6|6.0||||||
3881741|NCT01548287|3707317|B1|AD||Alzheimers disease (AD)/Mild cognitive impairment (MCI)||Participants|Number|3|3.0||||||
3881742|NCT01548287|3707313|B5|||Mini-Mental State Examination|Mini-Mental Scale Examination, Total Score range 0-30, higher score indicates less cognitive impairment|Scores on scale|Mean|26.8|26.8|Standard Deviation|1.77|1.77|||
3881743|NCT01548287|3707314|B4|||Mini-Mental State Examination|Mini-Mental Scale Examination, Total Score range 0-30, higher score indicates less cognitive impairment|Scores on scale|Mean|27.0|27.0|Standard Deviation|1.88|1.88|||
3881744|NCT01548287|3707315|B3|||Mini-Mental State Examination|Mini-Mental Scale Examination, Total Score range 0-30, higher score indicates less cognitive impairment|Scores on scale|Mean|26.1|26.1|Standard Deviation|1.62|1.62|||
3881745|NCT01548287|3707316|B2|||Mini-Mental State Examination|Mini-Mental Scale Examination, Total Score range 0-30, higher score indicates less cognitive impairment|Scores on scale|Mean|27.0|27.0|Standard Deviation|2.01|2.01|||
3881746|NCT01548287|3707317|B1|||Mini-Mental State Examination|Mini-Mental Scale Examination, Total Score range 0-30, higher score indicates less cognitive impairment|Scores on scale|Mean|27.2|27.2|Standard Deviation|1.38|1.38|||
3881747|NCT01548287|3707313|B5||Male|Gender||Participants|Count of Participants|25|25.0||||||
3881748|NCT01548287|3707314|B4||Male|Gender||Participants|Count of Participants|5|5.0||||||
3881749|NCT01548287|3707315|B3||Male|Gender||Participants|Count of Participants|7|7.0||||||
3881750|NCT01548287|3707316|B2||Male|Gender||Participants|Count of Participants|6|6.0||||||
3881751|NCT01548287|3707317|B1||Male|Gender||Participants|Count of Participants|7|7.0||||||
3881752|NCT01548287|3707313|B5||Female|Gender||Participants|Count of Participants|56|56.0||||||
3881753|NCT01548287|3707314|B4||Female|Gender||Participants|Count of Participants|15|15.0||||||
3881754|NCT01548287|3707315|B3||Female|Gender||Participants|Count of Participants|13|13.0||||||
3881755|NCT01548287|3707316|B2||Female|Gender||Participants|Count of Participants|16|16.0||||||
3881756|NCT01548287|3707317|B1||Female|Gender||Participants|Count of Participants|12|12.0||||||
3881757|NCT01548287|3707313|B5|||Age||years|Mean|66.1|66.1|Standard Deviation|8.62|8.62|||
3881758|NCT01548287|3707314|B4|||Age||years|Mean|64.2|64.2|Standard Deviation|7.62|7.62|||
3881759|NCT01548287|3707315|B3|||Age||years|Mean|69.3|69.3|Standard Deviation|10.32|10.32|||
3881760|NCT01548287|3707316|B2|||Age||years|Mean|65.1|65.1|Standard Deviation|8.04|8.04|||
3881761|NCT01548287|3707317|B1|||Age||years|Mean|66.1|66.1|Standard Deviation|8.02|8.02|||
3881762|NCT01548040|3707351|B3|||Body Mass Index (BMI)||Kg/m^2|Mean|29.7|29.7|Standard Deviation|5.11|5.11|||
3881763|NCT01548040|3707352|B2|||Body Mass Index (BMI)||Kg/m^2|Mean|29.4|29.4|Standard Deviation|5.23|5.23|||
3881764|NCT01548040|3707353|B1|||Body Mass Index (BMI)||Kg/m^2|Mean|30.0|30.0|Standard Deviation|5.03|5.03|||
3881765|NCT01548040|3707351|B3||Ex|Smoking Status||Participants|Count of Participants|37|37.0||||||
3881766|NCT01548040|3707352|B2||Ex|Smoking Status||Participants|Count of Participants|20|20.0||||||
3881767|NCT01548040|3707353|B1||Ex|Smoking Status||Participants|Count of Participants|17|17.0||||||
3881768|NCT01548040|3707351|B3||Non|Smoking Status||Participants|Count of Participants|70|70.0||||||
3881769|NCT01548040|3707352|B2||Non|Smoking Status||Participants|Count of Participants|34|34.0||||||
3881770|NCT01548040|3707353|B1||Non|Smoking Status||Participants|Count of Participants|36|36.0||||||
3881771|NCT01548040|3707351|B3||Current|Smoking Status||Participants|Count of Participants|4|4.0||||||
3881772|NCT01548040|3707352|B2||Current|Smoking Status||Participants|Count of Participants|1|1.0||||||
3881773|NCT01548040|3707353|B1||Current|Smoking Status||Participants|Count of Participants|3|3.0||||||
3881774|NCT01548040|3707351|B3|United States||Region of Enrollment||participants|Number|111|111.0||||||
3881775|NCT01548040|3707352|B2|United States||Region of Enrollment||participants|Number|55|55.0||||||
3881776|NCT01548040|3707353|B1|United States||Region of Enrollment||participants|Number|56|56.0||||||
3881777|NCT01548040|3707351|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3881778|NCT01548040|3707351|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3881779|NCT01548040|3707352|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3881780|NCT01548040|3707353|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3881781|NCT01548040|3707351|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3881782|NCT01548040|3707352|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3881783|NCT01548040|3707353|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3881784|NCT01548040|3707351|B3|||Age||years|Mean|64.8|64.8|Standard Deviation|9.24|9.24|||
3881785|NCT01548040|3707352|B2|||Age||years|Mean|64.5|64.5|Standard Deviation|10.23|10.23|||
3881786|NCT01548040|3707353|B1|||Age||years|Mean|65.1|65.1|Standard Deviation|8.23|8.23|||
3881787|NCT01547806|3707362|B1|United States||Region of Enrollment||Participants|Count of Participants|49|49.0||||||
3881788|NCT01547806|3707362|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881789|NCT01547806|3707362|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881790|NCT01547806|3707362|B1||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3881791|NCT01547806|3707362|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3881792|NCT01547806|3707362|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881793|NCT01547806|3707362|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3881794|NCT01547806|3707362|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3881795|NCT01547806|3707362|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3881796|NCT01547806|3707362|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3881797|NCT01547806|3707362|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881798|NCT01547806|3707362|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3881799|NCT01547806|3707362|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3881800|NCT01547806|3707362|B1|||Age||years|Mean|56.99|56.99|Standard Deviation|8.45|8.45|||
3881801|NCT01547806|3707362|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3881802|NCT01547806|3707362|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3881803|NCT01547806|3707362|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3881804|NCT01547728|3707378|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
3881805|NCT01547728|3707378|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3881806|NCT01547728|3707378|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3881807|NCT01547728|3707378|B1|||Age||years|Mean|64|64.0|Full Range|||19.0|83.0|
3881808|NCT01547715|3707382|B4||MALE|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3881809|NCT01547715|3707383|B3||MALE|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3881810|NCT01547715|3707384|B2||MALE|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3881811|NCT01547715|3707385|B1||MALE|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3881812|NCT01547715|3707382|B4||FEMALE|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3881813|NCT01547715|3707383|B3||FEMALE|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3881814|NCT01547715|3707384|B2||FEMALE|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3881815|NCT01547715|3707385|B1||FEMALE|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3881816|NCT01547715|3707382|B4|||Age||YEARS|Mean|17.49|17.49|Standard Deviation|13.432|13.432|||
3881817|NCT01547715|3707383|B3|||Age||YEARS|Mean|32.67|32.67|Standard Deviation|12.297|12.297|||
3881818|NCT01547715|3707384|B2|||Age||YEARS|Mean|14.03|14.03|Standard Deviation|1.931|1.931|||
3881819|NCT01547715|3707385|B1|||Age||YEARS|Mean|5.77|5.77|Standard Deviation|2.5|2.5|||
3881820|NCT01547598|3707485|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3881821|NCT01547598|3707486|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3881822|NCT01547598|3707487|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3881823|NCT01547598|3707485|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3881824|NCT01547598|3707486|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3881825|NCT01547598|3707487|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3881826|NCT01547598|3707485|B3|||Age||Years|Mean|66.2|66.2|Standard Deviation|10.3|10.3|||
3881827|NCT01547598|3707486|B2|||Age||Years|Mean|65.2|65.2|Standard Deviation|10.7|10.7|||
3881828|NCT01547598|3707487|B1|||Age||Years|Mean|67.2|67.2|Standard Deviation|9.7|9.7|||
3881829|NCT01547390|3707503|B3|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3881830|NCT01547390|3707504|B2|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3881831|NCT01547390|3707505|B1|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3881832|NCT01547390|3707503|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3881833|NCT01547390|3707504|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3881834|NCT01547390|3707505|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3881835|NCT01547390|3707503|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3881836|NCT01547390|3707504|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3881837|NCT01547390|3707505|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3881838|NCT01547390|3707503|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3881839|NCT01547390|3707504|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3881840|NCT01547390|3707505|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3881841|NCT01547390|3707503|B3|Sex|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3881842|NCT01547390|3707504|B2|Sex|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3881843|NCT01547390|3707505|B1|Sex|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3881844|NCT01547390|3707503|B3|Sex|Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3881845|NCT01547390|3707504|B2|Sex|Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3881846|NCT01547390|3707505|B1|Sex|Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3881847|NCT01547390|3707503|B3|||Age|Maternal age at enrolment as reported by the participant|years|Mean|30.8|30.8|Standard Deviation|5.5|5.5|||
3881848|NCT01547390|3707504|B2|||Age|Maternal age at enrolment as reported by the participant|years|Mean|30.0|30.0|Standard Deviation|5.0|5.0|||
3881849|NCT01547390|3707505|B1|||Age|Maternal age at enrolment as reported by the participant|years|Mean|31.6|31.6|Standard Deviation|6.1|6.1|||
3881850|NCT01547390|3707503|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3881851|NCT01547390|3707504|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3881852|NCT01547390|3707505|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3881853|NCT01547390|3707503|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3881854|NCT01547390|3707504|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3881855|NCT01547390|3707505|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3881856|NCT01547390|3707503|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3881857|NCT01547390|3707504|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3881858|NCT01547390|3707505|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3881859|NCT01547299|3707514|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3881860|NCT01547299|3707515|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3881861|NCT01547299|3707516|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3881862|NCT01547299|3707514|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3881863|NCT01547299|3707515|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3881864|NCT01547299|3707516|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3881865|NCT01547299|3707514|B3|||Age||years|Mean|61.1|61.1|Standard Deviation|7.26|7.26|||
3881866|NCT01547299|3707515|B2|||Age||years|Mean|61.4|61.4|Standard Deviation|7.65|7.65|||
3881867|NCT01547299|3707516|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|6.95|6.95|||
3881868|NCT01547286|3707583|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3881869|NCT01547286|3707583|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3881870|NCT01547286|3707583|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3881871|NCT01547286|3707583|B1|||Age||years|Mean|22.7|22.7|Standard Deviation|5.08|5.08|||
3881872|NCT01547286|3707583|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3881873|NCT01547286|3707583|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3881874|NCT01547286|3707583|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3881875|NCT01547247|3707590|B3|Czech Republic||Region of Enrollment||participants|Number|208|208.0||||||
3881876|NCT01547247|3707591|B2|Czech Republic||Region of Enrollment||participants|Number|104|104.0||||||
3881877|NCT01547247|3707592|B1|Czech Republic||Region of Enrollment||participants|Number|104|104.0||||||
3881878|NCT01547247|3707590|B3||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3881879|NCT01547247|3707591|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3881880|NCT01547247|3707592|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3881881|NCT01547247|3707590|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3881882|NCT01547247|3707591|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3881883|NCT01547247|3707592|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3881884|NCT01547247|3707590|B3|||Age||years|Mean|58.6|58.6|Standard Deviation|12.8|12.8|||
3881885|NCT01547247|3707591|B2|||Age||years|Mean|58.2|58.2|Standard Deviation|13.9|13.9|||
3881886|NCT01547247|3707592|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|12.0|12.0|||
3881887|NCT01547247|3707590|B3||>=65 years|Age||Participants|Count of Participants|108|108.0||||||
3881888|NCT01547247|3707591|B2||>=65 years|Age||Participants|Count of Participants|53|53.0||||||
3881889|NCT01547247|3707592|B1||>=65 years|Age||Participants|Count of Participants|55|55.0||||||
3881890|NCT01547247|3707590|B3||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
3881891|NCT01547247|3707591|B2||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3881892|NCT01547247|3707592|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3881893|NCT01547247|3707590|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3881894|NCT01547247|3707591|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3881895|NCT01547247|3707592|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3881896|NCT01547130|3707601|B3|United States||Region of Enrollment||participants|Number|147|147.0||||||
3881897|NCT01547130|3707602|B2|United States||Region of Enrollment||participants|Number|73|73.0||||||
3881898|NCT01547130|3707603|B1|United States||Region of Enrollment||participants|Number|74|74.0||||||
3881899|NCT01547130|3707601|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3881900|NCT01547130|3707602|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3881901|NCT01547130|3707603|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3881902|NCT01547130|3707601|B3||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3881903|NCT01547130|3707602|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3881904|NCT01547130|3707603|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3881905|NCT01547130|3707601|B3|||Age||years|Mean|44.2|44.2|Standard Deviation|10.2|10.2|||
3881906|NCT01547130|3707602|B2|||Age||years|Mean|44.8|44.8|Standard Deviation|10|10.0|||
3881907|NCT01547130|3707603|B1|||Age||years|Mean|43.6|43.6|Standard Deviation|10.5|10.5|||
3881908|NCT01547130|3707601|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3881909|NCT01547130|3707602|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3881910|NCT01547130|3707603|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3881911|NCT01547130|3707601|B3||Between 18 and 65 years|Age||Participants|Count of Participants|145|145.0||||||
3881912|NCT01547130|3707602|B2||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
3881913|NCT01547130|3707603|B1||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
3881914|NCT01547130|3707601|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3881915|NCT01547130|3707602|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3881916|NCT01547130|3707603|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3881917|NCT01547000|3707618|B3|||Rage Outbursts and Anger Rating Scale (ROARS)|The ROARS (Budman et al. 2008) is a 3-item, clinician-rated scale designed to quantify the severity of explosive outbursts in the past week, administered by an independent evaluator. The items are rated from 0 to 3 on frequency, intensity, and duration and then added together for a total score. The total score for the Rage Outbursts and Anger Rating Scale (ROARS) ranged from 0 to 9. Higher scores indicates greater severity.|units on a scale|Mean|2.6|2.6|Standard Deviation|4.1|4.1|||
3881918|NCT01547000|3707619|B2|||Rage Outbursts and Anger Rating Scale (ROARS)|The ROARS (Budman et al. 2008) is a 3-item, clinician-rated scale designed to quantify the severity of explosive outbursts in the past week, administered by an independent evaluator. The items are rated from 0 to 3 on frequency, intensity, and duration and then added together for a total score. The total score for the Rage Outbursts and Anger Rating Scale (ROARS) ranged from 0 to 9. Higher scores indicates greater severity.|units on a scale|Mean|3.1|3.1|Standard Deviation|2.87|2.87|||
3881919|NCT01547000|3707620|B1|||Rage Outbursts and Anger Rating Scale (ROARS)|The ROARS (Budman et al. 2008) is a 3-item, clinician-rated scale designed to quantify the severity of explosive outbursts in the past week, administered by an independent evaluator. The items are rated from 0 to 3 on frequency, intensity, and duration and then added together for a total score. The total score for the Rage Outbursts and Anger Rating Scale (ROARS) ranged from 0 to 9. Higher scores indicates greater severity.|units on a scale|Mean|2.2|2.2|Standard Deviation|2.87|2.87|||
3881920|NCT01547000|3707618|B3|||Children’s Yale-Brown Obsessive Compulsive Scale (CY-BOCS)|The CY-BOCS (Scahill et al. 1997) is a 10-item, semistructured interview administered by the independent evaluator and is designed to rate the severity of obsessive-compulsive disorder. Scores range from 0 to 40 with higher scores indicating greater severity.|units on a scale|Mean|10.1|10.1|Standard Deviation|15.5|15.5|||
3881921|NCT01547000|3707619|B2|||Children’s Yale-Brown Obsessive Compulsive Scale (CY-BOCS)|The CY-BOCS (Scahill et al. 1997) is a 10-item, semistructured interview administered by the independent evaluator and is designed to rate the severity of obsessive-compulsive disorder. Scores range from 0 to 40 with higher scores indicating greater severity.|units on a scale|Mean|9.6|9.6|Standard Deviation|10.41|10.41|||
3881922|NCT01547000|3707620|B1|||Children’s Yale-Brown Obsessive Compulsive Scale (CY-BOCS)|The CY-BOCS (Scahill et al. 1997) is a 10-item, semistructured interview administered by the independent evaluator and is designed to rate the severity of obsessive-compulsive disorder. Scores range from 0 to 40 with higher scores indicating greater severity.|units on a scale|Mean|10.5|10.5|Standard Deviation|11.43|11.43|||
3881923|NCT01547000|3707618|B3|||Disruptive Behavior Rating Scale (DBRS)|The DBRS (Barkley and Murphy 2006) is an 8-item measure of oppositional defiant disorder rated by the parent or caretaker, with each item rated on a 0 to 3 scale. The total score is the sum of all 8 item scores. The total score for the Disruptive Behavior Rating Scale (DBRS) ranged from 0 to 24. Higher scores means greater severity of disruptive behaviors. Scores of 12 and higher are considered clinically significant.|units on a scale|Mean|7.1|7.1|Standard Deviation|9.9|9.9|||
3881924|NCT01547000|3707619|B2|||Disruptive Behavior Rating Scale (DBRS)|The DBRS (Barkley and Murphy 2006) is an 8-item measure of oppositional defiant disorder rated by the parent or caretaker, with each item rated on a 0 to 3 scale. The total score is the sum of all 8 item scores. The total score for the Disruptive Behavior Rating Scale (DBRS) ranged from 0 to 24. Higher scores means greater severity of disruptive behaviors. Scores of 12 and higher are considered clinically significant.|units on a scale|Mean|8.8|8.8|Standard Deviation|6.59|6.59|||
3881925|NCT01547000|3707620|B1|||Disruptive Behavior Rating Scale (DBRS)|The DBRS (Barkley and Murphy 2006) is an 8-item measure of oppositional defiant disorder rated by the parent or caretaker, with each item rated on a 0 to 3 scale. The total score is the sum of all 8 item scores. The total score for the Disruptive Behavior Rating Scale (DBRS) ranged from 0 to 24. Higher scores means greater severity of disruptive behaviors. Scores of 12 and higher are considered clinically significant.|units on a scale|Mean|5.6|5.6|Standard Deviation|7.37|7.37|||
3881926|NCT01547000|3707618|B3|||Attention-Deficit/Hyperactivity Disorder Rating Scale (parent)|The ADHD Rating Scale (Reid et al. 1998) is an 18-item, DSM-IV referenced measure rated by a parent or caretaker in this study. The sum of nine inattention items and nine hyperactivity/impulsiveness items (each rated on a 0–3 scale) are included in the total score. The total score for the Attention-Deficit/Hyperactivity Disorder Rating Scale (parent) ranged from 0 to 54. A higher score means greater severity of ADHD symptoms.|units on a scale|Mean|18.5|18.5|Standard Deviation|18.4|18.4|||
3881927|NCT01547000|3707619|B2|||Attention-Deficit/Hyperactivity Disorder Rating Scale (parent)|The ADHD Rating Scale (Reid et al. 1998) is an 18-item, DSM-IV referenced measure rated by a parent or caretaker in this study. The sum of nine inattention items and nine hyperactivity/impulsiveness items (each rated on a 0–3 scale) are included in the total score. The total score for the Attention-Deficit/Hyperactivity Disorder Rating Scale (parent) ranged from 0 to 54. A higher score means greater severity of ADHD symptoms.|units on a scale|Mean|19.7|19.7|Standard Deviation|12.29|12.29|||
3881928|NCT01547000|3707620|B1|||Attention-Deficit/Hyperactivity Disorder Rating Scale (parent)|The ADHD Rating Scale (Reid et al. 1998) is an 18-item, DSM-IV referenced measure rated by a parent or caretaker in this study. The sum of nine inattention items and nine hyperactivity/impulsiveness items (each rated on a 0–3 scale) are included in the total score. The total score for the Attention-Deficit/Hyperactivity Disorder Rating Scale (parent) ranged from 0 to 54. A higher score means greater severity of ADHD symptoms.|units on a scale|Mean|17.5|17.5|Standard Deviation|13.65|13.65|||
3881929|NCT01547000|3707618|B3|||Premonitory Urge for Tics Scale (PUTS)|The PUTS (Woods et al. 2005) is a 10-item self-report measure of premonitory urges in individuals with tics. Individual item scores (1-4) are summed, yielding a total score (10-40) reflecting the presence and frequency of pre-tic (i.e., premonitory) urges along with relief that may be experienced after tics have been completed. Higher scores means higher frequency of premonitory urges.|units on a scale|Mean|20.4|20.4|Standard Deviation|9.8|9.8|||
3882004|NCT01547000|3707618|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3882005|NCT01547000|3707619|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3882006|NCT01547000|3707620|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3881930|NCT01547000|3707619|B2|||Premonitory Urge for Tics Scale (PUTS)|The PUTS (Woods et al. 2005) is a 10-item self-report measure of premonitory urges in individuals with tics. Individual item scores (1-4) are summed, yielding a total score (10-40) reflecting the presence and frequency of pre-tic (i.e., premonitory) urges along with relief that may be experienced after tics have been completed. Higher scores means higher frequency of premonitory urges.|units on a scale|Mean|19.8|19.8|Standard Deviation|5.39|5.39|||
3881931|NCT01547000|3707620|B1|||Premonitory Urge for Tics Scale (PUTS)|The PUTS (Woods et al. 2005) is a 10-item self-report measure of premonitory urges in individuals with tics. Individual item scores (1-4) are summed, yielding a total score (10-40) reflecting the presence and frequency of pre-tic (i.e., premonitory) urges along with relief that may be experienced after tics have been completed. Higher scores means higher frequency of premonitory urges.|units on a scale|Mean|20.9|20.9|Standard Deviation|8.18|8.18|||
3881932|NCT01547000|3707618|B3|||Tic Symptom Self-Report (TSSR)|The TSSR (Cohen and Leckman 1984) was completed by a parent or caretaker. It includes 20 motor and 20 phonic tics, each rated 0 to 3. The motor and phonic scores are summed to create a total score. The total score for Tic Symptom Self-Report ranged from 0-120. Higher scores means greater severity/worse outcome. It has been shown to be sensitive to treatment effects (Scahill et al. 2003).|units on a scale|Mean|25.7|25.7|Standard Deviation|28.5|28.5|||
3881933|NCT01547000|3707619|B2|||Tic Symptom Self-Report (TSSR)|The TSSR (Cohen and Leckman 1984) was completed by a parent or caretaker. It includes 20 motor and 20 phonic tics, each rated 0 to 3. The motor and phonic scores are summed to create a total score. The total score for Tic Symptom Self-Report ranged from 0-120. Higher scores means greater severity/worse outcome. It has been shown to be sensitive to treatment effects (Scahill et al. 2003).|units on a scale|Mean|26.9|26.9|Standard Deviation|22.83|22.83|||
3881934|NCT01547000|3707620|B1|||Tic Symptom Self-Report (TSSR)|The TSSR (Cohen and Leckman 1984) was completed by a parent or caretaker. It includes 20 motor and 20 phonic tics, each rated 0 to 3. The motor and phonic scores are summed to create a total score. The total score for Tic Symptom Self-Report ranged from 0-120. Higher scores means greater severity/worse outcome. It has been shown to be sensitive to treatment effects (Scahill et al. 2003).|units on a scale|Mean|24.6|24.6|Standard Deviation|16.94|16.94|||
3881935|NCT01547000|3707618|B3||Severely ill|Clinical Global Impressions (CGI)||Participants|Count of Participants|3|3.0||||||
3881936|NCT01547000|3707619|B2||Severely ill|Clinical Global Impressions (CGI)||Participants|Count of Participants|0|0.0||||||
3881937|NCT01547000|3707620|B1||Severely ill|Clinical Global Impressions (CGI)||Participants|Count of Participants|3|3.0||||||
3881938|NCT01547000|3707618|B3||Markedly ill|Clinical Global Impressions (CGI)||Participants|Count of Participants|10|10.0||||||
3881939|NCT01547000|3707619|B2||Markedly ill|Clinical Global Impressions (CGI)||Participants|Count of Participants|4|4.0||||||
3881940|NCT01547000|3707620|B1||Markedly ill|Clinical Global Impressions (CGI)||Participants|Count of Participants|6|6.0||||||
3881941|NCT01547000|3707618|B3||Moderately ill|Clinical Global Impressions (CGI)||Participants|Count of Participants|21|21.0||||||
3881942|NCT01547000|3707619|B2||Moderately ill|Clinical Global Impressions (CGI)||Participants|Count of Participants|12|12.0||||||
3881943|NCT01547000|3707620|B1||Moderately ill|Clinical Global Impressions (CGI)||Participants|Count of Participants|9|9.0||||||
3881944|NCT01547000|3707618|B3|Impairment||Yale Global Tic Severity Scale (YGTSS)|The YGTSS is a clinician-rated scale that begins with a systematic inquiry of tic symptoms in the preceding week. Current motor and phonic tics are rated separately according to number, frequency, intensity, complexity, and interference, each rated on 0 to 5 scale with higher scores indicating greater severity/worse outcome (Leckman et al. 1989). The YGTSS yields a total motor score (0–25), a total phonic score (0–25), a total tic score (sum of total motor and total phonic scores; 0–50), and an impairment score (0–50). Higher scores indicate greater severity/worse outcome.|units on a scale|Mean|29.2|29.2|Standard Deviation|11.4|11.4|||
3881945|NCT01547000|3707619|B2|Impairment||Yale Global Tic Severity Scale (YGTSS)|The YGTSS is a clinician-rated scale that begins with a systematic inquiry of tic symptoms in the preceding week. Current motor and phonic tics are rated separately according to number, frequency, intensity, complexity, and interference, each rated on 0 to 5 scale with higher scores indicating greater severity/worse outcome (Leckman et al. 1989). The YGTSS yields a total motor score (0–25), a total phonic score (0–25), a total tic score (sum of total motor and total phonic scores; 0–50), and an impairment score (0–50). Higher scores indicate greater severity/worse outcome.|units on a scale|Mean|29.8|29.8|Standard Deviation|8.18|8.18|||
3881946|NCT01547000|3707620|B1|Impairment||Yale Global Tic Severity Scale (YGTSS)|The YGTSS is a clinician-rated scale that begins with a systematic inquiry of tic symptoms in the preceding week. Current motor and phonic tics are rated separately according to number, frequency, intensity, complexity, and interference, each rated on 0 to 5 scale with higher scores indicating greater severity/worse outcome (Leckman et al. 1989). The YGTSS yields a total motor score (0–25), a total phonic score (0–25), a total tic score (sum of total motor and total phonic scores; 0–50), and an impairment score (0–50). Higher scores indicate greater severity/worse outcome.|units on a scale|Mean|28.6|28.6|Standard Deviation|8.01|8.01|||
3881947|NCT01547000|3707618|B3|Total Phonic score||Yale Global Tic Severity Scale (YGTSS)|The YGTSS is a clinician-rated scale that begins with a systematic inquiry of tic symptoms in the preceding week. Current motor and phonic tics are rated separately according to number, frequency, intensity, complexity, and interference, each rated on 0 to 5 scale with higher scores indicating greater severity/worse outcome (Leckman et al. 1989). The YGTSS yields a total motor score (0–25), a total phonic score (0–25), a total tic score (sum of total motor and total phonic scores; 0–50), and an impairment score (0–50). Higher scores indicate greater severity/worse outcome.|units on a scale|Mean|10.7|10.7|Standard Deviation|9.1|9.1|||
3881948|NCT01547000|3707619|B2|Total Phonic score||Yale Global Tic Severity Scale (YGTSS)|The YGTSS is a clinician-rated scale that begins with a systematic inquiry of tic symptoms in the preceding week. Current motor and phonic tics are rated separately according to number, frequency, intensity, complexity, and interference, each rated on 0 to 5 scale with higher scores indicating greater severity/worse outcome (Leckman et al. 1989). The YGTSS yields a total motor score (0–25), a total phonic score (0–25), a total tic score (sum of total motor and total phonic scores; 0–50), and an impairment score (0–50). Higher scores indicate greater severity/worse outcome.|units on a scale|Mean|11.1|11.1|Standard Deviation|6.13|6.13|||
3881949|NCT01547000|3707620|B1|Total Phonic score||Yale Global Tic Severity Scale (YGTSS)|The YGTSS is a clinician-rated scale that begins with a systematic inquiry of tic symptoms in the preceding week. Current motor and phonic tics are rated separately according to number, frequency, intensity, complexity, and interference, each rated on 0 to 5 scale with higher scores indicating greater severity/worse outcome (Leckman et al. 1989). The YGTSS yields a total motor score (0–25), a total phonic score (0–25), a total tic score (sum of total motor and total phonic scores; 0–50), and an impairment score (0–50). Higher scores indicate greater severity/worse outcome.|units on a scale|Mean|10.4|10.4|Standard Deviation|6.73|6.73|||
3881950|NCT01547000|3707618|B3|Total Motor score||Yale Global Tic Severity Scale (YGTSS)|The YGTSS is a clinician-rated scale that begins with a systematic inquiry of tic symptoms in the preceding week. Current motor and phonic tics are rated separately according to number, frequency, intensity, complexity, and interference, each rated on 0 to 5 scale with higher scores indicating greater severity/worse outcome (Leckman et al. 1989). The YGTSS yields a total motor score (0–25), a total phonic score (0–25), a total tic score (sum of total motor and total phonic scores; 0–50), and an impairment score (0–50). Higher scores indicate greater severity/worse outcome.|units on a scale|Mean|16.3|16.3|Standard Deviation|4.3|4.3|||
3881951|NCT01547000|3707619|B2|Total Motor score||Yale Global Tic Severity Scale (YGTSS)|The YGTSS is a clinician-rated scale that begins with a systematic inquiry of tic symptoms in the preceding week. Current motor and phonic tics are rated separately according to number, frequency, intensity, complexity, and interference, each rated on 0 to 5 scale with higher scores indicating greater severity/worse outcome (Leckman et al. 1989). The YGTSS yields a total motor score (0–25), a total phonic score (0–25), a total tic score (sum of total motor and total phonic scores; 0–50), and an impairment score (0–50). Higher scores indicate greater severity/worse outcome.|units on a scale|Mean|15.2|15.2|Standard Deviation|2.61|2.61|||
3881952|NCT01547000|3707620|B1|Total Motor score||Yale Global Tic Severity Scale (YGTSS)|The YGTSS is a clinician-rated scale that begins with a systematic inquiry of tic symptoms in the preceding week. Current motor and phonic tics are rated separately according to number, frequency, intensity, complexity, and interference, each rated on 0 to 5 scale with higher scores indicating greater severity/worse outcome (Leckman et al. 1989). The YGTSS yields a total motor score (0–25), a total phonic score (0–25), a total tic score (sum of total motor and total phonic scores; 0–50), and an impairment score (0–50). Higher scores indicate greater severity/worse outcome.|units on a scale|Mean|17.2|17.2|Standard Deviation|3.44|3.44|||
3881953|NCT01547000|3707618|B3|Total Tic Score||Yale Global Tic Severity Scale (YGTSS)|The YGTSS is a clinician-rated scale that begins with a systematic inquiry of tic symptoms in the preceding week. Current motor and phonic tics are rated separately according to number, frequency, intensity, complexity, and interference, each rated on 0 to 5 scale with higher scores indicating greater severity/worse outcome (Leckman et al. 1989). The YGTSS yields a total motor score (0–25), a total phonic score (0–25), a total tic score (sum of total motor and total phonic scores; 0–50), and an impairment score (0–50). Higher scores indicate greater severity/worse outcome.|units on a scale|Mean|27.0|27.0|Standard Deviation|10.9|10.9|||
3881954|NCT01547000|3707619|B2|Total Tic Score||Yale Global Tic Severity Scale (YGTSS)|The YGTSS is a clinician-rated scale that begins with a systematic inquiry of tic symptoms in the preceding week. Current motor and phonic tics are rated separately according to number, frequency, intensity, complexity, and interference, each rated on 0 to 5 scale with higher scores indicating greater severity/worse outcome (Leckman et al. 1989). The YGTSS yields a total motor score (0–25), a total phonic score (0–25), a total tic score (sum of total motor and total phonic scores; 0–50), and an impairment score (0–50). Higher scores indicate greater severity/worse outcome.|units on a scale|Mean|26.3|26.3|Standard Deviation|6.61|6.61|||
3881955|NCT01547000|3707620|B1|Total Tic Score||Yale Global Tic Severity Scale (YGTSS)|The YGTSS is a clinician-rated scale that begins with a systematic inquiry of tic symptoms in the preceding week. Current motor and phonic tics are rated separately according to number, frequency, intensity, complexity, and interference, each rated on 0 to 5 scale with higher scores indicating greater severity/worse outcome (Leckman et al. 1989). The YGTSS yields a total motor score (0–25), a total phonic score (0–25), a total tic score (sum of total motor and total phonic scores; 0–50), and an impairment score (0–50). Higher scores indicate greater severity/worse outcome.|units on a scale|Mean|27.7|27.7|Standard Deviation|8.7|8.7|||
3881956|NCT01547000|3707618|B3||Stage 3+|Tanner stage|The Tanner scale categorizes physical measurements of development based on external primary and secondary sex characteristics, such as the size of the breasts, genitals, testicular volume and development of pubic hair in children, adolescents, and adults. Stages are based on physical examination. Stages are not indicative of better or worse outcome. There is insufficient space given in this form to list all of the measurements here. In brief, Stage 1: no pubic hair; Stage 2: initial growth of pubic hair, breasts, nipples, scrotum, testes; Stage 3: additional growth of all mentioned in Stage 2.|Participants|Count of Participants|13|13.0||||||
3881957|NCT01547000|3707619|B2||Stage 3+|Tanner stage|The Tanner scale categorizes physical measurements of development based on external primary and secondary sex characteristics, such as the size of the breasts, genitals, testicular volume and development of pubic hair in children, adolescents, and adults. Stages are based on physical examination. Stages are not indicative of better or worse outcome. There is insufficient space given in this form to list all of the measurements here. In brief, Stage 1: no pubic hair; Stage 2: initial growth of pubic hair, breasts, nipples, scrotum, testes; Stage 3: additional growth of all mentioned in Stage 2.|Participants|Count of Participants|6|6.0||||||
3881958|NCT01547000|3707620|B1||Stage 3+|Tanner stage|The Tanner scale categorizes physical measurements of development based on external primary and secondary sex characteristics, such as the size of the breasts, genitals, testicular volume and development of pubic hair in children, adolescents, and adults. Stages are based on physical examination. Stages are not indicative of better or worse outcome. There is insufficient space given in this form to list all of the measurements here. In brief, Stage 1: no pubic hair; Stage 2: initial growth of pubic hair, breasts, nipples, scrotum, testes; Stage 3: additional growth of all mentioned in Stage 2.|Participants|Count of Participants|7|7.0||||||
3882007|NCT01547000|3707618|B3||<=18 years|Age||Participants|Count of Participants|34|34.0||||||
3882008|NCT01547000|3707619|B2||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
3882009|NCT01547000|3707620|B1||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
3882010|NCT01546922|3707627|B1|||Desmopressin substitution||participants|Number|9|9.0||||||
3881959|NCT01547000|3707618|B3||Stage 1 or 2|Tanner stage|The Tanner scale categorizes physical measurements of development based on external primary and secondary sex characteristics, such as the size of the breasts, genitals, testicular volume and development of pubic hair in children, adolescents, and adults. Stages are based on physical examination. Stages are not indicative of better or worse outcome. There is insufficient space given in this form to list all of the measurements here. In brief, Stage 1: no pubic hair; Stage 2: initial growth of pubic hair, breasts, nipples, scrotum, testes; Stage 3: additional growth of all mentioned in Stage 2.|Participants|Count of Participants|21|21.0||||||
3881960|NCT01547000|3707619|B2||Stage 1 or 2|Tanner stage|The Tanner scale categorizes physical measurements of development based on external primary and secondary sex characteristics, such as the size of the breasts, genitals, testicular volume and development of pubic hair in children, adolescents, and adults. Stages are based on physical examination. Stages are not indicative of better or worse outcome. There is insufficient space given in this form to list all of the measurements here. In brief, Stage 1: no pubic hair; Stage 2: initial growth of pubic hair, breasts, nipples, scrotum, testes; Stage 3: additional growth of all mentioned in Stage 2.|Participants|Count of Participants|10|10.0||||||
3881961|NCT01547000|3707620|B1||Stage 1 or 2|Tanner stage|The Tanner scale categorizes physical measurements of development based on external primary and secondary sex characteristics, such as the size of the breasts, genitals, testicular volume and development of pubic hair in children, adolescents, and adults. Stages are based on physical examination. Stages are not indicative of better or worse outcome. There is insufficient space given in this form to list all of the measurements here. In brief, Stage 1: no pubic hair; Stage 2: initial growth of pubic hair, breasts, nipples, scrotum, testes; Stage 3: additional growth of all mentioned in Stage 2.|Participants|Count of Participants|11|11.0||||||
3881962|NCT01547000|3707618|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881963|NCT01547000|3707619|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881964|NCT01547000|3707620|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881965|NCT01547000|3707618|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881966|NCT01547000|3707619|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881967|NCT01547000|3707620|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881968|NCT01547000|3707618|B3||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3881969|NCT01547000|3707619|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3881970|NCT01547000|3707620|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3881971|NCT01547000|3707618|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3881972|NCT01547000|3707619|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881973|NCT01547000|3707620|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3881974|NCT01547000|3707618|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881975|NCT01547000|3707619|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881976|NCT01547000|3707620|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881977|NCT01547000|3707618|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881978|NCT01547000|3707619|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881979|NCT01547000|3707620|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881980|NCT01547000|3707618|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881981|NCT01547000|3707619|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881982|NCT01547000|3707620|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881983|NCT01547000|3707618|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881984|NCT01547000|3707619|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881985|NCT01547000|3707620|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3881986|NCT01547000|3707618|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3881987|NCT01547000|3707619|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3881988|NCT01547000|3707620|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3881989|NCT01547000|3707618|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3881990|NCT01547000|3707619|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3881991|NCT01547000|3707620|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3881992|NCT01547000|3707618|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3881993|NCT01547000|3707619|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3881994|NCT01547000|3707620|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3881995|NCT01547000|3707618|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3881996|NCT01547000|3707619|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3881997|NCT01547000|3707620|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3881998|NCT01547000|3707618|B3|||Age||years|Mean|11.1|11.1|Standard Deviation|11.5|11.5|||
3881999|NCT01547000|3707619|B2|||Age||years|Mean|11.5|11.5|Standard Deviation|11|11.0|||
3882000|NCT01547000|3707620|B1|||Age||years|Mean|10.8|10.8|Standard Deviation|3.2|3.2|||
3882001|NCT01547000|3707618|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3882002|NCT01547000|3707619|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3882003|NCT01547000|3707620|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3882011|NCT01546922|3707627|B1|Premenopausal women: estrogen substitution||Sex hormone||participants|Number|4|4.0||||||
3882012|NCT01546922|3707627|B1|Men: testosterone substitution||Sex hormone||participants|Number|23|23.0||||||
3882013|NCT01546922|3707627|B1|Participants substituted||Sex hormone||participants|Number|27|27.0||||||
3882014|NCT01546922|3707627|B1|Participants unsubstituted||Growth hormone (GH)||participants|Number|10|10.0||||||
3882015|NCT01546922|3707627|B1|Participants substituted||Growth hormone (GH)||participants|Number|21|21.0||||||
3882016|NCT01546922|3707627|B1|||Thyroid hormone substitution||participants|Number|43|43.0||||||
3882017|NCT01546922|3707627|B1|5 hormonal replacements||Number of hormonal replacements||participants|Number|3|3.0||||||
3882018|NCT01546922|3707627|B1|4 hormonal replacements||Number of hormonal replacements||participants|Number|11|11.0||||||
3882019|NCT01546922|3707627|B1|3 hormonal replacements||Number of hormonal replacements||participants|Number|21|21.0||||||
3882020|NCT01546922|3707627|B1|2 hormonal replacements||Number of hormonal replacements||participants|Number|9|9.0||||||
3882021|NCT01546922|3707627|B1|1 hormonal replacement||Number of hormonal replacements||participants|Number|3|3.0||||||
3882022|NCT01546922|3707627|B1|||Duration of hydrocortisone treatment prior to randomization||years|Median|12|12.0|Inter-Quartile Range|||5.0|22.0|
3882023|NCT01546922|3707627|B1|3 doses per day||Number of daily dosings prior to randomization||participants|Number|11|11.0||||||
3882024|NCT01546922|3707627|B1|2 doses per day||Number of daily dosings prior to randomization||participants|Number|33|33.0||||||
3882025|NCT01546922|3707627|B1|1 dose per day||Number of daily dosings prior to randomization||participants|Number|3|3.0||||||
3882026|NCT01546922|3707627|B1|||Dose per kg body weight prior to randomization||mg/kg body weight|Median|0.32|0.32|Inter-Quartile Range|||0.25|0.35|
3882027|NCT01546922|3707627|B1|||Total daily dose hydrocortisone treatment prior to randomization||mg/day|Median|25|25.0|Inter-Quartile Range|||20.0|30.0|
3882028|NCT01546922|3707627|B1|||Median time since radiotherapy||years|Median|12|12.0|Inter-Quartile Range|||9.0|22.0|
3882029|NCT01546922|3707627|B1|||Age at radiotherapy||years|Median|43|43.0|Inter-Quartile Range|||25.0|52.0|
3882030|NCT01546922|3707627|B1|Radiotherapy for extracranial tumors||Type of radiotherapy|A total of 19 participants received radiotherapy|participants|Number|1|1.0||||||
3882031|NCT01546922|3707627|B1|Cranial irradiation||Type of radiotherapy|A total of 19 participants received radiotherapy|participants|Number|2|2.0||||||
3882032|NCT01546922|3707627|B1|Pituitary radiotherapy||Type of radiotherapy|A total of 19 participants received radiotherapy|participants|Number|16|16.0||||||
3882033|NCT01546922|3707627|B1|||Patients with a second surgery||participants|Number|5|5.0||||||
3882034|NCT01546922|3707627|B1|||Median time since surgery||years|Median|11|11.0|Inter-Quartile Range|||6.0|20.0|
3882035|NCT01546922|3707627|B1|||Age at surgery||years|Median|39|39.0|Inter-Quartile Range|||28.0|50.0|
3882036|NCT01546922|3707627|B1|Craniotomy||Type of surgery|A total of 32 participants underwent surgery|participants|Number|9|9.0||||||
3882037|NCT01546922|3707627|B1|Transsphenoïdal surgery||Type of surgery|A total of 32 participants underwent surgery|participants|Number|23|23.0||||||
3882038|NCT01546922|3707627|B1|||Body weight||kilogram|Median|82.5|82.5|Inter-Quartile Range|13.9|13.9|72.2|93.0|
3882039|NCT01546922|3707627|B1|Adult onset||Childhood onset/Adult onset||participants|Number|41|41.0||||||
3882040|NCT01546922|3707627|B1|Childhood onset||Childhood onset/Adult onset||participants|Number|6|6.0||||||
3882041|NCT01546922|3707627|B1|||Age at diagnosis||years|Median|31|31.0|Inter-Quartile Range|16|16.0|20.0|46.0|
3882042|NCT01546922|3707627|B1|Netherlands||Region of Enrollment||participants|Number|47|47.0||||||
3882043|NCT01546922|3707627|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3882044|NCT01546922|3707627|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3882045|NCT01546922|3707627|B1|||Age||years|Median|55|55.0|Inter-Quartile Range|14|14.0|43.0|61.0|
3882046|NCT01546883|3707634|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3882047|NCT01546883|3707634|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3882048|NCT01546883|3707634|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3882049|NCT01546883|3707634|B1|||Age||years|Mean|60|60.0|Standard Deviation|12|12.0|||
3882050|NCT01546688|3707638|B3|Not Hispanic or Latino||Race/Ethnicity, Customized|Ethnicity. Safety Population.|Participants|Number|48|48.0||||||
3882051|NCT01546688|3707639|B2|Not Hispanic or Latino||Race/Ethnicity, Customized|Ethnicity. Safety Population.|Participants|Number|31|31.0||||||
3882052|NCT01546688|3707640|B1|Not Hispanic or Latino||Race/Ethnicity, Customized|Ethnicity. Safety Population.|Participants|Number|17|17.0||||||
3882053|NCT01546688|3707638|B3|Hispanic or Latino||Race/Ethnicity, Customized|Ethnicity. Safety Population.|Participants|Number|3|3.0||||||
3882054|NCT01546688|3707639|B2|Hispanic or Latino||Race/Ethnicity, Customized|Ethnicity. Safety Population.|Participants|Number|2|2.0||||||
3882055|NCT01546688|3707640|B1|Hispanic or Latino||Race/Ethnicity, Customized|Ethnicity. Safety Population.|Participants|Number|1|1.0||||||
3882056|NCT01546688|3707638|B3|White||Race/Ethnicity, Customized|Race. Safety Population.|Participants|Number|51|51.0||||||
3882057|NCT01546688|3707639|B2|White||Race/Ethnicity, Customized|Race. Safety Population.|Participants|Number|33|33.0||||||
3882058|NCT01546688|3707640|B1|White||Race/Ethnicity, Customized|Race. Safety Population.|Participants|Number|18|18.0||||||
3882059|NCT01546688|3707638|B3||Male|Sex: Female, Male|Safety Population: All randomized subjects who received at least one dose of study medication.|Participants|Count of Participants|21|21.0||||||
3882060|NCT01546688|3707639|B2||Male|Sex: Female, Male|Safety Population: All randomized subjects who received at least one dose of study medication.|Participants|Count of Participants|14|14.0||||||
3882061|NCT01546688|3707640|B1||Male|Sex: Female, Male|Safety Population: All randomized subjects who received at least one dose of study medication.|Participants|Count of Participants|7|7.0||||||
3882062|NCT01546688|3707638|B3||Female|Sex: Female, Male|Safety Population: All randomized subjects who received at least one dose of study medication.|Participants|Count of Participants|30|30.0||||||
3882063|NCT01546688|3707639|B2||Female|Sex: Female, Male|Safety Population: All randomized subjects who received at least one dose of study medication.|Participants|Count of Participants|19|19.0||||||
3882064|NCT01546688|3707640|B1||Female|Sex: Female, Male|Safety Population: All randomized subjects who received at least one dose of study medication.|Participants|Count of Participants|11|11.0||||||
3882065|NCT01546688|3707638|B3|||Age|Safety Population|Years|Mean|72.0|72.0|Standard Deviation|5.29|5.29|||
3882066|NCT01546688|3707639|B2|||Age|Safety Population|Years|Mean|72.5|72.5|Standard Deviation|5.63|5.63|||
3882067|NCT01546688|3707640|B1|||Age|Safety Population|Years|Mean|71.1|71.1|Standard Deviation|4.61|4.61|||
3882068|NCT01546675|3707653|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882069|NCT01546675|3707654|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882070|NCT01546675|3707655|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882071|NCT01546675|3707653|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882072|NCT01546675|3707654|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882073|NCT01546675|3707655|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882074|NCT01546675|3707653|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3882075|NCT01546675|3707654|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3882076|NCT01546675|3707655|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3882077|NCT01546675|3707653|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882078|NCT01546675|3707654|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882079|NCT01546675|3707655|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882080|NCT01546675|3707653|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882081|NCT01546675|3707654|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882082|NCT01546675|3707655|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882083|NCT01546675|3707653|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882084|NCT01546675|3707654|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882085|NCT01546675|3707655|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882086|NCT01546675|3707653|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882087|NCT01546675|3707654|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882088|NCT01546675|3707655|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882089|NCT01546675|3707653|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3882090|NCT01546675|3707654|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3882091|NCT01546675|3707655|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3882092|NCT01546675|3707653|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3882093|NCT01546675|3707654|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3882094|NCT01546675|3707655|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3882095|NCT01546675|3707653|B3|||Age||years|Mean|24.5|24.5|Full Range|||20.0|29.0|
3882096|NCT01546675|3707654|B2|||Age||years|Mean|29|29.0|Full Range|||29.0|29.0|
3882097|NCT01546675|3707655|B1|||Age||years|Mean|20|20.0|Full Range|||20.0|20.0|
3882098|NCT01546649|3707671|B3|||Time from surgery or previous postoperative adjuvant therapy to administration of study drug||days|Mean|53.6|53.6|Standard Deviation|19.08|19.08|||
3882099|NCT01546649|3707672|B2|||Time from surgery or previous postoperative adjuvant therapy to administration of study drug||days|Mean|51.8|51.8|Standard Deviation|16.01|16.01|||
3882100|NCT01546649|3707673|B1|||Time from surgery or previous postoperative adjuvant therapy to administration of study drug||days|Mean|55.4|55.4|Standard Deviation|21.69|21.69|||
3882101|NCT01546649|3707671|B3|Ex-smoker||Smoking Classification, Customized||participants|Number|38|38.0||||||
3882102|NCT01546649|3707672|B2|Ex-smoker||Smoking Classification, Customized||participants|Number|19|19.0||||||
3882103|NCT01546649|3707673|B1|Ex-smoker||Smoking Classification, Customized||participants|Number|19|19.0||||||
3882104|NCT01546649|3707671|B3|Current Smoker||Smoking Classification, Customized||participants|Number|20|20.0||||||
3882105|NCT01546649|3707672|B2|Current Smoker||Smoking Classification, Customized||participants|Number|11|11.0||||||
3882106|NCT01546649|3707673|B1|Current Smoker||Smoking Classification, Customized||participants|Number|9|9.0||||||
3882107|NCT01546649|3707671|B3|Never Smoked||Smoking Classification, Customized||participants|Number|109|109.0||||||
3882108|NCT01546649|3707672|B2|Never Smoked||Smoking Classification, Customized||participants|Number|54|54.0||||||
3882109|NCT01546649|3707673|B1|Never Smoked||Smoking Classification, Customized||participants|Number|55|55.0||||||
3882110|NCT01546649|3707671|B3|Absent||Concomitant osteoporosis medication , Customized||participants|Number|152|152.0||||||
3882111|NCT01546649|3707672|B2|Absent||Concomitant osteoporosis medication , Customized||participants|Number|75|75.0||||||
3882112|NCT01546649|3707673|B1|Absent||Concomitant osteoporosis medication , Customized||participants|Number|77|77.0||||||
3882113|NCT01546649|3707671|B3|Present||Concomitant osteoporosis medication , Customized||participants|Number|15|15.0||||||
3882114|NCT01546649|3707672|B2|Present||Concomitant osteoporosis medication , Customized||participants|Number|9|9.0||||||
3882115|NCT01546649|3707673|B1|Present||Concomitant osteoporosis medication , Customized||participants|Number|6|6.0||||||
3882116|NCT01546649|3707671|B3|Absent||Previous breast cancer (other), Customized||participants|Number|167|167.0||||||
3882117|NCT01546649|3707672|B2|Absent||Previous breast cancer (other), Customized||participants|Number|84|84.0||||||
3882118|NCT01546649|3707673|B1|Absent||Previous breast cancer (other), Customized||participants|Number|83|83.0||||||
3882119|NCT01546649|3707671|B3|Present||Previous breast cancer (other), Customized||participants|Number|0|0.0||||||
3882120|NCT01546649|3707672|B2|Present||Previous breast cancer (other), Customized||participants|Number|0|0.0||||||
3882121|NCT01546649|3707673|B1|Present||Previous breast cancer (other), Customized||participants|Number|0|0.0||||||
3882122|NCT01546649|3707671|B3|Absent||Preoperative and postoperative chemotherapy, Customized||participants|Number|166|166.0||||||
3882123|NCT01546649|3707672|B2|Absent||Preoperative and postoperative chemotherapy, Customized||participants|Number|83|83.0||||||
3882124|NCT01546649|3707673|B1|Absent||Preoperative and postoperative chemotherapy, Customized||participants|Number|83|83.0||||||
3882125|NCT01546649|3707671|B3|Present||Preoperative and postoperative chemotherapy, Customized||participants|Number|1|1.0||||||
3882126|NCT01546649|3707672|B2|Present||Preoperative and postoperative chemotherapy, Customized||participants|Number|1|1.0||||||
3882127|NCT01546649|3707673|B1|Present||Preoperative and postoperative chemotherapy, Customized||participants|Number|0|0.0||||||
3882128|NCT01546649|3707671|B3|Absent||Radiation, Customized|Participants were classified based on whether they had received radiation therapy or not.|participants|Number|56|56.0||||||
3882129|NCT01546649|3707672|B2|Absent||Radiation, Customized|Participants were classified based on whether they had received radiation therapy or not.|participants|Number|25|25.0||||||
3882130|NCT01546649|3707673|B1|Absent||Radiation, Customized|Participants were classified based on whether they had received radiation therapy or not.|participants|Number|31|31.0||||||
3882131|NCT01546649|3707671|B3|Present||Radiation, Customized|Participants were classified based on whether they had received radiation therapy or not.|participants|Number|111|111.0||||||
3882132|NCT01546649|3707672|B2|Present||Radiation, Customized|Participants were classified based on whether they had received radiation therapy or not.|participants|Number|59|59.0||||||
3882133|NCT01546649|3707673|B1|Present||Radiation, Customized|Participants were classified based on whether they had received radiation therapy or not.|participants|Number|52|52.0||||||
3882134|NCT01546649|3707671|B3|>=30 pg/mL||Serum E2 concentration (pretreatment), Customized||participants|Number|149|149.0||||||
3882135|NCT01546649|3707672|B2|>=30 pg/mL||Serum E2 concentration (pretreatment), Customized||participants|Number|73|73.0||||||
3882136|NCT01546649|3707673|B1|>=30 pg/mL||Serum E2 concentration (pretreatment), Customized||participants|Number|76|76.0||||||
3882137|NCT01546649|3707671|B3|<=29 pg/mL||Serum E2 concentration (pretreatment), Customized||participants|Number|18|18.0||||||
3882138|NCT01546649|3707672|B2|<=29 pg/mL||Serum E2 concentration (pretreatment), Customized||participants|Number|11|11.0||||||
3882139|NCT01546649|3707673|B1|<=29 pg/mL||Serum E2 concentration (pretreatment), Customized||participants|Number|7|7.0||||||
3882140|NCT01546649|3707671|B3|||Serum Estradiol (E2) concentration (pretreatment)||picogram per milliliter (pg/mL)|Mean|153.0|153.0|Standard Deviation|145.66|145.66|||
3882141|NCT01546649|3707672|B2|||Serum Estradiol (E2) concentration (pretreatment)||picogram per milliliter (pg/mL)|Mean|138.2|138.2|Standard Deviation|125.45|125.45|||
3882142|NCT01546649|3707673|B1|||Serum Estradiol (E2) concentration (pretreatment)||picogram per milliliter (pg/mL)|Mean|168.0|168.0|Standard Deviation|162.99|162.99|||
3882143|NCT01546649|3707671|B3|Missing||Time from last menstruation to first dose, Customized||participants|Number|4|4.0||||||
3882144|NCT01546649|3707672|B2|Missing||Time from last menstruation to first dose, Customized||participants|Number|3|3.0||||||
3882145|NCT01546649|3707673|B1|Missing||Time from last menstruation to first dose, Customized||participants|Number|1|1.0||||||
3882146|NCT01546649|3707671|B3|>=57 days||Time from last menstruation to first dose, Customized||participants|Number|4|4.0||||||
3882147|NCT01546649|3707672|B2|>=57 days||Time from last menstruation to first dose, Customized||participants|Number|2|2.0||||||
3882148|NCT01546649|3707673|B1|>=57 days||Time from last menstruation to first dose, Customized||participants|Number|2|2.0||||||
3882149|NCT01546649|3707671|B3|>=29 to <=56 days||Time from last menstruation to first dose, Customized||participants|Number|14|14.0||||||
3882150|NCT01546649|3707672|B2|>=29 to <=56 days||Time from last menstruation to first dose, Customized||participants|Number|6|6.0||||||
3882151|NCT01546649|3707673|B1|>=29 to <=56 days||Time from last menstruation to first dose, Customized||participants|Number|8|8.0||||||
3882152|NCT01546649|3707671|B3|<=28 days||Time from last menstruation to first dose, Customized||participants|Number|145|145.0||||||
3882153|NCT01546649|3707672|B2|<=28 days||Time from last menstruation to first dose, Customized||participants|Number|73|73.0||||||
3882154|NCT01546649|3707673|B1|<=28 days||Time from last menstruation to first dose, Customized||participants|Number|72|72.0||||||
3882155|NCT01546649|3707671|B3|||Time from last menstruation to first dose||days|Mean|16.4|16.4|Standard Deviation|13.75|13.75|||
3882156|NCT01546649|3707672|B2|||Time from last menstruation to first dose||days|Mean|15.9|15.9|Standard Deviation|14.28|14.28|||
3882157|NCT01546649|3707673|B1|||Time from last menstruation to first dose||days|Mean|17.0|17.0|Standard Deviation|13.27|13.27|||
3882158|NCT01546649|3707671|B3|Absent||Menstruation (before the first dose), Customized||participants|Number|4|4.0||||||
3882159|NCT01546649|3707672|B2|Absent||Menstruation (before the first dose), Customized||participants|Number|3|3.0||||||
3882160|NCT01546649|3707673|B1|Absent||Menstruation (before the first dose), Customized||participants|Number|1|1.0||||||
3882161|NCT01546649|3707671|B3|Present||Menstruation (before the first dose), Customized||participants|Number|163|163.0||||||
3882162|NCT01546649|3707672|B2|Present||Menstruation (before the first dose), Customized||participants|Number|81|81.0||||||
3882163|NCT01546649|3707673|B1|Present||Menstruation (before the first dose), Customized||participants|Number|82|82.0||||||
3882187|NCT01546649|3707673|B1|3+||Human epidermal growth factor receptor 2 (HER2) (immunohistochemistry [IHC] scoring), Customized|Participants with HER expression by IHC was reported as 0, 1+, 2+, 3+, or unmeasured. The categories of HER expression is ranged from 0 (better) to 3+ (worse).|participants|Number|0|0.0||||||
3882224|NCT01546649|3707671|B3|Absent||Axillary lymph node metastases, Customized||participants|Number|138|138.0||||||
3882164|NCT01546649|3707671|B3|1||The eastern cooperative oncology group performance status (ECOG P.S.), Customized|Following are ECOG grades. 0: Fully active, perform all pre-disease activities without restriction. 1: Restricted in physically strenuous activity but ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of selfcare, unable to carry out any work activities, up and about more than (>) 50% of waking hours. 3: Capable of limited selfcare, confined to bed or chair >50% of waking hours. 4: Completely disabled, not capable of any selfcare, totally confined to bed or chair.|participants|Number|0|0.0||||||
3882165|NCT01546649|3707672|B2|1||The eastern cooperative oncology group performance status (ECOG P.S.), Customized|Following are ECOG grades. 0: Fully active, perform all pre-disease activities without restriction. 1: Restricted in physically strenuous activity but ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of selfcare, unable to carry out any work activities, up and about more than (>) 50% of waking hours. 3: Capable of limited selfcare, confined to bed or chair >50% of waking hours. 4: Completely disabled, not capable of any selfcare, totally confined to bed or chair.|participants|Number|0|0.0||||||
3882166|NCT01546649|3707673|B1|1||The eastern cooperative oncology group performance status (ECOG P.S.), Customized|Following are ECOG grades. 0: Fully active, perform all pre-disease activities without restriction. 1: Restricted in physically strenuous activity but ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of selfcare, unable to carry out any work activities, up and about more than (>) 50% of waking hours. 3: Capable of limited selfcare, confined to bed or chair >50% of waking hours. 4: Completely disabled, not capable of any selfcare, totally confined to bed or chair.|participants|Number|0|0.0||||||
3882167|NCT01546649|3707671|B3|0||The eastern cooperative oncology group performance status (ECOG P.S.), Customized|Following are ECOG grades. 0: Fully active, perform all pre-disease activities without restriction. 1: Restricted in physically strenuous activity but ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of selfcare, unable to carry out any work activities, up and about more than (>) 50% of waking hours. 3: Capable of limited selfcare, confined to bed or chair >50% of waking hours. 4: Completely disabled, not capable of any selfcare, totally confined to bed or chair.|participants|Number|167|167.0||||||
3882168|NCT01546649|3707672|B2|0||The eastern cooperative oncology group performance status (ECOG P.S.), Customized|Following are ECOG grades. 0: Fully active, perform all pre-disease activities without restriction. 1: Restricted in physically strenuous activity but ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of selfcare, unable to carry out any work activities, up and about more than (>) 50% of waking hours. 3: Capable of limited selfcare, confined to bed or chair >50% of waking hours. 4: Completely disabled, not capable of any selfcare, totally confined to bed or chair.|participants|Number|84|84.0||||||
3882169|NCT01546649|3707673|B1|0||The eastern cooperative oncology group performance status (ECOG P.S.), Customized|Following are ECOG grades. 0: Fully active, perform all pre-disease activities without restriction. 1: Restricted in physically strenuous activity but ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of selfcare, unable to carry out any work activities, up and about more than (>) 50% of waking hours. 3: Capable of limited selfcare, confined to bed or chair >50% of waking hours. 4: Completely disabled, not capable of any selfcare, totally confined to bed or chair.|participants|Number|83|83.0||||||
3882170|NCT01546649|3707671|B3|Not performed||HER2 (fluorescent in situ hybridization [FISH] testing), Customized||participants|Number|131|131.0||||||
3882171|NCT01546649|3707672|B2|Not performed||HER2 (fluorescent in situ hybridization [FISH] testing), Customized||participants|Number|61|61.0||||||
3882172|NCT01546649|3707673|B1|Not performed||HER2 (fluorescent in situ hybridization [FISH] testing), Customized||participants|Number|70|70.0||||||
3882173|NCT01546649|3707671|B3|Equivocal||HER2 (fluorescent in situ hybridization [FISH] testing), Customized||participants|Number|0|0.0||||||
3882174|NCT01546649|3707672|B2|Equivocal||HER2 (fluorescent in situ hybridization [FISH] testing), Customized||participants|Number|0|0.0||||||
3882175|NCT01546649|3707673|B1|Equivocal||HER2 (fluorescent in situ hybridization [FISH] testing), Customized||participants|Number|0|0.0||||||
3882176|NCT01546649|3707671|B3|Negative||HER2 (fluorescent in situ hybridization [FISH] testing), Customized||participants|Number|36|36.0||||||
3882177|NCT01546649|3707672|B2|Negative||HER2 (fluorescent in situ hybridization [FISH] testing), Customized||participants|Number|23|23.0||||||
3882178|NCT01546649|3707673|B1|Negative||HER2 (fluorescent in situ hybridization [FISH] testing), Customized||participants|Number|13|13.0||||||
3882179|NCT01546649|3707671|B3|Positive||HER2 (fluorescent in situ hybridization [FISH] testing), Customized||participants|Number|0|0.0||||||
3882180|NCT01546649|3707672|B2|Positive||HER2 (fluorescent in situ hybridization [FISH] testing), Customized||participants|Number|0|0.0||||||
3882181|NCT01546649|3707673|B1|Positive||HER2 (fluorescent in situ hybridization [FISH] testing), Customized||participants|Number|0|0.0||||||
3882182|NCT01546649|3707671|B3|Not performed||Human epidermal growth factor receptor 2 (HER2) (immunohistochemistry [IHC] scoring), Customized|Participants with HER expression by IHC was reported as 0, 1+, 2+, 3+, or unmeasured. The categories of HER expression is ranged from 0 (better) to 3+ (worse).|participants|Number|16|16.0||||||
3882183|NCT01546649|3707672|B2|Not performed||Human epidermal growth factor receptor 2 (HER2) (immunohistochemistry [IHC] scoring), Customized|Participants with HER expression by IHC was reported as 0, 1+, 2+, 3+, or unmeasured. The categories of HER expression is ranged from 0 (better) to 3+ (worse).|participants|Number|10|10.0||||||
3882184|NCT01546649|3707673|B1|Not performed||Human epidermal growth factor receptor 2 (HER2) (immunohistochemistry [IHC] scoring), Customized|Participants with HER expression by IHC was reported as 0, 1+, 2+, 3+, or unmeasured. The categories of HER expression is ranged from 0 (better) to 3+ (worse).|participants|Number|6|6.0||||||
3882185|NCT01546649|3707671|B3|3+||Human epidermal growth factor receptor 2 (HER2) (immunohistochemistry [IHC] scoring), Customized|Participants with HER expression by IHC was reported as 0, 1+, 2+, 3+, or unmeasured. The categories of HER expression is ranged from 0 (better) to 3+ (worse).|participants|Number|0|0.0||||||
3882186|NCT01546649|3707672|B2|3+||Human epidermal growth factor receptor 2 (HER2) (immunohistochemistry [IHC] scoring), Customized|Participants with HER expression by IHC was reported as 0, 1+, 2+, 3+, or unmeasured. The categories of HER expression is ranged from 0 (better) to 3+ (worse).|participants|Number|0|0.0||||||
3882223|NCT01546649|3707673|B1|0||Axillary lymph node metastases, Customized||participants|Number|68|68.0||||||
3882188|NCT01546649|3707671|B3|2+||Human epidermal growth factor receptor 2 (HER2) (immunohistochemistry [IHC] scoring), Customized|Participants with HER expression by IHC was reported as 0, 1+, 2+, 3+, or unmeasured. The categories of HER expression is ranged from 0 (better) to 3+ (worse).|participants|Number|20|20.0||||||
3882189|NCT01546649|3707672|B2|2+||Human epidermal growth factor receptor 2 (HER2) (immunohistochemistry [IHC] scoring), Customized|Participants with HER expression by IHC was reported as 0, 1+, 2+, 3+, or unmeasured. The categories of HER expression is ranged from 0 (better) to 3+ (worse).|participants|Number|13|13.0||||||
3882190|NCT01546649|3707673|B1|2+||Human epidermal growth factor receptor 2 (HER2) (immunohistochemistry [IHC] scoring), Customized|Participants with HER expression by IHC was reported as 0, 1+, 2+, 3+, or unmeasured. The categories of HER expression is ranged from 0 (better) to 3+ (worse).|participants|Number|7|7.0||||||
3882191|NCT01546649|3707671|B3|1+||Human epidermal growth factor receptor 2 (HER2) (immunohistochemistry [IHC] scoring), Customized|Participants with HER expression by IHC was reported as 0, 1+, 2+, 3+, or unmeasured. The categories of HER expression is ranged from 0 (better) to 3+ (worse).|participants|Number|61|61.0||||||
3882192|NCT01546649|3707672|B2|1+||Human epidermal growth factor receptor 2 (HER2) (immunohistochemistry [IHC] scoring), Customized|Participants with HER expression by IHC was reported as 0, 1+, 2+, 3+, or unmeasured. The categories of HER expression is ranged from 0 (better) to 3+ (worse).|participants|Number|28|28.0||||||
3882193|NCT01546649|3707673|B1|1+||Human epidermal growth factor receptor 2 (HER2) (immunohistochemistry [IHC] scoring), Customized|Participants with HER expression by IHC was reported as 0, 1+, 2+, 3+, or unmeasured. The categories of HER expression is ranged from 0 (better) to 3+ (worse).|participants|Number|33|33.0||||||
3882194|NCT01546649|3707671|B3|0||Human epidermal growth factor receptor 2 (HER2) (immunohistochemistry [IHC] scoring), Customized|Participants with HER expression by IHC was reported as 0, 1+, 2+, 3+, or unmeasured. The categories of HER expression is ranged from 0 (better) to 3+ (worse).|participants|Number|70|70.0||||||
3882195|NCT01546649|3707672|B2|0||Human epidermal growth factor receptor 2 (HER2) (immunohistochemistry [IHC] scoring), Customized|Participants with HER expression by IHC was reported as 0, 1+, 2+, 3+, or unmeasured. The categories of HER expression is ranged from 0 (better) to 3+ (worse).|participants|Number|33|33.0||||||
3882196|NCT01546649|3707673|B1|0||Human epidermal growth factor receptor 2 (HER2) (immunohistochemistry [IHC] scoring), Customized|Participants with HER expression by IHC was reported as 0, 1+, 2+, 3+, or unmeasured. The categories of HER expression is ranged from 0 (better) to 3+ (worse).|participants|Number|37|37.0||||||
3882197|NCT01546649|3707671|B3|ER -negative / PgR -positive||Primary tumor estrogen receptors (ER)/ progesterone receptors (PgR) status, Customized||participants|Number|0|0.0||||||
3882198|NCT01546649|3707672|B2|ER -negative / PgR -positive||Primary tumor estrogen receptors (ER)/ progesterone receptors (PgR) status, Customized||participants|Number|0|0.0||||||
3882199|NCT01546649|3707673|B1|ER -negative / PgR -positive||Primary tumor estrogen receptors (ER)/ progesterone receptors (PgR) status, Customized||participants|Number|0|0.0||||||
3882200|NCT01546649|3707671|B3|ER -positive / PgR -negative||Primary tumor estrogen receptors (ER)/ progesterone receptors (PgR) status, Customized||participants|Number|3|3.0||||||
3882201|NCT01546649|3707672|B2|ER -positive / PgR -negative||Primary tumor estrogen receptors (ER)/ progesterone receptors (PgR) status, Customized||participants|Number|2|2.0||||||
3882202|NCT01546649|3707673|B1|ER -positive / PgR -negative||Primary tumor estrogen receptors (ER)/ progesterone receptors (PgR) status, Customized||participants|Number|1|1.0||||||
3882203|NCT01546649|3707671|B3|ER -positive / PgR-positive||Primary tumor estrogen receptors (ER)/ progesterone receptors (PgR) status, Customized||participants|Number|164|164.0||||||
3882204|NCT01546649|3707672|B2|ER -positive / PgR-positive||Primary tumor estrogen receptors (ER)/ progesterone receptors (PgR) status, Customized||participants|Number|82|82.0||||||
3882205|NCT01546649|3707673|B1|ER -positive / PgR-positive||Primary tumor estrogen receptors (ER)/ progesterone receptors (PgR) status, Customized||participants|Number|82|82.0||||||
3882206|NCT01546649|3707671|B3|>=57 days||Time from surgery or previous postoperative adjuvant therapy to administration of study drug||participants|Number|67|67.0||||||
3882207|NCT01546649|3707672|B2|>=57 days||Time from surgery or previous postoperative adjuvant therapy to administration of study drug||participants|Number|32|32.0||||||
3882208|NCT01546649|3707673|B1|>=57 days||Time from surgery or previous postoperative adjuvant therapy to administration of study drug||participants|Number|35|35.0||||||
3882209|NCT01546649|3707671|B3|>=29 to <=56 days||Time from surgery or previous postoperative adjuvant therapy to administration of study drug||participants|Number|85|85.0||||||
3882210|NCT01546649|3707672|B2|>=29 to <=56 days||Time from surgery or previous postoperative adjuvant therapy to administration of study drug||participants|Number|43|43.0||||||
3882211|NCT01546649|3707673|B1|>=29 to <=56 days||Time from surgery or previous postoperative adjuvant therapy to administration of study drug||participants|Number|42|42.0||||||
3882212|NCT01546649|3707671|B3|<=28 days||Time from surgery or previous postoperative adjuvant therapy to administration of study drug||participants|Number|15|15.0||||||
3882213|NCT01546649|3707672|B2|<=28 days||Time from surgery or previous postoperative adjuvant therapy to administration of study drug||participants|Number|9|9.0||||||
3882214|NCT01546649|3707673|B1|<=28 days||Time from surgery or previous postoperative adjuvant therapy to administration of study drug||participants|Number|6|6.0||||||
3882215|NCT01546649|3707671|B3|>=4 metastases||Axillary lymph node metastases, Customized||participants|Number|0|0.0||||||
3882216|NCT01546649|3707672|B2|>=4 metastases||Axillary lymph node metastases, Customized||participants|Number|0|0.0||||||
3882217|NCT01546649|3707673|B1|>=4 metastases||Axillary lymph node metastases, Customized||participants|Number|0|0.0||||||
3882218|NCT01546649|3707671|B3|>=1 metastasis to <=3 metastases||Axillary lymph node metastases, Customized||participants|Number|29|29.0||||||
3882219|NCT01546649|3707672|B2|>=1 metastasis to <=3 metastases||Axillary lymph node metastases, Customized||participants|Number|14|14.0||||||
3882220|NCT01546649|3707673|B1|>=1 metastasis to <=3 metastases||Axillary lymph node metastases, Customized||participants|Number|15|15.0||||||
3882221|NCT01546649|3707671|B3|0||Axillary lymph node metastases, Customized||participants|Number|138|138.0||||||
3882222|NCT01546649|3707672|B2|0||Axillary lymph node metastases, Customized||participants|Number|70|70.0||||||
3882225|NCT01546649|3707672|B2|Absent||Axillary lymph node metastases, Customized||participants|Number|70|70.0||||||
3882226|NCT01546649|3707673|B1|Absent||Axillary lymph node metastases, Customized||participants|Number|68|68.0||||||
3882227|NCT01546649|3707671|B3|Present||Axillary lymph node metastases, Customized||participants|Number|29|29.0||||||
3882228|NCT01546649|3707672|B2|Present||Axillary lymph node metastases, Customized||participants|Number|14|14.0||||||
3882229|NCT01546649|3707673|B1|Present||Axillary lymph node metastases, Customized||participants|Number|15|15.0||||||
3882230|NCT01546649|3707671|B3|||Axillary lymph node metastases||number of metastases|Mean|0.2|0.2|Standard Deviation|0.52|0.52|||
3882231|NCT01546649|3707672|B2|||Axillary lymph node metastases||number of metastases|Mean|0.2|0.2|Standard Deviation|0.57|0.57|||
3882232|NCT01546649|3707673|B1|||Axillary lymph node metastases||number of metastases|Mean|0.2|0.2|Standard Deviation|0.46|0.46|||
3882233|NCT01546649|3707671|B3|>2.0 cm||Histopathological tumor size, Customized||participants|Number|36|36.0||||||
3882234|NCT01546649|3707672|B2|>2.0 cm||Histopathological tumor size, Customized||participants|Number|18|18.0||||||
3882235|NCT01546649|3707673|B1|>2.0 cm||Histopathological tumor size, Customized||participants|Number|18|18.0||||||
3882236|NCT01546649|3707671|B3|Less than equal to (<=) 2.0 cm||Histopathological tumor size, Customized||participants|Number|131|131.0||||||
3882237|NCT01546649|3707672|B2|Less than equal to (<=) 2.0 cm||Histopathological tumor size, Customized||participants|Number|66|66.0||||||
3882238|NCT01546649|3707673|B1|Less than equal to (<=) 2.0 cm||Histopathological tumor size, Customized||participants|Number|65|65.0||||||
3882239|NCT01546649|3707671|B3|||Histopathological tumor size||cm|Mean|1.59|1.59|Standard Deviation|1.173|1.173|||
3882240|NCT01546649|3707672|B2|||Histopathological tumor size||cm|Mean|1.55|1.55|Standard Deviation|1.023|1.023|||
3882241|NCT01546649|3707673|B1|||Histopathological tumor size||cm|Mean|1.64|1.64|Standard Deviation|1.312|1.312|||
3882242|NCT01546649|3707671|B3|IIIA||TNM staging (Stage), Customized|The stage of cancer based on TNM classification: Stage 0 (Carcinoma in situ which is staged by Tis, N0, M0), Stage IA (T1, N0, M0), IB (T0/T1, N1, M0), IIA (T0/T1, N1, M0 or T2, N0, M0), IIB (T2, N1, M0 or T3, N0, M0), IIIA (T0/T1/T2, N2, M0 or T3, N1/N2, M0), IIIB (T4, N0/N1/N2, M0) and IIIC (Any T, N3, M0), Stage IV(Any T, Any N, M1).|participants|Number|1|1.0||||||
3882243|NCT01546649|3707672|B2|IIIA||TNM staging (Stage), Customized|The stage of cancer based on TNM classification: Stage 0 (Carcinoma in situ which is staged by Tis, N0, M0), Stage IA (T1, N0, M0), IB (T0/T1, N1, M0), IIA (T0/T1, N1, M0 or T2, N0, M0), IIB (T2, N1, M0 or T3, N0, M0), IIIA (T0/T1/T2, N2, M0 or T3, N1/N2, M0), IIIB (T4, N0/N1/N2, M0) and IIIC (Any T, N3, M0), Stage IV(Any T, Any N, M1).|participants|Number|0|0.0||||||
3882244|NCT01546649|3707673|B1|IIIA||TNM staging (Stage), Customized|The stage of cancer based on TNM classification: Stage 0 (Carcinoma in situ which is staged by Tis, N0, M0), Stage IA (T1, N0, M0), IB (T0/T1, N1, M0), IIA (T0/T1, N1, M0 or T2, N0, M0), IIB (T2, N1, M0 or T3, N0, M0), IIIA (T0/T1/T2, N2, M0 or T3, N1/N2, M0), IIIB (T4, N0/N1/N2, M0) and IIIC (Any T, N3, M0), Stage IV(Any T, Any N, M1).|participants|Number|1|1.0||||||
3882245|NCT01546649|3707671|B3|IIB||TNM staging (Stage), Customized|The stage of cancer based on TNM classification: Stage 0 (Carcinoma in situ which is staged by Tis, N0, M0), Stage IA (T1, N0, M0), IB (T0/T1, N1, M0), IIA (T0/T1, N1, M0 or T2, N0, M0), IIB (T2, N1, M0 or T3, N0, M0), IIIA (T0/T1/T2, N2, M0 or T3, N1/N2, M0), IIIB (T4, N0/N1/N2, M0) and IIIC (Any T, N3, M0), Stage IV(Any T, Any N, M1).|participants|Number|4|4.0||||||
3882246|NCT01546649|3707672|B2|IIB||TNM staging (Stage), Customized|The stage of cancer based on TNM classification: Stage 0 (Carcinoma in situ which is staged by Tis, N0, M0), Stage IA (T1, N0, M0), IB (T0/T1, N1, M0), IIA (T0/T1, N1, M0 or T2, N0, M0), IIB (T2, N1, M0 or T3, N0, M0), IIIA (T0/T1/T2, N2, M0 or T3, N1/N2, M0), IIIB (T4, N0/N1/N2, M0) and IIIC (Any T, N3, M0), Stage IV(Any T, Any N, M1).|participants|Number|2|2.0||||||
3882247|NCT01546649|3707673|B1|IIB||TNM staging (Stage), Customized|The stage of cancer based on TNM classification: Stage 0 (Carcinoma in situ which is staged by Tis, N0, M0), Stage IA (T1, N0, M0), IB (T0/T1, N1, M0), IIA (T0/T1, N1, M0 or T2, N0, M0), IIB (T2, N1, M0 or T3, N0, M0), IIIA (T0/T1/T2, N2, M0 or T3, N1/N2, M0), IIIB (T4, N0/N1/N2, M0) and IIIC (Any T, N3, M0), Stage IV(Any T, Any N, M1).|participants|Number|2|2.0||||||
3882248|NCT01546649|3707671|B3|IIA||TNM staging (Stage), Customized|The stage of cancer based on TNM classification: Stage 0 (Carcinoma in situ which is staged by Tis, N0, M0), Stage IA (T1, N0, M0), IB (T0/T1, N1, M0), IIA (T0/T1, N1, M0 or T2, N0, M0), IIB (T2, N1, M0 or T3, N0, M0), IIIA (T0/T1/T2, N2, M0 or T3, N1/N2, M0), IIIB (T4, N0/N1/N2, M0) and IIIC (Any T, N3, M0), Stage IV(Any T, Any N, M1).|participants|Number|40|40.0||||||
3882249|NCT01546649|3707672|B2|IIA||TNM staging (Stage), Customized|The stage of cancer based on TNM classification: Stage 0 (Carcinoma in situ which is staged by Tis, N0, M0), Stage IA (T1, N0, M0), IB (T0/T1, N1, M0), IIA (T0/T1, N1, M0 or T2, N0, M0), IIB (T2, N1, M0 or T3, N0, M0), IIIA (T0/T1/T2, N2, M0 or T3, N1/N2, M0), IIIB (T4, N0/N1/N2, M0) and IIIC (Any T, N3, M0), Stage IV(Any T, Any N, M1).|participants|Number|21|21.0||||||
3882250|NCT01546649|3707673|B1|IIA||TNM staging (Stage), Customized|The stage of cancer based on TNM classification: Stage 0 (Carcinoma in situ which is staged by Tis, N0, M0), Stage IA (T1, N0, M0), IB (T0/T1, N1, M0), IIA (T0/T1, N1, M0 or T2, N0, M0), IIB (T2, N1, M0 or T3, N0, M0), IIIA (T0/T1/T2, N2, M0 or T3, N1/N2, M0), IIIB (T4, N0/N1/N2, M0) and IIIC (Any T, N3, M0), Stage IV(Any T, Any N, M1).|participants|Number|19|19.0||||||
3882251|NCT01546649|3707671|B3|I||TNM staging (Stage), Customized|The stage of cancer based on TNM classification: Stage 0 (Carcinoma in situ which is staged by Tis, N0, M0), Stage IA (T1, N0, M0), IB (T0/T1, N1, M0), IIA (T0/T1, N1, M0 or T2, N0, M0), IIB (T2, N1, M0 or T3, N0, M0), IIIA (T0/T1/T2, N2, M0 or T3, N1/N2, M0), IIIB (T4, N0/N1/N2, M0) and IIIC (Any T, N3, M0), Stage IV(Any T, Any N, M1).|participants|Number|122|122.0||||||
3882252|NCT01546649|3707672|B2|I||TNM staging (Stage), Customized|The stage of cancer based on TNM classification: Stage 0 (Carcinoma in situ which is staged by Tis, N0, M0), Stage IA (T1, N0, M0), IB (T0/T1, N1, M0), IIA (T0/T1, N1, M0 or T2, N0, M0), IIB (T2, N1, M0 or T3, N0, M0), IIIA (T0/T1/T2, N2, M0 or T3, N1/N2, M0), IIIB (T4, N0/N1/N2, M0) and IIIC (Any T, N3, M0), Stage IV(Any T, Any N, M1).|participants|Number|61|61.0||||||
3882313|NCT01546649|3707673|B1|<18.5 kg/m^2||BMI, Customized||participants|Number|8|8.0||||||
3882314|NCT01546649|3707671|B3|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|21.48|21.48|Standard Deviation|2.964|2.964|||
3882253|NCT01546649|3707673|B1|I||TNM staging (Stage), Customized|The stage of cancer based on TNM classification: Stage 0 (Carcinoma in situ which is staged by Tis, N0, M0), Stage IA (T1, N0, M0), IB (T0/T1, N1, M0), IIA (T0/T1, N1, M0 or T2, N0, M0), IIB (T2, N1, M0 or T3, N0, M0), IIIA (T0/T1/T2, N2, M0 or T3, N1/N2, M0), IIIB (T4, N0/N1/N2, M0) and IIIC (Any T, N3, M0), Stage IV(Any T, Any N, M1).|participants|Number|61|61.0||||||
3882254|NCT01546649|3707671|B3|||TNM classification: M0|The frequency of distant metastasis clinical stage M (0, 1) was assessed. The frequency of M was evaluated prior to surgery. The categories of M are represented by 0 (no distant metastasis) and 1 (distant metastasis).|participants|Number|167|167.0||||||
3882255|NCT01546649|3707672|B2|||TNM classification: M0|The frequency of distant metastasis clinical stage M (0, 1) was assessed. The frequency of M was evaluated prior to surgery. The categories of M are represented by 0 (no distant metastasis) and 1 (distant metastasis).|participants|Number|84|84.0||||||
3882256|NCT01546649|3707673|B1|||TNM classification: M0|The frequency of distant metastasis clinical stage M (0, 1) was assessed. The frequency of M was evaluated prior to surgery. The categories of M are represented by 0 (no distant metastasis) and 1 (distant metastasis).|participants|Number|83|83.0||||||
3882257|NCT01546649|3707671|B3|N1||TNM classification: regional lymph node stage N, Customized|The frequency of regional lymph nodes stage N (0, 1, 2, 3, or X) was assessed. The frequency of N was evaluated prior to surgery. The categories of N are ranged from 0 (No regional lymph node metastasis) to 3 (Metastasis in ipsilateral infraclavicular lymph node(s); or in clinically detected ipsilateral internal mammary lymph node(s); or metastasis in ipsilateral supraclavicular lymph node(s)). X is representing lymph nodes cannot be evaluated, 0 is tumor cells absent from regional lymph nodes.|participants|Number|8|8.0||||||
3882258|NCT01546649|3707672|B2|N1||TNM classification: regional lymph node stage N, Customized|The frequency of regional lymph nodes stage N (0, 1, 2, 3, or X) was assessed. The frequency of N was evaluated prior to surgery. The categories of N are ranged from 0 (No regional lymph node metastasis) to 3 (Metastasis in ipsilateral infraclavicular lymph node(s); or in clinically detected ipsilateral internal mammary lymph node(s); or metastasis in ipsilateral supraclavicular lymph node(s)). X is representing lymph nodes cannot be evaluated, 0 is tumor cells absent from regional lymph nodes.|participants|Number|3|3.0||||||
3882259|NCT01546649|3707673|B1|N1||TNM classification: regional lymph node stage N, Customized|The frequency of regional lymph nodes stage N (0, 1, 2, 3, or X) was assessed. The frequency of N was evaluated prior to surgery. The categories of N are ranged from 0 (No regional lymph node metastasis) to 3 (Metastasis in ipsilateral infraclavicular lymph node(s); or in clinically detected ipsilateral internal mammary lymph node(s); or metastasis in ipsilateral supraclavicular lymph node(s)). X is representing lymph nodes cannot be evaluated, 0 is tumor cells absent from regional lymph nodes.|participants|Number|5|5.0||||||
3882260|NCT01546649|3707671|B3|N0||TNM classification: regional lymph node stage N, Customized|The frequency of regional lymph nodes stage N (0, 1, 2, 3, or X) was assessed. The frequency of N was evaluated prior to surgery. The categories of N are ranged from 0 (No regional lymph node metastasis) to 3 (Metastasis in ipsilateral infraclavicular lymph node(s); or in clinically detected ipsilateral internal mammary lymph node(s); or metastasis in ipsilateral supraclavicular lymph node(s)). X is representing lymph nodes cannot be evaluated, 0 is tumor cells absent from regional lymph nodes.|participants|Number|159|159.0||||||
3882261|NCT01546649|3707672|B2|N0||TNM classification: regional lymph node stage N, Customized|The frequency of regional lymph nodes stage N (0, 1, 2, 3, or X) was assessed. The frequency of N was evaluated prior to surgery. The categories of N are ranged from 0 (No regional lymph node metastasis) to 3 (Metastasis in ipsilateral infraclavicular lymph node(s); or in clinically detected ipsilateral internal mammary lymph node(s); or metastasis in ipsilateral supraclavicular lymph node(s)). X is representing lymph nodes cannot be evaluated, 0 is tumor cells absent from regional lymph nodes.|participants|Number|81|81.0||||||
3882262|NCT01546649|3707673|B1|N0||TNM classification: regional lymph node stage N, Customized|The frequency of regional lymph nodes stage N (0, 1, 2, 3, or X) was assessed. The frequency of N was evaluated prior to surgery. The categories of N are ranged from 0 (No regional lymph node metastasis) to 3 (Metastasis in ipsilateral infraclavicular lymph node(s); or in clinically detected ipsilateral internal mammary lymph node(s); or metastasis in ipsilateral supraclavicular lymph node(s)). X is representing lymph nodes cannot be evaluated, 0 is tumor cells absent from regional lymph nodes.|participants|Number|78|78.0||||||
3882263|NCT01546649|3707671|B3|T3||TNM classification: clinical tumor stage T, Customized|The frequency of clinical tumor stage T (0, 1, 2, 3, 4, X, or Tis) was assessed. The frequency of T was evaluated prior to surgery. The categories of T are ranged from 0 (No evidence of primary tumor) to 4 (Tumor of any size with direct extension to chest wall and/or to skin). X is representing tumor cannot be evaluated, 0 is representing no signs of tumor, Tis is carcinoma in situ.|participants|Number|3|3.0||||||
3882264|NCT01546649|3707672|B2|T3||TNM classification: clinical tumor stage T, Customized|The frequency of clinical tumor stage T (0, 1, 2, 3, 4, X, or Tis) was assessed. The frequency of T was evaluated prior to surgery. The categories of T are ranged from 0 (No evidence of primary tumor) to 4 (Tumor of any size with direct extension to chest wall and/or to skin). X is representing tumor cannot be evaluated, 0 is representing no signs of tumor, Tis is carcinoma in situ.|participants|Number|2|2.0||||||
3882265|NCT01546649|3707673|B1|T3||TNM classification: clinical tumor stage T, Customized|The frequency of clinical tumor stage T (0, 1, 2, 3, 4, X, or Tis) was assessed. The frequency of T was evaluated prior to surgery. The categories of T are ranged from 0 (No evidence of primary tumor) to 4 (Tumor of any size with direct extension to chest wall and/or to skin). X is representing tumor cannot be evaluated, 0 is representing no signs of tumor, Tis is carcinoma in situ.|participants|Number|1|1.0||||||
3882266|NCT01546649|3707671|B3|T2||TNM classification: clinical tumor stage T, Customized|The frequency of clinical tumor stage T (0, 1, 2, 3, 4, X, or Tis) was assessed. The frequency of T was evaluated prior to surgery. The categories of T are ranged from 0 (No evidence of primary tumor) to 4 (Tumor of any size with direct extension to chest wall and/or to skin). X is representing tumor cannot be evaluated, 0 is representing no signs of tumor, Tis is carcinoma in situ.|participants|Number|37|37.0||||||
3882267|NCT01546649|3707672|B2|T2||TNM classification: clinical tumor stage T, Customized|The frequency of clinical tumor stage T (0, 1, 2, 3, 4, X, or Tis) was assessed. The frequency of T was evaluated prior to surgery. The categories of T are ranged from 0 (No evidence of primary tumor) to 4 (Tumor of any size with direct extension to chest wall and/or to skin). X is representing tumor cannot be evaluated, 0 is representing no signs of tumor, Tis is carcinoma in situ.|participants|Number|18|18.0||||||
3882268|NCT01546649|3707673|B1|T2||TNM classification: clinical tumor stage T, Customized|The frequency of clinical tumor stage T (0, 1, 2, 3, 4, X, or Tis) was assessed. The frequency of T was evaluated prior to surgery. The categories of T are ranged from 0 (No evidence of primary tumor) to 4 (Tumor of any size with direct extension to chest wall and/or to skin). X is representing tumor cannot be evaluated, 0 is representing no signs of tumor, Tis is carcinoma in situ.|participants|Number|19|19.0||||||
3882269|NCT01546649|3707671|B3|T1||TNM classification: clinical tumor stage T, Customized|The frequency of clinical tumor stage T (0, 1, 2, 3, 4, X, or Tis) was assessed. The frequency of T was evaluated prior to surgery. The categories of T are ranged from 0 (No evidence of primary tumor) to 4 (Tumor of any size with direct extension to chest wall and/or to skin). X is representing tumor cannot be evaluated, 0 is representing no signs of tumor, Tis is carcinoma in situ.|participants|Number|127|127.0||||||
3882270|NCT01546649|3707672|B2|T1||TNM classification: clinical tumor stage T, Customized|The frequency of clinical tumor stage T (0, 1, 2, 3, 4, X, or Tis) was assessed. The frequency of T was evaluated prior to surgery. The categories of T are ranged from 0 (No evidence of primary tumor) to 4 (Tumor of any size with direct extension to chest wall and/or to skin). X is representing tumor cannot be evaluated, 0 is representing no signs of tumor, Tis is carcinoma in situ.|participants|Number|64|64.0||||||
3882271|NCT01546649|3707673|B1|T1||TNM classification: clinical tumor stage T, Customized|The frequency of clinical tumor stage T (0, 1, 2, 3, 4, X, or Tis) was assessed. The frequency of T was evaluated prior to surgery. The categories of T are ranged from 0 (No evidence of primary tumor) to 4 (Tumor of any size with direct extension to chest wall and/or to skin). X is representing tumor cannot be evaluated, 0 is representing no signs of tumor, Tis is carcinoma in situ.|participants|Number|63|63.0||||||
3882272|NCT01546649|3707671|B3|Specified neoplasms (other)||Pathological diagnosis, Customized||participants|Number|1|1.0||||||
3882273|NCT01546649|3707672|B2|Specified neoplasms (other)||Pathological diagnosis, Customized||participants|Number|0|0.0||||||
3882274|NCT01546649|3707673|B1|Specified neoplasms (other)||Pathological diagnosis, Customized||participants|Number|1|1.0||||||
3882275|NCT01546649|3707671|B3|Invasive micropapillary carcinoma||Pathological diagnosis, Customized||participants|Number|4|4.0||||||
3882276|NCT01546649|3707672|B2|Invasive micropapillary carcinoma||Pathological diagnosis, Customized||participants|Number|3|3.0||||||
3882277|NCT01546649|3707673|B1|Invasive micropapillary carcinoma||Pathological diagnosis, Customized||participants|Number|1|1.0||||||
3882278|NCT01546649|3707671|B3|Tubular adenocarcinoma||Pathological diagnosis, Customized||participants|Number|1|1.0||||||
3882279|NCT01546649|3707672|B2|Tubular adenocarcinoma||Pathological diagnosis, Customized||participants|Number|0|0.0||||||
3882280|NCT01546649|3707673|B1|Tubular adenocarcinoma||Pathological diagnosis, Customized||participants|Number|1|1.0||||||
3882281|NCT01546649|3707671|B3|Invasive lobular carcinoma||Pathological diagnosis, Customized||participants|Number|12|12.0||||||
3882282|NCT01546649|3707672|B2|Invasive lobular carcinoma||Pathological diagnosis, Customized||participants|Number|6|6.0||||||
3882283|NCT01546649|3707673|B1|Invasive lobular carcinoma||Pathological diagnosis, Customized||participants|Number|6|6.0||||||
3882284|NCT01546649|3707671|B3|Mucinous carcinoma||Pathological diagnosis, Customized||participants|Number|5|5.0||||||
3882285|NCT01546649|3707672|B2|Mucinous carcinoma||Pathological diagnosis, Customized||participants|Number|1|1.0||||||
3882286|NCT01546649|3707673|B1|Mucinous carcinoma||Pathological diagnosis, Customized||participants|Number|4|4.0||||||
3882287|NCT01546649|3707671|B3|Scirrhous carcinoma||Pathological diagnosis, Customized||participants|Number|64|64.0||||||
3882288|NCT01546649|3707672|B2|Scirrhous carcinoma||Pathological diagnosis, Customized||participants|Number|34|34.0||||||
3882289|NCT01546649|3707673|B1|Scirrhous carcinoma||Pathological diagnosis, Customized||participants|Number|30|30.0||||||
3882290|NCT01546649|3707671|B3|Solid-tubular carcinoma||Pathological diagnosis, Customized||participants|Number|11|11.0||||||
3882291|NCT01546649|3707672|B2|Solid-tubular carcinoma||Pathological diagnosis, Customized||participants|Number|4|4.0||||||
3882292|NCT01546649|3707673|B1|Solid-tubular carcinoma||Pathological diagnosis, Customized||participants|Number|7|7.0||||||
3882293|NCT01546649|3707671|B3|Papillotubular carcinoma||Pathological diagnosis, Customized||participants|Number|69|69.0||||||
3882294|NCT01546649|3707672|B2|Papillotubular carcinoma||Pathological diagnosis, Customized||participants|Number|36|36.0||||||
3882295|NCT01546649|3707673|B1|Papillotubular carcinoma||Pathological diagnosis, Customized||participants|Number|33|33.0||||||
3882296|NCT01546649|3707671|B3|Mastectomy||Surgical procedure, Customized||participants|Number|56|56.0||||||
3882297|NCT01546649|3707672|B2|Mastectomy||Surgical procedure, Customized||participants|Number|26|26.0||||||
3882298|NCT01546649|3707673|B1|Mastectomy||Surgical procedure, Customized||participants|Number|30|30.0||||||
3882299|NCT01546649|3707671|B3|Breast-conserving surgery||Surgical procedure, Customized||participants|Number|111|111.0||||||
3882300|NCT01546649|3707672|B2|Breast-conserving surgery||Surgical procedure, Customized||participants|Number|58|58.0||||||
3882301|NCT01546649|3707673|B1|Breast-conserving surgery||Surgical procedure, Customized||participants|Number|53|53.0||||||
3882302|NCT01546649|3707671|B3|>=30.0 kg/m^2||BMI, Customized||participants|Number|1|1.0||||||
3882303|NCT01546649|3707672|B2|>=30.0 kg/m^2||BMI, Customized||participants|Number|1|1.0||||||
3882304|NCT01546649|3707673|B1|>=30.0 kg/m^2||BMI, Customized||participants|Number|0|0.0||||||
3882305|NCT01546649|3707671|B3|>=25.0 to <30.0 kg/m^2||BMI, Customized||participants|Number|21|21.0||||||
3882306|NCT01546649|3707672|B2|>=25.0 to <30.0 kg/m^2||BMI, Customized||participants|Number|9|9.0||||||
3882307|NCT01546649|3707673|B1|>=25.0 to <30.0 kg/m^2||BMI, Customized||participants|Number|12|12.0||||||
3882308|NCT01546649|3707671|B3|>=18.5 to <25.0 kg/m^2||BMI, Customized||participants|Number|124|124.0||||||
3882309|NCT01546649|3707672|B2|>=18.5 to <25.0 kg/m^2||BMI, Customized||participants|Number|61|61.0||||||
3882310|NCT01546649|3707673|B1|>=18.5 to <25.0 kg/m^2||BMI, Customized||participants|Number|63|63.0||||||
3882311|NCT01546649|3707671|B3|<18.5 kg/m^2||BMI, Customized||participants|Number|21|21.0||||||
3882312|NCT01546649|3707672|B2|<18.5 kg/m^2||BMI, Customized||participants|Number|13|13.0||||||
3882315|NCT01546649|3707672|B2|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|21.45|21.45|Standard Deviation|2.902|2.902|||
3882316|NCT01546649|3707673|B1|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|21.50|21.5|Standard Deviation|3.042|3.042|||
3882317|NCT01546649|3707671|B3|>=60 kg||Weight, Customized||participants|Number|33|33.0||||||
3882318|NCT01546649|3707672|B2|>=60 kg||Weight, Customized||participants|Number|15|15.0||||||
3882319|NCT01546649|3707673|B1|>=60 kg||Weight, Customized||participants|Number|18|18.0||||||
3882320|NCT01546649|3707671|B3|>=50 to <60 kg||Weight, Customized||participants|Number|80|80.0||||||
3882321|NCT01546649|3707672|B2|>=50 to <60 kg||Weight, Customized||participants|Number|40|40.0||||||
3882322|NCT01546649|3707673|B1|>=50 to <60 kg||Weight, Customized||participants|Number|40|40.0||||||
3882323|NCT01546649|3707671|B3|<50 kg||Weight, Customized||participants|Number|54|54.0||||||
3882324|NCT01546649|3707672|B2|<50 kg||Weight, Customized||participants|Number|29|29.0||||||
3882325|NCT01546649|3707673|B1|<50 kg||Weight, Customized||participants|Number|25|25.0||||||
3882326|NCT01546649|3707671|B3|||Weight||kilogram (kg)|Mean|54.02|54.02|Standard Deviation|7.574|7.574|||
3882327|NCT01546649|3707672|B2|||Weight||kilogram (kg)|Mean|53.57|53.57|Standard Deviation|7.498|7.498|||
3882328|NCT01546649|3707673|B1|||Weight||kilogram (kg)|Mean|54.48|54.48|Standard Deviation|7.670|7.67|||
3882329|NCT01546649|3707671|B3|>=160 cm||Height, Customized||participants|Number|69|69.0||||||
3882330|NCT01546649|3707672|B2|>=160 cm||Height, Customized||participants|Number|28|28.0||||||
3882331|NCT01546649|3707673|B1|>=160 cm||Height, Customized||participants|Number|41|41.0||||||
3882332|NCT01546649|3707671|B3|>=150 to <160 cm||Height, Customized||participants|Number|93|93.0||||||
3882333|NCT01546649|3707672|B2|>=150 to <160 cm||Height, Customized||participants|Number|53|53.0||||||
3882334|NCT01546649|3707673|B1|>=150 to <160 cm||Height, Customized||participants|Number|40|40.0||||||
3882335|NCT01546649|3707671|B3|<150 cm||Height, Customized||participants|Number|5|5.0||||||
3882336|NCT01546649|3707672|B2|<150 cm||Height, Customized||participants|Number|3|3.0||||||
3882337|NCT01546649|3707673|B1|<150 cm||Height, Customized||participants|Number|2|2.0||||||
3882338|NCT01546649|3707671|B3|||Height||centimeter (cm)|Mean|158.7|158.7|Standard Deviation|5.08|5.08|||
3882339|NCT01546649|3707672|B2|||Height||centimeter (cm)|Mean|158.1|158.1|Standard Deviation|5.00|5.0|||
3882340|NCT01546649|3707673|B1|||Height||centimeter (cm)|Mean|159.3|159.3|Standard Deviation|5.11|5.11|||
3882341|NCT01546649|3707671|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3882342|NCT01546649|3707672|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3882343|NCT01546649|3707673|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3882344|NCT01546649|3707671|B3||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3882345|NCT01546649|3707672|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3882346|NCT01546649|3707673|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3882347|NCT01546649|3707671|B3|>=45 years||Age, Customized||participants|Number|83|83.0||||||
3882348|NCT01546649|3707672|B2|>=45 years||Age, Customized||participants|Number|42|42.0||||||
3882349|NCT01546649|3707673|B1|>=45 years||Age, Customized||participants|Number|41|41.0||||||
3882350|NCT01546649|3707671|B3|Greater than equal to (>=) 40 to <45 years||Age, Customized||participants|Number|59|59.0||||||
3882351|NCT01546649|3707672|B2|Greater than equal to (>=) 40 to <45 years||Age, Customized||participants|Number|30|30.0||||||
3882352|NCT01546649|3707673|B1|Greater than equal to (>=) 40 to <45 years||Age, Customized||participants|Number|29|29.0||||||
3882353|NCT01546649|3707671|B3|Less than (<) 40 years||Age, Customized||participants|Number|25|25.0||||||
3882354|NCT01546649|3707672|B2|Less than (<) 40 years||Age, Customized||participants|Number|12|12.0||||||
3882355|NCT01546649|3707673|B1|Less than (<) 40 years||Age, Customized||participants|Number|13|13.0||||||
3882356|NCT01546649|3707671|B3|||Age||years|Mean|44.1|44.1|Standard Deviation|5.03|5.03|||
3882357|NCT01546649|3707672|B2|||Age||years|Mean|44.0|44.0|Standard Deviation|5.18|5.18|||
3882358|NCT01546649|3707673|B1|||Age||years|Mean|44.2|44.2|Standard Deviation|4.90|4.9|||
3882359|NCT01546636|3707694|B3|United States||Region of Enrollment||participants|Number|70|70.0||||||
3882360|NCT01546636|3707695|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
3882361|NCT01546636|3707696|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
3882362|NCT01546636|3707694|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3882363|NCT01546636|3707695|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3882364|NCT01546636|3707696|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3882365|NCT01546636|3707694|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3882366|NCT01546636|3707695|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3882367|NCT01546636|3707696|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3882368|NCT01546636|3707694|B3|||Age||years|Mean|53.3|53.3|Standard Deviation|12.8|12.8|||
3882369|NCT01546636|3707695|B2|||Age||years|Mean|54.7|54.7|Standard Deviation|12.4|12.4|||
3882370|NCT01546636|3707696|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|13.8|13.8|||
3882371|NCT01546636|3707694|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3882372|NCT01546636|3707695|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3882373|NCT01546636|3707696|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3882374|NCT01546636|3707694|B3||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
3882375|NCT01546636|3707695|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3882376|NCT01546636|3707696|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3882377|NCT01546636|3707694|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3882378|NCT01546636|3707695|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3882379|NCT01546636|3707696|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3882380|NCT01546623|3707707|B3|4||Eastern Cooperative Oncology Group (ECOG) Performance Status|Number of participants for whom ECOG Performance Status data is available in Baseline Characteristics is 81 and 79 in each treatment arm, respectively. The categories of ECOG Performance Status is represented from 0 (Fully active, better) to 4 (Completely disabled, worse).|Participants|Number|0|0.0||||||
3882381|NCT01546623|3707708|B2|4||Eastern Cooperative Oncology Group (ECOG) Performance Status|Number of participants for whom ECOG Performance Status data is available in Baseline Characteristics is 81 and 79 in each treatment arm, respectively. The categories of ECOG Performance Status is represented from 0 (Fully active, better) to 4 (Completely disabled, worse).|Participants|Number|0|0.0||||||
3882382|NCT01546623|3707709|B1|4||Eastern Cooperative Oncology Group (ECOG) Performance Status|Number of participants for whom ECOG Performance Status data is available in Baseline Characteristics is 81 and 79 in each treatment arm, respectively. The categories of ECOG Performance Status is represented from 0 (Fully active, better) to 4 (Completely disabled, worse).|Participants|Number|0|0.0||||||
3882383|NCT01546623|3707707|B3|3||Eastern Cooperative Oncology Group (ECOG) Performance Status|Number of participants for whom ECOG Performance Status data is available in Baseline Characteristics is 81 and 79 in each treatment arm, respectively. The categories of ECOG Performance Status is represented from 0 (Fully active, better) to 4 (Completely disabled, worse).|Participants|Number|0|0.0||||||
3882384|NCT01546623|3707708|B2|3||Eastern Cooperative Oncology Group (ECOG) Performance Status|Number of participants for whom ECOG Performance Status data is available in Baseline Characteristics is 81 and 79 in each treatment arm, respectively. The categories of ECOG Performance Status is represented from 0 (Fully active, better) to 4 (Completely disabled, worse).|Participants|Number|0|0.0||||||
3882385|NCT01546623|3707709|B1|3||Eastern Cooperative Oncology Group (ECOG) Performance Status|Number of participants for whom ECOG Performance Status data is available in Baseline Characteristics is 81 and 79 in each treatment arm, respectively. The categories of ECOG Performance Status is represented from 0 (Fully active, better) to 4 (Completely disabled, worse).|Participants|Number|0|0.0||||||
3882386|NCT01546623|3707707|B3|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Number of participants for whom ECOG Performance Status data is available in Baseline Characteristics is 81 and 79 in each treatment arm, respectively. The categories of ECOG Performance Status is represented from 0 (Fully active, better) to 4 (Completely disabled, worse).|Participants|Number|2|2.0||||||
3882387|NCT01546623|3707708|B2|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Number of participants for whom ECOG Performance Status data is available in Baseline Characteristics is 81 and 79 in each treatment arm, respectively. The categories of ECOG Performance Status is represented from 0 (Fully active, better) to 4 (Completely disabled, worse).|Participants|Number|1|1.0||||||
3882388|NCT01546623|3707709|B1|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Number of participants for whom ECOG Performance Status data is available in Baseline Characteristics is 81 and 79 in each treatment arm, respectively. The categories of ECOG Performance Status is represented from 0 (Fully active, better) to 4 (Completely disabled, worse).|Participants|Number|1|1.0||||||
3882389|NCT01546623|3707707|B3|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Number of participants for whom ECOG Performance Status data is available in Baseline Characteristics is 81 and 79 in each treatment arm, respectively. The categories of ECOG Performance Status is represented from 0 (Fully active, better) to 4 (Completely disabled, worse).|Participants|Number|14|14.0||||||
3882390|NCT01546623|3707708|B2|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Number of participants for whom ECOG Performance Status data is available in Baseline Characteristics is 81 and 79 in each treatment arm, respectively. The categories of ECOG Performance Status is represented from 0 (Fully active, better) to 4 (Completely disabled, worse).|Participants|Number|7|7.0||||||
3882391|NCT01546623|3707709|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Number of participants for whom ECOG Performance Status data is available in Baseline Characteristics is 81 and 79 in each treatment arm, respectively. The categories of ECOG Performance Status is represented from 0 (Fully active, better) to 4 (Completely disabled, worse).|Participants|Number|7|7.0||||||
3882392|NCT01546623|3707707|B3|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Number of participants for whom ECOG Performance Status data is available in Baseline Characteristics is 81 and 79 in each treatment arm, respectively. The categories of ECOG Performance Status is represented from 0 (Fully active, better) to 4 (Completely disabled, worse).|Participants|Number|144|144.0||||||
3882393|NCT01546623|3707708|B2|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Number of participants for whom ECOG Performance Status data is available in Baseline Characteristics is 81 and 79 in each treatment arm, respectively. The categories of ECOG Performance Status is represented from 0 (Fully active, better) to 4 (Completely disabled, worse).|Participants|Number|71|71.0||||||
3882394|NCT01546623|3707709|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Number of participants for whom ECOG Performance Status data is available in Baseline Characteristics is 81 and 79 in each treatment arm, respectively. The categories of ECOG Performance Status is represented from 0 (Fully active, better) to 4 (Completely disabled, worse).|Participants|Number|73|73.0||||||
3882395|NCT01546623|3707707|B3|||Period between first dose dates of leuproride acetate (over-the-counter) and the study drug||Weeks|Mean|46.460|46.46|Standard Deviation|20.4056|20.4056|||
3882396|NCT01546623|3707708|B2|||Period between first dose dates of leuproride acetate (over-the-counter) and the study drug||Weeks|Mean|46.595|46.595|Standard Deviation|20.8584|20.8584|||
3882397|NCT01546623|3707709|B1|||Period between first dose dates of leuproride acetate (over-the-counter) and the study drug||Weeks|Mean|46.328|46.328|Standard Deviation|20.0833|20.0833|||
3882398|NCT01546623|3707707|B3|||Period between date of first dianosis and date of informed consent||Years|Mean|1.700|1.7|Standard Deviation|2.0583|2.0583|||
3882399|NCT01546623|3707708|B2|||Period between date of first dianosis and date of informed consent||Years|Mean|1.748|1.748|Standard Deviation|2.0410|2.041|||
3882400|NCT01546623|3707709|B1|||Period between date of first dianosis and date of informed consent||Years|Mean|1.653|1.653|Standard Deviation|2.0866|2.0866|||
3882401|NCT01546623|3707707|B3|Unknown||TNM classification at diagnosis: M|Number of participants for whom TNM classification at diagnosis: M data is available in the TAP-144-SR(3M) treatment arm is 79, respectively. The categories of M is represented by M0 (no distant metastasis), and M1 (metastasis to distant organs (beyond regional lymph nodes).|participants|Number|0|0.0||||||
3882402|NCT01546623|3707708|B2|Unknown||TNM classification at diagnosis: M|Number of participants for whom TNM classification at diagnosis: M data is available in the TAP-144-SR(3M) treatment arm is 79, respectively. The categories of M is represented by M0 (no distant metastasis), and M1 (metastasis to distant organs (beyond regional lymph nodes).|participants|Number|0|0.0||||||
3882403|NCT01546623|3707709|B1|Unknown||TNM classification at diagnosis: M|Number of participants for whom TNM classification at diagnosis: M data is available in the TAP-144-SR(3M) treatment arm is 79, respectively. The categories of M is represented by M0 (no distant metastasis), and M1 (metastasis to distant organs (beyond regional lymph nodes).|participants|Number|0|0.0||||||
3882404|NCT01546623|3707707|B3|M1||TNM classification at diagnosis: M|Number of participants for whom TNM classification at diagnosis: M data is available in the TAP-144-SR(3M) treatment arm is 79, respectively. The categories of M is represented by M0 (no distant metastasis), and M1 (metastasis to distant organs (beyond regional lymph nodes).|participants|Number|36|36.0||||||
3882405|NCT01546623|3707708|B2|M1||TNM classification at diagnosis: M|Number of participants for whom TNM classification at diagnosis: M data is available in the TAP-144-SR(3M) treatment arm is 79, respectively. The categories of M is represented by M0 (no distant metastasis), and M1 (metastasis to distant organs (beyond regional lymph nodes).|participants|Number|17|17.0||||||
3882406|NCT01546623|3707709|B1|M1||TNM classification at diagnosis: M|Number of participants for whom TNM classification at diagnosis: M data is available in the TAP-144-SR(3M) treatment arm is 79, respectively. The categories of M is represented by M0 (no distant metastasis), and M1 (metastasis to distant organs (beyond regional lymph nodes).|participants|Number|19|19.0||||||
3882407|NCT01546623|3707707|B3|M0||TNM classification at diagnosis: M|Number of participants for whom TNM classification at diagnosis: M data is available in the TAP-144-SR(3M) treatment arm is 79, respectively. The categories of M is represented by M0 (no distant metastasis), and M1 (metastasis to distant organs (beyond regional lymph nodes).|participants|Number|125|125.0||||||
3882408|NCT01546623|3707708|B2|M0||TNM classification at diagnosis: M|Number of participants for whom TNM classification at diagnosis: M data is available in the TAP-144-SR(3M) treatment arm is 79, respectively. The categories of M is represented by M0 (no distant metastasis), and M1 (metastasis to distant organs (beyond regional lymph nodes).|participants|Number|62|62.0||||||
3882409|NCT01546623|3707709|B1|M0||TNM classification at diagnosis: M|Number of participants for whom TNM classification at diagnosis: M data is available in the TAP-144-SR(3M) treatment arm is 79, respectively. The categories of M is represented by M0 (no distant metastasis), and M1 (metastasis to distant organs (beyond regional lymph nodes).|participants|Number|63|63.0||||||
3882410|NCT01546623|3707707|B3|Unknown||TNM classification at diagnosis: N|Number of participants for whom TNM classification at diagnosis: N data is available in the TAP-144-SR(3M) treatment arm is 79, respectively. The categories of N is represented by Nx (lymph nodes cannot be evaluated), N0 (tumor cells absent from regional lymph nodes), and N1 (regional lymph node metastasis present).|Participant|Number|0|0.0||||||
3882411|NCT01546623|3707708|B2|Unknown||TNM classification at diagnosis: N|Number of participants for whom TNM classification at diagnosis: N data is available in the TAP-144-SR(3M) treatment arm is 79, respectively. The categories of N is represented by Nx (lymph nodes cannot be evaluated), N0 (tumor cells absent from regional lymph nodes), and N1 (regional lymph node metastasis present).|Participant|Number|0|0.0||||||
3882412|NCT01546623|3707709|B1|Unknown||TNM classification at diagnosis: N|Number of participants for whom TNM classification at diagnosis: N data is available in the TAP-144-SR(3M) treatment arm is 79, respectively. The categories of N is represented by Nx (lymph nodes cannot be evaluated), N0 (tumor cells absent from regional lymph nodes), and N1 (regional lymph node metastasis present).|Participant|Number|0|0.0||||||
3882413|NCT01546623|3707707|B3|NX||TNM classification at diagnosis: N|Number of participants for whom TNM classification at diagnosis: N data is available in the TAP-144-SR(3M) treatment arm is 79, respectively. The categories of N is represented by Nx (lymph nodes cannot be evaluated), N0 (tumor cells absent from regional lymph nodes), and N1 (regional lymph node metastasis present).|Participant|Number|0|0.0||||||
3882414|NCT01546623|3707708|B2|NX||TNM classification at diagnosis: N|Number of participants for whom TNM classification at diagnosis: N data is available in the TAP-144-SR(3M) treatment arm is 79, respectively. The categories of N is represented by Nx (lymph nodes cannot be evaluated), N0 (tumor cells absent from regional lymph nodes), and N1 (regional lymph node metastasis present).|Participant|Number|0|0.0||||||
3882415|NCT01546623|3707709|B1|NX||TNM classification at diagnosis: N|Number of participants for whom TNM classification at diagnosis: N data is available in the TAP-144-SR(3M) treatment arm is 79, respectively. The categories of N is represented by Nx (lymph nodes cannot be evaluated), N0 (tumor cells absent from regional lymph nodes), and N1 (regional lymph node metastasis present).|Participant|Number|0|0.0||||||
3882416|NCT01546623|3707707|B3|N1||TNM classification at diagnosis: N|Number of participants for whom TNM classification at diagnosis: N data is available in the TAP-144-SR(3M) treatment arm is 79, respectively. The categories of N is represented by Nx (lymph nodes cannot be evaluated), N0 (tumor cells absent from regional lymph nodes), and N1 (regional lymph node metastasis present).|Participant|Number|30|30.0||||||
3882417|NCT01546623|3707708|B2|N1||TNM classification at diagnosis: N|Number of participants for whom TNM classification at diagnosis: N data is available in the TAP-144-SR(3M) treatment arm is 79, respectively. The categories of N is represented by Nx (lymph nodes cannot be evaluated), N0 (tumor cells absent from regional lymph nodes), and N1 (regional lymph node metastasis present).|Participant|Number|17|17.0||||||
3882418|NCT01546623|3707709|B1|N1||TNM classification at diagnosis: N|Number of participants for whom TNM classification at diagnosis: N data is available in the TAP-144-SR(3M) treatment arm is 79, respectively. The categories of N is represented by Nx (lymph nodes cannot be evaluated), N0 (tumor cells absent from regional lymph nodes), and N1 (regional lymph node metastasis present).|Participant|Number|13|13.0||||||
3882504|NCT01546454|3707785|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3882419|NCT01546623|3707707|B3|N0||TNM classification at diagnosis: N|Number of participants for whom TNM classification at diagnosis: N data is available in the TAP-144-SR(3M) treatment arm is 79, respectively. The categories of N is represented by Nx (lymph nodes cannot be evaluated), N0 (tumor cells absent from regional lymph nodes), and N1 (regional lymph node metastasis present).|Participant|Number|131|131.0||||||
3882420|NCT01546623|3707708|B2|N0||TNM classification at diagnosis: N|Number of participants for whom TNM classification at diagnosis: N data is available in the TAP-144-SR(3M) treatment arm is 79, respectively. The categories of N is represented by Nx (lymph nodes cannot be evaluated), N0 (tumor cells absent from regional lymph nodes), and N1 (regional lymph node metastasis present).|Participant|Number|62|62.0||||||
3882421|NCT01546623|3707709|B1|N0||TNM classification at diagnosis: N|Number of participants for whom TNM classification at diagnosis: N data is available in the TAP-144-SR(3M) treatment arm is 79, respectively. The categories of N is represented by Nx (lymph nodes cannot be evaluated), N0 (tumor cells absent from regional lymph nodes), and N1 (regional lymph node metastasis present).|Participant|Number|69|69.0||||||
3882422|NCT01546623|3707707|B3|Unknown||Tumor-node-metastasis (TNM) classification at diagnosis: T|"Number of participants for whom TNM classification at diagnosis: T data is available in the TAP-144-SR(3M) treatment arm is 79, respectively.~The categories of T is ranged from T1 (better) to T4 (worse). Tx represents tumor cannot be evaluated and T0 represents no signs of tumor."|Participants|Number|0|0.0||||||
3882423|NCT01546623|3707708|B2|Unknown||Tumor-node-metastasis (TNM) classification at diagnosis: T|"Number of participants for whom TNM classification at diagnosis: T data is available in the TAP-144-SR(3M) treatment arm is 79, respectively.~The categories of T is ranged from T1 (better) to T4 (worse). Tx represents tumor cannot be evaluated and T0 represents no signs of tumor."|Participants|Number|0|0.0||0.0|0.0|||
3882424|NCT01546623|3707709|B1|Unknown||Tumor-node-metastasis (TNM) classification at diagnosis: T|"Number of participants for whom TNM classification at diagnosis: T data is available in the TAP-144-SR(3M) treatment arm is 79, respectively.~The categories of T is ranged from T1 (better) to T4 (worse). Tx represents tumor cannot be evaluated and T0 represents no signs of tumor."|Participants|Number|0|0.0||0|0.0|||
3882425|NCT01546623|3707707|B3|TX||Tumor-node-metastasis (TNM) classification at diagnosis: T|"Number of participants for whom TNM classification at diagnosis: T data is available in the TAP-144-SR(3M) treatment arm is 79, respectively.~The categories of T is ranged from T1 (better) to T4 (worse). Tx represents tumor cannot be evaluated and T0 represents no signs of tumor."|Participants|Number|0|0.0||||||
3882426|NCT01546623|3707708|B2|TX||Tumor-node-metastasis (TNM) classification at diagnosis: T|"Number of participants for whom TNM classification at diagnosis: T data is available in the TAP-144-SR(3M) treatment arm is 79, respectively.~The categories of T is ranged from T1 (better) to T4 (worse). Tx represents tumor cannot be evaluated and T0 represents no signs of tumor."|Participants|Number|0|0.0||0.0|0.0|||
3882427|NCT01546623|3707709|B1|TX||Tumor-node-metastasis (TNM) classification at diagnosis: T|"Number of participants for whom TNM classification at diagnosis: T data is available in the TAP-144-SR(3M) treatment arm is 79, respectively.~The categories of T is ranged from T1 (better) to T4 (worse). Tx represents tumor cannot be evaluated and T0 represents no signs of tumor."|Participants|Number|0|0.0||0.0|0.0|||
3882428|NCT01546623|3707707|B3|T4||Tumor-node-metastasis (TNM) classification at diagnosis: T|"Number of participants for whom TNM classification at diagnosis: T data is available in the TAP-144-SR(3M) treatment arm is 79, respectively.~The categories of T is ranged from T1 (better) to T4 (worse). Tx represents tumor cannot be evaluated and T0 represents no signs of tumor."|Participants|Number|10|10.0||||||
3882429|NCT01546623|3707708|B2|T4||Tumor-node-metastasis (TNM) classification at diagnosis: T|"Number of participants for whom TNM classification at diagnosis: T data is available in the TAP-144-SR(3M) treatment arm is 79, respectively.~The categories of T is ranged from T1 (better) to T4 (worse). Tx represents tumor cannot be evaluated and T0 represents no signs of tumor."|Participants|Number|6|6.0||7.6|7.6|||
3882430|NCT01546623|3707709|B1|T4||Tumor-node-metastasis (TNM) classification at diagnosis: T|"Number of participants for whom TNM classification at diagnosis: T data is available in the TAP-144-SR(3M) treatment arm is 79, respectively.~The categories of T is ranged from T1 (better) to T4 (worse). Tx represents tumor cannot be evaluated and T0 represents no signs of tumor."|Participants|Number|4|4.0||4.9|4.9|||
3882431|NCT01546623|3707707|B3|T3||Tumor-node-metastasis (TNM) classification at diagnosis: T|"Number of participants for whom TNM classification at diagnosis: T data is available in the TAP-144-SR(3M) treatment arm is 79, respectively.~The categories of T is ranged from T1 (better) to T4 (worse). Tx represents tumor cannot be evaluated and T0 represents no signs of tumor."|Participants|Number|62|62.0||||||
3882432|NCT01546623|3707708|B2|T3||Tumor-node-metastasis (TNM) classification at diagnosis: T|"Number of participants for whom TNM classification at diagnosis: T data is available in the TAP-144-SR(3M) treatment arm is 79, respectively.~The categories of T is ranged from T1 (better) to T4 (worse). Tx represents tumor cannot be evaluated and T0 represents no signs of tumor."|Participants|Number|33|33.0||41.8|41.8|||
3882433|NCT01546623|3707709|B1|T3||Tumor-node-metastasis (TNM) classification at diagnosis: T|"Number of participants for whom TNM classification at diagnosis: T data is available in the TAP-144-SR(3M) treatment arm is 79, respectively.~The categories of T is ranged from T1 (better) to T4 (worse). Tx represents tumor cannot be evaluated and T0 represents no signs of tumor."|Participants|Number|29|29.0||35.4|35.4|||
3882434|NCT01546623|3707707|B3|T2||Tumor-node-metastasis (TNM) classification at diagnosis: T|"Number of participants for whom TNM classification at diagnosis: T data is available in the TAP-144-SR(3M) treatment arm is 79, respectively.~The categories of T is ranged from T1 (better) to T4 (worse). Tx represents tumor cannot be evaluated and T0 represents no signs of tumor."|Participants|Number|56|56.0||||||
3882435|NCT01546623|3707708|B2|T2||Tumor-node-metastasis (TNM) classification at diagnosis: T|"Number of participants for whom TNM classification at diagnosis: T data is available in the TAP-144-SR(3M) treatment arm is 79, respectively.~The categories of T is ranged from T1 (better) to T4 (worse). Tx represents tumor cannot be evaluated and T0 represents no signs of tumor."|Participants|Number|24|24.0||30.4|30.4|||
3882436|NCT01546623|3707709|B1|T2||Tumor-node-metastasis (TNM) classification at diagnosis: T|"Number of participants for whom TNM classification at diagnosis: T data is available in the TAP-144-SR(3M) treatment arm is 79, respectively.~The categories of T is ranged from T1 (better) to T4 (worse). Tx represents tumor cannot be evaluated and T0 represents no signs of tumor."|Participants|Number|32|32.0||39.0|39.0|||
3882437|NCT01546623|3707707|B3|T1||Tumor-node-metastasis (TNM) classification at diagnosis: T|"Number of participants for whom TNM classification at diagnosis: T data is available in the TAP-144-SR(3M) treatment arm is 79, respectively.~The categories of T is ranged from T1 (better) to T4 (worse). Tx represents tumor cannot be evaluated and T0 represents no signs of tumor."|Participants|Number|33|33.0||||||
3882438|NCT01546623|3707708|B2|T1||Tumor-node-metastasis (TNM) classification at diagnosis: T|"Number of participants for whom TNM classification at diagnosis: T data is available in the TAP-144-SR(3M) treatment arm is 79, respectively.~The categories of T is ranged from T1 (better) to T4 (worse). Tx represents tumor cannot be evaluated and T0 represents no signs of tumor."|Participants|Number|16|16.0||20.3|20.3|||
3882439|NCT01546623|3707709|B1|T1||Tumor-node-metastasis (TNM) classification at diagnosis: T|"Number of participants for whom TNM classification at diagnosis: T data is available in the TAP-144-SR(3M) treatment arm is 79, respectively.~The categories of T is ranged from T1 (better) to T4 (worse). Tx represents tumor cannot be evaluated and T0 represents no signs of tumor."|Participants|Number|17|17.0||20.7|20.7|||
3882440|NCT01546623|3707707|B3|T0||Tumor-node-metastasis (TNM) classification at diagnosis: T|"Number of participants for whom TNM classification at diagnosis: T data is available in the TAP-144-SR(3M) treatment arm is 79, respectively.~The categories of T is ranged from T1 (better) to T4 (worse). Tx represents tumor cannot be evaluated and T0 represents no signs of tumor."|Participants|Number|0|0.0||||||
3882441|NCT01546623|3707708|B2|T0||Tumor-node-metastasis (TNM) classification at diagnosis: T|"Number of participants for whom TNM classification at diagnosis: T data is available in the TAP-144-SR(3M) treatment arm is 79, respectively.~The categories of T is ranged from T1 (better) to T4 (worse). Tx represents tumor cannot be evaluated and T0 represents no signs of tumor."|Participants|Number|0|0.0||0.0|0.0|||
3882442|NCT01546623|3707709|B1|T0||Tumor-node-metastasis (TNM) classification at diagnosis: T|"Number of participants for whom TNM classification at diagnosis: T data is available in the TAP-144-SR(3M) treatment arm is 79, respectively.~The categories of T is ranged from T1 (better) to T4 (worse). Tx represents tumor cannot be evaluated and T0 represents no signs of tumor."|Participants|Number|0|0.0||0.0|0.0|||
3882443|NCT01546623|3707707|B3|10||Gleason Score|Gleason score is a score used in prostate cancer grading. Prostate cancer staging is the process by which physicians categorize the risk of cancer having spread beyond the prostate, or equivalently, the probability of being cured with local therapies such as surgery or radiation. Gleason score are often grouped into four stages (I–IV) of prostate cancer. Gleason scores range from 2 to 10, with 2 representing the most well-differentiated tumors and 10 the least-differentiated tumors.|Participants|Number|3|3.0||||||
3882444|NCT01546623|3707708|B2|10||Gleason Score|Gleason score is a score used in prostate cancer grading. Prostate cancer staging is the process by which physicians categorize the risk of cancer having spread beyond the prostate, or equivalently, the probability of being cured with local therapies such as surgery or radiation. Gleason score are often grouped into four stages (I–IV) of prostate cancer. Gleason scores range from 2 to 10, with 2 representing the most well-differentiated tumors and 10 the least-differentiated tumors.|Participants|Number|0|0.0||||||
3882445|NCT01546623|3707709|B1|10||Gleason Score|Gleason score is a score used in prostate cancer grading. Prostate cancer staging is the process by which physicians categorize the risk of cancer having spread beyond the prostate, or equivalently, the probability of being cured with local therapies such as surgery or radiation. Gleason score are often grouped into four stages (I–IV) of prostate cancer. Gleason scores range from 2 to 10, with 2 representing the most well-differentiated tumors and 10 the least-differentiated tumors.|Participants|Number|3|3.0||3.7|3.7|||
3882446|NCT01546623|3707707|B3|9||Gleason Score|Gleason score is a score used in prostate cancer grading. Prostate cancer staging is the process by which physicians categorize the risk of cancer having spread beyond the prostate, or equivalently, the probability of being cured with local therapies such as surgery or radiation. Gleason score are often grouped into four stages (I–IV) of prostate cancer. Gleason scores range from 2 to 10, with 2 representing the most well-differentiated tumors and 10 the least-differentiated tumors.|Participants|Number|41|41.0||||||
3882447|NCT01546623|3707708|B2|9||Gleason Score|Gleason score is a score used in prostate cancer grading. Prostate cancer staging is the process by which physicians categorize the risk of cancer having spread beyond the prostate, or equivalently, the probability of being cured with local therapies such as surgery or radiation. Gleason score are often grouped into four stages (I–IV) of prostate cancer. Gleason scores range from 2 to 10, with 2 representing the most well-differentiated tumors and 10 the least-differentiated tumors.|Participants|Number|21|21.0||26.3|26.3|||
3882448|NCT01546623|3707709|B1|9||Gleason Score|Gleason score is a score used in prostate cancer grading. Prostate cancer staging is the process by which physicians categorize the risk of cancer having spread beyond the prostate, or equivalently, the probability of being cured with local therapies such as surgery or radiation. Gleason score are often grouped into four stages (I–IV) of prostate cancer. Gleason scores range from 2 to 10, with 2 representing the most well-differentiated tumors and 10 the least-differentiated tumors.|Participants|Number|20|20.0||24.4|24.4|||
3882449|NCT01546623|3707707|B3|8||Gleason Score|Gleason score is a score used in prostate cancer grading. Prostate cancer staging is the process by which physicians categorize the risk of cancer having spread beyond the prostate, or equivalently, the probability of being cured with local therapies such as surgery or radiation. Gleason score are often grouped into four stages (I–IV) of prostate cancer. Gleason scores range from 2 to 10, with 2 representing the most well-differentiated tumors and 10 the least-differentiated tumors.|Participants|Number|35|35.0||||||
3882450|NCT01546623|3707708|B2|8||Gleason Score|Gleason score is a score used in prostate cancer grading. Prostate cancer staging is the process by which physicians categorize the risk of cancer having spread beyond the prostate, or equivalently, the probability of being cured with local therapies such as surgery or radiation. Gleason score are often grouped into four stages (I–IV) of prostate cancer. Gleason scores range from 2 to 10, with 2 representing the most well-differentiated tumors and 10 the least-differentiated tumors.|Participants|Number|21|21.0||26.3|26.3|||
3882505|NCT01546402|3707791|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3882506|NCT01546402|3707792|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3882507|NCT01546402|3707793|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3882508|NCT01546402|3707791|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3882451|NCT01546623|3707709|B1|8||Gleason Score|Gleason score is a score used in prostate cancer grading. Prostate cancer staging is the process by which physicians categorize the risk of cancer having spread beyond the prostate, or equivalently, the probability of being cured with local therapies such as surgery or radiation. Gleason score are often grouped into four stages (I–IV) of prostate cancer. Gleason scores range from 2 to 10, with 2 representing the most well-differentiated tumors and 10 the least-differentiated tumors.|Participants|Number|14|14.0||17.1|17.1|||
3882452|NCT01546623|3707707|B3|7||Gleason Score|Gleason score is a score used in prostate cancer grading. Prostate cancer staging is the process by which physicians categorize the risk of cancer having spread beyond the prostate, or equivalently, the probability of being cured with local therapies such as surgery or radiation. Gleason score are often grouped into four stages (I–IV) of prostate cancer. Gleason scores range from 2 to 10, with 2 representing the most well-differentiated tumors and 10 the least-differentiated tumors.|Participants|Number|64|64.0||||||
3882453|NCT01546623|3707708|B2|7||Gleason Score|Gleason score is a score used in prostate cancer grading. Prostate cancer staging is the process by which physicians categorize the risk of cancer having spread beyond the prostate, or equivalently, the probability of being cured with local therapies such as surgery or radiation. Gleason score are often grouped into four stages (I–IV) of prostate cancer. Gleason scores range from 2 to 10, with 2 representing the most well-differentiated tumors and 10 the least-differentiated tumors.|Participants|Number|29|29.0||36.3|36.3|||
3882454|NCT01546623|3707709|B1|7||Gleason Score|Gleason score is a score used in prostate cancer grading. Prostate cancer staging is the process by which physicians categorize the risk of cancer having spread beyond the prostate, or equivalently, the probability of being cured with local therapies such as surgery or radiation. Gleason score are often grouped into four stages (I–IV) of prostate cancer. Gleason scores range from 2 to 10, with 2 representing the most well-differentiated tumors and 10 the least-differentiated tumors.|Participants|Number|35|35.0||42.7|42.7|||
3882455|NCT01546623|3707707|B3|6||Gleason Score|Gleason score is a score used in prostate cancer grading. Prostate cancer staging is the process by which physicians categorize the risk of cancer having spread beyond the prostate, or equivalently, the probability of being cured with local therapies such as surgery or radiation. Gleason score are often grouped into four stages (I–IV) of prostate cancer. Gleason scores range from 2 to 10, with 2 representing the most well-differentiated tumors and 10 the least-differentiated tumors.|Participants|Number|15|15.0||||||
3882456|NCT01546623|3707708|B2|6||Gleason Score|Gleason score is a score used in prostate cancer grading. Prostate cancer staging is the process by which physicians categorize the risk of cancer having spread beyond the prostate, or equivalently, the probability of being cured with local therapies such as surgery or radiation. Gleason score are often grouped into four stages (I–IV) of prostate cancer. Gleason scores range from 2 to 10, with 2 representing the most well-differentiated tumors and 10 the least-differentiated tumors.|Participants|Number|7|7.0||8.8|8.8|||
3882457|NCT01546623|3707709|B1|6||Gleason Score|Gleason score is a score used in prostate cancer grading. Prostate cancer staging is the process by which physicians categorize the risk of cancer having spread beyond the prostate, or equivalently, the probability of being cured with local therapies such as surgery or radiation. Gleason score are often grouped into four stages (I–IV) of prostate cancer. Gleason scores range from 2 to 10, with 2 representing the most well-differentiated tumors and 10 the least-differentiated tumors.|Participants|Number|8|8.0||9.8|9.8|||
3882458|NCT01546623|3707707|B3|5||Gleason Score|Gleason score is a score used in prostate cancer grading. Prostate cancer staging is the process by which physicians categorize the risk of cancer having spread beyond the prostate, or equivalently, the probability of being cured with local therapies such as surgery or radiation. Gleason score are often grouped into four stages (I–IV) of prostate cancer. Gleason scores range from 2 to 10, with 2 representing the most well-differentiated tumors and 10 the least-differentiated tumors.|Participants|Number|4|4.0||||||
3882459|NCT01546623|3707708|B2|5||Gleason Score|Gleason score is a score used in prostate cancer grading. Prostate cancer staging is the process by which physicians categorize the risk of cancer having spread beyond the prostate, or equivalently, the probability of being cured with local therapies such as surgery or radiation. Gleason score are often grouped into four stages (I–IV) of prostate cancer. Gleason scores range from 2 to 10, with 2 representing the most well-differentiated tumors and 10 the least-differentiated tumors.|Participants|Number|2|2.0||2.5|2.5|||
3882460|NCT01546623|3707709|B1|5||Gleason Score|Gleason score is a score used in prostate cancer grading. Prostate cancer staging is the process by which physicians categorize the risk of cancer having spread beyond the prostate, or equivalently, the probability of being cured with local therapies such as surgery or radiation. Gleason score are often grouped into four stages (I–IV) of prostate cancer. Gleason scores range from 2 to 10, with 2 representing the most well-differentiated tumors and 10 the least-differentiated tumors.|Participants|Number|2|2.0||2.4|2.4|||
3882461|NCT01546623|3707707|B3|4||Gleason Score|Gleason score is a score used in prostate cancer grading. Prostate cancer staging is the process by which physicians categorize the risk of cancer having spread beyond the prostate, or equivalently, the probability of being cured with local therapies such as surgery or radiation. Gleason score are often grouped into four stages (I–IV) of prostate cancer. Gleason scores range from 2 to 10, with 2 representing the most well-differentiated tumors and 10 the least-differentiated tumors.|Participants|Number|0|0.0||||||
3882462|NCT01546623|3707708|B2|4||Gleason Score|Gleason score is a score used in prostate cancer grading. Prostate cancer staging is the process by which physicians categorize the risk of cancer having spread beyond the prostate, or equivalently, the probability of being cured with local therapies such as surgery or radiation. Gleason score are often grouped into four stages (I–IV) of prostate cancer. Gleason scores range from 2 to 10, with 2 representing the most well-differentiated tumors and 10 the least-differentiated tumors.|Participants|Number|0|0.0||0.0|0.0|||
3882463|NCT01546623|3707709|B1|4||Gleason Score|Gleason score is a score used in prostate cancer grading. Prostate cancer staging is the process by which physicians categorize the risk of cancer having spread beyond the prostate, or equivalently, the probability of being cured with local therapies such as surgery or radiation. Gleason score are often grouped into four stages (I–IV) of prostate cancer. Gleason scores range from 2 to 10, with 2 representing the most well-differentiated tumors and 10 the least-differentiated tumors.|Participants|Number|0|0.0||0.0|0.0|||
3882509|NCT01546402|3707792|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3882510|NCT01546402|3707793|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3882464|NCT01546623|3707707|B3|3||Gleason Score|Gleason score is a score used in prostate cancer grading. Prostate cancer staging is the process by which physicians categorize the risk of cancer having spread beyond the prostate, or equivalently, the probability of being cured with local therapies such as surgery or radiation. Gleason score are often grouped into four stages (I–IV) of prostate cancer. Gleason scores range from 2 to 10, with 2 representing the most well-differentiated tumors and 10 the least-differentiated tumors.|Participants|Number|0|0.0||||||
3882465|NCT01546623|3707708|B2|3||Gleason Score|Gleason score is a score used in prostate cancer grading. Prostate cancer staging is the process by which physicians categorize the risk of cancer having spread beyond the prostate, or equivalently, the probability of being cured with local therapies such as surgery or radiation. Gleason score are often grouped into four stages (I–IV) of prostate cancer. Gleason scores range from 2 to 10, with 2 representing the most well-differentiated tumors and 10 the least-differentiated tumors.|Participants|Number|0|0.0||0.0|0.0|||
3882466|NCT01546623|3707709|B1|3||Gleason Score|Gleason score is a score used in prostate cancer grading. Prostate cancer staging is the process by which physicians categorize the risk of cancer having spread beyond the prostate, or equivalently, the probability of being cured with local therapies such as surgery or radiation. Gleason score are often grouped into four stages (I–IV) of prostate cancer. Gleason scores range from 2 to 10, with 2 representing the most well-differentiated tumors and 10 the least-differentiated tumors.|Participants|Number|0|0.0||0.0|0.0|||
3882467|NCT01546623|3707707|B3|2||Gleason Score|Gleason score is a score used in prostate cancer grading. Prostate cancer staging is the process by which physicians categorize the risk of cancer having spread beyond the prostate, or equivalently, the probability of being cured with local therapies such as surgery or radiation. Gleason score are often grouped into four stages (I–IV) of prostate cancer. Gleason scores range from 2 to 10, with 2 representing the most well-differentiated tumors and 10 the least-differentiated tumors.|Participants|Number|0|0.0||||||
3882468|NCT01546623|3707708|B2|2||Gleason Score|Gleason score is a score used in prostate cancer grading. Prostate cancer staging is the process by which physicians categorize the risk of cancer having spread beyond the prostate, or equivalently, the probability of being cured with local therapies such as surgery or radiation. Gleason score are often grouped into four stages (I–IV) of prostate cancer. Gleason scores range from 2 to 10, with 2 representing the most well-differentiated tumors and 10 the least-differentiated tumors.|Participants|Number|0|0.0||0.0|0.0|||
3882469|NCT01546623|3707709|B1|2||Gleason Score|Gleason score is a score used in prostate cancer grading. Prostate cancer staging is the process by which physicians categorize the risk of cancer having spread beyond the prostate, or equivalently, the probability of being cured with local therapies such as surgery or radiation. Gleason score are often grouped into four stages (I–IV) of prostate cancer. Gleason scores range from 2 to 10, with 2 representing the most well-differentiated tumors and 10 the least-differentiated tumors.|Participants|Number|0|0.0||0.0|0.0|||
3882470|NCT01546623|3707707|B3|||Body Mass Index (BMI)||kg/m^2|Mean|23.96|23.96|Standard Deviation|2.764|2.764|||
3882471|NCT01546623|3707708|B2|||Body Mass Index (BMI)||kg/m^2|Mean|24.32|24.32|Standard Deviation|2.769|2.769|||
3882472|NCT01546623|3707709|B1|||Body Mass Index (BMI)||kg/m^2|Mean|23.61|23.61|Standard Deviation|2.731|2.731|||
3882473|NCT01546623|3707707|B3|||Weight||kg|Mean|64.92|64.92|Standard Deviation|8.424|8.424|||
3882474|NCT01546623|3707708|B2|||Weight||kg|Mean|65.83|65.83|Standard Deviation|8.098|8.098|||
3882475|NCT01546623|3707709|B1|||Weight||kg|Mean|64.03|64.03|Standard Deviation|8.689|8.689|||
3882476|NCT01546623|3707707|B3||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3882477|NCT01546623|3707708|B2||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3882478|NCT01546623|3707709|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3882479|NCT01546623|3707707|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3882480|NCT01546623|3707708|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3882481|NCT01546623|3707709|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3882482|NCT01546623|3707707|B3|||Age||Years|Mean|73.0|73.0|Standard Deviation|6.39|6.39|||
3882483|NCT01546623|3707708|B2|||Age||Years|Mean|72.6|72.6|Standard Deviation|6.49|6.49|||
3882484|NCT01546623|3707709|B1|||Age||Years|Mean|73.3|73.3|Standard Deviation|6.32|6.32|||
3882485|NCT01546519|3707736|B5||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3882486|NCT01546519|3707737|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3882487|NCT01546519|3707738|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3882488|NCT01546519|3707739|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3882489|NCT01546519|3707740|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3882490|NCT01546519|3707736|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3882491|NCT01546519|3707737|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3882492|NCT01546519|3707738|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3882493|NCT01546519|3707739|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3882494|NCT01546519|3707740|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3882495|NCT01546519|3707736|B5|||Age||years|Mean|63.4|63.4|Standard Deviation|11.4|11.4|||
3882496|NCT01546519|3707737|B4|||Age||years|Mean|64.0|64.0|Standard Deviation|8.4|8.4|||
3882497|NCT01546519|3707738|B3|||Age||years|Mean|65.8|65.8|Standard Deviation|10.7|10.7|||
3882498|NCT01546519|3707739|B2|||Age||years|Mean|60.6|60.6|Standard Deviation|14.1|14.1|||
3882499|NCT01546519|3707740|B1|||Age||years|Mean|63.3|63.3|Standard Deviation|12.6|12.6|||
3882500|NCT01546454|3707785|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3882501|NCT01546454|3707785|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3882502|NCT01546454|3707785|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3882503|NCT01546454|3707785|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3882511|NCT01546402|3707791|B3|||Age||years|Mean|58.56|58.56|Standard Deviation|5.73|5.73|||
3882512|NCT01546402|3707792|B2|||Age||years|Mean|59.56|59.56|Standard Deviation|4.64|4.64|||
3882513|NCT01546402|3707793|B1|||Age||years|Mean|57.56|57.56|Standard Deviation|6.78|6.78|||
3882514|NCT01546285|3707802|B1|||Mean Arterial Pressure (MAP)||mmHg|Mean|92.7|92.7|Standard Deviation|17.2|17.2|||
3882515|NCT01546285|3707802|B1|||Diastolic Blood Pressure||mmHg|Mean|73|73.0|Standard Deviation|15.4|15.4|||
3882516|NCT01546285|3707802|B1|||Systolic Blood Pressure||mmHg|Mean|125.0|125.0|Standard Deviation|25.3|25.3|||
3882517|NCT01546285|3707802|B1|United States||Region of Enrollment||participants|Number|66|66.0||||||
3882518|NCT01546285|3707802|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3882519|NCT01546285|3707802|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3882520|NCT01546285|3707802|B1|||Age||years|Mean|32|32.0|Standard Deviation|19.7|19.7|||
3882521|NCT01546285|3707802|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3882522|NCT01546285|3707802|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3882523|NCT01546285|3707802|B1||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
3882524|NCT01546207|3707808|B1|Italy||Region of Enrollment||participants|Number|0|0.0||||||
3882525|NCT01546207|3707808|B1|Brazil||Region of Enrollment||participants|Number|0|0.0||||||
3882526|NCT01546207|3707808|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
3882527|NCT01546207|3707808|B1|Czech Republic||Region of Enrollment||participants|Number|0|0.0||||||
3882528|NCT01546207|3707808|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3882529|NCT01546207|3707808|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3882530|NCT01546207|3707808|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3882531|NCT01546207|3707808|B1|||Age||years|Mean|61.75|61.75|Standard Deviation|7.18|7.18|||
3882532|NCT01546194|3707812|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3882533|NCT01546194|3707813|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3882534|NCT01546194|3707814|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3882535|NCT01546194|3707812|B3||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3882536|NCT01546194|3707813|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3882537|NCT01546194|3707814|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3882538|NCT01546194|3707812|B3|||Age||years|Mean|56|56.0|Standard Deviation|10|10.0|||
3882539|NCT01546194|3707813|B2|||Age||years|Mean|56|56.0|Standard Deviation|11|11.0|||
3882540|NCT01546194|3707814|B1|||Age||years|Mean|57|57.0|Standard Deviation|10|10.0|||
3882541|NCT01546168|3707821|B3|||History of GERD||Participants|Count of Participants|9|9.0||||||
3882542|NCT01546168|3707822|B2|||History of GERD||Participants|Count of Participants|4|4.0||||||
3882543|NCT01546168|3707823|B1|||History of GERD||Participants|Count of Participants|5|5.0||||||
3882544|NCT01546168|3707821|B3|||CHADS Score|CHADS score for Stroke Risk Assessment in Atrial Fibrillation CHADS is a mnemonic for Congestive Heart Failure, Hypertension, Age over 75 years, Diabetes Mellitus, and Stroke or TIA history CHADS Score >2 (CVA risk >5% per year) CHADS Score 1 (CVA risk >4% per year) CHADS Score 0 (low risk)|units on a scale|Mean|0.83|0.83|Standard Deviation|0.9|0.9|||
3882545|NCT01546168|3707822|B2|||CHADS Score|CHADS score for Stroke Risk Assessment in Atrial Fibrillation CHADS is a mnemonic for Congestive Heart Failure, Hypertension, Age over 75 years, Diabetes Mellitus, and Stroke or TIA history CHADS Score >2 (CVA risk >5% per year) CHADS Score 1 (CVA risk >4% per year) CHADS Score 0 (low risk)|units on a scale|Mean|1|1.0|Standard Deviation|0.9|0.9|||
3882546|NCT01546168|3707823|B1|||CHADS Score|CHADS score for Stroke Risk Assessment in Atrial Fibrillation CHADS is a mnemonic for Congestive Heart Failure, Hypertension, Age over 75 years, Diabetes Mellitus, and Stroke or TIA history CHADS Score >2 (CVA risk >5% per year) CHADS Score 1 (CVA risk >4% per year) CHADS Score 0 (low risk)|units on a scale|Mean|0.7|0.7|Standard Deviation|0.8|0.8|||
3882547|NCT01546168|3707821|B3|||Paroxysmal AF||Participants|Count of Participants|38|38.0||||||
3882548|NCT01546168|3707822|B2|||Paroxysmal AF||Participants|Count of Participants|18|18.0||||||
3882549|NCT01546168|3707823|B1|||Paroxysmal AF||Participants|Count of Participants|20|20.0||||||
3882550|NCT01546168|3707821|B3|||Persistent AF||Participants|Count of Participants|31|31.0||||||
3882551|NCT01546168|3707822|B2|||Persistent AF||Participants|Count of Participants|15|15.0||||||
3882552|NCT01546168|3707823|B1|||Persistent AF||Participants|Count of Participants|16|16.0||||||
3882553|NCT01546168|3707821|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3882554|NCT01546168|3707822|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3882555|NCT01546168|3707823|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3882556|NCT01546168|3707821|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3882557|NCT01546168|3707822|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3882558|NCT01546168|3707823|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3882559|NCT01546168|3707821|B3|||Age||years|Mean|61.7|61.7|Standard Deviation|8.4|8.4|||
3882560|NCT01546168|3707822|B2|||Age||years|Mean|62.6|62.6|Standard Deviation|8.6|8.6|||
3882561|NCT01546168|3707823|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|8.3|8.3|||
3882562|NCT01546155|3707836|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3882563|NCT01546155|3707836|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3882564|NCT01546155|3707836|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3882565|NCT01546155|3707836|B1|||Age||years|Mean|24.1|24.1|Standard Deviation|2.7|2.7|||
3882600|NCT01546142|3707841|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3882566|NCT01546142|3707840|B3|IV - VI||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|170|170.0||||||
3882567|NCT01546142|3707841|B2|IV - VI||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|82|82.0||||||
3882568|NCT01546142|3707842|B1|IV - VI||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|88|88.0||||||
3882569|NCT01546142|3707840|B3|I - III||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|346|346.0||||||
3882570|NCT01546142|3707841|B2|I - III||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|176|176.0||||||
3882571|NCT01546142|3707842|B1|I - III||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|170|170.0||||||
3882572|NCT01546142|3707840|B3|||Body Mass Index (BMI)|Data available for 257 participants in each treatment group|kg/m²|Mean|29.26|29.26|Standard Deviation|4.520|4.52|||
3882573|NCT01546142|3707841|B2|||Body Mass Index (BMI)|Data available for 257 participants in each treatment group|kg/m²|Mean|29.30|29.3|Standard Deviation|4.282|4.282|||
3882574|NCT01546142|3707842|B1|||Body Mass Index (BMI)|Data available for 257 participants in each treatment group|kg/m²|Mean|29.22|29.22|Standard Deviation|4.755|4.755|||
3882575|NCT01546142|3707840|B3|||Weight|Data available for 257 participants in each treatment group|kg|Mean|80.84|80.84|Standard Deviation|14.912|14.912|||
3882576|NCT01546142|3707841|B2|||Weight|Data available for 257 participants in each treatment group|kg|Mean|80.31|80.31|Standard Deviation|15.041|15.041|||
3882577|NCT01546142|3707842|B1|||Weight|Data available for 257 participants in each treatment group|kg|Mean|81.38|81.38|Standard Deviation|14.791|14.791|||
3882578|NCT01546142|3707840|B3|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|437|437.0||||||
3882579|NCT01546142|3707841|B2|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|219|219.0||||||
3882580|NCT01546142|3707842|B1|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|218|218.0||||||
3882581|NCT01546142|3707840|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
3882582|NCT01546142|3707841|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
3882583|NCT01546142|3707842|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
3882584|NCT01546142|3707840|B3|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3882585|NCT01546142|3707841|B2|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3882586|NCT01546142|3707842|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3882587|NCT01546142|3707840|B3|Multiple||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3882588|NCT01546142|3707841|B2|Multiple||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3882589|NCT01546142|3707842|B1|Multiple||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3882590|NCT01546142|3707840|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3882591|NCT01546142|3707841|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3882592|NCT01546142|3707842|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3882593|NCT01546142|3707840|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3882594|NCT01546142|3707841|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3882595|NCT01546142|3707842|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3882596|NCT01546142|3707840|B3|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3882597|NCT01546142|3707841|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3882598|NCT01546142|3707842|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3882599|NCT01546142|3707840|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
3882601|NCT01546142|3707842|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3882602|NCT01546142|3707840|B3|White||Race/Ethnicity, Customized||participants|Number|444|444.0||||||
3882603|NCT01546142|3707841|B2|White||Race/Ethnicity, Customized||participants|Number|222|222.0||||||
3882604|NCT01546142|3707842|B1|White||Race/Ethnicity, Customized||participants|Number|222|222.0||||||
3882605|NCT01546142|3707840|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3882606|NCT01546142|3707841|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3882607|NCT01546142|3707842|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3882608|NCT01546142|3707840|B3||Female|Sex: Female, Male||Participants|Count of Participants|445|445.0||||||
3882609|NCT01546142|3707841|B2||Female|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
3882610|NCT01546142|3707842|B1||Female|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
3882611|NCT01546142|3707840|B3|51-65 years||Age, Customized||participants|Number|217|217.0||||||
3882612|NCT01546142|3707841|B2|51-65 years||Age, Customized||participants|Number|108|108.0||||||
3882613|NCT01546142|3707842|B1|51-65 years||Age, Customized||participants|Number|109|109.0||||||
3882614|NCT01546142|3707840|B3|18-50 years||Age, Customized||participants|Number|299|299.0||||||
3882615|NCT01546142|3707841|B2|18-50 years||Age, Customized||participants|Number|150|150.0||||||
3882616|NCT01546142|3707842|B1|18-50 years||Age, Customized||participants|Number|149|149.0||||||
3882617|NCT01546142|3707840|B3|||Age||years|Mean|47.9|47.9|Standard Deviation|9.14|9.14|||
3882618|NCT01546142|3707841|B2|||Age||years|Mean|47.6|47.6|Standard Deviation|8.99|8.99|||
3882619|NCT01546142|3707842|B1|||Age||years|Mean|48.2|48.2|Standard Deviation|9.30|9.3|||
3882620|NCT01546038|3707855|B7||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
3882621|NCT01546038|3707856|B6||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3882622|NCT01546038|3707857|B5||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3882623|NCT01546038|3707858|B4||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3882624|NCT01546038|3707859|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3882625|NCT01546038|3707860|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3882626|NCT01546038|3707861|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3882627|NCT01546038|3707855|B7||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3882628|NCT01546038|3707856|B6||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3882629|NCT01546038|3707857|B5||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3882630|NCT01546038|3707858|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3882631|NCT01546038|3707859|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3882632|NCT01546038|3707860|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3882633|NCT01546038|3707861|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3882634|NCT01546038|3707855|B7|||Age||Years|Mean|66.8|66.8|Standard Deviation|13.9|13.9|||
3882635|NCT01546038|3707856|B6|||Age||Years|Mean|74.5|74.5|Standard Deviation|4.9|4.9|||
3882636|NCT01546038|3707857|B5|||Age||Years|Mean|76.2|76.2|Standard Deviation|6.2|6.2|||
3882637|NCT01546038|3707858|B4|||Age||Years|Mean|61.9|61.9|Standard Deviation|9.6|9.6|||
3882638|NCT01546038|3707859|B3|||Age||Years|Mean|54.9|54.9|Standard Deviation|12.7|12.7|||
3882639|NCT01546038|3707860|B2|||Age||Years|Mean|75.0|75.0|Standard Deviation|4.4|4.4|||
3882640|NCT01546038|3707861|B1|||Age||Years|Mean|75.8|75.8|Standard Deviation|6.5|6.5|||
3882641|NCT01545843|3708029|B4||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3882642|NCT01545843|3708030|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3882643|NCT01545843|3708031|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3882644|NCT01545843|3708032|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3882645|NCT01545843|3708029|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3882646|NCT01545843|3708030|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3882647|NCT01545843|3708031|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3882648|NCT01545843|3708032|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3882649|NCT01545843|3708029|B4|||Age||years|Mean|25.4|25.4|Standard Deviation|6.6|6.6|||
3882650|NCT01545843|3708030|B3|||Age||years|Mean|25.7|25.7|Standard Deviation|7.0|7.0|||
3882651|NCT01545843|3708031|B2|||Age||years|Mean|24.4|24.4|Standard Deviation|5.6|5.6|||
3882652|NCT01545843|3708032|B1|||Age||years|Mean|26.4|26.4|Standard Deviation|7.4|7.4|||
3882653|NCT01545765|3708063|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
3882654|NCT01545765|3708063|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3882655|NCT01545765|3708063|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3882656|NCT01545765|3708063|B1|||Age||years|Mean|47.2|47.2|Standard Deviation|1.27|1.27|||
3882657|NCT01545765|3708063|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3882658|NCT01545765|3708063|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3882659|NCT01545765|3708063|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3882660|NCT01545700|3708074|B7|United States||Region of Enrollment||participants|Number|200|200.0||||||
3882661|NCT01545700|3708075|B6|United States||Region of Enrollment||participants|Number|33|33.0||||||
3882662|NCT01545700|3708076|B5|United States||Region of Enrollment||participants|Number|33|33.0||||||
3882663|NCT01545700|3708077|B4|United States||Region of Enrollment||participants|Number|34|34.0||||||
3882664|NCT01545700|3708078|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
3882665|NCT01545700|3708079|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
3882666|NCT01545700|3708080|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
3882667|NCT01545700|3708074|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3882668|NCT01545700|3708075|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3882669|NCT01545700|3708076|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3882670|NCT01545700|3708077|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3882671|NCT01545700|3708078|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3882672|NCT01545700|3708079|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3882673|NCT01545700|3708080|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3882674|NCT01545700|3708074|B7||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
3882675|NCT01545700|3708075|B6||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3882676|NCT01545700|3708076|B5||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3882677|NCT01545700|3708077|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3882678|NCT01545700|3708078|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3882679|NCT01545700|3708079|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3882680|NCT01545700|3708080|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3882681|NCT01545700|3708074|B7|||Age||years|Mean|54|54.0|Standard Deviation|9|9.0|||
3882682|NCT01545700|3708075|B6|||Age||years|Mean|56|56.0|Standard Deviation|11|11.0|||
3882683|NCT01545700|3708076|B5|||Age||years|Mean|53|53.0|Standard Deviation|13|13.0|||
3882684|NCT01545700|3708077|B4|||Age||years|Mean|57|57.0|Standard Deviation|12|12.0|||
3882685|NCT01545700|3708078|B3|||Age||years|Mean|53|53.0|Standard Deviation|11|11.0|||
3882686|NCT01545700|3708079|B2|||Age||years|Mean|53|53.0|Standard Deviation|9|9.0|||
3882687|NCT01545700|3708080|B1|||Age||years|Mean|53|53.0|Standard Deviation|10|10.0|||
3882688|NCT01545700|3708074|B7||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
3882689|NCT01545700|3708075|B6||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3882690|NCT01545700|3708076|B5||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3882691|NCT01545700|3708077|B4||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3882692|NCT01545700|3708078|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3882693|NCT01545700|3708079|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3882694|NCT01545700|3708080|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3882695|NCT01545700|3708074|B7||Between 18 and 65 years|Age||Participants|Count of Participants|169|169.0||||||
3882696|NCT01545700|3708075|B6||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3882697|NCT01545700|3708076|B5||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3882698|NCT01545700|3708077|B4||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3882699|NCT01545700|3708078|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3882700|NCT01545700|3708079|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3882701|NCT01545700|3708080|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3882702|NCT01545700|3708074|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3882703|NCT01545700|3708075|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3882704|NCT01545700|3708076|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3882705|NCT01545700|3708077|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3882706|NCT01545700|3708078|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3882707|NCT01545700|3708079|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3882708|NCT01545700|3708080|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3882709|NCT01545583|3708119|B10|United Kingdom||Region of Enrollment||participants|Number|56|56.0||||||
3882710|NCT01545583|3708120|B9|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3882711|NCT01545583|3708121|B8|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3882712|NCT01545583|3708122|B7|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3882713|NCT01545583|3708123|B6|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3882714|NCT01545583|3708124|B5|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3882715|NCT01545583|3708125|B4|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3882716|NCT01545583|3708126|B3|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3882717|NCT01545583|3708127|B2|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
3882718|NCT01545583|3708128|B1|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
3882719|NCT01545583|3708119|B10||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3882720|NCT01545583|3708120|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882721|NCT01545583|3708121|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3882722|NCT01545583|3708122|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882723|NCT01545583|3708123|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3882724|NCT01545583|3708124|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3882725|NCT01545583|3708125|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882726|NCT01545583|3708126|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3882727|NCT01545583|3708127|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3882728|NCT01545583|3708128|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882729|NCT01545583|3708119|B10||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882730|NCT01545583|3708120|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882731|NCT01545583|3708121|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882732|NCT01545583|3708122|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882733|NCT01545583|3708123|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882734|NCT01545583|3708124|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882735|NCT01545583|3708125|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882736|NCT01545583|3708126|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882737|NCT01545583|3708127|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882738|NCT01545583|3708128|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882739|NCT01545583|3708119|B10||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3882740|NCT01545583|3708120|B9||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3882741|NCT01545583|3708121|B8||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3882742|NCT01545583|3708122|B7||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3882743|NCT01545583|3708123|B6||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3882744|NCT01545583|3708124|B5||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3882745|NCT01545583|3708125|B4||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3882746|NCT01545583|3708126|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3882747|NCT01545583|3708127|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3882748|NCT01545583|3708128|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3882749|NCT01545583|3708119|B10||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3882750|NCT01545583|3708120|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3882751|NCT01545583|3708121|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3882752|NCT01545583|3708122|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3882753|NCT01545583|3708123|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882754|NCT01545583|3708124|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3882755|NCT01545583|3708125|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882756|NCT01545583|3708126|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882757|NCT01545583|3708127|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882758|NCT01545583|3708128|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3882759|NCT01545583|3708119|B10||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882760|NCT01545583|3708120|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882761|NCT01545583|3708121|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882762|NCT01545583|3708122|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882763|NCT01545583|3708123|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882764|NCT01545583|3708124|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882765|NCT01545583|3708125|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882766|NCT01545583|3708126|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882767|NCT01545583|3708127|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882768|NCT01545583|3708128|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882769|NCT01545583|3708119|B10||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3882770|NCT01545583|3708120|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3882771|NCT01545583|3708121|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3882772|NCT01545583|3708122|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882773|NCT01545583|3708123|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3882774|NCT01545583|3708124|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3882775|NCT01545583|3708125|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3882776|NCT01545583|3708126|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882777|NCT01545583|3708127|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882778|NCT01545583|3708128|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3882779|NCT01545583|3708119|B10||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882780|NCT01545583|3708120|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882781|NCT01545583|3708121|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882782|NCT01545583|3708122|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882783|NCT01545583|3708123|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882784|NCT01545583|3708124|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882785|NCT01545583|3708125|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882786|NCT01545583|3708126|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882787|NCT01545583|3708127|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882788|NCT01545583|3708128|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882789|NCT01545583|3708119|B10||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882790|NCT01545583|3708120|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882791|NCT01545583|3708121|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882792|NCT01545583|3708122|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882793|NCT01545583|3708123|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882794|NCT01545583|3708124|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882795|NCT01545583|3708125|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882796|NCT01545583|3708126|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882797|NCT01545583|3708127|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882798|NCT01545583|3708128|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882799|NCT01545583|3708119|B10||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3882800|NCT01545583|3708120|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3882801|NCT01545583|3708121|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3882802|NCT01545583|3708122|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3882803|NCT01545583|3708123|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3882804|NCT01545583|3708124|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3882805|NCT01545583|3708125|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3882806|NCT01545583|3708126|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3882807|NCT01545583|3708127|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3882808|NCT01545583|3708128|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3882809|NCT01545583|3708119|B10||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3882810|NCT01545583|3708120|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882811|NCT01545583|3708121|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882812|NCT01545583|3708122|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882813|NCT01545583|3708123|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882814|NCT01545583|3708124|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882815|NCT01545583|3708125|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882816|NCT01545583|3708126|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3882817|NCT01545583|3708127|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882818|NCT01545583|3708128|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882819|NCT01545583|3708119|B10||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3882820|NCT01545583|3708120|B9||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3882821|NCT01545583|3708121|B8||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3882822|NCT01545583|3708122|B7||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3882823|NCT01545583|3708123|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3882824|NCT01545583|3708124|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3882825|NCT01545583|3708125|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3882826|NCT01545583|3708126|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3882827|NCT01545583|3708127|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3882828|NCT01545583|3708128|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3882829|NCT01545583|3708119|B10||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3882830|NCT01545583|3708120|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3882831|NCT01545583|3708121|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3882832|NCT01545583|3708122|B7||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3882833|NCT01545583|3708123|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3882834|NCT01545583|3708124|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3882835|NCT01545583|3708125|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3882836|NCT01545583|3708126|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3882837|NCT01545583|3708127|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3882838|NCT01545583|3708128|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3882839|NCT01545583|3708119|B10|||Age||years|Mean|35.3|35.3|Standard Deviation|13.02|13.02|||
3882840|NCT01545583|3708120|B9|||Age||years|Mean|33.0|33.0|Standard Deviation|11.68|11.68|||
3882841|NCT01545583|3708121|B8|||Age||years|Mean|47.0|47.0|Standard Deviation|14.68|14.68|||
3882842|NCT01545583|3708122|B7|||Age||years|Mean|41.3|41.3|Standard Deviation|17.25|17.25|||
3882843|NCT01545583|3708123|B6|||Age||years|Mean|43.2|43.2|Standard Deviation|17.42|17.42|||
3882844|NCT01545583|3708124|B5|||Age||years|Mean|30.2|30.2|Standard Deviation|8.59|8.59|||
3882845|NCT01545583|3708125|B4|||Age||years|Mean|36.5|36.5|Standard Deviation|9.71|9.71|||
3882846|NCT01545583|3708126|B3|||Age||years|Mean|29.7|29.7|Standard Deviation|8.48|8.48|||
3882847|NCT01545583|3708127|B2|||Age||years|Mean|27.0|27.0|Standard Deviation|11.31|11.31|||
3882848|NCT01545583|3708128|B1|||Age||years|Mean|29.8|29.8|Standard Deviation|9.19|9.19|||
3882849|NCT01545518|3708188|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3882850|NCT01545518|3708188|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3882851|NCT01545518|3708188|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3882852|NCT01545518|3708188|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3882853|NCT01545518|3708188|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3882854|NCT01545518|3708188|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3882855|NCT01545388|3708192|B4|||Fasting plasma glucose (FPG)||mg/dL|Mean|153.95|153.95|Standard Deviation|29.42|29.42|||
3882856|NCT01545388|3708193|B3|||Fasting plasma glucose (FPG)||mg/dL|Mean|154.27|154.27|Standard Deviation|27.51|27.51|||
3882857|NCT01545388|3708194|B2|||Fasting plasma glucose (FPG)||mg/dL|Mean|148.98|148.98|Standard Deviation|26.27|26.27|||
3882858|NCT01545388|3708195|B1|||Fasting plasma glucose (FPG)||mg/dL|Mean|158.58|158.58|Standard Deviation|32.45|32.45|||
3882859|NCT01545388|3708192|B4|||Hemoglobin A1c (HbA1c)||Percent of glycosylated hemoglobin|Mean|7.51|7.51|Standard Deviation|0.76|0.76|||
3882860|NCT01545388|3708193|B3|||Hemoglobin A1c (HbA1c)||Percent of glycosylated hemoglobin|Mean|7.53|7.53|Standard Deviation|0.77|0.77|||
3882861|NCT01545388|3708194|B2|||Hemoglobin A1c (HbA1c)||Percent of glycosylated hemoglobin|Mean|7.40|7.4|Standard Deviation|0.68|0.68|||
3882862|NCT01545388|3708195|B1|||Hemoglobin A1c (HbA1c)||Percent of glycosylated hemoglobin|Mean|7.60|7.6|Standard Deviation|0.83|0.83|||
3882863|NCT01545388|3708192|B4||Male|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
3882864|NCT01545388|3708193|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3882865|NCT01545388|3708194|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3882866|NCT01545388|3708195|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3882867|NCT01545388|3708192|B4||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3882868|NCT01545388|3708193|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3882869|NCT01545388|3708194|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3882870|NCT01545388|3708195|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3882871|NCT01545388|3708192|B4|||Age||Years|Mean|59.65|59.65|Standard Deviation|9.37|9.37|||
3882872|NCT01545388|3708193|B3|||Age||Years|Mean|60.05|60.05|Standard Deviation|9.30|9.3|||
3882873|NCT01545388|3708194|B2|||Age||Years|Mean|59.65|59.65|Standard Deviation|9.22|9.22|||
3882874|NCT01545388|3708195|B1|||Age||Years|Mean|59.46|59.46|Standard Deviation|9.61|9.61|||
3882875|NCT01545375|3708214|B3|American indian or Alaskan native|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|1803|1803.0||||||
3882876|NCT01545375|3708215|B2|American indian or Alaskan native|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|903|903.0||||||
3882877|NCT01545375|3708216|B1|American indian or Alaskan native|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|900|900.0||||||
3882878|NCT01545375|3708214|B3||Male|Sex: Female, Male||Participants|Count of Participants|903|903.0||||||
3882879|NCT01545375|3708215|B2||Male|Sex: Female, Male||Participants|Count of Participants|462|462.0||||||
3882880|NCT01545375|3708216|B1||Male|Sex: Female, Male||Participants|Count of Participants|441|441.0||||||
3882881|NCT01545375|3708214|B3||Female|Sex: Female, Male||Participants|Count of Participants|900|900.0||||||
3882882|NCT01545375|3708215|B2||Female|Sex: Female, Male||Participants|Count of Participants|441|441.0||||||
3882883|NCT01545375|3708216|B1||Female|Sex: Female, Male||Participants|Count of Participants|459|459.0||||||
3882884|NCT01545375|3708214|B3|||Age||Weeks|Mean|7.6|7.6|Standard Deviation|1.67|1.67|||
3882885|NCT01545375|3708215|B2|||Age||Weeks|Mean|7.6|7.6|Standard Deviation|1.65|1.65|||
3882886|NCT01545375|3708216|B1|||Age||Weeks|Mean|7.7|7.7|Standard Deviation|1.69|1.69|||
3882887|NCT01545336|3708265|B3|||Six minute walk distance||meters|Mean|350|350.0|Standard Deviation|131|131.0|||
3882888|NCT01545336|3708266|B2|||Six minute walk distance||meters|Mean|378|378.0|Standard Deviation|161|161.0|||
3882889|NCT01545336|3708267|B1|||Six minute walk distance||meters|Mean|336|336.0|Standard Deviation|119|119.0|||
3882890|NCT01545336|3708265|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
3882891|NCT01545336|3708266|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3882892|NCT01545336|3708267|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3882893|NCT01545336|3708265|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882894|NCT01545336|3708266|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882895|NCT01545336|3708267|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882896|NCT01545336|3708265|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882897|NCT01545336|3708266|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882898|NCT01545336|3708267|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882899|NCT01545336|3708265|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3882900|NCT01545336|3708266|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3882901|NCT01545336|3708267|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3882902|NCT01545336|3708265|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3882903|NCT01545336|3708266|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882904|NCT01545336|3708267|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3882905|NCT01545336|3708265|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882906|NCT01545336|3708266|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882907|NCT01545336|3708267|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882908|NCT01545336|3708265|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882909|NCT01545336|3708266|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882910|NCT01545336|3708267|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882911|NCT01545336|3708265|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882912|NCT01545336|3708266|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882913|NCT01545336|3708267|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882914|NCT01545336|3708265|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882915|NCT01545336|3708266|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882916|NCT01545336|3708267|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882917|NCT01545336|3708265|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3882918|NCT01545336|3708266|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3882919|NCT01545336|3708267|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3882920|NCT01545336|3708265|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3882921|NCT01545336|3708266|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882922|NCT01545336|3708267|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3882923|NCT01545336|3708265|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3882924|NCT01545336|3708266|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3882925|NCT01545336|3708267|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3882926|NCT01545336|3708265|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3882927|NCT01545336|3708266|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3882928|NCT01545336|3708267|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3882929|NCT01545336|3708265|B3|||Age||years|Mean|60.06|60.06|Standard Deviation|11.5|11.5|||
3882930|NCT01545336|3708266|B2|||Age||years|Mean|59|59.0|Standard Deviation|10|10.0|||
3882931|NCT01545336|3708267|B1|||Age||years|Mean|61|61.0|Standard Deviation|13|13.0|||
3882932|NCT01545232|3708278|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3882933|NCT01545232|3708279|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3882934|NCT01545232|3708280|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3882935|NCT01545232|3708278|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3882936|NCT01545232|3708279|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882937|NCT01545232|3708280|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3882938|NCT01545232|3708278|B3||White|Race (NIH/OMB)||Participants|Count of Participants|434|434.0||||||
3882939|NCT01545232|3708279|B2||White|Race (NIH/OMB)||Participants|Count of Participants|224|224.0||||||
3882940|NCT01545232|3708280|B1||White|Race (NIH/OMB)||Participants|Count of Participants|210|210.0||||||
3882941|NCT01545232|3708278|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|186|186.0||||||
3882942|NCT01545232|3708279|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
3882943|NCT01545232|3708280|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
3882944|NCT01545232|3708278|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3882945|NCT01545232|3708279|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3882946|NCT01545232|3708280|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3882947|NCT01545232|3708278|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3882948|NCT01545232|3708279|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3882949|NCT01545232|3708280|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3882950|NCT01545232|3708278|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3882951|NCT01545232|3708279|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3882952|NCT01545232|3708280|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3882953|NCT01545232|3708278|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882954|NCT01545232|3708279|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882955|NCT01545232|3708280|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3882956|NCT01545232|3708278|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|560|560.0||||||
3882957|NCT01545232|3708279|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|283|283.0||||||
3882958|NCT01545232|3708280|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|277|277.0||||||
3882959|NCT01545232|3708278|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
3882960|NCT01545232|3708279|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3882961|NCT01545232|3708280|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3882962|NCT01545232|3708278|B3||Male|Sex: Female, Male||Participants|Count of Participants|546|546.0||||||
3882963|NCT01545232|3708279|B2||Male|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
3882964|NCT01545232|3708280|B1||Male|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
3882965|NCT01545232|3708278|B3||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3882966|NCT01545232|3708279|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3882967|NCT01545232|3708280|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3882968|NCT01545232|3708278|B3|||Age, Customized|15 years of age or older|participants|Number|680|680.0||||||
3882969|NCT01545232|3708279|B2|||Age, Customized|15 years of age or older|participants|Number|342|342.0||||||
3882970|NCT01545232|3708280|B1|||Age, Customized|15 years of age or older|participants|Number|338|338.0||||||
3882971|NCT01545193|3708309|B3|United States||Region of Enrollment||participants|Number|299|299.0||||||
3882972|NCT01545193|3708310|B2|United States||Region of Enrollment||participants|Number|149|149.0||||||
3882973|NCT01545193|3708311|B1|United States||Region of Enrollment||participants|Number|150|150.0||||||
3882974|NCT01545193|3708309|B3||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3882975|NCT01545193|3708310|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3882976|NCT01545193|3708311|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3882977|NCT01545193|3708309|B3||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3882978|NCT01545193|3708310|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3882979|NCT01545193|3708311|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3882980|NCT01545193|3708309|B3|||Age||years|Median|57|57.0|Inter-Quartile Range|||51.0|63.0|
3882981|NCT01545193|3708310|B2|||Age||years|Median|75|75.0|Inter-Quartile Range|||72.0|80.0|
3882982|NCT01545193|3708311|B1|||Age||years|Median|38|38.0|Inter-Quartile Range|||30.0|46.0|
3882983|NCT01545193|3708309|B3||>=65 years|Age||Participants|Count of Participants|149|149.0||||||
3882984|NCT01545193|3708310|B2||>=65 years|Age||Participants|Count of Participants|149|149.0||||||
3882985|NCT01545193|3708311|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3882986|NCT01545193|3708309|B3||Between 18 and 65 years|Age||Participants|Count of Participants|150|150.0||||||
3882987|NCT01545193|3708310|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3882988|NCT01545193|3708311|B1||Between 18 and 65 years|Age||Participants|Count of Participants|150|150.0||||||
3882989|NCT01545193|3708309|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3882990|NCT01545193|3708310|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3882991|NCT01545193|3708311|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3882992|NCT01545076|3708324|B1|Estonia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3882993|NCT01545076|3708324|B1|Germany||Region of Enrollment||Participants|Count of Participants|51|51.0||||||
3882994|NCT01545076|3708324|B1|France||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3882995|NCT01545076|3708324|B1|Australia||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3882996|NCT01545076|3708324|B1|Israel||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3882997|NCT01545076|3708324|B1|Italy||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3882998|NCT01545076|3708324|B1|Poland||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3882999|NCT01545076|3708324|B1|Finland||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3883000|NCT01545076|3708324|B1|Belgium||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3883001|NCT01545076|3708324|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3883002|NCT01545076|3708324|B1|Canada||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3883003|NCT01545076|3708324|B1|Spain||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3883004|NCT01545076|3708324|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3883005|NCT01545076|3708324|B1|Japan||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3883006|NCT01545076|3708324|B1|Czechia||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3883007|NCT01545076|3708324|B1|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3883008|NCT01545076|3708324|B1||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3883009|NCT01545076|3708324|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3883010|NCT01545076|3708324|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|12.76|12.76|||
3883011|NCT01545076|3708324|B1||>=65 years|Age||Participants|Count of Participants|57|57.0||||||
3883012|NCT01545076|3708324|B1||Between 18 and 65 years|Age||Participants|Count of Participants|150|150.0||||||
3883013|NCT01545076|3708324|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3883014|NCT01544998|3708378|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
3883015|NCT01544998|3708378|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3883016|NCT01544998|3708378|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3883017|NCT01544998|3708378|B1|||Age||years|Mean|69.3|69.3|Standard Deviation|11.9|11.9|||
3883018|NCT01544998|3708378|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3883019|NCT01544998|3708378|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3883020|NCT01544998|3708378|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3883021|NCT01544920|3708397|B3||Male|Sex: Female, Male||Participants|Count of Participants|422|422.0||||||
3883022|NCT01544920|3708398|B2||Male|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
3883023|NCT01544920|3708399|B1||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3883024|NCT01544920|3708397|B3||Female|Sex: Female, Male||Participants|Count of Participants|315|315.0||||||
3883025|NCT01544920|3708398|B2||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3883026|NCT01544920|3708399|B1||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3883027|NCT01544920|3708397|B3|||Age||Years|Mean|43.1|43.1|Standard Deviation|12.2|12.2|||
3883028|NCT01544920|3708398|B2|||Age||Years|Mean|42.4|42.4|Standard Deviation|12.4|12.4|||
3883029|NCT01544920|3708399|B1|||Age||Years|Mean|43.9|43.9|Standard Deviation|12.0|12.0|||
3883030|NCT01544595|3708408|B7|Other||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3883031|NCT01544595|3708409|B6|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3883032|NCT01544595|3708410|B5|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3883033|NCT01544595|3708411|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3883034|NCT01544595|3708412|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3883035|NCT01544595|3708413|B2|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3883036|NCT01544595|3708414|B1|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3883037|NCT01544595|3708408|B7|Unknown||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3883038|NCT01544595|3708409|B6|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3883039|NCT01544595|3708410|B5|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3883040|NCT01544595|3708411|B4|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3883041|NCT01544595|3708412|B3|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3883042|NCT01544595|3708413|B2|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3883043|NCT01544595|3708414|B1|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3883044|NCT01544595|3708408|B7|Pacific Islander||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3883045|NCT01544595|3708409|B6|Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3883046|NCT01544595|3708410|B5|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3883047|NCT01544595|3708411|B4|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3883048|NCT01544595|3708412|B3|Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3883049|NCT01544595|3708413|B2|Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3883050|NCT01544595|3708414|B1|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3883051|NCT01544595|3708408|B7|Native American||Race/Ethnicity, Customized||participants|Number|75|75.0||||||
3883052|NCT01544595|3708409|B6|Native American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3883053|NCT01544595|3708410|B5|Native American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3883054|NCT01544595|3708411|B4|Native American||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3883055|NCT01544595|3708412|B3|Native American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3883056|NCT01544595|3708413|B2|Native American||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3883057|NCT01544595|3708414|B1|Native American||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3883058|NCT01544595|3708408|B7|Asian||Race/Ethnicity, Customized||participants|Number|173|173.0||||||
3883059|NCT01544595|3708409|B6|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3883060|NCT01544595|3708410|B5|Asian||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3883061|NCT01544595|3708411|B4|Asian||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3883062|NCT01544595|3708412|B3|Asian||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3883063|NCT01544595|3708413|B2|Asian||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
3883064|NCT01544595|3708414|B1|Asian||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
3883065|NCT01544595|3708408|B7|Black||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3883066|NCT01544595|3708409|B6|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3883067|NCT01544595|3708410|B5|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3883068|NCT01544595|3708411|B4|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3883069|NCT01544595|3708412|B3|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3883070|NCT01544595|3708413|B2|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3883071|NCT01544595|3708414|B1|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3883072|NCT01544595|3708408|B7|Caucasian||Race/Ethnicity, Customized||participants|Number|855|855.0||||||
3883073|NCT01544595|3708409|B6|Caucasian||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
3883074|NCT01544595|3708410|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|73|73.0||||||
3883075|NCT01544595|3708411|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|136|136.0||||||
3883076|NCT01544595|3708412|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|115|115.0||||||
3883077|NCT01544595|3708413|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|276|276.0||||||
3883078|NCT01544595|3708414|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|213|213.0||||||
3883079|NCT01544595|3708408|B7||Male|Sex: Female, Male||Participants|Count of Participants|816|816.0||||||
3883080|NCT01544595|3708409|B6||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3883081|NCT01544595|3708410|B5||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3883082|NCT01544595|3708411|B4||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3883083|NCT01544595|3708412|B3||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3883084|NCT01544595|3708413|B2||Male|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
3883085|NCT01544595|3708414|B1||Male|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
3883086|NCT01544595|3708408|B7||Female|Sex: Female, Male||Participants|Count of Participants|330|330.0||||||
3883087|NCT01544595|3708409|B6||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3883088|NCT01544595|3708410|B5||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3883089|NCT01544595|3708411|B4||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3883090|NCT01544595|3708412|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3883091|NCT01544595|3708413|B2||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3883092|NCT01544595|3708414|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3883093|NCT01544595|3708408|B7|||Age||years|Mean|46.2|46.2|Standard Deviation|12.84|12.84|||
3883094|NCT01544595|3708409|B6|||Age||years|Mean|48.5|48.5|Standard Deviation|11.98|11.98|||
3883095|NCT01544595|3708410|B5|||Age||years|Mean|46.8|46.8|Standard Deviation|12.78|12.78|||
3883096|NCT01544595|3708411|B4|||Age||years|Mean|45.4|45.4|Standard Deviation|13.09|13.09|||
3883097|NCT01544595|3708412|B3|||Age||years|Mean|47.1|47.1|Standard Deviation|13.34|13.34|||
3883098|NCT01544595|3708413|B2|||Age||years|Mean|45.8|45.8|Standard Deviation|12.92|12.92|||
3883099|NCT01544595|3708414|B1|||Age||years|Mean|45.9|45.9|Standard Deviation|12.93|12.93|||
3883100|NCT01544582|3708492|B4||Male|Sex: Female, Male||Participants|Count of Participants|439|439.0||||||
3883101|NCT01544582|3708493|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3883102|NCT01544582|3708494|B2||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
3883103|NCT01544582|3708495|B1||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
3883104|NCT01544582|3708492|B4||Female|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
3883105|NCT01544582|3708493|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3883106|NCT01544582|3708494|B2||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3883107|NCT01544582|3708495|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3883108|NCT01544582|3708492|B4|||Age||years|Mean|50.3|50.3|Standard Deviation|10.8|10.8|||
3883109|NCT01544582|3708493|B3|||Age||years|Mean|46.3|46.3|Standard Deviation|11.6|11.6|||
3883110|NCT01544582|3708494|B2|||Age||years|Mean|50.1|50.1|Standard Deviation|10.9|10.9|||
3883111|NCT01544582|3708495|B1|||Age||years|Mean|51.4|51.4|Standard Deviation|10.3|10.3|||
3883112|NCT01544478|3708556|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1030|1030.0||||||
3883113|NCT01544478|3708556|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3883114|NCT01544478|3708556|B1||Female|Sex: Female, Male||Participants|Count of Participants|1030|1030.0||||||
3883115|NCT01544478|3708556|B1|||Age||Years|Mean|22.9|22.9|Standard Deviation|2.2|2.2|||
3883116|NCT01544361|3708560|B6||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3883117|NCT01544361|3708561|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3883118|NCT01544361|3708562|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3883119|NCT01544361|3708563|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3883120|NCT01544361|3708564|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3883121|NCT01544361|3708565|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3883122|NCT01544361|3708560|B6||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3883123|NCT01544361|3708561|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3883124|NCT01544361|3708562|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3883125|NCT01544361|3708563|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3883126|NCT01544361|3708564|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3883127|NCT01544361|3708565|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3883128|NCT01544361|3708560|B6|||Age||Years|Mean|33.5|33.5|Standard Deviation|9.1|9.1|||
3883129|NCT01544361|3708561|B5|||Age||Years|Mean|42.8|42.8|Standard Deviation|4.0|4.0|||
3883130|NCT01544361|3708562|B4|||Age||Years|Mean|28.0|28.0|Standard Deviation|8.9|8.9|||
3883131|NCT01544361|3708563|B3|||Age||Years|Mean|36.5|36.5|Standard Deviation|6.7|6.7|||
3883132|NCT01544361|3708564|B2|||Age||Years|Mean|28.5|28.5|Standard Deviation|6.8|6.8|||
3883133|NCT01544361|3708565|B1|||Age||Years|Mean|32.3|32.3|Standard Deviation|9.9|9.9|||
3883134|NCT01544348|3708591|B9||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3883135|NCT01544348|3708592|B8||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3883136|NCT01544348|3708593|B7||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3883137|NCT01544348|3708594|B6||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3883138|NCT01544348|3708595|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3883139|NCT01544348|3708596|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3883140|NCT01544348|3708597|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3883141|NCT01544348|3708598|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3883142|NCT01544348|3708599|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3883143|NCT01544348|3708591|B9||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3883144|NCT01544348|3708592|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3883145|NCT01544348|3708593|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3883146|NCT01544348|3708594|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3883147|NCT01544348|3708595|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3883148|NCT01544348|3708596|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3883149|NCT01544348|3708597|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3883150|NCT01544348|3708598|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3883151|NCT01544348|3708599|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3883152|NCT01544348|3708591|B9|||Age||years|Mean|39.0|39.0|Standard Deviation|11.2|11.2|||
3883153|NCT01544348|3708592|B8|||Age||years|Mean|38.0|38.0|Standard Deviation|8.6|8.6|||
3883154|NCT01544348|3708593|B7|||Age||years|Mean|35.9|35.9|Standard Deviation|13.1|13.1|||
3883155|NCT01544348|3708594|B6|||Age||years|Mean|40.3|40.3|Standard Deviation|11.1|11.1|||
3883156|NCT01544348|3708595|B5|||Age||years|Mean|38.7|38.7|Standard Deviation|12.5|12.5|||
3883157|NCT01544348|3708596|B4|||Age||years|Mean|40.3|40.3|Standard Deviation|9.6|9.6|||
3883158|NCT01544348|3708597|B3|||Age||years|Mean|44.7|44.7|Standard Deviation|3.2|3.2|||
3883159|NCT01544348|3708598|B2|||Age||years|Mean|39.3|39.3|Standard Deviation|9.2|9.2|||
3883160|NCT01544348|3708599|B1|||Age||years|Mean|39.6|39.6|Standard Deviation|12.6|12.6|||
3883161|NCT01544309|3708646|B3|||1,5-anhydro-D-glucitol (1,5-AG)||μg/mL|Mean|15.40|15.4|Standard Deviation|8.01|8.01|||
3883162|NCT01544309|3708647|B2|||1,5-anhydro-D-glucitol (1,5-AG)||μg/mL|Mean|15.39|15.39|Standard Deviation|8.10|8.1|||
3883163|NCT01544309|3708648|B1|||1,5-anhydro-D-glucitol (1,5-AG)||μg/mL|Mean|15.40|15.4|Standard Deviation|7.91|7.91|||
3883164|NCT01544309|3708646|B3|||Insulin||μU/mL|Mean|11.77|11.77|Standard Deviation|19.39|19.39|||
3883165|NCT01544309|3708647|B2|||Insulin||μU/mL|Mean|12.57|12.57|Standard Deviation|20.07|20.07|||
3883166|NCT01544309|3708648|B1|||Insulin||μU/mL|Mean|10.95|10.95|Standard Deviation|18.66|18.66|||
3883167|NCT01544309|3708646|B3|||Blood glucose||mg/dL|Mean|118.9|118.9|Standard Deviation|29.2|29.2|||
3883168|NCT01544309|3708647|B2|||Blood glucose||mg/dL|Mean|119.1|119.1|Standard Deviation|31.2|31.2|||
3883169|NCT01544309|3708648|B1|||Blood glucose||mg/dL|Mean|118.8|118.8|Standard Deviation|27.0|27.0|||
3883170|NCT01544309|3708646|B3|||HbA1c||% (NGSP value)|Mean|6.39|6.39|Standard Deviation|0.63|0.63|||
3883171|NCT01544309|3708647|B2|||HbA1c||% (NGSP value)|Mean|6.40|6.4|Standard Deviation|0.66|0.66|||
3883172|NCT01544309|3708648|B1|||HbA1c||% (NGSP value)|Mean|6.38|6.38|Standard Deviation|0.59|0.59|||
3883173|NCT01544309|3708646|B3|||Free fatty acids (FFA)||mEq/L|Mean|0.584|0.584|Standard Deviation|0.298|0.298|||
3883174|NCT01544309|3708647|B2|||Free fatty acids (FFA)||mEq/L|Mean|0.584|0.584|Standard Deviation|0.299|0.299|||
3883175|NCT01544309|3708648|B1|||Free fatty acids (FFA)||mEq/L|Mean|0.585|0.585|Standard Deviation|0.297|0.297|||
3883176|NCT01544309|3708646|B3|||LDL-C/HDL-C ratio||ratio|Mean|2.69|2.69|Standard Deviation|0.86|0.86|||
3883177|NCT01544309|3708647|B2|||LDL-C/HDL-C ratio||ratio|Mean|2.73|2.73|Standard Deviation|0.91|0.91|||
3883178|NCT01544309|3708648|B1|||LDL-C/HDL-C ratio||ratio|Mean|2.66|2.66|Standard Deviation|0.81|0.81|||
3883179|NCT01544309|3708646|B3|||Non-HDL-C/HDL-C ratio||ratio|Mean|3.30|3.3|Standard Deviation|1.20|1.2|||
3883180|NCT01544309|3708647|B2|||Non-HDL-C/HDL-C ratio||ratio|Mean|3.36|3.36|Standard Deviation|1.31|1.31|||
3883181|NCT01544309|3708648|B1|||Non-HDL-C/HDL-C ratio||ratio|Mean|3.25|3.25|Standard Deviation|1.07|1.07|||
3883182|NCT01544309|3708646|B3|||Triglyceride (TG)||mg/dL|Mean|152.1|152.1|Standard Deviation|115.8|115.8|||
3883183|NCT01544309|3708647|B2|||Triglyceride (TG)||mg/dL|Mean|154.5|154.5|Standard Deviation|137.1|137.1|||
3883184|NCT01544309|3708648|B1|||Triglyceride (TG)||mg/dL|Mean|149.6|149.6|Standard Deviation|89.1|89.1|||
3883185|NCT01544309|3708646|B3|||Total cholesterol (TC)||mg/dL|Mean|223.9|223.9|Standard Deviation|34.0|34.0|||
3883186|NCT01544309|3708647|B2|||Total cholesterol (TC)||mg/dL|Mean|223.0|223.0|Standard Deviation|36.0|36.0|||
3883187|NCT01544309|3708648|B1|||Total cholesterol (TC)||mg/dL|Mean|224.8|224.8|Standard Deviation|31.8|31.8|||
3883188|NCT01544309|3708646|B3|||HDL-C||mg/dL|Mean|54.9|54.9|Standard Deviation|14.1|14.1|||
3883189|NCT01544309|3708647|B2|||HDL-C||mg/dL|Mean|54.1|54.1|Standard Deviation|13.6|13.6|||
3883190|NCT01544309|3708648|B1|||HDL-C||mg/dL|Mean|55.8|55.8|Standard Deviation|14.6|14.6|||
3883191|NCT01544309|3708646|B3|||Low-density lipoprotein cholesterol (LDL-C)||mg/dL|Mean|139.4|139.4|Standard Deviation|30.0|30.0|||
3883192|NCT01544309|3708647|B2|||Low-density lipoprotein cholesterol (LDL-C)||mg/dL|Mean|139.2|139.2|Standard Deviation|31.9|31.9|||
3883193|NCT01544309|3708648|B1|||Low-density lipoprotein cholesterol (LDL-C)||mg/dL|Mean|139.6|139.6|Standard Deviation|27.9|27.9|||
3883194|NCT01544309|3708646|B3|||Non-high-density lipoprotein cholesterol (HDL-C)||mg/dL|Mean|168.9|168.9|Standard Deviation|33.3|33.3|||
3883254|NCT01544309|3708646|B3|With events||Cardiac arrhythmias||participants|Number|57|57.0||||||
3883195|NCT01544309|3708647|B2|||Non-high-density lipoprotein cholesterol (HDL-C)||mg/dL|Mean|168.9|168.9|Standard Deviation|35.8|35.8|||
3883196|NCT01544309|3708648|B1|||Non-high-density lipoprotein cholesterol (HDL-C)||mg/dL|Mean|169.0|169.0|Standard Deviation|30.6|30.6|||
3883197|NCT01544309|3708646|B3|Without hypertension||Hypertension||participants|Number|373|373.0||||||
3883198|NCT01544309|3708647|B2|Without hypertension||Hypertension||participants|Number|176|176.0||||||
3883199|NCT01544309|3708648|B1|Without hypertension||Hypertension||participants|Number|197|197.0||||||
3883200|NCT01544309|3708646|B3|With hypertension||Hypertension||participants|Number|645|645.0||||||
3883201|NCT01544309|3708647|B2|With hypertension||Hypertension||participants|Number|338|338.0||||||
3883202|NCT01544309|3708648|B1|With hypertension||Hypertension||participants|Number|307|307.0||||||
3883203|NCT01544309|3708646|B3|Without diabetic foot||Diabetic foot||participants|Number|1017|1017.0||||||
3883204|NCT01544309|3708647|B2|Without diabetic foot||Diabetic foot||participants|Number|513|513.0||||||
3883205|NCT01544309|3708648|B1|Without diabetic foot||Diabetic foot||participants|Number|504|504.0||||||
3883206|NCT01544309|3708646|B3|With diabetic foot||Diabetic foot||participants|Number|1|1.0||||||
3883207|NCT01544309|3708647|B2|With diabetic foot||Diabetic foot||participants|Number|1|1.0||||||
3883208|NCT01544309|3708648|B1|With diabetic foot||Diabetic foot||participants|Number|0|0.0||||||
3883209|NCT01544309|3708646|B3|Without diabetic neuropathy||Diabetic neuropathy||participants|Number|972|972.0||||||
3883210|NCT01544309|3708647|B2|Without diabetic neuropathy||Diabetic neuropathy||participants|Number|491|491.0||||||
3883211|NCT01544309|3708648|B1|Without diabetic neuropathy||Diabetic neuropathy||participants|Number|481|481.0||||||
3883212|NCT01544309|3708646|B3|With diabetic neuropathy||Diabetic neuropathy||participants|Number|46|46.0||||||
3883213|NCT01544309|3708647|B2|With diabetic neuropathy||Diabetic neuropathy||participants|Number|23|23.0||||||
3883214|NCT01544309|3708648|B1|With diabetic neuropathy||Diabetic neuropathy||participants|Number|23|23.0||||||
3883215|NCT01544309|3708646|B3|Without diabetic nephropathy||Diabetic nephropathy||participants|Number|984|984.0||||||
3883216|NCT01544309|3708647|B2|Without diabetic nephropathy||Diabetic nephropathy||participants|Number|493|493.0||||||
3883217|NCT01544309|3708648|B1|Without diabetic nephropathy||Diabetic nephropathy||participants|Number|491|491.0||||||
3883218|NCT01544309|3708646|B3|With diabetic nephropathy||Diabetic nephropathy||participants|Number|34|34.0||||||
3883219|NCT01544309|3708647|B2|With diabetic nephropathy||Diabetic nephropathy||participants|Number|21|21.0||||||
3883220|NCT01544309|3708648|B1|With diabetic nephropathy||Diabetic nephropathy||participants|Number|13|13.0||||||
3883221|NCT01544309|3708646|B3|Without diabetic retinopathy||Diabetic retinopathy||participants|Number|1005|1005.0||||||
3883222|NCT01544309|3708647|B2|Without diabetic retinopathy||Diabetic retinopathy||participants|Number|505|505.0||||||
3883223|NCT01544309|3708648|B1|Without diabetic retinopathy||Diabetic retinopathy||participants|Number|500|500.0||||||
3883224|NCT01544309|3708646|B3|With diabetic retinopathy||Diabetic retinopathy||participants|Number|13|13.0||||||
3883225|NCT01544309|3708647|B2|With diabetic retinopathy||Diabetic retinopathy||participants|Number|9|9.0||||||
3883226|NCT01544309|3708648|B1|With diabetic retinopathy||Diabetic retinopathy||participants|Number|4|4.0||||||
3883227|NCT01544309|3708646|B3|Without diabetic complications||Complications related to diabetes||participants|Number|902|902.0||||||
3883228|NCT01544309|3708647|B2|Without diabetic complications||Complications related to diabetes||participants|Number|447|447.0||||||
3883229|NCT01544309|3708648|B1|Without diabetic complications||Complications related to diabetes||participants|Number|455|455.0||||||
3883230|NCT01544309|3708646|B3|With diabetic complications||Complications related to diabetes||participants|Number|116|116.0||||||
3883231|NCT01544309|3708647|B2|With diabetic complications||Complications related to diabetes||participants|Number|67|67.0||||||
3883232|NCT01544309|3708648|B1|With diabetic complications||Complications related to diabetes||participants|Number|49|49.0||||||
3883233|NCT01544309|3708646|B3|Without events||Transient ischaemic attack||participants|Number|1009|1009.0||||||
3883234|NCT01544309|3708647|B2|Without events||Transient ischaemic attack||participants|Number|510|510.0||||||
3883235|NCT01544309|3708648|B1|Without events||Transient ischaemic attack||participants|Number|499|499.0||||||
3883236|NCT01544309|3708646|B3|With events||Transient ischaemic attack||participants|Number|9|9.0||||||
3883237|NCT01544309|3708647|B2|With events||Transient ischaemic attack||participants|Number|4|4.0||||||
3883238|NCT01544309|3708648|B1|With events||Transient ischaemic attack||participants|Number|5|5.0||||||
3883239|NCT01544309|3708646|B3|Without events||Cerebral infarction||participants|Number|967|967.0||||||
3883240|NCT01544309|3708647|B2|Without events||Cerebral infarction||participants|Number|484|484.0||||||
3883241|NCT01544309|3708648|B1|Without events||Cerebral infarction||participants|Number|483|483.0||||||
3883242|NCT01544309|3708646|B3|With events||Cerebral infarction||participants|Number|51|51.0||||||
3883243|NCT01544309|3708647|B2|With events||Cerebral infarction||participants|Number|30|30.0||||||
3883244|NCT01544309|3708648|B1|With events||Cerebral infarction||participants|Number|21|21.0||||||
3883245|NCT01544309|3708646|B3|Without events||Cerebral haemorrhage||participants|Number|1009|1009.0||||||
3883246|NCT01544309|3708647|B2|Without events||Cerebral haemorrhage||participants|Number|508|508.0||||||
3883247|NCT01544309|3708648|B1|Without events||Cerebral haemorrhage||participants|Number|501|501.0||||||
3883248|NCT01544309|3708646|B3|With events||Cerebral haemorrhage||participants|Number|9|9.0||||||
3883249|NCT01544309|3708647|B2|With events||Cerebral haemorrhage||participants|Number|6|6.0||||||
3883250|NCT01544309|3708648|B1|With events||Cerebral haemorrhage||participants|Number|3|3.0||||||
3883251|NCT01544309|3708646|B3|Without events||Cardiac arrhythmias||participants|Number|961|961.0||||||
3883252|NCT01544309|3708647|B2|Without events||Cardiac arrhythmias||participants|Number|488|488.0||||||
3883253|NCT01544309|3708648|B1|Without events||Cardiac arrhythmias||participants|Number|473|473.0||||||
3883255|NCT01544309|3708647|B2|With events||Cardiac arrhythmias||participants|Number|26|26.0||||||
3883256|NCT01544309|3708648|B1|With events||Cardiac arrhythmias||participants|Number|31|31.0||||||
3883257|NCT01544309|3708646|B3|Without events||Revascularization||participants|Number|1006|1006.0||||||
3883258|NCT01544309|3708647|B2|Without events||Revascularization||participants|Number|505|505.0||||||
3883259|NCT01544309|3708648|B1|Without events||Revascularization||participants|Number|501|501.0||||||
3883260|NCT01544309|3708646|B3|With events||Revascularization||participants|Number|12|12.0||||||
3883261|NCT01544309|3708647|B2|With events||Revascularization||participants|Number|9|9.0||||||
3883262|NCT01544309|3708648|B1|With events||Revascularization||participants|Number|3|3.0||||||
3883263|NCT01544309|3708646|B3|Without events||Heart failure||participants|Number|1000|1000.0||||||
3883264|NCT01544309|3708647|B2|Without events||Heart failure||participants|Number|506|506.0||||||
3883265|NCT01544309|3708648|B1|Without events||Heart failure||participants|Number|494|494.0||||||
3883266|NCT01544309|3708646|B3|With events||Heart failure||participants|Number|18|18.0||||||
3883267|NCT01544309|3708647|B2|With events||Heart failure||participants|Number|8|8.0||||||
3883268|NCT01544309|3708648|B1|With events||Heart failure||participants|Number|10|10.0||||||
3883269|NCT01544309|3708646|B3|Without events||Angina pectoris||participants|Number|956|956.0||||||
3883270|NCT01544309|3708647|B2|Without events||Angina pectoris||participants|Number|483|483.0||||||
3883271|NCT01544309|3708648|B1|Without events||Angina pectoris||participants|Number|473|473.0||||||
3883272|NCT01544309|3708646|B3|With events||Angina pectoris||participants|Number|62|62.0||||||
3883273|NCT01544309|3708647|B2|With events||Angina pectoris||participants|Number|31|31.0||||||
3883274|NCT01544309|3708648|B1|With events||Angina pectoris||participants|Number|31|31.0||||||
3883275|NCT01544309|3708646|B3|Without events||Myocardial infarction||participants|Number|1004|1004.0||||||
3883276|NCT01544309|3708647|B2|Without events||Myocardial infarction||participants|Number|507|507.0||||||
3883277|NCT01544309|3708648|B1|Without events||Myocardial infarction||participants|Number|497|497.0||||||
3883278|NCT01544309|3708646|B3|With events||Myocardial infarction||participants|Number|14|14.0||||||
3883279|NCT01544309|3708647|B2|With events||Myocardial infarction||participants|Number|7|7.0||||||
3883280|NCT01544309|3708648|B1|With events||Myocardial infarction||participants|Number|7|7.0||||||
3883281|NCT01544309|3708646|B3|Without events||Cardiovascular and Cerebrovascular events before entry||participants|Number|812|812.0||||||
3883282|NCT01544309|3708647|B2|Without events||Cardiovascular and Cerebrovascular events before entry||participants|Number|411|411.0||||||
3883283|NCT01544309|3708648|B1|Without events||Cardiovascular and Cerebrovascular events before entry||participants|Number|401|401.0||||||
3883284|NCT01544309|3708646|B3|With events||Cardiovascular and Cerebrovascular events before entry||participants|Number|206|206.0||||||
3883285|NCT01544309|3708647|B2|With events||Cardiovascular and Cerebrovascular events before entry||participants|Number|103|103.0||||||
3883286|NCT01544309|3708648|B1|With events||Cardiovascular and Cerebrovascular events before entry||participants|Number|103|103.0||||||
3883287|NCT01544309|3708646|B3|Not administered||Statin administration before entry||participants|Number|777|777.0||||||
3883288|NCT01544309|3708647|B2|Not administered||Statin administration before entry||participants|Number|393|393.0||||||
3883289|NCT01544309|3708648|B1|Not administered||Statin administration before entry||participants|Number|384|384.0||||||
3883290|NCT01544309|3708646|B3|Administered||Statin administration before entry||participants|Number|241|241.0||||||
3883291|NCT01544309|3708647|B2|Administered||Statin administration before entry||participants|Number|121|121.0||||||
3883292|NCT01544309|3708648|B1|Administered||Statin administration before entry||participants|Number|120|120.0||||||
3883293|NCT01544309|3708646|B3|Male||Sex/Gender, Customized||participants|Number|1018|1018.0||||||
3883294|NCT01544309|3708647|B2|Male||Sex/Gender, Customized||participants|Number|514|514.0||||||
3883295|NCT01544309|3708648|B1|Male||Sex/Gender, Customized||participants|Number|504|504.0||||||
3883296|NCT01544309|3708646|B3|||Age||years|Mean|66.4|66.4|Standard Deviation|11.1|11.1|||
3883297|NCT01544309|3708647|B2|||Age||years|Mean|66.3|66.3|Standard Deviation|11.6|11.6|||
3883298|NCT01544309|3708648|B1|||Age||years|Mean|66.6|66.6|Standard Deviation|10.6|10.6|||
3883299|NCT01544179|3708685|B3|White||Race/Ethnicity, Customized||Participants|Number|58|58.0||||||
3883300|NCT01544179|3708686|B2|White||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
3883301|NCT01544179|3708687|B1|White||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
3883302|NCT01544179|3708685|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3883303|NCT01544179|3708686|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3883304|NCT01544179|3708687|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3883305|NCT01544179|3708685|B3|Asian||Race/Ethnicity, Customized||Participants|Number|206|206.0||||||
3883306|NCT01544179|3708686|B2|Asian||Race/Ethnicity, Customized||Participants|Number|102|102.0||||||
3883307|NCT01544179|3708687|B1|Asian||Race/Ethnicity, Customized||Participants|Number|104|104.0||||||
3883308|NCT01544179|3708685|B3||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3883309|NCT01544179|3708686|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3883310|NCT01544179|3708687|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3883311|NCT01544179|3708685|B3||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3883312|NCT01544179|3708686|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3883313|NCT01544179|3708687|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3883314|NCT01544179|3708685|B3|>=65 years||Age, Customized||Participants|Number|77|77.0||||||
3883315|NCT01544179|3708686|B2|>=65 years||Age, Customized||Participants|Number|34|34.0||||||
3883316|NCT01544179|3708687|B1|>=65 years||Age, Customized||Participants|Number|43|43.0||||||
3883317|NCT01544179|3708685|B3|<65 years||Age, Customized||Participants|Number|188|188.0||||||
3883318|NCT01544179|3708686|B2|<65 years||Age, Customized||Participants|Number|98|98.0||||||
3883319|NCT01544179|3708687|B1|<65 years||Age, Customized||Participants|Number|90|90.0||||||
3883320|NCT01544166|3708716|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3883321|NCT01544166|3708716|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3883322|NCT01544166|3708716|B1|Infants and toddlers (28 days-23 months)||Age, Customized||Participants|Number|39|39.0||||||
3883323|NCT01544166|3708716|B1|Newborns (0-27 days)||Age, Customized||Participants|Number|5|5.0||||||
3883324|NCT01544166|3708716|B1|||Age||months|Mean|8.8|8.8|Standard Deviation|7.1|7.1|||
3883325|NCT01544153|3708777|B5|Unknown or Not Reported||Marital Status||Participants|Count of Participants|0|0.0||||||
3883326|NCT01544153|3708778|B4|Unknown or Not Reported||Marital Status||Participants|Count of Participants|0|0.0||||||
3883327|NCT01544153|3708779|B3|Unknown or Not Reported||Marital Status||Participants|Count of Participants|0|0.0||||||
3883328|NCT01544153|3708780|B2|Unknown or Not Reported||Marital Status||Participants|Count of Participants|0|0.0||||||
3883329|NCT01544153|3708781|B1|Unknown or Not Reported||Marital Status||Participants|Count of Participants|0|0.0||||||
3883330|NCT01544153|3708777|B5|No Partner||Marital Status||Participants|Count of Participants|2555|2555.0||||||
3883331|NCT01544153|3708778|B4|No Partner||Marital Status||Participants|Count of Participants|656|656.0||||||
3883332|NCT01544153|3708779|B3|No Partner||Marital Status||Participants|Count of Participants|648|648.0||||||
3883333|NCT01544153|3708780|B2|No Partner||Marital Status||Participants|Count of Participants|609|609.0||||||
3883334|NCT01544153|3708781|B1|No Partner||Marital Status||Participants|Count of Participants|642|642.0||||||
3883335|NCT01544153|3708777|B5|Has a Partner||Marital Status||Participants|Count of Participants|2735|2735.0||||||
3883336|NCT01544153|3708778|B4|Has a Partner||Marital Status||Participants|Count of Participants|661|661.0||||||
3883337|NCT01544153|3708779|B3|Has a Partner||Marital Status||Participants|Count of Participants|665|665.0||||||
3883338|NCT01544153|3708780|B2|Has a Partner||Marital Status||Participants|Count of Participants|714|714.0||||||
3883339|NCT01544153|3708781|B1|Has a Partner||Marital Status||Participants|Count of Participants|695|695.0||||||
3883340|NCT01544153|3708777|B5|Unkown or Not Reported||Employment||Participants|Count of Participants|0|0.0||||||
3883341|NCT01544153|3708778|B4|Unkown or Not Reported||Employment||Participants|Count of Participants|0|0.0||||||
3883342|NCT01544153|3708779|B3|Unkown or Not Reported||Employment||Participants|Count of Participants|0|0.0||||||
3883343|NCT01544153|3708780|B2|Unkown or Not Reported||Employment||Participants|Count of Participants|0|0.0||||||
3883344|NCT01544153|3708781|B1|Unkown or Not Reported||Employment||Participants|Count of Participants|0|0.0||||||
3883345|NCT01544153|3708777|B5|Not Employed Full-Time||Employment||Participants|Count of Participants|2888|2888.0||||||
3883346|NCT01544153|3708778|B4|Not Employed Full-Time||Employment||Participants|Count of Participants|734|734.0||||||
3883347|NCT01544153|3708779|B3|Not Employed Full-Time||Employment||Participants|Count of Participants|705|705.0||||||
3883348|NCT01544153|3708780|B2|Not Employed Full-Time||Employment||Participants|Count of Participants|709|709.0||||||
3883349|NCT01544153|3708781|B1|Not Employed Full-Time||Employment||Participants|Count of Participants|740|740.0||||||
3883350|NCT01544153|3708777|B5|Employed Full-Time||Employment||Participants|Count of Participants|2402|2402.0||||||
3883351|NCT01544153|3708778|B4|Employed Full-Time||Employment||Participants|Count of Participants|583|583.0||||||
3883352|NCT01544153|3708779|B3|Employed Full-Time||Employment||Participants|Count of Participants|608|608.0||||||
3883353|NCT01544153|3708780|B2|Employed Full-Time||Employment||Participants|Count of Participants|614|614.0||||||
3883354|NCT01544153|3708781|B1|Employed Full-Time||Employment||Participants|Count of Participants|597|597.0||||||
3883355|NCT01544153|3708777|B5|Unknown or Not Reported||Education||Participants|Count of Participants|0|0.0||||||
3883356|NCT01544153|3708778|B4|Unknown or Not Reported||Education||Participants|Count of Participants|0|0.0||||||
3883357|NCT01544153|3708779|B3|Unknown or Not Reported||Education||Participants|Count of Participants|0|0.0||||||
3883358|NCT01544153|3708780|B2|Unknown or Not Reported||Education||Participants|Count of Participants|0|0.0||||||
3883359|NCT01544153|3708781|B1|Unknown or Not Reported||Education||Participants|Count of Participants|0|0.0||||||
3883360|NCT01544153|3708777|B5|College Graduate||Education||Participants|Count of Participants|1212|1212.0||||||
3883361|NCT01544153|3708778|B4|College Graduate||Education||Participants|Count of Participants|285|285.0||||||
3883362|NCT01544153|3708779|B3|College Graduate||Education||Participants|Count of Participants|303|303.0||||||
3883363|NCT01544153|3708780|B2|College Graduate||Education||Participants|Count of Participants|315|315.0||||||
3883364|NCT01544153|3708781|B1|College Graduate||Education||Participants|Count of Participants|309|309.0||||||
3883365|NCT01544153|3708777|B5|Some College||Education||Participants|Count of Participants|2631|2631.0||||||
3883366|NCT01544153|3708778|B4|Some College||Education||Participants|Count of Participants|658|658.0||||||
3883367|NCT01544153|3708779|B3|Some College||Education||Participants|Count of Participants|658|658.0||||||
3883368|NCT01544153|3708780|B2|Some College||Education||Participants|Count of Participants|672|672.0||||||
3883369|NCT01544153|3708781|B1|Some College||Education||Participants|Count of Participants|643|643.0||||||
3883370|NCT01544153|3708777|B5|High School Graduate||Education||Participants|Count of Participants|1200|1200.0||||||
3883371|NCT01544153|3708778|B4|High School Graduate||Education||Participants|Count of Participants|309|309.0||||||
3883372|NCT01544153|3708779|B3|High School Graduate||Education||Participants|Count of Participants|293|293.0||||||
3883373|NCT01544153|3708780|B2|High School Graduate||Education||Participants|Count of Participants|279|279.0||||||
3883374|NCT01544153|3708781|B1|High School Graduate||Education||Participants|Count of Participants|319|319.0||||||
3883375|NCT01544153|3708777|B5|Some High School or Less||Education||Participants|Count of Participants|247|247.0||||||
3883376|NCT01544153|3708778|B4|Some High School or Less||Education||Participants|Count of Participants|65|65.0||||||
3883377|NCT01544153|3708779|B3|Some High School or Less||Education||Participants|Count of Participants|59|59.0||||||
3883378|NCT01544153|3708780|B2|Some High School or Less||Education||Participants|Count of Participants|57|57.0||||||
3883379|NCT01544153|3708781|B1|Some High School or Less||Education||Participants|Count of Participants|66|66.0||||||
3883380|NCT01544153|3708777|B5|United States||Region of Enrollment||participants|Number|5290|5290.0||||||
3883381|NCT01544153|3708778|B4|United States||Region of Enrollment||participants|Number|1317|1317.0||||||
3883382|NCT01544153|3708779|B3|United States||Region of Enrollment||participants|Number|1313|1313.0||||||
3883383|NCT01544153|3708780|B2|United States||Region of Enrollment||participants|Number|1323|1323.0||||||
3883384|NCT01544153|3708781|B1|United States||Region of Enrollment||participants|Number|1337|1337.0||||||
3883385|NCT01544153|3708777|B5||Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3883386|NCT01544153|3708778|B4||Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3883387|NCT01544153|3708779|B3||Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3883388|NCT01544153|3708780|B2||Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3883389|NCT01544153|3708781|B1||Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3883390|NCT01544153|3708777|B5||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|4996|4996.0||||||
3883391|NCT01544153|3708778|B4||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|1246|1246.0||||||
3883392|NCT01544153|3708779|B3||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|1252|1252.0||||||
3883393|NCT01544153|3708780|B2||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|1241|1241.0||||||
3883394|NCT01544153|3708781|B1||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|1257|1257.0||||||
3883395|NCT01544153|3708777|B5||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|294|294.0||||||
3883396|NCT01544153|3708778|B4||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|71|71.0||||||
3883397|NCT01544153|3708779|B3||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|61|61.0||||||
3883398|NCT01544153|3708780|B2||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|82|82.0||||||
3883399|NCT01544153|3708781|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|80|80.0||||||
3883400|NCT01544153|3708777|B5||Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3883401|NCT01544153|3708778|B4||Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3883402|NCT01544153|3708779|B3||Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3883403|NCT01544153|3708780|B2||Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3883404|NCT01544153|3708781|B1||Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3883405|NCT01544153|3708777|B5||More than one race|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3883406|NCT01544153|3708778|B4||More than one race|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3883407|NCT01544153|3708779|B3||More than one race|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3883408|NCT01544153|3708780|B2||More than one race|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3883409|NCT01544153|3708781|B1||More than one race|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3883410|NCT01544153|3708777|B5||White|Race/Ethnicity, Customized||Participants|Count of Participants|4237|4237.0||||||
3883411|NCT01544153|3708778|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|1060|1060.0||||||
3883412|NCT01544153|3708779|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|1044|1044.0||||||
3883413|NCT01544153|3708780|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|1073|1073.0||||||
3883414|NCT01544153|3708781|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|1060|1060.0||||||
3883415|NCT01544153|3708777|B5||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|802|802.0||||||
3883416|NCT01544153|3708778|B4||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|184|184.0||||||
3883417|NCT01544153|3708779|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|209|209.0||||||
3883418|NCT01544153|3708780|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|193|193.0||||||
3883419|NCT01544153|3708781|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|216|216.0||||||
3883420|NCT01544153|3708777|B5||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|55|55.0||||||
3883421|NCT01544153|3708778|B4||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3883422|NCT01544153|3708779|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3883423|NCT01544153|3708780|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3883424|NCT01544153|3708781|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3883425|NCT01544153|3708777|B5||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|82|82.0||||||
3883426|NCT01544153|3708778|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3883427|NCT01544153|3708779|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3883428|NCT01544153|3708780|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3883429|NCT01544153|3708781|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3883430|NCT01544153|3708777|B5||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|114|114.0||||||
3883431|NCT01544153|3708778|B4||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3883432|NCT01544153|3708779|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3883433|NCT01544153|3708780|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3883434|NCT01544153|3708781|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3883435|NCT01544153|3708777|B5||Male|Sex/Gender, Customized||Participants|Count of Participants|2073|2073.0||||||
3883436|NCT01544153|3708778|B4||Male|Sex/Gender, Customized||Participants|Count of Participants|519|519.0||||||
3883437|NCT01544153|3708779|B3||Male|Sex/Gender, Customized||Participants|Count of Participants|525|525.0||||||
3883438|NCT01544153|3708780|B2||Male|Sex/Gender, Customized||Participants|Count of Participants|514|514.0||||||
3883439|NCT01544153|3708781|B1||Male|Sex/Gender, Customized||Participants|Count of Participants|515|515.0||||||
3883440|NCT01544153|3708777|B5||Female|Sex/Gender, Customized||Participants|Count of Participants|3217|3217.0||||||
3883441|NCT01544153|3708778|B4||Female|Sex/Gender, Customized||Participants|Count of Participants|798|798.0||||||
3883442|NCT01544153|3708779|B3||Female|Sex/Gender, Customized||Participants|Count of Participants|788|788.0||||||
3883443|NCT01544153|3708780|B2||Female|Sex/Gender, Customized||Participants|Count of Participants|809|809.0||||||
3883444|NCT01544153|3708781|B1||Female|Sex/Gender, Customized||Participants|Count of Participants|822|822.0||||||
3883445|NCT01544153|3708777|B5|>=65 years||Age, Customized||Participants|Count of Participants|226|226.0||||||
3883446|NCT01544153|3708778|B4|>=65 years||Age, Customized||Participants|Count of Participants|52|52.0||||||
3883447|NCT01544153|3708779|B3|>=65 years||Age, Customized||Participants|Count of Participants|50|50.0||||||
3883448|NCT01544153|3708780|B2|>=65 years||Age, Customized||Participants|Count of Participants|58|58.0||||||
3883449|NCT01544153|3708781|B1|>=65 years||Age, Customized||Participants|Count of Participants|66|66.0||||||
3883450|NCT01544153|3708777|B5|45-64 years old||Age, Customized||Participants|Count of Participants|2121|2121.0||||||
3883451|NCT01544153|3708778|B4|45-64 years old||Age, Customized||Participants|Count of Participants|510|510.0||||||
3883452|NCT01544153|3708779|B3|45-64 years old||Age, Customized||Participants|Count of Participants|522|522.0||||||
3883453|NCT01544153|3708780|B2|45-64 years old||Age, Customized||Participants|Count of Participants|522|522.0||||||
3883454|NCT01544153|3708781|B1|45-64 years old||Age, Customized||Participants|Count of Participants|567|567.0||||||
3883455|NCT01544153|3708777|B5|25-44 years old||Age, Customized||Participants|Count of Participants|2395|2395.0||||||
3883456|NCT01544153|3708778|B4|25-44 years old||Age, Customized||Participants|Count of Participants|606|606.0||||||
3883457|NCT01544153|3708779|B3|25-44 years old||Age, Customized||Participants|Count of Participants|601|601.0||||||
3883458|NCT01544153|3708780|B2|25-44 years old||Age, Customized||Participants|Count of Participants|615|615.0||||||
3883459|NCT01544153|3708781|B1|25-44 years old||Age, Customized||Participants|Count of Participants|573|573.0||||||
3883460|NCT01544153|3708777|B5|18-24 years old||Age, Customized||Participants|Count of Participants|548|548.0||||||
3883461|NCT01544153|3708778|B4|18-24 years old||Age, Customized||Participants|Count of Participants|149|149.0||||||
3883462|NCT01544153|3708779|B3|18-24 years old||Age, Customized||Participants|Count of Participants|140|140.0||||||
3883463|NCT01544153|3708780|B2|18-24 years old||Age, Customized||Participants|Count of Participants|128|128.0||||||
3883464|NCT01544153|3708781|B1|18-24 years old||Age, Customized||Participants|Count of Participants|131|131.0||||||
3883465|NCT01544153|3708777|B5|< 18 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3883466|NCT01544153|3708778|B4|< 18 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3883467|NCT01544153|3708779|B3|< 18 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3883468|NCT01544153|3708780|B2|< 18 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3883469|NCT01544153|3708781|B1|< 18 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3883470|NCT01544114|3708798|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3883471|NCT01544114|3708799|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3883472|NCT01544114|3708800|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3883473|NCT01544114|3708801|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3883474|NCT01544114|3708798|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3883475|NCT01544114|3708799|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3883476|NCT01544114|3708800|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3883477|NCT01544114|3708801|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3883478|NCT01544114|3708798|B4|Age Group|16 years old|Age, Customized||Participants|Count of Participants|4|4.0||||||
3883479|NCT01544114|3708799|B3|Age Group|16 years old|Age, Customized||Participants|Count of Participants|2|2.0||||||
3883480|NCT01544114|3708800|B2|Age Group|16 years old|Age, Customized||Participants|Count of Participants|2|2.0||||||
3883481|NCT01544114|3708801|B1|Age Group|16 years old|Age, Customized||Participants|Count of Participants|0|0.0||||||
3883482|NCT01544114|3708798|B4|Age Group|15 years old|Age, Customized||Participants|Count of Participants|12|12.0||||||
3883483|NCT01544114|3708799|B3|Age Group|15 years old|Age, Customized||Participants|Count of Participants|7|7.0||||||
3883484|NCT01544114|3708800|B2|Age Group|15 years old|Age, Customized||Participants|Count of Participants|5|5.0||||||
3883485|NCT01544114|3708801|B1|Age Group|15 years old|Age, Customized||Participants|Count of Participants|0|0.0||||||
3883486|NCT01544114|3708798|B4|Age Group|14 years old|Age, Customized||Participants|Count of Participants|5|5.0||||||
3883487|NCT01544114|3708799|B3|Age Group|14 years old|Age, Customized||Participants|Count of Participants|2|2.0||||||
3883488|NCT01544114|3708800|B2|Age Group|14 years old|Age, Customized||Participants|Count of Participants|2|2.0||||||
3883489|NCT01544114|3708801|B1|Age Group|14 years old|Age, Customized||Participants|Count of Participants|1|1.0||||||
3883490|NCT01544114|3708798|B4|Age Group|13 years old|Age, Customized||Participants|Count of Participants|12|12.0||||||
3883491|NCT01544114|3708799|B3|Age Group|13 years old|Age, Customized||Participants|Count of Participants|7|7.0||||||
3883492|NCT01544114|3708800|B2|Age Group|13 years old|Age, Customized||Participants|Count of Participants|4|4.0||||||
3883493|NCT01544114|3708801|B1|Age Group|13 years old|Age, Customized||Participants|Count of Participants|1|1.0||||||
3883494|NCT01544114|3708798|B4|Age Group|12 years old|Age, Customized||Participants|Count of Participants|13|13.0||||||
3883495|NCT01544114|3708799|B3|Age Group|12 years old|Age, Customized||Participants|Count of Participants|4|4.0||||||
3883496|NCT01544114|3708800|B2|Age Group|12 years old|Age, Customized||Participants|Count of Participants|7|7.0||||||
3883497|NCT01544114|3708801|B1|Age Group|12 years old|Age, Customized||Participants|Count of Participants|2|2.0||||||
3883498|NCT01544114|3708798|B4|||Age||years|Mean|13.6|13.6|Standard Deviation|1.37|1.37|||
3883499|NCT01544114|3708799|B3|||Age||years|Mean|13.8|13.8|Standard Deviation|1.33|1.33|||
3883500|NCT01544114|3708800|B2|||Age||years|Mean|13.6|13.6|Standard Deviation|1.47|1.47|||
3883501|NCT01544114|3708801|B1|||Age||years|Mean|12.8|12.8|Standard Deviation|0.96|0.96|||
3883502|NCT01544062|3708832|B3|United States||Region of Enrollment||participants|Number|68|68.0||||||
3883503|NCT01544062|3708833|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
3883504|NCT01544062|3708834|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
3883505|NCT01544062|3708832|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3883506|NCT01544062|3708833|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3883507|NCT01544062|3708834|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3883508|NCT01544062|3708832|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3883509|NCT01544062|3708833|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3883510|NCT01544062|3708834|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3883511|NCT01544062|3708832|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3883512|NCT01544062|3708833|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3883513|NCT01544062|3708834|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3883514|NCT01544062|3708832|B3||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3883515|NCT01544062|3708833|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3883516|NCT01544062|3708834|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3883517|NCT01544062|3708832|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3883518|NCT01544062|3708833|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3883519|NCT01544062|3708834|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3883520|NCT01544023|3708881|B1|Germany||Region of Enrollment||participants|Number|207|207.0||||||
3883521|NCT01544023|3708881|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3883522|NCT01544023|3708881|B1||Female|Gender||Participants|Count of Participants|207|207.0||||||
3883523|NCT01544023|3708881|B1|||Age||years|Mean|47|47.0|Standard Deviation|11.6|11.6|||
3883524|NCT01543958|3708886|B1|||CD4 count||cells/mm^3|Median|580|580.0|Inter-Quartile Range|||494.0|716.0|
3883525|NCT01543958|3708886|B1|||Log10 HIV-1 RNA||copies/mL|Median|3.58|3.58|Inter-Quartile Range|||2.94|4.17|
3883526|NCT01543958|3708886|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3883527|NCT01543958|3708886|B1|Hispanic (regardless of Race)||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3883528|NCT01543958|3708886|B1|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3883529|NCT01543958|3708886|B1|White non-Hispanic||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3883530|NCT01543958|3708886|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3883531|NCT01543958|3708886|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3883532|NCT01543958|3708886|B1|||Age||years|Median|44|44.0|Inter-Quartile Range|||34.0|51.0|
3883533|NCT01543958|3708886|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3883534|NCT01543958|3708886|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3883535|NCT01543958|3708886|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3883536|NCT01543828|3708939|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3883537|NCT01543828|3708940|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3883538|NCT01543828|3708941|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3883539|NCT01543828|3708939|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3883540|NCT01543828|3708940|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3883541|NCT01543828|3708941|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3883542|NCT01543828|3708939|B3|||Age||years|Mean|61.5|61.5|Standard Deviation|8.68|8.68|||
3883543|NCT01543828|3708940|B2|||Age||years|Mean|60.8|60.8|Standard Deviation|6.90|6.9|||
3883544|NCT01543828|3708941|B1|||Age||years|Mean|62.2|62.2|Standard Deviation|10.29|10.29|||
3883545|NCT01543685|3708950|B6|United States||Region of Enrollment||participants|Number|462|462.0||||||
3883546|NCT01543685|3708951|B5|United States||Region of Enrollment||participants|Number|94|94.0||||||
3883547|NCT01543685|3708952|B4|United States||Region of Enrollment||participants|Number|93|93.0||||||
3883548|NCT01543685|3708953|B3|United States||Region of Enrollment||participants|Number|91|91.0||||||
3883549|NCT01543685|3708954|B2|United States||Region of Enrollment||participants|Number|91|91.0||||||
3883550|NCT01543685|3708955|B1|United States||Region of Enrollment||participants|Number|93|93.0||||||
3883551|NCT01543685|3708950|B6||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3883552|NCT01543685|3708951|B5||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3883553|NCT01543685|3708952|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3883554|NCT01543685|3708953|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3883555|NCT01543685|3708954|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3883556|NCT01543685|3708955|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3883557|NCT01543685|3708950|B6||Female|Sex: Female, Male||Participants|Count of Participants|384|384.0||||||
3883558|NCT01543685|3708951|B5||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3883559|NCT01543685|3708952|B4||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3883560|NCT01543685|3708953|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3883561|NCT01543685|3708954|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3883562|NCT01543685|3708955|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3883563|NCT01543685|3708950|B6|||Age||years|Mean|41.2|41.2|Standard Deviation|12.5|12.5|||
3883564|NCT01543685|3708951|B5|||Age||years|Mean|40.4|40.4|Standard Deviation|13.3|13.3|||
3883565|NCT01543685|3708952|B4|||Age||years|Mean|41.5|41.5|Standard Deviation|11.4|11.4|||
3883566|NCT01543685|3708953|B3|||Age||years|Mean|41.4|41.4|Standard Deviation|12.4|12.4|||
3883567|NCT01543685|3708954|B2|||Age||years|Mean|41.5|41.5|Standard Deviation|13.4|13.4|||
3883568|NCT01543685|3708955|B1|||Age||years|Mean|41.0|41.0|Standard Deviation|12.3|12.3|||
3883569|NCT01543607|3709006|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3883570|NCT01543607|3709006|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3883571|NCT01543607|3709006|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3883572|NCT01543607|3709006|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3883573|NCT01543607|3709006|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3883574|NCT01543607|3709006|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3883575|NCT01543581|3709012|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3883576|NCT01543581|3709012|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3883577|NCT01543581|3709012|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3883578|NCT01543581|3709012|B1||>=65 years|Age||Participants|Count of Participants|00|0.0||||||
3883579|NCT01543581|3709012|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3883580|NCT01543581|3709012|B1||<=18 years|Age||Participants|Count of Participants|00|0.0||||||
3883581|NCT01543568|3709019|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
3883582|NCT01543568|3709019|B1||Male|Gender||Participants|Count of Participants|22|22.0||||||
3883583|NCT01543568|3709019|B1||Female|Gender||Participants|Count of Participants|24|24.0||||||
3883584|NCT01543568|3709019|B1|||Age||years|Mean|77.8|77.8|Full Range|||55.0|95.0|
3883585|NCT01543568|3709019|B1||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
3883586|NCT01543568|3709019|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3883587|NCT01543568|3709019|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3883588|NCT01543503|3709029|B3||Male|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
3883589|NCT01543503|3709030|B2||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
3883590|NCT01543503|3709031|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3883591|NCT01543503|3709029|B3||Female|Sex: Female, Male||Participants|Count of Participants|966|966.0||||||
3883592|NCT01543503|3709030|B2||Female|Sex: Female, Male||Participants|Count of Participants|615|615.0||||||
3883593|NCT01543503|3709031|B1||Female|Sex: Female, Male||Participants|Count of Participants|351|351.0||||||
3883594|NCT01543503|3709029|B3|||Age||years|Mean|54.85|54.85|Standard Deviation|12.95|12.95|||
3883595|NCT01543503|3709030|B2|||Age||years|Mean|55.16|55.16|Standard Deviation|13.05|13.05|||
3883596|NCT01543503|3709031|B1|||Age||years|Mean|54.26|54.26|Standard Deviation|12.75|12.75|||
3883597|NCT01543204|3709076|B1|Positive||Anti-adalimumab Antibody Status at Screening||participants|Number|43|43.0||||||
3883598|NCT01543204|3709076|B1|Negative||Anti-adalimumab Antibody Status at Screening||participants|Number|21|21.0||||||
3883599|NCT01543204|3709076|B1|Missing||Patient Assessment of Treatment Satisfaction|Participants indicated their level of satisfaction with the medication’s control of psoriasis on a scale from “very dissatisfied” to “very satisfied”. The response scale was adapted from the Medical Outcomes Study: Patient Satisfaction Survey.|participants|Number|2|2.0||||||
3883600|NCT01543204|3709076|B1|Very satisfied||Patient Assessment of Treatment Satisfaction|Participants indicated their level of satisfaction with the medication’s control of psoriasis on a scale from “very dissatisfied” to “very satisfied”. The response scale was adapted from the Medical Outcomes Study: Patient Satisfaction Survey.|participants|Number|2|2.0||||||
3883601|NCT01543204|3709076|B1|Satisfied||Patient Assessment of Treatment Satisfaction|Participants indicated their level of satisfaction with the medication’s control of psoriasis on a scale from “very dissatisfied” to “very satisfied”. The response scale was adapted from the Medical Outcomes Study: Patient Satisfaction Survey.|participants|Number|2|2.0||||||
3883602|NCT01543204|3709076|B1|Neither satisfied nor dissatisfied||Patient Assessment of Treatment Satisfaction|Participants indicated their level of satisfaction with the medication’s control of psoriasis on a scale from “very dissatisfied” to “very satisfied”. The response scale was adapted from the Medical Outcomes Study: Patient Satisfaction Survey.|participants|Number|20|20.0||||||
3883603|NCT01543204|3709076|B1|Dissatisfied||Patient Assessment of Treatment Satisfaction|Participants indicated their level of satisfaction with the medication’s control of psoriasis on a scale from “very dissatisfied” to “very satisfied”. The response scale was adapted from the Medical Outcomes Study: Patient Satisfaction Survey.|participants|Number|14|14.0||||||
3883604|NCT01543204|3709076|B1|Very dissatisfied||Patient Assessment of Treatment Satisfaction|Participants indicated their level of satisfaction with the medication’s control of psoriasis on a scale from “very dissatisfied” to “very satisfied”. The response scale was adapted from the Medical Outcomes Study: Patient Satisfaction Survey.|participants|Number|24|24.0||||||
3883605|NCT01543204|3709076|B1|||Patient Assessment of Pain|The severity of the participant's psoriasis pain assessed by the participant on a scale between 0 and 10, with 0 indicating “does not hurt at all” and 10 indicating “worst hurt imaginable.” Data were available for 63 participants.|units on a scale|Mean|5.0|5.0|Standard Deviation|3.1|3.1|||
3883606|NCT01543204|3709076|B1|||Patient Assessment of Itch|The severity of a participant's itch assessed by the participant on a scale between 0 and 10, with 0 indicating “no itch at all” and 10 indicating “worst itch imaginable.” Data were available for 63 participants.|units on a scale|Mean|6.5|6.5|Standard Deviation|2.5|2.5|||
3883607|NCT01543204|3709076|B1|||Patient Assessment of Flaking|The severity of psoriasis flaking assessed by the participant on a scale between 0 and 10, with 0 indicating “no flaking at all” and 10 indicating “worst flaking imaginable.” Data were available for 63 participants.|units on a scale|Mean|7.0|7.0|Standard Deviation|2.3|2.3|||
3883608|NCT01543204|3709076|B1|||Dermatology Life Quality Index (DLQI)|The DLQI is a skin disease-specific instrument to evaluate health related quality of life ranging from 0 (best possible score) to 30 (worst possible score). Data were available for 63 participants.|units on a scale|Mean|12.7|12.7|Standard Deviation|6.7|6.7|||
3883609|NCT01543204|3709076|B1|5 = Very severe||Static Physician Global Assessment (sPGA) of Psoriasis|A physician’s global assessment of the participant's psoriasis based on severity of induration, scaling, and erythema. The sPGA of psoriasis comprises a 6-point scale ranging from 0 (clear) to 5 (very severe) with increasing severity.|participants|Number|0|0.0||||||
3883610|NCT01543204|3709076|B1|4 = Severe||Static Physician Global Assessment (sPGA) of Psoriasis|A physician’s global assessment of the participant's psoriasis based on severity of induration, scaling, and erythema. The sPGA of psoriasis comprises a 6-point scale ranging from 0 (clear) to 5 (very severe) with increasing severity.|participants|Number|14|14.0||||||
3883611|NCT01543204|3709076|B1|3 = Moderate||Static Physician Global Assessment (sPGA) of Psoriasis|A physician’s global assessment of the participant's psoriasis based on severity of induration, scaling, and erythema. The sPGA of psoriasis comprises a 6-point scale ranging from 0 (clear) to 5 (very severe) with increasing severity.|participants|Number|50|50.0||||||
3883612|NCT01543204|3709076|B1|2 = Mild||Static Physician Global Assessment (sPGA) of Psoriasis|A physician’s global assessment of the participant's psoriasis based on severity of induration, scaling, and erythema. The sPGA of psoriasis comprises a 6-point scale ranging from 0 (clear) to 5 (very severe) with increasing severity.|participants|Number|0|0.0||||||
3883613|NCT01543204|3709076|B1|1 = Almost clear||Static Physician Global Assessment (sPGA) of Psoriasis|A physician’s global assessment of the participant's psoriasis based on severity of induration, scaling, and erythema. The sPGA of psoriasis comprises a 6-point scale ranging from 0 (clear) to 5 (very severe) with increasing severity.|participants|Number|0|0.0||||||
3883614|NCT01543204|3709076|B1|0 = Clear||Static Physician Global Assessment (sPGA) of Psoriasis|A physician’s global assessment of the participant's psoriasis based on severity of induration, scaling, and erythema. The sPGA of psoriasis comprises a 6-point scale ranging from 0 (clear) to 5 (very severe) with increasing severity.|participants|Number|0|0.0||||||
3883615|NCT01543204|3709076|B1|||Percent of Body Surface Area (BSA) Involved in Psoriasis||percentage of BSA|Mean|20.90|20.9|Standard Deviation|16.00|16.0|||
3883616|NCT01543204|3709076|B1|||Psoriasis Area Severity Index (PASI)|The psoriasis area and severity index (PASI) score incorporates measures of erythema, desquamation, infiltration, and affected body surface area. Involvement and severity of psoriasis was scored by physicians using a scale from 0 to 72, where 0 = no psoriasis and 72 = severe disease.|units on a scale|Mean|16.81|16.81|Standard Deviation|6.86|6.86|||
3883617|NCT01543204|3709076|B1|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
3883618|NCT01543204|3709076|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3883619|NCT01543204|3709076|B1|Multiple||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3883620|NCT01543204|3709076|B1|White||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
3883621|NCT01543204|3709076|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3883622|NCT01543204|3709076|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3883623|NCT01543204|3709076|B1|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3883624|NCT01543204|3709076|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3883625|NCT01543204|3709076|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3883626|NCT01543204|3709076|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3883627|NCT01543204|3709076|B1|||Age||years|Mean|46.0|46.0|Standard Deviation|12.4|12.4|||
3883628|NCT01543178|3709120|B4||Male|Sex: Female, Male||Participants|Count of Participants|819|819.0||||||
3883629|NCT01543178|3709121|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3883630|NCT01543178|3709122|B2||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3883631|NCT01543178|3709123|B1||Male|Sex: Female, Male||Participants|Count of Participants|624|624.0||||||
3883632|NCT01543178|3709120|B4||Female|Sex: Female, Male||Participants|Count of Participants|1760|1760.0||||||
3883633|NCT01543178|3709121|B3||Female|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
3883634|NCT01543178|3709122|B2||Female|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
3883635|NCT01543178|3709123|B1||Female|Sex: Female, Male||Participants|Count of Participants|1319|1319.0||||||
3883636|NCT01543178|3709120|B4|||Age||years|Mean|46.4|46.4|Standard Deviation|13.7|13.7|||
3883637|NCT01543178|3709121|B3|||Age||years|Mean|45.6|45.6|Standard Deviation|13.8|13.8|||
3883638|NCT01543178|3709122|B2|||Age||years|Mean|47.9|47.9|Standard Deviation|14.2|14.2|||
3883639|NCT01543178|3709123|B1|||Age||years|Mean|46.3|46.3|Standard Deviation|13.5|13.5|||
3883640|NCT01543178|3709120|B4||>=65 years|Age||Participants|Count of Participants|240|240.0||||||
3883641|NCT01543178|3709121|B3||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
3883642|NCT01543178|3709122|B2||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
3883643|NCT01543178|3709123|B1||>=65 years|Age||Participants|Count of Participants|172|172.0||||||
3883644|NCT01543178|3709120|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2330|2330.0||||||
3883645|NCT01543178|3709121|B3||Between 18 and 65 years|Age||Participants|Count of Participants|278|278.0||||||
3883646|NCT01543178|3709122|B2||Between 18 and 65 years|Age||Participants|Count of Participants|289|289.0||||||
3883647|NCT01543178|3709123|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1763|1763.0||||||
3883648|NCT01543178|3709120|B4||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
3883649|NCT01543178|3709121|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3883650|NCT01543178|3709122|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3883651|NCT01543178|3709123|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
3883652|NCT01543074|3709132|B5|United States||Region of Enrollment||participants|Number|23|23.0||||||
3883653|NCT01543074|3709133|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
3883654|NCT01543074|3709134|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3883655|NCT01543074|3709135|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3883656|NCT01543074|3709136|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3883657|NCT01543074|3709132|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3883658|NCT01543074|3709133|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3883659|NCT01543074|3709134|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3883660|NCT01543074|3709135|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3883661|NCT01543074|3709136|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3883662|NCT01543074|3709132|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3883663|NCT01543074|3709133|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3883664|NCT01543074|3709134|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3883665|NCT01543074|3709135|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3883666|NCT01543074|3709136|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3883667|NCT01543074|3709132|B5|||Age||years|Mean|30|30.0|Standard Deviation|14|14.0|||
3883668|NCT01543074|3709133|B4|||Age||years|Mean|33.7|33.7|Standard Deviation|18.1|18.1|||
3883669|NCT01543074|3709134|B3|||Age||years|Mean|30.8|30.8|Standard Deviation|17.2|17.2|||
3883670|NCT01543074|3709135|B2|||Age||years|Mean|29.9|29.9|Standard Deviation|10.1|10.1|||
3883671|NCT01543074|3709136|B1|||Age||years|Mean|27.8|27.8|Standard Deviation|14.1|14.1|||
3883672|NCT01542957|3709153|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3883673|NCT01542957|3709154|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3883674|NCT01542957|3709155|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3883675|NCT01542957|3709153|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3883676|NCT01542957|3709154|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3883677|NCT01542957|3709155|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3883678|NCT01542957|3709153|B3|||Age||years|Mean|49.20|49.2|Standard Deviation|11.19|11.19|||
3883679|NCT01542957|3709154|B2|||Age||years|Mean|50.06|50.06|Standard Deviation|11.03|11.03|||
3883680|NCT01542957|3709155|B1|||Age||years|Mean|48.37|48.37|Standard Deviation|11.22|11.22|||
3883681|NCT01542788|3709166|B3|Unwilling||Interferon Classification||participants|Number|132|132.0||||||
3883682|NCT01542788|3709167|B2|Unwilling||Interferon Classification||participants|Number|30|30.0||||||
3883683|NCT01542788|3709168|B1|Unwilling||Interferon Classification||participants|Number|102|102.0||||||
3883684|NCT01542788|3709166|B3|Intolerant||Interferon Classification||participants|Number|25|25.0||||||
3883685|NCT01542788|3709167|B2|Intolerant||Interferon Classification||participants|Number|8|8.0||||||
3883686|NCT01542788|3709168|B1|Intolerant||Interferon Classification||participants|Number|17|17.0||||||
3883687|NCT01542788|3709166|B3|Ineligible||Interferon Classification||participants|Number|121|121.0||||||
3883688|NCT01542788|3709167|B2|Ineligible||Interferon Classification||participants|Number|33|33.0||||||
3883689|NCT01542788|3709168|B1|Ineligible||Interferon Classification||participants|Number|88|88.0||||||
3883690|NCT01542788|3709166|B3|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|194|194.0||||||
3883691|NCT01542788|3709167|B2|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|54|54.0||||||
3883692|NCT01542788|3709168|B1|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|140|140.0||||||
3883693|NCT01542788|3709166|B3|< 6 log10 IU/mL||HCV RNA Category||participants|Number|84|84.0||||||
3883694|NCT01542788|3709167|B2|< 6 log10 IU/mL||HCV RNA Category||participants|Number|17|17.0||||||
3883695|NCT01542788|3709168|B1|< 6 log10 IU/mL||HCV RNA Category||participants|Number|67|67.0||||||
3883696|NCT01542788|3709166|B3|||HCV RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.77|0.77|||
3883697|NCT01542788|3709167|B2|||HCV RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.76|0.76|||
3883698|NCT01542788|3709168|B1|||HCV RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.77|0.77|||
3883699|NCT01542788|3709166|B3|TT||IL28 Genotype||participants|Number|32|32.0||||||
3883700|NCT01542788|3709167|B2|TT||IL28 Genotype||participants|Number|6|6.0||||||
3883701|NCT01542788|3709168|B1|TT||IL28 Genotype||participants|Number|26|26.0||||||
3883702|NCT01542788|3709166|B3|CT||IL28 Genotype||participants|Number|120|120.0||||||
3883703|NCT01542788|3709167|B2|CT||IL28 Genotype||participants|Number|36|36.0||||||
3883704|NCT01542788|3709168|B1|CT||IL28 Genotype||participants|Number|84|84.0||||||
3883705|NCT01542788|3709166|B3|CC||IL28 Genotype||participants|Number|126|126.0||||||
3883706|NCT01542788|3709167|B2|CC||IL28 Genotype||participants|Number|29|29.0||||||
3883707|NCT01542788|3709168|B1|CC||IL28 Genotype||participants|Number|97|97.0||||||
3883708|NCT01542788|3709166|B3|Genotype 3||HCV Genotype||participants|Number|135|135.0||||||
3883709|NCT01542788|3709167|B2|Genotype 3||HCV Genotype||participants|Number|37|37.0||||||
3883710|NCT01542788|3709168|B1|Genotype 3||HCV Genotype||participants|Number|98|98.0||||||
3883711|NCT01542788|3709166|B3|Genotype 2||HCV Genotype||participants|Number|143|143.0||||||
3883712|NCT01542788|3709167|B2|Genotype 2||HCV Genotype||participants|Number|34|34.0||||||
3883713|NCT01542788|3709168|B1|Genotype 2||HCV Genotype||participants|Number|109|109.0||||||
3883714|NCT01542788|3709166|B3|Yes||Cirrhosis||participants|Number|44|44.0||||||
3883715|NCT01542788|3709167|B2|Yes||Cirrhosis||participants|Number|13|13.0||||||
3883716|NCT01542788|3709168|B1|Yes||Cirrhosis||participants|Number|31|31.0||||||
3883717|NCT01542788|3709166|B3|No||Cirrhosis||participants|Number|234|234.0||||||
3883718|NCT01542788|3709167|B2|No||Cirrhosis||participants|Number|58|58.0||||||
3883719|NCT01542788|3709168|B1|No||Cirrhosis||participants|Number|176|176.0||||||
3883720|NCT01542788|3709166|B3|New Zealand||Region of Enrollment||participants|Number|6|6.0||||||
3883721|NCT01542788|3709167|B2|New Zealand||Region of Enrollment||participants|Number|0|0.0||||||
3883722|NCT01542788|3709168|B1|New Zealand||Region of Enrollment||participants|Number|6|6.0||||||
3883723|NCT01542788|3709166|B3|Australia||Region of Enrollment||participants|Number|21|21.0||||||
3883724|NCT01542788|3709167|B2|Australia||Region of Enrollment||participants|Number|3|3.0||||||
3883725|NCT01542788|3709168|B1|Australia||Region of Enrollment||participants|Number|18|18.0||||||
3883726|NCT01542788|3709166|B3|Canada||Region of Enrollment||participants|Number|23|23.0||||||
3883727|NCT01542788|3709167|B2|Canada||Region of Enrollment||participants|Number|8|8.0||||||
3883728|NCT01542788|3709168|B1|Canada||Region of Enrollment||participants|Number|15|15.0||||||
3883729|NCT01542788|3709166|B3|United States||Region of Enrollment||participants|Number|228|228.0||||||
3883730|NCT01542788|3709167|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
3883731|NCT01542788|3709168|B1|United States||Region of Enrollment||participants|Number|168|168.0||||||
3883732|NCT01542788|3709166|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3883733|NCT01542788|3709167|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3883734|NCT01542788|3709168|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3883735|NCT01542788|3709166|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3883736|NCT01542788|3709167|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3883737|NCT01542788|3709168|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3883738|NCT01542788|3709166|B3||White|Race (NIH/OMB)||Participants|Count of Participants|254|254.0||||||
3883739|NCT01542788|3709167|B2||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3883740|NCT01542788|3709168|B1||White|Race (NIH/OMB)||Participants|Count of Participants|188|188.0||||||
3883741|NCT01542788|3709166|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3883742|NCT01542788|3709167|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3883743|NCT01542788|3709168|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3883744|NCT01542788|3709166|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3883745|NCT01542788|3709167|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3883746|NCT01542788|3709168|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3883747|NCT01542788|3709166|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3883748|NCT01542788|3709167|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3883749|NCT01542788|3709168|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3883750|NCT01542788|3709166|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3883751|NCT01542788|3709167|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3883752|NCT01542788|3709168|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3883753|NCT01542788|3709166|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3883754|NCT01542788|3709167|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3883755|NCT01542788|3709168|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3883756|NCT01542788|3709166|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|248|248.0||||||
3883757|NCT01542788|3709167|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3883758|NCT01542788|3709168|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|188|188.0||||||
3883759|NCT01542788|3709166|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3883760|NCT01542788|3709167|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3883761|NCT01542788|3709168|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3883762|NCT01542788|3709166|B3||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3883763|NCT01542788|3709167|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3883764|NCT01542788|3709168|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3883765|NCT01542788|3709166|B3||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3883766|NCT01542788|3709167|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3883767|NCT01542788|3709168|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3883768|NCT01542788|3709166|B3|||Age||years|Mean|52|52.0|Standard Deviation|9.5|9.5|||
3883769|NCT01542788|3709167|B2|||Age||years|Mean|52|52.0|Standard Deviation|8.2|8.2|||
3883770|NCT01542788|3709168|B1|||Age||years|Mean|52|52.0|Standard Deviation|9.9|9.9|||
3883771|NCT01542684|3709185|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3883772|NCT01542684|3709185|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3883773|NCT01542684|3709185|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3883774|NCT01542684|3709185|B1|||Age||Years|Median|69|69.0|Full Range|||54.0|82.0|
3883775|NCT01542645|3709189|B3||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3883776|NCT01542645|3709190|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3883777|NCT01542645|3709191|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3883778|NCT01542645|3709189|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3883779|NCT01542645|3709190|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3883780|NCT01542645|3709191|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3883781|NCT01542645|3709189|B3|||Age||years|Mean|65.1|65.1|Standard Deviation|10.8|10.8|||
3883782|NCT01542645|3709190|B2|||Age||years|Mean|65.5|65.5|Standard Deviation|11.1|11.1|||
3883783|NCT01542645|3709191|B1|||Age||years|Mean|64.7|64.7|Standard Deviation|10.5|10.5|||
3883784|NCT01542632|3709202|B7|||Body Mass Index (BMI)||kg/m^2|Mean|25.91|25.91|Standard Deviation|3.323|3.323|||
3883785|NCT01542632|3709203|B6|||Body Mass Index (BMI)||kg/m^2|Mean|26.35|26.35|Standard Deviation|3.517|3.517|||
3883786|NCT01542632|3709204|B5|||Body Mass Index (BMI)||kg/m^2|Mean|25.81|25.81|Standard Deviation|3.712|3.712|||
3883787|NCT01542632|3709205|B4|||Body Mass Index (BMI)||kg/m^2|Mean|26.09|26.09|Standard Deviation|3.202|3.202|||
3883788|NCT01542632|3709206|B3|||Body Mass Index (BMI)||kg/m^2|Mean|26.50|26.5|Standard Deviation|3.735|3.735|||
3883789|NCT01542632|3709207|B2|||Body Mass Index (BMI)||kg/m^2|Mean|25.97|25.97|Standard Deviation|3.314|3.314|||
3883790|NCT01542632|3709208|B1|||Body Mass Index (BMI)||kg/m^2|Mean|24.81|24.81|Standard Deviation|2.423|2.423|||
3883791|NCT01542632|3709202|B7|||Height||m|Mean|1.72|1.72|Standard Deviation|0.100|0.1|||
3883792|NCT01542632|3709203|B6|||Height||m|Mean|1.75|1.75|Standard Deviation|0.104|0.104|||
3883793|NCT01542632|3709204|B5|||Height||m|Mean|1.73|1.73|Standard Deviation|0.099|0.099|||
3883794|NCT01542632|3709205|B4|||Height||m|Mean|1.76|1.76|Standard Deviation|0.105|0.105|||
3883795|NCT01542632|3709206|B3|||Height||m|Mean|1.70|1.7|Standard Deviation|0.108|0.108|||
3883796|NCT01542632|3709207|B2|||Height||m|Mean|1.71|1.71|Standard Deviation|0.084|0.084|||
3883797|NCT01542632|3709208|B1|||Height||m|Mean|1.71|1.71|Standard Deviation|0.092|0.092|||
3883798|NCT01542632|3709202|B7|||Weight||kg|Mean|77.5|77.5|Standard Deviation|14.36|14.36|||
3883799|NCT01542632|3709203|B6|||Weight||kg|Mean|81.7|81.7|Standard Deviation|16.02|16.02|||
3883800|NCT01542632|3709204|B5|||Weight||kg|Mean|77.3|77.3|Standard Deviation|14.91|14.91|||
3883801|NCT01542632|3709205|B4|||Weight||kg|Mean|80.8|80.8|Standard Deviation|14.12|14.12|||
3883802|NCT01542632|3709206|B3|||Weight||kg|Mean|76.7|76.7|Standard Deviation|15.76|15.76|||
3883803|NCT01542632|3709207|B2|||Weight||kg|Mean|75.9|75.9|Standard Deviation|13.22|13.22|||
3883804|NCT01542632|3709208|B1|||Weight||kg|Mean|73.3|73.3|Standard Deviation|11.66|11.66|||
3883805|NCT01542632|3709202|B7|United States||Region of Enrollment||participants|Number|140|140.0||||||
3883806|NCT01542632|3709203|B6|United States||Region of Enrollment||participants|Number|24|24.0||||||
3883807|NCT01542632|3709204|B5|United States||Region of Enrollment||participants|Number|21|21.0||||||
3883808|NCT01542632|3709205|B4|United States||Region of Enrollment||participants|Number|21|21.0||||||
3883809|NCT01542632|3709206|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
3883810|NCT01542632|3709207|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3883811|NCT01542632|3709208|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3883812|NCT01542632|3709202|B7|White||Race/Ethnicity, Customized||participants|Number|112|112.0||||||
3883813|NCT01542632|3709203|B6|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3883814|NCT01542632|3709204|B5|White||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3883815|NCT01542632|3709205|B4|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3883816|NCT01542632|3709206|B3|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3883817|NCT01542632|3709207|B2|White||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3883818|NCT01542632|3709208|B1|White||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3883819|NCT01542632|3709202|B7|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3883820|NCT01542632|3709203|B6|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3883821|NCT01542632|3709204|B5|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3883822|NCT01542632|3709205|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3883823|NCT01542632|3709206|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3883824|NCT01542632|3709207|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3883825|NCT01542632|3709208|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3883826|NCT01542632|3709202|B7|Hispanic Or Latino||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3883827|NCT01542632|3709203|B6|Hispanic Or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3883828|NCT01542632|3709204|B5|Hispanic Or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3883829|NCT01542632|3709205|B4|Hispanic Or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3883830|NCT01542632|3709206|B3|Hispanic Or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3883831|NCT01542632|3709207|B2|Hispanic Or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3883832|NCT01542632|3709208|B1|Hispanic Or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3883833|NCT01542632|3709202|B7|Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3883834|NCT01542632|3709203|B6|Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3883835|NCT01542632|3709204|B5|Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3883836|NCT01542632|3709205|B4|Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3883837|NCT01542632|3709206|B3|Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3883838|NCT01542632|3709207|B2|Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3883839|NCT01542632|3709208|B1|Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3883840|NCT01542632|3709202|B7|Black/African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3883841|NCT01542632|3709203|B6|Black/African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3883842|NCT01542632|3709204|B5|Black/African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3883843|NCT01542632|3709205|B4|Black/African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3883844|NCT01542632|3709206|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3883845|NCT01542632|3709207|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3883846|NCT01542632|3709208|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3883847|NCT01542632|3709202|B7|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3883848|NCT01542632|3709203|B6|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3883849|NCT01542632|3709204|B5|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3883850|NCT01542632|3709205|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3883851|NCT01542632|3709206|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3883852|NCT01542632|3709207|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3883853|NCT01542632|3709208|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3883854|NCT01542632|3709202|B7||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3883855|NCT01542632|3709203|B6||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3883856|NCT01542632|3709204|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3883857|NCT01542632|3709205|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3883858|NCT01542632|3709206|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3883859|NCT01542632|3709207|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3883860|NCT01542632|3709208|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3883861|NCT01542632|3709202|B7||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3883862|NCT01542632|3709203|B6||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3883863|NCT01542632|3709204|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3883864|NCT01542632|3709205|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3883865|NCT01542632|3709206|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3883866|NCT01542632|3709207|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3883867|NCT01542632|3709208|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3883868|NCT01542632|3709202|B7|||Age||years|Mean|30.0|30.0|Standard Deviation|6.54|6.54|||
3883869|NCT01542632|3709203|B6|||Age||years|Mean|32.5|32.5|Standard Deviation|6.04|6.04|||
3883870|NCT01542632|3709204|B5|||Age||years|Mean|30.3|30.3|Standard Deviation|7.95|7.95|||
3883871|NCT01542632|3709205|B4|||Age||years|Mean|30.0|30.0|Standard Deviation|6.67|6.67|||
3883872|NCT01542632|3709206|B3|||Age||years|Mean|29.2|29.2|Standard Deviation|6.40|6.4|||
3883873|NCT01542632|3709207|B2|||Age||years|Mean|28.2|28.2|Standard Deviation|6.36|6.36|||
3883874|NCT01542632|3709208|B1|||Age||years|Mean|29.6|29.6|Standard Deviation|5.74|5.74|||
3883875|NCT01542541|3709257|B3|United States||Region of Enrollment||participants|Number|68|68.0||||||
3883876|NCT01542541|3709258|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3883877|NCT01542541|3709259|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
3883878|NCT01542541|3709257|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3883879|NCT01542541|3709258|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3883880|NCT01542541|3709259|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3883881|NCT01542541|3709257|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3883882|NCT01542541|3709258|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3883883|NCT01542541|3709259|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3883884|NCT01542541|3709257|B3|||Age||years|Mean|56|56.0|Standard Deviation|19|19.0|||
3883885|NCT01542541|3709258|B2|||Age||years|Mean|56|56.0|Standard Deviation|19|19.0|||
3883886|NCT01542541|3709259|B1|||Age||years|Mean|56|56.0|Standard Deviation|19|19.0|||
3883887|NCT01542528|3709268|B3|||Clinician Rated SNAP Swanson, Nolan, and Pelham Rating Scale score|ADHD severity was measured by the Swanson, Nolan, and Pelham Rating Scale (SNAP)-IV-ADHD consists of 18 items that closely parallel in wording the diagnostic symptoms for ADHD as they appear in the Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV. The range of scores are from 0 to 54. Higher scores indicate greater ADHD severity . The blinded assessors (Clinicians) used clinical judgement to provide an overall rating, based on all available information from the parents, teachers, and the assessors' own direct interactions with the child on the day of the assessment.|units on a scale|Mean|30.3|30.3|Standard Deviation|7.4|7.4|||
3883888|NCT01542528|3709269|B2|||Clinician Rated SNAP Swanson, Nolan, and Pelham Rating Scale score|ADHD severity was measured by the Swanson, Nolan, and Pelham Rating Scale (SNAP)-IV-ADHD consists of 18 items that closely parallel in wording the diagnostic symptoms for ADHD as they appear in the Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV. The range of scores are from 0 to 54. Higher scores indicate greater ADHD severity . The blinded assessors (Clinicians) used clinical judgement to provide an overall rating, based on all available information from the parents, teachers, and the assessors' own direct interactions with the child on the day of the assessment.|units on a scale|Mean|29.9|29.9|Standard Deviation|6.8|6.8|||
3883889|NCT01542528|3709270|B1|||Clinician Rated SNAP Swanson, Nolan, and Pelham Rating Scale score|ADHD severity was measured by the Swanson, Nolan, and Pelham Rating Scale (SNAP)-IV-ADHD consists of 18 items that closely parallel in wording the diagnostic symptoms for ADHD as they appear in the Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV. The range of scores are from 0 to 54. Higher scores indicate greater ADHD severity . The blinded assessors (Clinicians) used clinical judgement to provide an overall rating, based on all available information from the parents, teachers, and the assessors' own direct interactions with the child on the day of the assessment.|units on a scale|Mean|30.8|30.8|Standard Deviation|7.9|7.9|||
3883890|NCT01542528|3709268|B3|China||Region of Enrollment||participants|Number|20|20.0||||||
3883891|NCT01542528|3709269|B2|China||Region of Enrollment||participants|Number|9|9.0||||||
3883892|NCT01542528|3709270|B1|China||Region of Enrollment||participants|Number|11|11.0||||||
3883893|NCT01542528|3709268|B3|United States||Region of Enrollment||participants|Number|93|93.0||||||
3883894|NCT01542528|3709269|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
3883895|NCT01542528|3709270|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
3883896|NCT01542528|3709268|B3|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3883897|NCT01542528|3709269|B2|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3883898|NCT01542528|3709270|B1|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3883899|NCT01542528|3709268|B3|More than one race, other||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3883900|NCT01542528|3709269|B2|More than one race, other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3883901|NCT01542528|3709270|B1|More than one race, other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3883902|NCT01542528|3709268|B3|Asian||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3883903|NCT01542528|3709269|B2|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3883904|NCT01542528|3709270|B1|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3883905|NCT01542528|3709268|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3883906|NCT01542528|3709269|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3883907|NCT01542528|3709270|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3883908|NCT01542528|3709268|B3|African American||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3883909|NCT01542528|3709269|B2|African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3883910|NCT01542528|3709270|B1|African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3883911|NCT01542528|3709268|B3|White||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
3883912|NCT01542528|3709269|B2|White||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3883913|NCT01542528|3709270|B1|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3883914|NCT01542528|3709268|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3883915|NCT01542528|3709269|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3883916|NCT01542528|3709270|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3883917|NCT01542528|3709268|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3883918|NCT01542528|3709269|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3883919|NCT01542528|3709270|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3883920|NCT01542528|3709268|B3|||Age||Years|Mean|7.4|7.4|Standard Deviation|1.16|1.16|||
3883921|NCT01542528|3709269|B2|||Age||Years|Mean|7.3|7.3|Standard Deviation|1.17|1.17|||
3883922|NCT01542528|3709270|B1|||Age||Years|Mean|7.6|7.6|Standard Deviation|1.14|1.14|||
3883923|NCT01542502|3709279|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3883924|NCT01542502|3709279|B1||Male|Gender||Participants|Count of Participants|1|1.0||||||
3883925|NCT01542502|3709279|B1||Female|Gender||Participants|Count of Participants|11|11.0||||||
3883926|NCT01542502|3709279|B1|||Age||years|Median|61|61.0|Inter-Quartile Range|||55.0|64.0|
3883927|NCT01542502|3709279|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3883928|NCT01542502|3709279|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3883929|NCT01542502|3709279|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3883930|NCT01542398|3709288|B3|Congo||Region of Enrollment||participants|Number|159|159.0||||||
3883931|NCT01542398|3709289|B2|Congo||Region of Enrollment||participants|Number|80|80.0||||||
3883932|NCT01542398|3709290|B1|Congo||Region of Enrollment||participants|Number|79|79.0||||||
3883933|NCT01542398|3709288|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3883934|NCT01542398|3709289|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3883935|NCT01542398|3709290|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3883936|NCT01542398|3709288|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3883937|NCT01542398|3709289|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3883938|NCT01542398|3709290|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3883939|NCT01542398|3709288|B3|||Age||years|Mean|13.42|13.42|Standard Deviation|2.79|2.79|||
3883940|NCT01542398|3709289|B2|||Age||years|Mean|13.76|13.76|Standard Deviation|2.76|2.76|||
3883941|NCT01542398|3709290|B1|||Age||years|Mean|13.16|13.16|Standard Deviation|2.85|2.85|||
3883942|NCT01542372|3709299|B1|United States||Region of Enrollment||participants|Number|114|114.0||||||
3883943|NCT01542372|3709299|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3883944|NCT01542372|3709299|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3883945|NCT01542372|3709299|B1|||Age||years|Mean|52.8|52.8|Standard Deviation|4.8|4.8|||
3883946|NCT01542372|3709299|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3883947|NCT01542372|3709299|B1||Between 18 and 65 years|Age||Participants|Count of Participants|114|114.0||||||
3883948|NCT01542372|3709299|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3883949|NCT01542307|3709315|B1|Not Using||Using botulinum toxin for migraine prevention||Participants|Count of Participants|18|18.0||||||
3883950|NCT01542307|3709315|B1|Using||Using botulinum toxin for migraine prevention||Participants|Count of Participants|4|4.0||||||
3883951|NCT01542307|3709315|B1|Not Using||Beta-blockers for migraine prevention||Participants|Count of Participants|14|14.0||||||
3883952|NCT01542307|3709315|B1|Using||Beta-blockers for migraine prevention||Participants|Count of Participants|8|8.0||||||
3883953|NCT01542307|3709315|B1|Not Using||Anti-seizure meds for migraine prevention||Participants|Count of Participants|12|12.0||||||
3883954|NCT01542307|3709315|B1|Using||Anti-seizure meds for migraine prevention||Participants|Count of Participants|10|10.0||||||
3883955|NCT01542307|3709315|B1|Not Using||Opioids for acute migraine||Participants|Count of Participants|16|16.0||||||
3883956|NCT01542307|3709315|B1|Using||Opioids for acute migraine||Participants|Count of Participants|6|6.0||||||
3883957|NCT01542307|3709315|B1|Not Using||NSAIDs/acetaminophen for acute migraine||Participants|Count of Participants|0|0.0||||||
3883958|NCT01542307|3709315|B1|Using||NSAIDs/acetaminophen for acute migraine||Participants|Count of Participants|22|22.0||||||
3883959|NCT01542307|3709315|B1|Not Using||Triptans for acute migraine||Participants|Count of Participants|4|4.0||||||
3883960|NCT01542307|3709315|B1|Using||Triptans for acute migraine||Participants|Count of Participants|18|18.0||||||
3883961|NCT01542307|3709315|B1|Not visited||One or more ED visits in prior year||Participants|Count of Participants|11|11.0||||||
3883962|NCT01542307|3709315|B1|Visited||One or more ED visits in prior year||Participants|Count of Participants|11|11.0||||||
3883963|NCT01542307|3709315|B1|None||One or more lifetime ED visits||Participants|Count of Participants|5|5.0||||||
3883964|NCT01542307|3709315|B1|Yes||One or more lifetime ED visits||Participants|Count of Participants|17|17.0||||||
3883965|NCT01542307|3709315|B1|Absent||Vascular risk factors (eg. hypertension)||Participants|Count of Participants|20|20.0||||||
3883966|NCT01542307|3709315|B1|Present||Vascular risk factors (eg. hypertension)||Participants|Count of Participants|2|2.0||||||
3883967|NCT01542307|3709315|B1|Absent||Family history of migraine||Participants|Count of Participants|9|9.0||||||
3883968|NCT01542307|3709315|B1|Present||Family history of migraine||Participants|Count of Participants|13|13.0||||||
3883969|NCT01542307|3709315|B1|Non-smoker||Smoking Status||Participants|Count of Participants|20|20.0||||||
3883970|NCT01542307|3709315|B1|Prior smoker||Smoking Status||Participants|Count of Participants|2|2.0||||||
3883971|NCT01542307|3709315|B1|Single||Marital status||Participants|Count of Participants|12|12.0||||||
3883972|NCT01542307|3709315|B1|Married||Marital status||Participants|Count of Participants|10|10.0||||||
3883973|NCT01542307|3709315|B1|School or lower||Education Level||Participants|Count of Participants|2|2.0||||||
3883974|NCT01542307|3709315|B1|College or higher||Education Level||Participants|Count of Participants|20|20.0||||||
3883975|NCT01542307|3709315|B1|Not Employed Full Time||Employment||Participants|Count of Participants|5|5.0||||||
3883976|NCT01542307|3709315|B1|Employed Full Time||Employment||Participants|Count of Participants|17|17.0||||||
3883977|NCT01542307|3709315|B1|Migraine without Aura||Migraine||Participants|Count of Participants|15|15.0||||||
3883978|NCT01542307|3709315|B1|Migraine w Aura||Migraine||Participants|Count of Participants|7|7.0||||||
3883979|NCT01542307|3709315|B1|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3883980|NCT01542307|3709315|B1|Non-Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3883981|NCT01542307|3709315|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3883982|NCT01542307|3709315|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3883983|NCT01542307|3709315|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3883984|NCT01542307|3709315|B1|||Age||years|Mean|36|36.0|Standard Deviation|10|10.0|||
3883985|NCT01542255|3709336|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3883986|NCT01542255|3709336|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3883987|NCT01542255|3709336|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3883988|NCT01542255|3709336|B1|||Age||years|Median|65|65.0|Full Range|||48.0|79.0|
3883989|NCT01542125|3709340|B3||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3883990|NCT01542125|3709341|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3883991|NCT01542125|3709342|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3883992|NCT01542125|3709340|B3||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3883993|NCT01542125|3709341|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3883994|NCT01542125|3709342|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3883995|NCT01542125|3709340|B3|||Age||years|Mean|7.81|7.81|Standard Deviation|3.71|3.71|||
3883996|NCT01542125|3709341|B2|||Age||years|Mean|7.74|7.74|Standard Deviation|3.74|3.74|||
3883997|NCT01542125|3709342|B1|||Age||years|Mean|7.89|7.89|Standard Deviation|3.71|3.71|||
3883998|NCT01542034|3709349|B3|IV - VI||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|139|139.0||||||
3883999|NCT01542034|3709350|B2|IV - VI||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|63|63.0||||||
3884000|NCT01542034|3709351|B1|IV - VI||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|76|76.0||||||
3884001|NCT01542034|3709349|B3|I - III||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|367|367.0||||||
3884002|NCT01542034|3709350|B2|I - III||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|187|187.0||||||
3884003|NCT01542034|3709351|B1|I - III||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|180|180.0||||||
3884004|NCT01542034|3709349|B3|||Body Mass Index (BMI)|Data available for 256 and 249 participants in each treatment group respectively|kg/m²|Mean|29.25|29.25|Standard Deviation|4.340|4.34|||
3884005|NCT01542034|3709350|B2|||Body Mass Index (BMI)|Data available for 256 and 249 participants in each treatment group respectively|kg/m²|Mean|29.26|29.26|Standard Deviation|4.281|4.281|||
3884006|NCT01542034|3709351|B1|||Body Mass Index (BMI)|Data available for 256 and 249 participants in each treatment group respectively|kg/m²|Mean|29.23|29.23|Standard Deviation|4.406|4.406|||
3884007|NCT01542034|3709349|B3|||Weight|Data available for 256 and 249 participants in each treatment group respectively|kg|Mean|81.07|81.07|Standard Deviation|14.411|14.411|||
3884008|NCT01542034|3709350|B2|||Weight|Data available for 256 and 249 participants in each treatment group respectively|kg|Mean|80.98|80.98|Standard Deviation|14.296|14.296|||
3884009|NCT01542034|3709351|B1|||Weight|Data available for 256 and 249 participants in each treatment group respectively|kg|Mean|81.15|81.15|Standard Deviation|14.549|14.549|||
3884010|NCT01542034|3709349|B3|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|461|461.0||||||
3884011|NCT01542034|3709350|B2|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|233|233.0||||||
3884012|NCT01542034|3709351|B1|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|228|228.0||||||
3884013|NCT01542034|3709349|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
3884014|NCT01542034|3709350|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3884015|NCT01542034|3709351|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3884016|NCT01542034|3709349|B3|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3884017|NCT01542034|3709350|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3884018|NCT01542034|3709351|B1|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3884019|NCT01542034|3709349|B3|Multiple||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3884020|NCT01542034|3709350|B2|Multiple||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3884021|NCT01542034|3709351|B1|Multiple||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3884022|NCT01542034|3709349|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3884023|NCT01542034|3709350|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3884024|NCT01542034|3709351|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3884025|NCT01542034|3709349|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3884026|NCT01542034|3709350|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3884027|NCT01542034|3709351|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3884028|NCT01542034|3709349|B3|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3884029|NCT01542034|3709350|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3884030|NCT01542034|3709351|B1|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3884031|NCT01542034|3709349|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
3884032|NCT01542034|3709350|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3884033|NCT01542034|3709351|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3884034|NCT01542034|3709349|B3|White||Race/Ethnicity, Customized||participants|Number|445|445.0||||||
3884035|NCT01542034|3709350|B2|White||Race/Ethnicity, Customized||participants|Number|227|227.0||||||
3884036|NCT01542034|3709351|B1|White||Race/Ethnicity, Customized||participants|Number|218|218.0||||||
3884037|NCT01542034|3709349|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3884038|NCT01542034|3709350|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3884039|NCT01542034|3709351|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3884040|NCT01542034|3709349|B3||Female|Sex: Female, Male||Participants|Count of Participants|421|421.0||||||
3884041|NCT01542034|3709350|B2||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
3884042|NCT01542034|3709351|B1||Female|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
3884043|NCT01542034|3709349|B3|51 - 65 years||Age, Customized||participants|Number|263|263.0||||||
3884044|NCT01542034|3709350|B2|51 - 65 years||Age, Customized||participants|Number|129|129.0||||||
3884045|NCT01542034|3709351|B1|51 - 65 years||Age, Customized||participants|Number|134|134.0||||||
3884046|NCT01542034|3709349|B3|18 - 50 years||Age, Customized||participants|Number|243|243.0||||||
3884047|NCT01542034|3709350|B2|18 - 50 years||Age, Customized||participants|Number|121|121.0||||||
3884048|NCT01542034|3709351|B1|18 - 50 years||Age, Customized||participants|Number|122|122.0||||||
3884049|NCT01542034|3709349|B3|||Age||years|Mean|49.5|49.5|Standard Deviation|9.30|9.3|||
3884050|NCT01542034|3709350|B2|||Age||years|Mean|49.4|49.4|Standard Deviation|9.33|9.33|||
3884051|NCT01542034|3709351|B1|||Age||years|Mean|49.5|49.5|Standard Deviation|9.30|9.3|||
3884052|NCT01541969|3709364|B3|||Beck Depression Inventory|Multi-item questionnaire measure of depression symptomatology. Global score (0-63 scale). Higher score indicates greater severity of depression.|units on a scale|Mean|8.7|8.7|Standard Deviation|6.6|6.6|||
3884053|NCT01541969|3709365|B2|||Beck Depression Inventory|Multi-item questionnaire measure of depression symptomatology. Global score (0-63 scale). Higher score indicates greater severity of depression.|units on a scale|Mean|9.0|9.0|Standard Deviation|7.3|7.3|||
3884054|NCT01541969|3709366|B1|||Beck Depression Inventory|Multi-item questionnaire measure of depression symptomatology. Global score (0-63 scale). Higher score indicates greater severity of depression.|units on a scale|Mean|8.7|8.7|Standard Deviation|6.4|6.4|||
3884055|NCT01541969|3709364|B3|||Beck Anxiety Inventory|Global score (0-63 scale). Higher score indicates more anxiety.|units on a scale|Mean|5.1|5.1|Standard Deviation|5.7|5.7|||
3884056|NCT01541969|3709365|B2|||Beck Anxiety Inventory|Global score (0-63 scale). Higher score indicates more anxiety.|units on a scale|Mean|5.4|5.4|Standard Deviation|6.6|6.6|||
3884057|NCT01541969|3709366|B1|||Beck Anxiety Inventory|Global score (0-63 scale). Higher score indicates more anxiety.|units on a scale|Mean|4.7|4.7|Standard Deviation|4.7|4.7|||
3884058|NCT01541969|3709364|B3|||Tinnitus Handicap Inventory|Multi-item questionnaire measure of tinnitus severity. Global score (0-100 scale). Higher score indicates greater tinnitus handicap.|units on a scale|Mean|40.2|40.2|Standard Deviation|16.4|16.4|||
3884059|NCT01541969|3709365|B2|||Tinnitus Handicap Inventory|Multi-item questionnaire measure of tinnitus severity. Global score (0-100 scale). Higher score indicates greater tinnitus handicap.|units on a scale|Mean|40.9|40.9|Standard Deviation|15.8|15.8|||
3884060|NCT01541969|3709366|B1|||Tinnitus Handicap Inventory|Multi-item questionnaire measure of tinnitus severity. Global score (0-100 scale). Higher score indicates greater tinnitus handicap.|units on a scale|Mean|40.0|40.0|Standard Deviation|17.4|17.4|||
3884061|NCT01541969|3709364|B3|||Hearing level (worse ear)|Hearing level is measured by the pure tone audiometric threshold measures, averaged across four frequencies (0.5,1,2,and 4 kHz). Higher number equates to higher hearing thresholds (hearing worse).|decibel hearing level (dB HL)|Mean|18.6|18.6|Standard Deviation|12.3|12.3|||
3884062|NCT01541969|3709365|B2|||Hearing level (worse ear)|Hearing level is measured by the pure tone audiometric threshold measures, averaged across four frequencies (0.5,1,2,and 4 kHz). Higher number equates to higher hearing thresholds (hearing worse).|decibel hearing level (dB HL)|Mean|18.7|18.7|Standard Deviation|12.4|12.4|||
3884063|NCT01541969|3709366|B1|||Hearing level (worse ear)|Hearing level is measured by the pure tone audiometric threshold measures, averaged across four frequencies (0.5,1,2,and 4 kHz). Higher number equates to higher hearing thresholds (hearing worse).|decibel hearing level (dB HL)|Mean|18.5|18.5|Standard Deviation|12.4|12.4|||
3884064|NCT01541969|3709364|B3|||Hearing level (better ear)|Hearing level is measured by the pure tone audiometric threshold measures, averaged across four frequencies (0.5,1,2,and 4 kHz). Higher number equates to higher hearing thresholds (hearing worse).|decibel hearing level (dB HL)|Mean|13.7|13.7|Standard Deviation|11.2|11.2|||
3884065|NCT01541969|3709365|B2|||Hearing level (better ear)|Hearing level is measured by the pure tone audiometric threshold measures, averaged across four frequencies (0.5,1,2,and 4 kHz). Higher number equates to higher hearing thresholds (hearing worse).|decibel hearing level (dB HL)|Mean|14.3|14.3|Standard Deviation|12.0|12.0|||
3884066|NCT01541969|3709366|B1|||Hearing level (better ear)|Hearing level is measured by the pure tone audiometric threshold measures, averaged across four frequencies (0.5,1,2,and 4 kHz). Higher number equates to higher hearing thresholds (hearing worse).|decibel hearing level (dB HL)|Mean|13.1|13.1|Standard Deviation|10.2|10.2|||
3884067|NCT01541969|3709364|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3884068|NCT01541969|3709365|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3884069|NCT01541969|3709366|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3884070|NCT01541969|3709364|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3884071|NCT01541969|3709365|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3884072|NCT01541969|3709366|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3884073|NCT01541969|3709364|B3|||Age||years|Mean|50.5|50.5|Standard Deviation|11.7|11.7|||
3884074|NCT01541969|3709365|B2|||Age||years|Mean|51.8|51.8|Standard Deviation|12.2|12.2|||
3884075|NCT01541969|3709366|B1|||Age||years|Mean|49.1|49.1|Standard Deviation|11.3|11.3|||
3884076|NCT01541930|3709383|B1|||Skin Ulcer Size||cm^2|Mean|68.6|68.6|Standard Deviation|35.4|35.4|||
3884077|NCT01541930|3709383|B1|Other Cancer||Primary Disease||participants|Number|0|0.0||||||
3884078|NCT01541930|3709383|B1|Breast Cancer||Primary Disease||participants|Number|21|21.0||||||
3884079|NCT01541930|3709383|B1|Japan||Region of Enrollment||participants|Number|21|21.0||||||
3884080|NCT01541930|3709383|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3884081|NCT01541930|3709383|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3884082|NCT01541930|3709383|B1|||Age||years|Mean|64.4|64.4|Standard Deviation|12.2|12.2|||
3884083|NCT01541917|3709402|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884084|NCT01541917|3709403|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884085|NCT01541917|3709404|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884086|NCT01541917|3709405|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884087|NCT01541917|3709402|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3884088|NCT01541917|3709403|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3884089|NCT01541917|3709404|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3884090|NCT01541917|3709405|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3884091|NCT01541917|3709402|B4||White|Race (NIH/OMB)||Participants|Count of Participants|256|256.0||||||
3884092|NCT01541917|3709403|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3884093|NCT01541917|3709404|B2||White|Race (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
3884094|NCT01541917|3709405|B1||White|Race (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
3884095|NCT01541917|3709402|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3884096|NCT01541917|3709403|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3884097|NCT01541917|3709404|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3884098|NCT01541917|3709405|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3884099|NCT01541917|3709402|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3884100|NCT01541917|3709403|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884101|NCT01541917|3709404|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3884102|NCT01541917|3709405|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884103|NCT01541917|3709402|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3884104|NCT01541917|3709403|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884105|NCT01541917|3709404|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3884106|NCT01541917|3709405|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3884107|NCT01541917|3709402|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3884108|NCT01541917|3709403|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884109|NCT01541917|3709404|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884110|NCT01541917|3709405|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3884111|NCT01541917|3709402|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884112|NCT01541917|3709403|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884113|NCT01541917|3709404|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884114|NCT01541917|3709405|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884115|NCT01541917|3709402|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|266|266.0||||||
3884116|NCT01541917|3709403|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3884117|NCT01541917|3709404|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
3884118|NCT01541917|3709405|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
3884119|NCT01541917|3709402|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3884120|NCT01541917|3709403|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3884121|NCT01541917|3709404|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3884122|NCT01541917|3709405|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3884123|NCT01541917|3709402|B4||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3884124|NCT01541917|3709403|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3884125|NCT01541917|3709404|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3884126|NCT01541917|3709405|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3884127|NCT01541917|3709402|B4||Female|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
3884128|NCT01541917|3709403|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3884129|NCT01541917|3709404|B2||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3884130|NCT01541917|3709405|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3884131|NCT01541917|3709402|B4|||Age||years|Mean|14.59|14.59|Standard Deviation|1.79|1.79|||
3884132|NCT01541917|3709403|B3|||Age||years|Mean|15.06|15.06|Standard Deviation|1.69|1.69|||
3884133|NCT01541917|3709404|B2|||Age||years|Mean|14.55|14.55|Standard Deviation|1.76|1.76|||
3884134|NCT01541917|3709405|B1|||Age||years|Mean|14.65|14.65|Standard Deviation|1.85|1.85|||
3884135|NCT01541891|3709422|B3|Mexico||Region of Enrollment||participants|Number|28|28.0||||||
3884136|NCT01541891|3709423|B2|Mexico||Region of Enrollment||participants|Number|14|14.0||||||
3884137|NCT01541891|3709424|B1|Mexico||Region of Enrollment||participants|Number|14|14.0||||||
3884138|NCT01541891|3709422|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3884139|NCT01541891|3709423|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3884140|NCT01541891|3709424|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3884141|NCT01541891|3709422|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3884142|NCT01541891|3709423|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3884143|NCT01541891|3709424|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3884144|NCT01541891|3709422|B3|||Age||years|Mean|55.8|55.8|Standard Deviation|8.8|8.8|||
3884145|NCT01541891|3709423|B2|||Age||years|Mean|55.9|55.9|Standard Deviation|9.6|9.6|||
3884146|NCT01541891|3709424|B1|||Age||years|Mean|55.8|55.8|Standard Deviation|8.4|8.4|||
3884147|NCT01541891|3709422|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3884148|NCT01541891|3709423|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3884149|NCT01541891|3709424|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3884150|NCT01541891|3709422|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3884151|NCT01541891|3709423|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3884152|NCT01541891|3709424|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3884153|NCT01541891|3709422|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3884154|NCT01541891|3709423|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3884155|NCT01541891|3709424|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3884156|NCT01541865|3709435|B1|Subjects on 2 medications||Antihypertensive Medications||participants|Number|3|3.0||||||
3884157|NCT01541865|3709435|B1|Subjects on 3 medications||Antihypertensive Medications||participants|Number|26|26.0||||||
3884158|NCT01541865|3709435|B1|Subjects on 4 medications||Antihypertensive Medications||participants|Number|38|38.0||||||
3884159|NCT01541865|3709435|B1|Subjects on greater than or equal to 5 medications||Antihypertensive Medications||participants|Number|79|79.0||||||
3884160|NCT01541865|3709435|B1|||Number of Antihypertensive Medications per Patient||Antihypertensive Medications per Patient|Mean|4.8|4.8|Standard Deviation|1.5|1.5|||
3884161|NCT01541865|3709435|B1|||Serum Creatinine||micromol/L|Mean|82.0|82.0|Standard Deviation|20.0|20.0|||
3884162|NCT01541865|3709435|B1|||Estimated glomerular filtration rate (eGFR)||mL/min/1.73m^2|Mean|82.7|82.7|Standard Deviation|22.5|22.5|||
3884163|NCT01541865|3709435|B1|||Heart Rate||beats/min|Mean|71.7|71.7|Standard Deviation|14.8|14.8|||
3884164|NCT01541865|3709435|B1|||Baseline Diastolic Blood Pressure||mm Hg|Mean|100.2|100.2|Standard Deviation|14.0|14.0|||
3884165|NCT01541865|3709435|B1|||Baseline Systolic Blood Pressure||mm Hg|Mean|182.4|182.4|Standard Deviation|18.4|18.4|||
3884166|NCT01541865|3709435|B1|No Dyslipidemia||Dyslipidemia||participants|Number|61|61.0||||||
3884167|NCT01541865|3709435|B1|Dyslipidemia||Dyslipidemia||participants|Number|85|85.0||||||
3884168|NCT01541865|3709435|B1|No Congestive Heart Failure||Congestive Heart Failure||participants|Number|143|143.0||||||
3884169|NCT01541865|3709435|B1|Congestive Heart Failure||Congestive Heart Failure||participants|Number|3|3.0||||||
3884170|NCT01541865|3709435|B1|No Coronary Artery Disease||Coronary Artery Disease||participants|Number|91|91.0||||||
3884171|NCT01541865|3709435|B1|Coronary Artery Disease||Coronary Artery Disease||participants|Number|55|55.0||||||
3884172|NCT01541865|3709435|B1|Non-Diabetic||Type 2 Diabetes||participants|Number|105|105.0||||||
3884173|NCT01541865|3709435|B1|Type 2 Diabetes||Type 2 Diabetes||participants|Number|41|41.0||||||
3884174|NCT01541865|3709435|B1|Germany||Region of Enrollment||participants|Number|49|49.0||||||
3884175|NCT01541865|3709435|B1|Switzerland||Region of Enrollment||participants|Number|2|2.0||||||
3884176|NCT01541865|3709435|B1|France||Region of Enrollment||participants|Number|8|8.0||||||
3884177|NCT01541865|3709435|B1|Australia||Region of Enrollment||participants|Number|31|31.0||||||
3884178|NCT01541865|3709435|B1|Belgium||Region of Enrollment||participants|Number|17|17.0||||||
3884179|NCT01541865|3709435|B1|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
3884180|NCT01541865|3709435|B1|Austria||Region of Enrollment||participants|Number|13|13.0||||||
3884181|NCT01541865|3709435|B1|New Zealand||Region of Enrollment||participants|Number|21|21.0||||||
3884182|NCT01541865|3709435|B1|Black, Asian, Other||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3884183|NCT01541865|3709435|B1|White||Race/Ethnicity, Customized||participants|Number|135|135.0||||||
3884184|NCT01541865|3709435|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3884185|NCT01541865|3709435|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3884186|NCT01541865|3709435|B1|||Age||years|Mean|58.1|58.1|Standard Deviation|10.4|10.4|||
3884187|NCT01541826|3709450|B4|||Total cholesterol/HDL cholesterol||dimensionless ratio|Mean|8.0|8.0|Standard Deviation|2.3|2.3|||
3884188|NCT01541826|3709451|B3|||Total cholesterol/HDL cholesterol||dimensionless ratio|Mean|3.2|3.2|Standard Deviation|0.7|0.7|||
3884189|NCT01541826|3709452|B2|||Total cholesterol/HDL cholesterol||dimensionless ratio|Mean|8.5|8.5|Standard Deviation|2.7|2.7|||
3884190|NCT01541826|3709453|B1|||Total cholesterol/HDL cholesterol||dimensionless ratio|Mean|7.3|7.3|Standard Deviation|1.5|1.5|||
3884191|NCT01541826|3709450|B4|||Triglycerides||mg/dL|Mean|86.3|86.3|Standard Deviation|41.0|41.0|||
3884192|NCT01541826|3709451|B3|||Triglycerides||mg/dL|Mean|69.2|69.2|Standard Deviation|27.1|27.1|||
3884193|NCT01541826|3709452|B2|||Triglycerides||mg/dL|Mean|89.6|89.6|Standard Deviation|45.4|45.4|||
3884194|NCT01541826|3709453|B1|||Triglycerides||mg/dL|Mean|82.1|82.1|Standard Deviation|37.3|37.3|||
3884195|NCT01541826|3709450|B4|||LDL-cholesterol||mg/dL|Mean|168|168.0|Standard Deviation|44|44.0|||
3884196|NCT01541826|3709451|B3|||LDL-cholesterol||mg/dL|Mean|99.2|99.2|Standard Deviation|19.2|19.2|||
3884197|NCT01541826|3709452|B2|||LDL-cholesterol||mg/dL|Mean|175|175.0|Standard Deviation|54|54.0|||
3884198|NCT01541826|3709453|B1|||LDL-cholesterol||mg/dL|Mean|158|158.0|Standard Deviation|30|30.0|||
3884199|NCT01541826|3709450|B4|||HDL-cholesterol||mg/dL|Mean|27.6|27.6|Standard Deviation|6.9|6.9|||
3884200|NCT01541826|3709451|B3|||HDL-cholesterol||mg/dL|Mean|54.8|54.8|Standard Deviation|15.7|15.7|||
3884201|NCT01541826|3709452|B2|||HDL-cholesterol||mg/dL|Mean|26.8|26.8|Standard Deviation|7.6|7.6|||
3884202|NCT01541826|3709453|B1|||HDL-cholesterol||mg/dL|Mean|28.7|28.7|Standard Deviation|6.1|6.1|||
3884203|NCT01541826|3709450|B4|||Total cholesterol||mg/dL|Mean|213|213.0|Standard Deviation|51|51.0|||
3884204|NCT01541826|3709451|B3|||Total cholesterol||mg/dL|Mean|160|160.0|Standard Deviation|30|30.0|||
3884205|NCT01541826|3709452|B2|||Total cholesterol||mg/dL|Mean|220|220.0|Standard Deviation|63|63.0|||
3884206|NCT01541826|3709453|B1|||Total cholesterol||mg/dL|Mean|203|203.0|Standard Deviation|36|36.0|||
3884207|NCT01541826|3709450|B4|||Diastolic blood pressure||mmHg|Mean|75.6|75.6|Standard Deviation|11.0|11.0|||
3884208|NCT01541826|3709451|B3|||Diastolic blood pressure||mmHg|Mean|73.3|73.3|Standard Deviation|4.7|4.7|||
3884209|NCT01541826|3709452|B2|||Diastolic blood pressure||mmHg|Mean|75.3|75.3|Standard Deviation|12.0|12.0|||
3884210|NCT01541826|3709453|B1|||Diastolic blood pressure||mmHg|Mean|76.0|76.0|Standard Deviation|10.4|10.4|||
3884211|NCT01541826|3709450|B4|||Systolic blood pressure||mmHg|Mean|119|119.0|Standard Deviation|15|15.0|||
3884212|NCT01541826|3709451|B3|||Systolic blood pressure||mmHg|Mean|111.3|111.3|Standard Deviation|7.7|7.7|||
3884213|NCT01541826|3709452|B2|||Systolic blood pressure||mmHg|Mean|117|117.0|Standard Deviation|16|16.0|||
3884214|NCT01541826|3709453|B1|||Systolic blood pressure||mmHg|Mean|121|121.0|Standard Deviation|14|14.0|||
3884215|NCT01541826|3709450|B4|||Waist circumference||cm|Mean|88.5|88.5|Standard Deviation|27.6|27.6|||
3884216|NCT01541826|3709451|B3|||Waist circumference||cm|Mean|79.4|79.4|Standard Deviation|8.4|8.4|||
3884217|NCT01541826|3709452|B2|||Waist circumference||cm|Mean|90.9|90.9|Standard Deviation|35.1|35.1|||
3884218|NCT01541826|3709453|B1|||Waist circumference||cm|Mean|86.0|86.0|Standard Deviation|17.1|17.1|||
3884219|NCT01541826|3709450|B4|||BMI||kg/m^2|Mean|26.5|26.5|Standard Deviation|4.9|4.9|||
3884220|NCT01541826|3709451|B3|||BMI||kg/m^2|Mean|24.1|24.1|Standard Deviation|2.3|2.3|||
3884221|NCT01541826|3709452|B2|||BMI||kg/m^2|Mean|25.7|25.7|Standard Deviation|5.0|5.0|||
3884222|NCT01541826|3709453|B1|||BMI||kg/m^2|Mean|27.2|27.2|Standard Deviation|4.7|4.7|||
3884223|NCT01541826|3709450|B4|||Weight||kg|Mean|79.3|79.3|Standard Deviation|19.2|19.2|||
3884224|NCT01541826|3709451|B3|||Weight||kg|Mean|72.8|72.8|Standard Deviation|9.5|9.5|||
3884225|NCT01541826|3709452|B2|||Weight||kg|Mean|77.2|77.2|Standard Deviation|21.1|21.1|||
3884226|NCT01541826|3709453|B1|||Weight||kg|Mean|81.5|81.5|Standard Deviation|17.2|17.2|||
3884227|NCT01541826|3709450|B4|>20 cigarettes/day||Degree of past smoking||Participants|Count of Participants|8|8.0||||||
3884228|NCT01541826|3709451|B3|>20 cigarettes/day||Degree of past smoking||Participants|Count of Participants|1|1.0||||||
3884229|NCT01541826|3709452|B2|>20 cigarettes/day||Degree of past smoking||Participants|Count of Participants|4|4.0||||||
3884230|NCT01541826|3709453|B1|>20 cigarettes/day||Degree of past smoking||Participants|Count of Participants|3|3.0||||||
3884231|NCT01541826|3709450|B4|16-20 cigarettes/day||Degree of past smoking||Participants|Count of Participants|17|17.0||||||
3884232|NCT01541826|3709451|B3|16-20 cigarettes/day||Degree of past smoking||Participants|Count of Participants|0|0.0||||||
3884233|NCT01541826|3709452|B2|16-20 cigarettes/day||Degree of past smoking||Participants|Count of Participants|6|6.0||||||
3884234|NCT01541826|3709453|B1|16-20 cigarettes/day||Degree of past smoking||Participants|Count of Participants|11|11.0||||||
3884235|NCT01541826|3709450|B4|11-15 cigarettes/day||Degree of past smoking||Participants|Count of Participants|10|10.0||||||
3884236|NCT01541826|3709451|B3|11-15 cigarettes/day||Degree of past smoking||Participants|Count of Participants|2|2.0||||||
3884237|NCT01541826|3709452|B2|11-15 cigarettes/day||Degree of past smoking||Participants|Count of Participants|4|4.0||||||
3884238|NCT01541826|3709453|B1|11-15 cigarettes/day||Degree of past smoking||Participants|Count of Participants|4|4.0||||||
3884239|NCT01541826|3709450|B4|6-10 cigarettes/day||Degree of past smoking||Participants|Count of Participants|12|12.0||||||
3884240|NCT01541826|3709451|B3|6-10 cigarettes/day||Degree of past smoking||Participants|Count of Participants|1|1.0||||||
3884241|NCT01541826|3709452|B2|6-10 cigarettes/day||Degree of past smoking||Participants|Count of Participants|7|7.0||||||
3884242|NCT01541826|3709453|B1|6-10 cigarettes/day||Degree of past smoking||Participants|Count of Participants|4|4.0||||||
3884243|NCT01541826|3709450|B4|3-5 cigarettes/day||Degree of past smoking||Participants|Count of Participants|7|7.0||||||
3884244|NCT01541826|3709451|B3|3-5 cigarettes/day||Degree of past smoking||Participants|Count of Participants|1|1.0||||||
3884245|NCT01541826|3709452|B2|3-5 cigarettes/day||Degree of past smoking||Participants|Count of Participants|4|4.0||||||
3884246|NCT01541826|3709453|B1|3-5 cigarettes/day||Degree of past smoking||Participants|Count of Participants|2|2.0||||||
3884247|NCT01541826|3709450|B4|||Average years of smoking||years|Mean|11.9|11.9|Standard Deviation|10.0|10.0|||
3884248|NCT01541826|3709451|B3|||Average years of smoking||years|Mean|4.8|4.8|Standard Deviation|3.0|3.0|||
3884249|NCT01541826|3709452|B2|||Average years of smoking||years|Mean|8.96|8.96|Standard Deviation|6.68|6.68|||
3884250|NCT01541826|3709453|B1|||Average years of smoking||years|Mean|14.9|14.9|Standard Deviation|11.9|11.9|||
3884251|NCT01541826|3709450|B4|||Height||m|Mean|1.72|1.72|Standard Deviation|0.87|0.87|||
3884252|NCT01541826|3709451|B3|||Height||m|Mean|1.74|1.74|Standard Deviation|0.97|0.97|||
3884253|NCT01541826|3709452|B2|||Height||m|Mean|1.71|1.71|Standard Deviation|0.83|0.83|||
3884254|NCT01541826|3709453|B1|||Height||m|Mean|1.73|1.73|Standard Deviation|0.92|0.92|||
3884255|NCT01541826|3709450|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3884256|NCT01541826|3709451|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3884257|NCT01541826|3709452|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3884258|NCT01541826|3709453|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3884259|NCT01541826|3709450|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3884260|NCT01541826|3709451|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3884261|NCT01541826|3709452|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3884262|NCT01541826|3709453|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3884263|NCT01541826|3709450|B4|||Age||years|Mean|34.9|34.9|Standard Deviation|13.9|13.9|||
3884264|NCT01541826|3709451|B3|||Age||years|Mean|31.3|31.3|Standard Deviation|12.8|12.8|||
3884265|NCT01541826|3709452|B2|||Age||years|Mean|32.6|32.6|Standard Deviation|12.7|12.7|||
3884266|NCT01541826|3709453|B1|||Age||years|Mean|37.4|37.4|Standard Deviation|14.8|14.8|||
3884267|NCT01541735|3709522|B3|Mexico||Region of Enrollment||participants|Number|14|14.0||||||
3884268|NCT01541735|3709523|B2|Mexico||Region of Enrollment||participants|Number|7|7.0||||||
3884269|NCT01541735|3709524|B1|Mexico||Region of Enrollment||participants|Number|7|7.0||||||
3884270|NCT01541735|3709522|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3884271|NCT01541735|3709523|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3884272|NCT01541735|3709524|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3884273|NCT01541735|3709522|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3884274|NCT01541735|3709523|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3884275|NCT01541735|3709524|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3884276|NCT01541735|3709522|B3|||Age||years|Mean|48.0|48.0|Standard Deviation|8.39|8.39|||
3884277|NCT01541735|3709523|B2|||Age||years|Mean|46.2|46.2|Standard Deviation|9.6|9.6|||
3884278|NCT01541735|3709524|B1|||Age||years|Mean|49.8|49.8|Standard Deviation|7.1|7.1|||
3884279|NCT01541735|3709522|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3884280|NCT01541735|3709523|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3884281|NCT01541735|3709524|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3884282|NCT01541735|3709522|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3884283|NCT01541735|3709523|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3884284|NCT01541735|3709524|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3884285|NCT01541735|3709522|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3884286|NCT01541735|3709523|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3884287|NCT01541735|3709524|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3884288|NCT01541644|3709537|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3884289|NCT01541644|3709537|B1||Male|Gender||Participants|Count of Participants|14|14.0||||||
3884290|NCT01541644|3709537|B1||Female|Gender||Participants|Count of Participants|13|13.0||||||
3884291|NCT01541644|3709537|B1|||Age, Customized||years|Mean|63|63.0|Full Range|||49.0|77.0|
3884292|NCT01541553|3709541|B3|United States||Region of Enrollment||participants|Number|329|329.0||||||
3884293|NCT01541553|3709542|B2|United States||Region of Enrollment||participants|Number|162|162.0||||||
3884294|NCT01541553|3709543|B1|United States||Region of Enrollment||participants|Number|167|167.0||||||
3884295|NCT01541553|3709541|B3||Male|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
3884296|NCT01541553|3709542|B2||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3884297|NCT01541553|3709543|B1||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3884298|NCT01541553|3709541|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3884299|NCT01541553|3709542|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3884300|NCT01541553|3709543|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3884301|NCT01541553|3709541|B3||>=65 years|Age||Participants|Count of Participants|196|196.0||||||
3884302|NCT01541553|3709542|B2||>=65 years|Age||Participants|Count of Participants|101|101.0||||||
3884303|NCT01541553|3709543|B1||>=65 years|Age||Participants|Count of Participants|95|95.0||||||
3884304|NCT01541553|3709541|B3||Between 18 and 65 years|Age||Participants|Count of Participants|133|133.0||||||
3884305|NCT01541553|3709542|B2||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
3884306|NCT01541553|3709543|B1||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
3884307|NCT01541553|3709541|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3884308|NCT01541553|3709542|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3884309|NCT01541553|3709543|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3884310|NCT01541553|3709541|B3|||Age||years|Mean|67|67.0|Standard Deviation|9.3|9.3|||
3884311|NCT01541553|3709542|B2|||Age||years|Mean|67.4|67.4|Standard Deviation|9.3|9.3|||
3884312|NCT01541553|3709543|B1|||Age||years|Mean|66.7|66.7|Standard Deviation|9.4|9.4|||
3884313|NCT01541397|3709554|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3884314|NCT01541397|3709555|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3884315|NCT01541397|3709556|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3884316|NCT01541397|3709554|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3884317|NCT01541397|3709555|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3884318|NCT01541397|3709556|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3884319|NCT01541397|3709554|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3884320|NCT01541397|3709555|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3884321|NCT01541397|3709556|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3884322|NCT01541397|3709554|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3884323|NCT01541397|3709555|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3884324|NCT01541397|3709556|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3884325|NCT01541397|3709554|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3884326|NCT01541397|3709555|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3884327|NCT01541397|3709556|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3884328|NCT01541384|3709569|B4|United States||Region of Enrollment||participants|Number|120|120.0||||||
3884329|NCT01541384|3709570|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3884330|NCT01541384|3709571|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
3884331|NCT01541384|3709572|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3884332|NCT01541384|3709569|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3884333|NCT01541384|3709570|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3884334|NCT01541384|3709571|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3884335|NCT01541384|3709572|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3884336|NCT01541384|3709569|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884337|NCT01541384|3709570|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884338|NCT01541384|3709571|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884339|NCT01541384|3709572|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884340|NCT01541384|3709569|B4||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3884341|NCT01541384|3709570|B3||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3884342|NCT01541384|3709571|B2||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3884343|NCT01541384|3709572|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3884344|NCT01541384|3709569|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3884345|NCT01541384|3709570|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3884346|NCT01541384|3709571|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3884347|NCT01541384|3709572|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3884348|NCT01541384|3709569|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884349|NCT01541384|3709570|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884350|NCT01541384|3709571|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884351|NCT01541384|3709572|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884352|NCT01541384|3709569|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884353|NCT01541384|3709570|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884354|NCT01541384|3709571|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884355|NCT01541384|3709572|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884356|NCT01541384|3709569|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884357|NCT01541384|3709570|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884358|NCT01541384|3709571|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884359|NCT01541384|3709572|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884360|NCT01541384|3709569|B4||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3884361|NCT01541384|3709570|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3884362|NCT01541384|3709571|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3884363|NCT01541384|3709572|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3884364|NCT01541384|3709569|B4||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3884365|NCT01541384|3709570|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3884366|NCT01541384|3709571|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3884367|NCT01541384|3709572|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3884368|NCT01541384|3709569|B4|||Age||years|Mean|50|50.0|Standard Deviation|11|11.0|||
3884369|NCT01541384|3709570|B3|||Age||years|Mean|49|49.0|Standard Deviation|11|11.0|||
3884370|NCT01541384|3709571|B2|||Age||years|Mean|50|50.0|Standard Deviation|11|11.0|||
3884371|NCT01541384|3709572|B1|||Age||years|Mean|50|50.0|Standard Deviation|12|12.0|||
3884372|NCT01541371|3709582|B1||Male|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
3884373|NCT01541371|3709582|B1||Female|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
3884374|NCT01541371|3709582|B1|||Age|Information for demographics (age) was missing for 2 participants.|Years|Mean|30.88|30.88|Standard Deviation|10.39|10.39|||
3884375|NCT01541358|3709605|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3884376|NCT01541358|3709605|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884377|NCT01541358|3709605|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884378|NCT01541358|3709605|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884379|NCT01541358|3709605|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884380|NCT01541358|3709605|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884381|NCT01541358|3709605|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884382|NCT01541358|3709605|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3884383|NCT01541358|3709605|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884384|NCT01541358|3709605|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884385|NCT01541358|3709605|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3884386|NCT01541358|3709605|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3884387|NCT01541358|3709605|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3884388|NCT01541358|3709605|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3884389|NCT01541358|3709605|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3884390|NCT01541254|3709611|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
3884391|NCT01541254|3709611|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3884392|NCT01541254|3709611|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3884393|NCT01541254|3709611|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3884394|NCT01541254|3709611|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3884395|NCT01541254|3709611|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3884396|NCT01541254|3709611|B1|||Age||years|Mean|58.6|58.6|Standard Deviation|10.6|10.6|||
3884397|NCT01541215|3709616|B3|||Glycosylated hemoglobin (HbA1c)||percentage of HbA1c|Mean|7.78|7.78|Standard Deviation|1.34|1.34|||
3884398|NCT01541215|3709617|B2|||Glycosylated hemoglobin (HbA1c)||percentage of HbA1c|Mean|7.69|7.69|Standard Deviation|1.34|1.34|||
3884399|NCT01541215|3709618|B1|||Glycosylated hemoglobin (HbA1c)||percentage of HbA1c|Mean|7.87|7.87|Standard Deviation|1.35|1.35|||
3884400|NCT01541215|3709616|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3884401|NCT01541215|3709617|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3884402|NCT01541215|3709618|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3884403|NCT01541215|3709616|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884404|NCT01541215|3709617|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884405|NCT01541215|3709618|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884406|NCT01541215|3709616|B3||White|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3884407|NCT01541215|3709617|B2||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3884408|NCT01541215|3709618|B1||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3884409|NCT01541215|3709616|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3884410|NCT01541215|3709617|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3884411|NCT01541215|3709618|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3884412|NCT01541215|3709616|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884413|NCT01541215|3709617|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884414|NCT01541215|3709618|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884415|NCT01541215|3709616|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3884416|NCT01541215|3709617|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3884417|NCT01541215|3709618|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3884418|NCT01541215|3709616|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3884419|NCT01541215|3709617|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3884420|NCT01541215|3709618|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3884421|NCT01541215|3709616|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884422|NCT01541215|3709617|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884423|NCT01541215|3709618|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884424|NCT01541215|3709616|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3884425|NCT01541215|3709617|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3884426|NCT01541215|3709618|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3884427|NCT01541215|3709616|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3884428|NCT01541215|3709617|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3884429|NCT01541215|3709618|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3884430|NCT01541215|3709616|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3884431|NCT01541215|3709617|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3884432|NCT01541215|3709618|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3884433|NCT01541215|3709616|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3884434|NCT01541215|3709617|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3884435|NCT01541215|3709618|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3884436|NCT01541215|3709616|B3|||Age||years|Mean|14.57|14.57|Standard Deviation|1.72|1.72|||
3884437|NCT01541215|3709617|B2|||Age||years|Mean|14.57|14.57|Standard Deviation|1.73|1.73|||
3884438|NCT01541215|3709618|B1|||Age||years|Mean|14.57|14.57|Standard Deviation|1.73|1.73|||
3884439|NCT01540981|3709755|B3|||Age of Wound||days|Median|3.0|3.0|Full Range|||0.0|5.0|
3884440|NCT01540981|3709756|B2|||Age of Wound||days|Median|2.5|2.5|Full Range|||0.0|4.0|
3884441|NCT01540981|3709757|B1|||Age of Wound||days|Median|3.0|3.0|Full Range|||1.0|5.0|
3884442|NCT01540981|3709755|B3|Buttocks||Wound Location||participants|Number|1|1.0||||||
3884443|NCT01540981|3709756|B2|Buttocks||Wound Location||participants|Number|1|1.0||||||
3884444|NCT01540981|3709757|B1|Buttocks||Wound Location||participants|Number|0|0.0||||||
3884445|NCT01540981|3709755|B3|Sacrum/Coccyx||Wound Location||participants|Number|6|6.0||||||
3884446|NCT01540981|3709756|B2|Sacrum/Coccyx||Wound Location||participants|Number|2|2.0||||||
3884447|NCT01540981|3709757|B1|Sacrum/Coccyx||Wound Location||participants|Number|4|4.0||||||
3884448|NCT01540981|3709755|B3|Ischium||Wound Location||participants|Number|1|1.0||||||
3884449|NCT01540981|3709756|B2|Ischium||Wound Location||participants|Number|1|1.0||||||
3884450|NCT01540981|3709757|B1|Ischium||Wound Location||participants|Number|0|0.0||||||
3884451|NCT01540981|3709755|B3|Heel||Wound Location||participants|Number|3|3.0||||||
3884452|NCT01540981|3709756|B2|Heel||Wound Location||participants|Number|2|2.0||||||
3884453|NCT01540981|3709757|B1|Heel||Wound Location||participants|Number|1|1.0||||||
3884454|NCT01540981|3709755|B3|||Wound Size|Wound area measured as centimeters squared|centimeters squared|Median|7.4|7.4|Full Range|||0.6|168.8|
3884455|NCT01540981|3709756|B2|||Wound Size|Wound area measured as centimeters squared|centimeters squared|Median|13.9|13.9|Full Range|||1.0|168.8|
3884456|NCT01540981|3709757|B1|||Wound Size|Wound area measured as centimeters squared|centimeters squared|Median|3.8|3.8|Full Range|||0.6|10.0|
3884457|NCT01540981|3709755|B3|Other||Type of Injury Leading to Suspected DTI||participants|Number|3|3.0||||||
3884458|NCT01540981|3709756|B2|Other||Type of Injury Leading to Suspected DTI||participants|Number|1|1.0||||||
3884459|NCT01540981|3709757|B1|Other||Type of Injury Leading to Suspected DTI||participants|Number|2|2.0||||||
3884460|NCT01540981|3709755|B3|Cardiac Arrest/Hemodynamic Crash||Type of Injury Leading to Suspected DTI||participants|Number|1|1.0||||||
3884461|NCT01540981|3709756|B2|Cardiac Arrest/Hemodynamic Crash||Type of Injury Leading to Suspected DTI||participants|Number|0|0.0||||||
3884462|NCT01540981|3709757|B1|Cardiac Arrest/Hemodynamic Crash||Type of Injury Leading to Suspected DTI||participants|Number|1|1.0||||||
3884463|NCT01540981|3709755|B3|Shearing||Type of Injury Leading to Suspected DTI||participants|Number|1|1.0||||||
3884464|NCT01540981|3709756|B2|Shearing||Type of Injury Leading to Suspected DTI||participants|Number|0|0.0||||||
3884465|NCT01540981|3709757|B1|Shearing||Type of Injury Leading to Suspected DTI||participants|Number|1|1.0||||||
3884466|NCT01540981|3709755|B3|Sustained Immobility||Type of Injury Leading to Suspected DTI||participants|Number|6|6.0||||||
3884467|NCT01540981|3709756|B2|Sustained Immobility||Type of Injury Leading to Suspected DTI||participants|Number|5|5.0||||||
3884468|NCT01540981|3709757|B1|Sustained Immobility||Type of Injury Leading to Suspected DTI||participants|Number|1|1.0||||||
3884469|NCT01540981|3709755|B3|||BMI|kilograms per meter squared|kilograms per meter squared|Median|28.6|28.6|Full Range|||22.2|55.4|
3884526|NCT01540825|3709779|B12||Male|Gender||Participants|Count of Participants|80|80.0||||||
3884470|NCT01540981|3709756|B2|||BMI|kilograms per meter squared|kilograms per meter squared|Median|27.7|27.7|Full Range|||24.4|45.4|
3884471|NCT01540981|3709757|B1|||BMI|kilograms per meter squared|kilograms per meter squared|Median|28.6|28.6|Full Range|||22.2|55.4|
3884472|NCT01540981|3709755|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3884473|NCT01540981|3709756|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3884474|NCT01540981|3709757|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3884475|NCT01540981|3709755|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884476|NCT01540981|3709756|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884477|NCT01540981|3709757|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884478|NCT01540981|3709755|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884479|NCT01540981|3709756|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884480|NCT01540981|3709757|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884481|NCT01540981|3709755|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3884482|NCT01540981|3709756|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3884483|NCT01540981|3709757|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3884484|NCT01540981|3709755|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884485|NCT01540981|3709756|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884486|NCT01540981|3709757|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884487|NCT01540981|3709755|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884488|NCT01540981|3709756|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884489|NCT01540981|3709757|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884490|NCT01540981|3709755|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884491|NCT01540981|3709756|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884492|NCT01540981|3709757|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884493|NCT01540981|3709755|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884494|NCT01540981|3709756|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884495|NCT01540981|3709757|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884496|NCT01540981|3709755|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3884497|NCT01540981|3709756|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3884498|NCT01540981|3709757|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3884499|NCT01540981|3709755|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3884500|NCT01540981|3709756|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3884501|NCT01540981|3709757|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3884502|NCT01540981|3709755|B3|||Age||years|Median|65|65.0|Full Range|||28.0|77.0|
3884503|NCT01540981|3709756|B2|||Age||years|Median|69.5|69.5|Full Range|||62.0|77.0|
3884504|NCT01540981|3709757|B1|||Age||years|Median|55|55.0|Full Range|||28.0|77.0|
3884505|NCT01540851|3709766|B3|||WOMAC Pain score|The WOMAC Pain scale is scaled from 0 to 100, with 100 worst|units on a scale|Mean|41|41.0|Standard Deviation|18|18.0|||
3884506|NCT01540851|3709767|B2|||WOMAC Pain score|The WOMAC Pain scale is scaled from 0 to 100, with 100 worst|units on a scale|Mean|40|40.0|Standard Deviation|19|19.0|||
3884507|NCT01540851|3709768|B1|||WOMAC Pain score|The WOMAC Pain scale is scaled from 0 to 100, with 100 worst|units on a scale|Mean|42|42.0|Standard Deviation|16|16.0|||
3884508|NCT01540851|3709766|B3|||WOMAC Physical Function score|The WOMAC Physical Function scale is scaled from 0 to 100, with 100 worst|units on a scale|Mean|41|41.0|Standard Deviation|17|17.0|||
3884509|NCT01540851|3709767|B2|||WOMAC Physical Function score|The WOMAC Physical Function scale is scaled from 0 to 100, with 100 worst|units on a scale|Mean|41|41.0|Standard Deviation|19|19.0|||
3884510|NCT01540851|3709768|B1|||WOMAC Physical Function score|The WOMAC Physical Function scale is scaled from 0 to 100, with 100 worst|units on a scale|Mean|42|42.0|Standard Deviation|16|16.0|||
3884511|NCT01540851|3709766|B3|||BMI||kg/m^2|Mean|31|31.0|Standard Deviation|6|6.0|||
3884512|NCT01540851|3709767|B2|||BMI||kg/m^2|Mean|31|31.0|Standard Deviation|6|6.0|||
3884513|NCT01540851|3709768|B1|||BMI||kg/m^2|Mean|31|31.0|Standard Deviation|6|6.0|||
3884514|NCT01540851|3709766|B3|United States||Region of Enrollment||participants|Number|308|308.0||||||
3884515|NCT01540851|3709767|B2|United States||Region of Enrollment||participants|Number|154|154.0||||||
3884516|NCT01540851|3709768|B1|United States||Region of Enrollment||participants|Number|154|154.0||||||
3884517|NCT01540851|3709766|B3||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3884518|NCT01540851|3709767|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3884519|NCT01540851|3709768|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3884520|NCT01540851|3709766|B3||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
3884521|NCT01540851|3709767|B2||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3884522|NCT01540851|3709768|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3884523|NCT01540851|3709766|B3|||Age||years|Mean|66|66.0|Standard Deviation|8|8.0|||
3884524|NCT01540851|3709767|B2|||Age||years|Mean|67|67.0|Standard Deviation|8|8.0|||
3884525|NCT01540851|3709768|B1|||Age||years|Mean|66|66.0|Standard Deviation|8|8.0|||
3884527|NCT01540825|3709780|B11||Male|Gender||Participants|Count of Participants|6|6.0||||||
3884528|NCT01540825|3709781|B10||Male|Gender||Participants|Count of Participants|6|6.0||||||
3884529|NCT01540825|3709782|B9||Male|Gender||Participants|Count of Participants|6|6.0||||||
3884530|NCT01540825|3709783|B8||Male|Gender||Participants|Count of Participants|6|6.0||||||
3884531|NCT01540825|3709784|B7||Male|Gender||Participants|Count of Participants|6|6.0||||||
3884532|NCT01540825|3709785|B6||Male|Gender||Participants|Count of Participants|6|6.0||||||
3884533|NCT01540825|3709786|B5||Male|Gender||Participants|Count of Participants|6|6.0||||||
3884534|NCT01540825|3709787|B4||Male|Gender||Participants|Count of Participants|6|6.0||||||
3884535|NCT01540825|3709788|B3||Male|Gender||Participants|Count of Participants|6|6.0||||||
3884536|NCT01540825|3709789|B2||Male|Gender||Participants|Count of Participants|6|6.0||||||
3884537|NCT01540825|3709790|B1||Male|Gender||Participants|Count of Participants|20|20.0||||||
3884538|NCT01540825|3709779|B12||Female|Gender||Participants|Count of Participants|0|0.0||||||
3884539|NCT01540825|3709780|B11||Female|Gender||Participants|Count of Participants|0|0.0||||||
3884540|NCT01540825|3709781|B10||Female|Gender||Participants|Count of Participants|0|0.0||||||
3884541|NCT01540825|3709782|B9||Female|Gender||Participants|Count of Participants|0|0.0||||||
3884542|NCT01540825|3709783|B8||Female|Gender||Participants|Count of Participants|0|0.0||||||
3884543|NCT01540825|3709784|B7||Female|Gender||Participants|Count of Participants|0|0.0||||||
3884544|NCT01540825|3709785|B6||Female|Gender||Participants|Count of Participants|0|0.0||||||
3884545|NCT01540825|3709786|B5||Female|Gender||Participants|Count of Participants|0|0.0||||||
3884546|NCT01540825|3709787|B4||Female|Gender||Participants|Count of Participants|0|0.0||||||
3884547|NCT01540825|3709788|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
3884548|NCT01540825|3709789|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
3884549|NCT01540825|3709790|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3884550|NCT01540825|3709779|B12|||Age||Years|Mean|35.9|35.9|Standard Deviation|10.0|10.0|||
3884551|NCT01540825|3709780|B11|||Age||Years|Mean|38.8|38.8|Standard Deviation|9.2|9.2|||
3884552|NCT01540825|3709781|B10|||Age||Years|Mean|35.3|35.3|Standard Deviation|11.3|11.3|||
3884553|NCT01540825|3709782|B9|||Age||Years|Mean|39.7|39.7|Standard Deviation|11.7|11.7|||
3884554|NCT01540825|3709783|B8|||Age||Years|Mean|37.2|37.2|Standard Deviation|11.8|11.8|||
3884555|NCT01540825|3709784|B7|||Age||Years|Mean|30.5|30.5|Standard Deviation|9.6|9.6|||
3884556|NCT01540825|3709785|B6|||Age||Years|Mean|41.2|41.2|Standard Deviation|4.6|4.6|||
3884557|NCT01540825|3709786|B5|||Age||Years|Mean|28.5|28.5|Standard Deviation|9.5|9.5|||
3884558|NCT01540825|3709787|B4|||Age||Years|Mean|36.8|36.8|Standard Deviation|12.8|12.8|||
3884559|NCT01540825|3709788|B3|||Age||Years|Mean|34.8|34.8|Standard Deviation|6.4|6.4|||
3884560|NCT01540825|3709789|B2|||Age||Years|Mean|29.2|29.2|Standard Deviation|8.1|8.1|||
3884561|NCT01540825|3709790|B1|||Age||Years|Mean|38.0|38.0|Standard Deviation|10.0|10.0|||
3884562|NCT01540773|3709896|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3884563|NCT01540773|3709896|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884564|NCT01540773|3709896|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3884565|NCT01540773|3709896|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3884566|NCT01540773|3709896|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3884567|NCT01540773|3709896|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884568|NCT01540773|3709896|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884569|NCT01540773|3709896|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884570|NCT01540773|3709896|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3884571|NCT01540773|3709896|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3884572|NCT01540773|3709896|B1|||Age||years|Mean|23|23.0|Standard Deviation|14|14.0|||
3884573|NCT01540773|3709896|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3884574|NCT01540773|3709896|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3884575|NCT01540773|3709896|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3884576|NCT01540513|3709907|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3884577|NCT01540513|3709907|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884578|NCT01540513|3709907|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884579|NCT01540513|3709907|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3884580|NCT01540513|3709907|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884581|NCT01540513|3709907|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884582|NCT01540513|3709907|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884583|NCT01540513|3709907|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884584|NCT01540513|3709907|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884585|NCT01540513|3709907|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3884586|NCT01540513|3709907|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884587|NCT01540513|3709907|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3884588|NCT01540513|3709907|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3884589|NCT01540513|3709907|B1|||Age||years|Mean|43.9|43.9|Full Range|||23.0|66.0|
3884590|NCT01540513|3709907|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3884591|NCT01540513|3709907|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3884592|NCT01540513|3709907|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3884593|NCT01540487|3709914|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3884594|NCT01540487|3709915|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3884595|NCT01540487|3709916|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3884596|NCT01540487|3709914|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3884597|NCT01540487|3709915|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3884598|NCT01540487|3709916|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3884599|NCT01540487|3709914|B3|||Age||years|Mean|28.2|28.2|Standard Deviation|4.6|4.6|||
3884600|NCT01540487|3709915|B2|||Age||years|Mean|28.6|28.6|Standard Deviation|4.8|4.8|||
3884601|NCT01540487|3709916|B1|||Age||years|Mean|27.8|27.8|Standard Deviation|4.4|4.4|||
3884602|NCT01540370|3709951|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3884603|NCT01540370|3709951|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3884604|NCT01540370|3709951|B1|||Age||Years|Mean|64.1|64.1|Standard Deviation|12.18|12.18|||
3884605|NCT01540266|3709956|B7|Germany||Region of Enrollment||participants|Number|97|97.0||||||
3884606|NCT01540266|3709957|B6|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3884607|NCT01540266|3709958|B5|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3884608|NCT01540266|3709959|B4|Germany||Region of Enrollment||participants|Number|38|38.0||||||
3884609|NCT01540266|3709960|B3|Germany||Region of Enrollment||participants|Number|59|59.0||||||
3884610|NCT01540266|3709961|B2|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3884611|NCT01540266|3709962|B1|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3884612|NCT01540266|3709956|B7|Switzerland||Region of Enrollment||participants|Number|137|137.0||||||
3884613|NCT01540266|3709957|B6|Switzerland||Region of Enrollment||participants|Number|19|19.0||||||
3884614|NCT01540266|3709958|B5|Switzerland||Region of Enrollment||participants|Number|20|20.0||||||
3884615|NCT01540266|3709959|B4|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
3884616|NCT01540266|3709960|B3|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
3884617|NCT01540266|3709961|B2|Switzerland||Region of Enrollment||participants|Number|41|41.0||||||
3884618|NCT01540266|3709962|B1|Switzerland||Region of Enrollment||participants|Number|57|57.0||||||
3884619|NCT01540266|3709956|B7||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3884620|NCT01540266|3709957|B6||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3884621|NCT01540266|3709958|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3884622|NCT01540266|3709959|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3884623|NCT01540266|3709960|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3884624|NCT01540266|3709961|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3884625|NCT01540266|3709962|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3884626|NCT01540266|3709956|B7||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3884627|NCT01540266|3709957|B6||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3884628|NCT01540266|3709958|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3884629|NCT01540266|3709959|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3884630|NCT01540266|3709960|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3884631|NCT01540266|3709961|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3884632|NCT01540266|3709962|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3884633|NCT01540266|3709956|B7|||Age||years|Mean|22|22.0|Standard Deviation|3.6|3.6|||
3884634|NCT01540266|3709957|B6|||Age||years|Mean|24|24.0|Standard Deviation|4.5|4.5|||
3884635|NCT01540266|3709958|B5|||Age||years|Mean|23|23.0|Standard Deviation|0.9|0.9|||
3884636|NCT01540266|3709959|B4|||Age||years|Mean|22|22.0|Standard Deviation|3.6|3.6|||
3884637|NCT01540266|3709960|B3|||Age||years|Mean|21|21.0|Standard Deviation|3.1|3.1|||
3884638|NCT01540266|3709961|B2|||Age||years|Mean|22|22.0|Standard Deviation|4.3|4.3|||
3884639|NCT01540266|3709962|B1|||Age||years|Mean|22|22.0|Standard Deviation|3.5|3.5|||
3884640|NCT01540266|3709956|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3884641|NCT01540266|3709957|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3884642|NCT01540266|3709958|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3884643|NCT01540266|3709959|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3884644|NCT01540266|3709960|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3884645|NCT01540266|3709961|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3884646|NCT01540266|3709962|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3884647|NCT01540266|3709956|B7||Between 18 and 65 years|Age||Participants|Count of Participants|234|234.0||||||
3884648|NCT01540266|3709957|B6||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3884649|NCT01540266|3709958|B5||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3884650|NCT01540266|3709959|B4||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3884651|NCT01540266|3709960|B3||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
3884652|NCT01540266|3709961|B2||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3884653|NCT01540266|3709962|B1||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
3884654|NCT01540266|3709956|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3884655|NCT01540266|3709957|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3884656|NCT01540266|3709958|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3884657|NCT01540266|3709959|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3884658|NCT01540266|3709960|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3884659|NCT01540266|3709961|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3884660|NCT01540266|3709962|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3884661|NCT01540162|3709981|B3|Ukraine||Region of Enrollment||participants|Number|62|62.0||||||
3884662|NCT01540162|3709982|B2|Ukraine||Region of Enrollment||participants|Number|32|32.0||||||
3884663|NCT01540162|3709983|B1|Ukraine||Region of Enrollment||participants|Number|30|30.0||||||
3884664|NCT01540162|3709981|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3884665|NCT01540162|3709982|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3884666|NCT01540162|3709983|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3884667|NCT01540162|3709981|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3884668|NCT01540162|3709982|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3884669|NCT01540162|3709983|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3884670|NCT01540162|3709981|B3||>=65 years|Age|Newborns|Participants|Count of Participants|0|0.0||||||
3884671|NCT01540162|3709982|B2||>=65 years|Age|Newborns|Participants|Count of Participants|0|0.0||||||
3884672|NCT01540162|3709983|B1||>=65 years|Age|Newborns|Participants|Count of Participants|0|0.0||||||
3884673|NCT01540162|3709981|B3||Between 18 and 65 years|Age|Newborns|Participants|Count of Participants|0|0.0||||||
3884674|NCT01540162|3709982|B2||Between 18 and 65 years|Age|Newborns|Participants|Count of Participants|0|0.0||||||
3884675|NCT01540162|3709983|B1||Between 18 and 65 years|Age|Newborns|Participants|Count of Participants|0|0.0||||||
3884676|NCT01540162|3709981|B3||<=18 years|Age|Newborns|Participants|Count of Participants|62|62.0||||||
3884677|NCT01540162|3709982|B2||<=18 years|Age|Newborns|Participants|Count of Participants|32|32.0||||||
3884678|NCT01540162|3709983|B1||<=18 years|Age|Newborns|Participants|Count of Participants|30|30.0||||||
3884679|NCT01540045|3709994|B1|Mexico||Region of Enrollment||participants|Number|40|40.0||||||
3884680|NCT01540045|3709994|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3884681|NCT01540045|3709994|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3884682|NCT01540045|3709994|B1|||Age||years|Mean|55.5|55.5|Standard Deviation|15|15.0|||
3884683|NCT01539980|3710033|B1|||Body temperature||Degree celcius|Mean|36.73|36.73|Standard Deviation|0.37|0.37|||
3884684|NCT01539980|3710033|B1|||Wound size||square centrimeter|Mean|124.74|124.74|Standard Deviation|86.72|86.72|||
3884685|NCT01539980|3710033|B1|Thailand||Region of Enrollment||participants|Number|30|30.0||||||
3884686|NCT01539980|3710033|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3884687|NCT01539980|3710033|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3884688|NCT01539980|3710033|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3884689|NCT01539980|3710033|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3884690|NCT01539980|3710033|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3884691|NCT01539759|3710050|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3884692|NCT01539759|3710051|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3884693|NCT01539759|3710052|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3884694|NCT01539759|3710050|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3884695|NCT01539759|3710051|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3884696|NCT01539759|3710052|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3884697|NCT01539759|3710050|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3884698|NCT01539759|3710051|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3884699|NCT01539759|3710052|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3884700|NCT01539759|3710050|B3|Black||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3884701|NCT01539759|3710051|B2|Black||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3884702|NCT01539759|3710052|B1|Black||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3884703|NCT01539759|3710050|B3|White||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
3884704|NCT01539759|3710051|B2|White||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3884705|NCT01539759|3710052|B1|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3884706|NCT01539759|3710050|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3884707|NCT01539759|3710051|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3884708|NCT01539759|3710052|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3884709|NCT01539759|3710050|B3||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3884710|NCT01539759|3710051|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3884711|NCT01539759|3710052|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3884712|NCT01539759|3710050|B3|||Age||years|Mean|28|28.0|Standard Deviation|.51|0.51|||
3884713|NCT01539759|3710051|B2|||Age||years|Mean|28|28.0|Standard Deviation|.57|0.57|||
3884714|NCT01539759|3710052|B1|||Age||years|Mean|29|29.0|Standard Deviation|.51|0.51|||
3884715|NCT01539642|3710063|B3|United States||Region of Enrollment||participants|Number|172|172.0||||||
3884716|NCT01539642|3710064|B2|United States||Region of Enrollment||participants|Number|58|58.0||||||
3884717|NCT01539642|3710065|B1|United States||Region of Enrollment||participants|Number|114|114.0||||||
3884718|NCT01539642|3710063|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3884719|NCT01539642|3710064|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3884720|NCT01539642|3710065|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3884721|NCT01539642|3710063|B3||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3884722|NCT01539642|3710064|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3884723|NCT01539642|3710065|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3884724|NCT01539642|3710063|B3|||Age||years|Mean|55.2|55.2|Standard Deviation|14.0|14.0|||
3884725|NCT01539642|3710064|B2|||Age||years|Mean|57.4|57.4|Standard Deviation|14.9|14.9|||
3884726|NCT01539642|3710065|B1|||Age||years|Mean|54.2|54.2|Standard Deviation|13.5|13.5|||
3884727|NCT01539642|3710063|B3||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
3884728|NCT01539642|3710064|B2||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3884729|NCT01539642|3710065|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3884730|NCT01539642|3710063|B3||Between 18 and 65 years|Age||Participants|Count of Participants|127|127.0||||||
3884731|NCT01539642|3710064|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3884732|NCT01539642|3710065|B1||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
3884733|NCT01539642|3710063|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3884734|NCT01539642|3710064|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3884735|NCT01539642|3710065|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3884736|NCT01539590|3710072|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3884737|NCT01539590|3710073|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3884738|NCT01539590|3710074|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3884739|NCT01539590|3710072|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3884740|NCT01539590|3710073|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3884741|NCT01539590|3710074|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3884742|NCT01539590|3710072|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3884743|NCT01539590|3710073|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3884744|NCT01539590|3710074|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3884745|NCT01539590|3710072|B3|||Age||years|Mean|59|59.0|Full Range|||46.0|75.0|
3884746|NCT01539590|3710073|B2|||Age||years|Mean|57.5|57.5|Full Range|||46.0|69.0|
3884747|NCT01539590|3710074|B1|||Age||years|Mean|61|61.0|Full Range|||50.0|75.0|
3884748|NCT01539538|3710081|B3|United States||Region of Enrollment||participants|Number|357|357.0||||||
3884749|NCT01539538|3710082|B2|United States||Region of Enrollment||participants|Number|180|180.0||||||
3884750|NCT01539538|3710083|B1|United States||Region of Enrollment||participants|Number|177|177.0||||||
3884751|NCT01539538|3710081|B3||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3884752|NCT01539538|3710082|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3884753|NCT01539538|3710083|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3884754|NCT01539538|3710081|B3||Female|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
3884755|NCT01539538|3710082|B2||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3884756|NCT01539538|3710083|B1||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3884757|NCT01539538|3710081|B3|||Age||years|Mean|64|64.0|Standard Deviation|12.4|12.4|||
3884758|NCT01539538|3710082|B2|||Age||years|Mean|64|64.0|Standard Deviation|12.6|12.6|||
3884759|NCT01539538|3710083|B1|||Age||years|Mean|64|64.0|Standard Deviation|12.1|12.1|||
3884760|NCT01539538|3710081|B3||>=65 years|Age||Participants|Count of Participants|187|187.0||||||
3884761|NCT01539538|3710082|B2||>=65 years|Age||Participants|Count of Participants|95|95.0||||||
3884762|NCT01539538|3710083|B1||>=65 years|Age||Participants|Count of Participants|92|92.0||||||
3884763|NCT01539538|3710081|B3||Between 18 and 65 years|Age||Participants|Count of Participants|170|170.0||||||
3884764|NCT01539538|3710082|B2||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
3884765|NCT01539538|3710083|B1||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
3884766|NCT01539538|3710081|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3884767|NCT01539538|3710082|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3884768|NCT01539538|3710083|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3884769|NCT01539525|3710090|B4|||Fagerstrom Test for Nicotine Dependence Score|Scores range from 0 to 10, with higher scores indicating higher levels of nicotine dependence.|units on a scale|Mean|3.9|3.9|Standard Deviation|2.6|2.6|||
3884770|NCT01539525|3710091|B3|||Fagerstrom Test for Nicotine Dependence Score|Scores range from 0 to 10, with higher scores indicating higher levels of nicotine dependence.|units on a scale|Mean|3.9|3.9|Standard Deviation|2.7|2.7|||
3884771|NCT01539525|3710092|B2|||Fagerstrom Test for Nicotine Dependence Score|Scores range from 0 to 10, with higher scores indicating higher levels of nicotine dependence.|units on a scale|Mean|3.6|3.6|Standard Deviation|2.8|2.8|||
3884772|NCT01539525|3710093|B1|||Fagerstrom Test for Nicotine Dependence Score|Scores range from 0 to 10, with higher scores indicating higher levels of nicotine dependence.|units on a scale|Mean|3.8|3.8|Standard Deviation|2.7|2.7|||
3884829|NCT01539525|3710090|B4|missing||Education||participants|Number|2|2.0||||||
3884830|NCT01539525|3710091|B3|missing||Education||participants|Number|0|0.0||||||
3884773|NCT01539525|3710090|B4|||Alcohol, Smoking, and Substance Involvement Screening Test Score|Scores range from 0 to 39, with higher scores indicating greater need for more intensive intervention. Scores are for primary substance.|units on a scale|Mean|22.5|22.5|Standard Deviation|7.9|7.9|||
3884774|NCT01539525|3710091|B3|||Alcohol, Smoking, and Substance Involvement Screening Test Score|Scores range from 0 to 39, with higher scores indicating greater need for more intensive intervention. Scores are for primary substance.|units on a scale|Mean|22.2|22.2|Standard Deviation|8.1|8.1|||
3884775|NCT01539525|3710092|B2|||Alcohol, Smoking, and Substance Involvement Screening Test Score|Scores range from 0 to 39, with higher scores indicating greater need for more intensive intervention. Scores are for primary substance.|units on a scale|Mean|22.8|22.8|Standard Deviation|8.5|8.5|||
3884776|NCT01539525|3710093|B1|||Alcohol, Smoking, and Substance Involvement Screening Test Score|Scores range from 0 to 39, with higher scores indicating greater need for more intensive intervention. Scores are for primary substance.|units on a scale|Mean|22.5|22.5|Standard Deviation|8.1|8.1|||
3884777|NCT01539525|3710090|B4|Other illicit drug||Substance Use Disorders||participants|Number|47|47.0||||||
3884778|NCT01539525|3710091|B3|Other illicit drug||Substance Use Disorders||participants|Number|17|17.0||||||
3884779|NCT01539525|3710092|B2|Other illicit drug||Substance Use Disorders||participants|Number|13|13.0||||||
3884780|NCT01539525|3710093|B1|Other illicit drug||Substance Use Disorders||participants|Number|17|17.0||||||
3884781|NCT01539525|3710090|B4|Cannabis||Substance Use Disorders||participants|Number|90|90.0||||||
3884782|NCT01539525|3710091|B3|Cannabis||Substance Use Disorders||participants|Number|31|31.0||||||
3884783|NCT01539525|3710092|B2|Cannabis||Substance Use Disorders||participants|Number|27|27.0||||||
3884784|NCT01539525|3710093|B1|Cannabis||Substance Use Disorders||participants|Number|32|32.0||||||
3884785|NCT01539525|3710090|B4|Alcohol||Substance Use Disorders||participants|Number|51|51.0||||||
3884786|NCT01539525|3710091|B3|Alcohol||Substance Use Disorders||participants|Number|13|13.0||||||
3884787|NCT01539525|3710092|B2|Alcohol||Substance Use Disorders||participants|Number|23|23.0||||||
3884788|NCT01539525|3710093|B1|Alcohol||Substance Use Disorders||participants|Number|15|15.0||||||
3884789|NCT01539525|3710090|B4|Nicotine||Substance Use Disorders||participants|Number|251|251.0||||||
3884790|NCT01539525|3710091|B3|Nicotine||Substance Use Disorders||participants|Number|90|90.0||||||
3884791|NCT01539525|3710092|B2|Nicotine||Substance Use Disorders||participants|Number|80|80.0||||||
3884792|NCT01539525|3710093|B1|Nicotine||Substance Use Disorders||participants|Number|81|81.0||||||
3884793|NCT01539525|3710090|B4|||Any substance use||days per month|Mean|25.7|25.7|Standard Deviation|5.9|5.9|||
3884794|NCT01539525|3710091|B3|||Any substance use||days per month|Mean|25.7|25.7|Standard Deviation|6.1|6.1|||
3884795|NCT01539525|3710092|B2|||Any substance use||days per month|Mean|25.4|25.4|Standard Deviation|6.2|6.2|||
3884796|NCT01539525|3710093|B1|||Any substance use||days per month|Mean|26.0|26.0|Standard Deviation|5.5|5.5|||
3884797|NCT01539525|3710090|B4|||Primary substance use||days per month|Mean|23.7|23.7|Standard Deviation|7.9|7.9|||
3884798|NCT01539525|3710091|B3|||Primary substance use||days per month|Mean|24.2|24.2|Standard Deviation|7.7|7.7|||
3884799|NCT01539525|3710092|B2|||Primary substance use||days per month|Mean|23.7|23.7|Standard Deviation|7.7|7.7|||
3884800|NCT01539525|3710093|B1|||Primary substance use||days per month|Mean|23.2|23.2|Standard Deviation|8.3|8.3|||
3884801|NCT01539525|3710090|B4|Other illicit drug||Primary Substance||participants|Number|47|47.0||||||
3884802|NCT01539525|3710091|B3|Other illicit drug||Primary Substance||participants|Number|17|17.0||||||
3884803|NCT01539525|3710092|B2|Other illicit drug||Primary Substance||participants|Number|13|13.0||||||
3884804|NCT01539525|3710093|B1|Other illicit drug||Primary Substance||participants|Number|17|17.0||||||
3884805|NCT01539525|3710090|B4|Cannabis||Primary Substance||participants|Number|90|90.0||||||
3884806|NCT01539525|3710091|B3|Cannabis||Primary Substance||participants|Number|31|31.0||||||
3884807|NCT01539525|3710092|B2|Cannabis||Primary Substance||participants|Number|27|27.0||||||
3884808|NCT01539525|3710093|B1|Cannabis||Primary Substance||participants|Number|32|32.0||||||
3884809|NCT01539525|3710090|B4|Alcohol||Primary Substance||participants|Number|51|51.0||||||
3884810|NCT01539525|3710091|B3|Alcohol||Primary Substance||participants|Number|13|13.0||||||
3884811|NCT01539525|3710092|B2|Alcohol||Primary Substance||participants|Number|23|23.0||||||
3884812|NCT01539525|3710093|B1|Alcohol||Primary Substance||participants|Number|15|15.0||||||
3884813|NCT01539525|3710090|B4|Nicotine||Primary Substance||participants|Number|251|251.0||||||
3884814|NCT01539525|3710091|B3|Nicotine||Primary Substance||participants|Number|90|90.0||||||
3884815|NCT01539525|3710092|B2|Nicotine||Primary Substance||participants|Number|80|80.0||||||
3884816|NCT01539525|3710093|B1|Nicotine||Primary Substance||participants|Number|81|81.0||||||
3884817|NCT01539525|3710090|B4|Not working||Employment status||participants|Number|291|291.0||||||
3884818|NCT01539525|3710091|B3|Not working||Employment status||participants|Number|99|99.0||||||
3884819|NCT01539525|3710092|B2|Not working||Employment status||participants|Number|89|89.0||||||
3884820|NCT01539525|3710093|B1|Not working||Employment status||participants|Number|103|103.0||||||
3884821|NCT01539525|3710090|B4|Part-time||Employment status||participants|Number|82|82.0||||||
3884822|NCT01539525|3710091|B3|Part-time||Employment status||participants|Number|32|32.0||||||
3884823|NCT01539525|3710092|B2|Part-time||Employment status||participants|Number|26|26.0||||||
3884824|NCT01539525|3710093|B1|Part-time||Employment status||participants|Number|24|24.0||||||
3884825|NCT01539525|3710090|B4|Full-time||Employment status||participants|Number|66|66.0||||||
3884826|NCT01539525|3710091|B3|Full-time||Employment status||participants|Number|20|20.0||||||
3884827|NCT01539525|3710092|B2|Full-time||Employment status||participants|Number|28|28.0||||||
3884828|NCT01539525|3710093|B1|Full-time||Employment status||participants|Number|18|18.0||||||
3884831|NCT01539525|3710092|B2|missing||Education||participants|Number|2|2.0||||||
3884832|NCT01539525|3710093|B1|missing||Education||participants|Number|0|0.0||||||
3884833|NCT01539525|3710090|B4|Beyond high school||Education||participants|Number|110|110.0||||||
3884834|NCT01539525|3710091|B3|Beyond high school||Education||participants|Number|42|42.0||||||
3884835|NCT01539525|3710092|B2|Beyond high school||Education||participants|Number|33|33.0||||||
3884836|NCT01539525|3710093|B1|Beyond high school||Education||participants|Number|35|35.0||||||
3884837|NCT01539525|3710090|B4|High school graduate||Education||participants|Number|181|181.0||||||
3884838|NCT01539525|3710091|B3|High school graduate||Education||participants|Number|57|57.0||||||
3884839|NCT01539525|3710092|B2|High school graduate||Education||participants|Number|60|60.0||||||
3884840|NCT01539525|3710093|B1|High school graduate||Education||participants|Number|64|64.0||||||
3884841|NCT01539525|3710090|B4|Some high school or less||Education||participants|Number|146|146.0||||||
3884842|NCT01539525|3710091|B3|Some high school or less||Education||participants|Number|52|52.0||||||
3884843|NCT01539525|3710092|B2|Some high school or less||Education||participants|Number|48|48.0||||||
3884844|NCT01539525|3710093|B1|Some high school or less||Education||participants|Number|46|46.0||||||
3884845|NCT01539525|3710090|B4|Not pregnant||Pregnant||participants|Number|359|359.0||||||
3884846|NCT01539525|3710091|B3|Not pregnant||Pregnant||participants|Number|122|122.0||||||
3884847|NCT01539525|3710092|B2|Not pregnant||Pregnant||participants|Number|119|119.0||||||
3884848|NCT01539525|3710093|B1|Not pregnant||Pregnant||participants|Number|118|118.0||||||
3884849|NCT01539525|3710090|B4|Pregnant||Pregnant||participants|Number|80|80.0||||||
3884850|NCT01539525|3710091|B3|Pregnant||Pregnant||participants|Number|29|29.0||||||
3884851|NCT01539525|3710092|B2|Pregnant||Pregnant||participants|Number|24|24.0||||||
3884852|NCT01539525|3710093|B1|Pregnant||Pregnant||participants|Number|27|27.0||||||
3884853|NCT01539525|3710090|B4|Other living situation||Marital Status||participants|Number|242|242.0||||||
3884854|NCT01539525|3710091|B3|Other living situation||Marital Status||participants|Number|78|78.0||||||
3884855|NCT01539525|3710092|B2|Other living situation||Marital Status||participants|Number|89|89.0||||||
3884856|NCT01539525|3710093|B1|Other living situation||Marital Status||participants|Number|75|75.0||||||
3884857|NCT01539525|3710090|B4|Married/living with partner||Marital Status||participants|Number|197|197.0||||||
3884858|NCT01539525|3710091|B3|Married/living with partner||Marital Status||participants|Number|73|73.0||||||
3884859|NCT01539525|3710092|B2|Married/living with partner||Marital Status||participants|Number|54|54.0||||||
3884860|NCT01539525|3710093|B1|Married/living with partner||Marital Status||participants|Number|70|70.0||||||
3884861|NCT01539525|3710090|B4|Other race/ethnicity||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3884862|NCT01539525|3710091|B3|Other race/ethnicity||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3884863|NCT01539525|3710092|B2|Other race/ethnicity||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3884864|NCT01539525|3710093|B1|Other race/ethnicity||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3884865|NCT01539525|3710090|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
3884866|NCT01539525|3710091|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3884867|NCT01539525|3710092|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3884868|NCT01539525|3710093|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3884869|NCT01539525|3710090|B4|Caucasian-American, non-Hispanic||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
3884870|NCT01539525|3710091|B3|Caucasian-American, non-Hispanic||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3884871|NCT01539525|3710092|B2|Caucasian-American, non-Hispanic||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3884872|NCT01539525|3710093|B1|Caucasian-American, non-Hispanic||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3884873|NCT01539525|3710090|B4|Afican-American, non-Hispanic||Race/Ethnicity, Customized||participants|Number|293|293.0||||||
3884874|NCT01539525|3710091|B3|Afican-American, non-Hispanic||Race/Ethnicity, Customized||participants|Number|98|98.0||||||
3884875|NCT01539525|3710092|B2|Afican-American, non-Hispanic||Race/Ethnicity, Customized||participants|Number|93|93.0||||||
3884876|NCT01539525|3710093|B1|Afican-American, non-Hispanic||Race/Ethnicity, Customized||participants|Number|102|102.0||||||
3884877|NCT01539525|3710090|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3884878|NCT01539525|3710091|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3884879|NCT01539525|3710092|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3884880|NCT01539525|3710093|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3884881|NCT01539525|3710090|B4||Female|Sex: Female, Male||Participants|Count of Participants|439|439.0||||||
3884882|NCT01539525|3710091|B3||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3884883|NCT01539525|3710092|B2||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3884884|NCT01539525|3710093|B1||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3884885|NCT01539525|3710090|B4|||Age||years|Mean|34.2|34.2|Standard Deviation|11.1|11.1|||
3884886|NCT01539525|3710091|B3|||Age||years|Mean|34.4|34.4|Standard Deviation|12.0|12.0|||
3884887|NCT01539525|3710092|B2|||Age||years|Mean|34.6|34.6|Standard Deviation|10.3|10.3|||
3884888|NCT01539525|3710093|B1|||Age||years|Mean|33.6|33.6|Standard Deviation|109|109.0|||
3884933|NCT01539512|3710114|B1|70||Karnofsky Performance Status|Classifies patients according to their functional impairment. Scores range from 0-100; the lower the score, the worse the survival for most serious illnesses.|participants|Number|20|20.0||||||
3884987|NCT01539512|3710114|B1|≥ 65 years||Age, Customized||participants|Number|89|89.0||||||
3884988|NCT01539512|3710112|B3|< 65 years||Age, Customized||participants|Number|48|48.0||||||
3884889|NCT01539512|3710112|B3|Missing||Binet Stage at Screening|"Binet staging classifies CLL according to the number of lymphoid tissues involved, as well as the presence of anemia or thrombocytopenia. Stage A: fewer than three areas of enlarged lymphoid tissue; enlarged lymph nodes of the neck, underarms, and groin, as well as the spleen, are each considered one group whether unilateral (one-sided) or bilateral (on both sides). Binet Stage B: more than three areas of enlarged lymphoid tissue. Binet Stage C: anemia plus thrombocytopenia."|participants|Number|25|25.0||||||
3884890|NCT01539512|3710113|B2|Missing||Binet Stage at Screening|"Binet staging classifies CLL according to the number of lymphoid tissues involved, as well as the presence of anemia or thrombocytopenia. Stage A: fewer than three areas of enlarged lymphoid tissue; enlarged lymph nodes of the neck, underarms, and groin, as well as the spleen, are each considered one group whether unilateral (one-sided) or bilateral (on both sides). Binet Stage B: more than three areas of enlarged lymphoid tissue. Binet Stage C: anemia plus thrombocytopenia."|participants|Number|14|14.0||||||
3884891|NCT01539512|3710114|B1|Missing||Binet Stage at Screening|"Binet staging classifies CLL according to the number of lymphoid tissues involved, as well as the presence of anemia or thrombocytopenia. Stage A: fewer than three areas of enlarged lymphoid tissue; enlarged lymph nodes of the neck, underarms, and groin, as well as the spleen, are each considered one group whether unilateral (one-sided) or bilateral (on both sides). Binet Stage B: more than three areas of enlarged lymphoid tissue. Binet Stage C: anemia plus thrombocytopenia."|participants|Number|11|11.0||||||
3884892|NCT01539512|3710112|B3|Binet Stage C||Binet Stage at Screening|"Binet staging classifies CLL according to the number of lymphoid tissues involved, as well as the presence of anemia or thrombocytopenia. Stage A: fewer than three areas of enlarged lymphoid tissue; enlarged lymph nodes of the neck, underarms, and groin, as well as the spleen, are each considered one group whether unilateral (one-sided) or bilateral (on both sides). Binet Stage B: more than three areas of enlarged lymphoid tissue. Binet Stage C: anemia plus thrombocytopenia."|participants|Number|123|123.0||||||
3884893|NCT01539512|3710113|B2|Binet Stage C||Binet Stage at Screening|"Binet staging classifies CLL according to the number of lymphoid tissues involved, as well as the presence of anemia or thrombocytopenia. Stage A: fewer than three areas of enlarged lymphoid tissue; enlarged lymph nodes of the neck, underarms, and groin, as well as the spleen, are each considered one group whether unilateral (one-sided) or bilateral (on both sides). Binet Stage B: more than three areas of enlarged lymphoid tissue. Binet Stage C: anemia plus thrombocytopenia."|participants|Number|60|60.0||||||
3884894|NCT01539512|3710114|B1|Binet Stage C||Binet Stage at Screening|"Binet staging classifies CLL according to the number of lymphoid tissues involved, as well as the presence of anemia or thrombocytopenia. Stage A: fewer than three areas of enlarged lymphoid tissue; enlarged lymph nodes of the neck, underarms, and groin, as well as the spleen, are each considered one group whether unilateral (one-sided) or bilateral (on both sides). Binet Stage B: more than three areas of enlarged lymphoid tissue. Binet Stage C: anemia plus thrombocytopenia."|participants|Number|63|63.0||||||
3884895|NCT01539512|3710112|B3|Binet Stage B||Binet Stage at Screening|"Binet staging classifies CLL according to the number of lymphoid tissues involved, as well as the presence of anemia or thrombocytopenia. Stage A: fewer than three areas of enlarged lymphoid tissue; enlarged lymph nodes of the neck, underarms, and groin, as well as the spleen, are each considered one group whether unilateral (one-sided) or bilateral (on both sides). Binet Stage B: more than three areas of enlarged lymphoid tissue. Binet Stage C: anemia plus thrombocytopenia."|participants|Number|61|61.0||||||
3884896|NCT01539512|3710113|B2|Binet Stage B||Binet Stage at Screening|"Binet staging classifies CLL according to the number of lymphoid tissues involved, as well as the presence of anemia or thrombocytopenia. Stage A: fewer than three areas of enlarged lymphoid tissue; enlarged lymph nodes of the neck, underarms, and groin, as well as the spleen, are each considered one group whether unilateral (one-sided) or bilateral (on both sides). Binet Stage B: more than three areas of enlarged lymphoid tissue. Binet Stage C: anemia plus thrombocytopenia."|participants|Number|32|32.0||||||
3884897|NCT01539512|3710114|B1|Binet Stage B||Binet Stage at Screening|"Binet staging classifies CLL according to the number of lymphoid tissues involved, as well as the presence of anemia or thrombocytopenia. Stage A: fewer than three areas of enlarged lymphoid tissue; enlarged lymph nodes of the neck, underarms, and groin, as well as the spleen, are each considered one group whether unilateral (one-sided) or bilateral (on both sides). Binet Stage B: more than three areas of enlarged lymphoid tissue. Binet Stage C: anemia plus thrombocytopenia."|participants|Number|29|29.0||||||
3884898|NCT01539512|3710112|B3|Binet Stage A||Binet Stage at Screening|"Binet staging classifies CLL according to the number of lymphoid tissues involved, as well as the presence of anemia or thrombocytopenia. Stage A: fewer than three areas of enlarged lymphoid tissue; enlarged lymph nodes of the neck, underarms, and groin, as well as the spleen, are each considered one group whether unilateral (one-sided) or bilateral (on both sides). Binet Stage B: more than three areas of enlarged lymphoid tissue. Binet Stage C: anemia plus thrombocytopenia."|participants|Number|11|11.0||||||
3884899|NCT01539512|3710113|B2|Binet Stage A||Binet Stage at Screening|"Binet staging classifies CLL according to the number of lymphoid tissues involved, as well as the presence of anemia or thrombocytopenia. Stage A: fewer than three areas of enlarged lymphoid tissue; enlarged lymph nodes of the neck, underarms, and groin, as well as the spleen, are each considered one group whether unilateral (one-sided) or bilateral (on both sides). Binet Stage B: more than three areas of enlarged lymphoid tissue. Binet Stage C: anemia plus thrombocytopenia."|participants|Number|4|4.0||||||
3884900|NCT01539512|3710114|B1|Binet Stage A||Binet Stage at Screening|"Binet staging classifies CLL according to the number of lymphoid tissues involved, as well as the presence of anemia or thrombocytopenia. Stage A: fewer than three areas of enlarged lymphoid tissue; enlarged lymph nodes of the neck, underarms, and groin, as well as the spleen, are each considered one group whether unilateral (one-sided) or bilateral (on both sides). Binet Stage B: more than three areas of enlarged lymphoid tissue. Binet Stage C: anemia plus thrombocytopenia."|participants|Number|7|7.0||||||
3884901|NCT01539512|3710112|B3|Missing||Rai Stage at Screening|Rai staging categorizes the disease progression of chronic lymphocytic leukemia (CLL), with classifications of low- (Stage 0), intermediate- (Stage 1 and 2), and high-risk (Stages 3 and 4) categories. Rai Stage 0: high number of lymphocytes in the blood (lymphocytosis) only. Rai Stage 1: lymphocytosis with enlarged lymphoid tissues (lymphadenopathy). Rai Stage 2: lymphocytosis with enlarged liver (hepatomegaly) or spleen (splenomegaly). Rai Stage 3: lymphocytosis with low red blood cell count (anemia). Rai Stage 4: lymphocytosis with low number of blood platelets (thrombocytopenia).|participants|Number|14|14.0||||||
3884902|NCT01539512|3710113|B2|Missing||Rai Stage at Screening|Rai staging categorizes the disease progression of chronic lymphocytic leukemia (CLL), with classifications of low- (Stage 0), intermediate- (Stage 1 and 2), and high-risk (Stages 3 and 4) categories. Rai Stage 0: high number of lymphocytes in the blood (lymphocytosis) only. Rai Stage 1: lymphocytosis with enlarged lymphoid tissues (lymphadenopathy). Rai Stage 2: lymphocytosis with enlarged liver (hepatomegaly) or spleen (splenomegaly). Rai Stage 3: lymphocytosis with low red blood cell count (anemia). Rai Stage 4: lymphocytosis with low number of blood platelets (thrombocytopenia).|participants|Number|8|8.0||||||
3884903|NCT01539512|3710114|B1|Missing||Rai Stage at Screening|Rai staging categorizes the disease progression of chronic lymphocytic leukemia (CLL), with classifications of low- (Stage 0), intermediate- (Stage 1 and 2), and high-risk (Stages 3 and 4) categories. Rai Stage 0: high number of lymphocytes in the blood (lymphocytosis) only. Rai Stage 1: lymphocytosis with enlarged lymphoid tissues (lymphadenopathy). Rai Stage 2: lymphocytosis with enlarged liver (hepatomegaly) or spleen (splenomegaly). Rai Stage 3: lymphocytosis with low red blood cell count (anemia). Rai Stage 4: lymphocytosis with low number of blood platelets (thrombocytopenia).|participants|Number|6|6.0||||||
3884904|NCT01539512|3710112|B3|Rai Stage 4||Rai Stage at Screening|Rai staging categorizes the disease progression of chronic lymphocytic leukemia (CLL), with classifications of low- (Stage 0), intermediate- (Stage 1 and 2), and high-risk (Stages 3 and 4) categories. Rai Stage 0: high number of lymphocytes in the blood (lymphocytosis) only. Rai Stage 1: lymphocytosis with enlarged lymphoid tissues (lymphadenopathy). Rai Stage 2: lymphocytosis with enlarged liver (hepatomegaly) or spleen (splenomegaly). Rai Stage 3: lymphocytosis with low red blood cell count (anemia). Rai Stage 4: lymphocytosis with low number of blood platelets (thrombocytopenia).|participants|Number|102|102.0||||||
3884905|NCT01539512|3710113|B2|Rai Stage 4||Rai Stage at Screening|Rai staging categorizes the disease progression of chronic lymphocytic leukemia (CLL), with classifications of low- (Stage 0), intermediate- (Stage 1 and 2), and high-risk (Stages 3 and 4) categories. Rai Stage 0: high number of lymphocytes in the blood (lymphocytosis) only. Rai Stage 1: lymphocytosis with enlarged lymphoid tissues (lymphadenopathy). Rai Stage 2: lymphocytosis with enlarged liver (hepatomegaly) or spleen (splenomegaly). Rai Stage 3: lymphocytosis with low red blood cell count (anemia). Rai Stage 4: lymphocytosis with low number of blood platelets (thrombocytopenia).|participants|Number|54|54.0||||||
3884906|NCT01539512|3710114|B1|Rai Stage 4||Rai Stage at Screening|Rai staging categorizes the disease progression of chronic lymphocytic leukemia (CLL), with classifications of low- (Stage 0), intermediate- (Stage 1 and 2), and high-risk (Stages 3 and 4) categories. Rai Stage 0: high number of lymphocytes in the blood (lymphocytosis) only. Rai Stage 1: lymphocytosis with enlarged lymphoid tissues (lymphadenopathy). Rai Stage 2: lymphocytosis with enlarged liver (hepatomegaly) or spleen (splenomegaly). Rai Stage 3: lymphocytosis with low red blood cell count (anemia). Rai Stage 4: lymphocytosis with low number of blood platelets (thrombocytopenia).|participants|Number|48|48.0||||||
3884907|NCT01539512|3710112|B3|Rai Stage 3||Rai Stage at Screening|Rai staging categorizes the disease progression of chronic lymphocytic leukemia (CLL), with classifications of low- (Stage 0), intermediate- (Stage 1 and 2), and high-risk (Stages 3 and 4) categories. Rai Stage 0: high number of lymphocytes in the blood (lymphocytosis) only. Rai Stage 1: lymphocytosis with enlarged lymphoid tissues (lymphadenopathy). Rai Stage 2: lymphocytosis with enlarged liver (hepatomegaly) or spleen (splenomegaly). Rai Stage 3: lymphocytosis with low red blood cell count (anemia). Rai Stage 4: lymphocytosis with low number of blood platelets (thrombocytopenia).|participants|Number|40|40.0||||||
3884908|NCT01539512|3710113|B2|Rai Stage 3||Rai Stage at Screening|Rai staging categorizes the disease progression of chronic lymphocytic leukemia (CLL), with classifications of low- (Stage 0), intermediate- (Stage 1 and 2), and high-risk (Stages 3 and 4) categories. Rai Stage 0: high number of lymphocytes in the blood (lymphocytosis) only. Rai Stage 1: lymphocytosis with enlarged lymphoid tissues (lymphadenopathy). Rai Stage 2: lymphocytosis with enlarged liver (hepatomegaly) or spleen (splenomegaly). Rai Stage 3: lymphocytosis with low red blood cell count (anemia). Rai Stage 4: lymphocytosis with low number of blood platelets (thrombocytopenia).|participants|Number|18|18.0||||||
3884909|NCT01539512|3710114|B1|Rai Stage 3||Rai Stage at Screening|Rai staging categorizes the disease progression of chronic lymphocytic leukemia (CLL), with classifications of low- (Stage 0), intermediate- (Stage 1 and 2), and high-risk (Stages 3 and 4) categories. Rai Stage 0: high number of lymphocytes in the blood (lymphocytosis) only. Rai Stage 1: lymphocytosis with enlarged lymphoid tissues (lymphadenopathy). Rai Stage 2: lymphocytosis with enlarged liver (hepatomegaly) or spleen (splenomegaly). Rai Stage 3: lymphocytosis with low red blood cell count (anemia). Rai Stage 4: lymphocytosis with low number of blood platelets (thrombocytopenia).|participants|Number|22|22.0||||||
3884910|NCT01539512|3710112|B3|Rai Stage 2||Rai Stage at Screening|Rai staging categorizes the disease progression of chronic lymphocytic leukemia (CLL), with classifications of low- (Stage 0), intermediate- (Stage 1 and 2), and high-risk (Stages 3 and 4) categories. Rai Stage 0: high number of lymphocytes in the blood (lymphocytosis) only. Rai Stage 1: lymphocytosis with enlarged lymphoid tissues (lymphadenopathy). Rai Stage 2: lymphocytosis with enlarged liver (hepatomegaly) or spleen (splenomegaly). Rai Stage 3: lymphocytosis with low red blood cell count (anemia). Rai Stage 4: lymphocytosis with low number of blood platelets (thrombocytopenia).|participants|Number|26|26.0||||||
3884911|NCT01539512|3710113|B2|Rai Stage 2||Rai Stage at Screening|Rai staging categorizes the disease progression of chronic lymphocytic leukemia (CLL), with classifications of low- (Stage 0), intermediate- (Stage 1 and 2), and high-risk (Stages 3 and 4) categories. Rai Stage 0: high number of lymphocytes in the blood (lymphocytosis) only. Rai Stage 1: lymphocytosis with enlarged lymphoid tissues (lymphadenopathy). Rai Stage 2: lymphocytosis with enlarged liver (hepatomegaly) or spleen (splenomegaly). Rai Stage 3: lymphocytosis with low red blood cell count (anemia). Rai Stage 4: lymphocytosis with low number of blood platelets (thrombocytopenia).|participants|Number|10|10.0||||||
3884912|NCT01539512|3710114|B1|Rai Stage 2||Rai Stage at Screening|Rai staging categorizes the disease progression of chronic lymphocytic leukemia (CLL), with classifications of low- (Stage 0), intermediate- (Stage 1 and 2), and high-risk (Stages 3 and 4) categories. Rai Stage 0: high number of lymphocytes in the blood (lymphocytosis) only. Rai Stage 1: lymphocytosis with enlarged lymphoid tissues (lymphadenopathy). Rai Stage 2: lymphocytosis with enlarged liver (hepatomegaly) or spleen (splenomegaly). Rai Stage 3: lymphocytosis with low red blood cell count (anemia). Rai Stage 4: lymphocytosis with low number of blood platelets (thrombocytopenia).|participants|Number|16|16.0||||||
3884985|NCT01539512|3710112|B3|≥ 65 years||Age, Customized||participants|Number|172|172.0||||||
3884913|NCT01539512|3710112|B3|Rai Stage 1||Rai Stage at Screening|Rai staging categorizes the disease progression of chronic lymphocytic leukemia (CLL), with classifications of low- (Stage 0), intermediate- (Stage 1 and 2), and high-risk (Stages 3 and 4) categories. Rai Stage 0: high number of lymphocytes in the blood (lymphocytosis) only. Rai Stage 1: lymphocytosis with enlarged lymphoid tissues (lymphadenopathy). Rai Stage 2: lymphocytosis with enlarged liver (hepatomegaly) or spleen (splenomegaly). Rai Stage 3: lymphocytosis with low red blood cell count (anemia). Rai Stage 4: lymphocytosis with low number of blood platelets (thrombocytopenia).|participants|Number|37|37.0||||||
3884914|NCT01539512|3710113|B2|Rai Stage 1||Rai Stage at Screening|Rai staging categorizes the disease progression of chronic lymphocytic leukemia (CLL), with classifications of low- (Stage 0), intermediate- (Stage 1 and 2), and high-risk (Stages 3 and 4) categories. Rai Stage 0: high number of lymphocytes in the blood (lymphocytosis) only. Rai Stage 1: lymphocytosis with enlarged lymphoid tissues (lymphadenopathy). Rai Stage 2: lymphocytosis with enlarged liver (hepatomegaly) or spleen (splenomegaly). Rai Stage 3: lymphocytosis with low red blood cell count (anemia). Rai Stage 4: lymphocytosis with low number of blood platelets (thrombocytopenia).|participants|Number|19|19.0||||||
3884915|NCT01539512|3710114|B1|Rai Stage 1||Rai Stage at Screening|Rai staging categorizes the disease progression of chronic lymphocytic leukemia (CLL), with classifications of low- (Stage 0), intermediate- (Stage 1 and 2), and high-risk (Stages 3 and 4) categories. Rai Stage 0: high number of lymphocytes in the blood (lymphocytosis) only. Rai Stage 1: lymphocytosis with enlarged lymphoid tissues (lymphadenopathy). Rai Stage 2: lymphocytosis with enlarged liver (hepatomegaly) or spleen (splenomegaly). Rai Stage 3: lymphocytosis with low red blood cell count (anemia). Rai Stage 4: lymphocytosis with low number of blood platelets (thrombocytopenia).|participants|Number|18|18.0||||||
3884916|NCT01539512|3710112|B3|Rai Stage 0||Rai Stage at Screening|Rai staging categorizes the disease progression of chronic lymphocytic leukemia (CLL), with classifications of low- (Stage 0), intermediate- (Stage 1 and 2), and high-risk (Stages 3 and 4) categories. Rai Stage 0: high number of lymphocytes in the blood (lymphocytosis) only. Rai Stage 1: lymphocytosis with enlarged lymphoid tissues (lymphadenopathy). Rai Stage 2: lymphocytosis with enlarged liver (hepatomegaly) or spleen (splenomegaly). Rai Stage 3: lymphocytosis with low red blood cell count (anemia). Rai Stage 4: lymphocytosis with low number of blood platelets (thrombocytopenia).|participants|Number|1|1.0||||||
3884917|NCT01539512|3710113|B2|Rai Stage 0||Rai Stage at Screening|Rai staging categorizes the disease progression of chronic lymphocytic leukemia (CLL), with classifications of low- (Stage 0), intermediate- (Stage 1 and 2), and high-risk (Stages 3 and 4) categories. Rai Stage 0: high number of lymphocytes in the blood (lymphocytosis) only. Rai Stage 1: lymphocytosis with enlarged lymphoid tissues (lymphadenopathy). Rai Stage 2: lymphocytosis with enlarged liver (hepatomegaly) or spleen (splenomegaly). Rai Stage 3: lymphocytosis with low red blood cell count (anemia). Rai Stage 4: lymphocytosis with low number of blood platelets (thrombocytopenia).|participants|Number|1|1.0||||||
3884918|NCT01539512|3710114|B1|Rai Stage 0||Rai Stage at Screening|Rai staging categorizes the disease progression of chronic lymphocytic leukemia (CLL), with classifications of low- (Stage 0), intermediate- (Stage 1 and 2), and high-risk (Stages 3 and 4) categories. Rai Stage 0: high number of lymphocytes in the blood (lymphocytosis) only. Rai Stage 1: lymphocytosis with enlarged lymphoid tissues (lymphadenopathy). Rai Stage 2: lymphocytosis with enlarged liver (hepatomegaly) or spleen (splenomegaly). Rai Stage 3: lymphocytosis with low red blood cell count (anemia). Rai Stage 4: lymphocytosis with low number of blood platelets (thrombocytopenia).|participants|Number|0|0.0||||||
3884919|NCT01539512|3710112|B3|||Time Since Diagnosis||months|Mean|107.4|107.4|Standard Deviation|57.58|57.58|||
3884920|NCT01539512|3710113|B2|||Time Since Diagnosis||months|Mean|106.4|106.4|Standard Deviation|52.73|52.73|||
3884921|NCT01539512|3710114|B1|||Time Since Diagnosis||months|Mean|108.3|108.3|Standard Deviation|62.28|62.28|||
3884922|NCT01539512|3710112|B3|100||Karnofsky Performance Status|Classifies patients according to their functional impairment. Scores range from 0-100; the lower the score, the worse the survival for most serious illnesses.|participants|Number|28|28.0||||||
3884923|NCT01539512|3710113|B2|100||Karnofsky Performance Status|Classifies patients according to their functional impairment. Scores range from 0-100; the lower the score, the worse the survival for most serious illnesses.|participants|Number|13|13.0||||||
3884924|NCT01539512|3710114|B1|100||Karnofsky Performance Status|Classifies patients according to their functional impairment. Scores range from 0-100; the lower the score, the worse the survival for most serious illnesses.|participants|Number|15|15.0||||||
3884925|NCT01539512|3710112|B3|90||Karnofsky Performance Status|Classifies patients according to their functional impairment. Scores range from 0-100; the lower the score, the worse the survival for most serious illnesses.|participants|Number|51|51.0||||||
3884926|NCT01539512|3710113|B2|90||Karnofsky Performance Status|Classifies patients according to their functional impairment. Scores range from 0-100; the lower the score, the worse the survival for most serious illnesses.|participants|Number|28|28.0||||||
3884927|NCT01539512|3710114|B1|90||Karnofsky Performance Status|Classifies patients according to their functional impairment. Scores range from 0-100; the lower the score, the worse the survival for most serious illnesses.|participants|Number|23|23.0||||||
3884928|NCT01539512|3710112|B3|80||Karnofsky Performance Status|Classifies patients according to their functional impairment. Scores range from 0-100; the lower the score, the worse the survival for most serious illnesses.|participants|Number|88|88.0||||||
3884929|NCT01539512|3710113|B2|80||Karnofsky Performance Status|Classifies patients according to their functional impairment. Scores range from 0-100; the lower the score, the worse the survival for most serious illnesses.|participants|Number|46|46.0||||||
3884930|NCT01539512|3710114|B1|80||Karnofsky Performance Status|Classifies patients according to their functional impairment. Scores range from 0-100; the lower the score, the worse the survival for most serious illnesses.|participants|Number|42|42.0||||||
3884931|NCT01539512|3710112|B3|70||Karnofsky Performance Status|Classifies patients according to their functional impairment. Scores range from 0-100; the lower the score, the worse the survival for most serious illnesses.|participants|Number|33|33.0||||||
3884932|NCT01539512|3710113|B2|70||Karnofsky Performance Status|Classifies patients according to their functional impairment. Scores range from 0-100; the lower the score, the worse the survival for most serious illnesses.|participants|Number|13|13.0||||||
3884986|NCT01539512|3710113|B2|≥ 65 years||Age, Customized||participants|Number|83|83.0||||||
3884934|NCT01539512|3710112|B3|60||Karnofsky Performance Status|Classifies patients according to their functional impairment. Scores range from 0-100; the lower the score, the worse the survival for most serious illnesses.|participants|Number|11|11.0||||||
3884935|NCT01539512|3710113|B2|60||Karnofsky Performance Status|Classifies patients according to their functional impairment. Scores range from 0-100; the lower the score, the worse the survival for most serious illnesses.|participants|Number|5|5.0||||||
3884936|NCT01539512|3710114|B1|60||Karnofsky Performance Status|Classifies patients according to their functional impairment. Scores range from 0-100; the lower the score, the worse the survival for most serious illnesses.|participants|Number|6|6.0||||||
3884937|NCT01539512|3710112|B3|50||Karnofsky Performance Status|Classifies patients according to their functional impairment. Scores range from 0-100; the lower the score, the worse the survival for most serious illnesses.|participants|Number|7|7.0||||||
3884938|NCT01539512|3710113|B2|50||Karnofsky Performance Status|Classifies patients according to their functional impairment. Scores range from 0-100; the lower the score, the worse the survival for most serious illnesses.|participants|Number|4|4.0||||||
3884939|NCT01539512|3710114|B1|50||Karnofsky Performance Status|Classifies patients according to their functional impairment. Scores range from 0-100; the lower the score, the worse the survival for most serious illnesses.|participants|Number|3|3.0||||||
3884940|NCT01539512|3710112|B3|40||Karnofsky Performance Status|Classifies patients according to their functional impairment. Scores range from 0-100; the lower the score, the worse the survival for most serious illnesses.|participants|Number|2|2.0||||||
3884941|NCT01539512|3710113|B2|40||Karnofsky Performance Status|Classifies patients according to their functional impairment. Scores range from 0-100; the lower the score, the worse the survival for most serious illnesses.|participants|Number|1|1.0||||||
3884942|NCT01539512|3710114|B1|40||Karnofsky Performance Status|Classifies patients according to their functional impairment. Scores range from 0-100; the lower the score, the worse the survival for most serious illnesses.|participants|Number|1|1.0||||||
3884943|NCT01539512|3710112|B3|United States||Region of Enrollment||participants|Number|163|163.0||||||
3884944|NCT01539512|3710113|B2|United States||Region of Enrollment||participants|Number|83|83.0||||||
3884945|NCT01539512|3710114|B1|United States||Region of Enrollment||participants|Number|80|80.0||||||
3884946|NCT01539512|3710112|B3|United Kingdom||Region of Enrollment||participants|Number|32|32.0||||||
3884947|NCT01539512|3710113|B2|United Kingdom||Region of Enrollment||participants|Number|14|14.0||||||
3884948|NCT01539512|3710114|B1|United Kingdom||Region of Enrollment||participants|Number|18|18.0||||||
3884949|NCT01539512|3710112|B3|Italy||Region of Enrollment||participants|Number|7|7.0||||||
3884950|NCT01539512|3710113|B2|Italy||Region of Enrollment||participants|Number|5|5.0||||||
3884951|NCT01539512|3710114|B1|Italy||Region of Enrollment||participants|Number|2|2.0||||||
3884952|NCT01539512|3710112|B3|Germany||Region of Enrollment||participants|Number|12|12.0||||||
3884953|NCT01539512|3710113|B2|Germany||Region of Enrollment||participants|Number|5|5.0||||||
3884954|NCT01539512|3710114|B1|Germany||Region of Enrollment||participants|Number|7|7.0||||||
3884955|NCT01539512|3710112|B3|France||Region of Enrollment||participants|Number|6|6.0||||||
3884956|NCT01539512|3710113|B2|France||Region of Enrollment||participants|Number|3|3.0||||||
3884957|NCT01539512|3710114|B1|France||Region of Enrollment||participants|Number|3|3.0||||||
3884958|NCT01539512|3710112|B3|Not Permitted||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3884959|NCT01539512|3710113|B2|Not Permitted||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3884960|NCT01539512|3710114|B1|Not Permitted||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3884961|NCT01539512|3710112|B3|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3884962|NCT01539512|3710113|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3884963|NCT01539512|3710114|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3884964|NCT01539512|3710112|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3884965|NCT01539512|3710113|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3884966|NCT01539512|3710114|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3884967|NCT01539512|3710112|B3|White||Race/Ethnicity, Customized||participants|Number|198|198.0||||||
3884968|NCT01539512|3710113|B2|White||Race/Ethnicity, Customized||participants|Number|98|98.0||||||
3884969|NCT01539512|3710114|B1|White||Race/Ethnicity, Customized||participants|Number|100|100.0||||||
3884970|NCT01539512|3710112|B3|Not Permitted||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3884971|NCT01539512|3710113|B2|Not Permitted||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3884972|NCT01539512|3710114|B1|Not Permitted||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3884973|NCT01539512|3710112|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|203|203.0||||||
3884974|NCT01539512|3710113|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|102|102.0||||||
3884975|NCT01539512|3710114|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|101|101.0||||||
3884976|NCT01539512|3710112|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3884977|NCT01539512|3710113|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3884978|NCT01539512|3710114|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3884979|NCT01539512|3710112|B3||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3884980|NCT01539512|3710113|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3884981|NCT01539512|3710114|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3884982|NCT01539512|3710112|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3884983|NCT01539512|3710113|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3884984|NCT01539512|3710114|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3884989|NCT01539512|3710113|B2|< 65 years||Age, Customized||participants|Number|27|27.0||||||
3884990|NCT01539512|3710114|B1|< 65 years||Age, Customized||participants|Number|21|21.0||||||
3884991|NCT01539512|3710112|B3|||Age||years|Mean|71|71.0|Standard Deviation|7.9|7.9|||
3884992|NCT01539512|3710113|B2|||Age||years|Mean|70|70.0|Standard Deviation|8.1|8.1|||
3884993|NCT01539512|3710114|B1|||Age||years|Mean|71|71.0|Standard Deviation|7.7|7.7|||
3884994|NCT01539317|3710129|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3884995|NCT01539317|3710130|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3884996|NCT01539317|3710131|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3884997|NCT01539317|3710129|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884998|NCT01539317|3710130|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3884999|NCT01539317|3710131|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885000|NCT01539317|3710129|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3885001|NCT01539317|3710130|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3885002|NCT01539317|3710131|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3885003|NCT01539317|3710129|B3||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3885004|NCT01539317|3710130|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3885005|NCT01539317|3710131|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3885006|NCT01539317|3710129|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885007|NCT01539317|3710130|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885008|NCT01539317|3710131|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885009|NCT01539317|3710129|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3885010|NCT01539317|3710130|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885011|NCT01539317|3710131|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3885012|NCT01539317|3710129|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3885013|NCT01539317|3710130|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3885014|NCT01539317|3710131|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3885015|NCT01539317|3710129|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885016|NCT01539317|3710130|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885017|NCT01539317|3710131|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885018|NCT01539317|3710129|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885019|NCT01539317|3710130|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885020|NCT01539317|3710131|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885021|NCT01539317|3710129|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3885022|NCT01539317|3710130|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3885023|NCT01539317|3710131|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3885024|NCT01539317|3710129|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3885025|NCT01539317|3710130|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885026|NCT01539317|3710131|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3885027|NCT01539317|3710129|B3|Female||Sex/Gender, Customized||participants|Number|50|50.0||||||
3885028|NCT01539317|3710130|B2|Female||Sex/Gender, Customized||participants|Number|25|25.0||||||
3885029|NCT01539317|3710131|B1|Female||Sex/Gender, Customized||participants|Number|25|25.0||||||
3885030|NCT01539317|3710129|B3|||Age||years|Mean|55.34|55.34|Standard Deviation|8.77|8.77|||
3885031|NCT01539317|3710130|B2|||Age||years|Mean|54.7|54.7|Standard Deviation|8.9|8.9|||
3885032|NCT01539317|3710131|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|8.5|8.5|||
3885033|NCT01539135|3710147|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
3885034|NCT01539135|3710148|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
3885035|NCT01539135|3710149|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
3885036|NCT01539135|3710147|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3885037|NCT01539135|3710148|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3885038|NCT01539135|3710149|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3885039|NCT01539135|3710147|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3885040|NCT01539135|3710148|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3885041|NCT01539135|3710149|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3885042|NCT01539135|3710147|B3|||Age||years|Mean|56|56.0|Standard Deviation|13.8|13.8|||
3885043|NCT01539135|3710148|B2|||Age||years|Mean|53.5|53.5|Standard Deviation|14.7|14.7|||
3885044|NCT01539135|3710149|B1|||Age||years|Mean|58.2|58.2|Standard Deviation|12.7|12.7|||
3885045|NCT01539135|3710147|B3||>=65 years|Age|Age: >18years Gender, male, female|Participants|Count of Participants|10|10.0||||||
3885046|NCT01539135|3710148|B2||>=65 years|Age|Age: >18years Gender, male, female|Participants|Count of Participants|4|4.0||||||
3885107|NCT01538615|3710219|B1|||child BMIz||Z-score|Mean|0.95|0.95|Standard Deviation|0.78|0.78|||
3885047|NCT01539135|3710149|B1||>=65 years|Age|Age: >18years Gender, male, female|Participants|Count of Participants|6|6.0||||||
3885048|NCT01539135|3710147|B3||Between 18 and 65 years|Age|Age: >18years Gender, male, female|Participants|Count of Participants|70|70.0||||||
3885049|NCT01539135|3710148|B2||Between 18 and 65 years|Age|Age: >18years Gender, male, female|Participants|Count of Participants|33|33.0||||||
3885050|NCT01539135|3710149|B1||Between 18 and 65 years|Age|Age: >18years Gender, male, female|Participants|Count of Participants|37|37.0||||||
3885051|NCT01539135|3710147|B3||<=18 years|Age|Age: >18years Gender, male, female|Participants|Count of Participants|0|0.0||||||
3885052|NCT01539135|3710148|B2||<=18 years|Age|Age: >18years Gender, male, female|Participants|Count of Participants|0|0.0||||||
3885053|NCT01539135|3710149|B1||<=18 years|Age|Age: >18years Gender, male, female|Participants|Count of Participants|0|0.0||||||
3885054|NCT01539083|3710162|B1|Republic of Korea||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3885055|NCT01539083|3710162|B1|China||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3885056|NCT01539083|3710162|B1|Australia||Region of Enrollment||Participants|Count of Participants|207|207.0||||||
3885057|NCT01539083|3710162|B1||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3885058|NCT01539083|3710162|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3885059|NCT01539083|3710162|B1|||Age||years|Mean|57.8|57.8|Standard Deviation|7.76|7.76|||
3885060|NCT01539070|3710185|B3|Mexico||Region of Enrollment||participants|Number|306|306.0||||||
3885061|NCT01539070|3710186|B2|Mexico||Region of Enrollment||participants|Number|138|138.0||||||
3885062|NCT01539070|3710187|B1|Mexico||Region of Enrollment||participants|Number|168|168.0||||||
3885063|NCT01539070|3710185|B3||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3885064|NCT01539070|3710186|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3885065|NCT01539070|3710187|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3885066|NCT01539070|3710185|B3||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3885067|NCT01539070|3710186|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3885068|NCT01539070|3710187|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3885069|NCT01539070|3710185|B3|||Age||years|Mean|3.38|3.38|Standard Deviation|0.83|0.83|||
3885070|NCT01539070|3710186|B2|||Age||years|Mean|3.42|3.42|Standard Deviation|0.82|0.82|||
3885071|NCT01539070|3710187|B1|||Age||years|Mean|3.34|3.34|Standard Deviation|0.84|0.84|||
3885072|NCT01539070|3710185|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3885073|NCT01539070|3710186|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3885074|NCT01539070|3710187|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3885075|NCT01539070|3710185|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3885076|NCT01539070|3710186|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3885077|NCT01539070|3710187|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3885078|NCT01539070|3710185|B3||<=18 years|Age||Participants|Count of Participants|306|306.0||||||
3885079|NCT01539070|3710186|B2||<=18 years|Age||Participants|Count of Participants|138|138.0||||||
3885080|NCT01539070|3710187|B1||<=18 years|Age||Participants|Count of Participants|168|168.0||||||
3885081|NCT01538862|3710200|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3885082|NCT01538862|3710200|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3885083|NCT01538862|3710200|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3885084|NCT01538862|3710200|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3885085|NCT01538862|3710200|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3885086|NCT01538862|3710200|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3885087|NCT01538719|3710206|B3|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3885088|NCT01538719|3710207|B2|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3885089|NCT01538719|3710208|B1|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3885090|NCT01538719|3710206|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3885091|NCT01538719|3710207|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3885092|NCT01538719|3710208|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3885093|NCT01538719|3710206|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3885094|NCT01538719|3710207|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3885095|NCT01538719|3710208|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3885096|NCT01538719|3710206|B3|||Age||years|Mean|50.79|50.79|Standard Deviation|8.63|8.63|||
3885097|NCT01538719|3710207|B2|||Age||years|Mean|51.33|51.33|Standard Deviation|7.33|7.33|||
3885098|NCT01538719|3710208|B1|||Age||years|Mean|49.86|49.86|Standard Deviation|11.10|11.1|||
3885099|NCT01538615|3710217|B3|||receiving economic assistance||Participants|Count of Participants|124|124.0||||||
3885100|NCT01538615|3710218|B2|||receiving economic assistance||Participants|Count of Participants|52|52.0||||||
3885101|NCT01538615|3710219|B1|||receiving economic assistance||Participants|Count of Participants|72|72.0||||||
3885102|NCT01538615|3710217|B3|||parent BMI||kg/m^2|Mean|28.63|28.63|Standard Deviation|7.46|7.46|||
3885103|NCT01538615|3710218|B2|||parent BMI||kg/m^2|Mean|29.64|29.64|Standard Deviation|7.68|7.68|||
3885104|NCT01538615|3710219|B1|||parent BMI||kg/m^2|Mean|27.64|27.64|Standard Deviation|7.14|7.14|||
3885105|NCT01538615|3710217|B3|||child BMIz||Z-score|Mean|0.99|0.99|Standard Deviation|0.75|0.75|||
3885106|NCT01538615|3710218|B2|||child BMIz||Z-score|Mean|1.02|1.02|Standard Deviation|0.73|0.73|||
3885108|NCT01538615|3710217|B3|United States||Region of Enrollment||participants|Number|320|320.0||||||
3885109|NCT01538615|3710218|B2|United States||Region of Enrollment||participants|Number|158|158.0||||||
3885110|NCT01538615|3710219|B1|United States||Region of Enrollment||participants|Number|162|162.0||||||
3885111|NCT01538615|3710217|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885112|NCT01538615|3710218|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885113|NCT01538615|3710219|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885114|NCT01538615|3710217|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3885115|NCT01538615|3710218|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3885116|NCT01538615|3710219|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3885117|NCT01538615|3710217|B3||White|Race (NIH/OMB)||Participants|Count of Participants|232|232.0||||||
3885118|NCT01538615|3710218|B2||White|Race (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
3885119|NCT01538615|3710219|B1||White|Race (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
3885120|NCT01538615|3710217|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3885121|NCT01538615|3710218|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3885122|NCT01538615|3710219|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3885123|NCT01538615|3710217|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885124|NCT01538615|3710218|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885125|NCT01538615|3710219|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885126|NCT01538615|3710217|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3885127|NCT01538615|3710218|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3885128|NCT01538615|3710219|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3885129|NCT01538615|3710217|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3885130|NCT01538615|3710218|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3885131|NCT01538615|3710219|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3885132|NCT01538615|3710217|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885133|NCT01538615|3710218|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885134|NCT01538615|3710219|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885135|NCT01538615|3710217|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|300|300.0||||||
3885136|NCT01538615|3710218|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|147|147.0||||||
3885137|NCT01538615|3710219|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|153|153.0||||||
3885138|NCT01538615|3710217|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3885139|NCT01538615|3710218|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3885140|NCT01538615|3710219|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3885141|NCT01538615|3710217|B3|gender|Female|Sex/Gender, Customized||Participants|Count of Participants|227|227.0||||||
3885142|NCT01538615|3710218|B2|gender|Female|Sex/Gender, Customized||Participants|Count of Participants|113|113.0||||||
3885143|NCT01538615|3710219|B1|gender|Female|Sex/Gender, Customized||Participants|Count of Participants|114|114.0||||||
3885144|NCT01538615|3710217|B3|gender|Male|Sex/Gender, Customized||Participants|Count of Participants|93|93.0||||||
3885145|NCT01538615|3710218|B2|gender|Male|Sex/Gender, Customized||Participants|Count of Participants|45|45.0||||||
3885146|NCT01538615|3710219|B1|gender|Male|Sex/Gender, Customized||Participants|Count of Participants|48|48.0||||||
3885147|NCT01538615|3710217|B3|mean parent age||Age, Customized||years|Mean|41.3|41.3|Standard Deviation|7.7|7.7|||
3885148|NCT01538615|3710218|B2|mean parent age||Age, Customized||years|Mean|41.3|41.3|Standard Deviation|7.4|7.4|||
3885149|NCT01538615|3710219|B1|mean parent age||Age, Customized||years|Mean|41.3|41.3|Standard Deviation|8.0|8.0|||
3885150|NCT01538615|3710217|B3|mean child age||Age, Customized||years|Mean|10.4|10.4|Standard Deviation|1.4|1.4|||
3885151|NCT01538615|3710218|B2|mean child age||Age, Customized||years|Mean|10.1|10.1|Standard Deviation|1.4|1.4|||
3885152|NCT01538615|3710219|B1|mean child age||Age, Customized||years|Mean|10.5|10.5|Standard Deviation|1.4|1.4|||
3885153|NCT01538472|3710232|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3885154|NCT01538472|3710232|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3885155|NCT01538472|3710232|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3885156|NCT01538472|3710232|B1|||Age||years|Median|53|53.0|Full Range|||31.0|65.0|
3885157|NCT01538199|3710237|B7|United States||Region of Enrollment||participants|Number|54|54.0||||||
3885158|NCT01538199|3710238|B6|United States||Region of Enrollment||participants|Number|11|11.0||||||
3885159|NCT01538199|3710239|B5|United States||Region of Enrollment||participants|Number|3|3.0||||||
3885160|NCT01538199|3710240|B4|United States||Region of Enrollment||participants|Number|4|4.0||||||
3885161|NCT01538199|3710241|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
3885162|NCT01538199|3710242|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3885163|NCT01538199|3710243|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3885164|NCT01538199|3710237|B7||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3885165|NCT01538199|3710238|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3885166|NCT01538199|3710239|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3885167|NCT01538199|3710240|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3885168|NCT01538199|3710241|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3885169|NCT01538199|3710242|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3885170|NCT01538199|3710243|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3885171|NCT01538199|3710237|B7||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3885172|NCT01538199|3710238|B6||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3885173|NCT01538199|3710239|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3885174|NCT01538199|3710240|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3885175|NCT01538199|3710241|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3885176|NCT01538199|3710242|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3885177|NCT01538199|3710243|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3885178|NCT01538199|3710237|B7|||Age||years|Mean|46.4|46.4|Standard Deviation|12.7|12.7|||
3885179|NCT01538199|3710238|B6|||Age||years|Mean|38.3|38.3|Standard Deviation|11.7|11.7|||
3885180|NCT01538199|3710239|B5|||Age||years|Mean|47.7|47.7|Standard Deviation|13.5|13.5|||
3885181|NCT01538199|3710240|B4|||Age||years|Mean|47|47.0|Standard Deviation|14|14.0|||
3885182|NCT01538199|3710241|B3|||Age||years|Mean|49.9|49.9|Standard Deviation|10.8|10.8|||
3885183|NCT01538199|3710242|B2|||Age||years|Mean|50.7|50.7|Standard Deviation|13.3|13.3|||
3885184|NCT01538199|3710243|B1|||Age||years|Mean|45|45.0|Standard Deviation|12.8|12.8|||
3885185|NCT01538199|3710237|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3885186|NCT01538199|3710238|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3885187|NCT01538199|3710239|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3885188|NCT01538199|3710240|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3885189|NCT01538199|3710241|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3885190|NCT01538199|3710242|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3885191|NCT01538199|3710243|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3885192|NCT01538199|3710237|B7||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3885193|NCT01538199|3710238|B6||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3885194|NCT01538199|3710239|B5||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3885195|NCT01538199|3710240|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3885196|NCT01538199|3710241|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3885197|NCT01538199|3710242|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3885198|NCT01538199|3710243|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3885199|NCT01538199|3710237|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3885200|NCT01538199|3710238|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3885201|NCT01538199|3710239|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3885202|NCT01538199|3710240|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3885203|NCT01538199|3710241|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3885204|NCT01538199|3710242|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3885205|NCT01538199|3710243|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3885206|NCT01537900|3710269|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3885207|NCT01537900|3710269|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3885208|NCT01537900|3710269|B1|||Age||Years|Mean|42.5|42.5|Standard Deviation|12.9|12.9|||
3885209|NCT01537835|3710280|B4|||cared for colonized or infected patient||participants|Number|55|55.0||||||
3885210|NCT01537835|3710281|B3|||cared for colonized or infected patient||participants|Number|19|19.0||||||
3885211|NCT01537835|3710282|B2|||cared for colonized or infected patient||participants|Number|20|20.0||||||
3885212|NCT01537835|3710283|B1|||cared for colonized or infected patient||participants|Number|16|16.0||||||
3885213|NCT01537835|3710280|B4|nurse||healthcare worker type||participants|Number|37|37.0||||||
3885214|NCT01537835|3710281|B3|nurse||healthcare worker type||participants|Number|12|12.0||||||
3885215|NCT01537835|3710282|B2|nurse||healthcare worker type||participants|Number|14|14.0||||||
3885216|NCT01537835|3710283|B1|nurse||healthcare worker type||participants|Number|11|11.0||||||
3885217|NCT01537835|3710280|B4|midlevels||healthcare worker type||participants|Number|6|6.0||||||
3885218|NCT01537835|3710281|B3|midlevels||healthcare worker type||participants|Number|2|2.0||||||
3885219|NCT01537835|3710282|B2|midlevels||healthcare worker type||participants|Number|2|2.0||||||
3885220|NCT01537835|3710283|B1|midlevels||healthcare worker type||participants|Number|2|2.0||||||
3885221|NCT01537835|3710280|B4|intern/resident||healthcare worker type||participants|Number|51|51.0||||||
3885222|NCT01537835|3710281|B3|intern/resident||healthcare worker type||participants|Number|18|18.0||||||
3885223|NCT01537835|3710282|B2|intern/resident||healthcare worker type||participants|Number|16|16.0||||||
3885224|NCT01537835|3710283|B1|intern/resident||healthcare worker type||participants|Number|17|17.0||||||
3885225|NCT01537835|3710280|B4|attending physician||healthcare worker type||participants|Number|11|11.0||||||
3885226|NCT01537835|3710281|B3|attending physician||healthcare worker type||participants|Number|3|3.0||||||
3885227|NCT01537835|3710282|B2|attending physician||healthcare worker type||participants|Number|3|3.0||||||
3885228|NCT01537835|3710283|B1|attending physician||healthcare worker type||participants|Number|5|5.0||||||
3885229|NCT01537835|3710280|B4|Not Available||Sex/Gender, Customized|Gender was not collected.|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3885230|NCT01537835|3710281|B3|Not Available||Sex/Gender, Customized|Gender was not collected.|participants|Number|NA|||||||Gender was not collected
3885231|NCT01537835|3710282|B2|Not Available||Sex/Gender, Customized|Gender was not collected.|participants|Number|NA|||||||Gender was not collected
3885232|NCT01537835|3710283|B1|Not Available||Sex/Gender, Customized|Gender was not collected.|participants|Number|NA|||||||Gender was not collected
3885233|NCT01537835|3710280|B4|Not Available||Age, Customized|Age was not collected.|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3885234|NCT01537835|3710281|B3|Not Available||Age, Customized|Age was not collected.|participants|Number|NA|||||||Age was not collected
3885235|NCT01537835|3710282|B2|Not Available||Age, Customized|Age was not collected.|participants|Number|NA|||||||Age was not collected
3885236|NCT01537835|3710283|B1|Not Available||Age, Customized|Age was not collected.|participants|Number|NA|||||||Age was not collected
3885237|NCT01537783|3710296|B3|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3885238|NCT01537783|3710297|B2|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3885239|NCT01537783|3710298|B1|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3885240|NCT01537783|3710296|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3885241|NCT01537783|3710297|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3885242|NCT01537783|3710298|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3885243|NCT01537783|3710296|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3885244|NCT01537783|3710297|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3885245|NCT01537783|3710298|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3885246|NCT01537783|3710296|B3|||Age||years|Mean|31.2|31.2|Standard Deviation|10.9|10.9|||
3885247|NCT01537783|3710297|B2|||Age||years|Mean|35.4|35.4|Standard Deviation|11.4|11.4|||
3885248|NCT01537783|3710298|B1|||Age||years|Mean|24.3|24.3|Standard Deviation|5.2|5.2|||
3885249|NCT01537666|3710305|B5|Australia||Region of Enrollment||participants|Number|25|25.0||||||
3885250|NCT01537666|3710306|B4|Australia||Region of Enrollment||participants|Number|7|7.0||||||
3885251|NCT01537666|3710307|B3|Australia||Region of Enrollment||participants|Number|6|6.0||||||
3885252|NCT01537666|3710308|B2|Australia||Region of Enrollment||participants|Number|6|6.0||||||
3885253|NCT01537666|3710309|B1|Australia||Region of Enrollment||participants|Number|6|6.0||||||
3885254|NCT01537666|3710305|B5||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3885255|NCT01537666|3710306|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3885256|NCT01537666|3710307|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3885257|NCT01537666|3710308|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3885258|NCT01537666|3710309|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3885259|NCT01537666|3710305|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3885260|NCT01537666|3710306|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3885261|NCT01537666|3710307|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3885262|NCT01537666|3710308|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3885263|NCT01537666|3710309|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3885264|NCT01537666|3710305|B5|||Age||years|Mean|26.3|26.3|Standard Deviation|7.2|7.2|||
3885265|NCT01537666|3710306|B4|||Age||years|Mean|29.7|29.7|Standard Deviation|7.8|7.8|||
3885266|NCT01537666|3710307|B3|||Age||years|Mean|22.2|22.2|Standard Deviation|2.8|2.8|||
3885267|NCT01537666|3710308|B2|||Age||years|Mean|24.7|24.7|Standard Deviation|3.7|3.7|||
3885268|NCT01537666|3710309|B1|||Age||years|Mean|28.2|28.2|Standard Deviation|10.5|10.5|||
3885269|NCT01537666|3710305|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3885270|NCT01537666|3710306|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3885271|NCT01537666|3710307|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3885272|NCT01537666|3710308|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3885273|NCT01537666|3710309|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3885274|NCT01537666|3710305|B5||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3885275|NCT01537666|3710306|B4||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3885276|NCT01537666|3710307|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3885277|NCT01537666|3710308|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3885278|NCT01537666|3710309|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3885279|NCT01537666|3710305|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3885280|NCT01537666|3710306|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3885281|NCT01537666|3710307|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3885282|NCT01537666|3710308|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3885283|NCT01537666|3710309|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3885284|NCT01537549|3710350|B1|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3885285|NCT01537549|3710350|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3885286|NCT01537549|3710350|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3885287|NCT01537549|3710350|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3885288|NCT01537549|3710350|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3885289|NCT01537549|3710350|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3885290|NCT01537432|3710356|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3885291|NCT01537432|3710357|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3885292|NCT01537432|3710358|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3885293|NCT01537432|3710356|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3885294|NCT01537432|3710357|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3885295|NCT01537432|3710358|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3885296|NCT01537432|3710356|B3|||Age||years|Mean|48.4|48.4|Standard Deviation|13.8|13.8|||
3885297|NCT01537432|3710357|B2|||Age||years|Mean|50.3|50.3|Standard Deviation|13.8|13.8|||
3885298|NCT01537432|3710358|B1|||Age||years|Mean|47.5|47.5|Standard Deviation|14.0|14.0|||
3885299|NCT01537419|3710367|B3||Above Poverty Level|Socioeconomic Status||Participants|Count of Participants|89|89.0||||||
3885300|NCT01537419|3710368|B2||Above Poverty Level|Socioeconomic Status||Participants|Count of Participants|45|45.0||||||
3885301|NCT01537419|3710369|B1||Above Poverty Level|Socioeconomic Status||Participants|Count of Participants|44|44.0||||||
3885302|NCT01537419|3710367|B3||Below Poverty Level|Socioeconomic Status||Participants|Count of Participants|40|40.0||||||
3885303|NCT01537419|3710368|B2||Below Poverty Level|Socioeconomic Status||Participants|Count of Participants|21|21.0||||||
3885304|NCT01537419|3710369|B1||Below Poverty Level|Socioeconomic Status||Participants|Count of Participants|19|19.0||||||
3885305|NCT01537419|3710367|B3||Questioning|Sexual Orientation||Participants|Count of Participants|9|9.0||||||
3885306|NCT01537419|3710368|B2||Questioning|Sexual Orientation||Participants|Count of Participants|7|7.0||||||
3885307|NCT01537419|3710369|B1||Questioning|Sexual Orientation||Participants|Count of Participants|2|2.0||||||
3885308|NCT01537419|3710367|B3||Bisexual|Sexual Orientation||Participants|Count of Participants|22|22.0||||||
3885309|NCT01537419|3710368|B2||Bisexual|Sexual Orientation||Participants|Count of Participants|13|13.0||||||
3885310|NCT01537419|3710369|B1||Bisexual|Sexual Orientation||Participants|Count of Participants|9|9.0||||||
3885311|NCT01537419|3710367|B3||Lesbian/Gay|Sexual Orientation||Participants|Count of Participants|10|10.0||||||
3885312|NCT01537419|3710368|B2||Lesbian/Gay|Sexual Orientation||Participants|Count of Participants|8|8.0||||||
3885313|NCT01537419|3710369|B1||Lesbian/Gay|Sexual Orientation||Participants|Count of Participants|2|2.0||||||
3885314|NCT01537419|3710367|B3||Heterosexual|Sexual Orientation||Participants|Count of Participants|88|88.0||||||
3885315|NCT01537419|3710368|B2||Heterosexual|Sexual Orientation||Participants|Count of Participants|38|38.0||||||
3885316|NCT01537419|3710369|B1||Heterosexual|Sexual Orientation||Participants|Count of Participants|50|50.0||||||
3885317|NCT01537419|3710367|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3885318|NCT01537419|3710368|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3885319|NCT01537419|3710369|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3885320|NCT01537419|3710367|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3885321|NCT01537419|3710368|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3885322|NCT01537419|3710369|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3885323|NCT01537419|3710367|B3||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3885324|NCT01537419|3710368|B2||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3885325|NCT01537419|3710369|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3885326|NCT01537419|3710367|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3885327|NCT01537419|3710368|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3885328|NCT01537419|3710369|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3885329|NCT01537419|3710367|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3885330|NCT01537419|3710368|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885331|NCT01537419|3710369|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3885332|NCT01537419|3710367|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3885333|NCT01537419|3710368|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3885334|NCT01537419|3710369|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3885335|NCT01537419|3710367|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3885336|NCT01537419|3710368|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885337|NCT01537419|3710369|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3885338|NCT01537419|3710367|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885339|NCT01537419|3710368|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885340|NCT01537419|3710369|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885341|NCT01537419|3710367|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|109|109.0||||||
3885342|NCT01537419|3710368|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3885343|NCT01537419|3710369|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3885344|NCT01537419|3710367|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3885345|NCT01537419|3710368|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3885346|NCT01537419|3710369|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3885347|NCT01537419|3710367|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3885348|NCT01537419|3710368|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3885349|NCT01537419|3710369|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3885350|NCT01537419|3710367|B3||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3885351|NCT01537419|3710368|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3885352|NCT01537419|3710369|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3885353|NCT01537419|3710367|B3|>15 Years Old||Age, Customized||Participants|Count of Participants|53|53.0||||||
3885354|NCT01537419|3710368|B2|>15 Years Old||Age, Customized||Participants|Count of Participants|30|30.0||||||
3885355|NCT01537419|3710369|B1|>15 Years Old||Age, Customized||Participants|Count of Participants|23|23.0||||||
3885356|NCT01537419|3710367|B3|<=15 Years Old||Age, Customized||Participants|Count of Participants|76|76.0||||||
3885357|NCT01537419|3710368|B2|<=15 Years Old||Age, Customized||Participants|Count of Participants|36|36.0||||||
3885358|NCT01537419|3710369|B1|<=15 Years Old||Age, Customized||Participants|Count of Participants|40|40.0||||||
3885359|NCT01537393|3710380|B3|||Intraocular pressure (IOP)||mm Hg|Median|15|15.0|Inter-Quartile Range|||12.0|17.0|
3885360|NCT01537393|3710381|B2|||Intraocular pressure (IOP)||mm Hg|Median|15|15.0|Inter-Quartile Range|||12.0|17.0|
3885361|NCT01537393|3710382|B1|||Intraocular pressure (IOP)||mm Hg|Median|15|15.0|Inter-Quartile Range|||12.0|17.0|
3885362|NCT01537393|3710380|B3||Pseudophakic posterior chamber intraocular lens|Postoperative lens status||eyes|Count of Units|1320|1320.0||||||
3885363|NCT01537393|3710381|B2||Pseudophakic posterior chamber intraocular lens|Postoperative lens status||eyes|Count of Units|649|649.0||||||
3885364|NCT01537393|3710382|B1||Pseudophakic posterior chamber intraocular lens|Postoperative lens status||eyes|Count of Units|671|671.0||||||
3885365|NCT01537393|3710380|B3||Phakic|Postoperative lens status||eyes|Count of Units|10|10.0||||||
3885366|NCT01537393|3710381|B2||Phakic|Postoperative lens status||eyes|Count of Units|6|6.0||||||
3885367|NCT01537393|3710382|B1||Phakic|Postoperative lens status||eyes|Count of Units|4|4.0||||||
3885368|NCT01537393|3710380|B3||Pseudophakic posterior chamber intraocular lens|Preoperative lens status|During the slit lamp exam performed using the investigator's usual routine, the state of the crystalline lens was described as phakic (present), aphakic (removed), or pseudophakic (removed with posterior chamber intraocular lens inserted)|eyes|Count of Units|636|636.0||||||
3885369|NCT01537393|3710381|B2||Pseudophakic posterior chamber intraocular lens|Preoperative lens status|During the slit lamp exam performed using the investigator's usual routine, the state of the crystalline lens was described as phakic (present), aphakic (removed), or pseudophakic (removed with posterior chamber intraocular lens inserted)|eyes|Count of Units|302|302.0||||||
3885370|NCT01537393|3710382|B1||Pseudophakic posterior chamber intraocular lens|Preoperative lens status|During the slit lamp exam performed using the investigator's usual routine, the state of the crystalline lens was described as phakic (present), aphakic (removed), or pseudophakic (removed with posterior chamber intraocular lens inserted)|eyes|Count of Units|334|334.0||||||
3885371|NCT01537393|3710380|B3||Aphakic|Preoperative lens status|During the slit lamp exam performed using the investigator's usual routine, the state of the crystalline lens was described as phakic (present), aphakic (removed), or pseudophakic (removed with posterior chamber intraocular lens inserted)|eyes|Count of Units|2|2.0||||||
3885372|NCT01537393|3710381|B2||Aphakic|Preoperative lens status|During the slit lamp exam performed using the investigator's usual routine, the state of the crystalline lens was described as phakic (present), aphakic (removed), or pseudophakic (removed with posterior chamber intraocular lens inserted)|eyes|Count of Units|2|2.0||||||
3885373|NCT01537393|3710382|B1||Aphakic|Preoperative lens status|During the slit lamp exam performed using the investigator's usual routine, the state of the crystalline lens was described as phakic (present), aphakic (removed), or pseudophakic (removed with posterior chamber intraocular lens inserted)|eyes|Count of Units|0|0.0||||||
3885374|NCT01537393|3710380|B3||Phakic|Preoperative lens status|During the slit lamp exam performed using the investigator's usual routine, the state of the crystalline lens was described as phakic (present), aphakic (removed), or pseudophakic (removed with posterior chamber intraocular lens inserted)|eyes|Count of Units|692|692.0||||||
3885375|NCT01537393|3710381|B2||Phakic|Preoperative lens status|During the slit lamp exam performed using the investigator's usual routine, the state of the crystalline lens was described as phakic (present), aphakic (removed), or pseudophakic (removed with posterior chamber intraocular lens inserted)|eyes|Count of Units|351|351.0||||||
3885376|NCT01537393|3710382|B1||Phakic|Preoperative lens status|During the slit lamp exam performed using the investigator's usual routine, the state of the crystalline lens was described as phakic (present), aphakic (removed), or pseudophakic (removed with posterior chamber intraocular lens inserted)|eyes|Count of Units|341|341.0||||||
3885377|NCT01537393|3710380|B3|||Peripheral anterior synechiae present (nongonioscopic)||eyes|Count of Units|6|6.0||||||
3885378|NCT01537393|3710381|B2|||Peripheral anterior synechiae present (nongonioscopic)||eyes|Count of Units|2|2.0||||||
3885379|NCT01537393|3710382|B1|||Peripheral anterior synechiae present (nongonioscopic)||eyes|Count of Units|4|4.0||||||
3885380|NCT01537393|3710380|B3|||Central subepithelial/stromal scarring present (not affect postoperative stromal clarity assessment)||eyes|Count of Units|85|85.0||||||
3885381|NCT01537393|3710381|B2|||Central subepithelial/stromal scarring present (not affect postoperative stromal clarity assessment)||eyes|Count of Units|48|48.0||||||
3885382|NCT01537393|3710382|B1|||Central subepithelial/stromal scarring present (not affect postoperative stromal clarity assessment)||eyes|Count of Units|37|37.0||||||
3885383|NCT01537393|3710380|B3|||Stromal corneal vessels present (but not visually significant)||eyes|Count of Units|5|5.0||||||
3885384|NCT01537393|3710381|B2|||Stromal corneal vessels present (but not visually significant)||eyes|Count of Units|1|1.0||||||
3885385|NCT01537393|3710382|B1|||Stromal corneal vessels present (but not visually significant)||eyes|Count of Units|4|4.0||||||
3885386|NCT01537393|3710380|B3||Other|Corneal Dystrophy other than FECD (Fuchs endothelial corneal dystrophy))|During the slit lamp exam performed using the investigator's usual routine, the presence of other corneal dystrophies was recorded; EBMD=epithelial basement membrane dystrophy|eyes|Count of Units|9|9.0||||||
3885387|NCT01537393|3710381|B2||Other|Corneal Dystrophy other than FECD (Fuchs endothelial corneal dystrophy))|During the slit lamp exam performed using the investigator's usual routine, the presence of other corneal dystrophies was recorded; EBMD=epithelial basement membrane dystrophy|eyes|Count of Units|3|3.0||||||
3885388|NCT01537393|3710382|B1||Other|Corneal Dystrophy other than FECD (Fuchs endothelial corneal dystrophy))|During the slit lamp exam performed using the investigator's usual routine, the presence of other corneal dystrophies was recorded; EBMD=epithelial basement membrane dystrophy|eyes|Count of Units|6|6.0||||||
3885389|NCT01537393|3710380|B3||EBMD (epithelial basement membrane dystrophy)|Corneal Dystrophy other than FECD (Fuchs endothelial corneal dystrophy))|During the slit lamp exam performed using the investigator's usual routine, the presence of other corneal dystrophies was recorded; EBMD=epithelial basement membrane dystrophy|eyes|Count of Units|67|67.0||||||
3885390|NCT01537393|3710381|B2||EBMD (epithelial basement membrane dystrophy)|Corneal Dystrophy other than FECD (Fuchs endothelial corneal dystrophy))|During the slit lamp exam performed using the investigator's usual routine, the presence of other corneal dystrophies was recorded; EBMD=epithelial basement membrane dystrophy|eyes|Count of Units|29|29.0||||||
3885391|NCT01537393|3710382|B1||EBMD (epithelial basement membrane dystrophy)|Corneal Dystrophy other than FECD (Fuchs endothelial corneal dystrophy))|During the slit lamp exam performed using the investigator's usual routine, the presence of other corneal dystrophies was recorded; EBMD=epithelial basement membrane dystrophy|eyes|Count of Units|38|38.0||||||
3885392|NCT01537393|3710380|B3||Keratoconus|Corneal Dystrophy other than FECD (Fuchs endothelial corneal dystrophy))|During the slit lamp exam performed using the investigator's usual routine, the presence of other corneal dystrophies was recorded; EBMD=epithelial basement membrane dystrophy|eyes|Count of Units|1|1.0||||||
3885393|NCT01537393|3710381|B2||Keratoconus|Corneal Dystrophy other than FECD (Fuchs endothelial corneal dystrophy))|During the slit lamp exam performed using the investigator's usual routine, the presence of other corneal dystrophies was recorded; EBMD=epithelial basement membrane dystrophy|eyes|Count of Units|0|0.0||||||
3885394|NCT01537393|3710382|B1||Keratoconus|Corneal Dystrophy other than FECD (Fuchs endothelial corneal dystrophy))|During the slit lamp exam performed using the investigator's usual routine, the presence of other corneal dystrophies was recorded; EBMD=epithelial basement membrane dystrophy|eyes|Count of Units|1|1.0||||||
3885395|NCT01537393|3710380|B3||No|Corneal Dystrophy other than FECD (Fuchs endothelial corneal dystrophy))|During the slit lamp exam performed using the investigator's usual routine, the presence of other corneal dystrophies was recorded; EBMD=epithelial basement membrane dystrophy|eyes|Count of Units|1253|1253.0||||||
3885396|NCT01537393|3710381|B2||No|Corneal Dystrophy other than FECD (Fuchs endothelial corneal dystrophy))|During the slit lamp exam performed using the investigator's usual routine, the presence of other corneal dystrophies was recorded; EBMD=epithelial basement membrane dystrophy|eyes|Count of Units|623|623.0||||||
3885397|NCT01537393|3710382|B1||No|Corneal Dystrophy other than FECD (Fuchs endothelial corneal dystrophy))|During the slit lamp exam performed using the investigator's usual routine, the presence of other corneal dystrophies was recorded; EBMD=epithelial basement membrane dystrophy|eyes|Count of Units|630|630.0||||||
3885398|NCT01537393|3710380|B3||Fuchs endothelial corneal dystrophy (FECD)|Diagnosis||eyes|Count of Units|1255|1255.0||||||
3885399|NCT01537393|3710381|B2||Fuchs endothelial corneal dystrophy (FECD)|Diagnosis||eyes|Count of Units|624|624.0||||||
3885400|NCT01537393|3710382|B1||Fuchs endothelial corneal dystrophy (FECD)|Diagnosis||eyes|Count of Units|631|631.0||||||
3885401|NCT01537393|3710380|B3||Aphakic corneal edema without FECD|Diagnosis||eyes|Count of Units|2|2.0||||||
3885402|NCT01537393|3710381|B2||Aphakic corneal edema without FECD|Diagnosis||eyes|Count of Units|2|2.0||||||
3885403|NCT01537393|3710382|B1||Aphakic corneal edema without FECD|Diagnosis||eyes|Count of Units|0|0.0||||||
3885404|NCT01537393|3710380|B3||Pseudophakic corneal edema without FECD|Diagnosis||eyes|Count of Units|73|73.0||||||
3885405|NCT01537393|3710381|B2||Pseudophakic corneal edema without FECD|Diagnosis||eyes|Count of Units|29|29.0||||||
3885406|NCT01537393|3710382|B1||Pseudophakic corneal edema without FECD|Diagnosis||eyes|Count of Units|44|44.0||||||
3885407|NCT01537393|3710380|B3|||Glaucoma medication currently being used||eyes|Count of Units|99|99.0||||||
3885408|NCT01537393|3710381|B2|||Glaucoma medication currently being used||eyes|Count of Units|54|54.0||||||
3885409|NCT01537393|3710382|B1|||Glaucoma medication currently being used||eyes|Count of Units|45|45.0||||||
3885410|NCT01537393|3710380|B3|||Prior glaucoma surgery||eyes|Count of Units|31|31.0||||||
3885411|NCT01537393|3710381|B2|||Prior glaucoma surgery||eyes|Count of Units|13|13.0||||||
3885412|NCT01537393|3710382|B1|||Prior glaucoma surgery||eyes|Count of Units|18|18.0||||||
3885413|NCT01537393|3710380|B3|||Received any immunizations or vaccinations in last 3 mo||eyes|Count of Units|173|173.0||||||
3885414|NCT01537393|3710381|B2|||Received any immunizations or vaccinations in last 3 mo||eyes|Count of Units|81|81.0||||||
3885415|NCT01537393|3710382|B1|||Received any immunizations or vaccinations in last 3 mo||eyes|Count of Units|92|92.0||||||
3885416|NCT01537393|3710380|B3|||Current cigarette smoker||eyes|Count of Units|90|90.0||||||
3885417|NCT01537393|3710381|B2|||Current cigarette smoker||eyes|Count of Units|45|45.0||||||
3885418|NCT01537393|3710382|B1|||Current cigarette smoker||eyes|Count of Units|45|45.0||||||
3885419|NCT01537393|3710380|B3|||History of Diabetes||eyes|Count of Units|242|242.0||||||
3885420|NCT01537393|3710381|B2|||History of Diabetes||eyes|Count of Units|126|126.0||||||
3885421|NCT01537393|3710382|B1|||History of Diabetes||eyes|Count of Units|116|116.0||||||
3885422|NCT01537393|3710380|B3||Unknown or not reported|Race/Ethnicity, Customized||eyes|Count of Units|8|8.0||||||
3885423|NCT01537393|3710381|B2||Unknown or not reported|Race/Ethnicity, Customized||eyes|Count of Units|5|5.0||||||
3885424|NCT01537393|3710382|B1||Unknown or not reported|Race/Ethnicity, Customized||eyes|Count of Units|3|3.0||||||
3885425|NCT01537393|3710380|B3||More than 1 race|Race/Ethnicity, Customized||eyes|Count of Units|9|9.0||||||
3885426|NCT01537393|3710381|B2||More than 1 race|Race/Ethnicity, Customized||eyes|Count of Units|3|3.0||||||
3885427|NCT01537393|3710382|B1||More than 1 race|Race/Ethnicity, Customized||eyes|Count of Units|6|6.0||||||
3885428|NCT01537393|3710380|B3||American India or Alaskan Native|Race/Ethnicity, Customized||eyes|Count of Units|3|3.0||||||
3885429|NCT01537393|3710381|B2||American India or Alaskan Native|Race/Ethnicity, Customized||eyes|Count of Units|2|2.0||||||
3885430|NCT01537393|3710382|B1||American India or Alaskan Native|Race/Ethnicity, Customized||eyes|Count of Units|1|1.0||||||
3885431|NCT01537393|3710380|B3||Asian|Race/Ethnicity, Customized||eyes|Count of Units|12|12.0||||||
3885432|NCT01537393|3710381|B2||Asian|Race/Ethnicity, Customized||eyes|Count of Units|5|5.0||||||
3885433|NCT01537393|3710382|B1||Asian|Race/Ethnicity, Customized||eyes|Count of Units|7|7.0||||||
3885434|NCT01537393|3710380|B3||Hispanic or Latino|Race/Ethnicity, Customized||eyes|Count of Units|44|44.0||||||
3885435|NCT01537393|3710381|B2||Hispanic or Latino|Race/Ethnicity, Customized||eyes|Count of Units|25|25.0||||||
3885436|NCT01537393|3710382|B1||Hispanic or Latino|Race/Ethnicity, Customized||eyes|Count of Units|19|19.0||||||
3885437|NCT01537393|3710380|B3||African American|Race/Ethnicity, Customized||eyes|Count of Units|47|47.0||||||
3885438|NCT01537393|3710381|B2||African American|Race/Ethnicity, Customized||eyes|Count of Units|21|21.0||||||
3885439|NCT01537393|3710382|B1||African American|Race/Ethnicity, Customized||eyes|Count of Units|26|26.0||||||
3885440|NCT01537393|3710380|B3||White|Race/Ethnicity, Customized||eyes|Count of Units|1207|1207.0||||||
3885441|NCT01537393|3710381|B2||White|Race/Ethnicity, Customized||eyes|Count of Units|594|594.0||||||
3885442|NCT01537393|3710382|B1||White|Race/Ethnicity, Customized||eyes|Count of Units|613|613.0||||||
3885443|NCT01537393|3710380|B3||Male|Sex: Female, Male||eyes|Count of Units|529|529.0||||||
3885444|NCT01537393|3710381|B2||Male|Sex: Female, Male||eyes|Count of Units|263|263.0||||||
3885445|NCT01537393|3710382|B1||Male|Sex: Female, Male||eyes|Count of Units|266|266.0||||||
3885446|NCT01537393|3710380|B3||Female|Sex: Female, Male||eyes|Count of Units|801|801.0||||||
3885447|NCT01537393|3710381|B2||Female|Sex: Female, Male||eyes|Count of Units|392|392.0||||||
3885448|NCT01537393|3710382|B1||Female|Sex: Female, Male||eyes|Count of Units|409|409.0||||||
3885449|NCT01537393|3710380|B3|||Age||years|Median|70|70.0|Inter-Quartile Range|||64.0|76.0|
3885450|NCT01537393|3710381|B2|||Age||years|Median|70|70.0|Inter-Quartile Range|||64.0|77.0|
3885451|NCT01537393|3710382|B1|||Age||years|Median|70|70.0|Inter-Quartile Range|||64.0|76.0|
3885452|NCT01537367|3710391|B4|Hispanic||Race/Ethnicity, Customized|Mutually exclusive categories where Hispanic is treated as a distinct race category, over-riding any other selection from the OMB race variable.|participants|Number|288|288.0||||||
3885453|NCT01537367|3710392|B3|Hispanic||Race/Ethnicity, Customized|Mutually exclusive categories where Hispanic is treated as a distinct race category, over-riding any other selection from the OMB race variable.|participants|Number|108|108.0||||||
3885454|NCT01537367|3710393|B2|Hispanic||Race/Ethnicity, Customized|Mutually exclusive categories where Hispanic is treated as a distinct race category, over-riding any other selection from the OMB race variable.|participants|Number|101|101.0||||||
3885455|NCT01537367|3710394|B1|Hispanic||Race/Ethnicity, Customized|Mutually exclusive categories where Hispanic is treated as a distinct race category, over-riding any other selection from the OMB race variable.|participants|Number|79|79.0||||||
3885456|NCT01537367|3710391|B4|Other race||Race/Ethnicity, Customized|Mutually exclusive categories where Hispanic is treated as a distinct race category, over-riding any other selection from the OMB race variable.|participants|Number|53|53.0||||||
3885457|NCT01537367|3710392|B3|Other race||Race/Ethnicity, Customized|Mutually exclusive categories where Hispanic is treated as a distinct race category, over-riding any other selection from the OMB race variable.|participants|Number|20|20.0||||||
3885458|NCT01537367|3710393|B2|Other race||Race/Ethnicity, Customized|Mutually exclusive categories where Hispanic is treated as a distinct race category, over-riding any other selection from the OMB race variable.|participants|Number|15|15.0||||||
3885459|NCT01537367|3710394|B1|Other race||Race/Ethnicity, Customized|Mutually exclusive categories where Hispanic is treated as a distinct race category, over-riding any other selection from the OMB race variable.|participants|Number|18|18.0||||||
3885460|NCT01537367|3710391|B4|White||Race/Ethnicity, Customized|Mutually exclusive categories where Hispanic is treated as a distinct race category, over-riding any other selection from the OMB race variable.|participants|Number|235|235.0||||||
3885461|NCT01537367|3710392|B3|White||Race/Ethnicity, Customized|Mutually exclusive categories where Hispanic is treated as a distinct race category, over-riding any other selection from the OMB race variable.|participants|Number|76|76.0||||||
3885462|NCT01537367|3710393|B2|White||Race/Ethnicity, Customized|Mutually exclusive categories where Hispanic is treated as a distinct race category, over-riding any other selection from the OMB race variable.|participants|Number|72|72.0||||||
3885463|NCT01537367|3710394|B1|White||Race/Ethnicity, Customized|Mutually exclusive categories where Hispanic is treated as a distinct race category, over-riding any other selection from the OMB race variable.|participants|Number|87|87.0||||||
3885464|NCT01537367|3710391|B4|Black||Race/Ethnicity, Customized|Mutually exclusive categories where Hispanic is treated as a distinct race category, over-riding any other selection from the OMB race variable.|participants|Number|1262|1262.0||||||
3885465|NCT01537367|3710392|B3|Black||Race/Ethnicity, Customized|Mutually exclusive categories where Hispanic is treated as a distinct race category, over-riding any other selection from the OMB race variable.|participants|Number|409|409.0||||||
3885466|NCT01537367|3710393|B2|Black||Race/Ethnicity, Customized|Mutually exclusive categories where Hispanic is treated as a distinct race category, over-riding any other selection from the OMB race variable.|participants|Number|422|422.0||||||
3885467|NCT01537367|3710394|B1|Black||Race/Ethnicity, Customized|Mutually exclusive categories where Hispanic is treated as a distinct race category, over-riding any other selection from the OMB race variable.|participants|Number|431|431.0||||||
3885468|NCT01537367|3710391|B4||Male|Sex: Female, Male||Participants|Count of Participants|1173|1173.0||||||
3885469|NCT01537367|3710392|B3||Male|Sex: Female, Male||Participants|Count of Participants|385|385.0||||||
3885470|NCT01537367|3710393|B2||Male|Sex: Female, Male||Participants|Count of Participants|376|376.0||||||
3885471|NCT01537367|3710394|B1||Male|Sex: Female, Male||Participants|Count of Participants|412|412.0||||||
3885472|NCT01537367|3710391|B4||Female|Sex: Female, Male||Participants|Count of Participants|665|665.0||||||
3885473|NCT01537367|3710392|B3||Female|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
3885474|NCT01537367|3710393|B2||Female|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
3885475|NCT01537367|3710394|B1||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
3885476|NCT01537367|3710391|B4|60-plus years||Age, Customized|Five-category Age Age groups: 18-29 30-39 40-49 50-59 60-plus|participants|Number|124|124.0||||||
3885477|NCT01537367|3710392|B3|60-plus years||Age, Customized|Five-category Age Age groups: 18-29 30-39 40-49 50-59 60-plus|participants|Number|39|39.0||||||
3885478|NCT01537367|3710393|B2|60-plus years||Age, Customized|Five-category Age Age groups: 18-29 30-39 40-49 50-59 60-plus|participants|Number|44|44.0||||||
3885479|NCT01537367|3710394|B1|60-plus years||Age, Customized|Five-category Age Age groups: 18-29 30-39 40-49 50-59 60-plus|participants|Number|41|41.0||||||
3885480|NCT01537367|3710391|B4|50-59 years||Age, Customized|Five-category Age Age groups: 18-29 30-39 40-49 50-59 60-plus|participants|Number|530|530.0||||||
3885481|NCT01537367|3710392|B3|50-59 years||Age, Customized|Five-category Age Age groups: 18-29 30-39 40-49 50-59 60-plus|participants|Number|167|167.0||||||
3885482|NCT01537367|3710393|B2|50-59 years||Age, Customized|Five-category Age Age groups: 18-29 30-39 40-49 50-59 60-plus|participants|Number|176|176.0||||||
3885483|NCT01537367|3710394|B1|50-59 years||Age, Customized|Five-category Age Age groups: 18-29 30-39 40-49 50-59 60-plus|participants|Number|187|187.0||||||
3885484|NCT01537367|3710391|B4|40-49 years||Age, Customized|Five-category Age Age groups: 18-29 30-39 40-49 50-59 60-plus|participants|Number|624|624.0||||||
3885485|NCT01537367|3710392|B3|40-49 years||Age, Customized|Five-category Age Age groups: 18-29 30-39 40-49 50-59 60-plus|participants|Number|212|212.0||||||
3885486|NCT01537367|3710393|B2|40-49 years||Age, Customized|Five-category Age Age groups: 18-29 30-39 40-49 50-59 60-plus|participants|Number|202|202.0||||||
3885487|NCT01537367|3710394|B1|40-49 years||Age, Customized|Five-category Age Age groups: 18-29 30-39 40-49 50-59 60-plus|participants|Number|210|210.0||||||
3885488|NCT01537367|3710391|B4|30-39 years||Age, Customized|Five-category Age Age groups: 18-29 30-39 40-49 50-59 60-plus|participants|Number|361|361.0||||||
3885489|NCT01537367|3710392|B3|30-39 years||Age, Customized|Five-category Age Age groups: 18-29 30-39 40-49 50-59 60-plus|participants|Number|122|122.0||||||
3885490|NCT01537367|3710393|B2|30-39 years||Age, Customized|Five-category Age Age groups: 18-29 30-39 40-49 50-59 60-plus|participants|Number|121|121.0||||||
3885491|NCT01537367|3710394|B1|30-39 years||Age, Customized|Five-category Age Age groups: 18-29 30-39 40-49 50-59 60-plus|participants|Number|118|118.0||||||
3885492|NCT01537367|3710391|B4|18-29 years||Age, Customized|Five-category Age Age groups: 18-29 30-39 40-49 50-59 60-plus|participants|Number|199|199.0||||||
3885493|NCT01537367|3710392|B3|18-29 years||Age, Customized|Five-category Age Age groups: 18-29 30-39 40-49 50-59 60-plus|participants|Number|73|73.0||||||
3885494|NCT01537367|3710393|B2|18-29 years||Age, Customized|Five-category Age Age groups: 18-29 30-39 40-49 50-59 60-plus|participants|Number|67|67.0||||||
3885495|NCT01537367|3710394|B1|18-29 years||Age, Customized|Five-category Age Age groups: 18-29 30-39 40-49 50-59 60-plus|participants|Number|59|59.0||||||
3885496|NCT01537315|3710410|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3885497|NCT01537315|3710411|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3885498|NCT01537315|3710412|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3885499|NCT01537315|3710410|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3885500|NCT01537315|3710411|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3885501|NCT01537315|3710412|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3885502|NCT01537315|3710410|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3885503|NCT01537315|3710411|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3885504|NCT01537315|3710412|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3885505|NCT01537315|3710410|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3885506|NCT01537315|3710411|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3885507|NCT01537315|3710412|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3885508|NCT01537315|3710410|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3885509|NCT01537315|3710411|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3885510|NCT01537315|3710412|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3885511|NCT01537315|3710410|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3885512|NCT01537315|3710411|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3885513|NCT01537315|3710412|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3885514|NCT01537302|3710419|B1|||Body Mass Index||kg/m2|Mean|28.2|28.2|Standard Deviation|5.9|5.9|||
3885515|NCT01537302|3710419|B1|ABI Unobtainable||Ankle-Brachial Index||participants|Number|5|5.0||||||
3885516|NCT01537302|3710419|B1|ABI < 0.4: Chronic Limb Ischemia||Ankle-Brachial Index||participants|Number|16|16.0||||||
3885517|NCT01537302|3710419|B1|ABI < 0.6: Intermittent Claudication||Ankle-Brachial Index||participants|Number|79|79.0||||||
3885518|NCT01537302|3710419|B1|ABI < 0.95: Peripheral Vascular Disease||Ankle-Brachial Index||participants|Number|91|91.0||||||
3885519|NCT01537302|3710419|B1|ABI ≥ 0.95: Normal||Ankle-Brachial Index||participants|Number|9|9.0||||||
3885520|NCT01537302|3710419|B1|ABI >1.3: Non-Compressible Vessels||Ankle-Brachial Index||participants|Number|1|1.0||||||
3885521|NCT01537302|3710419|B1|6 - Major Tissue Loss||Rutherford||participants|Number|0|0.0||||||
3885522|NCT01537302|3710419|B1|5 - Minor Tissue Loss||Rutherford||participants|Number|14|14.0||||||
3885523|NCT01537302|3710419|B1|4 - Ischemic Rest Pain||Rutherford||participants|Number|34|34.0||||||
3885524|NCT01537302|3710419|B1|3 - Severe Claudication||Rutherford||participants|Number|119|119.0||||||
3885525|NCT01537302|3710419|B1|2 - Moderate Claudication||Rutherford||participants|Number|34|34.0||||||
3885526|NCT01537302|3710419|B1|1 - Mild Claudication||Rutherford||participants|Number|0|0.0||||||
3885527|NCT01537302|3710419|B1|0 - Asymptomatic||Rutherford||participants|Number|0|0.0||||||
3885528|NCT01537302|3710419|B1|Italy||Region of Enrollment||participants|Number|6|6.0||||||
3885529|NCT01537302|3710419|B1|Germany||Region of Enrollment||participants|Number|13|13.0||||||
3885530|NCT01537302|3710419|B1|United States||Region of Enrollment||participants|Number|182|182.0||||||
3885531|NCT01537302|3710419|B1|Not Captured||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3885532|NCT01537302|3710419|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3885533|NCT01537302|3710419|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3885534|NCT01537302|3710419|B1|American Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3885535|NCT01537302|3710419|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3885536|NCT01537302|3710419|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3885537|NCT01537302|3710419|B1|African American||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
3885538|NCT01537302|3710419|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|133|133.0||||||
3885539|NCT01537302|3710419|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3885540|NCT01537302|3710419|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3885541|NCT01537302|3710419|B1|||Age||years|Mean|68.9|68.9|Standard Deviation|9.4|9.4|||
3885542|NCT01537198|3710426|B1||Male|Sex: Female, Male||Participants|Count of Participants|336|336.0||||||
3885543|NCT01537198|3710426|B1||Female|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
3885544|NCT01537198|3710426|B1|Infants and toddlers (28 days to 23 months)||Age, Customized||participants|Number|451|451.0||||||
3885545|NCT01537198|3710426|B1|Newborn infants (0 to 27 days)||Age, Customized||participants|Number|166|166.0||||||
3885546|NCT01537198|3710426|B1|||Age||months|Mean|3.38|3.38|Standard Deviation|3.39|3.39|||
3885547|NCT01537185|3710430|B5|United States||Region of Enrollment||participants|Number|42|42.0||||||
3885548|NCT01537185|3710431|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
3885549|NCT01537185|3710432|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3885550|NCT01537185|3710433|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3885551|NCT01537185|3710434|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3885552|NCT01537185|3710430|B5||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3885553|NCT01537185|3710431|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3885554|NCT01537185|3710432|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3885555|NCT01537185|3710433|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3885556|NCT01537185|3710434|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3885557|NCT01537185|3710430|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3885558|NCT01537185|3710431|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3885559|NCT01537185|3710432|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3885560|NCT01537185|3710433|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3885561|NCT01537185|3710434|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3885562|NCT01537185|3710430|B5|||Age||years|Mean|28.1|28.1|Full Range|||18.0|40.0|
3885563|NCT01537185|3710431|B4|||Age||years|Mean|29.9|29.9|Full Range|||21.0|40.0|
3885564|NCT01537185|3710432|B3|||Age||years|Mean|25.2|25.2|Full Range|||18.0|34.0|
3885565|NCT01537185|3710433|B2|||Age||years|Mean|28.5|28.5|Full Range|||18.0|40.0|
3885566|NCT01537185|3710434|B1|||Age||years|Mean|28.9|28.9|Full Range|||19.0|40.0|
3885567|NCT01537133|3710451|B5|||Sputum eosinophils||percent of cells in sputum sample|Median|0.2|0.2|Inter-Quartile Range|||0.0|0.6|
3885568|NCT01537133|3710452|B4|||Sputum eosinophils||percent of cells in sputum sample|Median|0|0.0|Inter-Quartile Range|||0.0|0.4|
3885569|NCT01537133|3710453|B3|||Sputum eosinophils||percent of cells in sputum sample|Median|0|0.0|Inter-Quartile Range|||0.0|0.45|
3885570|NCT01537133|3710454|B2|||Sputum eosinophils||percent of cells in sputum sample|Median|0.7|0.7|Inter-Quartile Range|||0.0|1.5|
3885571|NCT01537133|3710455|B1|||Sputum eosinophils||percent of cells in sputum sample|Median|0.3|0.3|Inter-Quartile Range|||0.0|0.8|
3885572|NCT01537133|3710451|B5|||Blood Eosinophils||percent of cells in blood sample|Median|2.0|2.0|Inter-Quartile Range|||1.2|4.0|
3885573|NCT01537133|3710452|B4|||Blood Eosinophils||percent of cells in blood sample|Median|1.4|1.4|Inter-Quartile Range|||1.0|3.0|
3885574|NCT01537133|3710453|B3|||Blood Eosinophils||percent of cells in blood sample|Median|2.0|2.0|Inter-Quartile Range|||1.4|2.9|
3885575|NCT01537133|3710454|B2|||Blood Eosinophils||percent of cells in blood sample|Median|3.6|3.6|Inter-Quartile Range|||2.0|4.8|
3885576|NCT01537133|3710455|B1|||Blood Eosinophils||percent of cells in blood sample|Median|3.3|3.3|Inter-Quartile Range|||1.3|5.7|
3885577|NCT01537133|3710451|B5|||Forced Expiratory Volume in 1 second||percent of predicted|Median|96|96.0|Inter-Quartile Range|||86.0|105.0|
3885578|NCT01537133|3710452|B4|||Forced Expiratory Volume in 1 second||percent of predicted|Median|100|100.0|Inter-Quartile Range|||94.0|107.0|
3885579|NCT01537133|3710453|B3|||Forced Expiratory Volume in 1 second||percent of predicted|Median|98|98.0|Inter-Quartile Range|||89.0|108.0|
3885580|NCT01537133|3710454|B2|||Forced Expiratory Volume in 1 second||percent of predicted|Median|84|84.0|Inter-Quartile Range|||77.0|89.0|
3885581|NCT01537133|3710455|B1|||Forced Expiratory Volume in 1 second||percent of predicted|Median|94|94.0|Inter-Quartile Range|||76.0|99.0|
3885582|NCT01537133|3710451|B5|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3885583|NCT01537133|3710452|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3885584|NCT01537133|3710453|B3|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3885585|NCT01537133|3710454|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3885586|NCT01537133|3710455|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3885587|NCT01537133|3710451|B5|Hispanic or Latio||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3885588|NCT01537133|3710452|B4|Hispanic or Latio||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3885589|NCT01537133|3710453|B3|Hispanic or Latio||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3885590|NCT01537133|3710454|B2|Hispanic or Latio||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3885591|NCT01537133|3710455|B1|Hispanic or Latio||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3885592|NCT01537133|3710451|B5|Black||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3885593|NCT01537133|3710452|B4|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3885594|NCT01537133|3710453|B3|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3885595|NCT01537133|3710454|B2|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3885596|NCT01537133|3710455|B1|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3885597|NCT01537133|3710451|B5|White||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
3885598|NCT01537133|3710452|B4|White||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3885599|NCT01537133|3710453|B3|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3885600|NCT01537133|3710454|B2|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3885601|NCT01537133|3710455|B1|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3885602|NCT01537133|3710451|B5||Male|Gender||Participants|Count of Participants|38|38.0||||||
3885603|NCT01537133|3710452|B4||Male|Gender||Participants|Count of Participants|9|9.0||||||
3885604|NCT01537133|3710453|B3||Male|Gender||Participants|Count of Participants|10|10.0||||||
3885605|NCT01537133|3710454|B2||Male|Gender||Participants|Count of Participants|7|7.0||||||
3885606|NCT01537133|3710455|B1||Male|Gender||Participants|Count of Participants|12|12.0||||||
3885607|NCT01537133|3710451|B5||Female|Gender||Participants|Count of Participants|46|46.0||||||
3885608|NCT01537133|3710452|B4||Female|Gender||Participants|Count of Participants|12|12.0||||||
3885609|NCT01537133|3710453|B3||Female|Gender||Participants|Count of Participants|11|11.0||||||
3885610|NCT01537133|3710454|B2||Female|Gender||Participants|Count of Participants|7|7.0||||||
3885611|NCT01537133|3710455|B1||Female|Gender||Participants|Count of Participants|16|16.0||||||
3885612|NCT01537133|3710451|B5|||Age||years|Median|30|30.0|Inter-Quartile Range|||25.0|42.0|
3885613|NCT01537133|3710452|B4|||Age||years|Median|28|28.0|Inter-Quartile Range|||24.0|45.0|
3885614|NCT01537133|3710453|B3|||Age||years|Median|28|28.0|Inter-Quartile Range|||25.0|42.0|
3885615|NCT01537133|3710454|B2|||Age||years|Median|37|37.0|Inter-Quartile Range|||25.0|40.0|
3885616|NCT01537133|3710455|B1|||Age||years|Median|30|30.0|Inter-Quartile Range|||26.0|40.0|
3885617|NCT01537120|3710474|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3885618|NCT01537120|3710474|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3885619|NCT01537120|3710474|B1|||Age||Years|Mean|62|62.0|Standard Deviation|5.6|5.6|||
3885620|NCT01537081|3710484|B4|Other||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
3885621|NCT01537081|3710485|B3|Other||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3885622|NCT01537081|3710486|B2|Other||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3885623|NCT01537081|3710487|B1|Other||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3885624|NCT01537081|3710484|B4|White||Race/Ethnicity, Customized||participants|Number|1669|1669.0||||||
3885625|NCT01537081|3710485|B3|White||Race/Ethnicity, Customized||participants|Number|327|327.0||||||
3885626|NCT01537081|3710486|B2|White||Race/Ethnicity, Customized||participants|Number|656|656.0||||||
3885627|NCT01537081|3710487|B1|White||Race/Ethnicity, Customized||participants|Number|686|686.0||||||
3885628|NCT01537081|3710484|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|1001|1001.0||||||
3885629|NCT01537081|3710485|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|200|200.0||||||
3885630|NCT01537081|3710486|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|419|419.0||||||
3885631|NCT01537081|3710487|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|382|382.0||||||
3885632|NCT01537081|3710484|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3885633|NCT01537081|3710485|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3885634|NCT01537081|3710486|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3885635|NCT01537081|3710487|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3885636|NCT01537081|3710484|B4|Asian||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
3885637|NCT01537081|3710485|B3|Asian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3885638|NCT01537081|3710486|B2|Asian||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3885639|NCT01537081|3710487|B1|Asian||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3885640|NCT01537081|3710484|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3885641|NCT01537081|3710485|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3885642|NCT01537081|3710486|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3885643|NCT01537081|3710487|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3885644|NCT01537081|3710484|B4||Male|Sex: Female, Male||Participants|Count of Participants|1134|1134.0||||||
3885645|NCT01537081|3710485|B3||Male|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
3885646|NCT01537081|3710486|B2||Male|Sex: Female, Male||Participants|Count of Participants|454|454.0||||||
3885647|NCT01537081|3710487|B1||Male|Sex: Female, Male||Participants|Count of Participants|452|452.0||||||
3885648|NCT01537081|3710484|B4||Female|Sex: Female, Male||Participants|Count of Participants|1671|1671.0||||||
3885649|NCT01537081|3710485|B3||Female|Sex: Female, Male||Participants|Count of Participants|333|333.0||||||
3885650|NCT01537081|3710486|B2||Female|Sex: Female, Male||Participants|Count of Participants|668|668.0||||||
3885651|NCT01537081|3710487|B1||Female|Sex: Female, Male||Participants|Count of Participants|670|670.0||||||
3885652|NCT01537081|3710484|B4|||Age||years|Mean|37.2|37.2|Standard Deviation|13.87|13.87|||
3885653|NCT01537081|3710485|B3|||Age||years|Mean|37.9|37.9|Standard Deviation|14.09|14.09|||
3885654|NCT01537081|3710486|B2|||Age||years|Mean|36.8|36.8|Standard Deviation|13.81|13.81|||
3885655|NCT01537081|3710487|B1|||Age||years|Mean|37.3|37.3|Standard Deviation|13.81|13.81|||
3885656|NCT01537068|3710500|B3|United States||Region of Enrollment||participants|Number|59|59.0||||||
3885657|NCT01537068|3710501|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
3885658|NCT01537068|3710502|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3885659|NCT01537068|3710500|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3885660|NCT01537068|3710501|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3885661|NCT01537068|3710502|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3885662|NCT01537068|3710500|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3885663|NCT01537068|3710501|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3885664|NCT01537068|3710502|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3885665|NCT01537068|3710500|B3|||Age||years|Mean|38.07|38.07|Standard Deviation|13.01|13.01|||
3885666|NCT01537068|3710501|B2|||Age||years|Mean|36.28|36.28|Standard Deviation|11.65|11.65|||
3885667|NCT01537068|3710502|B1|||Age||years|Mean|39.80|39.8|Standard Deviation|14.18|14.18|||
3885668|NCT01537068|3710500|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3885669|NCT01537068|3710501|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3885670|NCT01537068|3710502|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3885671|NCT01537068|3710500|B3||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
3885672|NCT01537068|3710501|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3885673|NCT01537068|3710502|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3885674|NCT01537068|3710500|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3885675|NCT01537068|3710501|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3885676|NCT01537068|3710502|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3885677|NCT01537042|3710513|B3|||BMI||kg/ m^2|Mean|29.887|29.887|Standard Deviation|4.931|4.931|||
3885678|NCT01537042|3710514|B2|||BMI||kg/ m^2|Mean|30.405|30.405|Standard Deviation|4.262|4.262|||
3885679|NCT01537042|3710515|B1|||BMI||kg/ m^2|Mean|28.850|28.85|Standard Deviation|6.182|6.182|||
3885680|NCT01537042|3710513|B3|||Height||Centimeters|Mean|171.59|171.59|Standard Deviation|10.82|10.82|||
3885681|NCT01537042|3710514|B2|||Height||Centimeters|Mean|171.50|171.5|Standard Deviation|11.99|11.99|||
3885682|NCT01537042|3710515|B1|||Height||Centimeters|Mean|171.77|171.77|Standard Deviation|8.59|8.59|||
3885683|NCT01537042|3710513|B3|||Weight||Kilograms|Mean|88.07|88.07|Standard Deviation|17.17|17.17|||
3885684|NCT01537042|3710514|B2|||Weight||Kilograms|Mean|89.42|89.42|Standard Deviation|15.34|15.34|||
3885685|NCT01537042|3710515|B1|||Weight||Kilograms|Mean|85.38|85.38|Standard Deviation|20.99|20.99|||
3885686|NCT01537042|3710513|B3|Europe||Region of Enrollment||participants|Number|12|12.0||||||
3885687|NCT01537042|3710514|B2|Europe||Region of Enrollment||participants|Number|8|8.0||||||
3885688|NCT01537042|3710515|B1|Europe||Region of Enrollment||participants|Number|4|4.0||||||
3885689|NCT01537042|3710513|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
3885690|NCT01537042|3710514|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3885691|NCT01537042|3710515|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3885692|NCT01537042|3710513|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3885693|NCT01537042|3710514|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3885694|NCT01537042|3710515|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3885695|NCT01537042|3710513|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3885696|NCT01537042|3710514|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3885697|NCT01537042|3710515|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3885698|NCT01537042|3710513|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3885699|NCT01537042|3710514|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3885700|NCT01537042|3710515|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3885701|NCT01537042|3710513|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3885702|NCT01537042|3710514|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3885703|NCT01537042|3710515|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3885704|NCT01537042|3710513|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3885705|NCT01537042|3710514|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885706|NCT01537042|3710515|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3885707|NCT01537042|3710513|B3||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3885708|NCT01537042|3710514|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3885709|NCT01537042|3710515|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3885710|NCT01537042|3710513|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3885711|NCT01537042|3710514|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3885712|NCT01537042|3710515|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3885713|NCT01537042|3710513|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885714|NCT01537042|3710514|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885715|NCT01537042|3710515|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885716|NCT01537042|3710513|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885717|NCT01537042|3710514|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885718|NCT01537042|3710515|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885719|NCT01537042|3710513|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885720|NCT01537042|3710514|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885721|NCT01537042|3710515|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885722|NCT01537042|3710513|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3885723|NCT01537042|3710514|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3885724|NCT01537042|3710515|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3885725|NCT01537042|3710513|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3885726|NCT01537042|3710514|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3885727|NCT01537042|3710515|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3885728|NCT01537042|3710513|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3885729|NCT01537042|3710514|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3885730|NCT01537042|3710515|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3885731|NCT01537042|3710513|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3885732|NCT01537042|3710514|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3885733|NCT01537042|3710515|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3885734|NCT01537042|3710513|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3885735|NCT01537042|3710514|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3885736|NCT01537042|3710515|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3885737|NCT01537042|3710513|B3|||Age||years|Mean|55.0|55.0|Standard Deviation|14.0|14.0|||
3885738|NCT01537042|3710514|B2|||Age||years|Mean|57.2|57.2|Standard Deviation|12.6|12.6|||
3885739|NCT01537042|3710515|B1|||Age||years|Mean|50.7|50.7|Standard Deviation|16.3|16.3|||
3885740|NCT01537029|3710552|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3885741|NCT01537029|3710552|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885742|NCT01537029|3710552|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885743|NCT01537029|3710552|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3885744|NCT01537029|3710552|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3885745|NCT01537029|3710552|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885746|NCT01537029|3710552|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885747|NCT01537029|3710552|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885748|NCT01537029|3710552|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885749|NCT01537029|3710552|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3885750|NCT01537029|3710552|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3885751|NCT01537029|3710552|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3885752|NCT01537029|3710552|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3885753|NCT01537029|3710552|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3885754|NCT01537029|3710552|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3885755|NCT01537029|3710552|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3885756|NCT01536951|3710556|B3|United States||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
3885757|NCT01536951|3710557|B2|United States||Region of Enrollment||Participants|Count of Participants|53|53.0||||||
3885758|NCT01536951|3710558|B1|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3885759|NCT01536951|3710556|B3|More than 1 race||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3885760|NCT01536951|3710557|B2|More than 1 race||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3885761|NCT01536951|3710558|B1|More than 1 race||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3885762|NCT01536951|3710556|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
3885763|NCT01536951|3710557|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
3885764|NCT01536951|3710558|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3885765|NCT01536951|3710556|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3885766|NCT01536951|3710557|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3885767|NCT01536951|3710558|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3885768|NCT01536951|3710556|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885769|NCT01536951|3710557|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885770|NCT01536951|3710558|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3885771|NCT01536951|3710556|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3885772|NCT01536951|3710557|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3885773|NCT01536951|3710558|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3885774|NCT01536951|3710556|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3885775|NCT01536951|3710557|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3885776|NCT01536951|3710558|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3885777|NCT01536951|3710556|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3885778|NCT01536951|3710557|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3885779|NCT01536951|3710558|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3885780|NCT01536951|3710556|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3885781|NCT01536951|3710557|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3885782|NCT01536951|3710558|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3885783|NCT01536951|3710556|B3|||Age||years|Mean|40.8|40.8|Standard Deviation|12.0|12.0|||
3885784|NCT01536951|3710557|B2|||Age||years|Mean|39.9|39.9|Standard Deviation|11.3|11.3|||
3885785|NCT01536951|3710558|B1|||Age||years|Mean|45.9|45.9|Standard Deviation|15.4|15.4|||
3885786|NCT01536938|3710593|B4||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
3885787|NCT01536938|3710594|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3885788|NCT01536938|3710595|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3885789|NCT01536938|3710596|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3885790|NCT01536938|3710593|B4||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3885791|NCT01536938|3710594|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3885792|NCT01536938|3710595|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3885793|NCT01536938|3710596|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3885794|NCT01536938|3710593|B4|||Age||years|Mean|49.0|49.0|Standard Deviation|14.7|14.7|||
3885795|NCT01536938|3710594|B3|||Age||years|Mean|50.7|50.7|Standard Deviation|14.7|14.7|||
3885796|NCT01536938|3710595|B2|||Age||years|Mean|49.0|49.0|Standard Deviation|14.4|14.4|||
3885797|NCT01536938|3710596|B1|||Age||years|Mean|47.4|47.4|Standard Deviation|14.8|14.8|||
3885798|NCT01536886|3710606|B5||Male|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
3885799|NCT01536886|3710607|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3885800|NCT01536886|3710608|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3885801|NCT01536886|3710609|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3885802|NCT01536886|3710610|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3885803|NCT01536886|3710606|B5||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3885804|NCT01536886|3710607|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3885805|NCT01536886|3710608|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3885806|NCT01536886|3710609|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3885807|NCT01536886|3710610|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3885808|NCT01536886|3710606|B5|||Age||years|Mean|50.4|50.4|Standard Deviation|12.9|12.9|||
3885809|NCT01536886|3710607|B4|||Age||years|Mean|52.6|52.6|Standard Deviation|11.1|11.1|||
3885810|NCT01536886|3710608|B3|||Age||years|Mean|45.8|45.8|Standard Deviation|13.7|13.7|||
3885811|NCT01536886|3710609|B2|||Age||years|Mean|50.6|50.6|Standard Deviation|13.1|13.1|||
3885812|NCT01536886|3710610|B1|||Age||years|Mean|50.9|50.9|Standard Deviation|12.9|12.9|||
3885813|NCT01536860|3710623|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3885814|NCT01536860|3710623|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3885815|NCT01536860|3710623|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3885816|NCT01536860|3710623|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3885817|NCT01536860|3710623|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3885818|NCT01536704|3710633|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3885819|NCT01536704|3710633|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3885820|NCT01536704|3710633|B1|||Age||Years|Mean|30.3|30.3|Standard Deviation|9.58|9.58|||
3885821|NCT01536587|3710666|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3885822|NCT01536587|3710666|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3885823|NCT01536587|3710666|B1|||Age||Years|Mean|61.19|61.19|Standard Deviation|8.41|8.41|||
3885824|NCT01536574|3710703|B3|||Duration of Parkinson's Disease||months|Mean|100.7|100.7|Standard Deviation|55.44|55.44|||
3885825|NCT01536574|3710704|B2|||Duration of Parkinson's Disease||months|Mean|105.3|105.3|Standard Deviation|49.61|49.61|||
3885826|NCT01536574|3710705|B1|||Duration of Parkinson's Disease||months|Mean|96.8|96.8|Standard Deviation|59.68|59.68|||
3885827|NCT01536574|3710703|B3|Oriental||Race/Ethnicity, Customized||participants|Number|295|295.0||||||
3885828|NCT01536574|3710704|B2|Oriental||Race/Ethnicity, Customized||participants|Number|133|133.0||||||
3885829|NCT01536574|3710705|B1|Oriental||Race/Ethnicity, Customized||participants|Number|162|162.0||||||
3885830|NCT01536574|3710703|B3||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
3885831|NCT01536574|3710704|B2||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3885832|NCT01536574|3710705|B1||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3885833|NCT01536574|3710703|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3885834|NCT01536574|3710704|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3885835|NCT01536574|3710705|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3885836|NCT01536574|3710703|B3|||Age||Years|Mean|64.2|64.2|Standard Deviation|9.44|9.44|||
3885837|NCT01536574|3710704|B2|||Age||Years|Mean|63.9|63.9|Standard Deviation|9.87|9.87|||
3885838|NCT01536574|3710705|B1|||Age||Years|Mean|64.5|64.5|Standard Deviation|9.10|9.1|||
3885839|NCT01536561|3710724|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3885840|NCT01536561|3710724|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3885841|NCT01536561|3710724|B1|White||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
3885842|NCT01536561|3710724|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3885843|NCT01536561|3710724|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3885844|NCT01536561|3710724|B1|||Age||Years|Mean|49.9|49.9|Standard Deviation|12.6|12.6|||
3885845|NCT01536496|3710762|B3|||TEG LY30|The reference range of the local clinical laboratory is 0.0-7.4%. Percent of clot lysis 30 minutes after maximal amplitude (MA) was finalized.|percent of clot lysis at 30 minutes|Median|0.9|0.9|Inter-Quartile Range|||0.0|4.3|
3885846|NCT01536496|3710763|B2|||TEG LY30|The reference range of the local clinical laboratory is 0.0-7.4%. Percent of clot lysis 30 minutes after maximal amplitude (MA) was finalized.|percent of clot lysis at 30 minutes|Median|1.2|1.2|Inter-Quartile Range|||0.1|4.2|
3885847|NCT01536496|3710764|B1|||TEG LY30|The reference range of the local clinical laboratory is 0.0-7.4%. Percent of clot lysis 30 minutes after maximal amplitude (MA) was finalized.|percent of clot lysis at 30 minutes|Median|0.5|0.5|Inter-Quartile Range|||0.0|4.4|
3885848|NCT01536496|3710762|B3|||TEG MA (maximal amplitude)|The reference range of the local clinical laboratory is 54.0-72.0 mm.|mm|Median|50.9|50.9|Inter-Quartile Range|||31.0|60.0|
3885849|NCT01536496|3710763|B2|||TEG MA (maximal amplitude)|The reference range of the local clinical laboratory is 54.0-72.0 mm.|mm|Median|53.9|53.9|Inter-Quartile Range|||28.0|63.0|
3885850|NCT01536496|3710764|B1|||TEG MA (maximal amplitude)|The reference range of the local clinical laboratory is 54.0-72.0 mm.|mm|Median|47.5|47.5|Inter-Quartile Range|||34.0|53.0|
3885851|NCT01536496|3710762|B3|||TEG Angle|The reference range of the local clinical laboratory is 66.0-82.0 degrees.|degrees|Median|51.5|51.5|Inter-Quartile Range|||29.0|69.0|
3885852|NCT01536496|3710763|B2|||TEG Angle|The reference range of the local clinical laboratory is 66.0-82.0 degrees.|degrees|Median|52.3|52.3|Inter-Quartile Range|||30.0|70.0|
3885853|NCT01536496|3710764|B1|||TEG Angle|The reference range of the local clinical laboratory is 66.0-82.0 degrees.|degrees|Median|50.9|50.9|Inter-Quartile Range|||28.0|69.0|
3885854|NCT01536496|3710762|B3|||TEG ACT (activated clotting time)|The reference range of the local clinical laboratory is 78.0-110.0.|seconds|Median|128|128.0|Inter-Quartile Range|||113.0|195.0|
3885855|NCT01536496|3710763|B2|||TEG ACT (activated clotting time)|The reference range of the local clinical laboratory is 78.0-110.0.|seconds|Median|128|128.0|Inter-Quartile Range|||113.0|140.0|
3885856|NCT01536496|3710764|B1|||TEG ACT (activated clotting time)|The reference range of the local clinical laboratory is 78.0-110.0.|seconds|Median|128|128.0|Inter-Quartile Range|||113.0|278.0|
3885857|NCT01536496|3710762|B3|||D-dimer|The reference range of the local clinical laboratory is <0.50 ug/mL.|ug/mL|Median|11.1|11.1|Inter-Quartile Range|||4.0|20.0|
3885858|NCT01536496|3710763|B2|||D-dimer|The reference range of the local clinical laboratory is <0.50 ug/mL.|ug/mL|Median|10.3|10.3|Inter-Quartile Range|||2.0|20.0|
3885859|NCT01536496|3710764|B1|||D-dimer|The reference range of the local clinical laboratory is <0.50 ug/mL.|ug/mL|Median|12.9|12.9|Inter-Quartile Range|||6.0|20.0|
3885860|NCT01536496|3710762|B3|||Fibrinogen|The reference range of the local clinical laboratory is 200.0-485.0 mg/dL.|mg/dL|Median|122|122.0|Inter-Quartile Range|||75.0|201.0|
3885861|NCT01536496|3710763|B2|||Fibrinogen|The reference range of the local clinical laboratory is 200.0-485.0 mg/dL.|mg/dL|Median|132|132.0|Inter-Quartile Range|||94.0|240.0|
3885862|NCT01536496|3710764|B1|||Fibrinogen|The reference range of the local clinical laboratory is 200.0-485.0 mg/dL.|mg/dL|Median|113|113.0|Inter-Quartile Range|||68.0|139.0|
3885863|NCT01536496|3710762|B3|||Platelet count|The reference range of the local clinical laboratory is 150-400 k/uL.|k/uL|Median|214|214.0|Inter-Quartile Range|||150.0|291.0|
3885864|NCT01536496|3710763|B2|||Platelet count|The reference range of the local clinical laboratory is 150-400 k/uL.|k/uL|Median|214|214.0|Inter-Quartile Range|||145.0|318.0|
3885865|NCT01536496|3710764|B1|||Platelet count|The reference range of the local clinical laboratory is 150-400 k/uL.|k/uL|Median|214|214.0|Inter-Quartile Range|||165.0|279.0|
3885866|NCT01536496|3710762|B3|||International Normalized Ratio (INR)|The reference range of the local clinical laboratory is 0.83-1.19. A high INR indicates a higher risk of bleeding, while a low INR suggests a higher risk of developing a clot.|units on a scale|Median|1.45|1.45|Inter-Quartile Range|||1.2|1.9|
3885867|NCT01536496|3710763|B2|||International Normalized Ratio (INR)|The reference range of the local clinical laboratory is 0.83-1.19. A high INR indicates a higher risk of bleeding, while a low INR suggests a higher risk of developing a clot.|units on a scale|Median|1.45|1.45|Inter-Quartile Range|||1.2|1.7|
3885868|NCT01536496|3710764|B1|||International Normalized Ratio (INR)|The reference range of the local clinical laboratory is 0.83-1.19. A high INR indicates a higher risk of bleeding, while a low INR suggests a higher risk of developing a clot.|units on a scale|Median|1.46|1.46|Inter-Quartile Range|||1.2|2.3|
3885869|NCT01536496|3710762|B3|||Base Deficit (BD)|Base deficit refers to lack of bases in the blood. Bases are crucial in sustaining the acid-base homeostasis in the human body. Base deficit is an indicator of metabolic component of blood pH, as opposed to carbon dioxide, which is an indicator of respiratory component of blood pH. Base deficit outside of normal values (-2 to 2 mEq/L) usually means a shift in homeostasis towards acids or metabolic acidosis. More negative values are indicative of more profound disturbance in homeostasis.|mEq/L|Median|12.0|12.0|Inter-Quartile Range|||9.0|18.0|
3885870|NCT01536496|3710763|B2|||Base Deficit (BD)|Base deficit refers to lack of bases in the blood. Bases are crucial in sustaining the acid-base homeostasis in the human body. Base deficit is an indicator of metabolic component of blood pH, as opposed to carbon dioxide, which is an indicator of respiratory component of blood pH. Base deficit outside of normal values (-2 to 2 mEq/L) usually means a shift in homeostasis towards acids or metabolic acidosis. More negative values are indicative of more profound disturbance in homeostasis.|mEq/L|Median|11.0|11.0|Inter-Quartile Range|||9.0|16.0|
3885871|NCT01536496|3710764|B1|||Base Deficit (BD)|Base deficit refers to lack of bases in the blood. Bases are crucial in sustaining the acid-base homeostasis in the human body. Base deficit is an indicator of metabolic component of blood pH, as opposed to carbon dioxide, which is an indicator of respiratory component of blood pH. Base deficit outside of normal values (-2 to 2 mEq/L) usually means a shift in homeostasis towards acids or metabolic acidosis. More negative values are indicative of more profound disturbance in homeostasis.|mEq/L|Median|13.7|13.7|Inter-Quartile Range|||9.0|18.0|
3885872|NCT01536496|3710762|B3|||Injury Severity Score (ISS)|0 to 75, higher score means worse outcome|Scores on a scale|Median|30|30.0|Inter-Quartile Range|||24.0|43.0|
3885873|NCT01536496|3710763|B2|||Injury Severity Score (ISS)|0 to 75, higher score means worse outcome|Scores on a scale|Median|29.5|29.5|Inter-Quartile Range|||23.0|41.0|
3885874|NCT01536496|3710764|B1|||Injury Severity Score (ISS)|0 to 75, higher score means worse outcome|Scores on a scale|Median|33|33.0|Inter-Quartile Range|||25.0|43.0|
3885875|NCT01536496|3710762|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3885876|NCT01536496|3710763|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3885877|NCT01536496|3710764|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3885878|NCT01536496|3710762|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3885879|NCT01536496|3710763|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3885880|NCT01536496|3710764|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3885881|NCT01536496|3710762|B3|||Age||years|Median|39|39.0|Inter-Quartile Range|||28.0|55.0|
3885882|NCT01536496|3710763|B2|||Age||years|Median|41|41.0|Inter-Quartile Range|||28.0|54.0|
3885883|NCT01536496|3710764|B1|||Age||years|Median|38|38.0|Inter-Quartile Range|||25.0|55.0|
3885884|NCT01536418|3710799|B3|Multiple race||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3885885|NCT01536418|3710800|B2|Multiple race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3885886|NCT01536418|3710801|B1|Multiple race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3885887|NCT01536418|3710799|B3|Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3885888|NCT01536418|3710800|B2|Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3885889|NCT01536418|3710801|B1|Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3885890|NCT01536418|3710799|B3|Asian-Japanese||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3885891|NCT01536418|3710800|B2|Asian-Japanese||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3885892|NCT01536418|3710801|B1|Asian-Japanese||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3885893|NCT01536418|3710799|B3|Asian-South East||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3885894|NCT01536418|3710800|B2|Asian-South East||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3885895|NCT01536418|3710801|B1|Asian-South East||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3885896|NCT01536418|3710799|B3|Asian-East||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3885897|NCT01536418|3710800|B2|Asian-East||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3885898|NCT01536418|3710801|B1|Asian-East||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3885899|NCT01536418|3710799|B3|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3885900|NCT01536418|3710800|B2|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3885901|NCT01536418|3710801|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3885902|NCT01536418|3710799|B3|White-Arabic/North African||Race/Ethnicity, Customized||participants|Number|209|209.0||||||
3885903|NCT01536418|3710800|B2|White-Arabic/North African||Race/Ethnicity, Customized||participants|Number|105|105.0||||||
3885904|NCT01536418|3710801|B1|White-Arabic/North African||Race/Ethnicity, Customized||participants|Number|104|104.0||||||
3885905|NCT01536418|3710799|B3|White-Caucasian/European||Race/Ethnicity, Customized||participants|Number|214|214.0||||||
3885906|NCT01536418|3710800|B2|White-Caucasian/European||Race/Ethnicity, Customized||participants|Number|109|109.0||||||
3885907|NCT01536418|3710801|B1|White-Caucasian/European||Race/Ethnicity, Customized||participants|Number|105|105.0||||||
3885908|NCT01536418|3710799|B3||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3885909|NCT01536418|3710800|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3885910|NCT01536418|3710801|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3885911|NCT01536418|3710799|B3||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3885912|NCT01536418|3710800|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3885913|NCT01536418|3710801|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3885914|NCT01536418|3710799|B3|||Age||Years|Mean|39.1|39.1|Standard Deviation|13.00|13.0|||
3885915|NCT01536418|3710800|B2|||Age||Years|Mean|38.5|38.5|Standard Deviation|12.91|12.91|||
3885916|NCT01536418|3710801|B1|||Age||Years|Mean|39.6|39.6|Standard Deviation|13.11|13.11|||
3885917|NCT01536405|3710820|B3||Male|Sex: Female, Male||Participants|Count of Participants|744|744.0||||||
3885918|NCT01536405|3710821|B2||Male|Sex: Female, Male||Participants|Count of Participants|382|382.0||||||
3885919|NCT01536405|3710822|B1||Male|Sex: Female, Male||Participants|Count of Participants|362|362.0||||||
3885920|NCT01536405|3710820|B3||Female|Sex: Female, Male||Participants|Count of Participants|668|668.0||||||
3885921|NCT01536405|3710821|B2||Female|Sex: Female, Male||Participants|Count of Participants|324|324.0||||||
3885922|NCT01536405|3710822|B1||Female|Sex: Female, Male||Participants|Count of Participants|344|344.0||||||
3885923|NCT01536405|3710820|B3|||Age||Months|Mean|13.5|13.5|Standard Deviation|2.3|2.3|||
3885924|NCT01536405|3710821|B2|||Age||Months|Mean|13.6|13.6|Standard Deviation|2.5|2.5|||
3885925|NCT01536405|3710822|B1|||Age||Months|Mean|13.4|13.4|Standard Deviation|2.2|2.2|||
3885926|NCT01536379|3710859|B3|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3885927|NCT01536379|3710860|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3885928|NCT01536379|3710861|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3885929|NCT01536379|3710859|B3|White/Caucasian||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
3885930|NCT01536379|3710860|B2|White/Caucasian||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3885931|NCT01536379|3710861|B1|White/Caucasian||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3885932|NCT01536379|3710859|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3885933|NCT01536379|3710860|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3885934|NCT01536379|3710861|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3885935|NCT01536379|3710859|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3885936|NCT01536379|3710860|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3885937|NCT01536379|3710861|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3885938|NCT01536379|3710859|B3|||Age||Years|Mean|52.6|52.6|Standard Deviation|12.52|12.52|||
3885939|NCT01536379|3710860|B2|||Age||Years|Mean|54.3|54.3|Standard Deviation|11.02|11.02|||
3885940|NCT01536379|3710861|B1|||Age||Years|Mean|51.0|51.0|Standard Deviation|14.02|14.02|||
3885941|NCT01536366|3710936|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3885942|NCT01536366|3710937|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3885943|NCT01536366|3710938|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3885944|NCT01536366|3710936|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3885945|NCT01536366|3710937|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3885946|NCT01536366|3710938|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3885947|NCT01536366|3710936|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3885948|NCT01536366|3710937|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3885949|NCT01536366|3710938|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3885950|NCT01536366|3710936|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3885951|NCT01536366|3710937|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3885952|NCT01536366|3710938|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3885953|NCT01536366|3710936|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3885954|NCT01536366|3710937|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3885955|NCT01536366|3710938|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3885956|NCT01536262|3710951|B4||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3885957|NCT01536262|3710952|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3885958|NCT01536262|3710953|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3885959|NCT01536262|3710954|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3885960|NCT01536262|3710951|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3885961|NCT01536262|3710952|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3885962|NCT01536262|3710953|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3885963|NCT01536262|3710954|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3885964|NCT01536262|3710951|B4|||Age||years|Mean|69.9|69.9|Standard Deviation|7.3|7.3|||
3885965|NCT01536262|3710952|B3|||Age||years|Mean|68.1|68.1|Standard Deviation|7.1|7.1|||
3885966|NCT01536262|3710953|B2|||Age||years|Mean|70.0|70.0|Standard Deviation|7.5|7.5|||
3885967|NCT01536262|3710954|B1|||Age||years|Mean|71.5|71.5|Standard Deviation|7.2|7.2|||
3885968|NCT01536197|3710970|B3|||Body weight before surgery||Kg|Mean|128.7|128.7|Standard Deviation|27.2|27.2|||
3885969|NCT01536197|3710971|B2|||Body weight before surgery||Kg|Mean|127.1|127.1|Standard Deviation|31.0|31.0|||
3885970|NCT01536197|3710972|B1|||Body weight before surgery||Kg|Mean|129.8|129.8|Standard Deviation|26.1|26.1|||
3885971|NCT01536197|3710970|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3885972|NCT01536197|3710971|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3885973|NCT01536197|3710972|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3885974|NCT01536197|3710970|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3885975|NCT01536197|3710971|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3885976|NCT01536197|3710972|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3885977|NCT01536197|3710970|B3|||Age||years|Mean|43.5|43.5|Standard Deviation|10.2|10.2|||
3885978|NCT01536197|3710971|B2|||Age||years|Mean|46.8|46.8|Standard Deviation|13.9|13.9|||
3885979|NCT01536197|3710972|B1|||Age||years|Mean|43.0|43.0|Standard Deviation|9.6|9.6|||
3885980|NCT01536184|3710981|B3|Canada||Region of Enrollment||participants|Number|12|12.0||||||
3885981|NCT01536184|3710982|B2|Canada||Region of Enrollment||participants|Number|4|4.0||||||
3885982|NCT01536184|3710983|B1|Canada||Region of Enrollment||participants|Number|8|8.0||||||
3885983|NCT01536184|3710981|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3885984|NCT01536184|3710982|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3885985|NCT01536184|3710983|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3885986|NCT01536184|3710981|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3885987|NCT01536184|3710982|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3885988|NCT01536184|3710983|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3885989|NCT01536184|3710981|B3|Greater than 5 years old||Age, Customized||Participants|Number|0|0.0||||||
3885990|NCT01536184|3710982|B2|Greater than 5 years old||Age, Customized||Participants|Number|0|0.0||||||
3885991|NCT01536184|3710983|B1|Greater than 5 years old||Age, Customized||Participants|Number|0|0.0||||||
3885992|NCT01536184|3710981|B3|Less than or equal to 5 years old||Age, Customized||Participants|Number|12|12.0||||||
3885993|NCT01536184|3710982|B2|Less than or equal to 5 years old||Age, Customized||Participants|Number|4|4.0||||||
3885994|NCT01536184|3710983|B1|Less than or equal to 5 years old||Age, Customized||Participants|Number|8|8.0||||||
3885995|NCT01536184|3710981|B3|||Age||years|Mean|4.1|4.1|Full Range|||2.0|5.0|
3885996|NCT01536184|3710982|B2|||Age||years|Mean|NA||Full Range|||0.0|0.0|Specific age data not collected by the community therapists.
3885997|NCT01536184|3710983|B1|||Age||years|Mean|4.1|4.1|Full Range|||2.0|5.0|
3885998|NCT01536171|3710998|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3885999|NCT01536171|3710998|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3886000|NCT01536171|3710998|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3886001|NCT01536171|3710998|B1|||Age||years|Mean|30|30.0|Standard Deviation|10.9|10.9|||
3886002|NCT01536145|3711003|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3886003|NCT01536145|3711003|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3886004|NCT01536145|3711003|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|9.4|9.4|||
3886005|NCT01536119|3711118|B3|Canada||Region of Enrollment|All couples were enrolled in Canada. 214 couples with 107 couples per group|participants|Number|214|214.0||||||
3886006|NCT01536119|3711119|B2|Canada||Region of Enrollment|All couples were enrolled in Canada. 214 couples with 107 couples per group|participants|Number|107|107.0||||||
3886007|NCT01536119|3711120|B1|Canada||Region of Enrollment|All couples were enrolled in Canada. 214 couples with 107 couples per group|participants|Number|107|107.0||||||
3886008|NCT01536119|3711118|B3||Male|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
3886009|NCT01536119|3711119|B2||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3886010|NCT01536119|3711120|B1||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3886011|NCT01536119|3711118|B3||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
3886012|NCT01536119|3711119|B2||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3886013|NCT01536119|3711120|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3886014|NCT01536119|3711118|B3|||Age|Mean age of mothers in the study|years|Mean|30.6|30.6|Standard Deviation|3.8|3.8|||
3886015|NCT01536119|3711119|B2|||Age|Mean age of mothers in the study|years|Mean|30.7|30.7|Standard Deviation|3.8|3.8|||
3886016|NCT01536119|3711120|B1|||Age|Mean age of mothers in the study|years|Mean|30.4|30.4|Standard Deviation|3.7|3.7|||
3886017|NCT01536119|3711118|B3|||Age|Mean age of fathers in the study|years|Mean|33|33.0|Standard Deviation|5.4|5.4|||
3886018|NCT01536119|3711119|B2|||Age|Mean age of fathers in the study|years|Mean|33|33.0|Standard Deviation|5.5|5.5|||
3886019|NCT01536119|3711120|B1|||Age|Mean age of fathers in the study|years|Mean|33|33.0|Standard Deviation|5.2|5.2|||
3886020|NCT01536119|3711118|B3|>=65 years||Age|This is a measure of maternal age only|participants|Number|0|0.0||||||
3886021|NCT01536119|3711119|B2|>=65 years||Age|This is a measure of maternal age only|participants|Number|0|0.0||||||
3886022|NCT01536119|3711120|B1|>=65 years||Age|This is a measure of maternal age only|participants|Number|0|0.0||||||
3886023|NCT01536119|3711118|B3|Between 18 and 65 years||Age|This is a measure of maternal age only|participants|Number|214|214.0||||||
3886024|NCT01536119|3711119|B2|Between 18 and 65 years||Age|This is a measure of maternal age only|participants|Number|107|107.0||||||
3886025|NCT01536119|3711120|B1|Between 18 and 65 years||Age|This is a measure of maternal age only|participants|Number|107|107.0||||||
3886026|NCT01536119|3711118|B3|<=18 years||Age|This is a measure of maternal age only|participants|Number|0|0.0||||||
3886027|NCT01536119|3711119|B2|<=18 years||Age|This is a measure of maternal age only|participants|Number|0|0.0||||||
3886028|NCT01536119|3711120|B1|<=18 years||Age|This is a measure of maternal age only|participants|Number|0|0.0||||||
3886029|NCT01536093|3711145|B3|||Birth weight||g|Mean|849.3|849.3|Standard Deviation|239.8|239.8|||
3886030|NCT01536093|3711146|B2|||Birth weight||g|Mean|842.4|842.4|Standard Deviation|250.4|250.4|||
3886031|NCT01536093|3711147|B1|||Birth weight||g|Mean|862.2|862.2|Standard Deviation|234.8|234.8|||
3886032|NCT01536093|3711145|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3886033|NCT01536093|3711146|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3886034|NCT01536093|3711147|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3886035|NCT01536093|3711145|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3886036|NCT01536093|3711146|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3886037|NCT01536093|3711147|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3886038|NCT01536093|3711145|B3|||Age|Gestational Age|weeks|Mean|26.1|26.1|Standard Deviation|1.4|1.4|||
3886039|NCT01536093|3711146|B2|||Age|Gestational Age|weeks|Mean|26.0|26.0|Standard Deviation|1.4|1.4|||
3886040|NCT01536093|3711147|B1|||Age|Gestational Age|weeks|Mean|26.1|26.1|Standard Deviation|1.4|1.4|||
3886041|NCT01536067|3711164|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3886042|NCT01536067|3711164|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3886043|NCT01536067|3711164|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|1.8|1.8|||
3886044|NCT01536015|3711175|B3|||Body Mass Index (BMI)||kilogram/m^2|Mean|26.842|26.842|Standard Deviation|4.785|4.785|19.81|37.3|
3886045|NCT01536015|3711176|B2|||Body Mass Index (BMI)||kilogram/m^2|Mean|25.113|25.113|Standard Deviation|4.809|4.809|19.81|35.36|
3886046|NCT01536015|3711177|B1|||Body Mass Index (BMI)||kilogram/m^2|Mean|28.714|28.714|Standard Deviation|4.167|4.167|21.48|37.3|
3886047|NCT01536015|3711175|B3|||Height||centimeter|Mean|172.87|172.87|Standard Deviation|11.95|11.95|149.9|198.4|
3886048|NCT01536015|3711176|B2|||Height||centimeter|Mean|173.86|173.86|Standard Deviation|10.61|10.61|157.5|192.0|
3886049|NCT01536015|3711177|B1|||Height||centimeter|Mean|171.79|171.79|Standard Deviation|13.65|13.65|149.9|198.4|
3886050|NCT01536015|3711175|B3|||Weight||kilogram|Mean|80.50|80.5|Standard Deviation|17.58|17.58|49.4|121.6|
3886051|NCT01536015|3711176|B2|||Weight||kilogram|Mean|76.67|76.67|Standard Deviation|19.53|19.53|49.4|121.6|
3886052|NCT01536015|3711177|B1|||Weight||kilogram|Mean|84.64|84.64|Standard Deviation|14.93|14.93|65.8|112.4|
3886053|NCT01536015|3711175|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
3886054|NCT01536015|3711176|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3886055|NCT01536015|3711177|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3886056|NCT01536015|3711175|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886057|NCT01536015|3711176|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886058|NCT01536015|3711177|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886059|NCT01536015|3711175|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3886060|NCT01536015|3711176|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3886061|NCT01536015|3711177|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3886062|NCT01536015|3711175|B3||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3886063|NCT01536015|3711176|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3886064|NCT01536015|3711177|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3886065|NCT01536015|3711175|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3886066|NCT01536015|3711176|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3886067|NCT01536015|3711177|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886068|NCT01536015|3711175|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886069|NCT01536015|3711176|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886070|NCT01536015|3711177|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886071|NCT01536015|3711175|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886072|NCT01536015|3711176|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886073|NCT01536015|3711177|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886074|NCT01536015|3711175|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886075|NCT01536015|3711176|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886076|NCT01536015|3711177|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886077|NCT01536015|3711175|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3886078|NCT01536015|3711176|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3886079|NCT01536015|3711177|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3886080|NCT01536015|3711175|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3886081|NCT01536015|3711176|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3886082|NCT01536015|3711177|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3886083|NCT01536015|3711175|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3886084|NCT01536015|3711176|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3886085|NCT01536015|3711177|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3886086|NCT01536015|3711175|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3886087|NCT01536015|3711176|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3886088|NCT01536015|3711177|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3886089|NCT01536015|3711175|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886090|NCT01536015|3711176|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886091|NCT01536015|3711177|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886092|NCT01536015|3711175|B3|||Age||years|Mean|66.4|66.4|Standard Deviation|8.8|8.8|51.0|82.0|
3886093|NCT01536015|3711176|B2|||Age||years|Mean|66.7|66.7|Standard Deviation|9.6|9.6|51.0|82.0|
3886094|NCT01536015|3711177|B1|||Age||years|Mean|66.1|66.1|Standard Deviation|8.2|8.2|52.0|78.0|
3886095|NCT01535976|3711194|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
3886096|NCT01535976|3711195|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
3886097|NCT01535976|3711196|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3886098|NCT01535976|3711194|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3886099|NCT01535976|3711195|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3886100|NCT01535976|3711196|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3886101|NCT01535976|3711194|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3886102|NCT01535976|3711195|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3886103|NCT01535976|3711196|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3886104|NCT01535976|3711194|B3|||Age||years|Mean|47.65|47.65|Standard Deviation|7.55|7.55|||
3886105|NCT01535976|3711195|B2|||Age||years|Mean|46.89|46.89|Standard Deviation|7.35|7.35|||
3886106|NCT01535976|3711196|B1|||Age||years|Mean|48.4|48.4|Standard Deviation|7.67|7.67|||
3886107|NCT01535976|3711194|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3886108|NCT01535976|3711195|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3886109|NCT01535976|3711196|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3886110|NCT01535976|3711194|B3||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3886111|NCT01535976|3711195|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3886112|NCT01535976|3711196|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3886113|NCT01535976|3711194|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886114|NCT01535976|3711195|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886115|NCT01535976|3711196|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886116|NCT01535937|3711203|B3|United States||Region of Enrollment||Participants|Count of Participants|55|55.0||||||
3886117|NCT01535937|3711204|B2|United States||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3886118|NCT01535937|3711205|B1|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3886119|NCT01535937|3711203|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3886120|NCT01535937|3711204|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886121|NCT01535937|3711205|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3886122|NCT01535937|3711203|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3886123|NCT01535937|3711204|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3886124|NCT01535937|3711205|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3886125|NCT01535937|3711203|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3886126|NCT01535937|3711204|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3886127|NCT01535937|3711205|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3886128|NCT01535937|3711203|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3886129|NCT01535937|3711204|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3886130|NCT01535937|3711205|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3886131|NCT01535937|3711203|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886132|NCT01535937|3711204|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886133|NCT01535937|3711205|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886134|NCT01535937|3711203|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886135|NCT01535937|3711204|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886136|NCT01535937|3711205|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886137|NCT01535937|3711203|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886138|NCT01535937|3711204|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886139|NCT01535937|3711205|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886140|NCT01535937|3711203|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3886141|NCT01535937|3711204|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3886142|NCT01535937|3711205|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3886143|NCT01535937|3711203|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3886144|NCT01535937|3711204|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3886145|NCT01535937|3711205|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3886146|NCT01535937|3711203|B3|||Age||years|Mean|47|47.0|Standard Deviation|1|1.0|||
3886147|NCT01535937|3711204|B2|||Age||years|Mean|49|49.0|Standard Deviation|1|1.0|||
3886148|NCT01535937|3711205|B1|||Age||years|Mean|45|45.0|Standard Deviation|2|2.0|||
3886149|NCT01535807|3711214|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3886150|NCT01535807|3711215|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3886151|NCT01535807|3711216|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3886152|NCT01535807|3711214|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3886153|NCT01535807|3711215|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3886154|NCT01535807|3711216|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3886155|NCT01535807|3711214|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3886156|NCT01535807|3711215|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3886157|NCT01535807|3711216|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3886158|NCT01535807|3711214|B3|||Age||years|Mean|60.30|60.3|Standard Deviation|9.93|9.93|||
3886159|NCT01535807|3711215|B2|||Age||years|Mean|60.17|60.17|Standard Deviation|9.84|9.84|||
3886160|NCT01535807|3711216|B1|||Age||years|Mean|61.18|61.18|Standard Deviation|9.88|9.88|||
3886161|NCT01535729|3711223|B1||Male|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
3886162|NCT01535729|3711223|B1||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3886163|NCT01535729|3711223|B1|||Age||years|Mean|72.66|72.66|Standard Deviation|5.23|5.23|||
3886164|NCT01535664|3711250|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886165|NCT01535664|3711250|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886166|NCT01535664|3711250|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3886167|NCT01535664|3711250|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3886168|NCT01535664|3711250|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886169|NCT01535664|3711250|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886170|NCT01535664|3711250|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3886171|NCT01535664|3711250|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3886172|NCT01535664|3711250|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3886173|NCT01535664|3711250|B1|||Age||years|Mean|53.1|53.1|Standard Deviation|10.96|10.96|||
3886174|NCT01535638|3711264|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3886175|NCT01535638|3711264|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3886176|NCT01535638|3711264|B1|||Age||years|Mean|40.0|40.0|Standard Deviation|6.2|6.2|||
3886177|NCT01535599|3711281|B3||Male|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
3886178|NCT01535599|3711282|B2||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
3886179|NCT01535599|3711283|B1||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3886180|NCT01535599|3711281|B3||Female|Sex: Female, Male||Participants|Count of Participants|385|385.0||||||
3886181|NCT01535599|3711282|B2||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3886182|NCT01535599|3711283|B1||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3886183|NCT01535599|3711281|B3|Elderly (≥ 65 years)||Age, Customized||participants|Number|50|50.0||||||
3886184|NCT01535599|3711282|B2|Elderly (≥ 65 years)||Age, Customized||participants|Number|29|29.0||||||
3886185|NCT01535599|3711283|B1|Elderly (≥ 65 years)||Age, Customized||participants|Number|21|21.0||||||
3886186|NCT01535599|3711281|B3|Adults (18 to 64 years)||Age, Customized||participants|Number|381|381.0||||||
3886187|NCT01535599|3711282|B2|Adults (18 to 64 years)||Age, Customized||participants|Number|186|186.0||||||
3886188|NCT01535599|3711283|B1|Adults (18 to 64 years)||Age, Customized||participants|Number|195|195.0||||||
3886189|NCT01535599|3711281|B3|Adolescents (12 to 17 years)||Age, Customized||participants|Number|106|106.0||||||
3886190|NCT01535599|3711282|B2|Adolescents (12 to 17 years)||Age, Customized||participants|Number|42|42.0||||||
3886191|NCT01535599|3711283|B1|Adolescents (12 to 17 years)||Age, Customized||participants|Number|64|64.0||||||
3886192|NCT01535599|3711281|B3|Children (2 to 11 years)||Age, Customized||participants|Number|144|144.0||||||
3886193|NCT01535599|3711282|B2|Children (2 to 11 years)||Age, Customized||participants|Number|83|83.0||||||
3886194|NCT01535599|3711283|B1|Children (2 to 11 years)||Age, Customized||participants|Number|61|61.0||||||
3886195|NCT01535599|3711281|B3|Infants/Toddlers (18 days to 23 months)||Age, Customized||participants|Number|5|5.0||||||
3886196|NCT01535599|3711282|B2|Infants/Toddlers (18 days to 23 months)||Age, Customized||participants|Number|2|2.0||||||
3886197|NCT01535599|3711283|B1|Infants/Toddlers (18 days to 23 months)||Age, Customized||participants|Number|3|3.0||||||
3886198|NCT01535560|3711294|B3||Male|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
3886199|NCT01535560|3711295|B2||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3886200|NCT01535560|3711296|B1||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3886201|NCT01535560|3711294|B3||Female|Sex: Female, Male||Participants|Count of Participants|318|318.0||||||
3886202|NCT01535560|3711295|B2||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
3886203|NCT01535560|3711296|B1||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3886204|NCT01535560|3711294|B3|Elderly (≥ 65 years)||Age, Customized||Participants|Number|12|12.0||||||
3886205|NCT01535560|3711295|B2|Elderly (≥ 65 years)||Age, Customized||Participants|Number|4|4.0||||||
3886206|NCT01535560|3711296|B1|Elderly (≥ 65 years)||Age, Customized||Participants|Number|8|8.0||||||
3886207|NCT01535560|3711294|B3|Adults (18 to 64 years)||Age, Customized||Participants|Number|167|167.0||||||
3886208|NCT01535560|3711295|B2|Adults (18 to 64 years)||Age, Customized||Participants|Number|87|87.0||||||
3886209|NCT01535560|3711296|B1|Adults (18 to 64 years)||Age, Customized||Participants|Number|80|80.0||||||
3886210|NCT01535560|3711294|B3|Adolescents (12 to 17 years)||Age, Customized||Participants|Number|118|118.0||||||
3886211|NCT01535560|3711295|B2|Adolescents (12 to 17 years)||Age, Customized||Participants|Number|62|62.0||||||
3886212|NCT01535560|3711296|B1|Adolescents (12 to 17 years)||Age, Customized||Participants|Number|56|56.0||||||
3886213|NCT01535560|3711294|B3|Children (2 to 11 years)||Age, Customized||Participants|Number|250|250.0||||||
3886214|NCT01535560|3711295|B2|Children (2 to 11 years)||Age, Customized||Participants|Number|120|120.0||||||
3886215|NCT01535560|3711296|B1|Children (2 to 11 years)||Age, Customized||Participants|Number|130|130.0||||||
3886216|NCT01535560|3711294|B3|Infants and Toddlers (28 days to 23 months)||Age, Customized||Participants|Number|1|1.0||||||
3886217|NCT01535560|3711295|B2|Infants and Toddlers (28 days to 23 months)||Age, Customized||Participants|Number|1|1.0||||||
3886218|NCT01535560|3711296|B1|Infants and Toddlers (28 days to 23 months)||Age, Customized||Participants|Number|0|0.0||||||
3886219|NCT01535365|3711307|B3|United States||Region of Enrollment||participants|Number|60.0|60.0||||||
3886220|NCT01535365|3711308|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
3886221|NCT01535365|3711309|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
3886222|NCT01535365|3711307|B3||Male|Sex: Female, Male||Participants|Count of Participants|29.0|29.0||||||
3886223|NCT01535365|3711308|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3886224|NCT01535365|3711309|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3886225|NCT01535365|3711307|B3||Female|Sex: Female, Male||Participants|Count of Participants|31.0|31.0||||||
3886226|NCT01535365|3711308|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3886227|NCT01535365|3711309|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3886228|NCT01535365|3711307|B3|||Age||years|Mean|37.1|37.1|Standard Deviation|13.1|13.1|||
3886229|NCT01535365|3711308|B2|||Age||years|Mean|36.3|36.3|Standard Deviation|11.2|11.2|||
3886230|NCT01535365|3711309|B1|||Age||years|Mean|37.8|37.8|Standard Deviation|14.7|14.7|||
3886231|NCT01535365|3711307|B3||>=65 years|Age||Participants|Count of Participants|0.0|0.0||||||
3886232|NCT01535365|3711308|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3886233|NCT01535365|3711309|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3886234|NCT01535365|3711307|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60.0|60.0||||||
3886235|NCT01535365|3711308|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3886236|NCT01535365|3711309|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3886237|NCT01535365|3711307|B3||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
3886238|NCT01535365|3711308|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886239|NCT01535365|3711309|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886240|NCT01535326|3711318|B4||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3886241|NCT01535326|3711319|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3886242|NCT01535326|3711320|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3886243|NCT01535326|3711321|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3886244|NCT01535326|3711318|B4||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3886245|NCT01535326|3711319|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3886246|NCT01535326|3711320|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3886247|NCT01535326|3711321|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3886248|NCT01535326|3711318|B4|||Age||years|Median|55|55.0|Full Range|||23.0|79.0|
3886249|NCT01535326|3711319|B3|||Age||years|Median|58|58.0|Full Range|||23.0|77.0|
3886250|NCT01535326|3711320|B2|||Age||years|Median|53|53.0|Full Range|||28.0|79.0|
3886251|NCT01535326|3711321|B1|||Age||years|Median|59|59.0|Full Range|||25.0|78.0|
3886252|NCT01535287|3711340|B3|United States||Region of Enrollment||participants|Number|129|129.0||||||
3886253|NCT01535287|3711341|B2|United States||Region of Enrollment||participants|Number|64|64.0||||||
3886254|NCT01535287|3711342|B1|United States||Region of Enrollment||participants|Number|65|65.0||||||
3886255|NCT01535287|3711340|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3886256|NCT01535287|3711341|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3886257|NCT01535287|3711342|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3886258|NCT01535287|3711340|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3886259|NCT01535287|3711341|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3886260|NCT01535287|3711342|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3886261|NCT01535287|3711340|B3|||Age||month|Mean|38|38.0|Standard Deviation|30|30.0|||
3886262|NCT01535287|3711341|B2|||Age||month|Mean|39|39.0|Standard Deviation|30|30.0|||
3886263|NCT01535287|3711342|B1|||Age||month|Mean|37|37.0|Standard Deviation|26|26.0|||
3886264|NCT01535287|3711340|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3886265|NCT01535287|3711341|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3886266|NCT01535287|3711342|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3886267|NCT01535287|3711340|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3886268|NCT01535287|3711341|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3886269|NCT01535287|3711342|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3886270|NCT01535287|3711340|B3||<=18 years|Age||Participants|Count of Participants|129|129.0||||||
3886271|NCT01535287|3711341|B2||<=18 years|Age||Participants|Count of Participants|64|64.0||||||
3886272|NCT01535287|3711342|B1||<=18 years|Age||Participants|Count of Participants|65|65.0||||||
3886273|NCT01535261|3711359|B1||Male|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
3886274|NCT01535261|3711359|B1||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3886275|NCT01535261|3711359|B1|||Age||Years|Mean|65.5|65.5|Standard Deviation|12.68|12.68|||
3886276|NCT01535235|3711370|B3|||CD4+ T cell count||cells/mm^3|Median|362|362.0|Inter-Quartile Range|||237.0|636.0|
3886277|NCT01535235|3711371|B2|||CD4+ T cell count||cells/mm^3|Median|392|392.0|Inter-Quartile Range|||237.0|641.0|
3886278|NCT01535235|3711372|B1|||CD4+ T cell count||cells/mm^3|Median|349|349.0|Inter-Quartile Range|||230.0|415.0|
3886279|NCT01535235|3711370|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
3886280|NCT01535235|3711371|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3886281|NCT01535235|3711372|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3886282|NCT01535235|3711370|B3|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3886283|NCT01535235|3711371|B2|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3886284|NCT01535235|3711372|B1|Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3886285|NCT01535235|3711370|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3886286|NCT01535235|3711371|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3886287|NCT01535235|3711372|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3886288|NCT01535235|3711370|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3886289|NCT01535235|3711371|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3886290|NCT01535235|3711372|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3886291|NCT01535235|3711370|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3886292|NCT01535235|3711371|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3886293|NCT01535235|3711372|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3886294|NCT01535235|3711370|B3|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3886295|NCT01535235|3711371|B2|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3886296|NCT01535235|3711372|B1|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3886297|NCT01535235|3711370|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3886298|NCT01535235|3711371|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3886299|NCT01535235|3711372|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3886300|NCT01535235|3711370|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3886301|NCT01535235|3711371|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3886302|NCT01535235|3711372|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3886303|NCT01535235|3711370|B3|||Age||years|Median|54|54.0|Inter-Quartile Range|||47.0|57.0|
3886304|NCT01535235|3711371|B2|||Age||years|Median|54|54.0|Inter-Quartile Range|||47.0|58.0|
3886305|NCT01535235|3711372|B1|||Age||years|Median|53|53.0|Inter-Quartile Range|||45.5|56.0|
3886306|NCT01535235|3711370|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3886307|NCT01535235|3711371|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3886308|NCT01535235|3711372|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3886309|NCT01535235|3711370|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3886310|NCT01535235|3711371|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3886311|NCT01535235|3711372|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3886312|NCT01535235|3711370|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886313|NCT01535235|3711371|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886314|NCT01535235|3711372|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886315|NCT01535222|3711381|B7|Switzerland||Region of Enrollment||participants|Number|33|33.0||||||
3886316|NCT01535222|3711382|B6|Switzerland||Region of Enrollment||participants|Number|8|8.0||||||
3886317|NCT01535222|3711383|B5|Switzerland||Region of Enrollment||participants|Number|6|6.0||||||
3886318|NCT01535222|3711384|B4|Switzerland||Region of Enrollment||participants|Number|6|6.0||||||
3886319|NCT01535222|3711385|B3|Switzerland||Region of Enrollment||participants|Number|7|7.0||||||
3886320|NCT01535222|3711386|B2|Switzerland||Region of Enrollment||participants|Number|3|3.0||||||
3886321|NCT01535222|3711387|B1|Switzerland||Region of Enrollment||participants|Number|3|3.0||||||
3886322|NCT01535222|3711381|B7||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3886323|NCT01535222|3711382|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3886324|NCT01535222|3711383|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3886325|NCT01535222|3711384|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3886326|NCT01535222|3711385|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3886327|NCT01535222|3711386|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3886328|NCT01535222|3711387|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3886329|NCT01535222|3711381|B7||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3886330|NCT01535222|3711382|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3886331|NCT01535222|3711383|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3886332|NCT01535222|3711384|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3886333|NCT01535222|3711385|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3886334|NCT01535222|3711386|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3886335|NCT01535222|3711387|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3886336|NCT01535222|3711381|B7|||Age||years|Mean|63.9|63.9|Standard Deviation|9.2|9.2|||
3886337|NCT01535222|3711382|B6|||Age||years|Mean|65.9|65.9|Standard Deviation|5.6|5.6|||
3886338|NCT01535222|3711383|B5|||Age||years|Mean|63.2|63.2|Standard Deviation|12.4|12.4|||
3886339|NCT01535222|3711384|B4|||Age||years|Mean|68|68.0|Standard Deviation|9.6|9.6|||
3886340|NCT01535222|3711385|B3|||Age||years|Mean|59|59.0|Standard Deviation|8.3|8.3|||
3886341|NCT01535222|3711386|B2|||Age||years|Mean|62|62.0|Standard Deviation|10.8|10.8|||
3886342|NCT01535222|3711387|B1|||Age||years|Mean|63.3|63.3|Standard Deviation|12.1|12.1|||
3886343|NCT01535222|3711381|B7||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3886344|NCT01535222|3711382|B6||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3886345|NCT01535222|3711383|B5||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3886346|NCT01535222|3711384|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3886347|NCT01535222|3711385|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3886348|NCT01535222|3711386|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3886349|NCT01535222|3711387|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3886350|NCT01535222|3711381|B7||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3886351|NCT01535222|3711382|B6||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3886352|NCT01535222|3711383|B5||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3886353|NCT01535222|3711384|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3886354|NCT01535222|3711385|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3886355|NCT01535222|3711386|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3886356|NCT01535222|3711387|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3886357|NCT01535222|3711381|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886358|NCT01535222|3711382|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886359|NCT01535222|3711383|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886360|NCT01535222|3711384|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886361|NCT01535222|3711385|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886362|NCT01535222|3711386|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886363|NCT01535222|3711387|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886364|NCT01535118|3711412|B1|Unknown||Sex/Gender, Customized||participants|Number|1851|1851.0||||||
3886365|NCT01535118|3711412|B1|Male||Sex/Gender, Customized||participants|Number|333|333.0||||||
3886366|NCT01535118|3711412|B1|Female||Sex/Gender, Customized||participants|Number|581|581.0||||||
3886367|NCT01535118|3711412|B1|Don't Know/Refused||Age, Customized||participants|Number|33|33.0||||||
3886368|NCT01535118|3711412|B1|65+ years of age||Age, Customized||participants|Number|597|597.0||||||
3886369|NCT01535118|3711412|B1|55 to 64 years of age||Age, Customized||participants|Number|515|515.0||||||
3886370|NCT01535118|3711412|B1|45 to 54 years of age||Age, Customized||participants|Number|491|491.0||||||
3886371|NCT01535118|3711412|B1|35 to 44 years of age||Age, Customized||participants|Number|364|364.0||||||
3886372|NCT01535118|3711412|B1|25 to 34 years of age||Age, Customized||participants|Number|223|223.0||||||
3886373|NCT01535118|3711412|B1|18 to 24 years of age||Age, Customized||participants|Number|164|164.0||||||
3886374|NCT01535118|3711412|B1|12 to 17 years of age||Age, Customized||participants|Number|173|173.0||||||
3886375|NCT01535118|3711412|B1|5 to 11 years of age||Age, Customized||participants|Number|205|205.0||||||
3886376|NCT01535040|3711421|B3|United States||Region of Enrollment||participants|Number|130|130.0||||||
3886377|NCT01535040|3711422|B2|United States||Region of Enrollment||participants|Number|65|65.0||||||
3886378|NCT01535040|3711423|B1|United States||Region of Enrollment||participants|Number|65|65.0||||||
3886379|NCT01535040|3711421|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886380|NCT01535040|3711422|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886381|NCT01535040|3711423|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886382|NCT01535040|3711421|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886383|NCT01535040|3711422|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886384|NCT01535040|3711423|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886385|NCT01535040|3711421|B3||White|Race (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
3886386|NCT01535040|3711422|B2||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3886387|NCT01535040|3711423|B1||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3886388|NCT01535040|3711421|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3886389|NCT01535040|3711422|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3886390|NCT01535040|3711423|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3886391|NCT01535040|3711421|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886392|NCT01535040|3711422|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886393|NCT01535040|3711423|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886394|NCT01535040|3711421|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3886395|NCT01535040|3711422|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3886396|NCT01535040|3711423|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886397|NCT01535040|3711421|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886398|NCT01535040|3711422|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886399|NCT01535040|3711423|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886400|NCT01535040|3711421|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3886401|NCT01535040|3711422|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3886402|NCT01535040|3711423|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886403|NCT01535040|3711421|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
3886404|NCT01535040|3711422|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3886405|NCT01535040|3711423|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3886406|NCT01535040|3711421|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886407|NCT01535040|3711422|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886408|NCT01535040|3711423|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886409|NCT01535040|3711421|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3886410|NCT01535040|3711422|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3886411|NCT01535040|3711423|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3886412|NCT01535040|3711421|B3||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3886413|NCT01535040|3711422|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3886414|NCT01535040|3711423|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3886415|NCT01535040|3711421|B3|||Age||years|Median|57|57.0|Full Range|||29.0|84.0|
3886416|NCT01535040|3711422|B2|||Age||years|Median|56|56.0|Full Range|||31.0|76.0|
3886417|NCT01535040|3711423|B1|||Age||years|Median|57|57.0|Full Range|||29.0|84.0|
3886418|NCT01535040|3711421|B3||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
3886419|NCT01535040|3711422|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3886420|NCT01535040|3711423|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3886421|NCT01535040|3711421|B3||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
3886422|NCT01535040|3711422|B2||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3886423|NCT01535040|3711423|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
3886424|NCT01535040|3711421|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886425|NCT01535040|3711422|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886426|NCT01535040|3711423|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886427|NCT01535014|3711436|B5|||BMI||kilogram/m^2|Mean|32.0|32.0|Standard Deviation|1.4|1.4|||
3886428|NCT01535014|3711437|B4|||BMI||kilogram/m^2|Mean|31.6|31.6|Standard Deviation|1.3|1.3|||
3886429|NCT01535014|3711438|B3|||BMI||kilogram/m^2|Mean|32.2|32.2|Standard Deviation|1.5|1.5|||
3886430|NCT01535014|3711439|B2|||BMI||kilogram/m^2|Mean|32.0|32.0|Standard Deviation|1.5|1.5|||
3886431|NCT01535014|3711440|B1|||BMI||kilogram/m^2|Mean|32.1|32.1|Standard Deviation|1.4|1.4|||
3886432|NCT01535014|3711436|B5|||Weight||kilogram|Mean|88.1|88.1|Standard Deviation|9.9|9.9|||
3886433|NCT01535014|3711437|B4|||Weight||kilogram|Mean|86.1|86.1|Standard Deviation|9.8|9.8|||
3886434|NCT01535014|3711438|B3|||Weight||kilogram|Mean|87.1|87.1|Standard Deviation|7.7|7.7|||
3886435|NCT01535014|3711439|B2|||Weight||kilogram|Mean|87.5|87.5|Standard Deviation|9.5|9.5|||
3886436|NCT01535014|3711440|B1|||Weight||kilogram|Mean|89.1|89.1|Standard Deviation|10.6|10.6|||
3886437|NCT01535014|3711436|B5|||Height||centimeter|Mean|165.6|165.6|Standard Deviation|8.0|8.0|||
3886438|NCT01535014|3711437|B4|||Height||centimeter|Mean|164.9|164.9|Standard Deviation|7.8|7.8|||
3886439|NCT01535014|3711438|B3|||Height||centimeter|Mean|164.4|164.4|Standard Deviation|6.7|6.7|||
3886440|NCT01535014|3711439|B2|||Height||centimeter|Mean|165.1|165.1|Standard Deviation|7.9|7.9|||
3886441|NCT01535014|3711440|B1|||Height||centimeter|Mean|166.4|166.4|Standard Deviation|8.3|8.3|||
3886442|NCT01535014|3711436|B5||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3886443|NCT01535014|3711437|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3886444|NCT01535014|3711438|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3886445|NCT01535014|3711439|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3886446|NCT01535014|3711440|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3886447|NCT01535014|3711436|B5||Female|Sex: Female, Male||Participants|Count of Participants|422|422.0||||||
3886448|NCT01535014|3711437|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3886449|NCT01535014|3711438|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3886450|NCT01535014|3711439|B2||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3886451|NCT01535014|3711440|B1||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
3886452|NCT01535014|3711436|B5|||Age||years|Mean|41.9|41.9|Standard Deviation|11.8|11.8|||
3886453|NCT01535014|3711437|B4|||Age||years|Mean|42.8|42.8|Standard Deviation|11.3|11.3|||
3886454|NCT01535014|3711438|B3|||Age||years|Mean|41.4|41.4|Standard Deviation|10.3|10.3|||
3886455|NCT01535014|3711439|B2|||Age||years|Mean|42.4|42.4|Standard Deviation|12.1|12.1|||
3886456|NCT01535014|3711440|B1|||Age||years|Mean|41.2|41.2|Standard Deviation|12.1|12.1|||
3886457|NCT01535001|3711475|B3|||Body Mass Index||kg/m^2|Mean|30.0|30.0|Standard Deviation|5.4|5.4|||
3886458|NCT01535001|3711476|B2|||Body Mass Index||kg/m^2|Mean|29.4|29.4|Standard Deviation|5.2|5.2|||
3886459|NCT01535001|3711477|B1|||Body Mass Index||kg/m^2|Mean|30.6|30.6|Standard Deviation|5.6|5.6|||
3886460|NCT01535001|3711475|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3886461|NCT01535001|3711476|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3886462|NCT01535001|3711477|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3886463|NCT01535001|3711475|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3886464|NCT01535001|3711476|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3886465|NCT01535001|3711477|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3886466|NCT01535001|3711475|B3|||Age||years|Mean|66.0|66.0|Standard Deviation|8.9|8.9|||
3886467|NCT01535001|3711476|B2|||Age||years|Mean|67.1|67.1|Standard Deviation|9.1|9.1|||
3886468|NCT01535001|3711477|B1|||Age||years|Mean|64.8|64.8|Standard Deviation|8.7|8.7|||
3886469|NCT01534975|3711500|B5|United States||Region of Enrollment||participants|Number|513|513.0||||||
3886470|NCT01534975|3711501|B4|United States||Region of Enrollment||participants|Number|84|84.0||||||
3886471|NCT01534975|3711502|B3|United States||Region of Enrollment||participants|Number|160|160.0||||||
3886472|NCT01534975|3711503|B2|United States||Region of Enrollment||participants|Number|133|133.0||||||
3886473|NCT01534975|3711504|B1|United States||Region of Enrollment||participants|Number|136|136.0||||||
3886474|NCT01534975|3711500|B5||Male|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
3886475|NCT01534975|3711501|B4||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3886476|NCT01534975|3711502|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3886477|NCT01534975|3711503|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3886478|NCT01534975|3711504|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3886479|NCT01534975|3711500|B5||Female|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
3886480|NCT01534975|3711501|B4||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3886481|NCT01534975|3711502|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3886482|NCT01534975|3711503|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3886483|NCT01534975|3711504|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3886484|NCT01534975|3711500|B5|||Age||years|Mean|62|62.0|Standard Deviation|11.1|11.1|||
3886485|NCT01534975|3711501|B4|||Age||years|Mean|60.4|60.4|Standard Deviation|11.2|11.2|||
3886486|NCT01534975|3711502|B3|||Age||years|Mean|61.4|61.4|Standard Deviation|10.8|10.8|||
3886487|NCT01534975|3711503|B2|||Age||years|Mean|62.3|62.3|Standard Deviation|11.4|11.4|||
3886488|NCT01534975|3711504|B1|||Age||years|Mean|62|62.0|Standard Deviation|11.7|11.7|||
3886489|NCT01534975|3711500|B5||>=65 years|Age||Participants|Count of Participants|161|161.0||||||
3886490|NCT01534975|3711501|B4||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3886491|NCT01534975|3711502|B3||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
3886492|NCT01534975|3711503|B2||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
3886493|NCT01534975|3711504|B1||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
3886494|NCT01534975|3711500|B5||Between 18 and 65 years|Age||Participants|Count of Participants|352|352.0||||||
3886495|NCT01534975|3711501|B4||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3886496|NCT01534975|3711502|B3||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
3886497|NCT01534975|3711503|B2||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
3886498|NCT01534975|3711504|B1||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
3886499|NCT01534975|3711500|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886500|NCT01534975|3711501|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886501|NCT01534975|3711502|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886502|NCT01534975|3711503|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886503|NCT01534975|3711504|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886504|NCT01534962|3711517|B5|||Time since AF diagnosis||months|Mean|10.0|10.0|Standard Deviation|20.7|20.7|||
3886505|NCT01534962|3711518|B4|||Time since AF diagnosis||months|Mean|6.9|6.9|Standard Deviation|13.5|13.5|||
3886506|NCT01534962|3711519|B3|||Time since AF diagnosis||months|Mean|15.5|15.5|Standard Deviation|28.2|28.2|||
3886507|NCT01534962|3711520|B2|||Time since AF diagnosis||months|Mean|7.2|7.2|Standard Deviation|12.9|12.9|||
3886508|NCT01534962|3711521|B1|||Time since AF diagnosis||months|Mean|10.5|10.5|Standard Deviation|24.0|24.0|||
3886509|NCT01534962|3711517|B5||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3886510|NCT01534962|3711518|B4||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3886511|NCT01534962|3711519|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3886512|NCT01534962|3711520|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3886513|NCT01534962|3711521|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3886514|NCT01534962|3711517|B5||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3886515|NCT01534962|3711518|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3886516|NCT01534962|3711519|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3886517|NCT01534962|3711520|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3886518|NCT01534962|3711521|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3886519|NCT01534962|3711517|B5|||Age||years|Mean|65.3|65.3|Standard Deviation|10.4|10.4|||
3886520|NCT01534962|3711518|B4|||Age||years|Mean|65.2|65.2|Standard Deviation|9.5|9.5|||
3886521|NCT01534962|3711519|B3|||Age||years|Mean|63.6|63.6|Standard Deviation|11.3|11.3|||
3886522|NCT01534962|3711520|B2|||Age||years|Mean|65.5|65.5|Standard Deviation|8.5|8.5|||
3886523|NCT01534962|3711521|B1|||Age||years|Mean|66.9|66.9|Standard Deviation|11.8|11.8|||
3886524|NCT01534910|3711554|B3|United States||Region of Enrollment||participants|Number|65|65.0||||||
3886525|NCT01534910|3711555|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
3886526|NCT01534910|3711556|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
3886527|NCT01534910|3711554|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3886528|NCT01534910|3711555|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3886529|NCT01534910|3711556|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3886530|NCT01534910|3711554|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3886531|NCT01534910|3711555|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3886532|NCT01534910|3711556|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3886533|NCT01534910|3711554|B3|||Age||years|Mean|57|57.0|Standard Deviation|7|7.0|||
3886534|NCT01534910|3711555|B2|||Age||years|Mean|56|56.0|Standard Deviation|8|8.0|||
3886535|NCT01534910|3711556|B1|||Age||years|Mean|57|57.0|Standard Deviation|7|7.0|||
3886536|NCT01534910|3711554|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3886537|NCT01534910|3711555|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3886538|NCT01534910|3711556|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3886539|NCT01534910|3711554|B3||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
3886540|NCT01534910|3711555|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3886541|NCT01534910|3711556|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3886542|NCT01534910|3711554|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886543|NCT01534910|3711555|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886544|NCT01534910|3711556|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886545|NCT01534897|3711565|B1|||Prior targeted therapy||participants|Number|0|0.0||||||
3886546|NCT01534897|3711565|B1|||Prior chemotherapy||participants|Number|0|0.0||||||
3886547|NCT01534897|3711565|B1|||Prior external-beam radiotherapy||participants|Number|3|3.0||||||
3886548|NCT01534897|3711565|B1|||Prior surgeries per patient (not including initial thyroidectomy)||surgeries|Median|3|3.0|Full Range|||0.0|6.0|
3886549|NCT01534897|3711565|B1|||Prior radioiodine treatments per patient||treatments|Median|2|2.0|Full Range|||1.0|4.0|
3886550|NCT01534897|3711565|B1||Clear cell papillary|Type of tumor||Participants|Count of Participants|1|1.0||||||
3886551|NCT01534897|3711565|B1||Tall cell papillary|Type of tumor||Participants|Count of Participants|4|4.0||||||
3886552|NCT01534897|3711565|B1||Classic papillary|Type of tumor||Participants|Count of Participants|5|5.0||||||
3886553|NCT01534897|3711565|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3886554|NCT01534897|3711565|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3886555|NCT01534897|3711565|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3886556|NCT01534897|3711565|B1|>=65 years||Age, Customized||participants|Number|6|6.0||||||
3886557|NCT01534897|3711565|B1|Between 18 and 65 years||Age, Customized||participants|Number|4|4.0||||||
3886558|NCT01534897|3711565|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
3886559|NCT01534689|3711573|B1|||Percent (%) Toenail Onychomycosis Disease Involvement|The percent (%) of the toenail that had onychomycosis disease involvement was determined.|percent of toenail|Mean|57.39|57.39|Standard Deviation|21.86|21.86|||
3886560|NCT01534689|3711573|B1|United States||Region of Enrollment||participants|Number|105|105.0||||||
3886561|NCT01534689|3711573|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886562|NCT01534689|3711573|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886563|NCT01534689|3711573|B1||White|Race (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
3886564|NCT01534689|3711573|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3886565|NCT01534689|3711573|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886566|NCT01534689|3711573|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886567|NCT01534689|3711573|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886568|NCT01534689|3711573|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3886569|NCT01534689|3711573|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3886570|NCT01534689|3711573|B1|||Age||years|Mean|59.5|59.5|Standard Deviation|12.85|12.85|||
3886571|NCT01534676|3711579|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3886572|NCT01534676|3711580|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3886573|NCT01534676|3711581|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3886574|NCT01534676|3711579|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3886575|NCT01534676|3711580|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3886576|NCT01534676|3711581|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3886577|NCT01534676|3711579|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3886578|NCT01534676|3711580|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3886579|NCT01534676|3711581|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3886580|NCT01534676|3711579|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3886581|NCT01534676|3711580|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3886582|NCT01534676|3711581|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3886583|NCT01534676|3711579|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3886584|NCT01534676|3711580|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3886585|NCT01534676|3711581|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3886586|NCT01534676|3711579|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3886587|NCT01534676|3711580|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886588|NCT01534676|3711581|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3886589|NCT01534637|3711588|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3886590|NCT01534637|3711588|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3886591|NCT01534637|3711588|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3886592|NCT01534637|3711588|B1|||Age||years|Mean|62.4|62.4|Standard Deviation|11.4|11.4|||
3886593|NCT01534637|3711588|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3886594|NCT01534637|3711588|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3886595|NCT01534637|3711588|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886596|NCT01534533|3711594|B5|China||Region of Enrollment||participants|Number|192|192.0||||||
3886597|NCT01534533|3711595|B4|China||Region of Enrollment||participants|Number|48|48.0||||||
3886598|NCT01534533|3711596|B3|China||Region of Enrollment||participants|Number|48|48.0||||||
3886599|NCT01534533|3711597|B2|China||Region of Enrollment||participants|Number|48|48.0||||||
3886600|NCT01534533|3711598|B1|China||Region of Enrollment||participants|Number|48|48.0||||||
3886601|NCT01534533|3711594|B5||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3886602|NCT01534533|3711595|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3886603|NCT01534533|3711596|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3886604|NCT01534533|3711597|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3886605|NCT01534533|3711598|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3886606|NCT01534533|3711594|B5||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3886607|NCT01534533|3711595|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3886608|NCT01534533|3711596|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3886609|NCT01534533|3711597|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3886610|NCT01534533|3711598|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3886611|NCT01534533|3711594|B5|||Age||years|Mean|56.5|56.5|Standard Deviation|5.2|5.2|||
3886612|NCT01534533|3711595|B4|||Age||years|Mean|53.8|53.8|Standard Deviation|5.8|5.8|||
3886613|NCT01534533|3711596|B3|||Age||years|Mean|57.3|57.3|Standard Deviation|4.9|4.9|||
3886614|NCT01534533|3711597|B2|||Age||years|Mean|57.4|57.4|Standard Deviation|4.4|4.4|||
3886615|NCT01534533|3711598|B1|||Age||years|Mean|57.4|57.4|Standard Deviation|5.0|5.0|||
3886616|NCT01534533|3711594|B5||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3886617|NCT01534533|3711595|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3886618|NCT01534533|3711596|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3886619|NCT01534533|3711597|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3886620|NCT01534533|3711598|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3886621|NCT01534533|3711594|B5||Between 18 and 65 years|Age||Participants|Count of Participants|179|179.0||||||
3886622|NCT01534533|3711595|B4||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
3886623|NCT01534533|3711596|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3886624|NCT01534533|3711597|B2||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3886625|NCT01534533|3711598|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3886626|NCT01534533|3711594|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886627|NCT01534533|3711595|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886628|NCT01534533|3711596|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886629|NCT01534533|3711597|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886630|NCT01534533|3711598|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886631|NCT01534520|3711627|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3886632|NCT01534520|3711628|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3886633|NCT01534520|3711629|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3886634|NCT01534520|3711627|B3||Female|Gender||Participants|Count of Participants|59|59.0||||||
3886635|NCT01534520|3711628|B2||Female|Gender||Participants|Count of Participants|29|29.0||||||
3886636|NCT01534520|3711629|B1||Female|Gender||Participants|Count of Participants|30|30.0||||||
3886637|NCT01534520|3711627|B3|Between 14-50||Age, Customized|Randomization was blinded.|participants|Number|59|59.0||||||
3886638|NCT01534520|3711628|B2|Between 14-50||Age, Customized|Randomization was blinded.|participants|Number|29|29.0||||||
3886639|NCT01534520|3711629|B1|Between 14-50||Age, Customized|Randomization was blinded.|participants|Number|30|30.0||||||
3886640|NCT01534416|3711642|B3|||Admission Planned|planned overnight admission for non-medical reasons|admissions|Number|6|6.0||||||
3886641|NCT01534416|3711643|B2|||Admission Planned|planned overnight admission for non-medical reasons|admissions|Number|1|1.0||||||
3886642|NCT01534416|3711644|B1|||Admission Planned|planned overnight admission for non-medical reasons|admissions|Number|5|5.0||||||
3886643|NCT01534416|3711642|B3|||Preoperative Hematocrit||% of cells|Mean|36.7|36.7|Standard Deviation|4.1|4.1|||
3886644|NCT01534416|3711643|B2|||Preoperative Hematocrit||% of cells|Mean|36.6|36.6|Standard Deviation|4.2|4.2|||
3886645|NCT01534416|3711644|B1|||Preoperative Hematocrit||% of cells|Mean|36.8|36.8|Standard Deviation|4.0|4.0|||
3886646|NCT01534416|3711642|B3|||Uterine Size||weeks|Mean|14.0|14.0|Standard Deviation|5.1|5.1|||
3886647|NCT01534416|3711643|B2|||Uterine Size||weeks|Mean|14.2|14.2|Standard Deviation|4.6|4.6|||
3886648|NCT01534416|3711644|B1|||Uterine Size||weeks|Mean|13.7|13.7|Standard Deviation|5.5|5.5|||
3886649|NCT01534416|3711642|B3|Bleeding & pain||Surgical Indication||Participants|Count of Participants|9|9.0||||||
3886650|NCT01534416|3711643|B2|Bleeding & pain||Surgical Indication||Participants|Count of Participants|5|5.0||||||
3886651|NCT01534416|3711644|B1|Bleeding & pain||Surgical Indication||Participants|Count of Participants|4|4.0||||||
3886652|NCT01534416|3711642|B3|Fibroids, bleeding & pain||Surgical Indication||Participants|Count of Participants|41|41.0||||||
3886653|NCT01534416|3711643|B2|Fibroids, bleeding & pain||Surgical Indication||Participants|Count of Participants|23|23.0||||||
3886654|NCT01534416|3711644|B1|Fibroids, bleeding & pain||Surgical Indication||Participants|Count of Participants|18|18.0||||||
3886655|NCT01534416|3711642|B3|Fibroids & bleeding||Surgical Indication||Participants|Count of Participants|33|33.0||||||
3886656|NCT01534416|3711643|B2|Fibroids & bleeding||Surgical Indication||Participants|Count of Participants|14|14.0||||||
3886657|NCT01534416|3711644|B1|Fibroids & bleeding||Surgical Indication||Participants|Count of Participants|19|19.0||||||
3886658|NCT01534416|3711642|B3|Other||Surgical Indication||Participants|Count of Participants|3|3.0||||||
3886659|NCT01534416|3711643|B2|Other||Surgical Indication||Participants|Count of Participants|3|3.0||||||
3886660|NCT01534416|3711644|B1|Other||Surgical Indication||Participants|Count of Participants|0|0.0||||||
3886661|NCT01534416|3711642|B3|Pain||Surgical Indication||Participants|Count of Participants|5|5.0||||||
3886662|NCT01534416|3711643|B2|Pain||Surgical Indication||Participants|Count of Participants|1|1.0||||||
3886663|NCT01534416|3711644|B1|Pain||Surgical Indication||Participants|Count of Participants|4|4.0||||||
3886664|NCT01534416|3711642|B3|Prolapse||Surgical Indication||Participants|Count of Participants|22|22.0||||||
3886665|NCT01534416|3711643|B2|Prolapse||Surgical Indication||Participants|Count of Participants|8|8.0||||||
3886666|NCT01534416|3711644|B1|Prolapse||Surgical Indication||Participants|Count of Participants|14|14.0||||||
3886667|NCT01534416|3711642|B3|Bleeding||Surgical Indication||Participants|Count of Participants|3|3.0||||||
3886668|NCT01534416|3711643|B2|Bleeding||Surgical Indication||Participants|Count of Participants|1|1.0||||||
3886669|NCT01534416|3711644|B1|Bleeding||Surgical Indication||Participants|Count of Participants|2|2.0||||||
3886670|NCT01534416|3711642|B3|Fibroids||Surgical Indication||Participants|Count of Participants|16|16.0||||||
3886671|NCT01534416|3711643|B2|Fibroids||Surgical Indication||Participants|Count of Participants|9|9.0||||||
3886672|NCT01534416|3711644|B1|Fibroids||Surgical Indication||Participants|Count of Participants|7|7.0||||||
3886673|NCT01534416|3711642|B3|≥3||Parity||Participants|Count of Participants|26|26.0||||||
3886674|NCT01534416|3711643|B2|≥3||Parity||Participants|Count of Participants|11|11.0||||||
3886675|NCT01534416|3711644|B1|≥3||Parity||Participants|Count of Participants|15|15.0||||||
3886676|NCT01534416|3711642|B3|2||Parity||Participants|Count of Participants|41|41.0||||||
3886677|NCT01534416|3711643|B2|2||Parity||Participants|Count of Participants|19|19.0||||||
3886678|NCT01534416|3711644|B1|2||Parity||Participants|Count of Participants|22|22.0||||||
3886679|NCT01534416|3711642|B3|1||Parity||Participants|Count of Participants|20|20.0||||||
3886680|NCT01534416|3711643|B2|1||Parity||Participants|Count of Participants|10|10.0||||||
3886681|NCT01534416|3711644|B1|1||Parity||Participants|Count of Participants|10|10.0||||||
3886682|NCT01534416|3711642|B3|0||Parity||Participants|Count of Participants|59|59.0||||||
3886683|NCT01534416|3711643|B2|0||Parity||Participants|Count of Participants|38|38.0||||||
3886684|NCT01534416|3711644|B1|0||Parity||Participants|Count of Participants|21|21.0||||||
3886685|NCT01534416|3711642|B3|||Body Mass Index||kg/m^2|Mean|28.1|28.1|Standard Deviation|6.4|6.4|||
3886686|NCT01534416|3711643|B2|||Body Mass Index||kg/m^2|Mean|29.1|29.1|Standard Deviation|6.9|6.9|||
3886687|NCT01534416|3711644|B1|||Body Mass Index||kg/m^2|Mean|27.2|27.2|Standard Deviation|5.7|5.7|||
3886688|NCT01534416|3711642|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3886689|NCT01534416|3711643|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3886690|NCT01534416|3711644|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3886691|NCT01534416|3711642|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3886692|NCT01534416|3711643|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3886693|NCT01534416|3711644|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3886694|NCT01534416|3711642|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3886695|NCT01534416|3711643|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3886696|NCT01534416|3711644|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3886697|NCT01534416|3711642|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3886698|NCT01534416|3711643|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3886699|NCT01534416|3711644|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3886700|NCT01534416|3711642|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|64|64.0||||||
3886701|NCT01534416|3711643|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3886702|NCT01534416|3711644|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3886703|NCT01534416|3711642|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3886704|NCT01534416|3711643|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3886705|NCT01534416|3711644|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3886706|NCT01534416|3711642|B3||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3886707|NCT01534416|3711643|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3886708|NCT01534416|3711644|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3886709|NCT01534416|3711642|B3|||Age||years|Mean|48.1|48.1|Standard Deviation|9.2|9.2|||
3886710|NCT01534416|3711643|B2|||Age||years|Mean|47.8|47.8|Standard Deviation|9.3|9.3|||
3886711|NCT01534416|3711644|B1|||Age||years|Mean|48.4|48.4|Standard Deviation|9.2|9.2|||
3886712|NCT01534351|3711661|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3886713|NCT01534351|3711664|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3886714|NCT01534351|3711661|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3886715|NCT01534351|3711664|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3886716|NCT01534351|3711661|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3886717|NCT01534351|3711664|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3886718|NCT01534351|3711661|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3886719|NCT01534351|3711664|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3886720|NCT01534351|3711661|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886721|NCT01534351|3711664|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886722|NCT01534260|3711683|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3886723|NCT01534260|3711684|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3886724|NCT01534260|3711685|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886725|NCT01534260|3711683|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886726|NCT01534260|3711684|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886727|NCT01534260|3711685|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886728|NCT01534260|3711683|B3||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3886729|NCT01534260|3711684|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3886730|NCT01534260|3711685|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3886731|NCT01534260|3711683|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3886732|NCT01534260|3711684|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886733|NCT01534260|3711685|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3886734|NCT01534260|3711683|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886735|NCT01534260|3711684|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886736|NCT01534260|3711685|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886737|NCT01534260|3711683|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3886738|NCT01534260|3711684|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886739|NCT01534260|3711685|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3886740|NCT01534260|3711683|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886741|NCT01534260|3711684|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886742|NCT01534260|3711685|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886743|NCT01534260|3711683|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3886744|NCT01534260|3711684|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3886745|NCT01534260|3711685|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886746|NCT01534260|3711683|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3886747|NCT01534260|3711684|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3886748|NCT01534260|3711685|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3886749|NCT01534260|3711683|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886750|NCT01534260|3711684|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886949|NCT01533688|3711853|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3886751|NCT01534260|3711685|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886752|NCT01534260|3711683|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3886753|NCT01534260|3711684|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3886754|NCT01534260|3711685|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3886755|NCT01534260|3711683|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3886756|NCT01534260|3711684|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3886757|NCT01534260|3711685|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3886758|NCT01534260|3711683|B3|||Age||years|Mean|55.2|55.2|Standard Deviation|14.7|14.7|||
3886759|NCT01534260|3711684|B2|||Age||years|Mean|58.2|58.2|Standard Deviation|14.8|14.8|||
3886760|NCT01534260|3711685|B1|||Age||years|Mean|51.6|51.6|Standard Deviation|14.2|14.2|||
3886761|NCT01534260|3711683|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3886762|NCT01534260|3711684|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3886763|NCT01534260|3711685|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3886764|NCT01534260|3711683|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3886765|NCT01534260|3711684|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3886766|NCT01534260|3711685|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3886767|NCT01534260|3711683|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886768|NCT01534260|3711684|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886769|NCT01534260|3711685|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886770|NCT01534208|3711694|B3|United States||Region of Enrollment||participants|Number|499|499.0||||||
3886771|NCT01534208|3711695|B2|United States||Region of Enrollment||participants|Number|283|283.0||||||
3886772|NCT01534208|3711696|B1|United States||Region of Enrollment||participants|Number|216|216.0||||||
3886773|NCT01534208|3711694|B3||Male|Sex: Female, Male||Participants|Count of Participants|499|499.0||||||
3886774|NCT01534208|3711695|B2||Male|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
3886775|NCT01534208|3711696|B1||Male|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
3886776|NCT01534208|3711694|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3886777|NCT01534208|3711695|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3886778|NCT01534208|3711696|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3886779|NCT01534208|3711694|B3|||Age||years|Mean|48.6|48.6|Standard Deviation|8.1|8.1|||
3886780|NCT01534208|3711695|B2|||Age||years|Mean|49.5|49.5|Standard Deviation|7.7|7.7|||
3886781|NCT01534208|3711696|B1|||Age||years|Mean|47.5|47.5|Standard Deviation|8.5|8.5|||
3886782|NCT01534182|3711713|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3886783|NCT01534182|3711714|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3886784|NCT01534182|3711715|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3886785|NCT01534182|3711713|B3||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
3886786|NCT01534182|3711714|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3886787|NCT01534182|3711715|B1||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3886788|NCT01534182|3711713|B3|||Age||Years|Mean|35.6|35.6|Standard Deviation|9.8|9.8|||
3886789|NCT01534182|3711714|B2|||Age||Years|Mean|36.4|36.4|Standard Deviation|9.3|9.3|||
3886790|NCT01534182|3711715|B1|||Age||Years|Mean|35.4|35.4|Standard Deviation|9.9|9.9|||
3886791|NCT01534143|3711731|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3886792|NCT01534143|3711731|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3886793|NCT01534143|3711731|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3886794|NCT01534143|3711731|B1|||Age||years|Mean|46|46.0|Standard Deviation|0|0.0|||
3886795|NCT01534143|3711731|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3886796|NCT01534143|3711731|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3886797|NCT01534143|3711731|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886798|NCT01534078|3711747|B1|||Longest Tumor Diameter||Centimeters (cm)|Median|33.4|33.4|Full Range|||15.1|83.3|
3886799|NCT01534078|3711747|B1|||Number of Lesions||Lesions|Median|5|5.0|Full Range|||1.0|6.0|
3886800|NCT01534078|3711747|B1|Early Unfavorable||Risk Class|"Early Unfavorable: Stage I or II disease and one or more of the following risk factors:~B Symptoms (see stage description)~Extranodal disease~Bulky disease (≥10 cm or >33% of the chest diameter on chest x-ray)~Three or more sites of nodal involvement~Sedimentation rate of ≥50 mm/h~Early Favorable: Stage I or II disease with none of the risk factors listed above. Patients with favorable classification tend to have better outcomes."|Participants|Count of Participants|13|13.0||||||
3886801|NCT01534078|3711747|B1|Early Favorable||Risk Class|"Early Unfavorable: Stage I or II disease and one or more of the following risk factors:~B Symptoms (see stage description)~Extranodal disease~Bulky disease (≥10 cm or >33% of the chest diameter on chest x-ray)~Three or more sites of nodal involvement~Sedimentation rate of ≥50 mm/h~Early Favorable: Stage I or II disease with none of the risk factors listed above. Patients with favorable classification tend to have better outcomes."|Participants|Count of Participants|21|21.0||||||
3886825|NCT01534078|3711747|B1|20 - 30 years||Age, Customized||Participants|Count of Participants|10|10.0||||||
3886826|NCT01534078|3711747|B1|||Age||years|Median|36|36.0|Full Range|||20.0|75.0|
3886827|NCT01534052|3711754|B1|>= 365||Treatment Duration in Extension Study|Treatment duration in the extension study was calculated as (Date of last dose of MDV3100 – Date of first dose of MDV3100 in the extension study)+ 1.|Days|Number|27|27.0||||||
3886802|NCT01534078|3711747|B1|Nodular Sclerosis||Histology|"The histological subtypes of classic Hodgkin lymphoma:~Classical NOS: Not Otherwise Specified (specific subtype not identified)~Lymphocyte-Rich: Rarely found in more than a few lymph nodes and usually occurs in the upper half of the body~Mixed Cellularity: Seen predominantly in adults, this is the second most common type. It can start in any lymph node but most often occurs in the upper half of the body.~Nodular Sclerosis: The most common type in developed countries. This most common in teens and young adults. Tends to start in lymph nodes in the chest or neck."|Participants|Count of Participants|18|18.0||||||
3886803|NCT01534078|3711747|B1|Mixed Cellularity||Histology|"The histological subtypes of classic Hodgkin lymphoma:~Classical NOS: Not Otherwise Specified (specific subtype not identified)~Lymphocyte-Rich: Rarely found in more than a few lymph nodes and usually occurs in the upper half of the body~Mixed Cellularity: Seen predominantly in adults, this is the second most common type. It can start in any lymph node but most often occurs in the upper half of the body.~Nodular Sclerosis: The most common type in developed countries. This most common in teens and young adults. Tends to start in lymph nodes in the chest or neck."|Participants|Count of Participants|4|4.0||||||
3886804|NCT01534078|3711747|B1|Lymphocytic Rich||Histology|"The histological subtypes of classic Hodgkin lymphoma:~Classical NOS: Not Otherwise Specified (specific subtype not identified)~Lymphocyte-Rich: Rarely found in more than a few lymph nodes and usually occurs in the upper half of the body~Mixed Cellularity: Seen predominantly in adults, this is the second most common type. It can start in any lymph node but most often occurs in the upper half of the body.~Nodular Sclerosis: The most common type in developed countries. This most common in teens and young adults. Tends to start in lymph nodes in the chest or neck."|Participants|Count of Participants|4|4.0||||||
3886805|NCT01534078|3711747|B1|Classical Hodgkin Lymphoma, NOS||Histology|"The histological subtypes of classic Hodgkin lymphoma:~Classical NOS: Not Otherwise Specified (specific subtype not identified)~Lymphocyte-Rich: Rarely found in more than a few lymph nodes and usually occurs in the upper half of the body~Mixed Cellularity: Seen predominantly in adults, this is the second most common type. It can start in any lymph node but most often occurs in the upper half of the body.~Nodular Sclerosis: The most common type in developed countries. This most common in teens and young adults. Tends to start in lymph nodes in the chest or neck."|Participants|Count of Participants|8|8.0||||||
3886806|NCT01534078|3711747|B1|Missing||Cellularity|Hypercellular indicates more cells are being produce than expected, hypocellular means that fewer than expect number of cells are being produced, normocellular means an approximately normal amount of cells are being produced|Participants|Count of Participants|19|19.0||||||
3886807|NCT01534078|3711747|B1|Normocellular||Cellularity|Hypercellular indicates more cells are being produce than expected, hypocellular means that fewer than expect number of cells are being produced, normocellular means an approximately normal amount of cells are being produced|Participants|Count of Participants|10|10.0||||||
3886808|NCT01534078|3711747|B1|Hypocellular||Cellularity|Hypercellular indicates more cells are being produce than expected, hypocellular means that fewer than expect number of cells are being produced, normocellular means an approximately normal amount of cells are being produced|Participants|Count of Participants|4|4.0||||||
3886809|NCT01534078|3711747|B1|Hypercellular||Cellularity|Hypercellular indicates more cells are being produce than expected, hypocellular means that fewer than expect number of cells are being produced, normocellular means an approximately normal amount of cells are being produced|Participants|Count of Participants|1|1.0||||||
3886810|NCT01534078|3711747|B1|IIB||Stage|"Lugano Classification of disease stage~Stage I: Found in only 1 lymph node or lymphoid organ or the cancer is found in only 1 area of a single organ outside the lymph system.~Stage II: The cancer is found in 2 or more lymph node areas on the same side of the diaphragm or the cancer extends locally from one lymph node area into a nearby organ~Can be assigned a letter A or B. B is when a patient has any of the following symptoms:~Loss of > than 10% of body weight over the previous 6 months without dieting~Unexplained fever of at least 100.4°F (38°C)~Drenching night sweats"|Participants|Count of Participants|4|4.0||||||
3886811|NCT01534078|3711747|B1|IIA||Stage|"Lugano Classification of disease stage~Stage I: Found in only 1 lymph node or lymphoid organ or the cancer is found in only 1 area of a single organ outside the lymph system.~Stage II: The cancer is found in 2 or more lymph node areas on the same side of the diaphragm or the cancer extends locally from one lymph node area into a nearby organ~Can be assigned a letter A or B. B is when a patient has any of the following symptoms:~Loss of > than 10% of body weight over the previous 6 months without dieting~Unexplained fever of at least 100.4°F (38°C)~Drenching night sweats"|Participants|Count of Participants|24|24.0||||||
3886812|NCT01534078|3711747|B1|IA||Stage|"Lugano Classification of disease stage~Stage I: Found in only 1 lymph node or lymphoid organ or the cancer is found in only 1 area of a single organ outside the lymph system.~Stage II: The cancer is found in 2 or more lymph node areas on the same side of the diaphragm or the cancer extends locally from one lymph node area into a nearby organ~Can be assigned a letter A or B. B is when a patient has any of the following symptoms:~Loss of > than 10% of body weight over the previous 6 months without dieting~Unexplained fever of at least 100.4°F (38°C)~Drenching night sweats"|Participants|Count of Participants|6|6.0||||||
3886813|NCT01534078|3711747|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
3886814|NCT01534078|3711747|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3886815|NCT01534078|3711747|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3886816|NCT01534078|3711747|B1|More Than One Race||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3886817|NCT01534078|3711747|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3886818|NCT01534078|3711747|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3886819|NCT01534078|3711747|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886820|NCT01534078|3711747|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3886821|NCT01534078|3711747|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3886822|NCT01534078|3711747|B1|61 - 75 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
3886823|NCT01534078|3711747|B1|41 - 60 years||Age, Customized||Participants|Count of Participants|10|10.0||||||
3886824|NCT01534078|3711747|B1|31 - 40 years||Age, Customized||Participants|Count of Participants|9|9.0||||||
3886828|NCT01534052|3711754|B1|>= 182 – <365||Treatment Duration in Extension Study|Treatment duration in the extension study was calculated as (Date of last dose of MDV3100 – Date of first dose of MDV3100 in the extension study)+ 1.|Days|Number|9|9.0||||||
3886829|NCT01534052|3711754|B1|> 60 – <182||Treatment Duration in Extension Study|Treatment duration in the extension study was calculated as (Date of last dose of MDV3100 – Date of first dose of MDV3100 in the extension study)+ 1.|Days|Number|12|12.0||||||
3886830|NCT01534052|3711754|B1|<= 60||Treatment Duration in Extension Study|Treatment duration in the extension study was calculated as (Date of last dose of MDV3100 – Date of first dose of MDV3100 in the extension study)+ 1.|Days|Number|4|4.0||||||
3886831|NCT01534052|3711754|B1|Unknown||Distant Metastasis at Initial Diagnosis||Participants|Count of Participants|23|23.0||||||
3886832|NCT01534052|3711754|B1|M1 – Distant Metastasis||Distant Metastasis at Initial Diagnosis||Participants|Count of Participants|9|9.0||||||
3886833|NCT01534052|3711754|B1|M0 – No Distant Metastasis||Distant Metastasis at Initial Diagnosis||Participants|Count of Participants|12|12.0||||||
3886834|NCT01534052|3711754|B1|MX – Distant Metastasis Cannot be Assessed||Distant Metastasis at Initial Diagnosis||Participants|Count of Participants|8|8.0||||||
3886835|NCT01534052|3711754|B1|Unknown||Regional Lymph Nodes (N) at Initial Diagnosis||Participants|Count of Participants|36|36.0||||||
3886836|NCT01534052|3711754|B1|pN1 – Metastasis in Regional Nodes(s)||Regional Lymph Nodes (N) at Initial Diagnosis||Participants|Count of Participants|2|2.0||||||
3886837|NCT01534052|3711754|B1|pN0 – No Positive Regional Nodes||Regional Lymph Nodes (N) at Initial Diagnosis||Participants|Count of Participants|6|6.0||||||
3886838|NCT01534052|3711754|B1|pNX – Regional Lymph Nodes Not Sampled||Regional Lymph Nodes (N) at Initial Diagnosis||Participants|Count of Participants|8|8.0||||||
3886839|NCT01534052|3711754|B1|N1 – Metastasis in Regional Lymph Node(s)||Regional Lymph Nodes (N) at Initial Diagnosis||Participants|Count of Participants|6|6.0||||||
3886840|NCT01534052|3711754|B1|N0 – No Regional Lymph Node Metastasis||Regional Lymph Nodes (N) at Initial Diagnosis||Participants|Count of Participants|15|15.0||||||
3886841|NCT01534052|3711754|B1|NX – Regional Lymph Nodes Were Not Assessed||Regional Lymph Nodes (N) at Initial Diagnosis||Participants|Count of Participants|18|18.0||||||
3886842|NCT01534052|3711754|B1|Unknown||Pathologic Tumor Stage (pT)||Participants|Count of Participants|37|37.0||||||
3886843|NCT01534052|3711754|B1|pT4 – Invasion of Bladder, Rectum||Pathologic Tumor Stage (pT)||Participants|Count of Participants|1|1.0||||||
3886844|NCT01534052|3711754|B1|pT3 – Extraprostatic Extension||Pathologic Tumor Stage (pT)||Participants|Count of Participants|9|9.0||||||
3886845|NCT01534052|3711754|B1|pT2 – Organ Confined||Pathologic Tumor Stage (pT)||Participants|Count of Participants|5|5.0||||||
3886846|NCT01534052|3711754|B1|Unknown||Primary Tumor Assessment at Initial Diagnosis – Clinical Tumor Stage (T)||Participants|Count of Participants|23|23.0||||||
3886847|NCT01534052|3711754|B1|T4 – Tumor Fixed or Invades Adjacent Structures||Primary Tumor Assessment at Initial Diagnosis – Clinical Tumor Stage (T)||Participants|Count of Participants|3|3.0||||||
3886848|NCT01534052|3711754|B1|T3 – Tumor Extends Through the Prostatic Capsule||Primary Tumor Assessment at Initial Diagnosis – Clinical Tumor Stage (T)||Participants|Count of Participants|13|13.0||||||
3886849|NCT01534052|3711754|B1|T2 – Tumor Confined Within the Prostate||Primary Tumor Assessment at Initial Diagnosis – Clinical Tumor Stage (T)||Participants|Count of Participants|8|8.0||||||
3886850|NCT01534052|3711754|B1|T1 – Clinically Tumor Not Palpable or Visible||Primary Tumor Assessment at Initial Diagnosis – Clinical Tumor Stage (T)||Participants|Count of Participants|1|1.0||||||
3886851|NCT01534052|3711754|B1|T0 – No Evidence of Primary Tumor||Primary Tumor Assessment at Initial Diagnosis – Clinical Tumor Stage (T)||Participants|Count of Participants|1|1.0||||||
3886852|NCT01534052|3711754|B1|TX – Primary Tumor Cannot be Assessed||Primary Tumor Assessment at Initial Diagnosis – Clinical Tumor Stage (T)||Participants|Count of Participants|3|3.0||||||
3886853|NCT01534052|3711754|B1|Unknown||Total Gleason Score at Initial Diagnosis|Gleason score was a grading system for prostate cancer tissue based on how it looks under a microscope. Gleason scores ranged from 2 to 10 and indicated how likely it was that a tumor will spread. A low Gleason score meant the cancer tissue is similar to normal prostate tissue and the tumor was less likely to spread; a high Gleason score meant the cancer tissue was very different from normal and the tumor was more likely to spread.|Participants|Count of Participants|17|17.0||||||
3886854|NCT01534052|3711754|B1|Score 9||Total Gleason Score at Initial Diagnosis|Gleason score was a grading system for prostate cancer tissue based on how it looks under a microscope. Gleason scores ranged from 2 to 10 and indicated how likely it was that a tumor will spread. A low Gleason score meant the cancer tissue is similar to normal prostate tissue and the tumor was less likely to spread; a high Gleason score meant the cancer tissue was very different from normal and the tumor was more likely to spread.|Participants|Count of Participants|13|13.0||||||
3886855|NCT01534052|3711754|B1|Score 8||Total Gleason Score at Initial Diagnosis|Gleason score was a grading system for prostate cancer tissue based on how it looks under a microscope. Gleason scores ranged from 2 to 10 and indicated how likely it was that a tumor will spread. A low Gleason score meant the cancer tissue is similar to normal prostate tissue and the tumor was less likely to spread; a high Gleason score meant the cancer tissue was very different from normal and the tumor was more likely to spread.|Participants|Count of Participants|1|1.0||||||
3886856|NCT01534052|3711754|B1|Score 7||Total Gleason Score at Initial Diagnosis|Gleason score was a grading system for prostate cancer tissue based on how it looks under a microscope. Gleason scores ranged from 2 to 10 and indicated how likely it was that a tumor will spread. A low Gleason score meant the cancer tissue is similar to normal prostate tissue and the tumor was less likely to spread; a high Gleason score meant the cancer tissue was very different from normal and the tumor was more likely to spread.|Participants|Count of Participants|16|16.0||||||
3886857|NCT01534052|3711754|B1|Score 6||Total Gleason Score at Initial Diagnosis|Gleason score was a grading system for prostate cancer tissue based on how it looks under a microscope. Gleason scores ranged from 2 to 10 and indicated how likely it was that a tumor will spread. A low Gleason score meant the cancer tissue is similar to normal prostate tissue and the tumor was less likely to spread; a high Gleason score meant the cancer tissue was very different from normal and the tumor was more likely to spread.|Participants|Count of Participants|5|5.0||||||
3886858|NCT01534052|3711754|B1|Unknown||Secondary Gleason Score at Initial Diagnosis|Gleason score was a grading system for prostate cancer tissue based on how it looks under a microscope. Gleason scores ranged from 2 to 10 and indicated how likely it was that a tumor will spread. A low Gleason score meant the cancer tissue is similar to normal prostate tissue and the tumor was less likely to spread; a high Gleason score meant the cancer tissue was very different from normal and the tumor was more likely to spread.|Participants|Count of Participants|20|20.0||||||
3886859|NCT01534052|3711754|B1|Score 5||Secondary Gleason Score at Initial Diagnosis|Gleason score was a grading system for prostate cancer tissue based on how it looks under a microscope. Gleason scores ranged from 2 to 10 and indicated how likely it was that a tumor will spread. A low Gleason score meant the cancer tissue is similar to normal prostate tissue and the tumor was less likely to spread; a high Gleason score meant the cancer tissue was very different from normal and the tumor was more likely to spread.|Participants|Count of Participants|9|9.0||||||
3886860|NCT01534052|3711754|B1|Score 4||Secondary Gleason Score at Initial Diagnosis|Gleason score was a grading system for prostate cancer tissue based on how it looks under a microscope. Gleason scores ranged from 2 to 10 and indicated how likely it was that a tumor will spread. A low Gleason score meant the cancer tissue is similar to normal prostate tissue and the tumor was less likely to spread; a high Gleason score meant the cancer tissue was very different from normal and the tumor was more likely to spread.|Participants|Count of Participants|14|14.0||||||
3886861|NCT01534052|3711754|B1|Score 3||Secondary Gleason Score at Initial Diagnosis|Gleason score was a grading system for prostate cancer tissue based on how it looks under a microscope. Gleason scores ranged from 2 to 10 and indicated how likely it was that a tumor will spread. A low Gleason score meant the cancer tissue is similar to normal prostate tissue and the tumor was less likely to spread; a high Gleason score meant the cancer tissue was very different from normal and the tumor was more likely to spread.|Participants|Count of Participants|9|9.0||||||
3886862|NCT01534052|3711754|B1|Unknown||Primary Gleason Score at Initial Diagnosis|Gleason score was a grading system for prostate cancer tissue based on how it looks under a microscope. Gleason scores ranged from 2 to 10 and indicated how likely it was that a tumor will spread. A low Gleason score meant the cancer tissue is similar to normal prostate tissue and the tumor was less likely to spread; a high Gleason score meant the cancer tissue was very different from normal and the tumor was more likely to spread.|Participants|Count of Participants|20|20.0||||||
3886863|NCT01534052|3711754|B1|Score 5||Primary Gleason Score at Initial Diagnosis|Gleason score was a grading system for prostate cancer tissue based on how it looks under a microscope. Gleason scores ranged from 2 to 10 and indicated how likely it was that a tumor will spread. A low Gleason score meant the cancer tissue is similar to normal prostate tissue and the tumor was less likely to spread; a high Gleason score meant the cancer tissue was very different from normal and the tumor was more likely to spread.|Participants|Count of Participants|4|4.0||||||
3886864|NCT01534052|3711754|B1|Score 4||Primary Gleason Score at Initial Diagnosis|Gleason score was a grading system for prostate cancer tissue based on how it looks under a microscope. Gleason scores ranged from 2 to 10 and indicated how likely it was that a tumor will spread. A low Gleason score meant the cancer tissue is similar to normal prostate tissue and the tumor was less likely to spread; a high Gleason score meant the cancer tissue was very different from normal and the tumor was more likely to spread.|Participants|Count of Participants|13|13.0||||||
3886865|NCT01534052|3711754|B1|Score 3||Primary Gleason Score at Initial Diagnosis|Gleason score was a grading system for prostate cancer tissue based on how it looks under a microscope. Gleason scores ranged from 2 to 10 and indicated how likely it was that a tumor will spread. A low Gleason score meant the cancer tissue is similar to normal prostate tissue and the tumor was less likely to spread; a high Gleason score meant the cancer tissue was very different from normal and the tumor was more likely to spread.|Participants|Count of Participants|15|15.0||||||
3886866|NCT01534052|3711754|B1|||Duration of Prostate Cancer|The duration of prostate cancer was calculated as (Date of first enzalutamide intake in the parent study – Date of initial diagnosis) + 1.|months|Geometric Mean|69.4|69.4|Standard Deviation|64.10|64.1|||
3886867|NCT01534052|3711754|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3886868|NCT01534052|3711754|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886869|NCT01534052|3711754|B1||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3886870|NCT01534052|3711754|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3886871|NCT01534052|3711754|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886872|NCT01534052|3711754|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886873|NCT01534052|3711754|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886874|NCT01534052|3711754|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886875|NCT01534052|3711754|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3886876|NCT01534052|3711754|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886877|NCT01534052|3711754|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3886878|NCT01534052|3711754|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3886879|NCT01534052|3711754|B1|||Age||years|Geometric Mean|68.6|68.6|Standard Deviation|7.39|7.39|||
3886880|NCT01533974|3711758|B3||Male|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
3886881|NCT01533974|3711759|B2||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3886882|NCT01533974|3711760|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3886883|NCT01533974|3711758|B3||Female|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
3886884|NCT01533974|3711759|B2||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3886885|NCT01533974|3711760|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3886886|NCT01533974|3711758|B3|||Age||years|Mean|51.3|51.3|Standard Deviation|12.1|12.1|||
3886887|NCT01533974|3711759|B2|||Age||years|Mean|50.8|50.8|Standard Deviation|12.2|12.2|||
3886888|NCT01533974|3711760|B1|||Age||years|Mean|51.8|51.8|Standard Deviation|12.0|12.0|||
3886889|NCT01533948|3711767|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886890|NCT01533948|3711767|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886891|NCT01533948|3711767|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3886892|NCT01533948|3711767|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886893|NCT01533948|3711767|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886894|NCT01533948|3711767|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886895|NCT01533948|3711767|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3886896|NCT01533948|3711767|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3886897|NCT01533948|3711767|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3886898|NCT01533948|3711767|B1|||Age||years|Mean|68.8|68.8|Standard Deviation|11.5|11.5|||
3886899|NCT01533948|3711767|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3886900|NCT01533948|3711767|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3886901|NCT01533948|3711767|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886902|NCT01533935|3711775|B1||Male|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
3886903|NCT01533935|3711775|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3886904|NCT01533935|3711775|B1|||Age||years|Mean|61.2|61.2|Standard Deviation|7.9|7.9|||
3886905|NCT01533922|3711806|B1||Male|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
3886906|NCT01533922|3711806|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3886907|NCT01533922|3711806|B1|||Age||years|Mean|62.2|62.2|Standard Deviation|7.5|7.5|||
3886908|NCT01533753|3711837|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3886909|NCT01533753|3711838|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3886910|NCT01533753|3711839|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3886911|NCT01533753|3711837|B3|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3886912|NCT01533753|3711838|B2|African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3886913|NCT01533753|3711839|B1|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3886914|NCT01533753|3711837|B3|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3886915|NCT01533753|3711838|B2|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3886916|NCT01533753|3711839|B1|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3886917|NCT01533753|3711837|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3886918|NCT01533753|3711838|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3886919|NCT01533753|3711839|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3886920|NCT01533753|3711837|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3886921|NCT01533753|3711838|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3886922|NCT01533753|3711839|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3886923|NCT01533753|3711837|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3886924|NCT01533753|3711838|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3886925|NCT01533753|3711839|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3886926|NCT01533753|3711837|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3886927|NCT01533753|3711838|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3886928|NCT01533753|3711839|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3886929|NCT01533753|3711837|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886930|NCT01533753|3711838|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886931|NCT01533753|3711839|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886932|NCT01533688|3711852|B4|United States||Region of Enrollment||Participants|Count of Participants|186|186.0||||||
3886933|NCT01533688|3711853|B3|United States||Region of Enrollment||Participants|Count of Participants|63|63.0||||||
3886934|NCT01533688|3711854|B2|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3886935|NCT01533688|3711855|B1|United States||Region of Enrollment||Participants|Count of Participants|63|63.0||||||
3886936|NCT01533688|3711852|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|49|49.0||||||
3886937|NCT01533688|3711853|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3886938|NCT01533688|3711854|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3886939|NCT01533688|3711855|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3886940|NCT01533688|3711852|B4|White race||Race/Ethnicity, Customized||Participants|Count of Participants|137|137.0||||||
3886941|NCT01533688|3711853|B3|White race||Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
3886942|NCT01533688|3711854|B2|White race||Race/Ethnicity, Customized||Participants|Count of Participants|45|45.0||||||
3886943|NCT01533688|3711855|B1|White race||Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
3886944|NCT01533688|3711852|B4||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
3886945|NCT01533688|3711853|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3886946|NCT01533688|3711854|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3886947|NCT01533688|3711855|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3886948|NCT01533688|3711852|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3886950|NCT01533688|3711854|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3886951|NCT01533688|3711855|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3886952|NCT01533688|3711852|B4|||Age||years|Mean|63.5|63.5|Standard Deviation|6.8|6.8|||
3886953|NCT01533688|3711853|B3|||Age||years|Mean|63.2|63.2|Standard Deviation|6.7|6.7|||
3886954|NCT01533688|3711854|B2|||Age||years|Mean|62.8|62.8|Standard Deviation|7.2|7.2|||
3886955|NCT01533688|3711855|B1|||Age||years|Mean|64.7|64.7|Standard Deviation|6.4|6.4|||
3886956|NCT01533597|3711868|B3|Korea, Republic of||Region of Enrollment||participants|Number|70|70.0||||||
3886957|NCT01533597|3711869|B2|Korea, Republic of||Region of Enrollment||participants|Number|35|35.0||||||
3886958|NCT01533597|3711870|B1|Korea, Republic of||Region of Enrollment||participants|Number|35|35.0||||||
3886959|NCT01533597|3711868|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3886960|NCT01533597|3711869|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3886961|NCT01533597|3711870|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3886962|NCT01533597|3711868|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3886963|NCT01533597|3711869|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3886964|NCT01533597|3711870|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3886965|NCT01533597|3711868|B3|||Age||years|Mean|52.2|52.2|Standard Deviation|11.4|11.4|||
3886966|NCT01533597|3711869|B2|||Age||years|Mean|52.3|52.3|Standard Deviation|13.8|13.8|||
3886967|NCT01533597|3711870|B1|||Age||years|Mean|52.1|52.1|Standard Deviation|8.2|8.2|||
3886968|NCT01533597|3711868|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3886969|NCT01533597|3711869|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3886970|NCT01533597|3711870|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3886971|NCT01533597|3711868|B3||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
3886972|NCT01533597|3711869|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3886973|NCT01533597|3711870|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3886974|NCT01533597|3711868|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886975|NCT01533597|3711869|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886976|NCT01533597|3711870|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886977|NCT01533493|3711887|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
3886978|NCT01533493|3711888|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3886979|NCT01533493|3711889|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3886980|NCT01533493|3711887|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3886981|NCT01533493|3711888|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3886982|NCT01533493|3711889|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3886983|NCT01533493|3711887|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3886984|NCT01533493|3711888|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3886985|NCT01533493|3711889|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3886986|NCT01533493|3711887|B3|||Age||years|Mean|36.5|36.5|Standard Deviation|10.23|10.23|||
3886987|NCT01533493|3711888|B2|||Age||years|Mean|38.43|38.43|Standard Deviation|10.57|10.57|||
3886988|NCT01533493|3711889|B1|||Age||years|Mean|34.25|34.25|Standard Deviation|9.77|9.77|||
3886989|NCT01533493|3711887|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3886990|NCT01533493|3711888|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3886991|NCT01533493|3711889|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3886992|NCT01533493|3711887|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3886993|NCT01533493|3711888|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3886994|NCT01533493|3711889|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3886995|NCT01533493|3711887|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886996|NCT01533493|3711888|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886997|NCT01533493|3711889|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3886998|NCT01533428|3711896|B3|||Average Pain Score|Average pain was assessed by the Brief Pain Inventory-Diabetic Neuropathy (BPI-DN) on a numeric rating scale from 0 - 10, with 0 describing “no pain” and 10 describing severe pain listed as “pain as bad as you can imagine”.|units on a scale|Mean|6.51|6.51|Standard Deviation|1.449|1.449|||
3886999|NCT01533428|3711897|B2|||Average Pain Score|Average pain was assessed by the Brief Pain Inventory-Diabetic Neuropathy (BPI-DN) on a numeric rating scale from 0 - 10, with 0 describing “no pain” and 10 describing severe pain listed as “pain as bad as you can imagine”.|units on a scale|Mean|6.38|6.38|Standard Deviation|1.473|1.473|||
3887000|NCT01533428|3711898|B1|||Average Pain Score|Average pain was assessed by the Brief Pain Inventory-Diabetic Neuropathy (BPI-DN) on a numeric rating scale from 0 - 10, with 0 describing “no pain” and 10 describing severe pain listed as “pain as bad as you can imagine”.|units on a scale|Mean|6.64|6.64|Standard Deviation|1.416|1.416|||
3887001|NCT01533428|3711896|B3|||Glycosylated Hemoglobin (HbA1c)||Percentage of Glycosylated Hemoglobin|Mean|7.31|7.31|Standard Deviation|1.268|1.268|||
3887002|NCT01533428|3711897|B2|||Glycosylated Hemoglobin (HbA1c)||Percentage of Glycosylated Hemoglobin|Mean|7.23|7.23|Standard Deviation|1.223|1.223|||
3887003|NCT01533428|3711898|B1|||Glycosylated Hemoglobin (HbA1c)||Percentage of Glycosylated Hemoglobin|Mean|7.39|7.39|Standard Deviation|1.309|1.309|||
3887004|NCT01533428|3711896|B3|||Duration of Painful Diabetic Peripheral Neuropathy (PDPN)||years|Mean|5.78|5.78|Standard Deviation|3.99|3.99|||
3887005|NCT01533428|3711897|B2|||Duration of Painful Diabetic Peripheral Neuropathy (PDPN)||years|Mean|5.72|5.72|Standard Deviation|3.98|3.98|||
3887006|NCT01533428|3711898|B1|||Duration of Painful Diabetic Peripheral Neuropathy (PDPN)||years|Mean|5.83|5.83|Standard Deviation|4.01|4.01|||
3887007|NCT01533428|3711896|B3|Other||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3887008|NCT01533428|3711897|B2|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3887009|NCT01533428|3711898|B1|Other||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3887010|NCT01533428|3711896|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3887011|NCT01533428|3711897|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3887012|NCT01533428|3711898|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3887013|NCT01533428|3711896|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3887014|NCT01533428|3711897|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3887015|NCT01533428|3711898|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3887016|NCT01533428|3711896|B3|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3887017|NCT01533428|3711897|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3887018|NCT01533428|3711898|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3887019|NCT01533428|3711896|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
3887020|NCT01533428|3711897|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
3887021|NCT01533428|3711898|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3887022|NCT01533428|3711896|B3|White||Race/Ethnicity, Customized||participants|Number|263|263.0||||||
3887023|NCT01533428|3711897|B2|White||Race/Ethnicity, Customized||participants|Number|131|131.0||||||
3887024|NCT01533428|3711898|B1|White||Race/Ethnicity, Customized||participants|Number|132|132.0||||||
3887025|NCT01533428|3711896|B3||Male|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
3887026|NCT01533428|3711897|B2||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3887027|NCT01533428|3711898|B1||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3887028|NCT01533428|3711896|B3||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3887029|NCT01533428|3711897|B2||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3887030|NCT01533428|3711898|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3887031|NCT01533428|3711896|B3|||Age||years|Mean|63.00|63.0|Standard Deviation|10.75|10.75|||
3887032|NCT01533428|3711897|B2|||Age||years|Mean|62.00|62.0|Standard Deviation|10.81|10.81|||
3887033|NCT01533428|3711898|B1|||Age||years|Mean|63.90|63.9|Standard Deviation|10.64|10.64|||
3887034|NCT01533259|3711939|B1|AIDS||HIV Disease Status||participants|Number|2|2.0||||||
3887035|NCT01533259|3711939|B1|Symptomatic HIV Infection||HIV Disease Status||participants|Number|1|1.0||||||
3887036|NCT01533259|3711939|B1|Asymptomatic||HIV Disease Status||participants|Number|45|45.0||||||
3887037|NCT01533259|3711939|B1|||CD4 Cell Count||cells/µL|Mean|711|711.0|Standard Deviation|265.9|265.9|||
3887038|NCT01533259|3711939|B1|50 to < 200 copies/mL||Baseline HIV-1 RNA Category||participants|Number|2|2.0||||||
3887039|NCT01533259|3711939|B1|< 50 copies/mL||Baseline HIV-1 RNA Category||participants|Number|46|46.0||||||
3887040|NCT01533259|3711939|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3887041|NCT01533259|3711939|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3887042|NCT01533259|3711939|B1|White||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
3887043|NCT01533259|3711939|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887044|NCT01533259|3711939|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3887045|NCT01533259|3711939|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3887046|NCT01533259|3711939|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3887047|NCT01533259|3711939|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3887048|NCT01533259|3711939|B1|||Age||years|Mean|44|44.0|Standard Deviation|8.6|8.6|||
3887049|NCT01533246|3711945|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3887050|NCT01533246|3711945|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887051|NCT01533246|3711945|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887052|NCT01533246|3711945|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3887053|NCT01533246|3711945|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3887054|NCT01533246|3711945|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887055|NCT01533246|3711945|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887056|NCT01533246|3711945|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887057|NCT01533246|3711945|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887058|NCT01533246|3711945|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3887059|NCT01533246|3711945|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887060|NCT01533246|3711945|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3887061|NCT01533246|3711945|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3887062|NCT01533246|3711945|B1|70-79 years||Age, Customized||participants|Number|8|8.0||||||
3887063|NCT01533246|3711945|B1|60-69 years||Age, Customized||participants|Number|7|7.0||||||
3887064|NCT01533246|3711945|B1|50-59 years||Age, Customized||participants|Number|2|2.0||||||
3887065|NCT01533181|3711954|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
3887066|NCT01533181|3711955|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
3887067|NCT01533181|3711956|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3887068|NCT01533181|3711954|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3887069|NCT01533181|3711955|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3887070|NCT01533181|3711956|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3887071|NCT01533181|3711954|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3887072|NCT01533181|3711955|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3887073|NCT01533181|3711956|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3887074|NCT01533181|3711954|B3|||Age||years|Median|64|64.0|Full Range|||34.0|86.0|
3887075|NCT01533181|3711955|B2|||Age||years|Median|62|62.0|Full Range|||37.0|79.0|
3887076|NCT01533181|3711956|B1|||Age||years|Median|64|64.0|Full Range|||34.0|86.0|
3887077|NCT01533181|3711954|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3887078|NCT01533181|3711955|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3887079|NCT01533181|3711956|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3887080|NCT01533181|3711954|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3887081|NCT01533181|3711955|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3887082|NCT01533181|3711956|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3887083|NCT01533181|3711954|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3887084|NCT01533181|3711955|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3887085|NCT01533181|3711956|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3887086|NCT01533116|3711969|B5||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3887087|NCT01533116|3711970|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3887088|NCT01533116|3711971|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3887089|NCT01533116|3711972|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3887090|NCT01533116|3711973|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3887091|NCT01533116|3711969|B5||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3887092|NCT01533116|3711970|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3887093|NCT01533116|3711971|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3887094|NCT01533116|3711972|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3887095|NCT01533116|3711973|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3887096|NCT01533116|3711969|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3887097|NCT01533116|3711970|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3887098|NCT01533116|3711971|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3887099|NCT01533116|3711972|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3887100|NCT01533116|3711973|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3887101|NCT01533116|3711969|B5||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3887102|NCT01533116|3711970|B4||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3887103|NCT01533116|3711971|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3887104|NCT01533116|3711972|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3887105|NCT01533116|3711973|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3887106|NCT01533116|3711969|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3887107|NCT01533116|3711970|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3887108|NCT01533116|3711971|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3887109|NCT01533116|3711972|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3887110|NCT01533116|3711973|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3887111|NCT01533077|3712002|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3887112|NCT01533077|3712003|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3887113|NCT01533077|3712004|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3887114|NCT01533077|3712005|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3887115|NCT01533077|3712006|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3887116|NCT01533077|3712002|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3887117|NCT01533077|3712003|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3887118|NCT01533077|3712004|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3887119|NCT01533077|3712005|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3887120|NCT01533077|3712006|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3887121|NCT01533077|3712002|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3887122|NCT01533077|3712003|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3887123|NCT01533077|3712004|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3887124|NCT01533077|3712005|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3887125|NCT01533077|3712006|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3887126|NCT01533077|3712002|B5||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3887127|NCT01533077|3712003|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3887128|NCT01533077|3712004|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3887129|NCT01533077|3712005|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3887130|NCT01533077|3712006|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3887131|NCT01533077|3712002|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3887132|NCT01533077|3712003|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3887133|NCT01533077|3712004|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3887134|NCT01533077|3712005|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3887135|NCT01533077|3712006|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3887136|NCT01533038|3712063|B3|Germany||Region of Enrollment||participants|Number|30|30.0||||||
3887137|NCT01533038|3712064|B2|Germany||Region of Enrollment||participants|Number|13|13.0||||||
3887138|NCT01533038|3712065|B1|Germany||Region of Enrollment||participants|Number|17|17.0||||||
3887139|NCT01533038|3712063|B3|United Kingdom||Region of Enrollment||participants|Number|31|31.0||||||
3887140|NCT01533038|3712064|B2|United Kingdom||Region of Enrollment||participants|Number|13|13.0||||||
3887141|NCT01533038|3712065|B1|United Kingdom||Region of Enrollment||participants|Number|18|18.0||||||
3887142|NCT01533038|3712063|B3|Denmark||Region of Enrollment||participants|Number|19|19.0||||||
3887143|NCT01533038|3712064|B2|Denmark||Region of Enrollment||participants|Number|9|9.0||||||
3887144|NCT01533038|3712065|B1|Denmark||Region of Enrollment||participants|Number|10|10.0||||||
3887145|NCT01533038|3712063|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3887146|NCT01533038|3712064|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3887147|NCT01533038|3712065|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3887148|NCT01533038|3712063|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3887149|NCT01533038|3712064|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3887150|NCT01533038|3712065|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3887151|NCT01533038|3712063|B3|Age||Age, Customized||years|Mean|65|65.0|Full Range|||49.0|84.0|
3887152|NCT01533038|3712064|B2|Age||Age, Customized||years|Mean|65|65.0|Full Range|||51.0|78.0|
3887153|NCT01533038|3712065|B1|Age||Age, Customized||years|Mean|63|63.0|Full Range|||49.0|84.0|
3887154|NCT01532999|3712072|B3|||CAPS Total|Clinician Administered PTSD Scale (CAPS) is a 17-item standard rating scale that measures PTSD severity with scores ranging from 0-136 (higher score = more severe). Scores of frequency and intensity are summed for the 17-items to yield the total CAPS score.|units on a scale|Mean|83|83.0|Standard Deviation|18.2|18.2|||
3887155|NCT01532999|3712073|B2|||CAPS Total|Clinician Administered PTSD Scale (CAPS) is a 17-item standard rating scale that measures PTSD severity with scores ranging from 0-136 (higher score = more severe). Scores of frequency and intensity are summed for the 17-items to yield the total CAPS score.|units on a scale|Mean|80.7|80.7|Standard Deviation|16.7|16.7|||
3887156|NCT01532999|3712074|B1|||CAPS Total|Clinician Administered PTSD Scale (CAPS) is a 17-item standard rating scale that measures PTSD severity with scores ranging from 0-136 (higher score = more severe). Scores of frequency and intensity are summed for the 17-items to yield the total CAPS score.|units on a scale|Mean|84.3|84.3|Standard Deviation|19.5|19.5|||
3887157|NCT01532999|3712072|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3887158|NCT01532999|3712073|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3887159|NCT01532999|3712074|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887160|NCT01532999|3712072|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3887161|NCT01532999|3712073|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3887162|NCT01532999|3712074|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3887163|NCT01532999|3712072|B3||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3887164|NCT01532999|3712073|B2||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3887165|NCT01532999|3712074|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3887166|NCT01532999|3712072|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
3887167|NCT01532999|3712073|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3887168|NCT01532999|3712074|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3887169|NCT01532999|3712072|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887170|NCT01532999|3712073|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887171|NCT01532999|3712074|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887172|NCT01532999|3712072|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887173|NCT01532999|3712073|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887174|NCT01532999|3712074|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887175|NCT01532999|3712072|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887176|NCT01532999|3712073|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887177|NCT01532999|3712074|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887178|NCT01532999|3712072|B3||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3887179|NCT01532999|3712073|B2||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3887180|NCT01532999|3712074|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3887181|NCT01532999|3712072|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3887182|NCT01532999|3712073|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3887183|NCT01532999|3712074|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3887184|NCT01532999|3712072|B3|||Age||years|Mean|51|51.0|Standard Deviation|11|11.0|||
3887185|NCT01532999|3712073|B2|||Age||years|Mean|51|51.0|Standard Deviation|8.3|8.3|||
3887186|NCT01532999|3712074|B1|||Age||years|Mean|52|52.0|Standard Deviation|11|11.0|||
3887187|NCT01532973|3712097|B10||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3887188|NCT01532973|3712098|B9||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3887189|NCT01532973|3712099|B8||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3887190|NCT01532973|3712100|B7||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3887191|NCT01532973|3712101|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3887192|NCT01532973|3712102|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3887193|NCT01532973|3712103|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3887194|NCT01532973|3712104|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3887195|NCT01532973|3712105|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3887196|NCT01532973|3712106|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3887197|NCT01532973|3712097|B10||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3887198|NCT01532973|3712098|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3887199|NCT01532973|3712099|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3887200|NCT01532973|3712100|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3887201|NCT01532973|3712101|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3887202|NCT01532973|3712102|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3887203|NCT01532973|3712103|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3887204|NCT01532973|3712104|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3887205|NCT01532973|3712105|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3887206|NCT01532973|3712106|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3887207|NCT01532973|3712097|B10|||Age||years|Mean|43.0|43.0|Standard Deviation|11.0|11.0|||
3887208|NCT01532973|3712098|B9|||Age||years|Mean|47.8|47.8|Standard Deviation|10.8|10.8|||
3887209|NCT01532973|3712099|B8|||Age||years|Mean|53.2|53.2|Standard Deviation|11.6|11.6|||
3887210|NCT01532973|3712100|B7|||Age||years|Mean|51.0|51.0|Standard Deviation|5.0|5.0|||
3887211|NCT01532973|3712101|B6|||Age||years|Mean|34.6|34.6|Standard Deviation|6.8|6.8|||
3887212|NCT01532973|3712102|B5|||Age||years|Mean|35.8|35.8|Standard Deviation|8.9|8.9|||
3887213|NCT01532973|3712103|B4|||Age||years|Mean|34.8|34.8|Standard Deviation|6.4|6.4|||
3887214|NCT01532973|3712104|B3|||Age||years|Mean|51.6|51.6|Standard Deviation|8.8|8.8|||
3887215|NCT01532973|3712105|B2|||Age||years|Mean|36.8|36.8|Standard Deviation|6.9|6.9|||
3887216|NCT01532973|3712106|B1|||Age||years|Mean|38.8|38.8|Standard Deviation|10.8|10.8|||
3887217|NCT01532934|3712155|B3|||Psychopathy Checklist-Revised - Factor One (F1)|The Psychopathy Checklist - Revised is a valid measure of psychopathy with scores ranging from 0-40 (higher indicating higher levels of psychopathy). Factor One of this scale measures interpersonal and affective psychopathic traits and ranges from 0-16.|units on a scale|Mean|8.6|8.6|Standard Deviation|4.3|4.3|||
3887218|NCT01532934|3712156|B2|||Psychopathy Checklist-Revised - Factor One (F1)|The Psychopathy Checklist - Revised is a valid measure of psychopathy with scores ranging from 0-40 (higher indicating higher levels of psychopathy). Factor One of this scale measures interpersonal and affective psychopathic traits and ranges from 0-16.|units on a scale|Mean|9.0|9.0|Standard Deviation|4.4|4.4|||
3887219|NCT01532934|3712157|B1|||Psychopathy Checklist-Revised - Factor One (F1)|The Psychopathy Checklist - Revised is a valid measure of psychopathy with scores ranging from 0-40 (higher indicating higher levels of psychopathy). Factor One of this scale measures interpersonal and affective psychopathic traits and ranges from 0-16.|units on a scale|Mean|8.1|8.1|Standard Deviation|4.3|4.3|||
3887220|NCT01532934|3712155|B3|United States||Region of Enrollment||participants|Number|105|105.0||||||
3887221|NCT01532934|3712156|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
3887222|NCT01532934|3712157|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
3887223|NCT01532934|3712155|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887224|NCT01532934|3712156|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887225|NCT01532934|3712157|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887226|NCT01532934|3712155|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3887227|NCT01532934|3712156|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3887228|NCT01532934|3712157|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3887229|NCT01532934|3712155|B3||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3887230|NCT01532934|3712156|B2||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3887231|NCT01532934|3712157|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3887232|NCT01532934|3712155|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3887233|NCT01532934|3712156|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3887234|NCT01532934|3712157|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3887235|NCT01532934|3712155|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887236|NCT01532934|3712156|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887237|NCT01532934|3712157|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887238|NCT01532934|3712155|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887239|NCT01532934|3712156|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887240|NCT01532934|3712157|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887241|NCT01532934|3712155|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887242|NCT01532934|3712156|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887243|NCT01532934|3712157|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887244|NCT01532934|3712155|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3887245|NCT01532934|3712156|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3887246|NCT01532934|3712157|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3887247|NCT01532934|3712155|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3887248|NCT01532934|3712156|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3887249|NCT01532934|3712157|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3887250|NCT01532934|3712155|B3|||Age||years|Mean|33.4|33.4|Standard Deviation|10.9|10.9|||
3887251|NCT01532934|3712156|B2|||Age||years|Mean|33.8|33.8|Standard Deviation|11.8|11.8|||
3887252|NCT01532934|3712157|B1|||Age||years|Mean|33.1|33.1|Standard Deviation|10|10.0|||
3887253|NCT01532921|3712168|B1||NYHA Class IV|NYHA Class|The New York Heart Association (NYHA) Functional Classification provides a simple way of classifying the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity; the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina. NYHA I implies no limitations. NYHA II implies slight limitation of physical activity. NYHA III implies marked limitation of physical activity and finally, NYHA IV implies patients are Unable to carry on any physical activity without discomfort.|Participants|Count of Participants|9|9.0||||||
3887254|NCT01532921|3712168|B1||NYHA Class III|NYHA Class|The New York Heart Association (NYHA) Functional Classification provides a simple way of classifying the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity; the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina. NYHA I implies no limitations. NYHA II implies slight limitation of physical activity. NYHA III implies marked limitation of physical activity and finally, NYHA IV implies patients are Unable to carry on any physical activity without discomfort.|Participants|Count of Participants|40|40.0||||||
3887255|NCT01532921|3712168|B1||NYHA Class II|NYHA Class|The New York Heart Association (NYHA) Functional Classification provides a simple way of classifying the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity; the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina. NYHA I implies no limitations. NYHA II implies slight limitation of physical activity. NYHA III implies marked limitation of physical activity and finally, NYHA IV implies patients are Unable to carry on any physical activity without discomfort.|Participants|Count of Participants|23|23.0||||||
3887256|NCT01532921|3712168|B1||NYHA Class I|NYHA Class|The New York Heart Association (NYHA) Functional Classification provides a simple way of classifying the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity; the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina. NYHA I implies no limitations. NYHA II implies slight limitation of physical activity. NYHA III implies marked limitation of physical activity and finally, NYHA IV implies patients are Unable to carry on any physical activity without discomfort.|Participants|Count of Participants|4|4.0||||||
3887257|NCT01532921|3712168|B1|||EuroSCORE II percentage score|EuroSCORE II (European System for Cardiac Operative Risk Evaluation) is a risk model that allows the calculation of the risk of death after a heart operation. The higher the score, the higher the risk of death after surgery. The included risk factors are: age, gender, renal impairment, extracardiac arteriopathy, poor mobility, previous cardiac surgery, chronic lung disease, active endocarditis, critical preoperative state, diabetes on insulin, NYHA-class, CCS Class 4 Angina, Left ventricular function, recent myocardial infarction, pulmonary hypertension and 3 procedure-related factors.|percentage|Mean|8.7|8.7|Standard Deviation|9.4|9.4|||
3887258|NCT01532921|3712168|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3887259|NCT01532921|3712168|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3887260|NCT01532921|3712168|B1|||Age||years|Mean|72.2|72.2|Standard Deviation|7.2|7.2|||
3887261|NCT01532869|3712188|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3887262|NCT01532869|3712189|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3887263|NCT01532869|3712190|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3887264|NCT01532869|3712188|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3887265|NCT01532869|3712189|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3887266|NCT01532869|3712190|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3887267|NCT01532869|3712188|B3|||Age||years|Mean|49.6|49.6|Standard Deviation|12.3|12.3|||
3887268|NCT01532869|3712189|B2|||Age||years|Mean|51.2|51.2|Standard Deviation|11.7|11.7|||
3887269|NCT01532869|3712190|B1|||Age||years|Mean|48.1|48.1|Standard Deviation|12.9|12.9|||
3887270|NCT01532830|3712228|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3887271|NCT01532830|3712228|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3887272|NCT01532830|3712228|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3887273|NCT01532830|3712228|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3887274|NCT01532830|3712228|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3887275|NCT01532830|3712228|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3887276|NCT01532830|3712228|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3887277|NCT01532830|3712228|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3887278|NCT01532830|3712228|B1|||Age||years|Median|38.5|38.5|Full Range|||19.0|55.0|
3887279|NCT01532817|3712237|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3887280|NCT01532817|3712237|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3887281|NCT01532817|3712237|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3887282|NCT01532817|3712237|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3887283|NCT01532817|3712237|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3887284|NCT01532817|3712237|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3887285|NCT01532817|3712237|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3887286|NCT01532817|3712237|B1|Age||Age, Customized||years|Median|30|30.0|Full Range|||20.0|60.0|
3887287|NCT01532635|3712241|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3887288|NCT01532635|3712241|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887289|NCT01532635|3712241|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3887290|NCT01532635|3712241|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887291|NCT01532635|3712241|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887292|NCT01532635|3712241|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887293|NCT01532635|3712241|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3887294|NCT01532635|3712241|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887295|NCT01532635|3712241|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887296|NCT01532635|3712241|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887297|NCT01532635|3712241|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887298|NCT01532635|3712241|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3887299|NCT01532635|3712241|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3887300|NCT01532635|3712241|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3887301|NCT01532635|3712241|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3887302|NCT01532635|3712241|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3887303|NCT01532635|3712241|B1|||Age||years|Mean|50.35|50.35|Standard Deviation|20.64|20.64|||
3887304|NCT01532570|3712253|B5||Male|Gender||Participants|Count of Participants|10|10.0||||||
3887305|NCT01532570|3712254|B4||Male|Gender||Participants|Count of Participants|3|3.0||||||
3887306|NCT01532570|3712255|B3||Male|Gender||Participants|Count of Participants|1|1.0||||||
3887307|NCT01532570|3712256|B2||Male|Gender||Participants|Count of Participants|1|1.0||||||
3887308|NCT01532570|3712257|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
3887309|NCT01532570|3712253|B5||Female|Gender||Participants|Count of Participants|8|8.0||||||
3887310|NCT01532570|3712254|B4||Female|Gender||Participants|Count of Participants|1|1.0||||||
3887311|NCT01532570|3712255|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
3887312|NCT01532570|3712256|B2||Female|Gender||Participants|Count of Participants|1|1.0||||||
3887313|NCT01532570|3712257|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
3887314|NCT01532570|3712253|B5|||Age||years|Mean|37.6|37.6|Standard Deviation|11.4|11.4|||
3887315|NCT01532570|3712254|B4|||Age||years|Mean|44.0|44.0|Standard Deviation|2.9|2.9|||
3887316|NCT01532570|3712255|B3|||Age||years|Mean|47.0|47.0|Standard Deviation|NA||||There is no data because the Overall Number of Baseline Participant is 1.
3887317|NCT01532570|3712256|B2|||Age||years|Mean|34.0|34.0|Standard Deviation|5.7|5.7|||
3887318|NCT01532570|3712257|B1|||Age||years|Mean|35.0|35.0|Standard Deviation|13.4|13.4|||
3887319|NCT01532453|3712291|B3||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3887320|NCT01532453|3712292|B2||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3887321|NCT01532453|3712293|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3887322|NCT01532453|3712291|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3887323|NCT01532453|3712292|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3887324|NCT01532453|3712293|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3887325|NCT01532453|3712291|B3|||Age||years|Mean|62.59|62.59|Standard Deviation|9.075|9.075|||
3887326|NCT01532453|3712292|B2|||Age||years|Mean|62.29|62.29|Standard Deviation|8.875|8.875|||
3887327|NCT01532453|3712293|B1|||Age||years|Mean|63.20|63.2|Standard Deviation|9.483|9.483|||
3887328|NCT01532414|3712302|B4|||BMI||Kg/m^2|Mean|31.6|31.6|Standard Deviation|4.3|4.3|||
3887329|NCT01532414|3712303|B3|||BMI||Kg/m^2|Mean|31.3|31.3|Standard Deviation|3.8|3.8|||
3887330|NCT01532414|3712304|B2|||BMI||Kg/m^2|Mean|32.8|32.8|Standard Deviation|5.0|5.0|||
3887331|NCT01532414|3712305|B1|||BMI||Kg/m^2|Mean|31.5|31.5|Standard Deviation|4.3|4.3|||
3887332|NCT01532414|3712302|B4|United States||Region of Enrollment||participants|Number|151|151.0||||||
3887333|NCT01532414|3712303|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
3887334|NCT01532414|3712304|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
3887335|NCT01532414|3712305|B1|United States||Region of Enrollment||participants|Number|92|92.0||||||
3887336|NCT01532414|3712302|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887337|NCT01532414|3712303|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887338|NCT01532414|3712304|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887339|NCT01532414|3712305|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887340|NCT01532414|3712302|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887341|NCT01532414|3712303|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887342|NCT01532414|3712304|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887343|NCT01532414|3712305|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887344|NCT01532414|3712302|B4||White|Race (NIH/OMB)||Participants|Count of Participants|135|135.0||||||
3887345|NCT01532414|3712303|B3||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3887346|NCT01532414|3712304|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3887347|NCT01532414|3712305|B1||White|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3887348|NCT01532414|3712302|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3887349|NCT01532414|3712303|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887350|NCT01532414|3712304|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3887351|NCT01532414|3712305|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3887352|NCT01532414|3712302|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887353|NCT01532414|3712303|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887354|NCT01532414|3712304|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887355|NCT01532414|3712305|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887356|NCT01532414|3712302|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3887357|NCT01532414|3712303|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3887358|NCT01532414|3712304|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887359|NCT01532414|3712305|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3887360|NCT01532414|3712302|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887361|NCT01532414|3712303|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887362|NCT01532414|3712304|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887363|NCT01532414|3712305|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887364|NCT01532414|3712302|B4||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3887365|NCT01532414|3712303|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3887366|NCT01532414|3712304|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3887367|NCT01532414|3712305|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3887368|NCT01532414|3712302|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3887369|NCT01532414|3712303|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3887370|NCT01532414|3712304|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3887371|NCT01532414|3712305|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3887372|NCT01532414|3712302|B4|||Age||years|Mean|46.9|46.9|Standard Deviation|9.7|9.7|||
3887373|NCT01532414|3712303|B3|||Age||years|Mean|47.8|47.8|Standard Deviation|9.5|9.5|||
3887374|NCT01532414|3712304|B2|||Age||years|Mean|43.6|43.6|Standard Deviation|10.1|10.1|||
3887375|NCT01532414|3712305|B1|||Age||years|Mean|47.2|47.2|Standard Deviation|9.6|9.6|||
3887376|NCT01532362|3712315|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3887377|NCT01532362|3712317|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3887378|NCT01532362|3712315|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887379|NCT01532362|3712317|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887380|NCT01532362|3712315|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887381|NCT01532362|3712317|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887382|NCT01532362|3712315|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3887383|NCT01532362|3712317|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3887384|NCT01532362|3712315|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887385|NCT01532362|3712317|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887386|NCT01532362|3712315|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887387|NCT01532362|3712317|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887388|NCT01532362|3712315|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887389|NCT01532362|3712317|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887390|NCT01532362|3712315|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887453|NCT01532128|3712355|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3887391|NCT01532362|3712317|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887392|NCT01532362|3712315|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3887393|NCT01532362|3712317|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3887394|NCT01532362|3712315|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3887395|NCT01532362|3712317|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3887396|NCT01532362|3712315|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3887397|NCT01532362|3712317|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3887398|NCT01532362|3712315|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3887399|NCT01532362|3712317|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3887400|NCT01532362|3712315|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3887401|NCT01532362|3712317|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3887402|NCT01532349|3712324|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
3887403|NCT01532349|3712325|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3887404|NCT01532349|3712326|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3887405|NCT01532349|3712324|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3887406|NCT01532349|3712325|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3887407|NCT01532349|3712326|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3887408|NCT01532349|3712324|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3887409|NCT01532349|3712325|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3887410|NCT01532349|3712326|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3887411|NCT01532349|3712324|B3|||Age||years|Mean|10.9|10.9|Standard Deviation|5.8|5.8|||
3887412|NCT01532349|3712325|B2|||Age||years|Mean|10.8|10.8|Standard Deviation|5.5|5.5|||
3887413|NCT01532349|3712326|B1|||Age||years|Mean|10.9|10.9|Standard Deviation|6.3|6.3|||
3887414|NCT01532349|3712324|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3887415|NCT01532349|3712325|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3887416|NCT01532349|3712326|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3887417|NCT01532349|3712324|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3887418|NCT01532349|3712325|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3887419|NCT01532349|3712326|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3887420|NCT01532349|3712324|B3||<=18 years|Age||Participants|Count of Participants|28|28.0||||||
3887421|NCT01532349|3712325|B2||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
3887422|NCT01532349|3712326|B1||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
3887423|NCT01532141|3712333|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3887424|NCT01532141|3712334|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3887425|NCT01532141|3712335|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3887426|NCT01532141|3712336|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3887427|NCT01532141|3712333|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3887428|NCT01532141|3712334|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3887429|NCT01532141|3712335|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3887430|NCT01532141|3712336|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3887431|NCT01532141|3712333|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3887432|NCT01532141|3712334|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3887433|NCT01532141|3712335|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3887434|NCT01532141|3712336|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3887435|NCT01532141|3712333|B4||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3887436|NCT01532141|3712334|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3887437|NCT01532141|3712335|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3887438|NCT01532141|3712336|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3887439|NCT01532141|3712333|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3887440|NCT01532141|3712334|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3887441|NCT01532141|3712335|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3887442|NCT01532141|3712336|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3887443|NCT01532128|3712353|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3887444|NCT01532128|3712354|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3887445|NCT01532128|3712355|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3887446|NCT01532128|3712356|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3887447|NCT01532128|3712353|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3887448|NCT01532128|3712354|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3887449|NCT01532128|3712355|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3887450|NCT01532128|3712356|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3887451|NCT01532128|3712353|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3887452|NCT01532128|3712354|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3887454|NCT01532128|3712356|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3887455|NCT01532128|3712353|B4||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3887456|NCT01532128|3712354|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3887457|NCT01532128|3712355|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3887458|NCT01532128|3712356|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3887459|NCT01532128|3712353|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3887460|NCT01532128|3712354|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3887461|NCT01532128|3712355|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3887462|NCT01532128|3712356|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3887463|NCT01531998|3712373|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3887464|NCT01531998|3712373|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3887465|NCT01531998|3712373|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3887466|NCT01531998|3712373|B1|||Age||years|Median|62|62.0|Full Range|||47.0|73.0|
3887467|NCT01531725|3712378|B1|Germany||Region of Enrollment||participants|Number|38|38.0||||||
3887468|NCT01531725|3712378|B1|Netherlands||Region of Enrollment||participants|Number|76|76.0||||||
3887469|NCT01531725|3712378|B1|Belgium||Region of Enrollment||participants|Number|83|83.0||||||
3887470|NCT01531725|3712378|B1||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3887471|NCT01531725|3712378|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3887472|NCT01531725|3712378|B1|||Age||years|Mean|64.2|64.2|Standard Deviation|11.0|11.0|||
3887473|NCT01531725|3712378|B1||>=65 years|Age||Participants|Count of Participants|100|100.0||||||
3887474|NCT01531725|3712378|B1||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
3887475|NCT01531725|3712378|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3887476|NCT01531673|3712383|B14||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3887477|NCT01531673|3712384|B13||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3887478|NCT01531673|3712385|B12||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3887479|NCT01531673|3712386|B11||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3887480|NCT01531673|3712387|B10||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3887481|NCT01531673|3712388|B9||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3887482|NCT01531673|3712389|B8||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3887483|NCT01531673|3712390|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3887484|NCT01531673|3712391|B6||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3887485|NCT01531673|3712392|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3887486|NCT01531673|3712393|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3887487|NCT01531673|3712394|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3887488|NCT01531673|3712395|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3887489|NCT01531673|3712396|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3887490|NCT01531673|3712383|B14||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3887491|NCT01531673|3712384|B13||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3887492|NCT01531673|3712385|B12||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3887493|NCT01531673|3712386|B11||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3887494|NCT01531673|3712387|B10||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3887495|NCT01531673|3712388|B9||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3887496|NCT01531673|3712389|B8||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3887497|NCT01531673|3712390|B7||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3887498|NCT01531673|3712391|B6||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3887499|NCT01531673|3712392|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3887500|NCT01531673|3712393|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3887501|NCT01531673|3712394|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3887502|NCT01531673|3712395|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3887503|NCT01531673|3712396|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3887504|NCT01531673|3712383|B14|||Age||years|Mean|29.8|29.8|Standard Deviation|7.97|7.97|||
3887505|NCT01531673|3712384|B13|||Age||years|Mean|26.6|26.6|Standard Deviation|7.01|7.01|||
3887506|NCT01531673|3712385|B12|||Age||years|Mean|34.5|34.5|Standard Deviation|7.59|7.59|||
3887507|NCT01531673|3712386|B11|||Age||years|Mean|32.8|32.8|Standard Deviation|11.92|11.92|||
3887508|NCT01531673|3712387|B10|||Age||years|Mean|27.9|27.9|Standard Deviation|5.58|5.58|||
3887509|NCT01531673|3712388|B9|||Age||years|Mean|28.2|28.2|Standard Deviation|6.46|6.46|||
3887510|NCT01531673|3712389|B8|||Age||years|Mean|28.2|28.2|Standard Deviation|8.6|8.6|||
3887511|NCT01531673|3712390|B7|||Age||years|Mean|31|31.0|Standard Deviation|9.3|9.3|||
3887512|NCT01531673|3712391|B6|||Age||years|Mean|29.2|29.2|Standard Deviation|6.39|6.39|||
3887513|NCT01531673|3712392|B5|||Age||years|Mean|29.1|29.1|Standard Deviation|7.12|7.12|||
3887514|NCT01531673|3712393|B4|||Age||years|Mean|28.3|28.3|Standard Deviation|7.05|7.05|||
3887515|NCT01531673|3712394|B3|||Age||years|Mean|30.8|30.8|Standard Deviation|6.63|6.63|||
3887516|NCT01531673|3712395|B2|||Age||years|Mean|35.3|35.3|Standard Deviation|8.26|8.26|||
3887517|NCT01531673|3712396|B1|||Age||years|Mean|30.7|30.7|Standard Deviation|8.42|8.42|||
3887518|NCT01531387|3712517|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3887519|NCT01531387|3712518|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3887520|NCT01531387|3712519|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3887521|NCT01531387|3712517|B3|Brazil||Region of Enrollment||participants|Number|5|5.0||||||
3887522|NCT01531387|3712518|B2|Brazil||Region of Enrollment||participants|Number|3|3.0||||||
3887523|NCT01531387|3712519|B1|Brazil||Region of Enrollment||participants|Number|2|2.0||||||
3887524|NCT01531387|3712517|B3|Jamaica||Region of Enrollment||participants|Number|13|13.0||||||
3887525|NCT01531387|3712518|B2|Jamaica||Region of Enrollment||participants|Number|6|6.0||||||
3887526|NCT01531387|3712519|B1|Jamaica||Region of Enrollment||participants|Number|7|7.0||||||
3887527|NCT01531387|3712517|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3887528|NCT01531387|3712518|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3887529|NCT01531387|3712519|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3887530|NCT01531387|3712517|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3887531|NCT01531387|3712518|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3887532|NCT01531387|3712519|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3887533|NCT01531387|3712517|B3|||Age||Years|Mean|6.15|6.15|Standard Deviation|1.95|1.95|||
3887534|NCT01531387|3712518|B2|||Age||Years|Mean|6|6.0|Standard Deviation|2.4|2.4|||
3887535|NCT01531387|3712519|B1|||Age||Years|Mean|6.3|6.3|Standard Deviation|1.5|1.5|||
3887536|NCT01531387|3712517|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3887537|NCT01531387|3712518|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3887538|NCT01531387|3712519|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3887539|NCT01531387|3712517|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3887540|NCT01531387|3712518|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3887541|NCT01531387|3712519|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3887542|NCT01531387|3712517|B3||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
3887543|NCT01531387|3712518|B2||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
3887544|NCT01531387|3712519|B1||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
3887545|NCT01531374|3712534|B4|||Logistic European System for Cardiac Operative Risk Evaluation (EuroSCORE)|The European System for Cardiac Operative Risk Evaluation (EuroSCORE) is a method of calculating predicted operative mortality for patients undergoing cardiac surgery. If a risk factor is present, a weight/number is assigned. The weights are added to give an approximate percent of predicted mortality. A higher score indicates a higher risk. A lower score indicates a lower risk.|Percent of predicted mortality|Mean|22.6|22.6|Standard Deviation|15.9|15.9|||
3887546|NCT01531374|3712535|B3|||Logistic European System for Cardiac Operative Risk Evaluation (EuroSCORE)|The European System for Cardiac Operative Risk Evaluation (EuroSCORE) is a method of calculating predicted operative mortality for patients undergoing cardiac surgery. If a risk factor is present, a weight/number is assigned. The weights are added to give an approximate percent of predicted mortality. A higher score indicates a higher risk. A lower score indicates a lower risk.|Percent of predicted mortality|Mean|20.3|20.3|Standard Deviation|13.5|13.5|||
3887547|NCT01531374|3712536|B2|||Logistic European System for Cardiac Operative Risk Evaluation (EuroSCORE)|The European System for Cardiac Operative Risk Evaluation (EuroSCORE) is a method of calculating predicted operative mortality for patients undergoing cardiac surgery. If a risk factor is present, a weight/number is assigned. The weights are added to give an approximate percent of predicted mortality. A higher score indicates a higher risk. A lower score indicates a lower risk.|Percent of predicted mortality|Mean|24.2|24.2|Standard Deviation|17.1|17.1|||
3887548|NCT01531374|3712537|B1|||Logistic European System for Cardiac Operative Risk Evaluation (EuroSCORE)|The European System for Cardiac Operative Risk Evaluation (EuroSCORE) is a method of calculating predicted operative mortality for patients undergoing cardiac surgery. If a risk factor is present, a weight/number is assigned. The weights are added to give an approximate percent of predicted mortality. A higher score indicates a higher risk. A lower score indicates a lower risk.|Percent of predicted mortality|Mean|24.2|24.2|Standard Deviation|17.1|17.1|||
3887549|NCT01531374|3712534|B4|||Society of Thoracic Surgeons (STS) Risk Score|The Society of Thoracic Surgeons (STS) risk model predicts the risk of operative mortality and morbidity after adult cardiac surgery on the basis of patient demographic and clinical variables. After information has been entered on a given case, the online STS risk calculator provides a risk percentage for each of the outcomes. The risk percentage estimates the chance of a specific outcome for a patient with the indicated risk factors. A higher score indicates a higher risk. A lower score indicates a lower risk.|Percent of predicted mortality|Mean|8.7|8.7|Standard Deviation|4.6|4.6|||
3887550|NCT01531374|3712535|B3|||Society of Thoracic Surgeons (STS) Risk Score|The Society of Thoracic Surgeons (STS) risk model predicts the risk of operative mortality and morbidity after adult cardiac surgery on the basis of patient demographic and clinical variables. After information has been entered on a given case, the online STS risk calculator provides a risk percentage for each of the outcomes. The risk percentage estimates the chance of a specific outcome for a patient with the indicated risk factors. A higher score indicates a higher risk. A lower score indicates a lower risk.|Percent of predicted mortality|Mean|7.7|7.7|Standard Deviation|3.3|3.3|||
3887551|NCT01531374|3712536|B2|||Society of Thoracic Surgeons (STS) Risk Score|The Society of Thoracic Surgeons (STS) risk model predicts the risk of operative mortality and morbidity after adult cardiac surgery on the basis of patient demographic and clinical variables. After information has been entered on a given case, the online STS risk calculator provides a risk percentage for each of the outcomes. The risk percentage estimates the chance of a specific outcome for a patient with the indicated risk factors. A higher score indicates a higher risk. A lower score indicates a lower risk.|Percent of predicted mortality|Mean|10.2|10.2|Standard Deviation|5.6|5.6|||
3887552|NCT01531374|3712537|B1|||Society of Thoracic Surgeons (STS) Risk Score|The Society of Thoracic Surgeons (STS) risk model predicts the risk of operative mortality and morbidity after adult cardiac surgery on the basis of patient demographic and clinical variables. After information has been entered on a given case, the online STS risk calculator provides a risk percentage for each of the outcomes. The risk percentage estimates the chance of a specific outcome for a patient with the indicated risk factors. A higher score indicates a higher risk. A lower score indicates a lower risk.|Percent of predicted mortality|Mean|9.1|9.1|Standard Deviation|5.1|5.1|||
3887553|NCT01531374|3712534|B4|NYHA Classification IV||New York Heart Association (NYHA) Classification|"NYHA Classification:~Class I: Subjects with cardiac disease but without resulting limitations of physical activity.~Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.~Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.~Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort."|participants|Number|408|408.0||||||
3887554|NCT01531374|3712535|B3|NYHA Classification IV||New York Heart Association (NYHA) Classification|"NYHA Classification:~Class I: Subjects with cardiac disease but without resulting limitations of physical activity.~Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.~Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.~Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort."|participants|Number|117|117.0||||||
3887555|NCT01531374|3712536|B2|NYHA Classification IV||New York Heart Association (NYHA) Classification|"NYHA Classification:~Class I: Subjects with cardiac disease but without resulting limitations of physical activity.~Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.~Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.~Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort."|participants|Number|74|74.0||||||
3887556|NCT01531374|3712537|B1|NYHA Classification IV||New York Heart Association (NYHA) Classification|"NYHA Classification:~Class I: Subjects with cardiac disease but without resulting limitations of physical activity.~Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.~Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.~Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort."|participants|Number|217|217.0||||||
3887557|NCT01531374|3712534|B4|NYHA Classification III||New York Heart Association (NYHA) Classification|"NYHA Classification:~Class I: Subjects with cardiac disease but without resulting limitations of physical activity.~Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.~Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.~Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort."|participants|Number|1940|1940.0||||||
3887558|NCT01531374|3712535|B3|NYHA Classification III||New York Heart Association (NYHA) Classification|"NYHA Classification:~Class I: Subjects with cardiac disease but without resulting limitations of physical activity.~Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.~Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.~Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort."|participants|Number|811|811.0||||||
3887559|NCT01531374|3712536|B2|NYHA Classification III||New York Heart Association (NYHA) Classification|"NYHA Classification:~Class I: Subjects with cardiac disease but without resulting limitations of physical activity.~Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.~Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.~Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort."|participants|Number|248|248.0||||||
3887560|NCT01531374|3712537|B1|NYHA Classification III||New York Heart Association (NYHA) Classification|"NYHA Classification:~Class I: Subjects with cardiac disease but without resulting limitations of physical activity.~Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.~Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.~Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort."|participants|Number|881|881.0||||||
3887561|NCT01531374|3712534|B4|NYHA Classification II||New York Heart Association (NYHA) Classification|"NYHA Classification:~Class I: Subjects with cardiac disease but without resulting limitations of physical activity.~Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.~Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.~Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort."|participants|Number|384|384.0||||||
3887562|NCT01531374|3712535|B3|NYHA Classification II||New York Heart Association (NYHA) Classification|"NYHA Classification:~Class I: Subjects with cardiac disease but without resulting limitations of physical activity.~Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.~Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.~Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort."|participants|Number|180|180.0||||||
3887563|NCT01531374|3712536|B2|NYHA Classification II||New York Heart Association (NYHA) Classification|"NYHA Classification:~Class I: Subjects with cardiac disease but without resulting limitations of physical activity.~Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.~Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.~Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort."|participants|Number|45|45.0||||||
3887564|NCT01531374|3712537|B1|NYHA Classification II||New York Heart Association (NYHA) Classification|"NYHA Classification:~Class I: Subjects with cardiac disease but without resulting limitations of physical activity.~Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.~Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.~Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort."|participants|Number|159|159.0||||||
3887594|NCT01531374|3712535|B3|||Age|Participant Population= Consisted of all subjects with an attempted implant procedure.|years|Mean|83.6|83.6|Standard Deviation|7.1|7.1|||
3887655|NCT01531153|3712623|B2|Working||Employment||Participants|Count of Participants|6|6.0||||||
3887565|NCT01531374|3712534|B4|NYHA Classification I||New York Heart Association (NYHA) Classification|"NYHA Classification:~Class I: Subjects with cardiac disease but without resulting limitations of physical activity.~Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.~Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.~Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort."|participants|Number|0|0.0||||||
3887566|NCT01531374|3712535|B3|NYHA Classification I||New York Heart Association (NYHA) Classification|"NYHA Classification:~Class I: Subjects with cardiac disease but without resulting limitations of physical activity.~Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.~Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.~Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort."|participants|Number|0|0.0||||||
3887567|NCT01531374|3712536|B2|NYHA Classification I||New York Heart Association (NYHA) Classification|"NYHA Classification:~Class I: Subjects with cardiac disease but without resulting limitations of physical activity.~Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.~Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.~Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort."|participants|Number|0|0.0||||||
3887568|NCT01531374|3712537|B1|NYHA Classification I||New York Heart Association (NYHA) Classification|"NYHA Classification:~Class I: Subjects with cardiac disease but without resulting limitations of physical activity.~Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.~Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.~Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort."|participants|Number|0|0.0||||||
3887569|NCT01531374|3712534|B4|||Body Surface Area|Participant Population= Consisted of all subjects with an attempted implant procedure.|m^2|Mean|1.9|1.9|Standard Deviation|0.3|0.3|||
3887570|NCT01531374|3712535|B3|||Body Surface Area|Participant Population= Consisted of all subjects with an attempted implant procedure.|m^2|Mean|1.9|1.9|Standard Deviation|0.2|0.2|||
3887571|NCT01531374|3712536|B2|||Body Surface Area|Participant Population= Consisted of all subjects with an attempted implant procedure.|m^2|Mean|1.8|1.8|Standard Deviation|0.3|0.3|||
3887572|NCT01531374|3712537|B1|||Body Surface Area|Participant Population= Consisted of all subjects with an attempted implant procedure.|m^2|Mean|1.9|1.9|Standard Deviation|0.3|0.3|||
3887573|NCT01531374|3712534|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)|Participant Population= Consisted of all subjects with an attempted implant procedure.|Participants|Count of Participants|31|31.0||||||
3887574|NCT01531374|3712535|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)|Participant Population= Consisted of all subjects with an attempted implant procedure.|Participants|Count of Participants|14|14.0||||||
3887575|NCT01531374|3712536|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)|Participant Population= Consisted of all subjects with an attempted implant procedure.|Participants|Count of Participants|3|3.0||||||
3887576|NCT01531374|3712537|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|Participant Population= Consisted of all subjects with an attempted implant procedure.|Participants|Count of Participants|14|14.0||||||
3887577|NCT01531374|3712534|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Participant Population= Consisted of all subjects with an attempted implant procedure.|Participants|Count of Participants|2622|2622.0||||||
3887578|NCT01531374|3712535|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Participant Population= Consisted of all subjects with an attempted implant procedure.|Participants|Count of Participants|1056|1056.0||||||
3887579|NCT01531374|3712536|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Participant Population= Consisted of all subjects with an attempted implant procedure.|Participants|Count of Participants|360|360.0||||||
3887580|NCT01531374|3712537|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Participant Population= Consisted of all subjects with an attempted implant procedure.|Participants|Count of Participants|1206|1206.0||||||
3887581|NCT01531374|3712534|B4||Hispanic or Latino|Ethnicity (NIH/OMB)|Participant Population= Consisted of all subjects with an attempted implant procedure.|Participants|Count of Participants|79|79.0||||||
3887582|NCT01531374|3712535|B3||Hispanic or Latino|Ethnicity (NIH/OMB)|Participant Population= Consisted of all subjects with an attempted implant procedure.|Participants|Count of Participants|38|38.0||||||
3887583|NCT01531374|3712536|B2||Hispanic or Latino|Ethnicity (NIH/OMB)|Participant Population= Consisted of all subjects with an attempted implant procedure.|Participants|Count of Participants|4|4.0||||||
3887584|NCT01531374|3712537|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|Participant Population= Consisted of all subjects with an attempted implant procedure.|Participants|Count of Participants|37|37.0||||||
3887585|NCT01531374|3712534|B4||Male|Sex: Female, Male|Participant Population= Consisted of all subjects with an attempted implant procedure.|Participants|Count of Participants|1523|1523.0||||||
3887586|NCT01531374|3712535|B3||Male|Sex: Female, Male|Participant Population= Consisted of all subjects with an attempted implant procedure.|Participants|Count of Participants|652|652.0||||||
3887587|NCT01531374|3712536|B2||Male|Sex: Female, Male|Participant Population= Consisted of all subjects with an attempted implant procedure.|Participants|Count of Participants|182|182.0||||||
3887588|NCT01531374|3712537|B1||Male|Sex: Female, Male|Participant Population= Consisted of all subjects with an attempted implant procedure.|Participants|Count of Participants|689|689.0||||||
3887589|NCT01531374|3712534|B4||Female|Sex: Female, Male|Participant Population= Consisted of all subjects with an attempted implant procedure.|Participants|Count of Participants|1209|1209.0||||||
3887590|NCT01531374|3712535|B3||Female|Sex: Female, Male|Participant Population= Consisted of all subjects with an attempted implant procedure.|Participants|Count of Participants|456|456.0||||||
3887591|NCT01531374|3712536|B2||Female|Sex: Female, Male|Participant Population= Consisted of all subjects with an attempted implant procedure.|Participants|Count of Participants|185|185.0||||||
3887592|NCT01531374|3712537|B1||Female|Sex: Female, Male|Participant Population= Consisted of all subjects with an attempted implant procedure.|Participants|Count of Participants|568|568.0||||||
3887593|NCT01531374|3712534|B4|||Age|Participant Population= Consisted of all subjects with an attempted implant procedure.|years|Mean|83.3|83.3|Standard Deviation|7.7|7.7|||
3887595|NCT01531374|3712536|B2|||Age|Participant Population= Consisted of all subjects with an attempted implant procedure.|years|Mean|81.9|81.9|Standard Deviation|8.2|8.2|||
3887596|NCT01531374|3712537|B1|||Age|Participant Population= Consisted of all subjects with an attempted implant procedure.|years|Mean|83.5|83.5|Standard Deviation|8.1|8.1|||
3887597|NCT01531335|3712601|B3|Colombia||Region of Enrollment||participants|Number|80|80.0||||||
3887598|NCT01531335|3712602|B2|Colombia||Region of Enrollment||participants|Number|40|40.0||||||
3887599|NCT01531335|3712603|B1|Colombia||Region of Enrollment||participants|Number|40|40.0||||||
3887600|NCT01531335|3712601|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3887601|NCT01531335|3712602|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3887602|NCT01531335|3712603|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3887603|NCT01531335|3712601|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3887604|NCT01531335|3712602|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3887605|NCT01531335|3712603|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3887606|NCT01531335|3712601|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3887607|NCT01531335|3712602|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3887608|NCT01531335|3712603|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3887609|NCT01531335|3712601|B3||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
3887610|NCT01531335|3712602|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3887611|NCT01531335|3712603|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3887612|NCT01531335|3712601|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3887613|NCT01531335|3712602|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3887614|NCT01531335|3712603|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3887615|NCT01531335|3712601|B3|||Age||years|Mean|54.5|54.5|Standard Deviation|19.5|19.5|||
3887616|NCT01531335|3712602|B2|||Age||years|Mean|53.3|53.3|Standard Deviation|19.5|19.5|||
3887617|NCT01531335|3712603|B1|||Age||years|Mean|55.7|55.7|Standard Deviation|19.5|19.5|||
3887618|NCT01531205|3712612|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3887619|NCT01531205|3712612|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3887620|NCT01531205|3712612|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3887621|NCT01531205|3712612|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3887622|NCT01531205|3712612|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3887623|NCT01531205|3712612|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3887624|NCT01531205|3712612|B1|||Age||years|Mean|69|69.0|Full Range|||68.0|70.0|
3887625|NCT01531153|3712621|B4|Marijuana||Baseline Urine Positive||Participants|Count of Participants|18|18.0||||||
3887626|NCT01531153|3712622|B3|Marijuana||Baseline Urine Positive||Participants|Count of Participants|4|4.0||||||
3887627|NCT01531153|3712623|B2|Marijuana||Baseline Urine Positive||Participants|Count of Participants|10|10.0||||||
3887628|NCT01531153|3712624|B1|Marijuana||Baseline Urine Positive||Participants|Count of Participants|4|4.0||||||
3887629|NCT01531153|3712621|B4|Benzodiazepines||Baseline Urine Positive||Participants|Count of Participants|2|2.0||||||
3887630|NCT01531153|3712622|B3|Benzodiazepines||Baseline Urine Positive||Participants|Count of Participants|0|0.0||||||
3887631|NCT01531153|3712623|B2|Benzodiazepines||Baseline Urine Positive||Participants|Count of Participants|1|1.0||||||
3887632|NCT01531153|3712624|B1|Benzodiazepines||Baseline Urine Positive||Participants|Count of Participants|1|1.0||||||
3887633|NCT01531153|3712621|B4|Cocaine||Baseline Urine Positive||Participants|Count of Participants|79|79.0||||||
3887634|NCT01531153|3712622|B3|Cocaine||Baseline Urine Positive||Participants|Count of Participants|27|27.0||||||
3887635|NCT01531153|3712623|B2|Cocaine||Baseline Urine Positive||Participants|Count of Participants|23|23.0||||||
3887636|NCT01531153|3712624|B1|Cocaine||Baseline Urine Positive||Participants|Count of Participants|29|29.0||||||
3887637|NCT01531153|3712621|B4|Less than High School||Education||Participants|Count of Participants|25|25.0||||||
3887638|NCT01531153|3712622|B3|Less than High School||Education||Participants|Count of Participants|6|6.0||||||
3887639|NCT01531153|3712623|B2|Less than High School||Education||Participants|Count of Participants|11|11.0||||||
3887640|NCT01531153|3712624|B1|Less than High School||Education||Participants|Count of Participants|8|8.0||||||
3887641|NCT01531153|3712621|B4|High School||Education||Participants|Count of Participants|48|48.0||||||
3887642|NCT01531153|3712622|B3|High School||Education||Participants|Count of Participants|16|16.0||||||
3887643|NCT01531153|3712623|B2|High School||Education||Participants|Count of Participants|17|17.0||||||
3887644|NCT01531153|3712624|B1|High School||Education||Participants|Count of Participants|15|15.0||||||
3887645|NCT01531153|3712621|B4|Some College or More||Education||Participants|Count of Participants|20|20.0||||||
3887646|NCT01531153|3712622|B3|Some College or More||Education||Participants|Count of Participants|8|8.0||||||
3887647|NCT01531153|3712623|B2|Some College or More||Education||Participants|Count of Participants|3|3.0||||||
3887648|NCT01531153|3712624|B1|Some College or More||Education||Participants|Count of Participants|9|9.0||||||
3887649|NCT01531153|3712621|B4|Not Working||Employment||Participants|Count of Participants|69|69.0||||||
3887650|NCT01531153|3712622|B3|Not Working||Employment||Participants|Count of Participants|20|20.0||||||
3887651|NCT01531153|3712623|B2|Not Working||Employment||Participants|Count of Participants|25|25.0||||||
3887652|NCT01531153|3712624|B1|Not Working||Employment||Participants|Count of Participants|24|24.0||||||
3887653|NCT01531153|3712621|B4|Working||Employment||Participants|Count of Participants|21|21.0||||||
3887654|NCT01531153|3712622|B3|Working||Employment||Participants|Count of Participants|8|8.0||||||
3887656|NCT01531153|3712624|B1|Working||Employment||Participants|Count of Participants|7|7.0||||||
3887657|NCT01531153|3712621|B4|Not Married||Marital Status||Participants|Count of Participants|14|14.0||||||
3887658|NCT01531153|3712622|B3|Not Married||Marital Status||Participants|Count of Participants|6|6.0||||||
3887659|NCT01531153|3712623|B2|Not Married||Marital Status||Participants|Count of Participants|5|5.0||||||
3887660|NCT01531153|3712624|B1|Not Married||Marital Status||Participants|Count of Participants|3|3.0||||||
3887661|NCT01531153|3712621|B4|Married||Marital Status||Participants|Count of Participants|79|79.0||||||
3887662|NCT01531153|3712622|B3|Married||Marital Status||Participants|Count of Participants|24|24.0||||||
3887663|NCT01531153|3712623|B2|Married||Marital Status||Participants|Count of Participants|26|26.0||||||
3887664|NCT01531153|3712624|B1|Married||Marital Status||Participants|Count of Participants|29|29.0||||||
3887665|NCT01531153|3712621|B4|United States||Region of Enrollment||Participants|Count of Participants|93|93.0||||||
3887666|NCT01531153|3712622|B3|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3887667|NCT01531153|3712623|B2|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3887668|NCT01531153|3712624|B1|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3887669|NCT01531153|3712621|B4|Multiracial||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3887670|NCT01531153|3712622|B3|Multiracial||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3887671|NCT01531153|3712623|B2|Multiracial||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3887672|NCT01531153|3712624|B1|Multiracial||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3887673|NCT01531153|3712621|B4|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3887674|NCT01531153|3712622|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3887675|NCT01531153|3712623|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3887676|NCT01531153|3712624|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3887677|NCT01531153|3712621|B4|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3887678|NCT01531153|3712622|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3887679|NCT01531153|3712623|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3887680|NCT01531153|3712624|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3887681|NCT01531153|3712621|B4|African American||Race/Ethnicity, Customized||Participants|Count of Participants|62|62.0||||||
3887682|NCT01531153|3712622|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3887683|NCT01531153|3712623|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3887684|NCT01531153|3712624|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3887685|NCT01531153|3712621|B4||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3887686|NCT01531153|3712622|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3887687|NCT01531153|3712623|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3887688|NCT01531153|3712624|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3887689|NCT01531153|3712621|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3887690|NCT01531153|3712622|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3887691|NCT01531153|3712623|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3887692|NCT01531153|3712624|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3887693|NCT01531153|3712621|B4|||Age||years|Mean|46.3|46.3|Standard Deviation|7.6|7.6|||
3887694|NCT01531153|3712622|B3|||Age||years|Mean|43.3|43.3|Standard Deviation|8.3|8.3|||
3887695|NCT01531153|3712623|B2|||Age||years|Mean|47.4|47.4|Standard Deviation|6.8|6.8|||
3887696|NCT01531153|3712624|B1|||Age||years|Mean|48.1|48.1|Standard Deviation|7.2|7.2|||
3887697|NCT01530997|3712682|B1||HPV-/p16+|HPV/p16 Status|Human papilloma virus (HPV) is a common virus that can cause cancer. p16 is a tumor suppression gene that acts as a cyclin-dependent kinase inhibitor. HPV-related cancers with p16 overexpression (p16+) have a better prognosis than those not related to HPV due to an increased sensitivity to radiotherapy.|Participants|Count of Participants|16|16.0||||||
3887698|NCT01530997|3712682|B1||HPV+/p16+|HPV/p16 Status|Human papilloma virus (HPV) is a common virus that can cause cancer. p16 is a tumor suppression gene that acts as a cyclin-dependent kinase inhibitor. HPV-related cancers with p16 overexpression (p16+) have a better prognosis than those not related to HPV due to an increased sensitivity to radiotherapy.|Participants|Count of Participants|28|28.0||||||
3887699|NCT01530997|3712682|B1||N2c|N Stage|The Classification of Malignant Tumours (TNM) system is the most widely used cancer staging system. The T refers to the size and extent of the main tumor. N refers to the regional lymph nodes. N0 means there is no cancer in nearby lymph nodes. The larger the number following N means the more lymph nodes that contain cancer.|Participants|Count of Participants|7|7.0||||||
3887700|NCT01530997|3712682|B1||N2b|N Stage|The Classification of Malignant Tumours (TNM) system is the most widely used cancer staging system. The T refers to the size and extent of the main tumor. N refers to the regional lymph nodes. N0 means there is no cancer in nearby lymph nodes. The larger the number following N means the more lymph nodes that contain cancer.|Participants|Count of Participants|21|21.0||||||
3887701|NCT01530997|3712682|B1||N2a|N Stage|The Classification of Malignant Tumours (TNM) system is the most widely used cancer staging system. The T refers to the size and extent of the main tumor. N refers to the regional lymph nodes. N0 means there is no cancer in nearby lymph nodes. The larger the number following N means the more lymph nodes that contain cancer.|Participants|Count of Participants|2|2.0||||||
3887748|NCT01530477|3712714|B3||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
3887702|NCT01530997|3712682|B1||N1|N Stage|The Classification of Malignant Tumours (TNM) system is the most widely used cancer staging system. The T refers to the size and extent of the main tumor. N refers to the regional lymph nodes. N0 means there is no cancer in nearby lymph nodes. The larger the number following N means the more lymph nodes that contain cancer.|Participants|Count of Participants|10|10.0||||||
3887703|NCT01530997|3712682|B1||N0|N Stage|The Classification of Malignant Tumours (TNM) system is the most widely used cancer staging system. The T refers to the size and extent of the main tumor. N refers to the regional lymph nodes. N0 means there is no cancer in nearby lymph nodes. The larger the number following N means the more lymph nodes that contain cancer.|Participants|Count of Participants|4|4.0||||||
3887704|NCT01530997|3712682|B1||T3|T Stage|The Classification of Malignant Tumours (TNM) system is the most widely used cancer staging system. The T refers to the size and extent of the main tumor. N refers to the regional lymph nodes. N0 means there is no cancer in nearby lymph nodes. The larger the number following N means the more lymph nodes that contain cancer.|Participants|Count of Participants|7|7.0||||||
3887705|NCT01530997|3712682|B1||T2|T Stage|The Classification of Malignant Tumours (TNM) system is the most widely used cancer staging system. The T refers to the size and extent of the main tumor. N refers to the regional lymph nodes. N0 means there is no cancer in nearby lymph nodes. The larger the number following N means the more lymph nodes that contain cancer.|Participants|Count of Participants|22|22.0||||||
3887706|NCT01530997|3712682|B1||T1|T Stage|The Classification of Malignant Tumours (TNM) system is the most widely used cancer staging system. The T refers to the size and extent of the main tumor. N refers to the regional lymph nodes. N0 means there is no cancer in nearby lymph nodes. The larger the number following N means the more lymph nodes that contain cancer.|Participants|Count of Participants|13|13.0||||||
3887707|NCT01530997|3712682|B1||T0|T Stage|The Classification of Malignant Tumours (TNM) system is the most widely used cancer staging system. The T refers to the size and extent of the main tumor. N refers to the regional lymph nodes. N0 means there is no cancer in nearby lymph nodes. The larger the number following N means the more lymph nodes that contain cancer.|Participants|Count of Participants|2|2.0||||||
3887708|NCT01530997|3712682|B1||Unknown Primary|Primary Tumor Location||Participants|Count of Participants|2|2.0||||||
3887709|NCT01530997|3712682|B1||Base of Tongue|Primary Tumor Location||Participants|Count of Participants|26|26.0||||||
3887710|NCT01530997|3712682|B1||Tonsil|Primary Tumor Location||Participants|Count of Participants|16|16.0||||||
3887711|NCT01530997|3712682|B1||> 10 Pack Years|Tobacco Use||Participants|Count of Participants|2|2.0||||||
3887712|NCT01530997|3712682|B1||<=10 Pack Years|Tobacco Use||Participants|Count of Participants|6|6.0||||||
3887713|NCT01530997|3712682|B1||Never Smoker|Tobacco Use||Participants|Count of Participants|36|36.0||||||
3887714|NCT01530997|3712682|B1||Unmarried|Marital Status||Participants|Count of Participants|10|10.0||||||
3887715|NCT01530997|3712682|B1||Married|Marital Status||Participants|Count of Participants|34|34.0||||||
3887716|NCT01530997|3712682|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
3887717|NCT01530997|3712682|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887718|NCT01530997|3712682|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887719|NCT01530997|3712682|B1||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3887720|NCT01530997|3712682|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3887721|NCT01530997|3712682|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887722|NCT01530997|3712682|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887723|NCT01530997|3712682|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887724|NCT01530997|3712682|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3887725|NCT01530997|3712682|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3887726|NCT01530997|3712682|B1|||Age||years|Mean|61|61.0|Full Range|||44.0|76.0|
3887727|NCT01530880|3712702|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887728|NCT01530880|3712702|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3887729|NCT01530880|3712702|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3887730|NCT01530880|3712702|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3887731|NCT01530880|3712702|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3887732|NCT01530880|3712702|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3887733|NCT01530880|3712702|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3887734|NCT01530880|3712702|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3887735|NCT01530477|3712713|B4||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3887736|NCT01530477|3712714|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3887737|NCT01530477|3712715|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3887738|NCT01530477|3712716|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3887739|NCT01530477|3712713|B4||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3887740|NCT01530477|3712714|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3887741|NCT01530477|3712715|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3887742|NCT01530477|3712716|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3887743|NCT01530477|3712713|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3887744|NCT01530477|3712714|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3887745|NCT01530477|3712715|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3887746|NCT01530477|3712716|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3887747|NCT01530477|3712713|B4||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
3887749|NCT01530477|3712715|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3887750|NCT01530477|3712716|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3887751|NCT01530477|3712713|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3887752|NCT01530477|3712714|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3887753|NCT01530477|3712715|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3887754|NCT01530477|3712716|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3887755|NCT01530464|3712724|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887756|NCT01530464|3712725|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887757|NCT01530464|3712726|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887758|NCT01530464|3712724|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887759|NCT01530464|3712725|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887760|NCT01530464|3712726|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887761|NCT01530464|3712724|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3887762|NCT01530464|3712725|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887763|NCT01530464|3712726|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3887764|NCT01530464|3712724|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3887765|NCT01530464|3712725|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3887766|NCT01530464|3712726|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3887767|NCT01530464|3712724|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887768|NCT01530464|3712725|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887769|NCT01530464|3712726|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887770|NCT01530464|3712724|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887771|NCT01530464|3712725|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887772|NCT01530464|3712726|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887773|NCT01530464|3712724|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887774|NCT01530464|3712725|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887775|NCT01530464|3712726|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887776|NCT01530464|3712724|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3887777|NCT01530464|3712725|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3887778|NCT01530464|3712726|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3887779|NCT01530464|3712724|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3887780|NCT01530464|3712725|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3887781|NCT01530464|3712726|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3887782|NCT01530464|3712724|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3887783|NCT01530464|3712725|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3887784|NCT01530464|3712726|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3887785|NCT01530464|3712724|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3887786|NCT01530464|3712725|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3887787|NCT01530464|3712726|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3887788|NCT01530464|3712724|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3887789|NCT01530464|3712725|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3887790|NCT01530464|3712726|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3887791|NCT01530399|3712754|B7|Switzerland||Region of Enrollment||participants|Number|16|16.0||||||
3887792|NCT01530399|3712755|B6|Switzerland||Region of Enrollment||participants|Number|3|3.0||||||
3887793|NCT01530399|3712756|B5|Switzerland||Region of Enrollment||participants|Number|2|2.0||||||
3887794|NCT01530399|3712757|B4|Switzerland||Region of Enrollment||participants|Number|3|3.0||||||
3887795|NCT01530399|3712758|B3|Switzerland||Region of Enrollment||participants|Number|3|3.0||||||
3887796|NCT01530399|3712759|B2|Switzerland||Region of Enrollment||participants|Number|3|3.0||||||
3887797|NCT01530399|3712760|B1|Switzerland||Region of Enrollment||participants|Number|2|2.0||||||
3887798|NCT01530399|3712754|B7|Germany||Region of Enrollment||participants|Number|33|33.0||||||
3887799|NCT01530399|3712755|B6|Germany||Region of Enrollment||participants|Number|4|4.0||||||
3887800|NCT01530399|3712756|B5|Germany||Region of Enrollment||participants|Number|4|4.0||||||
3887801|NCT01530399|3712757|B4|Germany||Region of Enrollment||participants|Number|7|7.0||||||
3887802|NCT01530399|3712758|B3|Germany||Region of Enrollment||participants|Number|5|5.0||||||
3887803|NCT01530399|3712759|B2|Germany||Region of Enrollment||participants|Number|7|7.0||||||
3887804|NCT01530399|3712760|B1|Germany||Region of Enrollment||participants|Number|6|6.0||||||
3887805|NCT01530399|3712754|B7||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3887806|NCT01530399|3712755|B6||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3887807|NCT01530399|3712756|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3887808|NCT01530399|3712757|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3887809|NCT01530399|3712758|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3887810|NCT01530399|3712759|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3887811|NCT01530399|3712760|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3887812|NCT01530399|3712754|B7||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3887813|NCT01530399|3712755|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3887814|NCT01530399|3712756|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3887815|NCT01530399|3712757|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3887816|NCT01530399|3712758|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3887817|NCT01530399|3712759|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3887818|NCT01530399|3712760|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3887819|NCT01530399|3712754|B7|||Age||years|Median|69|69.0|Inter-Quartile Range|||61.0|73.0|
3887820|NCT01530399|3712755|B6|||Age||years|Median|58|58.0|Inter-Quartile Range|||52.0|62.0|
3887821|NCT01530399|3712756|B5|||Age||years|Median|66|66.0|Inter-Quartile Range|||60.0|71.0|
3887822|NCT01530399|3712757|B4|||Age||years|Median|73|73.0|Inter-Quartile Range|||68.0|73.0|
3887823|NCT01530399|3712758|B3|||Age||years|Median|66|66.0|Inter-Quartile Range|||60.0|79.0|
3887824|NCT01530399|3712759|B2|||Age||years|Median|70|70.0|Inter-Quartile Range|||57.0|73.0|
3887825|NCT01530399|3712760|B1|||Age||years|Median|71|71.0|Inter-Quartile Range|||64.0|75.0|
3887826|NCT01530334|3712779|B1|White||Race/Ethnicity, Customized|All patients were Caucasian (61, 100%)|Participants|Number|61|61.0||||||
3887827|NCT01530334|3712779|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3887828|NCT01530334|3712779|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3887829|NCT01530334|3712779|B1|||Age||years|Mean|66.9|66.9|Standard Deviation|10.1|10.1|||
3887830|NCT01530243|3712788|B5|Iran, Islamic Republic of||Region of Enrollment||participants|Number|94|94.0||||||
3887831|NCT01530243|3712789|B4|Iran, Islamic Republic of||Region of Enrollment||participants|Number|24|24.0||||||
3887832|NCT01530243|3712790|B3|Iran, Islamic Republic of||Region of Enrollment||participants|Number|23|23.0||||||
3887833|NCT01530243|3712791|B2|Iran, Islamic Republic of||Region of Enrollment||participants|Number|23|23.0||||||
3887834|NCT01530243|3712792|B1|Iran, Islamic Republic of||Region of Enrollment||participants|Number|24|24.0||||||
3887835|NCT01530243|3712788|B5||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3887836|NCT01530243|3712789|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3887837|NCT01530243|3712790|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3887838|NCT01530243|3712791|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3887839|NCT01530243|3712792|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3887840|NCT01530243|3712788|B5||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3887841|NCT01530243|3712789|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3887842|NCT01530243|3712790|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3887843|NCT01530243|3712791|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3887844|NCT01530243|3712792|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3887845|NCT01530243|3712788|B5|||Age||years|Mean|36.53|36.53|Standard Deviation|9.53|9.53|||
3887846|NCT01530243|3712789|B4|||Age||years|Mean|35.75|35.75|Standard Deviation|9.38|9.38|||
3887847|NCT01530243|3712790|B3|||Age||years|Mean|37.04|37.04|Standard Deviation|9.04|9.04|||
3887848|NCT01530243|3712791|B2|||Age||years|Mean|38.35|38.35|Standard Deviation|9.23|9.23|||
3887849|NCT01530243|3712792|B1|||Age||years|Mean|33.37|33.37|Standard Deviation|9.58|9.58|||
3887850|NCT01530178|3712813|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3887851|NCT01530178|3712814|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3887852|NCT01530178|3712815|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3887853|NCT01530178|3712813|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887854|NCT01530178|3712814|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887855|NCT01530178|3712815|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887856|NCT01530178|3712813|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3887857|NCT01530178|3712814|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3887858|NCT01530178|3712815|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3887859|NCT01530178|3712813|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3887860|NCT01530178|3712814|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3887861|NCT01530178|3712815|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887862|NCT01530178|3712813|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3887863|NCT01530178|3712814|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3887864|NCT01530178|3712815|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3887865|NCT01530178|3712813|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3887866|NCT01530178|3712814|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3887867|NCT01530178|3712815|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3887868|NCT01530178|3712813|B3|||Age||years|Mean|23.7|23.7|Standard Deviation|3.0|3.0|||
3887869|NCT01530178|3712814|B2|||Age||years|Mean|23.6|23.6|Standard Deviation|4.1|4.1|||
3887870|NCT01530178|3712815|B1|||Age||years|Mean|23.8|23.8|Standard Deviation|2.0|2.0|||
3887871|NCT01530087|3712826|B1|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3887872|NCT01530087|3712826|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3887873|NCT01530087|3712826|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3887874|NCT01530087|3712826|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3887875|NCT01530087|3712826|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3887876|NCT01530087|3712826|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3887877|NCT01529827|3712831|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887878|NCT01529827|3712831|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887879|NCT01529827|3712831|B1||White|Race (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
3887880|NCT01529827|3712831|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3887881|NCT01529827|3712831|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887882|NCT01529827|3712831|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887883|NCT01529827|3712831|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3887884|NCT01529827|3712831|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3887885|NCT01529827|3712831|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3887886|NCT01529827|3712831|B1|||Age||years|Mean|57.2|57.2|Standard Deviation|12.3|12.3|||
3887887|NCT01529827|3712831|B1||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
3887888|NCT01529827|3712831|B1||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
3887889|NCT01529827|3712831|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3887890|NCT01529645|3712838|B11||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
3887891|NCT01529645|3712839|B10||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3887892|NCT01529645|3712840|B9||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3887893|NCT01529645|3712841|B8||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3887894|NCT01529645|3712842|B7||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3887895|NCT01529645|3712843|B6||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3887896|NCT01529645|3712844|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3887897|NCT01529645|3712845|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3887898|NCT01529645|3712846|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3887899|NCT01529645|3712847|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3887900|NCT01529645|3712848|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3887901|NCT01529645|3712838|B11||Female|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
3887902|NCT01529645|3712839|B10||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3887903|NCT01529645|3712840|B9||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3887904|NCT01529645|3712841|B8||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3887905|NCT01529645|3712842|B7||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3887906|NCT01529645|3712843|B6||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3887907|NCT01529645|3712844|B5||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3887908|NCT01529645|3712845|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3887909|NCT01529645|3712846|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3887910|NCT01529645|3712847|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3887911|NCT01529645|3712848|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3887912|NCT01529645|3712838|B11|||Age||years|Mean|26.8|26.8|Standard Deviation|5.5|5.5|||
3887913|NCT01529645|3712839|B10|||Age||years|Mean|27.4|27.4|Standard Deviation|6.4|6.4|||
3887914|NCT01529645|3712840|B9|||Age||years|Mean|27.2|27.2|Standard Deviation|5.6|5.6|||
3887915|NCT01529645|3712841|B8|||Age||years|Mean|27.5|27.5|Standard Deviation|5.1|5.1|||
3887916|NCT01529645|3712842|B7|||Age||years|Mean|25.1|25.1|Standard Deviation|4.2|4.2|||
3887917|NCT01529645|3712843|B6|||Age||years|Mean|25.8|25.8|Standard Deviation|5.2|5.2|||
3887918|NCT01529645|3712844|B5|||Age||years|Mean|27.7|27.7|Standard Deviation|5.9|5.9|||
3887919|NCT01529645|3712845|B4|||Age||years|Mean|26.8|26.8|Standard Deviation|5.7|5.7|||
3887920|NCT01529645|3712846|B3|||Age||years|Mean|27.4|27.4|Standard Deviation|6.5|6.5|||
3887921|NCT01529645|3712847|B2|||Age||years|Mean|26.8|26.8|Standard Deviation|5.1|5.1|||
3887922|NCT01529645|3712848|B1|||Age||years|Mean|26.6|26.6|Standard Deviation|5.6|5.6|||
3887923|NCT01529632|3712953|B3||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3887924|NCT01529632|3712954|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3887925|NCT01529632|3712955|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3887926|NCT01529632|3712953|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3887927|NCT01529632|3712954|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3887928|NCT01529632|3712955|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3887929|NCT01529632|3712953|B3|||Age||years|Mean|64.9|64.9|Standard Deviation|7.36|7.36|||
3887930|NCT01529632|3712954|B2|||Age||years|Mean|64.2|64.2|Standard Deviation|7.40|7.4|||
3887931|NCT01529632|3712955|B1|||Age||years|Mean|65.6|65.6|Standard Deviation|7.28|7.28|||
3887932|NCT01529515|3712974|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
3887933|NCT01529515|3712975|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
3887934|NCT01529515|3712976|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
3887935|NCT01529515|3712974|B3|Ukraine||Region of Enrollment||participants|Number|137|137.0||||||
3887936|NCT01529515|3712975|B2|Ukraine||Region of Enrollment||participants|Number|74|74.0||||||
3887937|NCT01529515|3712976|B1|Ukraine||Region of Enrollment||participants|Number|63|63.0||||||
3887938|NCT01529515|3712974|B3|Turkey||Region of Enrollment||participants|Number|11|11.0||||||
3887939|NCT01529515|3712975|B2|Turkey||Region of Enrollment||participants|Number|6|6.0||||||
3887940|NCT01529515|3712976|B1|Turkey||Region of Enrollment||participants|Number|5|5.0||||||
3887941|NCT01529515|3712974|B3|South Korea||Region of Enrollment||participants|Number|6|6.0||||||
3887942|NCT01529515|3712975|B2|South Korea||Region of Enrollment||participants|Number|2|2.0||||||
3887943|NCT01529515|3712976|B1|South Korea||Region of Enrollment||participants|Number|4|4.0||||||
3887944|NCT01529515|3712974|B3|Romania||Region of Enrollment||participants|Number|27|27.0||||||
3887945|NCT01529515|3712975|B2|Romania||Region of Enrollment||participants|Number|13|13.0||||||
3887946|NCT01529515|3712976|B1|Romania||Region of Enrollment||participants|Number|14|14.0||||||
3887947|NCT01529515|3712974|B3|Mexico||Region of Enrollment||participants|Number|18|18.0||||||
3887948|NCT01529515|3712975|B2|Mexico||Region of Enrollment||participants|Number|8|8.0||||||
3887949|NCT01529515|3712976|B1|Mexico||Region of Enrollment||participants|Number|10|10.0||||||
3887950|NCT01529515|3712974|B3|Malaysia||Region of Enrollment||participants|Number|23|23.0||||||
3887951|NCT01529515|3712975|B2|Malaysia||Region of Enrollment||participants|Number|12|12.0||||||
3887952|NCT01529515|3712976|B1|Malaysia||Region of Enrollment||participants|Number|11|11.0||||||
3887953|NCT01529515|3712974|B3|Colombia||Region of Enrollment||participants|Number|25|25.0||||||
3887954|NCT01529515|3712975|B2|Colombia||Region of Enrollment||participants|Number|13|13.0||||||
3887955|NCT01529515|3712976|B1|Colombia||Region of Enrollment||participants|Number|12|12.0||||||
3887956|NCT01529515|3712974|B3||Male|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
3887957|NCT01529515|3712975|B2||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3887958|NCT01529515|3712976|B1||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3887959|NCT01529515|3712974|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3887960|NCT01529515|3712975|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3887961|NCT01529515|3712976|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3887962|NCT01529515|3712974|B3|||Age||years|Mean|37.8|37.8|Standard Deviation|11.01|11.01|||
3887963|NCT01529515|3712975|B2|||Age||years|Mean|37.1|37.1|Standard Deviation|10.87|10.87|||
3887964|NCT01529515|3712976|B1|||Age||years|Mean|38.5|38.5|Standard Deviation|11.16|11.16|||
3887965|NCT01529502|3712992|B7|||Body Mass Index||kg/m^2|Mean|33|33.0|Full Range|||28.0|40.0|
3887966|NCT01529502|3712993|B6|||Body Mass Index||kg/m^2|Mean|33|33.0|Full Range|||31.0|35.0|
3887967|NCT01529502|3712994|B5|||Body Mass Index||kg/m^2|Mean|35.5|35.5|Full Range|||31.0|40.0|
3887968|NCT01529502|3712995|B4|||Body Mass Index||kg/m^2|Mean|33.5|33.5|Full Range|||32.0|35.0|
3887969|NCT01529502|3712996|B3|||Body Mass Index||kg/m^2|Mean|30|30.0|Full Range|||28.0|31.0|
3887970|NCT01529502|3712997|B2|||Body Mass Index||kg/m^2|Mean|33|33.0|Full Range|||28.0|37.0|
3887971|NCT01529502|3712998|B1|||Body Mass Index||kg/m^2|Mean|37|37.0|Full Range|||33.0|40.0|
3887972|NCT01529502|3712992|B7|United States||Region of Enrollment||participants|Number|14|14.0||||||
3887973|NCT01529502|3712993|B6|United States||Region of Enrollment||participants|Number|2|2.0||||||
3887974|NCT01529502|3712994|B5|United States||Region of Enrollment||participants|Number|2|2.0||||||
3887975|NCT01529502|3712995|B4|United States||Region of Enrollment||participants|Number|2|2.0||||||
3887976|NCT01529502|3712996|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3887977|NCT01529502|3712997|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3887978|NCT01529502|3712998|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3887979|NCT01529502|3712992|B7||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3887980|NCT01529502|3712993|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3887981|NCT01529502|3712994|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3887982|NCT01529502|3712995|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3887983|NCT01529502|3712996|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3887984|NCT01529502|3712997|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3887985|NCT01529502|3712998|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3887986|NCT01529502|3712992|B7||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3887987|NCT01529502|3712993|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3887988|NCT01529502|3712994|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3887989|NCT01529502|3712995|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3887990|NCT01529502|3712996|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3887991|NCT01529502|3712997|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3887992|NCT01529502|3712998|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3887993|NCT01529502|3712992|B7|||Age||years|Mean|41|41.0|Full Range|||22.0|60.0|
3887994|NCT01529502|3712993|B6|||Age||years|Mean|41|41.0|Full Range|||29.0|53.0|
3887995|NCT01529502|3712994|B5|||Age||years|Mean|51|51.0|Full Range|||49.0|53.0|
3887996|NCT01529502|3712995|B4|||Age||years|Mean|26.5|26.5|Full Range|||26.0|27.0|
3887997|NCT01529502|3712996|B3|||Age||years|Mean|46|46.0|Full Range|||34.0|60.0|
3887998|NCT01529502|3712997|B2|||Age||years|Mean|37|37.0|Full Range|||22.0|46.0|
3887999|NCT01529502|3712998|B1|||Age||years|Mean|46|46.0|Full Range|||30.0|64.0|
3888000|NCT01529502|3712992|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3888001|NCT01529502|3712993|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3888002|NCT01529502|3712994|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3888003|NCT01529502|3712995|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3888004|NCT01529502|3712996|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3888005|NCT01529502|3712997|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3888006|NCT01529502|3712998|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3888007|NCT01529502|3712992|B7||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3888008|NCT01529502|3712993|B6||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3888009|NCT01529502|3712994|B5||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3888010|NCT01529502|3712995|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3888011|NCT01529502|3712996|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3888012|NCT01529502|3712997|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3888013|NCT01529502|3712998|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3888014|NCT01529502|3712992|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3888015|NCT01529502|3712993|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3888016|NCT01529502|3712994|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3888017|NCT01529502|3712995|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3888018|NCT01529502|3712996|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3888019|NCT01529502|3712997|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3888020|NCT01529502|3712998|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3888021|NCT01529450|3713014|B3|||Size of disease by RECIST criteria||centimeters|Mean|4.0|4.0|Standard Deviation|2.0|2.0|||
3888022|NCT01529450|3713015|B2|||Size of disease by RECIST criteria||centimeters|Mean|4.2|4.2|Standard Deviation|2.4|2.4|||
3888023|NCT01529450|3713016|B1|||Size of disease by RECIST criteria||centimeters|Mean|3.8|3.8|Standard Deviation|1.3|1.3|||
3888024|NCT01529450|3713014|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
3888025|NCT01529450|3713015|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3888026|NCT01529450|3713016|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3888027|NCT01529450|3713014|B3||Male|Gender||Participants|Count of Participants|8|8.0||||||
3888028|NCT01529450|3713015|B2||Male|Gender||Participants|Count of Participants|6|6.0||||||
3888029|NCT01529450|3713016|B1||Male|Gender||Participants|Count of Participants|2|2.0||||||
3888030|NCT01529450|3713014|B3||Female|Gender||Participants|Count of Participants|1|1.0||||||
3888031|NCT01529450|3713015|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
3888032|NCT01529450|3713016|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
3888033|NCT01529450|3713014|B3|||Age||years|Mean|57|57.0|Standard Deviation|15|15.0|||
3888034|NCT01529450|3713015|B2|||Age||years|Mean|54|54.0|Standard Deviation|9|9.0|||
3888035|NCT01529450|3713016|B1|||Age||years|Mean|65|65.0|Standard Deviation|24|24.0|||
3888036|NCT01529450|3713014|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3888037|NCT01529450|3713015|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3888038|NCT01529450|3713016|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3888039|NCT01529450|3713014|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3888040|NCT01529450|3713015|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3888041|NCT01529450|3713016|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3888042|NCT01529450|3713014|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3888043|NCT01529450|3713015|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3888044|NCT01529450|3713016|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3888045|NCT01529385|3713024|B3|||Body Mass Index||kg/m^2|Mean|35.0|35.0|Standard Deviation|6.9|6.9|||
3888046|NCT01529385|3713025|B2|||Body Mass Index||kg/m^2|Mean|35.6|35.6|Standard Deviation|7.4|7.4|||
3888047|NCT01529385|3713026|B1|||Body Mass Index||kg/m^2|Mean|34.3|34.3|Standard Deviation|6.3|6.3|||
3888048|NCT01529385|3713024|B3|United States||Region of Enrollment||participants|Number|77|77.0||||||
3888049|NCT01529385|3713025|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
3888050|NCT01529385|3713026|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
3888051|NCT01529385|3713024|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3888052|NCT01529385|3713025|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888053|NCT01529385|3713026|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3888054|NCT01529385|3713024|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888055|NCT01529385|3713025|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888056|NCT01529385|3713026|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888057|NCT01529385|3713024|B3||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3888058|NCT01529385|3713025|B2||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3888059|NCT01529385|3713026|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3888060|NCT01529385|3713024|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3888061|NCT01529385|3713025|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3888062|NCT01529385|3713026|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3888063|NCT01529385|3713024|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888064|NCT01529385|3713025|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888065|NCT01529385|3713026|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888066|NCT01529385|3713024|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3888067|NCT01529385|3713025|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3888068|NCT01529385|3713026|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3888069|NCT01529385|3713024|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3888070|NCT01529385|3713025|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3888071|NCT01529385|3713026|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888072|NCT01529385|3713024|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3888073|NCT01529385|3713025|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3888074|NCT01529385|3713026|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3888075|NCT01529385|3713024|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3888076|NCT01529385|3713025|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3888077|NCT01529385|3713026|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3888078|NCT01529385|3713024|B3|||Age||years|Mean|64|64.0|Standard Deviation|12|12.0|||
3888079|NCT01529385|3713025|B2|||Age||years|Mean|64|64.0|Standard Deviation|13|13.0|||
3888080|NCT01529385|3713026|B1|||Age||years|Mean|66|66.0|Standard Deviation|13|13.0|||
3888081|NCT01529346|3713051|B6||Male|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3888082|NCT01529346|3713052|B5||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3888083|NCT01529346|3713053|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3888084|NCT01529346|3713054|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3888085|NCT01529346|3713055|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3888086|NCT01529346|3713056|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3888087|NCT01529346|3713051|B6||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3888088|NCT01529346|3713052|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3888089|NCT01529346|3713053|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3888090|NCT01529346|3713054|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3888091|NCT01529346|3713055|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3888092|NCT01529346|3713056|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3888093|NCT01529346|3713051|B6|||Age||years|Mean|23.6|23.6|Standard Deviation|5.4|5.4|||
3888094|NCT01529346|3713052|B5|||Age||years|Mean|24.2|24.2|Standard Deviation|6.4|6.4|||
3888095|NCT01529346|3713053|B4|||Age||years|Mean|22.7|22.7|Standard Deviation|4.7|4.7|||
3888096|NCT01529346|3713054|B3|||Age||years|Mean|24.0|24.0|Standard Deviation|4.9|4.9|||
3888097|NCT01529346|3713055|B2|||Age||years|Mean|23.3|23.3|Standard Deviation|4.9|4.9|||
3888098|NCT01529346|3713056|B1|||Age||years|Mean|23.9|23.9|Standard Deviation|6.1|6.1|||
3888099|NCT01529268|3713146|B3|>80 kg||Weight group||participants|Number|98|98.0||||||
3888100|NCT01529268|3713147|B2|>80 kg||Weight group||participants|Number|48|48.0||||||
3888101|NCT01529268|3713148|B1|>80 kg||Weight group||participants|Number|50|50.0||||||
3888102|NCT01529268|3713146|B3|>65-80 kg||Weight group||participants|Number|24|24.0||||||
3888103|NCT01529268|3713147|B2|>65-80 kg||Weight group||participants|Number|10|10.0||||||
3888104|NCT01529268|3713148|B1|>65-80 kg||Weight group||participants|Number|14|14.0||||||
3888105|NCT01529268|3713146|B3|Less than or equal to 65 kg||Weight group||participants|Number|47|47.0||||||
3888106|NCT01529268|3713147|B2|Less than or equal to 65 kg||Weight group||participants|Number|23|23.0||||||
3888107|NCT01529268|3713148|B1|Less than or equal to 65 kg||Weight group||participants|Number|24|24.0||||||
3888108|NCT01529268|3713146|B3|||Aspartate aminotransferase||U/L|Mean|71|71.0|Standard Deviation|59|59.0|||
3888109|NCT01529268|3713147|B2|||Aspartate aminotransferase||U/L|Mean|59|59.0|Standard Deviation|38|38.0|||
3888110|NCT01529268|3713148|B1|||Aspartate aminotransferase||U/L|Mean|82|82.0|Standard Deviation|71|71.0|||
3888111|NCT01529268|3713146|B3|||Alanine aminotransferase||U/L|Mean|123|123.0|Standard Deviation|101|101.0|||
3888112|NCT01529268|3713147|B2|||Alanine aminotransferase||U/L|Mean|103|103.0|Standard Deviation|76|76.0|||
3888113|NCT01529268|3713148|B1|||Alanine aminotransferase||U/L|Mean|140|140.0|Standard Deviation|118|118.0|||
3888114|NCT01529268|3713146|B3|United States||Region of Enrollment||participants|Number|169|169.0||||||
3888115|NCT01529268|3713147|B2|United States||Region of Enrollment||participants|Number|81|81.0||||||
3888116|NCT01529268|3713148|B1|United States||Region of Enrollment||participants|Number|88|88.0||||||
3888117|NCT01529268|3713146|B3|Refusal/not stated||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
3888118|NCT01529268|3713147|B2|Refusal/not stated||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3888119|NCT01529268|3713148|B1|Refusal/not stated||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3888120|NCT01529268|3713146|B3|More than one race||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3888121|NCT01529268|3713147|B2|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3888122|NCT01529268|3713148|B1|More than one race||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3888123|NCT01529268|3713146|B3|White||Race/Ethnicity, Customized||participants|Number|102|102.0||||||
3888124|NCT01529268|3713147|B2|White||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
3888125|NCT01529268|3713148|B1|White||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
3888126|NCT01529268|3713146|B3|Black or African-American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3888127|NCT01529268|3713147|B2|Black or African-American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3888128|NCT01529268|3713148|B1|Black or African-American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3888129|NCT01529268|3713146|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3888130|NCT01529268|3713147|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3888131|NCT01529268|3713148|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3888132|NCT01529268|3713146|B3|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3888133|NCT01529268|3713147|B2|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3888134|NCT01529268|3713148|B1|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3888135|NCT01529268|3713146|B3||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3888136|NCT01529268|3713147|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3888137|NCT01529268|3713148|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3888138|NCT01529268|3713146|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3888139|NCT01529268|3713147|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3888140|NCT01529268|3713148|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3888141|NCT01529268|3713146|B3|||Age||years|Mean|13.7|13.7|Standard Deviation|2.7|2.7|||
3888142|NCT01529268|3713147|B2|||Age||years|Mean|13.6|13.6|Standard Deviation|2.5|2.5|||
3888143|NCT01529268|3713148|B1|||Age||years|Mean|13.8|13.8|Standard Deviation|2.9|2.9|||
3888144|NCT01529203|3713203|B1|United Kingdom||Region of Enrollment||participants|Number|20|20.0||||||
3888145|NCT01529203|3713203|B1|Spain||Region of Enrollment||participants|Number|20|20.0||||||
3888146|NCT01529203|3713203|B1|France||Region of Enrollment||participants|Number|20|20.0||||||
3888147|NCT01529203|3713203|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888148|NCT01529203|3713203|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888149|NCT01529203|3713203|B1||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3888150|NCT01529203|3713203|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888151|NCT01529203|3713203|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888152|NCT01529203|3713203|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888153|NCT01529203|3713203|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888154|NCT01529203|3713203|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3888155|NCT01529203|3713203|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3888156|NCT01529203|3713203|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3888157|NCT01529203|3713203|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3888158|NCT01529203|3713203|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3888159|NCT01529203|3713203|B1|||Age||years|Mean|47.6|47.6|Standard Deviation|7.5|7.5|||
3888160|NCT01529112|3713209|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3888161|NCT01529112|3713210|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3888162|NCT01529112|3713211|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3888163|NCT01529112|3713209|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3888164|NCT01529112|3713210|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3888165|NCT01529112|3713211|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3888166|NCT01529112|3713209|B3|||Age||Years|Median|63|63.0|Full Range|||41.0|82.0|
3888167|NCT01529112|3713210|B2|||Age||Years|Median|63.5|63.5|Full Range|||44.0|77.0|
3888168|NCT01529112|3713211|B1|||Age||Years|Median|63|63.0|Full Range|||41.0|82.0|
3888169|NCT01528969|3713237|B3|non-Kuwaiti Arab||Nationality of subjects||participants|Number|2|2.0||||||
3888170|NCT01528969|3713238|B2|non-Kuwaiti Arab||Nationality of subjects||participants|Number|1|1.0||||||
3888171|NCT01528969|3713239|B1|non-Kuwaiti Arab||Nationality of subjects||participants|Number|1|1.0||||||
3888172|NCT01528969|3713237|B3|Kuwaiti||Nationality of subjects||participants|Number|73|73.0||||||
3888173|NCT01528969|3713238|B2|Kuwaiti||Nationality of subjects||participants|Number|37|37.0||||||
3888174|NCT01528969|3713239|B1|Kuwaiti||Nationality of subjects||participants|Number|36|36.0||||||
3888175|NCT01528969|3713237|B3|Kuwait||Region of Enrollment||participants|Number|75|75.0||||||
3888176|NCT01528969|3713238|B2|Kuwait||Region of Enrollment||participants|Number|38|38.0||||||
3888177|NCT01528969|3713239|B1|Kuwait||Region of Enrollment||participants|Number|37|37.0||||||
3888178|NCT01528969|3713237|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888179|NCT01528969|3713238|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888180|NCT01528969|3713239|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888181|NCT01528969|3713237|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3888182|NCT01528969|3713238|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3888183|NCT01528969|3713239|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3888184|NCT01528969|3713237|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888185|NCT01528969|3713238|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888186|NCT01528969|3713239|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888187|NCT01528969|3713237|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888188|NCT01528969|3713238|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888189|NCT01528969|3713239|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888190|NCT01528969|3713237|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3888191|NCT01528969|3713238|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3888192|NCT01528969|3713239|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3888193|NCT01528969|3713237|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888194|NCT01528969|3713238|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888195|NCT01528969|3713239|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888196|NCT01528969|3713237|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3888197|NCT01528969|3713238|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3888198|NCT01528969|3713239|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3888199|NCT01528969|3713237|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3888200|NCT01528969|3713238|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3888201|NCT01528969|3713239|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3888202|NCT01528969|3713237|B3|||Age||years|Mean|11.5|11.5|Full Range|||10.0|12.0|
3888203|NCT01528969|3713238|B2|||Age||years|Mean|11.5|11.5|Full Range|||10.0|12.0|
3888204|NCT01528969|3713239|B1|||Age||years|Mean|11.5|11.5|Full Range|||10.0|12.0|
3888205|NCT01528891|3713246|B3|United States||Region of Enrollment||participants|Number|393|393.0||||||
3888206|NCT01528891|3713247|B2|United States||Region of Enrollment||participants|Number|198|198.0||||||
3888207|NCT01528891|3713248|B1|United States||Region of Enrollment||participants|Number|195|195.0||||||
3888208|NCT01528891|3713246|B3||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
3888209|NCT01528891|3713247|B2||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3888210|NCT01528891|3713248|B1||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3888211|NCT01528891|3713246|B3||Female|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
3888212|NCT01528891|3713247|B2||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3888213|NCT01528891|3713248|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3888214|NCT01528891|3713246|B3|||Age||years|Mean|6.0|6.0|Standard Deviation|1.6|1.6|||
3888215|NCT01528891|3713247|B2|||Age||years|Mean|5.8|5.8|Standard Deviation|1.6|1.6|||
3888216|NCT01528891|3713248|B1|||Age||years|Mean|6.1|6.1|Standard Deviation|1.6|1.6|||
3888217|NCT01528891|3713246|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3888218|NCT01528891|3713247|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3888219|NCT01528891|3713248|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3888220|NCT01528891|3713246|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3888221|NCT01528891|3713247|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3888222|NCT01528891|3713248|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3888223|NCT01528891|3713246|B3||<=18 years|Age||Participants|Count of Participants|393|393.0||||||
3888224|NCT01528891|3713247|B2||<=18 years|Age||Participants|Count of Participants|198|198.0||||||
3888225|NCT01528891|3713248|B1||<=18 years|Age||Participants|Count of Participants|195|195.0||||||
3888226|NCT01528878|3713261|B1|||Volume of liver receiving <15 Gy (cc)||cc|Median|1239|1239.0|Full Range|||721.0|2289.0|
3888227|NCT01528878|3713261|B1|||Mean liver dose (Gy) )||Gy|Median|10.3|10.3|Full Range|||4.4|16.5|
3888228|NCT01528878|3713261|B1|||Dose of Radiation Therapy (Gy)||Gray (Gy)|Median|45|45.0|Full Range|||27.5|45.0|
3888229|NCT01528878|3713261|B1||15 Gy x 3 = 45 Gy|Fractionation|When the total dose of radiation is divided into several, smaller doses over a period of several days, there are fewer toxic effects on healthy cells|Participants|Count of Participants|21|21.0||||||
3888230|NCT01528878|3713261|B1||13.33 Gy x 3 = 40 Gy|Fractionation|When the total dose of radiation is divided into several, smaller doses over a period of several days, there are fewer toxic effects on healthy cells|Participants|Count of Participants|1|1.0||||||
3888231|NCT01528878|3713261|B1||12.5 Gy x 3 = 37.5 Gy|Fractionation|When the total dose of radiation is divided into several, smaller doses over a period of several days, there are fewer toxic effects on healthy cells|Participants|Count of Participants|4|4.0||||||
3888232|NCT01528878|3713261|B1||10 Gy x 3 = 30 Gy|Fractionation|When the total dose of radiation is divided into several, smaller doses over a period of several days, there are fewer toxic effects on healthy cells|Participants|Count of Participants|1|1.0||||||
3888233|NCT01528878|3713261|B1||7 Gy x 5 = 35 Gy|Fractionation|When the total dose of radiation is divided into several, smaller doses over a period of several days, there are fewer toxic effects on healthy cells|Participants|Count of Participants|2|2.0||||||
3888389|NCT01528605|3713413|B7||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3888234|NCT01528878|3713261|B1||5.5 Gy x 5 = 27.5 Gy|Fractionation|When the total dose of radiation is divided into several, smaller doses over a period of several days, there are fewer toxic effects on healthy cells|Participants|Count of Participants|1|1.0||||||
3888235|NCT01528878|3713261|B1|||Planning target volume (cc) median (range)|Planning target volume (PTV) is created by expanding gross tumor volume (GTV) by 0.5-0.8 cm in all directions|cc|Median|65.5|65.5|Full Range|||17.7|258.1|
3888236|NCT01528878|3713261|B1|||Gross tumor volume (cc) median (range)|The demonstrable extent of a tumor seen or felt with standard examination techniques. The gross tumor volume is used in radiation oncology as the basis for initial estimates of the extent of a tumor that will undergo treatment with external beam radiation or brachytherapy|cc|Median|22.5|22.5|Full Range|||2.8|145.0|
3888237|NCT01528878|3713261|B1|||Lesion size (cm) median (range)||cm|Median|3.5|3.5|Full Range|||1.7|6.5|
3888238|NCT01528878|3713261|B1||>6|Lesion size (cm)||Participants|Count of Participants|3|3.0||||||
3888239|NCT01528878|3713261|B1||5-5.9|Lesion size (cm)||Participants|Count of Participants|5|5.0||||||
3888240|NCT01528878|3713261|B1||4-4.9|Lesion size (cm)||Participants|Count of Participants|2|2.0||||||
3888241|NCT01528878|3713261|B1||3-3.9|Lesion size (cm)||Participants|Count of Participants|9|9.0||||||
3888242|NCT01528878|3713261|B1||2-2.9|Lesion size (cm)||Participants|Count of Participants|10|10.0||||||
3888243|NCT01528878|3713261|B1||<2|Lesion size (cm)||Participants|Count of Participants|1|1.0||||||
3888244|NCT01528878|3713261|B1||3|Number of lesions treated||Participants|Count of Participants|1|1.0||||||
3888245|NCT01528878|3713261|B1||2|Number of lesions treated||Participants|Count of Participants|3|3.0||||||
3888246|NCT01528878|3713261|B1||1|Number of lesions treated||Participants|Count of Participants|26|26.0||||||
3888247|NCT01528878|3713261|B1|||Prior systemic therapy||Participants|Count of Participants|16|16.0||||||
3888248|NCT01528878|3713261|B1|TACE x 2||Prior liver-directed therapies||Participants|Count of Participants|1|1.0||||||
3888249|NCT01528878|3713261|B1|TACE x 2 + RFA||Prior liver-directed therapies||Participants|Count of Participants|1|1.0||||||
3888250|NCT01528878|3713261|B1|TACE + RFA x3||Prior liver-directed therapies||Participants|Count of Participants|1|1.0||||||
3888251|NCT01528878|3713261|B1|Resection x2 + RFA||Prior liver-directed therapies||Participants|Count of Participants|1|1.0||||||
3888252|NCT01528878|3713261|B1|Resection + TACE||Prior liver-directed therapies||Participants|Count of Participants|2|2.0||||||
3888253|NCT01528878|3713261|B1|Resection + RFA||Prior liver-directed therapies||Participants|Count of Participants|3|3.0||||||
3888254|NCT01528878|3713261|B1|> 1 prior local therapy||Prior liver-directed therapies||Participants|Count of Participants|9|9.0||||||
3888255|NCT01528878|3713261|B1|Radiofrequency ablation (RFA)||Prior liver-directed therapies||Participants|Count of Participants|6|6.0||||||
3888256|NCT01528878|3713261|B1|Trans-arterial chemoembolization (TACE)||Prior liver-directed therapies||Participants|Count of Participants|7|7.0||||||
3888257|NCT01528878|3713261|B1|Liver resection||Prior liver-directed therapies||Participants|Count of Participants|9|9.0||||||
3888258|NCT01528878|3713261|B1|Any local therapy||Prior liver-directed therapies||Participants|Count of Participants|14|14.0||||||
3888259|NCT01528878|3713261|B1||Metastatic cancer|Primary Disease||Participants|Count of Participants|19|19.0||||||
3888260|NCT01528878|3713261|B1||Hepatocellular carcinoma|Primary Disease||Participants|Count of Participants|11|11.0||||||
3888261|NCT01528878|3713261|B1||>=7 (Class B)|Child Pugh Score|"The Child-Pugh score consists of five clinical features and is used to assess the prognosis of chronic liver disease and cirrhosis. The score employs five clinical measures of liver disease. Each measure is scored 1–3, with 3 indicating most severe derangement.~Child- Pugh Class:~A 5-6 points B 7-9 points C >9 points"|Participants|Count of Participants|2|2.0||||||
3888262|NCT01528878|3713261|B1||6 (Class A)|Child Pugh Score|"The Child-Pugh score consists of five clinical features and is used to assess the prognosis of chronic liver disease and cirrhosis. The score employs five clinical measures of liver disease. Each measure is scored 1–3, with 3 indicating most severe derangement.~Child- Pugh Class:~A 5-6 points B 7-9 points C >9 points"|Participants|Count of Participants|6|6.0||||||
3888263|NCT01528878|3713261|B1||5 (Class A)|Child Pugh Score|"The Child-Pugh score consists of five clinical features and is used to assess the prognosis of chronic liver disease and cirrhosis. The score employs five clinical measures of liver disease. Each measure is scored 1–3, with 3 indicating most severe derangement.~Child- Pugh Class:~A 5-6 points B 7-9 points C >9 points"|Participants|Count of Participants|22|22.0||||||
3888264|NCT01528878|3713261|B1||1|Eastern Cooperative Oncology Group (ECOG) Performance Status|"Measure Description: A scale from 0-5 to describe a patient's level of functioning in terms of selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|Participants|Count of Participants|13|13.0||||||
3888265|NCT01528878|3713261|B1||0|Eastern Cooperative Oncology Group (ECOG) Performance Status|"Measure Description: A scale from 0-5 to describe a patient's level of functioning in terms of selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|Participants|Count of Participants|17|17.0||||||
3888266|NCT01528878|3713261|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3888267|NCT01528878|3713261|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3888268|NCT01528878|3713261|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888269|NCT01528878|3713261|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3888270|NCT01528878|3713261|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3888271|NCT01528878|3713261|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888272|NCT01528878|3713261|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888273|NCT01528878|3713261|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3888274|NCT01528878|3713261|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3888275|NCT01528878|3713261|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3888276|NCT01528878|3713261|B1|||Age||years|Median|65.5|65.5|Full Range|||23.0|86.0|
3888277|NCT01528787|3713269|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888278|NCT01528787|3713270|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888279|NCT01528787|3713271|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888280|NCT01528787|3713272|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888281|NCT01528787|3713273|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888282|NCT01528787|3713269|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888283|NCT01528787|3713270|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888284|NCT01528787|3713271|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888285|NCT01528787|3713272|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888286|NCT01528787|3713273|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888287|NCT01528787|3713269|B5||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3888288|NCT01528787|3713270|B4||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3888289|NCT01528787|3713271|B3||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3888290|NCT01528787|3713272|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3888291|NCT01528787|3713273|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3888292|NCT01528787|3713269|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3888293|NCT01528787|3713270|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3888294|NCT01528787|3713271|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3888295|NCT01528787|3713272|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3888296|NCT01528787|3713273|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3888297|NCT01528787|3713269|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888298|NCT01528787|3713270|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888299|NCT01528787|3713271|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888300|NCT01528787|3713272|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888301|NCT01528787|3713273|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888302|NCT01528787|3713269|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3888303|NCT01528787|3713270|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3888304|NCT01528787|3713271|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888305|NCT01528787|3713272|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3888306|NCT01528787|3713273|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3888307|NCT01528787|3713269|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888308|NCT01528787|3713270|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888309|NCT01528787|3713271|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888310|NCT01528787|3713272|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888311|NCT01528787|3713273|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888312|NCT01528787|3713269|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888313|NCT01528787|3713270|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888314|NCT01528787|3713271|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888315|NCT01528787|3713272|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888316|NCT01528787|3713273|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888317|NCT01528787|3713269|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3888318|NCT01528787|3713270|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3888319|NCT01528787|3713271|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3888320|NCT01528787|3713272|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3888321|NCT01528787|3713273|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3888322|NCT01528787|3713269|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3888323|NCT01528787|3713270|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3888324|NCT01528787|3713271|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3888325|NCT01528787|3713272|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3888390|NCT01528605|3713414|B6||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3888326|NCT01528787|3713273|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3888327|NCT01528787|3713269|B5||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3888328|NCT01528787|3713270|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3888329|NCT01528787|3713271|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3888330|NCT01528787|3713272|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3888331|NCT01528787|3713273|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3888332|NCT01528787|3713269|B5||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3888333|NCT01528787|3713270|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3888334|NCT01528787|3713271|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3888335|NCT01528787|3713272|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3888336|NCT01528787|3713273|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3888337|NCT01528787|3713269|B5|||Age||years|Mean|64.0|64.0|Standard Deviation|11.83|11.83|||
3888338|NCT01528787|3713270|B4|||Age||years|Mean|57.8|57.8|Standard Deviation|12.27|12.27|||
3888339|NCT01528787|3713271|B3|||Age||years|Mean|66.1|66.1|Standard Deviation|11.09|11.09|||
3888340|NCT01528787|3713272|B2|||Age||years|Mean|69.1|69.1|Standard Deviation|8.69|8.69|||
3888341|NCT01528787|3713273|B1|||Age||years|Mean|63.6|63.6|Standard Deviation|12.36|12.36|||
3888342|NCT01528735|3713286|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3888343|NCT01528735|3713287|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3888344|NCT01528735|3713288|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3888345|NCT01528735|3713286|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3888346|NCT01528735|3713287|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3888347|NCT01528735|3713288|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3888348|NCT01528735|3713286|B3|||Age||years|Mean|56.5|56.5|Standard Deviation|7.85|7.85|||
3888349|NCT01528735|3713287|B2|||Age||years|Mean|55.5|55.5|Standard Deviation|8.42|8.42|||
3888350|NCT01528735|3713288|B1|||Age||years|Mean|57.7|57.7|Standard Deviation|7.38|7.38|||
3888351|NCT01528709|3713389|B3|||Diabetes||Participants|Count of Participants|74|74.0||||||
3888352|NCT01528709|3713390|B2|||Diabetes||Participants|Count of Participants|38|38.0||||||
3888353|NCT01528709|3713391|B1|||Diabetes||Participants|Count of Participants|36|36.0||||||
3888354|NCT01528709|3713389|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3888355|NCT01528709|3713389|B3||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3888356|NCT01528709|3713390|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3888357|NCT01528709|3713391|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3888358|NCT01528709|3713389|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3888359|NCT01528709|3713390|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3888360|NCT01528709|3713391|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3888361|NCT01528709|3713389|B3|||Age||years|Mean|68.9|68.9|Standard Deviation|10.4|10.4|||
3888362|NCT01528709|3713390|B2|||Age||years|Mean|70.5|70.5|Standard Deviation|10.4|10.4|||
3888363|NCT01528709|3713391|B1|||Age||years|Mean|67.3|67.3|Standard Deviation|10.4|10.4|||
3888364|NCT01528696|3713400|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
3888365|NCT01528696|3713401|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3888366|NCT01528696|3713402|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3888367|NCT01528696|3713400|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3888368|NCT01528696|3713401|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3888369|NCT01528696|3713402|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3888370|NCT01528696|3713400|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3888371|NCT01528696|3713401|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3888372|NCT01528696|3713402|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3888373|NCT01528696|3713400|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3888374|NCT01528696|3713401|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3888375|NCT01528696|3713402|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3888376|NCT01528696|3713400|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3888377|NCT01528696|3713401|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3888378|NCT01528696|3713402|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3888379|NCT01528696|3713400|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3888380|NCT01528696|3713401|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3888381|NCT01528696|3713402|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3888382|NCT01528605|3713413|B7|China||Region of Enrollment||participants|Number|164|164.0||||||
3888383|NCT01528605|3713414|B6|China||Region of Enrollment||participants|Number|28|28.0||||||
3888384|NCT01528605|3713415|B5|China||Region of Enrollment||participants|Number|28|28.0||||||
3888385|NCT01528605|3713416|B4|China||Region of Enrollment||participants|Number|27|27.0||||||
3888386|NCT01528605|3713417|B3|China||Region of Enrollment||participants|Number|27|27.0||||||
3888387|NCT01528605|3713418|B2|China||Region of Enrollment||participants|Number|28|28.0||||||
3888388|NCT01528605|3713419|B1|China||Region of Enrollment||participants|Number|26|26.0||||||
3888391|NCT01528605|3713415|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3888392|NCT01528605|3713416|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3888393|NCT01528605|3713417|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3888394|NCT01528605|3713418|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3888395|NCT01528605|3713419|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3888396|NCT01528605|3713413|B7||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3888397|NCT01528605|3713414|B6||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3888398|NCT01528605|3713415|B5||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3888399|NCT01528605|3713416|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3888400|NCT01528605|3713417|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3888401|NCT01528605|3713418|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3888402|NCT01528605|3713419|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3888403|NCT01528605|3713413|B7|||Age||years|Mean|69.2|69.2|Standard Deviation|7.6|7.6|||
3888404|NCT01528605|3713414|B6|||Age||years|Mean|69.1|69.1|Standard Deviation|8.1|8.1|||
3888405|NCT01528605|3713415|B5|||Age||years|Mean|69.7|69.7|Standard Deviation|5.4|5.4|||
3888406|NCT01528605|3713416|B4|||Age||years|Mean|68.5|68.5|Standard Deviation|6.9|6.9|||
3888407|NCT01528605|3713417|B3|||Age||years|Mean|69.3|69.3|Standard Deviation|6.9|6.9|||
3888408|NCT01528605|3713418|B2|||Age||years|Mean|69.0|69.0|Standard Deviation|7.5|7.5|||
3888409|NCT01528605|3713419|B1|||Age||years|Mean|69.7|69.7|Standard Deviation|8.3|8.3|||
3888410|NCT01528592|3713448|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3888411|NCT01528592|3713448|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3888412|NCT01528592|3713448|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3888413|NCT01528592|3713448|B1|||Age||years|Mean|66.22|66.22|Standard Deviation|8.71|8.71|||
3888414|NCT01528592|3713448|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3888415|NCT01528592|3713448|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3888416|NCT01528592|3713448|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3888417|NCT01528345|3713452|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3888418|NCT01528345|3713453|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3888419|NCT01528345|3713454|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3888420|NCT01528345|3713452|B3||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3888421|NCT01528345|3713453|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3888422|NCT01528345|3713454|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3888423|NCT01528345|3713452|B3|||Age||Years|Mean|62.6|62.6|Standard Deviation|9.27|9.27|||
3888424|NCT01528345|3713453|B2|||Age||Years|Mean|61.7|61.7|Standard Deviation|9.51|9.51|||
3888425|NCT01528345|3713454|B1|||Age||Years|Mean|63.5|63.5|Standard Deviation|9.02|9.02|||
3888426|NCT01528332|3713471|B3|Germany||Region of Enrollment||participants|Number|171|171.0||||||
3888427|NCT01528332|3713472|B2|Germany||Region of Enrollment||participants|Number|86|86.0||||||
3888428|NCT01528332|3713473|B1|Germany||Region of Enrollment||participants|Number|85|85.0||||||
3888429|NCT01528332|3713471|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3888430|NCT01528332|3713472|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3888431|NCT01528332|3713473|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3888432|NCT01528332|3713471|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3888433|NCT01528332|3713472|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3888434|NCT01528332|3713473|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3888435|NCT01528332|3713471|B3|||Age||years|Mean|50.7|50.7|Standard Deviation|9.5|9.5|||
3888436|NCT01528332|3713472|B2|||Age||years|Mean|51.4|51.4|Standard Deviation|8.3|8.3|||
3888437|NCT01528332|3713473|B1|||Age||years|Mean|50.0|50.0|Standard Deviation|10.7|10.7|||
3888438|NCT01528332|3713471|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3888439|NCT01528332|3713472|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3888440|NCT01528332|3713473|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3888441|NCT01528332|3713471|B3||Between 18 and 65 years|Age||Participants|Count of Participants|171|171.0||||||
3888442|NCT01528332|3713472|B2||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
3888443|NCT01528332|3713473|B1||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
3888444|NCT01528332|3713471|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3888445|NCT01528332|3713472|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3888446|NCT01528332|3713473|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3888447|NCT01528319|3713480|B1|Japan||Region of Enrollment||participants|Number|24|24.0||||||
3888448|NCT01528319|3713480|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3888449|NCT01528319|3713480|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3888450|NCT01528319|3713480|B1|||Age||years|Mean|28.2|28.2|Standard Deviation|6.8|6.8|||
3888451|NCT01528319|3713480|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3888452|NCT01528319|3713480|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3888453|NCT01528319|3713480|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3888454|NCT01528293|3713489|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3888455|NCT01528293|3713490|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3888456|NCT01528293|3713489|B3||Male|Gender||Participants|Count of Participants|1|1.0||||||
3888457|NCT01528293|3713490|B2||Male|Gender||Participants|Count of Participants|1|1.0||||||
3888458|NCT01528293|3713489|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
3888459|NCT01528293|3713490|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
3888460|NCT01528293|3713489|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3888461|NCT01528293|3713490|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3888462|NCT01528293|3713489|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3888463|NCT01528293|3713490|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3888464|NCT01528293|3713489|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3888465|NCT01528293|3713490|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3888466|NCT01528215|3713504|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3888467|NCT01528215|3713505|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3888468|NCT01528215|3713506|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3888469|NCT01528215|3713504|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3888470|NCT01528215|3713505|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3888471|NCT01528215|3713506|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3888472|NCT01528215|3713504|B3|||Age||years|Mean|51|51.0|Standard Deviation|14|14.0|||
3888473|NCT01528215|3713505|B2|||Age||years|Mean|51|51.0|Standard Deviation|13|13.0|||
3888474|NCT01528215|3713506|B1|||Age||years|Mean|50|50.0|Standard Deviation|16|16.0|||
3888475|NCT01528150|3713513|B1|No Previous Neurocardiogenic Syncope||Neurocardiogenic Syncope||participants|Number|391|391.0||||||
3888476|NCT01528150|3713513|B1|Previous Neurocardiogenic Syncope||Neurocardiogenic Syncope||participants|Number|75|75.0||||||
3888477|NCT01528150|3713513|B1|No Sick Node Dysfunction||Sick Node Dysfunction||participants|Number|261|261.0||||||
3888478|NCT01528150|3713513|B1|Sick Node Dysfunction||Sick Node Dysfunction||participants|Number|205|205.0||||||
3888479|NCT01528150|3713513|B1|3rd Degree AV block||AtrioVentricular-Block (AV-Block)||participants|Number|147|147.0||||||
3888480|NCT01528150|3713513|B1|2nd Degree AV Block||AtrioVentricular-Block (AV-Block)||participants|Number|99|99.0||||||
3888481|NCT01528150|3713513|B1|1st Degree AV Block||AtrioVentricular-Block (AV-Block)||participants|Number|41|41.0||||||
3888482|NCT01528150|3713513|B1|No AV Block||AtrioVentricular-Block (AV-Block)||participants|Number|179|179.0||||||
3888483|NCT01528150|3713513|B1||Male|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
3888484|NCT01528150|3713513|B1||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
3888485|NCT01528150|3713513|B1|||Age||years|Mean|71.74|71.74|Standard Deviation|11.71|11.71|||
3888486|NCT01528124|3713517|B8|||Body Mass Index (BMI)||kilogram per meter squared (kg/m^2)|Mean|25.54|25.54|Standard Deviation|4.23|4.23|||
3888487|NCT01528124|3713518|B7|||Body Mass Index (BMI)||kilogram per meter squared (kg/m^2)|Mean|25.53|25.53|Standard Deviation|2.91|2.91|||
3888488|NCT01528124|3713519|B6|||Body Mass Index (BMI)||kilogram per meter squared (kg/m^2)|Mean|23.10|23.1|Standard Deviation|3.48|3.48|||
3888489|NCT01528124|3713520|B5|||Body Mass Index (BMI)||kilogram per meter squared (kg/m^2)|Mean|26.78|26.78|Standard Deviation|6.62|6.62|||
3888490|NCT01528124|3713521|B4|||Body Mass Index (BMI)||kilogram per meter squared (kg/m^2)|Mean|25.12|25.12|Standard Deviation|1.99|1.99|||
3888491|NCT01528124|3713522|B3|||Body Mass Index (BMI)||kilogram per meter squared (kg/m^2)|Mean|26.22|26.22|Standard Deviation|5.65|5.65|||
3888492|NCT01528124|3713523|B2|||Body Mass Index (BMI)||kilogram per meter squared (kg/m^2)|Mean|23.88|23.88|Standard Deviation|4.91|4.91|||
3888493|NCT01528124|3713524|B1|||Body Mass Index (BMI)||kilogram per meter squared (kg/m^2)|Mean|28.35|28.35|Standard Deviation|2.31|2.31|||
3888494|NCT01528124|3713517|B8|||Fasting Blood Glucose||millimole per liter (mmol/L)|Mean|4.57|4.57|Standard Deviation|0.38|0.38|||
3888495|NCT01528124|3713518|B7|||Fasting Blood Glucose||millimole per liter (mmol/L)|Mean|4.57|4.57|Standard Deviation|0.36|0.36|||
3888496|NCT01528124|3713519|B6|||Fasting Blood Glucose||millimole per liter (mmol/L)|Mean|4.20|4.2|Standard Deviation|0.35|0.35|||
3888497|NCT01528124|3713520|B5|||Fasting Blood Glucose||millimole per liter (mmol/L)|Mean|4.68|4.68|Standard Deviation|0.33|0.33|||
3888498|NCT01528124|3713521|B4|||Fasting Blood Glucose||millimole per liter (mmol/L)|Mean|4.97|4.97|Standard Deviation|0.27|0.27|||
3888499|NCT01528124|3713522|B3|||Fasting Blood Glucose||millimole per liter (mmol/L)|Mean|4.43|4.43|Standard Deviation|0.40|0.4|||
3888500|NCT01528124|3713523|B2|||Fasting Blood Glucose||millimole per liter (mmol/L)|Mean|4.45|4.45|Standard Deviation|0.40|0.4|||
3888501|NCT01528124|3713524|B1|||Fasting Blood Glucose||millimole per liter (mmol/L)|Mean|4.68|4.68|Standard Deviation|0.17|0.17|||
3888502|NCT01528124|3713517|B8|Singapore||Region of Enrollment||participants|Number|41|41.0||||||
3888503|NCT01528124|3713518|B7|Singapore||Region of Enrollment||participants|Number|6|6.0||||||
3888504|NCT01528124|3713519|B6|Singapore||Region of Enrollment||participants|Number|6|6.0||||||
3888505|NCT01528124|3713520|B5|Singapore||Region of Enrollment||participants|Number|5|5.0||||||
3888506|NCT01528124|3713521|B4|Singapore||Region of Enrollment||participants|Number|6|6.0||||||
3888507|NCT01528124|3713522|B3|Singapore||Region of Enrollment||participants|Number|6|6.0||||||
3888508|NCT01528124|3713523|B2|Singapore||Region of Enrollment||participants|Number|6|6.0||||||
3888509|NCT01528124|3713524|B1|Singapore||Region of Enrollment||participants|Number|6|6.0||||||
3888510|NCT01528124|3713517|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888511|NCT01528124|3713518|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888512|NCT01528124|3713519|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888513|NCT01528124|3713520|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888514|NCT01528124|3713521|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888515|NCT01528124|3713522|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888516|NCT01528124|3713523|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888517|NCT01528124|3713524|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888518|NCT01528124|3713517|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888519|NCT01528124|3713518|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888520|NCT01528124|3713519|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888521|NCT01528124|3713520|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888522|NCT01528124|3713521|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888523|NCT01528124|3713522|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888524|NCT01528124|3713523|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888525|NCT01528124|3713524|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888526|NCT01528124|3713517|B8||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888527|NCT01528124|3713518|B7||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888528|NCT01528124|3713519|B6||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888529|NCT01528124|3713520|B5||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888530|NCT01528124|3713521|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888531|NCT01528124|3713522|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888532|NCT01528124|3713523|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888533|NCT01528124|3713524|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888534|NCT01528124|3713517|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888535|NCT01528124|3713518|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888536|NCT01528124|3713519|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888537|NCT01528124|3713520|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888538|NCT01528124|3713521|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888539|NCT01528124|3713522|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888540|NCT01528124|3713523|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888541|NCT01528124|3713524|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888542|NCT01528124|3713517|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888543|NCT01528124|3713518|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888544|NCT01528124|3713519|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888545|NCT01528124|3713520|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888546|NCT01528124|3713521|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888547|NCT01528124|3713522|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888548|NCT01528124|3713523|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888549|NCT01528124|3713524|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888550|NCT01528124|3713517|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3888551|NCT01528124|3713518|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3888552|NCT01528124|3713519|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3888553|NCT01528124|3713520|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3888554|NCT01528124|3713521|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3888555|NCT01528124|3713522|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3888556|NCT01528124|3713523|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3888557|NCT01528124|3713524|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3888558|NCT01528124|3713517|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888559|NCT01528124|3713518|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888560|NCT01528124|3713519|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888561|NCT01528124|3713520|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888562|NCT01528124|3713521|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888563|NCT01528124|3713522|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888564|NCT01528124|3713523|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888565|NCT01528124|3713524|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888566|NCT01528124|3713517|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888567|NCT01528124|3713518|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888568|NCT01528124|3713519|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888569|NCT01528124|3713520|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888570|NCT01528124|3713521|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888571|NCT01528124|3713522|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888572|NCT01528124|3713523|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888573|NCT01528124|3713524|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888574|NCT01528124|3713517|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3888575|NCT01528124|3713518|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3888576|NCT01528124|3713519|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3888577|NCT01528124|3713520|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3888578|NCT01528124|3713521|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3888579|NCT01528124|3713522|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3888580|NCT01528124|3713523|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3888581|NCT01528124|3713524|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3888582|NCT01528124|3713517|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888583|NCT01528124|3713518|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888584|NCT01528124|3713519|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888585|NCT01528124|3713520|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888586|NCT01528124|3713521|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888587|NCT01528124|3713522|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888588|NCT01528124|3713523|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888589|NCT01528124|3713524|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888590|NCT01528124|3713517|B8||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3888591|NCT01528124|3713518|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3888592|NCT01528124|3713519|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3888593|NCT01528124|3713520|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3888594|NCT01528124|3713521|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3888595|NCT01528124|3713522|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3888596|NCT01528124|3713523|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3888597|NCT01528124|3713524|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3888598|NCT01528124|3713517|B8||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3888599|NCT01528124|3713518|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3888600|NCT01528124|3713519|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3888601|NCT01528124|3713520|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3888602|NCT01528124|3713521|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3888603|NCT01528124|3713522|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3888604|NCT01528124|3713523|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3888605|NCT01528124|3713524|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3888606|NCT01528124|3713517|B8|||Age||years|Mean|32.1|32.1|Standard Deviation|7.2|7.2|||
3888607|NCT01528124|3713518|B7|||Age||years|Mean|31.3|31.3|Standard Deviation|7.2|7.2|||
3888608|NCT01528124|3713519|B6|||Age||years|Mean|27.8|27.8|Standard Deviation|4.5|4.5|||
3888609|NCT01528124|3713520|B5|||Age||years|Mean|29.4|29.4|Standard Deviation|7.4|7.4|||
3888610|NCT01528124|3713521|B4|||Age||years|Mean|32.7|32.7|Standard Deviation|3.8|3.8|||
3888611|NCT01528124|3713522|B3|||Age||years|Mean|33.7|33.7|Standard Deviation|9.3|9.3|||
3888612|NCT01528124|3713523|B2|||Age||years|Mean|36.8|36.8|Standard Deviation|8.8|8.8|||
3888613|NCT01528124|3713524|B1|||Age||years|Mean|32.3|32.3|Standard Deviation|7.9|7.9|||
3888614|NCT01527942|3713564|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3888615|NCT01527942|3713565|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3888616|NCT01527942|3713566|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3888617|NCT01527942|3713564|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3888618|NCT01527942|3713565|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3888619|NCT01527942|3713566|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3888620|NCT01527942|3713564|B3|20 to 70 Years||Age, Customized||Participants|Number|34|34.0||||||
3888621|NCT01527942|3713565|B2|20 to 70 Years||Age, Customized||Participants|Number|18|18.0||||||
3888622|NCT01527942|3713566|B1|20 to 70 Years||Age, Customized||Participants|Number|16|16.0||||||
3888623|NCT01527513|3713577|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3888624|NCT01527513|3713578|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3888625|NCT01527513|3713579|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3888626|NCT01527513|3713577|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3888627|NCT01527513|3713578|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3888628|NCT01527513|3713579|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3888629|NCT01527513|3713577|B3|African (Black)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3888630|NCT01527513|3713578|B2|African (Black)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3888631|NCT01527513|3713579|B1|African (Black)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3888632|NCT01527513|3713577|B3|South American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3888633|NCT01527513|3713578|B2|South American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3888634|NCT01527513|3713579|B1|South American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3888635|NCT01527513|3713577|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|122|122.0||||||
3888636|NCT01527513|3713578|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
3888637|NCT01527513|3713579|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
3888638|NCT01527513|3713577|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3888639|NCT01527513|3713578|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3888640|NCT01527513|3713579|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3888641|NCT01527513|3713577|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3888642|NCT01527513|3713578|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3888643|NCT01527513|3713579|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3888644|NCT01527513|3713577|B3|12-16 Years||Age, Customized||participants|Number|69|69.0||||||
3888645|NCT01527513|3713578|B2|12-16 Years||Age, Customized||participants|Number|22|22.0||||||
3888646|NCT01527513|3713579|B1|12-16 Years||Age, Customized||participants|Number|47|47.0||||||
3888647|NCT01527513|3713577|B3|6-11 Years||Age, Customized||participants|Number|54|54.0||||||
3888648|NCT01527513|3713578|B2|6-11 Years||Age, Customized||participants|Number|18|18.0||||||
3888649|NCT01527513|3713579|B1|6-11 Years||Age, Customized||participants|Number|36|36.0||||||
3888650|NCT01527500|3713590|B5||Male|Sex: Female, Male|PART A (N=99, 51), LFG316 (50 mg/50 µL), sham injection every 28 days for 505 days. PART B (N=7, 1), LFG316 (10 mg/100 µL), single sham injection|Participants|Count of Participants|61|61.0||||||
3888651|NCT01527500|3713591|B4||Male|Sex: Female, Male|PART A (N=99, 51), LFG316 (50 mg/50 µL), sham injection every 28 days for 505 days. PART B (N=7, 1), LFG316 (10 mg/100 µL), single sham injection|Participants|Count of Participants|0|0.0||||||
3888652|NCT01527500|3713592|B3||Male|Sex: Female, Male|PART A (N=99, 51), LFG316 (50 mg/50 µL), sham injection every 28 days for 505 days. PART B (N=7, 1), LFG316 (10 mg/100 µL), single sham injection|Participants|Count of Participants|1|1.0||||||
3888653|NCT01527500|3713593|B2||Male|Sex: Female, Male|PART A (N=99, 51), LFG316 (50 mg/50 µL), sham injection every 28 days for 505 days. PART B (N=7, 1), LFG316 (10 mg/100 µL), single sham injection|Participants|Count of Participants|19|19.0||||||
3888654|NCT01527500|3713594|B1||Male|Sex: Female, Male|PART A (N=99, 51), LFG316 (50 mg/50 µL), sham injection every 28 days for 505 days. PART B (N=7, 1), LFG316 (10 mg/100 µL), single sham injection|Participants|Count of Participants|41|41.0||||||
3888655|NCT01527500|3713590|B5||Female|Sex: Female, Male|PART A (N=99, 51), LFG316 (50 mg/50 µL), sham injection every 28 days for 505 days. PART B (N=7, 1), LFG316 (10 mg/100 µL), single sham injection|Participants|Count of Participants|97|97.0||||||
3888656|NCT01527500|3713591|B4||Female|Sex: Female, Male|PART A (N=99, 51), LFG316 (50 mg/50 µL), sham injection every 28 days for 505 days. PART B (N=7, 1), LFG316 (10 mg/100 µL), single sham injection|Participants|Count of Participants|1|1.0||||||
3888657|NCT01527500|3713592|B3||Female|Sex: Female, Male|PART A (N=99, 51), LFG316 (50 mg/50 µL), sham injection every 28 days for 505 days. PART B (N=7, 1), LFG316 (10 mg/100 µL), single sham injection|Participants|Count of Participants|6|6.0||||||
3888658|NCT01527500|3713593|B2||Female|Sex: Female, Male|PART A (N=99, 51), LFG316 (50 mg/50 µL), sham injection every 28 days for 505 days. PART B (N=7, 1), LFG316 (10 mg/100 µL), single sham injection|Participants|Count of Participants|32|32.0||||||
3888659|NCT01527500|3713594|B1||Female|Sex: Female, Male|PART A (N=99, 51), LFG316 (50 mg/50 µL), sham injection every 28 days for 505 days. PART B (N=7, 1), LFG316 (10 mg/100 µL), single sham injection|Participants|Count of Participants|58|58.0||||||
3888660|NCT01527500|3713590|B5|||Age|PART A (N=99, 51), LFG316 (5 mg/50 µL), sham injection every 28 days for 505 days. PART B (N=7, 1), LFG316 (10 mg/100 µL), single sham injection|years|Mean|79.4|79.4|Standard Deviation|7.2|7.2|||
3888661|NCT01527500|3713591|B4|||Age|PART A (N=99, 51), LFG316 (5 mg/50 µL), sham injection every 28 days for 505 days. PART B (N=7, 1), LFG316 (10 mg/100 µL), single sham injection|years|Mean|81.0|81.0|Standard Deviation|NA||||Only a single participant was analyzed therefore there is no SD (NA)
3888662|NCT01527500|3713592|B3|||Age|PART A (N=99, 51), LFG316 (5 mg/50 µL), sham injection every 28 days for 505 days. PART B (N=7, 1), LFG316 (10 mg/100 µL), single sham injection|years|Mean|84.1|84.1|Standard Deviation|3.8|3.8|||
3888663|NCT01527500|3713593|B2|||Age|PART A (N=99, 51), LFG316 (5 mg/50 µL), sham injection every 28 days for 505 days. PART B (N=7, 1), LFG316 (10 mg/100 µL), single sham injection|years|Mean|80.8|80.8|Standard Deviation|6.5|6.5|||
3888664|NCT01527500|3713594|B1|||Age|PART A (N=99, 51), LFG316 (5 mg/50 µL), sham injection every 28 days for 505 days. PART B (N=7, 1), LFG316 (10 mg/100 µL), single sham injection|years|Mean|78.6|78.6|Standard Deviation|7.5|7.5|||
3888665|NCT01527487|3713623|B3|United States||Region of Enrollment||participants|Number|76|76.0||||||
3888666|NCT01527487|3713624|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
3888667|NCT01527487|3713625|B1|United States||Region of Enrollment||participants|Number|54|54.0||||||
3888668|NCT01527487|3713623|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3888669|NCT01527487|3713624|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3888670|NCT01527487|3713625|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3888671|NCT01527487|3713623|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3888672|NCT01527487|3713624|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3888673|NCT01527487|3713625|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3888674|NCT01527487|3713623|B3|||Age||years|Median|52|52.0|Full Range|||23.0|77.0|
3888675|NCT01527487|3713624|B2|||Age||years|Median|51|51.0|Full Range|||38.0|73.0|
3888676|NCT01527487|3713625|B1|||Age||years|Median|53|53.0|Full Range|||23.0|77.0|
3888677|NCT01527370|3713638|B1||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3888678|NCT01527370|3713638|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3888679|NCT01527370|3713638|B1|||Age||Years|Mean|58.6|58.6|Standard Deviation|7.1|7.1|||
3888680|NCT01527162|3713644|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3888681|NCT01527162|3713644|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3888682|NCT01527162|3713644|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3888683|NCT01527162|3713644|B1|||Age||years|Mean|4.3|4.3|Full Range|||3.0|5.9|
3888684|NCT01527162|3713644|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3888685|NCT01527162|3713644|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3888686|NCT01527162|3713644|B1||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
3888687|NCT01527110|3713655|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888688|NCT01527110|3713655|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888689|NCT01527110|3713655|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888690|NCT01527110|3713655|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888691|NCT01527110|3713655|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888692|NCT01527110|3713655|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3888693|NCT01527110|3713655|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888694|NCT01527110|3713655|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3888695|NCT01527110|3713655|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3888696|NCT01527110|3713655|B1|||Age||Years|Mean|67.3|67.3|Standard Deviation|23.58|23.58|||
3888697|NCT01527006|3713700|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3888698|NCT01527006|3713701|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3888699|NCT01527006|3713702|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3888700|NCT01527006|3713700|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3888701|NCT01527006|3713701|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3888702|NCT01527006|3713702|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3888703|NCT01527006|3713700|B3|||Age||Years|Median|7.5|7.5|Full Range|||2.0|11.0|
3888704|NCT01527006|3713701|B2|||Age||Years|Median|9|9.0|Full Range|||7.0|11.0|
3888705|NCT01527006|3713702|B1|||Age||Years|Median|5|5.0|Full Range|||2.0|6.0|
3888706|NCT01526902|3713753|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
3888707|NCT01526902|3713753|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3888708|NCT01526902|3713753|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3888709|NCT01526902|3713753|B1|||Age||years|Mean|53|53.0|Standard Deviation|6|6.0|||
3888710|NCT01526902|3713753|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3888711|NCT01526902|3713753|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3888712|NCT01526902|3713753|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3888713|NCT01526889|3713770|B3||Black|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3888714|NCT01526889|3713771|B2||Black|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3888715|NCT01526889|3713772|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3888716|NCT01526889|3713770|B3||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3888717|NCT01526889|3713771|B2||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3888718|NCT01526889|3713772|B1||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3888719|NCT01526889|3713770|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888720|NCT01526889|3713771|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888721|NCT01526889|3713772|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888722|NCT01526889|3713770|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3888723|NCT01526889|3713771|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3888724|NCT01526889|3713772|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3888725|NCT01526889|3713770|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3888726|NCT01526889|3713771|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888727|NCT01526889|3713772|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3888728|NCT01526889|3713770|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3888729|NCT01526889|3713771|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3888730|NCT01526889|3713772|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3888731|NCT01526889|3713770|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3888732|NCT01526889|3713771|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3888733|NCT01526889|3713772|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3888734|NCT01526889|3713770|B3|||Age||Years|Mean|43.6|43.6|Standard Deviation|14.81|14.81|||
3888735|NCT01526889|3713771|B2|||Age||Years|Mean|39.1|39.1|Standard Deviation|14.89|14.89|||
3888736|NCT01526889|3713772|B1|||Age||Years|Mean|45.3|45.3|Standard Deviation|14.84|14.84|||
3888737|NCT01526785|3713794|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3888738|NCT01526785|3713794|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3888739|NCT01526785|3713794|B1|||Age||years|Mean|4.8|4.8|Standard Deviation|3.73|3.73|||
3888740|NCT01526733|3713804|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3888741|NCT01526733|3713804|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888742|NCT01526733|3713804|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3888743|NCT01526733|3713804|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3888744|NCT01526733|3713804|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888745|NCT01526733|3713804|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888746|NCT01526733|3713804|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3888747|NCT01526733|3713804|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888748|NCT01526733|3713804|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3888749|NCT01526733|3713804|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888750|NCT01526733|3713804|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888751|NCT01526733|3713804|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3888752|NCT01526733|3713804|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3888753|NCT01526733|3713804|B1|||Age||years|Mean|31.6|31.6|Standard Deviation|9.13|9.13|||
3888754|NCT01526629|3713823|B1|France||Region of Enrollment||participants|Number|354|354.0||||||
3888755|NCT01526629|3713823|B1||Male|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
3888756|NCT01526629|3713823|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3888757|NCT01526629|3713823|B1|Women||Age, Customized||years|Mean|56|56.0|Full Range|||42.0|70.0|
3888758|NCT01526629|3713823|B1|Men||Age, Customized||years|Mean|65|65.0|Full Range|||55.0|75.0|
3888759|NCT01526577|3713827|B6||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3888760|NCT01526577|3713828|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3888761|NCT01526577|3713829|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3888762|NCT01526577|3713830|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3888763|NCT01526577|3713831|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3888764|NCT01526577|3713832|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3888765|NCT01526577|3713827|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3888766|NCT01526577|3713828|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3888767|NCT01526577|3713829|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3888768|NCT01526577|3713830|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3888769|NCT01526577|3713831|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3888770|NCT01526577|3713832|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3888771|NCT01526577|3713827|B6|Age||Age||years|Mean|27|27.0|Standard Deviation|4|4.0|||
3888772|NCT01526577|3713828|B5|Age||Age||years|Mean|31|31.0|Standard Deviation|6|6.0|||
3888773|NCT01526577|3713829|B4|Age||Age||years|Mean|26|26.0|Standard Deviation|4|4.0|||
3888774|NCT01526577|3713830|B3|Age||Age||years|Mean|28|28.0|Standard Deviation|4|4.0|||
3888775|NCT01526577|3713831|B2|Age||Age||years|Mean|27|27.0|Standard Deviation|3|3.0|||
3888776|NCT01526577|3713832|B1|Age||Age||years|Mean|27|27.0|Standard Deviation|4|4.0|||
3888777|NCT01526551|3713844|B1|3||Prior doses (baseline)||participants|Number|50|50.0||||||
3888778|NCT01526551|3713844|B1|2||Prior doses (baseline)||participants|Number|5|5.0||||||
3888779|NCT01526551|3713844|B1|1||Prior doses (baseline)||participants|Number|9|9.0||||||
3888780|NCT01526551|3713844|B1|0||Prior doses (baseline)||participants|Number|447|447.0||||||
3888781|NCT01526551|3713844|B1|Unknown||Insurance Status||participants|Number|165|165.0||||||
3888782|NCT01526551|3713844|B1|Underinsured||Insurance Status||participants|Number|28|28.0||||||
3888783|NCT01526551|3713844|B1|No Insurance||Insurance Status||participants|Number|22|22.0||||||
3888784|NCT01526551|3713844|B1|Medicaid/KCHIP||Insurance Status||participants|Number|182|182.0||||||
3888785|NCT01526551|3713844|B1|Insured||Insurance Status||participants|Number|114|114.0||||||
3888786|NCT01526551|3713844|B1|missing||Grade||participants|Number|1|1.0||||||
3888787|NCT01526551|3713844|B1|12th grade||Grade||participants|Number|124|124.0||||||
3888788|NCT01526551|3713844|B1|11th grade||Grade||participants|Number|116|116.0||||||
3888789|NCT01526551|3713844|B1|10th grade||Grade||participants|Number|128|128.0||||||
3888790|NCT01526551|3713844|B1|9th grade||Grade||participants|Number|142|142.0||||||
3888791|NCT01526551|3713844|B1||Male|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
3888792|NCT01526551|3713844|B1||Female|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
3888793|NCT01526551|3713844|B1|Ages 12-20||Age, Customized||participants|Number|511|511.0||||||
3888794|NCT01526538|3713849|B3||Male|Gender||Participants|Count of Participants|27|27.0||||||
3888795|NCT01526538|3713850|B2||Male|Gender||Participants|Count of Participants|12|12.0||||||
3888796|NCT01526538|3713851|B1||Male|Gender||Participants|Count of Participants|15|15.0||||||
3888797|NCT01526538|3713849|B3||Female|Gender||Participants|Count of Participants|12|12.0||||||
3888798|NCT01526538|3713850|B2||Female|Gender||Participants|Count of Participants|6|6.0||||||
3888799|NCT01526538|3713851|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
3888800|NCT01526538|3713849|B3|||Age||years|Mean|51.7|51.7|Standard Deviation|5.1|5.1|||
3888801|NCT01526538|3713850|B2|||Age||years|Mean|52.1|52.1|Standard Deviation|4.9|4.9|||
3888802|NCT01526538|3713851|B1|||Age||years|Mean|51.3|51.3|Standard Deviation|5.3|5.3|||
3888803|NCT01526343|3713862|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
3888804|NCT01526343|3713862|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3888805|NCT01526343|3713862|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3888806|NCT01526343|3713862|B1|||Age||years|Mean|67|67.0|Standard Deviation|10|10.0|||
3888807|NCT01526213|3713867|B7|United States||Region of Enrollment||participants|Number|18|18.0||||||
3888808|NCT01526213|3713868|B6|United States||Region of Enrollment||participants|Number|3|3.0||||||
3888809|NCT01526213|3713869|B5|United States||Region of Enrollment||participants|Number|3|3.0||||||
3888810|NCT01526213|3713870|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
3888811|NCT01526213|3713871|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3888812|NCT01526213|3713872|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3888813|NCT01526213|3713873|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3888814|NCT01526213|3713867|B7||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3888815|NCT01526213|3713868|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3888816|NCT01526213|3713869|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3888817|NCT01526213|3713870|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3888818|NCT01526213|3713871|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3888819|NCT01526213|3713872|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3888820|NCT01526213|3713873|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3888821|NCT01526213|3713867|B7||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3888822|NCT01526213|3713868|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3888823|NCT01526213|3713869|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3888824|NCT01526213|3713870|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3888825|NCT01526213|3713871|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3888826|NCT01526213|3713872|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3888827|NCT01526213|3713873|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3888828|NCT01526213|3713867|B7|Mean||Age||years|Mean|36|36.0|Standard Deviation|12|12.0|||
3888829|NCT01526213|3713868|B6|Mean||Age||years|Mean|30|30.0|Standard Deviation|7.5|7.5|||
3888830|NCT01526213|3713869|B5|Mean||Age||years|Mean|33|33.0|Standard Deviation|9.1|9.1|||
3888831|NCT01526213|3713870|B4|Mean||Age||years|Mean|39|39.0|Standard Deviation|11|11.0|||
3888832|NCT01526213|3713871|B3|Mean||Age||years|Mean|51|51.0|Standard Deviation|11|11.0|||
3888833|NCT01526213|3713872|B2|Mean||Age||years|Mean|34|34.0|Standard Deviation|17|17.0|||
3888834|NCT01526213|3713873|B1|Mean||Age||years|Mean|26|26.0|Standard Deviation|1.0|1.0|||
3888835|NCT01526148|3713889|B3|Bipolar NOS||Diagnosis||participants|Number|2|2.0||||||
3888836|NCT01526148|3713890|B2|Bipolar NOS||Diagnosis||participants|Number|2|2.0||||||
3888837|NCT01526148|3713891|B1|Bipolar NOS||Diagnosis||participants|Number|0|0.0||||||
3888838|NCT01526148|3713889|B3|Bipolar II Disorder||Diagnosis||participants|Number|16|16.0||||||
3888839|NCT01526148|3713890|B2|Bipolar II Disorder||Diagnosis||participants|Number|7|7.0||||||
3888840|NCT01526148|3713891|B1|Bipolar II Disorder||Diagnosis||participants|Number|9|9.0||||||
3888841|NCT01526148|3713889|B3|Bipolar I Disorder||Diagnosis||participants|Number|25|25.0||||||
3888842|NCT01526148|3713890|B2|Bipolar I Disorder||Diagnosis||participants|Number|15|15.0||||||
3888843|NCT01526148|3713891|B1|Bipolar I Disorder||Diagnosis||participants|Number|10|10.0||||||
3888844|NCT01526148|3713889|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888845|NCT01526148|3713890|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888846|NCT01526148|3713891|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888847|NCT01526148|3713889|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888848|NCT01526148|3713890|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888849|NCT01526148|3713891|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888850|NCT01526148|3713889|B3||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3888851|NCT01526148|3713890|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3888852|NCT01526148|3713891|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3888853|NCT01526148|3713889|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3888854|NCT01526148|3713890|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3888855|NCT01526148|3713891|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3888856|NCT01526148|3713889|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888857|NCT01526148|3713890|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888858|NCT01526148|3713891|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888859|NCT01526148|3713889|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3888860|NCT01526148|3713890|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888861|NCT01526148|3713891|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3888862|NCT01526148|3713889|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888863|NCT01526148|3713890|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888864|NCT01526148|3713891|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888865|NCT01526148|3713889|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3888866|NCT01526148|3713890|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3888867|NCT01526148|3713891|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3888868|NCT01526148|3713889|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3888869|NCT01526148|3713890|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3888870|NCT01526148|3713891|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3888871|NCT01526148|3713889|B3|||Age||years|Mean|38.98|38.98|Standard Deviation|14.88|14.88|||
3888872|NCT01526148|3713890|B2|||Age||years|Mean|35.58|35.58|Standard Deviation|12.64|12.64|||
3888873|NCT01526148|3713891|B1|||Age||years|Mean|43.26|43.26|Standard Deviation|16.66|16.66|||
3888874|NCT01525849|3713914|B3|||Sino-Nasal Outcome Test (SNOT-20) overall score|A validated patient-reported survey of 20 items related to sinonasal symptoms and severity assessed over the previous 2 weeks. Each item is scored from 0 (no problem) to 5 (problem as bad as it can be). The individual item scores are averaged to provide an overall score that ranges from 0 (best) to 5 (worst).|units on a scale|Mean|2.50|2.5|Standard Deviation|0.85|0.85|||
3888875|NCT01525849|3713915|B2|||Sino-Nasal Outcome Test (SNOT-20) overall score|A validated patient-reported survey of 20 items related to sinonasal symptoms and severity assessed over the previous 2 weeks. Each item is scored from 0 (no problem) to 5 (problem as bad as it can be). The individual item scores are averaged to provide an overall score that ranges from 0 (best) to 5 (worst).|units on a scale|Mean|2.52|2.52|Standard Deviation|0.83|0.83|||
3888876|NCT01525849|3713916|B1|||Sino-Nasal Outcome Test (SNOT-20) overall score|A validated patient-reported survey of 20 items related to sinonasal symptoms and severity assessed over the previous 2 weeks. Each item is scored from 0 (no problem) to 5 (problem as bad as it can be). The individual item scores are averaged to provide an overall score that ranges from 0 (best) to 5 (worst).|units on a scale|Mean|2.49|2.49|Standard Deviation|0.88|0.88|||
3888877|NCT01525849|3713914|B3|United States||Region of Enrollment||participants|Number|135|135.0||||||
3888878|NCT01525849|3713915|B2|United States||Region of Enrollment||participants|Number|61|61.0||||||
3888879|NCT01525849|3713916|B1|United States||Region of Enrollment||participants|Number|74|74.0||||||
3888880|NCT01525849|3713914|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888881|NCT01525849|3713915|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888882|NCT01525849|3713916|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888883|NCT01525849|3713914|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3888884|NCT01525849|3713915|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888885|NCT01525849|3713916|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3888886|NCT01525849|3713914|B3||White|Race (NIH/OMB)||Participants|Count of Participants|121|121.0||||||
3888887|NCT01525849|3713915|B2||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3888888|NCT01525849|3713916|B1||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3888889|NCT01525849|3713914|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3888890|NCT01525849|3713915|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3888891|NCT01525849|3713916|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3888892|NCT01525849|3713914|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888893|NCT01525849|3713915|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888894|NCT01525849|3713916|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888895|NCT01525849|3713914|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3888896|NCT01525849|3713915|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3888897|NCT01525849|3713916|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3888898|NCT01525849|3713914|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888899|NCT01525849|3713915|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888900|NCT01525849|3713916|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888901|NCT01525849|3713914|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888902|NCT01525849|3713915|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888903|NCT01525849|3713916|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3888966|NCT01525641|3713973|B1||Female|Sex: Female, Male||Participants|Count of Participants|341|341.0||||||
3888904|NCT01525849|3713914|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
3888905|NCT01525849|3713915|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3888906|NCT01525849|3713916|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3888907|NCT01525849|3713914|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3888908|NCT01525849|3713915|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3888909|NCT01525849|3713916|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3888910|NCT01525849|3713914|B3||Male|Gender||Participants|Count of Participants|51|51.0||||||
3888911|NCT01525849|3713915|B2||Male|Gender||Participants|Count of Participants|25|25.0||||||
3888912|NCT01525849|3713916|B1||Male|Gender||Participants|Count of Participants|26|26.0||||||
3888913|NCT01525849|3713914|B3||Female|Gender||Participants|Count of Participants|84|84.0||||||
3888914|NCT01525849|3713915|B2||Female|Gender||Participants|Count of Participants|36|36.0||||||
3888915|NCT01525849|3713916|B1||Female|Gender||Participants|Count of Participants|48|48.0||||||
3888916|NCT01525849|3713914|B3|||Age||years|Mean|46.9|46.9|Standard Deviation|13.8|13.8|||
3888917|NCT01525849|3713915|B2|||Age||years|Mean|47.8|47.8|Standard Deviation|14.1|14.1|||
3888918|NCT01525849|3713916|B1|||Age||years|Mean|46.1|46.1|Standard Deviation|13.6|13.6|||
3888919|NCT01525745|3713931|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3888920|NCT01525745|3713932|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3888921|NCT01525745|3713933|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3888922|NCT01525745|3713931|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3888923|NCT01525745|3713932|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3888924|NCT01525745|3713933|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3888925|NCT01525745|3713931|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3888926|NCT01525745|3713932|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3888927|NCT01525745|3713933|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3888928|NCT01525745|3713931|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3888929|NCT01525745|3713932|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3888930|NCT01525745|3713933|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3888931|NCT01525745|3713931|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3888932|NCT01525745|3713932|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3888933|NCT01525745|3713933|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3888934|NCT01525745|3713931|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3888935|NCT01525745|3713932|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3888936|NCT01525745|3713933|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3888937|NCT01525667|3713948|B4|Germany||Region of Enrollment||participants|Number|20|20.0||||||
3888938|NCT01525667|3713949|B3|Germany||Region of Enrollment||participants|Number|7|7.0||||||
3888939|NCT01525667|3713950|B2|Germany||Region of Enrollment||participants|Number|6|6.0||||||
3888940|NCT01525667|3713951|B1|Germany||Region of Enrollment||participants|Number|7|7.0||||||
3888941|NCT01525667|3713948|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3888942|NCT01525667|3713949|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3888943|NCT01525667|3713950|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3888944|NCT01525667|3713951|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3888945|NCT01525667|3713948|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3888946|NCT01525667|3713949|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3888947|NCT01525667|3713950|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3888948|NCT01525667|3713951|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3888949|NCT01525667|3713948|B4|||Age||years|Mean|64.8|64.8|Standard Deviation|6.2|6.2|||
3888950|NCT01525667|3713949|B3|||Age||years|Mean|64.3|64.3|Standard Deviation|6.4|6.4|||
3888951|NCT01525667|3713950|B2|||Age||years|Mean|64.5|64.5|Standard Deviation|7.4|7.4|||
3888952|NCT01525667|3713951|B1|||Age||years|Mean|65.4|65.4|Standard Deviation|5.9|5.9|||
3888953|NCT01525667|3713948|B4||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3888954|NCT01525667|3713949|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3888955|NCT01525667|3713950|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3888956|NCT01525667|3713951|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3888957|NCT01525667|3713948|B4||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3888958|NCT01525667|3713949|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3888959|NCT01525667|3713950|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3888960|NCT01525667|3713951|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3888961|NCT01525667|3713948|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3888962|NCT01525667|3713949|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3888963|NCT01525667|3713950|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3888964|NCT01525667|3713951|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3888965|NCT01525641|3713973|B1||Male|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
3888967|NCT01525641|3713973|B1|||Age||years|Mean|68.87|68.87|Standard Deviation|9.35|9.35|||
3888968|NCT01525628|3713982|B6||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3888969|NCT01525628|3713983|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3888970|NCT01525628|3713984|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3888971|NCT01525628|3713985|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3888972|NCT01525628|3713986|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3888973|NCT01525628|3713987|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3888974|NCT01525628|3713982|B6||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3888975|NCT01525628|3713983|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3888976|NCT01525628|3713984|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3888977|NCT01525628|3713985|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3888978|NCT01525628|3713986|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3888979|NCT01525628|3713987|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3888980|NCT01525628|3713982|B6|||Age||Years|Mean|51.1|51.1|Standard Deviation|10.9|10.9|||
3888981|NCT01525628|3713983|B5|||Age||Years|Mean|52.1|52.1|Standard Deviation|10.4|10.4|||
3888982|NCT01525628|3713984|B4|||Age||Years|Mean|48.4|48.4|Standard Deviation|12.7|12.7|||
3888983|NCT01525628|3713985|B3|||Age||Years|Mean|53.1|53.1|Standard Deviation|9.5|9.5|||
3888984|NCT01525628|3713986|B2|||Age||Years|Mean|53.6|53.6|Standard Deviation|9.3|9.3|||
3888985|NCT01525628|3713987|B1|||Age||Years|Mean|48.2|48.2|Standard Deviation|12.3|12.3|||
3888986|NCT01525615|3714055|B4||Male|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
3888987|NCT01525615|3714056|B3||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3888988|NCT01525615|3714057|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3888989|NCT01525615|3714058|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3888990|NCT01525615|3714055|B4||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3888991|NCT01525615|3714056|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3888992|NCT01525615|3714057|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3888993|NCT01525615|3714058|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3888994|NCT01525615|3714055|B4|||Age||years|Mean|62.0|62.0|Standard Deviation|7.5|7.5|||
3888995|NCT01525615|3714056|B3|||Age||years|Mean|63.1|63.1|Standard Deviation|7.5|7.5|||
3888996|NCT01525615|3714057|B2|||Age||years|Mean|61.9|61.9|Standard Deviation|7.3|7.3|||
3888997|NCT01525615|3714058|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|7.6|7.6|||
3888998|NCT01525563|3714104|B1|Female||Sex/Gender, Customized|All patients were female|participants|Number|1000|1000.0||||||
3888999|NCT01525563|3714104|B1|Age||Age, Customized||years|Mean|29.2|29.2|Standard Deviation|7.41|7.41|||
3889000|NCT01525550|3714114|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3889001|NCT01525550|3714115|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3889002|NCT01525550|3714116|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3889003|NCT01525550|3714114|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3889004|NCT01525550|3714115|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3889005|NCT01525550|3714116|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3889006|NCT01525550|3714114|B3|||Age||years|Mean|54.6|54.6|Standard Deviation|9.0|9.0|||
3889007|NCT01525550|3714115|B2|||Age||years|Mean|53.5|53.5|Standard Deviation|9.1|9.1|||
3889008|NCT01525550|3714116|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|8.9|8.9|||
3889009|NCT01525420|3714177|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3889010|NCT01525420|3714178|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3889011|NCT01525420|3714179|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3889012|NCT01525420|3714177|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3889013|NCT01525420|3714178|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3889014|NCT01525420|3714179|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3889015|NCT01525420|3714177|B3|||Age||years|Mean|39.1|39.1|Standard Deviation|9.8|9.8|||
3889016|NCT01525420|3714178|B2|||Age||years|Mean|38.6|38.6|Standard Deviation|10.2|10.2|||
3889017|NCT01525420|3714179|B1|||Age||years|Mean|39.6|39.6|Standard Deviation|9.5|9.5|||
3889018|NCT01525407|3714186|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3889019|NCT01525407|3714187|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3889020|NCT01525407|3714188|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3889021|NCT01525407|3714186|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3889022|NCT01525407|3714187|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3889023|NCT01525407|3714188|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889024|NCT01525407|3714186|B3||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3889025|NCT01525407|3714187|B2||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3889026|NCT01525407|3714188|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3889027|NCT01525407|3714186|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889086|NCT01525238|3714220|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3889028|NCT01525407|3714187|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889029|NCT01525407|3714188|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889030|NCT01525407|3714186|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889031|NCT01525407|3714187|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889032|NCT01525407|3714188|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889033|NCT01525407|3714186|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3889034|NCT01525407|3714187|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3889035|NCT01525407|3714188|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3889036|NCT01525407|3714186|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889037|NCT01525407|3714187|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889038|NCT01525407|3714188|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889039|NCT01525407|3714186|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3889040|NCT01525407|3714187|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3889041|NCT01525407|3714188|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3889042|NCT01525407|3714186|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3889043|NCT01525407|3714187|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3889044|NCT01525407|3714188|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3889045|NCT01525407|3714186|B3|||Age||years|Median|53|53.0|Full Range|||22.0|69.0|
3889046|NCT01525407|3714187|B2|||Age||years|Median|52|52.0|Full Range|||24.0|69.0|
3889047|NCT01525407|3714188|B1|||Age||years|Median|54|54.0|Full Range|||22.0|64.0|
3889048|NCT01525329|3714203|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889049|NCT01525329|3714204|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889050|NCT01525329|3714205|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889051|NCT01525329|3714203|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889052|NCT01525329|3714204|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889053|NCT01525329|3714205|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889054|NCT01525329|3714203|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3889055|NCT01525329|3714204|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3889056|NCT01525329|3714205|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3889057|NCT01525329|3714203|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889058|NCT01525329|3714204|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889059|NCT01525329|3714205|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889060|NCT01525329|3714203|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889061|NCT01525329|3714204|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889062|NCT01525329|3714205|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889063|NCT01525329|3714203|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889064|NCT01525329|3714204|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889065|NCT01525329|3714205|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889066|NCT01525329|3714203|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889067|NCT01525329|3714204|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889068|NCT01525329|3714205|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889069|NCT01525329|3714203|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3889070|NCT01525329|3714204|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3889071|NCT01525329|3714205|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3889072|NCT01525329|3714203|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3889073|NCT01525329|3714204|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3889074|NCT01525329|3714205|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3889075|NCT01525329|3714203|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3889076|NCT01525329|3714204|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3889077|NCT01525329|3714205|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3889078|NCT01525329|3714203|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3889079|NCT01525329|3714204|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3889080|NCT01525329|3714205|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3889081|NCT01525329|3714203|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3889082|NCT01525329|3714204|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3889083|NCT01525329|3714205|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3889084|NCT01525238|3714218|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3889085|NCT01525238|3714219|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3889087|NCT01525238|3714221|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3889088|NCT01525238|3714218|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3889089|NCT01525238|3714219|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3889090|NCT01525238|3714220|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3889091|NCT01525238|3714221|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3889092|NCT01525238|3714218|B4|16 to <= 17 years||Age, Customized||participants|Number|10|10.0||||||
3889093|NCT01525238|3714219|B3|16 to <= 17 years||Age, Customized||participants|Number|4|4.0||||||
3889094|NCT01525238|3714220|B2|16 to <= 17 years||Age, Customized||participants|Number|3|3.0||||||
3889095|NCT01525238|3714221|B1|16 to <= 17 years||Age, Customized||participants|Number|3|3.0||||||
3889096|NCT01525238|3714218|B4|10 to <= 15 years||Age, Customized||participants|Number|14|14.0||||||
3889097|NCT01525238|3714219|B3|10 to <= 15 years||Age, Customized||participants|Number|4|4.0||||||
3889098|NCT01525238|3714220|B2|10 to <= 15 years||Age, Customized||participants|Number|5|5.0||||||
3889099|NCT01525238|3714221|B1|10 to <= 15 years||Age, Customized||participants|Number|5|5.0||||||
3889100|NCT01525238|3714218|B4|||Age||years|Mean|14.5|14.5|Standard Deviation|2.04|2.04|||
3889101|NCT01525238|3714219|B3|||Age||years|Mean|14.6|14.6|Standard Deviation|2.13|2.13|||
3889102|NCT01525238|3714220|B2|||Age||years|Mean|14.0|14.0|Standard Deviation|2.39|2.39|||
3889103|NCT01525238|3714221|B1|||Age||years|Mean|15.0|15.0|Standard Deviation|1.69|1.69|||
3889104|NCT01525225|3714288|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3889105|NCT01525225|3714288|B1|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3889106|NCT01525225|3714288|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3889107|NCT01525225|3714288|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3889108|NCT01525225|3714288|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3889109|NCT01525225|3714288|B1|||Age||years|Median|13.0|13.0|Full Range|||10.0|16.0|
3889110|NCT01525173|3714293|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3889111|NCT01525173|3714294|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3889112|NCT01525173|3714295|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3889113|NCT01525173|3714293|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3889114|NCT01525173|3714294|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3889115|NCT01525173|3714295|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3889116|NCT01525173|3714293|B3|||Age||Years|Mean|63.4|63.4|Standard Deviation|13.06|13.06|||
3889117|NCT01525173|3714294|B2|||Age||Years|Mean|61.1|61.1|Standard Deviation|13.91|13.91|||
3889118|NCT01525173|3714295|B1|||Age||Years|Mean|65.7|65.7|Standard Deviation|11.87|11.87|||
3889119|NCT01524978|3714302|B12||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3889120|NCT01524978|3714303|B11||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3889121|NCT01524978|3714304|B10||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3889122|NCT01524978|3714305|B9||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3889123|NCT01524978|3714306|B8||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3889124|NCT01524978|3714307|B7||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3889125|NCT01524978|3714308|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3889126|NCT01524978|3714309|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3889127|NCT01524978|3714310|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3889128|NCT01524978|3714311|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3889129|NCT01524978|3714312|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3889130|NCT01524978|3714313|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3889131|NCT01524978|3714302|B12||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3889132|NCT01524978|3714303|B11||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3889133|NCT01524978|3714304|B10||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3889134|NCT01524978|3714305|B9||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3889135|NCT01524978|3714306|B8||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3889136|NCT01524978|3714307|B7||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3889137|NCT01524978|3714308|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3889138|NCT01524978|3714309|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3889139|NCT01524978|3714310|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3889140|NCT01524978|3714311|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3889141|NCT01524978|3714312|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3889142|NCT01524978|3714313|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3889143|NCT01524978|3714302|B12|||Age||years|Mean|59.0|59.0|Standard Deviation|14.5|14.5|||
3889144|NCT01524978|3714303|B11|||Age||years|Mean|53.7|53.7|Standard Deviation|17.5|17.5|||
3889145|NCT01524978|3714304|B10|||Age||years|Mean|34.3|34.3|Standard Deviation|20.7|20.7|||
3889146|NCT01524978|3714305|B9|||Age||years|Mean|41.6|41.6|Standard Deviation|12.2|12.2|||
3889147|NCT01524978|3714306|B8|||Age||years|Mean|66.8|66.8|Standard Deviation|9.2|9.2|||
3889148|NCT01524978|3714307|B7|||Age||years|Mean|60.8|60.8|Standard Deviation|13.3|13.3|||
3889149|NCT01524978|3714308|B6|||Age||years|Mean|62.1|62.1|Standard Deviation|4.3|4.3|||
3889150|NCT01524978|3714309|B5|||Age||years|Mean|53.2|53.2|Standard Deviation|9.7|9.7|||
3889151|NCT01524978|3714310|B4|||Age||years|Mean|64.3|64.3|Standard Deviation|8.8|8.8|||
3889152|NCT01524978|3714311|B3|||Age||years|Mean|57.3|57.3|Standard Deviation|5.4|5.4|||
3889153|NCT01524978|3714312|B2|||Age||years|Mean|45.8|45.8|Standard Deviation|5.3|5.3|||
3889154|NCT01524978|3714313|B1|||Age||years|Mean|65.4|65.4|Standard Deviation|10.2|10.2|||
3889155|NCT01524913|3714448|B4||No|Crepitus||Participants|Count of Participants|89|89.0||||||
3889156|NCT01524913|3714449|B3||No|Crepitus||Participants|Count of Participants|29|29.0||||||
3889157|NCT01524913|3714450|B2||No|Crepitus||Participants|Count of Participants|30|30.0||||||
3889158|NCT01524913|3714451|B1||No|Crepitus||Participants|Count of Participants|30|30.0||||||
3889159|NCT01524913|3714448|B4||Yes|Crepitus||Participants|Count of Participants|13|13.0||||||
3889160|NCT01524913|3714449|B3||Yes|Crepitus||Participants|Count of Participants|2|2.0||||||
3889161|NCT01524913|3714450|B2||Yes|Crepitus||Participants|Count of Participants|6|6.0||||||
3889162|NCT01524913|3714451|B1||Yes|Crepitus||Participants|Count of Participants|5|5.0||||||
3889163|NCT01524913|3714448|B4||No|Clicking Jaw||Participants|Count of Participants|65|65.0||||||
3889164|NCT01524913|3714449|B3||No|Clicking Jaw||Participants|Count of Participants|22|22.0||||||
3889165|NCT01524913|3714450|B2||No|Clicking Jaw||Participants|Count of Participants|22|22.0||||||
3889166|NCT01524913|3714451|B1||No|Clicking Jaw||Participants|Count of Participants|21|21.0||||||
3889167|NCT01524913|3714448|B4||Yes|Clicking Jaw||Participants|Count of Participants|37|37.0||||||
3889168|NCT01524913|3714449|B3||Yes|Clicking Jaw||Participants|Count of Participants|9|9.0||||||
3889169|NCT01524913|3714450|B2||Yes|Clicking Jaw||Participants|Count of Participants|14|14.0||||||
3889170|NCT01524913|3714451|B1||Yes|Clicking Jaw||Participants|Count of Participants|14|14.0||||||
3889171|NCT01524913|3714448|B4||No|Cervical Pain||Participants|Count of Participants|69|69.0||||||
3889172|NCT01524913|3714449|B3||No|Cervical Pain||Participants|Count of Participants|22|22.0||||||
3889173|NCT01524913|3714450|B2||No|Cervical Pain||Participants|Count of Participants|23|23.0||||||
3889174|NCT01524913|3714451|B1||No|Cervical Pain||Participants|Count of Participants|24|24.0||||||
3889175|NCT01524913|3714448|B4||Yes|Cervical Pain||Participants|Count of Participants|33|33.0||||||
3889176|NCT01524913|3714449|B3||Yes|Cervical Pain||Participants|Count of Participants|9|9.0||||||
3889177|NCT01524913|3714450|B2||Yes|Cervical Pain||Participants|Count of Participants|13|13.0||||||
3889178|NCT01524913|3714451|B1||Yes|Cervical Pain||Participants|Count of Participants|11|11.0||||||
3889179|NCT01524913|3714448|B4||No|Myofascial Pain||Participants|Count of Participants|43|43.0||||||
3889180|NCT01524913|3714449|B3||No|Myofascial Pain||Participants|Count of Participants|11|11.0||||||
3889181|NCT01524913|3714450|B2||No|Myofascial Pain||Participants|Count of Participants|12|12.0||||||
3889182|NCT01524913|3714451|B1||No|Myofascial Pain||Participants|Count of Participants|20|20.0||||||
3889183|NCT01524913|3714448|B4||Yes|Myofascial Pain||Participants|Count of Participants|59|59.0||||||
3889184|NCT01524913|3714449|B3||Yes|Myofascial Pain||Participants|Count of Participants|20|20.0||||||
3889185|NCT01524913|3714450|B2||Yes|Myofascial Pain||Participants|Count of Participants|24|24.0||||||
3889186|NCT01524913|3714451|B1||Yes|Myofascial Pain||Participants|Count of Participants|15|15.0||||||
3889187|NCT01524913|3714448|B4||No|Capsular Pain||Participants|Count of Participants|24|24.0||||||
3889188|NCT01524913|3714449|B3||No|Capsular Pain||Participants|Count of Participants|7|7.0||||||
3889189|NCT01524913|3714450|B2||No|Capsular Pain||Participants|Count of Participants|8|8.0||||||
3889190|NCT01524913|3714451|B1||No|Capsular Pain||Participants|Count of Participants|9|9.0||||||
3889191|NCT01524913|3714448|B4||Yes|Capsular Pain||Participants|Count of Participants|78|78.0||||||
3889192|NCT01524913|3714449|B3||Yes|Capsular Pain||Participants|Count of Participants|24|24.0||||||
3889193|NCT01524913|3714450|B2||Yes|Capsular Pain||Participants|Count of Participants|28|28.0||||||
3889194|NCT01524913|3714451|B1||Yes|Capsular Pain||Participants|Count of Participants|26|26.0||||||
3889195|NCT01524913|3714448|B4||No|Prior TMJ Surgery||Participants|Count of Participants|92|92.0||||||
3889196|NCT01524913|3714449|B3||No|Prior TMJ Surgery||Participants|Count of Participants|30|30.0||||||
3889197|NCT01524913|3714450|B2||No|Prior TMJ Surgery||Participants|Count of Participants|32|32.0||||||
3889198|NCT01524913|3714451|B1||No|Prior TMJ Surgery||Participants|Count of Participants|30|30.0||||||
3889199|NCT01524913|3714448|B4||Yes|Prior TMJ Surgery||Participants|Count of Participants|10|10.0||||||
3889200|NCT01524913|3714449|B3||Yes|Prior TMJ Surgery||Participants|Count of Participants|1|1.0||||||
3889201|NCT01524913|3714450|B2||Yes|Prior TMJ Surgery||Participants|Count of Participants|4|4.0||||||
3889202|NCT01524913|3714451|B1||Yes|Prior TMJ Surgery||Participants|Count of Participants|5|5.0||||||
3889203|NCT01524913|3714448|B4||No|Migraine||Participants|Count of Participants|74|74.0||||||
3889204|NCT01524913|3714449|B3||No|Migraine||Participants|Count of Participants|24|24.0||||||
3889205|NCT01524913|3714450|B2||No|Migraine||Participants|Count of Participants|27|27.0||||||
3889206|NCT01524913|3714451|B1||No|Migraine||Participants|Count of Participants|23|23.0||||||
3889207|NCT01524913|3714448|B4||Yes|Migraine||Participants|Count of Participants|28|28.0||||||
3889208|NCT01524913|3714449|B3||Yes|Migraine||Participants|Count of Participants|7|7.0||||||
3889209|NCT01524913|3714450|B2||Yes|Migraine||Participants|Count of Participants|9|9.0||||||
3889210|NCT01524913|3714451|B1||Yes|Migraine||Participants|Count of Participants|12|12.0||||||
3889211|NCT01524913|3714448|B4||No|Headache||Participants|Count of Participants|50|50.0||||||
3889212|NCT01524913|3714449|B3||No|Headache||Participants|Count of Participants|15|15.0||||||
3889213|NCT01524913|3714450|B2||No|Headache||Participants|Count of Participants|19|19.0||||||
3889214|NCT01524913|3714451|B1||No|Headache||Participants|Count of Participants|16|16.0||||||
3889215|NCT01524913|3714448|B4||Yes|Headache||Participants|Count of Participants|52|52.0||||||
3889216|NCT01524913|3714449|B3||Yes|Headache||Participants|Count of Participants|16|16.0||||||
3889217|NCT01524913|3714450|B2||Yes|Headache||Participants|Count of Participants|17|17.0||||||
3889218|NCT01524913|3714451|B1||Yes|Headache||Participants|Count of Participants|19|19.0||||||
3889219|NCT01524913|3714448|B4|United States||Region of Enrollment||participants|Number|102|102.0||||||
3889220|NCT01524913|3714449|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
3889221|NCT01524913|3714450|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
3889222|NCT01524913|3714451|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3889223|NCT01524913|3714448|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3889224|NCT01524913|3714449|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3889225|NCT01524913|3714450|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3889226|NCT01524913|3714451|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3889227|NCT01524913|3714448|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3889228|NCT01524913|3714449|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3889229|NCT01524913|3714450|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3889230|NCT01524913|3714451|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3889231|NCT01524913|3714448|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|76|76.0||||||
3889232|NCT01524913|3714449|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3889233|NCT01524913|3714450|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3889234|NCT01524913|3714451|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3889235|NCT01524913|3714448|B4|African American||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3889236|NCT01524913|3714449|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3889237|NCT01524913|3714450|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3889238|NCT01524913|3714451|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3889239|NCT01524913|3714448|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3889240|NCT01524913|3714449|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3889241|NCT01524913|3714450|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3889242|NCT01524913|3714451|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3889243|NCT01524913|3714448|B4||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3889244|NCT01524913|3714449|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3889245|NCT01524913|3714450|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3889246|NCT01524913|3714451|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3889247|NCT01524913|3714448|B4|||Age||years|Mean|45.0|45.0|Standard Deviation|18.1|18.1|||
3889248|NCT01524913|3714449|B3|||Age||years|Mean|51.8|51.8|Standard Deviation|17.2|17.2|||
3889249|NCT01524913|3714450|B2|||Age||years|Mean|44.3|44.3|Standard Deviation|17.2|17.2|||
3889250|NCT01524913|3714451|B1|||Age||years|Mean|39.6|39.6|Standard Deviation|18.4|18.4|||
3889251|NCT01524900|3714470|B6|Male||Gender|There are two patients with missing gender information, one in the group of the patients switching from nevirapine IR and one in the group of pretreated patients with HIV RNA>=50.|participants|Number|250|250.0||||||
3889252|NCT01524900|3714471|B5|Male||Gender|There are two patients with missing gender information, one in the group of the patients switching from nevirapine IR and one in the group of pretreated patients with HIV RNA>=50.|participants|Number|21|21.0||||||
3889253|NCT01524900|3714472|B4|Male||Gender|There are two patients with missing gender information, one in the group of the patients switching from nevirapine IR and one in the group of pretreated patients with HIV RNA>=50.|participants|Number|14|14.0||||||
3889254|NCT01524900|3714473|B3|Male||Gender|There are two patients with missing gender information, one in the group of the patients switching from nevirapine IR and one in the group of pretreated patients with HIV RNA>=50.|participants|Number|19|19.0||||||
3889255|NCT01524900|3714474|B2|Male||Gender|There are two patients with missing gender information, one in the group of the patients switching from nevirapine IR and one in the group of pretreated patients with HIV RNA>=50.|participants|Number|155|155.0||||||
3889256|NCT01524900|3714475|B1|Male||Gender|There are two patients with missing gender information, one in the group of the patients switching from nevirapine IR and one in the group of pretreated patients with HIV RNA>=50.|participants|Number|41|41.0||||||
3889257|NCT01524900|3714470|B6|Female||Gender|There are two patients with missing gender information, one in the group of the patients switching from nevirapine IR and one in the group of pretreated patients with HIV RNA>=50.|participants|Number|135|135.0||||||
3889258|NCT01524900|3714471|B5|Female||Gender|There are two patients with missing gender information, one in the group of the patients switching from nevirapine IR and one in the group of pretreated patients with HIV RNA>=50.|participants|Number|19|19.0||||||
3889259|NCT01524900|3714472|B4|Female||Gender|There are two patients with missing gender information, one in the group of the patients switching from nevirapine IR and one in the group of pretreated patients with HIV RNA>=50.|participants|Number|7|7.0||||||
3889260|NCT01524900|3714473|B3|Female||Gender|There are two patients with missing gender information, one in the group of the patients switching from nevirapine IR and one in the group of pretreated patients with HIV RNA>=50.|participants|Number|11|11.0||||||
3889319|NCT01524887|3714523|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3889261|NCT01524900|3714474|B2|Female||Gender|There are two patients with missing gender information, one in the group of the patients switching from nevirapine IR and one in the group of pretreated patients with HIV RNA>=50.|participants|Number|90|90.0||||||
3889262|NCT01524900|3714475|B1|Female||Gender|There are two patients with missing gender information, one in the group of the patients switching from nevirapine IR and one in the group of pretreated patients with HIV RNA>=50.|participants|Number|8|8.0||||||
3889263|NCT01524900|3714470|B6|||Age||years|Mean|38.5|38.5|Standard Deviation|13.1|13.1|||
3889264|NCT01524900|3714471|B5|||Age||years|Mean|37.4|37.4|Standard Deviation|13.2|13.2|||
3889265|NCT01524900|3714472|B4|||Age||years|Mean|33.1|33.1|Standard Deviation|10.4|10.4|||
3889266|NCT01524900|3714473|B3|||Age||years|Mean|38.1|38.1|Standard Deviation|11.1|11.1|||
3889267|NCT01524900|3714474|B2|||Age||years|Mean|39.8|39.8|Standard Deviation|13.8|13.8|||
3889268|NCT01524900|3714475|B1|||Age||years|Mean|34.9|34.9|Standard Deviation|9.9|9.9|||
3889269|NCT01524887|3714521|B4|Japan||Region of Enrollment||participants|Number|2|2.0||||||
3889270|NCT01524887|3714522|B3|Japan||Region of Enrollment||participants|Number|1|1.0||||||
3889271|NCT01524887|3714523|B2|Japan||Region of Enrollment||participants|Number|1|1.0||||||
3889272|NCT01524887|3714524|B1|Japan||Region of Enrollment||participants|Number|0|0.0||||||
3889273|NCT01524887|3714521|B4|Belgium||Region of Enrollment||participants|Number|17|17.0||||||
3889274|NCT01524887|3714522|B3|Belgium||Region of Enrollment||participants|Number|6|6.0||||||
3889275|NCT01524887|3714523|B2|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
3889276|NCT01524887|3714524|B1|Belgium||Region of Enrollment||participants|Number|6|6.0||||||
3889277|NCT01524887|3714521|B4|Spain||Region of Enrollment||participants|Number|11|11.0||||||
3889278|NCT01524887|3714522|B3|Spain||Region of Enrollment||participants|Number|3|3.0||||||
3889279|NCT01524887|3714523|B2|Spain||Region of Enrollment||participants|Number|5|5.0||||||
3889280|NCT01524887|3714524|B1|Spain||Region of Enrollment||participants|Number|3|3.0||||||
3889281|NCT01524887|3714521|B4|Canada||Region of Enrollment||participants|Number|22|22.0||||||
3889282|NCT01524887|3714522|B3|Canada||Region of Enrollment||participants|Number|7|7.0||||||
3889283|NCT01524887|3714523|B2|Canada||Region of Enrollment||participants|Number|7|7.0||||||
3889284|NCT01524887|3714524|B1|Canada||Region of Enrollment||participants|Number|8|8.0||||||
3889285|NCT01524887|3714521|B4|United States||Region of Enrollment||participants|Number|199|199.0||||||
3889286|NCT01524887|3714522|B3|United States||Region of Enrollment||participants|Number|66|66.0||||||
3889287|NCT01524887|3714523|B2|United States||Region of Enrollment||participants|Number|67|67.0||||||
3889288|NCT01524887|3714524|B1|United States||Region of Enrollment||participants|Number|66|66.0||||||
3889289|NCT01524887|3714521|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889290|NCT01524887|3714522|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889291|NCT01524887|3714523|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889292|NCT01524887|3714524|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889293|NCT01524887|3714521|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3889294|NCT01524887|3714522|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889295|NCT01524887|3714523|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3889296|NCT01524887|3714524|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889297|NCT01524887|3714521|B4||White|Race (NIH/OMB)||Participants|Count of Participants|238|238.0||||||
3889298|NCT01524887|3714522|B3||White|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3889299|NCT01524887|3714523|B2||White|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3889300|NCT01524887|3714524|B1||White|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
3889301|NCT01524887|3714521|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3889302|NCT01524887|3714522|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3889303|NCT01524887|3714523|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3889304|NCT01524887|3714524|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3889305|NCT01524887|3714521|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3889306|NCT01524887|3714522|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3889307|NCT01524887|3714523|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889308|NCT01524887|3714524|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3889309|NCT01524887|3714521|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3889310|NCT01524887|3714522|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3889311|NCT01524887|3714523|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3889312|NCT01524887|3714524|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889313|NCT01524887|3714521|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3889314|NCT01524887|3714522|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889315|NCT01524887|3714523|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3889316|NCT01524887|3714524|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889317|NCT01524887|3714521|B4||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3889318|NCT01524887|3714522|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3889320|NCT01524887|3714524|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3889321|NCT01524887|3714521|B4||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3889322|NCT01524887|3714522|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3889323|NCT01524887|3714523|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3889324|NCT01524887|3714524|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3889325|NCT01524887|3714521|B4|||Age||years|Mean|70.8|70.8|Standard Deviation|9.01|9.01|||
3889326|NCT01524887|3714522|B3|||Age||years|Mean|70.6|70.6|Standard Deviation|9.98|9.98|||
3889327|NCT01524887|3714523|B2|||Age||years|Mean|69.9|69.9|Standard Deviation|8.59|8.59|||
3889328|NCT01524887|3714524|B1|||Age||years|Mean|72.0|72.0|Standard Deviation|8.36|8.36|||
3889329|NCT01524796|3714570|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3889330|NCT01524796|3714570|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3889331|NCT01524796|3714570|B1|||Age||Years|Mean|58.2|58.2|Standard Deviation|16.5|16.5|||
3889332|NCT01524783|3714583|B3||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3889333|NCT01524783|3714584|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3889334|NCT01524783|3714585|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3889335|NCT01524783|3714583|B3||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3889336|NCT01524783|3714584|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3889337|NCT01524783|3714585|B1||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3889338|NCT01524783|3714583|B3|||Age||years|Mean|61.7|61.7|Standard Deviation|12.18|12.18|||
3889339|NCT01524783|3714584|B2|||Age||years|Mean|59.4|59.4|Standard Deviation|12.89|12.89|||
3889340|NCT01524783|3714585|B1|||Age||years|Mean|62.9|62.9|Standard Deviation|11.70|11.7|||
3889341|NCT01524770|3714594|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3889342|NCT01524770|3714594|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889343|NCT01524770|3714594|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3889344|NCT01524770|3714594|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3889345|NCT01524770|3714594|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3889346|NCT01524770|3714594|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889347|NCT01524770|3714594|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889348|NCT01524770|3714594|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889349|NCT01524770|3714594|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889350|NCT01524770|3714594|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3889351|NCT01524770|3714594|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3889352|NCT01524770|3714594|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3889353|NCT01524770|3714594|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3889354|NCT01524770|3714594|B1|||Age||years|Mean|42.3|42.3|Standard Deviation|17.2|17.2|||
3889355|NCT01524692|3714605|B1|||ECOG Performance Status|"ECOG PERFORMANCE STATUS~0 Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|units on a scale|Mean|1|1.0|Full Range|||0.0|2.0|
3889356|NCT01524692|3714605|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3889357|NCT01524692|3714605|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3889358|NCT01524692|3714605|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3889359|NCT01524692|3714605|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3889360|NCT01524692|3714605|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889361|NCT01524692|3714605|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3889362|NCT01524692|3714605|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889363|NCT01524692|3714605|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3889364|NCT01524692|3714605|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3889365|NCT01524692|3714605|B1|||Age||years|Median|56|56.0|Full Range|||28.0|75.0|
3889366|NCT01524627|3714613|B3|United States||Region of Enrollment||participants|Number|43|43.0||||||
3889367|NCT01524627|3714614|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
3889368|NCT01524627|3714615|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3889369|NCT01524627|3714613|B3|Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
3889370|NCT01524627|3714614|B2|Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3889371|NCT01524627|3714615|B1|Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3889372|NCT01524627|3714613|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3889373|NCT01524627|3714614|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3889374|NCT01524627|3714615|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3889375|NCT01524627|3714613|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3889376|NCT01524627|3714614|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3889377|NCT01524627|3714615|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3889378|NCT01524627|3714613|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3889379|NCT01524627|3714614|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3889380|NCT01524627|3714615|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3889381|NCT01524627|3714613|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3889382|NCT01524627|3714614|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3889383|NCT01524627|3714615|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3889384|NCT01524627|3714613|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3889385|NCT01524627|3714614|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3889386|NCT01524627|3714615|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3889387|NCT01524627|3714613|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3889388|NCT01524627|3714614|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3889389|NCT01524627|3714615|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3889390|NCT01524627|3714613|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3889391|NCT01524627|3714614|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3889392|NCT01524627|3714615|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3889393|NCT01524627|3714613|B3|||Age||years|Mean|38.1|38.1|Standard Deviation|1.8|1.8|||
3889394|NCT01524627|3714614|B2|||Age||years|Mean|36.2|36.2|Standard Deviation|11.9|11.9|||
3889395|NCT01524627|3714615|B1|||Age||years|Mean|40.6|40.6|Standard Deviation|11.1|11.1|||
3889396|NCT01524302|3714622|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3889397|NCT01524302|3714623|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3889398|NCT01524302|3714624|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3889399|NCT01524302|3714622|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3889400|NCT01524302|3714623|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3889401|NCT01524302|3714624|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3889402|NCT01524302|3714622|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3889403|NCT01524302|3714623|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3889404|NCT01524302|3714624|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3889405|NCT01524302|3714622|B3|||Age||years|Mean|54|54.0|Full Range|||26.0|72.0|
3889406|NCT01524302|3714623|B2|||Age||years|Mean|52|52.0|Full Range|||40.0|61.0|
3889407|NCT01524302|3714624|B1|||Age||years|Mean|56|56.0|Full Range|||26.0|72.0|
3889408|NCT01524302|3714622|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3889409|NCT01524302|3714623|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3889410|NCT01524302|3714624|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3889411|NCT01524302|3714622|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3889412|NCT01524302|3714623|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3889413|NCT01524302|3714624|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3889414|NCT01524302|3714622|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3889415|NCT01524302|3714623|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3889416|NCT01524302|3714624|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3889417|NCT01524198|3714641|B3|Saudi Arabia||Region of Enrollment||participants|Number|906|906.0||||||
3889418|NCT01524198|3714642|B2|Saudi Arabia||Region of Enrollment||participants|Number|458|458.0||||||
3889419|NCT01524198|3714643|B1|Saudi Arabia||Region of Enrollment||participants|Number|448|448.0||||||
3889420|NCT01524198|3714641|B3||Male|Sex: Female, Male||Participants|Count of Participants|589|589.0||||||
3889421|NCT01524198|3714642|B2||Male|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
3889422|NCT01524198|3714643|B1||Male|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
3889423|NCT01524198|3714641|B3||Female|Sex: Female, Male||Participants|Count of Participants|317|317.0||||||
3889424|NCT01524198|3714642|B2||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3889425|NCT01524198|3714643|B1||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3889426|NCT01524198|3714641|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3889427|NCT01524198|3714642|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3889428|NCT01524198|3714643|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3889429|NCT01524198|3714641|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3889430|NCT01524198|3714642|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3889431|NCT01524198|3714643|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3889432|NCT01524198|3714641|B3||<=18 years|Age||Participants|Count of Participants|906|906.0||||||
3889433|NCT01524198|3714642|B2||<=18 years|Age||Participants|Count of Participants|458|458.0||||||
3889434|NCT01524198|3714643|B1||<=18 years|Age||Participants|Count of Participants|448|448.0||||||
3889435|NCT01524133|3714652|B4|United States||Region of Enrollment||Participants|Count of Participants|207|207.0||||||
3889436|NCT01524133|3714653|B3|United States||Region of Enrollment||Participants|Count of Participants|67|67.0||||||
3889437|NCT01524133|3714654|B2|United States||Region of Enrollment||Participants|Count of Participants|69|69.0||||||
3889438|NCT01524133|3714655|B1|United States||Region of Enrollment||Participants|Count of Participants|71|71.0||||||
3889439|NCT01524133|3714652|B4|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3889440|NCT01524133|3714653|B3|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3889441|NCT01524133|3714654|B2|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3889442|NCT01524133|3714655|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3889443|NCT01524133|3714652|B4|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|62|62.0||||||
3889444|NCT01524133|3714653|B3|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3889445|NCT01524133|3714654|B2|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3889446|NCT01524133|3714655|B1|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3889447|NCT01524133|3714652|B4|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|119|119.0||||||
3889448|NCT01524133|3714653|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3889449|NCT01524133|3714654|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3889450|NCT01524133|3714655|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
3889451|NCT01524133|3714652|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889452|NCT01524133|3714653|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889453|NCT01524133|3714654|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889454|NCT01524133|3714655|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889455|NCT01524133|3714652|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|176|176.0||||||
3889456|NCT01524133|3714653|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3889457|NCT01524133|3714654|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3889458|NCT01524133|3714655|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3889459|NCT01524133|3714652|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3889460|NCT01524133|3714653|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3889461|NCT01524133|3714654|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3889462|NCT01524133|3714655|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3889463|NCT01524133|3714652|B4||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3889464|NCT01524133|3714653|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3889465|NCT01524133|3714654|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3889466|NCT01524133|3714655|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3889467|NCT01524133|3714652|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3889468|NCT01524133|3714653|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3889469|NCT01524133|3714654|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3889470|NCT01524133|3714655|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3889471|NCT01524133|3714652|B4|||Age||years|Mean|34.5|34.5|Standard Deviation|8.3|8.3|||
3889472|NCT01524133|3714653|B3|||Age||years|Mean|34.7|34.7|Standard Deviation|8.3|8.3|||
3889473|NCT01524133|3714654|B2|||Age||years|Mean|35.1|35.1|Standard Deviation|8.5|8.5|||
3889474|NCT01524133|3714655|B1|||Age||years|Mean|33.7|33.7|Standard Deviation|8.2|8.2|||
3889475|NCT01523964|3714668|B5|United States||Region of Enrollment||participants|Number|92|92.0||||||
3889476|NCT01523964|3714669|B4|United States||Region of Enrollment||participants|Number|15|15.0||||||
3889477|NCT01523964|3714670|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
3889478|NCT01523964|3714671|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3889479|NCT01523964|3714672|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
3889480|NCT01523964|3714668|B5||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3889481|NCT01523964|3714669|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3889482|NCT01523964|3714670|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3889483|NCT01523964|3714671|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3889484|NCT01523964|3714672|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3889485|NCT01523964|3714668|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3889486|NCT01523964|3714669|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3889487|NCT01523964|3714670|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3889488|NCT01523964|3714671|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3889489|NCT01523964|3714672|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3889490|NCT01523964|3714668|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3889491|NCT01523964|3714669|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3889492|NCT01523964|3714670|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3889493|NCT01523964|3714671|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3889494|NCT01523964|3714672|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3889495|NCT01523964|3714668|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3889496|NCT01523964|3714669|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3889497|NCT01523964|3714670|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3889498|NCT01523964|3714671|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3889499|NCT01523964|3714672|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3889500|NCT01523964|3714668|B5||<=18 years|Age||Participants|Count of Participants|92|92.0||||||
3889501|NCT01523964|3714669|B4||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
3889502|NCT01523964|3714670|B3||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
3889503|NCT01523964|3714671|B2||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
3889504|NCT01523964|3714672|B1||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
3889505|NCT01523899|3714685|B3|United States||Region of Enrollment||participants|Number|252|252.0||||||
3889506|NCT01523899|3714686|B2|United States||Region of Enrollment||participants|Number|126|126.0||||||
3889507|NCT01523899|3714687|B1|United States||Region of Enrollment||participants|Number|126|126.0||||||
3889508|NCT01523899|3714685|B3||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3889509|NCT01523899|3714686|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3889510|NCT01523899|3714687|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3889511|NCT01523899|3714685|B3||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3889512|NCT01523899|3714686|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3889513|NCT01523899|3714687|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3889514|NCT01523899|3714685|B3|||Age||years|Mean|36|36.0|Standard Deviation|13.4|13.4|||
3889515|NCT01523899|3714686|B2|||Age||years|Mean|36.5|36.5|Standard Deviation|13.8|13.8|||
3889516|NCT01523899|3714687|B1|||Age||years|Mean|36|36.0|Standard Deviation|13.4|13.4|||
3889517|NCT01523899|3714685|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3889518|NCT01523899|3714686|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3889519|NCT01523899|3714687|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3889520|NCT01523899|3714685|B3||Between 18 and 65 years|Age||Participants|Count of Participants|252|252.0||||||
3889521|NCT01523899|3714686|B2||Between 18 and 65 years|Age||Participants|Count of Participants|126|126.0||||||
3889522|NCT01523899|3714687|B1||Between 18 and 65 years|Age||Participants|Count of Participants|126|126.0||||||
3889523|NCT01523899|3714685|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3889524|NCT01523899|3714686|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3889525|NCT01523899|3714687|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3889526|NCT01523886|3714698|B3|Denmark||Region of Enrollment||participants|Number|48|48.0||||||
3889527|NCT01523886|3714699|B2|Denmark||Region of Enrollment||participants|Number|23|23.0||||||
3889528|NCT01523886|3714700|B1|Denmark||Region of Enrollment||participants|Number|25|25.0||||||
3889529|NCT01523886|3714698|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3889530|NCT01523886|3714699|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3889531|NCT01523886|3714700|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3889532|NCT01523886|3714698|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3889533|NCT01523886|3714699|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3889534|NCT01523886|3714700|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3889535|NCT01523886|3714698|B3|||Age||years|Median|45|45.0|Inter-Quartile Range|||36.0|56.0|
3889536|NCT01523886|3714699|B2|||Age||years|Median|48|48.0|Inter-Quartile Range|||35.0|59.0|
3889537|NCT01523886|3714700|B1|||Age||years|Median|45|45.0|Inter-Quartile Range|||42.0|49.0|
3889538|NCT01523873|3714707|B1|United Kingdom||Region of Enrollment||participants|Number|1467|1467.0||||||
3889539|NCT01523873|3714707|B1|Spain||Region of Enrollment||participants|Number|1039|1039.0||||||
3889540|NCT01523873|3714707|B1|Saudi Arabia||Region of Enrollment||participants|Number|372|372.0||||||
3889541|NCT01523873|3714707|B1|Italy||Region of Enrollment||participants|Number|328|328.0||||||
3889542|NCT01523873|3714707|B1|India||Region of Enrollment||participants|Number|6803|6803.0||||||
3889543|NCT01523873|3714707|B1|Germany||Region of Enrollment||participants|Number|9988|9988.0||||||
3889544|NCT01523873|3714707|B1|China||Region of Enrollment||participants|Number|7064|7064.0||||||
3889545|NCT01523873|3714707|B1|Austria||Region of Enrollment||participants|Number|703|703.0||||||
3889546|NCT01523873|3714707|B1|Argentina||Region of Enrollment||participants|Number|43|43.0||||||
3889547|NCT01523873|3714707|B1|France||Region of Enrollment||participants|Number|7692|7692.0||||||
3889548|NCT01523873|3714707|B1||Male|Gender||Participants|Count of Participants|16620|16620.0||||||
3889549|NCT01523873|3714707|B1||Female|Gender||Participants|Count of Participants|18838|18838.0||||||
3889550|NCT01523873|3714707|B1|≥65 years||Age, Customized||participants|Number|7735|7735.0||||||
3889551|NCT01523873|3714707|B1|from 18 to 64 years||Age, Customized||participants|Number|26058|26058.0||||||
3889552|NCT01523873|3714707|B1|<18 years||Age, Customized||participants|Number|1631|1631.0||||||
3889553|NCT01523873|3714707|B1|||Age||years|Mean|49.5|49.5|Standard Deviation|17.9|17.9|||
3889554|NCT01523821|3714714|B4|United States||Region of Enrollment||participants|Number|20|20.0||||||
3889555|NCT01523821|3714715|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3889556|NCT01523821|3714716|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3889557|NCT01523821|3714717|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3889558|NCT01523821|3714714|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3889559|NCT01523821|3714715|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3889560|NCT01523821|3714716|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3889561|NCT01523821|3714717|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3889562|NCT01523821|3714714|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3889563|NCT01523821|3714715|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3889564|NCT01523821|3714716|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3889565|NCT01523821|3714717|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3889566|NCT01523821|3714714|B4|||Age||years|Median|48|48.0|Full Range|||23.0|73.0|
3889567|NCT01523821|3714715|B3|||Age||years|Median|51|51.0|Full Range|||38.0|63.0|
3889568|NCT01523821|3714716|B2|||Age||years|Median|40|40.0|Full Range|||26.0|73.0|
3889569|NCT01523821|3714717|B1|||Age||years|Median|49|49.0|Full Range|||23.0|59.0|
3889570|NCT01523821|3714714|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3889571|NCT01523821|3714715|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3889572|NCT01523821|3714716|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3889573|NCT01523821|3714717|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3889574|NCT01523821|3714714|B4||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3889575|NCT01523821|3714715|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3889576|NCT01523821|3714716|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3889577|NCT01523821|3714717|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3889578|NCT01523821|3714714|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3889579|NCT01523821|3714715|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3889580|NCT01523821|3714716|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3889581|NCT01523821|3714717|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3889582|NCT01523782|3714742|B4|France||Region of Enrollment||participants|Number|30|30.0||||||
3889583|NCT01523782|3714743|B3|France||Region of Enrollment||participants|Number|14|14.0||||||
3889584|NCT01523782|3714744|B2|France||Region of Enrollment||participants|Number|13|13.0||||||
3889585|NCT01523782|3714745|B1|France||Region of Enrollment||participants|Number|3|3.0||||||
3889586|NCT01523782|3714742|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3889587|NCT01523782|3714743|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3889588|NCT01523782|3714744|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3889589|NCT01523782|3714745|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3889590|NCT01523782|3714742|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3889591|NCT01523782|3714743|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3889592|NCT01523782|3714744|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3889593|NCT01523782|3714745|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3889594|NCT01523782|3714742|B4|||Age||years|Mean|67.10|67.1|Full Range|||59.0|77.0|
3889595|NCT01523782|3714743|B3|||Age||years|Mean|67.00|67.0|Full Range|||61.0|77.0|
3889596|NCT01523782|3714744|B2|||Age||years|Mean|66.92|66.92|Full Range|||59.0|77.0|
3889597|NCT01523782|3714745|B1|||Age||years|Mean|68.33|68.33|Full Range|||65.0|72.0|
3889598|NCT01523756|3714794|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3889599|NCT01523756|3714794|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3889600|NCT01523756|3714794|B1|||Age||years|Mean|64|64.0|Standard Deviation|10.8|10.8|||
3889601|NCT01523743|3714803|B1|Sweden||Region of Enrollment||participants|Number|28|28.0||||||
3889602|NCT01523743|3714803|B1|Germany||Region of Enrollment||participants|Number|18|18.0||||||
3889603|NCT01523743|3714803|B1|Norway||Region of Enrollment||participants|Number|5|5.0||||||
3889604|NCT01523743|3714803|B1|Denmark||Region of Enrollment||participants|Number|27|27.0||||||
3889605|NCT01523743|3714803|B1|France||Region of Enrollment||participants|Number|40|40.0||||||
3889606|NCT01523743|3714803|B1||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3889607|NCT01523743|3714803|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3889608|NCT01523743|3714803|B1|||Age||years|Mean|53.8|53.8|Standard Deviation|15.5|15.5|||
3889609|NCT01523613|3714810|B4|United States||Region of Enrollment||Participants|Count of Participants|93|93.0||||||
3889610|NCT01523613|3714811|B3|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3889611|NCT01523613|3714812|B2|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3889612|NCT01523613|3714813|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3889613|NCT01523613|3714810|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889614|NCT01523613|3714811|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889615|NCT01523613|3714812|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889616|NCT01523613|3714813|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889617|NCT01523613|3714810|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889618|NCT01523613|3714811|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889619|NCT01523613|3714812|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889620|NCT01523613|3714813|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889621|NCT01523613|3714810|B4||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3889622|NCT01523613|3714811|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3889623|NCT01523613|3714812|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3889624|NCT01523613|3714813|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3889625|NCT01523613|3714810|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3889626|NCT01523613|3714811|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3889627|NCT01523613|3714812|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3889628|NCT01523613|3714813|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3889629|NCT01523613|3714810|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889630|NCT01523613|3714811|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889631|NCT01523613|3714812|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889632|NCT01523613|3714813|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889633|NCT01523613|3714810|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889634|NCT01523613|3714811|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889635|NCT01523613|3714812|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889636|NCT01523613|3714813|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889637|NCT01523613|3714810|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889638|NCT01523613|3714811|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889639|NCT01523613|3714812|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889640|NCT01523613|3714813|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889641|NCT01523613|3714810|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889642|NCT01523613|3714811|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889643|NCT01523613|3714812|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889644|NCT01523613|3714813|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889645|NCT01523613|3714810|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3889646|NCT01523613|3714811|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3889647|NCT01523613|3714812|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3889648|NCT01523613|3714813|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3889649|NCT01523613|3714810|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3889650|NCT01523613|3714811|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3889651|NCT01523613|3714812|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3889652|NCT01523613|3714813|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3889653|NCT01523613|3714810|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3889654|NCT01523613|3714811|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3889655|NCT01523613|3714812|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3889656|NCT01523613|3714813|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3889657|NCT01523613|3714810|B4||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3889658|NCT01523613|3714811|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3889659|NCT01523613|3714812|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3889660|NCT01523613|3714813|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3889661|NCT01523613|3714810|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3889662|NCT01523613|3714811|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3889663|NCT01523613|3714812|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3889664|NCT01523613|3714813|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3889665|NCT01523613|3714810|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3889666|NCT01523613|3714811|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3889667|NCT01523613|3714812|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3889668|NCT01523613|3714813|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3889669|NCT01523613|3714810|B4||<=18 years|Age||Participants|Count of Participants|93|93.0||||||
3889670|NCT01523613|3714811|B3||<=18 years|Age||Participants|Count of Participants|33|33.0||||||
3889671|NCT01523613|3714812|B2||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
3889672|NCT01523613|3714813|B1||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
3889673|NCT01523587|3714825|B3||Male|Sex: Female, Male||Participants|Count of Participants|566|566.0||||||
3889674|NCT01523587|3714826|B2||Male|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
3889675|NCT01523587|3714827|B1||Male|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
3889676|NCT01523587|3714825|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3889677|NCT01523587|3714826|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3889678|NCT01523587|3714827|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3889679|NCT01523587|3714825|B3|||Age||years|Mean|64.1|64.1|Standard Deviation|8.57|8.57|||
3889680|NCT01523587|3714826|B2|||Age||years|Mean|63.4|63.4|Standard Deviation|8.78|8.78|||
3889681|NCT01523587|3714827|B1|||Age||years|Mean|64.9|64.9|Standard Deviation|8.30|8.3|||
3889682|NCT01523587|3714825|B3||>=65 years|Age||Participants|Count of Participants|337|337.0||||||
3889683|NCT01523587|3714826|B2||>=65 years|Age||Participants|Count of Participants|160|160.0||||||
3889684|NCT01523587|3714827|B1||>=65 years|Age||Participants|Count of Participants|177|177.0||||||
3889685|NCT01523587|3714825|B3||Between 18 and 65 years|Age||Participants|Count of Participants|332|332.0||||||
3889686|NCT01523587|3714826|B2||Between 18 and 65 years|Age||Participants|Count of Participants|174|174.0||||||
3889687|NCT01523587|3714827|B1||Between 18 and 65 years|Age||Participants|Count of Participants|158|158.0||||||
3889688|NCT01523587|3714825|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3889689|NCT01523587|3714826|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3889690|NCT01523587|3714827|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3889691|NCT01523496|3714846|B5|United States||Region of Enrollment||participants|Number|190|190.0||||||
3889692|NCT01523496|3714847|B4|United States||Region of Enrollment||participants|Number|30|30.0||||||
3889693|NCT01523496|3714848|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
3889694|NCT01523496|3714849|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
3889695|NCT01523496|3714850|B1|United States||Region of Enrollment||participants|Number|66|66.0||||||
3889696|NCT01523496|3714846|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889697|NCT01523496|3714847|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889698|NCT01523496|3714848|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889699|NCT01523496|3714849|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889700|NCT01523496|3714850|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889701|NCT01523496|3714846|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889702|NCT01523496|3714847|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889703|NCT01523496|3714848|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889704|NCT01523496|3714849|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889705|NCT01523496|3714850|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889706|NCT01523496|3714846|B5||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3889707|NCT01523496|3714847|B4||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3889708|NCT01523496|3714848|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3889709|NCT01523496|3714849|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3889710|NCT01523496|3714850|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3889711|NCT01523496|3714846|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
3889712|NCT01523496|3714847|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3889713|NCT01523496|3714848|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3889714|NCT01523496|3714849|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3889715|NCT01523496|3714850|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3889716|NCT01523496|3714846|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889717|NCT01523496|3714847|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889718|NCT01523496|3714848|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889719|NCT01523496|3714849|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889720|NCT01523496|3714850|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889721|NCT01523496|3714846|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889722|NCT01523496|3714847|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889723|NCT01523496|3714848|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889724|NCT01523496|3714849|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889725|NCT01523496|3714850|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889726|NCT01523496|3714846|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889727|NCT01523496|3714847|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889728|NCT01523496|3714848|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889729|NCT01523496|3714849|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889730|NCT01523496|3714850|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889731|NCT01523496|3714846|B5||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3889732|NCT01523496|3714847|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3889733|NCT01523496|3714848|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3889734|NCT01523496|3714849|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3889735|NCT01523496|3714850|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3889736|NCT01523496|3714846|B5||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3889737|NCT01523496|3714847|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3889738|NCT01523496|3714848|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3889739|NCT01523496|3714849|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3889740|NCT01523496|3714850|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3889741|NCT01523496|3714846|B5|||Age||years|Median|19.9|19.9|Inter-Quartile Range|||15.5|23.0|
3889742|NCT01523496|3714847|B4|||Age||years|Median|18.4|18.4|Inter-Quartile Range|||14.4|22.2|
3889743|NCT01523496|3714848|B3|||Age||years|Median|19.6|19.6|Inter-Quartile Range|||14.4|23.2|
3889744|NCT01523496|3714849|B2|||Age||years|Median|19.9|19.9|Inter-Quartile Range|||15.9|21.6|
3889745|NCT01523496|3714850|B1|||Age||years|Median|20.9|20.9|Inter-Quartile Range|||17.0|23.6|
3889746|NCT01523457|3714867|B3|No||Biliary stent||participants|Number|42|42.0||||||
3889747|NCT01523457|3714868|B2|No||Biliary stent||participants|Number|14|14.0||||||
3889748|NCT01523457|3714869|B1|No||Biliary stent||participants|Number|28|28.0||||||
3889749|NCT01523457|3714867|B3|Yes||Biliary stent||participants|Number|26|26.0||||||
3889750|NCT01523457|3714868|B2|Yes||Biliary stent||participants|Number|17|17.0||||||
3889751|NCT01523457|3714869|B1|Yes||Biliary stent||participants|Number|9|9.0||||||
3889752|NCT01523457|3714867|B3|Elevated, >=59 Upper Limits of Normal||Level of CA19.9|CA 19-9 (carbohydrate antigen 19-9 is a tumor marker that is used primarily in the management of pancreatic cancer. Changes in CA 19-9 levels help determine if the tumor is growing, remaining stable or getting smaller.|participants|Number|19|19.0||||||
3889753|NCT01523457|3714868|B2|Elevated, >=59 Upper Limits of Normal||Level of CA19.9|CA 19-9 (carbohydrate antigen 19-9 is a tumor marker that is used primarily in the management of pancreatic cancer. Changes in CA 19-9 levels help determine if the tumor is growing, remaining stable or getting smaller.|participants|Number|4|4.0||||||
3889754|NCT01523457|3714869|B1|Elevated, >=59 Upper Limits of Normal||Level of CA19.9|CA 19-9 (carbohydrate antigen 19-9 is a tumor marker that is used primarily in the management of pancreatic cancer. Changes in CA 19-9 levels help determine if the tumor is growing, remaining stable or getting smaller.|participants|Number|15|15.0||||||
3889755|NCT01523457|3714867|B3|Elevated, <59 Upper Limits of Normal||Level of CA19.9|CA 19-9 (carbohydrate antigen 19-9 is a tumor marker that is used primarily in the management of pancreatic cancer. Changes in CA 19-9 levels help determine if the tumor is growing, remaining stable or getting smaller.|participants|Number|42|42.0||||||
3889756|NCT01523457|3714868|B2|Elevated, <59 Upper Limits of Normal||Level of CA19.9|CA 19-9 (carbohydrate antigen 19-9 is a tumor marker that is used primarily in the management of pancreatic cancer. Changes in CA 19-9 levels help determine if the tumor is growing, remaining stable or getting smaller.|participants|Number|24|24.0||||||
3889757|NCT01523457|3714869|B1|Elevated, <59 Upper Limits of Normal||Level of CA19.9|CA 19-9 (carbohydrate antigen 19-9 is a tumor marker that is used primarily in the management of pancreatic cancer. Changes in CA 19-9 levels help determine if the tumor is growing, remaining stable or getting smaller.|participants|Number|18|18.0||||||
3889758|NCT01523457|3714867|B3|Normal||Level of CA19.9|CA 19-9 (carbohydrate antigen 19-9 is a tumor marker that is used primarily in the management of pancreatic cancer. Changes in CA 19-9 levels help determine if the tumor is growing, remaining stable or getting smaller.|participants|Number|7|7.0||||||
3889759|NCT01523457|3714868|B2|Normal||Level of CA19.9|CA 19-9 (carbohydrate antigen 19-9 is a tumor marker that is used primarily in the management of pancreatic cancer. Changes in CA 19-9 levels help determine if the tumor is growing, remaining stable or getting smaller.|participants|Number|3|3.0||||||
3889760|NCT01523457|3714869|B1|Normal||Level of CA19.9|CA 19-9 (carbohydrate antigen 19-9 is a tumor marker that is used primarily in the management of pancreatic cancer. Changes in CA 19-9 levels help determine if the tumor is growing, remaining stable or getting smaller.|participants|Number|4|4.0||||||
3889761|NCT01523457|3714867|B3|Tumour Resection||Pancreatic tumour location|Location of the pancreatic tumour in either the head or body of the pancreas. Six subjects had their pancreatic tumour resected (so it is no longer located in the pancreas), but still qualified for the metastatic arm.|participants|Number|6|6.0||||||
3889762|NCT01523457|3714868|B2|Tumour Resection||Pancreatic tumour location|Location of the pancreatic tumour in either the head or body of the pancreas. Six subjects had their pancreatic tumour resected (so it is no longer located in the pancreas), but still qualified for the metastatic arm.|participants|Number|0|0.0||||||
3889763|NCT01523457|3714869|B1|Tumour Resection||Pancreatic tumour location|Location of the pancreatic tumour in either the head or body of the pancreas. Six subjects had their pancreatic tumour resected (so it is no longer located in the pancreas), but still qualified for the metastatic arm.|participants|Number|6|6.0||||||
3889764|NCT01523457|3714867|B3|Body||Pancreatic tumour location|Location of the pancreatic tumour in either the head or body of the pancreas. Six subjects had their pancreatic tumour resected (so it is no longer located in the pancreas), but still qualified for the metastatic arm.|participants|Number|18|18.0||||||
3889765|NCT01523457|3714868|B2|Body||Pancreatic tumour location|Location of the pancreatic tumour in either the head or body of the pancreas. Six subjects had their pancreatic tumour resected (so it is no longer located in the pancreas), but still qualified for the metastatic arm.|participants|Number|4|4.0||||||
3889766|NCT01523457|3714869|B1|Body||Pancreatic tumour location|Location of the pancreatic tumour in either the head or body of the pancreas. Six subjects had their pancreatic tumour resected (so it is no longer located in the pancreas), but still qualified for the metastatic arm.|participants|Number|14|14.0||||||
3889767|NCT01523457|3714867|B3|Head||Pancreatic tumour location|Location of the pancreatic tumour in either the head or body of the pancreas. Six subjects had their pancreatic tumour resected (so it is no longer located in the pancreas), but still qualified for the metastatic arm.|participants|Number|44|44.0||||||
3889768|NCT01523457|3714868|B2|Head||Pancreatic tumour location|Location of the pancreatic tumour in either the head or body of the pancreas. Six subjects had their pancreatic tumour resected (so it is no longer located in the pancreas), but still qualified for the metastatic arm.|participants|Number|27|27.0||||||
3889769|NCT01523457|3714869|B1|Head||Pancreatic tumour location|Location of the pancreatic tumour in either the head or body of the pancreas. Six subjects had their pancreatic tumour resected (so it is no longer located in the pancreas), but still qualified for the metastatic arm.|participants|Number|17|17.0||||||
3889770|NCT01523457|3714867|B3|1: Restricted in physically strenuous activity||ECOG Performance Status||participants|Number|36|36.0||||||
3889771|NCT01523457|3714868|B2|1: Restricted in physically strenuous activity||ECOG Performance Status||participants|Number|16|16.0||||||
3889772|NCT01523457|3714869|B1|1: Restricted in physically strenuous activity||ECOG Performance Status||participants|Number|20|20.0||||||
3889773|NCT01523457|3714867|B3|0: Fully active||ECOG Performance Status||participants|Number|32|32.0||||||
3889774|NCT01523457|3714868|B2|0: Fully active||ECOG Performance Status||participants|Number|15|15.0||||||
3889775|NCT01523457|3714869|B1|0: Fully active||ECOG Performance Status||participants|Number|17|17.0||||||
3889776|NCT01523457|3714867|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3889777|NCT01523457|3714868|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3889778|NCT01523457|3714869|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3889779|NCT01523457|3714867|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3889780|NCT01523457|3714868|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3889781|NCT01523457|3714869|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3889782|NCT01523457|3714867|B3|Age||Age, Customized||years|Median|62|62.0|Full Range|||46.0|79.0|
3889783|NCT01523457|3714868|B2|Age||Age, Customized||years|Median|63|63.0|Full Range|||46.0|79.0|
3889784|NCT01523457|3714869|B1|Age||Age, Customized||years|Median|62|62.0|Full Range|||50.0|77.0|
3889785|NCT01523392|3714886|B3|United States||Region of Enrollment||Participants|Number|34|34.0||||||
3889786|NCT01523392|3714887|B2|United States||Region of Enrollment||Participants|Number|14|14.0||||||
3889787|NCT01523392|3714888|B1|United States||Region of Enrollment||Participants|Number|20|20.0||||||
3889788|NCT01523392|3714886|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|34|34.0||||||
3889789|NCT01523392|3714887|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3889790|NCT01523392|3714888|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
3889791|NCT01523392|3714886|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|34|34.0||||||
3889792|NCT01523392|3714887|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3889793|NCT01523392|3714888|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
3889794|NCT01523392|3714886|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3889795|NCT01523392|3714887|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3889796|NCT01523392|3714888|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3889797|NCT01523392|3714886|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3889798|NCT01523392|3714887|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3889799|NCT01523392|3714888|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3889800|NCT01523392|3714886|B3|>= 65 years||Age, Customized||Participants|Number|12|12.0||||||
3889801|NCT01523392|3714887|B2|>= 65 years||Age, Customized||Participants|Number|4|4.0||||||
3889802|NCT01523392|3714888|B1|>= 65 years||Age, Customized||Participants|Number|8|8.0||||||
3889803|NCT01523392|3714886|B3|>=18 to <65 years||Age, Customized||Participants|Number|22|22.0||||||
3889804|NCT01523392|3714887|B2|>=18 to <65 years||Age, Customized||Participants|Number|10|10.0||||||
3889805|NCT01523392|3714888|B1|>=18 to <65 years||Age, Customized||Participants|Number|12|12.0||||||
3889806|NCT01523392|3714886|B3|<18 years||Age, Customized||Participants|Number|0|0.0||||||
3889807|NCT01523392|3714887|B2|<18 years||Age, Customized||Participants|Number|0|0.0||||||
3889808|NCT01523392|3714888|B1|<18 years||Age, Customized||Participants|Number|0|0.0||||||
3889809|NCT01523366|3714903|B3|United States||Region of Enrollment||Participants|Number|40|40.0||||||
3889810|NCT01523366|3714904|B2|United States||Region of Enrollment||Participants|Number|20|20.0||||||
3889811|NCT01523366|3714905|B1|United States||Region of Enrollment||Participants|Number|20|20.0||||||
3889812|NCT01523366|3714903|B3|United States||Region of Enrollment||Participants|Number|40|40.0||||||
3889813|NCT01523366|3714904|B2|United States||Region of Enrollment||Participants|Number|20|20.0||||||
3889814|NCT01523366|3714905|B1|United States||Region of Enrollment||Participants|Number|20|20.0||||||
3889815|NCT01523366|3714903|B3|Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3889816|NCT01523366|3714904|B2|Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3889817|NCT01523366|3714905|B1|Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3889818|NCT01523366|3714903|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
3889819|NCT01523366|3714904|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
3889820|NCT01523366|3714905|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
3889821|NCT01523366|3714903|B3|Not Reported||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3889822|NCT01523366|3714904|B2|Not Reported||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3889823|NCT01523366|3714905|B1|Not Reported||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3889824|NCT01523366|3714903|B3|White||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
3889825|NCT01523366|3714904|B2|White||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
3889826|NCT01523366|3714905|B1|White||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
3889827|NCT01523366|3714903|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3889828|NCT01523366|3714904|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3889829|NCT01523366|3714905|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3889830|NCT01523366|3714903|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3889831|NCT01523366|3714904|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3889832|NCT01523366|3714905|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3889833|NCT01523366|3714903|B3|>=65 years||Age, Customized||Participants|Number|18|18.0||||||
3889834|NCT01523366|3714904|B2|>=65 years||Age, Customized||Participants|Number|8|8.0||||||
3889835|NCT01523366|3714905|B1|>=65 years||Age, Customized||Participants|Number|10|10.0||||||
3889836|NCT01523366|3714903|B3|Between 18 and 65 years||Age, Customized||Participants|Number|22|22.0||||||
3889837|NCT01523366|3714904|B2|Between 18 and 65 years||Age, Customized||Participants|Number|12|12.0||||||
3889838|NCT01523366|3714905|B1|Between 18 and 65 years||Age, Customized||Participants|Number|10|10.0||||||
3889839|NCT01523366|3714903|B3|<18 years||Age, Customized||Participants|Number|0|0.0||||||
3889840|NCT01523366|3714904|B2|<18 years||Age, Customized||Participants|Number|0|0.0||||||
3889841|NCT01523366|3714905|B1|<18 years||Age, Customized||Participants|Number|0|0.0||||||
3889842|NCT01523301|3714920|B3|||Height||cm|Mean|159.59|159.59|Standard Deviation|8.27|8.27|||
3889843|NCT01523301|3714921|B2|||Height||cm|Mean|159.17|159.17|Standard Deviation|8.14|8.14|||
3889844|NCT01523301|3714922|B1|||Height||cm|Mean|160.04|160.04|Standard Deviation|8.41|8.41|||
3889845|NCT01523301|3714920|B3|||Weight||kg|Mean|61.90|61.9|Standard Deviation|9.76|9.76|||
3889846|NCT01523301|3714921|B2|||Weight||kg|Mean|62.24|62.24|Standard Deviation|9.84|9.84|||
3889847|NCT01523301|3714922|B1|||Weight||kg|Mean|61.54|61.54|Standard Deviation|9.68|9.68|||
3889848|NCT01523301|3714920|B3||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3889849|NCT01523301|3714921|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3889850|NCT01523301|3714922|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3889851|NCT01523301|3714920|B3||Female|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
3889852|NCT01523301|3714921|B2||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3889853|NCT01523301|3714922|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3889854|NCT01523301|3714920|B3|>=65 years||Age, Customized||participants|Number|216|216.0||||||
3889855|NCT01523301|3714921|B2|>=65 years||Age, Customized||participants|Number|108|108.0||||||
3889856|NCT01523301|3714922|B1|>=65 years||Age, Customized||participants|Number|108|108.0||||||
3889857|NCT01523301|3714920|B3|>18-<65 years||Age, Customized||participants|Number|164|164.0||||||
3889858|NCT01523301|3714921|B2|>18-<65 years||Age, Customized||participants|Number|88|88.0||||||
3889859|NCT01523301|3714922|B1|>18-<65 years||Age, Customized||participants|Number|76|76.0||||||
3889860|NCT01523301|3714920|B3|<=18 years||Age, Customized||participants|Number|0|0.0||||||
3889861|NCT01523301|3714921|B2|<=18 years||Age, Customized||participants|Number|0|0.0||||||
3889862|NCT01523301|3714922|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
3889863|NCT01523301|3714920|B3|||Age||years|Mean|65.2|65.2|Standard Deviation|8.5|8.5|||
3889864|NCT01523301|3714921|B2|||Age||years|Mean|64.9|64.9|Standard Deviation|8.2|8.2|||
3889865|NCT01523301|3714922|B1|||Age||years|Mean|65.6|65.6|Standard Deviation|8.9|8.9|||
3889866|NCT01522976|3714941|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3889867|NCT01522976|3714942|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3889868|NCT01522976|3714943|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3889869|NCT01522976|3714944|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3889870|NCT01522976|3714941|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889871|NCT01522976|3714942|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889872|NCT01522976|3714943|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889873|NCT01522976|3714944|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889874|NCT01522976|3714941|B4||White|Race (NIH/OMB)||Participants|Count of Participants|249|249.0||||||
3889875|NCT01522976|3714942|B3||White|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3889876|NCT01522976|3714943|B2||White|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3889877|NCT01522976|3714944|B1||White|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
3889878|NCT01522976|3714941|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3889879|NCT01522976|3714942|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3889880|NCT01522976|3714943|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3889881|NCT01522976|3714944|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3889882|NCT01522976|3714941|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3889883|NCT01522976|3714942|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3889884|NCT01522976|3714943|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889885|NCT01522976|3714944|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889886|NCT01522976|3714941|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3889887|NCT01522976|3714942|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3889888|NCT01522976|3714943|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3889889|NCT01522976|3714944|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3889890|NCT01522976|3714941|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3889891|NCT01522976|3714942|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3889892|NCT01522976|3714943|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889893|NCT01522976|3714944|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3889894|NCT01522976|3714941|B4||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
3889895|NCT01522976|3714942|B3||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3889896|NCT01522976|3714943|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3889897|NCT01522976|3714944|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3889898|NCT01522976|3714941|B4||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3889899|NCT01522976|3714942|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3889900|NCT01522976|3714943|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3889901|NCT01522976|3714944|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3889902|NCT01522976|3714941|B4|||Age||years|Median|70.18|70.18|Full Range|||28.69|93.01|
3889903|NCT01522976|3714942|B3|||Age||years|Median|70.36|70.36|Full Range|||28.69|93.01|
3889904|NCT01522976|3714943|B2|||Age||years|Median|69.67|69.67|Full Range|||42.69|88.96|
3889905|NCT01522976|3714944|B1|||Age||years|Median|70.81|70.81|Full Range|||51.29|86.68|
3889906|NCT01522963|3714969|B5|United States||Region of Enrollment||participants|Number|84|84.0||||||
3889907|NCT01522963|3714970|B4|United States||Region of Enrollment||participants|Number|18|18.0||||||
3889908|NCT01522963|3714971|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
3889909|NCT01522963|3714972|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
3889910|NCT01522963|3714973|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3889911|NCT01522963|3714969|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3889912|NCT01522963|3714970|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3889913|NCT01522963|3714971|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889914|NCT01522963|3714972|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3889915|NCT01522963|3714973|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889916|NCT01522963|3714969|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3889917|NCT01522963|3714970|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3889918|NCT01522963|3714971|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3889919|NCT01522963|3714972|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889920|NCT01522963|3714973|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3889921|NCT01522963|3714969|B5||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3889922|NCT01522963|3714970|B4||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3889923|NCT01522963|3714971|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3889924|NCT01522963|3714972|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3889925|NCT01522963|3714973|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3889926|NCT01522963|3714969|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3889927|NCT01522963|3714970|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3889928|NCT01522963|3714971|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3889929|NCT01522963|3714972|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3889930|NCT01522963|3714973|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3889931|NCT01522963|3714969|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889932|NCT01522963|3714970|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889933|NCT01522963|3714971|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889934|NCT01522963|3714972|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889935|NCT01522963|3714973|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889936|NCT01522963|3714969|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3889937|NCT01522963|3714970|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889938|NCT01522963|3714971|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889939|NCT01522963|3714972|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3889940|NCT01522963|3714973|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889941|NCT01522963|3714969|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3889942|NCT01522963|3714970|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3889943|NCT01522963|3714971|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3889944|NCT01522963|3714972|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3889945|NCT01522963|3714973|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3889946|NCT01522963|3714969|B5||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3889947|NCT01522963|3714970|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3889948|NCT01522963|3714971|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3889949|NCT01522963|3714972|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3889950|NCT01522963|3714973|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3889951|NCT01522963|3714969|B5||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3889952|NCT01522963|3714970|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3889953|NCT01522963|3714971|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3889954|NCT01522963|3714972|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3889955|NCT01522963|3714973|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3889956|NCT01522963|3714969|B5|||Age||years|Mean|38.3|38.3|Standard Deviation|12.9|12.9|||
3889957|NCT01522963|3714970|B4|||Age||years|Mean|37.9|37.9|Standard Deviation|14.1|14.1|||
3889958|NCT01522963|3714971|B3|||Age||years|Mean|38.1|38.1|Standard Deviation|16.2|16.2|||
3889959|NCT01522963|3714972|B2|||Age||years|Mean|39.7|39.7|Standard Deviation|10.9|10.9|||
3889960|NCT01522963|3714973|B1|||Age||years|Mean|37.2|37.2|Standard Deviation|10.6|10.6|||
3889961|NCT01522937|3714988|B1||Male|Gender||Participants|Count of Participants|116|116.0||||||
3889962|NCT01522937|3714988|B1||Female|Gender||Participants|Count of Participants|30|30.0||||||
3889963|NCT01522937|3714988|B1|||Age||years|Mean|65|65.0|Full Range|||25.0|86.0|
3889964|NCT01522924|3714996|B3|United States||Region of Enrollment||participants|Number|94|94.0||||||
3889965|NCT01522924|3714997|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
3889966|NCT01522924|3714998|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
3889967|NCT01522924|3714996|B3|Male||Sex/Gender, Customized|Missing data on one participant. Data is unknown.|participants|Number|58|58.0||||||
3889968|NCT01522924|3714997|B2|Male||Sex/Gender, Customized|Missing data on one participant. Data is unknown.|participants|Number|29|29.0||||||
3889969|NCT01522924|3714998|B1|Male||Sex/Gender, Customized|Missing data on one participant. Data is unknown.|participants|Number|29|29.0||||||
3889970|NCT01522924|3714996|B3|Female||Sex/Gender, Customized|Missing data on one participant. Data is unknown.|participants|Number|35|35.0||||||
3889971|NCT01522924|3714997|B2|Female||Sex/Gender, Customized|Missing data on one participant. Data is unknown.|participants|Number|23|23.0||||||
3889972|NCT01522924|3714998|B1|Female||Sex/Gender, Customized|Missing data on one participant. Data is unknown.|participants|Number|12|12.0||||||
3889973|NCT01522924|3714996|B3|||Age||years|Mean|25.29|25.29|Standard Deviation|3.99|3.99|||
3889974|NCT01522924|3714997|B2|||Age||years|Mean|25.00|25.0|Standard Deviation|3.74|3.74|||
3889975|NCT01522924|3714998|B1|||Age||years|Mean|25.66|25.66|Standard Deviation|4.31|4.31|||
3889976|NCT01522924|3714996|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3889977|NCT01522924|3714997|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3889978|NCT01522924|3714998|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3889979|NCT01522924|3714996|B3||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
3889980|NCT01522924|3714997|B2||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3889981|NCT01522924|3714998|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3889982|NCT01522924|3714996|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3889983|NCT01522924|3714997|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3889984|NCT01522924|3714998|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3889985|NCT01522703|3715017|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3889986|NCT01522703|3715018|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3889987|NCT01522703|3715019|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3889988|NCT01522703|3715017|B3||Male|Gender||Participants|Count of Participants|16|16.0||||||
3889989|NCT01522703|3715018|B2||Male|Gender||Participants|Count of Participants|7|7.0||||||
3889990|NCT01522703|3715019|B1||Male|Gender||Participants|Count of Participants|9|9.0||||||
3889991|NCT01522703|3715017|B3||Female|Gender||Participants|Count of Participants|24|24.0||||||
3889992|NCT01522703|3715018|B2||Female|Gender||Participants|Count of Participants|13|13.0||||||
3889993|NCT01522703|3715019|B1||Female|Gender||Participants|Count of Participants|11|11.0||||||
3889994|NCT01522703|3715017|B3|||Age||years|Mean|33.6|33.6|Standard Deviation|9.4|9.4|||
3889995|NCT01522703|3715018|B2|||Age||years|Mean|34.2|34.2|Standard Deviation|9.2|9.2|||
3889996|NCT01522703|3715019|B1|||Age||years|Mean|33.1|33.1|Standard Deviation|9.6|9.6|||
3889997|NCT01522456|3715026|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3889998|NCT01522456|3715026|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3889999|NCT01522456|3715026|B1|||Age||years|Mean|30.8|30.8|Standard Deviation|9.57|9.57|||
3890000|NCT01522443|3715087|B3||No|Prior cabazitaxel (per IVRS/IWRS)||Participants|Count of Participants|70|70.0||||||
3890001|NCT01522443|3715088|B2||No|Prior cabazitaxel (per IVRS/IWRS)||Participants|Count of Participants|34|34.0||||||
3890002|NCT01522443|3715089|B1||No|Prior cabazitaxel (per IVRS/IWRS)||Participants|Count of Participants|36|36.0||||||
3890003|NCT01522443|3715087|B3||Yes|Prior cabazitaxel (per IVRS/IWRS)||Participants|Count of Participants|49|49.0||||||
3890004|NCT01522443|3715088|B2||Yes|Prior cabazitaxel (per IVRS/IWRS)||Participants|Count of Participants|24|24.0||||||
3890005|NCT01522443|3715089|B1||Yes|Prior cabazitaxel (per IVRS/IWRS)||Participants|Count of Participants|25|25.0||||||
3890006|NCT01522443|3715087|B3|≥5||Number of prior anticancer agents||Participants|Count of Participants|72|72.0||||||
3890007|NCT01522443|3715088|B2|≥5||Number of prior anticancer agents||Participants|Count of Participants|37|37.0||||||
3890008|NCT01522443|3715089|B1|≥5||Number of prior anticancer agents||Participants|Count of Participants|35|35.0||||||
3890009|NCT01522443|3715087|B3|4||Number of prior anticancer agents||Participants|Count of Participants|34|34.0||||||
3890010|NCT01522443|3715088|B2|4||Number of prior anticancer agents||Participants|Count of Participants|14|14.0||||||
3890011|NCT01522443|3715089|B1|4||Number of prior anticancer agents||Participants|Count of Participants|20|20.0||||||
3890012|NCT01522443|3715087|B3|3||Number of prior anticancer agents||Participants|Count of Participants|10|10.0||||||
3890013|NCT01522443|3715088|B2|3||Number of prior anticancer agents||Participants|Count of Participants|4|4.0||||||
3890014|NCT01522443|3715089|B1|3||Number of prior anticancer agents||Participants|Count of Participants|6|6.0||||||
3890015|NCT01522443|3715087|B3|2||Number of prior anticancer agents||Participants|Count of Participants|3|3.0||||||
3890016|NCT01522443|3715088|B2|2||Number of prior anticancer agents||Participants|Count of Participants|3|3.0||||||
3890017|NCT01522443|3715089|B1|2||Number of prior anticancer agents||Participants|Count of Participants|0|0.0||||||
3890018|NCT01522443|3715087|B3|>7-8||Pain score (BPI Item 3) during Run-In Stage|During the Run-In State, subjects will self-report pain by phone via an interactive voice response system (IVRS) daily for 7 days and record analgesic medication information on a paper pain medication diary. Each day of the reporting periods, subjects will report their worst pain intensity and their average pain intensity over a 24-hour period using an 11-point numerical rating system (NRS) (ranging from 0 to 10, with 0 representing “No Pain,” and 10 representing “Pain as Bad as You Can Imagine”).|participants|Number|26|26.0||||||
3890019|NCT01522443|3715088|B2|>7-8||Pain score (BPI Item 3) during Run-In Stage|During the Run-In State, subjects will self-report pain by phone via an interactive voice response system (IVRS) daily for 7 days and record analgesic medication information on a paper pain medication diary. Each day of the reporting periods, subjects will report their worst pain intensity and their average pain intensity over a 24-hour period using an 11-point numerical rating system (NRS) (ranging from 0 to 10, with 0 representing “No Pain,” and 10 representing “Pain as Bad as You Can Imagine”).|participants|Number|15|15.0||||||
3890020|NCT01522443|3715089|B1|>7-8||Pain score (BPI Item 3) during Run-In Stage|During the Run-In State, subjects will self-report pain by phone via an interactive voice response system (IVRS) daily for 7 days and record analgesic medication information on a paper pain medication diary. Each day of the reporting periods, subjects will report their worst pain intensity and their average pain intensity over a 24-hour period using an 11-point numerical rating system (NRS) (ranging from 0 to 10, with 0 representing “No Pain,” and 10 representing “Pain as Bad as You Can Imagine”).|participants|Number|11|11.0||||||
3890021|NCT01522443|3715087|B3|>6-7||Pain score (BPI Item 3) during Run-In Stage|During the Run-In State, subjects will self-report pain by phone via an interactive voice response system (IVRS) daily for 7 days and record analgesic medication information on a paper pain medication diary. Each day of the reporting periods, subjects will report their worst pain intensity and their average pain intensity over a 24-hour period using an 11-point numerical rating system (NRS) (ranging from 0 to 10, with 0 representing “No Pain,” and 10 representing “Pain as Bad as You Can Imagine”).|participants|Number|33|33.0||||||
3890022|NCT01522443|3715088|B2|>6-7||Pain score (BPI Item 3) during Run-In Stage|During the Run-In State, subjects will self-report pain by phone via an interactive voice response system (IVRS) daily for 7 days and record analgesic medication information on a paper pain medication diary. Each day of the reporting periods, subjects will report their worst pain intensity and their average pain intensity over a 24-hour period using an 11-point numerical rating system (NRS) (ranging from 0 to 10, with 0 representing “No Pain,” and 10 representing “Pain as Bad as You Can Imagine”).|participants|Number|15|15.0||||||
3890023|NCT01522443|3715089|B1|>6-7||Pain score (BPI Item 3) during Run-In Stage|During the Run-In State, subjects will self-report pain by phone via an interactive voice response system (IVRS) daily for 7 days and record analgesic medication information on a paper pain medication diary. Each day of the reporting periods, subjects will report their worst pain intensity and their average pain intensity over a 24-hour period using an 11-point numerical rating system (NRS) (ranging from 0 to 10, with 0 representing “No Pain,” and 10 representing “Pain as Bad as You Can Imagine”).|participants|Number|18|18.0||||||
3890024|NCT01522443|3715087|B3|>5-6||Pain score (BPI Item 3) during Run-In Stage|During the Run-In State, subjects will self-report pain by phone via an interactive voice response system (IVRS) daily for 7 days and record analgesic medication information on a paper pain medication diary. Each day of the reporting periods, subjects will report their worst pain intensity and their average pain intensity over a 24-hour period using an 11-point numerical rating system (NRS) (ranging from 0 to 10, with 0 representing “No Pain,” and 10 representing “Pain as Bad as You Can Imagine”).|participants|Number|35|35.0||||||
3890025|NCT01522443|3715088|B2|>5-6||Pain score (BPI Item 3) during Run-In Stage|During the Run-In State, subjects will self-report pain by phone via an interactive voice response system (IVRS) daily for 7 days and record analgesic medication information on a paper pain medication diary. Each day of the reporting periods, subjects will report their worst pain intensity and their average pain intensity over a 24-hour period using an 11-point numerical rating system (NRS) (ranging from 0 to 10, with 0 representing “No Pain,” and 10 representing “Pain as Bad as You Can Imagine”).|participants|Number|13|13.0||||||
3890026|NCT01522443|3715089|B1|>5-6||Pain score (BPI Item 3) during Run-In Stage|During the Run-In State, subjects will self-report pain by phone via an interactive voice response system (IVRS) daily for 7 days and record analgesic medication information on a paper pain medication diary. Each day of the reporting periods, subjects will report their worst pain intensity and their average pain intensity over a 24-hour period using an 11-point numerical rating system (NRS) (ranging from 0 to 10, with 0 representing “No Pain,” and 10 representing “Pain as Bad as You Can Imagine”).|participants|Number|22|22.0||||||
3890057|NCT01522443|3715087|B3|Cyrosurgery||Prior prostate surgery/procedure|Baseline radical prostatectomy with and without retropubic with pelvic lymphadenectomy measures are provided.|participants|Number|1|1.0||||||
3890136|NCT01522443|3715088|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3890027|NCT01522443|3715087|B3|4-5||Pain score (BPI Item 3) during Run-In Stage|During the Run-In State, subjects will self-report pain by phone via an interactive voice response system (IVRS) daily for 7 days and record analgesic medication information on a paper pain medication diary. Each day of the reporting periods, subjects will report their worst pain intensity and their average pain intensity over a 24-hour period using an 11-point numerical rating system (NRS) (ranging from 0 to 10, with 0 representing “No Pain,” and 10 representing “Pain as Bad as You Can Imagine”).|participants|Number|25|25.0||||||
3890028|NCT01522443|3715088|B2|4-5||Pain score (BPI Item 3) during Run-In Stage|During the Run-In State, subjects will self-report pain by phone via an interactive voice response system (IVRS) daily for 7 days and record analgesic medication information on a paper pain medication diary. Each day of the reporting periods, subjects will report their worst pain intensity and their average pain intensity over a 24-hour period using an 11-point numerical rating system (NRS) (ranging from 0 to 10, with 0 representing “No Pain,” and 10 representing “Pain as Bad as You Can Imagine”).|participants|Number|15|15.0||||||
3890029|NCT01522443|3715089|B1|4-5||Pain score (BPI Item 3) during Run-In Stage|During the Run-In State, subjects will self-report pain by phone via an interactive voice response system (IVRS) daily for 7 days and record analgesic medication information on a paper pain medication diary. Each day of the reporting periods, subjects will report their worst pain intensity and their average pain intensity over a 24-hour period using an 11-point numerical rating system (NRS) (ranging from 0 to 10, with 0 representing “No Pain,” and 10 representing “Pain as Bad as You Can Imagine”).|participants|Number|10|10.0||||||
3890030|NCT01522443|3715087|B3|||Pain score (BPI Item 3) during Run-In Stage|During the Run-In State, subjects will self-report pain by phone via an interactive voice response system (IVRS) daily for 7 days and record analgesic medication information on a paper pain medication diary. Each day of the reporting periods, subjects will report their worst pain intensity and their average pain intensity over a 24-hour period using an 11-point numerical rating system (NRS) (ranging from 0 to 10, with 0 representing “No Pain,” and 10 representing “Pain as Bad as You Can Imagine”).|units on a scale|Median|6.00|6.0|Full Range|||4.0|8.0|
3890031|NCT01522443|3715088|B2|||Pain score (BPI Item 3) during Run-In Stage|During the Run-In State, subjects will self-report pain by phone via an interactive voice response system (IVRS) daily for 7 days and record analgesic medication information on a paper pain medication diary. Each day of the reporting periods, subjects will report their worst pain intensity and their average pain intensity over a 24-hour period using an 11-point numerical rating system (NRS) (ranging from 0 to 10, with 0 representing “No Pain,” and 10 representing “Pain as Bad as You Can Imagine”).|units on a scale|Median|6.14|6.14|Full Range|||4.0|8.0|
3890032|NCT01522443|3715089|B1|||Pain score (BPI Item 3) during Run-In Stage|During the Run-In State, subjects will self-report pain by phone via an interactive voice response system (IVRS) daily for 7 days and record analgesic medication information on a paper pain medication diary. Each day of the reporting periods, subjects will report their worst pain intensity and their average pain intensity over a 24-hour period using an 11-point numerical rating system (NRS) (ranging from 0 to 10, with 0 representing “No Pain,” and 10 representing “Pain as Bad as You Can Imagine”).|units on a scale|Median|6.00|6.0|Full Range|||4.0|8.0|
3890033|NCT01522443|3715087|B3|Other soft tissue||Sites of prostate cancer metastasis||participants|Number|10|10.0||||||
3890034|NCT01522443|3715088|B2|Other soft tissue||Sites of prostate cancer metastasis||participants|Number|3|3.0||||||
3890035|NCT01522443|3715089|B1|Other soft tissue||Sites of prostate cancer metastasis||participants|Number|7|7.0||||||
3890036|NCT01522443|3715087|B3|Visceral (soft tissue; lung)||Sites of prostate cancer metastasis||participants|Number|7|7.0||||||
3890037|NCT01522443|3715088|B2|Visceral (soft tissue; lung)||Sites of prostate cancer metastasis||participants|Number|5|5.0||||||
3890038|NCT01522443|3715089|B1|Visceral (soft tissue; lung)||Sites of prostate cancer metastasis||participants|Number|2|2.0||||||
3890039|NCT01522443|3715087|B3|Visceral (soft tissue; liver)||Sites of prostate cancer metastasis||participants|Number|16|16.0||||||
3890040|NCT01522443|3715088|B2|Visceral (soft tissue; liver)||Sites of prostate cancer metastasis||participants|Number|8|8.0||||||
3890041|NCT01522443|3715089|B1|Visceral (soft tissue; liver)||Sites of prostate cancer metastasis||participants|Number|8|8.0||||||
3890042|NCT01522443|3715087|B3|Lymph node||Sites of prostate cancer metastasis||participants|Number|47|47.0||||||
3890043|NCT01522443|3715088|B2|Lymph node||Sites of prostate cancer metastasis||participants|Number|18|18.0||||||
3890044|NCT01522443|3715089|B1|Lymph node||Sites of prostate cancer metastasis||participants|Number|29|29.0||||||
3890045|NCT01522443|3715087|B3|Bone||Sites of prostate cancer metastasis||participants|Number|119|119.0||||||
3890046|NCT01522443|3715088|B2|Bone||Sites of prostate cancer metastasis||participants|Number|58|58.0||||||
3890047|NCT01522443|3715089|B1|Bone||Sites of prostate cancer metastasis||participants|Number|61|61.0||||||
3890048|NCT01522443|3715087|B3|||Bone-scan lesion area (BSLA)||mm^2|Median|72865.0|72865.0|Full Range|||0.0|281936.0|
3890049|NCT01522443|3715088|B2|||Bone-scan lesion area (BSLA)||mm^2|Median|72702.5|72702.5|Full Range|||679.0|281936.0|
3890050|NCT01522443|3715089|B1|||Bone-scan lesion area (BSLA)||mm^2|Median|72865.0|72865.0|Full Range|||0.0|251469.0|
3890051|NCT01522443|3715087|B3|Other||Prior prostate surgery/procedure|Baseline radical prostatectomy with and without retropubic with pelvic lymphadenectomy measures are provided.|participants|Number|107|107.0||||||
3890052|NCT01522443|3715088|B2|Other||Prior prostate surgery/procedure|Baseline radical prostatectomy with and without retropubic with pelvic lymphadenectomy measures are provided.|participants|Number|52|52.0||||||
3890053|NCT01522443|3715089|B1|Other||Prior prostate surgery/procedure|Baseline radical prostatectomy with and without retropubic with pelvic lymphadenectomy measures are provided.|participants|Number|55|55.0||||||
3890054|NCT01522443|3715087|B3|Bilateral orchiectomy||Prior prostate surgery/procedure|Baseline radical prostatectomy with and without retropubic with pelvic lymphadenectomy measures are provided.|participants|Number|6|6.0||||||
3890055|NCT01522443|3715088|B2|Bilateral orchiectomy||Prior prostate surgery/procedure|Baseline radical prostatectomy with and without retropubic with pelvic lymphadenectomy measures are provided.|participants|Number|2|2.0||||||
3890056|NCT01522443|3715089|B1|Bilateral orchiectomy||Prior prostate surgery/procedure|Baseline radical prostatectomy with and without retropubic with pelvic lymphadenectomy measures are provided.|participants|Number|4|4.0||||||
3890058|NCT01522443|3715088|B2|Cyrosurgery||Prior prostate surgery/procedure|Baseline radical prostatectomy with and without retropubic with pelvic lymphadenectomy measures are provided.|participants|Number|1|1.0||||||
3890059|NCT01522443|3715089|B1|Cyrosurgery||Prior prostate surgery/procedure|Baseline radical prostatectomy with and without retropubic with pelvic lymphadenectomy measures are provided.|participants|Number|0|0.0||||||
3890060|NCT01522443|3715087|B3|Radical prostatectomy - without||Prior prostate surgery/procedure|Baseline radical prostatectomy with and without retropubic with pelvic lymphadenectomy measures are provided.|participants|Number|5|5.0||||||
3890061|NCT01522443|3715088|B2|Radical prostatectomy - without||Prior prostate surgery/procedure|Baseline radical prostatectomy with and without retropubic with pelvic lymphadenectomy measures are provided.|participants|Number|2|2.0||||||
3890062|NCT01522443|3715089|B1|Radical prostatectomy - without||Prior prostate surgery/procedure|Baseline radical prostatectomy with and without retropubic with pelvic lymphadenectomy measures are provided.|participants|Number|3|3.0||||||
3890063|NCT01522443|3715087|B3|Radical prostatectomy - with||Prior prostate surgery/procedure|Baseline radical prostatectomy with and without retropubic with pelvic lymphadenectomy measures are provided.|participants|Number|30|30.0||||||
3890064|NCT01522443|3715088|B2|Radical prostatectomy - with||Prior prostate surgery/procedure|Baseline radical prostatectomy with and without retropubic with pelvic lymphadenectomy measures are provided.|participants|Number|13|13.0||||||
3890065|NCT01522443|3715089|B1|Radical prostatectomy - with||Prior prostate surgery/procedure|Baseline radical prostatectomy with and without retropubic with pelvic lymphadenectomy measures are provided.|participants|Number|17|17.0||||||
3890066|NCT01522443|3715087|B3|Transurethral resection of the prostate (TURP)||Prior prostate surgery/procedure|Baseline radical prostatectomy with and without retropubic with pelvic lymphadenectomy measures are provided.|participants|Number|14|14.0||||||
3890067|NCT01522443|3715088|B2|Transurethral resection of the prostate (TURP)||Prior prostate surgery/procedure|Baseline radical prostatectomy with and without retropubic with pelvic lymphadenectomy measures are provided.|participants|Number|6|6.0||||||
3890068|NCT01522443|3715089|B1|Transurethral resection of the prostate (TURP)||Prior prostate surgery/procedure|Baseline radical prostatectomy with and without retropubic with pelvic lymphadenectomy measures are provided.|participants|Number|8|8.0||||||
3890069|NCT01522443|3715087|B3|Missing||Gleason score at diagnosis (Primary + Secondary)|The Gleason score is used to define prostate cancer prognosis by histologic grading with scores ranging from 2 to 10. A higher Gleason score indicates a more aggressive form of prostate cancer with a worse prognosis.|participants|Number|1|1.0||||||
3890070|NCT01522443|3715088|B2|Missing||Gleason score at diagnosis (Primary + Secondary)|The Gleason score is used to define prostate cancer prognosis by histologic grading with scores ranging from 2 to 10. A higher Gleason score indicates a more aggressive form of prostate cancer with a worse prognosis.|participants|Number|1|1.0||||||
3890071|NCT01522443|3715089|B1|Missing||Gleason score at diagnosis (Primary + Secondary)|The Gleason score is used to define prostate cancer prognosis by histologic grading with scores ranging from 2 to 10. A higher Gleason score indicates a more aggressive form of prostate cancer with a worse prognosis.|participants|Number|0|0.0||||||
3890072|NCT01522443|3715087|B3|Unknown||Gleason score at diagnosis (Primary + Secondary)|The Gleason score is used to define prostate cancer prognosis by histologic grading with scores ranging from 2 to 10. A higher Gleason score indicates a more aggressive form of prostate cancer with a worse prognosis.|participants|Number|6|6.0||||||
3890073|NCT01522443|3715088|B2|Unknown||Gleason score at diagnosis (Primary + Secondary)|The Gleason score is used to define prostate cancer prognosis by histologic grading with scores ranging from 2 to 10. A higher Gleason score indicates a more aggressive form of prostate cancer with a worse prognosis.|participants|Number|4|4.0||||||
3890074|NCT01522443|3715089|B1|Unknown||Gleason score at diagnosis (Primary + Secondary)|The Gleason score is used to define prostate cancer prognosis by histologic grading with scores ranging from 2 to 10. A higher Gleason score indicates a more aggressive form of prostate cancer with a worse prognosis.|participants|Number|2|2.0||||||
3890075|NCT01522443|3715087|B3|>7||Gleason score at diagnosis (Primary + Secondary)|The Gleason score is used to define prostate cancer prognosis by histologic grading with scores ranging from 2 to 10. A higher Gleason score indicates a more aggressive form of prostate cancer with a worse prognosis.|participants|Number|68|68.0||||||
3890076|NCT01522443|3715088|B2|>7||Gleason score at diagnosis (Primary + Secondary)|The Gleason score is used to define prostate cancer prognosis by histologic grading with scores ranging from 2 to 10. A higher Gleason score indicates a more aggressive form of prostate cancer with a worse prognosis.|participants|Number|28|28.0||||||
3890077|NCT01522443|3715089|B1|>7||Gleason score at diagnosis (Primary + Secondary)|The Gleason score is used to define prostate cancer prognosis by histologic grading with scores ranging from 2 to 10. A higher Gleason score indicates a more aggressive form of prostate cancer with a worse prognosis.|participants|Number|40|40.0||||||
3890078|NCT01522443|3715087|B3|7||Gleason score at diagnosis (Primary + Secondary)|The Gleason score is used to define prostate cancer prognosis by histologic grading with scores ranging from 2 to 10. A higher Gleason score indicates a more aggressive form of prostate cancer with a worse prognosis.|participants|Number|38|38.0||||||
3890079|NCT01522443|3715088|B2|7||Gleason score at diagnosis (Primary + Secondary)|The Gleason score is used to define prostate cancer prognosis by histologic grading with scores ranging from 2 to 10. A higher Gleason score indicates a more aggressive form of prostate cancer with a worse prognosis.|participants|Number|21|21.0||||||
3890080|NCT01522443|3715089|B1|7||Gleason score at diagnosis (Primary + Secondary)|The Gleason score is used to define prostate cancer prognosis by histologic grading with scores ranging from 2 to 10. A higher Gleason score indicates a more aggressive form of prostate cancer with a worse prognosis.|participants|Number|17|17.0||||||
3890081|NCT01522443|3715087|B3|<7||Gleason score at diagnosis (Primary + Secondary)|The Gleason score is used to define prostate cancer prognosis by histologic grading with scores ranging from 2 to 10. A higher Gleason score indicates a more aggressive form of prostate cancer with a worse prognosis.|participants|Number|6|6.0||||||
3890082|NCT01522443|3715088|B2|<7||Gleason score at diagnosis (Primary + Secondary)|The Gleason score is used to define prostate cancer prognosis by histologic grading with scores ranging from 2 to 10. A higher Gleason score indicates a more aggressive form of prostate cancer with a worse prognosis.|participants|Number|4|4.0||||||
3890083|NCT01522443|3715089|B1|<7||Gleason score at diagnosis (Primary + Secondary)|The Gleason score is used to define prostate cancer prognosis by histologic grading with scores ranging from 2 to 10. A higher Gleason score indicates a more aggressive form of prostate cancer with a worse prognosis.|participants|Number|2|2.0||||||
3890084|NCT01522443|3715087|B3|||Time from initial diagnosis to randomization||years|Median|5.0|5.0|Full Range|||0.0|18.0|
3890085|NCT01522443|3715088|B2|||Time from initial diagnosis to randomization||years|Median|5.3|5.3|Full Range|||0.0|16.0|
3890086|NCT01522443|3715089|B1|||Time from initial diagnosis to randomization||years|Median|4.7|4.7|Full Range|||0.0|18.0|
3890087|NCT01522443|3715087|B3|ECOG ≥ 2 and prior cabazitaxel: no||Randomization Stratification Factors (per IVRS/IWRS)||participants|Number|1|1.0||||||
3890088|NCT01522443|3715088|B2|ECOG ≥ 2 and prior cabazitaxel: no||Randomization Stratification Factors (per IVRS/IWRS)||participants|Number|0|0.0||||||
3890089|NCT01522443|3715089|B1|ECOG ≥ 2 and prior cabazitaxel: no||Randomization Stratification Factors (per IVRS/IWRS)||participants|Number|1|1.0||||||
3890090|NCT01522443|3715087|B3|ECOG ≥ 2 and prior cabazitaxel: yes||Randomization Stratification Factors (per IVRS/IWRS)||participants|Number|13|13.0||||||
3890091|NCT01522443|3715088|B2|ECOG ≥ 2 and prior cabazitaxel: yes||Randomization Stratification Factors (per IVRS/IWRS)||participants|Number|6|6.0||||||
3890092|NCT01522443|3715089|B1|ECOG ≥ 2 and prior cabazitaxel: yes||Randomization Stratification Factors (per IVRS/IWRS)||participants|Number|7|7.0||||||
3890093|NCT01522443|3715087|B3|ECOG = 0-1 and prior cabazitaxel: no||Randomization Stratification Factors (per IVRS/IWRS)||participants|Number|69|69.0||||||
3890094|NCT01522443|3715088|B2|ECOG = 0-1 and prior cabazitaxel: no||Randomization Stratification Factors (per IVRS/IWRS)||participants|Number|34|34.0||||||
3890095|NCT01522443|3715089|B1|ECOG = 0-1 and prior cabazitaxel: no||Randomization Stratification Factors (per IVRS/IWRS)||participants|Number|35|35.0||||||
3890096|NCT01522443|3715087|B3|ECOG = 0-1 and prior cabazitaxel: yes||Randomization Stratification Factors (per IVRS/IWRS)||participants|Number|36|36.0||||||
3890097|NCT01522443|3715088|B2|ECOG = 0-1 and prior cabazitaxel: yes||Randomization Stratification Factors (per IVRS/IWRS)||participants|Number|18|18.0||||||
3890098|NCT01522443|3715089|B1|ECOG = 0-1 and prior cabazitaxel: yes||Randomization Stratification Factors (per IVRS/IWRS)||participants|Number|18|18.0||||||
3890099|NCT01522443|3715087|B3|≥2 (ambulatory to incapable of self-care/death)||ECOG Performance Status (per IVRS/IWRS)||participants|Number|14|14.0||||||
3890100|NCT01522443|3715088|B2|≥2 (ambulatory to incapable of self-care/death)||ECOG Performance Status (per IVRS/IWRS)||participants|Number|6|6.0||||||
3890101|NCT01522443|3715089|B1|≥2 (ambulatory to incapable of self-care/death)||ECOG Performance Status (per IVRS/IWRS)||participants|Number|8|8.0||||||
3890102|NCT01522443|3715087|B3|0-1 (normal to symptoms, but ambulatory)||ECOG Performance Status (per IVRS/IWRS)||participants|Number|105|105.0||||||
3890103|NCT01522443|3715088|B2|0-1 (normal to symptoms, but ambulatory)||ECOG Performance Status (per IVRS/IWRS)||participants|Number|52|52.0||||||
3890104|NCT01522443|3715089|B1|0-1 (normal to symptoms, but ambulatory)||ECOG Performance Status (per IVRS/IWRS)||participants|Number|53|53.0||||||
3890105|NCT01522443|3715087|B3|Asia||Geographic Region||participants|Number|18|18.0||||||
3890106|NCT01522443|3715088|B2|Asia||Geographic Region||participants|Number|9|9.0||||||
3890107|NCT01522443|3715089|B1|Asia||Geographic Region||participants|Number|9|9.0||||||
3890108|NCT01522443|3715087|B3|Europe||Geographic Region||participants|Number|21|21.0||||||
3890109|NCT01522443|3715088|B2|Europe||Geographic Region||participants|Number|13|13.0||||||
3890110|NCT01522443|3715089|B1|Europe||Geographic Region||participants|Number|8|8.0||||||
3890111|NCT01522443|3715087|B3|North America||Geographic Region||participants|Number|80|80.0||||||
3890112|NCT01522443|3715088|B2|North America||Geographic Region||participants|Number|36|36.0||||||
3890113|NCT01522443|3715089|B1|North America||Geographic Region||participants|Number|44|44.0||||||
3890114|NCT01522443|3715087|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3890115|NCT01522443|3715088|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3890116|NCT01522443|3715089|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3890117|NCT01522443|3715087|B3|Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3890118|NCT01522443|3715088|B2|Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3890119|NCT01522443|3715089|B1|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3890120|NCT01522443|3715087|B3|White||Race/Ethnicity, Customized||participants|Number|100|100.0||||||
3890121|NCT01522443|3715088|B2|White||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
3890122|NCT01522443|3715089|B1|White||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
3890123|NCT01522443|3715087|B3|Multiple||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3890124|NCT01522443|3715088|B2|Multiple||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3890125|NCT01522443|3715089|B1|Multiple||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3890126|NCT01522443|3715087|B3|Black/African-American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3890127|NCT01522443|3715088|B2|Black/African-American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3890128|NCT01522443|3715089|B1|Black/African-American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3890129|NCT01522443|3715087|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3890130|NCT01522443|3715088|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3890131|NCT01522443|3715089|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3890132|NCT01522443|3715087|B3|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3890133|NCT01522443|3715088|B2|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3890134|NCT01522443|3715089|B1|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3890135|NCT01522443|3715087|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3890137|NCT01522443|3715089|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3890138|NCT01522443|3715087|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|114|114.0||||||
3890139|NCT01522443|3715088|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3890140|NCT01522443|3715089|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3890141|NCT01522443|3715087|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3890142|NCT01522443|3715088|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890143|NCT01522443|3715089|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3890144|NCT01522443|3715087|B3||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3890145|NCT01522443|3715088|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3890146|NCT01522443|3715089|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3890147|NCT01522443|3715087|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3890148|NCT01522443|3715088|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3890149|NCT01522443|3715089|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3890150|NCT01522443|3715087|B3|75 to <85 years||Age, Customized||participants|Number|13|13.0||||||
3890151|NCT01522443|3715088|B2|75 to <85 years||Age, Customized||participants|Number|6|6.0||||||
3890152|NCT01522443|3715089|B1|75 to <85 years||Age, Customized||participants|Number|7|7.0||||||
3890153|NCT01522443|3715087|B3|65 to <75 years||Age, Customized||participants|Number|56|56.0||||||
3890154|NCT01522443|3715088|B2|65 to <75 years||Age, Customized||participants|Number|26|26.0||||||
3890155|NCT01522443|3715089|B1|65 to <75 years||Age, Customized||participants|Number|30|30.0||||||
3890156|NCT01522443|3715087|B3|<65 years||Age, Customized||participants|Number|50|50.0||||||
3890157|NCT01522443|3715088|B2|<65 years||Age, Customized||participants|Number|26|26.0||||||
3890158|NCT01522443|3715089|B1|<65 years||Age, Customized||participants|Number|24|24.0||||||
3890159|NCT01522404|3715100|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
3890160|NCT01522404|3715101|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3890161|NCT01522404|3715102|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3890162|NCT01522404|3715100|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890163|NCT01522404|3715101|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890164|NCT01522404|3715102|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890165|NCT01522404|3715100|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890166|NCT01522404|3715101|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890167|NCT01522404|3715102|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890168|NCT01522404|3715100|B3||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3890169|NCT01522404|3715101|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3890170|NCT01522404|3715102|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3890171|NCT01522404|3715100|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890172|NCT01522404|3715101|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890173|NCT01522404|3715102|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890174|NCT01522404|3715100|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890175|NCT01522404|3715101|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890176|NCT01522404|3715102|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890177|NCT01522404|3715100|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890178|NCT01522404|3715101|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890179|NCT01522404|3715102|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890180|NCT01522404|3715100|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890181|NCT01522404|3715101|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890182|NCT01522404|3715102|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890183|NCT01522404|3715100|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890184|NCT01522404|3715101|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890185|NCT01522404|3715102|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890186|NCT01522404|3715100|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3890187|NCT01522404|3715101|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3890188|NCT01522404|3715102|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3890189|NCT01522404|3715100|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3890190|NCT01522404|3715101|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890191|NCT01522404|3715102|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3890192|NCT01522404|3715100|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3890193|NCT01522404|3715101|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3890194|NCT01522404|3715102|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3890195|NCT01522404|3715100|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3890196|NCT01522404|3715101|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3890197|NCT01522404|3715102|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3890198|NCT01522404|3715100|B3|||Age||years|Mean|71.1|71.1|Standard Deviation|6.6|6.6|||
3890199|NCT01522404|3715101|B2|||Age||years|Mean|72.0|72.0|Standard Deviation|7.5|7.5|||
3890200|NCT01522404|3715102|B1|||Age||years|Mean|70.2|70.2|Standard Deviation|5.7|5.7|||
3890201|NCT01522404|3715100|B3||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
3890202|NCT01522404|3715101|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3890203|NCT01522404|3715102|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3890204|NCT01522404|3715100|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3890205|NCT01522404|3715101|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3890206|NCT01522404|3715102|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3890207|NCT01522404|3715100|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890208|NCT01522404|3715101|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890209|NCT01522404|3715102|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890210|NCT01522391|3715115|B3|Sweden||Region of Enrollment||participants|Number|41|41.0||||||
3890211|NCT01522391|3715116|B2|Sweden||Region of Enrollment||participants|Number|21|21.0||||||
3890212|NCT01522391|3715117|B1|Sweden||Region of Enrollment||participants|Number|20|20.0||||||
3890213|NCT01522391|3715115|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3890214|NCT01522391|3715116|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3890215|NCT01522391|3715117|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3890216|NCT01522391|3715115|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3890217|NCT01522391|3715116|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3890218|NCT01522391|3715117|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3890219|NCT01522391|3715115|B3|||Age||years|Mean|32.5|32.5|Standard Deviation|13.9|13.9|||
3890220|NCT01522391|3715116|B2|||Age||years|Mean|33.1|33.1|Standard Deviation|13.5|13.5|||
3890221|NCT01522391|3715117|B1|||Age||years|Mean|31.9|31.9|Standard Deviation|14.6|14.6|||
3890222|NCT01522391|3715115|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3890223|NCT01522391|3715116|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3890224|NCT01522391|3715117|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3890225|NCT01522391|3715115|B3||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3890226|NCT01522391|3715116|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3890227|NCT01522391|3715117|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3890228|NCT01522391|3715115|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890229|NCT01522391|3715116|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890230|NCT01522391|3715117|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890231|NCT01522339|3715178|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3890232|NCT01522339|3715178|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3890233|NCT01522339|3715178|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3890234|NCT01522339|3715178|B1|||Age||years|Mean|.19|0.19|Standard Deviation|.09|0.09|||
3890235|NCT01522339|3715178|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3890236|NCT01522339|3715178|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3890237|NCT01522339|3715178|B1||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
3890238|NCT01522235|3715183|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3890239|NCT01522235|3715184|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3890240|NCT01522235|3715185|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3890241|NCT01522235|3715183|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3890242|NCT01522235|3715184|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3890243|NCT01522235|3715185|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3890244|NCT01522235|3715183|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3890245|NCT01522235|3715184|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3890246|NCT01522235|3715185|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3890247|NCT01522235|3715183|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3890248|NCT01522235|3715184|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3890249|NCT01522235|3715185|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3890250|NCT01522235|3715183|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890251|NCT01522235|3715184|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890252|NCT01522235|3715185|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890253|NCT01522131|3715202|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
3890254|NCT01522131|3715203|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3890255|NCT01522131|3715204|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3890256|NCT01522131|3715202|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3890257|NCT01522131|3715203|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3890258|NCT01522131|3715204|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3890259|NCT01522131|3715202|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3890260|NCT01522131|3715203|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3890261|NCT01522131|3715204|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3890262|NCT01522131|3715202|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3890263|NCT01522131|3715203|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3890264|NCT01522131|3715204|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3890265|NCT01522131|3715202|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3890266|NCT01522131|3715203|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3890267|NCT01522131|3715204|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3890268|NCT01522131|3715202|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890269|NCT01522131|3715203|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890270|NCT01522131|3715204|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890271|NCT01521949|3715213|B1|||Baseline PSA||ng/dL|Median|2.74|2.74|Full Range|||0.33|43.4|
3890272|NCT01521949|3715213|B1||Gleason 8, 9, 10 (4+4, 4+5, 5+4, 5+5)|Gleason Score|Gleason score is a system of grading prostate cancer tissue. A pathologist examines each biopsy core and determines a Gleason sum (X+Y=Z), ranging from 6 to 10. Gleason 6 cancers appear similar to normal prostate tissue and indicate that the tumor is less likely to spread and that have a low risk of recurrence after initial treatment. Gleason 8, 9, 10 cancers are high risk cancers, indicating that the tumor is more likely to spread and there is a high risk of cancer recurrence after initial treatment. Gleason 7 cancers are considered intermediate risk.|Participants|Count of Participants|4|4.0||||||
3890273|NCT01521949|3715213|B1||Gleason 7 (3+4 or 4+3)|Gleason Score|Gleason score is a system of grading prostate cancer tissue. A pathologist examines each biopsy core and determines a Gleason sum (X+Y=Z), ranging from 6 to 10. Gleason 6 cancers appear similar to normal prostate tissue and indicate that the tumor is less likely to spread and that have a low risk of recurrence after initial treatment. Gleason 8, 9, 10 cancers are high risk cancers, indicating that the tumor is more likely to spread and there is a high risk of cancer recurrence after initial treatment. Gleason 7 cancers are considered intermediate risk.|Participants|Count of Participants|14|14.0||||||
3890274|NCT01521949|3715213|B1||Gleason 6 (3+3)|Gleason Score|Gleason score is a system of grading prostate cancer tissue. A pathologist examines each biopsy core and determines a Gleason sum (X+Y=Z), ranging from 6 to 10. Gleason 6 cancers appear similar to normal prostate tissue and indicate that the tumor is less likely to spread and that have a low risk of recurrence after initial treatment. Gleason 8, 9, 10 cancers are high risk cancers, indicating that the tumor is more likely to spread and there is a high risk of cancer recurrence after initial treatment. Gleason 7 cancers are considered intermediate risk.|Participants|Count of Participants|3|3.0||||||
3890275|NCT01521949|3715213|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3890276|NCT01521949|3715213|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3890277|NCT01521949|3715213|B1|||Age||years|Median|69|69.0|Full Range|||54.0|80.0|
3890278|NCT01521923|3715218|B5||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3890279|NCT01521923|3715219|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3890280|NCT01521923|3715220|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3890281|NCT01521923|3715221|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3890282|NCT01521923|3715222|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3890283|NCT01521923|3715218|B5||Female|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
3890284|NCT01521923|3715219|B4||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3890285|NCT01521923|3715220|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3890286|NCT01521923|3715221|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3890287|NCT01521923|3715222|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3890288|NCT01521923|3715218|B5|||Age||years|Mean|49.2|49.2|Standard Deviation|13.3|13.3|||
3890289|NCT01521923|3715219|B4|||Age||years|Mean|49.1|49.1|Standard Deviation|13.2|13.2|||
3890290|NCT01521923|3715220|B3|||Age||years|Mean|49.1|49.1|Standard Deviation|12.5|12.5|||
3890291|NCT01521923|3715221|B2|||Age||years|Mean|47.9|47.9|Standard Deviation|14.1|14.1|||
3890292|NCT01521923|3715222|B1|||Age||years|Mean|51.2|51.2|Standard Deviation|13.7|13.7|||
3890293|NCT01521923|3715218|B5||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
3890294|NCT01521923|3715219|B4||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3890295|NCT01521923|3715220|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3890296|NCT01521923|3715221|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3890297|NCT01521923|3715222|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3890298|NCT01521923|3715218|B5||Between 18 and 65 years|Age||Participants|Count of Participants|310|310.0||||||
3890299|NCT01521923|3715219|B4||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
3890300|NCT01521923|3715220|B3||Between 18 and 65 years|Age||Participants|Count of Participants|114|114.0||||||
3890301|NCT01521923|3715221|B2||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
3890302|NCT01521923|3715222|B1||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3890303|NCT01521923|3715218|B5||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3890304|NCT01521923|3715219|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890305|NCT01521923|3715220|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3890306|NCT01521923|3715221|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890307|NCT01521923|3715222|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890308|NCT01521897|3715345|B1||Male|Sex: Female, Male|Participants were vaccinated with Prevenar™ (7-valent) according to the Japanese package insert.|Participants|Count of Participants|570|570.0||||||
3890309|NCT01521897|3715345|B1||Female|Sex: Female, Male|Participants were vaccinated with Prevenar™ (7-valent) according to the Japanese package insert.|Participants|Count of Participants|550|550.0||||||
3890310|NCT01521897|3715345|B1|6 to 7 < Months||Age, Customized|Participants were vaccinated with Prevenar™ (7-valent) according to the Japanese package insert (age in months at the first vaccination).|Participants|Number|76|76.0||||||
3890311|NCT01521897|3715345|B1|4 to 6 < Months||Age, Customized|Participants were vaccinated with Prevenar™ (7-valent) according to the Japanese package insert (age in months at the first vaccination).|Participants|Number|516|516.0||||||
3890312|NCT01521897|3715345|B1|2 to 4 < Months||Age, Customized|Participants were vaccinated with Prevenar™ (7-valent) according to the Japanese package insert (age in months at the first vaccination).|Participants|Number|528|528.0||||||
3890313|NCT01521884|3715357|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3890314|NCT01521884|3715357|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3890315|NCT01521884|3715357|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|11.28|11.28|||
3890316|NCT01521871|3715374|B3|Norway||Region of Enrollment||participants|Number|64|64.0||||||
3890317|NCT01521871|3715375|B2|Norway||Region of Enrollment||participants|Number|32|32.0||||||
3890318|NCT01521871|3715376|B1|Norway||Region of Enrollment||participants|Number|32|32.0||||||
3890319|NCT01521871|3715374|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3890320|NCT01521871|3715375|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3890321|NCT01521871|3715376|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3890322|NCT01521871|3715374|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3890323|NCT01521871|3715375|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3890324|NCT01521871|3715376|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3890325|NCT01521871|3715374|B3|||Age||years|Mean|47.9|47.9|Standard Deviation|12.4|12.4|||
3890326|NCT01521871|3715375|B2|||Age||years|Mean|48.4|48.4|Standard Deviation|13.58|13.58|||
3890327|NCT01521871|3715376|B1|||Age||years|Mean|47.4|47.4|Standard Deviation|11.25|11.25|||
3890328|NCT01521871|3715374|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3890329|NCT01521871|3715375|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3890330|NCT01521871|3715376|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3890331|NCT01521871|3715374|B3||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3890332|NCT01521871|3715375|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3890333|NCT01521871|3715376|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3890334|NCT01521871|3715374|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890335|NCT01521871|3715375|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890336|NCT01521871|3715376|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890337|NCT01521845|3715415|B3|Iran, Islamic Republic of||Region of Enrollment||participants|Number|90|90.0||||||
3890338|NCT01521845|3715416|B2|Iran, Islamic Republic of||Region of Enrollment||participants|Number|47|47.0||||||
3890339|NCT01521845|3715417|B1|Iran, Islamic Republic of||Region of Enrollment||participants|Number|43|43.0||||||
3890340|NCT01521845|3715415|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3890341|NCT01521845|3715416|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3890342|NCT01521845|3715417|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3890343|NCT01521845|3715415|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3890344|NCT01521845|3715416|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3890345|NCT01521845|3715417|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3890346|NCT01521845|3715415|B3|||Age||years|Mean|61|61.0|Standard Deviation|11|11.0|||
3890347|NCT01521845|3715416|B2|||Age||years|Mean|60|60.0|Standard Deviation|11|11.0|||
3890348|NCT01521845|3715417|B1|||Age||years|Mean|62|62.0|Standard Deviation|11|11.0|||
3890349|NCT01521780|3715428|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3890350|NCT01521780|3715428|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3890351|NCT01521780|3715428|B1|||Age||Years|Mean|61.4|61.4|Standard Deviation|14.43|14.43|||
3890352|NCT01521559|3715452|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3890353|NCT01521559|3715453|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3890354|NCT01521559|3715454|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3890355|NCT01521559|3715452|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3890356|NCT01521559|3715453|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3890357|NCT01521559|3715454|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3890358|NCT01521559|3715452|B3|||Age||years|Mean|65.5|65.5|Standard Deviation|10.98|10.98|||
3890359|NCT01521559|3715453|B2|||Age||years|Mean|67.0|67.0|Standard Deviation|10.41|10.41|||
3890360|NCT01521559|3715454|B1|||Age||years|Mean|63.9|63.9|Standard Deviation|11.37|11.37|||
3890361|NCT01521546|3715467|B3||Male|Sex: Female, Male|The study was approved for 42 participants and 42 participants were enrolled.|Participants|Count of Participants|42|42.0||||||
3890362|NCT01521546|3715468|B2||Male|Sex: Female, Male|The study was approved for 42 participants and 42 participants were enrolled.|Participants|Count of Participants|22|22.0||||||
3890416|NCT01521507|3715477|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3890363|NCT01521546|3715469|B1||Male|Sex: Female, Male|The study was approved for 42 participants and 42 participants were enrolled.|Participants|Count of Participants|20|20.0||||||
3890364|NCT01521546|3715467|B3||Female|Sex: Female, Male|The study was approved for 42 participants and 42 participants were enrolled.|Participants|Count of Participants|0|0.0||||||
3890365|NCT01521546|3715468|B2||Female|Sex: Female, Male|The study was approved for 42 participants and 42 participants were enrolled.|Participants|Count of Participants|0|0.0||||||
3890366|NCT01521546|3715469|B1||Female|Sex: Female, Male|The study was approved for 42 participants and 42 participants were enrolled.|Participants|Count of Participants|0|0.0||||||
3890367|NCT01521546|3715467|B3|Age||Age||years|Median|15.0|15.0|Inter-Quartile Range|||11.75|19.0|
3890368|NCT01521546|3715468|B2|Age||Age||years|Median|15.0|15.0|Inter-Quartile Range|||11.0|19.0|
3890369|NCT01521546|3715469|B1|Age||Age||years|Median|14.5|14.5|Inter-Quartile Range|||12.0|18.5|
3890370|NCT01521507|3715476|B3|||Duration of MGD or Dry Eye Diagnosis||years|Mean|5.4|5.4|Standard Deviation|6.0|6.0|||
3890371|NCT01521507|3715477|B2|||Duration of MGD or Dry Eye Diagnosis||years|Mean|5.5|5.5|Standard Deviation|5.9|5.9|||
3890372|NCT01521507|3715478|B1|||Duration of MGD or Dry Eye Diagnosis||years|Mean|5.3|5.3|Standard Deviation|6.2|6.2|||
3890373|NCT01521507|3715476|B3|||Duration of Dry Eye Symptoms||years|Mean|7.8|7.8|Standard Deviation|7.3|7.3|||
3890374|NCT01521507|3715477|B2|||Duration of Dry Eye Symptoms||years|Mean|8.7|8.7|Standard Deviation|7.7|7.7|||
3890375|NCT01521507|3715478|B1|||Duration of Dry Eye Symptoms||years|Mean|6.9|6.9|Standard Deviation|6.8|6.8|||
3890376|NCT01521507|3715476|B3|||Baseline Total OSDI Score||units on a scale|Mean|48.7|48.7|Standard Deviation|22.4|22.4|||
3890377|NCT01521507|3715477|B2|||Baseline Total OSDI Score||units on a scale|Mean|51.8|51.8|Standard Deviation|23.1|23.1|||
3890378|NCT01521507|3715478|B1|||Baseline Total OSDI Score||units on a scale|Mean|45.6|45.6|Standard Deviation|21.2|21.2|||
3890379|NCT01521507|3715476|B3|||Baseline Total Meibomian Gland Score||units on a scale|Mean|6.2|6.2|Standard Deviation|3.7|3.7|||
3890380|NCT01521507|3715477|B2|||Baseline Total Meibomian Gland Score||units on a scale|Mean|6.3|6.3|Standard Deviation|3.7|3.7|||
3890381|NCT01521507|3715478|B1|||Baseline Total Meibomian Gland Score||units on a scale|Mean|6.2|6.2|Standard Deviation|3.7|3.7|||
3890382|NCT01521507|3715476|B3|United States||Region of Enrollment||participants|Number|200|200.0||||||
3890383|NCT01521507|3715477|B2|United States||Region of Enrollment||participants|Number|99|99.0||||||
3890384|NCT01521507|3715478|B1|United States||Region of Enrollment||participants|Number|101|101.0||||||
3890385|NCT01521507|3715476|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890386|NCT01521507|3715477|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890387|NCT01521507|3715478|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890388|NCT01521507|3715476|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890389|NCT01521507|3715477|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890390|NCT01521507|3715478|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890391|NCT01521507|3715476|B3||White|Race (NIH/OMB)||Participants|Count of Participants|194|194.0||||||
3890392|NCT01521507|3715477|B2||White|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3890393|NCT01521507|3715478|B1||White|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3890394|NCT01521507|3715476|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890395|NCT01521507|3715477|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890396|NCT01521507|3715478|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890397|NCT01521507|3715476|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890398|NCT01521507|3715477|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890399|NCT01521507|3715478|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890400|NCT01521507|3715476|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3890401|NCT01521507|3715477|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3890402|NCT01521507|3715478|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3890403|NCT01521507|3715476|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3890404|NCT01521507|3715477|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890405|NCT01521507|3715478|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3890406|NCT01521507|3715476|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890407|NCT01521507|3715477|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890408|NCT01521507|3715478|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890409|NCT01521507|3715476|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|186|186.0||||||
3890410|NCT01521507|3715477|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
3890411|NCT01521507|3715478|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3890412|NCT01521507|3715476|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3890413|NCT01521507|3715477|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3890414|NCT01521507|3715478|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3890415|NCT01521507|3715476|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3890417|NCT01521507|3715478|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3890418|NCT01521507|3715476|B3||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3890419|NCT01521507|3715477|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3890420|NCT01521507|3715478|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3890421|NCT01521507|3715476|B3|||Age||years|Mean|56.2|56.2|Standard Deviation|15.3|15.3|||
3890422|NCT01521507|3715477|B2|||Age||years|Mean|56.1|56.1|Standard Deviation|14.7|14.7|||
3890423|NCT01521507|3715478|B1|||Age||years|Mean|56.3|56.3|Standard Deviation|15.9|15.9|||
3890424|NCT01521494|3715496|B6|||Dialysis vintage||months|Mean|83.7|83.7|Standard Deviation|63.5|63.5|||
3890425|NCT01521494|3715497|B5|||Dialysis vintage||months|Mean|71.0|71.0|Standard Deviation|45.0|45.0|||
3890426|NCT01521494|3715498|B4|||Dialysis vintage||months|Mean|91.5|91.5|Standard Deviation|58.6|58.6|||
3890427|NCT01521494|3715499|B3|||Dialysis vintage||months|Mean|95.8|95.8|Standard Deviation|81.9|81.9|||
3890428|NCT01521494|3715500|B2|||Dialysis vintage||months|Mean|85.1|85.1|Standard Deviation|60.7|60.7|||
3890429|NCT01521494|3715501|B1|||Dialysis vintage||months|Mean|77.6|77.6|Standard Deviation|67.5|67.5|||
3890430|NCT01521494|3715496|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890431|NCT01521494|3715497|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890432|NCT01521494|3715498|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890433|NCT01521494|3715499|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890434|NCT01521494|3715500|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890435|NCT01521494|3715501|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890436|NCT01521494|3715496|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890437|NCT01521494|3715497|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890438|NCT01521494|3715498|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890439|NCT01521494|3715499|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890440|NCT01521494|3715500|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890441|NCT01521494|3715501|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890442|NCT01521494|3715496|B6||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890443|NCT01521494|3715497|B5||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890444|NCT01521494|3715498|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890445|NCT01521494|3715499|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890446|NCT01521494|3715500|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890447|NCT01521494|3715501|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890448|NCT01521494|3715496|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890449|NCT01521494|3715497|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890450|NCT01521494|3715498|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890451|NCT01521494|3715499|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890452|NCT01521494|3715500|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890453|NCT01521494|3715501|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890454|NCT01521494|3715496|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890455|NCT01521494|3715497|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890456|NCT01521494|3715498|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890457|NCT01521494|3715499|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890458|NCT01521494|3715500|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890459|NCT01521494|3715501|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890460|NCT01521494|3715496|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|178|178.0||||||
3890461|NCT01521494|3715497|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3890462|NCT01521494|3715498|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3890463|NCT01521494|3715499|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3890464|NCT01521494|3715500|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3890465|NCT01521494|3715501|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3890466|NCT01521494|3715496|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890467|NCT01521494|3715497|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890468|NCT01521494|3715498|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890469|NCT01521494|3715499|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890470|NCT01521494|3715500|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890471|NCT01521494|3715501|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890472|NCT01521494|3715496|B6||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3890473|NCT01521494|3715497|B5||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3890474|NCT01521494|3715498|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3890475|NCT01521494|3715499|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3890476|NCT01521494|3715500|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3890477|NCT01521494|3715501|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3890478|NCT01521494|3715496|B6||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3890479|NCT01521494|3715497|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3890480|NCT01521494|3715498|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3890481|NCT01521494|3715499|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3890482|NCT01521494|3715500|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3890483|NCT01521494|3715501|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3890484|NCT01521494|3715496|B6|||Age||years|Mean|61.4|61.4|Standard Deviation|10.9|10.9|||
3890485|NCT01521494|3715497|B5|||Age||years|Mean|60.8|60.8|Standard Deviation|10.2|10.2|||
3890486|NCT01521494|3715498|B4|||Age||years|Mean|61.4|61.4|Standard Deviation|11.2|11.2|||
3890487|NCT01521494|3715499|B3|||Age||years|Mean|61.9|61.9|Standard Deviation|10.5|10.5|||
3890488|NCT01521494|3715500|B2|||Age||years|Mean|63.8|63.8|Standard Deviation|12.0|12.0|||
3890489|NCT01521494|3715501|B1|||Age||years|Mean|59.4|59.4|Standard Deviation|10.4|10.4|||
3890490|NCT01521364|3715527|B1|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
3890491|NCT01521364|3715527|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3890492|NCT01521364|3715527|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3890493|NCT01521364|3715527|B1|||Age||years|Mean|35|35.0|Standard Deviation|17|17.0|||
3890494|NCT01521364|3715527|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3890495|NCT01521364|3715527|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3890496|NCT01521364|3715527|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890497|NCT01521260|3715538|B3|Netherlands||Region of Enrollment||participants|Number|30|30.0||||||
3890498|NCT01521260|3715539|B2|Netherlands||Region of Enrollment||participants|Number|15|15.0||||||
3890499|NCT01521260|3715540|B1|Netherlands||Region of Enrollment||participants|Number|15|15.0||||||
3890500|NCT01521260|3715538|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3890501|NCT01521260|3715539|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3890502|NCT01521260|3715540|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3890503|NCT01521260|3715538|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3890504|NCT01521260|3715539|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3890505|NCT01521260|3715540|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3890506|NCT01521260|3715538|B3|||Age||years|Mean|60.4|60.4|Standard Deviation|12.0|12.0|||
3890507|NCT01521260|3715539|B2|||Age||years|Mean|59.4|59.4|Standard Deviation|14.0|14.0|||
3890508|NCT01521260|3715540|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|10.0|10.0|||
3890509|NCT01521260|3715538|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3890510|NCT01521260|3715539|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3890511|NCT01521260|3715540|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3890512|NCT01521260|3715538|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3890513|NCT01521260|3715539|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3890514|NCT01521260|3715540|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3890515|NCT01521260|3715538|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890516|NCT01521260|3715539|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890517|NCT01521260|3715540|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890518|NCT01521143|3715547|B5||Male|Gender||Participants|Count of Participants|0|0.0||||||
3890519|NCT01521143|3715548|B4||Male|Gender||Participants|Count of Participants|0|0.0||||||
3890520|NCT01521143|3715549|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3890521|NCT01521143|3715550|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3890522|NCT01521143|3715551|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3890523|NCT01521143|3715547|B5||Female|Gender||Participants|Count of Participants|47|47.0||||||
3890524|NCT01521143|3715548|B4||Female|Gender||Participants|Count of Participants|4|4.0||||||
3890525|NCT01521143|3715549|B3||Female|Gender||Participants|Count of Participants|3|3.0||||||
3890526|NCT01521143|3715550|B2||Female|Gender||Participants|Count of Participants|20|20.0||||||
3890527|NCT01521143|3715551|B1||Female|Gender||Participants|Count of Participants|20|20.0||||||
3890528|NCT01521143|3715547|B5|45-65 years of age||Age, Customized||Participants|Number|47|47.0||||||
3890529|NCT01521143|3715548|B4|45-65 years of age||Age, Customized||Participants|Number|4|4.0||||||
3890530|NCT01521143|3715549|B3|45-65 years of age||Age, Customized||Participants|Number|3|3.0||||||
3890531|NCT01521143|3715550|B2|45-65 years of age||Age, Customized||Participants|Number|20|20.0||||||
3890532|NCT01521143|3715551|B1|45-65 years of age||Age, Customized||Participants|Number|20|20.0||||||
3890533|NCT01521026|3715584|B3|United States||Region of Enrollment||participants|Number|69|69.0||||||
3890534|NCT01521026|3715585|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
3890535|NCT01521026|3715586|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
3890536|NCT01521026|3715584|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3890537|NCT01521026|3715585|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3890538|NCT01521026|3715586|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3890539|NCT01521026|3715584|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3890540|NCT01521026|3715585|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3890541|NCT01521026|3715586|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3890542|NCT01521026|3715584|B3|||Age||years|Mean|46.3|46.3|Standard Deviation|9.7|9.7|||
3890543|NCT01521026|3715585|B2|||Age||years|Mean|48.8|48.8|Standard Deviation|8.7|8.7|||
3890544|NCT01521026|3715586|B1|||Age||years|Mean|44.3|44.3|Standard Deviation|10.1|10.1|||
3890545|NCT01521026|3715584|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3890546|NCT01521026|3715585|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3890547|NCT01521026|3715586|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3890548|NCT01521026|3715584|B3||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
3890549|NCT01521026|3715585|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3890550|NCT01521026|3715586|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3890551|NCT01521026|3715584|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890552|NCT01521026|3715585|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890553|NCT01521026|3715586|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890554|NCT01520987|3715595|B9||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3890555|NCT01520987|3715596|B8||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3890556|NCT01520987|3715597|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3890557|NCT01520987|3715598|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3890558|NCT01520987|3715599|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3890559|NCT01520987|3715600|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3890560|NCT01520987|3715601|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3890561|NCT01520987|3715602|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3890562|NCT01520987|3715603|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3890563|NCT01520987|3715595|B9||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3890564|NCT01520987|3715596|B8||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3890565|NCT01520987|3715597|B7||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3890566|NCT01520987|3715598|B6||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3890567|NCT01520987|3715599|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3890568|NCT01520987|3715600|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3890569|NCT01520987|3715601|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3890570|NCT01520987|3715602|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3890571|NCT01520987|3715603|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3890572|NCT01520987|3715595|B9||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3890573|NCT01520987|3715596|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3890574|NCT01520987|3715597|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3890575|NCT01520987|3715598|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3890576|NCT01520987|3715599|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3890577|NCT01520987|3715600|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3890578|NCT01520987|3715601|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3890579|NCT01520987|3715602|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3890580|NCT01520987|3715603|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3890581|NCT01520987|3715595|B9||Between 18 and 65 years|Age||Participants|Count of Participants|105|105.0||||||
3890582|NCT01520987|3715596|B8||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3890583|NCT01520987|3715597|B7||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3890584|NCT01520987|3715598|B6||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3890585|NCT01520987|3715599|B5||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3890586|NCT01520987|3715600|B4||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3890587|NCT01520987|3715601|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3890588|NCT01520987|3715602|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3890589|NCT01520987|3715603|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3890590|NCT01520987|3715595|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890591|NCT01520987|3715596|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890592|NCT01520987|3715597|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890593|NCT01520987|3715598|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890594|NCT01520987|3715599|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890595|NCT01520987|3715600|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890596|NCT01520987|3715601|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890597|NCT01520987|3715602|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890598|NCT01520987|3715603|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890599|NCT01520922|3715668|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3890600|NCT01520922|3715669|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3890601|NCT01520922|3715670|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3890602|NCT01520922|3715668|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3890603|NCT01520922|3715669|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3890604|NCT01520922|3715670|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3890605|NCT01520922|3715668|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|95|95.0||||||
3890606|NCT01520922|3715669|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|53|53.0||||||
3890607|NCT01520922|3715670|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|42|42.0||||||
3890608|NCT01520922|3715668|B3||Male|Gender||Participants|Count of Participants|65|65.0||||||
3890609|NCT01520922|3715669|B2||Male|Gender||Participants|Count of Participants|36|36.0||||||
3890610|NCT01520922|3715670|B1||Male|Gender||Participants|Count of Participants|29|29.0||||||
3890611|NCT01520922|3715668|B3||Female|Gender||Participants|Count of Participants|32|32.0||||||
3890612|NCT01520922|3715669|B2||Female|Gender||Participants|Count of Participants|17|17.0||||||
3890613|NCT01520922|3715670|B1||Female|Gender||Participants|Count of Participants|15|15.0||||||
3890614|NCT01520922|3715668|B3|||Age||Years|Mean|65.0|65.0|Standard Deviation|9.76|9.76|||
3890615|NCT01520922|3715669|B2|||Age||Years|Mean|66.5|66.5|Standard Deviation|9.28|9.28|||
3890616|NCT01520922|3715670|B1|||Age||Years|Mean|63.2|63.2|Standard Deviation|10.11|10.11|||
3890617|NCT01520909|3715731|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3890618|NCT01520909|3715732|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3890619|NCT01520909|3715733|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3890620|NCT01520909|3715731|B3|White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|56|56.0||||||
3890621|NCT01520909|3715732|B2|White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|38|38.0||||||
3890622|NCT01520909|3715733|B1|White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
3890623|NCT01520909|3715731|B3|Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3890624|NCT01520909|3715732|B2|Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3890625|NCT01520909|3715733|B1|Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3890626|NCT01520909|3715731|B3|Japanese/East Asian/South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
3890627|NCT01520909|3715732|B2|Japanese/East Asian/South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
3890628|NCT01520909|3715733|B1|Japanese/East Asian/South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
3890629|NCT01520909|3715731|B3|Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3890630|NCT01520909|3715732|B2|Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3890631|NCT01520909|3715733|B1|Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3890632|NCT01520909|3715731|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3890633|NCT01520909|3715732|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3890634|NCT01520909|3715733|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3890635|NCT01520909|3715731|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3890636|NCT01520909|3715732|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3890637|NCT01520909|3715733|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3890638|NCT01520909|3715731|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3890639|NCT01520909|3715732|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3890640|NCT01520909|3715733|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3890641|NCT01520909|3715731|B3|||Age||Years|Mean|9.6|9.6|Standard Deviation|4.22|4.22|||
3890642|NCT01520909|3715732|B2|||Age||Years|Mean|9.4|9.4|Standard Deviation|4.43|4.43|||
3890643|NCT01520909|3715733|B1|||Age||Years|Mean|9.8|9.8|Standard Deviation|4.00|4.0|||
3890644|NCT01520727|3715797|B10||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3890645|NCT01520727|3715798|B9||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3890646|NCT01520727|3715799|B8||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3890647|NCT01520727|3715800|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3890648|NCT01520727|3715801|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3890649|NCT01520727|3715802|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3890650|NCT01520727|3715803|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3890651|NCT01520727|3715804|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3890652|NCT01520727|3715805|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3890653|NCT01520727|3715806|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3890654|NCT01520727|3715797|B10||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3890655|NCT01520727|3715798|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3890656|NCT01520727|3715799|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3890657|NCT01520727|3715800|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3890658|NCT01520727|3715801|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3890659|NCT01520727|3715802|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3890660|NCT01520727|3715803|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3890661|NCT01520727|3715804|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3890662|NCT01520727|3715805|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3890663|NCT01520727|3715806|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3890664|NCT01520727|3715797|B10||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3890665|NCT01520727|3715798|B9||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3890666|NCT01520727|3715799|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3890667|NCT01520727|3715800|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3890668|NCT01520727|3715801|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3890669|NCT01520727|3715802|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3890670|NCT01520727|3715803|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3890671|NCT01520727|3715804|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3890672|NCT01520727|3715805|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3890673|NCT01520727|3715806|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3890674|NCT01520727|3715797|B10||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
3890675|NCT01520727|3715798|B9||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3890676|NCT01520727|3715799|B8||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3890677|NCT01520727|3715800|B7||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3890678|NCT01520727|3715801|B6||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3890679|NCT01520727|3715802|B5||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3890680|NCT01520727|3715803|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3890681|NCT01520727|3715804|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3890682|NCT01520727|3715805|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3890683|NCT01520727|3715806|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3890684|NCT01520727|3715797|B10||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890685|NCT01520727|3715798|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890686|NCT01520727|3715799|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890687|NCT01520727|3715800|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890688|NCT01520727|3715801|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890689|NCT01520727|3715802|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890690|NCT01520727|3715803|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890691|NCT01520727|3715804|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890692|NCT01520727|3715805|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890693|NCT01520727|3715806|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890694|NCT01520714|3715850|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3890695|NCT01520714|3715851|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3890696|NCT01520714|3715850|B3|Male||Gender||participants|Number|10|10.0||||||
3890697|NCT01520714|3715851|B2|Male||Gender||participants|Number|10|10.0||||||
3890698|NCT01520714|3715850|B3|Female||Gender||participants|Number|1|1.0||||||
3890699|NCT01520714|3715851|B2|Female||Gender||participants|Number|1|1.0||||||
3890700|NCT01520714|3715850|B3|||Age||years|Mean|65|65.0|Standard Deviation|11|11.0|||
3890701|NCT01520714|3715851|B2|||Age||years|Mean|65|65.0|Standard Deviation|11|11.0|||
3890702|NCT01520714|3715850|B3|>=65 years||Age||participants|Number|4|4.0||||||
3890703|NCT01520714|3715851|B2|>=65 years||Age||participants|Number|4|4.0||||||
3890704|NCT01520714|3715850|B3|Between 18 and 65 years||Age||participants|Number|7|7.0||||||
3890705|NCT01520714|3715851|B2|Between 18 and 65 years||Age||participants|Number|7|7.0||||||
3890706|NCT01520714|3715850|B3|<=18 years||Age||participants|Number|0|0.0||||||
3890707|NCT01520714|3715851|B2|<=18 years||Age||participants|Number|0|0.0||||||
3890708|NCT01520558|3715859|B4|United States||Region of Enrollment||participants|Number|12|12.0||||||
3890709|NCT01520558|3715860|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3890710|NCT01520558|3715861|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3890711|NCT01520558|3715862|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3890712|NCT01520558|3715859|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890713|NCT01520558|3715860|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890714|NCT01520558|3715861|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890715|NCT01520558|3715862|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890716|NCT01520558|3715859|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890717|NCT01520558|3715860|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890718|NCT01520558|3715861|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890719|NCT01520558|3715862|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890720|NCT01520558|3715859|B4||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3890721|NCT01520558|3715860|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3890722|NCT01520558|3715861|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3890723|NCT01520558|3715862|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3890724|NCT01520558|3715859|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890725|NCT01520558|3715860|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890726|NCT01520558|3715861|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890727|NCT01520558|3715862|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890728|NCT01520558|3715859|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890729|NCT01520558|3715860|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890730|NCT01520558|3715861|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890731|NCT01520558|3715862|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890732|NCT01520558|3715859|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890733|NCT01520558|3715860|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890734|NCT01520558|3715861|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890735|NCT01520558|3715862|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890736|NCT01520558|3715859|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890737|NCT01520558|3715860|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890738|NCT01520558|3715861|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890739|NCT01520558|3715862|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890740|NCT01520558|3715859|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890741|NCT01520558|3715860|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890742|NCT01520558|3715861|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890743|NCT01520558|3715862|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890744|NCT01520558|3715859|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3890745|NCT01520558|3715860|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3890746|NCT01520558|3715861|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3890747|NCT01520558|3715862|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3890748|NCT01520558|3715859|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890749|NCT01520558|3715860|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890750|NCT01520558|3715861|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890751|NCT01520558|3715862|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890752|NCT01520558|3715859|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3890753|NCT01520558|3715860|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3890754|NCT01520558|3715861|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3890755|NCT01520558|3715862|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3890756|NCT01520558|3715859|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3890757|NCT01520558|3715860|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3890758|NCT01520558|3715861|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3890759|NCT01520558|3715862|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3890760|NCT01520558|3715859|B4|||Age||years|Mean|71.0|71.0|Standard Deviation|5.98|5.98|||
3890761|NCT01520558|3715860|B3|||Age||years|Mean|67.3|67.3|Standard Deviation|6.35|6.35|||
3890762|NCT01520558|3715861|B2|||Age||years|Mean|76.3|76.3|Standard Deviation|2.52|2.52|||
3890763|NCT01520558|3715862|B1|||Age||years|Mean|73|73.0|Standard Deviation|1.00|1.0|||
3890764|NCT01520532|3715872|B1|Italy||Region of Enrollment||participants|Number|11|11.0||||||
3890765|NCT01520532|3715872|B1|Netherlands||Region of Enrollment||participants|Number|12|12.0||||||
3890766|NCT01520532|3715872|B1|Germany||Region of Enrollment||participants|Number|12|12.0||||||
3890767|NCT01520532|3715872|B1|Belgium||Region of Enrollment||participants|Number|13|13.0||||||
3890768|NCT01520532|3715872|B1|Canada||Region of Enrollment||participants|Number|12|12.0||||||
3890769|NCT01520532|3715872|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3890770|NCT01520532|3715872|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3890771|NCT01520532|3715872|B1|||Age||years|Mean|60|60.0|Standard Deviation|10|10.0|||
3890772|NCT01520506|3715878|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3890773|NCT01520506|3715878|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3890774|NCT01520506|3715878|B1|||Age||years|Mean|63.0|63.0|Standard Deviation|9.5|9.5|||
3890775|NCT01520454|3715884|B5||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3890776|NCT01520454|3715885|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3890777|NCT01520454|3715886|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3890778|NCT01520454|3715887|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3890779|NCT01520454|3715888|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3890780|NCT01520454|3715884|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3890781|NCT01520454|3715885|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3890782|NCT01520454|3715886|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3890783|NCT01520454|3715887|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3890784|NCT01520454|3715888|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3890785|NCT01520454|3715884|B5|||Age, Customized||years|Median|35.2|35.2|Inter-Quartile Range|||29.5|47.0|
3890786|NCT01520454|3715885|B4|||Age, Customized||years|Median|27.6|27.6|Inter-Quartile Range|||24.2|46.9|
3890787|NCT01520454|3715886|B3|||Age, Customized||years|Median|48.6|48.6|Inter-Quartile Range|||44.4|54.9|
3890788|NCT01520454|3715887|B2|||Age, Customized||years|Median|29.1|29.1|Inter-Quartile Range|||24.2|38.7|
3890789|NCT01520454|3715888|B1|||Age, Customized||years|Median|35.3|35.3|Inter-Quartile Range|||25.0|47.6|
3890790|NCT01520402|3715933|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3890791|NCT01520402|3715933|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3890792|NCT01520402|3715933|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3890793|NCT01520402|3715933|B1|||Age||years|Mean|32|32.0|Standard Deviation|8|8.0|||
3890794|NCT01520402|3715933|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3890795|NCT01520402|3715933|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3890796|NCT01520402|3715933|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890797|NCT01520363|3715944|B3|Mexico||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3890798|NCT01520363|3715945|B2|Mexico||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3890799|NCT01520363|3715946|B1|Mexico||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3890800|NCT01520363|3715944|B3|Canada||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3890801|NCT01520363|3715945|B2|Canada||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3890802|NCT01520363|3715946|B1|Canada||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3890803|NCT01520363|3715944|B3|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3890804|NCT01520363|3715945|B2|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3890805|NCT01520363|3715946|B1|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3890806|NCT01520363|3715944|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3890807|NCT01520363|3715945|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3890808|NCT01520363|3715946|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3890809|NCT01520363|3715944|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3890810|NCT01520363|3715945|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3890811|NCT01520363|3715946|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3890812|NCT01520363|3715944|B3|||Age||years|Mean|4.83|4.83|Standard Deviation|2.22|2.22|||
3890813|NCT01520363|3715945|B2|||Age||years|Mean|4.91|4.91|Standard Deviation|1.91|1.91|||
3890814|NCT01520363|3715946|B1|||Age||years|Mean|4.75|4.75|Standard Deviation|2.52|2.52|||
3890815|NCT01520363|3715944|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3890816|NCT01520363|3715945|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3890817|NCT01520363|3715946|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3890818|NCT01520363|3715944|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3890819|NCT01520363|3715945|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3890820|NCT01520363|3715946|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3890821|NCT01520363|3715944|B3||<=18 years|Age||Participants|Count of Participants|52|52.0||||||
3890822|NCT01520363|3715945|B2||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
3890823|NCT01520363|3715946|B1||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
3890824|NCT01520207|3716021|B3|United States||Region of Enrollment||participants|Number|52|52.0||||||
3890825|NCT01520207|3716022|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3890826|NCT01520207|3716023|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3890827|NCT01520207|3716021|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3890828|NCT01520207|3716022|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3890829|NCT01520207|3716023|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3890830|NCT01520207|3716021|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3890831|NCT01520207|3716022|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3890832|NCT01520207|3716023|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3890833|NCT01520207|3716021|B3|||Age||years|Mean|55.6|55.6|Standard Deviation|16|16.0|||
3890834|NCT01520207|3716022|B2|||Age||years|Mean|53.4|53.4|Standard Deviation|17.4|17.4|||
3890835|NCT01520207|3716023|B1|||Age||years|Mean|57.7|57.7|Standard Deviation|14.7|14.7|||
3890836|NCT01519960|3716030|B4||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3890837|NCT01519960|3716031|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3890838|NCT01519960|3716032|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3890839|NCT01519960|3716033|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3890840|NCT01519960|3716030|B4||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3890841|NCT01519960|3716031|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3890842|NCT01519960|3716032|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3890843|NCT01519960|3716033|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3890844|NCT01519960|3716030|B4|||Age||years|Mean|10.42|10.42|Standard Deviation|4.73|4.73|||
3890845|NCT01519960|3716031|B3|||Age||years|Mean|6.70|6.7|Standard Deviation|3.27|3.27|||
3890846|NCT01519960|3716032|B2|||Age||years|Mean|11.20|11.2|Standard Deviation|5.01|5.01|||
3890847|NCT01519960|3716033|B1|||Age||years|Mean|10.41|10.41|Standard Deviation|4.57|4.57|||
3890848|NCT01519947|3716141|B5||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3890849|NCT01519947|3716142|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3890850|NCT01519947|3716143|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3890851|NCT01519947|3716144|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3890852|NCT01519947|3716145|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3890853|NCT01519947|3716141|B5||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3890854|NCT01519947|3716142|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3890855|NCT01519947|3716143|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3890856|NCT01519947|3716144|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3890857|NCT01519947|3716145|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3890858|NCT01519947|3716141|B5|||Age||years|Mean|56.2|56.2|Standard Deviation|17.8|17.8|||
3890859|NCT01519947|3716142|B4|||Age||years|Mean|56.5|56.5|Standard Deviation|17.4|17.4|||
3890860|NCT01519947|3716143|B3|||Age||years|Mean|61.7|61.7|Standard Deviation|15.6|15.6|||
3890861|NCT01519947|3716144|B2|||Age||years|Mean|38.5|38.5|Standard Deviation|18.8|18.8|||
3890862|NCT01519947|3716145|B1|||Age||years|Mean|60.7|60.7|Standard Deviation|15.1|15.1|||
3890863|NCT01519934|3716178|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
3890864|NCT01519934|3716178|B1|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3890865|NCT01519934|3716178|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3890866|NCT01519934|3716178|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3890867|NCT01519934|3716178|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
3890868|NCT01519934|3716178|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3890869|NCT01519934|3716178|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3890870|NCT01519934|3716178|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3890871|NCT01519934|3716178|B1|||Age||years|Mean|58|58.0|Full Range|||39.0|85.0|
3890872|NCT01519921|3716185|B3||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3890873|NCT01519921|3716186|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3890874|NCT01519921|3716187|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3890875|NCT01519921|3716185|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3890876|NCT01519921|3716186|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3890877|NCT01519921|3716187|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3890878|NCT01519921|3716185|B3|||Age||Years|Mean|35.9|35.9|Standard Deviation|9.1|9.1|||
3890879|NCT01519921|3716186|B2|||Age||Years|Mean|36.8|36.8|Standard Deviation|9.0|9.0|||
3890880|NCT01519921|3716187|B1|||Age||Years|Mean|35.3|35.3|Standard Deviation|9.20|9.2|||
3890881|NCT01519882|3716210|B3|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3890882|NCT01519882|3716212|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3890883|NCT01519882|3716210|B3|Male||Gender||participants|Number|0|0.0||||||
3890884|NCT01519882|3716212|B1|Male||Gender||participants|Number|0|0.0||||||
3890885|NCT01519882|3716210|B3|Female||Gender||participants|Number|1|1.0||||||
3890886|NCT01519882|3716212|B1|Female||Gender||participants|Number|1|1.0||||||
3890887|NCT01519882|3716210|B3|||Age||years|Mean|67|67.0|Standard Deviation|NA||||The mean presented here is the individual age of the only subject included.
3890888|NCT01519882|3716212|B1|||Age||years|Mean|67|67.0|Standard Deviation|NA||||The mean presented here is the individual age of the only subject included.
3890889|NCT01519882|3716210|B3|>=65 years||Age||participants|Number|1|1.0||||||
3890890|NCT01519882|3716212|B1|>=65 years||Age||participants|Number|1|1.0||||||
3890891|NCT01519882|3716210|B3|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
3890892|NCT01519882|3716212|B1|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
3890893|NCT01519882|3716210|B3|<=18 years||Age||participants|Number|0|0.0||||||
3890894|NCT01519882|3716212|B1|<=18 years||Age||participants|Number|0|0.0||||||
3890895|NCT01519817|3716237|B1|Systemic therapy||Prior Therapy|Surgery, radiotherapy and systemic therapy use surgical procedures, targeted therapy with radiation, steroids, and/or other immunosuppressive agents in an attempt to suppress one or more growing lesions.|Participants|Count of Participants|5|5.0||||||
3890896|NCT01519817|3716237|B1|Radiotherapy||Prior Therapy|Surgery, radiotherapy and systemic therapy use surgical procedures, targeted therapy with radiation, steroids, and/or other immunosuppressive agents in an attempt to suppress one or more growing lesions.|Participants|Count of Participants|11|11.0||||||
3890897|NCT01519817|3716237|B1|Surgery||Prior Therapy|Surgery, radiotherapy and systemic therapy use surgical procedures, targeted therapy with radiation, steroids, and/or other immunosuppressive agents in an attempt to suppress one or more growing lesions.|Participants|Count of Participants|11|11.0||||||
3890898|NCT01519817|3716237|B1|Spinal||Tumor Anatomical Location|Sacral (i.e., sacrum), spinal (i.e., backbone), and clival (i.e. base of skull).|Participants|Count of Participants|2|2.0||||||
3890899|NCT01519817|3716237|B1|Clival||Tumor Anatomical Location|Sacral (i.e., sacrum), spinal (i.e., backbone), and clival (i.e. base of skull).|Participants|Count of Participants|3|3.0||||||
3890900|NCT01519817|3716237|B1|Sacral||Tumor Anatomical Location|Sacral (i.e., sacrum), spinal (i.e., backbone), and clival (i.e. base of skull).|Participants|Count of Participants|6|6.0||||||
3890901|NCT01519817|3716237|B1|≥3 regimens||Prior Cytotoxic Regimens|Cytotoxic (i.e. poisonous to cancer cells)|Participants|Count of Participants|12|12.0||||||
3890902|NCT01519817|3716237|B1|2 regimens||Prior Cytotoxic Regimens|Cytotoxic (i.e. poisonous to cancer cells)|Participants|Count of Participants|8|8.0||||||
3890903|NCT01519817|3716237|B1|1 regimen||Prior Cytotoxic Regimens|Cytotoxic (i.e. poisonous to cancer cells)|Participants|Count of Participants|2|2.0||||||
3890904|NCT01519817|3716237|B1|0||Prior Cytotoxic Regimens|Cytotoxic (i.e. poisonous to cancer cells)|Participants|Count of Participants|1|1.0||||||
3890905|NCT01519817|3716237|B1|Chordomas|Progressive disease|Disease at Study Entry|Stable disease does not meet criteria for complete response (disappearance of all lesions; no new lesions), partial response (≥30% decrease in the sum of greatest diameters; no new lesions), or progressive disease. Progressive disease is ≥20% increase in the sum of greatest diameters; new lesions.|Participants|Count of Participants|9|9.0||||||
3890906|NCT01519817|3716237|B1|Chordomas|Stable disease|Disease at Study Entry|Stable disease does not meet criteria for complete response (disappearance of all lesions; no new lesions), partial response (≥30% decrease in the sum of greatest diameters; no new lesions), or progressive disease. Progressive disease is ≥20% increase in the sum of greatest diameters; new lesions.|Participants|Count of Participants|2|2.0||||||
3890907|NCT01519817|3716237|B1|Carcinomas|Progressive disease|Disease at Study Entry|Stable disease does not meet criteria for complete response (disappearance of all lesions; no new lesions), partial response (≥30% decrease in the sum of greatest diameters; no new lesions), or progressive disease. Progressive disease is ≥20% increase in the sum of greatest diameters; new lesions.|Participants|Count of Participants|22|22.0||||||
3890908|NCT01519817|3716237|B1|Carcinomas|Stable disease|Disease at Study Entry|Stable disease does not meet criteria for complete response (disappearance of all lesions; no new lesions), partial response (≥30% decrease in the sum of greatest diameters; no new lesions), or progressive disease. Progressive disease is ≥20% increase in the sum of greatest diameters; new lesions.|Participants|Count of Participants|1|1.0||||||
3890909|NCT01519817|3716237|B1||Lung|Tumor Type||Participants|Count of Participants|1|1.0||||||
3890910|NCT01519817|3716237|B1||Urothelial|Tumor Type||Participants|Count of Participants|1|1.0||||||
3890911|NCT01519817|3716237|B1||Prostate|Tumor Type||Participants|Count of Participants|2|2.0||||||
3890912|NCT01519817|3716237|B1||Pancreatic|Tumor Type||Participants|Count of Participants|3|3.0||||||
3890913|NCT01519817|3716237|B1||Breast|Tumor Type||Participants|Count of Participants|5|5.0||||||
3890914|NCT01519817|3716237|B1||Chordoma|Tumor Type||Participants|Count of Participants|11|11.0||||||
3890915|NCT01519817|3716237|B1||Colorectal|Tumor Type||Participants|Count of Participants|11|11.0||||||
3890916|NCT01519817|3716237|B1||1|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG: 0 is normal activity. Fully active, able to carry on all pre-disease performance without restriction. 1 is symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and bale to carry out work of a light or sedentary nature (e.g., light housework, office work).|Participants|Count of Participants|20|20.0||||||
3890917|NCT01519817|3716237|B1||0|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG: 0 is normal activity. Fully active, able to carry on all pre-disease performance without restriction. 1 is symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and bale to carry out work of a light or sedentary nature (e.g., light housework, office work).|Participants|Count of Participants|14|14.0||||||
3890918|NCT01519817|3716237|B1|United States||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3890919|NCT01519817|3716237|B1|Mexican, Puerto Rican, Cuban Central or So. Americ||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3890920|NCT01519817|3716237|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3890921|NCT01519817|3716237|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3890922|NCT01519817|3716237|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890923|NCT01519817|3716237|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890924|NCT01519817|3716237|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3890925|NCT01519817|3716237|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3890926|NCT01519817|3716237|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890927|NCT01519817|3716237|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3890928|NCT01519817|3716237|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3890929|NCT01519817|3716237|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3890930|NCT01519817|3716237|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3890931|NCT01519817|3716237|B1|||Age||years|Median|58|58.0|Full Range|||32.0|79.0|
3890932|NCT01519817|3716237|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3890933|NCT01519817|3716237|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3890934|NCT01519817|3716237|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3890935|NCT01519791|3716278|B3||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
3890936|NCT01519791|3716279|B2||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3890937|NCT01519791|3716280|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3890938|NCT01519791|3716278|B3||Female|Sex: Female, Male||Participants|Count of Participants|674|674.0||||||
3890939|NCT01519791|3716279|B2||Female|Sex: Female, Male||Participants|Count of Participants|499|499.0||||||
3890940|NCT01519791|3716280|B1||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
3890941|NCT01519791|3716278|B3|||Age||years|Mean|50.7|50.7|Standard Deviation|13.5|13.5|||
3890942|NCT01519791|3716279|B2|||Age||years|Mean|50.5|50.5|Standard Deviation|13.6|13.6|||
3890943|NCT01519791|3716280|B1|||Age||years|Mean|51.3|51.3|Standard Deviation|13.2|13.2|||
3890944|NCT01519791|3716278|B3||>=65 years|Age||Participants|Count of Participants|134|134.0||||||
3890945|NCT01519791|3716279|B2||>=65 years|Age||Participants|Count of Participants|98|98.0||||||
3890946|NCT01519791|3716280|B1||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
3890947|NCT01519791|3716278|B3||Between 18 and 65 years|Age||Participants|Count of Participants|742|742.0||||||
3890948|NCT01519791|3716279|B2||Between 18 and 65 years|Age||Participants|Count of Participants|560|560.0||||||
3890949|NCT01519791|3716280|B1||Between 18 and 65 years|Age||Participants|Count of Participants|182|182.0||||||
3890950|NCT01519791|3716278|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3890951|NCT01519791|3716279|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3890952|NCT01519791|3716280|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3890953|NCT01519778|3716345|B1||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3890954|NCT01519778|3716345|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3890955|NCT01519778|3716345|B1|||Age||years|Mean|39.5|39.5|Standard Deviation|13.04|13.04|||
3890956|NCT01519765|3716349|B3|||Fetal anomaly|Fetal anomaly was defined as any known congenital malformation diagnosed prior to admission.|participants|Number|7|7.0||||||
3890957|NCT01519765|3716350|B2|||Fetal anomaly|Fetal anomaly was defined as any known congenital malformation diagnosed prior to admission.|participants|Number|1|1.0||||||
3890958|NCT01519765|3716351|B1|||Fetal anomaly|Fetal anomaly was defined as any known congenital malformation diagnosed prior to admission.|participants|Number|6|6.0||||||
3890959|NCT01519765|3716349|B3|Other||Induction indication|"Postdates included gestational ages greater than 40 weeks.~Hypertensive disorder included chronic hypertension, gestational hypertension, preeclampsia, eclampsia, and HELLP.~Diabetes included all gestational diabetics, Type I, and Type II diabetics.~Oligohydramnios was defined as amniotic fluid index (AFI) less than 5 or deep vertical pocket less than 2."|participants|Number|3|3.0||||||
3890960|NCT01519765|3716350|B2|Other||Induction indication|"Postdates included gestational ages greater than 40 weeks.~Hypertensive disorder included chronic hypertension, gestational hypertension, preeclampsia, eclampsia, and HELLP.~Diabetes included all gestational diabetics, Type I, and Type II diabetics.~Oligohydramnios was defined as amniotic fluid index (AFI) less than 5 or deep vertical pocket less than 2."|participants|Number|1|1.0||||||
3890961|NCT01519765|3716351|B1|Other||Induction indication|"Postdates included gestational ages greater than 40 weeks.~Hypertensive disorder included chronic hypertension, gestational hypertension, preeclampsia, eclampsia, and HELLP.~Diabetes included all gestational diabetics, Type I, and Type II diabetics.~Oligohydramnios was defined as amniotic fluid index (AFI) less than 5 or deep vertical pocket less than 2."|participants|Number|2|2.0||||||
3890962|NCT01519765|3716349|B3|Cholestasis||Induction indication|"Postdates included gestational ages greater than 40 weeks.~Hypertensive disorder included chronic hypertension, gestational hypertension, preeclampsia, eclampsia, and HELLP.~Diabetes included all gestational diabetics, Type I, and Type II diabetics.~Oligohydramnios was defined as amniotic fluid index (AFI) less than 5 or deep vertical pocket less than 2."|participants|Number|4|4.0||||||
3890963|NCT01519765|3716350|B2|Cholestasis||Induction indication|"Postdates included gestational ages greater than 40 weeks.~Hypertensive disorder included chronic hypertension, gestational hypertension, preeclampsia, eclampsia, and HELLP.~Diabetes included all gestational diabetics, Type I, and Type II diabetics.~Oligohydramnios was defined as amniotic fluid index (AFI) less than 5 or deep vertical pocket less than 2."|participants|Number|2|2.0||||||
3890964|NCT01519765|3716351|B1|Cholestasis||Induction indication|"Postdates included gestational ages greater than 40 weeks.~Hypertensive disorder included chronic hypertension, gestational hypertension, preeclampsia, eclampsia, and HELLP.~Diabetes included all gestational diabetics, Type I, and Type II diabetics.~Oligohydramnios was defined as amniotic fluid index (AFI) less than 5 or deep vertical pocket less than 2."|participants|Number|2|2.0||||||
3890965|NCT01519765|3716349|B3|Oligohydramnios||Induction indication|"Postdates included gestational ages greater than 40 weeks.~Hypertensive disorder included chronic hypertension, gestational hypertension, preeclampsia, eclampsia, and HELLP.~Diabetes included all gestational diabetics, Type I, and Type II diabetics.~Oligohydramnios was defined as amniotic fluid index (AFI) less than 5 or deep vertical pocket less than 2."|participants|Number|4|4.0||||||
3890966|NCT01519765|3716350|B2|Oligohydramnios||Induction indication|"Postdates included gestational ages greater than 40 weeks.~Hypertensive disorder included chronic hypertension, gestational hypertension, preeclampsia, eclampsia, and HELLP.~Diabetes included all gestational diabetics, Type I, and Type II diabetics.~Oligohydramnios was defined as amniotic fluid index (AFI) less than 5 or deep vertical pocket less than 2."|participants|Number|3|3.0||||||
3890967|NCT01519765|3716351|B1|Oligohydramnios||Induction indication|"Postdates included gestational ages greater than 40 weeks.~Hypertensive disorder included chronic hypertension, gestational hypertension, preeclampsia, eclampsia, and HELLP.~Diabetes included all gestational diabetics, Type I, and Type II diabetics.~Oligohydramnios was defined as amniotic fluid index (AFI) less than 5 or deep vertical pocket less than 2."|participants|Number|1|1.0||||||
3890968|NCT01519765|3716349|B3|Elective||Induction indication|"Postdates included gestational ages greater than 40 weeks.~Hypertensive disorder included chronic hypertension, gestational hypertension, preeclampsia, eclampsia, and HELLP.~Diabetes included all gestational diabetics, Type I, and Type II diabetics.~Oligohydramnios was defined as amniotic fluid index (AFI) less than 5 or deep vertical pocket less than 2."|participants|Number|10|10.0||||||
3891046|NCT01519700|3716430|B1|||Age||years|Mean|51.5|51.5|Standard Deviation|11.16|11.16|||
3891047|NCT01519674|3716465|B4|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.0|9.0|Standard Deviation|2.6|2.6|||
3891048|NCT01519674|3716466|B3|||Fasting plasma glucose (FPG)||mmol/L|Mean|8.7|8.7|Standard Deviation|2.7|2.7|||
3890969|NCT01519765|3716350|B2|Elective||Induction indication|"Postdates included gestational ages greater than 40 weeks.~Hypertensive disorder included chronic hypertension, gestational hypertension, preeclampsia, eclampsia, and HELLP.~Diabetes included all gestational diabetics, Type I, and Type II diabetics.~Oligohydramnios was defined as amniotic fluid index (AFI) less than 5 or deep vertical pocket less than 2."|participants|Number|3|3.0||||||
3890970|NCT01519765|3716351|B1|Elective||Induction indication|"Postdates included gestational ages greater than 40 weeks.~Hypertensive disorder included chronic hypertension, gestational hypertension, preeclampsia, eclampsia, and HELLP.~Diabetes included all gestational diabetics, Type I, and Type II diabetics.~Oligohydramnios was defined as amniotic fluid index (AFI) less than 5 or deep vertical pocket less than 2."|participants|Number|7|7.0||||||
3890971|NCT01519765|3716349|B3|Diabetes||Induction indication|"Postdates included gestational ages greater than 40 weeks.~Hypertensive disorder included chronic hypertension, gestational hypertension, preeclampsia, eclampsia, and HELLP.~Diabetes included all gestational diabetics, Type I, and Type II diabetics.~Oligohydramnios was defined as amniotic fluid index (AFI) less than 5 or deep vertical pocket less than 2."|participants|Number|5|5.0||||||
3890972|NCT01519765|3716350|B2|Diabetes||Induction indication|"Postdates included gestational ages greater than 40 weeks.~Hypertensive disorder included chronic hypertension, gestational hypertension, preeclampsia, eclampsia, and HELLP.~Diabetes included all gestational diabetics, Type I, and Type II diabetics.~Oligohydramnios was defined as amniotic fluid index (AFI) less than 5 or deep vertical pocket less than 2."|participants|Number|2|2.0||||||
3890973|NCT01519765|3716351|B1|Diabetes||Induction indication|"Postdates included gestational ages greater than 40 weeks.~Hypertensive disorder included chronic hypertension, gestational hypertension, preeclampsia, eclampsia, and HELLP.~Diabetes included all gestational diabetics, Type I, and Type II diabetics.~Oligohydramnios was defined as amniotic fluid index (AFI) less than 5 or deep vertical pocket less than 2."|participants|Number|3|3.0||||||
3890974|NCT01519765|3716349|B3|Hypertensive disorder||Induction indication|"Postdates included gestational ages greater than 40 weeks.~Hypertensive disorder included chronic hypertension, gestational hypertension, preeclampsia, eclampsia, and HELLP.~Diabetes included all gestational diabetics, Type I, and Type II diabetics.~Oligohydramnios was defined as amniotic fluid index (AFI) less than 5 or deep vertical pocket less than 2."|participants|Number|11|11.0||||||
3890975|NCT01519765|3716350|B2|Hypertensive disorder||Induction indication|"Postdates included gestational ages greater than 40 weeks.~Hypertensive disorder included chronic hypertension, gestational hypertension, preeclampsia, eclampsia, and HELLP.~Diabetes included all gestational diabetics, Type I, and Type II diabetics.~Oligohydramnios was defined as amniotic fluid index (AFI) less than 5 or deep vertical pocket less than 2."|participants|Number|7|7.0||||||
3890976|NCT01519765|3716351|B1|Hypertensive disorder||Induction indication|"Postdates included gestational ages greater than 40 weeks.~Hypertensive disorder included chronic hypertension, gestational hypertension, preeclampsia, eclampsia, and HELLP.~Diabetes included all gestational diabetics, Type I, and Type II diabetics.~Oligohydramnios was defined as amniotic fluid index (AFI) less than 5 or deep vertical pocket less than 2."|participants|Number|4|4.0||||||
3890977|NCT01519765|3716349|B3|Post dates||Induction indication|"Postdates included gestational ages greater than 40 weeks.~Hypertensive disorder included chronic hypertension, gestational hypertension, preeclampsia, eclampsia, and HELLP.~Diabetes included all gestational diabetics, Type I, and Type II diabetics.~Oligohydramnios was defined as amniotic fluid index (AFI) less than 5 or deep vertical pocket less than 2."|participants|Number|31|31.0||||||
3890978|NCT01519765|3716350|B2|Post dates||Induction indication|"Postdates included gestational ages greater than 40 weeks.~Hypertensive disorder included chronic hypertension, gestational hypertension, preeclampsia, eclampsia, and HELLP.~Diabetes included all gestational diabetics, Type I, and Type II diabetics.~Oligohydramnios was defined as amniotic fluid index (AFI) less than 5 or deep vertical pocket less than 2."|participants|Number|16|16.0||||||
3890979|NCT01519765|3716351|B1|Post dates||Induction indication|"Postdates included gestational ages greater than 40 weeks.~Hypertensive disorder included chronic hypertension, gestational hypertension, preeclampsia, eclampsia, and HELLP.~Diabetes included all gestational diabetics, Type I, and Type II diabetics.~Oligohydramnios was defined as amniotic fluid index (AFI) less than 5 or deep vertical pocket less than 2."|participants|Number|15|15.0||||||
3890980|NCT01519765|3716349|B3|Nulliparous||Parity|"Multiparous is defined as parity of 1 or greater~Nulliparous is defined as parity of 0"|participants|Number|50|50.0||||||
3890981|NCT01519765|3716350|B2|Nulliparous||Parity|"Multiparous is defined as parity of 1 or greater~Nulliparous is defined as parity of 0"|participants|Number|25|25.0||||||
3890982|NCT01519765|3716351|B1|Nulliparous||Parity|"Multiparous is defined as parity of 1 or greater~Nulliparous is defined as parity of 0"|participants|Number|25|25.0||||||
3890983|NCT01519765|3716349|B3|Multiparous||Parity|"Multiparous is defined as parity of 1 or greater~Nulliparous is defined as parity of 0"|participants|Number|18|18.0||||||
3890984|NCT01519765|3716350|B2|Multiparous||Parity|"Multiparous is defined as parity of 1 or greater~Nulliparous is defined as parity of 0"|participants|Number|9|9.0||||||
3890985|NCT01519765|3716351|B1|Multiparous||Parity|"Multiparous is defined as parity of 1 or greater~Nulliparous is defined as parity of 0"|participants|Number|9|9.0||||||
3890986|NCT01519765|3716349|B3|||Bishop score|"The Bishop score grades patients who would be most likely to achieve a successful induction. If the Bishop score is 6 or less the chances of having a vaginal delivery are low. The score is calculated by taking the sum of five subscales of the vaginal examination: dilation, effacement, station, position, and consistency. Subscale score range 0 (worse outcome) to 3 ( better outcome). Total score range= 0 (worse outcome) to 13 (better outcome)~The Bishop score is assessed upon admission. Patients were included in this study if their Bishop score was 6 or less."|scores on a scale|Median|3|3.0|Full Range|||0.0|6.0|
3890987|NCT01519765|3716350|B2|||Bishop score|"The Bishop score grades patients who would be most likely to achieve a successful induction. If the Bishop score is 6 or less the chances of having a vaginal delivery are low. The score is calculated by taking the sum of five subscales of the vaginal examination: dilation, effacement, station, position, and consistency. Subscale score range 0 (worse outcome) to 3 ( better outcome). Total score range= 0 (worse outcome) to 13 (better outcome)~The Bishop score is assessed upon admission. Patients were included in this study if their Bishop score was 6 or less."|scores on a scale|Median|3|3.0|Full Range|||0.0|3.1|
3891049|NCT01519674|3716467|B2|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.3|9.3|Standard Deviation|2.8|2.8|||
3890988|NCT01519765|3716351|B1|||Bishop score|"The Bishop score grades patients who would be most likely to achieve a successful induction. If the Bishop score is 6 or less the chances of having a vaginal delivery are low. The score is calculated by taking the sum of five subscales of the vaginal examination: dilation, effacement, station, position, and consistency. Subscale score range 0 (worse outcome) to 3 ( better outcome). Total score range= 0 (worse outcome) to 13 (better outcome)~The Bishop score is assessed upon admission. Patients were included in this study if their Bishop score was 6 or less."|scores on a scale|Median|3|3.0|Full Range|||1.0|6.0|
3890989|NCT01519765|3716349|B3|||Gestational age||weeks|Median|40.5|40.5|Full Range|||35.3|42.3|
3890990|NCT01519765|3716350|B2|||Gestational age||weeks|Median|40.8|40.8|Full Range|||35.3|42.3|
3890991|NCT01519765|3716351|B1|||Gestational age||weeks|Median|40.2|40.2|Full Range|||35.8|41.8|
3890992|NCT01519765|3716349|B3|United States||Region of Enrollment||participants|Number|68|68.0||||||
3890993|NCT01519765|3716350|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
3890994|NCT01519765|3716351|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
3890995|NCT01519765|3716349|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3890996|NCT01519765|3716350|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3890997|NCT01519765|3716351|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3890998|NCT01519765|3716349|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3890999|NCT01519765|3716350|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3891000|NCT01519765|3716351|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3891001|NCT01519765|3716349|B3|||Age||years|Mean|29.3|29.3|Standard Deviation|6.39|6.39|||
3891002|NCT01519765|3716350|B2|||Age||years|Mean|30|30.0|Standard Deviation|6.51|6.51|||
3891003|NCT01519765|3716351|B1|||Age||years|Mean|28.6|28.6|Standard Deviation|6.3|6.3|||
3891004|NCT01519713|3716398|B4|Japan||Region of Enrollment||Participants|Number|200|200.0||||||
3891005|NCT01519713|3716399|B3|Japan||Region of Enrollment||Participants|Number|4|4.0||||||
3891006|NCT01519713|3716400|B2|Japan||Region of Enrollment||Participants|Number|2|2.0||||||
3891007|NCT01519713|3716401|B1|Japan||Region of Enrollment||Participants|Number|194|194.0||||||
3891008|NCT01519713|3716398|B4||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3891009|NCT01519713|3716399|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3891010|NCT01519713|3716400|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3891011|NCT01519713|3716401|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3891012|NCT01519713|3716398|B4||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3891013|NCT01519713|3716399|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3891014|NCT01519713|3716400|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3891015|NCT01519713|3716401|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3891016|NCT01519713|3716398|B4|||Age||Years|Mean|34.7|34.7|Standard Deviation|12.1|12.1|||
3891017|NCT01519713|3716399|B3|||Age||Years|Mean|4.3|4.3|Standard Deviation|2.6|2.6|||
3891018|NCT01519713|3716400|B2|||Age||Years|Mean|11.0|11.0|Standard Deviation|0.0|0.0|||
3891019|NCT01519713|3716401|B1|||Age||Years|Mean|35.6|35.6|Standard Deviation|11.2|11.2|||
3891020|NCT01519713|3716398|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3891021|NCT01519713|3716399|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3891022|NCT01519713|3716400|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3891023|NCT01519713|3716401|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3891024|NCT01519713|3716398|B4||Between 18 and 65 years|Age||Participants|Count of Participants|194|194.0||||||
3891025|NCT01519713|3716399|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3891026|NCT01519713|3716400|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3891027|NCT01519713|3716401|B1||Between 18 and 65 years|Age||Participants|Count of Participants|194|194.0||||||
3891028|NCT01519713|3716398|B4||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3891029|NCT01519713|3716399|B3||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3891030|NCT01519713|3716400|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3891031|NCT01519713|3716401|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3891032|NCT01519700|3716426|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3891033|NCT01519700|3716427|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3891034|NCT01519700|3716428|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3891035|NCT01519700|3716429|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3891036|NCT01519700|3716430|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3891037|NCT01519700|3716426|B5||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
3891038|NCT01519700|3716427|B4||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3891039|NCT01519700|3716428|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3891040|NCT01519700|3716429|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3891041|NCT01519700|3716430|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3891042|NCT01519700|3716426|B5|||Age||years|Mean|48.9|48.9|Standard Deviation|11.26|11.26|||
3891043|NCT01519700|3716427|B4|||Age||years|Mean|46.9|46.9|Standard Deviation|10.91|10.91|||
3891044|NCT01519700|3716428|B3|||Age||years|Mean|49.7|49.7|Standard Deviation|11.05|11.05|||
3891045|NCT01519700|3716429|B2|||Age||years|Mean|47.5|47.5|Standard Deviation|11.64|11.64|||
3891050|NCT01519674|3716468|B1|||Fasting plasma glucose (FPG)||mmol/L|Mean|8.9|8.9|Standard Deviation|2.2|2.2|||
3891051|NCT01519674|3716465|B4|||Glycosylated haemoglobin (HbA1c)||Percent (%) glycosylated haemoglobin|Mean|8.4|8.4|Standard Deviation|0.8|0.8|||
3891052|NCT01519674|3716466|B3|||Glycosylated haemoglobin (HbA1c)||Percent (%) glycosylated haemoglobin|Mean|8.4|8.4|Standard Deviation|0.8|0.8|||
3891053|NCT01519674|3716467|B2|||Glycosylated haemoglobin (HbA1c)||Percent (%) glycosylated haemoglobin|Mean|8.4|8.4|Standard Deviation|0.8|0.8|||
3891054|NCT01519674|3716468|B1|||Glycosylated haemoglobin (HbA1c)||Percent (%) glycosylated haemoglobin|Mean|8.4|8.4|Standard Deviation|0.8|0.8|||
3891055|NCT01519674|3716465|B4|||Body Mass Index (BMI)||kg/m^2|Mean|29.4|29.4|Standard Deviation|4.6|4.6|||
3891056|NCT01519674|3716466|B3|||Body Mass Index (BMI)||kg/m^2|Mean|29.4|29.4|Standard Deviation|5.0|5.0|||
3891057|NCT01519674|3716467|B2|||Body Mass Index (BMI)||kg/m^2|Mean|29.4|29.4|Standard Deviation|4.5|4.5|||
3891058|NCT01519674|3716468|B1|||Body Mass Index (BMI)||kg/m^2|Mean|29.3|29.3|Standard Deviation|4.3|4.3|||
3891059|NCT01519674|3716465|B4|||Body Weight||kg|Mean|78.4|78.4|Standard Deviation|16.2|16.2|||
3891060|NCT01519674|3716466|B3|||Body Weight||kg|Mean|77.5|77.5|Standard Deviation|16.8|16.8|||
3891061|NCT01519674|3716467|B2|||Body Weight||kg|Mean|78.3|78.3|Standard Deviation|16.1|16.1|||
3891062|NCT01519674|3716468|B1|||Body Weight||kg|Mean|79.4|79.4|Standard Deviation|15.8|15.8|||
3891063|NCT01519674|3716465|B4||Male|Gender||Participants|Count of Participants|301|301.0||||||
3891064|NCT01519674|3716466|B3||Male|Gender||Participants|Count of Participants|96|96.0||||||
3891065|NCT01519674|3716467|B2||Male|Gender||Participants|Count of Participants|94|94.0||||||
3891066|NCT01519674|3716468|B1||Male|Gender||Participants|Count of Participants|111|111.0||||||
3891067|NCT01519674|3716465|B4||Female|Gender||Participants|Count of Participants|281|281.0||||||
3891068|NCT01519674|3716466|B3||Female|Gender||Participants|Count of Participants|97|97.0||||||
3891069|NCT01519674|3716467|B2||Female|Gender||Participants|Count of Participants|101|101.0||||||
3891070|NCT01519674|3716468|B1||Female|Gender||Participants|Count of Participants|83|83.0||||||
3891071|NCT01519674|3716465|B4|||Age||years|Mean|55.6|55.6|Standard Deviation|10.0|10.0|||
3891072|NCT01519674|3716466|B3|||Age||years|Mean|55.7|55.7|Standard Deviation|10.4|10.4|||
3891073|NCT01519674|3716467|B2|||Age||years|Mean|56.3|56.3|Standard Deviation|10.2|10.2|||
3891074|NCT01519674|3716468|B1|||Age||years|Mean|54.8|54.8|Standard Deviation|9.5|9.5|||
3891075|NCT01519661|3716508|B1|Missing||P. aeruginosa tobramycin minimal inhibitory concentration (MIC)||percentage of participants|Number|0.6|0.6||||||
3891076|NCT01519661|3716508|B1|<= 8 ug/mL||P. aeruginosa tobramycin minimal inhibitory concentration (MIC)||percentage of participants|Number|73.2|73.2||||||
3891077|NCT01519661|3716508|B1|> 8 ug/mL||P. aeruginosa tobramycin minimal inhibitory concentration (MIC)||percentage of participants|Number|26.1|26.1||||||
3891078|NCT01519661|3716508|B1|||Sputum density of P. aeruginosa - sum of all biotypes||log10 Colony Forming Units (CFU)|Mean|7.6|7.6|Standard Deviation|1.65|1.65|||
3891079|NCT01519661|3716508|B1|||FEF25-75 % predicted||percent|Mean|21.8|21.8|Standard Deviation|12.75|12.75|||
3891080|NCT01519661|3716508|B1|||FVC % predicted||percent|Mean|73.9|73.9|Standard Deviation|15.88|15.88|||
3891081|NCT01519661|3716508|B1|||FEV1 % predicted||percent|Mean|50.2|50.2|Standard Deviation|13.95|13.95|||
3891082|NCT01519661|3716508|B1|||Body Mass Index||kg/m^2|Mean|20.5|20.5|Standard Deviation|3.35|3.35|||
3891083|NCT01519661|3716508|B1|||Weight||kilograms (kg)|Mean|57.4|57.4|Standard Deviation|13.52|13.52|||
3891084|NCT01519661|3716508|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3891085|NCT01519661|3716508|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3891086|NCT01519661|3716508|B1|||Age||Years|Mean|27.8|27.8|Standard Deviation|10.82|10.82|||
3891087|NCT01519648|3716523|B3|Russian Federation||Region of Enrollment||participants|Number|808|808.0||||||
3891088|NCT01519648|3716524|B2|Russian Federation||Region of Enrollment||participants|Number|306|306.0||||||
3891089|NCT01519648|3716525|B1|Russian Federation||Region of Enrollment||participants|Number|502|502.0||||||
3891090|NCT01519648|3716523|B3||Male|Sex: Female, Male||Participants|Count of Participants|397|397.0||||||
3891091|NCT01519648|3716524|B2||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3891092|NCT01519648|3716525|B1||Male|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
3891093|NCT01519648|3716523|B3||Female|Sex: Female, Male||Participants|Count of Participants|411|411.0||||||
3891094|NCT01519648|3716524|B2||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3891095|NCT01519648|3716525|B1||Female|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
3891096|NCT01519648|3716523|B3||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
3891097|NCT01519648|3716524|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3891098|NCT01519648|3716525|B1||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
3891099|NCT01519648|3716523|B3||Between 18 and 65 years|Age||Participants|Count of Participants|639|639.0||||||
3891100|NCT01519648|3716524|B2||Between 18 and 65 years|Age||Participants|Count of Participants|250|250.0||||||
3891101|NCT01519648|3716525|B1||Between 18 and 65 years|Age||Participants|Count of Participants|389|389.0||||||
3891102|NCT01519648|3716523|B3||<=18 years|Age||Participants|Count of Participants|124|124.0||||||
3891103|NCT01519648|3716524|B2||<=18 years|Age||Participants|Count of Participants|55|55.0||||||
3891104|NCT01519648|3716525|B1||<=18 years|Age||Participants|Count of Participants|69|69.0||||||
3891105|NCT01519648|3716523|B3|||Age||years|Median|40|40.0|Full Range|1-79|1.0|1.0|79.0|
3891106|NCT01519648|3716524|B2|||Age||years|Median|37|37.0|Full Range|1-66|1.0|1.0|66.0|
3891107|NCT01519648|3716525|B1|||Age||years|Median|42|42.0|Full Range|1-79|1.0|1.0|79.0|
3891108|NCT01519518|3716532|B3||Male|Sex: Female, Male||Participants|Count of Participants|1310|1310.0||||||
3891109|NCT01519518|3716533|B2||Male|Sex: Female, Male||Participants|Count of Participants|647|647.0||||||
3891110|NCT01519518|3716534|B1||Male|Sex: Female, Male||Participants|Count of Participants|663|663.0||||||
3891111|NCT01519518|3716532|B3||Female|Sex: Female, Male||Participants|Count of Participants|502|502.0||||||
3891112|NCT01519518|3716533|B2||Female|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
3891113|NCT01519518|3716534|B1||Female|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
3891114|NCT01519518|3716532|B3|||Age||years|Median|63.2|63.2|Inter-Quartile Range|||53.9|73.9|
3891115|NCT01519518|3716533|B2|||Age||years|Median|62.9|62.9|Inter-Quartile Range|||53.7|74.0|
3891116|NCT01519518|3716534|B1|||Age||years|Median|63.6|63.6|Inter-Quartile Range|||54.0|73.8|
3891117|NCT01519466|3716547|B3|||Screening HbA1c||Percentage of Glycosylated Haemoglobin|Mean|7.9|7.9|Standard Deviation|0.7|0.7|||
3891118|NCT01519466|3716548|B2|||Screening HbA1c||Percentage of Glycosylated Haemoglobin|Mean|8.1|8.1|Standard Deviation|0.6|0.6|||
3891119|NCT01519466|3716549|B1|||Screening HbA1c||Percentage of Glycosylated Haemoglobin|Mean|7.8|7.8|Standard Deviation|0.7|0.7|||
3891120|NCT01519466|3716547|B3|||Screening HbA1c||mmol/mol|Mean|62.7|62.7|Standard Deviation|7.5|7.5|||
3891121|NCT01519466|3716548|B2|||Screening HbA1c||mmol/mol|Mean|64.8|64.8|Standard Deviation|6.8|6.8|||
3891122|NCT01519466|3716549|B1|||Screening HbA1c||mmol/mol|Mean|61.7|61.7|Standard Deviation|7.7|7.7|||
3891123|NCT01519466|3716547|B3|||Duration of Diabetes||years|Mean|17.4|17.4|Standard Deviation|12.5|12.5|||
3891124|NCT01519466|3716548|B2|||Duration of Diabetes||years|Mean|14.6|14.6|Standard Deviation|8.0|8.0|||
3891125|NCT01519466|3716549|B1|||Duration of Diabetes||years|Mean|18.8|18.8|Standard Deviation|14.1|14.1|||
3891126|NCT01519466|3716547|B3|||Body Mass Index (BMI)||kg/m²|Mean|26.5|26.5|Standard Deviation|3.8|3.8|||
3891127|NCT01519466|3716548|B2|||Body Mass Index (BMI)||kg/m²|Mean|26.4|26.4|Standard Deviation|4.4|4.4|||
3891128|NCT01519466|3716549|B1|||Body Mass Index (BMI)||kg/m²|Mean|26.6|26.6|Standard Deviation|3.6|3.6|||
3891129|NCT01519466|3716547|B3|Germany||Region of Enrollment||participants|Number|37|37.0||||||
3891130|NCT01519466|3716548|B2|Germany||Region of Enrollment||participants|Number|12|12.0||||||
3891131|NCT01519466|3716549|B1|Germany||Region of Enrollment||participants|Number|25|25.0||||||
3891132|NCT01519466|3716547|B3|Netherlands||Region of Enrollment||participants|Number|12|12.0||||||
3891133|NCT01519466|3716548|B2|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
3891134|NCT01519466|3716549|B1|Netherlands||Region of Enrollment||participants|Number|8|8.0||||||
3891135|NCT01519466|3716547|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3891136|NCT01519466|3716548|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3891137|NCT01519466|3716549|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3891138|NCT01519466|3716547|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3891139|NCT01519466|3716548|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3891140|NCT01519466|3716549|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3891141|NCT01519466|3716547|B3|||Age||years|Mean|44.1|44.1|Standard Deviation|15.6|15.6|||
3891142|NCT01519466|3716548|B2|||Age||years|Mean|43.4|43.4|Standard Deviation|16.7|16.7|||
3891143|NCT01519466|3716549|B1|||Age||years|Mean|44.4|44.4|Standard Deviation|15.2|15.2|||
3891144|NCT01519427|3716560|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3891145|NCT01519427|3716560|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3891146|NCT01519427|3716560|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3891147|NCT01519427|3716560|B1|||Age||years|Mean|44|44.0|Standard Deviation|14|14.0|||
3891148|NCT01519427|3716560|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3891149|NCT01519427|3716560|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3891150|NCT01519427|3716560|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3891151|NCT01519414|3716567|B3|United States||Region of Enrollment||patients|Number|78|78.0||||||
3891152|NCT01519414|3716568|B2|United States||Region of Enrollment||patients|Number|26|26.0||||||
3891153|NCT01519414|3716569|B1|United States||Region of Enrollment||patients|Number|52|52.0||||||
3891154|NCT01519414|3716567|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891155|NCT01519414|3716568|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891156|NCT01519414|3716569|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891157|NCT01519414|3716567|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891158|NCT01519414|3716568|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891159|NCT01519414|3716569|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891160|NCT01519414|3716567|B3||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3891161|NCT01519414|3716568|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3891162|NCT01519414|3716569|B1||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3891163|NCT01519414|3716567|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3891164|NCT01519414|3716568|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3891165|NCT01519414|3716569|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3891166|NCT01519414|3716567|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891167|NCT01519414|3716568|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891321|NCT01519245|3716653|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3891168|NCT01519414|3716569|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891169|NCT01519414|3716567|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3891170|NCT01519414|3716568|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891171|NCT01519414|3716569|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3891172|NCT01519414|3716567|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891173|NCT01519414|3716568|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891174|NCT01519414|3716569|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891175|NCT01519414|3716567|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3891176|NCT01519414|3716568|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3891177|NCT01519414|3716569|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3891178|NCT01519414|3716567|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3891179|NCT01519414|3716568|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3891180|NCT01519414|3716569|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3891181|NCT01519414|3716567|B3|||Age||years|Median|67|67.0|Full Range|||43.0|85.0|
3891182|NCT01519414|3716568|B2|||Age||years|Median|66.5|66.5|Full Range|||48.0|85.0|
3891183|NCT01519414|3716569|B1|||Age||years|Median|67|67.0|Full Range|||43.0|84.0|
3891184|NCT01519323|3716592|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3891185|NCT01519323|3716592|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3891186|NCT01519323|3716592|B1|||Age||years|Mean|15.8|15.8|Standard Deviation|0.8|0.8|||
3891187|NCT01519284|3716604|B6||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3891188|NCT01519284|3716605|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3891189|NCT01519284|3716606|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3891190|NCT01519284|3716607|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3891191|NCT01519284|3716608|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3891192|NCT01519284|3716609|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3891193|NCT01519284|3716604|B6||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3891194|NCT01519284|3716605|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3891195|NCT01519284|3716606|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3891196|NCT01519284|3716607|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3891197|NCT01519284|3716608|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3891198|NCT01519284|3716609|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3891199|NCT01519284|3716604|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3891200|NCT01519284|3716605|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3891201|NCT01519284|3716606|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3891202|NCT01519284|3716607|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3891203|NCT01519284|3716608|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3891204|NCT01519284|3716609|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3891205|NCT01519284|3716604|B6||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
3891206|NCT01519284|3716605|B5||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3891207|NCT01519284|3716606|B4||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3891208|NCT01519284|3716607|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3891209|NCT01519284|3716608|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3891210|NCT01519284|3716609|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3891211|NCT01519284|3716604|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3891212|NCT01519284|3716605|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3891213|NCT01519284|3716606|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3891214|NCT01519284|3716607|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3891215|NCT01519284|3716608|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3891216|NCT01519284|3716609|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3891217|NCT01519271|3716640|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3891218|NCT01519271|3716641|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3891219|NCT01519271|3716642|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3891220|NCT01519271|3716640|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3891221|NCT01519271|3716641|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3891222|NCT01519271|3716642|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3891223|NCT01519271|3716640|B3|||Age||years|Mean|64.3|64.3|Standard Deviation|8.2|8.2|||
3891224|NCT01519271|3716641|B2|||Age||years|Mean|62.6|62.6|Standard Deviation|10.1|10.1|||
3891225|NCT01519271|3716642|B1|||Age||years|Mean|66.1|66.1|Standard Deviation|5.5|5.5|||
3891226|NCT01519245|3716651|B3|||Pre-operative Creatinine||umol/L|Mean|81|81.0|Standard Deviation|23|23.0|||
3891227|NCT01519245|3716652|B2|||Pre-operative Creatinine||umol/L|Mean|76|76.0|Standard Deviation|18|18.0|||
3891228|NCT01519245|3716653|B1|||Pre-operative Creatinine||umol/L|Mean|84|84.0|Standard Deviation|25|25.0|||
3891229|NCT01519245|3716651|B3|||Pre-operative International Normalized Ratio (INR)|The ratio of a patient's prothrombin time to a normal (control) sample, raised to the power of the International Sensitivity Index (ISI) value for the analytical system used. The calculated value indicates what a patient's PT ratio would be if it was measured using the primary World Health Organization International Reference reagent. The normal range is 0.8-1.2.|International Normalized Ratio|Mean|1.0|1.0|Standard Deviation|0.1|0.1|||
3891230|NCT01519245|3716652|B2|||Pre-operative International Normalized Ratio (INR)|The ratio of a patient's prothrombin time to a normal (control) sample, raised to the power of the International Sensitivity Index (ISI) value for the analytical system used. The calculated value indicates what a patient's PT ratio would be if it was measured using the primary World Health Organization International Reference reagent. The normal range is 0.8-1.2.|International Normalized Ratio|Mean|1.0|1.0|Standard Deviation|0.1|0.1|||
3891231|NCT01519245|3716653|B1|||Pre-operative International Normalized Ratio (INR)|The ratio of a patient's prothrombin time to a normal (control) sample, raised to the power of the International Sensitivity Index (ISI) value for the analytical system used. The calculated value indicates what a patient's PT ratio would be if it was measured using the primary World Health Organization International Reference reagent. The normal range is 0.8-1.2.|International Normalized Ratio|Mean|1.0|1.0|Standard Deviation|0.1|0.1|||
3891232|NCT01519245|3716651|B3|||Pre-operative white blood cell (WBC) count||WBC x 10^9/L|Mean|7.8|7.8|Standard Deviation|2.5|2.5|||
3891233|NCT01519245|3716652|B2|||Pre-operative white blood cell (WBC) count||WBC x 10^9/L|Mean|7.9|7.9|Standard Deviation|3.2|3.2|||
3891234|NCT01519245|3716653|B1|||Pre-operative white blood cell (WBC) count||WBC x 10^9/L|Mean|7.7|7.7|Standard Deviation|1.9|1.9|||
3891235|NCT01519245|3716651|B3|||Pre-operative platelet count||platelets x 10^9/L|Mean|239|239.0|Standard Deviation|66|66.0|||
3891236|NCT01519245|3716652|B2|||Pre-operative platelet count||platelets x 10^9/L|Mean|234|234.0|Standard Deviation|62|62.0|||
3891237|NCT01519245|3716653|B1|||Pre-operative platelet count||platelets x 10^9/L|Mean|242|242.0|Standard Deviation|70|70.0|||
3891238|NCT01519245|3716651|B3|||Pre-operative Hemoglobin||g/L|Mean|145|145.0|Standard Deviation|14|14.0|||
3891239|NCT01519245|3716652|B2|||Pre-operative Hemoglobin||g/L|Mean|142|142.0|Standard Deviation|14|14.0|||
3891240|NCT01519245|3716653|B1|||Pre-operative Hemoglobin||g/L|Mean|147|147.0|Standard Deviation|13|13.0|||
3891241|NCT01519245|3716651|B3|No||Hypertension||participants|Number|9|9.0||||||
3891242|NCT01519245|3716652|B2|No||Hypertension||participants|Number|4|4.0||||||
3891243|NCT01519245|3716653|B1|No||Hypertension||participants|Number|5|5.0||||||
3891244|NCT01519245|3716651|B3|Yes||Hypertension||participants|Number|32|32.0||||||
3891245|NCT01519245|3716652|B2|Yes||Hypertension||participants|Number|14|14.0||||||
3891246|NCT01519245|3716653|B1|Yes||Hypertension||participants|Number|18|18.0||||||
3891247|NCT01519245|3716651|B3|No||Atrial Fibrillation||participants|Number|41|41.0||||||
3891248|NCT01519245|3716652|B2|No||Atrial Fibrillation||participants|Number|18|18.0||||||
3891249|NCT01519245|3716653|B1|No||Atrial Fibrillation||participants|Number|23|23.0||||||
3891250|NCT01519245|3716651|B3|Yes||Atrial Fibrillation||participants|Number|0|0.0||||||
3891251|NCT01519245|3716652|B2|Yes||Atrial Fibrillation||participants|Number|0|0.0||||||
3891252|NCT01519245|3716653|B1|Yes||Atrial Fibrillation||participants|Number|0|0.0||||||
3891253|NCT01519245|3716651|B3|No||Dyslipidemia||participants|Number|11|11.0||||||
3891254|NCT01519245|3716652|B2|No||Dyslipidemia||participants|Number|5|5.0||||||
3891255|NCT01519245|3716653|B1|No||Dyslipidemia||participants|Number|6|6.0||||||
3891256|NCT01519245|3716651|B3|Yes||Dyslipidemia||participants|Number|30|30.0||||||
3891257|NCT01519245|3716652|B2|Yes||Dyslipidemia||participants|Number|13|13.0||||||
3891258|NCT01519245|3716653|B1|Yes||Dyslipidemia||participants|Number|17|17.0||||||
3891259|NCT01519245|3716651|B3|No||Diabetes|Diagnosis of Type 1 or 2 diabetes (non-insulin dependent or insulin dependent).|participants|Number|25|25.0||||||
3891260|NCT01519245|3716652|B2|No||Diabetes|Diagnosis of Type 1 or 2 diabetes (non-insulin dependent or insulin dependent).|participants|Number|11|11.0||||||
3891261|NCT01519245|3716653|B1|No||Diabetes|Diagnosis of Type 1 or 2 diabetes (non-insulin dependent or insulin dependent).|participants|Number|14|14.0||||||
3891262|NCT01519245|3716651|B3|Yes||Diabetes|Diagnosis of Type 1 or 2 diabetes (non-insulin dependent or insulin dependent).|participants|Number|16|16.0||||||
3891263|NCT01519245|3716652|B2|Yes||Diabetes|Diagnosis of Type 1 or 2 diabetes (non-insulin dependent or insulin dependent).|participants|Number|7|7.0||||||
3891264|NCT01519245|3716653|B1|Yes||Diabetes|Diagnosis of Type 1 or 2 diabetes (non-insulin dependent or insulin dependent).|participants|Number|9|9.0||||||
3891265|NCT01519245|3716651|B3|No||Stent in situ|Any history of participant receiving a coronary vascular stent (bare metal or drug eluding).|participants|Number|34|34.0||||||
3891266|NCT01519245|3716652|B2|No||Stent in situ|Any history of participant receiving a coronary vascular stent (bare metal or drug eluding).|participants|Number|14|14.0||||||
3891267|NCT01519245|3716653|B1|No||Stent in situ|Any history of participant receiving a coronary vascular stent (bare metal or drug eluding).|participants|Number|20|20.0||||||
3891268|NCT01519245|3716651|B3|Yes||Stent in situ|Any history of participant receiving a coronary vascular stent (bare metal or drug eluding).|participants|Number|7|7.0||||||
3891269|NCT01519245|3716652|B2|Yes||Stent in situ|Any history of participant receiving a coronary vascular stent (bare metal or drug eluding).|participants|Number|4|4.0||||||
3891270|NCT01519245|3716653|B1|Yes||Stent in situ|Any history of participant receiving a coronary vascular stent (bare metal or drug eluding).|participants|Number|3|3.0||||||
3891271|NCT01519245|3716651|B3|No||History of Myocardial Infarction|Diagnosed myocardial infarction at any time in participant's past history.|participants|Number|23|23.0||||||
3891272|NCT01519245|3716652|B2|No||History of Myocardial Infarction|Diagnosed myocardial infarction at any time in participant's past history.|participants|Number|9|9.0||||||
3891273|NCT01519245|3716653|B1|No||History of Myocardial Infarction|Diagnosed myocardial infarction at any time in participant's past history.|participants|Number|14|14.0||||||
3891417|NCT01518374|3716842|B1||Male|Sex: Female, Male||Participants|Count of Participants|848|848.0||||||
3891274|NCT01519245|3716651|B3|Yes||History of Myocardial Infarction|Diagnosed myocardial infarction at any time in participant's past history.|participants|Number|18|18.0||||||
3891275|NCT01519245|3716652|B2|Yes||History of Myocardial Infarction|Diagnosed myocardial infarction at any time in participant's past history.|participants|Number|9|9.0||||||
3891276|NCT01519245|3716653|B1|Yes||History of Myocardial Infarction|Diagnosed myocardial infarction at any time in participant's past history.|participants|Number|9|9.0||||||
3891277|NCT01519245|3716651|B3|No||Angina|Symptomatic angina in weeks leading up to surgery.|participants|Number|1|1.0||||||
3891278|NCT01519245|3716652|B2|No||Angina|Symptomatic angina in weeks leading up to surgery.|participants|Number|0|0.0||||||
3891279|NCT01519245|3716653|B1|No||Angina|Symptomatic angina in weeks leading up to surgery.|participants|Number|1|1.0||||||
3891280|NCT01519245|3716651|B3|Yes||Angina|Symptomatic angina in weeks leading up to surgery.|participants|Number|40|40.0||||||
3891281|NCT01519245|3716652|B2|Yes||Angina|Symptomatic angina in weeks leading up to surgery.|participants|Number|18|18.0||||||
3891282|NCT01519245|3716653|B1|Yes||Angina|Symptomatic angina in weeks leading up to surgery.|participants|Number|22|22.0||||||
3891283|NCT01519245|3716651|B3|Off more than 7 days||Pre-operative Antiplatelet Use|Participants receiving Aspirin (ASA) or Plavix (any dose) pre-operatively. Divided in to two categories: discontinuation of antiplatelet agents prior to, or at 7 days before surgery; and more than 7 days before surgery.|participants|Number|1|1.0||||||
3891284|NCT01519245|3716652|B2|Off more than 7 days||Pre-operative Antiplatelet Use|Participants receiving Aspirin (ASA) or Plavix (any dose) pre-operatively. Divided in to two categories: discontinuation of antiplatelet agents prior to, or at 7 days before surgery; and more than 7 days before surgery.|participants|Number|0|0.0||||||
3891285|NCT01519245|3716653|B1|Off more than 7 days||Pre-operative Antiplatelet Use|Participants receiving Aspirin (ASA) or Plavix (any dose) pre-operatively. Divided in to two categories: discontinuation of antiplatelet agents prior to, or at 7 days before surgery; and more than 7 days before surgery.|participants|Number|1|1.0||||||
3891286|NCT01519245|3716651|B3|Off 7 days or less||Pre-operative Antiplatelet Use|Participants receiving Aspirin (ASA) or Plavix (any dose) pre-operatively. Divided in to two categories: discontinuation of antiplatelet agents prior to, or at 7 days before surgery; and more than 7 days before surgery.|participants|Number|40|40.0||||||
3891287|NCT01519245|3716652|B2|Off 7 days or less||Pre-operative Antiplatelet Use|Participants receiving Aspirin (ASA) or Plavix (any dose) pre-operatively. Divided in to two categories: discontinuation of antiplatelet agents prior to, or at 7 days before surgery; and more than 7 days before surgery.|participants|Number|18|18.0||||||
3891288|NCT01519245|3716653|B1|Off 7 days or less||Pre-operative Antiplatelet Use|Participants receiving Aspirin (ASA) or Plavix (any dose) pre-operatively. Divided in to two categories: discontinuation of antiplatelet agents prior to, or at 7 days before surgery; and more than 7 days before surgery.|participants|Number|22|22.0||||||
3891289|NCT01519245|3716651|B3|||Number of Bypasses|Mean number of vessels bypassed per patient.|Number of vessels|Mean|4.2|4.2|Standard Deviation|1.1|1.1|||
3891290|NCT01519245|3716652|B2|||Number of Bypasses|Mean number of vessels bypassed per patient.|Number of vessels|Mean|4.3|4.3|Standard Deviation|1.1|1.1|||
3891291|NCT01519245|3716653|B1|||Number of Bypasses|Mean number of vessels bypassed per patient.|Number of vessels|Mean|4.1|4.1|Standard Deviation|1.0|1.0|||
3891292|NCT01519245|3716651|B3|||Body Mass Index||kg/m^2|Mean|31.1|31.1|Standard Deviation|4.6|4.6|||
3891293|NCT01519245|3716652|B2|||Body Mass Index||kg/m^2|Mean|31.2|31.2|Standard Deviation|5.1|5.1|||
3891294|NCT01519245|3716653|B1|||Body Mass Index||kg/m^2|Mean|31.1|31.1|Standard Deviation|4.2|4.2|||
3891295|NCT01519245|3716651|B3|||Height||meters|Mean|1.7|1.7|Standard Deviation|0.1|0.1|||
3891296|NCT01519245|3716652|B2|||Height||meters|Mean|1.7|1.7|Standard Deviation|0.1|0.1|||
3891297|NCT01519245|3716653|B1|||Height||meters|Mean|1.7|1.7|Standard Deviation|0.1|0.1|||
3891298|NCT01519245|3716651|B3|||Mass||kilograms|Mean|92.2|92.2|Standard Deviation|11.6|11.6|||
3891299|NCT01519245|3716652|B2|||Mass||kilograms|Mean|91.3|91.3|Standard Deviation|13.2|13.2|||
3891300|NCT01519245|3716653|B1|||Mass||kilograms|Mean|92.7|92.7|Standard Deviation|10.5|10.5|||
3891301|NCT01519245|3716651|B3|Canada||Region of Enrollment||participants|Number|41|41.0||||||
3891302|NCT01519245|3716652|B2|Canada||Region of Enrollment||participants|Number|18|18.0||||||
3891303|NCT01519245|3716653|B1|Canada||Region of Enrollment||participants|Number|23|23.0||||||
3891304|NCT01519245|3716651|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3891305|NCT01519245|3716652|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3891306|NCT01519245|3716653|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3891307|NCT01519245|3716651|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3891308|NCT01519245|3716652|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3891309|NCT01519245|3716653|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3891310|NCT01519245|3716651|B3|||Age||years|Mean|62|62.0|Standard Deviation|9.4|9.4|||
3891311|NCT01519245|3716652|B2|||Age||years|Mean|62|62.0|Standard Deviation|10.4|10.4|||
3891312|NCT01519245|3716653|B1|||Age||years|Mean|62|62.0|Standard Deviation|8.7|8.7|||
3891313|NCT01519245|3716651|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3891314|NCT01519245|3716652|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3891315|NCT01519245|3716653|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3891316|NCT01519245|3716651|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3891317|NCT01519245|3716652|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3891318|NCT01519245|3716653|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3891319|NCT01519245|3716651|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3891320|NCT01519245|3716652|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3891322|NCT01519206|3716666|B1|||Body Mass Index (BMI)||kg/m˄2|Mean|23.3|23.3|Full Range|||18.0|30.2|
3891323|NCT01519206|3716666|B1|VI||Fitzpatrick Skin Type|Skin Type I = White; very fair, red or blonde hair blue eyes; freckles; Always burns, never tans Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes; Usually burns, tans with difficulty Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily Skin Type VI = Black; Never burns, tans very easily|participants|Number|0|0.0||||||
3891324|NCT01519206|3716666|B1|V||Fitzpatrick Skin Type|Skin Type I = White; very fair, red or blonde hair blue eyes; freckles; Always burns, never tans Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes; Usually burns, tans with difficulty Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily Skin Type VI = Black; Never burns, tans very easily|participants|Number|1|1.0||||||
3891325|NCT01519206|3716666|B1|IV||Fitzpatrick Skin Type|Skin Type I = White; very fair, red or blonde hair blue eyes; freckles; Always burns, never tans Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes; Usually burns, tans with difficulty Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily Skin Type VI = Black; Never burns, tans very easily|participants|Number|0|0.0||||||
3891326|NCT01519206|3716666|B1|III||Fitzpatrick Skin Type|Skin Type I = White; very fair, red or blonde hair blue eyes; freckles; Always burns, never tans Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes; Usually burns, tans with difficulty Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily Skin Type VI = Black; Never burns, tans very easily|participants|Number|6|6.0||||||
3891327|NCT01519206|3716666|B1|II||Fitzpatrick Skin Type|Skin Type I = White; very fair, red or blonde hair blue eyes; freckles; Always burns, never tans Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes; Usually burns, tans with difficulty Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily Skin Type VI = Black; Never burns, tans very easily|participants|Number|24|24.0||||||
3891328|NCT01519206|3716666|B1|I||Fitzpatrick Skin Type|Skin Type I = White; very fair, red or blonde hair blue eyes; freckles; Always burns, never tans Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes; Usually burns, tans with difficulty Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily Skin Type VI = Black; Never burns, tans very easily|participants|Number|1|1.0||||||
3891329|NCT01519206|3716666|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
3891330|NCT01519206|3716666|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3891331|NCT01519206|3716666|B1|African American/Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3891332|NCT01519206|3716666|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3891333|NCT01519206|3716666|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3891334|NCT01519206|3716666|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3891335|NCT01519206|3716666|B1|||Age||years|Mean|55|55.0|Full Range|||44.0|64.0|
3891336|NCT01519167|3716678|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3891337|NCT01519167|3716679|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3891338|NCT01519167|3716680|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891339|NCT01519167|3716678|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891340|NCT01519167|3716679|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891341|NCT01519167|3716680|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891342|NCT01519167|3716678|B3||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3891343|NCT01519167|3716679|B2||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3891344|NCT01519167|3716680|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891345|NCT01519167|3716678|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3891346|NCT01519167|3716679|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3891347|NCT01519167|3716680|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3891348|NCT01519167|3716678|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891349|NCT01519167|3716679|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891350|NCT01519167|3716680|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891351|NCT01519167|3716678|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3891352|NCT01519167|3716679|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3891353|NCT01519167|3716680|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891354|NCT01519167|3716678|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891355|NCT01519167|3716679|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891356|NCT01519167|3716680|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891357|NCT01519167|3716678|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891358|NCT01519167|3716679|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891359|NCT01519167|3716680|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891360|NCT01519167|3716678|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3891361|NCT01519167|3716679|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3891362|NCT01519167|3716680|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3891363|NCT01519167|3716678|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3891364|NCT01519167|3716679|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3891365|NCT01519167|3716680|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891366|NCT01519167|3716678|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3891367|NCT01519167|3716679|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3891368|NCT01519167|3716680|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3891369|NCT01519167|3716678|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3891370|NCT01519167|3716679|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3891371|NCT01519167|3716680|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3891372|NCT01519167|3716678|B3|||Age||years|Mean|7.89|7.89|Full Range|||0.1|17.3|
3891373|NCT01519167|3716679|B2|||Age||years|Mean|7.97|7.97|Full Range|||0.3|17.3|
3891374|NCT01519167|3716680|B1|||Age||years|Mean|0.1|0.1|Full Range|||0.1|0.1|
3891375|NCT01519089|3716705|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3891376|NCT01519089|3716706|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3891377|NCT01519089|3716707|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3891378|NCT01519089|3716705|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3891379|NCT01519089|3716706|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3891380|NCT01519089|3716707|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3891381|NCT01519089|3716705|B3|||Age||years|Mean|48.7|48.7|Standard Deviation|11.5|11.5|||
3891382|NCT01519089|3716706|B2|||Age||years|Mean|46.4|46.4|Standard Deviation|10.8|10.8|||
3891383|NCT01519089|3716707|B1|||Age||years|Mean|50.9|50.9|Standard Deviation|11.8|11.8|||
3891384|NCT01518946|3716827|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3891385|NCT01518946|3716828|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3891386|NCT01518946|3716829|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3891387|NCT01518946|3716827|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3891388|NCT01518946|3716828|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3891389|NCT01518946|3716829|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3891390|NCT01518946|3716827|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3891391|NCT01518946|3716828|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3891392|NCT01518946|3716829|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3891393|NCT01518946|3716827|B3|>= 66 years||Age, Customized||participants|Number|4|4.0||||||
3891394|NCT01518946|3716828|B2|>= 66 years||Age, Customized||participants|Number|2|2.0||||||
3891395|NCT01518946|3716829|B1|>= 66 years||Age, Customized||participants|Number|2|2.0||||||
3891396|NCT01518946|3716827|B3|18 to 65 years, inclusive||Age, Customized||participants|Number|16|16.0||||||
3891397|NCT01518946|3716828|B2|18 to 65 years, inclusive||Age, Customized||participants|Number|8|8.0||||||
3891398|NCT01518946|3716829|B1|18 to 65 years, inclusive||Age, Customized||participants|Number|8|8.0||||||
3891399|NCT01518946|3716827|B3|||Age||years|Mean|45.1|45.1|Standard Deviation|18.82|18.82|||
3891400|NCT01518946|3716828|B2|||Age||years|Mean|42.1|42.1|Standard Deviation|18.64|18.64|||
3891401|NCT01518946|3716829|B1|||Age||years|Mean|48.0|48.0|Standard Deviation|19.52|19.52|||
3891402|NCT01518530|3716838|B1|Israel||Region of Enrollment||participants|Number|10|10.0||||||
3891403|NCT01518530|3716838|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3891404|NCT01518530|3716838|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3891405|NCT01518530|3716838|B1|||Age||years|Mean|47|47.0|Standard Deviation|11.21|11.21|||
3891406|NCT01518530|3716838|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3891407|NCT01518530|3716838|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3891408|NCT01518530|3716838|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3891409|NCT01518374|3716842|B1|United States||Region of Enrollment||Participants|Count of Participants|1768|1768.0||||||
3891410|NCT01518374|3716842|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3891411|NCT01518374|3716842|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891412|NCT01518374|3716842|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1487|1487.0||||||
3891413|NCT01518374|3716842|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|233|233.0||||||
3891414|NCT01518374|3716842|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891415|NCT01518374|3716842|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3891416|NCT01518374|3716842|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3891418|NCT01518374|3716842|B1||Female|Sex: Female, Male||Participants|Count of Participants|920|920.0||||||
3891419|NCT01518374|3716842|B1|||Age||years|Mean|68.3|68.3|Standard Deviation|13.43|13.43|||
3891420|NCT01518322|3716846|B1|United States||Region of Enrollment||participants|Number|235|235.0||||||
3891421|NCT01518322|3716846|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3891422|NCT01518322|3716846|B1||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3891423|NCT01518322|3716846|B1|||Age||years|Mean|40.9|40.9|Standard Deviation|14.45|14.45|||
3891424|NCT01518322|3716846|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3891425|NCT01518322|3716846|B1||Between 18 and 65 years|Age||Participants|Count of Participants|211|211.0||||||
3891426|NCT01518322|3716846|B1||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
3891427|NCT01518270|3716859|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3891428|NCT01518270|3716859|B1||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
3891429|NCT01518270|3716859|B1|||Age||Years|Mean|40.3|40.3|Full Range|10.3|10.3|22.0|65.0|
3891430|NCT01518257|3716865|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3891431|NCT01518257|3716866|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3891432|NCT01518257|3716867|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3891433|NCT01518257|3716865|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3891434|NCT01518257|3716866|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3891435|NCT01518257|3716867|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3891436|NCT01518257|3716865|B3|≥ 65 Years||Age, Customized||Participants|Number|60|60.0||||||
3891437|NCT01518257|3716866|B2|≥ 65 Years||Age, Customized||Participants|Number|29|29.0||||||
3891438|NCT01518257|3716867|B1|≥ 65 Years||Age, Customized||Participants|Number|31|31.0||||||
3891439|NCT01518257|3716865|B3|40 to 64 Years||Age, Customized||Participants|Number|61|61.0||||||
3891440|NCT01518257|3716866|B2|40 to 64 Years||Age, Customized||Participants|Number|31|31.0||||||
3891441|NCT01518257|3716867|B1|40 to 64 Years||Age, Customized||Participants|Number|30|30.0||||||
3891442|NCT01518244|3716890|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3891443|NCT01518244|3716890|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3891444|NCT01518244|3716890|B1|||Age||years|Mean|66.67|66.67|Standard Deviation|11.51|11.51|||
3891445|NCT01518192|3716895|B4|Slovenia||Region of Enrollment||participants|Number|544.0|544.0||||||
3891446|NCT01518192|3716896|B3|Slovenia||Region of Enrollment||participants|Number|259|259.0||||||
3891447|NCT01518192|3716897|B2|Slovenia||Region of Enrollment||participants|Number|140|140.0||||||
3891448|NCT01518192|3716898|B1|Slovenia||Region of Enrollment||participants|Number|145|145.0||||||
3891449|NCT01518192|3716895|B4||Male|Sex: Female, Male||Participants|Count of Participants|258.0|258.0||||||
3891450|NCT01518192|3716896|B3||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3891451|NCT01518192|3716897|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3891452|NCT01518192|3716898|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3891453|NCT01518192|3716895|B4||Female|Sex: Female, Male||Participants|Count of Participants|286.0|286.0||||||
3891454|NCT01518192|3716896|B3||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3891455|NCT01518192|3716897|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3891456|NCT01518192|3716898|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3891457|NCT01518192|3716895|B4|||Age||years|Median|52.5|52.5|Full Range|14.9|14.9|15.0|85.0|
3891458|NCT01518192|3716896|B3|||Age||years|Median|52|52.0|Full Range|||15.0|85.0|
3891459|NCT01518192|3716897|B2|||Age||years|Median|51.5|51.5|Full Range|14.9|14.9|19.0|82.0|
3891460|NCT01518192|3716898|B1|||Age||years|Median|54|54.0|Full Range|14.6|14.6|17.0|85.0|
3891461|NCT01518153|3716921|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3891462|NCT01518153|3716921|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3891463|NCT01518153|3716921|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3891464|NCT01518153|3716921|B1|||Age||years|Median|58|58.0|Full Range|||35.0|65.0|
3891465|NCT01517984|3716931|B4|Donor missing, Recipient -||CMV status (donor, recipient)|Cytomegalovirus (CMV) is a common virus, and is a concern when a person has a weakened immune system, such as during transplantation. Once infected with CMV, your body retains the virus for life. CMV can spread from donor to recipient during transplant and dormant CMV in the recipient could become active following transplantation due to weakened immune system. CMV positive recipients have a higher likelihood for incidence of CMV disease and allograft loss.|participants|Number|1|1.0||||||
3891466|NCT01517984|3716932|B3|Donor missing, Recipient -||CMV status (donor, recipient)|Cytomegalovirus (CMV) is a common virus, and is a concern when a person has a weakened immune system, such as during transplantation. Once infected with CMV, your body retains the virus for life. CMV can spread from donor to recipient during transplant and dormant CMV in the recipient could become active following transplantation due to weakened immune system. CMV positive recipients have a higher likelihood for incidence of CMV disease and allograft loss.|participants|Number|0|0.0||||||
3891467|NCT01517984|3716933|B2|Donor missing, Recipient -||CMV status (donor, recipient)|Cytomegalovirus (CMV) is a common virus, and is a concern when a person has a weakened immune system, such as during transplantation. Once infected with CMV, your body retains the virus for life. CMV can spread from donor to recipient during transplant and dormant CMV in the recipient could become active following transplantation due to weakened immune system. CMV positive recipients have a higher likelihood for incidence of CMV disease and allograft loss.|participants|Number|0|0.0||||||
3891497|NCT01517984|3716931|B4|Canada||Region of Enrollment||participants|Number|7|7.0||||||
3891498|NCT01517984|3716932|B3|Canada||Region of Enrollment||participants|Number|0|0.0||||||
3891468|NCT01517984|3716934|B1|Donor missing, Recipient -||CMV status (donor, recipient)|Cytomegalovirus (CMV) is a common virus, and is a concern when a person has a weakened immune system, such as during transplantation. Once infected with CMV, your body retains the virus for life. CMV can spread from donor to recipient during transplant and dormant CMV in the recipient could become active following transplantation due to weakened immune system. CMV positive recipients have a higher likelihood for incidence of CMV disease and allograft loss.|participants|Number|1|1.0||||||
3891469|NCT01517984|3716931|B4|Donor not done, Recipient +||CMV status (donor, recipient)|Cytomegalovirus (CMV) is a common virus, and is a concern when a person has a weakened immune system, such as during transplantation. Once infected with CMV, your body retains the virus for life. CMV can spread from donor to recipient during transplant and dormant CMV in the recipient could become active following transplantation due to weakened immune system. CMV positive recipients have a higher likelihood for incidence of CMV disease and allograft loss.|participants|Number|1|1.0||||||
3891470|NCT01517984|3716932|B3|Donor not done, Recipient +||CMV status (donor, recipient)|Cytomegalovirus (CMV) is a common virus, and is a concern when a person has a weakened immune system, such as during transplantation. Once infected with CMV, your body retains the virus for life. CMV can spread from donor to recipient during transplant and dormant CMV in the recipient could become active following transplantation due to weakened immune system. CMV positive recipients have a higher likelihood for incidence of CMV disease and allograft loss.|participants|Number|1|1.0||||||
3891471|NCT01517984|3716933|B2|Donor not done, Recipient +||CMV status (donor, recipient)|Cytomegalovirus (CMV) is a common virus, and is a concern when a person has a weakened immune system, such as during transplantation. Once infected with CMV, your body retains the virus for life. CMV can spread from donor to recipient during transplant and dormant CMV in the recipient could become active following transplantation due to weakened immune system. CMV positive recipients have a higher likelihood for incidence of CMV disease and allograft loss.|participants|Number|0|0.0||||||
3891472|NCT01517984|3716934|B1|Donor not done, Recipient +||CMV status (donor, recipient)|Cytomegalovirus (CMV) is a common virus, and is a concern when a person has a weakened immune system, such as during transplantation. Once infected with CMV, your body retains the virus for life. CMV can spread from donor to recipient during transplant and dormant CMV in the recipient could become active following transplantation due to weakened immune system. CMV positive recipients have a higher likelihood for incidence of CMV disease and allograft loss.|participants|Number|0|0.0||||||
3891473|NCT01517984|3716931|B4|Donor -, Recipient -||CMV status (donor, recipient)|Cytomegalovirus (CMV) is a common virus, and is a concern when a person has a weakened immune system, such as during transplantation. Once infected with CMV, your body retains the virus for life. CMV can spread from donor to recipient during transplant and dormant CMV in the recipient could become active following transplantation due to weakened immune system. CMV positive recipients have a higher likelihood for incidence of CMV disease and allograft loss.|participants|Number|17|17.0||||||
3891474|NCT01517984|3716932|B3|Donor -, Recipient -||CMV status (donor, recipient)|Cytomegalovirus (CMV) is a common virus, and is a concern when a person has a weakened immune system, such as during transplantation. Once infected with CMV, your body retains the virus for life. CMV can spread from donor to recipient during transplant and dormant CMV in the recipient could become active following transplantation due to weakened immune system. CMV positive recipients have a higher likelihood for incidence of CMV disease and allograft loss.|participants|Number|3|3.0||||||
3891475|NCT01517984|3716933|B2|Donor -, Recipient -||CMV status (donor, recipient)|Cytomegalovirus (CMV) is a common virus, and is a concern when a person has a weakened immune system, such as during transplantation. Once infected with CMV, your body retains the virus for life. CMV can spread from donor to recipient during transplant and dormant CMV in the recipient could become active following transplantation due to weakened immune system. CMV positive recipients have a higher likelihood for incidence of CMV disease and allograft loss.|participants|Number|5|5.0||||||
3891476|NCT01517984|3716934|B1|Donor -, Recipient -||CMV status (donor, recipient)|Cytomegalovirus (CMV) is a common virus, and is a concern when a person has a weakened immune system, such as during transplantation. Once infected with CMV, your body retains the virus for life. CMV can spread from donor to recipient during transplant and dormant CMV in the recipient could become active following transplantation due to weakened immune system. CMV positive recipients have a higher likelihood for incidence of CMV disease and allograft loss.|participants|Number|9|9.0||||||
3891477|NCT01517984|3716931|B4|Donor -, Recipient +||CMV status (donor, recipient)|Cytomegalovirus (CMV) is a common virus, and is a concern when a person has a weakened immune system, such as during transplantation. Once infected with CMV, your body retains the virus for life. CMV can spread from donor to recipient during transplant and dormant CMV in the recipient could become active following transplantation due to weakened immune system. CMV positive recipients have a higher likelihood for incidence of CMV disease and allograft loss.|participants|Number|7|7.0||||||
3891478|NCT01517984|3716932|B3|Donor -, Recipient +||CMV status (donor, recipient)|Cytomegalovirus (CMV) is a common virus, and is a concern when a person has a weakened immune system, such as during transplantation. Once infected with CMV, your body retains the virus for life. CMV can spread from donor to recipient during transplant and dormant CMV in the recipient could become active following transplantation due to weakened immune system. CMV positive recipients have a higher likelihood for incidence of CMV disease and allograft loss.|participants|Number|2|2.0||||||
3891479|NCT01517984|3716933|B2|Donor -, Recipient +||CMV status (donor, recipient)|Cytomegalovirus (CMV) is a common virus, and is a concern when a person has a weakened immune system, such as during transplantation. Once infected with CMV, your body retains the virus for life. CMV can spread from donor to recipient during transplant and dormant CMV in the recipient could become active following transplantation due to weakened immune system. CMV positive recipients have a higher likelihood for incidence of CMV disease and allograft loss.|participants|Number|2|2.0||||||
3891480|NCT01517984|3716934|B1|Donor -, Recipient +||CMV status (donor, recipient)|Cytomegalovirus (CMV) is a common virus, and is a concern when a person has a weakened immune system, such as during transplantation. Once infected with CMV, your body retains the virus for life. CMV can spread from donor to recipient during transplant and dormant CMV in the recipient could become active following transplantation due to weakened immune system. CMV positive recipients have a higher likelihood for incidence of CMV disease and allograft loss.|participants|Number|3|3.0||||||
3891499|NCT01517984|3716933|B2|Canada||Region of Enrollment||participants|Number|4|4.0||||||
3891481|NCT01517984|3716931|B4|Donor +, Recipient -||CMV status (donor, recipient)|Cytomegalovirus (CMV) is a common virus, and is a concern when a person has a weakened immune system, such as during transplantation. Once infected with CMV, your body retains the virus for life. CMV can spread from donor to recipient during transplant and dormant CMV in the recipient could become active following transplantation due to weakened immune system. CMV positive recipients have a higher likelihood for incidence of CMV disease and allograft loss.|participants|Number|8|8.0||||||
3891482|NCT01517984|3716932|B3|Donor +, Recipient -||CMV status (donor, recipient)|Cytomegalovirus (CMV) is a common virus, and is a concern when a person has a weakened immune system, such as during transplantation. Once infected with CMV, your body retains the virus for life. CMV can spread from donor to recipient during transplant and dormant CMV in the recipient could become active following transplantation due to weakened immune system. CMV positive recipients have a higher likelihood for incidence of CMV disease and allograft loss.|participants|Number|1|1.0||||||
3891483|NCT01517984|3716933|B2|Donor +, Recipient -||CMV status (donor, recipient)|Cytomegalovirus (CMV) is a common virus, and is a concern when a person has a weakened immune system, such as during transplantation. Once infected with CMV, your body retains the virus for life. CMV can spread from donor to recipient during transplant and dormant CMV in the recipient could become active following transplantation due to weakened immune system. CMV positive recipients have a higher likelihood for incidence of CMV disease and allograft loss.|participants|Number|2|2.0||||||
3891484|NCT01517984|3716934|B1|Donor +, Recipient -||CMV status (donor, recipient)|Cytomegalovirus (CMV) is a common virus, and is a concern when a person has a weakened immune system, such as during transplantation. Once infected with CMV, your body retains the virus for life. CMV can spread from donor to recipient during transplant and dormant CMV in the recipient could become active following transplantation due to weakened immune system. CMV positive recipients have a higher likelihood for incidence of CMV disease and allograft loss.|participants|Number|5|5.0||||||
3891485|NCT01517984|3716931|B4|Donor +, Recipient +||CMV status (donor, recipient)|Cytomegalovirus (CMV) is a common virus, and is a concern when a person has a weakened immune system, such as during transplantation. Once infected with CMV, your body retains the virus for life. CMV can spread from donor to recipient during transplant and dormant CMV in the recipient could become active following transplantation due to weakened immune system. CMV positive recipients have a higher likelihood for incidence of CMV disease and allograft loss.|participants|Number|13|13.0||||||
3891486|NCT01517984|3716932|B3|Donor +, Recipient +||CMV status (donor, recipient)|Cytomegalovirus (CMV) is a common virus, and is a concern when a person has a weakened immune system, such as during transplantation. Once infected with CMV, your body retains the virus for life. CMV can spread from donor to recipient during transplant and dormant CMV in the recipient could become active following transplantation due to weakened immune system. CMV positive recipients have a higher likelihood for incidence of CMV disease and allograft loss.|participants|Number|0|0.0||||||
3891487|NCT01517984|3716933|B2|Donor +, Recipient +||CMV status (donor, recipient)|Cytomegalovirus (CMV) is a common virus, and is a concern when a person has a weakened immune system, such as during transplantation. Once infected with CMV, your body retains the virus for life. CMV can spread from donor to recipient during transplant and dormant CMV in the recipient could become active following transplantation due to weakened immune system. CMV positive recipients have a higher likelihood for incidence of CMV disease and allograft loss.|participants|Number|5|5.0||||||
3891488|NCT01517984|3716934|B1|Donor +, Recipient +||CMV status (donor, recipient)|Cytomegalovirus (CMV) is a common virus, and is a concern when a person has a weakened immune system, such as during transplantation. Once infected with CMV, your body retains the virus for life. CMV can spread from donor to recipient during transplant and dormant CMV in the recipient could become active following transplantation due to weakened immune system. CMV positive recipients have a higher likelihood for incidence of CMV disease and allograft loss.|participants|Number|8|8.0||||||
3891489|NCT01517984|3716931|B4|||HLA mismatch|Human leukocyte antigen (HLA) is a protein – or marker – found on most cells in your body and is used to match you with a donor for your bone marrow or cord blood transplant. The best transplant outcome happens when a patient’s HLA and donor’s HLA closely match. There are at least 8 HLA markers that are typically compared prior to transplantation. A mismatch of greater than three indicates that there is a potential for a poorer outcome than a better HLA match between donor and recipient.|Number of HLA marker mismatches|Mean|3.4|3.4|Standard Deviation|1.4|1.4|||
3891490|NCT01517984|3716932|B3|||HLA mismatch|Human leukocyte antigen (HLA) is a protein – or marker – found on most cells in your body and is used to match you with a donor for your bone marrow or cord blood transplant. The best transplant outcome happens when a patient’s HLA and donor’s HLA closely match. There are at least 8 HLA markers that are typically compared prior to transplantation. A mismatch of greater than three indicates that there is a potential for a poorer outcome than a better HLA match between donor and recipient.|Number of HLA marker mismatches|Mean|3.4|3.4|Standard Deviation|1.3|1.3|||
3891491|NCT01517984|3716933|B2|||HLA mismatch|Human leukocyte antigen (HLA) is a protein – or marker – found on most cells in your body and is used to match you with a donor for your bone marrow or cord blood transplant. The best transplant outcome happens when a patient’s HLA and donor’s HLA closely match. There are at least 8 HLA markers that are typically compared prior to transplantation. A mismatch of greater than three indicates that there is a potential for a poorer outcome than a better HLA match between donor and recipient.|Number of HLA marker mismatches|Mean|3.4|3.4|Standard Deviation|1.3|1.3|||
3891492|NCT01517984|3716934|B1|||HLA mismatch|Human leukocyte antigen (HLA) is a protein – or marker – found on most cells in your body and is used to match you with a donor for your bone marrow or cord blood transplant. The best transplant outcome happens when a patient’s HLA and donor’s HLA closely match. There are at least 8 HLA markers that are typically compared prior to transplantation. A mismatch of greater than three indicates that there is a potential for a poorer outcome than a better HLA match between donor and recipient.|Number of HLA marker mismatches|Mean|3.6|3.6|Standard Deviation|1.7|1.7|||
3891493|NCT01517984|3716931|B4|United States||Region of Enrollment||participants|Number|40|40.0||||||
3891494|NCT01517984|3716932|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
3891495|NCT01517984|3716933|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3891496|NCT01517984|3716934|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
3891500|NCT01517984|3716934|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
3891501|NCT01517984|3716931|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891502|NCT01517984|3716932|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891503|NCT01517984|3716933|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891504|NCT01517984|3716934|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891505|NCT01517984|3716931|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891506|NCT01517984|3716932|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891507|NCT01517984|3716933|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891508|NCT01517984|3716934|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891509|NCT01517984|3716931|B4||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3891510|NCT01517984|3716932|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3891511|NCT01517984|3716933|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3891512|NCT01517984|3716934|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3891513|NCT01517984|3716931|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3891514|NCT01517984|3716932|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891515|NCT01517984|3716933|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3891516|NCT01517984|3716934|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3891517|NCT01517984|3716931|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891518|NCT01517984|3716932|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891519|NCT01517984|3716933|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891520|NCT01517984|3716934|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891521|NCT01517984|3716931|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3891522|NCT01517984|3716932|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891523|NCT01517984|3716933|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3891524|NCT01517984|3716934|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891525|NCT01517984|3716931|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3891526|NCT01517984|3716932|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891527|NCT01517984|3716933|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891528|NCT01517984|3716934|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3891529|NCT01517984|3716931|B4||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3891530|NCT01517984|3716932|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3891531|NCT01517984|3716933|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3891532|NCT01517984|3716934|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3891533|NCT01517984|3716931|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3891534|NCT01517984|3716932|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3891535|NCT01517984|3716933|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3891536|NCT01517984|3716934|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3891537|NCT01517984|3716931|B4|||Age||years|Mean|50.9|50.9|Standard Deviation|12.7|12.7|||
3891538|NCT01517984|3716932|B3|||Age||years|Mean|44.9|44.9|Standard Deviation|8.5|8.5|||
3891539|NCT01517984|3716933|B2|||Age||years|Mean|46.5|46.5|Standard Deviation|14.4|14.4|||
3891540|NCT01517984|3716934|B1|||Age||years|Mean|54.8|54.8|Standard Deviation|11.6|11.6|||
3891541|NCT01517893|3716961|B3|||Vitiligo area scoring index|"The vitiligo area scoring index (VASI) is a measure of the surface area affected by vitiligo in a given research subject. It ranges from 0% (no vitiligo) to 100% (complete depigmentation of the entire body surface area). In terms of treatment, a decrease in VASI is desirable as it indicates less surface area affected by vitiligo. The score represents an estimate made by the investigators, based on the approximation that one hand unit, is roughly equivalent to 1% of the body surface area."|percentage|Mean|19.23|19.23|Full Range|||3.23|46.26|
3891542|NCT01517893|3716962|B2|||Vitiligo area scoring index|"The vitiligo area scoring index (VASI) is a measure of the surface area affected by vitiligo in a given research subject. It ranges from 0% (no vitiligo) to 100% (complete depigmentation of the entire body surface area). In terms of treatment, a decrease in VASI is desirable as it indicates less surface area affected by vitiligo. The score represents an estimate made by the investigators, based on the approximation that one hand unit, is roughly equivalent to 1% of the body surface area."|percentage|Mean|23.09|23.09|Full Range|||5.12|46.26|
3891543|NCT01517893|3716963|B1|||Vitiligo area scoring index|"The vitiligo area scoring index (VASI) is a measure of the surface area affected by vitiligo in a given research subject. It ranges from 0% (no vitiligo) to 100% (complete depigmentation of the entire body surface area). In terms of treatment, a decrease in VASI is desirable as it indicates less surface area affected by vitiligo. The score represents an estimate made by the investigators, based on the approximation that one hand unit, is roughly equivalent to 1% of the body surface area."|percentage|Mean|14.81|14.81|Full Range|||3.23|40.93|
3891544|NCT01517893|3716961|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3891545|NCT01517893|3716962|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3891546|NCT01517893|3716963|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3891547|NCT01517893|3716961|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3891548|NCT01517893|3716962|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3891549|NCT01517893|3716963|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3891550|NCT01517893|3716961|B3|||Age||years|Mean|41.6|41.6|Full Range|||28.0|55.0|
3891551|NCT01517893|3716962|B2|||Age||years|Mean|39|39.0|Full Range|||32.0|49.0|
3891552|NCT01517893|3716963|B1|||Age||years|Mean|43.9|43.9|Full Range|||28.0|55.0|
3891553|NCT01517867|3716984|B3|United States||Region of Enrollment||Participants|Count of Participants|161|161.0||||||
3891554|NCT01517867|3716985|B2|United States||Region of Enrollment||Participants|Count of Participants|80|80.0||||||
3891555|NCT01517867|3716986|B1|United States||Region of Enrollment||Participants|Count of Participants|81|81.0||||||
3891556|NCT01517867|3716984|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891557|NCT01517867|3716985|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891558|NCT01517867|3716986|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891559|NCT01517867|3716984|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3891560|NCT01517867|3716985|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3891561|NCT01517867|3716986|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3891562|NCT01517867|3716984|B3||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3891563|NCT01517867|3716985|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3891564|NCT01517867|3716986|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3891565|NCT01517867|3716984|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|114|114.0||||||
3891566|NCT01517867|3716985|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3891567|NCT01517867|3716986|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3891568|NCT01517867|3716984|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891569|NCT01517867|3716985|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891570|NCT01517867|3716986|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891571|NCT01517867|3716984|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3891572|NCT01517867|3716985|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3891573|NCT01517867|3716986|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891574|NCT01517867|3716984|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3891575|NCT01517867|3716985|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891576|NCT01517867|3716986|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3891577|NCT01517867|3716984|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891578|NCT01517867|3716985|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891579|NCT01517867|3716986|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891580|NCT01517867|3716984|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|154|154.0||||||
3891581|NCT01517867|3716985|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3891582|NCT01517867|3716986|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
3891583|NCT01517867|3716984|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3891584|NCT01517867|3716985|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3891585|NCT01517867|3716986|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3891586|NCT01517867|3716984|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3891587|NCT01517867|3716985|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3891588|NCT01517867|3716986|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3891589|NCT01517867|3716984|B3||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3891590|NCT01517867|3716985|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3891591|NCT01517867|3716986|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3891592|NCT01517867|3716984|B3|||Age||years|Mean|33.76|33.76|Full Range|||22.0|71.0|
3891593|NCT01517867|3716985|B2|||Age||years|Mean|34.5|34.5|Full Range|||22.0|71.0|
3891594|NCT01517867|3716986|B1|||Age||years|Mean|33.0|33.0|Full Range|||22.0|69.0|
3891595|NCT01517750|3716995|B5|Germany||Region of Enrollment||participants|Number|72|72.0||||||
3891596|NCT01517750|3716996|B4|Germany||Region of Enrollment||participants|Number|18|18.0||||||
3891597|NCT01517750|3716997|B3|Germany||Region of Enrollment||participants|Number|17|17.0||||||
3891598|NCT01517750|3716998|B2|Germany||Region of Enrollment||participants|Number|20|20.0||||||
3891599|NCT01517750|3716999|B1|Germany||Region of Enrollment||participants|Number|17|17.0||||||
3891600|NCT01517750|3716995|B5||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3891601|NCT01517750|3716996|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3891602|NCT01517750|3716997|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3891603|NCT01517750|3716998|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3891604|NCT01517750|3716999|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3891605|NCT01517750|3716995|B5||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3891606|NCT01517750|3716996|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3891607|NCT01517750|3716997|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3891608|NCT01517750|3716998|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3891609|NCT01517750|3716999|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3891610|NCT01517750|3716995|B5|||Age||years|Mean|52.3|52.3|Standard Deviation|8.5|8.5|||
3891611|NCT01517750|3716996|B4|||Age||years|Mean|52.1|52.1|Standard Deviation|8.7|8.7|||
3891612|NCT01517750|3716997|B3|||Age||years|Mean|50.9|50.9|Standard Deviation|6.8|6.8|||
3891613|NCT01517750|3716998|B2|||Age||years|Mean|54.3|54.3|Standard Deviation|8.8|8.8|||
3891614|NCT01517750|3716999|B1|||Age||years|Mean|51.6|51.6|Standard Deviation|9.8|9.8|||
3891615|NCT01517529|3717032|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3891616|NCT01517529|3717032|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891617|NCT01517529|3717032|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891618|NCT01517529|3717032|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3891619|NCT01517529|3717032|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3891620|NCT01517529|3717032|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891621|NCT01517529|3717032|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891622|NCT01517529|3717032|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891623|NCT01517529|3717032|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3891624|NCT01517529|3717032|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3891625|NCT01517529|3717032|B1|Non responders||Age||years|Mean|60.00|60.0|Standard Deviation|5.29|5.29|||
3891626|NCT01517529|3717032|B1|Responders||Age||years|Mean|55.3|55.3|Standard Deviation|14.03|14.03|||
3891627|NCT01517412|3717037|B3|Dinner||Randomization Strata of Main Meal of the Day||participants|Number|178|178.0||||||
3891628|NCT01517412|3717038|B2|Dinner||Randomization Strata of Main Meal of the Day||participants|Number|89|89.0||||||
3891629|NCT01517412|3717039|B1|Dinner||Randomization Strata of Main Meal of the Day||participants|Number|89|89.0||||||
3891630|NCT01517412|3717037|B3|Lunch||Randomization Strata of Main Meal of the Day||participants|Number|233|233.0||||||
3891631|NCT01517412|3717038|B2|Lunch||Randomization Strata of Main Meal of the Day||participants|Number|117|117.0||||||
3891632|NCT01517412|3717039|B1|Lunch||Randomization Strata of Main Meal of the Day||participants|Number|116|116.0||||||
3891633|NCT01517412|3717037|B3|Breakfast||Randomization Strata of Main Meal of the Day||participants|Number|40|40.0||||||
3891634|NCT01517412|3717038|B2|Breakfast||Randomization Strata of Main Meal of the Day||participants|Number|20|20.0||||||
3891635|NCT01517412|3717039|B1|Breakfast||Randomization Strata of Main Meal of the Day||participants|Number|20|20.0||||||
3891636|NCT01517412|3717037|B3|||Metformin Daily Dose||mg|Mean|2066.0|2066.0|Standard Deviation|929.6|929.6|||
3891637|NCT01517412|3717038|B2|||Metformin Daily Dose||mg|Mean|2091.2|2091.2|Standard Deviation|1255.3|1255.3|||
3891638|NCT01517412|3717039|B1|||Metformin Daily Dose||mg|Mean|2040.7|2040.7|Standard Deviation|390.0|390.0|||
3891639|NCT01517412|3717037|B3|||Duration of Diabetes||years|Mean|7.24|7.24|Standard Deviation|5.27|5.27|||
3891640|NCT01517412|3717038|B2|||Duration of Diabetes||years|Mean|7.78|7.78|Standard Deviation|5.56|5.56|||
3891641|NCT01517412|3717039|B1|||Duration of Diabetes||years|Mean|6.69|6.69|Standard Deviation|4.92|4.92|||
3891642|NCT01517412|3717037|B3|||Average 7-point Self-monitored Plasma Glucose (SMPG)|N=211, 207|mmol/L|Mean|9.56|9.56|Standard Deviation|2.07|2.07|||
3891643|NCT01517412|3717038|B2|||Average 7-point Self-monitored Plasma Glucose (SMPG)|N=211, 207|mmol/L|Mean|9.71|9.71|Standard Deviation|2.13|2.13|||
3891644|NCT01517412|3717039|B1|||Average 7-point Self-monitored Plasma Glucose (SMPG)|N=211, 207|mmol/L|Mean|9.41|9.41|Standard Deviation|2.01|2.01|||
3891645|NCT01517412|3717037|B3|||Fasting Plasma Glucose (FPG)|N=225, 225|mmol/L|Mean|9.26|9.26|Standard Deviation|2.03|2.03|||
3891646|NCT01517412|3717038|B2|||Fasting Plasma Glucose (FPG)|N=225, 225|mmol/L|Mean|9.31|9.31|Standard Deviation|2.04|2.04|||
3891647|NCT01517412|3717039|B1|||Fasting Plasma Glucose (FPG)|N=225, 225|mmol/L|Mean|9.22|9.22|Standard Deviation|2.03|2.03|||
3891648|NCT01517412|3717037|B3|||HbA1c||Percentage of hemoglobin|Mean|7.89|7.89|Standard Deviation|0.77|0.77|||
3891649|NCT01517412|3717038|B2|||HbA1c||Percentage of hemoglobin|Mean|7.93|7.93|Standard Deviation|0.78|0.78|||
3891650|NCT01517412|3717039|B1|||HbA1c||Percentage of hemoglobin|Mean|7.85|7.85|Standard Deviation|0.76|0.76|||
3891651|NCT01517412|3717037|B3|||BMI, Continuous||kg/m^2|Mean|33.12|33.12|Standard Deviation|4.57|4.57|||
3891652|NCT01517412|3717038|B2|||BMI, Continuous||kg/m^2|Mean|32.77|32.77|Standard Deviation|4.62|4.62|||
3891653|NCT01517412|3717039|B1|||BMI, Continuous||kg/m^2|Mean|33.47|33.47|Standard Deviation|4.50|4.5|||
3891654|NCT01517412|3717037|B3|≥30 kg/m^2||Number of Participants with Categorical Body Mass Index (BMI)||participants|Number|340|340.0||||||
3891655|NCT01517412|3717038|B2|≥30 kg/m^2||Number of Participants with Categorical Body Mass Index (BMI)||participants|Number|166|166.0||||||
3891656|NCT01517412|3717039|B1|≥30 kg/m^2||Number of Participants with Categorical Body Mass Index (BMI)||participants|Number|174|174.0||||||
3891657|NCT01517412|3717037|B3|<30 kg/m^2||Number of Participants with Categorical Body Mass Index (BMI)||participants|Number|111|111.0||||||
3891658|NCT01517412|3717038|B2|<30 kg/m^2||Number of Participants with Categorical Body Mass Index (BMI)||participants|Number|60|60.0||||||
3891659|NCT01517412|3717039|B1|<30 kg/m^2||Number of Participants with Categorical Body Mass Index (BMI)||participants|Number|51|51.0||||||
3891660|NCT01517412|3717037|B3|Non-Hispanic||Ethnicity||participants|Number|428|428.0||||||
3891661|NCT01517412|3717038|B2|Non-Hispanic||Ethnicity||participants|Number|214|214.0||||||
3891662|NCT01517412|3717039|B1|Non-Hispanic||Ethnicity||participants|Number|214|214.0||||||
3891663|NCT01517412|3717037|B3|Hispanic||Ethnicity||participants|Number|23|23.0||||||
3891664|NCT01517412|3717038|B2|Hispanic||Ethnicity||participants|Number|12|12.0||||||
3891665|NCT01517412|3717039|B1|Hispanic||Ethnicity||participants|Number|11|11.0||||||
3891666|NCT01517412|3717037|B3|Asian/Oriental||Race||participants|Number|17|17.0||||||
3891667|NCT01517412|3717038|B2|Asian/Oriental||Race||participants|Number|7|7.0||||||
3891668|NCT01517412|3717039|B1|Asian/Oriental||Race||participants|Number|10|10.0||||||
3891669|NCT01517412|3717037|B3|Black||Race||participants|Number|12|12.0||||||
3891670|NCT01517412|3717038|B2|Black||Race||participants|Number|8|8.0||||||
3891671|NCT01517412|3717039|B1|Black||Race||participants|Number|4|4.0||||||
3891672|NCT01517412|3717037|B3|Caucasian/White||Race||participants|Number|422|422.0||||||
3891673|NCT01517412|3717038|B2|Caucasian/White||Race||participants|Number|211|211.0||||||
3891674|NCT01517412|3717039|B1|Caucasian/White||Race||participants|Number|211|211.0||||||
3891675|NCT01517412|3717037|B3||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
3891676|NCT01517412|3717038|B2||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3891677|NCT01517412|3717039|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3891678|NCT01517412|3717037|B3||Female|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
3891679|NCT01517412|3717038|B2||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3891680|NCT01517412|3717039|B1||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3891681|NCT01517412|3717037|B3|||Age||years|Mean|56.9|56.9|Standard Deviation|10.2|10.2|||
3891682|NCT01517412|3717038|B2|||Age||years|Mean|57.5|57.5|Standard Deviation|9.7|9.7|||
3891683|NCT01517412|3717039|B1|||Age||years|Mean|56.3|56.3|Standard Deviation|10.6|10.6|||
3891684|NCT01517373|3717064|B6||Male|Gender||Participants|Count of Participants|173|173.0||||||
3891685|NCT01517373|3717065|B5||Male|Gender||Participants|Count of Participants|39|39.0||||||
3891686|NCT01517373|3717066|B4||Male|Gender||Participants|Count of Participants|29|29.0||||||
3891687|NCT01517373|3717067|B3||Male|Gender||Participants|Count of Participants|37|37.0||||||
3891688|NCT01517373|3717068|B2||Male|Gender||Participants|Count of Participants|34|34.0||||||
3891689|NCT01517373|3717069|B1||Male|Gender||Participants|Count of Participants|34|34.0||||||
3891690|NCT01517373|3717064|B6||Female|Gender||Participants|Count of Participants|131|131.0||||||
3891691|NCT01517373|3717065|B5||Female|Gender||Participants|Count of Participants|22|22.0||||||
3891692|NCT01517373|3717066|B4||Female|Gender||Participants|Count of Participants|32|32.0||||||
3891693|NCT01517373|3717067|B3||Female|Gender||Participants|Count of Participants|24|24.0||||||
3891694|NCT01517373|3717068|B2||Female|Gender||Participants|Count of Participants|26|26.0||||||
3891695|NCT01517373|3717069|B1||Female|Gender||Participants|Count of Participants|27|27.0||||||
3891696|NCT01517373|3717064|B6|>64 years||Age, Customized||participants|Number|50|50.0||||||
3891697|NCT01517373|3717065|B5|>64 years||Age, Customized||participants|Number|6|6.0||||||
3891698|NCT01517373|3717066|B4|>64 years||Age, Customized||participants|Number|15|15.0||||||
3891699|NCT01517373|3717067|B3|>64 years||Age, Customized||participants|Number|13|13.0||||||
3891700|NCT01517373|3717068|B2|>64 years||Age, Customized||participants|Number|8|8.0||||||
3891701|NCT01517373|3717069|B1|>64 years||Age, Customized||participants|Number|8|8.0||||||
3891702|NCT01517373|3717064|B6|>=45 to =<64 years||Age, Customized||participants|Number|216|216.0||||||
3891703|NCT01517373|3717065|B5|>=45 to =<64 years||Age, Customized||participants|Number|48|48.0||||||
3891704|NCT01517373|3717066|B4|>=45 to =<64 years||Age, Customized||participants|Number|35|35.0||||||
3891705|NCT01517373|3717067|B3|>=45 to =<64 years||Age, Customized||participants|Number|40|40.0||||||
3891706|NCT01517373|3717068|B2|>=45 to =<64 years||Age, Customized||participants|Number|48|48.0||||||
3891707|NCT01517373|3717069|B1|>=45 to =<64 years||Age, Customized||participants|Number|45|45.0||||||
3891708|NCT01517373|3717064|B6|>=18 to =<44 years||Age, Customized||participants|Number|38|38.0||||||
3891709|NCT01517373|3717065|B5|>=18 to =<44 years||Age, Customized||participants|Number|7|7.0||||||
3891710|NCT01517373|3717066|B4|>=18 to =<44 years||Age, Customized||participants|Number|11|11.0||||||
3891711|NCT01517373|3717067|B3|>=18 to =<44 years||Age, Customized||participants|Number|8|8.0||||||
3891712|NCT01517373|3717068|B2|>=18 to =<44 years||Age, Customized||participants|Number|4|4.0||||||
3891713|NCT01517373|3717069|B1|>=18 to =<44 years||Age, Customized||participants|Number|8|8.0||||||
3891714|NCT01517295|3717142|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3891715|NCT01517295|3717143|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3891716|NCT01517295|3717144|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3891717|NCT01517295|3717142|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891718|NCT01517295|3717143|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891719|NCT01517295|3717144|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891720|NCT01517295|3717142|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891721|NCT01517295|3717143|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891722|NCT01517295|3717144|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891723|NCT01517295|3717142|B3||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3891724|NCT01517295|3717143|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3891725|NCT01517295|3717144|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3891726|NCT01517295|3717142|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3891727|NCT01517295|3717143|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3891728|NCT01517295|3717144|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3891729|NCT01517295|3717142|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891730|NCT01517295|3717143|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891731|NCT01517295|3717144|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891732|NCT01517295|3717142|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891733|NCT01517295|3717143|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891734|NCT01517295|3717144|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891735|NCT01517295|3717142|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891736|NCT01517295|3717143|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891737|NCT01517295|3717144|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891738|NCT01517295|3717142|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891739|NCT01517295|3717143|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891740|NCT01517295|3717144|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891741|NCT01517295|3717142|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3891742|NCT01517295|3717143|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3891743|NCT01517295|3717144|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3891744|NCT01517295|3717142|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3891745|NCT01517295|3717143|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3891746|NCT01517295|3717144|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891747|NCT01517295|3717142|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3891748|NCT01517295|3717143|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3891749|NCT01517295|3717144|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3891750|NCT01517295|3717142|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3891751|NCT01517295|3717143|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3891752|NCT01517295|3717144|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3891753|NCT01517295|3717142|B3|||Age||years|Mean|48.60|48.6|Standard Deviation|10.062|10.062|||
3891754|NCT01517295|3717143|B2|||Age||years|Mean|54.28|54.28|Standard Deviation|8.279|8.279|||
3891755|NCT01517295|3717144|B1|||Age||years|Mean|43.63|43.63|Standard Deviation|8.937|8.937|||
3891756|NCT01517282|3717155|B5|No Gd-enhancing lesions||Gadolinium (Gd)-enhancing lesions||participants|Number|21|21.0||||||
3891757|NCT01517282|3717156|B4|No Gd-enhancing lesions||Gadolinium (Gd)-enhancing lesions||participants|Number|3|3.0||||||
3891758|NCT01517282|3717157|B3|No Gd-enhancing lesions||Gadolinium (Gd)-enhancing lesions||participants|Number|8|8.0||||||
3891759|NCT01517282|3717158|B2|No Gd-enhancing lesions||Gadolinium (Gd)-enhancing lesions||participants|Number|5|5.0||||||
3891760|NCT01517282|3717159|B1|No Gd-enhancing lesions||Gadolinium (Gd)-enhancing lesions||participants|Number|5|5.0||||||
3891761|NCT01517282|3717155|B5|1 or more Gd-enhancing lesions||Gadolinium (Gd)-enhancing lesions||participants|Number|10|10.0||||||
3891762|NCT01517282|3717156|B4|1 or more Gd-enhancing lesions||Gadolinium (Gd)-enhancing lesions||participants|Number|3|3.0||||||
3891763|NCT01517282|3717157|B3|1 or more Gd-enhancing lesions||Gadolinium (Gd)-enhancing lesions||participants|Number|1|1.0||||||
3891764|NCT01517282|3717158|B2|1 or more Gd-enhancing lesions||Gadolinium (Gd)-enhancing lesions||participants|Number|3|3.0||||||
3891765|NCT01517282|3717159|B1|1 or more Gd-enhancing lesions||Gadolinium (Gd)-enhancing lesions||participants|Number|3|3.0||||||
3891766|NCT01517282|3717155|B5|||Time since diagnosis||years|Mean|9.0|9.0|Standard Deviation|8.51|8.51|||
3891767|NCT01517282|3717156|B4|||Time since diagnosis||years|Mean|5.5|5.5|Standard Deviation|7.66|7.66|||
3891768|NCT01517282|3717157|B3|||Time since diagnosis||years|Mean|10.7|10.7|Standard Deviation|8.97|8.97|||
3891769|NCT01517282|3717158|B2|||Time since diagnosis||years|Mean|13.1|13.1|Standard Deviation|7.38|7.38|||
3891770|NCT01517282|3717159|B1|||Time since diagnosis||years|Mean|5.6|5.6|Standard Deviation|8.68|8.68|||
3891771|NCT01517282|3717155|B5|Unknown||Diagnosis||participants|Number|1|1.0||||||
3891772|NCT01517282|3717156|B4|Unknown||Diagnosis||participants|Number|0|0.0||||||
3891773|NCT01517282|3717157|B3|Unknown||Diagnosis||participants|Number|0|0.0||||||
3891774|NCT01517282|3717158|B2|Unknown||Diagnosis||participants|Number|1|1.0||||||
3891775|NCT01517282|3717159|B1|Unknown||Diagnosis||participants|Number|0|0.0||||||
3891776|NCT01517282|3717155|B5|Secondary progressive multiple sclerosis||Diagnosis||participants|Number|5|5.0||||||
3891777|NCT01517282|3717156|B4|Secondary progressive multiple sclerosis||Diagnosis||participants|Number|0|0.0||||||
3891778|NCT01517282|3717157|B3|Secondary progressive multiple sclerosis||Diagnosis||participants|Number|3|3.0||||||
3891779|NCT01517282|3717158|B2|Secondary progressive multiple sclerosis||Diagnosis||participants|Number|1|1.0||||||
3891780|NCT01517282|3717159|B1|Secondary progressive multiple sclerosis||Diagnosis||participants|Number|1|1.0||||||
3891781|NCT01517282|3717155|B5|Relapsing-remitting multiple sclerosis||Diagnosis||participants|Number|25|25.0||||||
3891782|NCT01517282|3717156|B4|Relapsing-remitting multiple sclerosis||Diagnosis||participants|Number|6|6.0||||||
3891783|NCT01517282|3717157|B3|Relapsing-remitting multiple sclerosis||Diagnosis||participants|Number|6|6.0||||||
3891784|NCT01517282|3717158|B2|Relapsing-remitting multiple sclerosis||Diagnosis||participants|Number|6|6.0||||||
3891785|NCT01517282|3717159|B1|Relapsing-remitting multiple sclerosis||Diagnosis||participants|Number|7|7.0||||||
3891786|NCT01517282|3717155|B5|United Kingdom||Region of Enrollment||participants|Number|13|13.0||||||
3891787|NCT01517282|3717156|B4|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
3891788|NCT01517282|3717157|B3|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
3891789|NCT01517282|3717158|B2|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
3891790|NCT01517282|3717159|B1|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3891791|NCT01517282|3717155|B5|Germany||Region of Enrollment||participants|Number|12|12.0||||||
3891792|NCT01517282|3717156|B4|Germany||Region of Enrollment||participants|Number|2|2.0||||||
3891793|NCT01517282|3717157|B3|Germany||Region of Enrollment||participants|Number|3|3.0||||||
3891794|NCT01517282|3717158|B2|Germany||Region of Enrollment||participants|Number|5|5.0||||||
3891795|NCT01517282|3717159|B1|Germany||Region of Enrollment||participants|Number|2|2.0||||||
3891796|NCT01517282|3717155|B5|Poland||Region of Enrollment||participants|Number|6|6.0||||||
3891797|NCT01517282|3717156|B4|Poland||Region of Enrollment||participants|Number|2|2.0||||||
3891798|NCT01517282|3717157|B3|Poland||Region of Enrollment||participants|Number|1|1.0||||||
3891799|NCT01517282|3717158|B2|Poland||Region of Enrollment||participants|Number|1|1.0||||||
3891800|NCT01517282|3717159|B1|Poland||Region of Enrollment||participants|Number|2|2.0||||||
3891801|NCT01517282|3717155|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891802|NCT01517282|3717156|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891803|NCT01517282|3717157|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891804|NCT01517282|3717158|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891805|NCT01517282|3717159|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891806|NCT01517282|3717155|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891807|NCT01517282|3717156|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891808|NCT01517282|3717157|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891809|NCT01517282|3717158|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891810|NCT01517282|3717159|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891811|NCT01517282|3717155|B5||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3891812|NCT01517282|3717156|B4||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3891813|NCT01517282|3717157|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3891814|NCT01517282|3717158|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3891815|NCT01517282|3717159|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3891816|NCT01517282|3717155|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3891817|NCT01517282|3717156|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891818|NCT01517282|3717157|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891819|NCT01517282|3717158|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891820|NCT01517282|3717159|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3891821|NCT01517282|3717155|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891822|NCT01517282|3717156|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891823|NCT01517282|3717157|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891824|NCT01517282|3717158|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891825|NCT01517282|3717159|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891826|NCT01517282|3717155|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3891827|NCT01517282|3717156|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3891828|NCT01517282|3717157|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891829|NCT01517282|3717158|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891830|NCT01517282|3717159|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891831|NCT01517282|3717155|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891832|NCT01517282|3717156|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891833|NCT01517282|3717157|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891834|NCT01517282|3717158|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891835|NCT01517282|3717159|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3891836|NCT01517282|3717155|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3891837|NCT01517282|3717156|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3891838|NCT01517282|3717157|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3891839|NCT01517282|3717158|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3891840|NCT01517282|3717159|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3891841|NCT01517282|3717155|B5||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3891842|NCT01517282|3717156|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3891843|NCT01517282|3717157|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3891844|NCT01517282|3717158|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3891845|NCT01517282|3717159|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3891846|NCT01517282|3717155|B5|||Age||years|Mean|47.3|47.3|Standard Deviation|10.42|10.42|||
3891847|NCT01517282|3717156|B4|||Age||years|Mean|43.5|43.5|Standard Deviation|15.03|15.03|||
3891848|NCT01517282|3717157|B3|||Age||years|Mean|48.3|48.3|Standard Deviation|11.47|11.47|||
3891849|NCT01517282|3717158|B2|||Age||years|Mean|48.6|48.6|Standard Deviation|4.98|4.98|||
3891850|NCT01517282|3717159|B1|||Age||years|Mean|47.8|47.8|Standard Deviation|10.63|10.63|||
3891851|NCT01517178|3717196|B1|Germany||Region of Enrollment||participants|Number|1|1.0||||||
3891852|NCT01517178|3717196|B1|Iceland||Region of Enrollment||participants|Number|1|1.0||||||
3891853|NCT01517178|3717196|B1|Denmark||Region of Enrollment||participants|Number|19|19.0||||||
3891854|NCT01517178|3717196|B1|France||Region of Enrollment||participants|Number|6|6.0||||||
3891855|NCT01517178|3717196|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3891856|NCT01517178|3717196|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3891857|NCT01517178|3717196|B1|||Age||years|Mean|54.9|54.9|Standard Deviation|12.8|12.8|||
3891858|NCT01517074|3717203|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3891859|NCT01517074|3717203|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3891860|NCT01517074|3717203|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3891861|NCT01517074|3717203|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3891862|NCT01517074|3717203|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3891863|NCT01517074|3717203|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3891864|NCT01517074|3717203|B1|||Age||years|Mean|50.6|50.6|Standard Deviation|15.9|15.9|||
3891865|NCT01516970|3717214|B3||Male|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
3891866|NCT01516970|3717215|B2||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3891867|NCT01516970|3717216|B1||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3891868|NCT01516970|3717214|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3891869|NCT01516970|3717215|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3891870|NCT01516970|3717216|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3891871|NCT01516970|3717214|B3|||Age||years|Mean|33.3|33.3|Standard Deviation|9.3|9.3|||
3891872|NCT01516970|3717215|B2|||Age||years|Mean|32.3|32.3|Standard Deviation|9.3|9.3|||
3891873|NCT01516970|3717216|B1|||Age||years|Mean|34.2|34.2|Standard Deviation|9.2|9.2|||
3891874|NCT01516892|3717229|B1||Male|Gender||Participants|Count of Participants|109|109.0||||||
3891875|NCT01516892|3717229|B1||Female|Gender||Participants|Count of Participants|607|607.0||||||
3891876|NCT01516892|3717229|B1|≥ 40 years||Age, Customized||participants|Number|446|446.0||||||
3891877|NCT01516892|3717229|B1|< 40 years||Age, Customized||participants|Number|270|270.0||||||
3891878|NCT01516879|3717235|B3|||Very Low-density Lipoprotein Cholesterol (VLDL-C) Concentration|Data are provided for the Full Analysis Set|mg/dL|Mean|20.5|20.5|Standard Deviation|12.1|12.1|||
3891879|NCT01516879|3717236|B2|||Very Low-density Lipoprotein Cholesterol (VLDL-C) Concentration|Data are provided for the Full Analysis Set|mg/dL|Mean|20.0|20.0|Standard Deviation|11.4|11.4|||
3891880|NCT01516879|3717237|B1|||Very Low-density Lipoprotein Cholesterol (VLDL-C) Concentration|Data are provided for the Full Analysis Set|mg/dL|Mean|21.5|21.5|Standard Deviation|13.4|13.4|||
3891881|NCT01516879|3717235|B3|||High-density Lipoprotein Cholesterol (HDL-C) Concentration|Data are providedfor the Full Analysis Set|mg/dL|Mean|52.9|52.9|Standard Deviation|15.7|15.7|||
3891882|NCT01516879|3717236|B2|||High-density Lipoprotein Cholesterol (HDL-C) Concentration|Data are providedfor the Full Analysis Set|mg/dL|Mean|52.6|52.6|Standard Deviation|15.5|15.5|||
3891883|NCT01516879|3717237|B1|||High-density Lipoprotein Cholesterol (HDL-C) Concentration|Data are providedfor the Full Analysis Set|mg/dL|Mean|53.5|53.5|Standard Deviation|16.1|16.1|||
3891884|NCT01516879|3717235|B3|||Triglycerides Concentration|Data are provided for the Full Analysis Set|mg/dL|Mean|122.5|122.5|Standard Deviation|64.1|64.1|||
3891885|NCT01516879|3717236|B2|||Triglycerides Concentration|Data are provided for the Full Analysis Set|mg/dL|Mean|119.8|119.8|Standard Deviation|63.2|63.2|||
3891886|NCT01516879|3717237|B1|||Triglycerides Concentration|Data are provided for the Full Analysis Set|mg/dL|Mean|127.8|127.8|Standard Deviation|65.8|65.8|||
3891887|NCT01516879|3717235|B3|||Lipoprotein(a) Concentration|Data are provided for the Full Analysis Set|nmol/L|Mean|85.8|85.8|Standard Deviation|102.0|102.0|||
3891888|NCT01516879|3717236|B2|||Lipoprotein(a) Concentration|Data are provided for the Full Analysis Set|nmol/L|Mean|84.0|84.0|Standard Deviation|98.5|98.5|||
3891889|NCT01516879|3717237|B1|||Lipoprotein(a) Concentration|Data are provided for the Full Analysis Set|nmol/L|Mean|89.3|89.3|Standard Deviation|108.6|108.6|||
3891890|NCT01516879|3717235|B3|||Apolipoprotein B/Apolipoprotein A-1 Ratio|Data are provided for the Full Analysis Set|ratio|Mean|0.590|0.59|Standard Deviation|1.70|1.7|||
3891891|NCT01516879|3717236|B2|||Apolipoprotein B/Apolipoprotein A-1 Ratio|Data are provided for the Full Analysis Set|ratio|Mean|0.593|0.593|Standard Deviation|0.170|0.17|||
3891892|NCT01516879|3717237|B1|||Apolipoprotein B/Apolipoprotein A-1 Ratio|Data are provided for the Full Analysis Set|ratio|Mean|0.586|0.586|Standard Deviation|0.170|0.17|||
3891893|NCT01516879|3717235|B3|||Total Cholesterol/High Density Lipoprotein-Cholesterol (HDL-C) Ratio|Data are provided for the Full Analysis Set|ratio|Mean|3.599|3.599|Standard Deviation|1.06|1.06|||
3891894|NCT01516879|3717236|B2|||Total Cholesterol/High Density Lipoprotein-Cholesterol (HDL-C) Ratio|Data are provided for the Full Analysis Set|ratio|Mean|3.597|3.597|Standard Deviation|1.04|1.04|||
3891895|NCT01516879|3717237|B1|||Total Cholesterol/High Density Lipoprotein-Cholesterol (HDL-C) Ratio|Data are provided for the Full Analysis Set|ratio|Mean|3.603|3.603|Standard Deviation|1.11|1.11|||
3891896|NCT01516879|3717235|B3|||Apolipoprotein B Concentration|Data are provided for the Full Analysis Set|mg/dL|Mean|87.2|87.2|Standard Deviation|16.3|16.3|||
3891897|NCT01516879|3717236|B2|||Apolipoprotein B Concentration|Data are provided for the Full Analysis Set|mg/dL|Mean|87.0|87.0|Standard Deviation|16.3|16.3|||
3891898|NCT01516879|3717237|B1|||Apolipoprotein B Concentration|Data are provided for the Full Analysis Set|mg/dL|Mean|87.5|87.5|Standard Deviation|16.3|16.3|||
3891899|NCT01516879|3717235|B3|||Non-High-Density Lipoprotein Cholesterol (Non-HDL-C) Concentration|Data are provided for the Full Analysis Set|mg/dL|Mean|124.6|124.6|Standard Deviation|26.1|26.1|||
3891900|NCT01516879|3717236|B2|||Non-High-Density Lipoprotein Cholesterol (Non-HDL-C) Concentration|Data are provided for the Full Analysis Set|mg/dL|Mean|124.2|124.2|Standard Deviation|25.6|25.6|||
3891901|NCT01516879|3717237|B1|||Non-High-Density Lipoprotein Cholesterol (Non-HDL-C) Concentration|Data are provided for the Full Analysis Set|mg/dL|Mean|125.6|125.6|Standard Deviation|26.9|26.9|||
3891902|NCT01516879|3717235|B3|||Total Cholesterol|Data are provided for the Full Analysis Set|mg/dL|Mean|177.6|177.6|Standard Deviation|27.4|27.4|||
3891903|NCT01516879|3717236|B2|||Total Cholesterol|Data are provided for the Full Analysis Set|mg/dL|Mean|176.8|176.8|Standard Deviation|27.5|27.5|||
3891904|NCT01516879|3717237|B1|||Total Cholesterol|Data are provided for the Full Analysis Set|mg/dL|Mean|179.1|179.1|Standard Deviation|27.2|27.2|||
3891905|NCT01516879|3717235|B3|||Low-density Lipoprotein Cholesterol (LDL-C) Concentration|Cholesterol was measured by means of ultracentrifugation. Data are provided for the Full Analysis Set (all participants who were randomized and received at least 1 dose of study treatment).|mg/dL|Mean|104.1|104.1|Standard Deviation|22.0|22.0|||
3891906|NCT01516879|3717236|B2|||Low-density Lipoprotein Cholesterol (LDL-C) Concentration|Cholesterol was measured by means of ultracentrifugation. Data are provided for the Full Analysis Set (all participants who were randomized and received at least 1 dose of study treatment).|mg/dL|Mean|104.2|104.2|Standard Deviation|22.1|22.1|||
3891907|NCT01516879|3717237|B1|||Low-density Lipoprotein Cholesterol (LDL-C) Concentration|Cholesterol was measured by means of ultracentrifugation. Data are provided for the Full Analysis Set (all participants who were randomized and received at least 1 dose of study treatment).|mg/dL|Mean|104.0|104.0|Standard Deviation|21.6|21.6|||
3891908|NCT01516879|3717235|B3|Diet + Atorvastatin 80 mg + Ezetimibe 10 mg||Background Therapy||participants|Number|189|189.0||||||
3891909|NCT01516879|3717236|B2|Diet + Atorvastatin 80 mg + Ezetimibe 10 mg||Background Therapy||participants|Number|126|126.0||||||
3891910|NCT01516879|3717237|B1|Diet + Atorvastatin 80 mg + Ezetimibe 10 mg||Background Therapy||participants|Number|63|63.0||||||
3891911|NCT01516879|3717235|B3|Diet + Atorvastatin 80 mg||Background Therapy||participants|Number|219|219.0||||||
3891912|NCT01516879|3717236|B2|Diet + Atorvastatin 80 mg||Background Therapy||participants|Number|146|146.0||||||
3891913|NCT01516879|3717237|B1|Diet + Atorvastatin 80 mg||Background Therapy||participants|Number|73|73.0||||||
3891914|NCT01516879|3717235|B3|Diet + Atorvastatin 10 mg||Background Therapy||participants|Number|385|385.0||||||
3891915|NCT01516879|3717236|B2|Diet + Atorvastatin 10 mg||Background Therapy||participants|Number|256|256.0||||||
3891916|NCT01516879|3717237|B1|Diet + Atorvastatin 10 mg||Background Therapy||participants|Number|129|129.0||||||
3891917|NCT01516879|3717235|B3|Diet Only||Background Therapy||participants|Number|112|112.0||||||
3891918|NCT01516879|3717236|B2|Diet Only||Background Therapy||participants|Number|74|74.0||||||
3891919|NCT01516879|3717237|B1|Diet Only||Background Therapy||participants|Number|38|38.0||||||
3891920|NCT01516879|3717235|B3|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|855|855.0||||||
3891921|NCT01516879|3717236|B2|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|569|569.0||||||
3891922|NCT01516879|3717237|B1|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|286|286.0||||||
3891923|NCT01516879|3717235|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
3891924|NCT01516879|3717236|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
3891925|NCT01516879|3717237|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3891926|NCT01516879|3717235|B3|Mixed Race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3891927|NCT01516879|3717236|B2|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3891928|NCT01516879|3717237|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3891929|NCT01516879|3717235|B3|Other||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
3891930|NCT01516879|3717236|B2|Other||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3891931|NCT01516879|3717237|B1|Other||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3891932|NCT01516879|3717235|B3|White||Race/Ethnicity, Customized||participants|Number|727|727.0||||||
3891933|NCT01516879|3717236|B2|White||Race/Ethnicity, Customized||participants|Number|478|478.0||||||
3891934|NCT01516879|3717237|B1|White||Race/Ethnicity, Customized||participants|Number|249|249.0||||||
3891935|NCT01516879|3717235|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3891936|NCT01516879|3717236|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3891937|NCT01516879|3717237|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3891938|NCT01516879|3717235|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
3891939|NCT01516879|3717236|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
3891940|NCT01516879|3717237|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3891941|NCT01516879|3717235|B3|Asian||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
3891942|NCT01516879|3717236|B2|Asian||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
3891943|NCT01516879|3717237|B1|Asian||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3891944|NCT01516879|3717235|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3891945|NCT01516879|3717236|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3891946|NCT01516879|3717237|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3891947|NCT01516879|3717235|B3||Male|Sex: Female, Male||Participants|Count of Participants|431|431.0||||||
3891948|NCT01516879|3717236|B2||Male|Sex: Female, Male||Participants|Count of Participants|290|290.0||||||
3891949|NCT01516879|3717237|B1||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3891950|NCT01516879|3717235|B3||Female|Sex: Female, Male||Participants|Count of Participants|474|474.0||||||
3891951|NCT01516879|3717236|B2||Female|Sex: Female, Male||Participants|Count of Participants|312|312.0||||||
3891952|NCT01516879|3717237|B1||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3891953|NCT01516879|3717235|B3|||Age||years|Mean|56.1|56.1|Standard Deviation|10.7|10.7|||
3891954|NCT01516879|3717236|B2|||Age||years|Mean|55.9|55.9|Standard Deviation|10.9|10.9|||
3891955|NCT01516879|3717237|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|10.3|10.3|||
3891956|NCT01516749|3717272|B1|||Initial C-reactive protein|Normal <3.1 mg/L|mg/L|Mean|30.6|30.6|Standard Deviation|23.03|23.03|||
3891957|NCT01516749|3717272|B1|||Initial modified Sartorius score|The following are recorded by the dermatologist: (i) anatomical regions involved: axilla, groin, gluteal (left ⁄right) or other region, 3 points per region; (ii) numbers and scores of lesions (nodule 1 point, fistula 6 points) for each region; (iii) longest distance between two relevant lesions (or size of lesion if single) in each region: < 5 cm, 1 point; 5–10 cm, 3 points; > 10 cm, 9 points; and (iv) whether all lesions are separated by normal skin: yes, 0; no (= Hurley III), 9 points. Regional scores are added and summed up to the patient’s total score. The upper limit of the scale is open.|units on a scale|Mean|78.5|78.5|Full Range|||42.0|95.0|
3891958|NCT01516749|3717272|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3891959|NCT01516749|3717272|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3891960|NCT01516749|3717272|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3891961|NCT01516749|3717272|B1|||Age||years|Mean|37|37.0|Full Range|||27.0|41.0|
3891962|NCT01516736|3717279|B3|2||ECOG performance status|"Grading according to ECOG:~0: Fully active, able to carry on all pre-disease performance without restriction 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work 2: Ambulatory and capable of all self-care but unable to carry out any work activities up and about more than 50% of waking hours 3: Capable of only limited self-care, confined to bed or chair more than 50% of waking hours 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|Participants|Count of Participants|2|2.0||||||
3891963|NCT01516736|3717280|B2|2||ECOG performance status|"Grading according to ECOG:~0: Fully active, able to carry on all pre-disease performance without restriction 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work 2: Ambulatory and capable of all self-care but unable to carry out any work activities up and about more than 50% of waking hours 3: Capable of only limited self-care, confined to bed or chair more than 50% of waking hours 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|Participants|Count of Participants|0|0.0||||||
3891964|NCT01516736|3717281|B1|2||ECOG performance status|"Grading according to ECOG:~0: Fully active, able to carry on all pre-disease performance without restriction 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work 2: Ambulatory and capable of all self-care but unable to carry out any work activities up and about more than 50% of waking hours 3: Capable of only limited self-care, confined to bed or chair more than 50% of waking hours 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|Participants|Count of Participants|2|2.0||||||
3891965|NCT01516736|3717279|B3|1||ECOG performance status|"Grading according to ECOG:~0: Fully active, able to carry on all pre-disease performance without restriction 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work 2: Ambulatory and capable of all self-care but unable to carry out any work activities up and about more than 50% of waking hours 3: Capable of only limited self-care, confined to bed or chair more than 50% of waking hours 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|Participants|Count of Participants|79|79.0||||||
3891966|NCT01516736|3717280|B2|1||ECOG performance status|"Grading according to ECOG:~0: Fully active, able to carry on all pre-disease performance without restriction 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work 2: Ambulatory and capable of all self-care but unable to carry out any work activities up and about more than 50% of waking hours 3: Capable of only limited self-care, confined to bed or chair more than 50% of waking hours 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|Participants|Count of Participants|43|43.0||||||
3891967|NCT01516736|3717281|B1|1||ECOG performance status|"Grading according to ECOG:~0: Fully active, able to carry on all pre-disease performance without restriction 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work 2: Ambulatory and capable of all self-care but unable to carry out any work activities up and about more than 50% of waking hours 3: Capable of only limited self-care, confined to bed or chair more than 50% of waking hours 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|Participants|Count of Participants|36|36.0||||||
3892011|NCT01516736|3717280|B2||Asian|Race (NIH/OMB)|The 2 patients with race “More than one race” were reported as Hispanic origin.|Participants|Count of Participants|58|58.0||||||
3892012|NCT01516736|3717281|B1||Asian|Race (NIH/OMB)|The 2 patients with race “More than one race” were reported as Hispanic origin.|Participants|Count of Participants|62|62.0||||||
3892139|NCT01516632|3717302|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3891968|NCT01516736|3717279|B3|0||ECOG performance status|"Grading according to ECOG:~0: Fully active, able to carry on all pre-disease performance without restriction 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work 2: Ambulatory and capable of all self-care but unable to carry out any work activities up and about more than 50% of waking hours 3: Capable of only limited self-care, confined to bed or chair more than 50% of waking hours 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|Participants|Count of Participants|227|227.0||||||
3891969|NCT01516736|3717280|B2|0||ECOG performance status|"Grading according to ECOG:~0: Fully active, able to carry on all pre-disease performance without restriction 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work 2: Ambulatory and capable of all self-care but unable to carry out any work activities up and about more than 50% of waking hours 3: Capable of only limited self-care, confined to bed or chair more than 50% of waking hours 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|Participants|Count of Participants|110|110.0||||||
3891970|NCT01516736|3717281|B1|0||ECOG performance status|"Grading according to ECOG:~0: Fully active, able to carry on all pre-disease performance without restriction 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work 2: Ambulatory and capable of all self-care but unable to carry out any work activities up and about more than 50% of waking hours 3: Capable of only limited self-care, confined to bed or chair more than 50% of waking hours 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|Participants|Count of Participants|117|117.0||||||
3891971|NCT01516736|3717279|B3|||Previous radiotherapy||Participants|Count of Participants|3|3.0||||||
3891972|NCT01516736|3717280|B2|||Previous radiotherapy||Participants|Count of Participants|1|1.0||||||
3891973|NCT01516736|3717281|B1|||Previous radiotherapy||Participants|Count of Participants|2|2.0||||||
3891974|NCT01516736|3717279|B3|||Previous breast cancer surgery||Participants|Count of Participants|306|306.0||||||
3891975|NCT01516736|3717280|B2|||Previous breast cancer surgery||Participants|Count of Participants|152|152.0||||||
3891976|NCT01516736|3717281|B1|||Previous breast cancer surgery||Participants|Count of Participants|154|154.0||||||
3891977|NCT01516736|3717279|B3|IV||Disease stage|TNM Disease stage was defined according to the American Joint Committee on Cancer (AJCC): (I) = T1 N0 M0 / T0 N1mi M0 / T1 N1mi M0; (II) = T0 N1 M0 / T1 N1 M0 / T2 N0 M0 / T2 N1 M0 / T3 N0 M0; (III) = T0 N2 M0 / T1 N2 M0 / T2 N2 M0 / T3 N1 M0 / T3 N2 M0 / T4 N0 M0 / T4 N1 M0 / T4 N2 M0 / AnyT N3 M0; (IV) = AnyT AnyN M1; T: size or direct extent of the primary tumour; N: degree of spread to regional lymph nodes; N1mi: Micrometastases (> 0.2 mm and/or > 200 cells, but none > 2.0 mm); M: presence of distant; https://www.cancer.gov/types/breast/hp/breast-treatment-pdq#link/_27|Participants|Count of Participants|1|1.0||||||
3891978|NCT01516736|3717280|B2|IV||Disease stage|TNM Disease stage was defined according to the American Joint Committee on Cancer (AJCC): (I) = T1 N0 M0 / T0 N1mi M0 / T1 N1mi M0; (II) = T0 N1 M0 / T1 N1 M0 / T2 N0 M0 / T2 N1 M0 / T3 N0 M0; (III) = T0 N2 M0 / T1 N2 M0 / T2 N2 M0 / T3 N1 M0 / T3 N2 M0 / T4 N0 M0 / T4 N1 M0 / T4 N2 M0 / AnyT N3 M0; (IV) = AnyT AnyN M1; T: size or direct extent of the primary tumour; N: degree of spread to regional lymph nodes; N1mi: Micrometastases (> 0.2 mm and/or > 200 cells, but none > 2.0 mm); M: presence of distant; https://www.cancer.gov/types/breast/hp/breast-treatment-pdq#link/_27|Participants|Count of Participants|1|1.0||||||
3891979|NCT01516736|3717281|B1|IV||Disease stage|TNM Disease stage was defined according to the American Joint Committee on Cancer (AJCC): (I) = T1 N0 M0 / T0 N1mi M0 / T1 N1mi M0; (II) = T0 N1 M0 / T1 N1 M0 / T2 N0 M0 / T2 N1 M0 / T3 N0 M0; (III) = T0 N2 M0 / T1 N2 M0 / T2 N2 M0 / T3 N1 M0 / T3 N2 M0 / T4 N0 M0 / T4 N1 M0 / T4 N2 M0 / AnyT N3 M0; (IV) = AnyT AnyN M1; T: size or direct extent of the primary tumour; N: degree of spread to regional lymph nodes; N1mi: Micrometastases (> 0.2 mm and/or > 200 cells, but none > 2.0 mm); M: presence of distant; https://www.cancer.gov/types/breast/hp/breast-treatment-pdq#link/_27|Participants|Count of Participants|0|0.0||||||
3891980|NCT01516736|3717279|B3|III||Disease stage|TNM Disease stage was defined according to the American Joint Committee on Cancer (AJCC): (I) = T1 N0 M0 / T0 N1mi M0 / T1 N1mi M0; (II) = T0 N1 M0 / T1 N1 M0 / T2 N0 M0 / T2 N1 M0 / T3 N0 M0; (III) = T0 N2 M0 / T1 N2 M0 / T2 N2 M0 / T3 N1 M0 / T3 N2 M0 / T4 N0 M0 / T4 N1 M0 / T4 N2 M0 / AnyT N3 M0; (IV) = AnyT AnyN M1; T: size or direct extent of the primary tumour; N: degree of spread to regional lymph nodes; N1mi: Micrometastases (> 0.2 mm and/or > 200 cells, but none > 2.0 mm); M: presence of distant; https://www.cancer.gov/types/breast/hp/breast-treatment-pdq#link/_27|Participants|Count of Participants|156|156.0||||||
3891981|NCT01516736|3717280|B2|III||Disease stage|TNM Disease stage was defined according to the American Joint Committee on Cancer (AJCC): (I) = T1 N0 M0 / T0 N1mi M0 / T1 N1mi M0; (II) = T0 N1 M0 / T1 N1 M0 / T2 N0 M0 / T2 N1 M0 / T3 N0 M0; (III) = T0 N2 M0 / T1 N2 M0 / T2 N2 M0 / T3 N1 M0 / T3 N2 M0 / T4 N0 M0 / T4 N1 M0 / T4 N2 M0 / AnyT N3 M0; (IV) = AnyT AnyN M1; T: size or direct extent of the primary tumour; N: degree of spread to regional lymph nodes; N1mi: Micrometastases (> 0.2 mm and/or > 200 cells, but none > 2.0 mm); M: presence of distant; https://www.cancer.gov/types/breast/hp/breast-treatment-pdq#link/_27|Participants|Count of Participants|78|78.0||||||
3891982|NCT01516736|3717281|B1|III||Disease stage|TNM Disease stage was defined according to the American Joint Committee on Cancer (AJCC): (I) = T1 N0 M0 / T0 N1mi M0 / T1 N1mi M0; (II) = T0 N1 M0 / T1 N1 M0 / T2 N0 M0 / T2 N1 M0 / T3 N0 M0; (III) = T0 N2 M0 / T1 N2 M0 / T2 N2 M0 / T3 N1 M0 / T3 N2 M0 / T4 N0 M0 / T4 N1 M0 / T4 N2 M0 / AnyT N3 M0; (IV) = AnyT AnyN M1; T: size or direct extent of the primary tumour; N: degree of spread to regional lymph nodes; N1mi: Micrometastases (> 0.2 mm and/or > 200 cells, but none > 2.0 mm); M: presence of distant; https://www.cancer.gov/types/breast/hp/breast-treatment-pdq#link/_27|Participants|Count of Participants|78|78.0||||||
3891983|NCT01516736|3717279|B3|II||Disease stage|TNM Disease stage was defined according to the American Joint Committee on Cancer (AJCC): (I) = T1 N0 M0 / T0 N1mi M0 / T1 N1mi M0; (II) = T0 N1 M0 / T1 N1 M0 / T2 N0 M0 / T2 N1 M0 / T3 N0 M0; (III) = T0 N2 M0 / T1 N2 M0 / T2 N2 M0 / T3 N1 M0 / T3 N2 M0 / T4 N0 M0 / T4 N1 M0 / T4 N2 M0 / AnyT N3 M0; (IV) = AnyT AnyN M1; T: size or direct extent of the primary tumour; N: degree of spread to regional lymph nodes; N1mi: Micrometastases (> 0.2 mm and/or > 200 cells, but none > 2.0 mm); M: presence of distant; https://www.cancer.gov/types/breast/hp/breast-treatment-pdq#link/_27|Participants|Count of Participants|131|131.0||||||
3892131|NCT01516632|3717303|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3891984|NCT01516736|3717280|B2|II||Disease stage|TNM Disease stage was defined according to the American Joint Committee on Cancer (AJCC): (I) = T1 N0 M0 / T0 N1mi M0 / T1 N1mi M0; (II) = T0 N1 M0 / T1 N1 M0 / T2 N0 M0 / T2 N1 M0 / T3 N0 M0; (III) = T0 N2 M0 / T1 N2 M0 / T2 N2 M0 / T3 N1 M0 / T3 N2 M0 / T4 N0 M0 / T4 N1 M0 / T4 N2 M0 / AnyT N3 M0; (IV) = AnyT AnyN M1; T: size or direct extent of the primary tumour; N: degree of spread to regional lymph nodes; N1mi: Micrometastases (> 0.2 mm and/or > 200 cells, but none > 2.0 mm); M: presence of distant; https://www.cancer.gov/types/breast/hp/breast-treatment-pdq#link/_27|Participants|Count of Participants|61|61.0||||||
3891985|NCT01516736|3717281|B1|II||Disease stage|TNM Disease stage was defined according to the American Joint Committee on Cancer (AJCC): (I) = T1 N0 M0 / T0 N1mi M0 / T1 N1mi M0; (II) = T0 N1 M0 / T1 N1 M0 / T2 N0 M0 / T2 N1 M0 / T3 N0 M0; (III) = T0 N2 M0 / T1 N2 M0 / T2 N2 M0 / T3 N1 M0 / T3 N2 M0 / T4 N0 M0 / T4 N1 M0 / T4 N2 M0 / AnyT N3 M0; (IV) = AnyT AnyN M1; T: size or direct extent of the primary tumour; N: degree of spread to regional lymph nodes; N1mi: Micrometastases (> 0.2 mm and/or > 200 cells, but none > 2.0 mm); M: presence of distant; https://www.cancer.gov/types/breast/hp/breast-treatment-pdq#link/_27|Participants|Count of Participants|70|70.0||||||
3891986|NCT01516736|3717279|B3|I||Disease stage|TNM Disease stage was defined according to the American Joint Committee on Cancer (AJCC): (I) = T1 N0 M0 / T0 N1mi M0 / T1 N1mi M0; (II) = T0 N1 M0 / T1 N1 M0 / T2 N0 M0 / T2 N1 M0 / T3 N0 M0; (III) = T0 N2 M0 / T1 N2 M0 / T2 N2 M0 / T3 N1 M0 / T3 N2 M0 / T4 N0 M0 / T4 N1 M0 / T4 N2 M0 / AnyT N3 M0; (IV) = AnyT AnyN M1; T: size or direct extent of the primary tumour; N: degree of spread to regional lymph nodes; N1mi: Micrometastases (> 0.2 mm and/or > 200 cells, but none > 2.0 mm); M: presence of distant; https://www.cancer.gov/types/breast/hp/breast-treatment-pdq#link/_27|Participants|Count of Participants|20|20.0||||||
3891987|NCT01516736|3717280|B2|I||Disease stage|TNM Disease stage was defined according to the American Joint Committee on Cancer (AJCC): (I) = T1 N0 M0 / T0 N1mi M0 / T1 N1mi M0; (II) = T0 N1 M0 / T1 N1 M0 / T2 N0 M0 / T2 N1 M0 / T3 N0 M0; (III) = T0 N2 M0 / T1 N2 M0 / T2 N2 M0 / T3 N1 M0 / T3 N2 M0 / T4 N0 M0 / T4 N1 M0 / T4 N2 M0 / AnyT N3 M0; (IV) = AnyT AnyN M1; T: size or direct extent of the primary tumour; N: degree of spread to regional lymph nodes; N1mi: Micrometastases (> 0.2 mm and/or > 200 cells, but none > 2.0 mm); M: presence of distant; https://www.cancer.gov/types/breast/hp/breast-treatment-pdq#link/_27|Participants|Count of Participants|13|13.0||||||
3891988|NCT01516736|3717281|B1|I||Disease stage|TNM Disease stage was defined according to the American Joint Committee on Cancer (AJCC): (I) = T1 N0 M0 / T0 N1mi M0 / T1 N1mi M0; (II) = T0 N1 M0 / T1 N1 M0 / T2 N0 M0 / T2 N1 M0 / T3 N0 M0; (III) = T0 N2 M0 / T1 N2 M0 / T2 N2 M0 / T3 N1 M0 / T3 N2 M0 / T4 N0 M0 / T4 N1 M0 / T4 N2 M0 / AnyT N3 M0; (IV) = AnyT AnyN M1; T: size or direct extent of the primary tumour; N: degree of spread to regional lymph nodes; N1mi: Micrometastases (> 0.2 mm and/or > 200 cells, but none > 2.0 mm); M: presence of distant; https://www.cancer.gov/types/breast/hp/breast-treatment-pdq#link/_27|Participants|Count of Participants|7|7.0||||||
3891989|NCT01516736|3717279|B3|||Time since diagnosis||months|Median|1.28|1.28|Full Range|||0.2|42.3|
3891990|NCT01516736|3717280|B2|||Time since diagnosis||months|Median|1.28|1.28|Full Range|||0.3|11.2|
3891991|NCT01516736|3717281|B1|||Time since diagnosis||months|Median|1.28|1.28|Full Range|||0.2|42.3|
3891992|NCT01516736|3717279|B3|||BMI||kg/m^2|Mean|26.53|26.53|Standard Deviation|5.450|5.45|||
3891993|NCT01516736|3717280|B2|||BMI||kg/m^2|Mean|26.49|26.49|Standard Deviation|5.126|5.126|||
3891994|NCT01516736|3717281|B1|||BMI||kg/m^2|Mean|26.56|26.56|Standard Deviation|5.771|5.771|||
3891995|NCT01516736|3717279|B3||Unknown or Not Reported|Race (NIH/OMB)|The 2 patients with race “More than one race” were reported as Hispanic origin.|Participants|Count of Participants|0|0.0||||||
3891996|NCT01516736|3717280|B2||Unknown or Not Reported|Race (NIH/OMB)|The 2 patients with race “More than one race” were reported as Hispanic origin.|Participants|Count of Participants|0|0.0||||||
3891997|NCT01516736|3717281|B1||Unknown or Not Reported|Race (NIH/OMB)|The 2 patients with race “More than one race” were reported as Hispanic origin.|Participants|Count of Participants|0|0.0||||||
3891998|NCT01516736|3717279|B3||More than one race|Race (NIH/OMB)|The 2 patients with race “More than one race” were reported as Hispanic origin.|Participants|Count of Participants|2|2.0||||||
3891999|NCT01516736|3717280|B2||More than one race|Race (NIH/OMB)|The 2 patients with race “More than one race” were reported as Hispanic origin.|Participants|Count of Participants|0|0.0||||||
3892000|NCT01516736|3717281|B1||More than one race|Race (NIH/OMB)|The 2 patients with race “More than one race” were reported as Hispanic origin.|Participants|Count of Participants|2|2.0||||||
3892001|NCT01516736|3717279|B3||White|Race (NIH/OMB)|The 2 patients with race “More than one race” were reported as Hispanic origin.|Participants|Count of Participants|183|183.0||||||
3892002|NCT01516736|3717280|B2||White|Race (NIH/OMB)|The 2 patients with race “More than one race” were reported as Hispanic origin.|Participants|Count of Participants|93|93.0||||||
3892003|NCT01516736|3717281|B1||White|Race (NIH/OMB)|The 2 patients with race “More than one race” were reported as Hispanic origin.|Participants|Count of Participants|90|90.0||||||
3892004|NCT01516736|3717279|B3||Black or African American|Race (NIH/OMB)|The 2 patients with race “More than one race” were reported as Hispanic origin.|Participants|Count of Participants|3|3.0||||||
3892005|NCT01516736|3717280|B2||Black or African American|Race (NIH/OMB)|The 2 patients with race “More than one race” were reported as Hispanic origin.|Participants|Count of Participants|2|2.0||||||
3892006|NCT01516736|3717281|B1||Black or African American|Race (NIH/OMB)|The 2 patients with race “More than one race” were reported as Hispanic origin.|Participants|Count of Participants|1|1.0||||||
3892007|NCT01516736|3717279|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|The 2 patients with race “More than one race” were reported as Hispanic origin.|Participants|Count of Participants|0|0.0||||||
3892008|NCT01516736|3717280|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|The 2 patients with race “More than one race” were reported as Hispanic origin.|Participants|Count of Participants|0|0.0||||||
3892009|NCT01516736|3717281|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|The 2 patients with race “More than one race” were reported as Hispanic origin.|Participants|Count of Participants|0|0.0||||||
3892010|NCT01516736|3717279|B3||Asian|Race (NIH/OMB)|The 2 patients with race “More than one race” were reported as Hispanic origin.|Participants|Count of Participants|120|120.0||||||
3892132|NCT01516632|3717304|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3892013|NCT01516736|3717279|B3||American Indian or Alaska Native|Race (NIH/OMB)|The 2 patients with race “More than one race” were reported as Hispanic origin.|Participants|Count of Participants|0|0.0||||||
3892014|NCT01516736|3717280|B2||American Indian or Alaska Native|Race (NIH/OMB)|The 2 patients with race “More than one race” were reported as Hispanic origin.|Participants|Count of Participants|0|0.0||||||
3892015|NCT01516736|3717281|B1||American Indian or Alaska Native|Race (NIH/OMB)|The 2 patients with race “More than one race” were reported as Hispanic origin.|Participants|Count of Participants|0|0.0||||||
3892016|NCT01516736|3717279|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892017|NCT01516736|3717280|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892018|NCT01516736|3717281|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892019|NCT01516736|3717279|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|292|292.0||||||
3892020|NCT01516736|3717280|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|147|147.0||||||
3892021|NCT01516736|3717281|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|145|145.0||||||
3892022|NCT01516736|3717279|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3892023|NCT01516736|3717280|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3892024|NCT01516736|3717281|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3892025|NCT01516736|3717279|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3892026|NCT01516736|3717280|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3892027|NCT01516736|3717281|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3892028|NCT01516736|3717279|B3||Female|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
3892029|NCT01516736|3717280|B2||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3892030|NCT01516736|3717281|B1||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3892031|NCT01516736|3717279|B3|||Age||years|Mean|48.9|48.9|Standard Deviation|10.27|10.27|||
3892032|NCT01516736|3717280|B2|||Age||years|Mean|49.1|49.1|Standard Deviation|10.07|10.07|||
3892033|NCT01516736|3717281|B1|||Age||years|Mean|48.8|48.8|Standard Deviation|10.50|10.5|||
3892034|NCT01516632|3717302|B3|||Depressive Symptomatology|"Center for Epidemiologic Studies Depression Scale (Eaton, Muntaner, Smith, Tien, & Ybarra, 2004)~The scores range 0-27 with higher scores reflecting more depressive symptomatology"|units on a scale|Mean|8.3|8.3|Standard Deviation|6.3|6.3|||
3892035|NCT01516632|3717303|B2|||Depressive Symptomatology|"Center for Epidemiologic Studies Depression Scale (Eaton, Muntaner, Smith, Tien, & Ybarra, 2004)~The scores range 0-27 with higher scores reflecting more depressive symptomatology"|units on a scale|Mean|9.3|9.3|Standard Deviation|6.4|6.4|||
3892036|NCT01516632|3717304|B1|||Depressive Symptomatology|"Center for Epidemiologic Studies Depression Scale (Eaton, Muntaner, Smith, Tien, & Ybarra, 2004)~The scores range 0-27 with higher scores reflecting more depressive symptomatology"|units on a scale|Mean|7.8|7.8|Standard Deviation|6.2|6.2|||
3892037|NCT01516632|3717302|B3|||Social support from family|"Measured using the Multidimensional Scale of Perceived Social Support (Zimet, Dahlem, Zimet, & Farley, 1988)~The values range 4-20 with higher scores reflecting more social support"|units on a scale|Mean|15.5|15.5|Standard Deviation|4.1|4.1|||
3892038|NCT01516632|3717303|B2|||Social support from family|"Measured using the Multidimensional Scale of Perceived Social Support (Zimet, Dahlem, Zimet, & Farley, 1988)~The values range 4-20 with higher scores reflecting more social support"|units on a scale|Mean|15.9|15.9|Standard Deviation|3.6|3.6|||
3892039|NCT01516632|3717304|B1|||Social support from family|"Measured using the Multidimensional Scale of Perceived Social Support (Zimet, Dahlem, Zimet, & Farley, 1988)~The values range 4-20 with higher scores reflecting more social support"|units on a scale|Mean|15.3|15.3|Standard Deviation|4.3|4.3|||
3892040|NCT01516632|3717302|B3|||Social support from friends|"Measured using the Multidimensional Scale of Perceived Social Support (Zimet, Dahlem, Zimet, & Farley, 1988)~The values range 4-20 with higher scores reflecting more social support"|units on a scale|Mean|16.3|16.3|Standard Deviation|3.7|3.7|||
3892041|NCT01516632|3717303|B2|||Social support from friends|"Measured using the Multidimensional Scale of Perceived Social Support (Zimet, Dahlem, Zimet, & Farley, 1988)~The values range 4-20 with higher scores reflecting more social support"|units on a scale|Mean|16.6|16.6|Standard Deviation|3.1|3.1|||
3892042|NCT01516632|3717304|B1|||Social support from friends|"Measured using the Multidimensional Scale of Perceived Social Support (Zimet, Dahlem, Zimet, & Farley, 1988)~The values range 4-20 with higher scores reflecting more social support"|units on a scale|Mean|16.1|16.1|Standard Deviation|4.0|4.0|||
3892043|NCT01516632|3717302|B3|||"Social support from special person"|"Measured using the Multidimensional Scale of Perceived Social Support (Zimet, Dahlem, Zimet, & Farley, 1988)~The values range 4-20 with higher scores reflecting more social support"|units on a scale|Mean|15.6|15.6|Standard Deviation|4.9|4.9|||
3892044|NCT01516632|3717303|B2|||"Social support from special person"|"Measured using the Multidimensional Scale of Perceived Social Support (Zimet, Dahlem, Zimet, & Farley, 1988)~The values range 4-20 with higher scores reflecting more social support"|units on a scale|Mean|16.3|16.3|Standard Deviation|3.9|3.9|||
3892045|NCT01516632|3717304|B1|||"Social support from special person"|"Measured using the Multidimensional Scale of Perceived Social Support (Zimet, Dahlem, Zimet, & Farley, 1988)~The values range 4-20 with higher scores reflecting more social support"|units on a scale|Mean|15.1|15.1|Standard Deviation|5.4|5.4|||
3892046|NCT01516632|3717302|B3|||Resistance self-efficacy|"The scale was a 4-item measure developed by Lawrance L, Rubinson L. Self-efficacy as a predictor of smoking behavior in young adolescents. Addict Behav. 1986;11(4):367-382.~The possible range of scores was from 4-20 with higher scores reflecting more self-efficacy."|units on a scale|Mean|10.55|10.55|Standard Deviation|4.0|4.0|||
3892133|NCT01516632|3717302|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3892134|NCT01516632|3717303|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3892047|NCT01516632|3717303|B2|||Resistance self-efficacy|"The scale was a 4-item measure developed by Lawrance L, Rubinson L. Self-efficacy as a predictor of smoking behavior in young adolescents. Addict Behav. 1986;11(4):367-382.~The possible range of scores was from 4-20 with higher scores reflecting more self-efficacy."|units on a scale|Mean|10.5|10.5|Standard Deviation|4.0|4.0|||
3892048|NCT01516632|3717304|B1|||Resistance self-efficacy|"The scale was a 4-item measure developed by Lawrance L, Rubinson L. Self-efficacy as a predictor of smoking behavior in young adolescents. Addict Behav. 1986;11(4):367-382.~The possible range of scores was from 4-20 with higher scores reflecting more self-efficacy."|units on a scale|Mean|10.6|10.6|Standard Deviation|4.0|4.0|||
3892049|NCT01516632|3717302|B3|No||Planning on using an evidence-based quitting aid|Planning on using an evidence-based quitting aid for the current attempt|participants|Number|127|127.0||||||
3892050|NCT01516632|3717303|B2|No||Planning on using an evidence-based quitting aid|Planning on using an evidence-based quitting aid for the current attempt|participants|Number|52|52.0||||||
3892051|NCT01516632|3717304|B1|No||Planning on using an evidence-based quitting aid|Planning on using an evidence-based quitting aid for the current attempt|participants|Number|75|75.0||||||
3892052|NCT01516632|3717302|B3|Yes||Planning on using an evidence-based quitting aid|Planning on using an evidence-based quitting aid for the current attempt|participants|Number|37|37.0||||||
3892053|NCT01516632|3717303|B2|Yes||Planning on using an evidence-based quitting aid|Planning on using an evidence-based quitting aid for the current attempt|participants|Number|11|11.0||||||
3892054|NCT01516632|3717304|B1|Yes||Planning on using an evidence-based quitting aid|Planning on using an evidence-based quitting aid for the current attempt|participants|Number|26|26.0||||||
3892055|NCT01516632|3717302|B3|||Number of text messages received on an average day||text messages per day|Median|50|50.0|Inter-Quartile Range|||20.0|100.0|
3892056|NCT01516632|3717303|B2|||Number of text messages received on an average day||text messages per day|Median|50|50.0|Inter-Quartile Range|||18.0|100.0|
3892057|NCT01516632|3717304|B1|||Number of text messages received on an average day||text messages per day|Median|60|60.0|Inter-Quartile Range|||20.0|100.0|
3892058|NCT01516632|3717302|B3|||Number of text messages sent on an average day||units on a scale|Median|50|50.0|Inter-Quartile Range|||20.0|100.0|
3892059|NCT01516632|3717303|B2|||Number of text messages sent on an average day||units on a scale|Median|45|45.0|Inter-Quartile Range|||20.0|100.0|
3892060|NCT01516632|3717304|B1|||Number of text messages sent on an average day||units on a scale|Median|50|50.0|Inter-Quartile Range|||20.0|100.0|
3892061|NCT01516632|3717302|B3|||Tenure with current cell phone number (months)|The length of time they have had the current cellular phone number|Months|Mean|45.4|45.4|Standard Deviation|29.5|29.5|||
3892062|NCT01516632|3717303|B2|||Tenure with current cell phone number (months)|The length of time they have had the current cellular phone number|Months|Mean|46.4|46.4|Standard Deviation|31.6|31.6|||
3892063|NCT01516632|3717304|B1|||Tenure with current cell phone number (months)|The length of time they have had the current cellular phone number|Months|Mean|44.8|44.8|Standard Deviation|28.2|28.2|||
3892064|NCT01516632|3717302|B3|No||Currently Enrolled in College, University, or Junior College||participants|Number|96|96.0||||||
3892065|NCT01516632|3717303|B2|No||Currently Enrolled in College, University, or Junior College||participants|Number|38|38.0||||||
3892066|NCT01516632|3717304|B1|No||Currently Enrolled in College, University, or Junior College||participants|Number|58|58.0||||||
3892067|NCT01516632|3717302|B3|Yes||Currently Enrolled in College, University, or Junior College||participants|Number|68|68.0||||||
3892068|NCT01516632|3717303|B2|Yes||Currently Enrolled in College, University, or Junior College||participants|Number|25|25.0||||||
3892069|NCT01516632|3717304|B1|Yes||Currently Enrolled in College, University, or Junior College||participants|Number|43|43.0||||||
3892070|NCT01516632|3717302|B3|Working > 30 hr||Current Employment Status||participants|Number|57|57.0||||||
3892071|NCT01516632|3717303|B2|Working > 30 hr||Current Employment Status||participants|Number|16|16.0||||||
3892072|NCT01516632|3717304|B1|Working > 30 hr||Current Employment Status||participants|Number|41|41.0||||||
3892073|NCT01516632|3717302|B3|Working ≤ 30 hr||Current Employment Status||participants|Number|36|36.0||||||
3892074|NCT01516632|3717303|B2|Working ≤ 30 hr||Current Employment Status||participants|Number|12|12.0||||||
3892075|NCT01516632|3717304|B1|Working ≤ 30 hr||Current Employment Status||participants|Number|24|24.0||||||
3892076|NCT01516632|3717302|B3|Not Working||Current Employment Status||participants|Number|71|71.0||||||
3892077|NCT01516632|3717303|B2|Not Working||Current Employment Status||participants|Number|35|35.0||||||
3892078|NCT01516632|3717304|B1|Not Working||Current Employment Status||participants|Number|36|36.0||||||
3892079|NCT01516632|3717302|B3|No||Married/living with someone||participants|Number|118|118.0||||||
3892080|NCT01516632|3717303|B2|No||Married/living with someone||participants|Number|46|46.0||||||
3892081|NCT01516632|3717304|B1|No||Married/living with someone||participants|Number|72|72.0||||||
3892082|NCT01516632|3717302|B3|Yes||Married/living with someone||participants|Number|46|46.0||||||
3892083|NCT01516632|3717303|B2|Yes||Married/living with someone||participants|Number|17|17.0||||||
3892084|NCT01516632|3717304|B1|Yes||Married/living with someone||participants|Number|29|29.0||||||
3892085|NCT01516632|3717302|B3|>$35,000||Income|Low Income is <$35,000|participants|Number|22|22.0||||||
3892086|NCT01516632|3717303|B2|>$35,000||Income|Low Income is <$35,000|participants|Number|6|6.0||||||
3892087|NCT01516632|3717304|B1|>$35,000||Income|Low Income is <$35,000|participants|Number|16|16.0||||||
3892088|NCT01516632|3717302|B3|<$35,000||Income|Low Income is <$35,000|participants|Number|142|142.0||||||
3892089|NCT01516632|3717303|B2|<$35,000||Income|Low Income is <$35,000|participants|Number|57|57.0||||||
3892090|NCT01516632|3717304|B1|<$35,000||Income|Low Income is <$35,000|participants|Number|85|85.0||||||
3892135|NCT01516632|3717304|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3892136|NCT01516632|3717302|B3||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3892137|NCT01516632|3717303|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3892091|NCT01516632|3717302|B3|||Confidence of one's ability to quit|The score ranged from 0-10 with higher scores reflecting more confidence Miller, W. R., Zweben, A., DiClemente, C. C., & Rychtarik, R. G. (1992). Motivational Enhancement Therapy Manual: A clinical research guide for therapists treating individuals with alcohol abuse and dependence. Rockville, MD: National Institute on Alcohol Abuse and Alcoholism.|units on a scale|Mean|6.6|6.6|Standard Deviation|2.4|2.4|||
3892092|NCT01516632|3717303|B2|||Confidence of one's ability to quit|The score ranged from 0-10 with higher scores reflecting more confidence Miller, W. R., Zweben, A., DiClemente, C. C., & Rychtarik, R. G. (1992). Motivational Enhancement Therapy Manual: A clinical research guide for therapists treating individuals with alcohol abuse and dependence. Rockville, MD: National Institute on Alcohol Abuse and Alcoholism.|units on a scale|Mean|6.5|6.5|Standard Deviation|2.6|2.6|||
3892093|NCT01516632|3717304|B1|||Confidence of one's ability to quit|The score ranged from 0-10 with higher scores reflecting more confidence Miller, W. R., Zweben, A., DiClemente, C. C., & Rychtarik, R. G. (1992). Motivational Enhancement Therapy Manual: A clinical research guide for therapists treating individuals with alcohol abuse and dependence. Rockville, MD: National Institute on Alcohol Abuse and Alcoholism.|units on a scale|Mean|6.7|6.7|Standard Deviation|2.2|2.2|||
3892094|NCT01516632|3717302|B3|||Importance of Quitting|The score ranged from 0-10 with higher scores reflecting more importance Miller, W. R., Zweben, A., DiClemente, C. C., & Rychtarik, R. G. (1992). Motivational Enhancement Therapy Manual: A clinical research guide for therapists treating individuals with alcohol abuse and dependence. Rockville, MD: National Institute on Alcohol Abuse and Alcoholism.|units on a scale|Mean|8.8|8.8|Standard Deviation|1.4|1.4|||
3892095|NCT01516632|3717303|B2|||Importance of Quitting|The score ranged from 0-10 with higher scores reflecting more importance Miller, W. R., Zweben, A., DiClemente, C. C., & Rychtarik, R. G. (1992). Motivational Enhancement Therapy Manual: A clinical research guide for therapists treating individuals with alcohol abuse and dependence. Rockville, MD: National Institute on Alcohol Abuse and Alcoholism.|units on a scale|Mean|8.9|8.9|Standard Deviation|1.3|1.3|||
3892096|NCT01516632|3717304|B1|||Importance of Quitting|The score ranged from 0-10 with higher scores reflecting more importance Miller, W. R., Zweben, A., DiClemente, C. C., & Rychtarik, R. G. (1992). Motivational Enhancement Therapy Manual: A clinical research guide for therapists treating individuals with alcohol abuse and dependence. Rockville, MD: National Institute on Alcohol Abuse and Alcoholism.|units on a scale|Mean|8.7|8.7|Standard Deviation|1.5|1.5|||
3892097|NCT01516632|3717302|B3|No||Nicotine dependent||participants|Number|15|15.0||||||
3892098|NCT01516632|3717303|B2|No||Nicotine dependent||participants|Number|4|4.0||||||
3892099|NCT01516632|3717304|B1|No||Nicotine dependent||participants|Number|11|11.0||||||
3892100|NCT01516632|3717302|B3|Yes||Nicotine dependent||participants|Number|149|149.0||||||
3892101|NCT01516632|3717303|B2|Yes||Nicotine dependent||participants|Number|59|59.0||||||
3892102|NCT01516632|3717304|B1|Yes||Nicotine dependent||participants|Number|90|90.0||||||
3892103|NCT01516632|3717302|B3|||Average number of cigarettes smoke per day||number of cigarettes per day|Mean|12.2|12.2|Standard Deviation|6.1|6.1|||
3892104|NCT01516632|3717303|B2|||Average number of cigarettes smoke per day||number of cigarettes per day|Mean|11.9|11.9|Standard Deviation|5.7|5.7|||
3892105|NCT01516632|3717304|B1|||Average number of cigarettes smoke per day||number of cigarettes per day|Mean|12.4|12.4|Standard Deviation|6.3|6.3|||
3892106|NCT01516632|3717302|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3892107|NCT01516632|3717303|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892108|NCT01516632|3717304|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3892109|NCT01516632|3717302|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3892110|NCT01516632|3717303|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3892111|NCT01516632|3717304|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3892112|NCT01516632|3717302|B3||White|Race (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
3892113|NCT01516632|3717303|B2||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3892114|NCT01516632|3717304|B1||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3892115|NCT01516632|3717302|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3892116|NCT01516632|3717303|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3892117|NCT01516632|3717304|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3892118|NCT01516632|3717302|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3892119|NCT01516632|3717303|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3892120|NCT01516632|3717304|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892121|NCT01516632|3717302|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3892122|NCT01516632|3717303|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3892123|NCT01516632|3717304|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3892124|NCT01516632|3717302|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3892125|NCT01516632|3717303|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3892126|NCT01516632|3717304|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3892127|NCT01516632|3717302|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892128|NCT01516632|3717303|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892129|NCT01516632|3717304|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892130|NCT01516632|3717302|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
3892138|NCT01516632|3717304|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3892140|NCT01516632|3717303|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3892141|NCT01516632|3717304|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3892142|NCT01516632|3717302|B3|||Age||years|Mean|21.6|21.6|Standard Deviation|2.1|2.1|||
3892143|NCT01516632|3717303|B2|||Age||years|Mean|21.6|21.6|Standard Deviation|2.1|2.1|||
3892144|NCT01516632|3717304|B1|||Age||years|Mean|21.6|21.6|Standard Deviation|2.1|2.1|||
3892145|NCT01516437|3717315|B5||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3892146|NCT01516437|3717316|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3892147|NCT01516437|3717317|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3892148|NCT01516437|3717318|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3892149|NCT01516437|3717319|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3892150|NCT01516437|3717315|B5||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3892151|NCT01516437|3717316|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3892152|NCT01516437|3717317|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3892153|NCT01516437|3717318|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3892154|NCT01516437|3717319|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3892155|NCT01516437|3717315|B5|||Age||Years|Mean|60.26|60.26|Standard Deviation|8.85|8.85|||
3892156|NCT01516437|3717316|B4|||Age||Years|Mean|61.4|61.4|Standard Deviation|6.75|6.75|||
3892157|NCT01516437|3717317|B3|||Age||Years|Mean|64.1|64.1|Standard Deviation|7.39|7.39|||
3892158|NCT01516437|3717318|B2|||Age||Years|Mean|57.8|57.8|Standard Deviation|8.45|8.45|||
3892159|NCT01516437|3717319|B1|||Age||Years|Mean|60|60.0|Standard Deviation|10.10|10.1|||
3892160|NCT01516424|3717376|B3||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3892161|NCT01516424|3717377|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3892162|NCT01516424|3717378|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3892163|NCT01516424|3717376|B3||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3892164|NCT01516424|3717377|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3892165|NCT01516424|3717378|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3892166|NCT01516424|3717376|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3892167|NCT01516424|3717377|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3892168|NCT01516424|3717378|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3892169|NCT01516424|3717376|B3||Between 18 and 65 years|Age||Participants|Count of Participants|261|261.0||||||
3892170|NCT01516424|3717377|B2||Between 18 and 65 years|Age||Participants|Count of Participants|133|133.0||||||
3892171|NCT01516424|3717378|B1||Between 18 and 65 years|Age||Participants|Count of Participants|128|128.0||||||
3892172|NCT01516424|3717376|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3892173|NCT01516424|3717377|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3892174|NCT01516424|3717378|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3892175|NCT01516268|3717385|B3|Iran, Islamic Republic of||Region of Enrollment||participants|Number|50|50.0||||||
3892176|NCT01516268|3717386|B2|Iran, Islamic Republic of||Region of Enrollment||participants|Number|25|25.0||||||
3892177|NCT01516268|3717387|B1|Iran, Islamic Republic of||Region of Enrollment||participants|Number|25|25.0||||||
3892178|NCT01516268|3717385|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3892179|NCT01516268|3717386|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3892180|NCT01516268|3717387|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3892181|NCT01516268|3717385|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3892182|NCT01516268|3717386|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3892183|NCT01516268|3717387|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3892184|NCT01516268|3717385|B3|||Age||years|Mean|29.1|29.1|Standard Deviation|4.6|4.6|||
3892185|NCT01516268|3717386|B2|||Age||years|Mean|29.9|29.9|Standard Deviation|5.6|5.6|||
3892186|NCT01516268|3717387|B1|||Age||years|Mean|28.9|28.9|Standard Deviation|3.4|3.4|||
3892187|NCT01516268|3717385|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3892188|NCT01516268|3717386|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3892189|NCT01516268|3717387|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3892190|NCT01516268|3717385|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3892191|NCT01516268|3717386|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3892192|NCT01516268|3717387|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3892193|NCT01516268|3717385|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3892194|NCT01516268|3717386|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3892195|NCT01516268|3717387|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3892196|NCT01516034|3717394|B1|Israel||Region of Enrollment||participants|Number|8|8.0||||||
3892197|NCT01516034|3717394|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3892198|NCT01516034|3717394|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3892199|NCT01516034|3717394|B1|||Age||years|Mean|32.1|32.1|Standard Deviation|6.3|6.3|||
3892200|NCT01516034|3717394|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3892201|NCT01516034|3717394|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3892202|NCT01516034|3717394|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3892203|NCT01516008|3717398|B4|>=65 years||Age Customized||participants|Number|45|45.0||||||
3892204|NCT01516008|3717399|B3|>=65 years||Age Customized||participants|Number|18|18.0||||||
3892205|NCT01516008|3717400|B2|>=65 years||Age Customized||participants|Number|16|16.0||||||
3892206|NCT01516008|3717401|B1|>=65 years||Age Customized||participants|Number|11|11.0||||||
3892207|NCT01516008|3717398|B4|<65 years||Age Customized||participants|Number|307|307.0||||||
3892208|NCT01516008|3717399|B3|<65 years||Age Customized||participants|Number|99|99.0||||||
3892209|NCT01516008|3717400|B2|<65 years||Age Customized||participants|Number|105|105.0||||||
3892210|NCT01516008|3717401|B1|<65 years||Age Customized||participants|Number|103|103.0||||||
3892211|NCT01516008|3717398|B4|Korea, Republic Of||Region of Enrollment||participants|Number|352|352.0||||||
3892212|NCT01516008|3717399|B3|Korea, Republic Of||Region of Enrollment||participants|Number|117|117.0||||||
3892213|NCT01516008|3717400|B2|Korea, Republic Of||Region of Enrollment||participants|Number|121|121.0||||||
3892214|NCT01516008|3717401|B1|Korea, Republic Of||Region of Enrollment||participants|Number|114|114.0||||||
3892215|NCT01516008|3717398|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3892216|NCT01516008|3717399|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3892217|NCT01516008|3717400|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3892218|NCT01516008|3717401|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3892219|NCT01516008|3717398|B4||Female|Sex: Female, Male||Participants|Count of Participants|331|331.0||||||
3892220|NCT01516008|3717399|B3||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3892221|NCT01516008|3717400|B2||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3892222|NCT01516008|3717401|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3892223|NCT01516008|3717398|B4|||Age||years|Mean|51.3|51.3|Standard Deviation|12.33|12.33|||
3892224|NCT01516008|3717399|B3|||Age||years|Mean|50.7|50.7|Standard Deviation|13.45|13.45|||
3892225|NCT01516008|3717400|B2|||Age||years|Mean|51.8|51.8|Standard Deviation|11.9|11.9|||
3892226|NCT01516008|3717401|B1|||Age||years|Mean|51.3|51.3|Standard Deviation|11.62|11.62|||
3892227|NCT01515956|3717435|B1|||Urinary Keratan Sulfate Measures||ug/mg|Mean|35.9|35.9|Standard Deviation|12.32|12.32|||
3892228|NCT01515956|3717435|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3892229|NCT01515956|3717435|B1|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3892230|NCT01515956|3717435|B1|Italy||Region of Enrollment||participants|Number|2|2.0||||||
3892231|NCT01515956|3717435|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3892232|NCT01515956|3717435|B1|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3892233|NCT01515956|3717435|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3892234|NCT01515956|3717435|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892235|NCT01515956|3717435|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3892236|NCT01515956|3717435|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3892237|NCT01515956|3717435|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3892238|NCT01515956|3717435|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3892239|NCT01515956|3717435|B1|>=3 to <5 years||Age, Customized||participants|Number|8|8.0||||||
3892240|NCT01515956|3717435|B1|0 to <3 years||Age, Customized||participants|Number|7|7.0||||||
3892241|NCT01515956|3717435|B1|||Age||years|Mean|3.1|3.1|Standard Deviation|1.34|1.34|||
3892242|NCT01515943|3717441|B4|United States||Region of Enrollment||participants|Number|204|204.0||||||
3892243|NCT01515943|3717442|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
3892244|NCT01515943|3717443|B2|United States||Region of Enrollment||participants|Number|85|85.0||||||
3892245|NCT01515943|3717444|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
3892246|NCT01515943|3717441|B4||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3892247|NCT01515943|3717442|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3892248|NCT01515943|3717443|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3892249|NCT01515943|3717444|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3892250|NCT01515943|3717441|B4||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3892251|NCT01515943|3717442|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3892252|NCT01515943|3717443|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3892253|NCT01515943|3717444|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3892254|NCT01515943|3717441|B4|||Age||years|Mean|12.4|12.4|Standard Deviation|2.4|2.4|||
3892255|NCT01515943|3717442|B3|||Age||years|Mean|12.3|12.3|Standard Deviation|2.3|2.3|||
3892256|NCT01515943|3717443|B2|||Age||years|Mean|12.6|12.6|Standard Deviation|2.5|2.5|||
3892257|NCT01515943|3717444|B1|||Age||years|Mean|12.2|12.2|Standard Deviation|2.4|2.4|||
3892258|NCT01515943|3717441|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3892259|NCT01515943|3717442|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3892260|NCT01515943|3717443|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3892261|NCT01515943|3717444|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3892262|NCT01515943|3717441|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3892263|NCT01515943|3717442|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3892264|NCT01515943|3717443|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3892265|NCT01515943|3717444|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3892266|NCT01515943|3717441|B4||<=18 years|Age||Participants|Count of Participants|204|204.0||||||
3892267|NCT01515943|3717442|B3||<=18 years|Age||Participants|Count of Participants|44|44.0||||||
3892268|NCT01515943|3717443|B2||<=18 years|Age||Participants|Count of Participants|85|85.0||||||
3892269|NCT01515943|3717444|B1||<=18 years|Age||Participants|Count of Participants|75|75.0||||||
3892270|NCT01515891|3717492|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3892271|NCT01515891|3717492|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3892272|NCT01515891|3717492|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3892273|NCT01515891|3717492|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3892274|NCT01515891|3717492|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3892275|NCT01515865|3717499|B1|Poland||Region of Enrollment||participants|Number|5|5.0||||||
3892276|NCT01515865|3717499|B1|Slovakia||Region of Enrollment||participants|Number|3|3.0||||||
3892277|NCT01515865|3717499|B1|United States||Region of Enrollment||participants|Number|90|90.0||||||
3892278|NCT01515865|3717499|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3892279|NCT01515865|3717499|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3892280|NCT01515865|3717499|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|17.45|17.45|||
3892281|NCT01515696|3717509|B3|||birthweight||grams|Median|879|879.0|Full Range|0|0.0|480.0|1440.0|
3892282|NCT01515696|3717510|B2|||birthweight||grams|Median|900|900.0|Full Range|0|0.0|480.0|1414.0|
3892283|NCT01515696|3717511|B1|||birthweight||grams|Median|870|870.0|Full Range|0|0.0|490.0|1440.0|
3892284|NCT01515696|3717509|B3|Austria||Region of Enrollment||participants|Number|96|96.0||||||
3892285|NCT01515696|3717510|B2|Austria||Region of Enrollment||participants|Number|49|49.0||||||
3892286|NCT01515696|3717511|B1|Austria||Region of Enrollment||participants|Number|47|47.0||||||
3892287|NCT01515696|3717509|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3892288|NCT01515696|3717510|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3892289|NCT01515696|3717511|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3892290|NCT01515696|3717509|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3892291|NCT01515696|3717510|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3892292|NCT01515696|3717511|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3892293|NCT01515696|3717509|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3892294|NCT01515696|3717510|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3892295|NCT01515696|3717511|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3892296|NCT01515696|3717509|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3892297|NCT01515696|3717510|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3892298|NCT01515696|3717511|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3892299|NCT01515696|3717509|B3||<=18 years|Age||Participants|Count of Participants|96|96.0||||||
3892300|NCT01515696|3717510|B2||<=18 years|Age||Participants|Count of Participants|49|49.0||||||
3892301|NCT01515696|3717511|B1||<=18 years|Age||Participants|Count of Participants|47|47.0||||||
3892302|NCT01515657|3717522|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3892303|NCT01515657|3717522|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3892304|NCT01515657|3717522|B1|||Age||years|Mean|52.9|52.9|Standard Deviation|10.12|10.12|||
3892305|NCT01515566|3717532|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3892306|NCT01515566|3717533|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3892307|NCT01515566|3717534|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3892308|NCT01515566|3717532|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3892309|NCT01515566|3717533|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3892310|NCT01515566|3717534|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3892311|NCT01515566|3717532|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3892312|NCT01515566|3717533|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3892313|NCT01515566|3717534|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3892314|NCT01515566|3717532|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3892315|NCT01515566|3717533|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3892316|NCT01515566|3717534|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3892317|NCT01515566|3717532|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3892318|NCT01515566|3717533|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3892319|NCT01515566|3717534|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3892320|NCT01515566|3717532|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3892321|NCT01515566|3717533|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3892322|NCT01515566|3717534|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3892323|NCT01515540|3717545|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
3892324|NCT01515540|3717546|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
3892325|NCT01515540|3717547|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3892326|NCT01515540|3717545|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3892327|NCT01515540|3717546|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3892328|NCT01515540|3717547|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3892329|NCT01515540|3717545|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3892330|NCT01515540|3717546|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3892331|NCT01515540|3717547|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3892332|NCT01515540|3717545|B3|||Age||years|Mean|51.36|51.36|Standard Deviation|9.1|9.1|||
3892333|NCT01515540|3717546|B2|||Age||years|Mean|49.73|49.73|Standard Deviation|10.27|10.27|||
3892334|NCT01515540|3717547|B1|||Age||years|Mean|53|53.0|Standard Deviation|7.7|7.7|||
3892335|NCT01515540|3717545|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3892336|NCT01515540|3717546|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3892337|NCT01515540|3717547|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3892338|NCT01515540|3717545|B3||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3892339|NCT01515540|3717546|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3892340|NCT01515540|3717547|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3892341|NCT01515540|3717545|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3892342|NCT01515540|3717546|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3892343|NCT01515540|3717547|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3892344|NCT01515488|3717554|B3|United States||Region of Enrollment||participants|Number|400|400.0||||||
3892345|NCT01515488|3717555|B2|United States||Region of Enrollment||participants|Number|200|200.0||||||
3892346|NCT01515488|3717556|B1|United States||Region of Enrollment||participants|Number|200|200.0||||||
3892347|NCT01515488|3717554|B3||Male|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
3892348|NCT01515488|3717555|B2||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3892349|NCT01515488|3717556|B1||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3892350|NCT01515488|3717554|B3||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3892351|NCT01515488|3717555|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3892352|NCT01515488|3717556|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3892353|NCT01515488|3717554|B3|||Age||years|Mean|6|6.0|Standard Deviation|5|5.0|||
3892354|NCT01515488|3717555|B2|||Age||years|Mean|6|6.0|Standard Deviation|5|5.0|||
3892355|NCT01515488|3717556|B1|||Age||years|Mean|6|6.0|Standard Deviation|6|6.0|||
3892356|NCT01515488|3717554|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3892357|NCT01515488|3717555|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3892358|NCT01515488|3717556|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3892359|NCT01515488|3717554|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3892360|NCT01515488|3717555|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3892361|NCT01515488|3717556|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3892362|NCT01515488|3717554|B3||<=18 years|Age||Participants|Count of Participants|400|400.0||||||
3892363|NCT01515488|3717555|B2||<=18 years|Age||Participants|Count of Participants|200|200.0||||||
3892364|NCT01515488|3717556|B1||<=18 years|Age||Participants|Count of Participants|200|200.0||||||
3892365|NCT01515423|3717567|B3|Austria||Region of Enrollment||participants|Number|1|1.0||||||
3892366|NCT01515423|3717568|B2|Austria||Region of Enrollment||participants|Number|1|1.0||||||
3892367|NCT01515423|3717569|B1|Austria||Region of Enrollment||participants|Number|0|0.0||||||
3892368|NCT01515423|3717567|B3|France||Region of Enrollment||participants|Number|3|3.0||||||
3892369|NCT01515423|3717568|B2|France||Region of Enrollment||participants|Number|2|2.0||||||
3892370|NCT01515423|3717569|B1|France||Region of Enrollment||participants|Number|1|1.0||||||
3892371|NCT01515423|3717567|B3|Australia||Region of Enrollment||participants|Number|5|5.0||||||
3892372|NCT01515423|3717568|B2|Australia||Region of Enrollment||participants|Number|2|2.0||||||
3892373|NCT01515423|3717569|B1|Australia||Region of Enrollment||participants|Number|3|3.0||||||
3892374|NCT01515423|3717567|B3|Canada||Region of Enrollment||participants|Number|9|9.0||||||
3892375|NCT01515423|3717568|B2|Canada||Region of Enrollment||participants|Number|6|6.0||||||
3892376|NCT01515423|3717569|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
3892377|NCT01515423|3717567|B3|Greece||Region of Enrollment||participants|Number|11|11.0||||||
3892378|NCT01515423|3717568|B2|Greece||Region of Enrollment||participants|Number|6|6.0||||||
3892379|NCT01515423|3717569|B1|Greece||Region of Enrollment||participants|Number|5|5.0||||||
3892380|NCT01515423|3717567|B3|Belgium||Region of Enrollment||participants|Number|11|11.0||||||
3892381|NCT01515423|3717568|B2|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
3892382|NCT01515423|3717569|B1|Belgium||Region of Enrollment||participants|Number|7|7.0||||||
3892383|NCT01515423|3717567|B3|South Korea||Region of Enrollment||participants|Number|12|12.0||||||
3892384|NCT01515423|3717568|B2|South Korea||Region of Enrollment||participants|Number|5|5.0||||||
3892385|NCT01515423|3717569|B1|South Korea||Region of Enrollment||participants|Number|7|7.0||||||
3892386|NCT01515423|3717567|B3|Germany||Region of Enrollment||participants|Number|12|12.0||||||
3892387|NCT01515423|3717568|B2|Germany||Region of Enrollment||participants|Number|4|4.0||||||
3892388|NCT01515423|3717569|B1|Germany||Region of Enrollment||participants|Number|8|8.0||||||
3892389|NCT01515423|3717567|B3|Romania||Region of Enrollment||participants|Number|13|13.0||||||
3892390|NCT01515423|3717568|B2|Romania||Region of Enrollment||participants|Number|6|6.0||||||
3892391|NCT01515423|3717569|B1|Romania||Region of Enrollment||participants|Number|7|7.0||||||
3892392|NCT01515423|3717567|B3|Taiwan||Region of Enrollment||participants|Number|14|14.0||||||
3892393|NCT01515423|3717568|B2|Taiwan||Region of Enrollment||participants|Number|7|7.0||||||
3892394|NCT01515423|3717569|B1|Taiwan||Region of Enrollment||participants|Number|7|7.0||||||
3892395|NCT01515423|3717567|B3|Mexico||Region of Enrollment||participants|Number|16|16.0||||||
3892396|NCT01515423|3717568|B2|Mexico||Region of Enrollment||participants|Number|9|9.0||||||
3892397|NCT01515423|3717569|B1|Mexico||Region of Enrollment||participants|Number|7|7.0||||||
3892398|NCT01515423|3717567|B3|Portugal||Region of Enrollment||participants|Number|21|21.0||||||
3892399|NCT01515423|3717568|B2|Portugal||Region of Enrollment||participants|Number|10|10.0||||||
3892400|NCT01515423|3717569|B1|Portugal||Region of Enrollment||participants|Number|11|11.0||||||
3892401|NCT01515423|3717567|B3|Slovakia||Region of Enrollment||participants|Number|22|22.0||||||
3892402|NCT01515423|3717568|B2|Slovakia||Region of Enrollment||participants|Number|10|10.0||||||
3892403|NCT01515423|3717569|B1|Slovakia||Region of Enrollment||participants|Number|12|12.0||||||
3892404|NCT01515423|3717567|B3|Spain||Region of Enrollment||participants|Number|25|25.0||||||
3892405|NCT01515423|3717568|B2|Spain||Region of Enrollment||participants|Number|14|14.0||||||
3892406|NCT01515423|3717569|B1|Spain||Region of Enrollment||participants|Number|11|11.0||||||
3892407|NCT01515423|3717567|B3|Brazil||Region of Enrollment||participants|Number|25|25.0||||||
3892408|NCT01515423|3717568|B2|Brazil||Region of Enrollment||participants|Number|12|12.0||||||
3892409|NCT01515423|3717569|B1|Brazil||Region of Enrollment||participants|Number|13|13.0||||||
3892410|NCT01515423|3717567|B3|Bulgaria||Region of Enrollment||participants|Number|28|28.0||||||
3892411|NCT01515423|3717568|B2|Bulgaria||Region of Enrollment||participants|Number|16|16.0||||||
3892412|NCT01515423|3717569|B1|Bulgaria||Region of Enrollment||participants|Number|12|12.0||||||
3892413|NCT01515423|3717567|B3|Argentina||Region of Enrollment||participants|Number|30|30.0||||||
3892414|NCT01515423|3717568|B2|Argentina||Region of Enrollment||participants|Number|16|16.0||||||
3892415|NCT01515423|3717569|B1|Argentina||Region of Enrollment||participants|Number|14|14.0||||||
3892416|NCT01515423|3717567|B3|Poland||Region of Enrollment||participants|Number|37|37.0||||||
3892417|NCT01515423|3717568|B2|Poland||Region of Enrollment||participants|Number|20|20.0||||||
3892418|NCT01515423|3717569|B1|Poland||Region of Enrollment||participants|Number|17|17.0||||||
3892419|NCT01515423|3717567|B3|Hungary||Region of Enrollment||participants|Number|40|40.0||||||
3892420|NCT01515423|3717568|B2|Hungary||Region of Enrollment||participants|Number|19|19.0||||||
3892421|NCT01515423|3717569|B1|Hungary||Region of Enrollment||participants|Number|21|21.0||||||
3892422|NCT01515423|3717567|B3|Czech Republic||Region of Enrollment||participants|Number|60|60.0||||||
3892423|NCT01515423|3717568|B2|Czech Republic||Region of Enrollment||participants|Number|29|29.0||||||
3892424|NCT01515423|3717569|B1|Czech Republic||Region of Enrollment||participants|Number|31|31.0||||||
3892425|NCT01515423|3717567|B3|Ukraine||Region of Enrollment||participants|Number|64|64.0||||||
3892426|NCT01515423|3717568|B2|Ukraine||Region of Enrollment||participants|Number|29|29.0||||||
3892427|NCT01515423|3717569|B1|Ukraine||Region of Enrollment||participants|Number|35|35.0||||||
3892428|NCT01515423|3717567|B3|United States||Region of Enrollment||participants|Number|89|89.0||||||
3892429|NCT01515423|3717568|B2|United States||Region of Enrollment||participants|Number|48|48.0||||||
3892430|NCT01515423|3717569|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
3892431|NCT01515423|3717567|B3|Japan||Region of Enrollment||participants|Number|108|108.0||||||
3892432|NCT01515423|3717568|B2|Japan||Region of Enrollment||participants|Number|56|56.0||||||
3892433|NCT01515423|3717569|B1|Japan||Region of Enrollment||participants|Number|52|52.0||||||
3892434|NCT01515423|3717567|B3|Russian Federation||Region of Enrollment||participants|Number|150|150.0||||||
3892435|NCT01515423|3717568|B2|Russian Federation||Region of Enrollment||participants|Number|75|75.0||||||
3892436|NCT01515423|3717569|B1|Russian Federation||Region of Enrollment||participants|Number|75|75.0||||||
3892437|NCT01515423|3717567|B3|China||Region of Enrollment||participants|Number|210|210.0||||||
3892438|NCT01515423|3717568|B2|China||Region of Enrollment||participants|Number|106|106.0||||||
3892439|NCT01515423|3717569|B1|China||Region of Enrollment||participants|Number|104|104.0||||||
3892440|NCT01515423|3717567|B3||Male|Sex: Female, Male||Participants|Count of Participants|539|539.0||||||
3892441|NCT01515423|3717568|B2||Male|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
3892442|NCT01515423|3717569|B1||Male|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
3892443|NCT01515423|3717567|B3||Female|Sex: Female, Male||Participants|Count of Participants|477|477.0||||||
3892444|NCT01515423|3717568|B2||Female|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
3892445|NCT01515423|3717569|B1||Female|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
3892446|NCT01515423|3717567|B3|||Age||years|Mean|38.6|38.6|Standard Deviation|12.06|12.06|||
3892447|NCT01515423|3717568|B2|||Age||years|Mean|38.3|38.3|Standard Deviation|12.24|12.24|||
3892448|NCT01515423|3717569|B1|||Age||years|Mean|39.0|39.0|Standard Deviation|11.89|11.89|||
3892449|NCT01515410|3717590|B1|||"Percent OFF Time (%)"|Baseline is the average of the 3 days recorded in the patient diary prior to Day 1 of Period 1.|percentage of time|Mean|32.50|32.5|Standard Deviation|9.962|9.962|||
3892450|NCT01515410|3717590|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3892451|NCT01515410|3717590|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3892452|NCT01515410|3717590|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3892453|NCT01515410|3717590|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3892454|NCT01515410|3717590|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3892455|NCT01515410|3717590|B1|Afro-Caribbean||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3892456|NCT01515410|3717590|B1|White||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3892457|NCT01515410|3717590|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3892458|NCT01515410|3717590|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3892459|NCT01515410|3717590|B1|||Age||years|Mean|61.4|61.4|Standard Deviation|8.41|8.41|||
3892460|NCT01515345|3717597|B3|Austria||Region of Enrollment||participants|Number|1008|1008.0||||||
3892461|NCT01515345|3717598|B2|Austria||Region of Enrollment||participants|Number|343|343.0||||||
3892462|NCT01515345|3717599|B1|Austria||Region of Enrollment||participants|Number|665|665.0||||||
3892463|NCT01515345|3717597|B3||Male|Sex: Female, Male||Participants|Count of Participants|705|705.0||||||
3892464|NCT01515345|3717598|B2||Male|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
3892465|NCT01515345|3717599|B1||Male|Sex: Female, Male||Participants|Count of Participants|482|482.0||||||
3892466|NCT01515345|3717597|B3||Female|Sex: Female, Male||Participants|Count of Participants|303|303.0||||||
3892467|NCT01515345|3717598|B2||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3892468|NCT01515345|3717599|B1||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3892469|NCT01515345|3717597|B3|||Age||years|Mean|65|65.0|Standard Deviation|12|12.0|||
3892470|NCT01515345|3717598|B2|||Age||years|Mean|64|64.0|Standard Deviation|12|12.0|||
3892471|NCT01515345|3717599|B1|||Age||years|Mean|65|65.0|Standard Deviation|12|12.0|||
3892472|NCT01515345|3717597|B3||>=65 years|Age||Participants|Count of Participants|506|506.0||||||
3892473|NCT01515345|3717598|B2||>=65 years|Age||Participants|Count of Participants|174|174.0||||||
3892474|NCT01515345|3717599|B1||>=65 years|Age||Participants|Count of Participants|332|332.0||||||
3892475|NCT01515345|3717597|B3||Between 18 and 65 years|Age||Participants|Count of Participants|502|502.0||||||
3892476|NCT01515345|3717598|B2||Between 18 and 65 years|Age||Participants|Count of Participants|169|169.0||||||
3892477|NCT01515345|3717599|B1||Between 18 and 65 years|Age||Participants|Count of Participants|333|333.0||||||
3892478|NCT01515345|3717597|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3892479|NCT01515345|3717598|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3892480|NCT01515345|3717599|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3892481|NCT01515306|3717610|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3892482|NCT01515306|3717611|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3892483|NCT01515306|3717612|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3892484|NCT01515306|3717610|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892485|NCT01515306|3717611|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892486|NCT01515306|3717612|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892487|NCT01515306|3717610|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3892488|NCT01515306|3717611|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892489|NCT01515306|3717612|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3892490|NCT01515306|3717610|B3||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3892491|NCT01515306|3717611|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3892492|NCT01515306|3717612|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3892493|NCT01515306|3717610|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892494|NCT01515306|3717611|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892495|NCT01515306|3717612|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892496|NCT01515306|3717610|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892497|NCT01515306|3717611|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892498|NCT01515306|3717612|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892499|NCT01515306|3717610|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3892500|NCT01515306|3717611|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3892501|NCT01515306|3717612|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3892502|NCT01515306|3717610|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892503|NCT01515306|3717611|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892504|NCT01515306|3717612|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892505|NCT01515306|3717610|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892506|NCT01515306|3717611|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892507|NCT01515306|3717612|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892508|NCT01515306|3717610|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3892509|NCT01515306|3717611|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3892510|NCT01515306|3717612|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3892511|NCT01515306|3717610|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3892512|NCT01515306|3717611|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892513|NCT01515306|3717612|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3892514|NCT01515306|3717610|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3892515|NCT01515306|3717611|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3892516|NCT01515306|3717612|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3892517|NCT01515306|3717610|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3892518|NCT01515306|3717611|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3892519|NCT01515306|3717612|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3892520|NCT01515306|3717610|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3892521|NCT01515306|3717611|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3892522|NCT01515306|3717612|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3892523|NCT01515306|3717610|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3892524|NCT01515306|3717611|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3892525|NCT01515306|3717612|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3892526|NCT01515306|3717610|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3892527|NCT01515306|3717611|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3892528|NCT01515306|3717612|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3892529|NCT01515189|3717624|B3||Male|Sex: Female, Male||Participants|Count of Participants|450|450.0||||||
3892530|NCT01515189|3717625|B2||Male|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
3892531|NCT01515189|3717626|B1||Male|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
3892532|NCT01515189|3717624|B3||Female|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
3892533|NCT01515189|3717625|B2||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3892534|NCT01515189|3717626|B1||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3892535|NCT01515189|3717624|B3|||Age||years|Mean|59.7|59.7|Standard Deviation|13.92|13.92|||
3892536|NCT01515189|3717625|B2|||Age||years|Mean|60.7|60.7|Standard Deviation|13.22|13.22|||
3892537|NCT01515189|3717626|B1|||Age||years|Mean|58.6|58.6|Standard Deviation|14.52|14.52|||
3892538|NCT01515189|3717624|B3||>=65 years|Age||Participants|Count of Participants|295|295.0||||||
3892539|NCT01515189|3717625|B2||>=65 years|Age||Participants|Count of Participants|154|154.0||||||
3892540|NCT01515189|3717626|B1||>=65 years|Age||Participants|Count of Participants|141|141.0||||||
3892541|NCT01515189|3717624|B3||Between 18 and 65 years|Age||Participants|Count of Participants|432|432.0||||||
3892542|NCT01515189|3717625|B2||Between 18 and 65 years|Age||Participants|Count of Participants|208|208.0||||||
3892543|NCT01515189|3717626|B1||Between 18 and 65 years|Age||Participants|Count of Participants|224|224.0||||||
3892544|NCT01515189|3717624|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3892545|NCT01515189|3717625|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3892546|NCT01515189|3717626|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3892547|NCT01515176|3717647|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
3892548|NCT01515176|3717648|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
3892549|NCT01515176|3717649|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3892550|NCT01515176|3717647|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892551|NCT01515176|3717648|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892552|NCT01515176|3717649|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892553|NCT01515176|3717647|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892554|NCT01515176|3717648|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892555|NCT01515176|3717649|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892556|NCT01515176|3717647|B3||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3892557|NCT01515176|3717648|B2||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3892558|NCT01515176|3717649|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3892559|NCT01515176|3717647|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3892560|NCT01515176|3717648|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3892561|NCT01515176|3717649|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892562|NCT01515176|3717647|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892563|NCT01515176|3717648|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892564|NCT01515176|3717649|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892565|NCT01515176|3717647|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892566|NCT01515176|3717648|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892567|NCT01515176|3717649|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892568|NCT01515176|3717647|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892569|NCT01515176|3717648|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892570|NCT01515176|3717649|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892571|NCT01515176|3717647|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892572|NCT01515176|3717648|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892573|NCT01515176|3717649|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892574|NCT01515176|3717647|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3892575|NCT01515176|3717648|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3892576|NCT01515176|3717649|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3892577|NCT01515176|3717647|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892578|NCT01515176|3717648|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892579|NCT01515176|3717649|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892580|NCT01515176|3717647|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3892581|NCT01515176|3717648|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3892582|NCT01515176|3717649|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3892583|NCT01515176|3717647|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3892584|NCT01515176|3717648|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3892585|NCT01515176|3717649|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3892586|NCT01515176|3717647|B3||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3892587|NCT01515176|3717648|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3892588|NCT01515176|3717649|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3892589|NCT01515176|3717647|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3892590|NCT01515176|3717648|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3892591|NCT01515176|3717649|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3892592|NCT01515176|3717647|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3892593|NCT01515176|3717648|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3892594|NCT01515176|3717649|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3892595|NCT01515072|3717662|B3|||Serum Chemistry: Troponin I|"Serum Chemistry: Troponin I, ng/ml~Missing data:~No RIPC= 37 RIPC= 29"|ng/ml|Median|0.29|0.29|Inter-Quartile Range|||0.05|1.18|
3892596|NCT01515072|3717663|B2|||Serum Chemistry: Troponin I|"Serum Chemistry: Troponin I, ng/ml~Missing data:~No RIPC= 37 RIPC= 29"|ng/ml|Median|0.31|0.31|Inter-Quartile Range|||0.07|1.25|
3892597|NCT01515072|3717664|B1|||Serum Chemistry: Troponin I|"Serum Chemistry: Troponin I, ng/ml~Missing data:~No RIPC= 37 RIPC= 29"|ng/ml|Median|0.28|0.28|Inter-Quartile Range|||0.04|1.07|
3892598|NCT01515072|3717662|B3|||Serum Chemistry: Lactate|"Serum Chemistry: Lactate, mg/dL~Missing data:~No RIPC= 31 RIPC= 21"|mg/dL|Median|1.6|1.6|Inter-Quartile Range|||1.1|2.4|
3892599|NCT01515072|3717663|B2|||Serum Chemistry: Lactate|"Serum Chemistry: Lactate, mg/dL~Missing data:~No RIPC= 31 RIPC= 21"|mg/dL|Median|1.6|1.6|Inter-Quartile Range|||1.1|2.4|
3892600|NCT01515072|3717664|B1|||Serum Chemistry: Lactate|"Serum Chemistry: Lactate, mg/dL~Missing data:~No RIPC= 31 RIPC= 21"|mg/dL|Median|1.5|1.5|Inter-Quartile Range|||1.1|2.4|
3892601|NCT01515072|3717662|B3|||Serum Chemistry: Creatinine|"Serum Chemistry: Creatinine, mg/dL~Missing data:~No RIPC=3 RIPC=2"|mg/dL|Median|1.06|1.06|Inter-Quartile Range|||0.8|1.4|
3892602|NCT01515072|3717663|B2|||Serum Chemistry: Creatinine|"Serum Chemistry: Creatinine, mg/dL~Missing data:~No RIPC=3 RIPC=2"|mg/dL|Median|1.1|1.1|Inter-Quartile Range|||0.8|1.4|
3892603|NCT01515072|3717664|B1|||Serum Chemistry: Creatinine|"Serum Chemistry: Creatinine, mg/dL~Missing data:~No RIPC=3 RIPC=2"|mg/dL|Median|1.0|1.0|Inter-Quartile Range|||0.7|1.6|
3892604|NCT01515072|3717662|B3|||Ventricular Ejection Fraction|"Ventricular Ejection Fraction~Missing data:~No RIPC: 39 RIPC: 31"|proportion ejection fraction|Median|0.6|0.6|Inter-Quartile Range|||0.52|0.65|
3892605|NCT01515072|3717663|B2|||Ventricular Ejection Fraction|"Ventricular Ejection Fraction~Missing data:~No RIPC: 39 RIPC: 31"|proportion ejection fraction|Median|0.59|0.59|Inter-Quartile Range|||0.49|0.65|
3892606|NCT01515072|3717664|B1|||Ventricular Ejection Fraction|"Ventricular Ejection Fraction~Missing data:~No RIPC: 39 RIPC: 31"|proportion ejection fraction|Median|0.6|0.6|Inter-Quartile Range|||0.55|0.65|
3892607|NCT01515072|3717662|B3|||P:F ratio|"P:F ratio: Ratio of partial pressure of arterial oxygen: fraction of inspired oxygen.~Missing data:~No RIPC=2 RIPC=4"|ratio|Median|248|248.0|Inter-Quartile Range|||154.3|389.3|
3892608|NCT01515072|3717663|B2|||P:F ratio|"P:F ratio: Ratio of partial pressure of arterial oxygen: fraction of inspired oxygen.~Missing data:~No RIPC=2 RIPC=4"|ratio|Median|244.0|244.0|Inter-Quartile Range|||152.0|387.5|
3892609|NCT01515072|3717664|B1|||P:F ratio|"P:F ratio: Ratio of partial pressure of arterial oxygen: fraction of inspired oxygen.~Missing data:~No RIPC=2 RIPC=4"|ratio|Median|249.8|249.8|Inter-Quartile Range|||154.8|393.0|
3892610|NCT01515072|3717662|B3|||Vasopressor Score|"A numerical score calculated for number and dose of Vasopressors in use. The score is calculated using the following formula (from Zuppa AF et. al.CRIT CARE MED 2004 Vol. 32 p 2318-2322):~Vasopressor Score= (dopamine dose[y=ug/kg/min x 1]) + (dobutamine dose [ug/kg/min] x 1) + (epinephrine dose [ug/kg/min] x100) + (norepinephrine dose [ug/kg/min] x 100) + (phenylephrine dose [ug/kg/min] x 100).~The range for our study was 0-4900 with higher doses indicating higher vasopressor use in the donor.~Data missing per group:~No RIPC=2 RIPC=2"|units on a scale|Median|37|37.0|Inter-Quartile Range|||0.0|800.0|
3892611|NCT01515072|3717663|B2|||Vasopressor Score|"A numerical score calculated for number and dose of Vasopressors in use. The score is calculated using the following formula (from Zuppa AF et. al.CRIT CARE MED 2004 Vol. 32 p 2318-2322):~Vasopressor Score= (dopamine dose[y=ug/kg/min x 1]) + (dobutamine dose [ug/kg/min] x 1) + (epinephrine dose [ug/kg/min] x100) + (norepinephrine dose [ug/kg/min] x 100) + (phenylephrine dose [ug/kg/min] x 100).~The range for our study was 0-4900 with higher doses indicating higher vasopressor use in the donor.~Data missing per group:~No RIPC=2 RIPC=2"|units on a scale|Median|16.0|16.0|Inter-Quartile Range|||0.0|600.0|
3892653|NCT01515072|3717663|B2|Yes||Central Line Use|Donors who had Central line in place: Yes or No|participants|Number|116|116.0||||||
3892654|NCT01515072|3717664|B1|Yes||Central Line Use|Donors who had Central line in place: Yes or No|participants|Number|121|121.0||||||
3892655|NCT01515072|3717662|B3|Hypertension: No||Co-Morbidities|Hypertension: Yes or No|participants|Number|215|215.0||||||
3892612|NCT01515072|3717664|B1|||Vasopressor Score|"A numerical score calculated for number and dose of Vasopressors in use. The score is calculated using the following formula (from Zuppa AF et. al.CRIT CARE MED 2004 Vol. 32 p 2318-2322):~Vasopressor Score= (dopamine dose[y=ug/kg/min x 1]) + (dobutamine dose [ug/kg/min] x 1) + (epinephrine dose [ug/kg/min] x100) + (norepinephrine dose [ug/kg/min] x 100) + (phenylephrine dose [ug/kg/min] x 100).~The range for our study was 0-4900 with higher doses indicating higher vasopressor use in the donor.~Data missing per group:~No RIPC=2 RIPC=2"|units on a scale|Median|100|100.0|Inter-Quartile Range|||0.0|925.0|
3892613|NCT01515072|3717662|B3|Intervention to Cross Clamp: Data not available||Initial Intervention to Cross Clamp|"3 Groups:~5.9-24.0 hours~24.1-39.5 hours~Data Not Available"|participants|Number|23|23.0||||||
3892614|NCT01515072|3717663|B2|Intervention to Cross Clamp: Data not available||Initial Intervention to Cross Clamp|"3 Groups:~5.9-24.0 hours~24.1-39.5 hours~Data Not Available"|participants|Number|15|15.0||||||
3892615|NCT01515072|3717664|B1|Intervention to Cross Clamp: Data not available||Initial Intervention to Cross Clamp|"3 Groups:~5.9-24.0 hours~24.1-39.5 hours~Data Not Available"|participants|Number|8|8.0||||||
3892616|NCT01515072|3717662|B3|Intervention to Cross Clamp: 24.1-39.5 hours||Initial Intervention to Cross Clamp|"3 Groups:~5.9-24.0 hours~24.1-39.5 hours~Data Not Available"|participants|Number|60|60.0||||||
3892617|NCT01515072|3717663|B2|Intervention to Cross Clamp: 24.1-39.5 hours||Initial Intervention to Cross Clamp|"3 Groups:~5.9-24.0 hours~24.1-39.5 hours~Data Not Available"|participants|Number|25|25.0||||||
3892618|NCT01515072|3717664|B1|Intervention to Cross Clamp: 24.1-39.5 hours||Initial Intervention to Cross Clamp|"3 Groups:~5.9-24.0 hours~24.1-39.5 hours~Data Not Available"|participants|Number|35|35.0||||||
3892619|NCT01515072|3717662|B3|Intervention to Cross Clamp: 5.9-24.0 hours||Initial Intervention to Cross Clamp|"3 Groups:~5.9-24.0 hours~24.1-39.5 hours~Data Not Available"|participants|Number|238|238.0||||||
3892620|NCT01515072|3717663|B2|Intervention to Cross Clamp: 5.9-24.0 hours||Initial Intervention to Cross Clamp|"3 Groups:~5.9-24.0 hours~24.1-39.5 hours~Data Not Available"|participants|Number|115|115.0||||||
3892621|NCT01515072|3717664|B1|Intervention to Cross Clamp: 5.9-24.0 hours||Initial Intervention to Cross Clamp|"3 Groups:~5.9-24.0 hours~24.1-39.5 hours~Data Not Available"|participants|Number|123|123.0||||||
3892622|NCT01515072|3717662|B3|||Declaration of Death to Initial Intervention, Hours|Interval from declaration of brain death to the initial intervention.|hours|Median|6.5|6.5|Inter-Quartile Range|||4.7|10.4|
3892623|NCT01515072|3717663|B2|||Declaration of Death to Initial Intervention, Hours|Interval from declaration of brain death to the initial intervention.|hours|Median|7.3|7.3|Inter-Quartile Range|||5.0|12.1|
3892624|NCT01515072|3717664|B1|||Declaration of Death to Initial Intervention, Hours|Interval from declaration of brain death to the initial intervention.|hours|Median|5.8|5.8|Inter-Quartile Range|||4.2|8.8|
3892625|NCT01515072|3717662|B3|Insulin Infusion: No||Insulin Infusion|Insulin Infusion: Yes or No|participants|Number|232|232.0||||||
3892626|NCT01515072|3717663|B2|Insulin Infusion: No||Insulin Infusion|Insulin Infusion: Yes or No|participants|Number|113|113.0||||||
3892627|NCT01515072|3717664|B1|Insulin Infusion: No||Insulin Infusion|Insulin Infusion: Yes or No|participants|Number|119|119.0||||||
3892628|NCT01515072|3717662|B3|Insulin Infusion: Yes||Insulin Infusion|Insulin Infusion: Yes or No|participants|Number|89|89.0||||||
3892629|NCT01515072|3717663|B2|Insulin Infusion: Yes||Insulin Infusion|Insulin Infusion: Yes or No|participants|Number|42|42.0||||||
3892630|NCT01515072|3717664|B1|Insulin Infusion: Yes||Insulin Infusion|Insulin Infusion: Yes or No|participants|Number|47|47.0||||||
3892631|NCT01515072|3717662|B3|Steroids Administered: No||Steroids Administered|Steroids Administered: Yes or No|participants|Number|74|74.0||||||
3892632|NCT01515072|3717663|B2|Steroids Administered: No||Steroids Administered|Steroids Administered: Yes or No|participants|Number|33|33.0||||||
3892633|NCT01515072|3717664|B1|Steroids Administered: No||Steroids Administered|Steroids Administered: Yes or No|participants|Number|41|41.0||||||
3892634|NCT01515072|3717662|B3|Steroids Administered: Yes||Steroids Administered|Steroids Administered: Yes or No|participants|Number|247|247.0||||||
3892635|NCT01515072|3717663|B2|Steroids Administered: Yes||Steroids Administered|Steroids Administered: Yes or No|participants|Number|122|122.0||||||
3892636|NCT01515072|3717664|B1|Steroids Administered: Yes||Steroids Administered|Steroids Administered: Yes or No|participants|Number|125|125.0||||||
3892637|NCT01515072|3717662|B3|Past or Current Smoker:No||Co-Morbidities|Past or Current Smoker: Yes or No|participants|Number|133|133.0||||||
3892638|NCT01515072|3717663|B2|Past or Current Smoker:No||Co-Morbidities|Past or Current Smoker: Yes or No|participants|Number|56|56.0||||||
3892639|NCT01515072|3717664|B1|Past or Current Smoker:No||Co-Morbidities|Past or Current Smoker: Yes or No|participants|Number|77|77.0||||||
3892640|NCT01515072|3717662|B3|Past or Current Smoker:Yes||Co-Morbidities|Past or Current Smoker: Yes or No|participants|Number|188|188.0||||||
3892641|NCT01515072|3717663|B2|Past or Current Smoker:Yes||Co-Morbidities|Past or Current Smoker: Yes or No|participants|Number|99|99.0||||||
3892642|NCT01515072|3717664|B1|Past or Current Smoker:Yes||Co-Morbidities|Past or Current Smoker: Yes or No|participants|Number|89|89.0||||||
3892643|NCT01515072|3717662|B3|Diabetes: No||Co-Morbidities|Diabetes: Yes or No|participants|Number|281|281.0||||||
3892644|NCT01515072|3717663|B2|Diabetes: No||Co-Morbidities|Diabetes: Yes or No|participants|Number|134|134.0||||||
3892645|NCT01515072|3717664|B1|Diabetes: No||Co-Morbidities|Diabetes: Yes or No|participants|Number|147|147.0||||||
3892646|NCT01515072|3717662|B3|Diabetes: Yes||Co-Morbidities|Diabetes: Yes or No|participants|Number|40|40.0||||||
3892647|NCT01515072|3717663|B2|Diabetes: Yes||Co-Morbidities|Diabetes: Yes or No|participants|Number|21|21.0||||||
3892648|NCT01515072|3717664|B1|Diabetes: Yes||Co-Morbidities|Diabetes: Yes or No|participants|Number|19|19.0||||||
3892649|NCT01515072|3717662|B3|No||Central Line Use|Donors who had Central line in place: Yes or No|participants|Number|84|84.0||||||
3892650|NCT01515072|3717663|B2|No||Central Line Use|Donors who had Central line in place: Yes or No|participants|Number|39|39.0||||||
3892651|NCT01515072|3717664|B1|No||Central Line Use|Donors who had Central line in place: Yes or No|participants|Number|45|45.0||||||
3892652|NCT01515072|3717662|B3|Yes||Central Line Use|Donors who had Central line in place: Yes or No|participants|Number|237|237.0||||||
3892656|NCT01515072|3717663|B2|Hypertension: No||Co-Morbidities|Hypertension: Yes or No|participants|Number|107|107.0||||||
3892657|NCT01515072|3717664|B1|Hypertension: No||Co-Morbidities|Hypertension: Yes or No|participants|Number|108|108.0||||||
3892658|NCT01515072|3717662|B3|Hypertension: Yes||Co-Morbidities|Hypertension: Yes or No|participants|Number|106|106.0||||||
3892659|NCT01515072|3717663|B2|Hypertension: Yes||Co-Morbidities|Hypertension: Yes or No|participants|Number|48|48.0||||||
3892660|NCT01515072|3717664|B1|Hypertension: Yes||Co-Morbidities|Hypertension: Yes or No|participants|Number|58|58.0||||||
3892661|NCT01515072|3717662|B3|No||Hepatitis C Antibody|"Serological test for Hepatitis C antibody:~Yes or No"|participants|Number|298|298.0||||||
3892662|NCT01515072|3717663|B2|No||Hepatitis C Antibody|"Serological test for Hepatitis C antibody:~Yes or No"|participants|Number|139|139.0||||||
3892663|NCT01515072|3717664|B1|No||Hepatitis C Antibody|"Serological test for Hepatitis C antibody:~Yes or No"|participants|Number|159|159.0||||||
3892664|NCT01515072|3717662|B3|Yes||Hepatitis C Antibody|"Serological test for Hepatitis C antibody:~Yes or No"|participants|Number|23|23.0||||||
3892665|NCT01515072|3717663|B2|Yes||Hepatitis C Antibody|"Serological test for Hepatitis C antibody:~Yes or No"|participants|Number|16|16.0||||||
3892666|NCT01515072|3717664|B1|Yes||Hepatitis C Antibody|"Serological test for Hepatitis C antibody:~Yes or No"|participants|Number|7|7.0||||||
3892667|NCT01515072|3717662|B3|BMI =/> 30.0||Body Mass Index (BMI)|"2 Categories < 30.0~=/> 30.0"|participants|Number|91|91.0||||||
3892668|NCT01515072|3717663|B2|BMI =/> 30.0||Body Mass Index (BMI)|"2 Categories < 30.0~=/> 30.0"|participants|Number|51|51.0||||||
3892669|NCT01515072|3717664|B1|BMI =/> 30.0||Body Mass Index (BMI)|"2 Categories < 30.0~=/> 30.0"|participants|Number|40|40.0||||||
3892670|NCT01515072|3717662|B3|BMI < 30.0||Body Mass Index (BMI)|"2 Categories < 30.0~=/> 30.0"|participants|Number|230|230.0||||||
3892671|NCT01515072|3717663|B2|BMI < 30.0||Body Mass Index (BMI)|"2 Categories < 30.0~=/> 30.0"|participants|Number|104|104.0||||||
3892672|NCT01515072|3717664|B1|BMI < 30.0||Body Mass Index (BMI)|"2 Categories < 30.0~=/> 30.0"|participants|Number|126|126.0||||||
3892673|NCT01515072|3717662|B3|United States||Region of Enrollment||participants|Number|321|321.0||||||
3892674|NCT01515072|3717663|B2|United States||Region of Enrollment||participants|Number|155|155.0||||||
3892675|NCT01515072|3717664|B1|United States||Region of Enrollment||participants|Number|166|166.0||||||
3892676|NCT01515072|3717662|B3|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3892677|NCT01515072|3717663|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3892678|NCT01515072|3717664|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3892679|NCT01515072|3717662|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
3892680|NCT01515072|3717663|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
3892681|NCT01515072|3717664|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3892682|NCT01515072|3717662|B3|African-American||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
3892683|NCT01515072|3717663|B2|African-American||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
3892684|NCT01515072|3717664|B1|African-American||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3892685|NCT01515072|3717662|B3|White||Race/Ethnicity, Customized||participants|Number|171|171.0||||||
3892686|NCT01515072|3717663|B2|White||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
3892687|NCT01515072|3717664|B1|White||Race/Ethnicity, Customized||participants|Number|97|97.0||||||
3892688|NCT01515072|3717662|B3||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
3892689|NCT01515072|3717663|B2||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3892690|NCT01515072|3717664|B1||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3892691|NCT01515072|3717662|B3||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3892692|NCT01515072|3717663|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3892693|NCT01515072|3717664|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3892694|NCT01515072|3717662|B3|46-75||Age, Customized||participants|Number|137|137.0||||||
3892695|NCT01515072|3717663|B2|46-75||Age, Customized||participants|Number|60|60.0||||||
3892696|NCT01515072|3717664|B1|46-75||Age, Customized||participants|Number|77|77.0||||||
3892697|NCT01515072|3717662|B3|36-45||Age, Customized||participants|Number|60|60.0||||||
3892698|NCT01515072|3717663|B2|36-45||Age, Customized||participants|Number|34|34.0||||||
3892699|NCT01515072|3717664|B1|36-45||Age, Customized||participants|Number|26|26.0||||||
3892700|NCT01515072|3717662|B3|26-35||Age, Customized||participants|Number|66|66.0||||||
3892701|NCT01515072|3717663|B2|26-35||Age, Customized||participants|Number|27|27.0||||||
3892702|NCT01515072|3717664|B1|26-35||Age, Customized||participants|Number|39|39.0||||||
3892703|NCT01515072|3717662|B3|11-25||Age, Customized||participants|Number|58|58.0||||||
3892704|NCT01515072|3717663|B2|11-25||Age, Customized||participants|Number|34|34.0||||||
3892705|NCT01515072|3717664|B1|11-25||Age, Customized||participants|Number|24|24.0||||||
3892706|NCT01515072|3717662|B3|||Age||years|Median|43|43.0|Inter-Quartile Range|||29.0|52.0|
3892707|NCT01515072|3717663|B2|||Age||years|Median|42|42.0|Inter-Quartile Range|||29.0|51.0|
3892708|NCT01515072|3717664|B1|||Age||years|Median|44|44.0|Inter-Quartile Range|||29.0|54.0|
3892709|NCT01515046|3717705|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3892710|NCT01515046|3717705|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892711|NCT01515046|3717705|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892712|NCT01515046|3717705|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3892713|NCT01515046|3717705|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892714|NCT01515046|3717705|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892715|NCT01515046|3717705|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892716|NCT01515046|3717705|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892717|NCT01515046|3717705|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892718|NCT01515046|3717705|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3892719|NCT01515046|3717705|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892720|NCT01515046|3717705|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3892721|NCT01515046|3717705|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3892722|NCT01515046|3717705|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3892723|NCT01515046|3717705|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3892724|NCT01515046|3717705|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3892725|NCT01514864|3717713|B3|4||Number of Index Lesions||Participants|Number|4|4.0||||||
3892726|NCT01514864|3717714|B2|4||Number of Index Lesions||Participants|Number|1|1.0||||||
3892727|NCT01514864|3717715|B1|4||Number of Index Lesions||Participants|Number|3|3.0||||||
3892728|NCT01514864|3717713|B3|3||Number of Index Lesions||Participants|Number|5|5.0||||||
3892729|NCT01514864|3717714|B2|3||Number of Index Lesions||Participants|Number|1|1.0||||||
3892730|NCT01514864|3717715|B1|3||Number of Index Lesions||Participants|Number|4|4.0||||||
3892731|NCT01514864|3717713|B3|2||Number of Index Lesions||Participants|Number|2|2.0||||||
3892732|NCT01514864|3717714|B2|2||Number of Index Lesions||Participants|Number|2|2.0||||||
3892733|NCT01514864|3717715|B1|2||Number of Index Lesions||Participants|Number|0|0.0||||||
3892734|NCT01514864|3717713|B3|1||Number of Index Lesions||Participants|Number|3|3.0||||||
3892735|NCT01514864|3717714|B2|1||Number of Index Lesions||Participants|Number|1|1.0||||||
3892736|NCT01514864|3717715|B1|1||Number of Index Lesions||Participants|Number|2|2.0||||||
3892737|NCT01514864|3717713|B3|ECOG score 2||Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|3|3.0||||||
3892738|NCT01514864|3717714|B2|ECOG score 2||Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|1|1.0||||||
3892739|NCT01514864|3717715|B1|ECOG score 2||Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|2|2.0||||||
3892740|NCT01514864|3717713|B3|ECOG score 1||Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|9|9.0||||||
3892741|NCT01514864|3717714|B2|ECOG score 1||Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|3|3.0||||||
3892742|NCT01514864|3717715|B1|ECOG score 1||Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|6|6.0||||||
3892743|NCT01514864|3717713|B3|ECOG score 0||Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|2|2.0||||||
3892744|NCT01514864|3717714|B2|ECOG score 0||Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|1|1.0||||||
3892745|NCT01514864|3717715|B1|ECOG score 0||Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|1|1.0||||||
3892746|NCT01514864|3717713|B3|GX-grade cannot be assessed||Histopathologic Grade||Participants|Number|8|8.0||||||
3892747|NCT01514864|3717714|B2|GX-grade cannot be assessed||Histopathologic Grade||Participants|Number|3|3.0||||||
3892748|NCT01514864|3717715|B1|GX-grade cannot be assessed||Histopathologic Grade||Participants|Number|5|5.0||||||
3892749|NCT01514864|3717713|B3|G3-poorly differentiated||Histopathologic Grade||Participants|Number|2|2.0||||||
3892750|NCT01514864|3717714|B2|G3-poorly differentiated||Histopathologic Grade||Participants|Number|0|0.0||||||
3892751|NCT01514864|3717715|B1|G3-poorly differentiated||Histopathologic Grade||Participants|Number|2|2.0||||||
3892752|NCT01514864|3717713|B3|G2-moderately differentiated||Histopathologic Grade||Participants|Number|4|4.0||||||
3892753|NCT01514864|3717714|B2|G2-moderately differentiated||Histopathologic Grade||Participants|Number|2|2.0||||||
3892754|NCT01514864|3717715|B1|G2-moderately differentiated||Histopathologic Grade||Participants|Number|2|2.0||||||
3892755|NCT01514864|3717713|B3|Squamous cell carcinoma||Nonsmall-cell lung carcinoma histology||Participants|Number|4|4.0||||||
3892756|NCT01514864|3717714|B2|Squamous cell carcinoma||Nonsmall-cell lung carcinoma histology||Participants|Number|4|4.0||||||
3892757|NCT01514864|3717715|B1|Squamous cell carcinoma||Nonsmall-cell lung carcinoma histology||Participants|Number|0|0.0||||||
3892758|NCT01514864|3717713|B3|Large cell carcinoma||Nonsmall-cell lung carcinoma histology||Participants|Number|1|1.0||||||
3892759|NCT01514864|3717714|B2|Large cell carcinoma||Nonsmall-cell lung carcinoma histology||Participants|Number|0|0.0||||||
3892760|NCT01514864|3717715|B1|Large cell carcinoma||Nonsmall-cell lung carcinoma histology||Participants|Number|1|1.0||||||
3892761|NCT01514864|3717713|B3|Bronco-alveolar carcinoma||Nonsmall-cell lung carcinoma histology||Participants|Number|1|1.0||||||
3892762|NCT01514864|3717714|B2|Bronco-alveolar carcinoma||Nonsmall-cell lung carcinoma histology||Participants|Number|0|0.0||||||
3892763|NCT01514864|3717715|B1|Bronco-alveolar carcinoma||Nonsmall-cell lung carcinoma histology||Participants|Number|1|1.0||||||
3892764|NCT01514864|3717713|B3|Adenocarcinoma||Nonsmall-cell lung carcinoma histology||Participants|Number|8|8.0||||||
3892765|NCT01514864|3717714|B2|Adenocarcinoma||Nonsmall-cell lung carcinoma histology||Participants|Number|1|1.0||||||
3892766|NCT01514864|3717715|B1|Adenocarcinoma||Nonsmall-cell lung carcinoma histology||Participants|Number|7|7.0||||||
3892767|NCT01514864|3717713|B3|Other||Tumor Type||Participants|Number|0|0.0||||||
3892768|NCT01514864|3717714|B2|Other||Tumor Type||Participants|Number|0|0.0||||||
3892769|NCT01514864|3717715|B1|Other||Tumor Type||Participants|Number|0|0.0||||||
3892770|NCT01514864|3717713|B3|Nonsmall-cell lung carcinoma||Tumor Type||Participants|Number|14|14.0||||||
3892771|NCT01514864|3717714|B2|Nonsmall-cell lung carcinoma||Tumor Type||Participants|Number|5|5.0||||||
3892772|NCT01514864|3717715|B1|Nonsmall-cell lung carcinoma||Tumor Type||Participants|Number|9|9.0||||||
3892773|NCT01514864|3717713|B3|||Time from cancer diagnosis to start of study therapy||Months|Median|12.1|12.1|Full Range|||1.5|51.6|
3892774|NCT01514864|3717714|B2|||Time from cancer diagnosis to start of study therapy||Months|Median|8.5|8.5|Full Range|||1.5|51.6|
3892775|NCT01514864|3717715|B1|||Time from cancer diagnosis to start of study therapy||Months|Median|14.4|14.4|Full Range|||6.2|21.7|
3892776|NCT01514864|3717713|B3|Not reported||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3892777|NCT01514864|3717714|B2|Not reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3892778|NCT01514864|3717715|B1|Not reported||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3892779|NCT01514864|3717713|B3|Not Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
3892780|NCT01514864|3717714|B2|Not Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3892781|NCT01514864|3717715|B1|Not Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3892782|NCT01514864|3717713|B3|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3892783|NCT01514864|3717714|B2|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3892784|NCT01514864|3717715|B1|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3892785|NCT01514864|3717713|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892786|NCT01514864|3717714|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892787|NCT01514864|3717715|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892788|NCT01514864|3717713|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892789|NCT01514864|3717714|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892790|NCT01514864|3717715|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892791|NCT01514864|3717713|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3892792|NCT01514864|3717714|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3892793|NCT01514864|3717715|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3892794|NCT01514864|3717713|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3892795|NCT01514864|3717714|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3892796|NCT01514864|3717715|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892797|NCT01514864|3717713|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892798|NCT01514864|3717714|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892799|NCT01514864|3717715|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892800|NCT01514864|3717713|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892801|NCT01514864|3717714|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892802|NCT01514864|3717715|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892803|NCT01514864|3717713|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3892804|NCT01514864|3717714|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892805|NCT01514864|3717715|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3892806|NCT01514864|3717713|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3892807|NCT01514864|3717714|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3892808|NCT01514864|3717715|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3892809|NCT01514864|3717713|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3892810|NCT01514864|3717714|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3892811|NCT01514864|3717715|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3892812|NCT01514864|3717713|B3|||Age||Years|Median|66.5|66.5|Full Range|||50.0|75.0|
3892813|NCT01514864|3717714|B2|||Age||Years|Median|63.0|63.0|Full Range|||50.0|73.0|
3892814|NCT01514864|3717715|B1|||Age||Years|Median|67.0|67.0|Full Range|||51.0|75.0|
3892815|NCT01514864|3717713|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3892816|NCT01514864|3717714|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3892817|NCT01514864|3717715|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3892818|NCT01514864|3717713|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3892819|NCT01514864|3717714|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3892820|NCT01514864|3717715|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3892821|NCT01514864|3717713|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3892822|NCT01514864|3717714|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3892823|NCT01514864|3717715|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3892824|NCT01514786|3717732|B3|||Participants screened for colon cancer||Participants|Count of Participants|210|210.0||||||
3892825|NCT01514786|3717733|B2|||Participants screened for colon cancer||Participants|Count of Participants|99|99.0||||||
3892826|NCT01514786|3717734|B1|||Participants screened for colon cancer||Participants|Count of Participants|111|111.0||||||
3892827|NCT01514786|3717732|B3|United States||Region of Enrollment||Participants|Count of Participants|570|570.0||||||
3892828|NCT01514786|3717733|B2|United States||Region of Enrollment||Participants|Count of Participants|284|284.0||||||
3892829|NCT01514786|3717734|B1|United States||Region of Enrollment||Participants|Count of Participants|286|286.0||||||
3892830|NCT01514786|3717732|B3||Male|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
3892831|NCT01514786|3717733|B2||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3892832|NCT01514786|3717734|B1||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3892833|NCT01514786|3717732|B3||Female|Sex: Female, Male||Participants|Count of Participants|320|320.0||||||
3892834|NCT01514786|3717733|B2||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3892835|NCT01514786|3717734|B1||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
3892836|NCT01514786|3717732|B3|||Age||years|Mean|57.7|57.7|Standard Deviation|6.9|6.9|||
3892837|NCT01514786|3717733|B2|||Age||years|Mean|57.1|57.1|Standard Deviation|6.8|6.8|||
3892838|NCT01514786|3717734|B1|||Age||years|Mean|58.3|58.3|Standard Deviation|6.9|6.9|||
3892839|NCT01514786|3717732|B3||>=65 years|Age||Participants|Count of Participants|99|99.0||||||
3892840|NCT01514786|3717733|B2||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
3892841|NCT01514786|3717734|B1||>=65 years|Age||Participants|Count of Participants|55|55.0||||||
3892842|NCT01514786|3717732|B3||Between 18 and 65 years|Age||Participants|Count of Participants|471|471.0||||||
3892843|NCT01514786|3717733|B2||Between 18 and 65 years|Age||Participants|Count of Participants|240|240.0||||||
3892844|NCT01514786|3717734|B1||Between 18 and 65 years|Age||Participants|Count of Participants|231|231.0||||||
3892845|NCT01514786|3717732|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3892846|NCT01514786|3717733|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3892847|NCT01514786|3717734|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3892848|NCT01514760|3717741|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3892849|NCT01514760|3717741|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892850|NCT01514760|3717741|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3892851|NCT01514760|3717741|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3892852|NCT01514760|3717741|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892853|NCT01514760|3717741|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3892854|NCT01514760|3717741|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3892855|NCT01514760|3717741|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3892856|NCT01514760|3717741|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892857|NCT01514760|3717741|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892858|NCT01514760|3717741|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892859|NCT01514760|3717741|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3892860|NCT01514760|3717741|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3892861|NCT01514760|3717741|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3892862|NCT01514760|3717741|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3892863|NCT01514760|3717741|B1||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
3892864|NCT01514734|3717748|B1|Brazil||Region of Enrollment||participants|Number|9|9.0||||||
3892865|NCT01514734|3717748|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3892866|NCT01514734|3717748|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3892867|NCT01514734|3717748|B1|||Age||years|Mean|58.56|58.56|Standard Deviation|15.83|15.83|||
3892868|NCT01514682|3717752|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
3892869|NCT01514682|3717753|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3892870|NCT01514682|3717754|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3892871|NCT01514682|3717752|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892872|NCT01514682|3717753|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892873|NCT01514682|3717754|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892874|NCT01514682|3717752|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3892875|NCT01514682|3717753|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3892876|NCT01514682|3717754|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3892877|NCT01514682|3717752|B3||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3892878|NCT01514682|3717753|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3892879|NCT01514682|3717754|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3892880|NCT01514682|3717752|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3892881|NCT01514682|3717753|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3892882|NCT01514682|3717754|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3892883|NCT01514682|3717752|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892884|NCT01514682|3717753|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892885|NCT01514682|3717754|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892886|NCT01514682|3717752|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3892887|NCT01514682|3717753|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3892888|NCT01514682|3717754|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3892889|NCT01514682|3717752|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892890|NCT01514682|3717753|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892891|NCT01514682|3717754|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892892|NCT01514682|3717752|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3892893|NCT01514682|3717753|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3892894|NCT01514682|3717754|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892895|NCT01514682|3717752|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3892896|NCT01514682|3717753|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3892897|NCT01514682|3717754|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3892898|NCT01514682|3717752|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3892899|NCT01514682|3717753|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3892900|NCT01514682|3717754|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892901|NCT01514682|3717752|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3892902|NCT01514682|3717753|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3892903|NCT01514682|3717754|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3892904|NCT01514682|3717752|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3892905|NCT01514682|3717753|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3892906|NCT01514682|3717754|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3892907|NCT01514682|3717752|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3892908|NCT01514682|3717753|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3892909|NCT01514682|3717754|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3892910|NCT01514682|3717752|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3892911|NCT01514682|3717753|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3892912|NCT01514682|3717754|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3892913|NCT01514682|3717752|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3892914|NCT01514682|3717753|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3892915|NCT01514682|3717754|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3892916|NCT01514630|3717771|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3892917|NCT01514630|3717771|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3892918|NCT01514630|3717771|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3892919|NCT01514630|3717771|B1|||Age||years|Mean|37.4|37.4|Standard Deviation|9.9|9.9|||
3892920|NCT01514630|3717771|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3892921|NCT01514630|3717771|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3892922|NCT01514630|3717771|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3892923|NCT01514513|3717775|B3|Straight||Hair Curliness||participants|Number|18|18.0||||||
3892924|NCT01514513|3717776|B2|Straight||Hair Curliness||participants|Number|8|8.0||||||
3892925|NCT01514513|3717777|B1|Straight||Hair Curliness||participants|Number|10|10.0||||||
3892926|NCT01514513|3717775|B3|Wavy||Hair Curliness||participants|Number|18|18.0||||||
3892927|NCT01514513|3717776|B2|Wavy||Hair Curliness||participants|Number|8|8.0||||||
3892928|NCT01514513|3717777|B1|Wavy||Hair Curliness||participants|Number|10|10.0||||||
3892929|NCT01514513|3717775|B3|Curly||Hair Curliness||participants|Number|6|6.0||||||
3892930|NCT01514513|3717776|B2|Curly||Hair Curliness||participants|Number|5|5.0||||||
3892931|NCT01514513|3717777|B1|Curly||Hair Curliness||participants|Number|1|1.0||||||
3892932|NCT01514513|3717775|B3|Coarse||Hair Texture||participants|Number|10|10.0||||||
3892933|NCT01514513|3717776|B2|Coarse||Hair Texture||participants|Number|7|7.0||||||
3892934|NCT01514513|3717777|B1|Coarse||Hair Texture||participants|Number|3|3.0||||||
3892935|NCT01514513|3717775|B3|Average||Hair Texture||participants|Number|20|20.0||||||
3892936|NCT01514513|3717776|B2|Average||Hair Texture||participants|Number|10|10.0||||||
3892937|NCT01514513|3717777|B1|Average||Hair Texture||participants|Number|10|10.0||||||
3892938|NCT01514513|3717775|B3|Fine||Hair Texture||participants|Number|12|12.0||||||
3892939|NCT01514513|3717776|B2|Fine||Hair Texture||participants|Number|4|4.0||||||
3892940|NCT01514513|3717777|B1|Fine||Hair Texture||participants|Number|8|8.0||||||
3892941|NCT01514513|3717775|B3|Short||Hair Length||participants|Number|3|3.0||||||
3892942|NCT01514513|3717776|B2|Short||Hair Length||participants|Number|1|1.0||||||
3892943|NCT01514513|3717777|B1|Short||Hair Length||participants|Number|2|2.0||||||
3892944|NCT01514513|3717775|B3|Medium||Hair Length||participants|Number|18|18.0||||||
3892945|NCT01514513|3717776|B2|Medium||Hair Length||participants|Number|11|11.0||||||
3892946|NCT01514513|3717777|B1|Medium||Hair Length||participants|Number|7|7.0||||||
3892947|NCT01514513|3717775|B3|Long||Hair Length||participants|Number|13|13.0||||||
3892948|NCT01514513|3717776|B2|Long||Hair Length||participants|Number|6|6.0||||||
3892949|NCT01514513|3717777|B1|Long||Hair Length||participants|Number|7|7.0||||||
3892950|NCT01514513|3717775|B3|Extra long||Hair Length||participants|Number|8|8.0||||||
3892951|NCT01514513|3717776|B2|Extra long||Hair Length||participants|Number|3|3.0||||||
3892952|NCT01514513|3717777|B1|Extra long||Hair Length||participants|Number|5|5.0||||||
3892953|NCT01514513|3717775|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
3892954|NCT01514513|3717776|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
3892955|NCT01514513|3717777|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3892956|NCT01514513|3717775|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892957|NCT01514513|3717776|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892958|NCT01514513|3717777|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892959|NCT01514513|3717775|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892960|NCT01514513|3717776|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892961|NCT01514513|3717777|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892962|NCT01514513|3717775|B3||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3892963|NCT01514513|3717776|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3892964|NCT01514513|3717777|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3892965|NCT01514513|3717775|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3892966|NCT01514513|3717776|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892967|NCT01514513|3717777|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3892968|NCT01514513|3717775|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892969|NCT01514513|3717776|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892970|NCT01514513|3717777|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892971|NCT01514513|3717775|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3892972|NCT01514513|3717776|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3892973|NCT01514513|3717777|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892974|NCT01514513|3717775|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3892975|NCT01514513|3717776|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892976|NCT01514513|3717777|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3892977|NCT01514513|3717775|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892978|NCT01514513|3717776|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892979|NCT01514513|3717777|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3892980|NCT01514513|3717775|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3892981|NCT01514513|3717776|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3892982|NCT01514513|3717777|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3892983|NCT01514513|3717775|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3892984|NCT01514513|3717776|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3892985|NCT01514513|3717777|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3892986|NCT01514513|3717775|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3892987|NCT01514513|3717776|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3892988|NCT01514513|3717777|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3892989|NCT01514513|3717775|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3892990|NCT01514513|3717776|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3892991|NCT01514513|3717777|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3892992|NCT01514513|3717775|B3|||Age||years|Mean|15.17|15.17|Full Range|||4.0|43.0|
3892993|NCT01514513|3717776|B2|||Age||years|Mean|14.76|14.76|Full Range|||4.0|42.0|
3892994|NCT01514513|3717777|B1|||Age||years|Mean|15.57|15.57|Full Range|||6.0|43.0|
3892995|NCT01514461|3717786|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3892996|NCT01514461|3717787|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3892997|NCT01514461|3717788|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3892998|NCT01514461|3717789|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3892999|NCT01514461|3717786|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3893000|NCT01514461|3717787|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3893001|NCT01514461|3717788|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3893002|NCT01514461|3717789|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3893003|NCT01514461|3717786|B4|>=65 years||Age, Customized||Participants|Number|3|3.0||||||
3893004|NCT01514461|3717787|B3|>=65 years||Age, Customized||Participants|Number|0|0.0||||||
3893005|NCT01514461|3717788|B2|>=65 years||Age, Customized||Participants|Number|0|0.0||||||
3893006|NCT01514461|3717789|B1|>=65 years||Age, Customized||Participants|Number|3|3.0||||||
3893007|NCT01514461|3717786|B4|< 65 years||Age, Customized||Participants|Number|42|42.0||||||
3893008|NCT01514461|3717787|B3|< 65 years||Age, Customized||Participants|Number|15|15.0||||||
3893009|NCT01514461|3717788|B2|< 65 years||Age, Customized||Participants|Number|15|15.0||||||
3893010|NCT01514461|3717789|B1|< 65 years||Age, Customized||Participants|Number|12|12.0||||||
3893011|NCT01514461|3717786|B4|||Age||Years|Mean|45.9|45.9|Standard Deviation|12.63|12.63|||
3893012|NCT01514461|3717787|B3|||Age||Years|Mean|42.7|42.7|Standard Deviation|10.94|10.94|||
3893013|NCT01514461|3717788|B2|||Age||Years|Mean|42.3|42.3|Standard Deviation|13.61|13.61|||
3893014|NCT01514461|3717789|B1|||Age||Years|Mean|52.9|52.9|Standard Deviation|10.9|10.9|||
3893015|NCT01514448|3717828|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3893016|NCT01514448|3717829|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3893017|NCT01514448|3717830|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3893018|NCT01514448|3717828|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3893019|NCT01514448|3717829|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3893020|NCT01514448|3717830|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3893021|NCT01514448|3717828|B3|||Age||years|Mean|69.2|69.2|Standard Deviation|6.3|6.3|||
3893022|NCT01514448|3717829|B2|||Age||years|Mean|71.3|71.3|Standard Deviation|6.0|6.0|||
3893023|NCT01514448|3717830|B1|||Age||years|Mean|67.6|67.6|Standard Deviation|6.3|6.3|||
3893024|NCT01514422|3717846|B1||Male|Gender||Participants|Count of Participants|12|12.0||||||
3893025|NCT01514422|3717846|B1||Female|Gender||Participants|Count of Participants|8|8.0||||||
3893026|NCT01514422|3717846|B1|||Age||years|Mean|43.6|43.6|Standard Deviation|12.7|12.7|||
3893027|NCT01514396|3717852|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3893028|NCT01514396|3717852|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3893029|NCT01514396|3717852|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3893030|NCT01514396|3717852|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3893031|NCT01514396|3717852|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3893032|NCT01514396|3717852|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
3893033|NCT01514357|3717857|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3893034|NCT01514357|3717859|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3893035|NCT01514357|3717857|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3893036|NCT01514357|3717858|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3893037|NCT01514357|3717859|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3893038|NCT01514357|3717857|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3893039|NCT01514357|3717858|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3893040|NCT01514357|3717859|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3893041|NCT01514357|3717857|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3893042|NCT01514357|3717858|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3893043|NCT01514357|3717859|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3893044|NCT01514357|3717857|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3893045|NCT01514357|3717858|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3893046|NCT01514357|3717859|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3893047|NCT01514357|3717857|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3893048|NCT01514357|3717858|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3893049|NCT01514357|3717859|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3893050|NCT01514318|3717866|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3893051|NCT01514318|3717866|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3893052|NCT01514318|3717866|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3893053|NCT01514318|3717866|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|13|13.0|||
3893054|NCT01514318|3717866|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3893055|NCT01514318|3717866|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3893056|NCT01514318|3717866|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3893057|NCT01514292|3717872|B1|United States||Region of Enrollment||participants|Number|72|72.0||||||
3893058|NCT01514292|3717872|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3893059|NCT01514292|3717872|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3893060|NCT01514292|3717872|B1||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3893061|NCT01514292|3717872|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3893062|NCT01514292|3717872|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3893063|NCT01514292|3717872|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3893064|NCT01514292|3717872|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3893065|NCT01514292|3717872|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3893066|NCT01514292|3717872|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3893067|NCT01514292|3717872|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3893068|NCT01514292|3717872|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3893069|NCT01514292|3717872|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3893070|NCT01514292|3717872|B1|||Age||years|Mean|42|42.0|Standard Deviation|14|14.0|||
3893071|NCT01514292|3717872|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3893072|NCT01514292|3717872|B1||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
3893073|NCT01514292|3717872|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3893074|NCT01514240|3717876|B3|Black/African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3893075|NCT01514240|3717877|B2|Black/African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3893076|NCT01514240|3717878|B1|Black/African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3893077|NCT01514240|3717876|B3|Asian||Race/Ethnicity, Customized||Participants|Number|111|111.0||||||
3893078|NCT01514240|3717877|B2|Asian||Race/Ethnicity, Customized||Participants|Number|55|55.0||||||
3893079|NCT01514240|3717878|B1|Asian||Race/Ethnicity, Customized||Participants|Number|56|56.0||||||
3893080|NCT01514240|3717876|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3893081|NCT01514240|3717877|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3893082|NCT01514240|3717878|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3893083|NCT01514240|3717876|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3893084|NCT01514240|3717877|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3893085|NCT01514240|3717878|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3893086|NCT01514240|3717876|B3|>=30 Years||Age, Customized||Participants|Number|73|73.0||||||
3893087|NCT01514240|3717877|B2|>=30 Years||Age, Customized||Participants|Number|36|36.0||||||
3893088|NCT01514240|3717878|B1|>=30 Years||Age, Customized||Participants|Number|37|37.0||||||
3893089|NCT01514240|3717876|B3|<30 Years||Age, Customized||Participants|Number|39|39.0||||||
3893090|NCT01514240|3717877|B2|<30 Years||Age, Customized||Participants|Number|20|20.0||||||
3893091|NCT01514240|3717878|B1|<30 Years||Age, Customized||Participants|Number|19|19.0||||||
3893092|NCT01514240|3717876|B3|||Age||Years|Mean|36.9|36.9|Standard Deviation|12.15|12.15|16.0|77.0|
3893093|NCT01514240|3717877|B2|||Age||Years|Mean|35.8|35.8|Standard Deviation|10.71|10.71|19.0|64.0|
3893094|NCT01514240|3717878|B1|||Age||Years|Mean|38.1|38.1|Standard Deviation|13.43|13.43|16.0|77.0|
3893095|NCT01514162|3717953|B1|United States||Region of Enrollment||participants|Number|245|245.0||||||
3893096|NCT01514162|3717953|B1||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3893097|NCT01514162|3717953|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3893098|NCT01514162|3717953|B1|||Age||years|Mean|72|72.0|Standard Deviation|8.4|8.4|||
3893099|NCT01514162|3717953|B1||>=65 years|Age||Participants|Count of Participants|200|200.0||||||
3893100|NCT01514162|3717953|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3893101|NCT01514162|3717953|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3893102|NCT01514149|3717959|B6|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3893103|NCT01514149|3717959|B6||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3893104|NCT01514149|3717960|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3893105|NCT01514149|3717961|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3893106|NCT01514149|3717962|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3893107|NCT01514149|3717963|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3893108|NCT01514149|3717964|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3893109|NCT01514149|3717959|B6||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3893110|NCT01514149|3717960|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3893111|NCT01514149|3717961|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3893112|NCT01514149|3717962|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3893113|NCT01514149|3717963|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3893114|NCT01514149|3717964|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3893115|NCT01514149|3717959|B6|18 to 70 years||Age, Customized||Participants|Count of Participants|73|73.0||||||
3893116|NCT01514149|3717960|B5|18 to 70 years||Age, Customized||Participants|Count of Participants|15|15.0||||||
3893117|NCT01514149|3717961|B4|18 to 70 years||Age, Customized||Participants|Count of Participants|14|14.0||||||
3893118|NCT01514149|3717962|B3|18 to 70 years||Age, Customized||Participants|Count of Participants|14|14.0||||||
3893119|NCT01514149|3717963|B2|18 to 70 years||Age, Customized||Participants|Count of Participants|15|15.0||||||
3893120|NCT01514149|3717964|B1|18 to 70 years||Age, Customized||Participants|Count of Participants|15|15.0||||||
3893121|NCT01514136|3717990|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3893122|NCT01514136|3717991|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3893123|NCT01514136|3717992|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3893124|NCT01514136|3717990|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3893125|NCT01514136|3717991|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3893126|NCT01514136|3717992|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3893127|NCT01514136|3717990|B3|||Age||years|Mean|60.8|60.8|Standard Deviation|11.0|11.0|||
3893128|NCT01514136|3717991|B2|||Age||years|Mean|64.4|64.4|Standard Deviation|7.5|7.5|||
3893129|NCT01514136|3717992|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|11.9|11.9|||
3893130|NCT01513902|3718025|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3893131|NCT01513902|3718026|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3893132|NCT01513902|3718027|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3893133|NCT01513902|3718028|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3893134|NCT01513902|3718025|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3893135|NCT01513902|3718026|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3893136|NCT01513902|3718027|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3893137|NCT01513902|3718028|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3893138|NCT01513902|3718025|B4|||Age||years|Mean|9.0|9.0|Standard Deviation|4.5|4.5|||
3893139|NCT01513902|3718026|B3|||Age||years|Mean|4.0|4.0|Standard Deviation|1.0|1.0|||
3893140|NCT01513902|3718027|B2|||Age||years|Mean|9.4|9.4|Standard Deviation|1.8|1.8|||
3893141|NCT01513902|3718028|B1|||Age||years|Mean|14.1|14.1|Standard Deviation|2.0|2.0|||
3893142|NCT01513590|3718065|B3|||Body Weight|Body weight was measured at baseline.|kg|Mean|88.2|88.2|Standard Deviation|14.9|14.9|||
3893143|NCT01513590|3718066|B2|||Body Weight|Body weight was measured at baseline.|kg|Mean|88.5|88.5|Standard Deviation|14.9|14.9|||
3893144|NCT01513590|3718067|B1|||Body Weight|Body weight was measured at baseline.|kg|Mean|88.0|88.0|Standard Deviation|15.0|15.0|||
3893145|NCT01513590|3718065|B3|||Fasting plasma glucose (FPG)|Fasting plasma glucose (FPG) was measured at baseline.|mmol/L|Mean|10.2|10.2|Standard Deviation|2.3|2.3|||
3893146|NCT01513590|3718066|B2|||Fasting plasma glucose (FPG)|Fasting plasma glucose (FPG) was measured at baseline.|mmol/L|Mean|10.0|10.0|Standard Deviation|2.3|2.3|||
3893147|NCT01513590|3718067|B1|||Fasting plasma glucose (FPG)|Fasting plasma glucose (FPG) was measured at baseline.|mmol/L|Mean|10.5|10.5|Standard Deviation|2.4|2.4|||
3893148|NCT01513590|3718065|B3|||Glycosylated Haemoglobin (HbA1c)|Glycosylated haemoglobin (HbA1c) was measured at baseline.|Percent (%) glycosylated haemoglobin|Mean|8.4|8.4|Standard Deviation|0.8|0.8|||
3893149|NCT01513590|3718066|B2|||Glycosylated Haemoglobin (HbA1c)|Glycosylated haemoglobin (HbA1c) was measured at baseline.|Percent (%) glycosylated haemoglobin|Mean|8.3|8.3|Standard Deviation|0.7|0.7|||
3893150|NCT01513590|3718067|B1|||Glycosylated Haemoglobin (HbA1c)|Glycosylated haemoglobin (HbA1c) was measured at baseline.|Percent (%) glycosylated haemoglobin|Mean|8.5|8.5|Standard Deviation|0.8|0.8|||
3893151|NCT01513590|3718065|B3||Male|Sex: Female, Male|Male and female aged ≥18 years were enrolled in this study.|Participants|Count of Participants|203|203.0||||||
3893152|NCT01513590|3718066|B2||Male|Sex: Female, Male|Male and female aged ≥18 years were enrolled in this study.|Participants|Count of Participants|101|101.0||||||
3893153|NCT01513590|3718067|B1||Male|Sex: Female, Male|Male and female aged ≥18 years were enrolled in this study.|Participants|Count of Participants|102|102.0||||||
3893154|NCT01513590|3718065|B3||Female|Sex: Female, Male|Male and female aged ≥18 years were enrolled in this study.|Participants|Count of Participants|191|191.0||||||
3893155|NCT01513590|3718066|B2||Female|Sex: Female, Male|Male and female aged ≥18 years were enrolled in this study.|Participants|Count of Participants|96|96.0||||||
3893156|NCT01513590|3718067|B1||Female|Sex: Female, Male|Male and female aged ≥18 years were enrolled in this study.|Participants|Count of Participants|95|95.0||||||
3893157|NCT01513590|3718065|B3|||Age|Subjects aged ≥18 years were enrolled in this study.|years|Mean|58.9|58.9|Standard Deviation|8.9|8.9|||
3893158|NCT01513590|3718066|B2|||Age|Subjects aged ≥18 years were enrolled in this study.|years|Mean|58.8|58.8|Standard Deviation|8.4|8.4|||
3893159|NCT01513590|3718067|B1|||Age|Subjects aged ≥18 years were enrolled in this study.|years|Mean|59.0|59.0|Standard Deviation|9.5|9.5|||
3893160|NCT01513551|3718086|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3893161|NCT01513551|3718087|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3893162|NCT01513551|3718088|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3893163|NCT01513551|3718089|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3893164|NCT01513551|3718086|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3893165|NCT01513551|3718087|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3893166|NCT01513551|3718088|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3893167|NCT01513551|3718089|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3893168|NCT01513551|3718086|B4||White|Race (NIH/OMB)||Participants|Count of Participants|641|641.0||||||
3893169|NCT01513551|3718087|B3||White|Race (NIH/OMB)||Participants|Count of Participants|212|212.0||||||
3893170|NCT01513551|3718088|B2||White|Race (NIH/OMB)||Participants|Count of Participants|217|217.0||||||
3893171|NCT01513551|3718089|B1||White|Race (NIH/OMB)||Participants|Count of Participants|212|212.0||||||
3893172|NCT01513551|3718086|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3893173|NCT01513551|3718087|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3893174|NCT01513551|3718088|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3893175|NCT01513551|3718089|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3893176|NCT01513551|3718086|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3893177|NCT01513551|3718087|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3893178|NCT01513551|3718088|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3893179|NCT01513551|3718089|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3893180|NCT01513551|3718086|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3893181|NCT01513551|3718087|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3893182|NCT01513551|3718088|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3893183|NCT01513551|3718089|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3893184|NCT01513551|3718086|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3893185|NCT01513551|3718087|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3893186|NCT01513551|3718088|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3893187|NCT01513551|3718089|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3893188|NCT01513551|3718086|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3893189|NCT01513551|3718087|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3893190|NCT01513551|3718088|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3893191|NCT01513551|3718089|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3893192|NCT01513551|3718086|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|642|642.0||||||
3893193|NCT01513551|3718087|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|215|215.0||||||
3893194|NCT01513551|3718088|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|211|211.0||||||
3893195|NCT01513551|3718089|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|216|216.0||||||
3893196|NCT01513551|3718086|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3893197|NCT01513551|3718087|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3893198|NCT01513551|3718088|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3893199|NCT01513551|3718089|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3893200|NCT01513551|3718086|B4||Male|Sex: Female, Male||Participants|Count of Participants|324|324.0||||||
3893201|NCT01513551|3718087|B3||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3893202|NCT01513551|3718088|B2||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3893203|NCT01513551|3718089|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3893204|NCT01513551|3718086|B4||Female|Sex: Female, Male||Participants|Count of Participants|367|367.0||||||
3893205|NCT01513551|3718087|B3||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3893206|NCT01513551|3718088|B2||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3893207|NCT01513551|3718089|B1||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3893208|NCT01513551|3718086|B4|>= 75 years||Age, Customized||Participants|Count of Participants|227|227.0||||||
3893209|NCT01513551|3718087|B3|>= 75 years||Age, Customized||Participants|Count of Participants|76|76.0||||||
3893210|NCT01513551|3718088|B2|>= 75 years||Age, Customized||Participants|Count of Participants|75|75.0||||||
3893211|NCT01513551|3718089|B1|>= 75 years||Age, Customized||Participants|Count of Participants|76|76.0||||||
3893212|NCT01513551|3718086|B4|65 to 74 years||Age, Customized||Participants|Count of Participants|225|225.0||||||
3893213|NCT01513551|3718087|B3|65 to 74 years||Age, Customized||Participants|Count of Participants|74|74.0||||||
3893214|NCT01513551|3718088|B2|65 to 74 years||Age, Customized||Participants|Count of Participants|76|76.0||||||
3893215|NCT01513551|3718089|B1|65 to 74 years||Age, Customized||Participants|Count of Participants|75|75.0||||||
3893216|NCT01513551|3718086|B4|50 to 64 years||Age, Customized||Participants|Count of Participants|239|239.0||||||
3893217|NCT01513551|3718087|B3|50 to 64 years||Age, Customized||Participants|Count of Participants|80|80.0||||||
3893218|NCT01513551|3718088|B2|50 to 64 years||Age, Customized||Participants|Count of Participants|80|80.0||||||
3893219|NCT01513551|3718089|B1|50 to 64 years||Age, Customized||Participants|Count of Participants|79|79.0||||||
3893220|NCT01513538|3718117|B1|France||Region of Enrollment||participants|Number|578|578.0||||||
3893221|NCT01513538|3718117|B1|Women||Sex/Gender, Customized||participants|Number|231|231.0||||||
3893222|NCT01513538|3718117|B1|Men||Sex/Gender, Customized||participants|Number|347|347.0||||||
3893223|NCT01513538|3718117|B1|Women||Age, Customized||years|Mean|79|79.0|Full Range|||70.0|88.0|
3893224|NCT01513538|3718117|B1|Men||Age, Customized||years|Mean|77|77.0|Full Range|||67.0|87.0|
3893225|NCT01513473|3718121|B3||Male|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
3893226|NCT01513473|3718122|B2||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3893227|NCT01513473|3718123|B1||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3893228|NCT01513473|3718121|B3||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3893229|NCT01513473|3718122|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3893230|NCT01513473|3718123|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3893231|NCT01513473|3718121|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3893232|NCT01513473|3718122|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3893233|NCT01513473|3718123|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3893234|NCT01513473|3718121|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3893235|NCT01513473|3718122|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3893236|NCT01513473|3718123|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3893237|NCT01513473|3718121|B3||<=18 years|Age||Participants|Count of Participants|350|350.0||||||
3893238|NCT01513473|3718122|B2||<=18 years|Age||Participants|Count of Participants|176|176.0||||||
3893239|NCT01513473|3718123|B1||<=18 years|Age||Participants|Count of Participants|174|174.0||||||
3893240|NCT01513460|3718148|B4||Male|Sex: Female, Male||Participants|Count of Participants|497|497.0||||||
3893241|NCT01513460|3718149|B3||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3893242|NCT01513460|3718150|B2||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3893243|NCT01513460|3718151|B1||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3893244|NCT01513460|3718148|B4||Female|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
3893245|NCT01513460|3718149|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3893246|NCT01513460|3718150|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3893247|NCT01513460|3718151|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3893248|NCT01513460|3718148|B4|||Age||Years|Mean|68.0|68.0|Standard Deviation|8.20|8.2|||
3893249|NCT01513460|3718149|B3|||Age||Years|Mean|67.8|67.8|Standard Deviation|8.49|8.49|||
3893250|NCT01513460|3718150|B2|||Age||Years|Mean|68.0|68.0|Standard Deviation|7.74|7.74|||
3893251|NCT01513460|3718151|B1|||Age||Years|Mean|68.2|68.2|Standard Deviation|8.38|8.38|||
3893252|NCT01513447|3718177|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3893253|NCT01513447|3718178|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3893254|NCT01513447|3718179|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3893255|NCT01513447|3718177|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3893256|NCT01513447|3718178|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3893257|NCT01513447|3718179|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3893258|NCT01513447|3718177|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3893259|NCT01513447|3718178|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3893260|NCT01513447|3718179|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3893261|NCT01513447|3718177|B3|||Age||years|Mean|31|31.0|Standard Deviation|7|7.0|||
3893262|NCT01513447|3718178|B2|||Age||years|Mean|31|31.0|Standard Deviation|4|4.0|||
3893263|NCT01513447|3718179|B1|||Age||years|Mean|32|32.0|Standard Deviation|10|10.0|||
3893264|NCT01513330|3718188|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3893265|NCT01513330|3718188|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3893266|NCT01513330|3718188|B1|||Age||years|Mean|65.3|65.3|Standard Deviation|11.7|11.7|||
3893267|NCT01513317|3718195|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
3893268|NCT01513317|3718196|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3893269|NCT01513317|3718197|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
3893270|NCT01513317|3718195|B3|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
3893271|NCT01513317|3718196|B2|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
3893272|NCT01513317|3718197|B1|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
3893273|NCT01513317|3718195|B3|Spain||Region of Enrollment||participants|Number|15|15.0||||||
3893274|NCT01513317|3718196|B2|Spain||Region of Enrollment||participants|Number|5|5.0||||||
3893275|NCT01513317|3718197|B1|Spain||Region of Enrollment||participants|Number|10|10.0||||||
3893276|NCT01513317|3718195|B3|Russian Federation||Region of Enrollment||participants|Number|8|8.0||||||
3893277|NCT01513317|3718196|B2|Russian Federation||Region of Enrollment||participants|Number|3|3.0||||||
3893278|NCT01513317|3718197|B1|Russian Federation||Region of Enrollment||participants|Number|5|5.0||||||
3893279|NCT01513317|3718195|B3|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
3893280|NCT01513317|3718196|B2|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
3893281|NCT01513317|3718197|B1|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
3893282|NCT01513317|3718195|B3|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
3893283|NCT01513317|3718196|B2|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
3893284|NCT01513317|3718197|B1|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
3893285|NCT01513317|3718195|B3|Australia||Region of Enrollment||participants|Number|5|5.0||||||
3893286|NCT01513317|3718196|B2|Australia||Region of Enrollment||participants|Number|2|2.0||||||
3893287|NCT01513317|3718197|B1|Australia||Region of Enrollment||participants|Number|3|3.0||||||
3893288|NCT01513317|3718195|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3893289|NCT01513317|3718196|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3893290|NCT01513317|3718197|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3893291|NCT01513317|3718195|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3893292|NCT01513317|3718196|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3893293|NCT01513317|3718197|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3893294|NCT01513317|3718195|B3|||Age||years|Mean|70.8|70.8|Standard Deviation|7.67|7.67|||
3893295|NCT01513317|3718196|B2|||Age||years|Mean|72|72.0|Standard Deviation|7.61|7.61|||
3893296|NCT01513317|3718197|B1|||Age||years|Mean|70.2|70.2|Standard Deviation|7.7|7.7|||
3893297|NCT01513291|3718214|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3893298|NCT01513291|3718215|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3893299|NCT01513291|3718216|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3893300|NCT01513291|3718214|B3||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3893301|NCT01513291|3718215|B2||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3893302|NCT01513291|3718216|B1||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3893303|NCT01513291|3718214|B3|||Age||Years|Mean|42.2|42.2|Standard Deviation|11.0|11.0|||
3893304|NCT01513291|3718215|B2|||Age||Years|Mean|41.9|41.9|Standard Deviation|11.3|11.3|||
3893305|NCT01513291|3718216|B1|||Age||Years|Mean|42.5|42.5|Standard Deviation|10.7|10.7|||
3893306|NCT01513239|3718245|B4||Male|Sex: Female, Male||Participants|Count of Participants|528|528.0||||||
3893307|NCT01513239|3718246|B3||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3893308|NCT01513239|3718247|B2||Male|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
3893309|NCT01513239|3718248|B1||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
3893310|NCT01513239|3718245|B4||Female|Sex: Female, Male||Participants|Count of Participants|675|675.0||||||
3893311|NCT01513239|3718246|B3||Female|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
3893312|NCT01513239|3718247|B2||Female|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
3893313|NCT01513239|3718248|B1||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
3893314|NCT01513239|3718245|B4|||Age||Years|Mean|64.2|64.2|Standard Deviation|17.1|17.1|||
3893315|NCT01513239|3718246|B3|||Age||Years|Mean|64.3|64.3|Standard Deviation|16.4|16.4|||
3893316|NCT01513239|3718247|B2|||Age||Years|Mean|62.6|62.6|Standard Deviation|17.5|17.5|||
3893317|NCT01513239|3718248|B1|||Age||Years|Mean|65.9|65.9|Standard Deviation|17.3|17.3|||
3893318|NCT01513148|3718304|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
3893319|NCT01513148|3718305|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3893320|NCT01513148|3718306|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3893321|NCT01513148|3718304|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3893322|NCT01513148|3718305|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3893323|NCT01513148|3718306|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3893324|NCT01513148|3718304|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3893325|NCT01513148|3718305|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3893326|NCT01513148|3718306|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3893327|NCT01513148|3718304|B3|||Age||years|Mean|24.7|24.7|Standard Deviation|3.2|3.2|||
3893328|NCT01513148|3718305|B2|||Age||years|Mean|25.5|25.5|Standard Deviation|3.9|3.9|||
3893329|NCT01513148|3718306|B1|||Age||years|Mean|24.5|24.5|Standard Deviation|2.1|2.1|||
3893330|NCT01513148|3718304|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3893331|NCT01513148|3718305|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3893332|NCT01513148|3718306|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3893333|NCT01513148|3718304|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3893334|NCT01513148|3718305|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3893335|NCT01513148|3718306|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3893336|NCT01513148|3718304|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3893337|NCT01513148|3718305|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3893338|NCT01513148|3718306|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3893339|NCT01513122|3718353|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3893340|NCT01513122|3718354|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3893341|NCT01513122|3718355|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3893342|NCT01513122|3718353|B3||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3893343|NCT01513122|3718354|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3893344|NCT01513122|3718355|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3893345|NCT01513122|3718353|B3|||Age||years|Mean|38.5|38.5|Standard Deviation|7.8|7.8|||
3893346|NCT01513122|3718354|B2|||Age||years|Mean|38.5|38.5|Standard Deviation|7.7|7.7|||
3893347|NCT01513122|3718355|B1|||Age||years|Mean|38.5|38.5|Standard Deviation|7.8|7.8|||
3893397|NCT01512797|3718421|B2|||Weight regain from nadir weight||kg|Mean|12.96|12.96|Standard Deviation|10.94|10.94|||
3893348|NCT01512979|3718372|B3|||Baseline HbA1c|Baseline HbA1c was analyzed for the Full Analysis Set which includes all patients randomised, treated with at least 1 dose of study drug, with a baseline HbA1c value and at least 1 on-treatment HbA1c value. The Linagliptin 5mg + Metformin group includes 153 participants, the Linagliptin 5mg group includes 150 participants (303 participants in total).|percentage|Mean|9.83|9.83|Standard Deviation|1.14|1.14|||
3893349|NCT01512979|3718373|B2|||Baseline HbA1c|Baseline HbA1c was analyzed for the Full Analysis Set which includes all patients randomised, treated with at least 1 dose of study drug, with a baseline HbA1c value and at least 1 on-treatment HbA1c value. The Linagliptin 5mg + Metformin group includes 153 participants, the Linagliptin 5mg group includes 150 participants (303 participants in total).|percentage|Mean|9.88|9.88|Standard Deviation|1.10|1.1|||
3893350|NCT01512979|3718374|B1|||Baseline HbA1c|Baseline HbA1c was analyzed for the Full Analysis Set which includes all patients randomised, treated with at least 1 dose of study drug, with a baseline HbA1c value and at least 1 on-treatment HbA1c value. The Linagliptin 5mg + Metformin group includes 153 participants, the Linagliptin 5mg group includes 150 participants (303 participants in total).|percentage|Mean|9.79|9.79|Standard Deviation|1.19|1.19|||
3893351|NCT01512979|3718372|B3||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3893352|NCT01512979|3718373|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3893353|NCT01512979|3718374|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3893354|NCT01512979|3718372|B3||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
3893355|NCT01512979|3718373|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3893356|NCT01512979|3718374|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3893357|NCT01512979|3718372|B3|||Age||years|Mean|48.8|48.8|Standard Deviation|11.0|11.0|||
3893358|NCT01512979|3718373|B2|||Age||years|Mean|48.6|48.6|Standard Deviation|11.2|11.2|||
3893359|NCT01512979|3718374|B1|||Age||years|Mean|49.0|49.0|Standard Deviation|10.9|10.9|||
3893360|NCT01512849|3718393|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3893361|NCT01512849|3718394|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3893362|NCT01512849|3718395|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3893363|NCT01512849|3718393|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3893364|NCT01512849|3718394|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3893365|NCT01512849|3718395|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3893366|NCT01512849|3718393|B3|||Age||years|Mean|60.8|60.8|Full Range|||40.0|78.0|
3893367|NCT01512849|3718394|B2|||Age||years|Mean|57.8|57.8|Full Range|9.7|9.7|48.0|76.0|
3893368|NCT01512849|3718395|B1|||Age||years|Mean|63.7|63.7|Full Range|10.2|10.2|40.0|78.0|
3893369|NCT01512797|3718420|B3|||Diastolic blood pressure||mm Hg|Mean|72.48|72.48|Standard Deviation|11.79|11.79|||
3893370|NCT01512797|3718421|B2|||Diastolic blood pressure||mm Hg|Mean|69.77|69.77|Standard Deviation|11.05|11.05|||
3893371|NCT01512797|3718422|B1|||Diastolic blood pressure||mm Hg|Mean|74.69|74.69|Standard Deviation|12.26|12.26|||
3893372|NCT01512797|3718420|B3|||Systolic blood pressure||mm Hg|Mean|122.23|122.23|Standard Deviation|18.4|18.4|||
3893373|NCT01512797|3718421|B2|||Systolic blood pressure||mm Hg|Mean|119.1|119.1|Standard Deviation|14.4|14.4|||
3893374|NCT01512797|3718422|B1|||Systolic blood pressure||mm Hg|Mean|124.8|124.8|Standard Deviation|21.23|21.23|||
3893375|NCT01512797|3718420|B3|||Low-density lipoprotein||mg/dL|Mean|82.24|82.24|Standard Deviation|33.70|33.7|||
3893376|NCT01512797|3718421|B2|||Low-density lipoprotein||mg/dL|Mean|76.79|76.79|Standard Deviation|28.24|28.24|||
3893377|NCT01512797|3718422|B1|||Low-density lipoprotein||mg/dL|Mean|89.18|89.18|Standard Deviation|39.92|39.92|||
3893378|NCT01512797|3718420|B3|||High-density lipoprotein||mg/dL|Mean|57.19|57.19|Standard Deviation|23.58|23.58|||
3893379|NCT01512797|3718421|B2|||High-density lipoprotein||mg/dL|Mean|59.21|59.21|Standard Deviation|29.39|29.39|||
3893380|NCT01512797|3718422|B1|||High-density lipoprotein||mg/dL|Mean|54.83|54.83|Standard Deviation|15.21|15.21|||
3893381|NCT01512797|3718420|B3|||Triglycerides||mg/dL|Mean|135.1|135.1|Standard Deviation|90.6|90.6|||
3893382|NCT01512797|3718421|B2|||Triglycerides||mg/dL|Mean|124.7|124.7|Standard Deviation|50.2|50.2|||
3893383|NCT01512797|3718422|B1|||Triglycerides||mg/dL|Mean|147.3|147.3|Standard Deviation|123.9|123.9|||
3893384|NCT01512797|3718420|B3|||Total Cholesterol||mg/dL|Mean|161.1|161.1|Standard Deviation|37.67|37.67|||
3893385|NCT01512797|3718421|B2|||Total Cholesterol||mg/dL|Mean|151.78|151.78|Standard Deviation|32.67|32.67|||
3893386|NCT01512797|3718422|B1|||Total Cholesterol||mg/dL|Mean|172.0|172.0|Standard Deviation|41.5|41.5|||
3893387|NCT01512797|3718420|B3|||Participants on insulin at time of study||Participants|Count of Participants|7|7.0||||||
3893388|NCT01512797|3718421|B2|||Participants on insulin at time of study||Participants|Count of Participants|4|4.0||||||
3893389|NCT01512797|3718422|B1|||Participants on insulin at time of study||Participants|Count of Participants|3|3.0||||||
3893390|NCT01512797|3718420|B3|||Participants on insulin prior to RYGB||Participants|Count of Participants|20|20.0||||||
3893391|NCT01512797|3718421|B2|||Participants on insulin prior to RYGB||Participants|Count of Participants|10|10.0||||||
3893392|NCT01512797|3718422|B1|||Participants on insulin prior to RYGB||Participants|Count of Participants|10|10.0||||||
3893393|NCT01512797|3718420|B3|||Number of oral type 2 diabetes mellitus medications prior to Roux-en-Y gastric bypass||number of medications|Mean|1.81|1.81|Standard Deviation|0.90|0.9|||
3893394|NCT01512797|3718421|B2|||Number of oral type 2 diabetes mellitus medications prior to Roux-en-Y gastric bypass||number of medications|Mean|1.75|1.75|Standard Deviation|0.93|0.93|||
3893395|NCT01512797|3718422|B1|||Number of oral type 2 diabetes mellitus medications prior to Roux-en-Y gastric bypass||number of medications|Mean|1.88|1.88|Standard Deviation|0.89|0.89|||
3893396|NCT01512797|3718420|B3|||Weight regain from nadir weight||kg|Mean|12.84|12.84|Standard Deviation|10.64|10.64|||
3893398|NCT01512797|3718422|B1|||Weight regain from nadir weight||kg|Mean|12.73|12.73|Standard Deviation|10.70|10.7|||
3893399|NCT01512797|3718420|B3|||Current weight loss since Roux-en-Y gastric bypass||kg|Mean|33.00|33.0|Standard Deviation|12.82|12.82|||
3893400|NCT01512797|3718421|B2|||Current weight loss since Roux-en-Y gastric bypass||kg|Mean|34.47|34.47|Standard Deviation|13.91|13.91|||
3893401|NCT01512797|3718422|B1|||Current weight loss since Roux-en-Y gastric bypass||kg|Mean|31.53|31.53|Standard Deviation|11.90|11.9|||
3893402|NCT01512797|3718420|B3|||Current Weight||kg|Mean|90.90|90.9|Standard Deviation|18.02|18.02|||
3893403|NCT01512797|3718421|B2|||Current Weight||kg|Mean|95.82|95.82|Standard Deviation|19.71|19.71|||
3893404|NCT01512797|3718422|B1|||Current Weight||kg|Mean|85.98|85.98|Standard Deviation|15.21|15.21|||
3893405|NCT01512797|3718420|B3|||Nadir weight after Roux-en-Y gastric bypass||kg|Mean|78.22|78.22|Standard Deviation|16.06|16.06|||
3893406|NCT01512797|3718421|B2|||Nadir weight after Roux-en-Y gastric bypass||kg|Mean|82.93|82.93|Standard Deviation|13.38|13.38|||
3893407|NCT01512797|3718422|B1|||Nadir weight after Roux-en-Y gastric bypass||kg|Mean|73.51|73.51|Standard Deviation|17.52|17.52|||
3893408|NCT01512797|3718420|B3|||Weight at Roux-en-Y gastric bypass||kg|Mean|123.9|123.9|Standard Deviation|23.1|23.1|||
3893409|NCT01512797|3718421|B2|||Weight at Roux-en-Y gastric bypass||kg|Mean|130.23|130.23|Standard Deviation|24.6|24.6|||
3893410|NCT01512797|3718422|B1|||Weight at Roux-en-Y gastric bypass||kg|Mean|117.5|117.5|Standard Deviation|20.4|20.4|||
3893411|NCT01512797|3718420|B3|||Maximum Weight before Roux-en-Y gastric bypass surgery||kg|Mean|127.7|127.7|Standard Deviation|22.1|22.1|||
3893412|NCT01512797|3718421|B2|||Maximum Weight before Roux-en-Y gastric bypass surgery||kg|Mean|132.89|132.89|Standard Deviation|24.23|24.23|||
3893413|NCT01512797|3718422|B1|||Maximum Weight before Roux-en-Y gastric bypass surgery||kg|Mean|122.45|122.45|Standard Deviation|19.0|19.0|||
3893414|NCT01512797|3718420|B3|||Type 2 Diabetes Mellitus remission duration prior to study||years|Mean|2.44|2.44|Standard Deviation|2.89|2.89|||
3893415|NCT01512797|3718421|B2|||Type 2 Diabetes Mellitus remission duration prior to study||years|Mean|2.16|2.16|Standard Deviation|2.74|2.74|||
3893416|NCT01512797|3718422|B1|||Type 2 Diabetes Mellitus remission duration prior to study||years|Mean|2.72|2.72|Standard Deviation|3.10|3.1|||
3893417|NCT01512797|3718420|B3|||Type 2 Diabetes Mellitus duration prior to Roux-en-Y gastric bypass surgery||years|Mean|12.9|12.9|Standard Deviation|10.0|10.0|||
3893418|NCT01512797|3718421|B2|||Type 2 Diabetes Mellitus duration prior to Roux-en-Y gastric bypass surgery||years|Mean|12.9|12.9|Standard Deviation|9.3|9.3|||
3893419|NCT01512797|3718422|B1|||Type 2 Diabetes Mellitus duration prior to Roux-en-Y gastric bypass surgery||years|Mean|12.9|12.9|Standard Deviation|11.0|11.0|||
3893420|NCT01512797|3718420|B3|||Time since Roux-en-Y gastric bypass surgery||years|Mean|5.56|5.56|Standard Deviation|3.27|3.27|||
3893421|NCT01512797|3718421|B2|||Time since Roux-en-Y gastric bypass surgery||years|Mean|5.57|5.57|Standard Deviation|2.80|2.8|||
3893422|NCT01512797|3718422|B1|||Time since Roux-en-Y gastric bypass surgery||years|Mean|5.56|5.56|Standard Deviation|3.77|3.77|||
3893423|NCT01512797|3718420|B3|||HbA1c||%|Mean|7.21|7.21|Standard Deviation|0.77|0.77|||
3893424|NCT01512797|3718421|B2|||HbA1c||%|Mean|6.96|6.96|Standard Deviation|0.70|0.7|||
3893425|NCT01512797|3718422|B1|||HbA1c||%|Mean|7.46|7.46|Standard Deviation|0.78|0.78|||
3893426|NCT01512797|3718420|B3|||BMI||kg/m2|Mean|34.41|34.41|Standard Deviation|6.69|6.69|||
3893427|NCT01512797|3718421|B2|||BMI||kg/m2|Mean|36.12|36.12|Standard Deviation|7.69|7.69|||
3893428|NCT01512797|3718422|B1|||BMI||kg/m2|Mean|32.70|32.7|Standard Deviation|5.22|5.22|||
3893429|NCT01512797|3718420|B3||African-American|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3893430|NCT01512797|3718421|B2||African-American|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3893431|NCT01512797|3718422|B1||African-American|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3893432|NCT01512797|3718420|B3||Hispanic Black|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3893433|NCT01512797|3718421|B2||Hispanic Black|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3893434|NCT01512797|3718422|B1||Hispanic Black|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3893435|NCT01512797|3718420|B3||Hispanic White|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3893436|NCT01512797|3718421|B2||Hispanic White|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3893437|NCT01512797|3718422|B1||Hispanic White|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3893438|NCT01512797|3718420|B3||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3893439|NCT01512797|3718421|B2||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3893440|NCT01512797|3718422|B1||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3893441|NCT01512797|3718420|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3893442|NCT01512797|3718421|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3893443|NCT01512797|3718422|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3893444|NCT01512797|3718420|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3893445|NCT01512797|3718421|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3893446|NCT01512797|3718422|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3893447|NCT01512797|3718420|B3|||Age||years|Mean|56.3|56.3|Standard Deviation|8.2|8.2|||
3893448|NCT01512797|3718421|B2|||Age||years|Mean|58.4|58.4|Standard Deviation|7.0|7.0|||
3893449|NCT01512797|3718422|B1|||Age||years|Mean|54.2|54.2|Standard Deviation|9.0|9.0|||
3893450|NCT01512745|3718437|B3||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3893451|NCT01512745|3718438|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3893452|NCT01512745|3718439|B1||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3893453|NCT01512745|3718437|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3893454|NCT01512745|3718438|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3893455|NCT01512745|3718439|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3893456|NCT01512745|3718437|B3|||Age||years|Mean|55.37|55.37|Standard Deviation|9.81|9.81|||
3893457|NCT01512745|3718438|B2|||Age||years|Mean|56.08|56.08|Standard Deviation|9.74|9.74|||
3893458|NCT01512745|3718439|B1|||Age||years|Mean|55.01|55.01|Standard Deviation|9.92|9.92|||
3893459|NCT01512693|3718454|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3893460|NCT01512693|3718455|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3893461|NCT01512693|3718456|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3893462|NCT01512693|3718454|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3893463|NCT01512693|3718455|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3893464|NCT01512693|3718456|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3893465|NCT01512693|3718454|B3|||Age||years|Mean|53.7|53.7|Standard Deviation|5.0|5.0|||
3893466|NCT01512693|3718455|B2|||Age||years|Mean|54.2|54.2|Standard Deviation|5.3|5.3|||
3893467|NCT01512693|3718456|B1|||Age||years|Mean|53.1|53.1|Standard Deviation|4.9|4.9|||
3893468|NCT01512667|3718469|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3893469|NCT01512667|3718470|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3893470|NCT01512667|3718471|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3893471|NCT01512667|3718469|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3893472|NCT01512667|3718470|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3893473|NCT01512667|3718471|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3893474|NCT01512667|3718469|B3|||Age||years|Mean|59.4|59.4|Standard Deviation|10.9|10.9|||
3893475|NCT01512667|3718470|B2|||Age||years|Mean|55.6|55.6|Standard Deviation|10.0|10.0|||
3893476|NCT01512667|3718471|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|10.9|10.9|||
3893477|NCT01512368|3718484|B1|Mexico||Region of Enrollment||participants|Number|63|63.0||||||
3893478|NCT01512368|3718484|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3893479|NCT01512368|3718484|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3893480|NCT01512368|3718484|B1|||Age||years|Mean|24.0|24.0|Standard Deviation|3.7|3.7|||
3893481|NCT01512368|3718484|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3893482|NCT01512368|3718484|B1||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
3893483|NCT01512368|3718484|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3893484|NCT01512251|3718493|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3893485|NCT01512251|3718494|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3893486|NCT01512251|3718495|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3893487|NCT01512251|3718493|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3893488|NCT01512251|3718494|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3893489|NCT01512251|3718495|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3893490|NCT01512251|3718493|B3|||Age||years|Median|50|50.0|Full Range|||26.0|75.0|
3893491|NCT01512251|3718494|B2|||Age||years|Median|51|51.0|Full Range|||40.0|62.0|
3893492|NCT01512251|3718495|B1|||Age||years|Median|44|44.0|Full Range|||26.0|75.0|
3893493|NCT01512225|3718515|B3|||Mean milk Volume at entry||millilitres|Mean|118|118.0|Standard Deviation|96|96.0|||
3893494|NCT01512225|3718516|B2|||Mean milk Volume at entry||millilitres|Mean|115|115.0|Standard Deviation|95|95.0|||
3893495|NCT01512225|3718517|B1|||Mean milk Volume at entry||millilitres|Mean|121|121.0|Standard Deviation|96|96.0|||
3893496|NCT01512225|3718515|B3||Twins|Type of pregnancy||Participants|Count of Participants|13|13.0||||||
3893497|NCT01512225|3718516|B2||Twins|Type of pregnancy||Participants|Count of Participants|6|6.0||||||
3893498|NCT01512225|3718517|B1||Twins|Type of pregnancy||Participants|Count of Participants|7|7.0||||||
3893499|NCT01512225|3718515|B3||Singleton|Type of pregnancy||Participants|Count of Participants|77|77.0||||||
3893500|NCT01512225|3718516|B2||Singleton|Type of pregnancy||Participants|Count of Participants|39|39.0||||||
3893501|NCT01512225|3718517|B1||Singleton|Type of pregnancy||Participants|Count of Participants|38|38.0||||||
3893502|NCT01512225|3718515|B3||>/= 1|Parity||Participants|Count of Participants|29|29.0||||||
3893503|NCT01512225|3718516|B2||>/= 1|Parity||Participants|Count of Participants|12|12.0||||||
3893504|NCT01512225|3718517|B1||>/= 1|Parity||Participants|Count of Participants|17|17.0||||||
3893505|NCT01512225|3718515|B3||0|Parity||Participants|Count of Participants|61|61.0||||||
3893506|NCT01512225|3718516|B2||0|Parity||Participants|Count of Participants|33|33.0||||||
3893507|NCT01512225|3718517|B1||0|Parity||Participants|Count of Participants|28|28.0||||||
3893508|NCT01512225|3718515|B3||Other|Race/Ethnicity, Customized|Ethnicity was self-declared|Participants|Count of Participants|4|4.0||||||
3893509|NCT01512225|3718516|B2||Other|Race/Ethnicity, Customized|Ethnicity was self-declared|Participants|Count of Participants|2|2.0||||||
3893510|NCT01512225|3718517|B1||Other|Race/Ethnicity, Customized|Ethnicity was self-declared|Participants|Count of Participants|2|2.0||||||
3893511|NCT01512225|3718515|B3||Aboriginal|Race/Ethnicity, Customized|Ethnicity was self-declared|Participants|Count of Participants|1|1.0||||||
3893512|NCT01512225|3718516|B2||Aboriginal|Race/Ethnicity, Customized|Ethnicity was self-declared|Participants|Count of Participants|1|1.0||||||
3893513|NCT01512225|3718517|B1||Aboriginal|Race/Ethnicity, Customized|Ethnicity was self-declared|Participants|Count of Participants|0|0.0||||||
3893514|NCT01512225|3718515|B3||Asian|Race/Ethnicity, Customized|Ethnicity was self-declared|Participants|Count of Participants|16|16.0||||||
3893515|NCT01512225|3718516|B2||Asian|Race/Ethnicity, Customized|Ethnicity was self-declared|Participants|Count of Participants|8|8.0||||||
3893516|NCT01512225|3718517|B1||Asian|Race/Ethnicity, Customized|Ethnicity was self-declared|Participants|Count of Participants|8|8.0||||||
3893517|NCT01512225|3718515|B3||Black|Race/Ethnicity, Customized|Ethnicity was self-declared|Participants|Count of Participants|10|10.0||||||
3893518|NCT01512225|3718516|B2||Black|Race/Ethnicity, Customized|Ethnicity was self-declared|Participants|Count of Participants|4|4.0||||||
3893519|NCT01512225|3718517|B1||Black|Race/Ethnicity, Customized|Ethnicity was self-declared|Participants|Count of Participants|6|6.0||||||
3893520|NCT01512225|3718515|B3||Caucasian|Race/Ethnicity, Customized|Ethnicity was self-declared|Participants|Count of Participants|59|59.0||||||
3893521|NCT01512225|3718516|B2||Caucasian|Race/Ethnicity, Customized|Ethnicity was self-declared|Participants|Count of Participants|30|30.0||||||
3893522|NCT01512225|3718517|B1||Caucasian|Race/Ethnicity, Customized|Ethnicity was self-declared|Participants|Count of Participants|29|29.0||||||
3893523|NCT01512225|3718515|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3893524|NCT01512225|3718516|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3893525|NCT01512225|3718517|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3893526|NCT01512225|3718515|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3893527|NCT01512225|3718516|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3893528|NCT01512225|3718517|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3893529|NCT01512225|3718515|B3|||Age||years|Mean|32.41|32.41|Full Range|||20.96|40.59|
3893530|NCT01512225|3718516|B2|||Age||years|Mean|33.56|33.56|Full Range|||23.23|39.5|
3893531|NCT01512225|3718517|B1|||Age||years|Mean|31.25|31.25|Full Range|||20.96|40.59|
3893532|NCT01512160|3718538|B5||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3893533|NCT01512160|3718539|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3893534|NCT01512160|3718540|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3893535|NCT01512160|3718541|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3893536|NCT01512160|3718542|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3893537|NCT01512160|3718538|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3893538|NCT01512160|3718539|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3893539|NCT01512160|3718540|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3893540|NCT01512160|3718541|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3893541|NCT01512160|3718542|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3893542|NCT01512160|3718538|B5|||Age||years|Mean|24.2|24.2|Standard Deviation|4.9|4.9|||
3893543|NCT01512160|3718539|B4|||Age||years|Mean|25.3|25.3|Standard Deviation|5.4|5.4|||
3893544|NCT01512160|3718540|B3|||Age||years|Mean|25.3|25.3|Standard Deviation|4.5|4.5|||
3893545|NCT01512160|3718541|B2|||Age||years|Mean|23.4|23.4|Standard Deviation|5.7|5.7|||
3893546|NCT01512160|3718542|B1|||Age||years|Mean|22.9|22.9|Standard Deviation|3.7|3.7|||
3893547|NCT01512108|3718635|B3|||Fasting plasma glucose (FPG)||mmol/L|Mean|8.77|8.77|Standard Deviation|1.69|1.69|||
3893548|NCT01512108|3718636|B2|||Fasting plasma glucose (FPG)||mmol/L|Mean|8.96|8.96|Standard Deviation|1.82|1.82|||
3893549|NCT01512108|3718637|B1|||Fasting plasma glucose (FPG)||mmol/L|Mean|8.68|8.68|Standard Deviation|1.61|1.61|||
3893550|NCT01512108|3718635|B3|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.1|8.1|Standard Deviation|0.8|0.8|||
3893551|NCT01512108|3718636|B2|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.1|8.1|Standard Deviation|0.8|0.8|||
3893552|NCT01512108|3718637|B1|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.1|8.1|Standard Deviation|0.8|0.8|||
3893553|NCT01512108|3718635|B3||Male|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
3893554|NCT01512108|3718636|B2||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3893555|NCT01512108|3718637|B1||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3893556|NCT01512108|3718635|B3||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3893557|NCT01512108|3718636|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3893558|NCT01512108|3718637|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3893559|NCT01512108|3718635|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|11.1|11.1|||
3893560|NCT01512108|3718636|B2|||Age||years|Mean|59.2|59.2|Standard Deviation|10.2|10.2|||
3893561|NCT01512108|3718637|B1|||Age||years|Mean|59.6|59.6|Standard Deviation|11.6|11.6|||
3893562|NCT01511978|3718650|B3|||Number of 3,4-DAP individual daily doses at randomization||number of daily doses|Median|5.0|5.0|Full Range|||3.0|7.0|
3893563|NCT01511978|3718651|B2|||Number of 3,4-DAP individual daily doses at randomization||number of daily doses|Median|5.0|5.0|Full Range|||3.0|6.0|
3893564|NCT01511978|3718652|B1|||Number of 3,4-DAP individual daily doses at randomization||number of daily doses|Median|4.5|4.5|Full Range|||3.0|7.0|
3893565|NCT01511978|3718650|B3|||Total Daily Dose of 3,4-DAP at randomization||mg|Median|80|80.0|Full Range|||30.0|100.0|
3893566|NCT01511978|3718651|B2|||Total Daily Dose of 3,4-DAP at randomization||mg|Median|80.0|80.0|Full Range|||30.0|100.0|
3893567|NCT01511978|3718652|B1|||Total Daily Dose of 3,4-DAP at randomization||mg|Median|80.0|80.0|Full Range|||35.0|100.0|
3893568|NCT01511978|3718650|B3|||Compound Muscle Action Potential (CMAP) consistent with Lambert-Eaton Myasthenia (LEM) at screening||Participants|Count of Participants|17|17.0||||||
3893569|NCT01511978|3718651|B2|||Compound Muscle Action Potential (CMAP) consistent with Lambert-Eaton Myasthenia (LEM) at screening||Participants|Count of Participants|10|10.0||||||
3893570|NCT01511978|3718652|B1|||Compound Muscle Action Potential (CMAP) consistent with Lambert-Eaton Myasthenia (LEM) at screening||Participants|Count of Participants|7|7.0||||||
3893571|NCT01511978|3718650|B3|||Positive P/Q type voltage-gated calcium channel (VGCC) antibodies at screening||Participants|Count of Participants|29|29.0||||||
3893572|NCT01511978|3718651|B2|||Positive P/Q type voltage-gated calcium channel (VGCC) antibodies at screening||Participants|Count of Participants|17|17.0||||||
3893573|NCT01511978|3718652|B1|||Positive P/Q type voltage-gated calcium channel (VGCC) antibodies at screening||Participants|Count of Participants|12|12.0||||||
3893574|NCT01511978|3718650|B3|||Duration of diagnosis prior to randomization||years|Mean|6.7|6.7|Standard Deviation|5.82|5.82|||
3893575|NCT01511978|3718651|B2|||Duration of diagnosis prior to randomization||years|Mean|6.7|6.7|Standard Deviation|6.08|6.08|||
3893576|NCT01511978|3718652|B1|||Duration of diagnosis prior to randomization||years|Mean|6.7|6.7|Standard Deviation|5.70|5.7|||
3893577|NCT01511978|3718650|B3|||Time between symptom onset and diagnosis||years|Mean|1.7|1.7|Standard Deviation|2.35|2.35|||
3893578|NCT01511978|3718651|B2|||Time between symptom onset and diagnosis||years|Mean|2.2|2.2|Standard Deviation|3.00|3.0|||
3893579|NCT01511978|3718652|B1|||Time between symptom onset and diagnosis||years|Mean|0.9|0.9|Standard Deviation|0.62|0.62|||
3893580|NCT01511978|3718650|B3|||Age at diagnosis||years|Mean|48.9|48.9|Standard Deviation|14.76|14.76|||
3893581|NCT01511978|3718651|B2|||Age at diagnosis||years|Mean|52.7|52.7|Standard Deviation|14.76|14.76|||
3893582|NCT01511978|3718652|B1|||Age at diagnosis||years|Mean|44.1|44.1|Standard Deviation|13.79|13.79|||
3893583|NCT01511978|3718650|B3|||Body Mass Index (BMI)||kg/m2|Mean|27.5|27.5|Standard Deviation|5.39|5.39|||
3893584|NCT01511978|3718651|B2|||Body Mass Index (BMI)||kg/m2|Mean|27.7|27.7|Standard Deviation|5.14|5.14|||
3893585|NCT01511978|3718652|B1|||Body Mass Index (BMI)||kg/m2|Mean|27.3|27.3|Standard Deviation|5.92|5.92|||
3893586|NCT01511978|3718650|B3|||Weight||kg|Mean|79.3|79.3|Standard Deviation|18.73|18.73|||
3893587|NCT01511978|3718651|B2|||Weight||kg|Mean|80.3|80.3|Standard Deviation|18.95|18.95|||
3893588|NCT01511978|3718652|B1|||Weight||kg|Mean|78.0|78.0|Standard Deviation|19.11|19.11|||
3893589|NCT01511978|3718650|B3|||Height||cm|Mean|169.2|169.2|Standard Deviation|7.67|7.67|||
3893590|NCT01511978|3718651|B2|||Height||cm|Mean|169.6|169.6|Standard Deviation|8.98|8.98|||
3893591|NCT01511978|3718652|B1|||Height||cm|Mean|168.5|168.5|Standard Deviation|5.67|5.67|||
3893592|NCT01511978|3718650|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3893593|NCT01511978|3718651|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3893594|NCT01511978|3718652|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3893595|NCT01511978|3718650|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3893596|NCT01511978|3718651|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3893597|NCT01511978|3718652|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3893598|NCT01511978|3718650|B3||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3893599|NCT01511978|3718651|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3893600|NCT01511978|3718652|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3893601|NCT01511978|3718650|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3893602|NCT01511978|3718651|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3893603|NCT01511978|3718652|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3893604|NCT01511978|3718650|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3893605|NCT01511978|3718651|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3893606|NCT01511978|3718652|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3893607|NCT01511978|3718650|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3893608|NCT01511978|3718651|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3893609|NCT01511978|3718652|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3893610|NCT01511978|3718650|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3893611|NCT01511978|3718651|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3893612|NCT01511978|3718652|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3893613|NCT01511978|3718650|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3893614|NCT01511978|3718651|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3893615|NCT01511978|3718652|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3893616|NCT01511978|3718650|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3893617|NCT01511978|3718651|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3893618|NCT01511978|3718652|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3893619|NCT01511978|3718650|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3893620|NCT01511978|3718651|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3893621|NCT01511978|3718652|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3893622|NCT01511978|3718650|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3893623|NCT01511978|3718651|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3893624|NCT01511978|3718652|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3893625|NCT01511978|3718650|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3893626|NCT01511978|3718651|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3893627|NCT01511978|3718652|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3893628|NCT01511978|3718650|B3|||Age||years|Mean|55.5|55.5|Standard Deviation|15.77|15.77|||
3893629|NCT01511978|3718651|B2|||Age||years|Mean|59.3|59.3|Standard Deviation|14.99|14.99|||
3893630|NCT01511978|3718652|B1|||Age||years|Mean|50.7|50.7|Standard Deviation|15.97|15.97|||
3893631|NCT01511939|3718661|B4|United States||Region of Enrollment||participants|Number|22|22.0||||||
3893632|NCT01511939|3718662|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3893633|NCT01511939|3718663|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3893634|NCT01511939|3718664|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3893635|NCT01511939|3718661|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3893636|NCT01511939|3718662|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3893637|NCT01511939|3718663|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3893638|NCT01511939|3718664|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3893639|NCT01511939|3718661|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3893640|NCT01511939|3718662|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3893641|NCT01511939|3718663|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3893642|NCT01511939|3718664|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3893643|NCT01511939|3718661|B4|> / = 55 years||Age, Customized||participants|Number|22|22.0||||||
3893644|NCT01511939|3718662|B3|> / = 55 years||Age, Customized||participants|Number|8|8.0||||||
3893645|NCT01511939|3718663|B2|> / = 55 years||Age, Customized||participants|Number|5|5.0||||||
3893646|NCT01511939|3718664|B1|> / = 55 years||Age, Customized||participants|Number|9|9.0||||||
3893647|NCT01511809|3718683|B3|Absent||HCV coinfection||participants|Number|82|82.0||||||
3893648|NCT01511809|3718684|B2|Absent||HCV coinfection||participants|Number|42|42.0||||||
3893649|NCT01511809|3718685|B1|Absent||HCV coinfection||participants|Number|40|40.0||||||
3893650|NCT01511809|3718683|B3|Present||HCV coinfection||participants|Number|21|21.0||||||
3893651|NCT01511809|3718684|B2|Present||HCV coinfection||participants|Number|10|10.0||||||
3893652|NCT01511809|3718685|B1|Present||HCV coinfection||participants|Number|11|11.0||||||
3893653|NCT01511809|3718683|B3|||CD4+||cells/mm3|Median|575|575.0|Inter-Quartile Range|||432.0|744.0|
3893654|NCT01511809|3718684|B2|||CD4+||cells/mm3|Median|570|570.0|Inter-Quartile Range|||417.0|735.0|
3893655|NCT01511809|3718685|B1|||CD4+||cells/mm3|Median|599|599.0|Inter-Quartile Range|||457.0|774.0|
3893656|NCT01511809|3718683|B3|||HIV-RNA at ARV start||copies/mL|Median|59062|59062.0|Inter-Quartile Range|||10834.0|165850.0|
3893657|NCT01511809|3718684|B2|||HIV-RNA at ARV start||copies/mL|Median|42630|42630.0|Inter-Quartile Range|||9696.0|123700.0|
3893658|NCT01511809|3718685|B1|||HIV-RNA at ARV start||copies/mL|Median|79399|79399.0|Inter-Quartile Range|||31046.0|183613.0|
3893659|NCT01511809|3718683|B3|||HIV-1 RNA <50 copies/ml|Quantitative value of HIV-1 RNA copies/ml in plasma. HIV-1 RNA below 50 copies/ml (detection limit) is an indicator of efficacy of the antiretroviral therapy|months|Median|19|19.0|Inter-Quartile Range|||11.0|49.0|
3893660|NCT01511809|3718684|B2|||HIV-1 RNA <50 copies/ml|Quantitative value of HIV-1 RNA copies/ml in plasma. HIV-1 RNA below 50 copies/ml (detection limit) is an indicator of efficacy of the antiretroviral therapy|months|Median|18|18.0|Inter-Quartile Range|||12.0|49.0|
3893661|NCT01511809|3718685|B1|||HIV-1 RNA <50 copies/ml|Quantitative value of HIV-1 RNA copies/ml in plasma. HIV-1 RNA below 50 copies/ml (detection limit) is an indicator of efficacy of the antiretroviral therapy|months|Median|20|20.0|Inter-Quartile Range|||10.0|49.0|
3893662|NCT01511809|3718683|B3|||Years of antiretroviral treatment||years|Median|25|25.0|Inter-Quartile Range|||17.0|53.0|
3893663|NCT01511809|3718684|B2|||Years of antiretroviral treatment||years|Median|25|25.0|Inter-Quartile Range|||18.0|54.0|
3893664|NCT01511809|3718685|B1|||Years of antiretroviral treatment||years|Median|25|25.0|Inter-Quartile Range|||16.0|47.0|
3893665|NCT01511809|3718683|B3|||nadir CD4+|Lowest CD4+ value among those recorded since the first HIV positive test up to the start of MODAt study|cells/mm3|Median|276|276.0|Inter-Quartile Range|||211.0|361.0|
3893666|NCT01511809|3718684|B2|||nadir CD4+|Lowest CD4+ value among those recorded since the first HIV positive test up to the start of MODAt study|cells/mm3|Median|278|278.0|Inter-Quartile Range|||183.0|364.0|
3893667|NCT01511809|3718685|B1|||nadir CD4+|Lowest CD4+ value among those recorded since the first HIV positive test up to the start of MODAt study|cells/mm3|Median|274|274.0|Inter-Quartile Range|||221.0|355.0|
3893668|NCT01511809|3718683|B3|Italy||Region of Enrollment||participants|Number|103|103.0||||||
3893669|NCT01511809|3718684|B2|Italy||Region of Enrollment||participants|Number|52|52.0||||||
3893670|NCT01511809|3718685|B1|Italy||Region of Enrollment||participants|Number|51|51.0||||||
3893671|NCT01511809|3718683|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3893672|NCT01511809|3718684|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3893673|NCT01511809|3718685|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3893674|NCT01511809|3718683|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3893675|NCT01511809|3718684|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3893676|NCT01511809|3718685|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3893677|NCT01511809|3718683|B3|||Age||years|Median|41.5|41.5|Inter-Quartile Range|||35.6|48.0|
3893678|NCT01511809|3718684|B2|||Age||years|Median|41.7|41.7|Inter-Quartile Range|||36.6|49.8|
3893679|NCT01511809|3718685|B1|||Age||years|Median|41.4|41.4|Inter-Quartile Range|||35.4|47.7|
3893680|NCT01511536|3718692|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3893681|NCT01511536|3718693|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3893682|NCT01511536|3718694|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3893683|NCT01511536|3718695|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3893684|NCT01511536|3718692|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3893685|NCT01511536|3718693|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3893686|NCT01511536|3718694|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3893687|NCT01511536|3718695|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3893688|NCT01511536|3718692|B4|||Age||years|Mean|66.1|66.1|Standard Deviation|7.1|7.1|||
3893689|NCT01511536|3718693|B3|||Age||years|Mean|67.1|67.1|Standard Deviation|5.4|5.4|||
3893690|NCT01511536|3718694|B2|||Age||years|Mean|60.0|60.0|Standard Deviation|10.0|10.0|||
3893691|NCT01511536|3718695|B1|||Age||years|Mean|71.0|71.0|Standard Deviation|7.0|7.0|||
3893692|NCT01511445|3718717|B3||C7-T1|Symptomatic (operated) spinal level|Patients were operated at a single cervical spinal level from C3-C4 to C7-T1|Participants|Count of Participants|4|4.0||||||
3893693|NCT01511445|3718718|B2||C7-T1|Symptomatic (operated) spinal level|Patients were operated at a single cervical spinal level from C3-C4 to C7-T1|Participants|Count of Participants|2|2.0||||||
3893694|NCT01511445|3718719|B1||C7-T1|Symptomatic (operated) spinal level|Patients were operated at a single cervical spinal level from C3-C4 to C7-T1|Participants|Count of Participants|2|2.0||||||
3893695|NCT01511445|3718717|B3||C6-C7|Symptomatic (operated) spinal level|Patients were operated at a single cervical spinal level from C3-C4 to C7-T1|Participants|Count of Participants|32|32.0||||||
3893696|NCT01511445|3718718|B2||C6-C7|Symptomatic (operated) spinal level|Patients were operated at a single cervical spinal level from C3-C4 to C7-T1|Participants|Count of Participants|12|12.0||||||
3893697|NCT01511445|3718719|B1||C6-C7|Symptomatic (operated) spinal level|Patients were operated at a single cervical spinal level from C3-C4 to C7-T1|Participants|Count of Participants|20|20.0||||||
3893698|NCT01511445|3718717|B3||C5-C6|Symptomatic (operated) spinal level|Patients were operated at a single cervical spinal level from C3-C4 to C7-T1|Participants|Count of Participants|60|60.0||||||
3893699|NCT01511445|3718718|B2||C5-C6|Symptomatic (operated) spinal level|Patients were operated at a single cervical spinal level from C3-C4 to C7-T1|Participants|Count of Participants|30|30.0||||||
3893700|NCT01511445|3718719|B1||C5-C6|Symptomatic (operated) spinal level|Patients were operated at a single cervical spinal level from C3-C4 to C7-T1|Participants|Count of Participants|30|30.0||||||
3893701|NCT01511445|3718717|B3||C4-C5|Symptomatic (operated) spinal level|Patients were operated at a single cervical spinal level from C3-C4 to C7-T1|Participants|Count of Participants|6|6.0||||||
3893702|NCT01511445|3718718|B2||C4-C5|Symptomatic (operated) spinal level|Patients were operated at a single cervical spinal level from C3-C4 to C7-T1|Participants|Count of Participants|6|6.0||||||
3893703|NCT01511445|3718719|B1||C4-C5|Symptomatic (operated) spinal level|Patients were operated at a single cervical spinal level from C3-C4 to C7-T1|Participants|Count of Participants|0|0.0||||||
3893704|NCT01511445|3718717|B3||C3-C4|Symptomatic (operated) spinal level|Patients were operated at a single cervical spinal level from C3-C4 to C7-T1|Participants|Count of Participants|2|2.0||||||
3893705|NCT01511445|3718718|B2||C3-C4|Symptomatic (operated) spinal level|Patients were operated at a single cervical spinal level from C3-C4 to C7-T1|Participants|Count of Participants|1|1.0||||||
3893706|NCT01511445|3718719|B1||C3-C4|Symptomatic (operated) spinal level|Patients were operated at a single cervical spinal level from C3-C4 to C7-T1|Participants|Count of Participants|1|1.0||||||
3893707|NCT01511445|3718717|B3|||Use of nicotine products||Participants|Count of Participants|43|43.0||||||
3893708|NCT01511445|3718718|B2|||Use of nicotine products||Participants|Count of Participants|20|20.0||||||
3893709|NCT01511445|3718719|B1|||Use of nicotine products||Participants|Count of Participants|23|23.0||||||
3893710|NCT01511445|3718717|B3|Netherlands||Region of Enrollment||participants|Number|104|104.0||||||
3893711|NCT01511445|3718718|B2|Netherlands||Region of Enrollment||participants|Number|51|51.0||||||
3893712|NCT01511445|3718719|B1|Netherlands||Region of Enrollment||participants|Number|53|53.0||||||
3893713|NCT01511445|3718717|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3893714|NCT01511445|3718717|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3893715|NCT01511445|3718718|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3893716|NCT01511445|3718719|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3893717|NCT01511445|3718717|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3893718|NCT01511445|3718718|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3893719|NCT01511445|3718719|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3893720|NCT01511445|3718717|B3|||Age|Age at date of surgery|years|Mean|51.3|51.3|Standard Deviation|9.5|9.5|||
3893721|NCT01511445|3718718|B2|||Age|Age at date of surgery|years|Mean|49.6|49.6|Standard Deviation|9.5|9.5|||
3893722|NCT01511445|3718719|B1|||Age|Age at date of surgery|years|Mean|53.3|53.3|Standard Deviation|9.3|9.3|||
3893723|NCT01511315|3718728|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
3893724|NCT01511315|3718728|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3893725|NCT01511315|3718728|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3893726|NCT01511315|3718728|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3893727|NCT01511315|3718728|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3893728|NCT01511315|3718728|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3893729|NCT01511315|3718728|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3893730|NCT01511315|3718728|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3893731|NCT01511315|3718728|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3893732|NCT01511315|3718728|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3893733|NCT01511315|3718728|B1|||Age||years|Mean|41.2|41.2|Full Range|||19.0|67.0|
3893734|NCT01511250|3718738|B11|||Body Mass Index (BMI)||kg/m^2|Mean|18.83|18.83|Full Range|||12.1|41.3|
3893735|NCT01511250|3718739|B10|||Body Mass Index (BMI)||kg/m^2|Mean|17.08|17.08|Full Range|||13.2|24.3|
3893736|NCT01511250|3718740|B9|||Body Mass Index (BMI)||kg/m^2|Mean|17.02|17.02|Full Range|||12.1|30.1|
3893737|NCT01511250|3718741|B8|||Body Mass Index (BMI)||kg/m^2|Mean|16.95|16.95|Full Range|||13.2|20.4|
3893738|NCT01511250|3718742|B7|||Body Mass Index (BMI)||kg/m^2|Mean|15.63|15.63|Full Range|||12.5|19.0|
3893739|NCT01511250|3718743|B6|||Body Mass Index (BMI)||kg/m^2|Mean|16.56|16.56|Full Range|||14.2|20.6|
3893740|NCT01511250|3718744|B5|||Body Mass Index (BMI)||kg/m^2|Mean|18.38|18.38|Full Range|||12.9|28.8|
3893741|NCT01511250|3718745|B4|||Body Mass Index (BMI)||kg/m^2|Mean|23.09|23.09|Full Range|||18.6|31.5|
3893742|NCT01511250|3718746|B3|||Body Mass Index (BMI)||kg/m^2|Mean|22.60|22.6|Full Range|||15.0|33.6|
3893743|NCT01511250|3718747|B2|||Body Mass Index (BMI)||kg/m^2|Mean|29.05|29.05|Full Range|||21.3|38.7|
3893744|NCT01511250|3718748|B1|||Body Mass Index (BMI)||kg/m^2|Mean|28.81|28.81|Full Range|||14.7|41.3|
3893745|NCT01511250|3718738|B11|||Weight||kilograms (kg)|Mean|34.3|34.3|Full Range|||10.3|120.4|
3893746|NCT01511250|3718739|B10|||Weight||kilograms (kg)|Mean|26.7|26.7|Full Range|||10.6|53.2|
3893747|NCT01511250|3718740|B9|||Weight||kilograms (kg)|Mean|25.7|25.7|Full Range|||10.4|61.0|
3893748|NCT01511250|3718741|B8|||Weight||kilograms (kg)|Mean|16.5|16.5|Full Range|||13.3|20.8|
3893749|NCT01511250|3718742|B7|||Weight||kilograms (kg)|Mean|15.1|15.1|Full Range|||10.3|22.2|
3893750|NCT01511250|3718743|B6|||Weight||kilograms (kg)|Mean|27.0|27.0|Full Range|||20.3|37.5|
3893751|NCT01511250|3718744|B5|||Weight||kilograms (kg)|Mean|31.2|31.2|Full Range|||18.5|51.2|
3893752|NCT01511250|3718745|B4|||Weight||kilograms (kg)|Mean|59.5|59.5|Full Range|||48.6|89.9|
3893753|NCT01511250|3718746|B3|||Weight||kilograms (kg)|Mean|57.0|57.0|Full Range|||28.6|93.4|
3893754|NCT01511250|3718747|B2|||Weight||kilograms (kg)|Mean|80.2|80.2|Full Range|||56.3|120.4|
3893755|NCT01511250|3718748|B1|||Weight||kilograms (kg)|Mean|81.6|81.6|Full Range|||41.4|115.1|
3893756|NCT01511250|3718738|B11|||Height||meters (m)|Mean|1.28|1.28|Full Range|||0.77|1.87|
3893757|NCT01511250|3718739|B10|||Height||meters (m)|Mean|1.22|1.22|Full Range|||0.83|1.63|
3893758|NCT01511250|3718740|B9|||Height||meters (m)|Mean|1.20|1.2|Full Range|||0.77|1.62|
3893759|NCT01511250|3718741|B8|||Height||meters (m)|Mean|0.99|0.99|Full Range|||0.9|1.06|
3893760|NCT01511250|3718742|B7|||Height||meters (m)|Mean|0.98|0.98|Full Range|||0.83|1.13|
3893761|NCT01511250|3718743|B6|||Height||meters (m)|Mean|1.27|1.27|Full Range|||1.13|1.42|
3893762|NCT01511250|3718744|B5|||Height||meters (m)|Mean|1.29|1.29|Full Range|||1.08|1.52|
3893763|NCT01511250|3718745|B4|||Height||meters (m)|Mean|1.60|1.6|Full Range|||1.41|1.73|
3893764|NCT01511250|3718746|B3|||Height||meters (m)|Mean|1.58|1.58|Full Range|||1.38|1.72|
3893765|NCT01511250|3718747|B2|||Height||meters (m)|Mean|1.65|1.65|Full Range|||1.53|1.87|
3893766|NCT01511250|3718748|B1|||Height||meters (m)|Mean|1.68|1.68|Full Range|||1.57|1.82|
3893767|NCT01511250|3718738|B11|Seropositive to any Serotype=Yes||Seropositive to any Serotype at Day 0|Seropositivity is defined as a reciprocal neutralizing titer measured by a microneutralizing test 50% (MNT50) greater or equal to (≥)10.|participants|Number|174|174.0||||||
3893768|NCT01511250|3718739|B10|Seropositive to any Serotype=Yes||Seropositive to any Serotype at Day 0|Seropositivity is defined as a reciprocal neutralizing titer measured by a microneutralizing test 50% (MNT50) greater or equal to (≥)10.|participants|Number|29|29.0||||||
3893769|NCT01511250|3718740|B9|Seropositive to any Serotype=Yes||Seropositive to any Serotype at Day 0|Seropositivity is defined as a reciprocal neutralizing titer measured by a microneutralizing test 50% (MNT50) greater or equal to (≥)10.|participants|Number|66|66.0||||||
3893770|NCT01511250|3718741|B8|Seropositive to any Serotype=Yes||Seropositive to any Serotype at Day 0|Seropositivity is defined as a reciprocal neutralizing titer measured by a microneutralizing test 50% (MNT50) greater or equal to (≥)10.|participants|Number|1|1.0||||||
3893771|NCT01511250|3718742|B7|Seropositive to any Serotype=Yes||Seropositive to any Serotype at Day 0|Seropositivity is defined as a reciprocal neutralizing titer measured by a microneutralizing test 50% (MNT50) greater or equal to (≥)10.|participants|Number|7|7.0||||||
3893772|NCT01511250|3718743|B6|Seropositive to any Serotype=Yes||Seropositive to any Serotype at Day 0|Seropositivity is defined as a reciprocal neutralizing titer measured by a microneutralizing test 50% (MNT50) greater or equal to (≥)10.|participants|Number|3|3.0||||||
3893773|NCT01511250|3718744|B5|Seropositive to any Serotype=Yes||Seropositive to any Serotype at Day 0|Seropositivity is defined as a reciprocal neutralizing titer measured by a microneutralizing test 50% (MNT50) greater or equal to (≥)10.|participants|Number|9|9.0||||||
3893774|NCT01511250|3718745|B4|Seropositive to any Serotype=Yes||Seropositive to any Serotype at Day 0|Seropositivity is defined as a reciprocal neutralizing titer measured by a microneutralizing test 50% (MNT50) greater or equal to (≥)10.|participants|Number|13|13.0||||||
3893775|NCT01511250|3718746|B3|Seropositive to any Serotype=Yes||Seropositive to any Serotype at Day 0|Seropositivity is defined as a reciprocal neutralizing titer measured by a microneutralizing test 50% (MNT50) greater or equal to (≥)10.|participants|Number|15|15.0||||||
3893825|NCT01511250|3718741|B8|Asian||Race||participants|Number|6|6.0||||||
3893776|NCT01511250|3718747|B2|Seropositive to any Serotype=Yes||Seropositive to any Serotype at Day 0|Seropositivity is defined as a reciprocal neutralizing titer measured by a microneutralizing test 50% (MNT50) greater or equal to (≥)10.|participants|Number|12|12.0||||||
3893777|NCT01511250|3718748|B1|Seropositive to any Serotype=Yes||Seropositive to any Serotype at Day 0|Seropositivity is defined as a reciprocal neutralizing titer measured by a microneutralizing test 50% (MNT50) greater or equal to (≥)10.|participants|Number|19|19.0||||||
3893778|NCT01511250|3718738|B11|Seropositive to any Serotype=No||Seropositive to any Serotype at Day 0|Seropositivity is defined as a reciprocal neutralizing titer measured by a microneutralizing test 50% (MNT50) greater or equal to (≥)10.|participants|Number|186|186.0||||||
3893779|NCT01511250|3718739|B10|Seropositive to any Serotype=No||Seropositive to any Serotype at Day 0|Seropositivity is defined as a reciprocal neutralizing titer measured by a microneutralizing test 50% (MNT50) greater or equal to (≥)10.|participants|Number|24|24.0||||||
3893780|NCT01511250|3718740|B9|Seropositive to any Serotype=No||Seropositive to any Serotype at Day 0|Seropositivity is defined as a reciprocal neutralizing titer measured by a microneutralizing test 50% (MNT50) greater or equal to (≥)10.|participants|Number|93|93.0||||||
3893781|NCT01511250|3718741|B8|Seropositive to any Serotype=No||Seropositive to any Serotype at Day 0|Seropositivity is defined as a reciprocal neutralizing titer measured by a microneutralizing test 50% (MNT50) greater or equal to (≥)10.|participants|Number|12|12.0||||||
3893782|NCT01511250|3718742|B7|Seropositive to any Serotype=No||Seropositive to any Serotype at Day 0|Seropositivity is defined as a reciprocal neutralizing titer measured by a microneutralizing test 50% (MNT50) greater or equal to (≥)10.|participants|Number|16|16.0||||||
3893783|NCT01511250|3718743|B6|Seropositive to any Serotype=No||Seropositive to any Serotype at Day 0|Seropositivity is defined as a reciprocal neutralizing titer measured by a microneutralizing test 50% (MNT50) greater or equal to (≥)10.|participants|Number|14|14.0||||||
3893784|NCT01511250|3718744|B5|Seropositive to any Serotype=No||Seropositive to any Serotype at Day 0|Seropositivity is defined as a reciprocal neutralizing titer measured by a microneutralizing test 50% (MNT50) greater or equal to (≥)10.|participants|Number|12|12.0||||||
3893785|NCT01511250|3718745|B4|Seropositive to any Serotype=No||Seropositive to any Serotype at Day 0|Seropositivity is defined as a reciprocal neutralizing titer measured by a microneutralizing test 50% (MNT50) greater or equal to (≥)10.|participants|Number|1|1.0||||||
3893786|NCT01511250|3718746|B3|Seropositive to any Serotype=No||Seropositive to any Serotype at Day 0|Seropositivity is defined as a reciprocal neutralizing titer measured by a microneutralizing test 50% (MNT50) greater or equal to (≥)10.|participants|Number|7|7.0||||||
3893787|NCT01511250|3718747|B2|Seropositive to any Serotype=No||Seropositive to any Serotype at Day 0|Seropositivity is defined as a reciprocal neutralizing titer measured by a microneutralizing test 50% (MNT50) greater or equal to (≥)10.|participants|Number|2|2.0||||||
3893788|NCT01511250|3718748|B1|Seropositive to any Serotype=No||Seropositive to any Serotype at Day 0|Seropositivity is defined as a reciprocal neutralizing titer measured by a microneutralizing test 50% (MNT50) greater or equal to (≥)10.|participants|Number|5|5.0||||||
3893789|NCT01511250|3718738|B11|Black or African American||Race||participants|Number|5|5.0||||||
3893790|NCT01511250|3718739|B10|Black or African American||Race||participants|Number|2|2.0||||||
3893791|NCT01511250|3718740|B9|Black or African American||Race||participants|Number|3|3.0||||||
3893792|NCT01511250|3718741|B8|Black or African American||Race||participants|Number|0|0.0||||||
3893793|NCT01511250|3718742|B7|Black or African American||Race||participants|Number|0|0.0||||||
3893794|NCT01511250|3718743|B6|Black or African American||Race||participants|Number|0|0.0||||||
3893795|NCT01511250|3718744|B5|Black or African American||Race||participants|Number|0|0.0||||||
3893796|NCT01511250|3718745|B4|Black or African American||Race||participants|Number|0|0.0||||||
3893797|NCT01511250|3718746|B3|Black or African American||Race||participants|Number|0|0.0||||||
3893798|NCT01511250|3718747|B2|Black or African American||Race||participants|Number|0|0.0||||||
3893799|NCT01511250|3718748|B1|Black or African American||Race||participants|Number|0|0.0||||||
3893800|NCT01511250|3718738|B11|White||Race||participants|Number|3|3.0||||||
3893801|NCT01511250|3718739|B10|White||Race||participants|Number|0|0.0||||||
3893802|NCT01511250|3718740|B9|White||Race||participants|Number|0|0.0||||||
3893803|NCT01511250|3718741|B8|White||Race||participants|Number|0|0.0||||||
3893804|NCT01511250|3718742|B7|White||Race||participants|Number|0|0.0||||||
3893805|NCT01511250|3718743|B6|White||Race||participants|Number|0|0.0||||||
3893806|NCT01511250|3718744|B5|White||Race||participants|Number|1|1.0||||||
3893807|NCT01511250|3718745|B4|White||Race||participants|Number|0|0.0||||||
3893808|NCT01511250|3718746|B3|White||Race||participants|Number|0|0.0||||||
3893809|NCT01511250|3718747|B2|White||Race||participants|Number|1|1.0||||||
3893810|NCT01511250|3718748|B1|White||Race||participants|Number|1|1.0||||||
3893811|NCT01511250|3718738|B11|Hispanic or Latino||Race||participants|Number|175|175.0||||||
3893812|NCT01511250|3718739|B10|Hispanic or Latino||Race||participants|Number|27|27.0||||||
3893813|NCT01511250|3718740|B9|Hispanic or Latino||Race||participants|Number|79|79.0||||||
3893814|NCT01511250|3718741|B8|Hispanic or Latino||Race||participants|Number|7|7.0||||||
3893815|NCT01511250|3718742|B7|Hispanic or Latino||Race||participants|Number|11|11.0||||||
3893816|NCT01511250|3718743|B6|Hispanic or Latino||Race||participants|Number|5|5.0||||||
3893817|NCT01511250|3718744|B5|Hispanic or Latino||Race||participants|Number|4|4.0||||||
3893818|NCT01511250|3718745|B4|Hispanic or Latino||Race||participants|Number|6|6.0||||||
3893819|NCT01511250|3718746|B3|Hispanic or Latino||Race||participants|Number|6|6.0||||||
3893820|NCT01511250|3718747|B2|Hispanic or Latino||Race||participants|Number|10|10.0||||||
3893821|NCT01511250|3718748|B1|Hispanic or Latino||Race||participants|Number|20|20.0||||||
3893822|NCT01511250|3718738|B11|Asian||Race||participants|Number|177|177.0||||||
3893823|NCT01511250|3718739|B10|Asian||Race||participants|Number|24|24.0||||||
3893824|NCT01511250|3718740|B9|Asian||Race||participants|Number|77|77.0||||||
3893826|NCT01511250|3718742|B7|Asian||Race||participants|Number|12|12.0||||||
3893827|NCT01511250|3718743|B6|Asian||Race||participants|Number|12|12.0||||||
3893828|NCT01511250|3718744|B5|Asian||Race||participants|Number|16|16.0||||||
3893829|NCT01511250|3718745|B4|Asian||Race||participants|Number|8|8.0||||||
3893830|NCT01511250|3718746|B3|Asian||Race||participants|Number|16|16.0||||||
3893831|NCT01511250|3718747|B2|Asian||Race||participants|Number|3|3.0||||||
3893832|NCT01511250|3718748|B1|Asian||Race||participants|Number|3|3.0||||||
3893833|NCT01511250|3718738|B11||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3893834|NCT01511250|3718739|B10||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3893835|NCT01511250|3718740|B9||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3893836|NCT01511250|3718741|B8||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3893837|NCT01511250|3718742|B7||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3893838|NCT01511250|3718743|B6||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3893839|NCT01511250|3718744|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3893840|NCT01511250|3718745|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3893841|NCT01511250|3718746|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3893842|NCT01511250|3718747|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3893843|NCT01511250|3718748|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3893844|NCT01511250|3718738|B11||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3893845|NCT01511250|3718739|B10||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3893846|NCT01511250|3718740|B9||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3893847|NCT01511250|3718741|B8||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3893848|NCT01511250|3718742|B7||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3893849|NCT01511250|3718743|B6||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3893850|NCT01511250|3718744|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3893851|NCT01511250|3718745|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3893852|NCT01511250|3718746|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3893853|NCT01511250|3718747|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3893854|NCT01511250|3718748|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3893855|NCT01511250|3718738|B11|||Age||years|Mean|9.8|9.8|Full Range|||1.5|45.0|
3893856|NCT01511250|3718739|B10|||Age||years|Mean|6.8|6.8|Full Range|||2.1|11.0|
3893857|NCT01511250|3718740|B9|||Age||years|Mean|6.6|6.6|Full Range|||1.6|11.0|
3893858|NCT01511250|3718741|B8|||Age||years|Mean|3.5|3.5|Full Range|||2.3|5.0|
3893859|NCT01511250|3718742|B7|||Age||years|Mean|3.3|3.3|Full Range|||1.5|5.0|
3893860|NCT01511250|3718743|B6|||Age||years|Mean|7.8|7.8|Full Range|||6.0|11.0|
3893861|NCT01511250|3718744|B5|||Age||years|Mean|8.4|8.4|Full Range|||6.0|11.0|
3893862|NCT01511250|3718745|B4|||Age||years|Mean|16.8|16.8|Full Range|||12.0|20.0|
3893863|NCT01511250|3718746|B3|||Age||years|Mean|15.5|15.5|Full Range|||12.0|19.0|
3893864|NCT01511250|3718747|B2|||Age||years|Mean|30.1|30.1|Full Range|||21.0|40.0|
3893865|NCT01511250|3718748|B1|||Age||years|Mean|29.2|29.2|Full Range|||21.0|45.0|
3893866|NCT01511107|3718903|B3|Unknown, no culture||Haemophilus Influenzae (H influenzae) Sensitivity in Nasopharyngeal Cultures|Susceptible was defined as beta-lactamase-negative and E test MIC ≤1 µg/mL; nonsusceptible was defined as either beta-lactamase-positive or beta-lactamase-negative and E test MIC >1 µg/mL.|participants|Number|1|1.0||||||
3893867|NCT01511107|3718904|B2|Unknown, no culture||Haemophilus Influenzae (H influenzae) Sensitivity in Nasopharyngeal Cultures|Susceptible was defined as beta-lactamase-negative and E test MIC ≤1 µg/mL; nonsusceptible was defined as either beta-lactamase-positive or beta-lactamase-negative and E test MIC >1 µg/mL.|participants|Number|0|0.0||||||
3893868|NCT01511107|3718905|B1|Unknown, no culture||Haemophilus Influenzae (H influenzae) Sensitivity in Nasopharyngeal Cultures|Susceptible was defined as beta-lactamase-negative and E test MIC ≤1 µg/mL; nonsusceptible was defined as either beta-lactamase-positive or beta-lactamase-negative and E test MIC >1 µg/mL.|participants|Number|1|1.0||||||
3893869|NCT01511107|3718903|B3|H influenzae present, nonsusceptible||Haemophilus Influenzae (H influenzae) Sensitivity in Nasopharyngeal Cultures|Susceptible was defined as beta-lactamase-negative and E test MIC ≤1 µg/mL; nonsusceptible was defined as either beta-lactamase-positive or beta-lactamase-negative and E test MIC >1 µg/mL.|participants|Number|55|55.0||||||
3893870|NCT01511107|3718904|B2|H influenzae present, nonsusceptible||Haemophilus Influenzae (H influenzae) Sensitivity in Nasopharyngeal Cultures|Susceptible was defined as beta-lactamase-negative and E test MIC ≤1 µg/mL; nonsusceptible was defined as either beta-lactamase-positive or beta-lactamase-negative and E test MIC >1 µg/mL.|participants|Number|24|24.0||||||
3893871|NCT01511107|3718905|B1|H influenzae present, nonsusceptible||Haemophilus Influenzae (H influenzae) Sensitivity in Nasopharyngeal Cultures|Susceptible was defined as beta-lactamase-negative and E test MIC ≤1 µg/mL; nonsusceptible was defined as either beta-lactamase-positive or beta-lactamase-negative and E test MIC >1 µg/mL.|participants|Number|31|31.0||||||
3893872|NCT01511107|3718903|B3|H influenzae present, susceptible||Haemophilus Influenzae (H influenzae) Sensitivity in Nasopharyngeal Cultures|Susceptible was defined as beta-lactamase-negative and E test MIC ≤1 µg/mL; nonsusceptible was defined as either beta-lactamase-positive or beta-lactamase-negative and E test MIC >1 µg/mL.|participants|Number|90|90.0||||||
3893873|NCT01511107|3718904|B2|H influenzae present, susceptible||Haemophilus Influenzae (H influenzae) Sensitivity in Nasopharyngeal Cultures|Susceptible was defined as beta-lactamase-negative and E test MIC ≤1 µg/mL; nonsusceptible was defined as either beta-lactamase-positive or beta-lactamase-negative and E test MIC >1 µg/mL.|participants|Number|37|37.0||||||
3893874|NCT01511107|3718905|B1|H influenzae present, susceptible||Haemophilus Influenzae (H influenzae) Sensitivity in Nasopharyngeal Cultures|Susceptible was defined as beta-lactamase-negative and E test MIC ≤1 µg/mL; nonsusceptible was defined as either beta-lactamase-positive or beta-lactamase-negative and E test MIC >1 µg/mL.|participants|Number|53|53.0||||||
3893875|NCT01511107|3718903|B3|H influenzae absent||Haemophilus Influenzae (H influenzae) Sensitivity in Nasopharyngeal Cultures|Susceptible was defined as beta-lactamase-negative and E test MIC ≤1 µg/mL; nonsusceptible was defined as either beta-lactamase-positive or beta-lactamase-negative and E test MIC >1 µg/mL.|participants|Number|369|369.0||||||
3893876|NCT01511107|3718904|B2|H influenzae absent||Haemophilus Influenzae (H influenzae) Sensitivity in Nasopharyngeal Cultures|Susceptible was defined as beta-lactamase-negative and E test MIC ≤1 µg/mL; nonsusceptible was defined as either beta-lactamase-positive or beta-lactamase-negative and E test MIC >1 µg/mL.|participants|Number|197|197.0||||||
3893877|NCT01511107|3718905|B1|H influenzae absent||Haemophilus Influenzae (H influenzae) Sensitivity in Nasopharyngeal Cultures|Susceptible was defined as beta-lactamase-negative and E test MIC ≤1 µg/mL; nonsusceptible was defined as either beta-lactamase-positive or beta-lactamase-negative and E test MIC >1 µg/mL.|participants|Number|172|172.0||||||
3893878|NCT01511107|3718903|B3|Unknown, no culture||Streptococcus Pneumoniae (S pneumoniae) Sensitivity in Nasopharyngeal Cultures|Susceptibility to penicillin was determined as follows: When minimum inhibitory concentration (MIC) was available , susceptible was defined as MIC <0.1 µg/mL, intermediate as MIC 0.1 to 1 µg/mL, and resistant as MIC >1 µg/mL. When MIC was not available, susceptible was defined as showing oxacillin disk zone size >20 mm, intermediate as zone size 9 to 20 mm, and resistant as zone size ≤8 mm.|participants|Number|1|1.0||||||
3893879|NCT01511107|3718904|B2|Unknown, no culture||Streptococcus Pneumoniae (S pneumoniae) Sensitivity in Nasopharyngeal Cultures|Susceptibility to penicillin was determined as follows: When minimum inhibitory concentration (MIC) was available , susceptible was defined as MIC <0.1 µg/mL, intermediate as MIC 0.1 to 1 µg/mL, and resistant as MIC >1 µg/mL. When MIC was not available, susceptible was defined as showing oxacillin disk zone size >20 mm, intermediate as zone size 9 to 20 mm, and resistant as zone size ≤8 mm.|participants|Number|0|0.0||||||
3893880|NCT01511107|3718905|B1|Unknown, no culture||Streptococcus Pneumoniae (S pneumoniae) Sensitivity in Nasopharyngeal Cultures|Susceptibility to penicillin was determined as follows: When minimum inhibitory concentration (MIC) was available , susceptible was defined as MIC <0.1 µg/mL, intermediate as MIC 0.1 to 1 µg/mL, and resistant as MIC >1 µg/mL. When MIC was not available, susceptible was defined as showing oxacillin disk zone size >20 mm, intermediate as zone size 9 to 20 mm, and resistant as zone size ≤8 mm.|participants|Number|1|1.0||||||
3893881|NCT01511107|3718903|B3|S pneumoniae present, resistant||Streptococcus Pneumoniae (S pneumoniae) Sensitivity in Nasopharyngeal Cultures|Susceptibility to penicillin was determined as follows: When minimum inhibitory concentration (MIC) was available , susceptible was defined as MIC <0.1 µg/mL, intermediate as MIC 0.1 to 1 µg/mL, and resistant as MIC >1 µg/mL. When MIC was not available, susceptible was defined as showing oxacillin disk zone size >20 mm, intermediate as zone size 9 to 20 mm, and resistant as zone size ≤8 mm.|participants|Number|37|37.0||||||
3893882|NCT01511107|3718904|B2|S pneumoniae present, resistant||Streptococcus Pneumoniae (S pneumoniae) Sensitivity in Nasopharyngeal Cultures|Susceptibility to penicillin was determined as follows: When minimum inhibitory concentration (MIC) was available , susceptible was defined as MIC <0.1 µg/mL, intermediate as MIC 0.1 to 1 µg/mL, and resistant as MIC >1 µg/mL. When MIC was not available, susceptible was defined as showing oxacillin disk zone size >20 mm, intermediate as zone size 9 to 20 mm, and resistant as zone size ≤8 mm.|participants|Number|16|16.0||||||
3893883|NCT01511107|3718905|B1|S pneumoniae present, resistant||Streptococcus Pneumoniae (S pneumoniae) Sensitivity in Nasopharyngeal Cultures|Susceptibility to penicillin was determined as follows: When minimum inhibitory concentration (MIC) was available , susceptible was defined as MIC <0.1 µg/mL, intermediate as MIC 0.1 to 1 µg/mL, and resistant as MIC >1 µg/mL. When MIC was not available, susceptible was defined as showing oxacillin disk zone size >20 mm, intermediate as zone size 9 to 20 mm, and resistant as zone size ≤8 mm.|participants|Number|21|21.0||||||
3893884|NCT01511107|3718903|B3|S pneumoniae present, intermediate||Streptococcus Pneumoniae (S pneumoniae) Sensitivity in Nasopharyngeal Cultures|Susceptibility to penicillin was determined as follows: When minimum inhibitory concentration (MIC) was available , susceptible was defined as MIC <0.1 µg/mL, intermediate as MIC 0.1 to 1 µg/mL, and resistant as MIC >1 µg/mL. When MIC was not available, susceptible was defined as showing oxacillin disk zone size >20 mm, intermediate as zone size 9 to 20 mm, and resistant as zone size ≤8 mm.|participants|Number|48|48.0||||||
3893885|NCT01511107|3718904|B2|S pneumoniae present, intermediate||Streptococcus Pneumoniae (S pneumoniae) Sensitivity in Nasopharyngeal Cultures|Susceptibility to penicillin was determined as follows: When minimum inhibitory concentration (MIC) was available , susceptible was defined as MIC <0.1 µg/mL, intermediate as MIC 0.1 to 1 µg/mL, and resistant as MIC >1 µg/mL. When MIC was not available, susceptible was defined as showing oxacillin disk zone size >20 mm, intermediate as zone size 9 to 20 mm, and resistant as zone size ≤8 mm.|participants|Number|28|28.0||||||
3893886|NCT01511107|3718905|B1|S pneumoniae present, intermediate||Streptococcus Pneumoniae (S pneumoniae) Sensitivity in Nasopharyngeal Cultures|Susceptibility to penicillin was determined as follows: When minimum inhibitory concentration (MIC) was available , susceptible was defined as MIC <0.1 µg/mL, intermediate as MIC 0.1 to 1 µg/mL, and resistant as MIC >1 µg/mL. When MIC was not available, susceptible was defined as showing oxacillin disk zone size >20 mm, intermediate as zone size 9 to 20 mm, and resistant as zone size ≤8 mm.|participants|Number|20|20.0||||||
3893887|NCT01511107|3718903|B3|S pneumoniae present, susceptible||Streptococcus Pneumoniae (S pneumoniae) Sensitivity in Nasopharyngeal Cultures|Susceptibility to penicillin was determined as follows: When minimum inhibitory concentration (MIC) was available , susceptible was defined as MIC <0.1 µg/mL, intermediate as MIC 0.1 to 1 µg/mL, and resistant as MIC >1 µg/mL. When MIC was not available, susceptible was defined as showing oxacillin disk zone size >20 mm, intermediate as zone size 9 to 20 mm, and resistant as zone size ≤8 mm.|participants|Number|178|178.0||||||
3893910|NCT01511107|3718905|B1|Likely severe||Estimated severity of illness from pain and fever history only|"AOM episodes were categorized as “likely severe” if the parent described the child as having had “a lot” of ear tugging or “a lot” of fever during the preceding 24 hours, else the episode was categorized as likely nonsevere."|participants|Number|146|146.0||||||
3894167|NCT01510652|3719069|B3|Atrial Flutter||Atrial Arrhythmia History||participants|Number|28|28.0||||||
3893888|NCT01511107|3718904|B2|S pneumoniae present, susceptible||Streptococcus Pneumoniae (S pneumoniae) Sensitivity in Nasopharyngeal Cultures|Susceptibility to penicillin was determined as follows: When minimum inhibitory concentration (MIC) was available , susceptible was defined as MIC <0.1 µg/mL, intermediate as MIC 0.1 to 1 µg/mL, and resistant as MIC >1 µg/mL. When MIC was not available, susceptible was defined as showing oxacillin disk zone size >20 mm, intermediate as zone size 9 to 20 mm, and resistant as zone size ≤8 mm.|participants|Number|94|94.0||||||
3893889|NCT01511107|3718905|B1|S pneumoniae present, susceptible||Streptococcus Pneumoniae (S pneumoniae) Sensitivity in Nasopharyngeal Cultures|Susceptibility to penicillin was determined as follows: When minimum inhibitory concentration (MIC) was available , susceptible was defined as MIC <0.1 µg/mL, intermediate as MIC 0.1 to 1 µg/mL, and resistant as MIC >1 µg/mL. When MIC was not available, susceptible was defined as showing oxacillin disk zone size >20 mm, intermediate as zone size 9 to 20 mm, and resistant as zone size ≤8 mm.|participants|Number|84|84.0||||||
3893890|NCT01511107|3718903|B3|S pneumoniae absent||Streptococcus Pneumoniae (S pneumoniae) Sensitivity in Nasopharyngeal Cultures|Susceptibility to penicillin was determined as follows: When minimum inhibitory concentration (MIC) was available , susceptible was defined as MIC <0.1 µg/mL, intermediate as MIC 0.1 to 1 µg/mL, and resistant as MIC >1 µg/mL. When MIC was not available, susceptible was defined as showing oxacillin disk zone size >20 mm, intermediate as zone size 9 to 20 mm, and resistant as zone size ≤8 mm.|participants|Number|251|251.0||||||
3893891|NCT01511107|3718904|B2|S pneumoniae absent||Streptococcus Pneumoniae (S pneumoniae) Sensitivity in Nasopharyngeal Cultures|Susceptibility to penicillin was determined as follows: When minimum inhibitory concentration (MIC) was available , susceptible was defined as MIC <0.1 µg/mL, intermediate as MIC 0.1 to 1 µg/mL, and resistant as MIC >1 µg/mL. When MIC was not available, susceptible was defined as showing oxacillin disk zone size >20 mm, intermediate as zone size 9 to 20 mm, and resistant as zone size ≤8 mm.|participants|Number|120|120.0||||||
3893892|NCT01511107|3718905|B1|S pneumoniae absent||Streptococcus Pneumoniae (S pneumoniae) Sensitivity in Nasopharyngeal Cultures|Susceptibility to penicillin was determined as follows: When minimum inhibitory concentration (MIC) was available , susceptible was defined as MIC <0.1 µg/mL, intermediate as MIC 0.1 to 1 µg/mL, and resistant as MIC >1 µg/mL. When MIC was not available, susceptible was defined as showing oxacillin disk zone size >20 mm, intermediate as zone size 9 to 20 mm, and resistant as zone size ≤8 mm.|participants|Number|131|131.0||||||
3893893|NCT01511107|3718903|B3|Marked||Degree of Tympanic Membrane Bulging|If a child has unilateral AOM, the degree of bulging reflects the degree of bulging in the ear with AOM. If a child has bilateral AOM, the degree of bulging reflects the degree of bulging in the ear with the greater level of bulging,|participants|Number|163|163.0||||||
3893894|NCT01511107|3718904|B2|Marked||Degree of Tympanic Membrane Bulging|If a child has unilateral AOM, the degree of bulging reflects the degree of bulging in the ear with AOM. If a child has bilateral AOM, the degree of bulging reflects the degree of bulging in the ear with the greater level of bulging,|participants|Number|78|78.0||||||
3893895|NCT01511107|3718905|B1|Marked||Degree of Tympanic Membrane Bulging|If a child has unilateral AOM, the degree of bulging reflects the degree of bulging in the ear with AOM. If a child has bilateral AOM, the degree of bulging reflects the degree of bulging in the ear with the greater level of bulging,|participants|Number|85|85.0||||||
3893896|NCT01511107|3718903|B3|Moderate||Degree of Tympanic Membrane Bulging|If a child has unilateral AOM, the degree of bulging reflects the degree of bulging in the ear with AOM. If a child has bilateral AOM, the degree of bulging reflects the degree of bulging in the ear with the greater level of bulging,|participants|Number|272|272.0||||||
3893897|NCT01511107|3718904|B2|Moderate||Degree of Tympanic Membrane Bulging|If a child has unilateral AOM, the degree of bulging reflects the degree of bulging in the ear with AOM. If a child has bilateral AOM, the degree of bulging reflects the degree of bulging in the ear with the greater level of bulging,|participants|Number|135|135.0||||||
3893898|NCT01511107|3718905|B1|Moderate||Degree of Tympanic Membrane Bulging|If a child has unilateral AOM, the degree of bulging reflects the degree of bulging in the ear with AOM. If a child has bilateral AOM, the degree of bulging reflects the degree of bulging in the ear with the greater level of bulging,|participants|Number|137|137.0||||||
3893899|NCT01511107|3718903|B3|Slight||Degree of Tympanic Membrane Bulging|If a child has unilateral AOM, the degree of bulging reflects the degree of bulging in the ear with AOM. If a child has bilateral AOM, the degree of bulging reflects the degree of bulging in the ear with the greater level of bulging,|participants|Number|80|80.0||||||
3893900|NCT01511107|3718904|B2|Slight||Degree of Tympanic Membrane Bulging|If a child has unilateral AOM, the degree of bulging reflects the degree of bulging in the ear with AOM. If a child has bilateral AOM, the degree of bulging reflects the degree of bulging in the ear with the greater level of bulging,|participants|Number|45|45.0||||||
3893901|NCT01511107|3718905|B1|Slight||Degree of Tympanic Membrane Bulging|If a child has unilateral AOM, the degree of bulging reflects the degree of bulging in the ear with AOM. If a child has bilateral AOM, the degree of bulging reflects the degree of bulging in the ear with the greater level of bulging,|participants|Number|35|35.0||||||
3893902|NCT01511107|3718903|B3|Bilateral||Laterality of Acute Otitis Media (AOM)||participants|Number|253|253.0||||||
3893903|NCT01511107|3718904|B2|Bilateral||Laterality of Acute Otitis Media (AOM)||participants|Number|132|132.0||||||
3893904|NCT01511107|3718905|B1|Bilateral||Laterality of Acute Otitis Media (AOM)||participants|Number|121|121.0||||||
3893905|NCT01511107|3718903|B3|Unilateral||Laterality of Acute Otitis Media (AOM)||participants|Number|262|262.0||||||
3893906|NCT01511107|3718904|B2|Unilateral||Laterality of Acute Otitis Media (AOM)||participants|Number|126|126.0||||||
3893907|NCT01511107|3718905|B1|Unilateral||Laterality of Acute Otitis Media (AOM)||participants|Number|136|136.0||||||
3893908|NCT01511107|3718903|B3|Likely severe||Estimated severity of illness from pain and fever history only|"AOM episodes were categorized as “likely severe” if the parent described the child as having had “a lot” of ear tugging or “a lot” of fever during the preceding 24 hours, else the episode was categorized as likely nonsevere."|participants|Number|283|283.0||||||
3893909|NCT01511107|3718904|B2|Likely severe||Estimated severity of illness from pain and fever history only|"AOM episodes were categorized as “likely severe” if the parent described the child as having had “a lot” of ear tugging or “a lot” of fever during the preceding 24 hours, else the episode was categorized as likely nonsevere."|participants|Number|137|137.0||||||
3893911|NCT01511107|3718903|B3|Likely nonsevere||Estimated severity of illness from pain and fever history only|"AOM episodes were categorized as “likely severe” if the parent described the child as having had “a lot” of ear tugging or “a lot” of fever during the preceding 24 hours, else the episode was categorized as likely nonsevere."|participants|Number|232|232.0||||||
3893912|NCT01511107|3718904|B2|Likely nonsevere||Estimated severity of illness from pain and fever history only|"AOM episodes were categorized as “likely severe” if the parent described the child as having had “a lot” of ear tugging or “a lot” of fever during the preceding 24 hours, else the episode was categorized as likely nonsevere."|participants|Number|121|121.0||||||
3893913|NCT01511107|3718905|B1|Likely nonsevere||Estimated severity of illness from pain and fever history only|"AOM episodes were categorized as “likely severe” if the parent described the child as having had “a lot” of ear tugging or “a lot” of fever during the preceding 24 hours, else the episode was categorized as likely nonsevere."|participants|Number|111|111.0||||||
3893914|NCT01511107|3718903|B3|||Mean AOM-SOS Score|The AOM-SOS scale measures seven discrete items: tugging of ears, crying, irritability, difficulty sleeping, diminished activity, diminished appetite, and fever. Parents are asked to rate these symptoms in comparison with the child’s usual state, as “none,” “a little,” or “a lot,” with corresponding scores of 0, 1, and 2. Thus, total scores range from 0 to 14, with higher scores indicating greater severity of symptoms.|AOM-SOS score|Mean|8.4|8.4|Standard Deviation|3.0|3.0|||
3893915|NCT01511107|3718904|B2|||Mean AOM-SOS Score|The AOM-SOS scale measures seven discrete items: tugging of ears, crying, irritability, difficulty sleeping, diminished activity, diminished appetite, and fever. Parents are asked to rate these symptoms in comparison with the child’s usual state, as “none,” “a little,” or “a lot,” with corresponding scores of 0, 1, and 2. Thus, total scores range from 0 to 14, with higher scores indicating greater severity of symptoms.|AOM-SOS score|Mean|8.2|8.2|Standard Deviation|3.0|3.0|||
3893916|NCT01511107|3718905|B1|||Mean AOM-SOS Score|The AOM-SOS scale measures seven discrete items: tugging of ears, crying, irritability, difficulty sleeping, diminished activity, diminished appetite, and fever. Parents are asked to rate these symptoms in comparison with the child’s usual state, as “none,” “a little,” or “a lot,” with corresponding scores of 0, 1, and 2. Thus, total scores range from 0 to 14, with higher scores indicating greater severity of symptoms.|AOM-SOS score|Mean|8.6|8.6|Standard Deviation|2.9|2.9|||
3893917|NCT01511107|3718903|B3|12-14||Acute Otitis Media Severity of Symptoms (AOM-SOS) Score|The AOM-SOS scale measures seven discrete items: tugging of ears, crying, irritability, difficulty sleeping, diminished activity, diminished appetite, and fever. Parents are asked to rate these symptoms in comparison with the child’s usual state, as “none,” “a little,” or “a lot,” with corresponding scores of 0, 1, and 2. Thus, total scores range from 0 to 14, with higher scores indicating greater severity of symptoms. Children must have at least a total score of 3 at enrollment to qualify for the study.|participants|Number|75|75.0||||||
3893918|NCT01511107|3718904|B2|12-14||Acute Otitis Media Severity of Symptoms (AOM-SOS) Score|The AOM-SOS scale measures seven discrete items: tugging of ears, crying, irritability, difficulty sleeping, diminished activity, diminished appetite, and fever. Parents are asked to rate these symptoms in comparison with the child’s usual state, as “none,” “a little,” or “a lot,” with corresponding scores of 0, 1, and 2. Thus, total scores range from 0 to 14, with higher scores indicating greater severity of symptoms. Children must have at least a total score of 3 at enrollment to qualify for the study.|participants|Number|34|34.0||||||
3893919|NCT01511107|3718905|B1|12-14||Acute Otitis Media Severity of Symptoms (AOM-SOS) Score|The AOM-SOS scale measures seven discrete items: tugging of ears, crying, irritability, difficulty sleeping, diminished activity, diminished appetite, and fever. Parents are asked to rate these symptoms in comparison with the child’s usual state, as “none,” “a little,” or “a lot,” with corresponding scores of 0, 1, and 2. Thus, total scores range from 0 to 14, with higher scores indicating greater severity of symptoms. Children must have at least a total score of 3 at enrollment to qualify for the study.|participants|Number|41|41.0||||||
3893920|NCT01511107|3718903|B3|9-11||Acute Otitis Media Severity of Symptoms (AOM-SOS) Score|The AOM-SOS scale measures seven discrete items: tugging of ears, crying, irritability, difficulty sleeping, diminished activity, diminished appetite, and fever. Parents are asked to rate these symptoms in comparison with the child’s usual state, as “none,” “a little,” or “a lot,” with corresponding scores of 0, 1, and 2. Thus, total scores range from 0 to 14, with higher scores indicating greater severity of symptoms. Children must have at least a total score of 3 at enrollment to qualify for the study.|participants|Number|193|193.0||||||
3893921|NCT01511107|3718904|B2|9-11||Acute Otitis Media Severity of Symptoms (AOM-SOS) Score|The AOM-SOS scale measures seven discrete items: tugging of ears, crying, irritability, difficulty sleeping, diminished activity, diminished appetite, and fever. Parents are asked to rate these symptoms in comparison with the child’s usual state, as “none,” “a little,” or “a lot,” with corresponding scores of 0, 1, and 2. Thus, total scores range from 0 to 14, with higher scores indicating greater severity of symptoms. Children must have at least a total score of 3 at enrollment to qualify for the study.|participants|Number|95|95.0||||||
3893922|NCT01511107|3718905|B1|9-11||Acute Otitis Media Severity of Symptoms (AOM-SOS) Score|The AOM-SOS scale measures seven discrete items: tugging of ears, crying, irritability, difficulty sleeping, diminished activity, diminished appetite, and fever. Parents are asked to rate these symptoms in comparison with the child’s usual state, as “none,” “a little,” or “a lot,” with corresponding scores of 0, 1, and 2. Thus, total scores range from 0 to 14, with higher scores indicating greater severity of symptoms. Children must have at least a total score of 3 at enrollment to qualify for the study.|participants|Number|98|98.0||||||
3893923|NCT01511107|3718903|B3|6-8||Acute Otitis Media Severity of Symptoms (AOM-SOS) Score|The AOM-SOS scale measures seven discrete items: tugging of ears, crying, irritability, difficulty sleeping, diminished activity, diminished appetite, and fever. Parents are asked to rate these symptoms in comparison with the child’s usual state, as “none,” “a little,” or “a lot,” with corresponding scores of 0, 1, and 2. Thus, total scores range from 0 to 14, with higher scores indicating greater severity of symptoms. Children must have at least a total score of 3 at enrollment to qualify for the study.|participants|Number|145|145.0||||||
3893988|NCT01511107|3718905|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|Parents were asked what ethnicity they would use to describe their child.|Participants|Count of Participants|0|0.0||||||
3894168|NCT01510652|3719070|B2|Atrial Flutter||Atrial Arrhythmia History||participants|Number|7|7.0||||||
3893924|NCT01511107|3718904|B2|6-8||Acute Otitis Media Severity of Symptoms (AOM-SOS) Score|The AOM-SOS scale measures seven discrete items: tugging of ears, crying, irritability, difficulty sleeping, diminished activity, diminished appetite, and fever. Parents are asked to rate these symptoms in comparison with the child’s usual state, as “none,” “a little,” or “a lot,” with corresponding scores of 0, 1, and 2. Thus, total scores range from 0 to 14, with higher scores indicating greater severity of symptoms. Children must have at least a total score of 3 at enrollment to qualify for the study.|participants|Number|70|70.0||||||
3893925|NCT01511107|3718905|B1|6-8||Acute Otitis Media Severity of Symptoms (AOM-SOS) Score|The AOM-SOS scale measures seven discrete items: tugging of ears, crying, irritability, difficulty sleeping, diminished activity, diminished appetite, and fever. Parents are asked to rate these symptoms in comparison with the child’s usual state, as “none,” “a little,” or “a lot,” with corresponding scores of 0, 1, and 2. Thus, total scores range from 0 to 14, with higher scores indicating greater severity of symptoms. Children must have at least a total score of 3 at enrollment to qualify for the study.|participants|Number|75|75.0||||||
3893926|NCT01511107|3718903|B3|3-5||Acute Otitis Media Severity of Symptoms (AOM-SOS) Score|The AOM-SOS scale measures seven discrete items: tugging of ears, crying, irritability, difficulty sleeping, diminished activity, diminished appetite, and fever. Parents are asked to rate these symptoms in comparison with the child’s usual state, as “none,” “a little,” or “a lot,” with corresponding scores of 0, 1, and 2. Thus, total scores range from 0 to 14, with higher scores indicating greater severity of symptoms. Children must have at least a total score of 3 at enrollment to qualify for the study.|participants|Number|102|102.0||||||
3893927|NCT01511107|3718904|B2|3-5||Acute Otitis Media Severity of Symptoms (AOM-SOS) Score|The AOM-SOS scale measures seven discrete items: tugging of ears, crying, irritability, difficulty sleeping, diminished activity, diminished appetite, and fever. Parents are asked to rate these symptoms in comparison with the child’s usual state, as “none,” “a little,” or “a lot,” with corresponding scores of 0, 1, and 2. Thus, total scores range from 0 to 14, with higher scores indicating greater severity of symptoms. Children must have at least a total score of 3 at enrollment to qualify for the study.|participants|Number|59|59.0||||||
3893928|NCT01511107|3718905|B1|3-5||Acute Otitis Media Severity of Symptoms (AOM-SOS) Score|The AOM-SOS scale measures seven discrete items: tugging of ears, crying, irritability, difficulty sleeping, diminished activity, diminished appetite, and fever. Parents are asked to rate these symptoms in comparison with the child’s usual state, as “none,” “a little,” or “a lot,” with corresponding scores of 0, 1, and 2. Thus, total scores range from 0 to 14, with higher scores indicating greater severity of symptoms. Children must have at least a total score of 3 at enrollment to qualify for the study.|participants|Number|43|43.0||||||
3893929|NCT01511107|3718903|B3|Exposed||Exposure to Other Children|Exposed to other children is defined as a being exposed to 3 or more children for 10 or more hours per week or living in a home with at least 3 other children under the age of 18.|participants|Number|301|301.0||||||
3893930|NCT01511107|3718904|B2|Exposed||Exposure to Other Children|Exposed to other children is defined as a being exposed to 3 or more children for 10 or more hours per week or living in a home with at least 3 other children under the age of 18.|participants|Number|153|153.0||||||
3893931|NCT01511107|3718905|B1|Exposed||Exposure to Other Children|Exposed to other children is defined as a being exposed to 3 or more children for 10 or more hours per week or living in a home with at least 3 other children under the age of 18.|participants|Number|148|148.0||||||
3893932|NCT01511107|3718903|B3|Not exposed||Exposure to Other Children|Exposed to other children is defined as a being exposed to 3 or more children for 10 or more hours per week or living in a home with at least 3 other children under the age of 18.|participants|Number|214|214.0||||||
3893933|NCT01511107|3718904|B2|Not exposed||Exposure to Other Children|Exposed to other children is defined as a being exposed to 3 or more children for 10 or more hours per week or living in a home with at least 3 other children under the age of 18.|participants|Number|105|105.0||||||
3893934|NCT01511107|3718905|B1|Not exposed||Exposure to Other Children|Exposed to other children is defined as a being exposed to 3 or more children for 10 or more hours per week or living in a home with at least 3 other children under the age of 18.|participants|Number|109|109.0||||||
3893935|NCT01511107|3718903|B3|None||Type of Health Insurance|Type of health insurance relates to the child's insurance.|participants|Number|6|6.0||||||
3893936|NCT01511107|3718904|B2|None||Type of Health Insurance|Type of health insurance relates to the child's insurance.|participants|Number|4|4.0||||||
3893937|NCT01511107|3718905|B1|None||Type of Health Insurance|Type of health insurance relates to the child's insurance.|participants|Number|2|2.0||||||
3893938|NCT01511107|3718903|B3|Public||Type of Health Insurance|Type of health insurance relates to the child's insurance.|participants|Number|350|350.0||||||
3893939|NCT01511107|3718904|B2|Public||Type of Health Insurance|Type of health insurance relates to the child's insurance.|participants|Number|179|179.0||||||
3893940|NCT01511107|3718905|B1|Public||Type of Health Insurance|Type of health insurance relates to the child's insurance.|participants|Number|171|171.0||||||
3893941|NCT01511107|3718903|B3|Private||Type of Health Insurance|Type of health insurance relates to the child's insurance.|participants|Number|159|159.0||||||
3893942|NCT01511107|3718904|B2|Private||Type of Health Insurance|Type of health insurance relates to the child's insurance.|participants|Number|75|75.0||||||
3893943|NCT01511107|3718905|B1|Private||Type of Health Insurance|Type of health insurance relates to the child's insurance.|participants|Number|84|84.0||||||
3893944|NCT01511107|3718903|B3|Unknown||Maternal Education|Parent was asked about the highest level of maternal education. High school graduate or equivalent implies the mother has graduated high school graduate or has a General Education Diploma (GED) or has attended technical school or some college or has an associates degree.|participants|Number|1|1.0||||||
3893945|NCT01511107|3718904|B2|Unknown||Maternal Education|Parent was asked about the highest level of maternal education. High school graduate or equivalent implies the mother has graduated high school graduate or has a General Education Diploma (GED) or has attended technical school or some college or has an associates degree.|participants|Number|1|1.0||||||
3893989|NCT01511107|3718903|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Parents were asked what ethnicity they would use to describe their child.|Participants|Count of Participants|468|468.0||||||
3894100|NCT01510769|3718999|B2|>=65 Years||Age, Customized|<65 Years, >=65 Years|Participants|Number|19|19.0||||||
3893946|NCT01511107|3718905|B1|Unknown||Maternal Education|Parent was asked about the highest level of maternal education. High school graduate or equivalent implies the mother has graduated high school graduate or has a General Education Diploma (GED) or has attended technical school or some college or has an associates degree.|participants|Number|0|0.0||||||
3893947|NCT01511107|3718903|B3|College graduate||Maternal Education|Parent was asked about the highest level of maternal education. High school graduate or equivalent implies the mother has graduated high school graduate or has a General Education Diploma (GED) or has attended technical school or some college or has an associates degree.|participants|Number|138|138.0||||||
3893948|NCT01511107|3718904|B2|College graduate||Maternal Education|Parent was asked about the highest level of maternal education. High school graduate or equivalent implies the mother has graduated high school graduate or has a General Education Diploma (GED) or has attended technical school or some college or has an associates degree.|participants|Number|62|62.0||||||
3893949|NCT01511107|3718905|B1|College graduate||Maternal Education|Parent was asked about the highest level of maternal education. High school graduate or equivalent implies the mother has graduated high school graduate or has a General Education Diploma (GED) or has attended technical school or some college or has an associates degree.|participants|Number|76|76.0||||||
3893950|NCT01511107|3718903|B3|High school graduate or equivalent||Maternal Education|Parent was asked about the highest level of maternal education. High school graduate or equivalent implies the mother has graduated high school graduate or has a General Education Diploma (GED) or has attended technical school or some college or has an associates degree.|participants|Number|319|319.0||||||
3893951|NCT01511107|3718904|B2|High school graduate or equivalent||Maternal Education|Parent was asked about the highest level of maternal education. High school graduate or equivalent implies the mother has graduated high school graduate or has a General Education Diploma (GED) or has attended technical school or some college or has an associates degree.|participants|Number|169|169.0||||||
3893952|NCT01511107|3718905|B1|High school graduate or equivalent||Maternal Education|Parent was asked about the highest level of maternal education. High school graduate or equivalent implies the mother has graduated high school graduate or has a General Education Diploma (GED) or has attended technical school or some college or has an associates degree.|participants|Number|150|150.0||||||
3893953|NCT01511107|3718903|B3|Less than high school||Maternal Education|Parent was asked about the highest level of maternal education. High school graduate or equivalent implies the mother has graduated high school graduate or has a General Education Diploma (GED) or has attended technical school or some college or has an associates degree.|participants|Number|57|57.0||||||
3893954|NCT01511107|3718904|B2|Less than high school||Maternal Education|Parent was asked about the highest level of maternal education. High school graduate or equivalent implies the mother has graduated high school graduate or has a General Education Diploma (GED) or has attended technical school or some college or has an associates degree.|participants|Number|26|26.0||||||
3893955|NCT01511107|3718905|B1|Less than high school||Maternal Education|Parent was asked about the highest level of maternal education. High school graduate or equivalent implies the mother has graduated high school graduate or has a General Education Diploma (GED) or has attended technical school or some college or has an associates degree.|participants|Number|31|31.0||||||
3893956|NCT01511107|3718903|B3|Kentucky Pediatric and Adult Research||Study Site|Participating clinical study sites included: Children's Hospital of Pittsburgh (CHP) of University of Pittsburgh Medical Center (UPMC) Primary Care Center - Oakland, CHP of UPMC Emergency Department, Pittsburgh, Pennsylvania (PA); its affiliated University of Pittsburgh Clinical and Translational Science Institute (PittNet) Pediatric Practice-Based Research Network (PBRN) - PittNet North, East, South, City Loop, Pittsburgh, PA and Kittanning, PA; and Kentucky Pediatric/Adult Research (KPAR) and Physicians to Children and Adolescents (PTCA) Bardstown, Kentucky (KY).|participants|Number|95|95.0||||||
3893957|NCT01511107|3718904|B2|Kentucky Pediatric and Adult Research||Study Site|Participating clinical study sites included: Children's Hospital of Pittsburgh (CHP) of University of Pittsburgh Medical Center (UPMC) Primary Care Center - Oakland, CHP of UPMC Emergency Department, Pittsburgh, Pennsylvania (PA); its affiliated University of Pittsburgh Clinical and Translational Science Institute (PittNet) Pediatric Practice-Based Research Network (PBRN) - PittNet North, East, South, City Loop, Pittsburgh, PA and Kittanning, PA; and Kentucky Pediatric/Adult Research (KPAR) and Physicians to Children and Adolescents (PTCA) Bardstown, Kentucky (KY).|participants|Number|48|48.0||||||
3893958|NCT01511107|3718905|B1|Kentucky Pediatric and Adult Research||Study Site|Participating clinical study sites included: Children's Hospital of Pittsburgh (CHP) of University of Pittsburgh Medical Center (UPMC) Primary Care Center - Oakland, CHP of UPMC Emergency Department, Pittsburgh, Pennsylvania (PA); its affiliated University of Pittsburgh Clinical and Translational Science Institute (PittNet) Pediatric Practice-Based Research Network (PBRN) - PittNet North, East, South, City Loop, Pittsburgh, PA and Kittanning, PA; and Kentucky Pediatric/Adult Research (KPAR) and Physicians to Children and Adolescents (PTCA) Bardstown, Kentucky (KY).|participants|Number|47|47.0||||||
3893959|NCT01511107|3718903|B3|Children's Community Pediatrics||Study Site|Participating clinical study sites included: Children's Hospital of Pittsburgh (CHP) of University of Pittsburgh Medical Center (UPMC) Primary Care Center - Oakland, CHP of UPMC Emergency Department, Pittsburgh, Pennsylvania (PA); its affiliated University of Pittsburgh Clinical and Translational Science Institute (PittNet) Pediatric Practice-Based Research Network (PBRN) - PittNet North, East, South, City Loop, Pittsburgh, PA and Kittanning, PA; and Kentucky Pediatric/Adult Research (KPAR) and Physicians to Children and Adolescents (PTCA) Bardstown, Kentucky (KY).|participants|Number|94|94.0||||||
3893960|NCT01511107|3718904|B2|Children's Community Pediatrics||Study Site|Participating clinical study sites included: Children's Hospital of Pittsburgh (CHP) of University of Pittsburgh Medical Center (UPMC) Primary Care Center - Oakland, CHP of UPMC Emergency Department, Pittsburgh, Pennsylvania (PA); its affiliated University of Pittsburgh Clinical and Translational Science Institute (PittNet) Pediatric Practice-Based Research Network (PBRN) - PittNet North, East, South, City Loop, Pittsburgh, PA and Kittanning, PA; and Kentucky Pediatric/Adult Research (KPAR) and Physicians to Children and Adolescents (PTCA) Bardstown, Kentucky (KY).|participants|Number|47|47.0||||||
3893990|NCT01511107|3718904|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Parents were asked what ethnicity they would use to describe their child.|Participants|Count of Participants|235|235.0||||||
3894101|NCT01510769|3719000|B1|>=65 Years||Age, Customized|<65 Years, >=65 Years|Participants|Number|17|17.0||||||
3893961|NCT01511107|3718905|B1|Children's Community Pediatrics||Study Site|Participating clinical study sites included: Children's Hospital of Pittsburgh (CHP) of University of Pittsburgh Medical Center (UPMC) Primary Care Center - Oakland, CHP of UPMC Emergency Department, Pittsburgh, Pennsylvania (PA); its affiliated University of Pittsburgh Clinical and Translational Science Institute (PittNet) Pediatric Practice-Based Research Network (PBRN) - PittNet North, East, South, City Loop, Pittsburgh, PA and Kittanning, PA; and Kentucky Pediatric/Adult Research (KPAR) and Physicians to Children and Adolescents (PTCA) Bardstown, Kentucky (KY).|participants|Number|47|47.0||||||
3893962|NCT01511107|3718903|B3|Children's Hospital of Pittsburgh (CHP)||Study Site|Participating clinical study sites included: Children's Hospital of Pittsburgh (CHP) of University of Pittsburgh Medical Center (UPMC) Primary Care Center - Oakland, CHP of UPMC Emergency Department, Pittsburgh, Pennsylvania (PA); its affiliated University of Pittsburgh Clinical and Translational Science Institute (PittNet) Pediatric Practice-Based Research Network (PBRN) - PittNet North, East, South, City Loop, Pittsburgh, PA and Kittanning, PA; and Kentucky Pediatric/Adult Research (KPAR) and Physicians to Children and Adolescents (PTCA) Bardstown, Kentucky (KY).|participants|Number|326|326.0||||||
3893963|NCT01511107|3718904|B2|Children's Hospital of Pittsburgh (CHP)||Study Site|Participating clinical study sites included: Children's Hospital of Pittsburgh (CHP) of University of Pittsburgh Medical Center (UPMC) Primary Care Center - Oakland, CHP of UPMC Emergency Department, Pittsburgh, Pennsylvania (PA); its affiliated University of Pittsburgh Clinical and Translational Science Institute (PittNet) Pediatric Practice-Based Research Network (PBRN) - PittNet North, East, South, City Loop, Pittsburgh, PA and Kittanning, PA; and Kentucky Pediatric/Adult Research (KPAR) and Physicians to Children and Adolescents (PTCA) Bardstown, Kentucky (KY).|participants|Number|163|163.0||||||
3893964|NCT01511107|3718905|B1|Children's Hospital of Pittsburgh (CHP)||Study Site|Participating clinical study sites included: Children's Hospital of Pittsburgh (CHP) of University of Pittsburgh Medical Center (UPMC) Primary Care Center - Oakland, CHP of UPMC Emergency Department, Pittsburgh, Pennsylvania (PA); its affiliated University of Pittsburgh Clinical and Translational Science Institute (PittNet) Pediatric Practice-Based Research Network (PBRN) - PittNet North, East, South, City Loop, Pittsburgh, PA and Kittanning, PA; and Kentucky Pediatric/Adult Research (KPAR) and Physicians to Children and Adolescents (PTCA) Bardstown, Kentucky (KY).|participants|Number|163|163.0||||||
3893965|NCT01511107|3718903|B3||Unknown or Not Reported|Race (NIH/OMB)|Parents were asked what race or races they would use to describe their child.|Participants|Count of Participants|7|7.0||||||
3893966|NCT01511107|3718904|B2||Unknown or Not Reported|Race (NIH/OMB)|Parents were asked what race or races they would use to describe their child.|Participants|Count of Participants|4|4.0||||||
3893967|NCT01511107|3718905|B1||Unknown or Not Reported|Race (NIH/OMB)|Parents were asked what race or races they would use to describe their child.|Participants|Count of Participants|3|3.0||||||
3893968|NCT01511107|3718903|B3||More than one race|Race (NIH/OMB)|Parents were asked what race or races they would use to describe their child.|Participants|Count of Participants|42|42.0||||||
3893969|NCT01511107|3718904|B2||More than one race|Race (NIH/OMB)|Parents were asked what race or races they would use to describe their child.|Participants|Count of Participants|21|21.0||||||
3893970|NCT01511107|3718905|B1||More than one race|Race (NIH/OMB)|Parents were asked what race or races they would use to describe their child.|Participants|Count of Participants|21|21.0||||||
3893971|NCT01511107|3718903|B3||White|Race (NIH/OMB)|Parents were asked what race or races they would use to describe their child.|Participants|Count of Participants|226|226.0||||||
3893972|NCT01511107|3718904|B2||White|Race (NIH/OMB)|Parents were asked what race or races they would use to describe their child.|Participants|Count of Participants|110|110.0||||||
3893973|NCT01511107|3718905|B1||White|Race (NIH/OMB)|Parents were asked what race or races they would use to describe their child.|Participants|Count of Participants|116|116.0||||||
3893974|NCT01511107|3718903|B3||Black or African American|Race (NIH/OMB)|Parents were asked what race or races they would use to describe their child.|Participants|Count of Participants|228|228.0||||||
3893975|NCT01511107|3718904|B2||Black or African American|Race (NIH/OMB)|Parents were asked what race or races they would use to describe their child.|Participants|Count of Participants|118|118.0||||||
3893976|NCT01511107|3718905|B1||Black or African American|Race (NIH/OMB)|Parents were asked what race or races they would use to describe their child.|Participants|Count of Participants|110|110.0||||||
3893977|NCT01511107|3718903|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Parents were asked what race or races they would use to describe their child.|Participants|Count of Participants|0|0.0||||||
3893978|NCT01511107|3718904|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Parents were asked what race or races they would use to describe their child.|Participants|Count of Participants|0|0.0||||||
3893979|NCT01511107|3718905|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Parents were asked what race or races they would use to describe their child.|Participants|Count of Participants|0|0.0||||||
3893980|NCT01511107|3718903|B3||Asian|Race (NIH/OMB)|Parents were asked what race or races they would use to describe their child.|Participants|Count of Participants|12|12.0||||||
3893981|NCT01511107|3718904|B2||Asian|Race (NIH/OMB)|Parents were asked what race or races they would use to describe their child.|Participants|Count of Participants|5|5.0||||||
3893982|NCT01511107|3718905|B1||Asian|Race (NIH/OMB)|Parents were asked what race or races they would use to describe their child.|Participants|Count of Participants|7|7.0||||||
3893983|NCT01511107|3718903|B3||American Indian or Alaska Native|Race (NIH/OMB)|Parents were asked what race or races they would use to describe their child.|Participants|Count of Participants|0|0.0||||||
3893984|NCT01511107|3718904|B2||American Indian or Alaska Native|Race (NIH/OMB)|Parents were asked what race or races they would use to describe their child.|Participants|Count of Participants|0|0.0||||||
3893985|NCT01511107|3718905|B1||American Indian or Alaska Native|Race (NIH/OMB)|Parents were asked what race or races they would use to describe their child.|Participants|Count of Participants|0|0.0||||||
3893986|NCT01511107|3718903|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)|Parents were asked what ethnicity they would use to describe their child.|Participants|Count of Participants|0|0.0||||||
3893987|NCT01511107|3718904|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)|Parents were asked what ethnicity they would use to describe their child.|Participants|Count of Participants|0|0.0||||||
3894166|NCT01510652|3719071|B1|None||Atrial Arrhythmia History||participants|Number|583|583.0||||||
3893991|NCT01511107|3718905|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Parents were asked what ethnicity they would use to describe their child.|Participants|Count of Participants|233|233.0||||||
3893992|NCT01511107|3718903|B3||Hispanic or Latino|Ethnicity (NIH/OMB)|Parents were asked what ethnicity they would use to describe their child.|Participants|Count of Participants|47|47.0||||||
3893993|NCT01511107|3718904|B2||Hispanic or Latino|Ethnicity (NIH/OMB)|Parents were asked what ethnicity they would use to describe their child.|Participants|Count of Participants|23|23.0||||||
3893994|NCT01511107|3718905|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|Parents were asked what ethnicity they would use to describe their child.|Participants|Count of Participants|24|24.0||||||
3893995|NCT01511107|3718903|B3||Male|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
3893996|NCT01511107|3718904|B2||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3893997|NCT01511107|3718905|B1||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3893998|NCT01511107|3718903|B3||Female|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
3893999|NCT01511107|3718904|B2||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3894000|NCT01511107|3718905|B1||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3894001|NCT01511107|3718903|B3|18-23 months||Age, Customized||participants|Number|97|97.0||||||
3894002|NCT01511107|3718904|B2|18-23 months||Age, Customized||participants|Number|49|49.0||||||
3894003|NCT01511107|3718905|B1|18-23 months||Age, Customized||participants|Number|48|48.0||||||
3894004|NCT01511107|3718903|B3|12-17 months||Age, Customized||participants|Number|157|157.0||||||
3894005|NCT01511107|3718904|B2|12-17 months||Age, Customized||participants|Number|77|77.0||||||
3894006|NCT01511107|3718905|B1|12-17 months||Age, Customized||participants|Number|80|80.0||||||
3894007|NCT01511107|3718903|B3|6-11 months||Age, Customized||participants|Number|261|261.0||||||
3894008|NCT01511107|3718904|B2|6-11 months||Age, Customized||participants|Number|132|132.0||||||
3894009|NCT01511107|3718905|B1|6-11 months||Age, Customized||participants|Number|129|129.0||||||
3894010|NCT01511081|3718954|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
3894011|NCT01511081|3718955|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3894012|NCT01511081|3718956|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3894013|NCT01511081|3718954|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3894014|NCT01511081|3718955|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3894015|NCT01511081|3718956|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3894016|NCT01511081|3718954|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3894017|NCT01511081|3718955|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3894018|NCT01511081|3718956|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3894019|NCT01511081|3718954|B3|||Age||years|Median|74|74.0|Full Range|||57.0|88.0|
3894020|NCT01511081|3718955|B2|||Age||years|Median|72|72.0|Full Range|||57.0|87.0|
3894021|NCT01511081|3718956|B1|||Age||years|Median|77|77.0|Full Range|||66.0|88.0|
3894022|NCT01511016|3718965|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
3894023|NCT01511016|3718966|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3894024|NCT01511016|3718967|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3894025|NCT01511016|3718965|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3894026|NCT01511016|3718966|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3894027|NCT01511016|3718967|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3894028|NCT01511016|3718965|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3894029|NCT01511016|3718966|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3894030|NCT01511016|3718967|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3894031|NCT01511016|3718965|B3|||Age||years|Mean|46.9|46.9|Standard Deviation|7.3|7.3|||
3894032|NCT01511016|3718966|B2|||Age||years|Mean|44.9|44.9|Standard Deviation|7.8|7.8|||
3894033|NCT01511016|3718967|B1|||Age||years|Mean|49.1|49.1|Standard Deviation|6.8|6.8|||
3894034|NCT01511016|3718965|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3894035|NCT01511016|3718966|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3894036|NCT01511016|3718967|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3894037|NCT01511016|3718965|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3894038|NCT01511016|3718966|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3894039|NCT01511016|3718967|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3894040|NCT01511016|3718965|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3894041|NCT01511016|3718966|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3894042|NCT01511016|3718967|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3894043|NCT01510912|3718984|B1|||Baseline Physical Component Score of the Short Form-36 Questionnaire|The Short Form-36 is a validated 11-item health survey that assesses subject views about his/her functional health and well-being. The survey consists of 36 questions concerning daily or recent health-related activities and assesses 8 health domains using scaled scores. The physical component score is composed of a subset of the 8 health domains. Each scale is directly transformed into a 0 to 100 scale on the assumption that each question carries equal weight. A score of 0 is equal to maximum disability, and a score of 100 is equivalent to no disability.|units on a scale|Mean|39.5|39.5|Standard Deviation|7.72|7.72|||
3894098|NCT01510769|3718997|B4|>=65 Years||Age, Customized|<65 Years, >=65 Years|Participants|Number|56|56.0||||||
3894099|NCT01510769|3718998|B3|>=65 Years||Age, Customized|<65 Years, >=65 Years|Participants|Number|20|20.0||||||
3894044|NCT01510912|3718984|B1|||Baseline Mental Component Score of the Short Form-36 Questionnaire|The Short Form-36 is a validated 11-item health survey that assesses subject views about his/her functional health and well-being. The survey consists of 36 questions concerning daily or recent health-related activities and assesses 8 health domains using scaled scores. The mental component score is composed of a subset of the 8 health domains. Each scale is directly transformed into a 0 to 100 scale on the assumption that each question carries equal weight. A score of 0 is equal to maximum disability, and a score of 100 is equivalent to no disability.|units on a scale|Mean|52.0|52.0|Standard Deviation|9.60|9.6|||
3894045|NCT01510912|3718984|B1|||Body Mass Index||kg/m2|Mean|30.574|30.574|Standard Deviation|4.9818|4.9818|||
3894046|NCT01510912|3718984|B1|||Height||cm|Mean|169.25|169.25|Standard Deviation|9.898|9.898|||
3894047|NCT01510912|3718984|B1|||Weight||kg|Mean|87.93|87.93|Standard Deviation|17.005|17.005|||
3894048|NCT01510912|3718984|B1|Other||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|1|1.0||||||
3894049|NCT01510912|3718984|B1|White||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|506|506.0||||||
3894050|NCT01510912|3718984|B1|Black or African American||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|89|89.0||||||
3894051|NCT01510912|3718984|B1|Asian||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|6|6.0||||||
3894052|NCT01510912|3718984|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|2|2.0||||||
3894053|NCT01510912|3718984|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894054|NCT01510912|3718984|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|561|561.0||||||
3894055|NCT01510912|3718984|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3894056|NCT01510912|3718984|B1||Male|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
3894057|NCT01510912|3718984|B1||Female|Sex: Female, Male||Participants|Count of Participants|372|372.0||||||
3894058|NCT01510912|3718984|B1|||Age||years|Mean|59.7|59.7|Standard Deviation|8.89|8.89|||
3894059|NCT01510834|3718990|B1|United States||Region of Enrollment||participants|Number|90|90.0||||||
3894060|NCT01510834|3718990|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3894061|NCT01510834|3718990|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3894062|NCT01510834|3718990|B1|||Age||years|Mean|42.4|42.4|Standard Deviation|11.3|11.3|||
3894063|NCT01510834|3718990|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3894064|NCT01510834|3718990|B1||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
3894065|NCT01510834|3718990|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3894066|NCT01510769|3718997|B4|United States||Region of Enrollment||Participants|Number|244|244.0||||||
3894067|NCT01510769|3718998|B3|United States||Region of Enrollment||Participants|Number|79|79.0||||||
3894068|NCT01510769|3718999|B2|United States||Region of Enrollment||Participants|Number|84|84.0||||||
3894069|NCT01510769|3719000|B1|United States||Region of Enrollment||Participants|Number|81|81.0||||||
3894070|NCT01510769|3718997|B4|Switzerland||Region of Enrollment||Participants|Number|2|2.0||||||
3894071|NCT01510769|3718998|B3|Switzerland||Region of Enrollment||Participants|Number|1|1.0||||||
3894072|NCT01510769|3718999|B2|Switzerland||Region of Enrollment||Participants|Number|1|1.0||||||
3894073|NCT01510769|3719000|B1|Switzerland||Region of Enrollment||Participants|Number|0|0.0||||||
3894074|NCT01510769|3718997|B4|Poland||Region of Enrollment||Participants|Number|32|32.0||||||
3894075|NCT01510769|3718998|B3|Poland||Region of Enrollment||Participants|Number|14|14.0||||||
3894076|NCT01510769|3718999|B2|Poland||Region of Enrollment||Participants|Number|10|10.0||||||
3894077|NCT01510769|3719000|B1|Poland||Region of Enrollment||Participants|Number|8|8.0||||||
3894078|NCT01510769|3718997|B4|New Zealand||Region of Enrollment||Participants|Number|13|13.0||||||
3894079|NCT01510769|3718998|B3|New Zealand||Region of Enrollment||Participants|Number|5|5.0||||||
3894080|NCT01510769|3718999|B2|New Zealand||Region of Enrollment||Participants|Number|6|6.0||||||
3894081|NCT01510769|3719000|B1|New Zealand||Region of Enrollment||Participants|Number|2|2.0||||||
3894082|NCT01510769|3718997|B4|Canada||Region of Enrollment||Participants|Number|17|17.0||||||
3894083|NCT01510769|3718998|B3|Canada||Region of Enrollment||Participants|Number|6|6.0||||||
3894084|NCT01510769|3718999|B2|Canada||Region of Enrollment||Participants|Number|2|2.0||||||
3894085|NCT01510769|3719000|B1|Canada||Region of Enrollment||Participants|Number|9|9.0||||||
3894086|NCT01510769|3718997|B4|Australia||Region of Enrollment||Participants|Number|16|16.0||||||
3894087|NCT01510769|3718998|B3|Australia||Region of Enrollment||Participants|Number|4|4.0||||||
3894088|NCT01510769|3718999|B2|Australia||Region of Enrollment||Participants|Number|6|6.0||||||
3894089|NCT01510769|3719000|B1|Australia||Region of Enrollment||Participants|Number|6|6.0||||||
3894090|NCT01510769|3718997|B4||Male|Sex: Female, Male||Participants|Count of Participants|309|309.0||||||
3894091|NCT01510769|3718998|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3894092|NCT01510769|3718999|B2||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3894093|NCT01510769|3719000|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3894094|NCT01510769|3718997|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3894095|NCT01510769|3718998|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3894096|NCT01510769|3718999|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3894097|NCT01510769|3719000|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3894102|NCT01510769|3718997|B4|<65 Years||Age, Customized|<65 Years, >=65 Years|Participants|Number|268|268.0||||||
3894103|NCT01510769|3718998|B3|<65 Years||Age, Customized|<65 Years, >=65 Years|Participants|Number|89|89.0||||||
3894104|NCT01510769|3718999|B2|<65 Years||Age, Customized|<65 Years, >=65 Years|Participants|Number|90|90.0||||||
3894105|NCT01510769|3719000|B1|<65 Years||Age, Customized|<65 Years, >=65 Years|Participants|Number|89|89.0||||||
3894106|NCT01510769|3718997|B4|||Age||years|Mean|54.1|54.1|Standard Deviation|11.0|11.0|||
3894107|NCT01510769|3718998|B3|||Age||years|Mean|54.6|54.6|Standard Deviation|10.9|10.9|||
3894108|NCT01510769|3718999|B2|||Age||years|Mean|53.3|53.3|Standard Deviation|11.2|11.2|||
3894109|NCT01510769|3719000|B1|||Age||years|Mean|54.2|54.2|Standard Deviation|11.0|11.0|||
3894110|NCT01510756|3719019|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3894111|NCT01510756|3719019|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3894112|NCT01510756|3719019|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3894113|NCT01510756|3719019|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3894114|NCT01510756|3719019|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3894115|NCT01510756|3719019|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3894116|NCT01510717|3719025|B3|United States||Region of Enrollment||participants|Number|320|320.0||||||
3894117|NCT01510717|3719026|B2|United States||Region of Enrollment||participants|Number|165|165.0||||||
3894118|NCT01510717|3719027|B1|United States||Region of Enrollment||participants|Number|155|155.0||||||
3894119|NCT01510717|3719025|B3||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3894120|NCT01510717|3719026|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3894121|NCT01510717|3719027|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3894122|NCT01510717|3719025|B3||Female|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
3894123|NCT01510717|3719026|B2||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3894124|NCT01510717|3719027|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3894125|NCT01510717|3719025|B3|≥80 years||Age, Customized||participants|Number|31|31.0||||||
3894126|NCT01510717|3719026|B2|≥80 years||Age, Customized||participants|Number|17|17.0||||||
3894127|NCT01510717|3719027|B1|≥80 years||Age, Customized||participants|Number|14|14.0||||||
3894128|NCT01510717|3719025|B3|70-79 years||Age, Customized||participants|Number|136|136.0||||||
3894129|NCT01510717|3719026|B2|70-79 years||Age, Customized||participants|Number|71|71.0||||||
3894130|NCT01510717|3719027|B1|70-79 years||Age, Customized||participants|Number|65|65.0||||||
3894131|NCT01510717|3719025|B3|60-69 years||Age, Customized||participants|Number|115|115.0||||||
3894132|NCT01510717|3719026|B2|60-69 years||Age, Customized||participants|Number|62|62.0||||||
3894133|NCT01510717|3719027|B1|60-69 years||Age, Customized||participants|Number|53|53.0||||||
3894134|NCT01510717|3719025|B3|50-59 years||Age, Customized||participants|Number|30|30.0||||||
3894135|NCT01510717|3719026|B2|50-59 years||Age, Customized||participants|Number|12|12.0||||||
3894136|NCT01510717|3719027|B1|50-59 years||Age, Customized||participants|Number|18|18.0||||||
3894137|NCT01510717|3719025|B3|40-49 years||Age, Customized||participants|Number|5|5.0||||||
3894138|NCT01510717|3719026|B2|40-49 years||Age, Customized||participants|Number|3|3.0||||||
3894139|NCT01510717|3719027|B1|40-49 years||Age, Customized||participants|Number|2|2.0||||||
3894140|NCT01510717|3719025|B3|30-39 years||Age, Customized||participants|Number|2|2.0||||||
3894141|NCT01510717|3719026|B2|30-39 years||Age, Customized||participants|Number|0|0.0||||||
3894142|NCT01510717|3719027|B1|30-39 years||Age, Customized||participants|Number|2|2.0||||||
3894143|NCT01510717|3719025|B3|20-29 years||Age, Customized||participants|Number|1|1.0||||||
3894144|NCT01510717|3719026|B2|20-29 years||Age, Customized||participants|Number|0|0.0||||||
3894145|NCT01510717|3719027|B1|20-29 years||Age, Customized||participants|Number|1|1.0||||||
3894146|NCT01510717|3719025|B3|||Age||years|Mean|69.0|69.0|Standard Deviation|8.95|8.95|||
3894147|NCT01510717|3719026|B2|||Age||years|Mean|69.4|69.4|Standard Deviation|8.27|8.27|||
3894148|NCT01510717|3719027|B1|||Age||years|Mean|68.7|68.7|Standard Deviation|9.64|9.64|||
3894149|NCT01510704|3719052|B5||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3894150|NCT01510704|3719053|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3894151|NCT01510704|3719054|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3894152|NCT01510704|3719055|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3894153|NCT01510704|3719056|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3894154|NCT01510704|3719052|B5||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
3894155|NCT01510704|3719053|B4||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3894156|NCT01510704|3719054|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3894157|NCT01510704|3719055|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3894158|NCT01510704|3719056|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3894159|NCT01510704|3719052|B5|||Age||years|Mean|49.9|49.9|Standard Deviation|14.9|14.9|||
3894160|NCT01510704|3719053|B4|||Age||years|Mean|50.7|50.7|Standard Deviation|15.7|15.7|||
3894161|NCT01510704|3719054|B3|||Age||years|Mean|50|50.0|Standard Deviation|16.2|16.2|||
3894162|NCT01510704|3719055|B2|||Age||years|Mean|50|50.0|Standard Deviation|14.5|14.5|||
3894163|NCT01510704|3719056|B1|||Age||years|Mean|49.1|49.1|Standard Deviation|13.6|13.6|||
3894164|NCT01510652|3719069|B3|None||Atrial Arrhythmia History||participants|Number|866|866.0||||||
3894165|NCT01510652|3719070|B2|None||Atrial Arrhythmia History||participants|Number|283|283.0||||||
3894169|NCT01510652|3719071|B1|Atrial Flutter||Atrial Arrhythmia History||participants|Number|21|21.0||||||
3894170|NCT01510652|3719069|B3|Atrial Fibrillation||Atrial Arrhythmia History||participants|Number|172|172.0||||||
3894171|NCT01510652|3719070|B2|Atrial Fibrillation||Atrial Arrhythmia History||participants|Number|58|58.0||||||
3894172|NCT01510652|3719071|B1|Atrial Fibrillation||Atrial Arrhythmia History||participants|Number|114|114.0||||||
3894173|NCT01510652|3719069|B3|Non Ischemic||Cardiomyopathy||participants|Number|517|517.0||||||
3894174|NCT01510652|3719070|B2|Non Ischemic||Cardiomyopathy||participants|Number|152|152.0||||||
3894175|NCT01510652|3719071|B1|Non Ischemic||Cardiomyopathy||participants|Number|365|365.0||||||
3894176|NCT01510652|3719069|B3|Ischemic||Cardiomyopathy||participants|Number|549|549.0||||||
3894177|NCT01510652|3719070|B2|Ischemic||Cardiomyopathy||participants|Number|196|196.0||||||
3894178|NCT01510652|3719071|B1|Ischemic||Cardiomyopathy||participants|Number|353|353.0||||||
3894179|NCT01510652|3719069|B3|||QRS duration||ms|Mean|157.5|157.5|Standard Deviation|28.4|28.4|||
3894180|NCT01510652|3719070|B2|||QRS duration||ms|Mean|157|157.0|Standard Deviation|27|27.0|||
3894181|NCT01510652|3719071|B1|||QRS duration||ms|Mean|158|158.0|Standard Deviation|29|29.0|||
3894182|NCT01510652|3719069|B3|||Left Ventricular End-Systolic Volume (LVESV)||ml|Mean|150.5|150.5|Standard Deviation|62.2|62.2|||
3894183|NCT01510652|3719070|B2|||Left Ventricular End-Systolic Volume (LVESV)||ml|Mean|149.0|149.0|Standard Deviation|58.3|58.3|||
3894184|NCT01510652|3719071|B1|||Left Ventricular End-Systolic Volume (LVESV)||ml|Mean|151.2|151.2|Standard Deviation|64.0|64.0|||
3894185|NCT01510652|3719069|B3|||Left Ventricular End-Diastolic Volume (LVEDV)||ml|Mean|203.2|203.2|Standard Deviation|80.6|80.6|||
3894186|NCT01510652|3719070|B2|||Left Ventricular End-Diastolic Volume (LVEDV)||ml|Mean|204.5|204.5|Standard Deviation|72.0|72.0|||
3894187|NCT01510652|3719071|B1|||Left Ventricular End-Diastolic Volume (LVEDV)||ml|Mean|200.4|200.4|Standard Deviation|74.9|74.9|||
3894188|NCT01510652|3719069|B3|||Left Ventricular Ejection Fraction (LVEF)||%|Mean|27.2|27.2|Standard Deviation|7.7|7.7|||
3894189|NCT01510652|3719070|B2|||Left Ventricular Ejection Fraction (LVEF)||%|Mean|27.5|27.5|Standard Deviation|8.1|8.1|||
3894190|NCT01510652|3719071|B1|||Left Ventricular Ejection Fraction (LVEF)||%|Mean|27.1|27.1|Standard Deviation|7.6|7.6|||
3894191|NCT01510652|3719069|B3||Male|Sex: Female, Male||Participants|Count of Participants|819|819.0||||||
3894192|NCT01510652|3719070|B2||Male|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
3894193|NCT01510652|3719071|B1||Male|Sex: Female, Male||Participants|Count of Participants|545|545.0||||||
3894194|NCT01510652|3719069|B3||Female|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
3894195|NCT01510652|3719070|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3894196|NCT01510652|3719071|B1||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
3894197|NCT01510652|3719069|B3|||Age||years|Mean|67.9|67.9|Standard Deviation|10.1|10.1|||
3894198|NCT01510652|3719070|B2|||Age||years|Mean|68.4|68.4|Standard Deviation|9.7|9.7|||
3894199|NCT01510652|3719071|B1|||Age||years|Mean|67.6|67.6|Standard Deviation|10.2|10.2|||
3894200|NCT01510457|3719082|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
3894201|NCT01510457|3719083|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
3894202|NCT01510457|3719084|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3894203|NCT01510457|3719082|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3894204|NCT01510457|3719083|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3894205|NCT01510457|3719084|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3894206|NCT01510457|3719082|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3894207|NCT01510457|3719083|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3894208|NCT01510457|3719084|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3894209|NCT01510457|3719082|B3|||Age||years|Mean|56|56.0|Standard Deviation|8|8.0|||
3894210|NCT01510457|3719083|B2|||Age||years|Mean|57|57.0|Standard Deviation|9|9.0|||
3894211|NCT01510457|3719084|B1|||Age||years|Mean|53|53.0|Standard Deviation|7|7.0|||
3894212|NCT01510379|3719103|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
3894213|NCT01510379|3719104|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
3894214|NCT01510379|3719105|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
3894215|NCT01510379|3719103|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3894216|NCT01510379|3719104|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3894217|NCT01510379|3719105|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3894218|NCT01510379|3719103|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3894219|NCT01510379|3719104|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3894220|NCT01510379|3719105|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3894221|NCT01510379|3719103|B3|||Age||years|Mean|57|57.0|Standard Deviation|15.17|15.17|||
3894222|NCT01510379|3719104|B2|||Age||years|Mean|58|58.0|Standard Deviation|16.16|16.16|||
3894223|NCT01510379|3719105|B1|||Age||years|Mean|57|57.0|Standard Deviation|14.22|14.22|||
3894224|NCT01510379|3719103|B3||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
3894225|NCT01510379|3719104|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3894226|NCT01510379|3719105|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3894227|NCT01510379|3719103|B3||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
3894228|NCT01510379|3719104|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3894229|NCT01510379|3719105|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3894230|NCT01510379|3719103|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3894231|NCT01510379|3719104|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3894232|NCT01510379|3719105|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3894233|NCT01510327|3719114|B1|TIMI 3||Lesion Characteristic - Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|24 lesions treated in 22 participants. Thrombolysis In Myocardial Infarction (TIMI)0 - No perfusion; TIMI 1 - Penetration with minimal perfusion; TIMI 2 - Partial perfusion; TIMI 3 - Complete perfusion|Lesions|Number|24|24.0||||||
3894234|NCT01510327|3719114|B1|TIMI 2||Lesion Characteristic - Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|24 lesions treated in 22 participants. Thrombolysis In Myocardial Infarction (TIMI)0 - No perfusion; TIMI 1 - Penetration with minimal perfusion; TIMI 2 - Partial perfusion; TIMI 3 - Complete perfusion|Lesions|Number|0|0.0||||||
3894235|NCT01510327|3719114|B1|TIMI 1||Lesion Characteristic - Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|24 lesions treated in 22 participants. Thrombolysis In Myocardial Infarction (TIMI)0 - No perfusion; TIMI 1 - Penetration with minimal perfusion; TIMI 2 - Partial perfusion; TIMI 3 - Complete perfusion|Lesions|Number|0|0.0||||||
3894236|NCT01510327|3719114|B1|TIMI 0||Lesion Characteristic - Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|24 lesions treated in 22 participants. Thrombolysis In Myocardial Infarction (TIMI)0 - No perfusion; TIMI 1 - Penetration with minimal perfusion; TIMI 2 - Partial perfusion; TIMI 3 - Complete perfusion|Lesions|Number|0|0.0||||||
3894237|NCT01510327|3719114|B1|C||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A: minimally complex, readily accessible, non angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, absence of thrombus.~Type B: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, presence of thrombus; type B1 has one adverse characteristic and B2 has ≥2. Type C: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|Lesions|Number|4|4.0||||||
3894238|NCT01510327|3719114|B1|B2||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A: minimally complex, readily accessible, non angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, absence of thrombus.~Type B: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, presence of thrombus; type B1 has one adverse characteristic and B2 has ≥2. Type C: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|Lesions|Number|15|15.0||||||
3894239|NCT01510327|3719114|B1|B1||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A: minimally complex, readily accessible, non angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, absence of thrombus.~Type B: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, presence of thrombus; type B1 has one adverse characteristic and B2 has ≥2. Type C: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|Lesions|Number|4|4.0||||||
3894240|NCT01510327|3719114|B1|A||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A: minimally complex, readily accessible, non angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, absence of thrombus.~Type B: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, presence of thrombus; type B1 has one adverse characteristic and B2 has ≥2. Type C: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|Lesions|Number|1|1.0||||||
3894241|NCT01510327|3719114|B1|Bifurcation||Lesion Characteristics|There were 24 lesions treated in 22 participants. The same lesion may be included in more than one category, therefore the number of lesions for this baseline measure does not equal the total number of lesions in the group.|Lesions|Number|1|1.0||||||
3894242|NCT01510327|3719114|B1|Calcification, any||Lesion Characteristics|There were 24 lesions treated in 22 participants. The same lesion may be included in more than one category, therefore the number of lesions for this baseline measure does not equal the total number of lesions in the group.|Lesions|Number|4|4.0||||||
3894243|NCT01510327|3719114|B1|Tortuosity, any||Lesion Characteristics|There were 24 lesions treated in 22 participants. The same lesion may be included in more than one category, therefore the number of lesions for this baseline measure does not equal the total number of lesions in the group.|Lesions|Number|1|1.0||||||
3894244|NCT01510327|3719114|B1|Bend >90 Degrees||Lesion Characteristics|There were 24 lesions treated in 22 participants. The same lesion may be included in more than one category, therefore the number of lesions for this baseline measure does not equal the total number of lesions in the group.|Lesions|Number|2|2.0||||||
3894245|NCT01510327|3719114|B1|Bend >45 Degrees||Lesion Characteristics|There were 24 lesions treated in 22 participants. The same lesion may be included in more than one category, therefore the number of lesions for this baseline measure does not equal the total number of lesions in the group.|Lesions|Number|13|13.0||||||
3894246|NCT01510327|3719114|B1|Eccentric Lesion||Lesion Characteristics|There were 24 lesions treated in 22 participants. The same lesion may be included in more than one category, therefore the number of lesions for this baseline measure does not equal the total number of lesions in the group.|Lesions|Number|13|13.0||||||
3894247|NCT01510327|3719114|B1|||Lesion Characteristic-Percent Diameter Stenosis|There were 24 lesions treated in 22 participants.|Percent|Mean|73.15|73.15|Standard Deviation|11.24|11.24|||
3894248|NCT01510327|3719114|B1|Lesion Length||Lesion Characteristics: Reference Vessel Diameter, Minimum Lumen Diameter, Length|There were 24 lesions treated in 22 participants.|millimeters|Mean|12.11|12.11|Standard Deviation|4.69|4.69|||
3894249|NCT01510327|3719114|B1|Minimum Lumen Diameter||Lesion Characteristics: Reference Vessel Diameter, Minimum Lumen Diameter, Length|There were 24 lesions treated in 22 participants.|millimeters|Mean|0.73|0.73|Standard Deviation|0.38|0.38|||
3894283|NCT01510327|3719114|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3894250|NCT01510327|3719114|B1|Reference Vessel Diameter||Lesion Characteristics: Reference Vessel Diameter, Minimum Lumen Diameter, Length|There were 24 lesions treated in 22 participants.|millimeters|Mean|2.64|2.64|Standard Deviation|0.46|0.46|||
3894251|NCT01510327|3719114|B1|Distal||Lesion Characteristic: Lesion Location|24 lesions treated in 22 participants.|Participants|Number|2|2.0||||||
3894252|NCT01510327|3719114|B1|Mid||Lesion Characteristic: Lesion Location|24 lesions treated in 22 participants.|Participants|Number|13|13.0||||||
3894253|NCT01510327|3719114|B1|Proximal||Lesion Characteristic: Lesion Location|24 lesions treated in 22 participants.|Participants|Number|9|9.0||||||
3894254|NCT01510327|3719114|B1|Right Coronary Artery||Lesion Characteristic: Target Lesion Vessel|24 lesions in 22 participants were treated.|Lesions|Number|13|13.0||||||
3894255|NCT01510327|3719114|B1|Left Circumflex Artery||Lesion Characteristic: Target Lesion Vessel|24 lesions in 22 participants were treated.|Lesions|Number|7|7.0||||||
3894256|NCT01510327|3719114|B1|Left Anterior Descending Artery||Lesion Characteristic: Target Lesion Vessel|24 lesions in 22 participants were treated.|Lesions|Number|4|4.0||||||
3894257|NCT01510327|3719114|B1|History of Renal Disease||Comorbidities|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|0|0.0||||||
3894258|NCT01510327|3719114|B1|History of Peripheral Vascular Disease||Comorbidities|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|2|2.0||||||
3894259|NCT01510327|3719114|B1|History of Cerebrovascular Accident||Comorbidities|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|3|3.0||||||
3894260|NCT01510327|3719114|B1|History of Transient Ischemic Attack||Comorbidities|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|2|2.0||||||
3894261|NCT01510327|3719114|B1|Hypertension Requiring Medication||Cardiac Risk Factors|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|18|18.0||||||
3894262|NCT01510327|3719114|B1|Hyperlipidemia Requiring Medication||Cardiac Risk Factors|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|16|16.0||||||
3894263|NCT01510327|3719114|B1|Medically Treated Diabetes||Cardiac Risk Factors|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|5|5.0||||||
3894264|NCT01510327|3719114|B1|Smoking, ever||Cardiac Risk Factors|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|14|14.0||||||
3894265|NCT01510327|3719114|B1|||Body Mass Index||kg/m^2|Mean|26.52|26.52|Standard Deviation|4.79|4.79|||
3894266|NCT01510327|3719114|B1|||Weight||Kilograms|Mean|73.68|73.68|Standard Deviation|19.60|19.6|||
3894267|NCT01510327|3719114|B1|||Height||Centimeters|Mean|165.57|165.57|Standard Deviation|12.55|12.55|||
3894268|NCT01510327|3719114|B1|||Cardiac History - Left Ventricular Ejection Fraction|Left ventricular ejection fraction (LVEF) is an assessment (fraction) of the amount of blood emptied from the left ventricle during systolic contraction, which is indicative of global ventricular function.|Percent (of blood emptied)|Mean|59.64|59.64|Standard Deviation|10.09|10.09|||
3894269|NCT01510327|3719114|B1|History of Multivessel Disease||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|9|9.0||||||
3894270|NCT01510327|3719114|B1|Silent Ischemia||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|5|5.0||||||
3894271|NCT01510327|3719114|B1|Unstable Angina||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|2|2.0||||||
3894272|NCT01510327|3719114|B1|Stable Angina||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|15|15.0||||||
3894273|NCT01510327|3719114|B1|Previous Myocardial Infarction (MI)||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|4|4.0||||||
3894274|NCT01510327|3719114|B1|Previous Coronary Artery Bypass Graft (CABG)||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|2|2.0||||||
3894275|NCT01510327|3719114|B1|Previous Percutaneous Coronary Intervention (PCI)||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|9|9.0||||||
3894276|NCT01510327|3719114|B1|Japan||Region of Enrollment||participants|Number|11|11.0||||||
3894277|NCT01510327|3719114|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3894278|NCT01510327|3719114|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3894279|NCT01510327|3719114|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3894280|NCT01510327|3719114|B1|||Age||years|Mean|64.6|64.6|Standard Deviation|9.5|9.5|||
3894281|NCT01510327|3719114|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3894282|NCT01510327|3719114|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3894284|NCT01510158|3719145|B4|United States||Region of Enrollment||Participants|Number|603|603.0||||||
3894285|NCT01510158|3719146|B3|United States||Region of Enrollment||Participants|Number|201|201.0||||||
3894286|NCT01510158|3719147|B2|United States||Region of Enrollment||Participants|Number|201|201.0||||||
3894287|NCT01510158|3719148|B1|United States||Region of Enrollment||Participants|Number|201|201.0||||||
3894288|NCT01510158|3719145|B4||Male|Sex: Female, Male||Participants|Count of Participants|567|567.0||||||
3894289|NCT01510158|3719146|B3||Male|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
3894290|NCT01510158|3719147|B2||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
3894291|NCT01510158|3719148|B1||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
3894292|NCT01510158|3719145|B4||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3894293|NCT01510158|3719146|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3894294|NCT01510158|3719147|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3894295|NCT01510158|3719148|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3894296|NCT01510158|3719145|B4|>=65||Age, Customized||Participants|Number|85|85.0||||||
3894297|NCT01510158|3719146|B3|>=65||Age, Customized||Participants|Number|32|32.0||||||
3894298|NCT01510158|3719147|B2|>=65||Age, Customized||Participants|Number|33|33.0||||||
3894299|NCT01510158|3719148|B1|>=65||Age, Customized||Participants|Number|20|20.0||||||
3894300|NCT01510158|3719145|B4|<65||Age, Customized||Participants|Number|518|518.0||||||
3894301|NCT01510158|3719146|B3|<65||Age, Customized||Participants|Number|169|169.0||||||
3894302|NCT01510158|3719147|B2|<65||Age, Customized||Participants|Number|168|168.0||||||
3894303|NCT01510158|3719148|B1|<65||Age, Customized||Participants|Number|181|181.0||||||
3894304|NCT01510158|3719145|B4|||Age||Years|Mean|51.9|51.9|Standard Deviation|11.3|11.3|||
3894305|NCT01510158|3719146|B3|||Age||Years|Mean|51.7|51.7|Standard Deviation|11.7|11.7|||
3894306|NCT01510158|3719147|B2|||Age||Years|Mean|52.3|52.3|Standard Deviation|11.5|11.5|||
3894307|NCT01510158|3719148|B1|||Age||Years|Mean|51.6|51.6|Standard Deviation|10.7|10.7|||
3894308|NCT01510145|3719164|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3894309|NCT01510145|3719164|B1||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3894310|NCT01510145|3719164|B1|||Age||years|Mean|67.5|67.5|Standard Deviation|11.3|11.3|||
3894311|NCT01510028|3719169|B5|Ethnicity: Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3894312|NCT01510028|3719170|B4|Ethnicity: Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3894313|NCT01510028|3719171|B3|Ethnicity: Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3894314|NCT01510028|3719172|B2|Ethnicity: Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3894315|NCT01510028|3719173|B1|Ethnicity: Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3894316|NCT01510028|3719169|B5|Race: Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3894317|NCT01510028|3719170|B4|Race: Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3894318|NCT01510028|3719171|B3|Race: Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3894319|NCT01510028|3719172|B2|Race: Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3894320|NCT01510028|3719173|B1|Race: Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3894321|NCT01510028|3719169|B5|Race: Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3894322|NCT01510028|3719170|B4|Race: Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3894323|NCT01510028|3719171|B3|Race: Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3894324|NCT01510028|3719172|B2|Race: Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3894325|NCT01510028|3719173|B1|Race: Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3894326|NCT01510028|3719169|B5|Race: White||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3894327|NCT01510028|3719170|B4|Race: White||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3894328|NCT01510028|3719171|B3|Race: White||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3894329|NCT01510028|3719172|B2|Race: White||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3894330|NCT01510028|3719173|B1|Race: White||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3894331|NCT01510028|3719169|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3894332|NCT01510028|3719170|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3894333|NCT01510028|3719171|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3894334|NCT01510028|3719172|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3894335|NCT01510028|3719173|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3894336|NCT01510028|3719169|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3894337|NCT01510028|3719170|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3894338|NCT01510028|3719171|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3894339|NCT01510028|3719172|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3894340|NCT01510028|3719173|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3894341|NCT01510028|3719169|B5|||Age||Months|Mean|44.9|44.9|Standard Deviation|22.85|22.85|||
3894342|NCT01510028|3719170|B4|||Age||Months|Mean|48.5|48.5|Standard Deviation|24.22|24.22|||
3894343|NCT01510028|3719171|B3|||Age||Months|Mean|52.2|52.2|Standard Deviation|31.17|31.17|||
3894344|NCT01510028|3719172|B2|||Age||Months|Mean|47.3|47.3|Standard Deviation|20.23|20.23|||
3894345|NCT01510028|3719173|B1|||Age||Months|Mean|31.5|31.5|Standard Deviation|11.50|11.5|||
3894346|NCT01509807|3719290|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
3894347|NCT01509807|3719291|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3894348|NCT01509807|3719292|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3894349|NCT01509807|3719290|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3894350|NCT01509807|3719291|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3894351|NCT01509807|3719292|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3894352|NCT01509807|3719290|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3894353|NCT01509807|3719291|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3894354|NCT01509807|3719292|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3894355|NCT01509807|3719290|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3894356|NCT01509807|3719291|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3894357|NCT01509807|3719292|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3894358|NCT01509807|3719290|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3894359|NCT01509807|3719291|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3894360|NCT01509807|3719292|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3894361|NCT01509807|3719290|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3894362|NCT01509807|3719291|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3894363|NCT01509807|3719292|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3894364|NCT01509807|3719290|B3|||Age||years|Mean|53.8|53.8|Standard Deviation|15.8|15.8|||
3894365|NCT01509807|3719291|B2|||Age||years|Mean|52.1|52.1|Standard Deviation|15.89|15.89|||
3894366|NCT01509807|3719292|B1|||Age||years|Mean|55.7|55.7|Standard Deviation|16.03|16.03|||
3894367|NCT01509664|3719317|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894368|NCT01509664|3719318|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894369|NCT01509664|3719319|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894370|NCT01509664|3719317|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3894371|NCT01509664|3719318|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3894372|NCT01509664|3719319|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3894373|NCT01509664|3719317|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3894374|NCT01509664|3719318|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3894375|NCT01509664|3719319|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3894376|NCT01509664|3719317|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894377|NCT01509664|3719318|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894378|NCT01509664|3719319|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894379|NCT01509664|3719317|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3894380|NCT01509664|3719318|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894381|NCT01509664|3719319|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3894382|NCT01509664|3719317|B3||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3894383|NCT01509664|3719318|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3894384|NCT01509664|3719319|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3894385|NCT01509664|3719317|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3894386|NCT01509664|3719318|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3894387|NCT01509664|3719319|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3894388|NCT01509664|3719317|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894389|NCT01509664|3719318|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894390|NCT01509664|3719319|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894391|NCT01509664|3719317|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3894392|NCT01509664|3719318|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3894393|NCT01509664|3719319|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3894394|NCT01509664|3719317|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894395|NCT01509664|3719318|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894396|NCT01509664|3719319|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894397|NCT01509664|3719317|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3894398|NCT01509664|3719318|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3894399|NCT01509664|3719319|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3894400|NCT01509664|3719317|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3894401|NCT01509664|3719318|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3894402|NCT01509664|3719319|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3894403|NCT01509664|3719317|B3|||Age||years|Mean|41|41.0|Standard Deviation|14|14.0|||
3894404|NCT01509664|3719318|B2|||Age||years|Mean|41|41.0|Standard Deviation|14|14.0|||
3894405|NCT01509664|3719319|B1|||Age||years|Mean|40|40.0|Standard Deviation|14|14.0|||
3894406|NCT01509638|3719326|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
3894407|NCT01509638|3719327|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3894408|NCT01509638|3719328|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3894409|NCT01509638|3719326|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3894410|NCT01509638|3719327|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3894411|NCT01509638|3719328|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3894412|NCT01509638|3719326|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3894413|NCT01509638|3719327|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3894414|NCT01509638|3719328|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3894415|NCT01509638|3719326|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3894416|NCT01509638|3719327|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3894417|NCT01509638|3719328|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3894418|NCT01509638|3719326|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3894419|NCT01509638|3719327|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3894420|NCT01509638|3719328|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3894421|NCT01509638|3719326|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3894422|NCT01509638|3719327|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3894423|NCT01509638|3719328|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3894424|NCT01509638|3719326|B3|||Age||years|Mean|47.7|47.7|Standard Deviation|16.01|16.01|||
3894425|NCT01509638|3719327|B2|||Age||years|Mean|48.2|48.2|Standard Deviation|14.53|14.53|||
3894426|NCT01509638|3719328|B1|||Age||years|Mean|47.1|47.1|Standard Deviation|17.87|17.87|||
3894427|NCT01509625|3719353|B1|No specifical information||Estrogen receptor and Progesterone receptor status||participants|Number|13|13.0||||||
3894428|NCT01509625|3719353|B1|ER negative and PGR positive||Estrogen receptor and Progesterone receptor status||participants|Number|1|1.0||||||
3894429|NCT01509625|3719353|B1|ER positive and PGR negative||Estrogen receptor and Progesterone receptor status||participants|Number|61|61.0||||||
3894430|NCT01509625|3719353|B1|ER positive and PGR positive||Estrogen receptor and Progesterone receptor status||participants|Number|197|197.0||||||
3894431|NCT01509625|3719353|B1|not known||Histologic type||participants|Number|13|13.0||||||
3894432|NCT01509625|3719353|B1|others||Histologic type||participants|Number|7|7.0||||||
3894433|NCT01509625|3719353|B1|ductal+lobulillar||Histologic type||participants|Number|7|7.0||||||
3894434|NCT01509625|3719353|B1|lobulillar||Histologic type||participants|Number|37|37.0||||||
3894435|NCT01509625|3719353|B1|ductal||Histologic type||participants|Number|208|208.0||||||
3894436|NCT01509625|3719353|B1|Spain||Region of Enrollment||participants|Number|272|272.0||||||
3894437|NCT01509625|3719353|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3894438|NCT01509625|3719353|B1||Female|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
3894439|NCT01509625|3719353|B1|age||Age||years|Mean|65|65.0|Full Range|||64.2|67.2|
3894440|NCT01509625|3719353|B1||>=65 years|Age||Participants|Count of Participants|138|138.0||||||
3894441|NCT01509625|3719353|B1||Between 18 and 65 years|Age||Participants|Count of Participants|134|134.0||||||
3894442|NCT01509625|3719353|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3894443|NCT01509586|3719369|B3|||Cigarettes per day||average cigarettes per day at baseline|Mean|20.0|20.0|Standard Deviation|8.6|8.6|||
3894444|NCT01509586|3719370|B2|||Cigarettes per day||average cigarettes per day at baseline|Mean|19.9|19.9|Standard Deviation|8.4|8.4|||
3894445|NCT01509586|3719371|B1|||Cigarettes per day||average cigarettes per day at baseline|Mean|20.1|20.1|Standard Deviation|8.7|8.7|||
3894446|NCT01509586|3719369|B3|||Confidence to quit smoking|0 -10 scale, where 0 is no confidence to quit smoking and 10 is the most confidence to quit smoking, in the next 30 days|units on a scale|Mean|2.7|2.7|Standard Deviation|3.1|3.1|||
3894447|NCT01509586|3719370|B2|||Confidence to quit smoking|0 -10 scale, where 0 is no confidence to quit smoking and 10 is the most confidence to quit smoking, in the next 30 days|units on a scale|Mean|2.7|2.7|Standard Deviation|3.0|3.0|||
3894448|NCT01509586|3719371|B1|||Confidence to quit smoking|0 -10 scale, where 0 is no confidence to quit smoking and 10 is the most confidence to quit smoking, in the next 30 days|units on a scale|Mean|2.6|2.6|Standard Deviation|3.1|3.1|||
3894449|NCT01509586|3719369|B3|||Intend to quit smoking, next month|0 - 10 scale, where 0 is no intent to quit and 10 is the most intent to quit smoking in the next 30 days|units on a scale|Mean|1.4|1.4|Standard Deviation|2.4|2.4|||
3894450|NCT01509586|3719370|B2|||Intend to quit smoking, next month|0 - 10 scale, where 0 is no intent to quit and 10 is the most intent to quit smoking in the next 30 days|units on a scale|Mean|1.3|1.3|Standard Deviation|2.4|2.4|||
3894451|NCT01509586|3719371|B1|||Intend to quit smoking, next month|0 - 10 scale, where 0 is no intent to quit and 10 is the most intent to quit smoking in the next 30 days|units on a scale|Mean|1.4|1.4|Standard Deviation|2.3|2.3|||
3894452|NCT01509586|3719369|B3|Other||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3894453|NCT01509586|3719370|B2|Other||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3894454|NCT01509586|3719371|B1|Other||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3894455|NCT01509586|3719369|B3|African-American||Race/Ethnicity, Customized||participants|Number|117|117.0||||||
3894456|NCT01509586|3719370|B2|African-American||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
3894457|NCT01509586|3719371|B1|African-American||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
3894458|NCT01509586|3719369|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|1088|1088.0||||||
3894459|NCT01509586|3719370|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|531|531.0||||||
3894460|NCT01509586|3719371|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|557|557.0||||||
3894461|NCT01509586|3719369|B3||Male|Sex: Female, Male||Participants|Count of Participants|401|401.0||||||
3894462|NCT01509586|3719370|B2||Male|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
3894463|NCT01509586|3719371|B1||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3894464|NCT01509586|3719369|B3||Female|Sex: Female, Male||Participants|Count of Participants|835|835.0||||||
3894465|NCT01509586|3719370|B2||Female|Sex: Female, Male||Participants|Count of Participants|397|397.0||||||
3894466|NCT01509586|3719371|B1||Female|Sex: Female, Male||Participants|Count of Participants|438|438.0||||||
3894467|NCT01509586|3719369|B3|||Age||years|Mean|48.7|48.7|Standard Deviation|12.6|12.6|||
3894468|NCT01509586|3719370|B2|||Age||years|Mean|48.7|48.7|Standard Deviation|12.6|12.6|||
3894469|NCT01509586|3719371|B1|||Age||years|Mean|48.7|48.7|Standard Deviation|12.5|12.5|||
3894470|NCT01509404|3719378|B5|||Pre-emptive||Participants|Count of Participants|4|4.0||||||
3894471|NCT01509404|3719379|B4|||Pre-emptive||Participants|Count of Participants|0|0.0||||||
3894472|NCT01509404|3719380|B3|||Pre-emptive||Participants|Count of Participants|0|0.0||||||
3894473|NCT01509404|3719381|B2|||Pre-emptive||Participants|Count of Participants|1|1.0||||||
3894474|NCT01509404|3719382|B1|||Pre-emptive||Participants|Count of Participants|3|3.0||||||
3894475|NCT01509404|3719378|B5|||Weight (kg)||kg|Mean|84|84.0|Standard Deviation|20|20.0|||
3894476|NCT01509404|3719379|B4|||Weight (kg)||kg|Mean|91|91.0|Standard Deviation|25|25.0|||
3894477|NCT01509404|3719380|B3|||Weight (kg)||kg|Mean|84|84.0|Standard Deviation|13|13.0|||
3894478|NCT01509404|3719381|B2|||Weight (kg)||kg|Mean|88|88.0|Standard Deviation|21|21.0|||
3894479|NCT01509404|3719382|B1|||Weight (kg)||kg|Mean|71|71.0|Standard Deviation|20|20.0|||
3894480|NCT01509404|3719378|B5|||Retransplant||Participants|Count of Participants|4|4.0||||||
3894481|NCT01509404|3719379|B4|||Retransplant||Participants|Count of Participants|0|0.0||||||
3894482|NCT01509404|3719380|B3|||Retransplant||Participants|Count of Participants|0|0.0||||||
3894483|NCT01509404|3719381|B2|||Retransplant||Participants|Count of Participants|2|2.0||||||
3894484|NCT01509404|3719382|B1|||Retransplant||Participants|Count of Participants|2|2.0||||||
3894485|NCT01509404|3719378|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894486|NCT01509404|3719379|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894487|NCT01509404|3719380|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894488|NCT01509404|3719381|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894489|NCT01509404|3719382|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894490|NCT01509404|3719378|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894491|NCT01509404|3719379|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894492|NCT01509404|3719380|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894493|NCT01509404|3719381|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894494|NCT01509404|3719382|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894495|NCT01509404|3719378|B5||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3894496|NCT01509404|3719379|B4||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3894497|NCT01509404|3719380|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3894498|NCT01509404|3719381|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3894499|NCT01509404|3719382|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3894500|NCT01509404|3719378|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3894501|NCT01509404|3719379|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894502|NCT01509404|3719380|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894503|NCT01509404|3719381|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3894504|NCT01509404|3719382|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3894505|NCT01509404|3719378|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894506|NCT01509404|3719379|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894507|NCT01509404|3719380|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894508|NCT01509404|3719381|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894509|NCT01509404|3719382|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894510|NCT01509404|3719378|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894511|NCT01509404|3719379|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894512|NCT01509404|3719380|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894513|NCT01509404|3719381|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894514|NCT01509404|3719382|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894515|NCT01509404|3719378|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3894516|NCT01509404|3719379|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894517|NCT01509404|3719380|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894518|NCT01509404|3719381|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894519|NCT01509404|3719382|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3894520|NCT01509404|3719378|B5||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3894521|NCT01509404|3719379|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3894522|NCT01509404|3719380|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3894523|NCT01509404|3719381|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3894524|NCT01509404|3719382|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3894525|NCT01509404|3719378|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3894526|NCT01509404|3719379|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3894527|NCT01509404|3719380|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3894528|NCT01509404|3719381|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3894529|NCT01509404|3719382|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3894530|NCT01509404|3719378|B5|||Age||years|Mean|56|56.0|Full Range|||21.0|71.0|
3894531|NCT01509404|3719379|B4|||Age||years|Mean|60|60.0|Full Range|||48.0|61.0|
3894532|NCT01509404|3719380|B3|||Age||years|Mean|58|58.0|Full Range|||27.0|58.0|
3894533|NCT01509404|3719381|B2|||Age||years|Mean|54|54.0|Full Range|||26.0|69.0|
3894534|NCT01509404|3719382|B1|||Age||years|Mean|51|51.0|Full Range|||21.0|71.0|
3894535|NCT01509183|3719403|B3||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
3894536|NCT01509183|3719404|B2||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3894537|NCT01509183|3719405|B1||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3894538|NCT01509183|3719403|B3||Female|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
3894539|NCT01509183|3719404|B2||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3894540|NCT01509183|3719405|B1||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3894541|NCT01509183|3719403|B3||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3894542|NCT01509183|3719404|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3894543|NCT01509183|3719405|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3894544|NCT01509183|3719403|B3||Between 18 and 65 years|Age||Participants|Count of Participants|321|321.0||||||
3894545|NCT01509183|3719404|B2||Between 18 and 65 years|Age||Participants|Count of Participants|158|158.0||||||
3894546|NCT01509183|3719405|B1||Between 18 and 65 years|Age||Participants|Count of Participants|163|163.0||||||
3894547|NCT01509183|3719403|B3||<=18 years|Age||Participants|Count of Participants|149|149.0||||||
3894548|NCT01509183|3719404|B2||<=18 years|Age||Participants|Count of Participants|75|75.0||||||
3894549|NCT01509183|3719405|B1||<=18 years|Age||Participants|Count of Participants|74|74.0||||||
3894550|NCT01509105|3719414|B1||Male|Gender||Participants|Count of Participants|328|328.0||||||
3894551|NCT01509105|3719414|B1||Female|Gender||Participants|Count of Participants|321|321.0||||||
3894552|NCT01509105|3719414|B1|Mean Age||Age||months|Mean|4.26|4.26|Standard Deviation|12.86|12.86|||
3894553|NCT01509079|3719429|B3|United States||Region of Enrollment||participants|Number|113|113.0||||||
3894554|NCT01509079|3719430|B2|United States||Region of Enrollment||participants|Number|56|56.0||||||
3894555|NCT01509079|3719431|B1|United States||Region of Enrollment||participants|Number|57|57.0||||||
3894556|NCT01509079|3719429|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3894557|NCT01509079|3719430|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3894558|NCT01509079|3719431|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3894559|NCT01509079|3719429|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3894560|NCT01509079|3719430|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3894561|NCT01509079|3719431|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3894562|NCT01509079|3719429|B3|||Age||years|Mean|60.9|60.9|Standard Deviation|8.8|8.8|||
3894563|NCT01509079|3719430|B2|||Age||years|Mean|60.3|60.3|Standard Deviation|9.3|9.3|||
3894564|NCT01509079|3719431|B1|||Age||years|Mean|61.4|61.4|Standard Deviation|8.4|8.4|||
3894565|NCT01509053|3719448|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3894566|NCT01509053|3719448|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3894567|NCT01509053|3719448|B1|||Age||years|Mean|43.9|43.9|Standard Deviation|12.4|12.4|||
3894568|NCT01509040|3719459|B4|United States||Region of Enrollment||participants|Number|2|2.0||||||
3894569|NCT01509040|3719461|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3894570|NCT01509040|3719459|B4|Male||Gender||participants|Number|1|1.0||||||
3894571|NCT01509040|3719461|B2|Male||Gender||participants|Number|1|1.0||||||
3894572|NCT01509040|3719459|B4|Female||Gender||participants|Number|1|1.0||||||
3894573|NCT01509040|3719461|B2|Female||Gender||participants|Number|1|1.0||||||
3894574|NCT01509040|3719459|B4|||Age||years|Median|67|67.0|Inter-Quartile Range|||65.0|69.0|
3894575|NCT01509040|3719461|B2|||Age||years|Median|67|67.0|Inter-Quartile Range|||65.0|69.0|
3894576|NCT01509040|3719459|B4|>=65 years||Age||participants|Number|2|2.0||||||
3894577|NCT01509040|3719461|B2|>=65 years||Age||participants|Number|2|2.0||||||
3894578|NCT01509040|3719459|B4|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
3894579|NCT01509040|3719461|B2|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
3894580|NCT01509040|3719459|B4|<=18 years||Age||participants|Number|0|0.0||||||
3894581|NCT01509040|3719461|B2|<=18 years||Age||participants|Number|0|0.0||||||
3894582|NCT01508936|3719508|B3|||Average Daily Use of Short-Acting Beta-Agonist Therapy (SABA) in Past 3 Days|n=98, 395, 493|puffs of SABA/day|Mean|1.9|1.9|Standard Deviation|1.83|1.83|||
3894583|NCT01508936|3719509|B2|||Average Daily Use of Short-Acting Beta-Agonist Therapy (SABA) in Past 3 Days|n=98, 395, 493|puffs of SABA/day|Mean|1.9|1.9|Standard Deviation|1.84|1.84|||
3894584|NCT01508936|3719510|B1|||Average Daily Use of Short-Acting Beta-Agonist Therapy (SABA) in Past 3 Days|n=98, 395, 493|puffs of SABA/day|Mean|2.0|2.0|Standard Deviation|1.82|1.82|||
3894585|NCT01508936|3719508|B3|||Blood Eosinophil Counts|n=96, 397, 493|10^9 blood eosinophil/liter|Mean|0.280|0.28|Standard Deviation|0.2401|0.2401|||
3894586|NCT01508936|3719509|B2|||Blood Eosinophil Counts|n=96, 397, 493|10^9 blood eosinophil/liter|Mean|0.281|0.281|Standard Deviation|0.2448|0.2448|||
3894587|NCT01508936|3719510|B1|||Blood Eosinophil Counts|n=96, 397, 493|10^9 blood eosinophil/liter|Mean|0.277|0.277|Standard Deviation|0.2209|0.2209|||
3894588|NCT01508936|3719508|B3|||Percent Predicted Forced Expiratory Volume in 1 Second (% predicted FEV1)|n=98, 396, 494|% predicted|Mean|66.7|66.7|Standard Deviation|16.10|16.1|||
3894589|NCT01508936|3719509|B2|||Percent Predicted Forced Expiratory Volume in 1 Second (% predicted FEV1)|n=98, 396, 494|% predicted|Mean|66.8|66.8|Standard Deviation|16.26|16.26|||
3894590|NCT01508936|3719510|B1|||Percent Predicted Forced Expiratory Volume in 1 Second (% predicted FEV1)|n=98, 396, 494|% predicted|Mean|66.5|66.5|Standard Deviation|15.53|15.53|||
3894591|NCT01508936|3719508|B3|||Forced Expiratory Flow at 25% to 75% of the Forced Vital Capacity (FEF25%-75%)|n=96, 393, 489|liters/second|Mean|1.631|1.631|Standard Deviation|0.8645|0.8645|||
3894592|NCT01508936|3719509|B2|||Forced Expiratory Flow at 25% to 75% of the Forced Vital Capacity (FEF25%-75%)|n=96, 393, 489|liters/second|Mean|1.650|1.65|Standard Deviation|0.9037|0.9037|||
3894593|NCT01508936|3719510|B1|||Forced Expiratory Flow at 25% to 75% of the Forced Vital Capacity (FEF25%-75%)|n=96, 393, 489|liters/second|Mean|1.553|1.553|Standard Deviation|0.6791|0.6791|||
3894594|NCT01508936|3719508|B3|||Forced Vital Capacity (FVC)|n=98, 396, 494|liters|Mean|3.081|3.081|Standard Deviation|0.9494|0.9494|||
3894595|NCT01508936|3719509|B2|||Forced Vital Capacity (FVC)|n=98, 396, 494|liters|Mean|3.047|3.047|Standard Deviation|0.9577|0.9577|||
3894596|NCT01508936|3719510|B1|||Forced Vital Capacity (FVC)|n=98, 396, 494|liters|Mean|3.215|3.215|Standard Deviation|0.9076|0.9076|||
3894597|NCT01508936|3719508|B3|||Forced Expiratory Volume in 1 second (FEV1)|n=98, 396, 494|liters|Mean|2.117|2.117|Standard Deviation|0.6837|0.6837|||
3894598|NCT01508936|3719509|B2|||Forced Expiratory Volume in 1 second (FEV1)|n=98, 396, 494|liters|Mean|2.101|2.101|Standard Deviation|0.6950|0.695|||
3894599|NCT01508936|3719510|B1|||Forced Expiratory Volume in 1 second (FEV1)|n=98, 396, 494|liters|Mean|2.180|2.18|Standard Deviation|0.6355|0.6355|||
3894600|NCT01508936|3719508|B3|||Asthma Control Questionnaire (ACQ)|n=98, 396, 494 The ACQ score was measured using the ACQ-7. Six questions are-self assessments; the seventh item is the result of the patient's % predicted FEV1 measurement. Each item has 7 possible answers on a scale of 0 to 6, and the total score is the mean of all responses (the total scale is therefore 0-6). A score of 0 indicates good asthma control; higher scores indicate increasingly poorer asthma control.|units on a scale|Mean|2.559|2.559|Standard Deviation|0.6969|0.6969|||
3894601|NCT01508936|3719509|B2|||Asthma Control Questionnaire (ACQ)|n=98, 396, 494 The ACQ score was measured using the ACQ-7. Six questions are-self assessments; the seventh item is the result of the patient's % predicted FEV1 measurement. Each item has 7 possible answers on a scale of 0 to 6, and the total score is the mean of all responses (the total scale is therefore 0-6). A score of 0 indicates good asthma control; higher scores indicate increasingly poorer asthma control.|units on a scale|Mean|2.558|2.558|Standard Deviation|0.6992|0.6992|||
3894602|NCT01508936|3719510|B1|||Asthma Control Questionnaire (ACQ)|n=98, 396, 494 The ACQ score was measured using the ACQ-7. Six questions are-self assessments; the seventh item is the result of the patient's % predicted FEV1 measurement. Each item has 7 possible answers on a scale of 0 to 6, and the total score is the mean of all responses (the total scale is therefore 0-6). A score of 0 indicates good asthma control; higher scores indicate increasingly poorer asthma control.|units on a scale|Mean|2.564|2.564|Standard Deviation|0.6909|0.6909|||
3894603|NCT01508936|3719508|B3|||Body Mass Index||kg/m^2|Mean|32.2|32.2|Standard Deviation|8.33|8.33|||
3894604|NCT01508936|3719509|B2|||Body Mass Index||kg/m^2|Mean|32.2|32.2|Standard Deviation|8.69|8.69|||
3894605|NCT01508936|3719510|B1|||Body Mass Index||kg/m^2|Mean|31.6|31.6|Standard Deviation|6.66|6.66|||
3894606|NCT01508936|3719508|B3|||Height||cm|Mean|168.1|168.1|Standard Deviation|10.35|10.35|||
3894607|NCT01508936|3719509|B2|||Height||cm|Mean|167.7|167.7|Standard Deviation|10.35|10.35|||
3894608|NCT01508936|3719510|B1|||Height||cm|Mean|169.7|169.7|Standard Deviation|10.25|10.25|||
3894609|NCT01508936|3719508|B3|||Weight||kg|Mean|90.7|90.7|Standard Deviation|23.30|23.3|||
3894610|NCT01508936|3719509|B2|||Weight||kg|Mean|90.6|90.6|Standard Deviation|23.92|23.92|||
3894611|NCT01508936|3719510|B1|||Weight||kg|Mean|90.9|90.9|Standard Deviation|20.68|20.68|||
3894612|NCT01508936|3719508|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
3894613|NCT01508936|3719509|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
3894614|NCT01508936|3719510|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3894615|NCT01508936|3719508|B3|Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||participants|Number|444|444.0||||||
3894616|NCT01508936|3719509|B2|Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||participants|Number|354|354.0||||||
3894617|NCT01508936|3719510|B1|Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||participants|Number|90|90.0||||||
3894618|NCT01508936|3719508|B3|Other||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3894619|NCT01508936|3719509|B2|Other||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3894620|NCT01508936|3719510|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3894621|NCT01508936|3719508|B3|Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3894622|NCT01508936|3719509|B2|Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3894623|NCT01508936|3719510|B1|Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3894624|NCT01508936|3719508|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3894625|NCT01508936|3719509|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3894626|NCT01508936|3719510|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3894627|NCT01508936|3719508|B3|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3894628|NCT01508936|3719509|B2|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3894629|NCT01508936|3719510|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3894630|NCT01508936|3719508|B3|Black||Race/Ethnicity, Customized||participants|Number|134|134.0||||||
3894631|NCT01508936|3719509|B2|Black||Race/Ethnicity, Customized||participants|Number|113|113.0||||||
3894632|NCT01508936|3719510|B1|Black||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3894633|NCT01508936|3719508|B3|White||Race/Ethnicity, Customized||participants|Number|333|333.0||||||
3894634|NCT01508936|3719509|B2|White||Race/Ethnicity, Customized||participants|Number|260|260.0||||||
3894635|NCT01508936|3719510|B1|White||Race/Ethnicity, Customized||participants|Number|73|73.0||||||
3894636|NCT01508936|3719508|B3||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
3894637|NCT01508936|3719509|B2||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3894638|NCT01508936|3719510|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3894639|NCT01508936|3719508|B3||Female|Sex: Female, Male||Participants|Count of Participants|315|315.0||||||
3894640|NCT01508936|3719509|B2||Female|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
3894641|NCT01508936|3719510|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3894642|NCT01508936|3719508|B3|||Age||years|Mean|44.9|44.9|Standard Deviation|12.27|12.27|||
3894643|NCT01508936|3719509|B2|||Age||years|Mean|44.9|44.9|Standard Deviation|12.00|12.0|||
3894644|NCT01508936|3719510|B1|||Age||years|Mean|45.1|45.1|Standard Deviation|13.38|13.38|||
3894645|NCT01508910|3719547|B4||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3894646|NCT01508910|3719548|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3894647|NCT01508910|3719549|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3894648|NCT01508910|3719550|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3894649|NCT01508910|3719547|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3894650|NCT01508910|3719548|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3894651|NCT01508910|3719549|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3894652|NCT01508910|3719550|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3894653|NCT01508910|3719547|B4|||Age||Years|Mean|64|64.0|Standard Deviation|8|8.0|||
3894654|NCT01508910|3719548|B3|||Age||Years|Mean|63|63.0|Standard Deviation|10|10.0|||
3894655|NCT01508910|3719549|B2|||Age||Years|Mean|64|64.0|Standard Deviation|8|8.0|||
3894656|NCT01508910|3719550|B1|||Age||Years|Mean|64|64.0|Standard Deviation|8|8.0|||
3894657|NCT01508832|3719575|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3894658|NCT01508832|3719576|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3894659|NCT01508832|3719577|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3894660|NCT01508832|3719575|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3894661|NCT01508832|3719576|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3894662|NCT01508832|3719577|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3894663|NCT01508832|3719575|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3894664|NCT01508832|3719576|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3894665|NCT01508832|3719577|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3894666|NCT01508832|3719575|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3894667|NCT01508832|3719576|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3894668|NCT01508832|3719577|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3894669|NCT01508832|3719575|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3894670|NCT01508832|3719576|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3894671|NCT01508832|3719577|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3894672|NCT01508832|3719575|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3894673|NCT01508832|3719576|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3894674|NCT01508832|3719577|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3894675|NCT01508702|3719584|B3|United States||Region of Enrollment||Participants|Number|157|157.0||||||
3894676|NCT01508702|3719585|B2|United States||Region of Enrollment||Participants|Number|81|81.0||||||
3894677|NCT01508702|3719586|B1|United States||Region of Enrollment||Participants|Number|76|76.0||||||
3894678|NCT01508702|3719584|B3|South Africa||Region of Enrollment||Participants|Number|23|23.0||||||
3894679|NCT01508702|3719585|B2|South Africa||Region of Enrollment||Participants|Number|11|11.0||||||
3894680|NCT01508702|3719586|B1|South Africa||Region of Enrollment||Participants|Number|12|12.0||||||
3894681|NCT01508702|3719584|B3|New Zealand||Region of Enrollment||Participants|Number|5|5.0||||||
3894682|NCT01508702|3719585|B2|New Zealand||Region of Enrollment||Participants|Number|2|2.0||||||
3894683|NCT01508702|3719586|B1|New Zealand||Region of Enrollment||Participants|Number|3|3.0||||||
3894684|NCT01508702|3719584|B3|Germany||Region of Enrollment||Participants|Number|7|7.0||||||
3894685|NCT01508702|3719585|B2|Germany||Region of Enrollment||Participants|Number|2|2.0||||||
3894686|NCT01508702|3719586|B1|Germany||Region of Enrollment||Participants|Number|5|5.0||||||
3894687|NCT01508702|3719584|B3|Canada||Region of Enrollment||Participants|Number|11|11.0||||||
3894688|NCT01508702|3719585|B2|Canada||Region of Enrollment||Participants|Number|6|6.0||||||
3894689|NCT01508702|3719586|B1|Canada||Region of Enrollment||Participants|Number|5|5.0||||||
3894690|NCT01508702|3719584|B3|Belgium||Region of Enrollment||Participants|Number|9|9.0||||||
3894691|NCT01508702|3719585|B2|Belgium||Region of Enrollment||Participants|Number|4|4.0||||||
3894692|NCT01508702|3719586|B1|Belgium||Region of Enrollment||Participants|Number|5|5.0||||||
3894693|NCT01508702|3719584|B3|Australia||Region of Enrollment||Participants|Number|2|2.0||||||
3894694|NCT01508702|3719585|B2|Australia||Region of Enrollment||Participants|Number|1|1.0||||||
3894695|NCT01508702|3719586|B1|Australia||Region of Enrollment||Participants|Number|1|1.0||||||
3894696|NCT01508702|3719584|B3||Male|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
3894697|NCT01508702|3719585|B2||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3894698|NCT01508702|3719586|B1||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3894699|NCT01508702|3719584|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3894700|NCT01508702|3719585|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3894701|NCT01508702|3719586|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3894702|NCT01508702|3719584|B3|>=65||Age, Customized||Participants|Number|47|47.0||||||
3894703|NCT01508702|3719585|B2|>=65||Age, Customized||Participants|Number|27|27.0||||||
3894704|NCT01508702|3719586|B1|>=65||Age, Customized||Participants|Number|20|20.0||||||
3894705|NCT01508702|3719584|B3|<65||Age, Customized||Participants|Number|167|167.0||||||
3894706|NCT01508702|3719585|B2|<65||Age, Customized||Participants|Number|80|80.0||||||
3894707|NCT01508702|3719586|B1|<65||Age, Customized||Participants|Number|87|87.0||||||
3894708|NCT01508702|3719584|B3|||Age||Years|Mean|54.4|54.4|Standard Deviation|12.2|12.2|||
3894709|NCT01508702|3719585|B2|||Age||Years|Mean|55.3|55.3|Standard Deviation|12.0|12.0|||
3894710|NCT01508702|3719586|B1|||Age||Years|Mean|53.6|53.6|Standard Deviation|12.5|12.5|||
3894711|NCT01508676|3719593|B3||Male|Gender||Participants|Count of Participants|18|18.0||||||
3894712|NCT01508676|3719594|B2||Male|Gender||Participants|Count of Participants|9|9.0||||||
3894713|NCT01508676|3719595|B1||Male|Gender||Participants|Count of Participants|9|9.0||||||
3894714|NCT01508676|3719593|B3||Female|Gender||Participants|Count of Participants|17|17.0||||||
3894715|NCT01508676|3719594|B2||Female|Gender||Participants|Count of Participants|8|8.0||||||
3894716|NCT01508676|3719595|B1||Female|Gender||Participants|Count of Participants|9|9.0||||||
3894717|NCT01508676|3719593|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3894718|NCT01508676|3719594|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3894719|NCT01508676|3719595|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3894720|NCT01508676|3719593|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3894721|NCT01508676|3719594|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3894722|NCT01508676|3719595|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3894723|NCT01508676|3719593|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3894724|NCT01508676|3719594|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3894725|NCT01508676|3719595|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3894726|NCT01508455|3719606|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3894727|NCT01508455|3719606|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3894728|NCT01508455|3719606|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3894729|NCT01508455|3719606|B1|Age Continuous: units: Gestational Age||Age||weeks|Mean|32.5|32.5|Standard Deviation|2.74|2.74|||
3894730|NCT01508455|3719606|B1|Age Continuous||Age||weeks|Mean|0.8|0.8|Standard Deviation|1.36|1.36|||
3894731|NCT01508455|3719606|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3894732|NCT01508455|3719606|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3894733|NCT01508455|3719606|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3894734|NCT01508325|3719615|B3||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3894735|NCT01508325|3719616|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3894736|NCT01508325|3719617|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3894737|NCT01508325|3719615|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3894738|NCT01508325|3719616|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3894739|NCT01508325|3719617|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3894740|NCT01508325|3719615|B3|||Age||years|Mean|50.49|50.49|Standard Deviation|10.60|10.6|||
3894741|NCT01508325|3719616|B2|||Age||years|Mean|49.89|49.89|Standard Deviation|10.46|10.46|||
3894742|NCT01508325|3719617|B1|||Age||years|Mean|51.10|51.1|Standard Deviation|10.77|10.77|||
3894743|NCT01508169|3719646|B3|Brazil||Region of Enrollment||participants|Number|94|94.0||||||
3894744|NCT01508169|3719647|B2|Brazil||Region of Enrollment||participants|Number|47|47.0||||||
3894745|NCT01508169|3719648|B1|Brazil||Region of Enrollment||participants|Number|47|47.0||||||
3894746|NCT01508169|3719646|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3894747|NCT01508169|3719647|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3894748|NCT01508169|3719648|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3894749|NCT01508169|3719646|B3||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3894750|NCT01508169|3719647|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3894751|NCT01508169|3719648|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3894752|NCT01508169|3719646|B3|||Age||years|Mean|72.38|72.38|Standard Deviation|6.83|6.83|||
3894753|NCT01508169|3719647|B2|||Age||years|Mean|72.04|72.04|Standard Deviation|7.14|7.14|||
3894754|NCT01508169|3719648|B1|||Age||years|Mean|72.38|72.38|Standard Deviation|6.83|6.83|||
3894755|NCT01508169|3719646|B3||>=65 years|Age||Participants|Count of Participants|82|82.0||||||
3894756|NCT01508169|3719647|B2||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
3894757|NCT01508169|3719648|B1||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
3894758|NCT01508169|3719646|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3894759|NCT01508169|3719647|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3894760|NCT01508169|3719648|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3894761|NCT01508169|3719646|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3894762|NCT01508169|3719647|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3894763|NCT01508169|3719648|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3894764|NCT01508130|3719661|B3||Male|Sex: Female, Male||Participants|Count of Participants|370|370.0||||||
3894765|NCT01508130|3719662|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3894766|NCT01508130|3719663|B1||Male|Sex: Female, Male||Participants|Count of Participants|284|284.0||||||
3894767|NCT01508130|3719661|B3||Female|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
3894768|NCT01508130|3719662|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3894769|NCT01508130|3719663|B1||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
3894770|NCT01508130|3719661|B3|||Age||years|Mean|51.9|51.9|Standard Deviation|10.3|10.3|||
3894771|NCT01508130|3719662|B2|||Age||years|Mean|51.6|51.6|Standard Deviation|10.0|10.0|||
3894772|NCT01508130|3719663|B1|||Age||years|Mean|52.0|52.0|Standard Deviation|10.3|10.3|||
3894773|NCT01508117|3719706|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3894774|NCT01508117|3719706|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894775|NCT01508117|3719706|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894776|NCT01508117|3719706|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894777|NCT01508117|3719706|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3894778|NCT01508117|3719706|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894779|NCT01508117|3719706|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894780|NCT01508117|3719706|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894781|NCT01508117|3719706|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894782|NCT01508117|3719706|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3894783|NCT01508117|3719706|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894784|NCT01508117|3719706|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3894785|NCT01508117|3719706|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3894786|NCT01508117|3719706|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3894787|NCT01508117|3719706|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3894788|NCT01508117|3719706|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3894789|NCT01508052|3719710|B3|Korea, Republic of||Region of Enrollment||participants|Number|40|40.0||||||
3894790|NCT01508052|3719711|B2|Korea, Republic of||Region of Enrollment||participants|Number|20|20.0||||||
3894791|NCT01508052|3719712|B1|Korea, Republic of||Region of Enrollment||participants|Number|20|20.0||||||
3894792|NCT01508052|3719710|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3894793|NCT01508052|3719711|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3894794|NCT01508052|3719712|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3894795|NCT01508052|3719710|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3894796|NCT01508052|3719711|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3894797|NCT01508052|3719712|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3894798|NCT01508052|3719710|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3894799|NCT01508052|3719711|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3894800|NCT01508052|3719712|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3894801|NCT01508052|3719710|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3894802|NCT01508052|3719711|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3894803|NCT01508052|3719712|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3894804|NCT01508052|3719710|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3894805|NCT01508052|3719711|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3894806|NCT01508052|3719712|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3894807|NCT01508052|3719710|B3|||Age||years|Mean|48|48.0|Standard Deviation|10|10.0|||
3894808|NCT01508052|3719711|B2|||Age||years|Mean|48.2|48.2|Standard Deviation|11.5|11.5|||
3894809|NCT01508052|3719712|B1|||Age||years|Mean|47.6|47.6|Standard Deviation|9.3|9.3|||
3894810|NCT01508013|3719719|B3|||Indoor Tanning Skin Damage Susceptibility Scale|The Indoor Tanning Skin Damage Susceptibility scale can range from 5 (low perceived susceptibility to skin damage from indoor tanning; worse) to 25 (high perceived susceptibility to skin damage from indoor tanning; better).|units on a scale|Mean|19.00|19.0|Standard Deviation|4.71|4.71|||
3894811|NCT01508013|3719720|B2|||Indoor Tanning Skin Damage Susceptibility Scale|The Indoor Tanning Skin Damage Susceptibility scale can range from 5 (low perceived susceptibility to skin damage from indoor tanning; worse) to 25 (high perceived susceptibility to skin damage from indoor tanning; better).|units on a scale|Mean|19.20|19.2|Standard Deviation|4.61|4.61|||
3894812|NCT01508013|3719721|B1|||Indoor Tanning Skin Damage Susceptibility Scale|The Indoor Tanning Skin Damage Susceptibility scale can range from 5 (low perceived susceptibility to skin damage from indoor tanning; worse) to 25 (high perceived susceptibility to skin damage from indoor tanning; better).|units on a scale|Mean|18.79|18.79|Standard Deviation|4.81|4.81|||
3894813|NCT01508013|3719719|B3|||Indoor Tanning Social Approval Scale|The Indoor Tanning Social Approval Scale can range from 3 (strong beliefs peers do not approve indoor tanning; better) to 15 (strong beliefs peers do approve indoor tanning; worse)|units on a scale|Mean|11.59|11.59|Standard Deviation|2.74|2.74|||
3894814|NCT01508013|3719720|B2|||Indoor Tanning Social Approval Scale|The Indoor Tanning Social Approval Scale can range from 3 (strong beliefs peers do not approve indoor tanning; better) to 15 (strong beliefs peers do approve indoor tanning; worse)|units on a scale|Mean|11.23|11.23|Standard Deviation|2.87|2.87|||
3894815|NCT01508013|3719721|B1|||Indoor Tanning Social Approval Scale|The Indoor Tanning Social Approval Scale can range from 3 (strong beliefs peers do not approve indoor tanning; better) to 15 (strong beliefs peers do approve indoor tanning; worse)|units on a scale|Mean|11.99|11.99|Standard Deviation|2.54|2.54|||
3894816|NCT01508013|3719719|B3|||Indoor Tanning Attitudes Scale|The Indoor Tanning Attitudes Scale can range from 3 (strongly negative attitudes toward indoor tanning; better) to 15 (strongly positive attitudes toward indoor tanning; worse)|units on a scale|Mean|9.50|9.5|Standard Deviation|3.35|3.35|||
3894817|NCT01508013|3719720|B2|||Indoor Tanning Attitudes Scale|The Indoor Tanning Attitudes Scale can range from 3 (strongly negative attitudes toward indoor tanning; better) to 15 (strongly positive attitudes toward indoor tanning; worse)|units on a scale|Mean|9.34|9.34|Standard Deviation|3.35|3.35|||
3894818|NCT01508013|3719721|B1|||Indoor Tanning Attitudes Scale|The Indoor Tanning Attitudes Scale can range from 3 (strongly negative attitudes toward indoor tanning; better) to 15 (strongly positive attitudes toward indoor tanning; worse)|units on a scale|Mean|9.67|9.67|Standard Deviation|3.35|3.35|||
3894819|NCT01508013|3719719|B3|||Indoor Tanning Willingness Scale|The Indoor Tanning Willingness scale ranges from 1 (definitely not willing; better ) to 7 (definitely willing; worse).|units on a scale|Mean|4.60|4.6|Standard Deviation|1.88|1.88|||
3894820|NCT01508013|3719720|B2|||Indoor Tanning Willingness Scale|The Indoor Tanning Willingness scale ranges from 1 (definitely not willing; better ) to 7 (definitely willing; worse).|units on a scale|Mean|4.55|4.55|Standard Deviation|1.85|1.85|||
3894821|NCT01508013|3719721|B1|||Indoor Tanning Willingness Scale|The Indoor Tanning Willingness scale ranges from 1 (definitely not willing; better ) to 7 (definitely willing; worse).|units on a scale|Mean|4.66|4.66|Standard Deviation|1.92|1.92|||
3894822|NCT01508013|3719719|B3|||Indoor Tanning Intentions Scale|The Indoor Tanning Intentions Scale can range from 1 (definitely do not intend; better) to 7 (definitely do intend; worse).|units on a scale|Mean|3.93|3.93|Standard Deviation|2.01|2.01|||
3894823|NCT01508013|3719720|B2|||Indoor Tanning Intentions Scale|The Indoor Tanning Intentions Scale can range from 1 (definitely do not intend; better) to 7 (definitely do intend; worse).|units on a scale|Mean|3.74|3.74|Standard Deviation|2.01|2.01|||
3894824|NCT01508013|3719721|B1|||Indoor Tanning Intentions Scale|The Indoor Tanning Intentions Scale can range from 1 (definitely do not intend; better) to 7 (definitely do intend; worse).|units on a scale|Mean|4.14|4.14|Standard Deviation|2.00|2.0|||
3894825|NCT01508013|3719719|B3|||Indoor Tanning Frequency||Indoor tanning sessions|Mean|6.14|6.14|Standard Deviation|24.11|24.11|||
3894826|NCT01508013|3719720|B2|||Indoor Tanning Frequency||Indoor tanning sessions|Mean|5.94|5.94|Standard Deviation|23.01|23.01|||
3894827|NCT01508013|3719721|B1|||Indoor Tanning Frequency||Indoor tanning sessions|Mean|6.36|6.36|Standard Deviation|25.29|25.29|||
3894828|NCT01508013|3719719|B3|United States||Region of Enrollment||participants|Number|443|443.0||||||
3894829|NCT01508013|3719720|B2|United States||Region of Enrollment||participants|Number|229|229.0||||||
3894830|NCT01508013|3719721|B1|United States||Region of Enrollment||participants|Number|214|214.0||||||
3894831|NCT01508013|3719719|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894832|NCT01508013|3719720|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894833|NCT01508013|3719721|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894834|NCT01508013|3719719|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|389|389.0||||||
3894835|NCT01508013|3719720|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|201|201.0||||||
3894836|NCT01508013|3719721|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|188|188.0||||||
3894837|NCT01508013|3719719|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3894838|NCT01508013|3719720|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3894839|NCT01508013|3719721|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3894840|NCT01508013|3719719|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3894841|NCT01508013|3719720|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3894842|NCT01508013|3719721|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3894843|NCT01508013|3719719|B3||Female|Sex: Female, Male||Participants|Count of Participants|443|443.0||||||
3894844|NCT01508013|3719720|B2||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
3894845|NCT01508013|3719721|B1||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
3894846|NCT01508013|3719719|B3|||Age||years|Mean|15.21|15.21|Standard Deviation|1.89|1.89|||
3894847|NCT01508013|3719720|B2|||Age||years|Mean|15.24|15.24|Standard Deviation|1.91|1.91|||
3894848|NCT01508013|3719721|B1|||Age||years|Mean|15.19|15.19|Standard Deviation|1.89|1.89|||
3894849|NCT01507896|3719732|B1|Male||Sex/Gender, Customized||planned surgeries|Number|40|40.0||||||
3894850|NCT01507896|3719732|B1|Female||Sex/Gender, Customized||planned surgeries|Number|0|0.0||||||
3894851|NCT01507896|3719732|B1|||Age||years|Mean|39.7|39.7|Standard Deviation|11.2|11.2|||
3894852|NCT01507831|3719773|B3|||Calculated LDL-C in mmol/L||mmol/L|Mean|3.171|3.171|Standard Deviation|1.092|1.092|||
3894853|NCT01507831|3719774|B2|||Calculated LDL-C in mmol/L||mmol/L|Mean|3.178|3.178|Standard Deviation|1.102|1.102|||
3894854|NCT01507831|3719775|B1|||Calculated LDL-C in mmol/L||mmol/L|Mean|3.157|3.157|Standard Deviation|1.073|1.073|||
3894855|NCT01507831|3719773|B3|||Calculated LDL-C in mg/dL|Calculated LDL-C in mg/dL from Friedewald formula (LDL-C = Total cholesterol - High-density lipoprotein cholesterol - [Triglyceride/5]).|mg/dL|Mean|122.4|122.4|Standard Deviation|42.2|42.2|||
3894856|NCT01507831|3719774|B2|||Calculated LDL-C in mg/dL|Calculated LDL-C in mg/dL from Friedewald formula (LDL-C = Total cholesterol - High-density lipoprotein cholesterol - [Triglyceride/5]).|mg/dL|Mean|122.7|122.7|Standard Deviation|42.6|42.6|||
3894857|NCT01507831|3719775|B1|||Calculated LDL-C in mg/dL|Calculated LDL-C in mg/dL from Friedewald formula (LDL-C = Total cholesterol - High-density lipoprotein cholesterol - [Triglyceride/5]).|mg/dL|Mean|121.9|121.9|Standard Deviation|41.4|41.4|||
3894858|NCT01507831|3719773|B3||Male|Sex: Female, Male||Participants|Count of Participants|1457|1457.0||||||
3894859|NCT01507831|3719774|B2||Male|Sex: Female, Male||Participants|Count of Participants|983|983.0||||||
3894860|NCT01507831|3719775|B1||Male|Sex: Female, Male||Participants|Count of Participants|474|474.0||||||
3894861|NCT01507831|3719773|B3||Female|Sex: Female, Male||Participants|Count of Participants|884|884.0||||||
3894862|NCT01507831|3719774|B2||Female|Sex: Female, Male||Participants|Count of Participants|570|570.0||||||
3894863|NCT01507831|3719775|B1||Female|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
3894864|NCT01507831|3719773|B3|||Age||years|Mean|60.5|60.5|Standard Deviation|10.4|10.4|||
3894865|NCT01507831|3719774|B2|||Age||years|Mean|60.4|60.4|Standard Deviation|10.4|10.4|||
3894866|NCT01507831|3719775|B1|||Age||years|Mean|60.6|60.6|Standard Deviation|10.4|10.4|||
3894867|NCT01507662|3719844|B3|United States||Region of Enrollment||participants|Number|7749|7749.0||||||
3894868|NCT01507662|3719845|B2|United States||Region of Enrollment||participants|Number|3851|3851.0||||||
3894869|NCT01507662|3719846|B1|United States||Region of Enrollment||participants|Number|3898|3898.0||||||
3894870|NCT01507662|3719844|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3894871|NCT01507662|3719845|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3894872|NCT01507662|3719846|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3894873|NCT01507662|3719844|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894874|NCT01507662|3719845|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894875|NCT01507662|3719846|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894876|NCT01507662|3719844|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5935|5935.0||||||
3894877|NCT01507662|3719845|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2954|2954.0||||||
3894878|NCT01507662|3719846|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2981|2981.0||||||
3894879|NCT01507662|3719844|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1656|1656.0||||||
3894880|NCT01507662|3719845|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|814|814.0||||||
3894881|NCT01507662|3719846|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|842|842.0||||||
3894882|NCT01507662|3719844|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3894883|NCT01507662|3719845|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3894884|NCT01507662|3719846|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894885|NCT01507662|3719844|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3894886|NCT01507662|3719845|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3894887|NCT01507662|3719846|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3894888|NCT01507662|3719844|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3894889|NCT01507662|3719845|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3894890|NCT01507662|3719846|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3894891|NCT01507662|3719844|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894892|NCT01507662|3719845|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894893|NCT01507662|3719846|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3894894|NCT01507662|3719844|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7598|7598.0||||||
3894895|NCT01507662|3719845|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3774|3774.0||||||
3894896|NCT01507662|3719846|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3824|3824.0||||||
3894897|NCT01507662|3719844|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|151|151.0||||||
3894898|NCT01507662|3719845|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3894899|NCT01507662|3719846|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3894900|NCT01507662|3719844|B3||Male|Sex: Female, Male||Participants|Count of Participants|1260|1260.0||||||
3894901|NCT01507662|3719845|B2||Male|Sex: Female, Male||Participants|Count of Participants|621|621.0||||||
3894902|NCT01507662|3719846|B1||Male|Sex: Female, Male||Participants|Count of Participants|639|639.0||||||
3894903|NCT01507662|3719844|B3||Female|Sex: Female, Male||Participants|Count of Participants|6489|6489.0||||||
3894904|NCT01507662|3719845|B2||Female|Sex: Female, Male||Participants|Count of Participants|3230|3230.0||||||
3894905|NCT01507662|3719846|B1||Female|Sex: Female, Male||Participants|Count of Participants|3259|3259.0||||||
3894906|NCT01507662|3719844|B3|||Age||years|Mean|66.6|66.6|Standard Deviation|8.3|8.3|||
3894907|NCT01507662|3719845|B2|||Age||years|Mean|66.7|66.7|Standard Deviation|8.2|8.2|||
3894908|NCT01507662|3719846|B1|||Age||years|Mean|66.5|66.5|Standard Deviation|8.4|8.4|||
3894909|NCT01507493|3719853|B3|China||Region of Enrollment||participants|Number|200|200.0||||||
3894910|NCT01507493|3719854|B2|China||Region of Enrollment||participants|Number|178|178.0||||||
3894911|NCT01507493|3719855|B1|China||Region of Enrollment||participants|Number|22|22.0||||||
3894912|NCT01507493|3719853|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3894913|NCT01507493|3719854|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3894914|NCT01507493|3719855|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3894915|NCT01507493|3719853|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3894916|NCT01507493|3719854|B2||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3894917|NCT01507493|3719855|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3894918|NCT01507493|3719853|B3|||Age||years|Mean|55.2|55.2|Standard Deviation|5.7|5.7|||
3894919|NCT01507493|3719854|B2|||Age||years|Mean|55.6|55.6|Standard Deviation|5.3|5.3|||
3894920|NCT01507493|3719855|B1|||Age||years|Mean|51.9|51.9|Standard Deviation|9.3|9.3|||
3894921|NCT01507493|3719853|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3894922|NCT01507493|3719854|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3894923|NCT01507493|3719855|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3894924|NCT01507493|3719853|B3||Between 18 and 65 years|Age||Participants|Count of Participants|184|184.0||||||
3894925|NCT01507493|3719854|B2||Between 18 and 65 years|Age||Participants|Count of Participants|162|162.0||||||
3894926|NCT01507493|3719855|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3894927|NCT01507493|3719853|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3894928|NCT01507493|3719854|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3894929|NCT01507493|3719855|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3894930|NCT01507246|3719870|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
3894931|NCT01507246|3719871|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
3894932|NCT01507246|3719872|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3894933|NCT01507246|3719870|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3894934|NCT01507246|3719871|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3894935|NCT01507246|3719872|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3894936|NCT01507246|3719870|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3894937|NCT01507246|3719871|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3894938|NCT01507246|3719872|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3894939|NCT01507246|3719870|B3|||Age||years|Mean|53.3|53.3|Standard Deviation|16.53|16.53|||
3894940|NCT01507246|3719871|B2|||Age||years|Mean|52.6|52.6|Standard Deviation|17.51|17.51|||
3894941|NCT01507246|3719872|B1|||Age||years|Mean|54.1|54.1|Standard Deviation|15.77|15.77|||
3894942|NCT01507246|3719870|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3894943|NCT01507246|3719871|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3894944|NCT01507246|3719872|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3894945|NCT01507246|3719870|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3894946|NCT01507246|3719871|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3894947|NCT01507246|3719872|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3894948|NCT01507246|3719870|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3894949|NCT01507246|3719871|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3894950|NCT01507246|3719872|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3894951|NCT01507233|3719885|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3894952|NCT01507233|3719887|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3894953|NCT01507233|3719885|B3|Male||Gender||participants|Number|2|2.0||||||
3894954|NCT01507233|3719887|B1|Male||Gender||participants|Number|2|2.0||||||
3894955|NCT01507233|3719885|B3|Female||Gender||participants|Number|3|3.0||||||
3894956|NCT01507233|3719887|B1|Female||Gender||participants|Number|3|3.0||||||
3894957|NCT01507233|3719885|B3|>=65 years||Age||participants|Number|1|1.0||||||
3894958|NCT01507233|3719887|B1|>=65 years||Age||participants|Number|1|1.0||||||
3894959|NCT01507233|3719885|B3|Between 18 and 65 years||Age||participants|Number|4|4.0||||||
3894960|NCT01507233|3719887|B1|Between 18 and 65 years||Age||participants|Number|4|4.0||||||
3894961|NCT01507233|3719885|B3|<=18 years||Age||participants|Number|0|0.0||||||
3894962|NCT01507233|3719887|B1|<=18 years||Age||participants|Number|0|0.0||||||
3894963|NCT01507233|3719885|B3|||Age||years|Mean|53.6|53.6|Standard Deviation|13.76|13.76|||
3894964|NCT01507233|3719887|B1|||Age||years|Mean|53.6|53.6|Standard Deviation|13.76|13.76|||
3894965|NCT01507220|3719898|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3894966|NCT01507220|3719900|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3894967|NCT01507220|3719898|B3|Male||Gender||participants|Number|1|1.0||||||
3894968|NCT01507220|3719900|B1|Male||Gender||participants|Number|1|1.0||||||
3894969|NCT01507220|3719898|B3|Female||Gender||participants|Number|1|1.0||||||
3894970|NCT01507220|3719900|B1|Female||Gender||participants|Number|1|1.0||||||
3894971|NCT01507220|3719898|B3|>=65 years||Age||participants|Number|0|0.0||||||
3894972|NCT01507220|3719900|B1|>=65 years||Age||participants|Number|0|0.0||||||
3894973|NCT01507220|3719898|B3|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
3894974|NCT01507220|3719900|B1|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
3894975|NCT01507220|3719898|B3|<=18 years||Age||participants|Number|0|0.0||||||
3894976|NCT01507220|3719900|B1|<=18 years||Age||participants|Number|0|0.0||||||
3894977|NCT01507220|3719898|B3|||Age||years|Mean|51.5|51.5|Standard Deviation|12.02|12.02|||
3894978|NCT01507220|3719900|B1|||Age||years|Mean|51.5|51.5|Standard Deviation|12.02|12.02|||
3894979|NCT01507181|3719913|B3|GAD||Co-occurring disorders||participants|Number|6|6.0||||||
3894980|NCT01507181|3719914|B2|GAD||Co-occurring disorders||participants|Number|1|1.0||||||
3894981|NCT01507181|3719915|B1|GAD||Co-occurring disorders||participants|Number|5|5.0||||||
3894982|NCT01507181|3719913|B3|OCD||Co-occurring disorders||participants|Number|6|6.0||||||
3894983|NCT01507181|3719914|B2|OCD||Co-occurring disorders||participants|Number|3|3.0||||||
3894984|NCT01507181|3719915|B1|OCD||Co-occurring disorders||participants|Number|3|3.0||||||
3894985|NCT01507181|3719913|B3|SAD||Co-occurring disorders||participants|Number|6|6.0||||||
3894986|NCT01507181|3719914|B2|SAD||Co-occurring disorders||participants|Number|4|4.0||||||
3894987|NCT01507181|3719915|B1|SAD||Co-occurring disorders||participants|Number|2|2.0||||||
3894988|NCT01507181|3719913|B3|Panic disorder||Co-occurring disorders||participants|Number|4|4.0||||||
3894989|NCT01507181|3719914|B2|Panic disorder||Co-occurring disorders||participants|Number|1|1.0||||||
3894990|NCT01507181|3719915|B1|Panic disorder||Co-occurring disorders||participants|Number|3|3.0||||||
3894991|NCT01507181|3719913|B3|BPD||Co-occurring disorders||participants|Number|1|1.0||||||
3894992|NCT01507181|3719914|B2|BPD||Co-occurring disorders||participants|Number|0|0.0||||||
3894993|NCT01507181|3719915|B1|BPD||Co-occurring disorders||participants|Number|1|1.0||||||
3894994|NCT01507181|3719913|B3|PTSD||Co-occurring disorders||participants|Number|3|3.0||||||
3894995|NCT01507181|3719914|B2|PTSD||Co-occurring disorders||participants|Number|1|1.0||||||
3894996|NCT01507181|3719915|B1|PTSD||Co-occurring disorders||participants|Number|2|2.0||||||
3894997|NCT01507181|3719913|B3|MDD||Co-occurring disorders||participants|Number|4|4.0||||||
3894998|NCT01507181|3719914|B2|MDD||Co-occurring disorders||participants|Number|2|2.0||||||
3894999|NCT01507181|3719915|B1|MDD||Co-occurring disorders||participants|Number|2|2.0||||||
3895000|NCT01507181|3719913|B3|BPD||Primary Diagnosis||participants|Number|1|1.0||||||
3895001|NCT01507181|3719914|B2|BPD||Primary Diagnosis||participants|Number|0|0.0||||||
3895002|NCT01507181|3719915|B1|BPD||Primary Diagnosis||participants|Number|1|1.0||||||
3895003|NCT01507181|3719913|B3|PTSD||Primary Diagnosis||participants|Number|3|3.0||||||
3895004|NCT01507181|3719914|B2|PTSD||Primary Diagnosis||participants|Number|2|2.0||||||
3895005|NCT01507181|3719915|B1|PTSD||Primary Diagnosis||participants|Number|1|1.0||||||
3895006|NCT01507181|3719913|B3|Bipolar disorder||Primary Diagnosis||participants|Number|7|7.0||||||
3895007|NCT01507181|3719914|B2|Bipolar disorder||Primary Diagnosis||participants|Number|3|3.0||||||
3895008|NCT01507181|3719915|B1|Bipolar disorder||Primary Diagnosis||participants|Number|4|4.0||||||
3895009|NCT01507181|3719913|B3|MDD||Primary Diagnosis||participants|Number|13|13.0||||||
3895010|NCT01507181|3719914|B2|MDD||Primary Diagnosis||participants|Number|7|7.0||||||
3895011|NCT01507181|3719915|B1|MDD||Primary Diagnosis||participants|Number|6|6.0||||||
3895012|NCT01507181|3719913|B3|||MADRS score, baseline|The Montgomery–Asberg Depression Rating Scale – The MADRS is a 10-item instrument used for the evaluation of depressive symptoms in adults and for the assessment of any changes to those symptoms. Higher MADRS score indicates more severe depression, and each item yields a score of 0 to 6. The overall score ranges from 0 to 60.|units on a scale|Mean|34.8|34.8|Standard Deviation|5.1|5.1|||
3895013|NCT01507181|3719914|B2|||MADRS score, baseline|The Montgomery–Asberg Depression Rating Scale – The MADRS is a 10-item instrument used for the evaluation of depressive symptoms in adults and for the assessment of any changes to those symptoms. Higher MADRS score indicates more severe depression, and each item yields a score of 0 to 6. The overall score ranges from 0 to 60.|units on a scale|Mean|34.3|34.3|Standard Deviation|4.1|4.1|||
3895014|NCT01507181|3719915|B1|||MADRS score, baseline|The Montgomery–Asberg Depression Rating Scale – The MADRS is a 10-item instrument used for the evaluation of depressive symptoms in adults and for the assessment of any changes to those symptoms. Higher MADRS score indicates more severe depression, and each item yields a score of 0 to 6. The overall score ranges from 0 to 60.|units on a scale|Mean|35.2|35.2|Standard Deviation|6.1|6.1|||
3895015|NCT01507181|3719913|B3|||BSI score, baseline|Beck Scale for Suicidal Ideation - Beck Scale is a 21-item self or clinician administered instrumentation used to measure the current intensity of patients' specific attitudes, behaviors and plans to commit suicide. Score range 0-42, with higher score indicating higher intensity.|units on a scale|Mean|17.7|17.7|Standard Deviation|9.7|9.7|||
3895016|NCT01507181|3719914|B2|||BSI score, baseline|Beck Scale for Suicidal Ideation - Beck Scale is a 21-item self or clinician administered instrumentation used to measure the current intensity of patients' specific attitudes, behaviors and plans to commit suicide. Score range 0-42, with higher score indicating higher intensity.|units on a scale|Mean|17.9|17.9|Standard Deviation|11.9|11.9|||
3895287|NCT01506323|3720259|B3||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3895017|NCT01507181|3719915|B1|||BSI score, baseline|Beck Scale for Suicidal Ideation - Beck Scale is a 21-item self or clinician administered instrumentation used to measure the current intensity of patients' specific attitudes, behaviors and plans to commit suicide. Score range 0-42, with higher score indicating higher intensity.|units on a scale|Mean|17.5|17.5|Standard Deviation|7.2|7.2|||
3895018|NCT01507181|3719913|B3|no||History of suicide attempt||participants|Number|9|9.0||||||
3895019|NCT01507181|3719914|B2|no||History of suicide attempt||participants|Number|3|3.0||||||
3895020|NCT01507181|3719915|B1|no||History of suicide attempt||participants|Number|6|6.0||||||
3895021|NCT01507181|3719913|B3|yes||History of suicide attempt||participants|Number|15|15.0||||||
3895022|NCT01507181|3719914|B2|yes||History of suicide attempt||participants|Number|9|9.0||||||
3895023|NCT01507181|3719915|B1|yes||History of suicide attempt||participants|Number|6|6.0||||||
3895024|NCT01507181|3719913|B3||Male|Gender||Participants|Count of Participants|8|8.0||||||
3895025|NCT01507181|3719914|B2||Male|Gender||Participants|Count of Participants|4|4.0||||||
3895026|NCT01507181|3719915|B1||Male|Gender||Participants|Count of Participants|4|4.0||||||
3895027|NCT01507181|3719913|B3||Female|Gender||Participants|Count of Participants|16|16.0||||||
3895028|NCT01507181|3719914|B2||Female|Gender||Participants|Count of Participants|8|8.0||||||
3895029|NCT01507181|3719915|B1||Female|Gender||Participants|Count of Participants|8|8.0||||||
3895030|NCT01507181|3719913|B3|||Age||years|Mean|42.4|42.4|Standard Deviation|13.3|13.3|||
3895031|NCT01507181|3719914|B2|||Age||years|Mean|39.1|39.1|Standard Deviation|10.6|10.6|||
3895032|NCT01507181|3719915|B1|||Age||years|Mean|45.8|45.8|Standard Deviation|15.2|15.2|||
3895033|NCT01507155|3719936|B1|Unknown||Annual Income|Baseline measures only came from clinician assessments, explaining n=625.|participants|Number|276|276.0||||||
3895034|NCT01507155|3719936|B1|< $25,000||Annual Income|Baseline measures only came from clinician assessments, explaining n=625.|participants|Number|135|135.0||||||
3895035|NCT01507155|3719936|B1|$25,000-75,000||Annual Income|Baseline measures only came from clinician assessments, explaining n=625.|participants|Number|152|152.0||||||
3895036|NCT01507155|3719936|B1|> $75,000||Annual Income|Baseline measures only came from clinician assessments, explaining n=625.|participants|Number|62|62.0||||||
3895037|NCT01507155|3719936|B1|Unknown||Employment Status|Baseline measures only came from clinician assessments, explaining n=625.|participants|Number|276|276.0||||||
3895038|NCT01507155|3719936|B1|Retired||Employment Status|Baseline measures only came from clinician assessments, explaining n=625.|participants|Number|12|12.0||||||
3895039|NCT01507155|3719936|B1|Student||Employment Status|Baseline measures only came from clinician assessments, explaining n=625.|participants|Number|33|33.0||||||
3895040|NCT01507155|3719936|B1|Unemployed/disabled/leave of absence||Employment Status|Baseline measures only came from clinician assessments, explaining n=625.|participants|Number|83|83.0||||||
3895041|NCT01507155|3719936|B1|Part-time||Employment Status|Baseline measures only came from clinician assessments, explaining n=625.|participants|Number|39|39.0||||||
3895042|NCT01507155|3719936|B1|Full-time||Employment Status|Baseline measures only came from clinician assessments, explaining n=625.|participants|Number|182|182.0||||||
3895043|NCT01507155|3719936|B1|Unknown||Education|Baseline measures only came from clinician assessments, explaining n=625.|participants|Number|284|284.0||||||
3895044|NCT01507155|3719936|B1|No high school diploma||Education|Baseline measures only came from clinician assessments, explaining n=625.|participants|Number|6|6.0||||||
3895045|NCT01507155|3719936|B1|High school diploma||Education|Baseline measures only came from clinician assessments, explaining n=625.|participants|Number|50|50.0||||||
3895046|NCT01507155|3719936|B1|Some college||Education|Baseline measures only came from clinician assessments, explaining n=625.|participants|Number|140|140.0||||||
3895047|NCT01507155|3719936|B1|>College degree||Education|Baseline measures only came from clinician assessments, explaining n=625.|participants|Number|145|145.0||||||
3895048|NCT01507155|3719936|B1|Unknown||Marital Status|Baseline measures only came from clinician assessments, explaining n=625.|participants|Number|276|276.0||||||
3895049|NCT01507155|3719936|B1|Widowed||Marital Status|Baseline measures only came from clinician assessments, explaining n=625.|participants|Number|1|1.0||||||
3895050|NCT01507155|3719936|B1|Single||Marital Status|Baseline measures only came from clinician assessments, explaining n=625.|participants|Number|118|118.0||||||
3895051|NCT01507155|3719936|B1|Divorced/Separated||Marital Status|Baseline measures only came from clinician assessments, explaining n=625.|participants|Number|53|53.0||||||
3895052|NCT01507155|3719936|B1|Married||Marital Status|Baseline measures only came from clinician assessments, explaining n=625.|participants|Number|177|177.0||||||
3895053|NCT01507155|3719936|B1|Unknown||Current Smoker|Baseline measures only came from clinician assessments, explaining n=625.|participants|Number|362|362.0||||||
3895054|NCT01507155|3719936|B1|Not a smoker||Current Smoker|Baseline measures only came from clinician assessments, explaining n=625.|participants|Number|227|227.0||||||
3895055|NCT01507155|3719936|B1|Current Smoker||Current Smoker|Baseline measures only came from clinician assessments, explaining n=625.|participants|Number|36|36.0||||||
3895056|NCT01507155|3719936|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|Baseline measures only came from clinician assessments, explaining n=625.|Participants|Count of Participants|0|0.0||||||
3895057|NCT01507155|3719936|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Baseline measures only came from clinician assessments, explaining n=625.|Participants|Count of Participants|600|600.0||||||
3895058|NCT01507155|3719936|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|Baseline measures only came from clinician assessments, explaining n=625.|Participants|Count of Participants|25|25.0||||||
3895059|NCT01507155|3719936|B1||Male|Sex: Female, Male|Clinicians completed assessments for 625 patients. In addition, 197 patients completed self-assessments; however, 137 of these assessments corresponded with the clinicians'. The remaining 60 assessments that differed from the clinicians' were included in the data (n=625+60=685). Baseline measures only came from clinician assessments, explaining n=625.|Participants|Count of Participants|213|213.0||||||
3895120|NCT01506882|3720174|B1|||Height||centimeter (cm)|Mean|161.96|161.96|Standard Deviation|8.77|8.77|||
3895060|NCT01507155|3719936|B1||Female|Sex: Female, Male|Clinicians completed assessments for 625 patients. In addition, 197 patients completed self-assessments; however, 137 of these assessments corresponded with the clinicians'. The remaining 60 assessments that differed from the clinicians' were included in the data (n=625+60=685). Baseline measures only came from clinician assessments, explaining n=625.|Participants|Count of Participants|412|412.0||||||
3895061|NCT01507155|3719936|B1|||Age||years|Mean|40.5|40.5|Full Range|||18.0|65.0|
3895062|NCT01507103|3719943|B4||Male|Gender||Participants|Count of Participants|89|89.0||||||
3895063|NCT01507103|3719944|B3||Male|Gender||Participants|Count of Participants|32|32.0||||||
3895064|NCT01507103|3719945|B2||Male|Gender||Participants|Count of Participants|27|27.0||||||
3895065|NCT01507103|3719946|B1||Male|Gender||Participants|Count of Participants|30|30.0||||||
3895066|NCT01507103|3719943|B4||Female|Gender||Participants|Count of Participants|33|33.0||||||
3895067|NCT01507103|3719944|B3||Female|Gender||Participants|Count of Participants|10|10.0||||||
3895068|NCT01507103|3719945|B2||Female|Gender||Participants|Count of Participants|14|14.0||||||
3895069|NCT01507103|3719946|B1||Female|Gender||Participants|Count of Participants|9|9.0||||||
3895070|NCT01507103|3719943|B4|||Age||years|Mean|61.3|61.3|Standard Deviation|9.84|9.84|||
3895071|NCT01507103|3719944|B3|||Age||years|Mean|60.3|60.3|Standard Deviation|8.77|8.77|||
3895072|NCT01507103|3719945|B2|||Age||years|Mean|62.2|62.2|Standard Deviation|10.12|10.12|||
3895073|NCT01507103|3719946|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|10.74|10.74|||
3895074|NCT01507090|3719971|B1|United States||Region of Enrollment||participants|Number|642|642.0||||||
3895075|NCT01507090|3719971|B1||Male|Sex: Female, Male||Participants|Count of Participants|48.3|48.3||||||
3895076|NCT01507090|3719971|B1||Female|Sex: Female, Male||Participants|Count of Participants|51.7|51.7||||||
3895077|NCT01507090|3719971|B1|||Age||years|Mean|8.4|8.4|Standard Deviation|4.9|4.9|||
3895078|NCT01507090|3719971|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3895079|NCT01507090|3719971|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3895080|NCT01507090|3719971|B1||<=18 years|Age||Participants|Count of Participants|642|642.0||||||
3895081|NCT01507051|3720006|B5||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3895082|NCT01507051|3720007|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3895083|NCT01507051|3720008|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3895084|NCT01507051|3720009|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3895085|NCT01507051|3720010|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3895086|NCT01507051|3720006|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3895087|NCT01507051|3720007|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3895088|NCT01507051|3720008|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3895089|NCT01507051|3720009|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3895090|NCT01507051|3720010|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3895091|NCT01507051|3720006|B5|||Age||years|Mean|32.4|32.4|Standard Deviation|7.6|7.6|||
3895092|NCT01507051|3720007|B4|||Age||years|Mean|34.6|34.6|Standard Deviation|6.9|6.9|||
3895093|NCT01507051|3720008|B3|||Age||years|Mean|34.8|34.8|Standard Deviation|8.0|8.0|||
3895094|NCT01507051|3720009|B2|||Age||years|Mean|30.7|30.7|Standard Deviation|7.5|7.5|||
3895095|NCT01507051|3720010|B1|||Age||years|Mean|31.3|31.3|Standard Deviation|7.2|7.2|||
3895096|NCT01506960|3720131|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3895097|NCT01506960|3720131|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3895098|NCT01506960|3720131|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3895099|NCT01506960|3720131|B1|||Age||years|Mean|59.8|59.8|Standard Deviation|8.5|8.5|||
3895100|NCT01506960|3720131|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3895101|NCT01506960|3720131|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3895102|NCT01506960|3720131|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3895103|NCT01506947|3720137|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3895104|NCT01506947|3720137|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3895105|NCT01506947|3720137|B1|||Age||years|Mean|49.6|49.6|Standard Deviation|16.7|16.7|||
3895106|NCT01506908|3720153|B3|||Body Mass Index||Kilograms (kg)/ meter (m)^2|Mean|27.67|27.67|Standard Deviation|3.89|3.89|||
3895107|NCT01506908|3720154|B2|||Body Mass Index||Kilograms (kg)/ meter (m)^2|Mean|27.56|27.56|Standard Deviation|4.05|4.05|||
3895108|NCT01506908|3720155|B1|||Body Mass Index||Kilograms (kg)/ meter (m)^2|Mean|27.79|27.79|Standard Deviation|3.73|3.73|||
3895109|NCT01506908|3720153|B3||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3895110|NCT01506908|3720154|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3895111|NCT01506908|3720155|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3895112|NCT01506908|3720153|B3||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3895113|NCT01506908|3720154|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3895114|NCT01506908|3720155|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3895115|NCT01506908|3720153|B3|||Age||Years|Mean|44.07|44.07|Standard Deviation|11.88|11.88|||
3895116|NCT01506908|3720154|B2|||Age||Years|Mean|44.45|44.45|Standard Deviation|11.64|11.64|||
3895117|NCT01506908|3720155|B1|||Age||Years|Mean|43.69|43.69|Standard Deviation|12.13|12.13|||
3895118|NCT01506882|3720172|B3|||Height||centimeter (cm)|Mean|162.54|162.54|Standard Deviation|9.02|9.02|||
3895119|NCT01506882|3720173|B2|||Height||centimeter (cm)|Mean|166.07|166.07|Standard Deviation|10.21|10.21|||
3895121|NCT01506882|3720172|B3|||Weight||kilogram (kg)|Mean|59.48|59.48|Standard Deviation|12.67|12.67|||
3895122|NCT01506882|3720173|B2|||Weight||kilogram (kg)|Mean|62.58|62.58|Standard Deviation|15.11|15.11|||
3895123|NCT01506882|3720174|B1|||Weight||kilogram (kg)|Mean|58.98|58.98|Standard Deviation|12.30|12.3|||
3895124|NCT01506882|3720172|B3|Japan||Region of Enrollment||participants|Number|71|71.0||||||
3895125|NCT01506882|3720173|B2|Japan||Region of Enrollment||participants|Number|10|10.0||||||
3895126|NCT01506882|3720174|B1|Japan||Region of Enrollment||participants|Number|61|61.0||||||
3895127|NCT01506882|3720172|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3895128|NCT01506882|3720173|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3895129|NCT01506882|3720174|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3895130|NCT01506882|3720172|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3895131|NCT01506882|3720173|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3895132|NCT01506882|3720174|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3895133|NCT01506882|3720172|B3|||Age||years|Mean|36.5|36.5|Standard Deviation|17.9|17.9|||
3895134|NCT01506882|3720173|B2|||Age||years|Mean|37.0|37.0|Standard Deviation|18.6|18.6|||
3895135|NCT01506882|3720174|B1|||Age||years|Mean|36.5|36.5|Standard Deviation|18.0|18.0|||
3895136|NCT01506882|3720172|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3895137|NCT01506882|3720173|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3895138|NCT01506882|3720174|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3895139|NCT01506882|3720172|B3||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
3895140|NCT01506882|3720173|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3895141|NCT01506882|3720174|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3895142|NCT01506882|3720172|B3||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
3895143|NCT01506882|3720173|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3895144|NCT01506882|3720174|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
3895145|NCT01506726|3720187|B3|||Hemoglobin||g/dL|Mean|11.19|11.19|Standard Deviation|0.45|0.45|||
3895146|NCT01506726|3720188|B2|||Hemoglobin||g/dL|Mean|11.28|11.28|Standard Deviation|0.34|0.34|||
3895147|NCT01506726|3720189|B1|||Hemoglobin||g/dL|Mean|11.12|11.12|Standard Deviation|0.55|0.55|||
3895148|NCT01506726|3720187|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3895149|NCT01506726|3720188|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3895150|NCT01506726|3720189|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3895151|NCT01506726|3720187|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3895152|NCT01506726|3720188|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3895153|NCT01506726|3720189|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3895154|NCT01506726|3720187|B3|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3895155|NCT01506726|3720188|B2|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3895156|NCT01506726|3720189|B1|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3895157|NCT01506726|3720187|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895158|NCT01506726|3720188|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895159|NCT01506726|3720189|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895160|NCT01506726|3720187|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3895161|NCT01506726|3720188|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3895162|NCT01506726|3720189|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3895163|NCT01506726|3720187|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895164|NCT01506726|3720188|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895165|NCT01506726|3720189|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895166|NCT01506726|3720187|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3895167|NCT01506726|3720188|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3895168|NCT01506726|3720189|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3895169|NCT01506726|3720187|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3895170|NCT01506726|3720188|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3895171|NCT01506726|3720189|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3895172|NCT01506726|3720187|B3|||Age||years|Mean|78.5|78.5|Standard Deviation|5.6|5.6|||
3895173|NCT01506726|3720188|B2|||Age||years|Mean|74.2|74.2|Standard Deviation|4.7|4.7|||
3895174|NCT01506726|3720189|B1|||Age||years|Mean|82.2|82.2|Standard Deviation|3.4|3.4|||
3895175|NCT01506596|3720230|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
3895176|NCT01506596|3720230|B1||Male|Gender||Participants|Count of Participants|27|27.0||||||
3895177|NCT01506596|3720230|B1||Female|Gender||Participants|Count of Participants|14|14.0||||||
3895178|NCT01506596|3720230|B1|||Age||years|Mean|62.0|62.0|Standard Deviation|15.52|15.52|||
3895179|NCT01506479|3720238|B4||Stage 2|Hoehn and Yahr Stage|Stage 1 is Unilateral Disease; Stage 2 is Bilateral Disease without impairment of balance|Participants|Count of Participants|95|95.0||||||
3895180|NCT01506479|3720239|B3||Stage 2|Hoehn and Yahr Stage|Stage 1 is Unilateral Disease; Stage 2 is Bilateral Disease without impairment of balance|Participants|Count of Participants|32|32.0||||||
3895181|NCT01506479|3720240|B2||Stage 2|Hoehn and Yahr Stage|Stage 1 is Unilateral Disease; Stage 2 is Bilateral Disease without impairment of balance|Participants|Count of Participants|31|31.0||||||
3895182|NCT01506479|3720241|B1||Stage 2|Hoehn and Yahr Stage|Stage 1 is Unilateral Disease; Stage 2 is Bilateral Disease without impairment of balance|Participants|Count of Participants|32|32.0||||||
3895183|NCT01506479|3720238|B4||Stage 1|Hoehn and Yahr Stage|Stage 1 is Unilateral Disease; Stage 2 is Bilateral Disease without impairment of balance|Participants|Count of Participants|33|33.0||||||
3895184|NCT01506479|3720239|B3||Stage 1|Hoehn and Yahr Stage|Stage 1 is Unilateral Disease; Stage 2 is Bilateral Disease without impairment of balance|Participants|Count of Participants|13|13.0||||||
3895185|NCT01506479|3720240|B2||Stage 1|Hoehn and Yahr Stage|Stage 1 is Unilateral Disease; Stage 2 is Bilateral Disease without impairment of balance|Participants|Count of Participants|12|12.0||||||
3895186|NCT01506479|3720241|B1||Stage 1|Hoehn and Yahr Stage|Stage 1 is Unilateral Disease; Stage 2 is Bilateral Disease without impairment of balance|Participants|Count of Participants|8|8.0||||||
3895187|NCT01506479|3720238|B4|||Total daily steps||steps per day|Mean|5306|5306.0|Standard Deviation|2856|2856.0|||
3895188|NCT01506479|3720239|B3|||Total daily steps||steps per day|Mean|5702|5702.0|Standard Deviation|2521|2521.0|||
3895189|NCT01506479|3720240|B2|||Total daily steps||steps per day|Mean|5146|5146.0|Standard Deviation|3107|3107.0|||
3895190|NCT01506479|3720241|B1|||Total daily steps||steps per day|Mean|5005|5005.0|Standard Deviation|2987|2987.0|||
3895191|NCT01506479|3720238|B4|||Unified Parkinson Disease Rating Scale Part 3 Motor Evaluation|Sum of 27 items scored 0 to 4, minimum score is 0, maximum score is 108. Higher score indicates worse motor symptoms.|units on a scale|Mean|17|17.0|Standard Deviation|7|7.0|||
3895192|NCT01506479|3720239|B3|||Unified Parkinson Disease Rating Scale Part 3 Motor Evaluation|Sum of 27 items scored 0 to 4, minimum score is 0, maximum score is 108. Higher score indicates worse motor symptoms.|units on a scale|Mean|16|16.0|Standard Deviation|7|7.0|||
3895193|NCT01506479|3720240|B2|||Unified Parkinson Disease Rating Scale Part 3 Motor Evaluation|Sum of 27 items scored 0 to 4, minimum score is 0, maximum score is 108. Higher score indicates worse motor symptoms.|units on a scale|Mean|17|17.0|Standard Deviation|7|7.0|||
3895194|NCT01506479|3720241|B1|||Unified Parkinson Disease Rating Scale Part 3 Motor Evaluation|Sum of 27 items scored 0 to 4, minimum score is 0, maximum score is 108. Higher score indicates worse motor symptoms.|units on a scale|Mean|17|17.0|Standard Deviation|7|7.0|||
3895195|NCT01506479|3720238|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3895196|NCT01506479|3720239|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3895197|NCT01506479|3720240|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3895198|NCT01506479|3720241|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895199|NCT01506479|3720238|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895200|NCT01506479|3720239|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895201|NCT01506479|3720240|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895202|NCT01506479|3720241|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895203|NCT01506479|3720238|B4||White|Race (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
3895204|NCT01506479|3720239|B3||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3895205|NCT01506479|3720240|B2||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3895206|NCT01506479|3720241|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3895207|NCT01506479|3720238|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3895208|NCT01506479|3720239|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3895209|NCT01506479|3720240|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3895210|NCT01506479|3720241|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3895211|NCT01506479|3720238|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895212|NCT01506479|3720239|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895213|NCT01506479|3720240|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895214|NCT01506479|3720241|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895215|NCT01506479|3720238|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3895216|NCT01506479|3720239|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3895217|NCT01506479|3720240|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3895218|NCT01506479|3720241|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3895219|NCT01506479|3720238|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895220|NCT01506479|3720239|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895221|NCT01506479|3720240|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895222|NCT01506479|3720241|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895223|NCT01506479|3720238|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3895224|NCT01506479|3720239|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3895225|NCT01506479|3720240|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3895226|NCT01506479|3720241|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895227|NCT01506479|3720238|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
3895228|NCT01506479|3720239|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3895229|NCT01506479|3720240|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3895230|NCT01506479|3720241|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3895231|NCT01506479|3720238|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3895232|NCT01506479|3720239|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3895233|NCT01506479|3720240|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3895234|NCT01506479|3720241|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3895235|NCT01506479|3720238|B4||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3895236|NCT01506479|3720239|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3895237|NCT01506479|3720240|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3895238|NCT01506479|3720241|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3895239|NCT01506479|3720238|B4||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3895240|NCT01506479|3720239|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3895241|NCT01506479|3720240|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3895242|NCT01506479|3720241|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3895243|NCT01506479|3720238|B4|||Age||years|Mean|64|64.0|Standard Deviation|9|9.0|||
3895244|NCT01506479|3720239|B3|||Age||years|Mean|63|63.0|Standard Deviation|10|10.0|||
3895245|NCT01506479|3720240|B2|||Age||years|Mean|64|64.0|Standard Deviation|9|9.0|||
3895246|NCT01506479|3720241|B1|||Age||years|Mean|64|64.0|Standard Deviation|10|10.0|||
3895247|NCT01506362|3720255|B1|Israel||Region of Enrollment||participants|Number|22|22.0||||||
3895248|NCT01506362|3720255|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3895249|NCT01506362|3720255|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3895250|NCT01506362|3720255|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3895251|NCT01506362|3720255|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3895252|NCT01506362|3720255|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3895253|NCT01506362|3720255|B1|||Age||years|Mean|33.9|33.9|Standard Deviation|13.9|13.9|||
3895254|NCT01506323|3720259|B3|United States||Region of Enrollment||participants|Number|173|173.0||||||
3895255|NCT01506323|3720260|B2|United States||Region of Enrollment||participants|Number|84|84.0||||||
3895256|NCT01506323|3720261|B1|United States||Region of Enrollment||participants|Number|89|89.0||||||
3895257|NCT01506323|3720259|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895258|NCT01506323|3720260|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895259|NCT01506323|3720261|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895260|NCT01506323|3720259|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3895261|NCT01506323|3720260|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3895262|NCT01506323|3720261|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3895263|NCT01506323|3720259|B3||White|Race (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
3895264|NCT01506323|3720260|B2||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3895265|NCT01506323|3720261|B1||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3895266|NCT01506323|3720259|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3895267|NCT01506323|3720260|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3895268|NCT01506323|3720261|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3895269|NCT01506323|3720259|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3895270|NCT01506323|3720260|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3895271|NCT01506323|3720261|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3895272|NCT01506323|3720259|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3895273|NCT01506323|3720260|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3895274|NCT01506323|3720261|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3895275|NCT01506323|3720259|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3895276|NCT01506323|3720260|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3895277|NCT01506323|3720261|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3895278|NCT01506323|3720259|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895279|NCT01506323|3720260|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895280|NCT01506323|3720261|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895281|NCT01506323|3720259|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|143|143.0||||||
3895282|NCT01506323|3720260|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3895283|NCT01506323|3720261|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
3895284|NCT01506323|3720259|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3895285|NCT01506323|3720260|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3895286|NCT01506323|3720261|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3895288|NCT01506323|3720260|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3895289|NCT01506323|3720261|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3895290|NCT01506323|3720259|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3895291|NCT01506323|3720260|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3895292|NCT01506323|3720261|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3895293|NCT01506323|3720259|B3||>=65 years|Age|Baseline data was collected from participants who scored greater or equal to 50 on the PTSD Checklist-Military (PCL-M) and greater or equal to 45 on the Clinician Administered PTSD Scale (CAPS).|Participants|Count of Participants|29|29.0||||||
3895294|NCT01506323|3720260|B2||>=65 years|Age|Baseline data was collected from participants who scored greater or equal to 50 on the PTSD Checklist-Military (PCL-M) and greater or equal to 45 on the Clinician Administered PTSD Scale (CAPS).|Participants|Count of Participants|14|14.0||||||
3895295|NCT01506323|3720261|B1||>=65 years|Age|Baseline data was collected from participants who scored greater or equal to 50 on the PTSD Checklist-Military (PCL-M) and greater or equal to 45 on the Clinician Administered PTSD Scale (CAPS).|Participants|Count of Participants|15|15.0||||||
3895296|NCT01506323|3720259|B3||Between 18 and 65 years|Age|Baseline data was collected from participants who scored greater or equal to 50 on the PTSD Checklist-Military (PCL-M) and greater or equal to 45 on the Clinician Administered PTSD Scale (CAPS).|Participants|Count of Participants|144|144.0||||||
3895297|NCT01506323|3720260|B2||Between 18 and 65 years|Age|Baseline data was collected from participants who scored greater or equal to 50 on the PTSD Checklist-Military (PCL-M) and greater or equal to 45 on the Clinician Administered PTSD Scale (CAPS).|Participants|Count of Participants|70|70.0||||||
3895298|NCT01506323|3720261|B1||Between 18 and 65 years|Age|Baseline data was collected from participants who scored greater or equal to 50 on the PTSD Checklist-Military (PCL-M) and greater or equal to 45 on the Clinician Administered PTSD Scale (CAPS).|Participants|Count of Participants|74|74.0||||||
3895299|NCT01506323|3720259|B3||<=18 years|Age|Baseline data was collected from participants who scored greater or equal to 50 on the PTSD Checklist-Military (PCL-M) and greater or equal to 45 on the Clinician Administered PTSD Scale (CAPS).|Participants|Count of Participants|0|0.0||||||
3895300|NCT01506323|3720260|B2||<=18 years|Age|Baseline data was collected from participants who scored greater or equal to 50 on the PTSD Checklist-Military (PCL-M) and greater or equal to 45 on the Clinician Administered PTSD Scale (CAPS).|Participants|Count of Participants|0|0.0||||||
3895301|NCT01506323|3720261|B1||<=18 years|Age|Baseline data was collected from participants who scored greater or equal to 50 on the PTSD Checklist-Military (PCL-M) and greater or equal to 45 on the Clinician Administered PTSD Scale (CAPS).|Participants|Count of Participants|0|0.0||||||
3895302|NCT01506193|3720288|B4||Male|Sex: Female, Male||Participants|Count of Participants|376|376.0||||||
3895303|NCT01506193|3720289|B3||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3895304|NCT01506193|3720290|B2||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3895305|NCT01506193|3720291|B1||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3895306|NCT01506193|3720288|B4||Female|Sex: Female, Male||Participants|Count of Participants|340|340.0||||||
3895307|NCT01506193|3720289|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3895308|NCT01506193|3720290|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3895309|NCT01506193|3720291|B1||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3895310|NCT01506193|3720288|B4|||Age||Months|Mean|13.4|13.4|Standard Deviation|0.63|0.63|||
3895311|NCT01506193|3720289|B3|||Age||Months|Mean|13.4|13.4|Standard Deviation|0.7|0.7|||
3895312|NCT01506193|3720290|B2|||Age||Months|Mean|13.4|13.4|Standard Deviation|0.6|0.6|||
3895313|NCT01506193|3720291|B1|||Age||Months|Mean|13.4|13.4|Standard Deviation|0.6|0.6|||
3895314|NCT01505881|3720324|B3||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3895315|NCT01505881|3720325|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3895316|NCT01505881|3720326|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3895317|NCT01505881|3720324|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3895318|NCT01505881|3720325|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3895319|NCT01505881|3720326|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3895320|NCT01505881|3720324|B3|||Age||years|Mean|57.2|57.2|Standard Deviation|8.8|8.8|||
3895321|NCT01505881|3720325|B2|||Age||years|Mean|56.1|56.1|Standard Deviation|10.1|10.1|||
3895322|NCT01505881|3720326|B1|||Age||years|Mean|57.8|57.8|Standard Deviation|8.0|8.0|||
3895323|NCT01505764|3720339|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3895324|NCT01505764|3720340|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3895325|NCT01505764|3720341|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3895326|NCT01505764|3720339|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895327|NCT01505764|3720340|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895328|NCT01505764|3720341|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895329|NCT01505764|3720339|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895330|NCT01505764|3720340|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895331|NCT01505764|3720341|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895332|NCT01505764|3720339|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3895333|NCT01505764|3720340|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3895334|NCT01505764|3720341|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3895335|NCT01505764|3720339|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3895336|NCT01505764|3720340|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3895337|NCT01505764|3720341|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3895338|NCT01505764|3720339|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895339|NCT01505764|3720340|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895340|NCT01505764|3720341|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895341|NCT01505764|3720339|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3895342|NCT01505764|3720340|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895343|NCT01505764|3720341|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3895344|NCT01505764|3720339|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895345|NCT01505764|3720340|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895346|NCT01505764|3720341|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895347|NCT01505764|3720339|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895348|NCT01505764|3720340|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895349|NCT01505764|3720341|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895350|NCT01505764|3720339|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3895351|NCT01505764|3720340|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3895352|NCT01505764|3720341|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3895353|NCT01505764|3720339|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3895354|NCT01505764|3720340|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895355|NCT01505764|3720341|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3895356|NCT01505764|3720339|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3895357|NCT01505764|3720340|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3895358|NCT01505764|3720341|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3895359|NCT01505764|3720339|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3895360|NCT01505764|3720340|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3895361|NCT01505764|3720341|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3895362|NCT01505764|3720339|B3|||Age||years|Median|57|57.0|Full Range|||48.0|73.0|
3895363|NCT01505764|3720340|B2|||Age||years|Median|58|58.0|Full Range|||56.0|73.0|
3895364|NCT01505764|3720341|B1|||Age||years|Median|56|56.0|Full Range|||48.0|72.0|
3895365|NCT01505764|3720339|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3895366|NCT01505764|3720340|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3895367|NCT01505764|3720341|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3895368|NCT01505764|3720339|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3895369|NCT01505764|3720340|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3895370|NCT01505764|3720341|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3895371|NCT01505764|3720339|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3895372|NCT01505764|3720340|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3895373|NCT01505764|3720341|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3895374|NCT01505673|3720370|B3|United States||Region of Enrollment||Participants|Count of Participants|66|66.0||||||
3895375|NCT01505673|3720371|B2|United States||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3895376|NCT01505673|3720372|B1|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3895377|NCT01505673|3720370|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3895378|NCT01505673|3720371|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3895379|NCT01505673|3720372|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3895380|NCT01505673|3720370|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3895381|NCT01505673|3720371|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3895382|NCT01505673|3720372|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3895383|NCT01505673|3720370|B3|||Age||years|Mean|54.2|54.2|Standard Deviation|7.4|7.4|||
3895384|NCT01505673|3720371|B2|||Age||years|Mean|55.5|55.5|Standard Deviation|6.6|6.6|||
3895385|NCT01505673|3720372|B1|||Age||years|Mean|52.8|52.8|Standard Deviation|8.1|8.1|||
3895386|NCT01505673|3720370|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3895387|NCT01505673|3720371|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3895388|NCT01505673|3720372|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3895389|NCT01505673|3720370|B3||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
3895390|NCT01505673|3720371|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3895391|NCT01505673|3720372|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3895392|NCT01505673|3720370|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3895393|NCT01505673|3720371|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3895394|NCT01505673|3720372|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3895395|NCT01505647|3720431|B3||Male|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
3895396|NCT01505647|3720432|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3895397|NCT01505647|3720433|B1||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3895398|NCT01505647|3720431|B3||Female|Sex: Female, Male||Participants|Count of Participants|295|295.0||||||
3895399|NCT01505647|3720432|B2||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3895400|NCT01505647|3720433|B1||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
3895401|NCT01505647|3720431|B3|||Age||years|Mean|62.8|62.8|Standard Deviation|7.1|7.1|||
3895402|NCT01505647|3720432|B2|||Age||years|Mean|62.4|62.4|Standard Deviation|7.0|7.0|||
3895403|NCT01505647|3720433|B1|||Age||years|Mean|62.9|62.9|Standard Deviation|7.1|7.1|||
3895404|NCT01505608|3720448|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895405|NCT01505608|3720449|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895406|NCT01505608|3720450|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895407|NCT01505608|3720448|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895408|NCT01505608|3720449|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895409|NCT01505608|3720450|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895410|NCT01505608|3720448|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3895411|NCT01505608|3720449|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3895412|NCT01505608|3720450|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3895413|NCT01505608|3720448|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3895414|NCT01505608|3720449|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3895415|NCT01505608|3720450|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895416|NCT01505608|3720448|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895417|NCT01505608|3720449|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895418|NCT01505608|3720450|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895419|NCT01505608|3720448|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895420|NCT01505608|3720449|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895421|NCT01505608|3720450|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895422|NCT01505608|3720448|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895423|NCT01505608|3720449|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895424|NCT01505608|3720450|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895425|NCT01505608|3720448|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895426|NCT01505608|3720449|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895427|NCT01505608|3720450|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895428|NCT01505608|3720448|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3895429|NCT01505608|3720449|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3895430|NCT01505608|3720450|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3895431|NCT01505608|3720448|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3895432|NCT01505608|3720449|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895433|NCT01505608|3720450|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3895434|NCT01505608|3720448|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3895435|NCT01505608|3720449|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3895436|NCT01505608|3720450|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3895437|NCT01505608|3720448|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3895438|NCT01505608|3720449|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3895439|NCT01505608|3720450|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3895440|NCT01505608|3720448|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3895441|NCT01505608|3720449|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3895442|NCT01505608|3720450|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3895443|NCT01505608|3720448|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3895444|NCT01505608|3720449|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3895445|NCT01505608|3720450|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3895446|NCT01505608|3720448|B3||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
3895447|NCT01505608|3720449|B2||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
3895448|NCT01505608|3720450|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3895449|NCT01505530|3720467|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895450|NCT01505530|3720468|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895451|NCT01505530|3720469|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895452|NCT01505530|3720470|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895453|NCT01505530|3720467|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895454|NCT01505530|3720468|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895455|NCT01505530|3720469|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895456|NCT01505530|3720470|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895457|NCT01505530|3720467|B4||White|Race (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
3895458|NCT01505530|3720468|B3||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3895459|NCT01505530|3720469|B2||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3895460|NCT01505530|3720470|B1||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3895461|NCT01505530|3720467|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3895462|NCT01505530|3720468|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3895463|NCT01505530|3720469|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3895464|NCT01505530|3720470|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3895465|NCT01505530|3720467|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895466|NCT01505530|3720468|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895467|NCT01505530|3720469|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895468|NCT01505530|3720470|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895469|NCT01505530|3720467|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3895470|NCT01505530|3720468|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3895471|NCT01505530|3720469|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895472|NCT01505530|3720470|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895473|NCT01505530|3720467|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895474|NCT01505530|3720468|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895475|NCT01505530|3720469|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895476|NCT01505530|3720470|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895477|NCT01505530|3720467|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3895478|NCT01505530|3720468|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3895479|NCT01505530|3720469|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3895480|NCT01505530|3720470|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3895481|NCT01505530|3720467|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3895482|NCT01505530|3720468|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3895483|NCT01505530|3720469|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3895484|NCT01505530|3720470|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3895485|NCT01505530|3720467|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3895486|NCT01505530|3720468|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895487|NCT01505530|3720469|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3895488|NCT01505530|3720470|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895489|NCT01505530|3720467|B4||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3895490|NCT01505530|3720468|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3895491|NCT01505530|3720469|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3895492|NCT01505530|3720470|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3895493|NCT01505530|3720467|B4||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3895494|NCT01505530|3720468|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3895495|NCT01505530|3720469|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3895496|NCT01505530|3720470|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3895497|NCT01505530|3720467|B4|||Age||years|Mean|66.9|66.9|Standard Deviation|10.4|10.4|||
3895498|NCT01505530|3720468|B3|||Age||years|Mean|68.4|68.4|Standard Deviation|9.1|9.1|||
3895499|NCT01505530|3720469|B2|||Age||years|Mean|67.4|67.4|Standard Deviation|10.7|10.7|||
3895500|NCT01505530|3720470|B1|||Age||years|Mean|65.0|65.0|Standard Deviation|11.3|11.3|||
3895501|NCT01505465|3720513|B3|United States||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3895502|NCT01505465|3720514|B2|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3895503|NCT01505465|3720515|B1|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3895504|NCT01505465|3720513|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3895505|NCT01505465|3720513|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3895506|NCT01505465|3720514|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3895507|NCT01505465|3720515|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3895508|NCT01505465|3720513|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3895509|NCT01505465|3720514|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3895510|NCT01505465|3720515|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3895511|NCT01505465|3720513|B3|||Age||years|Mean|65.82|65.82|Standard Deviation|40.05|40.05|||
3895512|NCT01505465|3720514|B2|||Age||years|Mean|61.4|61.4|Standard Deviation|14.3|14.3|||
3895513|NCT01505465|3720515|B1|||Age||years|Mean|70|70.0|Standard Deviation|65.8|65.8|||
3895514|NCT01505387|3720530|B3|||BMI (kg/m^2)||kg/m^2|Mean|27.5|27.5|Standard Deviation|2.2|2.2|||
3895515|NCT01505387|3720531|B2|||BMI (kg/m^2)||kg/m^2|Mean|27.3|27.3|Standard Deviation|2.1|2.1|||
3895516|NCT01505387|3720532|B1|||BMI (kg/m^2)||kg/m^2|Mean|27.7|27.7|Standard Deviation|2.4|2.4|||
3895517|NCT01505387|3720530|B3|||Body weight (kg)||kg|Mean|78.7|78.7|Standard Deviation|10.2|10.2|||
3895518|NCT01505387|3720531|B2|||Body weight (kg)||kg|Mean|78.2|78.2|Standard Deviation|11.4|11.4|||
3895519|NCT01505387|3720532|B1|||Body weight (kg)||kg|Mean|79.3|79.3|Standard Deviation|9.0|9.0|||
3895520|NCT01505387|3720530|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3895521|NCT01505387|3720531|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3895522|NCT01505387|3720532|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3895523|NCT01505387|3720530|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3895524|NCT01505387|3720531|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3895525|NCT01505387|3720532|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3895526|NCT01505387|3720530|B3|||Age||years|Mean|44.4|44.4|Standard Deviation|11.2|11.2|||
3895527|NCT01505387|3720531|B2|||Age||years|Mean|44.7|44.7|Standard Deviation|11.4|11.4|||
3895528|NCT01505387|3720532|B1|||Age||years|Mean|44.1|44.1|Standard Deviation|11.2|11.2|||
3895529|NCT01505374|3720539|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
3895530|NCT01505374|3720539|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3895531|NCT01505374|3720539|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3895532|NCT01505374|3720539|B1|Age||Age, Customized|Age|years|Mean|64.41|64.41|Standard Deviation|7.36|7.36|||
3895533|NCT01505166|3720554|B4||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3895534|NCT01505166|3720557|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3895535|NCT01505166|3720554|B4||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3895536|NCT01505166|3720557|B1||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3895537|NCT01505166|3720554|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3895538|NCT01505166|3720557|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3895539|NCT01505166|3720554|B4||Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3895540|NCT01505166|3720557|B1||Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3895541|NCT01505166|3720554|B4||White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3895542|NCT01505166|3720557|B1||White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3895543|NCT01505166|3720554|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3895544|NCT01505166|3720557|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3895545|NCT01505166|3720554|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3895546|NCT01505166|3720557|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3895547|NCT01505166|3720554|B4|65 Years and Older||Age, Customized||Participants|Count of Participants|1|1.0||||||
3895548|NCT01505166|3720557|B1|65 Years and Older||Age, Customized||Participants|Count of Participants|1|1.0||||||
3895549|NCT01505166|3720554|B4|16-64 Years||Age, Customized||Participants|Count of Participants|2|2.0||||||
3895550|NCT01505166|3720557|B1|16-64 Years||Age, Customized||Participants|Count of Participants|2|2.0||||||
3895551|NCT01505166|3720554|B4|0-15 Years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3895552|NCT01505166|3720557|B1|0-15 Years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3895553|NCT01505114|3720571|B5|Not Employed||Employment Status||Participants|Count of Participants|202|202.0||||||
3895554|NCT01505114|3720572|B4|Not Employed||Employment Status||Participants|Count of Participants|49|49.0||||||
3895555|NCT01505114|3720573|B3|Not Employed||Employment Status||Participants|Count of Participants|52|52.0||||||
3895556|NCT01505114|3720574|B2|Not Employed||Employment Status||Participants|Count of Participants|48|48.0||||||
3895557|NCT01505114|3720575|B1|Not Employed||Employment Status||Participants|Count of Participants|53|53.0||||||
3895558|NCT01505114|3720571|B5|Part-time Employment||Employment Status||Participants|Count of Participants|134|134.0||||||
3895559|NCT01505114|3720572|B4|Part-time Employment||Employment Status||Participants|Count of Participants|25|25.0||||||
3895560|NCT01505114|3720573|B3|Part-time Employment||Employment Status||Participants|Count of Participants|36|36.0||||||
3895561|NCT01505114|3720574|B2|Part-time Employment||Employment Status||Participants|Count of Participants|35|35.0||||||
3895562|NCT01505114|3720575|B1|Part-time Employment||Employment Status||Participants|Count of Participants|38|38.0||||||
3895563|NCT01505114|3720571|B5|Full-time Employment||Employment Status||Participants|Count of Participants|257|257.0||||||
3895564|NCT01505114|3720572|B4|Full-time Employment||Employment Status||Participants|Count of Participants|74|74.0||||||
3895565|NCT01505114|3720573|B3|Full-time Employment||Employment Status||Participants|Count of Participants|59|59.0||||||
3895566|NCT01505114|3720574|B2|Full-time Employment||Employment Status||Participants|Count of Participants|68|68.0||||||
3895567|NCT01505114|3720575|B1|Full-time Employment||Employment Status||Participants|Count of Participants|56|56.0||||||
3895568|NCT01505114|3720571|B5|Other||Marital Status||Participants|Count of Participants|3|3.0||||||
3895569|NCT01505114|3720572|B4|Other||Marital Status||Participants|Count of Participants|1|1.0||||||
3895570|NCT01505114|3720573|B3|Other||Marital Status||Participants|Count of Participants|1|1.0||||||
3895571|NCT01505114|3720574|B2|Other||Marital Status||Participants|Count of Participants|1|1.0||||||
3895572|NCT01505114|3720575|B1|Other||Marital Status||Participants|Count of Participants|0|0.0||||||
3895573|NCT01505114|3720571|B5|Single/Divorced/Widowed||Marital Status||Participants|Count of Participants|399|399.0||||||
3895574|NCT01505114|3720572|B4|Single/Divorced/Widowed||Marital Status||Participants|Count of Participants|98|98.0||||||
3895575|NCT01505114|3720573|B3|Single/Divorced/Widowed||Marital Status||Participants|Count of Participants|96|96.0||||||
3895576|NCT01505114|3720574|B2|Single/Divorced/Widowed||Marital Status||Participants|Count of Participants|103|103.0||||||
3895577|NCT01505114|3720575|B1|Single/Divorced/Widowed||Marital Status||Participants|Count of Participants|102|102.0||||||
3895578|NCT01505114|3720571|B5|Not Living with Primary Partner||Marital Status||Participants|Count of Participants|62|62.0||||||
3895579|NCT01505114|3720572|B4|Not Living with Primary Partner||Marital Status||Participants|Count of Participants|14|14.0||||||
3895580|NCT01505114|3720573|B3|Not Living with Primary Partner||Marital Status||Participants|Count of Participants|19|19.0||||||
3895581|NCT01505114|3720574|B2|Not Living with Primary Partner||Marital Status||Participants|Count of Participants|17|17.0||||||
3895582|NCT01505114|3720575|B1|Not Living with Primary Partner||Marital Status||Participants|Count of Participants|12|12.0||||||
3895583|NCT01505114|3720571|B5|Living with Primary Partner||Marital Status||Participants|Count of Participants|92|92.0||||||
3895584|NCT01505114|3720572|B4|Living with Primary Partner||Marital Status||Participants|Count of Participants|21|21.0||||||
3895585|NCT01505114|3720573|B3|Living with Primary Partner||Marital Status||Participants|Count of Participants|25|25.0||||||
3895586|NCT01505114|3720574|B2|Living with Primary Partner||Marital Status||Participants|Count of Participants|21|21.0||||||
3895587|NCT01505114|3720575|B1|Living with Primary Partner||Marital Status||Participants|Count of Participants|25|25.0||||||
3895588|NCT01505114|3720571|B5|Married/Civil Union/Legal Partnership||Marital Status||Participants|Count of Participants|38|38.0||||||
3895589|NCT01505114|3720572|B4|Married/Civil Union/Legal Partnership||Marital Status||Participants|Count of Participants|14|14.0||||||
3895590|NCT01505114|3720573|B3|Married/Civil Union/Legal Partnership||Marital Status||Participants|Count of Participants|7|7.0||||||
3895591|NCT01505114|3720574|B2|Married/Civil Union/Legal Partnership||Marital Status||Participants|Count of Participants|9|9.0||||||
3895592|NCT01505114|3720575|B1|Married/Civil Union/Legal Partnership||Marital Status||Participants|Count of Participants|8|8.0||||||
3895593|NCT01505114|3720571|B5|masters or other advanced degree||education||Participants|Count of Participants|61|61.0||||||
3895594|NCT01505114|3720572|B4|masters or other advanced degree||education||Participants|Count of Participants|10|10.0||||||
3895595|NCT01505114|3720573|B3|masters or other advanced degree||education||Participants|Count of Participants|17|17.0||||||
3895596|NCT01505114|3720574|B2|masters or other advanced degree||education||Participants|Count of Participants|24|24.0||||||
3895597|NCT01505114|3720575|B1|masters or other advanced degree||education||Participants|Count of Participants|10|10.0||||||
3895598|NCT01505114|3720571|B5|Finished College||education||Participants|Count of Participants|153|153.0||||||
3895599|NCT01505114|3720572|B4|Finished College||education||Participants|Count of Participants|40|40.0||||||
3895600|NCT01505114|3720573|B3|Finished College||education||Participants|Count of Participants|36|36.0||||||
3895601|NCT01505114|3720574|B2|Finished College||education||Participants|Count of Participants|40|40.0||||||
3895602|NCT01505114|3720575|B1|Finished College||education||Participants|Count of Participants|37|37.0||||||
3895603|NCT01505114|3720571|B5|Some College or 2 Year Degree||education||Participants|Count of Participants|206|206.0||||||
3895604|NCT01505114|3720572|B4|Some College or 2 Year Degree||education||Participants|Count of Participants|55|55.0||||||
3895605|NCT01505114|3720573|B3|Some College or 2 Year Degree||education||Participants|Count of Participants|57|57.0||||||
3895606|NCT01505114|3720574|B2|Some College or 2 Year Degree||education||Participants|Count of Participants|43|43.0||||||
3895607|NCT01505114|3720575|B1|Some College or 2 Year Degree||education||Participants|Count of Participants|51|51.0||||||
3895608|NCT01505114|3720571|B5|Vocational/Trade/Technical School||education||Participants|Count of Participants|23|23.0||||||
3895609|NCT01505114|3720572|B4|Vocational/Trade/Technical School||education||Participants|Count of Participants|6|6.0||||||
3895610|NCT01505114|3720573|B3|Vocational/Trade/Technical School||education||Participants|Count of Participants|7|7.0||||||
3895611|NCT01505114|3720574|B2|Vocational/Trade/Technical School||education||Participants|Count of Participants|7|7.0||||||
3895612|NCT01505114|3720575|B1|Vocational/Trade/Technical School||education||Participants|Count of Participants|3|3.0||||||
3895613|NCT01505114|3720571|B5|High School Graduate or Equivalent||education||Participants|Count of Participants|114|114.0||||||
3895614|NCT01505114|3720572|B4|High School Graduate or Equivalent||education||Participants|Count of Participants|27|27.0||||||
3895615|NCT01505114|3720573|B3|High School Graduate or Equivalent||education||Participants|Count of Participants|25|25.0||||||
3895616|NCT01505114|3720574|B2|High School Graduate or Equivalent||education||Participants|Count of Participants|27|27.0||||||
3895617|NCT01505114|3720575|B1|High School Graduate or Equivalent||education||Participants|Count of Participants|35|35.0||||||
3895618|NCT01505114|3720571|B5|Some High School||education||Participants|Count of Participants|32|32.0||||||
3895619|NCT01505114|3720572|B4|Some High School||education||Participants|Count of Participants|9|9.0||||||
3895620|NCT01505114|3720573|B3|Some High School||education||Participants|Count of Participants|6|6.0||||||
3895621|NCT01505114|3720574|B2|Some High School||education||Participants|Count of Participants|7|7.0||||||
3895622|NCT01505114|3720575|B1|Some High School||education||Participants|Count of Participants|10|10.0||||||
3895623|NCT01505114|3720571|B5|8th Grade or Less||education||Participants|Count of Participants|5|5.0||||||
3895624|NCT01505114|3720572|B4|8th Grade or Less||education||Participants|Count of Participants|1|1.0||||||
3895625|NCT01505114|3720573|B3|8th Grade or Less||education||Participants|Count of Participants|0|0.0||||||
3895626|NCT01505114|3720574|B2|8th Grade or Less||education||Participants|Count of Participants|3|3.0||||||
3895627|NCT01505114|3720575|B1|8th Grade or Less||education||Participants|Count of Participants|1|1.0||||||
3895628|NCT01505114|3720571|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|55|55.0||||||
3895629|NCT01505114|3720572|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3895630|NCT01505114|3720573|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3895631|NCT01505114|3720574|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3895632|NCT01505114|3720575|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3895633|NCT01505114|3720571|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|303|303.0||||||
3895634|NCT01505114|3720572|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|78|78.0||||||
3895635|NCT01505114|3720573|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|72|72.0||||||
3895636|NCT01505114|3720574|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|80|80.0||||||
3895637|NCT01505114|3720575|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|73|73.0||||||
3895638|NCT01505114|3720571|B5|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3895639|NCT01505114|3720572|B4|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3895640|NCT01505114|3720573|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3895641|NCT01505114|3720574|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3895642|NCT01505114|3720575|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3895643|NCT01505114|3720571|B5|Black or African||Race/Ethnicity, Customized||Participants|Count of Participants|238|238.0||||||
3895644|NCT01505114|3720572|B4|Black or African||Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
3895645|NCT01505114|3720573|B3|Black or African||Race/Ethnicity, Customized||Participants|Count of Participants|62|62.0||||||
3895646|NCT01505114|3720574|B2|Black or African||Race/Ethnicity, Customized||Participants|Count of Participants|64|64.0||||||
3895647|NCT01505114|3720575|B1|Black or African||Race/Ethnicity, Customized||Participants|Count of Participants|61|61.0||||||
3895648|NCT01505114|3720571|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3895649|NCT01505114|3720572|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3895650|NCT01505114|3720573|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3895651|NCT01505114|3720574|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3895652|NCT01505114|3720575|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3895653|NCT01505114|3720571|B5|American Indian/Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3895654|NCT01505114|3720572|B4|American Indian/Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3895655|NCT01505114|3720573|B3|American Indian/Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3895656|NCT01505114|3720574|B2|American Indian/Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3895657|NCT01505114|3720575|B1|American Indian/Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3895658|NCT01505114|3720571|B5||Male|Sex: Female, Male||Participants|Count of Participants|406|406.0||||||
3895659|NCT01505114|3720572|B4||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3895660|NCT01505114|3720573|B3||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3895661|NCT01505114|3720574|B2||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3895662|NCT01505114|3720575|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3895663|NCT01505114|3720571|B5||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3895664|NCT01505114|3720572|B4||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3895665|NCT01505114|3720573|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3895666|NCT01505114|3720574|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3895667|NCT01505114|3720575|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3895668|NCT01505114|3720571|B5|Women||Age||years|Median|36|36.0|Full Range|||18.0|61.0|
3895669|NCT01505114|3720572|B4|Women||Age||years|Median|37|37.0|Full Range|||18.0|60.0|
3895670|NCT01505114|3720573|B3|Women||Age||years|Median|37|37.0|Full Range|||22.0|60.0|
3895671|NCT01505114|3720574|B2|Women||Age||years|Median|36|36.0|Full Range|||19.0|57.0|
3895672|NCT01505114|3720575|B1|Women||Age||years|Median|40|40.0|Full Range|||18.0|61.0|
3895673|NCT01505114|3720571|B5|||Age||years|Median|30|30.0|Full Range|||18.0|70.0|
3895674|NCT01505114|3720572|B4|||Age||years|Median|31|31.0|Full Range|||18.0|60.0|
3895675|NCT01505114|3720573|B3|||Age||years|Median|30|30.0|Full Range|||18.0|70.0|
3895676|NCT01505114|3720574|B2|||Age||years|Median|29.5|29.5|Full Range|||18.0|62.0|
3895677|NCT01505114|3720575|B1|||Age||years|Median|30|30.0|Full Range|||18.0|65.0|
3895678|NCT01504997|3720588|B1|Japan||Region of Enrollment||participants|Number|18|18.0||||||
3895679|NCT01504997|3720588|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3895680|NCT01504997|3720588|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3895681|NCT01504997|3720588|B1|||Age||years|Median|65.5|65.5|Full Range|||53.0|80.0|
3895682|NCT01504997|3720588|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3895683|NCT01504997|3720588|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3895684|NCT01504997|3720588|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3895685|NCT01504971|3720592|B1|China||Region of Enrollment||participants|Number|95|95.0||||||
3895686|NCT01504971|3720592|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3895687|NCT01504971|3720592|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3895688|NCT01504971|3720592|B1|||Age||years|Mean|49|49.0|Standard Deviation|12|12.0|||
3895689|NCT01504958|3720600|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3895690|NCT01504958|3720601|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3895691|NCT01504958|3720602|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3895692|NCT01504958|3720603|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3895693|NCT01504958|3720600|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3895694|NCT01504958|3720601|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3895695|NCT01504958|3720602|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3895696|NCT01504958|3720603|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3895697|NCT01504958|3720600|B4|||Age||years|Mean|69.24|69.24|Full Range|||52.0|86.0|
3895698|NCT01504958|3720601|B3|||Age||years|Mean|70|70.0|Full Range|||54.0|86.0|
3895699|NCT01504958|3720602|B2|||Age||years|Mean|68.6|68.6|Full Range|||54.0|86.0|
3895700|NCT01504958|3720603|B1|||Age||years|Mean|69.1|69.1|Full Range|||52.0|76.0|
3895701|NCT01504867|3720619|B3|United States||Region of Enrollment||participants|Number|390|390.0||||||
3895702|NCT01504867|3720620|B2|United States||Region of Enrollment||participants|Number|195|195.0||||||
3895703|NCT01504867|3720621|B1|United States||Region of Enrollment||participants|Number|195|195.0||||||
3895704|NCT01504867|3720619|B3||Male|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
3895705|NCT01504867|3720620|B2||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3895706|NCT01504867|3720621|B1||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3895707|NCT01504867|3720619|B3||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
3895708|NCT01504867|3720620|B2||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3895709|NCT01504867|3720621|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3895710|NCT01504867|3720619|B3|||Age||years|Median|57|57.0|Inter-Quartile Range|||45.0|68.0|
3895711|NCT01504867|3720620|B2|||Age||years|Median|57.0|57.0|Inter-Quartile Range|||47.0|68.0|
3895712|NCT01504867|3720621|B1|||Age||years|Median|57.0|57.0|Inter-Quartile Range|||44.0|67.0|
3895713|NCT01504854|3720640|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3895714|NCT01504854|3720641|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3895715|NCT01504854|3720642|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3895716|NCT01504854|3720640|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3895717|NCT01504854|3720641|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3895718|NCT01504854|3720642|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3895719|NCT01504854|3720640|B3|||Age||years|Mean|71.4|71.4|Standard Deviation|7.95|7.95|||
3895720|NCT01504854|3720641|B2|||Age||years|Mean|73|73.0|Standard Deviation|8.2|8.2|||
3895721|NCT01504854|3720642|B1|||Age||years|Mean|69.8|69.8|Standard Deviation|7.7|7.7|||
3895722|NCT01504204|3720657|B3|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3895723|NCT01504204|3720658|B2|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3895724|NCT01504204|3720659|B1|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3895725|NCT01504204|3720657|B3|Ethnicity(Non-Hispanic)||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3895726|NCT01504204|3720658|B2|Ethnicity(Non-Hispanic)||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3895727|NCT01504204|3720659|B1|Ethnicity(Non-Hispanic)||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3895728|NCT01504204|3720657|B3|Race(Caucasian)||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3895729|NCT01504204|3720658|B2|Race(Caucasian)||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3895730|NCT01504204|3720659|B1|Race(Caucasian)||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3895731|NCT01504204|3720657|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3895732|NCT01504204|3720658|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3895733|NCT01504204|3720659|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3895734|NCT01504204|3720657|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3895735|NCT01504204|3720658|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3895736|NCT01504204|3720659|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3895737|NCT01504204|3720657|B3|Age||Age, Customized||years|Median|19|19.0|Full Range|||13.0|31.0|
3895738|NCT01504204|3720658|B2|Age||Age, Customized||years|Median|19|19.0|Full Range|||13.0|29.0|
3895739|NCT01504204|3720659|B1|Age||Age, Customized||years|Median|19|19.0|Full Range|||13.0|31.0|
3895740|NCT01503749|3720670|B4|Korea, Republic of||Region of Enrollment||participants|Number|9|9.0||||||
3895741|NCT01503749|3720671|B3|Korea, Republic of||Region of Enrollment||participants|Number|3|3.0||||||
3895742|NCT01503749|3720672|B2|Korea, Republic of||Region of Enrollment||participants|Number|3|3.0||||||
3895743|NCT01503749|3720673|B1|Korea, Republic of||Region of Enrollment||participants|Number|3|3.0||||||
3895744|NCT01503749|3720670|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3895745|NCT01503749|3720671|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3895746|NCT01503749|3720672|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3895747|NCT01503749|3720673|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3895748|NCT01503749|3720670|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3895749|NCT01503749|3720671|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3895750|NCT01503749|3720672|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3895751|NCT01503749|3720673|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3895752|NCT01503749|3720670|B4|||Age||years|Mean|60.8|60.8|Full Range|||45.0|71.0|
3895753|NCT01503749|3720671|B3|||Age||years|Mean|63.3|63.3|Full Range|||54.0|71.0|
3895754|NCT01503749|3720672|B2|||Age||years|Mean|62|62.0|Full Range|||59.0|68.0|
3895755|NCT01503749|3720673|B1|||Age||years|Mean|57|57.0|Full Range|||45.0|65.0|
3895756|NCT01503749|3720670|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3895757|NCT01503749|3720671|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3895758|NCT01503749|3720672|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3895759|NCT01503749|3720673|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3895760|NCT01503749|3720670|B4||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3895761|NCT01503749|3720671|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3895762|NCT01503749|3720672|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3895763|NCT01503749|3720673|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3895764|NCT01503749|3720670|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3895765|NCT01503749|3720671|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3895766|NCT01503749|3720672|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3895767|NCT01503749|3720673|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3895768|NCT01503333|3720686|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
3895769|NCT01503333|3720687|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3895770|NCT01503333|3720688|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3895771|NCT01503333|3720686|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|190|190.0||||||
3895772|NCT01503333|3720687|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3895773|NCT01503333|3720688|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3895774|NCT01503333|3720686|B3||White|Race (NIH/OMB)||Participants|Count of Participants|412|412.0||||||
3895775|NCT01503333|3720687|B2||White|Race (NIH/OMB)||Participants|Count of Participants|214|214.0||||||
3895776|NCT01503333|3720688|B1||White|Race (NIH/OMB)||Participants|Count of Participants|198|198.0||||||
3895777|NCT01503333|3720686|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|756|756.0||||||
3895778|NCT01503333|3720687|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|340|340.0||||||
3895779|NCT01503333|3720688|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|416|416.0||||||
3895780|NCT01503333|3720686|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3895781|NCT01503333|3720687|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895782|NCT01503333|3720688|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3895783|NCT01503333|3720686|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3895784|NCT01503333|3720687|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3895785|NCT01503333|3720688|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3895786|NCT01503333|3720686|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3895787|NCT01503333|3720687|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3895788|NCT01503333|3720688|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3895789|NCT01503333|3720686|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
3895790|NCT01503333|3720687|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3895791|NCT01503333|3720688|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3895792|NCT01503333|3720686|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1232|1232.0||||||
3895793|NCT01503333|3720687|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|603|603.0||||||
3895794|NCT01503333|3720688|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|629|629.0||||||
3895795|NCT01503333|3720686|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|201|201.0||||||
3895796|NCT01503333|3720687|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
3895797|NCT01503333|3720688|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
3895798|NCT01503333|3720686|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3895799|NCT01503333|3720687|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3895800|NCT01503333|3720688|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3895992|NCT01502709|3720855|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3895801|NCT01503333|3720686|B3||Female|Sex: Female, Male||Participants|Count of Participants|1519|1519.0||||||
3895802|NCT01503333|3720687|B2||Female|Sex: Female, Male||Participants|Count of Participants|753|753.0||||||
3895803|NCT01503333|3720688|B1||Female|Sex: Female, Male||Participants|Count of Participants|766|766.0||||||
3895804|NCT01503333|3720686|B3|||Age|Single item multiple choice: How old are you?|years|Mean|12.05|12.05|Standard Deviation|1.01|1.01|||
3895805|NCT01503333|3720687|B2|||Age|Single item multiple choice: How old are you?|years|Mean|12.05|12.05|Standard Deviation|0.99|0.99|||
3895806|NCT01503333|3720688|B1|||Age|Single item multiple choice: How old are you?|years|Mean|12.05|12.05|Standard Deviation|1.02|1.02|||
3895807|NCT01503333|3720686|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3895808|NCT01503333|3720687|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3895809|NCT01503333|3720688|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3895810|NCT01503333|3720686|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3895811|NCT01503333|3720687|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3895812|NCT01503333|3720688|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3895813|NCT01503333|3720686|B3||<=18 years|Age||Participants|Count of Participants|1519|1519.0||||||
3895814|NCT01503333|3720687|B2||<=18 years|Age||Participants|Count of Participants|753|753.0||||||
3895815|NCT01503333|3720688|B1||<=18 years|Age||Participants|Count of Participants|766|766.0||||||
3895816|NCT01503164|3720715|B3|United States||Region of Enrollment||Participants|Count of Participants|108|108.0||||||
3895817|NCT01503164|3720716|B2|United States||Region of Enrollment||Participants|Count of Participants|55|55.0||||||
3895818|NCT01503164|3720717|B1|United States||Region of Enrollment||Participants|Count of Participants|53|53.0||||||
3895819|NCT01503164|3720715|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3895820|NCT01503164|3720716|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3895821|NCT01503164|3720717|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3895822|NCT01503164|3720715|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3895823|NCT01503164|3720716|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3895824|NCT01503164|3720717|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3895825|NCT01503164|3720715|B3|||Age||years|Mean|56.0|56.0|Standard Deviation|8.8|8.8|||
3895826|NCT01503164|3720716|B2|||Age||years|Mean|57.2|57.2|Standard Deviation|8.2|8.2|||
3895827|NCT01503164|3720717|B1|||Age||years|Mean|54.8|54.8|Standard Deviation|9.2|9.2|||
3895828|NCT01503164|3720715|B3||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3895829|NCT01503164|3720716|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3895830|NCT01503164|3720717|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3895831|NCT01503164|3720715|B3||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
3895832|NCT01503164|3720716|B2||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3895833|NCT01503164|3720717|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3895834|NCT01503164|3720715|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3895835|NCT01503164|3720716|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3895836|NCT01503164|3720717|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3895837|NCT01503021|3720746|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895838|NCT01503021|3720747|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895839|NCT01503021|3720748|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895840|NCT01503021|3720746|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3895841|NCT01503021|3720747|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3895842|NCT01503021|3720748|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3895843|NCT01503021|3720746|B3||White|Race (NIH/OMB)||Participants|Count of Participants|379|379.0||||||
3895844|NCT01503021|3720747|B2||White|Race (NIH/OMB)||Participants|Count of Participants|194|194.0||||||
3895845|NCT01503021|3720748|B1||White|Race (NIH/OMB)||Participants|Count of Participants|185|185.0||||||
3895846|NCT01503021|3720746|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|299|299.0||||||
3895847|NCT01503021|3720747|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|145|145.0||||||
3895848|NCT01503021|3720748|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|154|154.0||||||
3895849|NCT01503021|3720746|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895850|NCT01503021|3720747|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895851|NCT01503021|3720748|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895852|NCT01503021|3720746|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3895853|NCT01503021|3720747|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3895854|NCT01503021|3720748|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3895855|NCT01503021|3720746|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3895856|NCT01503021|3720747|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895857|NCT01503021|3720748|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3895858|NCT01503021|3720746|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895859|NCT01503021|3720747|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895860|NCT01503021|3720748|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895861|NCT01503021|3720746|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|507|507.0||||||
3895862|NCT01503021|3720747|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|246|246.0||||||
3895863|NCT01503021|3720748|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|261|261.0||||||
3895864|NCT01503021|3720746|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|196|196.0||||||
3895865|NCT01503021|3720747|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
3895866|NCT01503021|3720748|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
3895867|NCT01503021|3720746|B3||Male|Sex: Female, Male||Participants|Count of Participants|425|425.0||||||
3895868|NCT01503021|3720747|B2||Male|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
3895869|NCT01503021|3720748|B1||Male|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
3895870|NCT01503021|3720746|B3||Female|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
3895871|NCT01503021|3720747|B2||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3895872|NCT01503021|3720748|B1||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3895873|NCT01503021|3720746|B3|||Age||years|Mean|59.7|59.7|Standard Deviation|13.23|13.23|||
3895874|NCT01503021|3720747|B2|||Age||years|Mean|59.5|59.5|Standard Deviation|13.30|13.3|||
3895875|NCT01503021|3720748|B1|||Age||years|Mean|59.9|59.9|Standard Deviation|13.18|13.18|||
3895876|NCT01502956|3720796|B3|||Health Utilities Index Mark 3 (HUI-3)|Values are defined such that the score for dead is 0; the score for perfect health is 1.0.|units on a scale|Mean|0.73|0.73|Standard Deviation|0.29|0.29|||
3895877|NCT01502956|3720797|B2|||Health Utilities Index Mark 3 (HUI-3)|Values are defined such that the score for dead is 0; the score for perfect health is 1.0.|units on a scale|Mean|0.71|0.71|Standard Deviation|0.30|0.3|||
3895878|NCT01502956|3720798|B1|||Health Utilities Index Mark 3 (HUI-3)|Values are defined such that the score for dead is 0; the score for perfect health is 1.0.|units on a scale|Mean|0.74|0.74|Standard Deviation|0.28|0.28|||
3895879|NCT01502956|3720796|B3|||Incontinence Impact Questionnaire Short Form (IIQ-SF)|Values range from 0 to 100 with higher scores indicating worse quality of life.|units on a scale|Mean|52.6|52.6|Standard Deviation|26.7|26.7|||
3895880|NCT01502956|3720797|B2|||Incontinence Impact Questionnaire Short Form (IIQ-SF)|Values range from 0 to 100 with higher scores indicating worse quality of life.|units on a scale|Mean|52.7|52.7|Standard Deviation|27.6|27.6|||
3895881|NCT01502956|3720798|B1|||Incontinence Impact Questionnaire Short Form (IIQ-SF)|Values range from 0 to 100 with higher scores indicating worse quality of life.|units on a scale|Mean|52.5|52.5|Standard Deviation|25.8|25.8|||
3895882|NCT01502956|3720796|B3|||Urinary Distress Inventory Short Form (UDI-SF)|Values range from 0 to 100 with higher scores indicating greater distress.|units on a scale|Mean|60.1|60.1|Standard Deviation|17.7|17.7|||
3895883|NCT01502956|3720797|B2|||Urinary Distress Inventory Short Form (UDI-SF)|Values range from 0 to 100 with higher scores indicating greater distress.|units on a scale|Mean|60.9|60.9|Standard Deviation|18.3|18.3|||
3895884|NCT01502956|3720798|B1|||Urinary Distress Inventory Short Form (UDI-SF)|Values range from 0 to 100 with higher scores indicating greater distress.|units on a scale|Mean|59.2|59.2|Standard Deviation|16.9|16.9|||
3895885|NCT01502956|3720796|B3|Very Severe||Urinary Frequency and Nocturia - Sandvik Questionnaire|Patient-reported measure of incontinence severity as assessed on a scale of slight (1-2) to very severe (10-12) using the standard scoring algorithm.|Participants|Count of Participants|208|208.0||||||
3895886|NCT01502956|3720797|B2|Very Severe||Urinary Frequency and Nocturia - Sandvik Questionnaire|Patient-reported measure of incontinence severity as assessed on a scale of slight (1-2) to very severe (10-12) using the standard scoring algorithm.|Participants|Count of Participants|103|103.0||||||
3895887|NCT01502956|3720798|B1|Very Severe||Urinary Frequency and Nocturia - Sandvik Questionnaire|Patient-reported measure of incontinence severity as assessed on a scale of slight (1-2) to very severe (10-12) using the standard scoring algorithm.|Participants|Count of Participants|105|105.0||||||
3895888|NCT01502956|3720796|B3|Severe||Urinary Frequency and Nocturia - Sandvik Questionnaire|Patient-reported measure of incontinence severity as assessed on a scale of slight (1-2) to very severe (10-12) using the standard scoring algorithm.|Participants|Count of Participants|90|90.0||||||
3895889|NCT01502956|3720797|B2|Severe||Urinary Frequency and Nocturia - Sandvik Questionnaire|Patient-reported measure of incontinence severity as assessed on a scale of slight (1-2) to very severe (10-12) using the standard scoring algorithm.|Participants|Count of Participants|52|52.0||||||
3895890|NCT01502956|3720798|B1|Severe||Urinary Frequency and Nocturia - Sandvik Questionnaire|Patient-reported measure of incontinence severity as assessed on a scale of slight (1-2) to very severe (10-12) using the standard scoring algorithm.|Participants|Count of Participants|38|38.0||||||
3895891|NCT01502956|3720796|B3|Moderate||Urinary Frequency and Nocturia - Sandvik Questionnaire|Patient-reported measure of incontinence severity as assessed on a scale of slight (1-2) to very severe (10-12) using the standard scoring algorithm.|Participants|Count of Participants|52|52.0||||||
3895892|NCT01502956|3720797|B2|Moderate||Urinary Frequency and Nocturia - Sandvik Questionnaire|Patient-reported measure of incontinence severity as assessed on a scale of slight (1-2) to very severe (10-12) using the standard scoring algorithm.|Participants|Count of Participants|27|27.0||||||
3895893|NCT01502956|3720798|B1|Moderate||Urinary Frequency and Nocturia - Sandvik Questionnaire|Patient-reported measure of incontinence severity as assessed on a scale of slight (1-2) to very severe (10-12) using the standard scoring algorithm.|Participants|Count of Participants|25|25.0||||||
3895894|NCT01502956|3720796|B3|Slight||Urinary Frequency and Nocturia - Sandvik Questionnaire|Patient-reported measure of incontinence severity as assessed on a scale of slight (1-2) to very severe (10-12) using the standard scoring algorithm.|Participants|Count of Participants|3|3.0||||||
3895934|NCT01502956|3720797|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3895895|NCT01502956|3720797|B2|Slight||Urinary Frequency and Nocturia - Sandvik Questionnaire|Patient-reported measure of incontinence severity as assessed on a scale of slight (1-2) to very severe (10-12) using the standard scoring algorithm.|Participants|Count of Participants|2|2.0||||||
3895896|NCT01502956|3720798|B1|Slight||Urinary Frequency and Nocturia - Sandvik Questionnaire|Patient-reported measure of incontinence severity as assessed on a scale of slight (1-2) to very severe (10-12) using the standard scoring algorithm.|Participants|Count of Participants|1|1.0||||||
3895897|NCT01502956|3720796|B3|OABq-SF Quality of Life||Overactive Bladder Questionnaire – Short Form (OABq-SF)|Values range from 0 to 100 with higher scores on the symptom scale indicating greater severity of symptoms and higher scores on the quality of life scale indicating better quality of life.|units on a scale|Mean|37.5|37.5|Standard Deviation|22.3|22.3|||
3895898|NCT01502956|3720797|B2|OABq-SF Quality of Life||Overactive Bladder Questionnaire – Short Form (OABq-SF)|Values range from 0 to 100 with higher scores on the symptom scale indicating greater severity of symptoms and higher scores on the quality of life scale indicating better quality of life.|units on a scale|Mean|38.2|38.2|Standard Deviation|23.0|23.0|||
3895899|NCT01502956|3720798|B1|OABq-SF Quality of Life||Overactive Bladder Questionnaire – Short Form (OABq-SF)|Values range from 0 to 100 with higher scores on the symptom scale indicating greater severity of symptoms and higher scores on the quality of life scale indicating better quality of life.|units on a scale|Mean|36.8|36.8|Standard Deviation|21.6|21.6|||
3895900|NCT01502956|3720796|B3|OABq-SF Symptom Bother||Overactive Bladder Questionnaire – Short Form (OABq-SF)|Values range from 0 to 100 with higher scores on the symptom scale indicating greater severity of symptoms and higher scores on the quality of life scale indicating better quality of life.|units on a scale|Mean|75.3|75.3|Standard Deviation|18.3|18.3|||
3895901|NCT01502956|3720797|B2|OABq-SF Symptom Bother||Overactive Bladder Questionnaire – Short Form (OABq-SF)|Values range from 0 to 100 with higher scores on the symptom scale indicating greater severity of symptoms and higher scores on the quality of life scale indicating better quality of life.|units on a scale|Mean|74.6|74.6|Standard Deviation|19.5|19.5|||
3895902|NCT01502956|3720798|B1|OABq-SF Symptom Bother||Overactive Bladder Questionnaire – Short Form (OABq-SF)|Values range from 0 to 100 with higher scores on the symptom scale indicating greater severity of symptoms and higher scores on the quality of life scale indicating better quality of life.|units on a scale|Mean|76.1|76.1|Standard Deviation|16.8|16.8|||
3895903|NCT01502956|3720796|B3|||Nocturia (number of night voids per day)||Voids per day|Mean|1.7|1.7|Standard Deviation|1.3|1.3|||
3895904|NCT01502956|3720797|B2|||Nocturia (number of night voids per day)||Voids per day|Mean|1.7|1.7|Standard Deviation|1.2|1.2|||
3895905|NCT01502956|3720798|B1|||Nocturia (number of night voids per day)||Voids per day|Mean|1.7|1.7|Standard Deviation|1.4|1.4|||
3895906|NCT01502956|3720796|B3|Urge incontinence episodes per day||Urinary Incontinence Episodes Per Day||Episodes per day|Mean|5.3|5.3|Standard Deviation|2.7|2.7|||
3895907|NCT01502956|3720797|B2|Urge incontinence episodes per day||Urinary Incontinence Episodes Per Day||Episodes per day|Mean|5.4|5.4|Standard Deviation|2.7|2.7|||
3895908|NCT01502956|3720798|B1|Urge incontinence episodes per day||Urinary Incontinence Episodes Per Day||Episodes per day|Mean|5.2|5.2|Standard Deviation|2.7|2.7|||
3895909|NCT01502956|3720796|B3|Total incontinence episodes per day||Urinary Incontinence Episodes Per Day||Episodes per day|Mean|5.9|5.9|Standard Deviation|3.0|3.0|||
3895910|NCT01502956|3720797|B2|Total incontinence episodes per day||Urinary Incontinence Episodes Per Day||Episodes per day|Mean|6.0|6.0|Standard Deviation|3.0|3.0|||
3895911|NCT01502956|3720798|B1|Total incontinence episodes per day||Urinary Incontinence Episodes Per Day||Episodes per day|Mean|5.8|5.8|Standard Deviation|3.0|3.0|||
3895912|NCT01502956|3720796|B3||History of recurrent UTIs|History of Recurrent UTIs||Participants|Count of Participants|49|49.0||||||
3895913|NCT01502956|3720797|B2||History of recurrent UTIs|History of Recurrent UTIs||Participants|Count of Participants|24|24.0||||||
3895914|NCT01502956|3720798|B1||History of recurrent UTIs|History of Recurrent UTIs||Participants|Count of Participants|25|25.0||||||
3895915|NCT01502956|3720796|B3||No history of recurrent UTIs|History of Recurrent UTIs||Participants|Count of Participants|315|315.0||||||
3895916|NCT01502956|3720797|B2||No history of recurrent UTIs|History of Recurrent UTIs||Participants|Count of Participants|166|166.0||||||
3895917|NCT01502956|3720798|B1||No history of recurrent UTIs|History of Recurrent UTIs||Participants|Count of Participants|149|149.0||||||
3895918|NCT01502956|3720796|B3||Not sure|Menopausal Status||Participants|Count of Participants|15|15.0||||||
3895919|NCT01502956|3720797|B2||Not sure|Menopausal Status||Participants|Count of Participants|8|8.0||||||
3895920|NCT01502956|3720798|B1||Not sure|Menopausal Status||Participants|Count of Participants|7|7.0||||||
3895921|NCT01502956|3720796|B3||Post-menopausal|Menopausal Status||Participants|Count of Participants|311|311.0||||||
3895922|NCT01502956|3720797|B2||Post-menopausal|Menopausal Status||Participants|Count of Participants|162|162.0||||||
3895923|NCT01502956|3720798|B1||Post-menopausal|Menopausal Status||Participants|Count of Participants|149|149.0||||||
3895924|NCT01502956|3720796|B3||Pre-menopausal|Menopausal Status||Participants|Count of Participants|38|38.0||||||
3895925|NCT01502956|3720797|B2||Pre-menopausal|Menopausal Status||Participants|Count of Participants|20|20.0||||||
3895926|NCT01502956|3720798|B1||Pre-menopausal|Menopausal Status||Participants|Count of Participants|18|18.0||||||
3895927|NCT01502956|3720796|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3895928|NCT01502956|3720797|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3895929|NCT01502956|3720798|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3895930|NCT01502956|3720796|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3895931|NCT01502956|3720797|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3895932|NCT01502956|3720798|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3895933|NCT01502956|3720796|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3895935|NCT01502956|3720798|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3895936|NCT01502956|3720796|B3|American Indian/Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3895937|NCT01502956|3720797|B2|American Indian/Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3895938|NCT01502956|3720798|B1|American Indian/Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3895939|NCT01502956|3720796|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
3895940|NCT01502956|3720797|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3895941|NCT01502956|3720798|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3895942|NCT01502956|3720796|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|303|303.0||||||
3895943|NCT01502956|3720797|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|154|154.0||||||
3895944|NCT01502956|3720798|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|149|149.0||||||
3895945|NCT01502956|3720796|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3895946|NCT01502956|3720797|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3895947|NCT01502956|3720798|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3895948|NCT01502956|3720796|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|327|327.0||||||
3895949|NCT01502956|3720797|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
3895950|NCT01502956|3720798|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|160|160.0||||||
3895951|NCT01502956|3720796|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3895952|NCT01502956|3720797|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3895953|NCT01502956|3720798|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3895954|NCT01502956|3720796|B3|Female||Sex/Gender, Customized||Participants|Count of Participants|364|364.0||||||
3895955|NCT01502956|3720797|B2|Female||Sex/Gender, Customized||Participants|Count of Participants|190|190.0||||||
3895956|NCT01502956|3720798|B1|Female||Sex/Gender, Customized||Participants|Count of Participants|174|174.0||||||
3895957|NCT01502956|3720796|B3|Age => 65 years||Age, Customized||Participants|Count of Participants|173|173.0||||||
3895958|NCT01502956|3720797|B2|Age => 65 years||Age, Customized||Participants|Count of Participants|90|90.0||||||
3895959|NCT01502956|3720798|B1|Age => 65 years||Age, Customized||Participants|Count of Participants|83|83.0||||||
3895960|NCT01502956|3720796|B3|Age <65 years||Age, Customized||Participants|Count of Participants|191|191.0||||||
3895961|NCT01502956|3720797|B2|Age <65 years||Age, Customized||Participants|Count of Participants|100|100.0||||||
3895962|NCT01502956|3720798|B1|Age <65 years||Age, Customized||Participants|Count of Participants|91|91.0||||||
3895963|NCT01502956|3720796|B3|||Age||years|Mean|63.0|63.0|Standard Deviation|11.6|11.6|||
3895964|NCT01502956|3720797|B2|||Age||years|Mean|62.9|62.9|Standard Deviation|11.5|11.5|||
3895965|NCT01502956|3720798|B1|||Age||years|Mean|63.1|63.1|Standard Deviation|11.8|11.8|||
3895966|NCT01502787|3720823|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3895967|NCT01502787|3720823|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3895968|NCT01502787|3720823|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3895969|NCT01502787|3720823|B1|||Age||years|Mean|54|54.0|Standard Deviation|13.74|13.74|||
3895970|NCT01502761|3720834|B5|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3895971|NCT01502761|3720838|B1|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3895972|NCT01502761|3720834|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895973|NCT01502761|3720838|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895974|NCT01502761|3720834|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895975|NCT01502761|3720838|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895976|NCT01502761|3720834|B5||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3895977|NCT01502761|3720838|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3895978|NCT01502761|3720834|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895979|NCT01502761|3720838|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895980|NCT01502761|3720834|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895981|NCT01502761|3720838|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895982|NCT01502761|3720834|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895983|NCT01502761|3720838|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895984|NCT01502761|3720834|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895985|NCT01502761|3720838|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3895986|NCT01502761|3720834|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3895987|NCT01502761|3720838|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3895988|NCT01502761|3720834|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3895989|NCT01502761|3720838|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3895990|NCT01502761|3720834|B5|||Age||years|Mean|68.25|68.25|Standard Deviation|13.25|13.25|||
3895991|NCT01502761|3720838|B1|||Age||years|Mean|68.25|68.25|Standard Deviation|13.25|13.25|||
3895993|NCT01502709|3720857|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3895994|NCT01502709|3720855|B3|Male||Gender||participants|Number|0|0.0||||||
3895995|NCT01502709|3720857|B1|Male||Gender||participants|Number|0|0.0||||||
3895996|NCT01502709|3720855|B3|Female||Gender||participants|Number|5|5.0||||||
3895997|NCT01502709|3720857|B1|Female||Gender||participants|Number|5|5.0||||||
3895998|NCT01502709|3720855|B3|||Age||years|Mean|48|48.0|Standard Deviation|10.8|10.8|||
3895999|NCT01502709|3720857|B1|||Age||years|Mean|48|48.0|Standard Deviation|10.8|10.8|||
3896000|NCT01502709|3720855|B3|>=65 years||Age||participants|Number|0|0.0||||||
3896001|NCT01502709|3720857|B1|>=65 years||Age||participants|Number|0|0.0||||||
3896002|NCT01502709|3720855|B3|Between 18 and 65 years||Age||participants|Number|5|5.0||||||
3896003|NCT01502709|3720857|B1|Between 18 and 65 years||Age||participants|Number|5|5.0||||||
3896004|NCT01502709|3720855|B3|<=18 years||Age||participants|Number|0|0.0||||||
3896005|NCT01502709|3720857|B1|<=18 years||Age||participants|Number|0|0.0||||||
3896006|NCT01502644|3720868|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3896007|NCT01502644|3720869|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3896008|NCT01502644|3720870|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3896009|NCT01502644|3720871|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3896010|NCT01502644|3720868|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3896011|NCT01502644|3720869|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3896012|NCT01502644|3720870|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3896013|NCT01502644|3720871|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3896014|NCT01502644|3720868|B4|||Age||years|Mean|51.8|51.8|Standard Deviation|11.5|11.5|||
3896015|NCT01502644|3720869|B3|||Age||years|Mean|49|49.0|Standard Deviation|12.2|12.2|||
3896016|NCT01502644|3720870|B2|||Age||years|Mean|54|54.0|Standard Deviation|11.7|11.7|||
3896017|NCT01502644|3720871|B1|||Age||years|Mean|55|55.0|Standard Deviation|10.9|10.9|||
3896018|NCT01502423|3720882|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3896019|NCT01502423|3720883|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3896020|NCT01502423|3720884|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3896021|NCT01502423|3720882|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3896022|NCT01502423|3720883|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3896023|NCT01502423|3720884|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3896024|NCT01502423|3720882|B3|||Age||years|Mean|56.4|56.4|Standard Deviation|12.90|12.9|||
3896025|NCT01502423|3720883|B2|||Age||years|Mean|54.4|54.4|Standard Deviation|14.11|14.11|||
3896026|NCT01502423|3720884|B1|||Age||years|Mean|58.3|58.3|Standard Deviation|11.56|11.56|||
3896027|NCT01502410|3720903|B5|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3896028|NCT01502410|3720906|B2|Canada||Region of Enrollment||participants|Number|0|0.0||||||
3896029|NCT01502410|3720907|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3896030|NCT01502410|3720903|B5|United States||Region of Enrollment||participants|Number|19|19.0||||||
3896031|NCT01502410|3720906|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3896032|NCT01502410|3720907|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3896033|NCT01502410|3720903|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3896034|NCT01502410|3720906|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3896035|NCT01502410|3720907|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896036|NCT01502410|3720903|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896037|NCT01502410|3720906|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896038|NCT01502410|3720907|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896039|NCT01502410|3720903|B5||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3896040|NCT01502410|3720906|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3896041|NCT01502410|3720907|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3896042|NCT01502410|3720903|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3896043|NCT01502410|3720906|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896044|NCT01502410|3720907|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3896045|NCT01502410|3720903|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896046|NCT01502410|3720906|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896047|NCT01502410|3720907|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896048|NCT01502410|3720903|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3896049|NCT01502410|3720906|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3896050|NCT01502410|3720907|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896051|NCT01502410|3720903|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896052|NCT01502410|3720906|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896053|NCT01502410|3720907|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896054|NCT01502410|3720903|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896055|NCT01502410|3720906|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896056|NCT01502410|3720907|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896057|NCT01502410|3720903|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3896058|NCT01502410|3720906|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3896059|NCT01502410|3720907|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3896060|NCT01502410|3720903|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3896061|NCT01502410|3720906|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3896062|NCT01502410|3720907|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896063|NCT01502410|3720903|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3896064|NCT01502410|3720906|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3896065|NCT01502410|3720907|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3896066|NCT01502410|3720903|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3896067|NCT01502410|3720906|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3896068|NCT01502410|3720907|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3896069|NCT01502410|3720903|B5|||Age||years|Median|11|11.0|Full Range|||5.0|21.0|
3896070|NCT01502410|3720906|B2|||Age||years|Median|10.5|10.5|Full Range|||7.0|18.0|
3896071|NCT01502410|3720907|B1|||Age||years|Median|12|12.0|Full Range|||5.0|21.0|
3896072|NCT01502410|3720903|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3896073|NCT01502410|3720906|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3896074|NCT01502410|3720907|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3896075|NCT01502410|3720903|B5||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3896076|NCT01502410|3720906|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3896077|NCT01502410|3720907|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3896078|NCT01502410|3720903|B5||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
3896079|NCT01502410|3720906|B2||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
3896080|NCT01502410|3720907|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
3896081|NCT01502371|3720923|B6||Male|Sex: Female, Male||Participants|Count of Participants|346|346.0||||||
3896082|NCT01502371|3720924|B5||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3896083|NCT01502371|3720925|B4||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3896084|NCT01502371|3720926|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3896085|NCT01502371|3720927|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3896086|NCT01502371|3720928|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3896087|NCT01502371|3720923|B6||Female|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
3896088|NCT01502371|3720924|B5||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3896089|NCT01502371|3720925|B4||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3896090|NCT01502371|3720926|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3896091|NCT01502371|3720927|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3896092|NCT01502371|3720928|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3896093|NCT01502371|3720923|B6|||Age||Years|Mean|8.8|8.8|Standard Deviation|1.8|1.8|||
3896094|NCT01502371|3720924|B5|||Age||Years|Mean|9.0|9.0|Standard Deviation|1.7|1.7|||
3896095|NCT01502371|3720925|B4|||Age||Years|Mean|8.7|8.7|Standard Deviation|1.7|1.7|||
3896096|NCT01502371|3720926|B3|||Age||Years|Mean|8.7|8.7|Standard Deviation|1.7|1.7|||
3896097|NCT01502371|3720927|B2|||Age||Years|Mean|8.6|8.6|Standard Deviation|1.9|1.9|||
3896098|NCT01502371|3720928|B1|||Age||Years|Mean|8.7|8.7|Standard Deviation|1.7|1.7|||
3896099|NCT01502332|3720955|B3|Brazil||Region of Enrollment||participants|Number|320|320.0||||||
3896100|NCT01502332|3720956|B2|Brazil||Region of Enrollment||participants|Number|163|163.0||||||
3896101|NCT01502332|3720957|B1|Brazil||Region of Enrollment||participants|Number|157|157.0||||||
3896102|NCT01502332|3720955|B3||Male|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
3896103|NCT01502332|3720956|B2||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3896104|NCT01502332|3720957|B1||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3896105|NCT01502332|3720955|B3||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3896106|NCT01502332|3720956|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3896107|NCT01502332|3720957|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3896108|NCT01502332|3720955|B3|||Age||years|Median|62|62.0|Inter-Quartile Range|||56.0|70.0|
3896109|NCT01502332|3720956|B2|||Age||years|Median|63|63.0|Inter-Quartile Range|||57.0|70.0|
3896110|NCT01502332|3720957|B1|||Age||years|Median|62|62.0|Inter-Quartile Range|||56.0|68.0|
3896111|NCT01502332|3720955|B3||>=65 years|Age||Participants|Count of Participants|120|120.0||||||
3896112|NCT01502332|3720956|B2||>=65 years|Age||Participants|Count of Participants|63|63.0||||||
3896113|NCT01502332|3720957|B1||>=65 years|Age||Participants|Count of Participants|57|57.0||||||
3896114|NCT01502332|3720955|B3||Between 18 and 65 years|Age||Participants|Count of Participants|200|200.0||||||
3896115|NCT01502332|3720956|B2||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
3896116|NCT01502332|3720957|B1||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
3896117|NCT01502332|3720955|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3896118|NCT01502332|3720956|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3896119|NCT01502332|3720957|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3896120|NCT01502228|3720972|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896121|NCT01502228|3720972|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896122|NCT01502228|3720972|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3896123|NCT01502228|3720972|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896124|NCT01502228|3720972|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896125|NCT01502228|3720972|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896126|NCT01502228|3720972|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896127|NCT01502228|3720972|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3896128|NCT01502228|3720972|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3896129|NCT01502228|3720972|B1|||Age||years|Mean|60.7|60.7|Standard Deviation|7.26|7.26|||
3896130|NCT01502228|3720972|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3896131|NCT01502228|3720972|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3896132|NCT01502228|3720972|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3896133|NCT01502033|3720977|B1|||Children's Depression Rating Scale Revised|"Range of total score is 17-113 Total score of 40 or higher indicates moderate to severe depression (higher scores indicate increased severity of depressive symptoms).~A score below 40 indicates mild or minimal depressive symptoms."|units on a scale|Median|62.9|62.9|Standard Deviation|8.2|8.2|||
3896134|NCT01502033|3720977|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3896135|NCT01502033|3720977|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3896136|NCT01502033|3720977|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3896137|NCT01502033|3720977|B1|||Age||years|Mean|15.9|15.9|Standard Deviation|1.1|1.1|||
3896138|NCT01502033|3720977|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3896139|NCT01502033|3720977|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3896140|NCT01502033|3720977|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
3896141|NCT01501955|3720983|B3||Right|Operative Side||Participants|Count of Participants|13|13.0||||||
3896142|NCT01501955|3720984|B2||Right|Operative Side||Participants|Count of Participants|6|6.0||||||
3896143|NCT01501955|3720985|B1||Right|Operative Side||Participants|Count of Participants|7|7.0||||||
3896144|NCT01501955|3720983|B3||Left|Operative Side||Participants|Count of Participants|7|7.0||||||
3896145|NCT01501955|3720984|B2||Left|Operative Side||Participants|Count of Participants|3|3.0||||||
3896146|NCT01501955|3720985|B1||Left|Operative Side||Participants|Count of Participants|4|4.0||||||
3896147|NCT01501955|3720983|B3|Netherlands||Region of Enrollment||participants|Number|20|20.0||||||
3896148|NCT01501955|3720984|B2|Netherlands||Region of Enrollment||participants|Number|9|9.0||||||
3896149|NCT01501955|3720985|B1|Netherlands||Region of Enrollment||participants|Number|11|11.0||||||
3896150|NCT01501955|3720983|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3896151|NCT01501955|3720983|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3896152|NCT01501955|3720984|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3896153|NCT01501955|3720985|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3896154|NCT01501955|3720983|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3896155|NCT01501955|3720984|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3896156|NCT01501955|3720985|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3896157|NCT01501955|3720983|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3896158|NCT01501955|3720984|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3896159|NCT01501955|3720985|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3896160|NCT01501955|3720983|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3896161|NCT01501955|3720984|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3896162|NCT01501955|3720985|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3896163|NCT01501955|3720983|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3896164|NCT01501955|3720984|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3896165|NCT01501955|3720985|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3896166|NCT01501929|3721028|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3896167|NCT01501929|3721028|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3896168|NCT01501929|3721028|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3896169|NCT01501929|3721028|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3896170|NCT01501929|3721028|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3896171|NCT01501929|3721028|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3896172|NCT01501162|3721037|B3|Korea, Republic of||Region of Enrollment||participants|Number|117|117.0||||||
3896173|NCT01501162|3721038|B2|Korea, Republic of||Region of Enrollment||participants|Number|60|60.0||||||
3896174|NCT01501162|3721039|B1|Korea, Republic of||Region of Enrollment||participants|Number|57|57.0||||||
3896175|NCT01501162|3721037|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3896176|NCT01501162|3721038|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3896177|NCT01501162|3721039|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3896178|NCT01501162|3721037|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3896179|NCT01501162|3721038|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3896180|NCT01501162|3721039|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3896181|NCT01501162|3721037|B3|||Age||years|Mean|52.7|52.7|Standard Deviation|11.3|11.3|||
3896182|NCT01501162|3721038|B2|||Age||years|Mean|52.7|52.7|Standard Deviation|9.4|9.4|||
3896183|NCT01501162|3721039|B1|||Age||years|Mean|53.8|53.8|Standard Deviation|12.4|12.4|||
3896184|NCT01501162|3721037|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3896185|NCT01501162|3721038|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3896186|NCT01501162|3721039|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3896187|NCT01501162|3721037|B3||Between 18 and 65 years|Age||Participants|Count of Participants|117|117.0||||||
3896188|NCT01501162|3721038|B2||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3896189|NCT01501162|3721039|B1||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
3896190|NCT01501162|3721037|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3896191|NCT01501162|3721038|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3896192|NCT01501162|3721039|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3896193|NCT01501110|3721048|B3|||rT3||ng/dL|Mean|55|55.0|Standard Deviation|7.1|7.1|||
3896194|NCT01501110|3721049|B2|||rT3||ng/dL|Mean|55.2|55.2|Standard Deviation|6.1|6.1|||
3896195|NCT01501110|3721050|B1|||rT3||ng/dL|Mean|54.7|54.7|Standard Deviation|8.1|8.1|||
3896196|NCT01501110|3721048|B3|||FT4||ng/dL|Mean|1.1|1.1|Standard Deviation|0.2|0.2|||
3896197|NCT01501110|3721049|B2|||FT4||ng/dL|Mean|1.1|1.1|Standard Deviation|0.3|0.3|||
3896198|NCT01501110|3721050|B1|||FT4||ng/dL|Mean|1.1|1.1|Standard Deviation|0.2|0.2|||
3896199|NCT01501110|3721048|B3|||T4||mcg/dL|Median|7.4|7.4|Standard Deviation|1.5|1.5|||
3896200|NCT01501110|3721049|B2|||T4||mcg/dL|Median|7.4|7.4|Standard Deviation|1.4|1.4|||
3896201|NCT01501110|3721050|B1|||T4||mcg/dL|Median|7.4|7.4|Standard Deviation|1.9|1.9|||
3896202|NCT01501110|3721048|B3|||T3||ng/dL|Mean|99.3|99.3|Standard Deviation|17.4|17.4|||
3896203|NCT01501110|3721049|B2|||T3||ng/dL|Mean|98.7|98.7|Standard Deviation|20.7|20.7|||
3896204|NCT01501110|3721050|B1|||T3||ng/dL|Mean|100.4|100.4|Standard Deviation|16.5|16.5|||
3896205|NCT01501110|3721048|B3|||TSH||mcIU/mL|Mean|1.6|1.6|Standard Deviation|1.2|1.2|||
3896206|NCT01501110|3721049|B2|||TSH||mcIU/mL|Mean|1.6|1.6|Standard Deviation|1.1|1.1|||
3896207|NCT01501110|3721050|B1|||TSH||mcIU/mL|Mean|1.7|1.7|Standard Deviation|1.2|1.2|||
3896208|NCT01501110|3721048|B3|Brazil||Region of Enrollment||participants|Number|67|67.0||||||
3896209|NCT01501110|3721049|B2|Brazil||Region of Enrollment||participants|Number|33|33.0||||||
3896210|NCT01501110|3721050|B1|Brazil||Region of Enrollment||participants|Number|34|34.0||||||
3896211|NCT01501110|3721048|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3896212|NCT01501110|3721049|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3896213|NCT01501110|3721050|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3896214|NCT01501110|3721048|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3896215|NCT01501110|3721049|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3896216|NCT01501110|3721050|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3896217|NCT01501110|3721048|B3|||Age||years|Mean|57|57.0|Standard Deviation|9|9.0|||
3896218|NCT01501110|3721049|B2|||Age||years|Mean|57.4|57.4|Standard Deviation|8.4|8.4|||
3896219|NCT01501110|3721050|B1|||Age||years|Mean|56.9|56.9|Standard Deviation|9.4|9.4|||
3896220|NCT01500772|3721057|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3896221|NCT01500772|3721057|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3896222|NCT01500772|3721057|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3896223|NCT01500772|3721057|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3896224|NCT01500772|3721057|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3896225|NCT01500746|3721064|B3|United States||Region of Enrollment|Northwestern Memorial Hospital, Chicago, IL|participants|Number|8|8.0||||||
3896226|NCT01500746|3721065|B2|United States||Region of Enrollment|Northwestern Memorial Hospital, Chicago, IL|participants|Number|4|4.0||||||
3896227|NCT01500746|3721066|B1|United States||Region of Enrollment|Northwestern Memorial Hospital, Chicago, IL|participants|Number|4|4.0||||||
3896228|NCT01500746|3721064|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3896229|NCT01500746|3721065|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3896230|NCT01500746|3721066|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3896231|NCT01500746|3721064|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3896232|NCT01500746|3721065|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3896233|NCT01500746|3721066|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3896234|NCT01500746|3721064|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3896235|NCT01500746|3721065|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3896236|NCT01500746|3721066|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3896237|NCT01500746|3721064|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3896238|NCT01500746|3721065|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3896239|NCT01500746|3721066|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3896240|NCT01500746|3721064|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3896241|NCT01500746|3721065|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3896242|NCT01500746|3721066|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3896243|NCT01500733|3721073|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896244|NCT01500733|3721074|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896245|NCT01500733|3721075|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896246|NCT01500733|3721073|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3896247|NCT01500733|3721074|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3896248|NCT01500733|3721075|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896249|NCT01500733|3721073|B3||White|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3896250|NCT01500733|3721074|B2||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3896251|NCT01500733|3721075|B1||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3896252|NCT01500733|3721073|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3896253|NCT01500733|3721074|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3896254|NCT01500733|3721075|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3896255|NCT01500733|3721073|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896256|NCT01500733|3721074|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896257|NCT01500733|3721075|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896258|NCT01500733|3721073|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3896259|NCT01500733|3721074|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3896260|NCT01500733|3721075|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896261|NCT01500733|3721073|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896262|NCT01500733|3721074|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896263|NCT01500733|3721075|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896264|NCT01500733|3721073|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896265|NCT01500733|3721074|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896266|NCT01500733|3721075|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896267|NCT01500733|3721073|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3896268|NCT01500733|3721074|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3896269|NCT01500733|3721075|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3896270|NCT01500733|3721073|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3896271|NCT01500733|3721074|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3896272|NCT01500733|3721075|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896273|NCT01500733|3721073|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3896274|NCT01500733|3721074|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3896275|NCT01500733|3721075|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3896276|NCT01500733|3721073|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3896277|NCT01500733|3721074|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3896278|NCT01500733|3721075|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3896279|NCT01500733|3721073|B3||>=65 years|Age||Participants|Count of Participants|55|55.0||||||
3896280|NCT01500733|3721074|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3896281|NCT01500733|3721075|B1||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
3896282|NCT01500733|3721073|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3896283|NCT01500733|3721074|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3896284|NCT01500733|3721075|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3896285|NCT01500733|3721073|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3896286|NCT01500733|3721074|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3896287|NCT01500733|3721075|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3896288|NCT01500720|3721082|B3|||Number of Organs Involved||organs|Mean|3.7|3.7|Standard Deviation|1.3|1.3|||
3896289|NCT01500720|3721083|B2|||Number of Organs Involved||organs|Mean|3.8|3.8|Standard Deviation|1.4|1.4|||
3896290|NCT01500720|3721084|B1|||Number of Organs Involved||organs|Mean|3.6|3.6|Standard Deviation|1.3|1.3|||
3896291|NCT01500720|3721082|B3|Unknown||Stage at Diagnosis|Disease stages were decided based on tumor size, lymph nodes and metastasis (as per National Comprehensive Cancer Network guidelines Version 2.2013).|participants|Number|8|8.0||||||
3896292|NCT01500720|3721083|B2|Unknown||Stage at Diagnosis|Disease stages were decided based on tumor size, lymph nodes and metastasis (as per National Comprehensive Cancer Network guidelines Version 2.2013).|participants|Number|5|5.0||||||
3896377|NCT01500629|3721126|B1|||Age||years|Mean|25.0|25.0|Standard Deviation|5.64|5.64|||
3896293|NCT01500720|3721084|B1|Unknown||Stage at Diagnosis|Disease stages were decided based on tumor size, lymph nodes and metastasis (as per National Comprehensive Cancer Network guidelines Version 2.2013).|participants|Number|3|3.0||||||
3896294|NCT01500720|3721082|B3|IV||Stage at Diagnosis|Disease stages were decided based on tumor size, lymph nodes and metastasis (as per National Comprehensive Cancer Network guidelines Version 2.2013).|participants|Number|112|112.0||||||
3896295|NCT01500720|3721083|B2|IV||Stage at Diagnosis|Disease stages were decided based on tumor size, lymph nodes and metastasis (as per National Comprehensive Cancer Network guidelines Version 2.2013).|participants|Number|55|55.0||||||
3896296|NCT01500720|3721084|B1|IV||Stage at Diagnosis|Disease stages were decided based on tumor size, lymph nodes and metastasis (as per National Comprehensive Cancer Network guidelines Version 2.2013).|participants|Number|57|57.0||||||
3896297|NCT01500720|3721082|B3|IIIB||Stage at Diagnosis|Disease stages were decided based on tumor size, lymph nodes and metastasis (as per National Comprehensive Cancer Network guidelines Version 2.2013).|participants|Number|40|40.0||||||
3896298|NCT01500720|3721083|B2|IIIB||Stage at Diagnosis|Disease stages were decided based on tumor size, lymph nodes and metastasis (as per National Comprehensive Cancer Network guidelines Version 2.2013).|participants|Number|15|15.0||||||
3896299|NCT01500720|3721084|B1|IIIB||Stage at Diagnosis|Disease stages were decided based on tumor size, lymph nodes and metastasis (as per National Comprehensive Cancer Network guidelines Version 2.2013).|participants|Number|25|25.0||||||
3896300|NCT01500720|3721082|B3|IIIA||Stage at Diagnosis|Disease stages were decided based on tumor size, lymph nodes and metastasis (as per National Comprehensive Cancer Network guidelines Version 2.2013).|participants|Number|14|14.0||||||
3896301|NCT01500720|3721083|B2|IIIA||Stage at Diagnosis|Disease stages were decided based on tumor size, lymph nodes and metastasis (as per National Comprehensive Cancer Network guidelines Version 2.2013).|participants|Number|12|12.0||||||
3896302|NCT01500720|3721084|B1|IIIA||Stage at Diagnosis|Disease stages were decided based on tumor size, lymph nodes and metastasis (as per National Comprehensive Cancer Network guidelines Version 2.2013).|participants|Number|2|2.0||||||
3896303|NCT01500720|3721082|B3|IIB||Stage at Diagnosis|Disease stages were decided based on tumor size, lymph nodes and metastasis (as per National Comprehensive Cancer Network guidelines Version 2.2013).|participants|Number|3|3.0||||||
3896304|NCT01500720|3721083|B2|IIB||Stage at Diagnosis|Disease stages were decided based on tumor size, lymph nodes and metastasis (as per National Comprehensive Cancer Network guidelines Version 2.2013).|participants|Number|1|1.0||||||
3896305|NCT01500720|3721084|B1|IIB||Stage at Diagnosis|Disease stages were decided based on tumor size, lymph nodes and metastasis (as per National Comprehensive Cancer Network guidelines Version 2.2013).|participants|Number|2|2.0||||||
3896306|NCT01500720|3721082|B3|IIA||Stage at Diagnosis|Disease stages were decided based on tumor size, lymph nodes and metastasis (as per National Comprehensive Cancer Network guidelines Version 2.2013).|participants|Number|2|2.0||||||
3896307|NCT01500720|3721083|B2|IIA||Stage at Diagnosis|Disease stages were decided based on tumor size, lymph nodes and metastasis (as per National Comprehensive Cancer Network guidelines Version 2.2013).|participants|Number|1|1.0||||||
3896308|NCT01500720|3721084|B1|IIA||Stage at Diagnosis|Disease stages were decided based on tumor size, lymph nodes and metastasis (as per National Comprehensive Cancer Network guidelines Version 2.2013).|participants|Number|1|1.0||||||
3896309|NCT01500720|3721082|B3|Other: Mediastino-Hilar||Primary Tumor Site||participants|Number|1|1.0||||||
3896310|NCT01500720|3721083|B2|Other: Mediastino-Hilar||Primary Tumor Site||participants|Number|0|0.0||||||
3896311|NCT01500720|3721084|B1|Other: Mediastino-Hilar||Primary Tumor Site||participants|Number|1|1.0||||||
3896312|NCT01500720|3721082|B3|Left Lung||Primary Tumor Site||participants|Number|66|66.0||||||
3896313|NCT01500720|3721083|B2|Left Lung||Primary Tumor Site||participants|Number|26|26.0||||||
3896314|NCT01500720|3721084|B1|Left Lung||Primary Tumor Site||participants|Number|40|40.0||||||
3896315|NCT01500720|3721082|B3|Right Lung||Primary Tumor Site||participants|Number|76|76.0||||||
3896316|NCT01500720|3721083|B2|Right Lung||Primary Tumor Site||participants|Number|43|43.0||||||
3896317|NCT01500720|3721084|B1|Right Lung||Primary Tumor Site||participants|Number|33|33.0||||||
3896318|NCT01500720|3721082|B3|Lungs||Primary Tumor Site||participants|Number|36|36.0||||||
3896319|NCT01500720|3721083|B2|Lungs||Primary Tumor Site||participants|Number|20|20.0||||||
3896320|NCT01500720|3721084|B1|Lungs||Primary Tumor Site||participants|Number|16|16.0||||||
3896321|NCT01500720|3721082|B3|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG criteria:~0: Fully active~1: Ambulatory, carry out work of a light or sedentary nature~2: Ambulatory, capable of all selfcare~3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours~4: Completely disabled, no selfcare, totally confined to bed or chair~5: Dead"|participants|Number|1|1.0||||||
3896322|NCT01500720|3721083|B2|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG criteria:~0: Fully active~1: Ambulatory, carry out work of a light or sedentary nature~2: Ambulatory, capable of all selfcare~3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours~4: Completely disabled, no selfcare, totally confined to bed or chair~5: Dead"|participants|Number|1|1.0||||||
3896323|NCT01500720|3721084|B1|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG criteria:~0: Fully active~1: Ambulatory, carry out work of a light or sedentary nature~2: Ambulatory, capable of all selfcare~3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours~4: Completely disabled, no selfcare, totally confined to bed or chair~5: Dead"|participants|Number|0|0.0||||||
3896324|NCT01500720|3721082|B3|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG criteria:~0: Fully active~1: Ambulatory, carry out work of a light or sedentary nature~2: Ambulatory, capable of all selfcare~3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours~4: Completely disabled, no selfcare, totally confined to bed or chair~5: Dead"|participants|Number|130|130.0||||||
3896325|NCT01500720|3721083|B2|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG criteria:~0: Fully active~1: Ambulatory, carry out work of a light or sedentary nature~2: Ambulatory, capable of all selfcare~3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours~4: Completely disabled, no selfcare, totally confined to bed or chair~5: Dead"|participants|Number|71|71.0||||||
3896326|NCT01500720|3721084|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG criteria:~0: Fully active~1: Ambulatory, carry out work of a light or sedentary nature~2: Ambulatory, capable of all selfcare~3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours~4: Completely disabled, no selfcare, totally confined to bed or chair~5: Dead"|participants|Number|59|59.0||||||
3896327|NCT01500720|3721082|B3|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG criteria:~0: Fully active~1: Ambulatory, carry out work of a light or sedentary nature~2: Ambulatory, capable of all selfcare~3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours~4: Completely disabled, no selfcare, totally confined to bed or chair~5: Dead"|participants|Number|48|48.0||||||
3896328|NCT01500720|3721083|B2|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG criteria:~0: Fully active~1: Ambulatory, carry out work of a light or sedentary nature~2: Ambulatory, capable of all selfcare~3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours~4: Completely disabled, no selfcare, totally confined to bed or chair~5: Dead"|participants|Number|17|17.0||||||
3896329|NCT01500720|3721084|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG criteria:~0: Fully active~1: Ambulatory, carry out work of a light or sedentary nature~2: Ambulatory, capable of all selfcare~3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours~4: Completely disabled, no selfcare, totally confined to bed or chair~5: Dead"|participants|Number|31|31.0||||||
3896330|NCT01500720|3721082|B3|Ethnicity: Not Hispanic||Race/Ethnicity, Customized||participants|Number|172|172.0||||||
3896331|NCT01500720|3721083|B2|Ethnicity: Not Hispanic||Race/Ethnicity, Customized||participants|Number|86|86.0||||||
3896332|NCT01500720|3721084|B1|Ethnicity: Not Hispanic||Race/Ethnicity, Customized||participants|Number|86|86.0||||||
3896333|NCT01500720|3721082|B3|Ethnicity: Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3896334|NCT01500720|3721083|B2|Ethnicity: Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3896335|NCT01500720|3721084|B1|Ethnicity: Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3896336|NCT01500720|3721082|B3|Race: Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3896337|NCT01500720|3721083|B2|Race: Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3896338|NCT01500720|3721084|B1|Race: Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3896339|NCT01500720|3721082|B3|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3896340|NCT01500720|3721083|B2|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3896341|NCT01500720|3721084|B1|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3896342|NCT01500720|3721082|B3|Race: Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3896343|NCT01500720|3721083|B2|Race: Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3896344|NCT01500720|3721084|B1|Race: Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3896345|NCT01500720|3721082|B3|Race: Caucasian/White||Race/Ethnicity, Customized||participants|Number|162|162.0||||||
3896346|NCT01500720|3721083|B2|Race: Caucasian/White||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
3896347|NCT01500720|3721084|B1|Race: Caucasian/White||Race/Ethnicity, Customized||participants|Number|80|80.0||||||
3896348|NCT01500720|3721082|B3||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3896349|NCT01500720|3721083|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3896350|NCT01500720|3721084|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3896351|NCT01500720|3721082|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3896352|NCT01500720|3721083|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3896353|NCT01500720|3721084|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3896354|NCT01500720|3721082|B3|||Age||years|Mean|60.7|60.7|Standard Deviation|9.7|9.7|||
3896355|NCT01500720|3721083|B2|||Age||years|Mean|61.6|61.6|Standard Deviation|10.0|10.0|||
3896356|NCT01500720|3721084|B1|||Age||years|Mean|59.9|59.9|Standard Deviation|9.4|9.4|||
3896357|NCT01500694|3721097|B3||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3896358|NCT01500694|3721098|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3896359|NCT01500694|3721099|B1||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3896360|NCT01500694|3721097|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3896361|NCT01500694|3721098|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3896362|NCT01500694|3721099|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3896363|NCT01500694|3721097|B3|||Age||years|Mean|11.7|11.7|Standard Deviation|2.82|2.82|||
3896364|NCT01500694|3721098|B2|||Age||years|Mean|14.7|14.7|Standard Deviation|1.49|1.49|||
3896365|NCT01500694|3721099|B1|||Age||years|Mean|9.8|9.8|Standard Deviation|1.56|1.56|||
3896366|NCT01500629|3721124|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
3896367|NCT01500629|3721125|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3896368|NCT01500629|3721126|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3896369|NCT01500629|3721124|B3||Male|Gender||Participants|Count of Participants|9|9.0||||||
3896370|NCT01500629|3721125|B2||Male|Gender||Participants|Count of Participants|6|6.0||||||
3896371|NCT01500629|3721126|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
3896372|NCT01500629|3721124|B3||Female|Gender||Participants|Count of Participants|12|12.0||||||
3896373|NCT01500629|3721125|B2||Female|Gender||Participants|Count of Participants|4|4.0||||||
3896374|NCT01500629|3721126|B1||Female|Gender||Participants|Count of Participants|8|8.0||||||
3896375|NCT01500629|3721124|B3|||Age||years|Mean|28.1|28.1|Standard Deviation|8.71|8.71|||
3896376|NCT01500629|3721125|B2|||Age||years|Mean|31.6|31.6|Standard Deviation|10.38|10.38|||
3896378|NCT01500434|3721211|B1|TIMI 3||Lesion Characteristic - Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion; TIMI 1 - Penetration with minimal perfusion; TIMI 2 - Partial perfusion; TIMI 3 - Complete perfusion|Lesions|Number|96|96.0||||||
3896379|NCT01500434|3721211|B1|TIMI 2||Lesion Characteristic - Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion; TIMI 1 - Penetration with minimal perfusion; TIMI 2 - Partial perfusion; TIMI 3 - Complete perfusion|Lesions|Number|4|4.0||||||
3896380|NCT01500434|3721211|B1|TIMI 1||Lesion Characteristic - Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion; TIMI 1 - Penetration with minimal perfusion; TIMI 2 - Partial perfusion; TIMI 3 - Complete perfusion|Lesions|Number|0|0.0||||||
3896381|NCT01500434|3721211|B1|TIMI 0||Lesion Characteristic - Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion; TIMI 1 - Penetration with minimal perfusion; TIMI 2 - Partial perfusion; TIMI 3 - Complete perfusion|Lesions|Number|2|2.0||||||
3896382|NCT01500434|3721211|B1|Type C||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A lesions: minimally complex, readily accessible, non-angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, and an absence of thrombus.~Type B lesions: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, with presence of thrombus.~Type C lesions: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|Lesions|Number|78|78.0||||||
3896383|NCT01500434|3721211|B1|Type B2||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A lesions: minimally complex, readily accessible, non-angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, and an absence of thrombus.~Type B lesions: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, with presence of thrombus.~Type C lesions: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|Lesions|Number|21|21.0||||||
3896384|NCT01500434|3721211|B1|Type B1||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A lesions: minimally complex, readily accessible, non-angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, and an absence of thrombus.~Type B lesions: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, with presence of thrombus.~Type C lesions: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|Lesions|Number|2|2.0||||||
3896385|NCT01500434|3721211|B1|Type A||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A lesions: minimally complex, readily accessible, non-angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, and an absence of thrombus.~Type B lesions: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, with presence of thrombus.~Type C lesions: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|Lesions|Number|1|1.0||||||
3896386|NCT01500434|3721211|B1|Bifurcation||Lesion Characteristics||Lesions|Number|14|14.0||||||
3896387|NCT01500434|3721211|B1|Total Occlusion||Lesion Characteristics||Lesions|Number|2|2.0||||||
3896388|NCT01500434|3721211|B1|Calcification, any||Lesion Characteristics||Lesions|Number|37|37.0||||||
3896389|NCT01500434|3721211|B1|Tortuosity, any||Lesion Characteristics||Lesions|Number|5|5.0||||||
3896390|NCT01500434|3721211|B1|> 90 Degree Bend||Lesion Characteristics||Lesions|Number|3|3.0||||||
3896391|NCT01500434|3721211|B1|> 45 Degree Bend||Lesion Characteristics||Lesions|Number|34|34.0||||||
3896392|NCT01500434|3721211|B1|Eccentric Lesion||Lesion Characteristics||Lesions|Number|61|61.0||||||
3896393|NCT01500434|3721211|B1|||Lesion Characteristic: Percent Diameter Stenosis||percent|Mean|71.70|71.7|Standard Deviation|10.96|10.96|||
3896394|NCT01500434|3721211|B1|Lesion Length||Lesion Characteristics||millimeters|Mean|24.38|24.38|Standard Deviation|8.21|8.21|||
3896395|NCT01500434|3721211|B1|Minimum Lumen Diameter||Lesion Characteristics||millimeters|Mean|0.73|0.73|Standard Deviation|0.30|0.3|||
3896396|NCT01500434|3721211|B1|Reference Vessel Diameter||Lesion Characteristics||millimeters|Mean|2.56|2.56|Standard Deviation|0.40|0.4|||
3896397|NCT01500434|3721211|B1|Distal||Lesion Characteristic: Lesion Location||Lesions|Number|6|6.0||||||
3896398|NCT01500434|3721211|B1|Mid||Lesion Characteristic: Lesion Location||Lesions|Number|43|43.0||||||
3896399|NCT01500434|3721211|B1|Proximal||Lesion Characteristic: Lesion Location||Lesions|Number|48|48.0||||||
3896400|NCT01500434|3721211|B1|Ostial||Lesion Characteristic: Lesion Location||Lesions|Number|5|5.0||||||
3896401|NCT01500434|3721211|B1|Right Coronary Artery||Lesion Characteristic: Target Lesion Vessel||Lesions|Number|36|36.0||||||
3896402|NCT01500434|3721211|B1|Left Circumflex Artery||Lesion Characteristic: Target Lesion Vessel||Lesions|Number|22|22.0||||||
3896403|NCT01500434|3721211|B1|Left Anterior Descending Artery||Lesion Characteristic: Target Lesion Vessel||Lesions|Number|44|44.0||||||
3896404|NCT01500434|3721211|B1|History of Gastrointestinal Bleeding||Comorbidities|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|1|1.0||||||
3896405|NCT01500434|3721211|B1|History of Renal Disease||Comorbidities|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|7|7.0||||||
3896406|NCT01500434|3721211|B1|History of Cerebrovascular Accident||Comorbidities|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|7|7.0||||||
3896447|NCT01500382|3721242|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3896407|NCT01500434|3721211|B1|History of Transient Ischemic Attack||Comorbidities|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|5|5.0||||||
3896408|NCT01500434|3721211|B1|History of Peripheral Vascular Disease||Comorbidities|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|9|9.0||||||
3896409|NCT01500434|3721211|B1|Family History of Coronary Artery Disease||Cardiac Risk Factors|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|49|49.0||||||
3896410|NCT01500434|3721211|B1|Hypertension Requiring Medication||Cardiac Risk Factors|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|84|84.0||||||
3896411|NCT01500434|3721211|B1|Hyperlipidemia Requiring Medication||Cardiac Risk Factors|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|84|84.0||||||
3896412|NCT01500434|3721211|B1|Medically Treated Diabetes||Cardiac Risk Factors|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|30|30.0||||||
3896413|NCT01500434|3721211|B1|Smoking, Ever||Cardiac Risk Factors|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|64|64.0||||||
3896414|NCT01500434|3721211|B1|||Cardiac History: Ejection Fraction||Percent|Mean|59.09|59.09|Standard Deviation|11.05|11.05|||
3896415|NCT01500434|3721211|B1|Silent Ischemia||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|22|22.0||||||
3896416|NCT01500434|3721211|B1|Unstable Angina||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|24|24.0||||||
3896417|NCT01500434|3721211|B1|Stable Angina||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|57|57.0||||||
3896418|NCT01500434|3721211|B1|Congestive Heart Failure||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|3|3.0||||||
3896419|NCT01500434|3721211|B1|Previous Myocardial Infarction (MI)||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|34|34.0||||||
3896420|NCT01500434|3721211|B1|Previous Coronary Artery Bypass Graft (CABG)||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|12|12.0||||||
3896421|NCT01500434|3721211|B1|Previous Percutaneous Coronary Intervention (PCI)||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|39|39.0||||||
3896422|NCT01500434|3721211|B1|New Zealand||Region of Enrollment||participants|Number|3|3.0||||||
3896423|NCT01500434|3721211|B1|Japan||Region of Enrollment||participants|Number|7|7.0||||||
3896424|NCT01500434|3721211|B1|Latvia||Region of Enrollment||participants|Number|1|1.0||||||
3896425|NCT01500434|3721211|B1|Australia||Region of Enrollment||participants|Number|6|6.0||||||
3896426|NCT01500434|3721211|B1|Belgium||Region of Enrollment||participants|Number|13|13.0||||||
3896427|NCT01500434|3721211|B1|United States||Region of Enrollment||participants|Number|69|69.0||||||
3896428|NCT01500434|3721211|B1|France||Region of Enrollment||participants|Number|3|3.0||||||
3896429|NCT01500434|3721211|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participant|Number|1|1.0||||||
3896430|NCT01500434|3721211|B1|Black of African Heritage||Race/Ethnicity, Customized||participant|Number|3|3.0||||||
3896431|NCT01500434|3721211|B1|Asian||Race/Ethnicity, Customized||participant|Number|9|9.0||||||
3896432|NCT01500434|3721211|B1|Caucasian||Race/Ethnicity, Customized||participant|Number|83|83.0||||||
3896433|NCT01500434|3721211|B1|Hispanic or Latino||Race/Ethnicity, Customized||participant|Number|6|6.0||||||
3896434|NCT01500434|3721211|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3896435|NCT01500434|3721211|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3896436|NCT01500434|3721211|B1|||Age||years|Mean|65.9|65.9|Standard Deviation|9.8|9.8|||
3896437|NCT01500434|3721211|B1||>=65 years|Age||Participants|Count of Participants|58|58.0||||||
3896438|NCT01500434|3721211|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3896439|NCT01500434|3721211|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3896440|NCT01500382|3721240|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3896441|NCT01500382|3721241|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3896442|NCT01500382|3721242|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3896443|NCT01500382|3721243|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3896444|NCT01500382|3721244|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3896445|NCT01500382|3721240|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3896446|NCT01500382|3721241|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3896448|NCT01500382|3721243|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3896449|NCT01500382|3721244|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3896450|NCT01500382|3721240|B5|||Age||Years|Mean|58.3|58.3|Standard Deviation|8.14|8.14|||
3896451|NCT01500382|3721241|B4|||Age||Years|Mean|68|68.0|Standard Deviation|NA||||Only one participant in treatment group.
3896452|NCT01500382|3721242|B3|||Age||Years|Mean|55|55.0|Standard Deviation|NA||||Only one participant in treatment group.
3896453|NCT01500382|3721243|B2|||Age||Years|Mean|61|61.0|Standard Deviation|NA||||Only one participant in treatment group.
3896454|NCT01500382|3721244|B1|||Age||Years|Mean|49|49.0|Standard Deviation|NA||||Only one participant in treatment group.
3896455|NCT01500317|3721269|B4|||Body Mass Index (BMI)||kg/m^2|Mean|26.23|26.23|Standard Deviation|5.23|5.23|||
3896456|NCT01500317|3721270|B3|||Body Mass Index (BMI)||kg/m^2|Mean|25.16|25.16|Standard Deviation|4.88|4.88|||
3896457|NCT01500317|3721271|B2|||Body Mass Index (BMI)||kg/m^2|Mean|27.36|27.36|Standard Deviation|6.11|6.11|||
3896458|NCT01500317|3721272|B1|||Body Mass Index (BMI)||kg/m^2|Mean|26.27|26.27|Standard Deviation|4.88|4.88|||
3896459|NCT01500317|3721269|B4|United States||Region of Enrollment||participants|Number|38|38.0||||||
3896460|NCT01500317|3721270|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
3896461|NCT01500317|3721271|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3896462|NCT01500317|3721272|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3896463|NCT01500317|3721269|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3896464|NCT01500317|3721270|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3896465|NCT01500317|3721271|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3896466|NCT01500317|3721272|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3896467|NCT01500317|3721269|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3896468|NCT01500317|3721270|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3896469|NCT01500317|3721271|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3896470|NCT01500317|3721272|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3896471|NCT01500317|3721269|B4|||Age||years|Mean|35.98|35.98|Standard Deviation|11.11|11.11|||
3896472|NCT01500317|3721270|B3|||Age||years|Mean|39.48|39.48|Standard Deviation|12|12.0|||
3896473|NCT01500317|3721271|B2|||Age||years|Mean|33.26|33.26|Standard Deviation|12.94|12.94|||
3896474|NCT01500317|3721272|B1|||Age||years|Mean|34.99|34.99|Standard Deviation|7.82|7.82|||
3896475|NCT01500278|3721294|B3||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
3896476|NCT01500278|3721295|B2||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3896477|NCT01500278|3721296|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3896478|NCT01500278|3721294|B3||Female|Sex: Female, Male||Participants|Count of Participants|723|723.0||||||
3896479|NCT01500278|3721295|B2||Female|Sex: Female, Male||Participants|Count of Participants|363|363.0||||||
3896480|NCT01500278|3721296|B1||Female|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
3896481|NCT01500278|3721294|B3|Arithmetic mean (standard deviation)||Age||years|Mean|53.2|53.2|Standard Deviation|12.5|12.5|||
3896482|NCT01500278|3721295|B2|Arithmetic mean (standard deviation)||Age||years|Mean|52.9|52.9|Standard Deviation|12.8|12.8|||
3896483|NCT01500278|3721296|B1|Arithmetic mean (standard deviation)||Age||years|Mean|53.5|53.5|Standard Deviation|12.3|12.3|||
3896484|NCT01500278|3721294|B3||>=65 years|Age||Participants|Count of Participants|178|178.0||||||
3896485|NCT01500278|3721295|B2||>=65 years|Age||Participants|Count of Participants|85|85.0||||||
3896486|NCT01500278|3721296|B1||>=65 years|Age||Participants|Count of Participants|93|93.0||||||
3896487|NCT01500278|3721294|B3||Between 18 and 65 years|Age||Participants|Count of Participants|736|736.0||||||
3896488|NCT01500278|3721295|B2||Between 18 and 65 years|Age||Participants|Count of Participants|372|372.0||||||
3896489|NCT01500278|3721296|B1||Between 18 and 65 years|Age||Participants|Count of Participants|364|364.0||||||
3896490|NCT01500278|3721294|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3896491|NCT01500278|3721295|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3896492|NCT01500278|3721296|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3896493|NCT01500252|3721319|B3|Canada||Region of Enrollment||participants|Number|38|38.0||||||
3896494|NCT01500252|3721320|B2|Canada||Region of Enrollment||participants|Number|17|17.0||||||
3896495|NCT01500252|3721321|B1|Canada||Region of Enrollment||participants|Number|21|21.0||||||
3896496|NCT01500252|3721319|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3896497|NCT01500252|3721320|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3896498|NCT01500252|3721321|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3896499|NCT01500252|3721319|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3896500|NCT01500252|3721320|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3896501|NCT01500252|3721321|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3896502|NCT01500252|3721319|B3|||Age||years|Mean|63.6|63.6|Standard Deviation|4.9|4.9|||
3896503|NCT01500252|3721320|B2|||Age||years|Mean|62.0|62.0|Standard Deviation|5.6|5.6|||
3896504|NCT01500252|3721321|B1|||Age||years|Mean|64.9|64.9|Standard Deviation|4.0|4.0|||
3896505|NCT01500252|3721319|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3896506|NCT01500252|3721320|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3896507|NCT01500252|3721321|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3896508|NCT01500252|3721319|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3896509|NCT01500252|3721320|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3896510|NCT01500252|3721321|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3896511|NCT01500252|3721319|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3896512|NCT01500252|3721320|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3896513|NCT01500252|3721321|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3896514|NCT01500226|3721346|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3896515|NCT01500226|3721347|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3896516|NCT01500226|3721348|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3896517|NCT01500226|3721346|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896518|NCT01500226|3721347|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896519|NCT01500226|3721348|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896520|NCT01500226|3721346|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1020|1020.0||||||
3896521|NCT01500226|3721347|B2||White|Race (NIH/OMB)||Participants|Count of Participants|512|512.0||||||
3896522|NCT01500226|3721348|B1||White|Race (NIH/OMB)||Participants|Count of Participants|508|508.0||||||
3896523|NCT01500226|3721346|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3896524|NCT01500226|3721347|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3896525|NCT01500226|3721348|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3896526|NCT01500226|3721346|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3896527|NCT01500226|3721347|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3896528|NCT01500226|3721348|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3896529|NCT01500226|3721346|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|176|176.0||||||
3896530|NCT01500226|3721347|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3896531|NCT01500226|3721348|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
3896532|NCT01500226|3721346|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3896533|NCT01500226|3721347|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3896534|NCT01500226|3721348|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3896535|NCT01500226|3721346|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3896536|NCT01500226|3721347|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3896537|NCT01500226|3721348|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3896538|NCT01500226|3721346|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1177|1177.0||||||
3896539|NCT01500226|3721347|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|593|593.0||||||
3896540|NCT01500226|3721348|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|584|584.0||||||
3896541|NCT01500226|3721346|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|147|147.0||||||
3896542|NCT01500226|3721347|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3896543|NCT01500226|3721348|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3896544|NCT01500226|3721346|B3||Male|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
3896545|NCT01500226|3721347|B2||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3896546|NCT01500226|3721348|B1||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3896547|NCT01500226|3721346|B3||Female|Sex: Female, Male||Participants|Count of Participants|1067|1067.0||||||
3896548|NCT01500226|3721347|B2||Female|Sex: Female, Male||Participants|Count of Participants|536|536.0||||||
3896549|NCT01500226|3721348|B1||Female|Sex: Female, Male||Participants|Count of Participants|531|531.0||||||
3896550|NCT01500226|3721346|B3|||Age||years|Mean|56.7|56.7|Standard Deviation|11.83|11.83|||
3896551|NCT01500226|3721347|B2|||Age||years|Mean|56.6|56.6|Standard Deviation|12.01|12.01|||
3896552|NCT01500226|3721348|B1|||Age||years|Mean|56.7|56.7|Standard Deviation|11.65|11.65|||
3896553|NCT01500213|3721359|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3896554|NCT01500213|3721360|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3896555|NCT01500213|3721361|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3896556|NCT01500213|3721359|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896557|NCT01500213|3721360|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896558|NCT01500213|3721361|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896559|NCT01500213|3721359|B3||White|Race (NIH/OMB)||Participants|Count of Participants|438|438.0||||||
3896560|NCT01500213|3721360|B2||White|Race (NIH/OMB)||Participants|Count of Participants|212|212.0||||||
3896561|NCT01500213|3721361|B1||White|Race (NIH/OMB)||Participants|Count of Participants|226|226.0||||||
3896562|NCT01500213|3721359|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3896563|NCT01500213|3721360|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3896564|NCT01500213|3721361|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3896565|NCT01500213|3721359|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896566|NCT01500213|3721360|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896567|NCT01500213|3721361|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896568|NCT01500213|3721359|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3896569|NCT01500213|3721360|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3896570|NCT01500213|3721361|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3896571|NCT01500213|3721359|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3896572|NCT01500213|3721360|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3896573|NCT01500213|3721361|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3896574|NCT01500213|3721359|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896575|NCT01500213|3721360|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896576|NCT01500213|3721361|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896577|NCT01500213|3721359|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|470|470.0||||||
3896578|NCT01500213|3721360|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|235|235.0||||||
3896579|NCT01500213|3721361|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|235|235.0||||||
3896580|NCT01500213|3721359|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3896581|NCT01500213|3721360|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3896582|NCT01500213|3721361|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3896583|NCT01500213|3721359|B3||Male|Sex: Female, Male||Participants|Count of Participants|369|369.0||||||
3896584|NCT01500213|3721360|B2||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
3896585|NCT01500213|3721361|B1||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3896586|NCT01500213|3721359|B3||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
3896587|NCT01500213|3721360|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3896588|NCT01500213|3721361|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3896589|NCT01500213|3721359|B3|||Age||years|Mean|58.5|58.5|Standard Deviation|9.65|9.65|||
3896590|NCT01500213|3721360|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|9.25|9.25|||
3896591|NCT01500213|3721361|B1|||Age||years|Mean|58.5|58.5|Standard Deviation|10.05|10.05|||
3896592|NCT01500135|3721372|B3|Not Applicable||Fertility Status||participants|Number|91|91.0||||||
3896593|NCT01500135|3721373|B2|Not Applicable||Fertility Status||participants|Number|24|24.0||||||
3896594|NCT01500135|3721374|B1|Not Applicable||Fertility Status||participants|Number|67|67.0||||||
3896595|NCT01500135|3721372|B3|Surgically Sterile||Fertility Status||participants|Number|26|26.0||||||
3896596|NCT01500135|3721373|B2|Surgically Sterile||Fertility Status||participants|Number|10|10.0||||||
3896597|NCT01500135|3721374|B1|Surgically Sterile||Fertility Status||participants|Number|16|16.0||||||
3896598|NCT01500135|3721372|B3|Postmenstrual||Fertility Status||participants|Number|30|30.0||||||
3896599|NCT01500135|3721373|B2|Postmenstrual||Fertility Status||participants|Number|15|15.0||||||
3896600|NCT01500135|3721374|B1|Postmenstrual||Fertility Status||participants|Number|15|15.0||||||
3896601|NCT01500135|3721372|B3|Menstrual||Fertility Status||participants|Number|3|3.0||||||
3896602|NCT01500135|3721373|B2|Menstrual||Fertility Status||participants|Number|1|1.0||||||
3896603|NCT01500135|3721374|B1|Menstrual||Fertility Status||participants|Number|2|2.0||||||
3896604|NCT01500135|3721372|B3|||Body Mass Index (BMI)||kg/m^2|Mean|27.34|27.34|Standard Deviation|5.871|5.871|||
3896605|NCT01500135|3721373|B2|||Body Mass Index (BMI)||kg/m^2|Mean|27.13|27.13|Standard Deviation|6.246|6.246|||
3896606|NCT01500135|3721374|B1|||Body Mass Index (BMI)||kg/m^2|Mean|27.45|27.45|Standard Deviation|5.702|5.702|||
3896607|NCT01500135|3721372|B3|||Weight||kg|Mean|79.49|79.49|Standard Deviation|19.932|19.932|||
3896608|NCT01500135|3721373|B2|||Weight||kg|Mean|76.20|76.2|Standard Deviation|21.935|21.935|||
3896609|NCT01500135|3721374|B1|||Weight||kg|Mean|81.15|81.15|Standard Deviation|18.738|18.738|||
3896610|NCT01500135|3721372|B3|||Height||cm|Mean|170.07|170.07|Standard Deviation|10.479|10.479|||
3896611|NCT01500135|3721373|B2|||Height||cm|Mean|166.85|166.85|Standard Deviation|10.381|10.381|||
3896612|NCT01500135|3721374|B1|||Height||cm|Mean|171.70|171.7|Standard Deviation|10.197|10.197|||
3896613|NCT01500135|3721372|B3|United States||Region of Enrollment||participants|Number|150|150.0||||||
3896614|NCT01500135|3721373|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
3896615|NCT01500135|3721374|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
3896616|NCT01500135|3721372|B3|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3896617|NCT01500135|3721373|B2|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3896618|NCT01500135|3721374|B1|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3896619|NCT01500135|3721372|B3|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3896620|NCT01500135|3721373|B2|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3896621|NCT01500135|3721374|B1|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3896622|NCT01500135|3721372|B3|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|137|137.0||||||
3896623|NCT01500135|3721373|B2|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
3896624|NCT01500135|3721374|B1|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|95|95.0||||||
3896625|NCT01500135|3721372|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3896626|NCT01500135|3721373|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3896627|NCT01500135|3721374|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3896628|NCT01500135|3721372|B3|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3896629|NCT01500135|3721373|B2|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3896630|NCT01500135|3721374|B1|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3896631|NCT01500135|3721372|B3|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3896632|NCT01500135|3721373|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3896633|NCT01500135|3721374|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3896634|NCT01500135|3721372|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3896635|NCT01500135|3721373|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3896636|NCT01500135|3721374|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3896637|NCT01500135|3721372|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3896638|NCT01500135|3721373|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3896639|NCT01500135|3721374|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3896640|NCT01500135|3721372|B3|White/Caucasian||Race/Ethnicity, Customized||participants|Number|113|113.0||||||
3896641|NCT01500135|3721373|B2|White/Caucasian||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
3896642|NCT01500135|3721374|B1|White/Caucasian||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
3896643|NCT01500135|3721372|B3||Male|Gender||Participants|Count of Participants|91|91.0||||||
3896644|NCT01500135|3721373|B2||Male|Gender||Participants|Count of Participants|24|24.0||||||
3896645|NCT01500135|3721374|B1||Male|Gender||Participants|Count of Participants|67|67.0||||||
3896646|NCT01500135|3721372|B3||Female|Gender||Participants|Count of Participants|59|59.0||||||
3896647|NCT01500135|3721373|B2||Female|Gender||Participants|Count of Participants|26|26.0||||||
3896648|NCT01500135|3721374|B1||Female|Gender||Participants|Count of Participants|33|33.0||||||
3896649|NCT01500135|3721372|B3|>65 years||Age, Customized||participants|Number|80|80.0||||||
3896650|NCT01500135|3721373|B2|>65 years||Age, Customized||participants|Number|28|28.0||||||
3896651|NCT01500135|3721374|B1|>65 years||Age, Customized||participants|Number|52|52.0||||||
3896652|NCT01500135|3721372|B3|≤65 years||Age, Customized||participants|Number|70|70.0||||||
3896653|NCT01500135|3721373|B2|≤65 years||Age, Customized||participants|Number|22|22.0||||||
3896654|NCT01500135|3721374|B1|≤65 years||Age, Customized||participants|Number|48|48.0||||||
3896655|NCT01500135|3721372|B3|||Age||years|Mean|66.5|66.5|Standard Deviation|11.18|11.18|||
3896656|NCT01500135|3721373|B2|||Age||years|Mean|67.6|67.6|Standard Deviation|12.87|12.87|||
3896657|NCT01500135|3721374|B1|||Age||years|Mean|65.9|65.9|Standard Deviation|10.25|10.25|||
3896658|NCT01500109|3721385|B4|United States||Region of Enrollment||participants|Number|45|45.0||||||
3896659|NCT01500109|3721386|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
3896660|NCT01500109|3721387|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3896661|NCT01500109|3721388|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3896662|NCT01500109|3721385|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3896663|NCT01500109|3721386|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3896664|NCT01500109|3721387|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3896665|NCT01500109|3721388|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3896666|NCT01500109|3721385|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3896667|NCT01500109|3721386|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3896668|NCT01500109|3721387|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3896669|NCT01500109|3721388|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3896670|NCT01500109|3721385|B4|||Age||Months|Mean|8.2|8.2|Full Range|||6.6|11.7|
3896671|NCT01500109|3721386|B3|||Age||Months|Mean|8.2|8.2|Full Range|||7.2|10.1|
3896672|NCT01500109|3721387|B2|||Age||Months|Mean|8.7|8.7|Full Range|||7.0|11.7|
3896673|NCT01500109|3721388|B1|||Age||Months|Mean|7.7|7.7|Full Range|||6.6|10.4|
3896674|NCT01500109|3721385|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3896675|NCT01500109|3721386|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3896676|NCT01500109|3721387|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3896677|NCT01500109|3721388|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3896678|NCT01500109|3721385|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3896679|NCT01500109|3721386|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3896680|NCT01500109|3721387|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3896681|NCT01500109|3721388|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3896682|NCT01500109|3721385|B4||<=18 years|Age||Participants|Count of Participants|45|45.0||||||
3896683|NCT01500109|3721386|B3||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
3896684|NCT01500109|3721387|B2||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
3896685|NCT01500109|3721388|B1||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
3896686|NCT01500096|3721398|B5|United States||Region of Enrollment||Participants|Count of Participants|96|96.0||||||
3896687|NCT01500096|3721399|B4|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3896688|NCT01500096|3721400|B3|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3896689|NCT01500096|3721401|B2|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3896690|NCT01500096|3721402|B1|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3896691|NCT01500096|3721398|B5||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3896692|NCT01500096|3721399|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3896693|NCT01500096|3721400|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3896694|NCT01500096|3721401|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3896695|NCT01500096|3721402|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3896696|NCT01500096|3721398|B5||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3896697|NCT01500096|3721399|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3896698|NCT01500096|3721400|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3896699|NCT01500096|3721401|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3896700|NCT01500096|3721402|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3896701|NCT01500096|3721398|B5|||Age||years|Mean|52.2|52.2|Standard Deviation|7.3|7.3|||
3896702|NCT01500096|3721399|B4|||Age||years|Mean|50.2|50.2|Standard Deviation|4.83|4.83|||
3896703|NCT01500096|3721400|B3|||Age||years|Mean|53.7|53.7|Standard Deviation|6.8|6.8|||
3896704|NCT01500096|3721401|B2|||Age||years|Mean|52.1|52.1|Standard Deviation|9.5|9.5|||
3896705|NCT01500096|3721402|B1|||Age||years|Mean|51.8|51.8|Standard Deviation|7.5|7.5|||
3896706|NCT01500083|3721459|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3896707|NCT01500083|3721460|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3896708|NCT01500083|3721461|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3896709|NCT01500083|3721459|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3896710|NCT01500083|3721460|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3896711|NCT01500083|3721461|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3896712|NCT01500083|3721459|B3|||Age||years|Mean|64.2|64.2|Standard Deviation|10.51|10.51|||
3896713|NCT01500083|3721460|B2|||Age||years|Mean|63.1|63.1|Standard Deviation|10.84|10.84|||
3896714|NCT01500083|3721461|B1|||Age||years|Mean|69.3|69.3|Standard Deviation|7.12|7.12|||
3896715|NCT01500057|3721468|B3|United States||Region of Enrollment||Participants|Count of Participants|66|66.0||||||
3896716|NCT01500057|3721469|B2|United States||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3896717|NCT01500057|3721470|B1|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3896718|NCT01500057|3721468|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3896719|NCT01500057|3721469|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3896720|NCT01500057|3721470|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3896721|NCT01500057|3721468|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3896722|NCT01500057|3721469|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3896723|NCT01500057|3721470|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3896724|NCT01500057|3721468|B3|||Age||years|Mean|67.4|67.4|Standard Deviation|9.2|9.2|||
3896725|NCT01500057|3721469|B2|||Age||years|Mean|65.5|65.5|Standard Deviation|10.0|10.0|||
3896726|NCT01500057|3721470|B1|||Age||years|Mean|69.5|69.5|Standard Deviation|8.1|8.1|||
3896727|NCT01500031|3721481|B1|||Procedural Characteristics: Number of Participants currently taking medication||participants|Number|84|84.0||||||
3896728|NCT01500031|3721481|B1|||Procedural Characteristics: Number of non-target lesion treated|Additional non-target superficial femoral artery (SFA) lesions: e.g. carotid, renal, subclavian, iliac, opposite limb.|lesions|Mean|0.24|0.24|Standard Deviation|0.52|0.52|||
3896729|NCT01500031|3721481|B1|||Procedural Characteristics: Number of Participants with other Devices used||participants|Number|92|92.0||||||
3896730|NCT01500031|3721481|B1|||Procedural Characteristics: Number of Participants with stent placement performed||participants|Number|81|81.0||||||
3896731|NCT01500031|3721481|B1|||Procedural Characteristics: Number of participants with additional Vascular procedures performed||participants|Number|50|50.0||||||
3896732|NCT01500031|3721481|B1|||Procedural Characteristics: Total fluoroscopy time||minutes|Mean|20.99|20.99|Standard Deviation|13.10|13.1|||
3896733|NCT01500031|3721481|B1|||Procedural Characteristics: Total amount of contrast used||milliliters|Mean|143.11|143.11|Standard Deviation|74.57|74.57|||
3896734|NCT01500031|3721481|B1|Other||Procedural Characteristics: Puncture site||participants|Number|1|1.0||||||
3896735|NCT01500031|3721481|B1|Left brachial||Procedural Characteristics: Puncture site||participants|Number|0|0.0||||||
3896736|NCT01500031|3721481|B1|Left femoral||Procedural Characteristics: Puncture site||participants|Number|42|42.0||||||
3896737|NCT01500031|3721481|B1|Right brachial||Procedural Characteristics: Puncture site||participants|Number|0|0.0||||||
3896738|NCT01500031|3721481|B1|Right femoral||Procedural Characteristics: Puncture site||participants|Number|49|49.0||||||
3896739|NCT01500031|3721481|B1|||Procedural Characteristics: Time from artery access to sheath removal||minutes|Mean|87.51|87.51|Standard Deviation|135.33|135.33|||
3896740|NCT01500031|3721481|B1|Elective||Procedural Characteristics: Urgency of intervention||participants|Number|88|88.0||||||
3896741|NCT01500031|3721481|B1|Urgent||Procedural Characteristics: Urgency of intervention||participants|Number|3|3.0||||||
3896742|NCT01500031|3721481|B1|Emergent||Procedural Characteristics: Urgency of intervention||participants|Number|1|1.0||||||
3896743|NCT01500031|3721481|B1|Critical limb ischemia||Procedural Characteristics: Primary diagnosis||participants|Number|14|14.0||||||
3896744|NCT01500031|3721481|B1|Claudication||Procedural Characteristics: Primary diagnosis||participants|Number|78|78.0||||||
3896745|NCT01500031|3721481|B1|||Baseline Lesion Characteristics: Percent of Lesions with Flow limiting dissection|Type A: Small radiolucent area within vessel lumen disappearing with passage of contrast material, Type B: Appearance of contrast medium parallel to vessel lumen disappearing within a few cardiac cycles, Type C: Dissection protruding outside vessel lumen persisting after passage of contrast material, Type D: Spiral shaped filling defect with or without delayed run-off of contrast material in the antegrade flow, Type E: Persistent luminal filling defect with delayed run-off of contrast material in the distal lumen, Type F: Filling defect accompanied by total vessel occlusion.|percent of lesions|Number|2.2|2.2||||||
3896746|NCT01500031|3721481|B1|||Baseline Lesion Characteristics: Percent of Lesions with Perforation requiring intervention|Perforation defined as Angiographic Perforation (Perforation detected by the clinical center or Angiographic Core Laboratory at any point during the procedure) or clinical Perforation (perforation requiring additional treatment (including efforts to seal the perforation), or resulting in significant hemodynamic compromise, abrupt closure, or death).|percent of lesions|Number|4.3|4.3||||||
3896747|NCT01500031|3721481|B1|||Baseline Lesion Characteristics: Percent of Lesions with Re-entry into true lumen (site reported)|Re-entry in the true lumen defined as placement of a guidewire in the true lumen distal to a Chronic Total Occlusion (CTO).|percent of lesions|Number|84.8|84.8||||||
3896748|NCT01500031|3721481|B1|Severe||Baseline Lesion Characteristics: Presence of Calcification|"Readily apparent densities seen within the artery wall and site of lesion as an x-ray-absorbing mass. The protocol does not provide the criteria for assessing lesions as None/Mild, Moderate, or Severe. The assessment was left to the discretion of the Investigator."|lesions|Number|5|5.0||||||
3896749|NCT01500031|3721481|B1|Moderate||Baseline Lesion Characteristics: Presence of Calcification|"Readily apparent densities seen within the artery wall and site of lesion as an x-ray-absorbing mass. The protocol does not provide the criteria for assessing lesions as None/Mild, Moderate, or Severe. The assessment was left to the discretion of the Investigator."|lesions|Number|44|44.0||||||
3896750|NCT01500031|3721481|B1|None/Mild||Baseline Lesion Characteristics: Presence of Calcification|"Readily apparent densities seen within the artery wall and site of lesion as an x-ray-absorbing mass. The protocol does not provide the criteria for assessing lesions as None/Mild, Moderate, or Severe. The assessment was left to the discretion of the Investigator."|lesions|Number|43|43.0||||||
3896751|NCT01500031|3721481|B1|||Baseline Lesion Characteristics: Lesion Length||millimeters|Mean|175.12|175.12|Standard Deviation|85.42|85.42|||
3896752|NCT01500031|3721481|B1|||Baseline Lesion Characteristics: % Occluded||percentage Occluded|Mean|100.00|100.0|Standard Deviation|0.00|0.0|||
3896753|NCT01500031|3721481|B1|||Baseline Lesion Characteristics: Reference Vessel Diameter||millimeters|Mean|5.18|5.18|Standard Deviation|0.62|0.62|||
3896754|NCT01500031|3721481|B1|Left leg||Baseline Lesion Characteristics: Treated Limb||lesions|Number|44|44.0||||||
3896755|NCT01500031|3721481|B1|Right leg||Baseline Lesion Characteristics: Treated Limb||lesions|Number|48|48.0||||||
3896756|NCT01500031|3721481|B1|History of Claudication||Peripheral Vascular History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|82|82.0||||||
3896757|NCT01500031|3721481|B1|History of Other Peripheral Interventions||Peripheral Vascular History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|40|40.0||||||
3896758|NCT01500031|3721481|B1|History of Renal Percutaneous Intervention||Neurologic/Renal History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|0|0.0||||||
3896759|NCT01500031|3721481|B1|History of Renal Insufficiency||Neurologic/Renal History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|18|18.0||||||
3896760|NCT01500031|3721481|B1|History of Cerebrovascular Accident||Neurologic/Renal History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|11|11.0||||||
3896761|NCT01500031|3721481|B1|History of Transient Ischemic Attacks||Neurologic/Renal History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|0|0.0||||||
3896762|NCT01500031|3721481|B1|History of Coronary Artery Bypass Graft||Cardiac History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|5|5.0||||||
3896763|NCT01500031|3721481|B1|History of Percutaneous Coronary Intervention||Cardiac History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|16|16.0||||||
3896764|NCT01500031|3721481|B1|Unstable Angina||Cardiac History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|0|0.0||||||
3896765|NCT01500031|3721481|B1|Stable Angina||Cardiac History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|2|2.0||||||
3896799|NCT01499849|3721515|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3896800|NCT01499849|3721516|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3896766|NCT01500031|3721481|B1|History of Congestive Heart Failure||Cardiac History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|6|6.0||||||
3896767|NCT01500031|3721481|B1|History of Myocardial Infarction||Cardiac History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|16|16.0||||||
3896768|NCT01500031|3721481|B1|History of Coronary Artery Disease||Cardiac History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|30|30.0||||||
3896769|NCT01500031|3721481|B1|History of chronic obstructive pulmonary disease||General Medical History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|9|9.0||||||
3896770|NCT01500031|3721481|B1|History of Hypertension requiring medication||General Medical History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|75|75.0||||||
3896771|NCT01500031|3721481|B1|History of Hyperlipidemia requiring medication||General Medical History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|61|61.0||||||
3896772|NCT01500031|3721481|B1|Current Diabetes Mellitus||General Medical History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|47|47.0||||||
3896773|NCT01500031|3721481|B1|History of Smoking||General Medical History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|71|71.0||||||
3896774|NCT01500031|3721481|B1|Switzerland||Region of Enrollment||participants|Number|3|3.0||||||
3896775|NCT01500031|3721481|B1|Germany||Region of Enrollment||participants|Number|53|53.0||||||
3896776|NCT01500031|3721481|B1|Belgium||Region of Enrollment||participants|Number|36|36.0||||||
3896777|NCT01500031|3721481|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|91|91.0||||||
3896778|NCT01500031|3721481|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3896779|NCT01500031|3721481|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3896780|NCT01500031|3721481|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3896781|NCT01500031|3721481|B1|||Age||years|Mean|70.29|70.29|Standard Deviation|10.56|10.56|||
3896782|NCT01499862|3721496|B1|Mean Knee Score||Resting Extensor Tone (Modified Ashworth Scale)|The Modified Ashworth Scale (MAS) measures muscle hypertonia, with increasing scores signifying greater resting tone of muscle groups. Scores: 0 - No tone, 1 - Slight tone, with by a catch and release or by minimal resistance at the end of the range of motion, 1+ - Slight tone, manifested by a catch, followed by minimal resistance through less than half of the ROM, 2 - Marked increase in tone through most of ROM, but affected limb(s) easily moved, 3 - Considerable tone, passive movement difficult, 4 - Affected limb(s) rigid in flexion or extension|Units on a Scale|Median|3|3.0|Full Range|||1.0|4.0|
3896783|NCT01499862|3721496|B1|Mean Ankle Score||Resting Extensor Tone (Modified Ashworth Scale)|The Modified Ashworth Scale (MAS) measures muscle hypertonia, with increasing scores signifying greater resting tone of muscle groups. Scores: 0 - No tone, 1 - Slight tone, with by a catch and release or by minimal resistance at the end of the range of motion, 1+ - Slight tone, manifested by a catch, followed by minimal resistance through less than half of the ROM, 2 - Marked increase in tone through most of ROM, but affected limb(s) easily moved, 3 - Considerable tone, passive movement difficult, 4 - Affected limb(s) rigid in flexion or extension|Units on a Scale|Median|2|2.0|Full Range|||1.0|4.0|
3896784|NCT01499862|3721496|B1|||Right Lower Extremity Strength|The strength of the right lower extremity during active extension in pounds-force (lbf).|Pounds-Force|Median|105|105.0|Full Range|||97.0|138.0|
3896785|NCT01499862|3721496|B1|||Lower Left Extremity Strength|The strength of the left lower extremity during active extension in pounds-force (lbf).|Pounds-Force|Median|105|105.0|Full Range|||90.0|169.0|
3896786|NCT01499862|3721496|B1||Male|Sex: Female, Male|The Baseline measurement is to specify the gender of each participant.|Participants|Count of Participants|1|1.0||||||
3896787|NCT01499862|3721496|B1||Female|Sex: Female, Male|The Baseline measurement is to specify the gender of each participant.|Participants|Count of Participants|2|2.0||||||
3896788|NCT01499862|3721496|B1|||Age||Years|Median|50|50.0|Full Range|||40.0|60.0|
3896789|NCT01499849|3721514|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3896790|NCT01499849|3721515|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3896791|NCT01499849|3721516|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3896792|NCT01499849|3721514|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896793|NCT01499849|3721515|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896794|NCT01499849|3721516|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896795|NCT01499849|3721514|B3||White|Race (NIH/OMB)||Participants|Count of Participants|357|357.0||||||
3896796|NCT01499849|3721515|B2||White|Race (NIH/OMB)||Participants|Count of Participants|179|179.0||||||
3896797|NCT01499849|3721516|B1||White|Race (NIH/OMB)||Participants|Count of Participants|178|178.0||||||
3896798|NCT01499849|3721514|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3896801|NCT01499849|3721514|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896802|NCT01499849|3721515|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896803|NCT01499849|3721516|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896804|NCT01499849|3721514|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|117|117.0||||||
3896805|NCT01499849|3721515|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3896806|NCT01499849|3721516|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3896807|NCT01499849|3721514|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3896808|NCT01499849|3721515|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896809|NCT01499849|3721516|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3896810|NCT01499849|3721514|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896811|NCT01499849|3721515|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896812|NCT01499849|3721516|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896813|NCT01499849|3721514|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|459|459.0||||||
3896814|NCT01499849|3721515|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|228|228.0||||||
3896815|NCT01499849|3721516|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|231|231.0||||||
3896816|NCT01499849|3721514|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3896817|NCT01499849|3721515|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3896818|NCT01499849|3721516|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3896819|NCT01499849|3721514|B3||Male|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
3896820|NCT01499849|3721515|B2||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3896821|NCT01499849|3721516|B1||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3896822|NCT01499849|3721514|B3||Female|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
3896823|NCT01499849|3721515|B2||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3896824|NCT01499849|3721516|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3896825|NCT01499849|3721514|B3|||Age||years|Mean|57.3|57.3|Standard Deviation|10.62|10.62|||
3896826|NCT01499849|3721515|B2|||Age||years|Mean|57.7|57.7|Standard Deviation|11.15|11.15|||
3896827|NCT01499849|3721516|B1|||Age||years|Mean|57.0|57.0|Standard Deviation|10.08|10.08|||
3896828|NCT01499810|3721527|B1|Russian Federation||Region of Enrollment||participants|Number|53|53.0||||||
3896829|NCT01499810|3721527|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896830|NCT01499810|3721527|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3896831|NCT01499810|3721527|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896832|NCT01499810|3721527|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896833|NCT01499810|3721527|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896834|NCT01499810|3721527|B1||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3896835|NCT01499810|3721527|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896836|NCT01499810|3721527|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896837|NCT01499810|3721527|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3896838|NCT01499810|3721527|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896839|NCT01499810|3721527|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3896840|NCT01499810|3721527|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3896841|NCT01499810|3721527|B1|||Age||years|Mean|53.8|53.8|Standard Deviation|9.6|9.6|||
3896842|NCT01499667|3721574|B4||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3896843|NCT01499667|3721575|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3896844|NCT01499667|3721576|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3896845|NCT01499667|3721577|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3896846|NCT01499667|3721574|B4||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3896847|NCT01499667|3721575|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3896848|NCT01499667|3721576|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3896849|NCT01499667|3721577|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3896850|NCT01499667|3721574|B4|||Age||Years|Mean|41.6|41.6|Standard Deviation|8.780|8.78|||
3896851|NCT01499667|3721575|B3|||Age||Years|Mean|41.8|41.8|Standard Deviation|8.552|8.552|||
3896852|NCT01499667|3721576|B2|||Age||Years|Mean|41.9|41.9|Standard Deviation|7.445|7.445|||
3896853|NCT01499667|3721577|B1|||Age||Years|Mean|41.2|41.2|Standard Deviation|10.102|10.102|||
3896854|NCT01499654|3721608|B1|Diuretic||Medications||participants|Number|24|24.0||||||
3896855|NCT01499654|3721608|B1|Nitrates||Medications||participants|Number|11|11.0||||||
3896856|NCT01499654|3721608|B1|Statin||Medications||participants|Number|53|53.0||||||
3896857|NCT01499654|3721608|B1|Anti-platelet||Medications||participants|Number|21|21.0||||||
3896858|NCT01499654|3721608|B1|Aspirin||Medications||participants|Number|51|51.0||||||
3896859|NCT01499654|3721608|B1|Ca-channel blockers||Medications||participants|Number|19|19.0||||||
3896860|NCT01499654|3721608|B1|Beta-blockers||Medications||participants|Number|56|56.0||||||
3896861|NCT01499654|3721608|B1|ACE inhibitors/ARB||Medications||participants|Number|33|33.0||||||
3896862|NCT01499654|3721608|B1|||Previous nuclear stress||participants|Number|39|39.0||||||
3896863|NCT01499654|3721608|B1|Coronary artery bypass surgery||History||participants|Number|27|27.0||||||
3896864|NCT01499654|3721608|B1|Coronary artery disease||History||participants|Number|46|46.0||||||
3896865|NCT01499654|3721608|B1|Prior Myocardial Infarct||History||participants|Number|28|28.0||||||
3896866|NCT01499654|3721608|B1|Family history of CAD||History||participants|Number|19|19.0||||||
3896867|NCT01499654|3721608|B1|Diabetes mellitus||History||participants|Number|21|21.0||||||
3896868|NCT01499654|3721608|B1|Tobacco smoking (prior or current)||History||participants|Number|24|24.0||||||
3896869|NCT01499654|3721608|B1|Hypercholesterolemia||History||participants|Number|52|52.0||||||
3896870|NCT01499654|3721608|B1|Hypertension||History||participants|Number|58|58.0||||||
3896871|NCT01499654|3721608|B1|Other||Indications for stress test||participants|Number|9|9.0||||||
3896872|NCT01499654|3721608|B1|Prior PCI||Indications for stress test||participants|Number|5|5.0||||||
3896873|NCT01499654|3721608|B1|Prior CABG||Indications for stress test||participants|Number|8|8.0||||||
3896874|NCT01499654|3721608|B1|CHF||Indications for stress test||participants|Number|6|6.0||||||
3896875|NCT01499654|3721608|B1|Cardiomyopathy||Indications for stress test||participants|Number|5|5.0||||||
3896876|NCT01499654|3721608|B1|Prior Coronary Disease||Indications for stress test||participants|Number|18|18.0||||||
3896877|NCT01499654|3721608|B1|Prior Myocardial Infarct||Indications for stress test||participants|Number|7|7.0||||||
3896878|NCT01499654|3721608|B1|Dyspnea||Indications for stress test||participants|Number|9|9.0||||||
3896879|NCT01499654|3721608|B1|Chest pain||Indications for stress test||participants|Number|16|16.0||||||
3896880|NCT01499654|3721608|B1|||Body mass index||kg/m^2|Mean|30.2|30.2|Standard Deviation|6.0|6.0|||
3896881|NCT01499654|3721608|B1|||Weight||pounds|Mean|198.4|198.4|Standard Deviation|40.0|40.0|||
3896882|NCT01499654|3721608|B1|||Height||inches|Mean|68.0|68.0|Standard Deviation|4.1|4.1|||
3896883|NCT01499654|3721608|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3896884|NCT01499654|3721608|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3896885|NCT01499654|3721608|B1|||Age||years|Mean|66|66.0|Standard Deviation|11|11.0|||
3896886|NCT01499576|3721627|B1|Korea, Republic of||Region of Enrollment||participants|Number|105|105.0||||||
3896887|NCT01499576|3721627|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3896888|NCT01499576|3721627|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3896889|NCT01499576|3721627|B1|||Age||years|Mean|50.9|50.9|Standard Deviation|9.3|9.3|||
3896890|NCT01499576|3721627|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3896891|NCT01499576|3721627|B1||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
3896892|NCT01499576|3721627|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3896893|NCT01499498|3721633|B1|||Body Mass Index||kg/m2|Median|26.2|26.2|Full Range|||19.9|30.6|
3896894|NCT01499498|3721633|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896895|NCT01499498|3721633|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896896|NCT01499498|3721633|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3896897|NCT01499498|3721633|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3896898|NCT01499498|3721633|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896899|NCT01499498|3721633|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3896900|NCT01499498|3721633|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896901|NCT01499498|3721633|B1||Male|Gender||Participants|Count of Participants|13|13.0||||||
3896902|NCT01499498|3721633|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3896903|NCT01499498|3721633|B1|||Age||years|Median|36|36.0|Full Range|||22.0|47.0|
3896904|NCT01499355|3721641|B1||Male|Gender||Participants|Count of Participants|34|34.0||||||
3896905|NCT01499355|3721641|B1||Female|Gender||Participants|Count of Participants|242|242.0||||||
3896906|NCT01499355|3721641|B1|||Age||years|Mean|32.3|32.3|Standard Deviation|10.11|10.11|||
3896907|NCT01499303|3721675|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3896908|NCT01499303|3721676|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3896909|NCT01499303|3721677|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3896910|NCT01499303|3721675|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3896911|NCT01499303|3721676|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3896912|NCT01499303|3721677|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3896913|NCT01499303|3721675|B3|||Age||years|Mean|63.6|63.6|Standard Deviation|12.57|12.57|||
3896914|NCT01499303|3721676|B2|||Age||years|Mean|63.9|63.9|Standard Deviation|12.78|12.78|||
3896915|NCT01499303|3721677|B1|||Age||years|Mean|62.9|62.9|Standard Deviation|12.38|12.38|||
3896916|NCT01499290|3721684|B3||Male|Sex: Female, Male||Participants|Count of Participants|658|658.0||||||
3896917|NCT01499290|3721685|B2||Male|Sex: Female, Male||Participants|Count of Participants|332|332.0||||||
3896918|NCT01499290|3721686|B1||Male|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
3896919|NCT01499290|3721684|B3||Female|Sex: Female, Male||Participants|Count of Participants|385|385.0||||||
3896920|NCT01499290|3721685|B2||Female|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
3896921|NCT01499290|3721686|B1||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
3896922|NCT01499290|3721684|B3|||Age||Years|Mean|50.0|50.0|Standard Deviation|17.88|17.88|||
3896923|NCT01499290|3721685|B2|||Age||Years|Mean|50.3|50.3|Standard Deviation|18.29|18.29|||
3896924|NCT01499290|3721686|B1|||Age||Years|Mean|49.8|49.8|Standard Deviation|17.48|17.48|||
3896925|NCT01499277|3721735|B3||Male|Sex: Female, Male||Participants|Count of Participants|458|458.0||||||
3896926|NCT01499277|3721736|B2||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3896927|NCT01499277|3721737|B1||Male|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
3896928|NCT01499277|3721735|B3||Female|Sex: Female, Male||Participants|Count of Participants|303|303.0||||||
3896929|NCT01499277|3721736|B2||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3896930|NCT01499277|3721737|B1||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
3896931|NCT01499277|3721735|B3|||Age||Years|Mean|52.9|52.9|Standard Deviation|16.42|16.42|||
3896932|NCT01499277|3721736|B2|||Age||Years|Mean|53.6|53.6|Standard Deviation|16.25|16.25|||
3896933|NCT01499277|3721737|B1|||Age||Years|Mean|52.6|52.6|Standard Deviation|16.51|16.51|18.0|91.0|
3896934|NCT01499199|3721760|B1|>100000 copies/mL||Number of participants with Baseline plasma HIV-1 RNA <=100000 copies/mL and >100000 copies/mL|The number of participants with Baseline plasma HIV-1 RNA <= 100000 copies/mL and >100000 copies/mL was measured.|Participants|Number|5|5.0||||||
3896935|NCT01499199|3721760|B1|<=100000 copies/mL||Number of participants with Baseline plasma HIV-1 RNA <=100000 copies/mL and >100000 copies/mL|The number of participants with Baseline plasma HIV-1 RNA <= 100000 copies/mL and >100000 copies/mL was measured.|Participants|Number|8|8.0||||||
3896936|NCT01499199|3721760|B1|||Baseline plasma human immunodeficiency virus-1 (HIV-1) ribonucleic acid (RNA)|The absolute value of plasma HIV-1 RNA was measured at Baseline as log10 copies/milliliter (mL).|log10 copies/mL|Median|4.73|4.73|Full Range|||3.6|6.57|
3896937|NCT01499199|3721760|B1|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3896938|NCT01499199|3721760|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3896939|NCT01499199|3721760|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3896940|NCT01499199|3721760|B1|||Age||Years|Mean|40.2|40.2|Standard Deviation|6.90|6.9|||
3896941|NCT01499173|3721779|B1|United States||Region of Enrollment||Participants|Count of Participants|101|101.0||||||
3896942|NCT01499173|3721779|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896943|NCT01499173|3721779|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896944|NCT01499173|3721779|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896945|NCT01499173|3721779|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
3896946|NCT01499173|3721779|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896947|NCT01499173|3721779|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896948|NCT01499173|3721779|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896949|NCT01499173|3721779|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3896950|NCT01499173|3721779|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3896951|NCT01499173|3721779|B1|youth||Age||years|Median|14|14.0|Inter-Quartile Range|||11.0|16.0|
3896952|NCT01499173|3721779|B1|adults||Age||years|Median|56|56.0|Inter-Quartile Range|||35.0|65.0|
3896953|NCT01499160|3721789|B1|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3896954|NCT01499160|3721789|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3896955|NCT01499160|3721789|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3896956|NCT01499160|3721789|B1|||Age|age is a continuous variable and is collected from patient's charts|years|Median|60|60.0|Full Range|||50.0|71.0|
3896957|NCT01499147|3721794|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3896958|NCT01499147|3721795|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3896959|NCT01499147|3721796|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3896960|NCT01499147|3721794|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3896961|NCT01499147|3721795|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3896962|NCT01499147|3721796|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3896963|NCT01499147|3721794|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3896964|NCT01499147|3721795|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3896965|NCT01499147|3721796|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3896966|NCT01499147|3721794|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3896967|NCT01499147|3721795|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3896968|NCT01499147|3721796|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3896969|NCT01499147|3721794|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3896970|NCT01499147|3721795|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3896971|NCT01499147|3721796|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3896972|NCT01499147|3721794|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3896973|NCT01499147|3721795|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3896974|NCT01499147|3721796|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3896975|NCT01499147|3721794|B3|||Age||years|Median|42.5|42.5|Full Range|||19.0|61.0|
3896976|NCT01499147|3721795|B2|||Age||years|Median|49|49.0|Full Range|||22.0|61.0|
3896977|NCT01499147|3721796|B1|||Age||years|Median|34|34.0|Full Range|||19.0|61.0|
3896978|NCT01499134|3721810|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
3896979|NCT01499134|3721811|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3896980|NCT01499134|3721812|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3896981|NCT01499134|3721810|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896982|NCT01499134|3721811|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896983|NCT01499134|3721812|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896984|NCT01499134|3721810|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896985|NCT01499134|3721811|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896986|NCT01499134|3721812|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896987|NCT01499134|3721810|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3896988|NCT01499134|3721811|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3896989|NCT01499134|3721812|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3896990|NCT01499134|3721810|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3896991|NCT01499134|3721811|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3896992|NCT01499134|3721812|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3896993|NCT01499134|3721810|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896994|NCT01499134|3721811|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896995|NCT01499134|3721812|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896996|NCT01499134|3721810|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896997|NCT01499134|3721811|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896998|NCT01499134|3721812|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3896999|NCT01499134|3721810|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897000|NCT01499134|3721811|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897001|NCT01499134|3721812|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897002|NCT01499134|3721810|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897003|NCT01499134|3721811|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897004|NCT01499134|3721812|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897005|NCT01499134|3721810|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3897006|NCT01499134|3721811|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3897007|NCT01499134|3721812|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3897008|NCT01499134|3721810|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897009|NCT01499134|3721811|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897010|NCT01499134|3721812|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897011|NCT01499134|3721810|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3897012|NCT01499134|3721811|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3897013|NCT01499134|3721812|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3897014|NCT01499134|3721810|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3897015|NCT01499134|3721811|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3897016|NCT01499134|3721812|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3897017|NCT01499134|3721810|B3|||Age||years|Mean|66|66.0|Standard Deviation|8|8.0|||
3897018|NCT01499134|3721811|B2|||Age||years|Mean|65|65.0|Standard Deviation|8|8.0|||
3897019|NCT01499134|3721812|B1|||Age||years|Mean|66|66.0|Standard Deviation|8|8.0|||
3897020|NCT01499095|3721833|B3|Greater Than or Equal to (>=) 8%||Glycated Hemoglobin A1c (HbA1c)||participants|Number|521|521.0||||||
3897021|NCT01499095|3721834|B2|Greater Than or Equal to (>=) 8%||Glycated Hemoglobin A1c (HbA1c)||participants|Number|261|261.0||||||
3897022|NCT01499095|3721835|B1|Greater Than or Equal to (>=) 8%||Glycated Hemoglobin A1c (HbA1c)||participants|Number|260|260.0||||||
3897023|NCT01499095|3721833|B3|Less Than (<) 8%||Glycated Hemoglobin A1c (HbA1c)||participants|Number|290|290.0||||||
3897024|NCT01499095|3721834|B2|Less Than (<) 8%||Glycated Hemoglobin A1c (HbA1c)||participants|Number|146|146.0||||||
3897025|NCT01499095|3721835|B1|Less Than (<) 8%||Glycated Hemoglobin A1c (HbA1c)||participants|Number|144|144.0||||||
3897026|NCT01499095|3721833|B3|||Basal Insulin Daily Dose|Number of participants analyzed for this baseline characteristics = 378 and 382 in HOE901-U300 and Lantus arm, respectively.|units per kilogram|Mean|0.671|0.671|Standard Deviation|0.238|0.238|||
3897027|NCT01499095|3721834|B2|||Basal Insulin Daily Dose|Number of participants analyzed for this baseline characteristics = 378 and 382 in HOE901-U300 and Lantus arm, respectively.|units per kilogram|Mean|0.681|0.681|Standard Deviation|0.253|0.253|||
3897028|NCT01499095|3721835|B1|||Basal Insulin Daily Dose|Number of participants analyzed for this baseline characteristics = 378 and 382 in HOE901-U300 and Lantus arm, respectively.|units per kilogram|Mean|0.660|0.66|Standard Deviation|0.221|0.221|||
3897029|NCT01499095|3721833|B3|||Duration of Diabetes|Number of participants analyzed for this baseline characteristics = 403 and 407 in HOE901­U300 and Lantus arm, respectively.|years|Median|11.7|11.7|Full Range|||1.0|54.0|
3897030|NCT01499095|3721834|B2|||Duration of Diabetes|Number of participants analyzed for this baseline characteristics = 403 and 407 in HOE901­U300 and Lantus arm, respectively.|years|Median|11.7|11.7|Full Range|||1.0|51.0|
3897031|NCT01499095|3721835|B1|||Duration of Diabetes|Number of participants analyzed for this baseline characteristics = 403 and 407 in HOE901­U300 and Lantus arm, respectively.|years|Median|11.6|11.6|Full Range|||1.0|54.0|
3897032|NCT01499095|3721833|B3|||Body Mass Index (BMI)||kilogram per square meter|Mean|34.8|34.8|Standard Deviation|6.4|6.4|||
3897033|NCT01499095|3721834|B2|||Body Mass Index (BMI)||kilogram per square meter|Mean|34.8|34.8|Standard Deviation|6.1|6.1|||
3897034|NCT01499095|3721835|B1|||Body Mass Index (BMI)||kilogram per square meter|Mean|34.8|34.8|Standard Deviation|6.6|6.6|||
3897035|NCT01499095|3721833|B3||Male|Sex: Female, Male||Participants|Count of Participants|372|372.0||||||
3897036|NCT01499095|3721834|B2||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
3897037|NCT01499095|3721835|B1||Male|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
3897038|NCT01499095|3721833|B3||Female|Sex: Female, Male||Participants|Count of Participants|439|439.0||||||
3897039|NCT01499095|3721834|B2||Female|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
3897040|NCT01499095|3721835|B1||Female|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
3897041|NCT01499095|3721833|B3|||Age||years|Mean|58.2|58.2|Standard Deviation|9.2|9.2|||
3897042|NCT01499095|3721834|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|9.2|9.2|||
3897043|NCT01499095|3721835|B1|||Age||years|Mean|57.9|57.9|Standard Deviation|9.1|9.1|||
3897044|NCT01499082|3721864|B3|Greater Than or Equal to (>=) 8%||Glycated Hemoglobin A1c (HbA1c)||participants|Number|519|519.0||||||
3897045|NCT01499082|3721865|B2|Greater Than or Equal to (>=) 8%||Glycated Hemoglobin A1c (HbA1c)||participants|Number|259|259.0||||||
3897046|NCT01499082|3721866|B1|Greater Than or Equal to (>=) 8%||Glycated Hemoglobin A1c (HbA1c)||participants|Number|260|260.0||||||
3897047|NCT01499082|3721864|B3|Less Than (<) 8%||Glycated Hemoglobin A1c (HbA1c)||participants|Number|288|288.0||||||
3897048|NCT01499082|3721865|B2|Less Than (<) 8%||Glycated Hemoglobin A1c (HbA1c)||participants|Number|144|144.0||||||
3897049|NCT01499082|3721866|B1|Less Than (<) 8%||Glycated Hemoglobin A1c (HbA1c)||participants|Number|144|144.0||||||
3897050|NCT01499082|3721864|B3|||Total Insulin Daily Dose|Number of participants analyzed for this baseline characteristics = 367 and 360 in HOE901-U300 and Lantus arm, respectively|U/kg|Mean|1.197|1.197|Standard Deviation|0.466|0.466|||
3897051|NCT01499082|3721865|B2|||Total Insulin Daily Dose|Number of participants analyzed for this baseline characteristics = 367 and 360 in HOE901-U300 and Lantus arm, respectively|U/kg|Mean|1.200|1.2|Standard Deviation|0.448|0.448|||
3897052|NCT01499082|3721866|B1|||Total Insulin Daily Dose|Number of participants analyzed for this baseline characteristics = 367 and 360 in HOE901-U300 and Lantus arm, respectively|U/kg|Mean|1.194|1.194|Standard Deviation|0.483|0.483|||
3897053|NCT01499082|3721864|B3|||Basal Insulin Daily Dose|Number of participants analyzed for this baseline characteristics = 372 and 361 in HOE901-U300 and Lantus arm, respectively.|units per kilogram (U/kg)|Mean|0.668|0.668|Standard Deviation|0.252|0.252|||
3897054|NCT01499082|3721865|B2|||Basal Insulin Daily Dose|Number of participants analyzed for this baseline characteristics = 372 and 361 in HOE901-U300 and Lantus arm, respectively.|units per kilogram (U/kg)|Mean|0.667|0.667|Standard Deviation|0.241|0.241|||
3897055|NCT01499082|3721866|B1|||Basal Insulin Daily Dose|Number of participants analyzed for this baseline characteristics = 372 and 361 in HOE901-U300 and Lantus arm, respectively.|units per kilogram (U/kg)|Mean|0.668|0.668|Standard Deviation|0.263|0.263|||
3897056|NCT01499082|3721864|B3|||Duration of Diabetes||years|Mean|15.8|15.8|Standard Deviation|7.5|7.5|||
3897057|NCT01499082|3721865|B2|||Duration of Diabetes||years|Mean|16.1|16.1|Standard Deviation|7.8|7.8|||
3897058|NCT01499082|3721866|B1|||Duration of Diabetes||years|Mean|15.6|15.6|Standard Deviation|7.2|7.2|||
3897059|NCT01499082|3721864|B3|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|36.6|36.6|Standard Deviation|6.4|6.4|||
3897060|NCT01499082|3721865|B2|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|36.6|36.6|Standard Deviation|6.1|6.1|||
3897061|NCT01499082|3721866|B1|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|36.6|36.6|Standard Deviation|6.8|6.8|||
3897062|NCT01499082|3721864|B3||Male|Sex: Female, Male||Participants|Count of Participants|427|427.0||||||
3897063|NCT01499082|3721865|B2||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
3897064|NCT01499082|3721866|B1||Male|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
3897065|NCT01499082|3721864|B3||Female|Sex: Female, Male||Participants|Count of Participants|380|380.0||||||
3897066|NCT01499082|3721865|B2||Female|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
3897067|NCT01499082|3721866|B1||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
3897068|NCT01499082|3721864|B3|||Age||years|Mean|60.0|60.0|Standard Deviation|8.6|8.6|||
3897069|NCT01499082|3721865|B2|||Age||years|Mean|59.8|59.8|Standard Deviation|8.7|8.7|||
3897070|NCT01499082|3721866|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|8.5|8.5|||
3897071|NCT01498978|3721895|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3897072|NCT01498978|3721895|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897073|NCT01498978|3721895|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3897074|NCT01498978|3721895|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3897075|NCT01498978|3721895|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897076|NCT01498978|3721895|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897077|NCT01498978|3721895|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897078|NCT01498978|3721895|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897079|NCT01498978|3721895|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897080|NCT01498978|3721895|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3897081|NCT01498978|3721895|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897082|NCT01498978|3721895|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3897083|NCT01498978|3721895|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3897084|NCT01498978|3721895|B1|||Age||years|Median|64.5|64.5|Full Range|||56.0|69.0|
3897085|NCT01498978|3721895|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3897086|NCT01498978|3721895|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3897087|NCT01498978|3721895|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3897088|NCT01498822|3721915|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897089|NCT01498822|3721916|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897090|NCT01498822|3721917|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897091|NCT01498822|3721915|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897092|NCT01498822|3721916|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897093|NCT01498822|3721917|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897094|NCT01498822|3721915|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3897095|NCT01498822|3721916|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897096|NCT01498822|3721917|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3897097|NCT01498822|3721915|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897098|NCT01498822|3721916|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897099|NCT01498822|3721917|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897100|NCT01498822|3721915|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897101|NCT01498822|3721916|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897102|NCT01498822|3721917|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897103|NCT01498822|3721915|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|352|352.0||||||
3897104|NCT01498822|3721916|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|178|178.0||||||
3897105|NCT01498822|3721917|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|174|174.0||||||
3897106|NCT01498822|3721915|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897107|NCT01498822|3721916|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897108|NCT01498822|3721917|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897109|NCT01498822|3721915|B3||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
3897110|NCT01498822|3721916|B2||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3897111|NCT01498822|3721917|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3897112|NCT01498822|3721915|B3||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3897113|NCT01498822|3721916|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3897114|NCT01498822|3721917|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3897115|NCT01498822|3721915|B3|||Age||years|Mean|41.1|41.1|Standard Deviation|17.0|17.0|||
3897116|NCT01498822|3721916|B2|||Age||years|Mean|42.7|42.7|Standard Deviation|17.3|17.3|||
3897117|NCT01498822|3721917|B1|||Age||years|Mean|39.5|39.5|Standard Deviation|16.7|16.7|||
3897118|NCT01498822|3721915|B3||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
3897119|NCT01498822|3721916|B2||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3897120|NCT01498822|3721917|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3897121|NCT01498822|3721915|B3||Between 18 and 65 years|Age||Participants|Count of Participants|288|288.0||||||
3897122|NCT01498822|3721916|B2||Between 18 and 65 years|Age||Participants|Count of Participants|143|143.0||||||
3897123|NCT01498822|3721917|B1||Between 18 and 65 years|Age||Participants|Count of Participants|145|145.0||||||
3897124|NCT01498822|3721915|B3||<=18 years|Age||Participants|Count of Participants|27|27.0||||||
3897125|NCT01498822|3721916|B2||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
3897126|NCT01498822|3721917|B1||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
3897127|NCT01498744|3721930|B3|United States||Region of Enrollment||participants|Number|53|53.0||||||
3897128|NCT01498744|3721931|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
3897129|NCT01498744|3721932|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3897130|NCT01498744|3721930|B3||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3897131|NCT01498744|3721931|B2||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Gender was not collected before this study was closed
3897132|NCT01498744|3721932|B1||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Gender was not collected before this study was closed
3897133|NCT01498744|3721930|B3||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3897134|NCT01498744|3721931|B2||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Gender was not collected before this study was closed
3897135|NCT01498744|3721932|B1||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Gender was not collected before this study was closed
3897136|NCT01498744|3721930|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3897137|NCT01498744|3721931|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3897138|NCT01498744|3721932|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3897139|NCT01498744|3721930|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3897140|NCT01498744|3721931|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3897141|NCT01498744|3721932|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3897142|NCT01498744|3721930|B3||<=18 years|Age||Participants|Count of Participants|53|53.0||||||
3897143|NCT01498744|3721931|B2||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
3897144|NCT01498744|3721932|B1||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
3897145|NCT01498692|3721945|B1|TIMI 3||Lesion Characteristic - Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion; TIMI 1 - Penetration with minimal perfusion; TIMI 2 - Partial perfusion; TIMI 3 - Complete perfusion|participants|Number|88|88.0||||||
3897146|NCT01498692|3721945|B1|TIMI 2||Lesion Characteristic - Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion; TIMI 1 - Penetration with minimal perfusion; TIMI 2 - Partial perfusion; TIMI 3 - Complete perfusion|participants|Number|6|6.0||||||
3897147|NCT01498692|3721945|B1|TIMI 1||Lesion Characteristic - Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion; TIMI 1 - Penetration with minimal perfusion; TIMI 2 - Partial perfusion; TIMI 3 - Complete perfusion|participants|Number|0|0.0||||||
3897148|NCT01498692|3721945|B1|TIMI 0||Lesion Characteristic - Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion; TIMI 1 - Penetration with minimal perfusion; TIMI 2 - Partial perfusion; TIMI 3 - Complete perfusion|participants|Number|0|0.0||||||
3897149|NCT01498692|3721945|B1|Type C||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A lesions: minimally complex, readily accessible, non-angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, and an absence of thrombus.~Type B lesions: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, with presence of thrombus.~Type C lesions: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|lesions|Number|24|24.0||||||
3897150|NCT01498692|3721945|B1|Type B2||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A lesions: minimally complex, readily accessible, non-angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, and an absence of thrombus.~Type B lesions: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, with presence of thrombus.~Type C lesions: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|lesions|Number|41|41.0||||||
3897151|NCT01498692|3721945|B1|Type B1||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A lesions: minimally complex, readily accessible, non-angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, and an absence of thrombus.~Type B lesions: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, with presence of thrombus.~Type C lesions: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|lesions|Number|21|21.0||||||
3897152|NCT01498692|3721945|B1|Type A||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A lesions: minimally complex, readily accessible, non-angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, and an absence of thrombus.~Type B lesions: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, with presence of thrombus.~Type C lesions: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|lesions|Number|8|8.0||||||
3897153|NCT01498692|3721945|B1|Bifurcation||Lesion Characteristics|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|lesions|Number|6|6.0||||||
3897154|NCT01498692|3721945|B1|Total Occlusion||Lesion Characteristics|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|lesions|Number|0|0.0||||||
3897155|NCT01498692|3721945|B1|Calcification, any||Lesion Characteristics|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|lesions|Number|23|23.0||||||
3897156|NCT01498692|3721945|B1|Tortuosity, any||Lesion Characteristics|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|lesions|Number|5|5.0||||||
3897157|NCT01498692|3721945|B1|> 90 Degree Bend||Lesion Characteristics|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|lesions|Number|3|3.0||||||
3897158|NCT01498692|3721945|B1|> 45 Degree Bend||Lesion Characteristics|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|lesions|Number|21|21.0||||||
3897159|NCT01498692|3721945|B1|Eccentric Lesion||Lesion Characteristics|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|lesions|Number|66|66.0||||||
3897160|NCT01498692|3721945|B1|||Lesion Characteristic: Percent Diameter Stenosis||percent|Mean|75.10|75.1|Standard Deviation|9.50|9.5|||
3897161|NCT01498692|3721945|B1|Lesion Length||Lesion Characteristics||millimeters|Mean|14.15|14.15|Standard Deviation|7.03|7.03|||
3897162|NCT01498692|3721945|B1|Minimum Lumen Diameter||Lesion Characteristics||millimeters|Mean|0.51|0.51|Standard Deviation|0.21|0.21|||
3897163|NCT01498692|3721945|B1|Reference Vessel Diameter||Lesion Characteristics||millimeters|Mean|2.04|2.04|Standard Deviation|0.26|0.26|||
3897164|NCT01498692|3721945|B1|Distal||Lesion Characteristic: Lesion Location||Lesions|Number|15|15.0||||||
3897165|NCT01498692|3721945|B1|Mid||Lesion Characteristic: Lesion Location||Lesions|Number|37|37.0||||||
3897166|NCT01498692|3721945|B1|Proximal||Lesion Characteristic: Lesion Location||Lesions|Number|40|40.0||||||
3897167|NCT01498692|3721945|B1|Ostial||Lesion Characteristic: Lesion Location||Lesions|Number|2|2.0||||||
3897168|NCT01498692|3721945|B1|Right Coronary Artery||Lesion Characteristic: Target Lesion Vessel||lesions|Number|21|21.0||||||
3897169|NCT01498692|3721945|B1|Left Circumflex Artery||Lesion Characteristic: Target Lesion Vessel||lesions|Number|41|41.0||||||
3897170|NCT01498692|3721945|B1|Left Anterior Descending Artery||Lesion Characteristic: Target Lesion Vessel||lesions|Number|32|32.0||||||
3897171|NCT01498692|3721945|B1|History of Gastrointestinal Bleeding||Comorbidities|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|1|1.0||||||
3897172|NCT01498692|3721945|B1|History of Renal Disease||Comorbidities|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|2|2.0||||||
3897173|NCT01498692|3721945|B1|History of Cerebrovascular Accident||Comorbidities|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|3|3.0||||||
3897174|NCT01498692|3721945|B1|History of Transient Ischemic Attack||Comorbidities|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|5|5.0||||||
3897175|NCT01498692|3721945|B1|History of Peripheral Vascular Disease||Comorbidities|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|13|13.0||||||
3897176|NCT01498692|3721945|B1|Family History of Coronary Artery Disease||Cardiac Risk Factors|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|57|57.0||||||
3897177|NCT01498692|3721945|B1|Hypertension Requiring Medication||Cardiac Risk Factors|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|75|75.0||||||
3897178|NCT01498692|3721945|B1|Hyperlipidemia Requiring Medication||Cardiac Risk Factors|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|77|77.0||||||
3897179|NCT01498692|3721945|B1|Medically Treated Diabetes||Cardiac Risk Factors|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|40|40.0||||||
3897180|NCT01498692|3721945|B1|Smoking, Ever||Cardiac Risk Factors|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|59|59.0||||||
3897181|NCT01498692|3721945|B1|||Cardiac History: Ejection Fraction||ejection fraction percent|Mean|58.07|58.07|Standard Deviation|10.00|10.0|||
3897182|NCT01498692|3721945|B1|Silent Ischemia||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|21|21.0||||||
3897183|NCT01498692|3721945|B1|Unstable Angina||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|23|23.0||||||
3897184|NCT01498692|3721945|B1|Stable Angina||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|50|50.0||||||
3897185|NCT01498692|3721945|B1|Congestive Heart Failure||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|9|9.0||||||
3897186|NCT01498692|3721945|B1|Previous Myocardial Infarction (MI)||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|28|28.0||||||
3897187|NCT01498692|3721945|B1|Previous Coronary Artery Bypass Graft (CABG)||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|13|13.0||||||
3897188|NCT01498692|3721945|B1|Previous Percutaneous Coronary Intervention (PCI)||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|41|41.0||||||
3897189|NCT01498692|3721945|B1|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
3897190|NCT01498692|3721945|B1|Japan||Region of Enrollment||participants|Number|3|3.0||||||
3897191|NCT01498692|3721945|B1|Australia||Region of Enrollment||participants|Number|4|4.0||||||
3897192|NCT01498692|3721945|B1|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
3897193|NCT01498692|3721945|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
3897194|NCT01498692|3721945|B1|France||Region of Enrollment||participants|Number|6|6.0||||||
3897195|NCT01498692|3721945|B1|Black of African heritage||Race/Ethnicity, Customized|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|4|4.0||||||
3897251|NCT01498640|3722008|B1|||Age||Years|Mean|66.5|66.5|Standard Deviation|9.53|9.53|||
3897196|NCT01498692|3721945|B1|Asian||Race/Ethnicity, Customized|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|4|4.0||||||
3897197|NCT01498692|3721945|B1|Caucasian||Race/Ethnicity, Customized|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|80|80.0||||||
3897198|NCT01498692|3721945|B1|Hispanic or Latino||Race/Ethnicity, Customized|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|7|7.0||||||
3897199|NCT01498692|3721945|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3897200|NCT01498692|3721945|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3897201|NCT01498692|3721945|B1|||Age||years|Mean|64.33|64.33|Standard Deviation|11.03|11.03|||
3897202|NCT01498692|3721945|B1||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
3897203|NCT01498692|3721945|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
3897204|NCT01498692|3721945|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3897205|NCT01498679|3721974|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|50|50.0||||||
3897206|NCT01498679|3721975|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|28|28.0||||||
3897207|NCT01498679|3721976|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
3897208|NCT01498679|3721974|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|257|257.0||||||
3897209|NCT01498679|3721975|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|125|125.0||||||
3897210|NCT01498679|3721976|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|132|132.0||||||
3897211|NCT01498679|3721974|B3||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3897212|NCT01498679|3721975|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3897213|NCT01498679|3721976|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3897214|NCT01498679|3721974|B3||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3897215|NCT01498679|3721975|B2||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3897216|NCT01498679|3721976|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3897217|NCT01498679|3721974|B3|||Age||Years|Mean|47.2|47.2|Standard Deviation|13.94|13.94|||
3897218|NCT01498679|3721975|B2|||Age||Years|Mean|47.0|47.0|Standard Deviation|14.01|14.01|||
3897219|NCT01498679|3721976|B1|||Age||Years|Mean|47.4|47.4|Standard Deviation|13.90|13.9|||
3897220|NCT01498653|3721991|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
3897221|NCT01498653|3721992|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
3897222|NCT01498653|3721993|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
3897223|NCT01498653|3721991|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|255|255.0||||||
3897224|NCT01498653|3721992|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|127|127.0||||||
3897225|NCT01498653|3721993|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|128|128.0||||||
3897226|NCT01498653|3721991|B3||Male|Gender||Participants|Count of Participants|127|127.0||||||
3897227|NCT01498653|3721992|B2||Male|Gender||Participants|Count of Participants|68|68.0||||||
3897228|NCT01498653|3721993|B1||Male|Gender||Participants|Count of Participants|59|59.0||||||
3897229|NCT01498653|3721991|B3||Female|Gender||Participants|Count of Participants|182|182.0||||||
3897230|NCT01498653|3721992|B2||Female|Gender||Participants|Count of Participants|86|86.0||||||
3897231|NCT01498653|3721993|B1||Female|Gender||Participants|Count of Participants|96|96.0||||||
3897232|NCT01498653|3721991|B3|||Age||Years|Mean|47.9|47.9|Standard Deviation|13.19|13.19|||
3897233|NCT01498653|3721992|B2|||Age||Years|Mean|48.8|48.8|Standard Deviation|13.41|13.41|||
3897234|NCT01498653|3721993|B1|||Age||Years|Mean|46.9|46.9|Standard Deviation|12.93|12.93|||
3897235|NCT01498640|3722008|B1|Sweden||Region of Enrollment||participants|Number|6|6.0||||||
3897236|NCT01498640|3722008|B1|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3897237|NCT01498640|3722008|B1|Australia||Region of Enrollment||participants|Number|21|21.0||||||
3897238|NCT01498640|3722008|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3897239|NCT01498640|3722008|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897240|NCT01498640|3722008|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897241|NCT01498640|3722008|B1||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3897242|NCT01498640|3722008|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897243|NCT01498640|3722008|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897244|NCT01498640|3722008|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897245|NCT01498640|3722008|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897246|NCT01498640|3722008|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897247|NCT01498640|3722008|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3897248|NCT01498640|3722008|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897249|NCT01498640|3722008|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3897250|NCT01498640|3722008|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3897252|NCT01498640|3722008|B1||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
3897253|NCT01498640|3722008|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3897254|NCT01498640|3722008|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3897255|NCT01498601|3722022|B3|Canada||Region of Enrollment|The study was conducted on a 31 bed acute neurosurgical unit at a tertiary care trauma hospital in Western Canada. The hospital is one of 12 acute care centers in a large metropolitan health region. The study unit was outside of critical care environments. Unit staff consists of a mix of novice and experienced staff including registered nurses (RNs), licensed practice nurses (LPNs), patient care assistants (PCAs), and a rehabilitation team.|participants|Number|83|83.0||||||
3897256|NCT01498601|3722023|B2|Canada||Region of Enrollment|The study was conducted on a 31 bed acute neurosurgical unit at a tertiary care trauma hospital in Western Canada. The hospital is one of 12 acute care centers in a large metropolitan health region. The study unit was outside of critical care environments. Unit staff consists of a mix of novice and experienced staff including registered nurses (RNs), licensed practice nurses (LPNs), patient care assistants (PCAs), and a rehabilitation team.|participants|Number|51|51.0||||||
3897257|NCT01498601|3722024|B1|Canada||Region of Enrollment|The study was conducted on a 31 bed acute neurosurgical unit at a tertiary care trauma hospital in Western Canada. The hospital is one of 12 acute care centers in a large metropolitan health region. The study unit was outside of critical care environments. Unit staff consists of a mix of novice and experienced staff including registered nurses (RNs), licensed practice nurses (LPNs), patient care assistants (PCAs), and a rehabilitation team.|participants|Number|32|32.0||||||
3897258|NCT01498601|3722022|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3897259|NCT01498601|3722023|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3897260|NCT01498601|3722024|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3897261|NCT01498601|3722022|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3897262|NCT01498601|3722023|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3897263|NCT01498601|3722024|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3897264|NCT01498601|3722022|B3|Age >=19||Age, Customized||participants|Number|83|83.0||||||
3897265|NCT01498601|3722023|B2|Age >=19||Age, Customized||participants|Number|51|51.0||||||
3897266|NCT01498601|3722024|B1|Age >=19||Age, Customized||participants|Number|32|32.0||||||
3897267|NCT01498588|3722031|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3897268|NCT01498588|3722031|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3897269|NCT01498588|3722031|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897270|NCT01498588|3722031|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3897271|NCT01498588|3722031|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3897272|NCT01498588|3722031|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897273|NCT01498588|3722031|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897274|NCT01498588|3722031|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3897275|NCT01498588|3722031|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3897276|NCT01498588|3722031|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3897277|NCT01498588|3722031|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897278|NCT01498588|3722031|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3897279|NCT01498588|3722031|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3897280|NCT01498588|3722031|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3897281|NCT01498588|3722031|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3897282|NCT01498588|3722031|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3897283|NCT01498575|3722036|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3897284|NCT01498575|3722037|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3897285|NCT01498575|3722038|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3897286|NCT01498575|3722036|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3897287|NCT01498575|3722037|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3897288|NCT01498575|3722038|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3897289|NCT01498575|3722036|B3||White|Race (NIH/OMB)||Participants|Count of Participants|858|858.0||||||
3897290|NCT01498575|3722037|B2||White|Race (NIH/OMB)||Participants|Count of Participants|342|342.0||||||
3897291|NCT01498575|3722038|B1||White|Race (NIH/OMB)||Participants|Count of Participants|516|516.0||||||
3897292|NCT01498575|3722036|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|114|114.0||||||
3897293|NCT01498575|3722037|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3897294|NCT01498575|3722038|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3897295|NCT01498575|3722036|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3897296|NCT01498575|3722037|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3897297|NCT01498575|3722038|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897298|NCT01498575|3722036|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3897299|NCT01498575|3722037|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3897300|NCT01498575|3722038|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3897301|NCT01498575|3722036|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3897302|NCT01498575|3722037|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897303|NCT01498575|3722038|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3897304|NCT01498575|3722036|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3897305|NCT01498575|3722037|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3897306|NCT01498575|3722038|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3897307|NCT01498575|3722036|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|993|993.0||||||
3897308|NCT01498575|3722037|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|402|402.0||||||
3897309|NCT01498575|3722038|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|591|591.0||||||
3897310|NCT01498575|3722036|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3897311|NCT01498575|3722037|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3897312|NCT01498575|3722038|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3897313|NCT01498575|3722036|B3||Male|Sex: Female, Male||Participants|Count of Participants|361|361.0||||||
3897314|NCT01498575|3722037|B2||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3897315|NCT01498575|3722038|B1||Male|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
3897316|NCT01498575|3722036|B3||Female|Sex: Female, Male||Participants|Count of Participants|663|663.0||||||
3897317|NCT01498575|3722037|B2||Female|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
3897318|NCT01498575|3722038|B1||Female|Sex: Female, Male||Participants|Count of Participants|385|385.0||||||
3897319|NCT01498575|3722036|B3|Parents (n=295, 204)||Age, Customized||years|Median|48.5|48.5|Inter-Quartile Range|||45.0|52.0|
3897320|NCT01498575|3722037|B2|Parents (n=295, 204)||Age, Customized||years|Median|48.9|48.9|Inter-Quartile Range|||45.8|51.9|
3897321|NCT01498575|3722038|B1|Parents (n=295, 204)||Age, Customized||years|Median|48.4|48.4|Inter-Quartile Range|||44.7|51.8|
3897322|NCT01498575|3722036|B3|Teens (n=315, 210)||Age, Customized||years|Median|16.2|16.2|Inter-Quartile Range|||16.0|17.0|
3897323|NCT01498575|3722037|B2|Teens (n=315, 210)||Age, Customized||years|Median|16.3|16.3|Inter-Quartile Range|||16.1|16.7|
3897324|NCT01498575|3722038|B1|Teens (n=315, 210)||Age, Customized||years|Median|16.2|16.2|Inter-Quartile Range|||16.1|16.6|
3897325|NCT01498549|3722045|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897326|NCT01498549|3722045|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897327|NCT01498549|3722045|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3897328|NCT01498549|3722045|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3897329|NCT01498549|3722045|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897330|NCT01498549|3722045|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897331|NCT01498549|3722045|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897332|NCT01498549|3722045|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897333|NCT01498549|3722045|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3897334|NCT01498549|3722045|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3897335|NCT01498549|3722045|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3897336|NCT01498549|3722045|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3897337|NCT01498549|3722045|B1|||Age||years|Mean|41.21|41.21|Standard Deviation|7.47|7.47|||
3897338|NCT01498458|3722056|B1|Her2 Positive||HER2 Status||participants|Number|0|0.0||||||
3897339|NCT01498458|3722056|B1|Her2 Negative||HER2 Status||participants|Number|8|8.0||||||
3897340|NCT01498458|3722056|B1|ERpos/PRpos||Hormone Receptor Status||participants|Number|3|3.0||||||
3897341|NCT01498458|3722056|B1|ERpos/PRneg||Hormone Receptor Status||participants|Number|2|2.0||||||
3897342|NCT01498458|3722056|B1|ERneg/PRpos||Hormone Receptor Status||participants|Number|1|1.0||||||
3897343|NCT01498458|3722056|B1|ERneg/PRneg||Hormone Receptor Status||participants|Number|2|2.0||||||
3897344|NCT01498458|3722056|B1|G3||Grading|"Grading is a measure of the cell appearance in tumors and other neoplasms in pathology...Grade 1 Well differentiated (Low grade)...~Grade 2 Moderately differentiated (Intermediate grade)... Grade 3 poorly differentiated (High grade)"|participants|Number|3|3.0||||||
3897345|NCT01498458|3722056|B1|G2||Grading|"Grading is a measure of the cell appearance in tumors and other neoplasms in pathology...Grade 1 Well differentiated (Low grade)...~Grade 2 Moderately differentiated (Intermediate grade)... Grade 3 poorly differentiated (High grade)"|participants|Number|5|5.0||||||
3897346|NCT01498458|3722056|B1|G1||Grading|"Grading is a measure of the cell appearance in tumors and other neoplasms in pathology...Grade 1 Well differentiated (Low grade)...~Grade 2 Moderately differentiated (Intermediate grade)... Grade 3 poorly differentiated (High grade)"|participants|Number|0|0.0||||||
3897347|NCT01498458|3722056|B1|N3||N Status|N status is a categorisation of the number of lymph nodes..N0 – No cancer cells found in any nearby nodes...N1 is when 1 to 3 lymph nodes are found.....N2 is when 4 to 9 lymph nodes are found....N2 is when greater than 9 lymph nodes are found|participants|Number|1|1.0||||||
3897348|NCT01498458|3722056|B1|N2||N Status|N status is a categorisation of the number of lymph nodes..N0 – No cancer cells found in any nearby nodes...N1 is when 1 to 3 lymph nodes are found.....N2 is when 4 to 9 lymph nodes are found....N2 is when greater than 9 lymph nodes are found|participants|Number|0|0.0||||||
3897379|NCT01498419|3722067|B3|Resistant||Moxifloxacin susceptibility|Safety Analysis Population|participants|Number|1|1.0||||||
3897349|NCT01498458|3722056|B1|N1||N Status|N status is a categorisation of the number of lymph nodes..N0 – No cancer cells found in any nearby nodes...N1 is when 1 to 3 lymph nodes are found.....N2 is when 4 to 9 lymph nodes are found....N2 is when greater than 9 lymph nodes are found|participants|Number|5|5.0||||||
3897350|NCT01498458|3722056|B1|N0||N Status|N status is a categorisation of the number of lymph nodes..N0 – No cancer cells found in any nearby nodes...N1 is when 1 to 3 lymph nodes are found.....N2 is when 4 to 9 lymph nodes are found....N2 is when greater than 9 lymph nodes are found|participants|Number|2|2.0||||||
3897351|NCT01498458|3722056|B1|Tis||T status|T status describes the size of the original (primary) tumor and whether it has invaded nearby tissue,,,T1 – The tumour is 2 centimetres (cm) across or less...T2 – The tumour is more than 2 centimetres, but no more than 5 centimetres across...T3 – The tumour is bigger than 5 centimetres across...T4 refers to inflamatory breast cancer....Tis means DCIS(ductal carcinoma in situ...The tumors are all breast cancer tumors as the study has to do with breast cancer.|participants|Number|1|1.0||||||
3897352|NCT01498458|3722056|B1|T4||T status|T status describes the size of the original (primary) tumor and whether it has invaded nearby tissue,,,T1 – The tumour is 2 centimetres (cm) across or less...T2 – The tumour is more than 2 centimetres, but no more than 5 centimetres across...T3 – The tumour is bigger than 5 centimetres across...T4 refers to inflamatory breast cancer....Tis means DCIS(ductal carcinoma in situ...The tumors are all breast cancer tumors as the study has to do with breast cancer.|participants|Number|2|2.0||||||
3897353|NCT01498458|3722056|B1|T3||T status|T status describes the size of the original (primary) tumor and whether it has invaded nearby tissue,,,T1 – The tumour is 2 centimetres (cm) across or less...T2 – The tumour is more than 2 centimetres, but no more than 5 centimetres across...T3 – The tumour is bigger than 5 centimetres across...T4 refers to inflamatory breast cancer....Tis means DCIS(ductal carcinoma in situ...The tumors are all breast cancer tumors as the study has to do with breast cancer.|participants|Number|0|0.0||||||
3897354|NCT01498458|3722056|B1|T2||T status|T status describes the size of the original (primary) tumor and whether it has invaded nearby tissue,,,T1 – The tumour is 2 centimetres (cm) across or less...T2 – The tumour is more than 2 centimetres, but no more than 5 centimetres across...T3 – The tumour is bigger than 5 centimetres across...T4 refers to inflamatory breast cancer....Tis means DCIS(ductal carcinoma in situ...The tumors are all breast cancer tumors as the study has to do with breast cancer.|participants|Number|3|3.0||||||
3897355|NCT01498458|3722056|B1|T1||T status|T status describes the size of the original (primary) tumor and whether it has invaded nearby tissue,,,T1 – The tumour is 2 centimetres (cm) across or less...T2 – The tumour is more than 2 centimetres, but no more than 5 centimetres across...T3 – The tumour is bigger than 5 centimetres across...T4 refers to inflamatory breast cancer....Tis means DCIS(ductal carcinoma in situ...The tumors are all breast cancer tumors as the study has to do with breast cancer.|participants|Number|2|2.0||||||
3897356|NCT01498458|3722056|B1|ECOG 1||ECOG|"ECOG Status refers to the Eastern Cooperative Oncology Group scale . These scales and criteria are used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis...Grade 0 Fully active~Grade 1 restricted in physically strenuous activity~Grade 2 Ambulatory and capable of all selfcare~Grade 3 Capable of only limited selfcare~Grade 4 Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair~Grade 5 Dead"|participants|Number|2|2.0||||||
3897357|NCT01498458|3722056|B1|ECOG 0||ECOG|"ECOG Status refers to the Eastern Cooperative Oncology Group scale . These scales and criteria are used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis...Grade 0 Fully active~Grade 1 restricted in physically strenuous activity~Grade 2 Ambulatory and capable of all selfcare~Grade 3 Capable of only limited selfcare~Grade 4 Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair~Grade 5 Dead"|participants|Number|6|6.0||||||
3897358|NCT01498458|3722056|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3897359|NCT01498458|3722056|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3897360|NCT01498458|3722056|B1|Postmenopausal||Age, Customized||participants|Number|7|7.0||||||
3897361|NCT01498458|3722056|B1|premenopausal||Age, Customized||participants|Number|1|1.0||||||
3897362|NCT01498419|3722065|B5|Unclear||Moxifloxacin susceptibility|Safety Analysis Population|participants|Number|1|1.0||||||
3897363|NCT01498419|3722066|B4|Unclear||Moxifloxacin susceptibility|Safety Analysis Population|participants|Number|0|0.0||||||
3897364|NCT01498419|3722067|B3|Unclear||Moxifloxacin susceptibility|Safety Analysis Population|participants|Number|0|0.0||||||
3897365|NCT01498419|3722068|B2|Unclear||Moxifloxacin susceptibility|Safety Analysis Population|participants|Number|0|0.0||||||
3897366|NCT01498419|3722069|B1|Unclear||Moxifloxacin susceptibility|Safety Analysis Population|participants|Number|1|1.0||||||
3897367|NCT01498419|3722065|B5|No Result||Moxifloxacin susceptibility|Safety Analysis Population|participants|Number|6|6.0||||||
3897368|NCT01498419|3722066|B4|No Result||Moxifloxacin susceptibility|Safety Analysis Population|participants|Number|0|0.0||||||
3897369|NCT01498419|3722067|B3|No Result||Moxifloxacin susceptibility|Safety Analysis Population|participants|Number|1|1.0||||||
3897370|NCT01498419|3722068|B2|No Result||Moxifloxacin susceptibility|Safety Analysis Population|participants|Number|2|2.0||||||
3897371|NCT01498419|3722069|B1|No Result||Moxifloxacin susceptibility|Safety Analysis Population|participants|Number|3|3.0||||||
3897372|NCT01498419|3722065|B5|Sensitive||Moxifloxacin susceptibility|Safety Analysis Population|participants|Number|196|196.0||||||
3897373|NCT01498419|3722066|B4|Sensitive||Moxifloxacin susceptibility|Safety Analysis Population|participants|Number|25|25.0||||||
3897374|NCT01498419|3722067|B3|Sensitive||Moxifloxacin susceptibility|Safety Analysis Population|participants|Number|57|57.0||||||
3897375|NCT01498419|3722068|B2|Sensitive||Moxifloxacin susceptibility|Safety Analysis Population|participants|Number|58|58.0||||||
3897376|NCT01498419|3722069|B1|Sensitive||Moxifloxacin susceptibility|Safety Analysis Population|participants|Number|56|56.0||||||
3897377|NCT01498419|3722065|B5|Resistant||Moxifloxacin susceptibility|Safety Analysis Population|participants|Number|4|4.0||||||
3897378|NCT01498419|3722066|B4|Resistant||Moxifloxacin susceptibility|Safety Analysis Population|participants|Number|1|1.0||||||
3897380|NCT01498419|3722068|B2|Resistant||Moxifloxacin susceptibility|Safety Analysis Population|participants|Number|2|2.0||||||
3897381|NCT01498419|3722069|B1|Resistant||Moxifloxacin susceptibility|Safety Analysis Population|participants|Number|0|0.0||||||
3897382|NCT01498419|3722065|B5|Missing||Pyrazinamide susceptibility|Safety Analysis Population|participants|Number|1|1.0||||||
3897383|NCT01498419|3722066|B4|Missing||Pyrazinamide susceptibility|Safety Analysis Population|participants|Number|0|0.0||||||
3897384|NCT01498419|3722067|B3|Missing||Pyrazinamide susceptibility|Safety Analysis Population|participants|Number|0|0.0||||||
3897385|NCT01498419|3722068|B2|Missing||Pyrazinamide susceptibility|Safety Analysis Population|participants|Number|1|1.0||||||
3897386|NCT01498419|3722069|B1|Missing||Pyrazinamide susceptibility|Safety Analysis Population|participants|Number|0|0.0||||||
3897387|NCT01498419|3722065|B5|Sensitive||Pyrazinamide susceptibility|Safety Analysis Population|participants|Number|186|186.0||||||
3897388|NCT01498419|3722066|B4|Sensitive||Pyrazinamide susceptibility|Safety Analysis Population|participants|Number|9|9.0||||||
3897389|NCT01498419|3722067|B3|Sensitive||Pyrazinamide susceptibility|Safety Analysis Population|participants|Number|58|58.0||||||
3897390|NCT01498419|3722068|B2|Sensitive||Pyrazinamide susceptibility|Safety Analysis Population|participants|Number|59|59.0||||||
3897391|NCT01498419|3722069|B1|Sensitive||Pyrazinamide susceptibility|Safety Analysis Population|participants|Number|60|60.0||||||
3897392|NCT01498419|3722065|B5|Resistant||Pyrazinamide susceptibility|Safety Analysis Population|participants|Number|20|20.0||||||
3897393|NCT01498419|3722066|B4|Resistant||Pyrazinamide susceptibility|Safety Analysis Population|participants|Number|17|17.0||||||
3897394|NCT01498419|3722067|B3|Resistant||Pyrazinamide susceptibility|Safety Analysis Population|participants|Number|1|1.0||||||
3897395|NCT01498419|3722068|B2|Resistant||Pyrazinamide susceptibility|Safety Analysis Population|participants|Number|2|2.0||||||
3897396|NCT01498419|3722069|B1|Resistant||Pyrazinamide susceptibility|Safety Analysis Population|participants|Number|0|0.0||||||
3897397|NCT01498419|3722065|B5|Missing||HIV Status|Safety Analysis Population|participants|Number|2|2.0||||||
3897398|NCT01498419|3722066|B4|Missing||HIV Status|Safety Analysis Population|participants|Number|1|1.0||||||
3897399|NCT01498419|3722067|B3|Missing||HIV Status|Safety Analysis Population|participants|Number|0|0.0||||||
3897400|NCT01498419|3722068|B2|Missing||HIV Status|Safety Analysis Population|participants|Number|1|1.0||||||
3897401|NCT01498419|3722069|B1|Missing||HIV Status|Safety Analysis Population|participants|Number|0|0.0||||||
3897402|NCT01498419|3722065|B5|Indeterminate||HIV Status|Safety Analysis Population|participants|Number|1|1.0||||||
3897403|NCT01498419|3722066|B4|Indeterminate||HIV Status|Safety Analysis Population|participants|Number|0|0.0||||||
3897404|NCT01498419|3722067|B3|Indeterminate||HIV Status|Safety Analysis Population|participants|Number|1|1.0||||||
3897405|NCT01498419|3722068|B2|Indeterminate||HIV Status|Safety Analysis Population|participants|Number|0|0.0||||||
3897406|NCT01498419|3722069|B1|Indeterminate||HIV Status|Safety Analysis Population|participants|Number|0|0.0||||||
3897407|NCT01498419|3722065|B5|Negative||HIV Status|Safety Analysis Population|participants|Number|164|164.0||||||
3897408|NCT01498419|3722066|B4|Negative||HIV Status|Safety Analysis Population|participants|Number|18|18.0||||||
3897409|NCT01498419|3722067|B3|Negative||HIV Status|Safety Analysis Population|participants|Number|45|45.0||||||
3897410|NCT01498419|3722068|B2|Negative||HIV Status|Safety Analysis Population|participants|Number|53|53.0||||||
3897411|NCT01498419|3722069|B1|Negative||HIV Status|Safety Analysis Population|participants|Number|48|48.0||||||
3897412|NCT01498419|3722065|B5|Positive||HIV Status|Safety Analysis Population|participants|Number|40|40.0||||||
3897413|NCT01498419|3722066|B4|Positive||HIV Status|Safety Analysis Population|participants|Number|7|7.0||||||
3897414|NCT01498419|3722067|B3|Positive||HIV Status|Safety Analysis Population|participants|Number|13|13.0||||||
3897415|NCT01498419|3722068|B2|Positive||HIV Status|Safety Analysis Population|participants|Number|8|8.0||||||
3897416|NCT01498419|3722069|B1|Positive||HIV Status|Safety Analysis Population|participants|Number|12|12.0||||||
3897417|NCT01498419|3722065|B5|||Weight|Safety Analysis Population|kilograms|Mean|56|56.0|Standard Deviation|9.25|9.25|||
3897418|NCT01498419|3722066|B4|||Weight|Safety Analysis Population|kilograms|Mean|57.9|57.9|Standard Deviation|10.61|10.61|||
3897419|NCT01498419|3722067|B3|||Weight|Safety Analysis Population|kilograms|Mean|54.7|54.7|Standard Deviation|7.95|7.95|||
3897420|NCT01498419|3722068|B2|||Weight|Safety Analysis Population|kilograms|Mean|57.6|57.6|Standard Deviation|10.09|10.09|||
3897421|NCT01498419|3722069|B1|||Weight|Safety Analysis Population|kilograms|Mean|54.7|54.7|Standard Deviation|8.72|8.72|||
3897422|NCT01498419|3722065|B5|Mixed Ethnic||Race/Ethnicity, Customized|Safety Analysis Population|participants|Number|60|60.0||||||
3897423|NCT01498419|3722066|B4|Mixed Ethnic||Race/Ethnicity, Customized|Safety Analysis Population|participants|Number|11|11.0||||||
3897424|NCT01498419|3722067|B3|Mixed Ethnic||Race/Ethnicity, Customized|Safety Analysis Population|participants|Number|16|16.0||||||
3897425|NCT01498419|3722068|B2|Mixed Ethnic||Race/Ethnicity, Customized|Safety Analysis Population|participants|Number|16|16.0||||||
3897426|NCT01498419|3722069|B1|Mixed Ethnic||Race/Ethnicity, Customized|Safety Analysis Population|participants|Number|17|17.0||||||
3897427|NCT01498419|3722065|B5|Black||Race/Ethnicity, Customized|Safety Analysis Population|participants|Number|147|147.0||||||
3897428|NCT01498419|3722066|B4|Black||Race/Ethnicity, Customized|Safety Analysis Population|participants|Number|15|15.0||||||
3897429|NCT01498419|3722067|B3|Black||Race/Ethnicity, Customized|Safety Analysis Population|participants|Number|43|43.0||||||
3897430|NCT01498419|3722068|B2|Black||Race/Ethnicity, Customized|Safety Analysis Population|participants|Number|46|46.0||||||
3897431|NCT01498419|3722069|B1|Black||Race/Ethnicity, Customized|Safety Analysis Population|participants|Number|43|43.0||||||
3897432|NCT01498419|3722065|B5||Male|Sex: Female, Male|Safety Analysis Population|Participants|Count of Participants|135|135.0||||||
3897433|NCT01498419|3722066|B4||Male|Sex: Female, Male|Safety Analysis Population|Participants|Count of Participants|16|16.0||||||
3897434|NCT01498419|3722067|B3||Male|Sex: Female, Male|Safety Analysis Population|Participants|Count of Participants|41|41.0||||||
3897435|NCT01498419|3722068|B2||Male|Sex: Female, Male|Safety Analysis Population|Participants|Count of Participants|40|40.0||||||
3897436|NCT01498419|3722069|B1||Male|Sex: Female, Male|Safety Analysis Population|Participants|Count of Participants|38|38.0||||||
3897437|NCT01498419|3722065|B5||Female|Sex: Female, Male|Safety Analysis Population|Participants|Count of Participants|72|72.0||||||
3897438|NCT01498419|3722066|B4||Female|Sex: Female, Male|Safety Analysis Population|Participants|Count of Participants|10|10.0||||||
3897439|NCT01498419|3722067|B3||Female|Sex: Female, Male|Safety Analysis Population|Participants|Count of Participants|18|18.0||||||
3897440|NCT01498419|3722068|B2||Female|Sex: Female, Male|Safety Analysis Population|Participants|Count of Participants|22|22.0||||||
3897441|NCT01498419|3722069|B1||Female|Sex: Female, Male|Safety Analysis Population|Participants|Count of Participants|22|22.0||||||
3897442|NCT01498419|3722065|B5|||Age|Safety Analysis Population|years|Mean|30.6|30.6|Standard Deviation|9.77|9.77|||
3897443|NCT01498419|3722066|B4|||Age|Safety Analysis Population|years|Mean|32.4|32.4|Standard Deviation|9.75|9.75|||
3897444|NCT01498419|3722067|B3|||Age|Safety Analysis Population|years|Mean|30.4|30.4|Standard Deviation|9.75|9.75|||
3897445|NCT01498419|3722068|B2|||Age|Safety Analysis Population|years|Mean|30.9|30.9|Standard Deviation|8.96|8.96|||
3897446|NCT01498419|3722069|B1|||Age|Safety Analysis Population|years|Mean|29.5|29.5|Standard Deviation|10.63|10.63|||
3897447|NCT01498185|3722106|B6|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3897448|NCT01498185|3722107|B5|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3897449|NCT01498185|3722108|B4|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3897450|NCT01498185|3722109|B3|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3897451|NCT01498185|3722110|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3897452|NCT01498185|3722111|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3897453|NCT01498185|3722106|B6|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3897454|NCT01498185|3722107|B5|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3897455|NCT01498185|3722108|B4|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3897456|NCT01498185|3722109|B3|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3897457|NCT01498185|3722110|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3897458|NCT01498185|3722111|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3897459|NCT01498185|3722106|B6|Black/African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3897460|NCT01498185|3722107|B5|Black/African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3897461|NCT01498185|3722108|B4|Black/African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3897462|NCT01498185|3722109|B3|Black/African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3897463|NCT01498185|3722110|B2|Black/African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3897464|NCT01498185|3722111|B1|Black/African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3897465|NCT01498185|3722106|B6|White||Race/Ethnicity, Customized||Participants|Number|62|62.0||||||
3897466|NCT01498185|3722107|B5|White||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3897467|NCT01498185|3722108|B4|White||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3897468|NCT01498185|3722109|B3|White||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3897469|NCT01498185|3722110|B2|White||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3897470|NCT01498185|3722111|B1|White||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3897471|NCT01498185|3722106|B6|Female||Sex/Gender, Customized||Participants|Number|30|30.0||||||
3897472|NCT01498185|3722107|B5|Female||Sex/Gender, Customized||Participants|Number|7|7.0||||||
3897473|NCT01498185|3722108|B4|Female||Sex/Gender, Customized||Participants|Number|6|6.0||||||
3897474|NCT01498185|3722109|B3|Female||Sex/Gender, Customized||Participants|Number|4|4.0||||||
3897475|NCT01498185|3722110|B2|Female||Sex/Gender, Customized||Participants|Number|8|8.0||||||
3897476|NCT01498185|3722111|B1|Female||Sex/Gender, Customized||Participants|Number|5|5.0||||||
3897477|NCT01498185|3722106|B6|Male||Sex/Gender, Customized||Participants|Number|40|40.0||||||
3897478|NCT01498185|3722107|B5|Male||Sex/Gender, Customized||Participants|Number|8|8.0||||||
3897479|NCT01498185|3722108|B4|Male||Sex/Gender, Customized||Participants|Number|8|8.0||||||
3897480|NCT01498185|3722109|B3|Male||Sex/Gender, Customized||Participants|Number|11|11.0||||||
3897481|NCT01498185|3722110|B2|Male||Sex/Gender, Customized||Participants|Number|5|5.0||||||
3897482|NCT01498185|3722111|B1|Male||Sex/Gender, Customized||Participants|Number|8|8.0||||||
3897483|NCT01498185|3722106|B6|45 years and older||Age, Customized||Participants|Number|19|19.0||||||
3897484|NCT01498185|3722107|B5|45 years and older||Age, Customized||Participants|Number|5|5.0||||||
3897485|NCT01498185|3722108|B4|45 years and older||Age, Customized||Participants|Number|5|5.0||||||
3897486|NCT01498185|3722109|B3|45 years and older||Age, Customized||Participants|Number|4|4.0||||||
3897487|NCT01498185|3722110|B2|45 years and older||Age, Customized||Participants|Number|2|2.0||||||
3897488|NCT01498185|3722111|B1|45 years and older||Age, Customized||Participants|Number|3|3.0||||||
3897489|NCT01498185|3722106|B6|Younger than 45 years||Age, Customized||Participants|Number|51|51.0||||||
3897490|NCT01498185|3722107|B5|Younger than 45 years||Age, Customized||Participants|Number|10|10.0||||||
3897491|NCT01498185|3722108|B4|Younger than 45 years||Age, Customized||Participants|Number|9|9.0||||||
3897492|NCT01498185|3722109|B3|Younger than 45 years||Age, Customized||Participants|Number|11|11.0||||||
3897493|NCT01498185|3722110|B2|Younger than 45 years||Age, Customized||Participants|Number|11|11.0||||||
3897494|NCT01498185|3722111|B1|Younger than 45 years||Age, Customized||Participants|Number|10|10.0||||||
3897495|NCT01498185|3722106|B6|||Age||Years|Mean|35.3|35.3|Standard Deviation|12.86|12.86|||
3897496|NCT01498185|3722107|B5|||Age||Years|Mean|37.5|37.5|Standard Deviation|15.24|15.24|||
3897497|NCT01498185|3722108|B4|||Age||Years|Mean|34.8|34.8|Standard Deviation|14.00|14.0|||
3897498|NCT01498185|3722109|B3|||Age||Years|Mean|35.7|35.7|Standard Deviation|13.93|13.93|||
3897499|NCT01498185|3722110|B2|||Age||Years|Mean|33.7|33.7|Standard Deviation|9.11|9.11|||
3897500|NCT01498185|3722111|B1|||Age||Years|Mean|34.5|34.5|Standard Deviation|12.18|12.18|||
3897501|NCT01498120|3722155|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3897502|NCT01498120|3722155|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3897503|NCT01498120|3722155|B1|||Age||Years|Mean|15.4|15.4|Standard Deviation|1.2|1.2|||
3897504|NCT01498120|3722155|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3897505|NCT01498120|3722155|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3897506|NCT01498120|3722155|B1||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
3897507|NCT01498068|3722160|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3897508|NCT01498068|3722161|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3897509|NCT01498068|3722162|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3897510|NCT01498068|3722160|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3897511|NCT01498068|3722161|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3897512|NCT01498068|3722162|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3897513|NCT01498068|3722160|B3|> 65 years||Age, Customized||Participants|Number|1|1.0||||||
3897514|NCT01498068|3722161|B2|> 65 years||Age, Customized||Participants|Number|0|0.0||||||
3897515|NCT01498068|3722162|B1|> 65 years||Age, Customized||Participants|Number|1|1.0||||||
3897516|NCT01498068|3722160|B3|Between 45 and 65 years||Age, Customized||Participants|Number|10|10.0||||||
3897517|NCT01498068|3722161|B2|Between 45 and 65 years||Age, Customized||Participants|Number|8|8.0||||||
3897518|NCT01498068|3722162|B1|Between 45 and 65 years||Age, Customized||Participants|Number|2|2.0||||||
3897519|NCT01498068|3722160|B3|<= 45 years||Age, Customized||Participants|Number|25|25.0||||||
3897520|NCT01498068|3722161|B2|<= 45 years||Age, Customized||Participants|Number|12|12.0||||||
3897521|NCT01498068|3722162|B1|<= 45 years||Age, Customized||Participants|Number|13|13.0||||||
3897522|NCT01497938|3722179|B3|United States||Region of Enrollment||participants|Number|247|247.0||||||
3897523|NCT01497938|3722180|B2|United States||Region of Enrollment||participants|Number|126|126.0||||||
3897524|NCT01497938|3722181|B1|United States||Region of Enrollment||participants|Number|121|121.0||||||
3897525|NCT01497938|3722179|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3897526|NCT01497938|3722180|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3897527|NCT01497938|3722181|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3897528|NCT01497938|3722179|B3||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3897529|NCT01497938|3722180|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3897530|NCT01497938|3722181|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3897531|NCT01497938|3722179|B3|||Age||years|Mean|43.3|43.3|Standard Deviation|13.41|13.41|||
3897532|NCT01497938|3722180|B2|||Age||years|Mean|44.8|44.8|Standard Deviation|13.82|13.82|||
3897533|NCT01497938|3722181|B1|||Age||years|Mean|41.6|41.6|Standard Deviation|12.83|12.83|||
3897534|NCT01497938|3722179|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3897535|NCT01497938|3722180|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3897536|NCT01497938|3722181|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3897537|NCT01497938|3722179|B3||Between 18 and 65 years|Age||Participants|Count of Participants|224|224.0||||||
3897538|NCT01497938|3722180|B2||Between 18 and 65 years|Age||Participants|Count of Participants|114|114.0||||||
3897539|NCT01497938|3722181|B1||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
3897540|NCT01497938|3722179|B3||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
3897541|NCT01497938|3722180|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3897542|NCT01497938|3722181|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3897543|NCT01497899|3722190|B5||Male|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
3897544|NCT01497899|3722191|B4||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3897545|NCT01497899|3722192|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3897546|NCT01497899|3722193|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3897547|NCT01497899|3722194|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3897548|NCT01497899|3722190|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3897549|NCT01497899|3722191|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3897550|NCT01497899|3722192|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3897551|NCT01497899|3722193|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3897552|NCT01497899|3722194|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3897553|NCT01497899|3722190|B5|||Age||years|Mean|36|36.0|Standard Deviation|11.0|11.0|||
3897554|NCT01497899|3722191|B4|||Age||years|Mean|37|37.0|Standard Deviation|10.7|10.7|||
3897555|NCT01497899|3722192|B3|||Age||years|Mean|36|36.0|Standard Deviation|11.2|11.2|||
3897556|NCT01497899|3722193|B2|||Age||years|Mean|37|37.0|Standard Deviation|10.6|10.6|||
3897557|NCT01497899|3722194|B1|||Age||years|Mean|35|35.0|Standard Deviation|11.3|11.3|||
3897558|NCT01497756|3722210|B1|Nepal||Region of Enrollment||participants|Number|10|10.0||||||
3897559|NCT01497756|3722210|B1|United States||Region of Enrollment||participants|Number|0|0.0||||||
3897560|NCT01497756|3722210|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3897561|NCT01497756|3722210|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3897562|NCT01497756|3722210|B1|||Age||years|Mean|NA||Standard Deviation|NA||||DOB was not solicited. All subjects were legal adults and in emergency situations.
3897563|NCT01497756|3722210|B1||>=65 years|Age||Participants|Count of Participants|NA|||||||No subjects were 65 or older since such patients are unable to become pregnant.
3897564|NCT01497756|3722210|B1||Between 18 and 65 years|Age||Participants|Count of Participants|NA|||||||DOB was not solicited. All subjects were legal adults and in emergency situations.
3897565|NCT01497756|3722210|B1||<=18 years|Age||Participants|Count of Participants|NA|||||||DOB was not solicited. All subjects were legal adults and in emergency situations.
3897566|NCT01497665|3722215|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3897567|NCT01497665|3722215|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
3897568|NCT01497665|3722215|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3897569|NCT01497665|3722215|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3897570|NCT01497665|3722215|B1|||Age||years|Mean|57.2|57.2|Standard Deviation|5.91|5.91|||
3897571|NCT01497613|3722223|B3|United States||Region of Enrollment||participants|Number|150|150.0||||||
3897572|NCT01497613|3722224|B2|United States||Region of Enrollment||participants|Number|150|150.0||||||
3897573|NCT01497613|3722225|B1|United States||Region of Enrollment||participants|Number|150|150.0||||||
3897574|NCT01497613|3722223|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3897575|NCT01497613|3722224|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3897576|NCT01497613|3722225|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3897577|NCT01497613|3722223|B3||Female|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
3897578|NCT01497613|3722224|B2||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3897579|NCT01497613|3722225|B1||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3897580|NCT01497613|3722223|B3|||Age||years|Mean|76.15|76.15|Standard Deviation|7.4|7.4|||
3897581|NCT01497613|3722224|B2|||Age||years|Mean|76.97|76.97|Standard Deviation|7.3|7.3|||
3897582|NCT01497613|3722225|B1|||Age||years|Mean|75.34|75.34|Standard Deviation|7.4|7.4|||
3897583|NCT01497613|3722223|B3||>=65 years|Age||Participants|Count of Participants|300|300.0||||||
3897584|NCT01497613|3722224|B2||>=65 years|Age||Participants|Count of Participants|150|150.0||||||
3897585|NCT01497613|3722225|B1||>=65 years|Age||Participants|Count of Participants|150|150.0||||||
3897586|NCT01497613|3722223|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3897587|NCT01497613|3722224|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3897588|NCT01497613|3722225|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3897589|NCT01497613|3722223|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3897590|NCT01497613|3722224|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3897591|NCT01497613|3722225|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3897592|NCT01497366|3722262|B3|Missing||Cirrhosis||participants|Number|5|5.0||||||
3897593|NCT01497366|3722263|B2|Missing||Cirrhosis||participants|Number|4|4.0||||||
3897594|NCT01497366|3722264|B1|Missing||Cirrhosis||participants|Number|1|1.0||||||
3897595|NCT01497366|3722262|B3|Yes||Cirrhosis||participants|Number|100|100.0||||||
3897596|NCT01497366|3722263|B2|Yes||Cirrhosis||participants|Number|50|50.0||||||
3897597|NCT01497366|3722264|B1|Yes||Cirrhosis||participants|Number|50|50.0||||||
3897598|NCT01497366|3722262|B3|No||Cirrhosis||participants|Number|394|394.0||||||
3897599|NCT01497366|3722263|B2|No||Cirrhosis||participants|Number|189|189.0||||||
3897600|NCT01497366|3722264|B1|No||Cirrhosis||participants|Number|205|205.0||||||
3897601|NCT01497366|3722262|B3|Missing||IL28b genotype||participants|Number|3|3.0||||||
3897602|NCT01497366|3722263|B2|Missing||IL28b genotype||participants|Number|1|1.0||||||
3897603|NCT01497366|3722264|B1|Missing||IL28b genotype||participants|Number|2|2.0||||||
3897604|NCT01497366|3722262|B3|TT||IL28b genotype||participants|Number|63|63.0||||||
3897605|NCT01497366|3722263|B2|TT||IL28b genotype||participants|Number|38|38.0||||||
3897606|NCT01497366|3722264|B1|TT||IL28b genotype||participants|Number|25|25.0||||||
3897607|NCT01497366|3722262|B3|CT||IL28b genotype||participants|Number|219|219.0||||||
3897608|NCT01497366|3722263|B2|CT||IL28b genotype||participants|Number|98|98.0||||||
3897609|NCT01497366|3722264|B1|CT||IL28b genotype||participants|Number|121|121.0||||||
3897610|NCT01497366|3722262|B3|CC||IL28b genotype||participants|Number|214|214.0||||||
3897611|NCT01497366|3722263|B2|CC||IL28b genotype||participants|Number|106|106.0||||||
3897612|NCT01497366|3722264|B1|CC||IL28b genotype||participants|Number|108|108.0||||||
3897613|NCT01497366|3722262|B3|≥ 6 log10 IU/mL||Baseline HCV RNA Category||participants|Number|285|285.0||||||
3897614|NCT01497366|3722263|B2|≥ 6 log10 IU/mL||Baseline HCV RNA Category||participants|Number|137|137.0||||||
3897615|NCT01497366|3722264|B1|≥ 6 log10 IU/mL||Baseline HCV RNA Category||participants|Number|148|148.0||||||
3897616|NCT01497366|3722262|B3|< 6 log10 IU/mL||Baseline HCV RNA Category||participants|Number|214|214.0||||||
3897617|NCT01497366|3722263|B2|< 6 log10 IU/mL||Baseline HCV RNA Category||participants|Number|106|106.0||||||
3897618|NCT01497366|3722264|B1|< 6 log10 IU/mL||Baseline HCV RNA Category||participants|Number|108|108.0||||||
3897619|NCT01497366|3722262|B3|||Baseline HCV RNA||log10 IU/mL|Mean|6.0|6.0|Standard Deviation|0.80|0.8|||
3897620|NCT01497366|3722263|B2|||Baseline HCV RNA||log10 IU/mL|Mean|6.0|6.0|Standard Deviation|0.78|0.78|||
3897621|NCT01497366|3722264|B1|||Baseline HCV RNA||log10 IU/mL|Mean|6.0|6.0|Standard Deviation|0.82|0.82|||
3897622|NCT01497366|3722262|B3|Genotype 3||Hepatitis C Virus (HCV) genotype||participants|Number|359|359.0||||||
3897623|NCT01497366|3722263|B2|Genotype 3||Hepatitis C Virus (HCV) genotype||participants|Number|176|176.0||||||
3897624|NCT01497366|3722264|B1|Genotype 3||Hepatitis C Virus (HCV) genotype||participants|Number|183|183.0||||||
3897625|NCT01497366|3722262|B3|Genotype 2||Hepatitis C Virus (HCV) genotype||participants|Number|137|137.0||||||
3897626|NCT01497366|3722263|B2|Genotype 2||Hepatitis C Virus (HCV) genotype||participants|Number|67|67.0||||||
3897627|NCT01497366|3722264|B1|Genotype 2||Hepatitis C Virus (HCV) genotype||participants|Number|70|70.0||||||
3897628|NCT01497366|3722262|B3|Genotype 1||Hepatitis C Virus (HCV) genotype||participants|Number|3|3.0||||||
3897629|NCT01497366|3722263|B2|Genotype 1||Hepatitis C Virus (HCV) genotype||participants|Number|0|0.0||||||
3897630|NCT01497366|3722264|B1|Genotype 1||Hepatitis C Virus (HCV) genotype||participants|Number|3|3.0||||||
3897631|NCT01497366|3722262|B3|Sweden||Region of Enrollment||participants|Number|8|8.0||||||
3897632|NCT01497366|3722263|B2|Sweden||Region of Enrollment||participants|Number|4|4.0||||||
3897633|NCT01497366|3722264|B1|Sweden||Region of Enrollment||participants|Number|4|4.0||||||
3897634|NCT01497366|3722262|B3|New Zealand||Region of Enrollment||participants|Number|59|59.0||||||
3897635|NCT01497366|3722263|B2|New Zealand||Region of Enrollment||participants|Number|30|30.0||||||
3897636|NCT01497366|3722264|B1|New Zealand||Region of Enrollment||participants|Number|29|29.0||||||
3897637|NCT01497366|3722262|B3|Italy||Region of Enrollment||participants|Number|12|12.0||||||
3897638|NCT01497366|3722263|B2|Italy||Region of Enrollment||participants|Number|4|4.0||||||
3897639|NCT01497366|3722264|B1|Italy||Region of Enrollment||participants|Number|8|8.0||||||
3897640|NCT01497366|3722262|B3|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
3897641|NCT01497366|3722263|B2|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
3897642|NCT01497366|3722264|B1|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
3897643|NCT01497366|3722262|B3|Australia||Region of Enrollment||participants|Number|61|61.0||||||
3897644|NCT01497366|3722263|B2|Australia||Region of Enrollment||participants|Number|29|29.0||||||
3897645|NCT01497366|3722264|B1|Australia||Region of Enrollment||participants|Number|32|32.0||||||
3897646|NCT01497366|3722262|B3|Canada||Region of Enrollment||participants|Number|39|39.0||||||
3897647|NCT01497366|3722263|B2|Canada||Region of Enrollment||participants|Number|24|24.0||||||
3897648|NCT01497366|3722264|B1|Canada||Region of Enrollment||participants|Number|15|15.0||||||
3897649|NCT01497366|3722262|B3|United States||Region of Enrollment||participants|Number|316|316.0||||||
3897650|NCT01497366|3722263|B2|United States||Region of Enrollment||participants|Number|151|151.0||||||
3897651|NCT01497366|3722264|B1|United States||Region of Enrollment||participants|Number|165|165.0||||||
3897652|NCT01497366|3722262|B3|South American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3897653|NCT01497366|3722263|B2|South American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3897654|NCT01497366|3722264|B1|South American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3897655|NCT01497366|3722262|B3|Black and White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3897656|NCT01497366|3722263|B2|Black and White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3897657|NCT01497366|3722264|B1|Black and White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3897658|NCT01497366|3722262|B3|Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3897659|NCT01497366|3722263|B2|Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3897660|NCT01497366|3722264|B1|Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3897661|NCT01497366|3722262|B3|American Indian/Alaska Native/First Nations||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3897662|NCT01497366|3722263|B2|American Indian/Alaska Native/First Nations||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3897663|NCT01497366|3722264|B1|American Indian/Alaska Native/First Nations||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3897664|NCT01497366|3722262|B3|Asian||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3897665|NCT01497366|3722263|B2|Asian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3897666|NCT01497366|3722264|B1|Asian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3897667|NCT01497366|3722262|B3|White||Race/Ethnicity, Customized||participants|Number|435|435.0||||||
3897668|NCT01497366|3722263|B2|White||Race/Ethnicity, Customized||participants|Number|212|212.0||||||
3897669|NCT01497366|3722264|B1|White||Race/Ethnicity, Customized||participants|Number|223|223.0||||||
3897670|NCT01497366|3722262|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3897671|NCT01497366|3722263|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3897672|NCT01497366|3722264|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3897673|NCT01497366|3722262|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897674|NCT01497366|3722263|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897675|NCT01497366|3722264|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897676|NCT01497366|3722262|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|427|427.0||||||
3897677|NCT01497366|3722263|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|212|212.0||||||
3897678|NCT01497366|3722264|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|215|215.0||||||
3897740|NCT01497171|3722324|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3897679|NCT01497366|3722262|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3897680|NCT01497366|3722263|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3897681|NCT01497366|3722264|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3897682|NCT01497366|3722262|B3||Male|Sex: Female, Male||Participants|Count of Participants|327|327.0||||||
3897683|NCT01497366|3722263|B2||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3897684|NCT01497366|3722264|B1||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3897685|NCT01497366|3722262|B3||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3897686|NCT01497366|3722263|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3897687|NCT01497366|3722264|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3897688|NCT01497366|3722262|B3|||Age||years|Mean|48|48.0|Standard Deviation|11.0|11.0|||
3897689|NCT01497366|3722263|B2|||Age||years|Mean|48|48.0|Standard Deviation|11.4|11.4|||
3897690|NCT01497366|3722264|B1|||Age||years|Mean|48|48.0|Standard Deviation|10.8|10.8|||
3897691|NCT01497275|3722283|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3897692|NCT01497275|3722283|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897693|NCT01497275|3722283|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897694|NCT01497275|3722283|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3897695|NCT01497275|3722283|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897696|NCT01497275|3722283|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897697|NCT01497275|3722283|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897698|NCT01497275|3722283|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897699|NCT01497275|3722283|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897700|NCT01497275|3722283|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3897701|NCT01497275|3722283|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897702|NCT01497275|3722283|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3897703|NCT01497275|3722283|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3897704|NCT01497275|3722283|B1|60-69 Years||Age, Customized||participants|Number|3|3.0||||||
3897705|NCT01497275|3722283|B1|50-59 Years||Age, Customized||participants|Number|1|1.0||||||
3897706|NCT01497275|3722283|B1|18-49 Years||Age, Customized||participants|Number|1|1.0||||||
3897707|NCT01497262|3722290|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3897708|NCT01497262|3722290|B1||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3897709|NCT01497262|3722290|B1|>65 years||Age, Customized||Participants|Number|0|0.0||||||
3897710|NCT01497262|3722290|B1|56-65 years||Age, Customized||Participants|Number|8|8.0||||||
3897711|NCT01497262|3722290|B1|41-55 years||Age, Customized||Participants|Number|47|47.0||||||
3897712|NCT01497262|3722290|B1|31-40 years||Age, Customized||Participants|Number|60|60.0||||||
3897713|NCT01497262|3722290|B1|18-30 years||Age, Customized||Participants|Number|47|47.0||||||
3897714|NCT01497262|3722290|B1|<18 years||Age, Customized||Participants|Number|0|0.0||||||
3897715|NCT01497262|3722290|B1|||Age||Years|Mean|37.3|37.3|Standard Deviation|9.67|9.67|||
3897716|NCT01497197|3722295|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3897717|NCT01497197|3722296|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3897718|NCT01497197|3722297|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3897719|NCT01497197|3722295|B3||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3897720|NCT01497197|3722296|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3897721|NCT01497197|3722297|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3897722|NCT01497197|3722295|B3|||Age||years|Mean|37.9|37.9|Standard Deviation|1.65|1.65|||
3897723|NCT01497197|3722296|B2|||Age||years|Mean|38|38.0|Standard Deviation|1.7|1.7|||
3897724|NCT01497197|3722297|B1|||Age||years|Mean|37.8|37.8|Standard Deviation|1.6|1.6|||
3897725|NCT01497171|3722324|B3|Germany||Region of Enrollment||participants|Number|5|5.0||||||
3897726|NCT01497171|3722325|B2|Germany||Region of Enrollment||participants|Number|3|3.0||||||
3897727|NCT01497171|3722326|B1|Germany||Region of Enrollment||participants|Number|2|2.0||||||
3897728|NCT01497171|3722324|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3897729|NCT01497171|3722325|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3897730|NCT01497171|3722326|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3897731|NCT01497171|3722324|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3897732|NCT01497171|3722325|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3897733|NCT01497171|3722326|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3897734|NCT01497171|3722324|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3897735|NCT01497171|3722325|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3897736|NCT01497171|3722326|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3897737|NCT01497171|3722324|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3897738|NCT01497171|3722325|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3897739|NCT01497171|3722326|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3897741|NCT01497171|3722325|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3897742|NCT01497171|3722326|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3897743|NCT01496846|3722333|B7|United States||Region of Enrollment||participants|Number|199|199.0||||||
3897744|NCT01496846|3722334|B6|United States||Region of Enrollment||participants|Number|38|38.0||||||
3897745|NCT01496846|3722335|B5|United States||Region of Enrollment||participants|Number|35|35.0||||||
3897746|NCT01496846|3722336|B4|United States||Region of Enrollment||participants|Number|40|40.0||||||
3897747|NCT01496846|3722337|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
3897748|NCT01496846|3722338|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
3897749|NCT01496846|3722339|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3897750|NCT01496846|3722333|B7||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3897751|NCT01496846|3722334|B6||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3897752|NCT01496846|3722335|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3897753|NCT01496846|3722336|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3897754|NCT01496846|3722337|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3897755|NCT01496846|3722338|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3897756|NCT01496846|3722339|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3897757|NCT01496846|3722333|B7||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3897758|NCT01496846|3722334|B6||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3897759|NCT01496846|3722335|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3897760|NCT01496846|3722336|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3897761|NCT01496846|3722337|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3897762|NCT01496846|3722338|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3897763|NCT01496846|3722339|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3897764|NCT01496846|3722333|B7|||Age||years|Mean|39|39.0|Standard Deviation|15|15.0|||
3897765|NCT01496846|3722334|B6|||Age||years|Mean|40|40.0|Standard Deviation|14|14.0|||
3897766|NCT01496846|3722335|B5|||Age||years|Mean|35|35.0|Standard Deviation|14|14.0|||
3897767|NCT01496846|3722336|B4|||Age||years|Mean|38|38.0|Standard Deviation|15|15.0|||
3897768|NCT01496846|3722337|B3|||Age||years|Mean|40|40.0|Standard Deviation|14|14.0|||
3897769|NCT01496846|3722338|B2|||Age||years|Mean|50|50.0|Standard Deviation|18|18.0|||
3897770|NCT01496846|3722339|B1|||Age||years|Mean|35|35.0|Standard Deviation|11|11.0|||
3897771|NCT01496807|3722355|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
3897772|NCT01496807|3722355|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3897773|NCT01496807|3722355|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3897774|NCT01496807|3722355|B1|||Age||years|Median|65|65.0|Full Range|||38.0|83.0|
3897775|NCT01496807|3722355|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3897776|NCT01496807|3722355|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3897777|NCT01496807|3722355|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3897778|NCT01496469|3722365|B3|None||Baseline Medication|Baseline medication included angiotensin receptor blocker (ARB) and angiotensin-converting enzyme inhibitors (ACEi).|participants|Number|67|67.0||||||
3897779|NCT01496469|3722366|B2|None||Baseline Medication|Baseline medication included angiotensin receptor blocker (ARB) and angiotensin-converting enzyme inhibitors (ACEi).|participants|Number|33|33.0||||||
3897780|NCT01496469|3722367|B1|None||Baseline Medication|Baseline medication included angiotensin receptor blocker (ARB) and angiotensin-converting enzyme inhibitors (ACEi).|participants|Number|34|34.0||||||
3897781|NCT01496469|3722365|B3|ARB or ACEi||Baseline Medication|Baseline medication included angiotensin receptor blocker (ARB) and angiotensin-converting enzyme inhibitors (ACEi).|participants|Number|54|54.0||||||
3897782|NCT01496469|3722366|B2|ARB or ACEi||Baseline Medication|Baseline medication included angiotensin receptor blocker (ARB) and angiotensin-converting enzyme inhibitors (ACEi).|participants|Number|28|28.0||||||
3897783|NCT01496469|3722367|B1|ARB or ACEi||Baseline Medication|Baseline medication included angiotensin receptor blocker (ARB) and angiotensin-converting enzyme inhibitors (ACEi).|participants|Number|26|26.0||||||
3897784|NCT01496469|3722365|B3|>=8.0 mg/dL||Baseline serum uric acid (sUA)||participants|Number|34|34.0||||||
3897785|NCT01496469|3722366|B2|>=8.0 mg/dL||Baseline serum uric acid (sUA)||participants|Number|14|14.0||||||
3897786|NCT01496469|3722367|B1|>=8.0 mg/dL||Baseline serum uric acid (sUA)||participants|Number|20|20.0||||||
3897787|NCT01496469|3722365|B3|< 8.0 milligram per deciliter (mg/dL)||Baseline serum uric acid (sUA)||participants|Number|87|87.0||||||
3897788|NCT01496469|3722366|B2|< 8.0 milligram per deciliter (mg/dL)||Baseline serum uric acid (sUA)||participants|Number|47|47.0||||||
3897789|NCT01496469|3722367|B1|< 8.0 milligram per deciliter (mg/dL)||Baseline serum uric acid (sUA)||participants|Number|40|40.0||||||
3897790|NCT01496469|3722365|B3|Normal||Renal Function|Renal function categories were defined by estimated glomerular filtration rate (eGFR) calculated based on modification of diet in renal disease (MDRD) formula. Moderately impaired = eGFR 30 to 59 milliliter per minute (mL/min); mildly impaired = eGFR 60 to 89 mL/min; normal renal function=eGFR >=90 mL/min.|participants|Number|45|45.0||||||
3897791|NCT01496469|3722366|B2|Normal||Renal Function|Renal function categories were defined by estimated glomerular filtration rate (eGFR) calculated based on modification of diet in renal disease (MDRD) formula. Moderately impaired = eGFR 30 to 59 milliliter per minute (mL/min); mildly impaired = eGFR 60 to 89 mL/min; normal renal function=eGFR >=90 mL/min.|participants|Number|26|26.0||||||
3897838|NCT01496469|3722365|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|98|98.0||||||
3897792|NCT01496469|3722367|B1|Normal||Renal Function|Renal function categories were defined by estimated glomerular filtration rate (eGFR) calculated based on modification of diet in renal disease (MDRD) formula. Moderately impaired = eGFR 30 to 59 milliliter per minute (mL/min); mildly impaired = eGFR 60 to 89 mL/min; normal renal function=eGFR >=90 mL/min.|participants|Number|19|19.0||||||
3897793|NCT01496469|3722365|B3|Mildly Impaired||Renal Function|Renal function categories were defined by estimated glomerular filtration rate (eGFR) calculated based on modification of diet in renal disease (MDRD) formula. Moderately impaired = eGFR 30 to 59 milliliter per minute (mL/min); mildly impaired = eGFR 60 to 89 mL/min; normal renal function=eGFR >=90 mL/min.|participants|Number|63|63.0||||||
3897794|NCT01496469|3722366|B2|Mildly Impaired||Renal Function|Renal function categories were defined by estimated glomerular filtration rate (eGFR) calculated based on modification of diet in renal disease (MDRD) formula. Moderately impaired = eGFR 30 to 59 milliliter per minute (mL/min); mildly impaired = eGFR 60 to 89 mL/min; normal renal function=eGFR >=90 mL/min.|participants|Number|30|30.0||||||
3897795|NCT01496469|3722367|B1|Mildly Impaired||Renal Function|Renal function categories were defined by estimated glomerular filtration rate (eGFR) calculated based on modification of diet in renal disease (MDRD) formula. Moderately impaired = eGFR 30 to 59 milliliter per minute (mL/min); mildly impaired = eGFR 60 to 89 mL/min; normal renal function=eGFR >=90 mL/min.|participants|Number|33|33.0||||||
3897796|NCT01496469|3722365|B3|Moderately Impaired||Renal Function|Renal function categories were defined by estimated glomerular filtration rate (eGFR) calculated based on modification of diet in renal disease (MDRD) formula. Moderately impaired = eGFR 30 to 59 milliliter per minute (mL/min); mildly impaired = eGFR 60 to 89 mL/min; normal renal function=eGFR >=90 mL/min.|participants|Number|13|13.0||||||
3897797|NCT01496469|3722366|B2|Moderately Impaired||Renal Function|Renal function categories were defined by estimated glomerular filtration rate (eGFR) calculated based on modification of diet in renal disease (MDRD) formula. Moderately impaired = eGFR 30 to 59 milliliter per minute (mL/min); mildly impaired = eGFR 60 to 89 mL/min; normal renal function=eGFR >=90 mL/min.|participants|Number|5|5.0||||||
3897798|NCT01496469|3722367|B1|Moderately Impaired||Renal Function|Renal function categories were defined by estimated glomerular filtration rate (eGFR) calculated based on modification of diet in renal disease (MDRD) formula. Moderately impaired = eGFR 30 to 59 milliliter per minute (mL/min); mildly impaired = eGFR 60 to 89 mL/min; normal renal function=eGFR >=90 mL/min.|participants|Number|8|8.0||||||
3897799|NCT01496469|3722365|B3|Ex-Drinker||Alcohol History||participants|Number|6|6.0||||||
3897800|NCT01496469|3722366|B2|Ex-Drinker||Alcohol History||participants|Number|4|4.0||||||
3897801|NCT01496469|3722367|B1|Ex-Drinker||Alcohol History||participants|Number|2|2.0||||||
3897802|NCT01496469|3722365|B3|Current Drinker||Alcohol History||participants|Number|69|69.0||||||
3897803|NCT01496469|3722366|B2|Current Drinker||Alcohol History||participants|Number|37|37.0||||||
3897804|NCT01496469|3722367|B1|Current Drinker||Alcohol History||participants|Number|32|32.0||||||
3897805|NCT01496469|3722365|B3|Never Drunk||Alcohol History||participants|Number|46|46.0||||||
3897806|NCT01496469|3722366|B2|Never Drunk||Alcohol History||participants|Number|20|20.0||||||
3897807|NCT01496469|3722367|B1|Never Drunk||Alcohol History||participants|Number|26|26.0||||||
3897808|NCT01496469|3722365|B3|Ex-smoker||Smoking History||participants|Number|41|41.0||||||
3897809|NCT01496469|3722366|B2|Ex-smoker||Smoking History||participants|Number|21|21.0||||||
3897810|NCT01496469|3722367|B1|Ex-smoker||Smoking History||participants|Number|20|20.0||||||
3897811|NCT01496469|3722365|B3|Current smoker||Smoking History||participants|Number|18|18.0||||||
3897812|NCT01496469|3722366|B2|Current smoker||Smoking History||participants|Number|10|10.0||||||
3897813|NCT01496469|3722367|B1|Current smoker||Smoking History||participants|Number|8|8.0||||||
3897814|NCT01496469|3722365|B3|Never smoked||Smoking History||participants|Number|62|62.0||||||
3897815|NCT01496469|3722366|B2|Never smoked||Smoking History||participants|Number|30|30.0||||||
3897816|NCT01496469|3722367|B1|Never smoked||Smoking History||participants|Number|32|32.0||||||
3897817|NCT01496469|3722365|B3|>=30||BMI Category||participants|Number|80|80.0||||||
3897818|NCT01496469|3722366|B2|>=30||BMI Category||participants|Number|41|41.0||||||
3897819|NCT01496469|3722367|B1|>=30||BMI Category||participants|Number|39|39.0||||||
3897820|NCT01496469|3722365|B3|25 - <30||BMI Category||participants|Number|35|35.0||||||
3897821|NCT01496469|3722366|B2|25 - <30||BMI Category||participants|Number|17|17.0||||||
3897822|NCT01496469|3722367|B1|25 - <30||BMI Category||participants|Number|18|18.0||||||
3897823|NCT01496469|3722365|B3|18.5 - <25||BMI Category||participants|Number|6|6.0||||||
3897824|NCT01496469|3722366|B2|18.5 - <25||BMI Category||participants|Number|3|3.0||||||
3897825|NCT01496469|3722367|B1|18.5 - <25||BMI Category||participants|Number|3|3.0||||||
3897826|NCT01496469|3722365|B3|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|32.78|32.78|Standard Deviation|5.572|5.572|||
3897827|NCT01496469|3722366|B2|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|33.55|33.55|Standard Deviation|5.913|5.913|||
3897828|NCT01496469|3722367|B1|||Body Mass Index (BMI)||kilogram per square meter (kg/m^2)|Mean|31.99|31.99|Standard Deviation|5.133|5.133|||
3897829|NCT01496469|3722365|B3|||Weight||kilogram (kg)|Mean|98.14|98.14|Standard Deviation|20.460|20.46|||
3897830|NCT01496469|3722366|B2|||Weight||kilogram (kg)|Mean|100.88|100.88|Standard Deviation|19.490|19.49|||
3897831|NCT01496469|3722367|B1|||Weight||kilogram (kg)|Mean|95.35|95.35|Standard Deviation|21.199|21.199|||
3897832|NCT01496469|3722365|B3|||Height||centimeter (cm)|Mean|172.72|172.72|Standard Deviation|8.878|8.878|||
3897833|NCT01496469|3722366|B2|||Height||centimeter (cm)|Mean|173.33|173.33|Standard Deviation|9.206|9.206|||
3897834|NCT01496469|3722367|B1|||Height||centimeter (cm)|Mean|172.10|172.1|Standard Deviation|8.564|8.564|||
3897835|NCT01496469|3722365|B3|United States||Region of Enrollment||participants|Number|121|121.0||||||
3897836|NCT01496469|3722366|B2|United States||Region of Enrollment||participants|Number|61|61.0||||||
3897837|NCT01496469|3722367|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
3897839|NCT01496469|3722366|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
3897840|NCT01496469|3722367|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
3897841|NCT01496469|3722365|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3897842|NCT01496469|3722366|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3897843|NCT01496469|3722367|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3897844|NCT01496469|3722365|B3|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3897845|NCT01496469|3722366|B2|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3897846|NCT01496469|3722367|B1|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3897847|NCT01496469|3722365|B3|White||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
3897848|NCT01496469|3722366|B2|White||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
3897849|NCT01496469|3722367|B1|White||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
3897850|NCT01496469|3722365|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3897851|NCT01496469|3722366|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3897852|NCT01496469|3722367|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3897853|NCT01496469|3722365|B3|Asian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3897854|NCT01496469|3722366|B2|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3897855|NCT01496469|3722367|B1|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3897856|NCT01496469|3722365|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3897857|NCT01496469|3722366|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3897858|NCT01496469|3722367|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3897859|NCT01496469|3722365|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3897860|NCT01496469|3722366|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3897861|NCT01496469|3722367|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3897862|NCT01496469|3722365|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3897863|NCT01496469|3722366|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3897864|NCT01496469|3722367|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3897865|NCT01496469|3722365|B3|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|12|12.0||||||
3897866|NCT01496469|3722366|B2|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|4|4.0||||||
3897867|NCT01496469|3722367|B1|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|8|8.0||||||
3897868|NCT01496469|3722365|B3|45 - <65 years||Age, Customized||participants|Number|87|87.0||||||
3897869|NCT01496469|3722366|B2|45 - <65 years||Age, Customized||participants|Number|43|43.0||||||
3897870|NCT01496469|3722367|B1|45 - <65 years||Age, Customized||participants|Number|44|44.0||||||
3897871|NCT01496469|3722365|B3|Less than (<) 45 years||Age, Customized||participants|Number|22|22.0||||||
3897872|NCT01496469|3722366|B2|Less than (<) 45 years||Age, Customized||participants|Number|14|14.0||||||
3897873|NCT01496469|3722367|B1|Less than (<) 45 years||Age, Customized||participants|Number|8|8.0||||||
3897874|NCT01496469|3722365|B3|||Age||years|Mean|53.60|53.6|Standard Deviation|10.597|10.597|||
3897875|NCT01496469|3722366|B2|||Age||years|Mean|52.15|52.15|Standard Deviation|10.469|10.469|||
3897876|NCT01496469|3722367|B1|||Age||years|Mean|55.08|55.08|Standard Deviation|10.607|10.607|||
3897877|NCT01496456|3722378|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3897878|NCT01496456|3722378|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897879|NCT01496456|3722378|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897880|NCT01496456|3722378|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3897881|NCT01496456|3722378|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3897882|NCT01496456|3722378|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897883|NCT01496456|3722378|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3897884|NCT01496456|3722378|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897885|NCT01496456|3722378|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3897886|NCT01496456|3722378|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3897887|NCT01496456|3722378|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3897888|NCT01496456|3722378|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3897889|NCT01496456|3722378|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3897890|NCT01496456|3722378|B1|||Age||years|Mean|21.1|21.1|Standard Deviation|7.1|7.1|||
3897891|NCT01496456|3722378|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3897892|NCT01496456|3722378|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3897893|NCT01496456|3722378|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
3897894|NCT01496430|3722388|B4|N/A (participant is male)||Female Reproductive Status||participants|Number|63|63.0||||||
3897895|NCT01496430|3722389|B3|N/A (participant is male)||Female Reproductive Status||participants|Number|17|17.0||||||
3897896|NCT01496430|3722390|B2|N/A (participant is male)||Female Reproductive Status||participants|Number|25|25.0||||||
3897897|NCT01496430|3722391|B1|N/A (participant is male)||Female Reproductive Status||participants|Number|21|21.0||||||
3897898|NCT01496430|3722388|B4|Female of Childbearing Potential||Female Reproductive Status||participants|Number|7|7.0||||||
3897899|NCT01496430|3722389|B3|Female of Childbearing Potential||Female Reproductive Status||participants|Number|1|1.0||||||
3897900|NCT01496430|3722390|B2|Female of Childbearing Potential||Female Reproductive Status||participants|Number|2|2.0||||||
3897901|NCT01496430|3722391|B1|Female of Childbearing Potential||Female Reproductive Status||participants|Number|4|4.0||||||
3897902|NCT01496430|3722388|B4|Surgically Sterile||Female Reproductive Status||participants|Number|17|17.0||||||
3897903|NCT01496430|3722389|B3|Surgically Sterile||Female Reproductive Status||participants|Number|8|8.0||||||
3897904|NCT01496430|3722390|B2|Surgically Sterile||Female Reproductive Status||participants|Number|3|3.0||||||
3897905|NCT01496430|3722391|B1|Surgically Sterile||Female Reproductive Status||participants|Number|6|6.0||||||
3897906|NCT01496430|3722388|B4|Postmenopausal||Female Reproductive Status||participants|Number|18|18.0||||||
3897907|NCT01496430|3722389|B3|Postmenopausal||Female Reproductive Status||participants|Number|9|9.0||||||
3897908|NCT01496430|3722390|B2|Postmenopausal||Female Reproductive Status||participants|Number|5|5.0||||||
3897909|NCT01496430|3722391|B1|Postmenopausal||Female Reproductive Status||participants|Number|4|4.0||||||
3897910|NCT01496430|3722388|B4|Missing||Washout Required||participants|Number|20|20.0||||||
3897911|NCT01496430|3722389|B3|Missing||Washout Required||participants|Number|6|6.0||||||
3897912|NCT01496430|3722390|B2|Missing||Washout Required||participants|Number|9|9.0||||||
3897913|NCT01496430|3722391|B1|Missing||Washout Required||participants|Number|5|5.0||||||
3897914|NCT01496430|3722388|B4|4 Week Washout||Washout Required||participants|Number|9|9.0||||||
3897915|NCT01496430|3722389|B3|4 Week Washout||Washout Required||participants|Number|4|4.0||||||
3897916|NCT01496430|3722390|B2|4 Week Washout||Washout Required||participants|Number|2|2.0||||||
3897917|NCT01496430|3722391|B1|4 Week Washout||Washout Required||participants|Number|3|3.0||||||
3897918|NCT01496430|3722388|B4|21-Day Washout||Washout Required||participants|Number|76|76.0||||||
3897919|NCT01496430|3722389|B3|21-Day Washout||Washout Required||participants|Number|25|25.0||||||
3897920|NCT01496430|3722390|B2|21-Day Washout||Washout Required||participants|Number|24|24.0||||||
3897921|NCT01496430|3722391|B1|21-Day Washout||Washout Required||participants|Number|27|27.0||||||
3897922|NCT01496430|3722388|B4|No||Antihypertension Medication Within 28 Days||participants|Number|16|16.0||||||
3897923|NCT01496430|3722389|B3|No||Antihypertension Medication Within 28 Days||participants|Number|5|5.0||||||
3897924|NCT01496430|3722390|B2|No||Antihypertension Medication Within 28 Days||participants|Number|8|8.0||||||
3897925|NCT01496430|3722391|B1|No||Antihypertension Medication Within 28 Days||participants|Number|3|3.0||||||
3897926|NCT01496430|3722388|B4|Yes||Antihypertension Medication Within 28 Days||participants|Number|89|89.0||||||
3897927|NCT01496430|3722389|B3|Yes||Antihypertension Medication Within 28 Days||participants|Number|30|30.0||||||
3897928|NCT01496430|3722390|B2|Yes||Antihypertension Medication Within 28 Days||participants|Number|27|27.0||||||
3897929|NCT01496430|3722391|B1|Yes||Antihypertension Medication Within 28 Days||participants|Number|32|32.0||||||
3897930|NCT01496430|3722388|B4|DBP ≥ 90 mm Hg||Baseline Diastolic Blood Pressure (DBP) Hypertension Severity Category||participants|Number|37|37.0||||||
3897931|NCT01496430|3722389|B3|DBP ≥ 90 mm Hg||Baseline Diastolic Blood Pressure (DBP) Hypertension Severity Category||participants|Number|10|10.0||||||
3897932|NCT01496430|3722390|B2|DBP ≥ 90 mm Hg||Baseline Diastolic Blood Pressure (DBP) Hypertension Severity Category||participants|Number|17|17.0||||||
3897933|NCT01496430|3722391|B1|DBP ≥ 90 mm Hg||Baseline Diastolic Blood Pressure (DBP) Hypertension Severity Category||participants|Number|10|10.0||||||
3897934|NCT01496430|3722388|B4|DBP < 90 mm Hg||Baseline Diastolic Blood Pressure (DBP) Hypertension Severity Category||participants|Number|68|68.0||||||
3897935|NCT01496430|3722389|B3|DBP < 90 mm Hg||Baseline Diastolic Blood Pressure (DBP) Hypertension Severity Category||participants|Number|25|25.0||||||
3897936|NCT01496430|3722390|B2|DBP < 90 mm Hg||Baseline Diastolic Blood Pressure (DBP) Hypertension Severity Category||participants|Number|18|18.0||||||
3897937|NCT01496430|3722391|B1|DBP < 90 mm Hg||Baseline Diastolic Blood Pressure (DBP) Hypertension Severity Category||participants|Number|25|25.0||||||
3897938|NCT01496430|3722388|B4|SBP ≥ 180 mm Hg||Baseline Systolic Blood Pressure (SBP) Hypertension Severity Category||participants|Number|1|1.0||||||
3897939|NCT01496430|3722389|B3|SBP ≥ 180 mm Hg||Baseline Systolic Blood Pressure (SBP) Hypertension Severity Category||participants|Number|1|1.0||||||
3897940|NCT01496430|3722390|B2|SBP ≥ 180 mm Hg||Baseline Systolic Blood Pressure (SBP) Hypertension Severity Category||participants|Number|0|0.0||||||
3897941|NCT01496430|3722391|B1|SBP ≥ 180 mm Hg||Baseline Systolic Blood Pressure (SBP) Hypertension Severity Category||participants|Number|0|0.0||||||
3897942|NCT01496430|3722388|B4|160 ≤SBP <180 mm Hg||Baseline Systolic Blood Pressure (SBP) Hypertension Severity Category||participants|Number|11|11.0||||||
3897943|NCT01496430|3722389|B3|160 ≤SBP <180 mm Hg||Baseline Systolic Blood Pressure (SBP) Hypertension Severity Category||participants|Number|5|5.0||||||
3897944|NCT01496430|3722390|B2|160 ≤SBP <180 mm Hg||Baseline Systolic Blood Pressure (SBP) Hypertension Severity Category||participants|Number|6|6.0||||||
3897945|NCT01496430|3722391|B1|160 ≤SBP <180 mm Hg||Baseline Systolic Blood Pressure (SBP) Hypertension Severity Category||participants|Number|0|0.0||||||
3897946|NCT01496430|3722388|B4|140 ≤SBP <160 mm Hg||Baseline Systolic Blood Pressure (SBP) Hypertension Severity Category||participants|Number|58|58.0||||||
3897947|NCT01496430|3722389|B3|140 ≤SBP <160 mm Hg||Baseline Systolic Blood Pressure (SBP) Hypertension Severity Category||participants|Number|16|16.0||||||
3897948|NCT01496430|3722390|B2|140 ≤SBP <160 mm Hg||Baseline Systolic Blood Pressure (SBP) Hypertension Severity Category||participants|Number|23|23.0||||||
3897949|NCT01496430|3722391|B1|140 ≤SBP <160 mm Hg||Baseline Systolic Blood Pressure (SBP) Hypertension Severity Category||participants|Number|19|19.0||||||
3897950|NCT01496430|3722388|B4|SBP <140 mm Hg||Baseline Systolic Blood Pressure (SBP) Hypertension Severity Category||participants|Number|35|35.0||||||
3897951|NCT01496430|3722389|B3|SBP <140 mm Hg||Baseline Systolic Blood Pressure (SBP) Hypertension Severity Category||participants|Number|13|13.0||||||
3897952|NCT01496430|3722390|B2|SBP <140 mm Hg||Baseline Systolic Blood Pressure (SBP) Hypertension Severity Category||participants|Number|6|6.0||||||
3897953|NCT01496430|3722391|B1|SBP <140 mm Hg||Baseline Systolic Blood Pressure (SBP) Hypertension Severity Category||participants|Number|16|16.0||||||
3897954|NCT01496430|3722388|B4|≥90 mL/min/1.73 m^2||Estimated Glomerular Filtration Rate (eGFR) Categories||participants|Number|46|46.0||||||
3897955|NCT01496430|3722389|B3|≥90 mL/min/1.73 m^2||Estimated Glomerular Filtration Rate (eGFR) Categories||participants|Number|16|16.0||||||
3897956|NCT01496430|3722390|B2|≥90 mL/min/1.73 m^2||Estimated Glomerular Filtration Rate (eGFR) Categories||participants|Number|16|16.0||||||
3897957|NCT01496430|3722391|B1|≥90 mL/min/1.73 m^2||Estimated Glomerular Filtration Rate (eGFR) Categories||participants|Number|14|14.0||||||
3897958|NCT01496430|3722388|B4|60 - <90 mL/min/1.73 m^2||Estimated Glomerular Filtration Rate (eGFR) Categories||participants|Number|57|57.0||||||
3897959|NCT01496430|3722389|B3|60 - <90 mL/min/1.73 m^2||Estimated Glomerular Filtration Rate (eGFR) Categories||participants|Number|17|17.0||||||
3897960|NCT01496430|3722390|B2|60 - <90 mL/min/1.73 m^2||Estimated Glomerular Filtration Rate (eGFR) Categories||participants|Number|19|19.0||||||
3897961|NCT01496430|3722391|B1|60 - <90 mL/min/1.73 m^2||Estimated Glomerular Filtration Rate (eGFR) Categories||participants|Number|21|21.0||||||
3897962|NCT01496430|3722388|B4|30 - <60 mL/min/1.73 m^2||Estimated Glomerular Filtration Rate (eGFR) Categories||participants|Number|2|2.0||||||
3897963|NCT01496430|3722389|B3|30 - <60 mL/min/1.73 m^2||Estimated Glomerular Filtration Rate (eGFR) Categories||participants|Number|2|2.0||||||
3897964|NCT01496430|3722390|B2|30 - <60 mL/min/1.73 m^2||Estimated Glomerular Filtration Rate (eGFR) Categories||participants|Number|0|0.0||||||
3897965|NCT01496430|3722391|B1|30 - <60 mL/min/1.73 m^2||Estimated Glomerular Filtration Rate (eGFR) Categories||participants|Number|0|0.0||||||
3897966|NCT01496430|3722388|B4|||Estimated Glomerular Filtration Rate (eGFR)||ml/min/1.73 m^2|Mean|88.96|88.96|Standard Deviation|17.253|17.253|||
3897967|NCT01496430|3722389|B3|||Estimated Glomerular Filtration Rate (eGFR)||ml/min/1.73 m^2|Mean|89.72|89.72|Standard Deviation|18.379|18.379|||
3897968|NCT01496430|3722390|B2|||Estimated Glomerular Filtration Rate (eGFR)||ml/min/1.73 m^2|Mean|89.31|89.31|Standard Deviation|15.631|15.631|||
3897969|NCT01496430|3722391|B1|||Estimated Glomerular Filtration Rate (eGFR)||ml/min/1.73 m^2|Mean|87.86|87.86|Standard Deviation|18.068|18.068|||
3897970|NCT01496430|3722388|B4|>8.5%||Baseline Glycosylated Hemoglobin (HbA1c)||participants|Number|37|37.0||||||
3897971|NCT01496430|3722389|B3|>8.5%||Baseline Glycosylated Hemoglobin (HbA1c)||participants|Number|15|15.0||||||
3897972|NCT01496430|3722390|B2|>8.5%||Baseline Glycosylated Hemoglobin (HbA1c)||participants|Number|11|11.0||||||
3897973|NCT01496430|3722391|B1|>8.5%||Baseline Glycosylated Hemoglobin (HbA1c)||participants|Number|11|11.0||||||
3897974|NCT01496430|3722388|B4|≤8.5%||Baseline Glycosylated Hemoglobin (HbA1c)||participants|Number|68|68.0||||||
3897975|NCT01496430|3722389|B3|≤8.5%||Baseline Glycosylated Hemoglobin (HbA1c)||participants|Number|20|20.0||||||
3897976|NCT01496430|3722390|B2|≤8.5%||Baseline Glycosylated Hemoglobin (HbA1c)||participants|Number|24|24.0||||||
3897977|NCT01496430|3722391|B1|≤8.5%||Baseline Glycosylated Hemoglobin (HbA1c)||participants|Number|24|24.0||||||
3897978|NCT01496430|3722388|B4|Ex-smoker||Smoking Classification||participants|Number|28|28.0||||||
3897979|NCT01496430|3722389|B3|Ex-smoker||Smoking Classification||participants|Number|11|11.0||||||
3897980|NCT01496430|3722390|B2|Ex-smoker||Smoking Classification||participants|Number|10|10.0||||||
3897981|NCT01496430|3722391|B1|Ex-smoker||Smoking Classification||participants|Number|7|7.0||||||
3897982|NCT01496430|3722388|B4|Current smoker||Smoking Classification||participants|Number|16|16.0||||||
3897983|NCT01496430|3722389|B3|Current smoker||Smoking Classification||participants|Number|3|3.0||||||
3897984|NCT01496430|3722390|B2|Current smoker||Smoking Classification||participants|Number|2|2.0||||||
3897985|NCT01496430|3722391|B1|Current smoker||Smoking Classification||participants|Number|11|11.0||||||
3897986|NCT01496430|3722388|B4|Never smoked||Smoking Classification||participants|Number|61|61.0||||||
3897987|NCT01496430|3722389|B3|Never smoked||Smoking Classification||participants|Number|21|21.0||||||
3897988|NCT01496430|3722390|B2|Never smoked||Smoking Classification||participants|Number|23|23.0||||||
3897989|NCT01496430|3722391|B1|Never smoked||Smoking Classification||participants|Number|17|17.0||||||
3897990|NCT01496430|3722388|B4|||Body Mass Index (BMI)||kg/m^2|Mean|32.67|32.67|Standard Deviation|6.255|6.255|||
3897991|NCT01496430|3722389|B3|||Body Mass Index (BMI)||kg/m^2|Mean|32.94|32.94|Standard Deviation|7.339|7.339|||
3897992|NCT01496430|3722390|B2|||Body Mass Index (BMI)||kg/m^2|Mean|32.58|32.58|Standard Deviation|5.475|5.475|||
3897993|NCT01496430|3722391|B1|||Body Mass Index (BMI)||kg/m^2|Mean|32.50|32.5|Standard Deviation|5.977|5.977|||
3897994|NCT01496430|3722388|B4|||Weight||kg|Mean|93.43|93.43|Standard Deviation|21.012|21.012|||
3897995|NCT01496430|3722389|B3|||Weight||kg|Mean|92.33|92.33|Standard Deviation|24.027|24.027|||
3897996|NCT01496430|3722390|B2|||Weight||kg|Mean|94.56|94.56|Standard Deviation|20.084|20.084|||
3897997|NCT01496430|3722391|B1|||Weight||kg|Mean|93.41|93.41|Standard Deviation|19.165|19.165|||
3897998|NCT01496430|3722388|B4|||Height||cm|Mean|168.8|168.8|Standard Deviation|10.56|10.56|||
3897999|NCT01496430|3722389|B3|||Height||cm|Mean|167.0|167.0|Standard Deviation|12.30|12.3|||
3898000|NCT01496430|3722390|B2|||Height||cm|Mean|169.8|169.8|Standard Deviation|9.41|9.41|||
3898001|NCT01496430|3722391|B1|||Height||cm|Mean|169.4|169.4|Standard Deviation|9.81|9.81|||
3898002|NCT01496430|3722388|B4|United States||Region of Enrollment||participants|Number|105|105.0||||||
3898003|NCT01496430|3722389|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
3898004|NCT01496430|3722390|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
3898005|NCT01496430|3722391|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3898006|NCT01496430|3722388|B4|White||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
3898007|NCT01496430|3722389|B3|White||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3898008|NCT01496430|3722390|B2|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3898009|NCT01496430|3722391|B1|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3898010|NCT01496430|3722388|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3898011|NCT01496430|3722389|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3898012|NCT01496430|3722390|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3898013|NCT01496430|3722391|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3898014|NCT01496430|3722388|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3898015|NCT01496430|3722389|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3898016|NCT01496430|3722390|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3898017|NCT01496430|3722391|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3898018|NCT01496430|3722388|B4|Asian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3898019|NCT01496430|3722389|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3898020|NCT01496430|3722390|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3898021|NCT01496430|3722391|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3898022|NCT01496430|3722388|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3898023|NCT01496430|3722389|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3898024|NCT01496430|3722390|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3898025|NCT01496430|3722391|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3898026|NCT01496430|3722388|B4|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
3898027|NCT01496430|3722389|B3|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3898028|NCT01496430|3722390|B2|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3898029|NCT01496430|3722391|B1|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3898030|NCT01496430|3722388|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
3898031|NCT01496430|3722389|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3898032|NCT01496430|3722390|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3898033|NCT01496430|3722391|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3898034|NCT01496430|3722388|B4||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3898035|NCT01496430|3722389|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3898036|NCT01496430|3722390|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3898037|NCT01496430|3722391|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3898038|NCT01496430|3722388|B4||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3898039|NCT01496430|3722389|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3898040|NCT01496430|3722390|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3898041|NCT01496430|3722391|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3898042|NCT01496430|3722388|B4|≥65 years||Age, Customized||participants|Number|13|13.0||||||
3898043|NCT01496430|3722389|B3|≥65 years||Age, Customized||participants|Number|3|3.0||||||
3898044|NCT01496430|3722390|B2|≥65 years||Age, Customized||participants|Number|3|3.0||||||
3898045|NCT01496430|3722391|B1|≥65 years||Age, Customized||participants|Number|7|7.0||||||
3898046|NCT01496430|3722388|B4|Between 45 and 64 years||Age, Customized||participants|Number|84|84.0||||||
3898047|NCT01496430|3722389|B3|Between 45 and 64 years||Age, Customized||participants|Number|30|30.0||||||
3898048|NCT01496430|3722390|B2|Between 45 and 64 years||Age, Customized||participants|Number|29|29.0||||||
3898049|NCT01496430|3722391|B1|Between 45 and 64 years||Age, Customized||participants|Number|25|25.0||||||
3898050|NCT01496430|3722388|B4|<45 years||Age, Customized||participants|Number|8|8.0||||||
3898051|NCT01496430|3722389|B3|<45 years||Age, Customized||participants|Number|2|2.0||||||
3898052|NCT01496430|3722390|B2|<45 years||Age, Customized||participants|Number|3|3.0||||||
3898053|NCT01496430|3722391|B1|<45 years||Age, Customized||participants|Number|3|3.0||||||
3898054|NCT01496430|3722388|B4|||Age||years|Mean|55.9|55.9|Standard Deviation|7.89|7.89|||
3898055|NCT01496430|3722389|B3|||Age||years|Mean|55.8|55.8|Standard Deviation|7.37|7.37|||
3898056|NCT01496430|3722390|B2|||Age||years|Mean|54.7|54.7|Standard Deviation|7.63|7.63|||
3898057|NCT01496430|3722391|B1|||Age||years|Mean|57.1|57.1|Standard Deviation|8.66|8.66|||
3898058|NCT01496352|3722467|B3|||Body Mass Index||kg/m2|Mean|29.4|29.4|Standard Deviation|3.79|3.79|||
3898059|NCT01496352|3722468|B2|||Body Mass Index||kg/m2|Mean|27.8|27.8|Standard Deviation|2.47|2.47|||
3898060|NCT01496352|3722469|B1|||Body Mass Index||kg/m2|Mean|29.8|29.8|Standard Deviation|4.00|4.0|||
3898061|NCT01496352|3722467|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3898062|NCT01496352|3722468|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3898063|NCT01496352|3722469|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3898064|NCT01496352|3722467|B3|Black/African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3898065|NCT01496352|3722468|B2|Black/African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3898066|NCT01496352|3722469|B1|Black/African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3898067|NCT01496352|3722467|B3|White||Race/Ethnicity, Customized||Participants|Number|26|26.0||||||
3898068|NCT01496352|3722468|B2|White||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3898069|NCT01496352|3722469|B1|White||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
3898070|NCT01496352|3722467|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3898071|NCT01496352|3722468|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3898072|NCT01496352|3722469|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3898073|NCT01496352|3722467|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3898074|NCT01496352|3722468|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3898075|NCT01496352|3722469|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3898076|NCT01496352|3722467|B3|||Age||years|Mean|62.0|62.0|Standard Deviation|15.04|15.04|||
3898077|NCT01496352|3722468|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|16.7|16.7|||
3898078|NCT01496352|3722469|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|14.91|14.91|||
3898079|NCT01496313|3722486|B3|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3898080|NCT01496313|3722487|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3898081|NCT01496313|3722488|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3898082|NCT01496313|3722486|B3|White||Race/Ethnicity, Customized||Participants|Number|76|76.0||||||
3898083|NCT01496313|3722487|B2|White||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
3898084|NCT01496313|3722488|B1|White||Race/Ethnicity, Customized||Participants|Number|39|39.0||||||
3898085|NCT01496313|3722486|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3898086|NCT01496313|3722487|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3898087|NCT01496313|3722488|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3898088|NCT01496313|3722486|B3|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3898089|NCT01496313|3722487|B2|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3898090|NCT01496313|3722488|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3898091|NCT01496313|3722486|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3898092|NCT01496313|3722487|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3898093|NCT01496313|3722488|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3898094|NCT01496313|3722486|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3898095|NCT01496313|3722487|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3898096|NCT01496313|3722488|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3898097|NCT01496313|3722486|B3|>=75 years||Age, Customized||Participants|Number|4|4.0||||||
3898098|NCT01496313|3722487|B2|>=75 years||Age, Customized||Participants|Number|2|2.0||||||
3898099|NCT01496313|3722488|B1|>=75 years||Age, Customized||Participants|Number|2|2.0||||||
3898100|NCT01496313|3722486|B3|>=65 to <75 years||Age, Customized||Participants|Number|17|17.0||||||
3898101|NCT01496313|3722487|B2|>=65 to <75 years||Age, Customized||Participants|Number|10|10.0||||||
3898102|NCT01496313|3722488|B1|>=65 to <75 years||Age, Customized||Participants|Number|7|7.0||||||
3898103|NCT01496313|3722486|B3|>=40 to <65 years||Age, Customized||Participants|Number|42|42.0||||||
3898104|NCT01496313|3722487|B2|>=40 to <65 years||Age, Customized||Participants|Number|20|20.0||||||
3898105|NCT01496313|3722488|B1|>=40 to <65 years||Age, Customized||Participants|Number|22|22.0||||||
3898106|NCT01496313|3722486|B3|>=18 to <40 years||Age, Customized||Participants|Number|18|18.0||||||
3898107|NCT01496313|3722487|B2|>=18 to <40 years||Age, Customized||Participants|Number|9|9.0||||||
3898108|NCT01496313|3722488|B1|>=18 to <40 years||Age, Customized||Participants|Number|9|9.0||||||
3898109|NCT01496313|3722486|B3|||Age||Years|Mean|52.5|52.5|Standard Deviation|15.24|15.24|||
3898110|NCT01496313|3722487|B2|||Age||Years|Mean|52.7|52.7|Standard Deviation|15.42|15.42|||
3898111|NCT01496313|3722488|B1|||Age||Years|Mean|52.2|52.2|Standard Deviation|15.24|15.24|||
3898112|NCT01496287|3722505|B1|United States||Region of Enrollment||participants|Number|70|70.0||||||
3898113|NCT01496287|3722505|B1|Other or Unknown||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3898114|NCT01496287|3722505|B1|White||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
3898115|NCT01496287|3722505|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3898116|NCT01496287|3722505|B1|African American or Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3898117|NCT01496287|3722505|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3898118|NCT01496287|3722505|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3898119|NCT01496287|3722505|B1|||Age||years|Mean|7.0|7.0|Standard Deviation|3.9|3.9|||
3898120|NCT01496274|3722513|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3898121|NCT01496274|3722514|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3898122|NCT01496274|3722515|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3898123|NCT01496274|3722513|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3898124|NCT01496274|3722514|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3898125|NCT01496274|3722515|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3898126|NCT01496274|3722513|B3|65 years and over||Age, Customized||participants|Number|0|0.0||||||
3898127|NCT01496274|3722514|B2|65 years and over||Age, Customized||participants|Number|0|0.0||||||
3898128|NCT01496274|3722515|B1|65 years and over||Age, Customized||participants|Number|0|0.0||||||
3898129|NCT01496274|3722513|B3|18 to 64 years||Age, Customized||participants|Number|56|56.0||||||
3898130|NCT01496274|3722514|B2|18 to 64 years||Age, Customized||participants|Number|23|23.0||||||
3898131|NCT01496274|3722515|B1|18 to 64 years||Age, Customized||participants|Number|33|33.0||||||
3898132|NCT01496274|3722513|B3|12 to 17 years||Age, Customized||participants|Number|7|7.0||||||
3898133|NCT01496274|3722514|B2|12 to 17 years||Age, Customized||participants|Number|0|0.0||||||
3898134|NCT01496274|3722515|B1|12 to 17 years||Age, Customized||participants|Number|7|7.0||||||
3898135|NCT01496274|3722513|B3|0 to 11 years||Age, Customized||participants|Number|0|0.0||||||
3898136|NCT01496274|3722514|B2|0 to 11 years||Age, Customized||participants|Number|0|0.0||||||
3898137|NCT01496274|3722515|B1|0 to 11 years||Age, Customized||participants|Number|0|0.0||||||
3898138|NCT01496248|3722548|B1|Korea, Republic of||Region of Enrollment||participants|Number|35|35.0||||||
3898139|NCT01496248|3722548|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3898140|NCT01496248|3722548|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3898141|NCT01496248|3722548|B1|||Age||years|Mean|45.1|45.1|Standard Deviation|9.5|9.5|||
3898142|NCT01496183|3722559|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
3898143|NCT01496183|3722560|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3898144|NCT01496183|3722561|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3898145|NCT01496183|3722559|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3898146|NCT01496183|3722560|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3898147|NCT01496183|3722561|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3898148|NCT01496183|3722559|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3898149|NCT01496183|3722560|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3898150|NCT01496183|3722561|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3898151|NCT01496183|3722559|B3|||Age||years|Mean|23.6|23.6|Standard Deviation|4.4|4.4|||
3898152|NCT01496183|3722560|B2|||Age||years|Mean|23.1|23.1|Standard Deviation|5.1|5.1|||
3898153|NCT01496183|3722561|B1|||Age||years|Mean|24.8|24.8|Standard Deviation|2.5|2.5|||
3898154|NCT01496157|3722592|B1|Gleason 5+3||Prostatectomy gleason score|"The Gleason score is an indication of prognosis based on prostate pathology. The total score ranges from 2 to 10 (ie: 1+1 to 5+5) with a higher score reflecting less-differentiated tumors with worse prognosis. The total score is a sum of two numbers which are based on the microscopic appearance of cells. The first number is the score based on the dominant, cell morphology (scored 1-5) and the second number is based on the highest grade of the non-dominant cell pattern (scored 1-5)."|Participants|Count of Participants|1|1.0||||||
3898155|NCT01496157|3722592|B1|Gleason 4+5||Prostatectomy gleason score|"The Gleason score is an indication of prognosis based on prostate pathology. The total score ranges from 2 to 10 (ie: 1+1 to 5+5) with a higher score reflecting less-differentiated tumors with worse prognosis. The total score is a sum of two numbers which are based on the microscopic appearance of cells. The first number is the score based on the dominant, cell morphology (scored 1-5) and the second number is based on the highest grade of the non-dominant cell pattern (scored 1-5)."|Participants|Count of Participants|3|3.0||||||
3898156|NCT01496157|3722592|B1|Gleason 4+4||Prostatectomy gleason score|"The Gleason score is an indication of prognosis based on prostate pathology. The total score ranges from 2 to 10 (ie: 1+1 to 5+5) with a higher score reflecting less-differentiated tumors with worse prognosis. The total score is a sum of two numbers which are based on the microscopic appearance of cells. The first number is the score based on the dominant, cell morphology (scored 1-5) and the second number is based on the highest grade of the non-dominant cell pattern (scored 1-5)."|Participants|Count of Participants|1|1.0||||||
3898157|NCT01496157|3722592|B1|Gleason 4+3||Prostatectomy gleason score|"The Gleason score is an indication of prognosis based on prostate pathology. The total score ranges from 2 to 10 (ie: 1+1 to 5+5) with a higher score reflecting less-differentiated tumors with worse prognosis. The total score is a sum of two numbers which are based on the microscopic appearance of cells. The first number is the score based on the dominant, cell morphology (scored 1-5) and the second number is based on the highest grade of the non-dominant cell pattern (scored 1-5)."|Participants|Count of Participants|2|2.0||||||
3898158|NCT01496157|3722592|B1|Gleason 3+4||Prostatectomy gleason score|"The Gleason score is an indication of prognosis based on prostate pathology. The total score ranges from 2 to 10 (ie: 1+1 to 5+5) with a higher score reflecting less-differentiated tumors with worse prognosis. The total score is a sum of two numbers which are based on the microscopic appearance of cells. The first number is the score based on the dominant, cell morphology (scored 1-5) and the second number is based on the highest grade of the non-dominant cell pattern (scored 1-5)."|Participants|Count of Participants|5|5.0||||||
3898159|NCT01496157|3722592|B1|Gleason 3+3||Prostatectomy gleason score|"The Gleason score is an indication of prognosis based on prostate pathology. The total score ranges from 2 to 10 (ie: 1+1 to 5+5) with a higher score reflecting less-differentiated tumors with worse prognosis. The total score is a sum of two numbers which are based on the microscopic appearance of cells. The first number is the score based on the dominant, cell morphology (scored 1-5) and the second number is based on the highest grade of the non-dominant cell pattern (scored 1-5)."|Participants|Count of Participants|1|1.0||||||
3898160|NCT01496157|3722592|B1|Gleason Score 4+4||Biopsy Gleason Score|"The Gleason score is an indication of prognosis based on prostate pathology. The total score ranges from 2 to 10 (ie: 1+1 to 5+5) with a higher score reflecting less-differentiated tumors with worse prognosis. The total score is a sum of two numbers which are based on the microscopic appearance of cells. The first number is the score based on the dominant, cell morphology (scored 1-5) and the second number is based on the highest grade of the non-dominant cell pattern (scored 1-5)."|Participants|Count of Participants|3|3.0||||||
3898210|NCT01496066|3722612|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|575|575.0||||||
3898211|NCT01496066|3722613|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|190|190.0||||||
3898269|NCT01495988|3722634|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3898161|NCT01496157|3722592|B1|Gleason Score 4+3||Biopsy Gleason Score|"The Gleason score is an indication of prognosis based on prostate pathology. The total score ranges from 2 to 10 (ie: 1+1 to 5+5) with a higher score reflecting less-differentiated tumors with worse prognosis. The total score is a sum of two numbers which are based on the microscopic appearance of cells. The first number is the score based on the dominant, cell morphology (scored 1-5) and the second number is based on the highest grade of the non-dominant cell pattern (scored 1-5)."|Participants|Count of Participants|4|4.0||||||
3898162|NCT01496157|3722592|B1|Gleason Score 3+4||Biopsy Gleason Score|"The Gleason score is an indication of prognosis based on prostate pathology. The total score ranges from 2 to 10 (ie: 1+1 to 5+5) with a higher score reflecting less-differentiated tumors with worse prognosis. The total score is a sum of two numbers which are based on the microscopic appearance of cells. The first number is the score based on the dominant, cell morphology (scored 1-5) and the second number is based on the highest grade of the non-dominant cell pattern (scored 1-5)."|Participants|Count of Participants|5|5.0||||||
3898163|NCT01496157|3722592|B1|Gleason score 3+3||Biopsy Gleason Score|"The Gleason score is an indication of prognosis based on prostate pathology. The total score ranges from 2 to 10 (ie: 1+1 to 5+5) with a higher score reflecting less-differentiated tumors with worse prognosis. The total score is a sum of two numbers which are based on the microscopic appearance of cells. The first number is the score based on the dominant, cell morphology (scored 1-5) and the second number is based on the highest grade of the non-dominant cell pattern (scored 1-5)."|Participants|Count of Participants|1|1.0||||||
3898164|NCT01496157|3722592|B1|||Prostate specific antigen (PSA)||ng/mL|Mean|8.36|8.36|Standard Deviation|3.77|3.77|||
3898165|NCT01496157|3722592|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3898166|NCT01496157|3722592|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3898167|NCT01496157|3722592|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3898168|NCT01496157|3722592|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3898169|NCT01496157|3722592|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3898170|NCT01496157|3722592|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3898171|NCT01496131|3722597|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3898172|NCT01496131|3722598|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3898173|NCT01496131|3722599|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3898174|NCT01496131|3722597|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3898175|NCT01496131|3722598|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3898176|NCT01496131|3722599|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3898177|NCT01496131|3722597|B3|||Age||years|Median|64.5|64.5|Full Range|||48.0|78.0|
3898178|NCT01496131|3722598|B2|||Age||years|Median|64|64.0|Full Range|||54.0|78.0|
3898179|NCT01496131|3722599|B1|||Age||years|Median|69.0|69.0|Full Range|||48.0|75.0|
3898180|NCT01496066|3722612|B3|||Left Eye||Eyes|Number|278|278.0||||||
3898181|NCT01496066|3722613|B2|||Left Eye||Eyes|Number|101|101.0||||||
3898182|NCT01496066|3722614|B1|||Left Eye||Eyes|Number|177|177.0||||||
3898183|NCT01496066|3722612|B3|||Right Eye||Eyes|Number|322|322.0||||||
3898184|NCT01496066|3722613|B2|||Right Eye||Eyes|Number|96|96.0||||||
3898185|NCT01496066|3722614|B1|||Right Eye||Eyes|Number|226|226.0||||||
3898186|NCT01496066|3722612|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898187|NCT01496066|3722613|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898188|NCT01496066|3722614|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898189|NCT01496066|3722612|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3898190|NCT01496066|3722613|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3898191|NCT01496066|3722614|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898192|NCT01496066|3722612|B3||White|Race (NIH/OMB)||Participants|Count of Participants|571|571.0||||||
3898193|NCT01496066|3722613|B2||White|Race (NIH/OMB)||Participants|Count of Participants|188|188.0||||||
3898194|NCT01496066|3722614|B1||White|Race (NIH/OMB)||Participants|Count of Participants|383|383.0||||||
3898195|NCT01496066|3722612|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3898196|NCT01496066|3722613|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3898197|NCT01496066|3722614|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3898198|NCT01496066|3722612|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3898199|NCT01496066|3722613|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3898200|NCT01496066|3722614|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898201|NCT01496066|3722612|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3898202|NCT01496066|3722613|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898203|NCT01496066|3722614|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3898204|NCT01496066|3722612|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3898205|NCT01496066|3722613|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898206|NCT01496066|3722614|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3898207|NCT01496066|3722612|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898208|NCT01496066|3722613|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898209|NCT01496066|3722614|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898212|NCT01496066|3722614|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|385|385.0||||||
3898213|NCT01496066|3722612|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3898214|NCT01496066|3722613|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3898215|NCT01496066|3722614|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3898216|NCT01496066|3722612|B3||Male|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
3898217|NCT01496066|3722613|B2||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3898218|NCT01496066|3722614|B1||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3898219|NCT01496066|3722612|B3||Female|Sex: Female, Male||Participants|Count of Participants|344|344.0||||||
3898220|NCT01496066|3722613|B2||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3898221|NCT01496066|3722614|B1||Female|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
3898222|NCT01496066|3722612|B3|||Age||years|Mean|66.2|66.2|Standard Deviation|7.7|7.7|||
3898223|NCT01496066|3722613|B2|||Age||years|Mean|66.6|66.6|Standard Deviation|7.2|7.2|||
3898224|NCT01496066|3722614|B1|||Age||years|Mean|65.6|65.6|Standard Deviation|7.9|7.9|||
3898225|NCT01495988|3722634|B5|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3898226|NCT01495988|3722635|B4|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3898227|NCT01495988|3722636|B3|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3898228|NCT01495988|3722637|B2|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3898229|NCT01495988|3722634|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898230|NCT01495988|3722635|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898231|NCT01495988|3722636|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898232|NCT01495988|3722637|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898233|NCT01495988|3722634|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898234|NCT01495988|3722635|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898235|NCT01495988|3722636|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898236|NCT01495988|3722637|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898237|NCT01495988|3722634|B5||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3898238|NCT01495988|3722635|B4||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3898239|NCT01495988|3722636|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3898240|NCT01495988|3722637|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3898241|NCT01495988|3722634|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898242|NCT01495988|3722635|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898243|NCT01495988|3722636|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898244|NCT01495988|3722637|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898245|NCT01495988|3722634|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898246|NCT01495988|3722635|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898247|NCT01495988|3722636|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898248|NCT01495988|3722637|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898249|NCT01495988|3722634|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898250|NCT01495988|3722635|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898251|NCT01495988|3722636|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898252|NCT01495988|3722637|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898253|NCT01495988|3722634|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898254|NCT01495988|3722635|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898255|NCT01495988|3722636|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898256|NCT01495988|3722637|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898257|NCT01495988|3722634|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898258|NCT01495988|3722635|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898259|NCT01495988|3722636|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898260|NCT01495988|3722637|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898261|NCT01495988|3722634|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3898262|NCT01495988|3722635|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3898263|NCT01495988|3722636|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3898264|NCT01495988|3722637|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3898265|NCT01495988|3722634|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3898266|NCT01495988|3722635|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3898267|NCT01495988|3722636|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898268|NCT01495988|3722637|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898270|NCT01495988|3722635|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3898271|NCT01495988|3722636|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3898272|NCT01495988|3722637|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3898273|NCT01495988|3722634|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3898274|NCT01495988|3722635|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3898275|NCT01495988|3722636|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3898276|NCT01495988|3722637|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3898277|NCT01495988|3722634|B5||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3898278|NCT01495988|3722635|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3898279|NCT01495988|3722636|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3898280|NCT01495988|3722637|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3898281|NCT01495988|3722634|B5||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3898282|NCT01495988|3722635|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3898283|NCT01495988|3722636|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3898284|NCT01495988|3722637|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3898285|NCT01495988|3722634|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3898286|NCT01495988|3722635|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3898287|NCT01495988|3722636|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3898288|NCT01495988|3722637|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3898289|NCT01495975|3722675|B3|||Average glycated albumin||%|Mean|28|28.0|Standard Deviation|8.7|8.7|||
3898290|NCT01495975|3722676|B2|||Average glycated albumin||%|Mean|26|26.0|Standard Deviation|7|7.0|||
3898291|NCT01495975|3722677|B1|||Average glycated albumin||%|Mean|30|30.0|Standard Deviation|10|10.0|||
3898292|NCT01495975|3722675|B3|||Average HbA1c||%|Mean|10.3|10.3|Standard Deviation|2.2|2.2|||
3898293|NCT01495975|3722676|B2|||Average HbA1c||%|Mean|10.5|10.5|Standard Deviation|1.9|1.9|||
3898294|NCT01495975|3722677|B1|||Average HbA1c||%|Mean|10.2|10.2|Standard Deviation|2.4|2.4|||
3898295|NCT01495975|3722675|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
3898296|NCT01495975|3722676|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3898297|NCT01495975|3722677|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3898298|NCT01495975|3722675|B3|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3898299|NCT01495975|3722676|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3898300|NCT01495975|3722677|B1|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3898301|NCT01495975|3722675|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3898302|NCT01495975|3722676|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3898303|NCT01495975|3722677|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3898304|NCT01495975|3722675|B3|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3898305|NCT01495975|3722676|B2|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3898306|NCT01495975|3722677|B1|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3898307|NCT01495975|3722675|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3898308|NCT01495975|3722676|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3898309|NCT01495975|3722677|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3898310|NCT01495975|3722675|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3898311|NCT01495975|3722676|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3898312|NCT01495975|3722677|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3898313|NCT01495975|3722675|B3|Age||Age, Customized||years|Mean|53|53.0|Standard Deviation|15|15.0|||
3898314|NCT01495975|3722676|B2|Age||Age, Customized||years|Mean|54|54.0|Standard Deviation|16|16.0|||
3898315|NCT01495975|3722677|B1|Age||Age, Customized||years|Mean|52|52.0|Standard Deviation|14|14.0|||
3898316|NCT01495923|3722684|B3|Germany||Region of Enrollment||participants|Number|11|11.0||||||
3898317|NCT01495923|3722685|B2|Germany||Region of Enrollment||participants|Number|5|5.0||||||
3898318|NCT01495923|3722686|B1|Germany||Region of Enrollment||participants|Number|6|6.0||||||
3898319|NCT01495923|3722684|B3|United States||Region of Enrollment||participants|Number|134|134.0||||||
3898320|NCT01495923|3722685|B2|United States||Region of Enrollment||participants|Number|67|67.0||||||
3898321|NCT01495923|3722686|B1|United States||Region of Enrollment||participants|Number|67|67.0||||||
3898322|NCT01495923|3722684|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3898323|NCT01495923|3722685|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3898324|NCT01495923|3722686|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3898325|NCT01495923|3722684|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3898326|NCT01495923|3722685|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3898327|NCT01495923|3722686|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3898328|NCT01495923|3722684|B3|||Age||years|Mean|42.7|42.7|Standard Deviation|13.01|13.01|||
3898329|NCT01495923|3722685|B2|||Age||years|Mean|41.7|41.7|Standard Deviation|11.9|11.9|||
3898330|NCT01495923|3722686|B1|||Age||years|Mean|43.8|43.8|Standard Deviation|14|14.0|||
3898331|NCT01495923|3722684|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3898332|NCT01495923|3722685|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3898333|NCT01495923|3722686|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3898334|NCT01495923|3722684|B3||Between 18 and 65 years|Age||Participants|Count of Participants|145|145.0||||||
3898335|NCT01495923|3722685|B2||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
3898336|NCT01495923|3722686|B1||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
3898337|NCT01495923|3722684|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3898338|NCT01495923|3722685|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3898339|NCT01495923|3722686|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3898340|NCT01495858|3722717|B4|Severe pain||Baseline Categorical Pain Rating Scale||Participants|Number|107|107.0||||||
3898341|NCT01495858|3722718|B3|Severe pain||Baseline Categorical Pain Rating Scale||Participants|Number|26|26.0||||||
3898342|NCT01495858|3722719|B2|Severe pain||Baseline Categorical Pain Rating Scale||Participants|Number|43|43.0||||||
3898343|NCT01495858|3722720|B1|Severe pain||Baseline Categorical Pain Rating Scale||Participants|Number|38|38.0||||||
3898344|NCT01495858|3722717|B4|Moderate pain||Baseline Categorical Pain Rating Scale||Participants|Number|160|160.0||||||
3898345|NCT01495858|3722718|B3|Moderate pain||Baseline Categorical Pain Rating Scale||Participants|Number|28|28.0||||||
3898346|NCT01495858|3722719|B2|Moderate pain||Baseline Categorical Pain Rating Scale||Participants|Number|63|63.0||||||
3898347|NCT01495858|3722720|B1|Moderate pain||Baseline Categorical Pain Rating Scale||Participants|Number|69|69.0||||||
3898348|NCT01495858|3722717|B4|Mild pain||Baseline Categorical Pain Rating Scale||Participants|Number|0|0.0||||||
3898349|NCT01495858|3722718|B3|Mild pain||Baseline Categorical Pain Rating Scale||Participants|Number|0|0.0||||||
3898350|NCT01495858|3722719|B2|Mild pain||Baseline Categorical Pain Rating Scale||Participants|Number|0|0.0||||||
3898351|NCT01495858|3722720|B1|Mild pain||Baseline Categorical Pain Rating Scale||Participants|Number|0|0.0||||||
3898352|NCT01495858|3722717|B4|No pain||Baseline Categorical Pain Rating Scale||Participants|Number|0|0.0||||||
3898353|NCT01495858|3722718|B3|No pain||Baseline Categorical Pain Rating Scale||Participants|Number|0|0.0||||||
3898354|NCT01495858|3722719|B2|No pain||Baseline Categorical Pain Rating Scale||Participants|Number|0|0.0||||||
3898355|NCT01495858|3722720|B1|No pain||Baseline Categorical Pain Rating Scale||Participants|Number|0|0.0||||||
3898356|NCT01495858|3722717|B4||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3898357|NCT01495858|3722718|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3898358|NCT01495858|3722719|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3898359|NCT01495858|3722720|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3898360|NCT01495858|3722717|B4||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
3898361|NCT01495858|3722718|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3898362|NCT01495858|3722719|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3898363|NCT01495858|3722720|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3898364|NCT01495858|3722717|B4|||Age||Years|Mean|21.2|21.2|Standard Deviation|5.25|5.25|||
3898365|NCT01495858|3722718|B3|||Age||Years|Mean|20.8|20.8|Standard Deviation|4.64|4.64|||
3898366|NCT01495858|3722719|B2|||Age||Years|Mean|21.3|21.3|Standard Deviation|5.27|5.27|||
3898367|NCT01495858|3722720|B1|||Age||Years|Mean|21.4|21.4|Standard Deviation|5.55|5.55|||
3898368|NCT01495793|3722802|B1|||BMI (Body Mass Index)||kg/m^2|Mean|23.388|23.388|Standard Deviation|3.133|3.133|||
3898369|NCT01495793|3722802|B1|||Weight||kg|Mean|65.70|65.7|Standard Deviation|10.72|10.72|||
3898370|NCT01495793|3722802|B1|||Height||cm|Mean|167.39|167.39|Standard Deviation|6.89|6.89|||
3898371|NCT01495793|3722802|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898372|NCT01495793|3722802|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898373|NCT01495793|3722802|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3898374|NCT01495793|3722802|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3898375|NCT01495793|3722802|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898376|NCT01495793|3722802|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898377|NCT01495793|3722802|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898378|NCT01495793|3722802|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898379|NCT01495793|3722802|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3898380|NCT01495793|3722802|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3898381|NCT01495793|3722802|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3898382|NCT01495793|3722802|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3898383|NCT01495793|3722802|B1|17 years||Age, Customized||Participants|Number|6|6.0||||||
3898384|NCT01495793|3722802|B1|16 years||Age, Customized||Participants|Number|4|4.0||||||
3898385|NCT01495793|3722802|B1|15 years||Age, Customized||Participants|Number|6|6.0||||||
3898386|NCT01495793|3722802|B1|14 years||Age, Customized||Participants|Number|6|6.0||||||
3898387|NCT01495793|3722802|B1|13 years||Age, Customized||Participants|Number|2|2.0||||||
3898388|NCT01495793|3722802|B1|||Age||years|Mean|15.3|15.3|Standard Deviation|1.3|1.3|||
3898389|NCT01495702|3722813|B3|AIDS||HIV Disease Status||participants|Number|44|44.0||||||
3898390|NCT01495702|3722814|B2|AIDS||HIV Disease Status||participants|Number|14|14.0||||||
3898391|NCT01495702|3722815|B1|AIDS||HIV Disease Status||participants|Number|30|30.0||||||
3898392|NCT01495702|3722813|B3|Symptomatic HIV Infections||HIV Disease Status||participants|Number|50|50.0||||||
3898393|NCT01495702|3722814|B2|Symptomatic HIV Infections||HIV Disease Status||participants|Number|14|14.0||||||
3898394|NCT01495702|3722815|B1|Symptomatic HIV Infections||HIV Disease Status||participants|Number|36|36.0||||||
3898395|NCT01495702|3722813|B3|Asymptomatic||HIV Disease Status||participants|Number|340|340.0||||||
3898396|NCT01495702|3722814|B2|Asymptomatic||HIV Disease Status||participants|Number|115|115.0||||||
3898397|NCT01495702|3722815|B1|Asymptomatic||HIV Disease Status||participants|Number|225|225.0||||||
3898398|NCT01495702|3722813|B3|> 500 cells/µL||CD4+ Cell Count Category||participants|Number|275|275.0||||||
3898399|NCT01495702|3722814|B2|> 500 cells/µL||CD4+ Cell Count Category||participants|Number|89|89.0||||||
3898400|NCT01495702|3722815|B1|> 500 cells/µL||CD4+ Cell Count Category||participants|Number|186|186.0||||||
3898401|NCT01495702|3722813|B3|351 to ≤ 500 cells/µL||CD4+ Cell Count Category||participants|Number|108|108.0||||||
3898402|NCT01495702|3722814|B2|351 to ≤ 500 cells/µL||CD4+ Cell Count Category||participants|Number|33|33.0||||||
3898403|NCT01495702|3722815|B1|351 to ≤ 500 cells/µL||CD4+ Cell Count Category||participants|Number|75|75.0||||||
3898404|NCT01495702|3722813|B3|201 to ≤ 350 cells/µL||CD4+ Cell Count Category||participants|Number|46|46.0||||||
3898405|NCT01495702|3722814|B2|201 to ≤ 350 cells/µL||CD4+ Cell Count Category||participants|Number|20|20.0||||||
3898406|NCT01495702|3722815|B1|201 to ≤ 350 cells/µL||CD4+ Cell Count Category||participants|Number|26|26.0||||||
3898407|NCT01495702|3722813|B3|51 to ≤ 200 cells/µL||CD4+ Cell Count Category||participants|Number|5|5.0||||||
3898408|NCT01495702|3722814|B2|51 to ≤ 200 cells/µL||CD4+ Cell Count Category||participants|Number|1|1.0||||||
3898409|NCT01495702|3722815|B1|51 to ≤ 200 cells/µL||CD4+ Cell Count Category||participants|Number|4|4.0||||||
3898410|NCT01495702|3722813|B3|≤ 50 cells/µL||CD4+ Cell Count Category||participants|Number|0|0.0||||||
3898411|NCT01495702|3722814|B2|≤ 50 cells/µL||CD4+ Cell Count Category||participants|Number|0|0.0||||||
3898412|NCT01495702|3722815|B1|≤ 50 cells/µL||CD4+ Cell Count Category||participants|Number|0|0.0||||||
3898413|NCT01495702|3722813|B3|||CD4+ Cell Count||cells/µL|Mean|588|588.0|Standard Deviation|214.9|214.9|||
3898414|NCT01495702|3722814|B2|||CD4+ Cell Count||cells/µL|Mean|593|593.0|Standard Deviation|224.6|224.6|||
3898415|NCT01495702|3722815|B1|||CD4+ Cell Count||cells/µL|Mean|586|586.0|Standard Deviation|210.3|210.3|||
3898416|NCT01495702|3722813|B3|≥ 400 copies/mL||HIV-1 RNA Category||participants|Number|2|2.0||||||
3898417|NCT01495702|3722814|B2|≥ 400 copies/mL||HIV-1 RNA Category||participants|Number|0|0.0||||||
3898418|NCT01495702|3722815|B1|≥ 400 copies/mL||HIV-1 RNA Category||participants|Number|2|2.0||||||
3898419|NCT01495702|3722813|B3|200 to < 400 copies/mL||HIV-1 RNA Category||participants|Number|0|0.0||||||
3898420|NCT01495702|3722814|B2|200 to < 400 copies/mL||HIV-1 RNA Category||participants|Number|0|0.0||||||
3898421|NCT01495702|3722815|B1|200 to < 400 copies/mL||HIV-1 RNA Category||participants|Number|0|0.0||||||
3898422|NCT01495702|3722813|B3|50 to < 200 copies/mL||HIV-1 RNA Category||participants|Number|6|6.0||||||
3898423|NCT01495702|3722814|B2|50 to < 200 copies/mL||HIV-1 RNA Category||participants|Number|2|2.0||||||
3898424|NCT01495702|3722815|B1|50 to < 200 copies/mL||HIV-1 RNA Category||participants|Number|4|4.0||||||
3898425|NCT01495702|3722813|B3|< 50 copies/mL||HIV-1 RNA Category||participants|Number|426|426.0||||||
3898426|NCT01495702|3722814|B2|< 50 copies/mL||HIV-1 RNA Category||participants|Number|141|141.0||||||
3898427|NCT01495702|3722815|B1|< 50 copies/mL||HIV-1 RNA Category||participants|Number|285|285.0||||||
3898428|NCT01495702|3722813|B3|Italy||Region of Enrollment||participants|Number|37|37.0||||||
3898429|NCT01495702|3722814|B2|Italy||Region of Enrollment||participants|Number|13|13.0||||||
3898430|NCT01495702|3722815|B1|Italy||Region of Enrollment||participants|Number|24|24.0||||||
3898431|NCT01495702|3722813|B3|United Kingdom||Region of Enrollment||participants|Number|18|18.0||||||
3898432|NCT01495702|3722814|B2|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
3898433|NCT01495702|3722815|B1|United Kingdom||Region of Enrollment||participants|Number|13|13.0||||||
3898434|NCT01495702|3722813|B3|Germany||Region of Enrollment||participants|Number|34|34.0||||||
3898435|NCT01495702|3722814|B2|Germany||Region of Enrollment||participants|Number|10|10.0||||||
3898436|NCT01495702|3722815|B1|Germany||Region of Enrollment||participants|Number|24|24.0||||||
3898437|NCT01495702|3722813|B3|Australia||Region of Enrollment||participants|Number|12|12.0||||||
3898438|NCT01495702|3722814|B2|Australia||Region of Enrollment||participants|Number|4|4.0||||||
3898439|NCT01495702|3722815|B1|Australia||Region of Enrollment||participants|Number|8|8.0||||||
3898440|NCT01495702|3722813|B3|Austria||Region of Enrollment||participants|Number|9|9.0||||||
3898441|NCT01495702|3722814|B2|Austria||Region of Enrollment||participants|Number|3|3.0||||||
3898442|NCT01495702|3722815|B1|Austria||Region of Enrollment||participants|Number|6|6.0||||||
3898443|NCT01495702|3722813|B3|Belgium||Region of Enrollment||participants|Number|21|21.0||||||
3898444|NCT01495702|3722814|B2|Belgium||Region of Enrollment||participants|Number|7|7.0||||||
3898445|NCT01495702|3722815|B1|Belgium||Region of Enrollment||participants|Number|14|14.0||||||
3898446|NCT01495702|3722813|B3|Spain||Region of Enrollment||participants|Number|40|40.0||||||
3898447|NCT01495702|3722814|B2|Spain||Region of Enrollment||participants|Number|13|13.0||||||
3898448|NCT01495702|3722815|B1|Spain||Region of Enrollment||participants|Number|27|27.0||||||
3898449|NCT01495702|3722813|B3|Canada||Region of Enrollment||participants|Number|19|19.0||||||
3898450|NCT01495702|3722814|B2|Canada||Region of Enrollment||participants|Number|6|6.0||||||
3898451|NCT01495702|3722815|B1|Canada||Region of Enrollment||participants|Number|13|13.0||||||
3898452|NCT01495702|3722813|B3|Puerto Rico||Region of Enrollment||participants|Number|6|6.0||||||
3898453|NCT01495702|3722814|B2|Puerto Rico||Region of Enrollment||participants|Number|2|2.0||||||
3898454|NCT01495702|3722815|B1|Puerto Rico||Region of Enrollment||participants|Number|4|4.0||||||
3898455|NCT01495702|3722813|B3|United States||Region of Enrollment||participants|Number|227|227.0||||||
3898456|NCT01495702|3722814|B2|United States||Region of Enrollment||participants|Number|75|75.0||||||
3898457|NCT01495702|3722815|B1|United States||Region of Enrollment||participants|Number|152|152.0||||||
3898458|NCT01495702|3722813|B3|Portugal||Region of Enrollment||participants|Number|6|6.0||||||
3898459|NCT01495702|3722814|B2|Portugal||Region of Enrollment||participants|Number|4|4.0||||||
3898460|NCT01495702|3722815|B1|Portugal||Region of Enrollment||participants|Number|2|2.0||||||
3898461|NCT01495702|3722813|B3|France||Region of Enrollment||participants|Number|5|5.0||||||
3898462|NCT01495702|3722814|B2|France||Region of Enrollment||participants|Number|1|1.0||||||
3898463|NCT01495702|3722815|B1|France||Region of Enrollment||participants|Number|4|4.0||||||
3898464|NCT01495702|3722813|B3|Not Permitted||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3898465|NCT01495702|3722814|B2|Not Permitted||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3898466|NCT01495702|3722815|B1|Not Permitted||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3898467|NCT01495702|3722813|B3|Non-Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|388|388.0||||||
3898468|NCT01495702|3722814|B2|Non-Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|127|127.0||||||
3898469|NCT01495702|3722815|B1|Non-Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|261|261.0||||||
3898470|NCT01495702|3722813|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
3898471|NCT01495702|3722814|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3898472|NCT01495702|3722815|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3898473|NCT01495702|3722813|B3|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3898474|NCT01495702|3722814|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3898475|NCT01495702|3722815|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3898476|NCT01495702|3722813|B3|White||Race/Ethnicity, Customized||participants|Number|340|340.0||||||
3898477|NCT01495702|3722814|B2|White||Race/Ethnicity, Customized||participants|Number|109|109.0||||||
3898478|NCT01495702|3722815|B1|White||Race/Ethnicity, Customized||participants|Number|231|231.0||||||
3898479|NCT01495702|3722813|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3898480|NCT01495702|3722814|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3898481|NCT01495702|3722815|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3898482|NCT01495702|3722813|B3|Black or African Heritage||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
3898483|NCT01495702|3722814|B2|Black or African Heritage||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3898484|NCT01495702|3722815|B1|Black or African Heritage||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
3898485|NCT01495702|3722813|B3|Asian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3898486|NCT01495702|3722814|B2|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3898487|NCT01495702|3722815|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3898488|NCT01495702|3722813|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3898489|NCT01495702|3722814|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3898490|NCT01495702|3722815|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3898491|NCT01495702|3722813|B3||Male|Sex: Female, Male||Participants|Count of Participants|402|402.0||||||
3898492|NCT01495702|3722814|B2||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3898493|NCT01495702|3722815|B1||Male|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
3898494|NCT01495702|3722813|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3898495|NCT01495702|3722814|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3898496|NCT01495702|3722815|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3898497|NCT01495702|3722813|B3|≥ 50 years||Age, Customized||participants|Number|96|96.0||||||
3898498|NCT01495702|3722814|B2|≥ 50 years||Age, Customized||participants|Number|25|25.0||||||
3898499|NCT01495702|3722815|B1|≥ 50 years||Age, Customized||participants|Number|71|71.0||||||
3898500|NCT01495702|3722813|B3|≥ 40 to < 50 years||Age, Customized||participants|Number|150|150.0||||||
3898501|NCT01495702|3722814|B2|≥ 40 to < 50 years||Age, Customized||participants|Number|44|44.0||||||
3898502|NCT01495702|3722815|B1|≥ 40 to < 50 years||Age, Customized||participants|Number|106|106.0||||||
3898503|NCT01495702|3722813|B3|< 40 years||Age, Customized||participants|Number|188|188.0||||||
3898504|NCT01495702|3722814|B2|< 40 years||Age, Customized||participants|Number|74|74.0||||||
3898505|NCT01495702|3722815|B1|< 40 years||Age, Customized||participants|Number|114|114.0||||||
3898506|NCT01495702|3722813|B3|||Age||years|Mean|41|41.0|Standard Deviation|9.7|9.7|||
3898507|NCT01495702|3722814|B2|||Age||years|Mean|40|40.0|Standard Deviation|9.7|9.7|||
3898508|NCT01495702|3722815|B1|||Age||years|Mean|42|42.0|Standard Deviation|9.6|9.6|||
3898509|NCT01495689|3722829|B3|Canada||Region of Enrollment||Participants|Count of Participants|49|49.0||||||
3898510|NCT01495689|3722830|B2|Canada||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3898511|NCT01495689|3722831|B1|Canada||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3898512|NCT01495689|3722829|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3898513|NCT01495689|3722830|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3898514|NCT01495689|3722831|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3898515|NCT01495689|3722829|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3898516|NCT01495689|3722830|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3898517|NCT01495689|3722831|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3898518|NCT01495689|3722829|B3|||Age||years|Mean|49.8|49.8|Standard Deviation|11.3|11.3|||
3898519|NCT01495689|3722830|B2|||Age||years|Mean|48.3|48.3|Standard Deviation|12.6|12.6|||
3898520|NCT01495689|3722831|B1|||Age||years|Mean|50.9|50.9|Standard Deviation|10.4|10.4|||
3898521|NCT01495689|3722829|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3898522|NCT01495689|3722830|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3898523|NCT01495689|3722831|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3898524|NCT01495689|3722829|B3||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3898525|NCT01495689|3722830|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3898526|NCT01495689|3722831|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3898527|NCT01495689|3722829|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3898528|NCT01495689|3722830|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3898529|NCT01495689|3722831|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3898530|NCT01495585|3722838|B4|African||Ethnic origin||participants|Number|1|1.0||||||
3898531|NCT01495585|3722839|B3|African||Ethnic origin||participants|Number|0|0.0||||||
3898532|NCT01495585|3722840|B2|African||Ethnic origin||participants|Number|0|0.0||||||
3898533|NCT01495585|3722841|B1|African||Ethnic origin||participants|Number|1|1.0||||||
3898534|NCT01495585|3722838|B4|White||Ethnic origin||participants|Number|7|7.0||||||
3898535|NCT01495585|3722839|B3|White||Ethnic origin||participants|Number|3|3.0||||||
3898536|NCT01495585|3722840|B2|White||Ethnic origin||participants|Number|3|3.0||||||
3898537|NCT01495585|3722841|B1|White||Ethnic origin||participants|Number|1|1.0||||||
3898538|NCT01495585|3722838|B4|Asian||Ethnic origin||participants|Number|8|8.0||||||
3898539|NCT01495585|3722839|B3|Asian||Ethnic origin||participants|Number|3|3.0||||||
3898540|NCT01495585|3722840|B2|Asian||Ethnic origin||participants|Number|3|3.0||||||
3898541|NCT01495585|3722841|B1|Asian||Ethnic origin||participants|Number|2|2.0||||||
3898542|NCT01495585|3722838|B4|no||Pre-treatment mucleoside analogues||participants|Number|11|11.0||||||
3898543|NCT01495585|3722839|B3|no||Pre-treatment mucleoside analogues||participants|Number|4|4.0||||||
3898544|NCT01495585|3722840|B2|no||Pre-treatment mucleoside analogues||participants|Number|4|4.0||||||
3898545|NCT01495585|3722841|B1|no||Pre-treatment mucleoside analogues||participants|Number|3|3.0||||||
3898546|NCT01495585|3722838|B4|yes||Pre-treatment mucleoside analogues||participants|Number|5|5.0||||||
3898547|NCT01495585|3722839|B3|yes||Pre-treatment mucleoside analogues||participants|Number|2|2.0||||||
3898548|NCT01495585|3722840|B2|yes||Pre-treatment mucleoside analogues||participants|Number|2|2.0||||||
3898549|NCT01495585|3722841|B1|yes||Pre-treatment mucleoside analogues||participants|Number|1|1.0||||||
3898550|NCT01495585|3722838|B4|||Body mass index||kg/m^2|Median|24.4|24.4|Inter-Quartile Range|||21.9|27.3|
3898551|NCT01495585|3722839|B3|||Body mass index||kg/m^2|Median|26.1|26.1|Inter-Quartile Range|||25.5|27.3|
3898552|NCT01495585|3722840|B2|||Body mass index||kg/m^2|Median|22.8|22.8|Inter-Quartile Range|||21.9|23.5|
3898553|NCT01495585|3722841|B1|||Body mass index||kg/m^2|Median|26.5|26.5|Inter-Quartile Range|||24.1|28.9|
3898554|NCT01495585|3722838|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3898555|NCT01495585|3722839|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3898556|NCT01495585|3722840|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3898557|NCT01495585|3722841|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3898558|NCT01495585|3722838|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3898559|NCT01495585|3722839|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3898560|NCT01495585|3722840|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3898561|NCT01495585|3722841|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3898562|NCT01495585|3722838|B4|||Age||years|Median|38|38.0|Inter-Quartile Range|||33.0|48.0|
3898563|NCT01495585|3722839|B3|||Age||years|Median|45|45.0|Inter-Quartile Range|||38.0|55.0|
3898564|NCT01495585|3722840|B2|||Age||years|Median|36|36.0|Inter-Quartile Range|||30.0|42.0|
3898565|NCT01495585|3722841|B1|||Age||years|Median|34|34.0|Inter-Quartile Range|||33.0|39.0|
3898566|NCT01495572|3722854|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3898567|NCT01495572|3722855|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3898568|NCT01495572|3722854|B3|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
3898569|NCT01495572|3722855|B2|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
3898570|NCT01495572|3722854|B3|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|5|5.0||||||
3898571|NCT01495572|3722855|B2|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|5|5.0||||||
3898572|NCT01495572|3722854|B3|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
3898573|NCT01495572|3722855|B2|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
3898574|NCT01495572|3722854|B3|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
3898575|NCT01495572|3722855|B2|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
3898576|NCT01495572|3722854|B3|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
3898577|NCT01495572|3722855|B2|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
3898578|NCT01495572|3722854|B3|White||Race (NIH/OMB)||participants|Number|5|5.0||||||
3898579|NCT01495572|3722855|B2|White||Race (NIH/OMB)||participants|Number|5|5.0||||||
3898580|NCT01495572|3722854|B3|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
3898581|NCT01495572|3722855|B2|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
3898582|NCT01495572|3722854|B3|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
3898583|NCT01495572|3722855|B2|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
3898584|NCT01495572|3722854|B3|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
3898585|NCT01495572|3722855|B2|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
3898586|NCT01495572|3722854|B3|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
3898587|NCT01495572|3722855|B2|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
3898588|NCT01495572|3722854|B3|Male||Gender||participants|Number|3|3.0||||||
3898589|NCT01495572|3722855|B2|Male||Gender||participants|Number|3|3.0||||||
3898590|NCT01495572|3722854|B3|Female||Gender||participants|Number|2|2.0||||||
3898591|NCT01495572|3722855|B2|Female||Gender||participants|Number|2|2.0||||||
3898592|NCT01495572|3722854|B3|>=65 years||Age||participants|Number|1|1.0||||||
3898593|NCT01495572|3722855|B2|>=65 years||Age||participants|Number|1|1.0||||||
3898594|NCT01495572|3722854|B3|Between 18 and 65 years||Age||participants|Number|4|4.0||||||
3898595|NCT01495572|3722855|B2|Between 18 and 65 years||Age||participants|Number|4|4.0||||||
3898596|NCT01495572|3722854|B3|<=18 years||Age||participants|Number|0|0.0||||||
3898597|NCT01495572|3722855|B2|<=18 years||Age||participants|Number|0|0.0||||||
3898598|NCT01495572|3722854|B3|||Age||years|Mean|48.4|48.4|Standard Deviation|10.89|10.89|||
3898599|NCT01495572|3722855|B2|||Age||years|Mean|48.4|48.4|Standard Deviation|10.89|10.89|||
3898600|NCT01495481|3722865|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3898601|NCT01495481|3722865|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3898602|NCT01495481|3722865|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3898603|NCT01495481|3722865|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3898604|NCT01495481|3722865|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3898605|NCT01495481|3722865|B1||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
3898606|NCT01495286|3722877|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3898607|NCT01495286|3722877|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3898608|NCT01495286|3722877|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3898609|NCT01495286|3722877|B1|||Age||days|Mean|1|1.0|Standard Deviation|0|0.0|||
3898610|NCT01495286|3722877|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3898611|NCT01495286|3722877|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3898612|NCT01495286|3722877|B1||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
3898613|NCT01495221|3722885|B1|Occult CNV only||Lesion Type: ( Fluroscien Angiogram and||Participants|Count of Participants|4|4.0||||||
3898614|NCT01495221|3722885|B1|Occult CNV with CSC features||Lesion Type: ( Fluroscien Angiogram and||Participants|Count of Participants|2|2.0||||||
3898615|NCT01495221|3722885|B1|Occult CNV with PCV features||Lesion Type: ( Fluroscien Angiogram and||Participants|Count of Participants|3|3.0||||||
3898616|NCT01495221|3722885|B1|||EDTRS Visual Acuity Score||Letters|Mean|63|63.0|Full Range|||35.0|79.0|
3898617|NCT01495221|3722885|B1|||First Prescription for Choroidial NeoVascularization||Months|Mean|18.5|18.5|Full Range|||4.0|40.0|
3898618|NCT01495221|3722885|B1|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3898619|NCT01495221|3722885|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3898620|NCT01495221|3722885|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3898621|NCT01495221|3722885|B1|||Age||years|Mean|74|74.0|Full Range|||60.0|85.0|
3898622|NCT01495221|3722885|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3898623|NCT01495221|3722885|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3898624|NCT01495221|3722885|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3898625|NCT01495000|3722892|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|250|250.0||||||
3898626|NCT01495000|3722893|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|126|126.0||||||
3898627|NCT01495000|3722894|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|124|124.0||||||
3898628|NCT01495000|3722892|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3898629|NCT01495000|3722893|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3898630|NCT01495000|3722894|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3898631|NCT01495000|3722892|B3||Female|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
3898632|NCT01495000|3722893|B2||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3898633|NCT01495000|3722894|B1||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3898634|NCT01495000|3722892|B3|||Age||Years|Mean|62.6|62.6|Standard Deviation|4.96|4.96|||
3898635|NCT01495000|3722893|B2|||Age||Years|Mean|62.6|62.6|Standard Deviation|4.85|4.85|||
3898636|NCT01495000|3722894|B1|||Age||Years|Mean|62.6|62.6|Standard Deviation|5.10|5.1|||
3898637|NCT01494987|3722935|B3|||Estimated glomerular filtration rate (eGFR)||mL/min/1.73m^2|Mean|82.2|82.2|Standard Deviation|19.84|19.84|||
3898638|NCT01494987|3722936|B2|||Estimated glomerular filtration rate (eGFR)||mL/min/1.73m^2|Mean|81.2|81.2|Standard Deviation|20.85|20.85|||
3898757|NCT01494610|3723001|B1|Years||Age||Years|Mean|51.1|51.1|Standard Deviation|18.19|18.19|||
3898639|NCT01494987|3722937|B1|||Estimated glomerular filtration rate (eGFR)||mL/min/1.73m^2|Mean|83.2|83.2|Standard Deviation|18.77|18.77|||
3898640|NCT01494987|3722935|B3|||Duration of Diabetes|Participants in the Safety Analysis Set with available data were analyzed (n = 215 in both groups).|years|Mean|7.0|7.0|Standard Deviation|4.99|4.99|||
3898641|NCT01494987|3722936|B2|||Duration of Diabetes|Participants in the Safety Analysis Set with available data were analyzed (n = 215 in both groups).|years|Mean|7.1|7.1|Standard Deviation|4.92|4.92|||
3898642|NCT01494987|3722937|B1|||Duration of Diabetes|Participants in the Safety Analysis Set with available data were analyzed (n = 215 in both groups).|years|Mean|7.0|7.0|Standard Deviation|5.07|5.07|||
3898643|NCT01494987|3722935|B3|||Fasting Serum Glucose||mg/dL|Mean|177.3|177.3|Standard Deviation|35.63|35.63|||
3898644|NCT01494987|3722936|B2|||Fasting Serum Glucose||mg/dL|Mean|177.4|177.4|Standard Deviation|37.03|37.03|||
3898645|NCT01494987|3722937|B1|||Fasting Serum Glucose||mg/dL|Mean|177.2|177.2|Standard Deviation|34.27|34.27|||
3898646|NCT01494987|3722935|B3|||Glycosylated hemoglobin (HbA1c)||percent HbA1c in blood|Mean|8.08|8.08|Standard Deviation|0.760|0.76|||
3898647|NCT01494987|3722936|B2|||Glycosylated hemoglobin (HbA1c)||percent HbA1c in blood|Mean|8.07|8.07|Standard Deviation|0.776|0.776|||
3898648|NCT01494987|3722937|B1|||Glycosylated hemoglobin (HbA1c)||percent HbA1c in blood|Mean|8.10|8.1|Standard Deviation|0.746|0.746|||
3898649|NCT01494987|3722935|B3|||Body Mass Index||kg/m^2|Mean|32.5|32.5|Standard Deviation|4.13|4.13|||
3898650|NCT01494987|3722936|B2|||Body Mass Index||kg/m^2|Mean|32.2|32.2|Standard Deviation|3.88|3.88|||
3898651|NCT01494987|3722937|B1|||Body Mass Index||kg/m^2|Mean|32.8|32.8|Standard Deviation|4.35|4.35|||
3898652|NCT01494987|3722935|B3|Russian Federation||Region of Enrollment||participants|Number|203|203.0||||||
3898653|NCT01494987|3722936|B2|Russian Federation||Region of Enrollment||participants|Number|104|104.0||||||
3898654|NCT01494987|3722937|B1|Russian Federation||Region of Enrollment||participants|Number|99|99.0||||||
3898655|NCT01494987|3722935|B3|South Africa||Region of Enrollment||participants|Number|7|7.0||||||
3898656|NCT01494987|3722936|B2|South Africa||Region of Enrollment||participants|Number|3|3.0||||||
3898657|NCT01494987|3722937|B1|South Africa||Region of Enrollment||participants|Number|4|4.0||||||
3898658|NCT01494987|3722935|B3|Romania||Region of Enrollment||participants|Number|20|20.0||||||
3898659|NCT01494987|3722936|B2|Romania||Region of Enrollment||participants|Number|9|9.0||||||
3898660|NCT01494987|3722937|B1|Romania||Region of Enrollment||participants|Number|11|11.0||||||
3898661|NCT01494987|3722935|B3|Ukraine||Region of Enrollment||participants|Number|53|53.0||||||
3898662|NCT01494987|3722936|B2|Ukraine||Region of Enrollment||participants|Number|27|27.0||||||
3898663|NCT01494987|3722937|B1|Ukraine||Region of Enrollment||participants|Number|26|26.0||||||
3898664|NCT01494987|3722935|B3|Poland||Region of Enrollment||participants|Number|9|9.0||||||
3898665|NCT01494987|3722936|B2|Poland||Region of Enrollment||participants|Number|4|4.0||||||
3898666|NCT01494987|3722937|B1|Poland||Region of Enrollment||participants|Number|5|5.0||||||
3898667|NCT01494987|3722935|B3|Slovakia||Region of Enrollment||participants|Number|3|3.0||||||
3898668|NCT01494987|3722936|B2|Slovakia||Region of Enrollment||participants|Number|2|2.0||||||
3898669|NCT01494987|3722937|B1|Slovakia||Region of Enrollment||participants|Number|1|1.0||||||
3898670|NCT01494987|3722935|B3|Hungary||Region of Enrollment||participants|Number|10|10.0||||||
3898671|NCT01494987|3722936|B2|Hungary||Region of Enrollment||participants|Number|6|6.0||||||
3898672|NCT01494987|3722937|B1|Hungary||Region of Enrollment||participants|Number|4|4.0||||||
3898673|NCT01494987|3722935|B3|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
3898674|NCT01494987|3722936|B2|Czech Republic||Region of Enrollment||participants|Number|0|0.0||||||
3898675|NCT01494987|3722937|B1|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
3898676|NCT01494987|3722935|B3|United States||Region of Enrollment||participants|Number|121|121.0||||||
3898677|NCT01494987|3722936|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
3898678|NCT01494987|3722937|B1|United States||Region of Enrollment||participants|Number|61|61.0||||||
3898679|NCT01494987|3722935|B3|Serbia||Region of Enrollment||participants|Number|4|4.0||||||
3898680|NCT01494987|3722936|B2|Serbia||Region of Enrollment||participants|Number|0|0.0||||||
3898681|NCT01494987|3722937|B1|Serbia||Region of Enrollment||participants|Number|4|4.0||||||
3898682|NCT01494987|3722935|B3|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3898683|NCT01494987|3722936|B2|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3898684|NCT01494987|3722937|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3898685|NCT01494987|3722935|B3|White||Race/Ethnicity, Customized||participants|Number|402|402.0||||||
3898686|NCT01494987|3722936|B2|White||Race/Ethnicity, Customized||participants|Number|204|204.0||||||
3898687|NCT01494987|3722937|B1|White||Race/Ethnicity, Customized||participants|Number|198|198.0||||||
3898688|NCT01494987|3722935|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3898689|NCT01494987|3722936|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3898690|NCT01494987|3722937|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3898691|NCT01494987|3722935|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3898692|NCT01494987|3722936|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3898693|NCT01494987|3722937|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3898694|NCT01494987|3722935|B3|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3898695|NCT01494987|3722936|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3898696|NCT01494987|3722937|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3898697|NCT01494987|3722935|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3898698|NCT01494987|3722936|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3898699|NCT01494987|3722937|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3898700|NCT01494987|3722935|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3898701|NCT01494987|3722936|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3898702|NCT01494987|3722937|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3898703|NCT01494987|3722935|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|363|363.0||||||
3898704|NCT01494987|3722936|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|182|182.0||||||
3898705|NCT01494987|3722937|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|181|181.0||||||
3898706|NCT01494987|3722935|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3898707|NCT01494987|3722936|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3898708|NCT01494987|3722937|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3898709|NCT01494987|3722935|B3||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3898710|NCT01494987|3722936|B2||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3898711|NCT01494987|3722937|B1||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3898712|NCT01494987|3722935|B3||Female|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
3898713|NCT01494987|3722936|B2||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3898714|NCT01494987|3722937|B1||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3898715|NCT01494987|3722935|B3|||Age||years|Mean|59|59.0|Standard Deviation|8.7|8.7|||
3898716|NCT01494987|3722936|B2|||Age||years|Mean|59|59.0|Standard Deviation|8.8|8.8|||
3898717|NCT01494987|3722937|B1|||Age||years|Mean|59|59.0|Standard Deviation|8.6|8.6|||
3898718|NCT01494818|3722950|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3898719|NCT01494818|3722951|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3898720|NCT01494818|3722952|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3898721|NCT01494818|3722950|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3898722|NCT01494818|3722951|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3898723|NCT01494818|3722952|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3898724|NCT01494818|3722950|B3|||Age||years|Mean|35.1|35.1|Standard Deviation|10.1|10.1|||
3898725|NCT01494818|3722951|B2|||Age||years|Mean|35.5|35.5|Standard Deviation|10.5|10.5|||
3898726|NCT01494818|3722952|B1|||Age||years|Mean|34.8|34.8|Standard Deviation|9.8|9.8|||
3898727|NCT01494753|3722973|B3|India||Region of Enrollment||participants|Number|30|30.0||||||
3898728|NCT01494753|3722974|B2|India||Region of Enrollment||participants|Number|15|15.0||||||
3898729|NCT01494753|3722975|B1|India||Region of Enrollment||participants|Number|15|15.0||||||
3898730|NCT01494753|3722973|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3898731|NCT01494753|3722974|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3898732|NCT01494753|3722975|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3898733|NCT01494753|3722973|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3898734|NCT01494753|3722974|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3898735|NCT01494753|3722975|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3898736|NCT01494753|3722973|B3|||Age||years|Mean|50.7|50.7|Standard Deviation|12.8|12.8|||
3898737|NCT01494753|3722974|B2|||Age||years|Mean|50.2|50.2|Standard Deviation|13.4|13.4|||
3898738|NCT01494753|3722975|B1|||Age||years|Mean|51.1|51.1|Standard Deviation|12.6|12.6|||
3898739|NCT01494649|3722982|B3|USA||Region of Enrollment||Participants|Number|118|118.0||||||
3898740|NCT01494649|3722983|B2|USA||Region of Enrollment||Participants|Number|59|59.0||||||
3898741|NCT01494649|3722984|B1|USA||Region of Enrollment||Participants|Number|59|59.0||||||
3898742|NCT01494649|3722982|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3898743|NCT01494649|3722983|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3898744|NCT01494649|3722984|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3898745|NCT01494649|3722982|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3898746|NCT01494649|3722983|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3898747|NCT01494649|3722984|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3898748|NCT01494649|3722982|B3|||Age||Years|Mean|36.3|36.3|Standard Deviation|10.3|10.3|||
3898749|NCT01494649|3722983|B2|||Age||Years|Mean|37.0|37.0|Standard Deviation|9.98|9.98|||
3898750|NCT01494649|3722984|B1|||Age||Years|Mean|35.7|35.7|Standard Deviation|10.65|10.65|||
3898751|NCT01494610|3723001|B1|Asian-Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3898752|NCT01494610|3723001|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3898753|NCT01494610|3723001|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3898754|NCT01494610|3723001|B1|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
3898755|NCT01494610|3723001|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3898756|NCT01494610|3723001|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3898758|NCT01494584|3723070|B1|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3898759|NCT01494584|3723070|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3898760|NCT01494584|3723070|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3898761|NCT01494584|3723070|B1|||Age||Years|Mean|14.6|14.6|Standard Deviation|1.34|1.34|||
3898762|NCT01494545|3723159|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3898763|NCT01494545|3723159|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3898764|NCT01494545|3723159|B1|||Age||years|Mean|24.8|24.8|Standard Deviation|7.6|7.6|||
3898765|NCT01494532|3723196|B7|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|325|325.0||||||
3898766|NCT01494532|3723197|B6|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
3898767|NCT01494532|3723198|B5|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|69|69.0||||||
3898768|NCT01494532|3723199|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|68|68.0||||||
3898769|NCT01494532|3723200|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|73|73.0||||||
3898770|NCT01494532|3723201|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
3898771|NCT01494532|3723202|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|70|70.0||||||
3898772|NCT01494532|3723196|B7|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3898773|NCT01494532|3723197|B6|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3898774|NCT01494532|3723198|B5|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3898775|NCT01494532|3723199|B4|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3898776|NCT01494532|3723200|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3898777|NCT01494532|3723201|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3898778|NCT01494532|3723202|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3898779|NCT01494532|3723196|B7|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3898780|NCT01494532|3723197|B6|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3898781|NCT01494532|3723198|B5|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3898782|NCT01494532|3723199|B4|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3898783|NCT01494532|3723200|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3898784|NCT01494532|3723201|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3898785|NCT01494532|3723202|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3898786|NCT01494532|3723196|B7|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
3898787|NCT01494532|3723197|B6|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3898788|NCT01494532|3723198|B5|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3898789|NCT01494532|3723199|B4|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3898790|NCT01494532|3723200|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3898791|NCT01494532|3723201|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3898792|NCT01494532|3723202|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3898793|NCT01494532|3723196|B7|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3898794|NCT01494532|3723197|B6|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3898795|NCT01494532|3723198|B5|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3898796|NCT01494532|3723199|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3898797|NCT01494532|3723200|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3898798|NCT01494532|3723201|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3898799|NCT01494532|3723202|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3898800|NCT01494532|3723196|B7|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3898801|NCT01494532|3723197|B6|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3898802|NCT01494532|3723198|B5|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3898803|NCT01494532|3723199|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3898804|NCT01494532|3723200|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3898805|NCT01494532|3723201|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3898806|NCT01494532|3723202|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3898807|NCT01494532|3723196|B7||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3898808|NCT01494532|3723197|B6||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3898809|NCT01494532|3723198|B5||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3898810|NCT01494532|3723199|B4||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3898811|NCT01494532|3723200|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3898812|NCT01494532|3723201|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3898813|NCT01494532|3723202|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3898814|NCT01494532|3723196|B7||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3898815|NCT01494532|3723197|B6||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3898816|NCT01494532|3723198|B5||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3898817|NCT01494532|3723199|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3898818|NCT01494532|3723200|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3898819|NCT01494532|3723201|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3898820|NCT01494532|3723202|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3898821|NCT01494532|3723196|B7|||Age||Years|Mean|64.8|64.8|Standard Deviation|9.26|9.26|||
3898822|NCT01494532|3723197|B6|||Age||Years|Mean|66.9|66.9|Standard Deviation|7.94|7.94|||
3898823|NCT01494532|3723198|B5|||Age||Years|Mean|63.7|63.7|Standard Deviation|9.13|9.13|||
3898824|NCT01494532|3723199|B4|||Age||Years|Mean|65.2|65.2|Standard Deviation|9.62|9.62|||
3898825|NCT01494532|3723200|B3|||Age||Years|Mean|65.6|65.6|Standard Deviation|9.19|9.19|||
3898826|NCT01494532|3723201|B2|||Age||Years|Mean|66.5|66.5|Standard Deviation|7.45|7.45|||
3898827|NCT01494532|3723202|B1|||Age||Years|Mean|63.7|63.7|Standard Deviation|9.98|9.98|||
3898828|NCT01494506|3723359|B4|Unknown = not specified||Pancreatic Primary Tumor Location||participants|Number|15|15.0||||||
3898829|NCT01494506|3723360|B3|Unknown = not specified||Pancreatic Primary Tumor Location||participants|Number|6|6.0||||||
3898830|NCT01494506|3723361|B2|Unknown = not specified||Pancreatic Primary Tumor Location||participants|Number|4|4.0||||||
3898831|NCT01494506|3723362|B1|Unknown = not specified||Pancreatic Primary Tumor Location||participants|Number|5|5.0||||||
3898832|NCT01494506|3723359|B4|Multiple locations not including head||Pancreatic Primary Tumor Location||participants|Number|30|30.0||||||
3898833|NCT01494506|3723360|B3|Multiple locations not including head||Pancreatic Primary Tumor Location||participants|Number|9|9.0||||||
3898834|NCT01494506|3723361|B2|Multiple locations not including head||Pancreatic Primary Tumor Location||participants|Number|14|14.0||||||
3898835|NCT01494506|3723362|B1|Multiple locations not including head||Pancreatic Primary Tumor Location||participants|Number|7|7.0||||||
3898836|NCT01494506|3723359|B4|Multiple locations including head||Pancreatic Primary Tumor Location||participants|Number|17|17.0||||||
3898837|NCT01494506|3723360|B3|Multiple locations including head||Pancreatic Primary Tumor Location||participants|Number|6|6.0||||||
3898838|NCT01494506|3723361|B2|Multiple locations including head||Pancreatic Primary Tumor Location||participants|Number|4|4.0||||||
3898839|NCT01494506|3723362|B1|Multiple locations including head||Pancreatic Primary Tumor Location||participants|Number|7|7.0||||||
3898840|NCT01494506|3723359|B4|Tail||Pancreatic Primary Tumor Location||participants|Number|62|62.0||||||
3898841|NCT01494506|3723360|B3|Tail||Pancreatic Primary Tumor Location||participants|Number|14|14.0||||||
3898842|NCT01494506|3723361|B2|Tail||Pancreatic Primary Tumor Location||participants|Number|24|24.0||||||
3898843|NCT01494506|3723362|B1|Tail||Pancreatic Primary Tumor Location||participants|Number|24|24.0||||||
3898844|NCT01494506|3723359|B4|Body||Pancreatic Primary Tumor Location||participants|Number|54|54.0||||||
3898845|NCT01494506|3723360|B3|Body||Pancreatic Primary Tumor Location||participants|Number|12|12.0||||||
3898846|NCT01494506|3723361|B2|Body||Pancreatic Primary Tumor Location||participants|Number|26|26.0||||||
3898847|NCT01494506|3723362|B1|Body||Pancreatic Primary Tumor Location||participants|Number|16|16.0||||||
3898848|NCT01494506|3723359|B4|Head||Pancreatic Primary Tumor Location||participants|Number|239|239.0||||||
3898849|NCT01494506|3723360|B3|Head||Pancreatic Primary Tumor Location||participants|Number|70|70.0||||||
3898850|NCT01494506|3723361|B2|Head||Pancreatic Primary Tumor Location||participants|Number|77|77.0||||||
3898851|NCT01494506|3723362|B1|Head||Pancreatic Primary Tumor Location||participants|Number|92|92.0||||||
3898852|NCT01494506|3723359|B4|Not recorded||Karnofsky Performance Status (Baseline KPS)[1]|"One patient in the 5-FU/LV arm did not have a recorded Baseline KPS value.~Designation of the KPS level for the randomization strata is made during the screening period prior to knowledge of the treatment assignment. Baseline KPS is the last observed KPS value prior to treatment in treated patients and the last observed value in patients who were randomized and did not receive study drug. The observed baseline KPS value may be recorded post-randomization."|participants|Number|1|1.0||||||
3898853|NCT01494506|3723360|B3|Not recorded||Karnofsky Performance Status (Baseline KPS)[1]|"One patient in the 5-FU/LV arm did not have a recorded Baseline KPS value.~Designation of the KPS level for the randomization strata is made during the screening period prior to knowledge of the treatment assignment. Baseline KPS is the last observed KPS value prior to treatment in treated patients and the last observed value in patients who were randomized and did not receive study drug. The observed baseline KPS value may be recorded post-randomization."|participants|Number|0|0.0||||||
3898854|NCT01494506|3723361|B2|Not recorded||Karnofsky Performance Status (Baseline KPS)[1]|"One patient in the 5-FU/LV arm did not have a recorded Baseline KPS value.~Designation of the KPS level for the randomization strata is made during the screening period prior to knowledge of the treatment assignment. Baseline KPS is the last observed KPS value prior to treatment in treated patients and the last observed value in patients who were randomized and did not receive study drug. The observed baseline KPS value may be recorded post-randomization."|participants|Number|1|1.0||||||
3898855|NCT01494506|3723362|B1|Not recorded||Karnofsky Performance Status (Baseline KPS)[1]|"One patient in the 5-FU/LV arm did not have a recorded Baseline KPS value.~Designation of the KPS level for the randomization strata is made during the screening period prior to knowledge of the treatment assignment. Baseline KPS is the last observed KPS value prior to treatment in treated patients and the last observed value in patients who were randomized and did not receive study drug. The observed baseline KPS value may be recorded post-randomization."|participants|Number|0|0.0||||||
3898882|NCT01494506|3723361|B2|other race||RACE (NIH/OMB)||participants|Number|4|4.0||||||
3898856|NCT01494506|3723359|B4|50%[2]= needs help often and medical care||Karnofsky Performance Status (Baseline KPS)[1]|"One patient in the 5-FU/LV arm did not have a recorded Baseline KPS value.~Designation of the KPS level for the randomization strata is made during the screening period prior to knowledge of the treatment assignment. Baseline KPS is the last observed KPS value prior to treatment in treated patients and the last observed value in patients who were randomized and did not receive study drug. The observed baseline KPS value may be recorded post-randomization."|participants|Number|1|1.0||||||
3898857|NCT01494506|3723360|B3|50%[2]= needs help often and medical care||Karnofsky Performance Status (Baseline KPS)[1]|"One patient in the 5-FU/LV arm did not have a recorded Baseline KPS value.~Designation of the KPS level for the randomization strata is made during the screening period prior to knowledge of the treatment assignment. Baseline KPS is the last observed KPS value prior to treatment in treated patients and the last observed value in patients who were randomized and did not receive study drug. The observed baseline KPS value may be recorded post-randomization."|participants|Number|1|1.0||||||
3898858|NCT01494506|3723361|B2|50%[2]= needs help often and medical care||Karnofsky Performance Status (Baseline KPS)[1]|"One patient in the 5-FU/LV arm did not have a recorded Baseline KPS value.~Designation of the KPS level for the randomization strata is made during the screening period prior to knowledge of the treatment assignment. Baseline KPS is the last observed KPS value prior to treatment in treated patients and the last observed value in patients who were randomized and did not receive study drug. The observed baseline KPS value may be recorded post-randomization."|participants|Number|0|0.0||||||
3898859|NCT01494506|3723362|B1|50%[2]= needs help often and medical care||Karnofsky Performance Status (Baseline KPS)[1]|"One patient in the 5-FU/LV arm did not have a recorded Baseline KPS value.~Designation of the KPS level for the randomization strata is made during the screening period prior to knowledge of the treatment assignment. Baseline KPS is the last observed KPS value prior to treatment in treated patients and the last observed value in patients who were randomized and did not receive study drug. The observed baseline KPS value may be recorded post-randomization."|participants|Number|0|0.0||||||
3898860|NCT01494506|3723359|B4|60% [2] = needs help, can manage most tasks||Karnofsky Performance Status (Baseline KPS)[1]|"One patient in the 5-FU/LV arm did not have a recorded Baseline KPS value.~Designation of the KPS level for the randomization strata is made during the screening period prior to knowledge of the treatment assignment. Baseline KPS is the last observed KPS value prior to treatment in treated patients and the last observed value in patients who were randomized and did not receive study drug. The observed baseline KPS value may be recorded post-randomization."|participants|Number|2|2.0||||||
3898861|NCT01494506|3723360|B3|60% [2] = needs help, can manage most tasks||Karnofsky Performance Status (Baseline KPS)[1]|"One patient in the 5-FU/LV arm did not have a recorded Baseline KPS value.~Designation of the KPS level for the randomization strata is made during the screening period prior to knowledge of the treatment assignment. Baseline KPS is the last observed KPS value prior to treatment in treated patients and the last observed value in patients who were randomized and did not receive study drug. The observed baseline KPS value may be recorded post-randomization."|participants|Number|2|2.0||||||
3898862|NCT01494506|3723361|B2|60% [2] = needs help, can manage most tasks||Karnofsky Performance Status (Baseline KPS)[1]|"One patient in the 5-FU/LV arm did not have a recorded Baseline KPS value.~Designation of the KPS level for the randomization strata is made during the screening period prior to knowledge of the treatment assignment. Baseline KPS is the last observed KPS value prior to treatment in treated patients and the last observed value in patients who were randomized and did not receive study drug. The observed baseline KPS value may be recorded post-randomization."|participants|Number|0|0.0||||||
3898863|NCT01494506|3723362|B1|60% [2] = needs help, can manage most tasks||Karnofsky Performance Status (Baseline KPS)[1]|"One patient in the 5-FU/LV arm did not have a recorded Baseline KPS value.~Designation of the KPS level for the randomization strata is made during the screening period prior to knowledge of the treatment assignment. Baseline KPS is the last observed KPS value prior to treatment in treated patients and the last observed value in patients who were randomized and did not receive study drug. The observed baseline KPS value may be recorded post-randomization."|participants|Number|0|0.0||||||
3898864|NCT01494506|3723359|B4|70% = caring for self, unable to work||Karnofsky Performance Status (Baseline KPS)[1]|"One patient in the 5-FU/LV arm did not have a recorded Baseline KPS value.~Designation of the KPS level for the randomization strata is made during the screening period prior to knowledge of the treatment assignment. Baseline KPS is the last observed KPS value prior to treatment in treated patients and the last observed value in patients who were randomized and did not receive study drug. The observed baseline KPS value may be recorded post-randomization."|participants|Number|33|33.0||||||
3898865|NCT01494506|3723360|B3|70% = caring for self, unable to work||Karnofsky Performance Status (Baseline KPS)[1]|"One patient in the 5-FU/LV arm did not have a recorded Baseline KPS value.~Designation of the KPS level for the randomization strata is made during the screening period prior to knowledge of the treatment assignment. Baseline KPS is the last observed KPS value prior to treatment in treated patients and the last observed value in patients who were randomized and did not receive study drug. The observed baseline KPS value may be recorded post-randomization."|participants|Number|7|7.0||||||
3898866|NCT01494506|3723361|B2|70% = caring for self, unable to work||Karnofsky Performance Status (Baseline KPS)[1]|"One patient in the 5-FU/LV arm did not have a recorded Baseline KPS value.~Designation of the KPS level for the randomization strata is made during the screening period prior to knowledge of the treatment assignment. Baseline KPS is the last observed KPS value prior to treatment in treated patients and the last observed value in patients who were randomized and did not receive study drug. The observed baseline KPS value may be recorded post-randomization."|participants|Number|11|11.0||||||
3898867|NCT01494506|3723362|B1|70% = caring for self, unable to work||Karnofsky Performance Status (Baseline KPS)[1]|"One patient in the 5-FU/LV arm did not have a recorded Baseline KPS value.~Designation of the KPS level for the randomization strata is made during the screening period prior to knowledge of the treatment assignment. Baseline KPS is the last observed KPS value prior to treatment in treated patients and the last observed value in patients who were randomized and did not receive study drug. The observed baseline KPS value may be recorded post-randomization."|participants|Number|15|15.0||||||
3898883|NCT01494506|3723362|B1|other race||RACE (NIH/OMB)||participants|Number|6|6.0||||||
3898884|NCT01494506|3723359|B4|White||RACE (NIH/OMB)||participants|Number|253|253.0||||||
3898885|NCT01494506|3723360|B3|White||RACE (NIH/OMB)||participants|Number|72|72.0||||||
3898868|NCT01494506|3723359|B4|80% = normal activity, some symptoms of disease||Karnofsky Performance Status (Baseline KPS)[1]|"One patient in the 5-FU/LV arm did not have a recorded Baseline KPS value.~Designation of the KPS level for the randomization strata is made during the screening period prior to knowledge of the treatment assignment. Baseline KPS is the last observed KPS value prior to treatment in treated patients and the last observed value in patients who were randomized and did not receive study drug. The observed baseline KPS value may be recorded post-randomization."|participants|Number|149|149.0||||||
3898869|NCT01494506|3723360|B3|80% = normal activity, some symptoms of disease||Karnofsky Performance Status (Baseline KPS)[1]|"One patient in the 5-FU/LV arm did not have a recorded Baseline KPS value.~Designation of the KPS level for the randomization strata is made during the screening period prior to knowledge of the treatment assignment. Baseline KPS is the last observed KPS value prior to treatment in treated patients and the last observed value in patients who were randomized and did not receive study drug. The observed baseline KPS value may be recorded post-randomization."|participants|Number|38|38.0||||||
3898870|NCT01494506|3723361|B2|80% = normal activity, some symptoms of disease||Karnofsky Performance Status (Baseline KPS)[1]|"One patient in the 5-FU/LV arm did not have a recorded Baseline KPS value.~Designation of the KPS level for the randomization strata is made during the screening period prior to knowledge of the treatment assignment. Baseline KPS is the last observed KPS value prior to treatment in treated patients and the last observed value in patients who were randomized and did not receive study drug. The observed baseline KPS value may be recorded post-randomization."|participants|Number|61|61.0||||||
3898871|NCT01494506|3723362|B1|80% = normal activity, some symptoms of disease||Karnofsky Performance Status (Baseline KPS)[1]|"One patient in the 5-FU/LV arm did not have a recorded Baseline KPS value.~Designation of the KPS level for the randomization strata is made during the screening period prior to knowledge of the treatment assignment. Baseline KPS is the last observed KPS value prior to treatment in treated patients and the last observed value in patients who were randomized and did not receive study drug. The observed baseline KPS value may be recorded post-randomization."|participants|Number|50|50.0||||||
3898872|NCT01494506|3723359|B4|90% = normal activity, few symptoms of disease||Karnofsky Performance Status (Baseline KPS)[1]|"One patient in the 5-FU/LV arm did not have a recorded Baseline KPS value.~Designation of the KPS level for the randomization strata is made during the screening period prior to knowledge of the treatment assignment. Baseline KPS is the last observed KPS value prior to treatment in treated patients and the last observed value in patients who were randomized and did not receive study drug. The observed baseline KPS value may be recorded post-randomization."|participants|Number|169|169.0||||||
3898873|NCT01494506|3723360|B3|90% = normal activity, few symptoms of disease||Karnofsky Performance Status (Baseline KPS)[1]|"One patient in the 5-FU/LV arm did not have a recorded Baseline KPS value.~Designation of the KPS level for the randomization strata is made during the screening period prior to knowledge of the treatment assignment. Baseline KPS is the last observed KPS value prior to treatment in treated patients and the last observed value in patients who were randomized and did not receive study drug. The observed baseline KPS value may be recorded post-randomization."|participants|Number|51|51.0||||||
3898874|NCT01494506|3723361|B2|90% = normal activity, few symptoms of disease||Karnofsky Performance Status (Baseline KPS)[1]|"One patient in the 5-FU/LV arm did not have a recorded Baseline KPS value.~Designation of the KPS level for the randomization strata is made during the screening period prior to knowledge of the treatment assignment. Baseline KPS is the last observed KPS value prior to treatment in treated patients and the last observed value in patients who were randomized and did not receive study drug. The observed baseline KPS value may be recorded post-randomization."|participants|Number|54|54.0||||||
3898875|NCT01494506|3723362|B1|90% = normal activity, few symptoms of disease||Karnofsky Performance Status (Baseline KPS)[1]|"One patient in the 5-FU/LV arm did not have a recorded Baseline KPS value.~Designation of the KPS level for the randomization strata is made during the screening period prior to knowledge of the treatment assignment. Baseline KPS is the last observed KPS value prior to treatment in treated patients and the last observed value in patients who were randomized and did not receive study drug. The observed baseline KPS value may be recorded post-randomization."|participants|Number|64|64.0||||||
3898876|NCT01494506|3723359|B4|100% = normal, no complaints, no signs of disease||Karnofsky Performance Status (Baseline KPS)[1]|"One patient in the 5-FU/LV arm did not have a recorded Baseline KPS value.~Designation of the KPS level for the randomization strata is made during the screening period prior to knowledge of the treatment assignment. Baseline KPS is the last observed KPS value prior to treatment in treated patients and the last observed value in patients who were randomized and did not receive study drug. The observed baseline KPS value may be recorded post-randomization."|participants|Number|62|62.0||||||
3898877|NCT01494506|3723360|B3|100% = normal, no complaints, no signs of disease||Karnofsky Performance Status (Baseline KPS)[1]|"One patient in the 5-FU/LV arm did not have a recorded Baseline KPS value.~Designation of the KPS level for the randomization strata is made during the screening period prior to knowledge of the treatment assignment. Baseline KPS is the last observed KPS value prior to treatment in treated patients and the last observed value in patients who were randomized and did not receive study drug. The observed baseline KPS value may be recorded post-randomization."|participants|Number|18|18.0||||||
3898878|NCT01494506|3723361|B2|100% = normal, no complaints, no signs of disease||Karnofsky Performance Status (Baseline KPS)[1]|"One patient in the 5-FU/LV arm did not have a recorded Baseline KPS value.~Designation of the KPS level for the randomization strata is made during the screening period prior to knowledge of the treatment assignment. Baseline KPS is the last observed KPS value prior to treatment in treated patients and the last observed value in patients who were randomized and did not receive study drug. The observed baseline KPS value may be recorded post-randomization."|participants|Number|22|22.0||||||
3898879|NCT01494506|3723362|B1|100% = normal, no complaints, no signs of disease||Karnofsky Performance Status (Baseline KPS)[1]|"One patient in the 5-FU/LV arm did not have a recorded Baseline KPS value.~Designation of the KPS level for the randomization strata is made during the screening period prior to knowledge of the treatment assignment. Baseline KPS is the last observed KPS value prior to treatment in treated patients and the last observed value in patients who were randomized and did not receive study drug. The observed baseline KPS value may be recorded post-randomization."|participants|Number|22|22.0||||||
3898880|NCT01494506|3723359|B4|other race||RACE (NIH/OMB)||participants|Number|17|17.0||||||
3898881|NCT01494506|3723360|B3|other race||RACE (NIH/OMB)||participants|Number|7|7.0||||||
3898886|NCT01494506|3723361|B2|White||RACE (NIH/OMB)||participants|Number|92|92.0||||||
3898887|NCT01494506|3723362|B1|White||RACE (NIH/OMB)||participants|Number|89|89.0||||||
3898888|NCT01494506|3723359|B4|Black or African American||RACE (NIH/OMB)||participants|Number|10|10.0||||||
3898889|NCT01494506|3723360|B3|Black or African American||RACE (NIH/OMB)||participants|Number|4|4.0||||||
3898890|NCT01494506|3723361|B2|Black or African American||RACE (NIH/OMB)||participants|Number|3|3.0||||||
3898891|NCT01494506|3723362|B1|Black or African American||RACE (NIH/OMB)||participants|Number|3|3.0||||||
3898892|NCT01494506|3723359|B4|Asian||RACE (NIH/OMB)||participants|Number|136|136.0||||||
3898893|NCT01494506|3723360|B3|Asian||RACE (NIH/OMB)||participants|Number|34|34.0||||||
3898894|NCT01494506|3723361|B2|Asian||RACE (NIH/OMB)||participants|Number|50|50.0||||||
3898895|NCT01494506|3723362|B1|Asian||RACE (NIH/OMB)||participants|Number|52|52.0||||||
3898896|NCT01494506|3723359|B4|American Indian or Alaska Native||RACE (NIH/OMB)||participants|Number|1|1.0||||||
3898897|NCT01494506|3723360|B3|American Indian or Alaska Native||RACE (NIH/OMB)||participants|Number|0|0.0||||||
3898898|NCT01494506|3723361|B2|American Indian or Alaska Native||RACE (NIH/OMB)||participants|Number|0|0.0||||||
3898899|NCT01494506|3723362|B1|American Indian or Alaska Native||RACE (NIH/OMB)||participants|Number|1|1.0||||||
3898900|NCT01494506|3723359|B4||Male|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
3898901|NCT01494506|3723360|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3898902|NCT01494506|3723361|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3898903|NCT01494506|3723362|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3898904|NCT01494506|3723359|B4||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3898905|NCT01494506|3723360|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3898906|NCT01494506|3723361|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3898907|NCT01494506|3723362|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3898908|NCT01494506|3723359|B4|||Age||years|Mean|62.8|62.8|Standard Deviation|9.68|9.68|||
3898909|NCT01494506|3723360|B3|||Age||years|Mean|63.2|63.2|Standard Deviation|9.06|9.06|||
3898910|NCT01494506|3723361|B2|||Age||years|Mean|61.8|61.8|Standard Deviation|9.65|9.65|||
3898911|NCT01494506|3723362|B1|||Age||years|Mean|63.6|63.6|Standard Deviation|10.13|10.13|||
3898912|NCT01494506|3723359|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3898913|NCT01494506|3723360|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3898914|NCT01494506|3723361|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3898915|NCT01494506|3723362|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3898916|NCT01494506|3723359|B4||Between 18 and 65 years|Age||Participants|Count of Participants|417|417.0||||||
3898917|NCT01494506|3723360|B3||Between 18 and 65 years|Age||Participants|Count of Participants|117|117.0||||||
3898918|NCT01494506|3723361|B2||Between 18 and 65 years|Age||Participants|Count of Participants|149|149.0||||||
3898919|NCT01494506|3723362|B1||Between 18 and 65 years|Age||Participants|Count of Participants|151|151.0||||||
3898920|NCT01494506|3723359|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3898921|NCT01494506|3723360|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3898922|NCT01494506|3723361|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3898923|NCT01494506|3723362|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3898924|NCT01494467|3723399|B3|VI||Skin Photo Type|"DEFINITION OF SKIN PHOTOTYPE (T.B. Fitzpatrick):~I: Always burns easily ; never tans II: Always burns easily ; tans minimally and with difficulty III: Burns minimally ; tans gradually and uniformly (light Brown) IV: Burns minimally ; always tans well (moderate brown) V: Rarely burns ; tans profusely (dark brown)) VI:Never burns ; deeply pigmented (black), tans profusely"|Participants|Number|2|2.0||||||
3898925|NCT01494467|3723400|B2|VI||Skin Photo Type|"DEFINITION OF SKIN PHOTOTYPE (T.B. Fitzpatrick):~I: Always burns easily ; never tans II: Always burns easily ; tans minimally and with difficulty III: Burns minimally ; tans gradually and uniformly (light Brown) IV: Burns minimally ; always tans well (moderate brown) V: Rarely burns ; tans profusely (dark brown)) VI:Never burns ; deeply pigmented (black), tans profusely"|Participants|Number|2|2.0||||||
3898926|NCT01494467|3723401|B1|VI||Skin Photo Type|"DEFINITION OF SKIN PHOTOTYPE (T.B. Fitzpatrick):~I: Always burns easily ; never tans II: Always burns easily ; tans minimally and with difficulty III: Burns minimally ; tans gradually and uniformly (light Brown) IV: Burns minimally ; always tans well (moderate brown) V: Rarely burns ; tans profusely (dark brown)) VI:Never burns ; deeply pigmented (black), tans profusely"|Participants|Number|0|0.0||||||
3898927|NCT01494467|3723399|B3|V||Skin Photo Type|"DEFINITION OF SKIN PHOTOTYPE (T.B. Fitzpatrick):~I: Always burns easily ; never tans II: Always burns easily ; tans minimally and with difficulty III: Burns minimally ; tans gradually and uniformly (light Brown) IV: Burns minimally ; always tans well (moderate brown) V: Rarely burns ; tans profusely (dark brown)) VI:Never burns ; deeply pigmented (black), tans profusely"|Participants|Number|18|18.0||||||
3898928|NCT01494467|3723400|B2|V||Skin Photo Type|"DEFINITION OF SKIN PHOTOTYPE (T.B. Fitzpatrick):~I: Always burns easily ; never tans II: Always burns easily ; tans minimally and with difficulty III: Burns minimally ; tans gradually and uniformly (light Brown) IV: Burns minimally ; always tans well (moderate brown) V: Rarely burns ; tans profusely (dark brown)) VI:Never burns ; deeply pigmented (black), tans profusely"|Participants|Number|7|7.0||||||
3898929|NCT01494467|3723401|B1|V||Skin Photo Type|"DEFINITION OF SKIN PHOTOTYPE (T.B. Fitzpatrick):~I: Always burns easily ; never tans II: Always burns easily ; tans minimally and with difficulty III: Burns minimally ; tans gradually and uniformly (light Brown) IV: Burns minimally ; always tans well (moderate brown) V: Rarely burns ; tans profusely (dark brown)) VI:Never burns ; deeply pigmented (black), tans profusely"|Participants|Number|11|11.0||||||
3898957|NCT01494467|3723399|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3898958|NCT01494467|3723400|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3898930|NCT01494467|3723399|B3|IV||Skin Photo Type|"DEFINITION OF SKIN PHOTOTYPE (T.B. Fitzpatrick):~I: Always burns easily ; never tans II: Always burns easily ; tans minimally and with difficulty III: Burns minimally ; tans gradually and uniformly (light Brown) IV: Burns minimally ; always tans well (moderate brown) V: Rarely burns ; tans profusely (dark brown)) VI:Never burns ; deeply pigmented (black), tans profusely"|Participants|Number|81|81.0||||||
3898931|NCT01494467|3723400|B2|IV||Skin Photo Type|"DEFINITION OF SKIN PHOTOTYPE (T.B. Fitzpatrick):~I: Always burns easily ; never tans II: Always burns easily ; tans minimally and with difficulty III: Burns minimally ; tans gradually and uniformly (light Brown) IV: Burns minimally ; always tans well (moderate brown) V: Rarely burns ; tans profusely (dark brown)) VI:Never burns ; deeply pigmented (black), tans profusely"|Participants|Number|31|31.0||||||
3898932|NCT01494467|3723401|B1|IV||Skin Photo Type|"DEFINITION OF SKIN PHOTOTYPE (T.B. Fitzpatrick):~I: Always burns easily ; never tans II: Always burns easily ; tans minimally and with difficulty III: Burns minimally ; tans gradually and uniformly (light Brown) IV: Burns minimally ; always tans well (moderate brown) V: Rarely burns ; tans profusely (dark brown)) VI:Never burns ; deeply pigmented (black), tans profusely"|Participants|Number|50|50.0||||||
3898933|NCT01494467|3723399|B3|III||Skin Photo Type|"DEFINITION OF SKIN PHOTOTYPE (T.B. Fitzpatrick):~I: Always burns easily ; never tans II: Always burns easily ; tans minimally and with difficulty III: Burns minimally ; tans gradually and uniformly (light Brown) IV: Burns minimally ; always tans well (moderate brown) V: Rarely burns ; tans profusely (dark brown)) VI:Never burns ; deeply pigmented (black), tans profusely"|Participants|Number|210|210.0||||||
3898934|NCT01494467|3723400|B2|III||Skin Photo Type|"DEFINITION OF SKIN PHOTOTYPE (T.B. Fitzpatrick):~I: Always burns easily ; never tans II: Always burns easily ; tans minimally and with difficulty III: Burns minimally ; tans gradually and uniformly (light Brown) IV: Burns minimally ; always tans well (moderate brown) V: Rarely burns ; tans profusely (dark brown)) VI:Never burns ; deeply pigmented (black), tans profusely"|Participants|Number|71|71.0||||||
3898935|NCT01494467|3723401|B1|III||Skin Photo Type|"DEFINITION OF SKIN PHOTOTYPE (T.B. Fitzpatrick):~I: Always burns easily ; never tans II: Always burns easily ; tans minimally and with difficulty III: Burns minimally ; tans gradually and uniformly (light Brown) IV: Burns minimally ; always tans well (moderate brown) V: Rarely burns ; tans profusely (dark brown)) VI:Never burns ; deeply pigmented (black), tans profusely"|Participants|Number|139|139.0||||||
3898936|NCT01494467|3723399|B3|II||Skin Photo Type|"DEFINITION OF SKIN PHOTOTYPE (T.B. Fitzpatrick):~I: Always burns easily ; never tans II: Always burns easily ; tans minimally and with difficulty III: Burns minimally ; tans gradually and uniformly (light Brown) IV: Burns minimally ; always tans well (moderate brown) V: Rarely burns ; tans profusely (dark brown)) VI:Never burns ; deeply pigmented (black), tans profusely"|Participants|Number|307|307.0||||||
3898937|NCT01494467|3723400|B2|II||Skin Photo Type|"DEFINITION OF SKIN PHOTOTYPE (T.B. Fitzpatrick):~I: Always burns easily ; never tans II: Always burns easily ; tans minimally and with difficulty III: Burns minimally ; tans gradually and uniformly (light Brown) IV: Burns minimally ; always tans well (moderate brown) V: Rarely burns ; tans profusely (dark brown)) VI:Never burns ; deeply pigmented (black), tans profusely"|Participants|Number|96|96.0||||||
3898938|NCT01494467|3723401|B1|II||Skin Photo Type|"DEFINITION OF SKIN PHOTOTYPE (T.B. Fitzpatrick):~I: Always burns easily ; never tans II: Always burns easily ; tans minimally and with difficulty III: Burns minimally ; tans gradually and uniformly (light Brown) IV: Burns minimally ; always tans well (moderate brown) V: Rarely burns ; tans profusely (dark brown)) VI:Never burns ; deeply pigmented (black), tans profusely"|Participants|Number|211|211.0||||||
3898939|NCT01494467|3723399|B3|I||Skin Photo Type|"DEFINITION OF SKIN PHOTOTYPE (T.B. Fitzpatrick):~I: Always burns easily ; never tans II: Always burns easily ; tans minimally and with difficulty III: Burns minimally ; tans gradually and uniformly (light Brown) IV: Burns minimally ; always tans well (moderate brown) V: Rarely burns ; tans profusely (dark brown)) VI:Never burns ; deeply pigmented (black), tans profusely"|Participants|Number|70|70.0||||||
3898940|NCT01494467|3723400|B2|I||Skin Photo Type|"DEFINITION OF SKIN PHOTOTYPE (T.B. Fitzpatrick):~I: Always burns easily ; never tans II: Always burns easily ; tans minimally and with difficulty III: Burns minimally ; tans gradually and uniformly (light Brown) IV: Burns minimally ; always tans well (moderate brown) V: Rarely burns ; tans profusely (dark brown)) VI:Never burns ; deeply pigmented (black), tans profusely"|Participants|Number|22|22.0||||||
3898941|NCT01494467|3723401|B1|I||Skin Photo Type|"DEFINITION OF SKIN PHOTOTYPE (T.B. Fitzpatrick):~I: Always burns easily ; never tans II: Always burns easily ; tans minimally and with difficulty III: Burns minimally ; tans gradually and uniformly (light Brown) IV: Burns minimally ; always tans well (moderate brown) V: Rarely burns ; tans profusely (dark brown)) VI:Never burns ; deeply pigmented (black), tans profusely"|Participants|Number|48|48.0||||||
3898942|NCT01494467|3723399|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3898943|NCT01494467|3723400|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3898944|NCT01494467|3723401|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3898945|NCT01494467|3723399|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898946|NCT01494467|3723400|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898947|NCT01494467|3723401|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898948|NCT01494467|3723399|B3||White|Race (NIH/OMB)||Participants|Count of Participants|656|656.0||||||
3898949|NCT01494467|3723400|B2||White|Race (NIH/OMB)||Participants|Count of Participants|218|218.0||||||
3898950|NCT01494467|3723401|B1||White|Race (NIH/OMB)||Participants|Count of Participants|438|438.0||||||
3898951|NCT01494467|3723399|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3898952|NCT01494467|3723400|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3898953|NCT01494467|3723401|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3898954|NCT01494467|3723399|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898955|NCT01494467|3723400|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898956|NCT01494467|3723401|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898959|NCT01494467|3723401|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3898960|NCT01494467|3723399|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898961|NCT01494467|3723400|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898962|NCT01494467|3723401|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898963|NCT01494467|3723399|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898964|NCT01494467|3723400|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898965|NCT01494467|3723401|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898966|NCT01494467|3723399|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|601|601.0||||||
3898967|NCT01494467|3723400|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|198|198.0||||||
3898968|NCT01494467|3723401|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|403|403.0||||||
3898969|NCT01494467|3723399|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3898970|NCT01494467|3723400|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3898971|NCT01494467|3723401|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3898972|NCT01494467|3723399|B3||Male|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
3898973|NCT01494467|3723400|B2||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3898974|NCT01494467|3723401|B1||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3898975|NCT01494467|3723399|B3||Female|Sex: Female, Male||Participants|Count of Participants|459|459.0||||||
3898976|NCT01494467|3723400|B2||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3898977|NCT01494467|3723401|B1||Female|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
3898978|NCT01494467|3723399|B3|||Age||Year|Mean|50.2|50.2|Standard Deviation|12.29|12.29|||
3898979|NCT01494467|3723400|B2|||Age||Year|Mean|49.5|49.5|Standard Deviation|12.16|12.16|||
3898980|NCT01494467|3723401|B1|||Age||Year|Mean|50.5|50.5|Standard Deviation|12.35|12.35|||
3898981|NCT01494350|3723418|B1|||Number of lesions per subject||lesions|Mean|1.96|1.96|Standard Deviation|1.48|1.48|||
3898982|NCT01494350|3723418|B1|North African||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
3898983|NCT01494350|3723418|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3898984|NCT01494350|3723418|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3898985|NCT01494350|3723418|B1|||Age||years|Mean|38.7|38.7|Standard Deviation|13.1|13.1|||
3898986|NCT01494298|3723426|B3|United States||Region of Enrollment||participants|Number|101|101.0||||||
3898987|NCT01494298|3723427|B2|United States||Region of Enrollment||participants|Number|47|47.0||||||
3898988|NCT01494298|3723428|B1|United States||Region of Enrollment||participants|Number|54|54.0||||||
3898989|NCT01494298|3723426|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898990|NCT01494298|3723427|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898991|NCT01494298|3723428|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898992|NCT01494298|3723426|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898993|NCT01494298|3723427|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898994|NCT01494298|3723428|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898995|NCT01494298|3723426|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898996|NCT01494298|3723427|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898997|NCT01494298|3723428|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3898998|NCT01494298|3723426|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
3898999|NCT01494298|3723427|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3899000|NCT01494298|3723428|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3899001|NCT01494298|3723426|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899002|NCT01494298|3723427|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899003|NCT01494298|3723428|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899004|NCT01494298|3723426|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899005|NCT01494298|3723427|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899006|NCT01494298|3723428|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899007|NCT01494298|3723426|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899008|NCT01494298|3723427|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899009|NCT01494298|3723428|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899010|NCT01494298|3723426|B3||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3899011|NCT01494298|3723427|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3899012|NCT01494298|3723428|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3899013|NCT01494298|3723426|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3899014|NCT01494298|3723427|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3899015|NCT01494298|3723428|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3899016|NCT01494298|3723426|B3|||Age||Years|Mean|48.5|48.5|Standard Deviation|11.3|11.3|||
3899017|NCT01494298|3723427|B2|||Age||Years|Mean|44.5|44.5|Standard Deviation|13.1|13.1|||
3899018|NCT01494298|3723428|B1|||Age||Years|Mean|52|52.0|Standard Deviation|8|8.0|||
3899019|NCT01494038|3723439|B3||Indeterminate|Tuberculosis (TB) test result by Interferon-Gamma Release Assay (IGRA)||Participants|Count of Participants|61|61.0||||||
3899020|NCT01494038|3723440|B2||Indeterminate|Tuberculosis (TB) test result by Interferon-Gamma Release Assay (IGRA)||Participants|Count of Participants|31|31.0||||||
3899021|NCT01494038|3723441|B1||Indeterminate|Tuberculosis (TB) test result by Interferon-Gamma Release Assay (IGRA)||Participants|Count of Participants|30|30.0||||||
3899022|NCT01494038|3723439|B3||Negative|Tuberculosis (TB) test result by Interferon-Gamma Release Assay (IGRA)||Participants|Count of Participants|598|598.0||||||
3899023|NCT01494038|3723440|B2||Negative|Tuberculosis (TB) test result by Interferon-Gamma Release Assay (IGRA)||Participants|Count of Participants|297|297.0||||||
3899024|NCT01494038|3723441|B1||Negative|Tuberculosis (TB) test result by Interferon-Gamma Release Assay (IGRA)||Participants|Count of Participants|301|301.0||||||
3899025|NCT01494038|3723439|B3||Positive|Tuberculosis (TB) test result by Interferon-Gamma Release Assay (IGRA)||Participants|Count of Participants|283|283.0||||||
3899026|NCT01494038|3723440|B2||Positive|Tuberculosis (TB) test result by Interferon-Gamma Release Assay (IGRA)||Participants|Count of Participants|144|144.0||||||
3899027|NCT01494038|3723441|B1||Positive|Tuberculosis (TB) test result by Interferon-Gamma Release Assay (IGRA)||Participants|Count of Participants|139|139.0||||||
3899028|NCT01494038|3723439|B3||Yes|Efavirenz-containing anti-retroviral (ARV) regimen||Participants|Count of Participants|814|814.0||||||
3899029|NCT01494038|3723440|B2||Yes|Efavirenz-containing anti-retroviral (ARV) regimen||Participants|Count of Participants|409|409.0||||||
3899030|NCT01494038|3723441|B1||Yes|Efavirenz-containing anti-retroviral (ARV) regimen||Participants|Count of Participants|405|405.0||||||
3899031|NCT01494038|3723439|B3||No|Efavirenz-containing anti-retroviral (ARV) regimen||Participants|Count of Participants|142|142.0||||||
3899032|NCT01494038|3723440|B2||No|Efavirenz-containing anti-retroviral (ARV) regimen||Participants|Count of Participants|70|70.0||||||
3899033|NCT01494038|3723441|B1||No|Efavirenz-containing anti-retroviral (ARV) regimen||Participants|Count of Participants|72|72.0||||||
3899034|NCT01494038|3723439|B3||>= 650 cells/mm^3|CD4 Count||Participants|Count of Participants|263|263.0||||||
3899035|NCT01494038|3723440|B2||>= 650 cells/mm^3|CD4 Count||Participants|Count of Participants|130|130.0||||||
3899036|NCT01494038|3723441|B1||>= 650 cells/mm^3|CD4 Count||Participants|Count of Participants|133|133.0||||||
3899037|NCT01494038|3723439|B3||500 - <650 cells/mm^3|CD4 Count||Participants|Count of Participants|200|200.0||||||
3899038|NCT01494038|3723440|B2||500 - <650 cells/mm^3|CD4 Count||Participants|Count of Participants|105|105.0||||||
3899039|NCT01494038|3723441|B1||500 - <650 cells/mm^3|CD4 Count||Participants|Count of Participants|95|95.0||||||
3899040|NCT01494038|3723439|B3||350 - <500 cells/mm^3|CD4 Count||Participants|Count of Participants|257|257.0||||||
3899041|NCT01494038|3723440|B2||350 - <500 cells/mm^3|CD4 Count||Participants|Count of Participants|128|128.0||||||
3899042|NCT01494038|3723441|B1||350 - <500 cells/mm^3|CD4 Count||Participants|Count of Participants|129|129.0||||||
3899043|NCT01494038|3723439|B3||< 350 cells/mm^3|CD4 Count||Participants|Count of Participants|232|232.0||||||
3899044|NCT01494038|3723440|B2||< 350 cells/mm^3|CD4 Count||Participants|Count of Participants|114|114.0||||||
3899045|NCT01494038|3723441|B1||< 350 cells/mm^3|CD4 Count||Participants|Count of Participants|118|118.0||||||
3899046|NCT01494038|3723439|B3||24 - 34 weeks|Gestational age at entry||Participants|Count of Participants|635|635.0||||||
3899047|NCT01494038|3723440|B2||24 - 34 weeks|Gestational age at entry||Participants|Count of Participants|319|319.0||||||
3899048|NCT01494038|3723441|B1||24 - 34 weeks|Gestational age at entry||Participants|Count of Participants|316|316.0||||||
3899049|NCT01494038|3723439|B3||14 - <24 weeks|Gestational age at entry||Participants|Count of Participants|321|321.0||||||
3899050|NCT01494038|3723440|B2||14 - <24 weeks|Gestational age at entry||Participants|Count of Participants|160|160.0||||||
3899051|NCT01494038|3723441|B1||14 - <24 weeks|Gestational age at entry||Participants|Count of Participants|161|161.0||||||
3899052|NCT01494038|3723439|B3|India||Region of Enrollment||participants|Number|33|33.0||||||
3899053|NCT01494038|3723440|B2|India||Region of Enrollment||participants|Number|16|16.0||||||
3899054|NCT01494038|3723441|B1|India||Region of Enrollment||participants|Number|17|17.0||||||
3899055|NCT01494038|3723439|B3|Thailand||Region of Enrollment||participants|Number|33|33.0||||||
3899056|NCT01494038|3723440|B2|Thailand||Region of Enrollment||participants|Number|18|18.0||||||
3899057|NCT01494038|3723441|B1|Thailand||Region of Enrollment||participants|Number|15|15.0||||||
3899058|NCT01494038|3723439|B3|Zimbabwe||Region of Enrollment||participants|Number|319|319.0||||||
3899059|NCT01494038|3723440|B2|Zimbabwe||Region of Enrollment||participants|Number|157|157.0||||||
3899060|NCT01494038|3723441|B1|Zimbabwe||Region of Enrollment||participants|Number|162|162.0||||||
3899061|NCT01494038|3723439|B3|Uganda||Region of Enrollment||participants|Number|166|166.0||||||
3899062|NCT01494038|3723440|B2|Uganda||Region of Enrollment||participants|Number|83|83.0||||||
3899063|NCT01494038|3723441|B1|Uganda||Region of Enrollment||participants|Number|83|83.0||||||
3899064|NCT01494038|3723439|B3|South Africa||Region of Enrollment||participants|Number|182|182.0||||||
3899065|NCT01494038|3723440|B2|South Africa||Region of Enrollment||participants|Number|91|91.0||||||
3899066|NCT01494038|3723441|B1|South Africa||Region of Enrollment||participants|Number|91|91.0||||||
3899067|NCT01494038|3723439|B3|Tanzania||Region of Enrollment||participants|Number|80|80.0||||||
3899068|NCT01494038|3723440|B2|Tanzania||Region of Enrollment||participants|Number|39|39.0||||||
3899069|NCT01494038|3723441|B1|Tanzania||Region of Enrollment||participants|Number|41|41.0||||||
3899070|NCT01494038|3723439|B3|Botswana||Region of Enrollment||participants|Number|120|120.0||||||
3899071|NCT01494038|3723440|B2|Botswana||Region of Enrollment||participants|Number|60|60.0||||||
3899072|NCT01494038|3723441|B1|Botswana||Region of Enrollment||participants|Number|60|60.0||||||
3899073|NCT01494038|3723439|B3|Haiti||Region of Enrollment||participants|Number|23|23.0||||||
3899074|NCT01494038|3723440|B2|Haiti||Region of Enrollment||participants|Number|15|15.0||||||
3899075|NCT01494038|3723441|B1|Haiti||Region of Enrollment||participants|Number|8|8.0||||||
3899076|NCT01494038|3723439|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899077|NCT01494038|3723440|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899078|NCT01494038|3723441|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899079|NCT01494038|3723439|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899080|NCT01494038|3723440|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899081|NCT01494038|3723441|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899082|NCT01494038|3723439|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899083|NCT01494038|3723440|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899084|NCT01494038|3723441|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899085|NCT01494038|3723439|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|889|889.0||||||
3899086|NCT01494038|3723440|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|444|444.0||||||
3899087|NCT01494038|3723441|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|445|445.0||||||
3899088|NCT01494038|3723439|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899089|NCT01494038|3723440|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899090|NCT01494038|3723441|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899091|NCT01494038|3723439|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3899092|NCT01494038|3723440|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3899093|NCT01494038|3723441|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3899094|NCT01494038|3723439|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899095|NCT01494038|3723440|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899096|NCT01494038|3723441|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899097|NCT01494038|3723439|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3899098|NCT01494038|3723440|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3899099|NCT01494038|3723441|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3899100|NCT01494038|3723439|B3||Female|Sex: Female, Male||Participants|Count of Participants|956|956.0||||||
3899101|NCT01494038|3723440|B2||Female|Sex: Female, Male||Participants|Count of Participants|479|479.0||||||
3899102|NCT01494038|3723441|B1||Female|Sex: Female, Male||Participants|Count of Participants|477|477.0||||||
3899103|NCT01494038|3723439|B3|||Age||years|Median|29|29.0|Inter-Quartile Range|||24.0|33.0|
3899104|NCT01494038|3723440|B2|||Age||years|Median|29|29.0|Inter-Quartile Range|||24.0|33.0|
3899105|NCT01494038|3723441|B1|||Age||years|Median|29|29.0|Inter-Quartile Range|||25.0|33.0|
3899106|NCT01493960|3723528|B3|||Summary of CAI score at baseline by treatment group|Clinical Activity Index (CAI) which consists of a 7 item scale CAi score is a summary score ranging from 0-29 The summary score indicates increasing values with worsening symptoms|units on a scale|Mean|11.0|11.0|Standard Deviation|2.1|2.1|||
3899107|NCT01493960|3723529|B2|||Summary of CAI score at baseline by treatment group|Clinical Activity Index (CAI) which consists of a 7 item scale CAi score is a summary score ranging from 0-29 The summary score indicates increasing values with worsening symptoms|units on a scale|Mean|10.8|10.8|Standard Deviation|2.1|2.1|||
3899108|NCT01493960|3723530|B1|||Summary of CAI score at baseline by treatment group|Clinical Activity Index (CAI) which consists of a 7 item scale CAi score is a summary score ranging from 0-29 The summary score indicates increasing values with worsening symptoms|units on a scale|Mean|11.1|11.1|Standard Deviation|2.2|2.2|||
3899109|NCT01493960|3723528|B3|Germany||Region of Enrollment||participants|Number|31|31.0||||||
3899110|NCT01493960|3723529|B2|Germany||Region of Enrollment||participants|Number|11|11.0||||||
3899111|NCT01493960|3723530|B1|Germany||Region of Enrollment||participants|Number|20|20.0||||||
3899112|NCT01493960|3723528|B3|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
3899113|NCT01493960|3723529|B2|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3899114|NCT01493960|3723530|B1|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3899115|NCT01493960|3723528|B3|Italy||Region of Enrollment||participants|Number|5|5.0||||||
3899116|NCT01493960|3723529|B2|Italy||Region of Enrollment||participants|Number|3|3.0||||||
3899117|NCT01493960|3723530|B1|Italy||Region of Enrollment||participants|Number|2|2.0||||||
3899118|NCT01493960|3723528|B3|Poland||Region of Enrollment||participants|Number|39|39.0||||||
3899119|NCT01493960|3723529|B2|Poland||Region of Enrollment||participants|Number|14|14.0||||||
3899120|NCT01493960|3723530|B1|Poland||Region of Enrollment||participants|Number|25|25.0||||||
3899121|NCT01493960|3723528|B3|Hungary||Region of Enrollment||participants|Number|19|19.0||||||
3899122|NCT01493960|3723529|B2|Hungary||Region of Enrollment||participants|Number|6|6.0||||||
3899123|NCT01493960|3723530|B1|Hungary||Region of Enrollment||participants|Number|13|13.0||||||
3899124|NCT01493960|3723528|B3|Czech Republic||Region of Enrollment||participants|Number|19|19.0||||||
3899125|NCT01493960|3723529|B2|Czech Republic||Region of Enrollment||participants|Number|6|6.0||||||
3899126|NCT01493960|3723530|B1|Czech Republic||Region of Enrollment||participants|Number|13|13.0||||||
3899127|NCT01493960|3723528|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3899128|NCT01493960|3723529|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3899129|NCT01493960|3723530|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3899130|NCT01493960|3723528|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3899131|NCT01493960|3723529|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3899132|NCT01493960|3723530|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3899133|NCT01493960|3723528|B3|||Age||years|Mean|41.8|41.8|Standard Deviation|13.34|13.34|||
3899134|NCT01493960|3723529|B2|||Age||years|Mean|43.1|43.1|Standard Deviation|12.31|12.31|||
3899135|NCT01493960|3723530|B1|||Age||years|Mean|41.1|41.1|Standard Deviation|13.88|13.88|||
3899136|NCT01493960|3723528|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3899137|NCT01493960|3723529|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3899138|NCT01493960|3723530|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3899139|NCT01493960|3723528|B3||Between 18 and 65 years|Age||Participants|Count of Participants|116|116.0||||||
3899140|NCT01493960|3723529|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3899141|NCT01493960|3723530|B1||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
3899142|NCT01493960|3723528|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3899143|NCT01493960|3723529|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3899144|NCT01493960|3723530|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3899145|NCT01493947|3723549|B3|Germany||Region of Enrollment||participants|Number|226|226.0||||||
3899146|NCT01493947|3723550|B2|Germany||Region of Enrollment||participants|Number|114|114.0||||||
3899147|NCT01493947|3723551|B1|Germany||Region of Enrollment||participants|Number|112|112.0||||||
3899148|NCT01493947|3723549|B3|France||Region of Enrollment||participants|Number|67|67.0||||||
3899149|NCT01493947|3723550|B2|France||Region of Enrollment||participants|Number|36|36.0||||||
3899150|NCT01493947|3723551|B1|France||Region of Enrollment||participants|Number|31|31.0||||||
3899151|NCT01493947|3723549|B3|Bulgaria||Region of Enrollment||participants|Number|37|37.0||||||
3899152|NCT01493947|3723550|B2|Bulgaria||Region of Enrollment||participants|Number|17|17.0||||||
3899153|NCT01493947|3723551|B1|Bulgaria||Region of Enrollment||participants|Number|20|20.0||||||
3899154|NCT01493947|3723549|B3|United Kingdom||Region of Enrollment||participants|Number|35|35.0||||||
3899155|NCT01493947|3723550|B2|United Kingdom||Region of Enrollment||participants|Number|19|19.0||||||
3899156|NCT01493947|3723551|B1|United Kingdom||Region of Enrollment||participants|Number|16|16.0||||||
3899157|NCT01493947|3723549|B3|Poland||Region of Enrollment||participants|Number|114|114.0||||||
3899158|NCT01493947|3723550|B2|Poland||Region of Enrollment||participants|Number|57|57.0||||||
3899159|NCT01493947|3723551|B1|Poland||Region of Enrollment||participants|Number|57|57.0||||||
3899160|NCT01493947|3723549|B3|Ukraine||Region of Enrollment||participants|Number|60|60.0||||||
3899161|NCT01493947|3723550|B2|Ukraine||Region of Enrollment||participants|Number|30|30.0||||||
3899162|NCT01493947|3723551|B1|Ukraine||Region of Enrollment||participants|Number|30|30.0||||||
3899163|NCT01493947|3723549|B3|Hungary||Region of Enrollment||participants|Number|160|160.0||||||
3899164|NCT01493947|3723550|B2|Hungary||Region of Enrollment||participants|Number|84|84.0||||||
3899165|NCT01493947|3723551|B1|Hungary||Region of Enrollment||participants|Number|76|76.0||||||
3899166|NCT01493947|3723549|B3|Romania||Region of Enrollment||participants|Number|109|109.0||||||
3899167|NCT01493947|3723550|B2|Romania||Region of Enrollment||participants|Number|52|52.0||||||
3899168|NCT01493947|3723551|B1|Romania||Region of Enrollment||participants|Number|57|57.0||||||
3899169|NCT01493947|3723549|B3|Russian Federation||Region of Enrollment||participants|Number|74|74.0||||||
3899170|NCT01493947|3723550|B2|Russian Federation||Region of Enrollment||participants|Number|35|35.0||||||
3899171|NCT01493947|3723551|B1|Russian Federation||Region of Enrollment||participants|Number|39|39.0||||||
3899172|NCT01493947|3723549|B3|Czech Republic||Region of Enrollment||participants|Number|80|80.0||||||
3899173|NCT01493947|3723550|B2|Czech Republic||Region of Enrollment||participants|Number|40|40.0||||||
3899174|NCT01493947|3723551|B1|Czech Republic||Region of Enrollment||participants|Number|40|40.0||||||
3899175|NCT01493947|3723549|B3||Male|Sex: Female, Male||Participants|Count of Participants|335|335.0||||||
3899176|NCT01493947|3723550|B2||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3899177|NCT01493947|3723551|B1||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3899178|NCT01493947|3723549|B3||Female|Sex: Female, Male||Participants|Count of Participants|627|627.0||||||
3899179|NCT01493947|3723550|B2||Female|Sex: Female, Male||Participants|Count of Participants|316|316.0||||||
3899180|NCT01493947|3723551|B1||Female|Sex: Female, Male||Participants|Count of Participants|311|311.0||||||
3899181|NCT01493947|3723549|B3||>=65 years|Age||Participants|Count of Participants|170|170.0||||||
3899182|NCT01493947|3723550|B2||>=65 years|Age||Participants|Count of Participants|86|86.0||||||
3899183|NCT01493947|3723551|B1||>=65 years|Age||Participants|Count of Participants|84|84.0||||||
3899184|NCT01493947|3723549|B3||Between 18 and 65 years|Age||Participants|Count of Participants|792|792.0||||||
3899185|NCT01493947|3723550|B2||Between 18 and 65 years|Age||Participants|Count of Participants|398|398.0||||||
3899186|NCT01493947|3723551|B1||Between 18 and 65 years|Age||Participants|Count of Participants|394|394.0||||||
3899187|NCT01493947|3723549|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3899188|NCT01493947|3723550|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3899189|NCT01493947|3723551|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3899190|NCT01493778|3723562|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3899191|NCT01493778|3723562|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899192|NCT01493778|3723562|B1||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3899193|NCT01493778|3723562|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899194|NCT01493778|3723562|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899195|NCT01493778|3723562|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3899196|NCT01493778|3723562|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899197|NCT01493778|3723562|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899198|NCT01493778|3723562|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3899199|NCT01493778|3723562|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3899200|NCT01493778|3723562|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3899201|NCT01493778|3723562|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3899202|NCT01493778|3723562|B1|||Age||Months|Mean|10.4|10.4|Standard Deviation|7.83|7.83|||
3899203|NCT01493687|3723588|B3|VI||Skin Photo Type|"DEFINITION OF SKIN PHOTOTYPE (T.B. Fitzpatrick):~I: Always burns easily ; never tans II: Always burns easily ; tans minimally and with difficulty III: Burns minimally ; tans gradually and uniformly (light Brown) IV: Burns minimally ; always tans well (moderate brown) V: Rarely burns ; tans profusely (dark brown)) VI:Never burns ; deeply pigmented (black), tans profusely"|Participants|Number|4|4.0||||||
3899204|NCT01493687|3723589|B2|VI||Skin Photo Type|"DEFINITION OF SKIN PHOTOTYPE (T.B. Fitzpatrick):~I: Always burns easily ; never tans II: Always burns easily ; tans minimally and with difficulty III: Burns minimally ; tans gradually and uniformly (light Brown) IV: Burns minimally ; always tans well (moderate brown) V: Rarely burns ; tans profusely (dark brown)) VI:Never burns ; deeply pigmented (black), tans profusely"|Participants|Number|3|3.0||||||
3899205|NCT01493687|3723590|B1|VI||Skin Photo Type|"DEFINITION OF SKIN PHOTOTYPE (T.B. Fitzpatrick):~I: Always burns easily ; never tans II: Always burns easily ; tans minimally and with difficulty III: Burns minimally ; tans gradually and uniformly (light Brown) IV: Burns minimally ; always tans well (moderate brown) V: Rarely burns ; tans profusely (dark brown)) VI:Never burns ; deeply pigmented (black), tans profusely"|Participants|Number|1|1.0||||||
3899206|NCT01493687|3723588|B3|V||Skin Photo Type|"DEFINITION OF SKIN PHOTOTYPE (T.B. Fitzpatrick):~I: Always burns easily ; never tans II: Always burns easily ; tans minimally and with difficulty III: Burns minimally ; tans gradually and uniformly (light Brown) IV: Burns minimally ; always tans well (moderate brown) V: Rarely burns ; tans profusely (dark brown)) VI:Never burns ; deeply pigmented (black), tans profusely"|Participants|Number|19|19.0||||||
3899207|NCT01493687|3723589|B2|V||Skin Photo Type|"DEFINITION OF SKIN PHOTOTYPE (T.B. Fitzpatrick):~I: Always burns easily ; never tans II: Always burns easily ; tans minimally and with difficulty III: Burns minimally ; tans gradually and uniformly (light Brown) IV: Burns minimally ; always tans well (moderate brown) V: Rarely burns ; tans profusely (dark brown)) VI:Never burns ; deeply pigmented (black), tans profusely"|Participants|Number|11|11.0||||||
3899208|NCT01493687|3723590|B1|V||Skin Photo Type|"DEFINITION OF SKIN PHOTOTYPE (T.B. Fitzpatrick):~I: Always burns easily ; never tans II: Always burns easily ; tans minimally and with difficulty III: Burns minimally ; tans gradually and uniformly (light Brown) IV: Burns minimally ; always tans well (moderate brown) V: Rarely burns ; tans profusely (dark brown)) VI:Never burns ; deeply pigmented (black), tans profusely"|Participants|Number|8|8.0||||||
3899209|NCT01493687|3723588|B3|IV||Skin Photo Type|"DEFINITION OF SKIN PHOTOTYPE (T.B. Fitzpatrick):~I: Always burns easily ; never tans II: Always burns easily ; tans minimally and with difficulty III: Burns minimally ; tans gradually and uniformly (light Brown) IV: Burns minimally ; always tans well (moderate brown) V: Rarely burns ; tans profusely (dark brown)) VI:Never burns ; deeply pigmented (black), tans profusely"|Participants|Number|77|77.0||||||
3899210|NCT01493687|3723589|B2|IV||Skin Photo Type|"DEFINITION OF SKIN PHOTOTYPE (T.B. Fitzpatrick):~I: Always burns easily ; never tans II: Always burns easily ; tans minimally and with difficulty III: Burns minimally ; tans gradually and uniformly (light Brown) IV: Burns minimally ; always tans well (moderate brown) V: Rarely burns ; tans profusely (dark brown)) VI:Never burns ; deeply pigmented (black), tans profusely"|Participants|Number|26|26.0||||||
3899211|NCT01493687|3723590|B1|IV||Skin Photo Type|"DEFINITION OF SKIN PHOTOTYPE (T.B. Fitzpatrick):~I: Always burns easily ; never tans II: Always burns easily ; tans minimally and with difficulty III: Burns minimally ; tans gradually and uniformly (light Brown) IV: Burns minimally ; always tans well (moderate brown) V: Rarely burns ; tans profusely (dark brown)) VI:Never burns ; deeply pigmented (black), tans profusely"|Participants|Number|51|51.0||||||
3899212|NCT01493687|3723588|B3|III||Skin Photo Type|"DEFINITION OF SKIN PHOTOTYPE (T.B. Fitzpatrick):~I: Always burns easily ; never tans II: Always burns easily ; tans minimally and with difficulty III: Burns minimally ; tans gradually and uniformly (light Brown) IV: Burns minimally ; always tans well (moderate brown) V: Rarely burns ; tans profusely (dark brown)) VI:Never burns ; deeply pigmented (black), tans profusely"|Participants|Number|253|253.0||||||
3899213|NCT01493687|3723589|B2|III||Skin Photo Type|"DEFINITION OF SKIN PHOTOTYPE (T.B. Fitzpatrick):~I: Always burns easily ; never tans II: Always burns easily ; tans minimally and with difficulty III: Burns minimally ; tans gradually and uniformly (light Brown) IV: Burns minimally ; always tans well (moderate brown) V: Rarely burns ; tans profusely (dark brown)) VI:Never burns ; deeply pigmented (black), tans profusely"|Participants|Number|86|86.0||||||
3899214|NCT01493687|3723590|B1|III||Skin Photo Type|"DEFINITION OF SKIN PHOTOTYPE (T.B. Fitzpatrick):~I: Always burns easily ; never tans II: Always burns easily ; tans minimally and with difficulty III: Burns minimally ; tans gradually and uniformly (light Brown) IV: Burns minimally ; always tans well (moderate brown) V: Rarely burns ; tans profusely (dark brown)) VI:Never burns ; deeply pigmented (black), tans profusely"|Participants|Number|167|167.0||||||
3899215|NCT01493687|3723588|B3|II||Skin Photo Type|"DEFINITION OF SKIN PHOTOTYPE (T.B. Fitzpatrick):~I: Always burns easily ; never tans II: Always burns easily ; tans minimally and with difficulty III: Burns minimally ; tans gradually and uniformly (light Brown) IV: Burns minimally ; always tans well (moderate brown) V: Rarely burns ; tans profusely (dark brown)) VI:Never burns ; deeply pigmented (black), tans profusely"|Participants|Number|275|275.0||||||
3899216|NCT01493687|3723589|B2|II||Skin Photo Type|"DEFINITION OF SKIN PHOTOTYPE (T.B. Fitzpatrick):~I: Always burns easily ; never tans II: Always burns easily ; tans minimally and with difficulty III: Burns minimally ; tans gradually and uniformly (light Brown) IV: Burns minimally ; always tans well (moderate brown) V: Rarely burns ; tans profusely (dark brown)) VI:Never burns ; deeply pigmented (black), tans profusely"|Participants|Number|90|90.0||||||
3899217|NCT01493687|3723590|B1|II||Skin Photo Type|"DEFINITION OF SKIN PHOTOTYPE (T.B. Fitzpatrick):~I: Always burns easily ; never tans II: Always burns easily ; tans minimally and with difficulty III: Burns minimally ; tans gradually and uniformly (light Brown) IV: Burns minimally ; always tans well (moderate brown) V: Rarely burns ; tans profusely (dark brown)) VI:Never burns ; deeply pigmented (black), tans profusely"|Participants|Number|185|185.0||||||
3899218|NCT01493687|3723588|B3|I||Skin Photo Type|"DEFINITION OF SKIN PHOTOTYPE (T.B. Fitzpatrick):~I: Always burns easily ; never tans II: Always burns easily ; tans minimally and with difficulty III: Burns minimally ; tans gradually and uniformly (light Brown) IV: Burns minimally ; always tans well (moderate brown) V: Rarely burns ; tans profusely (dark brown)) VI:Never burns ; deeply pigmented (black), tans profusely"|Participants|Number|55|55.0||||||
3899219|NCT01493687|3723589|B2|I||Skin Photo Type|"DEFINITION OF SKIN PHOTOTYPE (T.B. Fitzpatrick):~I: Always burns easily ; never tans II: Always burns easily ; tans minimally and with difficulty III: Burns minimally ; tans gradually and uniformly (light Brown) IV: Burns minimally ; always tans well (moderate brown) V: Rarely burns ; tans profusely (dark brown)) VI:Never burns ; deeply pigmented (black), tans profusely"|Participants|Number|16|16.0||||||
3899220|NCT01493687|3723590|B1|I||Skin Photo Type|"DEFINITION OF SKIN PHOTOTYPE (T.B. Fitzpatrick):~I: Always burns easily ; never tans II: Always burns easily ; tans minimally and with difficulty III: Burns minimally ; tans gradually and uniformly (light Brown) IV: Burns minimally ; always tans well (moderate brown) V: Rarely burns ; tans profusely (dark brown)) VI:Never burns ; deeply pigmented (black), tans profusely"|Participants|Number|39|39.0||||||
3899221|NCT01493687|3723588|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3899222|NCT01493687|3723589|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3899223|NCT01493687|3723590|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3899224|NCT01493687|3723588|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899225|NCT01493687|3723589|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899226|NCT01493687|3723590|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899227|NCT01493687|3723588|B3||White|Race (NIH/OMB)||Participants|Count of Participants|657|657.0||||||
3899228|NCT01493687|3723589|B2||White|Race (NIH/OMB)||Participants|Count of Participants|220|220.0||||||
3899229|NCT01493687|3723590|B1||White|Race (NIH/OMB)||Participants|Count of Participants|437|437.0||||||
3899230|NCT01493687|3723588|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3899231|NCT01493687|3723589|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3899232|NCT01493687|3723590|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3899233|NCT01493687|3723588|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899234|NCT01493687|3723589|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899235|NCT01493687|3723590|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899236|NCT01493687|3723588|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3899237|NCT01493687|3723589|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3899238|NCT01493687|3723590|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3899239|NCT01493687|3723588|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899240|NCT01493687|3723589|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899241|NCT01493687|3723590|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899242|NCT01493687|3723588|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899243|NCT01493687|3723589|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899244|NCT01493687|3723590|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899245|NCT01493687|3723588|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|605|605.0||||||
3899246|NCT01493687|3723589|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|209|209.0||||||
3899247|NCT01493687|3723590|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|396|396.0||||||
3899248|NCT01493687|3723588|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3899249|NCT01493687|3723589|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3899250|NCT01493687|3723590|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3899251|NCT01493687|3723588|B3||Male|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
3899252|NCT01493687|3723589|B2||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3899253|NCT01493687|3723590|B1||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3899254|NCT01493687|3723588|B3||Female|Sex: Female, Male||Participants|Count of Participants|466|466.0||||||
3899255|NCT01493687|3723589|B2||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3899256|NCT01493687|3723590|B1||Female|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
3899257|NCT01493687|3723588|B3|||Age||Years|Mean|50.4|50.4|Standard Deviation|12.09|12.09|||
3899258|NCT01493687|3723589|B2|||Age||Years|Mean|51.6|51.6|Standard Deviation|11.92|11.92|||
3899259|NCT01493687|3723590|B1|||Age||Years|Mean|49.9|49.9|Standard Deviation|12.15|12.15|||
3899260|NCT01493557|3723607|B4||Male|Sex: Female, Male||Participants|Count of Participants|721|721.0||||||
3899261|NCT01493557|3723608|B3||Male|Sex: Female, Male||Participants|Count of Participants|646|646.0||||||
3899262|NCT01493557|3723609|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3899263|NCT01493557|3723610|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3899264|NCT01493557|3723607|B4||Female|Sex: Female, Male||Participants|Count of Participants|346|346.0||||||
3899265|NCT01493557|3723608|B3||Female|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
3899266|NCT01493557|3723609|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3899267|NCT01493557|3723610|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3899268|NCT01493557|3723607|B4|||Age||Years|Mean|69.7|69.7|Standard Deviation|10.7|10.7|||
3899269|NCT01493557|3723608|B3|||Age||Years|Mean|69.7|69.7|Standard Deviation|10.7|10.7|||
3899270|NCT01493557|3723609|B2|||Age||Years|Mean|69.6|69.6|Standard Deviation|10.8|10.8|||
3899271|NCT01493557|3723610|B1|||Age||Years|Mean|69.1|69.1|Standard Deviation|11.1|11.1|||
3899272|NCT01493531|3723637|B4|United States||Region of Enrollment||Participants|Number|309|309.0||||||
3899273|NCT01493531|3723638|B3|United States||Region of Enrollment||Participants|Number|107|107.0||||||
3899274|NCT01493531|3723639|B2|United States||Region of Enrollment||Participants|Number|94|94.0||||||
3899275|NCT01493531|3723640|B1|United States||Region of Enrollment||Participants|Number|108|108.0||||||
3899276|NCT01493531|3723637|B4|Ukraine||Region of Enrollment||Participants|Number|74|74.0||||||
3899277|NCT01493531|3723638|B3|Ukraine||Region of Enrollment||Participants|Number|25|25.0||||||
3899278|NCT01493531|3723639|B2|Ukraine||Region of Enrollment||Participants|Number|24|24.0||||||
3899279|NCT01493531|3723640|B1|Ukraine||Region of Enrollment||Participants|Number|25|25.0||||||
3899280|NCT01493531|3723637|B4|Switzerland||Region of Enrollment||Participants|Number|1|1.0||||||
3899281|NCT01493531|3723638|B3|Switzerland||Region of Enrollment||Participants|Number|0|0.0||||||
3899282|NCT01493531|3723639|B2|Switzerland||Region of Enrollment||Participants|Number|0|0.0||||||
3899283|NCT01493531|3723640|B1|Switzerland||Region of Enrollment||Participants|Number|1|1.0||||||
3899284|NCT01493531|3723637|B4|Spain||Region of Enrollment||Participants|Number|8|8.0||||||
3899285|NCT01493531|3723638|B3|Spain||Region of Enrollment||Participants|Number|2|2.0||||||
3899286|NCT01493531|3723639|B2|Spain||Region of Enrollment||Participants|Number|4|4.0||||||
3899287|NCT01493531|3723640|B1|Spain||Region of Enrollment||Participants|Number|2|2.0||||||
3899288|NCT01493531|3723637|B4|South Africa||Region of Enrollment||Participants|Number|99|99.0||||||
3899289|NCT01493531|3723638|B3|South Africa||Region of Enrollment||Participants|Number|33|33.0||||||
3899290|NCT01493531|3723639|B2|South Africa||Region of Enrollment||Participants|Number|36|36.0||||||
3899291|NCT01493531|3723640|B1|South Africa||Region of Enrollment||Participants|Number|30|30.0||||||
3899292|NCT01493531|3723637|B4|Poland||Region of Enrollment||Participants|Number|22|22.0||||||
3899293|NCT01493531|3723638|B3|Poland||Region of Enrollment||Participants|Number|6|6.0||||||
3899294|NCT01493531|3723639|B2|Poland||Region of Enrollment||Participants|Number|11|11.0||||||
3899295|NCT01493531|3723640|B1|Poland||Region of Enrollment||Participants|Number|5|5.0||||||
3899296|NCT01493531|3723637|B4|New Zealand||Region of Enrollment||Participants|Number|26|26.0||||||
3899297|NCT01493531|3723638|B3|New Zealand||Region of Enrollment||Participants|Number|7|7.0||||||
3899298|NCT01493531|3723639|B2|New Zealand||Region of Enrollment||Participants|Number|7|7.0||||||
3899299|NCT01493531|3723640|B1|New Zealand||Region of Enrollment||Participants|Number|12|12.0||||||
3899300|NCT01493531|3723637|B4|Germany||Region of Enrollment||Participants|Number|25|25.0||||||
3899301|NCT01493531|3723638|B3|Germany||Region of Enrollment||Participants|Number|8|8.0||||||
3899302|NCT01493531|3723639|B2|Germany||Region of Enrollment||Participants|Number|8|8.0||||||
3899303|NCT01493531|3723640|B1|Germany||Region of Enrollment||Participants|Number|9|9.0||||||
3899304|NCT01493531|3723637|B4|Canada||Region of Enrollment||Participants|Number|25|25.0||||||
3899305|NCT01493531|3723638|B3|Canada||Region of Enrollment||Participants|Number|12|12.0||||||
3899306|NCT01493531|3723639|B2|Canada||Region of Enrollment||Participants|Number|6|6.0||||||
3899307|NCT01493531|3723640|B1|Canada||Region of Enrollment||Participants|Number|7|7.0||||||
3899308|NCT01493531|3723637|B4|Belgium||Region of Enrollment||Participants|Number|4|4.0||||||
3899309|NCT01493531|3723638|B3|Belgium||Region of Enrollment||Participants|Number|2|2.0||||||
3899310|NCT01493531|3723639|B2|Belgium||Region of Enrollment||Participants|Number|1|1.0||||||
3899311|NCT01493531|3723640|B1|Belgium||Region of Enrollment||Participants|Number|1|1.0||||||
3899312|NCT01493531|3723637|B4|Australia||Region of Enrollment||Participants|Number|17|17.0||||||
3899313|NCT01493531|3723638|B3|Australia||Region of Enrollment||Participants|Number|4|4.0||||||
3899314|NCT01493531|3723639|B2|Australia||Region of Enrollment||Participants|Number|9|9.0||||||
3899315|NCT01493531|3723640|B1|Australia||Region of Enrollment||Participants|Number|4|4.0||||||
3899316|NCT01493531|3723637|B4||Male|Sex: Female, Male||Participants|Count of Participants|587|587.0||||||
3899317|NCT01493531|3723638|B3||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
3899318|NCT01493531|3723639|B2||Male|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
3899319|NCT01493531|3723640|B1||Male|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
3899320|NCT01493531|3723637|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3899321|NCT01493531|3723638|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3899322|NCT01493531|3723639|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3899323|NCT01493531|3723640|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3899324|NCT01493531|3723637|B4|>=65||Age, Customized||Participants|Number|66|66.0||||||
3899325|NCT01493531|3723638|B3|>=65||Age, Customized||Participants|Number|21|21.0||||||
3899326|NCT01493531|3723639|B2|>=65||Age, Customized||Participants|Number|25|25.0||||||
3899327|NCT01493531|3723640|B1|>=65||Age, Customized||Participants|Number|20|20.0||||||
3899328|NCT01493531|3723637|B4|<65||Age, Customized||Participants|Number|544|544.0||||||
3899329|NCT01493531|3723638|B3|<65||Age, Customized||Participants|Number|185|185.0||||||
3899330|NCT01493531|3723639|B2|<65||Age, Customized||Participants|Number|175|175.0||||||
3899331|NCT01493531|3723640|B1|<65||Age, Customized||Participants|Number|184|184.0||||||
3899332|NCT01493531|3723637|B4|||Age||years|Mean|51.2|51.2|Standard Deviation|10.9|10.9|||
3899333|NCT01493531|3723638|B3|||Age||years|Mean|51.4|51.4|Standard Deviation|10.6|10.6|||
3899334|NCT01493531|3723639|B2|||Age||years|Mean|51.3|51.3|Standard Deviation|11.1|11.1|||
3899335|NCT01493531|3723640|B1|||Age||years|Mean|51.0|51.0|Standard Deviation|11.1|11.1|||
3899336|NCT01493427|3723656|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3899337|NCT01493427|3723656|B1||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3899338|NCT01493427|3723656|B1|||Age||years|Mean|66.6|66.6|Standard Deviation|11.7|11.7|||
3899339|NCT01493284|3723661|B1|||Renal failure/insufficiency||Participants|Count of Participants|73|73.0||||||
3899340|NCT01493284|3723661|B1|||History of atrial fibrillation||Participants|Count of Participants|85|85.0||||||
3899341|NCT01493284|3723661|B1|||Porcelain aorta||Participants|Count of Participants|8|8.0||||||
3899342|NCT01493284|3723661|B1|||History of pulmonary hypertension||Participants|Count of Participants|68|68.0||||||
3899343|NCT01493284|3723661|B1|||NYHA class III/IV|"NYHA Class I: Subjects with cardiac disease but without resulting limitations of physical activity.~NYHA Class II: Subjects with cardiac disease resulting in slight limitation of physical activity.~NYHA Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.~NYHA Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort."|Participants|Count of Participants|175|175.0||||||
3899344|NCT01493284|3723661|B1|||STS risk score of mortality|The Society of Thoracic Surgeons (STS) score measures patient risk of operative mortality and morbidity after adult cardiac surgery on a scale that ranges from 0% to 100%, with higher numbers indicating greater risk.|Percentage|Mean|5.8|5.8|Standard Deviation|3.3|3.3|||
3899345|NCT01493284|3723661|B1|Germany||Region of Enrollment||Participants|Count of Participants|141|141.0||||||
3899346|NCT01493284|3723661|B1|Australia||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3899347|NCT01493284|3723661|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
3899348|NCT01493284|3723661|B1|Denmark||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3899349|NCT01493284|3723661|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3899350|NCT01493284|3723661|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3899351|NCT01493284|3723661|B1||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3899352|NCT01493284|3723661|B1|||Age||years|Mean|83.0|83.0|Standard Deviation|4.6|4.6|||
3899353|NCT01493180|3723668|B3|Japan||Region of Enrollment||participants|Number|102|102.0||||||
3899354|NCT01493180|3723669|B2|Japan||Region of Enrollment||participants|Number|51|51.0||||||
3899355|NCT01493180|3723670|B1|Japan||Region of Enrollment||participants|Number|51|51.0||||||
3899356|NCT01493180|3723668|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3899357|NCT01493180|3723669|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3899358|NCT01493180|3723670|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3899359|NCT01493180|3723668|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3899360|NCT01493180|3723669|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3899361|NCT01493180|3723670|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3899362|NCT01493180|3723668|B3||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
3899363|NCT01493180|3723669|B2||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3899364|NCT01493180|3723670|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3899365|NCT01493180|3723668|B3||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3899366|NCT01493180|3723669|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3899367|NCT01493180|3723670|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3899368|NCT01493180|3723668|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3899369|NCT01493180|3723669|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3899370|NCT01493180|3723670|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3899371|NCT01493180|3723668|B3|||Age||years|Mean|54.7|54.7|Standard Deviation|19.3|19.3|||
3899372|NCT01493180|3723669|B2|||Age||years|Mean|54.5|54.5|Standard Deviation|20.9|20.9|||
3899373|NCT01493180|3723670|B1|||Age||years|Mean|54.9|54.9|Standard Deviation|17.9|17.9|||
3899374|NCT01493167|3723677|B1|Finland||Region of Enrollment||participants|Number|97|97.0||||||
3899375|NCT01493167|3723677|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3899376|NCT01493167|3723677|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3899377|NCT01493167|3723677|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3899378|NCT01493167|3723677|B1||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
3899379|NCT01493167|3723677|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3899380|NCT01493089|3723681|B3|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
3899381|NCT01493089|3723682|B2|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3899382|NCT01493089|3723683|B1|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
3899383|NCT01493089|3723681|B3|Romania||Region of Enrollment||participants|Number|35|35.0||||||
3899384|NCT01493089|3723682|B2|Romania||Region of Enrollment||participants|Number|18|18.0||||||
3899385|NCT01493089|3723683|B1|Romania||Region of Enrollment||participants|Number|17|17.0||||||
3899386|NCT01493089|3723681|B3|Hungary||Region of Enrollment||participants|Number|33|33.0||||||
3899387|NCT01493089|3723682|B2|Hungary||Region of Enrollment||participants|Number|14|14.0||||||
3899388|NCT01493089|3723683|B1|Hungary||Region of Enrollment||participants|Number|19|19.0||||||
3899389|NCT01493089|3723681|B3|Czech Republic||Region of Enrollment||participants|Number|32|32.0||||||
3899390|NCT01493089|3723682|B2|Czech Republic||Region of Enrollment||participants|Number|15|15.0||||||
3899391|NCT01493089|3723683|B1|Czech Republic||Region of Enrollment||participants|Number|17|17.0||||||
3899392|NCT01493089|3723681|B3|Bulgaria||Region of Enrollment||participants|Number|31|31.0||||||
3899393|NCT01493089|3723682|B2|Bulgaria||Region of Enrollment||participants|Number|17|17.0||||||
3899394|NCT01493089|3723683|B1|Bulgaria||Region of Enrollment||participants|Number|14|14.0||||||
3899395|NCT01493089|3723681|B3|Poland||Region of Enrollment||participants|Number|97|97.0||||||
3899396|NCT01493089|3723682|B2|Poland||Region of Enrollment||participants|Number|49|49.0||||||
3899397|NCT01493089|3723683|B1|Poland||Region of Enrollment||participants|Number|48|48.0||||||
3899398|NCT01493089|3723681|B3||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3899399|NCT01493089|3723682|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3899400|NCT01493089|3723683|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3899401|NCT01493089|3723681|B3||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3899402|NCT01493089|3723682|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3899403|NCT01493089|3723683|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3899404|NCT01493089|3723681|B3|||Age||years|Mean|44.7|44.7|Standard Deviation|14.69|14.69|||
3899405|NCT01493089|3723682|B2|||Age||years|Mean|44.4|44.4|Standard Deviation|13.91|13.91|||
3899406|NCT01493089|3723683|B1|||Age||years|Mean|45.0|45.0|Standard Deviation|15.43|15.43|||
3899407|NCT01493089|3723681|B3||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3899408|NCT01493089|3723682|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3899409|NCT01493089|3723683|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3899410|NCT01493089|3723681|B3||Between 18 and 65 years|Age||Participants|Count of Participants|219|219.0||||||
3899411|NCT01493089|3723682|B2||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
3899412|NCT01493089|3723683|B1||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
3899413|NCT01493089|3723681|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3899414|NCT01493089|3723682|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3899415|NCT01493089|3723683|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3899416|NCT01493024|3723700|B5|||GFR at Study Day 0||mL/min/1.73 m^2|Mean|45.4|45.4|Standard Deviation|8.09|8.09|||
3899417|NCT01493024|3723701|B4|||GFR at Study Day 0||mL/min/1.73 m^2|Mean|43.5|43.5|Standard Deviation|9.01|9.01|||
3899418|NCT01493024|3723702|B3|||GFR at Study Day 0||mL/min/1.73 m^2|Mean|46.8|46.8|Standard Deviation|7.14|7.14|||
3899419|NCT01493024|3723703|B2|||GFR at Study Day 0||mL/min/1.73 m^2|Mean|46.2|46.2|Standard Deviation|4.99|4.99|||
3899420|NCT01493024|3723704|B1|||GFR at Study Day 0||mL/min/1.73 m^2|Mean|45.6|45.6|Standard Deviation|9.05|9.05|||
3899421|NCT01493024|3723700|B5|||Weight at baseline||kilograms|Mean|89.83|89.83|Standard Deviation|22.794|22.794|||
3899422|NCT01493024|3723701|B4|||Weight at baseline||kilograms|Mean|86.59|86.59|Standard Deviation|26.311|26.311|||
3899423|NCT01493024|3723702|B3|||Weight at baseline||kilograms|Mean|88.96|88.96|Standard Deviation|22.002|22.002|||
3899424|NCT01493024|3723703|B2|||Weight at baseline||kilograms|Mean|84.76|84.76|Standard Deviation|18.022|18.022|||
3899425|NCT01493024|3723704|B1|||Weight at baseline||kilograms|Mean|95.15|95.15|Standard Deviation|22.122|22.122|||
3899426|NCT01493024|3723700|B5|||Serum potassium|Mean of the screening time points (0 hour, 30 minutes, and 1 hour) determined by the central laboratory|mmol/L|Mean|5.16|5.16|Standard Deviation|0.314|0.314|||
3899427|NCT01493024|3723701|B4|||Serum potassium|Mean of the screening time points (0 hour, 30 minutes, and 1 hour) determined by the central laboratory|mmol/L|Mean|5.13|5.13|Standard Deviation|0.378|0.378|||
3899428|NCT01493024|3723702|B3|||Serum potassium|Mean of the screening time points (0 hour, 30 minutes, and 1 hour) determined by the central laboratory|mmol/L|Mean|5.11|5.11|Standard Deviation|0.328|0.328|||
3899429|NCT01493024|3723703|B2|||Serum potassium|Mean of the screening time points (0 hour, 30 minutes, and 1 hour) determined by the central laboratory|mmol/L|Mean|5.25|5.25|Standard Deviation|0.144|0.144|||
3899430|NCT01493024|3723704|B1|||Serum potassium|Mean of the screening time points (0 hour, 30 minutes, and 1 hour) determined by the central laboratory|mmol/L|Mean|5.19|5.19|Standard Deviation|0.301|0.301|||
3899431|NCT01493024|3723700|B5||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3899432|NCT01493024|3723701|B4||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3899433|NCT01493024|3723702|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3899434|NCT01493024|3723703|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3899435|NCT01493024|3723704|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3899436|NCT01493024|3723700|B5||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3899437|NCT01493024|3723701|B4||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3899438|NCT01493024|3723702|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3899439|NCT01493024|3723703|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3899440|NCT01493024|3723704|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3899441|NCT01493024|3723700|B5||White|Race/Ethnicity, Customized||Participants|Count of Participants|88|88.0||||||
3899442|NCT01493024|3723701|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3899443|NCT01493024|3723702|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3899444|NCT01493024|3723703|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3899445|NCT01493024|3723704|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3899446|NCT01493024|3723700|B5||Male|Sex/Gender, Customized|Patients' gender (Female / Male)|Participants|Count of Participants|52|52.0||||||
3899447|NCT01493024|3723701|B4||Male|Sex/Gender, Customized|Patients' gender (Female / Male)|Participants|Count of Participants|9|9.0||||||
3899448|NCT01493024|3723702|B3||Male|Sex/Gender, Customized|Patients' gender (Female / Male)|Participants|Count of Participants|14|14.0||||||
3899449|NCT01493024|3723703|B2||Male|Sex/Gender, Customized|Patients' gender (Female / Male)|Participants|Count of Participants|6|6.0||||||
3899450|NCT01493024|3723704|B1||Male|Sex/Gender, Customized|Patients' gender (Female / Male)|Participants|Count of Participants|23|23.0||||||
3899451|NCT01493024|3723700|B5||Female|Sex/Gender, Customized|Patients' gender (Female / Male)|Participants|Count of Participants|38|38.0||||||
3899452|NCT01493024|3723701|B4||Female|Sex/Gender, Customized|Patients' gender (Female / Male)|Participants|Count of Participants|15|15.0||||||
3899453|NCT01493024|3723702|B3||Female|Sex/Gender, Customized|Patients' gender (Female / Male)|Participants|Count of Participants|10|10.0||||||
3899454|NCT01493024|3723703|B2||Female|Sex/Gender, Customized|Patients' gender (Female / Male)|Participants|Count of Participants|6|6.0||||||
3899455|NCT01493024|3723704|B1||Female|Sex/Gender, Customized|Patients' gender (Female / Male)|Participants|Count of Participants|7|7.0||||||
3899456|NCT01493024|3723700|B5|||Age||Years|Mean|71.1|71.1|Standard Deviation|9.59|9.59|||
3899457|NCT01493024|3723701|B4|||Age||Years|Mean|72.3|72.3|Standard Deviation|11.7|11.7|||
3899458|NCT01493024|3723702|B3|||Age||Years|Mean|72.0|72.0|Standard Deviation|6.3|6.3|||
3899459|NCT01493024|3723703|B2|||Age||Years|Mean|70.3|70.3|Standard Deviation|6.9|6.9|||
3899460|NCT01493024|3723704|B1|||Age||Years|Mean|69.7|69.7|Standard Deviation|11.0|11.0|||
3899461|NCT01492686|3723781|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3899462|NCT01492686|3723782|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3899463|NCT01492686|3723783|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3899464|NCT01492686|3723781|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3899465|NCT01492686|3723782|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3899466|NCT01492686|3723783|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3899467|NCT01492686|3723781|B3||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
3899468|NCT01492686|3723782|B2||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3899469|NCT01492686|3723783|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3899470|NCT01492686|3723781|B3||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
3899471|NCT01492686|3723782|B2||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
3899472|NCT01492686|3723783|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
3899473|NCT01492686|3723781|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3899474|NCT01492686|3723782|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3899475|NCT01492686|3723783|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3899476|NCT01492439|3723808|B3|||Performance on the Wisconsin Card Sorting Test|The WCST is a commonly used test of executive functioning that measures cognitive flexibility and problem solving skills. The 'number of categories' measures the number of correct responses. The percentage of perseverative errors provides the concentration of perseverative errors in relation to the overall test performance. The percentage conceptual level response provides the percentage of consecutive correct responses in runs of 3 or more.|Total categories|Mean|38.41|38.41|Standard Deviation|10.26|10.26|||
3899477|NCT01492439|3723809|B2|||Performance on the Wisconsin Card Sorting Test|The WCST is a commonly used test of executive functioning that measures cognitive flexibility and problem solving skills. The 'number of categories' measures the number of correct responses. The percentage of perseverative errors provides the concentration of perseverative errors in relation to the overall test performance. The percentage conceptual level response provides the percentage of consecutive correct responses in runs of 3 or more.|Total categories|Mean|40.55|40.55|Standard Deviation|7.82|7.82|||
3899478|NCT01492439|3723810|B1|||Performance on the Wisconsin Card Sorting Test|The WCST is a commonly used test of executive functioning that measures cognitive flexibility and problem solving skills. The 'number of categories' measures the number of correct responses. The percentage of perseverative errors provides the concentration of perseverative errors in relation to the overall test performance. The percentage conceptual level response provides the percentage of consecutive correct responses in runs of 3 or more.|Total categories|Mean|36.37|36.37|Standard Deviation|11.98|11.98|||
3899479|NCT01492439|3723808|B3|||Performance on The Digit Vigilance Test|The Digit Vigilance test measures sustained attention/vigilance. Participants are asked to cross out either 6s or 9s which appear randomly within 59 rows of 35 single digits. Scores are calculated for Total Time and Total Errors, with higher scores indicating greater impairment.|Incorrect responses|Mean|7.59|7.59|Standard Deviation|5.77|5.77|||
3899532|NCT01492439|3723810|B1|Volunteer||Hours/week spent|Meaningful activity is defined as time spent engaged in something meaningful that provides an individual with a sense of purpose.|hours per week|Mean|0.9|0.9|Standard Deviation|2.1|2.1|||
3899480|NCT01492439|3723809|B2|||Performance on The Digit Vigilance Test|The Digit Vigilance test measures sustained attention/vigilance. Participants are asked to cross out either 6s or 9s which appear randomly within 59 rows of 35 single digits. Scores are calculated for Total Time and Total Errors, with higher scores indicating greater impairment.|Incorrect responses|Mean|6.72|6.72|Standard Deviation|4.79|4.79|||
3899481|NCT01492439|3723810|B1|||Performance on The Digit Vigilance Test|The Digit Vigilance test measures sustained attention/vigilance. Participants are asked to cross out either 6s or 9s which appear randomly within 59 rows of 35 single digits. Scores are calculated for Total Time and Total Errors, with higher scores indicating greater impairment.|Incorrect responses|Mean|8.42|8.42|Standard Deviation|6.59|6.59|||
3899482|NCT01492439|3723808|B3|||Performance on The Digit Vigilance Test|The Digit Vigilance test measures sustained attention/vigilance. Participants are asked to cross out either 6s or 9s which appear randomly within 59 rows of 35 single digits. Scores are calculated for Total Time and Total Errors, with higher scores indicating greater impairment.|Seconds|Mean|446.14|446.14|Standard Deviation|111.01|111.01|||
3899483|NCT01492439|3723809|B2|||Performance on The Digit Vigilance Test|The Digit Vigilance test measures sustained attention/vigilance. Participants are asked to cross out either 6s or 9s which appear randomly within 59 rows of 35 single digits. Scores are calculated for Total Time and Total Errors, with higher scores indicating greater impairment.|Seconds|Mean|433.22|433.22|Standard Deviation|103.34|103.34|||
3899484|NCT01492439|3723810|B1|||Performance on The Digit Vigilance Test|The Digit Vigilance test measures sustained attention/vigilance. Participants are asked to cross out either 6s or 9s which appear randomly within 59 rows of 35 single digits. Scores are calculated for Total Time and Total Errors, with higher scores indicating greater impairment.|Seconds|Mean|458.37|458.37|Standard Deviation|119.31|119.31|||
3899485|NCT01492439|3723808|B3|% conceptual level of responses||Performance on the Wisconsin Card Sorting Test (WCST)|The WCST is a commonly used test of executive functioning that measures cognitive flexibility and problem solving skills. The 'number of categories' measures the number of correct responses. The percentage of perseverative errors provides the concentration of perseverative errors in relation to the overall test performance. The percentage conceptual level response provides the percentage of consecutive correct responses in runs of 3 or more.|Percentage of responses|Mean|47.30|47.3|Standard Deviation|22.51|22.51|||
3899486|NCT01492439|3723809|B2|% conceptual level of responses||Performance on the Wisconsin Card Sorting Test (WCST)|The WCST is a commonly used test of executive functioning that measures cognitive flexibility and problem solving skills. The 'number of categories' measures the number of correct responses. The percentage of perseverative errors provides the concentration of perseverative errors in relation to the overall test performance. The percentage conceptual level response provides the percentage of consecutive correct responses in runs of 3 or more.|Percentage of responses|Mean|52.94|52.94|Standard Deviation|16.74|16.74|||
3899487|NCT01492439|3723810|B1|% conceptual level of responses||Performance on the Wisconsin Card Sorting Test (WCST)|The WCST is a commonly used test of executive functioning that measures cognitive flexibility and problem solving skills. The 'number of categories' measures the number of correct responses. The percentage of perseverative errors provides the concentration of perseverative errors in relation to the overall test performance. The percentage conceptual level response provides the percentage of consecutive correct responses in runs of 3 or more.|Percentage of responses|Mean|41.95|41.95|Standard Deviation|26.20|26.2|||
3899488|NCT01492439|3723808|B3|% perseverative errors||Performance on the Wisconsin Card Sorting Test (WCST)|The WCST is a commonly used test of executive functioning that measures cognitive flexibility and problem solving skills. The 'number of categories' measures the number of correct responses. The percentage of perseverative errors provides the concentration of perseverative errors in relation to the overall test performance. The percentage conceptual level response provides the percentage of consecutive correct responses in runs of 3 or more.|Percentage of responses|Mean|19.38|19.38|Standard Deviation|10.46|10.46|||
3899489|NCT01492439|3723809|B2|% perseverative errors||Performance on the Wisconsin Card Sorting Test (WCST)|The WCST is a commonly used test of executive functioning that measures cognitive flexibility and problem solving skills. The 'number of categories' measures the number of correct responses. The percentage of perseverative errors provides the concentration of perseverative errors in relation to the overall test performance. The percentage conceptual level response provides the percentage of consecutive correct responses in runs of 3 or more.|Percentage of responses|Mean|18.94|18.94|Standard Deviation|8.54|8.54|||
3899490|NCT01492439|3723810|B1|% perseverative errors||Performance on the Wisconsin Card Sorting Test (WCST)|The WCST is a commonly used test of executive functioning that measures cognitive flexibility and problem solving skills. The 'number of categories' measures the number of correct responses. The percentage of perseverative errors provides the concentration of perseverative errors in relation to the overall test performance. The percentage conceptual level response provides the percentage of consecutive correct responses in runs of 3 or more.|Percentage of responses|Mean|19.79|19.79|Standard Deviation|12.23|12.23|||
3899491|NCT01492439|3723808|B3|||Performance on the Trail Making Test Part B|The Trail Making Test Part B assesses executive function. Trail Making Part B requires subjects to connect consecutively numbered and lettered circles by alternating between the 2 sequences. For this timed test, participants are scored by the number of seconds taken to complete the task, with high scores revealing greater impairment.|Seconds|Mean|95.84|95.84|Standard Deviation|50.33|50.33|||
3899492|NCT01492439|3723809|B2|||Performance on the Trail Making Test Part B|The Trail Making Test Part B assesses executive function. Trail Making Part B requires subjects to connect consecutively numbered and lettered circles by alternating between the 2 sequences. For this timed test, participants are scored by the number of seconds taken to complete the task, with high scores revealing greater impairment.|Seconds|Mean|92.83|92.83|Standard Deviation|42.93|42.93|||
3899493|NCT01492439|3723810|B1|||Performance on the Trail Making Test Part B|The Trail Making Test Part B assesses executive function. Trail Making Part B requires subjects to connect consecutively numbered and lettered circles by alternating between the 2 sequences. For this timed test, participants are scored by the number of seconds taken to complete the task, with high scores revealing greater impairment.|Seconds|Mean|98.68|98.68|Standard Deviation|57.58|57.58|||
3899533|NCT01492439|3723808|B3|Student||Hours/week spent|Meaningful activity is defined as time spent engaged in something meaningful that provides an individual with a sense of purpose.|hours per week|Mean|19.4|19.4|Standard Deviation|1.3|1.3|||
3899494|NCT01492439|3723808|B3|Total||Performance on the digit span subtest of the Wechsler Adult Intelligence Scale -III|Short term memory will be evaluated with the digit span subtest of the Wechsler Adult Intelligence Scale-III. Participants are asked to recall a sequence of numbers, starting with 2 and increasing to a sequence of 9 numbers. If the participant repeats the sequence correctly they score a one, if incorrect then score a zero. This test consists of two lists, one to be repeated forwards and the other backwards. The total score is a sum of sequences recalled correctly on the forward and backwards list.|Correct responses|Mean|15.73|15.73|Standard Deviation|3.81|3.81|||
3899495|NCT01492439|3723809|B2|Total||Performance on the digit span subtest of the Wechsler Adult Intelligence Scale -III|Short term memory will be evaluated with the digit span subtest of the Wechsler Adult Intelligence Scale-III. Participants are asked to recall a sequence of numbers, starting with 2 and increasing to a sequence of 9 numbers. If the participant repeats the sequence correctly they score a one, if incorrect then score a zero. This test consists of two lists, one to be repeated forwards and the other backwards. The total score is a sum of sequences recalled correctly on the forward and backwards list.|Correct responses|Mean|16.78|16.78|Standard Deviation|3.08|3.08|||
3899496|NCT01492439|3723810|B1|Total||Performance on the digit span subtest of the Wechsler Adult Intelligence Scale -III|Short term memory will be evaluated with the digit span subtest of the Wechsler Adult Intelligence Scale-III. Participants are asked to recall a sequence of numbers, starting with 2 and increasing to a sequence of 9 numbers. If the participant repeats the sequence correctly they score a one, if incorrect then score a zero. This test consists of two lists, one to be repeated forwards and the other backwards. The total score is a sum of sequences recalled correctly on the forward and backwards list.|Correct responses|Mean|14.74|14.74|Standard Deviation|4.24|4.24|||
3899497|NCT01492439|3723808|B3|Backward sequence||Performance on the digit span subtest of the Wechsler Adult Intelligence Scale -III|Short term memory will be evaluated with the digit span subtest of the Wechsler Adult Intelligence Scale-III. Participants are asked to recall a sequence of numbers, starting with 2 and increasing to a sequence of 9 numbers. If the participant repeats the sequence correctly they score a one, if incorrect then score a zero. This test consists of two lists, one to be repeated forwards and the other backwards. The total score is a sum of sequences recalled correctly on the forward and backwards list.|Correct responses|Mean|5.78|5.78|Standard Deviation|1.97|1.97|||
3899498|NCT01492439|3723809|B2|Backward sequence||Performance on the digit span subtest of the Wechsler Adult Intelligence Scale -III|Short term memory will be evaluated with the digit span subtest of the Wechsler Adult Intelligence Scale-III. Participants are asked to recall a sequence of numbers, starting with 2 and increasing to a sequence of 9 numbers. If the participant repeats the sequence correctly they score a one, if incorrect then score a zero. This test consists of two lists, one to be repeated forwards and the other backwards. The total score is a sum of sequences recalled correctly on the forward and backwards list.|Correct responses|Mean|6.17|6.17|Standard Deviation|1.62|1.62|||
3899499|NCT01492439|3723810|B1|Backward sequence||Performance on the digit span subtest of the Wechsler Adult Intelligence Scale -III|Short term memory will be evaluated with the digit span subtest of the Wechsler Adult Intelligence Scale-III. Participants are asked to recall a sequence of numbers, starting with 2 and increasing to a sequence of 9 numbers. If the participant repeats the sequence correctly they score a one, if incorrect then score a zero. This test consists of two lists, one to be repeated forwards and the other backwards. The total score is a sum of sequences recalled correctly on the forward and backwards list.|Correct responses|Mean|5.18|5.18|Standard Deviation|2.22|2.22|||
3899500|NCT01492439|3723808|B3|Forward sequence||Performance on the digit span subtest of the Wechsler Adult Intelligence Scale -III|Short term memory will be evaluated with the digit span subtest of the Wechsler Adult Intelligence Scale-III. Participants are asked to recall a sequence of numbers, starting with 2 and increasing to a sequence of 9 numbers. If the participant repeats the sequence correctly they score a one, if incorrect then score a zero. This test consists of two lists, one to be repeated forwards and the other backwards. The total score is a sum of sequences recalled correctly on the forward and backwards list.|Correct responses|Mean|10.08|10.08|Standard Deviation|2.44|2.44|||
3899501|NCT01492439|3723809|B2|Forward sequence||Performance on the digit span subtest of the Wechsler Adult Intelligence Scale -III|Short term memory will be evaluated with the digit span subtest of the Wechsler Adult Intelligence Scale-III. Participants are asked to recall a sequence of numbers, starting with 2 and increasing to a sequence of 9 numbers. If the participant repeats the sequence correctly they score a one, if incorrect then score a zero. This test consists of two lists, one to be repeated forwards and the other backwards. The total score is a sum of sequences recalled correctly on the forward and backwards list.|Correct responses|Mean|10.61|10.61|Standard Deviation|2.30|2.3|||
3899502|NCT01492439|3723810|B1|Forward sequence||Performance on the digit span subtest of the Wechsler Adult Intelligence Scale -III|Short term memory will be evaluated with the digit span subtest of the Wechsler Adult Intelligence Scale-III. Participants are asked to recall a sequence of numbers, starting with 2 and increasing to a sequence of 9 numbers. If the participant repeats the sequence correctly they score a one, if incorrect then score a zero. This test consists of two lists, one to be repeated forwards and the other backwards. The total score is a sum of sequences recalled correctly on the forward and backwards list.|Correct responses|Mean|9.58|9.58|Standard Deviation|2.52|2.52|||
3899503|NCT01492439|3723808|B3|||Performance on the Trail Making Test Part A|The Trail Making Test Part A is a test involving using lines to connect numbers, it will be used to assess scanning ability and psychomotor speed. For this timed test, participants are scored by the number of seconds taken to complete the task, with high scores revealing greater impairment.|Seconds|Mean|44.30|44.3|Standard Deviation|29.10|29.1|||
3899504|NCT01492439|3723809|B2|||Performance on the Trail Making Test Part A|The Trail Making Test Part A is a test involving using lines to connect numbers, it will be used to assess scanning ability and psychomotor speed. For this timed test, participants are scored by the number of seconds taken to complete the task, with high scores revealing greater impairment.|Seconds|Mean|39.33|39.33|Standard Deviation|15.96|15.96|||
3899505|NCT01492439|3723810|B1|||Performance on the Trail Making Test Part A|The Trail Making Test Part A is a test involving using lines to connect numbers, it will be used to assess scanning ability and psychomotor speed. For this timed test, participants are scored by the number of seconds taken to complete the task, with high scores revealing greater impairment.|Seconds|Mean|49.00|49.0|Standard Deviation|37.48|37.48|||
3899588|NCT01492439|3723809|B2|No||English as a second language||participants|Number|11|11.0||||||
3899506|NCT01492439|3723808|B3|Long delay free recall||Performance on the California Verbal Learning Test|Verbal learning and memory will be assessed with the California Verbal Learning Test. A 9 word list is read to the participant (List A). Participants are asked to immediately free recall List A over 4 trials, then recall after a distractor task (short delay), then after a long delay.In the cued recall section, participants are asked to recall by category. In the long delay yes/no recognition, participants are asked to recall List A items out of a 27 word list. Higher repetitions and intrusions reveal greater impairment.|Correct responses|Mean|5.81|5.81|Standard Deviation|1.58|1.58|||
3899507|NCT01492439|3723809|B2|Long delay free recall||Performance on the California Verbal Learning Test|Verbal learning and memory will be assessed with the California Verbal Learning Test. A 9 word list is read to the participant (List A). Participants are asked to immediately free recall List A over 4 trials, then recall after a distractor task (short delay), then after a long delay.In the cued recall section, participants are asked to recall by category. In the long delay yes/no recognition, participants are asked to recall List A items out of a 27 word list. Higher repetitions and intrusions reveal greater impairment.|Correct responses|Mean|5.61|5.61|Standard Deviation|1.46|1.46|||
3899508|NCT01492439|3723810|B1|Long delay free recall||Performance on the California Verbal Learning Test|Verbal learning and memory will be assessed with the California Verbal Learning Test. A 9 word list is read to the participant (List A). Participants are asked to immediately free recall List A over 4 trials, then recall after a distractor task (short delay), then after a long delay.In the cued recall section, participants are asked to recall by category. In the long delay yes/no recognition, participants are asked to recall List A items out of a 27 word list. Higher repetitions and intrusions reveal greater impairment.|Correct responses|Mean|6.00|6.0|Standard Deviation|1.70|1.7|||
3899509|NCT01492439|3723808|B3|Total free recall (trials 1-4)||Performance on the California Verbal Learning Test|Verbal learning and memory will be assessed with the California Verbal Learning Test. A 9 word list is read to the participant (List A). Participants are asked to immediately free recall List A over 4 trials, then recall after a distractor task (short delay), then after a long delay.In the cued recall section, participants are asked to recall by category. In the long delay yes/no recognition, participants are asked to recall List A items out of a 27 word list. Higher repetitions and intrusions reveal greater impairment.|Correct responses|Mean|23.49|23.49|Standard Deviation|3.69|3.69|||
3899510|NCT01492439|3723809|B2|Total free recall (trials 1-4)||Performance on the California Verbal Learning Test|Verbal learning and memory will be assessed with the California Verbal Learning Test. A 9 word list is read to the participant (List A). Participants are asked to immediately free recall List A over 4 trials, then recall after a distractor task (short delay), then after a long delay.In the cued recall section, participants are asked to recall by category. In the long delay yes/no recognition, participants are asked to recall List A items out of a 27 word list. Higher repetitions and intrusions reveal greater impairment.|Correct responses|Mean|23.50|23.5|Standard Deviation|3.28|3.28|||
3899511|NCT01492439|3723810|B1|Total free recall (trials 1-4)||Performance on the California Verbal Learning Test|Verbal learning and memory will be assessed with the California Verbal Learning Test. A 9 word list is read to the participant (List A). Participants are asked to immediately free recall List A over 4 trials, then recall after a distractor task (short delay), then after a long delay.In the cued recall section, participants are asked to recall by category. In the long delay yes/no recognition, participants are asked to recall List A items out of a 27 word list. Higher repetitions and intrusions reveal greater impairment.|Correct responses|Mean|23.47|23.47|Standard Deviation|4.13|4.13|||
3899512|NCT01492439|3723808|B3|Trial 1||Performance on the California Verbal Learning Test|Verbal learning and memory will be assessed with the California Verbal Learning Test. A 9 word list is read to the participant (List A). Participants are asked to immediately free recall List A over 4 trials, then recall after a distractor task (short delay), then after a long delay.In the cued recall section, participants are asked to recall by category. In the long delay yes/no recognition, participants are asked to recall List A items out of a 27 word list. Higher repetitions and intrusions reveal greater impairment.|Correct responses|Mean|4.49|4.49|Standard Deviation|1.10|1.1|||
3899513|NCT01492439|3723809|B2|Trial 1||Performance on the California Verbal Learning Test|Verbal learning and memory will be assessed with the California Verbal Learning Test. A 9 word list is read to the participant (List A). Participants are asked to immediately free recall List A over 4 trials, then recall after a distractor task (short delay), then after a long delay.In the cued recall section, participants are asked to recall by category. In the long delay yes/no recognition, participants are asked to recall List A items out of a 27 word list. Higher repetitions and intrusions reveal greater impairment.|Correct responses|Mean|4.50|4.5|Standard Deviation|0.79|0.79|||
3899514|NCT01492439|3723810|B1|Trial 1||Performance on the California Verbal Learning Test|Verbal learning and memory will be assessed with the California Verbal Learning Test. A 9 word list is read to the participant (List A). Participants are asked to immediately free recall List A over 4 trials, then recall after a distractor task (short delay), then after a long delay.In the cued recall section, participants are asked to recall by category. In the long delay yes/no recognition, participants are asked to recall List A items out of a 27 word list. Higher repetitions and intrusions reveal greater impairment.|Correct responses|Mean|4.47|4.47|Standard Deviation|1.35|1.35|||
3899515|NCT01492439|3723808|B3|||The Rosenberg Self-Esteem Scale Score|The Rosenberg Self Esteem Scale measures self esteem. This is a ten item, four point Likert scale with scores ranging from strongly agree to strongly disagree. Scores can range from 0-30. Total sum scores between 15 and 25 are within normal range; with scores below 15 suggest low self-esteem.|units on a scale|Mean|18.30|18.3|Standard Deviation|4.69|4.69|||
3899516|NCT01492439|3723809|B2|||The Rosenberg Self-Esteem Scale Score|The Rosenberg Self Esteem Scale measures self esteem. This is a ten item, four point Likert scale with scores ranging from strongly agree to strongly disagree. Scores can range from 0-30. Total sum scores between 15 and 25 are within normal range; with scores below 15 suggest low self-esteem.|units on a scale|Mean|17.39|17.39|Standard Deviation|4.70|4.7|||
3899517|NCT01492439|3723810|B1|||The Rosenberg Self-Esteem Scale Score|The Rosenberg Self Esteem Scale measures self esteem. This is a ten item, four point Likert scale with scores ranging from strongly agree to strongly disagree. Scores can range from 0-30. Total sum scores between 15 and 25 are within normal range; with scores below 15 suggest low self-esteem.|units on a scale|Mean|19.16|19.16|Standard Deviation|4.63|4.63|||
3899589|NCT01492439|3723810|B1|No||English as a second language||participants|Number|14|14.0||||||
3899518|NCT01492439|3723808|B3|General psychopathology||Positive and Negative Syndrome Scale (PANSS) score|Symptoms of psychosis will be assessed using the Positive and Negative Syndrome Scale. The 30 item scale is comprised of 3 subscales measuring positive, negative and general psychopathology symptoms. Each item is scored using 7 anchoring criteria; 1=absent, 2=minimal, 3=mild, 4=moderate, 5=moderate severe, 6=severe, 7=extreme. Scores for the positive scale range from 7-49, the negative scale from 7-49, and general psychopathology 16-112, with total summed scores ranging from 30-210. 95>high, 75-95 medium and <75 low symptomology.|units on a scale|Mean|27.76|27.76|Standard Deviation|6.35|6.35|||
3899519|NCT01492439|3723809|B2|General psychopathology||Positive and Negative Syndrome Scale (PANSS) score|Symptoms of psychosis will be assessed using the Positive and Negative Syndrome Scale. The 30 item scale is comprised of 3 subscales measuring positive, negative and general psychopathology symptoms. Each item is scored using 7 anchoring criteria; 1=absent, 2=minimal, 3=mild, 4=moderate, 5=moderate severe, 6=severe, 7=extreme. Scores for the positive scale range from 7-49, the negative scale from 7-49, and general psychopathology 16-112, with total summed scores ranging from 30-210. 95>high, 75-95 medium and <75 low symptomology.|units on a scale|Mean|28.33|28.33|Standard Deviation|5.89|5.89|||
3899520|NCT01492439|3723810|B1|General psychopathology||Positive and Negative Syndrome Scale (PANSS) score|Symptoms of psychosis will be assessed using the Positive and Negative Syndrome Scale. The 30 item scale is comprised of 3 subscales measuring positive, negative and general psychopathology symptoms. Each item is scored using 7 anchoring criteria; 1=absent, 2=minimal, 3=mild, 4=moderate, 5=moderate severe, 6=severe, 7=extreme. Scores for the positive scale range from 7-49, the negative scale from 7-49, and general psychopathology 16-112, with total summed scores ranging from 30-210. 95>high, 75-95 medium and <75 low symptomology.|units on a scale|Mean|27.21|27.21|Standard Deviation|6.87|6.87|||
3899521|NCT01492439|3723808|B3|Negative||Positive and Negative Syndrome Scale (PANSS) score|Symptoms of psychosis will be assessed using the Positive and Negative Syndrome Scale. The 30 item scale is comprised of 3 subscales measuring positive, negative and general psychopathology symptoms. Each item is scored using 7 anchoring criteria; 1=absent, 2=minimal, 3=mild, 4=moderate, 5=moderate severe, 6=severe, 7=extreme. Scores for the positive scale range from 7-49, the negative scale from 7-49, and general psychopathology 16-112, with total summed scores ranging from 30-210. 95>high, 75-95 medium and <75 low symptomology.|units on a scale|Mean|13.97|13.97|Standard Deviation|4.48|4.48|||
3899522|NCT01492439|3723809|B2|Negative||Positive and Negative Syndrome Scale (PANSS) score|Symptoms of psychosis will be assessed using the Positive and Negative Syndrome Scale. The 30 item scale is comprised of 3 subscales measuring positive, negative and general psychopathology symptoms. Each item is scored using 7 anchoring criteria; 1=absent, 2=minimal, 3=mild, 4=moderate, 5=moderate severe, 6=severe, 7=extreme. Scores for the positive scale range from 7-49, the negative scale from 7-49, and general psychopathology 16-112, with total summed scores ranging from 30-210. 95>high, 75-95 medium and <75 low symptomology.|units on a scale|Mean|14.56|14.56|Standard Deviation|4.95|4.95|||
3899523|NCT01492439|3723810|B1|Negative||Positive and Negative Syndrome Scale (PANSS) score|Symptoms of psychosis will be assessed using the Positive and Negative Syndrome Scale. The 30 item scale is comprised of 3 subscales measuring positive, negative and general psychopathology symptoms. Each item is scored using 7 anchoring criteria; 1=absent, 2=minimal, 3=mild, 4=moderate, 5=moderate severe, 6=severe, 7=extreme. Scores for the positive scale range from 7-49, the negative scale from 7-49, and general psychopathology 16-112, with total summed scores ranging from 30-210. 95>high, 75-95 medium and <75 low symptomology.|units on a scale|Mean|13.42|13.42|Standard Deviation|4.03|4.03|||
3899524|NCT01492439|3723808|B3|Positive||Positive and Negative Syndrome Scale (PANSS) score|Symptoms of psychosis will be assessed using the Positive and Negative Syndrome Scale. The 30 item scale is comprised of 3 subscales measuring positive, negative and general psychopathology symptoms. Each item is scored using 7 anchoring criteria; 1=absent, 2=minimal, 3=mild, 4=moderate, 5=moderate severe, 6=severe, 7=extreme. Scores for the positive scale range from 7-49, the negative scale from 7-49, and general psychopathology 16-112, with total summed scores ranging from 30-210. 95>high, 75-95 medium and <75 low symptomology.|units on a scale|Mean|13.32|13.32|Standard Deviation|5.30|5.3|||
3899525|NCT01492439|3723809|B2|Positive||Positive and Negative Syndrome Scale (PANSS) score|Symptoms of psychosis will be assessed using the Positive and Negative Syndrome Scale. The 30 item scale is comprised of 3 subscales measuring positive, negative and general psychopathology symptoms. Each item is scored using 7 anchoring criteria; 1=absent, 2=minimal, 3=mild, 4=moderate, 5=moderate severe, 6=severe, 7=extreme. Scores for the positive scale range from 7-49, the negative scale from 7-49, and general psychopathology 16-112, with total summed scores ranging from 30-210. 95>high, 75-95 medium and <75 low symptomology.|units on a scale|Mean|13.06|13.06|Standard Deviation|3.95|3.95|||
3899526|NCT01492439|3723810|B1|Positive||Positive and Negative Syndrome Scale (PANSS) score|Symptoms of psychosis will be assessed using the Positive and Negative Syndrome Scale. The 30 item scale is comprised of 3 subscales measuring positive, negative and general psychopathology symptoms. Each item is scored using 7 anchoring criteria; 1=absent, 2=minimal, 3=mild, 4=moderate, 5=moderate severe, 6=severe, 7=extreme. Scores for the positive scale range from 7-49, the negative scale from 7-49, and general psychopathology 16-112, with total summed scores ranging from 30-210. 95>high, 75-95 medium and <75 low symptomology.|units on a scale|Mean|13.58|13.58|Standard Deviation|6.43|6.43|||
3899527|NCT01492439|3723808|B3|Total hours engaged in meaningful activity||Hours/week spent|Meaningful activity is defined as time spent engaged in something meaningful that provides an individual with a sense of purpose.|hours per week|Mean|23.1|23.1|Standard Deviation|6.2|6.2|||
3899528|NCT01492439|3723809|B2|Total hours engaged in meaningful activity||Hours/week spent|Meaningful activity is defined as time spent engaged in something meaningful that provides an individual with a sense of purpose.|hours per week|Mean|24.5|24.5|Standard Deviation|7.1|7.1|||
3899529|NCT01492439|3723810|B1|Total hours engaged in meaningful activity||Hours/week spent|Meaningful activity is defined as time spent engaged in something meaningful that provides an individual with a sense of purpose.|hours per week|Mean|21.8|21.8|Standard Deviation|5.0|5.0|||
3899530|NCT01492439|3723808|B3|Volunteer||Hours/week spent|Meaningful activity is defined as time spent engaged in something meaningful that provides an individual with a sense of purpose.|hours per week|Mean|1.3|1.3|Standard Deviation|3.0|3.0|||
3899531|NCT01492439|3723809|B2|Volunteer||Hours/week spent|Meaningful activity is defined as time spent engaged in something meaningful that provides an individual with a sense of purpose.|hours per week|Mean|1.7|1.7|Standard Deviation|3.7|3.7|||
3899534|NCT01492439|3723809|B2|Student||Hours/week spent|Meaningful activity is defined as time spent engaged in something meaningful that provides an individual with a sense of purpose.|hours per week|Mean|19.7|19.7|Standard Deviation|1.2|1.2|||
3899535|NCT01492439|3723810|B1|Student||Hours/week spent|Meaningful activity is defined as time spent engaged in something meaningful that provides an individual with a sense of purpose.|hours per week|Mean|19.1|19.1|Standard Deviation|1.5|1.5|||
3899536|NCT01492439|3723808|B3|Competitive Employment||Hours/week spent|Meaningful activity is defined as time spent engaged in something meaningful that provides an individual with a sense of purpose.|hours per week|Mean|2.4|2.4|Standard Deviation|5.7|5.7|||
3899537|NCT01492439|3723809|B2|Competitive Employment||Hours/week spent|Meaningful activity is defined as time spent engaged in something meaningful that provides an individual with a sense of purpose.|hours per week|Mean|3.0|3.0|Standard Deviation|6.9|6.9|||
3899538|NCT01492439|3723810|B1|Competitive Employment||Hours/week spent|Meaningful activity is defined as time spent engaged in something meaningful that provides an individual with a sense of purpose.|hours per week|Mean|1.7|1.7|Standard Deviation|4.3|4.3|||
3899539|NCT01492439|3723808|B3|||Years since last hospitalization||years|Mean|2.5|2.5|Standard Deviation|3.8|3.8|||
3899540|NCT01492439|3723809|B2|||Years since last hospitalization||years|Mean|1.7|1.7|Standard Deviation|2.9|2.9|||
3899541|NCT01492439|3723810|B1|||Years since last hospitalization||years|Mean|3.2|3.2|Standard Deviation|4.5|4.5|||
3899542|NCT01492439|3723808|B3|||Years since diagnosis||years|Mean|6.9|6.9|Standard Deviation|5.9|5.9|||
3899543|NCT01492439|3723809|B2|||Years since diagnosis||years|Mean|7.0|7.0|Standard Deviation|5.5|5.5|||
3899544|NCT01492439|3723810|B1|||Years since diagnosis||years|Mean|6.7|6.7|Standard Deviation|6.5|6.5|||
3899545|NCT01492439|3723808|B3|||Years of education||years|Mean|12.5|12.5|Standard Deviation|1.7|1.7|||
3899546|NCT01492439|3723809|B2|||Years of education||years|Mean|13.2|13.2|Standard Deviation|1.9|1.9|||
3899547|NCT01492439|3723810|B1|||Years of education||years|Mean|11.9|11.9|Standard Deviation|1.2|1.2|||
3899548|NCT01492439|3723808|B3|Shelter or other temporary residence||Housing||participants|Number|3|3.0||||||
3899549|NCT01492439|3723809|B2|Shelter or other temporary residence||Housing||participants|Number|2|2.0||||||
3899550|NCT01492439|3723810|B1|Shelter or other temporary residence||Housing||participants|Number|1|1.0||||||
3899551|NCT01492439|3723808|B3|Live with family||Housing||participants|Number|16|16.0||||||
3899552|NCT01492439|3723809|B2|Live with family||Housing||participants|Number|6|6.0||||||
3899553|NCT01492439|3723810|B1|Live with family||Housing||participants|Number|10|10.0||||||
3899554|NCT01492439|3723808|B3|Supported housing e.g. boarding home||Housing||participants|Number|7|7.0||||||
3899555|NCT01492439|3723809|B2|Supported housing e.g. boarding home||Housing||participants|Number|4|4.0||||||
3899556|NCT01492439|3723810|B1|Supported housing e.g. boarding home||Housing||participants|Number|3|3.0||||||
3899557|NCT01492439|3723808|B3|Own/rent apartment or house||Housing||participants|Number|11|11.0||||||
3899558|NCT01492439|3723809|B2|Own/rent apartment or house||Housing||participants|Number|6|6.0||||||
3899559|NCT01492439|3723810|B1|Own/rent apartment or house||Housing||participants|Number|5|5.0||||||
3899560|NCT01492439|3723808|B3|No||Hospitalized as a result of diagnosis||participants|Number|13|13.0||||||
3899561|NCT01492439|3723809|B2|No||Hospitalized as a result of diagnosis||participants|Number|9|9.0||||||
3899562|NCT01492439|3723810|B1|No||Hospitalized as a result of diagnosis||participants|Number|4|4.0||||||
3899563|NCT01492439|3723808|B3|Yes||Hospitalized as a result of diagnosis||participants|Number|24|24.0||||||
3899564|NCT01492439|3723809|B2|Yes||Hospitalized as a result of diagnosis||participants|Number|9|9.0||||||
3899565|NCT01492439|3723810|B1|Yes||Hospitalized as a result of diagnosis||participants|Number|15|15.0||||||
3899566|NCT01492439|3723808|B3|Psychosis NOS (Not otherwise specified)||Primary diagnosis||participants|Number|6|6.0||||||
3899567|NCT01492439|3723809|B2|Psychosis NOS (Not otherwise specified)||Primary diagnosis||participants|Number|4|4.0||||||
3899568|NCT01492439|3723810|B1|Psychosis NOS (Not otherwise specified)||Primary diagnosis||participants|Number|2|2.0||||||
3899569|NCT01492439|3723808|B3|Bipolar||Primary diagnosis||participants|Number|7|7.0||||||
3899570|NCT01492439|3723809|B2|Bipolar||Primary diagnosis||participants|Number|2|2.0||||||
3899571|NCT01492439|3723810|B1|Bipolar||Primary diagnosis||participants|Number|5|5.0||||||
3899572|NCT01492439|3723808|B3|Schizoaffective||Primary diagnosis||participants|Number|3|3.0||||||
3899573|NCT01492439|3723809|B2|Schizoaffective||Primary diagnosis||participants|Number|2|2.0||||||
3899574|NCT01492439|3723810|B1|Schizoaffective||Primary diagnosis||participants|Number|1|1.0||||||
3899575|NCT01492439|3723808|B3|Schizophrenia||Primary diagnosis||participants|Number|21|21.0||||||
3899576|NCT01492439|3723809|B2|Schizophrenia||Primary diagnosis||participants|Number|10|10.0||||||
3899577|NCT01492439|3723810|B1|Schizophrenia||Primary diagnosis||participants|Number|11|11.0||||||
3899578|NCT01492439|3723808|B3|Advanced||Self assessed level of competency in English||participants|Number|11|11.0||||||
3899579|NCT01492439|3723809|B2|Advanced||Self assessed level of competency in English||participants|Number|3|3.0||||||
3899580|NCT01492439|3723810|B1|Advanced||Self assessed level of competency in English||participants|Number|8|8.0||||||
3899581|NCT01492439|3723808|B3|Intermediate||Self assessed level of competency in English||participants|Number|24|24.0||||||
3899582|NCT01492439|3723809|B2|Intermediate||Self assessed level of competency in English||participants|Number|15|15.0||||||
3899583|NCT01492439|3723810|B1|Intermediate||Self assessed level of competency in English||participants|Number|9|9.0||||||
3899584|NCT01492439|3723808|B3|Beginner||Self assessed level of competency in English||participants|Number|2|2.0||||||
3899585|NCT01492439|3723809|B2|Beginner||Self assessed level of competency in English||participants|Number|0|0.0||||||
3899586|NCT01492439|3723810|B1|Beginner||Self assessed level of competency in English||participants|Number|2|2.0||||||
3899587|NCT01492439|3723808|B3|No||English as a second language||participants|Number|25|25.0||||||
3899590|NCT01492439|3723808|B3|Yes||English as a second language||participants|Number|12|12.0||||||
3899591|NCT01492439|3723809|B2|Yes||English as a second language||participants|Number|7|7.0||||||
3899592|NCT01492439|3723810|B1|Yes||English as a second language||participants|Number|5|5.0||||||
3899593|NCT01492439|3723808|B3|Canada||Region of Enrollment||participants|Number|37|37.0||||||
3899594|NCT01492439|3723809|B2|Canada||Region of Enrollment||participants|Number|18|18.0||||||
3899595|NCT01492439|3723810|B1|Canada||Region of Enrollment||participants|Number|19|19.0||||||
3899596|NCT01492439|3723808|B3|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3899597|NCT01492439|3723809|B2|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3899598|NCT01492439|3723810|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3899599|NCT01492439|3723808|B3|White European Origin||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3899600|NCT01492439|3723809|B2|White European Origin||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3899601|NCT01492439|3723810|B1|White European Origin||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3899602|NCT01492439|3723808|B3|Mixed Background||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3899603|NCT01492439|3723809|B2|Mixed Background||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3899604|NCT01492439|3723810|B1|Mixed Background||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3899605|NCT01492439|3723808|B3|Black Caribbean||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3899606|NCT01492439|3723809|B2|Black Caribbean||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3899607|NCT01492439|3723810|B1|Black Caribbean||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3899608|NCT01492439|3723808|B3|Black Canadian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3899609|NCT01492439|3723809|B2|Black Canadian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3899610|NCT01492439|3723810|B1|Black Canadian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3899611|NCT01492439|3723808|B3|Asian South||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3899612|NCT01492439|3723809|B2|Asian South||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3899613|NCT01492439|3723810|B1|Asian South||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3899614|NCT01492439|3723808|B3|Asian East||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3899615|NCT01492439|3723809|B2|Asian East||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3899616|NCT01492439|3723810|B1|Asian East||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3899617|NCT01492439|3723808|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3899618|NCT01492439|3723809|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3899619|NCT01492439|3723810|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3899620|NCT01492439|3723808|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3899621|NCT01492439|3723809|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3899622|NCT01492439|3723810|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3899623|NCT01492439|3723808|B3|||Age||years|Mean|34.2|34.2|Standard Deviation|10.9|10.9|||
3899624|NCT01492439|3723809|B2|||Age||years|Mean|34.7|34.7|Standard Deviation|9.5|9.5|||
3899625|NCT01492439|3723810|B1|||Age||years|Mean|33.7|33.7|Standard Deviation|12.3|12.3|||
3899626|NCT01492426|3723857|B3||Male|Sex: Female, Male||Participants|Count of Participants|376|376.0||||||
3899627|NCT01492426|3723858|B2||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3899628|NCT01492426|3723859|B1||Male|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
3899629|NCT01492426|3723857|B3||Female|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
3899630|NCT01492426|3723858|B2||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3899631|NCT01492426|3723859|B1||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3899632|NCT01492426|3723857|B3|65 years and older||Age, Customized||participants|Number|27|27.0||||||
3899633|NCT01492426|3723858|B2|65 years and older||Age, Customized||participants|Number|12|12.0||||||
3899634|NCT01492426|3723859|B1|65 years and older||Age, Customized||participants|Number|15|15.0||||||
3899635|NCT01492426|3723857|B3|Younger than 65 years||Age, Customized||participants|Number|575|575.0||||||
3899636|NCT01492426|3723858|B2|Younger than 65 years||Age, Customized||participants|Number|188|188.0||||||
3899637|NCT01492426|3723859|B1|Younger than 65 years||Age, Customized||participants|Number|387|387.0||||||
3899638|NCT01492426|3723857|B3|||Age||years|Mean|46.9|46.9|Standard Deviation|12.18|12.18|||
3899639|NCT01492426|3723858|B2|||Age||years|Mean|47.6|47.6|Standard Deviation|12.29|12.29|||
3899640|NCT01492426|3723859|B1|||Age||years|Mean|46.5|46.5|Standard Deviation|12.12|12.12|||
3899641|NCT01492400|3723876|B3||Male|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
3899642|NCT01492400|3723877|B2||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3899643|NCT01492400|3723878|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3899644|NCT01492400|3723876|B3||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3899645|NCT01492400|3723877|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3899646|NCT01492400|3723878|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3899647|NCT01492400|3723876|B3|>65 years||Age, Customized||Participants|Number|155|155.0||||||
3899648|NCT01492400|3723877|B2|>65 years||Age, Customized||Participants|Number|81|81.0||||||
3899649|NCT01492400|3723878|B1|>65 years||Age, Customized||Participants|Number|74|74.0||||||
3899650|NCT01492400|3723876|B3|45 to 65 years||Age, Customized||Participants|Number|198|198.0||||||
3899651|NCT01492400|3723877|B2|45 to 65 years||Age, Customized||Participants|Number|96|96.0||||||
3899652|NCT01492400|3723878|B1|45 to 65 years||Age, Customized||Participants|Number|102|102.0||||||
3899653|NCT01492400|3723876|B3|<45 years||Age, Customized||Participants|Number|10|10.0||||||
3899654|NCT01492400|3723877|B2|<45 years||Age, Customized||Participants|Number|5|5.0||||||
3899655|NCT01492400|3723878|B1|<45 years||Age, Customized||Participants|Number|5|5.0||||||
3899656|NCT01492309|3723889|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
3899657|NCT01492309|3723890|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3899658|NCT01492309|3723891|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3899659|NCT01492309|3723889|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3899660|NCT01492309|3723890|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3899661|NCT01492309|3723891|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3899662|NCT01492309|3723889|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3899663|NCT01492309|3723890|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3899664|NCT01492309|3723891|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3899665|NCT01492309|3723889|B3|||Age||Years|Mean|28.27|28.27|Standard Deviation|5.65|5.65|||
3899666|NCT01492309|3723890|B2|||Age||Years|Mean|26.41|26.41|Standard Deviation|5.11|5.11|||
3899667|NCT01492309|3723891|B1|||Age||Years|Mean|30.13|30.13|Standard Deviation|5.78|5.78|||
3899668|NCT01492088|3723900|B4|||Body Surface Area||m^2|Mean|1.469|1.469|Standard Deviation|0.3228|0.3228|||
3899669|NCT01492088|3723901|B3|||Body Surface Area||m^2|Mean|1.313|1.313|Standard Deviation|0.3103|0.3103|||
3899670|NCT01492088|3723902|B2|||Body Surface Area||m^2|Mean|1.617|1.617|Standard Deviation|0.2938|0.2938|||
3899671|NCT01492088|3723903|B1|||Body Surface Area||m^2|Mean|1.562|1.562|Standard Deviation|0.0967|0.0967|||
3899672|NCT01492088|3723900|B4|||Weight||kg|Mean|50.04|50.04|Standard Deviation|17.361|17.361|||
3899673|NCT01492088|3723901|B3|||Weight||kg|Mean|42.16|42.16|Standard Deviation|15.162|15.162|||
3899674|NCT01492088|3723902|B2|||Weight||kg|Mean|57.85|57.85|Standard Deviation|17.539|17.539|||
3899675|NCT01492088|3723903|B1|||Weight||kg|Mean|53.10|53.1|Standard Deviation|9.924|9.924|||
3899676|NCT01492088|3723900|B4|||Height||cm|Mean|158.02|158.02|Standard Deviation|17.493|17.493|||
3899677|NCT01492088|3723901|B3|||Height||cm|Mean|149.54|149.54|Standard Deviation|17.783|17.783|||
3899678|NCT01492088|3723902|B2|||Height||cm|Mean|165.31|165.31|Standard Deviation|14.350|14.35|||
3899679|NCT01492088|3723903|B1|||Height||cm|Mean|167.17|167.17|Standard Deviation|10.865|10.865|||
3899680|NCT01492088|3723900|B4|Mexico||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3899681|NCT01492088|3723901|B3|Mexico||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3899682|NCT01492088|3723902|B2|Mexico||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3899683|NCT01492088|3723903|B1|Mexico||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3899684|NCT01492088|3723900|B4|Spain||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3899685|NCT01492088|3723901|B3|Spain||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3899686|NCT01492088|3723902|B2|Spain||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3899687|NCT01492088|3723903|B1|Spain||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3899688|NCT01492088|3723900|B4|Italy||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3899689|NCT01492088|3723901|B3|Italy||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3899690|NCT01492088|3723902|B2|Italy||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3899691|NCT01492088|3723903|B1|Italy||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3899692|NCT01492088|3723900|B4|United Kingdom||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3899693|NCT01492088|3723901|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3899694|NCT01492088|3723902|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3899695|NCT01492088|3723903|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3899696|NCT01492088|3723900|B4|Netherlands||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3899697|NCT01492088|3723901|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3899698|NCT01492088|3723902|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3899699|NCT01492088|3723903|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3899700|NCT01492088|3723900|B4|Germany||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3899701|NCT01492088|3723901|B3|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3899702|NCT01492088|3723902|B2|Germany||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3899703|NCT01492088|3723903|B1|Germany||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3899704|NCT01492088|3723900|B4|France||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3899705|NCT01492088|3723901|B3|France||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3899706|NCT01492088|3723902|B2|France||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3899707|NCT01492088|3723903|B1|France||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3899708|NCT01492088|3723900|B4|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3899709|NCT01492088|3723901|B3|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3899710|NCT01492088|3723902|B2|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3899711|NCT01492088|3723903|B1|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3899771|NCT01491958|3723973|B2|||Age||years|Median|50|50.0|Full Range|||25.0|68.0|
3899712|NCT01492088|3723900|B4||Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3899713|NCT01492088|3723901|B3||Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3899714|NCT01492088|3723902|B2||Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3899715|NCT01492088|3723903|B1||Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3899716|NCT01492088|3723900|B4||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3899717|NCT01492088|3723901|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3899718|NCT01492088|3723902|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3899719|NCT01492088|3723903|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3899720|NCT01492088|3723900|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3899721|NCT01492088|3723901|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3899722|NCT01492088|3723902|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3899723|NCT01492088|3723903|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3899724|NCT01492088|3723900|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3899725|NCT01492088|3723901|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3899726|NCT01492088|3723902|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3899727|NCT01492088|3723903|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3899728|NCT01492088|3723900|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3899729|NCT01492088|3723901|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3899730|NCT01492088|3723902|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3899731|NCT01492088|3723903|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899732|NCT01492088|3723900|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3899733|NCT01492088|3723901|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3899734|NCT01492088|3723902|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3899735|NCT01492088|3723903|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3899736|NCT01492088|3723900|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3899737|NCT01492088|3723901|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3899738|NCT01492088|3723902|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899739|NCT01492088|3723903|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899740|NCT01492088|3723900|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3899741|NCT01492088|3723901|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3899742|NCT01492088|3723902|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3899743|NCT01492088|3723903|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3899744|NCT01492088|3723900|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3899745|NCT01492088|3723901|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3899746|NCT01492088|3723902|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3899747|NCT01492088|3723903|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3899748|NCT01492088|3723900|B4|||Age||years|Mean|13.1|13.1|Standard Deviation|3.19|3.19|||
3899749|NCT01492088|3723901|B3|||Age||years|Mean|11.5|11.5|Standard Deviation|3.18|3.18|||
3899750|NCT01492088|3723902|B2|||Age||years|Mean|14.5|14.5|Standard Deviation|2.68|2.68|||
3899751|NCT01492088|3723903|B1|||Age||years|Mean|14.7|14.7|Standard Deviation|1.15|1.15|||
3899752|NCT01491984|3723963|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3899753|NCT01491984|3723964|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3899754|NCT01491984|3723965|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3899755|NCT01491984|3723963|B3||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3899756|NCT01491984|3723964|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3899757|NCT01491984|3723965|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3899758|NCT01491984|3723963|B3|||Age, Customized||years|Mean|45|45.0|Standard Deviation|13|13.0|||
3899759|NCT01491984|3723964|B2|||Age, Customized||years|Mean|45|45.0|Standard Deviation|13|13.0|||
3899760|NCT01491984|3723965|B1|||Age, Customized||years|Mean|45|45.0|Standard Deviation|13|13.0|||
3899761|NCT01491958|3723972|B3|United States||Region of Enrollment||patients|Number|80|80.0||||||
3899762|NCT01491958|3723973|B2|United States||Region of Enrollment||patients|Number|40|40.0||||||
3899763|NCT01491958|3723974|B1|United States||Region of Enrollment||patients|Number|40|40.0||||||
3899764|NCT01491958|3723972|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3899765|NCT01491958|3723973|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3899766|NCT01491958|3723974|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3899767|NCT01491958|3723972|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3899768|NCT01491958|3723973|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3899769|NCT01491958|3723974|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3899770|NCT01491958|3723972|B3|||Age||years|Median|51|51.0|Full Range|||25.0|71.0|
3899772|NCT01491958|3723974|B1|||Age||years|Median|51|51.0|Full Range|||27.0|71.0|
3899773|NCT01491919|3723983|B4|||Weight||kg|Mean|51.3|51.3|Standard Deviation|23.8|23.8|||
3899774|NCT01491919|3723984|B3|||Weight||kg|Mean|23.1|23.1|Standard Deviation|3.0|3.0|||
3899775|NCT01491919|3723985|B2|||Weight||kg|Mean|50.2|50.2|Standard Deviation|28.7|28.7|||
3899776|NCT01491919|3723986|B1|||Weight||kg|Mean|56.8|56.8|Standard Deviation|19.4|19.4|||
3899777|NCT01491919|3723983|B4|Non-hispanic/non-latino||Ethnicity||participants|Number|18|18.0||||||
3899778|NCT01491919|3723984|B3|Non-hispanic/non-latino||Ethnicity||participants|Number|2|2.0||||||
3899779|NCT01491919|3723985|B2|Non-hispanic/non-latino||Ethnicity||participants|Number|6|6.0||||||
3899780|NCT01491919|3723986|B1|Non-hispanic/non-latino||Ethnicity||participants|Number|10|10.0||||||
3899781|NCT01491919|3723983|B4|Hispanic/Latino||Ethnicity||participants|Number|4|4.0||||||
3899782|NCT01491919|3723984|B3|Hispanic/Latino||Ethnicity||participants|Number|0|0.0||||||
3899783|NCT01491919|3723985|B2|Hispanic/Latino||Ethnicity||participants|Number|2|2.0||||||
3899784|NCT01491919|3723986|B1|Hispanic/Latino||Ethnicity||participants|Number|2|2.0||||||
3899785|NCT01491919|3723983|B4|||Time since transplant||years|Mean|4.5|4.5|Standard Deviation|4.1|4.1|||
3899786|NCT01491919|3723984|B3|||Time since transplant||years|Mean|0.9|0.9|Standard Deviation|0.4|0.4|||
3899787|NCT01491919|3723985|B2|||Time since transplant||years|Mean|4.9|4.9|Standard Deviation|3.4|3.4|||
3899788|NCT01491919|3723986|B1|||Time since transplant||years|Mean|4.8|4.8|Standard Deviation|4.7|4.7|||
3899789|NCT01491919|3723983|B4|||Estimated glomerular filtration rate (eGFR)|"Estimated glomerular filtration rate (eGFR) calculated by modified Schwartz formula [=0.413 x Length (cm)/serum creatinine (mg/dl)].~Note: text verified with protocol on 4/2/15 as '413xLength'. Added spaces for clarification."|ml/min per 1.73m^2|Mean|70.2|70.2|Standard Deviation|24.4|24.4|||
3899790|NCT01491919|3723984|B3|||Estimated glomerular filtration rate (eGFR)|"Estimated glomerular filtration rate (eGFR) calculated by modified Schwartz formula [=0.413 x Length (cm)/serum creatinine (mg/dl)].~Note: text verified with protocol on 4/2/15 as '413xLength'. Added spaces for clarification."|ml/min per 1.73m^2|Mean|89.3|89.3|Standard Deviation|44.4|44.4|||
3899791|NCT01491919|3723985|B2|||Estimated glomerular filtration rate (eGFR)|"Estimated glomerular filtration rate (eGFR) calculated by modified Schwartz formula [=0.413 x Length (cm)/serum creatinine (mg/dl)].~Note: text verified with protocol on 4/2/15 as '413xLength'. Added spaces for clarification."|ml/min per 1.73m^2|Mean|62|62.0|Standard Deviation|16.7|16.7|||
3899792|NCT01491919|3723986|B1|||Estimated glomerular filtration rate (eGFR)|"Estimated glomerular filtration rate (eGFR) calculated by modified Schwartz formula [=0.413 x Length (cm)/serum creatinine (mg/dl)].~Note: text verified with protocol on 4/2/15 as '413xLength'. Added spaces for clarification."|ml/min per 1.73m^2|Mean|72.5|72.5|Standard Deviation|25.7|25.7|||
3899793|NCT01491919|3723983|B4|United States||Region of Enrollment||participants|Number|22|22.0||||||
3899794|NCT01491919|3723984|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3899795|NCT01491919|3723985|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3899796|NCT01491919|3723986|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3899797|NCT01491919|3723983|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3899798|NCT01491919|3723984|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899799|NCT01491919|3723985|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3899800|NCT01491919|3723986|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3899801|NCT01491919|3723983|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899802|NCT01491919|3723984|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899803|NCT01491919|3723985|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899804|NCT01491919|3723986|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899805|NCT01491919|3723983|B4||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3899806|NCT01491919|3723984|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3899807|NCT01491919|3723985|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3899808|NCT01491919|3723986|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3899809|NCT01491919|3723983|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3899810|NCT01491919|3723984|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899811|NCT01491919|3723985|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3899812|NCT01491919|3723986|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3899813|NCT01491919|3723983|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899814|NCT01491919|3723984|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899815|NCT01491919|3723985|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899816|NCT01491919|3723986|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899817|NCT01491919|3723983|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899818|NCT01491919|3723984|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899819|NCT01491919|3723985|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899820|NCT01491919|3723986|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899821|NCT01491919|3723983|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3899822|NCT01491919|3723984|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899823|NCT01491919|3723985|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3899824|NCT01491919|3723986|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899825|NCT01491919|3723983|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3899826|NCT01491919|3723984|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3899827|NCT01491919|3723985|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3899828|NCT01491919|3723986|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3899829|NCT01491919|3723983|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3899830|NCT01491919|3723984|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3899831|NCT01491919|3723985|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3899832|NCT01491919|3723986|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3899833|NCT01491919|3723983|B4|||Age||years|Mean|13.8|13.8|Standard Deviation|3|3.0|||
3899834|NCT01491919|3723984|B3|||Age||years|Mean|9.5|9.5|Standard Deviation|3.5|3.5|||
3899835|NCT01491919|3723985|B2|||Age||years|Mean|13.0|13.0|Standard Deviation|3|3.0|||
3899836|NCT01491919|3723986|B1|||Age||years|Mean|14.9|14.9|Standard Deviation|2.3|2.3|||
3899837|NCT01491893|3724034|B1|United States||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
3899838|NCT01491893|3724034|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3899839|NCT01491893|3724034|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899840|NCT01491893|3724034|B1||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3899841|NCT01491893|3724034|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3899842|NCT01491893|3724034|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899843|NCT01491893|3724034|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3899844|NCT01491893|3724034|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3899845|NCT01491893|3724034|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3899846|NCT01491893|3724034|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3899847|NCT01491893|3724034|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3899848|NCT01491893|3724034|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3899849|NCT01491893|3724034|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3899850|NCT01491893|3724034|B1|||Age||years|Mean|52.9|52.9|Standard Deviation|12.3|12.3|||
3899851|NCT01491802|3724059|B1|||Baseline Dyspnea Index score|Scoring range for activity-related dyspnea is 0 (most severe) to 12 (none).|units on a scale|Mean|7.9|7.9|Standard Deviation|1.7|1.7|||
3899852|NCT01491802|3724059|B1|||Smoking history||pack-years|Mean|49|49.0|Standard Deviation|20|20.0|||
3899853|NCT01491802|3724059|B1|||FEV1/FVC % ratio|Post-bronchodilator measurement|%|Mean|55.6|55.6|Standard Deviation|7.7|7.7|||
3899854|NCT01491802|3724059|B1|||FEV1 %predicted|Post-bronchodilator measurement|% of predicted normal|Mean|70.9|70.9|Standard Deviation|69.4|69.4|||
3899855|NCT01491802|3724059|B1|Canada||Region of Enrollment||participants|Number|17|17.0||||||
3899856|NCT01491802|3724059|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899857|NCT01491802|3724059|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899858|NCT01491802|3724059|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3899859|NCT01491802|3724059|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899860|NCT01491802|3724059|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899861|NCT01491802|3724059|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899862|NCT01491802|3724059|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899863|NCT01491802|3724059|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3899864|NCT01491802|3724059|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3899865|NCT01491802|3724059|B1|||Age||years|Mean|66|66.0|Standard Deviation|10|10.0|||
3899866|NCT01491737|3724085|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3899867|NCT01491737|3724086|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3899868|NCT01491737|3724087|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3899869|NCT01491737|3724085|B3||Female|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
3899870|NCT01491737|3724086|B2||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3899871|NCT01491737|3724087|B1||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3899872|NCT01491737|3724085|B3|||Age||Years|Mean|61.6|61.6|Standard Deviation|11.20|11.2|||
3899873|NCT01491737|3724086|B2|||Age||Years|Mean|62.3|62.3|Standard Deviation|11.54|11.54|||
3899874|NCT01491737|3724087|B1|||Age||Years|Mean|60.9|60.9|Standard Deviation|10.85|10.85|||
3899875|NCT01491672|3724108|B4||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3899876|NCT01491672|3724109|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3899877|NCT01491672|3724110|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3899878|NCT01491672|3724111|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3899879|NCT01491672|3724108|B4||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3899880|NCT01491672|3724109|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3899881|NCT01491672|3724110|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3899882|NCT01491672|3724111|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3899883|NCT01491672|3724108|B4|||Age||Years|Mean|56.7|56.7|Standard Deviation|11.48|11.48|||
3899884|NCT01491672|3724109|B3|||Age||Years|Mean|60.3|60.3|Standard Deviation|10.59|10.59|||
3899885|NCT01491672|3724110|B2|||Age||Years|Mean|56.5|56.5|Standard Deviation|11.14|11.14|||
3899886|NCT01491672|3724111|B1|||Age||Years|Mean|56.0|56.0|Standard Deviation|12.06|12.06|||
3899887|NCT01491633|3724138|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3899888|NCT01491633|3724138|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3899889|NCT01491633|3724138|B1|||Age||years|Mean|59|59.0|Full Range|||55.0|78.0|
3899890|NCT01491607|3724146|B5|United States||Region of Enrollment||participants|Number|184|184.0||||||
3899891|NCT01491607|3724147|B4|United States||Region of Enrollment||participants|Number|49|49.0||||||
3899892|NCT01491607|3724148|B3|United States||Region of Enrollment||participants|Number|56|56.0||||||
3899893|NCT01491607|3724149|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
3899894|NCT01491607|3724150|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
3899895|NCT01491607|3724146|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3899896|NCT01491607|3724147|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3899897|NCT01491607|3724148|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3899898|NCT01491607|3724149|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3899899|NCT01491607|3724150|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3899900|NCT01491607|3724146|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3899901|NCT01491607|3724147|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3899902|NCT01491607|3724148|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3899903|NCT01491607|3724149|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3899904|NCT01491607|3724150|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3899905|NCT01491607|3724146|B5|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3899906|NCT01491607|3724147|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3899907|NCT01491607|3724148|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3899908|NCT01491607|3724149|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3899909|NCT01491607|3724150|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3899910|NCT01491607|3724146|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3899911|NCT01491607|3724147|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3899912|NCT01491607|3724148|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3899913|NCT01491607|3724149|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3899914|NCT01491607|3724150|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3899915|NCT01491607|3724146|B5|White||Race/Ethnicity, Customized||participants|Number|156|156.0||||||
3899916|NCT01491607|3724147|B4|White||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
3899917|NCT01491607|3724148|B3|White||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
3899918|NCT01491607|3724149|B2|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3899919|NCT01491607|3724150|B1|White||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
3899920|NCT01491607|3724146|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899921|NCT01491607|3724147|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899922|NCT01491607|3724148|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899923|NCT01491607|3724149|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899924|NCT01491607|3724150|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3899925|NCT01491607|3724146|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|164|164.0||||||
3899926|NCT01491607|3724147|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3899927|NCT01491607|3724148|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3899928|NCT01491607|3724149|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3899929|NCT01491607|3724150|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3899930|NCT01491607|3724146|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3899931|NCT01491607|3724147|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3899932|NCT01491607|3724148|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3899933|NCT01491607|3724149|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3899934|NCT01491607|3724150|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3899935|NCT01491607|3724146|B5||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3899936|NCT01491607|3724147|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3899937|NCT01491607|3724148|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3899938|NCT01491607|3724149|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3899939|NCT01491607|3724150|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3899940|NCT01491607|3724146|B5||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3899941|NCT01491607|3724147|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3899942|NCT01491607|3724148|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3899943|NCT01491607|3724149|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3899944|NCT01491607|3724150|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3899945|NCT01491607|3724146|B5|||Age||years|Mean|33.7|33.7|Standard Deviation|10.84|10.84|||
3899946|NCT01491607|3724147|B4|||Age||years|Mean|34.2|34.2|Standard Deviation|11.09|11.09|||
3899947|NCT01491607|3724148|B3|||Age||years|Mean|32.7|32.7|Standard Deviation|9.89|9.89|||
3899948|NCT01491607|3724149|B2|||Age||years|Mean|36.7|36.7|Standard Deviation|10.97|10.97|||
3899949|NCT01491607|3724150|B1|||Age||years|Mean|32.0|32.0|Standard Deviation|11.41|11.41|||
3899950|NCT01491607|3724146|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3899951|NCT01491607|3724147|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3899952|NCT01491607|3724148|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3899953|NCT01491607|3724149|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3899954|NCT01491607|3724150|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3899955|NCT01491607|3724146|B5||Between 18 and 65 years|Age||Participants|Count of Participants|181|181.0||||||
3899956|NCT01491607|3724147|B4||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
3899957|NCT01491607|3724148|B3||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
3899958|NCT01491607|3724149|B2||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3899959|NCT01491607|3724150|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3899960|NCT01491607|3724146|B5||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3899961|NCT01491607|3724147|B4||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3899962|NCT01491607|3724148|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3899963|NCT01491607|3724149|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3899964|NCT01491607|3724150|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3899965|NCT01491490|3724246|B3|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
3899966|NCT01491490|3724247|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3899967|NCT01491490|3724248|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3899968|NCT01491490|3724246|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3899969|NCT01491490|3724247|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3899970|NCT01491490|3724248|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3899971|NCT01491490|3724246|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3899972|NCT01491490|3724247|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3899973|NCT01491490|3724248|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3899974|NCT01491490|3724246|B3|||Age||years|Mean|30.5|30.5|Standard Deviation|6.5|6.5|||
3899975|NCT01491490|3724247|B2|||Age||years|Mean|37|37.0|Standard Deviation|NA||||Only 1 participant contributed to the mean.
3899976|NCT01491490|3724248|B1|||Age||years|Mean|24|24.0|Standard Deviation|NA||||Only 1 participant contributed to the mean.
3899977|NCT01491490|3724246|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3899978|NCT01491490|3724247|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3899979|NCT01491490|3724248|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3899980|NCT01491490|3724246|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3899981|NCT01491490|3724247|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3899982|NCT01491490|3724248|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3899983|NCT01491490|3724246|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3899984|NCT01491490|3724247|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3899985|NCT01491490|3724248|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3899986|NCT01491178|3724255|B1||Male|Sex: Female, Male||Participants|Count of Participants|4310|4310.0||||||
3899987|NCT01491178|3724255|B1||Female|Sex: Female, Male||Participants|Count of Participants|2133|2133.0||||||
3899988|NCT01491178|3724255|B1|||Age||Years|Mean|70.9|70.9|Standard Deviation|9.9|9.9|||
3899989|NCT01491113|3724260|B6|||Height||centimeters|Mean|163.60|163.6|Standard Deviation|5.68|5.68|||
3899990|NCT01491113|3724261|B5|||Height||centimeters|Mean|162.38|162.38|Standard Deviation|3.41|3.41|||
3899991|NCT01491113|3724262|B4|||Height||centimeters|Mean|164.50|164.5|Standard Deviation|6.34|6.34|||
3899992|NCT01491113|3724263|B3|||Height||centimeters|Mean|163.72|163.72|Standard Deviation|5.64|5.64|||
3899993|NCT01491113|3724264|B2|||Height||centimeters|Mean|165.65|165.65|Standard Deviation|3.11|3.11|||
3899994|NCT01491113|3724265|B1|||Height||centimeters|Mean|161.73|161.73|Standard Deviation|9.05|9.05|||
3899995|NCT01491113|3724260|B6|||Weight||kilogram|Mean|63.84|63.84|Standard Deviation|9.62|9.62|||
3899996|NCT01491113|3724261|B5|||Weight||kilogram|Mean|62.20|62.2|Standard Deviation|5.41|5.41|||
3899997|NCT01491113|3724262|B4|||Weight||kilogram|Mean|58.70|58.7|Standard Deviation|6.10|6.1|||
3899998|NCT01491113|3724263|B3|||Weight||kilogram|Mean|63.07|63.07|Standard Deviation|12.49|12.49|||
3899999|NCT01491113|3724264|B2|||Weight||kilogram|Mean|74.28|74.28|Standard Deviation|4.14|4.14|||
3900000|NCT01491113|3724265|B1|||Weight||kilogram|Mean|60.95|60.95|Standard Deviation|10.97|10.97|||
3900001|NCT01491113|3724260|B6|Japanese||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3900002|NCT01491113|3724261|B5|Japanese||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3900003|NCT01491113|3724262|B4|Japanese||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3900004|NCT01491113|3724263|B3|Japanese||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3900005|NCT01491113|3724264|B2|Japanese||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3900006|NCT01491113|3724265|B1|Japanese||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3900007|NCT01491113|3724260|B6|Asian||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3900008|NCT01491113|3724261|B5|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3900009|NCT01491113|3724262|B4|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3900010|NCT01491113|3724263|B3|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3900011|NCT01491113|3724264|B2|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3900012|NCT01491113|3724265|B1|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3900013|NCT01491113|3724260|B6||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3900014|NCT01491113|3724261|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3900015|NCT01491113|3724262|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3900016|NCT01491113|3724263|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3900017|NCT01491113|3724264|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3900018|NCT01491113|3724265|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3900019|NCT01491113|3724260|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3900020|NCT01491113|3724261|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3900021|NCT01491113|3724262|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3900022|NCT01491113|3724263|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3900023|NCT01491113|3724264|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3900024|NCT01491113|3724265|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3900025|NCT01491113|3724260|B6|>=65 years||Age, Customized||participants|Number|15|15.0||||||
3900026|NCT01491113|3724261|B5|>=65 years||Age, Customized||participants|Number|4|4.0||||||
3900027|NCT01491113|3724262|B4|>=65 years||Age, Customized||participants|Number|2|2.0||||||
3900028|NCT01491113|3724263|B3|>=65 years||Age, Customized||participants|Number|5|5.0||||||
3900029|NCT01491113|3724264|B2|>=65 years||Age, Customized||participants|Number|3|3.0||||||
3900030|NCT01491113|3724265|B1|>=65 years||Age, Customized||participants|Number|1|1.0||||||
3900031|NCT01491113|3724260|B6|20 - <65 years||Age, Customized||participants|Number|15|15.0||||||
3900032|NCT01491113|3724261|B5|20 - <65 years||Age, Customized||participants|Number|2|2.0||||||
3900033|NCT01491113|3724262|B4|20 - <65 years||Age, Customized||participants|Number|4|4.0||||||
3900034|NCT01491113|3724263|B3|20 - <65 years||Age, Customized||participants|Number|1|1.0||||||
3900035|NCT01491113|3724264|B2|20 - <65 years||Age, Customized||participants|Number|3|3.0||||||
3900036|NCT01491113|3724265|B1|20 - <65 years||Age, Customized||participants|Number|5|5.0||||||
3900037|NCT01491113|3724260|B6|||Age||years|Mean|64.6|64.6|Standard Deviation|10.0|10.0|||
3900038|NCT01491113|3724261|B5|||Age||years|Mean|68.8|68.8|Standard Deviation|7.9|7.9|||
3900039|NCT01491113|3724262|B4|||Age||years|Mean|55.8|55.8|Standard Deviation|17.1|17.1|||
3900040|NCT01491113|3724263|B3|||Age||years|Mean|69.3|69.3|Standard Deviation|6.1|6.1|||
3900041|NCT01491113|3724264|B2|||Age||years|Mean|67.5|67.5|Standard Deviation|5.0|5.0|||
3900042|NCT01491113|3724265|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|2.6|2.6|||
3900043|NCT01491035|3724356|B9|Germany||Region of Enrollment||participants|Number|5|5.0||||||
3900044|NCT01491035|3724357|B8|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3900045|NCT01491035|3724358|B7|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3900046|NCT01491035|3724359|B6|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3900047|NCT01491035|3724360|B5|Germany||Region of Enrollment||participants|Number|2|2.0||||||
3900048|NCT01491035|3724361|B4|Germany||Region of Enrollment||participants|Number|3|3.0||||||
3900049|NCT01491035|3724362|B3|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3900050|NCT01491035|3724363|B2|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3900051|NCT01491035|3724364|B1|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3900052|NCT01491035|3724356|B9|United States||Region of Enrollment||participants|Number|43|43.0||||||
3900053|NCT01491035|3724357|B8|United States||Region of Enrollment||participants|Number|6|6.0||||||
3900054|NCT01491035|3724358|B7|United States||Region of Enrollment||participants|Number|6|6.0||||||
3900055|NCT01491035|3724359|B6|United States||Region of Enrollment||participants|Number|6|6.0||||||
3900056|NCT01491035|3724360|B5|United States||Region of Enrollment||participants|Number|4|4.0||||||
3900057|NCT01491035|3724361|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
3900058|NCT01491035|3724362|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3900059|NCT01491035|3724363|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3900060|NCT01491035|3724364|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3900061|NCT01491035|3724356|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3900062|NCT01491035|3724357|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900063|NCT01491035|3724358|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900064|NCT01491035|3724359|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900065|NCT01491035|3724360|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3900066|NCT01491035|3724361|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900067|NCT01491035|3724362|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3900068|NCT01491035|3724363|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900069|NCT01491035|3724364|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3900070|NCT01491035|3724356|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900071|NCT01491035|3724357|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900072|NCT01491035|3724358|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900073|NCT01491035|3724359|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900074|NCT01491035|3724360|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900075|NCT01491035|3724361|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900076|NCT01491035|3724362|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900077|NCT01491035|3724363|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900078|NCT01491035|3724364|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900079|NCT01491035|3724356|B9||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3900080|NCT01491035|3724357|B8||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3900081|NCT01491035|3724358|B7||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3900082|NCT01491035|3724359|B6||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3900083|NCT01491035|3724360|B5||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3900084|NCT01491035|3724361|B4||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3900085|NCT01491035|3724362|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3900086|NCT01491035|3724363|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3900087|NCT01491035|3724364|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3900088|NCT01491035|3724356|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3900089|NCT01491035|3724357|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3900090|NCT01491035|3724358|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3900091|NCT01491035|3724359|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3900092|NCT01491035|3724360|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3900093|NCT01491035|3724361|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3900094|NCT01491035|3724362|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3900095|NCT01491035|3724363|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3900096|NCT01491035|3724364|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3900097|NCT01491035|3724356|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900098|NCT01491035|3724357|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900099|NCT01491035|3724358|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900100|NCT01491035|3724359|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900101|NCT01491035|3724360|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900102|NCT01491035|3724361|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900103|NCT01491035|3724362|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900104|NCT01491035|3724363|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900105|NCT01491035|3724364|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900106|NCT01491035|3724356|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900107|NCT01491035|3724357|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900108|NCT01491035|3724358|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900109|NCT01491035|3724359|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900110|NCT01491035|3724360|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900111|NCT01491035|3724361|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900112|NCT01491035|3724362|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900113|NCT01491035|3724363|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900114|NCT01491035|3724364|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900115|NCT01491035|3724356|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900116|NCT01491035|3724357|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900117|NCT01491035|3724358|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900118|NCT01491035|3724359|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900119|NCT01491035|3724360|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900120|NCT01491035|3724361|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900121|NCT01491035|3724362|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900122|NCT01491035|3724363|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900123|NCT01491035|3724364|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900124|NCT01491035|3724356|B9||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3900125|NCT01491035|3724357|B8||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3900126|NCT01491035|3724358|B7||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3900127|NCT01491035|3724359|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3900128|NCT01491035|3724360|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3900129|NCT01491035|3724361|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3900130|NCT01491035|3724362|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3900131|NCT01491035|3724363|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3900132|NCT01491035|3724364|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3900133|NCT01491035|3724356|B9||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3900134|NCT01491035|3724357|B8||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3900135|NCT01491035|3724358|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3900136|NCT01491035|3724359|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3900137|NCT01491035|3724360|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3900138|NCT01491035|3724361|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3900139|NCT01491035|3724362|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3900140|NCT01491035|3724363|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3900141|NCT01491035|3724364|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3900142|NCT01491035|3724356|B9|||Age||years|Mean|12.7|12.7|Standard Deviation|3.0|3.0|||
3900143|NCT01491035|3724357|B8|||Age||years|Mean|9.8|9.8|Standard Deviation|1.8|1.8|||
3900144|NCT01491035|3724358|B7|||Age||years|Mean|10.5|10.5|Standard Deviation|0.8|0.8|||
3900145|NCT01491035|3724359|B6|||Age||years|Mean|9.7|9.7|Standard Deviation|1.2|1.2|||
3900146|NCT01491035|3724360|B5|||Age||years|Mean|10.3|10.3|Standard Deviation|1.2|1.2|||
3900147|NCT01491035|3724361|B4|||Age||years|Mean|14.8|14.8|Standard Deviation|1.9|1.9|||
3900148|NCT01491035|3724362|B3|||Age||years|Mean|15.2|15.2|Standard Deviation|1.2|1.2|||
3900149|NCT01491035|3724363|B2|||Age||years|Mean|15.3|15.3|Standard Deviation|1.9|1.9|||
3900150|NCT01491035|3724364|B1|||Age||years|Mean|15.7|15.7|Standard Deviation|1.9|1.9|||
3900151|NCT01491022|3724437|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3900152|NCT01491022|3724438|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3900153|NCT01491022|3724439|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3900154|NCT01491022|3724437|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3900155|NCT01491022|3724438|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3900156|NCT01491022|3724439|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3900157|NCT01491022|3724437|B3|||Age||years|Mean|67.5|67.5|Standard Deviation|8.7|8.7|||
3900158|NCT01491022|3724438|B2|||Age||years|Mean|67.4|67.4|Standard Deviation|5.9|5.9|||
3900159|NCT01491022|3724439|B1|||Age||years|Mean|67.6|67.6|Standard Deviation|10.8|10.8|||
3900160|NCT01490931|3724456|B1|||pain intensity on 100 mm visual analog scale (VAS). 0=No pain 100=worst possible pain||units on a scale|Mean|54.4|54.4|Standard Deviation|14.3|14.3|||
3900161|NCT01490931|3724456|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3900162|NCT01490931|3724456|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3900163|NCT01490931|3724456|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3900164|NCT01490931|3724456|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3900165|NCT01490931|3724456|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3900166|NCT01490931|3724456|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3900167|NCT01490866|3724472|B1|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3900168|NCT01490866|3724472|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3900169|NCT01490866|3724472|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3900170|NCT01490866|3724472|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
3900171|NCT01490866|3724472|B1||Male|Gender||Participants|Count of Participants|36|36.0||||||
3900172|NCT01490866|3724472|B1||Female|Gender||Participants|Count of Participants|34|34.0||||||
3900173|NCT01490866|3724472|B1|||Age||years|Median|60|60.0|Full Range|||36.0|90.0|
3900174|NCT01490840|3724481|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3900175|NCT01490840|3724482|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3900176|NCT01490840|3724483|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3900177|NCT01490840|3724481|B3||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3900178|NCT01490840|3724482|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3900179|NCT01490840|3724483|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3900180|NCT01490840|3724481|B3|||Age||Years|Mean|40.2|40.2|Standard Deviation|9.6|9.6|||
3900181|NCT01490840|3724482|B2|||Age||Years|Mean|39.4|39.4|Standard Deviation|8.7|8.7|||
3900182|NCT01490840|3724483|B1|||Age||Years|Mean|40.9|40.9|Standard Deviation|10.4|10.4|||
3900183|NCT01490814|3724506|B3|||Years since first PAF diagnosis||years|Mean|4.6|4.6|Standard Deviation|5.2|5.2|||
3900184|NCT01490814|3724507|B2|||Years since first PAF diagnosis||years|Mean|4.7|4.7|Standard Deviation|5.3|5.3|||
3900185|NCT01490814|3724508|B1|||Years since first PAF diagnosis||years|Mean|4.6|4.6|Standard Deviation|5.1|5.1|||
3900186|NCT01490814|3724506|B3||Male|Sex: Female, Male||Participants|Count of Participants|457|457.0||||||
3900187|NCT01490814|3724507|B2||Male|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
3900188|NCT01490814|3724508|B1||Male|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
3900189|NCT01490814|3724506|B3||Female|Sex: Female, Male||Participants|Count of Participants|293|293.0||||||
3900190|NCT01490814|3724507|B2||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3900191|NCT01490814|3724508|B1||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3900192|NCT01490814|3724506|B3|||Age||years|Mean|60.0|60.0|Standard Deviation|9.5|9.5|||
3900193|NCT01490814|3724507|B2|||Age||years|Mean|60.1|60.1|Standard Deviation|9.2|9.2|||
3900194|NCT01490814|3724508|B1|||Age||years|Mean|59.9|59.9|Standard Deviation|9.8|9.8|||
3900195|NCT01490788|3724529|B1|Canada||Region of Enrollment||participants|Number|30|30.0||||||
3900196|NCT01490788|3724529|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3900197|NCT01490788|3724529|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3900198|NCT01490788|3724529|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3900199|NCT01490788|3724529|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3900200|NCT01490788|3724529|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3900201|NCT01490697|3724545|B3|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3900202|NCT01490697|3724546|B2|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3900203|NCT01490697|3724547|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3900204|NCT01490697|3724545|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3900205|NCT01490697|3724546|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3900206|NCT01490697|3724547|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3900207|NCT01490697|3724545|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3900208|NCT01490697|3724546|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3900209|NCT01490697|3724547|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3900210|NCT01490697|3724545|B3|||Age||years|Mean|38.5|38.5|Standard Deviation|12.9|12.9|||
3900211|NCT01490697|3724546|B2|||Age||years|Mean|41.9|41.9|Standard Deviation|13.9|13.9|||
3900212|NCT01490697|3724547|B1|||Age||years|Mean|35.1|35.1|Standard Deviation|11.8|11.8|||
3900213|NCT01490684|3724556|B1|Saudi Arabia||Region of Enrollment||participants|Number|162|162.0||||||
3900214|NCT01490684|3724556|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3900215|NCT01490684|3724556|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3900216|NCT01490684|3724556|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|18.9|18.9|||
3900217|NCT01490632|3724563|B6|||Baseline Psoriasis Area and Severity Index (PASI) Score|The PASI combines assessments of the extent of body-surface involvement in 4 anatomical regions (head, trunk, arms, and legs) and the severity of desquamation, erythema, and plaque induration/infiltration (thickness) in each region, yielding an overall score of 0 for no psoriasis to 72 for the most severe disease.|Units on a Scale|Mean|20.00|20.0|Standard Deviation|8.228|8.228|||
3900218|NCT01490632|3724564|B5|||Baseline Psoriasis Area and Severity Index (PASI) Score|The PASI combines assessments of the extent of body-surface involvement in 4 anatomical regions (head, trunk, arms, and legs) and the severity of desquamation, erythema, and plaque induration/infiltration (thickness) in each region, yielding an overall score of 0 for no psoriasis to 72 for the most severe disease.|Units on a Scale|Mean|19.01|19.01|Standard Deviation|6.177|6.177|||
3900219|NCT01490632|3724565|B4|||Baseline Psoriasis Area and Severity Index (PASI) Score|The PASI combines assessments of the extent of body-surface involvement in 4 anatomical regions (head, trunk, arms, and legs) and the severity of desquamation, erythema, and plaque induration/infiltration (thickness) in each region, yielding an overall score of 0 for no psoriasis to 72 for the most severe disease.|Units on a Scale|Mean|20.24|20.24|Standard Deviation|7.827|7.827|||
3900220|NCT01490632|3724566|B3|||Baseline Psoriasis Area and Severity Index (PASI) Score|The PASI combines assessments of the extent of body-surface involvement in 4 anatomical regions (head, trunk, arms, and legs) and the severity of desquamation, erythema, and plaque induration/infiltration (thickness) in each region, yielding an overall score of 0 for no psoriasis to 72 for the most severe disease.|Units on a Scale|Mean|20.58|20.58|Standard Deviation|9.438|9.438|||
3900221|NCT01490632|3724567|B2|||Baseline Psoriasis Area and Severity Index (PASI) Score|The PASI combines assessments of the extent of body-surface involvement in 4 anatomical regions (head, trunk, arms, and legs) and the severity of desquamation, erythema, and plaque induration/infiltration (thickness) in each region, yielding an overall score of 0 for no psoriasis to 72 for the most severe disease.|Units on a Scale|Mean|21.36|21.36|Standard Deviation|11.056|11.056|||
3900222|NCT01490632|3724568|B1|||Baseline Psoriasis Area and Severity Index (PASI) Score|The PASI combines assessments of the extent of body-surface involvement in 4 anatomical regions (head, trunk, arms, and legs) and the severity of desquamation, erythema, and plaque induration/infiltration (thickness) in each region, yielding an overall score of 0 for no psoriasis to 72 for the most severe disease.|Units on a Scale|Mean|19.06|19.06|Standard Deviation|6.805|6.805|||
3900223|NCT01490632|3724563|B6|||Percent Body Surface Area (BSA) Affected by Psoriasis||Percent of BSA|Mean|27.04|27.04|Standard Deviation|16.101|16.101|||
3900331|NCT01490359|3724715|B3|Less than high school||Completed high school||participants|Number|663|663.0||||||
3900224|NCT01490632|3724564|B5|||Percent Body Surface Area (BSA) Affected by Psoriasis||Percent of BSA|Mean|24.45|24.45|Standard Deviation|12.079|12.079|||
3900225|NCT01490632|3724565|B4|||Percent Body Surface Area (BSA) Affected by Psoriasis||Percent of BSA|Mean|28.23|28.23|Standard Deviation|15.726|15.726|||
3900226|NCT01490632|3724566|B3|||Percent Body Surface Area (BSA) Affected by Psoriasis||Percent of BSA|Mean|28.61|28.61|Standard Deviation|18.797|18.797|||
3900227|NCT01490632|3724567|B2|||Percent Body Surface Area (BSA) Affected by Psoriasis||Percent of BSA|Mean|30.78|30.78|Standard Deviation|20.523|20.523|||
3900228|NCT01490632|3724568|B1|||Percent Body Surface Area (BSA) Affected by Psoriasis||Percent of BSA|Mean|23.18|23.18|Standard Deviation|11.890|11.89|||
3900229|NCT01490632|3724563|B6|||Duration of Psoriasis (Ps)||Years|Mean|17.26|17.26|Standard Deviation|11.995|11.995|||
3900230|NCT01490632|3724564|B5|||Duration of Psoriasis (Ps)||Years|Mean|16.60|16.6|Standard Deviation|10.653|10.653|||
3900231|NCT01490632|3724565|B4|||Duration of Psoriasis (Ps)||Years|Mean|16.56|16.56|Standard Deviation|11.948|11.948|||
3900232|NCT01490632|3724566|B3|||Duration of Psoriasis (Ps)||Years|Mean|19.90|19.9|Standard Deviation|12.766|12.766|||
3900233|NCT01490632|3724567|B2|||Duration of Psoriasis (Ps)||Years|Mean|15.00|15.0|Standard Deviation|9.951|9.951|||
3900234|NCT01490632|3724568|B1|||Duration of Psoriasis (Ps)||Years|Mean|16.42|16.42|Standard Deviation|14.297|14.297|||
3900235|NCT01490632|3724563|B6|North America||Region of Enrollment||Participants|Count of Participants|238|238.0||||||
3900236|NCT01490632|3724564|B5|North America||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
3900237|NCT01490632|3724565|B4|North America||Region of Enrollment||Participants|Count of Participants|56|56.0||||||
3900238|NCT01490632|3724566|B3|North America||Region of Enrollment||Participants|Count of Participants|63|63.0||||||
3900239|NCT01490632|3724567|B2|North America||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3900240|NCT01490632|3724568|B1|North America||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3900241|NCT01490632|3724563|B6|Japan||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3900242|NCT01490632|3724564|B5|Japan||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3900243|NCT01490632|3724565|B4|Japan||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3900244|NCT01490632|3724566|B3|Japan||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3900245|NCT01490632|3724567|B2|Japan||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3900246|NCT01490632|3724568|B1|Japan||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3900247|NCT01490632|3724563|B6||Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3900248|NCT01490632|3724564|B5||Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3900249|NCT01490632|3724565|B4||Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3900250|NCT01490632|3724566|B3||Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3900251|NCT01490632|3724567|B2||Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3900252|NCT01490632|3724568|B1||Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3900253|NCT01490632|3724563|B6||More than one race|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3900254|NCT01490632|3724564|B5||More than one race|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3900255|NCT01490632|3724565|B4||More than one race|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3900256|NCT01490632|3724566|B3||More than one race|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3900257|NCT01490632|3724567|B2||More than one race|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3900258|NCT01490632|3724568|B1||More than one race|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3900259|NCT01490632|3724563|B6||White|Race/Ethnicity, Customized||Participants|Count of Participants|215|215.0||||||
3900260|NCT01490632|3724564|B5||White|Race/Ethnicity, Customized||Participants|Count of Participants|53|53.0||||||
3900261|NCT01490632|3724565|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|52|52.0||||||
3900262|NCT01490632|3724566|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|58|58.0||||||
3900263|NCT01490632|3724567|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3900264|NCT01490632|3724568|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3900265|NCT01490632|3724563|B6||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3900266|NCT01490632|3724564|B5||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3900267|NCT01490632|3724565|B4||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3900268|NCT01490632|3724566|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3900269|NCT01490632|3724567|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3900270|NCT01490632|3724568|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3900271|NCT01490632|3724563|B6||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3900272|NCT01490632|3724564|B5||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3900273|NCT01490632|3724565|B4||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3900274|NCT01490632|3724566|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3900275|NCT01490632|3724567|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3900276|NCT01490632|3724568|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3900277|NCT01490632|3724563|B6||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|45|45.0||||||
3900278|NCT01490632|3724564|B5||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3900279|NCT01490632|3724565|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3900280|NCT01490632|3724566|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3900281|NCT01490632|3724567|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3900282|NCT01490632|3724568|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3900283|NCT01490632|3724563|B6||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3900284|NCT01490632|3724564|B5||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3900285|NCT01490632|3724565|B4||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3900286|NCT01490632|3724566|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3900287|NCT01490632|3724567|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3900288|NCT01490632|3724568|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3900289|NCT01490632|3724563|B6||Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3900290|NCT01490632|3724564|B5||Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3900291|NCT01490632|3724565|B4||Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3900292|NCT01490632|3724566|B3||Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3900293|NCT01490632|3724567|B2||Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3900294|NCT01490632|3724568|B1||Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3900295|NCT01490632|3724563|B6||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|228|228.0||||||
3900296|NCT01490632|3724564|B5||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|59|59.0||||||
3900297|NCT01490632|3724565|B4||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|52|52.0||||||
3900298|NCT01490632|3724566|B3||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|61|61.0||||||
3900299|NCT01490632|3724567|B2||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3900300|NCT01490632|3724568|B1||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3900301|NCT01490632|3724563|B6||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
3900302|NCT01490632|3724564|B5||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3900303|NCT01490632|3724565|B4||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3900304|NCT01490632|3724566|B3||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3900305|NCT01490632|3724567|B2||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3900306|NCT01490632|3724568|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3900307|NCT01490632|3724563|B6||Male|Sex/Gender, Customized||Participants|Count of Participants|197|197.0||||||
3900308|NCT01490632|3724564|B5||Male|Sex/Gender, Customized||Participants|Count of Participants|51|51.0||||||
3900309|NCT01490632|3724565|B4||Male|Sex/Gender, Customized||Participants|Count of Participants|46|46.0||||||
3900310|NCT01490632|3724566|B3||Male|Sex/Gender, Customized||Participants|Count of Participants|54|54.0||||||
3900311|NCT01490632|3724567|B2||Male|Sex/Gender, Customized||Participants|Count of Participants|23|23.0||||||
3900312|NCT01490632|3724568|B1||Male|Sex/Gender, Customized||Participants|Count of Participants|23|23.0||||||
3900313|NCT01490632|3724563|B6||Female|Sex/Gender, Customized||Participants|Count of Participants|74|74.0||||||
3900314|NCT01490632|3724564|B5||Female|Sex/Gender, Customized||Participants|Count of Participants|18|18.0||||||
3900315|NCT01490632|3724565|B4||Female|Sex/Gender, Customized||Participants|Count of Participants|18|18.0||||||
3900316|NCT01490632|3724566|B3||Female|Sex/Gender, Customized||Participants|Count of Participants|18|18.0||||||
3900317|NCT01490632|3724567|B2||Female|Sex/Gender, Customized||Participants|Count of Participants|9|9.0||||||
3900318|NCT01490632|3724568|B1||Female|Sex/Gender, Customized||Participants|Count of Participants|11|11.0||||||
3900319|NCT01490632|3724563|B6|||Age, Customized||Years|Mean|47.31|47.31|Standard Deviation|13.268|13.268|||
3900320|NCT01490632|3724564|B5|||Age, Customized||Years|Mean|47.43|47.43|Standard Deviation|10.425|10.425|||
3900321|NCT01490632|3724565|B4|||Age, Customized||Years|Mean|47.37|47.37|Standard Deviation|15.829|15.829|||
3900322|NCT01490632|3724566|B3|||Age, Customized||Years|Mean|47.21|47.21|Standard Deviation|11.650|11.65|||
3900323|NCT01490632|3724567|B2|||Age, Customized||Years|Mean|47.81|47.81|Standard Deviation|15.165|15.165|||
3900324|NCT01490632|3724568|B1|||Age, Customized||Years|Mean|46.70|46.7|Standard Deviation|15.144|15.144|||
3900325|NCT01490359|3724715|B3|Not alcohol dependent||Alcohol dependent||participants|Number|474|474.0||||||
3900326|NCT01490359|3724716|B2|Not alcohol dependent||Alcohol dependent||participants|Number|242|242.0||||||
3900327|NCT01490359|3724717|B1|Not alcohol dependent||Alcohol dependent||participants|Number|232|232.0||||||
3900328|NCT01490359|3724715|B3|Alcohol dependent||Alcohol dependent||participants|Number|707|707.0||||||
3900329|NCT01490359|3724716|B2|Alcohol dependent||Alcohol dependent||participants|Number|330|330.0||||||
3900330|NCT01490359|3724717|B1|Alcohol dependent||Alcohol dependent||participants|Number|377|377.0||||||
3900332|NCT01490359|3724716|B2|Less than high school||Completed high school||participants|Number|333|333.0||||||
3900333|NCT01490359|3724717|B1|Less than high school||Completed high school||participants|Number|330|330.0||||||
3900334|NCT01490359|3724715|B3|Completed high school||Completed high school||participants|Number|518|518.0||||||
3900335|NCT01490359|3724716|B2|Completed high school||Completed high school||participants|Number|239|239.0||||||
3900336|NCT01490359|3724717|B1|Completed high school||Completed high school||participants|Number|279|279.0||||||
3900337|NCT01490359|3724715|B3|Employed||Employment Status||participants|Number|388|388.0||||||
3900338|NCT01490359|3724716|B2|Employed||Employment Status||participants|Number|204|204.0||||||
3900339|NCT01490359|3724717|B1|Employed||Employment Status||participants|Number|184|184.0||||||
3900340|NCT01490359|3724715|B3|Not employed||Employment Status||participants|Number|793|793.0||||||
3900341|NCT01490359|3724716|B2|Not employed||Employment Status||participants|Number|368|368.0||||||
3900342|NCT01490359|3724717|B1|Not employed||Employment Status||participants|Number|425|425.0||||||
3900343|NCT01490359|3724715|B3|Not Married||Married||participants|Number|1113|1113.0||||||
3900344|NCT01490359|3724716|B2|Not Married||Married||participants|Number|531|531.0||||||
3900345|NCT01490359|3724717|B1|Not Married||Married||participants|Number|582|582.0||||||
3900346|NCT01490359|3724715|B3|Married||Married||participants|Number|68|68.0||||||
3900347|NCT01490359|3724716|B2|Married||Married||participants|Number|41|41.0||||||
3900348|NCT01490359|3724717|B1|Married||Married||participants|Number|27|27.0||||||
3900349|NCT01490359|3724715|B3|South Africa||Region of Enrollment||participants|Number|1181|1181.0||||||
3900350|NCT01490359|3724716|B2|South Africa||Region of Enrollment||participants|Number|572|572.0||||||
3900351|NCT01490359|3724717|B1|South Africa||Region of Enrollment||participants|Number|609|609.0||||||
3900352|NCT01490359|3724715|B3|Not Black South African||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3900353|NCT01490359|3724716|B2|Not Black South African||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3900354|NCT01490359|3724717|B1|Not Black South African||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3900355|NCT01490359|3724715|B3|Black South African||Race/Ethnicity, Customized||participants|Number|1181|1181.0||||||
3900356|NCT01490359|3724716|B2|Black South African||Race/Ethnicity, Customized||participants|Number|572|572.0||||||
3900357|NCT01490359|3724717|B1|Black South African||Race/Ethnicity, Customized||participants|Number|609|609.0||||||
3900358|NCT01490359|3724715|B3||Male|Sex: Female, Male||Participants|Count of Participants|1181|1181.0||||||
3900359|NCT01490359|3724716|B2||Male|Sex: Female, Male||Participants|Count of Participants|572|572.0||||||
3900360|NCT01490359|3724717|B1||Male|Sex: Female, Male||Participants|Count of Participants|609|609.0||||||
3900361|NCT01490359|3724715|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3900362|NCT01490359|3724716|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3900363|NCT01490359|3724717|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3900364|NCT01490359|3724715|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3900365|NCT01490359|3724716|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3900366|NCT01490359|3724717|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3900367|NCT01490359|3724715|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1181|1181.0||||||
3900368|NCT01490359|3724716|B2||Between 18 and 65 years|Age||Participants|Count of Participants|572|572.0||||||
3900369|NCT01490359|3724717|B1||Between 18 and 65 years|Age||Participants|Count of Participants|609|609.0||||||
3900370|NCT01490359|3724715|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3900371|NCT01490359|3724716|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3900372|NCT01490359|3724717|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3900373|NCT01490294|3724738|B5|Unknown||History of myocardial infarction||Participants|Number|3|3.0||||||
3900374|NCT01490294|3724739|B4|Unknown||History of myocardial infarction||Participants|Number|2|2.0||||||
3900375|NCT01490294|3724740|B3|Unknown||History of myocardial infarction||Participants|Number|0|0.0||||||
3900376|NCT01490294|3724741|B2|Unknown||History of myocardial infarction||Participants|Number|1|1.0||||||
3900377|NCT01490294|3724742|B1|Unknown||History of myocardial infarction||Participants|Number|0|0.0||||||
3900378|NCT01490294|3724738|B5|Yes||History of myocardial infarction||Participants|Number|67|67.0||||||
3900379|NCT01490294|3724739|B4|Yes||History of myocardial infarction||Participants|Number|15|15.0||||||
3900380|NCT01490294|3724740|B3|Yes||History of myocardial infarction||Participants|Number|15|15.0||||||
3900381|NCT01490294|3724741|B2|Yes||History of myocardial infarction||Participants|Number|17|17.0||||||
3900382|NCT01490294|3724742|B1|Yes||History of myocardial infarction||Participants|Number|20|20.0||||||
3900383|NCT01490294|3724738|B5|No||History of myocardial infarction||Participants|Number|156|156.0||||||
3900384|NCT01490294|3724739|B4|No||History of myocardial infarction||Participants|Number|37|37.0||||||
3900385|NCT01490294|3724740|B3|No||History of myocardial infarction||Participants|Number|43|43.0||||||
3900386|NCT01490294|3724741|B2|No||History of myocardial infarction||Participants|Number|42|42.0||||||
3900387|NCT01490294|3724742|B1|No||History of myocardial infarction||Participants|Number|34|34.0||||||
3900388|NCT01490294|3724738|B5||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3900389|NCT01490294|3724739|B4||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3900390|NCT01490294|3724740|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3900391|NCT01490294|3724741|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3900392|NCT01490294|3724742|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3900393|NCT01490294|3724738|B5||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3900394|NCT01490294|3724739|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3900395|NCT01490294|3724740|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3900396|NCT01490294|3724741|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3900397|NCT01490294|3724742|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3900398|NCT01490294|3724738|B5|||Age|The study was planned and conducted to provide data for 4 different increasing doses of Gadobutrol. Therefore, the age was not calculated over all four dose groups of Gadobutrol.|Years|Median|62.0|62.0|Full Range|||29.0|83.0|
3900399|NCT01490294|3724739|B4|||Age|The study was planned and conducted to provide data for 4 different increasing doses of Gadobutrol. Therefore, the age was not calculated over all four dose groups of Gadobutrol.|Years|Median|61.0|61.0|Full Range|||35.0|79.0|
3900400|NCT01490294|3724740|B3|||Age|The study was planned and conducted to provide data for 4 different increasing doses of Gadobutrol. Therefore, the age was not calculated over all four dose groups of Gadobutrol.|Years|Median|64.5|64.5|Full Range|||39.0|81.0|
3900401|NCT01490294|3724741|B2|||Age|The study was planned and conducted to provide data for 4 different increasing doses of Gadobutrol. Therefore, the age was not calculated over all four dose groups of Gadobutrol.|Years|Median|61.5|61.5|Full Range|||32.0|83.0|
3900402|NCT01490294|3724742|B1|||Age|The study was planned and conducted to provide data for 4 different increasing doses of Gadobutrol. Therefore, the age was not calculated over all four dose groups of Gadobutrol.|Years|Median|62.0|62.0|Full Range|||29.0|78.0|
3900403|NCT01490190|3724979|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3900404|NCT01490190|3724979|B1||Female|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
3900405|NCT01490190|3724979|B1|||Age|Age data were only available for 218 participants.|Years|Mean|29.5|29.5|Standard Deviation|5.32|5.32|||
3900406|NCT01490151|3725000|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3900407|NCT01490151|3725000|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3900408|NCT01490151|3725000|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3900409|NCT01490151|3725000|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3900410|NCT01490151|3725000|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3900411|NCT01490125|3725006|B1||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
3900412|NCT01490125|3725006|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3900413|NCT01490125|3725006|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|8.19|8.19|||
3900414|NCT01490086|3725034|B6|India||Region of Enrollment||participants|Number|108|108.0||||||
3900415|NCT01490086|3725035|B5|India||Region of Enrollment||participants|Number|17|17.0||||||
3900416|NCT01490086|3725036|B4|India||Region of Enrollment||participants|Number|10|10.0||||||
3900417|NCT01490086|3725037|B3|India||Region of Enrollment||participants|Number|27|27.0||||||
3900418|NCT01490086|3725038|B2|India||Region of Enrollment||participants|Number|27|27.0||||||
3900419|NCT01490086|3725039|B1|India||Region of Enrollment||participants|Number|27|27.0||||||
3900420|NCT01490086|3725034|B6|Moldova, Republic of||Region of Enrollment||participants|Number|12|12.0||||||
3900421|NCT01490086|3725035|B5|Moldova, Republic of||Region of Enrollment||participants|Number|2|2.0||||||
3900422|NCT01490086|3725036|B4|Moldova, Republic of||Region of Enrollment||participants|Number|1|1.0||||||
3900423|NCT01490086|3725037|B3|Moldova, Republic of||Region of Enrollment||participants|Number|3|3.0||||||
3900424|NCT01490086|3725038|B2|Moldova, Republic of||Region of Enrollment||participants|Number|3|3.0||||||
3900425|NCT01490086|3725039|B1|Moldova, Republic of||Region of Enrollment||participants|Number|3|3.0||||||
3900426|NCT01490086|3725034|B6|Malaysia||Region of Enrollment||participants|Number|42|42.0||||||
3900427|NCT01490086|3725035|B5|Malaysia||Region of Enrollment||participants|Number|8|8.0||||||
3900428|NCT01490086|3725036|B4|Malaysia||Region of Enrollment||participants|Number|3|3.0||||||
3900429|NCT01490086|3725037|B3|Malaysia||Region of Enrollment||participants|Number|10|10.0||||||
3900430|NCT01490086|3725038|B2|Malaysia||Region of Enrollment||participants|Number|11|11.0||||||
3900431|NCT01490086|3725039|B1|Malaysia||Region of Enrollment||participants|Number|10|10.0||||||
3900432|NCT01490086|3725034|B6|Philippines||Region of Enrollment||participants|Number|59|59.0||||||
3900433|NCT01490086|3725035|B5|Philippines||Region of Enrollment||participants|Number|9|9.0||||||
3900434|NCT01490086|3725036|B4|Philippines||Region of Enrollment||participants|Number|5|5.0||||||
3900435|NCT01490086|3725037|B3|Philippines||Region of Enrollment||participants|Number|15|15.0||||||
3900436|NCT01490086|3725038|B2|Philippines||Region of Enrollment||participants|Number|15|15.0||||||
3900437|NCT01490086|3725039|B1|Philippines||Region of Enrollment||participants|Number|15|15.0||||||
3900438|NCT01490086|3725034|B6|United States||Region of Enrollment||participants|Number|12|12.0||||||
3900439|NCT01490086|3725035|B5|United States||Region of Enrollment||participants|Number|2|2.0||||||
3900440|NCT01490086|3725036|B4|United States||Region of Enrollment||participants|Number|1|1.0||||||
3900441|NCT01490086|3725037|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3900442|NCT01490086|3725038|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3900443|NCT01490086|3725039|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3900444|NCT01490086|3725034|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3900445|NCT01490086|3725035|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900446|NCT01490086|3725036|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900447|NCT01490086|3725037|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900448|NCT01490086|3725038|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900449|NCT01490086|3725039|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3900450|NCT01490086|3725034|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900451|NCT01490086|3725035|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900452|NCT01490086|3725036|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900453|NCT01490086|3725037|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900454|NCT01490086|3725038|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900455|NCT01490086|3725039|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900456|NCT01490086|3725034|B6||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3900457|NCT01490086|3725035|B5||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3900458|NCT01490086|3725036|B4||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3900459|NCT01490086|3725037|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3900460|NCT01490086|3725038|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3900461|NCT01490086|3725039|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3900462|NCT01490086|3725034|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3900463|NCT01490086|3725035|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3900464|NCT01490086|3725036|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3900465|NCT01490086|3725037|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3900466|NCT01490086|3725038|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3900467|NCT01490086|3725039|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3900468|NCT01490086|3725034|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3900469|NCT01490086|3725035|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3900470|NCT01490086|3725036|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900471|NCT01490086|3725037|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900472|NCT01490086|3725038|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900473|NCT01490086|3725039|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900474|NCT01490086|3725034|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|208|208.0||||||
3900475|NCT01490086|3725035|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3900476|NCT01490086|3725036|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3900477|NCT01490086|3725037|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3900478|NCT01490086|3725038|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3900479|NCT01490086|3725039|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3900480|NCT01490086|3725034|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900481|NCT01490086|3725035|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900482|NCT01490086|3725036|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900483|NCT01490086|3725037|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900484|NCT01490086|3725038|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900485|NCT01490086|3725039|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900486|NCT01490086|3725034|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900487|NCT01490086|3725035|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900488|NCT01490086|3725036|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900489|NCT01490086|3725037|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900490|NCT01490086|3725038|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900491|NCT01490086|3725039|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900492|NCT01490086|3725034|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|232|232.0||||||
3900493|NCT01490086|3725035|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3900494|NCT01490086|3725036|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3900495|NCT01490086|3725037|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3900496|NCT01490086|3725038|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3900497|NCT01490086|3725039|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3900498|NCT01490086|3725034|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3900499|NCT01490086|3725035|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3900500|NCT01490086|3725036|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900501|NCT01490086|3725037|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900502|NCT01490086|3725038|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900503|NCT01490086|3725039|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900504|NCT01490086|3725034|B6||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
3900505|NCT01490086|3725035|B5||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3900506|NCT01490086|3725036|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3900507|NCT01490086|3725037|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3900508|NCT01490086|3725038|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3900509|NCT01490086|3725039|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3900510|NCT01490086|3725034|B6||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3900511|NCT01490086|3725035|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3900512|NCT01490086|3725036|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3900513|NCT01490086|3725037|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3900514|NCT01490086|3725038|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3900515|NCT01490086|3725039|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3900516|NCT01490086|3725034|B6|||Age||years|Mean|36|36.0|Standard Deviation|11|11.0|||
3900517|NCT01490086|3725035|B5|||Age||years|Mean|36|36.0|Standard Deviation|12|12.0|||
3900518|NCT01490086|3725036|B4|||Age||years|Mean|35|35.0|Standard Deviation|10|10.0|||
3900519|NCT01490086|3725037|B3|||Age||years|Mean|35|35.0|Standard Deviation|9|9.0|||
3900520|NCT01490086|3725038|B2|||Age||years|Mean|37|37.0|Standard Deviation|12|12.0|||
3900521|NCT01490086|3725039|B1|||Age||years|Mean|36|36.0|Standard Deviation|10|10.0|||
3900522|NCT01490060|3725075|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
3900523|NCT01490060|3725076|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
3900524|NCT01490060|3725077|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3900525|NCT01490060|3725075|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3900526|NCT01490060|3725076|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3900527|NCT01490060|3725077|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3900528|NCT01490060|3725075|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3900529|NCT01490060|3725076|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3900530|NCT01490060|3725077|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3900531|NCT01490060|3725075|B3|Between 19 and 65 years||Age, Customized||participants|Number|47|47.0||||||
3900532|NCT01490060|3725076|B2|Between 19 and 65 years||Age, Customized||participants|Number|23|23.0||||||
3900533|NCT01490060|3725077|B1|Between 19 and 65 years||Age, Customized||participants|Number|24|24.0||||||
3900534|NCT01489969|3725088|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900535|NCT01489969|3725089|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900536|NCT01489969|3725090|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900537|NCT01489969|3725091|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900538|NCT01489969|3725088|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900539|NCT01489969|3725089|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900540|NCT01489969|3725090|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900541|NCT01489969|3725091|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900542|NCT01489969|3725088|B4||White|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3900543|NCT01489969|3725089|B3||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3900544|NCT01489969|3725090|B2||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3900545|NCT01489969|3725091|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3900546|NCT01489969|3725088|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3900547|NCT01489969|3725089|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3900548|NCT01489969|3725090|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3900549|NCT01489969|3725091|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3900550|NCT01489969|3725088|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900551|NCT01489969|3725089|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900552|NCT01489969|3725090|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900553|NCT01489969|3725091|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900554|NCT01489969|3725088|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3900555|NCT01489969|3725089|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3900556|NCT01489969|3725090|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900557|NCT01489969|3725091|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900558|NCT01489969|3725088|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900559|NCT01489969|3725089|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900560|NCT01489969|3725090|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900561|NCT01489969|3725091|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900562|NCT01489969|3725088|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900563|NCT01489969|3725089|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900564|NCT01489969|3725090|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900565|NCT01489969|3725091|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900566|NCT01489969|3725088|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3900567|NCT01489969|3725089|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3900568|NCT01489969|3725090|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3900569|NCT01489969|3725091|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3900570|NCT01489969|3725088|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3900571|NCT01489969|3725089|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3900572|NCT01489969|3725090|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3900573|NCT01489969|3725091|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3900574|NCT01489969|3725088|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3900575|NCT01489969|3725089|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3900576|NCT01489969|3725090|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3900577|NCT01489969|3725091|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3900578|NCT01489969|3725088|B4||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3900579|NCT01489969|3725089|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3900580|NCT01489969|3725090|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3900581|NCT01489969|3725091|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3900582|NCT01489969|3725088|B4|||Age||years|Mean|49.6|49.6|Standard Deviation|14.8|14.8|||
3900583|NCT01489969|3725089|B3|||Age||years|Mean|51.1|51.1|Standard Deviation|14.52|14.52|||
3900584|NCT01489969|3725090|B2|||Age||years|Mean|47.4|47.4|Standard Deviation|13.7|13.7|||
3900585|NCT01489969|3725091|B1|||Age||years|Mean|50.4|50.4|Standard Deviation|16.16|16.16|||
3900586|NCT01489956|3725107|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
3900587|NCT01489956|3725108|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3900588|NCT01489956|3725109|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3900589|NCT01489956|3725107|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3900590|NCT01489956|3725108|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3900591|NCT01489956|3725109|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3900592|NCT01489956|3725107|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3900593|NCT01489956|3725108|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3900594|NCT01489956|3725109|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3900595|NCT01489956|3725107|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3900596|NCT01489956|3725108|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3900597|NCT01489956|3725109|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3900598|NCT01489956|3725107|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3900599|NCT01489956|3725108|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3900600|NCT01489956|3725109|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3900601|NCT01489956|3725107|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3900602|NCT01489956|3725108|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3900603|NCT01489956|3725109|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3900604|NCT01489891|3725146|B3|Spain||Region of Enrollment||participants|Number|119|119.0||||||
3900605|NCT01489891|3725147|B2|Spain||Region of Enrollment||participants|Number|60|60.0||||||
3900606|NCT01489891|3725148|B1|Spain||Region of Enrollment||participants|Number|59|59.0||||||
3900607|NCT01489891|3725146|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3900608|NCT01489891|3725147|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3900609|NCT01489891|3725148|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3900610|NCT01489891|3725146|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3900611|NCT01489891|3725147|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3900612|NCT01489891|3725148|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3900613|NCT01489891|3725146|B3|||Age||years|Mean|50.7|50.7|Standard Deviation|15.3|15.3|||
3900614|NCT01489891|3725147|B2|||Age||years|Mean|51.7|51.7|Standard Deviation|14.9|14.9|||
3900615|NCT01489891|3725148|B1|||Age||years|Mean|49.7|49.7|Standard Deviation|15.8|15.8|||
3900616|NCT01489891|3725146|B3||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
3900617|NCT01489891|3725147|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3900618|NCT01489891|3725148|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3900619|NCT01489891|3725146|B3||Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
3900620|NCT01489891|3725147|B2||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
3900621|NCT01489891|3725148|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3900622|NCT01489891|3725146|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3900623|NCT01489891|3725147|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3900624|NCT01489891|3725148|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3900625|NCT01489826|3725161|B10||Male|Gender||Participants|Count of Participants|28|28.0||||||
3900626|NCT01489826|3725162|B9||Male|Gender||Participants|Count of Participants|2|2.0||||||
3900627|NCT01489826|3725163|B8||Male|Gender||Participants|Count of Participants|1|1.0||||||
3900628|NCT01489826|3725164|B7||Male|Gender||Participants|Count of Participants|9|9.0||||||
3900629|NCT01489826|3725165|B6||Male|Gender||Participants|Count of Participants|2|2.0||||||
3900630|NCT01489826|3725166|B5||Male|Gender||Participants|Count of Participants|2|2.0||||||
3900631|NCT01489826|3725167|B4||Male|Gender||Participants|Count of Participants|5|5.0||||||
3900632|NCT01489826|3725168|B3||Male|Gender||Participants|Count of Participants|3|3.0||||||
3900633|NCT01489826|3725169|B2||Male|Gender||Participants|Count of Participants|2|2.0||||||
3900634|NCT01489826|3725170|B1||Male|Gender||Participants|Count of Participants|2|2.0||||||
3900635|NCT01489826|3725161|B10||Female|Gender||Participants|Count of Participants|12|12.0||||||
3900636|NCT01489826|3725162|B9||Female|Gender||Participants|Count of Participants|4|4.0||||||
3900637|NCT01489826|3725163|B8||Female|Gender||Participants|Count of Participants|2|2.0||||||
3900638|NCT01489826|3725164|B7||Female|Gender||Participants|Count of Participants|0|0.0||||||
3900639|NCT01489826|3725165|B6||Female|Gender||Participants|Count of Participants|1|1.0||||||
3900640|NCT01489826|3725166|B5||Female|Gender||Participants|Count of Participants|1|1.0||||||
3900641|NCT01489826|3725167|B4||Female|Gender||Participants|Count of Participants|2|2.0||||||
3900642|NCT01489826|3725168|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
3900643|NCT01489826|3725169|B2||Female|Gender||Participants|Count of Participants|1|1.0||||||
3900644|NCT01489826|3725170|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
3900645|NCT01489826|3725161|B10|||Age||years|Mean|61.2|61.2|Standard Deviation|9.69|9.69|||
3900646|NCT01489826|3725162|B9|||Age||years|Mean|56.3|56.3|Standard Deviation|12.75|12.75|||
3900647|NCT01489826|3725163|B8|||Age||years|Mean|63.7|63.7|Standard Deviation|12.70|12.7|||
3900648|NCT01489826|3725164|B7|||Age||years|Mean|64.6|64.6|Standard Deviation|6.91|6.91|||
3900649|NCT01489826|3725165|B6|||Age||years|Mean|62.0|62.0|Standard Deviation|13.11|13.11|||
3900650|NCT01489826|3725166|B5|||Age||years|Mean|52.3|52.3|Standard Deviation|5.51|5.51|||
3900651|NCT01489826|3725167|B4|||Age||years|Mean|57.9|57.9|Standard Deviation|7.27|7.27|||
3900652|NCT01489826|3725168|B3|||Age||years|Mean|69.0|69.0|Standard Deviation|11.14|11.14|||
3900653|NCT01489826|3725169|B2|||Age||years|Mean|61.3|61.3|Standard Deviation|7.64|7.64|||
3900654|NCT01489826|3725170|B1|||Age||years|Mean|66.7|66.7|Standard Deviation|10.21|10.21|||
3900655|NCT01489826|3725161|B10||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3900656|NCT01489826|3725162|B9||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3900657|NCT01489826|3725163|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3900658|NCT01489826|3725164|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3900659|NCT01489826|3725165|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3900660|NCT01489826|3725166|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3900661|NCT01489826|3725167|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3900662|NCT01489826|3725168|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3900663|NCT01489826|3725169|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3900664|NCT01489826|3725170|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3900665|NCT01489826|3725161|B10||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3900666|NCT01489826|3725162|B9||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3900667|NCT01489826|3725163|B8||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3900668|NCT01489826|3725164|B7||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3900669|NCT01489826|3725165|B6||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3900670|NCT01489826|3725166|B5||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3900671|NCT01489826|3725167|B4||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3900672|NCT01489826|3725168|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3900673|NCT01489826|3725169|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3900674|NCT01489826|3725170|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3900675|NCT01489826|3725161|B10||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3900676|NCT01489826|3725162|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3900677|NCT01489826|3725163|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3900678|NCT01489826|3725164|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3900679|NCT01489826|3725165|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3900680|NCT01489826|3725166|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3900681|NCT01489826|3725167|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3900682|NCT01489826|3725168|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3900683|NCT01489826|3725169|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3900684|NCT01489826|3725170|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3900685|NCT01489670|3725275|B1||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3900686|NCT01489670|3725275|B1||Female|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
3900687|NCT01489670|3725275|B1|Missing data||Age, Customized||Participants|Number|2|2.0||||||
3900688|NCT01489670|3725275|B1|>=91 Years||Age, Customized||Participants|Number|5|5.0||||||
3900689|NCT01489670|3725275|B1|81 to 90 Years||Age, Customized||Participants|Number|62|62.0||||||
3900690|NCT01489670|3725275|B1|71 to 80 Years||Age, Customized||Participants|Number|120|120.0||||||
3900691|NCT01489670|3725275|B1|61 to 70 Years||Age, Customized||Participants|Number|113|113.0||||||
3900692|NCT01489670|3725275|B1|51 to 60 Years||Age, Customized||Participants|Number|53|53.0||||||
3900693|NCT01489670|3725275|B1|41 to 50 Years||Age, Customized||Participants|Number|28|28.0||||||
3900694|NCT01489670|3725275|B1|31 to 40 Years||Age, Customized||Participants|Number|3|3.0||||||
3900695|NCT01489670|3725275|B1|18 to 30 Years||Age, Customized||Participants|Number|1|1.0||||||
3900696|NCT01489527|3725285|B3|South Africa||Region of Enrollment||participants|Number|402|402.0||||||
3900697|NCT01489527|3725286|B2|South Africa||Region of Enrollment||participants|Number|200|200.0||||||
3900698|NCT01489527|3725287|B1|South Africa||Region of Enrollment||participants|Number|202|202.0||||||
3900699|NCT01489527|3725285|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3900700|NCT01489527|3725286|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3900701|NCT01489527|3725287|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3900702|NCT01489527|3725285|B3||Female|Sex: Female, Male||Participants|Count of Participants|402|402.0||||||
3900703|NCT01489527|3725286|B2||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
3900704|NCT01489527|3725287|B1||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3900705|NCT01489527|3725285|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3900706|NCT01489527|3725286|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3900707|NCT01489527|3725287|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3900708|NCT01489527|3725285|B3||Between 18 and 65 years|Age||Participants|Count of Participants|316|316.0||||||
3900709|NCT01489527|3725286|B2||Between 18 and 65 years|Age||Participants|Count of Participants|154|154.0||||||
3900710|NCT01489527|3725287|B1||Between 18 and 65 years|Age||Participants|Count of Participants|162|162.0||||||
3900711|NCT01489527|3725285|B3||<=18 years|Age||Participants|Count of Participants|86|86.0||||||
3900712|NCT01489527|3725286|B2||<=18 years|Age||Participants|Count of Participants|46|46.0||||||
3900713|NCT01489527|3725287|B1||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
3900714|NCT01489527|3725285|B3|||Age||years|Median|20|20.0|Full Range|||16.0|24.0|
3900715|NCT01489527|3725286|B2|||Age||years|Median|20|20.0|Full Range|||16.0|24.0|
3900716|NCT01489527|3725287|B1|||Age||years|Median|20|20.0|Full Range|||16.0|24.0|
3900717|NCT01489358|3725302|B4|United States||Region of Enrollment||participants|Number|25|25.0||||||
3900718|NCT01489358|3725303|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3900719|NCT01489358|3725304|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3900720|NCT01489358|3725305|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3900721|NCT01489358|3725302|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900722|NCT01489358|3725303|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900723|NCT01489358|3725304|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900724|NCT01489358|3725305|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900725|NCT01489358|3725302|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900726|NCT01489358|3725303|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900727|NCT01489358|3725304|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900728|NCT01489358|3725305|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900729|NCT01489358|3725302|B4||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3900730|NCT01489358|3725303|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3900731|NCT01489358|3725304|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3900732|NCT01489358|3725305|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3900733|NCT01489358|3725302|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3900734|NCT01489358|3725303|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3900735|NCT01489358|3725304|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3900736|NCT01489358|3725305|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3900737|NCT01489358|3725302|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900738|NCT01489358|3725303|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900739|NCT01489358|3725304|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900740|NCT01489358|3725305|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900741|NCT01489358|3725302|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3900742|NCT01489358|3725303|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3900743|NCT01489358|3725304|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3900744|NCT01489358|3725305|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3900745|NCT01489358|3725302|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900746|NCT01489358|3725303|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900747|NCT01489358|3725304|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900748|NCT01489358|3725305|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3900749|NCT01489358|3725302|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3900750|NCT01489358|3725303|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3900751|NCT01489358|3725304|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3900752|NCT01489358|3725305|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3900753|NCT01489358|3725302|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3900754|NCT01489358|3725303|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3900755|NCT01489358|3725304|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3900756|NCT01489358|3725305|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3900757|NCT01489358|3725302|B4|41-50 years||Age, Customized||participants|Number|3|3.0||||||
3900758|NCT01489358|3725303|B3|41-50 years||Age, Customized||participants|Number|1|1.0||||||
3900759|NCT01489358|3725304|B2|41-50 years||Age, Customized||participants|Number|2|2.0||||||
3900760|NCT01489358|3725305|B1|41-50 years||Age, Customized||participants|Number|0|0.0||||||
3900761|NCT01489358|3725302|B4|31-40 years||Age, Customized||participants|Number|9|9.0||||||
3900762|NCT01489358|3725303|B3|31-40 years||Age, Customized||participants|Number|3|3.0||||||
3900763|NCT01489358|3725304|B2|31-40 years||Age, Customized||participants|Number|4|4.0||||||
3900764|NCT01489358|3725305|B1|31-40 years||Age, Customized||participants|Number|2|2.0||||||
3900765|NCT01489358|3725302|B4|21-30 years||Age, Customized||participants|Number|12|12.0||||||
3900766|NCT01489358|3725303|B3|21-30 years||Age, Customized||participants|Number|6|6.0||||||
3900767|NCT01489358|3725304|B2|21-30 years||Age, Customized||participants|Number|4|4.0||||||
3900768|NCT01489358|3725305|B1|21-30 years||Age, Customized||participants|Number|2|2.0||||||
3900769|NCT01489358|3725302|B4|18-20 years||Age, Customized||participants|Number|1|1.0||||||
3900770|NCT01489358|3725303|B3|18-20 years||Age, Customized||participants|Number|0|0.0||||||
3900771|NCT01489358|3725304|B2|18-20 years||Age, Customized||participants|Number|0|0.0||||||
3900772|NCT01489358|3725305|B1|18-20 years||Age, Customized||participants|Number|1|1.0||||||
3900773|NCT01489254|3725354|B4|||Number of relapses in period within 2 year prior to signing ICF||Number of relapses|Mean|1.8|1.8|Standard Deviation|0.9|0.9|||
3900774|NCT01489254|3725355|B3|||Number of relapses in period within 2 year prior to signing ICF||Number of relapses|Mean|1.9|1.9|Standard Deviation|0.9|0.9|||
3900775|NCT01489254|3725356|B2|||Number of relapses in period within 2 year prior to signing ICF||Number of relapses|Mean|1.8|1.8|Standard Deviation|0.9|0.9|||
3900776|NCT01489254|3725357|B1|||Number of relapses in period within 2 year prior to signing ICF||Number of relapses|Mean|1.9|1.9|Standard Deviation|0.9|0.9|||
3900777|NCT01489254|3725354|B4|||Time from first clinical event to randomization||years|Mean|5.9|5.9|Standard Deviation|5.7|5.7|||
3900778|NCT01489254|3725355|B3|||Time from first clinical event to randomization||years|Mean|5.7|5.7|Standard Deviation|6.0|6.0|||
3900779|NCT01489254|3725356|B2|||Time from first clinical event to randomization||years|Mean|6.4|6.4|Standard Deviation|6.0|6.0|||
3900780|NCT01489254|3725357|B1|||Time from first clinical event to randomization||years|Mean|5.5|5.5|Standard Deviation|5.3|5.3|||
3900781|NCT01489254|3725354|B4||Male|Gender||Participants|Count of Participants|266|266.0||||||
3900782|NCT01489254|3725355|B3||Male|Gender||Participants|Count of Participants|27|27.0||||||
3900783|NCT01489254|3725356|B2||Male|Gender||Participants|Count of Participants|119|119.0||||||
3900784|NCT01489254|3725357|B1||Male|Gender||Participants|Count of Participants|120|120.0||||||
3900785|NCT01489254|3725354|B4||Female|Gender||Participants|Count of Participants|528|528.0||||||
3900786|NCT01489254|3725355|B3||Female|Gender||Participants|Count of Participants|57|57.0||||||
3900787|NCT01489254|3725356|B2||Female|Gender||Participants|Count of Participants|238|238.0||||||
3900788|NCT01489254|3725357|B1||Female|Gender||Participants|Count of Participants|233|233.0||||||
3900789|NCT01489254|3725354|B4|||Age||years|Mean|33.1|33.1|Standard Deviation|8.8|8.8|||
3900790|NCT01489254|3725355|B3|||Age||years|Mean|32.6|32.6|Standard Deviation|8.7|8.7|||
3900791|NCT01489254|3725356|B2|||Age||years|Mean|33.8|33.8|Standard Deviation|9.0|9.0|||
3900792|NCT01489254|3725357|B1|||Age||years|Mean|32.6|32.6|Standard Deviation|8.6|8.6|||
3900793|NCT01489189|3725369|B3|||Prior anti-VEGF treatment for DME||eyes|Number|34|34.0||||||
3900794|NCT01489189|3725370|B2|||Prior anti-VEGF treatment for DME||eyes|Number|13|13.0||||||
3900795|NCT01489189|3725371|B1|||Prior anti-VEGF treatment for DME||eyes|Number|21|21.0||||||
3900796|NCT01489189|3725369|B3|||Prior focal/grid laser treatment for DME||eyes|Number|59|59.0||||||
3900797|NCT01489189|3725370|B2|||Prior focal/grid laser treatment for DME||eyes|Number|29|29.0||||||
3900798|NCT01489189|3725371|B1|||Prior focal/grid laser treatment for DME||eyes|Number|30|30.0||||||
3900799|NCT01489189|3725369|B3|||Prior treatment for diabetic macular edema (DME)||eyes|Number|79|79.0||||||
3900800|NCT01489189|3725370|B2|||Prior treatment for diabetic macular edema (DME)||eyes|Number|36|36.0||||||
3900801|NCT01489189|3725371|B1|||Prior treatment for diabetic macular edema (DME)||eyes|Number|43|43.0||||||
3900802|NCT01489189|3725369|B3|Advanced PDR, macular center detached (level 85)||Diabetic Retinopathy Severity|Diabetic retinopathy level data were missing for 2 in the anti-VEGF+deferred PRP group and 4 in the prompt PRP group. Proliferative diabetic retinopathy (PDR) could not be identified by the reading center in 46 eyes (12%) but was subsequently confirmed by other imaging modes in 29 (63%) of the 46 eyes.|eyes|Number|2|2.0||||||
3900844|NCT01489189|3725369|B3|||Presence of Center-Involved Diabetic Macular Edema Regardless of Visual Acuity|OCT central subfield thickness measurements were missing for 2 in the anti-VEGF+deferred PRP group and 2 in the Prompt PRP group.|eyes|Number|117|117.0||||||
3900803|NCT01489189|3725370|B2|Advanced PDR, macular center detached (level 85)||Diabetic Retinopathy Severity|Diabetic retinopathy level data were missing for 2 in the anti-VEGF+deferred PRP group and 4 in the prompt PRP group. Proliferative diabetic retinopathy (PDR) could not be identified by the reading center in 46 eyes (12%) but was subsequently confirmed by other imaging modes in 29 (63%) of the 46 eyes.|eyes|Number|1|1.0||||||
3900804|NCT01489189|3725371|B1|Advanced PDR, macular center detached (level 85)||Diabetic Retinopathy Severity|Diabetic retinopathy level data were missing for 2 in the anti-VEGF+deferred PRP group and 4 in the prompt PRP group. Proliferative diabetic retinopathy (PDR) could not be identified by the reading center in 46 eyes (12%) but was subsequently confirmed by other imaging modes in 29 (63%) of the 46 eyes.|eyes|Number|1|1.0||||||
3900805|NCT01489189|3725369|B3|Advanced PDR, macular center attached (level 81)||Diabetic Retinopathy Severity|Diabetic retinopathy level data were missing for 2 in the anti-VEGF+deferred PRP group and 4 in the prompt PRP group. Proliferative diabetic retinopathy (PDR) could not be identified by the reading center in 46 eyes (12%) but was subsequently confirmed by other imaging modes in 29 (63%) of the 46 eyes.|eyes|Number|2|2.0||||||
3900806|NCT01489189|3725370|B2|Advanced PDR, macular center attached (level 81)||Diabetic Retinopathy Severity|Diabetic retinopathy level data were missing for 2 in the anti-VEGF+deferred PRP group and 4 in the prompt PRP group. Proliferative diabetic retinopathy (PDR) could not be identified by the reading center in 46 eyes (12%) but was subsequently confirmed by other imaging modes in 29 (63%) of the 46 eyes.|eyes|Number|0|0.0||||||
3900807|NCT01489189|3725371|B1|Advanced PDR, macular center attached (level 81)||Diabetic Retinopathy Severity|Diabetic retinopathy level data were missing for 2 in the anti-VEGF+deferred PRP group and 4 in the prompt PRP group. Proliferative diabetic retinopathy (PDR) could not be identified by the reading center in 46 eyes (12%) but was subsequently confirmed by other imaging modes in 29 (63%) of the 46 eyes.|eyes|Number|2|2.0||||||
3900808|NCT01489189|3725369|B3|High-risk PDR (levels 71 and 75)||Diabetic Retinopathy Severity|Diabetic retinopathy level data were missing for 2 in the anti-VEGF+deferred PRP group and 4 in the prompt PRP group. Proliferative diabetic retinopathy (PDR) could not be identified by the reading center in 46 eyes (12%) but was subsequently confirmed by other imaging modes in 29 (63%) of the 46 eyes.|eyes|Number|142|142.0||||||
3900809|NCT01489189|3725370|B2|High-risk PDR (levels 71 and 75)||Diabetic Retinopathy Severity|Diabetic retinopathy level data were missing for 2 in the anti-VEGF+deferred PRP group and 4 in the prompt PRP group. Proliferative diabetic retinopathy (PDR) could not be identified by the reading center in 46 eyes (12%) but was subsequently confirmed by other imaging modes in 29 (63%) of the 46 eyes.|eyes|Number|73|73.0||||||
3900810|NCT01489189|3725371|B1|High-risk PDR (levels 71 and 75)||Diabetic Retinopathy Severity|Diabetic retinopathy level data were missing for 2 in the anti-VEGF+deferred PRP group and 4 in the prompt PRP group. Proliferative diabetic retinopathy (PDR) could not be identified by the reading center in 46 eyes (12%) but was subsequently confirmed by other imaging modes in 29 (63%) of the 46 eyes.|eyes|Number|69|69.0||||||
3900811|NCT01489189|3725369|B3|Moderate PDR (level 65)||Diabetic Retinopathy Severity|Diabetic retinopathy level data were missing for 2 in the anti-VEGF+deferred PRP group and 4 in the prompt PRP group. Proliferative diabetic retinopathy (PDR) could not be identified by the reading center in 46 eyes (12%) but was subsequently confirmed by other imaging modes in 29 (63%) of the 46 eyes.|eyes|Number|135|135.0||||||
3900812|NCT01489189|3725370|B2|Moderate PDR (level 65)||Diabetic Retinopathy Severity|Diabetic retinopathy level data were missing for 2 in the anti-VEGF+deferred PRP group and 4 in the prompt PRP group. Proliferative diabetic retinopathy (PDR) could not be identified by the reading center in 46 eyes (12%) but was subsequently confirmed by other imaging modes in 29 (63%) of the 46 eyes.|eyes|Number|67|67.0||||||
3900813|NCT01489189|3725371|B1|Moderate PDR (level 65)||Diabetic Retinopathy Severity|Diabetic retinopathy level data were missing for 2 in the anti-VEGF+deferred PRP group and 4 in the prompt PRP group. Proliferative diabetic retinopathy (PDR) could not be identified by the reading center in 46 eyes (12%) but was subsequently confirmed by other imaging modes in 29 (63%) of the 46 eyes.|eyes|Number|68|68.0||||||
3900814|NCT01489189|3725369|B3|Mild PDR (level 61)||Diabetic Retinopathy Severity|Diabetic retinopathy level data were missing for 2 in the anti-VEGF+deferred PRP group and 4 in the prompt PRP group. Proliferative diabetic retinopathy (PDR) could not be identified by the reading center in 46 eyes (12%) but was subsequently confirmed by other imaging modes in 29 (63%) of the 46 eyes.|eyes|Number|61|61.0||||||
3900815|NCT01489189|3725370|B2|Mild PDR (level 61)||Diabetic Retinopathy Severity|Diabetic retinopathy level data were missing for 2 in the anti-VEGF+deferred PRP group and 4 in the prompt PRP group. Proliferative diabetic retinopathy (PDR) could not be identified by the reading center in 46 eyes (12%) but was subsequently confirmed by other imaging modes in 29 (63%) of the 46 eyes.|eyes|Number|31|31.0||||||
3900816|NCT01489189|3725371|B1|Mild PDR (level 61)||Diabetic Retinopathy Severity|Diabetic retinopathy level data were missing for 2 in the anti-VEGF+deferred PRP group and 4 in the prompt PRP group. Proliferative diabetic retinopathy (PDR) could not be identified by the reading center in 46 eyes (12%) but was subsequently confirmed by other imaging modes in 29 (63%) of the 46 eyes.|eyes|Number|30|30.0||||||
3900817|NCT01489189|3725369|B3|Prior PRP without active PDR (level 60)||Diabetic Retinopathy Severity|Diabetic retinopathy level data were missing for 2 in the anti-VEGF+deferred PRP group and 4 in the prompt PRP group. Proliferative diabetic retinopathy (PDR) could not be identified by the reading center in 46 eyes (12%) but was subsequently confirmed by other imaging modes in 29 (63%) of the 46 eyes.|eyes|Number|1|1.0||||||
3900818|NCT01489189|3725370|B2|Prior PRP without active PDR (level 60)||Diabetic Retinopathy Severity|Diabetic retinopathy level data were missing for 2 in the anti-VEGF+deferred PRP group and 4 in the prompt PRP group. Proliferative diabetic retinopathy (PDR) could not be identified by the reading center in 46 eyes (12%) but was subsequently confirmed by other imaging modes in 29 (63%) of the 46 eyes.|eyes|Number|1|1.0||||||
3900819|NCT01489189|3725371|B1|Prior PRP without active PDR (level 60)||Diabetic Retinopathy Severity|Diabetic retinopathy level data were missing for 2 in the anti-VEGF+deferred PRP group and 4 in the prompt PRP group. Proliferative diabetic retinopathy (PDR) could not be identified by the reading center in 46 eyes (12%) but was subsequently confirmed by other imaging modes in 29 (63%) of the 46 eyes.|eyes|Number|0|0.0||||||
3900845|NCT01489189|3725370|B2|||Presence of Center-Involved Diabetic Macular Edema Regardless of Visual Acuity|OCT central subfield thickness measurements were missing for 2 in the anti-VEGF+deferred PRP group and 2 in the Prompt PRP group.|eyes|Number|62|62.0||||||
3900820|NCT01489189|3725369|B3|Severe NPDR (level 53)||Diabetic Retinopathy Severity|Diabetic retinopathy level data were missing for 2 in the anti-VEGF+deferred PRP group and 4 in the prompt PRP group. Proliferative diabetic retinopathy (PDR) could not be identified by the reading center in 46 eyes (12%) but was subsequently confirmed by other imaging modes in 29 (63%) of the 46 eyes.|eyes|Number|2|2.0||||||
3900821|NCT01489189|3725370|B2|Severe NPDR (level 53)||Diabetic Retinopathy Severity|Diabetic retinopathy level data were missing for 2 in the anti-VEGF+deferred PRP group and 4 in the prompt PRP group. Proliferative diabetic retinopathy (PDR) could not be identified by the reading center in 46 eyes (12%) but was subsequently confirmed by other imaging modes in 29 (63%) of the 46 eyes.|eyes|Number|1|1.0||||||
3900822|NCT01489189|3725371|B1|Severe NPDR (level 53)||Diabetic Retinopathy Severity|Diabetic retinopathy level data were missing for 2 in the anti-VEGF+deferred PRP group and 4 in the prompt PRP group. Proliferative diabetic retinopathy (PDR) could not be identified by the reading center in 46 eyes (12%) but was subsequently confirmed by other imaging modes in 29 (63%) of the 46 eyes.|eyes|Number|1|1.0||||||
3900823|NCT01489189|3725369|B3|Moderately severe NPDR (level 47)||Diabetic Retinopathy Severity|Diabetic retinopathy level data were missing for 2 in the anti-VEGF+deferred PRP group and 4 in the prompt PRP group. Proliferative diabetic retinopathy (PDR) could not be identified by the reading center in 46 eyes (12%) but was subsequently confirmed by other imaging modes in 29 (63%) of the 46 eyes.|eyes|Number|25|25.0||||||
3900824|NCT01489189|3725370|B2|Moderately severe NPDR (level 47)||Diabetic Retinopathy Severity|Diabetic retinopathy level data were missing for 2 in the anti-VEGF+deferred PRP group and 4 in the prompt PRP group. Proliferative diabetic retinopathy (PDR) could not be identified by the reading center in 46 eyes (12%) but was subsequently confirmed by other imaging modes in 29 (63%) of the 46 eyes.|eyes|Number|15|15.0||||||
3900825|NCT01489189|3725371|B1|Moderately severe NPDR (level 47)||Diabetic Retinopathy Severity|Diabetic retinopathy level data were missing for 2 in the anti-VEGF+deferred PRP group and 4 in the prompt PRP group. Proliferative diabetic retinopathy (PDR) could not be identified by the reading center in 46 eyes (12%) but was subsequently confirmed by other imaging modes in 29 (63%) of the 46 eyes.|eyes|Number|10|10.0||||||
3900826|NCT01489189|3725369|B3|Moderate NPDR (level 43)||Diabetic Retinopathy Severity|Diabetic retinopathy level data were missing for 2 in the anti-VEGF+deferred PRP group and 4 in the prompt PRP group. Proliferative diabetic retinopathy (PDR) could not be identified by the reading center in 46 eyes (12%) but was subsequently confirmed by other imaging modes in 29 (63%) of the 46 eyes.|eyes|Number|7|7.0||||||
3900827|NCT01489189|3725370|B2|Moderate NPDR (level 43)||Diabetic Retinopathy Severity|Diabetic retinopathy level data were missing for 2 in the anti-VEGF+deferred PRP group and 4 in the prompt PRP group. Proliferative diabetic retinopathy (PDR) could not be identified by the reading center in 46 eyes (12%) but was subsequently confirmed by other imaging modes in 29 (63%) of the 46 eyes.|eyes|Number|5|5.0||||||
3900828|NCT01489189|3725371|B1|Moderate NPDR (level 43)||Diabetic Retinopathy Severity|Diabetic retinopathy level data were missing for 2 in the anti-VEGF+deferred PRP group and 4 in the prompt PRP group. Proliferative diabetic retinopathy (PDR) could not be identified by the reading center in 46 eyes (12%) but was subsequently confirmed by other imaging modes in 29 (63%) of the 46 eyes.|eyes|Number|2|2.0||||||
3900829|NCT01489189|3725369|B3|Mild NPDR (level 35)||Diabetic Retinopathy Severity|Diabetic retinopathy level data were missing for 2 in the anti-VEGF+deferred PRP group and 4 in the prompt PRP group. Proliferative diabetic retinopathy (PDR) could not be identified by the reading center in 46 eyes (12%) but was subsequently confirmed by other imaging modes in 29 (63%) of the 46 eyes.|eyes|Number|10|10.0||||||
3900830|NCT01489189|3725370|B2|Mild NPDR (level 35)||Diabetic Retinopathy Severity|Diabetic retinopathy level data were missing for 2 in the anti-VEGF+deferred PRP group and 4 in the prompt PRP group. Proliferative diabetic retinopathy (PDR) could not be identified by the reading center in 46 eyes (12%) but was subsequently confirmed by other imaging modes in 29 (63%) of the 46 eyes.|eyes|Number|4|4.0||||||
3900831|NCT01489189|3725371|B1|Mild NPDR (level 35)||Diabetic Retinopathy Severity|Diabetic retinopathy level data were missing for 2 in the anti-VEGF+deferred PRP group and 4 in the prompt PRP group. Proliferative diabetic retinopathy (PDR) could not be identified by the reading center in 46 eyes (12%) but was subsequently confirmed by other imaging modes in 29 (63%) of the 46 eyes.|eyes|Number|6|6.0||||||
3900832|NCT01489189|3725369|B3|Microaneurysms only (level 20)||Diabetic Retinopathy Severity|Diabetic retinopathy level data were missing for 2 in the anti-VEGF+deferred PRP group and 4 in the prompt PRP group. Proliferative diabetic retinopathy (PDR) could not be identified by the reading center in 46 eyes (12%) but was subsequently confirmed by other imaging modes in 29 (63%) of the 46 eyes.|eyes|Number|1|1.0||||||
3900833|NCT01489189|3725370|B2|Microaneurysms only (level 20)||Diabetic Retinopathy Severity|Diabetic retinopathy level data were missing for 2 in the anti-VEGF+deferred PRP group and 4 in the prompt PRP group. Proliferative diabetic retinopathy (PDR) could not be identified by the reading center in 46 eyes (12%) but was subsequently confirmed by other imaging modes in 29 (63%) of the 46 eyes.|eyes|Number|1|1.0||||||
3900834|NCT01489189|3725371|B1|Microaneurysms only (level 20)||Diabetic Retinopathy Severity|Diabetic retinopathy level data were missing for 2 in the anti-VEGF+deferred PRP group and 4 in the prompt PRP group. Proliferative diabetic retinopathy (PDR) could not be identified by the reading center in 46 eyes (12%) but was subsequently confirmed by other imaging modes in 29 (63%) of the 46 eyes.|eyes|Number|0|0.0||||||
3900835|NCT01489189|3725369|B3|||Phakic Lens Status on Clinical Exam||eyes|Number|357|357.0||||||
3900836|NCT01489189|3725370|B2|||Phakic Lens Status on Clinical Exam||eyes|Number|187|187.0||||||
3900837|NCT01489189|3725371|B1|||Phakic Lens Status on Clinical Exam||eyes|Number|170|170.0||||||
3900838|NCT01489189|3725369|B3|Elsewhere||Neovascularization on Clinical Examination||eyes|Number|340|340.0||||||
3900839|NCT01489189|3725370|B2|Elsewhere||Neovascularization on Clinical Examination||eyes|Number|174|174.0||||||
3900840|NCT01489189|3725371|B1|Elsewhere||Neovascularization on Clinical Examination||eyes|Number|166|166.0||||||
3900841|NCT01489189|3725369|B3|Of the disc||Neovascularization on Clinical Examination||eyes|Number|199|199.0||||||
3900842|NCT01489189|3725370|B2|Of the disc||Neovascularization on Clinical Examination||eyes|Number|103|103.0||||||
3900843|NCT01489189|3725371|B1|Of the disc||Neovascularization on Clinical Examination||eyes|Number|96|96.0||||||
3900890|NCT01489189|3725370|B2|More than 1 race||Race/Ethnicity, Customized||eyes|Number|2|2.0||||||
3900846|NCT01489189|3725371|B1|||Presence of Center-Involved Diabetic Macular Edema Regardless of Visual Acuity|OCT central subfield thickness measurements were missing for 2 in the anti-VEGF+deferred PRP group and 2 in the Prompt PRP group.|eyes|Number|55|55.0||||||
3900847|NCT01489189|3725369|B3|||Presence of Center-Involved Diabetic Macular Edema with Visual Acuity Impairment|OCT central subfield thickness measurements were missing for 2 in the anti-VEGF+deferred PRP group and 2 in the Prompt PRP group.|eyes|Number|88|88.0||||||
3900848|NCT01489189|3725370|B2|||Presence of Center-Involved Diabetic Macular Edema with Visual Acuity Impairment|OCT central subfield thickness measurements were missing for 2 in the anti-VEGF+deferred PRP group and 2 in the Prompt PRP group.|eyes|Number|46|46.0||||||
3900849|NCT01489189|3725371|B1|||Presence of Center-Involved Diabetic Macular Edema with Visual Acuity Impairment|OCT central subfield thickness measurements were missing for 2 in the anti-VEGF+deferred PRP group and 2 in the Prompt PRP group.|eyes|Number|42|42.0||||||
3900850|NCT01489189|3725369|B3|||Optical Coherence Tomography Central Subfield Thickness|"OCT central subfield thickness measurements were missing for 2 in the anti-VEGF+deferred PRP group and 2 in the prompt PRP group.~Assessments from OCT machines other than Zeiss Stratus were converted to equivalent on Zeiss Stratus machines."|µm|Median|229|229.0|Inter-Quartile Range|||199.0|266.0|
3900851|NCT01489189|3725370|B2|||Optical Coherence Tomography Central Subfield Thickness|"OCT central subfield thickness measurements were missing for 2 in the anti-VEGF+deferred PRP group and 2 in the prompt PRP group.~Assessments from OCT machines other than Zeiss Stratus were converted to equivalent on Zeiss Stratus machines."|µm|Median|230|230.0|Inter-Quartile Range|||203.0|265.0|
3900852|NCT01489189|3725371|B1|||Optical Coherence Tomography Central Subfield Thickness|"OCT central subfield thickness measurements were missing for 2 in the anti-VEGF+deferred PRP group and 2 in the prompt PRP group.~Assessments from OCT machines other than Zeiss Stratus were converted to equivalent on Zeiss Stratus machines."|µm|Median|223|223.0|Inter-Quartile Range|||196.0|271.0|
3900853|NCT01489189|3725369|B3|||Visual Acuity|Best corrected visual acuity letter score as measured by a certified tester using an electronic visual acuity testing machine based on the Early Treatment Diabetic Retinopathy Study (ETDRS) method. Best value on the scale 97, worst 0.|letters|Mean|75.1|75.1|Standard Deviation|12.6|12.6|||
3900854|NCT01489189|3725370|B2|||Visual Acuity|Best corrected visual acuity letter score as measured by a certified tester using an electronic visual acuity testing machine based on the Early Treatment Diabetic Retinopathy Study (ETDRS) method. Best value on the scale 97, worst 0.|letters|Mean|75.2|75.2|Standard Deviation|12.5|12.5|||
3900855|NCT01489189|3725371|B1|||Visual Acuity|Best corrected visual acuity letter score as measured by a certified tester using an electronic visual acuity testing machine based on the Early Treatment Diabetic Retinopathy Study (ETDRS) method. Best value on the scale 97, worst 0.|letters|Mean|75|75.0|Standard Deviation|12.8|12.8|||
3900856|NCT01489189|3725369|B3|||Arterial Blood Pressure||mmHg|Median|99|99.0|Inter-Quartile Range|||88.0|108.0|
3900857|NCT01489189|3725370|B2|||Arterial Blood Pressure||mmHg|Median|99|99.0|Inter-Quartile Range|||88.0|107.0|
3900858|NCT01489189|3725371|B1|||Arterial Blood Pressure||mmHg|Median|99|99.0|Inter-Quartile Range|||88.0|108.0|
3900859|NCT01489189|3725369|B3|||Prior Stroke||eyes|Number|7|7.0||||||
3900860|NCT01489189|3725370|B2|||Prior Stroke||eyes|Number|3|3.0||||||
3900861|NCT01489189|3725371|B1|||Prior Stroke||eyes|Number|4|4.0||||||
3900862|NCT01489189|3725369|B3|||Prior Myocardial Infarction||eyes|Number|7|7.0||||||
3900863|NCT01489189|3725370|B2|||Prior Myocardial Infarction||eyes|Number|4|4.0||||||
3900864|NCT01489189|3725371|B1|||Prior Myocardial Infarction||eyes|Number|3|3.0||||||
3900865|NCT01489189|3725369|B3|||Hemoglobin A1c|Hemoglobin A1c data were missing for 7 in the anti-VEGF+Deferred PRP group and 5 in the prompt PRP group.|percent|Median|8.7|8.7|Inter-Quartile Range|||7.5|10.4|
3900866|NCT01489189|3725370|B2|||Hemoglobin A1c|Hemoglobin A1c data were missing for 7 in the anti-VEGF+Deferred PRP group and 5 in the prompt PRP group.|percent|Median|8.9|8.9|Inter-Quartile Range|||7.5|10.4|
3900867|NCT01489189|3725371|B1|||Hemoglobin A1c|Hemoglobin A1c data were missing for 7 in the anti-VEGF+Deferred PRP group and 5 in the prompt PRP group.|percent|Median|8.6|8.6|Inter-Quartile Range|||7.5|10.4|
3900868|NCT01489189|3725369|B3|||Duration of Diabetes||years|Median|18|18.0|Inter-Quartile Range|||11.0|24.0|
3900869|NCT01489189|3725370|B2|||Duration of Diabetes||years|Median|17|17.0|Inter-Quartile Range|||11.0|23.0|
3900870|NCT01489189|3725371|B1|||Duration of Diabetes||years|Median|18|18.0|Inter-Quartile Range|||12.0|24.0|
3900871|NCT01489189|3725369|B3|Uncertain||Diabetes Type||eyes|Number|15|15.0||||||
3900872|NCT01489189|3725370|B2|Uncertain||Diabetes Type||eyes|Number|7|7.0||||||
3900873|NCT01489189|3725371|B1|Uncertain||Diabetes Type||eyes|Number|8|8.0||||||
3900874|NCT01489189|3725369|B3|Type 2||Diabetes Type||eyes|Number|295|295.0||||||
3900875|NCT01489189|3725370|B2|Type 2||Diabetes Type||eyes|Number|155|155.0||||||
3900876|NCT01489189|3725371|B1|Type 2||Diabetes Type||eyes|Number|140|140.0||||||
3900877|NCT01489189|3725369|B3|Type 1||Diabetes Type||eyes|Number|84|84.0||||||
3900878|NCT01489189|3725370|B2|Type 1||Diabetes Type||eyes|Number|41|41.0||||||
3900879|NCT01489189|3725371|B1|Type 1||Diabetes Type||eyes|Number|43|43.0||||||
3900880|NCT01489189|3725369|B3|Two (one in each group)||Number of study eyes||eyes|Number|178|178.0||||||
3900881|NCT01489189|3725370|B2|Two (one in each group)||Number of study eyes||eyes|Number|89|89.0||||||
3900882|NCT01489189|3725371|B1|Two (one in each group)||Number of study eyes||eyes|Number|89|89.0||||||
3900883|NCT01489189|3725369|B3|One||Number of study eyes||eyes|Number|216|216.0||||||
3900884|NCT01489189|3725370|B2|One||Number of study eyes||eyes|Number|114|114.0||||||
3900885|NCT01489189|3725371|B1|One||Number of study eyes||eyes|Number|102|102.0||||||
3900886|NCT01489189|3725369|B3|Unknown/not reported||Race/Ethnicity, Customized||eyes|Number|5|5.0||||||
3900887|NCT01489189|3725370|B2|Unknown/not reported||Race/Ethnicity, Customized||eyes|Number|3|3.0||||||
3900888|NCT01489189|3725371|B1|Unknown/not reported||Race/Ethnicity, Customized||eyes|Number|2|2.0||||||
3900889|NCT01489189|3725369|B3|More than 1 race||Race/Ethnicity, Customized||eyes|Number|2|2.0||||||
3900891|NCT01489189|3725371|B1|More than 1 race||Race/Ethnicity, Customized||eyes|Number|0|0.0||||||
3900892|NCT01489189|3725369|B3|American Indian/Alaskan Native||Race/Ethnicity, Customized||eyes|Number|1|1.0||||||
3900893|NCT01489189|3725370|B2|American Indian/Alaskan Native||Race/Ethnicity, Customized||eyes|Number|0|0.0||||||
3900894|NCT01489189|3725371|B1|American Indian/Alaskan Native||Race/Ethnicity, Customized||eyes|Number|1|1.0||||||
3900895|NCT01489189|3725369|B3|Asian||Race/Ethnicity, Customized||eyes|Number|5|5.0||||||
3900896|NCT01489189|3725370|B2|Asian||Race/Ethnicity, Customized||eyes|Number|3|3.0||||||
3900897|NCT01489189|3725371|B1|Asian||Race/Ethnicity, Customized||eyes|Number|2|2.0||||||
3900898|NCT01489189|3725369|B3|Black/African American||Race/Ethnicity, Customized||eyes|Number|81|81.0||||||
3900899|NCT01489189|3725370|B2|Black/African American||Race/Ethnicity, Customized||eyes|Number|43|43.0||||||
3900900|NCT01489189|3725371|B1|Black/African American||Race/Ethnicity, Customized||eyes|Number|38|38.0||||||
3900901|NCT01489189|3725369|B3|Hispanic||Race/Ethnicity, Customized||eyes|Number|99|99.0||||||
3900902|NCT01489189|3725370|B2|Hispanic||Race/Ethnicity, Customized||eyes|Number|51|51.0||||||
3900903|NCT01489189|3725371|B1|Hispanic||Race/Ethnicity, Customized||eyes|Number|48|48.0||||||
3900904|NCT01489189|3725369|B3|White||Race/Ethnicity, Customized||eyes|Number|201|201.0||||||
3900905|NCT01489189|3725370|B2|White||Race/Ethnicity, Customized||eyes|Number|101|101.0||||||
3900906|NCT01489189|3725371|B1|White||Race/Ethnicity, Customized||eyes|Number|100|100.0||||||
3900907|NCT01489189|3725369|B3|Male||Sex/Gender, Customized||eyes|Number|219|219.0||||||
3900908|NCT01489189|3725370|B2|Male||Sex/Gender, Customized||eyes|Number|111|111.0||||||
3900909|NCT01489189|3725371|B1|Male||Sex/Gender, Customized||eyes|Number|108|108.0||||||
3900910|NCT01489189|3725369|B3|Female||Sex/Gender, Customized||eyes|Number|175|175.0||||||
3900911|NCT01489189|3725370|B2|Female||Sex/Gender, Customized||eyes|Number|92|92.0||||||
3900912|NCT01489189|3725371|B1|Female||Sex/Gender, Customized||eyes|Number|83|83.0||||||
3900913|NCT01489189|3725369|B3|||Age, Customized||years|Median|51|51.0|Inter-Quartile Range|||44.0|59.0|
3900914|NCT01489189|3725370|B2|||Age, Customized||years|Median|51|51.0|Inter-Quartile Range|||44.0|59.0|
3900915|NCT01489189|3725371|B1|||Age, Customized||years|Median|52|52.0|Inter-Quartile Range|||44.0|59.0|
3900916|NCT01488994|3725397|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3900917|NCT01488994|3725398|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3900918|NCT01488994|3725399|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3900919|NCT01488994|3725397|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3900920|NCT01488994|3725398|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3900921|NCT01488994|3725399|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3900922|NCT01488994|3725397|B3|||Age||years|Mean|6.94|6.94|Full Range|||1.8|11.8|
3900923|NCT01488994|3725398|B2|||Age||years|Mean|9.8|9.8|Full Range|||7.1|11.8|
3900924|NCT01488994|3725399|B1|||Age||years|Mean|3.83|3.83|Full Range|||1.8|6.0|
3900925|NCT01488877|3725487|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3900926|NCT01488877|3725487|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3900927|NCT01488877|3725487|B1|greater than or equal to (>=) 65 years||Age, Customized||participants|Number|0|0.0||||||
3900928|NCT01488877|3725487|B1|45 to 64 years||Age, Customized||participants|Number|6|6.0||||||
3900929|NCT01488877|3725487|B1|18 to 44 years||Age, Customized||participants|Number|0|0.0||||||
3900930|NCT01488877|3725487|B1|less than (<) 18 years||Age, Customized||participants|Number|0|0.0||||||
3900931|NCT01488708|3725504|B3|||Anti-dsDNA Antibody Level (IU)||International Unit/Milliliter (IU/mL)|Mean|86.4|86.4|Standard Deviation|102.23|102.23|||
3900932|NCT01488708|3725505|B2|||Anti-dsDNA Antibody Level (IU)||International Unit/Milliliter (IU/mL)|Mean|92.3|92.3|Standard Deviation|102.35|102.35|||
3900933|NCT01488708|3725506|B1|||Anti-dsDNA Antibody Level (IU)||International Unit/Milliliter (IU/mL)|Mean|82.9|82.9|Standard Deviation|102.03|102.03|||
3900934|NCT01488708|3725504|B3|||Safety of Estrogens in Lupus Erythematosus National Assessment (SELENA-SLEDAI) Score|SELENA SLEDAI is calculated from 24 individual descriptors across 9 organ systems; 0 indicates inactive disease and the maximum theoretical score is 105; scores > 20 are rare.|units on a scale|Mean|5.2|5.2|Standard Deviation|3.79|3.79|||
3900935|NCT01488708|3725505|B2|||Safety of Estrogens in Lupus Erythematosus National Assessment (SELENA-SLEDAI) Score|SELENA SLEDAI is calculated from 24 individual descriptors across 9 organ systems; 0 indicates inactive disease and the maximum theoretical score is 105; scores > 20 are rare.|units on a scale|Mean|4.9|4.9|Standard Deviation|3.74|3.74|||
3900936|NCT01488708|3725506|B1|||Safety of Estrogens in Lupus Erythematosus National Assessment (SELENA-SLEDAI) Score|SELENA SLEDAI is calculated from 24 individual descriptors across 9 organ systems; 0 indicates inactive disease and the maximum theoretical score is 105; scores > 20 are rare.|units on a scale|Mean|5.4|5.4|Standard Deviation|3.81|3.81|||
3900937|NCT01488708|3725504|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3900938|NCT01488708|3725505|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3900939|NCT01488708|3725506|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3900940|NCT01488708|3725504|B3|Egypt||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3900941|NCT01488708|3725505|B2|Egypt||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3900942|NCT01488708|3725506|B1|Egypt||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3900943|NCT01488708|3725504|B3|Israel||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3900944|NCT01488708|3725505|B2|Israel||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3900945|NCT01488708|3725506|B1|Israel||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3900946|NCT01488708|3725504|B3|South Africa||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3900947|NCT01488708|3725505|B2|South Africa||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3900948|NCT01488708|3725506|B1|South Africa||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3900949|NCT01488708|3725504|B3|Tunisia||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3900950|NCT01488708|3725505|B2|Tunisia||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3900951|NCT01488708|3725506|B1|Tunisia||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3900952|NCT01488708|3725504|B3|France||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3900953|NCT01488708|3725505|B2|France||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3900954|NCT01488708|3725506|B1|France||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3900955|NCT01488708|3725504|B3|Croatia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3900956|NCT01488708|3725505|B2|Croatia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3900957|NCT01488708|3725506|B1|Croatia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3900958|NCT01488708|3725504|B3|Italy||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3900959|NCT01488708|3725505|B2|Italy||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3900960|NCT01488708|3725506|B1|Italy||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3900961|NCT01488708|3725504|B3|Austria||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3900962|NCT01488708|3725505|B2|Austria||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3900963|NCT01488708|3725506|B1|Austria||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3900964|NCT01488708|3725504|B3|Macedonia||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3900965|NCT01488708|3725505|B2|Macedonia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3900966|NCT01488708|3725506|B1|Macedonia||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3900967|NCT01488708|3725504|B3|Latvia||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3900968|NCT01488708|3725505|B2|Latvia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3900969|NCT01488708|3725506|B1|Latvia||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3900970|NCT01488708|3725504|B3|Bulgaria||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3900971|NCT01488708|3725505|B2|Bulgaria||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3900972|NCT01488708|3725506|B1|Bulgaria||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3900973|NCT01488708|3725504|B3|Belarus||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3900974|NCT01488708|3725505|B2|Belarus||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3900975|NCT01488708|3725506|B1|Belarus||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3900976|NCT01488708|3725504|B3|Germany||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3900977|NCT01488708|3725505|B2|Germany||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3900978|NCT01488708|3725506|B1|Germany||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3900979|NCT01488708|3725504|B3|Spain||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3900980|NCT01488708|3725505|B2|Spain||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3900981|NCT01488708|3725506|B1|Spain||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3900982|NCT01488708|3725504|B3|Romania||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3900983|NCT01488708|3725505|B2|Romania||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3900984|NCT01488708|3725506|B1|Romania||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3900985|NCT01488708|3725504|B3|Ukraine||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3900986|NCT01488708|3725505|B2|Ukraine||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3900987|NCT01488708|3725506|B1|Ukraine||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3900988|NCT01488708|3725504|B3|Russia||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
3900989|NCT01488708|3725505|B2|Russia||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3900990|NCT01488708|3725506|B1|Russia||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3900991|NCT01488708|3725504|B3|Poland||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3900992|NCT01488708|3725505|B2|Poland||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3900993|NCT01488708|3725506|B1|Poland||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3900994|NCT01488708|3725504|B3|Hungary||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3900995|NCT01488708|3725505|B2|Hungary||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3900996|NCT01488708|3725506|B1|Hungary||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3900997|NCT01488708|3725504|B3|Serbia||Region of Enrollment||Participants|Count of Participants|63|63.0||||||
3900998|NCT01488708|3725505|B2|Serbia||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3900999|NCT01488708|3725506|B1|Serbia||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3901000|NCT01488708|3725504|B3|Singapore||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3901001|NCT01488708|3725505|B2|Singapore||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3901002|NCT01488708|3725506|B1|Singapore||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3901003|NCT01488708|3725504|B3|Malaysia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3901004|NCT01488708|3725505|B2|Malaysia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3901005|NCT01488708|3725506|B1|Malaysia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3901006|NCT01488708|3725504|B3|New Zealand||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3901007|NCT01488708|3725505|B2|New Zealand||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3901008|NCT01488708|3725506|B1|New Zealand||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3901009|NCT01488708|3725504|B3|Australia||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3901010|NCT01488708|3725505|B2|Australia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3901011|NCT01488708|3725506|B1|Australia||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3901012|NCT01488708|3725504|B3|Thailand||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3901013|NCT01488708|3725505|B2|Thailand||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3901014|NCT01488708|3725506|B1|Thailand||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3901015|NCT01488708|3725504|B3|South Korea||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3901016|NCT01488708|3725505|B2|South Korea||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3901017|NCT01488708|3725506|B1|South Korea||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3901018|NCT01488708|3725504|B3|Japan||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3901019|NCT01488708|3725505|B2|Japan||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3901020|NCT01488708|3725506|B1|Japan||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3901021|NCT01488708|3725504|B3|Taiwan||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3901022|NCT01488708|3725505|B2|Taiwan||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3901023|NCT01488708|3725506|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3901024|NCT01488708|3725504|B3|Philippines||Region of Enrollment||Participants|Count of Participants|59|59.0||||||
3901025|NCT01488708|3725505|B2|Philippines||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3901026|NCT01488708|3725506|B1|Philippines||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3901027|NCT01488708|3725504|B3|Chile||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3901028|NCT01488708|3725505|B2|Chile||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3901029|NCT01488708|3725506|B1|Chile||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3901030|NCT01488708|3725504|B3|Guatemala||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3901031|NCT01488708|3725505|B2|Guatemala||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3901032|NCT01488708|3725506|B1|Guatemala||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3901033|NCT01488708|3725504|B3|Colombia||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3901034|NCT01488708|3725505|B2|Colombia||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3901035|NCT01488708|3725506|B1|Colombia||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3901036|NCT01488708|3725504|B3|Argentina||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3901037|NCT01488708|3725505|B2|Argentina||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3901038|NCT01488708|3725506|B1|Argentina||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3901039|NCT01488708|3725504|B3|Ecuador||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3901040|NCT01488708|3725505|B2|Ecuador||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3901041|NCT01488708|3725506|B1|Ecuador||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3901042|NCT01488708|3725504|B3|Mexico||Region of Enrollment||Participants|Count of Participants|51|51.0||||||
3901043|NCT01488708|3725505|B2|Mexico||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3901044|NCT01488708|3725506|B1|Mexico||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3901045|NCT01488708|3725504|B3|Brazil||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
3901046|NCT01488708|3725505|B2|Brazil||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3901047|NCT01488708|3725506|B1|Brazil||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3901048|NCT01488708|3725504|B3|Peru||Region of Enrollment||Participants|Count of Participants|69|69.0||||||
3901049|NCT01488708|3725505|B2|Peru||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
3901050|NCT01488708|3725506|B1|Peru||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3901051|NCT01488708|3725504|B3|Canada||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3901052|NCT01488708|3725505|B2|Canada||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3901053|NCT01488708|3725506|B1|Canada||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3901054|NCT01488708|3725504|B3|Puerto Rico||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3901055|NCT01488708|3725505|B2|Puerto Rico||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3901056|NCT01488708|3725506|B1|Puerto Rico||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3901057|NCT01488708|3725504|B3|United States||Region of Enrollment||Participants|Count of Participants|532|532.0||||||
3901058|NCT01488708|3725505|B2|United States||Region of Enrollment||Participants|Count of Participants|83|83.0||||||
3901059|NCT01488708|3725506|B1|United States||Region of Enrollment||Participants|Count of Participants|449|449.0||||||
3901060|NCT01488708|3725504|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901061|NCT01488708|3725505|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901062|NCT01488708|3725506|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901063|NCT01488708|3725504|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3901064|NCT01488708|3725505|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3901065|NCT01488708|3725506|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3901066|NCT01488708|3725504|B3||White|Race (NIH/OMB)||Participants|Count of Participants|916|916.0||||||
3901067|NCT01488708|3725505|B2||White|Race (NIH/OMB)||Participants|Count of Participants|337|337.0||||||
3901068|NCT01488708|3725506|B1||White|Race (NIH/OMB)||Participants|Count of Participants|579|579.0||||||
3901069|NCT01488708|3725504|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|163|163.0||||||
3901070|NCT01488708|3725505|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3901071|NCT01488708|3725506|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
3901072|NCT01488708|3725504|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3901073|NCT01488708|3725505|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3901074|NCT01488708|3725506|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901075|NCT01488708|3725504|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|209|209.0||||||
3901076|NCT01488708|3725505|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3901077|NCT01488708|3725506|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
3901078|NCT01488708|3725504|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|198|198.0||||||
3901079|NCT01488708|3725505|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3901080|NCT01488708|3725506|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
3901081|NCT01488708|3725504|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
3901082|NCT01488708|3725505|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3901083|NCT01488708|3725506|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3901084|NCT01488708|3725504|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|926|926.0||||||
3901085|NCT01488708|3725505|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|314|314.0||||||
3901086|NCT01488708|3725506|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|612|612.0||||||
3901087|NCT01488708|3725504|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|454|454.0||||||
3901088|NCT01488708|3725505|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|189|189.0||||||
3901089|NCT01488708|3725506|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|265|265.0||||||
3901090|NCT01488708|3725504|B3||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3901091|NCT01488708|3725505|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3901092|NCT01488708|3725506|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3901093|NCT01488708|3725504|B3||Female|Sex: Female, Male||Participants|Count of Participants|1407|1407.0||||||
3901094|NCT01488708|3725505|B2||Female|Sex: Female, Male||Participants|Count of Participants|527|527.0||||||
3901095|NCT01488708|3725506|B1||Female|Sex: Female, Male||Participants|Count of Participants|880|880.0||||||
3901096|NCT01488708|3725504|B3|||Age||years|Mean|42.4|42.4|Standard Deviation|11.93|11.93|||
3901097|NCT01488708|3725505|B2|||Age||years|Mean|40.4|40.4|Standard Deviation|11.35|11.35|||
3901098|NCT01488708|3725506|B1|||Age||years|Mean|43.6|43.6|Standard Deviation|12.12|12.12|||
3901099|NCT01488578|3725527|B1|8 mg||Starting dose||participants|Number|2|2.0||||||
3901100|NCT01488578|3725527|B1|4 mg||Starting dose||participants|Number|7506|7506.0||||||
3901101|NCT01488578|3725527|B1|2 mg||Starting dose||participants|Number|1813|1813.0||||||
3901102|NCT01488578|3725527|B1|Absent||Concomitant drug||participants|Number|4246|4246.0||||||
3901103|NCT01488578|3725527|B1|Present||Concomitant drug||participants|Number|5057|5057.0||||||
3901104|NCT01488578|3725527|B1|Absent||Complications||participants|Number|3484|3484.0||||||
3901105|NCT01488578|3725527|B1|Present||Complications||participants|Number|5837|5837.0||||||
3901106|NCT01488578|3725527|B1|Severe||Target disease severity|The severity of Overactive Bladder which was diagnosed by investigator.|participants|Number|606|606.0||||||
3901107|NCT01488578|3725527|B1|Moderate||Target disease severity|The severity of Overactive Bladder which was diagnosed by investigator.|participants|Number|5185|5185.0||||||
3901108|NCT01488578|3725527|B1|Mild||Target disease severity|The severity of Overactive Bladder which was diagnosed by investigator.|participants|Number|3530|3530.0||||||
3901109|NCT01488578|3725527|B1||Male|Sex: Female, Male||Participants|Count of Participants|4058|4058.0||||||
3901110|NCT01488578|3725527|B1||Female|Sex: Female, Male||Participants|Count of Participants|5263|5263.0||||||
3901111|NCT01488578|3725527|B1|>=65 years||Age, Customized||participants|Number|6473|6473.0||||||
3901112|NCT01488578|3725527|B1|<65 years||Age, Customized||participants|Number|2848|2848.0||||||
3901113|NCT01488487|3725561|B1|Missing||Prior therapy received for this cancer|Participants may have received more than one type of prior therapy.|participants receiving this prior tx|Number|1|1.0||||||
3901114|NCT01488487|3725561|B1|None||Prior therapy received for this cancer|Participants may have received more than one type of prior therapy.|participants receiving this prior tx|Number|12|12.0||||||
3901115|NCT01488487|3725561|B1|Surgery||Prior therapy received for this cancer|Participants may have received more than one type of prior therapy.|participants receiving this prior tx|Number|8|8.0||||||
3901158|NCT01488448|3725569|B2|||Age||months|Mean|4.39|4.39|Standard Deviation|2.95|2.95|||
3901116|NCT01488487|3725561|B1|Ablation||Prior therapy received for this cancer|Participants may have received more than one type of prior therapy.|participants receiving this prior tx|Number|2|2.0||||||
3901117|NCT01488487|3725561|B1|Transarterial radioembolization (TARE)||Prior therapy received for this cancer|Participants may have received more than one type of prior therapy.|participants receiving this prior tx|Number|2|2.0||||||
3901118|NCT01488487|3725561|B1|Transarterial chemoembolization (TACE)||Prior therapy received for this cancer|Participants may have received more than one type of prior therapy.|participants receiving this prior tx|Number|4|4.0||||||
3901119|NCT01488487|3725561|B1|Metastatic||Extent of cancer||participants|Number|11|11.0||||||
3901120|NCT01488487|3725561|B1|Multifocal||Extent of cancer||participants|Number|11|11.0||||||
3901121|NCT01488487|3725561|B1|Unifocal||Extent of cancer||participants|Number|2|2.0||||||
3901122|NCT01488487|3725561|B1|Absent||Portal vein involvement||participants|Number|15|15.0||||||
3901123|NCT01488487|3725561|B1|Present||Portal vein involvement||participants|Number|9|9.0||||||
3901124|NCT01488487|3725561|B1|Missing||BCLC (Barcelona Clinic Liver Cancer) Stage|Missing for one participant. Barcelona Clinic Liver Cancer (BCLC) staging criteria ranges from very early stage (0), to early stage (A), Intermediate stage (B), advanced stage (C), and end stage (D). Staging is based on Child-Pugh score, performance status, and number and size of nodules. Earlier stages (0,A) have better prognosis.|participants|Number|1|1.0||||||
3901125|NCT01488487|3725561|B1|Stage C||BCLC (Barcelona Clinic Liver Cancer) Stage|Missing for one participant. Barcelona Clinic Liver Cancer (BCLC) staging criteria ranges from very early stage (0), to early stage (A), Intermediate stage (B), advanced stage (C), and end stage (D). Staging is based on Child-Pugh score, performance status, and number and size of nodules. Earlier stages (0,A) have better prognosis.|participants|Number|21|21.0||||||
3901126|NCT01488487|3725561|B1|Stage B||BCLC (Barcelona Clinic Liver Cancer) Stage|Missing for one participant. Barcelona Clinic Liver Cancer (BCLC) staging criteria ranges from very early stage (0), to early stage (A), Intermediate stage (B), advanced stage (C), and end stage (D). Staging is based on Child-Pugh score, performance status, and number and size of nodules. Earlier stages (0,A) have better prognosis.|participants|Number|2|2.0||||||
3901127|NCT01488487|3725561|B1|||CLIP (Cancer of the Liver Italian Program) score|"The CLIP score for a patient with hepatocellular carcinoma is calculated by assigning a score (0, 1 or 2) to each of four clinical factors: a) Child-Pugh stage; b) number of tumor nodules and whether the tumor extends through <=50% or >50% of the liver; c) AFP; and d) portal vein thrombosis.~These scores are added together to yield a CLIP score of 0-6, with lower scores having a better outcome."|units on a scale|Median|1.5|1.5|Full Range|||0.0|5.0|
3901128|NCT01488487|3725561|B1|||Time from diagnosis to enrollment||Months|Median|4|4.0|Full Range|||1.0|88.0|
3901129|NCT01488487|3725561|B1|||Child-Pugh Score (Stage)|A scale to assess severity of liver disease based on five clinical features: 1) serum bilirubin, 2) serum albumin, 3) prothrombin time, 4) the degree of ascites, and 5) the grade of hepatic encephalopathy. One point given for absent/normal, 2 points for slight or mild, and 3 points for severe. Child-Pugh Score could range from 5 - 15, with lower scores equaling better prognosis.|units on a scale|Median|5|5.0|Full Range|||5.0|6.0|
3901130|NCT01488487|3725561|B1|Absent||Chronic Hepatitis B|Presence of Hepatitis B virus as a cause of hepatocellular carcinoma|participants|Number|22|22.0||||||
3901131|NCT01488487|3725561|B1|Present||Chronic Hepatitis B|Presence of Hepatitis B virus as a cause of hepatocellular carcinoma|participants|Number|2|2.0||||||
3901132|NCT01488487|3725561|B1|Absent||Chronic Hepatitis C|Presence of Hepatitis C virus as a cause of hepatocellular carcinoma|participants|Number|17|17.0||||||
3901133|NCT01488487|3725561|B1|Present||Chronic Hepatitis C|Presence of Hepatitis C virus as a cause of hepatocellular carcinoma|participants|Number|7|7.0||||||
3901134|NCT01488487|3725561|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3901135|NCT01488487|3725561|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901136|NCT01488487|3725561|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901137|NCT01488487|3725561|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3901138|NCT01488487|3725561|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3901139|NCT01488487|3725561|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901140|NCT01488487|3725561|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3901141|NCT01488487|3725561|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901142|NCT01488487|3725561|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901143|NCT01488487|3725561|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3901144|NCT01488487|3725561|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901145|NCT01488487|3725561|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3901146|NCT01488487|3725561|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3901147|NCT01488487|3725561|B1|||Age||years|Median|59|59.0|Full Range|||23.0|87.0|
3901148|NCT01488487|3725561|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3901149|NCT01488487|3725561|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3901150|NCT01488487|3725561|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3901151|NCT01488448|3725568|B3||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3901152|NCT01488448|3725569|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3901153|NCT01488448|3725570|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3901154|NCT01488448|3725568|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3901155|NCT01488448|3725569|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3901156|NCT01488448|3725570|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3901157|NCT01488448|3725568|B3|||Age||months|Mean|4.1|4.1|Standard Deviation|2.98|2.98|||
3901159|NCT01488448|3725570|B1|||Age||months|Mean|3.86|3.86|Standard Deviation|3.01|3.01|||
3901160|NCT01488409|3725593|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
3901161|NCT01488409|3725594|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3901162|NCT01488409|3725595|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3901163|NCT01488409|3725593|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3901164|NCT01488409|3725594|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3901165|NCT01488409|3725595|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3901166|NCT01488409|3725593|B3|Black||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3901167|NCT01488409|3725594|B2|Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3901168|NCT01488409|3725595|B1|Black||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3901169|NCT01488409|3725593|B3|White||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3901170|NCT01488409|3725594|B2|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3901171|NCT01488409|3725595|B1|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3901172|NCT01488409|3725593|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3901173|NCT01488409|3725594|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3901174|NCT01488409|3725595|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3901175|NCT01488409|3725593|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3901176|NCT01488409|3725594|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3901177|NCT01488409|3725595|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3901178|NCT01488409|3725593|B3|||Age||years|Mean|46|46.0|Standard Deviation|6|6.0|||
3901179|NCT01488409|3725594|B2|||Age||years|Mean|45|45.0|Standard Deviation|7|7.0|||
3901180|NCT01488409|3725595|B1|||Age||years|Mean|47|47.0|Standard Deviation|5|5.0|||
3901181|NCT01488370|3725610|B4|||Percentile Weight for Length||Percentile|Median|71.9|71.9|Full Range|||31.3|84.6|
3901182|NCT01488370|3725611|B3|||Percentile Weight for Length||Percentile|Median|72.1|72.1|Full Range|||47.6|84.0|
3901183|NCT01488370|3725612|B2|||Percentile Weight for Length||Percentile|Median|58.5|58.5|Full Range|||31.3|76.7|
3901184|NCT01488370|3725613|B1|||Percentile Weight for Length||Percentile|Median|71.9|71.9|Full Range|||49.2|84.6|
3901185|NCT01488370|3725610|B4|||Weight||Kg|Mean|8.0|8.0|Full Range|||6.0|9.3|
3901186|NCT01488370|3725611|B3|||Weight||Kg|Mean|8.0|8.0|Full Range|||6.9|9.2|
3901187|NCT01488370|3725612|B2|||Weight||Kg|Mean|8.0|8.0|Full Range|||6.0|9.1|
3901188|NCT01488370|3725613|B1|||Weight||Kg|Mean|8.2|8.2|Full Range|||7.1|9.3|
3901189|NCT01488370|3725610|B4|||ASA Status IV|ASA status was assigned based on standard American Society for Anesthesiologists guidelines. ASA IV = severe systemic disease that is a constant threat to life. All patients undergoing an anesthetic are assigned and ASA status.|Participants|Count of Participants|2|2.0||||||
3901190|NCT01488370|3725611|B3|||ASA Status IV|ASA status was assigned based on standard American Society for Anesthesiologists guidelines. ASA IV = severe systemic disease that is a constant threat to life. All patients undergoing an anesthetic are assigned and ASA status.|Participants|Count of Participants|0|0.0||||||
3901191|NCT01488370|3725612|B2|||ASA Status IV|ASA status was assigned based on standard American Society for Anesthesiologists guidelines. ASA IV = severe systemic disease that is a constant threat to life. All patients undergoing an anesthetic are assigned and ASA status.|Participants|Count of Participants|2|2.0||||||
3901192|NCT01488370|3725613|B1|||ASA Status IV|ASA status was assigned based on standard American Society for Anesthesiologists guidelines. ASA IV = severe systemic disease that is a constant threat to life. All patients undergoing an anesthetic are assigned and ASA status.|Participants|Count of Participants|0|0.0||||||
3901193|NCT01488370|3725610|B4|||ASA Status III|ASA status was assigned based on standard American Society for Anesthesiologists guidelines. ASA III = moderate to severe systemic disease. All patients undergoing an anesthetic are assigned and ASA status.|Participants|Count of Participants|14|14.0||||||
3901194|NCT01488370|3725611|B3|||ASA Status III|ASA status was assigned based on standard American Society for Anesthesiologists guidelines. ASA III = moderate to severe systemic disease. All patients undergoing an anesthetic are assigned and ASA status.|Participants|Count of Participants|6|6.0||||||
3901195|NCT01488370|3725612|B2|||ASA Status III|ASA status was assigned based on standard American Society for Anesthesiologists guidelines. ASA III = moderate to severe systemic disease. All patients undergoing an anesthetic are assigned and ASA status.|Participants|Count of Participants|5|5.0||||||
3901196|NCT01488370|3725613|B1|||ASA Status III|ASA status was assigned based on standard American Society for Anesthesiologists guidelines. ASA III = moderate to severe systemic disease. All patients undergoing an anesthetic are assigned and ASA status.|Participants|Count of Participants|3|3.0||||||
3901197|NCT01488370|3725610|B4|||ASA Status II|ASA status was assigned based on standard American Society for Anesthesiologists guidelines. ASA II = mild systemic disease. All patients undergoing an anesthetic are assigned and ASA status.|Participants|Count of Participants|34|34.0||||||
3901198|NCT01488370|3725611|B3|||ASA Status II|ASA status was assigned based on standard American Society for Anesthesiologists guidelines. ASA II = mild systemic disease. All patients undergoing an anesthetic are assigned and ASA status.|Participants|Count of Participants|9|9.0||||||
3901199|NCT01488370|3725612|B2|||ASA Status II|ASA status was assigned based on standard American Society for Anesthesiologists guidelines. ASA II = mild systemic disease. All patients undergoing an anesthetic are assigned and ASA status.|Participants|Count of Participants|12|12.0||||||
3901200|NCT01488370|3725613|B1|||ASA Status II|ASA status was assigned based on standard American Society for Anesthesiologists guidelines. ASA II = mild systemic disease. All patients undergoing an anesthetic are assigned and ASA status.|Participants|Count of Participants|13|13.0||||||
3901201|NCT01488370|3725610|B4|||ASA Status I|ASA status was assigned based on standard American Society for Anesthesiologists guidelines, ASA I = healthy. All patients undergoing an anesthetic are assigned and ASA status.|Participants|Count of Participants|13|13.0||||||
3901202|NCT01488370|3725611|B3|||ASA Status I|ASA status was assigned based on standard American Society for Anesthesiologists guidelines, ASA I = healthy. All patients undergoing an anesthetic are assigned and ASA status.|Participants|Count of Participants|4|4.0||||||
3901203|NCT01488370|3725612|B2|||ASA Status I|ASA status was assigned based on standard American Society for Anesthesiologists guidelines, ASA I = healthy. All patients undergoing an anesthetic are assigned and ASA status.|Participants|Count of Participants|3|3.0||||||
3901204|NCT01488370|3725613|B1|||ASA Status I|ASA status was assigned based on standard American Society for Anesthesiologists guidelines, ASA I = healthy. All patients undergoing an anesthetic are assigned and ASA status.|Participants|Count of Participants|6|6.0||||||
3901205|NCT01488370|3725610|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3901206|NCT01488370|3725611|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3901207|NCT01488370|3725612|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3901208|NCT01488370|3725613|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3901209|NCT01488370|3725610|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3901210|NCT01488370|3725611|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3901211|NCT01488370|3725612|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3901212|NCT01488370|3725613|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3901213|NCT01488370|3725610|B4|||Age||Months|Median|8.1|8.1|Full Range|||4.8|13.1|
3901214|NCT01488370|3725611|B3|||Age||Months|Median|8.1|8.1|Full Range|||5.7|13.1|
3901215|NCT01488370|3725612|B2|||Age||Months|Median|8.5|8.5|Full Range|||6.3|10.5|
3901216|NCT01488370|3725613|B1|||Age||Months|Median|7.6|7.6|Full Range|||4.8|10.8|
3901217|NCT01488318|3725635|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3901218|NCT01488318|3725635|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3901219|NCT01488318|3725635|B1|||Age||years|Median|62|62.0|Full Range|||51.7|72.2|
3901220|NCT01488279|3725642|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3901221|NCT01488279|3725643|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3901222|NCT01488279|3725644|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3901223|NCT01488279|3725642|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901224|NCT01488279|3725643|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901225|NCT01488279|3725644|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901226|NCT01488279|3725642|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901227|NCT01488279|3725643|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901228|NCT01488279|3725644|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901229|NCT01488279|3725642|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3901230|NCT01488279|3725643|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3901231|NCT01488279|3725644|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3901232|NCT01488279|3725642|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901233|NCT01488279|3725643|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901234|NCT01488279|3725644|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901235|NCT01488279|3725642|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901236|NCT01488279|3725643|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901237|NCT01488279|3725644|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901238|NCT01488279|3725642|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901239|NCT01488279|3725643|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901240|NCT01488279|3725644|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901241|NCT01488279|3725642|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901242|NCT01488279|3725643|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901243|NCT01488279|3725644|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901244|NCT01488279|3725642|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901245|NCT01488279|3725643|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901246|NCT01488279|3725644|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901247|NCT01488279|3725642|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3901248|NCT01488279|3725643|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3901249|NCT01488279|3725644|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3901250|NCT01488279|3725642|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901251|NCT01488279|3725643|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901252|NCT01488279|3725644|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901253|NCT01488279|3725642|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3901254|NCT01488279|3725643|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3901255|NCT01488279|3725644|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3901256|NCT01488279|3725642|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3901257|NCT01488279|3725643|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3901258|NCT01488279|3725644|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3901259|NCT01488279|3725642|B3|||Age||years|Mean|52.5|52.5|Standard Deviation|5.5|5.5|||
3901260|NCT01488279|3725643|B2|||Age||years|Mean|52.5|52.5|Standard Deviation|5.5|5.5|||
3901261|NCT01488279|3725644|B1|||Age||years|Mean|52.5|52.5|Standard Deviation|5.5|5.5|||
3901262|NCT01488279|3725642|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3901263|NCT01488279|3725643|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3901264|NCT01488279|3725644|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3901265|NCT01488279|3725642|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3901266|NCT01488279|3725643|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3901267|NCT01488279|3725644|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3901268|NCT01488279|3725642|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3901269|NCT01488279|3725643|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3901270|NCT01488279|3725644|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3901271|NCT01488188|3725659|B3|Korea, Republic of||Region of Enrollment||participants|Number|40|40.0||||||
3901272|NCT01488188|3725660|B2|Korea, Republic of||Region of Enrollment||participants|Number|20|20.0||||||
3901273|NCT01488188|3725661|B1|Korea, Republic of||Region of Enrollment||participants|Number|20|20.0||||||
3901274|NCT01488188|3725659|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3901275|NCT01488188|3725660|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3901276|NCT01488188|3725661|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3901277|NCT01488188|3725659|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3901278|NCT01488188|3725660|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3901279|NCT01488188|3725661|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3901280|NCT01488188|3725659|B3|||Age||years|Mean|25.7|25.7|Standard Deviation|5.1|5.1|||
3901281|NCT01488188|3725660|B2|||Age||years|Mean|25.9|25.9|Standard Deviation|4.5|4.5|||
3901282|NCT01488188|3725661|B1|||Age||years|Mean|25.5|25.5|Standard Deviation|5.8|5.8|||
3901283|NCT01488188|3725659|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3901284|NCT01488188|3725660|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3901285|NCT01488188|3725661|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3901286|NCT01488188|3725659|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3901287|NCT01488188|3725660|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3901288|NCT01488188|3725661|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3901289|NCT01488188|3725659|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3901290|NCT01488188|3725660|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3901291|NCT01488188|3725661|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3901292|NCT01488097|3725674|B1|France||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3901293|NCT01488097|3725674|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3901294|NCT01488097|3725674|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3901295|NCT01488097|3725674|B1|Czechia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3901296|NCT01488097|3725674|B1|Canada||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3901297|NCT01488097|3725674|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901298|NCT01488097|3725674|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901299|NCT01488097|3725674|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3901300|NCT01488097|3725674|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901301|NCT01488097|3725674|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901302|NCT01488097|3725674|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901303|NCT01488097|3725674|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901304|NCT01488097|3725674|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901305|NCT01488097|3725674|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3901306|NCT01488097|3725674|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901307|NCT01488097|3725674|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3901308|NCT01488097|3725674|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3901309|NCT01488097|3725674|B1|||Age||years|Mean|30.3|30.3|Standard Deviation|10.69|10.69|||
3901310|NCT01488097|3725674|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3901311|NCT01488097|3725674|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3901312|NCT01488097|3725674|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3901329|NCT01488071|3725686|B2||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
3901330|NCT01488071|3725687|B1||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
3901331|NCT01488071|3725685|B3|||Age||years|Mean|46.3|46.3|Standard Deviation|12.4|12.4|||
3901332|NCT01488071|3725686|B2|||Age||years|Mean|45.6|45.6|Standard Deviation|12.4|12.4|||
3901333|NCT01488071|3725687|B1|||Age||years|Mean|47.0|47.0|Standard Deviation|12.4|12.4|||
3901313|NCT01488071|3725685|B3|||SDS Total Baseline Score|The Sheehan Disability Scale (SDS) comprises self-rated items designed to measure impairment. The patient rates the extent to which his or her (1) work, (2) social life or leisure activities and (3) home life or family responsibilities are impaired on a 10-point visual analogue scales, on which 0 = normal functioning and 10 = severe functional impairment. The three items may be summed into a single dimensional measure of global functional impairment that ranges from 0 (unimpaired) to 30 (highly impaired). The higher the score, the more severe.|units on a scale|Mean|19.3|19.3|Standard Deviation|5.3|5.3|||
3901314|NCT01488071|3725686|B2|||SDS Total Baseline Score|The Sheehan Disability Scale (SDS) comprises self-rated items designed to measure impairment. The patient rates the extent to which his or her (1) work, (2) social life or leisure activities and (3) home life or family responsibilities are impaired on a 10-point visual analogue scales, on which 0 = normal functioning and 10 = severe functional impairment. The three items may be summed into a single dimensional measure of global functional impairment that ranges from 0 (unimpaired) to 30 (highly impaired). The higher the score, the more severe.|units on a scale|Mean|19.3|19.3|Standard Deviation|5.2|5.2|||
3901315|NCT01488071|3725687|B1|||SDS Total Baseline Score|The Sheehan Disability Scale (SDS) comprises self-rated items designed to measure impairment. The patient rates the extent to which his or her (1) work, (2) social life or leisure activities and (3) home life or family responsibilities are impaired on a 10-point visual analogue scales, on which 0 = normal functioning and 10 = severe functional impairment. The three items may be summed into a single dimensional measure of global functional impairment that ranges from 0 (unimpaired) to 30 (highly impaired). The higher the score, the more severe.|units on a scale|Mean|19.2|19.2|Standard Deviation|5.3|5.3|||
3901316|NCT01488071|3725685|B3|||CGI-S Baseline Severity Score|The Clinical Global Impression - Severity of Illness (CGI-S) is a 7-point scale rated from 1 (normal, not at all ill) to 7 (among the most extremely ill patients). The investigator should use his/her total clinical experience with this patient population to judge how mentally ill the patient is at the time of rating. Higher score indicates that the patient is more ill.|units on a scale|Mean|4.4|4.4|Standard Deviation|0.6|0.6|||
3901317|NCT01488071|3725686|B2|||CGI-S Baseline Severity Score|The Clinical Global Impression - Severity of Illness (CGI-S) is a 7-point scale rated from 1 (normal, not at all ill) to 7 (among the most extremely ill patients). The investigator should use his/her total clinical experience with this patient population to judge how mentally ill the patient is at the time of rating. Higher score indicates that the patient is more ill.|units on a scale|Mean|4.4|4.4|Standard Deviation|0.6|0.6|||
3901318|NCT01488071|3725687|B1|||CGI-S Baseline Severity Score|The Clinical Global Impression - Severity of Illness (CGI-S) is a 7-point scale rated from 1 (normal, not at all ill) to 7 (among the most extremely ill patients). The investigator should use his/her total clinical experience with this patient population to judge how mentally ill the patient is at the time of rating. Higher score indicates that the patient is more ill.|units on a scale|Mean|4.4|4.4|Standard Deviation|0.6|0.6|||
3901319|NCT01488071|3725685|B3|||HAM-A: Baseline Total Score|The Hamilton Anxiety Rating Scale (HAM-A) consists of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behaviour at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic, and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total score from 0 to 56; higher score indicates greater anxiety.|units on a scale|Mean|21.5|21.5|Standard Deviation|6.2|6.2|||
3901320|NCT01488071|3725686|B2|||HAM-A: Baseline Total Score|The Hamilton Anxiety Rating Scale (HAM-A) consists of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behaviour at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic, and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total score from 0 to 56; higher score indicates greater anxiety.|units on a scale|Mean|21.4|21.4|Standard Deviation|6.2|6.2|||
3901321|NCT01488071|3725687|B1|||HAM-A: Baseline Total Score|The Hamilton Anxiety Rating Scale (HAM-A) consists of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behaviour at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic, and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total score from 0 to 56; higher score indicates greater anxiety.|units on a scale|Mean|21.6|21.6|Standard Deviation|6.3|6.3|||
3901322|NCT01488071|3725685|B3|||MADRS: Baseline Total Score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 (no symptom) to 6 (severe symptom). The 10 items represent the core symptoms of depressive illness. The rating should be based on a clinical interview with the patient, moving from broadly phrased questions about symptoms to more detailed ones, which allow a precise rating of severity, covering the last 7 days. Total score from 0 - 60. The higher the score, the more severe.|units on a scale|Mean|28.9|28.9|Standard Deviation|4.2|4.2|||
3901323|NCT01488071|3725686|B2|||MADRS: Baseline Total Score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 (no symptom) to 6 (severe symptom). The 10 items represent the core symptoms of depressive illness. The rating should be based on a clinical interview with the patient, moving from broadly phrased questions about symptoms to more detailed ones, which allow a precise rating of severity, covering the last 7 days. Total score from 0 - 60. The higher the score, the more severe.|units on a scale|Mean|28.7|28.7|Standard Deviation|4.0|4.0|||
3901324|NCT01488071|3725687|B1|||MADRS: Baseline Total Score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 (no symptom) to 6 (severe symptom). The 10 items represent the core symptoms of depressive illness. The rating should be based on a clinical interview with the patient, moving from broadly phrased questions about symptoms to more detailed ones, which allow a precise rating of severity, covering the last 7 days. Total score from 0 - 60. The higher the score, the more severe.|units on a scale|Mean|29.1|29.1|Standard Deviation|4.4|4.4|||
3901325|NCT01488071|3725685|B3||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3901326|NCT01488071|3725686|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3901327|NCT01488071|3725687|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3901328|NCT01488071|3725685|B3||Female|Sex: Female, Male||Participants|Count of Participants|370|370.0||||||
3901334|NCT01488019|3725720|B3|||Baseline Dyspnea Index|The Baseline Dyspnea Index (BDI) is an interviewer-administered rating of severity of dyspnea at baseline. It has 3 components: functional impairment, magnitude of task, and magnitude of effort, and each component is rated on a graded scale from 0 (very severe) to 4 (no impairment). The 3 components are summed to provide a total score ranging from 0 to 12. The lower the score, the worse the severity of dyspnea.|units on a scale|Mean|6.2|6.2|Standard Deviation|1.99|1.99|||
3901335|NCT01488019|3725721|B2|||Baseline Dyspnea Index|The Baseline Dyspnea Index (BDI) is an interviewer-administered rating of severity of dyspnea at baseline. It has 3 components: functional impairment, magnitude of task, and magnitude of effort, and each component is rated on a graded scale from 0 (very severe) to 4 (no impairment). The 3 components are summed to provide a total score ranging from 0 to 12. The lower the score, the worse the severity of dyspnea.|units on a scale|Mean|6.2|6.2|Standard Deviation|1.99|1.99|||
3901336|NCT01488019|3725722|B1|||Baseline Dyspnea Index|The Baseline Dyspnea Index (BDI) is an interviewer-administered rating of severity of dyspnea at baseline. It has 3 components: functional impairment, magnitude of task, and magnitude of effort, and each component is rated on a graded scale from 0 (very severe) to 4 (no impairment). The 3 components are summed to provide a total score ranging from 0 to 12. The lower the score, the worse the severity of dyspnea.|units on a scale|Mean|6.1|6.1|Standard Deviation|1.99|1.99|||
3901337|NCT01488019|3725720|B3|||Baseline Saint Georges Respiratory Questionnaire Score|Saint Georges Respiratory Questionnaire comprises 50 items in 3 sections (Symptoms, Activity, Impact) measuring health status in chronic airflow limitation. Symptoms captures level of symptomatology. Activity and Impact responses are either “yes” or “no”. Scoring is from 0 to 100; 0 = no life quality impairment. A summary score for all items is calculated and ranges from 0 to 100, where 0 indicates best possible health status, 100 represents worst possible health status. Scores are calculated using weights attached to each item in the questionnaire - 4 unit changes are clinically meaningful.|units on a scale|Mean|52.992|52.992|Standard Deviation|16.9756|16.9756|||
3901338|NCT01488019|3725721|B2|||Baseline Saint Georges Respiratory Questionnaire Score|Saint Georges Respiratory Questionnaire comprises 50 items in 3 sections (Symptoms, Activity, Impact) measuring health status in chronic airflow limitation. Symptoms captures level of symptomatology. Activity and Impact responses are either “yes” or “no”. Scoring is from 0 to 100; 0 = no life quality impairment. A summary score for all items is calculated and ranges from 0 to 100, where 0 indicates best possible health status, 100 represents worst possible health status. Scores are calculated using weights attached to each item in the questionnaire - 4 unit changes are clinically meaningful.|units on a scale|Mean|52.550|52.55|Standard Deviation|16.9953|16.9953|||
3901339|NCT01488019|3725722|B1|||Baseline Saint Georges Respiratory Questionnaire Score|Saint Georges Respiratory Questionnaire comprises 50 items in 3 sections (Symptoms, Activity, Impact) measuring health status in chronic airflow limitation. Symptoms captures level of symptomatology. Activity and Impact responses are either “yes” or “no”. Scoring is from 0 to 100; 0 = no life quality impairment. A summary score for all items is calculated and ranges from 0 to 100, where 0 indicates best possible health status, 100 represents worst possible health status. Scores are calculated using weights attached to each item in the questionnaire - 4 unit changes are clinically meaningful.|units on a scale|Mean|53.429|53.429|Standard Deviation|16.9607|16.9607|||
3901340|NCT01488019|3725720|B3|Current Smoker||Smoking Status n (%)||Participants|Count of Participants|560|560.0||||||
3901341|NCT01488019|3725721|B2|Current Smoker||Smoking Status n (%)||Participants|Count of Participants|278|278.0||||||
3901342|NCT01488019|3725722|B1|Current Smoker||Smoking Status n (%)||Participants|Count of Participants|282|282.0||||||
3901343|NCT01488019|3725720|B3|Ex-smoker||Smoking Status n (%)||Participants|Count of Participants|511|511.0||||||
3901344|NCT01488019|3725721|B2|Ex-smoker||Smoking Status n (%)||Participants|Count of Participants|252|252.0||||||
3901345|NCT01488019|3725722|B1|Ex-smoker||Smoking Status n (%)||Participants|Count of Participants|259|259.0||||||
3901346|NCT01488019|3725720|B3|||Number of Pack Years||Pack Years|Median|43.00|43.0|Full Range|||10.0|232.0|
3901347|NCT01488019|3725721|B2|||Number of Pack Years||Pack Years|Median|44.00|44.0|Full Range|||10.0|232.0|
3901348|NCT01488019|3725722|B1|||Number of Pack Years||Pack Years|Median|41|41.0|Full Range|||10.0|184.0|
3901349|NCT01488019|3725720|B3|||Number of Pack Years||Pack Years|Mean|49.60|49.6|Standard Deviation|27.066|27.066|||
3901350|NCT01488019|3725721|B2|||Number of Pack Years||Pack Years|Mean|50.87|50.87|Standard Deviation|27.912|27.912|||
3901351|NCT01488019|3725722|B1|||Number of Pack Years||Pack Years|Mean|48.37|48.37|Standard Deviation|26.176|26.176|||
3901352|NCT01488019|3725720|B3|||Baseline IC|Inspiratory Capacity|Litres|Mean|1.9619|1.9619|Standard Deviation|0.66734|0.66734|||
3901353|NCT01488019|3725721|B2|||Baseline IC|Inspiratory Capacity|Litres|Mean|1.9783|1.9783|Standard Deviation|0.66897|0.66897|||
3901354|NCT01488019|3725722|B1|||Baseline IC|Inspiratory Capacity|Litres|Mean|1.9458|1.9458|Standard Deviation|0.66598|0.66598|||
3901355|NCT01488019|3725720|B3|||Baseline FVC|Forced vital capacity|Litres|Mean|2.451|2.451|Standard Deviation|0.76373|0.76373|||
3901356|NCT01488019|3725721|B2|||Baseline FVC|Forced vital capacity|Litres|Mean|2.4740|2.474|Standard Deviation|0.78394|0.78394|||
3901357|NCT01488019|3725722|B1|||Baseline FVC|Forced vital capacity|Litres|Mean|2.4276|2.4276|Standard Deviation|0.74347|0.74347|||
3901358|NCT01488019|3725720|B3|||Baseline % Predicted FEV1|Forced expiratory volume in one second, percent of predicted NHANES III reference values|%|Mean|44.35|44.35|Standard Deviation|13.226|13.226|||
3901359|NCT01488019|3725721|B2|||Baseline % Predicted FEV1|Forced expiratory volume in one second, percent of predicted NHANES III reference values|%|Mean|44.89|44.89|Standard Deviation|13.787|13.787|||
3901360|NCT01488019|3725722|B1|||Baseline % Predicted FEV1|Forced expiratory volume in one second, percent of predicted NHANES III reference values|%|Mean|43.82|43.82|Standard Deviation|12.646|12.646|||
3901361|NCT01488019|3725720|B3|||Baseline FEV1|Forced expiratory volume in one second|Litres|Mean|1.2707|1.2707|Standard Deviation|0.49073|0.49073|||
3901362|NCT01488019|3725721|B2|||Baseline FEV1|Forced expiratory volume in one second|Litres|Mean|1.2926|1.2926|Standard Deviation|0.50496|0.50496|||
3901363|NCT01488019|3725722|B1|||Baseline FEV1|Forced expiratory volume in one second|Litres|Mean|1.2494|1.2494|Standard Deviation|0.47593|0.47593|||
3901364|NCT01488019|3725720|B3|Not Reported/Unknown||Screening COPD Severity (GOLD) n (%)||Participants|Count of Participants|6|6.0||||||
3901365|NCT01488019|3725721|B2|Not Reported/Unknown||Screening COPD Severity (GOLD) n (%)||Participants|Count of Participants|3|3.0||||||
3901366|NCT01488019|3725722|B1|Not Reported/Unknown||Screening COPD Severity (GOLD) n (%)||Participants|Count of Participants|3|3.0||||||
3901367|NCT01488019|3725720|B3|Very Severe (% Predicted FEV1 <30%)||Screening COPD Severity (GOLD) n (%)||Participants|Count of Participants|7|7.0||||||
3901368|NCT01488019|3725721|B2|Very Severe (% Predicted FEV1 <30%)||Screening COPD Severity (GOLD) n (%)||Participants|Count of Participants|4|4.0||||||
3901369|NCT01488019|3725722|B1|Very Severe (% Predicted FEV1 <30%)||Screening COPD Severity (GOLD) n (%)||Participants|Count of Participants|3|3.0||||||
3901370|NCT01488019|3725720|B3|Severe (% Predicted FEV1 30 to <50%)||Screening COPD Severity (GOLD) n (%)||Participants|Count of Participants|511|511.0||||||
3901371|NCT01488019|3725721|B2|Severe (% Predicted FEV1 30 to <50%)||Screening COPD Severity (GOLD) n (%)||Participants|Count of Participants|250|250.0||||||
3901372|NCT01488019|3725722|B1|Severe (% Predicted FEV1 30 to <50%)||Screening COPD Severity (GOLD) n (%)||Participants|Count of Participants|261|261.0||||||
3901373|NCT01488019|3725720|B3|Moderate (% Predicted FEV1 50 to <80%)||Screening COPD Severity (GOLD) n (%)||Participants|Count of Participants|547|547.0||||||
3901374|NCT01488019|3725721|B2|Moderate (% Predicted FEV1 50 to <80%)||Screening COPD Severity (GOLD) n (%)||Participants|Count of Participants|273|273.0||||||
3901375|NCT01488019|3725722|B1|Moderate (% Predicted FEV1 50 to <80%)||Screening COPD Severity (GOLD) n (%)||Participants|Count of Participants|274|274.0||||||
3901376|NCT01488019|3725720|B3|United States||Region of Enrollment||Participants|Count of Participants|1071|1071.0||||||
3901377|NCT01488019|3725721|B2|United States||Region of Enrollment||Participants|Count of Participants|530|530.0||||||
3901378|NCT01488019|3725722|B1|United States||Region of Enrollment||Participants|Count of Participants|541|541.0||||||
3901379|NCT01488019|3725720|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3901380|NCT01488019|3725721|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3901381|NCT01488019|3725722|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3901382|NCT01488019|3725720|B3|Asian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3901383|NCT01488019|3725721|B2|Asian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3901384|NCT01488019|3725722|B1|Asian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3901385|NCT01488019|3725720|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3901386|NCT01488019|3725721|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3901387|NCT01488019|3725722|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3901388|NCT01488019|3725720|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|97|97.0||||||
3901389|NCT01488019|3725721|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
3901390|NCT01488019|3725722|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
3901391|NCT01488019|3725720|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|961|961.0||||||
3901392|NCT01488019|3725721|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|478|478.0||||||
3901393|NCT01488019|3725722|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|483|483.0||||||
3901394|NCT01488019|3725720|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901395|NCT01488019|3725721|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901396|NCT01488019|3725722|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901397|NCT01488019|3725720|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1016|1016.0||||||
3901398|NCT01488019|3725721|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|504|504.0||||||
3901399|NCT01488019|3725722|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|512|512.0||||||
3901400|NCT01488019|3725720|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3901401|NCT01488019|3725721|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3901402|NCT01488019|3725722|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3901403|NCT01488019|3725720|B3||Male|Sex: Female, Male||Participants|Count of Participants|519|519.0||||||
3901404|NCT01488019|3725721|B2||Male|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
3901405|NCT01488019|3725722|B1||Male|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
3901406|NCT01488019|3725720|B3||Female|Sex: Female, Male||Participants|Count of Participants|552|552.0||||||
3901407|NCT01488019|3725721|B2||Female|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
3901408|NCT01488019|3725722|B1||Female|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
3901409|NCT01488019|3725720|B3|||Age||years|Mean|62.6|62.6|Standard Deviation|9.09|9.09|||
3901410|NCT01488019|3725721|B2|||Age||years|Mean|62.5|62.5|Standard Deviation|9.17|9.17|||
3901411|NCT01488019|3725722|B1|||Age||years|Mean|62.7|62.7|Standard Deviation|9.01|9.01|||
3901412|NCT01487954|3725755|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
3901413|NCT01487954|3725756|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3901414|NCT01487954|3725757|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3901415|NCT01487954|3725755|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901416|NCT01487954|3725756|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901417|NCT01487954|3725757|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901418|NCT01487954|3725755|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901419|NCT01487954|3725756|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901420|NCT01487954|3725757|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901421|NCT01487954|3725755|B3||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3901422|NCT01487954|3725756|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3901423|NCT01487954|3725757|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3901424|NCT01487954|3725755|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3901425|NCT01487954|3725756|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901426|NCT01487954|3725757|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3901427|NCT01487954|3725755|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901428|NCT01487954|3725756|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901429|NCT01487954|3725757|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901430|NCT01487954|3725755|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3901431|NCT01487954|3725756|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901432|NCT01487954|3725757|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3901433|NCT01487954|3725755|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901434|NCT01487954|3725756|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901435|NCT01487954|3725757|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901436|NCT01487954|3725755|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901437|NCT01487954|3725756|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901438|NCT01487954|3725757|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901439|NCT01487954|3725755|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3901440|NCT01487954|3725756|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3901441|NCT01487954|3725757|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3901442|NCT01487954|3725755|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3901443|NCT01487954|3725756|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901444|NCT01487954|3725757|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3901445|NCT01487954|3725755|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3901446|NCT01487954|3725756|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3901447|NCT01487954|3725757|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3901448|NCT01487954|3725755|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3901449|NCT01487954|3725756|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3901450|NCT01487954|3725757|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3901451|NCT01487954|3725755|B3|||Age||years|Median|57|57.0|Full Range|||40.0|79.0|
3901452|NCT01487954|3725756|B2|||Age||years|Median|53|53.0|Full Range|||40.0|66.0|
3901453|NCT01487954|3725757|B1|||Age||years|Median|57|57.0|Full Range|||45.0|79.0|
3901454|NCT01487863|3725766|B3|Gleason Score - Missing Data||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|1|1.0||||||
3901455|NCT01487863|3725767|B2|Gleason Score - Missing Data||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|1|1.0||||||
3901456|NCT01487863|3725768|B1|Gleason Score - Missing Data||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|0|0.0||||||
3901501|NCT01487863|3725768|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901502|NCT01487863|3725766|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3901503|NCT01487863|3725767|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3901504|NCT01487863|3725768|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3901457|NCT01487863|3725766|B3|Gleason Score ≥ 8||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|38|38.0||||||
3901458|NCT01487863|3725767|B2|Gleason Score ≥ 8||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|20|20.0||||||
3901459|NCT01487863|3725768|B1|Gleason Score ≥ 8||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|18|18.0||||||
3901460|NCT01487863|3725766|B3|Gleason Score = 7||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|20|20.0||||||
3901461|NCT01487863|3725767|B2|Gleason Score = 7||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|8|8.0||||||
3901462|NCT01487863|3725768|B1|Gleason Score = 7||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|12|12.0||||||
3901463|NCT01487863|3725766|B3|Gleason Score ≤ 6||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|10|10.0||||||
3901464|NCT01487863|3725767|B2|Gleason Score ≤ 6||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|5|5.0||||||
3901465|NCT01487863|3725768|B1|Gleason Score ≤ 6||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|5|5.0||||||
3901466|NCT01487863|3725766|B3|ECOG 1= Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|15|15.0||||||
3901505|NCT01487863|3725766|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3901506|NCT01487863|3725767|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3901507|NCT01487863|3725768|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3901508|NCT01487863|3725766|B3|||Age||years|Mean|70.1|70.1|Standard Deviation|9.91|9.91|||
3901467|NCT01487863|3725767|B2|ECOG 1= Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|8|8.0||||||
3901468|NCT01487863|3725768|B1|ECOG 1= Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|7|7.0||||||
3901469|NCT01487863|3725766|B3|ECOG 0=Fully Active; No restrictions||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|54|54.0||||||
3901470|NCT01487863|3725767|B2|ECOG 0=Fully Active; No restrictions||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|26|26.0||||||
3901471|NCT01487863|3725768|B1|ECOG 0=Fully Active; No restrictions||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|28|28.0||||||
3901472|NCT01487863|3725766|B3|||Height||Centimeters|Mean|176.73|176.73|Standard Deviation|8.12|8.12|||
3901473|NCT01487863|3725767|B2|||Height||Centimeters|Mean|177.39|177.39|Standard Deviation|8.06|8.06|||
3901474|NCT01487863|3725768|B1|||Height||Centimeters|Mean|176.10|176.1|Standard Deviation|8.25|8.25|||
3901475|NCT01487863|3725766|B3|||Weight||Kg|Mean|93.85|93.85|Standard Deviation|18.90|18.9|||
3901476|NCT01487863|3725767|B2|||Weight||Kg|Mean|93.46|93.46|Standard Deviation|16.29|16.29|||
3901477|NCT01487863|3725768|B1|||Weight||Kg|Mean|94.22|94.22|Standard Deviation|21.38|21.38|||
3901478|NCT01487863|3725766|B3|United States||Region of Enrollment||participants|Number|69|69.0||||||
3901479|NCT01487863|3725767|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
3901480|NCT01487863|3725768|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3901481|NCT01487863|3725766|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901482|NCT01487863|3725767|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901483|NCT01487863|3725768|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901484|NCT01487863|3725766|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901485|NCT01487863|3725767|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901486|NCT01487863|3725768|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901487|NCT01487863|3725766|B3||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3901488|NCT01487863|3725767|B2||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3901489|NCT01487863|3725768|B1||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3901490|NCT01487863|3725766|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3901491|NCT01487863|3725767|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3901492|NCT01487863|3725768|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3901493|NCT01487863|3725766|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901494|NCT01487863|3725767|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901495|NCT01487863|3725768|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901496|NCT01487863|3725766|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3901497|NCT01487863|3725767|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3901498|NCT01487863|3725768|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901499|NCT01487863|3725766|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901500|NCT01487863|3725767|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901509|NCT01487863|3725767|B2|||Age||years|Mean|70.5|70.5|Standard Deviation|10.15|10.15|||
3901510|NCT01487863|3725768|B1|||Age||years|Mean|69.7|69.7|Standard Deviation|9.8|9.8|||
3901511|NCT01487863|3725766|B3||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
3901512|NCT01487863|3725767|B2||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3901513|NCT01487863|3725768|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3901514|NCT01487863|3725766|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3901515|NCT01487863|3725767|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3901516|NCT01487863|3725768|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3901517|NCT01487863|3725766|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3901518|NCT01487863|3725767|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3901519|NCT01487863|3725768|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3901520|NCT01487668|3725775|B3|United States||Region of Enrollment||participants|Number|287|287.0||||||
3901521|NCT01487668|3725776|B2|United States||Region of Enrollment||participants|Number|141|141.0||||||
3901522|NCT01487668|3725777|B1|United States||Region of Enrollment||participants|Number|146|146.0||||||
3901523|NCT01487668|3725775|B3||Male|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
3901524|NCT01487668|3725776|B2||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3901525|NCT01487668|3725777|B1||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3901526|NCT01487668|3725775|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3901527|NCT01487668|3725776|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3901528|NCT01487668|3725777|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3901529|NCT01487668|3725775|B3|||Age||years|Mean|55.3|55.3|Standard Deviation|10.8|10.8|||
3901530|NCT01487668|3725776|B2|||Age||years|Mean|55.3|55.3|Standard Deviation|10.7|10.7|||
3901531|NCT01487668|3725777|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|11.0|11.0|||
3901532|NCT01487668|3725775|B3||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
3901533|NCT01487668|3725776|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3901534|NCT01487668|3725777|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3901535|NCT01487668|3725775|B3||Between 18 and 65 years|Age||Participants|Count of Participants|246|246.0||||||
3901536|NCT01487668|3725776|B2||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
3901537|NCT01487668|3725777|B1||Between 18 and 65 years|Age||Participants|Count of Participants|126|126.0||||||
3901538|NCT01487668|3725775|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3901539|NCT01487668|3725776|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3901540|NCT01487668|3725777|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3901541|NCT01487577|3725786|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3901542|NCT01487577|3725786|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901543|NCT01487577|3725786|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3901544|NCT01487577|3725786|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3901545|NCT01487577|3725786|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3901546|NCT01487577|3725786|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901547|NCT01487577|3725786|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3901548|NCT01487577|3725786|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901549|NCT01487577|3725786|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3901550|NCT01487577|3725786|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3901551|NCT01487577|3725786|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3901552|NCT01487577|3725786|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3901553|NCT01487577|3725786|B1||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
3901554|NCT01487525|3725798|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
3901555|NCT01487525|3725799|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3901556|NCT01487525|3725800|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3901557|NCT01487525|3725798|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3901558|NCT01487525|3725799|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3901559|NCT01487525|3725800|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3901560|NCT01487525|3725798|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3901561|NCT01487525|3725799|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3901562|NCT01487525|3725800|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3901563|NCT01487525|3725798|B3|||Age||years|Mean|57.2|57.2|Standard Deviation|5.8|5.8|||
3901564|NCT01487525|3725799|B2|||Age||years|Mean|58.4|58.4|Standard Deviation|8.7|8.7|||
3901565|NCT01487525|3725800|B1|||Age||years|Mean|56.1|56.1|Standard Deviation|7.7|7.7|||
3901566|NCT01487499|3725811|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3901567|NCT01487499|3725811|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3901568|NCT01487499|3725811|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3901569|NCT01487499|3725811|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3901570|NCT01487499|3725811|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3901571|NCT01487499|3725811|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3901572|NCT01487265|3725817|B1||Former smoker|Smoking Status||Participants|Count of Participants|16|16.0||||||
3901573|NCT01487265|3725817|B1||Current smoker|Smoking Status||Participants|Count of Participants|2|2.0||||||
3901574|NCT01487265|3725817|B1||Never smoker|Smoking Status||Participants|Count of Participants|19|19.0||||||
3901575|NCT01487265|3725817|B1|United States||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3901576|NCT01487265|3725817|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3901577|NCT01487265|3725817|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3901578|NCT01487265|3725817|B1|||Age||years|Median|69|69.0|Full Range|||42.0|85.0|
3901579|NCT01487161|3725825|B5||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3901580|NCT01487161|3725826|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3901581|NCT01487161|3725827|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3901582|NCT01487161|3725828|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3901583|NCT01487161|3725829|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3901584|NCT01487161|3725825|B5||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3901585|NCT01487161|3725826|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3901586|NCT01487161|3725827|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3901587|NCT01487161|3725828|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3901588|NCT01487161|3725829|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3901589|NCT01487161|3725825|B5|||Age||years|Mean|61.5|61.5|Full Range|||40.0|86.0|
3901590|NCT01487161|3725826|B4|||Age||years|Mean|61.6|61.6|Full Range|||42.0|83.0|
3901591|NCT01487161|3725827|B3|||Age||years|Mean|61.9|61.9|Full Range|||44.0|86.0|
3901592|NCT01487161|3725828|B2|||Age||years|Mean|60.9|60.9|Full Range|||40.0|80.0|
3901593|NCT01487161|3725829|B1|||Age||years|Mean|61.5|61.5|Full Range|||43.0|82.0|
3901594|NCT01486966|3725895|B3|Macroangiopathy||Diabetes complications||participants|Number|7|7.0||||||
3901595|NCT01486966|3725896|B2|Macroangiopathy||Diabetes complications||participants|Number|5|5.0||||||
3901596|NCT01486966|3725897|B1|Macroangiopathy||Diabetes complications||participants|Number|2|2.0||||||
3901597|NCT01486966|3725895|B3|Diabetic Nephropathy||Diabetes complications||participants|Number|7|7.0||||||
3901598|NCT01486966|3725896|B2|Diabetic Nephropathy||Diabetes complications||participants|Number|3|3.0||||||
3901599|NCT01486966|3725897|B1|Diabetic Nephropathy||Diabetes complications||participants|Number|4|4.0||||||
3901600|NCT01486966|3725895|B3|Diabetic neuropathy||Diabetes complications||participants|Number|21|21.0||||||
3901601|NCT01486966|3725896|B2|Diabetic neuropathy||Diabetes complications||participants|Number|11|11.0||||||
3901602|NCT01486966|3725897|B1|Diabetic neuropathy||Diabetes complications||participants|Number|10|10.0||||||
3901603|NCT01486966|3725895|B3|Diabetic retinopathy||Diabetes complications||participants|Number|15|15.0||||||
3901604|NCT01486966|3725896|B2|Diabetic retinopathy||Diabetes complications||participants|Number|8|8.0||||||
3901605|NCT01486966|3725897|B1|Diabetic retinopathy||Diabetes complications||participants|Number|7|7.0||||||
3901606|NCT01486966|3725895|B3|Diabetic complications||Diabetes complications||participants|Number|28|28.0||||||
3901607|NCT01486966|3725896|B2|Diabetic complications||Diabetes complications||participants|Number|15|15.0||||||
3901608|NCT01486966|3725897|B1|Diabetic complications||Diabetes complications||participants|Number|13|13.0||||||
3901609|NCT01486966|3725895|B3|||Duration of diagnosed diabetes||years|Mean|11.10|11.1|Standard Deviation|6.20|6.2|||
3901610|NCT01486966|3725896|B2|||Duration of diagnosed diabetes||years|Mean|11.97|11.97|Standard Deviation|7.14|7.14|||
3901611|NCT01486966|3725897|B1|||Duration of diagnosed diabetes||years|Mean|10.23|10.23|Standard Deviation|5.08|5.08|||
3901612|NCT01486966|3725895|B3|||Type 2 diabetes||participants|Number|58|58.0||||||
3901613|NCT01486966|3725896|B2|||Type 2 diabetes||participants|Number|29|29.0||||||
3901614|NCT01486966|3725897|B1|||Type 2 diabetes||participants|Number|29|29.0||||||
3901615|NCT01486966|3725895|B3|||Glycosylated haemoglobin A1c (HbA1c)|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|percentage of glycosylated haemoglobin|Mean|8.62|8.62|Standard Deviation|0.75|0.75|||
3901616|NCT01486966|3725896|B2|||Glycosylated haemoglobin A1c (HbA1c)|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|percentage of glycosylated haemoglobin|Mean|8.49|8.49|Standard Deviation|0.76|0.76|||
3901617|NCT01486966|3725897|B1|||Glycosylated haemoglobin A1c (HbA1c)|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|percentage of glycosylated haemoglobin|Mean|8.76|8.76|Standard Deviation|0.73|0.73|||
3901618|NCT01486966|3725895|B3|premixed insulin (twice daily)||Pre-trial insulin treatment||participants|Number|45|45.0||||||
3901619|NCT01486966|3725896|B2|premixed insulin (twice daily)||Pre-trial insulin treatment||participants|Number|22|22.0||||||
3901620|NCT01486966|3725897|B1|premixed insulin (twice daily)||Pre-trial insulin treatment||participants|Number|23|23.0||||||
3901621|NCT01486966|3725895|B3|basal insulin (once daily)||Pre-trial insulin treatment||participants|Number|13|13.0||||||
3901622|NCT01486966|3725896|B2|basal insulin (once daily)||Pre-trial insulin treatment||participants|Number|7|7.0||||||
3901623|NCT01486966|3725897|B1|basal insulin (once daily)||Pre-trial insulin treatment||participants|Number|6|6.0||||||
3901624|NCT01486966|3725895|B3|Repaglinide||Pre-trial treatment of oral antidiabetic drug||participants|Number|4|4.0||||||
3901625|NCT01486966|3725896|B2|Repaglinide||Pre-trial treatment of oral antidiabetic drug||participants|Number|2|2.0||||||
3901626|NCT01486966|3725897|B1|Repaglinide||Pre-trial treatment of oral antidiabetic drug||participants|Number|2|2.0||||||
3901627|NCT01486966|3725895|B3|Metformin hydrochloride||Pre-trial treatment of oral antidiabetic drug||participants|Number|5|5.0||||||
3901628|NCT01486966|3725896|B2|Metformin hydrochloride||Pre-trial treatment of oral antidiabetic drug||participants|Number|3|3.0||||||
3901629|NCT01486966|3725897|B1|Metformin hydrochloride||Pre-trial treatment of oral antidiabetic drug||participants|Number|2|2.0||||||
3901630|NCT01486966|3725895|B3|Metformin||Pre-trial treatment of oral antidiabetic drug||participants|Number|21|21.0||||||
3901631|NCT01486966|3725896|B2|Metformin||Pre-trial treatment of oral antidiabetic drug||participants|Number|8|8.0||||||
3901632|NCT01486966|3725897|B1|Metformin||Pre-trial treatment of oral antidiabetic drug||participants|Number|13|13.0||||||
3901633|NCT01486966|3725895|B3|Glimepiride||Pre-trial treatment of oral antidiabetic drug||participants|Number|6|6.0||||||
3901634|NCT01486966|3725896|B2|Glimepiride||Pre-trial treatment of oral antidiabetic drug||participants|Number|4|4.0||||||
3901635|NCT01486966|3725897|B1|Glimepiride||Pre-trial treatment of oral antidiabetic drug||participants|Number|2|2.0||||||
3901636|NCT01486966|3725895|B3|Gliclazide||Pre-trial treatment of oral antidiabetic drug||participants|Number|3|3.0||||||
3901637|NCT01486966|3725896|B2|Gliclazide||Pre-trial treatment of oral antidiabetic drug||participants|Number|3|3.0||||||
3901638|NCT01486966|3725897|B1|Gliclazide||Pre-trial treatment of oral antidiabetic drug||participants|Number|0|0.0||||||
3901639|NCT01486966|3725895|B3|Acarbose||Pre-trial treatment of oral antidiabetic drug||participants|Number|19|19.0||||||
3901640|NCT01486966|3725896|B2|Acarbose||Pre-trial treatment of oral antidiabetic drug||participants|Number|10|10.0||||||
3901641|NCT01486966|3725897|B1|Acarbose||Pre-trial treatment of oral antidiabetic drug||participants|Number|9|9.0||||||
3901642|NCT01486966|3725895|B3|||Body mass index (BMI)|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|kg/m^2|Mean|25.36|25.36|Standard Deviation|2.98|2.98|||
3901643|NCT01486966|3725896|B2|||Body mass index (BMI)|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|kg/m^2|Mean|24.63|24.63|Standard Deviation|2.67|2.67|||
3901644|NCT01486966|3725897|B1|||Body mass index (BMI)|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|kg/m^2|Mean|26.09|26.09|Standard Deviation|3.13|3.13|||
3901645|NCT01486966|3725895|B3|||Weight|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|kg|Mean|68.7|68.7|Standard Deviation|11.4|11.4|||
3901646|NCT01486966|3725896|B2|||Weight|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|kg|Mean|66.5|66.5|Standard Deviation|9.0|9.0|||
3901647|NCT01486966|3725897|B1|||Weight|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|kg|Mean|70.9|70.9|Standard Deviation|13.1|13.1|||
3901648|NCT01486966|3725895|B3|||Height|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|cm|Mean|164.2|164.2|Standard Deviation|8.4|8.4|||
3901649|NCT01486966|3725896|B2|||Height|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|cm|Mean|164.2|164.2|Standard Deviation|8.4|8.4|||
3901650|NCT01486966|3725897|B1|||Height|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|cm|Mean|164.2|164.2|Standard Deviation|8.5|8.5|||
3901651|NCT01486966|3725895|B3||Unknown or Not Reported|Race (NIH/OMB)|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|Participants|Count of Participants|0|0.0||||||
3901652|NCT01486966|3725896|B2||Unknown or Not Reported|Race (NIH/OMB)|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|Participants|Count of Participants|0|0.0||||||
3901653|NCT01486966|3725897|B1||Unknown or Not Reported|Race (NIH/OMB)|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|Participants|Count of Participants|0|0.0||||||
3901654|NCT01486966|3725895|B3||More than one race|Race (NIH/OMB)|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|Participants|Count of Participants|0|0.0||||||
3901655|NCT01486966|3725896|B2||More than one race|Race (NIH/OMB)|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|Participants|Count of Participants|0|0.0||||||
3901656|NCT01486966|3725897|B1||More than one race|Race (NIH/OMB)|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|Participants|Count of Participants|0|0.0||||||
3901657|NCT01486966|3725895|B3||White|Race (NIH/OMB)|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|Participants|Count of Participants|0|0.0||||||
3901658|NCT01486966|3725896|B2||White|Race (NIH/OMB)|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|Participants|Count of Participants|0|0.0||||||
3901659|NCT01486966|3725897|B1||White|Race (NIH/OMB)|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|Participants|Count of Participants|0|0.0||||||
3901660|NCT01486966|3725895|B3||Black or African American|Race (NIH/OMB)|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|Participants|Count of Participants|0|0.0||||||
3901661|NCT01486966|3725896|B2||Black or African American|Race (NIH/OMB)|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|Participants|Count of Participants|0|0.0||||||
3901662|NCT01486966|3725897|B1||Black or African American|Race (NIH/OMB)|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|Participants|Count of Participants|0|0.0||||||
3901663|NCT01486966|3725895|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|Participants|Count of Participants|0|0.0||||||
3901664|NCT01486966|3725896|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|Participants|Count of Participants|0|0.0||||||
3901665|NCT01486966|3725897|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|Participants|Count of Participants|0|0.0||||||
3901666|NCT01486966|3725895|B3||Asian|Race (NIH/OMB)|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|Participants|Count of Participants|58|58.0||||||
3901667|NCT01486966|3725896|B2||Asian|Race (NIH/OMB)|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|Participants|Count of Participants|29|29.0||||||
3901668|NCT01486966|3725897|B1||Asian|Race (NIH/OMB)|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|Participants|Count of Participants|29|29.0||||||
3901669|NCT01486966|3725895|B3||American Indian or Alaska Native|Race (NIH/OMB)|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|Participants|Count of Participants|0|0.0||||||
3901670|NCT01486966|3725896|B2||American Indian or Alaska Native|Race (NIH/OMB)|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|Participants|Count of Participants|0|0.0||||||
3901671|NCT01486966|3725897|B1||American Indian or Alaska Native|Race (NIH/OMB)|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|Participants|Count of Participants|0|0.0||||||
3901672|NCT01486966|3725895|B3||Male|Sex: Female, Male|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|Participants|Count of Participants|29|29.0||||||
3901673|NCT01486966|3725896|B2||Male|Sex: Female, Male|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|Participants|Count of Participants|14|14.0||||||
3901674|NCT01486966|3725897|B1||Male|Sex: Female, Male|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|Participants|Count of Participants|15|15.0||||||
3901675|NCT01486966|3725895|B3||Female|Sex: Female, Male|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|Participants|Count of Participants|29|29.0||||||
3901676|NCT01486966|3725896|B2||Female|Sex: Female, Male|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|Participants|Count of Participants|15|15.0||||||
3901677|NCT01486966|3725897|B1||Female|Sex: Female, Male|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|Participants|Count of Participants|14|14.0||||||
3901678|NCT01486966|3725895|B3|||Age|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|years|Mean|56.7|56.7|Standard Deviation|9.9|9.9|||
3901679|NCT01486966|3725896|B2|||Age|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|years|Mean|55.8|55.8|Standard Deviation|9.8|9.8|||
3901680|NCT01486966|3725897|B1|||Age|Recorded at Visit 1 (screening visit), which was 1 week but no earlier than 2 weeks prior to randomisation.|years|Mean|57.6|57.6|Standard Deviation|10.2|10.2|||
3901681|NCT01486927|3725922|B1|On-demand||Treatment modality of FVIII therapy before enrollment|Treatment modality of FVIII therapy before enrollment, ie, routine prophylaxis or on-demand treatment. If a subject used both modalities, only the most recent one was counted.|participants|Number|92|92.0||||||
3901682|NCT01486927|3725922|B1|Prophylaxis||Treatment modality of FVIII therapy before enrollment|Treatment modality of FVIII therapy before enrollment, ie, routine prophylaxis or on-demand treatment. If a subject used both modalities, only the most recent one was counted.|participants|Number|82|82.0||||||
3901683|NCT01486927|3725922|B1|Recombinant Product||Type of FVIII product used before enrollment|Type of FVIII product used by the subjects before enrollment into the study. This could have been a plasma-derived FVIII product or a recombinant FVIII product.|participants|Number|91|91.0||||||
3901684|NCT01486927|3725922|B1|Plasma-derived Product||Type of FVIII product used before enrollment|Type of FVIII product used by the subjects before enrollment into the study. This could have been a plasma-derived FVIII product or a recombinant FVIII product.|participants|Number|83|83.0||||||
3901685|NCT01486927|3725922|B1||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3901686|NCT01486927|3725922|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3901687|NCT01486927|3725922|B1|Adults (18-65 years)||Age, Customized||participants|Number|160|160.0||||||
3901688|NCT01486927|3725922|B1|Adolescents (12-17 years)||Age, Customized||participants|Number|14|14.0||||||
3901689|NCT01486927|3725922|B1|||Age||years|Mean|31.3|31.3|Standard Deviation|11.77|11.77|||
3901690|NCT01486810|3725953|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901691|NCT01486810|3725953|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3901692|NCT01486810|3725953|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3901693|NCT01486810|3725953|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3901694|NCT01486810|3725953|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901695|NCT01486810|3725953|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901696|NCT01486810|3725953|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3901697|NCT01486810|3725953|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901698|NCT01486810|3725953|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3901699|NCT01486810|3725953|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3901700|NCT01486810|3725953|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3901701|NCT01486810|3725953|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3901702|NCT01486810|3725953|B1|||Age||years|Mean|43.8|43.8|Standard Deviation|8.4|8.4|||
3901703|NCT01486758|3725958|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3901704|NCT01486758|3725959|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3901705|NCT01486758|3725960|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3901706|NCT01486758|3725958|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901707|NCT01486758|3725959|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901708|NCT01486758|3725960|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901709|NCT01486758|3725958|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901710|NCT01486758|3725959|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901711|NCT01486758|3725960|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901712|NCT01486758|3725958|B3||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3901713|NCT01486758|3725959|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3901714|NCT01486758|3725960|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3901715|NCT01486758|3725958|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3901716|NCT01486758|3725959|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3901717|NCT01486758|3725960|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3901718|NCT01486758|3725958|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901719|NCT01486758|3725959|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901720|NCT01486758|3725960|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901721|NCT01486758|3725958|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901722|NCT01486758|3725959|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901723|NCT01486758|3725960|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901724|NCT01486758|3725958|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901725|NCT01486758|3725959|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901726|NCT01486758|3725960|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901727|NCT01486758|3725958|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3901728|NCT01486758|3725959|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3901729|NCT01486758|3725960|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3901730|NCT01486758|3725958|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3901731|NCT01486758|3725959|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3901732|NCT01486758|3725960|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3901733|NCT01486758|3725958|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3901734|NCT01486758|3725959|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3901735|NCT01486758|3725960|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3901736|NCT01486758|3725958|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3901737|NCT01486758|3725959|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3901738|NCT01486758|3725960|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3901739|NCT01486758|3725958|B3||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
3901740|NCT01486758|3725959|B2||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
3901741|NCT01486758|3725960|B1||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
3901742|NCT01486615|3725981|B5|||Anaesthesia time||minutes|Mean|71.6|71.6|Standard Deviation|23.7|23.7|||
3901743|NCT01486615|3725982|B4|||Anaesthesia time||minutes|Mean|71.7|71.7|Standard Deviation|17.6|17.6|||
3901744|NCT01486615|3725983|B3|||Anaesthesia time||minutes|Mean|73.7|73.7|Standard Deviation|21.0|21.0|||
3901745|NCT01486615|3725984|B2|||Anaesthesia time||minutes|Mean|77.2|77.2|Standard Deviation|34.3|34.3|||
3901746|NCT01486615|3725985|B1|||Anaesthesia time||minutes|Mean|65.8|65.8|Standard Deviation|18.1|18.1|||
3901747|NCT01486615|3725981|B5|||Vas baseline (cm)|VAS (Visual Analogue Score) Anxiety Scale is 10 cm long and has the patient's side (front) and the clinician's side (back). The extremes of the front are colored as white and black; with a gradual darkening of color from white to black in between. The back is marked in centimeter from 0 to 10 and 0 correlates with white color (no anxiety at all) and 10 correlates to black color (anxiety as bad as ever can be). The patient is asked to point at the color on the scale according to his anxiety level. As anxiety is worsened, the score is more. The maximum value of assessment is 10 and minimum is 0.|centimeters|Median|5|5.0|Inter-Quartile Range|||4.0|6.0|
3901748|NCT01486615|3725982|B4|||Vas baseline (cm)|VAS (Visual Analogue Score) Anxiety Scale is 10 cm long and has the patient's side (front) and the clinician's side (back). The extremes of the front are colored as white and black; with a gradual darkening of color from white to black in between. The back is marked in centimeter from 0 to 10 and 0 correlates with white color (no anxiety at all) and 10 correlates to black color (anxiety as bad as ever can be). The patient is asked to point at the color on the scale according to his anxiety level. As anxiety is worsened, the score is more. The maximum value of assessment is 10 and minimum is 0.|centimeters|Median|5|5.0|Inter-Quartile Range|||4.0|6.0|
3901749|NCT01486615|3725983|B3|||Vas baseline (cm)|VAS (Visual Analogue Score) Anxiety Scale is 10 cm long and has the patient's side (front) and the clinician's side (back). The extremes of the front are colored as white and black; with a gradual darkening of color from white to black in between. The back is marked in centimeter from 0 to 10 and 0 correlates with white color (no anxiety at all) and 10 correlates to black color (anxiety as bad as ever can be). The patient is asked to point at the color on the scale according to his anxiety level. As anxiety is worsened, the score is more. The maximum value of assessment is 10 and minimum is 0.|centimeters|Median|5|5.0|Inter-Quartile Range|||4.2|7.0|
3901803|NCT01486446|3726027|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3901804|NCT01486446|3726028|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3901805|NCT01486446|3726026|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3901806|NCT01486446|3726027|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3901750|NCT01486615|3725984|B2|||Vas baseline (cm)|VAS (Visual Analogue Score) Anxiety Scale is 10 cm long and has the patient's side (front) and the clinician's side (back). The extremes of the front are colored as white and black; with a gradual darkening of color from white to black in between. The back is marked in centimeter from 0 to 10 and 0 correlates with white color (no anxiety at all) and 10 correlates to black color (anxiety as bad as ever can be). The patient is asked to point at the color on the scale according to his anxiety level. As anxiety is worsened, the score is more. The maximum value of assessment is 10 and minimum is 0.|centimeters|Median|5|5.0|Inter-Quartile Range|||3.6|6.0|
3901751|NCT01486615|3725985|B1|||Vas baseline (cm)|VAS (Visual Analogue Score) Anxiety Scale is 10 cm long and has the patient's side (front) and the clinician's side (back). The extremes of the front are colored as white and black; with a gradual darkening of color from white to black in between. The back is marked in centimeter from 0 to 10 and 0 correlates with white color (no anxiety at all) and 10 correlates to black color (anxiety as bad as ever can be). The patient is asked to point at the color on the scale according to his anxiety level. As anxiety is worsened, the score is more. The maximum value of assessment is 10 and minimum is 0.|centimeters|Median|5|5.0|Inter-Quartile Range|||4.0|6.0|
3901752|NCT01486615|3725981|B5|Nepal||Region of Enrollment||participants|Number|80|80.0||||||
3901753|NCT01486615|3725982|B4|Nepal||Region of Enrollment||participants|Number|20|20.0||||||
3901754|NCT01486615|3725983|B3|Nepal||Region of Enrollment||participants|Number|20|20.0||||||
3901755|NCT01486615|3725984|B2|Nepal||Region of Enrollment||participants|Number|20|20.0||||||
3901756|NCT01486615|3725985|B1|Nepal||Region of Enrollment||participants|Number|20|20.0||||||
3901757|NCT01486615|3725981|B5||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3901758|NCT01486615|3725982|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3901759|NCT01486615|3725983|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3901760|NCT01486615|3725984|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3901761|NCT01486615|3725985|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3901762|NCT01486615|3725981|B5||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3901763|NCT01486615|3725982|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3901764|NCT01486615|3725983|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3901765|NCT01486615|3725984|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3901766|NCT01486615|3725985|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3901767|NCT01486615|3725981|B5|||Age||years|Mean|36|36.0|Standard Deviation|12|12.0|||
3901768|NCT01486615|3725982|B4|||Age||years|Mean|36.2|36.2|Standard Deviation|12.9|12.9|||
3901769|NCT01486615|3725983|B3|||Age||years|Mean|36.9|36.9|Standard Deviation|10.0|10.0|||
3901770|NCT01486615|3725984|B2|||Age||years|Mean|38.0|38.0|Standard Deviation|13.5|13.5|||
3901771|NCT01486615|3725985|B1|||Age||years|Mean|33.8|33.8|Standard Deviation|10.9|10.9|||
3901772|NCT01486615|3725981|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3901773|NCT01486615|3725982|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3901774|NCT01486615|3725983|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3901775|NCT01486615|3725984|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3901776|NCT01486615|3725985|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3901777|NCT01486615|3725981|B5||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
3901778|NCT01486615|3725982|B4||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3901779|NCT01486615|3725983|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3901780|NCT01486615|3725984|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3901781|NCT01486615|3725985|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3901782|NCT01486615|3725981|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3901783|NCT01486615|3725982|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3901784|NCT01486615|3725983|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3901785|NCT01486615|3725984|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3901786|NCT01486615|3725985|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3901787|NCT01486446|3726026|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3901788|NCT01486446|3726027|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3901789|NCT01486446|3726028|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3901790|NCT01486446|3726026|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3901791|NCT01486446|3726027|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3901792|NCT01486446|3726028|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3901793|NCT01486446|3726026|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3901794|NCT01486446|3726027|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3901795|NCT01486446|3726028|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3901796|NCT01486446|3726026|B3|||Age||years|Mean|44.4|44.4|Standard Deviation|22.2|22.2|||
3901797|NCT01486446|3726027|B2|||Age||years|Mean|77|77.0|Standard Deviation|NA||||Only 1 placebo subject, therefore no SD.
3901798|NCT01486446|3726028|B1|||Age||years|Mean|39.7|39.7|Standard Deviation|19.3|19.3|||
3901799|NCT01486446|3726026|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3901800|NCT01486446|3726027|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3901801|NCT01486446|3726028|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3901802|NCT01486446|3726026|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3901807|NCT01486446|3726028|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3901808|NCT01486316|3726049|B4|Not available||Heart Failure Stage||Participants|Number|4|4.0||||||
3901809|NCT01486316|3726050|B3|Not available||Heart Failure Stage||Participants|Number|2|2.0||||||
3901810|NCT01486316|3726051|B2|Not available||Heart Failure Stage||Participants|Number|1|1.0||||||
3901811|NCT01486316|3726052|B1|Not available||Heart Failure Stage||Participants|Number|1|1.0||||||
3901812|NCT01486316|3726049|B4|Stage C||Heart Failure Stage||Participants|Number|20|20.0||||||
3901813|NCT01486316|3726050|B3|Stage C||Heart Failure Stage||Participants|Number|5|5.0||||||
3901814|NCT01486316|3726051|B2|Stage C||Heart Failure Stage||Participants|Number|9|9.0||||||
3901815|NCT01486316|3726052|B1|Stage C||Heart Failure Stage||Participants|Number|6|6.0||||||
3901816|NCT01486316|3726049|B4|||LVEF||percentage|Mean|57.3|57.3|Standard Deviation|10.2|10.2|||
3901817|NCT01486316|3726050|B3|||LVEF||percentage|Mean|50.6|50.6|Standard Deviation|11.6|11.6|||
3901818|NCT01486316|3726051|B2|||LVEF||percentage|Mean|60.2|60.2|Standard Deviation|10.7|10.7|||
3901819|NCT01486316|3726052|B1|||LVEF||percentage|Mean|60.0|60.0|Standard Deviation|4.1|4.1|||
3901820|NCT01486316|3726049|B4|NYHA Class III||New York Heart Assocation (NYHA) Functional Classification|"NYHA Class is a measure of a patient's degree of heart failure with 4 possible scores, ranging from I to IV. The classifications and 2015 definitions are as follows:~I: No limitation of physical activity. II: Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea.~III: Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~IV: Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest."|number|Number|10|10.0||||||
3901821|NCT01486316|3726050|B3|NYHA Class III||New York Heart Assocation (NYHA) Functional Classification|"NYHA Class is a measure of a patient's degree of heart failure with 4 possible scores, ranging from I to IV. The classifications and 2015 definitions are as follows:~I: No limitation of physical activity. II: Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea.~III: Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~IV: Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest."|number|Number|4|4.0||||||
3901822|NCT01486316|3726051|B2|NYHA Class III||New York Heart Assocation (NYHA) Functional Classification|"NYHA Class is a measure of a patient's degree of heart failure with 4 possible scores, ranging from I to IV. The classifications and 2015 definitions are as follows:~I: No limitation of physical activity. II: Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea.~III: Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~IV: Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest."|number|Number|4|4.0||||||
3901823|NCT01486316|3726052|B1|NYHA Class III||New York Heart Assocation (NYHA) Functional Classification|"NYHA Class is a measure of a patient's degree of heart failure with 4 possible scores, ranging from I to IV. The classifications and 2015 definitions are as follows:~I: No limitation of physical activity. II: Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea.~III: Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~IV: Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest."|number|Number|2|2.0||||||
3901824|NCT01486316|3726049|B4|NYHA Class II||New York Heart Assocation (NYHA) Functional Classification|"NYHA Class is a measure of a patient's degree of heart failure with 4 possible scores, ranging from I to IV. The classifications and 2015 definitions are as follows:~I: No limitation of physical activity. II: Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea.~III: Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~IV: Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest."|number|Number|14|14.0||||||
3901825|NCT01486316|3726050|B3|NYHA Class II||New York Heart Assocation (NYHA) Functional Classification|"NYHA Class is a measure of a patient's degree of heart failure with 4 possible scores, ranging from I to IV. The classifications and 2015 definitions are as follows:~I: No limitation of physical activity. II: Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea.~III: Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~IV: Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest."|number|Number|3|3.0||||||
3901826|NCT01486316|3726051|B2|NYHA Class II||New York Heart Assocation (NYHA) Functional Classification|"NYHA Class is a measure of a patient's degree of heart failure with 4 possible scores, ranging from I to IV. The classifications and 2015 definitions are as follows:~I: No limitation of physical activity. II: Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea.~III: Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~IV: Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest."|number|Number|6|6.0||||||
3901827|NCT01486316|3726052|B1|NYHA Class II||New York Heart Assocation (NYHA) Functional Classification|"NYHA Class is a measure of a patient's degree of heart failure with 4 possible scores, ranging from I to IV. The classifications and 2015 definitions are as follows:~I: No limitation of physical activity. II: Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea.~III: Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~IV: Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest."|number|Number|5|5.0||||||
3901828|NCT01486316|3726049|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901829|NCT01486316|3726050|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901830|NCT01486316|3726051|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901831|NCT01486316|3726052|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901832|NCT01486316|3726049|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901833|NCT01486316|3726050|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901834|NCT01486316|3726051|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901835|NCT01486316|3726052|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901836|NCT01486316|3726049|B4||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3901837|NCT01486316|3726050|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3901838|NCT01486316|3726051|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3901839|NCT01486316|3726052|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3901840|NCT01486316|3726049|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3901841|NCT01486316|3726050|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901842|NCT01486316|3726051|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901843|NCT01486316|3726052|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3901844|NCT01486316|3726049|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901845|NCT01486316|3726050|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901846|NCT01486316|3726051|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901847|NCT01486316|3726052|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901848|NCT01486316|3726049|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901849|NCT01486316|3726050|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901850|NCT01486316|3726051|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901851|NCT01486316|3726052|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901852|NCT01486316|3726049|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901853|NCT01486316|3726050|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901854|NCT01486316|3726051|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901855|NCT01486316|3726052|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901856|NCT01486316|3726049|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3901857|NCT01486316|3726050|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3901858|NCT01486316|3726051|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3901859|NCT01486316|3726052|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3901860|NCT01486316|3726049|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3901861|NCT01486316|3726050|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3901862|NCT01486316|3726051|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3901863|NCT01486316|3726052|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3901864|NCT01486316|3726049|B4|||Age||years|Mean|69.9|69.9|Standard Deviation|12.0|12.0|||
3901865|NCT01486316|3726050|B3|||Age||years|Mean|70.3|70.3|Standard Deviation|9.7|9.7|||
3901866|NCT01486316|3726051|B2|||Age||years|Mean|66.2|66.2|Standard Deviation|15.3|15.3|||
3901867|NCT01486316|3726052|B1|||Age||years|Mean|74.9|74.9|Standard Deviation|7.6|7.6|||
3901868|NCT01486238|3726065|B3|United States||Region of Enrollment||participants|Number|64|64.0||||||
3901869|NCT01486238|3726066|B2|United States||Region of Enrollment||participants|Number|43|43.0||||||
3901870|NCT01486238|3726067|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3901871|NCT01486238|3726065|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3901872|NCT01486238|3726066|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3901873|NCT01486238|3726067|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3901874|NCT01486238|3726065|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3901875|NCT01486238|3726066|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3901876|NCT01486238|3726067|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3901877|NCT01486238|3726065|B3|||Age||years|Mean|62.5|62.5|Standard Deviation|20|20.0|||
3901878|NCT01486238|3726066|B2|||Age||years|Mean|62|62.0|Standard Deviation|30|30.0|||
3901879|NCT01486238|3726067|B1|||Age||years|Mean|63|63.0|Standard Deviation|10|10.0|||
3901880|NCT01486238|3726065|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3901881|NCT01486238|3726066|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3901882|NCT01486238|3726067|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3901883|NCT01486238|3726065|B3||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
3901884|NCT01486238|3726066|B2||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3901885|NCT01486238|3726067|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3901886|NCT01486238|3726065|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3901887|NCT01486238|3726066|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3901888|NCT01486238|3726067|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3901889|NCT01486199|3726074|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3901890|NCT01486199|3726075|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3901891|NCT01486199|3726076|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3901892|NCT01486199|3726074|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3901893|NCT01486199|3726075|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3901894|NCT01486199|3726076|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3901895|NCT01486199|3726074|B3|||Age||years|Mean|20.9|20.9|Standard Deviation|14.9|14.9|||
3901896|NCT01486199|3726075|B2|||Age||years|Mean|31.2|31.2|Standard Deviation|15.0|15.0|||
3901897|NCT01486199|3726076|B1|||Age||years|Mean|10.5|10.5|Standard Deviation|1.5|1.5|||
3901898|NCT01486043|3726089|B1|||# of Day of Induction at Onset of Hyperglycemia||days|Mean|2|2.0|Full Range|||2.0|2.0|
3901899|NCT01486043|3726089|B1|||Fructosamine||uM|Mean|193|193.0|Full Range|||178.0|207.0|
3901900|NCT01486043|3726089|B1|||Hemoglobin A1C||%|Mean|5.8|5.8|Full Range|||5.5|6.0|
3901901|NCT01486043|3726089|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3901902|NCT01486043|3726089|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3901903|NCT01486043|3726089|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3901904|NCT01486043|3726089|B1|||Age||years|Mean|13.5|13.5|Full Range|||12.0|15.0|
3901905|NCT01485991|3726095|B3||Male|Sex: Female, Male||Participants|Count of Participants|466|466.0||||||
3901906|NCT01485991|3726096|B2||Male|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
3901907|NCT01485991|3726097|B1||Male|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
3901908|NCT01485991|3726095|B3||Female|Sex: Female, Male||Participants|Count of Participants|297|297.0||||||
3901909|NCT01485991|3726096|B2||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3901910|NCT01485991|3726097|B1||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3901911|NCT01485991|3726095|B3|||Age||years|Median|51|51.0|Full Range|||18.0|69.0|
3901912|NCT01485991|3726096|B2|||Age||years|Median|52|52.0|Full Range|||20.0|69.0|
3901913|NCT01485991|3726097|B1|||Age||years|Median|50|50.0|Full Range|||18.0|69.0|
3901914|NCT01485887|3726108|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3901915|NCT01485887|3726108|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3901916|NCT01485887|3726108|B1|||Age||years|Mean|43.7|43.7|Standard Deviation|13.6|13.6|||
3901917|NCT01485796|3726120|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3901918|NCT01485796|3726120|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3901919|NCT01485796|3726120|B1|||Age||Years|Median|33.0|33.0|Full Range|||6.0|69.0|
3901920|NCT01485796|3726120|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3901921|NCT01485796|3726120|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3901922|NCT01485796|3726120|B1||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
3901923|NCT01485640|3726142|B1|India||Region of Enrollment||participants|Number|32|32.0||||||
3901924|NCT01485640|3726142|B1|Colombia||Region of Enrollment||participants|Number|6|6.0||||||
3901925|NCT01485640|3726142|B1|South Africa||Region of Enrollment||participants|Number|26|26.0||||||
3901926|NCT01485640|3726142|B1|Russian Federation||Region of Enrollment||participants|Number|20|20.0||||||
3901927|NCT01485640|3726142|B1|Lithuania||Region of Enrollment||participants|Number|8|8.0||||||
3901928|NCT01485640|3726142|B1|Romania||Region of Enrollment||participants|Number|2|2.0||||||
3901929|NCT01485640|3726142|B1|Ukraine||Region of Enrollment||participants|Number|11|11.0||||||
3901930|NCT01485640|3726142|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
3901931|NCT01485640|3726142|B1|Slovakia||Region of Enrollment||participants|Number|17|17.0||||||
3901932|NCT01485640|3726142|B1|Czech Republic||Region of Enrollment||participants|Number|25|25.0||||||
3901933|NCT01485640|3726142|B1|France||Region of Enrollment||participants|Number|6|6.0||||||
3901934|NCT01485640|3726142|B1|Serbia||Region of Enrollment||participants|Number|6|6.0||||||
3901935|NCT01485640|3726142|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3901936|NCT01485640|3726142|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901937|NCT01485640|3726142|B1||White|Race (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
3901938|NCT01485640|3726142|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3901939|NCT01485640|3726142|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901940|NCT01485640|3726142|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3901941|NCT01485640|3726142|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901942|NCT01485640|3726142|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3901943|NCT01485640|3726142|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3901944|NCT01485640|3726142|B1|||Age||years|Mean|41.3|41.3|Standard Deviation|12.08|12.08|||
3901945|NCT01485640|3726142|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3901946|NCT01485640|3726142|B1||Between 18 and 65 years|Age||Participants|Count of Participants|159|159.0||||||
3901947|NCT01485640|3726142|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3901948|NCT01485536|3726147|B1|Unknown||Baseline Lymphoma Diagnosis|Histologically confirmed participant diagnosis at baseline by Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) or peripheral T-cell lymphoma (PTCL)|Participants|Count of Participants|1|1.0||||||
3901949|NCT01485536|3726147|B1|PTCL||Baseline Lymphoma Diagnosis|Histologically confirmed participant diagnosis at baseline by Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) or peripheral T-cell lymphoma (PTCL)|Participants|Count of Participants|6|6.0||||||
3902007|NCT01485172|3726165|B6|Asian - East Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3902068|NCT01485094|3726252|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3901950|NCT01485536|3726147|B1|DLBCL||Baseline Lymphoma Diagnosis|Histologically confirmed participant diagnosis at baseline by Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) or peripheral T-cell lymphoma (PTCL)|Participants|Count of Participants|14|14.0||||||
3901951|NCT01485536|3726147|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3901952|NCT01485536|3726147|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3901953|NCT01485536|3726147|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3901954|NCT01485536|3726147|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3901955|NCT01485536|3726147|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3901956|NCT01485536|3726147|B1||Male|Gender||Participants|Count of Participants|16|16.0||||||
3901957|NCT01485536|3726147|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
3901958|NCT01485536|3726147|B1|||Age||years|Median|60|60.0|Full Range|||33.0|77.0|
3901959|NCT01485380|3726152|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3901960|NCT01485380|3726152|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3901961|NCT01485380|3726152|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3901962|NCT01485380|3726152|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3901963|NCT01485380|3726152|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3901964|NCT01485354|3726156|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3901965|NCT01485354|3726156|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901966|NCT01485354|3726156|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901967|NCT01485354|3726156|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3901968|NCT01485354|3726156|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3901969|NCT01485354|3726156|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901970|NCT01485354|3726156|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901971|NCT01485354|3726156|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901972|NCT01485354|3726156|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901973|NCT01485354|3726156|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3901974|NCT01485354|3726156|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3901975|NCT01485354|3726156|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3901976|NCT01485354|3726156|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3901977|NCT01485354|3726156|B1|||Age||years|Mean|58.5|58.5|Standard Deviation|10.6|10.6|||
3901978|NCT01485172|3726164|B7|Missing||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3901979|NCT01485172|3726165|B6|Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3901980|NCT01485172|3726166|B5|Missing||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3901981|NCT01485172|3726167|B4|Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3901982|NCT01485172|3726168|B3|Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3901983|NCT01485172|3726169|B2|Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3901984|NCT01485172|3726170|B1|Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3901985|NCT01485172|3726164|B7|White - White/Caucasian||Race/Ethnicity, Customized||Participants|Number|170|170.0||||||
3901986|NCT01485172|3726165|B6|White - White/Caucasian||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3901987|NCT01485172|3726166|B5|White - White/Caucasian||Race/Ethnicity, Customized||Participants|Number|36|36.0||||||
3901988|NCT01485172|3726167|B4|White - White/Caucasian||Race/Ethnicity, Customized||Participants|Number|34|34.0||||||
3901989|NCT01485172|3726168|B3|White - White/Caucasian||Race/Ethnicity, Customized||Participants|Number|39|39.0||||||
3901990|NCT01485172|3726169|B2|White - White/Caucasian||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
3901991|NCT01485172|3726170|B1|White - White/Caucasian||Race/Ethnicity, Customized||Participants|Number|36|36.0||||||
3901992|NCT01485172|3726164|B7|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3901993|NCT01485172|3726165|B6|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3901994|NCT01485172|3726166|B5|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3901995|NCT01485172|3726167|B4|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3901996|NCT01485172|3726168|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3901997|NCT01485172|3726169|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3901998|NCT01485172|3726170|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3901999|NCT01485172|3726164|B7|Asian - Japanese||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3902000|NCT01485172|3726165|B6|Asian - Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3902001|NCT01485172|3726166|B5|Asian - Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3902002|NCT01485172|3726167|B4|Asian - Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3902003|NCT01485172|3726168|B3|Asian - Japanese||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3902004|NCT01485172|3726169|B2|Asian - Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3902005|NCT01485172|3726170|B1|Asian - Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3902006|NCT01485172|3726164|B7|Asian - East Asian||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3902008|NCT01485172|3726166|B5|Asian - East Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3902009|NCT01485172|3726167|B4|Asian - East Asian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3902010|NCT01485172|3726168|B3|Asian - East Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3902011|NCT01485172|3726169|B2|Asian - East Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3902012|NCT01485172|3726170|B1|Asian - East Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3902013|NCT01485172|3726164|B7|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3902014|NCT01485172|3726165|B6|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3902015|NCT01485172|3726166|B5|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3902016|NCT01485172|3726167|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3902017|NCT01485172|3726168|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3902018|NCT01485172|3726169|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3902019|NCT01485172|3726170|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3902020|NCT01485172|3726164|B7||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3902021|NCT01485172|3726165|B6||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3902022|NCT01485172|3726166|B5||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3902023|NCT01485172|3726167|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3902024|NCT01485172|3726168|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3902025|NCT01485172|3726169|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3902026|NCT01485172|3726170|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3902027|NCT01485172|3726164|B7||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3902028|NCT01485172|3726165|B6||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3902029|NCT01485172|3726166|B5||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3902030|NCT01485172|3726167|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3902031|NCT01485172|3726168|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3902032|NCT01485172|3726169|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3902033|NCT01485172|3726170|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3902034|NCT01485172|3726164|B7|||Age||Years|Mean|61.6|61.6|Standard Deviation|10.85|10.85|||
3902035|NCT01485172|3726165|B6|||Age||Years|Mean|62.5|62.5|Standard Deviation|12.88|12.88|||
3902036|NCT01485172|3726166|B5|||Age||Years|Mean|61.7|61.7|Standard Deviation|10.78|10.78|||
3902037|NCT01485172|3726167|B4|||Age||Years|Mean|60.3|60.3|Standard Deviation|11.72|11.72|||
3902038|NCT01485172|3726168|B3|||Age||Years|Mean|62.1|62.1|Standard Deviation|11.38|11.38|||
3902039|NCT01485172|3726169|B2|||Age||Years|Mean|58.2|58.2|Standard Deviation|11.12|11.12|||
3902040|NCT01485172|3726170|B1|||Age||Years|Mean|63.1|63.1|Standard Deviation|8.82|8.82|||
3902041|NCT01485094|3726249|B4|||Time since diagnosis of neuropathic pain||months|Mean|59.84|59.84|Standard Deviation|49.49|49.49|||
3902042|NCT01485094|3726250|B3|||Time since diagnosis of neuropathic pain||months|Mean|63.32|63.32|Standard Deviation|54.79|54.79|||
3902043|NCT01485094|3726251|B2|||Time since diagnosis of neuropathic pain||months|Mean|83.26|83.26|Standard Deviation|49.86|49.86|||
3902044|NCT01485094|3726252|B1|||Time since diagnosis of neuropathic pain||months|Mean|32.95|32.95|Standard Deviation|27.84|27.84|||
3902045|NCT01485094|3726249|B4|||Body mass index||kg/m2|Mean|27.40|27.4|Standard Deviation|3.34|3.34|||
3902046|NCT01485094|3726250|B3|||Body mass index||kg/m2|Mean|27.27|27.27|Standard Deviation|3.32|3.32|||
3902047|NCT01485094|3726251|B2|||Body mass index||kg/m2|Mean|27.37|27.37|Standard Deviation|3.03|3.03|||
3902048|NCT01485094|3726252|B1|||Body mass index||kg/m2|Mean|27.56|27.56|Standard Deviation|3.80|3.8|||
3902049|NCT01485094|3726249|B4|United Kingdom||Region of Enrollment||participants|Number|46|46.0||||||
3902050|NCT01485094|3726250|B3|United Kingdom||Region of Enrollment||participants|Number|16|16.0||||||
3902051|NCT01485094|3726251|B2|United Kingdom||Region of Enrollment||participants|Number|15|15.0||||||
3902052|NCT01485094|3726252|B1|United Kingdom||Region of Enrollment||participants|Number|15|15.0||||||
3902053|NCT01485094|3726249|B4|Germany||Region of Enrollment||participants|Number|3|3.0||||||
3902054|NCT01485094|3726250|B3|Germany||Region of Enrollment||participants|Number|1|1.0||||||
3902055|NCT01485094|3726251|B2|Germany||Region of Enrollment||participants|Number|1|1.0||||||
3902056|NCT01485094|3726252|B1|Germany||Region of Enrollment||participants|Number|1|1.0||||||
3902057|NCT01485094|3726249|B4|Poland||Region of Enrollment||participants|Number|1|1.0||||||
3902058|NCT01485094|3726250|B3|Poland||Region of Enrollment||participants|Number|0|0.0||||||
3902059|NCT01485094|3726251|B2|Poland||Region of Enrollment||participants|Number|1|1.0||||||
3902060|NCT01485094|3726252|B1|Poland||Region of Enrollment||participants|Number|0|0.0||||||
3902061|NCT01485094|3726249|B4|Hungary||Region of Enrollment||participants|Number|7|7.0||||||
3902062|NCT01485094|3726250|B3|Hungary||Region of Enrollment||participants|Number|2|2.0||||||
3902063|NCT01485094|3726251|B2|Hungary||Region of Enrollment||participants|Number|2|2.0||||||
3902064|NCT01485094|3726252|B1|Hungary||Region of Enrollment||participants|Number|3|3.0||||||
3902065|NCT01485094|3726249|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3902066|NCT01485094|3726250|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3902067|NCT01485094|3726251|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3902069|NCT01485094|3726249|B4||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3902070|NCT01485094|3726250|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3902071|NCT01485094|3726251|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3902072|NCT01485094|3726252|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3902073|NCT01485094|3726249|B4|||Age||years|Mean|50.35|50.35|Standard Deviation|13.41|13.41|||
3902074|NCT01485094|3726250|B3|||Age||years|Mean|50.53|50.53|Standard Deviation|14.55|14.55|||
3902075|NCT01485094|3726251|B2|||Age||years|Mean|54.00|54.0|Standard Deviation|9.93|9.93|||
3902076|NCT01485094|3726252|B1|||Age||years|Mean|46.53|46.53|Standard Deviation|14.83|14.83|||
3902077|NCT01485094|3726249|B4||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3902078|NCT01485094|3726250|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3902079|NCT01485094|3726251|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3902080|NCT01485094|3726252|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3902081|NCT01485094|3726249|B4||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3902082|NCT01485094|3726250|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3902083|NCT01485094|3726251|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3902084|NCT01485094|3726252|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3902085|NCT01485094|3726249|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3902086|NCT01485094|3726250|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3902087|NCT01485094|3726251|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3902088|NCT01485094|3726252|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3902089|NCT01484977|3726295|B1|Not Hispanic or Latino||Ethnicity||participants|Number|103|103.0||||||
3902090|NCT01484977|3726295|B1|Hispanic or Latino||Ethnicity||participants|Number|17|17.0||||||
3902091|NCT01484977|3726295|B1|Other/Mixed||Racial Group||participants|Number|12|12.0||||||
3902092|NCT01484977|3726295|B1|White||Racial Group||participants|Number|96|96.0||||||
3902093|NCT01484977|3726295|B1|Native Hawaiian or other Pacific Islander||Racial Group||participants|Number|0|0.0||||||
3902094|NCT01484977|3726295|B1|Black||Racial Group||participants|Number|8|8.0||||||
3902095|NCT01484977|3726295|B1|Asian||Racial Group||participants|Number|3|3.0||||||
3902096|NCT01484977|3726295|B1|American Indian/Alaskan Native||Racial Group||participants|Number|1|1.0||||||
3902097|NCT01484977|3726295|B1|||BMI||kilogram/ square meter|Mean|27.00|27.0|Standard Deviation|6.45|6.45|||
3902098|NCT01484977|3726295|B1|||Height||centimeters|Mean|168.02|168.02|Standard Deviation|10.55|10.55|||
3902099|NCT01484977|3726295|B1|||Weight||kilograms|Mean|76.39|76.39|Standard Deviation|19.98|19.98|||
3902100|NCT01484977|3726295|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3902101|NCT01484977|3726295|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3902102|NCT01484977|3726295|B1|||Age||years|Mean|39.7|39.7|Standard Deviation|12.6|12.6|||
3902103|NCT01484977|3726295|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3902104|NCT01484977|3726295|B1||Between 18 and 65 years|Age||Participants|Count of Participants|114|114.0||||||
3902105|NCT01484977|3726295|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3902106|NCT01484951|3726299|B1|Taiwan||Region of Enrollment||participants|Number|74|74.0||||||
3902107|NCT01484951|3726299|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3902108|NCT01484951|3726299|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3902109|NCT01484951|3726299|B1|||Age||years|Mean|60|60.0|Standard Deviation|15|15.0|||
3902110|NCT01484938|3726304|B1|Australia||Region of Enrollment||participants|Number|28|28.0||||||
3902111|NCT01484938|3726304|B1|Sweden||Region of Enrollment||participants|Number|75|75.0||||||
3902112|NCT01484938|3726304|B1|Netherlands||Region of Enrollment||participants|Number|72|72.0||||||
3902113|NCT01484938|3726304|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3902114|NCT01484938|3726304|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3902115|NCT01484938|3726304|B1|||Age||years|Mean|37.6|37.6|Standard Deviation|11.66|11.66|||
3902116|NCT01484912|3726309|B3|Taiwan||Region of Enrollment||participants|Number|79|79.0||||||
3902117|NCT01484912|3726310|B2|Taiwan||Region of Enrollment||participants|Number|40|40.0||||||
3902118|NCT01484912|3726311|B1|Taiwan||Region of Enrollment||participants|Number|39|39.0||||||
3902119|NCT01484912|3726309|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3902120|NCT01484912|3726310|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3902121|NCT01484912|3726311|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3902122|NCT01484912|3726309|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3902123|NCT01484912|3726310|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3902124|NCT01484912|3726311|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3902125|NCT01484912|3726309|B3||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
3902126|NCT01484912|3726310|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3902127|NCT01484912|3726311|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3902128|NCT01484912|3726309|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
3902129|NCT01484912|3726310|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3902130|NCT01484912|3726311|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3902131|NCT01484912|3726309|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3902132|NCT01484912|3726310|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3902133|NCT01484912|3726311|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3902134|NCT01484873|3726322|B1|||Gastric emptying half life||minutes|Mean|175.4|175.4|Standard Deviation|81.0|81.0|||
3902135|NCT01484873|3726322|B1|||Insulin AUC||120 min*uU/mL|Mean|13076|13076.0|Standard Deviation|7482|7482.0|||
3902136|NCT01484873|3726322|B1|||Satiety|minimum 0, maximum 100|mm|Mean|68.9|68.9|Standard Deviation|15.4|15.4|||
3902137|NCT01484873|3726322|B1|||Resting energy expenditure||kcal/day|Mean|2215.0|2215.0|Standard Deviation|654.9|654.9|||
3902138|NCT01484873|3726322|B1|||Weight||kg|Mean|137.2|137.2|Standard Deviation|37.6|37.6|||
3902139|NCT01484873|3726322|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3902140|NCT01484873|3726322|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902141|NCT01484873|3726322|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902142|NCT01484873|3726322|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3902143|NCT01484873|3726322|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902144|NCT01484873|3726322|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902145|NCT01484873|3726322|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902146|NCT01484873|3726322|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902147|NCT01484873|3726322|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902148|NCT01484873|3726322|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3902149|NCT01484873|3726322|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3902150|NCT01484873|3726322|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
3902151|NCT01484873|3726322|B1||Female|Gender||Participants|Count of Participants|7|7.0||||||
3902152|NCT01484873|3726322|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3902153|NCT01484873|3726322|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3902154|NCT01484873|3726322|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3902155|NCT01484834|3726330|B5|Brazil||Region of Enrollment||participants|Number|190|190.0||||||
3902156|NCT01484834|3726331|B4|Brazil||Region of Enrollment||participants|Number|24|24.0||||||
3902157|NCT01484834|3726332|B3|Brazil||Region of Enrollment||participants|Number|39|39.0||||||
3902158|NCT01484834|3726333|B2|Brazil||Region of Enrollment||participants|Number|62|62.0||||||
3902159|NCT01484834|3726334|B1|Brazil||Region of Enrollment||participants|Number|65|65.0||||||
3902160|NCT01484834|3726330|B5||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3902161|NCT01484834|3726331|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3902162|NCT01484834|3726332|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3902163|NCT01484834|3726333|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3902164|NCT01484834|3726334|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3902165|NCT01484834|3726330|B5||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3902166|NCT01484834|3726331|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3902167|NCT01484834|3726332|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3902168|NCT01484834|3726333|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3902169|NCT01484834|3726334|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3902170|NCT01484834|3726330|B5|||Age||years|Mean|26|26.0|Standard Deviation|6|6.0|||
3902171|NCT01484834|3726331|B4|||Age||years|Mean|27.2|27.2|Standard Deviation|7.7|7.7|||
3902172|NCT01484834|3726332|B3|||Age||years|Mean|28.6|28.6|Standard Deviation|7.57|7.57|||
3902173|NCT01484834|3726333|B2|||Age||years|Mean|23.9|23.9|Standard Deviation|5.23|5.23|||
3902174|NCT01484834|3726334|B1|||Age||years|Mean|24.6|24.6|Standard Deviation|3.54|3.54|||
3902175|NCT01484834|3726330|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3902176|NCT01484834|3726331|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3902177|NCT01484834|3726332|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3902178|NCT01484834|3726333|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3902179|NCT01484834|3726334|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3902180|NCT01484834|3726330|B5||Between 18 and 65 years|Age||Participants|Count of Participants|190|190.0||||||
3902181|NCT01484834|3726331|B4||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3902182|NCT01484834|3726332|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3902183|NCT01484834|3726333|B2||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
3902184|NCT01484834|3726334|B1||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
3902185|NCT01484834|3726330|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3902186|NCT01484834|3726331|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3902187|NCT01484834|3726332|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3902188|NCT01484834|3726333|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3902189|NCT01484834|3726334|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3902190|NCT01484652|3726363|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902191|NCT01484652|3726364|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902192|NCT01484652|3726365|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902193|NCT01484652|3726363|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|247|247.0||||||
3902194|NCT01484652|3726364|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
3902195|NCT01484652|3726365|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
3902196|NCT01484652|3726363|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3902197|NCT01484652|3726364|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3902198|NCT01484652|3726365|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3902199|NCT01484652|3726363|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3902200|NCT01484652|3726364|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3902201|NCT01484652|3726365|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3902202|NCT01484652|3726363|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902203|NCT01484652|3726364|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902204|NCT01484652|3726365|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902205|NCT01484652|3726363|B3||White|Race (NIH/OMB)||Participants|Count of Participants|201|201.0||||||
3902206|NCT01484652|3726364|B2||White|Race (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
3902207|NCT01484652|3726365|B1||White|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3902208|NCT01484652|3726363|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3902209|NCT01484652|3726364|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3902210|NCT01484652|3726365|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3902211|NCT01484652|3726363|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3902212|NCT01484652|3726364|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3902213|NCT01484652|3726365|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902214|NCT01484652|3726363|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3902215|NCT01484652|3726364|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3902216|NCT01484652|3726365|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3902217|NCT01484652|3726363|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3902218|NCT01484652|3726364|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902219|NCT01484652|3726365|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3902220|NCT01484652|3726363|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3902221|NCT01484652|3726364|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3902222|NCT01484652|3726365|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3902223|NCT01484652|3726363|B3||Female|Sex: Female, Male||Participants|Count of Participants|280|280.0||||||
3902224|NCT01484652|3726364|B2||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3902225|NCT01484652|3726365|B1||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3902226|NCT01484652|3726363|B3|||Age||years|Mean|43.4|43.4|Standard Deviation|13.69|13.69|||
3902227|NCT01484652|3726364|B2|||Age||years|Mean|44.6|44.6|Standard Deviation|14.14|14.14|||
3902228|NCT01484652|3726365|B1|||Age||years|Mean|42.3|42.3|Standard Deviation|13.17|13.17|||
3902229|NCT01484626|3726372|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3902230|NCT01484626|3726372|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3902231|NCT01484626|3726372|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902232|NCT01484626|3726372|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902233|NCT01484626|3726372|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3902234|NCT01484626|3726372|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902235|NCT01484626|3726372|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902236|NCT01484626|3726372|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902237|NCT01484626|3726372|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3902238|NCT01484626|3726372|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3902239|NCT01484626|3726372|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3902240|NCT01484626|3726372|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3902241|NCT01484626|3726372|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3902242|NCT01484561|3726376|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3902243|NCT01484561|3726377|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3902244|NCT01484561|3726378|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3902245|NCT01484561|3726376|B3||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3902246|NCT01484561|3726377|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3902247|NCT01484561|3726378|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3902248|NCT01484561|3726376|B3|||Age||years|Mean|50.3|50.3|Standard Deviation|12.6|12.6|||
3902249|NCT01484561|3726377|B2|||Age||years|Mean|47.3|47.3|Standard Deviation|11.8|11.8|||
3902250|NCT01484561|3726378|B1|||Age||years|Mean|51.9|51.9|Standard Deviation|12.7|12.7|||
3902251|NCT01484496|3726467|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3902252|NCT01484496|3726468|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3902253|NCT01484496|3726469|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3902254|NCT01484496|3726467|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|64|64.0||||||
3902255|NCT01484496|3726468|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
3902256|NCT01484496|3726469|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3902257|NCT01484496|3726467|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|86|86.0||||||
3902258|NCT01484496|3726468|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
3902259|NCT01484496|3726469|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3902260|NCT01484496|3726467|B3|Southeast Asian Heritage||Race/Ethnicity, Customized||participants|Number|105|105.0||||||
3902261|NCT01484496|3726468|B2|Southeast Asian Heritage||Race/Ethnicity, Customized||participants|Number|73|73.0||||||
3902262|NCT01484496|3726469|B1|Southeast Asian Heritage||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3902263|NCT01484496|3726467|B3|South Asian Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3902264|NCT01484496|3726468|B2|South Asian Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3902265|NCT01484496|3726469|B1|South Asian Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3902266|NCT01484496|3726467|B3|Japanese Heritage||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3902267|NCT01484496|3726468|B2|Japanese Heritage||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3902268|NCT01484496|3726469|B1|Japanese Heritage||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3902269|NCT01484496|3726467|B3|East Asian Heritage||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
3902270|NCT01484496|3726468|B2|East Asian Heritage||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3902271|NCT01484496|3726469|B1|East Asian Heritage||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3902272|NCT01484496|3726467|B3|Central Asian Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3902273|NCT01484496|3726468|B2|Central Asian Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3902274|NCT01484496|3726469|B1|Central Asian Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3902275|NCT01484496|3726467|B3|Middle East/North African Heritage||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3902276|NCT01484496|3726468|B2|Middle East/North African Heritage||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3902277|NCT01484496|3726469|B1|Middle East/North African Heritage||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3902278|NCT01484496|3726467|B3|White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|486|486.0||||||
3902279|NCT01484496|3726468|B2|White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|326|326.0||||||
3902280|NCT01484496|3726469|B1|White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|160|160.0||||||
3902281|NCT01484496|3726467|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3902282|NCT01484496|3726468|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3902283|NCT01484496|3726469|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3902284|NCT01484496|3726467|B3||Female|Sex: Female, Male||Participants|Count of Participants|789|789.0||||||
3902285|NCT01484496|3726468|B2||Female|Sex: Female, Male||Participants|Count of Participants|521|521.0||||||
3902286|NCT01484496|3726469|B1||Female|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
3902287|NCT01484496|3726467|B3|||Age||Years|Mean|38.6|38.6|Standard Deviation|12.29|12.29|||
3902288|NCT01484496|3726468|B2|||Age||Years|Mean|38.1|38.1|Standard Deviation|12.10|12.1|||
3902289|NCT01484496|3726469|B1|||Age||Years|Mean|39.6|39.6|Standard Deviation|12.61|12.61|||
3902290|NCT01484340|3726484|B3|||Number of cigarettes smoked per day||cigarettes per day|Median|10|10.0|Inter-Quartile Range|||5.0|15.0|
3902291|NCT01484340|3726485|B2|||Number of cigarettes smoked per day||cigarettes per day|Median|9|9.0|Inter-Quartile Range|||5.0|15.0|
3902292|NCT01484340|3726486|B1|||Number of cigarettes smoked per day||cigarettes per day|Median|10|10.0|Inter-Quartile Range|||6.0|15.0|
3902293|NCT01484340|3726484|B3|South Africa||Region of Enrollment||participants|Number|560|560.0||||||
3902294|NCT01484340|3726485|B2|South Africa||Region of Enrollment||participants|Number|279|279.0||||||
3902295|NCT01484340|3726486|B1|South Africa||Region of Enrollment||participants|Number|281|281.0||||||
3902296|NCT01484340|3726484|B3|Race|Not documented|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3902297|NCT01484340|3726485|B2|Race|Not documented|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3902298|NCT01484340|3726486|B1|Race|Not documented|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3902299|NCT01484340|3726484|B3|Race|Indian/Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3902300|NCT01484340|3726485|B2|Race|Indian/Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3902301|NCT01484340|3726486|B1|Race|Indian/Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3902302|NCT01484340|3726484|B3|Race|Colored|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3902303|NCT01484340|3726485|B2|Race|Colored|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3902304|NCT01484340|3726486|B1|Race|Colored|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3902305|NCT01484340|3726484|B3|Race|African/Black|Race/Ethnicity, Customized||Participants|Count of Participants|557|557.0||||||
3902306|NCT01484340|3726485|B2|Race|African/Black|Race/Ethnicity, Customized||Participants|Count of Participants|276|276.0||||||
3902307|NCT01484340|3726486|B1|Race|African/Black|Race/Ethnicity, Customized||Participants|Count of Participants|281|281.0||||||
3902308|NCT01484340|3726484|B3||Male|Sex: Female, Male||Participants|Count of Participants|437|437.0||||||
3902309|NCT01484340|3726485|B2||Male|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
3902310|NCT01484340|3726486|B1||Male|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
3902311|NCT01484340|3726484|B3||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3902312|NCT01484340|3726485|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3902313|NCT01484340|3726486|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3902314|NCT01484340|3726484|B3|||Age||years|Median|37|37.0|Inter-Quartile Range|||31.0|46.0|
3902315|NCT01484340|3726485|B2|||Age||years|Median|39|39.0|Inter-Quartile Range|||32.0|46.0|
3902316|NCT01484340|3726486|B1|||Age||years|Median|36|36.0|Inter-Quartile Range|||30.0|44.0|
3902317|NCT01484197|3726505|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3902318|NCT01484197|3726505|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3902319|NCT01484197|3726505|B1|||Age||Years|Mean|45.8|45.8|Standard Deviation|12.39|12.39|||
3902320|NCT01484132|3726591|B1|Other||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3902321|NCT01484132|3726591|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
3902322|NCT01484132|3726591|B1|Black - Non Hispanic||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3902323|NCT01484132|3726591|B1|White - Non Hispanic||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
3902324|NCT01484132|3726591|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3902325|NCT01484132|3726591|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3902326|NCT01484132|3726591|B1|||Age||Years|Mean|9.36|9.36|Standard Deviation|3.75|3.75|||
3902327|NCT01484054|3726599|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
3902328|NCT01484054|3726599|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3902329|NCT01484054|3726599|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3902330|NCT01484054|3726599|B1|||Age||years|Mean|25.07|25.07|Standard Deviation|4.879|4.879|||
3902331|NCT01484041|3726610|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3902332|NCT01484041|3726610|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3902333|NCT01484041|3726610|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3902334|NCT01484041|3726610|B1|||Age||years|Median|53.5|53.5|Full Range|||32.0|74.0|
3902335|NCT01484028|3726618|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3902336|NCT01484028|3726618|B1||Female|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
3902337|NCT01484028|3726618|B1|||Age||years|Mean|24.94|24.94|Standard Deviation|4.654|4.654|||
3902338|NCT01484028|3726618|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3902339|NCT01484028|3726618|B1||Between 18 and 65 years|Age||Participants|Count of Participants|267|267.0||||||
3902340|NCT01484028|3726618|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3902341|NCT01483963|3726631|B6|United States||Region of Enrollment||participants|Number|50|50.0||||||
3902342|NCT01483963|3726632|B5|United States||Region of Enrollment||participants|Number|10|10.0||||||
3902343|NCT01483963|3726633|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
3902344|NCT01483963|3726634|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3902345|NCT01483963|3726635|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3902346|NCT01483963|3726636|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3902347|NCT01483963|3726631|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902348|NCT01483963|3726632|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902349|NCT01483963|3726633|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902350|NCT01483963|3726634|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902351|NCT01483963|3726635|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902352|NCT01483963|3726636|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902353|NCT01483963|3726631|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902354|NCT01483963|3726632|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902355|NCT01483963|3726633|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902356|NCT01483963|3726634|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902357|NCT01483963|3726635|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902358|NCT01483963|3726636|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902359|NCT01483963|3726631|B6||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3902360|NCT01483963|3726632|B5||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3902361|NCT01483963|3726633|B4||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3902362|NCT01483963|3726634|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3902363|NCT01483963|3726635|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3902364|NCT01483963|3726636|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3902365|NCT01483963|3726631|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902366|NCT01483963|3726632|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902367|NCT01483963|3726633|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902368|NCT01483963|3726634|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902369|NCT01483963|3726635|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902370|NCT01483963|3726636|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902371|NCT01483963|3726631|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3902372|NCT01483963|3726632|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902373|NCT01483963|3726633|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902374|NCT01483963|3726634|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902375|NCT01483963|3726635|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902376|NCT01483963|3726636|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3902377|NCT01483963|3726631|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3902378|NCT01483963|3726632|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902379|NCT01483963|3726633|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902380|NCT01483963|3726634|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3902381|NCT01483963|3726635|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902382|NCT01483963|3726636|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902383|NCT01483963|3726631|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902384|NCT01483963|3726632|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902385|NCT01483963|3726633|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902386|NCT01483963|3726634|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902387|NCT01483963|3726635|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902388|NCT01483963|3726636|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902389|NCT01483963|3726631|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902390|NCT01483963|3726632|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902391|NCT01483963|3726633|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902392|NCT01483963|3726634|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902393|NCT01483963|3726635|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902394|NCT01483963|3726636|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902395|NCT01483963|3726631|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3902396|NCT01483963|3726632|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3902397|NCT01483963|3726633|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3902398|NCT01483963|3726634|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3902399|NCT01483963|3726635|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3902400|NCT01483963|3726636|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3902401|NCT01483963|3726631|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3902402|NCT01483963|3726632|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902403|NCT01483963|3726633|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902404|NCT01483963|3726634|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902405|NCT01483963|3726635|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902406|NCT01483963|3726636|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3902407|NCT01483963|3726631|B6||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3902408|NCT01483963|3726632|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3902409|NCT01483963|3726633|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3902410|NCT01483963|3726634|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3902411|NCT01483963|3726635|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3902412|NCT01483963|3726636|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3902413|NCT01483963|3726631|B6||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3902414|NCT01483963|3726632|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3902415|NCT01483963|3726633|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3902416|NCT01483963|3726634|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3902417|NCT01483963|3726635|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3902418|NCT01483963|3726636|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3902419|NCT01483963|3726631|B6|||Age||years|Mean|54.0|54.0|Standard Deviation|7.60|7.6|||
3902420|NCT01483963|3726632|B5|||Age||years|Mean|55.1|55.1|Standard Deviation|7.02|7.02|||
3902421|NCT01483963|3726633|B4|||Age||years|Mean|53.2|53.2|Standard Deviation|5.71|5.71|||
3902422|NCT01483963|3726634|B3|||Age||years|Mean|58.4|58.4|Standard Deviation|8.97|8.97|||
3902423|NCT01483963|3726635|B2|||Age||years|Mean|54.1|54.1|Standard Deviation|8.81|8.81|||
3902424|NCT01483963|3726636|B1|||Age||years|Mean|49.1|49.1|Standard Deviation|4.93|4.93|||
3902425|NCT01483937|3726712|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
3902426|NCT01483937|3726713|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3902427|NCT01483937|3726714|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3902428|NCT01483937|3726712|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3902429|NCT01483937|3726713|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3902430|NCT01483937|3726714|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3902431|NCT01483937|3726712|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3902432|NCT01483937|3726713|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3902433|NCT01483937|3726714|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3902434|NCT01483937|3726712|B3|||Age||years|Mean|71.64|71.64|Standard Deviation|8.70|8.7|||
3902435|NCT01483937|3726713|B2|||Age||years|Mean|73.35|73.35|Standard Deviation|7.46|7.46|||
3902436|NCT01483937|3726714|B1|||Age||years|Mean|69.44|69.44|Standard Deviation|10.00|10.0|||
3902437|NCT01483937|3726712|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3902438|NCT01483937|3726713|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3902439|NCT01483937|3726714|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3902440|NCT01483937|3726712|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3902441|NCT01483937|3726713|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3902442|NCT01483937|3726714|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3902443|NCT01483937|3726712|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3902444|NCT01483937|3726713|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3902445|NCT01483937|3726714|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3902446|NCT01483924|3726737|B6|Canada||Region of Enrollment||participants|Number|9|9.0||||||
3902447|NCT01483924|3726738|B5|Canada||Region of Enrollment||participants|Number|5|5.0||||||
3902448|NCT01483924|3726739|B4|Canada||Region of Enrollment||participants|Number|3|3.0||||||
3902449|NCT01483924|3726740|B3|Canada||Region of Enrollment||participants|Number|0|0.0||||||
3902450|NCT01483924|3726741|B2|Canada||Region of Enrollment||participants|Number|0|0.0||||||
3902451|NCT01483924|3726742|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3902452|NCT01483924|3726737|B6|United States||Region of Enrollment||participants|Number|51|51.0||||||
3902453|NCT01483924|3726738|B5|United States||Region of Enrollment||participants|Number|7|7.0||||||
3902454|NCT01483924|3726739|B4|United States||Region of Enrollment||participants|Number|9|9.0||||||
3902455|NCT01483924|3726740|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3902456|NCT01483924|3726741|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3902457|NCT01483924|3726742|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3902458|NCT01483924|3726737|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902459|NCT01483924|3726738|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902460|NCT01483924|3726739|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902461|NCT01483924|3726740|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902462|NCT01483924|3726741|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902463|NCT01483924|3726742|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902464|NCT01483924|3726737|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902465|NCT01483924|3726738|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902466|NCT01483924|3726739|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902467|NCT01483924|3726740|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902468|NCT01483924|3726741|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902469|NCT01483924|3726742|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902470|NCT01483924|3726737|B6||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3902471|NCT01483924|3726738|B5||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3902472|NCT01483924|3726739|B4||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3902473|NCT01483924|3726740|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3902474|NCT01483924|3726741|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3902475|NCT01483924|3726742|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3902476|NCT01483924|3726737|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3902477|NCT01483924|3726738|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3902478|NCT01483924|3726739|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3902479|NCT01483924|3726740|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902480|NCT01483924|3726741|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3902481|NCT01483924|3726742|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3902540|NCT01483820|3726794|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3902482|NCT01483924|3726737|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902483|NCT01483924|3726738|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902484|NCT01483924|3726739|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902485|NCT01483924|3726740|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902486|NCT01483924|3726741|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902487|NCT01483924|3726742|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902488|NCT01483924|3726737|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3902489|NCT01483924|3726738|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902490|NCT01483924|3726739|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3902491|NCT01483924|3726740|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3902492|NCT01483924|3726741|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902493|NCT01483924|3726742|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3902494|NCT01483924|3726737|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902495|NCT01483924|3726738|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902496|NCT01483924|3726739|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902497|NCT01483924|3726740|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902498|NCT01483924|3726741|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902499|NCT01483924|3726742|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902500|NCT01483924|3726737|B6||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3902501|NCT01483924|3726738|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3902502|NCT01483924|3726739|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3902503|NCT01483924|3726740|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3902504|NCT01483924|3726741|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3902505|NCT01483924|3726742|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3902506|NCT01483924|3726737|B6||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3902507|NCT01483924|3726738|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3902508|NCT01483924|3726739|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3902509|NCT01483924|3726740|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3902510|NCT01483924|3726741|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3902511|NCT01483924|3726742|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3902512|NCT01483924|3726737|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3902513|NCT01483924|3726738|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3902514|NCT01483924|3726739|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3902515|NCT01483924|3726740|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3902516|NCT01483924|3726741|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3902517|NCT01483924|3726742|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3902518|NCT01483924|3726737|B6||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3902519|NCT01483924|3726738|B5||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3902520|NCT01483924|3726739|B4||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3902521|NCT01483924|3726740|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3902522|NCT01483924|3726741|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3902523|NCT01483924|3726742|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3902524|NCT01483924|3726737|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3902525|NCT01483924|3726738|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3902526|NCT01483924|3726739|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3902527|NCT01483924|3726740|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3902528|NCT01483924|3726741|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3902529|NCT01483924|3726742|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3902530|NCT01483820|3726794|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902531|NCT01483820|3726794|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902532|NCT01483820|3726794|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3902533|NCT01483820|3726794|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902534|NCT01483820|3726794|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902535|NCT01483820|3726794|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902536|NCT01483820|3726794|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902537|NCT01483820|3726794|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902538|NCT01483820|3726794|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3902539|NCT01483820|3726794|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3902541|NCT01483820|3726794|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3902542|NCT01483820|3726794|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3902543|NCT01483820|3726794|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3902544|NCT01483820|3726794|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
3902545|NCT01483651|3726803|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3902546|NCT01483651|3726803|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3902547|NCT01483651|3726803|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3902548|NCT01483651|3726803|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3902549|NCT01483651|3726803|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3902550|NCT01483625|3726816|B3|||Trough forced expiratory value (FEV1)||Litre|Mean|1.65|1.65|Standard Deviation|0.64|0.64|||
3902551|NCT01483625|3726817|B2|||Trough forced expiratory value (FEV1)||Litre|Mean|1.56|1.56|Standard Deviation|0.61|0.61|||
3902552|NCT01483625|3726818|B1|||Trough forced expiratory value (FEV1)||Litre|Mean|1.75|1.75|Standard Deviation|0.65|0.65|||
3902553|NCT01483625|3726816|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3902554|NCT01483625|3726817|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3902555|NCT01483625|3726818|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3902556|NCT01483625|3726816|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3902557|NCT01483625|3726817|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3902558|NCT01483625|3726818|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3902559|NCT01483625|3726816|B3|||Age||years|Mean|58.0|58.0|Standard Deviation|8.7|8.7|||
3902560|NCT01483625|3726817|B2|||Age||years|Mean|59.2|59.2|Standard Deviation|8.5|8.5|||
3902561|NCT01483625|3726818|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|8.7|8.7|||
3902562|NCT01483625|3726816|B3||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
3902563|NCT01483625|3726817|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3902564|NCT01483625|3726818|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3902565|NCT01483625|3726816|B3||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
3902566|NCT01483625|3726817|B2||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
3902567|NCT01483625|3726818|B1||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
3902568|NCT01483625|3726816|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3902569|NCT01483625|3726817|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3902570|NCT01483625|3726818|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3902571|NCT01483599|3726835|B8|United States||Region of Enrollment||participants|Number|127|127.0||||||
3902572|NCT01483599|3726836|B7|United States||Region of Enrollment||participants|Number|21|21.0||||||
3902573|NCT01483599|3726837|B6|United States||Region of Enrollment||participants|Number|16|16.0||||||
3902574|NCT01483599|3726838|B5|United States||Region of Enrollment||participants|Number|18|18.0||||||
3902575|NCT01483599|3726839|B4|United States||Region of Enrollment||participants|Number|16|16.0||||||
3902576|NCT01483599|3726840|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
3902577|NCT01483599|3726841|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3902578|NCT01483599|3726842|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3902579|NCT01483599|3726835|B8|Canada||Region of Enrollment||participants|Number|83|83.0||||||
3902580|NCT01483599|3726836|B7|Canada||Region of Enrollment||participants|Number|11|11.0||||||
3902581|NCT01483599|3726837|B6|Canada||Region of Enrollment||participants|Number|14|14.0||||||
3902582|NCT01483599|3726838|B5|Canada||Region of Enrollment||participants|Number|12|12.0||||||
3902583|NCT01483599|3726839|B4|Canada||Region of Enrollment||participants|Number|11|11.0||||||
3902584|NCT01483599|3726840|B3|Canada||Region of Enrollment||participants|Number|11|11.0||||||
3902585|NCT01483599|3726841|B2|Canada||Region of Enrollment||participants|Number|11|11.0||||||
3902586|NCT01483599|3726842|B1|Canada||Region of Enrollment||participants|Number|13|13.0||||||
3902587|NCT01483599|3726835|B8|Poland||Region of Enrollment||participants|Number|55|55.0||||||
3902588|NCT01483599|3726836|B7|Poland||Region of Enrollment||participants|Number|8|8.0||||||
3902589|NCT01483599|3726837|B6|Poland||Region of Enrollment||participants|Number|8|8.0||||||
3902590|NCT01483599|3726838|B5|Poland||Region of Enrollment||participants|Number|7|7.0||||||
3902591|NCT01483599|3726839|B4|Poland||Region of Enrollment||participants|Number|10|10.0||||||
3902592|NCT01483599|3726840|B3|Poland||Region of Enrollment||participants|Number|7|7.0||||||
3902593|NCT01483599|3726841|B2|Poland||Region of Enrollment||participants|Number|8|8.0||||||
3902594|NCT01483599|3726842|B1|Poland||Region of Enrollment||participants|Number|7|7.0||||||
3902595|NCT01483599|3726835|B8|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
3902596|NCT01483599|3726836|B7|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
3902597|NCT01483599|3726837|B6|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
3902598|NCT01483599|3726838|B5|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
3902599|NCT01483599|3726839|B4|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
3902600|NCT01483599|3726840|B3|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
3902601|NCT01483599|3726841|B2|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
3902602|NCT01483599|3726842|B1|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
3902603|NCT01483599|3726835|B8|Germany||Region of Enrollment||participants|Number|23|23.0||||||
3902604|NCT01483599|3726836|B7|Germany||Region of Enrollment||participants|Number|3|3.0||||||
3902605|NCT01483599|3726837|B6|Germany||Region of Enrollment||participants|Number|3|3.0||||||
3902606|NCT01483599|3726838|B5|Germany||Region of Enrollment||participants|Number|4|4.0||||||
3902607|NCT01483599|3726839|B4|Germany||Region of Enrollment||participants|Number|5|5.0||||||
3902608|NCT01483599|3726840|B3|Germany||Region of Enrollment||participants|Number|4|4.0||||||
3902609|NCT01483599|3726841|B2|Germany||Region of Enrollment||participants|Number|2|2.0||||||
3902610|NCT01483599|3726842|B1|Germany||Region of Enrollment||participants|Number|2|2.0||||||
3902611|NCT01483599|3726835|B8||Male|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
3902612|NCT01483599|3726836|B7||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3902613|NCT01483599|3726837|B6||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3902614|NCT01483599|3726838|B5||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3902615|NCT01483599|3726839|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3902616|NCT01483599|3726840|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3902617|NCT01483599|3726841|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3902618|NCT01483599|3726842|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3902619|NCT01483599|3726835|B8||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3902620|NCT01483599|3726836|B7||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3902621|NCT01483599|3726837|B6||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3902622|NCT01483599|3726838|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3902623|NCT01483599|3726839|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3902624|NCT01483599|3726840|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3902625|NCT01483599|3726841|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3902626|NCT01483599|3726842|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3902627|NCT01483599|3726835|B8|||Age||years|Mean|44.9|44.9|Standard Deviation|13.02|13.02|||
3902628|NCT01483599|3726836|B7|||Age||years|Mean|47.5|47.5|Standard Deviation|14.91|14.91|||
3902629|NCT01483599|3726837|B6|||Age||years|Mean|45.1|45.1|Standard Deviation|10.96|10.96|||
3902630|NCT01483599|3726838|B5|||Age||years|Mean|45.3|45.3|Standard Deviation|13.72|13.72|||
3902631|NCT01483599|3726839|B4|||Age||years|Mean|42.6|42.6|Standard Deviation|12.14|12.14|||
3902632|NCT01483599|3726840|B3|||Age||years|Mean|43.8|43.8|Standard Deviation|13.5|13.5|||
3902633|NCT01483599|3726841|B2|||Age||years|Mean|45.2|45.2|Standard Deviation|13.92|13.92|||
3902634|NCT01483599|3726842|B1|||Age||years|Mean|45|45.0|Standard Deviation|11.97|11.97|||
3902635|NCT01483599|3726835|B8||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3902636|NCT01483599|3726836|B7||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3902637|NCT01483599|3726837|B6||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3902638|NCT01483599|3726838|B5||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3902639|NCT01483599|3726839|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3902640|NCT01483599|3726840|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3902641|NCT01483599|3726841|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3902642|NCT01483599|3726842|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3902643|NCT01483599|3726835|B8||Between 18 and 65 years|Age||Participants|Count of Participants|271|271.0||||||
3902644|NCT01483599|3726836|B7||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3902645|NCT01483599|3726837|B6||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3902646|NCT01483599|3726838|B5||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3902647|NCT01483599|3726839|B4||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3902648|NCT01483599|3726840|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3902649|NCT01483599|3726841|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3902650|NCT01483599|3726842|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3902651|NCT01483599|3726835|B8||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3902652|NCT01483599|3726836|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3902653|NCT01483599|3726837|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3902654|NCT01483599|3726838|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3902655|NCT01483599|3726839|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3902656|NCT01483599|3726840|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3902657|NCT01483599|3726841|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3902658|NCT01483599|3726842|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3902659|NCT01483378|3726904|B1|United States||Region of Enrollment||participants|Number|166|166.0||||||
3902660|NCT01483378|3726904|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3902661|NCT01483378|3726904|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3902662|NCT01483378|3726904|B1|Age||Age||years|Mean|68|68.0|Standard Deviation|15|15.0|||
3902663|NCT01483352|3726911|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3902664|NCT01483352|3726911|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3902665|NCT01483352|3726911|B1|||Age||years|Mean|49|49.0|Standard Deviation|14|14.0|||
3902666|NCT01483209|3726930|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3902667|NCT01483209|3726930|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3902668|NCT01483209|3726930|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3902669|NCT01483209|3726930|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3902670|NCT01483209|3726930|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3902671|NCT01483209|3726930|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3902672|NCT01483183|3726935|B11||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3902673|NCT01483183|3726936|B10||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3902674|NCT01483183|3726937|B9||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3902675|NCT01483183|3726938|B8||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3902676|NCT01483183|3726939|B7||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3902677|NCT01483183|3726940|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3902678|NCT01483183|3726941|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3902679|NCT01483183|3726942|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3902680|NCT01483183|3726943|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3902681|NCT01483183|3726944|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3902682|NCT01483183|3726945|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3902683|NCT01483183|3726935|B11||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3902684|NCT01483183|3726936|B10||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3902685|NCT01483183|3726937|B9||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3902686|NCT01483183|3726938|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3902687|NCT01483183|3726939|B7||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3902688|NCT01483183|3726940|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3902689|NCT01483183|3726941|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3902690|NCT01483183|3726942|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3902691|NCT01483183|3726943|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3902692|NCT01483183|3726944|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3902693|NCT01483183|3726945|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3902694|NCT01483183|3726935|B11|||Age||years|Mean|66.6|66.6|Standard Deviation|11.75|11.75|||
3902695|NCT01483183|3726936|B10|||Age||years|Mean|70.4|70.4|Standard Deviation|8.8|8.8|||
3902696|NCT01483183|3726937|B9|||Age||years|Mean|64.3|64.3|Standard Deviation|7.7|7.7|||
3902697|NCT01483183|3726938|B8|||Age||years|Mean|64.8|64.8|Standard Deviation|12.9|12.9|||
3902698|NCT01483183|3726939|B7|||Age||years|Mean|63.5|63.5|Standard Deviation|14.7|14.7|||
3902699|NCT01483183|3726940|B6|||Age||years|Mean|75.0|75.0|Standard Deviation|10.1|10.1|||
3902700|NCT01483183|3726941|B5|||Age||years|Mean|65.0|65.0|Standard Deviation|5.7|5.7|||
3902701|NCT01483183|3726942|B4|||Age||years|Mean|61.0|61.0|Standard Deviation|14.1|14.1|||
3902702|NCT01483183|3726943|B3|||Age||years|Mean|68.4|68.4|Standard Deviation|9.1|9.1|||
3902703|NCT01483183|3726944|B2|||Age||years|Mean|75.0|75.0|Standard Deviation|0.0|0.0|||
3902704|NCT01483183|3726945|B1|||Age||years|Mean|65.3|65.3|Standard Deviation|19.0|19.0|||
3902705|NCT01483118|3727022|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
3902706|NCT01483118|3727023|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
3902707|NCT01483118|3727024|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
3902708|NCT01483118|3727022|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3902709|NCT01483118|3727023|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3902710|NCT01483118|3727024|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3902711|NCT01483118|3727022|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3902712|NCT01483118|3727023|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3902713|NCT01483118|3727024|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3902714|NCT01483118|3727022|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3902715|NCT01483118|3727023|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3902716|NCT01483118|3727024|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3902717|NCT01483118|3727022|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3902718|NCT01483118|3727023|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3902719|NCT01483118|3727024|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3902720|NCT01483118|3727022|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3902721|NCT01483118|3727023|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3902722|NCT01483118|3727024|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3902723|NCT01483118|3727022|B3|||Age||years|Mean|27.5|27.5|Full Range|||18.0|38.0|
3902724|NCT01483118|3727023|B2|||Age||years|Mean|27.86|27.86|Full Range|||18.0|38.0|
3902725|NCT01483118|3727024|B1|||Age||years|Mean|26.95|26.95|Full Range|||18.0|34.0|
3902726|NCT01482962|3727035|B3|||Body Surface Area (BSA)||m^2|Mean|1.877|1.877|Standard Deviation|0.2517|0.2517|||
3902727|NCT01482962|3727036|B2|||Body Surface Area (BSA)||m^2|Mean|1.855|1.855|Standard Deviation|0.2562|0.2562|||
3902728|NCT01482962|3727037|B1|||Body Surface Area (BSA)||m^2|Mean|1.897|1.897|Standard Deviation|0.2465|0.2465|||
3902729|NCT01482962|3727035|B3|||Weight||kg|Mean|75.76|75.76|Standard Deviation|18.437|18.437|||
3902730|NCT01482962|3727036|B2|||Weight||kg|Mean|74.63|74.63|Standard Deviation|19.601|19.601|||
3902731|NCT01482962|3727037|B1|||Weight||kg|Mean|76.85|76.85|Standard Deviation|17.242|17.242|||
3902732|NCT01482962|3727035|B3|||Height||cm|Mean|169.3|169.3|Standard Deviation|9.45|9.45|||
3902733|NCT01482962|3727036|B2|||Height||cm|Mean|168.2|168.2|Standard Deviation|8.99|8.99|||
3902734|NCT01482962|3727037|B1|||Height||cm|Mean|170.3|170.3|Standard Deviation|9.80|9.8|||
3902735|NCT01482962|3727035|B3|United States||Region of Enrollment||participants|Number|68|68.0||||||
3902736|NCT01482962|3727036|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
3902737|NCT01482962|3727037|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3902738|NCT01482962|3727035|B3|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
3902739|NCT01482962|3727036|B2|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3902740|NCT01482962|3727037|B1|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3902741|NCT01482962|3727035|B3|Turkey||Region of Enrollment||participants|Number|21|21.0||||||
3902742|NCT01482962|3727036|B2|Turkey||Region of Enrollment||participants|Number|11|11.0||||||
3902743|NCT01482962|3727037|B1|Turkey||Region of Enrollment||participants|Number|10|10.0||||||
3902744|NCT01482962|3727035|B3|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
3902745|NCT01482962|3727036|B2|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
3902746|NCT01482962|3727037|B1|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
3902747|NCT01482962|3727035|B3|Spain||Region of Enrollment||participants|Number|25|25.0||||||
3902748|NCT01482962|3727036|B2|Spain||Region of Enrollment||participants|Number|11|11.0||||||
3902749|NCT01482962|3727037|B1|Spain||Region of Enrollment||participants|Number|14|14.0||||||
3902750|NCT01482962|3727035|B3|Russia||Region of Enrollment||participants|Number|8|8.0||||||
3902751|NCT01482962|3727036|B2|Russia||Region of Enrollment||participants|Number|4|4.0||||||
3902752|NCT01482962|3727037|B1|Russia||Region of Enrollment||participants|Number|4|4.0||||||
3902753|NCT01482962|3727035|B3|Romania||Region of Enrollment||participants|Number|3|3.0||||||
3902754|NCT01482962|3727036|B2|Romania||Region of Enrollment||participants|Number|1|1.0||||||
3902755|NCT01482962|3727037|B1|Romania||Region of Enrollment||participants|Number|2|2.0||||||
3902756|NCT01482962|3727035|B3|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
3902757|NCT01482962|3727036|B2|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
3902758|NCT01482962|3727037|B1|Puerto Rico||Region of Enrollment||participants|Number|0|0.0||||||
3902759|NCT01482962|3727035|B3|Portugal||Region of Enrollment||participants|Number|2|2.0||||||
3902760|NCT01482962|3727036|B2|Portugal||Region of Enrollment||participants|Number|1|1.0||||||
3902761|NCT01482962|3727037|B1|Portugal||Region of Enrollment||participants|Number|1|1.0||||||
3902762|NCT01482962|3727035|B3|Poland||Region of Enrollment||participants|Number|10|10.0||||||
3902763|NCT01482962|3727036|B2|Poland||Region of Enrollment||participants|Number|3|3.0||||||
3902764|NCT01482962|3727037|B1|Poland||Region of Enrollment||participants|Number|7|7.0||||||
3902765|NCT01482962|3727035|B3|Peru||Region of Enrollment||participants|Number|4|4.0||||||
3902766|NCT01482962|3727036|B2|Peru||Region of Enrollment||participants|Number|3|3.0||||||
3902767|NCT01482962|3727037|B1|Peru||Region of Enrollment||participants|Number|1|1.0||||||
3902768|NCT01482962|3727035|B3|New Zealand||Region of Enrollment||participants|Number|5|5.0||||||
3902769|NCT01482962|3727036|B2|New Zealand||Region of Enrollment||participants|Number|2|2.0||||||
3902770|NCT01482962|3727037|B1|New Zealand||Region of Enrollment||participants|Number|3|3.0||||||
3902771|NCT01482962|3727035|B3|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
3902772|NCT01482962|3727036|B2|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
3902773|NCT01482962|3727037|B1|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
3902774|NCT01482962|3727035|B3|Mexico||Region of Enrollment||participants|Number|4|4.0||||||
3902775|NCT01482962|3727036|B2|Mexico||Region of Enrollment||participants|Number|1|1.0||||||
3902776|NCT01482962|3727037|B1|Mexico||Region of Enrollment||participants|Number|3|3.0||||||
3902777|NCT01482962|3727035|B3|Italy||Region of Enrollment||participants|Number|12|12.0||||||
3902778|NCT01482962|3727036|B2|Italy||Region of Enrollment||participants|Number|6|6.0||||||
3902779|NCT01482962|3727037|B1|Italy||Region of Enrollment||participants|Number|6|6.0||||||
3902780|NCT01482962|3727035|B3|Israel||Region of Enrollment||participants|Number|3|3.0||||||
3902781|NCT01482962|3727036|B2|Israel||Region of Enrollment||participants|Number|3|3.0||||||
3902782|NCT01482962|3727037|B1|Israel||Region of Enrollment||participants|Number|0|0.0||||||
3902783|NCT01482962|3727035|B3|Hungary||Region of Enrollment||participants|Number|16|16.0||||||
3902784|NCT01482962|3727036|B2|Hungary||Region of Enrollment||participants|Number|7|7.0||||||
3902785|NCT01482962|3727037|B1|Hungary||Region of Enrollment||participants|Number|9|9.0||||||
3902786|NCT01482962|3727035|B3|Germany||Region of Enrollment||participants|Number|7|7.0||||||
3902787|NCT01482962|3727036|B2|Germany||Region of Enrollment||participants|Number|1|1.0||||||
3902788|NCT01482962|3727037|B1|Germany||Region of Enrollment||participants|Number|6|6.0||||||
3902789|NCT01482962|3727035|B3|France||Region of Enrollment||participants|Number|8|8.0||||||
3902790|NCT01482962|3727036|B2|France||Region of Enrollment||participants|Number|3|3.0||||||
3902791|NCT01482962|3727037|B1|France||Region of Enrollment||participants|Number|5|5.0||||||
3902792|NCT01482962|3727035|B3|Denmark||Region of Enrollment||participants|Number|5|5.0||||||
3902793|NCT01482962|3727036|B2|Denmark||Region of Enrollment||participants|Number|2|2.0||||||
3902794|NCT01482962|3727037|B1|Denmark||Region of Enrollment||participants|Number|3|3.0||||||
3902795|NCT01482962|3727035|B3|Czech Republic||Region of Enrollment||participants|Number|7|7.0||||||
3902796|NCT01482962|3727036|B2|Czech Republic||Region of Enrollment||participants|Number|2|2.0||||||
3902797|NCT01482962|3727037|B1|Czech Republic||Region of Enrollment||participants|Number|5|5.0||||||
3902798|NCT01482962|3727035|B3|Canada||Region of Enrollment||participants|Number|3|3.0||||||
3902799|NCT01482962|3727036|B2|Canada||Region of Enrollment||participants|Number|0|0.0||||||
3902800|NCT01482962|3727037|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
3902801|NCT01482962|3727035|B3|Bulgaria||Region of Enrollment||participants|Number|1|1.0||||||
3902802|NCT01482962|3727036|B2|Bulgaria||Region of Enrollment||participants|Number|1|1.0||||||
3902803|NCT01482962|3727037|B1|Bulgaria||Region of Enrollment||participants|Number|0|0.0||||||
3902804|NCT01482962|3727035|B3|Brazil||Region of Enrollment||participants|Number|22|22.0||||||
3902805|NCT01482962|3727036|B2|Brazil||Region of Enrollment||participants|Number|10|10.0||||||
3902806|NCT01482962|3727037|B1|Brazil||Region of Enrollment||participants|Number|12|12.0||||||
3902807|NCT01482962|3727035|B3|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
3902808|NCT01482962|3727036|B2|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
3902809|NCT01482962|3727037|B1|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
3902810|NCT01482962|3727035|B3|Austria||Region of Enrollment||participants|Number|4|4.0||||||
3902811|NCT01482962|3727036|B2|Austria||Region of Enrollment||participants|Number|2|2.0||||||
3902812|NCT01482962|3727037|B1|Austria||Region of Enrollment||participants|Number|2|2.0||||||
3902813|NCT01482962|3727035|B3|Australia||Region of Enrollment||participants|Number|9|9.0||||||
3902814|NCT01482962|3727036|B2|Australia||Region of Enrollment||participants|Number|4|4.0||||||
3902815|NCT01482962|3727037|B1|Australia||Region of Enrollment||participants|Number|5|5.0||||||
3902816|NCT01482962|3727035|B3|Not Reported||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3902817|NCT01482962|3727036|B2|Not Reported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3902818|NCT01482962|3727037|B1|Not Reported||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3902819|NCT01482962|3727035|B3|Other||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3902820|NCT01482962|3727036|B2|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3902821|NCT01482962|3727037|B1|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3902822|NCT01482962|3727035|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3902823|NCT01482962|3727036|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3902824|NCT01482962|3727037|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3902825|NCT01482962|3727035|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3902826|NCT01482962|3727036|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3902827|NCT01482962|3727037|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3902828|NCT01482962|3727035|B3|White||Race/Ethnicity, Customized||participants|Number|229|229.0||||||
3902829|NCT01482962|3727036|B2|White||Race/Ethnicity, Customized||participants|Number|114|114.0||||||
3902830|NCT01482962|3727037|B1|White||Race/Ethnicity, Customized||participants|Number|115|115.0||||||
3902831|NCT01482962|3727035|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3902832|NCT01482962|3727036|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3902833|NCT01482962|3727037|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3902834|NCT01482962|3727035|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|212|212.0||||||
3902835|NCT01482962|3727036|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
3902836|NCT01482962|3727037|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
3902837|NCT01482962|3727035|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3902838|NCT01482962|3727036|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3902839|NCT01482962|3727037|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3902840|NCT01482962|3727035|B3||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
3902841|NCT01482962|3727036|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3902842|NCT01482962|3727037|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3902843|NCT01482962|3727035|B3||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3902844|NCT01482962|3727036|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3902845|NCT01482962|3727037|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3902846|NCT01482962|3727035|B3|||Age||years|Mean|61.3|61.3|Standard Deviation|12.90|12.9|||
3902847|NCT01482962|3727036|B2|||Age||years|Mean|61.4|61.4|Standard Deviation|13.16|13.16|||
3902848|NCT01482962|3727037|B1|||Age||years|Mean|61.1|61.1|Standard Deviation|12.69|12.69|||
3902849|NCT01482910|3727069|B3||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
3902850|NCT01482910|3727070|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3902851|NCT01482910|3727071|B1||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3902852|NCT01482910|3727069|B3||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3902853|NCT01482910|3727070|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3902854|NCT01482910|3727071|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3902855|NCT01482910|3727069|B3|||Age||Years|Mean|65.1|65.1|Standard Deviation|8.7|8.7|||
3902856|NCT01482910|3727070|B2|||Age||Years|Mean|64.9|64.9|Standard Deviation|8.5|8.5|||
3902857|NCT01482910|3727071|B1|||Age||Years|Mean|65.1|65.1|Standard Deviation|8.8|8.8|||
3902858|NCT01482884|3727082|B3|Unknown||Glucocorticosteroid-refractory status|Yes: if participants had received a glucocorticosteroid treatment prior to baseline and the outcome of that treatment was no improvement. No: If the outcome of the treatment was improvement or missing. Unknown: If the outcome of the treatment was unknown.|Participants|Number|1|1.0||||||
3902859|NCT01482884|3727083|B2|Unknown||Glucocorticosteroid-refractory status|Yes: if participants had received a glucocorticosteroid treatment prior to baseline and the outcome of that treatment was no improvement. No: If the outcome of the treatment was improvement or missing. Unknown: If the outcome of the treatment was unknown.|Participants|Number|1|1.0||||||
3902860|NCT01482884|3727084|B1|Unknown||Glucocorticosteroid-refractory status|Yes: if participants had received a glucocorticosteroid treatment prior to baseline and the outcome of that treatment was no improvement. No: If the outcome of the treatment was improvement or missing. Unknown: If the outcome of the treatment was unknown.|Participants|Number|0|0.0||||||
3902861|NCT01482884|3727082|B3|No||Glucocorticosteroid-refractory status|Yes: if participants had received a glucocorticosteroid treatment prior to baseline and the outcome of that treatment was no improvement. No: If the outcome of the treatment was improvement or missing. Unknown: If the outcome of the treatment was unknown.|Participants|Number|99|99.0||||||
3902862|NCT01482884|3727083|B2|No||Glucocorticosteroid-refractory status|Yes: if participants had received a glucocorticosteroid treatment prior to baseline and the outcome of that treatment was no improvement. No: If the outcome of the treatment was improvement or missing. Unknown: If the outcome of the treatment was unknown.|Participants|Number|46|46.0||||||
3902863|NCT01482884|3727084|B1|No||Glucocorticosteroid-refractory status|Yes: if participants had received a glucocorticosteroid treatment prior to baseline and the outcome of that treatment was no improvement. No: If the outcome of the treatment was improvement or missing. Unknown: If the outcome of the treatment was unknown.|Participants|Number|53|53.0||||||
3902864|NCT01482884|3727082|B3|Yes||Glucocorticosteroid-refractory status|Yes: if participants had received a glucocorticosteroid treatment prior to baseline and the outcome of that treatment was no improvement. No: If the outcome of the treatment was improvement or missing. Unknown: If the outcome of the treatment was unknown.|Participants|Number|11|11.0||||||
3902865|NCT01482884|3727083|B2|Yes||Glucocorticosteroid-refractory status|Yes: if participants had received a glucocorticosteroid treatment prior to baseline and the outcome of that treatment was no improvement. No: If the outcome of the treatment was improvement or missing. Unknown: If the outcome of the treatment was unknown.|Participants|Number|8|8.0||||||
3902866|NCT01482884|3727084|B1|Yes||Glucocorticosteroid-refractory status|Yes: if participants had received a glucocorticosteroid treatment prior to baseline and the outcome of that treatment was no improvement. No: If the outcome of the treatment was improvement or missing. Unknown: If the outcome of the treatment was unknown.|Participants|Number|3|3.0||||||
3902867|NCT01482884|3727082|B3|||Partial Mayo score at baseline|The partial Mayo score is the sum of the three sub-score areas: stool frequency, rectal bleeding, and the physician’s global assessment.The partial Mayo score ranges from 0-9, with higher scores indicating a more severe disease.|Scores on scale|Mean|5.88|5.88|Full Range|||3.0|8.0|
3902868|NCT01482884|3727083|B2|||Partial Mayo score at baseline|The partial Mayo score is the sum of the three sub-score areas: stool frequency, rectal bleeding, and the physician’s global assessment.The partial Mayo score ranges from 0-9, with higher scores indicating a more severe disease.|Scores on scale|Mean|5.85|5.85|Full Range|||3.0|8.0|
3902869|NCT01482884|3727084|B1|||Partial Mayo score at baseline|The partial Mayo score is the sum of the three sub-score areas: stool frequency, rectal bleeding, and the physician’s global assessment.The partial Mayo score ranges from 0-9, with higher scores indicating a more severe disease.|Scores on scale|Mean|5.91|5.91|Full Range|||3.0|8.0|
3902870|NCT01482884|3727082|B3|||Mayo score at baseline|Mayo score is the sum of four sub-scores: stool frequency, rectal bleeding, endoscopy findings and the physician’s global assessment. The total Mayo score ranges from 0-12, with higher scores indicating a more severe disease.|Scores on scale|Mean|8.34|8.34|Full Range|||5.0|11.0|
3902871|NCT01482884|3727083|B2|||Mayo score at baseline|Mayo score is the sum of four sub-scores: stool frequency, rectal bleeding, endoscopy findings and the physician’s global assessment. The total Mayo score ranges from 0-12, with higher scores indicating a more severe disease.|Scores on scale|Mean|8.33|8.33|Full Range|||6.0|11.0|
3902872|NCT01482884|3727084|B1|||Mayo score at baseline|Mayo score is the sum of four sub-scores: stool frequency, rectal bleeding, endoscopy findings and the physician’s global assessment. The total Mayo score ranges from 0-12, with higher scores indicating a more severe disease.|Scores on scale|Mean|8.36|8.36|Full Range|||5.0|11.0|
3902873|NCT01482884|3727082|B3|||Duration of disease||Years|Mean|8.51|8.51|Standard Deviation|8.585|8.585|||
3902874|NCT01482884|3727083|B2|||Duration of disease||Years|Mean|7.78|7.78|Standard Deviation|8.664|8.664|||
3902875|NCT01482884|3727084|B1|||Duration of disease||Years|Mean|9.22|9.22|Standard Deviation|8.523|8.523|||
3902876|NCT01482884|3727082|B3|Other||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
3902877|NCT01482884|3727083|B2|Other||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
3902878|NCT01482884|3727084|B1|Other||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
3902879|NCT01482884|3727082|B3|Not Applicable||Race/Ethnicity, Customized||Participants|Number|75|75.0||||||
3902880|NCT01482884|3727083|B2|Not Applicable||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
3902881|NCT01482884|3727084|B1|Not Applicable||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
3902882|NCT01482884|3727082|B3|Asian (Other than Chinese And Japanese)||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3902883|NCT01482884|3727083|B2|Asian (Other than Chinese And Japanese)||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3902884|NCT01482884|3727084|B1|Asian (Other than Chinese And Japanese)||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3902885|NCT01482884|3727082|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3902886|NCT01482884|3727083|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3902887|NCT01482884|3727084|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3902888|NCT01482884|3727082|B3|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3902889|NCT01482884|3727083|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3902890|NCT01482884|3727084|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3902891|NCT01482884|3727082|B3|White||Race/Ethnicity, Customized||Participants|Number|108|108.0||||||
3902892|NCT01482884|3727083|B2|White||Race/Ethnicity, Customized||Participants|Number|54|54.0||||||
3902893|NCT01482884|3727084|B1|White||Race/Ethnicity, Customized||Participants|Number|54|54.0||||||
3902894|NCT01482884|3727082|B3|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3902895|NCT01482884|3727083|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3902896|NCT01482884|3727084|B1|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3902897|NCT01482884|3727082|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3902898|NCT01482884|3727083|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3902899|NCT01482884|3727084|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3902900|NCT01482884|3727082|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3902901|NCT01482884|3727083|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3902902|NCT01482884|3727084|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3902903|NCT01482884|3727082|B3|||Age||Years|Mean|41.5|41.5|Standard Deviation|12.39|12.39|||
3902904|NCT01482884|3727083|B2|||Age||Years|Mean|40.8|40.8|Standard Deviation|13.26|13.26|||
3902905|NCT01482884|3727084|B1|||Age||Years|Mean|42.2|42.2|Standard Deviation|11.54|11.54|||
3902906|NCT01482819|3727111|B1|Australia||Region of Enrollment||participants|Number|21|21.0||||||
3902907|NCT01482819|3727111|B1|Multiple||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3902908|NCT01482819|3727111|B1|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3902909|NCT01482819|3727111|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3902910|NCT01482819|3727111|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3902911|NCT01482819|3727111|B1|||Age||years|Mean|23.7|23.7|Standard Deviation|6.11|6.11|||
3902912|NCT01482767|3727129|B3|Unknown||HIV-1 RNA Quantitation at Entry|Unquantifiable HIV-1 RNA was defined as below the lower limit of the assay (LLOQ). Abbott RealTime HIV-1 assay (LLOQ=40 copies/ml) or Roche COBAS Ampliprep/Taqman HIV-1 assay (LLOQ=20 copies/ml) was used.|participants|Number|2|2.0||||||
3902913|NCT01482767|3727130|B2|Unknown||HIV-1 RNA Quantitation at Entry|Unquantifiable HIV-1 RNA was defined as below the lower limit of the assay (LLOQ). Abbott RealTime HIV-1 assay (LLOQ=40 copies/ml) or Roche COBAS Ampliprep/Taqman HIV-1 assay (LLOQ=20 copies/ml) was used.|participants|Number|0|0.0||||||
3902914|NCT01482767|3727131|B1|Unknown||HIV-1 RNA Quantitation at Entry|Unquantifiable HIV-1 RNA was defined as below the lower limit of the assay (LLOQ). Abbott RealTime HIV-1 assay (LLOQ=40 copies/ml) or Roche COBAS Ampliprep/Taqman HIV-1 assay (LLOQ=20 copies/ml) was used.|participants|Number|2|2.0||||||
3902915|NCT01482767|3727129|B3|Quantifiable||HIV-1 RNA Quantitation at Entry|Unquantifiable HIV-1 RNA was defined as below the lower limit of the assay (LLOQ). Abbott RealTime HIV-1 assay (LLOQ=40 copies/ml) or Roche COBAS Ampliprep/Taqman HIV-1 assay (LLOQ=20 copies/ml) was used.|participants|Number|9|9.0||||||
3902916|NCT01482767|3727130|B2|Quantifiable||HIV-1 RNA Quantitation at Entry|Unquantifiable HIV-1 RNA was defined as below the lower limit of the assay (LLOQ). Abbott RealTime HIV-1 assay (LLOQ=40 copies/ml) or Roche COBAS Ampliprep/Taqman HIV-1 assay (LLOQ=20 copies/ml) was used.|participants|Number|9|9.0||||||
3902917|NCT01482767|3727131|B1|Quantifiable||HIV-1 RNA Quantitation at Entry|Unquantifiable HIV-1 RNA was defined as below the lower limit of the assay (LLOQ). Abbott RealTime HIV-1 assay (LLOQ=40 copies/ml) or Roche COBAS Ampliprep/Taqman HIV-1 assay (LLOQ=20 copies/ml) was used.|participants|Number|0|0.0||||||
3902918|NCT01482767|3727129|B3|Unquantifiable||HIV-1 RNA Quantitation at Entry|Unquantifiable HIV-1 RNA was defined as below the lower limit of the assay (LLOQ). Abbott RealTime HIV-1 assay (LLOQ=40 copies/ml) or Roche COBAS Ampliprep/Taqman HIV-1 assay (LLOQ=20 copies/ml) was used.|participants|Number|246|246.0||||||
3902919|NCT01482767|3727130|B2|Unquantifiable||HIV-1 RNA Quantitation at Entry|Unquantifiable HIV-1 RNA was defined as below the lower limit of the assay (LLOQ). Abbott RealTime HIV-1 assay (LLOQ=40 copies/ml) or Roche COBAS Ampliprep/Taqman HIV-1 assay (LLOQ=20 copies/ml) was used.|participants|Number|113|113.0||||||
3902920|NCT01482767|3727131|B1|Unquantifiable||HIV-1 RNA Quantitation at Entry|Unquantifiable HIV-1 RNA was defined as below the lower limit of the assay (LLOQ). Abbott RealTime HIV-1 assay (LLOQ=40 copies/ml) or Roche COBAS Ampliprep/Taqman HIV-1 assay (LLOQ=20 copies/ml) was used.|participants|Number|133|133.0||||||
3902921|NCT01482767|3727129|B3|||CD4 Cell Count at Entry|Among n=133 Group A and n=120 Group B participants who had results available.|cells/mm^3|Median|625|625.0|Inter-Quartile Range|||473.0|835.0|
3902922|NCT01482767|3727130|B2|||CD4 Cell Count at Entry|Among n=133 Group A and n=120 Group B participants who had results available.|cells/mm^3|Median|622|622.0|Inter-Quartile Range|||489.0|859.0|
3902923|NCT01482767|3727131|B1|||CD4 Cell Count at Entry|Among n=133 Group A and n=120 Group B participants who had results available.|cells/mm^3|Median|646|646.0|Inter-Quartile Range|||462.0|818.0|
3902924|NCT01482767|3727129|B3|Not on ART||ART Regimen at Entry||participants|Number|8|8.0||||||
3902925|NCT01482767|3727130|B2|Not on ART||ART Regimen at Entry||participants|Number|6|6.0||||||
3902926|NCT01482767|3727131|B1|Not on ART||ART Regimen at Entry||participants|Number|2|2.0||||||
3902927|NCT01482767|3727129|B3|DRV/RTV + 2 NRTIs||ART Regimen at Entry||participants|Number|12|12.0||||||
3902928|NCT01482767|3727130|B2|DRV/RTV + 2 NRTIs||ART Regimen at Entry||participants|Number|6|6.0||||||
3902929|NCT01482767|3727131|B1|DRV/RTV + 2 NRTIs||ART Regimen at Entry||participants|Number|6|6.0||||||
3902930|NCT01482767|3727129|B3|ATV/RTV + 2 NRTIs||ART Regimen at Entry||participants|Number|28|28.0||||||
3902931|NCT01482767|3727130|B2|ATV/RTV + 2 NRTIs||ART Regimen at Entry||participants|Number|10|10.0||||||
3902932|NCT01482767|3727131|B1|ATV/RTV + 2 NRTIs||ART Regimen at Entry||participants|Number|18|18.0||||||
3902933|NCT01482767|3727129|B3|LPV/RTV + 2 NRTIs||ART Regimen at Entry||participants|Number|8|8.0||||||
3902934|NCT01482767|3727130|B2|LPV/RTV + 2 NRTIs||ART Regimen at Entry||participants|Number|4|4.0||||||
3902935|NCT01482767|3727131|B1|LPV/RTV + 2 NRTIs||ART Regimen at Entry||participants|Number|4|4.0||||||
3902936|NCT01482767|3727129|B3|RAL + 2 NRTIs||ART Regimen at Entry||participants|Number|92|92.0||||||
3902937|NCT01482767|3727130|B2|RAL + 2 NRTIs||ART Regimen at Entry||participants|Number|45|45.0||||||
3902938|NCT01482767|3727131|B1|RAL + 2 NRTIs||ART Regimen at Entry||participants|Number|47|47.0||||||
3902939|NCT01482767|3727129|B3|EFV + 2 NRTIs||ART Regimen at Entry||participants|Number|109|109.0||||||
3902940|NCT01482767|3727130|B2|EFV + 2 NRTIs||ART Regimen at Entry||participants|Number|51|51.0||||||
3902941|NCT01482767|3727131|B1|EFV + 2 NRTIs||ART Regimen at Entry||participants|Number|58|58.0||||||
3902942|NCT01482767|3727129|B3|||HCV RNA at Entry|Group A: Among n=134 participants with samples collected.|log10 IU/mL|Median|6.8|6.8|Inter-Quartile Range|||6.4|7.2|
3902943|NCT01482767|3727130|B2|||HCV RNA at Entry|Group A: Among n=134 participants with samples collected.|log10 IU/mL|Median|6.9|6.9|Inter-Quartile Range|||6.5|7.3|
3902944|NCT01482767|3727131|B1|||HCV RNA at Entry|Group A: Among n=134 participants with samples collected.|log10 IU/mL|Median|6.7|6.7|Inter-Quartile Range|||6.2|7.1|
3902945|NCT01482767|3727129|B3|Non-cirrhotic||Cirrhosis Status at Screening|Liver cirrhosis was defined as cirrhosis identified by screening liver biopsy or screening FibroSure score greater than 0.74.|participants|Number|201|201.0||||||
3902946|NCT01482767|3727130|B2|Non-cirrhotic||Cirrhosis Status at Screening|Liver cirrhosis was defined as cirrhosis identified by screening liver biopsy or screening FibroSure score greater than 0.74.|participants|Number|84|84.0||||||
3902947|NCT01482767|3727131|B1|Non-cirrhotic||Cirrhosis Status at Screening|Liver cirrhosis was defined as cirrhosis identified by screening liver biopsy or screening FibroSure score greater than 0.74.|participants|Number|117|117.0||||||
3902948|NCT01482767|3727129|B3|Cirrhotic||Cirrhosis Status at Screening|Liver cirrhosis was defined as cirrhosis identified by screening liver biopsy or screening FibroSure score greater than 0.74.|participants|Number|56|56.0||||||
3902949|NCT01482767|3727130|B2|Cirrhotic||Cirrhosis Status at Screening|Liver cirrhosis was defined as cirrhosis identified by screening liver biopsy or screening FibroSure score greater than 0.74.|participants|Number|38|38.0||||||
3902950|NCT01482767|3727131|B1|Cirrhotic||Cirrhosis Status at Screening|Liver cirrhosis was defined as cirrhosis identified by screening liver biopsy or screening FibroSure score greater than 0.74.|participants|Number|18|18.0||||||
3902951|NCT01482767|3727129|B3|Previously||Intravenous Drug Use History||participants|Number|116|116.0||||||
3902952|NCT01482767|3727130|B2|Previously||Intravenous Drug Use History||participants|Number|52|52.0||||||
3902953|NCT01482767|3727131|B1|Previously||Intravenous Drug Use History||participants|Number|64|64.0||||||
3902954|NCT01482767|3727129|B3|Never||Intravenous Drug Use History||participants|Number|141|141.0||||||
3902955|NCT01482767|3727130|B2|Never||Intravenous Drug Use History||participants|Number|70|70.0||||||
3902956|NCT01482767|3727131|B1|Never||Intravenous Drug Use History||participants|Number|71|71.0||||||
3902957|NCT01482767|3727129|B3|United States||Region of Enrollment||participants|Number|257|257.0||||||
3902958|NCT01482767|3727130|B2|United States||Region of Enrollment||participants|Number|122|122.0||||||
3902959|NCT01482767|3727131|B1|United States||Region of Enrollment||participants|Number|135|135.0||||||
3902960|NCT01482767|3727129|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3902961|NCT01482767|3727130|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3902962|NCT01482767|3727131|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3902963|NCT01482767|3727129|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3902964|NCT01482767|3727130|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3902965|NCT01482767|3727131|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3902966|NCT01482767|3727129|B3||White|Race (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
3902967|NCT01482767|3727130|B2||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3902968|NCT01482767|3727131|B1||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3902969|NCT01482767|3727129|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
3902970|NCT01482767|3727130|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3902971|NCT01482767|3727131|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3902972|NCT01482767|3727129|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902973|NCT01482767|3727130|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902974|NCT01482767|3727131|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902975|NCT01482767|3727129|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3902976|NCT01482767|3727130|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3902977|NCT01482767|3727131|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3902978|NCT01482767|3727129|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3902979|NCT01482767|3727130|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3902980|NCT01482767|3727131|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3902981|NCT01482767|3727129|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3902982|NCT01482767|3727130|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3902983|NCT01482767|3727131|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3902984|NCT01482767|3727129|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|210|210.0||||||
3902985|NCT01482767|3727130|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
3902986|NCT01482767|3727131|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|117|117.0||||||
3902987|NCT01482767|3727129|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3902988|NCT01482767|3727130|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3902989|NCT01482767|3727131|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3902990|NCT01482767|3727129|B3||Male|Sex: Female, Male|Sex at birth.|Participants|Count of Participants|203|203.0||||||
3902991|NCT01482767|3727130|B2||Male|Sex: Female, Male|Sex at birth.|Participants|Count of Participants|93|93.0||||||
3902992|NCT01482767|3727131|B1||Male|Sex: Female, Male|Sex at birth.|Participants|Count of Participants|110|110.0||||||
3902993|NCT01482767|3727129|B3||Female|Sex: Female, Male|Sex at birth.|Participants|Count of Participants|54|54.0||||||
3902994|NCT01482767|3727130|B2||Female|Sex: Female, Male|Sex at birth.|Participants|Count of Participants|29|29.0||||||
3902995|NCT01482767|3727131|B1||Female|Sex: Female, Male|Sex at birth.|Participants|Count of Participants|25|25.0||||||
3902996|NCT01482767|3727129|B3|||Age||years|Median|52|52.0|Inter-Quartile Range|||47.0|57.0|
3902997|NCT01482767|3727130|B2|||Age||years|Median|53|53.0|Inter-Quartile Range|||49.0|57.0|
3902998|NCT01482767|3727131|B1|||Age||years|Median|51|51.0|Inter-Quartile Range|||44.0|57.0|
3902999|NCT01482429|3727152|B3|Brazil||Region of Enrollment||participants|Number|235|235.0||||||
3903000|NCT01482429|3727153|B2|Brazil||Region of Enrollment||participants|Number|96|96.0||||||
3903001|NCT01482429|3727154|B1|Brazil||Region of Enrollment||participants|Number|139|139.0||||||
3903002|NCT01482429|3727152|B3||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3903003|NCT01482429|3727153|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3903004|NCT01482429|3727154|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3903005|NCT01482429|3727152|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3903006|NCT01482429|3727153|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3903007|NCT01482429|3727154|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3903008|NCT01482429|3727152|B3|||Age||years|Mean|47.28|47.28|Standard Deviation|19.50|19.5|||
3903009|NCT01482429|3727153|B2|||Age||years|Mean|43.5|43.5|Standard Deviation|17.89|17.89|||
3903010|NCT01482429|3727154|B1|||Age||years|Mean|49.9|49.9|Standard Deviation|20.18|20.18|||
3903011|NCT01482325|3727163|B1||Male|Sex: Female, Male|Gender|Participants|Count of Participants|13|13.0||||||
3903012|NCT01482325|3727163|B1||Female|Sex: Female, Male|Gender|Participants|Count of Participants|18|18.0||||||
3903013|NCT01482325|3727163|B1|||Age||years|Mean|48.49|48.49|Standard Deviation|32.74|32.74|||
3903014|NCT01482312|3727167|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3903015|NCT01482312|3727167|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3903016|NCT01482312|3727167|B1|||Age||years|Mean|44.3|44.3|Standard Deviation|12.7|12.7|||
3903017|NCT01482221|3727180|B4|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3903018|NCT01482221|3727181|B3|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3903019|NCT01482221|3727182|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3903020|NCT01482221|3727183|B1|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3903021|NCT01482221|3727180|B4|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3903022|NCT01482221|3727181|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3903023|NCT01482221|3727182|B2|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3903024|NCT01482221|3727183|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3903025|NCT01482221|3727180|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
3903026|NCT01482221|3727181|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3903027|NCT01482221|3727182|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3903028|NCT01482221|3727183|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3903029|NCT01482221|3727180|B4|White||Race/Ethnicity, Customized||Participants|Number|269|269.0||||||
3903030|NCT01482221|3727181|B3|White||Race/Ethnicity, Customized||Participants|Number|91|91.0||||||
3903031|NCT01482221|3727182|B2|White||Race/Ethnicity, Customized||Participants|Number|87|87.0||||||
3903032|NCT01482221|3727183|B1|White||Race/Ethnicity, Customized||Participants|Number|91|91.0||||||
3903033|NCT01482221|3727180|B4||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3903034|NCT01482221|3727181|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3903035|NCT01482221|3727182|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3903036|NCT01482221|3727183|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3903037|NCT01482221|3727180|B4||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
3903038|NCT01482221|3727181|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3903039|NCT01482221|3727182|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3903040|NCT01482221|3727183|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3903041|NCT01482221|3727180|B4|||Age||Years|Mean|48.2|48.2|Standard Deviation|11.40|11.4|||
3903042|NCT01482221|3727181|B3|||Age||Years|Mean|49.5|49.5|Standard Deviation|11.12|11.12|||
3903043|NCT01482221|3727182|B2|||Age||Years|Mean|47.5|47.5|Standard Deviation|11.89|11.89|||
3903044|NCT01482221|3727183|B1|||Age||Years|Mean|47.7|47.7|Standard Deviation|11.19|11.19|||
3903045|NCT01482169|3727226|B1|United States||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
3903046|NCT01482169|3727226|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3903047|NCT01482169|3727226|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3903048|NCT01482169|3727226|B1|||Age||years|Median|61.5|61.5|Standard Deviation|0|0.0|||
3903049|NCT01482169|3727226|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3903050|NCT01482169|3727226|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3903051|NCT01482169|3727226|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3903052|NCT01482091|3727233|B3|||Oral analgesic within 2h prior to study drug||participants|Number|5|5.0||||||
3903053|NCT01482091|3727234|B2|||Oral analgesic within 2h prior to study drug||participants|Number|3|3.0||||||
3903054|NCT01482091|3727235|B1|||Oral analgesic within 2h prior to study drug||participants|Number|2|2.0||||||
3903055|NCT01482091|3727233|B3|Legs||Location of VOC||participants|Number|22|22.0||||||
3903056|NCT01482091|3727234|B2|Legs||Location of VOC||participants|Number|10|10.0||||||
3903057|NCT01482091|3727235|B1|Legs||Location of VOC||participants|Number|12|12.0||||||
3903058|NCT01482091|3727233|B3|Arms||Location of VOC||participants|Number|14|14.0||||||
3903059|NCT01482091|3727234|B2|Arms||Location of VOC||participants|Number|9|9.0||||||
3903060|NCT01482091|3727235|B1|Arms||Location of VOC||participants|Number|5|5.0||||||
3903061|NCT01482091|3727233|B3|Head||Location of VOC||participants|Number|5|5.0||||||
3903062|NCT01482091|3727234|B2|Head||Location of VOC||participants|Number|4|4.0||||||
3903063|NCT01482091|3727235|B1|Head||Location of VOC||participants|Number|1|1.0||||||
3903064|NCT01482091|3727233|B3|Chest||Location of VOC||participants|Number|11|11.0||||||
3903065|NCT01482091|3727234|B2|Chest||Location of VOC||participants|Number|7|7.0||||||
3903066|NCT01482091|3727235|B1|Chest||Location of VOC||participants|Number|4|4.0||||||
3903067|NCT01482091|3727233|B3|Back||Location of VOC||participants|Number|24|24.0||||||
3903068|NCT01482091|3727234|B2|Back||Location of VOC||participants|Number|12|12.0||||||
3903069|NCT01482091|3727235|B1|Back||Location of VOC||participants|Number|12|12.0||||||
3903070|NCT01482091|3727233|B3|Abdomen||Location of VOC||participants|Number|16|16.0||||||
3903071|NCT01482091|3727234|B2|Abdomen||Location of VOC||participants|Number|10|10.0||||||
3903072|NCT01482091|3727235|B1|Abdomen||Location of VOC||participants|Number|6|6.0||||||
3903073|NCT01482091|3727233|B3|>2 day||Duration of VOC||participants|Number|11|11.0||||||
3903074|NCT01482091|3727234|B2|>2 day||Duration of VOC||participants|Number|4|4.0||||||
3903075|NCT01482091|3727235|B1|>2 day||Duration of VOC||participants|Number|7|7.0||||||
3903076|NCT01482091|3727233|B3|1-2 day||Duration of VOC||participants|Number|10|10.0||||||
3903077|NCT01482091|3727234|B2|1-2 day||Duration of VOC||participants|Number|4|4.0||||||
3903078|NCT01482091|3727235|B1|1-2 day||Duration of VOC||participants|Number|6|6.0||||||
3903079|NCT01482091|3727233|B3|1/2-1day||Duration of VOC||participants|Number|12|12.0||||||
3903080|NCT01482091|3727234|B2|1/2-1day||Duration of VOC||participants|Number|7|7.0||||||
3903081|NCT01482091|3727235|B1|1/2-1day||Duration of VOC||participants|Number|5|5.0||||||
3903082|NCT01482091|3727233|B3|<1/2 day||Duration of VOC||participants|Number|16|16.0||||||
3903083|NCT01482091|3727234|B2|<1/2 day||Duration of VOC||participants|Number|9|9.0||||||
3903084|NCT01482091|3727235|B1|<1/2 day||Duration of VOC||participants|Number|7|7.0||||||
3903085|NCT01482091|3727233|B3|SB||Type of Sickle Cell Disease|SS, SC and SB refer to different genotypes of sickle cell disease, commonly referred to as Hemoglobin SS, Hemoglobin SC and Hemoglobin S/Beta thalassemia, respectively|participants|Number|1|1.0||||||
3903086|NCT01482091|3727234|B2|SB||Type of Sickle Cell Disease|SS, SC and SB refer to different genotypes of sickle cell disease, commonly referred to as Hemoglobin SS, Hemoglobin SC and Hemoglobin S/Beta thalassemia, respectively|participants|Number|1|1.0||||||
3903087|NCT01482091|3727235|B1|SB||Type of Sickle Cell Disease|SS, SC and SB refer to different genotypes of sickle cell disease, commonly referred to as Hemoglobin SS, Hemoglobin SC and Hemoglobin S/Beta thalassemia, respectively|participants|Number|0|0.0||||||
3903088|NCT01482091|3727233|B3|SC||Type of Sickle Cell Disease|SS, SC and SB refer to different genotypes of sickle cell disease, commonly referred to as Hemoglobin SS, Hemoglobin SC and Hemoglobin S/Beta thalassemia, respectively|participants|Number|9|9.0||||||
3903089|NCT01482091|3727234|B2|SC||Type of Sickle Cell Disease|SS, SC and SB refer to different genotypes of sickle cell disease, commonly referred to as Hemoglobin SS, Hemoglobin SC and Hemoglobin S/Beta thalassemia, respectively|participants|Number|3|3.0||||||
3903090|NCT01482091|3727235|B1|SC||Type of Sickle Cell Disease|SS, SC and SB refer to different genotypes of sickle cell disease, commonly referred to as Hemoglobin SS, Hemoglobin SC and Hemoglobin S/Beta thalassemia, respectively|participants|Number|6|6.0||||||
3903091|NCT01482091|3727233|B3|SS||Type of Sickle Cell Disease|SS, SC and SB refer to different genotypes of sickle cell disease, commonly referred to as Hemoglobin SS, Hemoglobin SC and Hemoglobin S/Beta thalassemia, respectively|participants|Number|39|39.0||||||
3903092|NCT01482091|3727234|B2|SS||Type of Sickle Cell Disease|SS, SC and SB refer to different genotypes of sickle cell disease, commonly referred to as Hemoglobin SS, Hemoglobin SC and Hemoglobin S/Beta thalassemia, respectively|participants|Number|20|20.0||||||
3903093|NCT01482091|3727235|B1|SS||Type of Sickle Cell Disease|SS, SC and SB refer to different genotypes of sickle cell disease, commonly referred to as Hemoglobin SS, Hemoglobin SC and Hemoglobin S/Beta thalassemia, respectively|participants|Number|19|19.0||||||
3903094|NCT01482091|3727233|B3|||weight||kg|Median|37|37.0|Inter-Quartile Range|||24.5|64.0|
3903095|NCT01482091|3727234|B2|||weight||kg|Median|28|28.0|Inter-Quartile Range|||24.0|52.5|
3903096|NCT01482091|3727235|B1|||weight||kg|Median|45|45.0|Inter-Quartile Range|||29.0|70.0|
3903097|NCT01482091|3727233|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3903098|NCT01482091|3727234|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3903099|NCT01482091|3727235|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3903100|NCT01482091|3727233|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3903101|NCT01482091|3727234|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3903102|NCT01482091|3727235|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3903103|NCT01482091|3727233|B3|||Age||years|Mean|11.6|11.6|Standard Deviation|5.2|5.2|||
3903104|NCT01482091|3727234|B2|||Age||years|Mean|10.6|10.6|Standard Deviation|5.3|5.3|||
3903105|NCT01482091|3727235|B1|||Age||years|Mean|12.5|12.5|Standard Deviation|5.1|5.1|||
3903106|NCT01482065|3727266|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
3903107|NCT01482065|3727267|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3903108|NCT01482065|3727268|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3903109|NCT01482065|3727266|B3||Male|Gender||Participants|Count of Participants|5|5.0||||||
3903110|NCT01482065|3727267|B2||Male|Gender||Participants|Count of Participants|3|3.0||||||
3903111|NCT01482065|3727268|B1||Male|Gender||Participants|Count of Participants|2|2.0||||||
3903112|NCT01482065|3727266|B3||Female|Gender||Participants|Count of Participants|4|4.0||||||
3903113|NCT01482065|3727267|B2||Female|Gender||Participants|Count of Participants|2|2.0||||||
3903114|NCT01482065|3727268|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
3903115|NCT01482065|3727266|B3|||Age||years|Mean|49.56|49.56|Standard Deviation|14.73|14.73|||
3903116|NCT01482065|3727267|B2|||Age||years|Mean|42.8|42.8|Standard Deviation|16.63|16.63|||
3903117|NCT01482065|3727268|B1|||Age||years|Mean|58|58.0|Standard Deviation|3.74|3.74|||
3903118|NCT01481935|3727281|B3|United States||Region of Enrollment||participants|Number|190|190.0||||||
3903119|NCT01481935|3727282|B2|United States||Region of Enrollment||participants|Number|97|97.0||||||
3903120|NCT01481935|3727283|B1|United States||Region of Enrollment||participants|Number|93|93.0||||||
3903121|NCT01481935|3727281|B3||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3903122|NCT01481935|3727282|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3903123|NCT01481935|3727283|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3903124|NCT01481935|3727281|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3903125|NCT01481935|3727282|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3903126|NCT01481935|3727283|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3903127|NCT01481935|3727281|B3|||Age||years|Mean|54|54.0|Standard Deviation|18|18.0|||
3903128|NCT01481935|3727282|B2|||Age||years|Mean|56|56.0|Standard Deviation|17|17.0|||
3903129|NCT01481935|3727283|B1|||Age||years|Mean|51|51.0|Standard Deviation|19|19.0|||
3903130|NCT01481935|3727281|B3||>=65 years|Age||Participants|Count of Participants|58|58.0||||||
3903131|NCT01481935|3727282|B2||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
3903132|NCT01481935|3727283|B1||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
3903133|NCT01481935|3727281|B3||Between 18 and 65 years|Age||Participants|Count of Participants|132|132.0||||||
3903134|NCT01481935|3727282|B2||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
3903135|NCT01481935|3727283|B1||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
3903136|NCT01481935|3727281|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3903137|NCT01481935|3727282|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3903138|NCT01481935|3727283|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3903139|NCT01481896|3727290|B1|United States||Region of Enrollment||participants|Number|131|131.0||||||
3903140|NCT01481896|3727290|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3903141|NCT01481896|3727290|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3903142|NCT01481896|3727290|B1|||Age||years|Mean|53|53.0|Standard Deviation|10|10.0|||
3903143|NCT01481896|3727290|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3903144|NCT01481896|3727290|B1||Between 18 and 65 years|Age||Participants|Count of Participants|121|121.0||||||
3903145|NCT01481896|3727290|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3903146|NCT01481779|3727304|B3|Italy||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3903147|NCT01481779|3727305|B2|Italy||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3903148|NCT01481779|3727306|B1|Italy||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3903149|NCT01481779|3727304|B3|Japan||Region of Enrollment||Participants|Count of Participants|91|91.0||||||
3903150|NCT01481779|3727305|B2|Japan||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3903151|NCT01481779|3727306|B1|Japan||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3903152|NCT01481779|3727304|B3|Germany||Region of Enrollment||Participants|Count of Participants|66|66.0||||||
3903153|NCT01481779|3727305|B2|Germany||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3903154|NCT01481779|3727306|B1|Germany||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3903155|NCT01481779|3727304|B3|Russia||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3903156|NCT01481779|3727305|B2|Russia||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3903157|NCT01481779|3727306|B1|Russia||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3903158|NCT01481779|3727304|B3|Austria||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3903159|NCT01481779|3727305|B2|Austria||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3903160|NCT01481779|3727306|B1|Austria||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3903161|NCT01481779|3727304|B3|Poland||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3903162|NCT01481779|3727305|B2|Poland||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3903163|NCT01481779|3727306|B1|Poland||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3903164|NCT01481779|3727304|B3|Mexico||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3903165|NCT01481779|3727305|B2|Mexico||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3903166|NCT01481779|3727306|B1|Mexico||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3903167|NCT01481779|3727304|B3|United States||Region of Enrollment||Participants|Count of Participants|130|130.0||||||
3903168|NCT01481779|3727305|B2|United States||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3903169|NCT01481779|3727306|B1|United States||Region of Enrollment||Participants|Count of Participants|85|85.0||||||
3903170|NCT01481779|3727304|B3|France||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3903171|NCT01481779|3727305|B2|France||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3903172|NCT01481779|3727306|B1|France||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3903173|NCT01481779|3727304|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903174|NCT01481779|3727305|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903175|NCT01481779|3727306|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903176|NCT01481779|3727304|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3903177|NCT01481779|3727305|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3903178|NCT01481779|3727306|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903179|NCT01481779|3727304|B3||White|Race (NIH/OMB)||Participants|Count of Participants|346|346.0||||||
3903180|NCT01481779|3727305|B2||White|Race (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
3903181|NCT01481779|3727306|B1||White|Race (NIH/OMB)||Participants|Count of Participants|221|221.0||||||
3903182|NCT01481779|3727304|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3903183|NCT01481779|3727305|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903184|NCT01481779|3727306|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3903185|NCT01481779|3727304|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903186|NCT01481779|3727305|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903187|NCT01481779|3727306|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903188|NCT01481779|3727304|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3903189|NCT01481779|3727305|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3903190|NCT01481779|3727306|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3903191|NCT01481779|3727304|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3903192|NCT01481779|3727305|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3903193|NCT01481779|3727306|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3903194|NCT01481779|3727304|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|168|168.0||||||
3903195|NCT01481779|3727305|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3903196|NCT01481779|3727306|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|109|109.0||||||
3903197|NCT01481779|3727304|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|238|238.0||||||
3903198|NCT01481779|3727305|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3903199|NCT01481779|3727306|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|153|153.0||||||
3903200|NCT01481779|3727304|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3903201|NCT01481779|3727305|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3903202|NCT01481779|3727306|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3903203|NCT01481779|3727304|B3||Male|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
3903204|NCT01481779|3727305|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3903205|NCT01481779|3727306|B1||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3903206|NCT01481779|3727304|B3||Female|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
3903207|NCT01481779|3727305|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3903208|NCT01481779|3727306|B1||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3903209|NCT01481779|3727304|B3|||Age||years|Mean|39.41|39.41|Standard Deviation|13.34|13.34|||
3903210|NCT01481779|3727305|B2|||Age||years|Mean|38.91|38.91|Standard Deviation|14.10|14.1|||
3903211|NCT01481779|3727306|B1|||Age||years|Mean|39.68|39.68|Standard Deviation|12.93|12.93|||
3903212|NCT01481740|3727353|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3903213|NCT01481740|3727354|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3903214|NCT01481740|3727355|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3903215|NCT01481740|3727353|B3|Canada||Region of Enrollment||participants|Number|110|110.0||||||
3903216|NCT01481740|3727354|B2|Canada||Region of Enrollment||participants|Number|56|56.0||||||
3903217|NCT01481740|3727355|B1|Canada||Region of Enrollment||participants|Number|54|54.0||||||
3903218|NCT01481740|3727353|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3903219|NCT01481740|3727354|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3903220|NCT01481740|3727355|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3903221|NCT01481740|3727353|B3||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3903222|NCT01481740|3727354|B2||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3903223|NCT01481740|3727355|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3903224|NCT01481740|3727353|B3|||Age||years|Mean|31|31.0|Standard Deviation|5|5.0|||
3903225|NCT01481740|3727354|B2|||Age||years|Mean|31|31.0|Standard Deviation|5|5.0|||
3903226|NCT01481740|3727355|B1|||Age||years|Mean|32|32.0|Standard Deviation|6|6.0|||
3903227|NCT01481558|3727372|B3|Brazil||Region of Enrollment||participants|Number|40|40.0||||||
3903228|NCT01481558|3727373|B2|Brazil||Region of Enrollment||participants|Number|20|20.0||||||
3903229|NCT01481558|3727374|B1|Brazil||Region of Enrollment||participants|Number|20|20.0||||||
3903230|NCT01481558|3727372|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3903231|NCT01481558|3727373|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3903232|NCT01481558|3727374|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3903233|NCT01481558|3727372|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3903234|NCT01481558|3727373|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3903235|NCT01481558|3727374|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3903236|NCT01481558|3727372|B3|||Age||years|Mean|80.5|80.5|Standard Deviation|7.5|7.5|||
3903237|NCT01481558|3727373|B2|||Age||years|Mean|79.4|79.4|Standard Deviation|7.1|7.1|||
3903238|NCT01481558|3727374|B1|||Age||years|Mean|81.6|81.6|Standard Deviation|8.0|8.0|||
3903239|NCT01481558|3727372|B3||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
3903240|NCT01481558|3727373|B2||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3903241|NCT01481558|3727374|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3903242|NCT01481558|3727372|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3903243|NCT01481558|3727373|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3903244|NCT01481558|3727374|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3903245|NCT01481558|3727372|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3903246|NCT01481558|3727373|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3903247|NCT01481558|3727374|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3903248|NCT01481376|3727381|B1||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3903249|NCT01481376|3727381|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3903250|NCT01481376|3727381|B1|||Age||years|Mean|54.7|54.7|Full Range|||21.0|86.0|
3903251|NCT01481324|3727389|B4||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3903252|NCT01481324|3727390|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3903253|NCT01481324|3727391|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3903254|NCT01481324|3727392|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3903255|NCT01481324|3727389|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3903256|NCT01481324|3727390|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3903257|NCT01481324|3727391|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3903258|NCT01481324|3727392|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3903259|NCT01481324|3727389|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3903260|NCT01481324|3727390|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3903261|NCT01481324|3727391|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3903262|NCT01481324|3727392|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3903263|NCT01481324|3727389|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3903264|NCT01481324|3727390|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3903265|NCT01481324|3727391|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3903266|NCT01481324|3727392|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3903267|NCT01481324|3727389|B4||<=18 years|Age||Participants|Count of Participants|63|63.0||||||
3903268|NCT01481324|3727390|B3||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
3903269|NCT01481324|3727391|B2||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
3903270|NCT01481324|3727392|B1||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
3903271|NCT01481129|3727402|B1|France||Region of Enrollment||participants|Number|22|22.0||||||
3903272|NCT01481129|3727402|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3903273|NCT01481129|3727402|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3903274|NCT01481129|3727402|B1|||Age||years|Mean|64.9|64.9|Full Range|||43.7|85.1|
3903275|NCT01481129|3727402|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3903276|NCT01481129|3727402|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3903277|NCT01481129|3727402|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3903278|NCT01481116|3727410|B4|||Duration of Diabetes|For this outcome measure, number of participants evaluable were 823, 817 and 812 for each arm, respectively.|years|Mean|6.312|6.312|Standard Deviation|5.056|5.056|||
3903279|NCT01481116|3727411|B3|||Duration of Diabetes|For this outcome measure, number of participants evaluable were 823, 817 and 812 for each arm, respectively.|years|Mean|5.995|5.995|Standard Deviation|4.711|4.711|||
3903280|NCT01481116|3727412|B2|||Duration of Diabetes|For this outcome measure, number of participants evaluable were 823, 817 and 812 for each arm, respectively.|years|Mean|6.566|6.566|Standard Deviation|5.132|5.132|||
3903281|NCT01481116|3727413|B1|||Duration of Diabetes|For this outcome measure, number of participants evaluable were 823, 817 and 812 for each arm, respectively.|years|Mean|6.372|6.372|Standard Deviation|5.293|5.293|||
3903282|NCT01481116|3727410|B4|Not Available||Baseline Glycosylated Hemoglobin (HbA1c) Category||participants|Number|3|3.0||||||
3903283|NCT01481116|3727411|B3|Not Available||Baseline Glycosylated Hemoglobin (HbA1c) Category||participants|Number|0|0.0||||||
3903284|NCT01481116|3727412|B2|Not Available||Baseline Glycosylated Hemoglobin (HbA1c) Category||participants|Number|1|1.0||||||
3903285|NCT01481116|3727413|B1|Not Available||Baseline Glycosylated Hemoglobin (HbA1c) Category||participants|Number|2|2.0||||||
3903286|NCT01481116|3727410|B4|>=8.5%||Baseline Glycosylated Hemoglobin (HbA1c) Category||participants|Number|691|691.0||||||
3903287|NCT01481116|3727411|B3|>=8.5%||Baseline Glycosylated Hemoglobin (HbA1c) Category||participants|Number|221|221.0||||||
3903288|NCT01481116|3727412|B2|>=8.5%||Baseline Glycosylated Hemoglobin (HbA1c) Category||participants|Number|232|232.0||||||
3903289|NCT01481116|3727413|B1|>=8.5%||Baseline Glycosylated Hemoglobin (HbA1c) Category||participants|Number|238|238.0||||||
3903290|NCT01481116|3727410|B4|< 8.5 percent (%)||Baseline Glycosylated Hemoglobin (HbA1c) Category||participants|Number|1760|1760.0||||||
3903291|NCT01481116|3727411|B3|< 8.5 percent (%)||Baseline Glycosylated Hemoglobin (HbA1c) Category||participants|Number|592|592.0||||||
3903292|NCT01481116|3727412|B2|< 8.5 percent (%)||Baseline Glycosylated Hemoglobin (HbA1c) Category||participants|Number|584|584.0||||||
3903293|NCT01481116|3727413|B1|< 8.5 percent (%)||Baseline Glycosylated Hemoglobin (HbA1c) Category||participants|Number|584|584.0||||||
3903294|NCT01481116|3727410|B4|Ex-smoker||Smoking Classification||participants|Number|484|484.0||||||
3903295|NCT01481116|3727411|B3|Ex-smoker||Smoking Classification||participants|Number|185|185.0||||||
3903296|NCT01481116|3727412|B2|Ex-smoker||Smoking Classification||participants|Number|141|141.0||||||
3903297|NCT01481116|3727413|B1|Ex-smoker||Smoking Classification||participants|Number|158|158.0||||||
3903298|NCT01481116|3727410|B4|Current smoker||Smoking Classification||participants|Number|383|383.0||||||
3903299|NCT01481116|3727411|B3|Current smoker||Smoking Classification||participants|Number|126|126.0||||||
3903300|NCT01481116|3727412|B2|Current smoker||Smoking Classification||participants|Number|143|143.0||||||
3903301|NCT01481116|3727413|B1|Current smoker||Smoking Classification||participants|Number|114|114.0||||||
3903302|NCT01481116|3727410|B4|Never smoked||Smoking Classification||participants|Number|1587|1587.0||||||
3903303|NCT01481116|3727411|B3|Never smoked||Smoking Classification||participants|Number|502|502.0||||||
3903304|NCT01481116|3727412|B2|Never smoked||Smoking Classification||participants|Number|533|533.0||||||
3903305|NCT01481116|3727413|B1|Never smoked||Smoking Classification||participants|Number|552|552.0||||||
3903306|NCT01481116|3727410|B4|||Body Mass Index (BMI)|For this outcome measure, number of participants evaluable were 821, 816 and 813 for each arm, respectively.|kilogram per square meter (kg/m^2)|Mean|31.42|31.42|Standard Deviation|5.329|5.329|||
3903307|NCT01481116|3727411|B3|||Body Mass Index (BMI)|For this outcome measure, number of participants evaluable were 821, 816 and 813 for each arm, respectively.|kilogram per square meter (kg/m^2)|Mean|31.43|31.43|Standard Deviation|5.403|5.403|||
3903308|NCT01481116|3727412|B2|||Body Mass Index (BMI)|For this outcome measure, number of participants evaluable were 821, 816 and 813 for each arm, respectively.|kilogram per square meter (kg/m^2)|Mean|31.50|31.5|Standard Deviation|5.253|5.253|||
3903309|NCT01481116|3727413|B1|||Body Mass Index (BMI)|For this outcome measure, number of participants evaluable were 821, 816 and 813 for each arm, respectively.|kilogram per square meter (kg/m^2)|Mean|31.34|31.34|Standard Deviation|5.334|5.334|||
3903310|NCT01481116|3727410|B4|||Weight|For this outcome measure, number of participants evaluable were 822, 816 and 813 for each arm, respectively.|kilogram (kg)|Mean|87.55|87.55|Standard Deviation|18.501|18.501|||
3903311|NCT01481116|3727411|B3|||Weight|For this outcome measure, number of participants evaluable were 822, 816 and 813 for each arm, respectively.|kilogram (kg)|Mean|88.37|88.37|Standard Deviation|18.796|18.796|||
3903312|NCT01481116|3727412|B2|||Weight|For this outcome measure, number of participants evaluable were 822, 816 and 813 for each arm, respectively.|kilogram (kg)|Mean|87.35|87.35|Standard Deviation|18.283|18.283|||
3903313|NCT01481116|3727413|B1|||Weight|For this outcome measure, number of participants evaluable were 822, 816 and 813 for each arm, respectively.|kilogram (kg)|Mean|86.95|86.95|Standard Deviation|18.415|18.415|||
3903314|NCT01481116|3727410|B4|||Height|For this outcome measure, number of participants evaluable were 823, 817 and 813 for each arm, respectively.|centimeter (cm)|Mean|166.6|166.6|Standard Deviation|10.37|10.37|||
3903315|NCT01481116|3727411|B3|||Height|For this outcome measure, number of participants evaluable were 823, 817 and 813 for each arm, respectively.|centimeter (cm)|Mean|167.3|167.3|Standard Deviation|10.19|10.19|||
3903316|NCT01481116|3727412|B2|||Height|For this outcome measure, number of participants evaluable were 823, 817 and 813 for each arm, respectively.|centimeter (cm)|Mean|166.2|166.2|Standard Deviation|10.23|10.23|||
3903317|NCT01481116|3727413|B1|||Height|For this outcome measure, number of participants evaluable were 823, 817 and 813 for each arm, respectively.|centimeter (cm)|Mean|166.2|166.2|Standard Deviation|10.66|10.66|||
3903318|NCT01481116|3727410|B4|United States||Region of Enrollment||participants|Number|492|492.0||||||
3903319|NCT01481116|3727411|B3|United States||Region of Enrollment||participants|Number|163|163.0||||||
3903320|NCT01481116|3727412|B2|United States||Region of Enrollment||participants|Number|164|164.0||||||
3903321|NCT01481116|3727413|B1|United States||Region of Enrollment||participants|Number|165|165.0||||||
3903322|NCT01481116|3727410|B4|United Kingdom||Region of Enrollment||participants|Number|51|51.0||||||
3903323|NCT01481116|3727411|B3|United Kingdom||Region of Enrollment||participants|Number|17|17.0||||||
3903324|NCT01481116|3727412|B2|United Kingdom||Region of Enrollment||participants|Number|16|16.0||||||
3903325|NCT01481116|3727413|B1|United Kingdom||Region of Enrollment||participants|Number|18|18.0||||||
3903326|NCT01481116|3727410|B4|Ukraine||Region of Enrollment||participants|Number|239|239.0||||||
3903327|NCT01481116|3727411|B3|Ukraine||Region of Enrollment||participants|Number|79|79.0||||||
3903328|NCT01481116|3727412|B2|Ukraine||Region of Enrollment||participants|Number|80|80.0||||||
3903329|NCT01481116|3727413|B1|Ukraine||Region of Enrollment||participants|Number|80|80.0||||||
3903330|NCT01481116|3727410|B4|Taiwan, Province Of China||Region of Enrollment||participants|Number|34|34.0||||||
3903331|NCT01481116|3727411|B3|Taiwan, Province Of China||Region of Enrollment||participants|Number|12|12.0||||||
3903332|NCT01481116|3727412|B2|Taiwan, Province Of China||Region of Enrollment||participants|Number|11|11.0||||||
3903333|NCT01481116|3727413|B1|Taiwan, Province Of China||Region of Enrollment||participants|Number|11|11.0||||||
3903334|NCT01481116|3727410|B4|South Africa||Region of Enrollment||participants|Number|247|247.0||||||
3903335|NCT01481116|3727411|B3|South Africa||Region of Enrollment||participants|Number|83|83.0||||||
3903336|NCT01481116|3727412|B2|South Africa||Region of Enrollment||participants|Number|81|81.0||||||
3903337|NCT01481116|3727413|B1|South Africa||Region of Enrollment||participants|Number|83|83.0||||||
3903338|NCT01481116|3727410|B4|Russian Federation||Region of Enrollment||participants|Number|78|78.0||||||
3903339|NCT01481116|3727411|B3|Russian Federation||Region of Enrollment||participants|Number|26|26.0||||||
3903340|NCT01481116|3727412|B2|Russian Federation||Region of Enrollment||participants|Number|26|26.0||||||
3903341|NCT01481116|3727413|B1|Russian Federation||Region of Enrollment||participants|Number|26|26.0||||||
3903342|NCT01481116|3727410|B4|Romania||Region of Enrollment||participants|Number|155|155.0||||||
3903343|NCT01481116|3727411|B3|Romania||Region of Enrollment||participants|Number|51|51.0||||||
3903344|NCT01481116|3727412|B2|Romania||Region of Enrollment||participants|Number|52|52.0||||||
3903345|NCT01481116|3727413|B1|Romania||Region of Enrollment||participants|Number|52|52.0||||||
3903346|NCT01481116|3727410|B4|Poland||Region of Enrollment||participants|Number|193|193.0||||||
3903347|NCT01481116|3727411|B3|Poland||Region of Enrollment||participants|Number|63|63.0||||||
3903348|NCT01481116|3727412|B2|Poland||Region of Enrollment||participants|Number|66|66.0||||||
3903349|NCT01481116|3727413|B1|Poland||Region of Enrollment||participants|Number|64|64.0||||||
3903350|NCT01481116|3727410|B4|Philippines||Region of Enrollment||participants|Number|114|114.0||||||
3903351|NCT01481116|3727411|B3|Philippines||Region of Enrollment||participants|Number|37|37.0||||||
3903352|NCT01481116|3727412|B2|Philippines||Region of Enrollment||participants|Number|38|38.0||||||
3903353|NCT01481116|3727413|B1|Philippines||Region of Enrollment||participants|Number|39|39.0||||||
3903354|NCT01481116|3727410|B4|New Zealand||Region of Enrollment||participants|Number|44|44.0||||||
3903355|NCT01481116|3727411|B3|New Zealand||Region of Enrollment||participants|Number|15|15.0||||||
3903356|NCT01481116|3727412|B2|New Zealand||Region of Enrollment||participants|Number|14|14.0||||||
3903357|NCT01481116|3727413|B1|New Zealand||Region of Enrollment||participants|Number|15|15.0||||||
3903358|NCT01481116|3727410|B4|Mexico||Region of Enrollment||participants|Number|43|43.0||||||
3903359|NCT01481116|3727411|B3|Mexico||Region of Enrollment||participants|Number|15|15.0||||||
3903360|NCT01481116|3727412|B2|Mexico||Region of Enrollment||participants|Number|14|14.0||||||
3903361|NCT01481116|3727413|B1|Mexico||Region of Enrollment||participants|Number|14|14.0||||||
3903362|NCT01481116|3727410|B4|Malaysia||Region of Enrollment||participants|Number|50|50.0||||||
3903363|NCT01481116|3727411|B3|Malaysia||Region of Enrollment||participants|Number|17|17.0||||||
3903364|NCT01481116|3727412|B2|Malaysia||Region of Enrollment||participants|Number|16|16.0||||||
3903365|NCT01481116|3727413|B1|Malaysia||Region of Enrollment||participants|Number|17|17.0||||||
3903366|NCT01481116|3727410|B4|Lithuania||Region of Enrollment||participants|Number|66|66.0||||||
3903367|NCT01481116|3727411|B3|Lithuania||Region of Enrollment||participants|Number|22|22.0||||||
3903368|NCT01481116|3727412|B2|Lithuania||Region of Enrollment||participants|Number|23|23.0||||||
3903369|NCT01481116|3727413|B1|Lithuania||Region of Enrollment||participants|Number|21|21.0||||||
3903370|NCT01481116|3727410|B4|Latvia||Region of Enrollment||participants|Number|43|43.0||||||
3903371|NCT01481116|3727411|B3|Latvia||Region of Enrollment||participants|Number|14|14.0||||||
3903372|NCT01481116|3727412|B2|Latvia||Region of Enrollment||participants|Number|14|14.0||||||
3903373|NCT01481116|3727413|B1|Latvia||Region of Enrollment||participants|Number|15|15.0||||||
3903374|NCT01481116|3727410|B4|Israel||Region of Enrollment||participants|Number|150|150.0||||||
3903375|NCT01481116|3727411|B3|Israel||Region of Enrollment||participants|Number|50|50.0||||||
3903376|NCT01481116|3727412|B2|Israel||Region of Enrollment||participants|Number|50|50.0||||||
3903377|NCT01481116|3727413|B1|Israel||Region of Enrollment||participants|Number|50|50.0||||||
3903378|NCT01481116|3727410|B4|Hong Kong||Region of Enrollment||participants|Number|29|29.0||||||
3903379|NCT01481116|3727411|B3|Hong Kong||Region of Enrollment||participants|Number|10|10.0||||||
3903380|NCT01481116|3727412|B2|Hong Kong||Region of Enrollment||participants|Number|10|10.0||||||
3903381|NCT01481116|3727413|B1|Hong Kong||Region of Enrollment||participants|Number|9|9.0||||||
3903382|NCT01481116|3727410|B4|Estonia||Region of Enrollment||participants|Number|36|36.0||||||
3903383|NCT01481116|3727411|B3|Estonia||Region of Enrollment||participants|Number|12|12.0||||||
3903384|NCT01481116|3727412|B2|Estonia||Region of Enrollment||participants|Number|12|12.0||||||
3903385|NCT01481116|3727413|B1|Estonia||Region of Enrollment||participants|Number|12|12.0||||||
3903386|NCT01481116|3727410|B4|Czech Republic||Region of Enrollment||participants|Number|93|93.0||||||
3903387|NCT01481116|3727411|B3|Czech Republic||Region of Enrollment||participants|Number|31|31.0||||||
3903388|NCT01481116|3727412|B2|Czech Republic||Region of Enrollment||participants|Number|31|31.0||||||
3903389|NCT01481116|3727413|B1|Czech Republic||Region of Enrollment||participants|Number|31|31.0||||||
3903390|NCT01481116|3727410|B4|Colombia||Region of Enrollment||participants|Number|3|3.0||||||
3903391|NCT01481116|3727411|B3|Colombia||Region of Enrollment||participants|Number|1|1.0||||||
3903392|NCT01481116|3727412|B2|Colombia||Region of Enrollment||participants|Number|0|0.0||||||
3903393|NCT01481116|3727413|B1|Colombia||Region of Enrollment||participants|Number|2|2.0||||||
3903394|NCT01481116|3727410|B4|Canada||Region of Enrollment||participants|Number|121|121.0||||||
3903395|NCT01481116|3727411|B3|Canada||Region of Enrollment||participants|Number|39|39.0||||||
3903396|NCT01481116|3727412|B2|Canada||Region of Enrollment||participants|Number|40|40.0||||||
3903397|NCT01481116|3727413|B1|Canada||Region of Enrollment||participants|Number|42|42.0||||||
3903398|NCT01481116|3727410|B4|Bulgaria||Region of Enrollment||participants|Number|51|51.0||||||
3903399|NCT01481116|3727411|B3|Bulgaria||Region of Enrollment||participants|Number|16|16.0||||||
3903400|NCT01481116|3727412|B2|Bulgaria||Region of Enrollment||participants|Number|18|18.0||||||
3903401|NCT01481116|3727413|B1|Bulgaria||Region of Enrollment||participants|Number|17|17.0||||||
3903402|NCT01481116|3727410|B4|Australia||Region of Enrollment||participants|Number|9|9.0||||||
3903403|NCT01481116|3727411|B3|Australia||Region of Enrollment||participants|Number|3|3.0||||||
3903404|NCT01481116|3727412|B2|Australia||Region of Enrollment||participants|Number|2|2.0||||||
3903405|NCT01481116|3727413|B1|Australia||Region of Enrollment||participants|Number|4|4.0||||||
3903406|NCT01481116|3727410|B4|Argentina||Region of Enrollment||participants|Number|113|113.0||||||
3903407|NCT01481116|3727411|B3|Argentina||Region of Enrollment||participants|Number|37|37.0||||||
3903408|NCT01481116|3727412|B2|Argentina||Region of Enrollment||participants|Number|39|39.0||||||
3903409|NCT01481116|3727413|B1|Argentina||Region of Enrollment||participants|Number|37|37.0||||||
3903410|NCT01481116|3727410|B4|Multiracial||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
3903411|NCT01481116|3727411|B3|Multiracial||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3903412|NCT01481116|3727412|B2|Multiracial||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3903413|NCT01481116|3727413|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
3903414|NCT01481116|3727410|B4|White||Race/Ethnicity, Customized||participants|Number|1816|1816.0||||||
3903415|NCT01481116|3727411|B3|White||Race/Ethnicity, Customized||participants|Number|601|601.0||||||
3903416|NCT01481116|3727412|B2|White||Race/Ethnicity, Customized||participants|Number|598|598.0||||||
3903417|NCT01481116|3727413|B1|White||Race/Ethnicity, Customized||participants|Number|617|617.0||||||
3903418|NCT01481116|3727410|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3903419|NCT01481116|3727411|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3903420|NCT01481116|3727412|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3903421|NCT01481116|3727413|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3903422|NCT01481116|3727410|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|209|209.0||||||
3903423|NCT01481116|3727411|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
3903424|NCT01481116|3727412|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
3903425|NCT01481116|3727413|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
3903426|NCT01481116|3727410|B4|Asian||Race/Ethnicity, Customized||participants|Number|293|293.0||||||
3903427|NCT01481116|3727411|B3|Asian||Race/Ethnicity, Customized||participants|Number|93|93.0||||||
3903428|NCT01481116|3727412|B2|Asian||Race/Ethnicity, Customized||participants|Number|99|99.0||||||
3903429|NCT01481116|3727413|B1|Asian||Race/Ethnicity, Customized||participants|Number|101|101.0||||||
3903430|NCT01481116|3727410|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
3903431|NCT01481116|3727411|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3903432|NCT01481116|3727412|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3903433|NCT01481116|3727413|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3903434|NCT01481116|3727410|B4|Not Available||Race/Ethnicity, Customized||participants|Number|1929|1929.0||||||
3903435|NCT01481116|3727411|B3|Not Available||Race/Ethnicity, Customized||participants|Number|637|637.0||||||
3903436|NCT01481116|3727412|B2|Not Available||Race/Ethnicity, Customized||participants|Number|641|641.0||||||
3903437|NCT01481116|3727413|B1|Not Available||Race/Ethnicity, Customized||participants|Number|651|651.0||||||
3903438|NCT01481116|3727410|B4|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|321|321.0||||||
3903439|NCT01481116|3727411|B3|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|106|106.0||||||
3903440|NCT01481116|3727412|B2|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|110|110.0||||||
3903441|NCT01481116|3727413|B1|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|105|105.0||||||
3903442|NCT01481116|3727410|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|204|204.0||||||
3903443|NCT01481116|3727411|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
3903444|NCT01481116|3727412|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
3903445|NCT01481116|3727413|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
3903446|NCT01481116|3727410|B4||Male|Sex: Female, Male||Participants|Count of Participants|1242|1242.0||||||
3903447|NCT01481116|3727411|B3||Male|Sex: Female, Male||Participants|Count of Participants|451|451.0||||||
3903448|NCT01481116|3727412|B2||Male|Sex: Female, Male||Participants|Count of Participants|395|395.0||||||
3903449|NCT01481116|3727413|B1||Male|Sex: Female, Male||Participants|Count of Participants|396|396.0||||||
3903450|NCT01481116|3727410|B4||Female|Sex: Female, Male||Participants|Count of Participants|1212|1212.0||||||
3903451|NCT01481116|3727411|B3||Female|Sex: Female, Male||Participants|Count of Participants|362|362.0||||||
3903452|NCT01481116|3727412|B2||Female|Sex: Female, Male||Participants|Count of Participants|422|422.0||||||
3903453|NCT01481116|3727413|B1||Female|Sex: Female, Male||Participants|Count of Participants|428|428.0||||||
3903454|NCT01481116|3727410|B4|>=65 years||Age, Customized||participants|Number|523|523.0||||||
3903455|NCT01481116|3727411|B3|>=65 years||Age, Customized||participants|Number|165|165.0||||||
3903456|NCT01481116|3727412|B2|>=65 years||Age, Customized||participants|Number|171|171.0||||||
3903457|NCT01481116|3727413|B1|>=65 years||Age, Customized||participants|Number|187|187.0||||||
3903458|NCT01481116|3727410|B4|Less than (<) 65 years||Age, Customized||participants|Number|1931|1931.0||||||
3903459|NCT01481116|3727411|B3|Less than (<) 65 years||Age, Customized||participants|Number|648|648.0||||||
3903460|NCT01481116|3727412|B2|Less than (<) 65 years||Age, Customized||participants|Number|646|646.0||||||
3903461|NCT01481116|3727413|B1|Less than (<) 65 years||Age, Customized||participants|Number|637|637.0||||||
3903462|NCT01481116|3727410|B4|||Age||years|Mean|56.9|56.9|Standard Deviation|9.57|9.57|||
3903463|NCT01481116|3727411|B3|||Age||years|Mean|56.6|56.6|Standard Deviation|9.81|9.81|||
3903464|NCT01481116|3727412|B2|||Age||years|Mean|56.8|56.8|Standard Deviation|9.34|9.34|||
3903465|NCT01481116|3727413|B1|||Age||years|Mean|57.3|57.3|Standard Deviation|9.56|9.56|||
3903466|NCT01480843|3727441|B1|United States||Region of Enrollment||participants|Number|65|65.0||||||
3903467|NCT01480843|3727441|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903468|NCT01480843|3727441|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903469|NCT01480843|3727441|B1||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3903470|NCT01480843|3727441|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3903471|NCT01480843|3727441|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903472|NCT01480843|3727441|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903473|NCT01480843|3727441|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903474|NCT01480843|3727441|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3903475|NCT01480843|3727441|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3903476|NCT01480843|3727441|B1||>=65 years|Age||Participants|Count of Participants|65|65.0||||||
3903477|NCT01480843|3727441|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3903478|NCT01480843|3727441|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3903479|NCT01480674|3727446|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3903480|NCT01480674|3727446|B1||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3903481|NCT01480674|3727446|B1|||Age||Years|Mean|61.3|61.3|Standard Deviation|12.2|12.2|||
3903482|NCT01480596|3727458|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|36|36.0||||||
3903483|NCT01480596|3727459|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
3903484|NCT01480596|3727460|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
3903485|NCT01480596|3727458|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3903486|NCT01480596|3727459|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3903487|NCT01480596|3727460|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3903488|NCT01480596|3727458|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3903489|NCT01480596|3727459|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3903490|NCT01480596|3727460|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3903491|NCT01480596|3727458|B3||Male|Gender||Participants|Count of Participants|15|15.0||||||
3903492|NCT01480596|3727459|B2||Male|Gender||Participants|Count of Participants|8|8.0||||||
3903493|NCT01480596|3727460|B1||Male|Gender||Participants|Count of Participants|7|7.0||||||
3903494|NCT01480596|3727458|B3||Female|Gender||Participants|Count of Participants|24|24.0||||||
3903495|NCT01480596|3727459|B2||Female|Gender||Participants|Count of Participants|10|10.0||||||
3903496|NCT01480596|3727460|B1||Female|Gender||Participants|Count of Participants|14|14.0||||||
3903497|NCT01480596|3727458|B3|||Age||Years|Mean|56.1|56.1|Standard Deviation|15.67|15.67|||
3903498|NCT01480596|3727459|B2|||Age||Years|Mean|52.7|52.7|Standard Deviation|17.32|17.32|||
3903499|NCT01480596|3727460|B1|||Age||Years|Mean|59.0|59.0|Standard Deviation|13.88|13.88|||
3903500|NCT01480297|3727503|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3903501|NCT01480297|3727503|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903502|NCT01480297|3727503|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903503|NCT01480297|3727503|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3903504|NCT01480297|3727503|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903505|NCT01480297|3727503|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903506|NCT01480297|3727503|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903507|NCT01480297|3727503|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903508|NCT01480297|3727503|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3903509|NCT01480297|3727503|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3903510|NCT01480297|3727503|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3903511|NCT01480297|3727503|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3903512|NCT01480297|3727503|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3903513|NCT01480297|3727503|B1|||Age||Years|Mean|57.0|57.0|Standard Deviation|5.7|5.7|||
3903514|NCT01480284|3727507|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized|Baseline characteristics are presented for the full analysis set, which is defined as all participants who entered into the study, received at least one dose of investigational product, and have at least one efficacy assessment after the treatment initiation.|Participants|Number|165|165.0||||||
3903515|NCT01480284|3727508|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized|Baseline characteristics are presented for the full analysis set, which is defined as all participants who entered into the study, received at least one dose of investigational product, and have at least one efficacy assessment after the treatment initiation.|Participants|Number|56|56.0||||||
3903516|NCT01480284|3727509|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized|Baseline characteristics are presented for the full analysis set, which is defined as all participants who entered into the study, received at least one dose of investigational product, and have at least one efficacy assessment after the treatment initiation.|Participants|Number|109|109.0||||||
3903517|NCT01480284|3727507|B3||Male|Sex: Female, Male|Baseline characteristics are presented for the full analysis set, which is defined as all participants who entered into the study, received at least one dose of investigational product, and have at least one efficacy assessment after the treatment initiation.|Participants|Count of Participants|108|108.0||||||
3903518|NCT01480284|3727508|B2||Male|Sex: Female, Male|Baseline characteristics are presented for the full analysis set, which is defined as all participants who entered into the study, received at least one dose of investigational product, and have at least one efficacy assessment after the treatment initiation.|Participants|Count of Participants|40|40.0||||||
3903519|NCT01480284|3727509|B1||Male|Sex: Female, Male|Baseline characteristics are presented for the full analysis set, which is defined as all participants who entered into the study, received at least one dose of investigational product, and have at least one efficacy assessment after the treatment initiation.|Participants|Count of Participants|68|68.0||||||
3903520|NCT01480284|3727507|B3||Female|Sex: Female, Male|Baseline characteristics are presented for the full analysis set, which is defined as all participants who entered into the study, received at least one dose of investigational product, and have at least one efficacy assessment after the treatment initiation.|Participants|Count of Participants|57|57.0||||||
3903521|NCT01480284|3727508|B2||Female|Sex: Female, Male|Baseline characteristics are presented for the full analysis set, which is defined as all participants who entered into the study, received at least one dose of investigational product, and have at least one efficacy assessment after the treatment initiation.|Participants|Count of Participants|16|16.0||||||
3903522|NCT01480284|3727509|B1||Female|Sex: Female, Male|Baseline characteristics are presented for the full analysis set, which is defined as all participants who entered into the study, received at least one dose of investigational product, and have at least one efficacy assessment after the treatment initiation.|Participants|Count of Participants|41|41.0||||||
3903523|NCT01480284|3727507|B3|||Age|Baseline characteristics are presented for the full analysis set, which is defined as all participants who entered into the study, received at least one dose of investigational product, and have at least one efficacy assessment after the treatment initiation.|Years|Mean|45.6|45.6|Standard Deviation|9.36|9.36|||
3903524|NCT01480284|3727508|B2|||Age|Baseline characteristics are presented for the full analysis set, which is defined as all participants who entered into the study, received at least one dose of investigational product, and have at least one efficacy assessment after the treatment initiation.|Years|Mean|46.1|46.1|Standard Deviation|9.68|9.68|||
3903525|NCT01480284|3727509|B1|||Age|Baseline characteristics are presented for the full analysis set, which is defined as all participants who entered into the study, received at least one dose of investigational product, and have at least one efficacy assessment after the treatment initiation.|Years|Mean|45.4|45.4|Standard Deviation|9.23|9.23|||
3903526|NCT01480232|3727538|B5|||FTND Score|Fagerström Test for Nicotine Dependence (FTND) will determine the level of nicotine dependence. The scale score ranges from 0 to 10. An FTND score ≥6 indicates high nicotine dependence and a score of <6 indicates a low to moderate level of dependence|units on a scale|Mean|5.36|5.36|Standard Deviation|2.06|2.06|||
3903527|NCT01480232|3727539|B4|||FTND Score|Fagerström Test for Nicotine Dependence (FTND) will determine the level of nicotine dependence. The scale score ranges from 0 to 10. An FTND score ≥6 indicates high nicotine dependence and a score of <6 indicates a low to moderate level of dependence|units on a scale|Mean|5.32|5.32|Standard Deviation|2.07|2.07|||
3903528|NCT01480232|3727540|B3|||FTND Score|Fagerström Test for Nicotine Dependence (FTND) will determine the level of nicotine dependence. The scale score ranges from 0 to 10. An FTND score ≥6 indicates high nicotine dependence and a score of <6 indicates a low to moderate level of dependence|units on a scale|Mean|5.39|5.39|Standard Deviation|1.94|1.94|||
3903529|NCT01480232|3727541|B2|||FTND Score|Fagerström Test for Nicotine Dependence (FTND) will determine the level of nicotine dependence. The scale score ranges from 0 to 10. An FTND score ≥6 indicates high nicotine dependence and a score of <6 indicates a low to moderate level of dependence|units on a scale|Mean|5.34|5.34|Standard Deviation|2.17|2.17|||
3903530|NCT01480232|3727542|B1|||FTND Score|Fagerström Test for Nicotine Dependence (FTND) will determine the level of nicotine dependence. The scale score ranges from 0 to 10. An FTND score ≥6 indicates high nicotine dependence and a score of <6 indicates a low to moderate level of dependence|units on a scale|Mean|5.40|5.4|Standard Deviation|2.07|2.07|||
3903576|NCT01480232|3727538|B5||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3903577|NCT01480232|3727539|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3903531|NCT01480232|3727538|B5|||Expired CO, ppm|Measurements of CO in expired breath was the primary means of biochemical verification of smoking self-report during the study at each study visit. End-expiratory CO levels ≥10 ppm indicate current cigarette use, whereas levels of <10 ppm indicate abstinence.|parts per million|Mean|4.78|4.78|Standard Deviation|3.69|3.69|||
3903532|NCT01480232|3727539|B4|||Expired CO, ppm|Measurements of CO in expired breath was the primary means of biochemical verification of smoking self-report during the study at each study visit. End-expiratory CO levels ≥10 ppm indicate current cigarette use, whereas levels of <10 ppm indicate abstinence.|parts per million|Mean|4.85|4.85|Standard Deviation|4.38|4.38|||
3903533|NCT01480232|3727540|B3|||Expired CO, ppm|Measurements of CO in expired breath was the primary means of biochemical verification of smoking self-report during the study at each study visit. End-expiratory CO levels ≥10 ppm indicate current cigarette use, whereas levels of <10 ppm indicate abstinence.|parts per million|Mean|4.78|4.78|Standard Deviation|3.46|3.46|||
3903534|NCT01480232|3727541|B2|||Expired CO, ppm|Measurements of CO in expired breath was the primary means of biochemical verification of smoking self-report during the study at each study visit. End-expiratory CO levels ≥10 ppm indicate current cigarette use, whereas levels of <10 ppm indicate abstinence.|parts per million|Mean|4.29|4.29|Standard Deviation|2.76|2.76|||
3903535|NCT01480232|3727542|B1|||Expired CO, ppm|Measurements of CO in expired breath was the primary means of biochemical verification of smoking self-report during the study at each study visit. End-expiratory CO levels ≥10 ppm indicate current cigarette use, whereas levels of <10 ppm indicate abstinence.|parts per million|Mean|5.18|5.18|Standard Deviation|4.17|4.17|||
3903536|NCT01480232|3727538|B5|||Cigarettes Smoked Per Day||cigarettes per day|Mean|20.21|20.21|Standard Deviation|17.23|17.23|||
3903537|NCT01480232|3727539|B4|||Cigarettes Smoked Per Day||cigarettes per day|Mean|20.04|20.04|Standard Deviation|13.85|13.85|||
3903538|NCT01480232|3727540|B3|||Cigarettes Smoked Per Day||cigarettes per day|Mean|22.87|22.87|Standard Deviation|30.63|30.63|||
3903539|NCT01480232|3727541|B2|||Cigarettes Smoked Per Day||cigarettes per day|Mean|19.41|19.41|Standard Deviation|15.09|15.09|||
3903540|NCT01480232|3727542|B1|||Cigarettes Smoked Per Day||cigarettes per day|Mean|18.53|18.53|Standard Deviation|9.35|9.35|||
3903541|NCT01480232|3727538|B5|||Years of Regular Smoking||years|Mean|25.26|25.26|Standard Deviation|12.32|12.32|||
3903542|NCT01480232|3727539|B4|||Years of Regular Smoking||years|Mean|26.46|26.46|Standard Deviation|12.17|12.17|||
3903543|NCT01480232|3727540|B3|||Years of Regular Smoking||years|Mean|24.89|24.89|Standard Deviation|12.84|12.84|||
3903544|NCT01480232|3727541|B2|||Years of Regular Smoking||years|Mean|26.38|26.38|Standard Deviation|13.24|13.24|||
3903545|NCT01480232|3727542|B1|||Years of Regular Smoking||years|Mean|23.31|23.31|Standard Deviation|11.01|11.01|||
3903546|NCT01480232|3727538|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3903547|NCT01480232|3727539|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3903548|NCT01480232|3727540|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3903549|NCT01480232|3727541|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3903550|NCT01480232|3727542|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3903551|NCT01480232|3727538|B5|African American||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3903552|NCT01480232|3727539|B4|African American||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3903553|NCT01480232|3727540|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3903554|NCT01480232|3727541|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3903555|NCT01480232|3727542|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3903556|NCT01480232|3727538|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|125|125.0||||||
3903557|NCT01480232|3727539|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3903558|NCT01480232|3727540|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3903559|NCT01480232|3727541|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3903560|NCT01480232|3727542|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3903561|NCT01480232|3727538|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903562|NCT01480232|3727539|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903563|NCT01480232|3727540|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903564|NCT01480232|3727541|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903565|NCT01480232|3727542|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903566|NCT01480232|3727538|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
3903567|NCT01480232|3727539|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3903568|NCT01480232|3727540|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3903569|NCT01480232|3727541|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3903570|NCT01480232|3727542|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3903571|NCT01480232|3727538|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3903572|NCT01480232|3727539|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3903573|NCT01480232|3727540|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3903574|NCT01480232|3727541|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3903575|NCT01480232|3727542|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3903578|NCT01480232|3727540|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3903579|NCT01480232|3727541|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3903580|NCT01480232|3727542|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3903581|NCT01480232|3727538|B5||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3903582|NCT01480232|3727539|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3903583|NCT01480232|3727540|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3903584|NCT01480232|3727541|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3903585|NCT01480232|3727542|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3903586|NCT01480232|3727538|B5|||Age||years|Mean|44.30|44.3|Standard Deviation|11.86|11.86|||
3903587|NCT01480232|3727539|B4|||Age||years|Mean|45.15|45.15|Standard Deviation|11.42|11.42|||
3903588|NCT01480232|3727540|B3|||Age||years|Mean|44.03|44.03|Standard Deviation|12.81|12.81|||
3903589|NCT01480232|3727541|B2|||Age||years|Mean|44.70|44.7|Standard Deviation|13.06|13.06|||
3903590|NCT01480232|3727542|B1|||Age||years|Mean|42.63|42.63|Standard Deviation|12.17|12.17|||
3903591|NCT01480219|3727571|B3||Male|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
3903592|NCT01480219|3727572|B2||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3903593|NCT01480219|3727573|B1||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3903594|NCT01480219|3727571|B3||Female|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
3903595|NCT01480219|3727572|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3903596|NCT01480219|3727573|B1||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3903597|NCT01480219|3727571|B3|Greater than or equal to 70 years||Age, Customized||participants|Number|20|20.0||||||
3903598|NCT01480219|3727572|B2|Greater than or equal to 70 years||Age, Customized||participants|Number|6|6.0||||||
3903599|NCT01480219|3727573|B1|Greater than or equal to 70 years||Age, Customized||participants|Number|14|14.0||||||
3903600|NCT01480219|3727571|B3|60 to 69 years||Age, Customized||participants|Number|181|181.0||||||
3903601|NCT01480219|3727572|B2|60 to 69 years||Age, Customized||participants|Number|60|60.0||||||
3903602|NCT01480219|3727573|B1|60 to 69 years||Age, Customized||participants|Number|121|121.0||||||
3903603|NCT01480219|3727571|B3|50 to 59 years||Age, Customized||participants|Number|149|149.0||||||
3903604|NCT01480219|3727572|B2|50 to 59 years||Age, Customized||participants|Number|44|44.0||||||
3903605|NCT01480219|3727573|B1|50 to 59 years||Age, Customized||participants|Number|105|105.0||||||
3903606|NCT01480219|3727571|B3|30 to 49 years||Age, Customized||participants|Number|87|87.0||||||
3903607|NCT01480219|3727572|B2|30 to 49 years||Age, Customized||participants|Number|22|22.0||||||
3903608|NCT01480219|3727573|B1|30 to 49 years||Age, Customized||participants|Number|65|65.0||||||
3903609|NCT01480219|3727571|B3|18 to 29 years||Age, Customized||participants|Number|30|30.0||||||
3903610|NCT01480219|3727572|B2|18 to 29 years||Age, Customized||participants|Number|10|10.0||||||
3903611|NCT01480219|3727573|B1|18 to 29 years||Age, Customized||participants|Number|20|20.0||||||
3903612|NCT01480089|3727580|B3|Greater than 48 hours||Length of Hospital Stay||participants|Number|13|13.0||||||
3903613|NCT01480089|3727581|B2|Greater than 48 hours||Length of Hospital Stay||participants|Number|7|7.0||||||
3903614|NCT01480089|3727582|B1|Greater than 48 hours||Length of Hospital Stay||participants|Number|6|6.0||||||
3903615|NCT01480089|3727580|B3|24 to 48 hours||Length of Hospital Stay||participants|Number|42|42.0||||||
3903616|NCT01480089|3727581|B2|24 to 48 hours||Length of Hospital Stay||participants|Number|23|23.0||||||
3903617|NCT01480089|3727582|B1|24 to 48 hours||Length of Hospital Stay||participants|Number|19|19.0||||||
3903618|NCT01480089|3727580|B3|Less than 24 hours||Length of Hospital Stay||participants|Number|0|0.0||||||
3903619|NCT01480089|3727581|B2|Less than 24 hours||Length of Hospital Stay||participants|Number|0|0.0||||||
3903620|NCT01480089|3727582|B1|Less than 24 hours||Length of Hospital Stay||participants|Number|0|0.0||||||
3903621|NCT01480089|3727580|B3|Gynecologic Oncology||Attending Specialty||participants|Number|23|23.0||||||
3903622|NCT01480089|3727581|B2|Gynecologic Oncology||Attending Specialty||participants|Number|12|12.0||||||
3903623|NCT01480089|3727582|B1|Gynecologic Oncology||Attending Specialty||participants|Number|11|11.0||||||
3903624|NCT01480089|3727580|B3|Urogynecology||Attending Specialty||participants|Number|26|26.0||||||
3903625|NCT01480089|3727581|B2|Urogynecology||Attending Specialty||participants|Number|14|14.0||||||
3903626|NCT01480089|3727582|B1|Urogynecology||Attending Specialty||participants|Number|12|12.0||||||
3903627|NCT01480089|3727580|B3|Benign Gynecology||Attending Specialty||participants|Number|6|6.0||||||
3903628|NCT01480089|3727581|B2|Benign Gynecology||Attending Specialty||participants|Number|4|4.0||||||
3903629|NCT01480089|3727582|B1|Benign Gynecology||Attending Specialty||participants|Number|2|2.0||||||
3903630|NCT01480089|3727580|B3|Robotic||Surgical Approach||participants|Number|33|33.0||||||
3903631|NCT01480089|3727581|B2|Robotic||Surgical Approach||participants|Number|19|19.0||||||
3903632|NCT01480089|3727582|B1|Robotic||Surgical Approach||participants|Number|14|14.0||||||
3903633|NCT01480089|3727580|B3|Laparoscopic||Surgical Approach||participants|Number|22|22.0||||||
3903634|NCT01480089|3727581|B2|Laparoscopic||Surgical Approach||participants|Number|11|11.0||||||
3903635|NCT01480089|3727582|B1|Laparoscopic||Surgical Approach||participants|Number|11|11.0||||||
3903636|NCT01480089|3727580|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3903637|NCT01480089|3727581|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3903638|NCT01480089|3727582|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3903639|NCT01480089|3727580|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3903640|NCT01480089|3727581|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3903641|NCT01480089|3727582|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3903642|NCT01480089|3727580|B3|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3903643|NCT01480089|3727581|B2|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3903644|NCT01480089|3727582|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3903645|NCT01480089|3727580|B3|White||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
3903646|NCT01480089|3727581|B2|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3903647|NCT01480089|3727582|B1|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3903648|NCT01480089|3727580|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3903649|NCT01480089|3727581|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3903650|NCT01480089|3727582|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3903651|NCT01480089|3727580|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3903652|NCT01480089|3727581|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3903653|NCT01480089|3727582|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3903654|NCT01480089|3727580|B3|||Age||years|Mean|56.9|56.9|Full Range|||31.0|74.0|
3903655|NCT01480089|3727581|B2|||Age||years|Mean|58.8|58.8|Full Range|||31.0|74.0|
3903656|NCT01480089|3727582|B1|||Age||years|Mean|54.6|54.6|Full Range|||31.0|72.0|
3903657|NCT01480076|3727591|B3||Male|Sex: Female, Male||Participants|Count of Participants|354|354.0||||||
3903658|NCT01480076|3727592|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3903659|NCT01480076|3727593|B1||Male|Sex: Female, Male||Participants|Count of Participants|305|305.0||||||
3903660|NCT01480076|3727591|B3||Female|Sex: Female, Male||Participants|Count of Participants|481|481.0||||||
3903661|NCT01480076|3727592|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3903662|NCT01480076|3727593|B1||Female|Sex: Female, Male||Participants|Count of Participants|402|402.0||||||
3903663|NCT01480076|3727591|B3|||Age||years|Mean|49.5|49.5|Standard Deviation|9.75|9.75|||
3903664|NCT01480076|3727592|B2|||Age||years|Mean|50.5|50.5|Standard Deviation|10.0|10.0|||
3903665|NCT01480076|3727593|B1|||Age||years|Mean|49.3|49.3|Standard Deviation|9.70|9.7|||
3903666|NCT01479985|3727712|B3|United States||Region of Enrollment||participants|Number|241|241.0||||||
3903667|NCT01479985|3727713|B2|United States||Region of Enrollment||participants|Number|80|80.0||||||
3903668|NCT01479985|3727714|B1|United States||Region of Enrollment||participants|Number|161|161.0||||||
3903669|NCT01479985|3727712|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3903670|NCT01479985|3727713|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3903671|NCT01479985|3727714|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3903672|NCT01479985|3727712|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|136|136.0||||||
3903673|NCT01479985|3727713|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|54|54.0||||||
3903674|NCT01479985|3727714|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|82|82.0||||||
3903675|NCT01479985|3727712|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|81|81.0||||||
3903676|NCT01479985|3727713|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3903677|NCT01479985|3727714|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|60|60.0||||||
3903678|NCT01479985|3727712|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3903679|NCT01479985|3727713|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3903680|NCT01479985|3727714|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3903681|NCT01479985|3727712|B3||Female|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
3903682|NCT01479985|3727713|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3903683|NCT01479985|3727714|B1||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3903684|NCT01479985|3727712|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3903685|NCT01479985|3727713|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3903686|NCT01479985|3727714|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3903687|NCT01479985|3727712|B3||Between 18 and 65 years|Age||Participants|Count of Participants|241|241.0||||||
3903688|NCT01479985|3727713|B2||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
3903689|NCT01479985|3727714|B1||Between 18 and 65 years|Age||Participants|Count of Participants|161|161.0||||||
3903690|NCT01479985|3727712|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3903691|NCT01479985|3727713|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3903692|NCT01479985|3727714|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3903693|NCT01479868|3727723|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3903694|NCT01479868|3727723|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3903695|NCT01479868|3727723|B1|||Age||years|Median|48|48.0|Full Range|||27.0|67.0|
3903696|NCT01479777|3727738|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3903697|NCT01479777|3727738|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3903698|NCT01479777|3727738|B1|||Age||years|Mean|37|37.0|Standard Deviation|15|15.0|||
3903699|NCT01479764|3727748|B3||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3903700|NCT01479764|3727749|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3903701|NCT01479764|3727750|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3903702|NCT01479764|3727748|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3903703|NCT01479764|3727749|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3903704|NCT01479764|3727750|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3903705|NCT01479764|3727748|B3|||Age||years|Mean|56.7|56.7|Standard Deviation|12.7|12.7|||
3903706|NCT01479764|3727749|B2|||Age||years|Mean|57.0|57.0|Standard Deviation|12.7|12.7|||
3903707|NCT01479764|3727750|B1|||Age||years|Mean|56.4|56.4|Standard Deviation|12.8|12.8|||
3903708|NCT01479725|3727759|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3903709|NCT01479725|3727760|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3903710|NCT01479725|3727761|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3903711|NCT01479725|3727759|B3||Male|Gender||Participants|Count of Participants|2|2.0||||||
3903712|NCT01479725|3727760|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3903713|NCT01479725|3727761|B1||Male|Gender||Participants|Count of Participants|2|2.0||||||
3903714|NCT01479725|3727759|B3||Female|Gender||Participants|Count of Participants|6|6.0||||||
3903715|NCT01479725|3727760|B2||Female|Gender||Participants|Count of Participants|2|2.0||||||
3903716|NCT01479725|3727761|B1||Female|Gender||Participants|Count of Participants|4|4.0||||||
3903717|NCT01479725|3727759|B3|||Age||years|Mean|54|54.0|Full Range|||35.0|66.0|
3903718|NCT01479725|3727760|B2|||Age||years|Mean|53|53.0|Full Range|||51.0|55.0|
3903719|NCT01479725|3727761|B1|||Age||years|Mean|54.3|54.3|Full Range|||35.0|66.0|
3903720|NCT01479621|3727768|B7|||Qualifying Airway Reversibility|Patients demonstrated a ≥15% reversibility of FEV1 within 30 minutes following 2-4 inhalations of albuterol/salbutamol inhalation aerosol at the screening visit. If subjects failed to demonstrate an increase in FEV1 ≥15% then subjects were not eligible for the study; however, based on investigator judgment, they were allowed to retest once within 7 days. Reversibility values of 14.50 through 14.99% were rounded to 15%.|percentage increase in FEV1|Mean|26.9|26.9|Standard Deviation|13.25|13.25|||
3903721|NCT01479621|3727769|B6|||Qualifying Airway Reversibility|Patients demonstrated a ≥15% reversibility of FEV1 within 30 minutes following 2-4 inhalations of albuterol/salbutamol inhalation aerosol at the screening visit. If subjects failed to demonstrate an increase in FEV1 ≥15% then subjects were not eligible for the study; however, based on investigator judgment, they were allowed to retest once within 7 days. Reversibility values of 14.50 through 14.99% were rounded to 15%.|percentage increase in FEV1|Mean|26.2|26.2|Standard Deviation|12.50|12.5|||
3903722|NCT01479621|3727770|B5|||Qualifying Airway Reversibility|Patients demonstrated a ≥15% reversibility of FEV1 within 30 minutes following 2-4 inhalations of albuterol/salbutamol inhalation aerosol at the screening visit. If subjects failed to demonstrate an increase in FEV1 ≥15% then subjects were not eligible for the study; however, based on investigator judgment, they were allowed to retest once within 7 days. Reversibility values of 14.50 through 14.99% were rounded to 15%.|percentage increase in FEV1|Mean|30.6|30.6|Standard Deviation|17.84|17.84|||
3903723|NCT01479621|3727771|B4|||Qualifying Airway Reversibility|Patients demonstrated a ≥15% reversibility of FEV1 within 30 minutes following 2-4 inhalations of albuterol/salbutamol inhalation aerosol at the screening visit. If subjects failed to demonstrate an increase in FEV1 ≥15% then subjects were not eligible for the study; however, based on investigator judgment, they were allowed to retest once within 7 days. Reversibility values of 14.50 through 14.99% were rounded to 15%.|percentage increase in FEV1|Mean|27.6|27.6|Standard Deviation|12.92|12.92|||
3903724|NCT01479621|3727772|B3|||Qualifying Airway Reversibility|Patients demonstrated a ≥15% reversibility of FEV1 within 30 minutes following 2-4 inhalations of albuterol/salbutamol inhalation aerosol at the screening visit. If subjects failed to demonstrate an increase in FEV1 ≥15% then subjects were not eligible for the study; however, based on investigator judgment, they were allowed to retest once within 7 days. Reversibility values of 14.50 through 14.99% were rounded to 15%.|percentage increase in FEV1|Mean|24.3|24.3|Standard Deviation|10.63|10.63|||
3903725|NCT01479621|3727773|B2|||Qualifying Airway Reversibility|Patients demonstrated a ≥15% reversibility of FEV1 within 30 minutes following 2-4 inhalations of albuterol/salbutamol inhalation aerosol at the screening visit. If subjects failed to demonstrate an increase in FEV1 ≥15% then subjects were not eligible for the study; however, based on investigator judgment, they were allowed to retest once within 7 days. Reversibility values of 14.50 through 14.99% were rounded to 15%.|percentage increase in FEV1|Mean|26.0|26.0|Standard Deviation|11.86|11.86|||
3903726|NCT01479621|3727774|B1|||Qualifying Airway Reversibility|Patients demonstrated a ≥15% reversibility of FEV1 within 30 minutes following 2-4 inhalations of albuterol/salbutamol inhalation aerosol at the screening visit. If subjects failed to demonstrate an increase in FEV1 ≥15% then subjects were not eligible for the study; however, based on investigator judgment, they were allowed to retest once within 7 days. Reversibility values of 14.50 through 14.99% were rounded to 15%.|percentage increase in FEV1|Mean|26.7|26.7|Standard Deviation|12.01|12.01|||
3903727|NCT01479621|3727768|B7|||% Predicted Expiratory Volume In 1 Second||percent predicted FEV1|Mean|66.4|66.4|Standard Deviation|11.30|11.3|||
3903728|NCT01479621|3727769|B6|||% Predicted Expiratory Volume In 1 Second||percent predicted FEV1|Mean|65.3|65.3|Standard Deviation|11.74|11.74|||
3903729|NCT01479621|3727770|B5|||% Predicted Expiratory Volume In 1 Second||percent predicted FEV1|Mean|66.4|66.4|Standard Deviation|11.14|11.14|||
3903730|NCT01479621|3727771|B4|||% Predicted Expiratory Volume In 1 Second||percent predicted FEV1|Mean|66.4|66.4|Standard Deviation|11.61|11.61|||
3903731|NCT01479621|3727772|B3|||% Predicted Expiratory Volume In 1 Second||percent predicted FEV1|Mean|66.3|66.3|Standard Deviation|11.15|11.15|||
3903732|NCT01479621|3727773|B2|||% Predicted Expiratory Volume In 1 Second||percent predicted FEV1|Mean|67.5|67.5|Standard Deviation|10.50|10.5|||
3903733|NCT01479621|3727774|B1|||% Predicted Expiratory Volume In 1 Second||percent predicted FEV1|Mean|66.6|66.6|Standard Deviation|11.80|11.8|||
3903734|NCT01479621|3727768|B7|||Forced Expiratory Volume in 1 Second (FEV1)||liters|Mean|2.2|2.2|Standard Deviation|0.64|0.64|||
3903735|NCT01479621|3727769|B6|||Forced Expiratory Volume in 1 Second (FEV1)||liters|Mean|2.2|2.2|Standard Deviation|0.66|0.66|||
3903736|NCT01479621|3727770|B5|||Forced Expiratory Volume in 1 Second (FEV1)||liters|Mean|2.3|2.3|Standard Deviation|0.62|0.62|||
3903737|NCT01479621|3727771|B4|||Forced Expiratory Volume in 1 Second (FEV1)||liters|Mean|2.3|2.3|Standard Deviation|0.66|0.66|||
3903738|NCT01479621|3727772|B3|||Forced Expiratory Volume in 1 Second (FEV1)||liters|Mean|2.2|2.2|Standard Deviation|0.63|0.63|||
3903739|NCT01479621|3727773|B2|||Forced Expiratory Volume in 1 Second (FEV1)||liters|Mean|2.2|2.2|Standard Deviation|0.59|0.59|||
3903740|NCT01479621|3727774|B1|||Forced Expiratory Volume in 1 Second (FEV1)||liters|Mean|2.3|2.3|Standard Deviation|0.69|0.69|||
3903741|NCT01479621|3727768|B7|||Body Mass Index||kg/m^2|Mean|28.4|28.4|Standard Deviation|7.04|7.04|||
3903742|NCT01479621|3727769|B6|||Body Mass Index||kg/m^2|Mean|28.4|28.4|Standard Deviation|7.31|7.31|||
3903743|NCT01479621|3727770|B5|||Body Mass Index||kg/m^2|Mean|28.0|28.0|Standard Deviation|6.61|6.61|||
3903744|NCT01479621|3727771|B4|||Body Mass Index||kg/m^2|Mean|29.6|29.6|Standard Deviation|7.54|7.54|||
3903745|NCT01479621|3727772|B3|||Body Mass Index||kg/m^2|Mean|27.5|27.5|Standard Deviation|6.78|6.78|||
3903746|NCT01479621|3727773|B2|||Body Mass Index||kg/m^2|Mean|28.1|28.1|Standard Deviation|6.47|6.47|||
3903747|NCT01479621|3727774|B1|||Body Mass Index||kg/m^2|Mean|28.7|28.7|Standard Deviation|7.43|7.43|||
3903748|NCT01479621|3727768|B7|||Height||cm|Mean|169.0|169.0|Standard Deviation|9.88|9.88|||
3903749|NCT01479621|3727769|B6|||Height||cm|Mean|169.0|169.0|Standard Deviation|9.39|9.39|||
3903750|NCT01479621|3727770|B5|||Height||cm|Mean|169.5|169.5|Standard Deviation|9.25|9.25|||
3903751|NCT01479621|3727771|B4|||Height||cm|Mean|168.7|168.7|Standard Deviation|10.94|10.94|||
3903752|NCT01479621|3727772|B3|||Height||cm|Mean|168.6|168.6|Standard Deviation|10.33|10.33|||
3903753|NCT01479621|3727773|B2|||Height||cm|Mean|169.2|169.2|Standard Deviation|8.89|8.89|||
3903754|NCT01479621|3727774|B1|||Height||cm|Mean|168.8|168.8|Standard Deviation|10.54|10.54|||
3903755|NCT01479621|3727768|B7|||Weight||kg|Mean|81.3|81.3|Standard Deviation|22.22|22.22|||
3903756|NCT01479621|3727769|B6|||Weight||kg|Mean|81.5|81.5|Standard Deviation|23.53|23.53|||
3903757|NCT01479621|3727770|B5|||Weight||kg|Mean|80.5|80.5|Standard Deviation|20.00|20.0|||
3903758|NCT01479621|3727771|B4|||Weight||kg|Mean|84.6|84.6|Standard Deviation|23.51|23.51|||
3903759|NCT01479621|3727772|B3|||Weight||kg|Mean|78.7|78.7|Standard Deviation|23.08|23.08|||
3903760|NCT01479621|3727773|B2|||Weight||kg|Mean|80.4|80.4|Standard Deviation|19.62|19.62|||
3903761|NCT01479621|3727774|B1|||Weight||kg|Mean|82.0|82.0|Standard Deviation|23.29|23.29|||
3903762|NCT01479621|3727768|B7|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|572|572.0||||||
3903763|NCT01479621|3727769|B6|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|98|98.0||||||
3903764|NCT01479621|3727770|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|93|93.0||||||
3903765|NCT01479621|3727771|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|90|90.0||||||
3903766|NCT01479621|3727772|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|97|97.0||||||
3903767|NCT01479621|3727773|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|100|100.0||||||
3903768|NCT01479621|3727774|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|94|94.0||||||
3903769|NCT01479621|3727768|B7|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
3903770|NCT01479621|3727769|B6|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3903771|NCT01479621|3727770|B5|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3903772|NCT01479621|3727771|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3903773|NCT01479621|3727772|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3903774|NCT01479621|3727773|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3903775|NCT01479621|3727774|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3903776|NCT01479621|3727768|B7|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3903777|NCT01479621|3727769|B6|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3903778|NCT01479621|3727770|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3903779|NCT01479621|3727771|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3903780|NCT01479621|3727772|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3903781|NCT01479621|3727773|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3903782|NCT01479621|3727774|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3903783|NCT01479621|3727768|B7|Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3903784|NCT01479621|3727769|B6|Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3903785|NCT01479621|3727770|B5|Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3903786|NCT01479621|3727771|B4|Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3903787|NCT01479621|3727772|B3|Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3903788|NCT01479621|3727773|B2|Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3903789|NCT01479621|3727774|B1|Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3903790|NCT01479621|3727768|B7|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3903791|NCT01479621|3727769|B6|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3903792|NCT01479621|3727770|B5|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3903793|NCT01479621|3727771|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3903794|NCT01479621|3727772|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3903795|NCT01479621|3727773|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3903796|NCT01479621|3727774|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3903797|NCT01479621|3727768|B7|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3903798|NCT01479621|3727769|B6|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3903799|NCT01479621|3727770|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3903800|NCT01479621|3727771|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3903801|NCT01479621|3727772|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3903802|NCT01479621|3727773|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3903803|NCT01479621|3727774|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3903804|NCT01479621|3727768|B7|Black||Race/Ethnicity, Customized||Participants|Count of Participants|81|81.0||||||
3903805|NCT01479621|3727769|B6|Black||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3903806|NCT01479621|3727770|B5|Black||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3903807|NCT01479621|3727771|B4|Black||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3903808|NCT01479621|3727772|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3903809|NCT01479621|3727773|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3903810|NCT01479621|3727774|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3903811|NCT01479621|3727768|B7|White||Race/Ethnicity, Customized||Participants|Count of Participants|527|527.0||||||
3903812|NCT01479621|3727769|B6|White||Race/Ethnicity, Customized||Participants|Count of Participants|85|85.0||||||
3903813|NCT01479621|3727770|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|85|85.0||||||
3903814|NCT01479621|3727771|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|85|85.0||||||
3903815|NCT01479621|3727772|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|90|90.0||||||
3903816|NCT01479621|3727773|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|91|91.0||||||
3903817|NCT01479621|3727774|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|91|91.0||||||
3903818|NCT01479621|3727768|B7||Male|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
3903819|NCT01479621|3727769|B6||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3903820|NCT01479621|3727770|B5||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3903821|NCT01479621|3727771|B4||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3903822|NCT01479621|3727772|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3903823|NCT01479621|3727773|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3903824|NCT01479621|3727774|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3903825|NCT01479621|3727768|B7||Female|Sex: Female, Male||Participants|Count of Participants|358|358.0||||||
3903826|NCT01479621|3727769|B6||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3903827|NCT01479621|3727770|B5||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3903828|NCT01479621|3727771|B4||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3903829|NCT01479621|3727772|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3903830|NCT01479621|3727773|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3903831|NCT01479621|3727774|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3903832|NCT01479621|3727768|B7|Adults (65+ years)||Age, Customized||Participants|Count of Participants|35|35.0||||||
3903833|NCT01479621|3727769|B6|Adults (65+ years)||Age, Customized||Participants|Count of Participants|4|4.0||||||
3903834|NCT01479621|3727770|B5|Adults (65+ years)||Age, Customized||Participants|Count of Participants|6|6.0||||||
3903835|NCT01479621|3727771|B4|Adults (65+ years)||Age, Customized||Participants|Count of Participants|6|6.0||||||
3903836|NCT01479621|3727772|B3|Adults (65+ years)||Age, Customized||Participants|Count of Participants|4|4.0||||||
3903837|NCT01479621|3727773|B2|Adults (65+ years)||Age, Customized||Participants|Count of Participants|7|7.0||||||
3903838|NCT01479621|3727774|B1|Adults (65+ years)||Age, Customized||Participants|Count of Participants|8|8.0||||||
3903839|NCT01479621|3727768|B7|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|535|535.0||||||
3903840|NCT01479621|3727769|B6|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|93|93.0||||||
3903841|NCT01479621|3727770|B5|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|93|93.0||||||
3903842|NCT01479621|3727771|B4|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|88|88.0||||||
3903843|NCT01479621|3727772|B3|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|86|86.0||||||
3903844|NCT01479621|3727773|B2|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|90|90.0||||||
3903845|NCT01479621|3727774|B1|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|85|85.0||||||
3903846|NCT01479621|3727768|B7|12-17 years||Age, Customized||Participants|Count of Participants|52|52.0||||||
3903847|NCT01479621|3727769|B6|12-17 years||Age, Customized||Participants|Count of Participants|7|7.0||||||
3903848|NCT01479621|3727770|B5|12-17 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
3903849|NCT01479621|3727771|B4|12-17 years||Age, Customized||Participants|Count of Participants|9|9.0||||||
3903850|NCT01479621|3727772|B3|12-17 years||Age, Customized||Participants|Count of Participants|14|14.0||||||
3903851|NCT01479621|3727773|B2|12-17 years||Age, Customized||Participants|Count of Participants|7|7.0||||||
3903852|NCT01479621|3727774|B1|12-17 years||Age, Customized||Participants|Count of Participants|10|10.0||||||
3903853|NCT01479621|3727768|B7|||Age||years|Mean|39.9|39.9|Standard Deviation|15.87|15.87|||
3903854|NCT01479621|3727769|B6|||Age||years|Mean|40.0|40.0|Standard Deviation|15.34|15.34|||
3903855|NCT01479621|3727770|B5|||Age||years|Mean|39.7|39.7|Standard Deviation|15.28|15.28|||
3903856|NCT01479621|3727771|B4|||Age||years|Mean|36.9|36.9|Standard Deviation|15.34|15.34|||
3903857|NCT01479621|3727772|B3|||Age||years|Mean|39.1|39.1|Standard Deviation|16.06|16.06|||
3903858|NCT01479621|3727773|B2|||Age||years|Mean|42.4|42.4|Standard Deviation|16.02|16.02|||
3903859|NCT01479621|3727774|B1|||Age||years|Mean|41.0|41.0|Standard Deviation|16.94|16.94|||
3903860|NCT01479595|3727866|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3903861|NCT01479595|3727867|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3903862|NCT01479595|3727868|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3903863|NCT01479595|3727866|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3903864|NCT01479595|3727867|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3903865|NCT01479595|3727868|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3903866|NCT01479595|3727866|B3|||Age||Years|Mean|42.6|42.6|Standard Deviation|12.22|12.22|||
3903867|NCT01479595|3727867|B2|||Age||Years|Mean|42.8|42.8|Standard Deviation|13.54|13.54|||
3903868|NCT01479595|3727868|B1|||Age||Years|Mean|42.5|42.5|Standard Deviation|11.71|11.71|||
3903869|NCT01479543|3727891|B6|Spain||Region of Enrollment||participants|Number|100|100.0||||||
3903870|NCT01479543|3727892|B5|Spain||Region of Enrollment||participants|Number|20|20.0||||||
3903871|NCT01479543|3727893|B4|Spain||Region of Enrollment||participants|Number|20|20.0||||||
3903872|NCT01479543|3727894|B3|Spain||Region of Enrollment||participants|Number|20|20.0||||||
3903873|NCT01479543|3727895|B2|Spain||Region of Enrollment||participants|Number|20|20.0||||||
3903874|NCT01479543|3727896|B1|Spain||Region of Enrollment||participants|Number|20|20.0||||||
3903875|NCT01479543|3727891|B6||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3903876|NCT01479543|3727892|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3903877|NCT01479543|3727893|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3903878|NCT01479543|3727894|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3903879|NCT01479543|3727895|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3903880|NCT01479543|3727896|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3903881|NCT01479543|3727891|B6||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3903882|NCT01479543|3727892|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3903883|NCT01479543|3727893|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3903884|NCT01479543|3727894|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3903885|NCT01479543|3727895|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3903886|NCT01479543|3727896|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3903887|NCT01479543|3727891|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3903888|NCT01479543|3727892|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3903889|NCT01479543|3727893|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3903890|NCT01479543|3727894|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3903891|NCT01479543|3727895|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3903892|NCT01479543|3727896|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3903893|NCT01479543|3727891|B6||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
3903894|NCT01479543|3727892|B5||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3903895|NCT01479543|3727893|B4||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3903896|NCT01479543|3727894|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3903897|NCT01479543|3727895|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3903898|NCT01479543|3727896|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3903899|NCT01479543|3727891|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3903900|NCT01479543|3727892|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3903901|NCT01479543|3727893|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3903902|NCT01479543|3727894|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3903903|NCT01479543|3727895|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3903904|NCT01479543|3727896|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3903905|NCT01479543|3727891|B6|||Age||years|Mean|28.78|28.78|Standard Deviation|1.22|1.22|||
3903906|NCT01479543|3727892|B5|||Age||years|Mean|28.5|28.5|Standard Deviation|7.6|7.6|||
3903907|NCT01479543|3727893|B4|||Age||years|Mean|30.3|30.3|Standard Deviation|7.6|7.6|||
3903908|NCT01479543|3727894|B3|||Age||years|Mean|29.4|29.4|Standard Deviation|7.1|7.1|||
3903909|NCT01479543|3727895|B2|||Age||years|Mean|27|27.0|Standard Deviation|5.7|5.7|||
3903910|NCT01479543|3727896|B1|||Age||years|Mean|28.7|28.7|Standard Deviation|5|5.0|||
3903925|NCT01479530|3727914|B1||Male|Sex: Female, Male|APTS|Participants|Count of Participants|109|109.0||||||
3903911|NCT01479530|3727912|B3|||UPDRS Motor Score During ON time|"UPDRS is a 42-item rating scale designed to assess PD-related disability and impairment using a patient interview and a physical examination. It has 4 parts and 4 subsection scores. A higher score indicates a worse outcome. I: mentation, behaviour and mood symptoms - 0 to 16; II: ADL - 0 to 52; III: motor function - 0 to 108; IV: complications of dopaminergic therapy - 0 to 23. Subsection scores for I to III are used to calculate a total score that ranges from 0 (no disability) to 176 (total dependence).~FAS."|units on a scale|Mean|24.70|24.7|Standard Deviation|10.50|10.5|||
3903912|NCT01479530|3727913|B2|||UPDRS Motor Score During ON time|"UPDRS is a 42-item rating scale designed to assess PD-related disability and impairment using a patient interview and a physical examination. It has 4 parts and 4 subsection scores. A higher score indicates a worse outcome. I: mentation, behaviour and mood symptoms - 0 to 16; II: ADL - 0 to 52; III: motor function - 0 to 108; IV: complications of dopaminergic therapy - 0 to 23. Subsection scores for I to III are used to calculate a total score that ranges from 0 (no disability) to 176 (total dependence).~FAS."|units on a scale|Mean|23.82|23.82|Standard Deviation|10.47|10.47|||
3903913|NCT01479530|3727914|B1|||UPDRS Motor Score During ON time|"UPDRS is a 42-item rating scale designed to assess PD-related disability and impairment using a patient interview and a physical examination. It has 4 parts and 4 subsection scores. A higher score indicates a worse outcome. I: mentation, behaviour and mood symptoms - 0 to 16; II: ADL - 0 to 52; III: motor function - 0 to 108; IV: complications of dopaminergic therapy - 0 to 23. Subsection scores for I to III are used to calculate a total score that ranges from 0 (no disability) to 176 (total dependence).~FAS."|units on a scale|Mean|25.62|25.62|Standard Deviation|10.48|10.48|||
3903914|NCT01479530|3727912|B3|||UPDRS-ADL Score During OFF Time|"Unified Parkinson’s Disease Rating Scale (UPDRS) is a 42-item rating scale designed to assess PD-related disability and impairment using a patient interview and a physical examination. It has 4 parts and 4 subsection scores. A higher score indicates a worse outcome. I: mentation, behaviour and mood symptoms - 0 to 16; II: activities of daily living (ADL) - 0 to 52; III: motor function - 0 to 108; IV: complications of dopaminergic therapy - 0 to 23. Subsection scores for I to III are used to calculate a total score that ranges from 0 (no disability) to 176 (total dependence).~FAS."|units on a scale|Mean|16.01|16.01|Standard Deviation|7.34|7.34|||
3903915|NCT01479530|3727913|B2|||UPDRS-ADL Score During OFF Time|"Unified Parkinson’s Disease Rating Scale (UPDRS) is a 42-item rating scale designed to assess PD-related disability and impairment using a patient interview and a physical examination. It has 4 parts and 4 subsection scores. A higher score indicates a worse outcome. I: mentation, behaviour and mood symptoms - 0 to 16; II: activities of daily living (ADL) - 0 to 52; III: motor function - 0 to 108; IV: complications of dopaminergic therapy - 0 to 23. Subsection scores for I to III are used to calculate a total score that ranges from 0 (no disability) to 176 (total dependence).~FAS."|units on a scale|Mean|15.59|15.59|Standard Deviation|7.15|7.15|||
3903916|NCT01479530|3727914|B1|||UPDRS-ADL Score During OFF Time|"Unified Parkinson’s Disease Rating Scale (UPDRS) is a 42-item rating scale designed to assess PD-related disability and impairment using a patient interview and a physical examination. It has 4 parts and 4 subsection scores. A higher score indicates a worse outcome. I: mentation, behaviour and mood symptoms - 0 to 16; II: activities of daily living (ADL) - 0 to 52; III: motor function - 0 to 108; IV: complications of dopaminergic therapy - 0 to 23. Subsection scores for I to III are used to calculate a total score that ranges from 0 (no disability) to 176 (total dependence).~FAS."|units on a scale|Mean|16.45|16.45|Standard Deviation|7.54|7.54|||
3903917|NCT01479530|3727912|B3|||CGI-S|"Clinical Global Impression - Severity of Illness (CGI-S) is a single-item rating scale used to evaluate a patient’s severity of illness on a 7-point scale, based on the investigator’s total clinical experience with patients. The scale ranges from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).~FAS."|units on a scale|Mean|4.00|4.0|Standard Deviation|0.77|0.77|||
3903918|NCT01479530|3727913|B2|||CGI-S|"Clinical Global Impression - Severity of Illness (CGI-S) is a single-item rating scale used to evaluate a patient’s severity of illness on a 7-point scale, based on the investigator’s total clinical experience with patients. The scale ranges from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).~FAS."|units on a scale|Mean|3.94|3.94|Standard Deviation|0.76|0.76|||
3903919|NCT01479530|3727914|B1|||CGI-S|"Clinical Global Impression - Severity of Illness (CGI-S) is a single-item rating scale used to evaluate a patient’s severity of illness on a 7-point scale, based on the investigator’s total clinical experience with patients. The scale ranges from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).~FAS."|units on a scale|Mean|4.07|4.07|Standard Deviation|0.77|0.77|||
3903920|NCT01479530|3727912|B3|||Total Daily OFF Time|"Parkinson's Disease Patient Diary is a self-administered diary designed to assess motor fluctuations throughout the day. It is divided into 30-minute intervals, and the patient selects one of four options for each interval: asleep; off; on with no dyskinesia or without troublesome dyskinesia; or on with troublesome dyskinesia.~Full-analysis set (FAS) – all patients in the APTS who had at least one valid post-baseline measurement of the total daily OFF time (a valid post-baseline diary was a diary reported from Week 4 onwards based on pre-defined visit windows)."|hours|Mean|6.12|6.12|Standard Deviation|2.66|2.66|||
3903921|NCT01479530|3727913|B2|||Total Daily OFF Time|"Parkinson's Disease Patient Diary is a self-administered diary designed to assess motor fluctuations throughout the day. It is divided into 30-minute intervals, and the patient selects one of four options for each interval: asleep; off; on with no dyskinesia or without troublesome dyskinesia; or on with troublesome dyskinesia.~Full-analysis set (FAS) – all patients in the APTS who had at least one valid post-baseline measurement of the total daily OFF time (a valid post-baseline diary was a diary reported from Week 4 onwards based on pre-defined visit windows)."|hours|Mean|6.10|6.1|Standard Deviation|2.60|2.6|||
3903922|NCT01479530|3727914|B1|||Total Daily OFF Time|"Parkinson's Disease Patient Diary is a self-administered diary designed to assess motor fluctuations throughout the day. It is divided into 30-minute intervals, and the patient selects one of four options for each interval: asleep; off; on with no dyskinesia or without troublesome dyskinesia; or on with troublesome dyskinesia.~Full-analysis set (FAS) – all patients in the APTS who had at least one valid post-baseline measurement of the total daily OFF time (a valid post-baseline diary was a diary reported from Week 4 onwards based on pre-defined visit windows)."|hours|Mean|6.13|6.13|Standard Deviation|2.72|2.72|||
3903923|NCT01479530|3727912|B3||Male|Sex: Female, Male|APTS|Participants|Count of Participants|212|212.0||||||
3903924|NCT01479530|3727913|B2||Male|Sex: Female, Male|APTS|Participants|Count of Participants|103|103.0||||||
3903926|NCT01479530|3727912|B3||Female|Sex: Female, Male|APTS|Participants|Count of Participants|109|109.0||||||
3903927|NCT01479530|3727913|B2||Female|Sex: Female, Male|APTS|Participants|Count of Participants|60|60.0||||||
3903928|NCT01479530|3727914|B1||Female|Sex: Female, Male|APTS|Participants|Count of Participants|49|49.0||||||
3903929|NCT01479530|3727912|B3|||Age|all-patients-treated set (APTS) - all patients in the all-patients-randomised set (APRS) who took at least one dose of investigational medicinal product (IMP).|years|Mean|62.2|62.2|Standard Deviation|9.4|9.4|||
3903930|NCT01479530|3727913|B2|||Age|all-patients-treated set (APTS) - all patients in the all-patients-randomised set (APRS) who took at least one dose of investigational medicinal product (IMP).|years|Mean|62.7|62.7|Standard Deviation|8.9|8.9|||
3903931|NCT01479530|3727914|B1|||Age|all-patients-treated set (APTS) - all patients in the all-patients-randomised set (APRS) who took at least one dose of investigational medicinal product (IMP).|years|Mean|61.7|61.7|Standard Deviation|9.9|9.9|||
3903932|NCT01479517|3727927|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903933|NCT01479517|3727928|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903934|NCT01479517|3727929|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903935|NCT01479517|3727930|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903936|NCT01479517|3727927|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3903937|NCT01479517|3727928|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903938|NCT01479517|3727929|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903939|NCT01479517|3727930|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3903940|NCT01479517|3727927|B4||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3903941|NCT01479517|3727928|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3903942|NCT01479517|3727929|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3903943|NCT01479517|3727930|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3903944|NCT01479517|3727927|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903945|NCT01479517|3727928|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903946|NCT01479517|3727929|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903947|NCT01479517|3727930|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903948|NCT01479517|3727927|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903949|NCT01479517|3727928|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903950|NCT01479517|3727929|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903951|NCT01479517|3727930|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903952|NCT01479517|3727927|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903953|NCT01479517|3727928|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903954|NCT01479517|3727929|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903955|NCT01479517|3727930|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903956|NCT01479517|3727927|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903957|NCT01479517|3727928|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903958|NCT01479517|3727929|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903959|NCT01479517|3727930|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903960|NCT01479517|3727927|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903961|NCT01479517|3727928|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903962|NCT01479517|3727929|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903963|NCT01479517|3727930|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903964|NCT01479517|3727927|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3903965|NCT01479517|3727928|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3903966|NCT01479517|3727929|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3903967|NCT01479517|3727930|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3903968|NCT01479517|3727927|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903969|NCT01479517|3727928|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903970|NCT01479517|3727929|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903971|NCT01479517|3727930|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3903972|NCT01479517|3727927|B4||Male|Gender||Participants|Count of Participants|10|10.0||||||
3903973|NCT01479517|3727928|B3||Male|Gender||Participants|Count of Participants|3|3.0||||||
3903974|NCT01479517|3727929|B2||Male|Gender||Participants|Count of Participants|4|4.0||||||
3903975|NCT01479517|3727930|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
3903976|NCT01479517|3727927|B4||Female|Gender||Participants|Count of Participants|20|20.0||||||
3903977|NCT01479517|3727928|B3||Female|Gender||Participants|Count of Participants|7|7.0||||||
3903978|NCT01479517|3727929|B2||Female|Gender||Participants|Count of Participants|6|6.0||||||
3903979|NCT01479517|3727930|B1||Female|Gender||Participants|Count of Participants|7|7.0||||||
3903980|NCT01479517|3727927|B4|||Age||years|Mean|54.7|54.7|Standard Deviation|12.53|12.53|||
3903981|NCT01479517|3727928|B3|||Age||years|Mean|54.0|54.0|Standard Deviation|15.2|15.2|||
3903982|NCT01479517|3727929|B2|||Age||years|Mean|58.6|58.6|Standard Deviation|9.55|9.55|||
3903983|NCT01479517|3727930|B1|||Age||years|Mean|51.5|51.5|Standard Deviation|12.42|12.42|||
3903984|NCT01479478|3727949|B3|||Pre-pregnancy Body Mass Index||kg/m^2|Mean|26.1|26.1|Standard Deviation|7|7.0|||
3903985|NCT01479478|3727950|B2|||Pre-pregnancy Body Mass Index||kg/m^2|Mean|26.0|26.0|Standard Deviation|7.5|7.5|||
3903986|NCT01479478|3727951|B1|||Pre-pregnancy Body Mass Index||kg/m^2|Mean|26.1|26.1|Standard Deviation|6.5|6.5|||
3903987|NCT01479478|3727949|B3|United States||Region of Enrollment||Participants|Count of Participants|251|251.0||||||
3903988|NCT01479478|3727950|B2|United States||Region of Enrollment||Participants|Count of Participants|126|126.0||||||
3903989|NCT01479478|3727951|B1|United States||Region of Enrollment||Participants|Count of Participants|125|125.0||||||
3903990|NCT01479478|3727949|B3|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3903991|NCT01479478|3727950|B2|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3903992|NCT01479478|3727951|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3903993|NCT01479478|3727949|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|58|58.0||||||
3903994|NCT01479478|3727950|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3903995|NCT01479478|3727951|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3903996|NCT01479478|3727949|B3|Non-Hispanic other||Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
3903997|NCT01479478|3727950|B2|Non-Hispanic other||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3903998|NCT01479478|3727951|B1|Non-Hispanic other||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3903999|NCT01479478|3727949|B3|Non-Hispanic white||Race/Ethnicity, Customized||Participants|Count of Participants|137|137.0||||||
3904000|NCT01479478|3727950|B2|Non-Hispanic white||Race/Ethnicity, Customized||Participants|Count of Participants|71|71.0||||||
3904001|NCT01479478|3727951|B1|Non-Hispanic white||Race/Ethnicity, Customized||Participants|Count of Participants|66|66.0||||||
3904002|NCT01479478|3727949|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3904003|NCT01479478|3727950|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3904004|NCT01479478|3727951|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3904005|NCT01479478|3727949|B3||Female|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
3904006|NCT01479478|3727950|B2||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3904007|NCT01479478|3727951|B1||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3904008|NCT01479478|3727949|B3|||Age||years|Mean|31.7|31.7|Standard Deviation|5.5|5.5|||
3904009|NCT01479478|3727950|B2|||Age||years|Mean|31.9|31.9|Standard Deviation|5.3|5.3|||
3904010|NCT01479478|3727951|B1|||Age||years|Mean|31.4|31.4|Standard Deviation|5.7|5.7|||
3904011|NCT01479374|3727992|B4|United States||Region of Enrollment||participants|Number|202|202.0||||||
3904012|NCT01479374|3727993|B3|United States||Region of Enrollment||participants|Number|68|68.0||||||
3904013|NCT01479374|3727994|B2|United States||Region of Enrollment||participants|Number|68|68.0||||||
3904014|NCT01479374|3727995|B1|United States||Region of Enrollment||participants|Number|66|66.0||||||
3904015|NCT01479374|3727992|B4||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3904016|NCT01479374|3727993|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3904017|NCT01479374|3727994|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3904018|NCT01479374|3727995|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3904019|NCT01479374|3727992|B4||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3904020|NCT01479374|3727993|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3904021|NCT01479374|3727994|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3904022|NCT01479374|3727995|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3904023|NCT01479374|3727992|B4|>=65 years||Age, Customized||participants|Number|6|6.0||||||
3904024|NCT01479374|3727993|B3|>=65 years||Age, Customized||participants|Number|2|2.0||||||
3904025|NCT01479374|3727994|B2|>=65 years||Age, Customized||participants|Number|2|2.0||||||
3904026|NCT01479374|3727995|B1|>=65 years||Age, Customized||participants|Number|2|2.0||||||
3904027|NCT01479374|3727992|B4|18 to 64 years||Age, Customized||participants|Number|196|196.0||||||
3904028|NCT01479374|3727993|B3|18 to 64 years||Age, Customized||participants|Number|66|66.0||||||
3904029|NCT01479374|3727994|B2|18 to 64 years||Age, Customized||participants|Number|66|66.0||||||
3904030|NCT01479374|3727995|B1|18 to 64 years||Age, Customized||participants|Number|64|64.0||||||
3904031|NCT01479270|3728023|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3904032|NCT01479270|3728024|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3904033|NCT01479270|3728025|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3904034|NCT01479270|3728023|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3904035|NCT01479270|3728024|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3904036|NCT01479270|3728025|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3904037|NCT01479270|3728023|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3904038|NCT01479270|3728024|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3904039|NCT01479270|3728025|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3904040|NCT01479270|3728023|B3||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
3904041|NCT01479270|3728024|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3904042|NCT01479270|3728025|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3904043|NCT01479270|3728023|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3904044|NCT01479270|3728024|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3904045|NCT01479270|3728025|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3904046|NCT01479127|3728038|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3904047|NCT01479127|3728038|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3904048|NCT01479127|3728038|B1|>/= 65 years||Age, Customized||participants|Number|4|4.0||||||
3904049|NCT01479127|3728038|B1|< 65 years||Age, Customized||participants|Number|4|4.0||||||
3904050|NCT01479127|3728038|B1|||Age||years|Mean|65.4|65.4|Standard Deviation|6.19|6.19|||
3904051|NCT01478971|3728083|B1|||Transferrin saturation|Transferrin saturation data only available for 146 participants.|percent saturation|Mean|35.2|35.2|Standard Deviation|13.85|13.85|||
3904052|NCT01478971|3728083|B1|||Ferritin|Ferritin data only available for 149 participants.|ng/mL|Mean|1068.7|1068.7|Standard Deviation|513.1|513.1|||
3904053|NCT01478971|3728083|B1|||Baseline hemoglobin||g/dL|Mean|10.9|10.9|Standard Deviation|0.96|0.96|||
3904054|NCT01478971|3728083|B1|6 times a week||Current dialysis frequency||participants|Number|1|1.0||||||
3904055|NCT01478971|3728083|B1|5 times a week||Current dialysis frequency||participants|Number|1|1.0||||||
3904056|NCT01478971|3728083|B1|4 times a week||Current dialysis frequency||participants|Number|4|4.0||||||
3904057|NCT01478971|3728083|B1|3 times a week||Current dialysis frequency||participants|Number|169|169.0||||||
3904058|NCT01478971|3728083|B1|2 times a week||Current dialysis frequency||participants|Number|3|3.0||||||
3904059|NCT01478971|3728083|B1|Other||Primary cause of chronic kidney disease||participants|Number|10|10.0||||||
3904060|NCT01478971|3728083|B1|Unknown||Primary cause of chronic kidney disease||participants|Number|3|3.0||||||
3904061|NCT01478971|3728083|B1|Congenital||Primary cause of chronic kidney disease||participants|Number|1|1.0||||||
3904062|NCT01478971|3728083|B1|Immunoglobulin (Ig) A nephropathy||Primary cause of chronic kidney disease||participants|Number|3|3.0||||||
3904063|NCT01478971|3728083|B1|Urological||Primary cause of chronic kidney disease||participants|Number|4|4.0||||||
3904064|NCT01478971|3728083|B1|Glomerulonephritis||Primary cause of chronic kidney disease||participants|Number|15|15.0||||||
3904065|NCT01478971|3728083|B1|Interstitial nephritis||Primary cause of chronic kidney disease||participants|Number|2|2.0||||||
3904066|NCT01478971|3728083|B1|Cystic renal disease||Primary cause of chronic kidney disease||participants|Number|6|6.0||||||
3904067|NCT01478971|3728083|B1|Hypertension||Primary cause of chronic kidney disease||participants|Number|37|37.0||||||
3904068|NCT01478971|3728083|B1|Diabetes||Primary cause of chronic kidney disease||participants|Number|97|97.0||||||
3904069|NCT01478971|3728083|B1|No||Nephrotic syndrome history||participants|Number|148|148.0||||||
3904070|NCT01478971|3728083|B1|Yes||Nephrotic syndrome history||participants|Number|30|30.0||||||
3904071|NCT01478971|3728083|B1|No||Kidney transplant recipient||participants|Number|161|161.0||||||
3904072|NCT01478971|3728083|B1|Yes||Kidney transplant recipient||participants|Number|17|17.0||||||
3904073|NCT01478971|3728083|B1|||Time on dialysis||years|Mean|4.2|4.2|Standard Deviation|3.71|3.71|||
3904074|NCT01478971|3728083|B1|||Weight|Weight data only available for 177 participants.|kg|Mean|83.8|83.8|Standard Deviation|22.93|22.93|||
3904075|NCT01478971|3728083|B1|United States||Region of Enrollment||participants|Number|178|178.0||3.71|3.71|||
3904076|NCT01478971|3728083|B1|White||Race/Ethnicity, Customized||participants|Number|119|119.0||||||
3904077|NCT01478971|3728083|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3904078|NCT01478971|3728083|B1|Black||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
3904079|NCT01478971|3728083|B1|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3904080|NCT01478971|3728083|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3904081|NCT01478971|3728083|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|102|102.0||||||
3904082|NCT01478971|3728083|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
3904083|NCT01478971|3728083|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3904084|NCT01478971|3728083|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3904085|NCT01478971|3728083|B1|≥ 75 years||Age, Customized||participants|Number|31|31.0||||||
3904086|NCT01478971|3728083|B1|65 - 74 years||Age, Customized||participants|Number|44|44.0||||||
3904087|NCT01478971|3728083|B1|< 65 years||Age, Customized||participants|Number|103|103.0||||||
3904088|NCT01478971|3728083|B1|||Age||years|Mean|59.6|59.6|Standard Deviation|15.33|15.33|||
3904089|NCT01478958|3728097|B4|||Fasting Glucose||mmol/L|Mean|5.05|5.05|Standard Deviation|0.44|0.44|||
3904090|NCT01478958|3728098|B3|||Fasting Glucose||mmol/L|Mean|5.05|5.05|Standard Deviation|0.44|0.44|||
3904091|NCT01478958|3728099|B2|||Fasting Glucose||mmol/L|Mean|5.00|5.0|Standard Deviation|0.45|0.45|||
3904092|NCT01478958|3728100|B1|||Fasting Glucose||mmol/L|Mean|5.09|5.09|Standard Deviation|0.43|0.43|||
3904093|NCT01478958|3728097|B4|||Fasting Triacylglycerol (TAG)||mmol/L|Mean|1.25|1.25|Standard Deviation|0.67|0.67|||
3904094|NCT01478958|3728098|B3|||Fasting Triacylglycerol (TAG)||mmol/L|Mean|1.26|1.26|Standard Deviation|0.67|0.67|||
3904095|NCT01478958|3728099|B2|||Fasting Triacylglycerol (TAG)||mmol/L|Mean|1.18|1.18|Standard Deviation|0.53|0.53|||
3904096|NCT01478958|3728100|B1|||Fasting Triacylglycerol (TAG)||mmol/L|Mean|1.31|1.31|Standard Deviation|0.77|0.77|||
3904097|NCT01478958|3728097|B4|||Fasting Low-Density Lipoprotein Cholesterol (LDL-C)||mmol/L|Mean|3.73|3.73|Standard Deviation|0.98|0.98|||
3904098|NCT01478958|3728098|B3|||Fasting Low-Density Lipoprotein Cholesterol (LDL-C)||mmol/L|Mean|3.81|3.81|Standard Deviation|1.13|1.13|||
3904099|NCT01478958|3728099|B2|||Fasting Low-Density Lipoprotein Cholesterol (LDL-C)||mmol/L|Mean|3.71|3.71|Standard Deviation|0.88|0.88|||
3904100|NCT01478958|3728100|B1|||Fasting Low-Density Lipoprotein Cholesterol (LDL-C)||mmol/L|Mean|3.67|3.67|Standard Deviation|0.93|0.93|||
3904101|NCT01478958|3728097|B4|||Ratio of TC:HDL-C|||Mean|3.87|3.87|Standard Deviation|1.10|1.1|||
3904102|NCT01478958|3728098|B3|||Ratio of TC:HDL-C|||Mean|3.85|3.85|Standard Deviation|1.12|1.12|||
3904103|NCT01478958|3728099|B2|||Ratio of TC:HDL-C|||Mean|3.85|3.85|Standard Deviation|0.99|0.99|||
3904104|NCT01478958|3728100|B1|||Ratio of TC:HDL-C|||Mean|3.92|3.92|Standard Deviation|1.20|1.2|||
3904105|NCT01478958|3728097|B4|||Fasting High-Density Lipoprotein Cholesterol (HDL-C)||mmol/L|Mean|1.48|1.48|Standard Deviation|0.37|0.37|||
3904106|NCT01478958|3728098|B3|||Fasting High-Density Lipoprotein Cholesterol (HDL-C)||mmol/L|Mean|1.51|1.51|Standard Deviation|0.38|0.38|||
3904107|NCT01478958|3728099|B2|||Fasting High-Density Lipoprotein Cholesterol (HDL-C)||mmol/L|Mean|1.48|1.48|Standard Deviation|0.39|0.39|||
3904108|NCT01478958|3728100|B1|||Fasting High-Density Lipoprotein Cholesterol (HDL-C)||mmol/L|Mean|1.45|1.45|Standard Deviation|0.33|0.33|||
3904109|NCT01478958|3728097|B4|||Fasting Total Cholesterol (TC)||mmol/L|Mean|5.46|5.46|Standard Deviation|1.09|1.09|||
3904110|NCT01478958|3728098|B3|||Fasting Total Cholesterol (TC)||mmol/L|Mean|5.57|5.57|Standard Deviation|1.27|1.27|||
3904111|NCT01478958|3728099|B2|||Fasting Total Cholesterol (TC)||mmol/L|Mean|5.43|5.43|Standard Deviation|1.07|1.07|||
3904112|NCT01478958|3728100|B1|||Fasting Total Cholesterol (TC)||mmol/L|Mean|5.38|5.38|Standard Deviation|0.98|0.98|||
3904113|NCT01478958|3728097|B4|||24-hour Diastolic Blood Pressure (DBP)||mm Hg|Mean|75|75.0|Standard Deviation|7|7.0|||
3904114|NCT01478958|3728098|B3|||24-hour Diastolic Blood Pressure (DBP)||mm Hg|Mean|76|76.0|Standard Deviation|8|8.0|||
3904115|NCT01478958|3728099|B2|||24-hour Diastolic Blood Pressure (DBP)||mm Hg|Mean|74|74.0|Standard Deviation|6|6.0|||
3904116|NCT01478958|3728100|B1|||24-hour Diastolic Blood Pressure (DBP)||mm Hg|Mean|75|75.0|Standard Deviation|8|8.0|||
3904117|NCT01478958|3728097|B4|||24-hour Systolic Blood Pressure (SBP)||mm Hg|Mean|122|122.0|Standard Deviation|11|11.0|||
3904118|NCT01478958|3728098|B3|||24-hour Systolic Blood Pressure (SBP)||mm Hg|Mean|124|124.0|Standard Deviation|11|11.0|||
3904119|NCT01478958|3728099|B2|||24-hour Systolic Blood Pressure (SBP)||mm Hg|Mean|121|121.0|Standard Deviation|10|10.0|||
3904120|NCT01478958|3728100|B1|||24-hour Systolic Blood Pressure (SBP)||mm Hg|Mean|121|121.0|Standard Deviation|12|12.0|||
3904121|NCT01478958|3728097|B4|||Waist Circumference||cm|Mean|90.9|90.9|Standard Deviation|12.0|12.0|||
3904122|NCT01478958|3728098|B3|||Waist Circumference||cm|Mean|92.1|92.1|Standard Deviation|13.1|13.1|||
3904123|NCT01478958|3728099|B2|||Waist Circumference||cm|Mean|88.2|88.2|Standard Deviation|10.3|10.3|||
3904124|NCT01478958|3728100|B1|||Waist Circumference||cm|Mean|92.1|92.1|Standard Deviation|12.1|12.1|||
3904125|NCT01478958|3728097|B4|||Body Mass Index (BMI)||kg/m^2|Mean|26.7|26.7|Standard Deviation|4.0|4.0|||
3904126|NCT01478958|3728098|B3|||Body Mass Index (BMI)||kg/m^2|Mean|27.0|27.0|Standard Deviation|3.7|3.7|||
3904127|NCT01478958|3728099|B2|||Body Mass Index (BMI)||kg/m^2|Mean|26.3|26.3|Standard Deviation|3.9|3.9|||
3904128|NCT01478958|3728100|B1|||Body Mass Index (BMI)||kg/m^2|Mean|26.7|26.7|Standard Deviation|4.4|4.4|||
3904129|NCT01478958|3728097|B4|United Kingdom||Region of Enrollment||participants|Number|195|195.0||||||
3904130|NCT01478958|3728098|B3|United Kingdom||Region of Enrollment||participants|Number|66|66.0||||||
3904131|NCT01478958|3728099|B2|United Kingdom||Region of Enrollment||participants|Number|64|64.0||||||
3904132|NCT01478958|3728100|B1|United Kingdom||Region of Enrollment||participants|Number|65|65.0||||||
3904133|NCT01478958|3728097|B4||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3904134|NCT01478958|3728098|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3904135|NCT01478958|3728099|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3904136|NCT01478958|3728100|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3904137|NCT01478958|3728097|B4||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3904138|NCT01478958|3728098|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3904139|NCT01478958|3728099|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3904140|NCT01478958|3728100|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3904141|NCT01478958|3728097|B4|||Age||years|Mean|44|44.0|Standard Deviation|10|10.0|||
3904142|NCT01478958|3728098|B3|||Age||years|Mean|45|45.0|Standard Deviation|10|10.0|||
3904143|NCT01478958|3728099|B2|||Age||years|Mean|43|43.0|Standard Deviation|11|11.0|||
3904144|NCT01478958|3728100|B1|||Age||years|Mean|45|45.0|Standard Deviation|9|9.0|||
3904145|NCT01478828|3728110|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3904146|NCT01478828|3728110|B1|Male||Sex/Gender, Customized||participants|Number|2|2.0||||||
3904147|NCT01478828|3728110|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3904148|NCT01478828|3728110|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3904149|NCT01478828|3728110|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3904150|NCT01478620|3728115|B1|||uncomplicated urinary tract infection symptom score|"The severity of uUTI symptoms was assessed daily by the patient as well as by the investigator at each study visit. The following uUTI symptoms were rated on a 5-point scale: dysuria, frequency, urgency, acute development of incontinence or worsening of incontinence, nocturia, pain or discomfort in lower abdomen or pelvic areas and increased body temperature.~The assessment of the symptoms ranged from 0 (absent or </= 37°C) to 4 (very severe or >/= 40°C).~At baseline the total sum score (sum of subscales) of the symptoms dysuria, frequency and urgency had to be at least >/= 6."|score on a scale|Mean|7.3|7.3|Standard Deviation|1.25|1.25|||
3904151|NCT01478620|3728115|B1|Russian Federation||Region of Enrollment||participants|Number|0|0.0||||||
3904152|NCT01478620|3728115|B1|Ukraine||Region of Enrollment||participants|Number|125|125.0||||||
3904153|NCT01478620|3728115|B1|||Sex/Gender, Customized|female participants|participants|Number|125|125.0||||||
3904154|NCT01478620|3728115|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3904155|NCT01478620|3728115|B1||Between 18 and 65 years|Age||Participants|Count of Participants|123|123.0||||||
3904156|NCT01478620|3728115|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3904157|NCT01478594|3728119|B3|||Number of metastatic sites at screening||metastatic sites|Mean|2.0|2.0|Standard Deviation|0.97|0.97|||
3904158|NCT01478594|3728120|B2|||Number of metastatic sites at screening||metastatic sites|Mean|2.0|2.0|Standard Deviation|0.85|0.85|||
3904159|NCT01478594|3728121|B1|||Number of metastatic sites at screening||metastatic sites|Mean|2.0|2.0|Standard Deviation|1.02|1.02|||
3904160|NCT01478594|3728119|B3|||Time Since Initial Diagnosis||months|Mean|9.90|9.9|Standard Deviation|20.640|20.64|||
3904161|NCT01478594|3728120|B2|||Time Since Initial Diagnosis||months|Mean|10.88|10.88|Standard Deviation|21.055|21.055|||
3904162|NCT01478594|3728121|B1|||Time Since Initial Diagnosis||months|Mean|9.41|9.41|Standard Deviation|20.473|20.473|||
3904163|NCT01478594|3728119|B3|Unknown||Kirsten rat sarcoma (KRAS) Mutation Status||participants|Number|172|172.0||||||
3904164|NCT01478594|3728120|B2|Unknown||Kirsten rat sarcoma (KRAS) Mutation Status||participants|Number|51|51.0||||||
3904165|NCT01478594|3728121|B1|Unknown||Kirsten rat sarcoma (KRAS) Mutation Status||participants|Number|121|121.0||||||
3904166|NCT01478594|3728119|B3|Mutant||Kirsten rat sarcoma (KRAS) Mutation Status||participants|Number|39|39.0||||||
3904167|NCT01478594|3728120|B2|Mutant||Kirsten rat sarcoma (KRAS) Mutation Status||participants|Number|16|16.0||||||
3904168|NCT01478594|3728121|B1|Mutant||Kirsten rat sarcoma (KRAS) Mutation Status||participants|Number|23|23.0||||||
3904169|NCT01478594|3728119|B3|Wild-type||Kirsten rat sarcoma (KRAS) Mutation Status||participants|Number|54|54.0||||||
3904170|NCT01478594|3728120|B2|Wild-type||Kirsten rat sarcoma (KRAS) Mutation Status||participants|Number|21|21.0||||||
3904171|NCT01478594|3728121|B1|Wild-type||Kirsten rat sarcoma (KRAS) Mutation Status||participants|Number|33|33.0||||||
3904172|NCT01478594|3728119|B3|≥ 4||Number of metastatic sites/organs||participants|Number|15|15.0||||||
3904173|NCT01478594|3728120|B2|≥ 4||Number of metastatic sites/organs||participants|Number|3|3.0||||||
3904174|NCT01478594|3728121|B1|≥ 4||Number of metastatic sites/organs||participants|Number|12|12.0||||||
3904175|NCT01478594|3728119|B3|3||Number of metastatic sites/organs||participants|Number|50|50.0||||||
3904176|NCT01478594|3728120|B2|3||Number of metastatic sites/organs||participants|Number|21|21.0||||||
3904177|NCT01478594|3728121|B1|3||Number of metastatic sites/organs||participants|Number|29|29.0||||||
3904178|NCT01478594|3728119|B3|2||Number of metastatic sites/organs||participants|Number|114|114.0||||||
3904179|NCT01478594|3728120|B2|2||Number of metastatic sites/organs||participants|Number|34|34.0||||||
3904180|NCT01478594|3728121|B1|2||Number of metastatic sites/organs||participants|Number|80|80.0||||||
3904181|NCT01478594|3728119|B3|1||Number of metastatic sites/organs||participants|Number|86|86.0||||||
3904182|NCT01478594|3728120|B2|1||Number of metastatic sites/organs||participants|Number|30|30.0||||||
3904183|NCT01478594|3728121|B1|1||Number of metastatic sites/organs||participants|Number|56|56.0||||||
3904184|NCT01478594|3728119|B3|Colon||Origin of Cancer||participants|Number|188|188.0||||||
3904185|NCT01478594|3728120|B2|Colon||Origin of Cancer||participants|Number|64|64.0||||||
3904186|NCT01478594|3728121|B1|Colon||Origin of Cancer||participants|Number|124|124.0||||||
3904187|NCT01478594|3728119|B3|Rectal||Origin of Cancer||participants|Number|77|77.0||||||
3904188|NCT01478594|3728120|B2|Rectal||Origin of Cancer||participants|Number|24|24.0||||||
3904189|NCT01478594|3728121|B1|Rectal||Origin of Cancer||participants|Number|53|53.0||||||
3904190|NCT01478594|3728119|B3|≥ 1.5 Upper Limit of Normal||Lactate dehydrogenase (LDH) Status|The upper limit of normal (ULN) from the site was used.|participants|Number|74|74.0||||||
3904191|NCT01478594|3728120|B2|≥ 1.5 Upper Limit of Normal||Lactate dehydrogenase (LDH) Status|The upper limit of normal (ULN) from the site was used.|participants|Number|24|24.0||||||
3904192|NCT01478594|3728121|B1|≥ 1.5 Upper Limit of Normal||Lactate dehydrogenase (LDH) Status|The upper limit of normal (ULN) from the site was used.|participants|Number|50|50.0||||||
3904193|NCT01478594|3728119|B3|< 1.5 Upper Limit of Normal||Lactate dehydrogenase (LDH) Status|The upper limit of normal (ULN) from the site was used.|participants|Number|191|191.0||||||
3904194|NCT01478594|3728120|B2|< 1.5 Upper Limit of Normal||Lactate dehydrogenase (LDH) Status|The upper limit of normal (ULN) from the site was used.|participants|Number|64|64.0||||||
3904195|NCT01478594|3728121|B1|< 1.5 Upper Limit of Normal||Lactate dehydrogenase (LDH) Status|The upper limit of normal (ULN) from the site was used.|participants|Number|127|127.0||||||
3904196|NCT01478594|3728119|B3|ECOG Performance Status 4||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all self-care. 3: Capable of limited self-care, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no self-care, totally confined to bed or chair. 5: Dead.|participants|Number|0|0.0||||||
3904197|NCT01478594|3728120|B2|ECOG Performance Status 4||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all self-care. 3: Capable of limited self-care, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no self-care, totally confined to bed or chair. 5: Dead.|participants|Number|0|0.0||||||
3904198|NCT01478594|3728121|B1|ECOG Performance Status 4||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all self-care. 3: Capable of limited self-care, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no self-care, totally confined to bed or chair. 5: Dead.|participants|Number|0|0.0||||||
3904199|NCT01478594|3728119|B3|ECOG Performance Status 3||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all self-care. 3: Capable of limited self-care, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no self-care, totally confined to bed or chair. 5: Dead.|participants|Number|0|0.0||||||
3904200|NCT01478594|3728120|B2|ECOG Performance Status 3||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all self-care. 3: Capable of limited self-care, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no self-care, totally confined to bed or chair. 5: Dead.|participants|Number|0|0.0||||||
3904201|NCT01478594|3728121|B1|ECOG Performance Status 3||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all self-care. 3: Capable of limited self-care, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no self-care, totally confined to bed or chair. 5: Dead.|participants|Number|0|0.0||||||
3904202|NCT01478594|3728119|B3|ECOG Performance Status 2||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all self-care. 3: Capable of limited self-care, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no self-care, totally confined to bed or chair. 5: Dead.|participants|Number|0|0.0||||||
3904203|NCT01478594|3728120|B2|ECOG Performance Status 2||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all self-care. 3: Capable of limited self-care, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no self-care, totally confined to bed or chair. 5: Dead.|participants|Number|0|0.0||||||
3904204|NCT01478594|3728121|B1|ECOG Performance Status 2||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all self-care. 3: Capable of limited self-care, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no self-care, totally confined to bed or chair. 5: Dead.|participants|Number|0|0.0||||||
3904205|NCT01478594|3728119|B3|ECOG Performance Status 1||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all self-care. 3: Capable of limited self-care, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no self-care, totally confined to bed or chair. 5: Dead.|participants|Number|112|112.0||||||
3904206|NCT01478594|3728120|B2|ECOG Performance Status 1||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all self-care. 3: Capable of limited self-care, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no self-care, totally confined to bed or chair. 5: Dead.|participants|Number|30|30.0||||||
3904207|NCT01478594|3728121|B1|ECOG Performance Status 1||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all self-care. 3: Capable of limited self-care, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no self-care, totally confined to bed or chair. 5: Dead.|participants|Number|82|82.0||||||
3904208|NCT01478594|3728119|B3|ECOG Performance Status 0||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all self-care. 3: Capable of limited self-care, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no self-care, totally confined to bed or chair. 5: Dead.|participants|Number|153|153.0||||||
3904209|NCT01478594|3728120|B2|ECOG Performance Status 0||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all self-care. 3: Capable of limited self-care, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no self-care, totally confined to bed or chair. 5: Dead.|participants|Number|58|58.0||||||
3904210|NCT01478594|3728121|B1|ECOG Performance Status 0||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all self-care. 3: Capable of limited self-care, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no self-care, totally confined to bed or chair. 5: Dead.|participants|Number|95|95.0||||||
3904211|NCT01478594|3728119|B3|Italy||Region of Enrollment||participants|Number|7|7.0||||||
3904212|NCT01478594|3728120|B2|Italy||Region of Enrollment||participants|Number|3|3.0||||||
3904213|NCT01478594|3728121|B1|Italy||Region of Enrollment||participants|Number|4|4.0||||||
3904214|NCT01478594|3728119|B3|United Kingdom||Region of Enrollment||participants|Number|26|26.0||||||
3904215|NCT01478594|3728120|B2|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
3904216|NCT01478594|3728121|B1|United Kingdom||Region of Enrollment||participants|Number|19|19.0||||||
3904217|NCT01478594|3728119|B3|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
3904218|NCT01478594|3728120|B2|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
3904219|NCT01478594|3728121|B1|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
3904220|NCT01478594|3728119|B3|Australia||Region of Enrollment||participants|Number|24|24.0||||||
3904221|NCT01478594|3728120|B2|Australia||Region of Enrollment||participants|Number|9|9.0||||||
3904222|NCT01478594|3728121|B1|Australia||Region of Enrollment||participants|Number|15|15.0||||||
3904223|NCT01478594|3728119|B3|Austria||Region of Enrollment||participants|Number|11|11.0||||||
3904224|NCT01478594|3728120|B2|Austria||Region of Enrollment||participants|Number|3|3.0||||||
3904225|NCT01478594|3728121|B1|Austria||Region of Enrollment||participants|Number|8|8.0||||||
3904226|NCT01478594|3728119|B3|Belgium||Region of Enrollment||participants|Number|19|19.0||||||
3904227|NCT01478594|3728120|B2|Belgium||Region of Enrollment||participants|Number|9|9.0||||||
3904228|NCT01478594|3728121|B1|Belgium||Region of Enrollment||participants|Number|10|10.0||||||
3904229|NCT01478594|3728119|B3|Spain||Region of Enrollment||participants|Number|30|30.0||||||
3904230|NCT01478594|3728120|B2|Spain||Region of Enrollment||participants|Number|8|8.0||||||
3904231|NCT01478594|3728121|B1|Spain||Region of Enrollment||participants|Number|22|22.0||||||
3904232|NCT01478594|3728119|B3|Finland||Region of Enrollment||participants|Number|6|6.0||||||
3904233|NCT01478594|3728120|B2|Finland||Region of Enrollment||participants|Number|1|1.0||||||
3904234|NCT01478594|3728121|B1|Finland||Region of Enrollment||participants|Number|5|5.0||||||
3904235|NCT01478594|3728119|B3|Canada||Region of Enrollment||participants|Number|17|17.0||||||
3904236|NCT01478594|3728120|B2|Canada||Region of Enrollment||participants|Number|4|4.0||||||
3904237|NCT01478594|3728121|B1|Canada||Region of Enrollment||participants|Number|13|13.0||||||
3904238|NCT01478594|3728119|B3|Czech Republic||Region of Enrollment||participants|Number|21|21.0||||||
3904239|NCT01478594|3728120|B2|Czech Republic||Region of Enrollment||participants|Number|9|9.0||||||
3904240|NCT01478594|3728121|B1|Czech Republic||Region of Enrollment||participants|Number|12|12.0||||||
3904241|NCT01478594|3728119|B3|Hungary||Region of Enrollment||participants|Number|32|32.0||||||
3904242|NCT01478594|3728120|B2|Hungary||Region of Enrollment||participants|Number|8|8.0||||||
3904243|NCT01478594|3728121|B1|Hungary||Region of Enrollment||participants|Number|24|24.0||||||
3904244|NCT01478594|3728119|B3|United States||Region of Enrollment||participants|Number|70|70.0||||||
3904245|NCT01478594|3728120|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
3904246|NCT01478594|3728121|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
3904247|NCT01478594|3728119|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3904248|NCT01478594|3728120|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3904249|NCT01478594|3728121|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3904250|NCT01478594|3728119|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3904251|NCT01478594|3728120|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3904252|NCT01478594|3728121|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3904253|NCT01478594|3728119|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3904254|NCT01478594|3728120|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3904255|NCT01478594|3728121|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3904256|NCT01478594|3728119|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3904257|NCT01478594|3728120|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3904258|NCT01478594|3728121|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3904259|NCT01478594|3728119|B3|White||Race/Ethnicity, Customized||participants|Number|254|254.0||||||
3904260|NCT01478594|3728120|B2|White||Race/Ethnicity, Customized||participants|Number|85|85.0||||||
3904261|NCT01478594|3728121|B1|White||Race/Ethnicity, Customized||participants|Number|169|169.0||||||
3904262|NCT01478594|3728119|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3904263|NCT01478594|3728120|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904264|NCT01478594|3728121|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3904265|NCT01478594|3728119|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|256|256.0||||||
3904266|NCT01478594|3728120|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
3904267|NCT01478594|3728121|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|170|170.0||||||
3904268|NCT01478594|3728119|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3904269|NCT01478594|3728120|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3904270|NCT01478594|3728121|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3904271|NCT01478594|3728119|B3||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
3904272|NCT01478594|3728120|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3904273|NCT01478594|3728121|B1||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3904274|NCT01478594|3728119|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3904275|NCT01478594|3728120|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3904276|NCT01478594|3728121|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3904277|NCT01478594|3728119|B3|||Age||years|Mean|62.2|62.2|Standard Deviation|10.12|10.12|||
3904278|NCT01478594|3728120|B2|||Age||years|Mean|62.6|62.6|Standard Deviation|11.17|11.17|||
3904279|NCT01478594|3728121|B1|||Age||years|Mean|61.9|61.9|Standard Deviation|9.58|9.58|||
3904280|NCT01478581|3728194|B5|United States||Region of Enrollment||participants|Number|92|92.0||||||
3904281|NCT01478581|3728195|B4|United States||Region of Enrollment||participants|Number|43|43.0||||||
3904282|NCT01478581|3728196|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
3904283|NCT01478581|3728197|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
3904284|NCT01478581|3728198|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3904285|NCT01478581|3728194|B5|Other Race|Unknown or Not Reported|Race (NIH/OMB)|"We have 5 patients with Race reported as Other. For these 5 patients we reported the race data under Unknown or Not Reported as no Other category available in this database."|Participants|Count of Participants|5|5.0||||||
3904354|NCT01478360|3728259|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3904355|NCT01478360|3728260|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3904286|NCT01478581|3728195|B4|Other Race|Unknown or Not Reported|Race (NIH/OMB)|"We have 5 patients with Race reported as Other. For these 5 patients we reported the race data under Unknown or Not Reported as no Other category available in this database."|Participants|Count of Participants|4|4.0||||||
3904287|NCT01478581|3728196|B3|Other Race|Unknown or Not Reported|Race (NIH/OMB)|"We have 5 patients with Race reported as Other. For these 5 patients we reported the race data under Unknown or Not Reported as no Other category available in this database."|Participants|Count of Participants|0|0.0||||||
3904288|NCT01478581|3728197|B2|Other Race|Unknown or Not Reported|Race (NIH/OMB)|"We have 5 patients with Race reported as Other. For these 5 patients we reported the race data under Unknown or Not Reported as no Other category available in this database."|Participants|Count of Participants|0|0.0||||||
3904289|NCT01478581|3728198|B1|Other Race|Unknown or Not Reported|Race (NIH/OMB)|"We have 5 patients with Race reported as Other. For these 5 patients we reported the race data under Unknown or Not Reported as no Other category available in this database."|Participants|Count of Participants|1|1.0||||||
3904290|NCT01478581|3728194|B5|Other Race|More than one race|Race (NIH/OMB)|"We have 5 patients with Race reported as Other. For these 5 patients we reported the race data under Unknown or Not Reported as no Other category available in this database."|Participants|Count of Participants|1|1.0||||||
3904291|NCT01478581|3728195|B4|Other Race|More than one race|Race (NIH/OMB)|"We have 5 patients with Race reported as Other. For these 5 patients we reported the race data under Unknown or Not Reported as no Other category available in this database."|Participants|Count of Participants|0|0.0||||||
3904292|NCT01478581|3728196|B3|Other Race|More than one race|Race (NIH/OMB)|"We have 5 patients with Race reported as Other. For these 5 patients we reported the race data under Unknown or Not Reported as no Other category available in this database."|Participants|Count of Participants|1|1.0||||||
3904293|NCT01478581|3728197|B2|Other Race|More than one race|Race (NIH/OMB)|"We have 5 patients with Race reported as Other. For these 5 patients we reported the race data under Unknown or Not Reported as no Other category available in this database."|Participants|Count of Participants|0|0.0||||||
3904294|NCT01478581|3728198|B1|Other Race|More than one race|Race (NIH/OMB)|"We have 5 patients with Race reported as Other. For these 5 patients we reported the race data under Unknown or Not Reported as no Other category available in this database."|Participants|Count of Participants|0|0.0||||||
3904295|NCT01478581|3728194|B5|Other Race|White|Race (NIH/OMB)|"We have 5 patients with Race reported as Other. For these 5 patients we reported the race data under Unknown or Not Reported as no Other category available in this database."|Participants|Count of Participants|67|67.0||||||
3904296|NCT01478581|3728195|B4|Other Race|White|Race (NIH/OMB)|"We have 5 patients with Race reported as Other. For these 5 patients we reported the race data under Unknown or Not Reported as no Other category available in this database."|Participants|Count of Participants|33|33.0||||||
3904297|NCT01478581|3728196|B3|Other Race|White|Race (NIH/OMB)|"We have 5 patients with Race reported as Other. For these 5 patients we reported the race data under Unknown or Not Reported as no Other category available in this database."|Participants|Count of Participants|12|12.0||||||
3904298|NCT01478581|3728197|B2|Other Race|White|Race (NIH/OMB)|"We have 5 patients with Race reported as Other. For these 5 patients we reported the race data under Unknown or Not Reported as no Other category available in this database."|Participants|Count of Participants|12|12.0||||||
3904299|NCT01478581|3728198|B1|Other Race|White|Race (NIH/OMB)|"We have 5 patients with Race reported as Other. For these 5 patients we reported the race data under Unknown or Not Reported as no Other category available in this database."|Participants|Count of Participants|10|10.0||||||
3904300|NCT01478581|3728194|B5|Other Race|Black or African American|Race (NIH/OMB)|"We have 5 patients with Race reported as Other. For these 5 patients we reported the race data under Unknown or Not Reported as no Other category available in this database."|Participants|Count of Participants|18|18.0||||||
3904301|NCT01478581|3728195|B4|Other Race|Black or African American|Race (NIH/OMB)|"We have 5 patients with Race reported as Other. For these 5 patients we reported the race data under Unknown or Not Reported as no Other category available in this database."|Participants|Count of Participants|6|6.0||||||
3904302|NCT01478581|3728196|B3|Other Race|Black or African American|Race (NIH/OMB)|"We have 5 patients with Race reported as Other. For these 5 patients we reported the race data under Unknown or Not Reported as no Other category available in this database."|Participants|Count of Participants|4|4.0||||||
3904303|NCT01478581|3728197|B2|Other Race|Black or African American|Race (NIH/OMB)|"We have 5 patients with Race reported as Other. For these 5 patients we reported the race data under Unknown or Not Reported as no Other category available in this database."|Participants|Count of Participants|6|6.0||||||
3904304|NCT01478581|3728198|B1|Other Race|Black or African American|Race (NIH/OMB)|"We have 5 patients with Race reported as Other. For these 5 patients we reported the race data under Unknown or Not Reported as no Other category available in this database."|Participants|Count of Participants|2|2.0||||||
3904305|NCT01478581|3728194|B5|Other Race|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|"We have 5 patients with Race reported as Other. For these 5 patients we reported the race data under Unknown or Not Reported as no Other category available in this database."|Participants|Count of Participants|0|0.0||||||
3904306|NCT01478581|3728195|B4|Other Race|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|"We have 5 patients with Race reported as Other. For these 5 patients we reported the race data under Unknown or Not Reported as no Other category available in this database."|Participants|Count of Participants|0|0.0||||||
3904307|NCT01478581|3728196|B3|Other Race|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|"We have 5 patients with Race reported as Other. For these 5 patients we reported the race data under Unknown or Not Reported as no Other category available in this database."|Participants|Count of Participants|0|0.0||||||
3904308|NCT01478581|3728197|B2|Other Race|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|"We have 5 patients with Race reported as Other. For these 5 patients we reported the race data under Unknown or Not Reported as no Other category available in this database."|Participants|Count of Participants|0|0.0||||||
3904309|NCT01478581|3728198|B1|Other Race|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|"We have 5 patients with Race reported as Other. For these 5 patients we reported the race data under Unknown or Not Reported as no Other category available in this database."|Participants|Count of Participants|0|0.0||||||
3904310|NCT01478581|3728194|B5|Other Race|Asian|Race (NIH/OMB)|"We have 5 patients with Race reported as Other. For these 5 patients we reported the race data under Unknown or Not Reported as no Other category available in this database."|Participants|Count of Participants|1|1.0||||||
3904311|NCT01478581|3728195|B4|Other Race|Asian|Race (NIH/OMB)|"We have 5 patients with Race reported as Other. For these 5 patients we reported the race data under Unknown or Not Reported as no Other category available in this database."|Participants|Count of Participants|0|0.0||||||
3904312|NCT01478581|3728196|B3|Other Race|Asian|Race (NIH/OMB)|"We have 5 patients with Race reported as Other. For these 5 patients we reported the race data under Unknown or Not Reported as no Other category available in this database."|Participants|Count of Participants|1|1.0||||||
3904313|NCT01478581|3728197|B2|Other Race|Asian|Race (NIH/OMB)|"We have 5 patients with Race reported as Other. For these 5 patients we reported the race data under Unknown or Not Reported as no Other category available in this database."|Participants|Count of Participants|0|0.0||||||
3904314|NCT01478581|3728198|B1|Other Race|Asian|Race (NIH/OMB)|"We have 5 patients with Race reported as Other. For these 5 patients we reported the race data under Unknown or Not Reported as no Other category available in this database."|Participants|Count of Participants|0|0.0||||||
3904315|NCT01478581|3728194|B5|Other Race|American Indian or Alaska Native|Race (NIH/OMB)|"We have 5 patients with Race reported as Other. For these 5 patients we reported the race data under Unknown or Not Reported as no Other category available in this database."|Participants|Count of Participants|0|0.0||||||
3904316|NCT01478581|3728195|B4|Other Race|American Indian or Alaska Native|Race (NIH/OMB)|"We have 5 patients with Race reported as Other. For these 5 patients we reported the race data under Unknown or Not Reported as no Other category available in this database."|Participants|Count of Participants|0|0.0||||||
3904317|NCT01478581|3728196|B3|Other Race|American Indian or Alaska Native|Race (NIH/OMB)|"We have 5 patients with Race reported as Other. For these 5 patients we reported the race data under Unknown or Not Reported as no Other category available in this database."|Participants|Count of Participants|0|0.0||||||
3904318|NCT01478581|3728197|B2|Other Race|American Indian or Alaska Native|Race (NIH/OMB)|"We have 5 patients with Race reported as Other. For these 5 patients we reported the race data under Unknown or Not Reported as no Other category available in this database."|Participants|Count of Participants|0|0.0||||||
3904319|NCT01478581|3728198|B1|Other Race|American Indian or Alaska Native|Race (NIH/OMB)|"We have 5 patients with Race reported as Other. For these 5 patients we reported the race data under Unknown or Not Reported as no Other category available in this database."|Participants|Count of Participants|0|0.0||||||
3904320|NCT01478581|3728194|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3904321|NCT01478581|3728195|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3904322|NCT01478581|3728196|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904323|NCT01478581|3728197|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904324|NCT01478581|3728198|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904325|NCT01478581|3728194|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3904326|NCT01478581|3728195|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3904327|NCT01478581|3728196|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3904328|NCT01478581|3728197|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3904329|NCT01478581|3728198|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3904330|NCT01478581|3728194|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3904331|NCT01478581|3728195|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3904332|NCT01478581|3728196|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3904333|NCT01478581|3728197|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904334|NCT01478581|3728198|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904335|NCT01478581|3728194|B5||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3904336|NCT01478581|3728195|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3904337|NCT01478581|3728196|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3904338|NCT01478581|3728197|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3904339|NCT01478581|3728198|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3904340|NCT01478581|3728194|B5||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3904341|NCT01478581|3728195|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3904342|NCT01478581|3728196|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3904343|NCT01478581|3728197|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3904344|NCT01478581|3728198|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3904345|NCT01478581|3728194|B5|||Age||years|Median|65.0|65.0|Standard Deviation|7.63|7.63|||
3904346|NCT01478581|3728195|B4|||Age||years|Median|65.0|65.0|Standard Deviation|7.40|7.4|||
3904347|NCT01478581|3728196|B3|||Age||years|Median|65.5|65.5|Standard Deviation|7.52|7.52|||
3904348|NCT01478581|3728197|B2|||Age||years|Median|65.5|65.5|Standard Deviation|8.44|8.44|||
3904349|NCT01478581|3728198|B1|||Age||years|Median|62.0|62.0|Standard Deviation|7.57|7.57|||
3904350|NCT01478373|3728247|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3904351|NCT01478373|3728247|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3904352|NCT01478373|3728247|B1|||Age||Years|Mean|59.2|59.2|Standard Deviation|10.14|10.14|||
3904353|NCT01478360|3728258|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3904356|NCT01478360|3728258|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3904357|NCT01478360|3728259|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3904358|NCT01478360|3728260|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3904359|NCT01478360|3728258|B3|||Age||Years|Mean|48.6|48.6|Standard Deviation|11.25|11.25|||
3904360|NCT01478360|3728259|B2|||Age||Years|Mean|46.2|46.2|Standard Deviation|10.40|10.4|||
3904361|NCT01478360|3728260|B1|||Age||Years|Mean|49.8|49.8|Standard Deviation|11.62|11.62|||
3904362|NCT01478347|3728267|B1|rMenB( part II; male)||Sex/Gender, Customized||subjects|Number|3|3.0||||||
3904363|NCT01478347|3728267|B1|rMenB( part II; female)||Sex/Gender, Customized||subjects|Number|8|8.0||||||
3904364|NCT01478347|3728267|B1|rMenB( part I; male)||Sex/Gender, Customized||subjects|Number|5|5.0||||||
3904365|NCT01478347|3728267|B1|rMenB( part I; female)||Sex/Gender, Customized||subjects|Number|13|13.0||||||
3904366|NCT01478347|3728267|B1|rMenB (part II; N=11)||Age, Customized|Of the 18 subjects enrolled for part I of the study, only 12 subjects continued participation into protocol part II of the study. Of these, 11 subjects were included in safety set.|years|Mean|34.1|34.1|Standard Deviation|5.6|5.6|||
3904367|NCT01478347|3728267|B1|rMenB (part I; N=18)||Age, Customized|Of the 18 subjects enrolled for part I of the study, only 12 subjects continued participation into protocol part II of the study. Of these, 11 subjects were included in safety set.|years|Mean|34.5|34.5|Standard Deviation|5.7|5.7|||
3904368|NCT01478256|3728272|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3904369|NCT01478256|3728273|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3904370|NCT01478256|3728274|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3904371|NCT01478256|3728272|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3904372|NCT01478256|3728273|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3904373|NCT01478256|3728274|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3904374|NCT01478256|3728272|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3904375|NCT01478256|3728273|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3904376|NCT01478256|3728274|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3904377|NCT01478256|3728272|B3|||Age||years|Mean|49|49.0|Standard Deviation|11|11.0|||
3904378|NCT01478256|3728273|B2|||Age||years|Mean|50|50.0|Standard Deviation|12|12.0|||
3904379|NCT01478256|3728274|B1|||Age||years|Mean|48|48.0|Standard Deviation|10|10.0|||
3904380|NCT01478256|3728272|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3904381|NCT01478256|3728273|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3904382|NCT01478256|3728274|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3904383|NCT01478256|3728272|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3904384|NCT01478256|3728273|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3904385|NCT01478256|3728274|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3904386|NCT01478256|3728272|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3904387|NCT01478256|3728273|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3904388|NCT01478256|3728274|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3904389|NCT01478113|3728283|B3|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3904390|NCT01478113|3728284|B2|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3904391|NCT01478113|3728285|B1|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3904392|NCT01478113|3728283|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3904393|NCT01478113|3728284|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3904394|NCT01478113|3728285|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3904395|NCT01478113|3728283|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3904396|NCT01478113|3728284|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3904397|NCT01478113|3728285|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3904398|NCT01478113|3728283|B3|||Age||years|Mean|52|52.0|Full Range|||45.0|55.0|
3904399|NCT01478113|3728284|B2|||Age||years|Mean|54|54.0|Full Range|||53.0|55.0|
3904400|NCT01478113|3728285|B1|||Age||years|Mean|50|50.0|Full Range|||45.0|55.0|
3904401|NCT01478113|3728283|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3904402|NCT01478113|3728284|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3904403|NCT01478113|3728285|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3904404|NCT01478113|3728283|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3904405|NCT01478113|3728284|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3904406|NCT01478113|3728285|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3904407|NCT01478113|3728283|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3904408|NCT01478113|3728284|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3904409|NCT01478113|3728285|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3904410|NCT01478087|3728304|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3904411|NCT01478087|3728304|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3904412|NCT01478087|3728304|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3904413|NCT01478087|3728304|B1|||Age||years|Mean|54.0|54.0|Standard Deviation|6.3|6.3|||
3904414|NCT01478087|3728304|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3904501|NCT01477892|3728339|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3904415|NCT01478087|3728304|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3904416|NCT01478087|3728304|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3904417|NCT01478048|3728309|B3|2 or 3 lines of prior therapy||Number of Prior Lines of Therapy|Categories presented as they were at randomization based on information collected via the Interactive Voice Recognition System (IVRS) system.|Participants|Count of Participants|46|46.0||||||
3904418|NCT01478048|3728310|B2|2 or 3 lines of prior therapy||Number of Prior Lines of Therapy|Categories presented as they were at randomization based on information collected via the Interactive Voice Recognition System (IVRS) system.|Participants|Count of Participants|24|24.0||||||
3904419|NCT01478048|3728311|B1|2 or 3 lines of prior therapy||Number of Prior Lines of Therapy|Categories presented as they were at randomization based on information collected via the Interactive Voice Recognition System (IVRS) system.|Participants|Count of Participants|22|22.0||||||
3904420|NCT01478048|3728309|B3|1 line of prior therapy||Number of Prior Lines of Therapy|Categories presented as they were at randomization based on information collected via the Interactive Voice Recognition System (IVRS) system.|Participants|Count of Participants|106|106.0||||||
3904421|NCT01478048|3728310|B2|1 line of prior therapy||Number of Prior Lines of Therapy|Categories presented as they were at randomization based on information collected via the Interactive Voice Recognition System (IVRS) system.|Participants|Count of Participants|51|51.0||||||
3904422|NCT01478048|3728311|B1|1 line of prior therapy||Number of Prior Lines of Therapy|Categories presented as they were at randomization based on information collected via the Interactive Voice Recognition System (IVRS) system.|Participants|Count of Participants|55|55.0||||||
3904423|NCT01478048|3728309|B3|No||Presence of At Least 1 FcγRIIIa V allele|An allele is any one of a series of 2 or more different genes that may be on a specific chromosome. Categories presented as they were at randomization based on information collected via the Interactive Voice Recognition System (IVRS) system.|Participants|Count of Participants|43|43.0||||||
3904424|NCT01478048|3728310|B2|No||Presence of At Least 1 FcγRIIIa V allele|An allele is any one of a series of 2 or more different genes that may be on a specific chromosome. Categories presented as they were at randomization based on information collected via the Interactive Voice Recognition System (IVRS) system.|Participants|Count of Participants|21|21.0||||||
3904425|NCT01478048|3728311|B1|No||Presence of At Least 1 FcγRIIIa V allele|An allele is any one of a series of 2 or more different genes that may be on a specific chromosome. Categories presented as they were at randomization based on information collected via the Interactive Voice Recognition System (IVRS) system.|Participants|Count of Participants|22|22.0||||||
3904426|NCT01478048|3728309|B3|Yes||Presence of At Least 1 FcγRIIIa V allele|An allele is any one of a series of 2 or more different genes that may be on a specific chromosome. Categories presented as they were at randomization based on information collected via the Interactive Voice Recognition System (IVRS) system.|Participants|Count of Participants|109|109.0||||||
3904427|NCT01478048|3728310|B2|Yes||Presence of At Least 1 FcγRIIIa V allele|An allele is any one of a series of 2 or more different genes that may be on a specific chromosome. Categories presented as they were at randomization based on information collected via the Interactive Voice Recognition System (IVRS) system.|Participants|Count of Participants|54|54.0||||||
3904428|NCT01478048|3728311|B1|Yes||Presence of At Least 1 FcγRIIIa V allele|An allele is any one of a series of 2 or more different genes that may be on a specific chromosome. Categories presented as they were at randomization based on information collected via the Interactive Voice Recognition System (IVRS) system.|Participants|Count of Participants|55|55.0||||||
3904429|NCT01478048|3728309|B3|No||Prior Protease Inhibitor Use|Categories presented as they were at randomization based on information collected via the Interactive Voice Recognition System (IVRS) system.|Participants|Count of Participants|77|77.0||||||
3904430|NCT01478048|3728310|B2|No||Prior Protease Inhibitor Use|Categories presented as they were at randomization based on information collected via the Interactive Voice Recognition System (IVRS) system.|Participants|Count of Participants|38|38.0||||||
3904431|NCT01478048|3728311|B1|No||Prior Protease Inhibitor Use|Categories presented as they were at randomization based on information collected via the Interactive Voice Recognition System (IVRS) system.|Participants|Count of Participants|39|39.0||||||
3904432|NCT01478048|3728309|B3|Yes||Prior Protease Inhibitor Use|Categories presented as they were at randomization based on information collected via the Interactive Voice Recognition System (IVRS) system.|Participants|Count of Participants|75|75.0||||||
3904433|NCT01478048|3728310|B2|Yes||Prior Protease Inhibitor Use|Categories presented as they were at randomization based on information collected via the Interactive Voice Recognition System (IVRS) system.|Participants|Count of Participants|37|37.0||||||
3904434|NCT01478048|3728311|B1|Yes||Prior Protease Inhibitor Use|Categories presented as they were at randomization based on information collected via the Interactive Voice Recognition System (IVRS) system.|Participants|Count of Participants|38|38.0||||||
3904435|NCT01478048|3728309|B3|Spain||Region of Enrollment|Number of participants enrolled, by country, were summarized.|Participants|Count of Participants|17|17.0||||||
3904436|NCT01478048|3728310|B2|Spain||Region of Enrollment|Number of participants enrolled, by country, were summarized.|Participants|Count of Participants|9|9.0||||||
3904437|NCT01478048|3728311|B1|Spain||Region of Enrollment|Number of participants enrolled, by country, were summarized.|Participants|Count of Participants|8|8.0||||||
3904438|NCT01478048|3728309|B3|France||Region of Enrollment|Number of participants enrolled, by country, were summarized.|Participants|Count of Participants|21|21.0||||||
3904439|NCT01478048|3728310|B2|France||Region of Enrollment|Number of participants enrolled, by country, were summarized.|Participants|Count of Participants|11|11.0||||||
3904440|NCT01478048|3728311|B1|France||Region of Enrollment|Number of participants enrolled, by country, were summarized.|Participants|Count of Participants|10|10.0||||||
3904441|NCT01478048|3728309|B3|Italy||Region of Enrollment|Number of participants enrolled, by country, were summarized.|Participants|Count of Participants|66|66.0||||||
3904442|NCT01478048|3728310|B2|Italy||Region of Enrollment|Number of participants enrolled, by country, were summarized.|Participants|Count of Participants|32|32.0||||||
3904443|NCT01478048|3728311|B1|Italy||Region of Enrollment|Number of participants enrolled, by country, were summarized.|Participants|Count of Participants|34|34.0||||||
3904444|NCT01478048|3728309|B3|United States||Region of Enrollment|Number of participants enrolled, by country, were summarized.|Participants|Count of Participants|48|48.0||||||
3904445|NCT01478048|3728310|B2|United States||Region of Enrollment|Number of participants enrolled, by country, were summarized.|Participants|Count of Participants|23|23.0||||||
3904446|NCT01478048|3728311|B1|United States||Region of Enrollment|Number of participants enrolled, by country, were summarized.|Participants|Count of Participants|25|25.0||||||
3904447|NCT01478048|3728309|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3904448|NCT01478048|3728310|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3904449|NCT01478048|3728311|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3904450|NCT01478048|3728309|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3904451|NCT01478048|3728310|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3904452|NCT01478048|3728311|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3904453|NCT01478048|3728309|B3|>= 75 years||Age, Customized|Less than (<); Greater than, equal to (≥).|Participants|Count of Participants|29|29.0||||||
3904454|NCT01478048|3728310|B2|>= 75 years||Age, Customized|Less than (<); Greater than, equal to (≥).|Participants|Count of Participants|14|14.0||||||
3904455|NCT01478048|3728311|B1|>= 75 years||Age, Customized|Less than (<); Greater than, equal to (≥).|Participants|Count of Participants|15|15.0||||||
3904456|NCT01478048|3728309|B3|≥65 and <75 years||Age, Customized|Less than (<); Greater than, equal to (≥).|Participants|Count of Participants|56|56.0||||||
3904457|NCT01478048|3728310|B2|≥65 and <75 years||Age, Customized|Less than (<); Greater than, equal to (≥).|Participants|Count of Participants|28|28.0||||||
3904458|NCT01478048|3728311|B1|≥65 and <75 years||Age, Customized|Less than (<); Greater than, equal to (≥).|Participants|Count of Participants|28|28.0||||||
3904459|NCT01478048|3728309|B3|< 65 years||Age, Customized|Less than (<); Greater than, equal to (≥).|Participants|Count of Participants|67|67.0||||||
3904460|NCT01478048|3728310|B2|< 65 years||Age, Customized|Less than (<); Greater than, equal to (≥).|Participants|Count of Participants|33|33.0||||||
3904461|NCT01478048|3728311|B1|< 65 years||Age, Customized|Less than (<); Greater than, equal to (≥).|Participants|Count of Participants|34|34.0||||||
3904462|NCT01478048|3728309|B3|||Age||years|Mean|65.3|65.3|Standard Deviation|9.88|9.88|||
3904463|NCT01478048|3728310|B2|||Age||years|Mean|65.1|65.1|Standard Deviation|10.34|10.34|||
3904464|NCT01478048|3728311|B1|||Age||years|Mean|65.4|65.4|Standard Deviation|9.48|9.48|||
3904465|NCT01478009|3728328|B3|Korea, Republic of||Region of Enrollment||participants|Number|100|100.0||||||
3904466|NCT01478009|3728329|B2|Korea, Republic of||Region of Enrollment||participants|Number|50|50.0||||||
3904467|NCT01478009|3728330|B1|Korea, Republic of||Region of Enrollment||participants|Number|50|50.0||||||
3904468|NCT01478009|3728328|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3904469|NCT01478009|3728329|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3904470|NCT01478009|3728330|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3904471|NCT01478009|3728328|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3904472|NCT01478009|3728329|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3904473|NCT01478009|3728330|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3904474|NCT01478009|3728328|B3|||Age||years|Mean|45.9|45.9|Standard Deviation|8.9|8.9|||
3904475|NCT01478009|3728329|B2|||Age||years|Mean|46.3|46.3|Standard Deviation|9.8|9.8|||
3904476|NCT01478009|3728330|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|8.1|8.1|||
3904477|NCT01478009|3728328|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3904478|NCT01478009|3728329|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3904479|NCT01478009|3728330|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3904480|NCT01478009|3728328|B3||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
3904481|NCT01478009|3728329|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3904482|NCT01478009|3728330|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3904483|NCT01478009|3728328|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3904484|NCT01478009|3728329|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3904485|NCT01478009|3728330|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3904486|NCT01477892|3728339|B3|||Gestatonal age||days|Median|182|182.0|Full Range|0.03|0.03|171.0|223.0|
3904487|NCT01477892|3728340|B2|||Gestatonal age||days|Median|181|181.0|Full Range|0.03|0.03|171.0|214.0|
3904488|NCT01477892|3728341|B1|||Gestatonal age||days|Median|183|183.0|Full Range|0.03|0.03|171.0|214.0|
3904489|NCT01477892|3728339|B3|Korea, Republic of||Region of Enrollment||participants|Number|12|12.0||||||
3904490|NCT01477892|3728340|B2|Korea, Republic of||Region of Enrollment||participants|Number|5|5.0||||||
3904491|NCT01477892|3728341|B1|Korea, Republic of||Region of Enrollment||participants|Number|7|7.0||||||
3904492|NCT01477892|3728339|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3904493|NCT01477892|3728340|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3904494|NCT01477892|3728341|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3904495|NCT01477892|3728339|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3904496|NCT01477892|3728340|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3904497|NCT01477892|3728341|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3904498|NCT01477892|3728339|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3904499|NCT01477892|3728340|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3904500|NCT01477892|3728341|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3904502|NCT01477892|3728340|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3904503|NCT01477892|3728341|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3904504|NCT01477892|3728339|B3||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
3904505|NCT01477892|3728340|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3904506|NCT01477892|3728341|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
3904507|NCT01477853|3728350|B4||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3904508|NCT01477853|3728351|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3904509|NCT01477853|3728352|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3904510|NCT01477853|3728353|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3904511|NCT01477853|3728350|B4||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3904512|NCT01477853|3728351|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3904513|NCT01477853|3728352|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3904514|NCT01477853|3728353|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3904515|NCT01477853|3728350|B4|||Age||Years|Mean|55.4|55.4|Standard Deviation|9.4|9.4|||
3904516|NCT01477853|3728351|B3|||Age||Years|Mean|53.7|53.7|Standard Deviation|10.0|10.0|||
3904517|NCT01477853|3728352|B2|||Age||Years|Mean|56.3|56.3|Standard Deviation|8.2|8.2|||
3904518|NCT01477853|3728353|B1|||Age||Years|Mean|56.2|56.2|Standard Deviation|9.7|9.7|||
3904519|NCT01477762|3728393|B5|United States||Region of Enrollment||participants|Number|63|63.0||||||
3904520|NCT01477762|3728394|B4|United States||Region of Enrollment||participants|Number|11|11.0||||||
3904521|NCT01477762|3728395|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
3904522|NCT01477762|3728396|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3904523|NCT01477762|3728397|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3904524|NCT01477762|3728393|B5|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3904525|NCT01477762|3728394|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3904526|NCT01477762|3728395|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3904527|NCT01477762|3728396|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3904528|NCT01477762|3728397|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3904529|NCT01477762|3728393|B5|African American||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
3904530|NCT01477762|3728394|B4|African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3904531|NCT01477762|3728395|B3|African American||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3904532|NCT01477762|3728396|B2|African American||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3904533|NCT01477762|3728397|B1|African American||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3904534|NCT01477762|3728393|B5||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3904535|NCT01477762|3728394|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3904536|NCT01477762|3728395|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3904537|NCT01477762|3728396|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3904538|NCT01477762|3728397|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3904539|NCT01477762|3728393|B5||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3904540|NCT01477762|3728394|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3904541|NCT01477762|3728395|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3904542|NCT01477762|3728396|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3904543|NCT01477762|3728397|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3904544|NCT01477762|3728393|B5|||Age||years|Mean|42.4|42.4|Standard Deviation|11.8|11.8|||
3904545|NCT01477762|3728394|B4|||Age||years|Mean|45.46|45.46|Standard Deviation|3.78|3.78|||
3904546|NCT01477762|3728395|B3|||Age||years|Mean|43.067|43.067|Standard Deviation|3.237|3.237|||
3904547|NCT01477762|3728396|B2|||Age||years|Mean|43.10|43.1|Standard Deviation|2.80|2.8|||
3904548|NCT01477762|3728397|B1|||Age||years|Mean|39.13|39.13|Standard Deviation|3.13|3.13|||
3904549|NCT01477749|3728422|B1|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
3904550|NCT01477749|3728422|B1|Netherlands||Region of Enrollment||participants|Number|15|15.0||||||
3904551|NCT01477749|3728422|B1|Austria||Region of Enrollment||participants|Number|17|17.0||||||
3904552|NCT01477749|3728422|B1|France||Region of Enrollment||participants|Number|8|8.0||||||
3904553|NCT01477749|3728422|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3904554|NCT01477749|3728422|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3904555|NCT01477749|3728422|B1||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
3904556|NCT01477749|3728422|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3904557|NCT01477749|3728422|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3904558|NCT01477710|3728429|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3904559|NCT01477710|3728429|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3904560|NCT01477710|3728429|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3904561|NCT01477710|3728429|B1|||Age||years|Mean|36.9|36.9|Standard Deviation|8.0|8.0|||
3904562|NCT01477710|3728429|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3904563|NCT01477710|3728429|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3904564|NCT01477710|3728429|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3904565|NCT01477567|3728437|B8|||Fasting Blood Glucose||milligrams per deciliter (mg/dL)|Mean|89.62|89.62|Standard Deviation|8.29|8.29|||
3904566|NCT01477567|3728438|B7|||Fasting Blood Glucose||milligrams per deciliter (mg/dL)|Mean|89.08|89.08|Standard Deviation|5.17|5.17|||
3904567|NCT01477567|3728439|B6|||Fasting Blood Glucose||milligrams per deciliter (mg/dL)|Mean|92.46|92.46|Standard Deviation|11.12|11.12|||
3904568|NCT01477567|3728440|B5|||Fasting Blood Glucose||milligrams per deciliter (mg/dL)|Mean|89.40|89.4|Standard Deviation|6.29|6.29|||
3904569|NCT01477567|3728441|B4|||Fasting Blood Glucose||milligrams per deciliter (mg/dL)|Mean|96.02|96.02|Standard Deviation|8.35|8.35|||
3904570|NCT01477567|3728442|B3|||Fasting Blood Glucose||milligrams per deciliter (mg/dL)|Mean|84.45|84.45|Standard Deviation|10.60|10.6|||
3904571|NCT01477567|3728443|B2|||Fasting Blood Glucose||milligrams per deciliter (mg/dL)|Mean|92.40|92.4|Standard Deviation|4.86|4.86|||
3904572|NCT01477567|3728444|B1|||Fasting Blood Glucose||milligrams per deciliter (mg/dL)|Mean|82.84|82.84|Standard Deviation|4.99|4.99|||
3904573|NCT01477567|3728437|B8|Singapore||Region of Enrollment||participants|Number|40|40.0||||||
3904574|NCT01477567|3728438|B7|Singapore||Region of Enrollment||participants|Number|6|6.0||||||
3904575|NCT01477567|3728439|B6|Singapore||Region of Enrollment||participants|Number|5|5.0||||||
3904576|NCT01477567|3728440|B5|Singapore||Region of Enrollment||participants|Number|6|6.0||||||
3904577|NCT01477567|3728441|B4|Singapore||Region of Enrollment||participants|Number|6|6.0||||||
3904578|NCT01477567|3728442|B3|Singapore||Region of Enrollment||participants|Number|6|6.0||||||
3904579|NCT01477567|3728443|B2|Singapore||Region of Enrollment||participants|Number|6|6.0||||||
3904580|NCT01477567|3728444|B1|Singapore||Region of Enrollment||participants|Number|5|5.0||||||
3904581|NCT01477567|3728437|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904582|NCT01477567|3728438|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904583|NCT01477567|3728439|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904584|NCT01477567|3728440|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904585|NCT01477567|3728441|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904586|NCT01477567|3728442|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904587|NCT01477567|3728443|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904588|NCT01477567|3728444|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904589|NCT01477567|3728437|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904590|NCT01477567|3728438|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904591|NCT01477567|3728439|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904592|NCT01477567|3728440|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904593|NCT01477567|3728441|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904594|NCT01477567|3728442|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904595|NCT01477567|3728443|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904596|NCT01477567|3728444|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904597|NCT01477567|3728437|B8||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904598|NCT01477567|3728438|B7||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904599|NCT01477567|3728439|B6||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904600|NCT01477567|3728440|B5||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904601|NCT01477567|3728441|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904602|NCT01477567|3728442|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904603|NCT01477567|3728443|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904604|NCT01477567|3728444|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904605|NCT01477567|3728437|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904606|NCT01477567|3728438|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904607|NCT01477567|3728439|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904608|NCT01477567|3728440|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904609|NCT01477567|3728441|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904610|NCT01477567|3728442|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904611|NCT01477567|3728443|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904612|NCT01477567|3728444|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904613|NCT01477567|3728437|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904614|NCT01477567|3728438|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904615|NCT01477567|3728439|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904616|NCT01477567|3728440|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904617|NCT01477567|3728441|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904618|NCT01477567|3728442|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904619|NCT01477567|3728443|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904620|NCT01477567|3728444|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904621|NCT01477567|3728437|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3904622|NCT01477567|3728438|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3904623|NCT01477567|3728439|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3904624|NCT01477567|3728440|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3904625|NCT01477567|3728441|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3904626|NCT01477567|3728442|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3904627|NCT01477567|3728443|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3904628|NCT01477567|3728444|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3904629|NCT01477567|3728437|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904630|NCT01477567|3728438|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904631|NCT01477567|3728439|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904632|NCT01477567|3728440|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904633|NCT01477567|3728441|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904634|NCT01477567|3728442|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904635|NCT01477567|3728443|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904636|NCT01477567|3728444|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904637|NCT01477567|3728437|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904638|NCT01477567|3728438|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904639|NCT01477567|3728439|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904640|NCT01477567|3728440|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904641|NCT01477567|3728441|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904642|NCT01477567|3728442|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904643|NCT01477567|3728443|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904644|NCT01477567|3728444|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904645|NCT01477567|3728437|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3904646|NCT01477567|3728438|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3904647|NCT01477567|3728439|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3904648|NCT01477567|3728440|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3904649|NCT01477567|3728441|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3904650|NCT01477567|3728442|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3904651|NCT01477567|3728443|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3904652|NCT01477567|3728444|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3904653|NCT01477567|3728437|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904654|NCT01477567|3728438|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904655|NCT01477567|3728439|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904656|NCT01477567|3728440|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904657|NCT01477567|3728441|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904658|NCT01477567|3728442|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904659|NCT01477567|3728443|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904660|NCT01477567|3728444|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904661|NCT01477567|3728437|B8||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3904662|NCT01477567|3728438|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3904663|NCT01477567|3728439|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3904664|NCT01477567|3728440|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3904665|NCT01477567|3728441|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3904666|NCT01477567|3728442|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3904667|NCT01477567|3728443|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3904668|NCT01477567|3728444|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3904669|NCT01477567|3728437|B8||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3904670|NCT01477567|3728438|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3904671|NCT01477567|3728439|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3904672|NCT01477567|3728440|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3904673|NCT01477567|3728441|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3904674|NCT01477567|3728442|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3904675|NCT01477567|3728443|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3904676|NCT01477567|3728444|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3904677|NCT01477567|3728437|B8|||Age||years|Mean|33.8|33.8|Standard Deviation|10.6|10.6|||
3904678|NCT01477567|3728438|B7|||Age||years|Mean|27.5|27.5|Standard Deviation|4.3|4.3|||
3904679|NCT01477567|3728439|B6|||Age||years|Mean|34.6|34.6|Standard Deviation|9.9|9.9|||
3904680|NCT01477567|3728440|B5|||Age||years|Mean|34.7|34.7|Standard Deviation|10.4|10.4|||
3904681|NCT01477567|3728441|B4|||Age||years|Mean|31.7|31.7|Standard Deviation|8.4|8.4|||
3904682|NCT01477567|3728442|B3|||Age||years|Mean|33.3|33.3|Standard Deviation|14.0|14.0|||
3904683|NCT01477567|3728443|B2|||Age||years|Mean|36.7|36.7|Standard Deviation|12.5|12.5|||
3904684|NCT01477567|3728444|B1|||Age||years|Mean|39.2|39.2|Standard Deviation|13.5|13.5|||
3904685|NCT01477463|3728504|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
3904686|NCT01477463|3728505|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3904687|NCT01477463|3728506|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3904688|NCT01477463|3728504|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3904689|NCT01477463|3728505|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3904690|NCT01477463|3728506|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3904691|NCT01477463|3728504|B3||Female|Gender||Participants|Count of Participants|24|24.0||||||
3904692|NCT01477463|3728505|B2||Female|Gender||Participants|Count of Participants|6|6.0||||||
3904693|NCT01477463|3728506|B1||Female|Gender||Participants|Count of Participants|18|18.0||||||
3904694|NCT01477463|3728504|B3|||Age||years|Mean|56.1|56.1|Standard Deviation|10.6|10.6|||
3904695|NCT01477463|3728505|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|5.7|5.7|||
3904696|NCT01477463|3728506|B1|||Age||years|Mean|56.2|56.2|Standard Deviation|12.6|12.6|||
3904697|NCT01477450|3728517|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904698|NCT01477450|3728518|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904699|NCT01477450|3728519|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904700|NCT01477450|3728520|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904701|NCT01477450|3728517|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3904702|NCT01477450|3728518|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3904703|NCT01477450|3728519|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3904704|NCT01477450|3728520|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3904705|NCT01477450|3728517|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3904706|NCT01477450|3728518|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3904707|NCT01477450|3728519|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3904708|NCT01477450|3728520|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3904709|NCT01477450|3728517|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3904710|NCT01477450|3728518|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3904711|NCT01477450|3728519|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3904712|NCT01477450|3728520|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3904713|NCT01477450|3728517|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3904714|NCT01477450|3728518|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3904715|NCT01477450|3728519|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3904716|NCT01477450|3728520|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3904717|NCT01477450|3728517|B4|18-65 years||Age, Customized||participants|Number|30|30.0||||||
3904718|NCT01477450|3728518|B3|18-65 years||Age, Customized||participants|Number|10|10.0||||||
3904719|NCT01477450|3728519|B2|18-65 years||Age, Customized||participants|Number|10|10.0||||||
3904720|NCT01477450|3728520|B1|18-65 years||Age, Customized||participants|Number|10|10.0||||||
3904721|NCT01477333|3728530|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3904722|NCT01477333|3728530|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904723|NCT01477333|3728530|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904724|NCT01477333|3728530|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3904725|NCT01477333|3728530|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904726|NCT01477333|3728530|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904727|NCT01477333|3728530|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904728|NCT01477333|3728530|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904729|NCT01477333|3728530|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904730|NCT01477333|3728530|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3904731|NCT01477333|3728530|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3904732|NCT01477333|3728530|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
3904733|NCT01477333|3728530|B1||Female|Gender||Participants|Count of Participants|13|13.0||||||
3904734|NCT01477333|3728530|B1|||Age||years|Mean|51.3|51.3|Full Range|||20.0|70.0|
3904735|NCT01477333|3728530|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3904736|NCT01477333|3728530|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3904737|NCT01477333|3728530|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3904738|NCT01477320|3728546|B3|United States||Region of Enrollment||participants|Number|102|102.0||||||
3904739|NCT01477320|3728547|B2|United States||Region of Enrollment||participants|Number|47|47.0||||||
3904740|NCT01477320|3728548|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
3904741|NCT01477320|3728546|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3904742|NCT01477320|3728547|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3904743|NCT01477320|3728548|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3904744|NCT01477320|3728546|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3904745|NCT01477320|3728547|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3904746|NCT01477320|3728548|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3904747|NCT01477320|3728546|B3|||Age||years|Median|60|60.0|Inter-Quartile Range|||40.5|68.0|
3904748|NCT01477320|3728547|B2|||Age||years|Median|58|58.0|Inter-Quartile Range|||40.5|66.5|
3904749|NCT01477320|3728548|B1|||Age||years|Median|62|62.0|Inter-Quartile Range|||49.5|68.0|
3904750|NCT01476748|3728557|B4|United States||Region of Enrollment||participants|Number|15|15.0||||||
3904751|NCT01476748|3728558|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3904752|NCT01476748|3728559|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3904753|NCT01476748|3728560|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3904754|NCT01476748|3728557|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3904755|NCT01476748|3728558|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3904756|NCT01476748|3728559|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3904757|NCT01476748|3728560|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3904758|NCT01476748|3728557|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3904759|NCT01476748|3728558|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3904760|NCT01476748|3728559|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3904761|NCT01476748|3728560|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3904762|NCT01476748|3728557|B4|||Age||years|Mean|45.13|45.13|Standard Deviation|6.63|6.63|||
3904763|NCT01476748|3728558|B3|||Age||years|Mean|44.6|44.6|Standard Deviation|6.34|6.34|||
3904764|NCT01476748|3728559|B2|||Age||years|Mean|43|43.0|Standard Deviation|9.61|9.61|||
3904765|NCT01476748|3728560|B1|||Age||years|Mean|47.8|47.8|Standard Deviation|2.48|2.48|||
3904766|NCT01476748|3728557|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3904767|NCT01476748|3728558|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3904768|NCT01476748|3728559|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3904769|NCT01476748|3728560|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3904770|NCT01476748|3728557|B4||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3904771|NCT01476748|3728558|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3904772|NCT01476748|3728559|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3904773|NCT01476748|3728560|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3904774|NCT01476748|3728557|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3904775|NCT01476748|3728558|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3904776|NCT01476748|3728559|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3904777|NCT01476748|3728560|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3904778|NCT01476722|3728573|B1|United States||Region of Enrollment||participants|Number|124|124.0||||||
3904779|NCT01476722|3728573|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3904780|NCT01476722|3728573|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3904781|NCT01476722|3728573|B1|||Age|Baseline characteristics are presented for all enrolled subjects who received test article and had at least 1 on-therapy visit (ITT): 124.|years|Mean|32.2|32.2|Standard Deviation|11.39|11.39|||
3904782|NCT01476696|3728580|B1|HbS Beta^0 Thalassemia||Genotype|The number of participants who have the homozygous sickle cell (HbSS) or hemoglobin S beta^0 thalassemia (HbS β^0 thalassemia)] sickle cell genotype.|participants|Number|3|3.0||||||
3904783|NCT01476696|3728580|B1|HbSS||Genotype|The number of participants who have the homozygous sickle cell (HbSS) or hemoglobin S beta^0 thalassemia (HbS β^0 thalassemia)] sickle cell genotype.|participants|Number|30|30.0||||||
3904784|NCT01476696|3728580|B1|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|18.64|18.64|Standard Deviation|4.091|4.091|||
3904785|NCT01476696|3728580|B1|||Weight||kilograms (kg)|Mean|38.55|38.55|Standard Deviation|18.785|18.785|||
3904786|NCT01476696|3728580|B1|||Height||centimeters (cm)|Mean|139.21|139.21|Standard Deviation|22.663|22.663|||
3904787|NCT01476696|3728580|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
3904788|NCT01476696|3728580|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3904789|NCT01476696|3728580|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3904790|NCT01476696|3728580|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904791|NCT01476696|3728580|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3904792|NCT01476696|3728580|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3904793|NCT01476696|3728580|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3904794|NCT01476696|3728580|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3904795|NCT01476696|3728580|B1|≥12 and ≤17 years||Age, Customized||participants|Number|12|12.0||||||
3904796|NCT01476696|3728580|B1|≥6 and ≤11 years||Age, Customized||participants|Number|14|14.0||||||
3904797|NCT01476696|3728580|B1|≥2 and ≤5 years||Age, Customized||participants|Number|7|7.0||||||
3904798|NCT01476475|3728596|B3|||Fasting Plasma Glucose (FPG)||mmol/L|Mean|9.61|9.61|Standard Deviation|2.18|2.18|||
3904799|NCT01476475|3728597|B2|||Fasting Plasma Glucose (FPG)||mmol/L|Mean|9.46|9.46|Standard Deviation|2.16|2.16|||
3904800|NCT01476475|3728598|B1|||Fasting Plasma Glucose (FPG)||mmol/L|Mean|9.76|9.76|Standard Deviation|2.19|2.19|||
3904801|NCT01476475|3728596|B3|||Daily Dose of Metformin||mg|Mean|2084.8|2084.8|Standard Deviation|427.7|427.7|||
3904802|NCT01476475|3728597|B2|||Daily Dose of Metformin||mg|Mean|2093.7|2093.7|Standard Deviation|415.5|415.5|||
3904803|NCT01476475|3728598|B1|||Daily Dose of Metformin||mg|Mean|2075.8|2075.8|Standard Deviation|440.7|440.7|||
3904804|NCT01476475|3728596|B3|||Duration of Diabetes||years|Mean|6.69|6.69|Standard Deviation|4.82|4.82|||
3904805|NCT01476475|3728597|B2|||Duration of Diabetes||years|Mean|7.10|7.1|Standard Deviation|5.27|5.27|||
3904806|NCT01476475|3728598|B1|||Duration of Diabetes||years|Mean|6.29|6.29|Standard Deviation|4.29|4.29|||
3904807|NCT01476475|3728596|B3|||Baseline BMI||kg/m^2|Mean|32.13|32.13|Standard Deviation|4.55|4.55|||
3904808|NCT01476475|3728597|B2|||Baseline BMI||kg/m^2|Mean|32.02|32.02|Standard Deviation|4.35|4.35|||
3904809|NCT01476475|3728598|B1|||Baseline BMI||kg/m^2|Mean|32.24|32.24|Standard Deviation|4.75|4.75|||
3904810|NCT01476475|3728596|B3|||Screening HbA1c||percentage of haemoglobin|Mean|8.10|8.1|Standard Deviation|0.78|0.78|||
3904811|NCT01476475|3728597|B2|||Screening HbA1c||percentage of haemoglobin|Mean|8.08|8.08|Standard Deviation|0.77|0.77|||
3904812|NCT01476475|3728598|B1|||Screening HbA1c||percentage of haemoglobin|Mean|8.12|8.12|Standard Deviation|0.80|0.8|||
3904813|NCT01476475|3728596|B3|Non Hispanic||Ethnicity||participants|Number|258|258.0||||||
3904814|NCT01476475|3728597|B2|Non Hispanic||Ethnicity||participants|Number|132|132.0||||||
3904815|NCT01476475|3728598|B1|Non Hispanic||Ethnicity||participants|Number|126|126.0||||||
3904816|NCT01476475|3728596|B3|Hispanic||Ethnicity||participants|Number|65|65.0||||||
3904817|NCT01476475|3728597|B2|Hispanic||Ethnicity||participants|Number|30|30.0||||||
3904818|NCT01476475|3728598|B1|Hispanic||Ethnicity||participants|Number|35|35.0||||||
3904819|NCT01476475|3728596|B3|Asian/Oriental||Race||participants|Number|2|2.0||||||
3904820|NCT01476475|3728597|B2|Asian/Oriental||Race||participants|Number|1|1.0||||||
3904821|NCT01476475|3728598|B1|Asian/Oriental||Race||participants|Number|1|1.0||||||
3904822|NCT01476475|3728596|B3|Black||Race||participants|Number|3|3.0||||||
3904823|NCT01476475|3728597|B2|Black||Race||participants|Number|1|1.0||||||
3904824|NCT01476475|3728598|B1|Black||Race||participants|Number|2|2.0||||||
3904825|NCT01476475|3728596|B3|Caucasian/White||Race||participants|Number|318|318.0||||||
3904826|NCT01476475|3728597|B2|Caucasian/White||Race||participants|Number|160|160.0||||||
3904827|NCT01476475|3728598|B1|Caucasian/White||Race||participants|Number|158|158.0||||||
3904828|NCT01476475|3728596|B3||Male|Gender||Participants|Count of Participants|165|165.0||||||
3904829|NCT01476475|3728597|B2||Male|Gender||Participants|Count of Participants|85|85.0||||||
3904830|NCT01476475|3728598|B1||Male|Gender||Participants|Count of Participants|80|80.0||||||
3904831|NCT01476475|3728596|B3||Female|Gender||Participants|Count of Participants|158|158.0||||||
3904832|NCT01476475|3728597|B2||Female|Gender||Participants|Count of Participants|77|77.0||||||
3904833|NCT01476475|3728598|B1||Female|Gender||Participants|Count of Participants|81|81.0||||||
3904834|NCT01476475|3728596|B3|||Age||years|Mean|56.7|56.7|Standard Deviation|9.4|9.4|||
3904835|NCT01476475|3728597|B2|||Age||years|Mean|56.6|56.6|Standard Deviation|9.4|9.4|||
3904836|NCT01476475|3728598|B1|||Age||years|Mean|56.9|56.9|Standard Deviation|9.5|9.5|||
3904837|NCT01476345|3728631|B1|South Africa||Region of Enrollment||participants|Number|80|80.0||||||
3904838|NCT01476345|3728631|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904839|NCT01476345|3728631|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3904840|NCT01476345|3728631|B1||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3904841|NCT01476345|3728631|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3904842|NCT01476345|3728631|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904843|NCT01476345|3728631|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904844|NCT01476345|3728631|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3904845|NCT01476345|3728631|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3904846|NCT01476345|3728631|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3904847|NCT01476345|3728631|B1|||Age||years|Mean|32.0|32.0|Standard Deviation|10.9|10.9|||
3904848|NCT01476202|3728644|B4||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3904849|NCT01476202|3728645|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3904850|NCT01476202|3728646|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3904851|NCT01476202|3728647|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3904852|NCT01476202|3728644|B4||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3904853|NCT01476202|3728645|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3904854|NCT01476202|3728646|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3904855|NCT01476202|3728647|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3904856|NCT01476202|3728644|B4|||Age||Years|Mean|35.0|35.0|Standard Deviation|11.2|11.2|||
3904857|NCT01476202|3728645|B3|||Age||Years|Mean|37.4|37.4|Standard Deviation|11.5|11.5|||
3904858|NCT01476202|3728646|B2|||Age||Years|Mean|34.8|34.8|Standard Deviation|10.9|10.9|||
3904859|NCT01476202|3728647|B1|||Age||Years|Mean|35.5|35.5|Standard Deviation|11.4|11.4|||
3904860|NCT01475955|3728660|B6|United States||Region of Enrollment||participants|Number|235|235.0||||||
3904861|NCT01475955|3728661|B5|United States||Region of Enrollment||participants|Number|46|46.0||||||
3904862|NCT01475955|3728662|B4|United States||Region of Enrollment||participants|Number|46|46.0||||||
3904863|NCT01475955|3728663|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
3904864|NCT01475955|3728664|B2|United States||Region of Enrollment||participants|Number|48|48.0||||||
3904865|NCT01475955|3728665|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
3904866|NCT01475955|3728660|B6||Male|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
3904867|NCT01475955|3728661|B5||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3904868|NCT01475955|3728662|B4||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3904869|NCT01475955|3728663|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3904870|NCT01475955|3728664|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3904871|NCT01475955|3728665|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3904872|NCT01475955|3728660|B6||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3904873|NCT01475955|3728661|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3904874|NCT01475955|3728662|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3904875|NCT01475955|3728663|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3904876|NCT01475955|3728664|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3904877|NCT01475955|3728665|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3904878|NCT01475955|3728660|B6|||Age||years|Mean|67.5|67.5|Standard Deviation|9.3|9.3|||
3904879|NCT01475955|3728661|B5|||Age||years|Mean|68.4|68.4|Standard Deviation|9.4|9.4|||
3904880|NCT01475955|3728662|B4|||Age||years|Mean|69.5|69.5|Standard Deviation|9.7|9.7|||
3904881|NCT01475955|3728663|B3|||Age||years|Mean|66.4|66.4|Standard Deviation|10.6|10.6|||
3904882|NCT01475955|3728664|B2|||Age||years|Mean|67.1|67.1|Standard Deviation|9.4|9.4|||
3904883|NCT01475955|3728665|B1|||Age||years|Mean|66.3|66.3|Standard Deviation|7.0|7.0|||
3904884|NCT01475851|3729026|B3|Asian-Japanese Heritage||Race/Ethnicity, Customized|HER=Heritage|Participants|Number|34|34.0||||||
3904885|NCT01475851|3729027|B2|Asian-Japanese Heritage||Race/Ethnicity, Customized|HER=Heritage|Participants|Number|21|21.0||||||
3904886|NCT01475851|3729028|B1|Asian-Japanese Heritage||Race/Ethnicity, Customized|HER=Heritage|Participants|Number|13|13.0||||||
3904887|NCT01475851|3729026|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3904888|NCT01475851|3729027|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3904889|NCT01475851|3729028|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3904890|NCT01475851|3729026|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3904891|NCT01475851|3729027|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3904892|NCT01475851|3729028|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3904893|NCT01475851|3729026|B3|||Age||Years|Mean|51.0|51.0|Standard Deviation|8.52|8.52|||
3904894|NCT01475851|3729027|B2|||Age||Years|Mean|50.3|50.3|Standard Deviation|9.18|9.18|||
3904895|NCT01475851|3729028|B1|||Age||Years|Mean|52.1|52.1|Standard Deviation|7.57|7.57|||
3904896|NCT01475838|3729055|B3|AIDS||HIV Disease Status||participants|Number|59|59.0||||||
3904897|NCT01475838|3729056|B2|AIDS||HIV Disease Status||participants|Number|18|18.0||||||
3904898|NCT01475838|3729057|B1|AIDS||HIV Disease Status||participants|Number|41|41.0||||||
3904899|NCT01475838|3729055|B3|Symptomatic HIV Infections||HIV Disease Status||participants|Number|55|55.0||||||
3904900|NCT01475838|3729056|B2|Symptomatic HIV Infections||HIV Disease Status||participants|Number|17|17.0||||||
3904901|NCT01475838|3729057|B1|Symptomatic HIV Infections||HIV Disease Status||participants|Number|38|38.0||||||
3904902|NCT01475838|3729055|B3|Asymptomatic||HIV Disease Status||participants|Number|319|319.0||||||
3904903|NCT01475838|3729056|B2|Asymptomatic||HIV Disease Status||participants|Number|105|105.0||||||
3904904|NCT01475838|3729057|B1|Asymptomatic||HIV Disease Status||participants|Number|214|214.0||||||
3904905|NCT01475838|3729055|B3|> 500 cells/µL||CD4+ Cell Count Category||participants|Number|272|272.0||||||
3904906|NCT01475838|3729056|B2|> 500 cells/µL||CD4+ Cell Count Category||participants|Number|94|94.0||||||
3904907|NCT01475838|3729057|B1|> 500 cells/µL||CD4+ Cell Count Category||participants|Number|178|178.0||||||
3904908|NCT01475838|3729055|B3|351 to ≤ 500 cells/µL||CD4+ Cell Count Category||participants|Number|95|95.0||||||
3904909|NCT01475838|3729056|B2|351 to ≤ 500 cells/µL||CD4+ Cell Count Category||participants|Number|26|26.0||||||
3904910|NCT01475838|3729057|B1|351 to ≤ 500 cells/µL||CD4+ Cell Count Category||participants|Number|69|69.0||||||
3904911|NCT01475838|3729055|B3|201 to ≤ 350 cells/µL||CD4+ Cell Count Category||participants|Number|51|51.0||||||
3904912|NCT01475838|3729056|B2|201 to ≤ 350 cells/µL||CD4+ Cell Count Category||participants|Number|14|14.0||||||
3904913|NCT01475838|3729057|B1|201 to ≤ 350 cells/µL||CD4+ Cell Count Category||participants|Number|37|37.0||||||
3904914|NCT01475838|3729055|B3|51 to ≤ 200 cells/µL||CD4+ Cell Count Category||participants|Number|15|15.0||||||
3904915|NCT01475838|3729056|B2|51 to ≤ 200 cells/µL||CD4+ Cell Count Category||participants|Number|6|6.0||||||
3904916|NCT01475838|3729057|B1|51 to ≤ 200 cells/µL||CD4+ Cell Count Category||participants|Number|9|9.0||||||
3904917|NCT01475838|3729055|B3|≤ 50 cells/µL||CD4+ Cell Count Category||participants|Number|0|0.0||||||
3904918|NCT01475838|3729056|B2|≤ 50 cells/µL||CD4+ Cell Count Category||participants|Number|0|0.0||||||
3904919|NCT01475838|3729057|B1|≤ 50 cells/µL||CD4+ Cell Count Category||participants|Number|0|0.0||||||
3904920|NCT01475838|3729055|B3|||CD4+ Cell Count||cells/µL|Mean|610|610.0|Standard Deviation|272.9|272.9|||
3904921|NCT01475838|3729056|B2|||CD4+ Cell Count||cells/µL|Mean|624|624.0|Standard Deviation|269.9|269.9|||
3904922|NCT01475838|3729057|B1|||CD4+ Cell Count||cells/µL|Mean|604|604.0|Standard Deviation|274.6|274.6|||
3904923|NCT01475838|3729055|B3|≥ 400 copies/mL||HIV-1 RNA Category||participants|Number|1|1.0||||||
3904924|NCT01475838|3729056|B2|≥ 400 copies/mL||HIV-1 RNA Category||participants|Number|1|1.0||||||
3904925|NCT01475838|3729057|B1|≥ 400 copies/mL||HIV-1 RNA Category||participants|Number|0|0.0||||||
3904926|NCT01475838|3729055|B3|200 to < 400 copies/mL||HIV-1 RNA Category||participants|Number|0|0.0||||||
3904927|NCT01475838|3729056|B2|200 to < 400 copies/mL||HIV-1 RNA Category||participants|Number|0|0.0||||||
3904928|NCT01475838|3729057|B1|200 to < 400 copies/mL||HIV-1 RNA Category||participants|Number|0|0.0||||||
3904929|NCT01475838|3729055|B3|50 to < 200 copies/mL||HIV-1 RNA Category||participants|Number|4|4.0||||||
3904930|NCT01475838|3729056|B2|50 to < 200 copies/mL||HIV-1 RNA Category||participants|Number|2|2.0||||||
3904931|NCT01475838|3729057|B1|50 to < 200 copies/mL||HIV-1 RNA Category||participants|Number|2|2.0||||||
3904932|NCT01475838|3729055|B3|< 50 copies/mL||HIV-1 RNA Category||participants|Number|428|428.0||||||
3904933|NCT01475838|3729056|B2|< 50 copies/mL||HIV-1 RNA Category||participants|Number|137|137.0||||||
3904934|NCT01475838|3729057|B1|< 50 copies/mL||HIV-1 RNA Category||participants|Number|291|291.0||||||
3904935|NCT01475838|3729055|B3|Italy||Region of Enrollment||participants|Number|60|60.0||||||
3904936|NCT01475838|3729056|B2|Italy||Region of Enrollment||participants|Number|16|16.0||||||
3904937|NCT01475838|3729057|B1|Italy||Region of Enrollment||participants|Number|44|44.0||||||
3904938|NCT01475838|3729055|B3|Switzerland||Region of Enrollment||participants|Number|20|20.0||||||
3904939|NCT01475838|3729056|B2|Switzerland||Region of Enrollment||participants|Number|8|8.0||||||
3904940|NCT01475838|3729057|B1|Switzerland||Region of Enrollment||participants|Number|12|12.0||||||
3904941|NCT01475838|3729055|B3|United Kingdom||Region of Enrollment||participants|Number|14|14.0||||||
3904942|NCT01475838|3729056|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3904943|NCT01475838|3729057|B1|United Kingdom||Region of Enrollment||participants|Number|13|13.0||||||
3904944|NCT01475838|3729055|B3|Germany||Region of Enrollment||participants|Number|57|57.0||||||
3904945|NCT01475838|3729056|B2|Germany||Region of Enrollment||participants|Number|21|21.0||||||
3904946|NCT01475838|3729057|B1|Germany||Region of Enrollment||participants|Number|36|36.0||||||
3904947|NCT01475838|3729055|B3|Austria||Region of Enrollment||participants|Number|15|15.0||||||
3904948|NCT01475838|3729056|B2|Austria||Region of Enrollment||participants|Number|4|4.0||||||
3904949|NCT01475838|3729057|B1|Austria||Region of Enrollment||participants|Number|11|11.0||||||
3904950|NCT01475838|3729055|B3|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
3904951|NCT01475838|3729056|B2|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
3904952|NCT01475838|3729057|B1|Belgium||Region of Enrollment||participants|Number|6|6.0||||||
3904953|NCT01475838|3729055|B3|Spain||Region of Enrollment||participants|Number|49|49.0||||||
3904954|NCT01475838|3729056|B2|Spain||Region of Enrollment||participants|Number|21|21.0||||||
3904955|NCT01475838|3729057|B1|Spain||Region of Enrollment||participants|Number|28|28.0||||||
3904956|NCT01475838|3729055|B3|Canada||Region of Enrollment||participants|Number|8|8.0||||||
3904957|NCT01475838|3729056|B2|Canada||Region of Enrollment||participants|Number|3|3.0||||||
3904958|NCT01475838|3729057|B1|Canada||Region of Enrollment||participants|Number|5|5.0||||||
3904959|NCT01475838|3729055|B3|Puerto Rico||Region of Enrollment||participants|Number|5|5.0||||||
3904960|NCT01475838|3729056|B2|Puerto Rico||Region of Enrollment||participants|Number|2|2.0||||||
3904961|NCT01475838|3729057|B1|Puerto Rico||Region of Enrollment||participants|Number|3|3.0||||||
3904962|NCT01475838|3729055|B3|United States||Region of Enrollment||participants|Number|124|124.0||||||
3904963|NCT01475838|3729056|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
3904964|NCT01475838|3729057|B1|United States||Region of Enrollment||participants|Number|84|84.0||||||
3904965|NCT01475838|3729055|B3|France||Region of Enrollment||participants|Number|54|54.0||||||
3904966|NCT01475838|3729056|B2|France||Region of Enrollment||participants|Number|15|15.0||||||
3904967|NCT01475838|3729057|B1|France||Region of Enrollment||participants|Number|39|39.0||||||
3904968|NCT01475838|3729055|B3|Portugal||Region of Enrollment||participants|Number|19|19.0||||||
3904969|NCT01475838|3729056|B2|Portugal||Region of Enrollment||participants|Number|7|7.0||||||
3904970|NCT01475838|3729057|B1|Portugal||Region of Enrollment||participants|Number|12|12.0||||||
3904971|NCT01475838|3729055|B3|Not Permitted||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3904972|NCT01475838|3729056|B2|Not Permitted||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3904973|NCT01475838|3729057|B1|Not Permitted||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3904974|NCT01475838|3729055|B3|Non-Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|372|372.0||||||
3904975|NCT01475838|3729056|B2|Non-Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|123|123.0||||||
3904976|NCT01475838|3729057|B1|Non-Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|249|249.0||||||
3904977|NCT01475838|3729055|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
3904978|NCT01475838|3729056|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3904979|NCT01475838|3729057|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
3904980|NCT01475838|3729055|B3|Not Permitted||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3904981|NCT01475838|3729056|B2|Not Permitted||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3904982|NCT01475838|3729057|B1|Not Permitted||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3904983|NCT01475838|3729055|B3|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3904984|NCT01475838|3729056|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3904985|NCT01475838|3729057|B1|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3904986|NCT01475838|3729055|B3|White||Race/Ethnicity, Customized||participants|Number|347|347.0||||||
3904987|NCT01475838|3729056|B2|White||Race/Ethnicity, Customized||participants|Number|113|113.0||||||
3904988|NCT01475838|3729057|B1|White||Race/Ethnicity, Customized||participants|Number|234|234.0||||||
3904989|NCT01475838|3729055|B3|Black or African Heritage||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
3904990|NCT01475838|3729056|B2|Black or African Heritage||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3904991|NCT01475838|3729057|B1|Black or African Heritage||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
3904992|NCT01475838|3729055|B3|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3904993|NCT01475838|3729056|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3904994|NCT01475838|3729057|B1|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3904995|NCT01475838|3729055|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3904996|NCT01475838|3729056|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3904997|NCT01475838|3729057|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3904998|NCT01475838|3729055|B3||Male|Sex: Female, Male||Participants|Count of Participants|371|371.0||||||
3904999|NCT01475838|3729056|B2||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3905000|NCT01475838|3729057|B1||Male|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
3905001|NCT01475838|3729055|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3905002|NCT01475838|3729056|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3905003|NCT01475838|3729057|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3905004|NCT01475838|3729055|B3|≥ 50 years||Age, Customized||participants|Number|77|77.0||||||
3905005|NCT01475838|3729056|B2|≥ 50 years||Age, Customized||participants|Number|23|23.0||||||
3905006|NCT01475838|3729057|B1|≥ 50 years||Age, Customized||participants|Number|54|54.0||||||
3905007|NCT01475838|3729055|B3|≥ 40 to < 50 years||Age, Customized||participants|Number|158|158.0||||||
3905008|NCT01475838|3729056|B2|≥ 40 to < 50 years||Age, Customized||participants|Number|49|49.0||||||
3905009|NCT01475838|3729057|B1|≥ 40 to < 50 years||Age, Customized||participants|Number|109|109.0||||||
3905010|NCT01475838|3729055|B3|< 40 years||Age, Customized||participants|Number|198|198.0||||||
3905011|NCT01475838|3729056|B2|< 40 years||Age, Customized||participants|Number|68|68.0||||||
3905012|NCT01475838|3729057|B1|< 40 years||Age, Customized||participants|Number|130|130.0||||||
3905013|NCT01475838|3729055|B3|||Age||years|Mean|41|41.0|Standard Deviation|9.4|9.4|||
3905014|NCT01475838|3729056|B2|||Age||years|Mean|41|41.0|Standard Deviation|8.9|8.9|||
3905015|NCT01475838|3729057|B1|||Age||years|Mean|41|41.0|Standard Deviation|9.7|9.7|||
3905016|NCT01475734|3729071|B3|Persian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3905017|NCT01475734|3729072|B2|Persian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3905018|NCT01475734|3729073|B1|Persian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3905019|NCT01475734|3729071|B3|Mexican||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3905020|NCT01475734|3729072|B2|Mexican||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3905021|NCT01475734|3729073|B1|Mexican||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3905022|NCT01475734|3729071|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3905023|NCT01475734|3729072|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3905024|NCT01475734|3729073|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3905025|NCT01475734|3729071|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|34|34.0||||||
3905026|NCT01475734|3729072|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3905027|NCT01475734|3729073|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
3905028|NCT01475734|3729071|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3905029|NCT01475734|3729072|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3905030|NCT01475734|3729073|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3905031|NCT01475734|3729071|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3905032|NCT01475734|3729072|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3905033|NCT01475734|3729073|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3905034|NCT01475734|3729071|B3||Male|Gender||Participants|Count of Participants|20|20.0||||||
3905035|NCT01475734|3729072|B2||Male|Gender||Participants|Count of Participants|10|10.0||||||
3905036|NCT01475734|3729073|B1||Male|Gender||Participants|Count of Participants|10|10.0||||||
3905037|NCT01475734|3729071|B3||Female|Gender||Participants|Count of Participants|24|24.0||||||
3905038|NCT01475734|3729072|B2||Female|Gender||Participants|Count of Participants|12|12.0||||||
3905039|NCT01475734|3729073|B1||Female|Gender||Participants|Count of Participants|12|12.0||||||
3905040|NCT01475734|3729071|B3|||Age||Years|Mean|49.1|49.1|Standard Deviation|8.12|8.12|||
3905041|NCT01475734|3729072|B2|||Age||Years|Mean|48.4|48.4|Standard Deviation|9.32|9.32|||
3905042|NCT01475734|3729073|B1|||Age||Years|Mean|49.9|49.9|Standard Deviation|6.86|6.86|||
3905043|NCT01475721|3729100|B3|Multiple||Race/Ethnicity, Customized||Participants|Number|193|193.0||||||
3905044|NCT01475721|3729101|B2|Multiple||Race/Ethnicity, Customized||Participants|Number|91|91.0||||||
3905045|NCT01475721|3729102|B1|Multiple||Race/Ethnicity, Customized||Participants|Number|102|102.0||||||
3905046|NCT01475721|3729100|B3|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|8740|8740.0||||||
3905047|NCT01475721|3729101|B2|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|4388|4388.0||||||
3905048|NCT01475721|3729102|B1|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|4352|4352.0||||||
3905049|NCT01475721|3729100|B3|White-Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|43|43.0||||||
3905050|NCT01475721|3729101|B2|White-Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
3905051|NCT01475721|3729102|B1|White-Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
3905052|NCT01475721|3729100|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
3905053|NCT01475721|3729101|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
3905054|NCT01475721|3729102|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3905055|NCT01475721|3729100|B3|Asian-South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|458|458.0||||||
3905056|NCT01475721|3729101|B2|Asian-South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|224|224.0||||||
3905057|NCT01475721|3729102|B1|Asian-South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|234|234.0||||||
3905058|NCT01475721|3729100|B3|Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3905059|NCT01475721|3729101|B2|Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3905060|NCT01475721|3729102|B1|Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3905061|NCT01475721|3729100|B3|Asian-East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|182|182.0||||||
3905062|NCT01475721|3729101|B2|Asian-East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|88|88.0||||||
3905063|NCT01475721|3729102|B1|Asian-East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|94|94.0||||||
3905064|NCT01475721|3729100|B3|Asian-Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|81|81.0||||||
3905065|NCT01475721|3729101|B2|Asian-Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|45|45.0||||||
3905066|NCT01475721|3729102|B1|Asian-Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|36|36.0||||||
3905067|NCT01475721|3729100|B3|American Indian/Alaska native||Race/Ethnicity, Customized||Participants|Number|225|225.0||||||
3905068|NCT01475721|3729101|B2|American Indian/Alaska native||Race/Ethnicity, Customized||Participants|Number|116|116.0||||||
3905069|NCT01475721|3729102|B1|American Indian/Alaska native||Race/Ethnicity, Customized||Participants|Number|109|109.0||||||
3905070|NCT01475721|3729100|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1726|1726.0||||||
3905071|NCT01475721|3729101|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|856|856.0||||||
3905072|NCT01475721|3729102|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|870|870.0||||||
3905073|NCT01475721|3729100|B3|Missing||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3905074|NCT01475721|3729101|B2|Missing||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3905075|NCT01475721|3729102|B1|Missing||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3905076|NCT01475721|3729100|B3||Male|Sex: Female, Male||Participants|Count of Participants|3930|3930.0||||||
3905077|NCT01475721|3729101|B2||Male|Sex: Female, Male||Participants|Count of Participants|1947|1947.0||||||
3905078|NCT01475721|3729102|B1||Male|Sex: Female, Male||Participants|Count of Participants|1983|1983.0||||||
3905079|NCT01475721|3729100|B3||Female|Sex: Female, Male||Participants|Count of Participants|7749|7749.0||||||
3905080|NCT01475721|3729101|B2||Female|Sex: Female, Male||Participants|Count of Participants|3898|3898.0||||||
3905081|NCT01475721|3729102|B1||Female|Sex: Female, Male||Participants|Count of Participants|3851|3851.0||||||
3905082|NCT01475721|3729100|B3|||Age||Years|Mean|43.4|43.4|Standard Deviation|17.36|17.36|||
3905083|NCT01475721|3729101|B2|||Age||Years|Mean|43.4|43.4|Standard Deviation|17.28|17.28|||
3905084|NCT01475721|3729102|B1|||Age||Years|Mean|43.4|43.4|Standard Deviation|17.45|17.45|||
3905085|NCT01475513|3729117|B3|United States||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3905086|NCT01475513|3729118|B2|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3905087|NCT01475513|3729119|B1|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3905088|NCT01475513|3729117|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905089|NCT01475513|3729118|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905090|NCT01475513|3729119|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905091|NCT01475513|3729117|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905092|NCT01475513|3729118|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905093|NCT01475513|3729119|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905094|NCT01475513|3729117|B3||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3905095|NCT01475513|3729118|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3905096|NCT01475513|3729119|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905097|NCT01475513|3729117|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3905098|NCT01475513|3729118|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905099|NCT01475513|3729119|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3905100|NCT01475513|3729117|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905101|NCT01475513|3729118|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905102|NCT01475513|3729119|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905103|NCT01475513|3729117|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905104|NCT01475513|3729118|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905105|NCT01475513|3729119|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905106|NCT01475513|3729117|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905107|NCT01475513|3729118|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905108|NCT01475513|3729119|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905109|NCT01475513|3729117|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3905110|NCT01475513|3729118|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3905111|NCT01475513|3729119|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3905112|NCT01475513|3729117|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3905113|NCT01475513|3729118|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3905114|NCT01475513|3729119|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3905115|NCT01475513|3729117|B3|||Age||years|Mean|21.0|21.0|Standard Deviation|3.68|3.68|||
3905116|NCT01475513|3729118|B2|||Age||years|Mean|21.6|21.6|Standard Deviation|3.92|3.92|||
3905117|NCT01475513|3729119|B1|||Age||years|Mean|20.3|20.3|Standard Deviation|3.43|3.43|||
3905118|NCT01475487|3729156|B3|FELLOWS||Years post graduate trainee level||Participants|Number|8|8.0||||||
3905119|NCT01475487|3729157|B2|FELLOWS||Years post graduate trainee level||Participants|Number|4|4.0||||||
3905120|NCT01475487|3729158|B1|FELLOWS||Years post graduate trainee level||Participants|Number|4|4.0||||||
3905121|NCT01475487|3729156|B3|POST GRADUATE YEAR-5||Years post graduate trainee level||Participants|Number|6|6.0||||||
3905122|NCT01475487|3729157|B2|POST GRADUATE YEAR-5||Years post graduate trainee level||Participants|Number|4|4.0||||||
3905123|NCT01475487|3729158|B1|POST GRADUATE YEAR-5||Years post graduate trainee level||Participants|Number|2|2.0||||||
3905124|NCT01475487|3729156|B3|POST GRADUATE YEAR-4||Years post graduate trainee level||Participants|Number|5|5.0||||||
3905125|NCT01475487|3729157|B2|POST GRADUATE YEAR-4||Years post graduate trainee level||Participants|Number|3|3.0||||||
3905126|NCT01475487|3729158|B1|POST GRADUATE YEAR-4||Years post graduate trainee level||Participants|Number|2|2.0||||||
3905127|NCT01475487|3729156|B3|POST GRADUATE YEAR-3||Years post graduate trainee level||Participants|Number|6|6.0||||||
3905128|NCT01475487|3729157|B2|POST GRADUATE YEAR-3||Years post graduate trainee level||Participants|Number|2|2.0||||||
3905129|NCT01475487|3729158|B1|POST GRADUATE YEAR-3||Years post graduate trainee level||Participants|Number|4|4.0||||||
3905130|NCT01475487|3729156|B3|POST GRADUATE YEAR-2||Years post graduate trainee level||Participants|Number|11|11.0||||||
3905131|NCT01475487|3729157|B2|POST GRADUATE YEAR-2||Years post graduate trainee level||Participants|Number|4|4.0||||||
3905132|NCT01475487|3729158|B1|POST GRADUATE YEAR-2||Years post graduate trainee level||Participants|Number|7|7.0||||||
3905133|NCT01475487|3729156|B3|POST GRADUATE YEAR-1||Years post graduate trainee level||Participants|Number|11|11.0||||||
3905134|NCT01475487|3729157|B2|POST GRADUATE YEAR-1||Years post graduate trainee level||Participants|Number|7|7.0||||||
3905135|NCT01475487|3729158|B1|POST GRADUATE YEAR-1||Years post graduate trainee level||Participants|Number|4|4.0||||||
3905136|NCT01475487|3729156|B3|Grade-4||Landmark grade|Landmark grade indicate the difficulty in identification of anatomical landmarks on the cadavers. Higher grades indicate a greater difficulty in identification|participants|Number|11|11.0||||||
3905137|NCT01475487|3729157|B2|Grade-4||Landmark grade|Landmark grade indicate the difficulty in identification of anatomical landmarks on the cadavers. Higher grades indicate a greater difficulty in identification|participants|Number|7|7.0||||||
3905138|NCT01475487|3729158|B1|Grade-4||Landmark grade|Landmark grade indicate the difficulty in identification of anatomical landmarks on the cadavers. Higher grades indicate a greater difficulty in identification|participants|Number|4|4.0||||||
3905139|NCT01475487|3729156|B3|Grade-3||Landmark grade|Landmark grade indicate the difficulty in identification of anatomical landmarks on the cadavers. Higher grades indicate a greater difficulty in identification|participants|Number|16|16.0||||||
3905140|NCT01475487|3729157|B2|Grade-3||Landmark grade|Landmark grade indicate the difficulty in identification of anatomical landmarks on the cadavers. Higher grades indicate a greater difficulty in identification|participants|Number|8|8.0||||||
3905141|NCT01475487|3729158|B1|Grade-3||Landmark grade|Landmark grade indicate the difficulty in identification of anatomical landmarks on the cadavers. Higher grades indicate a greater difficulty in identification|participants|Number|8|8.0||||||
3905142|NCT01475487|3729156|B3|Grade-2||Landmark grade|Landmark grade indicate the difficulty in identification of anatomical landmarks on the cadavers. Higher grades indicate a greater difficulty in identification|participants|Number|20|20.0||||||
3905143|NCT01475487|3729157|B2|Grade-2||Landmark grade|Landmark grade indicate the difficulty in identification of anatomical landmarks on the cadavers. Higher grades indicate a greater difficulty in identification|participants|Number|9|9.0||||||
3905144|NCT01475487|3729158|B1|Grade-2||Landmark grade|Landmark grade indicate the difficulty in identification of anatomical landmarks on the cadavers. Higher grades indicate a greater difficulty in identification|participants|Number|11|11.0||||||
3905145|NCT01475487|3729156|B3|||Neck circumference||Centimeters|Mean|21.45|21.45|Standard Deviation|1.74|1.74|||
3905146|NCT01475487|3729157|B2|||Neck circumference||Centimeters|Mean|21.54|21.54|Standard Deviation|1.74|1.74|||
3905147|NCT01475487|3729158|B1|||Neck circumference||Centimeters|Mean|21.35|21.35|Standard Deviation|1.92|1.92|||
3905148|NCT01475487|3729156|B3||Male|Sex: Female, Male|Gender description is for Cadvaers only|Participants|Count of Participants|19|19.0||||||
3905149|NCT01475487|3729157|B2||Male|Sex: Female, Male|Gender description is for Cadvaers only|Participants|Count of Participants|7|7.0||||||
3905150|NCT01475487|3729158|B1||Male|Sex: Female, Male|Gender description is for Cadvaers only|Participants|Count of Participants|12|12.0||||||
3905151|NCT01475487|3729156|B3||Female|Sex: Female, Male|Gender description is for Cadvaers only|Participants|Count of Participants|28|28.0||||||
3905152|NCT01475487|3729157|B2||Female|Sex: Female, Male|Gender description is for Cadvaers only|Participants|Count of Participants|17|17.0||||||
3905153|NCT01475487|3729158|B1||Female|Sex: Female, Male|Gender description is for Cadvaers only|Participants|Count of Participants|11|11.0||||||
3905154|NCT01475487|3729156|B3|||Age, Customized|||Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3905155|NCT01475487|3729157|B2|||Age, Customized|||Number|NA|||||||Age was not collected for this study
3905156|NCT01475487|3729158|B1|||Age, Customized|||Number|NA|||||||Age was not collected for this study
3905157|NCT01475474|3729171|B1|United States||Region of Enrollment||participants|Number|97|97.0||||||
3905158|NCT01475474|3729171|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3905159|NCT01475474|3729171|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3905160|NCT01475474|3729171|B1||>=65 years|Age||Participants|Count of Participants|63|63.0||||||
3905161|NCT01475474|3729171|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3905162|NCT01475474|3729171|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3905163|NCT01475461|3729176|B7||Male|Gender||Participants|Count of Participants|192|192.0||||||
3905164|NCT01475461|3729177|B6||Male|Gender||Participants|Count of Participants|33|33.0||||||
3905165|NCT01475461|3729178|B5||Male|Gender||Participants|Count of Participants|30|30.0||||||
3905166|NCT01475461|3729179|B4||Male|Gender||Participants|Count of Participants|33|33.0||||||
3905167|NCT01475461|3729180|B3||Male|Gender||Participants|Count of Participants|32|32.0||||||
3905168|NCT01475461|3729181|B2||Male|Gender||Participants|Count of Participants|28|28.0||||||
3905169|NCT01475461|3729182|B1||Male|Gender||Participants|Count of Participants|36|36.0||||||
3905170|NCT01475461|3729176|B7||Female|Gender||Participants|Count of Participants|143|143.0||||||
3905171|NCT01475461|3729177|B6||Female|Gender||Participants|Count of Participants|22|22.0||||||
3905172|NCT01475461|3729178|B5||Female|Gender||Participants|Count of Participants|26|26.0||||||
3905173|NCT01475461|3729179|B4||Female|Gender||Participants|Count of Participants|23|23.0||||||
3905174|NCT01475461|3729180|B3||Female|Gender||Participants|Count of Participants|22|22.0||||||
3905175|NCT01475461|3729181|B2||Female|Gender||Participants|Count of Participants|29|29.0||||||
3905176|NCT01475461|3729182|B1||Female|Gender||Participants|Count of Participants|21|21.0||||||
3905177|NCT01475461|3729176|B7|>=45 to =<64 years||Age, Customized||Participants|Number|242|242.0||||||
3905178|NCT01475461|3729177|B6|>=45 to =<64 years||Age, Customized||Participants|Number|38|38.0||||||
3905179|NCT01475461|3729178|B5|>=45 to =<64 years||Age, Customized||Participants|Number|41|41.0||||||
3905180|NCT01475461|3729179|B4|>=45 to =<64 years||Age, Customized||Participants|Number|41|41.0||||||
3905181|NCT01475461|3729180|B3|>=45 to =<64 years||Age, Customized||Participants|Number|40|40.0||||||
3905182|NCT01475461|3729181|B2|>=45 to =<64 years||Age, Customized||Participants|Number|40|40.0||||||
3905183|NCT01475461|3729182|B1|>=45 to =<64 years||Age, Customized||Participants|Number|42|42.0||||||
3905184|NCT01475461|3729176|B7|>=18 to =<44 years||Age, Customized||Participants|Number|93|93.0||||||
3905185|NCT01475461|3729177|B6|>=18 to =<44 years||Age, Customized||Participants|Number|17|17.0||||||
3905186|NCT01475461|3729178|B5|>=18 to =<44 years||Age, Customized||Participants|Number|15|15.0||||||
3905187|NCT01475461|3729179|B4|>=18 to =<44 years||Age, Customized||Participants|Number|15|15.0||||||
3905188|NCT01475461|3729180|B3|>=18 to =<44 years||Age, Customized||Participants|Number|14|14.0||||||
3905189|NCT01475461|3729181|B2|>=18 to =<44 years||Age, Customized||Participants|Number|17|17.0||||||
3905190|NCT01475461|3729182|B1|>=18 to =<44 years||Age, Customized||Participants|Number|15|15.0||||||
3905191|NCT01475331|3729266|B3|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3905192|NCT01475331|3729267|B2|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3905193|NCT01475331|3729268|B1|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3905194|NCT01475331|3729266|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905195|NCT01475331|3729267|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905196|NCT01475331|3729268|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905197|NCT01475331|3729266|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905198|NCT01475331|3729267|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905199|NCT01475331|3729268|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905200|NCT01475331|3729266|B3||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3905201|NCT01475331|3729267|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3905202|NCT01475331|3729268|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3905203|NCT01475331|3729266|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3905204|NCT01475331|3729267|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3905205|NCT01475331|3729268|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3905206|NCT01475331|3729266|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905207|NCT01475331|3729267|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905208|NCT01475331|3729268|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905209|NCT01475331|3729266|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905210|NCT01475331|3729267|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905211|NCT01475331|3729268|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905212|NCT01475331|3729266|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3905213|NCT01475331|3729267|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3905214|NCT01475331|3729268|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905215|NCT01475331|3729266|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3905216|NCT01475331|3729267|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3905217|NCT01475331|3729268|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3905218|NCT01475331|3729266|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3905219|NCT01475331|3729267|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3905220|NCT01475331|3729268|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3905221|NCT01475331|3729266|B3||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
3905222|NCT01475331|3729267|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3905223|NCT01475331|3729268|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3905224|NCT01475331|3729266|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3905225|NCT01475331|3729267|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3905226|NCT01475331|3729268|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3905227|NCT01475331|3729266|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3905228|NCT01475331|3729267|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3905229|NCT01475331|3729268|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3905230|NCT01475305|3729275|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3905231|NCT01475305|3729276|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3905232|NCT01475305|3729277|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3905233|NCT01475305|3729275|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3905234|NCT01475305|3729276|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3905235|NCT01475305|3729277|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3905236|NCT01475305|3729275|B3|||Age||Years|Mean|26.0|26.0|Standard Deviation|6.6|6.6|||
3905237|NCT01475305|3729276|B2|||Age||Years|Mean|28.0|28.0|Standard Deviation|9.5|9.5|||
3905238|NCT01475305|3729277|B1|||Age||Years|Mean|24.5|24.5|Standard Deviation|4.4|4.4|||
3905239|NCT01475253|3729318|B4|Canada||Region of Enrollment||participants|Number|5|5.0||||||
3905240|NCT01475253|3729319|B3|Canada||Region of Enrollment||participants|Number|0|0.0||||||
3905241|NCT01475253|3729320|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
3905242|NCT01475253|3729321|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
3905243|NCT01475253|3729318|B4|United States||Region of Enrollment||participants|Number|99|99.0||||||
3905244|NCT01475253|3729319|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3905245|NCT01475253|3729320|B2|United States||Region of Enrollment||participants|Number|44|44.0||||||
3905246|NCT01475253|3729321|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
3905247|NCT01475253|3729318|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3905248|NCT01475253|3729319|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3905249|NCT01475253|3729320|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3905250|NCT01475253|3729321|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3905251|NCT01475253|3729318|B4||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3905252|NCT01475253|3729319|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3905253|NCT01475253|3729320|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3905254|NCT01475253|3729321|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3905255|NCT01475253|3729318|B4|||Age||years|Mean|44.4|44.4|Standard Deviation|15.12|15.12|||
3905256|NCT01475253|3729319|B3|||Age||years|Mean|38.1|38.1|Standard Deviation|12.90|12.9|||
3905257|NCT01475253|3729320|B2|||Age||years|Mean|45.9|45.9|Standard Deviation|15.85|15.85|||
3905258|NCT01475253|3729321|B1|||Age||years|Mean|44.4|44.4|Standard Deviation|14.76|14.76|||
3905259|NCT01475253|3729318|B4||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3905260|NCT01475253|3729319|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3905261|NCT01475253|3729320|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3905262|NCT01475253|3729321|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3905263|NCT01475253|3729318|B4||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
3905264|NCT01475253|3729319|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3905265|NCT01475253|3729320|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3905266|NCT01475253|3729321|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3905267|NCT01475253|3729318|B4||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3905268|NCT01475253|3729319|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3905269|NCT01475253|3729320|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3905270|NCT01475253|3729321|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3905271|NCT01475214|3729350|B4|||Urine calcium/creatinine||mg/g|Mean|104|104.0|Standard Deviation|55|55.0|||
3905272|NCT01475214|3729351|B3|||Urine calcium/creatinine||mg/g|Mean|114|114.0|Standard Deviation|69|69.0|||
3905273|NCT01475214|3729352|B2|||Urine calcium/creatinine||mg/g|Mean|99|99.0|Standard Deviation|48|48.0|||
3905274|NCT01475214|3729353|B1|||Urine calcium/creatinine||mg/g|Mean|99|99.0|Standard Deviation|43|43.0|||
3905275|NCT01475214|3729350|B4|||Serum bicarbonate||mmol/L|Mean|26.0|26.0|Standard Deviation|2.2|2.2|||
3905276|NCT01475214|3729351|B3|||Serum bicarbonate||mmol/L|Mean|26.1|26.1|Standard Deviation|2.4|2.4|||
3905277|NCT01475214|3729352|B2|||Serum bicarbonate||mmol/L|Mean|25.8|25.8|Standard Deviation|2.4|2.4|||
3905278|NCT01475214|3729353|B1|||Serum bicarbonate||mmol/L|Mean|26.1|26.1|Standard Deviation|1.9|1.9|||
3905279|NCT01475214|3729350|B4|||Serum potassium||meq/L|Mean|4.33|4.33|Standard Deviation|0.32|0.32|||
3905280|NCT01475214|3729351|B3|||Serum potassium||meq/L|Mean|4.30|4.3|Standard Deviation|0.31|0.31|||
3905281|NCT01475214|3729352|B2|||Serum potassium||meq/L|Mean|4.39|4.39|Standard Deviation|0.36|0.36|||
3905282|NCT01475214|3729353|B1|||Serum potassium||meq/L|Mean|4.31|4.31|Standard Deviation|0.29|0.29|||
3905283|NCT01475214|3729350|B4|||Glomerular Filtration Rate (GFR)||ml/min/1.73m^2|Mean|76.3|76.3|Standard Deviation|13.0|13.0|||
3905284|NCT01475214|3729351|B3|||Glomerular Filtration Rate (GFR)||ml/min/1.73m^2|Mean|74.8|74.8|Standard Deviation|12.9|12.9|||
3905285|NCT01475214|3729352|B2|||Glomerular Filtration Rate (GFR)||ml/min/1.73m^2|Mean|77.5|77.5|Standard Deviation|12.8|12.8|||
3905286|NCT01475214|3729353|B1|||Glomerular Filtration Rate (GFR)||ml/min/1.73m^2|Mean|76.5|76.5|Standard Deviation|13.2|13.2|||
3905287|NCT01475214|3729350|B4|||Weight||kg|Mean|74.1|74.1|Standard Deviation|13.6|13.6|||
3905288|NCT01475214|3729351|B3|||Weight||kg|Mean|73.2|73.2|Standard Deviation|14.0|14.0|||
3905289|NCT01475214|3729352|B2|||Weight||kg|Mean|74.2|74.2|Standard Deviation|13.0|13.0|||
3905290|NCT01475214|3729353|B1|||Weight||kg|Mean|74.8|74.8|Standard Deviation|13.7|13.7|||
3905291|NCT01475214|3729350|B4|United States||Region of Enrollment||participants|Number|244|244.0||||||
3905292|NCT01475214|3729351|B3|United States||Region of Enrollment||participants|Number|81|81.0||||||
3905293|NCT01475214|3729352|B2|United States||Region of Enrollment||participants|Number|79|79.0||||||
3905294|NCT01475214|3729353|B1|United States||Region of Enrollment||participants|Number|84|84.0||||||
3905295|NCT01475214|3729350|B4|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3905296|NCT01475214|3729351|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3905297|NCT01475214|3729352|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3905298|NCT01475214|3729353|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3905299|NCT01475214|3729350|B4|African-American||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3905300|NCT01475214|3729351|B3|African-American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3905301|NCT01475214|3729352|B2|African-American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3905302|NCT01475214|3729353|B1|African-American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3905303|NCT01475214|3729350|B4|Caucasian, Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3905304|NCT01475214|3729351|B3|Caucasian, Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3905305|NCT01475214|3729352|B2|Caucasian, Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3905306|NCT01475214|3729353|B1|Caucasian, Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3905307|NCT01475214|3729350|B4|Caucasian, Non-hispanic||Race/Ethnicity, Customized||participants|Number|219|219.0||||||
3905308|NCT01475214|3729351|B3|Caucasian, Non-hispanic||Race/Ethnicity, Customized||participants|Number|75|75.0||||||
3905309|NCT01475214|3729352|B2|Caucasian, Non-hispanic||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
3905310|NCT01475214|3729353|B1|Caucasian, Non-hispanic||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
3905311|NCT01475214|3729350|B4||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3905312|NCT01475214|3729351|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3905313|NCT01475214|3729352|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3905314|NCT01475214|3729353|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3905315|NCT01475214|3729350|B4||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3905316|NCT01475214|3729351|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3905317|NCT01475214|3729352|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3905318|NCT01475214|3729353|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3905319|NCT01475214|3729350|B4|||Age||years|Mean|66.9|66.9|Standard Deviation|5.6|5.6|||
3905320|NCT01475214|3729351|B3|||Age||years|Mean|66.8|66.8|Standard Deviation|6.1|6.1|||
3905321|NCT01475214|3729352|B2|||Age||years|Mean|66.4|66.4|Standard Deviation|5.1|5.1|||
3905322|NCT01475214|3729353|B1|||Age||years|Mean|67.4|67.4|Standard Deviation|5.5|5.5|||
3905323|NCT01475214|3729350|B4||>=65 years|Age||Participants|Count of Participants|123|123.0||||||
3905324|NCT01475214|3729351|B3||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
3905325|NCT01475214|3729352|B2||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
3905326|NCT01475214|3729353|B1||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
3905327|NCT01475214|3729350|B4||Between 18 and 65 years|Age||Participants|Count of Participants|121|121.0||||||
3905328|NCT01475214|3729351|B3||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3905329|NCT01475214|3729352|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3905330|NCT01475214|3729353|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3905331|NCT01475214|3729350|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3905332|NCT01475214|3729351|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3905333|NCT01475214|3729352|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3905334|NCT01475214|3729353|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3905335|NCT01475175|3729366|B1|Germany||Region of Enrollment||participants|Number|2|2.0||||||
3905336|NCT01475175|3729366|B1|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
3905337|NCT01475175|3729366|B1|Norway||Region of Enrollment||participants|Number|2|2.0||||||
3905338|NCT01475175|3729366|B1|Austria||Region of Enrollment||participants|Number|2|2.0||||||
3905339|NCT01475175|3729366|B1|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
3905340|NCT01475175|3729366|B1|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
3905341|NCT01475175|3729366|B1|Serbia||Region of Enrollment||participants|Number|0|0.0||||||
3905342|NCT01475175|3729366|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3905343|NCT01475175|3729366|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3905344|NCT01475175|3729366|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|16.8|16.8|||
3905345|NCT01475175|3729366|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3905346|NCT01475175|3729366|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3905347|NCT01475175|3729366|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3905348|NCT01475097|3729378|B3|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
3905349|NCT01475097|3729379|B2|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
3905350|NCT01475097|3729380|B1|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
3905351|NCT01475097|3729378|B3|Spain||Region of Enrollment||participants|Number|115|115.0||||||
3905352|NCT01475097|3729379|B2|Spain||Region of Enrollment||participants|Number|58|58.0||||||
3905353|NCT01475097|3729380|B1|Spain||Region of Enrollment||participants|Number|57|57.0||||||
3905354|NCT01475097|3729378|B3|Germany||Region of Enrollment||participants|Number|77|77.0||||||
3905355|NCT01475097|3729379|B2|Germany||Region of Enrollment||participants|Number|39|39.0||||||
3905356|NCT01475097|3729380|B1|Germany||Region of Enrollment||participants|Number|38|38.0||||||
3905357|NCT01475097|3729378|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
3905358|NCT01475097|3729379|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
3905359|NCT01475097|3729380|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3905360|NCT01475097|3729378|B3||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
3905361|NCT01475097|3729379|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3905362|NCT01475097|3729380|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3905363|NCT01475097|3729378|B3||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3905364|NCT01475097|3729379|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3905365|NCT01475097|3729380|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3905366|NCT01475097|3729378|B3||>=65 years|Age||Participants|Count of Participants|130|130.0||||||
3905367|NCT01475097|3729379|B2||>=65 years|Age||Participants|Count of Participants|58|58.0||||||
3905368|NCT01475097|3729380|B1||>=65 years|Age||Participants|Count of Participants|72|72.0||||||
3905369|NCT01475097|3729378|B3||Between 18 and 65 years|Age||Participants|Count of Participants|123|123.0||||||
3905370|NCT01475097|3729379|B2||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
3905371|NCT01475097|3729380|B1||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
3905372|NCT01475097|3729378|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3905373|NCT01475097|3729379|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3905374|NCT01475097|3729380|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3905375|NCT01475097|3729378|B3|||Age||years|Mean|63.2|63.2|Standard Deviation|14.38|14.38|||
3905376|NCT01475097|3729379|B2|||Age||years|Mean|62.0|62.0|Standard Deviation|15.30|15.3|||
3905377|NCT01475097|3729380|B1|||Age||years|Mean|64.5|64.5|Standard Deviation|13.34|13.34|||
3905378|NCT01475071|3729389|B1|Australia||Region of Enrollment||participants|Number|100|100.0||||||
3905379|NCT01475071|3729389|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3905380|NCT01475071|3729389|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3905381|NCT01475071|3729389|B1|||Age||years|Mean|66.9|66.9|Standard Deviation|10.5|10.5|||
3905382|NCT01475071|3729389|B1||>=65 years|Age||Participants|Count of Participants|59|59.0||||||
3905383|NCT01475071|3729389|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3905384|NCT01475071|3729389|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3905385|NCT01474993|3729397|B3|||Blood chemistry: Thyroid Stimulating Hormone (TSH)||uIU/mL|Mean|1.9|1.9|Standard Deviation|1.8|1.8|||
3905386|NCT01474993|3729398|B2|||Blood chemistry: Thyroid Stimulating Hormone (TSH)||uIU/mL|Mean|2.0|2.0|Standard Deviation|2.1|2.1|||
3905387|NCT01474993|3729399|B1|||Blood chemistry: Thyroid Stimulating Hormone (TSH)||uIU/mL|Mean|1.6|1.6|Standard Deviation|0.9|0.9|||
3905388|NCT01474993|3729397|B3|||Blood Chemistry: Serum glutamic pyruvic transaminase (SGPT)||U/L|Mean|26.3|26.3|Standard Deviation|18.1|18.1|||
3905389|NCT01474993|3729398|B2|||Blood Chemistry: Serum glutamic pyruvic transaminase (SGPT)||U/L|Mean|30.0|30.0|Standard Deviation|20.6|20.6|||
3905390|NCT01474993|3729399|B1|||Blood Chemistry: Serum glutamic pyruvic transaminase (SGPT)||U/L|Mean|18.3|18.3|Standard Deviation|6.1|6.1|||
3905391|NCT01474993|3729397|B3|||Blood Chemistry: Serum glutamic oxaloacetic transaminase (SGOT)||U/L|Mean|22.7|22.7|Standard Deviation|7.9|7.9|||
3905392|NCT01474993|3729398|B2|||Blood Chemistry: Serum glutamic oxaloacetic transaminase (SGOT)||U/L|Mean|22.6|22.6|Standard Deviation|8.6|8.6|||
3905393|NCT01474993|3729399|B1|||Blood Chemistry: Serum glutamic oxaloacetic transaminase (SGOT)||U/L|Mean|22.8|22.8|Standard Deviation|6.4|6.4|||
3905394|NCT01474993|3729397|B3|||Blood chemistry: serum creatinine||mg/dL|Mean|0.8|0.8|Standard Deviation|0.1|0.1|||
3905395|NCT01474993|3729398|B2|||Blood chemistry: serum creatinine||mg/dL|Mean|0.8|0.8|Standard Deviation|0.1|0.1|||
3905396|NCT01474993|3729399|B1|||Blood chemistry: serum creatinine||mg/dL|Mean|0.8|0.8|Standard Deviation|0.1|0.1|||
3905397|NCT01474993|3729397|B3|||Hematology: platelet counts||*10^03 cells/µL|Mean|249.6|249.6|Standard Deviation|52.6|52.6|||
3905398|NCT01474993|3729398|B2|||Hematology: platelet counts||*10^03 cells/µL|Mean|251.5|251.5|Standard Deviation|55.5|55.5|||
3905399|NCT01474993|3729399|B1|||Hematology: platelet counts||*10^03 cells/µL|Mean|245.5|245.5|Standard Deviation|47.8|47.8|||
3905400|NCT01474993|3729397|B3|||Hematology: White Blood Cell (WBC) counts||*10^03 cells/µL|Mean|6.8|6.8|Standard Deviation|1.9|1.9|||
3905401|NCT01474993|3729398|B2|||Hematology: White Blood Cell (WBC) counts||*10^03 cells/µL|Mean|6.8|6.8|Standard Deviation|1.7|1.7|||
3905402|NCT01474993|3729399|B1|||Hematology: White Blood Cell (WBC) counts||*10^03 cells/µL|Mean|6.9|6.9|Standard Deviation|2.3|2.3|||
3905403|NCT01474993|3729397|B3|||Hematology: Red Blood Cell (RBC) counts||*10^6 cells/µL|Mean|5.2|5.2|Standard Deviation|0.4|0.4|||
3905404|NCT01474993|3729398|B2|||Hematology: Red Blood Cell (RBC) counts||*10^6 cells/µL|Mean|5.2|5.2|Standard Deviation|0.5|0.5|||
3905405|NCT01474993|3729399|B1|||Hematology: Red Blood Cell (RBC) counts||*10^6 cells/µL|Mean|5.1|5.1|Standard Deviation|0.3|0.3|||
3905406|NCT01474993|3729397|B3|||OACIS-S restricted interests score|This question on Ohio Autism Clinical Impressions Scale - Severity (OACIS-S) inquires about restricted and narrow interests of the patient. The question is rated on a scale of 1 to 7 where 1 is normal, 2 is some symptoms sometimes affecting individual and family, 3 is mild symptoms affecting individual daily and sometimes family, 4 is moderate symptoms affecting individual and family daily, 5 is marked symptoms affecting individual daily and sometimes family, 6 is severe symptoms affecting individual daily and sometimes family, and 7 is severe symptoms affecting individual and family daily.|units on a scale|Mean|4.38|4.38|Standard Deviation|0.65|0.65|||
3905407|NCT01474993|3729398|B2|||OACIS-S restricted interests score|This question on Ohio Autism Clinical Impressions Scale - Severity (OACIS-S) inquires about restricted and narrow interests of the patient. The question is rated on a scale of 1 to 7 where 1 is normal, 2 is some symptoms sometimes affecting individual and family, 3 is mild symptoms affecting individual daily and sometimes family, 4 is moderate symptoms affecting individual and family daily, 5 is marked symptoms affecting individual daily and sometimes family, 6 is severe symptoms affecting individual daily and sometimes family, and 7 is severe symptoms affecting individual and family daily.|units on a scale|Mean|4.41|4.41|Standard Deviation|0.63|0.63|||
3905408|NCT01474993|3729399|B1|||OACIS-S restricted interests score|This question on Ohio Autism Clinical Impressions Scale - Severity (OACIS-S) inquires about restricted and narrow interests of the patient. The question is rated on a scale of 1 to 7 where 1 is normal, 2 is some symptoms sometimes affecting individual and family, 3 is mild symptoms affecting individual daily and sometimes family, 4 is moderate symptoms affecting individual and family daily, 5 is marked symptoms affecting individual daily and sometimes family, 6 is severe symptoms affecting individual daily and sometimes family, and 7 is severe symptoms affecting individual and family daily.|units on a scale|Mean|4.33|4.33|Standard Deviation|0.72|0.72|||
3905409|NCT01474993|3729397|B3|||OACIS-S sensory sensitivity score|This question on the Ohio Autism Clinical Impressions Scale - Severity (OACIS-S) inquires about severity of sensory sensitivities. The question is rated on a scale of 1 to 7 where 1 is normal, 2 is some symptoms sometimes affecting individual and family, 3 is mild symptoms affecting individual daily and sometimes family, 4 is moderate symptoms affecting individual and family daily, 5 is marked symptoms affecting individual daily and sometimes family, 6 is severe symptoms affecting individual daily and sometimes family, and 7 is severe symptoms affecting individual and family daily.|units on a scale|Mean|4.18|4.18|Standard Deviation|0.69|0.69|||
3905410|NCT01474993|3729398|B2|||OACIS-S sensory sensitivity score|This question on the Ohio Autism Clinical Impressions Scale - Severity (OACIS-S) inquires about severity of sensory sensitivities. The question is rated on a scale of 1 to 7 where 1 is normal, 2 is some symptoms sometimes affecting individual and family, 3 is mild symptoms affecting individual daily and sometimes family, 4 is moderate symptoms affecting individual and family daily, 5 is marked symptoms affecting individual daily and sometimes family, 6 is severe symptoms affecting individual daily and sometimes family, and 7 is severe symptoms affecting individual and family daily.|units on a scale|Mean|4.07|4.07|Standard Deviation|0.65|0.65|||
3905411|NCT01474993|3729399|B1|||OACIS-S sensory sensitivity score|This question on the Ohio Autism Clinical Impressions Scale - Severity (OACIS-S) inquires about severity of sensory sensitivities. The question is rated on a scale of 1 to 7 where 1 is normal, 2 is some symptoms sometimes affecting individual and family, 3 is mild symptoms affecting individual daily and sometimes family, 4 is moderate symptoms affecting individual and family daily, 5 is marked symptoms affecting individual daily and sometimes family, 6 is severe symptoms affecting individual daily and sometimes family, and 7 is severe symptoms affecting individual and family daily.|units on a scale|Mean|4.40|4.4|Standard Deviation|0.74|0.74|||
3905452|NCT01474993|3729398|B2||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3905453|NCT01474993|3729399|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3905454|NCT01474993|3729397|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3905412|NCT01474993|3729397|B3|||OACIS-S anxiety score|This question on the Ohio Autism Clinical Impressions Scale - Severity (OACIS-S) inquires about severity of anxiety. The question is rated on a scale of 1 to 7 where 1 is normal, 2 is some symptoms sometimes affecting individual and family, 3 is mild symptoms affecting individual daily and sometimes family, 4 is moderate symptoms affecting individual and family daily, 5 is marked symptoms affecting individual daily and sometimes family, 6 is severe symptoms affecting individual daily and sometimes family, and 7 is severe symptoms affecting individual and family daily.|units on a scale|Mean|4.23|4.23|Standard Deviation|0.91|0.91|||
3905413|NCT01474993|3729398|B2|||OACIS-S anxiety score|This question on the Ohio Autism Clinical Impressions Scale - Severity (OACIS-S) inquires about severity of anxiety. The question is rated on a scale of 1 to 7 where 1 is normal, 2 is some symptoms sometimes affecting individual and family, 3 is mild symptoms affecting individual daily and sometimes family, 4 is moderate symptoms affecting individual and family daily, 5 is marked symptoms affecting individual daily and sometimes family, 6 is severe symptoms affecting individual daily and sometimes family, and 7 is severe symptoms affecting individual and family daily.|units on a scale|Mean|4.17|4.17|Standard Deviation|0.71|0.71|||
3905414|NCT01474993|3729399|B1|||OACIS-S anxiety score|This question on the Ohio Autism Clinical Impressions Scale - Severity (OACIS-S) inquires about severity of anxiety. The question is rated on a scale of 1 to 7 where 1 is normal, 2 is some symptoms sometimes affecting individual and family, 3 is mild symptoms affecting individual daily and sometimes family, 4 is moderate symptoms affecting individual and family daily, 5 is marked symptoms affecting individual daily and sometimes family, 6 is severe symptoms affecting individual daily and sometimes family, and 7 is severe symptoms affecting individual and family daily.|units on a scale|Mean|4.33|4.33|Standard Deviation|1.23|1.23|||
3905415|NCT01474993|3729397|B3|||OACIS-S hyperactivity/inattention score|This question on the Ohio Autism Clinical Impressions Scale - Severity (OACIS-S) inquires about severity of hyperactivity and inattentiveness. The question is rated on a scale of 1 to 7 where 1 is normal, 2 is some symptoms sometimes affecting individual and family, 3 is mild symptoms affecting individual daily and sometimes family, 4 is moderate symptoms affecting individual and family daily, 5 is marked symptoms affecting individual daily and sometimes family, 6 is severe symptoms affecting individual daily and sometimes family, and 7 is severe symptoms affecting individual and family daily.|units on a scale|Mean|4.20|4.2|Standard Deviation|0.90|0.9|||
3905416|NCT01474993|3729398|B2|||OACIS-S hyperactivity/inattention score|This question on the Ohio Autism Clinical Impressions Scale - Severity (OACIS-S) inquires about severity of hyperactivity and inattentiveness. The question is rated on a scale of 1 to 7 where 1 is normal, 2 is some symptoms sometimes affecting individual and family, 3 is mild symptoms affecting individual daily and sometimes family, 4 is moderate symptoms affecting individual and family daily, 5 is marked symptoms affecting individual daily and sometimes family, 6 is severe symptoms affecting individual daily and sometimes family, and 7 is severe symptoms affecting individual and family daily.|units on a scale|Mean|4.10|4.1|Standard Deviation|0.90|0.9|||
3905417|NCT01474993|3729399|B1|||OACIS-S hyperactivity/inattention score|This question on the Ohio Autism Clinical Impressions Scale - Severity (OACIS-S) inquires about severity of hyperactivity and inattentiveness. The question is rated on a scale of 1 to 7 where 1 is normal, 2 is some symptoms sometimes affecting individual and family, 3 is mild symptoms affecting individual daily and sometimes family, 4 is moderate symptoms affecting individual and family daily, 5 is marked symptoms affecting individual daily and sometimes family, 6 is severe symptoms affecting individual daily and sometimes family, and 7 is severe symptoms affecting individual and family daily.|units on a scale|Mean|4.40|4.4|Standard Deviation|0.91|0.91|||
3905418|NCT01474993|3729397|B3|||OACIS-S nonverbal communication score|This question on the Ohio Autism Clinical Impressions Scale - Severity (OACIS-S) inquires about impairment of non-verbal communication skills. The question is rated on a scale of 1 to 7 where 1 is normal, 2 is some symptoms sometimes affecting individual and family, 3 is mild symptoms affecting individual daily and sometimes family, 4 is moderate symptoms affecting individual and family daily, 5 is marked symptoms affecting individual daily and sometimes family, 6 is severe symptoms affecting individual daily and sometimes family, and 7 is severe symptoms affecting individual and family daily.|units on a scale|Mean|4.16|4.16|Standard Deviation|0.81|0.81|||
3905419|NCT01474993|3729398|B2|||OACIS-S nonverbal communication score|This question on the Ohio Autism Clinical Impressions Scale - Severity (OACIS-S) inquires about impairment of non-verbal communication skills. The question is rated on a scale of 1 to 7 where 1 is normal, 2 is some symptoms sometimes affecting individual and family, 3 is mild symptoms affecting individual daily and sometimes family, 4 is moderate symptoms affecting individual and family daily, 5 is marked symptoms affecting individual daily and sometimes family, 6 is severe symptoms affecting individual daily and sometimes family, and 7 is severe symptoms affecting individual and family daily.|units on a scale|Mean|4.10|4.1|Standard Deviation|0.72|0.72|||
3905420|NCT01474993|3729399|B1|||OACIS-S nonverbal communication score|This question on the Ohio Autism Clinical Impressions Scale - Severity (OACIS-S) inquires about impairment of non-verbal communication skills. The question is rated on a scale of 1 to 7 where 1 is normal, 2 is some symptoms sometimes affecting individual and family, 3 is mild symptoms affecting individual daily and sometimes family, 4 is moderate symptoms affecting individual and family daily, 5 is marked symptoms affecting individual daily and sometimes family, 6 is severe symptoms affecting individual daily and sometimes family, and 7 is severe symptoms affecting individual and family daily.|units on a scale|Mean|4.27|4.27|Standard Deviation|0.96|0.96|||
3905421|NCT01474993|3729397|B3|||OACIS-S verbal communication score|This question on the Ohio Autism Clinical Impressions Scale - Severity (OACIS-S) inquires about impairment of verbal communication skills. The question is rated on a scale of 1 to 7 where 1 is normal, 2 is some symptoms sometimes affecting individual and family, 3 is mild symptoms affecting individual daily and sometimes family, 4 is moderate symptoms affecting individual and family daily, 5 is marked symptoms affecting individual daily and sometimes family, 6 is severe symptoms affecting individual daily and sometimes family, and 7 is severe symptoms affecting individual and family daily.|units on a scale|Mean|4.48|4.48|Standard Deviation|1.09|1.09|||
3905455|NCT01474993|3729398|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3905456|NCT01474993|3729399|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905457|NCT01474993|3729397|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905422|NCT01474993|3729398|B2|||OACIS-S verbal communication score|This question on the Ohio Autism Clinical Impressions Scale - Severity (OACIS-S) inquires about impairment of verbal communication skills. The question is rated on a scale of 1 to 7 where 1 is normal, 2 is some symptoms sometimes affecting individual and family, 3 is mild symptoms affecting individual daily and sometimes family, 4 is moderate symptoms affecting individual and family daily, 5 is marked symptoms affecting individual daily and sometimes family, 6 is severe symptoms affecting individual daily and sometimes family, and 7 is severe symptoms affecting individual and family daily.|units on a scale|Mean|4.45|4.45|Standard Deviation|0.95|0.95|||
3905423|NCT01474993|3729399|B1|||OACIS-S verbal communication score|This question on the Ohio Autism Clinical Impressions Scale - Severity (OACIS-S) inquires about impairment of verbal communication skills. The question is rated on a scale of 1 to 7 where 1 is normal, 2 is some symptoms sometimes affecting individual and family, 3 is mild symptoms affecting individual daily and sometimes family, 4 is moderate symptoms affecting individual and family daily, 5 is marked symptoms affecting individual daily and sometimes family, 6 is severe symptoms affecting individual daily and sometimes family, and 7 is severe symptoms affecting individual and family daily.|units on a scale|Mean|4.53|4.53|Standard Deviation|1.36|1.36|||
3905424|NCT01474993|3729397|B3|||OACIS-S repetitive behavior score|This question on the Ohio Autism Clinical Impressions Scale - Severity (OACIS-S) inquires about repetitive/ritualistic behaviors. The question is rated on a scale of 1 to 7 where 1 is normal, 2 is some symptoms sometimes affecting individual and family, 3 is mild symptoms affecting individual daily and sometimes family, 4 is moderate symptoms affecting individual and family daily, 5 is marked symptoms affecting individual daily and sometimes family, 6 is severe symptoms affecting individual daily and sometimes family, and 7 is severe symptoms affecting individual and family daily.|units on a scale|Mean|4.13|4.13|Standard Deviation|0.77|0.77|||
3905425|NCT01474993|3729398|B2|||OACIS-S repetitive behavior score|This question on the Ohio Autism Clinical Impressions Scale - Severity (OACIS-S) inquires about repetitive/ritualistic behaviors. The question is rated on a scale of 1 to 7 where 1 is normal, 2 is some symptoms sometimes affecting individual and family, 3 is mild symptoms affecting individual daily and sometimes family, 4 is moderate symptoms affecting individual and family daily, 5 is marked symptoms affecting individual daily and sometimes family, 6 is severe symptoms affecting individual daily and sometimes family, and 7 is severe symptoms affecting individual and family daily.|units on a scale|Mean|4.14|4.14|Standard Deviation|0.74|0.74|||
3905426|NCT01474993|3729399|B1|||OACIS-S repetitive behavior score|This question on the Ohio Autism Clinical Impressions Scale - Severity (OACIS-S) inquires about repetitive/ritualistic behaviors. The question is rated on a scale of 1 to 7 where 1 is normal, 2 is some symptoms sometimes affecting individual and family, 3 is mild symptoms affecting individual daily and sometimes family, 4 is moderate symptoms affecting individual and family daily, 5 is marked symptoms affecting individual daily and sometimes family, 6 is severe symptoms affecting individual daily and sometimes family, and 7 is severe symptoms affecting individual and family daily.|units on a scale|Mean|4.13|4.13|Standard Deviation|0.83|0.83|||
3905427|NCT01474993|3729397|B3|||OACIS-S aberrant behavior score|This question on the Ohio Autism Clinical Impressions Scale - Severity (OACIS-S) inquires aberrant behaviors (such as aggressions etc.). The question is rated on a scale of 1 to 7 where 1 is normal, 2 is some symptoms sometimes affecting individual and family, 3 is mild symptoms affecting individual daily and sometimes family, 4 is moderate symptoms affecting individual and family daily, 5 is marked symptoms affecting individual daily and sometimes family, 6 is severe symptoms affecting individual daily and sometimes family, and 7 is severe symptoms affecting individual and family daily.|units on a scale|Mean|4.20|4.2|Standard Deviation|1.05|1.05|||
3905428|NCT01474993|3729398|B2|||OACIS-S aberrant behavior score|This question on the Ohio Autism Clinical Impressions Scale - Severity (OACIS-S) inquires aberrant behaviors (such as aggressions etc.). The question is rated on a scale of 1 to 7 where 1 is normal, 2 is some symptoms sometimes affecting individual and family, 3 is mild symptoms affecting individual daily and sometimes family, 4 is moderate symptoms affecting individual and family daily, 5 is marked symptoms affecting individual daily and sometimes family, 6 is severe symptoms affecting individual daily and sometimes family, and 7 is severe symptoms affecting individual and family daily.|units on a scale|Mean|4.21|4.21|Standard Deviation|0.86|0.86|||
3905429|NCT01474993|3729399|B1|||OACIS-S aberrant behavior score|This question on the Ohio Autism Clinical Impressions Scale - Severity (OACIS-S) inquires aberrant behaviors (such as aggressions etc.). The question is rated on a scale of 1 to 7 where 1 is normal, 2 is some symptoms sometimes affecting individual and family, 3 is mild symptoms affecting individual daily and sometimes family, 4 is moderate symptoms affecting individual and family daily, 5 is marked symptoms affecting individual daily and sometimes family, 6 is severe symptoms affecting individual daily and sometimes family, and 7 is severe symptoms affecting individual and family daily.|units on a scale|Mean|4.20|4.2|Standard Deviation|1.37|1.37|||
3905430|NCT01474993|3729397|B3|||OACIS-S social interaction score|This question on the Ohio Autism Clinical Impressions Scale - Severity (OACIS-S) inquires about social interaction impairment. The question is rated on a scale of 1 to 7 where 1 is normal, 2 is some symptoms sometimes affecting individual and family, 3 is mild symptoms affecting individual daily and sometimes family, 4 is moderate symptoms affecting individual and family daily, 5 is marked symptoms affecting individual daily and sometimes family, 6 is severe symptoms affecting individual daily and sometimes family, and 7 is severe symptoms affecting individual and family daily.|units on a scale|Mean|4.61|4.61|Standard Deviation|0.81|0.81|||
3905431|NCT01474993|3729398|B2|||OACIS-S social interaction score|This question on the Ohio Autism Clinical Impressions Scale - Severity (OACIS-S) inquires about social interaction impairment. The question is rated on a scale of 1 to 7 where 1 is normal, 2 is some symptoms sometimes affecting individual and family, 3 is mild symptoms affecting individual daily and sometimes family, 4 is moderate symptoms affecting individual and family daily, 5 is marked symptoms affecting individual daily and sometimes family, 6 is severe symptoms affecting individual daily and sometimes family, and 7 is severe symptoms affecting individual and family daily.|units on a scale|Mean|4.51|4.51|Standard Deviation|0.69|0.69|||
3905458|NCT01474993|3729398|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905459|NCT01474993|3729399|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905460|NCT01474993|3729397|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3905432|NCT01474993|3729399|B1|||OACIS-S social interaction score|This question on the Ohio Autism Clinical Impressions Scale - Severity (OACIS-S) inquires about social interaction impairment. The question is rated on a scale of 1 to 7 where 1 is normal, 2 is some symptoms sometimes affecting individual and family, 3 is mild symptoms affecting individual daily and sometimes family, 4 is moderate symptoms affecting individual and family daily, 5 is marked symptoms affecting individual daily and sometimes family, 6 is severe symptoms affecting individual daily and sometimes family, and 7 is severe symptoms affecting individual and family daily.|units on a scale|Mean|4.80|4.8|Standard Deviation|1.01|1.01|||
3905433|NCT01474993|3729397|B3|||OACIS-S general level of autism score|This question on the Ohio Autism Clinical Impressions Scale - Severity (OACIS-S) inquires about the overall level of autism. The question is rated on a scale of 1 to 7 where 1 is normal, 2 is some symptoms sometimes affecting individual and family, 3 is mild symptoms affecting individual daily and sometimes family, 4 is moderate symptoms affecting individual and family daily, 5 is marked symptoms affecting individual daily and sometimes family, 6 is severe symptoms affecting individual daily and sometimes family, and 7 is severe symptoms affecting individual and family daily.|units on a scale|Mean|4.43|4.43|Standard Deviation|0.62|0.62|||
3905434|NCT01474993|3729398|B2|||OACIS-S general level of autism score|This question on the Ohio Autism Clinical Impressions Scale - Severity (OACIS-S) inquires about the overall level of autism. The question is rated on a scale of 1 to 7 where 1 is normal, 2 is some symptoms sometimes affecting individual and family, 3 is mild symptoms affecting individual daily and sometimes family, 4 is moderate symptoms affecting individual and family daily, 5 is marked symptoms affecting individual daily and sometimes family, 6 is severe symptoms affecting individual daily and sometimes family, and 7 is severe symptoms affecting individual and family daily.|units on a scale|Mean|4.38|4.38|Standard Deviation|0.56|0.56|||
3905435|NCT01474993|3729399|B1|||OACIS-S general level of autism score|This question on the Ohio Autism Clinical Impressions Scale - Severity (OACIS-S) inquires about the overall level of autism. The question is rated on a scale of 1 to 7 where 1 is normal, 2 is some symptoms sometimes affecting individual and family, 3 is mild symptoms affecting individual daily and sometimes family, 4 is moderate symptoms affecting individual and family daily, 5 is marked symptoms affecting individual daily and sometimes family, 6 is severe symptoms affecting individual daily and sometimes family, and 7 is severe symptoms affecting individual and family daily.|units on a scale|Mean|4.53|4.53|Standard Deviation|0.74|0.74|||
3905436|NCT01474993|3729397|B3|||Social Responsiveness Scale total score|"The Social Responsiveness Scale is a parent- and/or teacher-reported 65 question scale. Each question on the scale inquires about an observed aspect of reciprocal social behavior that is rated on the scoring sheet on a scale from “0” to 3, where 0 is best possible behavior and 3 is the worst possible behavior. The total SRS score may range from 0 to 195 where higher values represent the worse outcome."|units on a scale|Mean|121.5|121.5|Standard Deviation|21.6|21.6|||
3905437|NCT01474993|3729398|B2|||Social Responsiveness Scale total score|"The Social Responsiveness Scale is a parent- and/or teacher-reported 65 question scale. Each question on the scale inquires about an observed aspect of reciprocal social behavior that is rated on the scoring sheet on a scale from “0” to 3, where 0 is best possible behavior and 3 is the worst possible behavior. The total SRS score may range from 0 to 195 where higher values represent the worse outcome."|units on a scale|Mean|122.2|122.2|Standard Deviation|24.1|24.1|||
3905438|NCT01474993|3729399|B1|||Social Responsiveness Scale total score|"The Social Responsiveness Scale is a parent- and/or teacher-reported 65 question scale. Each question on the scale inquires about an observed aspect of reciprocal social behavior that is rated on the scoring sheet on a scale from “0” to 3, where 0 is best possible behavior and 3 is the worst possible behavior. The total SRS score may range from 0 to 195 where higher values represent the worse outcome."|units on a scale|Mean|120.1|120.1|Standard Deviation|16.6|16.6|||
3905439|NCT01474993|3729397|B3|||Aberrant Behavior Checklist total score|The Aberrant Behavior Checklist has 58 questions rated by parents or teachers on a scale of 0 to 3, where a score of “0” for particular behavior is not a problem at all, “1” indicates that the behavior is a problem but slight in degree, “2” indicates that the problem is moderately serious, and “3” indicates that the problem is severe in degree. The possible ABC scores may range from 0 to 174, where higher values represent the worse outcome.|units on a scale|Mean|62.3|62.3|Standard Deviation|24.4|24.4|||
3905440|NCT01474993|3729398|B2|||Aberrant Behavior Checklist total score|The Aberrant Behavior Checklist has 58 questions rated by parents or teachers on a scale of 0 to 3, where a score of “0” for particular behavior is not a problem at all, “1” indicates that the behavior is a problem but slight in degree, “2” indicates that the problem is moderately serious, and “3” indicates that the problem is severe in degree. The possible ABC scores may range from 0 to 174, where higher values represent the worse outcome.|units on a scale|Mean|63.6|63.6|Standard Deviation|25.3|25.3|||
3905441|NCT01474993|3729399|B1|||Aberrant Behavior Checklist total score|The Aberrant Behavior Checklist has 58 questions rated by parents or teachers on a scale of 0 to 3, where a score of “0” for particular behavior is not a problem at all, “1” indicates that the behavior is a problem but slight in degree, “2” indicates that the problem is moderately serious, and “3” indicates that the problem is severe in degree. The possible ABC scores may range from 0 to 174, where higher values represent the worse outcome.|units on a scale|Mean|60|60.0|Standard Deviation|23.2|23.2|||
3905442|NCT01474993|3729397|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
3905443|NCT01474993|3729398|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
3905444|NCT01474993|3729399|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3905445|NCT01474993|3729397|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3905446|NCT01474993|3729398|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905447|NCT01474993|3729399|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3905448|NCT01474993|3729397|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905449|NCT01474993|3729398|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905450|NCT01474993|3729399|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905451|NCT01474993|3729397|B3||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3905461|NCT01474993|3729398|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3905462|NCT01474993|3729399|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3905463|NCT01474993|3729397|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905464|NCT01474993|3729398|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905465|NCT01474993|3729399|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905466|NCT01474993|3729397|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3905467|NCT01474993|3729398|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3905468|NCT01474993|3729399|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3905469|NCT01474993|3729397|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3905470|NCT01474993|3729398|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3905471|NCT01474993|3729399|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3905472|NCT01474993|3729397|B3|||Age||years|Mean|17.4|17.4|Standard Deviation|3.9|3.9|||
3905473|NCT01474993|3729398|B2|||Age||years|Mean|17.9|17.9|Standard Deviation|3.9|3.9|||
3905474|NCT01474993|3729399|B1|||Age||years|Mean|16.6|16.6|Standard Deviation|3.5|3.5|||
3905475|NCT01474915|3729428|B3|United States||Region of Enrollment||participants|Number|121|121.0||||||
3905476|NCT01474915|3729429|B2|United States||Region of Enrollment||participants|Number|61|61.0||||||
3905477|NCT01474915|3729430|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
3905478|NCT01474915|3729428|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3905479|NCT01474915|3729429|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3905480|NCT01474915|3729430|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3905481|NCT01474915|3729428|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3905482|NCT01474915|3729429|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3905483|NCT01474915|3729430|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3905484|NCT01474915|3729428|B3|||Age||years|Mean|50.9748|50.9748|Standard Deviation|15.6062|15.6062|||
3905485|NCT01474915|3729429|B2|||Age||years|Mean|50.15|50.15|Standard Deviation|16.4|16.4|||
3905486|NCT01474915|3729430|B1|||Age||years|Mean|51.8136|51.8136|Standard Deviation|14.7|14.7|||
3905487|NCT01474915|3729428|B3||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
3905488|NCT01474915|3729429|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3905489|NCT01474915|3729430|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3905490|NCT01474915|3729428|B3||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
3905491|NCT01474915|3729429|B2||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3905492|NCT01474915|3729430|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3905493|NCT01474915|3729428|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3905494|NCT01474915|3729429|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3905495|NCT01474915|3729430|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3905496|NCT01474876|3729439|B4||Male|Sex: Female, Male||Participants|Count of Participants|381|381.0||||||
3905497|NCT01474876|3729440|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3905498|NCT01474876|3729441|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3905499|NCT01474876|3729442|B1||Male|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
3905500|NCT01474876|3729439|B4||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3905501|NCT01474876|3729440|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3905502|NCT01474876|3729441|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3905503|NCT01474876|3729442|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3905504|NCT01474876|3729439|B4|||Age||years|Mean|45.6|45.6|Standard Deviation|12.9|12.9|||
3905505|NCT01474876|3729440|B3|||Age||years|Mean|40|40.0|Standard Deviation|NA||||n=1 participant
3905506|NCT01474876|3729441|B2|||Age||years|Mean|49.7|49.7|Standard Deviation|12.1|12.1|||
3905507|NCT01474876|3729442|B1|||Age||years|Mean|44.0|44.0|Standard Deviation|12.8|12.8|||
3905508|NCT01474863|3729475|B4|United States||Region of Enrollment||participants|Number|72|72.0||||||
3905509|NCT01474863|3729476|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
3905510|NCT01474863|3729477|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
3905511|NCT01474863|3729478|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
3905512|NCT01474863|3729475|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905513|NCT01474863|3729476|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905514|NCT01474863|3729477|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905515|NCT01474863|3729478|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905516|NCT01474863|3729475|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905517|NCT01474863|3729476|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905518|NCT01474863|3729477|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905519|NCT01474863|3729478|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905520|NCT01474863|3729475|B4||White|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3905521|NCT01474863|3729476|B3||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3905522|NCT01474863|3729477|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3905523|NCT01474863|3729478|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3905524|NCT01474863|3729475|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3905525|NCT01474863|3729476|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3905526|NCT01474863|3729477|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3905527|NCT01474863|3729478|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3905528|NCT01474863|3729475|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905529|NCT01474863|3729476|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905530|NCT01474863|3729477|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905531|NCT01474863|3729478|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905532|NCT01474863|3729475|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905533|NCT01474863|3729476|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905534|NCT01474863|3729477|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905535|NCT01474863|3729478|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905536|NCT01474863|3729475|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905537|NCT01474863|3729476|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905538|NCT01474863|3729477|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905539|NCT01474863|3729478|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905540|NCT01474863|3729475|B4||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3905541|NCT01474863|3729476|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3905542|NCT01474863|3729477|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3905543|NCT01474863|3729478|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3905544|NCT01474863|3729475|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3905545|NCT01474863|3729476|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3905546|NCT01474863|3729477|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3905547|NCT01474863|3729478|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3905548|NCT01474863|3729475|B4|||Age||years|Mean|54.1|54.1|Standard Deviation|16.8|16.8|||
3905549|NCT01474863|3729476|B3|||Age||years|Mean|51.8|51.8|Standard Deviation|16.6|16.6|||
3905550|NCT01474863|3729477|B2|||Age||years|Mean|56.2|56.2|Standard Deviation|16.8|16.8|||
3905551|NCT01474863|3729478|B1|||Age||years|Mean|54.4|54.4|Standard Deviation|17.1|17.1|||
3905552|NCT01474772|3729488|B3||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3905553|NCT01474772|3729489|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3905554|NCT01474772|3729490|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3905555|NCT01474772|3729488|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3905556|NCT01474772|3729489|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3905557|NCT01474772|3729490|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3905558|NCT01474772|3729488|B3|||Age||Years|Mean|58.7|58.7|Standard Deviation|8.9|8.9|||
3905559|NCT01474772|3729489|B2|||Age||Years|Mean|58.4|58.4|Standard Deviation|9.3|9.3|||
3905560|NCT01474772|3729490|B1|||Age||Years|Mean|59.1|59.1|Standard Deviation|8.5|8.5|||
3905561|NCT01474746|3729539|B3|United States||Region of Enrollment||participants|Number|57|57.0||||||
3905562|NCT01474746|3729540|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
3905563|NCT01474746|3729541|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3905564|NCT01474746|3729539|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3905565|NCT01474746|3729540|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3905566|NCT01474746|3729541|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3905567|NCT01474746|3729539|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3905568|NCT01474746|3729540|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3905569|NCT01474746|3729541|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3905570|NCT01474746|3729539|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3905571|NCT01474746|3729540|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3905572|NCT01474746|3729541|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3905573|NCT01474746|3729539|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3905574|NCT01474746|3729540|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3905575|NCT01474746|3729541|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3905576|NCT01474746|3729539|B3||<=18 years|Age||Participants|Count of Participants|57|57.0||||||
3905577|NCT01474746|3729540|B2||<=18 years|Age||Participants|Count of Participants|27|27.0||||||
3905578|NCT01474746|3729541|B1||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
3905579|NCT01474681|3729604|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3905580|NCT01474681|3729605|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3905581|NCT01474681|3729606|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3905582|NCT01474681|3729604|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3905583|NCT01474681|3729605|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3905584|NCT01474681|3729606|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3905585|NCT01474681|3729604|B3|||Age||years|Mean|32.0|32.0|Standard Deviation|14.67|14.67|||
3905586|NCT01474681|3729605|B2|||Age||years|Mean|31.3|31.3|Standard Deviation|13.75|13.75|||
3905587|NCT01474681|3729606|B1|||Age||years|Mean|33.3|33.3|Standard Deviation|17.18|17.18|||
3905588|NCT01474590|3729651|B3|||nodule counts||nodules|Mean|7.8|7.8|Standard Deviation|3.1|3.1|||
3905589|NCT01474590|3729652|B2|||nodule counts||nodules|Mean|7.6|7.6|Standard Deviation|2.5|2.5|||
3905590|NCT01474590|3729653|B1|||nodule counts||nodules|Mean|8.0|8.0|Standard Deviation|3.6|3.6|||
3905591|NCT01474590|3729651|B3|5||IGA|"the global severity assessment is outlined as per below:~Investigator’s Global Assessment (IGA)~score~0. Clear: Residual hyperpigmentation and erythema may be present~Almost Clear A few scattered comedones and a few small papules~Mild Some comedones and some papules and pustules. No nodules present~Moderate Many comedones, papules and pustules. One nodule may be present~Severe Covered with comedones, numerous papules and pustules and few nodules may be present~Very severe Highly inflammatory acne covering the face; with nodules present"|count of participants|Number|33|33.0||||||
3905592|NCT01474590|3729652|B2|5||IGA|"the global severity assessment is outlined as per below:~Investigator’s Global Assessment (IGA)~score~0. Clear: Residual hyperpigmentation and erythema may be present~Almost Clear A few scattered comedones and a few small papules~Mild Some comedones and some papules and pustules. No nodules present~Moderate Many comedones, papules and pustules. One nodule may be present~Severe Covered with comedones, numerous papules and pustules and few nodules may be present~Very severe Highly inflammatory acne covering the face; with nodules present"|count of participants|Number|18|18.0||||||
3905593|NCT01474590|3729653|B1|5||IGA|"the global severity assessment is outlined as per below:~Investigator’s Global Assessment (IGA)~score~0. Clear: Residual hyperpigmentation and erythema may be present~Almost Clear A few scattered comedones and a few small papules~Mild Some comedones and some papules and pustules. No nodules present~Moderate Many comedones, papules and pustules. One nodule may be present~Severe Covered with comedones, numerous papules and pustules and few nodules may be present~Very severe Highly inflammatory acne covering the face; with nodules present"|count of participants|Number|15|15.0||||||
3905594|NCT01474590|3729651|B3|4||IGA|"the global severity assessment is outlined as per below:~Investigator’s Global Assessment (IGA)~score~0. Clear: Residual hyperpigmentation and erythema may be present~Almost Clear A few scattered comedones and a few small papules~Mild Some comedones and some papules and pustules. No nodules present~Moderate Many comedones, papules and pustules. One nodule may be present~Severe Covered with comedones, numerous papules and pustules and few nodules may be present~Very severe Highly inflammatory acne covering the face; with nodules present"|count of participants|Number|233|233.0||||||
3905595|NCT01474590|3729652|B2|4||IGA|"the global severity assessment is outlined as per below:~Investigator’s Global Assessment (IGA)~score~0. Clear: Residual hyperpigmentation and erythema may be present~Almost Clear A few scattered comedones and a few small papules~Mild Some comedones and some papules and pustules. No nodules present~Moderate Many comedones, papules and pustules. One nodule may be present~Severe Covered with comedones, numerous papules and pustules and few nodules may be present~Very severe Highly inflammatory acne covering the face; with nodules present"|count of participants|Number|115|115.0||||||
3905596|NCT01474590|3729653|B1|4||IGA|"the global severity assessment is outlined as per below:~Investigator’s Global Assessment (IGA)~score~0. Clear: Residual hyperpigmentation and erythema may be present~Almost Clear A few scattered comedones and a few small papules~Mild Some comedones and some papules and pustules. No nodules present~Moderate Many comedones, papules and pustules. One nodule may be present~Severe Covered with comedones, numerous papules and pustules and few nodules may be present~Very severe Highly inflammatory acne covering the face; with nodules present"|count of participants|Number|118|118.0||||||
3905597|NCT01474590|3729651|B3|Canada||Region of Enrollment||count of participants|Number|266|266.0||||||
3905598|NCT01474590|3729652|B2|Canada||Region of Enrollment||count of participants|Number|133|133.0||||||
3905599|NCT01474590|3729653|B1|Canada||Region of Enrollment||count of participants|Number|133|133.0||||||
3905600|NCT01474590|3729651|B3||Male|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
3905601|NCT01474590|3729652|B2||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3905602|NCT01474590|3729653|B1||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3905603|NCT01474590|3729651|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3905604|NCT01474590|3729652|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3905605|NCT01474590|3729653|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3905606|NCT01474590|3729651|B3|||Age||years|Mean|19.4|19.4|Standard Deviation|4.8|4.8|||
3905607|NCT01474590|3729652|B2|||Age||years|Mean|19.3|19.3|Standard Deviation|4.5|4.5|||
3905608|NCT01474590|3729653|B1|||Age||years|Mean|19.5|19.5|Standard Deviation|5.0|5.0|||
3905609|NCT01474551|3729660|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3905610|NCT01474551|3729660|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3905611|NCT01474551|3729660|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3905612|NCT01474551|3729660|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3905613|NCT01474551|3729660|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3905614|NCT01474551|3729660|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3905615|NCT01474538|3729664|B3|United States||Region of Enrollment||participants|Number|122|122.0||||||
3905616|NCT01474538|3729665|B2|United States||Region of Enrollment||participants|Number|62|62.0||||||
3905617|NCT01474538|3729666|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
3905618|NCT01474538|3729664|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|119|119.0||||||
3905619|NCT01474538|3729665|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
3905620|NCT01474538|3729666|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
3905621|NCT01474538|3729664|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3905622|NCT01474538|3729665|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3905623|NCT01474538|3729666|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3905624|NCT01474538|3729664|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905625|NCT01474538|3729665|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905626|NCT01474538|3729666|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905627|NCT01474538|3729664|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3905628|NCT01474538|3729665|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3905629|NCT01474538|3729666|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3905630|NCT01474538|3729664|B3||White|Race (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
3905631|NCT01474538|3729665|B2||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3905632|NCT01474538|3729666|B1||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3905633|NCT01474538|3729664|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3905634|NCT01474538|3729665|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3905635|NCT01474538|3729666|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3905636|NCT01474538|3729664|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905637|NCT01474538|3729665|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905638|NCT01474538|3729666|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905639|NCT01474538|3729664|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3905640|NCT01474538|3729665|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3905641|NCT01474538|3729666|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905642|NCT01474538|3729664|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3905643|NCT01474538|3729665|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905644|NCT01474538|3729666|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3905645|NCT01474538|3729664|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3905646|NCT01474538|3729665|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3905647|NCT01474538|3729666|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3905648|NCT01474538|3729664|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3905649|NCT01474538|3729665|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3905650|NCT01474538|3729666|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3905651|NCT01474538|3729664|B3|||Age||years|Mean|59.58|59.58|Standard Deviation|10.06|10.06|||
3905652|NCT01474538|3729665|B2|||Age||years|Mean|60.40|60.4|Standard Deviation|9.72|9.72|||
3905653|NCT01474538|3729666|B1|||Age||years|Mean|58.73|58.73|Standard Deviation|10.41|10.41|||
3905654|NCT01474512|3729681|B4|||Patient's Global Assessment of Disease Severity (PatGA) (n=431, 430, 430)|"The PatGA is a single-item self-reported instrument asking the participant to rate severity of their psoriasis today by circling a number on a 0 to 5 numeric rating scale from 0 (Clear = no psoriasis) to 5 (Severe = the worst their psoriasis has ever been)."|units on a scale|Mean|4.1|4.1|Standard Deviation|0.92|0.92|||
3905655|NCT01474512|3729682|B3|||Patient's Global Assessment of Disease Severity (PatGA) (n=431, 430, 430)|"The PatGA is a single-item self-reported instrument asking the participant to rate severity of their psoriasis today by circling a number on a 0 to 5 numeric rating scale from 0 (Clear = no psoriasis) to 5 (Severe = the worst their psoriasis has ever been)."|units on a scale|Mean|4.1|4.1|Standard Deviation|0.94|0.94|||
3905656|NCT01474512|3729683|B2|||Patient's Global Assessment of Disease Severity (PatGA) (n=431, 430, 430)|"The PatGA is a single-item self-reported instrument asking the participant to rate severity of their psoriasis today by circling a number on a 0 to 5 numeric rating scale from 0 (Clear = no psoriasis) to 5 (Severe = the worst their psoriasis has ever been)."|units on a scale|Mean|4.1|4.1|Standard Deviation|0.88|0.88|||
3905657|NCT01474512|3729684|B1|||Patient's Global Assessment of Disease Severity (PatGA) (n=431, 430, 430)|"The PatGA is a single-item self-reported instrument asking the participant to rate severity of their psoriasis today by circling a number on a 0 to 5 numeric rating scale from 0 (Clear = no psoriasis) to 5 (Severe = the worst their psoriasis has ever been)."|units on a scale|Mean|4.1|4.1|Standard Deviation|0.95|0.95|||
3905658|NCT01474512|3729681|B4|MCS (n=428, 428, 432)||Medical Outcomes Study 36-Item Short Form (SF36) Physical component (PCS) and Mental Component (MCS)|The SF-36 is a self-reported instrument that measures the participant's health status during the previous 7 days. It comprises 36-items covering 8 domains: physical functioning, role physical, role emotional, bodily pain, vitality, social functioning, mental health, and general health. Items are answered on Likert scales of varying lengths. The 8 domains are regrouped in the PCS and MCS scores. Scores range from 0 to 100, with higher scores indicating better levels of function and/or better health.|units on a scale|Mean|48.05|48.05|Standard Deviation|11.463|11.463|||
3905688|NCT01474512|3729683|B2|||Psoriasis Scalp Severity Index (PSSI) (n=393, 413, 393)|The PSSI is a physician assessment of erythema, induration and desquamation and percent of scalp that is covered with a scores range from 0 (none) to 4 (very severe). The composite score is derived from the sum of scores for erythema, induration, and desquamation multiplied by the score recorded for the extent of the scalp area involved, 1 (<10%) to 6 (90%-100%) with a total scores range from 0 to 72, with lower scores indicating less severity.|units on a scale|Mean|19.9|19.9|Standard Deviation|14.83|14.83|||
3905659|NCT01474512|3729682|B3|MCS (n=428, 428, 432)||Medical Outcomes Study 36-Item Short Form (SF36) Physical component (PCS) and Mental Component (MCS)|The SF-36 is a self-reported instrument that measures the participant's health status during the previous 7 days. It comprises 36-items covering 8 domains: physical functioning, role physical, role emotional, bodily pain, vitality, social functioning, mental health, and general health. Items are answered on Likert scales of varying lengths. The 8 domains are regrouped in the PCS and MCS scores. Scores range from 0 to 100, with higher scores indicating better levels of function and/or better health.|units on a scale|Mean|47.94|47.94|Standard Deviation|11.535|11.535|||
3905660|NCT01474512|3729683|B2|MCS (n=428, 428, 432)||Medical Outcomes Study 36-Item Short Form (SF36) Physical component (PCS) and Mental Component (MCS)|The SF-36 is a self-reported instrument that measures the participant's health status during the previous 7 days. It comprises 36-items covering 8 domains: physical functioning, role physical, role emotional, bodily pain, vitality, social functioning, mental health, and general health. Items are answered on Likert scales of varying lengths. The 8 domains are regrouped in the PCS and MCS scores. Scores range from 0 to 100, with higher scores indicating better levels of function and/or better health.|units on a scale|Mean|47.46|47.46|Standard Deviation|11.655|11.655|||
3905661|NCT01474512|3729684|B1|MCS (n=428, 428, 432)||Medical Outcomes Study 36-Item Short Form (SF36) Physical component (PCS) and Mental Component (MCS)|The SF-36 is a self-reported instrument that measures the participant's health status during the previous 7 days. It comprises 36-items covering 8 domains: physical functioning, role physical, role emotional, bodily pain, vitality, social functioning, mental health, and general health. Items are answered on Likert scales of varying lengths. The 8 domains are regrouped in the PCS and MCS scores. Scores range from 0 to 100, with higher scores indicating better levels of function and/or better health.|units on a scale|Mean|48.77|48.77|Standard Deviation|11.182|11.182|||
3905662|NCT01474512|3729681|B4|PCS (n=428, 428, 432)||Medical Outcomes Study 36-Item Short Form (SF36) Physical component (PCS) and Mental Component (MCS)|The SF-36 is a self-reported instrument that measures the participant's health status during the previous 7 days. It comprises 36-items covering 8 domains: physical functioning, role physical, role emotional, bodily pain, vitality, social functioning, mental health, and general health. Items are answered on Likert scales of varying lengths. The 8 domains are regrouped in the PCS and MCS scores. Scores range from 0 to 100, with higher scores indicating better levels of function and/or better health.|units on a scale|Mean|46.95|46.95|Standard Deviation|9.363|9.363|||
3905663|NCT01474512|3729682|B3|PCS (n=428, 428, 432)||Medical Outcomes Study 36-Item Short Form (SF36) Physical component (PCS) and Mental Component (MCS)|The SF-36 is a self-reported instrument that measures the participant's health status during the previous 7 days. It comprises 36-items covering 8 domains: physical functioning, role physical, role emotional, bodily pain, vitality, social functioning, mental health, and general health. Items are answered on Likert scales of varying lengths. The 8 domains are regrouped in the PCS and MCS scores. Scores range from 0 to 100, with higher scores indicating better levels of function and/or better health.|units on a scale|Mean|46.58|46.58|Standard Deviation|9.146|9.146|||
3905664|NCT01474512|3729683|B2|PCS (n=428, 428, 432)||Medical Outcomes Study 36-Item Short Form (SF36) Physical component (PCS) and Mental Component (MCS)|The SF-36 is a self-reported instrument that measures the participant's health status during the previous 7 days. It comprises 36-items covering 8 domains: physical functioning, role physical, role emotional, bodily pain, vitality, social functioning, mental health, and general health. Items are answered on Likert scales of varying lengths. The 8 domains are regrouped in the PCS and MCS scores. Scores range from 0 to 100, with higher scores indicating better levels of function and/or better health.|units on a scale|Mean|47.34|47.34|Standard Deviation|9.169|9.169|||
3905665|NCT01474512|3729684|B1|PCS (n=428, 428, 432)||Medical Outcomes Study 36-Item Short Form (SF36) Physical component (PCS) and Mental Component (MCS)|The SF-36 is a self-reported instrument that measures the participant's health status during the previous 7 days. It comprises 36-items covering 8 domains: physical functioning, role physical, role emotional, bodily pain, vitality, social functioning, mental health, and general health. Items are answered on Likert scales of varying lengths. The 8 domains are regrouped in the PCS and MCS scores. Scores range from 0 to 100, with higher scores indicating better levels of function and/or better health.|units on a scale|Mean|46.92|46.92|Standard Deviation|9.769|9.769|||
3905666|NCT01474512|3729681|B4|Work Productively Loss (n=279, 284, 288)||Work Productivity Activity Impairment Questionnaire-Psoriasis (WPAI-PSO)|WPAI-PSO is a self-administered, 6-item instrument used to assess the impact of Ps on productivity impairment within the past 7 days. WPAI-PSO has 4 domains: absenteeism, presenteeism (reduced productivity at work), an overall work impairment score and impairment in daily activities performed outside work. Four scores are derived as percentages: absenteeism, presenteeism (reduced productivity while at work), overall work impairment (absenteeism and presenteeism), and impairment in activities performed outside of work. Percentage = each score * 100. Greater scores indicate greater impairment.|units on a scale|Mean|25.5|25.5|Standard Deviation|28.18|28.18|||
3905667|NCT01474512|3729682|B3|Work Productively Loss (n=279, 284, 288)||Work Productivity Activity Impairment Questionnaire-Psoriasis (WPAI-PSO)|WPAI-PSO is a self-administered, 6-item instrument used to assess the impact of Ps on productivity impairment within the past 7 days. WPAI-PSO has 4 domains: absenteeism, presenteeism (reduced productivity at work), an overall work impairment score and impairment in daily activities performed outside work. Four scores are derived as percentages: absenteeism, presenteeism (reduced productivity while at work), overall work impairment (absenteeism and presenteeism), and impairment in activities performed outside of work. Percentage = each score * 100. Greater scores indicate greater impairment.|units on a scale|Mean|24.9|24.9|Standard Deviation|28.77|28.77|||
3905668|NCT01474512|3729683|B2|Work Productively Loss (n=279, 284, 288)||Work Productivity Activity Impairment Questionnaire-Psoriasis (WPAI-PSO)|WPAI-PSO is a self-administered, 6-item instrument used to assess the impact of Ps on productivity impairment within the past 7 days. WPAI-PSO has 4 domains: absenteeism, presenteeism (reduced productivity at work), an overall work impairment score and impairment in daily activities performed outside work. Four scores are derived as percentages: absenteeism, presenteeism (reduced productivity while at work), overall work impairment (absenteeism and presenteeism), and impairment in activities performed outside of work. Percentage = each score * 100. Greater scores indicate greater impairment.|units on a scale|Mean|27.0|27.0|Standard Deviation|27.90|27.9|||
3905780|NCT01474434|3729759|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3905781|NCT01474434|3729760|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3905669|NCT01474512|3729684|B1|Work Productively Loss (n=279, 284, 288)||Work Productivity Activity Impairment Questionnaire-Psoriasis (WPAI-PSO)|WPAI-PSO is a self-administered, 6-item instrument used to assess the impact of Ps on productivity impairment within the past 7 days. WPAI-PSO has 4 domains: absenteeism, presenteeism (reduced productivity at work), an overall work impairment score and impairment in daily activities performed outside work. Four scores are derived as percentages: absenteeism, presenteeism (reduced productivity while at work), overall work impairment (absenteeism and presenteeism), and impairment in activities performed outside of work. Percentage = each score * 100. Greater scores indicate greater impairment.|units on a scale|Mean|24.6|24.6|Standard Deviation|27.90|27.9|||
3905670|NCT01474512|3729681|B4|Presenteeism (297, 301, 299)||Work Productivity Activity Impairment Questionnaire-Psoriasis (WPAI-PSO)|WPAI-PSO is a self-administered, 6-item instrument used to assess the impact of Ps on productivity impairment within the past 7 days. WPAI-PSO has 4 domains: absenteeism, presenteeism (reduced productivity at work), an overall work impairment score and impairment in daily activities performed outside work. Four scores are derived as percentages: absenteeism, presenteeism (reduced productivity while at work), overall work impairment (absenteeism and presenteeism), and impairment in activities performed outside of work. Percentage = each score * 100. Greater scores indicate greater impairment.|units on a scale|Mean|23.3|23.3|Standard Deviation|26.53|26.53|||
3905671|NCT01474512|3729682|B3|Presenteeism (297, 301, 299)||Work Productivity Activity Impairment Questionnaire-Psoriasis (WPAI-PSO)|WPAI-PSO is a self-administered, 6-item instrument used to assess the impact of Ps on productivity impairment within the past 7 days. WPAI-PSO has 4 domains: absenteeism, presenteeism (reduced productivity at work), an overall work impairment score and impairment in daily activities performed outside work. Four scores are derived as percentages: absenteeism, presenteeism (reduced productivity while at work), overall work impairment (absenteeism and presenteeism), and impairment in activities performed outside of work. Percentage = each score * 100. Greater scores indicate greater impairment.|units on a scale|Mean|22.6|22.6|Standard Deviation|26.46|26.46|||
3905672|NCT01474512|3729683|B2|Presenteeism (297, 301, 299)||Work Productivity Activity Impairment Questionnaire-Psoriasis (WPAI-PSO)|WPAI-PSO is a self-administered, 6-item instrument used to assess the impact of Ps on productivity impairment within the past 7 days. WPAI-PSO has 4 domains: absenteeism, presenteeism (reduced productivity at work), an overall work impairment score and impairment in daily activities performed outside work. Four scores are derived as percentages: absenteeism, presenteeism (reduced productivity while at work), overall work impairment (absenteeism and presenteeism), and impairment in activities performed outside of work. Percentage = each score * 100. Greater scores indicate greater impairment.|units on a scale|Mean|25.2|25.2|Standard Deviation|27.22|27.22|||
3905673|NCT01474512|3729684|B1|Presenteeism (297, 301, 299)||Work Productivity Activity Impairment Questionnaire-Psoriasis (WPAI-PSO)|WPAI-PSO is a self-administered, 6-item instrument used to assess the impact of Ps on productivity impairment within the past 7 days. WPAI-PSO has 4 domains: absenteeism, presenteeism (reduced productivity at work), an overall work impairment score and impairment in daily activities performed outside work. Four scores are derived as percentages: absenteeism, presenteeism (reduced productivity while at work), overall work impairment (absenteeism and presenteeism), and impairment in activities performed outside of work. Percentage = each score * 100. Greater scores indicate greater impairment.|units on a scale|Mean|22.2|22.2|Standard Deviation|25.85|25.85|||
3905674|NCT01474512|3729681|B4|Activity Impairment (n=431, 429, 432)||Work Productivity Activity Impairment Questionnaire-Psoriasis (WPAI-PSO)|WPAI-PSO is a self-administered, 6-item instrument used to assess the impact of Ps on productivity impairment within the past 7 days. WPAI-PSO has 4 domains: absenteeism, presenteeism (reduced productivity at work), an overall work impairment score and impairment in daily activities performed outside work. Four scores are derived as percentages: absenteeism, presenteeism (reduced productivity while at work), overall work impairment (absenteeism and presenteeism), and impairment in activities performed outside of work. Percentage = each score * 100. Greater scores indicate greater impairment.|units on a scale|Mean|33.4|33.4|Standard Deviation|29.05|29.05|||
3905675|NCT01474512|3729682|B3|Activity Impairment (n=431, 429, 432)||Work Productivity Activity Impairment Questionnaire-Psoriasis (WPAI-PSO)|WPAI-PSO is a self-administered, 6-item instrument used to assess the impact of Ps on productivity impairment within the past 7 days. WPAI-PSO has 4 domains: absenteeism, presenteeism (reduced productivity at work), an overall work impairment score and impairment in daily activities performed outside work. Four scores are derived as percentages: absenteeism, presenteeism (reduced productivity while at work), overall work impairment (absenteeism and presenteeism), and impairment in activities performed outside of work. Percentage = each score * 100. Greater scores indicate greater impairment.|units on a scale|Mean|34.2|34.2|Standard Deviation|28.99|28.99|||
3905676|NCT01474512|3729683|B2|Activity Impairment (n=431, 429, 432)||Work Productivity Activity Impairment Questionnaire-Psoriasis (WPAI-PSO)|WPAI-PSO is a self-administered, 6-item instrument used to assess the impact of Ps on productivity impairment within the past 7 days. WPAI-PSO has 4 domains: absenteeism, presenteeism (reduced productivity at work), an overall work impairment score and impairment in daily activities performed outside work. Four scores are derived as percentages: absenteeism, presenteeism (reduced productivity while at work), overall work impairment (absenteeism and presenteeism), and impairment in activities performed outside of work. Percentage = each score * 100. Greater scores indicate greater impairment.|units on a scale|Mean|34.7|34.7|Standard Deviation|28.83|28.83|||
3905677|NCT01474512|3729684|B1|Activity Impairment (n=431, 429, 432)||Work Productivity Activity Impairment Questionnaire-Psoriasis (WPAI-PSO)|WPAI-PSO is a self-administered, 6-item instrument used to assess the impact of Ps on productivity impairment within the past 7 days. WPAI-PSO has 4 domains: absenteeism, presenteeism (reduced productivity at work), an overall work impairment score and impairment in daily activities performed outside work. Four scores are derived as percentages: absenteeism, presenteeism (reduced productivity while at work), overall work impairment (absenteeism and presenteeism), and impairment in activities performed outside of work. Percentage = each score * 100. Greater scores indicate greater impairment.|units on a scale|Mean|31.3|31.3|Standard Deviation|29.29|29.29|||
3905715|NCT01474512|3729682|B3|sPGA=3||Static Physician Global Assessment (sPGA)|The sPGA is the physician's determination of the participant's Ps lesions overall at a given time point. Lesions were categorized by descriptions for induration, erythema, and scaling. Participants Ps were assessed as 0 (clear), 1 (minimal), 2 (mild), 3 (moderate), 4 (severe), or 5 (very severe).|participants|Number|231|231.0||||||
3905782|NCT01474434|3729761|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3905678|NCT01474512|3729681|B4|Absenteeism (n=281, 287, 290)||Work Productivity Activity Impairment Questionnaire-Psoriasis (WPAI-PSO)|WPAI-PSO is a self-administered, 6-item instrument used to assess the impact of Ps on productivity impairment within the past 7 days. WPAI-PSO has 4 domains: absenteeism, presenteeism (reduced productivity at work), an overall work impairment score and impairment in daily activities performed outside work. Four scores are derived as percentages: absenteeism, presenteeism (reduced productivity while at work), overall work impairment (absenteeism and presenteeism), and impairment in activities performed outside of work. Percentage = each score * 100. Greater scores indicate greater impairment.|units on a scale|Mean|4.7|4.7|Standard Deviation|17.63|17.63|||
3905679|NCT01474512|3729682|B3|Absenteeism (n=281, 287, 290)||Work Productivity Activity Impairment Questionnaire-Psoriasis (WPAI-PSO)|WPAI-PSO is a self-administered, 6-item instrument used to assess the impact of Ps on productivity impairment within the past 7 days. WPAI-PSO has 4 domains: absenteeism, presenteeism (reduced productivity at work), an overall work impairment score and impairment in daily activities performed outside work. Four scores are derived as percentages: absenteeism, presenteeism (reduced productivity while at work), overall work impairment (absenteeism and presenteeism), and impairment in activities performed outside of work. Percentage = each score * 100. Greater scores indicate greater impairment.|units on a scale|Mean|5.7|5.7|Standard Deviation|19.41|19.41|||
3905680|NCT01474512|3729683|B2|Absenteeism (n=281, 287, 290)||Work Productivity Activity Impairment Questionnaire-Psoriasis (WPAI-PSO)|WPAI-PSO is a self-administered, 6-item instrument used to assess the impact of Ps on productivity impairment within the past 7 days. WPAI-PSO has 4 domains: absenteeism, presenteeism (reduced productivity at work), an overall work impairment score and impairment in daily activities performed outside work. Four scores are derived as percentages: absenteeism, presenteeism (reduced productivity while at work), overall work impairment (absenteeism and presenteeism), and impairment in activities performed outside of work. Percentage = each score * 100. Greater scores indicate greater impairment.|units on a scale|Mean|4.0|4.0|Standard Deviation|16.26|16.26|||
3905681|NCT01474512|3729684|B1|Absenteeism (n=281, 287, 290)||Work Productivity Activity Impairment Questionnaire-Psoriasis (WPAI-PSO)|WPAI-PSO is a self-administered, 6-item instrument used to assess the impact of Ps on productivity impairment within the past 7 days. WPAI-PSO has 4 domains: absenteeism, presenteeism (reduced productivity at work), an overall work impairment score and impairment in daily activities performed outside work. Four scores are derived as percentages: absenteeism, presenteeism (reduced productivity while at work), overall work impairment (absenteeism and presenteeism), and impairment in activities performed outside of work. Percentage = each score * 100. Greater scores indicate greater impairment.|units on a scale|Mean|4.5|4.5|Standard Deviation|17.07|17.07|||
3905682|NCT01474512|3729681|B4|||Quick Inventory of Depressive Symptomatology-Self Reported 16 Items (QIDS-SR16) (n=430, 431, 431)|QIDS-SR16 is a participant-administered, 16-item instrument to assess the existence and severity of depression symptoms. A participant is asked to consider each statement as it relates to the way they have felt for the past 7 days and rate each on a 4-point scale: 0 (best) to 3 (worst). The sum of the 16 items corresponding to 9 depression domains (sad mood, concentration, self-criticism, suicidal ideation, interest, energy, sleep disturbance, change in appetite/weight, and psychomotor agitation/retardation) to give a total scores range from 0 to 27, higher scores indicate greater severity.|units on a scale|Mean|4.8|4.8|Standard Deviation|4.26|4.26|||
3905683|NCT01474512|3729682|B3|||Quick Inventory of Depressive Symptomatology-Self Reported 16 Items (QIDS-SR16) (n=430, 431, 431)|QIDS-SR16 is a participant-administered, 16-item instrument to assess the existence and severity of depression symptoms. A participant is asked to consider each statement as it relates to the way they have felt for the past 7 days and rate each on a 4-point scale: 0 (best) to 3 (worst). The sum of the 16 items corresponding to 9 depression domains (sad mood, concentration, self-criticism, suicidal ideation, interest, energy, sleep disturbance, change in appetite/weight, and psychomotor agitation/retardation) to give a total scores range from 0 to 27, higher scores indicate greater severity.|units on a scale|Mean|4.5|4.5|Standard Deviation|4.09|4.09|||
3905684|NCT01474512|3729683|B2|||Quick Inventory of Depressive Symptomatology-Self Reported 16 Items (QIDS-SR16) (n=430, 431, 431)|QIDS-SR16 is a participant-administered, 16-item instrument to assess the existence and severity of depression symptoms. A participant is asked to consider each statement as it relates to the way they have felt for the past 7 days and rate each on a 4-point scale: 0 (best) to 3 (worst). The sum of the 16 items corresponding to 9 depression domains (sad mood, concentration, self-criticism, suicidal ideation, interest, energy, sleep disturbance, change in appetite/weight, and psychomotor agitation/retardation) to give a total scores range from 0 to 27, higher scores indicate greater severity.|units on a scale|Mean|5.0|5.0|Standard Deviation|4.34|4.34|||
3905685|NCT01474512|3729684|B1|||Quick Inventory of Depressive Symptomatology-Self Reported 16 Items (QIDS-SR16) (n=430, 431, 431)|QIDS-SR16 is a participant-administered, 16-item instrument to assess the existence and severity of depression symptoms. A participant is asked to consider each statement as it relates to the way they have felt for the past 7 days and rate each on a 4-point scale: 0 (best) to 3 (worst). The sum of the 16 items corresponding to 9 depression domains (sad mood, concentration, self-criticism, suicidal ideation, interest, energy, sleep disturbance, change in appetite/weight, and psychomotor agitation/retardation) to give a total scores range from 0 to 27, higher scores indicate greater severity.|units on a scale|Mean|4.7|4.7|Standard Deviation|4.34|4.34|||
3905686|NCT01474512|3729681|B4|||Psoriasis Scalp Severity Index (PSSI) (n=393, 413, 393)|The PSSI is a physician assessment of erythema, induration and desquamation and percent of scalp that is covered with a scores range from 0 (none) to 4 (very severe). The composite score is derived from the sum of scores for erythema, induration, and desquamation multiplied by the score recorded for the extent of the scalp area involved, 1 (<10%) to 6 (90%-100%) with a total scores range from 0 to 72, with lower scores indicating less severity.|units on a scale|Mean|20.9|20.9|Standard Deviation|15.08|15.08|||
3905687|NCT01474512|3729682|B3|||Psoriasis Scalp Severity Index (PSSI) (n=393, 413, 393)|The PSSI is a physician assessment of erythema, induration and desquamation and percent of scalp that is covered with a scores range from 0 (none) to 4 (very severe). The composite score is derived from the sum of scores for erythema, induration, and desquamation multiplied by the score recorded for the extent of the scalp area involved, 1 (<10%) to 6 (90%-100%) with a total scores range from 0 to 72, with lower scores indicating less severity.|units on a scale|Mean|21.1|21.1|Standard Deviation|14.69|14.69|||
3905783|NCT01474434|3729762|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3905689|NCT01474512|3729684|B1|||Psoriasis Scalp Severity Index (PSSI) (n=393, 413, 393)|The PSSI is a physician assessment of erythema, induration and desquamation and percent of scalp that is covered with a scores range from 0 (none) to 4 (very severe). The composite score is derived from the sum of scores for erythema, induration, and desquamation multiplied by the score recorded for the extent of the scalp area involved, 1 (<10%) to 6 (90%-100%) with a total scores range from 0 to 72, with lower scores indicating less severity.|units on a scale|Mean|21.8|21.8|Standard Deviation|15.70|15.7|||
3905690|NCT01474512|3729681|B4|||Percent of Body Surface Area (BSA) involvement of Ps|BSA is a physician rating of the percentage of involvement of Ps for each participant. BSA is assessed on a continuous scale from 0% (no involvement) to 100% (full involvement), where 1% corresponds to the size of the participants hand (includes the palm, fingers and thumb).|percent of body surface|Mean|27.7|27.7|Standard Deviation|17.27|17.27|||
3905691|NCT01474512|3729682|B3|||Percent of Body Surface Area (BSA) involvement of Ps|BSA is a physician rating of the percentage of involvement of Ps for each participant. BSA is assessed on a continuous scale from 0% (no involvement) to 100% (full involvement), where 1% corresponds to the size of the participants hand (includes the palm, fingers and thumb).|percent of body surface|Mean|28.2|28.2|Standard Deviation|17.83|17.83|||
3905692|NCT01474512|3729683|B2|||Percent of Body Surface Area (BSA) involvement of Ps|BSA is a physician rating of the percentage of involvement of Ps for each participant. BSA is assessed on a continuous scale from 0% (no involvement) to 100% (full involvement), where 1% corresponds to the size of the participants hand (includes the palm, fingers and thumb).|percent of body surface|Mean|27.4|27.4|Standard Deviation|16.20|16.2|||
3905693|NCT01474512|3729684|B1|||Percent of Body Surface Area (BSA) involvement of Ps|BSA is a physician rating of the percentage of involvement of Ps for each participant. BSA is assessed on a continuous scale from 0% (no involvement) to 100% (full involvement), where 1% corresponds to the size of the participants hand (includes the palm, fingers and thumb).|percent of body surface|Mean|27.4|27.4|Standard Deviation|17.77|17.77|||
3905694|NCT01474512|3729681|B4|||Nail Psoriasis Severity Index (NAPSI) (n=283, 281, 283)|The NAPSI is a numeric, reproducible, objective tool to evaluate the severity of fingernail bed Ps and fingernail matrix Ps. Each fingernail is given a score for fingernail bed Ps and fingernail matrix Ps, each with scores of 0 (none) to 4 (Ps in all 4 quadrants) depending on the features of each fingernail bed and fingernail matrix Ps.The NAPSI score of a fingernail is the sum of scores in fingernail bed and fingernail matrix from each quadrant (maximum of 8). The sum of all fingernails equals the total NAPSI score with a range from 0 to 80. Higher scores indicated more severe psoriasis.|units on a scale|Mean|24.95|24.95|Standard Deviation|19.238|19.238|||
3905695|NCT01474512|3729682|B3|||Nail Psoriasis Severity Index (NAPSI) (n=283, 281, 283)|The NAPSI is a numeric, reproducible, objective tool to evaluate the severity of fingernail bed Ps and fingernail matrix Ps. Each fingernail is given a score for fingernail bed Ps and fingernail matrix Ps, each with scores of 0 (none) to 4 (Ps in all 4 quadrants) depending on the features of each fingernail bed and fingernail matrix Ps.The NAPSI score of a fingernail is the sum of scores in fingernail bed and fingernail matrix from each quadrant (maximum of 8). The sum of all fingernails equals the total NAPSI score with a range from 0 to 80. Higher scores indicated more severe psoriasis.|units on a scale|Mean|24.64|24.64|Standard Deviation|18.916|18.916|||
3905696|NCT01474512|3729683|B2|||Nail Psoriasis Severity Index (NAPSI) (n=283, 281, 283)|The NAPSI is a numeric, reproducible, objective tool to evaluate the severity of fingernail bed Ps and fingernail matrix Ps. Each fingernail is given a score for fingernail bed Ps and fingernail matrix Ps, each with scores of 0 (none) to 4 (Ps in all 4 quadrants) depending on the features of each fingernail bed and fingernail matrix Ps.The NAPSI score of a fingernail is the sum of scores in fingernail bed and fingernail matrix from each quadrant (maximum of 8). The sum of all fingernails equals the total NAPSI score with a range from 0 to 80. Higher scores indicated more severe psoriasis.|units on a scale|Mean|24.12|24.12|Standard Deviation|18.243|18.243|||
3905697|NCT01474512|3729684|B1|||Nail Psoriasis Severity Index (NAPSI) (n=283, 281, 283)|The NAPSI is a numeric, reproducible, objective tool to evaluate the severity of fingernail bed Ps and fingernail matrix Ps. Each fingernail is given a score for fingernail bed Ps and fingernail matrix Ps, each with scores of 0 (none) to 4 (Ps in all 4 quadrants) depending on the features of each fingernail bed and fingernail matrix Ps.The NAPSI score of a fingernail is the sum of scores in fingernail bed and fingernail matrix from each quadrant (maximum of 8). The sum of all fingernails equals the total NAPSI score with a range from 0 to 80. Higher scores indicated more severe psoriasis.|units on a scale|Mean|26.9|26.9|Standard Deviation|20.492|20.492|||
3905698|NCT01474512|3729681|B4|||Dermatology-Specific Quality of Life Index (DLQI) Score|"DLQI is a participant-administered, 10-question, validated, quality-of-life questionnaire that covers 6 domains, including symptoms and feelings, daily activities, leisure, work and school, personal relationships, and treatment. Response categories include 0 (not at all), 1 (a little), 2 (a lot), and 3 (very much) and unanswered (not relevant) responses were scored as 0. Total scores range from 0 to 30, with higher score indicating greater quality of life is impairment."|units on a scale|Mean|13.1|13.1|Standard Deviation|7.05|7.05|||
3905699|NCT01474512|3729682|B3|||Dermatology-Specific Quality of Life Index (DLQI) Score|"DLQI is a participant-administered, 10-question, validated, quality-of-life questionnaire that covers 6 domains, including symptoms and feelings, daily activities, leisure, work and school, personal relationships, and treatment. Response categories include 0 (not at all), 1 (a little), 2 (a lot), and 3 (very much) and unanswered (not relevant) responses were scored as 0. Total scores range from 0 to 30, with higher score indicating greater quality of life is impairment."|units on a scale|Mean|13.4|13.4|Standard Deviation|7.02|7.02|||
3905700|NCT01474512|3729683|B2|||Dermatology-Specific Quality of Life Index (DLQI) Score|"DLQI is a participant-administered, 10-question, validated, quality-of-life questionnaire that covers 6 domains, including symptoms and feelings, daily activities, leisure, work and school, personal relationships, and treatment. Response categories include 0 (not at all), 1 (a little), 2 (a lot), and 3 (very much) and unanswered (not relevant) responses were scored as 0. Total scores range from 0 to 30, with higher score indicating greater quality of life is impairment."|units on a scale|Mean|13.2|13.2|Standard Deviation|7.02|7.02|||
3905716|NCT01474512|3729683|B2|sPGA=3||Static Physician Global Assessment (sPGA)|The sPGA is the physician's determination of the participant's Ps lesions overall at a given time point. Lesions were categorized by descriptions for induration, erythema, and scaling. Participants Ps were assessed as 0 (clear), 1 (minimal), 2 (mild), 3 (moderate), 4 (severe), or 5 (very severe).|participants|Number|197|197.0||||||
3905701|NCT01474512|3729684|B1|||Dermatology-Specific Quality of Life Index (DLQI) Score|"DLQI is a participant-administered, 10-question, validated, quality-of-life questionnaire that covers 6 domains, including symptoms and feelings, daily activities, leisure, work and school, personal relationships, and treatment. Response categories include 0 (not at all), 1 (a little), 2 (a lot), and 3 (very much) and unanswered (not relevant) responses were scored as 0. Total scores range from 0 to 30, with higher score indicating greater quality of life is impairment."|units on a scale|Mean|12.8|12.8|Standard Deviation|7.11|7.11|||
3905702|NCT01474512|3729681|B4|||Itch Numeric Rating Scale (NRS)|The Itch NRS is a participant-administered, 11-point horizontal scale anchored at 0 (no itch) and 10 (worst itch imaginable). Overall severity of a participant's itching from psoriasis (Ps) is indicated by circling the number that best describes the worst level of itching in the past 24 hours.|units on a scale|Mean|7.1|7.1|Standard Deviation|2.49|2.49|||
3905703|NCT01474512|3729682|B3|||Itch Numeric Rating Scale (NRS)|The Itch NRS is a participant-administered, 11-point horizontal scale anchored at 0 (no itch) and 10 (worst itch imaginable). Overall severity of a participant's itching from psoriasis (Ps) is indicated by circling the number that best describes the worst level of itching in the past 24 hours.|units on a scale|Mean|7.2|7.2|Standard Deviation|2.39|2.39|||
3905704|NCT01474512|3729683|B2|||Itch Numeric Rating Scale (NRS)|The Itch NRS is a participant-administered, 11-point horizontal scale anchored at 0 (no itch) and 10 (worst itch imaginable). Overall severity of a participant's itching from psoriasis (Ps) is indicated by circling the number that best describes the worst level of itching in the past 24 hours.|units on a scale|Mean|7.0|7.0|Standard Deviation|2.50|2.5|||
3905705|NCT01474512|3729684|B1|||Itch Numeric Rating Scale (NRS)|The Itch NRS is a participant-administered, 11-point horizontal scale anchored at 0 (no itch) and 10 (worst itch imaginable). Overall severity of a participant's itching from psoriasis (Ps) is indicated by circling the number that best describes the worst level of itching in the past 24 hours.|units on a scale|Mean|7.0|7.0|Standard Deviation|2.58|2.58|||
3905706|NCT01474512|3729681|B4|||Psoriasis Area and Severity Index (PASI)|PASI combines body surface involvement in 4 regions (head, trunk, arms, and legs), percent area of skin involved was estimated from 0 (0%) to 6 (90%-100%) and severity was estimated by clinical signs of erythema, induration and scaling with a scores range from 0 (no involvement) to 4 (severe involvement). Each area is scored separately and the scores then combined for final PASI, calculated as: sum of severity parameters for each region*area score*weighing factor [head (0.1), upper limbs (0.2), trunk (0.3), lower limbs (0.4)]. Scores range from 0 (no Ps) to 72 (the most severe disease).|units on a scale|Mean|20.15|20.15|Standard Deviation|7.992|7.992|||
3905707|NCT01474512|3729682|B3|||Psoriasis Area and Severity Index (PASI)|PASI combines body surface involvement in 4 regions (head, trunk, arms, and legs), percent area of skin involved was estimated from 0 (0%) to 6 (90%-100%) and severity was estimated by clinical signs of erythema, induration and scaling with a scores range from 0 (no involvement) to 4 (severe involvement). Each area is scored separately and the scores then combined for final PASI, calculated as: sum of severity parameters for each region*area score*weighing factor [head (0.1), upper limbs (0.2), trunk (0.3), lower limbs (0.4)]. Scores range from 0 (no Ps) to 72 (the most severe disease).|units on a scale|Mean|20.09|20.09|Standard Deviation|7.992|7.992|||
3905708|NCT01474512|3729683|B2|||Psoriasis Area and Severity Index (PASI)|PASI combines body surface involvement in 4 regions (head, trunk, arms, and legs), percent area of skin involved was estimated from 0 (0%) to 6 (90%-100%) and severity was estimated by clinical signs of erythema, induration and scaling with a scores range from 0 (no involvement) to 4 (severe involvement). Each area is scored separately and the scores then combined for final PASI, calculated as: sum of severity parameters for each region*area score*weighing factor [head (0.1), upper limbs (0.2), trunk (0.3), lower limbs (0.4)]. Scores range from 0 (no Ps) to 72 (the most severe disease).|units on a scale|Mean|20.03|20.03|Standard Deviation|7.304|7.304|||
3905709|NCT01474512|3729684|B1|||Psoriasis Area and Severity Index (PASI)|PASI combines body surface involvement in 4 regions (head, trunk, arms, and legs), percent area of skin involved was estimated from 0 (0%) to 6 (90%-100%) and severity was estimated by clinical signs of erythema, induration and scaling with a scores range from 0 (no involvement) to 4 (severe involvement). Each area is scored separately and the scores then combined for final PASI, calculated as: sum of severity parameters for each region*area score*weighing factor [head (0.1), upper limbs (0.2), trunk (0.3), lower limbs (0.4)]. Scores range from 0 (no Ps) to 72 (the most severe disease).|units on a scale|Mean|20.32|20.32|Standard Deviation|8.641|8.641|||
3905710|NCT01474512|3729681|B4|sPGA=4, 5||Static Physician Global Assessment (sPGA)|The sPGA is the physician's determination of the participant's Ps lesions overall at a given time point. Lesions were categorized by descriptions for induration, erythema, and scaling. Participants Ps were assessed as 0 (clear), 1 (minimal), 2 (mild), 3 (moderate), 4 (severe), or 5 (very severe).|participants|Number|664|664.0||||||
3905711|NCT01474512|3729682|B3|sPGA=4, 5||Static Physician Global Assessment (sPGA)|The sPGA is the physician's determination of the participant's Ps lesions overall at a given time point. Lesions were categorized by descriptions for induration, erythema, and scaling. Participants Ps were assessed as 0 (clear), 1 (minimal), 2 (mild), 3 (moderate), 4 (severe), or 5 (very severe).|participants|Number|202|202.0||||||
3905712|NCT01474512|3729683|B2|sPGA=4, 5||Static Physician Global Assessment (sPGA)|The sPGA is the physician's determination of the participant's Ps lesions overall at a given time point. Lesions were categorized by descriptions for induration, erythema, and scaling. Participants Ps were assessed as 0 (clear), 1 (minimal), 2 (mild), 3 (moderate), 4 (severe), or 5 (very severe).|participants|Number|235|235.0||||||
3905713|NCT01474512|3729684|B1|sPGA=4, 5||Static Physician Global Assessment (sPGA)|The sPGA is the physician's determination of the participant's Ps lesions overall at a given time point. Lesions were categorized by descriptions for induration, erythema, and scaling. Participants Ps were assessed as 0 (clear), 1 (minimal), 2 (mild), 3 (moderate), 4 (severe), or 5 (very severe).|participants|Number|227|227.0||||||
3905714|NCT01474512|3729681|B4|sPGA=3||Static Physician Global Assessment (sPGA)|The sPGA is the physician's determination of the participant's Ps lesions overall at a given time point. Lesions were categorized by descriptions for induration, erythema, and scaling. Participants Ps were assessed as 0 (clear), 1 (minimal), 2 (mild), 3 (moderate), 4 (severe), or 5 (very severe).|participants|Number|632|632.0||||||
3905778|NCT01474434|3729762|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3905779|NCT01474434|3729758|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3905717|NCT01474512|3729684|B1|sPGA=3||Static Physician Global Assessment (sPGA)|The sPGA is the physician's determination of the participant's Ps lesions overall at a given time point. Lesions were categorized by descriptions for induration, erythema, and scaling. Participants Ps were assessed as 0 (clear), 1 (minimal), 2 (mild), 3 (moderate), 4 (severe), or 5 (very severe).|participants|Number|204|204.0||||||
3905718|NCT01474512|3729681|B4|Germany||Region of Enrollment||participants|Number|287|287.0||||||
3905719|NCT01474512|3729682|B3|Germany||Region of Enrollment||participants|Number|93|93.0||||||
3905720|NCT01474512|3729683|B2|Germany||Region of Enrollment||participants|Number|106|106.0||||||
3905721|NCT01474512|3729684|B1|Germany||Region of Enrollment||participants|Number|88|88.0||||||
3905722|NCT01474512|3729681|B4|Australia||Region of Enrollment||participants|Number|42|42.0||||||
3905723|NCT01474512|3729682|B3|Australia||Region of Enrollment||participants|Number|8|8.0||||||
3905724|NCT01474512|3729683|B2|Australia||Region of Enrollment||participants|Number|15|15.0||||||
3905725|NCT01474512|3729684|B1|Australia||Region of Enrollment||participants|Number|19|19.0||||||
3905726|NCT01474512|3729681|B4|United Kingdom||Region of Enrollment||participants|Number|21|21.0||||||
3905727|NCT01474512|3729682|B3|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
3905728|NCT01474512|3729683|B2|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
3905729|NCT01474512|3729684|B1|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
3905730|NCT01474512|3729681|B4|Italy||Region of Enrollment||participants|Number|6|6.0||||||
3905731|NCT01474512|3729682|B3|Italy||Region of Enrollment||participants|Number|1|1.0||||||
3905732|NCT01474512|3729683|B2|Italy||Region of Enrollment||participants|Number|2|2.0||||||
3905733|NCT01474512|3729684|B1|Italy||Region of Enrollment||participants|Number|3|3.0||||||
3905734|NCT01474512|3729681|B4|Poland||Region of Enrollment||participants|Number|139|139.0||||||
3905735|NCT01474512|3729682|B3|Poland||Region of Enrollment||participants|Number|55|55.0||||||
3905736|NCT01474512|3729683|B2|Poland||Region of Enrollment||participants|Number|41|41.0||||||
3905737|NCT01474512|3729684|B1|Poland||Region of Enrollment||participants|Number|43|43.0||||||
3905738|NCT01474512|3729681|B4|Denmark||Region of Enrollment||participants|Number|16|16.0||||||
3905739|NCT01474512|3729682|B3|Denmark||Region of Enrollment||participants|Number|8|8.0||||||
3905740|NCT01474512|3729683|B2|Denmark||Region of Enrollment||participants|Number|4|4.0||||||
3905741|NCT01474512|3729684|B1|Denmark||Region of Enrollment||participants|Number|4|4.0||||||
3905742|NCT01474512|3729681|B4|Japan||Region of Enrollment||participants|Number|33|33.0||||||
3905743|NCT01474512|3729682|B3|Japan||Region of Enrollment||participants|Number|8|8.0||||||
3905744|NCT01474512|3729683|B2|Japan||Region of Enrollment||participants|Number|12|12.0||||||
3905745|NCT01474512|3729684|B1|Japan||Region of Enrollment||participants|Number|13|13.0||||||
3905746|NCT01474512|3729681|B4|United States||Region of Enrollment||participants|Number|461|461.0||||||
3905747|NCT01474512|3729682|B3|United States||Region of Enrollment||participants|Number|159|159.0||||||
3905748|NCT01474512|3729683|B2|United States||Region of Enrollment||participants|Number|156|156.0||||||
3905749|NCT01474512|3729684|B1|United States||Region of Enrollment||participants|Number|146|146.0||||||
3905750|NCT01474512|3729681|B4|Hungary||Region of Enrollment||participants|Number|66|66.0||||||
3905751|NCT01474512|3729682|B3|Hungary||Region of Enrollment||participants|Number|26|26.0||||||
3905752|NCT01474512|3729683|B2|Hungary||Region of Enrollment||participants|Number|17|17.0||||||
3905753|NCT01474512|3729684|B1|Hungary||Region of Enrollment||participants|Number|23|23.0||||||
3905754|NCT01474512|3729681|B4|Romania||Region of Enrollment||participants|Number|13|13.0||||||
3905755|NCT01474512|3729682|B3|Romania||Region of Enrollment||participants|Number|2|2.0||||||
3905756|NCT01474512|3729683|B2|Romania||Region of Enrollment||participants|Number|3|3.0||||||
3905757|NCT01474512|3729684|B1|Romania||Region of Enrollment||participants|Number|8|8.0||||||
3905758|NCT01474512|3729681|B4|Canada||Region of Enrollment||participants|Number|212|212.0||||||
3905759|NCT01474512|3729682|B3|Canada||Region of Enrollment||participants|Number|66|66.0||||||
3905760|NCT01474512|3729683|B2|Canada||Region of Enrollment||participants|Number|69|69.0||||||
3905761|NCT01474512|3729684|B1|Canada||Region of Enrollment||participants|Number|77|77.0||||||
3905762|NCT01474512|3729681|B4||Male|Sex: Female, Male||Participants|Count of Participants|883|883.0||||||
3905763|NCT01474512|3729682|B3||Male|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
3905764|NCT01474512|3729683|B2||Male|Sex: Female, Male||Participants|Count of Participants|289|289.0||||||
3905765|NCT01474512|3729684|B1||Male|Sex: Female, Male||Participants|Count of Participants|303|303.0||||||
3905766|NCT01474512|3729681|B4||Female|Sex: Female, Male||Participants|Count of Participants|413|413.0||||||
3905767|NCT01474512|3729682|B3||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3905768|NCT01474512|3729683|B2||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3905769|NCT01474512|3729684|B1||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3905770|NCT01474512|3729681|B4|||Age||years|Mean|45.7|45.7|Standard Deviation|12.93|12.93|||
3905771|NCT01474512|3729682|B3|||Age||years|Mean|45.1|45.1|Standard Deviation|12.40|12.4|||
3905772|NCT01474512|3729683|B2|||Age||years|Mean|45.6|45.6|Standard Deviation|12.95|12.95|||
3905773|NCT01474512|3729684|B1|||Age||years|Mean|46.4|46.4|Standard Deviation|13.40|13.4|||
3905774|NCT01474434|3729758|B5||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3905775|NCT01474434|3729759|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3905776|NCT01474434|3729760|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3905777|NCT01474434|3729761|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3905784|NCT01474434|3729758|B5|||Age||years|Mean|57.5|57.5|Standard Deviation|8.5|8.5|||
3905785|NCT01474434|3729759|B4|||Age||years|Mean|56.1|56.1|Standard Deviation|8.85|8.85|||
3905786|NCT01474434|3729760|B3|||Age||years|Mean|56.7|56.7|Standard Deviation|9.79|9.79|||
3905787|NCT01474434|3729761|B2|||Age||years|Mean|58.4|58.4|Standard Deviation|8.79|8.79|||
3905788|NCT01474434|3729762|B1|||Age||years|Mean|59.6|59.6|Standard Deviation|6.67|6.67|||
3905789|NCT01474317|3729807|B1|United States||Region of Enrollment||participants|Number|224|224.0||||||
3905790|NCT01474317|3729807|B1||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3905791|NCT01474317|3729807|B1||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3905792|NCT01474317|3729807|B1|||Age|224 subjects completed the study|years|Mean|54.4|54.4|Full Range|||23.0|78.0|
3905793|NCT01474291|3729814|B3||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3905794|NCT01474291|3729815|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3905795|NCT01474291|3729816|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3905796|NCT01474291|3729814|B3||Female|Sex: Female, Male||Participants|Count of Participants|454|454.0||||||
3905797|NCT01474291|3729815|B2||Female|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
3905798|NCT01474291|3729816|B1||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3905799|NCT01474291|3729814|B3|||Age||years|Mean|56.8|56.8|Standard Deviation|12.7|12.7|||
3905800|NCT01474291|3729815|B2|||Age||years|Mean|55.3|55.3|Standard Deviation|12.5|12.5|||
3905801|NCT01474291|3729816|B1|||Age||years|Mean|59.1|59.1|Standard Deviation|12.7|12.7|||
3905802|NCT01474239|3729858|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3905803|NCT01474239|3729859|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3905804|NCT01474239|3729860|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3905805|NCT01474239|3729858|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3905806|NCT01474239|3729859|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3905807|NCT01474239|3729860|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3905808|NCT01474239|3729858|B3|||Age||years|Mean|56.43|56.43|Standard Deviation|9.81|9.81|||
3905809|NCT01474239|3729859|B2|||Age||years|Mean|55.63|55.63|Standard Deviation|10.64|10.64|||
3905810|NCT01474239|3729860|B1|||Age||years|Mean|56.86|56.86|Standard Deviation|9.40|9.4|||
3905811|NCT01474213|3729897|B3|China||Region of Enrollment||participants|Number|40|40.0||||||
3905812|NCT01474213|3729898|B2|China||Region of Enrollment||participants|Number|20|20.0||||||
3905813|NCT01474213|3729899|B1|China||Region of Enrollment||participants|Number|20|20.0||||||
3905814|NCT01474213|3729897|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3905815|NCT01474213|3729898|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3905816|NCT01474213|3729899|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3905817|NCT01474213|3729897|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3905818|NCT01474213|3729898|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3905819|NCT01474213|3729899|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3905820|NCT01474213|3729897|B3|||Age||years|Mean|38.6|38.6|Standard Deviation|14.8|14.8|||
3905821|NCT01474213|3729898|B2|||Age||years|Mean|37.8|37.8|Standard Deviation|14.9|14.9|||
3905822|NCT01474213|3729899|B1|||Age||years|Mean|39.4|39.4|Standard Deviation|15.2|15.2|||
3905823|NCT01474213|3729897|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3905824|NCT01474213|3729898|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3905825|NCT01474213|3729899|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3905826|NCT01474213|3729897|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3905827|NCT01474213|3729898|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3905828|NCT01474213|3729899|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3905829|NCT01474213|3729897|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3905830|NCT01474213|3729898|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3905831|NCT01474213|3729899|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3905832|NCT01474200|3729922|B3|||Body Mass Index (BMI)||Kg/m2|Mean|36.61|36.61|Standard Deviation|10.10|10.1|||
3905833|NCT01474200|3729923|B2|||Body Mass Index (BMI)||Kg/m2|Mean|36.32|36.32|Standard Deviation|10.10|10.1|||
3905834|NCT01474200|3729924|B1|||Body Mass Index (BMI)||Kg/m2|Mean|36.89|36.89|Standard Deviation|10.13|10.13|||
3905835|NCT01474200|3729922|B3|||Weight||Kilograms|Mean|110.49|110.49|Standard Deviation|33.64|33.64|||
3905836|NCT01474200|3729923|B2|||Weight||Kilograms|Mean|110.92|110.92|Standard Deviation|35.09|35.09|||
3905837|NCT01474200|3729924|B1|||Weight||Kilograms|Mean|110.06|110.06|Standard Deviation|32.26|32.26|||
3905838|NCT01474200|3729922|B3|||Height||Centimeters|Mean|173.29|173.29|Standard Deviation|10.79|10.79|||
3905839|NCT01474200|3729923|B2|||Height||Centimeters|Mean|174.12|174.12|Standard Deviation|10.52|10.52|||
3905840|NCT01474200|3729924|B1|||Height||Centimeters|Mean|172.45|172.45|Standard Deviation|11.04|11.04|||
3905841|NCT01474200|3729922|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3905842|NCT01474200|3729923|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3905843|NCT01474200|3729924|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3905844|NCT01474200|3729922|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905906|NCT01474122|3729978|B1|Poland||Region of Enrollment||participants|Number|7|7.0||||||
3905845|NCT01474200|3729923|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905846|NCT01474200|3729924|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905847|NCT01474200|3729922|B3||White|Race (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
3905848|NCT01474200|3729923|B2||White|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3905849|NCT01474200|3729924|B1||White|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3905850|NCT01474200|3729922|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3905851|NCT01474200|3729923|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3905852|NCT01474200|3729924|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3905853|NCT01474200|3729922|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905854|NCT01474200|3729923|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905855|NCT01474200|3729924|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3905856|NCT01474200|3729922|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3905857|NCT01474200|3729923|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3905858|NCT01474200|3729924|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3905859|NCT01474200|3729922|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3905860|NCT01474200|3729923|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3905861|NCT01474200|3729924|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3905862|NCT01474200|3729922|B3||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3905863|NCT01474200|3729923|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3905864|NCT01474200|3729924|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3905865|NCT01474200|3729922|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3905866|NCT01474200|3729923|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3905867|NCT01474200|3729924|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3905868|NCT01474200|3729922|B3|||Age||Years|Mean|66.95|66.95|Standard Deviation|13.01|13.01|||
3905869|NCT01474200|3729923|B2|||Age||Years|Mean|66.87|66.87|Standard Deviation|13.45|13.45|||
3905870|NCT01474200|3729924|B1|||Age||Years|Mean|67.03|67.03|Standard Deviation|12.61|12.61|||
3905871|NCT01474122|3729975|B4|United States||Region of Enrollment||participants|Number|48|48.0||||||
3905872|NCT01474122|3729976|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
3905873|NCT01474122|3729977|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3905874|NCT01474122|3729978|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3905875|NCT01474122|3729975|B4|United Kingdom||Region of Enrollment||participants|Number|16|16.0||||||
3905876|NCT01474122|3729976|B3|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3905877|NCT01474122|3729977|B2|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3905878|NCT01474122|3729978|B1|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
3905879|NCT01474122|3729975|B4|Ukraine||Region of Enrollment||participants|Number|20|20.0||||||
3905880|NCT01474122|3729976|B3|Ukraine||Region of Enrollment||participants|Number|4|4.0||||||
3905881|NCT01474122|3729977|B2|Ukraine||Region of Enrollment||participants|Number|7|7.0||||||
3905882|NCT01474122|3729978|B1|Ukraine||Region of Enrollment||participants|Number|9|9.0||||||
3905883|NCT01474122|3729975|B4|Turkey||Region of Enrollment||participants|Number|1|1.0||||||
3905884|NCT01474122|3729976|B3|Turkey||Region of Enrollment||participants|Number|1|1.0||||||
3905885|NCT01474122|3729977|B2|Turkey||Region of Enrollment||participants|Number|0|0.0||||||
3905886|NCT01474122|3729978|B1|Turkey||Region of Enrollment||participants|Number|0|0.0||||||
3905887|NCT01474122|3729975|B4|South Africa||Region of Enrollment||participants|Number|9|9.0||||||
3905888|NCT01474122|3729976|B3|South Africa||Region of Enrollment||participants|Number|2|2.0||||||
3905889|NCT01474122|3729977|B2|South Africa||Region of Enrollment||participants|Number|4|4.0||||||
3905890|NCT01474122|3729978|B1|South Africa||Region of Enrollment||participants|Number|3|3.0||||||
3905891|NCT01474122|3729975|B4|Russian Federation||Region of Enrollment||participants|Number|16|16.0||||||
3905892|NCT01474122|3729976|B3|Russian Federation||Region of Enrollment||participants|Number|7|7.0||||||
3905893|NCT01474122|3729977|B2|Russian Federation||Region of Enrollment||participants|Number|4|4.0||||||
3905894|NCT01474122|3729978|B1|Russian Federation||Region of Enrollment||participants|Number|5|5.0||||||
3905895|NCT01474122|3729975|B4|Puerto Rico||Region of Enrollment||participants|Number|2|2.0||||||
3905896|NCT01474122|3729976|B3|Puerto Rico||Region of Enrollment||participants|Number|0|0.0||||||
3905897|NCT01474122|3729977|B2|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
3905898|NCT01474122|3729978|B1|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
3905899|NCT01474122|3729975|B4|Portugal||Region of Enrollment||participants|Number|7|7.0||||||
3905900|NCT01474122|3729976|B3|Portugal||Region of Enrollment||participants|Number|4|4.0||||||
3905901|NCT01474122|3729977|B2|Portugal||Region of Enrollment||participants|Number|2|2.0||||||
3905902|NCT01474122|3729978|B1|Portugal||Region of Enrollment||participants|Number|1|1.0||||||
3905903|NCT01474122|3729975|B4|Poland||Region of Enrollment||participants|Number|23|23.0||||||
3905904|NCT01474122|3729976|B3|Poland||Region of Enrollment||participants|Number|5|5.0||||||
3905905|NCT01474122|3729977|B2|Poland||Region of Enrollment||participants|Number|11|11.0||||||
3905907|NCT01474122|3729975|B4|New Zealand||Region of Enrollment||participants|Number|6|6.0||||||
3905908|NCT01474122|3729976|B3|New Zealand||Region of Enrollment||participants|Number|3|3.0||||||
3905909|NCT01474122|3729977|B2|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
3905910|NCT01474122|3729978|B1|New Zealand||Region of Enrollment||participants|Number|2|2.0||||||
3905911|NCT01474122|3729975|B4|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
3905912|NCT01474122|3729976|B3|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
3905913|NCT01474122|3729977|B2|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
3905914|NCT01474122|3729978|B1|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
3905915|NCT01474122|3729975|B4|Mexico||Region of Enrollment||participants|Number|21|21.0||||||
3905916|NCT01474122|3729976|B3|Mexico||Region of Enrollment||participants|Number|6|6.0||||||
3905917|NCT01474122|3729977|B2|Mexico||Region of Enrollment||participants|Number|9|9.0||||||
3905918|NCT01474122|3729978|B1|Mexico||Region of Enrollment||participants|Number|6|6.0||||||
3905919|NCT01474122|3729975|B4|Israel||Region of Enrollment||participants|Number|24|24.0||||||
3905920|NCT01474122|3729976|B3|Israel||Region of Enrollment||participants|Number|12|12.0||||||
3905921|NCT01474122|3729977|B2|Israel||Region of Enrollment||participants|Number|7|7.0||||||
3905922|NCT01474122|3729978|B1|Israel||Region of Enrollment||participants|Number|5|5.0||||||
3905923|NCT01474122|3729975|B4|Ireland||Region of Enrollment||participants|Number|4|4.0||||||
3905924|NCT01474122|3729976|B3|Ireland||Region of Enrollment||participants|Number|1|1.0||||||
3905925|NCT01474122|3729977|B2|Ireland||Region of Enrollment||participants|Number|2|2.0||||||
3905926|NCT01474122|3729978|B1|Ireland||Region of Enrollment||participants|Number|1|1.0||||||
3905927|NCT01474122|3729975|B4|Greece||Region of Enrollment||participants|Number|11|11.0||||||
3905928|NCT01474122|3729976|B3|Greece||Region of Enrollment||participants|Number|5|5.0||||||
3905929|NCT01474122|3729977|B2|Greece||Region of Enrollment||participants|Number|4|4.0||||||
3905930|NCT01474122|3729978|B1|Greece||Region of Enrollment||participants|Number|2|2.0||||||
3905931|NCT01474122|3729975|B4|Germany||Region of Enrollment||participants|Number|7|7.0||||||
3905932|NCT01474122|3729976|B3|Germany||Region of Enrollment||participants|Number|2|2.0||||||
3905933|NCT01474122|3729977|B2|Germany||Region of Enrollment||participants|Number|3|3.0||||||
3905934|NCT01474122|3729978|B1|Germany||Region of Enrollment||participants|Number|2|2.0||||||
3905935|NCT01474122|3729975|B4|Colombia||Region of Enrollment||participants|Number|14|14.0||||||
3905936|NCT01474122|3729976|B3|Colombia||Region of Enrollment||participants|Number|6|6.0||||||
3905937|NCT01474122|3729977|B2|Colombia||Region of Enrollment||participants|Number|5|5.0||||||
3905938|NCT01474122|3729978|B1|Colombia||Region of Enrollment||participants|Number|3|3.0||||||
3905939|NCT01474122|3729975|B4|China||Region of Enrollment||participants|Number|11|11.0||||||
3905940|NCT01474122|3729976|B3|China||Region of Enrollment||participants|Number|5|5.0||||||
3905941|NCT01474122|3729977|B2|China||Region of Enrollment||participants|Number|3|3.0||||||
3905942|NCT01474122|3729978|B1|China||Region of Enrollment||participants|Number|3|3.0||||||
3905943|NCT01474122|3729975|B4|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
3905944|NCT01474122|3729976|B3|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
3905945|NCT01474122|3729977|B2|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
3905946|NCT01474122|3729978|B1|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
3905947|NCT01474122|3729975|B4|Argentina||Region of Enrollment||participants|Number|18|18.0||||||
3905948|NCT01474122|3729976|B3|Argentina||Region of Enrollment||participants|Number|3|3.0||||||
3905949|NCT01474122|3729977|B2|Argentina||Region of Enrollment||participants|Number|3|3.0||||||
3905950|NCT01474122|3729978|B1|Argentina||Region of Enrollment||participants|Number|12|12.0||||||
3905951|NCT01474122|3729975|B4|Other||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3905952|NCT01474122|3729976|B3|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3905953|NCT01474122|3729977|B2|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3905954|NCT01474122|3729978|B1|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3905955|NCT01474122|3729975|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3905956|NCT01474122|3729976|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3905957|NCT01474122|3729977|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3905958|NCT01474122|3729978|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3905959|NCT01474122|3729975|B4|Asian||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3905960|NCT01474122|3729976|B3|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3905961|NCT01474122|3729977|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3905962|NCT01474122|3729978|B1|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3905963|NCT01474122|3729975|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3905964|NCT01474122|3729976|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3905965|NCT01474122|3729977|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3905966|NCT01474122|3729978|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3905967|NCT01474122|3729975|B4|White||Race/Ethnicity, Customized||participants|Number|193|193.0||||||
3905968|NCT01474122|3729976|B3|White||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
3905969|NCT01474122|3729977|B2|White||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
3905970|NCT01474122|3729978|B1|White||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
3905971|NCT01474122|3729975|B4||Male|Gender||Participants|Count of Participants|48|48.0||||||
3905972|NCT01474122|3729976|B3||Male|Gender||Participants|Count of Participants|18|18.0||||||
3905973|NCT01474122|3729977|B2||Male|Gender||Participants|Count of Participants|17|17.0||||||
3905974|NCT01474122|3729978|B1||Male|Gender||Participants|Count of Participants|13|13.0||||||
3905975|NCT01474122|3729975|B4||Female|Gender||Participants|Count of Participants|217|217.0||||||
3905976|NCT01474122|3729976|B3||Female|Gender||Participants|Count of Participants|71|71.0||||||
3905977|NCT01474122|3729977|B2||Female|Gender||Participants|Count of Participants|71|71.0||||||
3905978|NCT01474122|3729978|B1||Female|Gender||Participants|Count of Participants|75|75.0||||||
3905979|NCT01474122|3729975|B4|||Age||years|Mean|49.6|49.6|Standard Deviation|13.06|13.06|||
3905980|NCT01474122|3729976|B3|||Age||years|Mean|50.6|50.6|Standard Deviation|12.88|12.88|||
3905981|NCT01474122|3729977|B2|||Age||years|Mean|47.4|47.4|Standard Deviation|13.02|13.02|||
3905982|NCT01474122|3729978|B1|||Age||years|Mean|50.6|50.6|Standard Deviation|13.20|13.2|||
3905983|NCT01474122|3729975|B4||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
3905984|NCT01474122|3729976|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3905985|NCT01474122|3729977|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3905986|NCT01474122|3729978|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3905987|NCT01474122|3729975|B4||Between 18 and 65 years|Age||Participants|Count of Participants|234|234.0||||||
3905988|NCT01474122|3729976|B3||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
3905989|NCT01474122|3729977|B2||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
3905990|NCT01474122|3729978|B1||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
3905991|NCT01474122|3729975|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3905992|NCT01474122|3729976|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3905993|NCT01474122|3729977|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3905994|NCT01474122|3729978|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3905995|NCT01474109|3730003|B4|United States||Region of Enrollment||participants|Number|37|37.0||||||
3905996|NCT01474109|3730004|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
3905997|NCT01474109|3730005|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3905998|NCT01474109|3730006|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3905999|NCT01474109|3730003|B4|Ukraine||Region of Enrollment||participants|Number|22|22.0||||||
3906000|NCT01474109|3730004|B3|Ukraine||Region of Enrollment||participants|Number|7|7.0||||||
3906001|NCT01474109|3730005|B2|Ukraine||Region of Enrollment||participants|Number|5|5.0||||||
3906002|NCT01474109|3730006|B1|Ukraine||Region of Enrollment||participants|Number|10|10.0||||||
3906003|NCT01474109|3730003|B4|Russian Federation||Region of Enrollment||participants|Number|21|21.0||||||
3906004|NCT01474109|3730004|B3|Russian Federation||Region of Enrollment||participants|Number|8|8.0||||||
3906005|NCT01474109|3730005|B2|Russian Federation||Region of Enrollment||participants|Number|7|7.0||||||
3906006|NCT01474109|3730006|B1|Russian Federation||Region of Enrollment||participants|Number|6|6.0||||||
3906007|NCT01474109|3730003|B4|Poland||Region of Enrollment||participants|Number|11|11.0||||||
3906008|NCT01474109|3730004|B3|Poland||Region of Enrollment||participants|Number|3|3.0||||||
3906009|NCT01474109|3730005|B2|Poland||Region of Enrollment||participants|Number|3|3.0||||||
3906010|NCT01474109|3730006|B1|Poland||Region of Enrollment||participants|Number|5|5.0||||||
3906011|NCT01474109|3730003|B4|Italy||Region of Enrollment||participants|Number|8|8.0||||||
3906012|NCT01474109|3730004|B3|Italy||Region of Enrollment||participants|Number|2|2.0||||||
3906013|NCT01474109|3730005|B2|Italy||Region of Enrollment||participants|Number|3|3.0||||||
3906014|NCT01474109|3730006|B1|Italy||Region of Enrollment||participants|Number|3|3.0||||||
3906015|NCT01474109|3730003|B4|India||Region of Enrollment||participants|Number|13|13.0||||||
3906016|NCT01474109|3730004|B3|India||Region of Enrollment||participants|Number|4|4.0||||||
3906017|NCT01474109|3730005|B2|India||Region of Enrollment||participants|Number|5|5.0||||||
3906018|NCT01474109|3730006|B1|India||Region of Enrollment||participants|Number|4|4.0||||||
3906019|NCT01474109|3730003|B4|Hungary||Region of Enrollment||participants|Number|14|14.0||||||
3906020|NCT01474109|3730004|B3|Hungary||Region of Enrollment||participants|Number|3|3.0||||||
3906021|NCT01474109|3730005|B2|Hungary||Region of Enrollment||participants|Number|7|7.0||||||
3906022|NCT01474109|3730006|B1|Hungary||Region of Enrollment||participants|Number|4|4.0||||||
3906023|NCT01474109|3730003|B4|Germany||Region of Enrollment||participants|Number|27|27.0||||||
3906024|NCT01474109|3730004|B3|Germany||Region of Enrollment||participants|Number|11|11.0||||||
3906025|NCT01474109|3730005|B2|Germany||Region of Enrollment||participants|Number|7|7.0||||||
3906026|NCT01474109|3730006|B1|Germany||Region of Enrollment||participants|Number|9|9.0||||||
3906027|NCT01474109|3730003|B4|France||Region of Enrollment||participants|Number|1|1.0||||||
3906028|NCT01474109|3730004|B3|France||Region of Enrollment||participants|Number|1|1.0||||||
3906029|NCT01474109|3730005|B2|France||Region of Enrollment||participants|Number|0|0.0||||||
3906030|NCT01474109|3730006|B1|France||Region of Enrollment||participants|Number|0|0.0||||||
3906031|NCT01474109|3730003|B4|Czech Republic||Region of Enrollment||participants|Number|14|14.0||||||
3906032|NCT01474109|3730004|B3|Czech Republic||Region of Enrollment||participants|Number|5|5.0||||||
3906033|NCT01474109|3730005|B2|Czech Republic||Region of Enrollment||participants|Number|3|3.0||||||
3906034|NCT01474109|3730006|B1|Czech Republic||Region of Enrollment||participants|Number|6|6.0||||||
3906035|NCT01474109|3730003|B4|Croatia||Region of Enrollment||participants|Number|10|10.0||||||
3906036|NCT01474109|3730004|B3|Croatia||Region of Enrollment||participants|Number|6|6.0||||||
3906037|NCT01474109|3730005|B2|Croatia||Region of Enrollment||participants|Number|1|1.0||||||
3906038|NCT01474109|3730006|B1|Croatia||Region of Enrollment||participants|Number|3|3.0||||||
3906039|NCT01474109|3730003|B4|Colombia||Region of Enrollment||participants|Number|3|3.0||||||
3906040|NCT01474109|3730004|B3|Colombia||Region of Enrollment||participants|Number|1|1.0||||||
3906041|NCT01474109|3730005|B2|Colombia||Region of Enrollment||participants|Number|2|2.0||||||
3906042|NCT01474109|3730006|B1|Colombia||Region of Enrollment||participants|Number|0|0.0||||||
3906043|NCT01474109|3730003|B4|Chile||Region of Enrollment||participants|Number|17|17.0||||||
3906044|NCT01474109|3730004|B3|Chile||Region of Enrollment||participants|Number|4|4.0||||||
3906045|NCT01474109|3730005|B2|Chile||Region of Enrollment||participants|Number|7|7.0||||||
3906046|NCT01474109|3730006|B1|Chile||Region of Enrollment||participants|Number|6|6.0||||||
3906047|NCT01474109|3730003|B4|Canada||Region of Enrollment||participants|Number|6|6.0||||||
3906048|NCT01474109|3730004|B3|Canada||Region of Enrollment||participants|Number|2|2.0||||||
3906049|NCT01474109|3730005|B2|Canada||Region of Enrollment||participants|Number|3|3.0||||||
3906050|NCT01474109|3730006|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3906051|NCT01474109|3730003|B4|Bulgaria||Region of Enrollment||participants|Number|46|46.0||||||
3906052|NCT01474109|3730004|B3|Bulgaria||Region of Enrollment||participants|Number|17|17.0||||||
3906053|NCT01474109|3730005|B2|Bulgaria||Region of Enrollment||participants|Number|16|16.0||||||
3906054|NCT01474109|3730006|B1|Bulgaria||Region of Enrollment||participants|Number|13|13.0||||||
3906055|NCT01474109|3730003|B4|Belarus||Region of Enrollment||participants|Number|11|11.0||||||
3906056|NCT01474109|3730004|B3|Belarus||Region of Enrollment||participants|Number|5|5.0||||||
3906057|NCT01474109|3730005|B2|Belarus||Region of Enrollment||participants|Number|3|3.0||||||
3906058|NCT01474109|3730006|B1|Belarus||Region of Enrollment||participants|Number|3|3.0||||||
3906059|NCT01474109|3730003|B4|Australia||Region of Enrollment||participants|Number|28|28.0||||||
3906060|NCT01474109|3730004|B3|Australia||Region of Enrollment||participants|Number|9|9.0||||||
3906061|NCT01474109|3730005|B2|Australia||Region of Enrollment||participants|Number|9|9.0||||||
3906062|NCT01474109|3730006|B1|Australia||Region of Enrollment||participants|Number|10|10.0||||||
3906063|NCT01474109|3730003|B4|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3906064|NCT01474109|3730004|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3906065|NCT01474109|3730005|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3906066|NCT01474109|3730006|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3906067|NCT01474109|3730003|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3906068|NCT01474109|3730004|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3906069|NCT01474109|3730005|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3906070|NCT01474109|3730006|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3906071|NCT01474109|3730003|B4|Asian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3906072|NCT01474109|3730004|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3906073|NCT01474109|3730005|B2|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3906074|NCT01474109|3730006|B1|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3906075|NCT01474109|3730003|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3906076|NCT01474109|3730004|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3906077|NCT01474109|3730005|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3906078|NCT01474109|3730006|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3906079|NCT01474109|3730003|B4|White||Race/Ethnicity, Customized||participants|Number|256|256.0||||||
3906080|NCT01474109|3730004|B3|White||Race/Ethnicity, Customized||participants|Number|88|88.0||||||
3906081|NCT01474109|3730005|B2|White||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
3906082|NCT01474109|3730006|B1|White||Race/Ethnicity, Customized||participants|Number|86|86.0||||||
3906083|NCT01474109|3730003|B4||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3906084|NCT01474109|3730004|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3906085|NCT01474109|3730005|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3906086|NCT01474109|3730006|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3906087|NCT01474109|3730003|B4||Female|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
3906088|NCT01474109|3730004|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3906089|NCT01474109|3730005|B2||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3906090|NCT01474109|3730006|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3906091|NCT01474109|3730003|B4|||Age||years|Mean|51.2|51.2|Standard Deviation|12.58|12.58|||
3906092|NCT01474109|3730004|B3|||Age||years|Mean|50.6|50.6|Standard Deviation|12.12|12.12|||
3906093|NCT01474109|3730005|B2|||Age||years|Mean|51.6|51.6|Standard Deviation|11.10|11.1|||
3906094|NCT01474109|3730006|B1|||Age||years|Mean|51.4|51.4|Standard Deviation|14.44|14.44|||
3906095|NCT01474109|3730003|B4||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
3906096|NCT01474109|3730004|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3906097|NCT01474109|3730005|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3906098|NCT01474109|3730006|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3906099|NCT01474109|3730003|B4||Between 18 and 65 years|Age||Participants|Count of Participants|245|245.0||||||
3906100|NCT01474109|3730004|B3||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
3906101|NCT01474109|3730005|B2||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
3906102|NCT01474109|3730006|B1||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
3906103|NCT01474109|3730003|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3906104|NCT01474109|3730004|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3906105|NCT01474109|3730005|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3906106|NCT01474109|3730006|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3906107|NCT01473992|3730031|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3906108|NCT01473992|3730032|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3906109|NCT01473992|3730033|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3906110|NCT01473992|3730031|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3906111|NCT01473992|3730032|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3906112|NCT01473992|3730033|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3906113|NCT01473992|3730031|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3906114|NCT01473992|3730032|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3906115|NCT01473992|3730033|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3906116|NCT01473992|3730031|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3906117|NCT01473992|3730032|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3906118|NCT01473992|3730033|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3906119|NCT01473992|3730031|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3906120|NCT01473992|3730032|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3906121|NCT01473992|3730033|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3906122|NCT01473992|3730031|B3|||Age||years|Mean|51.9|51.9|Standard Deviation|15.0|15.0|||
3906123|NCT01473992|3730032|B2|||Age||years|Mean|57.2|57.2|Standard Deviation|15.7|15.7|||
3906124|NCT01473992|3730033|B1|||Age||years|Mean|46.5|46.5|Standard Deviation|14.2|14.2|||
3906125|NCT01473953|3730050|B6||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3906126|NCT01473953|3730051|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3906127|NCT01473953|3730052|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3906128|NCT01473953|3730053|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3906129|NCT01473953|3730054|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3906130|NCT01473953|3730055|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3906131|NCT01473953|3730050|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3906132|NCT01473953|3730051|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3906133|NCT01473953|3730052|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3906134|NCT01473953|3730053|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3906135|NCT01473953|3730054|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3906136|NCT01473953|3730055|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3906137|NCT01473953|3730050|B6|||Age||years|Mean|32.9|32.9|Standard Deviation|10.3|10.3|||
3906138|NCT01473953|3730051|B5|||Age||years|Mean|28.5|28.5|Standard Deviation|7.9|7.9|||
3906139|NCT01473953|3730052|B4|||Age||years|Mean|39.0|39.0|Standard Deviation|8.4|8.4|||
3906140|NCT01473953|3730053|B3|||Age||years|Mean|29.8|29.8|Standard Deviation|7.7|7.7|||
3906141|NCT01473953|3730054|B2|||Age||years|Mean|30.0|30.0|Standard Deviation|12.6|12.6|||
3906142|NCT01473953|3730055|B1|||Age||years|Mean|39.8|39.8|Standard Deviation|11.4|11.4|||
3906143|NCT01473836|3730101|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3906144|NCT01473836|3730101|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3906145|NCT01473836|3730101|B1|||Age||years|Mean|48.9|48.9|Standard Deviation|16.9|16.9|||
3906146|NCT01473758|3730110|B3|≥ 2||Historical Chronic Obstructive Pulmonary Disease (COPD) Exacerbations||participants|Number|25|25.0||||||
3906147|NCT01473758|3730111|B2|≥ 2||Historical Chronic Obstructive Pulmonary Disease (COPD) Exacerbations||participants|Number|15|15.0||||||
3906148|NCT01473758|3730112|B1|≥ 2||Historical Chronic Obstructive Pulmonary Disease (COPD) Exacerbations||participants|Number|10|10.0||||||
3906149|NCT01473758|3730110|B3|< 2||Historical Chronic Obstructive Pulmonary Disease (COPD) Exacerbations||participants|Number|56|56.0||||||
3906150|NCT01473758|3730111|B2|< 2||Historical Chronic Obstructive Pulmonary Disease (COPD) Exacerbations||participants|Number|28|28.0||||||
3906151|NCT01473758|3730112|B1|< 2||Historical Chronic Obstructive Pulmonary Disease (COPD) Exacerbations||participants|Number|28|28.0||||||
3906152|NCT01473758|3730110|B3|Yes||Chronic Bronchitis||participants|Number|50|50.0||||||
3906153|NCT01473758|3730111|B2|Yes||Chronic Bronchitis||participants|Number|26|26.0||||||
3906154|NCT01473758|3730112|B1|Yes||Chronic Bronchitis||participants|Number|24|24.0||||||
3906155|NCT01473758|3730110|B3|No||Chronic Bronchitis||participants|Number|31|31.0||||||
3906156|NCT01473758|3730111|B2|No||Chronic Bronchitis||participants|Number|17|17.0||||||
3906157|NCT01473758|3730112|B1|No||Chronic Bronchitis||participants|Number|14|14.0||||||
3906158|NCT01473758|3730110|B3|Missing||Weight Category by Body Mass Index (BMI)||participants|Number|1|1.0||||||
3906159|NCT01473758|3730111|B2|Missing||Weight Category by Body Mass Index (BMI)||participants|Number|1|1.0||||||
3906160|NCT01473758|3730112|B1|Missing||Weight Category by Body Mass Index (BMI)||participants|Number|0|0.0||||||
3906161|NCT01473758|3730110|B3|Obese||Weight Category by Body Mass Index (BMI)||participants|Number|18|18.0||||||
3906162|NCT01473758|3730111|B2|Obese||Weight Category by Body Mass Index (BMI)||participants|Number|9|9.0||||||
3906163|NCT01473758|3730112|B1|Obese||Weight Category by Body Mass Index (BMI)||participants|Number|9|9.0||||||
3906164|NCT01473758|3730110|B3|Overweight||Weight Category by Body Mass Index (BMI)||participants|Number|26|26.0||||||
3906165|NCT01473758|3730111|B2|Overweight||Weight Category by Body Mass Index (BMI)||participants|Number|15|15.0||||||
3906166|NCT01473758|3730112|B1|Overweight||Weight Category by Body Mass Index (BMI)||participants|Number|11|11.0||||||
3906167|NCT01473758|3730110|B3|Normal Weight||Weight Category by Body Mass Index (BMI)||participants|Number|33|33.0||||||
3906168|NCT01473758|3730111|B2|Normal Weight||Weight Category by Body Mass Index (BMI)||participants|Number|18|18.0||||||
3906169|NCT01473758|3730112|B1|Normal Weight||Weight Category by Body Mass Index (BMI)||participants|Number|15|15.0||||||
3906170|NCT01473758|3730110|B3|Underweight||Weight Category by Body Mass Index (BMI)||participants|Number|3|3.0||||||
3906171|NCT01473758|3730111|B2|Underweight||Weight Category by Body Mass Index (BMI)||participants|Number|0|0.0||||||
3906172|NCT01473758|3730112|B1|Underweight||Weight Category by Body Mass Index (BMI)||participants|Number|3|3.0||||||
3906173|NCT01473758|3730110|B3|Missing||Baseline COPD Assessment Test (CAT) Total Score|The CAT is a short, validated, patient-completed questionnaire to assess the impact of COPD on health status. It comprises 8 questions that cover a broad range of effects of COPD on patients’ health. Each question is scored in a range between 0 and 5, with the higher end indicating a higher impact of COPD on the patient’s wellbeing. The CAT Total score ranges from 0 best) to 40 (Worst).|participants|Number|35|35.0||||||
3906174|NCT01473758|3730111|B2|Missing||Baseline COPD Assessment Test (CAT) Total Score|The CAT is a short, validated, patient-completed questionnaire to assess the impact of COPD on health status. It comprises 8 questions that cover a broad range of effects of COPD on patients’ health. Each question is scored in a range between 0 and 5, with the higher end indicating a higher impact of COPD on the patient’s wellbeing. The CAT Total score ranges from 0 best) to 40 (Worst).|participants|Number|15|15.0||||||
3906175|NCT01473758|3730112|B1|Missing||Baseline COPD Assessment Test (CAT) Total Score|The CAT is a short, validated, patient-completed questionnaire to assess the impact of COPD on health status. It comprises 8 questions that cover a broad range of effects of COPD on patients’ health. Each question is scored in a range between 0 and 5, with the higher end indicating a higher impact of COPD on the patient’s wellbeing. The CAT Total score ranges from 0 best) to 40 (Worst).|participants|Number|20|20.0||||||
3906176|NCT01473758|3730110|B3|≥ 10||Baseline COPD Assessment Test (CAT) Total Score|The CAT is a short, validated, patient-completed questionnaire to assess the impact of COPD on health status. It comprises 8 questions that cover a broad range of effects of COPD on patients’ health. Each question is scored in a range between 0 and 5, with the higher end indicating a higher impact of COPD on the patient’s wellbeing. The CAT Total score ranges from 0 best) to 40 (Worst).|participants|Number|41|41.0||||||
3906177|NCT01473758|3730111|B2|≥ 10||Baseline COPD Assessment Test (CAT) Total Score|The CAT is a short, validated, patient-completed questionnaire to assess the impact of COPD on health status. It comprises 8 questions that cover a broad range of effects of COPD on patients’ health. Each question is scored in a range between 0 and 5, with the higher end indicating a higher impact of COPD on the patient’s wellbeing. The CAT Total score ranges from 0 best) to 40 (Worst).|participants|Number|25|25.0||||||
3906178|NCT01473758|3730112|B1|≥ 10||Baseline COPD Assessment Test (CAT) Total Score|The CAT is a short, validated, patient-completed questionnaire to assess the impact of COPD on health status. It comprises 8 questions that cover a broad range of effects of COPD on patients’ health. Each question is scored in a range between 0 and 5, with the higher end indicating a higher impact of COPD on the patient’s wellbeing. The CAT Total score ranges from 0 best) to 40 (Worst).|participants|Number|16|16.0||||||
3906179|NCT01473758|3730110|B3|< 10||Baseline COPD Assessment Test (CAT) Total Score|The CAT is a short, validated, patient-completed questionnaire to assess the impact of COPD on health status. It comprises 8 questions that cover a broad range of effects of COPD on patients’ health. Each question is scored in a range between 0 and 5, with the higher end indicating a higher impact of COPD on the patient’s wellbeing. The CAT Total score ranges from 0 best) to 40 (Worst).|participants|Number|5|5.0||||||
3906180|NCT01473758|3730111|B2|< 10||Baseline COPD Assessment Test (CAT) Total Score|The CAT is a short, validated, patient-completed questionnaire to assess the impact of COPD on health status. It comprises 8 questions that cover a broad range of effects of COPD on patients’ health. Each question is scored in a range between 0 and 5, with the higher end indicating a higher impact of COPD on the patient’s wellbeing. The CAT Total score ranges from 0 best) to 40 (Worst).|participants|Number|3|3.0||||||
3906181|NCT01473758|3730112|B1|< 10||Baseline COPD Assessment Test (CAT) Total Score|The CAT is a short, validated, patient-completed questionnaire to assess the impact of COPD on health status. It comprises 8 questions that cover a broad range of effects of COPD on patients’ health. Each question is scored in a range between 0 and 5, with the higher end indicating a higher impact of COPD on the patient’s wellbeing. The CAT Total score ranges from 0 best) to 40 (Worst).|participants|Number|2|2.0||||||
3906182|NCT01473758|3730110|B3|Former smoker||Smoking status||participants|Number|62|62.0||||||
3906183|NCT01473758|3730111|B2|Former smoker||Smoking status||participants|Number|32|32.0||||||
3906184|NCT01473758|3730112|B1|Former smoker||Smoking status||participants|Number|30|30.0||||||
3906185|NCT01473758|3730110|B3|Current smoker||Smoking status||participants|Number|19|19.0||||||
3906186|NCT01473758|3730111|B2|Current smoker||Smoking status||participants|Number|11|11.0||||||
3906187|NCT01473758|3730112|B1|Current smoker||Smoking status||participants|Number|8|8.0||||||
3906188|NCT01473758|3730110|B3|Non-smoker||Smoking status||participants|Number|0|0.0||||||
3906189|NCT01473758|3730111|B2|Non-smoker||Smoking status||participants|Number|0|0.0||||||
3906190|NCT01473758|3730112|B1|Non-smoker||Smoking status||participants|Number|0|0.0||||||
3906191|NCT01473758|3730110|B3|White||Race/Ethnicity, Customized||participants|Number|78|78.0||||||
3906192|NCT01473758|3730111|B2|White||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
3906193|NCT01473758|3730112|B1|White||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3906194|NCT01473758|3730110|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3906195|NCT01473758|3730111|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3906196|NCT01473758|3730112|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3906197|NCT01473758|3730110|B3||Male|Gender||Participants|Count of Participants|50|50.0||||||
3906198|NCT01473758|3730111|B2||Male|Gender||Participants|Count of Participants|28|28.0||||||
3906199|NCT01473758|3730112|B1||Male|Gender||Participants|Count of Participants|22|22.0||||||
3906200|NCT01473758|3730110|B3||Female|Gender||Participants|Count of Participants|31|31.0||||||
3906201|NCT01473758|3730111|B2||Female|Gender||Participants|Count of Participants|15|15.0||||||
3906202|NCT01473758|3730112|B1||Female|Gender||Participants|Count of Participants|16|16.0||||||
3906203|NCT01473758|3730110|B3|> 65 years||Age, Customized||participants|Number|63|63.0||||||
3906204|NCT01473758|3730111|B2|> 65 years||Age, Customized||participants|Number|32|32.0||||||
3906205|NCT01473758|3730112|B1|> 65 years||Age, Customized||participants|Number|31|31.0||||||
3906206|NCT01473758|3730110|B3|≤ 65 years||Age, Customized||participants|Number|18|18.0||||||
3906207|NCT01473758|3730111|B2|≤ 65 years||Age, Customized||participants|Number|11|11.0||||||
3906208|NCT01473758|3730112|B1|≤ 65 years||Age, Customized||participants|Number|7|7.0||||||
3906209|NCT01473745|3730237|B3|Taiwan||Region of Enrollment||participants|Number|48|48.0||||||
3906210|NCT01473745|3730238|B2|Taiwan||Region of Enrollment||participants|Number|24|24.0||||||
3906211|NCT01473745|3730239|B1|Taiwan||Region of Enrollment||participants|Number|24|24.0||||||
3906212|NCT01473745|3730237|B3|Taiwanese||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
3906213|NCT01473745|3730238|B2|Taiwanese||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3906214|NCT01473745|3730239|B1|Taiwanese||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3906215|NCT01473745|3730237|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3906216|NCT01473745|3730238|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3906217|NCT01473745|3730239|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3906218|NCT01473745|3730237|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3906219|NCT01473745|3730238|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3906220|NCT01473745|3730239|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3906221|NCT01473745|3730237|B3|Age||Age, Customized||years|Mean|23.92|23.92|Full Range|||18.0|57.0|
3906222|NCT01473745|3730238|B2|Age||Age, Customized||years|Mean|23.78|23.78|Full Range|||18.0|34.0|
3906223|NCT01473745|3730239|B1|Age||Age, Customized||years|Mean|24.13|24.13|Full Range|||19.0|57.0|
3906224|NCT01473732|3730250|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906225|NCT01473732|3730252|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906226|NCT01473732|3730250|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3906227|NCT01473732|3730252|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3906228|NCT01473732|3730250|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906229|NCT01473732|3730252|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906230|NCT01473732|3730250|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3906231|NCT01473732|3730252|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3906232|NCT01473732|3730250|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906233|NCT01473732|3730252|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906234|NCT01473732|3730250|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906235|NCT01473732|3730252|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906236|NCT01473732|3730250|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906237|NCT01473732|3730252|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906238|NCT01473732|3730250|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3906239|NCT01473732|3730252|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3906240|NCT01473732|3730250|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3906241|NCT01473732|3730252|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3906242|NCT01473732|3730250|B3|||Age||years|Mean|63|63.0|Standard Deviation|2|2.0|||
3906243|NCT01473732|3730252|B1|||Age||years|Mean|63|63.0|Standard Deviation|2|2.0|||
3906244|NCT01473602|3730259|B3|Sliding Hip Screws||Surgical screw type|Surgical screws used in initial surgery to repair femur neck hip fracture.|participants|Number|2|2.0||||||
3906245|NCT01473602|3730260|B2|Sliding Hip Screws||Surgical screw type|Surgical screws used in initial surgery to repair femur neck hip fracture.|participants|Number|2|2.0||||||
3906246|NCT01473602|3730261|B1|Sliding Hip Screws||Surgical screw type|Surgical screws used in initial surgery to repair femur neck hip fracture.|participants|Number|0|0.0||||||
3906247|NCT01473602|3730259|B3|Cancellous Screws||Surgical screw type|Surgical screws used in initial surgery to repair femur neck hip fracture.|participants|Number|36|36.0||||||
3906248|NCT01473602|3730260|B2|Cancellous Screws||Surgical screw type|Surgical screws used in initial surgery to repair femur neck hip fracture.|participants|Number|18|18.0||||||
3906249|NCT01473602|3730261|B1|Cancellous Screws||Surgical screw type|Surgical screws used in initial surgery to repair femur neck hip fracture.|participants|Number|18|18.0||||||
3906250|NCT01473602|3730259|B3|Korea, Republic of||Region of Enrollment||participants|Number|9|9.0||||||
3906251|NCT01473602|3730260|B2|Korea, Republic of||Region of Enrollment||participants|Number|5|5.0||||||
3906252|NCT01473602|3730261|B1|Korea, Republic of||Region of Enrollment||participants|Number|4|4.0||||||
3906253|NCT01473602|3730259|B3|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
3906254|NCT01473602|3730260|B2|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
3906255|NCT01473602|3730261|B1|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
3906256|NCT01473602|3730259|B3|Romania||Region of Enrollment||participants|Number|5|5.0||||||
3906257|NCT01473602|3730260|B2|Romania||Region of Enrollment||participants|Number|3|3.0||||||
3906258|NCT01473602|3730261|B1|Romania||Region of Enrollment||participants|Number|2|2.0||||||
3906259|NCT01473602|3730259|B3|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
3906260|NCT01473602|3730260|B2|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
3906261|NCT01473602|3730261|B1|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
3906262|NCT01473602|3730259|B3|Hungary||Region of Enrollment||participants|Number|14|14.0||||||
3906263|NCT01473602|3730260|B2|Hungary||Region of Enrollment||participants|Number|8|8.0||||||
3906264|NCT01473602|3730261|B1|Hungary||Region of Enrollment||participants|Number|6|6.0||||||
3906265|NCT01473602|3730259|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3906266|NCT01473602|3730260|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3906267|NCT01473602|3730261|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3906268|NCT01473602|3730259|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906269|NCT01473602|3730260|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906270|NCT01473602|3730261|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906271|NCT01473602|3730259|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906272|NCT01473602|3730260|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906273|NCT01473602|3730261|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906274|NCT01473602|3730259|B3||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3906275|NCT01473602|3730260|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3906276|NCT01473602|3730261|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3906277|NCT01473602|3730259|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906278|NCT01473602|3730260|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906279|NCT01473602|3730261|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906280|NCT01473602|3730259|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906281|NCT01473602|3730260|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906282|NCT01473602|3730261|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906283|NCT01473602|3730259|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3906284|NCT01473602|3730260|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3906285|NCT01473602|3730261|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3906286|NCT01473602|3730259|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906287|NCT01473602|3730260|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906288|NCT01473602|3730261|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906289|NCT01473602|3730259|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3906290|NCT01473602|3730260|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3906291|NCT01473602|3730261|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3906292|NCT01473602|3730259|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3906293|NCT01473602|3730260|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3906294|NCT01473602|3730261|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3906295|NCT01473602|3730259|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3906296|NCT01473602|3730260|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3906297|NCT01473602|3730261|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3906298|NCT01473602|3730259|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3906299|NCT01473602|3730260|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3906300|NCT01473602|3730261|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3906301|NCT01473602|3730259|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3906302|NCT01473602|3730260|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3906303|NCT01473602|3730261|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3906304|NCT01473602|3730259|B3|||Age||years|Mean|71.57|71.57|Standard Deviation|10.351|10.351|||
3906305|NCT01473602|3730260|B2|||Age||years|Mean|69.93|69.93|Standard Deviation|10.417|10.417|||
3906306|NCT01473602|3730261|B1|||Age||years|Mean|73.39|73.39|Standard Deviation|10.259|10.259|||
3906307|NCT01473589|3730296|B3|Sliding Hip Screws||Surgical screw type|Surgical screws used in initial surgery to repair femur neck hip fracture.|participants|Number|14|14.0||||||
3906308|NCT01473589|3730297|B2|Sliding Hip Screws||Surgical screw type|Surgical screws used in initial surgery to repair femur neck hip fracture.|participants|Number|8|8.0||||||
3906309|NCT01473589|3730298|B1|Sliding Hip Screws||Surgical screw type|Surgical screws used in initial surgery to repair femur neck hip fracture.|participants|Number|6|6.0||||||
3906310|NCT01473589|3730296|B3|Cancellous Screws||Surgical screw type|Surgical screws used in initial surgery to repair femur neck hip fracture.|participants|Number|107|107.0||||||
3906311|NCT01473589|3730297|B2|Cancellous Screws||Surgical screw type|Surgical screws used in initial surgery to repair femur neck hip fracture.|participants|Number|53|53.0||||||
3906312|NCT01473589|3730298|B1|Cancellous Screws||Surgical screw type|Surgical screws used in initial surgery to repair femur neck hip fracture.|participants|Number|54|54.0||||||
3906313|NCT01473589|3730296|B3|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
3906314|NCT01473589|3730297|B2|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
3906315|NCT01473589|3730298|B1|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
3906316|NCT01473589|3730296|B3|Korea, Republic of||Region of Enrollment||participants|Number|18|18.0||||||
3906317|NCT01473589|3730297|B2|Korea, Republic of||Region of Enrollment||participants|Number|9|9.0||||||
3906318|NCT01473589|3730298|B1|Korea, Republic of||Region of Enrollment||participants|Number|9|9.0||||||
3906319|NCT01473589|3730296|B3|New Zealand||Region of Enrollment||participants|Number|11|11.0||||||
3906320|NCT01473589|3730297|B2|New Zealand||Region of Enrollment||participants|Number|6|6.0||||||
3906321|NCT01473589|3730298|B1|New Zealand||Region of Enrollment||participants|Number|5|5.0||||||
3906322|NCT01473589|3730296|B3|Japan||Region of Enrollment||participants|Number|29|29.0||||||
3906323|NCT01473589|3730297|B2|Japan||Region of Enrollment||participants|Number|15|15.0||||||
3906324|NCT01473589|3730298|B1|Japan||Region of Enrollment||participants|Number|14|14.0||||||
3906325|NCT01473589|3730296|B3|Latvia||Region of Enrollment||participants|Number|5|5.0||||||
3906326|NCT01473589|3730297|B2|Latvia||Region of Enrollment||participants|Number|3|3.0||||||
3906327|NCT01473589|3730298|B1|Latvia||Region of Enrollment||participants|Number|2|2.0||||||
3906328|NCT01473589|3730296|B3|Australia||Region of Enrollment||participants|Number|1|1.0||||||
3906329|NCT01473589|3730297|B2|Australia||Region of Enrollment||participants|Number|0|0.0||||||
3906330|NCT01473589|3730298|B1|Australia||Region of Enrollment||participants|Number|1|1.0||||||
3906331|NCT01473589|3730296|B3|Denmark||Region of Enrollment||participants|Number|2|2.0||||||
3906332|NCT01473589|3730297|B2|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
3906333|NCT01473589|3730298|B1|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
3906334|NCT01473589|3730296|B3|Canada||Region of Enrollment||participants|Number|4|4.0||||||
3906335|NCT01473589|3730297|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3906336|NCT01473589|3730298|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
3906337|NCT01473589|3730296|B3|India||Region of Enrollment||participants|Number|3|3.0||||||
3906338|NCT01473589|3730297|B2|India||Region of Enrollment||participants|Number|1|1.0||||||
3906339|NCT01473589|3730298|B1|India||Region of Enrollment||participants|Number|2|2.0||||||
3906340|NCT01473589|3730296|B3|Israel||Region of Enrollment||participants|Number|7|7.0||||||
3906341|NCT01473589|3730297|B2|Israel||Region of Enrollment||participants|Number|4|4.0||||||
3906342|NCT01473589|3730298|B1|Israel||Region of Enrollment||participants|Number|3|3.0||||||
3906343|NCT01473589|3730296|B3|Lithuania||Region of Enrollment||participants|Number|4|4.0||||||
3906344|NCT01473589|3730297|B2|Lithuania||Region of Enrollment||participants|Number|2|2.0||||||
3906345|NCT01473589|3730298|B1|Lithuania||Region of Enrollment||participants|Number|2|2.0||||||
3906346|NCT01473589|3730296|B3|Taiwan||Region of Enrollment||participants|Number|19|19.0||||||
3906347|NCT01473589|3730297|B2|Taiwan||Region of Enrollment||participants|Number|9|9.0||||||
3906348|NCT01473589|3730298|B1|Taiwan||Region of Enrollment||participants|Number|10|10.0||||||
3906349|NCT01473589|3730296|B3|Spain||Region of Enrollment||participants|Number|15|15.0||||||
3906350|NCT01473589|3730297|B2|Spain||Region of Enrollment||participants|Number|8|8.0||||||
3906351|NCT01473589|3730298|B1|Spain||Region of Enrollment||participants|Number|7|7.0||||||
3906352|NCT01473589|3730296|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3906353|NCT01473589|3730297|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3906354|NCT01473589|3730298|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3906355|NCT01473589|3730296|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906356|NCT01473589|3730297|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906357|NCT01473589|3730298|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906358|NCT01473589|3730296|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906359|NCT01473589|3730297|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906360|NCT01473589|3730298|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906361|NCT01473589|3730296|B3||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3906362|NCT01473589|3730297|B2||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3906363|NCT01473589|3730298|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3906364|NCT01473589|3730296|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906365|NCT01473589|3730297|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906366|NCT01473589|3730298|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906367|NCT01473589|3730296|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906368|NCT01473589|3730297|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906369|NCT01473589|3730298|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906370|NCT01473589|3730296|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3906371|NCT01473589|3730297|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3906372|NCT01473589|3730298|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3906373|NCT01473589|3730296|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906374|NCT01473589|3730297|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906375|NCT01473589|3730298|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906376|NCT01473589|3730296|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3906377|NCT01473589|3730297|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3906378|NCT01473589|3730298|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3906379|NCT01473589|3730296|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3906380|NCT01473589|3730297|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3906381|NCT01473589|3730298|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3906382|NCT01473589|3730296|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3906383|NCT01473589|3730297|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3906384|NCT01473589|3730298|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906385|NCT01473589|3730296|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3906386|NCT01473589|3730297|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3906387|NCT01473589|3730298|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3906388|NCT01473589|3730296|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3906389|NCT01473589|3730297|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3906390|NCT01473589|3730298|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3906391|NCT01473589|3730296|B3|||Age||years|Mean|69.73|69.73|Standard Deviation|11.698|11.698|||
3906392|NCT01473589|3730297|B2|||Age||years|Mean|70.96|70.96|Standard Deviation|12.023|12.023|||
3906393|NCT01473589|3730298|B1|||Age||years|Mean|68.49|68.49|Standard Deviation|11.321|11.321|||
3906394|NCT01473563|3730333|B1|Progressive Disease (PD)||Best Response to Prior Systemic Therapy|Best response to prior systemic therapy was defined using Response Evaluation Criteria In Solid Tumors [RECIST, version (v) 1.1] criteria. PR was having at least a 30% decrease in sum of longest diameter of target lesions; PD was having at least 20% increase in sum of longest diameter of target lesions and minimum 5 mm increase above nadir; SD was small changes that did not meet above criteria. Participant with PD (borderline tumor increase) was considered a protocol violation.|participants|Number|1|1.0||||||
3906395|NCT01473563|3730333|B1|Stable Disease (SD)||Best Response to Prior Systemic Therapy|Best response to prior systemic therapy was defined using Response Evaluation Criteria In Solid Tumors [RECIST, version (v) 1.1] criteria. PR was having at least a 30% decrease in sum of longest diameter of target lesions; PD was having at least 20% increase in sum of longest diameter of target lesions and minimum 5 mm increase above nadir; SD was small changes that did not meet above criteria. Participant with PD (borderline tumor increase) was considered a protocol violation.|participants|Number|26|26.0||||||
3906396|NCT01473563|3730333|B1|Partial Response (PR)||Best Response to Prior Systemic Therapy|Best response to prior systemic therapy was defined using Response Evaluation Criteria In Solid Tumors [RECIST, version (v) 1.1] criteria. PR was having at least a 30% decrease in sum of longest diameter of target lesions; PD was having at least 20% increase in sum of longest diameter of target lesions and minimum 5 mm increase above nadir; SD was small changes that did not meet above criteria. Participant with PD (borderline tumor increase) was considered a protocol violation.|participants|Number|25|25.0||||||
3906397|NCT01473563|3730333|B1|Platinum-Based Therapy + Pemetrexed||Prior Systemic Therapy|Prior systemic therapies include carboplatin and gemcitabine; carboplatin and pemetrexed; cisplatin and pemetrexed; platinum-based therapy and pemetrexed. Participants pre-exposed to cisplatin and carboplatin were considered to have platinum-based therapy.|participants|Number|4|4.0||||||
3906398|NCT01473563|3730333|B1|Cisplatin + Pemetrexed||Prior Systemic Therapy|Prior systemic therapies include carboplatin and gemcitabine; carboplatin and pemetrexed; cisplatin and pemetrexed; platinum-based therapy and pemetrexed. Participants pre-exposed to cisplatin and carboplatin were considered to have platinum-based therapy.|participants|Number|20|20.0||||||
3906399|NCT01473563|3730333|B1|Carboplatin + Pemetrexed||Prior Systemic Therapy|Prior systemic therapies include carboplatin and gemcitabine; carboplatin and pemetrexed; cisplatin and pemetrexed; platinum-based therapy and pemetrexed. Participants pre-exposed to cisplatin and carboplatin were considered to have platinum-based therapy.|participants|Number|19|19.0||||||
3906400|NCT01473563|3730333|B1|Carboplatin + Gemcitabine||Prior Systemic Therapy|Prior systemic therapies include carboplatin and gemcitabine; carboplatin and pemetrexed; cisplatin and pemetrexed; platinum-based therapy and pemetrexed. Participants pre-exposed to cisplatin and carboplatin were considered to have platinum-based therapy.|participants|Number|9|9.0||||||
3906401|NCT01473563|3730333|B1|Stage IIIA||Stage of Disease|Disease stage described using American Joint Committee on Cancer (AJCC). Stages ranged from I (cancer was small and had not spread to the lymph nodes) to IV (cancer spread throughout the body). Stage III (cancer had spread to nearby tissue or lymph nodes) was further differentiated based on regional lymph nodes: Stage IIIA (spread to nearby lymph nodes) and Stage IIIB (spread to distance lymph nodes). The participant with Stage IIIA disease was enrolled in study because investigator considered participant not eligible for curative treatment.|participants|Number|1|1.0||||||
3906448|NCT01473524|3730353|B3|France||Region of Enrollment||participants|Number|1|1.0||||||
3906449|NCT01473524|3730354|B2|France||Region of Enrollment||participants|Number|0|0.0||||||
3906450|NCT01473524|3730355|B1|France||Region of Enrollment||participants|Number|0|0.0||||||
3906402|NCT01473563|3730333|B1|Stage IV||Stage of Disease|Disease stage described using American Joint Committee on Cancer (AJCC). Stages ranged from I (cancer was small and had not spread to the lymph nodes) to IV (cancer spread throughout the body). Stage III (cancer had spread to nearby tissue or lymph nodes) was further differentiated based on regional lymph nodes: Stage IIIA (spread to nearby lymph nodes) and Stage IIIB (spread to distance lymph nodes). The participant with Stage IIIA disease was enrolled in study because investigator considered participant not eligible for curative treatment.|participants|Number|48|48.0||||||
3906403|NCT01473563|3730333|B1|Stage IIIB||Stage of Disease|Disease stage described using American Joint Committee on Cancer (AJCC). Stages ranged from I (cancer was small and had not spread to the lymph nodes) to IV (cancer spread throughout the body). Stage III (cancer had spread to nearby tissue or lymph nodes) was further differentiated based on regional lymph nodes: Stage IIIA (spread to nearby lymph nodes) and Stage IIIB (spread to distance lymph nodes). The participant with Stage IIIA disease was enrolled in study because investigator considered participant not eligible for curative treatment.|participants|Number|3|3.0||||||
3906404|NCT01473563|3730333|B1|Histopathological||Basis for Most Recent Pathological Diagnosis||participants|Number|42|42.0||||||
3906405|NCT01473563|3730333|B1|Cytological||Basis for Most Recent Pathological Diagnosis||participants|Number|10|10.0||||||
3906406|NCT01473563|3730333|B1|Carcinoma, Non-Small Cell, Lung NOS||Most Recent Pathological Diagnosis||participants|Number|2|2.0||||||
3906407|NCT01473563|3730333|B1|Adenocarcinoma, Moderately Differentiated, Lung||Most Recent Pathological Diagnosis||participants|Number|1|1.0||||||
3906408|NCT01473563|3730333|B1|Adenocarcinoma, Mucinous, No Other Symptoms (NOS)||Most Recent Pathological Diagnosis||participants|Number|1|1.0||||||
3906409|NCT01473563|3730333|B1|Adenocarcinoma, Lung||Most Recent Pathological Diagnosis||participants|Number|48|48.0||||||
3906410|NCT01473563|3730333|B1|1: Restricted||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classified participants according to their functional impairment. Scores could have ranged from 0 (Fully Active) to 5 (Death).|participants|Number|38|38.0||||||
3906411|NCT01473563|3730333|B1|0: Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classified participants according to their functional impairment. Scores could have ranged from 0 (Fully Active) to 5 (Death).|participants|Number|14|14.0||||||
3906412|NCT01473563|3730333|B1|Sweden||Region of Enrollment||participants|Number|9|9.0||||||
3906413|NCT01473563|3730333|B1|United Kingdom||Region of Enrollment||participants|Number|43|43.0||||||
3906414|NCT01473563|3730333|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3906415|NCT01473563|3730333|B1|White||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
3906416|NCT01473563|3730333|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3906417|NCT01473563|3730333|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3906418|NCT01473563|3730333|B1|||Age||years|Median|66.0|66.0|Full Range|12.05|12.05|27.0|82.5|
3906419|NCT01473524|3730352|B4|||Gamma-Glutamyltransferase (GGT) (U/L)||U/L|Mean|274.79|274.79|Standard Deviation|302.673|302.673|||
3906420|NCT01473524|3730353|B3|||Gamma-Glutamyltransferase (GGT) (U/L)||U/L|Mean|309.58|309.58|Standard Deviation|449.356|449.356|||
3906421|NCT01473524|3730354|B2|||Gamma-Glutamyltransferase (GGT) (U/L)||U/L|Mean|261.07|261.07|Standard Deviation|207.396|207.396|||
3906422|NCT01473524|3730355|B1|||Gamma-Glutamyltransferase (GGT) (U/L)||U/L|Mean|252.83|252.83|Standard Deviation|167.038|167.038|||
3906423|NCT01473524|3730352|B4|||Aspartate Aminotransferase (AST) (U/L)||U/L|Mean|50.49|50.49|Standard Deviation|26.456|26.456|||
3906424|NCT01473524|3730353|B3|||Aspartate Aminotransferase (AST) (U/L)||U/L|Mean|48.79|48.79|Standard Deviation|22.449|22.449|||
3906425|NCT01473524|3730354|B2|||Aspartate Aminotransferase (AST) (U/L)||U/L|Mean|50.49|50.49|Standard Deviation|31.100|31.1|||
3906426|NCT01473524|3730355|B1|||Aspartate Aminotransferase (AST) (U/L)||U/L|Mean|52.25|52.25|Standard Deviation|25.289|25.289|||
3906427|NCT01473524|3730352|B4|||Alanine Aminotransferase (ALT) (U/L)||U/L|Mean|57.9|57.9|Standard Deviation|36.498|36.498|||
3906428|NCT01473524|3730353|B3|||Alanine Aminotransferase (ALT) (U/L)||U/L|Mean|55.99|55.99|Standard Deviation|30.312|30.312|||
3906429|NCT01473524|3730354|B2|||Alanine Aminotransferase (ALT) (U/L)||U/L|Mean|56.31|56.31|Standard Deviation|39.741|39.741|||
3906430|NCT01473524|3730355|B1|||Alanine Aminotransferase (ALT) (U/L)||U/L|Mean|61.56|61.56|Standard Deviation|39.037|39.037|||
3906431|NCT01473524|3730352|B4|||Direct Bilirubin (umol/L)||umol/L|Mean|4.919|4.919|Standard Deviation|5.138|5.138|||
3906432|NCT01473524|3730353|B3|||Direct Bilirubin (umol/L)||umol/L|Mean|5.469|5.469|Standard Deviation|6.214|6.214|||
3906433|NCT01473524|3730354|B2|||Direct Bilirubin (umol/L)||umol/L|Mean|4.868|4.868|Standard Deviation|4.473|4.473|||
3906434|NCT01473524|3730355|B1|||Direct Bilirubin (umol/L)||umol/L|Mean|4.398|4.398|Standard Deviation|4.528|4.528|||
3906435|NCT01473524|3730352|B4|||Total Bilirubin (umol/L)||umol/L|Mean|11.088|11.088|Standard Deviation|6.522|6.522|||
3906436|NCT01473524|3730353|B3|||Total Bilirubin (umol/L)||umol/L|Mean|11.757|11.757|Standard Deviation|7.227|7.227|||
3906437|NCT01473524|3730354|B2|||Total Bilirubin (umol/L)||umol/L|Mean|11.278|11.278|Standard Deviation|6.634|6.634|||
3906438|NCT01473524|3730355|B1|||Total Bilirubin (umol/L)||umol/L|Mean|10.192|10.192|Standard Deviation|5.549|5.549|||
3906439|NCT01473524|3730352|B4|||Alkaline Phosphatase (U/L)||U/L|Mean|323.19|323.19|Standard Deviation|111.375|111.375|||
3906440|NCT01473524|3730353|B3|||Alkaline Phosphatase (U/L)||U/L|Mean|327.49|327.49|Standard Deviation|115.014|115.014|||
3906441|NCT01473524|3730354|B2|||Alkaline Phosphatase (U/L)||U/L|Mean|316.34|316.34|Standard Deviation|103.881|103.881|||
3906442|NCT01473524|3730355|B1|||Alkaline Phosphatase (U/L)||U/L|Mean|325.87|325.87|Standard Deviation|116.238|116.238|||
3906443|NCT01473524|3730352|B4|Germany||Region of Enrollment||participants|Number|28|28.0||||||
3906444|NCT01473524|3730353|B3|Germany||Region of Enrollment||participants|Number|9|9.0||||||
3906445|NCT01473524|3730354|B2|Germany||Region of Enrollment||participants|Number|11|11.0||||||
3906446|NCT01473524|3730355|B1|Germany||Region of Enrollment||participants|Number|8|8.0||||||
3906447|NCT01473524|3730352|B4|France||Region of Enrollment||participants|Number|1|1.0||||||
3906451|NCT01473524|3730352|B4|Australia||Region of Enrollment||participants|Number|9|9.0||||||
3906452|NCT01473524|3730353|B3|Australia||Region of Enrollment||participants|Number|3|3.0||||||
3906453|NCT01473524|3730354|B2|Australia||Region of Enrollment||participants|Number|1|1.0||||||
3906454|NCT01473524|3730355|B1|Australia||Region of Enrollment||participants|Number|5|5.0||||||
3906455|NCT01473524|3730352|B4|Italy||Region of Enrollment||participants|Number|32|32.0||||||
3906456|NCT01473524|3730353|B3|Italy||Region of Enrollment||participants|Number|11|11.0||||||
3906457|NCT01473524|3730354|B2|Italy||Region of Enrollment||participants|Number|10|10.0||||||
3906458|NCT01473524|3730355|B1|Italy||Region of Enrollment||participants|Number|11|11.0||||||
3906459|NCT01473524|3730352|B4|Poland||Region of Enrollment||participants|Number|14|14.0||||||
3906460|NCT01473524|3730353|B3|Poland||Region of Enrollment||participants|Number|4|4.0||||||
3906461|NCT01473524|3730354|B2|Poland||Region of Enrollment||participants|Number|6|6.0||||||
3906462|NCT01473524|3730355|B1|Poland||Region of Enrollment||participants|Number|4|4.0||||||
3906463|NCT01473524|3730352|B4|Belgium||Region of Enrollment||participants|Number|16|16.0||||||
3906464|NCT01473524|3730353|B3|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
3906465|NCT01473524|3730354|B2|Belgium||Region of Enrollment||participants|Number|9|9.0||||||
3906466|NCT01473524|3730355|B1|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
3906467|NCT01473524|3730352|B4|Sweden||Region of Enrollment||participants|Number|4|4.0||||||
3906468|NCT01473524|3730353|B3|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
3906469|NCT01473524|3730354|B2|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
3906470|NCT01473524|3730355|B1|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
3906471|NCT01473524|3730352|B4|Netherlands||Region of Enrollment||participants|Number|16|16.0||||||
3906472|NCT01473524|3730353|B3|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
3906473|NCT01473524|3730354|B2|Netherlands||Region of Enrollment||participants|Number|7|7.0||||||
3906474|NCT01473524|3730355|B1|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
3906475|NCT01473524|3730352|B4|Austria||Region of Enrollment||participants|Number|3|3.0||||||
3906476|NCT01473524|3730353|B3|Austria||Region of Enrollment||participants|Number|1|1.0||||||
3906477|NCT01473524|3730354|B2|Austria||Region of Enrollment||participants|Number|0|0.0||||||
3906478|NCT01473524|3730355|B1|Austria||Region of Enrollment||participants|Number|2|2.0||||||
3906479|NCT01473524|3730352|B4|Canada||Region of Enrollment||participants|Number|8|8.0||||||
3906480|NCT01473524|3730353|B3|Canada||Region of Enrollment||participants|Number|4|4.0||||||
3906481|NCT01473524|3730354|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
3906482|NCT01473524|3730355|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
3906483|NCT01473524|3730352|B4|Spain||Region of Enrollment||participants|Number|9|9.0||||||
3906484|NCT01473524|3730353|B3|Spain||Region of Enrollment||participants|Number|3|3.0||||||
3906485|NCT01473524|3730354|B2|Spain||Region of Enrollment||participants|Number|2|2.0||||||
3906486|NCT01473524|3730355|B1|Spain||Region of Enrollment||participants|Number|4|4.0||||||
3906487|NCT01473524|3730352|B4|United Kingdom||Region of Enrollment||participants|Number|22|22.0||||||
3906488|NCT01473524|3730353|B3|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
3906489|NCT01473524|3730354|B2|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
3906490|NCT01473524|3730355|B1|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3906491|NCT01473524|3730352|B4|United States||Region of Enrollment||participants|Number|54|54.0||||||
3906492|NCT01473524|3730353|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
3906493|NCT01473524|3730354|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3906494|NCT01473524|3730355|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3906495|NCT01473524|3730352|B4|White||Race/Ethnicity, Customized||participants|Number|203|203.0||||||
3906496|NCT01473524|3730353|B3|White||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
3906497|NCT01473524|3730354|B2|White||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
3906498|NCT01473524|3730355|B1|White||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
3906499|NCT01473524|3730352|B4|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3906500|NCT01473524|3730353|B3|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3906501|NCT01473524|3730354|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3906502|NCT01473524|3730355|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3906503|NCT01473524|3730352|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3906504|NCT01473524|3730353|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3906505|NCT01473524|3730354|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3906506|NCT01473524|3730355|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3906507|NCT01473524|3730352|B4|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3906508|NCT01473524|3730353|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3906509|NCT01473524|3730354|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3906510|NCT01473524|3730355|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3906511|NCT01473524|3730352|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3906512|NCT01473524|3730353|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3906513|NCT01473524|3730354|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3906514|NCT01473524|3730355|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3906515|NCT01473524|3730352|B4||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
3906516|NCT01473524|3730353|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3906517|NCT01473524|3730354|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3906518|NCT01473524|3730355|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3906519|NCT01473524|3730352|B4|||Age||years|Mean|55.8|55.8|Standard Deviation|10.48|10.48|||
3906520|NCT01473524|3730353|B3|||Age||years|Mean|55.5|55.5|Standard Deviation|10.03|10.03|||
3906521|NCT01473524|3730354|B2|||Age||years|Mean|56.2|56.2|Standard Deviation|11.00|11.0|||
3906522|NCT01473524|3730355|B1|||Age||years|Mean|55.8|55.8|Standard Deviation|10.53|10.53|||
3906523|NCT01473524|3730352|B4||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
3906524|NCT01473524|3730353|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3906525|NCT01473524|3730354|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3906526|NCT01473524|3730355|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3906527|NCT01473524|3730352|B4||Between 18 and 65 years|Age||Participants|Count of Participants|176|176.0||||||
3906528|NCT01473524|3730353|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3906529|NCT01473524|3730354|B2||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
3906530|NCT01473524|3730355|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3906531|NCT01473524|3730352|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3906532|NCT01473524|3730353|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3906533|NCT01473524|3730354|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3906534|NCT01473524|3730355|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3906535|NCT01473420|3730388|B3||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
3906536|NCT01473420|3730389|B2||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3906537|NCT01473420|3730390|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3906538|NCT01473420|3730388|B3||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3906539|NCT01473420|3730389|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3906540|NCT01473420|3730390|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3906541|NCT01473420|3730388|B3||>=65 years|Age||Participants|Count of Participants|94|94.0||||||
3906542|NCT01473420|3730389|B2||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
3906543|NCT01473420|3730390|B1||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
3906544|NCT01473420|3730388|B3||Between 18 and 65 years|Age||Participants|Count of Participants|226|226.0||||||
3906545|NCT01473420|3730389|B2||Between 18 and 65 years|Age||Participants|Count of Participants|117|117.0||||||
3906546|NCT01473420|3730390|B1||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
3906547|NCT01473420|3730388|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3906548|NCT01473420|3730389|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3906549|NCT01473420|3730390|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3906550|NCT01473407|3730473|B3||Male|Sex: Female, Male||Participants|Count of Participants|335|335.0||||||
3906551|NCT01473407|3730474|B2||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
3906552|NCT01473407|3730475|B1||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3906553|NCT01473407|3730473|B3||Female|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
3906554|NCT01473407|3730474|B2||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3906555|NCT01473407|3730475|B1||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3906556|NCT01473407|3730473|B3|||Age||years|Mean|56.34|56.34|Standard Deviation|12.307|12.307|||
3906557|NCT01473407|3730474|B2|||Age||years|Mean|57.35|57.35|Standard Deviation|11.440|11.44|||
3906558|NCT01473407|3730475|B1|||Age||years|Mean|55.32|55.32|Standard Deviation|13.057|13.057|||
3906559|NCT01473394|3730528|B3|||Body mass index||kg/m^2|Mean|28.75|28.75|Standard Deviation|5.49|5.49|||
3906560|NCT01473394|3730529|B2|||Body mass index||kg/m^2|Mean|28.41|28.41|Standard Deviation|5.47|5.47|||
3906561|NCT01473394|3730530|B1|||Body mass index||kg/m^2|Mean|29.08|29.08|Standard Deviation|5.50|5.5|||
3906562|NCT01473394|3730528|B3|||Height||cm|Mean|170.23|170.23|Standard Deviation|9.36|9.36|||
3906563|NCT01473394|3730529|B2|||Height||cm|Mean|170.32|170.32|Standard Deviation|9.60|9.6|||
3906564|NCT01473394|3730530|B1|||Height||cm|Mean|170.15|170.15|Standard Deviation|9.12|9.12|||
3906565|NCT01473394|3730528|B3|||Weight||kg|Mean|83.78|83.78|Standard Deviation|18.12|18.12|||
3906566|NCT01473394|3730529|B2|||Weight||kg|Mean|82.89|82.89|Standard Deviation|18.39|18.39|||
3906567|NCT01473394|3730530|B1|||Weight||kg|Mean|84.68|84.68|Standard Deviation|17.84|17.84|||
3906568|NCT01473394|3730528|B3|Other||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
3906569|NCT01473394|3730529|B2|Other||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3906570|NCT01473394|3730530|B1|Other||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3906571|NCT01473394|3730528|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3906572|NCT01473394|3730529|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3906573|NCT01473394|3730530|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3906574|NCT01473394|3730528|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3906575|NCT01473394|3730529|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3906636|NCT01473381|3730545|B1|||Height||cm|Median|167.60|167.6|Full Range|||144.8|198.1|
3906576|NCT01473394|3730530|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3906577|NCT01473394|3730528|B3|Asian||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
3906578|NCT01473394|3730529|B2|Asian||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3906579|NCT01473394|3730530|B1|Asian||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3906580|NCT01473394|3730528|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|122|122.0||||||
3906581|NCT01473394|3730529|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|52|52.0||||||
3906582|NCT01473394|3730530|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|70|70.0||||||
3906583|NCT01473394|3730528|B3|White||Race/Ethnicity, Customized||Participants|Number|342|342.0||||||
3906584|NCT01473394|3730529|B2|White||Race/Ethnicity, Customized||Participants|Number|174|174.0||||||
3906585|NCT01473394|3730530|B1|White||Race/Ethnicity, Customized||Participants|Number|168|168.0||||||
3906586|NCT01473394|3730528|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906587|NCT01473394|3730529|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906588|NCT01473394|3730530|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906589|NCT01473394|3730528|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|433|433.0||||||
3906590|NCT01473394|3730529|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|213|213.0||||||
3906591|NCT01473394|3730530|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|220|220.0||||||
3906592|NCT01473394|3730528|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3906593|NCT01473394|3730529|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3906594|NCT01473394|3730530|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3906595|NCT01473394|3730528|B3||Male|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
3906596|NCT01473394|3730529|B2||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3906597|NCT01473394|3730530|B1||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3906598|NCT01473394|3730528|B3||Female|Sex: Female, Male||Participants|Count of Participants|273|273.0||||||
3906599|NCT01473394|3730529|B2||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3906600|NCT01473394|3730530|B1||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3906601|NCT01473394|3730528|B3|≥ 60||Age, Customized||Participants|Number|43|43.0||||||
3906602|NCT01473394|3730529|B2|≥ 60||Age, Customized||Participants|Number|19|19.0||||||
3906603|NCT01473394|3730530|B1|≥ 60||Age, Customized||Participants|Number|24|24.0||||||
3906604|NCT01473394|3730528|B3|≥ 50-59||Age, Customized||Participants|Number|92|92.0||||||
3906605|NCT01473394|3730529|B2|≥ 50-59||Age, Customized||Participants|Number|44|44.0||||||
3906606|NCT01473394|3730530|B1|≥ 50-59||Age, Customized||Participants|Number|48|48.0||||||
3906607|NCT01473394|3730528|B3|≥ 40-49||Age, Customized||Participants|Number|129|129.0||||||
3906608|NCT01473394|3730529|B2|≥ 40-49||Age, Customized||Participants|Number|62|62.0||||||
3906609|NCT01473394|3730530|B1|≥ 40-49||Age, Customized||Participants|Number|67|67.0||||||
3906610|NCT01473394|3730528|B3|≥ 30-39||Age, Customized||Participants|Number|110|110.0||||||
3906611|NCT01473394|3730529|B2|≥ 30-39||Age, Customized||Participants|Number|56|56.0||||||
3906612|NCT01473394|3730530|B1|≥ 30-39||Age, Customized||Participants|Number|54|54.0||||||
3906613|NCT01473394|3730528|B3|≥ 20-29||Age, Customized||Participants|Number|121|121.0||||||
3906614|NCT01473394|3730529|B2|≥ 20-29||Age, Customized||Participants|Number|68|68.0||||||
3906615|NCT01473394|3730530|B1|≥ 20-29||Age, Customized||Participants|Number|53|53.0||||||
3906616|NCT01473394|3730528|B3|< 20||Age, Customized||Participants|Number|13|13.0||||||
3906617|NCT01473394|3730529|B2|< 20||Age, Customized||Participants|Number|6|6.0||||||
3906618|NCT01473394|3730530|B1|< 20||Age, Customized||Participants|Number|7|7.0||||||
3906619|NCT01473394|3730528|B3|||Age||Years|Mean|40.2|40.2|Standard Deviation|13.0|13.0|||
3906620|NCT01473394|3730529|B2|||Age||Years|Mean|39.3|39.3|Standard Deviation|12.8|12.8|||
3906621|NCT01473394|3730530|B1|||Age||Years|Mean|41.1|41.1|Standard Deviation|13.2|13.2|||
3906622|NCT01473381|3730541|B5|||Body Mass Index (BMI)||kilograms per meter squared|Median|28.10|28.1|Full Range|||18.0|40.0|
3906623|NCT01473381|3730542|B4|||Body Mass Index (BMI)||kilograms per meter squared|Median|27.90|27.9|Full Range|||18.0|39.9|
3906624|NCT01473381|3730543|B3|||Body Mass Index (BMI)||kilograms per meter squared|Median|27.80|27.8|Full Range|||18.3|40.0|
3906625|NCT01473381|3730544|B2|||Body Mass Index (BMI)||kilograms per meter squared|Median|28.20|28.2|Full Range|||18.4|39.6|
3906626|NCT01473381|3730545|B1|||Body Mass Index (BMI)||kilograms per meter squared|Median|28.30|28.3|Full Range|||18.5|40.0|
3906627|NCT01473381|3730541|B5|||Body Mass Index (BMI)||kilograms per meter squared|Mean|28.58|28.58|Standard Deviation|5.37|5.37|||
3906628|NCT01473381|3730542|B4|||Body Mass Index (BMI)||kilograms per meter squared|Mean|28.36|28.36|Standard Deviation|5.17|5.17|||
3906629|NCT01473381|3730543|B3|||Body Mass Index (BMI)||kilograms per meter squared|Mean|28.45|28.45|Standard Deviation|5.43|5.43|||
3906630|NCT01473381|3730544|B2|||Body Mass Index (BMI)||kilograms per meter squared|Mean|28.79|28.79|Standard Deviation|5.49|5.49|||
3906631|NCT01473381|3730545|B1|||Body Mass Index (BMI)||kilograms per meter squared|Mean|28.70|28.7|Standard Deviation|5.40|5.4|||
3906632|NCT01473381|3730541|B5|||Height||cm|Median|168.50|168.5|Full Range|||144.8|200.7|
3906633|NCT01473381|3730542|B4|||Height||cm|Median|169.00|169.0|Full Range|||144.8|200.7|
3906634|NCT01473381|3730543|B3|||Height||cm|Median|168.90|168.9|Full Range|||146.0|193.0|
3906635|NCT01473381|3730544|B2|||Height||cm|Median|167.60|167.6|Full Range|||147.3|195.6|
3906637|NCT01473381|3730541|B5|||Height||cm|Mean|169.39|169.39|Standard Deviation|9.60|9.6|||
3906638|NCT01473381|3730542|B4|||Height||cm|Mean|169.78|169.78|Standard Deviation|9.57|9.57|||
3906639|NCT01473381|3730543|B3|||Height||cm|Mean|169.87|169.87|Standard Deviation|9.71|9.71|||
3906640|NCT01473381|3730544|B2|||Height||cm|Mean|168.86|168.86|Standard Deviation|9.72|9.72|||
3906641|NCT01473381|3730545|B1|||Height||cm|Mean|169.03|169.03|Standard Deviation|9.38|9.38|||
3906642|NCT01473381|3730541|B5|||Weight||kg|Median|81.60|81.6|Full Range|||45.0|151.6|
3906643|NCT01473381|3730542|B4|||Weight||kg|Median|79.50|79.5|Full Range|||46.6|151.6|
3906644|NCT01473381|3730543|B3|||Weight||kg|Median|82.10|82.1|Full Range|||48.8|132.9|
3906645|NCT01473381|3730544|B2|||Weight||kg|Median|82.40|82.4|Full Range|||45.0|137.9|
3906646|NCT01473381|3730545|B1|||Weight||kg|Median|82.50|82.5|Full Range|||46.5|127.1|
3906647|NCT01473381|3730541|B5|||Weight||kg|Mean|82.41|82.41|Standard Deviation|17.82|17.82|||
3906648|NCT01473381|3730542|B4|||Weight||kg|Mean|82.37|82.37|Standard Deviation|18.30|18.3|||
3906649|NCT01473381|3730543|B3|||Weight||kg|Mean|82.45|82.45|Standard Deviation|17.85|17.85|||
3906650|NCT01473381|3730544|B2|||Weight||kg|Mean|82.55|82.55|Standard Deviation|18.16|18.16|||
3906651|NCT01473381|3730545|B1|||Weight||kg|Mean|82.27|82.27|Standard Deviation|17.02|17.02|||
3906652|NCT01473381|3730541|B5|Other||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3906653|NCT01473381|3730542|B4|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3906654|NCT01473381|3730543|B3|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3906655|NCT01473381|3730544|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3906656|NCT01473381|3730545|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3906657|NCT01473381|3730541|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3906658|NCT01473381|3730542|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3906659|NCT01473381|3730543|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3906660|NCT01473381|3730544|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3906661|NCT01473381|3730545|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3906662|NCT01473381|3730541|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3906663|NCT01473381|3730542|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3906664|NCT01473381|3730543|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3906665|NCT01473381|3730544|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3906666|NCT01473381|3730545|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3906667|NCT01473381|3730541|B5|Asian||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3906668|NCT01473381|3730542|B4|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3906669|NCT01473381|3730543|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3906670|NCT01473381|3730544|B2|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3906671|NCT01473381|3730545|B1|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3906672|NCT01473381|3730541|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|301|301.0||||||
3906673|NCT01473381|3730542|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
3906674|NCT01473381|3730543|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
3906675|NCT01473381|3730544|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|73|73.0||||||
3906676|NCT01473381|3730545|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|71|71.0||||||
3906677|NCT01473381|3730541|B5|White||Race/Ethnicity, Customized||participants|Number|788|788.0||||||
3906678|NCT01473381|3730542|B4|White||Race/Ethnicity, Customized||participants|Number|184|184.0||||||
3906679|NCT01473381|3730543|B3|White||Race/Ethnicity, Customized||participants|Number|202|202.0||||||
3906680|NCT01473381|3730544|B2|White||Race/Ethnicity, Customized||participants|Number|205|205.0||||||
3906681|NCT01473381|3730545|B1|White||Race/Ethnicity, Customized||participants|Number|197|197.0||||||
3906682|NCT01473381|3730541|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906683|NCT01473381|3730542|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906684|NCT01473381|3730543|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906685|NCT01473381|3730544|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906686|NCT01473381|3730545|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906687|NCT01473381|3730541|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|928|928.0||||||
3906688|NCT01473381|3730542|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|229|229.0||||||
3906689|NCT01473381|3730543|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|244|244.0||||||
3906690|NCT01473381|3730544|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|233|233.0||||||
3906691|NCT01473381|3730545|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|222|222.0||||||
3906692|NCT01473381|3730541|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|210|210.0||||||
3906693|NCT01473381|3730542|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3906694|NCT01473381|3730543|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3906695|NCT01473381|3730544|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3906696|NCT01473381|3730545|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3906697|NCT01473381|3730541|B5||Male|Sex: Female, Male||Participants|Count of Participants|485|485.0||||||
3906698|NCT01473381|3730542|B4||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3906699|NCT01473381|3730543|B3||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3906700|NCT01473381|3730544|B2||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3906701|NCT01473381|3730545|B1||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3906702|NCT01473381|3730541|B5||Female|Sex: Female, Male||Participants|Count of Participants|653|653.0||||||
3906703|NCT01473381|3730542|B4||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3906704|NCT01473381|3730543|B3||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3906705|NCT01473381|3730544|B2||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3906706|NCT01473381|3730545|B1||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3906707|NCT01473381|3730541|B5|≥ 60 years||Age, Customized||participants|Number|102|102.0||||||
3906708|NCT01473381|3730542|B4|≥ 60 years||Age, Customized||participants|Number|26|26.0||||||
3906709|NCT01473381|3730543|B3|≥ 60 years||Age, Customized||participants|Number|23|23.0||||||
3906710|NCT01473381|3730544|B2|≥ 60 years||Age, Customized||participants|Number|27|27.0||||||
3906711|NCT01473381|3730545|B1|≥ 60 years||Age, Customized||participants|Number|26|26.0||||||
3906712|NCT01473381|3730541|B5|≥ 50-59 years||Age, Customized||participants|Number|244|244.0||||||
3906713|NCT01473381|3730542|B4|≥ 50-59 years||Age, Customized||participants|Number|66|66.0||||||
3906714|NCT01473381|3730543|B3|≥ 50-59 years||Age, Customized||participants|Number|62|62.0||||||
3906715|NCT01473381|3730544|B2|≥ 50-59 years||Age, Customized||participants|Number|50|50.0||||||
3906716|NCT01473381|3730545|B1|≥ 50-59 years||Age, Customized||participants|Number|66|66.0||||||
3906717|NCT01473381|3730541|B5|≥ 40-49 years||Age, Customized||participants|Number|299|299.0||||||
3906718|NCT01473381|3730542|B4|≥ 40-49 years||Age, Customized||participants|Number|76|76.0||||||
3906719|NCT01473381|3730543|B3|≥ 40-49 years||Age, Customized||participants|Number|62|62.0||||||
3906720|NCT01473381|3730544|B2|≥ 40-49 years||Age, Customized||participants|Number|88|88.0||||||
3906721|NCT01473381|3730545|B1|≥ 40-49 years||Age, Customized||participants|Number|73|73.0||||||
3906722|NCT01473381|3730541|B5|≥ 30-39 years||Age, Customized||participants|Number|234|234.0||||||
3906723|NCT01473381|3730542|B4|≥ 30-39 years||Age, Customized||participants|Number|59|59.0||||||
3906724|NCT01473381|3730543|B3|≥ 30-39 years||Age, Customized||participants|Number|68|68.0||||||
3906725|NCT01473381|3730544|B2|≥ 30-39 years||Age, Customized||participants|Number|59|59.0||||||
3906726|NCT01473381|3730545|B1|≥ 30-39 years||Age, Customized||participants|Number|48|48.0||||||
3906727|NCT01473381|3730541|B5|≥ 20-29 years||Age, Customized||participants|Number|241|241.0||||||
3906728|NCT01473381|3730542|B4|≥ 20-29 years||Age, Customized||participants|Number|53|53.0||||||
3906729|NCT01473381|3730543|B3|≥ 20-29 years||Age, Customized||participants|Number|63|63.0||||||
3906730|NCT01473381|3730544|B2|≥ 20-29 years||Age, Customized||participants|Number|62|62.0||||||
3906731|NCT01473381|3730545|B1|≥ 20-29 years||Age, Customized||participants|Number|63|63.0||||||
3906732|NCT01473381|3730541|B5|< 20 years||Age, Customized||participants|Number|18|18.0||||||
3906733|NCT01473381|3730542|B4|< 20 years||Age, Customized||participants|Number|2|2.0||||||
3906734|NCT01473381|3730543|B3|< 20 years||Age, Customized||participants|Number|9|9.0||||||
3906735|NCT01473381|3730544|B2|< 20 years||Age, Customized||participants|Number|2|2.0||||||
3906736|NCT01473381|3730545|B1|< 20 years||Age, Customized||participants|Number|5|5.0||||||
3906737|NCT01473381|3730541|B5|||Age||years|Mean|41.8|41.8|Standard Deviation|12.8|12.8|||
3906738|NCT01473381|3730542|B4|||Age||years|Mean|42.6|42.6|Standard Deviation|12.6|12.6|||
3906739|NCT01473381|3730543|B3|||Age||years|Mean|40.8|40.8|Standard Deviation|13.2|13.2|||
3906740|NCT01473381|3730544|B2|||Age||years|Mean|41.7|41.7|Standard Deviation|12.7|12.7|||
3906741|NCT01473381|3730545|B1|||Age||years|Mean|42.0|42.0|Standard Deviation|13.0|13.0|||
3906742|NCT01473368|3730566|B5|United States||Region of Enrollment||participants|Number|49|49.0||||||
3906743|NCT01473368|3730567|B4|United States||Region of Enrollment||participants|Number|12|12.0||||||
3906744|NCT01473368|3730568|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3906745|NCT01473368|3730569|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3906746|NCT01473368|3730570|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3906747|NCT01473368|3730566|B5||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3906748|NCT01473368|3730567|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3906749|NCT01473368|3730568|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3906750|NCT01473368|3730569|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3906751|NCT01473368|3730570|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3906752|NCT01473368|3730566|B5||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3906753|NCT01473368|3730567|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3906754|NCT01473368|3730568|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3906755|NCT01473368|3730569|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3906756|NCT01473368|3730570|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3906757|NCT01473368|3730566|B5|||Age||years|Mean|30.1|30.1|Standard Deviation|8.8|8.8|||
3906758|NCT01473368|3730567|B4|||Age||years|Mean|27.2|27.2|Standard Deviation|4.3|4.3|||
3906759|NCT01473368|3730568|B3|||Age||years|Mean|34.2|34.2|Standard Deviation|11.4|11.4|||
3906760|NCT01473368|3730569|B2|||Age||years|Mean|27.4|27.4|Standard Deviation|6.6|6.6|||
3906761|NCT01473368|3730570|B1|||Age||years|Mean|31.6|31.6|Standard Deviation|9.9|9.9|||
3906762|NCT01473368|3730566|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3906763|NCT01473368|3730567|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3906764|NCT01473368|3730568|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3906765|NCT01473368|3730569|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3906766|NCT01473368|3730570|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3906767|NCT01473368|3730566|B5||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3906768|NCT01473368|3730567|B4||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3906769|NCT01473368|3730568|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3906770|NCT01473368|3730569|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3906771|NCT01473368|3730570|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3906772|NCT01473368|3730566|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3906773|NCT01473368|3730567|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3906774|NCT01473368|3730568|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3906775|NCT01473368|3730569|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3906776|NCT01473368|3730570|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3906777|NCT01473160|3730610|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3906778|NCT01473160|3730610|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3906779|NCT01473160|3730610|B1|||Age||years|Mean|31|31.0|Standard Deviation|7|7.0|||
3906780|NCT01472965|3730628|B3|Australia||Region of Enrollment||participants|Number|7|7.0||||||
3906781|NCT01472965|3730629|B2|Australia||Region of Enrollment||participants|Number|1|1.0||||||
3906782|NCT01472965|3730630|B1|Australia||Region of Enrollment||participants|Number|6|6.0||||||
3906783|NCT01472965|3730628|B3|United States||Region of Enrollment||participants|Number|87|87.0||||||
3906784|NCT01472965|3730629|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
3906785|NCT01472965|3730630|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
3906786|NCT01472965|3730628|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3906787|NCT01472965|3730629|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3906788|NCT01472965|3730630|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3906789|NCT01472965|3730628|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3906790|NCT01472965|3730629|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3906791|NCT01472965|3730630|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3906792|NCT01472965|3730628|B3||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3906793|NCT01472965|3730629|B2||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3906794|NCT01472965|3730630|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3906795|NCT01472965|3730628|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3906796|NCT01472965|3730629|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3906797|NCT01472965|3730630|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3906798|NCT01472965|3730628|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3906799|NCT01472965|3730629|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906800|NCT01472965|3730630|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3906801|NCT01472965|3730628|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3906802|NCT01472965|3730629|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3906803|NCT01472965|3730630|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3906804|NCT01472965|3730628|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3906805|NCT01472965|3730629|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906806|NCT01472965|3730630|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3906807|NCT01472965|3730628|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3906808|NCT01472965|3730629|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3906809|NCT01472965|3730630|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3906810|NCT01472965|3730628|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3906811|NCT01472965|3730629|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3906812|NCT01472965|3730630|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3906813|NCT01472965|3730628|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3906814|NCT01472965|3730629|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3906815|NCT01472965|3730630|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3906816|NCT01472965|3730628|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3906817|NCT01472965|3730629|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3906818|NCT01472965|3730630|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3906819|NCT01472965|3730628|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3906820|NCT01472965|3730629|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3906821|NCT01472965|3730630|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3906822|NCT01472965|3730628|B3|||Age||years|Mean|8.6|8.6|Standard Deviation|6.4|6.4|||
3906823|NCT01472965|3730629|B2|||Age||years|Mean|8.3|8.3|Standard Deviation|6.7|6.7|||
3906824|NCT01472965|3730630|B1|||Age||years|Mean|8.8|8.8|Standard Deviation|6.3|6.3|||
3906825|NCT01472939|3730647|B5|UNITED STATES||Region of Enrollment|All randomized subjects (n = 480)|Participants|Number|367|367.0||||||
3906826|NCT01472939|3730648|B4|UNITED STATES||Region of Enrollment|All randomized subjects (n = 480)|Participants|Number|91|91.0||||||
3906827|NCT01472939|3730649|B3|UNITED STATES||Region of Enrollment|All randomized subjects (n = 480)|Participants|Number|92|92.0||||||
3906828|NCT01472939|3730650|B2|UNITED STATES||Region of Enrollment|All randomized subjects (n = 480)|Participants|Number|92|92.0||||||
3906829|NCT01472939|3730651|B1|UNITED STATES||Region of Enrollment|All randomized subjects (n = 480)|Participants|Number|92|92.0||||||
3906830|NCT01472939|3730647|B5|ROMANIA||Region of Enrollment|All randomized subjects (n = 480)|Participants|Number|33|33.0||||||
3906831|NCT01472939|3730648|B4|ROMANIA||Region of Enrollment|All randomized subjects (n = 480)|Participants|Number|8|8.0||||||
3906832|NCT01472939|3730649|B3|ROMANIA||Region of Enrollment|All randomized subjects (n = 480)|Participants|Number|8|8.0||||||
3906833|NCT01472939|3730650|B2|ROMANIA||Region of Enrollment|All randomized subjects (n = 480)|Participants|Number|8|8.0||||||
3906834|NCT01472939|3730651|B1|ROMANIA||Region of Enrollment|All randomized subjects (n = 480)|Participants|Number|9|9.0||||||
3906835|NCT01472939|3730647|B5|POLAND||Region of Enrollment|All randomized subjects (n = 480)|Participants|Number|28|28.0||||||
3906836|NCT01472939|3730648|B4|POLAND||Region of Enrollment|All randomized subjects (n = 480)|Participants|Number|8|8.0||||||
3906837|NCT01472939|3730649|B3|POLAND||Region of Enrollment|All randomized subjects (n = 480)|Participants|Number|7|7.0||||||
3906838|NCT01472939|3730650|B2|POLAND||Region of Enrollment|All randomized subjects (n = 480)|Participants|Number|7|7.0||||||
3906839|NCT01472939|3730651|B1|POLAND||Region of Enrollment|All randomized subjects (n = 480)|Participants|Number|6|6.0||||||
3906840|NCT01472939|3730647|B5|LATVIA||Region of Enrollment|All randomized subjects (n = 480)|Participants|Number|17|17.0||||||
3906841|NCT01472939|3730648|B4|LATVIA||Region of Enrollment|All randomized subjects (n = 480)|Participants|Number|4|4.0||||||
3906842|NCT01472939|3730649|B3|LATVIA||Region of Enrollment|All randomized subjects (n = 480)|Participants|Number|4|4.0||||||
3906843|NCT01472939|3730650|B2|LATVIA||Region of Enrollment|All randomized subjects (n = 480)|Participants|Number|4|4.0||||||
3906844|NCT01472939|3730651|B1|LATVIA||Region of Enrollment|All randomized subjects (n = 480)|Participants|Number|5|5.0||||||
3906845|NCT01472939|3730647|B5|HUNGARY||Region of Enrollment|All randomized subjects (n = 480)|Participants|Number|7|7.0||||||
3906846|NCT01472939|3730648|B4|HUNGARY||Region of Enrollment|All randomized subjects (n = 480)|Participants|Number|1|1.0||||||
3906847|NCT01472939|3730649|B3|HUNGARY||Region of Enrollment|All randomized subjects (n = 480)|Participants|Number|2|2.0||||||
3906848|NCT01472939|3730650|B2|HUNGARY||Region of Enrollment|All randomized subjects (n = 480)|Participants|Number|1|1.0||||||
3906849|NCT01472939|3730651|B1|HUNGARY||Region of Enrollment|All randomized subjects (n = 480)|Participants|Number|3|3.0||||||
3906850|NCT01472939|3730647|B5|GERMANY||Region of Enrollment|All randomized subjects (n = 480)|Participants|Number|17|17.0||||||
3906851|NCT01472939|3730648|B4|GERMANY||Region of Enrollment|All randomized subjects (n = 480)|Participants|Number|4|4.0||||||
3906852|NCT01472939|3730649|B3|GERMANY||Region of Enrollment|All randomized subjects (n = 480)|Participants|Number|4|4.0||||||
3906853|NCT01472939|3730650|B2|GERMANY||Region of Enrollment|All randomized subjects (n = 480)|Participants|Number|4|4.0||||||
3906854|NCT01472939|3730651|B1|GERMANY||Region of Enrollment|All randomized subjects (n = 480)|Participants|Number|5|5.0||||||
3906855|NCT01472939|3730647|B5|FRANCE||Region of Enrollment|All randomized subjects (n = 480)|Participants|Number|7|7.0||||||
3906856|NCT01472939|3730648|B4|FRANCE||Region of Enrollment|All randomized subjects (n = 480)|Participants|Number|2|2.0||||||
3906857|NCT01472939|3730649|B3|FRANCE||Region of Enrollment|All randomized subjects (n = 480)|Participants|Number|1|1.0||||||
3906858|NCT01472939|3730650|B2|FRANCE||Region of Enrollment|All randomized subjects (n = 480)|Participants|Number|2|2.0||||||
3906859|NCT01472939|3730651|B1|FRANCE||Region of Enrollment|All randomized subjects (n = 480)|Participants|Number|2|2.0||||||
3906860|NCT01472939|3730647|B5|CZECH REPUBLIC||Region of Enrollment|All randomized subjects (n = 480)|Participants|Number|4|4.0||||||
3906861|NCT01472939|3730648|B4|CZECH REPUBLIC||Region of Enrollment|All randomized subjects (n = 480)|Participants|Number|1|1.0||||||
3906862|NCT01472939|3730649|B3|CZECH REPUBLIC||Region of Enrollment|All randomized subjects (n = 480)|Participants|Number|1|1.0||||||
3906863|NCT01472939|3730650|B2|CZECH REPUBLIC||Region of Enrollment|All randomized subjects (n = 480)|Participants|Number|1|1.0||||||
3906864|NCT01472939|3730651|B1|CZECH REPUBLIC||Region of Enrollment|All randomized subjects (n = 480)|Participants|Number|1|1.0||||||
3906865|NCT01472939|3730647|B5||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3906866|NCT01472939|3730648|B4||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3906867|NCT01472939|3730649|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3906868|NCT01472939|3730650|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3906869|NCT01472939|3730651|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3906870|NCT01472939|3730647|B5||Female|Sex: Female, Male||Participants|Count of Participants|289|289.0||||||
3906871|NCT01472939|3730648|B4||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3906872|NCT01472939|3730649|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3906873|NCT01472939|3730650|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3906874|NCT01472939|3730651|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3906875|NCT01472939|3730647|B5|>65||Age, Customized||Participants|Number|26|26.0||||||
3906876|NCT01472939|3730648|B4|>65||Age, Customized||Participants|Number|3|3.0||||||
3906877|NCT01472939|3730649|B3|>65||Age, Customized||Participants|Number|8|8.0||||||
3906878|NCT01472939|3730650|B2|>65||Age, Customized||Participants|Number|9|9.0||||||
3906879|NCT01472939|3730651|B1|>65||Age, Customized||Participants|Number|6|6.0||||||
3906880|NCT01472939|3730647|B5|51 - 65||Age, Customized||Participants|Number|193|193.0||||||
3906881|NCT01472939|3730648|B4|51 - 65||Age, Customized||Participants|Number|51|51.0||||||
3906882|NCT01472939|3730649|B3|51 - 65||Age, Customized||Participants|Number|49|49.0||||||
3906883|NCT01472939|3730650|B2|51 - 65||Age, Customized||Participants|Number|52|52.0||||||
3906884|NCT01472939|3730651|B1|51 - 65||Age, Customized||Participants|Number|41|41.0||||||
3906885|NCT01472939|3730647|B5|41 - 50||Age, Customized||Participants|Number|122|122.0||||||
3906886|NCT01472939|3730648|B4|41 - 50||Age, Customized||Participants|Number|32|32.0||||||
3906887|NCT01472939|3730649|B3|41 - 50||Age, Customized||Participants|Number|32|32.0||||||
3906888|NCT01472939|3730650|B2|41 - 50||Age, Customized||Participants|Number|23|23.0||||||
3906889|NCT01472939|3730651|B1|41 - 50||Age, Customized||Participants|Number|35|35.0||||||
3906890|NCT01472939|3730647|B5|18 - 40||Age, Customized||Participants|Number|136|136.0||||||
3906891|NCT01472939|3730648|B4|18 - 40||Age, Customized||Participants|Number|32|32.0||||||
3906892|NCT01472939|3730649|B3|18 - 40||Age, Customized||Participants|Number|29|29.0||||||
3906893|NCT01472939|3730650|B2|18 - 40||Age, Customized||Participants|Number|35|35.0||||||
3906894|NCT01472939|3730651|B1|18 - 40||Age, Customized||Participants|Number|40|40.0||||||
3906895|NCT01472939|3730647|B5|||Age||Years|Mean|47.9|47.9|Standard Deviation|12.11|12.11|||
3906896|NCT01472939|3730648|B4|||Age||Years|Mean|47.6|47.6|Standard Deviation|11.3|11.3|||
3906897|NCT01472939|3730649|B3|||Age||Years|Mean|49.2|49.2|Standard Deviation|12.31|12.31|||
3906898|NCT01472939|3730650|B2|||Age||Years|Mean|48.8|48.8|Standard Deviation|12.59|12.59|||
3906899|NCT01472939|3730651|B1|||Age||Years|Mean|46.2|46.2|Standard Deviation|12.1|12.1|||
3906900|NCT01472874|3730681|B1|trientine BID||Prior Treatment|Treatment for Wilson's Disease prior to study entry|participants|Number|5|5.0||||||
3906901|NCT01472874|3730681|B1|d-penicillamine||Prior Treatment|Treatment for Wilson's Disease prior to study entry|participants|Number|1|1.0||||||
3906902|NCT01472874|3730681|B1|zinc acetate||Prior Treatment|Treatment for Wilson's Disease prior to study entry|participants|Number|2|2.0||||||
3906903|NCT01472874|3730681|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3906904|NCT01472874|3730681|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906905|NCT01472874|3730681|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906906|NCT01472874|3730681|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3906907|NCT01472874|3730681|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906908|NCT01472874|3730681|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906909|NCT01472874|3730681|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3906910|NCT01472874|3730681|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906911|NCT01472874|3730681|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906912|NCT01472874|3730681|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3906913|NCT01472874|3730681|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3906914|NCT01472874|3730681|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3906915|NCT01472874|3730681|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3906916|NCT01472874|3730681|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3906917|NCT01472874|3730681|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3906918|NCT01472874|3730681|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3906919|NCT01472835|3730696|B3|United States||Region of Enrollment||participants|Number|73|73.0||||||
3906920|NCT01472835|3730697|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
3906921|NCT01472835|3730698|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
3906922|NCT01472835|3730696|B3||Male|Gender||Participants|Count of Participants|31|31.0||||||
3906923|NCT01472835|3730697|B2||Male|Gender||Participants|Count of Participants|14|14.0||||||
3906924|NCT01472835|3730698|B1||Male|Gender||Participants|Count of Participants|17|17.0||||||
3906925|NCT01472835|3730696|B3||Female|Gender||Participants|Count of Participants|42|42.0||||||
3906926|NCT01472835|3730697|B2||Female|Gender||Participants|Count of Participants|22|22.0||||||
3906927|NCT01472835|3730698|B1||Female|Gender||Participants|Count of Participants|20|20.0||||||
3906928|NCT01472835|3730696|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3906929|NCT01472835|3730697|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3906930|NCT01472835|3730698|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3906931|NCT01472835|3730696|B3||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
3906932|NCT01472835|3730697|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3907084|NCT01472185|3730806|B1|White||Race/Ethnicity, Customized||participants|Number|209|209.0||||||
3906933|NCT01472835|3730698|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3906934|NCT01472835|3730696|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3906935|NCT01472835|3730697|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3906936|NCT01472835|3730698|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3906937|NCT01472835|3730696|B3|||Age||years|Mean|50.0|50.0|Standard Deviation|15.0|15.0|||
3906938|NCT01472835|3730697|B2|||Age||years|Mean|50.3|50.3|Standard Deviation|13.8|13.8|||
3906939|NCT01472835|3730698|B1|||Age||years|Mean|49.7|49.7|Standard Deviation|16.1|16.1|||
3906940|NCT01472822|3730713|B3|Korea, Republic of||Region of Enrollment||participants|Number|60|60.0||||||
3906941|NCT01472822|3730714|B2|Korea, Republic of||Region of Enrollment||participants|Number|30|30.0||||||
3906942|NCT01472822|3730715|B1|Korea, Republic of||Region of Enrollment||participants|Number|30|30.0||||||
3906943|NCT01472822|3730713|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3906944|NCT01472822|3730714|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3906945|NCT01472822|3730715|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3906946|NCT01472822|3730713|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3906947|NCT01472822|3730714|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3906948|NCT01472822|3730715|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3906949|NCT01472822|3730713|B3|||Age||years|Mean|52.2|52.2|Standard Deviation|9.5|9.5|||
3906950|NCT01472822|3730714|B2|||Age||years|Mean|52.4|52.4|Standard Deviation|9.6|9.6|||
3906951|NCT01472822|3730715|B1|||Age||years|Mean|52.1|52.1|Standard Deviation|9.5|9.5|||
3906952|NCT01472822|3730713|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3906953|NCT01472822|3730714|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3906954|NCT01472822|3730715|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3906955|NCT01472822|3730713|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3906956|NCT01472822|3730714|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3906957|NCT01472822|3730715|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3906958|NCT01472822|3730713|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3906959|NCT01472822|3730714|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3906960|NCT01472822|3730715|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3906961|NCT01472562|3730730|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3906962|NCT01472562|3730730|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3906963|NCT01472562|3730730|B1|||Age||years|Median|65|65.0|Full Range|||42.0|86.0|
3906964|NCT01472549|3730735|B3|||Scheduled cesarean||Participants|Count of Participants|669|669.0||||||
3906965|NCT01472549|3730736|B2|||Scheduled cesarean||Participants|Count of Participants|335|335.0||||||
3906966|NCT01472549|3730737|B1|||Scheduled cesarean||Participants|Count of Participants|334|334.0||||||
3906967|NCT01472549|3730735|B3|||Body mass index||kg/m2|Mean|34.6|34.6|Standard Deviation|8.5|8.5|||
3906968|NCT01472549|3730736|B2|||Body mass index||kg/m2|Mean|34.1|34.1|Standard Deviation|8.1|8.1|||
3906969|NCT01472549|3730737|B1|||Body mass index||kg/m2|Mean|35.1|35.1|Standard Deviation|8.9|8.9|||
3906970|NCT01472549|3730735|B3|United States||Region of Enrollment||participants|Number|1147|1147.0||||||
3906971|NCT01472549|3730736|B2|United States||Region of Enrollment||participants|Number|575|575.0||||||
3906972|NCT01472549|3730737|B1|United States||Region of Enrollment||participants|Number|572|572.0||||||
3906973|NCT01472549|3730735|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3906974|NCT01472549|3730736|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3906975|NCT01472549|3730737|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3906976|NCT01472549|3730735|B3||Female|Sex: Female, Male||Participants|Count of Participants|1147|1147.0||||||
3906977|NCT01472549|3730736|B2||Female|Sex: Female, Male||Participants|Count of Participants|575|575.0||||||
3906978|NCT01472549|3730737|B1||Female|Sex: Female, Male||Participants|Count of Participants|572|572.0||||||
3906979|NCT01472549|3730735|B3|||Age||years|Mean|28.4|28.4|Standard Deviation|5.8|5.8|||
3906980|NCT01472549|3730736|B2|||Age||years|Mean|28.4|28.4|Standard Deviation|5.8|5.8|||
3906981|NCT01472549|3730737|B1|||Age||years|Mean|28.3|28.3|Standard Deviation|5.8|5.8|||
3906982|NCT01472432|3730758|B3|Italy||Region of Enrollment||participants|Number|106|106.0||||||
3906983|NCT01472432|3730759|B2|Italy||Region of Enrollment||participants|Number|53|53.0||||||
3906984|NCT01472432|3730760|B1|Italy||Region of Enrollment||participants|Number|53|53.0||||||
3906985|NCT01472432|3730758|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3906986|NCT01472432|3730759|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3906987|NCT01472432|3730760|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3906988|NCT01472432|3730758|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3906989|NCT01472432|3730759|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3906990|NCT01472432|3730760|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3906991|NCT01472432|3730758|B3|||Age|The study group comprised 106 type 2 diabetic with chronic non-healing diabetic foot ulcers for more than 3 months duration. Patients were enrolled in the study between December 2008 and March 2011. Fifty-three diabetic patients were randomized (simple randomization, open labeled) to receive vildagliptin (50 mg b.i.d., n= 53) in addition to other concomitant hypoglycemic medication for 3 months.|years|Mean|64|64.0|Standard Deviation|21|21.0|||
3907236|NCT01471379|3730896|B1|||Age||years|Mean|47|47.0|Standard Deviation|0|0.0|||
3906992|NCT01472432|3730759|B2|||Age|The study group comprised 106 type 2 diabetic with chronic non-healing diabetic foot ulcers for more than 3 months duration. Patients were enrolled in the study between December 2008 and March 2011. Fifty-three diabetic patients were randomized (simple randomization, open labeled) to receive vildagliptin (50 mg b.i.d., n= 53) in addition to other concomitant hypoglycemic medication for 3 months.|years|Mean|64|64.0|Standard Deviation|15|15.0|||
3906993|NCT01472432|3730760|B1|||Age|The study group comprised 106 type 2 diabetic with chronic non-healing diabetic foot ulcers for more than 3 months duration. Patients were enrolled in the study between December 2008 and March 2011. Fifty-three diabetic patients were randomized (simple randomization, open labeled) to receive vildagliptin (50 mg b.i.d., n= 53) in addition to other concomitant hypoglycemic medication for 3 months.|years|Mean|63|63.0|Standard Deviation|14|14.0|||
3906994|NCT01472432|3730758|B3||>=65 years|Age||Participants|Count of Participants|81|81.0||||||
3906995|NCT01472432|3730759|B2||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
3906996|NCT01472432|3730760|B1||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
3906997|NCT01472432|3730758|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3906998|NCT01472432|3730759|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3906999|NCT01472432|3730760|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3907000|NCT01472432|3730758|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3907001|NCT01472432|3730759|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3907002|NCT01472432|3730760|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3907003|NCT01472380|3730777|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3907004|NCT01472380|3730777|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3907005|NCT01472380|3730777|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907006|NCT01472380|3730777|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3907007|NCT01472380|3730777|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3907008|NCT01472380|3730777|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3907009|NCT01472380|3730777|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3907010|NCT01472380|3730777|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907011|NCT01472380|3730777|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907012|NCT01472380|3730777|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3907013|NCT01472380|3730777|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3907014|NCT01472380|3730777|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3907015|NCT01472380|3730777|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3907016|NCT01472380|3730777|B1|||Age||years|Mean|26.8|26.8|Standard Deviation|7.0|7.0|||
3907017|NCT01472380|3730777|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3907018|NCT01472380|3730777|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3907019|NCT01472380|3730777|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3907020|NCT01472341|3730788|B1||Male|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
3907021|NCT01472341|3730788|B1||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
3907022|NCT01472341|3730788|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|8.1|8.1|||
3907023|NCT01472289|3730794|B1|India||Region of Enrollment||participants|Number|17|17.0||||||
3907024|NCT01472289|3730794|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907025|NCT01472289|3730794|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907026|NCT01472289|3730794|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907027|NCT01472289|3730794|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907028|NCT01472289|3730794|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907029|NCT01472289|3730794|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3907030|NCT01472289|3730794|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907031|NCT01472289|3730794|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3907032|NCT01472289|3730794|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3907033|NCT01472289|3730794|B1|||Age||years|Mean|48.8|48.8|Standard Deviation|13.07|13.07|||
3907034|NCT01472185|3730804|B3|||Estimated glomerular filtration rate (eGFR)||mL/min/1.73m^2|Mean|83.9|83.9|Standard Deviation|18.59|18.59|||
3907035|NCT01472185|3730805|B2|||Estimated glomerular filtration rate (eGFR)||mL/min/1.73m^2|Mean|84.5|84.5|Standard Deviation|18.80|18.8|||
3907036|NCT01472185|3730806|B1|||Estimated glomerular filtration rate (eGFR)||mL/min/1.73m^2|Mean|83.3|83.3|Standard Deviation|18.40|18.4|||
3907037|NCT01472185|3730804|B3|||Duration of Diabetes||years|Mean|3.0|3.0|Standard Deviation|4.14|4.14|||
3907038|NCT01472185|3730805|B2|||Duration of Diabetes||years|Mean|3.0|3.0|Standard Deviation|4.29|4.29|||
3907039|NCT01472185|3730806|B1|||Duration of Diabetes||years|Mean|3.0|3.0|Standard Deviation|4.00|4.0|||
3907040|NCT01472185|3730804|B3|||Fasting Serum Glucose||mg/dL|Mean|171.8|171.8|Standard Deviation|34.35|34.35|||
3907041|NCT01472185|3730805|B2|||Fasting Serum Glucose||mg/dL|Mean|172.1|172.1|Standard Deviation|34.32|34.32|||
3907042|NCT01472185|3730806|B1|||Fasting Serum Glucose||mg/dL|Mean|171.5|171.5|Standard Deviation|34.45|34.45|||
3907043|NCT01472185|3730804|B3|||Glycosylated hemoglobin (HbA1c)||percent HbA1c in blood|Mean|8.04|8.04|Standard Deviation|0.729|0.729|||
3907044|NCT01472185|3730805|B2|||Glycosylated hemoglobin (HbA1c)||percent HbA1c in blood|Mean|8.06|8.06|Standard Deviation|0.732|0.732|||
3907045|NCT01472185|3730806|B1|||Glycosylated hemoglobin (HbA1c)||percent HbA1c in blood|Mean|8.01|8.01|Standard Deviation|0.727|0.727|||
3907046|NCT01472185|3730804|B3|||Body Mass Index||kg/m^2|Mean|32.8|32.8|Standard Deviation|4.80|4.8|||
3907047|NCT01472185|3730805|B2|||Body Mass Index||kg/m^2|Mean|32.8|32.8|Standard Deviation|4.75|4.75|||
3907048|NCT01472185|3730806|B1|||Body Mass Index||kg/m^2|Mean|32.8|32.8|Standard Deviation|4.85|4.85|||
3907049|NCT01472185|3730804|B3|Russian Federation||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 232; ranolazine, n = 233).|participants|Number|165|165.0||||||
3907050|NCT01472185|3730805|B2|Russian Federation||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 232; ranolazine, n = 233).|participants|Number|82|82.0||||||
3907051|NCT01472185|3730806|B1|Russian Federation||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 232; ranolazine, n = 233).|participants|Number|83|83.0||||||
3907052|NCT01472185|3730804|B3|South Africa||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 232; ranolazine, n = 233).|participants|Number|24|24.0||||||
3907053|NCT01472185|3730805|B2|South Africa||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 232; ranolazine, n = 233).|participants|Number|13|13.0||||||
3907054|NCT01472185|3730806|B1|South Africa||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 232; ranolazine, n = 233).|participants|Number|11|11.0||||||
3907055|NCT01472185|3730804|B3|Romania||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 232; ranolazine, n = 233).|participants|Number|21|21.0||||||
3907056|NCT01472185|3730805|B2|Romania||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 232; ranolazine, n = 233).|participants|Number|11|11.0||||||
3907057|NCT01472185|3730806|B1|Romania||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 232; ranolazine, n = 233).|participants|Number|10|10.0||||||
3907058|NCT01472185|3730804|B3|Ukraine||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 232; ranolazine, n = 233).|participants|Number|75|75.0||||||
3907059|NCT01472185|3730805|B2|Ukraine||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 232; ranolazine, n = 233).|participants|Number|36|36.0||||||
3907060|NCT01472185|3730806|B1|Ukraine||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 232; ranolazine, n = 233).|participants|Number|39|39.0||||||
3907061|NCT01472185|3730804|B3|Poland||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 232; ranolazine, n = 233).|participants|Number|18|18.0||||||
3907062|NCT01472185|3730805|B2|Poland||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 232; ranolazine, n = 233).|participants|Number|11|11.0||||||
3907063|NCT01472185|3730806|B1|Poland||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 232; ranolazine, n = 233).|participants|Number|7|7.0||||||
3907064|NCT01472185|3730804|B3|Slovakia||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 232; ranolazine, n = 233).|participants|Number|21|21.0||||||
3907065|NCT01472185|3730805|B2|Slovakia||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 232; ranolazine, n = 233).|participants|Number|13|13.0||||||
3907066|NCT01472185|3730806|B1|Slovakia||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 232; ranolazine, n = 233).|participants|Number|8|8.0||||||
3907067|NCT01472185|3730804|B3|Hungary||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 232; ranolazine, n = 233).|participants|Number|21|21.0||||||
3907068|NCT01472185|3730805|B2|Hungary||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 232; ranolazine, n = 233).|participants|Number|9|9.0||||||
3907069|NCT01472185|3730806|B1|Hungary||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 232; ranolazine, n = 233).|participants|Number|12|12.0||||||
3907070|NCT01472185|3730804|B3|United States||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 232; ranolazine, n = 233).|participants|Number|118|118.0||||||
3907071|NCT01472185|3730805|B2|United States||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 232; ranolazine, n = 233).|participants|Number|56|56.0||||||
3907072|NCT01472185|3730806|B1|United States||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 232; ranolazine, n = 233).|participants|Number|62|62.0||||||
3907073|NCT01472185|3730804|B3|Serbia||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 232; ranolazine, n = 233).|participants|Number|2|2.0||||||
3907074|NCT01472185|3730805|B2|Serbia||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 232; ranolazine, n = 233).|participants|Number|2|2.0||||||
3907075|NCT01472185|3730806|B1|Serbia||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 232; ranolazine, n = 233).|participants|Number|0|0.0||||||
3907076|NCT01472185|3730804|B3|Not Permitted||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3907077|NCT01472185|3730805|B2|Not Permitted||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3907078|NCT01472185|3730806|B1|Not Permitted||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3907079|NCT01472185|3730804|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3907080|NCT01472185|3730805|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3907081|NCT01472185|3730806|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3907082|NCT01472185|3730804|B3|White||Race/Ethnicity, Customized||participants|Number|422|422.0||||||
3907083|NCT01472185|3730805|B2|White||Race/Ethnicity, Customized||participants|Number|213|213.0||||||
3907085|NCT01472185|3730804|B3|Black or African-American||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3907086|NCT01472185|3730805|B2|Black or African-American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3907087|NCT01472185|3730806|B1|Black or African-American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3907088|NCT01472185|3730804|B3|Asian||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3907089|NCT01472185|3730805|B2|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3907090|NCT01472185|3730806|B1|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3907091|NCT01472185|3730804|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3907092|NCT01472185|3730805|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3907093|NCT01472185|3730806|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907094|NCT01472185|3730804|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|403|403.0||||||
3907095|NCT01472185|3730805|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|202|202.0||||||
3907096|NCT01472185|3730806|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|201|201.0||||||
3907097|NCT01472185|3730804|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3907098|NCT01472185|3730805|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3907099|NCT01472185|3730806|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3907100|NCT01472185|3730804|B3||Male|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
3907101|NCT01472185|3730805|B2||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3907102|NCT01472185|3730806|B1||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3907103|NCT01472185|3730804|B3||Female|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
3907104|NCT01472185|3730805|B2||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3907105|NCT01472185|3730806|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3907106|NCT01472185|3730804|B3|≥ 65 years||Age, Customized||participants|Number|68|68.0||||||
3907107|NCT01472185|3730805|B2|≥ 65 years||Age, Customized||participants|Number|33|33.0||||||
3907108|NCT01472185|3730806|B1|≥ 65 years||Age, Customized||participants|Number|35|35.0||||||
3907109|NCT01472185|3730804|B3|< 65 years||Age, Customized||participants|Number|396|396.0||||||
3907110|NCT01472185|3730805|B2|< 65 years||Age, Customized||participants|Number|199|199.0||||||
3907111|NCT01472185|3730806|B1|< 65 years||Age, Customized||participants|Number|197|197.0||||||
3907112|NCT01472185|3730804|B3|||Age||years|Mean|56|56.0|Standard Deviation|9.4|9.4|||
3907113|NCT01472185|3730805|B2|||Age||years|Mean|55|55.0|Standard Deviation|9.5|9.5|||
3907114|NCT01472185|3730806|B1|||Age||years|Mean|56|56.0|Standard Deviation|9.3|9.3|||
3907115|NCT01471782|3730821|B7|No||Prior Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)||participants|Number|38|38.0||||||
3907116|NCT01471782|3730822|B6|No||Prior Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)||participants|Number|19|19.0||||||
3907117|NCT01471782|3730823|B5|No||Prior Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)||participants|Number|11|11.0||||||
3907118|NCT01471782|3730824|B4|No||Prior Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)||participants|Number|2|2.0||||||
3907119|NCT01471782|3730825|B3|No||Prior Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)||participants|Number|3|3.0||||||
3907120|NCT01471782|3730826|B2|No||Prior Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)||participants|Number|1|1.0||||||
3907121|NCT01471782|3730827|B1|No||Prior Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)||participants|Number|2|2.0||||||
3907122|NCT01471782|3730821|B7|Yes||Prior Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)||participants|Number|55|55.0||||||
3907123|NCT01471782|3730822|B6|Yes||Prior Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)||participants|Number|25|25.0||||||
3907124|NCT01471782|3730823|B5|Yes||Prior Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)||participants|Number|15|15.0||||||
3907125|NCT01471782|3730824|B4|Yes||Prior Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)||participants|Number|4|4.0||||||
3907126|NCT01471782|3730825|B3|Yes||Prior Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)||participants|Number|2|2.0||||||
3907127|NCT01471782|3730826|B2|Yes||Prior Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)||participants|Number|6|6.0||||||
3907128|NCT01471782|3730827|B1|Yes||Prior Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)||participants|Number|3|3.0||||||
3907129|NCT01471782|3730821|B7|Unknown||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|7|7.0||||||
3907130|NCT01471782|3730822|B6|Unknown||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|6|6.0||||||
3907131|NCT01471782|3730823|B5|Unknown||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|1|1.0||||||
3907132|NCT01471782|3730824|B4|Unknown||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|0|0.0||||||
3907133|NCT01471782|3730825|B3|Unknown||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|0|0.0||||||
3907134|NCT01471782|3730826|B2|Unknown||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|0|0.0||||||
3907135|NCT01471782|3730827|B1|Unknown||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|0|0.0||||||
3907136|NCT01471782|3730821|B7|Other||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|9|9.0||||||
3907237|NCT01471379|3730893|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3907137|NCT01471782|3730822|B6|Other||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|5|5.0||||||
3907138|NCT01471782|3730823|B5|Other||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|3|3.0||||||
3907139|NCT01471782|3730824|B4|Other||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|1|1.0||||||
3907140|NCT01471782|3730825|B3|Other||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|0|0.0||||||
3907141|NCT01471782|3730826|B2|Other||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|0|0.0||||||
3907142|NCT01471782|3730827|B1|Other||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|0|0.0||||||
3907143|NCT01471782|3730821|B7|Native Hawaiian or other Pacific islander||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|0|0.0||||||
3907144|NCT01471782|3730822|B6|Native Hawaiian or other Pacific islander||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|0|0.0||||||
3907145|NCT01471782|3730823|B5|Native Hawaiian or other Pacific islander||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|0|0.0||||||
3907146|NCT01471782|3730824|B4|Native Hawaiian or other Pacific islander||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|0|0.0||||||
3907147|NCT01471782|3730825|B3|Native Hawaiian or other Pacific islander||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|0|0.0||||||
3907148|NCT01471782|3730826|B2|Native Hawaiian or other Pacific islander||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|0|0.0||||||
3907149|NCT01471782|3730827|B1|Native Hawaiian or other Pacific islander||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|0|0.0||||||
3907150|NCT01471782|3730821|B7|American Indian or Alaska native||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|0|0.0||||||
3907151|NCT01471782|3730822|B6|American Indian or Alaska native||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|0|0.0||||||
3907152|NCT01471782|3730823|B5|American Indian or Alaska native||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|0|0.0||||||
3907153|NCT01471782|3730824|B4|American Indian or Alaska native||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|0|0.0||||||
3907154|NCT01471782|3730825|B3|American Indian or Alaska native||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|0|0.0||||||
3907155|NCT01471782|3730826|B2|American Indian or Alaska native||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|0|0.0||||||
3907156|NCT01471782|3730827|B1|American Indian or Alaska native||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|0|0.0||||||
3907157|NCT01471782|3730821|B7|Black or African American||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|0|0.0||||||
3907158|NCT01471782|3730822|B6|Black or African American||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|0|0.0||||||
3907159|NCT01471782|3730823|B5|Black or African American||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|0|0.0||||||
3907160|NCT01471782|3730824|B4|Black or African American||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|0|0.0||||||
3907161|NCT01471782|3730825|B3|Black or African American||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|0|0.0||||||
3907162|NCT01471782|3730826|B2|Black or African American||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|0|0.0||||||
3907163|NCT01471782|3730827|B1|Black or African American||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|0|0.0||||||
3907164|NCT01471782|3730821|B7|Asian||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|0|0.0||||||
3907165|NCT01471782|3730822|B6|Asian||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|0|0.0||||||
3907166|NCT01471782|3730823|B5|Asian||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|0|0.0||||||
3907167|NCT01471782|3730824|B4|Asian||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|0|0.0||||||
3907168|NCT01471782|3730825|B3|Asian||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|0|0.0||||||
3907169|NCT01471782|3730826|B2|Asian||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|0|0.0||||||
3907170|NCT01471782|3730827|B1|Asian||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|0|0.0||||||
3907171|NCT01471782|3730821|B7|White||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|77|77.0||||||
3907172|NCT01471782|3730822|B6|White||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|33|33.0||||||
3907173|NCT01471782|3730823|B5|White||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|22|22.0||||||
3907174|NCT01471782|3730824|B4|White||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|5|5.0||||||
3907175|NCT01471782|3730825|B3|White||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|5|5.0||||||
3907176|NCT01471782|3730826|B2|White||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|7|7.0||||||
3907177|NCT01471782|3730827|B1|White||Race/Ethnicity, Customized|Race was not recorded for any patient from France and for two further patients.|participants|Number|5|5.0||||||
3907178|NCT01471782|3730821|B7||Male|Gender||Participants|Count of Participants|60|60.0||||||
3907179|NCT01471782|3730822|B6||Male|Gender||Participants|Count of Participants|32|32.0||||||
3907180|NCT01471782|3730823|B5||Male|Gender||Participants|Count of Participants|15|15.0||||||
3907181|NCT01471782|3730824|B4||Male|Gender||Participants|Count of Participants|5|5.0||||||
3907182|NCT01471782|3730825|B3||Male|Gender||Participants|Count of Participants|3|3.0||||||
3907183|NCT01471782|3730826|B2||Male|Gender||Participants|Count of Participants|3|3.0||||||
3907184|NCT01471782|3730827|B1||Male|Gender||Participants|Count of Participants|2|2.0||||||
3907185|NCT01471782|3730821|B7||Female|Gender||Participants|Count of Participants|33|33.0||||||
3907186|NCT01471782|3730822|B6||Female|Gender||Participants|Count of Participants|12|12.0||||||
3907187|NCT01471782|3730823|B5||Female|Gender||Participants|Count of Participants|11|11.0||||||
3907188|NCT01471782|3730824|B4||Female|Gender||Participants|Count of Participants|1|1.0||||||
3907189|NCT01471782|3730825|B3||Female|Gender||Participants|Count of Participants|2|2.0||||||
3907190|NCT01471782|3730826|B2||Female|Gender||Participants|Count of Participants|4|4.0||||||
3907191|NCT01471782|3730827|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
3907192|NCT01471782|3730821|B7|7 - 17 years||Age, Customized||participants|Number|49|49.0||||||
3907193|NCT01471782|3730822|B6|7 - 17 years||Age, Customized||participants|Number|31|31.0||||||
3907194|NCT01471782|3730823|B5|7 - 17 years||Age, Customized||participants|Number|9|9.0||||||
3907195|NCT01471782|3730824|B4|7 - 17 years||Age, Customized||participants|Number|2|2.0||||||
3907196|NCT01471782|3730825|B3|7 - 17 years||Age, Customized||participants|Number|3|3.0||||||
3907197|NCT01471782|3730826|B2|7 - 17 years||Age, Customized||participants|Number|2|2.0||||||
3907198|NCT01471782|3730827|B1|7 - 17 years||Age, Customized||participants|Number|2|2.0||||||
3907199|NCT01471782|3730821|B7|2 - 6 years||Age, Customized||participants|Number|34|34.0||||||
3907200|NCT01471782|3730822|B6|2 - 6 years||Age, Customized||participants|Number|11|11.0||||||
3907201|NCT01471782|3730823|B5|2 - 6 years||Age, Customized||participants|Number|9|9.0||||||
3907202|NCT01471782|3730824|B4|2 - 6 years||Age, Customized||participants|Number|4|4.0||||||
3907203|NCT01471782|3730825|B3|2 - 6 years||Age, Customized||participants|Number|2|2.0||||||
3907204|NCT01471782|3730826|B2|2 - 6 years||Age, Customized||participants|Number|5|5.0||||||
3907205|NCT01471782|3730827|B1|2 - 6 years||Age, Customized||participants|Number|3|3.0||||||
3907206|NCT01471782|3730821|B7|< 2 years||Age, Customized||participants|Number|10|10.0||||||
3907207|NCT01471782|3730822|B6|< 2 years||Age, Customized||participants|Number|2|2.0||||||
3907208|NCT01471782|3730823|B5|< 2 years||Age, Customized||participants|Number|8|8.0||||||
3907209|NCT01471782|3730824|B4|< 2 years||Age, Customized||participants|Number|0|0.0||||||
3907210|NCT01471782|3730825|B3|< 2 years||Age, Customized||participants|Number|0|0.0||||||
3907211|NCT01471782|3730826|B2|< 2 years||Age, Customized||participants|Number|0|0.0||||||
3907212|NCT01471782|3730827|B1|< 2 years||Age, Customized||participants|Number|0|0.0||||||
3907213|NCT01471691|3730884|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
3907214|NCT01471691|3730885|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3907215|NCT01471691|3730886|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3907216|NCT01471691|3730884|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3907217|NCT01471691|3730885|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3907218|NCT01471691|3730886|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3907219|NCT01471691|3730884|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3907220|NCT01471691|3730885|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3907221|NCT01471691|3730886|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3907222|NCT01471691|3730884|B3|||Age||years|Mean|75|75.0|Standard Deviation|5.0|5.0|||
3907223|NCT01471691|3730885|B2|||Age||years|Mean|78|78.0|Standard Deviation|5.0|5.0|||
3907224|NCT01471691|3730886|B1|||Age||years|Mean|73|73.0|Standard Deviation|5.0|5.0|||
3907225|NCT01471379|3730893|B4|United States||Region of Enrollment||participants|Number|2|2.0||||||
3907226|NCT01471379|3730895|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3907227|NCT01471379|3730896|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3907228|NCT01471379|3730893|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3907229|NCT01471379|3730895|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3907230|NCT01471379|3730896|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3907231|NCT01471379|3730893|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3907232|NCT01471379|3730895|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3907233|NCT01471379|3730896|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3907234|NCT01471379|3730893|B4|||Age||years|Mean|56.5|56.5|Standard Deviation|9.5|9.5|||
3907235|NCT01471379|3730895|B2|||Age||years|Mean|66|66.0|Standard Deviation|0|0.0|||
3907238|NCT01471379|3730895|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3907239|NCT01471379|3730896|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3907240|NCT01471379|3730893|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3907241|NCT01471379|3730895|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3907242|NCT01471379|3730896|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3907243|NCT01471379|3730893|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3907244|NCT01471379|3730895|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3907245|NCT01471379|3730896|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3907246|NCT01471353|3730918|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
3907247|NCT01471353|3730918|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907248|NCT01471353|3730918|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907249|NCT01471353|3730918|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3907250|NCT01471353|3730918|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3907251|NCT01471353|3730918|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907252|NCT01471353|3730918|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907253|NCT01471353|3730918|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907254|NCT01471353|3730918|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907255|NCT01471353|3730918|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3907256|NCT01471353|3730918|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907257|NCT01471353|3730918|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3907258|NCT01471353|3730918|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3907259|NCT01471353|3730918|B1|||Age||years|Mean|57|57.0|Full Range|||36.0|79.0|
3907260|NCT01471353|3730918|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3907261|NCT01471353|3730918|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3907262|NCT01471353|3730918|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3907263|NCT01471340|3730927|B3|MF 400 mcg||Treatment Covariates (MF/F or MF) and ICS Dose Level (100 or 200 mcg, per actuation)|The primary safety hypothesis will be evaluated using Cox proportional-hazard model including covariates of treatment (MF/F MDI BID vs MF MDI BID) and ICS dose level (100 mcg vs 200 mcg, per actuation).|Participants|Count of Participants|2260|2260.0||||||
3907264|NCT01471340|3730928|B2|MF 400 mcg||Treatment Covariates (MF/F or MF) and ICS Dose Level (100 or 200 mcg, per actuation)|The primary safety hypothesis will be evaluated using Cox proportional-hazard model including covariates of treatment (MF/F MDI BID vs MF MDI BID) and ICS dose level (100 mcg vs 200 mcg, per actuation).|Participants|Count of Participants|2260|2260.0||||||
3907265|NCT01471340|3730929|B1|MF 400 mcg||Treatment Covariates (MF/F or MF) and ICS Dose Level (100 or 200 mcg, per actuation)|The primary safety hypothesis will be evaluated using Cox proportional-hazard model including covariates of treatment (MF/F MDI BID vs MF MDI BID) and ICS dose level (100 mcg vs 200 mcg, per actuation).|Participants|Count of Participants|0|0.0||||||
3907266|NCT01471340|3730927|B3|MF 200 mcg||Treatment Covariates (MF/F or MF) and ICS Dose Level (100 or 200 mcg, per actuation)|The primary safety hypothesis will be evaluated using Cox proportional-hazard model including covariates of treatment (MF/F MDI BID vs MF MDI BID) and ICS dose level (100 mcg vs 200 mcg, per actuation).|Participants|Count of Participants|3601|3601.0||||||
3907267|NCT01471340|3730928|B2|MF 200 mcg||Treatment Covariates (MF/F or MF) and ICS Dose Level (100 or 200 mcg, per actuation)|The primary safety hypothesis will be evaluated using Cox proportional-hazard model including covariates of treatment (MF/F MDI BID vs MF MDI BID) and ICS dose level (100 mcg vs 200 mcg, per actuation).|Participants|Count of Participants|3601|3601.0||||||
3907268|NCT01471340|3730929|B1|MF 200 mcg||Treatment Covariates (MF/F or MF) and ICS Dose Level (100 or 200 mcg, per actuation)|The primary safety hypothesis will be evaluated using Cox proportional-hazard model including covariates of treatment (MF/F MDI BID vs MF MDI BID) and ICS dose level (100 mcg vs 200 mcg, per actuation).|Participants|Count of Participants|0|0.0||||||
3907269|NCT01471340|3730927|B3|MF/F 400/10 mcg||Treatment Covariates (MF/F or MF) and ICS Dose Level (100 or 200 mcg, per actuation)|The primary safety hypothesis will be evaluated using Cox proportional-hazard model including covariates of treatment (MF/F MDI BID vs MF MDI BID) and ICS dose level (100 mcg vs 200 mcg, per actuation).|Participants|Count of Participants|2264|2264.0||||||
3907270|NCT01471340|3730928|B2|MF/F 400/10 mcg||Treatment Covariates (MF/F or MF) and ICS Dose Level (100 or 200 mcg, per actuation)|The primary safety hypothesis will be evaluated using Cox proportional-hazard model including covariates of treatment (MF/F MDI BID vs MF MDI BID) and ICS dose level (100 mcg vs 200 mcg, per actuation).|Participants|Count of Participants|0|0.0||||||
3907271|NCT01471340|3730929|B1|MF/F 400/10 mcg||Treatment Covariates (MF/F or MF) and ICS Dose Level (100 or 200 mcg, per actuation)|The primary safety hypothesis will be evaluated using Cox proportional-hazard model including covariates of treatment (MF/F MDI BID vs MF MDI BID) and ICS dose level (100 mcg vs 200 mcg, per actuation).|Participants|Count of Participants|2264|2264.0||||||
3907272|NCT01471340|3730927|B3|MF/F 200/10 mcg||Treatment Covariates (MF/F or MF) and ICS Dose Level (100 or 200 mcg, per actuation)|The primary safety hypothesis will be evaluated using Cox proportional-hazard model including covariates of treatment (MF/F MDI BID vs MF MDI BID) and ICS dose level (100 mcg vs 200 mcg, per actuation).|Participants|Count of Participants|3604|3604.0||||||
3907273|NCT01471340|3730928|B2|MF/F 200/10 mcg||Treatment Covariates (MF/F or MF) and ICS Dose Level (100 or 200 mcg, per actuation)|The primary safety hypothesis will be evaluated using Cox proportional-hazard model including covariates of treatment (MF/F MDI BID vs MF MDI BID) and ICS dose level (100 mcg vs 200 mcg, per actuation).|Participants|Count of Participants|0|0.0||||||
3907378|NCT01471015|3731014|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3907274|NCT01471340|3730929|B1|MF/F 200/10 mcg||Treatment Covariates (MF/F or MF) and ICS Dose Level (100 or 200 mcg, per actuation)|The primary safety hypothesis will be evaluated using Cox proportional-hazard model including covariates of treatment (MF/F MDI BID vs MF MDI BID) and ICS dose level (100 mcg vs 200 mcg, per actuation).|Participants|Count of Participants|3604|3604.0||||||
3907275|NCT01471340|3730927|B3||Male|Sex: Female, Male||Participants|Count of Participants|4013|4013.0||||||
3907276|NCT01471340|3730928|B2||Male|Sex: Female, Male||Participants|Count of Participants|1986|1986.0||||||
3907277|NCT01471340|3730929|B1||Male|Sex: Female, Male||Participants|Count of Participants|2027|2027.0||||||
3907278|NCT01471340|3730927|B3||Female|Sex: Female, Male||Participants|Count of Participants|7716|7716.0||||||
3907279|NCT01471340|3730928|B2||Female|Sex: Female, Male||Participants|Count of Participants|3875|3875.0||||||
3907280|NCT01471340|3730929|B1||Female|Sex: Female, Male||Participants|Count of Participants|3841|3841.0||||||
3907281|NCT01471340|3730927|B3|||Age||Years|Mean|45.1|45.1|Standard Deviation|17.37|17.37|||
3907282|NCT01471340|3730928|B2|||Age||Years|Mean|44.8|44.8|Standard Deviation|17.55|17.55|||
3907283|NCT01471340|3730929|B1|||Age||Years|Mean|45.3|45.3|Standard Deviation|17.19|17.19|||
3907284|NCT01471639|3730940|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
3907285|NCT01471639|3730940|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907286|NCT01471639|3730940|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907287|NCT01471639|3730940|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3907288|NCT01471639|3730940|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3907289|NCT01471639|3730940|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907290|NCT01471639|3730940|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907291|NCT01471639|3730940|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907292|NCT01471639|3730940|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3907293|NCT01471639|3730940|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3907294|NCT01471639|3730940|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3907295|NCT01471639|3730940|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3907296|NCT01471639|3730940|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3907297|NCT01471639|3730940|B1|||Age||years|Mean|37.2|37.2|Standard Deviation|11.3|11.3|||
3907298|NCT01471639|3730940|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3907299|NCT01471639|3730940|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3907300|NCT01471639|3730940|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3907301|NCT01471626|3730945|B1|Belgium||Region of Enrollment||participants|Number|21|21.0||||||
3907302|NCT01471626|3730945|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3907303|NCT01471626|3730945|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3907304|NCT01471626|3730945|B1|||Age||years|Mean|50|50.0|Standard Deviation|11|11.0|||
3907305|NCT01471626|3730945|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3907306|NCT01471626|3730945|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3907307|NCT01471626|3730945|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3907308|NCT01471574|3730949|B5||Male|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
3907309|NCT01471574|3730950|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3907310|NCT01471574|3730951|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3907311|NCT01471574|3730952|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3907312|NCT01471574|3730953|B1||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3907313|NCT01471574|3730949|B5||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3907314|NCT01471574|3730950|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3907315|NCT01471574|3730951|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3907316|NCT01471574|3730952|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3907317|NCT01471574|3730953|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3907318|NCT01471574|3730949|B5|65 years and older||Age, Customized||participants|Number|9|9.0||||||
3907319|NCT01471574|3730950|B4|65 years and older||Age, Customized||participants|Number|0|0.0||||||
3907320|NCT01471574|3730951|B3|65 years and older||Age, Customized||participants|Number|2|2.0||||||
3907321|NCT01471574|3730952|B2|65 years and older||Age, Customized||participants|Number|0|0.0||||||
3907322|NCT01471574|3730953|B1|65 years and older||Age, Customized||participants|Number|7|7.0||||||
3907323|NCT01471574|3730949|B5|Younger than 65 years||Age, Customized||participants|Number|292|292.0||||||
3907324|NCT01471574|3730950|B4|Younger than 65 years||Age, Customized||participants|Number|24|24.0||||||
3907325|NCT01471574|3730951|B3|Younger than 65 years||Age, Customized||participants|Number|104|104.0||||||
3907326|NCT01471574|3730952|B2|Younger than 65 years||Age, Customized||participants|Number|39|39.0||||||
3907327|NCT01471574|3730953|B1|Younger than 65 years||Age, Customized||participants|Number|125|125.0||||||
3907328|NCT01471574|3730949|B5|||Age||years|Mean|46.1|46.1|Standard Deviation|9.90|9.9|||
3907329|NCT01471574|3730950|B4|||Age||years|Mean|36|36.0|Standard Deviation|9.02|9.02|||
3907330|NCT01471574|3730951|B3|||Age||years|Mean|46.5|46.5|Standard Deviation|9.42|9.42|||
3907331|NCT01471574|3730952|B2|||Age||years|Mean|47.9|47.9|Standard Deviation|9.03|9.03|||
3907332|NCT01471574|3730953|B1|||Age||years|Mean|47|47.0|Standard Deviation|9.72|9.72|||
3907333|NCT01471197|3730985|B3|ECOG PS 1||Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group Performance Status (ECOG PS) is a questionnaire which measures the activity of a an oncology patient. Measurements range from 0 to 5 with 0=fully active; 1= restricted in physically strenuous activity; 2= ambulatory; 3=limited self care; 4= completely disabled; 5=dead.|participants|Number|4|4.0||||||
3907334|NCT01471197|3730986|B2|ECOG PS 1||Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group Performance Status (ECOG PS) is a questionnaire which measures the activity of a an oncology patient. Measurements range from 0 to 5 with 0=fully active; 1= restricted in physically strenuous activity; 2= ambulatory; 3=limited self care; 4= completely disabled; 5=dead.|participants|Number|1|1.0||||||
3907335|NCT01471197|3730987|B1|ECOG PS 1||Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group Performance Status (ECOG PS) is a questionnaire which measures the activity of a an oncology patient. Measurements range from 0 to 5 with 0=fully active; 1= restricted in physically strenuous activity; 2= ambulatory; 3=limited self care; 4= completely disabled; 5=dead.|participants|Number|3|3.0||||||
3907336|NCT01471197|3730985|B3|ECOG PS 0||Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group Performance Status (ECOG PS) is a questionnaire which measures the activity of a an oncology patient. Measurements range from 0 to 5 with 0=fully active; 1= restricted in physically strenuous activity; 2= ambulatory; 3=limited self care; 4= completely disabled; 5=dead.|participants|Number|4|4.0||||||
3907337|NCT01471197|3730986|B2|ECOG PS 0||Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group Performance Status (ECOG PS) is a questionnaire which measures the activity of a an oncology patient. Measurements range from 0 to 5 with 0=fully active; 1= restricted in physically strenuous activity; 2= ambulatory; 3=limited self care; 4= completely disabled; 5=dead.|participants|Number|1|1.0||||||
3907338|NCT01471197|3730987|B1|ECOG PS 0||Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group Performance Status (ECOG PS) is a questionnaire which measures the activity of a an oncology patient. Measurements range from 0 to 5 with 0=fully active; 1= restricted in physically strenuous activity; 2= ambulatory; 3=limited self care; 4= completely disabled; 5=dead.|participants|Number|3|3.0||||||
3907339|NCT01471197|3730985|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3907340|NCT01471197|3730986|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3907341|NCT01471197|3730987|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3907342|NCT01471197|3730985|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3907343|NCT01471197|3730986|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3907344|NCT01471197|3730987|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3907345|NCT01471197|3730985|B3|Greater than, equal to (>=) 65 years||Age, Customized||participants|Number|2|2.0||||||
3907346|NCT01471197|3730986|B2|Greater than, equal to (>=) 65 years||Age, Customized||participants|Number|0|0.0||||||
3907347|NCT01471197|3730987|B1|Greater than, equal to (>=) 65 years||Age, Customized||participants|Number|2|2.0||||||
3907348|NCT01471197|3730985|B3|Less than (<) 65 years||Age, Customized||participants|Number|6|6.0||||||
3907349|NCT01471197|3730986|B2|Less than (<) 65 years||Age, Customized||participants|Number|2|2.0||||||
3907350|NCT01471197|3730987|B1|Less than (<) 65 years||Age, Customized||participants|Number|4|4.0||||||
3907351|NCT01471197|3730985|B3|||Age||years|Mean|62.3|62.3|Standard Deviation|7.54|7.54|||
3907352|NCT01471197|3730986|B2|||Age||years|Mean|61.0|61.0|Standard Deviation|1.41|1.41|||
3907353|NCT01471197|3730987|B1|||Age||years|Mean|62.7|62.7|Standard Deviation|8.85|8.85|||
3907354|NCT01471171|3730998|B1|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3907355|NCT01471171|3730998|B1|Germany||Region of Enrollment||participants|Number|89|89.0||||||
3907356|NCT01471171|3730998|B1|Spain||Region of Enrollment||participants|Number|20|20.0||||||
3907357|NCT01471171|3730998|B1||Male|Gender||Participants|Count of Participants|76|76.0||||||
3907358|NCT01471171|3730998|B1||Female|Gender||Participants|Count of Participants|36|36.0||||||
3907359|NCT01471171|3730998|B1|||Age||years|Mean|60.3|60.3|Standard Deviation|8.1|8.1|||
3907360|NCT01471041|3731009|B1|United States||Region of Enrollment||participants|Number|54|54.0||||||
3907361|NCT01471041|3731009|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907362|NCT01471041|3731009|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907363|NCT01471041|3731009|B1||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3907364|NCT01471041|3731009|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3907365|NCT01471041|3731009|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3907366|NCT01471041|3731009|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907367|NCT01471041|3731009|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3907368|NCT01471041|3731009|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907369|NCT01471041|3731009|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3907370|NCT01471041|3731009|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3907371|NCT01471041|3731009|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3907372|NCT01471041|3731009|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3907373|NCT01471041|3731009|B1|||Age||Years|Mean|60|60.0|Standard Deviation|14|14.0|||
3907374|NCT01471015|3731014|B4|United States||Region of Enrollment||participants|Number|30|30.0||||||
3907375|NCT01471015|3731015|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3907376|NCT01471015|3731016|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3907377|NCT01471015|3731017|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3907379|NCT01471015|3731015|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3907380|NCT01471015|3731016|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3907381|NCT01471015|3731017|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3907382|NCT01471015|3731014|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3907383|NCT01471015|3731015|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3907384|NCT01471015|3731016|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3907385|NCT01471015|3731017|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3907386|NCT01471015|3731014|B4|||Age||days|Mean|1|1.0|Full Range|||1.0|1.0|
3907387|NCT01471015|3731015|B3|||Age||days|Mean|1|1.0|Full Range|||1.0|1.0|
3907388|NCT01471015|3731016|B2|||Age||days|Mean|1|1.0|Full Range|||1.0|1.0|
3907389|NCT01471015|3731017|B1|||Age||days|Mean|1|1.0|Full Range|||1.0|1.0|
3907390|NCT01470859|3731031|B3|China||Region of Enrollment||participants|Number|29|29.0||||||
3907391|NCT01470859|3731032|B2|China||Region of Enrollment||participants|Number|14|14.0||||||
3907392|NCT01470859|3731033|B1|China||Region of Enrollment||participants|Number|15|15.0||||||
3907393|NCT01470859|3731031|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3907394|NCT01470859|3731032|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3907395|NCT01470859|3731033|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3907396|NCT01470859|3731031|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3907397|NCT01470859|3731032|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3907398|NCT01470859|3731033|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3907399|NCT01470859|3731031|B3|||Age||years|Mean|62.9|62.9|Standard Deviation|6.14|6.14|||
3907400|NCT01470859|3731032|B2|||Age||years|Mean|61.9|61.9|Standard Deviation|6.66|6.66|||
3907401|NCT01470859|3731033|B1|||Age||years|Mean|63.87|63.87|Standard Deviation|5.68|5.68|||
3907402|NCT01470651|3731048|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
3907403|NCT01470651|3731049|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3907404|NCT01470651|3731050|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3907405|NCT01470651|3731048|B3||Male|Gender||Participants|Count of Participants|20|20.0||||||
3907406|NCT01470651|3731049|B2||Male|Gender||Participants|Count of Participants|10|10.0||||||
3907407|NCT01470651|3731050|B1||Male|Gender||Participants|Count of Participants|10|10.0||||||
3907408|NCT01470651|3731048|B3||Female|Gender||Participants|Count of Participants|6|6.0||||||
3907409|NCT01470651|3731049|B2||Female|Gender||Participants|Count of Participants|3|3.0||||||
3907410|NCT01470651|3731050|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
3907411|NCT01470651|3731048|B3|||Age||years|Mean|55.5|55.5|Full Range|||28.0|70.0|
3907412|NCT01470651|3731049|B2|||Age||years|Mean|57.23|57.23|Full Range|||36.0|70.0|
3907413|NCT01470651|3731050|B1|||Age||years|Mean|53.77|53.77|Full Range|||28.0|65.0|
3907414|NCT01470651|3731048|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3907415|NCT01470651|3731049|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3907416|NCT01470651|3731050|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3907417|NCT01470651|3731048|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3907418|NCT01470651|3731049|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3907419|NCT01470651|3731050|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3907420|NCT01470651|3731048|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3907421|NCT01470651|3731049|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3907422|NCT01470651|3731050|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3907423|NCT01470599|3731059|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3907424|NCT01470599|3731060|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3907425|NCT01470599|3731061|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3907426|NCT01470599|3731059|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3907427|NCT01470599|3731060|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3907428|NCT01470599|3731061|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3907429|NCT01470599|3731059|B3|||Age||Years|Mean|39.4|39.4|Standard Deviation|12.1|12.1|||
3907430|NCT01470599|3731060|B2|||Age||Years|Mean|38.2|38.2|Standard Deviation|11.6|11.6|||
3907431|NCT01470599|3731061|B1|||Age||Years|Mean|41.0|41.0|Standard Deviation|12.6|12.6|||
3907432|NCT01470469|3731124|B3|UNITED STATES||Region of Enrollment||Participants|Number|83|83.0||||||
3907433|NCT01470469|3731125|B2|UNITED STATES||Region of Enrollment||Participants|Number|62|62.0||||||
3907434|NCT01470469|3731126|B1|UNITED STATES||Region of Enrollment||Participants|Number|21|21.0||||||
3907435|NCT01470469|3731124|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3907436|NCT01470469|3731125|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3907437|NCT01470469|3731126|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3907438|NCT01470469|3731124|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3907439|NCT01470469|3731125|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3907440|NCT01470469|3731126|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3907441|NCT01470469|3731124|B3|Age 13-17 years||Age, Customized||Participants|Number|33|33.0||||||
3907442|NCT01470469|3731125|B2|Age 13-17 years||Age, Customized||Participants|Number|24|24.0||||||
3907443|NCT01470469|3731126|B1|Age 13-17 years||Age, Customized||Participants|Number|9|9.0||||||
3907444|NCT01470469|3731124|B3|Age 6-12 years||Age, Customized||Participants|Number|50|50.0||||||
3907445|NCT01470469|3731125|B2|Age 6-12 years||Age, Customized||Participants|Number|38|38.0||||||
3907446|NCT01470469|3731126|B1|Age 6-12 years||Age, Customized||Participants|Number|12|12.0||||||
3907447|NCT01470469|3731124|B3|||Age||Years|Mean|11.7|11.7|Standard Deviation|3.38|3.38|||
3907448|NCT01470469|3731125|B2|||Age||Years|Mean|11.7|11.7|Standard Deviation|3.39|3.39|||
3907449|NCT01470469|3731126|B1|||Age||Years|Mean|11.8|11.8|Standard Deviation|3.46|3.46|||
3907450|NCT01470417|3731145|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3907451|NCT01470417|3731146|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3907452|NCT01470417|3731147|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3907453|NCT01470417|3731145|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3907454|NCT01470417|3731146|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3907455|NCT01470417|3731147|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3907456|NCT01470417|3731145|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3907457|NCT01470417|3731146|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3907458|NCT01470417|3731147|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3907459|NCT01470417|3731145|B3|||Age||years|Mean|67.9|67.9|Full Range|||55.0|78.0|
3907460|NCT01470417|3731146|B2|||Age||years|Mean|67.3|67.3|Full Range|||55.0|78.0|
3907461|NCT01470417|3731147|B1|||Age||years|Mean|69.3|69.3|Full Range|||64.0|78.0|
3907462|NCT01470326|3731160|B1|Unknown||Fracture History||Participants|Count of Participants|385|385.0||||||
3907463|NCT01470326|3731160|B1|No||Fracture History||Participants|Count of Participants|1807|1807.0||||||
3907464|NCT01470326|3731160|B1|Yes||Fracture History||Participants|Count of Participants|842|842.0||||||
3907465|NCT01470326|3731160|B1|No||Use of Concomitant Medication||Participants|Count of Participants|931|931.0||||||
3907466|NCT01470326|3731160|B1|Yes||Use of Concomitant Medication||Participants|Count of Participants|2103|2103.0||||||
3907467|NCT01470326|3731160|B1|Unknown||Use of Previous Medication||Participants|Count of Participants|116|116.0||||||
3907468|NCT01470326|3731160|B1|No||Use of Previous Medication||Participants|Count of Participants|1647|1647.0||||||
3907469|NCT01470326|3731160|B1|Yes||Use of Previous Medication||Participants|Count of Participants|1271|1271.0||||||
3907470|NCT01470326|3731160|B1|Unknown||Use of Steroid||Participants|Count of Participants|410|410.0||||||
3907471|NCT01470326|3731160|B1|No||Use of Steroid||Participants|Count of Participants|2523|2523.0||||||
3907472|NCT01470326|3731160|B1|Yes||Use of Steroid||Participants|Count of Participants|101|101.0||||||
3907473|NCT01470326|3731160|B1|Unknown||Smoking Status||Participants|Count of Participants|729|729.0||||||
3907474|NCT01470326|3731160|B1|Non-Smoker||Smoking Status||Participants|Count of Participants|2211|2211.0||||||
3907475|NCT01470326|3731160|B1|Smoker||Smoking Status||Participants|Count of Participants|94|94.0||||||
3907476|NCT01470326|3731160|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3907477|NCT01470326|3731160|B1||Female|Sex: Female, Male||Participants|Count of Participants|3034|3034.0||||||
3907478|NCT01470326|3731160|B1|≥65 years||Age, Customized||Participants|Count of Participants|2520|2520.0||||||
3907479|NCT01470326|3731160|B1|≥15 and <65 years||Age, Customized||Participants|Count of Participants|514|514.0||||||
3907480|NCT01470326|3731160|B1|<15 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3907481|NCT01470248|3731171|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3907482|NCT01470248|3731171|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907483|NCT01470248|3731171|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907484|NCT01470248|3731171|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3907485|NCT01470248|3731171|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3907486|NCT01470248|3731171|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907487|NCT01470248|3731171|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907488|NCT01470248|3731171|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907489|NCT01470248|3731171|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3907490|NCT01470248|3731171|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3907491|NCT01470248|3731171|B1|||Age||years|Mean|63.40|63.4|Standard Deviation|10.67|10.67|||
3907492|NCT01470196|3731178|B1|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3907493|NCT01470196|3731178|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3907494|NCT01470196|3731178|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3907495|NCT01470196|3731178|B1|||Age||years|Median|61|61.0|Full Range|||47.0|75.0|
3907496|NCT01470196|3731178|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3907497|NCT01470196|3731178|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3907498|NCT01470196|3731178|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3907499|NCT01470170|3731186|B6|||SpO2||percentage of saturation|Mean|98.9|98.9|Standard Deviation|1.4|1.4|||
3907500|NCT01470170|3731187|B5|||SpO2||percentage of saturation|Mean|99.1|99.1|Standard Deviation|1.5|1.5|||
3907501|NCT01470170|3731188|B4|||SpO2||percentage of saturation|Mean|99.2|99.2|Standard Deviation|1.3|1.3|||
3907502|NCT01470170|3731189|B3|||SpO2||percentage of saturation|Mean|99.0|99.0|Standard Deviation|1.4|1.4|||
3907503|NCT01470170|3731190|B2|||SpO2||percentage of saturation|Mean|98.6|98.6|Standard Deviation|1.5|1.5|||
3907504|NCT01470170|3731191|B1|||SpO2||percentage of saturation|Mean|98.8|98.8|Standard Deviation|1.5|1.5|||
3907505|NCT01470170|3731186|B6|||DBP||mmHg|Mean|79.2|79.2|Standard Deviation|12.2|12.2|||
3907506|NCT01470170|3731187|B5|||DBP||mmHg|Mean|80.2|80.2|Standard Deviation|11.4|11.4|||
3907507|NCT01470170|3731188|B4|||DBP||mmHg|Mean|79.5|79.5|Standard Deviation|12.1|12.1|||
3907508|NCT01470170|3731189|B3|||DBP||mmHg|Mean|76.9|76.9|Standard Deviation|11.8|11.8|||
3907509|NCT01470170|3731190|B2|||DBP||mmHg|Mean|78.7|78.7|Standard Deviation|13.5|13.5|||
3907510|NCT01470170|3731191|B1|||DBP||mmHg|Mean|80.8|80.8|Standard Deviation|12.7|12.7|||
3907511|NCT01470170|3731186|B6|||SBP||mmHg|Mean|142.9|142.9|Standard Deviation|21.5|21.5|||
3907512|NCT01470170|3731187|B5|||SBP||mmHg|Mean|145.8|145.8|Standard Deviation|20.5|20.5|||
3907513|NCT01470170|3731188|B4|||SBP||mmHg|Mean|142.4|142.4|Standard Deviation|21.5|21.5|||
3907514|NCT01470170|3731189|B3|||SBP||mmHg|Mean|139.2|139.2|Standard Deviation|20.8|20.8|||
3907515|NCT01470170|3731190|B2|||SBP||mmHg|Mean|139.9|139.9|Standard Deviation|20.5|20.5|||
3907516|NCT01470170|3731191|B1|||SBP||mmHg|Mean|147.1|147.1|Standard Deviation|24.3|24.3|||
3907517|NCT01470170|3731186|B6|||heart rate||beats/min|Mean|78.6|78.6|Standard Deviation|14.4|14.4|||
3907518|NCT01470170|3731187|B5|||heart rate||beats/min|Mean|80.2|80.2|Standard Deviation|11.4|11.4|||
3907519|NCT01470170|3731188|B4|||heart rate||beats/min|Mean|80.3|80.3|Standard Deviation|14.5|14.5|||
3907520|NCT01470170|3731189|B3|||heart rate||beats/min|Mean|73.9|73.9|Standard Deviation|14.2|14.2|||
3907521|NCT01470170|3731190|B2|||heart rate||beats/min|Mean|78.1|78.1|Standard Deviation|12.6|12.6|||
3907522|NCT01470170|3731191|B1|||heart rate||beats/min|Mean|80.3|80.3|Standard Deviation|15.5|15.5|||
3907523|NCT01470170|3731186|B6|ex-||smoking status||participants|Number|31|31.0||||||
3907524|NCT01470170|3731187|B5|ex-||smoking status||participants|Number|8|8.0||||||
3907525|NCT01470170|3731188|B4|ex-||smoking status||participants|Number|6|6.0||||||
3907526|NCT01470170|3731189|B3|ex-||smoking status||participants|Number|5|5.0||||||
3907527|NCT01470170|3731190|B2|ex-||smoking status||participants|Number|5|5.0||||||
3907528|NCT01470170|3731191|B1|ex-||smoking status||participants|Number|7|7.0||||||
3907529|NCT01470170|3731186|B6|current||smoking status||participants|Number|44|44.0||||||
3907530|NCT01470170|3731187|B5|current||smoking status||participants|Number|6|6.0||||||
3907531|NCT01470170|3731188|B4|current||smoking status||participants|Number|11|11.0||||||
3907532|NCT01470170|3731189|B3|current||smoking status||participants|Number|8|8.0||||||
3907533|NCT01470170|3731190|B2|current||smoking status||participants|Number|12|12.0||||||
3907534|NCT01470170|3731191|B1|current||smoking status||participants|Number|7|7.0||||||
3907535|NCT01470170|3731186|B6|never||smoking status||participants|Number|98|98.0||||||
3907536|NCT01470170|3731187|B5|never||smoking status||participants|Number|20|20.0||||||
3907537|NCT01470170|3731188|B4|never||smoking status||participants|Number|19|19.0||||||
3907538|NCT01470170|3731189|B3|never||smoking status||participants|Number|21|21.0||||||
3907539|NCT01470170|3731190|B2|never||smoking status||participants|Number|18|18.0||||||
3907540|NCT01470170|3731191|B1|never||smoking status||participants|Number|20|20.0||||||
3907541|NCT01470170|3731186|B6|||Alcohol use|alcohol drinking for more than 5 days per week|participants|Number|17|17.0||||||
3907542|NCT01470170|3731187|B5|||Alcohol use|alcohol drinking for more than 5 days per week|participants|Number|4|4.0||||||
3907543|NCT01470170|3731188|B4|||Alcohol use|alcohol drinking for more than 5 days per week|participants|Number|5|5.0||||||
3907544|NCT01470170|3731189|B3|||Alcohol use|alcohol drinking for more than 5 days per week|participants|Number|1|1.0||||||
3907545|NCT01470170|3731190|B2|||Alcohol use|alcohol drinking for more than 5 days per week|participants|Number|4|4.0||||||
3907546|NCT01470170|3731191|B1|||Alcohol use|alcohol drinking for more than 5 days per week|participants|Number|3|3.0||||||
3907547|NCT01470170|3731186|B6|||Regular use of sedation drugs|use of sleeping pill or sedative medication for more than 5 days per week|participants|Number|17|17.0||||||
3907548|NCT01470170|3731187|B5|||Regular use of sedation drugs|use of sleeping pill or sedative medication for more than 5 days per week|participants|Number|3|3.0||||||
3907549|NCT01470170|3731188|B4|||Regular use of sedation drugs|use of sleeping pill or sedative medication for more than 5 days per week|participants|Number|5|5.0||||||
3907550|NCT01470170|3731189|B3|||Regular use of sedation drugs|use of sleeping pill or sedative medication for more than 5 days per week|participants|Number|4|4.0||||||
3907551|NCT01470170|3731190|B2|||Regular use of sedation drugs|use of sleeping pill or sedative medication for more than 5 days per week|participants|Number|2|2.0||||||
3907552|NCT01470170|3731191|B1|||Regular use of sedation drugs|use of sleeping pill or sedative medication for more than 5 days per week|participants|Number|3|3.0||||||
3907553|NCT01470170|3731186|B6|||Regular use of opioid|use of opioid related medication for more than 5 days per week|participants|Number|3|3.0||||||
3907554|NCT01470170|3731187|B5|||Regular use of opioid|use of opioid related medication for more than 5 days per week|participants|Number|0|0.0||||||
3907555|NCT01470170|3731188|B4|||Regular use of opioid|use of opioid related medication for more than 5 days per week|participants|Number|0|0.0||||||
3907556|NCT01470170|3731189|B3|||Regular use of opioid|use of opioid related medication for more than 5 days per week|participants|Number|1|1.0||||||
3907557|NCT01470170|3731190|B2|||Regular use of opioid|use of opioid related medication for more than 5 days per week|participants|Number|1|1.0||||||
3907558|NCT01470170|3731191|B1|||Regular use of opioid|use of opioid related medication for more than 5 days per week|participants|Number|1|1.0||||||
3907559|NCT01470170|3731186|B6|III: soft palate, base of uvula visible||Mallampati Score||participants|Number|82|82.0||||||
3907560|NCT01470170|3731187|B5|III: soft palate, base of uvula visible||Mallampati Score||participants|Number|15|15.0||||||
3907561|NCT01470170|3731188|B4|III: soft palate, base of uvula visible||Mallampati Score||participants|Number|21|21.0||||||
3907562|NCT01470170|3731189|B3|III: soft palate, base of uvula visible||Mallampati Score||participants|Number|16|16.0||||||
3907563|NCT01470170|3731190|B2|III: soft palate, base of uvula visible||Mallampati Score||participants|Number|16|16.0||||||
3907564|NCT01470170|3731191|B1|III: soft palate, base of uvula visible||Mallampati Score||participants|Number|14|14.0||||||
3907565|NCT01470170|3731186|B6|II: soft palate, uvula, fauces visible||Mallampati Score||participants|Number|65|65.0||||||
3907566|NCT01470170|3731187|B5|II: soft palate, uvula, fauces visible||Mallampati Score||participants|Number|12|12.0||||||
3907567|NCT01470170|3731188|B4|II: soft palate, uvula, fauces visible||Mallampati Score||participants|Number|10|10.0||||||
3907568|NCT01470170|3731189|B3|II: soft palate, uvula, fauces visible||Mallampati Score||participants|Number|14|14.0||||||
3907569|NCT01470170|3731190|B2|II: soft palate, uvula, fauces visible||Mallampati Score||participants|Number|13|13.0||||||
3907570|NCT01470170|3731191|B1|II: soft palate, uvula, fauces visible||Mallampati Score||participants|Number|16|16.0||||||
3907571|NCT01470170|3731186|B6|I: soft palate, uvula, fauces, pillars visible||Mallampati Score||participants|Number|26|26.0||||||
3907572|NCT01470170|3731187|B5|I: soft palate, uvula, fauces, pillars visible||Mallampati Score||participants|Number|7|7.0||||||
3907573|NCT01470170|3731188|B4|I: soft palate, uvula, fauces, pillars visible||Mallampati Score||participants|Number|5|5.0||||||
3907574|NCT01470170|3731189|B3|I: soft palate, uvula, fauces, pillars visible||Mallampati Score||participants|Number|4|4.0||||||
3907575|NCT01470170|3731190|B2|I: soft palate, uvula, fauces, pillars visible||Mallampati Score||participants|Number|6|6.0||||||
3907576|NCT01470170|3731191|B1|I: soft palate, uvula, fauces, pillars visible||Mallampati Score||participants|Number|4|4.0||||||
3907577|NCT01470170|3731186|B6|3 Serious, non-incapacitating systemic disease||American Society of Anaethesiology Physical Status Score||participants|Number|30|30.0||||||
3907578|NCT01470170|3731187|B5|3 Serious, non-incapacitating systemic disease||American Society of Anaethesiology Physical Status Score||participants|Number|4|4.0||||||
3907579|NCT01470170|3731188|B4|3 Serious, non-incapacitating systemic disease||American Society of Anaethesiology Physical Status Score||participants|Number|7|7.0||||||
3907580|NCT01470170|3731189|B3|3 Serious, non-incapacitating systemic disease||American Society of Anaethesiology Physical Status Score||participants|Number|4|4.0||||||
3907581|NCT01470170|3731190|B2|3 Serious, non-incapacitating systemic disease||American Society of Anaethesiology Physical Status Score||participants|Number|7|7.0||||||
3907582|NCT01470170|3731191|B1|3 Serious, non-incapacitating systemic disease||American Society of Anaethesiology Physical Status Score||participants|Number|8|8.0||||||
3907583|NCT01470170|3731186|B6|2 Discrete systemic disease||American Society of Anaethesiology Physical Status Score||participants|Number|35|35.0||||||
3907584|NCT01470170|3731187|B5|2 Discrete systemic disease||American Society of Anaethesiology Physical Status Score||participants|Number|6|6.0||||||
3907585|NCT01470170|3731188|B4|2 Discrete systemic disease||American Society of Anaethesiology Physical Status Score||participants|Number|10|10.0||||||
3907586|NCT01470170|3731189|B3|2 Discrete systemic disease||American Society of Anaethesiology Physical Status Score||participants|Number|7|7.0||||||
3907587|NCT01470170|3731190|B2|2 Discrete systemic disease||American Society of Anaethesiology Physical Status Score||participants|Number|5|5.0||||||
3907588|NCT01470170|3731191|B1|2 Discrete systemic disease||American Society of Anaethesiology Physical Status Score||participants|Number|7|7.0||||||
3907589|NCT01470170|3731186|B6|1 Normally healthy||American Society of Anaethesiology Physical Status Score||participants|Number|108|108.0||||||
3907590|NCT01470170|3731187|B5|1 Normally healthy||American Society of Anaethesiology Physical Status Score||participants|Number|24|24.0||||||
3907591|NCT01470170|3731188|B4|1 Normally healthy||American Society of Anaethesiology Physical Status Score||participants|Number|19|19.0||||||
3907592|NCT01470170|3731189|B3|1 Normally healthy||American Society of Anaethesiology Physical Status Score||participants|Number|23|23.0||||||
3907593|NCT01470170|3731190|B2|1 Normally healthy||American Society of Anaethesiology Physical Status Score||participants|Number|23|23.0||||||
3907594|NCT01470170|3731191|B1|1 Normally healthy||American Society of Anaethesiology Physical Status Score||participants|Number|19|19.0||||||
3907595|NCT01470170|3731186|B6|||Body Mass Index||kg/m^2|Mean|23.54|23.54|Standard Deviation|3.5|3.5|||
3907596|NCT01470170|3731187|B5|||Body Mass Index||kg/m^2|Mean|23.2|23.2|Standard Deviation|3.7|3.7|||
3907597|NCT01470170|3731188|B4|||Body Mass Index||kg/m^2|Mean|23.5|23.5|Standard Deviation|3.3|3.3|||
3907598|NCT01470170|3731189|B3|||Body Mass Index||kg/m^2|Mean|23.8|23.8|Standard Deviation|4.5|4.5|||
3907599|NCT01470170|3731190|B2|||Body Mass Index||kg/m^2|Mean|23.5|23.5|Standard Deviation|3.4|3.4|||
3907600|NCT01470170|3731191|B1|||Body Mass Index||kg/m^2|Mean|23.7|23.7|Standard Deviation|2.4|2.4|||
3907601|NCT01470170|3731186|B6||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3907602|NCT01470170|3731187|B5||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3907603|NCT01470170|3731188|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3907604|NCT01470170|3731189|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3907605|NCT01470170|3731190|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3907606|NCT01470170|3731191|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3907607|NCT01470170|3731186|B6||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3907608|NCT01470170|3731187|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3907609|NCT01470170|3731188|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3907610|NCT01470170|3731189|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3907611|NCT01470170|3731190|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3907612|NCT01470170|3731191|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3907613|NCT01470170|3731186|B6|||Age||years|Mean|60.5|60.5|Standard Deviation|12.1|12.1|||
3907614|NCT01470170|3731187|B5|||Age||years|Mean|62.2|62.2|Standard Deviation|11.1|11.1|||
3907615|NCT01470170|3731188|B4|||Age||years|Mean|60.9|60.9|Standard Deviation|13.9|13.9|||
3907616|NCT01470170|3731189|B3|||Age||years|Mean|58.8|58.8|Standard Deviation|13.0|13.0|||
3907617|NCT01470170|3731190|B2|||Age||years|Mean|60.3|60.3|Standard Deviation|15.8|15.8|||
3907618|NCT01470170|3731191|B1|||Age||years|Mean|60.3|60.3|Standard Deviation|11.9|11.9|||
3907619|NCT01470144|3731227|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3907620|NCT01470144|3731227|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3907621|NCT01470144|3731227|B1|||Age||Years|Median|46.0|46.0|Full Range|||23.0|78.0|
3907622|NCT01470118|3731232|B4||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3907623|NCT01470118|3731233|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3907624|NCT01470118|3731234|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3907625|NCT01470118|3731235|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3907626|NCT01470118|3731232|B4||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3907627|NCT01470118|3731233|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3907628|NCT01470118|3731234|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3907629|NCT01470118|3731235|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3907630|NCT01470118|3731232|B4|||Age||Years|Mean|38.5|38.5|Standard Deviation|13.21|13.21|||
3907631|NCT01470118|3731233|B3|||Age||Years|Mean|39.3|39.3|Standard Deviation|12.31|12.31|||
3907632|NCT01470118|3731234|B2|||Age||Years|Mean|37.0|37.0|Standard Deviation|14.84|14.84|||
3907633|NCT01470118|3731235|B1|||Age||Years|Mean|39.3|39.3|Standard Deviation|12.44|12.44|||
3907634|NCT01470027|3731266|B7|United States||Region of Enrollment||participants|Number|47|47.0||||||
3907635|NCT01470027|3731267|B6|United States||Region of Enrollment||participants|Number|9|9.0||||||
3907636|NCT01470027|3731268|B5|United States||Region of Enrollment||participants|Number|8|8.0||||||
3907637|NCT01470027|3731269|B4|United States||Region of Enrollment||participants|Number|9|9.0||||||
3907638|NCT01470027|3731270|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
3907639|NCT01470027|3731271|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3907640|NCT01470027|3731272|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3907641|NCT01470027|3731266|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907642|NCT01470027|3731267|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907643|NCT01470027|3731268|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907644|NCT01470027|3731269|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907645|NCT01470027|3731270|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907646|NCT01470027|3731271|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907647|NCT01470027|3731272|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907648|NCT01470027|3731266|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907649|NCT01470027|3731267|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907650|NCT01470027|3731268|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907651|NCT01470027|3731269|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907652|NCT01470027|3731270|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907653|NCT01470027|3731271|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907654|NCT01470027|3731272|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907655|NCT01470027|3731266|B7||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3907656|NCT01470027|3731267|B6||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3907657|NCT01470027|3731268|B5||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3907658|NCT01470027|3731269|B4||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3907659|NCT01470027|3731270|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3907660|NCT01470027|3731271|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3907661|NCT01470027|3731272|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3907662|NCT01470027|3731266|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3907663|NCT01470027|3731267|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3907664|NCT01470027|3731268|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3907665|NCT01470027|3731269|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3907666|NCT01470027|3731270|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907667|NCT01470027|3731271|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907668|NCT01470027|3731272|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907669|NCT01470027|3731266|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907670|NCT01470027|3731267|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907671|NCT01470027|3731268|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907672|NCT01470027|3731269|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907673|NCT01470027|3731270|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907674|NCT01470027|3731271|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907675|NCT01470027|3731272|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907676|NCT01470027|3731266|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3907677|NCT01470027|3731267|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907678|NCT01470027|3731268|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907679|NCT01470027|3731269|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907680|NCT01470027|3731270|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3907681|NCT01470027|3731271|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907682|NCT01470027|3731272|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3907683|NCT01470027|3731266|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907684|NCT01470027|3731267|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907685|NCT01470027|3731268|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907686|NCT01470027|3731269|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907687|NCT01470027|3731270|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907688|NCT01470027|3731271|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907689|NCT01470027|3731272|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907690|NCT01470027|3731266|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907691|NCT01470027|3731267|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907692|NCT01470027|3731268|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907693|NCT01470027|3731269|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907694|NCT01470027|3731270|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907695|NCT01470027|3731271|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907696|NCT01470027|3731272|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907697|NCT01470027|3731266|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3907698|NCT01470027|3731267|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3907699|NCT01470027|3731268|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3907700|NCT01470027|3731269|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3907701|NCT01470027|3731270|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3907702|NCT01470027|3731271|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3907703|NCT01470027|3731272|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3907704|NCT01470027|3731266|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3907705|NCT01470027|3731267|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3907706|NCT01470027|3731268|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3907707|NCT01470027|3731269|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3907708|NCT01470027|3731270|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907709|NCT01470027|3731271|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3907710|NCT01470027|3731272|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3907711|NCT01470027|3731266|B7||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3907712|NCT01470027|3731267|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3907713|NCT01470027|3731268|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3907714|NCT01470027|3731269|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3907715|NCT01470027|3731270|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3907716|NCT01470027|3731271|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3907717|NCT01470027|3731272|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3907718|NCT01470027|3731266|B7||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3907719|NCT01470027|3731267|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3907720|NCT01470027|3731268|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3907721|NCT01470027|3731269|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3907722|NCT01470027|3731270|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3907723|NCT01470027|3731271|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3907724|NCT01470027|3731272|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3907725|NCT01470027|3731266|B7|||Age||Years|Mean|60.809|60.809|Standard Deviation|6.173|6.173|||
3907726|NCT01470027|3731267|B6|||Age||Years|Mean|59.778|59.778|Standard Deviation|5.995|5.995|||
3907727|NCT01470027|3731268|B5|||Age||Years|Mean|56.625|56.625|Standard Deviation|5.927|5.927|||
3907728|NCT01470027|3731269|B4|||Age||Years|Mean|64.222|64.222|Standard Deviation|7.807|7.807|||
3907729|NCT01470027|3731270|B3|||Age||Years|Mean|62.429|62.429|Standard Deviation|2.820|2.82|||
3907730|NCT01470027|3731271|B2|||Age||Years|Mean|61.714|61.714|Standard Deviation|6.264|6.264|||
3907731|NCT01470027|3731272|B1|||Age||Years|Mean|60.000|60.0|Standard Deviation|5.259|5.259|||
3907732|NCT01470001|3731330|B3|||urgency episodes per day||urgency episodes per day|Mean|2.76|2.76|Standard Deviation|3.90|3.9|||
3907733|NCT01470001|3731331|B2|||urgency episodes per day||urgency episodes per day|Mean|2.87|2.87|Standard Deviation|4.73|4.73|||
3907734|NCT01470001|3731332|B1|||urgency episodes per day||urgency episodes per day|Mean|2.64|2.64|Standard Deviation|2.84|2.84|||
3907735|NCT01470001|3731330|B3|||voids per day||voids per day|Mean|9.39|9.39|Standard Deviation|4.48|4.48|||
3907736|NCT01470001|3731331|B2|||voids per day||voids per day|Mean|9.23|9.23|Standard Deviation|3.68|3.68|||
3907737|NCT01470001|3731332|B1|||voids per day||voids per day|Mean|9.55|9.55|Standard Deviation|5.20|5.2|||
3907738|NCT01470001|3731330|B3|||post void dribbling episodes per day||post void dribbling episodes|Mean|3.25|3.25|Standard Deviation|2.76|2.76|||
3907739|NCT01470001|3731331|B2|||post void dribbling episodes per day||post void dribbling episodes|Mean|3.11|3.11|Standard Deviation|2.65|2.65|||
3907740|NCT01470001|3731332|B1|||post void dribbling episodes per day||post void dribbling episodes|Mean|3.38|3.38|Standard Deviation|2.84|2.84|||
3907741|NCT01470001|3731330|B3|United States||Region of Enrollment||participants|Number|118|118.0||||||
3907742|NCT01470001|3731331|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
3907743|NCT01470001|3731332|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
3907744|NCT01470001|3731330|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3907745|NCT01470001|3731331|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3907746|NCT01470001|3731332|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3907747|NCT01470001|3731330|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907748|NCT01470001|3731331|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907749|NCT01470001|3731332|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907750|NCT01470001|3731330|B3||White|Race (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
3907751|NCT01470001|3731331|B2||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3907752|NCT01470001|3731332|B1||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3907753|NCT01470001|3731330|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3907754|NCT01470001|3731331|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3907755|NCT01470001|3731332|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3907756|NCT01470001|3731330|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907757|NCT01470001|3731331|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907758|NCT01470001|3731332|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907759|NCT01470001|3731330|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3907760|NCT01470001|3731331|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3907761|NCT01470001|3731332|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907762|NCT01470001|3731330|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3907763|NCT01470001|3731331|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907764|NCT01470001|3731332|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3907765|NCT01470001|3731330|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3907766|NCT01470001|3731331|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907767|NCT01470001|3731332|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3907768|NCT01470001|3731330|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
3907769|NCT01470001|3731331|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3907770|NCT01470001|3731332|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3907771|NCT01470001|3731330|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3907772|NCT01470001|3731331|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3907773|NCT01470001|3731332|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3907774|NCT01470001|3731330|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3907775|NCT01470001|3731331|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3907776|NCT01470001|3731332|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3907777|NCT01470001|3731330|B3||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3907778|NCT01470001|3731331|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3907779|NCT01470001|3731332|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3907780|NCT01470001|3731330|B3|||Age||years|Mean|51.8|51.8|Standard Deviation|13.9|13.9|||
3907781|NCT01470001|3731331|B2|||Age||years|Mean|48.2|48.2|Standard Deviation|12.8|12.8|||
3907782|NCT01470001|3731332|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|14.2|14.2|||
3907783|NCT01469819|3731343|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3907784|NCT01469819|3731343|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3907785|NCT01469819|3731343|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3907786|NCT01469819|3731343|B1|||Age||years|Mean|39|39.0|Full Range|||19.0|64.0|
3907787|NCT01469819|3731343|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3907788|NCT01469819|3731343|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3907789|NCT01469819|3731343|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3907790|NCT01469767|3731353|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3907791|NCT01469767|3731353|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907792|NCT01469767|3731353|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907793|NCT01469767|3731353|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3907794|NCT01469767|3731353|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3907795|NCT01469767|3731353|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907796|NCT01469767|3731353|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907797|NCT01469767|3731353|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907798|NCT01469767|3731353|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3907799|NCT01469767|3731353|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3907800|NCT01469767|3731353|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3907801|NCT01469767|3731353|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3907802|NCT01469767|3731353|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3907803|NCT01469715|3731361|B1|||Duration of Diabetes|Time since diagnosis of Type 1 Diabetes|years|Mean|22|22.0|Standard Deviation|11|11.0|||
3907804|NCT01469715|3731361|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3907805|NCT01469715|3731361|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3907806|NCT01469715|3731361|B1|||Age||years|Mean|42|42.0|Standard Deviation|4|4.0|||
3907807|NCT01469637|3731365|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
3907808|NCT01469637|3731366|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
3907809|NCT01469637|3731367|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3907810|NCT01469637|3731365|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3907811|NCT01469637|3731366|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3907812|NCT01469637|3731367|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3907813|NCT01469637|3731365|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3907814|NCT01469637|3731366|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3907815|NCT01469637|3731367|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3907816|NCT01469637|3731365|B3|Between 18 and 55 years||Age, Customized||participants|Number|44|44.0||||||
3907817|NCT01469637|3731366|B2|Between 18 and 55 years||Age, Customized||participants|Number|22|22.0||||||
3907818|NCT01469637|3731367|B1|Between 18 and 55 years||Age, Customized||participants|Number|22|22.0||||||
3907819|NCT01469637|3731365|B3|||Age||years|Mean|36.7|36.7|Standard Deviation|12.0|12.0|||
3907820|NCT01469637|3731366|B2|||Age||years|Mean|35.4|35.4|Standard Deviation|12.6|12.6|||
3907821|NCT01469637|3731367|B1|||Age||years|Mean|38.0|38.0|Standard Deviation|11.7|11.7|||
3907822|NCT01469546|3731376|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3907823|NCT01469546|3731376|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3907824|NCT01469546|3731376|B1|||Age||years|Median|62|62.0|Full Range|||40.0|84.0|
3907825|NCT01469377|3731383|B4|||Waist Circumference||cm|Mean|94.20|94.2|Standard Deviation|14.12|14.12|||
3907826|NCT01469377|3731384|B3|||Waist Circumference||cm|Mean|94.91|94.91|Standard Deviation|14.66|14.66|||
3907827|NCT01469377|3731385|B2|||Waist Circumference||cm|Mean|93.36|93.36|Standard Deviation|14.20|14.2|||
3907828|NCT01469377|3731386|B1|||Waist Circumference||cm|Mean|94.32|94.32|Standard Deviation|13.44|13.44|||
3907829|NCT01469377|3731383|B4|||Body Mass Index (BMI)||kg/m^2|Mean|28.73|28.73|Standard Deviation|5.41|5.41|||
3907830|NCT01469377|3731384|B3|||Body Mass Index (BMI)||kg/m^2|Mean|29.05|29.05|Standard Deviation|5.59|5.59|||
3907831|NCT01469377|3731385|B2|||Body Mass Index (BMI)||kg/m^2|Mean|28.21|28.21|Standard Deviation|5.51|5.51|||
3907832|NCT01469377|3731386|B1|||Body Mass Index (BMI)||kg/m^2|Mean|28.93|28.93|Standard Deviation|5.09|5.09|||
3907833|NCT01469377|3731383|B4|||Weight||kg|Mean|81.13|81.13|Standard Deviation|16.65|16.65|||
3907834|NCT01469377|3731384|B3|||Weight||kg|Mean|82.17|82.17|Standard Deviation|17.37|17.37|||
3907835|NCT01469377|3731385|B2|||Weight||kg|Mean|79.69|79.69|Standard Deviation|16.31|16.31|||
3907836|NCT01469377|3731386|B1|||Weight||kg|Mean|81.53|81.53|Standard Deviation|16.19|16.19|||
3907837|NCT01469377|3731383|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|759|759.0||||||
3907838|NCT01469377|3731384|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|251|251.0||||||
3907839|NCT01469377|3731385|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|256|256.0||||||
3907840|NCT01469377|3731386|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|252|252.0||||||
3907841|NCT01469377|3731383|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
3907842|NCT01469377|3731384|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3907843|NCT01469377|3731385|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3907844|NCT01469377|3731386|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3907845|NCT01469377|3731383|B4|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3907846|NCT01469377|3731384|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3907847|NCT01469377|3731385|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3907848|NCT01469377|3731386|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3907849|NCT01469377|3731383|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3907850|NCT01469377|3731384|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3907851|NCT01469377|3731385|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3907852|NCT01469377|3731386|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3907853|NCT01469377|3731383|B4|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3907854|NCT01469377|3731384|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3907855|NCT01469377|3731385|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3907856|NCT01469377|3731386|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3907857|NCT01469377|3731383|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|87|87.0||||||
3907858|NCT01469377|3731384|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3907859|NCT01469377|3731385|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3907860|NCT01469377|3731386|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3907861|NCT01469377|3731383|B4|All other races||Race/Ethnicity, Customized||participants|Number|106|106.0||||||
3907862|NCT01469377|3731384|B3|All other races||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3907863|NCT01469377|3731385|B2|All other races||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
3907864|NCT01469377|3731386|B1|All other races||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3907865|NCT01469377|3731383|B4|White||Race/Ethnicity, Customized||participants|Number|706|706.0||||||
3907866|NCT01469377|3731384|B3|White||Race/Ethnicity, Customized||participants|Number|242|242.0||||||
3907867|NCT01469377|3731385|B2|White||Race/Ethnicity, Customized||participants|Number|234|234.0||||||
3907868|NCT01469377|3731386|B1|White||Race/Ethnicity, Customized||participants|Number|230|230.0||||||
3907869|NCT01469377|3731383|B4||Male|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
3907870|NCT01469377|3731384|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3907871|NCT01469377|3731385|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3907872|NCT01469377|3731386|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3907873|NCT01469377|3731383|B4||Female|Sex: Female, Male||Participants|Count of Participants|578|578.0||||||
3907874|NCT01469377|3731384|B3||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3907875|NCT01469377|3731385|B2||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
3907876|NCT01469377|3731386|B1||Female|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
3907877|NCT01469377|3731383|B4|||Age||years|Mean|45.7|45.7|Standard Deviation|11.6|11.6|||
3907878|NCT01469377|3731384|B3|||Age||years|Mean|45.1|45.1|Standard Deviation|11.4|11.4|||
3907879|NCT01469377|3731385|B2|||Age||years|Mean|45.5|45.5|Standard Deviation|11.9|11.9|||
3907880|NCT01469377|3731386|B1|||Age||years|Mean|46.4|46.4|Standard Deviation|11.6|11.6|||
3907881|NCT01469364|3731399|B1|||FEF 25-75||liters|Median|1.18|1.18|Inter-Quartile Range|||0.85|1.96|
3907882|NCT01469364|3731399|B1|||FVC||liters|Median|2.68|2.68|Inter-Quartile Range|||2.34|3.22|
3907883|NCT01469364|3731399|B1|||FEV1||liters|Median|1.87|1.87|Inter-Quartile Range|||1.57|2.46|
3907884|NCT01469364|3731399|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3907885|NCT01469364|3731399|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3907886|NCT01469364|3731399|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3907887|NCT01469364|3731399|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3907888|NCT01469364|3731399|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3907889|NCT01469364|3731399|B1|||Age||years|Median|64|64.0|Inter-Quartile Range|||33.0|70.0|
3907890|NCT01469234|3731414|B4||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3907891|NCT01469234|3731415|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3907892|NCT01469234|3731416|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3907893|NCT01469234|3731417|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3907894|NCT01469234|3731414|B4||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3907895|NCT01469234|3731415|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3907896|NCT01469234|3731416|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3907897|NCT01469234|3731417|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3907898|NCT01469234|3731414|B4|||Age||years|Mean|41.7|41.7|Standard Deviation|12.77|12.77|||
3907899|NCT01469234|3731415|B3|||Age||years|Mean|40.6|40.6|Standard Deviation|12.56|12.56|||
3907900|NCT01469234|3731416|B2|||Age||years|Mean|43.1|43.1|Standard Deviation|12.21|12.21|||
3907901|NCT01469234|3731417|B1|||Age||years|Mean|41.5|41.5|Standard Deviation|13.52|13.52|||
3907902|NCT01469221|3731448|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907903|NCT01469221|3731449|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907904|NCT01469221|3731450|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907905|NCT01469221|3731448|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907965|NCT01469065|3731486|B6||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3907906|NCT01469221|3731449|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907907|NCT01469221|3731450|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907908|NCT01469221|3731448|B3||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3907909|NCT01469221|3731449|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3907910|NCT01469221|3731450|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3907911|NCT01469221|3731448|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907912|NCT01469221|3731449|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907913|NCT01469221|3731450|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907914|NCT01469221|3731448|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907915|NCT01469221|3731449|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907916|NCT01469221|3731450|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907917|NCT01469221|3731448|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3907918|NCT01469221|3731449|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907919|NCT01469221|3731450|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3907920|NCT01469221|3731448|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907921|NCT01469221|3731449|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907922|NCT01469221|3731450|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907923|NCT01469221|3731448|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907924|NCT01469221|3731449|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907925|NCT01469221|3731450|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907926|NCT01469221|3731448|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3907927|NCT01469221|3731449|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3907928|NCT01469221|3731450|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3907929|NCT01469221|3731448|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907930|NCT01469221|3731449|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907931|NCT01469221|3731450|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3907932|NCT01469221|3731448|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3907933|NCT01469221|3731449|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3907934|NCT01469221|3731450|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3907935|NCT01469221|3731448|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3907936|NCT01469221|3731449|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3907937|NCT01469221|3731450|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3907938|NCT01469221|3731448|B3|||Age||years|Mean|65.7|65.7|Standard Deviation|9.7|9.7|||
3907939|NCT01469221|3731449|B2|||Age||years|Mean|63.6|63.6|Standard Deviation|9.2|9.2|||
3907940|NCT01469221|3731450|B1|||Age||years|Mean|68.4|68.4|Standard Deviation|9.9|9.9|||
3907941|NCT01469221|3731448|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3907942|NCT01469221|3731449|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3907943|NCT01469221|3731450|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3907944|NCT01469221|3731448|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3907945|NCT01469221|3731449|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3907946|NCT01469221|3731450|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3907947|NCT01469221|3731448|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3907948|NCT01469221|3731449|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3907949|NCT01469221|3731450|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3907950|NCT01469182|3731461|B3||Male|Gender||Participants|Count of Participants|392|392.0||||||
3907951|NCT01469182|3731462|B2||Male|Gender||Participants|Count of Participants|127|127.0||||||
3907952|NCT01469182|3731463|B1||Male|Gender||Participants|Count of Participants|265|265.0||||||
3907953|NCT01469182|3731461|B3||Female|Gender||Participants|Count of Participants|522|522.0||||||
3907954|NCT01469182|3731462|B2||Female|Gender||Participants|Count of Participants|177|177.0||||||
3907955|NCT01469182|3731463|B1||Female|Gender||Participants|Count of Participants|345|345.0||||||
3907956|NCT01469182|3731461|B3|||Age||Years|Mean|41.2|41.2|Standard Deviation|12.5|12.5|||
3907957|NCT01469182|3731462|B2|||Age||Years|Mean|42.3|42.3|Standard Deviation|12.2|12.2|||
3907958|NCT01469182|3731463|B1|||Age||Years|Mean|40.7|40.7|Standard Deviation|12.6|12.6|||
3907959|NCT01469065|3731486|B6||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3907960|NCT01469065|3731487|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3907961|NCT01469065|3731488|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3907962|NCT01469065|3731489|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3907963|NCT01469065|3731490|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3907964|NCT01469065|3731491|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3907966|NCT01469065|3731487|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3907967|NCT01469065|3731488|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3907968|NCT01469065|3731489|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3907969|NCT01469065|3731490|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3907970|NCT01469065|3731491|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3907971|NCT01469065|3731486|B6|||Age||years|Mean|57.2|57.2|Standard Deviation|8.9|8.9|||
3907972|NCT01469065|3731487|B5|||Age||years|Mean|56.1|56.1|Standard Deviation|8.0|8.0|||
3907973|NCT01469065|3731488|B4|||Age||years|Mean|57.0|57.0|Standard Deviation|9.4|9.4|||
3907974|NCT01469065|3731489|B3|||Age||years|Mean|57.4|57.4|Standard Deviation|10.7|10.7|||
3907975|NCT01469065|3731490|B2|||Age||years|Mean|56.4|56.4|Standard Deviation|9.0|9.0|||
3907976|NCT01469065|3731491|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|8.2|8.2|||
3907977|NCT01469052|3731585|B7||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3907978|NCT01469052|3731586|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3907979|NCT01469052|3731587|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3907980|NCT01469052|3731588|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3907981|NCT01469052|3731589|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3907982|NCT01469052|3731590|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3907983|NCT01469052|3731591|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3907984|NCT01469052|3731585|B7||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3907985|NCT01469052|3731586|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3907986|NCT01469052|3731587|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3907987|NCT01469052|3731588|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3907988|NCT01469052|3731589|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3907989|NCT01469052|3731590|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3907990|NCT01469052|3731591|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3907991|NCT01469052|3731585|B7|||Age||Years|Mean|56.86|56.86|Standard Deviation|8.53|8.53|||
3907992|NCT01469052|3731586|B6|||Age||Years|Mean|64.17|64.17|Standard Deviation|10.01|10.01|||
3907993|NCT01469052|3731587|B5|||Age||Years|Mean|54.88|54.88|Standard Deviation|7.95|7.95|||
3907994|NCT01469052|3731588|B4|||Age||Years|Mean|56.00|56.0|Standard Deviation|9.44|9.44|||
3907995|NCT01469052|3731589|B3|||Age||Years|Mean|55.00|55.0|Standard Deviation|7.27|7.27|||
3907996|NCT01469052|3731590|B2|||Age||Years|Mean|58.50|58.5|Standard Deviation|4.80|4.8|||
3907997|NCT01469052|3731591|B1|||Age||Years|Mean|53.83|53.83|Standard Deviation|8.75|8.75|||
3907998|NCT01469039|3731640|B4|Russian Federation||Region of Enrollment||participants|Number|73|73.0||||||
3907999|NCT01469039|3731641|B3|Russian Federation||Region of Enrollment||participants|Number|25|25.0||||||
3908000|NCT01469039|3731642|B2|Russian Federation||Region of Enrollment||participants|Number|24|24.0||||||
3908001|NCT01469039|3731643|B1|Russian Federation||Region of Enrollment||participants|Number|24|24.0||||||
3908002|NCT01469039|3731640|B4|Bulgaria||Region of Enrollment||participants|Number|59|59.0||||||
3908003|NCT01469039|3731641|B3|Bulgaria||Region of Enrollment||participants|Number|17|17.0||||||
3908004|NCT01469039|3731642|B2|Bulgaria||Region of Enrollment||participants|Number|19|19.0||||||
3908005|NCT01469039|3731643|B1|Bulgaria||Region of Enrollment||participants|Number|23|23.0||||||
3908006|NCT01469039|3731640|B4|Romania||Region of Enrollment||participants|Number|17|17.0||||||
3908007|NCT01469039|3731641|B3|Romania||Region of Enrollment||participants|Number|6|6.0||||||
3908008|NCT01469039|3731642|B2|Romania||Region of Enrollment||participants|Number|6|6.0||||||
3908009|NCT01469039|3731643|B1|Romania||Region of Enrollment||participants|Number|5|5.0||||||
3908010|NCT01469039|3731640|B4|Ukraine||Region of Enrollment||participants|Number|90|90.0||||||
3908011|NCT01469039|3731641|B3|Ukraine||Region of Enrollment||participants|Number|32|32.0||||||
3908012|NCT01469039|3731642|B2|Ukraine||Region of Enrollment||participants|Number|29|29.0||||||
3908013|NCT01469039|3731643|B1|Ukraine||Region of Enrollment||participants|Number|29|29.0||||||
3908014|NCT01469039|3731640|B4|Malaysia||Region of Enrollment||participants|Number|24|24.0||||||
3908015|NCT01469039|3731641|B3|Malaysia||Region of Enrollment||participants|Number|10|10.0||||||
3908016|NCT01469039|3731642|B2|Malaysia||Region of Enrollment||participants|Number|7|7.0||||||
3908017|NCT01469039|3731643|B1|Malaysia||Region of Enrollment||participants|Number|7|7.0||||||
3908018|NCT01469039|3731640|B4|Philippines||Region of Enrollment||participants|Number|53|53.0||||||
3908019|NCT01469039|3731641|B3|Philippines||Region of Enrollment||participants|Number|16|16.0||||||
3908020|NCT01469039|3731642|B2|Philippines||Region of Enrollment||participants|Number|21|21.0||||||
3908021|NCT01469039|3731643|B1|Philippines||Region of Enrollment||participants|Number|16|16.0||||||
3908022|NCT01469039|3731640|B4|United States||Region of Enrollment||participants|Number|307|307.0||||||
3908023|NCT01469039|3731641|B3|United States||Region of Enrollment||participants|Number|102|102.0||||||
3908024|NCT01469039|3731642|B2|United States||Region of Enrollment||participants|Number|102|102.0||||||
3908025|NCT01469039|3731643|B1|United States||Region of Enrollment||participants|Number|103|103.0||||||
3908026|NCT01469039|3731640|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908027|NCT01469039|3731641|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908028|NCT01469039|3731642|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908029|NCT01469039|3731643|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908030|NCT01469039|3731640|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908031|NCT01469039|3731641|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908032|NCT01469039|3731642|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908033|NCT01469039|3731643|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908034|NCT01469039|3731640|B4||White|Race (NIH/OMB)||Participants|Count of Participants|291|291.0||||||
3908035|NCT01469039|3731641|B3||White|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3908036|NCT01469039|3731642|B2||White|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3908037|NCT01469039|3731643|B1||White|Race (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3908038|NCT01469039|3731640|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|248|248.0||||||
3908039|NCT01469039|3731641|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3908040|NCT01469039|3731642|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
3908041|NCT01469039|3731643|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3908042|NCT01469039|3731640|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3908043|NCT01469039|3731641|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908044|NCT01469039|3731642|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908045|NCT01469039|3731643|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3908046|NCT01469039|3731640|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
3908047|NCT01469039|3731641|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3908048|NCT01469039|3731642|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3908049|NCT01469039|3731643|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3908050|NCT01469039|3731640|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3908051|NCT01469039|3731641|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3908052|NCT01469039|3731642|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3908053|NCT01469039|3731643|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908054|NCT01469039|3731640|B4||Male|Gender||Participants|Count of Participants|423|423.0||||||
3908055|NCT01469039|3731641|B3||Male|Gender||Participants|Count of Participants|139|139.0||||||
3908056|NCT01469039|3731642|B2||Male|Gender||Participants|Count of Participants|143|143.0||||||
3908057|NCT01469039|3731643|B1||Male|Gender||Participants|Count of Participants|141|141.0||||||
3908058|NCT01469039|3731640|B4||Female|Gender||Participants|Count of Participants|200|200.0||||||
3908059|NCT01469039|3731641|B3||Female|Gender||Participants|Count of Participants|69|69.0||||||
3908060|NCT01469039|3731642|B2||Female|Gender||Participants|Count of Participants|65|65.0||||||
3908061|NCT01469039|3731643|B1||Female|Gender||Participants|Count of Participants|66|66.0||||||
3908062|NCT01469039|3731640|B4|||Age||Years|Mean|39.7|39.7|Standard Deviation|11.02|11.02|||
3908063|NCT01469039|3731641|B3|||Age||Years|Mean|39.5|39.5|Standard Deviation|11.85|11.85|||
3908064|NCT01469039|3731642|B2|||Age||Years|Mean|39.7|39.7|Standard Deviation|11.06|11.06|||
3908065|NCT01469039|3731643|B1|||Age||Years|Mean|39.9|39.9|Standard Deviation|10.13|10.13|||
3908066|NCT01469039|3731640|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3908067|NCT01469039|3731641|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3908068|NCT01469039|3731642|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3908069|NCT01469039|3731643|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3908070|NCT01469039|3731640|B4||Between 18 and 65 years|Age||Participants|Count of Participants|618|618.0||||||
3908071|NCT01469039|3731641|B3||Between 18 and 65 years|Age||Participants|Count of Participants|206|206.0||||||
3908072|NCT01469039|3731642|B2||Between 18 and 65 years|Age||Participants|Count of Participants|207|207.0||||||
3908073|NCT01469039|3731643|B1||Between 18 and 65 years|Age||Participants|Count of Participants|205|205.0||||||
3908074|NCT01469039|3731640|B4||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3908075|NCT01469039|3731641|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3908076|NCT01469039|3731642|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3908077|NCT01469039|3731643|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3908078|NCT01469013|3731656|B6|Japan||Region of Enrollment||Participants|Count of Participants|145|145.0||||||
3908079|NCT01469013|3731657|B5|Japan||Region of Enrollment||Participants|Count of Participants|49|49.0||||||
3908080|NCT01469013|3731658|B4|Japan||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3908081|NCT01469013|3731659|B3|Japan||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3908082|NCT01469013|3731660|B2|Japan||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3908083|NCT01469013|3731661|B1|Japan||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3908084|NCT01469013|3731656|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908085|NCT01469013|3731657|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908086|NCT01469013|3731658|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908087|NCT01469013|3731659|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908088|NCT01469013|3731660|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908089|NCT01469013|3731661|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908090|NCT01469013|3731656|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908091|NCT01469013|3731657|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908092|NCT01469013|3731658|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908093|NCT01469013|3731659|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908094|NCT01469013|3731660|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908095|NCT01469013|3731661|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908096|NCT01469013|3731656|B6||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908097|NCT01469013|3731657|B5||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908098|NCT01469013|3731658|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908099|NCT01469013|3731659|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908100|NCT01469013|3731660|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908101|NCT01469013|3731661|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908102|NCT01469013|3731656|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908103|NCT01469013|3731657|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908104|NCT01469013|3731658|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908105|NCT01469013|3731659|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908106|NCT01469013|3731660|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908107|NCT01469013|3731661|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908108|NCT01469013|3731656|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908109|NCT01469013|3731657|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908110|NCT01469013|3731658|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908111|NCT01469013|3731659|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908112|NCT01469013|3731660|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908113|NCT01469013|3731661|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908114|NCT01469013|3731656|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|145|145.0||||||
3908115|NCT01469013|3731657|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3908116|NCT01469013|3731658|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3908117|NCT01469013|3731659|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3908118|NCT01469013|3731660|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3908119|NCT01469013|3731661|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3908120|NCT01469013|3731656|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908121|NCT01469013|3731657|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908122|NCT01469013|3731658|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908123|NCT01469013|3731659|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908124|NCT01469013|3731660|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908125|NCT01469013|3731661|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908126|NCT01469013|3731656|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908127|NCT01469013|3731657|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908128|NCT01469013|3731658|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908129|NCT01469013|3731659|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908130|NCT01469013|3731660|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908131|NCT01469013|3731661|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908132|NCT01469013|3731656|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|145|145.0||||||
3908133|NCT01469013|3731657|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3908134|NCT01469013|3731658|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3908135|NCT01469013|3731659|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3908136|NCT01469013|3731660|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3908137|NCT01469013|3731661|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3908138|NCT01469013|3731656|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908139|NCT01469013|3731657|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908140|NCT01469013|3731658|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908141|NCT01469013|3731659|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908142|NCT01469013|3731660|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908143|NCT01469013|3731661|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908144|NCT01469013|3731656|B6||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3908145|NCT01469013|3731657|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3908146|NCT01469013|3731658|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3908147|NCT01469013|3731659|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3908148|NCT01469013|3731660|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3908149|NCT01469013|3731661|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3908150|NCT01469013|3731656|B6||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3908151|NCT01469013|3731657|B5||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3908152|NCT01469013|3731658|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3908153|NCT01469013|3731659|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3908154|NCT01469013|3731660|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3908155|NCT01469013|3731661|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3908156|NCT01469013|3731656|B6|||Age||years|Mean|53.6|53.6|Standard Deviation|11.8|11.8|||
3908157|NCT01469013|3731657|B5|||Age||years|Mean|51.1|51.1|Standard Deviation|12.0|12.0|||
3908158|NCT01469013|3731658|B4|||Age||years|Mean|53.6|53.6|Standard Deviation|11.3|11.3|||
3908159|NCT01469013|3731659|B3|||Age||years|Mean|57.5|57.5|Standard Deviation|10.4|10.4|||
3908160|NCT01469013|3731660|B2|||Age||years|Mean|56.1|56.1|Standard Deviation|11.5|11.5|||
3908161|NCT01469013|3731661|B1|||Age||years|Mean|52.7|52.7|Standard Deviation|12.8|12.8|||
3908162|NCT01469000|3731756|B3|Korea, Republic of||Region of Enrollment||participants|Number|41|41.0||||||
3908163|NCT01469000|3731757|B2|Korea, Republic of||Region of Enrollment||participants|Number|18|18.0||||||
3908164|NCT01469000|3731758|B1|Korea, Republic of||Region of Enrollment||participants|Number|23|23.0||||||
3908165|NCT01469000|3731756|B3|Taiwan||Region of Enrollment||participants|Number|41|41.0||||||
3908166|NCT01469000|3731757|B2|Taiwan||Region of Enrollment||participants|Number|13|13.0||||||
3908167|NCT01469000|3731758|B1|Taiwan||Region of Enrollment||participants|Number|28|28.0||||||
3908168|NCT01469000|3731756|B3|Japan||Region of Enrollment||participants|Number|57|57.0||||||
3908169|NCT01469000|3731757|B2|Japan||Region of Enrollment||participants|Number|15|15.0||||||
3908170|NCT01469000|3731758|B1|Japan||Region of Enrollment||participants|Number|42|42.0||||||
3908171|NCT01469000|3731756|B3|China||Region of Enrollment||participants|Number|52|52.0||||||
3908172|NCT01469000|3731757|B2|China||Region of Enrollment||participants|Number|19|19.0||||||
3908173|NCT01469000|3731758|B1|China||Region of Enrollment||participants|Number|33|33.0||||||
3908174|NCT01469000|3731756|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908175|NCT01469000|3731757|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908176|NCT01469000|3731758|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908177|NCT01469000|3731756|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908178|NCT01469000|3731757|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908179|NCT01469000|3731758|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908180|NCT01469000|3731756|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908181|NCT01469000|3731757|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908182|NCT01469000|3731758|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908183|NCT01469000|3731756|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908184|NCT01469000|3731757|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908185|NCT01469000|3731758|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908186|NCT01469000|3731756|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908187|NCT01469000|3731757|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908188|NCT01469000|3731758|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908189|NCT01469000|3731756|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|191|191.0||||||
3908190|NCT01469000|3731757|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3908191|NCT01469000|3731758|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
3908192|NCT01469000|3731756|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908193|NCT01469000|3731757|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908194|NCT01469000|3731758|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908195|NCT01469000|3731756|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908196|NCT01469000|3731757|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908197|NCT01469000|3731758|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908198|NCT01469000|3731756|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|191|191.0||||||
3908199|NCT01469000|3731757|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3908200|NCT01469000|3731758|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
3908201|NCT01469000|3731756|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908202|NCT01469000|3731757|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908203|NCT01469000|3731758|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908204|NCT01469000|3731756|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3908205|NCT01469000|3731757|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3908206|NCT01469000|3731758|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3908207|NCT01469000|3731756|B3||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3908208|NCT01469000|3731757|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3908209|NCT01469000|3731758|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3908210|NCT01469000|3731756|B3|||Age||years|Mean|61.71|61.71|Standard Deviation|9.38|9.38|||
3908211|NCT01469000|3731757|B2|||Age||years|Mean|60.94|60.94|Standard Deviation|9.45|9.45|||
3908212|NCT01469000|3731758|B1|||Age||years|Mean|62.11|62.11|Standard Deviation|9.36|9.36|||
3908213|NCT01468987|3731773|B3|Japan||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3908214|NCT01468987|3731774|B2|Japan||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3908215|NCT01468987|3731775|B1|Japan||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3908216|NCT01468987|3731773|B3|Germany||Region of Enrollment||Participants|Count of Participants|104|104.0||||||
3908217|NCT01468987|3731774|B2|Germany||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
3908218|NCT01468987|3731775|B1|Germany||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3908219|NCT01468987|3731773|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3908220|NCT01468987|3731774|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3908221|NCT01468987|3731775|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3908222|NCT01468987|3731773|B3|Australia||Region of Enrollment||Participants|Count of Participants|51|51.0||||||
3908223|NCT01468987|3731774|B2|Australia||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3908224|NCT01468987|3731775|B1|Australia||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3908225|NCT01468987|3731773|B3|Denmark||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3908226|NCT01468987|3731774|B2|Denmark||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3908227|NCT01468987|3731775|B1|Denmark||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3908228|NCT01468987|3731773|B3|Croatia||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3908229|NCT01468987|3731774|B2|Croatia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3908230|NCT01468987|3731775|B1|Croatia||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3908231|NCT01468987|3731773|B3|Romania||Region of Enrollment||Participants|Count of Participants|65|65.0||||||
3908232|NCT01468987|3731774|B2|Romania||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3908233|NCT01468987|3731775|B1|Romania||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3908234|NCT01468987|3731773|B3|Brazil||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3908235|NCT01468987|3731774|B2|Brazil||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3908236|NCT01468987|3731775|B1|Brazil||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3908237|NCT01468987|3731773|B3|Poland||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3908238|NCT01468987|3731774|B2|Poland||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3908239|NCT01468987|3731775|B1|Poland||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3908240|NCT01468987|3731773|B3|Puerto Rico||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
3908241|NCT01468987|3731774|B2|Puerto Rico||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3908242|NCT01468987|3731775|B1|Puerto Rico||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3908243|NCT01468987|3731773|B3|Mexico||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3908244|NCT01468987|3731774|B2|Mexico||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3908245|NCT01468987|3731775|B1|Mexico||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3908246|NCT01468987|3731773|B3|Hungary||Region of Enrollment||Participants|Count of Participants|72|72.0||||||
3908247|NCT01468987|3731774|B2|Hungary||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3908248|NCT01468987|3731775|B1|Hungary||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3908249|NCT01468987|3731773|B3|Czechia||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3908250|NCT01468987|3731774|B2|Czechia||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3908251|NCT01468987|3731775|B1|Czechia||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3908252|NCT01468987|3731773|B3|Italy||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3908253|NCT01468987|3731774|B2|Italy||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3908254|NCT01468987|3731775|B1|Italy||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3908255|NCT01468987|3731773|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3908256|NCT01468987|3731774|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3908257|NCT01468987|3731775|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3908258|NCT01468987|3731773|B3|Israel||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3908259|NCT01468987|3731774|B2|Israel||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3908260|NCT01468987|3731775|B1|Israel||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3908261|NCT01468987|3731773|B3|Russia||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3908262|NCT01468987|3731774|B2|Russia||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3908263|NCT01468987|3731775|B1|Russia||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3908264|NCT01468987|3731773|B3|Austria||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3908265|NCT01468987|3731774|B2|Austria||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3908266|NCT01468987|3731775|B1|Austria||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3908267|NCT01468987|3731773|B3|Turkey||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3908268|NCT01468987|3731774|B2|Turkey||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3908269|NCT01468987|3731775|B1|Turkey||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3908270|NCT01468987|3731773|B3|Lithuania||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3908271|NCT01468987|3731774|B2|Lithuania||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3908272|NCT01468987|3731775|B1|Lithuania||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3908273|NCT01468987|3731773|B3|Spain||Region of Enrollment||Participants|Count of Participants|65|65.0||||||
3908274|NCT01468987|3731774|B2|Spain||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3908275|NCT01468987|3731775|B1|Spain||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3908276|NCT01468987|3731773|B3|Greece||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3908277|NCT01468987|3731774|B2|Greece||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3908278|NCT01468987|3731775|B1|Greece||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3908279|NCT01468987|3731773|B3|Slovakia||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3908280|NCT01468987|3731774|B2|Slovakia||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3908281|NCT01468987|3731775|B1|Slovakia||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3908282|NCT01468987|3731773|B3|Taiwan||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3908283|NCT01468987|3731774|B2|Taiwan||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3908284|NCT01468987|3731775|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3908285|NCT01468987|3731773|B3|United States||Region of Enrollment||Participants|Count of Participants|546|546.0||||||
3908286|NCT01468987|3731774|B2|United States||Region of Enrollment||Participants|Count of Participants|270|270.0||||||
3908287|NCT01468987|3731775|B1|United States||Region of Enrollment||Participants|Count of Participants|276|276.0||||||
3908288|NCT01468987|3731773|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908289|NCT01468987|3731774|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908290|NCT01468987|3731775|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908291|NCT01468987|3731773|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3908292|NCT01468987|3731774|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3908293|NCT01468987|3731775|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3908294|NCT01468987|3731773|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1200|1200.0||||||
3908295|NCT01468987|3731774|B2||White|Race (NIH/OMB)||Participants|Count of Participants|585|585.0||||||
3908296|NCT01468987|3731775|B1||White|Race (NIH/OMB)||Participants|Count of Participants|615|615.0||||||
3908297|NCT01468987|3731773|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
3908298|NCT01468987|3731774|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3908299|NCT01468987|3731775|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3908300|NCT01468987|3731773|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3908301|NCT01468987|3731774|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3908302|NCT01468987|3731775|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3908303|NCT01468987|3731773|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3908304|NCT01468987|3731774|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3908305|NCT01468987|3731775|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3908306|NCT01468987|3731773|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3908307|NCT01468987|3731774|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3908308|NCT01468987|3731775|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3908309|NCT01468987|3731773|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|338|338.0||||||
3908310|NCT01468987|3731774|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|173|173.0||||||
3908311|NCT01468987|3731775|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|165|165.0||||||
3908312|NCT01468987|3731773|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|879|879.0||||||
3908313|NCT01468987|3731774|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|427|427.0||||||
3908314|NCT01468987|3731775|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|452|452.0||||||
3908315|NCT01468987|3731773|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|152|152.0||||||
3908316|NCT01468987|3731774|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3908317|NCT01468987|3731775|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3908318|NCT01468987|3731773|B3||Male|Sex: Female, Male||Participants|Count of Participants|780|780.0||||||
3908319|NCT01468987|3731774|B2||Male|Sex: Female, Male||Participants|Count of Participants|404|404.0||||||
3908320|NCT01468987|3731775|B1||Male|Sex: Female, Male||Participants|Count of Participants|376|376.0||||||
3908321|NCT01468987|3731773|B3||Female|Sex: Female, Male||Participants|Count of Participants|589|589.0||||||
3908322|NCT01468987|3731774|B2||Female|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
3908323|NCT01468987|3731775|B1||Female|Sex: Female, Male||Participants|Count of Participants|315|315.0||||||
3908324|NCT01468987|3731773|B3|||Age||years|Mean|57.6|57.6|Standard Deviation|9.19|9.19|||
3908325|NCT01468987|3731774|B2|||Age||years|Mean|57.77|57.77|Standard Deviation|9.17|9.17|||
3908326|NCT01468987|3731775|B1|||Age||years|Mean|57.43|57.43|Standard Deviation|9.21|9.21|||
3908327|NCT01468896|3731820|B3|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3908328|NCT01468896|3731821|B2|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3908329|NCT01468896|3731822|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3908330|NCT01468896|3731820|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3908331|NCT01468896|3731821|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3908332|NCT01468896|3731822|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908333|NCT01468896|3731820|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3908334|NCT01468896|3731821|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908335|NCT01468896|3731822|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3908336|NCT01468896|3731820|B3||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3908337|NCT01468896|3731821|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3908338|NCT01468896|3731822|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3908339|NCT01468896|3731820|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3908340|NCT01468896|3731821|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3908341|NCT01468896|3731822|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908342|NCT01468896|3731820|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908343|NCT01468896|3731821|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908344|NCT01468896|3731822|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908345|NCT01468896|3731820|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3908346|NCT01468896|3731821|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3908347|NCT01468896|3731822|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908348|NCT01468896|3731820|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908349|NCT01468896|3731821|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908350|NCT01468896|3731822|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908351|NCT01468896|3731820|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3908352|NCT01468896|3731821|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3908353|NCT01468896|3731822|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908354|NCT01468896|3731820|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3908355|NCT01468896|3731821|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3908356|NCT01468896|3731822|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3908357|NCT01468896|3731820|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908358|NCT01468896|3731821|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908359|NCT01468896|3731822|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908360|NCT01468896|3731820|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3908361|NCT01468896|3731821|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3908362|NCT01468896|3731822|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3908363|NCT01468896|3731820|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3908364|NCT01468896|3731821|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3908365|NCT01468896|3731822|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3908366|NCT01468896|3731820|B3|||Age||years|Median|61|61.0|Full Range|||51.0|84.0|
3908367|NCT01468896|3731821|B2|||Age||years|Median|62|62.0|Full Range|||51.0|84.0|
3908368|NCT01468896|3731822|B1|||Age||years|Median|56.5|56.5|Full Range|||52.0|64.0|
3908369|NCT01468818|3731839|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3908370|NCT01468818|3731839|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908371|NCT01468818|3731839|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908372|NCT01468818|3731839|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3908373|NCT01468818|3731839|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908374|NCT01468818|3731839|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908375|NCT01468818|3731839|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908376|NCT01468818|3731839|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908377|NCT01468818|3731839|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908378|NCT01468818|3731839|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3908379|NCT01468818|3731839|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908380|NCT01468818|3731839|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3908381|NCT01468818|3731839|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3908382|NCT01468818|3731839|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|9.1|9.1|||
3908383|NCT01468818|3731839|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3908384|NCT01468818|3731839|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3908385|NCT01468818|3731839|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3908386|NCT01468675|3731844|B3|United States||Region of Enrollment||participants|Number|3703|3703.0||||||
3908387|NCT01468675|3731845|B2|United States||Region of Enrollment||participants|Number|2004|2004.0||||||
3908388|NCT01468675|3731846|B1|United States||Region of Enrollment||participants|Number|1699|1699.0||||||
3908389|NCT01468675|3731844|B3|Other/ unknown||Race/Ethnicity, Customized||participants|Number|253|253.0||||||
3908390|NCT01468675|3731845|B2|Other/ unknown||Race/Ethnicity, Customized||participants|Number|142|142.0||||||
3908391|NCT01468675|3731846|B1|Other/ unknown||Race/Ethnicity, Customized||participants|Number|111|111.0||||||
3908392|NCT01468675|3731844|B3|Latino||Race/Ethnicity, Customized||participants|Number|196|196.0||||||
3908393|NCT01468675|3731845|B2|Latino||Race/Ethnicity, Customized||participants|Number|105|105.0||||||
3908394|NCT01468675|3731846|B1|Latino||Race/Ethnicity, Customized||participants|Number|91|91.0||||||
3908395|NCT01468675|3731844|B3|black||Race/Ethnicity, Customized||participants|Number|161|161.0||||||
3908396|NCT01468675|3731845|B2|black||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
3908397|NCT01468675|3731846|B1|black||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
3908398|NCT01468675|3731844|B3|white||Race/Ethnicity, Customized||participants|Number|3093|3093.0||||||
3908399|NCT01468675|3731845|B2|white||Race/Ethnicity, Customized||participants|Number|1675|1675.0||||||
3908400|NCT01468675|3731846|B1|white||Race/Ethnicity, Customized||participants|Number|1418|1418.0||||||
3908401|NCT01468675|3731844|B3||Male|Sex: Female, Male||Participants|Count of Participants|950|950.0||||||
3908402|NCT01468675|3731845|B2||Male|Sex: Female, Male||Participants|Count of Participants|589|589.0||||||
3908403|NCT01468675|3731846|B1||Male|Sex: Female, Male||Participants|Count of Participants|361|361.0||||||
3908404|NCT01468675|3731844|B3||Female|Sex: Female, Male||Participants|Count of Participants|2753|2753.0||||||
3908405|NCT01468675|3731845|B2||Female|Sex: Female, Male||Participants|Count of Participants|1415|1415.0||||||
3908406|NCT01468675|3731846|B1||Female|Sex: Female, Male||Participants|Count of Participants|1338|1338.0||||||
3908407|NCT01468675|3731844|B3|||Age||years|Median|55|55.0|Full Range|||18.0|75.0|
3908408|NCT01468675|3731845|B2|||Age||years|Median|56|56.0|Full Range|||18.0|75.0|
3908409|NCT01468675|3731846|B1|||Age||years|Median|55|55.0|Full Range|||18.0|75.0|
3908410|NCT01468584|3731853|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3908411|NCT01468584|3731853|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3908412|NCT01468584|3731853|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|6.7|6.7|||
3908413|NCT01468558|3731857|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3908414|NCT01468558|3731857|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3908415|NCT01468558|3731857|B1|||Age||years|Mean|29.58|29.58|Standard Deviation|8.3|8.3|||
3908416|NCT01468350|3731868|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908417|NCT01468350|3731869|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908418|NCT01468350|3731870|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908419|NCT01468350|3731871|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908420|NCT01468350|3731872|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908421|NCT01468350|3731868|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908422|NCT01468350|3731869|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908423|NCT01468350|3731870|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908424|NCT01468350|3731871|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908425|NCT01468350|3731872|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908426|NCT01468350|3731868|B5||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3908427|NCT01468350|3731869|B4||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3908428|NCT01468350|3731870|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3908429|NCT01468350|3731871|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3908430|NCT01468350|3731872|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3908431|NCT01468350|3731868|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3908432|NCT01468350|3731869|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3908433|NCT01468350|3731870|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3908434|NCT01468350|3731871|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908435|NCT01468350|3731872|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3908436|NCT01468350|3731868|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908437|NCT01468350|3731869|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908438|NCT01468350|3731870|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908439|NCT01468350|3731871|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908440|NCT01468350|3731872|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908441|NCT01468350|3731868|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3908442|NCT01468350|3731869|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3908443|NCT01468350|3731870|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908444|NCT01468350|3731871|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3908445|NCT01468350|3731872|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3908446|NCT01468350|3731868|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908447|NCT01468350|3731869|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908448|NCT01468350|3731870|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908449|NCT01468350|3731871|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908450|NCT01468350|3731872|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908451|NCT01468350|3731868|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3908452|NCT01468350|3731869|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3908453|NCT01468350|3731870|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3908454|NCT01468350|3731871|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3908455|NCT01468350|3731872|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3908456|NCT01468350|3731868|B5||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3908457|NCT01468350|3731869|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3908458|NCT01468350|3731870|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3908459|NCT01468350|3731871|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3908460|NCT01468350|3731872|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3908461|NCT01468350|3731868|B5|||Age||years|Mean|37.05|37.05|Standard Deviation|12.99|12.99|||
3908462|NCT01468350|3731869|B4|||Age||years|Mean|36.1|36.1|Standard Deviation|14.04|14.04|||
3908463|NCT01468350|3731870|B3|||Age||years|Mean|41.1|41.1|Standard Deviation|14.25|14.25|||
3908464|NCT01468350|3731871|B2|||Age||years|Mean|37.2|37.2|Standard Deviation|9.39|9.39|||
3908465|NCT01468350|3731872|B1|||Age||years|Mean|33.8|33.8|Standard Deviation|14.29|14.29|||
3908466|NCT01468337|3731885|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3908467|NCT01468337|3731885|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3908468|NCT01468337|3731885|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3908469|NCT01468337|3731885|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3908470|NCT01468337|3731885|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3908471|NCT01468311|3731897|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3908472|NCT01468311|3731897|B1|Ethnicity, customized|Not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3908473|NCT01468311|3731897|B1|Ethnicity, customized|Not provided or available|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3908474|NCT01468311|3731897|B1|Ethnicity, customized|Mexican, Puerto Rican, Cuban, Central or South Am.|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3908475|NCT01468311|3731897|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3908476|NCT01468311|3731897|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908477|NCT01468311|3731897|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3908478|NCT01468311|3731897|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3908479|NCT01468311|3731897|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908480|NCT01468311|3731897|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908481|NCT01468311|3731897|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908482|NCT01468311|3731897|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3908483|NCT01468311|3731897|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3908484|NCT01468311|3731897|B1|||Age||years|Mean|29.05|29.05|Standard Deviation|8.35|8.35|||
3908485|NCT01468311|3731897|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3908486|NCT01468311|3731897|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3908487|NCT01468311|3731897|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3908488|NCT01468233|3731907|B3||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3908489|NCT01468233|3731908|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3908490|NCT01468233|3731909|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3908491|NCT01468233|3731907|B3||Female|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
3908492|NCT01468233|3731908|B2||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3908493|NCT01468233|3731909|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3908494|NCT01468233|3731907|B3|||Age||years|Mean|35.5|35.5|Standard Deviation|11.13|11.13|||
3908495|NCT01468233|3731908|B2|||Age||years|Mean|34.9|34.9|Standard Deviation|9.96|9.96|||
3908496|NCT01468233|3731909|B1|||Age||years|Mean|36.1|36.1|Standard Deviation|12.18|12.18|||
3908497|NCT01468207|3731934|B3||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3908498|NCT01468207|3731935|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3908499|NCT01468207|3731936|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3908500|NCT01468207|3731934|B3||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
3908501|NCT01468207|3731935|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3908502|NCT01468207|3731936|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3908503|NCT01468207|3731934|B3|||Age||years|Mean|37.0|37.0|Standard Deviation|11.10|11.1|||
3908504|NCT01468207|3731935|B2|||Age||years|Mean|36.2|36.2|Standard Deviation|10.83|10.83|||
3908505|NCT01468207|3731936|B1|||Age||years|Mean|37.8|37.8|Standard Deviation|11.33|11.33|||
3908506|NCT01468181|3731961|B6|Japan||Region of Enrollment||participants|Number|394|394.0||||||
3908507|NCT01468181|3731962|B5|Japan||Region of Enrollment||participants|Number|71|71.0||||||
3908508|NCT01468181|3731963|B4|Japan||Region of Enrollment||participants|Number|66|66.0||||||
3908509|NCT01468181|3731964|B3|Japan||Region of Enrollment||participants|Number|65|65.0||||||
3908510|NCT01468181|3731965|B2|Japan||Region of Enrollment||participants|Number|61|61.0||||||
3908511|NCT01468181|3731966|B1|Japan||Region of Enrollment||participants|Number|131|131.0||||||
3908512|NCT01468181|3731961|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908513|NCT01468181|3731962|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908514|NCT01468181|3731963|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908515|NCT01468181|3731964|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908516|NCT01468181|3731965|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908517|NCT01468181|3731966|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908518|NCT01468181|3731961|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908519|NCT01468181|3731962|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908520|NCT01468181|3731963|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908521|NCT01468181|3731964|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908522|NCT01468181|3731965|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908523|NCT01468181|3731966|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908524|NCT01468181|3731961|B6||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908525|NCT01468181|3731962|B5||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908526|NCT01468181|3731963|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908527|NCT01468181|3731964|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908528|NCT01468181|3731965|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908529|NCT01468181|3731966|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908530|NCT01468181|3731961|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908531|NCT01468181|3731962|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908532|NCT01468181|3731963|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908533|NCT01468181|3731964|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908534|NCT01468181|3731965|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908535|NCT01468181|3731966|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908536|NCT01468181|3731961|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908537|NCT01468181|3731962|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908538|NCT01468181|3731963|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908539|NCT01468181|3731964|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908540|NCT01468181|3731965|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908541|NCT01468181|3731966|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908542|NCT01468181|3731961|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|394|394.0||||||
3908543|NCT01468181|3731962|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3908544|NCT01468181|3731963|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3908545|NCT01468181|3731964|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3908546|NCT01468181|3731965|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3908547|NCT01468181|3731966|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
3908548|NCT01468181|3731961|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908549|NCT01468181|3731962|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908550|NCT01468181|3731963|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908551|NCT01468181|3731964|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908552|NCT01468181|3731965|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908553|NCT01468181|3731966|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908554|NCT01468181|3731961|B6||Male|Sex: Female, Male||Participants|Count of Participants|296|296.0||||||
3908555|NCT01468181|3731962|B5||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3908556|NCT01468181|3731963|B4||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3908557|NCT01468181|3731964|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3908558|NCT01468181|3731965|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3908559|NCT01468181|3731966|B1||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3908560|NCT01468181|3731961|B6||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3908561|NCT01468181|3731962|B5||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3908562|NCT01468181|3731963|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3908563|NCT01468181|3731964|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3908564|NCT01468181|3731965|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3908565|NCT01468181|3731966|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3908566|NCT01468181|3731961|B6|||Age||years|Mean|57.35|57.35|Standard Deviation|10.96|10.96|||
3908567|NCT01468181|3731962|B5|||Age||years|Mean|58.17|58.17|Standard Deviation|10.30|10.3|||
3908568|NCT01468181|3731963|B4|||Age||years|Mean|56.40|56.4|Standard Deviation|10.51|10.51|||
3908569|NCT01468181|3731964|B3|||Age||years|Mean|59.13|59.13|Standard Deviation|10.51|10.51|||
3908570|NCT01468181|3731965|B2|||Age||years|Mean|52.69|52.69|Standard Deviation|10.19|10.19|||
3908571|NCT01468181|3731966|B1|||Age||years|Mean|58.68|58.68|Standard Deviation|11.59|11.59|||
3908572|NCT01468077|3732017|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3908573|NCT01468077|3732018|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3908574|NCT01468077|3732019|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3908575|NCT01468077|3732017|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3908576|NCT01468077|3732018|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3908577|NCT01468077|3732019|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3908578|NCT01468077|3732017|B3|||Age||years|Mean|58.7|58.7|Standard Deviation|12.4|12.4|||
3908579|NCT01468077|3732018|B2|||Age||years|Mean|59.8|59.8|Standard Deviation|13.1|13.1|||
3908580|NCT01468077|3732019|B1|||Age||years|Mean|57.5|57.5|Standard Deviation|11.8|11.8|||
3908581|NCT01468012|3732056|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3908582|NCT01468012|3732057|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908583|NCT01468012|3732058|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908584|NCT01468012|3732059|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3908585|NCT01468012|3732056|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3908586|NCT01468012|3732057|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908587|NCT01468012|3732058|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908588|NCT01468012|3732059|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3908589|NCT01468012|3732056|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908590|NCT01468012|3732057|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908591|NCT01468012|3732058|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908592|NCT01468012|3732059|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908593|NCT01468012|3732056|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3908594|NCT01468012|3732057|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3908595|NCT01468012|3732058|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3908596|NCT01468012|3732059|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3908597|NCT01468012|3732056|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908598|NCT01468012|3732057|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908599|NCT01468012|3732058|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908600|NCT01468012|3732059|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908601|NCT01468012|3732056|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908602|NCT01468012|3732057|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908603|NCT01468012|3732058|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908604|NCT01468012|3732059|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908605|NCT01468012|3732056|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908606|NCT01468012|3732057|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908607|NCT01468012|3732058|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908608|NCT01468012|3732059|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908609|NCT01468012|3732056|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3908610|NCT01468012|3732057|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3908611|NCT01468012|3732058|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3908612|NCT01468012|3732059|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3908613|NCT01468012|3732056|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3908614|NCT01468012|3732057|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3908615|NCT01468012|3732058|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3908616|NCT01468012|3732059|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3908617|NCT01468012|3732056|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3908618|NCT01468012|3732057|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3908619|NCT01468012|3732058|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3908620|NCT01468012|3732059|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3908621|NCT01468012|3732056|B4||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3908622|NCT01468012|3732057|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3908623|NCT01468012|3732058|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3908624|NCT01468012|3732059|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3908625|NCT01468012|3732056|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3908626|NCT01468012|3732057|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3908627|NCT01468012|3732058|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3908628|NCT01468012|3732059|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3908629|NCT01467999|3732072|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3908630|NCT01467999|3732072|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3908631|NCT01467999|3732072|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3908632|NCT01467999|3732072|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3908633|NCT01467999|3732072|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908634|NCT01467999|3732072|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908635|NCT01467999|3732072|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3908636|NCT01467999|3732072|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3908637|NCT01467999|3732072|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3908638|NCT01467999|3732072|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3908639|NCT01467999|3732072|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3908640|NCT01467999|3732072|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3908641|NCT01467999|3732072|B1|||Age||years|Mean|36.1|36.1|Standard Deviation|10.3|10.3|||
3908642|NCT01467960|3732076|B7|Italy||Region of Enrollment||participants|Number|180|180.0||||||
3908643|NCT01467960|3732077|B6|Italy||Region of Enrollment||participants|Number|30|30.0||||||
3908644|NCT01467960|3732078|B5|Italy||Region of Enrollment||participants|Number|30|30.0||||||
3908645|NCT01467960|3732079|B4|Italy||Region of Enrollment||participants|Number|30|30.0||||||
3908646|NCT01467960|3732080|B3|Italy||Region of Enrollment||participants|Number|30|30.0||||||
3908647|NCT01467960|3732081|B2|Italy||Region of Enrollment||participants|Number|30|30.0||||||
3908648|NCT01467960|3732082|B1|Italy||Region of Enrollment||participants|Number|30|30.0||||||
3908649|NCT01467960|3732076|B7||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3908650|NCT01467960|3732077|B6||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3908651|NCT01467960|3732078|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3908652|NCT01467960|3732079|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3908653|NCT01467960|3732080|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3908654|NCT01467960|3732081|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3908655|NCT01467960|3732082|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3908656|NCT01467960|3732076|B7||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3908657|NCT01467960|3732077|B6||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3908658|NCT01467960|3732078|B5||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3908659|NCT01467960|3732079|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3908660|NCT01467960|3732080|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3908661|NCT01467960|3732081|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3908662|NCT01467960|3732082|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3908663|NCT01467960|3732076|B7||>=65 years|Age||Participants|Count of Participants|120|120.0||||||
3908664|NCT01467960|3732077|B6||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
3908665|NCT01467960|3732078|B5||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
3908666|NCT01467960|3732079|B4||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
3908667|NCT01467960|3732080|B3||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
3908668|NCT01467960|3732081|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3908669|NCT01467960|3732082|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3908670|NCT01467960|3732076|B7||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3908671|NCT01467960|3732077|B6||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3908672|NCT01467960|3732078|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3908673|NCT01467960|3732079|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3908674|NCT01467960|3732080|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3908675|NCT01467960|3732081|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3908676|NCT01467960|3732082|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3908677|NCT01467960|3732076|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3908678|NCT01467960|3732077|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3908679|NCT01467960|3732078|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3908680|NCT01467960|3732079|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3908681|NCT01467960|3732080|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3908682|NCT01467960|3732081|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3908683|NCT01467960|3732082|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3908684|NCT01467947|3732101|B1|Bulgaria||Region of Enrollment||participants|Number|10|10.0||||||
3908685|NCT01467947|3732101|B1|Poland||Region of Enrollment||participants|Number|13|13.0||||||
3908686|NCT01467947|3732101|B1|Hungary||Region of Enrollment||participants|Number|8|8.0||||||
3908687|NCT01467947|3732101|B1|Romania||Region of Enrollment||participants|Number|15|15.0||||||
3908688|NCT01467947|3732101|B1||Male|Gender||Participants|Count of Participants|14|14.0||||||
3908689|NCT01467947|3732101|B1||Female|Gender||Participants|Count of Participants|32|32.0||||||
3908690|NCT01467947|3732101|B1|||Age||years|Mean|38.9|38.9|Standard Deviation|14.42|14.42|||
3908691|NCT01467947|3732101|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3908692|NCT01467947|3732101|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3908693|NCT01467947|3732101|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3908694|NCT01467934|3732106|B4|Other non-Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3908695|NCT01467934|3732107|B3|Other non-Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3908696|NCT01467934|3732108|B2|Other non-Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3908697|NCT01467934|3732109|B1|Other non-Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3908698|NCT01467934|3732106|B4|White non-Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3908699|NCT01467934|3732107|B3|White non-Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3908700|NCT01467934|3732108|B2|White non-Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3908701|NCT01467934|3732109|B1|White non-Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3908702|NCT01467934|3732106|B4|Black Latino||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
3908703|NCT01467934|3732107|B3|Black Latino||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3908704|NCT01467934|3732108|B2|Black Latino||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3908705|NCT01467934|3732109|B1|Black Latino||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3908706|NCT01467934|3732106|B4|Latino||Race/Ethnicity, Customized||participants|Number|458|458.0||||||
3908707|NCT01467934|3732107|B3|Latino||Race/Ethnicity, Customized||participants|Number|100|100.0||||||
3908708|NCT01467934|3732108|B2|Latino||Race/Ethnicity, Customized||participants|Number|187|187.0||||||
3908709|NCT01467934|3732109|B1|Latino||Race/Ethnicity, Customized||participants|Number|171|171.0||||||
3908710|NCT01467934|3732106|B4||Male|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
3908711|NCT01467934|3732107|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3908712|NCT01467934|3732108|B2||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3908713|NCT01467934|3732109|B1||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3908714|NCT01467934|3732106|B4||Female|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
3908715|NCT01467934|3732107|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3908716|NCT01467934|3732108|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3908717|NCT01467934|3732109|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3908718|NCT01467934|3732106|B4|12-23 months||Age, Customized||participants|Number|243|243.0||||||
3908719|NCT01467934|3732107|B3|12-23 months||Age, Customized||participants|Number|92|92.0||||||
3908720|NCT01467934|3732108|B2|12-23 months||Age, Customized||participants|Number|67|67.0||||||
3908721|NCT01467934|3732109|B1|12-23 months||Age, Customized||participants|Number|84|84.0||||||
3908722|NCT01467934|3732106|B4|6-11 months||Age, Customized||participants|Number|287|287.0||||||
3908723|NCT01467934|3732107|B3|6-11 months||Age, Customized||participants|Number|18|18.0||||||
3908724|NCT01467934|3732108|B2|6-11 months||Age, Customized||participants|Number|145|145.0||||||
3908725|NCT01467934|3732109|B1|6-11 months||Age, Customized||participants|Number|124|124.0||||||
3908726|NCT01467882|3732119|B1|Chile||Region of Enrollment||participants|Number|15|15.0||||||
3908727|NCT01467882|3732119|B1|Mexico||Region of Enrollment||participants|Number|1|1.0||||||
3908728|NCT01467882|3732119|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
3908729|NCT01467882|3732119|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3908730|NCT01467882|3732119|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3908731|NCT01467882|3732119|B1|||Age||years|Mean|7.41|7.41|Standard Deviation|1.28|1.28|||
3908732|NCT01467882|3732119|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3908733|NCT01467882|3732119|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3908734|NCT01467882|3732119|B1||<=18 years|Age||Participants|Count of Participants|44|44.0||||||
3908735|NCT01467713|3732142|B5|No||Does Participant Consume Caffeine?||participants|Number|150|150.0||||||
3908736|NCT01467713|3732143|B4|No||Does Participant Consume Caffeine?||participants|Number|27|27.0||||||
3908737|NCT01467713|3732144|B3|No||Does Participant Consume Caffeine?||participants|Number|38|38.0||||||
3908738|NCT01467713|3732145|B2|No||Does Participant Consume Caffeine?||participants|Number|42|42.0||||||
3908739|NCT01467713|3732146|B1|No||Does Participant Consume Caffeine?||participants|Number|43|43.0||||||
3908740|NCT01467713|3732142|B5|Yes||Does Participant Consume Caffeine?||participants|Number|492|492.0||||||
3908741|NCT01467713|3732143|B4|Yes||Does Participant Consume Caffeine?||participants|Number|127|127.0||||||
3908742|NCT01467713|3732144|B3|Yes||Does Participant Consume Caffeine?||participants|Number|122|122.0||||||
3908743|NCT01467713|3732145|B2|Yes||Does Participant Consume Caffeine?||participants|Number|122|122.0||||||
3908744|NCT01467713|3732146|B1|Yes||Does Participant Consume Caffeine?||participants|Number|121|121.0||||||
3908745|NCT01467713|3732142|B5|>= 4 Drinks per Day||If Drinker, Amount Consumed|Only participants with drinking status Current Drinker are accounted for: N=49, 43, 47, 55 in each treatment arm, respectively.|participants|Number|1|1.0||||||
3908746|NCT01467713|3732143|B4|>= 4 Drinks per Day||If Drinker, Amount Consumed|Only participants with drinking status Current Drinker are accounted for: N=49, 43, 47, 55 in each treatment arm, respectively.|participants|Number|0|0.0||||||
3908747|NCT01467713|3732144|B3|>= 4 Drinks per Day||If Drinker, Amount Consumed|Only participants with drinking status Current Drinker are accounted for: N=49, 43, 47, 55 in each treatment arm, respectively.|participants|Number|0|0.0||||||
3908748|NCT01467713|3732145|B2|>= 4 Drinks per Day||If Drinker, Amount Consumed|Only participants with drinking status Current Drinker are accounted for: N=49, 43, 47, 55 in each treatment arm, respectively.|participants|Number|1|1.0||||||
3908749|NCT01467713|3732146|B1|>= 4 Drinks per Day||If Drinker, Amount Consumed|Only participants with drinking status Current Drinker are accounted for: N=49, 43, 47, 55 in each treatment arm, respectively.|participants|Number|0|0.0||||||
3908750|NCT01467713|3732142|B5|<4 Drinks per Day||If Drinker, Amount Consumed|Only participants with drinking status Current Drinker are accounted for: N=49, 43, 47, 55 in each treatment arm, respectively.|participants|Number|193|193.0||||||
3908751|NCT01467713|3732143|B4|<4 Drinks per Day||If Drinker, Amount Consumed|Only participants with drinking status Current Drinker are accounted for: N=49, 43, 47, 55 in each treatment arm, respectively.|participants|Number|55|55.0||||||
3908752|NCT01467713|3732144|B3|<4 Drinks per Day||If Drinker, Amount Consumed|Only participants with drinking status Current Drinker are accounted for: N=49, 43, 47, 55 in each treatment arm, respectively.|participants|Number|47|47.0||||||
3908753|NCT01467713|3732145|B2|<4 Drinks per Day||If Drinker, Amount Consumed|Only participants with drinking status Current Drinker are accounted for: N=49, 43, 47, 55 in each treatment arm, respectively.|participants|Number|42|42.0||||||
3908754|NCT01467713|3732146|B1|<4 Drinks per Day||If Drinker, Amount Consumed|Only participants with drinking status Current Drinker are accounted for: N=49, 43, 47, 55 in each treatment arm, respectively.|participants|Number|49|49.0||||||
3908755|NCT01467713|3732142|B5|Missing||Participant Drinking Status||participants|Number|1|1.0||||||
3908756|NCT01467713|3732143|B4|Missing||Participant Drinking Status||participants|Number|0|0.0||||||
3908757|NCT01467713|3732144|B3|Missing||Participant Drinking Status||participants|Number|0|0.0||||||
3908758|NCT01467713|3732145|B2|Missing||Participant Drinking Status||participants|Number|1|1.0||||||
3908759|NCT01467713|3732146|B1|Missing||Participant Drinking Status||participants|Number|0|0.0||||||
3908760|NCT01467713|3732142|B5|Current Drinker||Participant Drinking Status||participants|Number|194|194.0||||||
3908761|NCT01467713|3732143|B4|Current Drinker||Participant Drinking Status||participants|Number|55|55.0||||||
3908762|NCT01467713|3732144|B3|Current Drinker||Participant Drinking Status||participants|Number|47|47.0||||||
3908763|NCT01467713|3732145|B2|Current Drinker||Participant Drinking Status||participants|Number|43|43.0||||||
3908764|NCT01467713|3732146|B1|Current Drinker||Participant Drinking Status||participants|Number|49|49.0||||||
3908765|NCT01467713|3732142|B5|Ex-Drinker||Participant Drinking Status||participants|Number|186|186.0||||||
3908766|NCT01467713|3732143|B4|Ex-Drinker||Participant Drinking Status||participants|Number|41|41.0||||||
3908767|NCT01467713|3732144|B3|Ex-Drinker||Participant Drinking Status||participants|Number|48|48.0||||||
3908768|NCT01467713|3732145|B2|Ex-Drinker||Participant Drinking Status||participants|Number|50|50.0||||||
3908769|NCT01467713|3732146|B1|Ex-Drinker||Participant Drinking Status||participants|Number|47|47.0||||||
3908770|NCT01467713|3732142|B5|Has Never Drunk||Participant Drinking Status||participants|Number|261|261.0||||||
3908771|NCT01467713|3732143|B4|Has Never Drunk||Participant Drinking Status||participants|Number|58|58.0||||||
3908772|NCT01467713|3732144|B3|Has Never Drunk||Participant Drinking Status||participants|Number|65|65.0||||||
3908773|NCT01467713|3732145|B2|Has Never Drunk||Participant Drinking Status||participants|Number|70|70.0||||||
3908774|NCT01467713|3732146|B1|Has Never Drunk||Participant Drinking Status||participants|Number|68|68.0||||||
3908775|NCT01467713|3732142|B5|Participant is an Ex-smoker||Smoking Classification||participants|Number|116|116.0||||||
3908776|NCT01467713|3732143|B4|Participant is an Ex-smoker||Smoking Classification||participants|Number|29|29.0||||||
3908777|NCT01467713|3732144|B3|Participant is an Ex-smoker||Smoking Classification||participants|Number|27|27.0||||||
3908778|NCT01467713|3732145|B2|Participant is an Ex-smoker||Smoking Classification||participants|Number|27|27.0||||||
3908779|NCT01467713|3732146|B1|Participant is an Ex-smoker||Smoking Classification||participants|Number|33|33.0||||||
3908780|NCT01467713|3732142|B5|Participant is a Current Smoker||Smoking Classification||participants|Number|245|245.0||||||
3908781|NCT01467713|3732143|B4|Participant is a Current Smoker||Smoking Classification||participants|Number|63|63.0||||||
3909066|NCT01467700|3732200|B4|||Age||years|Mean|43.97|43.97|Standard Deviation|10.243|10.243|||
3908782|NCT01467713|3732144|B3|Participant is a Current Smoker||Smoking Classification||participants|Number|58|58.0||||||
3908783|NCT01467713|3732145|B2|Participant is a Current Smoker||Smoking Classification||participants|Number|68|68.0||||||
3908784|NCT01467713|3732146|B1|Participant is a Current Smoker||Smoking Classification||participants|Number|56|56.0||||||
3908785|NCT01467713|3732142|B5|Participant Has Never Smoked||Smoking Classification||participants|Number|281|281.0||||||
3908786|NCT01467713|3732143|B4|Participant Has Never Smoked||Smoking Classification||participants|Number|62|62.0||||||
3908787|NCT01467713|3732144|B3|Participant Has Never Smoked||Smoking Classification||participants|Number|75|75.0||||||
3908788|NCT01467713|3732145|B2|Participant Has Never Smoked||Smoking Classification||participants|Number|69|69.0||||||
3908789|NCT01467713|3732146|B1|Participant Has Never Smoked||Smoking Classification||participants|Number|75|75.0||||||
3908790|NCT01467713|3732142|B5|||Body Mass Index (BMI)|BMI is calculated using the weight collected at the first screening visit (Visit 1): BMI=weight(kg)/[height(m)]^2|kg/m^2|Mean|30.75|30.75|Standard Deviation|6.900|6.9|||
3908791|NCT01467713|3732143|B4|||Body Mass Index (BMI)|BMI is calculated using the weight collected at the first screening visit (Visit 1): BMI=weight(kg)/[height(m)]^2|kg/m^2|Mean|30.11|30.11|Standard Deviation|6.702|6.702|||
3908792|NCT01467713|3732144|B3|||Body Mass Index (BMI)|BMI is calculated using the weight collected at the first screening visit (Visit 1): BMI=weight(kg)/[height(m)]^2|kg/m^2|Mean|31.52|31.52|Standard Deviation|7.108|7.108|||
3908793|NCT01467713|3732145|B2|||Body Mass Index (BMI)|BMI is calculated using the weight collected at the first screening visit (Visit 1): BMI=weight(kg)/[height(m)]^2|kg/m^2|Mean|30.66|30.66|Standard Deviation|6.382|6.382|||
3908794|NCT01467713|3732146|B1|||Body Mass Index (BMI)|BMI is calculated using the weight collected at the first screening visit (Visit 1): BMI=weight(kg)/[height(m)]^2|kg/m^2|Mean|30.68|30.68|Standard Deviation|7.351|7.351|||
3908795|NCT01467713|3732142|B5|||Weight||kg|Mean|87.25|87.25|Standard Deviation|21.500|21.5|||
3908796|NCT01467713|3732143|B4|||Weight||kg|Mean|85.71|85.71|Standard Deviation|21.386|21.386|||
3908797|NCT01467713|3732144|B3|||Weight||kg|Mean|88.68|88.68|Standard Deviation|22.291|22.291|||
3908798|NCT01467713|3732145|B2|||Weight||kg|Mean|87.52|87.52|Standard Deviation|21.265|21.265|||
3908799|NCT01467713|3732146|B1|||Weight||kg|Mean|87.04|87.04|Standard Deviation|21.148|21.148|||
3908800|NCT01467713|3732142|B5|||Height||cm|Mean|168.30|168.3|Standard Deviation|9.943|9.943|||
3908801|NCT01467713|3732143|B4|||Height||cm|Mean|168.47|168.47|Standard Deviation|9.608|9.608|||
3908802|NCT01467713|3732144|B3|||Height||cm|Mean|167.49|167.49|Standard Deviation|10.235|10.235|||
3908803|NCT01467713|3732145|B2|||Height||cm|Mean|168.56|168.56|Standard Deviation|9.790|9.79|||
3908804|NCT01467713|3732146|B1|||Height||cm|Mean|168.65|168.65|Standard Deviation|10.159|10.159|||
3908805|NCT01467713|3732142|B5|United States||Region of Enrollment||participants|Number|467|467.0||||||
3908806|NCT01467713|3732143|B4|United States||Region of Enrollment||participants|Number|114|114.0||||||
3908807|NCT01467713|3732144|B3|United States||Region of Enrollment||participants|Number|115|115.0||||||
3908808|NCT01467713|3732145|B2|United States||Region of Enrollment||participants|Number|116|116.0||||||
3908809|NCT01467713|3732146|B1|United States||Region of Enrollment||participants|Number|122|122.0||||||
3908810|NCT01467713|3732142|B5|Mexico||Region of Enrollment||participants|Number|39|39.0||||||
3908811|NCT01467713|3732143|B4|Mexico||Region of Enrollment||participants|Number|10|10.0||||||
3908812|NCT01467713|3732144|B3|Mexico||Region of Enrollment||participants|Number|8|8.0||||||
3908813|NCT01467713|3732145|B2|Mexico||Region of Enrollment||participants|Number|12|12.0||||||
3908814|NCT01467713|3732146|B1|Mexico||Region of Enrollment||participants|Number|9|9.0||||||
3908815|NCT01467713|3732142|B5|Colombia||Region of Enrollment||participants|Number|24|24.0||||||
3908816|NCT01467713|3732143|B4|Colombia||Region of Enrollment||participants|Number|6|6.0||||||
3908817|NCT01467713|3732144|B3|Colombia||Region of Enrollment||participants|Number|7|7.0||||||
3908818|NCT01467713|3732145|B2|Colombia||Region of Enrollment||participants|Number|7|7.0||||||
3908819|NCT01467713|3732146|B1|Colombia||Region of Enrollment||participants|Number|4|4.0||||||
3908820|NCT01467713|3732142|B5|Chile||Region of Enrollment||participants|Number|46|46.0||||||
3908821|NCT01467713|3732143|B4|Chile||Region of Enrollment||participants|Number|11|11.0||||||
3908822|NCT01467713|3732144|B3|Chile||Region of Enrollment||participants|Number|12|12.0||||||
3908823|NCT01467713|3732145|B2|Chile||Region of Enrollment||participants|Number|10|10.0||||||
3908824|NCT01467713|3732146|B1|Chile||Region of Enrollment||participants|Number|13|13.0||||||
3908825|NCT01467713|3732142|B5|Argentina||Region of Enrollment||participants|Number|66|66.0||||||
3908826|NCT01467713|3732143|B4|Argentina||Region of Enrollment||participants|Number|13|13.0||||||
3908827|NCT01467713|3732144|B3|Argentina||Region of Enrollment||participants|Number|18|18.0||||||
3908828|NCT01467713|3732145|B2|Argentina||Region of Enrollment||participants|Number|19|19.0||||||
3908829|NCT01467713|3732146|B1|Argentina||Region of Enrollment||participants|Number|16|16.0||||||
3908830|NCT01467713|3732142|B5|Multiple||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3908831|NCT01467713|3732143|B4|Multiple||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3908832|NCT01467713|3732144|B3|Multiple||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3908833|NCT01467713|3732145|B2|Multiple||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3908834|NCT01467713|3732146|B1|Multiple||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3908835|NCT01467713|3732142|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3908836|NCT01467713|3732143|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3908837|NCT01467713|3732144|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3909067|NCT01467700|3732201|B3|||Age||years|Mean|42.96|42.96|Standard Deviation|13.211|13.211|||
3908838|NCT01467713|3732145|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3908839|NCT01467713|3732146|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3908840|NCT01467713|3732142|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3908841|NCT01467713|3732143|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3908842|NCT01467713|3732144|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3908843|NCT01467713|3732145|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3908844|NCT01467713|3732146|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3908845|NCT01467713|3732142|B5|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3908846|NCT01467713|3732143|B4|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3908847|NCT01467713|3732144|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3908848|NCT01467713|3732145|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3908849|NCT01467713|3732146|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3908850|NCT01467713|3732142|B5|Black||Race/Ethnicity, Customized||participants|Number|140|140.0||||||
3908851|NCT01467713|3732143|B4|Black||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3908852|NCT01467713|3732144|B3|Black||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
3908853|NCT01467713|3732145|B2|Black||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
3908854|NCT01467713|3732146|B1|Black||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3908855|NCT01467713|3732142|B5|White||Race/Ethnicity, Customized||participants|Number|455|455.0||||||
3908856|NCT01467713|3732143|B4|White||Race/Ethnicity, Customized||participants|Number|104|104.0||||||
3908857|NCT01467713|3732144|B3|White||Race/Ethnicity, Customized||participants|Number|117|117.0||||||
3908858|NCT01467713|3732145|B2|White||Race/Ethnicity, Customized||participants|Number|116|116.0||||||
3908859|NCT01467713|3732146|B1|White||Race/Ethnicity, Customized||participants|Number|118|118.0||||||
3908860|NCT01467713|3732142|B5|Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||participants|Number|427|427.0||||||
3908861|NCT01467713|3732143|B4|Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||participants|Number|108|108.0||||||
3908862|NCT01467713|3732144|B3|Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||participants|Number|106|106.0||||||
3908863|NCT01467713|3732145|B2|Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||participants|Number|101|101.0||||||
3908864|NCT01467713|3732146|B1|Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||participants|Number|112|112.0||||||
3908865|NCT01467713|3732142|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|215|215.0||||||
3908866|NCT01467713|3732143|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
3908867|NCT01467713|3732144|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
3908868|NCT01467713|3732145|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
3908869|NCT01467713|3732146|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
3908870|NCT01467713|3732142|B5||Male|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
3908871|NCT01467713|3732143|B4||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3908872|NCT01467713|3732144|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3908873|NCT01467713|3732145|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3908874|NCT01467713|3732146|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3908875|NCT01467713|3732142|B5||Female|Sex: Female, Male||Participants|Count of Participants|367|367.0||||||
3908876|NCT01467713|3732143|B4||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3908877|NCT01467713|3732144|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3908878|NCT01467713|3732145|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3908879|NCT01467713|3732146|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3908880|NCT01467713|3732142|B5|>50 Years||Age, Customized||participants|Number|203|203.0||||||
3908881|NCT01467713|3732143|B4|>50 Years||Age, Customized||participants|Number|42|42.0||||||
3908882|NCT01467713|3732144|B3|>50 Years||Age, Customized||participants|Number|47|47.0||||||
3908883|NCT01467713|3732145|B2|>50 Years||Age, Customized||participants|Number|59|59.0||||||
3908884|NCT01467713|3732146|B1|>50 Years||Age, Customized||participants|Number|55|55.0||||||
3908885|NCT01467713|3732142|B5|<=50 Years||Age, Customized||participants|Number|439|439.0||||||
3908886|NCT01467713|3732143|B4|<=50 Years||Age, Customized||participants|Number|112|112.0||||||
3908887|NCT01467713|3732144|B3|<=50 Years||Age, Customized||participants|Number|113|113.0||||||
3908888|NCT01467713|3732145|B2|<=50 Years||Age, Customized||participants|Number|105|105.0||||||
3908889|NCT01467713|3732146|B1|<=50 Years||Age, Customized||participants|Number|109|109.0||||||
3908890|NCT01467713|3732142|B5|||Age||years|Mean|42.98|42.98|Standard Deviation|12.440|12.44|||
3908891|NCT01467713|3732143|B4|||Age||years|Mean|41.71|41.71|Standard Deviation|12.534|12.534|||
3908892|NCT01467713|3732144|B3|||Age||years|Mean|42.93|42.93|Standard Deviation|11.666|11.666|||
3908893|NCT01467713|3732145|B2|||Age||years|Mean|42.97|42.97|Standard Deviation|13.262|13.262|||
3908894|NCT01467713|3732146|B1|||Age||years|Mean|44.21|44.21|Standard Deviation|12.224|12.224|||
3908895|NCT01467700|3732199|B5|Missing||Does Participant Consume Caffeine?||participants|Number|63|63.0||||||
3908896|NCT01467700|3732200|B4|Missing||Does Participant Consume Caffeine?||participants|Number|12|12.0||||||
3908897|NCT01467700|3732201|B3|Missing||Does Participant Consume Caffeine?||participants|Number|18|18.0||||||
3908898|NCT01467700|3732202|B2|Missing||Does Participant Consume Caffeine?||participants|Number|17|17.0||||||
3908899|NCT01467700|3732203|B1|Missing||Does Participant Consume Caffeine?||participants|Number|16|16.0||||||
3908900|NCT01467700|3732199|B5|No||Does Participant Consume Caffeine?||participants|Number|102|102.0||||||
3908901|NCT01467700|3732200|B4|No||Does Participant Consume Caffeine?||participants|Number|30|30.0||||||
3908902|NCT01467700|3732201|B3|No||Does Participant Consume Caffeine?||participants|Number|23|23.0||||||
3908903|NCT01467700|3732202|B2|No||Does Participant Consume Caffeine?||participants|Number|27|27.0||||||
3908904|NCT01467700|3732203|B1|No||Does Participant Consume Caffeine?||participants|Number|22|22.0||||||
3908905|NCT01467700|3732199|B5|Yes||Does Participant Consume Caffeine?||participants|Number|325|325.0||||||
3908906|NCT01467700|3732200|B4|Yes||Does Participant Consume Caffeine?||participants|Number|81|81.0||||||
3908907|NCT01467700|3732201|B3|Yes||Does Participant Consume Caffeine?||participants|Number|83|83.0||||||
3908908|NCT01467700|3732202|B2|Yes||Does Participant Consume Caffeine?||participants|Number|84|84.0||||||
3908909|NCT01467700|3732203|B1|Yes||Does Participant Consume Caffeine?||participants|Number|77|77.0||||||
3908910|NCT01467700|3732199|B5|>= 4 drinks per day||If Drinker, Amount Consumed|Only participants with drinking status Current Drinker are accounted for: N=22, 34, 33, 25 in each treatment arm, respectively.|participants|Number|0|0.0||||||
3908911|NCT01467700|3732200|B4|>= 4 drinks per day||If Drinker, Amount Consumed|Only participants with drinking status Current Drinker are accounted for: N=22, 34, 33, 25 in each treatment arm, respectively.|participants|Number|0|0.0||||||
3908912|NCT01467700|3732201|B3|>= 4 drinks per day||If Drinker, Amount Consumed|Only participants with drinking status Current Drinker are accounted for: N=22, 34, 33, 25 in each treatment arm, respectively.|participants|Number|0|0.0||||||
3908913|NCT01467700|3732202|B2|>= 4 drinks per day||If Drinker, Amount Consumed|Only participants with drinking status Current Drinker are accounted for: N=22, 34, 33, 25 in each treatment arm, respectively.|participants|Number|0|0.0||||||
3908914|NCT01467700|3732203|B1|>= 4 drinks per day||If Drinker, Amount Consumed|Only participants with drinking status Current Drinker are accounted for: N=22, 34, 33, 25 in each treatment arm, respectively.|participants|Number|0|0.0||||||
3908915|NCT01467700|3732199|B5|< 4 drinks per day||If Drinker, Amount Consumed|Only participants with drinking status Current Drinker are accounted for: N=22, 34, 33, 25 in each treatment arm, respectively.|participants|Number|114|114.0||||||
3908916|NCT01467700|3732200|B4|< 4 drinks per day||If Drinker, Amount Consumed|Only participants with drinking status Current Drinker are accounted for: N=22, 34, 33, 25 in each treatment arm, respectively.|participants|Number|25|25.0||||||
3908917|NCT01467700|3732201|B3|< 4 drinks per day||If Drinker, Amount Consumed|Only participants with drinking status Current Drinker are accounted for: N=22, 34, 33, 25 in each treatment arm, respectively.|participants|Number|33|33.0||||||
3908918|NCT01467700|3732202|B2|< 4 drinks per day||If Drinker, Amount Consumed|Only participants with drinking status Current Drinker are accounted for: N=22, 34, 33, 25 in each treatment arm, respectively.|participants|Number|34|34.0||||||
3908919|NCT01467700|3732203|B1|< 4 drinks per day||If Drinker, Amount Consumed|Only participants with drinking status Current Drinker are accounted for: N=22, 34, 33, 25 in each treatment arm, respectively.|participants|Number|22|22.0||||||
3908920|NCT01467700|3732199|B5|Missing||Participant Drinking Status||participants|Number|63|63.0||||||
3908921|NCT01467700|3732200|B4|Missing||Participant Drinking Status||participants|Number|12|12.0||||||
3908922|NCT01467700|3732201|B3|Missing||Participant Drinking Status||participants|Number|18|18.0||||||
3908923|NCT01467700|3732202|B2|Missing||Participant Drinking Status||participants|Number|17|17.0||||||
3908924|NCT01467700|3732203|B1|Missing||Participant Drinking Status||participants|Number|16|16.0||||||
3908925|NCT01467700|3732199|B5|Current Drinker||Participant Drinking Status||participants|Number|114|114.0||||||
3908926|NCT01467700|3732200|B4|Current Drinker||Participant Drinking Status||participants|Number|25|25.0||||||
3908927|NCT01467700|3732201|B3|Current Drinker||Participant Drinking Status||participants|Number|33|33.0||||||
3908928|NCT01467700|3732202|B2|Current Drinker||Participant Drinking Status||participants|Number|34|34.0||||||
3908929|NCT01467700|3732203|B1|Current Drinker||Participant Drinking Status||participants|Number|22|22.0||||||
3908930|NCT01467700|3732199|B5|Ex-Drinker||Participant Drinking Status||participants|Number|126|126.0||||||
3908931|NCT01467700|3732200|B4|Ex-Drinker||Participant Drinking Status||participants|Number|37|37.0||||||
3908932|NCT01467700|3732201|B3|Ex-Drinker||Participant Drinking Status||participants|Number|28|28.0||||||
3908933|NCT01467700|3732202|B2|Ex-Drinker||Participant Drinking Status||participants|Number|36|36.0||||||
3908934|NCT01467700|3732203|B1|Ex-Drinker||Participant Drinking Status||participants|Number|25|25.0||||||
3908935|NCT01467700|3732199|B5|Has Never Drunk||Participant Drinking Status||participants|Number|187|187.0||||||
3908936|NCT01467700|3732200|B4|Has Never Drunk||Participant Drinking Status||participants|Number|49|49.0||||||
3908937|NCT01467700|3732201|B3|Has Never Drunk||Participant Drinking Status||participants|Number|45|45.0||||||
3908938|NCT01467700|3732202|B2|Has Never Drunk||Participant Drinking Status||participants|Number|41|41.0||||||
3908939|NCT01467700|3732203|B1|Has Never Drunk||Participant Drinking Status||participants|Number|52|52.0||||||
3908940|NCT01467700|3732199|B5|Participant is an Ex-smoker||Smoking Classification||participants|Number|70|70.0||||||
3908941|NCT01467700|3732200|B4|Participant is an Ex-smoker||Smoking Classification||participants|Number|20|20.0||||||
3908942|NCT01467700|3732201|B3|Participant is an Ex-smoker||Smoking Classification||participants|Number|17|17.0||||||
3908943|NCT01467700|3732202|B2|Participant is an Ex-smoker||Smoking Classification||participants|Number|15|15.0||||||
3908944|NCT01467700|3732203|B1|Participant is an Ex-smoker||Smoking Classification||participants|Number|18|18.0||||||
3908945|NCT01467700|3732199|B5|Participant is a Current Smoker||Smoking Classification||participants|Number|224|224.0||||||
3908946|NCT01467700|3732200|B4|Participant is a Current Smoker||Smoking Classification||participants|Number|58|58.0||||||
3908947|NCT01467700|3732201|B3|Participant is a Current Smoker||Smoking Classification||participants|Number|58|58.0||||||
3908948|NCT01467700|3732202|B2|Participant is a Current Smoker||Smoking Classification||participants|Number|58|58.0||||||
3908949|NCT01467700|3732203|B1|Participant is a Current Smoker||Smoking Classification||participants|Number|50|50.0||||||
3908950|NCT01467700|3732199|B5|Participant Has Never Smoked||Smoking Classification||participants|Number|196|196.0||||||
3908951|NCT01467700|3732200|B4|Participant Has Never Smoked||Smoking Classification||participants|Number|45|45.0||||||
3908952|NCT01467700|3732201|B3|Participant Has Never Smoked||Smoking Classification||participants|Number|49|49.0||||||
3908953|NCT01467700|3732202|B2|Participant Has Never Smoked||Smoking Classification||participants|Number|55|55.0||||||
3908954|NCT01467700|3732203|B1|Participant Has Never Smoked||Smoking Classification||participants|Number|47|47.0||||||
3908955|NCT01467700|3732199|B5|||Body Mass Index (BMI)|BMI is calculated using the weight collected at the first screening visit: BMI=weight(kg)/[height(m)]^2.|kg/m^2|Mean|30.56|30.56|Standard Deviation|6.904|6.904|||
3908956|NCT01467700|3732200|B4|||Body Mass Index (BMI)|BMI is calculated using the weight collected at the first screening visit: BMI=weight(kg)/[height(m)]^2.|kg/m^2|Mean|30.61|30.61|Standard Deviation|6.825|6.825|||
3908957|NCT01467700|3732201|B3|||Body Mass Index (BMI)|BMI is calculated using the weight collected at the first screening visit: BMI=weight(kg)/[height(m)]^2.|kg/m^2|Mean|30.37|30.37|Standard Deviation|6.808|6.808|||
3908958|NCT01467700|3732202|B2|||Body Mass Index (BMI)|BMI is calculated using the weight collected at the first screening visit: BMI=weight(kg)/[height(m)]^2.|kg/m^2|Mean|30.63|30.63|Standard Deviation|7.254|7.254|||
3908959|NCT01467700|3732203|B1|||Body Mass Index (BMI)|BMI is calculated using the weight collected at the first screening visit: BMI=weight(kg)/[height(m)]^2.|kg/m^2|Mean|30.62|30.62|Standard Deviation|6.778|6.778|||
3908960|NCT01467700|3732199|B5|||Weight||kg|Mean|86.22|86.22|Standard Deviation|20.989|20.989|||
3908961|NCT01467700|3732200|B4|||Weight||kg|Mean|86.69|86.69|Standard Deviation|21.535|21.535|||
3908962|NCT01467700|3732201|B3|||Weight||kg|Mean|85.09|85.09|Standard Deviation|20.873|20.873|||
3908963|NCT01467700|3732202|B2|||Weight||kg|Mean|87.58|87.58|Standard Deviation|21.555|21.555|||
3908964|NCT01467700|3732203|B1|||Weight||kg|Mean|85.44|85.44|Standard Deviation|20.034|20.034|||
3908965|NCT01467700|3732199|B5|||Height||cm|Mean|167.85|167.85|Standard Deviation|10.139|10.139|||
3908966|NCT01467700|3732200|B4|||Height||cm|Mean|168.15|168.15|Standard Deviation|10.590|10.59|||
3908967|NCT01467700|3732201|B3|||Height||cm|Mean|167.22|167.22|Standard Deviation|9.677|9.677|||
3908968|NCT01467700|3732202|B2|||Height||cm|Mean|169.00|169.0|Standard Deviation|9.937|9.937|||
3908969|NCT01467700|3732203|B1|||Height||cm|Mean|166.93|166.93|Standard Deviation|10.345|10.345|||
3908970|NCT01467700|3732199|B5|Mexico||Region of Enrollment||participants|Number|45|45.0||||||
3908971|NCT01467700|3732200|B4|Mexico||Region of Enrollment||participants|Number|12|12.0||||||
3908972|NCT01467700|3732201|B3|Mexico||Region of Enrollment||participants|Number|11|11.0||||||
3908973|NCT01467700|3732202|B2|Mexico||Region of Enrollment||participants|Number|12|12.0||||||
3908974|NCT01467700|3732203|B1|Mexico||Region of Enrollment||participants|Number|10|10.0||||||
3908975|NCT01467700|3732199|B5|Colombia||Region of Enrollment||participants|Number|10|10.0||||||
3908976|NCT01467700|3732200|B4|Colombia||Region of Enrollment||participants|Number|3|3.0||||||
3908977|NCT01467700|3732201|B3|Colombia||Region of Enrollment||participants|Number|1|1.0||||||
3908978|NCT01467700|3732202|B2|Colombia||Region of Enrollment||participants|Number|3|3.0||||||
3908979|NCT01467700|3732203|B1|Colombia||Region of Enrollment||participants|Number|3|3.0||||||
3908980|NCT01467700|3732199|B5|Chile||Region of Enrollment||participants|Number|19|19.0||||||
3908981|NCT01467700|3732200|B4|Chile||Region of Enrollment||participants|Number|3|3.0||||||
3908982|NCT01467700|3732201|B3|Chile||Region of Enrollment||participants|Number|6|6.0||||||
3908983|NCT01467700|3732202|B2|Chile||Region of Enrollment||participants|Number|5|5.0||||||
3908984|NCT01467700|3732203|B1|Chile||Region of Enrollment||participants|Number|5|5.0||||||
3908985|NCT01467700|3732199|B5|Argentina||Region of Enrollment||participants|Number|45|45.0||||||
3908986|NCT01467700|3732200|B4|Argentina||Region of Enrollment||participants|Number|11|11.0||||||
3908987|NCT01467700|3732201|B3|Argentina||Region of Enrollment||participants|Number|11|11.0||||||
3908988|NCT01467700|3732202|B2|Argentina||Region of Enrollment||participants|Number|11|11.0||||||
3908989|NCT01467700|3732203|B1|Argentina||Region of Enrollment||participants|Number|12|12.0||||||
3908990|NCT01467700|3732199|B5|United States||Region of Enrollment||participants|Number|371|371.0||||||
3908991|NCT01467700|3732200|B4|United States||Region of Enrollment||participants|Number|94|94.0||||||
3908992|NCT01467700|3732201|B3|United States||Region of Enrollment||participants|Number|95|95.0||||||
3908993|NCT01467700|3732202|B2|United States||Region of Enrollment||participants|Number|97|97.0||||||
3908994|NCT01467700|3732203|B1|United States||Region of Enrollment||participants|Number|85|85.0||||||
3908995|NCT01467700|3732199|B5|Multiple||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3908996|NCT01467700|3732200|B4|Multiple||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3908997|NCT01467700|3732201|B3|Multiple||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3908998|NCT01467700|3732202|B2|Multiple||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3908999|NCT01467700|3732203|B1|Multiple||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3909000|NCT01467700|3732199|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3909001|NCT01467700|3732200|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3909002|NCT01467700|3732201|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3909003|NCT01467700|3732202|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3909004|NCT01467700|3732203|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3909005|NCT01467700|3732199|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3909006|NCT01467700|3732200|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3909007|NCT01467700|3732201|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3909008|NCT01467700|3732202|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3909009|NCT01467700|3732203|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3909010|NCT01467700|3732199|B5|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3909011|NCT01467700|3732200|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3909012|NCT01467700|3732201|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3909013|NCT01467700|3732202|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3909014|NCT01467700|3732203|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3909015|NCT01467700|3732199|B5|Black||Race/Ethnicity, Customized||participants|Number|141|141.0||||||
3909016|NCT01467700|3732200|B4|Black||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
3909017|NCT01467700|3732201|B3|Black||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3909018|NCT01467700|3732202|B2|Black||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
3909019|NCT01467700|3732203|B1|Black||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3909020|NCT01467700|3732199|B5|White||Race/Ethnicity, Customized||participants|Number|321|321.0||||||
3909021|NCT01467700|3732200|B4|White||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
3909022|NCT01467700|3732201|B3|White||Race/Ethnicity, Customized||participants|Number|85|85.0||||||
3909023|NCT01467700|3732202|B2|White||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
3909024|NCT01467700|3732203|B1|White||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
3909025|NCT01467700|3732199|B5|Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||participants|Number|344|344.0||||||
3909026|NCT01467700|3732200|B4|Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||participants|Number|86|86.0||||||
3909027|NCT01467700|3732201|B3|Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||participants|Number|89|89.0||||||
3909028|NCT01467700|3732202|B2|Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||participants|Number|90|90.0||||||
3909029|NCT01467700|3732203|B1|Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
3909030|NCT01467700|3732199|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|146|146.0||||||
3909031|NCT01467700|3732200|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
3909032|NCT01467700|3732201|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3909033|NCT01467700|3732202|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
3909034|NCT01467700|3732203|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3909035|NCT01467700|3732199|B5||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
3909036|NCT01467700|3732200|B4||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3909037|NCT01467700|3732201|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3909038|NCT01467700|3732202|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3909039|NCT01467700|3732203|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3909040|NCT01467700|3732199|B5||Female|Sex: Female, Male||Participants|Count of Participants|292|292.0||||||
3909041|NCT01467700|3732200|B4||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3909042|NCT01467700|3732201|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3909043|NCT01467700|3732202|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3909044|NCT01467700|3732203|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3909045|NCT01467700|3732199|B5|>65 Years||Age, Customized||participants|Number|13|13.0||||||
3909046|NCT01467700|3732200|B4|>65 Years||Age, Customized||participants|Number|2|2.0||||||
3909047|NCT01467700|3732201|B3|>65 Years||Age, Customized||participants|Number|5|5.0||||||
3909048|NCT01467700|3732202|B2|>65 Years||Age, Customized||participants|Number|2|2.0||||||
3909049|NCT01467700|3732203|B1|>65 Years||Age, Customized||participants|Number|4|4.0||||||
3909050|NCT01467700|3732199|B5|<=65 years||Age, Customized||participants|Number|477|477.0||||||
3909051|NCT01467700|3732200|B4|<=65 years||Age, Customized||participants|Number|121|121.0||||||
3909052|NCT01467700|3732201|B3|<=65 years||Age, Customized||participants|Number|119|119.0||||||
3909053|NCT01467700|3732202|B2|<=65 years||Age, Customized||participants|Number|126|126.0||||||
3909054|NCT01467700|3732203|B1|<=65 years||Age, Customized||participants|Number|111|111.0||||||
3909055|NCT01467700|3732199|B5|>50 Years||Age, Customized||participants|Number|128|128.0||||||
3909056|NCT01467700|3732200|B4|>50 Years||Age, Customized||participants|Number|26|26.0||||||
3909057|NCT01467700|3732201|B3|>50 Years||Age, Customized||participants|Number|36|36.0||||||
3909058|NCT01467700|3732202|B2|>50 Years||Age, Customized||participants|Number|36|36.0||||||
3909059|NCT01467700|3732203|B1|>50 Years||Age, Customized||participants|Number|30|30.0||||||
3909060|NCT01467700|3732199|B5|<=50 Years||Age, Customized||participants|Number|362|362.0||||||
3909061|NCT01467700|3732200|B4|<=50 Years||Age, Customized||participants|Number|97|97.0||||||
3909062|NCT01467700|3732201|B3|<=50 Years||Age, Customized||participants|Number|88|88.0||||||
3909063|NCT01467700|3732202|B2|<=50 Years||Age, Customized||participants|Number|92|92.0||||||
3909064|NCT01467700|3732203|B1|<=50 Years||Age, Customized||participants|Number|85|85.0||||||
3909065|NCT01467700|3732199|B5|||Age||years|Mean|43.69|43.69|Standard Deviation|11.646|11.646|||
3909068|NCT01467700|3732202|B2|||Age||years|Mean|43.01|43.01|Standard Deviation|11.998|11.998|||
3909069|NCT01467700|3732203|B1|||Age||years|Mean|44.95|44.95|Standard Deviation|10.867|10.867|||
3909070|NCT01467661|3732248|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3909071|NCT01467661|3732248|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3909072|NCT01467661|3732248|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|13.10|13.1|||
3909073|NCT01467583|3732265|B4|United States||Region of Enrollment||participants|Number|32|32.0||||||
3909074|NCT01467583|3732266|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3909075|NCT01467583|3732267|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3909076|NCT01467583|3732268|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3909077|NCT01467583|3732265|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3909078|NCT01467583|3732266|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3909079|NCT01467583|3732267|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3909080|NCT01467583|3732268|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3909081|NCT01467583|3732265|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3909082|NCT01467583|3732266|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3909083|NCT01467583|3732267|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3909084|NCT01467583|3732268|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3909085|NCT01467583|3732265|B4|||Age||years|Mean|62|62.0|Standard Deviation|12|12.0|||
3909086|NCT01467583|3732266|B3|||Age||years|Mean|62|62.0|Standard Deviation|12|12.0|||
3909087|NCT01467583|3732267|B2|||Age||years|Mean|63|63.0|Standard Deviation|10|10.0|||
3909088|NCT01467583|3732268|B1|||Age||years|Mean|61|61.0|Standard Deviation|12|12.0|||
3909089|NCT01467570|3732281|B3|Poland||Region of Enrollment||participants|Number|147|147.0||||||
3909090|NCT01467570|3732282|B2|Poland||Region of Enrollment||participants|Number|72|72.0||||||
3909091|NCT01467570|3732283|B1|Poland||Region of Enrollment||participants|Number|75|75.0||||||
3909092|NCT01467570|3732281|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3909093|NCT01467570|3732282|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3909094|NCT01467570|3732283|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3909095|NCT01467570|3732281|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3909096|NCT01467570|3732282|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3909097|NCT01467570|3732283|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3909098|NCT01467570|3732281|B3|||Age||years|Mean|1.75|1.75|Standard Deviation|0.89|0.89|||
3909099|NCT01467570|3732282|B2|||Age||years|Mean|1.6|1.6|Standard Deviation|0.8|0.8|||
3909100|NCT01467570|3732283|B1|||Age||years|Mean|1.8|1.8|Standard Deviation|0.5|0.5|||
3909101|NCT01467570|3732281|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3909102|NCT01467570|3732282|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3909103|NCT01467570|3732283|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3909104|NCT01467570|3732281|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3909105|NCT01467570|3732282|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3909106|NCT01467570|3732283|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3909107|NCT01467570|3732281|B3||<=18 years|Age||Participants|Count of Participants|147|147.0||||||
3909108|NCT01467570|3732282|B2||<=18 years|Age||Participants|Count of Participants|72|72.0||||||
3909109|NCT01467570|3732283|B1||<=18 years|Age||Participants|Count of Participants|75|75.0||||||
3909110|NCT01467557|3732308|B3|United States||Region of Enrollment||participants|Number|1171|1171.0||||||
3909111|NCT01467557|3732309|B2|United States||Region of Enrollment||participants|Number|570|570.0||||||
3909112|NCT01467557|3732310|B1|United States||Region of Enrollment||participants|Number|601|601.0||||||
3909113|NCT01467557|3732308|B3||Male|Sex: Female, Male||Participants|Count of Participants|379|379.0||||||
3909114|NCT01467557|3732309|B2||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
3909115|NCT01467557|3732310|B1||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3909116|NCT01467557|3732308|B3||Female|Sex: Female, Male||Participants|Count of Participants|792|792.0||||||
3909117|NCT01467557|3732309|B2||Female|Sex: Female, Male||Participants|Count of Participants|392|392.0||||||
3909118|NCT01467557|3732310|B1||Female|Sex: Female, Male||Participants|Count of Participants|400|400.0||||||
3909119|NCT01467557|3732308|B3|||Age||years|Mean|31.8|31.8|Standard Deviation|13.5|13.5|||
3909120|NCT01467557|3732309|B2|||Age||years|Mean|30.3|30.3|Standard Deviation|12.9|12.9|||
3909121|NCT01467557|3732310|B1|||Age||years|Mean|33.2|33.2|Standard Deviation|13.9|13.9|||
3909122|NCT01467557|3732308|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3909123|NCT01467557|3732309|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3909124|NCT01467557|3732310|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3909125|NCT01467557|3732308|B3||Between 18 and 65 years|Age||Participants|Count of Participants|929|929.0||||||
3909126|NCT01467557|3732309|B2||Between 18 and 65 years|Age||Participants|Count of Participants|445|445.0||||||
3909127|NCT01467557|3732310|B1||Between 18 and 65 years|Age||Participants|Count of Participants|484|484.0||||||
3909128|NCT01467557|3732308|B3||<=18 years|Age||Participants|Count of Participants|227|227.0||||||
3909129|NCT01467557|3732309|B2||<=18 years|Age||Participants|Count of Participants|121|121.0||||||
3909130|NCT01467557|3732310|B1||<=18 years|Age||Participants|Count of Participants|106|106.0||||||
3909131|NCT01467505|3732319|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3909132|NCT01467505|3732320|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3909133|NCT01467505|3732321|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3909134|NCT01467505|3732319|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3909135|NCT01467505|3732320|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3909136|NCT01467505|3732321|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3909137|NCT01467505|3732319|B3|||Age||Years|Mean|57.3|57.3|Standard Deviation|4.02|4.02|||
3909138|NCT01467505|3732320|B2|||Age||Years|Mean|59.5|59.5|Standard Deviation|2.95|2.95|||
3909139|NCT01467505|3732321|B1|||Age||Years|Mean|56.8|56.8|Standard Deviation|4.08|4.08|||
3909140|NCT01467492|3732352|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3909141|NCT01467492|3732353|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3909142|NCT01467492|3732354|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3909143|NCT01467492|3732352|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3909144|NCT01467492|3732353|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3909145|NCT01467492|3732354|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3909146|NCT01467492|3732352|B3|||Age||years|Mean|57.1|57.1|Standard Deviation|5.76|5.76|||
3909147|NCT01467492|3732353|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|5.95|5.95|||
3909148|NCT01467492|3732354|B1|||Age||years|Mean|57.7|57.7|Standard Deviation|5.59|5.59|||
3909149|NCT01467479|3732376|B4||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3909150|NCT01467479|3732377|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3909151|NCT01467479|3732378|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3909152|NCT01467479|3732379|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3909153|NCT01467479|3732376|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3909154|NCT01467479|3732377|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3909155|NCT01467479|3732378|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3909156|NCT01467479|3732379|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3909157|NCT01467479|3732376|B4|||Age||years|Mean|49.5|49.5|Standard Deviation|9.06|9.06|||
3909158|NCT01467479|3732377|B3|||Age||years|Mean|48.4|48.4|Standard Deviation|9.58|9.58|||
3909159|NCT01467479|3732378|B2|||Age||years|Mean|49.6|49.6|Standard Deviation|8.84|8.84|||
3909160|NCT01467479|3732379|B1|||Age||years|Mean|50.4|50.4|Standard Deviation|8.81|8.81|||
3909161|NCT01467466|3732408|B5|Australia||Region of Enrollment||Participants|Count of Participants|317|317.0||||||
3909162|NCT01467466|3732409|B4|Australia||Region of Enrollment||Participants|Count of Participants|77|77.0||||||
3909163|NCT01467466|3732410|B3|Australia||Region of Enrollment||Participants|Count of Participants|83|83.0||||||
3909164|NCT01467466|3732411|B2|Australia||Region of Enrollment||Participants|Count of Participants|82|82.0||||||
3909165|NCT01467466|3732412|B1|Australia||Region of Enrollment||Participants|Count of Participants|75|75.0||||||
3909166|NCT01467466|3732408|B5|Malaysia||Region of Enrollment||Participants|Count of Participants|230|230.0||||||
3909167|NCT01467466|3732409|B4|Malaysia||Region of Enrollment||Participants|Count of Participants|58|58.0||||||
3909168|NCT01467466|3732410|B3|Malaysia||Region of Enrollment||Participants|Count of Participants|59|59.0||||||
3909169|NCT01467466|3732411|B2|Malaysia||Region of Enrollment||Participants|Count of Participants|57|57.0||||||
3909170|NCT01467466|3732412|B1|Malaysia||Region of Enrollment||Participants|Count of Participants|56|56.0||||||
3909171|NCT01467466|3732408|B5|United States||Region of Enrollment||Participants|Count of Participants|4267|4267.0||||||
3909172|NCT01467466|3732409|B4|United States||Region of Enrollment||Participants|Count of Participants|1077|1077.0||||||
3909173|NCT01467466|3732410|B3|United States||Region of Enrollment||Participants|Count of Participants|1068|1068.0||||||
3909174|NCT01467466|3732411|B2|United States||Region of Enrollment||Participants|Count of Participants|1054|1054.0||||||
3909175|NCT01467466|3732412|B1|United States||Region of Enrollment||Participants|Count of Participants|1068|1068.0||||||
3909176|NCT01467466|3732408|B5|New Zealand||Region of Enrollment||Participants|Count of Participants|179|179.0||||||
3909177|NCT01467466|3732409|B4|New Zealand||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3909178|NCT01467466|3732410|B3|New Zealand||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3909179|NCT01467466|3732411|B2|New Zealand||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3909180|NCT01467466|3732412|B1|New Zealand||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3909181|NCT01467466|3732408|B5|Ethnicity|Chose Not to Answer|Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
3909182|NCT01467466|3732409|B4|Ethnicity|Chose Not to Answer|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3909183|NCT01467466|3732410|B3|Ethnicity|Chose Not to Answer|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3909184|NCT01467466|3732411|B2|Ethnicity|Chose Not to Answer|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3909185|NCT01467466|3732412|B1|Ethnicity|Chose Not to Answer|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3909186|NCT01467466|3732408|B5|Ethnicity|Other Spanish Hispanic, or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|95|95.0||||||
3909187|NCT01467466|3732409|B4|Ethnicity|Other Spanish Hispanic, or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3909188|NCT01467466|3732410|B3|Ethnicity|Other Spanish Hispanic, or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3909189|NCT01467466|3732411|B2|Ethnicity|Other Spanish Hispanic, or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3909190|NCT01467466|3732412|B1|Ethnicity|Other Spanish Hispanic, or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3909191|NCT01467466|3732408|B5|Ethnicity|Cuban|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3909192|NCT01467466|3732409|B4|Ethnicity|Cuban|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3909193|NCT01467466|3732410|B3|Ethnicity|Cuban|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3909194|NCT01467466|3732411|B2|Ethnicity|Cuban|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3909195|NCT01467466|3732412|B1|Ethnicity|Cuban|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3909196|NCT01467466|3732408|B5|Ethnicity|Puerto Rican|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3909197|NCT01467466|3732409|B4|Ethnicity|Puerto Rican|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3909198|NCT01467466|3732410|B3|Ethnicity|Puerto Rican|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3909199|NCT01467466|3732411|B2|Ethnicity|Puerto Rican|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3909200|NCT01467466|3732412|B1|Ethnicity|Puerto Rican|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3909201|NCT01467466|3732408|B5|Ethnicity|Mexican, Mexican American, or Chicano|Race/Ethnicity, Customized||Participants|Count of Participants|73|73.0||||||
3909202|NCT01467466|3732409|B4|Ethnicity|Mexican, Mexican American, or Chicano|Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3909203|NCT01467466|3732410|B3|Ethnicity|Mexican, Mexican American, or Chicano|Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3909204|NCT01467466|3732411|B2|Ethnicity|Mexican, Mexican American, or Chicano|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3909205|NCT01467466|3732412|B1|Ethnicity|Mexican, Mexican American, or Chicano|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3909206|NCT01467466|3732408|B5|Ethnicity|Not Spanish, Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|4764|4764.0||||||
3909207|NCT01467466|3732409|B4|Ethnicity|Not Spanish, Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|1197|1197.0||||||
3909208|NCT01467466|3732410|B3|Ethnicity|Not Spanish, Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|1179|1179.0||||||
3909209|NCT01467466|3732411|B2|Ethnicity|Not Spanish, Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|1198|1198.0||||||
3909210|NCT01467466|3732412|B1|Ethnicity|Not Spanish, Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|1190|1190.0||||||
3909211|NCT01467466|3732408|B5|Race|Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3909212|NCT01467466|3732409|B4|Race|Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3909213|NCT01467466|3732410|B3|Race|Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3909214|NCT01467466|3732411|B2|Race|Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3909215|NCT01467466|3732412|B1|Race|Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3909216|NCT01467466|3732408|B5|Race|More than one race|Race/Ethnicity, Customized||Participants|Count of Participants|161|161.0||||||
3909217|NCT01467466|3732409|B4|Race|More than one race|Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
3909218|NCT01467466|3732410|B3|Race|More than one race|Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
3909219|NCT01467466|3732411|B2|Race|More than one race|Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
3909220|NCT01467466|3732412|B1|Race|More than one race|Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3909221|NCT01467466|3732408|B5|Race|Indigenous Austrailian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3909222|NCT01467466|3732409|B4|Race|Indigenous Austrailian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3909223|NCT01467466|3732410|B3|Race|Indigenous Austrailian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3909224|NCT01467466|3732411|B2|Race|Indigenous Austrailian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3909225|NCT01467466|3732412|B1|Race|Indigenous Austrailian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3909226|NCT01467466|3732408|B5|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|3893|3893.0||||||
3909227|NCT01467466|3732409|B4|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|993|993.0||||||
3909228|NCT01467466|3732410|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|962|962.0||||||
3909229|NCT01467466|3732411|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|967|967.0||||||
3909230|NCT01467466|3732412|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|971|971.0||||||
3909231|NCT01467466|3732408|B5|Race|Black or AFrican American|Race/Ethnicity, Customized||Participants|Count of Participants|570|570.0||||||
3909232|NCT01467466|3732409|B4|Race|Black or AFrican American|Race/Ethnicity, Customized||Participants|Count of Participants|121|121.0||||||
3909233|NCT01467466|3732410|B3|Race|Black or AFrican American|Race/Ethnicity, Customized||Participants|Count of Participants|150|150.0||||||
3909234|NCT01467466|3732411|B2|Race|Black or AFrican American|Race/Ethnicity, Customized||Participants|Count of Participants|158|158.0||||||
3909235|NCT01467466|3732412|B1|Race|Black or AFrican American|Race/Ethnicity, Customized||Participants|Count of Participants|141|141.0||||||
3909236|NCT01467466|3732408|B5|Race|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|62|62.0||||||
3909237|NCT01467466|3732409|B4|Race|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3909296|NCT01467076|3732446|B4||Female|Gender||Participants|Count of Participants|4|4.0||||||
3909238|NCT01467466|3732410|B3|Race|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3909239|NCT01467466|3732411|B2|Race|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3909240|NCT01467466|3732412|B1|Race|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3909241|NCT01467466|3732408|B5|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|256|256.0||||||
3909242|NCT01467466|3732409|B4|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|65|65.0||||||
3909243|NCT01467466|3732410|B3|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|69|69.0||||||
3909244|NCT01467466|3732411|B2|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|58|58.0||||||
3909245|NCT01467466|3732412|B1|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|64|64.0||||||
3909246|NCT01467466|3732408|B5|Race|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
3909247|NCT01467466|3732409|B4|Race|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3909248|NCT01467466|3732410|B3|Race|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3909249|NCT01467466|3732411|B2|Race|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3909250|NCT01467466|3732412|B1|Race|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3909251|NCT01467466|3732408|B5|Sex|Unknown/Not Stated|Sex/Gender, Customized||Participants|Count of Participants|1|1.0||||||
3909252|NCT01467466|3732409|B4|Sex|Unknown/Not Stated|Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3909253|NCT01467466|3732410|B3|Sex|Unknown/Not Stated|Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3909254|NCT01467466|3732411|B2|Sex|Unknown/Not Stated|Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3909255|NCT01467466|3732412|B1|Sex|Unknown/Not Stated|Sex/Gender, Customized||Participants|Count of Participants|1|1.0||||||
3909256|NCT01467466|3732408|B5|Sex|Male|Sex/Gender, Customized||Participants|Count of Participants|4671|4671.0||||||
3909257|NCT01467466|3732409|B4|Sex|Male|Sex/Gender, Customized||Participants|Count of Participants|1184|1184.0||||||
3909258|NCT01467466|3732410|B3|Sex|Male|Sex/Gender, Customized||Participants|Count of Participants|1167|1167.0||||||
3909259|NCT01467466|3732411|B2|Sex|Male|Sex/Gender, Customized||Participants|Count of Participants|1163|1163.0||||||
3909260|NCT01467466|3732412|B1|Sex|Male|Sex/Gender, Customized||Participants|Count of Participants|1157|1157.0||||||
3909261|NCT01467466|3732408|B5|Sex|Female|Sex/Gender, Customized||Participants|Count of Participants|321|321.0||||||
3909262|NCT01467466|3732409|B4|Sex|Female|Sex/Gender, Customized||Participants|Count of Participants|73|73.0||||||
3909263|NCT01467466|3732410|B3|Sex|Female|Sex/Gender, Customized||Participants|Count of Participants|87|87.0||||||
3909264|NCT01467466|3732411|B2|Sex|Female|Sex/Gender, Customized||Participants|Count of Participants|75|75.0||||||
3909265|NCT01467466|3732412|B1|Sex|Female|Sex/Gender, Customized||Participants|Count of Participants|86|86.0||||||
3909266|NCT01467466|3732408|B5|||Age||Years|Mean|69.8|69.8|Standard Deviation|8.2|8.2|||
3909267|NCT01467466|3732409|B4|||Age||Years|Mean|70.2|70.2|Standard Deviation|8.0|8.0|||
3909268|NCT01467466|3732410|B3|||Age||Years|Mean|69.6|69.6|Standard Deviation|8.3|8.3|||
3909269|NCT01467466|3732411|B2|||Age||Years|Mean|69.8|69.8|Standard Deviation|8.3|8.3|||
3909270|NCT01467466|3732412|B1|||Age||Years|Mean|69.6|69.6|Standard Deviation|8.4|8.4|||
3909271|NCT01467427|3732425|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3909272|NCT01467427|3732426|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3909273|NCT01467427|3732427|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3909274|NCT01467427|3732425|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3909275|NCT01467427|3732426|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3909276|NCT01467427|3732427|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3909277|NCT01467427|3732425|B3|||Age||years|Mean|6.5|6.5|Standard Deviation|3.7|3.7|||
3909278|NCT01467427|3732426|B2|||Age||years|Mean|9.6|9.6|Standard Deviation|1.6|1.6|||
3909279|NCT01467427|3732427|B1|||Age||years|Mean|3.1|3.1|Standard Deviation|1.7|1.7|||
3909280|NCT01467076|3732446|B4|||Intubation in Delivery Room||participants|Number|4|4.0||||||
3909281|NCT01467076|3732447|B3|||Intubation in Delivery Room||participants|Number|2|2.0||||||
3909282|NCT01467076|3732448|B2|||Intubation in Delivery Room||participants|Number|2|2.0||||||
3909283|NCT01467076|3732449|B1|||Intubation in Delivery Room||participants|Number|0|0.0||||||
3909284|NCT01467076|3732446|B4|||Delivery by Cesarean Section||participants|Number|5|5.0||||||
3909285|NCT01467076|3732447|B3|||Delivery by Cesarean Section||participants|Number|1|1.0||||||
3909286|NCT01467076|3732448|B2|||Delivery by Cesarean Section||participants|Number|2|2.0||||||
3909287|NCT01467076|3732449|B1|||Delivery by Cesarean Section||participants|Number|2|2.0||||||
3909288|NCT01467076|3732446|B4|||Birthweight||grams|Mean|3496|3496.0|Full Range|||2880.0|3965.0|
3909289|NCT01467076|3732447|B3|||Birthweight||grams|Mean|3320|3320.0|Full Range|||3103.0|3537.0|
3909290|NCT01467076|3732448|B2|||Birthweight||grams|Mean|3530|3530.0|Full Range|||3470.0|3590.0|
3909291|NCT01467076|3732449|B1|||Birthweight||grams|Mean|3591|3591.0|Full Range|||2880.0|3965.0|
3909292|NCT01467076|3732446|B4||Male|Gender||Participants|Count of Participants|3|3.0||||||
3909293|NCT01467076|3732447|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3909294|NCT01467076|3732448|B2||Male|Gender||Participants|Count of Participants|1|1.0||||||
3909295|NCT01467076|3732449|B1||Male|Gender||Participants|Count of Participants|2|2.0||||||
3909297|NCT01467076|3732447|B3||Female|Gender||Participants|Count of Participants|2|2.0||||||
3909298|NCT01467076|3732448|B2||Female|Gender||Participants|Count of Participants|1|1.0||||||
3909299|NCT01467076|3732449|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
3909300|NCT01467076|3732446|B4|Age at Randomization||Age, Customized||hours|Mean|28.73|28.73|Full Range|||7.1|58.33|
3909301|NCT01467076|3732447|B3|Age at Randomization||Age, Customized||hours|Mean|26.65|26.65|Full Range|||10.28|43.03|
3909302|NCT01467076|3732448|B2|Age at Randomization||Age, Customized||hours|Mean|11.30|11.3|Full Range|||7.1|15.5|
3909303|NCT01467076|3732449|B1|Age at Randomization||Age, Customized||hours|Mean|41.75|41.75|Full Range|||27.8|58.33|
3909304|NCT01467037|3732459|B3|RV-vaccination ≥2 doses||Rotavirus vaccination||participants|Number|261|261.0||||||
3909305|NCT01467037|3732460|B2|RV-vaccination ≥2 doses||Rotavirus vaccination||participants|Number|7|7.0||||||
3909306|NCT01467037|3732461|B1|RV-vaccination ≥2 doses||Rotavirus vaccination||participants|Number|254|254.0||||||
3909307|NCT01467037|3732459|B3|RV-vaccination 1-dose||Rotavirus vaccination||participants|Number|27|27.0||||||
3909308|NCT01467037|3732460|B2|RV-vaccination 1-dose||Rotavirus vaccination||participants|Number|1|1.0||||||
3909309|NCT01467037|3732461|B1|RV-vaccination 1-dose||Rotavirus vaccination||participants|Number|26|26.0||||||
3909310|NCT01467037|3732459|B3|RV-vaccination 0 dose||Rotavirus vaccination||participants|Number|86|86.0||||||
3909311|NCT01467037|3732460|B2|RV-vaccination 0 dose||Rotavirus vaccination||participants|Number|24|24.0||||||
3909312|NCT01467037|3732461|B1|RV-vaccination 0 dose||Rotavirus vaccination||participants|Number|62|62.0||||||
3909313|NCT01467037|3732459|B3|Canada||Region of Enrollment||participants|Number|374|374.0||||||
3909314|NCT01467037|3732460|B2|Canada||Region of Enrollment||participants|Number|32|32.0||||||
3909315|NCT01467037|3732461|B1|Canada||Region of Enrollment||participants|Number|342|342.0||||||
3909316|NCT01467037|3732459|B3||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
3909317|NCT01467037|3732460|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3909318|NCT01467037|3732461|B1||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3909319|NCT01467037|3732459|B3||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3909320|NCT01467037|3732460|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3909321|NCT01467037|3732461|B1||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3909322|NCT01467037|3732459|B3|||Age||months|Mean|13|13.0|Standard Deviation|6.4|6.4|||
3909323|NCT01467037|3732460|B2|||Age||months|Mean|16.6|16.6|Standard Deviation|6.5|6.5|||
3909324|NCT01467037|3732461|B1|||Age||months|Mean|12.6|12.6|Standard Deviation|6.3|6.3|||
3909325|NCT01466881|3732468|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3909326|NCT01466881|3732468|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909327|NCT01466881|3732468|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3909328|NCT01466881|3732468|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3909329|NCT01466881|3732468|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909330|NCT01466881|3732468|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3909331|NCT01466881|3732468|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909332|NCT01466881|3732468|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3909333|NCT01466881|3732468|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3909334|NCT01466881|3732468|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3909335|NCT01466881|3732468|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3909336|NCT01466881|3732468|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3909337|NCT01466881|3732468|B1|||Age||years|Median|62.0|62.0|Full Range|||21.6|86.1|
3909338|NCT01466790|3732477|B9||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3909339|NCT01466790|3732478|B8||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3909340|NCT01466790|3732479|B7||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3909341|NCT01466790|3732480|B6||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3909342|NCT01466790|3732481|B5||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3909343|NCT01466790|3732482|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3909344|NCT01466790|3732483|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3909345|NCT01466790|3732484|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3909346|NCT01466790|3732485|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3909347|NCT01466790|3732477|B9||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3909348|NCT01466790|3732478|B8||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3909349|NCT01466790|3732479|B7||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3909350|NCT01466790|3732480|B6||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3909351|NCT01466790|3732481|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3909352|NCT01466790|3732482|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3909353|NCT01466790|3732483|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3909354|NCT01466790|3732484|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3909355|NCT01466790|3732485|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3909356|NCT01466790|3732477|B9|||Age||years|Median|57|57.0|Full Range|||27.0|70.0|
3909357|NCT01466790|3732478|B8|||Age||years|Median|57.5|57.5|Full Range|||47.0|64.0|
3909358|NCT01466790|3732479|B7|||Age||years|Median|57|57.0|Full Range|||36.0|68.0|
3909359|NCT01466790|3732480|B6|||Age||years|Median|57.5|57.5|Full Range|||49.0|63.0|
3909360|NCT01466790|3732481|B5|||Age||years|Median|58|58.0|Full Range|||28.0|70.0|
3909361|NCT01466790|3732482|B4|||Age||years|Median|55.5|55.5|Full Range|||35.0|68.0|
3909362|NCT01466790|3732483|B3|||Age||years|Median|55|55.0|Full Range|||28.0|67.0|
3909363|NCT01466790|3732484|B2|||Age||years|Median|56|56.0|Full Range|||27.0|61.0|
3909364|NCT01466790|3732485|B1|||Age||years|Median|56|56.0|Full Range|||27.0|70.0|
3909365|NCT01466764|3732554|B3|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3909366|NCT01466764|3732555|B2|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3909367|NCT01466764|3732556|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3909368|NCT01466764|3732554|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3909369|NCT01466764|3732555|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3909370|NCT01466764|3732556|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3909371|NCT01466764|3732554|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3909372|NCT01466764|3732555|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3909373|NCT01466764|3732556|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3909374|NCT01466764|3732554|B3|||Age||years|Median|73|73.0|Full Range|||52.0|89.0|
3909375|NCT01466764|3732555|B2|||Age||years|Median|74|74.0|Full Range|||57.0|89.0|
3909376|NCT01466764|3732556|B1|||Age||years|Median|71.4|71.4|Full Range|||52.0|79.0|
3909377|NCT01466673|3732575|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3909378|NCT01466673|3732576|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3909379|NCT01466673|3732577|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3909380|NCT01466673|3732575|B3||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3909381|NCT01466673|3732576|B2||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3909382|NCT01466673|3732577|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3909383|NCT01466673|3732575|B3|Between 18 and 45 years||Age, Customized||Participants|Number|201|201.0||||||
3909384|NCT01466673|3732576|B2|Between 18 and 45 years||Age, Customized||Participants|Number|101|101.0||||||
3909385|NCT01466673|3732577|B1|Between 18 and 45 years||Age, Customized||Participants|Number|100|100.0||||||
3909386|NCT01466673|3732575|B3|Less than and equal to 18 years||Age, Customized||Participants|Number|0|0.0||||||
3909387|NCT01466673|3732576|B2|Less than and equal to 18 years||Age, Customized||Participants|Number|0|0.0||||||
3909388|NCT01466673|3732577|B1|Less than and equal to 18 years||Age, Customized||Participants|Number|0|0.0||||||
3909389|NCT01466660|3732602|B3||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3909390|NCT01466660|3732603|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3909391|NCT01466660|3732604|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3909392|NCT01466660|3732602|B3||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
3909393|NCT01466660|3732603|B2||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3909394|NCT01466660|3732604|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3909395|NCT01466660|3732602|B3|||Age||Years|Mean|62.4|62.4|Standard Deviation|11.0|11.0|||
3909396|NCT01466660|3732603|B2|||Age||Years|Mean|63.0|63.0|Standard Deviation|10.4|10.4|||
3909397|NCT01466660|3732604|B1|||Age||Years|Mean|61.7|61.7|Standard Deviation|11.5|11.5|||
3909398|NCT01466595|3732629|B3|||CD4 count|Total CD4+ T-cell count at baseline|cells/mm^3|Median|236|236.0|Inter-Quartile Range|||189.0|284.0|
3909399|NCT01466595|3732630|B2|||CD4 count|Total CD4+ T-cell count at baseline|cells/mm^3|Median|223|223.0|Inter-Quartile Range|||176.0|283.0|
3909400|NCT01466595|3732631|B1|||CD4 count|Total CD4+ T-cell count at baseline|cells/mm^3|Median|240|240.0|Inter-Quartile Range|||197.0|284.0|
3909401|NCT01466595|3732629|B3|||Number of participants with HIV-1 RNA below assay lower limit|The number of participants with HIV-RNA below assay lower limit (<40 copies/mL) at baseline|participants|Number|73|73.0||||||
3909402|NCT01466595|3732630|B2|||Number of participants with HIV-1 RNA below assay lower limit|The number of participants with HIV-RNA below assay lower limit (<40 copies/mL) at baseline|participants|Number|24|24.0||||||
3909403|NCT01466595|3732631|B1|||Number of participants with HIV-1 RNA below assay lower limit|The number of participants with HIV-RNA below assay lower limit (<40 copies/mL) at baseline|participants|Number|49|49.0||||||
3909404|NCT01466595|3732629|B3|United States||Region of Enrollment||participants|Number|73|73.0||||||
3909405|NCT01466595|3732630|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
3909406|NCT01466595|3732631|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
3909407|NCT01466595|3732629|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3909408|NCT01466595|3732630|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3909409|NCT01466595|3732631|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3909410|NCT01466595|3732629|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3909411|NCT01466595|3732630|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3909412|NCT01466595|3732631|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3909413|NCT01466595|3732629|B3|||Age||years|Mean|49.6|49.6|Standard Deviation|8.6|8.6|||
3909414|NCT01466595|3732630|B2|||Age||years|Mean|49.7|49.7|Standard Deviation|9.7|9.7|||
3909415|NCT01466595|3732631|B1|||Age||years|Mean|49.5|49.5|Standard Deviation|8.1|8.1|||
3909416|NCT01466595|3732629|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3909417|NCT01466595|3732630|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3909418|NCT01466595|3732631|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3909419|NCT01466595|3732629|B3||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
3909420|NCT01466595|3732630|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3909421|NCT01466595|3732631|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
3909422|NCT01466595|3732629|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3909423|NCT01466595|3732630|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3909424|NCT01466595|3732631|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3909425|NCT01466491|3732722|B5|United States||Region of Enrollment||participants|Number|326|326.0||||||
3909426|NCT01466491|3732723|B4|United States||Region of Enrollment||participants|Number|83|83.0||||||
3909427|NCT01466491|3732724|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
3909428|NCT01466491|3732725|B2|United States||Region of Enrollment||participants|Number|80|80.0||||||
3909429|NCT01466491|3732726|B1|United States||Region of Enrollment||participants|Number|83|83.0||||||
3909430|NCT01466491|3732722|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3909431|NCT01466491|3732723|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3909432|NCT01466491|3732724|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3909433|NCT01466491|3732725|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3909434|NCT01466491|3732726|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3909435|NCT01466491|3732722|B5||Female|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
3909436|NCT01466491|3732723|B4||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3909437|NCT01466491|3732724|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3909438|NCT01466491|3732725|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3909439|NCT01466491|3732726|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3909440|NCT01466491|3732722|B5|||Age||years|Mean|25.575|25.575|Standard Deviation|5.3|5.3|||
3909441|NCT01466491|3732723|B4|||Age||years|Mean|26.4|26.4|Standard Deviation|5.5|5.5|||
3909442|NCT01466491|3732724|B3|||Age||years|Mean|25.2|25.2|Standard Deviation|5.2|5.2|||
3909443|NCT01466491|3732725|B2|||Age||years|Mean|25.5|25.5|Standard Deviation|5.3|5.3|||
3909444|NCT01466491|3732726|B1|||Age||years|Mean|25.2|25.2|Standard Deviation|5.2|5.2|||
3909445|NCT01466491|3732722|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3909446|NCT01466491|3732723|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3909447|NCT01466491|3732724|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3909448|NCT01466491|3732725|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3909449|NCT01466491|3732726|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3909450|NCT01466491|3732722|B5||Between 18 and 65 years|Age||Participants|Count of Participants|326|326.0||||||
3909451|NCT01466491|3732723|B4||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
3909452|NCT01466491|3732724|B3||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
3909453|NCT01466491|3732725|B2||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
3909454|NCT01466491|3732726|B1||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
3909455|NCT01466491|3732722|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3909456|NCT01466491|3732723|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3909457|NCT01466491|3732724|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3909458|NCT01466491|3732725|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3909459|NCT01466491|3732726|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3909460|NCT01466387|3732743|B7||Male|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
3909461|NCT01466387|3732744|B6||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3909462|NCT01466387|3732745|B5||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3909463|NCT01466387|3732746|B4||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3909464|NCT01466387|3732747|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3909465|NCT01466387|3732748|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3909466|NCT01466387|3732749|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3909467|NCT01466387|3732743|B7||Female|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
3909468|NCT01466387|3732744|B6||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3909469|NCT01466387|3732745|B5||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3909470|NCT01466387|3732746|B4||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3909471|NCT01466387|3732747|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3909472|NCT01466387|3732748|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3909473|NCT01466387|3732749|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3909474|NCT01466387|3732743|B7|||Age||years|Mean|35.7|35.7|Standard Deviation|11.2|11.2|||
3909475|NCT01466387|3732744|B6|||Age||years|Mean|36.9|36.9|Standard Deviation|11.2|11.2|||
3909476|NCT01466387|3732745|B5|||Age||years|Mean|35.8|35.8|Standard Deviation|11.6|11.6|||
3909477|NCT01466387|3732746|B4|||Age||years|Mean|35.0|35.0|Standard Deviation|11.1|11.1|||
3909478|NCT01466387|3732747|B3|||Age||years|Mean|35.0|35.0|Standard Deviation|11.5|11.5|||
3909479|NCT01466387|3732748|B2|||Age||years|Mean|35.1|35.1|Standard Deviation|11.0|11.0|||
3909480|NCT01466387|3732749|B1|||Age||years|Mean|36.5|36.5|Standard Deviation|10.8|10.8|||
3909481|NCT01466361|3732792|B5|Baseline score post provoked craving paradigm (B2)||Nicotine cravings assessment baseline scores on a Visual Analogue scale (VAS)|Participants were prohibited from smoking for 4 hours and then exposed to a provoked craving paradigm. During the provoked craving paradigm subjects were exposed to the sight and smell of a lit cigarette and were forbidden from putting the cigarette in their mouth. Cravings assessment was completed at the start of and immediately following the provoked craving paradigm using a VAS.|Score on a scale|Mean|75.1|75.1|Standard Deviation|24.127|24.127|||
3909482|NCT01466361|3732793|B4|Baseline score post provoked craving paradigm (B2)||Nicotine cravings assessment baseline scores on a Visual Analogue scale (VAS)|Participants were prohibited from smoking for 4 hours and then exposed to a provoked craving paradigm. During the provoked craving paradigm subjects were exposed to the sight and smell of a lit cigarette and were forbidden from putting the cigarette in their mouth. Cravings assessment was completed at the start of and immediately following the provoked craving paradigm using a VAS.|Score on a scale|Mean|69.1|69.1|Standard Deviation|26.335|26.335|||
3909483|NCT01466361|3732794|B3|Baseline score post provoked craving paradigm (B2)||Nicotine cravings assessment baseline scores on a Visual Analogue scale (VAS)|Participants were prohibited from smoking for 4 hours and then exposed to a provoked craving paradigm. During the provoked craving paradigm subjects were exposed to the sight and smell of a lit cigarette and were forbidden from putting the cigarette in their mouth. Cravings assessment was completed at the start of and immediately following the provoked craving paradigm using a VAS.|Score on a scale|Mean|76.96|76.96|Standard Deviation|21.667|21.667|||
3909484|NCT01466361|3732795|B2|Baseline score post provoked craving paradigm (B2)||Nicotine cravings assessment baseline scores on a Visual Analogue scale (VAS)|Participants were prohibited from smoking for 4 hours and then exposed to a provoked craving paradigm. During the provoked craving paradigm subjects were exposed to the sight and smell of a lit cigarette and were forbidden from putting the cigarette in their mouth. Cravings assessment was completed at the start of and immediately following the provoked craving paradigm using a VAS.|Score on a scale|Mean|78.39|78.39|Standard Deviation|23.659|23.659|||
3909485|NCT01466361|3732796|B1|Baseline score post provoked craving paradigm (B2)||Nicotine cravings assessment baseline scores on a Visual Analogue scale (VAS)|Participants were prohibited from smoking for 4 hours and then exposed to a provoked craving paradigm. During the provoked craving paradigm subjects were exposed to the sight and smell of a lit cigarette and were forbidden from putting the cigarette in their mouth. Cravings assessment was completed at the start of and immediately following the provoked craving paradigm using a VAS.|Score on a scale|Mean|76.03|76.03|Standard Deviation|24.849|24.849|||
3909486|NCT01466361|3732792|B5|Baseline score prior provoked craving paradigm(B1)||Nicotine cravings assessment baseline scores on a Visual Analogue scale (VAS)|Participants were prohibited from smoking for 4 hours and then exposed to a provoked craving paradigm. During the provoked craving paradigm subjects were exposed to the sight and smell of a lit cigarette and were forbidden from putting the cigarette in their mouth. Cravings assessment was completed at the start of and immediately following the provoked craving paradigm using a VAS.|Score on a scale|Mean|67.5|67.5|Standard Deviation|26.090|26.09|||
3909487|NCT01466361|3732793|B4|Baseline score prior provoked craving paradigm(B1)||Nicotine cravings assessment baseline scores on a Visual Analogue scale (VAS)|Participants were prohibited from smoking for 4 hours and then exposed to a provoked craving paradigm. During the provoked craving paradigm subjects were exposed to the sight and smell of a lit cigarette and were forbidden from putting the cigarette in their mouth. Cravings assessment was completed at the start of and immediately following the provoked craving paradigm using a VAS.|Score on a scale|Mean|62.3|62.3|Standard Deviation|25.785|25.785|||
3909488|NCT01466361|3732794|B3|Baseline score prior provoked craving paradigm(B1)||Nicotine cravings assessment baseline scores on a Visual Analogue scale (VAS)|Participants were prohibited from smoking for 4 hours and then exposed to a provoked craving paradigm. During the provoked craving paradigm subjects were exposed to the sight and smell of a lit cigarette and were forbidden from putting the cigarette in their mouth. Cravings assessment was completed at the start of and immediately following the provoked craving paradigm using a VAS.|Score on a scale|Mean|70.00|70.0|Standard Deviation|20.895|20.895|||
3909489|NCT01466361|3732795|B2|Baseline score prior provoked craving paradigm(B1)||Nicotine cravings assessment baseline scores on a Visual Analogue scale (VAS)|Participants were prohibited from smoking for 4 hours and then exposed to a provoked craving paradigm. During the provoked craving paradigm subjects were exposed to the sight and smell of a lit cigarette and were forbidden from putting the cigarette in their mouth. Cravings assessment was completed at the start of and immediately following the provoked craving paradigm using a VAS.|Score on a scale|Mean|69.54|69.54|Standard Deviation|26.534|26.534|||
3909490|NCT01466361|3732796|B1|Baseline score prior provoked craving paradigm(B1)||Nicotine cravings assessment baseline scores on a Visual Analogue scale (VAS)|Participants were prohibited from smoking for 4 hours and then exposed to a provoked craving paradigm. During the provoked craving paradigm subjects were exposed to the sight and smell of a lit cigarette and were forbidden from putting the cigarette in their mouth. Cravings assessment was completed at the start of and immediately following the provoked craving paradigm using a VAS.|Score on a scale|Mean|68.3|68.3|Standard Deviation|29.147|29.147|||
3909491|NCT01466361|3732792|B5||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3909492|NCT01466361|3732793|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3909493|NCT01466361|3732794|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3909494|NCT01466361|3732795|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3909495|NCT01466361|3732796|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3909496|NCT01466361|3732792|B5||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3909497|NCT01466361|3732793|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3909498|NCT01466361|3732794|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3909499|NCT01466361|3732795|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3909500|NCT01466361|3732796|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3909501|NCT01466361|3732792|B5|||Age||Years|Mean|45.0|45.0|Standard Deviation|10.48|10.48|||
3909502|NCT01466361|3732793|B4|||Age||Years|Mean|45.0|45.0|Standard Deviation|10.59|10.59|||
3909503|NCT01466361|3732794|B3|||Age||Years|Mean|43.9|43.9|Standard Deviation|11.48|11.48|||
3909504|NCT01466361|3732795|B2|||Age||Years|Mean|45.9|45.9|Standard Deviation|9.43|9.43|||
3909505|NCT01466361|3732796|B1|||Age||Years|Mean|45.1|45.1|Standard Deviation|10.42|10.42|||
3909506|NCT01466348|3732815|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3909507|NCT01466348|3732815|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3909508|NCT01466348|3732815|B1|||Age||Years|Mean|20.8|20.8|Standard Deviation|4.19|4.19|||
3909509|NCT01466270|3732842|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
3909510|NCT01466270|3732843|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
3909511|NCT01466270|3732844|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
3909512|NCT01466270|3732842|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909513|NCT01466270|3732843|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909514|NCT01466270|3732844|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909515|NCT01466270|3732842|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3909516|NCT01466270|3732843|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3909517|NCT01466270|3732844|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909518|NCT01466270|3732842|B3||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3909519|NCT01466270|3732843|B2||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3909520|NCT01466270|3732844|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3909521|NCT01466270|3732842|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3909522|NCT01466270|3732843|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3909523|NCT01466270|3732844|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3909524|NCT01466270|3732842|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909525|NCT01466270|3732843|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909526|NCT01466270|3732844|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909527|NCT01466270|3732842|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909528|NCT01466270|3732843|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909529|NCT01466270|3732844|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909530|NCT01466270|3732842|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909531|NCT01466270|3732843|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909532|NCT01466270|3732844|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909533|NCT01466270|3732842|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909534|NCT01466270|3732843|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909535|NCT01466270|3732844|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909536|NCT01466270|3732842|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3909537|NCT01466270|3732843|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3909538|NCT01466270|3732844|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3909539|NCT01466270|3732842|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909540|NCT01466270|3732843|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909541|NCT01466270|3732844|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909542|NCT01466270|3732842|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3909543|NCT01466270|3732843|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3909544|NCT01466270|3732844|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3909545|NCT01466270|3732842|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3909546|NCT01466270|3732843|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3909547|NCT01466270|3732844|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3909548|NCT01466270|3732842|B3|||Age||years|Median|56|56.0|Full Range|||39.0|79.0|
3909549|NCT01466270|3732843|B2|||Age||years|Median|56|56.0|Full Range|||41.0|78.0|
3909550|NCT01466270|3732844|B1|||Age||years|Median|56|56.0|Full Range|||39.0|79.0|
3909551|NCT01466270|3732842|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3909552|NCT01466270|3732843|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3909553|NCT01466270|3732844|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3909554|NCT01466270|3732842|B3||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3909555|NCT01466270|3732843|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3909556|NCT01466270|3732844|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3909557|NCT01466270|3732842|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3909558|NCT01466270|3732843|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3909559|NCT01466270|3732844|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3909560|NCT01466192|3732857|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3909561|NCT01466192|3732857|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3909562|NCT01466192|3732857|B1|||Age||years|Mean|56.1|56.1|Standard Deviation|8.0|8.0|||
3909563|NCT01466179|3732861|B1|≥ 50%||Baseline bone marrow blast category|Bone marrow blasts were assessed by local and central laboratories; reported data are based on maximum central and local laboratory assessments.|participants|Number|145|145.0||||||
3909564|NCT01466179|3732861|B1|10% - < 50%||Baseline bone marrow blast category|Bone marrow blasts were assessed by local and central laboratories; reported data are based on maximum central and local laboratory assessments.|participants|Number|43|43.0||||||
3909565|NCT01466179|3732861|B1|< 10%||Baseline bone marrow blast category|Bone marrow blasts were assessed by local and central laboratories; reported data are based on maximum central and local laboratory assessments.|participants|Number|1|1.0||||||
3909566|NCT01466179|3732861|B1|||Time since last relapse|Reported for 173 participants with a prior relapse (the other16 participants were primary refractory with no prior relapses).|months|Median|1.38|1.38|Full Range|||0.1|56.8|
3909567|NCT01466179|3732861|B1|||Time since initial diagnosis||months|Median|16.59|16.59|Full Range|||1.9|249.0|
3909568|NCT01466179|3732861|B1|> 2 prior salvage therapies||Number of prior salvage therapies||participants|Number|32|32.0||||||
3909569|NCT01466179|3732861|B1|2 prior salvage therapies||Number of prior salvage therapies||participants|Number|42|42.0||||||
3909570|NCT01466179|3732861|B1|1 prior salvage therapy||Number of prior salvage therapies||participants|Number|77|77.0||||||
3909571|NCT01466179|3732861|B1|No prior salvage therapy||Number of prior salvage therapies||participants|Number|38|38.0||||||
3909572|NCT01466179|3732861|B1|No prior alloHSCT, > 2 prior relapses||Prior allogeneic HSCT and prior relapses|alloHSCT = allogeneic hematopoietic stem cell transplantation|participants|Number|3|3.0||||||
3909573|NCT01466179|3732861|B1|No prior alloHSCT, 2 prior relapses||Prior allogeneic HSCT and prior relapses|alloHSCT = allogeneic hematopoietic stem cell transplantation|participants|Number|22|22.0||||||
3909574|NCT01466179|3732861|B1|No prior alloHSCT, 1 prior relapse||Prior allogeneic HSCT and prior relapses|alloHSCT = allogeneic hematopoietic stem cell transplantation|participants|Number|84|84.0||||||
3909575|NCT01466179|3732861|B1|No prior alloHSCT, no prior relapse||Prior allogeneic HSCT and prior relapses|alloHSCT = allogeneic hematopoietic stem cell transplantation|participants|Number|16|16.0||||||
3909576|NCT01466179|3732861|B1|Prior allogeneic HSCT||Prior allogeneic HSCT and prior relapses|alloHSCT = allogeneic hematopoietic stem cell transplantation|participants|Number|64|64.0||||||
3909577|NCT01466179|3732861|B1|>2||Number of prior relapses||participants|Number|20|20.0||||||
3909578|NCT01466179|3732861|B1|2||Number of prior relapses||participants|Number|46|46.0||||||
3909579|NCT01466179|3732861|B1|1||Number of prior relapses||participants|Number|107|107.0||||||
3909580|NCT01466179|3732861|B1|0||Number of prior relapses||participants|Number|16|16.0||||||
3909581|NCT01466179|3732861|B1|No criteria met||Disease stage entry criteria met|HSCT = hematopoietic stem cell transplantation|participants|Number|3|3.0||||||
3909582|NCT01466179|3732861|B1|Entering second or greater salvage therapies||Disease stage entry criteria met|HSCT = hematopoietic stem cell transplantation|participants|Number|108|108.0||||||
3909583|NCT01466179|3732861|B1|Entering first salvage; first remission ≤ 12 mo||Disease stage entry criteria met|HSCT = hematopoietic stem cell transplantation|participants|Number|23|23.0||||||
3909584|NCT01466179|3732861|B1|Relapse ≤ 12 months of allogeneic HSCT||Disease stage entry criteria met|HSCT = hematopoietic stem cell transplantation|participants|Number|39|39.0||||||
3909585|NCT01466179|3732861|B1|Primary refractory||Disease stage entry criteria met|HSCT = hematopoietic stem cell transplantation|participants|Number|16|16.0||||||
3909586|NCT01466179|3732861|B1|Not recorded||Race/Ethnicity, Customized|Race was not permitted to be collected in France|participants|Number|20|20.0||||||
3909587|NCT01466179|3732861|B1|Other||Race/Ethnicity, Customized|Race was not permitted to be collected in France|participants|Number|9|9.0||||||
3909588|NCT01466179|3732861|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|Race was not permitted to be collected in France|participants|Number|1|1.0||||||
3909589|NCT01466179|3732861|B1|American Indian or Alaska native||Race/Ethnicity, Customized|Race was not permitted to be collected in France|participants|Number|1|1.0||||||
3909590|NCT01466179|3732861|B1|Black or African American||Race/Ethnicity, Customized|Race was not permitted to be collected in France|participants|Number|7|7.0||||||
3909591|NCT01466179|3732861|B1|Asian||Race/Ethnicity, Customized|Race was not permitted to be collected in France|participants|Number|6|6.0||||||
3909592|NCT01466179|3732861|B1|White||Race/Ethnicity, Customized|Race was not permitted to be collected in France|participants|Number|145|145.0||||||
3909593|NCT01466179|3732861|B1||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3909594|NCT01466179|3732861|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3909595|NCT01466179|3732861|B1|≥ 65 years||Age, Customized||participants|Number|25|25.0||||||
3909596|NCT01466179|3732861|B1|55 to < 65 years||Age, Customized||participants|Number|28|28.0||||||
3909597|NCT01466179|3732861|B1|35 to < 55 years||Age, Customized||participants|Number|46|46.0||||||
3909598|NCT01466179|3732861|B1|18 to < 35 years||Age, Customized||participants|Number|90|90.0||||||
3909599|NCT01466179|3732861|B1|||Age||years|Median|39.0|39.0|Full Range|||18.0|79.0|
3909600|NCT01466153|3732881|B4||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3909601|NCT01466153|3732882|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3909602|NCT01466153|3732883|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3909603|NCT01466153|3732884|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3909604|NCT01466153|3732881|B4||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3909605|NCT01466153|3732882|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3909606|NCT01466153|3732883|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3909607|NCT01466153|3732884|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3909608|NCT01466153|3732881|B4|||Age||YEARS|Mean|65.1|65.1|Standard Deviation|8.8|8.8|||
3909609|NCT01466153|3732882|B3|||Age||YEARS|Mean|66.3|66.3|Standard Deviation|8.9|8.9|||
3909610|NCT01466153|3732883|B2|||Age||YEARS|Mean|65.1|65.1|Standard Deviation|8.7|8.7|||
3909611|NCT01466153|3732884|B1|||Age||YEARS|Mean|63.4|63.4|Standard Deviation|8.8|8.8|||
3909612|NCT01466127|3732925|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3909613|NCT01466127|3732926|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3909614|NCT01466127|3732927|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3909615|NCT01466127|3732925|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3909616|NCT01466127|3732926|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3909617|NCT01466127|3732927|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3909618|NCT01466127|3732925|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3909619|NCT01466127|3732926|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3909620|NCT01466127|3732927|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3909621|NCT01466127|3732925|B3|||Age||Years|Mean|35.6|35.6|Standard Deviation|15.5|15.5|||
3909622|NCT01466127|3732926|B2|||Age||Years|Mean|39.9|39.9|Standard Deviation|15.8|15.8|||
3909623|NCT01466127|3732927|B1|||Age||Years|Mean|31.9|31.9|Standard Deviation|14.7|14.7|||
3909624|NCT01466127|3732925|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3909625|NCT01466127|3732926|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3909626|NCT01466127|3732927|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3909627|NCT01466127|3732925|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3909628|NCT01466127|3732926|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3909629|NCT01466127|3732927|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3909630|NCT01466127|3732925|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3909631|NCT01466127|3732926|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3909632|NCT01466127|3732927|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3909633|NCT01466075|3732934|B1|United States||Region of Enrollment||participants|Number|207|207.0||||||
3909634|NCT01466075|3732934|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3909635|NCT01466075|3732934|B1||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3909636|NCT01466075|3732934|B1|||Age||years|Mean|55.7|55.7|Full Range|||18.0|82.0|
3909637|NCT01466062|3732941|B1|Japan||Region of Enrollment||participants|Number|28|28.0||||||
3909638|NCT01466062|3732941|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3909639|NCT01466062|3732941|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3909640|NCT01466062|3732941|B1|||Age||months|Mean|14.2|14.2|Standard Deviation|6.20|6.2|||
3909641|NCT01465997|3732962|B3||Male|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
3909642|NCT01465997|3732963|B2||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3909643|NCT01465997|3732964|B1||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3909644|NCT01465997|3732962|B3||Female|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
3909645|NCT01465997|3732963|B2||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3909646|NCT01465997|3732964|B1||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3909647|NCT01465997|3732962|B3|||Age||years|Mean|42.9|42.9|Standard Deviation|17.0|17.0|||
3909648|NCT01465997|3732963|B2|||Age||years|Mean|42.7|42.7|Standard Deviation|16.7|16.7|||
3909649|NCT01465997|3732964|B1|||Age||years|Mean|43.2|43.2|Standard Deviation|17.2|17.2|||
3909650|NCT01465997|3732962|B3||>=65 years|Age||Participants|Count of Participants|77|77.0||||||
3909651|NCT01465997|3732963|B2||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
3909652|NCT01465997|3732964|B1||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
3909653|NCT01465997|3732962|B3||Between 18 and 65 years|Age||Participants|Count of Participants|455|455.0||||||
3909654|NCT01465997|3732963|B2||Between 18 and 65 years|Age||Participants|Count of Participants|225|225.0||||||
3909655|NCT01465997|3732964|B1||Between 18 and 65 years|Age||Participants|Count of Participants|230|230.0||||||
3909656|NCT01465997|3732962|B3||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
3909657|NCT01465997|3732963|B2||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
3909658|NCT01465997|3732964|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
3909659|NCT01465958|3732975|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3909660|NCT01465958|3732975|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3909661|NCT01465958|3732975|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3909662|NCT01465958|3732975|B1|||Age||years|Mean|10.8|10.8|Standard Deviation|3.7|3.7|||
3909663|NCT01465958|3732975|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3909664|NCT01465958|3732975|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3909665|NCT01465958|3732975|B1||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
3909666|NCT01465802|3732984|B6||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3909667|NCT01465802|3732985|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3909668|NCT01465802|3732986|B4||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3909669|NCT01465802|3732987|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3909670|NCT01465802|3732988|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3909671|NCT01465802|3732989|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3909672|NCT01465802|3732984|B6||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3909673|NCT01465802|3732985|B5||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3909674|NCT01465802|3732986|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3909675|NCT01465802|3732987|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3909676|NCT01465802|3732988|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3909677|NCT01465802|3732989|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3909678|NCT01465802|3732984|B6|||Age||Years|Mean|64.9|64.9|Standard Deviation|10.59|10.59|||
3909679|NCT01465802|3732985|B5|||Age||Years|Mean|64.2|64.2|Standard Deviation|14.29|14.29|||
3909680|NCT01465802|3732986|B4|||Age||Years|Mean|66.0|66.0|Standard Deviation|9.63|9.63|||
3909681|NCT01465802|3732987|B3|||Age||Years|Mean|61.3|61.3|Standard Deviation|7.67|7.67|||
3909682|NCT01465802|3732988|B2|||Age||Years|Mean|64.4|64.4|Standard Deviation|10.55|10.55|||
3909683|NCT01465802|3732989|B1|||Age||Years|Mean|65.0|65.0|Standard Deviation|10.38|10.38|||
3909684|NCT01465763|3733042|B4||Male|Sex: Female, Male||Participants|Count of Participants|363|363.0||||||
3909685|NCT01465763|3733043|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3909686|NCT01465763|3733044|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3909687|NCT01465763|3733045|B1||Male|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
3909688|NCT01465763|3733042|B4||Female|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
3909689|NCT01465763|3733043|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3909690|NCT01465763|3733044|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3909691|NCT01465763|3733045|B1||Female|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
3909692|NCT01465763|3733042|B4|Greater Than or Equal to (>=) 65 Years||Age, Customized||participants|Number|48|48.0||||||
3909693|NCT01465763|3733043|B3|Greater Than or Equal to (>=) 65 Years||Age, Customized||participants|Number|11|11.0||||||
3909694|NCT01465763|3733044|B2|Greater Than or Equal to (>=) 65 Years||Age, Customized||participants|Number|1|1.0||||||
3909695|NCT01465763|3733045|B1|Greater Than or Equal to (>=) 65 Years||Age, Customized||participants|Number|36|36.0||||||
3909696|NCT01465763|3733042|B4|45 to 64 Years||Age, Customized||participants|Number|188|188.0||||||
3909697|NCT01465763|3733043|B3|45 to 64 Years||Age, Customized||participants|Number|39|39.0||||||
3909698|NCT01465763|3733044|B2|45 to 64 Years||Age, Customized||participants|Number|4|4.0||||||
3909699|NCT01465763|3733045|B1|45 to 64 Years||Age, Customized||participants|Number|145|145.0||||||
3909700|NCT01465763|3733042|B4|18 to 44 Years||Age, Customized||participants|Number|378|378.0||||||
3909701|NCT01465763|3733043|B3|18 to 44 Years||Age, Customized||participants|Number|72|72.0||||||
3909702|NCT01465763|3733044|B2|18 to 44 Years||Age, Customized||participants|Number|11|11.0||||||
3909703|NCT01465763|3733045|B1|18 to 44 Years||Age, Customized||participants|Number|295|295.0||||||
3909704|NCT01465412|3733072|B5||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3909705|NCT01465412|3733073|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3909706|NCT01465412|3733074|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3909707|NCT01465412|3733075|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3909708|NCT01465412|3733076|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3909709|NCT01465412|3733072|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3909710|NCT01465412|3733073|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3909711|NCT01465412|3733074|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3909712|NCT01465412|3733075|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3909713|NCT01465412|3733076|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3909714|NCT01465412|3733072|B5|||Age||Years|Mean|52.7|52.7|Standard Deviation|5.9|5.9|||
3909715|NCT01465412|3733073|B4|||Age||Years|Mean|50.1|50.1|Standard Deviation|3.3|3.3|||
3909716|NCT01465412|3733074|B3|||Age||Years|Mean|52.2|52.2|Standard Deviation|4.8|4.8|||
3909717|NCT01465412|3733075|B2|||Age||Years|Mean|52.3|52.3|Standard Deviation|7.1|7.1|||
3909718|NCT01465412|3733076|B1|||Age||Years|Mean|55.3|55.3|Standard Deviation|6.5|6.5|||
3909719|NCT01465386|3733117|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3909720|NCT01465386|3733117|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909721|NCT01465386|3733117|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909722|NCT01465386|3733117|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3909723|NCT01465386|3733117|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3909724|NCT01465386|3733117|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909725|NCT01465386|3733117|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909726|NCT01465386|3733117|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909727|NCT01465386|3733117|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909728|NCT01465386|3733117|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3909729|NCT01465386|3733117|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909730|NCT01465386|3733117|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3909731|NCT01465386|3733117|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3909732|NCT01465386|3733117|B1|||Age||years|Median|78|78.0|Full Range|||61.0|87.0|
3909733|NCT01465347|3733121|B1|||Count of participants||participants|Number|56|56.0||||||
3909734|NCT01465347|3733121|B1|United States||Region of Enrollment||participants|Number|56|56.0||||||
3909735|NCT01465347|3733121|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3909736|NCT01465347|3733121|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909737|NCT01465347|3733121|B1||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3909738|NCT01465347|3733121|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3909739|NCT01465347|3733121|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909740|NCT01465347|3733121|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909741|NCT01465347|3733121|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909742|NCT01465347|3733121|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3909743|NCT01465347|3733121|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3909744|NCT01465347|3733121|B1|||Age||years|Mean|57.2|57.2|Standard Deviation|10.79|10.79|||
3909745|NCT01465347|3733121|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3909746|NCT01465347|3733121|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3909747|NCT01465347|3733121|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3909748|NCT01465230|3733132|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3909749|NCT01465230|3733132|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3909750|NCT01465230|3733132|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3909751|NCT01465230|3733132|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3909752|NCT01465230|3733132|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3909753|NCT01465178|3733136|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
3909754|NCT01465178|3733137|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
3909755|NCT01465178|3733138|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
3909756|NCT01465178|3733136|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909757|NCT01465178|3733137|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909758|NCT01465178|3733138|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909759|NCT01465178|3733136|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909760|NCT01465178|3733137|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909761|NCT01465178|3733138|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909762|NCT01465178|3733136|B3||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3909763|NCT01465178|3733137|B2||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3909764|NCT01465178|3733138|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3909765|NCT01465178|3733136|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909766|NCT01465178|3733137|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909767|NCT01465178|3733138|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909768|NCT01465178|3733136|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909769|NCT01465178|3733137|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909770|NCT01465178|3733138|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909771|NCT01465178|3733136|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909772|NCT01465178|3733137|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909773|NCT01465178|3733138|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909774|NCT01465178|3733136|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909775|NCT01465178|3733137|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909776|NCT01465178|3733138|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909777|NCT01465178|3733136|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909778|NCT01465178|3733137|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909779|NCT01465178|3733138|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909780|NCT01465178|3733136|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3909781|NCT01465178|3733137|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3909782|NCT01465178|3733138|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3909783|NCT01465178|3733136|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909784|NCT01465178|3733137|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909785|NCT01465178|3733138|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909786|NCT01465178|3733136|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3909787|NCT01465178|3733137|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3909788|NCT01465178|3733138|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3909789|NCT01465178|3733136|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3909790|NCT01465178|3733137|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3909791|NCT01465178|3733138|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3909792|NCT01465178|3733136|B3|||Age||years|Mean|67.8|67.8|Standard Deviation|9.1|9.1|||
3909793|NCT01465178|3733137|B2|||Age||years|Mean|65.9|65.9|Standard Deviation|8.2|8.2|||
3909794|NCT01465178|3733138|B1|||Age||years|Mean|69.7|69.7|Standard Deviation|9.7|9.7|||
3909795|NCT01465048|3733147|B4|United Kingdom||Region of Enrollment||participants|Number|18|18.0||||||
3909796|NCT01465048|3733148|B3|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3909797|NCT01465048|3733149|B2|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3909798|NCT01465048|3733150|B1|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3909799|NCT01465048|3733147|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3909800|NCT01465048|3733148|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3909801|NCT01465048|3733149|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3909802|NCT01465048|3733150|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3909803|NCT01465048|3733147|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3909804|NCT01465048|3733148|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3909805|NCT01465048|3733149|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3909806|NCT01465048|3733150|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3909807|NCT01465048|3733147|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3909808|NCT01465048|3733148|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3909809|NCT01465048|3733149|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3909810|NCT01465048|3733150|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3909811|NCT01465048|3733147|B4||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3909812|NCT01465048|3733148|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3909813|NCT01465048|3733149|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3909814|NCT01465048|3733150|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3909815|NCT01465048|3733147|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3909816|NCT01465048|3733148|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3909817|NCT01465048|3733149|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3909818|NCT01465048|3733150|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3909819|NCT01465022|3733160|B4|United States||Region of Enrollment||participants|Number|197|197.0||||||
3909820|NCT01465022|3733161|B3|United States||Region of Enrollment||participants|Number|70|70.0||||||
3909821|NCT01465022|3733162|B2|United States||Region of Enrollment||participants|Number|63|63.0||||||
3909822|NCT01465022|3733163|B1|United States||Region of Enrollment||participants|Number|64|64.0||||||
3909823|NCT01465022|3733160|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3909824|NCT01465022|3733161|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3909825|NCT01465022|3733162|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3909826|NCT01465022|3733163|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3909827|NCT01465022|3733160|B4||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
3909828|NCT01465022|3733161|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3909829|NCT01465022|3733162|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3909830|NCT01465022|3733163|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3909831|NCT01465022|3733160|B4|||Age||years|Mean|24.4|24.4|Standard Deviation|197|197.0|||
3909832|NCT01465022|3733161|B3|||Age||years|Mean|23.4|23.4|Standard Deviation|5.0|5.0|||
3909833|NCT01465022|3733162|B2|||Age||years|Mean|25.0|25.0|Standard Deviation|5.4|5.4|||
3909834|NCT01465022|3733163|B1|||Age||years|Mean|23.8|23.8|Standard Deviation|4.4|4.4|||
3909835|NCT01465022|3733160|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3909836|NCT01465022|3733161|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3909837|NCT01465022|3733162|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3909838|NCT01465022|3733163|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3909839|NCT01465022|3733160|B4||Between 18 and 65 years|Age||Participants|Count of Participants|197|197.0||||||
3909840|NCT01465022|3733161|B3||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
3909841|NCT01465022|3733162|B2||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
3909842|NCT01465022|3733163|B1||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
3909843|NCT01465022|3733160|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3909844|NCT01465022|3733161|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3909845|NCT01465022|3733162|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3909846|NCT01465022|3733163|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3909847|NCT01464996|3733179|B1|OptiBond FL||Stressful Occlusion, Categorical||Number of teeth with stressful occlusion|Number|20|20.0||||||
3909848|NCT01464996|3733179|B1|OptiBond XTR||Stressful Occlusion, Categorical||Number of teeth with stressful occlusion|Number|20|20.0||||||
3909849|NCT01464996|3733179|B1|OptiBond FL||Number of Restorations, Categorical||number of restorations, unit|Number|42|42.0||||||
3909850|NCT01464996|3733179|B1|OptiBond XTR||Number of Restorations, Categorical||number of restorations, unit|Number|41|41.0||||||
3909851|NCT01464996|3733179|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3909852|NCT01464996|3733179|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3909853|NCT01464996|3733179|B1|||Age||Years|Mean|56|56.0|Standard Deviation|20|20.0|||
3909854|NCT01464931|3733197|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3909855|NCT01464931|3733198|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3909856|NCT01464931|3733199|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3909857|NCT01464931|3733197|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3909858|NCT01464931|3733198|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3909859|NCT01464931|3733199|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3909860|NCT01464931|3733197|B3|||Age||years|Mean|72.5|72.5|Standard Deviation|12.8|12.8|||
3909861|NCT01464931|3733198|B2|||Age||years|Mean|65.9|65.9|Standard Deviation|12.4|12.4|||
3909862|NCT01464931|3733199|B1|||Age||years|Mean|79.2|79.2|Standard Deviation|9.5|9.5|||
3909863|NCT01464879|3733237|B1|||Body Mass Index (BMI)||kg/m^2|Mean|29.8|29.8|Standard Deviation|3.1|3.1|||
3909864|NCT01464879|3733237|B1|||Weight||lbs|Mean|203.7|203.7|Standard Deviation|29.9|29.9|||
3909865|NCT01464879|3733237|B1|||Height||inch|Mean|69.2|69.2|Standard Deviation|2.7|2.7|||
3909866|NCT01464879|3733237|B1|United States||Region of Enrollment||subjects|Number|20|20.0||||||
3909867|NCT01464879|3733237|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909868|NCT01464879|3733237|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909869|NCT01464879|3733237|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3909870|NCT01464879|3733237|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3909871|NCT01464879|3733237|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909872|NCT01464879|3733237|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3909873|NCT01464879|3733237|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909874|NCT01464879|3733237|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909875|NCT01464879|3733237|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3909876|NCT01464879|3733237|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3909877|NCT01464879|3733237|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3909878|NCT01464879|3733237|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3909879|NCT01464879|3733237|B1|||Age||Year|Mean|52.1|52.1|Standard Deviation|8.2|8.2|||
3909880|NCT01464840|3733271|B4|United States||Region of Enrollment||participants|Number|30|30.0||||||
3909881|NCT01464840|3733272|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3909882|NCT01464840|3733273|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3909883|NCT01464840|3733274|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3909884|NCT01464840|3733271|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3909885|NCT01464840|3733272|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3909886|NCT01464840|3733273|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3909887|NCT01464840|3733274|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3909888|NCT01464840|3733271|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3909889|NCT01464840|3733272|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3909890|NCT01464840|3733273|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3909891|NCT01464840|3733274|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3909892|NCT01464840|3733271|B4|||Age||years|Mean|28|28.0|Standard Deviation|5|5.0|||
3909893|NCT01464840|3733272|B3|||Age||years|Mean|29|29.0|Standard Deviation|6|6.0|||
3909894|NCT01464840|3733273|B2|||Age||years|Mean|27|27.0|Standard Deviation|5|5.0|||
3909895|NCT01464840|3733274|B1|||Age||years|Mean|27|27.0|Standard Deviation|4|4.0|||
3909896|NCT01464840|3733271|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3909897|NCT01464840|3733272|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3909898|NCT01464840|3733273|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3909899|NCT01464840|3733274|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3909900|NCT01464840|3733271|B4||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3909901|NCT01464840|3733272|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3909902|NCT01464840|3733273|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3909903|NCT01464840|3733274|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3909904|NCT01464840|3733271|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3909905|NCT01464840|3733272|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3909906|NCT01464840|3733273|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3909907|NCT01464840|3733274|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3909908|NCT01464827|3733284|B15||Male|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
3909909|NCT01464827|3733285|B14||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3909910|NCT01464827|3733286|B13||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3909911|NCT01464827|3733287|B12||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3909912|NCT01464827|3733288|B11||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3909913|NCT01464827|3733289|B10||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3909914|NCT01464827|3733290|B9||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3909915|NCT01464827|3733291|B8||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3909916|NCT01464827|3733292|B7||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3909917|NCT01464827|3733293|B6||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3909918|NCT01464827|3733294|B5||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3909919|NCT01464827|3733295|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3909920|NCT01464827|3733296|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3909921|NCT01464827|3733297|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3909922|NCT01464827|3733298|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3909923|NCT01464827|3733284|B15||Female|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
3909924|NCT01464827|3733285|B14||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3909925|NCT01464827|3733286|B13||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3909926|NCT01464827|3733287|B12||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3909927|NCT01464827|3733288|B11||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3909928|NCT01464827|3733289|B10||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3909929|NCT01464827|3733290|B9||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3909930|NCT01464827|3733291|B8||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3909931|NCT01464827|3733292|B7||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3909932|NCT01464827|3733293|B6||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3909933|NCT01464827|3733294|B5||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3909934|NCT01464827|3733295|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3909935|NCT01464827|3733296|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3909936|NCT01464827|3733297|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3909937|NCT01464827|3733298|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3909938|NCT01464827|3733284|B15|||Age||years|Mean|50.3|50.3|Standard Deviation|10.49|10.49|||
3909939|NCT01464827|3733285|B14|||Age||years|Mean|54.6|54.6|Standard Deviation|11.78|11.78|||
3909940|NCT01464827|3733286|B13|||Age||years|Mean|51.5|51.5|Standard Deviation|9.06|9.06|||
3909941|NCT01464827|3733287|B12|||Age||years|Mean|51.2|51.2|Standard Deviation|12.07|12.07|||
3909942|NCT01464827|3733288|B11|||Age||years|Mean|48.5|48.5|Standard Deviation|12.91|12.91|||
3909943|NCT01464827|3733289|B10|||Age||years|Mean|50.6|50.6|Standard Deviation|11.19|11.19|||
3909944|NCT01464827|3733290|B9|||Age||years|Mean|51.5|51.5|Standard Deviation|9.78|9.78|||
3909945|NCT01464827|3733291|B8|||Age||years|Mean|51.5|51.5|Standard Deviation|11.95|11.95|||
3909946|NCT01464827|3733292|B7|||Age||years|Mean|51.0|51.0|Standard Deviation|11.08|11.08|||
3909947|NCT01464827|3733293|B6|||Age||years|Mean|49.4|49.4|Standard Deviation|9.72|9.72|||
3909948|NCT01464827|3733294|B5|||Age||years|Mean|48.3|48.3|Standard Deviation|10.53|10.53|||
3909949|NCT01464827|3733295|B4|||Age||years|Mean|49.0|49.0|Standard Deviation|10.59|10.59|||
3909950|NCT01464827|3733296|B3|||Age||years|Mean|51.1|51.1|Standard Deviation|8.07|8.07|||
3909951|NCT01464827|3733297|B2|||Age||years|Mean|50.8|50.8|Standard Deviation|9.84|9.84|||
3909952|NCT01464827|3733298|B1|||Age||years|Mean|50.1|50.1|Standard Deviation|9.99|9.99|||
3909953|NCT01464788|3733355|B4|United Kingdom||Region of Enrollment||participants|Number|25|25.0||||||
3909954|NCT01464788|3733356|B3|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3909955|NCT01464788|3733357|B2|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
3909956|NCT01464788|3733358|B1|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3909957|NCT01464788|3733355|B4|United States||Region of Enrollment||participants|Number|65|65.0||||||
3909958|NCT01464788|3733356|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
3909959|NCT01464788|3733357|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
3909960|NCT01464788|3733358|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3909961|NCT01464788|3733355|B4||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3909962|NCT01464788|3733356|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3909963|NCT01464788|3733357|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3909964|NCT01464788|3733358|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3909965|NCT01464788|3733355|B4||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3909966|NCT01464788|3733356|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3909967|NCT01464788|3733357|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3909968|NCT01464788|3733358|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3909969|NCT01464788|3733355|B4|||Age||years|Mean|68.9|68.9|Standard Deviation|14.6|14.6|||
3909970|NCT01464788|3733356|B3|||Age||years|Mean|68.9|68.9|Standard Deviation|15.4|15.4|||
3909971|NCT01464788|3733357|B2|||Age||years|Mean|67.1|67.1|Standard Deviation|13.4|13.4|||
3909972|NCT01464788|3733358|B1|||Age||years|Mean|70.9|70.9|Standard Deviation|15.1|15.1|||
3909973|NCT01464788|3733355|B4||>=65 years|Age||Participants|Count of Participants|53|53.0||||||
3909974|NCT01464788|3733356|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3909975|NCT01464788|3733357|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3909976|NCT01464788|3733358|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3909977|NCT01464788|3733355|B4||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3909978|NCT01464788|3733356|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3909979|NCT01464788|3733357|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3909980|NCT01464788|3733358|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3909981|NCT01464788|3733355|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3909982|NCT01464788|3733356|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3909983|NCT01464788|3733357|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3909984|NCT01464788|3733358|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3909985|NCT01464619|3733371|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909986|NCT01464619|3733372|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909987|NCT01464619|3733373|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909988|NCT01464619|3733371|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909989|NCT01464619|3733372|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909990|NCT01464619|3733373|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909991|NCT01464619|3733371|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3909992|NCT01464619|3733372|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3909993|NCT01464619|3733373|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3909994|NCT01464619|3733371|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3909995|NCT01464619|3733372|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3909996|NCT01464619|3733373|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3909997|NCT01464619|3733371|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909998|NCT01464619|3733372|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3909999|NCT01464619|3733373|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910000|NCT01464619|3733371|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910001|NCT01464619|3733372|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910002|NCT01464619|3733373|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910003|NCT01464619|3733371|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910004|NCT01464619|3733372|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910005|NCT01464619|3733373|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910006|NCT01464619|3733371|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3910007|NCT01464619|3733372|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3910008|NCT01464619|3733373|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3910009|NCT01464619|3733371|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3910010|NCT01464619|3733372|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3910011|NCT01464619|3733373|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3910012|NCT01464619|3733371|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3910013|NCT01464619|3733372|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3910014|NCT01464619|3733373|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3910015|NCT01464619|3733371|B3||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
3910016|NCT01464619|3733372|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3910017|NCT01464619|3733373|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3910018|NCT01464619|3733371|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3910019|NCT01464619|3733372|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3910020|NCT01464619|3733373|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3910021|NCT01464424|3733394|B1|United States||Region of Enrollment||participants|Number|84|84.0||||||
3910022|NCT01464424|3733394|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3910023|NCT01464424|3733394|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3910024|NCT01464424|3733394|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|11.41|11.41|||
3910025|NCT01464359|3733403|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3910026|NCT01464359|3733403|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3910027|NCT01464359|3733403|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3910028|NCT01464359|3733403|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3910029|NCT01464359|3733403|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3910030|NCT01464359|3733403|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3910031|NCT01464346|3733415|B1|United States||Region of Enrollment||participants|Number|90|90.0||||||
3910032|NCT01464346|3733415|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3910033|NCT01464346|3733415|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3910034|NCT01464346|3733415|B1|||Age||years|Mean|44.4|44.4|Standard Deviation|13.8|13.8|||
3910035|NCT01464346|3733415|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3910036|NCT01464346|3733415|B1||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
3910037|NCT01464346|3733415|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3910038|NCT01464307|3733426|B3||Male|Gender||Participants|Count of Participants|194|194.0||||||
3910039|NCT01464307|3733427|B2||Male|Gender||Participants|Count of Participants|90|90.0||||||
3910040|NCT01464307|3733428|B1||Male|Gender||Participants|Count of Participants|104|104.0||||||
3910041|NCT01464307|3733426|B3||Female|Gender||Participants|Count of Participants|95|95.0||||||
3910042|NCT01464307|3733427|B2||Female|Gender||Participants|Count of Participants|55|55.0||||||
3910043|NCT01464307|3733428|B1||Female|Gender||Participants|Count of Participants|40|40.0||||||
3910044|NCT01464307|3733426|B3|||Age||years|Mean|57.2|57.2|Standard Deviation|12.1|12.1|||
3910045|NCT01464307|3733427|B2|||Age||years|Mean|57.0|57.0|Standard Deviation|13.0|13.0|||
3910046|NCT01464307|3733428|B1|||Age||years|Mean|57.3|57.3|Standard Deviation|11.2|11.2|||
3910047|NCT01464255|3733442|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
3910048|NCT01464255|3733443|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
3910049|NCT01464255|3733444|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3910050|NCT01464255|3733442|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3910051|NCT01464255|3733443|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3910052|NCT01464255|3733444|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3910053|NCT01464255|3733442|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3910054|NCT01464255|3733443|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3910055|NCT01464255|3733444|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3910056|NCT01464255|3733442|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3910057|NCT01464255|3733443|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3910058|NCT01464255|3733444|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3910059|NCT01464255|3733442|B3||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3910060|NCT01464255|3733443|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3910061|NCT01464255|3733444|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3910062|NCT01464255|3733442|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3910063|NCT01464255|3733443|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3910064|NCT01464255|3733444|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3910065|NCT01464229|3733468|B3|Males||Sex/Gender, Customized||Participants|Count of Participants|6|6.0||||||
3910066|NCT01464229|3733469|B2|Males||Sex/Gender, Customized||Participants|Count of Participants|2|2.0||||||
3910067|NCT01464229|3733470|B1|Males||Sex/Gender, Customized||Participants|Count of Participants|4|4.0||||||
3910068|NCT01464229|3733468|B3|Females||Sex/Gender, Customized||Participants|Count of Participants|14|14.0||||||
3910069|NCT01464229|3733469|B2|Females||Sex/Gender, Customized||Participants|Count of Participants|8|8.0||||||
3910070|NCT01464229|3733470|B1|Females||Sex/Gender, Customized||Participants|Count of Participants|6|6.0||||||
3910071|NCT01464229|3733468|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3910072|NCT01464229|3733469|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3910073|NCT01464229|3733470|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3910074|NCT01464229|3733468|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3910075|NCT01464229|3733469|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3910076|NCT01464229|3733470|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3910077|NCT01464229|3733468|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3910078|NCT01464229|3733469|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3910079|NCT01464229|3733470|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3910080|NCT01464190|3733477|B3|South Africa||Region of Enrollment||participants|Number|3|3.0||||||
3910081|NCT01464190|3733478|B2|South Africa||Region of Enrollment||participants|Number|1|1.0||||||
3910082|NCT01464190|3733479|B1|South Africa||Region of Enrollment||participants|Number|2|2.0||||||
3910083|NCT01464190|3733477|B3|Ukraine||Region of Enrollment||participants|Number|47|47.0||||||
3910084|NCT01464190|3733478|B2|Ukraine||Region of Enrollment||participants|Number|15|15.0||||||
3910085|NCT01464190|3733479|B1|Ukraine||Region of Enrollment||participants|Number|32|32.0||||||
3910086|NCT01464190|3733477|B3|Serbia||Region of Enrollment||participants|Number|55|55.0||||||
3910087|NCT01464190|3733478|B2|Serbia||Region of Enrollment||participants|Number|18|18.0||||||
3910088|NCT01464190|3733479|B1|Serbia||Region of Enrollment||participants|Number|37|37.0||||||
3910089|NCT01464190|3733477|B3|Russian Federation||Region of Enrollment||participants|Number|109|109.0||||||
3910090|NCT01464190|3733478|B2|Russian Federation||Region of Enrollment||participants|Number|44|44.0||||||
3910091|NCT01464190|3733479|B1|Russian Federation||Region of Enrollment||participants|Number|65|65.0||||||
3910092|NCT01464190|3733477|B3|Croatia||Region of Enrollment||participants|Number|24|24.0||||||
3910093|NCT01464190|3733478|B2|Croatia||Region of Enrollment||participants|Number|8|8.0||||||
3910094|NCT01464190|3733479|B1|Croatia||Region of Enrollment||participants|Number|16|16.0||||||
3910095|NCT01464190|3733477|B3|Europe||Region of Enrollment||participants|Number|134|134.0||||||
3910096|NCT01464190|3733478|B2|Europe||Region of Enrollment||participants|Number|49|49.0||||||
3910097|NCT01464190|3733479|B1|Europe||Region of Enrollment||participants|Number|85|85.0||||||
3910098|NCT01464190|3733477|B3|United States||Region of Enrollment||participants|Number|287|287.0||||||
3910099|NCT01464190|3733478|B2|United States||Region of Enrollment||participants|Number|133|133.0||||||
3910100|NCT01464190|3733479|B1|United States||Region of Enrollment||participants|Number|154|154.0||||||
3910101|NCT01464190|3733477|B3||Male|Sex: Female, Male||Participants|Count of Participants|386|386.0||||||
3910102|NCT01464190|3733478|B2||Male|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3910103|NCT01464190|3733479|B1||Male|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
3910104|NCT01464190|3733477|B3||Female|Sex: Female, Male||Participants|Count of Participants|273|273.0||||||
3910105|NCT01464190|3733478|B2||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3910106|NCT01464190|3733479|B1||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3910107|NCT01464190|3733477|B3||>=65 years|Age||Participants|Count of Participants|173|173.0||||||
3910108|NCT01464190|3733478|B2||>=65 years|Age||Participants|Count of Participants|78|78.0||||||
3910109|NCT01464190|3733479|B1||>=65 years|Age||Participants|Count of Participants|95|95.0||||||
3910110|NCT01464190|3733477|B3||Between 18 and 65 years|Age||Participants|Count of Participants|486|486.0||||||
3910111|NCT01464190|3733478|B2||Between 18 and 65 years|Age||Participants|Count of Participants|190|190.0||||||
3910112|NCT01464190|3733479|B1||Between 18 and 65 years|Age||Participants|Count of Participants|296|296.0||||||
3910113|NCT01464190|3733477|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3910114|NCT01464190|3733478|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3910115|NCT01464190|3733479|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3910116|NCT01464190|3733477|B3|||Age||years|Mean|55.4|55.4|Standard Deviation|13.77|13.77|||
3910117|NCT01464190|3733478|B2|||Age||years|Mean|55.6|55.6|Standard Deviation|14.58|14.58|||
3910118|NCT01464190|3733479|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|13.20|13.2|||
3910119|NCT01464021|3733490|B1|Asian||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3910120|NCT01464021|3733490|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3910121|NCT01464021|3733490|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3910122|NCT01464021|3733490|B1|||Age||years|Mean|45.0|45.0|Standard Deviation|11.17|11.17|||
3910123|NCT01463982|3733502|B5|Korea, Republic of||Region of Enrollment||participants|Number|21|21.0||||||
3910124|NCT01463982|3733503|B4|Korea, Republic of||Region of Enrollment||participants|Number|6|6.0||||||
3910125|NCT01463982|3733504|B3|Korea, Republic of||Region of Enrollment||participants|Number|4|4.0||||||
3910126|NCT01463982|3733505|B2|Korea, Republic of||Region of Enrollment||participants|Number|8|8.0||||||
3910127|NCT01463982|3733506|B1|Korea, Republic of||Region of Enrollment||participants|Number|3|3.0||||||
3910128|NCT01463982|3733502|B5||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3910129|NCT01463982|3733503|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3910130|NCT01463982|3733504|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3910131|NCT01463982|3733505|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3910132|NCT01463982|3733506|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3910133|NCT01463982|3733502|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3910134|NCT01463982|3733503|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3910135|NCT01463982|3733504|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3910136|NCT01463982|3733505|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3910137|NCT01463982|3733506|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3910138|NCT01463982|3733502|B5|||Age||years|Mean|61.5|61.5|Standard Deviation|9.6|9.6|||
3910139|NCT01463982|3733503|B4|||Age||years|Mean|61.8|61.8|Standard Deviation|11.5|11.5|||
3910140|NCT01463982|3733504|B3|||Age||years|Mean|63.8|63.8|Standard Deviation|11.1|11.1|||
3910141|NCT01463982|3733505|B2|||Age||years|Mean|59.5|59.5|Standard Deviation|9.6|9.6|||
3910142|NCT01463982|3733506|B1|||Age||years|Mean|63.3|63.3|Standard Deviation|6.5|6.5|||
3910143|NCT01463878|3733523|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
3910144|NCT01463878|3733524|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3910145|NCT01463878|3733525|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3910146|NCT01463878|3733523|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3910147|NCT01463878|3733524|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3910148|NCT01463878|3733525|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3910149|NCT01463878|3733523|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3910150|NCT01463878|3733524|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3910151|NCT01463878|3733525|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3910152|NCT01463878|3733523|B3|||Age||years|Mean|73|73.0|Standard Deviation|11|11.0|||
3910153|NCT01463878|3733524|B2|||Age||years|Mean|74|74.0|Standard Deviation|9|9.0|||
3910154|NCT01463878|3733525|B1|||Age||years|Mean|72|72.0|Standard Deviation|12|12.0|||
3910155|NCT01463878|3733523|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3910156|NCT01463878|3733524|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3910157|NCT01463878|3733525|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3910158|NCT01463878|3733523|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3910159|NCT01463878|3733524|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3910160|NCT01463878|3733525|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3910161|NCT01463878|3733523|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3910162|NCT01463878|3733524|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3910163|NCT01463878|3733525|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3910164|NCT01463696|3733532|B9||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3910165|NCT01463696|3733533|B8||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3910166|NCT01463696|3733534|B7||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3910167|NCT01463696|3733535|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3910168|NCT01463696|3733536|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3910169|NCT01463696|3733537|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3910170|NCT01463696|3733538|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3910171|NCT01463696|3733539|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3910172|NCT01463696|3733540|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3910173|NCT01463696|3733532|B9||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3910174|NCT01463696|3733533|B8||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3910175|NCT01463696|3733534|B7||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3910176|NCT01463696|3733535|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3910177|NCT01463696|3733536|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3910178|NCT01463696|3733537|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3910179|NCT01463696|3733538|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3910180|NCT01463696|3733539|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3910181|NCT01463696|3733540|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3910182|NCT01463696|3733532|B9|||Age||Years|Mean|61.3|61.3|Standard Deviation|10.8|10.8|||
3910183|NCT01463696|3733533|B8|||Age||Years|Mean|62.5|62.5|Standard Deviation|12.8|12.8|||
3910184|NCT01463696|3733534|B7|||Age||Years|Mean|63.9|63.9|Standard Deviation|10.4|10.4|||
3910185|NCT01463696|3733535|B6|||Age||Years|Mean|58.2|58.2|Standard Deviation|10.2|10.2|||
3910186|NCT01463696|3733536|B5|||Age||Years|Mean|53.3|53.3|Standard Deviation|12.3|12.3|||
3910187|NCT01463696|3733537|B4|||Age||Years|Mean|60.3|60.3|Standard Deviation|11.4|11.4|||
3910188|NCT01463696|3733538|B3|||Age||Years|Mean|68.3|68.3|Standard Deviation|7.4|7.4|||
3910189|NCT01463696|3733539|B2|||Age||Years|Mean|60.0|60.0|Standard Deviation|11.0|11.0|||
3910190|NCT01463696|3733540|B1|||Age||Years|Mean|47.0|47.0|Standard Deviation|NA||||Only 1 participant in population; no SD calculated.
3910191|NCT01463683|3733597|B4||Male|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
3910192|NCT01463683|3733598|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3910193|NCT01463683|3733599|B2||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3910194|NCT01463683|3733600|B1||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3910195|NCT01463683|3733597|B4||Female|Sex: Female, Male||Participants|Count of Participants|361|361.0||||||
3910196|NCT01463683|3733598|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3910197|NCT01463683|3733599|B2||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3910198|NCT01463683|3733600|B1||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3910199|NCT01463683|3733597|B4|||Age||Years|Mean|27.1|27.1|Standard Deviation|4.7|4.7|||
3910200|NCT01463683|3733598|B3|||Age||Years|Mean|26.9|26.9|Standard Deviation|4.9|4.9|||
3910201|NCT01463683|3733599|B2|||Age||Years|Mean|26.8|26.8|Standard Deviation|4.6|4.6|||
3910202|NCT01463683|3733600|B1|||Age||Years|Mean|27.3|27.3|Standard Deviation|4.7|4.7|||
3910203|NCT01463631|3733615|B5|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3910204|NCT01463631|3733616|B4|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3910205|NCT01463631|3733617|B3|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3910206|NCT01463631|3733618|B2|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3910207|NCT01463631|3733619|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3910208|NCT01463631|3733615|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910209|NCT01463631|3733616|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910210|NCT01463631|3733617|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910211|NCT01463631|3733618|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910212|NCT01463631|3733619|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910213|NCT01463631|3733615|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910214|NCT01463631|3733616|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910215|NCT01463631|3733617|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910216|NCT01463631|3733618|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910217|NCT01463631|3733619|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910218|NCT01463631|3733615|B5||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3910219|NCT01463631|3733616|B4||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3910220|NCT01463631|3733617|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3910221|NCT01463631|3733618|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3910222|NCT01463631|3733619|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3910223|NCT01463631|3733615|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3910224|NCT01463631|3733616|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3910225|NCT01463631|3733617|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910226|NCT01463631|3733618|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910227|NCT01463631|3733619|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910228|NCT01463631|3733615|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910229|NCT01463631|3733616|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910230|NCT01463631|3733617|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910231|NCT01463631|3733618|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910232|NCT01463631|3733619|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910233|NCT01463631|3733615|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3910234|NCT01463631|3733616|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910235|NCT01463631|3733617|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3910236|NCT01463631|3733618|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910237|NCT01463631|3733619|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3910238|NCT01463631|3733615|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910239|NCT01463631|3733616|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910240|NCT01463631|3733617|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910241|NCT01463631|3733618|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910242|NCT01463631|3733619|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910243|NCT01463631|3733615|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910244|NCT01463631|3733616|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910245|NCT01463631|3733617|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910246|NCT01463631|3733618|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910247|NCT01463631|3733619|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910248|NCT01463631|3733615|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3910249|NCT01463631|3733616|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3910250|NCT01463631|3733617|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3910251|NCT01463631|3733618|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3910252|NCT01463631|3733619|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3910253|NCT01463631|3733615|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3910254|NCT01463631|3733616|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3910255|NCT01463631|3733617|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910256|NCT01463631|3733618|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3910257|NCT01463631|3733619|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910258|NCT01463631|3733615|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3910259|NCT01463631|3733616|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3910260|NCT01463631|3733617|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3910261|NCT01463631|3733618|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3910262|NCT01463631|3733619|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3910263|NCT01463631|3733615|B5||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3910264|NCT01463631|3733616|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3910265|NCT01463631|3733617|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3910266|NCT01463631|3733618|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3910267|NCT01463631|3733619|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3910268|NCT01463631|3733615|B5||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3910269|NCT01463631|3733616|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3910270|NCT01463631|3733617|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3910271|NCT01463631|3733618|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3910272|NCT01463631|3733619|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3910273|NCT01463631|3733615|B5||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3910274|NCT01463631|3733616|B4||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3910275|NCT01463631|3733617|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3910276|NCT01463631|3733618|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3910277|NCT01463631|3733619|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3910278|NCT01463631|3733615|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3910279|NCT01463631|3733616|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3910280|NCT01463631|3733617|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3910281|NCT01463631|3733618|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3910282|NCT01463631|3733619|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3910283|NCT01463527|3733642|B3|||Weight||kg|Mean|35.8|35.8|Standard Deviation|21.3|21.3|||
3910284|NCT01463527|3733643|B2|||Weight||kg|Mean|35.8|35.8|Standard Deviation|21.8|21.8|||
3910285|NCT01463527|3733644|B1|||Weight||kg|Mean|35.8|35.8|Standard Deviation|20.8|20.8|||
3910286|NCT01463527|3733642|B3|Other||Indication for sedation||participants|Number|2|2.0||||||
3910287|NCT01463527|3733643|B2|Other||Indication for sedation||participants|Number|0|0.0||||||
3910288|NCT01463527|3733644|B1|Other||Indication for sedation||participants|Number|2|2.0||||||
3910289|NCT01463527|3733642|B3|Dislocation||Indication for sedation||participants|Number|5|5.0||||||
3910290|NCT01463527|3733643|B2|Dislocation||Indication for sedation||participants|Number|4|4.0||||||
3910291|NCT01463527|3733644|B1|Dislocation||Indication for sedation||participants|Number|1|1.0||||||
3910292|NCT01463527|3733642|B3|Arthorcentesis||Indication for sedation||participants|Number|5|5.0||||||
3910293|NCT01463527|3733643|B2|Arthorcentesis||Indication for sedation||participants|Number|3|3.0||||||
3910294|NCT01463527|3733644|B1|Arthorcentesis||Indication for sedation||participants|Number|2|2.0||||||
3910295|NCT01463527|3733642|B3|Incision and drainage of abscess||Indication for sedation||participants|Number|28|28.0||||||
3910296|NCT01463527|3733643|B2|Incision and drainage of abscess||Indication for sedation||participants|Number|12|12.0||||||
3910297|NCT01463527|3733644|B1|Incision and drainage of abscess||Indication for sedation||participants|Number|16|16.0||||||
3910298|NCT01463527|3733642|B3|Laceration repair||Indication for sedation||participants|Number|29|29.0||||||
3910299|NCT01463527|3733643|B2|Laceration repair||Indication for sedation||participants|Number|16|16.0||||||
3910300|NCT01463527|3733644|B1|Laceration repair||Indication for sedation||participants|Number|13|13.0||||||
3910301|NCT01463527|3733642|B3|Fracture reduction||Indication for sedation||participants|Number|85|85.0||||||
3910302|NCT01463527|3733643|B2|Fracture reduction||Indication for sedation||participants|Number|42|42.0||||||
3910303|NCT01463527|3733644|B1|Fracture reduction||Indication for sedation||participants|Number|43|43.0||||||
3910304|NCT01463527|3733642|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3910305|NCT01463527|3733643|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3910306|NCT01463527|3733644|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3910307|NCT01463527|3733642|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910308|NCT01463527|3733643|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910309|NCT01463527|3733644|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910310|NCT01463527|3733642|B3||White|Race (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
3910311|NCT01463527|3733643|B2||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3910312|NCT01463527|3733644|B1||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3910313|NCT01463527|3733642|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3910314|NCT01463527|3733643|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3910315|NCT01463527|3733644|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3910316|NCT01463527|3733642|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910317|NCT01463527|3733643|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910318|NCT01463527|3733644|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910319|NCT01463527|3733642|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910320|NCT01463527|3733643|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910321|NCT01463527|3733644|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910322|NCT01463527|3733642|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910323|NCT01463527|3733643|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910324|NCT01463527|3733644|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910325|NCT01463527|3733642|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3910326|NCT01463527|3733643|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3910327|NCT01463527|3733644|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3910328|NCT01463527|3733642|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3910329|NCT01463527|3733643|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3910330|NCT01463527|3733644|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3910331|NCT01463527|3733642|B3|||Age||years|Mean|8.4|8.4|Standard Deviation|5.0|5.0|||
3910332|NCT01463527|3733643|B2|||Age||years|Mean|8.2|8.2|Standard Deviation|4.8|4.8|||
3910333|NCT01463527|3733644|B1|||Age||years|Mean|8.6|8.6|Standard Deviation|5.1|5.1|||
3910334|NCT01463384|3733653|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3910335|NCT01463384|3733653|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3910336|NCT01463384|3733653|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3910337|NCT01463384|3733653|B1|||Age||years|Mean|73.5|73.5|Standard Deviation|8.8|8.8|||
3910338|NCT01463384|3733653|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3910339|NCT01463384|3733653|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3910340|NCT01463384|3733653|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3910341|NCT01463293|3733665|B4|||BMI||Kg/m^2|Mean|27.0|27.0|Standard Deviation|4.4|4.4|||
3910342|NCT01463293|3733666|B3|||BMI||Kg/m^2|Mean|26.6|26.6|Standard Deviation|4.7|4.7|||
3910343|NCT01463293|3733667|B2|||BMI||Kg/m^2|Mean|27.4|27.4|Standard Deviation|4.4|4.4|||
3910344|NCT01463293|3733668|B1|||BMI||Kg/m^2|Mean|27.0|27.0|Standard Deviation|4.2|4.2|||
3910345|NCT01463293|3733665|B4|||Weight, Kg||Kg|Mean|75.6|75.6|Standard Deviation|15.0|15.0|||
3910346|NCT01463293|3733666|B3|||Weight, Kg||Kg|Mean|74.3|74.3|Standard Deviation|14.9|14.9|||
3910347|NCT01463293|3733667|B2|||Weight, Kg||Kg|Mean|77.5|77.5|Standard Deviation|15.9|15.9|||
3910348|NCT01463293|3733668|B1|||Weight, Kg||Kg|Mean|74.9|74.9|Standard Deviation|15.2|15.2|||
3910349|NCT01463293|3733665|B4|||Height, M||M|Mean|1.68|1.68|Standard Deviation|0.10|0.1|||
3910350|NCT01463293|3733666|B3|||Height, M||M|Mean|1.68|1.68|Standard Deviation|0.10|0.1|||
3910351|NCT01463293|3733667|B2|||Height, M||M|Mean|1.68|1.68|Standard Deviation|0.09|0.09|||
3910352|NCT01463293|3733668|B1|||Height, M||M|Mean|1.66|1.66|Standard Deviation|0.12|0.12|||
3910353|NCT01463293|3733665|B4|United States||Region of Enrollment||participants|Number|224|224.0||||||
3910354|NCT01463293|3733666|B3|United States||Region of Enrollment||participants|Number|71|71.0||||||
3910355|NCT01463293|3733667|B2|United States||Region of Enrollment||participants|Number|79|79.0||||||
3910356|NCT01463293|3733668|B1|United States||Region of Enrollment||participants|Number|74|74.0||||||
3910357|NCT01463293|3733665|B4|Other||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3910358|NCT01463293|3733666|B3|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3910359|NCT01463293|3733667|B2|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3910360|NCT01463293|3733668|B1|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3910361|NCT01463293|3733665|B4|African-American, Black||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
3910362|NCT01463293|3733666|B3|African-American, Black||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3910363|NCT01463293|3733667|B2|African-American, Black||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3910364|NCT01463293|3733668|B1|African-American, Black||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3910365|NCT01463293|3733665|B4|Native American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3910366|NCT01463293|3733666|B3|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3910367|NCT01463293|3733667|B2|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3910368|NCT01463293|3733668|B1|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3910369|NCT01463293|3733665|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
3910370|NCT01463293|3733666|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3910371|NCT01463293|3733667|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3910372|NCT01463293|3733668|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3910373|NCT01463293|3733665|B4|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3910374|NCT01463293|3733666|B3|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3910375|NCT01463293|3733667|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3910376|NCT01463293|3733668|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3910377|NCT01463293|3733665|B4|Caucasian, non-Hispanic||Race/Ethnicity, Customized||participants|Number|88|88.0||||||
3910378|NCT01463293|3733666|B3|Caucasian, non-Hispanic||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3910379|NCT01463293|3733667|B2|Caucasian, non-Hispanic||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3910380|NCT01463293|3733668|B1|Caucasian, non-Hispanic||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
3910381|NCT01463293|3733665|B4||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3910382|NCT01463293|3733666|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3910383|NCT01463293|3733667|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3910384|NCT01463293|3733668|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3910385|NCT01463293|3733665|B4||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3910386|NCT01463293|3733666|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3910387|NCT01463293|3733667|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3910388|NCT01463293|3733668|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3910389|NCT01463293|3733665|B4|||Age||years|Mean|41.8|41.8|Standard Deviation|12.2|12.2|||
3910390|NCT01463293|3733666|B3|||Age||years|Mean|41.1|41.1|Standard Deviation|12.6|12.6|||
3910391|NCT01463293|3733667|B2|||Age||years|Mean|42.9|42.9|Standard Deviation|12.0|12.0|||
3910392|NCT01463293|3733668|B1|||Age||years|Mean|41.3|41.3|Standard Deviation|12.1|12.1|||
3910393|NCT01463202|3733678|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3910394|NCT01463202|3733679|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3910395|NCT01463202|3733680|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3910396|NCT01463202|3733678|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3910397|NCT01463202|3733679|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3910398|NCT01463202|3733680|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3910399|NCT01463202|3733678|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|122|122.0||||||
3910400|NCT01463202|3733679|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|61|61.0||||||
3910401|NCT01463202|3733680|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|61|61.0||||||
3910402|NCT01463202|3733678|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3910403|NCT01463202|3733679|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3910404|NCT01463202|3733680|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3910405|NCT01463202|3733678|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3910406|NCT01463202|3733679|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3910407|NCT01463202|3733680|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3910408|NCT01463202|3733678|B3||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3910409|NCT01463202|3733679|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3910410|NCT01463202|3733680|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3910411|NCT01463202|3733678|B3|||Age||years|Mean|24.1|24.1|Standard Deviation|4.8|4.8|||
3910412|NCT01463202|3733679|B2|||Age||years|Mean|24.4|24.4|Standard Deviation|4.7|4.7|||
3910413|NCT01463202|3733680|B1|||Age||years|Mean|23.9|23.9|Standard Deviation|4.9|4.9|||
3910414|NCT01463111|3733693|B1|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3910415|NCT01463111|3733693|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3910416|NCT01463111|3733693|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3910417|NCT01463111|3733693|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3910418|NCT01463111|3733693|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3910419|NCT01463111|3733693|B1|||Age||years|Mean|36.19|36.19|Standard Deviation|12.41|12.41|||
3910420|NCT01463033|3733701|B3||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3910421|NCT01463033|3733702|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3910422|NCT01463033|3733703|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3910423|NCT01463033|3733701|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3910424|NCT01463033|3733702|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3910425|NCT01463033|3733703|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3910426|NCT01463033|3733701|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3910427|NCT01463033|3733702|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3910428|NCT01463033|3733703|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3910429|NCT01463033|3733701|B3||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
3910430|NCT01463033|3733702|B2||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3910431|NCT01463033|3733703|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3910432|NCT01463033|3733701|B3||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
3910433|NCT01463033|3733702|B2||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
3910434|NCT01463033|3733703|B1||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
3910435|NCT01463007|3733711|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
3910436|NCT01463007|3733711|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3910437|NCT01463007|3733711|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3910438|NCT01463007|3733711|B1|||Age||years|Mean|61.46|61.46|Full Range|||50.0|92.0|
3910439|NCT01463007|3733711|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3910440|NCT01463007|3733711|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3910441|NCT01463007|3733711|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3910442|NCT01462942|3733717|B6||Male|Gender||Participants|Count of Participants|1169|1169.0||||||
3910443|NCT01462942|3733718|B5||Male|Gender||Participants|Count of Participants|255|255.0||||||
3910444|NCT01462942|3733719|B4||Male|Gender||Participants|Count of Participants|256|256.0||||||
3910445|NCT01462942|3733720|B3||Male|Gender||Participants|Count of Participants|259|259.0||||||
3910446|NCT01462942|3733721|B2||Male|Gender||Participants|Count of Participants|261|261.0||||||
3910447|NCT01462942|3733722|B1||Male|Gender||Participants|Count of Participants|138|138.0||||||
3910448|NCT01462942|3733717|B6||Female|Gender||Participants|Count of Participants|560|560.0||||||
3910449|NCT01462942|3733718|B5||Female|Gender||Participants|Count of Participants|129|129.0||||||
3910450|NCT01462942|3733719|B4||Female|Gender||Participants|Count of Participants|129|129.0||||||
3910451|NCT01462942|3733720|B3||Female|Gender||Participants|Count of Participants|122|122.0||||||
3910452|NCT01462942|3733721|B2||Female|Gender||Participants|Count of Participants|124|124.0||||||
3910453|NCT01462942|3733722|B1||Female|Gender||Participants|Count of Participants|56|56.0||||||
3910454|NCT01462942|3733717|B6|||Age||Years|Mean|63.2|63.2|Standard Deviation|8.0|8.0|||
3910455|NCT01462942|3733718|B5|||Age||Years|Mean|63.4|63.4|Standard Deviation|7.8|7.8|||
3910456|NCT01462942|3733719|B4|||Age||Years|Mean|63.1|63.1|Standard Deviation|8.2|8.2|||
3910457|NCT01462942|3733720|B3|||Age||Years|Mean|62.9|62.9|Standard Deviation|7.7|7.7|||
3910458|NCT01462942|3733721|B2|||Age||Years|Mean|62.7|62.7|Standard Deviation|8.1|8.1|||
3910459|NCT01462942|3733722|B1|||Age||Years|Mean|64.2|64.2|Standard Deviation|8.0|8.0|||
3910460|NCT01462929|3733753|B4|Germany||Region of Enrollment||participants|Number|205|205.0||||||
3910461|NCT01462929|3733754|B3|Germany||Region of Enrollment||participants|Number|40|40.0||||||
3910462|NCT01462929|3733755|B2|Germany||Region of Enrollment||participants|Number|81|81.0||||||
3910463|NCT01462929|3733756|B1|Germany||Region of Enrollment||participants|Number|84|84.0||||||
3910464|NCT01462929|3733753|B4|Poland||Region of Enrollment||participants|Number|154|154.0||||||
3910465|NCT01462929|3733754|B3|Poland||Region of Enrollment||participants|Number|32|32.0||||||
3910466|NCT01462929|3733755|B2|Poland||Region of Enrollment||participants|Number|58|58.0||||||
3910467|NCT01462929|3733756|B1|Poland||Region of Enrollment||participants|Number|64|64.0||||||
3910468|NCT01462929|3733753|B4|Czech Republic||Region of Enrollment||participants|Number|11|11.0||||||
3910469|NCT01462929|3733754|B3|Czech Republic||Region of Enrollment||participants|Number|3|3.0||||||
3910470|NCT01462929|3733755|B2|Czech Republic||Region of Enrollment||participants|Number|3|3.0||||||
3910471|NCT01462929|3733756|B1|Czech Republic||Region of Enrollment||participants|Number|5|5.0||||||
3910472|NCT01462929|3733753|B4|Hungary||Region of Enrollment||participants|Number|44|44.0||||||
3910473|NCT01462929|3733754|B3|Hungary||Region of Enrollment||participants|Number|10|10.0||||||
3910474|NCT01462929|3733755|B2|Hungary||Region of Enrollment||participants|Number|16|16.0||||||
3910475|NCT01462929|3733756|B1|Hungary||Region of Enrollment||participants|Number|18|18.0||||||
3910476|NCT01462929|3733753|B4||Male|Gender||Participants|Count of Participants|278|278.0||||||
3910477|NCT01462929|3733754|B3||Male|Gender||Participants|Count of Participants|48|48.0||||||
3910478|NCT01462929|3733755|B2||Male|Gender||Participants|Count of Participants|116|116.0||||||
3910479|NCT01462929|3733756|B1||Male|Gender||Participants|Count of Participants|114|114.0||||||
3910480|NCT01462929|3733753|B4||Female|Gender||Participants|Count of Participants|136|136.0||||||
3910481|NCT01462929|3733754|B3||Female|Gender||Participants|Count of Participants|37|37.0||||||
3910482|NCT01462929|3733755|B2||Female|Gender||Participants|Count of Participants|42|42.0||||||
3910483|NCT01462929|3733756|B1||Female|Gender||Participants|Count of Participants|57|57.0||||||
3910484|NCT01462929|3733753|B4|||Age||years|Mean|62.3|62.3|Standard Deviation|8.1|8.1|||
3910485|NCT01462929|3733754|B3|||Age||years|Mean|62.2|62.2|Standard Deviation|8.2|8.2|||
3910486|NCT01462929|3733755|B2|||Age||years|Mean|62.8|62.8|Standard Deviation|7.9|7.9|||
3910487|NCT01462929|3733756|B1|||Age||years|Mean|61.8|61.8|Standard Deviation|8.2|8.2|||
3910488|NCT01462877|3733769|B1|||diastolic blood pressure||mmHg|Mean|78.54|78.54|Standard Deviation|8.97|8.97|||
3910489|NCT01462877|3733769|B1|||Systolic blood pressure||mmHg|Mean|130.93|130.93|Standard Deviation|12.50|12.5|||
3910490|NCT01462877|3733769|B1||Male|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
3910491|NCT01462877|3733769|B1||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
3910492|NCT01462877|3733769|B1|||Age||years|Mean|58|58.0|Standard Deviation|9.91|9.91|||
3910493|NCT01462812|3733783|B3|United States||Region of Enrollment||participants|Number|223|223.0||||||
3910494|NCT01462812|3733784|B2|United States||Region of Enrollment||participants|Number|112|112.0||||||
3910495|NCT01462812|3733785|B1|United States||Region of Enrollment||participants|Number|111|111.0||||||
3910496|NCT01462812|3733783|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3910497|NCT01462812|3733784|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3910498|NCT01462812|3733785|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3910499|NCT01462812|3733783|B3||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
3910500|NCT01462812|3733784|B2||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3910501|NCT01462812|3733785|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3910502|NCT01462812|3733783|B3|||Age||years|Mean|42.2|42.2|Standard Deviation|10.47|10.47|||
3910503|NCT01462812|3733784|B2|||Age||years|Mean|42.2|42.2|Standard Deviation|10.27|10.27|||
3910504|NCT01462812|3733785|B1|||Age||years|Mean|42.3|42.3|Standard Deviation|10.71|10.71|||
3910505|NCT01462812|3733783|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3910506|NCT01462812|3733784|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3910507|NCT01462812|3733785|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3910508|NCT01462812|3733783|B3||Between 18 and 65 years|Age||Participants|Count of Participants|223|223.0||||||
3910509|NCT01462812|3733784|B2||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
3910510|NCT01462812|3733785|B1||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
3910511|NCT01462812|3733783|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3910512|NCT01462812|3733784|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3910513|NCT01462812|3733785|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3910514|NCT01462773|3733792|B1|United States||Region of Enrollment||patients|Number|16|16.0||||||
3910515|NCT01462773|3733792|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3910516|NCT01462773|3733792|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3910517|NCT01462773|3733792|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3910518|NCT01462773|3733792|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3910519|NCT01462773|3733792|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3910520|NCT01462695|3733797|B3|Saudi Arabia||Region of Enrollment||participants|Number|1|1.0||||||
3910521|NCT01462695|3733798|B2|Saudi Arabia||Region of Enrollment||participants|Number|1|1.0||||||
3910522|NCT01462695|3733799|B1|Saudi Arabia||Region of Enrollment||participants|Number|0|0.0||||||
3910523|NCT01462695|3733797|B3|Australia||Region of Enrollment||participants|Number|1|1.0||||||
3910524|NCT01462695|3733798|B2|Australia||Region of Enrollment||participants|Number|1|1.0||||||
3910525|NCT01462695|3733799|B1|Australia||Region of Enrollment||participants|Number|0|0.0||||||
3910526|NCT01462695|3733797|B3|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3910527|NCT01462695|3733798|B2|Canada||Region of Enrollment||participants|Number|0|0.0||||||
3910528|NCT01462695|3733799|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3910529|NCT01462695|3733797|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
3910530|NCT01462695|3733798|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3910531|NCT01462695|3733799|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3910532|NCT01462695|3733797|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3910533|NCT01462695|3733798|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3910534|NCT01462695|3733799|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910535|NCT01462695|3733797|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910536|NCT01462695|3733798|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910537|NCT01462695|3733799|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910538|NCT01462695|3733797|B3||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3910539|NCT01462695|3733798|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3910540|NCT01462695|3733799|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3910541|NCT01462695|3733797|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3910542|NCT01462695|3733798|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910543|NCT01462695|3733799|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3910544|NCT01462695|3733797|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910545|NCT01462695|3733798|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910546|NCT01462695|3733799|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910547|NCT01462695|3733797|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910548|NCT01462695|3733798|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910549|NCT01462695|3733799|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910550|NCT01462695|3733797|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910551|NCT01462695|3733798|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910552|NCT01462695|3733799|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910553|NCT01462695|3733797|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3910554|NCT01462695|3733798|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3910555|NCT01462695|3733799|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3910556|NCT01462695|3733797|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3910557|NCT01462695|3733798|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3910558|NCT01462695|3733799|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3910559|NCT01462695|3733797|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3910560|NCT01462695|3733798|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3910561|NCT01462695|3733799|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3910562|NCT01462695|3733797|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3910563|NCT01462695|3733798|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3910564|NCT01462695|3733799|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3910565|NCT01462695|3733797|B3||<=18 years|Age||Participants|Count of Participants|29|29.0||||||
3910566|NCT01462695|3733798|B2||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
3910567|NCT01462695|3733799|B1||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
3910568|NCT01462695|3733797|B3|||Age||years|Median|13.4|13.4|Full Range|||3.0|19.9|
3910569|NCT01462695|3733798|B2|||Age||years|Median|12.0|12.0|Full Range|||3.0|16.9|
3910570|NCT01462695|3733799|B1|||Age||years|Median|14.2|14.2|Full Range|||4.7|19.9|
3910571|NCT01462565|3733806|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910572|NCT01462565|3733806|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3910573|NCT01462565|3733806|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3910574|NCT01462565|3733806|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3910575|NCT01462565|3733806|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3910576|NCT01462565|3733806|B1|||Age||Years|Mean|50.0|50.0|Standard Deviation|13.37|13.37|||
3910577|NCT01462435|3733824|B5|United States||Region of Enrollment||participants|Number|428|428.0||||||
3910578|NCT01462435|3733825|B4|United States||Region of Enrollment||participants|Number|106|106.0||||||
3910579|NCT01462435|3733826|B3|United States||Region of Enrollment||participants|Number|107|107.0||||||
3910580|NCT01462435|3733827|B2|United States||Region of Enrollment||participants|Number|109|109.0||||||
3910581|NCT01462435|3733828|B1|United States||Region of Enrollment||participants|Number|106|106.0||||||
3910582|NCT01462435|3733824|B5||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3910583|NCT01462435|3733825|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3910584|NCT01462435|3733826|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3910585|NCT01462435|3733827|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3910586|NCT01462435|3733828|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3910587|NCT01462435|3733824|B5||Female|Sex: Female, Male||Participants|Count of Participants|371|371.0||||||
3910588|NCT01462435|3733825|B4||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3910589|NCT01462435|3733826|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3910590|NCT01462435|3733827|B2||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3910591|NCT01462435|3733828|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3910592|NCT01462435|3733824|B5|||Age||years|Mean|39.7|39.7|Standard Deviation|12.0|12.0|||
3910593|NCT01462435|3733825|B4|||Age||years|Mean|39.9|39.9|Standard Deviation|12.6|12.6|||
3910594|NCT01462435|3733826|B3|||Age||years|Mean|39.3|39.3|Standard Deviation|11.8|11.8|||
3910595|NCT01462435|3733827|B2|||Age||years|Mean|39.4|39.4|Standard Deviation|11.7|11.7|||
3910596|NCT01462435|3733828|B1|||Age||years|Mean|40.3|40.3|Standard Deviation|11.9|11.9|||
3910597|NCT01462370|3733869|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3910598|NCT01462370|3733869|B1||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3910599|NCT01462370|3733869|B1|>=30 years||Age, Customized||Participants|Number|7|7.0||||||
3910600|NCT01462370|3733869|B1|21-29 years||Age, Customized||Participants|Number|118|118.0||||||
3910601|NCT01462370|3733869|B1|<=20 years||Age, Customized||Participants|Number|14|14.0||||||
3910602|NCT01462357|3733902|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3910603|NCT01462357|3733903|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3910604|NCT01462357|3733904|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3910605|NCT01462357|3733905|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3910606|NCT01462357|3733902|B4||Female|Sex: Female, Male||Participants|Count of Participants|1075|1075.0||||||
3910607|NCT01462357|3733903|B3||Female|Sex: Female, Male||Participants|Count of Participants|358|358.0||||||
3910608|NCT01462357|3733904|B2||Female|Sex: Female, Male||Participants|Count of Participants|358|358.0||||||
3910609|NCT01462357|3733905|B1||Female|Sex: Female, Male||Participants|Count of Participants|359|359.0||||||
3910610|NCT01462357|3733902|B4|||Age||Years|Mean|11.53|11.53|Standard Deviation|1.61|1.61|||
3910611|NCT01462357|3733903|B3|||Age||Years|Mean|11.6|11.6|Standard Deviation|1.64|1.64|||
3910612|NCT01462357|3733904|B2|||Age||Years|Mean|11.5|11.5|Standard Deviation|1.56|1.56|||
3910613|NCT01462357|3733905|B1|||Age||Years|Mean|11.5|11.5|Standard Deviation|1.64|1.64|||
3910614|NCT01462344|3733978|B3|Missing||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3910615|NCT01462344|3733979|B2|Missing||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3910616|NCT01462344|3733980|B1|Missing||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3910617|NCT01462344|3733978|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|347|347.0||||||
3910618|NCT01462344|3733979|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|180|180.0||||||
3910619|NCT01462344|3733980|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|167|167.0||||||
3910620|NCT01462344|3733978|B3|White - White / Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Number|4002|4002.0||||||
3910621|NCT01462344|3733979|B2|White - White / Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Number|2017|2017.0||||||
3910622|NCT01462344|3733980|B1|White - White / Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Number|1985|1985.0||||||
3910623|NCT01462344|3733978|B3|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Number|28|28.0||||||
3910624|NCT01462344|3733979|B2|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
3910625|NCT01462344|3733980|B1|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
3910626|NCT01462344|3733978|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3910627|NCT01462344|3733979|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3910628|NCT01462344|3733980|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3910629|NCT01462344|3733978|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|230|230.0||||||
3910630|NCT01462344|3733979|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|108|108.0||||||
3910631|NCT01462344|3733980|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|122|122.0||||||
3910632|NCT01462344|3733978|B3|Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3910633|NCT01462344|3733979|B2|Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3910634|NCT01462344|3733980|B1|Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3910635|NCT01462344|3733978|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|208|208.0||||||
3910636|NCT01462344|3733979|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|112|112.0||||||
3910637|NCT01462344|3733980|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|96|96.0||||||
3910638|NCT01462344|3733978|B3|Asian - Central / South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|67|67.0||||||
3910639|NCT01462344|3733979|B2|Asian - Central / South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
3910640|NCT01462344|3733980|B1|Asian - Central / South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
3910641|NCT01462344|3733978|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|262|262.0||||||
3910642|NCT01462344|3733979|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|118|118.0||||||
3910643|NCT01462344|3733980|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|144|144.0||||||
3910644|NCT01462344|3733978|B3|African American / African Heritage||Race/Ethnicity, Customized||Participants|Number|1050|1050.0||||||
3910645|NCT01462344|3733979|B2|African American / African Heritage||Race/Ethnicity, Customized||Participants|Number|511|511.0||||||
3910646|NCT01462344|3733980|B1|African American / African Heritage||Race/Ethnicity, Customized||Participants|Number|539|539.0||||||
3910647|NCT01462344|3733978|B3||Male|Sex: Female, Male||Participants|Count of Participants|3794|3794.0||||||
3910648|NCT01462344|3733979|B2||Male|Sex: Female, Male||Participants|Count of Participants|1874|1874.0||||||
3910649|NCT01462344|3733980|B1||Male|Sex: Female, Male||Participants|Count of Participants|1920|1920.0||||||
3910650|NCT01462344|3733978|B3||Female|Sex: Female, Male||Participants|Count of Participants|2414|2414.0||||||
3910651|NCT01462344|3733979|B2||Female|Sex: Female, Male||Participants|Count of Participants|1227|1227.0||||||
3910652|NCT01462344|3733980|B1||Female|Sex: Female, Male||Participants|Count of Participants|1187|1187.0||||||
3910653|NCT01462344|3733978|B3|||Age||Years|Mean|7.6|7.6|Standard Deviation|2.20|2.2|||
3910654|NCT01462344|3733979|B2|||Age||Years|Mean|7.6|7.6|Standard Deviation|2.20|2.2|||
3910655|NCT01462344|3733980|B1|||Age||Years|Mean|7.6|7.6|Standard Deviation|2.21|2.21|||
3910656|NCT01462318|3734001|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3910657|NCT01462318|3734002|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3910658|NCT01462318|3734003|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3910659|NCT01462318|3734001|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3910660|NCT01462318|3734002|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3910661|NCT01462318|3734003|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3910662|NCT01462318|3734001|B3|> 55 years||Age, Customized||participants|Number|0|0.0||||||
3910663|NCT01462318|3734002|B2|> 55 years||Age, Customized||participants|Number|0|0.0||||||
3910664|NCT01462318|3734003|B1|> 55 years||Age, Customized||participants|Number|0|0.0||||||
3910665|NCT01462318|3734001|B3|50 - 55 years||Age, Customized||participants|Number|17|17.0||||||
3910666|NCT01462318|3734002|B2|50 - 55 years||Age, Customized||participants|Number|3|3.0||||||
3910667|NCT01462318|3734003|B1|50 - 55 years||Age, Customized||participants|Number|14|14.0||||||
3910668|NCT01462318|3734001|B3|40 - 49 years||Age, Customized||participants|Number|36|36.0||||||
3910669|NCT01462318|3734002|B2|40 - 49 years||Age, Customized||participants|Number|5|5.0||||||
3910670|NCT01462318|3734003|B1|40 - 49 years||Age, Customized||participants|Number|31|31.0||||||
3910671|NCT01462318|3734001|B3|30 - 39 years||Age, Customized||participants|Number|47|47.0||||||
3910672|NCT01462318|3734002|B2|30 - 39 years||Age, Customized||participants|Number|7|7.0||||||
3910673|NCT01462318|3734003|B1|30 - 39 years||Age, Customized||participants|Number|40|40.0||||||
3910674|NCT01462318|3734001|B3|20 - 29 years||Age, Customized||participants|Number|32|32.0||||||
3910675|NCT01462318|3734002|B2|20 - 29 years||Age, Customized||participants|Number|4|4.0||||||
3910676|NCT01462318|3734003|B1|20 - 29 years||Age, Customized||participants|Number|28|28.0||||||
3910677|NCT01462318|3734001|B3|18 - 19 years||Age, Customized||participants|Number|1|1.0||||||
3910678|NCT01462318|3734002|B2|18 - 19 years||Age, Customized||participants|Number|1|1.0||||||
3910679|NCT01462318|3734003|B1|18 - 19 years||Age, Customized||participants|Number|0|0.0||||||
3910680|NCT01462318|3734001|B3|< 18 years||Age, Customized||participants|Number|0|0.0||||||
3910681|NCT01462318|3734002|B2|< 18 years||Age, Customized||participants|Number|0|0.0||||||
3910682|NCT01462318|3734003|B1|< 18 years||Age, Customized||participants|Number|0|0.0||||||
3910683|NCT01462292|3734022|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910684|NCT01462292|3734023|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910685|NCT01462292|3734024|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910686|NCT01462292|3734025|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910687|NCT01462292|3734022|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3910688|NCT01462292|3734023|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910689|NCT01462292|3734024|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910690|NCT01462292|3734025|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3910691|NCT01462292|3734022|B4||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3910692|NCT01462292|3734023|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3910693|NCT01462292|3734024|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3910694|NCT01462292|3734025|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3910695|NCT01462292|3734022|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3910696|NCT01462292|3734023|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3910697|NCT01462292|3734024|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3910698|NCT01462292|3734025|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3910699|NCT01462292|3734022|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910700|NCT01462292|3734023|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910701|NCT01462292|3734024|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910702|NCT01462292|3734025|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910703|NCT01462292|3734022|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3910704|NCT01462292|3734023|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3910705|NCT01462292|3734024|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910706|NCT01462292|3734025|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910707|NCT01462292|3734022|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910708|NCT01462292|3734023|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910709|NCT01462292|3734024|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910710|NCT01462292|3734025|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910711|NCT01462292|3734022|B4||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3910712|NCT01462292|3734023|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3910713|NCT01462292|3734024|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3910714|NCT01462292|3734025|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3910715|NCT01462292|3734022|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3910716|NCT01462292|3734023|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3910717|NCT01462292|3734024|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3910718|NCT01462292|3734025|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3910719|NCT01462292|3734022|B4|||Age||years|Mean|7.8|7.8|Standard Deviation|2.15|2.15|||
3910720|NCT01462292|3734023|B3|||Age||years|Mean|7.6|7.6|Standard Deviation|2.70|2.7|||
3910721|NCT01462292|3734024|B2|||Age||years|Mean|7.8|7.8|Standard Deviation|1.91|1.91|||
3910722|NCT01462292|3734025|B1|||Age||years|Mean|8.0|8.0|Standard Deviation|1.79|1.79|||
3910723|NCT01462279|3734086|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3910724|NCT01462279|3734086|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910725|NCT01462279|3734086|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910726|NCT01462279|3734086|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3910727|NCT01462279|3734086|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3910728|NCT01462279|3734086|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910729|NCT01462279|3734086|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3910730|NCT01462279|3734086|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910731|NCT01462279|3734086|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3910732|NCT01462279|3734086|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3910733|NCT01462279|3734086|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910734|NCT01462279|3734086|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3910735|NCT01462279|3734086|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3910736|NCT01462279|3734086|B1|||Age||years|Mean|66|66.0|Standard Deviation|17|17.0|||
3910737|NCT01462266|3734091|B3||Male|Sex: Female, Male||Participants|Count of Participants|315|315.0||||||
3910738|NCT01462266|3734092|B2||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3910739|NCT01462266|3734093|B1||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3910740|NCT01462266|3734091|B3||Female|Sex: Female, Male||Participants|Count of Participants|343|343.0||||||
3910741|NCT01462266|3734092|B2||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3910742|NCT01462266|3734093|B1||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
3910743|NCT01462266|3734091|B3|||Age||Years|Mean|58.8|58.8|Standard Deviation|9.3|9.3|||
3910744|NCT01462266|3734092|B2|||Age||Years|Mean|58.3|58.3|Standard Deviation|9.7|9.7|||
3910745|NCT01462266|3734093|B1|||Age||Years|Mean|59.3|59.3|Standard Deviation|8.9|8.9|||
3910746|NCT01462227|3734108|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3910747|NCT01462227|3734109|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3910748|NCT01462227|3734110|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3910749|NCT01462227|3734108|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3910750|NCT01462227|3734109|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3910751|NCT01462227|3734110|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3910752|NCT01462227|3734108|B3|||Age||years|Mean|32.4|32.4|Standard Deviation|11|11.0|||
3910753|NCT01462227|3734109|B2|||Age||years|Mean|32.4|32.4|Standard Deviation|12|12.0|||
3910754|NCT01462227|3734110|B1|||Age||years|Mean|32.3|32.3|Standard Deviation|11|11.0|||
3910755|NCT01462162|3734131|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3910756|NCT01462162|3734131|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3910757|NCT01462162|3734131|B1|||Age||years|Mean|52.2|52.2|Standard Deviation|12.6|12.6|||
3910758|NCT01462084|3734156|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3910759|NCT01462084|3734156|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3910760|NCT01462084|3734156|B1|||Age||years|Mean|52.9|52.9|Full Range|||24.0|76.0|
3910761|NCT01462045|3734165|B4|United States||Region of Enrollment||participants|Number|29|29.0||||||
3910762|NCT01462045|3734166|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
3910763|NCT01462045|3734167|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3910764|NCT01462045|3734168|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3910765|NCT01462045|3734165|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3910766|NCT01462045|3734166|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3910767|NCT01462045|3734167|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3910768|NCT01462045|3734168|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3910769|NCT01462045|3734165|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3910770|NCT01462045|3734166|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3910771|NCT01462045|3734167|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3910772|NCT01462045|3734168|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3910773|NCT01462045|3734165|B4|||Age||years|Mean|46|46.0|Standard Deviation|10.1|10.1|||
3910774|NCT01462045|3734166|B3|||Age||years|Mean|44|44.0|Standard Deviation|15.1|15.1|||
3910775|NCT01462045|3734167|B2|||Age||years|Mean|45|45.0|Standard Deviation|9.9|9.9|||
3910776|NCT01462045|3734168|B1|||Age||years|Mean|49|49.0|Standard Deviation|6.4|6.4|||
3910777|NCT01462045|3734165|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3910778|NCT01462045|3734166|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3910779|NCT01462045|3734167|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3910780|NCT01462045|3734168|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3910781|NCT01462045|3734165|B4||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3910782|NCT01462045|3734166|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3910783|NCT01462045|3734167|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3910784|NCT01462045|3734168|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3910785|NCT01462045|3734165|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3910786|NCT01462045|3734166|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3910787|NCT01462045|3734167|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3910788|NCT01462045|3734168|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3910789|NCT01461993|3734181|B4||Male|Sex: Female, Male||Participants|Count of Participants|1656|1656.0||||||
3910790|NCT01461993|3734182|B3||Male|Sex: Female, Male||Participants|Count of Participants|332|332.0||||||
3910791|NCT01461993|3734183|B2||Male|Sex: Female, Male||Participants|Count of Participants|666|666.0||||||
3910792|NCT01461993|3734184|B1||Male|Sex: Female, Male||Participants|Count of Participants|658|658.0||||||
3910793|NCT01461993|3734181|B4||Female|Sex: Female, Male||Participants|Count of Participants|843|843.0||||||
3910794|NCT01461993|3734182|B3||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
3910795|NCT01461993|3734183|B2||Female|Sex: Female, Male||Participants|Count of Participants|332|332.0||||||
3910796|NCT01461993|3734184|B1||Female|Sex: Female, Male||Participants|Count of Participants|341|341.0||||||
3910797|NCT01461993|3734181|B4|15 - <18 years||Age, Customized||participants|Number|849|849.0||||||
3910798|NCT01461993|3734182|B3|15 - <18 years||Age, Customized||participants|Number|159|159.0||||||
3910799|NCT01461993|3734183|B2|15 - <18 years||Age, Customized||participants|Number|338|338.0||||||
3910800|NCT01461993|3734184|B1|15 - <18 years||Age, Customized||participants|Number|352|352.0||||||
3910801|NCT01461993|3734181|B4|11 - less than (<) 15 years||Age, Customized||participants|Number|1650|1650.0||||||
3910802|NCT01461993|3734182|B3|11 - less than (<) 15 years||Age, Customized||participants|Number|343|343.0||||||
3910803|NCT01461993|3734183|B2|11 - less than (<) 15 years||Age, Customized||participants|Number|660|660.0||||||
3910804|NCT01461993|3734184|B1|11 - less than (<) 15 years||Age, Customized||participants|Number|647|647.0||||||
3910805|NCT01461980|3734208|B4||Male|Sex: Female, Male||Participants|Count of Participants|1350|1350.0||||||
3910806|NCT01461980|3734209|B3||Male|Sex: Female, Male||Participants|Count of Participants|465|465.0||||||
3910807|NCT01461980|3734210|B2||Male|Sex: Female, Male||Participants|Count of Participants|451|451.0||||||
3910808|NCT01461980|3734211|B1||Male|Sex: Female, Male||Participants|Count of Participants|434|434.0||||||
3910809|NCT01461980|3734208|B4||Female|Sex: Female, Male||Participants|Count of Participants|1298|1298.0||||||
3910810|NCT01461980|3734209|B3||Female|Sex: Female, Male||Participants|Count of Participants|417|417.0||||||
3910811|NCT01461980|3734210|B2||Female|Sex: Female, Male||Participants|Count of Participants|427|427.0||||||
3910812|NCT01461980|3734211|B1||Female|Sex: Female, Male||Participants|Count of Participants|454|454.0||||||
3910813|NCT01461980|3734208|B4|||Age||Years|Mean|10.6|10.6|Standard Deviation|0.69|0.69|||
3910814|NCT01461980|3734209|B3|||Age||Years|Mean|10.6|10.6|Standard Deviation|0.67|0.67|||
3910815|NCT01461980|3734210|B2|||Age||Years|Mean|10.6|10.6|Standard Deviation|0.69|0.69|||
3910816|NCT01461980|3734211|B1|||Age||Years|Mean|10.6|10.6|Standard Deviation|0.70|0.7|||
3910817|NCT01461863|3734243|B3|Tanzania||Region of Enrollment||Participants|Count of Participants|96|96.0||||||
3910818|NCT01461863|3734244|B2|Tanzania||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
3910819|NCT01461863|3734245|B1|Tanzania||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
3910820|NCT01461863|3734243|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910821|NCT01461863|3734244|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910822|NCT01461863|3734245|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910823|NCT01461863|3734243|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910824|NCT01461863|3734244|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910825|NCT01461863|3734245|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910826|NCT01461863|3734243|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910827|NCT01461863|3734244|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910828|NCT01461863|3734245|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910829|NCT01461863|3734243|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3910830|NCT01461863|3734244|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3910831|NCT01461863|3734245|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3910832|NCT01461863|3734243|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910833|NCT01461863|3734244|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910834|NCT01461863|3734245|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910835|NCT01461863|3734243|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910836|NCT01461863|3734244|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910837|NCT01461863|3734245|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910838|NCT01461863|3734243|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910839|NCT01461863|3734244|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910840|NCT01461863|3734245|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910841|NCT01461863|3734243|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3910842|NCT01461863|3734244|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3910843|NCT01461863|3734245|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3910844|NCT01461863|3734243|B3||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3910845|NCT01461863|3734244|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3910846|NCT01461863|3734245|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3910847|NCT01461863|3734243|B3|18 to 65 years||Age, Customized||Participants|Count of Participants|96|96.0||||||
3910848|NCT01461863|3734244|B2|18 to 65 years||Age, Customized||Participants|Count of Participants|48|48.0||||||
3910849|NCT01461863|3734245|B1|18 to 65 years||Age, Customized||Participants|Count of Participants|48|48.0||||||
3910850|NCT01461824|3734254|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910851|NCT01461824|3734255|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910852|NCT01461824|3734256|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910853|NCT01461824|3734257|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910854|NCT01461824|3734254|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910855|NCT01461824|3734255|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910856|NCT01461824|3734256|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910857|NCT01461824|3734257|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910858|NCT01461824|3734254|B4||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3910859|NCT01461824|3734255|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3910860|NCT01461824|3734256|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3910861|NCT01461824|3734257|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3910862|NCT01461824|3734254|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3910863|NCT01461824|3734255|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3910864|NCT01461824|3734256|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3910865|NCT01461824|3734257|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3910866|NCT01461824|3734254|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910867|NCT01461824|3734255|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910868|NCT01461824|3734256|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910869|NCT01461824|3734257|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910870|NCT01461824|3734254|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910871|NCT01461824|3734255|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910872|NCT01461824|3734256|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910873|NCT01461824|3734257|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910874|NCT01461824|3734254|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910875|NCT01461824|3734255|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910876|NCT01461824|3734256|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910877|NCT01461824|3734257|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910878|NCT01461824|3734254|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3910879|NCT01461824|3734255|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3910880|NCT01461824|3734256|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3910881|NCT01461824|3734257|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3910882|NCT01461824|3734254|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3910883|NCT01461824|3734255|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3910884|NCT01461824|3734256|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3910885|NCT01461824|3734257|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3910886|NCT01461824|3734254|B4|||Age||years|Mean|18.6|18.6|Standard Deviation|2.51|2.51|||
3910887|NCT01461824|3734255|B3|||Age||years|Mean|19.0|19.0|Standard Deviation|2.43|2.43|||
3910888|NCT01461824|3734256|B2|||Age||years|Mean|18.3|18.3|Standard Deviation|2.65|2.65|||
3910889|NCT01461824|3734257|B1|||Age||years|Mean|18.6|18.6|Standard Deviation|2.1|2.1|||
3910890|NCT01461811|3734273|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3910891|NCT01461811|3734274|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3910892|NCT01461811|3734275|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3910893|NCT01461811|3734273|B3||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3910894|NCT01461811|3734274|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3910895|NCT01461811|3734275|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3910896|NCT01461811|3734273|B3|||Age||years|Mean|34.9|34.9|Standard Deviation|12.2|12.2|||
3910897|NCT01461811|3734274|B2|||Age||years|Mean|37.2|37.2|Standard Deviation|11.4|11.4|||
3910898|NCT01461811|3734275|B1|||Age||years|Mean|33.6|33.6|Standard Deviation|12.5|12.5|||
3910899|NCT01461733|3734304|B3|Canada||Region of Enrollment||participants|Number|24|24.0||||||
3910900|NCT01461733|3734305|B2|Canada||Region of Enrollment||participants|Number|12|12.0||||||
3910901|NCT01461733|3734306|B1|Canada||Region of Enrollment||participants|Number|12|12.0||||||
3910902|NCT01461733|3734304|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3910903|NCT01461733|3734305|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3910904|NCT01461733|3734306|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3910905|NCT01461733|3734304|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3910906|NCT01461733|3734305|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3910907|NCT01461733|3734306|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3910908|NCT01461733|3734304|B3|||Age||years|Mean|65|65.0|Standard Deviation|17|17.0|||
3910909|NCT01461733|3734305|B2|||Age||years|Mean|61|61.0|Standard Deviation|17|17.0|||
3910910|NCT01461733|3734306|B1|||Age||years|Mean|70|70.0|Standard Deviation|17|17.0|||
3910911|NCT01461707|3734313|B3|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3910912|NCT01461707|3734314|B2|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3910913|NCT01461707|3734315|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3910914|NCT01461707|3734313|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3910915|NCT01461707|3734314|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3910916|NCT01461707|3734315|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3910917|NCT01461707|3734313|B3|Race|Hispanic/Latina|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3910918|NCT01461707|3734314|B2|Race|Hispanic/Latina|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3910919|NCT01461707|3734315|B1|Race|Hispanic/Latina|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3910920|NCT01461707|3734313|B3|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3910921|NCT01461707|3734314|B2|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3910922|NCT01461707|3734315|B1|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3910923|NCT01461707|3734313|B3|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3910924|NCT01461707|3734314|B2|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3910925|NCT01461707|3734315|B1|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3910926|NCT01461707|3734313|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3910927|NCT01461707|3734314|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3910928|NCT01461707|3734315|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3910929|NCT01461707|3734313|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3910930|NCT01461707|3734314|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3910931|NCT01461707|3734315|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3910932|NCT01461707|3734313|B3|||Age||years|Mean|33.7|33.7|Standard Deviation|2.6|2.6|||
3910933|NCT01461707|3734314|B2|||Age||years|Mean|34.5|34.5|Standard Deviation|2.5|2.5|||
3910934|NCT01461707|3734315|B1|||Age||years|Mean|32.9|32.9|Standard Deviation|2.5|2.5|||
3910935|NCT01461707|3734313|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3910936|NCT01461707|3734314|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3910937|NCT01461707|3734315|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3910938|NCT01461707|3734313|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3910939|NCT01461707|3734314|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3910940|NCT01461707|3734315|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3910941|NCT01461707|3734313|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3910942|NCT01461707|3734314|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3910943|NCT01461707|3734315|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3910944|NCT01461668|3734324|B3|United States||Region of Enrollment||Participants|Count of Participants|53|53.0||||||
3910945|NCT01461668|3734325|B2|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3910946|NCT01461668|3734326|B1|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3910947|NCT01461668|3734324|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910948|NCT01461668|3734325|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910949|NCT01461668|3734326|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910950|NCT01461668|3734324|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910951|NCT01461668|3734325|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910952|NCT01461668|3734326|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910953|NCT01461668|3734324|B3||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3910954|NCT01461668|3734325|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3910955|NCT01461668|3734326|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3910956|NCT01461668|3734324|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3910957|NCT01461668|3734325|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3910958|NCT01461668|3734326|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3910959|NCT01461668|3734324|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910960|NCT01461668|3734325|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910961|NCT01461668|3734326|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910962|NCT01461668|3734324|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3910963|NCT01461668|3734325|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3910964|NCT01461668|3734326|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3910965|NCT01461668|3734324|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910966|NCT01461668|3734325|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910967|NCT01461668|3734326|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910968|NCT01461668|3734324|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910969|NCT01461668|3734325|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910970|NCT01461668|3734326|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3910971|NCT01461668|3734324|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3910972|NCT01461668|3734325|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3910973|NCT01461668|3734326|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3910974|NCT01461668|3734324|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3910975|NCT01461668|3734325|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3910976|NCT01461668|3734326|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3910977|NCT01461668|3734324|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3910978|NCT01461668|3734325|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3910979|NCT01461668|3734326|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3910980|NCT01461668|3734324|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3910981|NCT01461668|3734325|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3910982|NCT01461668|3734326|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3910983|NCT01461668|3734324|B3|||Age||years|Mean|59.7|59.7|Standard Deviation|16.4|16.4|||
3910984|NCT01461668|3734325|B2|||Age||years|Mean|59.0|59.0|Standard Deviation|16.2|16.2|||
3910985|NCT01461668|3734326|B1|||Age||years|Mean|60.3|60.3|Standard Deviation|16.9|16.9|||
3910986|NCT01461655|3734333|B1|France||Region of Enrollment||participants|Number|40|40.0||||||
3910987|NCT01461655|3734333|B1||Male|Gender||Participants|Count of Participants|17|17.0||||||
3910988|NCT01461655|3734333|B1||Female|Gender||Participants|Count of Participants|23|23.0||||||
3910989|NCT01461655|3734333|B1|||Age||years|Mean|23.7|23.7|Standard Deviation|4.2|4.2|||
3910990|NCT01461655|3734333|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3910991|NCT01461655|3734333|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3910992|NCT01461655|3734333|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3910993|NCT01461551|3734350|B4|China||Region of Enrollment||participants|Number|100|100.0||||||
3910994|NCT01461551|3734351|B3|China||Region of Enrollment||participants|Number|33|33.0||||||
3910995|NCT01461551|3734352|B2|China||Region of Enrollment||participants|Number|34|34.0||||||
3910996|NCT01461551|3734353|B1|China||Region of Enrollment||participants|Number|33|33.0||||||
3910997|NCT01461551|3734350|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3910998|NCT01461551|3734351|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3910999|NCT01461551|3734352|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3911000|NCT01461551|3734353|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3911001|NCT01461551|3734350|B4||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3911002|NCT01461551|3734351|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3911003|NCT01461551|3734352|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3911004|NCT01461551|3734353|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3911005|NCT01461551|3734350|B4|||Age||years|Mean|63|63.0|Standard Deviation|8|8.0|||
3911006|NCT01461551|3734351|B3|||Age||years|Mean|65|65.0|Standard Deviation|9|9.0|||
3911007|NCT01461551|3734352|B2|||Age||years|Mean|62|62.0|Standard Deviation|8|8.0|||
3911008|NCT01461551|3734353|B1|||Age||years|Mean|61|61.0|Standard Deviation|8|8.0|||
3911009|NCT01461538|3734363|B4|||Body Mass Index||kg per meter squared (kg/m^2)|Median|26.0|26.0|Full Range|||18.0|47.0|
3911010|NCT01461538|3734364|B3|||Body Mass Index||kg per meter squared (kg/m^2)|Median|26.3|26.3|Full Range|||20.0|47.0|
3911011|NCT01461538|3734365|B2|||Body Mass Index||kg per meter squared (kg/m^2)|Median|27.4|27.4|Full Range|||18.0|36.0|
3911012|NCT01461538|3734366|B1|||Body Mass Index||kg per meter squared (kg/m^2)|Median|25.3|25.3|Full Range|||19.0|40.0|
3911013|NCT01461538|3734363|B4|||Weight||kilograms (kg)|Median|74.8|74.8|Full Range|||45.0|137.0|
3911014|NCT01461538|3734364|B3|||Weight||kilograms (kg)|Median|73.4|73.4|Full Range|||45.0|137.0|
3911015|NCT01461538|3734365|B2|||Weight||kilograms (kg)|Median|75.1|75.1|Full Range|||49.0|104.0|
3911016|NCT01461538|3734366|B1|||Weight||kilograms (kg)|Median|74.8|74.8|Full Range|||46.0|109.0|
3911017|NCT01461538|3734363|B4|||Height||centimeters (cm)|Median|170.2|170.2|Full Range|||142.0|188.0|
3911018|NCT01461538|3734364|B3|||Height||centimeters (cm)|Median|167.6|167.6|Full Range|||144.0|180.0|
3911019|NCT01461538|3734365|B2|||Height||centimeters (cm)|Median|171.9|171.9|Full Range|||150.0|186.0|
3911020|NCT01461538|3734366|B1|||Height||centimeters (cm)|Median|170.2|170.2|Full Range|||142.0|188.0|
3911021|NCT01461538|3734363|B4|Missing||Eastern Cooperative Oncology Group Performance Status|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|23|23.0||||||
3911022|NCT01461538|3734364|B3|Missing||Eastern Cooperative Oncology Group Performance Status|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|2|2.0||||||
3911023|NCT01461538|3734365|B2|Missing||Eastern Cooperative Oncology Group Performance Status|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|8|8.0||||||
3911024|NCT01461538|3734366|B1|Missing||Eastern Cooperative Oncology Group Performance Status|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|13|13.0||||||
3911025|NCT01461538|3734363|B4|3-5||Eastern Cooperative Oncology Group Performance Status|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|0|0.0||||||
3911026|NCT01461538|3734364|B3|3-5||Eastern Cooperative Oncology Group Performance Status|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|0|0.0||||||
3911027|NCT01461538|3734365|B2|3-5||Eastern Cooperative Oncology Group Performance Status|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|0|0.0||||||
3911028|NCT01461538|3734366|B1|3-5||Eastern Cooperative Oncology Group Performance Status|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|0|0.0||||||
3911029|NCT01461538|3734363|B4|2||Eastern Cooperative Oncology Group Performance Status|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|1|1.0||||||
3911030|NCT01461538|3734364|B3|2||Eastern Cooperative Oncology Group Performance Status|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|1|1.0||||||
3911031|NCT01461538|3734365|B2|2||Eastern Cooperative Oncology Group Performance Status|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|0|0.0||||||
3911032|NCT01461538|3734366|B1|2||Eastern Cooperative Oncology Group Performance Status|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|0|0.0||||||
3911033|NCT01461538|3734363|B4|1||Eastern Cooperative Oncology Group Performance Status|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|40|40.0||||||
3911034|NCT01461538|3734364|B3|1||Eastern Cooperative Oncology Group Performance Status|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|5|5.0||||||
3911035|NCT01461538|3734365|B2|1||Eastern Cooperative Oncology Group Performance Status|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|15|15.0||||||
3911036|NCT01461538|3734366|B1|1||Eastern Cooperative Oncology Group Performance Status|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|20|20.0||||||
3911037|NCT01461538|3734363|B4|0||Eastern Cooperative Oncology Group Performance Status|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|19|19.0||||||
3911038|NCT01461538|3734364|B3|0||Eastern Cooperative Oncology Group Performance Status|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|1|1.0||||||
3911094|NCT01461538|3734364|B3|||Age||years|Median|76|76.0|Full Range|||33.0|87.0|
3911095|NCT01461538|3734365|B2|||Age||years|Median|64|64.0|Full Range|||18.0|85.0|
3911039|NCT01461538|3734365|B2|0||Eastern Cooperative Oncology Group Performance Status|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|5|5.0||||||
3911040|NCT01461538|3734366|B1|0||Eastern Cooperative Oncology Group Performance Status|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|13|13.0||||||
3911041|NCT01461538|3734363|B4|United States||Region of Enrollment||participants|Number|83|83.0||||||
3911042|NCT01461538|3734364|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
3911043|NCT01461538|3734365|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
3911044|NCT01461538|3734366|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
3911045|NCT01461538|3734363|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3911046|NCT01461538|3734364|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911047|NCT01461538|3734365|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3911048|NCT01461538|3734366|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3911049|NCT01461538|3734363|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911050|NCT01461538|3734364|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911051|NCT01461538|3734365|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911052|NCT01461538|3734366|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911053|NCT01461538|3734363|B4||White|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
3911054|NCT01461538|3734364|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3911055|NCT01461538|3734365|B2||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3911056|NCT01461538|3734366|B1||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3911057|NCT01461538|3734363|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3911058|NCT01461538|3734364|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911059|NCT01461538|3734365|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911060|NCT01461538|3734366|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3911061|NCT01461538|3734363|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911062|NCT01461538|3734364|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911063|NCT01461538|3734365|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911064|NCT01461538|3734366|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911065|NCT01461538|3734363|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3911066|NCT01461538|3734364|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911067|NCT01461538|3734365|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3911068|NCT01461538|3734366|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3911069|NCT01461538|3734363|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911070|NCT01461538|3734364|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911071|NCT01461538|3734365|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911072|NCT01461538|3734366|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911073|NCT01461538|3734363|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911074|NCT01461538|3734364|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911075|NCT01461538|3734365|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911076|NCT01461538|3734366|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911077|NCT01461538|3734363|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3911078|NCT01461538|3734364|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3911079|NCT01461538|3734365|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3911080|NCT01461538|3734366|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3911081|NCT01461538|3734363|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3911082|NCT01461538|3734364|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911083|NCT01461538|3734365|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3911084|NCT01461538|3734366|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3911085|NCT01461538|3734363|B4||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3911086|NCT01461538|3734364|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3911087|NCT01461538|3734365|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3911088|NCT01461538|3734366|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3911089|NCT01461538|3734363|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3911090|NCT01461538|3734364|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3911091|NCT01461538|3734365|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3911092|NCT01461538|3734366|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3911093|NCT01461538|3734363|B4|||Age||years|Median|65|65.0|Full Range|||18.0|87.0|
3911096|NCT01461538|3734366|B1|||Age||years|Median|64|64.0|Full Range|||24.0|85.0|
3911097|NCT01461499|3734404|B3|Japan||Region of Enrollment||participants|Number|225|225.0||||||
3911098|NCT01461499|3734405|B2|Japan||Region of Enrollment||participants|Number|114|114.0||||||
3911099|NCT01461499|3734406|B1|Japan||Region of Enrollment||participants|Number|111|111.0||||||
3911100|NCT01461499|3734404|B3||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3911101|NCT01461499|3734405|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3911102|NCT01461499|3734406|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3911103|NCT01461499|3734404|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3911104|NCT01461499|3734405|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3911105|NCT01461499|3734406|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3911106|NCT01461499|3734404|B3|||Age||years|Mean|63.0|63.0|Standard Deviation|8.8|8.8|||
3911107|NCT01461499|3734405|B2|||Age||years|Mean|63.0|63.0|Standard Deviation|8.4|8.4|||
3911108|NCT01461499|3734406|B1|||Age||years|Mean|62.9|62.9|Standard Deviation|9.3|9.3|||
3911109|NCT01461499|3734404|B3||>=65 years|Age||Participants|Count of Participants|113|113.0||||||
3911110|NCT01461499|3734405|B2||>=65 years|Age||Participants|Count of Participants|57|57.0||||||
3911111|NCT01461499|3734406|B1||>=65 years|Age||Participants|Count of Participants|56|56.0||||||
3911112|NCT01461499|3734404|B3||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
3911113|NCT01461499|3734405|B2||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
3911114|NCT01461499|3734406|B1||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
3911115|NCT01461499|3734404|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3911116|NCT01461499|3734405|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3911117|NCT01461499|3734406|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3911118|NCT01461473|3734415|B3|United States||Region of Enrollment||participants|Number|131|131.0||||||
3911119|NCT01461473|3734416|B2|United States||Region of Enrollment||participants|Number|59|59.0||||||
3911120|NCT01461473|3734417|B1|United States||Region of Enrollment||participants|Number|72|72.0||||||
3911121|NCT01461473|3734415|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3911122|NCT01461473|3734416|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3911123|NCT01461473|3734417|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3911124|NCT01461473|3734415|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911125|NCT01461473|3734416|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911126|NCT01461473|3734417|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911127|NCT01461473|3734415|B3||White|Race (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
3911128|NCT01461473|3734416|B2||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3911129|NCT01461473|3734417|B1||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3911130|NCT01461473|3734415|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3911131|NCT01461473|3734416|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3911132|NCT01461473|3734417|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3911133|NCT01461473|3734415|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911134|NCT01461473|3734416|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911135|NCT01461473|3734417|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911136|NCT01461473|3734415|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3911137|NCT01461473|3734416|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3911138|NCT01461473|3734417|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3911139|NCT01461473|3734415|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911140|NCT01461473|3734416|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911141|NCT01461473|3734417|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911142|NCT01461473|3734415|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911143|NCT01461473|3734416|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911144|NCT01461473|3734417|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911145|NCT01461473|3734415|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
3911146|NCT01461473|3734416|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3911147|NCT01461473|3734417|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3911148|NCT01461473|3734415|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3911149|NCT01461473|3734416|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3911150|NCT01461473|3734417|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3911151|NCT01461473|3734415|B3||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3911152|NCT01461473|3734416|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3911153|NCT01461473|3734417|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3911154|NCT01461473|3734415|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3911155|NCT01461473|3734416|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3911156|NCT01461473|3734417|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3911157|NCT01461473|3734415|B3|||Age||years|Mean|53.84|53.84|Standard Deviation|11.20|11.2|||
3911158|NCT01461473|3734416|B2|||Age||years|Mean|52.61|52.61|Standard Deviation|9.84|9.84|||
3911159|NCT01461473|3734417|B1|||Age||years|Mean|54.85|54.85|Standard Deviation|12.17|12.17|||
3911160|NCT01461369|3734434|B4|||Baseline Pain Intensity Visual Analogue Scale Score|"The pain intensity is assessed using a visual analogue scale (VAS), which is a horizontal line 100 mm in length. Subjects mark the VAS with a single vertical line to indicate their current pain level, with 0 mm representing No Pain and 100 mm representing Worst Possible Pain.~The Baseline Pain Intensity VAS score was calculated for 100 subjects in the Diclofenac Test Capsules two times daily group, 94 subjects in the Diclofenac Test Capsules three times daily group, and 100 subjects in the placebo group."|mm|Mean|71.0|71.0|Standard Deviation|19.35|19.35|||
3911161|NCT01461369|3734435|B3|||Baseline Pain Intensity Visual Analogue Scale Score|"The pain intensity is assessed using a visual analogue scale (VAS), which is a horizontal line 100 mm in length. Subjects mark the VAS with a single vertical line to indicate their current pain level, with 0 mm representing No Pain and 100 mm representing Worst Possible Pain.~The Baseline Pain Intensity VAS score was calculated for 100 subjects in the Diclofenac Test Capsules two times daily group, 94 subjects in the Diclofenac Test Capsules three times daily group, and 100 subjects in the placebo group."|mm|Mean|71.5|71.5|Standard Deviation|18.82|18.82|||
3911162|NCT01461369|3734436|B2|||Baseline Pain Intensity Visual Analogue Scale Score|"The pain intensity is assessed using a visual analogue scale (VAS), which is a horizontal line 100 mm in length. Subjects mark the VAS with a single vertical line to indicate their current pain level, with 0 mm representing No Pain and 100 mm representing Worst Possible Pain.~The Baseline Pain Intensity VAS score was calculated for 100 subjects in the Diclofenac Test Capsules two times daily group, 94 subjects in the Diclofenac Test Capsules three times daily group, and 100 subjects in the placebo group."|mm|Mean|71.8|71.8|Standard Deviation|19.33|19.33|||
3911163|NCT01461369|3734437|B1|||Baseline Pain Intensity Visual Analogue Scale Score|"The pain intensity is assessed using a visual analogue scale (VAS), which is a horizontal line 100 mm in length. Subjects mark the VAS with a single vertical line to indicate their current pain level, with 0 mm representing No Pain and 100 mm representing Worst Possible Pain.~The Baseline Pain Intensity VAS score was calculated for 100 subjects in the Diclofenac Test Capsules two times daily group, 94 subjects in the Diclofenac Test Capsules three times daily group, and 100 subjects in the placebo group."|mm|Mean|69.6|69.6|Standard Deviation|19.99|19.99|||
3911164|NCT01461369|3734434|B4|||Baseline Total (Composite) Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Sc|"The pain, stiffness, and physical function in subjects with osteoarthritis were measured at baseline using the total (composite) Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scale. The total WOMAC score is the average of the mean visual analogue scale scores, with 0 mm meaning No Limitation and 100 mm meaning Extreme Limitation.~Baseline total (composite) WOMAC score was calculated for 100 subjects in the Diclofenac Test Capsules two times daily group, 94 subjects in the Diclofenac Test Capsules three times daily group, and 100 subjects in the placebo group."|mm|Mean|71.54|71.54|Standard Deviation|16.27|16.27|||
3911165|NCT01461369|3734435|B3|||Baseline Total (Composite) Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Sc|"The pain, stiffness, and physical function in subjects with osteoarthritis were measured at baseline using the total (composite) Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scale. The total WOMAC score is the average of the mean visual analogue scale scores, with 0 mm meaning No Limitation and 100 mm meaning Extreme Limitation.~Baseline total (composite) WOMAC score was calculated for 100 subjects in the Diclofenac Test Capsules two times daily group, 94 subjects in the Diclofenac Test Capsules three times daily group, and 100 subjects in the placebo group."|mm|Mean|71.60|71.6|Standard Deviation|17.24|17.24|||
3911166|NCT01461369|3734436|B2|||Baseline Total (Composite) Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Sc|"The pain, stiffness, and physical function in subjects with osteoarthritis were measured at baseline using the total (composite) Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scale. The total WOMAC score is the average of the mean visual analogue scale scores, with 0 mm meaning No Limitation and 100 mm meaning Extreme Limitation.~Baseline total (composite) WOMAC score was calculated for 100 subjects in the Diclofenac Test Capsules two times daily group, 94 subjects in the Diclofenac Test Capsules three times daily group, and 100 subjects in the placebo group."|mm|Mean|72.83|72.83|Standard Deviation|15.87|15.87|||
3911167|NCT01461369|3734437|B1|||Baseline Total (Composite) Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Sc|"The pain, stiffness, and physical function in subjects with osteoarthritis were measured at baseline using the total (composite) Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scale. The total WOMAC score is the average of the mean visual analogue scale scores, with 0 mm meaning No Limitation and 100 mm meaning Extreme Limitation.~Baseline total (composite) WOMAC score was calculated for 100 subjects in the Diclofenac Test Capsules two times daily group, 94 subjects in the Diclofenac Test Capsules three times daily group, and 100 subjects in the placebo group."|mm|Mean|70.26|70.26|Standard Deviation|15.69|15.69|||
3911168|NCT01461369|3734434|B4|||Baseline Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscale Score|"The pain in subjects with osteoarthritis was measured at baseline using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain subscale score. The WOMAC pain subscale score is calculated as the mean of the visual analogue scale (VAS) scores from 5 pain subscale questions. Subjects mark the VAS, which is a horizontal line 100 mm in length, with a single vertical line to indicate their pain level within the past 24 hours, with 0 mm representing No Pain and 100 mm representing Worst Possible Pain."|mm|Mean|74.93|74.93|Standard Deviation|15.61|15.61|||
3911201|NCT01461369|3734435|B3|Asian||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|0|0.0||||||
3911202|NCT01461369|3734436|B2|Asian||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|0|0.0||||||
3911203|NCT01461369|3734437|B1|Asian||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|0|0.0||||||
3911169|NCT01461369|3734435|B3|||Baseline Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscale Score|"The pain in subjects with osteoarthritis was measured at baseline using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain subscale score. The WOMAC pain subscale score is calculated as the mean of the visual analogue scale (VAS) scores from 5 pain subscale questions. Subjects mark the VAS, which is a horizontal line 100 mm in length, with a single vertical line to indicate their pain level within the past 24 hours, with 0 mm representing No Pain and 100 mm representing Worst Possible Pain."|mm|Mean|75.27|75.27|Standard Deviation|17.27|17.27|||
3911170|NCT01461369|3734436|B2|||Baseline Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscale Score|"The pain in subjects with osteoarthritis was measured at baseline using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain subscale score. The WOMAC pain subscale score is calculated as the mean of the visual analogue scale (VAS) scores from 5 pain subscale questions. Subjects mark the VAS, which is a horizontal line 100 mm in length, with a single vertical line to indicate their pain level within the past 24 hours, with 0 mm representing No Pain and 100 mm representing Worst Possible Pain."|mm|Mean|76.18|76.18|Standard Deviation|14.15|14.15|||
3911171|NCT01461369|3734437|B1|||Baseline Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscale Score|"The pain in subjects with osteoarthritis was measured at baseline using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain subscale score. The WOMAC pain subscale score is calculated as the mean of the visual analogue scale (VAS) scores from 5 pain subscale questions. Subjects mark the VAS, which is a horizontal line 100 mm in length, with a single vertical line to indicate their pain level within the past 24 hours, with 0 mm representing No Pain and 100 mm representing Worst Possible Pain."|mm|Mean|73.42|73.42|Standard Deviation|15.22|15.22|||
3911172|NCT01461369|3734434|B4|||Body Mass Index||kg/m^2|Mean|31.2|31.2|Standard Deviation|5.16|5.16|||
3911173|NCT01461369|3734435|B3|||Body Mass Index||kg/m^2|Mean|31.3|31.3|Standard Deviation|5.18|5.18|||
3911174|NCT01461369|3734436|B2|||Body Mass Index||kg/m^2|Mean|31.8|31.8|Standard Deviation|5.09|5.09|||
3911175|NCT01461369|3734437|B1|||Body Mass Index||kg/m^2|Mean|30.6|30.6|Standard Deviation|5.18|5.18|||
3911176|NCT01461369|3734434|B4|||Height||cm|Mean|168.76|168.76|Standard Deviation|9.898|9.898|||
3911177|NCT01461369|3734435|B3|||Height||cm|Mean|168.70|168.7|Standard Deviation|9.245|9.245|||
3911178|NCT01461369|3734436|B2|||Height||cm|Mean|167.60|167.6|Standard Deviation|9.794|9.794|||
3911179|NCT01461369|3734437|B1|||Height||cm|Mean|169.91|169.91|Standard Deviation|10.561|10.561|||
3911180|NCT01461369|3734434|B4|||Weight||kg|Mean|88.97|88.97|Standard Deviation|17.167|17.167|||
3911181|NCT01461369|3734435|B3|||Weight||kg|Mean|89.44|89.44|Standard Deviation|17.991|17.991|||
3911182|NCT01461369|3734436|B2|||Weight||kg|Mean|89.35|89.35|Standard Deviation|16.552|16.552|||
3911183|NCT01461369|3734437|B1|||Weight||kg|Mean|88.16|88.16|Standard Deviation|17.037|17.037|||
3911184|NCT01461369|3734434|B4|Other||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|2|2.0||||||
3911185|NCT01461369|3734435|B3|Other||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|1|1.0||||||
3911186|NCT01461369|3734436|B2|Other||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|1|1.0||||||
3911187|NCT01461369|3734437|B1|Other||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|0|0.0||||||
3911188|NCT01461369|3734434|B4|White or Caucasian||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|245|245.0||||||
3911189|NCT01461369|3734435|B3|White or Caucasian||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|82|82.0||||||
3911190|NCT01461369|3734436|B2|White or Caucasian||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|83|83.0||||||
3911191|NCT01461369|3734437|B1|White or Caucasian||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|80|80.0||||||
3911192|NCT01461369|3734434|B4|Black or African American||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|57|57.0||||||
3911193|NCT01461369|3734435|B3|Black or African American||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|20|20.0||||||
3911194|NCT01461369|3734436|B2|Black or African American||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|14|14.0||||||
3911195|NCT01461369|3734437|B1|Black or African American||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|23|23.0||||||
3911196|NCT01461369|3734434|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|1|1.0||||||
3911197|NCT01461369|3734435|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|0|0.0||||||
3911198|NCT01461369|3734436|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|0|0.0||||||
3911199|NCT01461369|3734437|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|1|1.0||||||
3911200|NCT01461369|3734434|B4|Asian||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|0|0.0||||||
3911431|NCT01460368|3734673|B3||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3911204|NCT01461369|3734434|B4|American Indian or Alaska Native||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|1|1.0||||||
3911205|NCT01461369|3734435|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|0|0.0||||||
3911206|NCT01461369|3734436|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|0|0.0||||||
3911207|NCT01461369|3734437|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Subjects were allowed to select more than one race; therefore, some subjects are counted multiple times.|participants|Number|1|1.0||||||
3911208|NCT01461369|3734434|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911209|NCT01461369|3734435|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911210|NCT01461369|3734436|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911211|NCT01461369|3734437|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911212|NCT01461369|3734434|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|288|288.0||||||
3911213|NCT01461369|3734435|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3911214|NCT01461369|3734436|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3911215|NCT01461369|3734437|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
3911216|NCT01461369|3734434|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3911217|NCT01461369|3734435|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3911218|NCT01461369|3734436|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3911219|NCT01461369|3734437|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3911220|NCT01461369|3734434|B4||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3911221|NCT01461369|3734435|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3911222|NCT01461369|3734436|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3911223|NCT01461369|3734437|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3911224|NCT01461369|3734434|B4||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
3911225|NCT01461369|3734435|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3911226|NCT01461369|3734436|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3911227|NCT01461369|3734437|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3911228|NCT01461369|3734434|B4|||Age||years|Mean|61.6|61.6|Standard Deviation|8.87|8.87|||
3911229|NCT01461369|3734435|B3|||Age||years|Mean|61.8|61.8|Standard Deviation|8.42|8.42|||
3911230|NCT01461369|3734436|B2|||Age||years|Mean|61.7|61.7|Standard Deviation|9.90|9.9|||
3911231|NCT01461369|3734437|B1|||Age||years|Mean|61.4|61.4|Standard Deviation|8.33|8.33|||
3911232|NCT01461096|3734462|B3|||Percent CD4||%|Median|31.70|31.7|Inter-Quartile Range|||25.0|38.0|
3911233|NCT01461096|3734463|B2|||Percent CD4||%|Median|31|31.0|Inter-Quartile Range|||23.9|37.9|
3911234|NCT01461096|3734464|B1|||Percent CD4||%|Median|32|32.0|Inter-Quartile Range|||25.0|38.8|
3911235|NCT01461096|3734462|B3|||Absolute CD4 count||cells/mm^3|Median|602|602.0|Inter-Quartile Range|||436.0|767.0|
3911236|NCT01461096|3734463|B2|||Absolute CD4 count||cells/mm^3|Median|614|614.0|Inter-Quartile Range|||435.0|803.0|
3911237|NCT01461096|3734464|B1|||Absolute CD4 count||cells/mm^3|Median|598|598.0|Inter-Quartile Range|||438.0|761.0|
3911238|NCT01461096|3734462|B3|||Lowest documented CD4 count||cells/mm^3|Median|255|255.0|Inter-Quartile Range|||110.0|403.0|
3911239|NCT01461096|3734463|B2|||Lowest documented CD4 count||cells/mm^3|Median|259|259.0|Inter-Quartile Range|||119.0|419.0|
3911240|NCT01461096|3734464|B1|||Lowest documented CD4 count||cells/mm^3|Median|254|254.0|Inter-Quartile Range|||105.0|373.0|
3911241|NCT01461096|3734462|B3||Missing|HIV RNA results (copies/mL)||Participants|Count of Participants|11|11.0||||||
3911242|NCT01461096|3734463|B2||Missing|HIV RNA results (copies/mL)||Participants|Count of Participants|5|5.0||||||
3911243|NCT01461096|3734464|B1||Missing|HIV RNA results (copies/mL)||Participants|Count of Participants|6|6.0||||||
3911244|NCT01461096|3734462|B3||>=10000|HIV RNA results (copies/mL)||Participants|Count of Participants|16|16.0||||||
3911245|NCT01461096|3734463|B2||>=10000|HIV RNA results (copies/mL)||Participants|Count of Participants|9|9.0||||||
3911246|NCT01461096|3734464|B1||>=10000|HIV RNA results (copies/mL)||Participants|Count of Participants|7|7.0||||||
3911247|NCT01461096|3734462|B3||1000-<10000|HIV RNA results (copies/mL)||Participants|Count of Participants|16|16.0||||||
3911248|NCT01461096|3734463|B2||1000-<10000|HIV RNA results (copies/mL)||Participants|Count of Participants|6|6.0||||||
3911249|NCT01461096|3734464|B1||1000-<10000|HIV RNA results (copies/mL)||Participants|Count of Participants|10|10.0||||||
3911250|NCT01461096|3734462|B3||500-<1000|HIV RNA results (copies/mL)||Participants|Count of Participants|7|7.0||||||
3911251|NCT01461096|3734463|B2||500-<1000|HIV RNA results (copies/mL)||Participants|Count of Participants|4|4.0||||||
3911252|NCT01461096|3734464|B1||500-<1000|HIV RNA results (copies/mL)||Participants|Count of Participants|3|3.0||||||
3911253|NCT01461096|3734462|B3||200-<500|HIV RNA results (copies/mL)||Participants|Count of Participants|17|17.0||||||
3911254|NCT01461096|3734463|B2||200-<500|HIV RNA results (copies/mL)||Participants|Count of Participants|4|4.0||||||
3911255|NCT01461096|3734464|B1||200-<500|HIV RNA results (copies/mL)||Participants|Count of Participants|13|13.0||||||
3911256|NCT01461096|3734462|B3||50-<200|HIV RNA results (copies/mL)||Participants|Count of Participants|38|38.0||||||
3911432|NCT01460368|3734674|B2||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3911257|NCT01461096|3734463|B2||50-<200|HIV RNA results (copies/mL)||Participants|Count of Participants|15|15.0||||||
3911258|NCT01461096|3734464|B1||50-<200|HIV RNA results (copies/mL)||Participants|Count of Participants|23|23.0||||||
3911259|NCT01461096|3734462|B3||<50|HIV RNA results (copies/mL)||Participants|Count of Participants|470|470.0||||||
3911260|NCT01461096|3734463|B2||<50|HIV RNA results (copies/mL)||Participants|Count of Participants|244|244.0||||||
3911261|NCT01461096|3734464|B1||<50|HIV RNA results (copies/mL)||Participants|Count of Participants|226|226.0||||||
3911262|NCT01461096|3734462|B3||Previously|IV drug history||Participants|Count of Participants|46|46.0||||||
3911263|NCT01461096|3734463|B2||Previously|IV drug history||Participants|Count of Participants|28|28.0||||||
3911264|NCT01461096|3734464|B1||Previously|IV drug history||Participants|Count of Participants|18|18.0||||||
3911265|NCT01461096|3734462|B3||Never|IV drug history||Participants|Count of Participants|529|529.0||||||
3911266|NCT01461096|3734463|B2||Never|IV drug history||Participants|Count of Participants|259|259.0||||||
3911267|NCT01461096|3734464|B1||Never|IV drug history||Participants|Count of Participants|270|270.0||||||
3911268|NCT01461096|3734462|B3||No HGAIN|Presence of HGAIN at entry||Participants|Count of Participants|388|388.0||||||
3911269|NCT01461096|3734463|B2||No HGAIN|Presence of HGAIN at entry||Participants|Count of Participants|195|195.0||||||
3911270|NCT01461096|3734464|B1||No HGAIN|Presence of HGAIN at entry||Participants|Count of Participants|193|193.0||||||
3911271|NCT01461096|3734462|B3||HGAIN|Presence of HGAIN at entry||Participants|Count of Participants|187|187.0||||||
3911272|NCT01461096|3734463|B2||HGAIN|Presence of HGAIN at entry||Participants|Count of Participants|92|92.0||||||
3911273|NCT01461096|3734464|B1||HGAIN|Presence of HGAIN at entry||Participants|Count of Participants|95|95.0||||||
3911274|NCT01461096|3734462|B3||More than one race|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3911275|NCT01461096|3734463|B2||More than one race|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3911276|NCT01461096|3734464|B1||More than one race|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3911277|NCT01461096|3734462|B3||American Indian, Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3911278|NCT01461096|3734463|B2||American Indian, Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3911279|NCT01461096|3734464|B1||American Indian, Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3911280|NCT01461096|3734462|B3||Asian, Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3911281|NCT01461096|3734463|B2||Asian, Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3911282|NCT01461096|3734464|B1||Asian, Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3911283|NCT01461096|3734462|B3||Hispanic (Regardless of Race)|Race/Ethnicity, Customized||Participants|Count of Participants|117|117.0||||||
3911284|NCT01461096|3734463|B2||Hispanic (Regardless of Race)|Race/Ethnicity, Customized||Participants|Count of Participants|54|54.0||||||
3911285|NCT01461096|3734464|B1||Hispanic (Regardless of Race)|Race/Ethnicity, Customized||Participants|Count of Participants|63|63.0||||||
3911286|NCT01461096|3734462|B3||Black Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|180|180.0||||||
3911287|NCT01461096|3734463|B2||Black Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|89|89.0||||||
3911288|NCT01461096|3734464|B1||Black Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|91|91.0||||||
3911289|NCT01461096|3734462|B3||White Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|261|261.0||||||
3911290|NCT01461096|3734463|B2||White Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|136|136.0||||||
3911291|NCT01461096|3734464|B1||White Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|125|125.0||||||
3911292|NCT01461096|3734462|B3||Male|Sex: Female, Male||Participants|Count of Participants|472|472.0||||||
3911293|NCT01461096|3734463|B2||Male|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
3911294|NCT01461096|3734464|B1||Male|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
3911295|NCT01461096|3734462|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3911296|NCT01461096|3734463|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3911297|NCT01461096|3734464|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3911298|NCT01461096|3734462|B3|||Age||years|Median|47|47.0|Inter-Quartile Range|||41.0|53.0|
3911299|NCT01461096|3734463|B2|||Age||years|Median|48|48.0|Inter-Quartile Range|||42.0|53.0|
3911300|NCT01461096|3734464|B1|||Age||years|Median|47|47.0|Inter-Quartile Range|||40.0|52.0|
3911301|NCT01461057|3734479|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3911302|NCT01461057|3734480|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3911303|NCT01461057|3734481|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3911304|NCT01461057|3734479|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3911305|NCT01461057|3734480|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3911306|NCT01461057|3734481|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3911307|NCT01461057|3734479|B3||Greater than or equal to (>=) 65 years|Age, Customized||Participants|Count of Participants|14|14.0||||||
3911308|NCT01461057|3734480|B2||Greater than or equal to (>=) 65 years|Age, Customized||Participants|Count of Participants|5|5.0||||||
3911309|NCT01461057|3734481|B1||Greater than or equal to (>=) 65 years|Age, Customized||Participants|Count of Participants|9|9.0||||||
3911310|NCT01461057|3734479|B3||41 - 64 years|Age, Customized||Participants|Count of Participants|13|13.0||||||
3911311|NCT01461057|3734480|B2||41 - 64 years|Age, Customized||Participants|Count of Participants|9|9.0||||||
3911312|NCT01461057|3734481|B1||41 - 64 years|Age, Customized||Participants|Count of Participants|4|4.0||||||
3911313|NCT01461057|3734479|B3||18 - 40 years|Age, Customized||Participants|Count of Participants|3|3.0||||||
3911314|NCT01461057|3734480|B2||18 - 40 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
3911315|NCT01461057|3734481|B1||18 - 40 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
3911316|NCT01461044|3734490|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3911317|NCT01461044|3734491|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3911318|NCT01461044|3734492|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3911319|NCT01461044|3734490|B3||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3911320|NCT01461044|3734491|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3911321|NCT01461044|3734492|B1||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3911322|NCT01461044|3734490|B3|||Age||years|Mean|55.2|55.2|Standard Deviation|11.4|11.4|||
3911323|NCT01461044|3734491|B2|||Age||years|Mean|55.6|55.6|Standard Deviation|10.3|10.3|||
3911324|NCT01461044|3734492|B1|||Age||years|Mean|55.0|55.0|Standard Deviation|12.0|12.0|||
3911325|NCT01460940|3734566|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3911326|NCT01460940|3734566|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3911327|NCT01460940|3734566|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3911328|NCT01460940|3734566|B1|||Age||years|Median|45|45.0|Full Range|||22.0|72.0|
3911329|NCT01460927|3734572|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3911330|NCT01460927|3734572|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3911331|NCT01460927|3734572|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3911332|NCT01460927|3734572|B1|||Age||years|Mean|49|49.0|Standard Deviation|7.4|7.4|||
3911333|NCT01460927|3734572|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3911334|NCT01460927|3734572|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3911335|NCT01460927|3734572|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3911336|NCT01460927|3734572|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3911337|NCT01460927|3734572|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3911338|NCT01460927|3734572|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3911339|NCT01460875|3734580|B1|United States||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3911340|NCT01460875|3734580|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911341|NCT01460875|3734580|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3911342|NCT01460875|3734580|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3911343|NCT01460875|3734580|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3911344|NCT01460875|3734580|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3911345|NCT01460875|3734580|B1|||Age||years|Median|52|52.0|Full Range|||22.0|77.0|
3911346|NCT01460732|3734591|B1|Greece||Region of Enrollment||participants|Number|81|81.0||||||
3911347|NCT01460732|3734591|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3911348|NCT01460732|3734591|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3911349|NCT01460732|3734591|B1|||Age||years|Mean|58.1|58.1|Standard Deviation|10.7|10.7|||
3911350|NCT01460732|3734591|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3911351|NCT01460732|3734591|B1||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
3911352|NCT01460732|3734591|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3911353|NCT01460628|3734604|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3911354|NCT01460628|3734604|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3911355|NCT01460628|3734604|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3911356|NCT01460628|3734604|B1|||Age||years|Mean|53.8|53.8|Standard Deviation|5.13|5.13|||
3911357|NCT01460446|3734614|B3||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3911358|NCT01460446|3734615|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3911359|NCT01460446|3734616|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3911360|NCT01460446|3734614|B3||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3911361|NCT01460446|3734615|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3911362|NCT01460446|3734616|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3911363|NCT01460446|3734614|B3|||Age||years|Mean|42.4|42.4|Standard Deviation|14.0|14.0|||
3911364|NCT01460446|3734615|B2|||Age||years|Mean|42.0|42.0|Standard Deviation|14.5|14.5|||
3911365|NCT01460446|3734616|B1|||Age||years|Mean|42.7|42.7|Standard Deviation|13.5|13.5|||
3911366|NCT01460407|3734644|B1|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3911367|NCT01460407|3734644|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911368|NCT01460407|3734644|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3911369|NCT01460407|3734644|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3911370|NCT01460407|3734644|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911371|NCT01460407|3734644|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911372|NCT01460407|3734644|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3911373|NCT01460407|3734644|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911374|NCT01460407|3734644|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911375|NCT01460407|3734644|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3911376|NCT01460407|3734644|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3911377|NCT01460407|3734644|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3911378|NCT01460407|3734644|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3911379|NCT01460407|3734644|B1|||Age||years|Mean|43.5|43.5|Standard Deviation|11.0|11.0|||
3911380|NCT01460381|3734656|B3|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3911381|NCT01460381|3734657|B2|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3911382|NCT01460381|3734658|B1|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3911383|NCT01460381|3734656|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911384|NCT01460381|3734657|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911385|NCT01460381|3734658|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911386|NCT01460381|3734656|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3911387|NCT01460381|3734657|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3911388|NCT01460381|3734658|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911389|NCT01460381|3734656|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3911390|NCT01460381|3734657|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3911391|NCT01460381|3734658|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3911392|NCT01460381|3734656|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3911393|NCT01460381|3734657|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3911394|NCT01460381|3734658|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3911395|NCT01460381|3734656|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911396|NCT01460381|3734657|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911397|NCT01460381|3734658|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911398|NCT01460381|3734656|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3911399|NCT01460381|3734657|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911400|NCT01460381|3734658|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3911401|NCT01460381|3734656|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911402|NCT01460381|3734657|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911403|NCT01460381|3734658|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911404|NCT01460381|3734656|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911405|NCT01460381|3734657|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911406|NCT01460381|3734658|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911407|NCT01460381|3734656|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3911408|NCT01460381|3734657|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3911409|NCT01460381|3734658|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3911410|NCT01460381|3734656|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3911411|NCT01460381|3734657|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3911412|NCT01460381|3734658|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3911413|NCT01460381|3734656|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3911414|NCT01460381|3734657|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3911415|NCT01460381|3734658|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3911416|NCT01460381|3734656|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3911417|NCT01460381|3734657|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3911418|NCT01460381|3734658|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3911419|NCT01460381|3734656|B3|||Age||years|Mean|43.1|43.1|Standard Deviation|11.6|11.6|||
3911420|NCT01460381|3734657|B2|||Age||years|Mean|44.9|44.9|Standard Deviation|12.1|12.1|||
3911421|NCT01460381|3734658|B1|||Age||years|Mean|40.1|40.1|Standard Deviation|11.1|11.1|||
3911422|NCT01460368|3734673|B3|United States||Region of Enrollment||Participants|Count of Participants|67|67.0||||||
3911423|NCT01460368|3734674|B2|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3911424|NCT01460368|3734675|B1|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3911425|NCT01460368|3734673|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911426|NCT01460368|3734674|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911427|NCT01460368|3734675|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911428|NCT01460368|3734673|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911429|NCT01460368|3734674|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911430|NCT01460368|3734675|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911433|NCT01460368|3734675|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3911434|NCT01460368|3734673|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3911435|NCT01460368|3734674|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3911436|NCT01460368|3734675|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3911437|NCT01460368|3734673|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911438|NCT01460368|3734674|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911439|NCT01460368|3734675|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911440|NCT01460368|3734673|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911441|NCT01460368|3734674|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911442|NCT01460368|3734675|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911443|NCT01460368|3734673|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3911444|NCT01460368|3734674|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3911445|NCT01460368|3734675|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911446|NCT01460368|3734673|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911447|NCT01460368|3734674|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911448|NCT01460368|3734675|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911449|NCT01460368|3734673|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3911450|NCT01460368|3734674|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3911451|NCT01460368|3734675|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3911452|NCT01460368|3734673|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3911453|NCT01460368|3734674|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3911454|NCT01460368|3734675|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3911455|NCT01460368|3734673|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3911456|NCT01460368|3734674|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3911457|NCT01460368|3734675|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3911458|NCT01460368|3734673|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3911459|NCT01460368|3734674|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3911460|NCT01460368|3734675|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3911461|NCT01460368|3734673|B3|||Age||years|Mean|40.4|40.4|Standard Deviation|12.5|12.5|||
3911462|NCT01460368|3734674|B2|||Age||years|Mean|39.7|39.7|Standard Deviation|12.8|12.8|||
3911463|NCT01460368|3734675|B1|||Age||years|Mean|47.3|47.3|Standard Deviation|7.7|7.7|||
3911464|NCT01460342|3734691|B3|||Prostate Volume|The volume of prostate, estimated by transabdominal or transrectal ultrasound.|mL|Mean|31.1|31.1|Standard Deviation|9.0|9.0|||
3911465|NCT01460342|3734692|B2|||Prostate Volume|The volume of prostate, estimated by transabdominal or transrectal ultrasound.|mL|Mean|30.7|30.7|Standard Deviation|8.5|8.5|||
3911466|NCT01460342|3734693|B1|||Prostate Volume|The volume of prostate, estimated by transabdominal or transrectal ultrasound.|mL|Mean|31.6|31.6|Standard Deviation|9.5|9.5|||
3911467|NCT01460342|3734691|B3|||Postvoid Residual Volume (PVR)|PVR was defined as the volume of urine remaining in the bladder after voiding, estimated by ultrasound.|milliliters (mL)|Mean|29.8|29.8|Standard Deviation|44.3|44.3|||
3911468|NCT01460342|3734692|B2|||Postvoid Residual Volume (PVR)|PVR was defined as the volume of urine remaining in the bladder after voiding, estimated by ultrasound.|milliliters (mL)|Mean|26.9|26.9|Standard Deviation|37.7|37.7|||
3911469|NCT01460342|3734693|B1|||Postvoid Residual Volume (PVR)|PVR was defined as the volume of urine remaining in the bladder after voiding, estimated by ultrasound.|milliliters (mL)|Mean|32.7|32.7|Standard Deviation|50.0|50.0|||
3911470|NCT01460342|3734691|B3|No||Previous Benign Prostatic Hyperplasia - Lower Urinary Tract Symptoms (BPH-LUTS) Therapy|Previous BPH-LUTS therapy during the 12 months prior to study enrollment. Alpha-blocker therapy excluded.|Participants|Number|567|567.0||||||
3911471|NCT01460342|3734692|B2|No||Previous Benign Prostatic Hyperplasia - Lower Urinary Tract Symptoms (BPH-LUTS) Therapy|Previous BPH-LUTS therapy during the 12 months prior to study enrollment. Alpha-blocker therapy excluded.|Participants|Number|284|284.0||||||
3911472|NCT01460342|3734693|B1|No||Previous Benign Prostatic Hyperplasia - Lower Urinary Tract Symptoms (BPH-LUTS) Therapy|Previous BPH-LUTS therapy during the 12 months prior to study enrollment. Alpha-blocker therapy excluded.|Participants|Number|283|283.0||||||
3911473|NCT01460342|3734691|B3|Yes||Previous Benign Prostatic Hyperplasia - Lower Urinary Tract Symptoms (BPH-LUTS) Therapy|Previous BPH-LUTS therapy during the 12 months prior to study enrollment. Alpha-blocker therapy excluded.|Participants|Number|43|43.0||||||
3911474|NCT01460342|3734692|B2|Yes||Previous Benign Prostatic Hyperplasia - Lower Urinary Tract Symptoms (BPH-LUTS) Therapy|Previous BPH-LUTS therapy during the 12 months prior to study enrollment. Alpha-blocker therapy excluded.|Participants|Number|22|22.0||||||
3911475|NCT01460342|3734693|B1|Yes||Previous Benign Prostatic Hyperplasia - Lower Urinary Tract Symptoms (BPH-LUTS) Therapy|Previous BPH-LUTS therapy during the 12 months prior to study enrollment. Alpha-blocker therapy excluded.|Participants|Number|21|21.0||||||
3911476|NCT01460342|3734691|B3|No||Previous Alpha-Blocker Therapy|Previous alpha-blocker therapy during the 12 months prior to study enrollment.|participants|Number|528|528.0||||||
3911477|NCT01460342|3734692|B2|No||Previous Alpha-Blocker Therapy|Previous alpha-blocker therapy during the 12 months prior to study enrollment.|participants|Number|267|267.0||||||
3911522|NCT01460342|3734692|B2|Yes||Alcohol Use||participants|Number|206|206.0||||||
3911478|NCT01460342|3734693|B1|No||Previous Alpha-Blocker Therapy|Previous alpha-blocker therapy during the 12 months prior to study enrollment.|participants|Number|261|261.0||||||
3911479|NCT01460342|3734691|B3|Yes||Previous Alpha-Blocker Therapy|Previous alpha-blocker therapy during the 12 months prior to study enrollment.|participants|Number|82|82.0||||||
3911480|NCT01460342|3734692|B2|Yes||Previous Alpha-Blocker Therapy|Previous alpha-blocker therapy during the 12 months prior to study enrollment.|participants|Number|39|39.0||||||
3911481|NCT01460342|3734693|B1|Yes||Previous Alpha-Blocker Therapy|Previous alpha-blocker therapy during the 12 months prior to study enrollment.|participants|Number|43|43.0||||||
3911482|NCT01460342|3734691|B3|Severe||Clinical Global Impression of Severity (CGI-S) Scale|The CGI-S Scale measured the clinician's perception of severity of illness at the time of the assessment. Scores were 1 (Normal), 2 (Mild), 3 (Moderate), and 4 (Severe).|participants|Number|107|107.0||||||
3911483|NCT01460342|3734692|B2|Severe||Clinical Global Impression of Severity (CGI-S) Scale|The CGI-S Scale measured the clinician's perception of severity of illness at the time of the assessment. Scores were 1 (Normal), 2 (Mild), 3 (Moderate), and 4 (Severe).|participants|Number|54|54.0||||||
3911484|NCT01460342|3734693|B1|Severe||Clinical Global Impression of Severity (CGI-S) Scale|The CGI-S Scale measured the clinician's perception of severity of illness at the time of the assessment. Scores were 1 (Normal), 2 (Mild), 3 (Moderate), and 4 (Severe).|participants|Number|53|53.0||||||
3911485|NCT01460342|3734691|B3|Moderate||Clinical Global Impression of Severity (CGI-S) Scale|The CGI-S Scale measured the clinician's perception of severity of illness at the time of the assessment. Scores were 1 (Normal), 2 (Mild), 3 (Moderate), and 4 (Severe).|participants|Number|429|429.0||||||
3911486|NCT01460342|3734692|B2|Moderate||Clinical Global Impression of Severity (CGI-S) Scale|The CGI-S Scale measured the clinician's perception of severity of illness at the time of the assessment. Scores were 1 (Normal), 2 (Mild), 3 (Moderate), and 4 (Severe).|participants|Number|211|211.0||||||
3911487|NCT01460342|3734693|B1|Moderate||Clinical Global Impression of Severity (CGI-S) Scale|The CGI-S Scale measured the clinician's perception of severity of illness at the time of the assessment. Scores were 1 (Normal), 2 (Mild), 3 (Moderate), and 4 (Severe).|participants|Number|218|218.0||||||
3911488|NCT01460342|3734691|B3|Mild||Clinical Global Impression of Severity (CGI-S) Scale|The CGI-S Scale measured the clinician's perception of severity of illness at the time of the assessment. Scores were 1 (Normal), 2 (Mild), 3 (Moderate), and 4 (Severe).|participants|Number|74|74.0||||||
3911489|NCT01460342|3734692|B2|Mild||Clinical Global Impression of Severity (CGI-S) Scale|The CGI-S Scale measured the clinician's perception of severity of illness at the time of the assessment. Scores were 1 (Normal), 2 (Mild), 3 (Moderate), and 4 (Severe).|participants|Number|41|41.0||||||
3911490|NCT01460342|3734693|B1|Mild||Clinical Global Impression of Severity (CGI-S) Scale|The CGI-S Scale measured the clinician's perception of severity of illness at the time of the assessment. Scores were 1 (Normal), 2 (Mild), 3 (Moderate), and 4 (Severe).|participants|Number|33|33.0||||||
3911491|NCT01460342|3734691|B3|Normal||Clinical Global Impression of Severity (CGI-S) Scale|The CGI-S Scale measured the clinician's perception of severity of illness at the time of the assessment. Scores were 1 (Normal), 2 (Mild), 3 (Moderate), and 4 (Severe).|participants|Number|0|0.0||||||
3911492|NCT01460342|3734692|B2|Normal||Clinical Global Impression of Severity (CGI-S) Scale|The CGI-S Scale measured the clinician's perception of severity of illness at the time of the assessment. Scores were 1 (Normal), 2 (Mild), 3 (Moderate), and 4 (Severe).|participants|Number|0|0.0||||||
3911493|NCT01460342|3734693|B1|Normal||Clinical Global Impression of Severity (CGI-S) Scale|The CGI-S Scale measured the clinician's perception of severity of illness at the time of the assessment. Scores were 1 (Normal), 2 (Mild), 3 (Moderate), and 4 (Severe).|participants|Number|0|0.0||||||
3911494|NCT01460342|3734691|B3|Severe||Patient Global Impression of Severity (PGI-S) Scale|The PGI-S Scale measured the participant's perception of severity of illness at the time of assessment. Scores were 1 (Normal), 2 (Mild), 3 (Moderate), and 4 (Severe).|participants|Number|97|97.0||||||
3911495|NCT01460342|3734692|B2|Severe||Patient Global Impression of Severity (PGI-S) Scale|The PGI-S Scale measured the participant's perception of severity of illness at the time of assessment. Scores were 1 (Normal), 2 (Mild), 3 (Moderate), and 4 (Severe).|participants|Number|47|47.0||||||
3911496|NCT01460342|3734693|B1|Severe||Patient Global Impression of Severity (PGI-S) Scale|The PGI-S Scale measured the participant's perception of severity of illness at the time of assessment. Scores were 1 (Normal), 2 (Mild), 3 (Moderate), and 4 (Severe).|participants|Number|50|50.0||||||
3911497|NCT01460342|3734691|B3|Moderate||Patient Global Impression of Severity (PGI-S) Scale|The PGI-S Scale measured the participant's perception of severity of illness at the time of assessment. Scores were 1 (Normal), 2 (Mild), 3 (Moderate), and 4 (Severe).|participants|Number|382|382.0||||||
3911498|NCT01460342|3734692|B2|Moderate||Patient Global Impression of Severity (PGI-S) Scale|The PGI-S Scale measured the participant's perception of severity of illness at the time of assessment. Scores were 1 (Normal), 2 (Mild), 3 (Moderate), and 4 (Severe).|participants|Number|195|195.0||||||
3911499|NCT01460342|3734693|B1|Moderate||Patient Global Impression of Severity (PGI-S) Scale|The PGI-S Scale measured the participant's perception of severity of illness at the time of assessment. Scores were 1 (Normal), 2 (Mild), 3 (Moderate), and 4 (Severe).|participants|Number|187|187.0||||||
3911500|NCT01460342|3734691|B3|Mild||Patient Global Impression of Severity (PGI-S) Scale|The PGI-S Scale measured the participant's perception of severity of illness at the time of assessment. Scores were 1 (Normal), 2 (Mild), 3 (Moderate), and 4 (Severe).|participants|Number|131|131.0||||||
3911501|NCT01460342|3734692|B2|Mild||Patient Global Impression of Severity (PGI-S) Scale|The PGI-S Scale measured the participant's perception of severity of illness at the time of assessment. Scores were 1 (Normal), 2 (Mild), 3 (Moderate), and 4 (Severe).|participants|Number|64|64.0||||||
3911502|NCT01460342|3734693|B1|Mild||Patient Global Impression of Severity (PGI-S) Scale|The PGI-S Scale measured the participant's perception of severity of illness at the time of assessment. Scores were 1 (Normal), 2 (Mild), 3 (Moderate), and 4 (Severe).|participants|Number|67|67.0||||||
3911503|NCT01460342|3734691|B3|Normal||Patient Global Impression of Severity (PGI-S) Scale|The PGI-S Scale measured the participant's perception of severity of illness at the time of assessment. Scores were 1 (Normal), 2 (Mild), 3 (Moderate), and 4 (Severe).|participants|Number|0|0.0||||||
3911523|NCT01460342|3734693|B1|Yes||Alcohol Use||participants|Number|196|196.0||||||
3911504|NCT01460342|3734692|B2|Normal||Patient Global Impression of Severity (PGI-S) Scale|The PGI-S Scale measured the participant's perception of severity of illness at the time of assessment. Scores were 1 (Normal), 2 (Mild), 3 (Moderate), and 4 (Severe).|participants|Number|0|0.0||||||
3911505|NCT01460342|3734693|B1|Normal||Patient Global Impression of Severity (PGI-S) Scale|The PGI-S Scale measured the participant's perception of severity of illness at the time of assessment. Scores were 1 (Normal), 2 (Mild), 3 (Moderate), and 4 (Severe).|participants|Number|0|0.0||||||
3911506|NCT01460342|3734691|B3|||Duration of BPH||years|Mean|4.0|4.0|Standard Deviation|3.2|3.2|||
3911507|NCT01460342|3734692|B2|||Duration of BPH||years|Mean|4.1|4.1|Standard Deviation|3.2|3.2|||
3911508|NCT01460342|3734693|B1|||Duration of BPH||years|Mean|4.0|4.0|Standard Deviation|3.3|3.3|||
3911509|NCT01460342|3734691|B3|Severe (IPSS Total Score >=20)||Benign Prostatic Hyperplasia (BPH) Severity|BPH severity rated mild [an International Prostate Symptom Score (IPSS) Total Score from 0 to 7], moderate (IPSS Total Score from 8 to 19), or severe (an IPSS Total Score >=20). The IPSS Total Score was the sum of Questions 1 through 7 in the IPSS questionnaire. Each question was based on the participant's urination experiences and prostate symptoms during the last month. Scores ranged from 0 (none/no symptoms) to 5 (frequent symptoms) for an IPSS Total Score that ranged from 0 to 35; higher numerical scores represented a greater severity of symptoms.|participants|Number|266|266.0||||||
3911510|NCT01460342|3734692|B2|Severe (IPSS Total Score >=20)||Benign Prostatic Hyperplasia (BPH) Severity|BPH severity rated mild [an International Prostate Symptom Score (IPSS) Total Score from 0 to 7], moderate (IPSS Total Score from 8 to 19), or severe (an IPSS Total Score >=20). The IPSS Total Score was the sum of Questions 1 through 7 in the IPSS questionnaire. Each question was based on the participant's urination experiences and prostate symptoms during the last month. Scores ranged from 0 (none/no symptoms) to 5 (frequent symptoms) for an IPSS Total Score that ranged from 0 to 35; higher numerical scores represented a greater severity of symptoms.|participants|Number|134|134.0||||||
3911511|NCT01460342|3734693|B1|Severe (IPSS Total Score >=20)||Benign Prostatic Hyperplasia (BPH) Severity|BPH severity rated mild [an International Prostate Symptom Score (IPSS) Total Score from 0 to 7], moderate (IPSS Total Score from 8 to 19), or severe (an IPSS Total Score >=20). The IPSS Total Score was the sum of Questions 1 through 7 in the IPSS questionnaire. Each question was based on the participant's urination experiences and prostate symptoms during the last month. Scores ranged from 0 (none/no symptoms) to 5 (frequent symptoms) for an IPSS Total Score that ranged from 0 to 35; higher numerical scores represented a greater severity of symptoms.|participants|Number|132|132.0||||||
3911512|NCT01460342|3734691|B3|Moderate (IPSS Total Score 8 to 19)||Benign Prostatic Hyperplasia (BPH) Severity|BPH severity rated mild [an International Prostate Symptom Score (IPSS) Total Score from 0 to 7], moderate (IPSS Total Score from 8 to 19), or severe (an IPSS Total Score >=20). The IPSS Total Score was the sum of Questions 1 through 7 in the IPSS questionnaire. Each question was based on the participant's urination experiences and prostate symptoms during the last month. Scores ranged from 0 (none/no symptoms) to 5 (frequent symptoms) for an IPSS Total Score that ranged from 0 to 35; higher numerical scores represented a greater severity of symptoms.|participants|Number|333|333.0||||||
3911513|NCT01460342|3734692|B2|Moderate (IPSS Total Score 8 to 19)||Benign Prostatic Hyperplasia (BPH) Severity|BPH severity rated mild [an International Prostate Symptom Score (IPSS) Total Score from 0 to 7], moderate (IPSS Total Score from 8 to 19), or severe (an IPSS Total Score >=20). The IPSS Total Score was the sum of Questions 1 through 7 in the IPSS questionnaire. Each question was based on the participant's urination experiences and prostate symptoms during the last month. Scores ranged from 0 (none/no symptoms) to 5 (frequent symptoms) for an IPSS Total Score that ranged from 0 to 35; higher numerical scores represented a greater severity of symptoms.|participants|Number|166|166.0||||||
3911514|NCT01460342|3734693|B1|Moderate (IPSS Total Score 8 to 19)||Benign Prostatic Hyperplasia (BPH) Severity|BPH severity rated mild [an International Prostate Symptom Score (IPSS) Total Score from 0 to 7], moderate (IPSS Total Score from 8 to 19), or severe (an IPSS Total Score >=20). The IPSS Total Score was the sum of Questions 1 through 7 in the IPSS questionnaire. Each question was based on the participant's urination experiences and prostate symptoms during the last month. Scores ranged from 0 (none/no symptoms) to 5 (frequent symptoms) for an IPSS Total Score that ranged from 0 to 35; higher numerical scores represented a greater severity of symptoms.|participants|Number|167|167.0||||||
3911515|NCT01460342|3734691|B3|Mild (IPSS Total Score 0 to 7)||Benign Prostatic Hyperplasia (BPH) Severity|BPH severity rated mild [an International Prostate Symptom Score (IPSS) Total Score from 0 to 7], moderate (IPSS Total Score from 8 to 19), or severe (an IPSS Total Score >=20). The IPSS Total Score was the sum of Questions 1 through 7 in the IPSS questionnaire. Each question was based on the participant's urination experiences and prostate symptoms during the last month. Scores ranged from 0 (none/no symptoms) to 5 (frequent symptoms) for an IPSS Total Score that ranged from 0 to 35; higher numerical scores represented a greater severity of symptoms.|participants|Number|11|11.0||||||
3911516|NCT01460342|3734692|B2|Mild (IPSS Total Score 0 to 7)||Benign Prostatic Hyperplasia (BPH) Severity|BPH severity rated mild [an International Prostate Symptom Score (IPSS) Total Score from 0 to 7], moderate (IPSS Total Score from 8 to 19), or severe (an IPSS Total Score >=20). The IPSS Total Score was the sum of Questions 1 through 7 in the IPSS questionnaire. Each question was based on the participant's urination experiences and prostate symptoms during the last month. Scores ranged from 0 (none/no symptoms) to 5 (frequent symptoms) for an IPSS Total Score that ranged from 0 to 35; higher numerical scores represented a greater severity of symptoms.|participants|Number|6|6.0||||||
3911517|NCT01460342|3734693|B1|Mild (IPSS Total Score 0 to 7)||Benign Prostatic Hyperplasia (BPH) Severity|BPH severity rated mild [an International Prostate Symptom Score (IPSS) Total Score from 0 to 7], moderate (IPSS Total Score from 8 to 19), or severe (an IPSS Total Score >=20). The IPSS Total Score was the sum of Questions 1 through 7 in the IPSS questionnaire. Each question was based on the participant's urination experiences and prostate symptoms during the last month. Scores ranged from 0 (none/no symptoms) to 5 (frequent symptoms) for an IPSS Total Score that ranged from 0 to 35; higher numerical scores represented a greater severity of symptoms.|participants|Number|5|5.0||||||
3911518|NCT01460342|3734691|B3|No||Alcohol Use||participants|Number|208|208.0||||||
3911519|NCT01460342|3734692|B2|No||Alcohol Use||participants|Number|100|100.0||||||
3911520|NCT01460342|3734693|B1|No||Alcohol Use||participants|Number|108|108.0||||||
3911521|NCT01460342|3734691|B3|Yes||Alcohol Use||participants|Number|402|402.0||||||
3911524|NCT01460342|3734691|B3|No||Current Tobacco Use||participants|Number|498|498.0||||||
3911525|NCT01460342|3734692|B2|No||Current Tobacco Use||participants|Number|249|249.0||||||
3911526|NCT01460342|3734693|B1|No||Current Tobacco Use||participants|Number|249|249.0||||||
3911527|NCT01460342|3734691|B3|Yes||Current Tobacco Use||participants|Number|112|112.0||||||
3911528|NCT01460342|3734692|B2|Yes||Current Tobacco Use||participants|Number|57|57.0||||||
3911529|NCT01460342|3734693|B1|Yes||Current Tobacco Use||participants|Number|55|55.0||||||
3911530|NCT01460342|3734691|B3|||Body Mass Index (BMI)|BMI was an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|24.0|24.0|Standard Deviation|3.0|3.0|||
3911531|NCT01460342|3734692|B2|||Body Mass Index (BMI)|BMI was an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|24.0|24.0|Standard Deviation|3.0|3.0|||
3911532|NCT01460342|3734693|B1|||Body Mass Index (BMI)|BMI was an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|24.1|24.1|Standard Deviation|2.9|2.9|||
3911533|NCT01460342|3734691|B3|Korea, Republic of||Region of Enrollment||participants|Number|161|161.0||||||
3911534|NCT01460342|3734692|B2|Korea, Republic of||Region of Enrollment||participants|Number|79|79.0||||||
3911535|NCT01460342|3734693|B1|Korea, Republic of||Region of Enrollment||participants|Number|82|82.0||||||
3911536|NCT01460342|3734691|B3|Japan||Region of Enrollment||participants|Number|449|449.0||||||
3911537|NCT01460342|3734692|B2|Japan||Region of Enrollment||participants|Number|227|227.0||||||
3911538|NCT01460342|3734693|B1|Japan||Region of Enrollment||participants|Number|222|222.0||||||
3911539|NCT01460342|3734691|B3|Asian||Race/Ethnicity, Customized||participants|Number|610|610.0||||||
3911540|NCT01460342|3734692|B2|Asian||Race/Ethnicity, Customized||participants|Number|306|306.0||||||
3911541|NCT01460342|3734693|B1|Asian||Race/Ethnicity, Customized||participants|Number|304|304.0||||||
3911542|NCT01460342|3734691|B3||Male|Sex: Female, Male||Participants|Count of Participants|610|610.0||||||
3911543|NCT01460342|3734692|B2||Male|Sex: Female, Male||Participants|Count of Participants|306|306.0||||||
3911544|NCT01460342|3734693|B1||Male|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
3911545|NCT01460342|3734691|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3911546|NCT01460342|3734692|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3911547|NCT01460342|3734693|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3911548|NCT01460342|3734691|B3|>=65 years||Age, Customized||participants|Number|211|211.0||||||
3911549|NCT01460342|3734692|B2|>=65 years||Age, Customized||participants|Number|108|108.0||||||
3911550|NCT01460342|3734693|B1|>=65 years||Age, Customized||participants|Number|103|103.0||||||
3911551|NCT01460342|3734691|B3|<65 years||Age, Customized||participants|Number|399|399.0||||||
3911552|NCT01460342|3734692|B2|<65 years||Age, Customized||participants|Number|198|198.0||||||
3911553|NCT01460342|3734693|B1|<65 years||Age, Customized||participants|Number|201|201.0||||||
3911554|NCT01460342|3734691|B3|||Age||years|Mean|60.9|60.9|Standard Deviation|7.9|7.9|||
3911555|NCT01460342|3734692|B2|||Age||years|Mean|60.8|60.8|Standard Deviation|7.7|7.7|||
3911556|NCT01460342|3734693|B1|||Age||years|Mean|60.9|60.9|Standard Deviation|8.1|8.1|||
3911557|NCT01460303|3734714|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
3911558|NCT01460303|3734715|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
3911559|NCT01460303|3734716|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3911560|NCT01460303|3734714|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3911561|NCT01460303|3734715|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3911562|NCT01460303|3734716|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3911563|NCT01460303|3734714|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911564|NCT01460303|3734715|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911565|NCT01460303|3734716|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911566|NCT01460303|3734714|B3||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3911567|NCT01460303|3734715|B2||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3911568|NCT01460303|3734716|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3911569|NCT01460303|3734714|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911570|NCT01460303|3734715|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911571|NCT01460303|3734716|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911572|NCT01460303|3734714|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911573|NCT01460303|3734715|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911574|NCT01460303|3734716|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911575|NCT01460303|3734714|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911576|NCT01460303|3734715|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911577|NCT01460303|3734716|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911578|NCT01460303|3734714|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911579|NCT01460303|3734715|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911580|NCT01460303|3734716|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911581|NCT01460303|3734714|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3911582|NCT01460303|3734715|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3911583|NCT01460303|3734716|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3911584|NCT01460303|3734714|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3911585|NCT01460303|3734715|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3911586|NCT01460303|3734716|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3911587|NCT01460303|3734714|B3|||Age||years|Mean|60.6|60.6|Standard Deviation|1.27|1.27|||
3911588|NCT01460303|3734715|B2|||Age||years|Mean|59.7|59.7|Standard Deviation|12.4|12.4|||
3911589|NCT01460303|3734716|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|12.4|12.4|||
3911590|NCT01460290|3734725|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3911591|NCT01460290|3734725|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3911592|NCT01460290|3734725|B1|||Age||years|Mean|68.6|68.6|Standard Deviation|6.1|6.1|||
3911593|NCT01460225|3734745|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3911594|NCT01460225|3734745|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3911595|NCT01460225|3734745|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3911596|NCT01460225|3734745|B1|||Age||years|Mean|42|42.0|Standard Deviation|12.5|12.5|||
3911597|NCT01460225|3734745|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3911598|NCT01460225|3734745|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3911599|NCT01460225|3734745|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3911600|NCT01460160|3734750|B3|P210||BCR-ABL Mutation||Participants|Count of Participants|16|16.0||||||
3911601|NCT01460160|3734751|B2|P210||BCR-ABL Mutation||Participants|Count of Participants|5|5.0||||||
3911602|NCT01460160|3734752|B1|P210||BCR-ABL Mutation||Participants|Count of Participants|11|11.0||||||
3911603|NCT01460160|3734750|B3|P190||BCR-ABL Mutation||Participants|Count of Participants|75|75.0||||||
3911604|NCT01460160|3734751|B2|P190||BCR-ABL Mutation||Participants|Count of Participants|15|15.0||||||
3911605|NCT01460160|3734752|B1|P190||BCR-ABL Mutation||Participants|Count of Participants|60|60.0||||||
3911606|NCT01460160|3734750|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3911607|NCT01460160|3734751|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911608|NCT01460160|3734752|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3911609|NCT01460160|3734750|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911610|NCT01460160|3734751|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911611|NCT01460160|3734752|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911612|NCT01460160|3734750|B3||White|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3911613|NCT01460160|3734751|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3911614|NCT01460160|3734752|B1||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3911615|NCT01460160|3734750|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3911616|NCT01460160|3734751|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3911617|NCT01460160|3734752|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3911618|NCT01460160|3734750|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3911619|NCT01460160|3734751|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911620|NCT01460160|3734752|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3911621|NCT01460160|3734750|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3911622|NCT01460160|3734751|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911623|NCT01460160|3734752|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3911624|NCT01460160|3734750|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3911625|NCT01460160|3734751|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3911626|NCT01460160|3734752|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911627|NCT01460160|3734750|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3911628|NCT01460160|3734751|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3911629|NCT01460160|3734752|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3911630|NCT01460160|3734750|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3911631|NCT01460160|3734751|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3911632|NCT01460160|3734752|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3911633|NCT01460160|3734750|B3|||Age||Years|Mean|9.29|9.29|Standard Deviation|4.467|4.467|||
3911634|NCT01460160|3734751|B2|||Age||Years|Mean|5.73|5.73|Standard Deviation|3.612|3.612|||
3911635|NCT01460160|3734752|B1|||Age||Years|Mean|10.33|10.33|Standard Deviation|4.160|4.16|||
3911636|NCT01459913|3734790|B5||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3911637|NCT01459913|3734791|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3911638|NCT01459913|3734792|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3911639|NCT01459913|3734793|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3911640|NCT01459913|3734794|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3911641|NCT01459913|3734790|B5||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3911642|NCT01459913|3734791|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3911643|NCT01459913|3734792|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3911644|NCT01459913|3734793|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3911645|NCT01459913|3734794|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3911646|NCT01459913|3734790|B5|||Age||years|Mean|47.4|47.4|Standard Deviation|12.26|12.26|||
3911647|NCT01459913|3734791|B4|||Age||years|Mean|49.8|49.8|Standard Deviation|10.56|10.56|||
3911648|NCT01459913|3734792|B3|||Age||years|Mean|54.4|54.4|Standard Deviation|8.70|8.7|||
3911649|NCT01459913|3734793|B2|||Age||years|Mean|44.8|44.8|Standard Deviation|12.89|12.89|||
3911650|NCT01459913|3734794|B1|||Age||years|Mean|46.1|46.1|Standard Deviation|12.82|12.82|||
3911651|NCT01459796|3734826|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911652|NCT01459796|3734827|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911653|NCT01459796|3734828|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911654|NCT01459796|3734826|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911655|NCT01459796|3734827|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911656|NCT01459796|3734828|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911657|NCT01459796|3734826|B3||White|Race (NIH/OMB)||Participants|Count of Participants|162|162.0||||||
3911658|NCT01459796|3734827|B2||White|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3911659|NCT01459796|3734828|B1||White|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3911660|NCT01459796|3734826|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3911661|NCT01459796|3734827|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3911662|NCT01459796|3734828|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3911663|NCT01459796|3734826|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3911664|NCT01459796|3734827|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3911665|NCT01459796|3734828|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911666|NCT01459796|3734826|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3911667|NCT01459796|3734827|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3911668|NCT01459796|3734828|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3911669|NCT01459796|3734826|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3911670|NCT01459796|3734827|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911671|NCT01459796|3734828|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3911672|NCT01459796|3734826|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911673|NCT01459796|3734827|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911674|NCT01459796|3734828|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911675|NCT01459796|3734826|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|207|207.0||||||
3911676|NCT01459796|3734827|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
3911677|NCT01459796|3734828|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3911678|NCT01459796|3734826|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3911679|NCT01459796|3734827|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3911680|NCT01459796|3734828|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3911681|NCT01459796|3734826|B3||Male|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
3911682|NCT01459796|3734827|B2||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3911683|NCT01459796|3734828|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3911684|NCT01459796|3734826|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3911685|NCT01459796|3734827|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3911686|NCT01459796|3734828|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3911687|NCT01459796|3734826|B3|||Age||years|Mean|51.9|51.9|Standard Deviation|10.95|10.95|||
3911688|NCT01459796|3734827|B2|||Age||years|Mean|52.1|52.1|Standard Deviation|11.18|11.18|||
3911689|NCT01459796|3734828|B1|||Age||years|Mean|51.5|51.5|Standard Deviation|10.69|10.69|||
3911690|NCT01459783|3734845|B3|Other||Relationship type to care recipient|This is the caregiver's relationship to the care recipient/person with dementia.|participants|Number|33|33.0||||||
3911691|NCT01459783|3734846|B2|Other||Relationship type to care recipient|This is the caregiver's relationship to the care recipient/person with dementia.|participants|Number|14|14.0||||||
3911692|NCT01459783|3734847|B1|Other||Relationship type to care recipient|This is the caregiver's relationship to the care recipient/person with dementia.|participants|Number|19|19.0||||||
3911693|NCT01459783|3734845|B3|Cousin/other relative||Relationship type to care recipient|This is the caregiver's relationship to the care recipient/person with dementia.|participants|Number|7|7.0||||||
3911694|NCT01459783|3734846|B2|Cousin/other relative||Relationship type to care recipient|This is the caregiver's relationship to the care recipient/person with dementia.|participants|Number|1|1.0||||||
3911695|NCT01459783|3734847|B1|Cousin/other relative||Relationship type to care recipient|This is the caregiver's relationship to the care recipient/person with dementia.|participants|Number|6|6.0||||||
3911696|NCT01459783|3734845|B3|Brother/sister||Relationship type to care recipient|This is the caregiver's relationship to the care recipient/person with dementia.|participants|Number|2|2.0||||||
3911697|NCT01459783|3734846|B2|Brother/sister||Relationship type to care recipient|This is the caregiver's relationship to the care recipient/person with dementia.|participants|Number|1|1.0||||||
3911698|NCT01459783|3734847|B1|Brother/sister||Relationship type to care recipient|This is the caregiver's relationship to the care recipient/person with dementia.|participants|Number|1|1.0||||||
3911699|NCT01459783|3734845|B3|Son/Daughter||Relationship type to care recipient|This is the caregiver's relationship to the care recipient/person with dementia.|participants|Number|77|77.0||||||
3911700|NCT01459783|3734846|B2|Son/Daughter||Relationship type to care recipient|This is the caregiver's relationship to the care recipient/person with dementia.|participants|Number|41|41.0||||||
3911701|NCT01459783|3734847|B1|Son/Daughter||Relationship type to care recipient|This is the caregiver's relationship to the care recipient/person with dementia.|participants|Number|36|36.0||||||
3911702|NCT01459783|3734845|B3|Spouse||Relationship type to care recipient|This is the caregiver's relationship to the care recipient/person with dementia.|participants|Number|25|25.0||||||
3911703|NCT01459783|3734846|B2|Spouse||Relationship type to care recipient|This is the caregiver's relationship to the care recipient/person with dementia.|participants|Number|16|16.0||||||
3911704|NCT01459783|3734847|B1|Spouse||Relationship type to care recipient|This is the caregiver's relationship to the care recipient/person with dementia.|participants|Number|9|9.0||||||
3911705|NCT01459783|3734845|B3|Other||Language spoken with friends and family|This is the caregiver's language spoken with friends and family|participants|Number|10|10.0||||||
3911706|NCT01459783|3734846|B2|Other||Language spoken with friends and family|This is the caregiver's language spoken with friends and family|participants|Number|3|3.0||||||
3911707|NCT01459783|3734847|B1|Other||Language spoken with friends and family|This is the caregiver's language spoken with friends and family|participants|Number|7|7.0||||||
3911708|NCT01459783|3734845|B3|Spanish||Language spoken with friends and family|This is the caregiver's language spoken with friends and family|participants|Number|85|85.0||||||
3911709|NCT01459783|3734846|B2|Spanish||Language spoken with friends and family|This is the caregiver's language spoken with friends and family|participants|Number|46|46.0||||||
3911710|NCT01459783|3734847|B1|Spanish||Language spoken with friends and family|This is the caregiver's language spoken with friends and family|participants|Number|39|39.0||||||
3911711|NCT01459783|3734845|B3|English||Language spoken with friends and family|This is the caregiver's language spoken with friends and family|participants|Number|49|49.0||||||
3911712|NCT01459783|3734846|B2|English||Language spoken with friends and family|This is the caregiver's language spoken with friends and family|participants|Number|24|24.0||||||
3911713|NCT01459783|3734847|B1|English||Language spoken with friends and family|This is the caregiver's language spoken with friends and family|participants|Number|25|25.0||||||
3911714|NCT01459783|3734845|B3|4-year college or more||Education|This is the caregiver's educational attainment|participants|Number|26|26.0||||||
3911715|NCT01459783|3734846|B2|4-year college or more||Education|This is the caregiver's educational attainment|participants|Number|11|11.0||||||
3911716|NCT01459783|3734847|B1|4-year college or more||Education|This is the caregiver's educational attainment|participants|Number|15|15.0||||||
3911717|NCT01459783|3734845|B3|Some college or 2-year degree||Education|This is the caregiver's educational attainment|participants|Number|34|34.0||||||
3911718|NCT01459783|3734846|B2|Some college or 2-year degree||Education|This is the caregiver's educational attainment|participants|Number|22|22.0||||||
3911719|NCT01459783|3734847|B1|Some college or 2-year degree||Education|This is the caregiver's educational attainment|participants|Number|12|12.0||||||
3911720|NCT01459783|3734845|B3|High school graduate or GED||Education|This is the caregiver's educational attainment|participants|Number|32|32.0||||||
3911721|NCT01459783|3734846|B2|High school graduate or GED||Education|This is the caregiver's educational attainment|participants|Number|13|13.0||||||
3911722|NCT01459783|3734847|B1|High school graduate or GED||Education|This is the caregiver's educational attainment|participants|Number|19|19.0||||||
3911723|NCT01459783|3734845|B3|Less than high school||Education|This is the caregiver's educational attainment|participants|Number|52|52.0||||||
3911724|NCT01459783|3734846|B2|Less than high school||Education|This is the caregiver's educational attainment|participants|Number|27|27.0||||||
3911725|NCT01459783|3734847|B1|Less than high school||Education|This is the caregiver's educational attainment|participants|Number|25|25.0||||||
3911726|NCT01459783|3734845|B3|Other||Race/Ethnicity, Customized|This is the caregiver's race/ethnicity|participants|Number|10|10.0||||||
3911727|NCT01459783|3734846|B2|Other||Race/Ethnicity, Customized|This is the caregiver's race/ethnicity|participants|Number|4|4.0||||||
3911728|NCT01459783|3734847|B1|Other||Race/Ethnicity, Customized|This is the caregiver's race/ethnicity|participants|Number|6|6.0||||||
3911729|NCT01459783|3734845|B3|Hispanic or Latino||Race/Ethnicity, Customized|This is the caregiver's race/ethnicity|participants|Number|112|112.0||||||
3911730|NCT01459783|3734846|B2|Hispanic or Latino||Race/Ethnicity, Customized|This is the caregiver's race/ethnicity|participants|Number|60|60.0||||||
3911731|NCT01459783|3734847|B1|Hispanic or Latino||Race/Ethnicity, Customized|This is the caregiver's race/ethnicity|participants|Number|52|52.0||||||
3911732|NCT01459783|3734845|B3|Caucasian or Euro-American||Race/Ethnicity, Customized|This is the caregiver's race/ethnicity|participants|Number|13|13.0||||||
3911733|NCT01459783|3734846|B2|Caucasian or Euro-American||Race/Ethnicity, Customized|This is the caregiver's race/ethnicity|participants|Number|6|6.0||||||
3911734|NCT01459783|3734847|B1|Caucasian or Euro-American||Race/Ethnicity, Customized|This is the caregiver's race/ethnicity|participants|Number|7|7.0||||||
3911735|NCT01459783|3734845|B3|African American||Race/Ethnicity, Customized|This is the caregiver's race/ethnicity|participants|Number|9|9.0||||||
3911736|NCT01459783|3734846|B2|African American||Race/Ethnicity, Customized|This is the caregiver's race/ethnicity|participants|Number|3|3.0||||||
3911737|NCT01459783|3734847|B1|African American||Race/Ethnicity, Customized|This is the caregiver's race/ethnicity|participants|Number|6|6.0||||||
3911738|NCT01459783|3734845|B3||Male|Sex: Female, Male|This is the caregiver's gender|Participants|Count of Participants|50|50.0||||||
3911739|NCT01459783|3734846|B2||Male|Sex: Female, Male|This is the caregiver's gender|Participants|Count of Participants|27|27.0||||||
3911740|NCT01459783|3734847|B1||Male|Sex: Female, Male|This is the caregiver's gender|Participants|Count of Participants|23|23.0||||||
3911741|NCT01459783|3734845|B3||Female|Sex: Female, Male|This is the caregiver's gender|Participants|Count of Participants|94|94.0||||||
3911742|NCT01459783|3734846|B2||Female|Sex: Female, Male|This is the caregiver's gender|Participants|Count of Participants|46|46.0||||||
3911743|NCT01459783|3734847|B1||Female|Sex: Female, Male|This is the caregiver's gender|Participants|Count of Participants|48|48.0||||||
3911744|NCT01459783|3734845|B3|||Age|This is the caregiver age.|years|Mean|49.53|49.53|Standard Deviation|13.53|13.53|||
3911745|NCT01459783|3734846|B2|||Age|This is the caregiver age.|years|Mean|50.95|50.95|Standard Deviation|12.71|12.71|||
3911746|NCT01459783|3734847|B1|||Age|This is the caregiver age.|years|Mean|48.07|48.07|Standard Deviation|14.28|14.28|||
3911747|NCT01459705|3734856|B4|United States||Region of Enrollment||participants|Number|162|162.0||||||
3911748|NCT01459705|3734857|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
3911749|NCT01459705|3734858|B2|United States||Region of Enrollment||participants|Number|54|54.0||||||
3911750|NCT01459705|3734859|B1|United States||Region of Enrollment||participants|Number|54|54.0||||||
3911751|NCT01459705|3734856|B4||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3911752|NCT01459705|3734857|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3911753|NCT01459705|3734858|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3911754|NCT01459705|3734859|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3911755|NCT01459705|3734856|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3911756|NCT01459705|3734857|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3911757|NCT01459705|3734858|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3911758|NCT01459705|3734859|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3911759|NCT01459705|3734856|B4|||Age||years|Mean|30.27|30.27|Standard Deviation|6.66|6.66|||
3911760|NCT01459705|3734857|B3|||Age||years|Mean|30.39|30.39|Standard Deviation|6.45|6.45|||
3911761|NCT01459705|3734858|B2|||Age||years|Mean|29.52|29.52|Standard Deviation|6.47|6.47|||
3911762|NCT01459705|3734859|B1|||Age||years|Mean|30.89|30.89|Standard Deviation|7.09|7.09|||
3911763|NCT01459705|3734856|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3911764|NCT01459705|3734857|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3911765|NCT01459705|3734858|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3911766|NCT01459705|3734859|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3911767|NCT01459705|3734856|B4||Between 18 and 65 years|Age||Participants|Count of Participants|162|162.0||||||
3911768|NCT01459705|3734857|B3||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3911769|NCT01459705|3734858|B2||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3911770|NCT01459705|3734859|B1||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3911771|NCT01459705|3734856|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3911772|NCT01459705|3734857|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3911773|NCT01459705|3734858|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3911774|NCT01459705|3734859|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3911775|NCT01459653|3734879|B1|Hematological tumor (n=330), Stage unknown||Cancer stage by tumor type|DLBCL: Diffuse Large B-cell Lymphoma; Solid tumors include breast, lung, ovary, prostate and bladder; hematologic cancers include lymphoma (DLBCL) and multiple myeloma|participants|Number|23|23.0||||||
3911776|NCT01459653|3734879|B1|Solid tumor (n=1117), Stage unknown||Cancer stage by tumor type|DLBCL: Diffuse Large B-cell Lymphoma; Solid tumors include breast, lung, ovary, prostate and bladder; hematologic cancers include lymphoma (DLBCL) and multiple myeloma|participants|Number|8|8.0||||||
3911777|NCT01459653|3734879|B1|Hematological tumor (n=330), Stage IV||Cancer stage by tumor type|DLBCL: Diffuse Large B-cell Lymphoma; Solid tumors include breast, lung, ovary, prostate and bladder; hematologic cancers include lymphoma (DLBCL) and multiple myeloma|participants|Number|151|151.0||||||
3911778|NCT01459653|3734879|B1|Hematological tumor (n=330), Stage III||Cancer stage by tumor type|DLBCL: Diffuse Large B-cell Lymphoma; Solid tumors include breast, lung, ovary, prostate and bladder; hematologic cancers include lymphoma (DLBCL) and multiple myeloma|participants|Number|156|156.0||||||
3911779|NCT01459653|3734879|B1|Solid tumor (n=1117), Stage IV||Cancer stage by tumor type|DLBCL: Diffuse Large B-cell Lymphoma; Solid tumors include breast, lung, ovary, prostate and bladder; hematologic cancers include lymphoma (DLBCL) and multiple myeloma|participants|Number|655|655.0||||||
3911780|NCT01459653|3734879|B1|Solid tumor (n=1117), Stage III||Cancer stage by tumor type|DLBCL: Diffuse Large B-cell Lymphoma; Solid tumors include breast, lung, ovary, prostate and bladder; hematologic cancers include lymphoma (DLBCL) and multiple myeloma|participants|Number|454|454.0||||||
3911781|NCT01459653|3734879|B1|Headache||History of prior clinical events|Table shows number of patients with a specific prior clinical event. Only such events with a relative frequency threshold of 1% are displayed. A patient may be counted in more than one or none of the events displayed.|participants|Number|28|28.0||||||
3911782|NCT01459653|3734879|B1|Joint pain||History of prior clinical events|Table shows number of patients with a specific prior clinical event. Only such events with a relative frequency threshold of 1% are displayed. A patient may be counted in more than one or none of the events displayed.|participants|Number|78|78.0||||||
3911783|NCT01459653|3734879|B1|Muscle pain||History of prior clinical events|Table shows number of patients with a specific prior clinical event. Only such events with a relative frequency threshold of 1% are displayed. A patient may be counted in more than one or none of the events displayed.|participants|Number|31|31.0||||||
3911784|NCT01459653|3734879|B1|Bone pain||History of prior clinical events|Table shows number of patients with a specific prior clinical event. Only such events with a relative frequency threshold of 1% are displayed. A patient may be counted in more than one or none of the events displayed.|participants|Number|116|116.0||||||
3911785|NCT01459653|3734879|B1|Diabetes mellitus||Cause(s) of prior repeated infections|35 patients had prior repeated infections. Only those causes of prior repeated infections are shown with a frequency threshold of 5% based on the 35 patients with prior repeated infections are displayed. A patient may be counted in more than one or none of the categories displayed.|participants|Number|2|2.0||||||
3911786|NCT01459653|3734879|B1|Immunosuppression||Cause(s) of prior repeated infections|35 patients had prior repeated infections. Only those causes of prior repeated infections are shown with a frequency threshold of 5% based on the 35 patients with prior repeated infections are displayed. A patient may be counted in more than one or none of the categories displayed.|participants|Number|3|3.0||||||
3911787|NCT01459653|3734879|B1|Urinary tract infections||Cause(s) of prior repeated infections|35 patients had prior repeated infections. Only those causes of prior repeated infections are shown with a frequency threshold of 5% based on the 35 patients with prior repeated infections are displayed. A patient may be counted in more than one or none of the categories displayed.|participants|Number|3|3.0||||||
3911788|NCT01459653|3734879|B1|High use of antibiotics||Cause(s) of prior repeated infections|35 patients had prior repeated infections. Only those causes of prior repeated infections are shown with a frequency threshold of 5% based on the 35 patients with prior repeated infections are displayed. A patient may be counted in more than one or none of the categories displayed.|participants|Number|3|3.0||||||
3911789|NCT01459653|3734879|B1|Cancer||Cause(s) of prior repeated infections|35 patients had prior repeated infections. Only those causes of prior repeated infections are shown with a frequency threshold of 5% based on the 35 patients with prior repeated infections are displayed. A patient may be counted in more than one or none of the categories displayed.|participants|Number|8|8.0||||||
3911790|NCT01459653|3734879|B1|Neutropenia||Cause(s) of prior repeated infections|35 patients had prior repeated infections. Only those causes of prior repeated infections are shown with a frequency threshold of 5% based on the 35 patients with prior repeated infections are displayed. A patient may be counted in more than one or none of the categories displayed.|participants|Number|11|11.0||||||
3911791|NCT01459653|3734879|B1|Respiratory infections||Cause(s) of prior repeated infections|35 patients had prior repeated infections. Only those causes of prior repeated infections are shown with a frequency threshold of 5% based on the 35 patients with prior repeated infections are displayed. A patient may be counted in more than one or none of the categories displayed.|participants|Number|15|15.0||||||
3911792|NCT01459653|3734879|B1|ECOG score Missing||ECOG score at enrollment|"ECOG (European Cooperative Oncology Group) score is a severity scale from 0 to 5 (highest) to grade toxicity and is defined as follows: 0=none, 1=mild, 2=moderate, 3=severe, 4=life-threatening, 5=lethal.~ECOG is described in more detail by Oken et al, Am J Clin Oncol (CCT) 5:649-655, 1982."|participants|Number|94|94.0||||||
3911793|NCT01459653|3734879|B1|ECOG Score 4||ECOG score at enrollment|"ECOG (European Cooperative Oncology Group) score is a severity scale from 0 to 5 (highest) to grade toxicity and is defined as follows: 0=none, 1=mild, 2=moderate, 3=severe, 4=life-threatening, 5=lethal.~ECOG is described in more detail by Oken et al, Am J Clin Oncol (CCT) 5:649-655, 1982."|participants|Number|1|1.0||||||
3911794|NCT01459653|3734879|B1|ECOG Score 3||ECOG score at enrollment|"ECOG (European Cooperative Oncology Group) score is a severity scale from 0 to 5 (highest) to grade toxicity and is defined as follows: 0=none, 1=mild, 2=moderate, 3=severe, 4=life-threatening, 5=lethal.~ECOG is described in more detail by Oken et al, Am J Clin Oncol (CCT) 5:649-655, 1982."|participants|Number|26|26.0||||||
3911795|NCT01459653|3734879|B1|ECOG Score 2||ECOG score at enrollment|"ECOG (European Cooperative Oncology Group) score is a severity scale from 0 to 5 (highest) to grade toxicity and is defined as follows: 0=none, 1=mild, 2=moderate, 3=severe, 4=life-threatening, 5=lethal.~ECOG is described in more detail by Oken et al, Am J Clin Oncol (CCT) 5:649-655, 1982."|participants|Number|121|121.0||||||
3911796|NCT01459653|3734879|B1|ECOG Score 1||ECOG score at enrollment|"ECOG (European Cooperative Oncology Group) score is a severity scale from 0 to 5 (highest) to grade toxicity and is defined as follows: 0=none, 1=mild, 2=moderate, 3=severe, 4=life-threatening, 5=lethal.~ECOG is described in more detail by Oken et al, Am J Clin Oncol (CCT) 5:649-655, 1982."|participants|Number|652|652.0||||||
3911797|NCT01459653|3734879|B1|ECOG Score 0||ECOG score at enrollment|"ECOG (European Cooperative Oncology Group) score is a severity scale from 0 to 5 (highest) to grade toxicity and is defined as follows: 0=none, 1=mild, 2=moderate, 3=severe, 4=life-threatening, 5=lethal.~ECOG is described in more detail by Oken et al, Am J Clin Oncol (CCT) 5:649-655, 1982."|participants|Number|553|553.0||||||
3911798|NCT01459653|3734879|B1|Antiviral||Treatment(s) for prior infections|35 patients had prior infections. A patient can fall into more than category of prior infection treatment.|participants|Number|1|1.0||||||
3911799|NCT01459653|3734879|B1|GCSF||Treatment(s) for prior infections|35 patients had prior infections. A patient can fall into more than category of prior infection treatment.|participants|Number|2|2.0||||||
3911800|NCT01459653|3734879|B1|Antifungal||Treatment(s) for prior infections|35 patients had prior infections. A patient can fall into more than category of prior infection treatment.|participants|Number|2|2.0||||||
3911801|NCT01459653|3734879|B1|Antibiotic||Treatment(s) for prior infections|35 patients had prior infections. A patient can fall into more than category of prior infection treatment.|participants|Number|33|33.0||||||
3911802|NCT01459653|3734879|B1|Prior treatments for CIN/FN (antipyretics)||History of prior CIN/FN and prior CIN/FN treatments|History of prior CIN/FN and prior CIN/FN treatment is recorded. A patient can fall into more than one or none of the categories displayed.|participants|Number|12|12.0||||||
3911803|NCT01459653|3734879|B1|Prior treatments for CIN/FN (corticosteroids)||History of prior CIN/FN and prior CIN/FN treatments|History of prior CIN/FN and prior CIN/FN treatment is recorded. A patient can fall into more than one or none of the categories displayed.|participants|Number|5|5.0||||||
3911804|NCT01459653|3734879|B1|Prior treatments for CIN/FN (antifungal)||History of prior CIN/FN and prior CIN/FN treatments|History of prior CIN/FN and prior CIN/FN treatment is recorded. A patient can fall into more than one or none of the categories displayed.|participants|Number|7|7.0||||||
3911910|NCT01459588|3735028|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3911805|NCT01459653|3734879|B1|Prior treatments for CIN/FN (antiviral)||History of prior CIN/FN and prior CIN/FN treatments|History of prior CIN/FN and prior CIN/FN treatment is recorded. A patient can fall into more than one or none of the categories displayed.|participants|Number|0|0.0||||||
3911806|NCT01459653|3734879|B1|Prior treatments for CIN/FN (antibiotics)||History of prior CIN/FN and prior CIN/FN treatments|History of prior CIN/FN and prior CIN/FN treatment is recorded. A patient can fall into more than one or none of the categories displayed.|participants|Number|44|44.0||||||
3911807|NCT01459653|3734879|B1|Prior treatments for CIN/FN (CSF therapy)||History of prior CIN/FN and prior CIN/FN treatments|History of prior CIN/FN and prior CIN/FN treatment is recorded. A patient can fall into more than one or none of the categories displayed.|participants|Number|55|55.0||||||
3911808|NCT01459653|3734879|B1|Any chemotherapy disturbance due to CIN/FN||History of prior CIN/FN and prior CIN/FN treatments|History of prior CIN/FN and prior CIN/FN treatment is recorded. A patient can fall into more than one or none of the categories displayed.|participants|Number|48|48.0||||||
3911809|NCT01459653|3734879|B1|Hospitalization for CIN/FN||History of prior CIN/FN and prior CIN/FN treatments|History of prior CIN/FN and prior CIN/FN treatment is recorded. A patient can fall into more than one or none of the categories displayed.|participants|Number|33|33.0||||||
3911810|NCT01459653|3734879|B1|Prior FN||History of prior CIN/FN and prior CIN/FN treatments|History of prior CIN/FN and prior CIN/FN treatment is recorded. A patient can fall into more than one or none of the categories displayed.|participants|Number|27|27.0||||||
3911811|NCT01459653|3734879|B1|Prior CIN grade 4 episodes (missing)||History of prior CIN/FN and prior CIN/FN treatments|History of prior CIN/FN and prior CIN/FN treatment is recorded. A patient can fall into more than one or none of the categories displayed.|participants|Number|7|7.0||||||
3911812|NCT01459653|3734879|B1|Prior CIN grade 4 episodes (≥3)||History of prior CIN/FN and prior CIN/FN treatments|History of prior CIN/FN and prior CIN/FN treatment is recorded. A patient can fall into more than one or none of the categories displayed.|participants|Number|15|15.0||||||
3911813|NCT01459653|3734879|B1|Prior CIN grade 4 episodes (2)||History of prior CIN/FN and prior CIN/FN treatments|History of prior CIN/FN and prior CIN/FN treatment is recorded. A patient can fall into more than one or none of the categories displayed.|participants|Number|5|5.0||||||
3911814|NCT01459653|3734879|B1|Prior CIN grade 4 episodes (1)||History of prior CIN/FN and prior CIN/FN treatments|History of prior CIN/FN and prior CIN/FN treatment is recorded. A patient can fall into more than one or none of the categories displayed.|participants|Number|79|79.0||||||
3911815|NCT01459653|3734879|B1|Prior CIN grade 4 episodes (any)||History of prior CIN/FN and prior CIN/FN treatments|History of prior CIN/FN and prior CIN/FN treatment is recorded. A patient can fall into more than one or none of the categories displayed.|participants|Number|106|106.0||||||
3911816|NCT01459653|3734879|B1|Chemotherapy cycle at study entry (6)||Cancer treatment||participants|Number|17|17.0||||||
3911817|NCT01459653|3734879|B1|Chemotherapy cycle at study entry (5)||Cancer treatment||participants|Number|26|26.0||||||
3911818|NCT01459653|3734879|B1|Chemotherapy cycle at study entry (4)||Cancer treatment||participants|Number|44|44.0||||||
3911819|NCT01459653|3734879|B1|Chemotherapy cycle at study entry (3)||Cancer treatment||participants|Number|93|93.0||||||
3911820|NCT01459653|3734879|B1|Chemotherapy cycle at study entry (2)||Cancer treatment||participants|Number|221|221.0||||||
3911821|NCT01459653|3734879|B1|Chemotherapy cycle at study entry (1)||Cancer treatment||participants|Number|1046|1046.0||||||
3911822|NCT01459653|3734879|B1|Prior Chemotherapy, metastatic setting||Prior cancer treatments|Prior cancer treatments for all patients are recorded. A patient can have more than one prior cancer treatment. In addition, prior chemotherapy is also displayed by adjuvant or metastatic setting for those patients for whom this information was available.|participants|Number|206|206.0||||||
3911823|NCT01459653|3734879|B1|Prior Chemotherapy, Adjuvant||Prior cancer treatments|Prior cancer treatments for all patients are recorded. A patient can have more than one prior cancer treatment. In addition, prior chemotherapy is also displayed by adjuvant or metastatic setting for those patients for whom this information was available.|participants|Number|196|196.0||||||
3911824|NCT01459653|3734879|B1|Other (including CAM)||Prior cancer treatments|Prior cancer treatments for all patients are recorded. A patient can have more than one prior cancer treatment. In addition, prior chemotherapy is also displayed by adjuvant or metastatic setting for those patients for whom this information was available.|participants|Number|25|25.0||||||
3911825|NCT01459653|3734879|B1|Bone marrow transplant||Prior cancer treatments|Prior cancer treatments for all patients are recorded. A patient can have more than one prior cancer treatment. In addition, prior chemotherapy is also displayed by adjuvant or metastatic setting for those patients for whom this information was available.|participants|Number|12|12.0||||||
3911826|NCT01459653|3734879|B1|Targeted therapy||Prior cancer treatments|Prior cancer treatments for all patients are recorded. A patient can have more than one prior cancer treatment. In addition, prior chemotherapy is also displayed by adjuvant or metastatic setting for those patients for whom this information was available.|participants|Number|45|45.0||||||
3911827|NCT01459653|3734879|B1|Hormonal therapy||Prior cancer treatments|Prior cancer treatments for all patients are recorded. A patient can have more than one prior cancer treatment. In addition, prior chemotherapy is also displayed by adjuvant or metastatic setting for those patients for whom this information was available.|participants|Number|198|198.0||||||
3911828|NCT01459653|3734879|B1|Radiation therapy||Prior cancer treatments|Prior cancer treatments for all patients are recorded. A patient can have more than one prior cancer treatment. In addition, prior chemotherapy is also displayed by adjuvant or metastatic setting for those patients for whom this information was available.|participants|Number|274|274.0||||||
3911829|NCT01459653|3734879|B1|Chemotherapy||Prior cancer treatments|Prior cancer treatments for all patients are recorded. A patient can have more than one prior cancer treatment. In addition, prior chemotherapy is also displayed by adjuvant or metastatic setting for those patients for whom this information was available.|participants|Number|460|460.0||||||
3911830|NCT01459653|3734879|B1|Surgery||Prior cancer treatments|Prior cancer treatments for all patients are recorded. A patient can have more than one prior cancer treatment. In addition, prior chemotherapy is also displayed by adjuvant or metastatic setting for those patients for whom this information was available.|participants|Number|472|472.0||||||
3911831|NCT01459653|3734879|B1|None||Prior cancer treatments|Prior cancer treatments for all patients are recorded. A patient can have more than one prior cancer treatment. In addition, prior chemotherapy is also displayed by adjuvant or metastatic setting for those patients for whom this information was available.|participants|Number|518|518.0||||||
3911832|NCT01459653|3734879|B1|Overall, unknown||Cancer stage & type|Table presents cancer stage by cancer stage. In addition, table presents cancer stage for all patients.|participants|Number|31|31.0||||||
3911833|NCT01459653|3734879|B1|Multiple myeloma (unknown, N=85)||Cancer stage & type|Table presents cancer stage by cancer stage. In addition, table presents cancer stage for all patients.|participants|Number|16|16.0||||||
3911834|NCT01459653|3734879|B1|Lymphoma (DLBCL) (unknown, n=245)||Cancer stage & type|Table presents cancer stage by cancer stage. In addition, table presents cancer stage for all patients.|participants|Number|7|7.0||||||
3911835|NCT01459653|3734879|B1|Lung (unknown, n=345)||Cancer stage & type|Table presents cancer stage by cancer stage. In addition, table presents cancer stage for all patients.|participants|Number|3|3.0||||||
3911836|NCT01459653|3734879|B1|Breast (unknown, n=466)||Cancer stage & type|Table presents cancer stage by cancer stage. In addition, table presents cancer stage for all patients.|participants|Number|5|5.0||||||
3911837|NCT01459653|3734879|B1|Overall, Stage IV||Cancer stage & type|Table presents cancer stage by cancer stage. In addition, table presents cancer stage for all patients.|participants|Number|806|806.0||||||
3911838|NCT01459653|3734879|B1|Overall, Stage III||Cancer stage & type|Table presents cancer stage by cancer stage. In addition, table presents cancer stage for all patients.|participants|Number|610|610.0||||||
3911839|NCT01459653|3734879|B1|Bladder (stage IV, n=64)||Cancer stage & type|Table presents cancer stage by cancer stage. In addition, table presents cancer stage for all patients.|participants|Number|48|48.0||||||
3911840|NCT01459653|3734879|B1|Bladder (stage III, n=64)||Cancer stage & type|Table presents cancer stage by cancer stage. In addition, table presents cancer stage for all patients.|participants|Number|16|16.0||||||
3911841|NCT01459653|3734879|B1|Multiple myeloma (stage IV, n=85)||Cancer stage & type|Table presents cancer stage by cancer stage. In addition, table presents cancer stage for all patients.|participants|Number|16|16.0||||||
3911842|NCT01459653|3734879|B1|Multiple myeloma (stage III, n=85)||Cancer stage & type|Table presents cancer stage by cancer stage. In addition, table presents cancer stage for all patients.|participants|Number|53|53.0||||||
3911843|NCT01459653|3734879|B1|Prostate (stage IV, n=102)||Cancer stage & type|Table presents cancer stage by cancer stage. In addition, table presents cancer stage for all patients.|participants|Number|95|95.0||||||
3911844|NCT01459653|3734879|B1|Prostate (stage III, n=102)||Cancer stage & type|Table presents cancer stage by cancer stage. In addition, table presents cancer stage for all patients.|participants|Number|7|7.0||||||
3911845|NCT01459653|3734879|B1|Ovarian (stage IV, n=140)||Cancer stage & type|Table presents cancer stage by cancer stage. In addition, table presents cancer stage for all patients.|participants|Number|77|77.0||||||
3911846|NCT01459653|3734879|B1|Ovarian (stage III, n=140)||Cancer stage & type|Table presents cancer stage by cancer stage. In addition, table presents cancer stage for all patients.|participants|Number|63|63.0||||||
3911847|NCT01459653|3734879|B1|Lymphoma (DLBCL) (stage IV, n=245)||Cancer stage & type|Table presents cancer stage by cancer stage. In addition, table presents cancer stage for all patients.|participants|Number|135|135.0||||||
3911848|NCT01459653|3734879|B1|Lymphoma (DLBCL) (stage III, n=245)||Cancer stage & type|Table presents cancer stage by cancer stage. In addition, table presents cancer stage for all patients.|participants|Number|103|103.0||||||
3911849|NCT01459653|3734879|B1|Lung (stage IV, n=345)||Cancer stage & type|Table presents cancer stage by cancer stage. In addition, table presents cancer stage for all patients.|participants|Number|241|241.0||||||
3911850|NCT01459653|3734879|B1|Lung (stage III, n=345)||Cancer stage & type|Table presents cancer stage by cancer stage. In addition, table presents cancer stage for all patients.|participants|Number|101|101.0||||||
3911851|NCT01459653|3734879|B1|Breast (stage IV, n=466)||Cancer stage & type|Table presents cancer stage by cancer stage. In addition, table presents cancer stage for all patients.|participants|Number|194|194.0||||||
3911852|NCT01459653|3734879|B1|Breast (stage III, n=466)||Cancer stage & type|Table presents cancer stage by cancer stage. In addition, table presents cancer stage for all patients.|participants|Number|267|267.0||||||
3911853|NCT01459653|3734879|B1|Bladder||Cancer type||participants|Number|64|64.0||||||
3911854|NCT01459653|3734879|B1|Multiple myeloma||Cancer type||participants|Number|85|85.0||||||
3911855|NCT01459653|3734879|B1|Prostate||Cancer type||participants|Number|102|102.0||||||
3911856|NCT01459653|3734879|B1|Ovarian||Cancer type||participants|Number|140|140.0||||||
3911857|NCT01459653|3734879|B1|Lymphoma (DLBCL)||Cancer type||participants|Number|245|245.0||||||
3911858|NCT01459653|3734879|B1|Lung||Cancer type||participants|Number|345|345.0||||||
3911859|NCT01459653|3734879|B1|Breast||Cancer type||participants|Number|466|466.0||||||
3911860|NCT01459653|3734879|B1|3 or more infectious episodes in past 3 months||History of repeated infections|History of repeated infections for each patient was recoded. A patient can fall into more than one or none of the categories displayed.|participants|Number|3|3.0||||||
3911861|NCT01459653|3734879|B1|2 infectious episodes in past 3 months||History of repeated infections|History of repeated infections for each patient was recoded. A patient can fall into more than one or none of the categories displayed.|participants|Number|7|7.0||||||
3911862|NCT01459653|3734879|B1|1 infectious episode in past 3 months||History of repeated infections|History of repeated infections for each patient was recoded. A patient can fall into more than one or none of the categories displayed.|participants|Number|15|15.0||||||
3911863|NCT01459653|3734879|B1|Type of repeated infection (recurrent, acute)||History of repeated infections|History of repeated infections for each patient was recoded. A patient can fall into more than one or none of the categories displayed.|participants|Number|27|27.0||||||
3911864|NCT01459653|3734879|B1|Type of repeated infection (chronic)||History of repeated infections|History of repeated infections for each patient was recoded. A patient can fall into more than one or none of the categories displayed.|participants|Number|8|8.0||||||
3911911|NCT01459588|3735029|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3911912|NCT01459588|3735025|B5|>40 years||Age, Customized||Participants|Number|262|262.0||||||
3911865|NCT01459653|3734879|B1|History of any repeated infection||History of repeated infections|History of repeated infections for each patient was recoded. A patient can fall into more than one or none of the categories displayed.|participants|Number|35|35.0||||||
3911866|NCT01459653|3734879|B1|COPD||Comorbidities|Comorbidities for each patient were recorded. Only those comorbidities with a relative frequency of 5% or more are displayed in the table. A patient can fall into more than one or none of the categories displayed.|participants|Number|86|86.0||||||
3911867|NCT01459653|3734879|B1|Allergies||Comorbidities|Comorbidities for each patient were recorded. Only those comorbidities with a relative frequency of 5% or more are displayed in the table. A patient can fall into more than one or none of the categories displayed.|participants|Number|90|90.0||||||
3911868|NCT01459653|3734879|B1|Coronary disease||Comorbidities|Comorbidities for each patient were recorded. Only those comorbidities with a relative frequency of 5% or more are displayed in the table. A patient can fall into more than one or none of the categories displayed.|participants|Number|93|93.0||||||
3911869|NCT01459653|3734879|B1|Diabetes Type II||Comorbidities|Comorbidities for each patient were recorded. Only those comorbidities with a relative frequency of 5% or more are displayed in the table. A patient can fall into more than one or none of the categories displayed.|participants|Number|122|122.0||||||
3911870|NCT01459653|3734879|B1|Anemia||Comorbidities|Comorbidities for each patient were recorded. Only those comorbidities with a relative frequency of 5% or more are displayed in the table. A patient can fall into more than one or none of the categories displayed.|participants|Number|138|138.0||||||
3911871|NCT01459653|3734879|B1|Hypertension||Comorbidities|Comorbidities for each patient were recorded. Only those comorbidities with a relative frequency of 5% or more are displayed in the table. A patient can fall into more than one or none of the categories displayed.|participants|Number|458|458.0||||||
3911872|NCT01459653|3734879|B1|Skin hemorrhage||Medical history|Medical history for each patient was recorded. A patient can fall into more than one or none of the categories displayed.|participants|Number|1|1.0||||||
3911873|NCT01459653|3734879|B1|GI bleeding||Medical history|Medical history for each patient was recorded. A patient can fall into more than one or none of the categories displayed.|participants|Number|7|7.0||||||
3911874|NCT01459653|3734879|B1|Epistaxis||Medical history|Medical history for each patient was recorded. A patient can fall into more than one or none of the categories displayed.|participants|Number|8|8.0||||||
3911875|NCT01459653|3734879|B1|Headache||Medical history|Medical history for each patient was recorded. A patient can fall into more than one or none of the categories displayed.|participants|Number|28|28.0||||||
3911876|NCT01459653|3734879|B1|Muscle pain||Medical history|Medical history for each patient was recorded. A patient can fall into more than one or none of the categories displayed.|participants|Number|31|31.0||||||
3911877|NCT01459653|3734879|B1|Joint pain||Medical history|Medical history for each patient was recorded. A patient can fall into more than one or none of the categories displayed.|participants|Number|78|78.0||||||
3911878|NCT01459653|3734879|B1|Bone pain||Medical history|Medical history for each patient was recorded. A patient can fall into more than one or none of the categories displayed.|participants|Number|116|116.0||||||
3911879|NCT01459653|3734879|B1|||Body-Mass Index (BMI)|Number of participants analyzed: 1354|kg/m^2|Mean|26.3|26.3|Standard Deviation|5.0|5.0|||
3911880|NCT01459653|3734879|B1|||Weight|Number of participants analyzed: 1357|kg|Mean|72.1|72.1|Standard Deviation|15.0|15.0|||
3911881|NCT01459653|3734879|B1|||Height|Number of participants analyzed: 1358|cm|Mean|165.6|165.6|Standard Deviation|8.5|8.5|||
3911882|NCT01459653|3734879|B1|Italy||Region of Enrollment||participants|Number|175|175.0||||||
3911883|NCT01459653|3734879|B1|Switzerland||Region of Enrollment||participants|Number|11|11.0||||||
3911884|NCT01459653|3734879|B1|United Kingdom||Region of Enrollment||participants|Number|32|32.0||||||
3911885|NCT01459653|3734879|B1|Germany||Region of Enrollment||participants|Number|145|145.0||||||
3911886|NCT01459653|3734879|B1|Austria||Region of Enrollment||participants|Number|27|27.0||||||
3911887|NCT01459653|3734879|B1|Romania||Region of Enrollment||participants|Number|64|64.0||||||
3911888|NCT01459653|3734879|B1|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
3911889|NCT01459653|3734879|B1|Poland||Region of Enrollment||participants|Number|286|286.0||||||
3911890|NCT01459653|3734879|B1|Spain||Region of Enrollment||participants|Number|116|116.0||||||
3911891|NCT01459653|3734879|B1|Czech Republic||Region of Enrollment||participants|Number|50|50.0||||||
3911892|NCT01459653|3734879|B1|Hungary||Region of Enrollment||participants|Number|143|143.0||||||
3911893|NCT01459653|3734879|B1|France||Region of Enrollment||participants|Number|395|395.0||||||
3911894|NCT01459653|3734879|B1|Missing||Race/Ethnicity, Customized||participants|Number|395|395.0||||||
3911895|NCT01459653|3734879|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3911896|NCT01459653|3734879|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3911897|NCT01459653|3734879|B1|African||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3911898|NCT01459653|3734879|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|1042|1042.0||||||
3911899|NCT01459653|3734879|B1||Male|Sex: Female, Male||Participants|Count of Participants|561|561.0||||||
3911900|NCT01459653|3734879|B1||Female|Sex: Female, Male||Participants|Count of Participants|886|886.0||||||
3911901|NCT01459653|3734879|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|11.8|11.8|||
3911902|NCT01459588|3735025|B5||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3911903|NCT01459588|3735026|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3911904|NCT01459588|3735027|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3911905|NCT01459588|3735028|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3911906|NCT01459588|3735029|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3911907|NCT01459588|3735025|B5||Female|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
3911908|NCT01459588|3735026|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3911909|NCT01459588|3735027|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3911913|NCT01459588|3735026|B4|>40 years||Age, Customized||Participants|Number|48|48.0||||||
3911914|NCT01459588|3735027|B3|>40 years||Age, Customized||Participants|Number|85|85.0||||||
3911915|NCT01459588|3735028|B2|>40 years||Age, Customized||Participants|Number|43|43.0||||||
3911916|NCT01459588|3735029|B1|>40 years||Age, Customized||Participants|Number|86|86.0||||||
3911917|NCT01459588|3735025|B5|30 to 40 years||Age, Customized||Participants|Number|28|28.0||||||
3911918|NCT01459588|3735026|B4|30 to 40 years||Age, Customized||Participants|Number|3|3.0||||||
3911919|NCT01459588|3735027|B3|30 to 40 years||Age, Customized||Participants|Number|12|12.0||||||
3911920|NCT01459588|3735028|B2|30 to 40 years||Age, Customized||Participants|Number|3|3.0||||||
3911921|NCT01459588|3735029|B1|30 to 40 years||Age, Customized||Participants|Number|10|10.0||||||
3911922|NCT01459588|3735025|B5|<30 years||Age, Customized||Participants|Number|25|25.0||||||
3911923|NCT01459588|3735026|B4|<30 years||Age, Customized||Participants|Number|5|5.0||||||
3911924|NCT01459588|3735027|B3|<30 years||Age, Customized||Participants|Number|6|6.0||||||
3911925|NCT01459588|3735028|B2|<30 years||Age, Customized||Participants|Number|5|5.0||||||
3911926|NCT01459588|3735029|B1|<30 years||Age, Customized||Participants|Number|9|9.0||||||
3911927|NCT01459068|3735058|B3||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3911928|NCT01459068|3735059|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3911929|NCT01459068|3735060|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3911930|NCT01459068|3735058|B3||Female|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
3911931|NCT01459068|3735059|B2||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3911932|NCT01459068|3735060|B1||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3911933|NCT01459068|3735058|B3|||Age||years|Mean|35.4|35.4|Standard Deviation|12.1|12.1|||
3911934|NCT01459068|3735059|B2|||Age||years|Mean|36.5|36.5|Standard Deviation|12.6|12.6|||
3911935|NCT01459068|3735060|B1|||Age||years|Mean|34.3|34.3|Standard Deviation|11.4|11.4|||
3911936|NCT01459016|3735077|B1|France||Region of Enrollment||Participants|Count of Participants|56|56.0||||||
3911937|NCT01459016|3735077|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3911938|NCT01459016|3735077|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3911939|NCT01459016|3735077|B1|||Age||years|Mean|73.2|73.2|Standard Deviation|7.7|7.7|||
3911940|NCT01458990|3735091|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
3911941|NCT01458990|3735092|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3911942|NCT01458990|3735093|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
3911943|NCT01458990|3735091|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911944|NCT01458990|3735092|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911945|NCT01458990|3735093|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911946|NCT01458990|3735091|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911947|NCT01458990|3735092|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911948|NCT01458990|3735093|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911949|NCT01458990|3735091|B3||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3911950|NCT01458990|3735092|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3911951|NCT01458990|3735093|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3911952|NCT01458990|3735091|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3911953|NCT01458990|3735092|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3911954|NCT01458990|3735093|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3911955|NCT01458990|3735091|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911956|NCT01458990|3735092|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911957|NCT01458990|3735093|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911958|NCT01458990|3735091|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911959|NCT01458990|3735092|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911960|NCT01458990|3735093|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911961|NCT01458990|3735091|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911962|NCT01458990|3735092|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911963|NCT01458990|3735093|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3911964|NCT01458990|3735091|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3911965|NCT01458990|3735092|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3911966|NCT01458990|3735093|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3911967|NCT01458990|3735091|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3911968|NCT01458990|3735092|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3911969|NCT01458990|3735093|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3911970|NCT01458990|3735091|B3|||Age||years|Mean|58|58.0|Standard Deviation|7.0|7.0|||
3911971|NCT01458990|3735092|B2|||Age||years|Mean|59|59.0|Standard Deviation|6.7|6.7|||
3911972|NCT01458990|3735093|B1|||Age||years|Mean|58|58.0|Standard Deviation|7.6|7.6|||
3911973|NCT01458990|3735091|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3911974|NCT01458990|3735092|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3911975|NCT01458990|3735093|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3911976|NCT01458990|3735091|B3||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3911977|NCT01458990|3735092|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3911978|NCT01458990|3735093|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3911979|NCT01458990|3735091|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3911980|NCT01458990|3735092|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3911981|NCT01458990|3735093|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3911982|NCT01458951|3735102|B4||Male|Sex: Female, Male||Participants|Count of Participants|317|317.0||||||
3911983|NCT01458951|3735103|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3911984|NCT01458951|3735104|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3911985|NCT01458951|3735105|B1||Male|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
3911986|NCT01458951|3735102|B4||Female|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
3911987|NCT01458951|3735103|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3911988|NCT01458951|3735104|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3911989|NCT01458951|3735105|B1||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
3911990|NCT01458951|3735102|B4|Greater Than or Equal to (>=) 65 Years||Age, Customized||participants|Number|30|30.0||||||
3911991|NCT01458951|3735103|B3|Greater Than or Equal to (>=) 65 Years||Age, Customized||participants|Number|5|5.0||||||
3911992|NCT01458951|3735104|B2|Greater Than or Equal to (>=) 65 Years||Age, Customized||participants|Number|0|0.0||||||
3911993|NCT01458951|3735105|B1|Greater Than or Equal to (>=) 65 Years||Age, Customized||participants|Number|25|25.0||||||
3911994|NCT01458951|3735102|B4|45 to 64 Years||Age, Customized||participants|Number|175|175.0||||||
3911995|NCT01458951|3735103|B3|45 to 64 Years||Age, Customized||participants|Number|35|35.0||||||
3911996|NCT01458951|3735104|B2|45 to 64 Years||Age, Customized||participants|Number|1|1.0||||||
3911997|NCT01458951|3735105|B1|45 to 64 Years||Age, Customized||participants|Number|139|139.0||||||
3911998|NCT01458951|3735102|B4|18 to 44 Years||Age, Customized||participants|Number|342|342.0||||||
3911999|NCT01458951|3735103|B3|18 to 44 Years||Age, Customized||participants|Number|72|72.0||||||
3912000|NCT01458951|3735104|B2|18 to 44 Years||Age, Customized||participants|Number|5|5.0||||||
3912001|NCT01458951|3735105|B1|18 to 44 Years||Age, Customized||participants|Number|265|265.0||||||
3912002|NCT01458639|3735132|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3912003|NCT01458639|3735132|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912004|NCT01458639|3735132|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912005|NCT01458639|3735132|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3912006|NCT01458639|3735132|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3912007|NCT01458639|3735132|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912008|NCT01458639|3735132|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912009|NCT01458639|3735132|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912010|NCT01458639|3735132|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912011|NCT01458639|3735132|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3912012|NCT01458639|3735132|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3912013|NCT01458639|3735132|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3912014|NCT01458639|3735132|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3912015|NCT01458639|3735132|B1|||Age||years|Mean|59.5|59.5|Full Range|||34.0|81.0|
3912016|NCT01458639|3735132|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3912017|NCT01458639|3735132|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3912018|NCT01458639|3735132|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3912019|NCT01458587|3735142|B3|United States||Region of Enrollment||participants|Number|70|70.0||||||
3912020|NCT01458587|3735143|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
3912021|NCT01458587|3735144|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3912022|NCT01458587|3735142|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912023|NCT01458587|3735143|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912024|NCT01458587|3735144|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912025|NCT01458587|3735142|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912026|NCT01458587|3735143|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912027|NCT01458587|3735144|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912028|NCT01458587|3735142|B3||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3912029|NCT01458587|3735143|B2||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3912030|NCT01458587|3735144|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3912031|NCT01458587|3735142|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912032|NCT01458587|3735143|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912033|NCT01458587|3735144|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912034|NCT01458587|3735142|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912035|NCT01458587|3735143|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912036|NCT01458587|3735144|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912037|NCT01458587|3735142|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912038|NCT01458587|3735143|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912039|NCT01458587|3735144|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912040|NCT01458587|3735142|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912041|NCT01458587|3735143|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912042|NCT01458587|3735144|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912043|NCT01458587|3735142|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912044|NCT01458587|3735143|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912045|NCT01458587|3735144|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912046|NCT01458587|3735142|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3912047|NCT01458587|3735143|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3912048|NCT01458587|3735144|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3912049|NCT01458587|3735142|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912050|NCT01458587|3735143|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912051|NCT01458587|3735144|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912052|NCT01458587|3735142|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3912053|NCT01458587|3735143|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3912054|NCT01458587|3735144|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3912055|NCT01458587|3735142|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3912056|NCT01458587|3735143|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3912057|NCT01458587|3735144|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3912058|NCT01458587|3735142|B3|||Age||years|Mean|63.8|63.8|Standard Deviation|9.72|9.72|||
3912059|NCT01458587|3735143|B2|||Age||years|Mean|65.6|65.6|Standard Deviation|9.30|9.3|||
3912060|NCT01458587|3735144|B1|||Age||years|Mean|62.1|62.1|Standard Deviation|9.96|9.96|||
3912061|NCT01458574|3735305|B4||Male|Sex: Female, Male||Participants|Count of Participants|329|329.0||||||
3912062|NCT01458574|3735306|B3||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3912063|NCT01458574|3735307|B2||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3912064|NCT01458574|3735308|B1||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3912065|NCT01458574|3735305|B4||Female|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
3912066|NCT01458574|3735306|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3912067|NCT01458574|3735307|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3912068|NCT01458574|3735308|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3912069|NCT01458574|3735305|B4|||Age||years|Mean|42.7|42.7|Standard Deviation|14|14.0|||
3912070|NCT01458574|3735306|B3|||Age||years|Mean|43.4|43.4|Standard Deviation|14|14.0|||
3912071|NCT01458574|3735307|B2|||Age||years|Mean|42.9|42.9|Standard Deviation|14.4|14.4|||
3912072|NCT01458574|3735308|B1|||Age||years|Mean|41.9|41.9|Standard Deviation|13.7|13.7|||
3912073|NCT01458561|3735393|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3912074|NCT01458561|3735394|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3912075|NCT01458561|3735393|B3|Male||Gender||participants|Number|1|1.0||||||
3912076|NCT01458561|3735394|B2|Male||Gender||participants|Number|1|1.0||||||
3912077|NCT01458561|3735393|B3|Female||Gender||participants|Number|0|0.0||||||
3912078|NCT01458561|3735394|B2|Female||Gender||participants|Number|0|0.0||||||
3912079|NCT01458561|3735393|B3|||Age||years|Mean|57|57.0|Standard Deviation|0|0.0|||
3912080|NCT01458561|3735394|B2|||Age||years|Mean|57|57.0|Standard Deviation|0|0.0|||
3912081|NCT01458561|3735393|B3|>=65 years||Age||participants|Number|0|0.0||||||
3912082|NCT01458561|3735394|B2|>=65 years||Age||participants|Number|0|0.0||||||
3912083|NCT01458561|3735393|B3|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
3912084|NCT01458561|3735394|B2|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
3912085|NCT01458561|3735393|B3|<=18 years||Age||participants|Number|0|0.0||||||
3912086|NCT01458561|3735394|B2|<=18 years||Age||participants|Number|0|0.0||||||
3912087|NCT01458535|3735434|B7|Missing||Interleukin 28B (IL28B)||participants|Number|0|0.0||||||
3912088|NCT01458535|3735435|B6|Missing||Interleukin 28B (IL28B)||participants|Number|0|0.0||||||
3912089|NCT01458535|3735436|B5|Missing||Interleukin 28B (IL28B)||participants|Number|0|0.0||||||
3912090|NCT01458535|3735437|B4|Missing||Interleukin 28B (IL28B)||participants|Number|0|0.0||||||
3912091|NCT01458535|3735438|B3|Missing||Interleukin 28B (IL28B)||participants|Number|0|0.0||||||
3912092|NCT01458535|3735439|B2|Missing||Interleukin 28B (IL28B)||participants|Number|0|0.0||||||
3912093|NCT01458535|3735440|B1|Missing||Interleukin 28B (IL28B)||participants|Number|0|0.0||||||
3912094|NCT01458535|3735434|B7|TT||Interleukin 28B (IL28B)||participants|Number|11|11.0||||||
3912095|NCT01458535|3735435|B6|TT||Interleukin 28B (IL28B)||participants|Number|1|1.0||||||
3912096|NCT01458535|3735436|B5|TT||Interleukin 28B (IL28B)||participants|Number|1|1.0||||||
3912097|NCT01458535|3735437|B4|TT||Interleukin 28B (IL28B)||participants|Number|2|2.0||||||
3912098|NCT01458535|3735438|B3|TT||Interleukin 28B (IL28B)||participants|Number|1|1.0||||||
3912099|NCT01458535|3735439|B2|TT||Interleukin 28B (IL28B)||participants|Number|4|4.0||||||
3912100|NCT01458535|3735440|B1|TT||Interleukin 28B (IL28B)||participants|Number|2|2.0||||||
3912101|NCT01458535|3735434|B7|CT||Interleukin 28B (IL28B)||participants|Number|34|34.0||||||
3912102|NCT01458535|3735435|B6|CT||Interleukin 28B (IL28B)||participants|Number|7|7.0||||||
3912103|NCT01458535|3735436|B5|CT||Interleukin 28B (IL28B)||participants|Number|5|5.0||||||
3912104|NCT01458535|3735437|B4|CT||Interleukin 28B (IL28B)||participants|Number|4|4.0||||||
3912105|NCT01458535|3735438|B3|CT||Interleukin 28B (IL28B)||participants|Number|7|7.0||||||
3912106|NCT01458535|3735439|B2|CT||Interleukin 28B (IL28B)||participants|Number|4|4.0||||||
3912107|NCT01458535|3735440|B1|CT||Interleukin 28B (IL28B)||participants|Number|7|7.0||||||
3912108|NCT01458535|3735434|B7|CC||Interleukin 28B (IL28B)||participants|Number|16|16.0||||||
3912109|NCT01458535|3735435|B6|CC||Interleukin 28B (IL28B)||participants|Number|3|3.0||||||
3912110|NCT01458535|3735436|B5|CC||Interleukin 28B (IL28B)||participants|Number|4|4.0||||||
3912111|NCT01458535|3735437|B4|CC||Interleukin 28B (IL28B)||participants|Number|4|4.0||||||
3912112|NCT01458535|3735438|B3|CC||Interleukin 28B (IL28B)||participants|Number|2|2.0||||||
3912113|NCT01458535|3735439|B2|CC||Interleukin 28B (IL28B)||participants|Number|2|2.0||||||
3912114|NCT01458535|3735440|B1|CC||Interleukin 28B (IL28B)||participants|Number|1|1.0||||||
3912115|NCT01458535|3735434|B7|3B||HCV Genotype/ Subtype||participants|Number|0|0.0||||||
3912116|NCT01458535|3735435|B6|3B||HCV Genotype/ Subtype||participants|Number|0|0.0||||||
3912117|NCT01458535|3735436|B5|3B||HCV Genotype/ Subtype||participants|Number|0|0.0||||||
3912118|NCT01458535|3735437|B4|3B||HCV Genotype/ Subtype||participants|Number|0|0.0||||||
3912119|NCT01458535|3735438|B3|3B||HCV Genotype/ Subtype||participants|Number|0|0.0||||||
3912120|NCT01458535|3735439|B2|3B||HCV Genotype/ Subtype||participants|Number|0|0.0||||||
3912121|NCT01458535|3735440|B1|3B||HCV Genotype/ Subtype||participants|Number|0|0.0||||||
3912122|NCT01458535|3735434|B7|3A||HCV Genotype/ Subtype||participants|Number|21|21.0||||||
3912123|NCT01458535|3735435|B6|3A||HCV Genotype/ Subtype||participants|Number|11|11.0||||||
3912124|NCT01458535|3735436|B5|3A||HCV Genotype/ Subtype||participants|Number|0|0.0||||||
3912125|NCT01458535|3735437|B4|3A||HCV Genotype/ Subtype||participants|Number|0|0.0||||||
3912126|NCT01458535|3735438|B3|3A||HCV Genotype/ Subtype||participants|Number|10|10.0||||||
3912127|NCT01458535|3735439|B2|3A||HCV Genotype/ Subtype||participants|Number|0|0.0||||||
3912128|NCT01458535|3735440|B1|3A||HCV Genotype/ Subtype||participants|Number|0|0.0||||||
3912129|NCT01458535|3735434|B7|2B||HCV Genotype/ Subtype||participants|Number|16|16.0||||||
3912130|NCT01458535|3735435|B6|2B||HCV Genotype/ Subtype||participants|Number|0|0.0||||||
3912131|NCT01458535|3735436|B5|2B||HCV Genotype/ Subtype||participants|Number|8|8.0||||||
3912132|NCT01458535|3735437|B4|2B||HCV Genotype/ Subtype||participants|Number|0|0.0||||||
3912133|NCT01458535|3735438|B3|2B||HCV Genotype/ Subtype||participants|Number|0|0.0||||||
3912134|NCT01458535|3735439|B2|2B||HCV Genotype/ Subtype||participants|Number|8|8.0||||||
3912135|NCT01458535|3735440|B1|2B||HCV Genotype/ Subtype||participants|Number|0|0.0||||||
3912136|NCT01458535|3735434|B7|2A||HCV Genotype/ Subtype||participants|Number|4|4.0||||||
3912137|NCT01458535|3735435|B6|2A||HCV Genotype/ Subtype||participants|Number|0|0.0||||||
3912138|NCT01458535|3735436|B5|2A||HCV Genotype/ Subtype||participants|Number|2|2.0||||||
3912139|NCT01458535|3735437|B4|2A||HCV Genotype/ Subtype||participants|Number|0|0.0||||||
3912140|NCT01458535|3735438|B3|2A||HCV Genotype/ Subtype||participants|Number|0|0.0||||||
3912141|NCT01458535|3735439|B2|2A||HCV Genotype/ Subtype||participants|Number|2|2.0||||||
3912142|NCT01458535|3735440|B1|2A||HCV Genotype/ Subtype||participants|Number|0|0.0||||||
3912143|NCT01458535|3735434|B7|1B||HCV Genotype/ Subtype||participants|Number|4|4.0||||||
3912144|NCT01458535|3735435|B6|1B||HCV Genotype/ Subtype||participants|Number|0|0.0||||||
3912145|NCT01458535|3735436|B5|1B||HCV Genotype/ Subtype||participants|Number|0|0.0||||||
3912146|NCT01458535|3735437|B4|1B||HCV Genotype/ Subtype||participants|Number|2|2.0||||||
3912147|NCT01458535|3735438|B3|1B||HCV Genotype/ Subtype||participants|Number|0|0.0||||||
3912148|NCT01458535|3735439|B2|1B||HCV Genotype/ Subtype||participants|Number|0|0.0||||||
3912149|NCT01458535|3735440|B1|1B||HCV Genotype/ Subtype||participants|Number|2|2.0||||||
3912150|NCT01458535|3735434|B7|1A||HCV Genotype/ Subtype||participants|Number|16|16.0||||||
3912151|NCT01458535|3735435|B6|1A||HCV Genotype/ Subtype||participants|Number|0|0.0||||||
3912152|NCT01458535|3735436|B5|1A||HCV Genotype/ Subtype||participants|Number|0|0.0||||||
3912153|NCT01458535|3735437|B4|1A||HCV Genotype/ Subtype||participants|Number|8|8.0||||||
3912154|NCT01458535|3735438|B3|1A||HCV Genotype/ Subtype||participants|Number|0|0.0||||||
3912155|NCT01458535|3735439|B2|1A||HCV Genotype/ Subtype||participants|Number|0|0.0||||||
3912156|NCT01458535|3735440|B1|1A||HCV Genotype/ Subtype||participants|Number|8|8.0||||||
3912157|NCT01458535|3735434|B7||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3912158|NCT01458535|3735435|B6||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3912159|NCT01458535|3735436|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3912160|NCT01458535|3735437|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3912161|NCT01458535|3735438|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3912162|NCT01458535|3735439|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3912163|NCT01458535|3735440|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3912164|NCT01458535|3735434|B7||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3912165|NCT01458535|3735435|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3912166|NCT01458535|3735436|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3912167|NCT01458535|3735437|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3912168|NCT01458535|3735438|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3912169|NCT01458535|3735439|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3912170|NCT01458535|3735440|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3912171|NCT01458535|3735434|B7|||Age||years|Mean|47.6|47.6|Standard Deviation|10.90|10.9|||
3912172|NCT01458535|3735435|B6|||Age||years|Mean|48.7|48.7|Standard Deviation|8.91|8.91|||
3912173|NCT01458535|3735436|B5|||Age||years|Mean|54.9|54.9|Standard Deviation|10.85|10.85|||
3912174|NCT01458535|3735437|B4|||Age||years|Mean|45.9|45.9|Standard Deviation|7.03|7.03|||
3912175|NCT01458535|3735438|B3|||Age||years|Mean|40.3|40.3|Standard Deviation|13.10|13.1|||
3912176|NCT01458535|3735439|B2|||Age||years|Mean|51.1|51.1|Standard Deviation|8.25|8.25|||
3912177|NCT01458535|3735440|B1|||Age||years|Mean|44.3|44.3|Standard Deviation|12.19|12.19|||
3912178|NCT01458522|3735495|B3|United States||Region of Enrollment||Participants|Count of Participants|74|74.0||||||
3912179|NCT01458522|3735496|B2|United States||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3912180|NCT01458522|3735497|B1|United States||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3912181|NCT01458522|3735495|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3912182|NCT01458522|3735496|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3912183|NCT01458522|3735497|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3912184|NCT01458522|3735495|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3912185|NCT01458522|3735496|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3912186|NCT01458522|3735497|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3912187|NCT01458522|3735495|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|58|58.0||||||
3912188|NCT01458522|3735496|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3912189|NCT01458522|3735497|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3912190|NCT01458522|3735495|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3912191|NCT01458522|3735496|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3912192|NCT01458522|3735497|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3912193|NCT01458522|3735495|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3912194|NCT01458522|3735496|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3912195|NCT01458522|3735497|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3912196|NCT01458522|3735495|B3|||Age||years|Mean|63.6|63.6|Standard Deviation|16.6|16.6|||
3912197|NCT01458522|3735496|B2|||Age||years|Mean|63.4|63.4|Standard Deviation|20.4|20.4|||
3912198|NCT01458522|3735497|B1|||Age||years|Mean|63.8|63.8|Standard Deviation|12.1|12.1|||
3912199|NCT01458392|3735524|B4|United States||Region of Enrollment||participants|Number|46|46.0||||||
3912200|NCT01458392|3735525|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
3912201|NCT01458392|3735526|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3912202|NCT01458392|3735527|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3912203|NCT01458392|3735524|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3912204|NCT01458392|3735525|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3912205|NCT01458392|3735526|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912206|NCT01458392|3735527|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912207|NCT01458392|3735524|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912208|NCT01458392|3735525|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912209|NCT01458392|3735526|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912210|NCT01458392|3735527|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912211|NCT01458392|3735524|B4||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3912212|NCT01458392|3735525|B3||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3912213|NCT01458392|3735526|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3912214|NCT01458392|3735527|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3912215|NCT01458392|3735524|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3912216|NCT01458392|3735525|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3912217|NCT01458392|3735526|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912218|NCT01458392|3735527|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912219|NCT01458392|3735524|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912220|NCT01458392|3735525|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912221|NCT01458392|3735526|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912282|NCT01458275|3735561|B1|||Age||years|Mean|8.6|8.6|Standard Deviation|1.72|1.72|||
3912222|NCT01458392|3735527|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912223|NCT01458392|3735524|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3912224|NCT01458392|3735525|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3912225|NCT01458392|3735526|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912226|NCT01458392|3735527|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912227|NCT01458392|3735524|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912228|NCT01458392|3735525|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912229|NCT01458392|3735526|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912230|NCT01458392|3735527|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912231|NCT01458392|3735524|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912232|NCT01458392|3735525|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912233|NCT01458392|3735526|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912234|NCT01458392|3735527|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912235|NCT01458392|3735524|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3912236|NCT01458392|3735525|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3912237|NCT01458392|3735526|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3912238|NCT01458392|3735527|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3912239|NCT01458392|3735524|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3912240|NCT01458392|3735525|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912241|NCT01458392|3735526|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3912242|NCT01458392|3735527|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912243|NCT01458392|3735524|B4||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3912244|NCT01458392|3735525|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3912245|NCT01458392|3735526|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3912246|NCT01458392|3735527|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3912247|NCT01458392|3735524|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3912248|NCT01458392|3735525|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3912249|NCT01458392|3735526|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3912250|NCT01458392|3735527|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3912251|NCT01458392|3735524|B4|||Age||years|Mean|60.5|60.5|Standard Deviation|8.5|8.5|||
3912252|NCT01458392|3735525|B3|||Age||years|Mean|61.1|61.1|Standard Deviation|9.5|9.5|||
3912253|NCT01458392|3735526|B2|||Age||years|Mean|59.6|59.6|Standard Deviation|5.1|5.1|||
3912254|NCT01458392|3735527|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|13.4|13.4|||
3912255|NCT01458288|3735549|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3912256|NCT01458288|3735549|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3912257|NCT01458288|3735549|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3912258|NCT01458288|3735549|B1|18 to 75 years old||Age, Customized||participants|Number|12|12.0||||||
3912259|NCT01458275|3735558|B4|United States||Region of Enrollment||participants|Number|847|847.0||||||
3912260|NCT01458275|3735559|B3|United States||Region of Enrollment||participants|Number|282|282.0||||||
3912261|NCT01458275|3735560|B2|United States||Region of Enrollment||participants|Number|282|282.0||||||
3912262|NCT01458275|3735561|B1|United States||Region of Enrollment||participants|Number|283|283.0||||||
3912263|NCT01458275|3735558|B4||Male|Sex: Female, Male||Participants|Count of Participants|473|473.0||||||
3912264|NCT01458275|3735559|B3||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3912265|NCT01458275|3735560|B2||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
3912266|NCT01458275|3735561|B1||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3912267|NCT01458275|3735558|B4||Female|Sex: Female, Male||Participants|Count of Participants|374|374.0||||||
3912268|NCT01458275|3735559|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3912269|NCT01458275|3735560|B2||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3912270|NCT01458275|3735561|B1||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3912271|NCT01458275|3735558|B4|9-11 Years||Age, Customized||participants|Number|473|473.0||||||
3912272|NCT01458275|3735559|B3|9-11 Years||Age, Customized||participants|Number|162|162.0||||||
3912273|NCT01458275|3735560|B2|9-11 Years||Age, Customized||participants|Number|159|159.0||||||
3912274|NCT01458275|3735561|B1|9-11 Years||Age, Customized||participants|Number|152|152.0||||||
3912275|NCT01458275|3735558|B4|6-8 Years||Age, Customized||participants|Number|374|374.0||||||
3912276|NCT01458275|3735559|B3|6-8 Years||Age, Customized||participants|Number|120|120.0||||||
3912277|NCT01458275|3735560|B2|6-8 Years||Age, Customized||participants|Number|123|123.0||||||
3912278|NCT01458275|3735561|B1|6-8 Years||Age, Customized||participants|Number|131|131.0||||||
3912279|NCT01458275|3735558|B4|||Age||years|Mean|8.6|8.6|Standard Deviation|1.65|1.65|||
3912280|NCT01458275|3735559|B3|||Age||years|Mean|8.7|8.7|Standard Deviation|1.65|1.65|||
3912281|NCT01458275|3735560|B2|||Age||years|Mean|8.5|8.5|Standard Deviation|1.64|1.64|||
3912283|NCT01458275|3735558|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3912284|NCT01458275|3735559|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3912285|NCT01458275|3735560|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3912286|NCT01458275|3735561|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3912287|NCT01458275|3735558|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3912288|NCT01458275|3735559|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3912289|NCT01458275|3735560|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3912290|NCT01458275|3735561|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3912291|NCT01458275|3735558|B4||<=18 years|Age||Participants|Count of Participants|847|847.0||||||
3912292|NCT01458275|3735559|B3||<=18 years|Age||Participants|Count of Participants|282|282.0||||||
3912293|NCT01458275|3735560|B2||<=18 years|Age||Participants|Count of Participants|282|282.0||||||
3912294|NCT01458275|3735561|B1||<=18 years|Age||Participants|Count of Participants|283|283.0||||||
3912295|NCT01458249|3735603|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3912296|NCT01458249|3735604|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3912297|NCT01458249|3735605|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3912298|NCT01458249|3735603|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3912299|NCT01458249|3735604|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3912300|NCT01458249|3735605|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3912301|NCT01458249|3735603|B3|||Age||Years|Mean|51.1|51.1|Standard Deviation|12.10|12.1|||
3912302|NCT01458249|3735604|B2|||Age||Years|Mean|50.4|50.4|Standard Deviation|12.44|12.44|||
3912303|NCT01458249|3735605|B1|||Age||Years|Mean|51.4|51.4|Standard Deviation|12.11|12.11|||
3912304|NCT01458210|3735624|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3912305|NCT01458210|3735624|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912306|NCT01458210|3735624|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912307|NCT01458210|3735624|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3912308|NCT01458210|3735624|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3912309|NCT01458210|3735624|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912310|NCT01458210|3735624|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912311|NCT01458210|3735624|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912312|NCT01458210|3735624|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912313|NCT01458210|3735624|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3912314|NCT01458210|3735624|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3912315|NCT01458210|3735624|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3912316|NCT01458210|3735624|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3912317|NCT01458210|3735624|B1|||Age||years|Mean|33.4|33.4|Standard Deviation|7.4|7.4|||
3912318|NCT01458171|3735641|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3912319|NCT01458171|3735641|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3912320|NCT01458171|3735641|B1|||Age||years|Mean|20.8|20.8|Standard Deviation|13.68|13.68|||
3912321|NCT01458119|3735662|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3912322|NCT01458119|3735662|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3912323|NCT01458119|3735662|B1|||Age||years|Mean|48.8|48.8|Standard Deviation|12.25|12.25|||
3912324|NCT01458106|3735667|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3912325|NCT01458106|3735668|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3912326|NCT01458106|3735669|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3912327|NCT01458106|3735667|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3912328|NCT01458106|3735668|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3912329|NCT01458106|3735669|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3912330|NCT01458106|3735667|B3|||Age||years|Median|5.0|5.0|Full Range|||1.0|11.0|
3912331|NCT01458106|3735668|B2|||Age||years|Median|8.0|8.0|Full Range|||6.0|11.0|
3912332|NCT01458106|3735669|B1|||Age||years|Median|4.0|4.0|Full Range|||1.0|5.0|
3912333|NCT01457950|3735745|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|135|135.0||||||
3912334|NCT01457950|3735746|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|66|66.0||||||
3912335|NCT01457950|3735747|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|69|69.0||||||
3912336|NCT01457950|3735745|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3912337|NCT01457950|3735746|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3912338|NCT01457950|3735747|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3912339|NCT01457950|3735745|B3||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3912340|NCT01457950|3735746|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3912341|NCT01457950|3735747|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3912342|NCT01457950|3735745|B3|||Age||Years|Mean|66.5|66.5|Standard Deviation|4.83|4.83|||
3912343|NCT01457950|3735746|B2|||Age||Years|Mean|66.0|66.0|Standard Deviation|4.77|4.77|||
3912344|NCT01457950|3735747|B1|||Age||Years|Mean|67.0|67.0|Standard Deviation|4.86|4.86|||
3912345|NCT01457924|3735824|B6|Mixed Race||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3912346|NCT01457924|3735825|B5|Mixed Race||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3912347|NCT01457924|3735826|B4|Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3912348|NCT01457924|3735827|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3912349|NCT01457924|3735828|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3912350|NCT01457924|3735829|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3912351|NCT01457924|3735824|B6|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|225|225.0||||||
3912352|NCT01457924|3735825|B5|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|61|61.0||||||
3912353|NCT01457924|3735826|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|34|34.0||||||
3912354|NCT01457924|3735827|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|31|31.0||||||
3912355|NCT01457924|3735828|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|34|34.0||||||
3912356|NCT01457924|3735829|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|65|65.0||||||
3912357|NCT01457924|3735824|B6|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3912358|NCT01457924|3735825|B5|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3912359|NCT01457924|3735826|B4|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3912360|NCT01457924|3735827|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3912361|NCT01457924|3735828|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3912362|NCT01457924|3735829|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3912363|NCT01457924|3735824|B6|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3912364|NCT01457924|3735825|B5|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3912365|NCT01457924|3735826|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3912366|NCT01457924|3735827|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3912367|NCT01457924|3735828|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3912368|NCT01457924|3735829|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3912369|NCT01457924|3735824|B6||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3912370|NCT01457924|3735825|B5||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3912371|NCT01457924|3735826|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3912372|NCT01457924|3735827|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3912373|NCT01457924|3735828|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3912374|NCT01457924|3735829|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3912375|NCT01457924|3735824|B6||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3912376|NCT01457924|3735825|B5||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3912377|NCT01457924|3735826|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3912378|NCT01457924|3735827|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3912379|NCT01457924|3735828|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3912380|NCT01457924|3735829|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3912381|NCT01457924|3735824|B6|||Age||Years|Mean|37.2|37.2|Standard Deviation|9.36|9.36|||
3912382|NCT01457924|3735825|B5|||Age||Years|Mean|36.2|36.2|Standard Deviation|9.57|9.57|||
3912383|NCT01457924|3735826|B4|||Age||Years|Mean|37.3|37.3|Standard Deviation|9.67|9.67|||
3912384|NCT01457924|3735827|B3|||Age||Years|Mean|37.2|37.2|Standard Deviation|10.04|10.04|||
3912385|NCT01457924|3735828|B2|||Age||Years|Mean|38.1|38.1|Standard Deviation|8.29|8.29|||
3912386|NCT01457924|3735829|B1|||Age||Years|Mean|37.7|37.7|Standard Deviation|9.38|9.38|||
3912387|NCT01457885|3735895|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3912388|NCT01457885|3735895|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3912389|NCT01457885|3735895|B1|||Age||years|Median|56|56.0|Full Range|||19.0|65.0|
3912390|NCT01457846|3735901|B3||Male|Gender||Participants|Count of Participants|51|51.0||||||
3912391|NCT01457846|3735902|B2||Male|Gender||Participants|Count of Participants|29|29.0||||||
3912392|NCT01457846|3735903|B1||Male|Gender||Participants|Count of Participants|22|22.0||||||
3912393|NCT01457846|3735901|B3||Female|Gender||Participants|Count of Participants|20|20.0||||||
3912394|NCT01457846|3735902|B2||Female|Gender||Participants|Count of Participants|12|12.0||||||
3912395|NCT01457846|3735903|B1||Female|Gender||Participants|Count of Participants|8|8.0||||||
3912396|NCT01457846|3735901|B3|>= 65 years||Age, Customized||Participants|Number|27|27.0||||||
3912397|NCT01457846|3735902|B2|>= 65 years||Age, Customized||Participants|Number|14|14.0||||||
3912398|NCT01457846|3735903|B1|>= 65 years||Age, Customized||Participants|Number|13|13.0||||||
3912399|NCT01457846|3735901|B3|>=50 - < 65 years||Age, Customized||Participants|Number|33|33.0||||||
3912400|NCT01457846|3735902|B2|>=50 - < 65 years||Age, Customized||Participants|Number|20|20.0||||||
3912401|NCT01457846|3735903|B1|>=50 - < 65 years||Age, Customized||Participants|Number|13|13.0||||||
3912402|NCT01457846|3735901|B3|<50 years||Age, Customized||Participants|Number|11|11.0||||||
3912403|NCT01457846|3735902|B2|<50 years||Age, Customized||Participants|Number|7|7.0||||||
3912404|NCT01457846|3735903|B1|<50 years||Age, Customized||Participants|Number|4|4.0||||||
3912405|NCT01457846|3735901|B3|||Age|Age at time of screening|years|Mean|61.2|61.2|Standard Deviation|11.02|11.02|||
3912406|NCT01457846|3735902|B2|||Age|Age at time of screening|years|Mean|60.6|60.6|Standard Deviation|11.38|11.38|||
3912407|NCT01457846|3735903|B1|||Age|Age at time of screening|years|Mean|61.9|61.9|Standard Deviation|10.65|10.65|||
3912408|NCT01457703|3735918|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
3912409|NCT01457703|3735919|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
3912410|NCT01457703|3735920|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3912411|NCT01457703|3735918|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3912412|NCT01457703|3735919|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3912413|NCT01457703|3735920|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3912414|NCT01457703|3735918|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3912415|NCT01457703|3735919|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3912416|NCT01457703|3735920|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3912417|NCT01457703|3735918|B3||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3912418|NCT01457703|3735919|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3912419|NCT01457703|3735920|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3912420|NCT01457703|3735918|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3912421|NCT01457703|3735919|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3912422|NCT01457703|3735920|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3912423|NCT01457703|3735918|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912424|NCT01457703|3735919|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912425|NCT01457703|3735920|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912426|NCT01457703|3735918|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3912427|NCT01457703|3735919|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912428|NCT01457703|3735920|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3912429|NCT01457703|3735918|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912430|NCT01457703|3735919|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912431|NCT01457703|3735920|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912432|NCT01457703|3735918|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3912433|NCT01457703|3735919|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912434|NCT01457703|3735920|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3912435|NCT01457703|3735918|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3912436|NCT01457703|3735919|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3912437|NCT01457703|3735920|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3912438|NCT01457703|3735918|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3912439|NCT01457703|3735919|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3912440|NCT01457703|3735920|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3912441|NCT01457703|3735918|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3912442|NCT01457703|3735919|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3912443|NCT01457703|3735920|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3912444|NCT01457703|3735918|B3||Female|Gender||Participants|Count of Participants|62|62.0||||||
3912445|NCT01457703|3735919|B2||Female|Gender||Participants|Count of Participants|33|33.0||||||
3912446|NCT01457703|3735920|B1||Female|Gender||Participants|Count of Participants|29|29.0||||||
3912447|NCT01457703|3735918|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3912448|NCT01457703|3735919|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3912449|NCT01457703|3735920|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3912450|NCT01457703|3735918|B3||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
3912451|NCT01457703|3735919|B2||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3912452|NCT01457703|3735920|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3912453|NCT01457703|3735918|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3912454|NCT01457703|3735919|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3912455|NCT01457703|3735920|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3912456|NCT01457573|3735935|B1|||Baseline Urinary Nerve Growth Factor|Urine collected for urinary nerve growth factor (u-NGF with units: pg/ml) measurement at baseline.|pg/ml|Mean|37.10|37.1|Standard Deviation|21.24|21.24|||
3912457|NCT01457573|3735935|B1|||Baseline Urinary Nerve Growth Factor (pg/ml)/Cr (mg/dl)|Urinary Nerve Growth Factor (uNGF) from a biomarker in pg/ml in a ratio over urinary creatinine (u-Cr) obtained from a lab tested urinalysis in mg/dl.|ratio|Mean|34.20|34.2|Standard Deviation|56.69|56.69|||
3912507|NCT01457417|3735966|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3912458|NCT01457573|3735935|B1|||Baseline International Consultation on Incontinence Mod. Questions Lower Urinary Tract Symptoms QoL|ICIQ LUTs Quality of Life with max score = 288 from a questionnaire taken at baseline. Low score (none to few symptoms) to 288 (very symptomatic).|units on a scale|Mean|122.6|122.6|Standard Deviation|59.53|59.53|||
3912459|NCT01457573|3735935|B1|||Baseline International Consultation on Incontinence Mod. Questions-Male Lower Urinary Tract Symptoms|ICIQ MLUTS (max score = 182) quality of life questionnaire to measure baseline. Low score (none to few symptoms) to 182 (very symptomatic).|units on a scale|Mean|67.2|67.2|Standard Deviation|21.04|21.04|||
3912460|NCT01457573|3735935|B1|||Baseline Perception of Bladder Condition (PBC)|Perception of bladder control measured in questionnaire format with single max rating up to 6, comparing baseline. Low score (none) to 6 (symptoms).|units on a scale|Mean|3.5|3.5|Standard Deviation|0.85|0.85|||
3912461|NCT01457573|3735935|B1|||Baseline Patient Perception of Urgency Score (PPUS)|PPUS is in questionnaire format with a max score of 4. Subject have a single rating, low score (none) to 4 (symptoms).|units on a scale|Mean|2.5|2.5|Standard Deviation|0.85|0.85|||
3912462|NCT01457573|3735935|B1|||Baseline International Prostate Symptom Score (IPSS)|IPSS is a questionnaire, max of 35 points, none (0), to few symptoms to 35 (symptomatic), administered at baseline, which measures incomplete bladder emptying, frequency, urgency, straining, and nocturia.|units on a scale|Mean|18.2|18.2|Standard Deviation|5.07|5.07|||
3912463|NCT01457573|3735935|B1|||Baseline Maximum urinary flow rate|Max urinary flow rate in ml/sec measured by urodynamics at baseline. An average rate in males is 21 ml/sec (ages 14-45 years-old) and 12 ml/sec in males (ages 46-65 years-old).|ml/s|Mean|18.71|18.71|Standard Deviation|9.27|9.27|||
3912464|NCT01457573|3735935|B1|||Baseline Post-void residual (PVR) of urine|PVR is the measure of urine measured in milliliters (ml), by an ultrasound over the abdomen, to measure how much urine remains in the bladder after it is completely empty following urodynamic measurements. Urodynamics is the test done right before the PVR to measure how fast and how much, volume of urine is emptied from the bladder. These measurements help identify issues related to enlarged prostate or other issue.|ml|Mean|53.89|53.89|Standard Deviation|51.74|51.74|||
3912465|NCT01457573|3735935|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3912466|NCT01457573|3735935|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3912467|NCT01457573|3735935|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3912468|NCT01457573|3735935|B1|||Age||years|Mean|64|64.0|Full Range|||48.0|85.0|
3912469|NCT01457573|3735935|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3912470|NCT01457573|3735935|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3912471|NCT01457573|3735935|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3912472|NCT01457521|3735949|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3912473|NCT01457521|3735950|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3912474|NCT01457521|3735951|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3912475|NCT01457521|3735949|B3||Female|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
3912476|NCT01457521|3735950|B2||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3912477|NCT01457521|3735951|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3912478|NCT01457521|3735949|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3912479|NCT01457521|3735950|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3912480|NCT01457521|3735951|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3912481|NCT01457521|3735949|B3||Between 18 and 65 years|Age||Participants|Count of Participants|224|224.0||||||
3912482|NCT01457521|3735950|B2||Between 18 and 65 years|Age||Participants|Count of Participants|115|115.0||||||
3912483|NCT01457521|3735951|B1||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
3912484|NCT01457521|3735949|B3||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3912485|NCT01457521|3735950|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3912486|NCT01457521|3735951|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3912487|NCT01457430|3735958|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3912488|NCT01457430|3735958|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3912489|NCT01457430|3735958|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3912490|NCT01457430|3735958|B1|||Age||years|Mean|41|41.0|Full Range|||19.0|69.0|
3912491|NCT01457430|3735958|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3912492|NCT01457430|3735958|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3912493|NCT01457430|3735958|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3912494|NCT01457417|3735965|B6|United States||Region of Enrollment||participants|Number|32|32.0||||||
3912495|NCT01457417|3735966|B5|United States||Region of Enrollment||participants|Number|19|19.0||||||
3912496|NCT01457417|3735967|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
3912497|NCT01457417|3735968|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3912498|NCT01457417|3735969|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3912499|NCT01457417|3735970|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3912500|NCT01457417|3735965|B6||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3912501|NCT01457417|3735966|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3912502|NCT01457417|3735967|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3912503|NCT01457417|3735968|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3912504|NCT01457417|3735969|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3912505|NCT01457417|3735970|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3912506|NCT01457417|3735965|B6||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3912508|NCT01457417|3735967|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3912509|NCT01457417|3735968|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3912510|NCT01457417|3735969|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3912511|NCT01457417|3735970|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3912512|NCT01457417|3735965|B6||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3912513|NCT01457417|3735966|B5||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3912514|NCT01457417|3735967|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3912515|NCT01457417|3735968|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3912516|NCT01457417|3735969|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3912517|NCT01457417|3735970|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3912518|NCT01457417|3735965|B6||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3912519|NCT01457417|3735966|B5||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3912520|NCT01457417|3735967|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3912521|NCT01457417|3735968|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3912522|NCT01457417|3735969|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3912523|NCT01457417|3735970|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3912524|NCT01457417|3735965|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3912525|NCT01457417|3735966|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3912526|NCT01457417|3735967|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3912527|NCT01457417|3735968|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3912528|NCT01457417|3735969|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3912529|NCT01457417|3735970|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3912530|NCT01457417|3735965|B6|||Age||years|Mean|65.0|65.0|Standard Deviation|10.29|10.29|||
3912531|NCT01457417|3735966|B5|||Age||years|Mean|65.4|65.4|Standard Deviation|9.25|9.25|||
3912532|NCT01457417|3735967|B4|||Age||years|Mean|68.3|68.3|Standard Deviation|8.96|8.96|||
3912533|NCT01457417|3735968|B3|||Age||years|Mean|65.0|65.0|Standard Deviation|19.20|19.2|||
3912534|NCT01457417|3735969|B2|||Age||years|Mean|66.3|66.3|Standard Deviation|8.62|8.62|||
3912535|NCT01457417|3735970|B1|||Age||years|Mean|57.7|57.7|Standard Deviation|7.77|7.77|||
3912536|NCT01457339|3736030|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
3912537|NCT01457339|3736031|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
3912538|NCT01457339|3736032|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3912539|NCT01457339|3736030|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3912540|NCT01457339|3736031|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3912541|NCT01457339|3736032|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3912542|NCT01457339|3736030|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3912543|NCT01457339|3736031|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3912544|NCT01457339|3736032|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3912545|NCT01457339|3736030|B3|||Age||years|Mean|47.1|47.1|Standard Deviation|7.35|7.35|||
3912546|NCT01457339|3736031|B2|||Age||years|Mean|46.4|46.4|Standard Deviation|7.86|7.86|||
3912547|NCT01457339|3736032|B1|||Age||years|Mean|49.6|49.6|Standard Deviation|4.93|4.93|||
3912548|NCT01457339|3736030|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3912549|NCT01457339|3736031|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3912550|NCT01457339|3736032|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3912551|NCT01457339|3736030|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3912552|NCT01457339|3736031|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3912553|NCT01457339|3736032|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3912554|NCT01457339|3736030|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3912555|NCT01457339|3736031|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3912556|NCT01457339|3736032|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3912557|NCT01457053|3736199|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
3912558|NCT01457053|3736199|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
3912559|NCT01457053|3736199|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3912560|NCT01457053|3736199|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3912561|NCT01457053|3736199|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3912562|NCT01457014|3736206|B1|||Morphine equivalents|"Calculate the total daily dose (24h) for each long acting and short acting opioid.~Divide the total daily dose for each opioid by its equianalgesic dose (ED) (see chart) to get the equianalgesic dose units (EDU).~Add the EDU for each opioid to get the total EDU for all opioids.~Multiply the total EDU by 30 mg to get the morphine equivalent dose (meq of morphine).~Opioid- ED Morphine- 30 Hydrocodone- 30 Oxycodone- 20 Hydromorphone- 7.5 Codeine- 200 Methadone- 2-4 (chronic opioid users) Meperidine- 300 Tramadol- 1:5 ratio whereas10 mg morphine = 50mg Tramadol"|mEq|Mean|390.1|390.1|Standard Deviation|338.1|338.1|||
3912563|NCT01457014|3736206|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
3912564|NCT01457014|3736206|B1|African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3912565|NCT01457014|3736206|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3912566|NCT01457014|3736206|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3912567|NCT01457014|3736206|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3912568|NCT01457014|3736206|B1|||Age||years|Mean|50.7|50.7|Standard Deviation|11.6|11.6|||
3912569|NCT01456962|3736224|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
3912570|NCT01456962|3736225|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3912571|NCT01456962|3736226|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3912572|NCT01456962|3736224|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3912573|NCT01456962|3736225|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3912574|NCT01456962|3736226|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3912575|NCT01456962|3736224|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3912576|NCT01456962|3736225|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3912577|NCT01456962|3736226|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3912578|NCT01456962|3736224|B3|||Age||years|Mean|43|43.0|Full Range|||28.0|65.0|
3912579|NCT01456962|3736225|B2|||Age||years|Mean|43|43.0|Full Range|||28.0|65.0|
3912580|NCT01456962|3736226|B1|||Age||years|Mean|44|44.0|Full Range|||31.0|53.0|
3912581|NCT01456936|3736233|B5||Male|Sex: Female, Male||Participants|Count of Participants|3549|3549.0||||||
3912582|NCT01456936|3736234|B4||Male|Sex: Female, Male||Participants|Count of Participants|876|876.0||||||
3912583|NCT01456936|3736235|B3||Male|Sex: Female, Male||Participants|Count of Participants|881|881.0||||||
3912584|NCT01456936|3736236|B2||Male|Sex: Female, Male||Participants|Count of Participants|890|890.0||||||
3912585|NCT01456936|3736237|B1||Male|Sex: Female, Male||Participants|Count of Participants|902|902.0||||||
3912586|NCT01456936|3736233|B5||Female|Sex: Female, Male||Participants|Count of Participants|4509|4509.0||||||
3912587|NCT01456936|3736234|B4||Female|Sex: Female, Male||Participants|Count of Participants|1138|1138.0||||||
3912588|NCT01456936|3736235|B3||Female|Sex: Female, Male||Participants|Count of Participants|1141|1141.0||||||
3912589|NCT01456936|3736236|B2||Female|Sex: Female, Male||Participants|Count of Participants|1116|1116.0||||||
3912590|NCT01456936|3736237|B1||Female|Sex: Female, Male||Participants|Count of Participants|1114|1114.0||||||
3912591|NCT01456936|3736233|B5|||Age||Years|Mean|46.5|46.5|Standard Deviation|12.3|12.3|||
3912592|NCT01456936|3736234|B4|||Age||Years|Mean|46.4|46.4|Standard Deviation|12.2|12.2|||
3912593|NCT01456936|3736235|B3|||Age||Years|Mean|46.8|46.8|Standard Deviation|12.2|12.2|||
3912594|NCT01456936|3736236|B2|||Age||Years|Mean|46.3|46.3|Standard Deviation|12.6|12.6|||
3912595|NCT01456936|3736237|B1|||Age||Years|Mean|46.5|46.5|Standard Deviation|12.4|12.4|||
3912596|NCT01456780|3736346|B4|||Corneal Fluorescein Staining (CFS)|The CFS scale ranges from 0 to 15 scale, with 0 representing the minimum level of corneal epitheliopathy and 15 representing the maximum level of corneal epitheliopathy.|units on a scale|Mean|6.5|6.5|Standard Deviation|2.3|2.3|||
3912597|NCT01456780|3736347|B3|||Corneal Fluorescein Staining (CFS)|The CFS scale ranges from 0 to 15 scale, with 0 representing the minimum level of corneal epitheliopathy and 15 representing the maximum level of corneal epitheliopathy.|units on a scale|Mean|6.1|6.1|Standard Deviation|2.0|2.0|||
3912598|NCT01456780|3736348|B2|||Corneal Fluorescein Staining (CFS)|The CFS scale ranges from 0 to 15 scale, with 0 representing the minimum level of corneal epitheliopathy and 15 representing the maximum level of corneal epitheliopathy.|units on a scale|Mean|6.6|6.6|Standard Deviation|2.5|2.5|||
3912599|NCT01456780|3736349|B1|||Corneal Fluorescein Staining (CFS)|The CFS scale ranges from 0 to 15 scale, with 0 representing the minimum level of corneal epitheliopathy and 15 representing the maximum level of corneal epitheliopathy.|units on a scale|Mean|6.8|6.8|Standard Deviation|2.6|2.6|||
3912600|NCT01456780|3736346|B4|||Symptom Assessment in Dry Eye (SANDE) Severity Score|The range of the SANDE frequency scale is 0-100, with 0 being the minimum level of severity of dry eye symptoms and 100 being the maximum level of severity of dry eye symptoms.|units on a scale|Mean|63.2|63.2|Standard Deviation|19.6|19.6|||
3912601|NCT01456780|3736347|B3|||Symptom Assessment in Dry Eye (SANDE) Severity Score|The range of the SANDE frequency scale is 0-100, with 0 being the minimum level of severity of dry eye symptoms and 100 being the maximum level of severity of dry eye symptoms.|units on a scale|Mean|64.2|64.2|Standard Deviation|19.5|19.5|||
3912602|NCT01456780|3736348|B2|||Symptom Assessment in Dry Eye (SANDE) Severity Score|The range of the SANDE frequency scale is 0-100, with 0 being the minimum level of severity of dry eye symptoms and 100 being the maximum level of severity of dry eye symptoms.|units on a scale|Mean|58.1|58.1|Standard Deviation|19.6|19.6|||
3912603|NCT01456780|3736349|B1|||Symptom Assessment in Dry Eye (SANDE) Severity Score|The range of the SANDE frequency scale is 0-100, with 0 being the minimum level of severity of dry eye symptoms and 100 being the maximum level of severity of dry eye symptoms.|units on a scale|Mean|67.0|67.0|Standard Deviation|19.8|19.8|||
3912604|NCT01456780|3736346|B4|||Symptom Assessment in Dry Eye (SANDE) Frequency Score|The range of the SANDE frequency scale is 0-100, with 0 being the minimum level of frequency of dry eye symptoms and 100 being the maximum level of frequency of dry eye symptoms.|units on a scale|Mean|68.9|68.9|Standard Deviation|18.3|18.3|||
3912605|NCT01456780|3736347|B3|||Symptom Assessment in Dry Eye (SANDE) Frequency Score|The range of the SANDE frequency scale is 0-100, with 0 being the minimum level of frequency of dry eye symptoms and 100 being the maximum level of frequency of dry eye symptoms.|units on a scale|Mean|68.1|68.1|Standard Deviation|17.8|17.8|||
3912606|NCT01456780|3736348|B2|||Symptom Assessment in Dry Eye (SANDE) Frequency Score|The range of the SANDE frequency scale is 0-100, with 0 being the minimum level of frequency of dry eye symptoms and 100 being the maximum level of frequency of dry eye symptoms.|units on a scale|Mean|60.9|60.9|Standard Deviation|19.4|19.4|||
3912607|NCT01456780|3736349|B1|||Symptom Assessment in Dry Eye (SANDE) Frequency Score|The range of the SANDE frequency scale is 0-100, with 0 being the minimum level of frequency of dry eye symptoms and 100 being the maximum level of frequency of dry eye symptoms.|units on a scale|Mean|77.8|77.8|Standard Deviation|14.2|14.2|||
3912608|NCT01456780|3736346|B4|||Ocular Surface Disease Index|The Ocular Surface Disease Index score ranges from 0-100, with 100 being severe dry eye symptoms and 0 being no dry eye symptoms|units on a scale|Mean|56.3|56.3|Standard Deviation|20.6|20.6|||
3912609|NCT01456780|3736347|B3|||Ocular Surface Disease Index|The Ocular Surface Disease Index score ranges from 0-100, with 100 being severe dry eye symptoms and 0 being no dry eye symptoms|units on a scale|Mean|57.0|57.0|Standard Deviation|21.3|21.3|||
3912610|NCT01456780|3736348|B2|||Ocular Surface Disease Index|The Ocular Surface Disease Index score ranges from 0-100, with 100 being severe dry eye symptoms and 0 being no dry eye symptoms|units on a scale|Mean|52.0|52.0|Standard Deviation|22.6|22.6|||
3912611|NCT01456780|3736349|B1|||Ocular Surface Disease Index|The Ocular Surface Disease Index score ranges from 0-100, with 100 being severe dry eye symptoms and 0 being no dry eye symptoms|units on a scale|Mean|59.7|59.7|Standard Deviation|18.0|18.0|||
3912612|NCT01456780|3736346|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3912613|NCT01456780|3736347|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3912614|NCT01456780|3736348|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3912615|NCT01456780|3736349|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3912616|NCT01456780|3736346|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3912617|NCT01456780|3736347|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3912618|NCT01456780|3736348|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3912619|NCT01456780|3736349|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3912620|NCT01456780|3736346|B4|||Age||years|Mean|55|55.0|Standard Deviation|13|13.0|||
3912621|NCT01456780|3736347|B3|||Age||years|Mean|57|57.0|Standard Deviation|12|12.0|||
3912622|NCT01456780|3736348|B2|||Age||years|Mean|52|52.0|Standard Deviation|12|12.0|||
3912623|NCT01456780|3736349|B1|||Age||years|Mean|55|55.0|Standard Deviation|13|13.0|||
3912624|NCT01456299|3736368|B4|Korea, Republic of||Region of Enrollment||participants|Number|100|100.0||||||
3912625|NCT01456299|3736369|B3|Korea, Republic of||Region of Enrollment||participants|Number|33|33.0||||||
3912626|NCT01456299|3736370|B2|Korea, Republic of||Region of Enrollment||participants|Number|34|34.0||||||
3912627|NCT01456299|3736371|B1|Korea, Republic of||Region of Enrollment||participants|Number|33|33.0||||||
3912628|NCT01456299|3736368|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3912629|NCT01456299|3736369|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3912630|NCT01456299|3736370|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3912631|NCT01456299|3736371|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3912632|NCT01456299|3736368|B4||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3912633|NCT01456299|3736369|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3912634|NCT01456299|3736370|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3912635|NCT01456299|3736371|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3912636|NCT01456299|3736368|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3912637|NCT01456299|3736369|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3912638|NCT01456299|3736370|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3912639|NCT01456299|3736371|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3912640|NCT01456299|3736368|B4||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
3912641|NCT01456299|3736369|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3912642|NCT01456299|3736370|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3912643|NCT01456299|3736371|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3912644|NCT01456299|3736368|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3912645|NCT01456299|3736369|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3912646|NCT01456299|3736370|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3912647|NCT01456299|3736371|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3912648|NCT01456299|3736368|B4|||Age||years|Mean|38|38.0|Standard Deviation|11|11.0|||
3912649|NCT01456299|3736369|B3|||Age||years|Mean|38|38.0|Standard Deviation|11|11.0|||
3912650|NCT01456299|3736370|B2|||Age||years|Mean|37|37.0|Standard Deviation|12|12.0|||
3912651|NCT01456299|3736371|B1|||Age||years|Mean|38|38.0|Standard Deviation|11|11.0|||
3912652|NCT01456195|3736381|B4|||Duration of Diabetes||years|Mean|3.345|3.345|Standard Deviation|3.773|3.773|||
3912653|NCT01456195|3736382|B3|||Duration of Diabetes||years|Mean|3.700|3.7|Standard Deviation|4.560|4.56|||
3912654|NCT01456195|3736383|B2|||Duration of Diabetes||years|Mean|3.290|3.29|Standard Deviation|3.447|3.447|||
3912655|NCT01456195|3736384|B1|||Duration of Diabetes||years|Mean|3.048|3.048|Standard Deviation|3.164|3.164|||
3912656|NCT01456195|3736381|B4|Ex-smoker||Smoking Classification||participants|Number|66|66.0||||||
3912657|NCT01456195|3736382|B3|Ex-smoker||Smoking Classification||participants|Number|21|21.0||||||
3912658|NCT01456195|3736383|B2|Ex-smoker||Smoking Classification||participants|Number|22|22.0||||||
3912659|NCT01456195|3736384|B1|Ex-smoker||Smoking Classification||participants|Number|23|23.0||||||
3912660|NCT01456195|3736381|B4|Current smoker||Smoking Classification||participants|Number|61|61.0||||||
3912661|NCT01456195|3736382|B3|Current smoker||Smoking Classification||participants|Number|23|23.0||||||
3912662|NCT01456195|3736383|B2|Current smoker||Smoking Classification||participants|Number|17|17.0||||||
3912663|NCT01456195|3736384|B1|Current smoker||Smoking Classification||participants|Number|21|21.0||||||
3912664|NCT01456195|3736381|B4|Never smoked||Smoking Classification||participants|Number|294|294.0||||||
3912665|NCT01456195|3736382|B3|Never smoked||Smoking Classification||participants|Number|97|97.0||||||
3912666|NCT01456195|3736383|B2|Never smoked||Smoking Classification||participants|Number|98|98.0||||||
3912667|NCT01456195|3736384|B1|Never smoked||Smoking Classification||participants|Number|99|99.0||||||
3912668|NCT01456195|3736381|B4|≥ 8.5 %||Baseline HbA1c Category||participants|Number|126|126.0||||||
3912669|NCT01456195|3736382|B3|≥ 8.5 %||Baseline HbA1c Category||participants|Number|39|39.0||||||
3912670|NCT01456195|3736383|B2|≥ 8.5 %||Baseline HbA1c Category||participants|Number|46|46.0||||||
3912671|NCT01456195|3736384|B1|≥ 8.5 %||Baseline HbA1c Category||participants|Number|41|41.0||||||
3912672|NCT01456195|3736381|B4|< 8.5%||Baseline HbA1c Category||participants|Number|295|295.0||||||
3912673|NCT01456195|3736382|B3|< 8.5%||Baseline HbA1c Category||participants|Number|102|102.0||||||
3912674|NCT01456195|3736383|B2|< 8.5%||Baseline HbA1c Category||participants|Number|91|91.0||||||
3912675|NCT01456195|3736384|B1|< 8.5%||Baseline HbA1c Category||participants|Number|102|102.0||||||
3912676|NCT01456195|3736381|B4|≥ 30 kg/m^2||Baseline BMI Group||participants|Number|262|262.0||||||
3912677|NCT01456195|3736382|B3|≥ 30 kg/m^2||Baseline BMI Group||participants|Number|85|85.0||||||
3912678|NCT01456195|3736383|B2|≥ 30 kg/m^2||Baseline BMI Group||participants|Number|88|88.0||||||
3912679|NCT01456195|3736384|B1|≥ 30 kg/m^2||Baseline BMI Group||participants|Number|89|89.0||||||
3912680|NCT01456195|3736381|B4|< 30 kg/m^2||Baseline BMI Group||participants|Number|159|159.0||||||
3912681|NCT01456195|3736382|B3|< 30 kg/m^2||Baseline BMI Group||participants|Number|56|56.0||||||
3912682|NCT01456195|3736383|B2|< 30 kg/m^2||Baseline BMI Group||participants|Number|49|49.0||||||
3912683|NCT01456195|3736384|B1|< 30 kg/m^2||Baseline BMI Group||participants|Number|54|54.0||||||
3912684|NCT01456195|3736381|B4|||Baseline Body Mass Index (BMI)||kg/m^2|Mean|32.29|32.29|Standard Deviation|5.443|5.443|||
3912685|NCT01456195|3736382|B3|||Baseline Body Mass Index (BMI)||kg/m^2|Mean|32.05|32.05|Standard Deviation|5.369|5.369|||
3912686|NCT01456195|3736383|B2|||Baseline Body Mass Index (BMI)||kg/m^2|Mean|32.50|32.5|Standard Deviation|5.256|5.256|||
3912687|NCT01456195|3736384|B1|||Baseline Body Mass Index (BMI)||kg/m^2|Mean|32.33|32.33|Standard Deviation|5.714|5.714|||
3912688|NCT01456195|3736381|B4|||Weight||kg|Mean|89.45|89.45|Standard Deviation|18.660|18.66|||
3912689|NCT01456195|3736382|B3|||Weight||kg|Mean|89.43|89.43|Standard Deviation|18.706|18.706|||
3912690|NCT01456195|3736383|B2|||Weight||kg|Mean|89.24|89.24|Standard Deviation|18.541|18.541|||
3912691|NCT01456195|3736384|B1|||Weight||kg|Mean|89.66|89.66|Standard Deviation|18.858|18.858|||
3912692|NCT01456195|3736381|B4|||Height||cm|Mean|166.1|166.1|Standard Deviation|10.96|10.96|||
3912693|NCT01456195|3736382|B3|||Height||cm|Mean|166.7|166.7|Standard Deviation|11.11|11.11|||
3912694|NCT01456195|3736383|B2|||Height||cm|Mean|165.3|165.3|Standard Deviation|11.17|11.17|||
3912695|NCT01456195|3736384|B1|||Height||cm|Mean|166.3|166.3|Standard Deviation|10.63|10.63|||
3912696|NCT01456195|3736381|B4|United States||Region of Enrollment||participants|Number|184|184.0||||||
3912697|NCT01456195|3736382|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
3912698|NCT01456195|3736383|B2|United States||Region of Enrollment||participants|Number|61|61.0||||||
3912699|NCT01456195|3736384|B1|United States||Region of Enrollment||participants|Number|61|61.0||||||
3912700|NCT01456195|3736381|B4|Ukraine||Region of Enrollment||participants|Number|28|28.0||||||
3912701|NCT01456195|3736382|B3|Ukraine||Region of Enrollment||participants|Number|8|8.0||||||
3912702|NCT01456195|3736383|B2|Ukraine||Region of Enrollment||participants|Number|9|9.0||||||
3912703|NCT01456195|3736384|B1|Ukraine||Region of Enrollment||participants|Number|11|11.0||||||
3912704|NCT01456195|3736381|B4|Slovakia||Region of Enrollment||participants|Number|72|72.0||||||
3912705|NCT01456195|3736382|B3|Slovakia||Region of Enrollment||participants|Number|24|24.0||||||
3912706|NCT01456195|3736383|B2|Slovakia||Region of Enrollment||participants|Number|24|24.0||||||
3912707|NCT01456195|3736384|B1|Slovakia||Region of Enrollment||participants|Number|24|24.0||||||
3912708|NCT01456195|3736381|B4|Mexico||Region of Enrollment||participants|Number|18|18.0||||||
3912709|NCT01456195|3736382|B3|Mexico||Region of Enrollment||participants|Number|7|7.0||||||
3912710|NCT01456195|3736383|B2|Mexico||Region of Enrollment||participants|Number|5|5.0||||||
3912711|NCT01456195|3736384|B1|Mexico||Region of Enrollment||participants|Number|6|6.0||||||
3912712|NCT01456195|3736381|B4|Hungary||Region of Enrollment||participants|Number|23|23.0||||||
3912713|NCT01456195|3736382|B3|Hungary||Region of Enrollment||participants|Number|8|8.0||||||
3912714|NCT01456195|3736383|B2|Hungary||Region of Enrollment||participants|Number|7|7.0||||||
3912715|NCT01456195|3736384|B1|Hungary||Region of Enrollment||participants|Number|8|8.0||||||
3912716|NCT01456195|3736381|B4|Guatemala||Region of Enrollment||participants|Number|42|42.0||||||
3912717|NCT01456195|3736382|B3|Guatemala||Region of Enrollment||participants|Number|13|13.0||||||
3912718|NCT01456195|3736383|B2|Guatemala||Region of Enrollment||participants|Number|14|14.0||||||
3912719|NCT01456195|3736384|B1|Guatemala||Region of Enrollment||participants|Number|15|15.0||||||
3912720|NCT01456195|3736381|B4|Bulgaria||Region of Enrollment||participants|Number|24|24.0||||||
3912721|NCT01456195|3736382|B3|Bulgaria||Region of Enrollment||participants|Number|9|9.0||||||
3912722|NCT01456195|3736383|B2|Bulgaria||Region of Enrollment||participants|Number|7|7.0||||||
3912723|NCT01456195|3736384|B1|Bulgaria||Region of Enrollment||participants|Number|8|8.0||||||
3912724|NCT01456195|3736381|B4|Argentina||Region of Enrollment||participants|Number|30|30.0||||||
3912725|NCT01456195|3736382|B3|Argentina||Region of Enrollment||participants|Number|10|10.0||||||
3912726|NCT01456195|3736383|B2|Argentina||Region of Enrollment||participants|Number|10|10.0||||||
3912727|NCT01456195|3736384|B1|Argentina||Region of Enrollment||participants|Number|10|10.0||||||
3912728|NCT01456195|3736381|B4|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3912729|NCT01456195|3736382|B3|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3912730|NCT01456195|3736383|B2|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3912731|NCT01456195|3736384|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3912732|NCT01456195|3736381|B4|White||Race/Ethnicity, Customized||participants|Number|335|335.0||||||
3912733|NCT01456195|3736382|B3|White||Race/Ethnicity, Customized||participants|Number|113|113.0||||||
3912734|NCT01456195|3736383|B2|White||Race/Ethnicity, Customized||participants|Number|112|112.0||||||
3912735|NCT01456195|3736384|B1|White||Race/Ethnicity, Customized||participants|Number|110|110.0||||||
3912736|NCT01456195|3736381|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3912737|NCT01456195|3736382|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3912738|NCT01456195|3736383|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3912739|NCT01456195|3736384|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3912740|NCT01456195|3736381|B4|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3912741|NCT01456195|3736382|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3912742|NCT01456195|3736383|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3912743|NCT01456195|3736384|B1|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3912744|NCT01456195|3736381|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
3912745|NCT01456195|3736382|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3912746|NCT01456195|3736383|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3912747|NCT01456195|3736384|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3912748|NCT01456195|3736381|B4|Not Applicable||Race/Ethnicity, Customized||participants|Number|236|236.0||||||
3912749|NCT01456195|3736382|B3|Not Applicable||Race/Ethnicity, Customized||participants|Number|78|78.0||||||
3912750|NCT01456195|3736383|B2|Not Applicable||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
3912751|NCT01456195|3736384|B1|Not Applicable||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
3912752|NCT01456195|3736381|B4|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|116|116.0||||||
3912753|NCT01456195|3736382|B3|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
3912754|NCT01456195|3736383|B2|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3912755|NCT01456195|3736384|B1|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
3912756|NCT01456195|3736381|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
3912757|NCT01456195|3736382|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3912758|NCT01456195|3736383|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3912759|NCT01456195|3736384|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3912760|NCT01456195|3736381|B4||Male|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
3912761|NCT01456195|3736382|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3912762|NCT01456195|3736383|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3912763|NCT01456195|3736384|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3912764|NCT01456195|3736381|B4||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
3912765|NCT01456195|3736382|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3912766|NCT01456195|3736383|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3912767|NCT01456195|3736384|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3912768|NCT01456195|3736381|B4|≥ 65 years||Age, Customized||participants|Number|69|69.0||||||
3912769|NCT01456195|3736382|B3|≥ 65 years||Age, Customized||participants|Number|27|27.0||||||
3912770|NCT01456195|3736383|B2|≥ 65 years||Age, Customized||participants|Number|23|23.0||||||
3912771|NCT01456195|3736384|B1|≥ 65 years||Age, Customized||participants|Number|19|19.0||||||
3912772|NCT01456195|3736381|B4|< 65 years||Age, Customized||participants|Number|352|352.0||||||
3912773|NCT01456195|3736382|B3|< 65 years||Age, Customized||participants|Number|114|114.0||||||
3912774|NCT01456195|3736383|B2|< 65 years||Age, Customized||participants|Number|114|114.0||||||
3912775|NCT01456195|3736384|B1|< 65 years||Age, Customized||participants|Number|124|124.0||||||
3912776|NCT01456195|3736381|B4|||Age||years|Mean|53.5|53.5|Standard Deviation|10.82|10.82|||
3912777|NCT01456195|3736382|B3|||Age||years|Mean|54.2|54.2|Standard Deviation|10.57|10.57|||
3912778|NCT01456195|3736383|B2|||Age||years|Mean|53.2|53.2|Standard Deviation|11.31|11.31|||
3912779|NCT01456195|3736384|B1|||Age||years|Mean|53.1|53.1|Standard Deviation|10.61|10.61|||
3912780|NCT01456169|3736403|B4|≥90 mmHg||Trough Clinic DBP Categories (mmHg)||participants|Number|185|185.0||||||
3912781|NCT01456169|3736404|B3|≥90 mmHg||Trough Clinic DBP Categories (mmHg)||participants|Number|65|65.0||||||
3912782|NCT01456169|3736405|B2|≥90 mmHg||Trough Clinic DBP Categories (mmHg)||participants|Number|55|55.0||||||
3912783|NCT01456169|3736406|B1|≥90 mmHg||Trough Clinic DBP Categories (mmHg)||participants|Number|65|65.0||||||
3912784|NCT01456169|3736403|B4|<90 mmHg||Trough Clinic DBP Categories (mmHg)||participants|Number|210|210.0||||||
3912785|NCT01456169|3736404|B3|<90 mmHg||Trough Clinic DBP Categories (mmHg)||participants|Number|70|70.0||||||
3912786|NCT01456169|3736405|B2|<90 mmHg||Trough Clinic DBP Categories (mmHg)||participants|Number|72|72.0||||||
3912787|NCT01456169|3736406|B1|<90 mmHg||Trough Clinic DBP Categories (mmHg)||participants|Number|68|68.0||||||
3912788|NCT01456169|3736403|B4|||Trough Clinic Diastolic Blood Pressure (DBP)||mmHg|Mean|88.7|88.7|Standard Deviation|8.39|8.39|||
3912789|NCT01456169|3736404|B3|||Trough Clinic Diastolic Blood Pressure (DBP)||mmHg|Mean|88.8|88.8|Standard Deviation|7.99|7.99|||
3912790|NCT01456169|3736405|B2|||Trough Clinic Diastolic Blood Pressure (DBP)||mmHg|Mean|87.6|87.6|Standard Deviation|9.31|9.31|||
3912791|NCT01456169|3736406|B1|||Trough Clinic Diastolic Blood Pressure (DBP)||mmHg|Mean|89.8|89.8|Standard Deviation|7.76|7.76|||
3912792|NCT01456169|3736403|B4|≥180 mmHg||Trough Clinic SBP Category (mmHg)||participants|Number|0|0.0||||||
3912793|NCT01456169|3736404|B3|≥180 mmHg||Trough Clinic SBP Category (mmHg)||participants|Number|0|0.0||||||
3912794|NCT01456169|3736405|B2|≥180 mmHg||Trough Clinic SBP Category (mmHg)||participants|Number|0|0.0||||||
3912795|NCT01456169|3736406|B1|≥180 mmHg||Trough Clinic SBP Category (mmHg)||participants|Number|0|0.0||||||
3912796|NCT01456169|3736403|B4|≥160 - <180 mmHg||Trough Clinic SBP Category (mmHg)||participants|Number|79|79.0||||||
3912797|NCT01456169|3736404|B3|≥160 - <180 mmHg||Trough Clinic SBP Category (mmHg)||participants|Number|25|25.0||||||
3912798|NCT01456169|3736405|B2|≥160 - <180 mmHg||Trough Clinic SBP Category (mmHg)||participants|Number|23|23.0||||||
3912799|NCT01456169|3736406|B1|≥160 - <180 mmHg||Trough Clinic SBP Category (mmHg)||participants|Number|31|31.0||||||
3912800|NCT01456169|3736403|B4|≥140 - <160 mmHg||Trough Clinic SBP Category (mmHg)||participants|Number|266|266.0||||||
3912801|NCT01456169|3736404|B3|≥140 - <160 mmHg||Trough Clinic SBP Category (mmHg)||participants|Number|93|93.0||||||
3912802|NCT01456169|3736405|B2|≥140 - <160 mmHg||Trough Clinic SBP Category (mmHg)||participants|Number|87|87.0||||||
3912803|NCT01456169|3736406|B1|≥140 - <160 mmHg||Trough Clinic SBP Category (mmHg)||participants|Number|86|86.0||||||
3912804|NCT01456169|3736403|B4|<140 mmHg||Trough Clinic SBP Category (mmHg)||participants|Number|50|50.0||||||
3912805|NCT01456169|3736404|B3|<140 mmHg||Trough Clinic SBP Category (mmHg)||participants|Number|17|17.0||||||
3912806|NCT01456169|3736405|B2|<140 mmHg||Trough Clinic SBP Category (mmHg)||participants|Number|17|17.0||||||
3912807|NCT01456169|3736406|B1|<140 mmHg||Trough Clinic SBP Category (mmHg)||participants|Number|16|16.0||||||
3912808|NCT01456169|3736403|B4|||Trough Clinic Systolic Blood Pressure (SBP)||mmHg|Mean|150.0|150.0|Standard Deviation|11.04|11.04|||
3912809|NCT01456169|3736404|B3|||Trough Clinic Systolic Blood Pressure (SBP)||mmHg|Mean|149.8|149.8|Standard Deviation|10.95|10.95|||
3912810|NCT01456169|3736405|B2|||Trough Clinic Systolic Blood Pressure (SBP)||mmHg|Mean|149.6|149.6|Standard Deviation|11.54|11.54|||
3912811|NCT01456169|3736406|B1|||Trough Clinic Systolic Blood Pressure (SBP)||mmHg|Mean|150.7|150.7|Standard Deviation|10.69|10.69|||
3912812|NCT01456169|3736403|B4|≥ 90 ml/min/1.73 m^2||Baseline eGFR Categories (mL/min/1.73 m^2)||participants|Number|120|120.0||||||
3912813|NCT01456169|3736404|B3|≥ 90 ml/min/1.73 m^2||Baseline eGFR Categories (mL/min/1.73 m^2)||participants|Number|44|44.0||||||
3912814|NCT01456169|3736405|B2|≥ 90 ml/min/1.73 m^2||Baseline eGFR Categories (mL/min/1.73 m^2)||participants|Number|32|32.0||||||
3912815|NCT01456169|3736406|B1|≥ 90 ml/min/1.73 m^2||Baseline eGFR Categories (mL/min/1.73 m^2)||participants|Number|44|44.0||||||
3912816|NCT01456169|3736403|B4|60 to < 90 ml/min/1.73 m^2||Baseline eGFR Categories (mL/min/1.73 m^2)||participants|Number|243|243.0||||||
3912817|NCT01456169|3736404|B3|60 to < 90 ml/min/1.73 m^2||Baseline eGFR Categories (mL/min/1.73 m^2)||participants|Number|80|80.0||||||
3912818|NCT01456169|3736405|B2|60 to < 90 ml/min/1.73 m^2||Baseline eGFR Categories (mL/min/1.73 m^2)||participants|Number|85|85.0||||||
3912819|NCT01456169|3736406|B1|60 to < 90 ml/min/1.73 m^2||Baseline eGFR Categories (mL/min/1.73 m^2)||participants|Number|78|78.0||||||
3912820|NCT01456169|3736403|B4|30 to < 60 ml/min/1.73 m^2||Baseline eGFR Categories (mL/min/1.73 m^2)||participants|Number|32|32.0||||||
3912821|NCT01456169|3736404|B3|30 to < 60 ml/min/1.73 m^2||Baseline eGFR Categories (mL/min/1.73 m^2)||participants|Number|11|11.0||||||
3912822|NCT01456169|3736405|B2|30 to < 60 ml/min/1.73 m^2||Baseline eGFR Categories (mL/min/1.73 m^2)||participants|Number|10|10.0||||||
3912823|NCT01456169|3736406|B1|30 to < 60 ml/min/1.73 m^2||Baseline eGFR Categories (mL/min/1.73 m^2)||participants|Number|11|11.0||||||
3912824|NCT01456169|3736403|B4|||Estimated Glomerular Filtration Rate (eGFR)||mL/min/1.73 m^2|Mean|82.9|82.9|Standard Deviation|16.41|16.41|||
3912825|NCT01456169|3736404|B3|||Estimated Glomerular Filtration Rate (eGFR)||mL/min/1.73 m^2|Mean|82.4|82.4|Standard Deviation|16.51|16.51|||
3912826|NCT01456169|3736405|B2|||Estimated Glomerular Filtration Rate (eGFR)||mL/min/1.73 m^2|Mean|81.5|81.5|Standard Deviation|16.25|16.25|||
3912827|NCT01456169|3736406|B1|||Estimated Glomerular Filtration Rate (eGFR)||mL/min/1.73 m^2|Mean|84.8|84.8|Standard Deviation|16.41|16.41|||
3912828|NCT01456169|3736403|B4|No||Diabetes Status||participants|Number|328|328.0||||||
3912829|NCT01456169|3736404|B3|No||Diabetes Status||participants|Number|115|115.0||||||
3912830|NCT01456169|3736405|B2|No||Diabetes Status||participants|Number|100|100.0||||||
3912831|NCT01456169|3736406|B1|No||Diabetes Status||participants|Number|113|113.0||||||
3912832|NCT01456169|3736403|B4|Yes||Diabetes Status||participants|Number|67|67.0||||||
3912833|NCT01456169|3736404|B3|Yes||Diabetes Status||participants|Number|20|20.0||||||
3912834|NCT01456169|3736405|B2|Yes||Diabetes Status||participants|Number|27|27.0||||||
3912835|NCT01456169|3736406|B1|Yes||Diabetes Status||participants|Number|20|20.0||||||
3912836|NCT01456169|3736403|B4|Ex-smoker||Smoking Classification||participants|Number|72|72.0||||||
3912837|NCT01456169|3736404|B3|Ex-smoker||Smoking Classification||participants|Number|28|28.0||||||
3912838|NCT01456169|3736405|B2|Ex-smoker||Smoking Classification||participants|Number|19|19.0||||||
3912839|NCT01456169|3736406|B1|Ex-smoker||Smoking Classification||participants|Number|25|25.0||||||
3912840|NCT01456169|3736403|B4|Current smoker||Smoking Classification||participants|Number|86|86.0||||||
3912841|NCT01456169|3736404|B3|Current smoker||Smoking Classification||participants|Number|30|30.0||||||
3912842|NCT01456169|3736405|B2|Current smoker||Smoking Classification||participants|Number|25|25.0||||||
3912843|NCT01456169|3736406|B1|Current smoker||Smoking Classification||participants|Number|31|31.0||||||
3912844|NCT01456169|3736403|B4|Never smoked||Smoking Classification||participants|Number|237|237.0||||||
3912845|NCT01456169|3736404|B3|Never smoked||Smoking Classification||participants|Number|77|77.0||||||
3912846|NCT01456169|3736405|B2|Never smoked||Smoking Classification||participants|Number|83|83.0||||||
3912847|NCT01456169|3736406|B1|Never smoked||Smoking Classification||participants|Number|77|77.0||||||
3912848|NCT01456169|3736403|B4|||Body Mass Index (BMI)|BMI data only available for 126 participants in the Azilsartan medoxomil + chlorthalidone 40/12.5 mg treatment group.|kg/m^2|Mean|29.64|29.64|Standard Deviation|4.937|4.937|||
3912849|NCT01456169|3736404|B3|||Body Mass Index (BMI)|BMI data only available for 126 participants in the Azilsartan medoxomil + chlorthalidone 40/12.5 mg treatment group.|kg/m^2|Mean|29.52|29.52|Standard Deviation|4.572|4.572|||
3912850|NCT01456169|3736405|B2|||Body Mass Index (BMI)|BMI data only available for 126 participants in the Azilsartan medoxomil + chlorthalidone 40/12.5 mg treatment group.|kg/m^2|Mean|29.78|29.78|Standard Deviation|5.206|5.206|||
3912851|NCT01456169|3736406|B1|||Body Mass Index (BMI)|BMI data only available for 126 participants in the Azilsartan medoxomil + chlorthalidone 40/12.5 mg treatment group.|kg/m^2|Mean|29.63|29.63|Standard Deviation|5.066|5.066|||
3912852|NCT01456169|3736403|B4|||Height|Height data only available for 126 participants in the Azilsartan medoxomil + chlorthalidone 40/12.5 mg treatment group.|cm|Mean|171.5|171.5|Standard Deviation|9.53|9.53|||
3912853|NCT01456169|3736404|B3|||Height|Height data only available for 126 participants in the Azilsartan medoxomil + chlorthalidone 40/12.5 mg treatment group.|cm|Mean|172.1|172.1|Standard Deviation|9.74|9.74|||
3912854|NCT01456169|3736405|B2|||Height|Height data only available for 126 participants in the Azilsartan medoxomil + chlorthalidone 40/12.5 mg treatment group.|cm|Mean|170.6|170.6|Standard Deviation|9.96|9.96|||
3912855|NCT01456169|3736406|B1|||Height|Height data only available for 126 participants in the Azilsartan medoxomil + chlorthalidone 40/12.5 mg treatment group.|cm|Mean|171.8|171.8|Standard Deviation|8.87|8.87|||
3912856|NCT01456169|3736403|B4|||Weight||kg|Mean|87.24|87.24|Standard Deviation|15.868|15.868|||
3912857|NCT01456169|3736404|B3|||Weight||kg|Mean|87.39|87.39|Standard Deviation|14.876|14.876|||
3912858|NCT01456169|3736405|B2|||Weight||kg|Mean|86.71|86.71|Standard Deviation|17.037|17.037|||
3912859|NCT01456169|3736406|B1|||Weight||kg|Mean|87.59|87.59|Standard Deviation|15.794|15.794|||
3912860|NCT01456169|3736403|B4|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
3912861|NCT01456169|3736404|B3|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3912862|NCT01456169|3736405|B2|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3912863|NCT01456169|3736406|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3912864|NCT01456169|3736403|B4|Sweden||Region of Enrollment||participants|Number|4|4.0||||||
3912865|NCT01456169|3736404|B3|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
3912866|NCT01456169|3736405|B2|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
3912867|NCT01456169|3736406|B1|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
3912868|NCT01456169|3736403|B4|Spain||Region of Enrollment||participants|Number|3|3.0||||||
3912869|NCT01456169|3736404|B3|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3912870|NCT01456169|3736405|B2|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3912871|NCT01456169|3736406|B1|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3912872|NCT01456169|3736403|B4|Slovakia||Region of Enrollment||participants|Number|74|74.0||||||
3912873|NCT01456169|3736404|B3|Slovakia||Region of Enrollment||participants|Number|26|26.0||||||
3912874|NCT01456169|3736405|B2|Slovakia||Region of Enrollment||participants|Number|24|24.0||||||
3912875|NCT01456169|3736406|B1|Slovakia||Region of Enrollment||participants|Number|24|24.0||||||
3912876|NCT01456169|3736403|B4|Serbia||Region of Enrollment||participants|Number|11|11.0||||||
3912877|NCT01456169|3736404|B3|Serbia||Region of Enrollment||participants|Number|4|4.0||||||
3912878|NCT01456169|3736405|B2|Serbia||Region of Enrollment||participants|Number|3|3.0||||||
3912879|NCT01456169|3736406|B1|Serbia||Region of Enrollment||participants|Number|4|4.0||||||
3912880|NCT01456169|3736403|B4|Poland||Region of Enrollment||participants|Number|52|52.0||||||
3912881|NCT01456169|3736404|B3|Poland||Region of Enrollment||participants|Number|17|17.0||||||
3912882|NCT01456169|3736405|B2|Poland||Region of Enrollment||participants|Number|18|18.0||||||
3912883|NCT01456169|3736406|B1|Poland||Region of Enrollment||participants|Number|17|17.0||||||
3912884|NCT01456169|3736403|B4|Netherlands||Region of Enrollment||participants|Number|15|15.0||||||
3912885|NCT01456169|3736404|B3|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
3912886|NCT01456169|3736405|B2|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
3912887|NCT01456169|3736406|B1|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
3912888|NCT01456169|3736403|B4|Lithuania||Region of Enrollment||participants|Number|15|15.0||||||
3912889|NCT01456169|3736404|B3|Lithuania||Region of Enrollment||participants|Number|6|6.0||||||
3912890|NCT01456169|3736405|B2|Lithuania||Region of Enrollment||participants|Number|4|4.0||||||
3912891|NCT01456169|3736406|B1|Lithuania||Region of Enrollment||participants|Number|5|5.0||||||
3912892|NCT01456169|3736403|B4|Italy||Region of Enrollment||participants|Number|15|15.0||||||
3912893|NCT01456169|3736404|B3|Italy||Region of Enrollment||participants|Number|5|5.0||||||
3912894|NCT01456169|3736405|B2|Italy||Region of Enrollment||participants|Number|4|4.0||||||
3912895|NCT01456169|3736406|B1|Italy||Region of Enrollment||participants|Number|6|6.0||||||
3912896|NCT01456169|3736403|B4|Hungary||Region of Enrollment||participants|Number|29|29.0||||||
3912897|NCT01456169|3736404|B3|Hungary||Region of Enrollment||participants|Number|10|10.0||||||
3912898|NCT01456169|3736405|B2|Hungary||Region of Enrollment||participants|Number|9|9.0||||||
3912899|NCT01456169|3736406|B1|Hungary||Region of Enrollment||participants|Number|10|10.0||||||
3912900|NCT01456169|3736403|B4|Germany||Region of Enrollment||participants|Number|86|86.0||||||
3912901|NCT01456169|3736404|B3|Germany||Region of Enrollment||participants|Number|28|28.0||||||
3912902|NCT01456169|3736405|B2|Germany||Region of Enrollment||participants|Number|29|29.0||||||
3912903|NCT01456169|3736406|B1|Germany||Region of Enrollment||participants|Number|29|29.0||||||
3912904|NCT01456169|3736403|B4|France||Region of Enrollment||participants|Number|5|5.0||||||
3912905|NCT01456169|3736404|B3|France||Region of Enrollment||participants|Number|2|2.0||||||
3912906|NCT01456169|3736405|B2|France||Region of Enrollment||participants|Number|1|1.0||||||
3912907|NCT01456169|3736406|B1|France||Region of Enrollment||participants|Number|2|2.0||||||
3912908|NCT01456169|3736403|B4|Estonia||Region of Enrollment||participants|Number|52|52.0||||||
3912909|NCT01456169|3736404|B3|Estonia||Region of Enrollment||participants|Number|18|18.0||||||
3912910|NCT01456169|3736405|B2|Estonia||Region of Enrollment||participants|Number|16|16.0||||||
3912911|NCT01456169|3736406|B1|Estonia||Region of Enrollment||participants|Number|18|18.0||||||
3912912|NCT01456169|3736403|B4|Bulgaria||Region of Enrollment||participants|Number|32|32.0||||||
3912913|NCT01456169|3736404|B3|Bulgaria||Region of Enrollment||participants|Number|11|11.0||||||
3912914|NCT01456169|3736405|B2|Bulgaria||Region of Enrollment||participants|Number|10|10.0||||||
3912915|NCT01456169|3736406|B1|Bulgaria||Region of Enrollment||participants|Number|11|11.0||||||
3912916|NCT01456169|3736403|B4|Multiracial||Race/Ethnicity, Customized|Participants could choose more than 1 category for race and those who indicated more than 1 race category were included in each category and in the Multiracial category. Thus the total number of participants may not generally add up to the total number of each group.|participants|Number|2|2.0||||||
3912917|NCT01456169|3736404|B3|Multiracial||Race/Ethnicity, Customized|Participants could choose more than 1 category for race and those who indicated more than 1 race category were included in each category and in the Multiracial category. Thus the total number of participants may not generally add up to the total number of each group.|participants|Number|1|1.0||||||
3912918|NCT01456169|3736405|B2|Multiracial||Race/Ethnicity, Customized|Participants could choose more than 1 category for race and those who indicated more than 1 race category were included in each category and in the Multiracial category. Thus the total number of participants may not generally add up to the total number of each group.|participants|Number|0|0.0||||||
3912919|NCT01456169|3736406|B1|Multiracial||Race/Ethnicity, Customized|Participants could choose more than 1 category for race and those who indicated more than 1 race category were included in each category and in the Multiracial category. Thus the total number of participants may not generally add up to the total number of each group.|participants|Number|1|1.0||||||
3912920|NCT01456169|3736403|B4|White||Race/Ethnicity, Customized|Participants could choose more than 1 category for race and those who indicated more than 1 race category were included in each category and in the Multiracial category. Thus the total number of participants may not generally add up to the total number of each group.|participants|Number|392|392.0||||||
3912921|NCT01456169|3736404|B3|White||Race/Ethnicity, Customized|Participants could choose more than 1 category for race and those who indicated more than 1 race category were included in each category and in the Multiracial category. Thus the total number of participants may not generally add up to the total number of each group.|participants|Number|134|134.0||||||
3912922|NCT01456169|3736405|B2|White||Race/Ethnicity, Customized|Participants could choose more than 1 category for race and those who indicated more than 1 race category were included in each category and in the Multiracial category. Thus the total number of participants may not generally add up to the total number of each group.|participants|Number|126|126.0||||||
3912923|NCT01456169|3736406|B1|White||Race/Ethnicity, Customized|Participants could choose more than 1 category for race and those who indicated more than 1 race category were included in each category and in the Multiracial category. Thus the total number of participants may not generally add up to the total number of each group.|participants|Number|132|132.0||||||
3912924|NCT01456169|3736403|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Participants could choose more than 1 category for race and those who indicated more than 1 race category were included in each category and in the Multiracial category. Thus the total number of participants may not generally add up to the total number of each group.|participants|Number|1|1.0||||||
3912925|NCT01456169|3736404|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Participants could choose more than 1 category for race and those who indicated more than 1 race category were included in each category and in the Multiracial category. Thus the total number of participants may not generally add up to the total number of each group.|participants|Number|1|1.0||||||
3912926|NCT01456169|3736405|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Participants could choose more than 1 category for race and those who indicated more than 1 race category were included in each category and in the Multiracial category. Thus the total number of participants may not generally add up to the total number of each group.|participants|Number|0|0.0||||||
3912927|NCT01456169|3736406|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Participants could choose more than 1 category for race and those who indicated more than 1 race category were included in each category and in the Multiracial category. Thus the total number of participants may not generally add up to the total number of each group.|participants|Number|0|0.0||||||
3912928|NCT01456169|3736403|B4|Black or African American||Race/Ethnicity, Customized|Participants could choose more than 1 category for race and those who indicated more than 1 race category were included in each category and in the Multiracial category. Thus the total number of participants may not generally add up to the total number of each group.|participants|Number|1|1.0||||||
3912929|NCT01456169|3736404|B3|Black or African American||Race/Ethnicity, Customized|Participants could choose more than 1 category for race and those who indicated more than 1 race category were included in each category and in the Multiracial category. Thus the total number of participants may not generally add up to the total number of each group.|participants|Number|0|0.0||||||
3912930|NCT01456169|3736405|B2|Black or African American||Race/Ethnicity, Customized|Participants could choose more than 1 category for race and those who indicated more than 1 race category were included in each category and in the Multiracial category. Thus the total number of participants may not generally add up to the total number of each group.|participants|Number|0|0.0||||||
3912931|NCT01456169|3736406|B1|Black or African American||Race/Ethnicity, Customized|Participants could choose more than 1 category for race and those who indicated more than 1 race category were included in each category and in the Multiracial category. Thus the total number of participants may not generally add up to the total number of each group.|participants|Number|1|1.0||||||
3912932|NCT01456169|3736403|B4|Asian||Race/Ethnicity, Customized|Participants could choose more than 1 category for race and those who indicated more than 1 race category were included in each category and in the Multiracial category. Thus the total number of participants may not generally add up to the total number of each group.|participants|Number|1|1.0||||||
3912933|NCT01456169|3736404|B3|Asian||Race/Ethnicity, Customized|Participants could choose more than 1 category for race and those who indicated more than 1 race category were included in each category and in the Multiracial category. Thus the total number of participants may not generally add up to the total number of each group.|participants|Number|0|0.0||||||
3912934|NCT01456169|3736405|B2|Asian||Race/Ethnicity, Customized|Participants could choose more than 1 category for race and those who indicated more than 1 race category were included in each category and in the Multiracial category. Thus the total number of participants may not generally add up to the total number of each group.|participants|Number|1|1.0||||||
3912935|NCT01456169|3736406|B1|Asian||Race/Ethnicity, Customized|Participants could choose more than 1 category for race and those who indicated more than 1 race category were included in each category and in the Multiracial category. Thus the total number of participants may not generally add up to the total number of each group.|participants|Number|0|0.0||||||
3912936|NCT01456169|3736403|B4|American Indian or Alaska Native||Race/Ethnicity, Customized|Participants could choose more than 1 category for race and those who indicated more than 1 race category were included in each category and in the Multiracial category. Thus the total number of participants may not generally add up to the total number of each group.|participants|Number|2|2.0||||||
3912937|NCT01456169|3736404|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|Participants could choose more than 1 category for race and those who indicated more than 1 race category were included in each category and in the Multiracial category. Thus the total number of participants may not generally add up to the total number of each group.|participants|Number|1|1.0||||||
3912938|NCT01456169|3736405|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|Participants could choose more than 1 category for race and those who indicated more than 1 race category were included in each category and in the Multiracial category. Thus the total number of participants may not generally add up to the total number of each group.|participants|Number|0|0.0||||||
3912939|NCT01456169|3736406|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Participants could choose more than 1 category for race and those who indicated more than 1 race category were included in each category and in the Multiracial category. Thus the total number of participants may not generally add up to the total number of each group.|participants|Number|1|1.0||||||
3912940|NCT01456169|3736403|B4||Male|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
3912941|NCT01456169|3736404|B3||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3912942|NCT01456169|3736405|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3912943|NCT01456169|3736406|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3912944|NCT01456169|3736403|B4||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3912945|NCT01456169|3736404|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3912946|NCT01456169|3736405|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3912947|NCT01456169|3736406|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3912948|NCT01456169|3736403|B4|≥ 65 years||Age, Customized||participants|Number|106|106.0||||||
3912949|NCT01456169|3736404|B3|≥ 65 years||Age, Customized||participants|Number|35|35.0||||||
3912950|NCT01456169|3736405|B2|≥ 65 years||Age, Customized||participants|Number|38|38.0||||||
3912951|NCT01456169|3736406|B1|≥ 65 years||Age, Customized||participants|Number|33|33.0||||||
3912952|NCT01456169|3736403|B4|45 to < 65 years||Age, Customized||participants|Number|254|254.0||||||
3912953|NCT01456169|3736404|B3|45 to < 65 years||Age, Customized||participants|Number|88|88.0||||||
3912954|NCT01456169|3736405|B2|45 to < 65 years||Age, Customized||participants|Number|79|79.0||||||
3912955|NCT01456169|3736406|B1|45 to < 65 years||Age, Customized||participants|Number|87|87.0||||||
3912956|NCT01456169|3736403|B4|< 45 years||Age, Customized||participants|Number|35|35.0||||||
3912957|NCT01456169|3736404|B3|< 45 years||Age, Customized||participants|Number|12|12.0||||||
3912958|NCT01456169|3736405|B2|< 45 years||Age, Customized||participants|Number|10|10.0||||||
3912959|NCT01456169|3736406|B1|< 45 years||Age, Customized||participants|Number|13|13.0||||||
3912960|NCT01456169|3736403|B4|||Age||years|Mean|58.2|58.2|Standard Deviation|10.45|10.45|||
3912961|NCT01456169|3736404|B3|||Age||years|Mean|57.7|57.7|Standard Deviation|10.46|10.46|||
3912962|NCT01456169|3736405|B2|||Age||years|Mean|59.2|59.2|Standard Deviation|10.72|10.72|||
3912963|NCT01456169|3736406|B1|||Age||years|Mean|57.9|57.9|Standard Deviation|10.18|10.18|||
3912964|NCT01456143|3736459|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
3912965|NCT01456143|3736459|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3912966|NCT01456143|3736459|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3912967|NCT01456143|3736459|B1|||Age||years|Mean|59.09|59.09|Standard Deviation|12.47|12.47|||
3912968|NCT01456130|3736468|B1|≥ 160 mg/dL||Fasting blood glucose categories||participants|Number|44|44.0||||||
3912969|NCT01456130|3736468|B1|≥ 130 to < 160 mg/dL||Fasting blood glucose categories||participants|Number|17|17.0||||||
3912970|NCT01456130|3736468|B1|< 130 mg/dL||Fasting blood glucose categories||participants|Number|6|6.0||||||
3912971|NCT01456130|3736468|B1|||Fasting blood glucose||mg/dL|Mean|182.1|182.1|Standard Deviation|45.07|45.07|||
3912972|NCT01456130|3736468|B1|≥ 8.0%||Baseline hemoglobin A1c (HbA1c) categories||participants|Number|22|22.0||||||
3912973|NCT01456130|3736468|B1|≥ 7.0 and < 8.0%||Baseline hemoglobin A1c (HbA1c) categories||participants|Number|25|25.0||||||
3912974|NCT01456130|3736468|B1|≥ 6.5 and < 7.0%||Baseline hemoglobin A1c (HbA1c) categories||participants|Number|17|17.0||||||
3912975|NCT01456130|3736468|B1|< 6.5 %||Baseline hemoglobin A1c (HbA1c) categories||participants|Number|3|3.0||||||
3912976|NCT01456130|3736468|B1|||Glycosylated Hemoglobin (HbA1c)||percent glycosylated hemoglobin|Mean|7.63|7.63|Standard Deviation|0.957|0.957|||
3912977|NCT01456130|3736468|B1|||Duration of Diabetes||years|Mean|7.44|7.44|Standard Deviation|5.872|5.872|||
3912978|NCT01456130|3736468|B1|||Body Mass Index (BMI)||kg/m^2|Mean|25.38|25.38|Standard Deviation|4.347|4.347|||
3912979|NCT01456130|3736468|B1|||Height||cm|Mean|161.7|161.7|Standard Deviation|10.22|10.22|||
3912980|NCT01456130|3736468|B1|||Weight||kg|Mean|66.64|66.64|Standard Deviation|14.409|14.409|||
3912981|NCT01456130|3736468|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3912982|NCT01456130|3736468|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3912983|NCT01456130|3736468|B1|≥ 65 years||Age, Customized||participants|Number|30|30.0||||||
3912984|NCT01456130|3736468|B1|< 65 years||Age, Customized||participants|Number|37|37.0||||||
3912985|NCT01456130|3736468|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|10.52|10.52|||
3912986|NCT01456052|3736475|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912987|NCT01456052|3736476|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912988|NCT01456052|3736477|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912989|NCT01456052|3736478|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912990|NCT01456052|3736475|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912991|NCT01456052|3736476|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912992|NCT01456052|3736477|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912993|NCT01456052|3736478|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3912994|NCT01456052|3736475|B4||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3912995|NCT01456052|3736476|B3||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3912996|NCT01456052|3736477|B2||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3912997|NCT01456052|3736478|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3912998|NCT01456052|3736475|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3912999|NCT01456052|3736476|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3913000|NCT01456052|3736477|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913001|NCT01456052|3736478|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913002|NCT01456052|3736475|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913003|NCT01456052|3736476|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913004|NCT01456052|3736477|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913005|NCT01456052|3736478|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913006|NCT01456052|3736475|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3913007|NCT01456052|3736476|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3913008|NCT01456052|3736477|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913009|NCT01456052|3736478|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913010|NCT01456052|3736475|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913011|NCT01456052|3736476|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913012|NCT01456052|3736477|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913013|NCT01456052|3736478|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913014|NCT01456052|3736475|B4||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3913015|NCT01456052|3736476|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3913016|NCT01456052|3736477|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3913017|NCT01456052|3736478|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3913018|NCT01456052|3736475|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3913019|NCT01456052|3736476|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3913020|NCT01456052|3736477|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3913021|NCT01456052|3736478|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3913022|NCT01456052|3736475|B4|||Age||years|Mean|42.8|42.8|Standard Deviation|13.23|13.23|||
3913023|NCT01456052|3736476|B3|||Age||years|Mean|41.7|41.7|Standard Deviation|12.69|12.69|||
3913024|NCT01456052|3736477|B2|||Age||years|Mean|45.5|45.5|Standard Deviation|12.49|12.49|||
3913025|NCT01456052|3736478|B1|||Age||years|Mean|39.2|39.2|Standard Deviation|16.16|16.16|||
3913026|NCT01456039|3736497|B4|||Body Surface Area (BSA)|BSA is the total surface area of the body and was used to calculate the dosage for romidepsin.|m2|Mean|1.561|1.561|Standard Deviation|0.1757|0.1757|||
3913027|NCT01456039|3736498|B3|||Body Surface Area (BSA)|BSA is the total surface area of the body and was used to calculate the dosage for romidepsin.|m2|Mean|1.554|1.554|Standard Deviation|0.1768|0.1768|||
3913028|NCT01456039|3736499|B2|||Body Surface Area (BSA)|BSA is the total surface area of the body and was used to calculate the dosage for romidepsin.|m2|Mean|1.563|1.563|Standard Deviation|0.2034|0.2034|||
3913099|NCT01455519|3736612|B1|||Duration of Pain||years|Mean|12.6|12.6|Standard Deviation|12.3|12.3|||
3913029|NCT01456039|3736500|B1|||Body Surface Area (BSA)|BSA is the total surface area of the body and was used to calculate the dosage for romidepsin.|m2|Mean|1.640|1.64|Standard Deviation|0.1114|0.1114|||
3913030|NCT01456039|3736497|B4|4 = (Completely Disabled)||Eastern Cooperative Oncology Group (ECOG)|Eastern Cooperative Oncology Group (ECOG) performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|0|0.0||||||
3913031|NCT01456039|3736498|B3|4 = (Completely Disabled)||Eastern Cooperative Oncology Group (ECOG)|Eastern Cooperative Oncology Group (ECOG) performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|0|0.0||||||
3913032|NCT01456039|3736499|B2|4 = (Completely Disabled)||Eastern Cooperative Oncology Group (ECOG)|Eastern Cooperative Oncology Group (ECOG) performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|0|0.0||||||
3913033|NCT01456039|3736500|B1|4 = (Completely Disabled)||Eastern Cooperative Oncology Group (ECOG)|Eastern Cooperative Oncology Group (ECOG) performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|0|0.0||||||
3913034|NCT01456039|3736497|B4|3 = (Limited self care)||Eastern Cooperative Oncology Group (ECOG)|Eastern Cooperative Oncology Group (ECOG) performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|0|0.0||||||
3913035|NCT01456039|3736498|B3|3 = (Limited self care)||Eastern Cooperative Oncology Group (ECOG)|Eastern Cooperative Oncology Group (ECOG) performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|0|0.0||||||
3913036|NCT01456039|3736499|B2|3 = (Limited self care)||Eastern Cooperative Oncology Group (ECOG)|Eastern Cooperative Oncology Group (ECOG) performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|0|0.0||||||
3913037|NCT01456039|3736500|B1|3 = (Limited self care)||Eastern Cooperative Oncology Group (ECOG)|Eastern Cooperative Oncology Group (ECOG) performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|0|0.0||||||
3913038|NCT01456039|3736497|B4|2 = (Ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG)|Eastern Cooperative Oncology Group (ECOG) performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|7|7.0||||||
3913039|NCT01456039|3736498|B3|2 = (Ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG)|Eastern Cooperative Oncology Group (ECOG) performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|4|4.0||||||
3913040|NCT01456039|3736499|B2|2 = (Ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG)|Eastern Cooperative Oncology Group (ECOG) performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|1|1.0||||||
3913100|NCT01455519|3736610|B3|||Body Mass Index||kg/m2|Mean|30.5|30.5|Standard Deviation|9.1|9.1|||
3913101|NCT01455519|3736611|B2|||Body Mass Index||kg/m2|Mean|29.3|29.3|Standard Deviation|8.4|8.4|||
3913102|NCT01455519|3736612|B1|||Body Mass Index||kg/m2|Mean|32.8|32.8|Standard Deviation|10.4|10.4|||
3913164|NCT01455415|3736701|B2|||Age||years|Mean|58.4|58.4|Standard Deviation|9.5|9.5|||
3913041|NCT01456039|3736500|B1|2 = (Ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG)|Eastern Cooperative Oncology Group (ECOG) performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|2|2.0||||||
3913042|NCT01456039|3736497|B4|1 = (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG)|Eastern Cooperative Oncology Group (ECOG) performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|17|17.0||||||
3913043|NCT01456039|3736498|B3|1 = (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG)|Eastern Cooperative Oncology Group (ECOG) performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|14|14.0||||||
3913044|NCT01456039|3736499|B2|1 = (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG)|Eastern Cooperative Oncology Group (ECOG) performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|2|2.0||||||
3913045|NCT01456039|3736500|B1|1 = (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG)|Eastern Cooperative Oncology Group (ECOG) performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|1|1.0||||||
3913046|NCT01456039|3736497|B4|0 = (Fully Active)||Eastern Cooperative Oncology Group (ECOG)|Eastern Cooperative Oncology Group (ECOG) performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|26|26.0||||||
3913047|NCT01456039|3736498|B3|0 = (Fully Active)||Eastern Cooperative Oncology Group (ECOG)|Eastern Cooperative Oncology Group (ECOG) performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|22|22.0||||||
3913048|NCT01456039|3736499|B2|0 = (Fully Active)||Eastern Cooperative Oncology Group (ECOG)|Eastern Cooperative Oncology Group (ECOG) performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|4|4.0||||||
3913049|NCT01456039|3736500|B1|0 = (Fully Active)||Eastern Cooperative Oncology Group (ECOG)|Eastern Cooperative Oncology Group (ECOG) performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|0|0.0||||||
3913050|NCT01456039|3736497|B4|CTCL||Disease Type by Investigator|PTCL is included in a heterogenous group of rare diseases resulting from clonal proliferation of mature thymic lymphocytes. These T-cell tumors account for about 10% to 15% of all lymphoid tumors. CTCL is a non-Hodgkin’s lymphoma of helper T-cells that usually presents in the skin. It is classified mainly into mycosis fungoides and Sézary syndrome, and the stage is classified by the Tumor Node Metastasis Blood (TNMB) classification.|participants|Number|2|2.0||||||
3913051|NCT01456039|3736498|B3|CTCL||Disease Type by Investigator|PTCL is included in a heterogenous group of rare diseases resulting from clonal proliferation of mature thymic lymphocytes. These T-cell tumors account for about 10% to 15% of all lymphoid tumors. CTCL is a non-Hodgkin’s lymphoma of helper T-cells that usually presents in the skin. It is classified mainly into mycosis fungoides and Sézary syndrome, and the stage is classified by the Tumor Node Metastasis Blood (TNMB) classification.|participants|Number|0|0.0||||||
3913052|NCT01456039|3736499|B2|CTCL||Disease Type by Investigator|PTCL is included in a heterogenous group of rare diseases resulting from clonal proliferation of mature thymic lymphocytes. These T-cell tumors account for about 10% to 15% of all lymphoid tumors. CTCL is a non-Hodgkin’s lymphoma of helper T-cells that usually presents in the skin. It is classified mainly into mycosis fungoides and Sézary syndrome, and the stage is classified by the Tumor Node Metastasis Blood (TNMB) classification.|participants|Number|1|1.0||||||
3913103|NCT01455519|3736610|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3913104|NCT01455519|3736611|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3913053|NCT01456039|3736500|B1|CTCL||Disease Type by Investigator|PTCL is included in a heterogenous group of rare diseases resulting from clonal proliferation of mature thymic lymphocytes. These T-cell tumors account for about 10% to 15% of all lymphoid tumors. CTCL is a non-Hodgkin’s lymphoma of helper T-cells that usually presents in the skin. It is classified mainly into mycosis fungoides and Sézary syndrome, and the stage is classified by the Tumor Node Metastasis Blood (TNMB) classification.|participants|Number|1|1.0||||||
3913054|NCT01456039|3736497|B4|PTCL||Disease Type by Investigator|PTCL is included in a heterogenous group of rare diseases resulting from clonal proliferation of mature thymic lymphocytes. These T-cell tumors account for about 10% to 15% of all lymphoid tumors. CTCL is a non-Hodgkin’s lymphoma of helper T-cells that usually presents in the skin. It is classified mainly into mycosis fungoides and Sézary syndrome, and the stage is classified by the Tumor Node Metastasis Blood (TNMB) classification.|participants|Number|48|48.0||||||
3913055|NCT01456039|3736498|B3|PTCL||Disease Type by Investigator|PTCL is included in a heterogenous group of rare diseases resulting from clonal proliferation of mature thymic lymphocytes. These T-cell tumors account for about 10% to 15% of all lymphoid tumors. CTCL is a non-Hodgkin’s lymphoma of helper T-cells that usually presents in the skin. It is classified mainly into mycosis fungoides and Sézary syndrome, and the stage is classified by the Tumor Node Metastasis Blood (TNMB) classification.|participants|Number|40|40.0||||||
3913056|NCT01456039|3736499|B2|PTCL||Disease Type by Investigator|PTCL is included in a heterogenous group of rare diseases resulting from clonal proliferation of mature thymic lymphocytes. These T-cell tumors account for about 10% to 15% of all lymphoid tumors. CTCL is a non-Hodgkin’s lymphoma of helper T-cells that usually presents in the skin. It is classified mainly into mycosis fungoides and Sézary syndrome, and the stage is classified by the Tumor Node Metastasis Blood (TNMB) classification.|participants|Number|6|6.0||||||
3913057|NCT01456039|3736500|B1|PTCL||Disease Type by Investigator|PTCL is included in a heterogenous group of rare diseases resulting from clonal proliferation of mature thymic lymphocytes. These T-cell tumors account for about 10% to 15% of all lymphoid tumors. CTCL is a non-Hodgkin’s lymphoma of helper T-cells that usually presents in the skin. It is classified mainly into mycosis fungoides and Sézary syndrome, and the stage is classified by the Tumor Node Metastasis Blood (TNMB) classification.|participants|Number|2|2.0||||||
3913058|NCT01456039|3736497|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3913059|NCT01456039|3736498|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3913060|NCT01456039|3736499|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3913061|NCT01456039|3736500|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3913062|NCT01456039|3736497|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3913063|NCT01456039|3736498|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3913064|NCT01456039|3736499|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3913065|NCT01456039|3736500|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3913066|NCT01456039|3736497|B4|≥65 years||Age, Customized||participants|Number|36|36.0||||||
3913067|NCT01456039|3736498|B3|≥65 years||Age, Customized||participants|Number|28|28.0||||||
3913068|NCT01456039|3736499|B2|≥65 years||Age, Customized||participants|Number|7|7.0||||||
3913069|NCT01456039|3736500|B1|≥65 years||Age, Customized||participants|Number|1|1.0||||||
3913070|NCT01456039|3736497|B4|<65 years||Age, Customized||participants|Number|14|14.0||||||
3913071|NCT01456039|3736498|B3|<65 years||Age, Customized||participants|Number|12|12.0||||||
3913072|NCT01456039|3736499|B2|<65 years||Age, Customized||participants|Number|0|0.0||||||
3913073|NCT01456039|3736500|B1|<65 years||Age, Customized||participants|Number|2|2.0||||||
3913074|NCT01456039|3736497|B4|||Age||years|Mean|68.7|68.7|Standard Deviation|8.47|8.47|||
3913075|NCT01456039|3736498|B3|||Age||years|Mean|68.5|68.5|Standard Deviation|8.43|8.43|||
3913076|NCT01456039|3736499|B2|||Age||years|Mean|73.6|73.6|Standard Deviation|4.20|4.2|||
3913077|NCT01456039|3736500|B1|||Age||years|Mean|59.0|59.0|Standard Deviation|9.54|9.54|||
3913078|NCT01456000|3736572|B3|United States||Region of Enrollment||participants|Number|342|342.0||||||
3913079|NCT01456000|3736573|B2|United States||Region of Enrollment||participants|Number|172|172.0||||||
3913080|NCT01456000|3736574|B1|United States||Region of Enrollment||participants|Number|170|170.0||||||
3913081|NCT01456000|3736572|B3||Male|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
3913082|NCT01456000|3736573|B2||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3913083|NCT01456000|3736574|B1||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3913084|NCT01456000|3736572|B3||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3913085|NCT01456000|3736573|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3913086|NCT01456000|3736574|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3913087|NCT01456000|3736572|B3|Age||Age, Customized||Years|Mean|59.9|59.9|Standard Deviation|9.7|9.7|||
3913088|NCT01456000|3736573|B2|Age||Age, Customized||Years|Mean|60.1|60.1|Standard Deviation|8.9|8.9|||
3913089|NCT01456000|3736574|B1|Age||Age, Customized||Years|Mean|59.7|59.7|Standard Deviation|10.4|10.4|||
3913090|NCT01455545|3736581|B1|Spain||Region of Enrollment||participants|Number|100|100.0||||||
3913091|NCT01455545|3736581|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3913092|NCT01455545|3736581|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3913093|NCT01455545|3736581|B1|||Age||years|Mean|45.25|45.25|Standard Deviation|15.89|15.89|||
3913094|NCT01455545|3736581|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3913095|NCT01455545|3736581|B1||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
3913096|NCT01455545|3736581|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3913097|NCT01455519|3736610|B3|||Duration of Pain||years|Mean|10.0|10.0|Standard Deviation|9.3|9.3|||
3913098|NCT01455519|3736611|B2|||Duration of Pain||years|Mean|8.7|8.7|Standard Deviation|7.8|7.8|||
3913105|NCT01455519|3736612|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3913106|NCT01455519|3736610|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3913107|NCT01455519|3736611|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913108|NCT01455519|3736612|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3913109|NCT01455519|3736610|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3913110|NCT01455519|3736611|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3913111|NCT01455519|3736612|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3913112|NCT01455519|3736610|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3913113|NCT01455519|3736611|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3913114|NCT01455519|3736612|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3913115|NCT01455519|3736610|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913116|NCT01455519|3736611|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913117|NCT01455519|3736612|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913118|NCT01455519|3736610|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913119|NCT01455519|3736611|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913120|NCT01455519|3736612|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913121|NCT01455519|3736610|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913122|NCT01455519|3736611|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913123|NCT01455519|3736612|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913124|NCT01455519|3736610|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913125|NCT01455519|3736611|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913126|NCT01455519|3736612|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913127|NCT01455519|3736610|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3913128|NCT01455519|3736611|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3913129|NCT01455519|3736612|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3913130|NCT01455519|3736610|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3913131|NCT01455519|3736611|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913132|NCT01455519|3736612|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3913133|NCT01455519|3736610|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3913134|NCT01455519|3736611|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3913135|NCT01455519|3736612|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3913136|NCT01455519|3736610|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3913137|NCT01455519|3736611|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3913138|NCT01455519|3736612|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3913139|NCT01455519|3736610|B3|||Age||years|Mean|47.7|47.7|Standard Deviation|9.7|9.7|||
3913140|NCT01455519|3736611|B2|||Age||years|Mean|46.6|46.6|Standard Deviation|9.2|9.2|||
3913141|NCT01455519|3736612|B1|||Age||years|Mean|49.8|49.8|Standard Deviation|10.7|10.7|||
3913142|NCT01455428|3736643|B3||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3913143|NCT01455428|3736644|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3913144|NCT01455428|3736645|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3913145|NCT01455428|3736643|B3||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3913146|NCT01455428|3736644|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3913147|NCT01455428|3736645|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3913148|NCT01455428|3736643|B3|More than or equal to (>=)65 years||Age, Customized||participants|Number|127|127.0||||||
3913149|NCT01455428|3736644|B2|More than or equal to (>=)65 years||Age, Customized||participants|Number|59|59.0||||||
3913150|NCT01455428|3736645|B1|More than or equal to (>=)65 years||Age, Customized||participants|Number|68|68.0||||||
3913151|NCT01455428|3736643|B3|45-64 years||Age, Customized||participants|Number|86|86.0||||||
3913152|NCT01455428|3736644|B2|45-64 years||Age, Customized||participants|Number|47|47.0||||||
3913153|NCT01455428|3736645|B1|45-64 years||Age, Customized||participants|Number|39|39.0||||||
3913154|NCT01455428|3736643|B3|18-44 years||Age, Customized||participants|Number|7|7.0||||||
3913155|NCT01455428|3736644|B2|18-44 years||Age, Customized||participants|Number|3|3.0||||||
3913156|NCT01455428|3736645|B1|18-44 years||Age, Customized||participants|Number|4|4.0||||||
3913157|NCT01455415|3736700|B3||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3913158|NCT01455415|3736701|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3913159|NCT01455415|3736702|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3913160|NCT01455415|3736700|B3||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3913161|NCT01455415|3736701|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3913162|NCT01455415|3736702|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3913163|NCT01455415|3736700|B3|||Age||years|Mean|58.9|58.9|Standard Deviation|9.7|9.7|||
3913165|NCT01455415|3736702|B1|||Age||years|Mean|59.4|59.4|Standard Deviation|9.8|9.8|||
3913166|NCT01455220|3736753|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3913167|NCT01455220|3736753|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3913168|NCT01455220|3736753|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3913169|NCT01455220|3736753|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3913170|NCT01455220|3736753|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3913171|NCT01455194|3736760|B4|||Post FEV1 predicted|Post-FEV1 is the maximal volume of air exhaled in the first second of a forced expiration from a position of full inspiration after salbutamol administration. It is converted to the percentage of predicted FEV1 based on age, gender, weight and race of participants. Generally, values between 80% to 120% are considered normal.|percent of predicted|Mean|87.875|87.875|Standard Deviation|18.3373|18.3373|||
3913172|NCT01455194|3736761|B3|||Post FEV1 predicted|Post-FEV1 is the maximal volume of air exhaled in the first second of a forced expiration from a position of full inspiration after salbutamol administration. It is converted to the percentage of predicted FEV1 based on age, gender, weight and race of participants. Generally, values between 80% to 120% are considered normal.|percent of predicted|Mean|88.505|88.505|Standard Deviation|17.7105|17.7105|||
3913173|NCT01455194|3736762|B2|||Post FEV1 predicted|Post-FEV1 is the maximal volume of air exhaled in the first second of a forced expiration from a position of full inspiration after salbutamol administration. It is converted to the percentage of predicted FEV1 based on age, gender, weight and race of participants. Generally, values between 80% to 120% are considered normal.|percent of predicted|Mean|90.168|90.168|Standard Deviation|17.7365|17.7365|||
3913174|NCT01455194|3736763|B1|||Post FEV1 predicted|Post-FEV1 is the maximal volume of air exhaled in the first second of a forced expiration from a position of full inspiration after salbutamol administration. It is converted to the percentage of predicted FEV1 based on age, gender, weight and race of participants. Generally, values between 80% to 120% are considered normal.|percent of predicted|Mean|84.893|84.893|Standard Deviation|19.3038|19.3038|||
3913175|NCT01455194|3736760|B4|||Pre FEV1 predicted|Pre-FEV1 is the maximal volume of air exhaled in the first second of a forced expiration from a position of full inspiration prior to salbutamol administration. It is converted to the percentage of predicted FEV1 based on age, gender, weight and race of participants. Generally, values between 80% to 120% are considered normal.|percent of predicted|Mean|71.773|71.773|Standard Deviation|17.9737|17.9737|||
3913176|NCT01455194|3736761|B3|||Pre FEV1 predicted|Pre-FEV1 is the maximal volume of air exhaled in the first second of a forced expiration from a position of full inspiration prior to salbutamol administration. It is converted to the percentage of predicted FEV1 based on age, gender, weight and race of participants. Generally, values between 80% to 120% are considered normal.|percent of predicted|Mean|71.835|71.835|Standard Deviation|18.4365|18.4365|||
3913177|NCT01455194|3736762|B2|||Pre FEV1 predicted|Pre-FEV1 is the maximal volume of air exhaled in the first second of a forced expiration from a position of full inspiration prior to salbutamol administration. It is converted to the percentage of predicted FEV1 based on age, gender, weight and race of participants. Generally, values between 80% to 120% are considered normal.|percent of predicted|Mean|74.345|74.345|Standard Deviation|16.7285|16.7285|||
3913178|NCT01455194|3736763|B1|||Pre FEV1 predicted|Pre-FEV1 is the maximal volume of air exhaled in the first second of a forced expiration from a position of full inspiration prior to salbutamol administration. It is converted to the percentage of predicted FEV1 based on age, gender, weight and race of participants. Generally, values between 80% to 120% are considered normal.|percent of predicted|Mean|69.095|69.095|Standard Deviation|18.4683|18.4683|||
3913179|NCT01455194|3736760|B4|||FEV1 reversibility|Reversibility is assessed using FEV1 measurements. Percent reversibility is calculated as the difference between highest FEV1 after salbutamol and highest FEV 1 before salbutamol divided by highest FEV 1 before salbutamol. FEV1 is the maximal volume of air exhaled in the first second of a forced expiration from a position of full inspiration.|percent reversibility|Mean|25.0|25.0|Standard Deviation|18.41|18.41|||
3913180|NCT01455194|3736761|B3|||FEV1 reversibility|Reversibility is assessed using FEV1 measurements. Percent reversibility is calculated as the difference between highest FEV1 after salbutamol and highest FEV 1 before salbutamol divided by highest FEV 1 before salbutamol. FEV1 is the maximal volume of air exhaled in the first second of a forced expiration from a position of full inspiration.|percent reversibility|Mean|26.5|26.5|Standard Deviation|20.78|20.78|||
3913181|NCT01455194|3736762|B2|||FEV1 reversibility|Reversibility is assessed using FEV1 measurements. Percent reversibility is calculated as the difference between highest FEV1 after salbutamol and highest FEV 1 before salbutamol divided by highest FEV 1 before salbutamol. FEV1 is the maximal volume of air exhaled in the first second of a forced expiration from a position of full inspiration.|percent reversibility|Mean|23|23.0|Standard Deviation|17.10|17.1|||
3913182|NCT01455194|3736763|B1|||FEV1 reversibility|Reversibility is assessed using FEV1 measurements. Percent reversibility is calculated as the difference between highest FEV1 after salbutamol and highest FEV 1 before salbutamol divided by highest FEV 1 before salbutamol. FEV1 is the maximal volume of air exhaled in the first second of a forced expiration from a position of full inspiration.|percent reversibility|Mean|25.5|25.5|Standard Deviation|17.02|17.02|||
3913183|NCT01455194|3736760|B4|||Post-FEV1|Post-FEV1 is the maximal volume of air exhaled in the first second of a forced expiration from a position of full inspiration after salbutamol administration.|L|Mean|2.77|2.77|Standard Deviation|0.900|0.9|||
3913184|NCT01455194|3736761|B3|||Post-FEV1|Post-FEV1 is the maximal volume of air exhaled in the first second of a forced expiration from a position of full inspiration after salbutamol administration.|L|Mean|2.76|2.76|Standard Deviation|0.906|0.906|||
3913185|NCT01455194|3736762|B2|||Post-FEV1|Post-FEV1 is the maximal volume of air exhaled in the first second of a forced expiration from a position of full inspiration after salbutamol administration.|L|Mean|2.84|2.84|Standard Deviation|0.883|0.883|||
3913186|NCT01455194|3736763|B1|||Post-FEV1|Post-FEV1 is the maximal volume of air exhaled in the first second of a forced expiration from a position of full inspiration after salbutamol administration.|L|Mean|2.71|2.71|Standard Deviation|0.915|0.915|||
3913222|NCT01455194|3736763|B1|Never||Smoking Status||participants|Number|109|109.0||||||
3913249|NCT01455194|3736762|B2|||Weight||kilograms (kg)|Mean|77.98|77.98|Standard Deviation|18.993|18.993|||
3913187|NCT01455194|3736760|B4|||Pre-forced expiratory volume in 1 second (FEV1)|Pre-FEV1 is the maximal volume of air exhaled in the first second of a forced expiration from a position of full inspiration prior to salbutamol administration.|liter (L)|Mean|2.26|2.26|Standard Deviation|0.797|0.797|||
3913188|NCT01455194|3736761|B3|||Pre-forced expiratory volume in 1 second (FEV1)|Pre-FEV1 is the maximal volume of air exhaled in the first second of a forced expiration from a position of full inspiration prior to salbutamol administration.|liter (L)|Mean|2.23|2.23|Standard Deviation|0.801|0.801|||
3913189|NCT01455194|3736762|B2|||Pre-forced expiratory volume in 1 second (FEV1)|Pre-FEV1 is the maximal volume of air exhaled in the first second of a forced expiration from a position of full inspiration prior to salbutamol administration.|liter (L)|Mean|2.35|2.35|Standard Deviation|0.798|0.798|||
3913190|NCT01455194|3736763|B1|||Pre-forced expiratory volume in 1 second (FEV1)|Pre-FEV1 is the maximal volume of air exhaled in the first second of a forced expiration from a position of full inspiration prior to salbutamol administration.|liter (L)|Mean|2.20|2.2|Standard Deviation|0.792|0.792|||
3913191|NCT01455194|3736760|B4|||Baseline asthma control questionnaire (ACQ)|ACQ=5 questions about symptoms,1 question about beta 2-agonist use and 1 about lung function (FEV1% predicted).Participants recall their experiences during the previous 7 days and respond to each question using a 7-point scale.The items are equally weighted and the ACQ score is the mean of 7 items and ranges between 0 (well controlled) and 6 (extremely poorly controlled). Mean scores of =<0.75 indicate well-controlled asthma, scores between 0.76 and < 1.5 indicate partly controlled asthma, and a score >= 1.5 indicates uncontrolled asthma.|units on scale|Mean|2.20|2.2|Standard Deviation|0.363|0.363|||
3913192|NCT01455194|3736761|B3|||Baseline asthma control questionnaire (ACQ)|ACQ=5 questions about symptoms,1 question about beta 2-agonist use and 1 about lung function (FEV1% predicted).Participants recall their experiences during the previous 7 days and respond to each question using a 7-point scale.The items are equally weighted and the ACQ score is the mean of 7 items and ranges between 0 (well controlled) and 6 (extremely poorly controlled). Mean scores of =<0.75 indicate well-controlled asthma, scores between 0.76 and < 1.5 indicate partly controlled asthma, and a score >= 1.5 indicates uncontrolled asthma.|units on scale|Mean|2.20|2.2|Standard Deviation|0.361|0.361|||
3913193|NCT01455194|3736762|B2|||Baseline asthma control questionnaire (ACQ)|ACQ=5 questions about symptoms,1 question about beta 2-agonist use and 1 about lung function (FEV1% predicted).Participants recall their experiences during the previous 7 days and respond to each question using a 7-point scale.The items are equally weighted and the ACQ score is the mean of 7 items and ranges between 0 (well controlled) and 6 (extremely poorly controlled). Mean scores of =<0.75 indicate well-controlled asthma, scores between 0.76 and < 1.5 indicate partly controlled asthma, and a score >= 1.5 indicates uncontrolled asthma.|units on scale|Mean|2.16|2.16|Standard Deviation|0.384|0.384|||
3913194|NCT01455194|3736763|B1|||Baseline asthma control questionnaire (ACQ)|ACQ=5 questions about symptoms,1 question about beta 2-agonist use and 1 about lung function (FEV1% predicted).Participants recall their experiences during the previous 7 days and respond to each question using a 7-point scale.The items are equally weighted and the ACQ score is the mean of 7 items and ranges between 0 (well controlled) and 6 (extremely poorly controlled). Mean scores of =<0.75 indicate well-controlled asthma, scores between 0.76 and < 1.5 indicate partly controlled asthma, and a score >= 1.5 indicates uncontrolled asthma.|units on scale|Mean|2.24|2.24|Standard Deviation|0.304|0.304|||
3913195|NCT01455194|3736760|B4|High:>500 mcg/dayto=<1000 mcg/day FP equivalent||Prestudy ICS dose||participants|Number|23|23.0||||||
3913196|NCT01455194|3736761|B3|High:>500 mcg/dayto=<1000 mcg/day FP equivalent||Prestudy ICS dose||participants|Number|11|11.0||||||
3913197|NCT01455194|3736762|B2|High:>500 mcg/dayto=<1000 mcg/day FP equivalent||Prestudy ICS dose||participants|Number|7|7.0||||||
3913198|NCT01455194|3736763|B1|High:>500 mcg/dayto=<1000 mcg/day FP equivalent||Prestudy ICS dose||participants|Number|5|5.0||||||
3913199|NCT01455194|3736760|B4|Medium:>250 mcg/dayto=<500 mcg/day FP equivalent||Prestudy ICS dose||participants|Number|217|217.0||||||
3913200|NCT01455194|3736761|B3|Medium:>250 mcg/dayto=<500 mcg/day FP equivalent||Prestudy ICS dose||participants|Number|70|70.0||||||
3913201|NCT01455194|3736762|B2|Medium:>250 mcg/dayto=<500 mcg/day FP equivalent||Prestudy ICS dose||participants|Number|75|75.0||||||
3913202|NCT01455194|3736763|B1|Medium:>250 mcg/dayto=<500 mcg/day FP equivalent||Prestudy ICS dose||participants|Number|72|72.0||||||
3913203|NCT01455194|3736760|B4|Low:>=200 mcg/day(=<)250 mcg/day FP equivalent||Prestudy ICS dose||participants|Number|119|119.0||||||
3913204|NCT01455194|3736761|B3|Low:>=200 mcg/day(=<)250 mcg/day FP equivalent||Prestudy ICS dose||participants|Number|42|42.0||||||
3913205|NCT01455194|3736762|B2|Low:>=200 mcg/day(=<)250 mcg/day FP equivalent||Prestudy ICS dose||participants|Number|37|37.0||||||
3913206|NCT01455194|3736763|B1|Low:>=200 mcg/day(=<)250 mcg/day FP equivalent||Prestudy ICS dose||participants|Number|40|40.0||||||
3913207|NCT01455194|3736760|B4|<200(mcg/day) fluticasone propionate(FP)equivalent||Prestudy ICS dose||participants|Number|8|8.0||||||
3913208|NCT01455194|3736761|B3|<200(mcg/day) fluticasone propionate(FP)equivalent||Prestudy ICS dose||participants|Number|2|2.0||||||
3913209|NCT01455194|3736762|B2|<200(mcg/day) fluticasone propionate(FP)equivalent||Prestudy ICS dose||participants|Number|3|3.0||||||
3913210|NCT01455194|3736763|B1|<200(mcg/day) fluticasone propionate(FP)equivalent||Prestudy ICS dose||participants|Number|3|3.0||||||
3913211|NCT01455194|3736760|B4|Former||Smoking Status||participants|Number|44|44.0||||||
3913212|NCT01455194|3736761|B3|Former||Smoking Status||participants|Number|15|15.0||||||
3913213|NCT01455194|3736762|B2|Former||Smoking Status||participants|Number|19|19.0||||||
3913214|NCT01455194|3736763|B1|Former||Smoking Status||participants|Number|10|10.0||||||
3913215|NCT01455194|3736760|B4|Current||Smoking Status||participants|Number|3|3.0||||||
3913216|NCT01455194|3736761|B3|Current||Smoking Status||participants|Number|1|1.0||||||
3913217|NCT01455194|3736762|B2|Current||Smoking Status||participants|Number|1|1.0||||||
3913218|NCT01455194|3736763|B1|Current||Smoking Status||participants|Number|1|1.0||||||
3913219|NCT01455194|3736760|B4|Never||Smoking Status||participants|Number|320|320.0||||||
3913220|NCT01455194|3736761|B3|Never||Smoking Status||participants|Number|109|109.0||||||
3913221|NCT01455194|3736762|B2|Never||Smoking Status||participants|Number|102|102.0||||||
3913223|NCT01455194|3736760|B4|Unknown||History of exacerbations|Asthma exacerbations were defined as a worsening of asthma requiring either treatment with oral (or other systemic) glucocorticosteroids for at least 3 days or hospitalisation or a visit to the emergency room because of asthma.|participants|Number|96|96.0||||||
3913224|NCT01455194|3736761|B3|Unknown||History of exacerbations|Asthma exacerbations were defined as a worsening of asthma requiring either treatment with oral (or other systemic) glucocorticosteroids for at least 3 days or hospitalisation or a visit to the emergency room because of asthma.|participants|Number|37|37.0||||||
3913225|NCT01455194|3736762|B2|Unknown||History of exacerbations|Asthma exacerbations were defined as a worsening of asthma requiring either treatment with oral (or other systemic) glucocorticosteroids for at least 3 days or hospitalisation or a visit to the emergency room because of asthma.|participants|Number|30|30.0||||||
3913226|NCT01455194|3736763|B1|Unknown||History of exacerbations|Asthma exacerbations were defined as a worsening of asthma requiring either treatment with oral (or other systemic) glucocorticosteroids for at least 3 days or hospitalisation or a visit to the emergency room because of asthma.|participants|Number|29|29.0||||||
3913227|NCT01455194|3736760|B4|4+||History of exacerbations|Asthma exacerbations were defined as a worsening of asthma requiring either treatment with oral (or other systemic) glucocorticosteroids for at least 3 days or hospitalisation or a visit to the emergency room because of asthma.|participants|Number|0|0.0||||||
3913228|NCT01455194|3736761|B3|4+||History of exacerbations|Asthma exacerbations were defined as a worsening of asthma requiring either treatment with oral (or other systemic) glucocorticosteroids for at least 3 days or hospitalisation or a visit to the emergency room because of asthma.|participants|Number|0|0.0||||||
3913229|NCT01455194|3736762|B2|4+||History of exacerbations|Asthma exacerbations were defined as a worsening of asthma requiring either treatment with oral (or other systemic) glucocorticosteroids for at least 3 days or hospitalisation or a visit to the emergency room because of asthma.|participants|Number|0|0.0||||||
3913230|NCT01455194|3736763|B1|4+||History of exacerbations|Asthma exacerbations were defined as a worsening of asthma requiring either treatment with oral (or other systemic) glucocorticosteroids for at least 3 days or hospitalisation or a visit to the emergency room because of asthma.|participants|Number|0|0.0||||||
3913231|NCT01455194|3736760|B4|2-3||History of exacerbations|Asthma exacerbations were defined as a worsening of asthma requiring either treatment with oral (or other systemic) glucocorticosteroids for at least 3 days or hospitalisation or a visit to the emergency room because of asthma.|participants|Number|11|11.0||||||
3913232|NCT01455194|3736761|B3|2-3||History of exacerbations|Asthma exacerbations were defined as a worsening of asthma requiring either treatment with oral (or other systemic) glucocorticosteroids for at least 3 days or hospitalisation or a visit to the emergency room because of asthma.|participants|Number|4|4.0||||||
3913233|NCT01455194|3736762|B2|2-3||History of exacerbations|Asthma exacerbations were defined as a worsening of asthma requiring either treatment with oral (or other systemic) glucocorticosteroids for at least 3 days or hospitalisation or a visit to the emergency room because of asthma.|participants|Number|3|3.0||||||
3913234|NCT01455194|3736763|B1|2-3||History of exacerbations|Asthma exacerbations were defined as a worsening of asthma requiring either treatment with oral (or other systemic) glucocorticosteroids for at least 3 days or hospitalisation or a visit to the emergency room because of asthma.|participants|Number|4|4.0||||||
3913235|NCT01455194|3736760|B4|1||History of exacerbations|Asthma exacerbations were defined as a worsening of asthma requiring either treatment with oral (or other systemic) glucocorticosteroids for at least 3 days or hospitalisation or a visit to the emergency room because of asthma.|participants|Number|57|57.0||||||
3913236|NCT01455194|3736761|B3|1||History of exacerbations|Asthma exacerbations were defined as a worsening of asthma requiring either treatment with oral (or other systemic) glucocorticosteroids for at least 3 days or hospitalisation or a visit to the emergency room because of asthma.|participants|Number|21|21.0||||||
3913237|NCT01455194|3736762|B2|1||History of exacerbations|Asthma exacerbations were defined as a worsening of asthma requiring either treatment with oral (or other systemic) glucocorticosteroids for at least 3 days or hospitalisation or a visit to the emergency room because of asthma.|participants|Number|19|19.0||||||
3913238|NCT01455194|3736763|B1|1||History of exacerbations|Asthma exacerbations were defined as a worsening of asthma requiring either treatment with oral (or other systemic) glucocorticosteroids for at least 3 days or hospitalisation or a visit to the emergency room because of asthma.|participants|Number|17|17.0||||||
3913239|NCT01455194|3736760|B4|0||History of exacerbations|Asthma exacerbations were defined as a worsening of asthma requiring either treatment with oral (or other systemic) glucocorticosteroids for at least 3 days or hospitalisation or a visit to the emergency room because of asthma.|participants|Number|203|203.0||||||
3913240|NCT01455194|3736761|B3|0||History of exacerbations|Asthma exacerbations were defined as a worsening of asthma requiring either treatment with oral (or other systemic) glucocorticosteroids for at least 3 days or hospitalisation or a visit to the emergency room because of asthma.|participants|Number|63|63.0||||||
3913241|NCT01455194|3736762|B2|0||History of exacerbations|Asthma exacerbations were defined as a worsening of asthma requiring either treatment with oral (or other systemic) glucocorticosteroids for at least 3 days or hospitalisation or a visit to the emergency room because of asthma.|participants|Number|70|70.0||||||
3913242|NCT01455194|3736763|B1|0||History of exacerbations|Asthma exacerbations were defined as a worsening of asthma requiring either treatment with oral (or other systemic) glucocorticosteroids for at least 3 days or hospitalisation or a visit to the emergency room because of asthma.|participants|Number|70|70.0||||||
3913243|NCT01455194|3736760|B4|||Body Mass Index||kilogram per meter square (kg/m^2)|Mean|27.62|27.62|Standard Deviation|5.681|5.681|||
3913244|NCT01455194|3736761|B3|||Body Mass Index||kilogram per meter square (kg/m^2)|Mean|27.12|27.12|Standard Deviation|5.373|5.373|||
3913245|NCT01455194|3736762|B2|||Body Mass Index||kilogram per meter square (kg/m^2)|Mean|28.42|28.42|Standard Deviation|6.346|6.346|||
3913246|NCT01455194|3736763|B1|||Body Mass Index||kilogram per meter square (kg/m^2)|Mean|27.34|27.34|Standard Deviation|5.217|5.217|||
3913247|NCT01455194|3736760|B4|||Weight||kilograms (kg)|Mean|75.42|75.42|Standard Deviation|16.811|16.811|||
3913248|NCT01455194|3736761|B3|||Weight||kilograms (kg)|Mean|73.72|73.72|Standard Deviation|14.660|14.66|||
3913250|NCT01455194|3736763|B1|||Weight||kilograms (kg)|Mean|74.59|74.59|Standard Deviation|16.371|16.371|||
3913251|NCT01455194|3736760|B4|||Height||meter (m)|Mean|1.65|1.65|Standard Deviation|0.099|0.099|||
3913252|NCT01455194|3736761|B3|||Height||meter (m)|Mean|1.65|1.65|Standard Deviation|0.104|0.104|||
3913253|NCT01455194|3736762|B2|||Height||meter (m)|Mean|1.66|1.66|Standard Deviation|0.101|0.101|||
3913254|NCT01455194|3736763|B1|||Height||meter (m)|Mean|1.65|1.65|Standard Deviation|0.093|0.093|||
3913255|NCT01455194|3736760|B4|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3913256|NCT01455194|3736761|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3913257|NCT01455194|3736762|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3913258|NCT01455194|3736763|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3913259|NCT01455194|3736760|B4|White||Race/Ethnicity, Customized||participants|Number|342|342.0||||||
3913260|NCT01455194|3736761|B3|White||Race/Ethnicity, Customized||participants|Number|114|114.0||||||
3913261|NCT01455194|3736762|B2|White||Race/Ethnicity, Customized||participants|Number|115|115.0||||||
3913262|NCT01455194|3736763|B1|White||Race/Ethnicity, Customized||participants|Number|113|113.0||||||
3913263|NCT01455194|3736760|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3913264|NCT01455194|3736761|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3913265|NCT01455194|3736762|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3913266|NCT01455194|3736763|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3913267|NCT01455194|3736760|B4||Male|Gender||Participants|Count of Participants|137|137.0||||||
3913268|NCT01455194|3736761|B3||Male|Gender||Participants|Count of Participants|44|44.0||||||
3913269|NCT01455194|3736762|B2||Male|Gender||Participants|Count of Participants|45|45.0||||||
3913270|NCT01455194|3736763|B1||Male|Gender||Participants|Count of Participants|48|48.0||||||
3913271|NCT01455194|3736760|B4||Female|Gender||Participants|Count of Participants|230|230.0||||||
3913272|NCT01455194|3736761|B3||Female|Gender||Participants|Count of Participants|81|81.0||||||
3913273|NCT01455194|3736762|B2||Female|Gender||Participants|Count of Participants|77|77.0||||||
3913274|NCT01455194|3736763|B1||Female|Gender||Participants|Count of Participants|72|72.0||||||
3913275|NCT01455194|3736760|B4|||Age||years|Mean|44.4|44.4|Standard Deviation|15.57|15.57|||
3913276|NCT01455194|3736761|B3|||Age||years|Mean|45.3|45.3|Standard Deviation|16.22|16.22|||
3913277|NCT01455194|3736762|B2|||Age||years|Mean|44.7|44.7|Standard Deviation|15.60|15.6|||
3913278|NCT01455194|3736763|B1|||Age||years|Mean|43.2|43.2|Standard Deviation|14.86|14.86|||
3913279|NCT01455181|3736815|B1|Hungary||Region of Enrollment||participants|Number|24|24.0||||||
3913280|NCT01455181|3736815|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913281|NCT01455181|3736815|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913282|NCT01455181|3736815|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3913283|NCT01455181|3736815|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913284|NCT01455181|3736815|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913285|NCT01455181|3736815|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913286|NCT01455181|3736815|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913287|NCT01455181|3736815|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913288|NCT01455181|3736815|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3913289|NCT01455181|3736815|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913290|NCT01455181|3736815|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3913291|NCT01455181|3736815|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3913292|NCT01455181|3736815|B1|≥ 65 years||Age, Customized||participants|Number|1|1.0||||||
3913293|NCT01455181|3736815|B1|45 to 64 years||Age, Customized||participants|Number|17|17.0||||||
3913294|NCT01455181|3736815|B1|< 45 years||Age, Customized||participants|Number|6|6.0||||||
3913295|NCT01455064|3736823|B1|||Total number of injections per day||injections (N subjects = 18)|Mean|3.6|3.6|Full Range|||2.0|5.0|
3913296|NCT01455064|3736823|B1|||Daily total insulin dosage||units|Mean|72.8|72.8|Full Range|||22.0|186.0|
3913297|NCT01455064|3736823|B1|||Years since diagnosis||years|Mean|19.6|19.6|Full Range|||5.0|47.0|
3913298|NCT01455064|3736823|B1|||Height||meters|Mean|1.70|1.7|Full Range|||1.5|1.93|
3913299|NCT01455064|3736823|B1|||Weight||kilograms|Mean|90.4|90.4|Full Range|||52.6|163.7|
3913300|NCT01455064|3736823|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3913301|NCT01455064|3736823|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3913302|NCT01455064|3736823|B1|||Age, Customized||years|Mean|48.4|48.4|Full Range|||21.0|71.0|
3913303|NCT01455012|3736827|B3|Germany||Region of Enrollment||participants|Number|66|66.0||||||
3913304|NCT01455012|3736828|B2|Germany||Region of Enrollment||participants|Number|37|37.0||||||
3913305|NCT01455012|3736829|B1|Germany||Region of Enrollment||participants|Number|29|29.0||||||
3913306|NCT01455012|3736827|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3913307|NCT01455012|3736828|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3913308|NCT01455012|3736829|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3913309|NCT01455012|3736827|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3913310|NCT01455012|3736828|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3913311|NCT01455012|3736829|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3913312|NCT01455012|3736827|B3|||Age||years|Mean|57.0|57.0|Standard Deviation|9.9|9.9|||
3913313|NCT01455012|3736828|B2|||Age||years|Mean|57.9|57.9|Standard Deviation|10.2|10.2|||
3913314|NCT01455012|3736829|B1|||Age||years|Mean|56.0|56.0|Standard Deviation|9.6|9.6|||
3913315|NCT01455012|3736827|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3913316|NCT01455012|3736828|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3913317|NCT01455012|3736829|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3913318|NCT01455012|3736827|B3||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3913319|NCT01455012|3736828|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3913320|NCT01455012|3736829|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3913321|NCT01455012|3736827|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3913322|NCT01455012|3736828|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3913323|NCT01455012|3736829|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3913324|NCT01454947|3736862|B9||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3913325|NCT01454947|3736863|B8||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3913326|NCT01454947|3736864|B7||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3913327|NCT01454947|3736865|B6||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3913328|NCT01454947|3736866|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3913329|NCT01454947|3736867|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3913330|NCT01454947|3736868|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3913331|NCT01454947|3736869|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3913332|NCT01454947|3736870|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3913333|NCT01454947|3736862|B9||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3913334|NCT01454947|3736863|B8||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3913335|NCT01454947|3736864|B7||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3913336|NCT01454947|3736865|B6||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3913337|NCT01454947|3736866|B5||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3913338|NCT01454947|3736867|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3913339|NCT01454947|3736868|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3913340|NCT01454947|3736869|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3913341|NCT01454947|3736870|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3913342|NCT01454947|3736862|B9|||Age||years|Mean|48|48.0|Standard Deviation|10|10.0|||
3913343|NCT01454947|3736863|B8|||Age||years|Mean|46|46.0|Standard Deviation|9|9.0|||
3913344|NCT01454947|3736864|B7|||Age||years|Mean|48|48.0|Standard Deviation|10|10.0|||
3913345|NCT01454947|3736865|B6|||Age||years|Mean|51|51.0|Standard Deviation|11|11.0|||
3913346|NCT01454947|3736866|B5|||Age||years|Mean|48|48.0|Standard Deviation|9|9.0|||
3913347|NCT01454947|3736867|B4|||Age||years|Mean|46|46.0|Standard Deviation|9|9.0|||
3913348|NCT01454947|3736868|B3|||Age||years|Mean|49|49.0|Standard Deviation|9|9.0|||
3913349|NCT01454947|3736869|B2|||Age||years|Mean|49|49.0|Standard Deviation|10|10.0|||
3913350|NCT01454947|3736870|B1|||Age||years|Mean|47|47.0|Standard Deviation|12|12.0|||
3913351|NCT01454934|3736895|B3||Male|Sex: Female, Male||Participants|Count of Participants|332|332.0||||||
3913352|NCT01454934|3736896|B2||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3913353|NCT01454934|3736897|B1||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3913354|NCT01454934|3736895|B3||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
3913355|NCT01454934|3736896|B2||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3913356|NCT01454934|3736897|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3913357|NCT01454934|3736895|B3|||Age||Years|Mean|61.1|61.1|Standard Deviation|9.47|9.47|||
3913358|NCT01454934|3736896|B2|||Age||Years|Mean|60.8|60.8|Standard Deviation|9.32|9.32|||
3913359|NCT01454934|3736897|B1|||Age||Years|Mean|61.4|61.4|Standard Deviation|9.62|9.62|||
3913360|NCT01454830|3736908|B3|Severe: >30 events/hr||Apnea-hypopnea Index (AHI), Categorical||participants|Number|29|29.0||||||
3913361|NCT01454830|3736909|B2|Severe: >30 events/hr||Apnea-hypopnea Index (AHI), Categorical||participants|Number|15|15.0||||||
3913362|NCT01454830|3736910|B1|Severe: >30 events/hr||Apnea-hypopnea Index (AHI), Categorical||participants|Number|14|14.0||||||
3913363|NCT01454830|3736908|B3|Moderate: >15-30 events/hr||Apnea-hypopnea Index (AHI), Categorical||participants|Number|20|20.0||||||
3913364|NCT01454830|3736909|B2|Moderate: >15-30 events/hr||Apnea-hypopnea Index (AHI), Categorical||participants|Number|7|7.0||||||
3913365|NCT01454830|3736910|B1|Moderate: >15-30 events/hr||Apnea-hypopnea Index (AHI), Categorical||participants|Number|13|13.0||||||
3913366|NCT01454830|3736908|B3|Mild: 5-15 events/hr||Apnea-hypopnea Index (AHI), Categorical||participants|Number|11|11.0||||||
3913367|NCT01454830|3736909|B2|Mild: 5-15 events/hr||Apnea-hypopnea Index (AHI), Categorical||participants|Number|8|8.0||||||
3913368|NCT01454830|3736910|B1|Mild: 5-15 events/hr||Apnea-hypopnea Index (AHI), Categorical||participants|Number|3|3.0||||||
3913369|NCT01454830|3736908|B3|||Apnea-hypopnea Index (AHI), events/hr, Continuous||events/hour|Mean|35.9|35.9|Standard Deviation|25.2|25.2|||
3913370|NCT01454830|3736909|B2|||Apnea-hypopnea Index (AHI), events/hr, Continuous||events/hour|Mean|38.0|38.0|Standard Deviation|28.8|28.8|||
3913371|NCT01454830|3736910|B1|||Apnea-hypopnea Index (AHI), events/hr, Continuous||events/hour|Mean|33.9|33.9|Standard Deviation|21.3|21.3|||
3913372|NCT01454830|3736908|B3|||Daytime Sleepiness by Epworth Sleepiness Scale, Continuous|Total score (sum) range is 0-24; higher scores indicate worse daytime subjective sleepiness|units on a scale|Mean|19.6|19.6|Standard Deviation|5.2|5.2|||
3913373|NCT01454830|3736909|B2|||Daytime Sleepiness by Epworth Sleepiness Scale, Continuous|Total score (sum) range is 0-24; higher scores indicate worse daytime subjective sleepiness|units on a scale|Mean|20.4|20.4|Standard Deviation|5.3|5.3|||
3913374|NCT01454830|3736910|B1|||Daytime Sleepiness by Epworth Sleepiness Scale, Continuous|Total score (sum) range is 0-24; higher scores indicate worse daytime subjective sleepiness|units on a scale|Mean|18.7|18.7|Standard Deviation|5.1|5.1|||
3913375|NCT01454830|3736908|B3|Widow(er)||Marital Status, Categorical||participants|Number|2|2.0||||||
3913376|NCT01454830|3736909|B2|Widow(er)||Marital Status, Categorical||participants|Number|0|0.0||||||
3913377|NCT01454830|3736910|B1|Widow(er)||Marital Status, Categorical||participants|Number|2|2.0||||||
3913378|NCT01454830|3736908|B3|Separated or Divorced||Marital Status, Categorical||participants|Number|9|9.0||||||
3913379|NCT01454830|3736909|B2|Separated or Divorced||Marital Status, Categorical||participants|Number|3|3.0||||||
3913380|NCT01454830|3736910|B1|Separated or Divorced||Marital Status, Categorical||participants|Number|6|6.0||||||
3913381|NCT01454830|3736908|B3|Single||Marital Status, Categorical||participants|Number|4|4.0||||||
3913382|NCT01454830|3736909|B2|Single||Marital Status, Categorical||participants|Number|2|2.0||||||
3913383|NCT01454830|3736910|B1|Single||Marital Status, Categorical||participants|Number|2|2.0||||||
3913384|NCT01454830|3736908|B3|Married||Marital Status, Categorical||participants|Number|45|45.0||||||
3913385|NCT01454830|3736909|B2|Married||Marital Status, Categorical||participants|Number|25|25.0||||||
3913386|NCT01454830|3736910|B1|Married||Marital Status, Categorical||participants|Number|20|20.0||||||
3913387|NCT01454830|3736908|B3|||Body Mass Index, Continuous||kg/m2|Mean|38.0|38.0|Standard Deviation|9.2|9.2|||
3913388|NCT01454830|3736909|B2|||Body Mass Index, Continuous||kg/m2|Mean|39.0|39.0|Standard Deviation|10.3|10.3|||
3913389|NCT01454830|3736910|B1|||Body Mass Index, Continuous||kg/m2|Mean|37.0|37.0|Standard Deviation|8.1|8.1|||
3913390|NCT01454830|3736908|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
3913391|NCT01454830|3736909|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3913392|NCT01454830|3736910|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3913393|NCT01454830|3736908|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913394|NCT01454830|3736909|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913395|NCT01454830|3736910|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913396|NCT01454830|3736908|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913397|NCT01454830|3736909|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913398|NCT01454830|3736910|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913399|NCT01454830|3736908|B3||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3913400|NCT01454830|3736909|B2||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3913401|NCT01454830|3736910|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3913402|NCT01454830|3736908|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3913403|NCT01454830|3736909|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3913404|NCT01454830|3736910|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3913405|NCT01454830|3736908|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913406|NCT01454830|3736909|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913407|NCT01454830|3736910|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913408|NCT01454830|3736908|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913409|NCT01454830|3736909|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913410|NCT01454830|3736910|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913411|NCT01454830|3736908|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3913412|NCT01454830|3736909|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3913413|NCT01454830|3736910|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3913414|NCT01454830|3736908|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913415|NCT01454830|3736909|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913416|NCT01454830|3736910|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913417|NCT01454830|3736908|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3913418|NCT01454830|3736909|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3913419|NCT01454830|3736910|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3913420|NCT01454830|3736908|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3913421|NCT01454830|3736909|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3913422|NCT01454830|3736910|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3913423|NCT01454830|3736908|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3913424|NCT01454830|3736909|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3913425|NCT01454830|3736910|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3913426|NCT01454830|3736908|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3913427|NCT01454830|3736909|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3913428|NCT01454830|3736910|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3913429|NCT01454830|3736908|B3|||Age||years|Mean|51.3|51.3|Standard Deviation|11.1|11.1|||
3913430|NCT01454830|3736909|B2|||Age||years|Mean|50.1|50.1|Standard Deviation|10.5|10.5|||
3913431|NCT01454830|3736910|B1|||Age||years|Mean|52.5|52.5|Standard Deviation|11.7|11.7|||
3913432|NCT01454791|3736929|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3913433|NCT01454791|3736930|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3913434|NCT01454791|3736931|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3913435|NCT01454791|3736929|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3913436|NCT01454791|3736930|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3913437|NCT01454791|3736931|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3913438|NCT01454791|3736929|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3913439|NCT01454791|3736930|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3913440|NCT01454791|3736931|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3913441|NCT01454791|3736929|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3913442|NCT01454791|3736930|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3913443|NCT01454791|3736931|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3913444|NCT01454791|3736929|B3||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3913445|NCT01454791|3736930|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3913446|NCT01454791|3736931|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3913447|NCT01454791|3736929|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3913448|NCT01454791|3736930|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3913449|NCT01454791|3736931|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3913450|NCT01454778|3736942|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3913451|NCT01454778|3736942|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3913452|NCT01454778|3736942|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3913453|NCT01454778|3736942|B1|||Age, Customized||years|Mean|71.5|71.5|Full Range|||44.0|90.0|
3913454|NCT01454739|3736951|B3|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3913455|NCT01454739|3736952|B2|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3913456|NCT01454739|3736953|B1|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3913457|NCT01454739|3736951|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3913458|NCT01454739|3736952|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3913459|NCT01454739|3736953|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3913460|NCT01454739|3736951|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3913461|NCT01454739|3736952|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3913462|NCT01454739|3736953|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3913463|NCT01454739|3736951|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3913464|NCT01454739|3736952|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3913465|NCT01454739|3736953|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3913466|NCT01454739|3736951|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
3913467|NCT01454739|3736952|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
3913468|NCT01454739|3736953|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3913469|NCT01454739|3736951|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3913470|NCT01454739|3736952|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3913471|NCT01454739|3736953|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3913472|NCT01454739|3736951|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|143|143.0||||||
3913473|NCT01454739|3736952|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|101|101.0||||||
3913474|NCT01454739|3736953|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3913475|NCT01454739|3736951|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3913476|NCT01454739|3736952|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3913477|NCT01454739|3736953|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913478|NCT01454739|3736951|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|206|206.0||||||
3913479|NCT01454739|3736952|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|147|147.0||||||
3913480|NCT01454739|3736953|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3913481|NCT01454739|3736951|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3913482|NCT01454739|3736952|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3913483|NCT01454739|3736953|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3913484|NCT01454739|3736951|B3||Male|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
3913485|NCT01454739|3736952|B2||Male|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
3913486|NCT01454739|3736953|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3913487|NCT01454739|3736951|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3913488|NCT01454739|3736952|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3913489|NCT01454739|3736953|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3913490|NCT01454739|3736951|B3|> 65 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3913491|NCT01454739|3736952|B2|> 65 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3913492|NCT01454739|3736953|B1|> 65 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3913493|NCT01454739|3736951|B3|Between 18 and 65 years||Age, Customized||Participants|Count of Participants|156|156.0||||||
3913494|NCT01454739|3736952|B2|Between 18 and 65 years||Age, Customized||Participants|Count of Participants|156|156.0||||||
3913495|NCT01454739|3736953|B1|Between 18 and 65 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3913496|NCT01454739|3736951|B3|<18 years||Age, Customized||Participants|Count of Participants|83|83.0||||||
3913497|NCT01454739|3736952|B2|<18 years||Age, Customized||Participants|Count of Participants|22|22.0||||||
3913498|NCT01454739|3736953|B1|<18 years||Age, Customized||Participants|Count of Participants|61|61.0||||||
3913499|NCT01454726|3736981|B3|China||Region of Enrollment||participants|Number|27|27.0||||||
3913500|NCT01454726|3736982|B2|China||Region of Enrollment||participants|Number|11|11.0||||||
3913501|NCT01454726|3736983|B1|China||Region of Enrollment||participants|Number|16|16.0||||||
3913502|NCT01454726|3736981|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3913503|NCT01454726|3736982|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3913504|NCT01454726|3736983|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3913505|NCT01454726|3736981|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3913506|NCT01454726|3736982|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3913507|NCT01454726|3736983|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3913508|NCT01454726|3736981|B3|||Age||years|Mean|51.48|51.48|Standard Deviation|11.27|11.27|||
3913509|NCT01454726|3736982|B2|||Age||years|Mean|54.00|54.0|Standard Deviation|8.91|8.91|||
3913510|NCT01454726|3736983|B1|||Age||years|Mean|49.75|49.75|Standard Deviation|12.63|12.63|||
3913511|NCT01454726|3736981|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3913512|NCT01454726|3736982|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3913513|NCT01454726|3736983|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3913514|NCT01454726|3736981|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3913515|NCT01454726|3736982|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3913516|NCT01454726|3736983|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3913517|NCT01454726|3736981|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3913518|NCT01454726|3736982|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3913519|NCT01454726|3736983|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3913520|NCT01454583|3736990|B4||Male|Sex: Female, Male||Participants|Count of Participants|8014|8014.0||||||
3913521|NCT01454583|3736991|B3||Male|Sex: Female, Male||Participants|Count of Participants|1028|1028.0||||||
3913522|NCT01454583|3736992|B2||Male|Sex: Female, Male||Participants|Count of Participants|1467|1467.0||||||
3913523|NCT01454583|3736993|B1||Male|Sex: Female, Male||Participants|Count of Participants|5519|5519.0||||||
3913524|NCT01454583|3736990|B4||Female|Sex: Female, Male||Participants|Count of Participants|6972|6972.0||||||
3913525|NCT01454583|3736991|B3||Female|Sex: Female, Male||Participants|Count of Participants|1085|1085.0||||||
3913526|NCT01454583|3736992|B2||Female|Sex: Female, Male||Participants|Count of Participants|1229|1229.0||||||
3913527|NCT01454583|3736993|B1||Female|Sex: Female, Male||Participants|Count of Participants|4658|4658.0||||||
3913528|NCT01454583|3736990|B4|||Age||years|Mean|63.3|63.3|Standard Deviation|12.26|12.26|||
3913529|NCT01454583|3736991|B3|||Age||years|Mean|61.3|61.3|Standard Deviation|13.36|13.36|||
3913530|NCT01454583|3736992|B2|||Age||years|Mean|63.7|63.7|Standard Deviation|11.92|11.92|||
3913531|NCT01454583|3736993|B1|||Age||years|Mean|63.6|63.6|Standard Deviation|12.06|12.06|||
3913532|NCT01454583|3736990|B4||>=65 years|Age||Participants|Count of Participants|7396|7396.0||||||
3913533|NCT01454583|3736991|B3||>=65 years|Age||Participants|Count of Participants|932|932.0||||||
3913534|NCT01454583|3736992|B2||>=65 years|Age||Participants|Count of Participants|1396|1396.0||||||
3913535|NCT01454583|3736993|B1||>=65 years|Age||Participants|Count of Participants|5068|5068.0||||||
3913536|NCT01454583|3736990|B4||Between 18 and 65 years|Age||Participants|Count of Participants|7590|7590.0||||||
3913537|NCT01454583|3736991|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1181|1181.0||||||
3913538|NCT01454583|3736992|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1300|1300.0||||||
3913539|NCT01454583|3736993|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5109|5109.0||||||
3913540|NCT01454583|3736990|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3913541|NCT01454583|3736991|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3913542|NCT01454583|3736992|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3913543|NCT01454583|3736993|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3913544|NCT01454531|3737063|B1|Spain||Region of Enrollment||participants|Number|192|192.0||||||
3913545|NCT01454531|3737063|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3913546|NCT01454531|3737063|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3913547|NCT01454531|3737063|B1|||Age||years|Mean|32.8|32.8|Standard Deviation|9.4|9.4|||
3913548|NCT01454505|3737072|B4|Canada||Region of Enrollment||participants|Number|110|110.0||||||
3913549|NCT01454505|3737073|B3|Canada||Region of Enrollment||participants|Number|20|20.0||||||
3913550|NCT01454505|3737074|B2|Canada||Region of Enrollment||participants|Number|40|40.0||||||
3913551|NCT01454505|3737075|B1|Canada||Region of Enrollment||participants|Number|50|50.0||||||
3913552|NCT01454505|3737072|B4||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3913553|NCT01454505|3737073|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3913554|NCT01454505|3737074|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3913555|NCT01454505|3737075|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3913556|NCT01454505|3737072|B4||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3913557|NCT01454505|3737073|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3913558|NCT01454505|3737074|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3913559|NCT01454505|3737075|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3913560|NCT01454505|3737072|B4|≥65||Age, Customized||participants|Number|2|2.0||||||
3913561|NCT01454505|3737073|B3|≥65||Age, Customized||participants|Number|0|0.0||||||
3913562|NCT01454505|3737074|B2|≥65||Age, Customized||participants|Number|1|1.0||||||
3913563|NCT01454505|3737075|B1|≥65||Age, Customized||participants|Number|1|1.0||||||
3913564|NCT01454505|3737072|B4|<65||Age, Customized||participants|Number|108|108.0||||||
3913565|NCT01454505|3737073|B3|<65||Age, Customized||participants|Number|20|20.0||||||
3913566|NCT01454505|3737074|B2|<65||Age, Customized||participants|Number|39|39.0||||||
3913567|NCT01454505|3737075|B1|<65||Age, Customized||participants|Number|49|49.0||||||
3913568|NCT01454414|3737090|B3|||Use of self-applied permethrin on clothing||participants|Number|64|64.0||||||
3913569|NCT01454414|3737091|B2|||Use of self-applied permethrin on clothing||participants|Number|34|34.0||||||
3913570|NCT01454414|3737092|B1|||Use of self-applied permethrin on clothing||participants|Number|30|30.0||||||
3913571|NCT01454414|3737090|B3|Tick checks after working outdoors||Use of tick bite prevention measures||participants|Number|118|118.0||||||
3913572|NCT01454414|3737091|B2|Tick checks after working outdoors||Use of tick bite prevention measures||participants|Number|60|60.0||||||
3913573|NCT01454414|3737092|B1|Tick checks after working outdoors||Use of tick bite prevention measures||participants|Number|58|58.0||||||
3913574|NCT01454414|3737090|B3|Repellent on clothing||Use of tick bite prevention measures||participants|Number|73|73.0||||||
3913575|NCT01454414|3737091|B2|Repellent on clothing||Use of tick bite prevention measures||participants|Number|35|35.0||||||
3913576|NCT01454414|3737092|B1|Repellent on clothing||Use of tick bite prevention measures||participants|Number|38|38.0||||||
3913577|NCT01454414|3737090|B3|Repellent on skin||Use of tick bite prevention measures||participants|Number|44|44.0||||||
3913578|NCT01454414|3737091|B2|Repellent on skin||Use of tick bite prevention measures||participants|Number|22|22.0||||||
3913579|NCT01454414|3737092|B1|Repellent on skin||Use of tick bite prevention measures||participants|Number|22|22.0||||||
3913580|NCT01454414|3737090|B3|Tucked or taped pant legs||Use of tick bite prevention measures||participants|Number|12|12.0||||||
3913581|NCT01454414|3737091|B2|Tucked or taped pant legs||Use of tick bite prevention measures||participants|Number|7|7.0||||||
3913582|NCT01454414|3737092|B1|Tucked or taped pant legs||Use of tick bite prevention measures||participants|Number|5|5.0||||||
3913583|NCT01454414|3737090|B3|Hat||Use of tick bite prevention measures||participants|Number|81|81.0||||||
3913584|NCT01454414|3737091|B2|Hat||Use of tick bite prevention measures||participants|Number|38|38.0||||||
3913585|NCT01454414|3737092|B1|Hat||Use of tick bite prevention measures||participants|Number|43|43.0||||||
3913586|NCT01454414|3737090|B3|Long sleeves||Use of tick bite prevention measures||participants|Number|100|100.0||||||
3913587|NCT01454414|3737091|B2|Long sleeves||Use of tick bite prevention measures||participants|Number|52|52.0||||||
3913588|NCT01454414|3737092|B1|Long sleeves||Use of tick bite prevention measures||participants|Number|48|48.0||||||
3913589|NCT01454414|3737090|B3|Long pants||Use of tick bite prevention measures||participants|Number|124|124.0||||||
3913590|NCT01454414|3737091|B2|Long pants||Use of tick bite prevention measures||participants|Number|62|62.0||||||
3913591|NCT01454414|3737092|B1|Long pants||Use of tick bite prevention measures||participants|Number|62|62.0||||||
3913592|NCT01454414|3737090|B3|Babesiosis||Previous diagnosis with tick-borne illness|Self-reported diagnosis with a tick-borne illness prior to enrollment in the study.|participants|Number|0|0.0||||||
3913593|NCT01454414|3737091|B2|Babesiosis||Previous diagnosis with tick-borne illness|Self-reported diagnosis with a tick-borne illness prior to enrollment in the study.|participants|Number|0|0.0||||||
3913594|NCT01454414|3737092|B1|Babesiosis||Previous diagnosis with tick-borne illness|Self-reported diagnosis with a tick-borne illness prior to enrollment in the study.|participants|Number|0|0.0||||||
3913595|NCT01454414|3737090|B3|Anaplasmosis||Previous diagnosis with tick-borne illness|Self-reported diagnosis with a tick-borne illness prior to enrollment in the study.|participants|Number|0|0.0||||||
3913596|NCT01454414|3737091|B2|Anaplasmosis||Previous diagnosis with tick-borne illness|Self-reported diagnosis with a tick-borne illness prior to enrollment in the study.|participants|Number|0|0.0||||||
3913597|NCT01454414|3737092|B1|Anaplasmosis||Previous diagnosis with tick-borne illness|Self-reported diagnosis with a tick-borne illness prior to enrollment in the study.|participants|Number|0|0.0||||||
3913598|NCT01454414|3737090|B3|Ehrlichiosis||Previous diagnosis with tick-borne illness|Self-reported diagnosis with a tick-borne illness prior to enrollment in the study.|participants|Number|5|5.0||||||
3913599|NCT01454414|3737091|B2|Ehrlichiosis||Previous diagnosis with tick-borne illness|Self-reported diagnosis with a tick-borne illness prior to enrollment in the study.|participants|Number|3|3.0||||||
3913600|NCT01454414|3737092|B1|Ehrlichiosis||Previous diagnosis with tick-borne illness|Self-reported diagnosis with a tick-borne illness prior to enrollment in the study.|participants|Number|2|2.0||||||
3913601|NCT01454414|3737090|B3|Rocky Mountain spotted fever||Previous diagnosis with tick-borne illness|Self-reported diagnosis with a tick-borne illness prior to enrollment in the study.|participants|Number|13|13.0||||||
3913602|NCT01454414|3737091|B2|Rocky Mountain spotted fever||Previous diagnosis with tick-borne illness|Self-reported diagnosis with a tick-borne illness prior to enrollment in the study.|participants|Number|7|7.0||||||
3913603|NCT01454414|3737092|B1|Rocky Mountain spotted fever||Previous diagnosis with tick-borne illness|Self-reported diagnosis with a tick-borne illness prior to enrollment in the study.|participants|Number|6|6.0||||||
3913604|NCT01454414|3737090|B3|Lyme disease||Previous diagnosis with tick-borne illness|Self-reported diagnosis with a tick-borne illness prior to enrollment in the study.|participants|Number|8|8.0||||||
3913605|NCT01454414|3737091|B2|Lyme disease||Previous diagnosis with tick-borne illness|Self-reported diagnosis with a tick-borne illness prior to enrollment in the study.|participants|Number|4|4.0||||||
3913606|NCT01454414|3737092|B1|Lyme disease||Previous diagnosis with tick-borne illness|Self-reported diagnosis with a tick-borne illness prior to enrollment in the study.|participants|Number|4|4.0||||||
3913607|NCT01454414|3737090|B3|||Tick bites in previous year, continuous||tick bites|Mean|19.4|19.4|Standard Deviation|35.8|35.8|||
3913608|NCT01454414|3737091|B2|||Tick bites in previous year, continuous||tick bites|Mean|19.6|19.6|Standard Deviation|39.3|39.3|||
3913609|NCT01454414|3737092|B1|||Tick bites in previous year, continuous||tick bites|Mean|19.3|19.3|Standard Deviation|32.0|32.0|||
3913610|NCT01454414|3737090|B3|||Years in current position, continuous||years|Mean|8.0|8.0|Standard Deviation|6.7|6.7|||
3913611|NCT01454414|3737091|B2|||Years in current position, continuous||years|Mean|8.2|8.2|Standard Deviation|6.8|6.8|||
3913612|NCT01454414|3737092|B1|||Years in current position, continuous||years|Mean|7.9|7.9|Standard Deviation|6.7|6.7|||
3913613|NCT01454414|3737090|B3|NC Local or County Parks and Recreation||Work division, categorical|One subject did not provide information on work division.|participants|Number|9|9.0||||||
3913614|NCT01454414|3737091|B2|NC Local or County Parks and Recreation||Work division, categorical|One subject did not provide information on work division.|participants|Number|4|4.0||||||
3913615|NCT01454414|3737092|B1|NC Local or County Parks and Recreation||Work division, categorical|One subject did not provide information on work division.|participants|Number|5|5.0||||||
3913616|NCT01454414|3737090|B3|NC Wildlife Resources Commission||Work division, categorical|One subject did not provide information on work division.|participants|Number|19|19.0||||||
3913617|NCT01454414|3737091|B2|NC Wildlife Resources Commission||Work division, categorical|One subject did not provide information on work division.|participants|Number|10|10.0||||||
3913618|NCT01454414|3737092|B1|NC Wildlife Resources Commission||Work division, categorical|One subject did not provide information on work division.|participants|Number|9|9.0||||||
3913619|NCT01454414|3737090|B3|NC Division of Parks and Recreation||Work division, categorical|One subject did not provide information on work division.|participants|Number|56|56.0||||||
3913620|NCT01454414|3737091|B2|NC Division of Parks and Recreation||Work division, categorical|One subject did not provide information on work division.|participants|Number|25|25.0||||||
3913621|NCT01454414|3737092|B1|NC Division of Parks and Recreation||Work division, categorical|One subject did not provide information on work division.|participants|Number|31|31.0||||||
3913622|NCT01454414|3737090|B3|NC Forest service||Work division, categorical|One subject did not provide information on work division.|participants|Number|48|48.0||||||
3913623|NCT01454414|3737091|B2|NC Forest service||Work division, categorical|One subject did not provide information on work division.|participants|Number|27|27.0||||||
3913624|NCT01454414|3737092|B1|NC Forest service||Work division, categorical|One subject did not provide information on work division.|participants|Number|21|21.0||||||
3913625|NCT01454414|3737090|B3|Bachelor or graduate degree||Education, categorical|Two subjects did not provide education information on the baseline questionnaire.|participants|Number|82|82.0||||||
3913626|NCT01454414|3737091|B2|Bachelor or graduate degree||Education, categorical|Two subjects did not provide education information on the baseline questionnaire.|participants|Number|42|42.0||||||
3913627|NCT01454414|3737092|B1|Bachelor or graduate degree||Education, categorical|Two subjects did not provide education information on the baseline questionnaire.|participants|Number|40|40.0||||||
3913628|NCT01454414|3737090|B3|Some college||Education, categorical|Two subjects did not provide education information on the baseline questionnaire.|participants|Number|34|34.0||||||
3913629|NCT01454414|3737091|B2|Some college||Education, categorical|Two subjects did not provide education information on the baseline questionnaire.|participants|Number|14|14.0||||||
3913630|NCT01454414|3737092|B1|Some college||Education, categorical|Two subjects did not provide education information on the baseline questionnaire.|participants|Number|20|20.0||||||
3913631|NCT01454414|3737090|B3|High school or less||Education, categorical|Two subjects did not provide education information on the baseline questionnaire.|participants|Number|15|15.0||||||
3913632|NCT01454414|3737091|B2|High school or less||Education, categorical|Two subjects did not provide education information on the baseline questionnaire.|participants|Number|10|10.0||||||
3913633|NCT01454414|3737092|B1|High school or less||Education, categorical|Two subjects did not provide education information on the baseline questionnaire.|participants|Number|5|5.0||||||
3913634|NCT01454414|3737090|B3|Other||Race/Ethnicity, Customized|Sixteen subjects did not provide race or ethnicity information.|participants|Number|1|1.0||||||
3913635|NCT01454414|3737091|B2|Other||Race/Ethnicity, Customized|Sixteen subjects did not provide race or ethnicity information.|participants|Number|1|1.0||||||
3913636|NCT01454414|3737092|B1|Other||Race/Ethnicity, Customized|Sixteen subjects did not provide race or ethnicity information.|participants|Number|0|0.0||||||
3913637|NCT01454414|3737090|B3|Black||Race/Ethnicity, Customized|Sixteen subjects did not provide race or ethnicity information.|participants|Number|2|2.0||||||
3913638|NCT01454414|3737091|B2|Black||Race/Ethnicity, Customized|Sixteen subjects did not provide race or ethnicity information.|participants|Number|0|0.0||||||
3913639|NCT01454414|3737092|B1|Black||Race/Ethnicity, Customized|Sixteen subjects did not provide race or ethnicity information.|participants|Number|2|2.0||||||
3913640|NCT01454414|3737090|B3|White||Race/Ethnicity, Customized|Sixteen subjects did not provide race or ethnicity information.|participants|Number|114|114.0||||||
3913641|NCT01454414|3737091|B2|White||Race/Ethnicity, Customized|Sixteen subjects did not provide race or ethnicity information.|participants|Number|58|58.0||||||
3913642|NCT01454414|3737092|B1|White||Race/Ethnicity, Customized|Sixteen subjects did not provide race or ethnicity information.|participants|Number|56|56.0||||||
3913643|NCT01454414|3737090|B3|Male||Gender|One subject did not provide information on gender.|participants|Number|107|107.0||||||
3913644|NCT01454414|3737091|B2|Male||Gender|One subject did not provide information on gender.|participants|Number|55|55.0||||||
3913645|NCT01454414|3737092|B1|Male||Gender|One subject did not provide information on gender.|participants|Number|52|52.0||||||
3913646|NCT01454414|3737090|B3|Female||Gender|One subject did not provide information on gender.|participants|Number|25|25.0||||||
3913647|NCT01454414|3737091|B2|Female||Gender|One subject did not provide information on gender.|participants|Number|11|11.0||||||
3913648|NCT01454414|3737092|B1|Female||Gender|One subject did not provide information on gender.|participants|Number|14|14.0||||||
3913649|NCT01454414|3737090|B3|||Age||years|Mean|39.0|39.0|Standard Deviation|9.2|9.2|||
3913650|NCT01454414|3737091|B2|||Age||years|Mean|38.8|38.8|Standard Deviation|9.3|9.3|||
3913651|NCT01454414|3737092|B1|||Age||years|Mean|39.1|39.1|Standard Deviation|9.2|9.2|||
3913652|NCT01454401|3737099|B1|||HbA1c||mmol/mol|Median|65|65.0|Inter-Quartile Range|||55.0|79.0|
3913653|NCT01454401|3737099|B1|||HbA1c||%|Median|8.1|8.1|Inter-Quartile Range|||6.2|10.1|
3913654|NCT01454401|3737099|B1|Leucocytes||Biochemistry||10^9 cells/l|Median|8.0|8.0|Inter-Quartile Range|||6.2|10.1|
3913655|NCT01454401|3737099|B1|Platelets||Biochemistry||10^9 cells/l|Median|262|262.0|Inter-Quartile Range|||225.0|330.0|
3913656|NCT01454401|3737099|B1|||Biochemistry Haemoglobin||g/l|Median|126|126.0|Inter-Quartile Range|||114.0|139.0|
3913657|NCT01454401|3737099|B1|Wagner grade 2||Wagner classification|The Wagner classification is based mainly on wound depth and consists of 6 wound grades. These include: grade 0 (intact skin), grade 1 (superficial ulcer), grade 2 (deep ulcer to tendon, bone, or joint), grade 3 (deep ulcer with abscess or osteomyelitis), grade 4 (forefoot gangrene), and grade 5 (whole foot gangrene).|participants|Number|25|25.0||||||
3913658|NCT01454401|3737099|B1|Wagner grade 1||Wagner classification|The Wagner classification is based mainly on wound depth and consists of 6 wound grades. These include: grade 0 (intact skin), grade 1 (superficial ulcer), grade 2 (deep ulcer to tendon, bone, or joint), grade 3 (deep ulcer with abscess or osteomyelitis), grade 4 (forefoot gangrene), and grade 5 (whole foot gangrene).|participants|Number|19|19.0||||||
3913659|NCT01454401|3737099|B1|||Ulcer area||cm^2|Median|1.1|1.1|Inter-Quartile Range|||0.5|2.9|
3913660|NCT01454401|3737099|B1|||Ulcer duration (weeks)||weeks|Median|35|35.0|Inter-Quartile Range|||16.0|60.0|
3913661|NCT01454401|3737099|B1|No||Presence of neuropathy||participants|Number|2|2.0||||||
3913662|NCT01454401|3737099|B1|Yes||Presence of neuropathy||participants|Number|42|42.0||||||
3913663|NCT01454401|3737099|B1|||Body Mass Index (kg/m2)||kg/m^2|Median|29.7|29.7|Inter-Quartile Range|||25.6|32.5|
3913664|NCT01454401|3737099|B1|Type 2||Diabetes||participants|Number|36|36.0||||||
3913665|NCT01454401|3737099|B1|Type 1||Diabetes||participants|Number|8|8.0||||||
3913666|NCT01454401|3737099|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3913667|NCT01454401|3737099|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3913668|NCT01454401|3737099|B1|All||Age||years|Median|63|63.0|Inter-Quartile Range|||58.0|73.0|
3913669|NCT01454401|3737099|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3913670|NCT01454401|3737099|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3913671|NCT01454401|3737099|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3913672|NCT01454284|3737104|B3|Sweden||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3913673|NCT01454284|3737105|B2|Sweden||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3913674|NCT01454284|3737106|B1|Sweden||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3913675|NCT01454284|3737104|B3|New Zealand||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3913676|NCT01454284|3737105|B2|New Zealand||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3913677|NCT01454284|3737106|B1|New Zealand||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3913678|NCT01454284|3737104|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3913679|NCT01454284|3737105|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3913680|NCT01454284|3737106|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3913681|NCT01454284|3737104|B3|South Africa||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3913682|NCT01454284|3737105|B2|South Africa||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3913683|NCT01454284|3737106|B1|South Africa||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3913684|NCT01454284|3737104|B3|Australia||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3913685|NCT01454284|3737105|B2|Australia||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3913686|NCT01454284|3737106|B1|Australia||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3913687|NCT01454284|3737104|B3|Denmark||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3913688|NCT01454284|3737105|B2|Denmark||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3913689|NCT01454284|3737106|B1|Denmark||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3913690|NCT01454284|3737104|B3|Croatia||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3913691|NCT01454284|3737105|B2|Croatia||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3913692|NCT01454284|3737106|B1|Croatia||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3913693|NCT01454284|3737104|B3|Poland||Region of Enrollment||Participants|Count of Participants|84|84.0||||||
3913694|NCT01454284|3737105|B2|Poland||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3913695|NCT01454284|3737106|B1|Poland||Region of Enrollment||Participants|Count of Participants|51|51.0||||||
3913696|NCT01454284|3737104|B3|Brazil||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3913697|NCT01454284|3737105|B2|Brazil||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3913698|NCT01454284|3737106|B1|Brazil||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3913699|NCT01454284|3737104|B3|Belgium||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3913700|NCT01454284|3737105|B2|Belgium||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3913701|NCT01454284|3737106|B1|Belgium||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3913702|NCT01454284|3737104|B3|Canada||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
3913703|NCT01454284|3737105|B2|Canada||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3913704|NCT01454284|3737106|B1|Canada||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3913705|NCT01454284|3737104|B3|France||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3913706|NCT01454284|3737105|B2|France||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3913707|NCT01454284|3737106|B1|France||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3913708|NCT01454284|3737104|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|63|63.0||||||
3913709|NCT01454284|3737105|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3913710|NCT01454284|3737106|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
3913711|NCT01454284|3737104|B3|Israel||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3913712|NCT01454284|3737105|B2|Israel||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3913713|NCT01454284|3737106|B1|Israel||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3913714|NCT01454284|3737104|B3|Lithuania||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3913715|NCT01454284|3737105|B2|Lithuania||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3913716|NCT01454284|3737106|B1|Lithuania||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3913717|NCT01454284|3737104|B3|Ireland||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3913718|NCT01454284|3737105|B2|Ireland||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3913719|NCT01454284|3737106|B1|Ireland||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3913720|NCT01454284|3737104|B3|Spain||Region of Enrollment||Participants|Count of Participants|74|74.0||||||
3913721|NCT01454284|3737105|B2|Spain||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3913722|NCT01454284|3737106|B1|Spain||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3913723|NCT01454284|3737104|B3|Greece||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3913724|NCT01454284|3737105|B2|Greece||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3913725|NCT01454284|3737106|B1|Greece||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3913726|NCT01454284|3737104|B3|Slovakia||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3913727|NCT01454284|3737105|B2|Slovakia||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3913728|NCT01454284|3737106|B1|Slovakia||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3913729|NCT01454284|3737104|B3|United States||Region of Enrollment||Participants|Count of Participants|572|572.0||||||
3913730|NCT01454284|3737105|B2|United States||Region of Enrollment||Participants|Count of Participants|229|229.0||||||
3913731|NCT01454284|3737106|B1|United States||Region of Enrollment||Participants|Count of Participants|343|343.0||||||
3913732|NCT01454284|3737104|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913733|NCT01454284|3737105|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913734|NCT01454284|3737106|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913735|NCT01454284|3737104|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3913736|NCT01454284|3737105|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3913737|NCT01454284|3737106|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3913738|NCT01454284|3737104|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1051|1051.0||||||
3913739|NCT01454284|3737105|B2||White|Race (NIH/OMB)||Participants|Count of Participants|426|426.0||||||
3913740|NCT01454284|3737106|B1||White|Race (NIH/OMB)||Participants|Count of Participants|625|625.0||||||
3913741|NCT01454284|3737104|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3913742|NCT01454284|3737105|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3913743|NCT01454284|3737106|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3913744|NCT01454284|3737104|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3913745|NCT01454284|3737105|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913746|NCT01454284|3737106|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3913747|NCT01454284|3737104|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3913748|NCT01454284|3737105|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3913749|NCT01454284|3737106|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3913750|NCT01454284|3737104|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3913751|NCT01454284|3737105|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3913752|NCT01454284|3737106|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3913753|NCT01454284|3737104|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|281|281.0||||||
3913754|NCT01454284|3737105|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|117|117.0||||||
3913755|NCT01454284|3737106|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|164|164.0||||||
3913756|NCT01454284|3737104|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|792|792.0||||||
3913757|NCT01454284|3737105|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|315|315.0||||||
3913758|NCT01454284|3737106|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|477|477.0||||||
3913759|NCT01454284|3737104|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3913760|NCT01454284|3737105|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3913761|NCT01454284|3737106|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3913762|NCT01454284|3737104|B3||Male|Sex: Female, Male||Participants|Count of Participants|678|678.0||||||
3913763|NCT01454284|3737105|B2||Male|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
3913764|NCT01454284|3737106|B1||Male|Sex: Female, Male||Participants|Count of Participants|397|397.0||||||
3913765|NCT01454284|3737104|B3||Female|Sex: Female, Male||Participants|Count of Participants|436|436.0||||||
3913766|NCT01454284|3737105|B2||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3913767|NCT01454284|3737106|B1||Female|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
3913768|NCT01454284|3737104|B3|||Age||years|Mean|41.86|41.86|Standard Deviation|13.36|13.36|||
3913769|NCT01454284|3737105|B2|||Age||years|Mean|42.28|42.28|Standard Deviation|13.16|13.16|||
3913770|NCT01454284|3737106|B1|||Age||years|Mean|41.58|41.58|Standard Deviation|13.50|13.5|||
3913771|NCT01454258|3737155|B1|||Sex/Gender, Customized||participants|Number|NA|||||||Gender data not collected.
3913772|NCT01454258|3737155|B1|||Age, Customized||years|Number|NA|||||||Age data not collected.
3913773|NCT01454076|3737161|B6|||Weight||kilogram (kg)|Mean|76.64|76.64|Standard Deviation|18.083|18.083|||
3913774|NCT01454076|3737162|B5|||Weight||kilogram (kg)|Mean|81.93|81.93|Standard Deviation|20.973|20.973|||
3913775|NCT01454076|3737163|B4|||Weight||kilogram (kg)|Mean|80.22|80.22|Standard Deviation|17.183|17.183|||
3913776|NCT01454076|3737164|B3|||Weight||kilogram (kg)|Mean|74.09|74.09|Standard Deviation|16.358|16.358|||
3913777|NCT01454076|3737165|B2|||Weight||kilogram (kg)|Mean|69.78|69.78|Standard Deviation|13.057|13.057|||
3913778|NCT01454076|3737166|B1|||Weight||kilogram (kg)|Mean|77.44|77.44|Standard Deviation|19.956|19.956|||
3913779|NCT01454076|3737161|B6|||Height||centimeter (cm)|Mean|168.9|168.9|Standard Deviation|10.00|10.0|||
3913780|NCT01454076|3737162|B5|||Height||centimeter (cm)|Mean|172.6|172.6|Standard Deviation|11.11|11.11|||
3913781|NCT01454076|3737163|B4|||Height||centimeter (cm)|Mean|169.2|169.2|Standard Deviation|10.03|10.03|||
3913782|NCT01454076|3737164|B3|||Height||centimeter (cm)|Mean|170.2|170.2|Standard Deviation|9.76|9.76|||
3913783|NCT01454076|3737165|B2|||Height||centimeter (cm)|Mean|166.4|166.4|Standard Deviation|9.64|9.64|||
3913784|NCT01454076|3737166|B1|||Height||centimeter (cm)|Mean|166.6|166.6|Standard Deviation|9.26|9.26|||
3913785|NCT01454076|3737161|B6|United States||Region of Enrollment||participants|Number|112|112.0||||||
3913786|NCT01454076|3737162|B5|United States||Region of Enrollment||participants|Number|21|21.0||||||
3913787|NCT01454076|3737163|B4|United States||Region of Enrollment||participants|Number|18|18.0||||||
3913788|NCT01454076|3737164|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
3913789|NCT01454076|3737165|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3913790|NCT01454076|3737166|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3913791|NCT01454076|3737161|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3913792|NCT01454076|3737162|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913793|NCT01454076|3737163|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913794|NCT01454076|3737164|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3913795|NCT01454076|3737165|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3913796|NCT01454076|3737166|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3913797|NCT01454076|3737161|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3913798|NCT01454076|3737162|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3913799|NCT01454076|3737163|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913800|NCT01454076|3737164|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3913801|NCT01454076|3737165|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3913802|NCT01454076|3737166|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3913803|NCT01454076|3737161|B6||White|Race (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3913804|NCT01454076|3737162|B5||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3913805|NCT01454076|3737163|B4||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3913806|NCT01454076|3737164|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3913807|NCT01454076|3737165|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3913808|NCT01454076|3737166|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3913809|NCT01454076|3737161|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3913810|NCT01454076|3737162|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913811|NCT01454076|3737163|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913812|NCT01454076|3737164|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3913813|NCT01454076|3737165|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3913814|NCT01454076|3737166|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3913815|NCT01454076|3737161|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913816|NCT01454076|3737162|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913817|NCT01454076|3737163|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913818|NCT01454076|3737164|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913819|NCT01454076|3737165|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913820|NCT01454076|3737166|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913821|NCT01454076|3737161|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3913822|NCT01454076|3737162|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3913823|NCT01454076|3737163|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3913824|NCT01454076|3737164|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913825|NCT01454076|3737165|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913826|NCT01454076|3737166|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913827|NCT01454076|3737161|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913828|NCT01454076|3737162|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913829|NCT01454076|3737163|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913830|NCT01454076|3737164|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913831|NCT01454076|3737165|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913832|NCT01454076|3737166|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913833|NCT01454076|3737161|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913834|NCT01454076|3737162|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913835|NCT01454076|3737163|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913836|NCT01454076|3737164|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913837|NCT01454076|3737165|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913838|NCT01454076|3737166|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3913839|NCT01454076|3737161|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3913840|NCT01454076|3737162|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3913841|NCT01454076|3737163|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3913842|NCT01454076|3737164|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3913843|NCT01454076|3737165|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3913844|NCT01454076|3737166|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3913845|NCT01454076|3737161|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3913846|NCT01454076|3737162|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3913847|NCT01454076|3737163|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3913848|NCT01454076|3737164|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3913849|NCT01454076|3737165|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3913850|NCT01454076|3737166|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3913851|NCT01454076|3737161|B6||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3913852|NCT01454076|3737162|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3913853|NCT01454076|3737163|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3913854|NCT01454076|3737164|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3913855|NCT01454076|3737165|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3913856|NCT01454076|3737166|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3913857|NCT01454076|3737161|B6||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3913858|NCT01454076|3737162|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3913859|NCT01454076|3737163|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3913860|NCT01454076|3737164|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3913861|NCT01454076|3737165|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3913862|NCT01454076|3737166|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3913863|NCT01454076|3737161|B6|||Age||years|Mean|61.3|61.3|Standard Deviation|11.01|11.01|||
3913864|NCT01454076|3737162|B5|||Age||years|Mean|60.0|60.0|Standard Deviation|11.04|11.04|||
3913865|NCT01454076|3737163|B4|||Age||years|Mean|61.6|61.6|Standard Deviation|11.33|11.33|||
3913866|NCT01454076|3737164|B3|||Age||years|Mean|62.3|62.3|Standard Deviation|11.86|11.86|||
3913867|NCT01454076|3737165|B2|||Age||years|Mean|60.5|60.5|Standard Deviation|13.33|13.33|||
3913868|NCT01454076|3737166|B1|||Age||years|Mean|61.8|61.8|Standard Deviation|8.71|8.71|||
3913869|NCT01454063|3737221|B3||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3913870|NCT01454063|3737222|B2||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3913871|NCT01454063|3737223|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3913872|NCT01454063|3737221|B3||Female|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
3913873|NCT01454063|3737222|B2||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3913874|NCT01454063|3737223|B1||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3913875|NCT01454063|3737221|B3|||Age||years|Mean|68.4|68.4|Standard Deviation|9.7|9.7|||
3913876|NCT01454063|3737222|B2|||Age||years|Mean|68.5|68.5|Standard Deviation|9.9|9.9|||
3913877|NCT01454063|3737223|B1|||Age||years|Mean|68.2|68.2|Standard Deviation|9.6|9.6|||
3913878|NCT01453998|3737242|B4|Male||Gender|Baseline measure for subjects enrolled after protocol amendment 2.|Subjects|Number|195|195.0||||||
3913879|NCT01453998|3737243|B3|Male||Gender|Baseline measure for subjects enrolled after protocol amendment 2.|Subjects|Number|94|94.0||||||
3913880|NCT01453998|3737244|B2|Male||Gender|Baseline measure for subjects enrolled after protocol amendment 2.|Subjects|Number|45|45.0||||||
3913881|NCT01453998|3737245|B1|Male||Gender|Baseline measure for subjects enrolled after protocol amendment 2.|Subjects|Number|56|56.0||||||
3913882|NCT01453998|3737242|B4|Female||Gender|Baseline measure for subjects enrolled after protocol amendment 2.|Subjects|Number|190|190.0||||||
3913883|NCT01453998|3737243|B3|Female||Gender|Baseline measure for subjects enrolled after protocol amendment 2.|Subjects|Number|89|89.0||||||
3913884|NCT01453998|3737244|B2|Female||Gender|Baseline measure for subjects enrolled after protocol amendment 2.|Subjects|Number|54|54.0||||||
3913885|NCT01453998|3737245|B1|Female||Gender|Baseline measure for subjects enrolled after protocol amendment 2.|Subjects|Number|47|47.0||||||
3913886|NCT01453998|3737242|B4|Male||Gender|Baseline measure for subjects enrolled before protocol amendment 2.|Subjects|Number|138|138.0||||||
3913887|NCT01453998|3737243|B3|Male||Gender|Baseline measure for subjects enrolled before protocol amendment 2.|Subjects|Number|61|61.0||||||
3913888|NCT01453998|3737244|B2|Male||Gender|Baseline measure for subjects enrolled before protocol amendment 2.|Subjects|Number|39|39.0||||||
3913889|NCT01453998|3737245|B1|Male||Gender|Baseline measure for subjects enrolled before protocol amendment 2.|Subjects|Number|38|38.0||||||
3913890|NCT01453998|3737242|B4|Female||Gender|Baseline measure for subjects enrolled before protocol amendment 2.|Subjects|Number|134|134.0||||||
3913891|NCT01453998|3737243|B3|Female||Gender|Baseline measure for subjects enrolled before protocol amendment 2.|Subjects|Number|38|38.0||||||
3913892|NCT01453998|3737244|B2|Female||Gender|Baseline measure for subjects enrolled before protocol amendment 2.|Subjects|Number|49|49.0||||||
3913893|NCT01453998|3737245|B1|Female||Gender|Baseline measure for subjects enrolled before protocol amendment 2.|Subjects|Number|47|47.0||||||
3913894|NCT01453998|3737242|B4|||Age|Baseline measure for subjects enrolled after protocol amendment 2.|Months|Mean|14.00|14.0|Standard Deviation|0.61|0.61|||
3913895|NCT01453998|3737243|B3|||Age|Baseline measure for subjects enrolled after protocol amendment 2.|Months|Mean|14.00|14.0|Standard Deviation|0.72|0.72|||
3913896|NCT01453998|3737244|B2|||Age|Baseline measure for subjects enrolled after protocol amendment 2.|Months|Mean|14.00|14.0|Standard Deviation|0.46|0.46|||
3913897|NCT01453998|3737245|B1|||Age|Baseline measure for subjects enrolled after protocol amendment 2.|Months|Mean|14.00|14.0|Standard Deviation|0.50|0.5|||
3913898|NCT01453998|3737242|B4|||Age|Baseline measure for subjects enrolled before protocol amendment 2.|Months|Mean|12.97|12.97|Standard Deviation|0.71|0.71|||
3913899|NCT01453998|3737243|B3|||Age|Baseline measure for subjects enrolled before protocol amendment 2.|Months|Mean|13.0|13.0|Standard Deviation|0.79|0.79|||
3913900|NCT01453998|3737244|B2|||Age|Baseline measure for subjects enrolled before protocol amendment 2.|Months|Mean|13.0|13.0|Standard Deviation|0.66|0.66|||
3913901|NCT01453998|3737245|B1|||Age|Baseline measure for subjects enrolled before protocol amendment 2.|Months|Mean|12.9|12.9|Standard Deviation|0.67|0.67|||
3913902|NCT01453946|3737312|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3913903|NCT01453946|3737312|B1|Black or african american||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3913904|NCT01453946|3737312|B1|White||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
3913905|NCT01453946|3737312|B1||Male|Gender||Participants|Count of Participants|30|30.0||||||
3913906|NCT01453946|3737312|B1||Female|Gender||Participants|Count of Participants|20|20.0||||||
3913907|NCT01453946|3737312|B1|>8 years||Age, Customized||participants|Number|48|48.0||||||
3913908|NCT01453946|3737312|B1|<=8 years||Age, Customized||participants|Number|2|2.0||||||
3913909|NCT01453946|3737312|B1|||Age||years|Mean|13.8|13.8|Full Range|||8.0|17.0|
3913910|NCT01453894|3737318|B3|Insured||Insurance Status||participants|Number|104|104.0||||||
3913911|NCT01453894|3737319|B2|Insured||Insurance Status||participants|Number|53|53.0||||||
3913912|NCT01453894|3737320|B1|Insured||Insurance Status||participants|Number|51|51.0||||||
3913913|NCT01453894|3737318|B3|Uninsured||Insurance Status||participants|Number|346|346.0||||||
3913914|NCT01453894|3737319|B2|Uninsured||Insurance Status||participants|Number|172|172.0||||||
3913915|NCT01453894|3737320|B1|Uninsured||Insurance Status||participants|Number|174|174.0||||||
3913916|NCT01453894|3737318|B3|United States||Region of Enrollment||participants|Number|450|450.0||||||
3913917|NCT01453894|3737319|B2|United States||Region of Enrollment||participants|Number|225|225.0||||||
3913918|NCT01453894|3737320|B1|United States||Region of Enrollment||participants|Number|225|225.0||||||
3913919|NCT01453894|3737318|B3|Other||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
3913920|NCT01453894|3737319|B2|Other||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3913921|NCT01453894|3737320|B1|Other||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3913922|NCT01453894|3737318|B3|Latino/Hispanic||Race/Ethnicity, Customized||participants|Number|402|402.0||||||
3913923|NCT01453894|3737319|B2|Latino/Hispanic||Race/Ethnicity, Customized||participants|Number|205|205.0||||||
3913924|NCT01453894|3737320|B1|Latino/Hispanic||Race/Ethnicity, Customized||participants|Number|197|197.0||||||
3913925|NCT01453894|3737318|B3||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3913926|NCT01453894|3737319|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3913927|NCT01453894|3737320|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3913928|NCT01453894|3737318|B3||Female|Sex: Female, Male||Participants|Count of Participants|322|322.0||||||
3913929|NCT01453894|3737319|B2||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3913930|NCT01453894|3737320|B1||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3913931|NCT01453894|3737318|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|5.9|5.9|||
3913932|NCT01453894|3737319|B2|||Age||years|Mean|59.6|59.6|Standard Deviation|5.7|5.7|||
3913933|NCT01453894|3737320|B1|||Age||years|Mean|59.5|59.5|Standard Deviation|6.1|6.1|||
3913934|NCT01453855|3737327|B3||Male|Sex: Female, Male||Participants|Count of Participants|348|348.0||||||
3913935|NCT01453855|3737328|B2||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
3913936|NCT01453855|3737329|B1||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
3913937|NCT01453855|3737327|B3||Female|Sex: Female, Male||Participants|Count of Participants|515|515.0||||||
3913938|NCT01453855|3737328|B2||Female|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
3913939|NCT01453855|3737329|B1||Female|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
3913940|NCT01453855|3737327|B3|≥ 65 years||Age, Customized||Participants|Number|481|481.0||||||
3913941|NCT01453855|3737328|B2|≥ 65 years||Age, Customized||Participants|Number|228|228.0||||||
3913942|NCT01453855|3737329|B1|≥ 65 years||Age, Customized||Participants|Number|253|253.0||||||
3913943|NCT01453855|3737327|B3|18 to 64 years||Age, Customized||Participants|Number|382|382.0||||||
3913944|NCT01453855|3737328|B2|18 to 64 years||Age, Customized||Participants|Number|193|193.0||||||
3913945|NCT01453855|3737329|B1|18 to 64 years||Age, Customized||Participants|Number|189|189.0||||||
3913946|NCT01453725|3737336|B3||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3913947|NCT01453725|3737337|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3913948|NCT01453725|3737338|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3913949|NCT01453725|3737336|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3913950|NCT01453725|3737337|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3913951|NCT01453725|3737338|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3913952|NCT01453725|3737336|B3|||Age||Years|Mean|31.2|31.2|Standard Deviation|7.2|7.2|||
3913953|NCT01453725|3737337|B2|||Age||Years|Mean|31.7|31.7|Standard Deviation|7.2|7.2|||
3913954|NCT01453725|3737338|B1|||Age||Years|Mean|30.7|30.7|Standard Deviation|7.1|7.1|||
3913955|NCT01453595|3737359|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
3913956|NCT01453595|3737360|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3913957|NCT01453595|3737361|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3913958|NCT01453595|3737362|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3913959|NCT01453595|3737359|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3913960|NCT01453595|3737360|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3913961|NCT01453595|3737361|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3913962|NCT01453595|3737362|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3913963|NCT01453595|3737359|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3913964|NCT01453595|3737360|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3913965|NCT01453595|3737361|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3913966|NCT01453595|3737362|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3913967|NCT01453595|3737359|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3913968|NCT01453595|3737360|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3913969|NCT01453595|3737361|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3913970|NCT01453595|3737362|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3913971|NCT01453595|3737359|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3913972|NCT01453595|3737360|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3913973|NCT01453595|3737361|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3913974|NCT01453595|3737362|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3913975|NCT01453595|3737359|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3913976|NCT01453595|3737360|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3913977|NCT01453595|3737361|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3913978|NCT01453595|3737362|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3913979|NCT01453569|3737370|B4||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3913980|NCT01453569|3737371|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3913981|NCT01453569|3737372|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3913982|NCT01453569|3737373|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3913983|NCT01453569|3737370|B4||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3913984|NCT01453569|3737371|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3913985|NCT01453569|3737372|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3913986|NCT01453569|3737373|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3913987|NCT01453569|3737370|B4|||Age||years|Mean|70.33|70.33|Standard Deviation|8.24|8.24|||
3913988|NCT01453569|3737371|B3|||Age||years|Mean|70.34|70.34|Standard Deviation|8.13|8.13|||
3913989|NCT01453569|3737372|B2|||Age||years|Mean|70.26|70.26|Standard Deviation|8.40|8.4|||
3913990|NCT01453569|3737373|B1|||Age||years|Mean|70.39|70.39|Standard Deviation|8.51|8.51|||
3913991|NCT01453413|3737392|B1|United States||Region of Enrollment||participants|Number|294|294.0||||||
3913992|NCT01453413|3737392|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3913993|NCT01453413|3737392|B1||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
3913994|NCT01453413|3737392|B1|||Age||years|Mean|59|59.0|Full Range|||19.0|86.0|
3913995|NCT01453387|3737397|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3913996|NCT01453387|3737398|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3913997|NCT01453387|3737399|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3913998|NCT01453387|3737397|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3913999|NCT01453387|3737398|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3914000|NCT01453387|3737399|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3914001|NCT01453387|3737397|B3|>=65 years||Age, Customized||Subjects|Number|11|11.0||||||
3914002|NCT01453387|3737398|B2|>=65 years||Age, Customized||Subjects|Number|2|2.0||||||
3914003|NCT01453387|3737399|B1|>=65 years||Age, Customized||Subjects|Number|9|9.0||||||
3914004|NCT01453387|3737397|B3|Greater than equal to (>=) 45 to <65 years||Age, Customized||Subjects|Number|15|15.0||||||
3914005|NCT01453387|3737398|B2|Greater than equal to (>=) 45 to <65 years||Age, Customized||Subjects|Number|5|5.0||||||
3914006|NCT01453387|3737399|B1|Greater than equal to (>=) 45 to <65 years||Age, Customized||Subjects|Number|10|10.0||||||
3914007|NCT01453387|3737397|B3|18 to less than (<) 45 years||Age, Customized||Subjects|Number|2|2.0||||||
3914008|NCT01453387|3737398|B2|18 to less than (<) 45 years||Age, Customized||Subjects|Number|0|0.0||||||
3914009|NCT01453387|3737399|B1|18 to less than (<) 45 years||Age, Customized||Subjects|Number|2|2.0||||||
3914010|NCT01453374|3737483|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3914011|NCT01453374|3737483|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914012|NCT01453374|3737483|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914013|NCT01453374|3737483|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3914014|NCT01453374|3737483|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3914015|NCT01453374|3737483|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914016|NCT01453374|3737483|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914017|NCT01453374|3737483|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914018|NCT01453374|3737483|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914019|NCT01453374|3737483|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3914020|NCT01453374|3737483|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914021|NCT01453374|3737483|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3914022|NCT01453374|3737483|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3914023|NCT01453374|3737483|B1|||Age||Years|Mean|39.9|39.9|Standard Deviation|8.3|8.3|||
3914024|NCT01453374|3737483|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3914025|NCT01453374|3737483|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3914026|NCT01453374|3737483|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3914027|NCT01453361|3737499|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3914028|NCT01453361|3737499|B1||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3914029|NCT01453361|3737499|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3914030|NCT01453361|3737499|B1||Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3914031|NCT01453361|3737499|B1||White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3914032|NCT01453361|3737499|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3914033|NCT01453361|3737499|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3914034|NCT01453361|3737499|B1|Age|65 and Older Years|Age, Customized||Participants|Count of Participants|9|9.0||||||
3914035|NCT01453361|3737499|B1|Age|16-64 Years|Age, Customized||Participants|Count of Participants|9|9.0||||||
3914036|NCT01453361|3737499|B1|Age|0-15 Years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3914037|NCT01453348|3737504|B4||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3914038|NCT01453348|3737505|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3914039|NCT01453348|3737506|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3914040|NCT01453348|3737507|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3914041|NCT01453348|3737504|B4||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3914042|NCT01453348|3737505|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3914043|NCT01453348|3737506|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3914044|NCT01453348|3737507|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3914045|NCT01453348|3737504|B4|||Age||years|Mean|39.5|39.5|Standard Deviation|11.9|11.9|||
3914046|NCT01453348|3737505|B3|||Age||years|Mean|39.7|39.7|Standard Deviation|11.0|11.0|||
3914047|NCT01453348|3737506|B2|||Age||years|Mean|39.9|39.9|Standard Deviation|12.6|12.6|||
3914048|NCT01453348|3737507|B1|||Age||years|Mean|39.0|39.0|Standard Deviation|12.3|12.3|||
3914049|NCT01453296|3737525|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3914050|NCT01453296|3737525|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
3914051|NCT01453296|3737525|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3914052|NCT01453296|3737525|B1||Male|Gender||Participants|Count of Participants|18|18.0||||||
3914053|NCT01453296|3737525|B1||Female|Gender||Participants|Count of Participants|10|10.0||||||
3914054|NCT01453296|3737525|B1|||Age||Years|Mean|8.0|8.0|Standard Deviation|1.90|1.9|||
3914055|NCT01453205|3737590|B4||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3914056|NCT01453205|3737591|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3914057|NCT01453205|3737592|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3914058|NCT01453205|3737593|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3914059|NCT01453205|3737590|B4||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3914060|NCT01453205|3737591|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3914061|NCT01453205|3737592|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3914062|NCT01453205|3737593|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3914063|NCT01453205|3737590|B4|>= 65 YEARS||Age, Customized||Participants|Count of Participants|49|49.0||||||
3914064|NCT01453205|3737591|B3|>= 65 YEARS||Age, Customized||Participants|Count of Participants|12|12.0||||||
3914065|NCT01453205|3737592|B2|>= 65 YEARS||Age, Customized||Participants|Count of Participants|17|17.0||||||
3914066|NCT01453205|3737593|B1|>= 65 YEARS||Age, Customized||Participants|Count of Participants|20|20.0||||||
3914067|NCT01453205|3737590|B4|< 65 YEARS||Age, Customized||Participants|Count of Participants|138|138.0||||||
3914068|NCT01453205|3737591|B3|< 65 YEARS||Age, Customized||Participants|Count of Participants|43|43.0||||||
3914069|NCT01453205|3737592|B2|< 65 YEARS||Age, Customized||Participants|Count of Participants|35|35.0||||||
3914070|NCT01453205|3737593|B1|< 65 YEARS||Age, Customized||Participants|Count of Participants|60|60.0||||||
3914071|NCT01453205|3737590|B4|||Age||YEARS|Mean|56.4|56.4|Standard Deviation|11.8|11.8|||
3914072|NCT01453205|3737591|B3|||Age||YEARS|Mean|55.9|55.9|Standard Deviation|11.6|11.6|||
3914073|NCT01453205|3737592|B2|||Age||YEARS|Mean|56.9|56.9|Standard Deviation|11.4|11.4|||
3914074|NCT01453205|3737593|B1|||Age||YEARS|Mean|56.4|56.4|Standard Deviation|12.3|12.3|||
3914075|NCT01453166|3737643|B4|Brazil||Region of Enrollment||participants|Number|122|122.0||||||
3914076|NCT01453166|3737644|B3|Brazil||Region of Enrollment||participants|Number|39|39.0||||||
3914077|NCT01453166|3737645|B2|Brazil||Region of Enrollment||participants|Number|41|41.0||||||
3914078|NCT01453166|3737646|B1|Brazil||Region of Enrollment||participants|Number|42|42.0||||||
3914079|NCT01453166|3737643|B4||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3914080|NCT01453166|3737644|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3914081|NCT01453166|3737645|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3914082|NCT01453166|3737646|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3914083|NCT01453166|3737643|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3914084|NCT01453166|3737644|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3914085|NCT01453166|3737645|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3914086|NCT01453166|3737646|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3914087|NCT01453166|3737643|B4|||Age||years|Mean|63|63.0|Standard Deviation|9|9.0|||
3914088|NCT01453166|3737644|B3|||Age||years|Mean|62|62.0|Standard Deviation|11|11.0|||
3914089|NCT01453166|3737645|B2|||Age||years|Mean|65|65.0|Standard Deviation|8|8.0|||
3914090|NCT01453166|3737646|B1|||Age||years|Mean|62|62.0|Standard Deviation|7|7.0|||
3914091|NCT01453166|3737643|B4||>=65 years|Age||Participants|Count of Participants|59|59.0||||||
3914092|NCT01453166|3737644|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3914093|NCT01453166|3737645|B2||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3914094|NCT01453166|3737646|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3914095|NCT01453166|3737643|B4||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
3914096|NCT01453166|3737644|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3914097|NCT01453166|3737645|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3914098|NCT01453166|3737646|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3914099|NCT01453166|3737643|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3914100|NCT01453166|3737644|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3914101|NCT01453166|3737645|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3914102|NCT01453166|3737646|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3914103|NCT01453153|3737668|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914104|NCT01453153|3737669|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914105|NCT01453153|3737670|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914106|NCT01453153|3737671|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914107|NCT01453153|3737668|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914108|NCT01453153|3737669|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914109|NCT01453153|3737670|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914110|NCT01453153|3737671|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914111|NCT01453153|3737668|B4||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3914112|NCT01453153|3737669|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3914113|NCT01453153|3737670|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3914114|NCT01453153|3737671|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3914115|NCT01453153|3737668|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914116|NCT01453153|3737669|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914117|NCT01453153|3737670|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914118|NCT01453153|3737671|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914119|NCT01453153|3737668|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914120|NCT01453153|3737669|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914121|NCT01453153|3737670|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914122|NCT01453153|3737671|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914123|NCT01453153|3737668|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3914124|NCT01453153|3737669|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3914125|NCT01453153|3737670|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914126|NCT01453153|3737671|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3914127|NCT01453153|3737668|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914128|NCT01453153|3737669|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914129|NCT01453153|3737670|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914130|NCT01453153|3737671|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914131|NCT01453153|3737668|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3914132|NCT01453153|3737669|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3914133|NCT01453153|3737670|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3914134|NCT01453153|3737671|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3914135|NCT01453153|3737668|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3914136|NCT01453153|3737669|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3914137|NCT01453153|3737670|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3914138|NCT01453153|3737671|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3914139|NCT01453153|3737668|B4|||Age||years|Mean|58.7|58.7|Standard Deviation|12.48|12.48|||
3914140|NCT01453153|3737669|B3|||Age||years|Mean|60.3|60.3|Standard Deviation|13.50|13.5|||
3914141|NCT01453153|3737670|B2|||Age||years|Mean|59.0|59.0|Standard Deviation|8.72|8.72|||
3914142|NCT01453153|3737671|B1|||Age||years|Mean|50.5|50.5|Standard Deviation|8.06|8.06|||
3914143|NCT01453075|3737744|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3914144|NCT01453075|3737745|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3914145|NCT01453075|3737746|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3914146|NCT01453075|3737744|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3914147|NCT01453075|3737745|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3914148|NCT01453075|3737746|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3914149|NCT01453075|3737744|B3|||Age||years|Mean|58.8|58.8|Standard Deviation|3.5|3.5|||
3914150|NCT01453075|3737745|B2|||Age||years|Mean|58.8|58.8|Standard Deviation|3.5|3.5|||
3914151|NCT01453075|3737746|B1|||Age||years|Mean|58.8|58.8|Standard Deviation|3.5|3.5|||
3914152|NCT01453049|3737753|B3||Male|Sex: Female, Male|Baseline Characteristic data are presented for all members of the Full Analysis Set, comprised of all randomized participants who received at least one dose of study medication and had at least one post-baseline efficacy assessment.|Participants|Count of Participants|37|37.0||||||
3914153|NCT01453049|3737754|B2||Male|Sex: Female, Male|Baseline Characteristic data are presented for all members of the Full Analysis Set, comprised of all randomized participants who received at least one dose of study medication and had at least one post-baseline efficacy assessment.|Participants|Count of Participants|15|15.0||||||
3914154|NCT01453049|3737755|B1||Male|Sex: Female, Male|Baseline Characteristic data are presented for all members of the Full Analysis Set, comprised of all randomized participants who received at least one dose of study medication and had at least one post-baseline efficacy assessment.|Participants|Count of Participants|22|22.0||||||
3914155|NCT01453049|3737753|B3||Female|Sex: Female, Male|Baseline Characteristic data are presented for all members of the Full Analysis Set, comprised of all randomized participants who received at least one dose of study medication and had at least one post-baseline efficacy assessment.|Participants|Count of Participants|36|36.0||||||
3914156|NCT01453049|3737754|B2||Female|Sex: Female, Male|Baseline Characteristic data are presented for all members of the Full Analysis Set, comprised of all randomized participants who received at least one dose of study medication and had at least one post-baseline efficacy assessment.|Participants|Count of Participants|23|23.0||||||
3914157|NCT01453049|3737755|B1||Female|Sex: Female, Male|Baseline Characteristic data are presented for all members of the Full Analysis Set, comprised of all randomized participants who received at least one dose of study medication and had at least one post-baseline efficacy assessment.|Participants|Count of Participants|13|13.0||||||
3914158|NCT01453049|3737753|B3|||Age|Baseline Characteristic data are presented for all members of the Full Analysis Set, comprised of all randomized participants who received at least one dose of study medication and had at least one post-baseline efficacy assessment.|Years|Mean|52.9|52.9|Standard Deviation|9.52|9.52|||
3914159|NCT01453049|3737754|B2|||Age|Baseline Characteristic data are presented for all members of the Full Analysis Set, comprised of all randomized participants who received at least one dose of study medication and had at least one post-baseline efficacy assessment.|Years|Mean|52.2|52.2|Standard Deviation|8.57|8.57|||
3914160|NCT01453049|3737755|B1|||Age|Baseline Characteristic data are presented for all members of the Full Analysis Set, comprised of all randomized participants who received at least one dose of study medication and had at least one post-baseline efficacy assessment.|Years|Mean|53.6|53.6|Standard Deviation|10.54|10.54|||
3914161|NCT01453036|3737826|B4|Korea, Republic of||Region of Enrollment||participants|Number|834|834.0||||||
3914162|NCT01453036|3737827|B3|Korea, Republic of||Region of Enrollment||participants|Number|308|308.0||||||
3914163|NCT01453036|3737828|B2|Korea, Republic of||Region of Enrollment||participants|Number|218|218.0||||||
3914164|NCT01453036|3737829|B1|Korea, Republic of||Region of Enrollment||participants|Number|308|308.0||||||
3914165|NCT01453036|3737826|B4||Male|Sex: Female, Male||Participants|Count of Participants|430|430.0||||||
3914166|NCT01453036|3737827|B3||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3914167|NCT01453036|3737828|B2||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3914168|NCT01453036|3737829|B1||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3914169|NCT01453036|3737826|B4||Female|Sex: Female, Male||Participants|Count of Participants|404|404.0||||||
3914170|NCT01453036|3737827|B3||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3914171|NCT01453036|3737828|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3914172|NCT01453036|3737829|B1||Female|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
3914173|NCT01453036|3737826|B4|||Age||years|Mean|54.9|54.9|Standard Deviation|12.4|12.4|||
3914174|NCT01453036|3737827|B3|||Age||years|Mean|56.2|56.2|Standard Deviation|13.2|13.2|||
3914175|NCT01453036|3737828|B2|||Age||years|Mean|54.7|54.7|Standard Deviation|12.2|12.2|||
3914176|NCT01453036|3737829|B1|||Age||years|Mean|54.0|54.0|Standard Deviation|12.0|12.0|||
3914177|NCT01453036|3737826|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3914178|NCT01453036|3737827|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3914179|NCT01453036|3737828|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3914180|NCT01453036|3737829|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3914181|NCT01453036|3737826|B4||Between 18 and 65 years|Age||Participants|Count of Participants|834|834.0||||||
3914182|NCT01453036|3737827|B3||Between 18 and 65 years|Age||Participants|Count of Participants|308|308.0||||||
3914183|NCT01453036|3737828|B2||Between 18 and 65 years|Age||Participants|Count of Participants|218|218.0||||||
3914184|NCT01453036|3737829|B1||Between 18 and 65 years|Age||Participants|Count of Participants|308|308.0||||||
3914185|NCT01453036|3737826|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3914186|NCT01453036|3737827|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3914187|NCT01453036|3737828|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3914188|NCT01453036|3737829|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3914189|NCT01453023|3737839|B1|African American/African Heritage & White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3914190|NCT01453023|3737839|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
3914191|NCT01453023|3737839|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3914192|NCT01453023|3737839|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3914193|NCT01453023|3737839|B1||Male|Gender||Participants|Count of Participants|15|15.0||||||
3914194|NCT01453023|3737839|B1||Female|Gender||Participants|Count of Participants|11|11.0||||||
3914195|NCT01453023|3737839|B1|||Age||Years|Mean|8.1|8.1|Standard Deviation|1.97|1.97|||
3914196|NCT01452854|3737908|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3914197|NCT01452854|3737908|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3914198|NCT01452854|3737908|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3914199|NCT01452854|3737908|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3914200|NCT01452854|3737908|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3914201|NCT01452854|3737908|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3914202|NCT01452529|3737912|B3|||Screening Baseline Pain Over the Last 24 Hours|"Average pain over the last 24 hours score (on an 11-point numerical rating scale where 0 = no pain and 10 = pain as bad as you can imagine)."|units on a scale|Mean|7.4|7.4|Standard Deviation|1.16|1.16|||
3914259|NCT01452269|3737955|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3914203|NCT01452529|3737913|B2|||Screening Baseline Pain Over the Last 24 Hours|"Average pain over the last 24 hours score (on an 11-point numerical rating scale where 0 = no pain and 10 = pain as bad as you can imagine)."|units on a scale|Mean|7.4|7.4|Standard Deviation|1.19|1.19|||
3914204|NCT01452529|3737914|B1|||Screening Baseline Pain Over the Last 24 Hours|"Average pain over the last 24 hours score (on an 11-point numerical rating scale where 0 = no pain and 10 = pain as bad as you can imagine)."|units on a scale|Mean|7.4|7.4|Standard Deviation|1.13|1.13|||
3914205|NCT01452529|3737912|B3|Other||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3914206|NCT01452529|3737913|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3914207|NCT01452529|3737914|B1|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3914208|NCT01452529|3737912|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3914209|NCT01452529|3737913|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3914210|NCT01452529|3737914|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3914211|NCT01452529|3737912|B3|Asian||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
3914212|NCT01452529|3737913|B2|Asian||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3914213|NCT01452529|3737914|B1|Asian||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3914214|NCT01452529|3737912|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|118|118.0||||||
3914215|NCT01452529|3737913|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
3914216|NCT01452529|3737914|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
3914217|NCT01452529|3737912|B3|White||Race/Ethnicity, Customized||participants|Number|402|402.0||||||
3914218|NCT01452529|3737913|B2|White||Race/Ethnicity, Customized||participants|Number|207|207.0||||||
3914219|NCT01452529|3737914|B1|White||Race/Ethnicity, Customized||participants|Number|195|195.0||||||
3914220|NCT01452529|3737912|B3||Male|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
3914221|NCT01452529|3737913|B2||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3914222|NCT01452529|3737914|B1||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3914223|NCT01452529|3737912|B3||Female|Sex: Female, Male||Participants|Count of Participants|338|338.0||||||
3914224|NCT01452529|3737913|B2||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3914225|NCT01452529|3737914|B1||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3914226|NCT01452529|3737912|B3|||Age||years|Mean|48.6|48.6|Standard Deviation|13.38|13.38|||
3914227|NCT01452529|3737913|B2|||Age||years|Mean|47.9|47.9|Standard Deviation|13.23|13.23|||
3914228|NCT01452529|3737914|B1|||Age||years|Mean|49.2|49.2|Standard Deviation|13.51|13.51|||
3914229|NCT01452425|3737931|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3914230|NCT01452425|3737931|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3914231|NCT01452425|3737931|B1|age||Age, Customized||years|Mean|33|33.0|Standard Deviation|4|4.0|||
3914232|NCT01452347|3737936|B3||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3914233|NCT01452347|3737937|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3914234|NCT01452347|3737938|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3914235|NCT01452347|3737936|B3||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3914236|NCT01452347|3737937|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3914237|NCT01452347|3737938|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3914238|NCT01452347|3737936|B3|||Age||years|Mean|56.2|56.2|Standard Deviation|9.5|9.5|||
3914239|NCT01452347|3737937|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|10.2|10.2|||
3914240|NCT01452347|3737938|B1|||Age||years|Mean|56.3|56.3|Standard Deviation|9.2|9.2|||
3914241|NCT01452269|3737955|B3|Became Deaf age 4 or older, or unknown age||Became Deaf age 3 or younger||participants|Number|18|18.0||||||
3914242|NCT01452269|3737956|B2|Became Deaf age 4 or older, or unknown age||Became Deaf age 3 or younger||participants|Number|12|12.0||||||
3914243|NCT01452269|3737957|B1|Became Deaf age 4 or older, or unknown age||Became Deaf age 3 or younger||participants|Number|6|6.0||||||
3914244|NCT01452269|3737955|B3|Became Deaf age 3 or younger||Became Deaf age 3 or younger||participants|Number|86|86.0||||||
3914245|NCT01452269|3737956|B2|Became Deaf age 3 or younger||Became Deaf age 3 or younger||participants|Number|44|44.0||||||
3914246|NCT01452269|3737957|B1|Became Deaf age 3 or younger||Became Deaf age 3 or younger||participants|Number|42|42.0||||||
3914247|NCT01452269|3737955|B3|United States||Region of Enrollment||participants|Number|104|104.0||||||
3914248|NCT01452269|3737956|B2|United States||Region of Enrollment||participants|Number|56|56.0||||||
3914249|NCT01452269|3737957|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
3914250|NCT01452269|3737955|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914251|NCT01452269|3737956|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914252|NCT01452269|3737957|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914253|NCT01452269|3737955|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3914254|NCT01452269|3737956|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3914255|NCT01452269|3737957|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3914256|NCT01452269|3737955|B3||White|Race (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3914257|NCT01452269|3737956|B2||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3914258|NCT01452269|3737957|B1||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3914260|NCT01452269|3737956|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3914261|NCT01452269|3737957|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914262|NCT01452269|3737955|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914263|NCT01452269|3737956|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914264|NCT01452269|3737957|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914265|NCT01452269|3737955|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3914266|NCT01452269|3737956|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914267|NCT01452269|3737957|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3914268|NCT01452269|3737955|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914269|NCT01452269|3737956|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914270|NCT01452269|3737957|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914271|NCT01452269|3737955|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3914272|NCT01452269|3737956|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3914273|NCT01452269|3737957|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3914274|NCT01452269|3737955|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3914275|NCT01452269|3737956|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3914276|NCT01452269|3737957|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3914277|NCT01452269|3737955|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3914278|NCT01452269|3737956|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3914279|NCT01452269|3737957|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3914280|NCT01452269|3737955|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3914281|NCT01452269|3737956|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3914282|NCT01452269|3737957|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3914283|NCT01452269|3737955|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3914284|NCT01452269|3737956|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3914285|NCT01452269|3737957|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3914286|NCT01452269|3737955|B3|||Age||years|Mean|53.5|53.5|Standard Deviation|7.6|7.6|||
3914287|NCT01452269|3737956|B2|||Age||years|Mean|53.4|53.4|Standard Deviation|7.8|7.8|||
3914288|NCT01452269|3737957|B1|||Age||years|Mean|53.6|53.6|Standard Deviation|7.4|7.4|||
3914289|NCT01452269|3737955|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3914290|NCT01452269|3737956|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3914291|NCT01452269|3737957|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3914292|NCT01452269|3737955|B3||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
3914293|NCT01452269|3737956|B2||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
3914294|NCT01452269|3737957|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3914295|NCT01452269|3737955|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3914296|NCT01452269|3737956|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3914297|NCT01452269|3737957|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3914298|NCT01452152|3737968|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3914299|NCT01452152|3737969|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3914300|NCT01452152|3737971|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914301|NCT01452152|3737968|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914302|NCT01452152|3737969|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914303|NCT01452152|3737971|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914304|NCT01452152|3737968|B4||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3914305|NCT01452152|3737969|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3914306|NCT01452152|3737971|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3914307|NCT01452152|3737968|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3914308|NCT01452152|3737969|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3914309|NCT01452152|3737971|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914310|NCT01452152|3737968|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914311|NCT01452152|3737969|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914312|NCT01452152|3737971|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914313|NCT01452152|3737968|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914314|NCT01452152|3737969|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914315|NCT01452152|3737971|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914316|NCT01452152|3737968|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914317|NCT01452152|3737969|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914318|NCT01452152|3737971|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914319|NCT01452152|3737968|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914320|NCT01452152|3737969|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914321|NCT01452152|3737971|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914322|NCT01452152|3737968|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3914323|NCT01452152|3737969|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3914324|NCT01452152|3737971|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3914325|NCT01452152|3737968|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3914326|NCT01452152|3737969|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3914327|NCT01452152|3737971|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914328|NCT01452152|3737968|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3914329|NCT01452152|3737969|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3914330|NCT01452152|3737971|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3914331|NCT01452152|3737968|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3914332|NCT01452152|3737969|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3914333|NCT01452152|3737971|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3914334|NCT01452152|3737968|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3914335|NCT01452152|3737969|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3914336|NCT01452152|3737971|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3914337|NCT01452152|3737968|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3914338|NCT01452152|3737969|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3914339|NCT01452152|3737971|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3914340|NCT01452152|3737968|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3914341|NCT01452152|3737969|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3914342|NCT01452152|3737971|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3914343|NCT01452126|3737996|B1||Male|Gender||Participants|Count of Participants|30|30.0||||||
3914344|NCT01452126|3737996|B1||Female|Gender||Participants|Count of Participants|19|19.0||||||
3914345|NCT01452126|3737996|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3914346|NCT01452126|3737996|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3914347|NCT01452126|3737996|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3914348|NCT01451996|3738004|B5|United States||Region of Enrollment||Participants|Count of Participants|340|340.0||||||
3914349|NCT01451996|3738005|B4|United States||Region of Enrollment||Participants|Count of Participants|85|85.0||||||
3914350|NCT01451996|3738006|B3|United States||Region of Enrollment||Participants|Count of Participants|85|85.0||||||
3914351|NCT01451996|3738007|B2|United States||Region of Enrollment||Participants|Count of Participants|87|87.0||||||
3914352|NCT01451996|3738008|B1|United States||Region of Enrollment||Participants|Count of Participants|83|83.0||||||
3914353|NCT01451996|3738004|B5|Not Black||Race/Ethnicity, Customized||Participants|Count of Participants|230|230.0||||||
3914354|NCT01451996|3738005|B4|Not Black||Race/Ethnicity, Customized||Participants|Count of Participants|63|63.0||||||
3914355|NCT01451996|3738006|B3|Not Black||Race/Ethnicity, Customized||Participants|Count of Participants|61|61.0||||||
3914356|NCT01451996|3738007|B2|Not Black||Race/Ethnicity, Customized||Participants|Count of Participants|52|52.0||||||
3914357|NCT01451996|3738008|B1|Not Black||Race/Ethnicity, Customized||Participants|Count of Participants|54|54.0||||||
3914358|NCT01451996|3738004|B5|Black||Race/Ethnicity, Customized||Participants|Count of Participants|110|110.0||||||
3914359|NCT01451996|3738005|B4|Black||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3914360|NCT01451996|3738006|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3914361|NCT01451996|3738007|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
3914362|NCT01451996|3738008|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3914363|NCT01451996|3738004|B5||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3914364|NCT01451996|3738005|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3914365|NCT01451996|3738006|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3914366|NCT01451996|3738007|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3914367|NCT01451996|3738008|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3914368|NCT01451996|3738004|B5||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
3914369|NCT01451996|3738005|B4||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3914370|NCT01451996|3738006|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3914371|NCT01451996|3738007|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3914372|NCT01451996|3738008|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3914373|NCT01451996|3738004|B5|||Age||years|Mean|27.70|27.7|Full Range|||18.0|65.0|
3914374|NCT01451996|3738005|B4|||Age||years|Mean|26.40|26.4|Full Range|||18.0|65.0|
3914375|NCT01451996|3738006|B3|||Age||years|Mean|27.25|27.25|Full Range|||18.0|65.0|
3914376|NCT01451996|3738007|B2|||Age||years|Mean|29.30|29.3|Full Range|||18.0|65.0|
3914377|NCT01451996|3738008|B1|||Age||years|Mean|27.83|27.83|Full Range|||18.0|65.0|
3914378|NCT01451983|3738025|B5||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3914379|NCT01451983|3738026|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3914380|NCT01451983|3738027|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3914381|NCT01451983|3738028|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3914382|NCT01451983|3738029|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3914383|NCT01451983|3738025|B5||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3914384|NCT01451983|3738026|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3914385|NCT01451983|3738027|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3914386|NCT01451983|3738028|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3914387|NCT01451983|3738029|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3914388|NCT01451983|3738025|B5|||Age||years|Mean|11.4|11.4|Full Range|||2.0|45.0|
3914389|NCT01451983|3738026|B4|||Age||years|Mean|11.7|11.7|Full Range|||2.0|36.0|
3914390|NCT01451983|3738027|B3|||Age||years|Mean|9.0|9.0|Full Range|||2.0|45.0|
3914391|NCT01451983|3738028|B2|||Age||years|Mean|13.3|13.3|Full Range|||2.0|38.0|
3914392|NCT01451983|3738029|B1|||Age||years|Mean|11.9|11.9|Full Range|||2.0|34.0|
3914393|NCT01451931|3738042|B4|||Self-Reported Pain Score|Range 0-10, higher numbers indicate more severe pain|units on a scale|Mean|8.1|8.1|Standard Deviation|2.2|2.2|||
3914394|NCT01451931|3738043|B3|||Self-Reported Pain Score|Range 0-10, higher numbers indicate more severe pain|units on a scale|Mean|8.1|8.1|Standard Deviation|2.2|2.2|||
3914395|NCT01451931|3738044|B2|||Self-Reported Pain Score|Range 0-10, higher numbers indicate more severe pain|units on a scale|Mean|8.0|8.0|Standard Deviation|2.4|2.4|||
3914396|NCT01451931|3738045|B1|||Self-Reported Pain Score|Range 0-10, higher numbers indicate more severe pain|units on a scale|Mean|8.3|8.3|Standard Deviation|2.0|2.0|||
3914397|NCT01451931|3738042|B4|No Kidney Stone||History of Kidney Stones or Cancer||number of participants|Number|1610|1610.0||||||
3914398|NCT01451931|3738043|B3|No Kidney Stone||History of Kidney Stones or Cancer||number of participants|Number|571|571.0||||||
3914399|NCT01451931|3738044|B2|No Kidney Stone||History of Kidney Stones or Cancer||number of participants|Number|508|508.0||||||
3914400|NCT01451931|3738045|B1|No Kidney Stone||History of Kidney Stones or Cancer||number of participants|Number|531|531.0||||||
3914401|NCT01451931|3738042|B4|Prior Kidney Stones||History of Kidney Stones or Cancer||number of participants|Number|1149|1149.0||||||
3914402|NCT01451931|3738043|B3|Prior Kidney Stones||History of Kidney Stones or Cancer||number of participants|Number|387|387.0||||||
3914403|NCT01451931|3738044|B2|Prior Kidney Stones||History of Kidney Stones or Cancer||number of participants|Number|385|385.0||||||
3914404|NCT01451931|3738045|B1|Prior Kidney Stones||History of Kidney Stones or Cancer||number of participants|Number|377|377.0||||||
3914405|NCT01451931|3738042|B4|United States||Region of Enrollment||participants|Number|2759|2759.0||||||
3914406|NCT01451931|3738043|B3|United States||Region of Enrollment||participants|Number|958|958.0||||||
3914407|NCT01451931|3738044|B2|United States||Region of Enrollment||participants|Number|893|893.0||||||
3914408|NCT01451931|3738045|B1|United States||Region of Enrollment||participants|Number|908|908.0||||||
3914409|NCT01451931|3738042|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3914410|NCT01451931|3738043|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3914411|NCT01451931|3738044|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3914412|NCT01451931|3738045|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3914413|NCT01451931|3738042|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2075|2075.0||||||
3914414|NCT01451931|3738043|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|727|727.0||||||
3914415|NCT01451931|3738044|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|663|663.0||||||
3914416|NCT01451931|3738045|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|685|685.0||||||
3914417|NCT01451931|3738042|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|668|668.0||||||
3914418|NCT01451931|3738043|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|226|226.0||||||
3914419|NCT01451931|3738044|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|224|224.0||||||
3914420|NCT01451931|3738045|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|218|218.0||||||
3914421|NCT01451931|3738042|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3914422|NCT01451931|3738043|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3914423|NCT01451931|3738044|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3914424|NCT01451931|3738045|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3914425|NCT01451931|3738042|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3914426|NCT01451931|3738043|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3914427|NCT01451931|3738044|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3914428|NCT01451931|3738045|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3914429|NCT01451931|3738042|B4||White|Race (NIH/OMB)||Participants|Count of Participants|1796|1796.0||||||
3914430|NCT01451931|3738043|B3||White|Race (NIH/OMB)||Participants|Count of Participants|616|616.0||||||
3914431|NCT01451931|3738044|B2||White|Race (NIH/OMB)||Participants|Count of Participants|593|593.0||||||
3914432|NCT01451931|3738045|B1||White|Race (NIH/OMB)||Participants|Count of Participants|587|587.0||||||
3914433|NCT01451931|3738042|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|690|690.0||||||
3914434|NCT01451931|3738043|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|241|241.0||||||
3914435|NCT01451931|3738044|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|213|213.0||||||
3914436|NCT01451931|3738045|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|236|236.0||||||
3914437|NCT01451931|3738042|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3914438|NCT01451931|3738043|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3914439|NCT01451931|3738044|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3914440|NCT01451931|3738045|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3914441|NCT01451931|3738042|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
3914442|NCT01451931|3738043|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3914443|NCT01451931|3738044|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3914444|NCT01451931|3738045|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3914445|NCT01451931|3738042|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3914446|NCT01451931|3738043|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3914447|NCT01451931|3738044|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3914448|NCT01451931|3738045|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3914449|NCT01451931|3738042|B4||Male|Sex: Female, Male||Participants|Count of Participants|1428|1428.0||||||
3914450|NCT01451931|3738043|B3||Male|Sex: Female, Male||Participants|Count of Participants|486|486.0||||||
3914451|NCT01451931|3738044|B2||Male|Sex: Female, Male||Participants|Count of Participants|477|477.0||||||
3914452|NCT01451931|3738045|B1||Male|Sex: Female, Male||Participants|Count of Participants|465|465.0||||||
3914453|NCT01451931|3738042|B4||Female|Sex: Female, Male||Participants|Count of Participants|1331|1331.0||||||
3914454|NCT01451931|3738043|B3||Female|Sex: Female, Male||Participants|Count of Participants|472|472.0||||||
3914455|NCT01451931|3738044|B2||Female|Sex: Female, Male||Participants|Count of Participants|416|416.0||||||
3914456|NCT01451931|3738045|B1||Female|Sex: Female, Male||Participants|Count of Participants|443|443.0||||||
3914457|NCT01451931|3738042|B4||>=65 years|Age||Participants|Count of Participants|66|66.0||||||
3914458|NCT01451931|3738043|B3||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
3914459|NCT01451931|3738044|B2||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3914460|NCT01451931|3738045|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3914461|NCT01451931|3738042|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2672|2672.0||||||
3914462|NCT01451931|3738043|B3||Between 18 and 65 years|Age||Participants|Count of Participants|918|918.0||||||
3914463|NCT01451931|3738044|B2||Between 18 and 65 years|Age||Participants|Count of Participants|866|866.0||||||
3914464|NCT01451931|3738045|B1||Between 18 and 65 years|Age||Participants|Count of Participants|888|888.0||||||
3914465|NCT01451931|3738042|B4||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
3914466|NCT01451931|3738043|B3||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
3914467|NCT01451931|3738044|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3914468|NCT01451931|3738045|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3914469|NCT01451931|3738042|B4|||Age||years|Mean|40.4|40.4|Standard Deviation|12.7|12.7|||
3914470|NCT01451931|3738043|B3|||Age||years|Mean|40.7|40.7|Standard Deviation|12.8|12.8|||
3914471|NCT01451931|3738044|B2|||Age||years|Mean|40.4|40.4|Standard Deviation|12.8|12.8|||
3914472|NCT01451931|3738045|B1|||Age||years|Mean|40.1|40.1|Standard Deviation|12.4|12.4|||
3914473|NCT01451827|3738067|B5||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3914474|NCT01451827|3738068|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3914475|NCT01451827|3738069|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3914476|NCT01451827|3738070|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3914477|NCT01451827|3738071|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3914478|NCT01451827|3738067|B5||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3914479|NCT01451827|3738068|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3914480|NCT01451827|3738069|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3914481|NCT01451827|3738070|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3914482|NCT01451827|3738071|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3914483|NCT01451827|3738067|B5|||Age||years|Mean|34.0|34.0|Standard Deviation|8.5|8.5|||
3914484|NCT01451827|3738068|B4|||Age||years|Mean|33.9|33.9|Standard Deviation|8.1|8.1|||
3914485|NCT01451827|3738069|B3|||Age||years|Mean|32.2|32.2|Standard Deviation|7.6|7.6|||
3914486|NCT01451827|3738070|B2|||Age||years|Mean|35.8|35.8|Standard Deviation|7.9|7.9|||
3914487|NCT01451827|3738071|B1|||Age||years|Mean|34.1|34.1|Standard Deviation|10.1|10.1|||
3914488|NCT01451814|3738092|B3|||Fagstrom Test for Nicotine Dependence|Score ranges from 0 to 10 with higher scores indicating greater dependence.|units on a scale|Mean|5.5|5.5|Standard Deviation|2.3|2.3|||
3914489|NCT01451814|3738093|B2|||Fagstrom Test for Nicotine Dependence|Score ranges from 0 to 10 with higher scores indicating greater dependence.|units on a scale|Mean|5.4|5.4|Standard Deviation|2.2|2.2|||
3914490|NCT01451814|3738094|B1|||Fagstrom Test for Nicotine Dependence|Score ranges from 0 to 10 with higher scores indicating greater dependence.|units on a scale|Mean|5.6|5.6|Standard Deviation|2.4|2.4|||
3914491|NCT01451814|3738092|B3|United States||Region of Enrollment||participants|Number|66|66.0||||||
3914492|NCT01451814|3738093|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
3914493|NCT01451814|3738094|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3914494|NCT01451814|3738092|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914495|NCT01451814|3738093|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914496|NCT01451814|3738094|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914497|NCT01451814|3738092|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3914498|NCT01451814|3738093|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3914499|NCT01451814|3738094|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914500|NCT01451814|3738092|B3||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3914501|NCT01451814|3738093|B2||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3914502|NCT01451814|3738094|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3914503|NCT01451814|3738092|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3914504|NCT01451814|3738093|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3914505|NCT01451814|3738094|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3914506|NCT01451814|3738092|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914507|NCT01451814|3738093|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914508|NCT01451814|3738094|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914509|NCT01451814|3738092|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3914510|NCT01451814|3738093|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3914511|NCT01451814|3738094|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914512|NCT01451814|3738092|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3914513|NCT01451814|3738093|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3914514|NCT01451814|3738094|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914515|NCT01451814|3738092|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914516|NCT01451814|3738093|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914517|NCT01451814|3738094|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914518|NCT01451814|3738092|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3914519|NCT01451814|3738093|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3914520|NCT01451814|3738094|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3914521|NCT01451814|3738092|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3914522|NCT01451814|3738093|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3914523|NCT01451814|3738094|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914524|NCT01451814|3738092|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3914525|NCT01451814|3738093|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3914526|NCT01451814|3738094|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3914527|NCT01451814|3738092|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3914528|NCT01451814|3738093|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3914529|NCT01451814|3738094|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3914530|NCT01451814|3738092|B3|||Age||years|Mean|46.2|46.2|Standard Deviation|13.5|13.5|||
3914531|NCT01451814|3738093|B2|||Age||years|Mean|44.5|44.5|Standard Deviation|13.8|13.8|||
3914532|NCT01451814|3738094|B1|||Age||years|Mean|47.4|47.4|Standard Deviation|13.1|13.1|||
3914533|NCT01451775|3738105|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3914534|NCT01451775|3738105|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3914535|NCT01451775|3738105|B1|||Age||years|Mean|36.1|36.1|Standard Deviation|7.6|7.6|||
3914536|NCT01451762|3738124|B4|United States||Region of Enrollment||participants|Number|90|90.0||||||
3914537|NCT01451762|3738125|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3914538|NCT01451762|3738126|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3914539|NCT01451762|3738127|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3914540|NCT01451762|3738124|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3914541|NCT01451762|3738125|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3914542|NCT01451762|3738126|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3914543|NCT01451762|3738127|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3914544|NCT01451762|3738124|B4||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3914545|NCT01451762|3738125|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3914546|NCT01451762|3738126|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3914547|NCT01451762|3738127|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3914548|NCT01451762|3738124|B4|||Age||years|Mean|37|37.0|Standard Deviation|9.1|9.1|||
3914549|NCT01451762|3738125|B3|||Age||years|Mean|37|37.0|Standard Deviation|8.3|8.3|||
3914550|NCT01451762|3738126|B2|||Age||years|Mean|36.5|36.5|Standard Deviation|10.7|10.7|||
3914551|NCT01451762|3738127|B1|||Age||years|Mean|35|35.0|Standard Deviation|8.36|8.36|||
3914552|NCT01451762|3738124|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3914553|NCT01451762|3738125|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3914554|NCT01451762|3738126|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3914555|NCT01451762|3738127|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3914556|NCT01451762|3738124|B4||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
3914557|NCT01451762|3738125|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3914558|NCT01451762|3738126|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3914559|NCT01451762|3738127|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3914560|NCT01451762|3738124|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3914561|NCT01451762|3738125|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3914562|NCT01451762|3738126|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3914563|NCT01451762|3738127|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3914564|NCT01451749|3738137|B3|||Hamilton depression rating scale|The Hamilton Rating Scale for Depression is designed for adults and is used to rate the severity of their depression by probing mood, feelings of guilt, suicide ideation, insomnia, agitation or retardation, anxiety, weight loss, and somatic symptoms.The HAMD scale contains 17 tems, each item is scored on a 3 or 5 point scale, and the total score is compared to the corresponding descriptor. The total score ranges from 0-52 points. A score of 0-7 is considered to be normal. Scores of 20 or higher indicate moderate, severe, or very severe depression. Both group ranges form 0-12 points.|units on a scale|Mean|6.40|6.4|Full Range|||0.0|12.0|
3914565|NCT01451749|3738138|B2|||Hamilton depression rating scale|The Hamilton Rating Scale for Depression is designed for adults and is used to rate the severity of their depression by probing mood, feelings of guilt, suicide ideation, insomnia, agitation or retardation, anxiety, weight loss, and somatic symptoms.The HAMD scale contains 17 tems, each item is scored on a 3 or 5 point scale, and the total score is compared to the corresponding descriptor. The total score ranges from 0-52 points. A score of 0-7 is considered to be normal. Scores of 20 or higher indicate moderate, severe, or very severe depression. Both group ranges form 0-12 points.|units on a scale|Mean|6.39|6.39|Full Range|||0.0|12.0|
3914566|NCT01451749|3738139|B1|||Hamilton depression rating scale|The Hamilton Rating Scale for Depression is designed for adults and is used to rate the severity of their depression by probing mood, feelings of guilt, suicide ideation, insomnia, agitation or retardation, anxiety, weight loss, and somatic symptoms.The HAMD scale contains 17 tems, each item is scored on a 3 or 5 point scale, and the total score is compared to the corresponding descriptor. The total score ranges from 0-52 points. A score of 0-7 is considered to be normal. Scores of 20 or higher indicate moderate, severe, or very severe depression. Both group ranges form 0-12 points.|units on a scale|Mean|6.44|6.44|Full Range|||0.0|12.0|
3914567|NCT01451749|3738137|B3|Stage 3||Global Deterioration Scale|"The Global Deterioration Scale (GDS), provides caregivers an overview of the stages of cognitive function for those suffering from a primary degenerative dementia such as Alzheimer's disease. It is broken down into 7 different stages. Stages 1-3 are the pre-dementia stages. Stages 4-7 are the dementia stages.~Beginning in stage 5, an individual can no longer survive without assistance."|participants|Number|173|173.0||||||
3914568|NCT01451749|3738138|B2|Stage 3||Global Deterioration Scale|"The Global Deterioration Scale (GDS), provides caregivers an overview of the stages of cognitive function for those suffering from a primary degenerative dementia such as Alzheimer's disease. It is broken down into 7 different stages. Stages 1-3 are the pre-dementia stages. Stages 4-7 are the dementia stages.~Beginning in stage 5, an individual can no longer survive without assistance."|participants|Number|59|59.0||||||
3914569|NCT01451749|3738139|B1|Stage 3||Global Deterioration Scale|"The Global Deterioration Scale (GDS), provides caregivers an overview of the stages of cognitive function for those suffering from a primary degenerative dementia such as Alzheimer's disease. It is broken down into 7 different stages. Stages 1-3 are the pre-dementia stages. Stages 4-7 are the dementia stages.~Beginning in stage 5, an individual can no longer survive without assistance."|participants|Number|114|114.0||||||
3914570|NCT01451749|3738137|B3|Stage 2||Global Deterioration Scale|"The Global Deterioration Scale (GDS), provides caregivers an overview of the stages of cognitive function for those suffering from a primary degenerative dementia such as Alzheimer's disease. It is broken down into 7 different stages. Stages 1-3 are the pre-dementia stages. Stages 4-7 are the dementia stages.~Beginning in stage 5, an individual can no longer survive without assistance."|participants|Number|148|148.0||||||
3914571|NCT01451749|3738138|B2|Stage 2||Global Deterioration Scale|"The Global Deterioration Scale (GDS), provides caregivers an overview of the stages of cognitive function for those suffering from a primary degenerative dementia such as Alzheimer's disease. It is broken down into 7 different stages. Stages 1-3 are the pre-dementia stages. Stages 4-7 are the dementia stages.~Beginning in stage 5, an individual can no longer survive without assistance."|participants|Number|47|47.0||||||
3914572|NCT01451749|3738139|B1|Stage 2||Global Deterioration Scale|"The Global Deterioration Scale (GDS), provides caregivers an overview of the stages of cognitive function for those suffering from a primary degenerative dementia such as Alzheimer's disease. It is broken down into 7 different stages. Stages 1-3 are the pre-dementia stages. Stages 4-7 are the dementia stages.~Beginning in stage 5, an individual can no longer survive without assistance."|participants|Number|101|101.0||||||
3914573|NCT01451749|3738137|B3|Stage 1||Global Deterioration Scale|"The Global Deterioration Scale (GDS), provides caregivers an overview of the stages of cognitive function for those suffering from a primary degenerative dementia such as Alzheimer's disease. It is broken down into 7 different stages. Stages 1-3 are the pre-dementia stages. Stages 4-7 are the dementia stages.~Beginning in stage 5, an individual can no longer survive without assistance."|participants|Number|1|1.0||||||
3914574|NCT01451749|3738138|B2|Stage 1||Global Deterioration Scale|"The Global Deterioration Scale (GDS), provides caregivers an overview of the stages of cognitive function for those suffering from a primary degenerative dementia such as Alzheimer's disease. It is broken down into 7 different stages. Stages 1-3 are the pre-dementia stages. Stages 4-7 are the dementia stages.~Beginning in stage 5, an individual can no longer survive without assistance."|participants|Number|1|1.0||||||
3914575|NCT01451749|3738139|B1|Stage 1||Global Deterioration Scale|"The Global Deterioration Scale (GDS), provides caregivers an overview of the stages of cognitive function for those suffering from a primary degenerative dementia such as Alzheimer's disease. It is broken down into 7 different stages. Stages 1-3 are the pre-dementia stages. Stages 4-7 are the dementia stages.~Beginning in stage 5, an individual can no longer survive without assistance."|participants|Number|0|0.0||||||
3914576|NCT01451749|3738137|B3|Longer than middle school||Education||participants|Number|256|256.0||||||
3914577|NCT01451749|3738138|B2|Longer than middle school||Education||participants|Number|81|81.0||||||
3914578|NCT01451749|3738139|B1|Longer than middle school||Education||participants|Number|175|175.0||||||
3914579|NCT01451749|3738137|B3|Primary school||Education||participants|Number|66|66.0||||||
3914580|NCT01451749|3738138|B2|Primary school||Education||participants|Number|26|26.0||||||
3914581|NCT01451749|3738139|B1|Primary school||Education||participants|Number|40|40.0||||||
3914582|NCT01451749|3738137|B3|||Mini-mental state examinition|The Mini-mental State Examination(MMSE) is a brief 30-point questionnaire test that is used to screen for cognitive impairment. It is used to estimate the severity of cognitive impairment and to follow the course of cognitive changes in an individual over time, thus making it an effective way to document an individual's response to treatment. The scores of the MMSE ranges from 0 to 30, and a lower score indicate higher impairment. The MMSE score ranges from 24-30 points in both group.|units on a scale|Mean|27.30|27.3|Full Range|||24.0|30.0|
3914583|NCT01451749|3738138|B2|||Mini-mental state examinition|The Mini-mental State Examination(MMSE) is a brief 30-point questionnaire test that is used to screen for cognitive impairment. It is used to estimate the severity of cognitive impairment and to follow the course of cognitive changes in an individual over time, thus making it an effective way to document an individual's response to treatment. The scores of the MMSE ranges from 0 to 30, and a lower score indicate higher impairment. The MMSE score ranges from 24-30 points in both group.|units on a scale|Mean|27.11|27.11|Full Range|||24.0|30.0|
3914584|NCT01451749|3738139|B1|||Mini-mental state examinition|The Mini-mental State Examination(MMSE) is a brief 30-point questionnaire test that is used to screen for cognitive impairment. It is used to estimate the severity of cognitive impairment and to follow the course of cognitive changes in an individual over time, thus making it an effective way to document an individual's response to treatment. The scores of the MMSE ranges from 0 to 30, and a lower score indicate higher impairment. The MMSE score ranges from 24-30 points in both group.|units on a scale|Mean|27.38|27.38|Full Range|||24.0|30.0|
3914585|NCT01451749|3738137|B3|China||Region of Enrollment||participants|Number|322|322.0||||||
3914586|NCT01451749|3738138|B2|China||Region of Enrollment||participants|Number|107|107.0||||||
3914587|NCT01451749|3738139|B1|China||Region of Enrollment||participants|Number|215|215.0||||||
3914588|NCT01451749|3738137|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914589|NCT01451749|3738138|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914590|NCT01451749|3738139|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914591|NCT01451749|3738137|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914592|NCT01451749|3738138|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914593|NCT01451749|3738139|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914594|NCT01451749|3738137|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914595|NCT01451749|3738138|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914596|NCT01451749|3738139|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914597|NCT01451749|3738137|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914598|NCT01451749|3738138|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914599|NCT01451749|3738139|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914600|NCT01451749|3738137|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914601|NCT01451749|3738138|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914602|NCT01451749|3738139|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914603|NCT01451749|3738137|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|322|322.0||||||
3914604|NCT01451749|3738138|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
3914605|NCT01451749|3738139|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|215|215.0||||||
3914606|NCT01451749|3738137|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914607|NCT01451749|3738138|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914608|NCT01451749|3738139|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914609|NCT01451749|3738137|B3||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3914610|NCT01451749|3738138|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3914611|NCT01451749|3738139|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3914612|NCT01451749|3738137|B3||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3914613|NCT01451749|3738138|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3914614|NCT01451749|3738139|B1||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3914615|NCT01451749|3738137|B3|||Age||years|Mean|62.97|62.97|Standard Deviation|8.10|8.1|||
3914616|NCT01451749|3738138|B2|||Age||years|Mean|63.80|63.8|Standard Deviation|8.25|8.25|||
3914617|NCT01451749|3738139|B1|||Age||years|Mean|62.67|62.67|Standard Deviation|7.96|7.96|||
3914618|NCT01451723|3738150|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3914619|NCT01451723|3738151|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3914620|NCT01451723|3738152|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3914621|NCT01451723|3738150|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914622|NCT01451723|3738151|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914623|NCT01451723|3738152|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914624|NCT01451723|3738150|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3914625|NCT01451723|3738151|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3914626|NCT01451723|3738152|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3914627|NCT01451723|3738150|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914628|NCT01451723|3738151|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914629|NCT01451723|3738152|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914630|NCT01451723|3738150|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914631|NCT01451723|3738151|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914632|NCT01451723|3738152|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914633|NCT01451723|3738150|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914634|NCT01451723|3738151|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914635|NCT01451723|3738152|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914636|NCT01451723|3738150|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3914637|NCT01451723|3738151|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3914638|NCT01451723|3738152|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3914639|NCT01451723|3738150|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914640|NCT01451723|3738151|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914641|NCT01451723|3738152|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914642|NCT01451723|3738150|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914643|NCT01451723|3738151|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914644|NCT01451723|3738152|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914645|NCT01451723|3738150|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914646|NCT01451723|3738151|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914647|NCT01451723|3738152|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914648|NCT01451723|3738150|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914649|NCT01451723|3738151|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914650|NCT01451723|3738152|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914651|NCT01451723|3738150|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3914652|NCT01451723|3738151|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3914653|NCT01451723|3738152|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3914654|NCT01451723|3738150|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3914655|NCT01451723|3738151|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3914656|NCT01451723|3738152|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3914657|NCT01451723|3738150|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3914658|NCT01451723|3738151|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3914659|NCT01451723|3738152|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3914660|NCT01451723|3738150|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3914661|NCT01451723|3738151|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3914662|NCT01451723|3738152|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3914663|NCT01451723|3738150|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3914664|NCT01451723|3738151|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3914665|NCT01451723|3738152|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3914666|NCT01451723|3738150|B3|||Age||years|Mean|48.2|48.2|Standard Deviation|6.9|6.9|||
3914667|NCT01451723|3738151|B2|||Age||years|Mean|47|47.0|Standard Deviation|7.6|7.6|||
3914668|NCT01451723|3738152|B1|||Age||years|Mean|49.6|49.6|Standard Deviation|6.2|6.2|||
3914669|NCT01451645|3738161|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3914670|NCT01451645|3738162|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3914671|NCT01451645|3738163|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3914672|NCT01451645|3738161|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3914673|NCT01451645|3738162|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3914674|NCT01451645|3738163|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3914675|NCT01451645|3738161|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3914676|NCT01451645|3738162|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3914677|NCT01451645|3738163|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3914678|NCT01451645|3738161|B3||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
3914679|NCT01451645|3738162|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3914680|NCT01451645|3738163|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3914681|NCT01451645|3738161|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3914682|NCT01451645|3738162|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3914683|NCT01451645|3738163|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3914684|NCT01451632|3738176|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
3914685|NCT01451632|3738177|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3914686|NCT01451632|3738178|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
3914687|NCT01451632|3738176|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3914688|NCT01451632|3738177|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3914689|NCT01451632|3738178|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3914690|NCT01451632|3738176|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914691|NCT01451632|3738177|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914692|NCT01451632|3738178|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914693|NCT01451632|3738176|B3||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3914694|NCT01451632|3738177|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3914695|NCT01451632|3738178|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3914696|NCT01451632|3738176|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3914697|NCT01451632|3738177|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914698|NCT01451632|3738178|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3914699|NCT01451632|3738176|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914700|NCT01451632|3738177|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914701|NCT01451632|3738178|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914702|NCT01451632|3738176|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3914703|NCT01451632|3738177|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914704|NCT01451632|3738178|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3914705|NCT01451632|3738176|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914706|NCT01451632|3738177|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914707|NCT01451632|3738178|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914708|NCT01451632|3738176|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3914709|NCT01451632|3738177|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914710|NCT01451632|3738178|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3914711|NCT01451632|3738176|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3914712|NCT01451632|3738177|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3914713|NCT01451632|3738178|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3914714|NCT01451632|3738176|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3914715|NCT01451632|3738177|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3914716|NCT01451632|3738178|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3914717|NCT01451632|3738176|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3914718|NCT01451632|3738177|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3914719|NCT01451632|3738178|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3914720|NCT01451632|3738176|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3914721|NCT01451632|3738177|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3914722|NCT01451632|3738178|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3914723|NCT01451632|3738176|B3|||Age||years|Mean|56.35|56.35|Standard Deviation|12.79|12.79|||
3914724|NCT01451632|3738177|B2|||Age||years|Mean|56.6|56.6|Standard Deviation|11.38|11.38|||
3914725|NCT01451632|3738178|B1|||Age||years|Mean|56.1|56.1|Standard Deviation|14.19|14.19|||
3914726|NCT01451606|3738233|B3|United States||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3914727|NCT01451606|3738234|B2|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3914728|NCT01451606|3738235|B1|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3914729|NCT01451606|3738233|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914730|NCT01451606|3738234|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914731|NCT01451606|3738235|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914732|NCT01451606|3738233|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3914733|NCT01451606|3738234|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914734|NCT01451606|3738235|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3914735|NCT01451606|3738233|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3914736|NCT01451606|3738234|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3914737|NCT01451606|3738235|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3914738|NCT01451606|3738233|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3914739|NCT01451606|3738234|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3914740|NCT01451606|3738235|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3914741|NCT01451606|3738233|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3914742|NCT01451606|3738234|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3914743|NCT01451606|3738235|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914744|NCT01451606|3738233|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914745|NCT01451606|3738234|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914746|NCT01451606|3738235|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914747|NCT01451606|3738233|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914748|NCT01451606|3738234|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914749|NCT01451606|3738235|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914750|NCT01451606|3738233|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914751|NCT01451606|3738234|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914752|NCT01451606|3738235|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914753|NCT01451606|3738233|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3914754|NCT01451606|3738234|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3914755|NCT01451606|3738235|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3914756|NCT01451606|3738233|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3914757|NCT01451606|3738234|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3914758|NCT01451606|3738235|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914759|NCT01451606|3738233|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3914760|NCT01451606|3738234|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3914761|NCT01451606|3738235|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3914762|NCT01451606|3738233|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3914763|NCT01451606|3738234|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3914764|NCT01451606|3738235|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3914765|NCT01451606|3738233|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3914766|NCT01451606|3738234|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3914767|NCT01451606|3738235|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3914768|NCT01451606|3738233|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3914769|NCT01451606|3738234|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3914770|NCT01451606|3738235|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3914771|NCT01451606|3738233|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3914772|NCT01451606|3738234|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3914773|NCT01451606|3738235|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3914774|NCT01451554|3738244|B3|||Baseline Weight|Weight in Kilograms at the study entry|Kg|Mean|98.2|98.2|Standard Deviation|12.6|12.6|||
3914775|NCT01451554|3738245|B2|||Baseline Weight|Weight in Kilograms at the study entry|Kg|Mean|98.8|98.8|Standard Deviation|12.5|12.5|||
3914776|NCT01451554|3738246|B1|||Baseline Weight|Weight in Kilograms at the study entry|Kg|Mean|97.6|97.6|Standard Deviation|12.8|12.8|||
3914777|NCT01451554|3738244|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3914778|NCT01451554|3738245|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3914779|NCT01451554|3738246|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3914780|NCT01451554|3738244|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3914781|NCT01451554|3738245|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3914782|NCT01451554|3738246|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3914783|NCT01451554|3738244|B3|||Age||years|Mean|55.9|55.9|Standard Deviation|10.0|10.0|||
3914784|NCT01451554|3738245|B2|||Age||years|Mean|56.3|56.3|Standard Deviation|10.7|10.7|||
3914785|NCT01451554|3738246|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|9.4|9.4|||
3914786|NCT01451554|3738244|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3914787|NCT01451554|3738245|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3914788|NCT01451554|3738246|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3914789|NCT01451554|3738244|B3||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3914790|NCT01451554|3738245|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3914791|NCT01451554|3738246|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3914792|NCT01451554|3738244|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3914793|NCT01451554|3738245|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3914794|NCT01451554|3738246|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3914795|NCT01451541|3738255|B4|United States||Region of Enrollment||participants|Number|846|846.0||||||
3914796|NCT01451541|3738256|B3|United States||Region of Enrollment||participants|Number|281|281.0||||||
3914797|NCT01451541|3738257|B2|United States||Region of Enrollment||participants|Number|282|282.0||||||
3914798|NCT01451541|3738258|B1|United States||Region of Enrollment||participants|Number|283|283.0||||||
3914799|NCT01451541|3738255|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|565|565.0||||||
3914800|NCT01451541|3738256|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|190|190.0||||||
3914801|NCT01451541|3738257|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|181|181.0||||||
3914802|NCT01451541|3738258|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|194|194.0||||||
3914803|NCT01451541|3738255|B4|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3914804|NCT01451541|3738256|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3914805|NCT01451541|3738257|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3914806|NCT01451541|3738258|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3914807|NCT01451541|3738255|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|281|281.0||||||
3914808|NCT01451541|3738256|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|91|91.0||||||
3914809|NCT01451541|3738257|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|101|101.0||||||
3914810|NCT01451541|3738258|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|89|89.0||||||
3914811|NCT01451541|3738255|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3914812|NCT01451541|3738256|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3914813|NCT01451541|3738257|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3914814|NCT01451541|3738258|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3914815|NCT01451541|3738255|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3914816|NCT01451541|3738256|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3914817|NCT01451541|3738257|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3914818|NCT01451541|3738258|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3914819|NCT01451541|3738255|B4||White|Race (NIH/OMB)||Participants|Count of Participants|656|656.0||||||
3914820|NCT01451541|3738256|B3||White|Race (NIH/OMB)||Participants|Count of Participants|216|216.0||||||
3914821|NCT01451541|3738257|B2||White|Race (NIH/OMB)||Participants|Count of Participants|216|216.0||||||
3914822|NCT01451541|3738258|B1||White|Race (NIH/OMB)||Participants|Count of Participants|224|224.0||||||
3914823|NCT01451541|3738255|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
3914824|NCT01451541|3738256|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3914825|NCT01451541|3738257|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3914826|NCT01451541|3738258|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3914827|NCT01451541|3738255|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3914828|NCT01451541|3738256|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3914829|NCT01451541|3738257|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914830|NCT01451541|3738258|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914831|NCT01451541|3738255|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3914832|NCT01451541|3738256|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3914833|NCT01451541|3738257|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3914834|NCT01451541|3738258|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3914835|NCT01451541|3738255|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3914836|NCT01451541|3738256|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3914837|NCT01451541|3738257|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3914838|NCT01451541|3738258|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3914839|NCT01451541|3738255|B4||Male|Sex: Female, Male||Participants|Count of Participants|483|483.0||||||
3914840|NCT01451541|3738256|B3||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3914841|NCT01451541|3738257|B2||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3914842|NCT01451541|3738258|B1||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3914843|NCT01451541|3738255|B4||Female|Sex: Female, Male||Participants|Count of Participants|363|363.0||||||
3914844|NCT01451541|3738256|B3||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3914845|NCT01451541|3738257|B2||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3914846|NCT01451541|3738258|B1||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3914847|NCT01451541|3738255|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3914848|NCT01451541|3738256|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3914849|NCT01451541|3738257|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3914850|NCT01451541|3738258|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3914851|NCT01451541|3738255|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3914852|NCT01451541|3738256|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3914853|NCT01451541|3738257|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3914854|NCT01451541|3738258|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3914855|NCT01451541|3738255|B4||<=18 years|Age||Participants|Count of Participants|846|846.0||||||
3914856|NCT01451541|3738256|B3||<=18 years|Age||Participants|Count of Participants|281|281.0||||||
3914857|NCT01451541|3738257|B2||<=18 years|Age||Participants|Count of Participants|282|282.0||||||
3914858|NCT01451541|3738258|B1||<=18 years|Age||Participants|Count of Participants|283|283.0||||||
3914859|NCT01451463|3738300|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3914860|NCT01451463|3738300|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3914861|NCT01451463|3738300|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3914862|NCT01451463|3738300|B1|||Age||years|Mean|52.2|52.2|Standard Deviation|10.0|10.0|||
3914863|NCT01451463|3738300|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3914864|NCT01451463|3738300|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3914865|NCT01451463|3738300|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3914866|NCT01451437|3738309|B10|Unknown||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3914867|NCT01451437|3738310|B9|Unknown||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3914868|NCT01451437|3738311|B8|Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3914869|NCT01451437|3738312|B7|Unknown||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3914870|NCT01451437|3738313|B6|Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3914871|NCT01451437|3738314|B5|Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3914872|NCT01451437|3738315|B4|Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3914873|NCT01451437|3738316|B3|Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3914874|NCT01451437|3738317|B2|Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3914875|NCT01451437|3738318|B1|Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3914876|NCT01451437|3738309|B10|Not Reported||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3914877|NCT01451437|3738310|B9|Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3914878|NCT01451437|3738311|B8|Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3914879|NCT01451437|3738312|B7|Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3914880|NCT01451437|3738313|B6|Not Reported||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3914881|NCT01451437|3738314|B5|Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3914882|NCT01451437|3738315|B4|Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3914883|NCT01451437|3738316|B3|Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3914884|NCT01451437|3738317|B2|Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3914885|NCT01451437|3738318|B1|Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3914886|NCT01451437|3738309|B10|Not Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
3914887|NCT01451437|3738310|B9|Not Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3914888|NCT01451437|3738311|B8|Not Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3914889|NCT01451437|3738312|B7|Not Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3914890|NCT01451437|3738313|B6|Not Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3914891|NCT01451437|3738314|B5|Not Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3914892|NCT01451437|3738315|B4|Not Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3914893|NCT01451437|3738316|B3|Not Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3914894|NCT01451437|3738317|B2|Not Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3914895|NCT01451437|3738318|B1|Not Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3914896|NCT01451437|3738309|B10|Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3914897|NCT01451437|3738310|B9|Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3914898|NCT01451437|3738311|B8|Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3914899|NCT01451437|3738312|B7|Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3914900|NCT01451437|3738313|B6|Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3914901|NCT01451437|3738314|B5|Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3914902|NCT01451437|3738315|B4|Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3914903|NCT01451437|3738316|B3|Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3914904|NCT01451437|3738317|B2|Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3914905|NCT01451437|3738318|B1|Hispanic Or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3914906|NCT01451437|3738309|B10|White||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
3914907|NCT01451437|3738310|B9|White||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3914908|NCT01451437|3738311|B8|White||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3914909|NCT01451437|3738312|B7|White||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3914910|NCT01451437|3738313|B6|White||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3914911|NCT01451437|3738314|B5|White||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3914912|NCT01451437|3738315|B4|White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3914913|NCT01451437|3738316|B3|White||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3914914|NCT01451437|3738317|B2|White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3914915|NCT01451437|3738318|B1|White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3914916|NCT01451437|3738309|B10|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3914917|NCT01451437|3738310|B9|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3914918|NCT01451437|3738311|B8|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3914919|NCT01451437|3738312|B7|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3914920|NCT01451437|3738313|B6|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3914921|NCT01451437|3738314|B5|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3914922|NCT01451437|3738315|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3914923|NCT01451437|3738316|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3914924|NCT01451437|3738317|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3914925|NCT01451437|3738318|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3914926|NCT01451437|3738309|B10|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3914927|NCT01451437|3738310|B9|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3914928|NCT01451437|3738311|B8|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3914929|NCT01451437|3738312|B7|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3914930|NCT01451437|3738313|B6|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3914931|NCT01451437|3738314|B5|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3914932|NCT01451437|3738315|B4|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3914933|NCT01451437|3738316|B3|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3914934|NCT01451437|3738317|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3914935|NCT01451437|3738318|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3914936|NCT01451437|3738309|B10||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3914937|NCT01451437|3738310|B9||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3914938|NCT01451437|3738311|B8||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3914939|NCT01451437|3738312|B7||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3914940|NCT01451437|3738313|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3914941|NCT01451437|3738314|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3914942|NCT01451437|3738315|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3914943|NCT01451437|3738316|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3914944|NCT01451437|3738317|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3914945|NCT01451437|3738318|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3914946|NCT01451437|3738309|B10||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3914947|NCT01451437|3738310|B9||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3914948|NCT01451437|3738311|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3914949|NCT01451437|3738312|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3914950|NCT01451437|3738313|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3914951|NCT01451437|3738314|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3914952|NCT01451437|3738315|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3914953|NCT01451437|3738316|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3914954|NCT01451437|3738317|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3914955|NCT01451437|3738318|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3914956|NCT01451437|3738309|B10|From 65 to 84 years||Age, Customized||Participants|Number|14|14.0||||||
3914957|NCT01451437|3738310|B9|From 65 to 84 years||Age, Customized||Participants|Number|0|0.0||||||
3914958|NCT01451437|3738311|B8|From 65 to 84 years||Age, Customized||Participants|Number|2|2.0||||||
3914959|NCT01451437|3738312|B7|From 65 to 84 years||Age, Customized||Participants|Number|3|3.0||||||
3914960|NCT01451437|3738313|B6|From 65 to 84 years||Age, Customized||Participants|Number|2|2.0||||||
3914961|NCT01451437|3738314|B5|From 65 to 84 years||Age, Customized||Participants|Number|2|2.0||||||
3914962|NCT01451437|3738315|B4|From 65 to 84 years||Age, Customized||Participants|Number|1|1.0||||||
3914963|NCT01451437|3738316|B3|From 65 to 84 years||Age, Customized||Participants|Number|3|3.0||||||
3914964|NCT01451437|3738317|B2|From 65 to 84 years||Age, Customized||Participants|Number|1|1.0||||||
3914965|NCT01451437|3738318|B1|From 65 to 84 years||Age, Customized||Participants|Number|0|0.0||||||
3914966|NCT01451437|3738309|B10|Adults between 18 and 64 years||Age, Customized||Participants|Number|12|12.0||||||
3914967|NCT01451437|3738310|B9|Adults between 18 and 64 years||Age, Customized||Participants|Number|4|4.0||||||
3914968|NCT01451437|3738311|B8|Adults between 18 and 64 years||Age, Customized||Participants|Number|1|1.0||||||
3914969|NCT01451437|3738312|B7|Adults between 18 and 64 years||Age, Customized||Participants|Number|3|3.0||||||
3914970|NCT01451437|3738313|B6|Adults between 18 and 64 years||Age, Customized||Participants|Number|1|1.0||||||
3914971|NCT01451437|3738314|B5|Adults between 18 and 64 years||Age, Customized||Participants|Number|2|2.0||||||
3914972|NCT01451437|3738315|B4|Adults between 18 and 64 years||Age, Customized||Participants|Number|0|0.0||||||
3914973|NCT01451437|3738316|B3|Adults between 18 and 64 years||Age, Customized||Participants|Number|0|0.0||||||
3914974|NCT01451437|3738317|B2|Adults between 18 and 64 years||Age, Customized||Participants|Number|0|0.0||||||
3914975|NCT01451437|3738318|B1|Adults between 18 and 64 years||Age, Customized||Participants|Number|1|1.0||||||
3914976|NCT01451437|3738309|B10|||Age||Years|Mean|62.2|62.2|Standard Deviation|15.5|15.5|||
3914977|NCT01451437|3738310|B9|||Age||Years|Mean|41.0|41.0|Standard Deviation|14.3|14.3|||
3914978|NCT01451437|3738311|B8|||Age||Years|Mean|72.3|72.3|Standard Deviation|12.5|12.5|||
3914979|NCT01451437|3738312|B7|||Age||Years|Mean|63.5|63.5|Standard Deviation|11.5|11.5|||
3914980|NCT01451437|3738313|B6|||Age||Years|Mean|63.3|63.3|Standard Deviation|14.6|14.6|||
3914981|NCT01451437|3738314|B5|||Age||Years|Mean|58.8|58.8|Standard Deviation|18.5|18.5|||
3914982|NCT01451437|3738315|B4|||Age||Years|Mean|77.0|77.0|Standard Deviation|NA||||not calculated for n=1
3914983|NCT01451437|3738316|B3|||Age||Years|Mean|72.3|72.3|Standard Deviation|6.7|6.7|||
3914984|NCT01451437|3738317|B2|||Age||Years|Mean|74.0|74.0|Standard Deviation|NA||||not calculated for n=1
3914985|NCT01451437|3738318|B1|||Age||Years|Mean|63.0|63.0|Standard Deviation|NA||||not calculated for n=1
3914986|NCT01451424|3738454|B5|United States||Region of Enrollment||participants|Number|40|40.0||||||
3914987|NCT01451424|3738455|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
3914988|NCT01451424|3738456|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3914989|NCT01451424|3738457|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3914990|NCT01451424|3738458|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3914991|NCT01451424|3738454|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3914992|NCT01451424|3738455|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3914993|NCT01451424|3738456|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3914994|NCT01451424|3738457|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3914995|NCT01451424|3738458|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3914996|NCT01451424|3738454|B5||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3914997|NCT01451424|3738455|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3914998|NCT01451424|3738456|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3914999|NCT01451424|3738457|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3915000|NCT01451424|3738458|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3915001|NCT01451424|3738454|B5|||Age||years|Mean|39.8|39.8|Standard Deviation|5.6|5.6|||
3915002|NCT01451424|3738455|B4|||Age||years|Mean|40.9|40.9|Standard Deviation|5.2|5.2|||
3915003|NCT01451424|3738456|B3|||Age||years|Mean|39.8|39.8|Standard Deviation|4.8|4.8|||
3915004|NCT01451424|3738457|B2|||Age||years|Mean|39.9|39.9|Standard Deviation|6.9|6.9|||
3915005|NCT01451424|3738458|B1|||Age||years|Mean|38.7|38.7|Standard Deviation|6.3|6.3|||
3915006|NCT01451411|3738492|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3915007|NCT01451411|3738493|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3915008|NCT01451411|3738494|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3915009|NCT01451411|3738492|B3|Colombia||Region of Enrollment||participants|Number|2|2.0||||||
3915010|NCT01451411|3738493|B2|Colombia||Region of Enrollment||participants|Number|0|0.0||||||
3915011|NCT01451411|3738494|B1|Colombia||Region of Enrollment||participants|Number|2|2.0||||||
3915012|NCT01451411|3738492|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3915013|NCT01451411|3738493|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915014|NCT01451411|3738494|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3915015|NCT01451411|3738492|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915016|NCT01451411|3738493|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915017|NCT01451411|3738494|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915018|NCT01451411|3738492|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3915019|NCT01451411|3738493|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915020|NCT01451411|3738494|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3915021|NCT01451411|3738492|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3915022|NCT01451411|3738493|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3915023|NCT01451411|3738494|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915024|NCT01451411|3738492|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915025|NCT01451411|3738493|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915026|NCT01451411|3738494|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915027|NCT01451411|3738492|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915028|NCT01451411|3738493|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915029|NCT01451411|3738494|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915030|NCT01451411|3738492|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915031|NCT01451411|3738493|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915032|NCT01451411|3738494|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915033|NCT01451411|3738492|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915034|NCT01451411|3738493|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915035|NCT01451411|3738494|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915036|NCT01451411|3738492|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3915037|NCT01451411|3738493|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915038|NCT01451411|3738494|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3915039|NCT01451411|3738492|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3915040|NCT01451411|3738493|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3915041|NCT01451411|3738494|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3915042|NCT01451411|3738492|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3915043|NCT01451411|3738493|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3915044|NCT01451411|3738494|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3915045|NCT01451411|3738492|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3915046|NCT01451411|3738493|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3915047|NCT01451411|3738494|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3915048|NCT01451411|3738492|B3|11 - 17 years||Age, Customized||participants|Number|2|2.0||||||
3915049|NCT01451411|3738493|B2|11 - 17 years||Age, Customized||participants|Number|1|1.0||||||
3915050|NCT01451411|3738494|B1|11 - 17 years||Age, Customized||participants|Number|1|1.0||||||
3915051|NCT01451411|3738492|B3|6 - 10 years||Age, Customized||participants|Number|2|2.0||||||
3915052|NCT01451411|3738493|B2|6 - 10 years||Age, Customized||participants|Number|0|0.0||||||
3915053|NCT01451411|3738494|B1|6 - 10 years||Age, Customized||participants|Number|2|2.0||||||
3915054|NCT01451411|3738492|B3|2 - 5 years||Age, Customized||participants|Number|0|0.0||||||
3915055|NCT01451411|3738493|B2|2 - 5 years||Age, Customized||participants|Number|0|0.0||||||
3915056|NCT01451411|3738494|B1|2 - 5 years||Age, Customized||participants|Number|0|0.0||||||
3915057|NCT01451398|3738517|B3|2 or more OADs (not including Metformin)||Oral Anti-Diabetic Drug (OAD) Type||participants|Number|6|6.0||||||
3915058|NCT01451398|3738518|B2|2 or more OADs (not including Metformin)||Oral Anti-Diabetic Drug (OAD) Type||participants|Number|3|3.0||||||
3915059|NCT01451398|3738519|B1|2 or more OADs (not including Metformin)||Oral Anti-Diabetic Drug (OAD) Type||participants|Number|3|3.0||||||
3915060|NCT01451398|3738517|B3|Metformin + 1 or more OADs not specified above||Oral Anti-Diabetic Drug (OAD) Type||participants|Number|18|18.0||||||
3915061|NCT01451398|3738518|B2|Metformin + 1 or more OADs not specified above||Oral Anti-Diabetic Drug (OAD) Type||participants|Number|9|9.0||||||
3915062|NCT01451398|3738519|B1|Metformin + 1 or more OADs not specified above||Oral Anti-Diabetic Drug (OAD) Type||participants|Number|9|9.0||||||
3915063|NCT01451398|3738517|B3|Metformin + DPP-4 Inhibitor||Oral Anti-Diabetic Drug (OAD) Type||participants|Number|18|18.0||||||
3915064|NCT01451398|3738518|B2|Metformin + DPP-4 Inhibitor||Oral Anti-Diabetic Drug (OAD) Type||participants|Number|9|9.0||||||
3915065|NCT01451398|3738519|B1|Metformin + DPP-4 Inhibitor||Oral Anti-Diabetic Drug (OAD) Type||participants|Number|9|9.0||||||
3915066|NCT01451398|3738517|B3|Metformin + Sulfonylurea||Oral Anti-Diabetic Drug (OAD) Type||participants|Number|229|229.0||||||
3915067|NCT01451398|3738518|B2|Metformin + Sulfonylurea||Oral Anti-Diabetic Drug (OAD) Type||participants|Number|115|115.0||||||
3915068|NCT01451398|3738519|B1|Metformin + Sulfonylurea||Oral Anti-Diabetic Drug (OAD) Type||participants|Number|114|114.0||||||
3915069|NCT01451398|3738517|B3|Metformin Only||Oral Anti-Diabetic Drug (OAD) Type||participants|Number|82|82.0||||||
3915070|NCT01451398|3738518|B2|Metformin Only||Oral Anti-Diabetic Drug (OAD) Type||participants|Number|40|40.0||||||
3915071|NCT01451398|3738519|B1|Metformin Only||Oral Anti-Diabetic Drug (OAD) Type||participants|Number|42|42.0||||||
3915072|NCT01451398|3738517|B3|||HbA1c||Percent of hemoglobin|Mean|8.31|8.31|Full Range|||5.1|10.9|
3915073|NCT01451398|3738518|B2|||HbA1c||Percent of hemoglobin|Mean|8.35|8.35|Full Range|||5.1|10.9|
3915074|NCT01451398|3738519|B1|||HbA1c||Percent of hemoglobin|Mean|8.26|8.26|Full Range|||6.6|10.1|
3915075|NCT01451398|3738517|B3|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|178.2|178.2|Full Range|||49.0|316.0|
3915076|NCT01451398|3738518|B2|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|177.2|177.2|Full Range|||54.0|316.0|
3915077|NCT01451398|3738519|B1|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|179.1|179.1|Full Range|||49.0|306.0|
3915078|NCT01451398|3738517|B3|||BMI||kg/m^2|Mean|32.1|32.1|Full Range|||21.1|44.6|
3915079|NCT01451398|3738518|B2|||BMI||kg/m^2|Mean|32.4|32.4|Full Range|||21.1|44.4|
3915080|NCT01451398|3738519|B1|||BMI||kg/m^2|Mean|31.8|31.8|Full Range|||21.6|44.6|
3915081|NCT01451398|3738517|B3|||Weight||kg|Mean|90.5|90.5|Full Range|||54.0|142.3|
3915082|NCT01451398|3738518|B2|||Weight||kg|Mean|90.8|90.8|Full Range|||58.0|136.6|
3915083|NCT01451398|3738519|B1|||Weight||kg|Mean|90.2|90.2|Full Range|||54.0|142.3|
3915084|NCT01451398|3738517|B3|||Duration of Diabetes||years|Mean|9.5|9.5|Full Range|||1.0|34.7|
3915085|NCT01451398|3738518|B2|||Duration of Diabetes||years|Mean|9.2|9.2|Full Range|||1.0|28.8|
3915086|NCT01451398|3738519|B1|||Duration of Diabetes||years|Mean|9.7|9.7|Full Range|||1.1|34.7|
3915087|NCT01451398|3738517|B3|Russian Federation||Region of Enrollment||participants|Number|111|111.0||||||
3915088|NCT01451398|3738518|B2|Russian Federation||Region of Enrollment||participants|Number|56|56.0||||||
3915089|NCT01451398|3738519|B1|Russian Federation||Region of Enrollment||participants|Number|55|55.0||||||
3915090|NCT01451398|3738517|B3|Ukraine||Region of Enrollment||participants|Number|38|38.0||||||
3915091|NCT01451398|3738518|B2|Ukraine||Region of Enrollment||participants|Number|19|19.0||||||
3915092|NCT01451398|3738519|B1|Ukraine||Region of Enrollment||participants|Number|19|19.0||||||
3915093|NCT01451398|3738517|B3|Brazil||Region of Enrollment||participants|Number|29|29.0||||||
3915094|NCT01451398|3738518|B2|Brazil||Region of Enrollment||participants|Number|14|14.0||||||
3915095|NCT01451398|3738519|B1|Brazil||Region of Enrollment||participants|Number|15|15.0||||||
3915096|NCT01451398|3738517|B3|United States||Region of Enrollment||participants|Number|175|175.0||||||
3915097|NCT01451398|3738518|B2|United States||Region of Enrollment||participants|Number|87|87.0||||||
3915098|NCT01451398|3738519|B1|United States||Region of Enrollment||participants|Number|88|88.0||||||
3915099|NCT01451398|3738517|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915100|NCT01451398|3738518|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915101|NCT01451398|3738519|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915102|NCT01451398|3738517|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|269|269.0||||||
3915103|NCT01451398|3738518|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|135|135.0||||||
3915104|NCT01451398|3738519|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
3915105|NCT01451398|3738517|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3915106|NCT01451398|3738518|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3915107|NCT01451398|3738519|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3915108|NCT01451398|3738517|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3915109|NCT01451398|3738518|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3915110|NCT01451398|3738519|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3915111|NCT01451398|3738517|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915112|NCT01451398|3738518|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915113|NCT01451398|3738519|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915114|NCT01451398|3738517|B3||White|Race (NIH/OMB)||Participants|Count of Participants|306|306.0||||||
3915115|NCT01451398|3738518|B2||White|Race (NIH/OMB)||Participants|Count of Participants|155|155.0||||||
3915116|NCT01451398|3738519|B1||White|Race (NIH/OMB)||Participants|Count of Participants|151|151.0||||||
3915117|NCT01451398|3738517|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3915118|NCT01451398|3738518|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3915119|NCT01451398|3738519|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3915120|NCT01451398|3738517|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915121|NCT01451398|3738518|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915122|NCT01451398|3738519|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915123|NCT01451398|3738517|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3915124|NCT01451398|3738518|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3915125|NCT01451398|3738519|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3915126|NCT01451398|3738517|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3915127|NCT01451398|3738518|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3915128|NCT01451398|3738519|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3915129|NCT01451398|3738517|B3||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3915130|NCT01451398|3738518|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3915131|NCT01451398|3738519|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3915132|NCT01451398|3738517|B3||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
3915133|NCT01451398|3738518|B2||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3915134|NCT01451398|3738519|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3915135|NCT01451398|3738517|B3|>=65 years||Age, Customized||participants|Number|70|70.0||||||
3915136|NCT01451398|3738518|B2|>=65 years||Age, Customized||participants|Number|33|33.0||||||
3915137|NCT01451398|3738519|B1|>=65 years||Age, Customized||participants|Number|37|37.0||||||
3915138|NCT01451398|3738517|B3|50-64 years||Age, Customized||participants|Number|212|212.0||||||
3915139|NCT01451398|3738518|B2|50-64 years||Age, Customized||participants|Number|110|110.0||||||
3915140|NCT01451398|3738519|B1|50-64 years||Age, Customized||participants|Number|102|102.0||||||
3915141|NCT01451398|3738517|B3|31-49 years||Age, Customized||participants|Number|70|70.0||||||
3915142|NCT01451398|3738518|B2|31-49 years||Age, Customized||participants|Number|33|33.0||||||
3915143|NCT01451398|3738519|B1|31-49 years||Age, Customized||participants|Number|37|37.0||||||
3915144|NCT01451398|3738517|B3|18-30 years||Age, Customized||participants|Number|1|1.0||||||
3915145|NCT01451398|3738518|B2|18-30 years||Age, Customized||participants|Number|0|0.0||||||
3915146|NCT01451398|3738519|B1|18-30 years||Age, Customized||participants|Number|1|1.0||||||
3915147|NCT01451203|3738552|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3915148|NCT01451203|3738553|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3915149|NCT01451203|3738554|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3915150|NCT01451203|3738552|B3||Female|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
3915151|NCT01451203|3738553|B2||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3915152|NCT01451203|3738554|B1||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3915153|NCT01451203|3738552|B3|||Age||years|Mean|49.2|49.2|Standard Deviation|10.5|10.5|||
3915154|NCT01451203|3738553|B2|||Age||years|Mean|49.4|49.4|Standard Deviation|10.6|10.6|||
3915155|NCT01451203|3738554|B1|||Age||years|Mean|49.0|49.0|Standard Deviation|10.3|10.3|||
3915156|NCT01450826|3738569|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3915157|NCT01450826|3738569|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3915158|NCT01450826|3738570|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3915159|NCT01450826|3738571|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3915160|NCT01450826|3738569|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3915161|NCT01450826|3738570|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3915162|NCT01450826|3738571|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3915163|NCT01450826|3738569|B3|||Age||years|Mean|53.96|53.96|Standard Deviation|13.27|13.27|||
3915164|NCT01450826|3738570|B2|||Age||years|Mean|55.03|55.03|Standard Deviation|12.17|12.17|||
3915165|NCT01450826|3738571|B1|||Age||years|Mean|52.96|52.96|Standard Deviation|14.25|14.25|||
3915166|NCT01450813|3738584|B5||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3915167|NCT01450813|3738585|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3915168|NCT01450813|3738586|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3915169|NCT01450813|3738587|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3915170|NCT01450813|3738588|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3915171|NCT01450813|3738584|B5||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3915172|NCT01450813|3738585|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3915173|NCT01450813|3738586|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3915174|NCT01450813|3738587|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3915175|NCT01450813|3738588|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3915176|NCT01450813|3738584|B5|||Age||years|Mean|37.9|37.9|Standard Deviation|11.34|11.34|||
3915177|NCT01450813|3738585|B4|||Age||years|Mean|32.9|32.9|Standard Deviation|6.4|6.4|||
3915178|NCT01450813|3738586|B3|||Age||years|Mean|39.4|39.4|Standard Deviation|12.7|12.7|||
3915179|NCT01450813|3738587|B2|||Age||years|Mean|38.6|38.6|Standard Deviation|14.6|14.6|||
3915180|NCT01450813|3738588|B1|||Age||years|Mean|35.9|35.9|Standard Deviation|12.3|12.3|||
3915181|NCT01450800|3738603|B3|United States||Region of Enrollment||participants|Number|163|163.0||||||
3915182|NCT01450800|3738604|B2|United States||Region of Enrollment||participants|Number|81|81.0||||||
3915183|NCT01450800|3738605|B1|United States||Region of Enrollment||participants|Number|82|82.0||||||
3915184|NCT01450800|3738603|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3915185|NCT01450800|3738604|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3915186|NCT01450800|3738605|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3915187|NCT01450800|3738603|B3||Female|Gender||Participants|Count of Participants|163|163.0||||||
3915188|NCT01450800|3738604|B2||Female|Gender||Participants|Count of Participants|81|81.0||||||
3915189|NCT01450800|3738605|B1||Female|Gender||Participants|Count of Participants|82|82.0||||||
3915190|NCT01450800|3738603|B3|||Age||years|Mean|57|57.0|Standard Deviation|13|13.0|||
3915191|NCT01450800|3738604|B2|||Age||years|Mean|57|57.0|Standard Deviation|13|13.0|||
3915192|NCT01450800|3738605|B1|||Age||years|Mean|57|57.0|Standard Deviation|13|13.0|||
3915193|NCT01450800|3738603|B3||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
3915194|NCT01450800|3738604|B2||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
3915195|NCT01450800|3738605|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3915196|NCT01450800|3738603|B3||Between 18 and 65 years|Age||Participants|Count of Participants|113|113.0||||||
3915197|NCT01450800|3738604|B2||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
3915198|NCT01450800|3738605|B1||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3915199|NCT01450800|3738603|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3915200|NCT01450800|3738604|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3915201|NCT01450800|3738605|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3915202|NCT01450787|3738620|B3|United States||Region of Enrollment||participants|Number|63|63.0||||||
3915203|NCT01450787|3738621|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3915204|NCT01450787|3738622|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
3915205|NCT01450787|3738620|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3915206|NCT01450787|3738621|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3915207|NCT01450787|3738622|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3915208|NCT01450787|3738620|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3915209|NCT01450787|3738621|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3915210|NCT01450787|3738622|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3915211|NCT01450787|3738620|B3|||Age, Customized||participants|Number|63|63.0||||||
3915212|NCT01450787|3738621|B2|||Age, Customized||participants|Number|25|25.0||||||
3915213|NCT01450787|3738622|B1|||Age, Customized||participants|Number|38|38.0||||||
3915214|NCT01450761|3738639|B3||Male|Sex: Female, Male||Participants|Count of Participants|643|643.0||||||
3915215|NCT01450761|3738640|B2||Male|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
3915216|NCT01450761|3738641|B1||Male|Sex: Female, Male||Participants|Count of Participants|317|317.0||||||
3915217|NCT01450761|3738639|B3||Female|Sex: Female, Male||Participants|Count of Participants|311|311.0||||||
3915218|NCT01450761|3738640|B2||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3915219|NCT01450761|3738641|B1||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3915220|NCT01450761|3738639|B3|||Age||years|Mean|61.9|61.9|Standard Deviation|8.78|8.78|||
3915221|NCT01450761|3738640|B2|||Age||years|Mean|62.6|62.6|Standard Deviation|8.61|8.61|||
3915222|NCT01450761|3738641|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|8.90|8.9|||
3915223|NCT01450696|3738652|B3||Male|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
3915224|NCT01450696|3738653|B2||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3915225|NCT01450696|3738654|B1||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3915226|NCT01450696|3738652|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3915227|NCT01450696|3738653|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3915228|NCT01450696|3738654|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3915229|NCT01450696|3738652|B3|||Age||years|Mean|60.0|60.0|Standard Deviation|10.7|10.7|||
3915230|NCT01450696|3738653|B2|||Age||years|Mean|62.4|62.4|Standard Deviation|10.7|10.7|||
3915231|NCT01450696|3738654|B1|||Age||years|Mean|59.5|59.5|Standard Deviation|10.6|10.6|||
3915232|NCT01450683|3738677|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3915233|NCT01450683|3738677|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3915234|NCT01450683|3738677|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915235|NCT01450683|3738677|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915236|NCT01450683|3738677|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915237|NCT01450683|3738677|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3915238|NCT01450683|3738677|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3915239|NCT01450683|3738677|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915240|NCT01450683|3738677|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3915241|NCT01450683|3738677|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915242|NCT01450683|3738677|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3915243|NCT01450683|3738677|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3915244|NCT01450683|3738677|B1|||Age||years|Median|78|78.0|Full Range|||73.0|88.0|
3915245|NCT01450631|3738681|B3|||Gestational Age (weeks)||weeks|Mean|37.97|37.97|Standard Deviation|1.972|1.972|||
3915246|NCT01450631|3738682|B2|||Gestational Age (weeks)||weeks|Mean|38.08|38.08|Standard Deviation|1.983|1.983|||
3915247|NCT01450631|3738683|B1|||Gestational Age (weeks)||weeks|Mean|37.87|37.87|Standard Deviation|1.976|1.976|||
3915248|NCT01450631|3738681|B3|||BMI (kg/m2)||kg/m2|Mean|46.52|46.52|Standard Deviation|6.489|6.489|||
3915249|NCT01450631|3738682|B2|||BMI (kg/m2)||kg/m2|Mean|46.25|46.25|Standard Deviation|7.319|7.319|||
3915250|NCT01450631|3738683|B1|||BMI (kg/m2)||kg/m2|Mean|46.79|46.79|Standard Deviation|5.608|5.608|||
3915251|NCT01450631|3738681|B3|United States||Region of Enrollment||participants|Number|92|92.0||||||
3915252|NCT01450631|3738682|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
3915253|NCT01450631|3738683|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
3915254|NCT01450631|3738681|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915255|NCT01450631|3738682|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915256|NCT01450631|3738683|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915257|NCT01450631|3738681|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3915258|NCT01450631|3738682|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3915259|NCT01450631|3738683|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3915260|NCT01450631|3738681|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3915261|NCT01450631|3738682|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3915262|NCT01450631|3738683|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3915263|NCT01450631|3738681|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915264|NCT01450631|3738682|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915265|NCT01450631|3738683|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915266|NCT01450631|3738681|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915267|NCT01450631|3738682|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915268|NCT01450631|3738683|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915269|NCT01450631|3738681|B3||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3915270|NCT01450631|3738682|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3915271|NCT01450631|3738683|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3915272|NCT01450631|3738681|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3915273|NCT01450631|3738682|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3915274|NCT01450631|3738683|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3915275|NCT01450631|3738681|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915276|NCT01450631|3738682|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915277|NCT01450631|3738683|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915278|NCT01450631|3738681|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915279|NCT01450631|3738682|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915280|NCT01450631|3738683|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915281|NCT01450631|3738681|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3915282|NCT01450631|3738682|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915283|NCT01450631|3738683|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3915284|NCT01450631|3738681|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3915285|NCT01450631|3738682|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3915286|NCT01450631|3738683|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3915287|NCT01450631|3738681|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3915288|NCT01450631|3738682|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3915289|NCT01450631|3738683|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3915290|NCT01450631|3738681|B3|||Age||years|Mean|30.01|30.01|Standard Deviation|5.334|5.334|||
3915291|NCT01450631|3738682|B2|||Age||years|Mean|30.35|30.35|Standard Deviation|5.724|5.724|||
3915292|NCT01450631|3738683|B1|||Age||years|Mean|29.67|29.67|Standard Deviation|4.953|4.953|||
3915293|NCT01450397|3738692|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3915294|NCT01450397|3738692|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3915295|NCT01450397|3738692|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3915296|NCT01450397|3738692|B1|||Age||years|Mean|67.6|67.6|Standard Deviation|5.5|5.5|||
3915297|NCT01450397|3738692|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3915298|NCT01450397|3738692|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3915299|NCT01450397|3738692|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3915300|NCT01450319|3738696|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3915301|NCT01450319|3738696|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3915302|NCT01450319|3738696|B1|||Age||Years|Mean|63.61|63.61|Standard Deviation|10.54|10.54|||
3915303|NCT01450306|3738707|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3915304|NCT01450306|3738708|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3915305|NCT01450306|3738709|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3915306|NCT01450306|3738707|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3915307|NCT01450306|3738708|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3915308|NCT01450306|3738709|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3915309|NCT01450306|3738707|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3915310|NCT01450306|3738708|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3915311|NCT01450306|3738709|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3915312|NCT01450306|3738707|B3|||Age||years|Mean|37|37.0|Standard Deviation|13|13.0|||
3915313|NCT01450306|3738708|B2|||Age||years|Mean|34.6|34.6|Standard Deviation|12.69|12.69|||
3915314|NCT01450306|3738709|B1|||Age||years|Mean|39|39.0|Standard Deviation|13.91|13.91|||
3915315|NCT01450306|3738707|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3915316|NCT01450306|3738708|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3915317|NCT01450306|3738709|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3915318|NCT01450306|3738707|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3915319|NCT01450306|3738708|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3915320|NCT01450306|3738709|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3915321|NCT01450306|3738707|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3915322|NCT01450306|3738708|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3915323|NCT01450306|3738709|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3915324|NCT01450189|3738720|B4|Malawi||Region of Enrollment||participants|Number|46|46.0||||||
3915325|NCT01450189|3738721|B3|Malawi||Region of Enrollment||participants|Number|19|19.0||||||
3915326|NCT01450189|3738722|B2|Malawi||Region of Enrollment||participants|Number|18|18.0||||||
3915327|NCT01450189|3738723|B1|Malawi||Region of Enrollment||participants|Number|9|9.0||||||
3915328|NCT01450189|3738720|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3915329|NCT01450189|3738721|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3915330|NCT01450189|3738722|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3915331|NCT01450189|3738723|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3915332|NCT01450189|3738720|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3915333|NCT01450189|3738721|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3915334|NCT01450189|3738722|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3915335|NCT01450189|3738723|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3915336|NCT01450189|3738720|B4|||Age||years|Mean|27.7|27.7|Standard Deviation|7.0|7.0|||
3915337|NCT01450189|3738721|B3|||Age||years|Mean|27.1|27.1|Standard Deviation|7.9|7.9|||
3915338|NCT01450189|3738722|B2|||Age||years|Mean|26.7|26.7|Standard Deviation|5.1|5.1|||
3915339|NCT01450189|3738723|B1|||Age||years|Mean|31.6|31.6|Standard Deviation|8.1|8.1|||
3915340|NCT01450098|3738812|B3|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3915341|NCT01450098|3738813|B2|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3915342|NCT01450098|3738814|B1|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3915343|NCT01450098|3738812|B3|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3915344|NCT01450098|3738813|B2|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3915345|NCT01450098|3738814|B1|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3915346|NCT01450098|3738812|B3|Asian (Japanese)||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3915347|NCT01450098|3738813|B2|Asian (Japanese)||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3915348|NCT01450098|3738814|B1|Asian (Japanese)||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3915349|NCT01450098|3738812|B3|Asian (Chinese)||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3915350|NCT01450098|3738813|B2|Asian (Chinese)||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3915351|NCT01450098|3738814|B1|Asian (Chinese)||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3915352|NCT01450098|3738812|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3915353|NCT01450098|3738813|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3915354|NCT01450098|3738814|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3915355|NCT01450098|3738812|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3915356|NCT01450098|3738813|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3915357|NCT01450098|3738814|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3915358|NCT01450098|3738812|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3915359|NCT01450098|3738813|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3915360|NCT01450098|3738814|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3915361|NCT01450098|3738812|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915362|NCT01450098|3738813|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915363|NCT01450098|3738814|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915364|NCT01450098|3738812|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3915365|NCT01450098|3738813|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3915366|NCT01450098|3738814|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3915367|NCT01450098|3738812|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3915368|NCT01450098|3738813|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3915369|NCT01450098|3738814|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3915370|NCT01450098|3738812|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3915371|NCT01450098|3738813|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3915372|NCT01450098|3738814|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3915373|NCT01450098|3738812|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3915374|NCT01450098|3738813|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3915375|NCT01450098|3738814|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3915376|NCT01450098|3738812|B3|||Age||years|Mean|36.2|36.2|Standard Deviation|10.73|10.73|||
3915377|NCT01450098|3738813|B2|||Age||years|Mean|37.3|37.3|Standard Deviation|11.4|11.4|||
3915378|NCT01450098|3738814|B1|||Age||years|Mean|32.0|32.0|Standard Deviation|6.2|6.2|||
3915379|NCT01450007|3738831|B4|United States||Region of Enrollment||participants|Number|120|120.0||||||
3915380|NCT01450007|3738832|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
3915381|NCT01450007|3738833|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
3915382|NCT01450007|3738834|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
3915383|NCT01450007|3738831|B4||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3915384|NCT01450007|3738832|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3915385|NCT01450007|3738833|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3915386|NCT01450007|3738834|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3915387|NCT01450007|3738831|B4||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3915388|NCT01450007|3738832|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3915389|NCT01450007|3738833|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3915390|NCT01450007|3738834|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3915391|NCT01450007|3738831|B4|||Age|Baseline measures were provided for participants who completed the study.|years|Mean|66.14|66.14|Standard Deviation|10.7|10.7|||
3915392|NCT01450007|3738832|B3|||Age|Baseline measures were provided for participants who completed the study.|years|Mean|62.7|62.7|Standard Deviation|11.3|11.3|||
3915393|NCT01450007|3738833|B2|||Age|Baseline measures were provided for participants who completed the study.|years|Mean|68.4|68.4|Standard Deviation|7.7|7.7|||
3915394|NCT01450007|3738834|B1|||Age|Baseline measures were provided for participants who completed the study.|years|Mean|67.5|67.5|Standard Deviation|12.7|12.7|||
3915395|NCT01449955|3738853|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
3915396|NCT01449955|3738854|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
3915397|NCT01449955|3738855|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
3915398|NCT01449955|3738853|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3915399|NCT01449955|3738854|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3915400|NCT01449955|3738855|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3915401|NCT01449955|3738853|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3915402|NCT01449955|3738854|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3915403|NCT01449955|3738855|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3915404|NCT01449955|3738853|B3|||Age||years|Mean|42.21|42.21|Standard Deviation|14.77|14.77|||
3915405|NCT01449955|3738854|B2|||Age||years|Mean|42.15|42.15|Standard Deviation|15.46|15.46|||
3915406|NCT01449955|3738855|B1|||Age||years|Mean|42.64|42.64|Standard Deviation|14.39|14.39|||
3915407|NCT01449955|3738853|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3915408|NCT01449955|3738854|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3915409|NCT01449955|3738855|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3915410|NCT01449955|3738853|B3||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
3915411|NCT01449955|3738854|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3915412|NCT01449955|3738855|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3915413|NCT01449955|3738853|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3915414|NCT01449955|3738854|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3915415|NCT01449955|3738855|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3915416|NCT01449929|3738882|B3|Missing||Race/Ethnicity, Customized|Results from the mITT-E are presented in this report.|Participants|Number|1|1.0||||||
3915417|NCT01449929|3738883|B2|Missing||Race/Ethnicity, Customized|Results from the mITT-E are presented in this report.|Participants|Number|0|0.0||||||
3915418|NCT01449929|3738884|B1|Missing||Race/Ethnicity, Customized|Results from the mITT-E are presented in this report.|Participants|Number|1|1.0||||||
3915419|NCT01449929|3738882|B3|Mixed Race||Race/Ethnicity, Customized|Results from the mITT-E are presented in this report.|Participants|Number|4|4.0||||||
3915420|NCT01449929|3738883|B2|Mixed Race||Race/Ethnicity, Customized|Results from the mITT-E are presented in this report.|Participants|Number|3|3.0||||||
3915421|NCT01449929|3738884|B1|Mixed Race||Race/Ethnicity, Customized|Results from the mITT-E are presented in this report.|Participants|Number|1|1.0||||||
3915422|NCT01449929|3738882|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|Results from the mITT-E are presented in this report.|Participants|Number|342|342.0||||||
3915423|NCT01449929|3738883|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|Results from the mITT-E are presented in this report.|Participants|Number|173|173.0||||||
3915424|NCT01449929|3738884|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|Results from the mITT-E are presented in this report.|Participants|Number|169|169.0||||||
3915425|NCT01449929|3738882|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized|Results from the mITT-E are presented in this report.|Participants|Number|7|7.0||||||
3915426|NCT01449929|3738883|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized|Results from the mITT-E are presented in this report.|Participants|Number|3|3.0||||||
3915427|NCT01449929|3738884|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized|Results from the mITT-E are presented in this report.|Participants|Number|4|4.0||||||
3915428|NCT01449929|3738882|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|Results from the mITT-E are presented in this report.|Participants|Number|2|2.0||||||
3915429|NCT01449929|3738883|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|Results from the mITT-E are presented in this report.|Participants|Number|0|0.0||||||
3915430|NCT01449929|3738884|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|Results from the mITT-E are presented in this report.|Participants|Number|2|2.0||||||
3915431|NCT01449929|3738882|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Results from the mITT-E are presented in this report.|Participants|Number|1|1.0||||||
3915432|NCT01449929|3738883|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Results from the mITT-E are presented in this report.|Participants|Number|0|0.0||||||
3915433|NCT01449929|3738884|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Results from the mITT-E are presented in this report.|Participants|Number|1|1.0||||||
3915434|NCT01449929|3738882|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized|Results from the mITT-E are presented in this report.|Participants|Number|1|1.0||||||
3915435|NCT01449929|3738883|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized|Results from the mITT-E are presented in this report.|Participants|Number|0|0.0||||||
3915436|NCT01449929|3738884|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized|Results from the mITT-E are presented in this report.|Participants|Number|1|1.0||||||
3915437|NCT01449929|3738882|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Results from the mITT-E are presented in this report.|Participants|Number|1|1.0||||||
3915438|NCT01449929|3738883|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Results from the mITT-E are presented in this report.|Participants|Number|1|1.0||||||
3915439|NCT01449929|3738884|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Results from the mITT-E are presented in this report.|Participants|Number|0|0.0||||||
3915440|NCT01449929|3738882|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|Results from the mITT-E are presented in this report.|Participants|Number|12|12.0||||||
3915441|NCT01449929|3738883|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|Results from the mITT-E are presented in this report.|Participants|Number|9|9.0||||||
3915442|NCT01449929|3738884|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Results from the mITT-E are presented in this report.|Participants|Number|3|3.0||||||
3915443|NCT01449929|3738882|B3|African American/African Heritage||Race/Ethnicity, Customized|Results from the mITT-E are presented in this report.|Participants|Number|113|113.0||||||
3915444|NCT01449929|3738883|B2|African American/African Heritage||Race/Ethnicity, Customized|Results from the mITT-E are presented in this report.|Participants|Number|53|53.0||||||
3915445|NCT01449929|3738884|B1|African American/African Heritage||Race/Ethnicity, Customized|Results from the mITT-E are presented in this report.|Participants|Number|60|60.0||||||
3915446|NCT01449929|3738882|B3||Male|Sex: Female, Male|Results from the mITT-E are presented in this report.|Participants|Count of Participants|412|412.0||||||
3915447|NCT01449929|3738883|B2||Male|Sex: Female, Male|Results from the mITT-E are presented in this report.|Participants|Count of Participants|201|201.0||||||
3915448|NCT01449929|3738884|B1||Male|Sex: Female, Male|Results from the mITT-E are presented in this report.|Participants|Count of Participants|211|211.0||||||
3915449|NCT01449929|3738882|B3||Female|Sex: Female, Male|Results from the mITT-E are presented in this report.|Participants|Count of Participants|72|72.0||||||
3915450|NCT01449929|3738883|B2||Female|Sex: Female, Male|Results from the mITT-E are presented in this report.|Participants|Count of Participants|41|41.0||||||
3915451|NCT01449929|3738884|B1||Female|Sex: Female, Male|Results from the mITT-E are presented in this report.|Participants|Count of Participants|31|31.0||||||
3915452|NCT01449929|3738882|B3|||Age|Results from the mITT-E Population are presented in this report.|Years|Mean|35.9|35.9|Standard Deviation|10.64|10.64|||
3915453|NCT01449929|3738883|B2|||Age|Results from the mITT-E Population are presented in this report.|Years|Mean|36.2|36.2|Standard Deviation|10.64|10.64|||
3915454|NCT01449929|3738884|B1|||Age|Results from the mITT-E Population are presented in this report.|Years|Mean|35.7|35.7|Standard Deviation|10.66|10.66|||
3915455|NCT01449812|3738923|B4|Asian-Chinese heritage||Race/Ethnicity, Customized||Participants|Count of Participants|825|825.0||||||
3915456|NCT01449812|3738924|B3|Asian-Chinese heritage||Race/Ethnicity, Customized||Participants|Count of Participants|280|280.0||||||
3915457|NCT01449812|3738925|B2|Asian-Chinese heritage||Race/Ethnicity, Customized||Participants|Count of Participants|273|273.0||||||
3915458|NCT01449812|3738926|B1|Asian-Chinese heritage||Race/Ethnicity, Customized||Participants|Count of Participants|272|272.0||||||
3915459|NCT01449812|3738923|B4||Male|Sex: Female, Male||Participants|Count of Participants|448|448.0||||||
3915460|NCT01449812|3738924|B3||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3915461|NCT01449812|3738925|B2||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3915462|NCT01449812|3738926|B1||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3915463|NCT01449812|3738923|B4||Female|Sex: Female, Male||Participants|Count of Participants|377|377.0||||||
3915464|NCT01449812|3738924|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3915465|NCT01449812|3738925|B2||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3915466|NCT01449812|3738926|B1||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3915467|NCT01449812|3738923|B4|||Age||Months|Mean|19.47|19.47|Standard Deviation|0.94|0.94|||
3915468|NCT01449812|3738924|B3|||Age||Months|Mean|19.5|19.5|Standard Deviation|0.97|0.97|||
3915469|NCT01449812|3738925|B2|||Age||Months|Mean|19.4|19.4|Standard Deviation|0.91|0.91|||
3915470|NCT01449812|3738926|B1|||Age||Months|Mean|19.5|19.5|Standard Deviation|0.93|0.93|||
3915471|NCT01449747|3739020|B3|||HbA1c||%|Mean|7.2|7.2|Standard Deviation|0.9|0.9|||
3915472|NCT01449747|3739021|B2|||HbA1c||%|Mean|6.6|6.6|Standard Deviation|0.7|0.7|||
3915473|NCT01449747|3739022|B1|||HbA1c||%|Mean|7.7|7.7|Standard Deviation|0.6|0.6|||
3915474|NCT01449747|3739020|B3|||Body mass index||kg/m^2|Mean|24.8|24.8|Standard Deviation|2.9|2.9|||
3915475|NCT01449747|3739021|B2|||Body mass index||kg/m^2|Mean|24.4|24.4|Standard Deviation|3.8|3.8|||
3915476|NCT01449747|3739022|B1|||Body mass index||kg/m^2|Mean|25.1|25.1|Standard Deviation|1.7|1.7|||
3915477|NCT01449747|3739020|B3|||Duration of diabetes mellitus||years|Mean|6.2|6.2|Standard Deviation|4.4|4.4|||
3915478|NCT01449747|3739021|B2|||Duration of diabetes mellitus||years|Mean|5.2|5.2|Standard Deviation|2.7|2.7|||
3915479|NCT01449747|3739022|B1|||Duration of diabetes mellitus||years|Mean|7.2|7.2|Standard Deviation|5.5|5.5|||
3915480|NCT01449747|3739020|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3915481|NCT01449747|3739021|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3915482|NCT01449747|3739022|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3915483|NCT01449747|3739020|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3915484|NCT01449747|3739021|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3915485|NCT01449747|3739022|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3915486|NCT01449747|3739020|B3|||Age||years|Mean|58.1|58.1|Standard Deviation|6.3|6.3|||
3915487|NCT01449747|3739021|B2|||Age||years|Mean|57.4|57.4|Standard Deviation|7.0|7.0|||
3915488|NCT01449747|3739022|B1|||Age||years|Mean|58.8|58.8|Standard Deviation|5.7|5.7|||
3915489|NCT01449734|3739037|B1|Male||Gender|Gender of participating relatives. Numbers do not add to 215 because of non-response.|participants|Number|62|62.0||||||
3915490|NCT01449734|3739037|B1|Female||Gender|Gender of participating relatives. Numbers do not add to 215 because of non-response.|participants|Number|136|136.0||||||
3915491|NCT01449734|3739037|B1|> 64||Age, Customized|Numbers in categories do not add to 215 because of non-response.|participants|Number|60|60.0||||||
3915492|NCT01449734|3739037|B1|55-64||Age, Customized|Numbers in categories do not add to 215 because of non-response.|participants|Number|55|55.0||||||
3915493|NCT01449734|3739037|B1|45-54||Age, Customized|Numbers in categories do not add to 215 because of non-response.|participants|Number|55|55.0||||||
3915494|NCT01449734|3739037|B1|35-44||Age, Customized|Numbers in categories do not add to 215 because of non-response.|participants|Number|28|28.0||||||
3915495|NCT01449734|3739037|B1|18-34||Age, Customized|Numbers in categories do not add to 215 because of non-response.|participants|Number|11|11.0||||||
3915496|NCT01449721|3739041|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3915497|NCT01449721|3739042|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3915498|NCT01449721|3739043|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3915499|NCT01449721|3739041|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3915500|NCT01449721|3739042|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3915501|NCT01449721|3739043|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3915502|NCT01449721|3739041|B3|||Age||years|Mean|58|58.0|Standard Deviation|15|15.0|||
3915503|NCT01449721|3739042|B2|||Age||years|Mean|56.8|56.8|Standard Deviation|16|16.0|||
3915504|NCT01449721|3739043|B1|||Age||years|Mean|58.3|58.3|Standard Deviation|15|15.0|||
3915505|NCT01449708|3739054|B3|United States||Region of Enrollment||participants|Number|119|119.0||||||
3915506|NCT01449708|3739055|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
3915507|NCT01449708|3739056|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
3915508|NCT01449708|3739054|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3915509|NCT01449708|3739055|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3915510|NCT01449708|3739056|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3915511|NCT01449708|3739054|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3915512|NCT01449708|3739055|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3915513|NCT01449708|3739056|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3915514|NCT01449708|3739054|B3|||Age||years|Mean|50.4|50.4|Standard Deviation|2.4|2.4|||
3915515|NCT01449708|3739055|B2|||Age||years|Mean|50.5|50.5|Standard Deviation|3.5|3.5|||
3915516|NCT01449708|3739056|B1|||Age||years|Mean|50.4|50.4|Standard Deviation|3.2|3.2|||
3915517|NCT01449682|3739066|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3915518|NCT01449682|3739067|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3915519|NCT01449682|3739068|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3915520|NCT01449682|3739066|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3915521|NCT01449682|3739067|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3915522|NCT01449682|3739068|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3915523|NCT01449682|3739066|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3915524|NCT01449682|3739067|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3915525|NCT01449682|3739068|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3915526|NCT01449682|3739066|B3|||Age||years|Mean|66.2|66.2|Standard Deviation|4.7|4.7|||
3915527|NCT01449682|3739067|B2|||Age||years|Mean|63.3|63.3|Standard Deviation|8.0|8.0|||
3915528|NCT01449682|3739068|B1|||Age||years|Mean|69.1|69.1|Standard Deviation|5.7|5.7|||
3915529|NCT01449682|3739066|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3915530|NCT01449682|3739067|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3915531|NCT01449682|3739068|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3915532|NCT01449682|3739066|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3915533|NCT01449682|3739067|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3915534|NCT01449682|3739068|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3915535|NCT01449682|3739066|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3915536|NCT01449682|3739067|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3915537|NCT01449682|3739068|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3915538|NCT01449539|3739081|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3915539|NCT01449539|3739081|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3915540|NCT01449539|3739081|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3915541|NCT01449539|3739081|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3915542|NCT01449539|3739081|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3915543|NCT01449539|3739081|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3915544|NCT01449539|3739081|B1|||Age||years|Mean|68.25|68.25|Standard Deviation|50.185|50.185|||
3915545|NCT01449526|3739085|B3|United States||Region of Enrollment||participants|Number|166|166.0||||||
3915546|NCT01449526|3739086|B2|United States||Region of Enrollment||participants|Number|83|83.0||||||
3915547|NCT01449526|3739087|B1|United States||Region of Enrollment||participants|Number|83|83.0||||||
3915744|NCT01449461|3739156|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3915548|NCT01449526|3739085|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3915549|NCT01449526|3739086|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915550|NCT01449526|3739087|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3915551|NCT01449526|3739085|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915552|NCT01449526|3739086|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915553|NCT01449526|3739087|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915554|NCT01449526|3739085|B3||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3915555|NCT01449526|3739086|B2||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3915556|NCT01449526|3739087|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3915557|NCT01449526|3739085|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3915558|NCT01449526|3739086|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3915559|NCT01449526|3739087|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3915560|NCT01449526|3739085|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3915561|NCT01449526|3739086|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3915562|NCT01449526|3739087|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3915563|NCT01449526|3739085|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
3915564|NCT01449526|3739086|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3915565|NCT01449526|3739087|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3915566|NCT01449526|3739085|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915567|NCT01449526|3739086|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915568|NCT01449526|3739087|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3915569|NCT01449526|3739085|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3915570|NCT01449526|3739086|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3915571|NCT01449526|3739087|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3915572|NCT01449526|3739085|B3||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3915573|NCT01449526|3739086|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3915574|NCT01449526|3739087|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3915575|NCT01449526|3739085|B3|||Age||years|Median|29.0|29.0|Full Range|||18.0|40.0|
3915576|NCT01449526|3739086|B2|||Age||years|Median|29.0|29.0|Full Range|||18.0|40.0|
3915577|NCT01449526|3739087|B1|||Age||years|Median|29.0|29.0|Full Range|||19.0|40.0|
3915578|NCT01449513|3739096|B3|Germany||Region of Enrollment||participants|Number|24|24.0||||||
3915579|NCT01449513|3739097|B2|Germany||Region of Enrollment||participants|Number|8|8.0||||||
3915580|NCT01449513|3739098|B1|Germany||Region of Enrollment||participants|Number|16|16.0||||||
3915581|NCT01449513|3739096|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3915582|NCT01449513|3739097|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3915583|NCT01449513|3739098|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3915584|NCT01449513|3739096|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3915585|NCT01449513|3739097|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3915586|NCT01449513|3739098|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3915587|NCT01449513|3739096|B3|||Age||years|Mean|70.5|70.5|Standard Deviation|6.3|6.3|||
3915588|NCT01449513|3739097|B2|||Age||years|Mean|69.9|69.9|Standard Deviation|3.5|3.5|||
3915589|NCT01449513|3739098|B1|||Age||years|Mean|70.8|70.8|Standard Deviation|7.5|7.5|||
3915590|NCT01449513|3739096|B3||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3915591|NCT01449513|3739097|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3915592|NCT01449513|3739098|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3915593|NCT01449513|3739096|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3915594|NCT01449513|3739097|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3915595|NCT01449513|3739098|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3915596|NCT01449513|3739096|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3915597|NCT01449513|3739097|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3915598|NCT01449513|3739098|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3915599|NCT01449461|3739151|B7|Yes||Participants with Prior Radiotherapy to Brain||participants|Number|27|27.0||||||
3915600|NCT01449461|3739152|B6|Yes||Participants with Prior Radiotherapy to Brain||participants|Number|1|1.0||||||
3915601|NCT01449461|3739153|B5|Yes||Participants with Prior Radiotherapy to Brain||participants|Number|12|12.0||||||
3915602|NCT01449461|3739154|B4|Yes||Participants with Prior Radiotherapy to Brain||participants|Number|8|8.0||||||
3915603|NCT01449461|3739155|B3|Yes||Participants with Prior Radiotherapy to Brain||participants|Number|1|1.0||||||
3915604|NCT01449461|3739156|B2|Yes||Participants with Prior Radiotherapy to Brain||participants|Number|5|5.0||||||
3915605|NCT01449461|3739157|B1|Yes||Participants with Prior Radiotherapy to Brain||participants|Number|0|0.0||||||
3915606|NCT01449461|3739151|B7|No||Participants with Prior Radiotherapy to Brain||participants|Number|110|110.0||||||
3915745|NCT01449461|3739157|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3915607|NCT01449461|3739152|B6|No||Participants with Prior Radiotherapy to Brain||participants|Number|14|14.0||||||
3915608|NCT01449461|3739153|B5|No||Participants with Prior Radiotherapy to Brain||participants|Number|36|36.0||||||
3915609|NCT01449461|3739154|B4|No||Participants with Prior Radiotherapy to Brain||participants|Number|24|24.0||||||
3915610|NCT01449461|3739155|B3|No||Participants with Prior Radiotherapy to Brain||participants|Number|17|17.0||||||
3915611|NCT01449461|3739156|B2|No||Participants with Prior Radiotherapy to Brain||participants|Number|13|13.0||||||
3915612|NCT01449461|3739157|B1|No||Participants with Prior Radiotherapy to Brain||participants|Number|6|6.0||||||
3915613|NCT01449461|3739151|B7|> 2||Participants with Prior Chemotherapy Regimen||participants|Number|30|30.0||||||
3915614|NCT01449461|3739152|B6|> 2||Participants with Prior Chemotherapy Regimen||participants|Number|5|5.0||||||
3915615|NCT01449461|3739153|B5|> 2||Participants with Prior Chemotherapy Regimen||participants|Number|9|9.0||||||
3915616|NCT01449461|3739154|B4|> 2||Participants with Prior Chemotherapy Regimen||participants|Number|6|6.0||||||
3915617|NCT01449461|3739155|B3|> 2||Participants with Prior Chemotherapy Regimen||participants|Number|4|4.0||||||
3915618|NCT01449461|3739156|B2|> 2||Participants with Prior Chemotherapy Regimen||participants|Number|3|3.0||||||
3915619|NCT01449461|3739157|B1|> 2||Participants with Prior Chemotherapy Regimen||participants|Number|3|3.0||||||
3915620|NCT01449461|3739151|B7|2||Participants with Prior Chemotherapy Regimen||participants|Number|36|36.0||||||
3915621|NCT01449461|3739152|B6|2||Participants with Prior Chemotherapy Regimen||participants|Number|5|5.0||||||
3915622|NCT01449461|3739153|B5|2||Participants with Prior Chemotherapy Regimen||participants|Number|10|10.0||||||
3915623|NCT01449461|3739154|B4|2||Participants with Prior Chemotherapy Regimen||participants|Number|8|8.0||||||
3915624|NCT01449461|3739155|B3|2||Participants with Prior Chemotherapy Regimen||participants|Number|4|4.0||||||
3915625|NCT01449461|3739156|B2|2||Participants with Prior Chemotherapy Regimen||participants|Number|9|9.0||||||
3915626|NCT01449461|3739157|B1|2||Participants with Prior Chemotherapy Regimen||participants|Number|0|0.0||||||
3915627|NCT01449461|3739151|B7|1||Participants with Prior Chemotherapy Regimen||participants|Number|35|35.0||||||
3915628|NCT01449461|3739152|B6|1||Participants with Prior Chemotherapy Regimen||participants|Number|2|2.0||||||
3915629|NCT01449461|3739153|B5|1||Participants with Prior Chemotherapy Regimen||participants|Number|17|17.0||||||
3915630|NCT01449461|3739154|B4|1||Participants with Prior Chemotherapy Regimen||participants|Number|6|6.0||||||
3915631|NCT01449461|3739155|B3|1||Participants with Prior Chemotherapy Regimen||participants|Number|3|3.0||||||
3915632|NCT01449461|3739156|B2|1||Participants with Prior Chemotherapy Regimen||participants|Number|4|4.0||||||
3915633|NCT01449461|3739157|B1|1||Participants with Prior Chemotherapy Regimen||participants|Number|3|3.0||||||
3915634|NCT01449461|3739151|B7|0||Participants with Prior Chemotherapy Regimen||participants|Number|36|36.0||||||
3915635|NCT01449461|3739152|B6|0||Participants with Prior Chemotherapy Regimen||participants|Number|3|3.0||||||
3915636|NCT01449461|3739153|B5|0||Participants with Prior Chemotherapy Regimen||participants|Number|12|12.0||||||
3915637|NCT01449461|3739154|B4|0||Participants with Prior Chemotherapy Regimen||participants|Number|12|12.0||||||
3915638|NCT01449461|3739155|B3|0||Participants with Prior Chemotherapy Regimen||participants|Number|7|7.0||||||
3915639|NCT01449461|3739156|B2|0||Participants with Prior Chemotherapy Regimen||participants|Number|2|2.0||||||
3915640|NCT01449461|3739157|B1|0||Participants with Prior Chemotherapy Regimen||participants|Number|0|0.0||||||
3915641|NCT01449461|3739151|B7|Other||Number of Participants with Mutation Types||participants|Number|6|6.0||||||
3915642|NCT01449461|3739152|B6|Other||Number of Participants with Mutation Types||participants|Number|0|0.0||||||
3915643|NCT01449461|3739153|B5|Other||Number of Participants with Mutation Types||participants|Number|0|0.0||||||
3915644|NCT01449461|3739154|B4|Other||Number of Participants with Mutation Types||participants|Number|0|0.0||||||
3915645|NCT01449461|3739155|B3|Other||Number of Participants with Mutation Types||participants|Number|2|2.0||||||
3915646|NCT01449461|3739156|B2|Other||Number of Participants with Mutation Types||participants|Number|1|1.0||||||
3915647|NCT01449461|3739157|B1|Other||Number of Participants with Mutation Types||participants|Number|3|3.0||||||
3915648|NCT01449461|3739151|B7|ROS proto-oncogene 1 (ROS1+)||Number of Participants with Mutation Types||participants|Number|4|4.0||||||
3915649|NCT01449461|3739152|B6|ROS proto-oncogene 1 (ROS1+)||Number of Participants with Mutation Types||participants|Number|1|1.0||||||
3915650|NCT01449461|3739153|B5|ROS proto-oncogene 1 (ROS1+)||Number of Participants with Mutation Types||participants|Number|3|3.0||||||
3915651|NCT01449461|3739154|B4|ROS proto-oncogene 1 (ROS1+)||Number of Participants with Mutation Types||participants|Number|0|0.0||||||
3915652|NCT01449461|3739155|B3|ROS proto-oncogene 1 (ROS1+)||Number of Participants with Mutation Types||participants|Number|0|0.0||||||
3915653|NCT01449461|3739156|B2|ROS proto-oncogene 1 (ROS1+)||Number of Participants with Mutation Types||participants|Number|0|0.0||||||
3915654|NCT01449461|3739157|B1|ROS proto-oncogene 1 (ROS1+)||Number of Participants with Mutation Types||participants|Number|0|0.0||||||
3915655|NCT01449461|3739151|B7|Epidermal Growth Factor Receptor (EGFRm)||Number of Participants with Mutation Types||participants|Number|43|43.0||||||
3915656|NCT01449461|3739152|B6|Epidermal Growth Factor Receptor (EGFRm)||Number of Participants with Mutation Types||participants|Number|9|9.0||||||
3915657|NCT01449461|3739153|B5|Epidermal Growth Factor Receptor (EGFRm)||Number of Participants with Mutation Types||participants|Number|18|18.0||||||
3915658|NCT01449461|3739154|B4|Epidermal Growth Factor Receptor (EGFRm)||Number of Participants with Mutation Types||participants|Number|3|3.0||||||
3915659|NCT01449461|3739155|B3|Epidermal Growth Factor Receptor (EGFRm)||Number of Participants with Mutation Types||participants|Number|10|10.0||||||
3915660|NCT01449461|3739156|B2|Epidermal Growth Factor Receptor (EGFRm)||Number of Participants with Mutation Types||participants|Number|1|1.0||||||
3915661|NCT01449461|3739157|B1|Epidermal Growth Factor Receptor (EGFRm)||Number of Participants with Mutation Types||participants|Number|2|2.0||||||
3915662|NCT01449461|3739151|B7|anaplastic lymphoma kinase (ALK+)||Number of Participants with Mutation Types||participants|Number|84|84.0||||||
3915663|NCT01449461|3739152|B6|anaplastic lymphoma kinase (ALK+)||Number of Participants with Mutation Types||participants|Number|5|5.0||||||
3915664|NCT01449461|3739153|B5|anaplastic lymphoma kinase (ALK+)||Number of Participants with Mutation Types||participants|Number|27|27.0||||||
3915665|NCT01449461|3739154|B4|anaplastic lymphoma kinase (ALK+)||Number of Participants with Mutation Types||participants|Number|29|29.0||||||
3915666|NCT01449461|3739155|B3|anaplastic lymphoma kinase (ALK+)||Number of Participants with Mutation Types||participants|Number|6|6.0||||||
3915667|NCT01449461|3739156|B2|anaplastic lymphoma kinase (ALK+)||Number of Participants with Mutation Types||participants|Number|16|16.0||||||
3915668|NCT01449461|3739157|B1|anaplastic lymphoma kinase (ALK+)||Number of Participants with Mutation Types||participants|Number|1|1.0||||||
3915669|NCT01449461|3739151|B7|Other||Participants with Diagnosis of Cancer Type||participants|Number|9|9.0||||||
3915670|NCT01449461|3739152|B6|Other||Participants with Diagnosis of Cancer Type||participants|Number|0|0.0||||||
3915671|NCT01449461|3739153|B5|Other||Participants with Diagnosis of Cancer Type||participants|Number|3|3.0||||||
3915672|NCT01449461|3739154|B4|Other||Participants with Diagnosis of Cancer Type||participants|Number|1|1.0||||||
3915673|NCT01449461|3739155|B3|Other||Participants with Diagnosis of Cancer Type||participants|Number|0|0.0||||||
3915674|NCT01449461|3739156|B2|Other||Participants with Diagnosis of Cancer Type||participants|Number|2|2.0||||||
3915675|NCT01449461|3739157|B1|Other||Participants with Diagnosis of Cancer Type||participants|Number|3|3.0||||||
3915676|NCT01449461|3739151|B7|NSCLC||Participants with Diagnosis of Cancer Type||participants|Number|128|128.0||||||
3915677|NCT01449461|3739152|B6|NSCLC||Participants with Diagnosis of Cancer Type||participants|Number|15|15.0||||||
3915678|NCT01449461|3739153|B5|NSCLC||Participants with Diagnosis of Cancer Type||participants|Number|45|45.0||||||
3915679|NCT01449461|3739154|B4|NSCLC||Participants with Diagnosis of Cancer Type||participants|Number|31|31.0||||||
3915680|NCT01449461|3739155|B3|NSCLC||Participants with Diagnosis of Cancer Type||participants|Number|18|18.0||||||
3915681|NCT01449461|3739156|B2|NSCLC||Participants with Diagnosis of Cancer Type||participants|Number|16|16.0||||||
3915682|NCT01449461|3739157|B1|NSCLC||Participants with Diagnosis of Cancer Type||participants|Number|3|3.0||||||
3915683|NCT01449461|3739151|B7|||Time Since Diagnosis of Cancer||years|Mean|2.93|2.93|Standard Deviation|2.192|2.192|||
3915684|NCT01449461|3739152|B6|||Time Since Diagnosis of Cancer||years|Mean|3.27|3.27|Standard Deviation|1.913|1.913|||
3915685|NCT01449461|3739153|B5|||Time Since Diagnosis of Cancer||years|Mean|2.77|2.77|Standard Deviation|2.053|2.053|||
3915686|NCT01449461|3739154|B4|||Time Since Diagnosis of Cancer||years|Mean|3.19|3.19|Standard Deviation|2.726|2.726|||
3915687|NCT01449461|3739155|B3|||Time Since Diagnosis of Cancer||years|Mean|2.41|2.41|Standard Deviation|1.346|1.346|||
3915688|NCT01449461|3739156|B2|||Time Since Diagnosis of Cancer||years|Mean|3.33|3.33|Standard Deviation|2.184|2.184|||
3915689|NCT01449461|3739157|B1|||Time Since Diagnosis of Cancer||years|Mean|2.48|2.48|Standard Deviation|3.303|3.303|||
3915690|NCT01449461|3739151|B7|2||Eastern Cooperative Oncology Group (ECOG) Performance Score|ECOG assessed participant's performance status on a 5 point scale: 0 equals (=) fully active/able to carry on all pre-disease activities without restriction; 1=restricted in physically strenuous activity, but ambulatory/able to carry out light or sedentary work; 2=ambulatory (greater than [>] 50 percentage [%] of waking hours [h]), capable of all self care, but unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4= completely disabled, cannot carry on any selfcare, totally confined to bed or chair and 5=Dead.|participants|Number|2|2.0||||||
3915691|NCT01449461|3739152|B6|2||Eastern Cooperative Oncology Group (ECOG) Performance Score|ECOG assessed participant's performance status on a 5 point scale: 0 equals (=) fully active/able to carry on all pre-disease activities without restriction; 1=restricted in physically strenuous activity, but ambulatory/able to carry out light or sedentary work; 2=ambulatory (greater than [>] 50 percentage [%] of waking hours [h]), capable of all self care, but unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4= completely disabled, cannot carry on any selfcare, totally confined to bed or chair and 5=Dead.|participants|Number|0|0.0||||||
3915692|NCT01449461|3739153|B5|2||Eastern Cooperative Oncology Group (ECOG) Performance Score|ECOG assessed participant's performance status on a 5 point scale: 0 equals (=) fully active/able to carry on all pre-disease activities without restriction; 1=restricted in physically strenuous activity, but ambulatory/able to carry out light or sedentary work; 2=ambulatory (greater than [>] 50 percentage [%] of waking hours [h]), capable of all self care, but unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4= completely disabled, cannot carry on any selfcare, totally confined to bed or chair and 5=Dead.|participants|Number|2|2.0||||||
3915693|NCT01449461|3739154|B4|2||Eastern Cooperative Oncology Group (ECOG) Performance Score|ECOG assessed participant's performance status on a 5 point scale: 0 equals (=) fully active/able to carry on all pre-disease activities without restriction; 1=restricted in physically strenuous activity, but ambulatory/able to carry out light or sedentary work; 2=ambulatory (greater than [>] 50 percentage [%] of waking hours [h]), capable of all self care, but unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4= completely disabled, cannot carry on any selfcare, totally confined to bed or chair and 5=Dead.|participants|Number|0|0.0||||||
3915694|NCT01449461|3739155|B3|2||Eastern Cooperative Oncology Group (ECOG) Performance Score|ECOG assessed participant's performance status on a 5 point scale: 0 equals (=) fully active/able to carry on all pre-disease activities without restriction; 1=restricted in physically strenuous activity, but ambulatory/able to carry out light or sedentary work; 2=ambulatory (greater than [>] 50 percentage [%] of waking hours [h]), capable of all self care, but unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4= completely disabled, cannot carry on any selfcare, totally confined to bed or chair and 5=Dead.|participants|Number|0|0.0||||||
3915738|NCT01449461|3739157|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3915695|NCT01449461|3739156|B2|2||Eastern Cooperative Oncology Group (ECOG) Performance Score|ECOG assessed participant's performance status on a 5 point scale: 0 equals (=) fully active/able to carry on all pre-disease activities without restriction; 1=restricted in physically strenuous activity, but ambulatory/able to carry out light or sedentary work; 2=ambulatory (greater than [>] 50 percentage [%] of waking hours [h]), capable of all self care, but unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4= completely disabled, cannot carry on any selfcare, totally confined to bed or chair and 5=Dead.|participants|Number|0|0.0||||||
3915696|NCT01449461|3739157|B1|2||Eastern Cooperative Oncology Group (ECOG) Performance Score|ECOG assessed participant's performance status on a 5 point scale: 0 equals (=) fully active/able to carry on all pre-disease activities without restriction; 1=restricted in physically strenuous activity, but ambulatory/able to carry out light or sedentary work; 2=ambulatory (greater than [>] 50 percentage [%] of waking hours [h]), capable of all self care, but unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4= completely disabled, cannot carry on any selfcare, totally confined to bed or chair and 5=Dead.|participants|Number|0|0.0||||||
3915697|NCT01449461|3739151|B7|1||Eastern Cooperative Oncology Group (ECOG) Performance Score|ECOG assessed participant's performance status on a 5 point scale: 0 equals (=) fully active/able to carry on all pre-disease activities without restriction; 1=restricted in physically strenuous activity, but ambulatory/able to carry out light or sedentary work; 2=ambulatory (greater than [>] 50 percentage [%] of waking hours [h]), capable of all self care, but unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4= completely disabled, cannot carry on any selfcare, totally confined to bed or chair and 5=Dead.|participants|Number|101|101.0||||||
3915698|NCT01449461|3739152|B6|1||Eastern Cooperative Oncology Group (ECOG) Performance Score|ECOG assessed participant's performance status on a 5 point scale: 0 equals (=) fully active/able to carry on all pre-disease activities without restriction; 1=restricted in physically strenuous activity, but ambulatory/able to carry out light or sedentary work; 2=ambulatory (greater than [>] 50 percentage [%] of waking hours [h]), capable of all self care, but unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4= completely disabled, cannot carry on any selfcare, totally confined to bed or chair and 5=Dead.|participants|Number|13|13.0||||||
3915699|NCT01449461|3739153|B5|1||Eastern Cooperative Oncology Group (ECOG) Performance Score|ECOG assessed participant's performance status on a 5 point scale: 0 equals (=) fully active/able to carry on all pre-disease activities without restriction; 1=restricted in physically strenuous activity, but ambulatory/able to carry out light or sedentary work; 2=ambulatory (greater than [>] 50 percentage [%] of waking hours [h]), capable of all self care, but unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4= completely disabled, cannot carry on any selfcare, totally confined to bed or chair and 5=Dead.|participants|Number|33|33.0||||||
3915700|NCT01449461|3739154|B4|1||Eastern Cooperative Oncology Group (ECOG) Performance Score|ECOG assessed participant's performance status on a 5 point scale: 0 equals (=) fully active/able to carry on all pre-disease activities without restriction; 1=restricted in physically strenuous activity, but ambulatory/able to carry out light or sedentary work; 2=ambulatory (greater than [>] 50 percentage [%] of waking hours [h]), capable of all self care, but unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4= completely disabled, cannot carry on any selfcare, totally confined to bed or chair and 5=Dead.|participants|Number|19|19.0||||||
3915701|NCT01449461|3739155|B3|1||Eastern Cooperative Oncology Group (ECOG) Performance Score|ECOG assessed participant's performance status on a 5 point scale: 0 equals (=) fully active/able to carry on all pre-disease activities without restriction; 1=restricted in physically strenuous activity, but ambulatory/able to carry out light or sedentary work; 2=ambulatory (greater than [>] 50 percentage [%] of waking hours [h]), capable of all self care, but unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4= completely disabled, cannot carry on any selfcare, totally confined to bed or chair and 5=Dead.|participants|Number|15|15.0||||||
3915702|NCT01449461|3739156|B2|1||Eastern Cooperative Oncology Group (ECOG) Performance Score|ECOG assessed participant's performance status on a 5 point scale: 0 equals (=) fully active/able to carry on all pre-disease activities without restriction; 1=restricted in physically strenuous activity, but ambulatory/able to carry out light or sedentary work; 2=ambulatory (greater than [>] 50 percentage [%] of waking hours [h]), capable of all self care, but unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4= completely disabled, cannot carry on any selfcare, totally confined to bed or chair and 5=Dead.|participants|Number|15|15.0||||||
3915703|NCT01449461|3739157|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Score|ECOG assessed participant's performance status on a 5 point scale: 0 equals (=) fully active/able to carry on all pre-disease activities without restriction; 1=restricted in physically strenuous activity, but ambulatory/able to carry out light or sedentary work; 2=ambulatory (greater than [>] 50 percentage [%] of waking hours [h]), capable of all self care, but unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4= completely disabled, cannot carry on any selfcare, totally confined to bed or chair and 5=Dead.|participants|Number|6|6.0||||||
3915704|NCT01449461|3739151|B7|0||Eastern Cooperative Oncology Group (ECOG) Performance Score|ECOG assessed participant's performance status on a 5 point scale: 0 equals (=) fully active/able to carry on all pre-disease activities without restriction; 1=restricted in physically strenuous activity, but ambulatory/able to carry out light or sedentary work; 2=ambulatory (greater than [>] 50 percentage [%] of waking hours [h]), capable of all self care, but unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4= completely disabled, cannot carry on any selfcare, totally confined to bed or chair and 5=Dead.|participants|Number|34|34.0||||||
3915739|NCT01449461|3739151|B7|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3915740|NCT01449461|3739152|B6|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3915741|NCT01449461|3739153|B5|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3915742|NCT01449461|3739154|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3915743|NCT01449461|3739155|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3915705|NCT01449461|3739152|B6|0||Eastern Cooperative Oncology Group (ECOG) Performance Score|ECOG assessed participant's performance status on a 5 point scale: 0 equals (=) fully active/able to carry on all pre-disease activities without restriction; 1=restricted in physically strenuous activity, but ambulatory/able to carry out light or sedentary work; 2=ambulatory (greater than [>] 50 percentage [%] of waking hours [h]), capable of all self care, but unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4= completely disabled, cannot carry on any selfcare, totally confined to bed or chair and 5=Dead.|participants|Number|2|2.0||||||
3915706|NCT01449461|3739153|B5|0||Eastern Cooperative Oncology Group (ECOG) Performance Score|ECOG assessed participant's performance status on a 5 point scale: 0 equals (=) fully active/able to carry on all pre-disease activities without restriction; 1=restricted in physically strenuous activity, but ambulatory/able to carry out light or sedentary work; 2=ambulatory (greater than [>] 50 percentage [%] of waking hours [h]), capable of all self care, but unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4= completely disabled, cannot carry on any selfcare, totally confined to bed or chair and 5=Dead.|participants|Number|13|13.0||||||
3915707|NCT01449461|3739154|B4|0||Eastern Cooperative Oncology Group (ECOG) Performance Score|ECOG assessed participant's performance status on a 5 point scale: 0 equals (=) fully active/able to carry on all pre-disease activities without restriction; 1=restricted in physically strenuous activity, but ambulatory/able to carry out light or sedentary work; 2=ambulatory (greater than [>] 50 percentage [%] of waking hours [h]), capable of all self care, but unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4= completely disabled, cannot carry on any selfcare, totally confined to bed or chair and 5=Dead.|participants|Number|13|13.0||||||
3915708|NCT01449461|3739155|B3|0||Eastern Cooperative Oncology Group (ECOG) Performance Score|ECOG assessed participant's performance status on a 5 point scale: 0 equals (=) fully active/able to carry on all pre-disease activities without restriction; 1=restricted in physically strenuous activity, but ambulatory/able to carry out light or sedentary work; 2=ambulatory (greater than [>] 50 percentage [%] of waking hours [h]), capable of all self care, but unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4= completely disabled, cannot carry on any selfcare, totally confined to bed or chair and 5=Dead.|participants|Number|3|3.0||||||
3915709|NCT01449461|3739156|B2|0||Eastern Cooperative Oncology Group (ECOG) Performance Score|ECOG assessed participant's performance status on a 5 point scale: 0 equals (=) fully active/able to carry on all pre-disease activities without restriction; 1=restricted in physically strenuous activity, but ambulatory/able to carry out light or sedentary work; 2=ambulatory (greater than [>] 50 percentage [%] of waking hours [h]), capable of all self care, but unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4= completely disabled, cannot carry on any selfcare, totally confined to bed or chair and 5=Dead.|participants|Number|3|3.0||||||
3915710|NCT01449461|3739157|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Score|ECOG assessed participant's performance status on a 5 point scale: 0 equals (=) fully active/able to carry on all pre-disease activities without restriction; 1=restricted in physically strenuous activity, but ambulatory/able to carry out light or sedentary work; 2=ambulatory (greater than [>] 50 percentage [%] of waking hours [h]), capable of all self care, but unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4= completely disabled, cannot carry on any selfcare, totally confined to bed or chair and 5=Dead.|participants|Number|0|0.0||||||
3915711|NCT01449461|3739151|B7|Spain||Region of Enrollment||participants|Number|7|7.0||||||
3915712|NCT01449461|3739152|B6|Spain||Region of Enrollment||participants|Number|0|0.0||||||
3915713|NCT01449461|3739153|B5|Spain||Region of Enrollment||participants|Number|7|7.0||||||
3915714|NCT01449461|3739154|B4|Spain||Region of Enrollment||participants|Number|0|0.0||||||
3915715|NCT01449461|3739155|B3|Spain||Region of Enrollment||participants|Number|0|0.0||||||
3915716|NCT01449461|3739156|B2|Spain||Region of Enrollment||participants|Number|0|0.0||||||
3915717|NCT01449461|3739157|B1|Spain||Region of Enrollment||participants|Number|0|0.0||||||
3915718|NCT01449461|3739151|B7|United States||Region of Enrollment||participants|Number|130|130.0||||||
3915719|NCT01449461|3739152|B6|United States||Region of Enrollment||participants|Number|15|15.0||||||
3915720|NCT01449461|3739153|B5|United States||Region of Enrollment||participants|Number|41|41.0||||||
3915721|NCT01449461|3739154|B4|United States||Region of Enrollment||participants|Number|32|32.0||||||
3915722|NCT01449461|3739155|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
3915723|NCT01449461|3739156|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
3915724|NCT01449461|3739157|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3915725|NCT01449461|3739151|B7|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|134|134.0||||||
3915726|NCT01449461|3739152|B6|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3915727|NCT01449461|3739153|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
3915728|NCT01449461|3739154|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3915729|NCT01449461|3739155|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3915730|NCT01449461|3739156|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3915731|NCT01449461|3739157|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3915732|NCT01449461|3739151|B7|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3915733|NCT01449461|3739152|B6|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3915734|NCT01449461|3739153|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3915735|NCT01449461|3739154|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3915736|NCT01449461|3739155|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3915737|NCT01449461|3739156|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3915746|NCT01449461|3739151|B7|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3915747|NCT01449461|3739152|B6|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3915748|NCT01449461|3739153|B5|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3915749|NCT01449461|3739154|B4|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3915750|NCT01449461|3739155|B3|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3915751|NCT01449461|3739156|B2|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3915752|NCT01449461|3739157|B1|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3915753|NCT01449461|3739151|B7|White||Race/Ethnicity, Customized||participants|Number|110|110.0||||||
3915754|NCT01449461|3739152|B6|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3915755|NCT01449461|3739153|B5|White||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
3915756|NCT01449461|3739154|B4|White||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
3915757|NCT01449461|3739155|B3|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3915758|NCT01449461|3739156|B2|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3915759|NCT01449461|3739157|B1|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3915760|NCT01449461|3739151|B7|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3915761|NCT01449461|3739152|B6|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3915762|NCT01449461|3739153|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3915763|NCT01449461|3739154|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3915764|NCT01449461|3739155|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3915765|NCT01449461|3739156|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3915766|NCT01449461|3739157|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3915767|NCT01449461|3739151|B7|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3915768|NCT01449461|3739152|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3915769|NCT01449461|3739153|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3915770|NCT01449461|3739154|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3915771|NCT01449461|3739155|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3915772|NCT01449461|3739156|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3915773|NCT01449461|3739157|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3915774|NCT01449461|3739151|B7|Asian||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3915775|NCT01449461|3739152|B6|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3915776|NCT01449461|3739153|B5|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3915777|NCT01449461|3739154|B4|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3915778|NCT01449461|3739155|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3915779|NCT01449461|3739156|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3915780|NCT01449461|3739157|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3915781|NCT01449461|3739151|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3915782|NCT01449461|3739152|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3915783|NCT01449461|3739153|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3915784|NCT01449461|3739154|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3915785|NCT01449461|3739155|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3915786|NCT01449461|3739156|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3915787|NCT01449461|3739157|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3915788|NCT01449461|3739151|B7||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3915789|NCT01449461|3739152|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3915790|NCT01449461|3739153|B5||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3915791|NCT01449461|3739154|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3915792|NCT01449461|3739155|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3915793|NCT01449461|3739156|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3915794|NCT01449461|3739157|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3915795|NCT01449461|3739151|B7||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3915796|NCT01449461|3739152|B6||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3915797|NCT01449461|3739153|B5||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3915798|NCT01449461|3739154|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3915799|NCT01449461|3739155|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3915800|NCT01449461|3739156|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3915801|NCT01449461|3739157|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3915802|NCT01449461|3739151|B7|≥65 years||Age, Customized||participants|Number|39|39.0||||||
3915803|NCT01449461|3739152|B6|≥65 years||Age, Customized||participants|Number|6|6.0||||||
3915804|NCT01449461|3739153|B5|≥65 years||Age, Customized||participants|Number|9|9.0||||||
3915805|NCT01449461|3739154|B4|≥65 years||Age, Customized||participants|Number|7|7.0||||||
3915806|NCT01449461|3739155|B3|≥65 years||Age, Customized||participants|Number|6|6.0||||||
3915807|NCT01449461|3739156|B2|≥65 years||Age, Customized||participants|Number|7|7.0||||||
3915808|NCT01449461|3739157|B1|≥65 years||Age, Customized||participants|Number|4|4.0||||||
3915809|NCT01449461|3739151|B7|18 – 64 years||Age, Customized||participants|Number|98|98.0||||||
3915810|NCT01449461|3739152|B6|18 – 64 years||Age, Customized||participants|Number|9|9.0||||||
3915811|NCT01449461|3739153|B5|18 – 64 years||Age, Customized||participants|Number|39|39.0||||||
3915812|NCT01449461|3739154|B4|18 – 64 years||Age, Customized||participants|Number|25|25.0||||||
3915813|NCT01449461|3739155|B3|18 – 64 years||Age, Customized||participants|Number|12|12.0||||||
3915814|NCT01449461|3739156|B2|18 – 64 years||Age, Customized||participants|Number|11|11.0||||||
3915815|NCT01449461|3739157|B1|18 – 64 years||Age, Customized||participants|Number|2|2.0||||||
3915816|NCT01449461|3739151|B7|||Age||years|Mean|56.4|56.4|Standard Deviation|12.02|12.02|||
3915817|NCT01449461|3739152|B6|||Age||years|Mean|58.5|58.5|Standard Deviation|15.60|15.6|||
3915818|NCT01449461|3739153|B5|||Age||years|Mean|53.9|53.9|Standard Deviation|11.10|11.1|||
3915819|NCT01449461|3739154|B4|||Age||years|Mean|55.7|55.7|Standard Deviation|11.41|11.41|||
3915820|NCT01449461|3739155|B3|||Age||years|Mean|57.8|57.8|Standard Deviation|10.91|10.91|||
3915821|NCT01449461|3739156|B2|||Age||years|Mean|57.9|57.9|Standard Deviation|12.93|12.93|||
3915822|NCT01449461|3739157|B1|||Age||years|Mean|66.8|66.8|Standard Deviation|9.30|9.3|||
3915823|NCT01449370|3739274|B26|||Body Surface Area (BSA)|BSA data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|square meter (m^2)|Mean|1.79|1.79|Standard Deviation|0.219|0.219|||
3915824|NCT01449370|3739275|B25|||Body Surface Area (BSA)|BSA data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|square meter (m^2)|Mean|1.71|1.71|Standard Deviation|0.170|0.17|||
3915825|NCT01449370|3739276|B24|||Body Surface Area (BSA)|BSA data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|square meter (m^2)|Mean|1.82|1.82|Standard Deviation|0.256|0.256|||
3915826|NCT01449370|3739277|B23|||Body Surface Area (BSA)|BSA data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|square meter (m^2)|Mean|1.68|1.68|Standard Deviation|0.154|0.154|||
3915827|NCT01449370|3739278|B22|||Body Surface Area (BSA)|BSA data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|square meter (m^2)|Mean|1.80|1.8|Standard Deviation|0.217|0.217|||
3915828|NCT01449370|3739279|B21|||Body Surface Area (BSA)|BSA data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|square meter (m^2)|Mean|1.72|1.72|Standard Deviation|0.253|0.253|||
3915829|NCT01449370|3739280|B20|||Body Surface Area (BSA)|BSA data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|square meter (m^2)|Mean|1.70|1.7|Standard Deviation|0.250|0.25|||
3915830|NCT01449370|3739281|B19|||Body Surface Area (BSA)|BSA data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|square meter (m^2)|Mean|1.97|1.97|Standard Deviation|0.262|0.262|||
3915831|NCT01449370|3739282|B18|||Body Surface Area (BSA)|BSA data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|square meter (m^2)|Mean|1.95|1.95|Standard Deviation|0.384|0.384|||
3915832|NCT01449370|3739283|B17|||Body Surface Area (BSA)|BSA data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|square meter (m^2)|Mean|1.92|1.92|Standard Deviation|0.210|0.21|||
3915833|NCT01449370|3739284|B16|||Body Surface Area (BSA)|BSA data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|square meter (m^2)|Mean|1.88|1.88|Standard Deviation|0.235|0.235|||
3915834|NCT01449370|3739285|B15|||Body Surface Area (BSA)|BSA data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|square meter (m^2)|Mean|1.85|1.85|Standard Deviation|0.151|0.151|||
3915835|NCT01449370|3739286|B14|||Body Surface Area (BSA)|BSA data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|square meter (m^2)|Mean|1.85|1.85|Standard Deviation|0.214|0.214|||
3915836|NCT01449370|3739287|B13|||Body Surface Area (BSA)|BSA data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|square meter (m^2)|Mean|1.66|1.66|Standard Deviation|0.110|0.11|||
3915837|NCT01449370|3739288|B12|||Body Surface Area (BSA)|BSA data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|square meter (m^2)|Mean|1.99|1.99|Standard Deviation|0.354|0.354|||
3915838|NCT01449370|3739289|B11|||Body Surface Area (BSA)|BSA data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|square meter (m^2)|Mean|1.81|1.81|Standard Deviation|0.209|0.209|||
3915839|NCT01449370|3739290|B10|||Body Surface Area (BSA)|BSA data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|square meter (m^2)|Mean|1.69|1.69|Standard Deviation|0.192|0.192|||
3915840|NCT01449370|3739291|B9|||Body Surface Area (BSA)|BSA data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|square meter (m^2)|Mean|1.76|1.76|Standard Deviation|0.248|0.248|||
3915841|NCT01449370|3739292|B8|||Body Surface Area (BSA)|BSA data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|square meter (m^2)|Mean|1.70|1.7|Standard Deviation|0.063|0.063|||
3915842|NCT01449370|3739293|B7|||Body Surface Area (BSA)|BSA data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|square meter (m^2)|Mean|1.63|1.63|Standard Deviation|0.041|0.041|||
3915843|NCT01449370|3739294|B6|||Body Surface Area (BSA)|BSA data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|square meter (m^2)|Mean|1.66|1.66|Standard Deviation|0.060|0.06|||
3915844|NCT01449370|3739295|B5|||Body Surface Area (BSA)|BSA data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|square meter (m^2)|Mean|1.81|1.81|Standard Deviation|0.241|0.241|||
3915845|NCT01449370|3739296|B4|||Body Surface Area (BSA)|BSA data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|square meter (m^2)|Mean|1.85|1.85|Standard Deviation|0.500|0.5|||
3915846|NCT01449370|3739297|B3|||Body Surface Area (BSA)|BSA data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|square meter (m^2)|Mean|1.83|1.83|Standard Deviation|0.152|0.152|||
3915847|NCT01449370|3739298|B2|||Body Surface Area (BSA)|BSA data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|square meter (m^2)|Mean|1.78|1.78|Standard Deviation|0.266|0.266|||
3915848|NCT01449370|3739299|B1|||Body Surface Area (BSA)|BSA data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|square meter (m^2)|Mean|1.67|1.67|Standard Deviation|0.108|0.108|||
3915849|NCT01449370|3739274|B26|||Weight|Weight data was available only for 123 participants as follow: n=5,6,8,4,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,10,8.|kilogram (kg)|Mean|70.17|70.17|Standard Deviation|14.958|14.958|||
3915850|NCT01449370|3739275|B25|||Weight|Weight data was available only for 123 participants as follow: n=5,6,8,4,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,10,8.|kilogram (kg)|Mean|65.11|65.11|Standard Deviation|9.599|9.599|||
3915851|NCT01449370|3739276|B24|||Weight|Weight data was available only for 123 participants as follow: n=5,6,8,4,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,10,8.|kilogram (kg)|Mean|70.51|70.51|Standard Deviation|15.263|15.263|||
3915852|NCT01449370|3739277|B23|||Weight|Weight data was available only for 123 participants as follow: n=5,6,8,4,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,10,8.|kilogram (kg)|Mean|65.37|65.37|Standard Deviation|11.853|11.853|||
3915853|NCT01449370|3739278|B22|||Weight|Weight data was available only for 123 participants as follow: n=5,6,8,4,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,10,8.|kilogram (kg)|Mean|73.65|73.65|Standard Deviation|16.747|16.747|||
3915854|NCT01449370|3739279|B21|||Weight|Weight data was available only for 123 participants as follow: n=5,6,8,4,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,10,8.|kilogram (kg)|Mean|64.59|64.59|Standard Deviation|16.477|16.477|||
3915855|NCT01449370|3739280|B20|||Weight|Weight data was available only for 123 participants as follow: n=5,6,8,4,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,10,8.|kilogram (kg)|Mean|62.61|62.61|Standard Deviation|15.706|15.706|||
3915856|NCT01449370|3739281|B19|||Weight|Weight data was available only for 123 participants as follow: n=5,6,8,4,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,10,8.|kilogram (kg)|Mean|82.72|82.72|Standard Deviation|17.982|17.982|||
3915857|NCT01449370|3739282|B18|||Weight|Weight data was available only for 123 participants as follow: n=5,6,8,4,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,10,8.|kilogram (kg)|Mean|81.07|81.07|Standard Deviation|25.417|25.417|||
3915858|NCT01449370|3739283|B17|||Weight|Weight data was available only for 123 participants as follow: n=5,6,8,4,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,10,8.|kilogram (kg)|Mean|79.84|79.84|Standard Deviation|16.648|16.648|||
3915859|NCT01449370|3739284|B16|||Weight|Weight data was available only for 123 participants as follow: n=5,6,8,4,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,10,8.|kilogram (kg)|Mean|75.22|75.22|Standard Deviation|12.679|12.679|||
3915860|NCT01449370|3739285|B15|||Weight|Weight data was available only for 123 participants as follow: n=5,6,8,4,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,10,8.|kilogram (kg)|Mean|72.26|72.26|Standard Deviation|11.235|11.235|||
3915861|NCT01449370|3739286|B14|||Weight|Weight data was available only for 123 participants as follow: n=5,6,8,4,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,10,8.|kilogram (kg)|Mean|73.78|73.78|Standard Deviation|12.955|12.955|||
3915862|NCT01449370|3739287|B13|||Weight|Weight data was available only for 123 participants as follow: n=5,6,8,4,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,10,8.|kilogram (kg)|Mean|60.60|60.6|Standard Deviation|9.016|9.016|||
3915863|NCT01449370|3739288|B12|||Weight|Weight data was available only for 123 participants as follow: n=5,6,8,4,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,10,8.|kilogram (kg)|Mean|83.39|83.39|Standard Deviation|28.852|28.852|||
3915864|NCT01449370|3739289|B11|||Weight|Weight data was available only for 123 participants as follow: n=5,6,8,4,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,10,8.|kilogram (kg)|Mean|70.76|70.76|Standard Deviation|16.458|16.458|||
3915865|NCT01449370|3739290|B10|||Weight|Weight data was available only for 123 participants as follow: n=5,6,8,4,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,10,8.|kilogram (kg)|Mean|65.03|65.03|Standard Deviation|15.137|15.137|||
3915866|NCT01449370|3739291|B9|||Weight|Weight data was available only for 123 participants as follow: n=5,6,8,4,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,10,8.|kilogram (kg)|Mean|69.14|69.14|Standard Deviation|15.486|15.486|||
3915867|NCT01449370|3739292|B8|||Weight|Weight data was available only for 123 participants as follow: n=5,6,8,4,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,10,8.|kilogram (kg)|Mean|63.41|63.41|Standard Deviation|3.880|3.88|||
3915868|NCT01449370|3739293|B7|||Weight|Weight data was available only for 123 participants as follow: n=5,6,8,4,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,10,8.|kilogram (kg)|Mean|57.73|57.73|Standard Deviation|0.462|0.462|||
3915869|NCT01449370|3739294|B6|||Weight|Weight data was available only for 123 participants as follow: n=5,6,8,4,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,10,8.|kilogram (kg)|Mean|61.54|61.54|Standard Deviation|2.487|2.487|||
3915870|NCT01449370|3739295|B5|||Weight|Weight data was available only for 123 participants as follow: n=5,6,8,4,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,10,8.|kilogram (kg)|Mean|72.48|72.48|Standard Deviation|17.665|17.665|||
3915871|NCT01449370|3739296|B4|||Weight|Weight data was available only for 123 participants as follow: n=5,6,8,4,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,10,8.|kilogram (kg)|Mean|67.65|67.65|Standard Deviation|24.513|24.513|||
3915872|NCT01449370|3739297|B3|||Weight|Weight data was available only for 123 participants as follow: n=5,6,8,4,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,10,8.|kilogram (kg)|Mean|73.48|73.48|Standard Deviation|9.159|9.159|||
3915873|NCT01449370|3739298|B2|||Weight|Weight data was available only for 123 participants as follow: n=5,6,8,4,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,10,8.|kilogram (kg)|Mean|71.15|71.15|Standard Deviation|21.862|21.862|||
3915874|NCT01449370|3739299|B1|||Weight|Weight data was available only for 123 participants as follow: n=5,6,8,4,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,10,8.|kilogram (kg)|Mean|62.18|62.18|Standard Deviation|6.403|6.403|||
3915875|NCT01449370|3739274|B26|||Height|Height data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|centimeter (cm)|Mean|165.49|165.49|Standard Deviation|9.098|9.098|||
3915876|NCT01449370|3739275|B25|||Height|Height data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|centimeter (cm)|Mean|164.87|164.87|Standard Deviation|9.638|9.638|||
3915877|NCT01449370|3739276|B24|||Height|Height data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|centimeter (cm)|Mean|168.79|168.79|Standard Deviation|13.186|13.186|||
3915878|NCT01449370|3739277|B23|||Height|Height data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|centimeter (cm)|Mean|157.05|157.05|Standard Deviation|3.316|3.316|||
3915879|NCT01449370|3739278|B22|||Height|Height data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|centimeter (cm)|Mean|159.00|159.0|Standard Deviation|3.939|3.939|||
3915880|NCT01449370|3739279|B21|||Height|Height data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|centimeter (cm)|Mean|165.97|165.97|Standard Deviation|6.472|6.472|||
3915881|NCT01449370|3739280|B20|||Height|Height data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|centimeter (cm)|Mean|168.11|168.11|Standard Deviation|6.887|6.887|||
3915882|NCT01449370|3739281|B19|||Height|Height data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|centimeter (cm)|Mean|169.52|169.52|Standard Deviation|8.713|8.713|||
3915883|NCT01449370|3739282|B18|||Height|Height data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|centimeter (cm)|Mean|169.83|169.83|Standard Deviation|13.829|13.829|||
3915884|NCT01449370|3739283|B17|||Height|Height data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|centimeter (cm)|Mean|168.32|168.32|Standard Deviation|4.243|4.243|||
3915885|NCT01449370|3739284|B16|||Height|Height data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|centimeter (cm)|Mean|168.93|168.93|Standard Deviation|16.176|16.176|||
3915886|NCT01449370|3739285|B15|||Height|Height data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|centimeter (cm)|Mean|170.22|170.22|Standard Deviation|1.683|1.683|||
3915887|NCT01449370|3739286|B14|||Height|Height data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|centimeter (cm)|Mean|167.46|167.46|Standard Deviation|10.274|10.274|||
3915888|NCT01449370|3739287|B13|||Height|Height data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|centimeter (cm)|Mean|164.67|164.67|Standard Deviation|3.055|3.055|||
3915889|NCT01449370|3739288|B12|||Height|Height data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|centimeter (cm)|Mean|173.43|173.43|Standard Deviation|6.072|6.072|||
3915890|NCT01449370|3739289|B11|||Height|Height data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|centimeter (cm)|Mean|168.76|168.76|Standard Deviation|2.043|2.043|||
3915891|NCT01449370|3739290|B10|||Height|Height data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|centimeter (cm)|Mean|158.76|158.76|Standard Deviation|9.161|9.161|||
3915892|NCT01449370|3739291|B9|||Height|Height data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|centimeter (cm)|Mean|163.08|163.08|Standard Deviation|12.871|12.871|||
3915893|NCT01449370|3739292|B8|||Height|Height data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|centimeter (cm)|Mean|163.49|163.49|Standard Deviation|6.883|6.883|||
3915894|NCT01449370|3739293|B7|||Height|Height data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|centimeter (cm)|Mean|165.17|165.17|Standard Deviation|7.848|7.848|||
3915895|NCT01449370|3739294|B6|||Height|Height data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|centimeter (cm)|Mean|161.81|161.81|Standard Deviation|5.222|5.222|||
3915896|NCT01449370|3739295|B5|||Height|Height data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|centimeter (cm)|Mean|164.19|164.19|Standard Deviation|5.195|5.195|||
3915897|NCT01449370|3739296|B4|||Height|Height data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|centimeter (cm)|Mean|164.15|164.15|Standard Deviation|5.837|5.837|||
3915898|NCT01449370|3739297|B3|||Height|Height data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|centimeter (cm)|Mean|165.25|165.25|Standard Deviation|9.403|9.403|||
3915899|NCT01449370|3739298|B2|||Height|Height data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|centimeter (cm)|Mean|164.29|164.29|Standard Deviation|7.241|7.241|||
3915900|NCT01449370|3739299|B1|||Height|Height data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.|centimeter (cm)|Mean|161.70|161.7|Standard Deviation|10.758|10.758|||
3915901|NCT01449370|3739274|B26|Males (Excluded from this analysis)||Female Child Bearing Potential||participants|Number|41|41.0||||||
3915902|NCT01449370|3739275|B25|Males (Excluded from this analysis)||Female Child Bearing Potential||participants|Number|2|2.0||||||
3915903|NCT01449370|3739276|B24|Males (Excluded from this analysis)||Female Child Bearing Potential||participants|Number|5|5.0||||||
3915904|NCT01449370|3739277|B23|Males (Excluded from this analysis)||Female Child Bearing Potential||participants|Number|0|0.0||||||
3915905|NCT01449370|3739278|B22|Males (Excluded from this analysis)||Female Child Bearing Potential||participants|Number|0|0.0||||||
3915906|NCT01449370|3739279|B21|Males (Excluded from this analysis)||Female Child Bearing Potential||participants|Number|2|2.0||||||
3915907|NCT01449370|3739280|B20|Males (Excluded from this analysis)||Female Child Bearing Potential||participants|Number|1|1.0||||||
3915908|NCT01449370|3739281|B19|Males (Excluded from this analysis)||Female Child Bearing Potential||participants|Number|1|1.0||||||
3915909|NCT01449370|3739282|B18|Males (Excluded from this analysis)||Female Child Bearing Potential||participants|Number|2|2.0||||||
3915910|NCT01449370|3739283|B17|Males (Excluded from this analysis)||Female Child Bearing Potential||participants|Number|2|2.0||||||
3915911|NCT01449370|3739284|B16|Males (Excluded from this analysis)||Female Child Bearing Potential||participants|Number|2|2.0||||||
3915912|NCT01449370|3739285|B15|Males (Excluded from this analysis)||Female Child Bearing Potential||participants|Number|2|2.0||||||
3915913|NCT01449370|3739286|B14|Males (Excluded from this analysis)||Female Child Bearing Potential||participants|Number|4|4.0||||||
3915914|NCT01449370|3739287|B13|Males (Excluded from this analysis)||Female Child Bearing Potential||participants|Number|0|0.0||||||
3915915|NCT01449370|3739288|B12|Males (Excluded from this analysis)||Female Child Bearing Potential||participants|Number|2|2.0||||||
3915916|NCT01449370|3739289|B11|Males (Excluded from this analysis)||Female Child Bearing Potential||participants|Number|2|2.0||||||
3915917|NCT01449370|3739290|B10|Males (Excluded from this analysis)||Female Child Bearing Potential||participants|Number|0|0.0||||||
3915918|NCT01449370|3739291|B9|Males (Excluded from this analysis)||Female Child Bearing Potential||participants|Number|3|3.0||||||
3915919|NCT01449370|3739292|B8|Males (Excluded from this analysis)||Female Child Bearing Potential||participants|Number|0|0.0||||||
3915920|NCT01449370|3739293|B7|Males (Excluded from this analysis)||Female Child Bearing Potential||participants|Number|1|1.0||||||
3915921|NCT01449370|3739294|B6|Males (Excluded from this analysis)||Female Child Bearing Potential||participants|Number|1|1.0||||||
3915922|NCT01449370|3739295|B5|Males (Excluded from this analysis)||Female Child Bearing Potential||participants|Number|1|1.0||||||
3915923|NCT01449370|3739296|B4|Males (Excluded from this analysis)||Female Child Bearing Potential||participants|Number|1|1.0||||||
3915924|NCT01449370|3739297|B3|Males (Excluded from this analysis)||Female Child Bearing Potential||participants|Number|3|3.0||||||
3915925|NCT01449370|3739298|B2|Males (Excluded from this analysis)||Female Child Bearing Potential||participants|Number|2|2.0||||||
3915926|NCT01449370|3739299|B1|Males (Excluded from this analysis)||Female Child Bearing Potential||participants|Number|2|2.0||||||
3915927|NCT01449370|3739274|B26|Sterilized Females||Female Child Bearing Potential||participants|Number|26|26.0||||||
3915928|NCT01449370|3739275|B25|Sterilized Females||Female Child Bearing Potential||participants|Number|2|2.0||||||
3915929|NCT01449370|3739276|B24|Sterilized Females||Female Child Bearing Potential||participants|Number|1|1.0||||||
3915930|NCT01449370|3739277|B23|Sterilized Females||Female Child Bearing Potential||participants|Number|0|0.0||||||
3915931|NCT01449370|3739278|B22|Sterilized Females||Female Child Bearing Potential||participants|Number|0|0.0||||||
3915932|NCT01449370|3739279|B21|Sterilized Females||Female Child Bearing Potential||participants|Number|0|0.0||||||
3915933|NCT01449370|3739280|B20|Sterilized Females||Female Child Bearing Potential||participants|Number|1|1.0||||||
3915934|NCT01449370|3739281|B19|Sterilized Females||Female Child Bearing Potential||participants|Number|0|0.0||||||
3915935|NCT01449370|3739282|B18|Sterilized Females||Female Child Bearing Potential||participants|Number|0|0.0||||||
3915936|NCT01449370|3739283|B17|Sterilized Females||Female Child Bearing Potential||participants|Number|1|1.0||||||
3915937|NCT01449370|3739284|B16|Sterilized Females||Female Child Bearing Potential||participants|Number|0|0.0||||||
3915938|NCT01449370|3739285|B15|Sterilized Females||Female Child Bearing Potential||participants|Number|1|1.0||||||
3915939|NCT01449370|3739286|B14|Sterilized Females||Female Child Bearing Potential||participants|Number|5|5.0||||||
3915940|NCT01449370|3739287|B13|Sterilized Females||Female Child Bearing Potential||participants|Number|1|1.0||||||
3915941|NCT01449370|3739288|B12|Sterilized Females||Female Child Bearing Potential||participants|Number|0|0.0||||||
3915942|NCT01449370|3739289|B11|Sterilized Females||Female Child Bearing Potential||participants|Number|1|1.0||||||
3915943|NCT01449370|3739290|B10|Sterilized Females||Female Child Bearing Potential||participants|Number|1|1.0||||||
3915944|NCT01449370|3739291|B9|Sterilized Females||Female Child Bearing Potential||participants|Number|4|4.0||||||
3915945|NCT01449370|3739292|B8|Sterilized Females||Female Child Bearing Potential||participants|Number|2|2.0||||||
3915946|NCT01449370|3739293|B7|Sterilized Females||Female Child Bearing Potential||participants|Number|1|1.0||||||
3915947|NCT01449370|3739294|B6|Sterilized Females||Female Child Bearing Potential||participants|Number|1|1.0||||||
3915948|NCT01449370|3739295|B5|Sterilized Females||Female Child Bearing Potential||participants|Number|0|0.0||||||
3915949|NCT01449370|3739296|B4|Sterilized Females||Female Child Bearing Potential||participants|Number|2|2.0||||||
3915950|NCT01449370|3739297|B3|Sterilized Females||Female Child Bearing Potential||participants|Number|1|1.0||||||
3915951|NCT01449370|3739298|B2|Sterilized Females||Female Child Bearing Potential||participants|Number|1|1.0||||||
3915952|NCT01449370|3739299|B1|Sterilized Females||Female Child Bearing Potential||participants|Number|0|0.0||||||
3915953|NCT01449370|3739274|B26|Post-menopausal||Female Child Bearing Potential||participants|Number|51|51.0||||||
3915954|NCT01449370|3739275|B25|Post-menopausal||Female Child Bearing Potential||participants|Number|4|4.0||||||
3915955|NCT01449370|3739276|B24|Post-menopausal||Female Child Bearing Potential||participants|Number|3|3.0||||||
3915956|NCT01449370|3739277|B23|Post-menopausal||Female Child Bearing Potential||participants|Number|3|3.0||||||
3915957|NCT01449370|3739278|B22|Post-menopausal||Female Child Bearing Potential||participants|Number|4|4.0||||||
3915958|NCT01449370|3739279|B21|Post-menopausal||Female Child Bearing Potential||participants|Number|4|4.0||||||
3915959|NCT01449370|3739280|B20|Post-menopausal||Female Child Bearing Potential||participants|Number|1|1.0||||||
3915960|NCT01449370|3739281|B19|Post-menopausal||Female Child Bearing Potential||participants|Number|2|2.0||||||
3915961|NCT01449370|3739282|B18|Post-menopausal||Female Child Bearing Potential||participants|Number|1|1.0||||||
3915962|NCT01449370|3739283|B17|Post-menopausal||Female Child Bearing Potential||participants|Number|4|4.0||||||
3915963|NCT01449370|3739284|B16|Post-menopausal||Female Child Bearing Potential||participants|Number|1|1.0||||||
3915964|NCT01449370|3739285|B15|Post-menopausal||Female Child Bearing Potential||participants|Number|0|0.0||||||
3915965|NCT01449370|3739286|B14|Post-menopausal||Female Child Bearing Potential||participants|Number|2|2.0||||||
3915966|NCT01449370|3739287|B13|Post-menopausal||Female Child Bearing Potential||participants|Number|2|2.0||||||
3915967|NCT01449370|3739288|B12|Post-menopausal||Female Child Bearing Potential||participants|Number|0|0.0||||||
3915968|NCT01449370|3739289|B11|Post-menopausal||Female Child Bearing Potential||participants|Number|0|0.0||||||
3915969|NCT01449370|3739290|B10|Post-menopausal||Female Child Bearing Potential||participants|Number|2|2.0||||||
3915970|NCT01449370|3739291|B9|Post-menopausal||Female Child Bearing Potential||participants|Number|4|4.0||||||
3915971|NCT01449370|3739292|B8|Post-menopausal||Female Child Bearing Potential||participants|Number|1|1.0||||||
3915972|NCT01449370|3739293|B7|Post-menopausal||Female Child Bearing Potential||participants|Number|1|1.0||||||
3915973|NCT01449370|3739294|B6|Post-menopausal||Female Child Bearing Potential||participants|Number|1|1.0||||||
3915974|NCT01449370|3739295|B5|Post-menopausal||Female Child Bearing Potential||participants|Number|1|1.0||||||
3915975|NCT01449370|3739296|B4|Post-menopausal||Female Child Bearing Potential||participants|Number|0|0.0||||||
3915976|NCT01449370|3739297|B3|Post-menopausal||Female Child Bearing Potential||participants|Number|3|3.0||||||
3915977|NCT01449370|3739298|B2|Post-menopausal||Female Child Bearing Potential||participants|Number|3|3.0||||||
3915978|NCT01449370|3739299|B1|Post-menopausal||Female Child Bearing Potential||participants|Number|4|4.0||||||
3915979|NCT01449370|3739274|B26|Females of Child-bearing Potential||Female Child Bearing Potential||participants|Number|7|7.0||||||
3915980|NCT01449370|3739275|B25|Females of Child-bearing Potential||Female Child Bearing Potential||participants|Number|0|0.0||||||
3915981|NCT01449370|3739276|B24|Females of Child-bearing Potential||Female Child Bearing Potential||participants|Number|1|1.0||||||
3915982|NCT01449370|3739277|B23|Females of Child-bearing Potential||Female Child Bearing Potential||participants|Number|1|1.0||||||
3915983|NCT01449370|3739278|B22|Females of Child-bearing Potential||Female Child Bearing Potential||participants|Number|0|0.0||||||
3915984|NCT01449370|3739279|B21|Females of Child-bearing Potential||Female Child Bearing Potential||participants|Number|0|0.0||||||
3915985|NCT01449370|3739280|B20|Females of Child-bearing Potential||Female Child Bearing Potential||participants|Number|0|0.0||||||
3915986|NCT01449370|3739281|B19|Females of Child-bearing Potential||Female Child Bearing Potential||participants|Number|0|0.0||||||
3915987|NCT01449370|3739282|B18|Females of Child-bearing Potential||Female Child Bearing Potential||participants|Number|0|0.0||||||
3915988|NCT01449370|3739283|B17|Females of Child-bearing Potential||Female Child Bearing Potential||participants|Number|0|0.0||||||
3915989|NCT01449370|3739284|B16|Females of Child-bearing Potential||Female Child Bearing Potential||participants|Number|0|0.0||||||
3915990|NCT01449370|3739285|B15|Females of Child-bearing Potential||Female Child Bearing Potential||participants|Number|0|0.0||||||
3915991|NCT01449370|3739286|B14|Females of Child-bearing Potential||Female Child Bearing Potential||participants|Number|0|0.0||||||
3915992|NCT01449370|3739287|B13|Females of Child-bearing Potential||Female Child Bearing Potential||participants|Number|0|0.0||||||
3915993|NCT01449370|3739288|B12|Females of Child-bearing Potential||Female Child Bearing Potential||participants|Number|1|1.0||||||
3915994|NCT01449370|3739289|B11|Females of Child-bearing Potential||Female Child Bearing Potential||participants|Number|0|0.0||||||
3915995|NCT01449370|3739290|B10|Females of Child-bearing Potential||Female Child Bearing Potential||participants|Number|0|0.0||||||
3915996|NCT01449370|3739291|B9|Females of Child-bearing Potential||Female Child Bearing Potential||participants|Number|1|1.0||||||
3915997|NCT01449370|3739292|B8|Females of Child-bearing Potential||Female Child Bearing Potential||participants|Number|0|0.0||||||
3915998|NCT01449370|3739293|B7|Females of Child-bearing Potential||Female Child Bearing Potential||participants|Number|0|0.0||||||
3915999|NCT01449370|3739294|B6|Females of Child-bearing Potential||Female Child Bearing Potential||participants|Number|0|0.0||||||
3916000|NCT01449370|3739295|B5|Females of Child-bearing Potential||Female Child Bearing Potential||participants|Number|1|1.0||||||
3916001|NCT01449370|3739296|B4|Females of Child-bearing Potential||Female Child Bearing Potential||participants|Number|1|1.0||||||
3916002|NCT01449370|3739297|B3|Females of Child-bearing Potential||Female Child Bearing Potential||participants|Number|1|1.0||||||
3916003|NCT01449370|3739298|B2|Females of Child-bearing Potential||Female Child Bearing Potential||participants|Number|0|0.0||||||
3916004|NCT01449370|3739299|B1|Females of Child-bearing Potential||Female Child Bearing Potential||participants|Number|0|0.0||||||
3916005|NCT01449370|3739274|B26|Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3916006|NCT01449370|3739275|B25|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916007|NCT01449370|3739276|B24|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916008|NCT01449370|3739277|B23|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916009|NCT01449370|3739278|B22|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916010|NCT01449370|3739279|B21|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916011|NCT01449370|3739280|B20|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916012|NCT01449370|3739281|B19|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916013|NCT01449370|3739282|B18|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916014|NCT01449370|3739283|B17|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916015|NCT01449370|3739284|B16|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916016|NCT01449370|3739285|B15|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916017|NCT01449370|3739286|B14|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916018|NCT01449370|3739287|B13|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916019|NCT01449370|3739288|B12|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916020|NCT01449370|3739289|B11|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916021|NCT01449370|3739290|B10|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916022|NCT01449370|3739291|B9|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916023|NCT01449370|3739292|B8|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916024|NCT01449370|3739293|B7|Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3916025|NCT01449370|3739294|B6|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916026|NCT01449370|3739295|B5|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916027|NCT01449370|3739296|B4|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916028|NCT01449370|3739297|B3|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916029|NCT01449370|3739298|B2|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916030|NCT01449370|3739299|B1|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916031|NCT01449370|3739274|B26|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3916032|NCT01449370|3739275|B25|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916033|NCT01449370|3739276|B24|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916034|NCT01449370|3739277|B23|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916035|NCT01449370|3739278|B22|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3916036|NCT01449370|3739279|B21|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916037|NCT01449370|3739280|B20|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916038|NCT01449370|3739281|B19|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916039|NCT01449370|3739282|B18|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916040|NCT01449370|3739283|B17|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916041|NCT01449370|3739284|B16|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916042|NCT01449370|3739285|B15|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3916043|NCT01449370|3739286|B14|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916044|NCT01449370|3739287|B13|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916045|NCT01449370|3739288|B12|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916046|NCT01449370|3739289|B11|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916047|NCT01449370|3739290|B10|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916048|NCT01449370|3739291|B9|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916049|NCT01449370|3739292|B8|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916050|NCT01449370|3739293|B7|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916051|NCT01449370|3739294|B6|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916052|NCT01449370|3739295|B5|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916053|NCT01449370|3739296|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916054|NCT01449370|3739297|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916055|NCT01449370|3739298|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916056|NCT01449370|3739299|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916057|NCT01449370|3739274|B26|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3916058|NCT01449370|3739275|B25|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916059|NCT01449370|3739276|B24|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916060|NCT01449370|3739277|B23|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916061|NCT01449370|3739278|B22|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916062|NCT01449370|3739279|B21|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916063|NCT01449370|3739280|B20|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916064|NCT01449370|3739281|B19|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916065|NCT01449370|3739282|B18|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916066|NCT01449370|3739283|B17|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916067|NCT01449370|3739284|B16|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916068|NCT01449370|3739285|B15|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916069|NCT01449370|3739286|B14|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916070|NCT01449370|3739287|B13|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916071|NCT01449370|3739288|B12|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3916072|NCT01449370|3739289|B11|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916073|NCT01449370|3739290|B10|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916074|NCT01449370|3739291|B9|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916075|NCT01449370|3739292|B8|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916076|NCT01449370|3739293|B7|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3916077|NCT01449370|3739294|B6|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916078|NCT01449370|3739295|B5|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916079|NCT01449370|3739296|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3916080|NCT01449370|3739297|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916081|NCT01449370|3739298|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916082|NCT01449370|3739299|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916083|NCT01449370|3739274|B26|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3916084|NCT01449370|3739275|B25|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916085|NCT01449370|3739276|B24|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916086|NCT01449370|3739277|B23|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3916087|NCT01449370|3739278|B22|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916088|NCT01449370|3739279|B21|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916089|NCT01449370|3739280|B20|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916090|NCT01449370|3739281|B19|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916091|NCT01449370|3739282|B18|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916092|NCT01449370|3739283|B17|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916093|NCT01449370|3739284|B16|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3916094|NCT01449370|3739285|B15|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916095|NCT01449370|3739286|B14|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916096|NCT01449370|3739287|B13|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916097|NCT01449370|3739288|B12|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3916098|NCT01449370|3739289|B11|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916099|NCT01449370|3739290|B10|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916100|NCT01449370|3739291|B9|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916101|NCT01449370|3739292|B8|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916102|NCT01449370|3739293|B7|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916103|NCT01449370|3739294|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3916104|NCT01449370|3739295|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916105|NCT01449370|3739296|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916106|NCT01449370|3739297|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916107|NCT01449370|3739298|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916108|NCT01449370|3739299|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916109|NCT01449370|3739274|B26|White||Race/Ethnicity, Customized||participants|Number|115|115.0||||||
3916110|NCT01449370|3739275|B25|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3916111|NCT01449370|3739276|B24|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3916112|NCT01449370|3739277|B23|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3916113|NCT01449370|3739278|B22|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3916114|NCT01449370|3739279|B21|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3916115|NCT01449370|3739280|B20|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3916116|NCT01449370|3739281|B19|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3916117|NCT01449370|3739282|B18|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3916118|NCT01449370|3739283|B17|White||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3916119|NCT01449370|3739284|B16|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3916120|NCT01449370|3739285|B15|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3916121|NCT01449370|3739286|B14|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3916122|NCT01449370|3739287|B13|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3916123|NCT01449370|3739288|B12|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3916124|NCT01449370|3739289|B11|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3916125|NCT01449370|3739290|B10|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3916126|NCT01449370|3739291|B9|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3916127|NCT01449370|3739292|B8|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3916128|NCT01449370|3739293|B7|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3916129|NCT01449370|3739294|B6|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3916130|NCT01449370|3739295|B5|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3916131|NCT01449370|3739296|B4|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3916132|NCT01449370|3739297|B3|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3916133|NCT01449370|3739298|B2|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3916134|NCT01449370|3739299|B1|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3916135|NCT01449370|3739274|B26||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3916136|NCT01449370|3739275|B25||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916137|NCT01449370|3739276|B24||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916138|NCT01449370|3739277|B23||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916139|NCT01449370|3739278|B22||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916140|NCT01449370|3739279|B21||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916141|NCT01449370|3739280|B20||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916142|NCT01449370|3739281|B19||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916143|NCT01449370|3739282|B18||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916144|NCT01449370|3739283|B17||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916145|NCT01449370|3739284|B16||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916146|NCT01449370|3739285|B15||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916147|NCT01449370|3739286|B14||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916148|NCT01449370|3739287|B13||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916149|NCT01449370|3739288|B12||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3916150|NCT01449370|3739289|B11||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916151|NCT01449370|3739290|B10||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916152|NCT01449370|3739291|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3916153|NCT01449370|3739292|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916154|NCT01449370|3739293|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3916155|NCT01449370|3739294|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916156|NCT01449370|3739295|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916157|NCT01449370|3739296|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916158|NCT01449370|3739297|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3916159|NCT01449370|3739298|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916160|NCT01449370|3739299|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3916161|NCT01449370|3739274|B26||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|117|117.0||||||
3916162|NCT01449370|3739275|B25||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3916163|NCT01449370|3739276|B24||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3916164|NCT01449370|3739277|B23||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3916165|NCT01449370|3739278|B22||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3916166|NCT01449370|3739279|B21||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3916167|NCT01449370|3739280|B20||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3916168|NCT01449370|3739281|B19||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3916169|NCT01449370|3739282|B18||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3916170|NCT01449370|3739283|B17||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3916171|NCT01449370|3739284|B16||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3916172|NCT01449370|3739285|B15||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3916173|NCT01449370|3739286|B14||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3916174|NCT01449370|3739287|B13||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3916175|NCT01449370|3739288|B12||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3916176|NCT01449370|3739289|B11||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3916177|NCT01449370|3739290|B10||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3916178|NCT01449370|3739291|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3916179|NCT01449370|3739292|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3916180|NCT01449370|3739293|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3916181|NCT01449370|3739294|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3916182|NCT01449370|3739295|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3916183|NCT01449370|3739296|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3916184|NCT01449370|3739297|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3916185|NCT01449370|3739298|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3916186|NCT01449370|3739299|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3916187|NCT01449370|3739274|B26||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3916188|NCT01449370|3739275|B25||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3916189|NCT01449370|3739276|B24||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3916190|NCT01449370|3739277|B23||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916191|NCT01449370|3739278|B22||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916192|NCT01449370|3739279|B21||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916193|NCT01449370|3739280|B20||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916194|NCT01449370|3739281|B19||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916195|NCT01449370|3739282|B18||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916196|NCT01449370|3739283|B17||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916197|NCT01449370|3739284|B16||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916261|NCT01449370|3739296|B4||Female|Gender||Participants|Count of Participants|3|3.0||||||
3916198|NCT01449370|3739285|B15||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916199|NCT01449370|3739286|B14||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916200|NCT01449370|3739287|B13||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916201|NCT01449370|3739288|B12||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916202|NCT01449370|3739289|B11||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916203|NCT01449370|3739290|B10||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916204|NCT01449370|3739291|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916205|NCT01449370|3739292|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916206|NCT01449370|3739293|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916207|NCT01449370|3739294|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916208|NCT01449370|3739295|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916209|NCT01449370|3739296|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916210|NCT01449370|3739297|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916211|NCT01449370|3739298|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916212|NCT01449370|3739299|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916213|NCT01449370|3739274|B26||Male|Gender||Participants|Count of Participants|41|41.0||||||
3916214|NCT01449370|3739275|B25||Male|Gender||Participants|Count of Participants|2|2.0||||||
3916215|NCT01449370|3739276|B24||Male|Gender||Participants|Count of Participants|5|5.0||||||
3916216|NCT01449370|3739277|B23||Male|Gender||Participants|Count of Participants|0|0.0||||||
3916217|NCT01449370|3739278|B22||Male|Gender||Participants|Count of Participants|0|0.0||||||
3916218|NCT01449370|3739279|B21||Male|Gender||Participants|Count of Participants|2|2.0||||||
3916219|NCT01449370|3739280|B20||Male|Gender||Participants|Count of Participants|1|1.0||||||
3916220|NCT01449370|3739281|B19||Male|Gender||Participants|Count of Participants|1|1.0||||||
3916221|NCT01449370|3739282|B18||Male|Gender||Participants|Count of Participants|2|2.0||||||
3916222|NCT01449370|3739283|B17||Male|Gender||Participants|Count of Participants|2|2.0||||||
3916223|NCT01449370|3739284|B16||Male|Gender||Participants|Count of Participants|2|2.0||||||
3916224|NCT01449370|3739285|B15||Male|Gender||Participants|Count of Participants|2|2.0||||||
3916225|NCT01449370|3739286|B14||Male|Gender||Participants|Count of Participants|4|4.0||||||
3916226|NCT01449370|3739287|B13||Male|Gender||Participants|Count of Participants|0|0.0||||||
3916227|NCT01449370|3739288|B12||Male|Gender||Participants|Count of Participants|2|2.0||||||
3916228|NCT01449370|3739289|B11||Male|Gender||Participants|Count of Participants|2|2.0||||||
3916229|NCT01449370|3739290|B10||Male|Gender||Participants|Count of Participants|0|0.0||||||
3916230|NCT01449370|3739291|B9||Male|Gender||Participants|Count of Participants|3|3.0||||||
3916231|NCT01449370|3739292|B8||Male|Gender||Participants|Count of Participants|0|0.0||||||
3916232|NCT01449370|3739293|B7||Male|Gender||Participants|Count of Participants|1|1.0||||||
3916233|NCT01449370|3739294|B6||Male|Gender||Participants|Count of Participants|1|1.0||||||
3916234|NCT01449370|3739295|B5||Male|Gender||Participants|Count of Participants|1|1.0||||||
3916235|NCT01449370|3739296|B4||Male|Gender||Participants|Count of Participants|1|1.0||||||
3916236|NCT01449370|3739297|B3||Male|Gender||Participants|Count of Participants|3|3.0||||||
3916237|NCT01449370|3739298|B2||Male|Gender||Participants|Count of Participants|2|2.0||||||
3916238|NCT01449370|3739299|B1||Male|Gender||Participants|Count of Participants|2|2.0||||||
3916239|NCT01449370|3739274|B26||Female|Gender||Participants|Count of Participants|84|84.0||||||
3916240|NCT01449370|3739275|B25||Female|Gender||Participants|Count of Participants|6|6.0||||||
3916241|NCT01449370|3739276|B24||Female|Gender||Participants|Count of Participants|5|5.0||||||
3916242|NCT01449370|3739277|B23||Female|Gender||Participants|Count of Participants|4|4.0||||||
3916243|NCT01449370|3739278|B22||Female|Gender||Participants|Count of Participants|4|4.0||||||
3916244|NCT01449370|3739279|B21||Female|Gender||Participants|Count of Participants|4|4.0||||||
3916245|NCT01449370|3739280|B20||Female|Gender||Participants|Count of Participants|2|2.0||||||
3916246|NCT01449370|3739281|B19||Female|Gender||Participants|Count of Participants|2|2.0||||||
3916247|NCT01449370|3739282|B18||Female|Gender||Participants|Count of Participants|1|1.0||||||
3916248|NCT01449370|3739283|B17||Female|Gender||Participants|Count of Participants|5|5.0||||||
3916249|NCT01449370|3739284|B16||Female|Gender||Participants|Count of Participants|1|1.0||||||
3916250|NCT01449370|3739285|B15||Female|Gender||Participants|Count of Participants|1|1.0||||||
3916251|NCT01449370|3739286|B14||Female|Gender||Participants|Count of Participants|7|7.0||||||
3916252|NCT01449370|3739287|B13||Female|Gender||Participants|Count of Participants|3|3.0||||||
3916253|NCT01449370|3739288|B12||Female|Gender||Participants|Count of Participants|1|1.0||||||
3916254|NCT01449370|3739289|B11||Female|Gender||Participants|Count of Participants|1|1.0||||||
3916255|NCT01449370|3739290|B10||Female|Gender||Participants|Count of Participants|3|3.0||||||
3916256|NCT01449370|3739291|B9||Female|Gender||Participants|Count of Participants|9|9.0||||||
3916257|NCT01449370|3739292|B8||Female|Gender||Participants|Count of Participants|3|3.0||||||
3916258|NCT01449370|3739293|B7||Female|Gender||Participants|Count of Participants|2|2.0||||||
3916259|NCT01449370|3739294|B6||Female|Gender||Participants|Count of Participants|2|2.0||||||
3916260|NCT01449370|3739295|B5||Female|Gender||Participants|Count of Participants|2|2.0||||||
3916262|NCT01449370|3739297|B3||Female|Gender||Participants|Count of Participants|5|5.0||||||
3916263|NCT01449370|3739298|B2||Female|Gender||Participants|Count of Participants|4|4.0||||||
3916264|NCT01449370|3739299|B1||Female|Gender||Participants|Count of Participants|4|4.0||||||
3916265|NCT01449370|3739274|B26|||Age||years|Mean|59.4|59.4|Standard Deviation|11.89|11.89|||
3916266|NCT01449370|3739275|B25|||Age||years|Mean|59.5|59.5|Standard Deviation|10.39|10.39|||
3916267|NCT01449370|3739276|B24|||Age||years|Mean|66.0|66.0|Standard Deviation|8.71|8.71|||
3916268|NCT01449370|3739277|B23|||Age||years|Mean|60.3|60.3|Standard Deviation|11.81|11.81|||
3916269|NCT01449370|3739278|B22|||Age||years|Mean|72.5|72.5|Standard Deviation|4.65|4.65|||
3916270|NCT01449370|3739279|B21|||Age||years|Mean|61.3|61.3|Standard Deviation|13.68|13.68|||
3916271|NCT01449370|3739280|B20|||Age||years|Mean|66.7|66.7|Standard Deviation|2.52|2.52|||
3916272|NCT01449370|3739281|B19|||Age||years|Mean|53.7|53.7|Standard Deviation|1.53|1.53|||
3916273|NCT01449370|3739282|B18|||Age||years|Mean|52.7|52.7|Standard Deviation|19.76|19.76|||
3916274|NCT01449370|3739283|B17|||Age||years|Mean|61.0|61.0|Standard Deviation|11.89|11.89|||
3916275|NCT01449370|3739284|B16|||Age||years|Mean|62.7|62.7|Standard Deviation|16.17|16.17|||
3916276|NCT01449370|3739285|B15|||Age||years|Mean|65.7|65.7|Standard Deviation|12.86|12.86|||
3916277|NCT01449370|3739286|B14|||Age||years|Mean|57.4|57.4|Standard Deviation|10.88|10.88|||
3916278|NCT01449370|3739287|B13|||Age||years|Mean|55.0|55.0|Standard Deviation|9.54|9.54|||
3916279|NCT01449370|3739288|B12|||Age||years|Mean|50.0|50.0|Standard Deviation|11.53|11.53|||
3916280|NCT01449370|3739289|B11|||Age||years|Mean|64.7|64.7|Standard Deviation|18.58|18.58|||
3916281|NCT01449370|3739290|B10|||Age||years|Mean|53.3|53.3|Standard Deviation|19.40|19.4|||
3916282|NCT01449370|3739291|B9|||Age||years|Mean|56.4|56.4|Standard Deviation|13.28|13.28|||
3916283|NCT01449370|3739292|B8|||Age||years|Mean|65.0|65.0|Standard Deviation|13.11|13.11|||
3916284|NCT01449370|3739293|B7|||Age||years|Mean|54.3|54.3|Standard Deviation|12.58|12.58|||
3916285|NCT01449370|3739294|B6|||Age||years|Mean|52.7|52.7|Standard Deviation|14.01|14.01|||
3916286|NCT01449370|3739295|B5|||Age||years|Mean|56.3|56.3|Standard Deviation|17.67|17.67|||
3916287|NCT01449370|3739296|B4|||Age||years|Mean|45.3|45.3|Standard Deviation|7.27|7.27|||
3916288|NCT01449370|3739297|B3|||Age||years|Mean|59.3|59.3|Standard Deviation|9.05|9.05|||
3916289|NCT01449370|3739298|B2|||Age||years|Mean|59.0|59.0|Standard Deviation|10.88|10.88|||
3916290|NCT01449370|3739299|B1|||Age||years|Mean|64.7|64.7|Standard Deviation|9.79|9.79|||
3916291|NCT01449305|3739696|B1|Taiwan||Region of Enrollment||participants|Number|44|44.0||||||
3916292|NCT01449305|3739696|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3916293|NCT01449305|3739696|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3916294|NCT01449305|3739696|B1|||Age||years|Mean|22.4|22.4|Standard Deviation|4.2|4.2|||
3916295|NCT01449305|3739696|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3916296|NCT01449305|3739696|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3916297|NCT01449305|3739696|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3916298|NCT01449279|3739701|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3916299|NCT01449279|3739701|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3916300|NCT01449279|3739701|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3916301|NCT01449279|3739701|B1|||Age||Years|Mean|59|59.0|Full Range|||18.0|89.0|
3916302|NCT01449266|3739712|B1|Belgium||Region of Enrollment||participants|Number|10|10.0||||||
3916303|NCT01449266|3739712|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3916304|NCT01449266|3739712|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3916305|NCT01449266|3739712|B1|||Age||years|Median|64.0|64.0|Full Range|||31.0|79.0|
3916306|NCT01449266|3739712|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3916307|NCT01449266|3739712|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3916308|NCT01449266|3739712|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3916309|NCT01449240|3739719|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3916310|NCT01449240|3739719|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3916311|NCT01449240|3739719|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3916312|NCT01449240|3739719|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3916313|NCT01449240|3739719|B1||>=65 years|Age|Age (years) at CSF sample collection|Participants|Count of Participants|0|0.0||||||
3916314|NCT01449240|3739719|B1||Between 18 and 65 years|Age|Age (years) at CSF sample collection|Participants|Count of Participants|5|5.0||||||
3916315|NCT01449240|3739719|B1||<=18 years|Age|Age (years) at CSF sample collection|Participants|Count of Participants|4|4.0||||||
3916316|NCT01449240|3739719|B1|||Age|Age (years) at CSF sample collection|years|Mean|19.36|19.36|Full Range|||4.1|36.8|
3916317|NCT01449006|3739724|B3|HIV-Associated Dementia (HAD)||HAND Status||participants|Number|2|2.0||||||
3916318|NCT01449006|3739725|B2|HIV-Associated Dementia (HAD)||HAND Status||participants|Number|0|0.0||||||
3916319|NCT01449006|3739726|B1|HIV-Associated Dementia (HAD)||HAND Status||participants|Number|2|2.0||||||
3916320|NCT01449006|3739724|B3|Mild Neurocognitive Disorder (MND)||HAND Status||participants|Number|10|10.0||||||
3916321|NCT01449006|3739725|B2|Mild Neurocognitive Disorder (MND)||HAND Status||participants|Number|8|8.0||||||
3916322|NCT01449006|3739726|B1|Mild Neurocognitive Disorder (MND)||HAND Status||participants|Number|2|2.0||||||
3916323|NCT01449006|3739724|B3|Asymptomatic Neurocognitive Impairment (ANI)||HAND Status||participants|Number|2|2.0||||||
3916377|NCT01448707|3739765|B3|ITALY||Region of Enrollment||participants|Number|46|46.0||||||
3916324|NCT01449006|3739725|B2|Asymptomatic Neurocognitive Impairment (ANI)||HAND Status||participants|Number|1|1.0||||||
3916325|NCT01449006|3739726|B1|Asymptomatic Neurocognitive Impairment (ANI)||HAND Status||participants|Number|1|1.0||||||
3916326|NCT01449006|3739724|B3|||Current CD4||cells/mm3|Median|625.5|625.5|Inter-Quartile Range|||400.8|979.3|
3916327|NCT01449006|3739725|B2|||Current CD4||cells/mm3|Median|499|499.0|Inter-Quartile Range|||338.0|827.5|
3916328|NCT01449006|3739726|B1|||Current CD4||cells/mm3|Median|980|980.0|Inter-Quartile Range|||548.0|1041.0|
3916329|NCT01449006|3739724|B3|||Nadir cluster of differentiation 4 (CD4)||cells/mm3|Median|174.5|174.5|Inter-Quartile Range|||36.8|312.5|
3916330|NCT01449006|3739725|B2|||Nadir cluster of differentiation 4 (CD4)||cells/mm3|Median|150|150.0|Inter-Quartile Range|||33.5|253.5|
3916331|NCT01449006|3739726|B1|||Nadir cluster of differentiation 4 (CD4)||cells/mm3|Median|310|310.0|Inter-Quartile Range|||51.0|390.0|
3916332|NCT01449006|3739724|B3|||Premorbid intelligence quotient (IQ)|Full-scale IQ based on National Adult Reading Test (NART) error score. NART is a test of reading ability that has been extensively validated for use as a proxy measure of pre-morbid intellectual functioning. Full-Scale IQ score is expressed as a Standard Score with Mean=100 and Standard Deviation=15. Values range from 69-131. Higher scores indicate better performance.|units on a scale|Mean|103|103.0|Standard Deviation|16.6|16.6|||
3916333|NCT01449006|3739725|B2|||Premorbid intelligence quotient (IQ)|Full-scale IQ based on National Adult Reading Test (NART) error score. NART is a test of reading ability that has been extensively validated for use as a proxy measure of pre-morbid intellectual functioning. Full-Scale IQ score is expressed as a Standard Score with Mean=100 and Standard Deviation=15. Values range from 69-131. Higher scores indicate better performance.|units on a scale|Mean|102.2|102.2|Standard Deviation|16.3|16.3|||
3916334|NCT01449006|3739726|B1|||Premorbid intelligence quotient (IQ)|Full-scale IQ based on National Adult Reading Test (NART) error score. NART is a test of reading ability that has been extensively validated for use as a proxy measure of pre-morbid intellectual functioning. Full-Scale IQ score is expressed as a Standard Score with Mean=100 and Standard Deviation=15. Values range from 69-131. Higher scores indicate better performance.|units on a scale|Mean|104.4|104.4|Standard Deviation|18.9|18.9|||
3916335|NCT01449006|3739724|B3|||Education||years|Mean|12.1|12.1|Standard Deviation|2.6|2.6|||
3916336|NCT01449006|3739725|B2|||Education||years|Mean|12.3|12.3|Standard Deviation|2.8|2.8|||
3916337|NCT01449006|3739726|B1|||Education||years|Mean|11.6|11.6|Standard Deviation|2.3|2.3|||
3916338|NCT01449006|3739724|B3|Australia||Region of Enrollment||participants|Number|14|14.0||||||
3916339|NCT01449006|3739725|B2|Australia||Region of Enrollment||participants|Number|9|9.0||||||
3916340|NCT01449006|3739726|B1|Australia||Region of Enrollment||participants|Number|5|5.0||||||
3916341|NCT01449006|3739724|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3916342|NCT01449006|3739725|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3916343|NCT01449006|3739726|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3916344|NCT01449006|3739724|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3916345|NCT01449006|3739725|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3916346|NCT01449006|3739726|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3916347|NCT01449006|3739724|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3916348|NCT01449006|3739725|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3916349|NCT01449006|3739726|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3916350|NCT01449006|3739724|B3|||Age||years|Mean|55|55.0|Standard Deviation|7.1|7.1|||
3916351|NCT01449006|3739725|B2|||Age||years|Mean|52.2|52.2|Standard Deviation|3.7|3.7|||
3916352|NCT01449006|3739726|B1|||Age||years|Mean|60|60.0|Standard Deviation|9.4|9.4|||
3916353|NCT01448850|3739739|B3||Male|Gender||Participants|Count of Participants|220|220.0||||||
3916354|NCT01448850|3739740|B2||Male|Gender||Participants|Count of Participants|110|110.0||||||
3916355|NCT01448850|3739741|B1||Male|Gender||Participants|Count of Participants|110|110.0||||||
3916356|NCT01448850|3739739|B3||Female|Gender||Participants|Count of Participants|104|104.0||||||
3916357|NCT01448850|3739740|B2||Female|Gender||Participants|Count of Participants|50|50.0||||||
3916358|NCT01448850|3739741|B1||Female|Gender||Participants|Count of Participants|54|54.0||||||
3916359|NCT01448850|3739739|B3|||Age||years|Mean|62.9|62.9|Standard Deviation|6.8|6.8|||
3916360|NCT01448850|3739740|B2|||Age||years|Mean|62.8|62.8|Standard Deviation|6.7|6.7|||
3916361|NCT01448850|3739741|B1|||Age||years|Mean|63.0|63.0|Standard Deviation|6.8|6.8|||
3916362|NCT01448707|3739765|B3|UNITED KINGDOM||Region of Enrollment||participants|Number|36|36.0||||||
3916363|NCT01448707|3739766|B2|UNITED KINGDOM||Region of Enrollment||participants|Number|18|18.0||||||
3916364|NCT01448707|3739767|B1|UNITED KINGDOM||Region of Enrollment||participants|Number|18|18.0||||||
3916365|NCT01448707|3739765|B3|SWITZERLAND||Region of Enrollment||participants|Number|15|15.0||||||
3916366|NCT01448707|3739766|B2|SWITZERLAND||Region of Enrollment||participants|Number|5|5.0||||||
3916367|NCT01448707|3739767|B1|SWITZERLAND||Region of Enrollment||participants|Number|10|10.0||||||
3916368|NCT01448707|3739765|B3|SWEDEN||Region of Enrollment||participants|Number|7|7.0||||||
3916369|NCT01448707|3739766|B2|SWEDEN||Region of Enrollment||participants|Number|4|4.0||||||
3916370|NCT01448707|3739767|B1|SWEDEN||Region of Enrollment||participants|Number|3|3.0||||||
3916371|NCT01448707|3739765|B3|SPAIN||Region of Enrollment||participants|Number|40|40.0||||||
3916372|NCT01448707|3739766|B2|SPAIN||Region of Enrollment||participants|Number|23|23.0||||||
3916373|NCT01448707|3739767|B1|SPAIN||Region of Enrollment||participants|Number|17|17.0||||||
3916374|NCT01448707|3739765|B3|POLAND||Region of Enrollment||participants|Number|13|13.0||||||
3916375|NCT01448707|3739766|B2|POLAND||Region of Enrollment||participants|Number|6|6.0||||||
3916376|NCT01448707|3739767|B1|POLAND||Region of Enrollment||participants|Number|7|7.0||||||
3916378|NCT01448707|3739766|B2|ITALY||Region of Enrollment||participants|Number|24|24.0||||||
3916379|NCT01448707|3739767|B1|ITALY||Region of Enrollment||participants|Number|22|22.0||||||
3916380|NCT01448707|3739765|B3|ISRAEL||Region of Enrollment||participants|Number|10|10.0||||||
3916381|NCT01448707|3739766|B2|ISRAEL||Region of Enrollment||participants|Number|5|5.0||||||
3916382|NCT01448707|3739767|B1|ISRAEL||Region of Enrollment||participants|Number|5|5.0||||||
3916383|NCT01448707|3739765|B3|IRELAND||Region of Enrollment||participants|Number|8|8.0||||||
3916384|NCT01448707|3739766|B2|IRELAND||Region of Enrollment||participants|Number|5|5.0||||||
3916385|NCT01448707|3739767|B1|IRELAND||Region of Enrollment||participants|Number|3|3.0||||||
3916386|NCT01448707|3739765|B3|HUNGARY||Region of Enrollment||participants|Number|8|8.0||||||
3916387|NCT01448707|3739766|B2|HUNGARY||Region of Enrollment||participants|Number|3|3.0||||||
3916388|NCT01448707|3739767|B1|HUNGARY||Region of Enrollment||participants|Number|5|5.0||||||
3916389|NCT01448707|3739765|B3|GERMANY||Region of Enrollment||participants|Number|22|22.0||||||
3916390|NCT01448707|3739766|B2|GERMANY||Region of Enrollment||participants|Number|11|11.0||||||
3916391|NCT01448707|3739767|B1|GERMANY||Region of Enrollment||participants|Number|11|11.0||||||
3916392|NCT01448707|3739765|B3|FRANCE||Region of Enrollment||participants|Number|28|28.0||||||
3916393|NCT01448707|3739766|B2|FRANCE||Region of Enrollment||participants|Number|12|12.0||||||
3916394|NCT01448707|3739767|B1|FRANCE||Region of Enrollment||participants|Number|16|16.0||||||
3916395|NCT01448707|3739765|B3|DENMARK||Region of Enrollment||participants|Number|15|15.0||||||
3916396|NCT01448707|3739766|B2|DENMARK||Region of Enrollment||participants|Number|7|7.0||||||
3916397|NCT01448707|3739767|B1|DENMARK||Region of Enrollment||participants|Number|8|8.0||||||
3916398|NCT01448707|3739765|B3|BELGIUM||Region of Enrollment||participants|Number|15|15.0||||||
3916399|NCT01448707|3739766|B2|BELGIUM||Region of Enrollment||participants|Number|8|8.0||||||
3916400|NCT01448707|3739767|B1|BELGIUM||Region of Enrollment||participants|Number|7|7.0||||||
3916401|NCT01448707|3739765|B3|AUSTRIA||Region of Enrollment||participants|Number|10|10.0||||||
3916402|NCT01448707|3739766|B2|AUSTRIA||Region of Enrollment||participants|Number|5|5.0||||||
3916403|NCT01448707|3739767|B1|AUSTRIA||Region of Enrollment||participants|Number|5|5.0||||||
3916404|NCT01448707|3739765|B3||Male|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
3916405|NCT01448707|3739766|B2||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3916406|NCT01448707|3739767|B1||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3916407|NCT01448707|3739765|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3916408|NCT01448707|3739766|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3916409|NCT01448707|3739767|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3916410|NCT01448707|3739765|B3|||Age||years|Mean|43.9|43.9|Standard Deviation|10.82|10.82|||
3916411|NCT01448707|3739766|B2|||Age||years|Mean|43.1|43.1|Standard Deviation|10.41|10.41|||
3916412|NCT01448707|3739767|B1|||Age||years|Mean|44.6|44.6|Standard Deviation|11.21|11.21|||
3916413|NCT01448616|3739786|B4|United States||Region of Enrollment||participants|Number|64|64.0||||||
3916414|NCT01448616|3739787|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
3916415|NCT01448616|3739788|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
3916416|NCT01448616|3739789|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3916417|NCT01448616|3739786|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3916418|NCT01448616|3739787|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3916419|NCT01448616|3739788|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3916420|NCT01448616|3739789|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3916421|NCT01448616|3739786|B4||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3916422|NCT01448616|3739787|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3916423|NCT01448616|3739788|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3916424|NCT01448616|3739789|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3916425|NCT01448616|3739786|B4|||Age||years|Median|37.3|37.3|Full Range|||20.8|50.7|
3916426|NCT01448616|3739787|B3|||Age||years|Median|41.0|41.0|Full Range|||19.2|48.7|
3916427|NCT01448616|3739788|B2|||Age||years|Median|36.7|36.7|Full Range|||21.1|50.7|
3916428|NCT01448616|3739789|B1|||Age||years|Median|39.1|39.1|Full Range|||20.8|50.8|
3916429|NCT01448616|3739786|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3916430|NCT01448616|3739787|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3916431|NCT01448616|3739788|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3916432|NCT01448616|3739789|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3916433|NCT01448616|3739786|B4||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
3916434|NCT01448616|3739787|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3916435|NCT01448616|3739788|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3916436|NCT01448616|3739789|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3916437|NCT01448616|3739786|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3916438|NCT01448616|3739787|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3916439|NCT01448616|3739788|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3916440|NCT01448616|3739789|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3916441|NCT01448525|3739810|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3916442|NCT01448525|3739811|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3916443|NCT01448525|3739812|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3916444|NCT01448525|3739810|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3916445|NCT01448525|3739811|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3916446|NCT01448525|3739812|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3916447|NCT01448525|3739810|B3|||Age||Years|Mean|49.7|49.7|Standard Deviation|11.5|11.5|||
3916448|NCT01448525|3739811|B2|||Age||Years|Mean|50.2|50.2|Standard Deviation|10.5|10.5|||
3916449|NCT01448525|3739812|B1|||Age||Years|Mean|49.2|49.2|Standard Deviation|12.6|12.6|||
3916450|NCT01448486|3739821|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3916451|NCT01448486|3739822|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3916452|NCT01448486|3739823|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3916453|NCT01448486|3739821|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3916454|NCT01448486|3739822|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3916455|NCT01448486|3739823|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3916456|NCT01448486|3739821|B3|||Age||years|Mean|55.7|55.7|Standard Deviation|7.5|7.5|||
3916457|NCT01448486|3739822|B2|||Age||years|Mean|59.3|59.3|Standard Deviation|4.9|4.9|||
3916458|NCT01448486|3739823|B1|||Age||years|Mean|52.0|52.0|Standard Deviation|8.7|8.7|||
3916459|NCT01448486|3739821|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3916460|NCT01448486|3739822|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3916461|NCT01448486|3739823|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3916462|NCT01448486|3739821|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3916463|NCT01448486|3739822|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3916464|NCT01448486|3739823|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3916465|NCT01448486|3739821|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3916466|NCT01448486|3739822|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3916467|NCT01448486|3739823|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3916468|NCT01448356|3739832|B1|Singapore||Region of Enrollment||participants|Number|10|10.0||||||
3916469|NCT01448356|3739832|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3916470|NCT01448356|3739832|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3916471|NCT01448356|3739832|B1|||Age||years|Mean|20.4|20.4|Standard Deviation|1.3|1.3|||
3916472|NCT01448356|3739832|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3916473|NCT01448356|3739832|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3916474|NCT01448356|3739832|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3916475|NCT01448213|3739837|B3||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3916476|NCT01448213|3739838|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3916477|NCT01448213|3739839|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3916478|NCT01448213|3739837|B3||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
3916479|NCT01448213|3739838|B2||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3916480|NCT01448213|3739839|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3916481|NCT01448213|3739837|B3|||Age||years|Median|68|68.0|Full Range|||35.0|94.0|
3916482|NCT01448213|3739838|B2|||Age||years|Median|67|67.0|Full Range|||42.0|94.0|
3916483|NCT01448213|3739839|B1|||Age||years|Median|69|69.0|Full Range|||35.0|91.0|
3916484|NCT01448057|3739848|B3|Brazil||Region of Enrollment||participants|Number|341|341.0||||||
3916485|NCT01448057|3739849|B2|Brazil||Region of Enrollment||participants|Number|171|171.0||||||
3916486|NCT01448057|3739850|B1|Brazil||Region of Enrollment||participants|Number|170|170.0||||||
3916487|NCT01448057|3739848|B3||Male|Gender||Participants|Count of Participants|85|85.0||||||
3916488|NCT01448057|3739849|B2||Male|Gender||Participants|Count of Participants|37|37.0||||||
3916489|NCT01448057|3739850|B1||Male|Gender||Participants|Count of Participants|48|48.0||||||
3916490|NCT01448057|3739848|B3||Female|Gender||Participants|Count of Participants|256|256.0||||||
3916491|NCT01448057|3739849|B2||Female|Gender||Participants|Count of Participants|134|134.0||||||
3916492|NCT01448057|3739850|B1||Female|Gender||Participants|Count of Participants|122|122.0||||||
3916493|NCT01448057|3739848|B3|||Age||years|Mean|35.3|35.3|Standard Deviation|11.71|11.71|||
3916494|NCT01448057|3739849|B2|||Age||years|Mean|34.5|34.5|Standard Deviation|11.76|11.76|||
3916495|NCT01448057|3739850|B1|||Age||years|Mean|36|36.0|Standard Deviation|11.64|11.64|||
3916496|NCT01448057|3739848|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3916497|NCT01448057|3739849|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3916498|NCT01448057|3739850|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3916499|NCT01448057|3739848|B3||Between 18 and 65 years|Age||Participants|Count of Participants|341|341.0||||||
3916500|NCT01448057|3739849|B2||Between 18 and 65 years|Age||Participants|Count of Participants|171|171.0||||||
3916501|NCT01448057|3739850|B1||Between 18 and 65 years|Age||Participants|Count of Participants|170|170.0||||||
3916502|NCT01448057|3739848|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3916503|NCT01448057|3739849|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3916504|NCT01448057|3739850|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3916505|NCT01448044|3739859|B3||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3916506|NCT01448044|3739860|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3916507|NCT01448044|3739861|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3916508|NCT01448044|3739859|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3916509|NCT01448044|3739860|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3916510|NCT01448044|3739861|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3916511|NCT01448044|3739859|B3|>= 65 years||Age, Customized||participants|Number|3|3.0||||||
3916512|NCT01448044|3739860|B2|>= 65 years||Age, Customized||participants|Number|0|0.0||||||
3916513|NCT01448044|3739861|B1|>= 65 years||Age, Customized||participants|Number|3|3.0||||||
3916514|NCT01448044|3739859|B3|21 to < 65 years||Age, Customized||participants|Number|120|120.0||||||
3916515|NCT01448044|3739860|B2|21 to < 65 years||Age, Customized||participants|Number|42|42.0||||||
3916516|NCT01448044|3739861|B1|21 to < 65 years||Age, Customized||participants|Number|78|78.0||||||
3916517|NCT01448044|3739859|B3|< 21 years||Age, Customized||participants|Number|1|1.0||||||
3916518|NCT01448044|3739860|B2|< 21 years||Age, Customized||participants|Number|0|0.0||||||
3916519|NCT01448044|3739861|B1|< 21 years||Age, Customized||participants|Number|1|1.0||||||
3916520|NCT01448044|3739859|B3|||Age||years|Mean|48.0|48.0|Standard Deviation|9.53|9.53|||
3916521|NCT01448044|3739860|B2|||Age||years|Mean|48.4|48.4|Standard Deviation|8.09|8.09|||
3916522|NCT01448044|3739861|B1|||Age||years|Mean|47.7|47.7|Standard Deviation|10.23|10.23|||
3916523|NCT01447927|3739876|B3|No Regular Use||Non-steroidal anti-inflammatory drug (NSAID) use||participants|Number|57|57.0||||||
3916524|NCT01447927|3739877|B2|No Regular Use||Non-steroidal anti-inflammatory drug (NSAID) use||participants|Number|28|28.0||||||
3916525|NCT01447927|3739878|B1|No Regular Use||Non-steroidal anti-inflammatory drug (NSAID) use||participants|Number|29|29.0||||||
3916526|NCT01447927|3739876|B3|Regular Use||Non-steroidal anti-inflammatory drug (NSAID) use||participants|Number|17|17.0||||||
3916527|NCT01447927|3739877|B2|Regular Use||Non-steroidal anti-inflammatory drug (NSAID) use||participants|Number|8|8.0||||||
3916528|NCT01447927|3739878|B1|Regular Use||Non-steroidal anti-inflammatory drug (NSAID) use||participants|Number|9|9.0||||||
3916529|NCT01447927|3739876|B3|>=5 cm of circumferential involvement||Length of Barrett's segment||participants|Number|52|52.0||||||
3916530|NCT01447927|3739877|B2|>=5 cm of circumferential involvement||Length of Barrett's segment||participants|Number|25|25.0||||||
3916531|NCT01447927|3739878|B1|>=5 cm of circumferential involvement||Length of Barrett's segment||participants|Number|27|27.0||||||
3916532|NCT01447927|3739876|B3|<5 cm of circumferential involvement||Length of Barrett's segment||participants|Number|22|22.0||||||
3916533|NCT01447927|3739877|B2|<5 cm of circumferential involvement||Length of Barrett's segment||participants|Number|11|11.0||||||
3916534|NCT01447927|3739878|B1|<5 cm of circumferential involvement||Length of Barrett's segment||participants|Number|11|11.0||||||
3916535|NCT01447927|3739876|B3|||Body Mass Index||kg/m^2|Median|30.0|30.0|Full Range|||20.2|52.0|
3916536|NCT01447927|3739877|B2|||Body Mass Index||kg/m^2|Median|29.9|29.9|Full Range|||20.2|52.0|
3916537|NCT01447927|3739878|B1|||Body Mass Index||kg/m^2|Median|30.1|30.1|Full Range|||22.3|44.5|
3916538|NCT01447927|3739876|B3|1-Ambulatory, restricted strenuous activity||Performance Score|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|2|2.0||||||
3916539|NCT01447927|3739877|B2|1-Ambulatory, restricted strenuous activity||Performance Score|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|1|1.0||||||
3916540|NCT01447927|3739878|B1|1-Ambulatory, restricted strenuous activity||Performance Score|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|1|1.0||||||
3916541|NCT01447927|3739876|B3|0-Fully active||Performance Score|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|72|72.0||||||
3916542|NCT01447927|3739877|B2|0-Fully active||Performance Score|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|35|35.0||||||
3916543|NCT01447927|3739878|B1|0-Fully active||Performance Score|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|37|37.0||||||
3916544|NCT01447927|3739876|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3916545|NCT01447927|3739877|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3916546|NCT01447927|3739878|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3916547|NCT01447927|3739876|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3916548|NCT01447927|3739877|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3916549|NCT01447927|3739878|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3916550|NCT01447927|3739876|B3|||Age||years|Median|60.5|60.5|Full Range|||20.0|81.0|
3916551|NCT01447927|3739877|B2|||Age||years|Median|60.5|60.5|Full Range|||39.0|79.0|
3916552|NCT01447927|3739878|B1|||Age||years|Median|60.5|60.5|Full Range|||20.0|81.0|
3916553|NCT01447914|3739887|B1|No Prior SCT||Prior Stem Cell Transplantation (SCT)|Number of participants who had or did not have SCT procedures prior beginning study.|participants|Number|6|6.0||||||
3916554|NCT01447914|3739887|B1|Prior SCT||Prior Stem Cell Transplantation (SCT)|Number of participants who had or did not have SCT procedures prior beginning study.|participants|Number|10|10.0||||||
3916555|NCT01447914|3739887|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3916556|NCT01447914|3739887|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916557|NCT01447914|3739887|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916558|NCT01447914|3739887|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3916559|NCT01447914|3739887|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3916560|NCT01447914|3739887|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916561|NCT01447914|3739887|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3916562|NCT01447914|3739887|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916563|NCT01447914|3739887|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916564|NCT01447914|3739887|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3916565|NCT01447914|3739887|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3916566|NCT01447914|3739887|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3916567|NCT01447914|3739887|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3916568|NCT01447914|3739887|B1|||Age||years|Mean|66.3|66.3|Full Range|||49.0|76.0|
3916569|NCT01447849|3739892|B5|United States||Region of Enrollment||participants|Number|40|40.0||||||
3916570|NCT01447849|3739893|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
3916571|NCT01447849|3739894|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3916572|NCT01447849|3739895|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3916573|NCT01447849|3739896|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3916574|NCT01447849|3739892|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3916575|NCT01447849|3739893|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3916576|NCT01447849|3739894|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3916577|NCT01447849|3739895|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3916578|NCT01447849|3739896|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3916579|NCT01447849|3739892|B5||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3916580|NCT01447849|3739893|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3916581|NCT01447849|3739894|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3916582|NCT01447849|3739895|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3916583|NCT01447849|3739896|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3916584|NCT01447849|3739892|B5|||Age||years|Mean|40|40.0|Standard Deviation|17|17.0|||
3916585|NCT01447849|3739893|B4|||Age||years|Mean|42|42.0|Standard Deviation|18|18.0|||
3916586|NCT01447849|3739894|B3|||Age||years|Mean|42|42.0|Standard Deviation|18|18.0|||
3916587|NCT01447849|3739895|B2|||Age||years|Mean|37|37.0|Standard Deviation|16|16.0|||
3916588|NCT01447849|3739896|B1|||Age||years|Mean|37|37.0|Standard Deviation|16|16.0|||
3916589|NCT01447849|3739892|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3916590|NCT01447849|3739893|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3916591|NCT01447849|3739894|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3916592|NCT01447849|3739895|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3916593|NCT01447849|3739896|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3916594|NCT01447849|3739892|B5||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3916595|NCT01447849|3739893|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3916596|NCT01447849|3739894|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3916597|NCT01447849|3739895|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3916598|NCT01447849|3739896|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3916599|NCT01447849|3739892|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3916600|NCT01447849|3739893|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3916601|NCT01447849|3739894|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3916602|NCT01447849|3739895|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3916603|NCT01447849|3739896|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3916604|NCT01447719|3739909|B1|Mild cognitive impairment||Baseline clinical diagnosis||participants|Number|5|5.0||||||
3916605|NCT01447719|3739909|B1|No history of cognitive impairment||Baseline clinical diagnosis||participants|Number|12|12.0||||||
3916606|NCT01447719|3739909|B1|Other dementing disorder||Baseline clinical diagnosis||participants|Number|13|13.0||||||
3916607|NCT01447719|3739909|B1|AD diagnosis||Baseline clinical diagnosis||participants|Number|29|29.0||||||
3916608|NCT01447719|3739909|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
3916609|NCT01447719|3739909|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3916610|NCT01447719|3739909|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3916611|NCT01447719|3739909|B1|||Age||years|Mean|79.4|79.4|Standard Deviation|12.64|12.64|||
3916612|NCT01447706|3739920|B3|Data Not Reported||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3916613|NCT01447706|3739921|B2|Data Not Reported||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3916614|NCT01447706|3739922|B1|Data Not Reported||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3916615|NCT01447706|3739920|B3|Other||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3916616|NCT01447706|3739921|B2|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3916617|NCT01447706|3739922|B1|Other||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3916618|NCT01447706|3739920|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916619|NCT01447706|3739921|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916620|NCT01447706|3739922|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916621|NCT01447706|3739920|B3|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3916622|NCT01447706|3739921|B2|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3916623|NCT01447706|3739922|B1|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3916624|NCT01447706|3739920|B3|Alaska Native or American Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916625|NCT01447706|3739921|B2|Alaska Native or American Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916626|NCT01447706|3739922|B1|Alaska Native or American Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3916627|NCT01447706|3739920|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3916628|NCT01447706|3739921|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3916629|NCT01447706|3739922|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3916630|NCT01447706|3739920|B3|White/Caucasian||Race/Ethnicity, Customized||participants|Number|177|177.0||||||
3916631|NCT01447706|3739921|B2|White/Caucasian||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
3916632|NCT01447706|3739922|B1|White/Caucasian||Race/Ethnicity, Customized||participants|Number|111|111.0||||||
3916633|NCT01447706|3739920|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3916634|NCT01447706|3739921|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3916635|NCT01447706|3739922|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3916636|NCT01447706|3739920|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|169|169.0||||||
3916637|NCT01447706|3739921|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3916638|NCT01447706|3739922|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
3916639|NCT01447706|3739920|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3916640|NCT01447706|3739921|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3916641|NCT01447706|3739922|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3916642|NCT01447706|3739920|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3916643|NCT01447706|3739921|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3916644|NCT01447706|3739922|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3916645|NCT01447706|3739920|B3||Female|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
3916646|NCT01447706|3739921|B2||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3916647|NCT01447706|3739922|B1||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3916648|NCT01447706|3739920|B3|||Age||years|Mean|59.6|59.6|Standard Deviation|11.19|11.19|||
3916649|NCT01447706|3739921|B2|||Age||years|Mean|60.6|60.6|Standard Deviation|11.85|11.85|||
3916650|NCT01447706|3739922|B1|||Age||years|Mean|58.5|58.5|Standard Deviation|10.53|10.53|||
3916651|NCT01447576|3739935|B1||Male|Sex: Female, Male||Participants|Count of Participants|334|334.0||||||
3916652|NCT01447576|3739935|B1||Female|Sex: Female, Male||Participants|Count of Participants|702|702.0||||||
3916653|NCT01447576|3739935|B1|||Age||Years|Mean|44.0|44.0|Standard Deviation|11.0|11.0|||
3916654|NCT01447511|3739941|B6|United States||Region of Enrollment||participants|Number|29|29.0||||||
3916655|NCT01447511|3739942|B5|United States||Region of Enrollment||participants|Number|4|4.0||||||
3916656|NCT01447511|3739943|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
3916657|NCT01447511|3739944|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
3916658|NCT01447511|3739945|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3916659|NCT01447511|3739946|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3916660|NCT01447511|3739941|B6||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3916661|NCT01447511|3739942|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3916662|NCT01447511|3739943|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3916663|NCT01447511|3739944|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3916664|NCT01447511|3739945|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3916665|NCT01447511|3739946|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3916666|NCT01447511|3739941|B6||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3916667|NCT01447511|3739942|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3916668|NCT01447511|3739943|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3916669|NCT01447511|3739944|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3916670|NCT01447511|3739945|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3916671|NCT01447511|3739946|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3916672|NCT01447511|3739941|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3916673|NCT01447511|3739942|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3916674|NCT01447511|3739943|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3916675|NCT01447511|3739944|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3916676|NCT01447511|3739945|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3916677|NCT01447511|3739946|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3916678|NCT01447511|3739941|B6||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3916679|NCT01447511|3739942|B5||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3916680|NCT01447511|3739943|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3916681|NCT01447511|3739944|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3916682|NCT01447511|3739945|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3916683|NCT01447511|3739946|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3916684|NCT01447511|3739941|B6||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3916685|NCT01447511|3739942|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3916686|NCT01447511|3739943|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3916687|NCT01447511|3739944|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3916688|NCT01447511|3739945|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3916689|NCT01447511|3739946|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3916690|NCT01447511|3739941|B6|||Age||years|Median|25|25.0|Full Range|||18.0|54.0|
3916691|NCT01447511|3739942|B5|||Age||years|Median|29|29.0|Full Range|||19.0|33.0|
3916692|NCT01447511|3739943|B4|||Age||years|Median|28|28.0|Full Range|||21.0|51.0|
3916693|NCT01447511|3739944|B3|||Age||years|Median|26|26.0|Full Range|||18.0|52.0|
3916694|NCT01447511|3739945|B2|||Age||years|Median|23|23.0|Full Range|||22.0|31.0|
3916695|NCT01447511|3739946|B1|||Age||years|Median|22|22.0|Full Range|||19.0|54.0|
3916696|NCT01447446|3739962|B7||Male|Sex: Female, Male||Participants|Count of Participants|2421|2421.0||||||
3916697|NCT01447446|3739963|B6||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3916698|NCT01447446|3739964|B5||Male|Sex: Female, Male||Participants|Count of Participants|490|490.0||||||
3916699|NCT01447446|3739965|B4||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3916700|NCT01447446|3739966|B3||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3916701|NCT01447446|3739967|B2||Male|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
3916702|NCT01447446|3739968|B1||Male|Sex: Female, Male||Participants|Count of Participants|1402|1402.0||||||
3916703|NCT01447446|3739962|B7||Female|Sex: Female, Male||Participants|Count of Participants|1679|1679.0||||||
3916704|NCT01447446|3739963|B6||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3916705|NCT01447446|3739964|B5||Female|Sex: Female, Male||Participants|Count of Participants|331|331.0||||||
3916706|NCT01447446|3739965|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3916707|NCT01447446|3739966|B3||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3916708|NCT01447446|3739967|B2||Female|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
3916709|NCT01447446|3739968|B1||Female|Sex: Female, Male||Participants|Count of Participants|910|910.0||||||
3916710|NCT01447446|3739962|B7|Greater (>) 45 years||Age, Customized||participants|Number|2643|2643.0||||||
3916711|NCT01447446|3739963|B6|Greater (>) 45 years||Age, Customized||participants|Number|72|72.0||||||
3916712|NCT01447446|3739964|B5|Greater (>) 45 years||Age, Customized||participants|Number|637|637.0||||||
3916713|NCT01447446|3739965|B4|Greater (>) 45 years||Age, Customized||participants|Number|72|72.0||||||
3916714|NCT01447446|3739966|B3|Greater (>) 45 years||Age, Customized||participants|Number|219|219.0||||||
3916715|NCT01447446|3739967|B2|Greater (>) 45 years||Age, Customized||participants|Number|318|318.0||||||
3916716|NCT01447446|3739968|B1|Greater (>) 45 years||Age, Customized||participants|Number|1325|1325.0||||||
3916717|NCT01447446|3739962|B7|Less Than or Equal to (<=) 45 Years||Age, Customized||participants|Number|1457|1457.0||||||
3916718|NCT01447446|3739963|B6|Less Than or Equal to (<=) 45 Years||Age, Customized||participants|Number|14|14.0||||||
3916719|NCT01447446|3739964|B5|Less Than or Equal to (<=) 45 Years||Age, Customized||participants|Number|184|184.0||||||
3916720|NCT01447446|3739965|B4|Less Than or Equal to (<=) 45 Years||Age, Customized||participants|Number|21|21.0||||||
3916721|NCT01447446|3739966|B3|Less Than or Equal to (<=) 45 Years||Age, Customized||participants|Number|73|73.0||||||
3916722|NCT01447446|3739967|B2|Less Than or Equal to (<=) 45 Years||Age, Customized||participants|Number|178|178.0||||||
3916723|NCT01447446|3739968|B1|Less Than or Equal to (<=) 45 Years||Age, Customized||participants|Number|987|987.0||||||
3916724|NCT01447433|3740061|B3|China||Region of Enrollment||participants|Number|53|53.0||||||
3916725|NCT01447433|3740062|B2|China||Region of Enrollment||participants|Number|27|27.0||||||
3916726|NCT01447433|3740063|B1|China||Region of Enrollment||participants|Number|26|26.0||||||
3916727|NCT01447433|3740061|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3916728|NCT01447433|3740062|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3916729|NCT01447433|3740063|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3916730|NCT01447433|3740061|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3916731|NCT01447433|3740062|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3916732|NCT01447433|3740063|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3916733|NCT01447433|3740061|B3|||Age||years|Mean|20.3|20.3|Standard Deviation|1.1|1.1|||
3916734|NCT01447433|3740062|B2|||Age||years|Mean|20.4|20.4|Standard Deviation|0.8|0.8|||
3916735|NCT01447433|3740063|B1|||Age||years|Mean|20.3|20.3|Standard Deviation|1.4|1.4|||
3916736|NCT01447433|3740061|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3916737|NCT01447433|3740062|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3916738|NCT01447433|3740063|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3916739|NCT01447433|3740061|B3||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
3916740|NCT01447433|3740062|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3916741|NCT01447433|3740063|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3916742|NCT01447433|3740061|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3916743|NCT01447433|3740062|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3916744|NCT01447433|3740063|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3916745|NCT01447420|3740088|B4||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3916746|NCT01447420|3740089|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3916747|NCT01447420|3740090|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3916748|NCT01447420|3740091|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3916749|NCT01447420|3740088|B4||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3916750|NCT01447420|3740089|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3916751|NCT01447420|3740090|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3916752|NCT01447420|3740091|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3916753|NCT01447420|3740088|B4|||Age||years|Mean|50.12|50.12|Standard Deviation|11.38|11.38|||
3916754|NCT01447420|3740089|B3|||Age||years|Mean|52.33|52.33|Standard Deviation|10.22|10.22|||
3916755|NCT01447420|3740090|B2|||Age||years|Mean|50.43|50.43|Standard Deviation|10.92|10.92|||
3916756|NCT01447420|3740091|B1|||Age||years|Mean|48.51|48.51|Standard Deviation|12.71|12.71|||
3916757|NCT01447225|3740109|B5|France||Region of Enrollment||participants|Number|9|9.0||||||
3916758|NCT01447225|3740110|B4|France||Region of Enrollment||participants|Number|3|3.0||||||
3916759|NCT01447225|3740111|B3|France||Region of Enrollment||participants|Number|3|3.0||||||
3916760|NCT01447225|3740112|B2|France||Region of Enrollment||participants|Number|0|0.0||||||
3916761|NCT01447225|3740113|B1|France||Region of Enrollment||participants|Number|3|3.0||||||
3916762|NCT01447225|3740109|B5|United States||Region of Enrollment||participants|Number|34|34.0||||||
3916763|NCT01447225|3740110|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
3916764|NCT01447225|3740111|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
3916765|NCT01447225|3740112|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3916766|NCT01447225|3740113|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3916767|NCT01447225|3740109|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916768|NCT01447225|3740110|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916769|NCT01447225|3740111|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916770|NCT01447225|3740112|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916771|NCT01447225|3740113|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916772|NCT01447225|3740109|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916773|NCT01447225|3740110|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916774|NCT01447225|3740111|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916775|NCT01447225|3740112|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916776|NCT01447225|3740113|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916777|NCT01447225|3740109|B5||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3916778|NCT01447225|3740110|B4||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3916779|NCT01447225|3740111|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3916780|NCT01447225|3740112|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3916781|NCT01447225|3740113|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3916782|NCT01447225|3740109|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916783|NCT01447225|3740110|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916784|NCT01447225|3740111|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916785|NCT01447225|3740112|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916786|NCT01447225|3740113|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916787|NCT01447225|3740109|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916788|NCT01447225|3740110|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916789|NCT01447225|3740111|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916790|NCT01447225|3740112|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916791|NCT01447225|3740113|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916792|NCT01447225|3740109|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3916793|NCT01447225|3740110|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916794|NCT01447225|3740111|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3916795|NCT01447225|3740112|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916796|NCT01447225|3740113|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916797|NCT01447225|3740109|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3916798|NCT01447225|3740110|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916799|NCT01447225|3740111|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916800|NCT01447225|3740112|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916801|NCT01447225|3740113|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3916802|NCT01447225|3740109|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916803|NCT01447225|3740110|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916804|NCT01447225|3740111|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916805|NCT01447225|3740112|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916806|NCT01447225|3740113|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916807|NCT01447225|3740109|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3916808|NCT01447225|3740110|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3916809|NCT01447225|3740111|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3916810|NCT01447225|3740112|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3916811|NCT01447225|3740113|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3916812|NCT01447225|3740109|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3916813|NCT01447225|3740110|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916814|NCT01447225|3740111|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916815|NCT01447225|3740112|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916816|NCT01447225|3740113|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3916817|NCT01447225|3740109|B5||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3916818|NCT01447225|3740110|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3916819|NCT01447225|3740111|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3916820|NCT01447225|3740112|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3916821|NCT01447225|3740113|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3916822|NCT01447225|3740109|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3916823|NCT01447225|3740110|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3916824|NCT01447225|3740111|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3916825|NCT01447225|3740112|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3916826|NCT01447225|3740113|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3916827|NCT01447225|3740109|B5|||Age||years|Mean|61.28|61.28|Standard Deviation|8.98|8.98|||
3916828|NCT01447225|3740110|B4|||Age||years|Mean|64.1|64.1|Standard Deviation|6.66|6.66|||
3916829|NCT01447225|3740111|B3|||Age||years|Mean|60.0|60.0|Standard Deviation|12.29|12.29|||
3916830|NCT01447225|3740112|B2|||Age||years|Mean|62.7|62.7|Standard Deviation|9.18|9.18|||
3916831|NCT01447225|3740113|B1|||Age||years|Mean|58.3|58.3|Standard Deviation|7.79|7.79|||
3916832|NCT01447121|3740192|B1|United States||Region of Enrollment||participants|Number|116|116.0||||||
3916833|NCT01447121|3740192|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3916834|NCT01447121|3740192|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3916835|NCT01447121|3740192|B1|||Age, Customized||years|Mean|52.3|52.3|Full Range|||18.0|79.0|
3916836|NCT01447017|3740197|B3|Sweden||Region of Enrollment||participants|Number|69|69.0||||||
3916837|NCT01447017|3740198|B2|Sweden||Region of Enrollment||participants|Number|24|24.0||||||
3916838|NCT01447017|3740199|B1|Sweden||Region of Enrollment||participants|Number|45|45.0||||||
3916839|NCT01447017|3740197|B3|Male||Gender|Based on the Full Analysis Set|participants|Number|25|25.0||||||
3916840|NCT01447017|3740198|B2|Male||Gender|Based on the Full Analysis Set|participants|Number|11|11.0||||||
3916841|NCT01447017|3740199|B1|Male||Gender|Based on the Full Analysis Set|participants|Number|14|14.0||||||
3916842|NCT01447017|3740197|B3|Female||Gender|Based on the Full Analysis Set|participants|Number|39|39.0||||||
3916843|NCT01447017|3740198|B2|Female||Gender|Based on the Full Analysis Set|participants|Number|13|13.0||||||
3916844|NCT01447017|3740199|B1|Female||Gender|Based on the Full Analysis Set|participants|Number|26|26.0||||||
3916845|NCT01447017|3740197|B3|||Age|Based on the Full Analysis Set|years|Mean|56.2|56.2|Standard Deviation|15.3|15.3|||
3916846|NCT01447017|3740198|B2|||Age|Based on the Full Analysis Set|years|Mean|58.1|58.1|Standard Deviation|12.3|12.3|||
3916847|NCT01447017|3740199|B1|||Age|Based on the Full Analysis Set|years|Mean|55.0|55.0|Standard Deviation|16.8|16.8|||
3916848|NCT01446874|3740206|B4|United States||Region of Enrollment||Participants|Count of Participants|132|132.0||||||
3916849|NCT01446874|3740207|B3|United States||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
3916850|NCT01446874|3740208|B2|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3916851|NCT01446874|3740209|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3916852|NCT01446874|3740206|B4||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3916853|NCT01446874|3740207|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3916854|NCT01446874|3740208|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3916855|NCT01446874|3740209|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3916856|NCT01446874|3740206|B4||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3916857|NCT01446874|3740207|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3916858|NCT01446874|3740208|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3916859|NCT01446874|3740209|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3916860|NCT01446874|3740206|B4|||Age||years|Median|62|62.0|Full Range|||24.0|88.0|
3916861|NCT01446874|3740207|B3|||Age||years|Median|63|63.0|Full Range|||47.0|88.0|
3916862|NCT01446874|3740208|B2|||Age||years|Median|58|58.0|Full Range|||24.0|77.0|
3916863|NCT01446874|3740209|B1|||Age||years|Median|66|66.0|Full Range|||42.0|83.0|
3916864|NCT01446796|3740237|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3916865|NCT01446796|3740237|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3916866|NCT01446796|3740237|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3916867|NCT01446796|3740237|B1|||Age||years|Mean|68|68.0|Standard Deviation|10|10.0|||
3916868|NCT01446796|3740237|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3916869|NCT01446796|3740237|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3916870|NCT01446796|3740237|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3916871|NCT01446705|3740250|B3|||Charlson Score|Charlson comorbidity index is a scoring system which assigns points to varied conditions in an effort to determine severity of medical comorbidities. It is an integer scale with a theoretical range of 0 to 43. A score of 0 would represent a healthy individual with no significant comorbidities. A score of 3 would indicate an individual with significant number of comorbidities. An individual with a score of 8 would have several sever comorbidities. Any score above 8 would be unlikely as with that many comorbidities and individual would be incapacitated.|units on a scale|Median|.73|0.73|Standard Deviation|1.5|1.5|||
3916872|NCT01446705|3740251|B2|||Charlson Score|Charlson comorbidity index is a scoring system which assigns points to varied conditions in an effort to determine severity of medical comorbidities. It is an integer scale with a theoretical range of 0 to 43. A score of 0 would represent a healthy individual with no significant comorbidities. A score of 3 would indicate an individual with significant number of comorbidities. An individual with a score of 8 would have several sever comorbidities. Any score above 8 would be unlikely as with that many comorbidities and individual would be incapacitated.|units on a scale|Median|1.25|1.25|Standard Deviation|1.92|1.92|||
3916873|NCT01446705|3740252|B1|||Charlson Score|Charlson comorbidity index is a scoring system which assigns points to varied conditions in an effort to determine severity of medical comorbidities. It is an integer scale with a theoretical range of 0 to 43. A score of 0 would represent a healthy individual with no significant comorbidities. A score of 3 would indicate an individual with significant number of comorbidities. An individual with a score of 8 would have several sever comorbidities. Any score above 8 would be unlikely as with that many comorbidities and individual would be incapacitated.|units on a scale|Median|.66|0.66|Standard Deviation|1.42|1.42|||
3916874|NCT01446705|3740250|B3|United States||Region of Enrollment||participants|Number|57073|57073.0||||||
3916875|NCT01446705|3740251|B2|United States||Region of Enrollment||participants|Number|6627|6627.0||||||
3916876|NCT01446705|3740252|B1|United States||Region of Enrollment||participants|Number|50446|50446.0||||||
3916877|NCT01446705|3740250|B3||Male|Sex: Female, Male||Participants|Count of Participants|52952|52952.0||||||
3916878|NCT01446705|3740251|B2||Male|Sex: Female, Male||Participants|Count of Participants|6113|6113.0||||||
3916879|NCT01446705|3740252|B1||Male|Sex: Female, Male||Participants|Count of Participants|46839|46839.0||||||
3916880|NCT01446705|3740250|B3||Female|Sex: Female, Male||Participants|Count of Participants|4121|4121.0||||||
3916881|NCT01446705|3740251|B2||Female|Sex: Female, Male||Participants|Count of Participants|514|514.0||||||
3916882|NCT01446705|3740252|B1||Female|Sex: Female, Male||Participants|Count of Participants|3607|3607.0||||||
3916883|NCT01446705|3740250|B3|||Age||years|Median|60.91|60.91|Standard Deviation|15.58|15.58|||
3916884|NCT01446705|3740251|B2|||Age||years|Median|62.17|62.17|Standard Deviation|13.98|13.98|||
3916885|NCT01446705|3740252|B1|||Age||years|Median|60.74|60.74|Standard Deviation|15.77|15.77|||
3916886|NCT01446419|3740261|B3|||Oswestry Disability Index (ODI)|ODI is a patient questionnaire that assesses back dysfunction due to back pain. There are 10 questions that are scored from 0-5. The obtained score is multiplied by 2 to produce a percentage score that is reported on a scale of 0-100. Scores are interpreted as follows: 0-20% minimum disability; 21-40% moderate disability; 41-60% severe disability; 61-80% crippled; 81-100% bed bound or exaggerating their symptoms.|units on a scale|Mean|42.2|42.2|Standard Deviation|10.63|10.63|||
3916887|NCT01446419|3740262|B2|||Oswestry Disability Index (ODI)|ODI is a patient questionnaire that assesses back dysfunction due to back pain. There are 10 questions that are scored from 0-5. The obtained score is multiplied by 2 to produce a percentage score that is reported on a scale of 0-100. Scores are interpreted as follows: 0-20% minimum disability; 21-40% moderate disability; 41-60% severe disability; 61-80% crippled; 81-100% bed bound or exaggerating their symptoms.|units on a scale|Mean|41.1|41.1|Standard Deviation|10.39|10.39|||
3916888|NCT01446419|3740263|B1|||Oswestry Disability Index (ODI)|ODI is a patient questionnaire that assesses back dysfunction due to back pain. There are 10 questions that are scored from 0-5. The obtained score is multiplied by 2 to produce a percentage score that is reported on a scale of 0-100. Scores are interpreted as follows: 0-20% minimum disability; 21-40% moderate disability; 41-60% severe disability; 61-80% crippled; 81-100% bed bound or exaggerating their symptoms.|units on a scale|Mean|42.9|42.9|Standard Deviation|10.73|10.73|||
3916889|NCT01446419|3740261|B3|Germany||Region of Enrollment||participants|Number|23|23.0||||||
3916890|NCT01446419|3740262|B2|Germany||Region of Enrollment||participants|Number|9|9.0||||||
3916891|NCT01446419|3740263|B1|Germany||Region of Enrollment||participants|Number|14|14.0||||||
3916892|NCT01446419|3740261|B3|United States||Region of Enrollment||participants|Number|202|202.0||||||
3916893|NCT01446419|3740262|B2|United States||Region of Enrollment||participants|Number|69|69.0||||||
3916894|NCT01446419|3740263|B1|United States||Region of Enrollment||participants|Number|133|133.0||||||
3917065|NCT01446042|3740414|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3916895|NCT01446419|3740261|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3916896|NCT01446419|3740262|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3916897|NCT01446419|3740263|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3916898|NCT01446419|3740261|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3916899|NCT01446419|3740262|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916900|NCT01446419|3740263|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3916901|NCT01446419|3740261|B3||White|Race (NIH/OMB)||Participants|Count of Participants|205|205.0||||||
3916902|NCT01446419|3740262|B2||White|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3916903|NCT01446419|3740263|B1||White|Race (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
3916904|NCT01446419|3740261|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3916905|NCT01446419|3740262|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3916906|NCT01446419|3740263|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3916907|NCT01446419|3740261|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916908|NCT01446419|3740262|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916909|NCT01446419|3740263|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916910|NCT01446419|3740261|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3916911|NCT01446419|3740262|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916912|NCT01446419|3740263|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3916913|NCT01446419|3740261|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3916914|NCT01446419|3740262|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3916915|NCT01446419|3740263|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916916|NCT01446419|3740261|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916917|NCT01446419|3740262|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916918|NCT01446419|3740263|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916919|NCT01446419|3740261|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|211|211.0||||||
3916920|NCT01446419|3740262|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3916921|NCT01446419|3740263|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
3916922|NCT01446419|3740261|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3916923|NCT01446419|3740262|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3916924|NCT01446419|3740263|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3916925|NCT01446419|3740261|B3||Male|Gender||Participants|Count of Participants|123|123.0||||||
3916926|NCT01446419|3740262|B2||Male|Gender||Participants|Count of Participants|41|41.0||||||
3916927|NCT01446419|3740263|B1||Male|Gender||Participants|Count of Participants|82|82.0||||||
3916928|NCT01446419|3740261|B3||Female|Gender||Participants|Count of Participants|102|102.0||||||
3916929|NCT01446419|3740262|B2||Female|Gender||Participants|Count of Participants|37|37.0||||||
3916930|NCT01446419|3740263|B1||Female|Gender||Participants|Count of Participants|65|65.0||||||
3916931|NCT01446419|3740261|B3|||Age||years|Mean|47.0|47.0|Standard Deviation|9.95|9.95|||
3916932|NCT01446419|3740262|B2|||Age||years|Mean|47.1|47.1|Standard Deviation|8.97|8.97|||
3916933|NCT01446419|3740263|B1|||Age||years|Mean|46.9|46.9|Standard Deviation|10.46|10.46|||
3916934|NCT01446419|3740261|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3916935|NCT01446419|3740262|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3916936|NCT01446419|3740263|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3916937|NCT01446419|3740261|B3||Between 18 and 65 years|Age||Participants|Count of Participants|212|212.0||||||
3916938|NCT01446419|3740262|B2||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
3916939|NCT01446419|3740263|B1||Between 18 and 65 years|Age||Participants|Count of Participants|138|138.0||||||
3916940|NCT01446419|3740261|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3916941|NCT01446419|3740262|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3916942|NCT01446419|3740263|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3916943|NCT01446289|3740274|B5|Belgium||Region of Enrollment||participants|Number|120|120.0||||||
3916944|NCT01446289|3740275|B4|Belgium||Region of Enrollment||participants|Number|24|24.0||||||
3916945|NCT01446289|3740276|B3|Belgium||Region of Enrollment||participants|Number|36|36.0||||||
3916946|NCT01446289|3740277|B2|Belgium||Region of Enrollment||participants|Number|24|24.0||||||
3916947|NCT01446289|3740278|B1|Belgium||Region of Enrollment||participants|Number|36|36.0||||||
3916948|NCT01446289|3740274|B5|Canada||Region of Enrollment||participants|Number|52|52.0||||||
3916949|NCT01446289|3740275|B4|Canada||Region of Enrollment||participants|Number|11|11.0||||||
3916950|NCT01446289|3740276|B3|Canada||Region of Enrollment||participants|Number|15|15.0||||||
3916951|NCT01446289|3740277|B2|Canada||Region of Enrollment||participants|Number|11|11.0||||||
3916952|NCT01446289|3740278|B1|Canada||Region of Enrollment||participants|Number|15|15.0||||||
3916953|NCT01446289|3740274|B5||Male|Sex: Female, Male|Analysis was done on the enrolled population.|Participants|Count of Participants|50|50.0||||||
3916954|NCT01446289|3740275|B4||Male|Sex: Female, Male|Analysis was done on the enrolled population.|Participants|Count of Participants|20|20.0||||||
3916955|NCT01446289|3740276|B3||Male|Sex: Female, Male|Analysis was done on the enrolled population.|Participants|Count of Participants|30|30.0||||||
3916956|NCT01446289|3740277|B2||Male|Sex: Female, Male|Analysis was done on the enrolled population.|Participants|Count of Participants|0|0.0||||||
3916957|NCT01446289|3740278|B1||Male|Sex: Female, Male|Analysis was done on the enrolled population.|Participants|Count of Participants|0|0.0||||||
3916958|NCT01446289|3740274|B5||Female|Sex: Female, Male|Analysis was done on the enrolled population.|Participants|Count of Participants|122|122.0||||||
3916959|NCT01446289|3740275|B4||Female|Sex: Female, Male|Analysis was done on the enrolled population.|Participants|Count of Participants|15|15.0||||||
3916960|NCT01446289|3740276|B3||Female|Sex: Female, Male|Analysis was done on the enrolled population.|Participants|Count of Participants|21|21.0||||||
3916961|NCT01446289|3740277|B2||Female|Sex: Female, Male|Analysis was done on the enrolled population.|Participants|Count of Participants|35|35.0||||||
3916962|NCT01446289|3740278|B1||Female|Sex: Female, Male|Analysis was done on the enrolled population.|Participants|Count of Participants|51|51.0||||||
3916963|NCT01446289|3740274|B5|||Age|Analysis was done on the enrolled population.|days|Mean|0|0.0|Standard Deviation|0|0.0|||
3916964|NCT01446289|3740275|B4|||Age|Analysis was done on the enrolled population.|days|Mean|0|0.0|Standard Deviation|0|0.0|||
3916965|NCT01446289|3740276|B3|||Age|Analysis was done on the enrolled population.|days|Mean|0|0.0|Standard Deviation|0|0.0|||
3916966|NCT01446289|3740277|B2|||Age|Analysis was done on the enrolled population.|days|Mean|NA||Standard Deviation|NA||||presented elsewhere
3916967|NCT01446289|3740278|B1|||Age|Analysis was done on the enrolled population.|days|Mean|NA||Standard Deviation|NA||||presented elsewhere
3916968|NCT01446289|3740274|B5|||Age|Analysis was done on the enrolled population.|years|Mean|29.8|29.8|Standard Deviation|5.1|5.1|||
3916969|NCT01446289|3740275|B4|||Age|Analysis was done on the enrolled population.|years|Mean|NA||Standard Deviation|NA||||presented elsewhere
3916970|NCT01446289|3740276|B3|||Age|Analysis was done on the enrolled population.|years|Mean|NA||Standard Deviation|NA||||presented elsewhere
3916971|NCT01446289|3740277|B2|||Age|Analysis was done on the enrolled population.|years|Mean|30|30.0|Standard Deviation|5.5|5.5|||
3916972|NCT01446289|3740278|B1|||Age|Analysis was done on the enrolled population.|years|Mean|29.7|29.7|Standard Deviation|4.9|4.9|||
3916973|NCT01446250|3740309|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
3916974|NCT01446250|3740309|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
3916975|NCT01446250|3740309|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3916976|NCT01446250|3740309|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3916977|NCT01446250|3740309|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3916978|NCT01446237|3740324|B1|Biracial||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3916979|NCT01446237|3740324|B1|American Indian or Alaska Native/Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3916980|NCT01446237|3740324|B1|American Indian or Alaska Native/Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3916981|NCT01446237|3740324|B1|White||Race/Ethnicity, Customized||Participants|Number|84|84.0||||||
3916982|NCT01446237|3740324|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3916983|NCT01446237|3740324|B1|Black||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
3916984|NCT01446237|3740324|B1|Asian||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3916985|NCT01446237|3740324|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3916986|NCT01446237|3740324|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3916987|NCT01446237|3740324|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3916988|NCT01446237|3740324|B1|||Age||Years|Mean|19.0|19.0|Standard Deviation|5.7|5.7|||
3916989|NCT01446159|3740332|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3916990|NCT01446159|3740333|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3916991|NCT01446159|3740334|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3916992|NCT01446159|3740335|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916993|NCT01446159|3740336|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916994|NCT01446159|3740332|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916995|NCT01446159|3740333|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916996|NCT01446159|3740334|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916997|NCT01446159|3740335|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916998|NCT01446159|3740336|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3916999|NCT01446159|3740332|B5||White|Race (NIH/OMB)||Participants|Count of Participants|171|171.0||||||
3917000|NCT01446159|3740333|B4||White|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3917001|NCT01446159|3740334|B3||White|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3917002|NCT01446159|3740335|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3917003|NCT01446159|3740336|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3917004|NCT01446159|3740332|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3917005|NCT01446159|3740333|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3917006|NCT01446159|3740334|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3917007|NCT01446159|3740335|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917008|NCT01446159|3740336|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3917009|NCT01446159|3740332|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917010|NCT01446159|3740333|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917011|NCT01446159|3740334|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917012|NCT01446159|3740335|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917013|NCT01446159|3740336|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917014|NCT01446159|3740332|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3917015|NCT01446159|3740333|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3917016|NCT01446159|3740334|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917017|NCT01446159|3740335|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917018|NCT01446159|3740336|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917019|NCT01446159|3740332|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917020|NCT01446159|3740333|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917021|NCT01446159|3740334|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917022|NCT01446159|3740335|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917023|NCT01446159|3740336|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917024|NCT01446159|3740332|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917025|NCT01446159|3740333|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917026|NCT01446159|3740334|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917027|NCT01446159|3740335|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917028|NCT01446159|3740336|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917029|NCT01446159|3740332|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|170|170.0||||||
3917030|NCT01446159|3740333|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3917031|NCT01446159|3740334|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3917032|NCT01446159|3740335|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3917033|NCT01446159|3740336|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3917034|NCT01446159|3740332|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3917035|NCT01446159|3740333|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3917036|NCT01446159|3740334|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3917037|NCT01446159|3740335|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917038|NCT01446159|3740336|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917039|NCT01446159|3740332|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3917040|NCT01446159|3740333|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3917041|NCT01446159|3740334|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3917042|NCT01446159|3740335|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3917043|NCT01446159|3740336|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3917044|NCT01446159|3740332|B5||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3917045|NCT01446159|3740333|B4||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3917046|NCT01446159|3740334|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3917047|NCT01446159|3740335|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3917048|NCT01446159|3740336|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3917049|NCT01446159|3740332|B5|||Age||Years|Mean|63.2|63.2|Standard Deviation|10.7|10.7|||
3917050|NCT01446159|3740333|B4|||Age||Years|Mean|63.3|63.3|Standard Deviation|11.0|11.0|||
3917051|NCT01446159|3740334|B3|||Age||Years|Mean|63.2|63.2|Standard Deviation|10.5|10.5|||
3917052|NCT01446159|3740335|B2|||Age||Years|Mean|61.0|61.0|Standard Deviation|8.7|8.7|||
3917053|NCT01446159|3740336|B1|||Age||Years|Mean|66.3|66.3|Standard Deviation|12.3|12.3|||
3917054|NCT01446042|3740411|B4|United States||Region of Enrollment||Participants|Count of Participants|306|306.0||||||
3917055|NCT01446042|3740412|B3|United States||Region of Enrollment||Participants|Count of Participants|78|78.0||||||
3917056|NCT01446042|3740413|B2|United States||Region of Enrollment||Participants|Count of Participants|86|86.0||||||
3917057|NCT01446042|3740414|B1|United States||Region of Enrollment||Participants|Count of Participants|142|142.0||||||
3917058|NCT01446042|3740411|B4||Male|Sex: Female, Male||Participants|Count of Participants|306|306.0||||||
3917059|NCT01446042|3740412|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3917060|NCT01446042|3740413|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3917061|NCT01446042|3740414|B1||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3917062|NCT01446042|3740411|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3917063|NCT01446042|3740412|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3917064|NCT01446042|3740413|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3917066|NCT01446042|3740411|B4||>=65 years|Age||Participants|Count of Participants|60|60.0||||||
3917067|NCT01446042|3740412|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3917068|NCT01446042|3740413|B2||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3917069|NCT01446042|3740414|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3917070|NCT01446042|3740411|B4||Between 18 and 65 years|Age||Participants|Count of Participants|246|246.0||||||
3917071|NCT01446042|3740412|B3||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
3917072|NCT01446042|3740413|B2||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
3917073|NCT01446042|3740414|B1||Between 18 and 65 years|Age||Participants|Count of Participants|121|121.0||||||
3917074|NCT01446042|3740411|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3917075|NCT01446042|3740412|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3917076|NCT01446042|3740413|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3917077|NCT01446042|3740414|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3917078|NCT01446003|3740427|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3917079|NCT01446003|3740427|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3917080|NCT01446003|3740427|B1|>=65 years||Age, Customized||Participants|Number|1|1.0||||||
3917081|NCT01446003|3740427|B1|Between 18 and 65 years||Age, Customized||Participants|Number|30|30.0||||||
3917082|NCT01446003|3740427|B1|||Age||Years|Mean|52.3|52.3|Standard Deviation|5.9|5.9|||
3917083|NCT01445951|3740446|B4|||HbA1c||Percent of hemoglobin|Mean|7.95|7.95|Full Range|||5.8|10.6|
3917084|NCT01445951|3740447|B3|||HbA1c||Percent of hemoglobin|Mean|7.88|7.88|Full Range|||5.8|10.1|
3917085|NCT01445951|3740448|B2|||HbA1c||Percent of hemoglobin|Mean|8.00|8.0|Full Range|||6.1|10.2|
3917086|NCT01445951|3740449|B1|||HbA1c||Percent of hemoglobin|Mean|7.98|7.98|Full Range|||6.2|10.6|
3917087|NCT01445951|3740446|B4|||Fasting Plasma Glucose||mg/dL|Mean|150.2|150.2|Full Range|||21.0|403.0|
3917088|NCT01445951|3740447|B3|||Fasting Plasma Glucose||mg/dL|Mean|151.2|151.2|Full Range|||23.0|375.0|
3917089|NCT01445951|3740448|B2|||Fasting Plasma Glucose||mg/dL|Mean|144.3|144.3|Full Range|||43.0|358.0|
3917090|NCT01445951|3740449|B1|||Fasting Plasma Glucose||mg/dL|Mean|155.0|155.0|Full Range|||21.0|403.0|
3917091|NCT01445951|3740446|B4|||BMI||kg/m^2|Mean|25.9|25.9|Full Range|||16.6|38.6|
3917092|NCT01445951|3740447|B3|||BMI||kg/m^2|Mean|25.4|25.4|Full Range|||17.4|37.2|
3917093|NCT01445951|3740448|B2|||BMI||kg/m^2|Mean|26.2|26.2|Full Range|||18.1|36.4|
3917094|NCT01445951|3740449|B1|||BMI||kg/m^2|Mean|26.0|26.0|Full Range|||16.6|38.6|
3917095|NCT01445951|3740446|B4|||Weight||kg|Mean|75.1|75.1|Full Range|||41.7|129.4|
3917096|NCT01445951|3740447|B3|||Weight||kg|Mean|72.6|72.6|Full Range|||46.6|120.2|
3917097|NCT01445951|3740448|B2|||Weight||kg|Mean|76.8|76.8|Full Range|||47.6|124.0|
3917098|NCT01445951|3740449|B1|||Weight||kg|Mean|75.7|75.7|Full Range|||41.7|129.4|
3917099|NCT01445951|3740446|B4|||Duration of Diabetes||years|Mean|16.8|16.8|Full Range|||1.0|57.3|
3917100|NCT01445951|3740447|B3|||Duration of Diabetes||years|Mean|16.7|16.7|Full Range|||1.0|42.2|
3917101|NCT01445951|3740448|B2|||Duration of Diabetes||years|Mean|17.7|17.7|Full Range|||1.1|49.5|
3917102|NCT01445951|3740449|B1|||Duration of Diabetes||years|Mean|16.0|16.0|Full Range|||1.1|57.3|
3917103|NCT01445951|3740446|B4|Russian Federation||Region of Enrollment||participants|Number|149|149.0||||||
3917104|NCT01445951|3740447|B3|Russian Federation||Region of Enrollment||participants|Number|52|52.0||||||
3917105|NCT01445951|3740448|B2|Russian Federation||Region of Enrollment||participants|Number|52|52.0||||||
3917106|NCT01445951|3740449|B1|Russian Federation||Region of Enrollment||participants|Number|45|45.0||||||
3917107|NCT01445951|3740446|B4|Ukraine||Region of Enrollment||participants|Number|120|120.0||||||
3917108|NCT01445951|3740447|B3|Ukraine||Region of Enrollment||participants|Number|38|38.0||||||
3917109|NCT01445951|3740448|B2|Ukraine||Region of Enrollment||participants|Number|38|38.0||||||
3917110|NCT01445951|3740449|B1|Ukraine||Region of Enrollment||participants|Number|44|44.0||||||
3917111|NCT01445951|3740446|B4|Brazil||Region of Enrollment||participants|Number|42|42.0||||||
3917112|NCT01445951|3740447|B3|Brazil||Region of Enrollment||participants|Number|13|13.0||||||
3917113|NCT01445951|3740448|B2|Brazil||Region of Enrollment||participants|Number|15|15.0||||||
3917114|NCT01445951|3740449|B1|Brazil||Region of Enrollment||participants|Number|14|14.0||||||
3917115|NCT01445951|3740446|B4|United States||Region of Enrollment||participants|Number|207|207.0||||||
3917116|NCT01445951|3740447|B3|United States||Region of Enrollment||participants|Number|67|67.0||||||
3917117|NCT01445951|3740448|B2|United States||Region of Enrollment||participants|Number|69|69.0||||||
3917118|NCT01445951|3740449|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
3917119|NCT01445951|3740446|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3917120|NCT01445951|3740447|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3917121|NCT01445951|3740448|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3917122|NCT01445951|3740449|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917123|NCT01445951|3740446|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917124|NCT01445951|3740447|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917125|NCT01445951|3740448|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917126|NCT01445951|3740449|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917127|NCT01445951|3740446|B4||White|Race (NIH/OMB)||Participants|Count of Participants|497|497.0||||||
3917128|NCT01445951|3740447|B3||White|Race (NIH/OMB)||Participants|Count of Participants|166|166.0||||||
3917129|NCT01445951|3740448|B2||White|Race (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
3917130|NCT01445951|3740449|B1||White|Race (NIH/OMB)||Participants|Count of Participants|164|164.0||||||
3917131|NCT01445951|3740446|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3917132|NCT01445951|3740447|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3917133|NCT01445951|3740448|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3917134|NCT01445951|3740449|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3917135|NCT01445951|3740446|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3917136|NCT01445951|3740447|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917137|NCT01445951|3740448|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917138|NCT01445951|3740449|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3917139|NCT01445951|3740446|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3917140|NCT01445951|3740447|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917141|NCT01445951|3740448|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3917142|NCT01445951|3740449|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3917143|NCT01445951|3740446|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917144|NCT01445951|3740447|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917145|NCT01445951|3740448|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917146|NCT01445951|3740449|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917147|NCT01445951|3740446|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917148|NCT01445951|3740447|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917149|NCT01445951|3740448|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917150|NCT01445951|3740449|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917151|NCT01445951|3740446|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|461|461.0||||||
3917152|NCT01445951|3740447|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|152|152.0||||||
3917153|NCT01445951|3740448|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|152|152.0||||||
3917154|NCT01445951|3740449|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|157|157.0||||||
3917155|NCT01445951|3740446|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3917156|NCT01445951|3740447|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3917157|NCT01445951|3740448|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3917158|NCT01445951|3740449|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3917159|NCT01445951|3740446|B4||Male|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
3917160|NCT01445951|3740447|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3917161|NCT01445951|3740448|B2||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3917162|NCT01445951|3740449|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3917163|NCT01445951|3740446|B4||Female|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
3917164|NCT01445951|3740447|B3||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3917165|NCT01445951|3740448|B2||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3917166|NCT01445951|3740449|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3917167|NCT01445951|3740446|B4|>= 65 years||Age, Customized||participants|Number|24|24.0||||||
3917168|NCT01445951|3740447|B3|>= 65 years||Age, Customized||participants|Number|8|8.0||||||
3917169|NCT01445951|3740448|B2|>= 65 years||Age, Customized||participants|Number|9|9.0||||||
3917170|NCT01445951|3740449|B1|>= 65 years||Age, Customized||participants|Number|7|7.0||||||
3917171|NCT01445951|3740446|B4|50-64 years||Age, Customized||participants|Number|79|79.0||||||
3917172|NCT01445951|3740447|B3|50-64 years||Age, Customized||participants|Number|28|28.0||||||
3917173|NCT01445951|3740448|B2|50-64 years||Age, Customized||participants|Number|33|33.0||||||
3917174|NCT01445951|3740449|B1|50-64 years||Age, Customized||participants|Number|18|18.0||||||
3917175|NCT01445951|3740446|B4|31-49 years||Age, Customized||participants|Number|265|265.0||||||
3917176|NCT01445951|3740447|B3|31-49 years||Age, Customized||participants|Number|88|88.0||||||
3917177|NCT01445951|3740448|B2|31-49 years||Age, Customized||participants|Number|84|84.0||||||
3917178|NCT01445951|3740449|B1|31-49 years||Age, Customized||participants|Number|93|93.0||||||
3917179|NCT01445951|3740446|B4|18-30 years||Age, Customized||participants|Number|150|150.0||||||
3917180|NCT01445951|3740447|B3|18-30 years||Age, Customized||participants|Number|46|46.0||||||
3917181|NCT01445951|3740448|B2|18-30 years||Age, Customized||participants|Number|48|48.0||||||
3917182|NCT01445951|3740449|B1|18-30 years||Age, Customized||participants|Number|56|56.0||||||
3917183|NCT01445873|3740489|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3917184|NCT01445873|3740489|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3917185|NCT01445873|3740489|B1|85 to 90 years||Age, Customized||participants|Number|1|1.0||||||
3917186|NCT01445873|3740489|B1|79 to 84 years||Age, Customized||participants|Number|1|1.0||||||
3917187|NCT01445873|3740489|B1|73 to 78 years||Age, Customized||participants|Number|7|7.0||||||
3917188|NCT01445873|3740489|B1|67 to 72 years||Age, Customized||participants|Number|9|9.0||||||
3917189|NCT01445873|3740489|B1|61 to 66 years||Age, Customized||participants|Number|5|5.0||||||
3917190|NCT01445873|3740489|B1|55 to 60 years||Age, Customized||participants|Number|2|2.0||||||
3917191|NCT01445873|3740489|B1|49 to 54 years||Age, Customized||participants|Number|4|4.0||||||
3917192|NCT01445873|3740489|B1|43 to 48 years||Age, Customized||participants|Number|2|2.0||||||
3917193|NCT01445873|3740489|B1|37 to 42 years||Age, Customized||participants|Number|1|1.0||||||
3917194|NCT01445873|3740489|B1|31 to 36 years||Age, Customized||participants|Number|2|2.0||||||
3917195|NCT01445873|3740489|B1|25 to 30 years||Age, Customized||participants|Number|2|2.0||||||
3917196|NCT01445873|3740489|B1|19 to 24 years||Age, Customized||participants|Number|0|0.0||||||
3917197|NCT01445847|3740517|B3|Saudi Arabia||Region of Enrollment||participants|Number|72|72.0||||||
3917198|NCT01445847|3740518|B2|Saudi Arabia||Region of Enrollment||participants|Number|36|36.0||||||
3917199|NCT01445847|3740519|B1|Saudi Arabia||Region of Enrollment||participants|Number|36|36.0||||||
3917200|NCT01445847|3740517|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3917201|NCT01445847|3740518|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3917202|NCT01445847|3740519|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3917203|NCT01445847|3740517|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3917204|NCT01445847|3740518|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3917205|NCT01445847|3740519|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3917206|NCT01445847|3740517|B3|||Age||years|Mean|38.01|38.01|Standard Deviation|10.51868595|10.51868595|||
3917207|NCT01445847|3740518|B2|||Age||years|Mean|39.39|39.39|Standard Deviation|10.84|10.84|||
3917208|NCT01445847|3740519|B1|||Age||years|Mean|35.61|35.61|Standard Deviation|8.73|8.73|||
3917209|NCT01445847|3740517|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3917210|NCT01445847|3740518|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3917211|NCT01445847|3740519|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3917212|NCT01445847|3740517|B3||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
3917213|NCT01445847|3740518|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3917214|NCT01445847|3740519|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3917215|NCT01445847|3740517|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3917216|NCT01445847|3740518|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3917217|NCT01445847|3740519|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3917218|NCT01445769|3740526|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3917219|NCT01445769|3740526|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3917220|NCT01445769|3740526|B1|||Age||years|Mean|70.2|70.2|Standard Deviation|9.10|9.1|||
3917221|NCT01445678|3740544|B3||Male|Sex: Female, Male||Participants|Count of Participants|578|578.0||||||
3917222|NCT01445678|3740545|B2||Male|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
3917223|NCT01445678|3740546|B1||Male|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
3917224|NCT01445678|3740544|B3||Female|Sex: Female, Male||Participants|Count of Participants|401|401.0||||||
3917225|NCT01445678|3740545|B2||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
3917226|NCT01445678|3740546|B1||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
3917227|NCT01445678|3740544|B3|||Age||years|Mean|50.5|50.5|Standard Deviation|17.38|17.38|||
3917228|NCT01445678|3740545|B2|||Age||years|Mean|50.5|50.5|Standard Deviation|16.85|16.85|||
3917229|NCT01445678|3740546|B1|||Age||years|Mean|50.6|50.6|Standard Deviation|17.94|17.94|||
3917230|NCT01445652|3740563|B3|United Kingdom||Region of Enrollment||participants|Number|110|110.0||||||
3917231|NCT01445652|3740564|B2|United Kingdom||Region of Enrollment||participants|Number|53|53.0||||||
3917232|NCT01445652|3740565|B1|United Kingdom||Region of Enrollment||participants|Number|57|57.0||||||
3917233|NCT01445652|3740563|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3917234|NCT01445652|3740564|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3917235|NCT01445652|3740565|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3917236|NCT01445652|3740563|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3917237|NCT01445652|3740564|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3917238|NCT01445652|3740565|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3917239|NCT01445652|3740563|B3|||Age||years|Mean|16.2|16.2|Standard Deviation|1.9|1.9|||
3917240|NCT01445652|3740564|B2|||Age||years|Mean|16.3|16.3|Standard Deviation|2.0|2.0|||
3917241|NCT01445652|3740565|B1|||Age||years|Mean|16.2|16.2|Standard Deviation|1.8|1.8|||
3917242|NCT01445626|3740574|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3917243|NCT01445626|3740574|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3917244|NCT01445626|3740574|B1|||Age|Age Mean and Standard Deviation is based on data available for 83 patients. Age data is missing for 4 patients.|Years|Mean|68.48|68.48|Standard Deviation|9.15|9.15|||
3917245|NCT01445613|3740584|B1|United States||Region of Enrollment||participants|Number|1200|1200.0||||||
3917246|NCT01445613|3740584|B1|Information not available||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3917247|NCT01445613|3740584|B1|Refused to answer||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3917248|NCT01445613|3740584|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3917249|NCT01445613|3740584|B1|White||Race/Ethnicity, Customized||participants|Number|1083|1083.0||||||
3917250|NCT01445613|3740584|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3917251|NCT01445613|3740584|B1|Black or African Heritage||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
3917252|NCT01445613|3740584|B1|Asian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3917253|NCT01445613|3740584|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3917254|NCT01445613|3740584|B1||Male|Sex: Female, Male||Participants|Count of Participants|709|709.0||||||
3917255|NCT01445613|3740584|B1||Female|Sex: Female, Male||Participants|Count of Participants|491|491.0||||||
3917256|NCT01445613|3740584|B1|||Age||years|Mean|69.52|69.52|Standard Deviation|8.46|8.46|||
3917257|NCT01445548|3740602|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3917258|NCT01445548|3740602|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3917259|NCT01445548|3740602|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3917260|NCT01445548|3740602|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3917261|NCT01445548|3740602|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3917262|NCT01445548|3740602|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3917263|NCT01445548|3740602|B1|||Age||years|Mean|74.33|74.33|Standard Deviation|8.45|8.45|||
3917264|NCT01445301|3740623|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917265|NCT01445301|3740624|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917266|NCT01445301|3740625|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917267|NCT01445301|3740626|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917268|NCT01445301|3740623|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917269|NCT01445301|3740624|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917270|NCT01445301|3740625|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917271|NCT01445301|3740626|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917272|NCT01445301|3740623|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917273|NCT01445301|3740624|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917274|NCT01445301|3740625|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917275|NCT01445301|3740626|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917276|NCT01445301|3740623|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917277|NCT01445301|3740624|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917278|NCT01445301|3740625|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917279|NCT01445301|3740626|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917280|NCT01445301|3740623|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917281|NCT01445301|3740624|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917282|NCT01445301|3740625|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917283|NCT01445301|3740626|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917284|NCT01445301|3740623|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|799|799.0||||||
3917285|NCT01445301|3740624|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|299|299.0||||||
3917286|NCT01445301|3740625|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|296|296.0||||||
3917287|NCT01445301|3740626|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|204|204.0||||||
3917288|NCT01445301|3740623|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917289|NCT01445301|3740624|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917290|NCT01445301|3740625|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917291|NCT01445301|3740626|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917292|NCT01445301|3740623|B4||Male|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
3917293|NCT01445301|3740624|B3||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3917294|NCT01445301|3740625|B2||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3917295|NCT01445301|3740626|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3917296|NCT01445301|3740623|B4||Female|Sex: Female, Male||Participants|Count of Participants|528|528.0||||||
3917297|NCT01445301|3740624|B3||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3917298|NCT01445301|3740625|B2||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
3917299|NCT01445301|3740626|B1||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3917300|NCT01445301|3740623|B4|||Age||Years|Mean|20.8|20.8|Standard Deviation|6.34|6.34|||
3917301|NCT01445301|3740624|B3|||Age||Years|Mean|21.1|21.1|Standard Deviation|6.55|6.55|||
3917302|NCT01445301|3740625|B2|||Age||Years|Mean|20.7|20.7|Standard Deviation|6.33|6.33|||
3917303|NCT01445301|3740626|B1|||Age||Years|Mean|20.4|20.4|Standard Deviation|6.06|6.06|||
3917304|NCT01445028|3740663|B3|United States||Region of Enrollment||participants|Number|109|109.0||||||
3917305|NCT01445028|3740664|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
3917306|NCT01445028|3740665|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
3917307|NCT01445028|3740663|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3917308|NCT01445028|3740664|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3917309|NCT01445028|3740665|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3917310|NCT01445028|3740663|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3917311|NCT01445028|3740664|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3917312|NCT01445028|3740665|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3917313|NCT01445028|3740663|B3|||Age||years|Mean|57.1|57.1|Standard Deviation|10.3|10.3|||
3917314|NCT01445028|3740664|B2|||Age||years|Mean|59.7|59.7|Standard Deviation|11.8|11.8|||
3917315|NCT01445028|3740665|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|10.0|10.0|||
3917316|NCT01445028|3740663|B3||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3917317|NCT01445028|3740664|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3917318|NCT01445028|3740665|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3917319|NCT01445028|3740663|B3||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
3917320|NCT01445028|3740664|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3917321|NCT01445028|3740665|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3917322|NCT01445028|3740663|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3917323|NCT01445028|3740664|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3917324|NCT01445028|3740665|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3917325|NCT01444924|3740672|B3|||Body Mass Index (BMI)||kg/m^2|Mean|35.3|35.3|Standard Deviation|12.32|12.32|||
3917326|NCT01444924|3740673|B2|||Body Mass Index (BMI)||kg/m^2|Mean|36.3|36.3|Standard Deviation|9.01|9.01|||
3917327|NCT01444924|3740674|B1|||Body Mass Index (BMI)||kg/m^2|Mean|34.2|34.2|Standard Deviation|12.12|12.12|||
3917328|NCT01444924|3740672|B3|United States||Region of Enrollment||participants|Number|64|64.0||||||
3917329|NCT01444924|3740673|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
3917330|NCT01444924|3740674|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
3917331|NCT01444924|3740672|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917332|NCT01444924|3740673|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917333|NCT01444924|3740674|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917334|NCT01444924|3740672|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917335|NCT01444924|3740673|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917336|NCT01444924|3740674|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917337|NCT01444924|3740672|B3||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3917338|NCT01444924|3740673|B2||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3917339|NCT01444924|3740674|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3917340|NCT01444924|3740672|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3917341|NCT01444924|3740673|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3917342|NCT01444924|3740674|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917343|NCT01444924|3740672|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917344|NCT01444924|3740673|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917345|NCT01444924|3740674|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917346|NCT01444924|3740672|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917347|NCT01444924|3740673|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917348|NCT01444924|3740674|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917349|NCT01444924|3740672|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917350|NCT01444924|3740673|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917351|NCT01444924|3740674|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917352|NCT01444924|3740672|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3917353|NCT01444924|3740673|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3917354|NCT01444924|3740674|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3917355|NCT01444924|3740672|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3917356|NCT01444924|3740673|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3917357|NCT01444924|3740674|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3917358|NCT01444924|3740672|B3|||Age||years|Mean|58.7|58.7|Standard Deviation|14.29|14.29|||
3917359|NCT01444924|3740673|B2|||Age||years|Mean|62.1|62.1|Standard Deviation|14.29|14.29|||
3917360|NCT01444924|3740674|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|11.48|11.48|||
3917361|NCT01444911|3740683|B3|Dual Primary (Ovary and Endometrium)||Primary Disease Site||participants|Number|2|2.0||||||
3917362|NCT01444911|3740684|B2|Dual Primary (Ovary and Endometrium)||Primary Disease Site||participants|Number|1|1.0||||||
3917363|NCT01444911|3740685|B1|Dual Primary (Ovary and Endometrium)||Primary Disease Site||participants|Number|1|1.0||||||
3917364|NCT01444911|3740683|B3|Vulva||Primary Disease Site||participants|Number|1|1.0||||||
3917365|NCT01444911|3740684|B2|Vulva||Primary Disease Site||participants|Number|0|0.0||||||
3917366|NCT01444911|3740685|B1|Vulva||Primary Disease Site||participants|Number|1|1.0||||||
3917367|NCT01444911|3740683|B3|Cervix||Primary Disease Site||participants|Number|4|4.0||||||
3917368|NCT01444911|3740684|B2|Cervix||Primary Disease Site||participants|Number|1|1.0||||||
3917369|NCT01444911|3740685|B1|Cervix||Primary Disease Site||participants|Number|3|3.0||||||
3917370|NCT01444911|3740683|B3|Endometrium||Primary Disease Site||participants|Number|12|12.0||||||
3917371|NCT01444911|3740684|B2|Endometrium||Primary Disease Site||participants|Number|6|6.0||||||
3917372|NCT01444911|3740685|B1|Endometrium||Primary Disease Site||participants|Number|6|6.0||||||
3917373|NCT01444911|3740683|B3|Ovary||Primary Disease Site||participants|Number|10|10.0||||||
3917374|NCT01444911|3740684|B2|Ovary||Primary Disease Site||participants|Number|5|5.0||||||
3917375|NCT01444911|3740685|B1|Ovary||Primary Disease Site||participants|Number|5|5.0||||||
3917376|NCT01444911|3740683|B3|No Prior Pelvic Radiation||Pelvic Radiation||participants|Number|26|26.0||||||
3917377|NCT01444911|3740684|B2|No Prior Pelvic Radiation||Pelvic Radiation||participants|Number|12|12.0||||||
3917378|NCT01444911|3740685|B1|No Prior Pelvic Radiation||Pelvic Radiation||participants|Number|14|14.0||||||
3917379|NCT01444911|3740683|B3|Prior Pelvic Radiation||Pelvic Radiation||participants|Number|3|3.0||||||
3917380|NCT01444911|3740684|B2|Prior Pelvic Radiation||Pelvic Radiation||participants|Number|1|1.0||||||
3917381|NCT01444911|3740685|B1|Prior Pelvic Radiation||Pelvic Radiation||participants|Number|2|2.0||||||
3917382|NCT01444911|3740683|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
3917383|NCT01444911|3740684|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3917384|NCT01444911|3740685|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3917385|NCT01444911|3740683|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3917386|NCT01444911|3740684|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3917387|NCT01444911|3740685|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3917388|NCT01444911|3740683|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3917389|NCT01444911|3740684|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3917390|NCT01444911|3740685|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3917391|NCT01444911|3740683|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3917392|NCT01444911|3740684|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3917393|NCT01444911|3740685|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3917394|NCT01444911|3740683|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3917395|NCT01444911|3740684|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3917396|NCT01444911|3740685|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3917397|NCT01444911|3740683|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3917398|NCT01444911|3740684|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3917399|NCT01444911|3740685|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3917400|NCT01444898|3740698|B1|||Adiposity|Mean truncal fat|kg|Mean|20|20.0|Standard Deviation|4.6|4.6|||
3917401|NCT01444898|3740698|B1|||Adiposity|Truncal fat as measured by dual x-ray absorptiometry|percentage of fat|Number|44.7|44.7||||||
3917402|NCT01444898|3740698|B1|Appetite Severity||Appetite|"Appetite scores - For 1 and 2: 11 item questionnaire divided into subcategories of behavior (5 questions), drive (4 questions), severity (2 questions). Tallied and analyzed as total and subcategory scores. Each question scored 1-5 with higher scores correlating with worse hyperphagia.~Possible ranges: Total 11-55, behavior 5-25, drive 4-20, severity 2-10"|units on a scale|Mean|5.1|5.1|Standard Deviation|1.5|1.5|||
3917403|NCT01444898|3740698|B1|Appetite Drive||Appetite|"Appetite scores - For 1 and 2: 11 item questionnaire divided into subcategories of behavior (5 questions), drive (4 questions), severity (2 questions). Tallied and analyzed as total and subcategory scores. Each question scored 1-5 with higher scores correlating with worse hyperphagia.~Possible ranges: Total 11-55, behavior 5-25, drive 4-20, severity 2-10"|units on a scale|Mean|12.6|12.6|Standard Deviation|3.1|3.1|||
3917404|NCT01444898|3740698|B1|Appetite Behavior||Appetite|"Appetite scores - For 1 and 2: 11 item questionnaire divided into subcategories of behavior (5 questions), drive (4 questions), severity (2 questions). Tallied and analyzed as total and subcategory scores. Each question scored 1-5 with higher scores correlating with worse hyperphagia.~Possible ranges: Total 11-55, behavior 5-25, drive 4-20, severity 2-10"|units on a scale|Mean|14.5|14.5|Standard Deviation|4.9|4.9|||
3917405|NCT01444898|3740698|B1|Total Appetite Score||Appetite|"Appetite scores - For 1 and 2: 11 item questionnaire divided into subcategories of behavior (5 questions), drive (4 questions), severity (2 questions). Tallied and analyzed as total and subcategory scores. Each question scored 1-5 with higher scores correlating with worse hyperphagia.~Possible ranges: Total 11-55, behavior 5-25, drive 4-20, severity 2-10"|units on a scale|Mean|32.2|32.2|Standard Deviation|8.7|8.7|||
3917406|NCT01444898|3740698|B1|||PP|Pancreatic polypeptide, PP (pg ml ^-1)|pg ml ^-1|Median|89|89.0|Inter-Quartile Range|||31.0|662.0|
3917407|NCT01444898|3740698|B1|||Acy Ghr|Acylated ghrelin, Acy Ghr (pg ml ^-1)|pg ml ^-1|Median|362.3|362.3|Inter-Quartile Range|||259.0|740.7|
3917408|NCT01444898|3740698|B1|||Leptin|Leptin (ng ml ^-1)|ng ml ^-1|Mean|36.4|36.4|Standard Deviation|18.3|18.3|||
3917409|NCT01444898|3740698|B1|||Insulin|Insulin (u/U ml^-1)|uIU ml^-1|Median|10.5|10.5|Inter-Quartile Range|||6.0|21.0|
3917410|NCT01444898|3740698|B1|||Glycosylated hemoglobin (HbA1c)|Glycosylated hemoglobin (HbA1c), percentage of total hemoglobin|percentage of total hemoglobin|Median|5.9|5.9|Inter-Quartile Range|||5.6|7.9|
3917411|NCT01444898|3740698|B1|||BMI Z-Score||units on a scale|Mean|3.5|3.5|Standard Deviation|1.1|1.1|||
3917412|NCT01444898|3740698|B1|||BMI|BMI (kg m^-2)|kg m^-2|Median|41.7|41.7|Inter-Quartile Range|||34.1|55.0|
3917413|NCT01444898|3740698|B1|||Weight|Weight (kg)|kg|Mean|102.5|102.5|Standard Deviation|18.6|18.6|||
3917414|NCT01444898|3740698|B1|United States||Region of Enrollment|Region of Enrollment = California|participants|Number|10|10.0||||||
3917415|NCT01444898|3740698|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3917416|NCT01444898|3740698|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3917417|NCT01444898|3740698|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3917418|NCT01444898|3740698|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3917419|NCT01444898|3740698|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917420|NCT01444898|3740698|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917421|NCT01444898|3740698|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917422|NCT01444898|3740698|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3917423|NCT01444898|3740698|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3917424|NCT01444898|3740698|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3917425|NCT01444898|3740698|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3917426|NCT01444898|3740698|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3917427|NCT01444898|3740698|B1|||Age||years|Median|16|16.0|Full Range|||14.7|24.6|
3917428|NCT01444898|3740698|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3917429|NCT01444898|3740698|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3917430|NCT01444898|3740698|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3917431|NCT01444781|3740710|B4|Costa Rica||Region of Enrollment||Participants|Number|402|402.0||||||
3917432|NCT01444781|3740711|B3|Costa Rica||Region of Enrollment||Participants|Number|103|103.0||||||
3917433|NCT01444781|3740712|B2|Costa Rica||Region of Enrollment||Participants|Number|149|149.0||||||
3917434|NCT01444781|3740713|B1|Costa Rica||Region of Enrollment||Participants|Number|150|150.0||||||
3917435|NCT01444781|3740710|B4|Colombia||Region of Enrollment||Participants|Number|704|704.0||||||
3917436|NCT01444781|3740711|B3|Colombia||Region of Enrollment||Participants|Number|172|172.0||||||
3917437|NCT01444781|3740712|B2|Colombia||Region of Enrollment||Participants|Number|266|266.0||||||
3917438|NCT01444781|3740713|B1|Colombia||Region of Enrollment||Participants|Number|266|266.0||||||
3917439|NCT01444781|3740710|B4||Male|Sex: Female, Male||Participants|Count of Participants|589|589.0||||||
3917440|NCT01444781|3740711|B3||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3917441|NCT01444781|3740712|B2||Male|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
3917442|NCT01444781|3740713|B1||Male|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
3917443|NCT01444781|3740710|B4||Female|Sex: Female, Male||Participants|Count of Participants|517|517.0||||||
3917444|NCT01444781|3740711|B3||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3917445|NCT01444781|3740712|B2||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
3917446|NCT01444781|3740713|B1||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
3917447|NCT01444781|3740710|B4|||Age||Months|Mean|17.7|17.7|Standard Deviation|3.29|3.29|||
3917448|NCT01444781|3740711|B3|||Age||Months|Mean|17.8|17.8|Standard Deviation|3.26|3.26|||
3917449|NCT01444781|3740712|B2|||Age||Months|Mean|17.6|17.6|Standard Deviation|3.34|3.34|||
3917450|NCT01444781|3740713|B1|||Age||Months|Mean|17.6|17.6|Standard Deviation|3.25|3.25|||
3917451|NCT01444781|3740710|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3917452|NCT01444781|3740711|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3917453|NCT01444781|3740712|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3917454|NCT01444781|3740713|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3917455|NCT01444781|3740710|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3917456|NCT01444781|3740711|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3917457|NCT01444781|3740712|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3917458|NCT01444781|3740713|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3917459|NCT01444781|3740710|B4||<=18 years|Age||Participants|Count of Participants|1106|1106.0||||||
3917460|NCT01444781|3740711|B3||<=18 years|Age||Participants|Count of Participants|275|275.0||||||
3917461|NCT01444781|3740712|B2||<=18 years|Age||Participants|Count of Participants|415|415.0||||||
3917462|NCT01444781|3740713|B1||<=18 years|Age||Participants|Count of Participants|416|416.0||||||
3917463|NCT01444742|3740753|B1|United States||Region of Enrollment||Participants|Count of Participants|81|81.0||||||
3917464|NCT01444742|3740753|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3917465|NCT01444742|3740753|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917466|NCT01444742|3740753|B1||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3917467|NCT01444742|3740753|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3917468|NCT01444742|3740753|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917469|NCT01444742|3740753|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3917470|NCT01444742|3740753|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917471|NCT01444742|3740753|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3917472|NCT01444742|3740753|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3917473|NCT01444742|3740753|B1|||Age||years|Median|71|71.0|Full Range|||30.0|83.0|
3917474|NCT01444742|3740753|B1||>=65 years|Age||Participants|Count of Participants|65|65.0||||||
3917475|NCT01444742|3740753|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3917476|NCT01444742|3740753|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3917477|NCT01444651|3740758|B3|||Fasting insulin||microunits/mL|Mean|17|17.0|Standard Deviation|13|13.0|||
3917478|NCT01444651|3740759|B2|||Fasting insulin||microunits/mL|Mean|17|17.0|Standard Deviation|16|16.0|||
3917479|NCT01444651|3740760|B1|||Fasting insulin||microunits/mL|Mean|17|17.0|Standard Deviation|10|10.0|||
3917480|NCT01444651|3740758|B3|||Body mass index||kg/m^2|Mean|37.7|37.7|Standard Deviation|6.8|6.8|||
3917481|NCT01444651|3740759|B2|||Body mass index||kg/m^2|Mean|36.8|36.8|Standard Deviation|6.8|6.8|||
3917482|NCT01444651|3740760|B1|||Body mass index||kg/m^2|Mean|38.7|38.7|Standard Deviation|6.8|6.8|||
3917483|NCT01444651|3740758|B3|United States||Region of Enrollment||participants|Number|53|53.0||||||
3917484|NCT01444651|3740759|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
3917485|NCT01444651|3740760|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3917486|NCT01444651|3740758|B3||Male|Gender||Participants|Count of Participants|33|33.0||||||
3917487|NCT01444651|3740759|B2||Male|Gender||Participants|Count of Participants|15|15.0||||||
3917488|NCT01444651|3740760|B1||Male|Gender||Participants|Count of Participants|18|18.0||||||
3917489|NCT01444651|3740758|B3||Female|Gender||Participants|Count of Participants|20|20.0||||||
3917490|NCT01444651|3740759|B2||Female|Gender||Participants|Count of Participants|13|13.0||||||
3917491|NCT01444651|3740760|B1||Female|Gender||Participants|Count of Participants|7|7.0||||||
3917492|NCT01444651|3740758|B3|||Age||years|Mean|33|33.0|Standard Deviation|9|9.0|||
3917493|NCT01444651|3740759|B2|||Age||years|Mean|34|34.0|Standard Deviation|9|9.0|||
3917494|NCT01444651|3740760|B1|||Age||years|Mean|33|33.0|Standard Deviation|9|9.0|||
3917495|NCT01444456|3740777|B1|||Hemoglobin level|Baseline hemoglobin levels were available for 1133 participants.|g/dL|Mean|9.3|9.3|Standard Deviation|0.6|0.6|||
3917496|NCT01444456|3740777|B1|||Functional Assessment of Cancer Therapy-Fatigue (FACT-F) score|The FACT-F subscale consists of 13 fatigue-related items that are a subset of the Functional Assessment of Cancer Therapy - Anaemia (FACT-An) questionnaire. Participants indicate how they feel in response to 13 statements on a scale from 0 for “Not at all” to 4 for “Very much”. Total scores for the FACT-F subscale range from 0 to 52; the higher the score the better the quality of life. Baseline data were available for 1109 participants.|units on a scale|Mean|28.4|28.4|Standard Deviation|10.5|10.5|||
3917497|NCT01444456|3740777|B1|||Fatigue-Visual Analog Scale (VAS) Score|The fatigue VAS is a 100-point scale where fatigue-levels are rated from 0 (least fatigue) to 100 (worst possible fatigue). Baseline VAS data were available for 1109 participants.|units on a scale|Mean|51.2|51.2|Standard Deviation|22.6|22.6|||
3917498|NCT01444456|3740777|B1||Male|Sex: Female, Male||Participants|Count of Participants|467|467.0||||||
3917499|NCT01444456|3740777|B1||Female|Sex: Female, Male||Participants|Count of Participants|691|691.0||||||
3917500|NCT01444456|3740777|B1|||Age||years|Mean|63.9|63.9|Standard Deviation|11.1|11.1|||
3917501|NCT01444430|3740786|B3|Other||Race/Ethnicity, Customized||Participants|Number|650|650.0||||||
3917502|NCT01444430|3740787|B2|Other||Race/Ethnicity, Customized||Participants|Number|326|326.0||||||
3917503|NCT01444430|3740788|B1|Other||Race/Ethnicity, Customized||Participants|Number|324|324.0||||||
3917504|NCT01444430|3740786|B3|American Indian/Alaska Native||Race/Ethnicity, Customized||Participants|Number|432|432.0||||||
3917505|NCT01444430|3740787|B2|American Indian/Alaska Native||Race/Ethnicity, Customized||Participants|Number|207|207.0||||||
3917506|NCT01444430|3740788|B1|American Indian/Alaska Native||Race/Ethnicity, Customized||Participants|Number|225|225.0||||||
3917507|NCT01444430|3740786|B3|Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3917508|NCT01444430|3740787|B2|Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3917509|NCT01444430|3740788|B1|Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3917510|NCT01444430|3740786|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1755|1755.0||||||
3917511|NCT01444430|3740787|B2|Asian||Race/Ethnicity, Customized||Participants|Number|907|907.0||||||
3917512|NCT01444430|3740788|B1|Asian||Race/Ethnicity, Customized||Participants|Number|848|848.0||||||
3917513|NCT01444430|3740786|B3|Black/African American||Race/Ethnicity, Customized||Participants|Number|797|797.0||||||
3917514|NCT01444430|3740787|B2|Black/African American||Race/Ethnicity, Customized||Participants|Number|401|401.0||||||
3917515|NCT01444430|3740788|B1|Black/African American||Race/Ethnicity, Customized||Participants|Number|396|396.0||||||
3917516|NCT01444430|3740786|B3|White||Race/Ethnicity, Customized||Participants|Number|8053|8053.0||||||
3917517|NCT01444430|3740787|B2|White||Race/Ethnicity, Customized||Participants|Number|4003|4003.0||||||
3917518|NCT01444430|3740788|B1|White||Race/Ethnicity, Customized||Participants|Number|4050|4050.0||||||
3917519|NCT01444430|3740786|B3||Male|Gender||Participants|Count of Participants|4024|4024.0||||||
3917520|NCT01444430|3740787|B2||Male|Gender||Participants|Count of Participants|2027|2027.0||||||
3917521|NCT01444430|3740788|B1||Male|Gender||Participants|Count of Participants|1997|1997.0||||||
3917522|NCT01444430|3740786|B3||Female|Gender||Participants|Count of Participants|7669|7669.0||||||
3917523|NCT01444430|3740787|B2||Female|Gender||Participants|Count of Participants|3820|3820.0||||||
3917524|NCT01444430|3740788|B1||Female|Gender||Participants|Count of Participants|3849|3849.0||||||
3917525|NCT01444430|3740786|B3|||Age||Years|Mean|43.5|43.5|Standard Deviation|17.3|17.3|||
3917526|NCT01444430|3740787|B2|||Age||Years|Mean|43.5|43.5|Standard Deviation|17.3|17.3|||
3917527|NCT01444430|3740788|B1|||Age||Years|Mean|43.4|43.4|Standard Deviation|17.4|17.4|||
3917528|NCT01444417|3740809|B3|||Platelets||10^9/L|Mean|18.3|18.3|Standard Deviation|13.9|13.9|||
3917529|NCT01444417|3740810|B2|||Platelets||10^9/L|Mean|17.5|17.5|Standard Deviation|10.7|10.7|||
3917530|NCT01444417|3740811|B1|||Platelets||10^9/L|Mean|19.9|19.9|Standard Deviation|19.3|19.3|||
3917531|NCT01444417|3740809|B3|White||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
3917532|NCT01444417|3740810|B2|White||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3917533|NCT01444417|3740811|B1|White||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3917534|NCT01444417|3740809|B3|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3917535|NCT01444417|3740810|B2|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3917536|NCT01444417|3740811|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3917537|NCT01444417|3740809|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3917538|NCT01444417|3740810|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3917539|NCT01444417|3740811|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3917540|NCT01444417|3740809|B3|Multiple||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3917541|NCT01444417|3740810|B2|Multiple||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3917542|NCT01444417|3740811|B1|Multiple||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3917543|NCT01444417|3740809|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3917544|NCT01444417|3740810|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3917545|NCT01444417|3740811|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3917546|NCT01444417|3740809|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3917547|NCT01444417|3740810|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3917548|NCT01444417|3740811|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3917549|NCT01444417|3740809|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3917550|NCT01444417|3740810|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3917551|NCT01444417|3740811|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3917552|NCT01444417|3740809|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3917553|NCT01444417|3740810|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3917554|NCT01444417|3740811|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3917555|NCT01444417|3740809|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3917556|NCT01444417|3740810|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3917557|NCT01444417|3740811|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3917558|NCT01444417|3740809|B3|≥ 12 - < 18 years||Age, Customized||participants|Number|23|23.0||||||
3917559|NCT01444417|3740810|B2|≥ 12 - < 18 years||Age, Customized||participants|Number|16|16.0||||||
3917560|NCT01444417|3740811|B1|≥ 12 - < 18 years||Age, Customized||participants|Number|7|7.0||||||
3917561|NCT01444417|3740809|B3|≥ 6 - < 12 years||Age, Customized||participants|Number|27|27.0||||||
3917562|NCT01444417|3740810|B2|≥ 6 - < 12 years||Age, Customized||participants|Number|18|18.0||||||
3917563|NCT01444417|3740811|B1|≥ 6 - < 12 years||Age, Customized||participants|Number|9|9.0||||||
3917564|NCT01444417|3740809|B3|≥ 1 - < 6 years||Age, Customized||participants|Number|12|12.0||||||
3917565|NCT01444417|3740810|B2|≥ 1 - < 6 years||Age, Customized||participants|Number|8|8.0||||||
3917566|NCT01444417|3740811|B1|≥ 1 - < 6 years||Age, Customized||participants|Number|4|4.0||||||
3917567|NCT01444417|3740809|B3|||Age||years|Mean|9.6|9.6|Standard Deviation|4.3|4.3|||
3917568|NCT01444417|3740810|B2|||Age||years|Mean|9.7|9.7|Standard Deviation|4.1|4.1|||
3917569|NCT01444417|3740811|B1|||Age||years|Mean|9.4|9.4|Standard Deviation|4.7|4.7|||
3917570|NCT01444391|3740828|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
3917571|NCT01444391|3740828|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3917572|NCT01444391|3740828|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917573|NCT01444391|3740828|B1||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3917574|NCT01444391|3740828|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3917575|NCT01444391|3740828|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917576|NCT01444391|3740828|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917577|NCT01444391|3740828|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917578|NCT01444391|3740828|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3917579|NCT01444391|3740828|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3917580|NCT01444391|3740828|B1|||Age||years|Mean|39.6|39.6|Standard Deviation|26.6|26.6|||
3917581|NCT01444378|3740836|B1|United States||Region of Enrollment||participants|Number|141|141.0||||||
3917582|NCT01444378|3740836|B1|White||Race/Ethnicity, Customized|Subjects who are in multiple race categories are counted in each checked category. The sum of the percentages of all race categories may not equal 100%.|participants|Number|120|120.0||||||
3917583|NCT01444378|3740836|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Subjects who are in multiple race categories are counted in each checked category. The sum of the percentages of all race categories may not equal 100%.|participants|Number|0|0.0||||||
3917584|NCT01444378|3740836|B1|Latino-Hispanic||Race/Ethnicity, Customized|Subjects who are in multiple race categories are counted in each checked category. The sum of the percentages of all race categories may not equal 100%.|participants|Number|3|3.0||||||
3917585|NCT01444378|3740836|B1|Black or African Heritage||Race/Ethnicity, Customized|Subjects who are in multiple race categories are counted in each checked category. The sum of the percentages of all race categories may not equal 100%.|participants|Number|19|19.0||||||
3917643|NCT01444092|3740981|B1|>8 Yrs||Age, Customized||Participants|Number|103|103.0||||||
3917586|NCT01444378|3740836|B1|Asian||Race/Ethnicity, Customized|Subjects who are in multiple race categories are counted in each checked category. The sum of the percentages of all race categories may not equal 100%.|participants|Number|1|1.0||||||
3917587|NCT01444378|3740836|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Subjects who are in multiple race categories are counted in each checked category. The sum of the percentages of all race categories may not equal 100%.|participants|Number|0|0.0||||||
3917588|NCT01444378|3740836|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3917589|NCT01444378|3740836|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3917590|NCT01444378|3740836|B1|||Age||years|Mean|67.3|67.3|Standard Deviation|10.3|10.3|||
3917591|NCT01444300|3740946|B3|Primary Progressive MS (PPMS)||MS Subtype||participants|Number|2|2.0||||||
3917592|NCT01444300|3740947|B2|Primary Progressive MS (PPMS)||MS Subtype||participants|Number|2|2.0||||||
3917593|NCT01444300|3740948|B1|Primary Progressive MS (PPMS)||MS Subtype||participants|Number|0|0.0||||||
3917594|NCT01444300|3740946|B3|Secondary Progressive MS (SPMS)||MS Subtype||participants|Number|2|2.0||||||
3917595|NCT01444300|3740947|B2|Secondary Progressive MS (SPMS)||MS Subtype||participants|Number|2|2.0||||||
3917596|NCT01444300|3740948|B1|Secondary Progressive MS (SPMS)||MS Subtype||participants|Number|0|0.0||||||
3917597|NCT01444300|3740946|B3|Relapsing Remitting MS (RRMS)||MS Subtype||participants|Number|20|20.0||||||
3917598|NCT01444300|3740947|B2|Relapsing Remitting MS (RRMS)||MS Subtype||participants|Number|8|8.0||||||
3917599|NCT01444300|3740948|B1|Relapsing Remitting MS (RRMS)||MS Subtype||participants|Number|12|12.0||||||
3917600|NCT01444300|3740946|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3917601|NCT01444300|3740947|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917602|NCT01444300|3740948|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3917603|NCT01444300|3740946|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917604|NCT01444300|3740947|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917605|NCT01444300|3740948|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917606|NCT01444300|3740946|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3917607|NCT01444300|3740947|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3917608|NCT01444300|3740948|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3917609|NCT01444300|3740946|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3917610|NCT01444300|3740947|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3917611|NCT01444300|3740948|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917612|NCT01444300|3740946|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917613|NCT01444300|3740947|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917614|NCT01444300|3740948|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917615|NCT01444300|3740946|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3917616|NCT01444300|3740947|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3917617|NCT01444300|3740948|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917618|NCT01444300|3740946|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917619|NCT01444300|3740947|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917620|NCT01444300|3740948|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917621|NCT01444300|3740946|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3917622|NCT01444300|3740947|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3917623|NCT01444300|3740948|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3917624|NCT01444300|3740946|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3917625|NCT01444300|3740947|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3917626|NCT01444300|3740948|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3917627|NCT01444300|3740946|B3|||Age||years|Mean|47.5|47.5|Standard Deviation|9.7|9.7|||
3917628|NCT01444300|3740947|B2|||Age||years|Mean|47.8|47.8|Standard Deviation|10.9|10.9|||
3917629|NCT01444300|3740948|B1|||Age||years|Mean|47.2|47.2|Standard Deviation|8.9|8.9|||
3917630|NCT01444287|3740959|B1|Australia||Region of Enrollment||participants|Number|22|22.0||||||
3917631|NCT01444287|3740959|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3917632|NCT01444287|3740959|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3917633|NCT01444287|3740959|B1|||Age||years|Mean|30.8|30.8|Standard Deviation|10.6|10.6|||
3917634|NCT01444287|3740959|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3917635|NCT01444287|3740959|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3917636|NCT01444287|3740959|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3917637|NCT01444092|3740981|B1|White||Race/Ethnicity, Customized||Participants|Number|100|100.0||||||
3917638|NCT01444092|3740981|B1|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3917639|NCT01444092|3740981|B1|Black Or African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3917640|NCT01444092|3740981|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3917641|NCT01444092|3740981|B1||Male|Gender||Participants|Count of Participants|57|57.0||||||
3917642|NCT01444092|3740981|B1||Female|Gender||Participants|Count of Participants|51|51.0||||||
3917644|NCT01444092|3740981|B1|=<8 Yrs||Age, Customized||Participants|Number|5|5.0||||||
3917645|NCT01444092|3740981|B1|||Age||Years|Mean|13.7|13.7|Standard Deviation|2.41|2.41|6.0|17.0|
3917646|NCT01444027|3740987|B4|United States||Region of Enrollment||Participants|Count of Participants|514|514.0||||||
3917647|NCT01444027|3740988|B3|United States||Region of Enrollment||Participants|Count of Participants|171|171.0||||||
3917648|NCT01444027|3740989|B2|United States||Region of Enrollment||Participants|Count of Participants|171|171.0||||||
3917649|NCT01444027|3740990|B1|United States||Region of Enrollment||Participants|Count of Participants|172|172.0||||||
3917650|NCT01444027|3740987|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3917651|NCT01444027|3740988|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3917652|NCT01444027|3740989|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917653|NCT01444027|3740990|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3917654|NCT01444027|3740987|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3917655|NCT01444027|3740988|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3917656|NCT01444027|3740989|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3917657|NCT01444027|3740990|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3917658|NCT01444027|3740987|B4||White|Race (NIH/OMB)||Participants|Count of Participants|460|460.0||||||
3917659|NCT01444027|3740988|B3||White|Race (NIH/OMB)||Participants|Count of Participants|152|152.0||||||
3917660|NCT01444027|3740989|B2||White|Race (NIH/OMB)||Participants|Count of Participants|153|153.0||||||
3917661|NCT01444027|3740990|B1||White|Race (NIH/OMB)||Participants|Count of Participants|155|155.0||||||
3917662|NCT01444027|3740987|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3917663|NCT01444027|3740988|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3917664|NCT01444027|3740989|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3917665|NCT01444027|3740990|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3917666|NCT01444027|3740987|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917667|NCT01444027|3740988|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917668|NCT01444027|3740989|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917669|NCT01444027|3740990|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917670|NCT01444027|3740987|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3917671|NCT01444027|3740988|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3917672|NCT01444027|3740989|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3917673|NCT01444027|3740990|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3917674|NCT01444027|3740987|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3917675|NCT01444027|3740988|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3917676|NCT01444027|3740989|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3917677|NCT01444027|3740990|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917678|NCT01444027|3740987|B4||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3917679|NCT01444027|3740988|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3917680|NCT01444027|3740989|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3917681|NCT01444027|3740990|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3917682|NCT01444027|3740987|B4||Female|Sex: Female, Male||Participants|Count of Participants|386|386.0||||||
3917683|NCT01444027|3740988|B3||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3917684|NCT01444027|3740989|B2||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3917685|NCT01444027|3740990|B1||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3917686|NCT01444027|3740987|B4|||Age||years|Mean|60.3|60.3|Standard Deviation|12.4|12.4|||
3917687|NCT01444027|3740988|B3|||Age||years|Mean|61.3|61.3|Standard Deviation|12.0|12.0|||
3917688|NCT01444027|3740989|B2|||Age||years|Mean|59.9|59.9|Standard Deviation|11.6|11.6|||
3917689|NCT01444027|3740990|B1|||Age||years|Mean|59.7|59.7|Standard Deviation|13.6|13.6|||
3917690|NCT01443923|3741012|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3917691|NCT01443923|3741013|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3917692|NCT01443923|3741014|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3917693|NCT01443923|3741012|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3917694|NCT01443923|3741013|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3917695|NCT01443923|3741014|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3917696|NCT01443923|3741012|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3917697|NCT01443923|3741013|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3917698|NCT01443923|3741014|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3917699|NCT01443923|3741012|B3|||Age||Years|Mean|57.5|57.5|Standard Deviation|2.64575|2.64575|||
3917700|NCT01443923|3741013|B2|||Age||Years|Mean|56|56.0|Standard Deviation|0|0.0|||
3917701|NCT01443923|3741014|B1|||Age||Years|Mean|58|58.0|Standard Deviation|3|3.0|||
3917702|NCT01443923|3741012|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3917703|NCT01443923|3741013|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3917704|NCT01443923|3741014|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3917705|NCT01443923|3741012|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3917706|NCT01443923|3741013|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3917707|NCT01443923|3741014|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3917708|NCT01443923|3741012|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3917709|NCT01443923|3741013|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3917710|NCT01443923|3741014|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3917711|NCT01443858|3741029|B4|United States||Region of Enrollment||participants|Number|75|75.0||||||
3917712|NCT01443858|3741030|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
3917713|NCT01443858|3741031|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3917714|NCT01443858|3741032|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3917715|NCT01443858|3741029|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917716|NCT01443858|3741030|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917717|NCT01443858|3741031|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917718|NCT01443858|3741032|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917719|NCT01443858|3741029|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3917720|NCT01443858|3741030|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3917721|NCT01443858|3741031|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3917722|NCT01443858|3741032|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3917723|NCT01443858|3741029|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3917724|NCT01443858|3741030|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3917725|NCT01443858|3741031|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917726|NCT01443858|3741032|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917727|NCT01443858|3741029|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917728|NCT01443858|3741030|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917729|NCT01443858|3741031|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917730|NCT01443858|3741032|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917731|NCT01443858|3741029|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917732|NCT01443858|3741030|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917733|NCT01443858|3741031|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917734|NCT01443858|3741032|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917735|NCT01443858|3741029|B4||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3917736|NCT01443858|3741030|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3917737|NCT01443858|3741031|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3917738|NCT01443858|3741032|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3917739|NCT01443858|3741029|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3917740|NCT01443858|3741030|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3917741|NCT01443858|3741031|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3917742|NCT01443858|3741032|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3917743|NCT01443858|3741029|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3917744|NCT01443858|3741030|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917745|NCT01443858|3741031|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3917746|NCT01443858|3741032|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917747|NCT01443858|3741029|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3917748|NCT01443858|3741030|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917749|NCT01443858|3741031|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3917750|NCT01443858|3741032|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917751|NCT01443858|3741029|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3917752|NCT01443858|3741030|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3917753|NCT01443858|3741031|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3917754|NCT01443858|3741032|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917755|NCT01443858|3741029|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3917756|NCT01443858|3741030|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3917757|NCT01443858|3741031|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3917758|NCT01443858|3741032|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3917759|NCT01443858|3741029|B4||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3917760|NCT01443858|3741030|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3917761|NCT01443858|3741031|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3917762|NCT01443858|3741032|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3917763|NCT01443858|3741029|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3917764|NCT01443858|3741030|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3917765|NCT01443858|3741031|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3917766|NCT01443858|3741032|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3917767|NCT01443858|3741029|B4||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
3917768|NCT01443858|3741030|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3917769|NCT01443858|3741031|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3917770|NCT01443858|3741032|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3917771|NCT01443858|3741029|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3917772|NCT01443858|3741030|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3917773|NCT01443858|3741031|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3917774|NCT01443858|3741032|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3917775|NCT01443858|3741029|B4|||Age||years|Mean|43.67|43.67|Standard Deviation|11.47|11.47|||
3917776|NCT01443858|3741030|B3|||Age||years|Mean|45.80|45.8|Standard Deviation|10.09|10.09|||
3917777|NCT01443858|3741031|B2|||Age||years|Mean|42.40|42.4|Standard Deviation|11.60|11.6|||
3917778|NCT01443858|3741032|B1|||Age||years|Mean|42.80|42.8|Standard Deviation|12.3|12.3|||
3917779|NCT01443845|3741054|B3|||Body-Mass Index (BMI)||kg/m2|Mean|25.86|25.86|Standard Deviation|5.82|5.82|||
3917780|NCT01443845|3741055|B2|||Body-Mass Index (BMI)||kg/m2|Mean|25.99|25.99|Standard Deviation|5.91|5.91|||
3917781|NCT01443845|3741056|B1|||Body-Mass Index (BMI)||kg/m2|Mean|25.72|25.72|Standard Deviation|5.72|5.72|||
3917782|NCT01443845|3741054|B3|||Height||cm|Median|167.67|167.67|Standard Deviation|9.37|9.37|||
3917783|NCT01443845|3741055|B2|||Height||cm|Median|167.80|167.8|Standard Deviation|9.35|9.35|||
3917784|NCT01443845|3741056|B1|||Height||cm|Median|167.53|167.53|Standard Deviation|9.39|9.39|||
3917785|NCT01443845|3741054|B3|||Weight||kg|Mean|73.10|73.1|Standard Deviation|19.13|19.13|||
3917786|NCT01443845|3741055|B2|||Weight||kg|Mean|73.63|73.63|Standard Deviation|19.57|19.57|||
3917787|NCT01443845|3741056|B1|||Weight||kg|Mean|72.57|72.57|Standard Deviation|18.67|18.67|||
3917788|NCT01443845|3741054|B3|Obese: >= 30||BMI Category||Participants|Number|520|520.0||||||
3917789|NCT01443845|3741055|B2|Obese: >= 30||BMI Category||Participants|Number|268|268.0||||||
3917790|NCT01443845|3741056|B1|Obese: >= 30||BMI Category||Participants|Number|252|252.0||||||
3917791|NCT01443845|3741054|B3|Over weight: >= 25 to < 30||BMI Category||Participants|Number|689|689.0||||||
3917792|NCT01443845|3741055|B2|Over weight: >= 25 to < 30||BMI Category||Participants|Number|342|342.0||||||
3917793|NCT01443845|3741056|B1|Over weight: >= 25 to < 30||BMI Category||Participants|Number|347|347.0||||||
3917794|NCT01443845|3741054|B3|Normal weight: >= 18.5 to < 25||BMI Category||Participants|Number|948|948.0||||||
3917795|NCT01443845|3741055|B2|Normal weight: >= 18.5 to < 25||BMI Category||Participants|Number|468|468.0||||||
3917796|NCT01443845|3741056|B1|Normal weight: >= 18.5 to < 25||BMI Category||Participants|Number|480|480.0||||||
3917797|NCT01443845|3741054|B3|Under weight: < 18.5||BMI Category||Participants|Number|195|195.0||||||
3917798|NCT01443845|3741055|B2|Under weight: < 18.5||BMI Category||Participants|Number|100|100.0||||||
3917799|NCT01443845|3741056|B1|Under weight: < 18.5||BMI Category||Participants|Number|95|95.0||||||
3917800|NCT01443845|3741054|B3|No-LAMA||Long-acting muscarinic antagonist(s) (LAMA) use||Participants|Number|1258|1258.0||||||
3917801|NCT01443845|3741055|B2|No-LAMA||Long-acting muscarinic antagonist(s) (LAMA) use||Participants|Number|630|630.0||||||
3917802|NCT01443845|3741056|B1|No-LAMA||Long-acting muscarinic antagonist(s) (LAMA) use||Participants|Number|628|628.0||||||
3917803|NCT01443845|3741054|B3|LAMA||Long-acting muscarinic antagonist(s) (LAMA) use||Participants|Number|1094|1094.0||||||
3917804|NCT01443845|3741055|B2|LAMA||Long-acting muscarinic antagonist(s) (LAMA) use||Participants|Number|548|548.0||||||
3917805|NCT01443845|3741056|B1|LAMA||Long-acting muscarinic antagonist(s) (LAMA) use||Participants|Number|546|546.0||||||
3917806|NCT01443845|3741054|B3|Symbicort||ICS/LABA Therapy||Participants|Number|818|818.0||||||
3917807|NCT01443845|3741055|B2|Symbicort||ICS/LABA Therapy||Participants|Number|410|410.0||||||
3917808|NCT01443845|3741056|B1|Symbicort||ICS/LABA Therapy||Participants|Number|408|408.0||||||
3917809|NCT01443845|3741054|B3|Advair||ICS/LABA Therapy||Participants|Number|1534|1534.0||||||
3917810|NCT01443845|3741055|B2|Advair||ICS/LABA Therapy||Participants|Number|768|768.0||||||
3917811|NCT01443845|3741056|B1|Advair||ICS/LABA Therapy||Participants|Number|766|766.0||||||
3917812|NCT01443845|3741054|B3|Not Hispanic or Latino||Ethnicity||Participants|Number|1812|1812.0||||||
3917813|NCT01443845|3741055|B2|Not Hispanic or Latino||Ethnicity||Participants|Number|910|910.0||||||
3917814|NCT01443845|3741056|B1|Not Hispanic or Latino||Ethnicity||Participants|Number|902|902.0||||||
3917815|NCT01443845|3741054|B3|Hispanic or Latino||Ethnicity||Participants|Number|540|540.0||||||
3917816|NCT01443845|3741055|B2|Hispanic or Latino||Ethnicity||Participants|Number|268|268.0||||||
3917817|NCT01443845|3741056|B1|Hispanic or Latino||Ethnicity||Participants|Number|272|272.0||||||
3917818|NCT01443845|3741054|B3|Peru||Region of Enrollment||participants|Number|71|71.0||||||
3917819|NCT01443845|3741055|B2|Peru||Region of Enrollment||participants|Number|36|36.0||||||
3917820|NCT01443845|3741056|B1|Peru||Region of Enrollment||participants|Number|35|35.0||||||
3917821|NCT01443845|3741054|B3|Serbia||Region of Enrollment||participants|Number|94|94.0||||||
3917822|NCT01443845|3741055|B2|Serbia||Region of Enrollment||participants|Number|47|47.0||||||
3917823|NCT01443845|3741056|B1|Serbia||Region of Enrollment||participants|Number|47|47.0||||||
3917824|NCT01443845|3741054|B3|Mexico||Region of Enrollment||participants|Number|44|44.0||||||
3917825|NCT01443845|3741055|B2|Mexico||Region of Enrollment||participants|Number|22|22.0||||||
3917826|NCT01443845|3741056|B1|Mexico||Region of Enrollment||participants|Number|22|22.0||||||
3917827|NCT01443845|3741054|B3|Italy||Region of Enrollment||participants|Number|1|1.0||||||
3917828|NCT01443845|3741055|B2|Italy||Region of Enrollment||participants|Number|1|1.0||||||
3917829|NCT01443845|3741056|B1|Italy||Region of Enrollment||participants|Number|0|0.0||||||
3917830|NCT01443845|3741054|B3|Taiwan||Region of Enrollment||participants|Number|13|13.0||||||
3917831|NCT01443845|3741055|B2|Taiwan||Region of Enrollment||participants|Number|6|6.0||||||
3917832|NCT01443845|3741056|B1|Taiwan||Region of Enrollment||participants|Number|7|7.0||||||
3917833|NCT01443845|3741054|B3|Canada||Region of Enrollment||participants|Number|29|29.0||||||
3917834|NCT01443845|3741055|B2|Canada||Region of Enrollment||participants|Number|15|15.0||||||
3917835|NCT01443845|3741056|B1|Canada||Region of Enrollment||participants|Number|14|14.0||||||
3917836|NCT01443845|3741054|B3|Spain||Region of Enrollment||participants|Number|12|12.0||||||
3917837|NCT01443845|3741055|B2|Spain||Region of Enrollment||participants|Number|6|6.0||||||
3917838|NCT01443845|3741056|B1|Spain||Region of Enrollment||participants|Number|6|6.0||||||
3917839|NCT01443845|3741054|B3|Thailand||Region of Enrollment||participants|Number|34|34.0||||||
3917840|NCT01443845|3741055|B2|Thailand||Region of Enrollment||participants|Number|16|16.0||||||
3917841|NCT01443845|3741056|B1|Thailand||Region of Enrollment||participants|Number|18|18.0||||||
3917842|NCT01443845|3741054|B3|Malaysia||Region of Enrollment||participants|Number|13|13.0||||||
3917843|NCT01443845|3741055|B2|Malaysia||Region of Enrollment||participants|Number|7|7.0||||||
3917844|NCT01443845|3741056|B1|Malaysia||Region of Enrollment||participants|Number|6|6.0||||||
3917845|NCT01443845|3741054|B3|Ukraine||Region of Enrollment||participants|Number|190|190.0||||||
3917846|NCT01443845|3741055|B2|Ukraine||Region of Enrollment||participants|Number|95|95.0||||||
3917847|NCT01443845|3741056|B1|Ukraine||Region of Enrollment||participants|Number|95|95.0||||||
3917848|NCT01443845|3741054|B3|Philippines||Region of Enrollment||participants|Number|261|261.0||||||
3917849|NCT01443845|3741055|B2|Philippines||Region of Enrollment||participants|Number|131|131.0||||||
3917850|NCT01443845|3741056|B1|Philippines||Region of Enrollment||participants|Number|130|130.0||||||
3917851|NCT01443845|3741054|B3|United States||Region of Enrollment||participants|Number|915|915.0||||||
3917852|NCT01443845|3741055|B2|United States||Region of Enrollment||participants|Number|457|457.0||||||
3917853|NCT01443845|3741056|B1|United States||Region of Enrollment||participants|Number|458|458.0||||||
3917854|NCT01443845|3741054|B3|Romania||Region of Enrollment||participants|Number|109|109.0||||||
3917855|NCT01443845|3741055|B2|Romania||Region of Enrollment||participants|Number|54|54.0||||||
3917856|NCT01443845|3741056|B1|Romania||Region of Enrollment||participants|Number|55|55.0||||||
3917857|NCT01443845|3741054|B3|Russian Federation||Region of Enrollment||participants|Number|154|154.0||||||
3917858|NCT01443845|3741055|B2|Russian Federation||Region of Enrollment||participants|Number|77|77.0||||||
3917859|NCT01443845|3741056|B1|Russian Federation||Region of Enrollment||participants|Number|77|77.0||||||
3917860|NCT01443845|3741054|B3|Argentina||Region of Enrollment||participants|Number|395|395.0||||||
3917861|NCT01443845|3741055|B2|Argentina||Region of Enrollment||participants|Number|198|198.0||||||
3917862|NCT01443845|3741056|B1|Argentina||Region of Enrollment||participants|Number|197|197.0||||||
3917863|NCT01443845|3741054|B3|Colombia||Region of Enrollment||participants|Number|17|17.0||||||
3917864|NCT01443845|3741055|B2|Colombia||Region of Enrollment||participants|Number|10|10.0||||||
3917865|NCT01443845|3741056|B1|Colombia||Region of Enrollment||participants|Number|7|7.0||||||
3917866|NCT01443845|3741054|B3|Other||Race/Ethnicity, Customized||Participants|Number|50|50.0||||||
3917867|NCT01443845|3741055|B2|Other||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
3917868|NCT01443845|3741056|B1|Other||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
3917869|NCT01443845|3741054|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3917870|NCT01443845|3741055|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3917871|NCT01443845|3741056|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3917872|NCT01443845|3741054|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
3917873|NCT01443845|3741055|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
3917874|NCT01443845|3741056|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3917875|NCT01443845|3741054|B3|Asian||Race/Ethnicity, Customized||Participants|Number|337|337.0||||||
3917876|NCT01443845|3741055|B2|Asian||Race/Ethnicity, Customized||Participants|Number|167|167.0||||||
3917877|NCT01443845|3741056|B1|Asian||Race/Ethnicity, Customized||Participants|Number|170|170.0||||||
3917878|NCT01443845|3741054|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|62|62.0||||||
3917879|NCT01443845|3741055|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
3917880|NCT01443845|3741056|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
3917881|NCT01443845|3741054|B3|White||Race/Ethnicity, Customized||Participants|Number|1879|1879.0||||||
3917882|NCT01443845|3741055|B2|White||Race/Ethnicity, Customized||Participants|Number|935|935.0||||||
3917883|NCT01443845|3741056|B1|White||Race/Ethnicity, Customized||Participants|Number|944|944.0||||||
3917884|NCT01443845|3741054|B3|Female||Sex/Gender, Customized||Participants|Number|737|737.0||||||
3917885|NCT01443845|3741055|B2|Female||Sex/Gender, Customized||Participants|Number|357|357.0||||||
3917886|NCT01443845|3741056|B1|Female||Sex/Gender, Customized||Participants|Number|380|380.0||||||
3917887|NCT01443845|3741054|B3|Male||Sex/Gender, Customized||Participants|Number|1615|1615.0||||||
3917888|NCT01443845|3741055|B2|Male||Sex/Gender, Customized||Participants|Number|821|821.0||||||
3917889|NCT01443845|3741056|B1|Male||Sex/Gender, Customized||Participants|Number|794|794.0||||||
3917890|NCT01443845|3741054|B3|Adults over 65 years||Age, Customized||Participants|Number|1078|1078.0||||||
3917891|NCT01443845|3741055|B2|Adults over 65 years||Age, Customized||Participants|Number|538|538.0||||||
3917892|NCT01443845|3741056|B1|Adults over 65 years||Age, Customized||Participants|Number|540|540.0||||||
3917893|NCT01443845|3741054|B3|Adults 40-65 years||Age, Customized||Participants|Number|1274|1274.0||||||
3917894|NCT01443845|3741055|B2|Adults 40-65 years||Age, Customized||Participants|Number|640|640.0||||||
3917895|NCT01443845|3741056|B1|Adults 40-65 years||Age, Customized||Participants|Number|634|634.0||||||
3917896|NCT01443845|3741054|B3|||Age||years|Mean|64.5|64.5|Standard Deviation|8.6|8.6|||
3917897|NCT01443845|3741055|B2|||Age||years|Mean|64.4|64.4|Standard Deviation|8.8|8.8|||
3917898|NCT01443845|3741056|B1|||Age||years|Mean|64.5|64.5|Standard Deviation|8.4|8.4|||
3917899|NCT01443494|3741069|B1|China||Region of Enrollment||participants|Number|19|19.0||||||
3917900|NCT01443494|3741069|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3917901|NCT01443494|3741069|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3917902|NCT01443494|3741069|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3917903|NCT01443494|3741069|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3917904|NCT01443494|3741069|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3917905|NCT01443403|3741074|B5|||Spontaneous Bowel Movement (SBM) Frequency per Week||SBMs/week|Mean|1.36|1.36|Standard Deviation|0.851|0.851|||
3917906|NCT01443403|3741075|B4|||Spontaneous Bowel Movement (SBM) Frequency per Week||SBMs/week|Mean|1.20|1.2|Standard Deviation|0.948|0.948|||
3917907|NCT01443403|3741076|B3|||Spontaneous Bowel Movement (SBM) Frequency per Week||SBMs/week|Mean|1.52|1.52|Standard Deviation|0.916|0.916|||
3917908|NCT01443403|3741077|B2|||Spontaneous Bowel Movement (SBM) Frequency per Week||SBMs/week|Mean|1.51|1.51|Standard Deviation|0.820|0.82|||
3917909|NCT01443403|3741078|B1|||Spontaneous Bowel Movement (SBM) Frequency per Week||SBMs/week|Mean|1.22|1.22|Standard Deviation|0.720|0.72|||
3917910|NCT01443403|3741074|B5|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3917911|NCT01443403|3741075|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3917912|NCT01443403|3741076|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3917913|NCT01443403|3741077|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3917914|NCT01443403|3741078|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3917915|NCT01443403|3741074|B5|White||Race/Ethnicity, Customized||participants|Number|196|196.0||||||
3917916|NCT01443403|3741075|B4|White||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
3917917|NCT01443403|3741076|B3|White||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
3917918|NCT01443403|3741077|B2|White||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
3917919|NCT01443403|3741078|B1|White||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
3917920|NCT01443403|3741074|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3917921|NCT01443403|3741075|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3917922|NCT01443403|3741076|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3917923|NCT01443403|3741077|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3917924|NCT01443403|3741078|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3917925|NCT01443403|3741074|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
3917926|NCT01443403|3741075|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3917927|NCT01443403|3741076|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3917928|NCT01443403|3741077|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3917929|NCT01443403|3741078|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3917930|NCT01443403|3741074|B5|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3917931|NCT01443403|3741075|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3917932|NCT01443403|3741076|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3917933|NCT01443403|3741077|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3917934|NCT01443403|3741078|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3917935|NCT01443403|3741074|B5|American Indian or Alaska Naive||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3917936|NCT01443403|3741075|B4|American Indian or Alaska Naive||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3917937|NCT01443403|3741076|B3|American Indian or Alaska Naive||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3917938|NCT01443403|3741077|B2|American Indian or Alaska Naive||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3917939|NCT01443403|3741078|B1|American Indian or Alaska Naive||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3917940|NCT01443403|3741074|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917941|NCT01443403|3741075|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918002|NCT01443364|3741228|B1||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3917942|NCT01443403|3741076|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917943|NCT01443403|3741077|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917944|NCT01443403|3741078|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917945|NCT01443403|3741074|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|222|222.0||||||
3917946|NCT01443403|3741075|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3917947|NCT01443403|3741076|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3917948|NCT01443403|3741077|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3917949|NCT01443403|3741078|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3917950|NCT01443403|3741074|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3917951|NCT01443403|3741075|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3917952|NCT01443403|3741076|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3917953|NCT01443403|3741077|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3917954|NCT01443403|3741078|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3917955|NCT01443403|3741074|B5||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3917956|NCT01443403|3741075|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3917957|NCT01443403|3741076|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3917958|NCT01443403|3741077|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3917959|NCT01443403|3741078|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3917960|NCT01443403|3741074|B5||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3917961|NCT01443403|3741075|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3917962|NCT01443403|3741076|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3917963|NCT01443403|3741077|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3917964|NCT01443403|3741078|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3917965|NCT01443403|3741074|B5|≥ 75 years||Age, Customized||participants|Number|4|4.0||||||
3917966|NCT01443403|3741075|B4|≥ 75 years||Age, Customized||participants|Number|1|1.0||||||
3917967|NCT01443403|3741076|B3|≥ 75 years||Age, Customized||participants|Number|1|1.0||||||
3917968|NCT01443403|3741077|B2|≥ 75 years||Age, Customized||participants|Number|0|0.0||||||
3917969|NCT01443403|3741078|B1|≥ 75 years||Age, Customized||participants|Number|2|2.0||||||
3917970|NCT01443403|3741074|B5|≥ 65 - < 75 years||Age, Customized||participants|Number|19|19.0||||||
3917971|NCT01443403|3741075|B4|≥ 65 - < 75 years||Age, Customized||participants|Number|8|8.0||||||
3917972|NCT01443403|3741076|B3|≥ 65 - < 75 years||Age, Customized||participants|Number|3|3.0||||||
3917973|NCT01443403|3741077|B2|≥ 65 - < 75 years||Age, Customized||participants|Number|2|2.0||||||
3917974|NCT01443403|3741078|B1|≥ 65 - < 75 years||Age, Customized||participants|Number|6|6.0||||||
3917975|NCT01443403|3741074|B5|≥ 50 - < 65 years||Age, Customized||participants|Number|127|127.0||||||
3917976|NCT01443403|3741075|B4|≥ 50 - < 65 years||Age, Customized||participants|Number|29|29.0||||||
3917977|NCT01443403|3741076|B3|≥ 50 - < 65 years||Age, Customized||participants|Number|34|34.0||||||
3917978|NCT01443403|3741077|B2|≥ 50 - < 65 years||Age, Customized||participants|Number|31|31.0||||||
3917979|NCT01443403|3741078|B1|≥ 50 - < 65 years||Age, Customized||participants|Number|33|33.0||||||
3917980|NCT01443403|3741074|B5|≥ 40 - < 50 years||Age, Customized||participants|Number|52|52.0||||||
3917981|NCT01443403|3741075|B4|≥ 40 - < 50 years||Age, Customized||participants|Number|12|12.0||||||
3917982|NCT01443403|3741076|B3|≥ 40 - < 50 years||Age, Customized||participants|Number|8|8.0||||||
3917983|NCT01443403|3741077|B2|≥ 40 - < 50 years||Age, Customized||participants|Number|18|18.0||||||
3917984|NCT01443403|3741078|B1|≥ 40 - < 50 years||Age, Customized||participants|Number|14|14.0||||||
3917985|NCT01443403|3741074|B5|≥ 18 - < 40 years||Age, Customized||participants|Number|36|36.0||||||
3917986|NCT01443403|3741075|B4|≥ 18 - < 40 years||Age, Customized||participants|Number|7|7.0||||||
3917987|NCT01443403|3741076|B3|≥ 18 - < 40 years||Age, Customized||participants|Number|13|13.0||||||
3917988|NCT01443403|3741077|B2|≥ 18 - < 40 years||Age, Customized||participants|Number|10|10.0||||||
3917989|NCT01443403|3741078|B1|≥ 18 - < 40 years||Age, Customized||participants|Number|6|6.0||||||
3917990|NCT01443403|3741074|B5|||Age||Years|Mean|51.9|51.9|Standard Deviation|10.80|10.8|||
3917991|NCT01443403|3741075|B4|||Age||Years|Mean|54.1|54.1|Standard Deviation|11.19|11.19|||
3917992|NCT01443403|3741076|B3|||Age||Years|Mean|50.7|50.7|Standard Deviation|11.40|11.4|||
3917993|NCT01443403|3741077|B2|||Age||Years|Mean|49.5|49.5|Standard Deviation|9.71|9.71|||
3917994|NCT01443403|3741078|B1|||Age||Years|Mean|53.1|53.1|Standard Deviation|10.88|10.88|||
3917995|NCT01443364|3741228|B1|||BMI||kg/m^2|Mean|25.66|25.66|Standard Deviation|4.52|4.52|||
3917996|NCT01443364|3741228|B1|||Height||centimeter|Mean|164.16|164.16|Standard Deviation|8.48|8.48|||
3917997|NCT01443364|3741228|B1|||Weight||kilogram|Mean|69.33|69.33|Standard Deviation|14.10|14.1|||
3917998|NCT01443364|3741228|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3917999|NCT01443364|3741228|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
3918000|NCT01443364|3741228|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3918001|NCT01443364|3741228|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3918003|NCT01443364|3741228|B1|||Age||years|Mean|54.8|54.8|Standard Deviation|13.2|13.2|||
3918004|NCT01443364|3741228|B1||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
3918005|NCT01443364|3741228|B1||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
3918006|NCT01443364|3741228|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918007|NCT01443130|3741351|B7|Malawi||Region of Enrollment||participants|Number|1703|1703.0||||||
3918008|NCT01443130|3741352|B6|Malawi||Region of Enrollment||participants|Number|259|259.0||||||
3918009|NCT01443130|3741353|B5|Malawi||Region of Enrollment||participants|Number|274|274.0||||||
3918010|NCT01443130|3741354|B4|Malawi||Region of Enrollment||participants|Number|270|270.0||||||
3918011|NCT01443130|3741355|B3|Malawi||Region of Enrollment||participants|Number|300|300.0||||||
3918012|NCT01443130|3741356|B2|Malawi||Region of Enrollment||participants|Number|300|300.0||||||
3918013|NCT01443130|3741357|B1|Malawi||Region of Enrollment||participants|Number|300|300.0||||||
3918014|NCT01443130|3741351|B7||Male|Gender||Participants|Count of Participants|391|391.0||||||
3918015|NCT01443130|3741352|B6||Male|Gender||Participants|Count of Participants|123|123.0||||||
3918016|NCT01443130|3741353|B5||Male|Gender||Participants|Count of Participants|131|131.0||||||
3918017|NCT01443130|3741354|B4||Male|Gender||Participants|Count of Participants|137|137.0||||||
3918018|NCT01443130|3741355|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3918019|NCT01443130|3741356|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3918020|NCT01443130|3741357|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3918021|NCT01443130|3741351|B7||Female|Gender||Participants|Count of Participants|1312|1312.0||||||
3918022|NCT01443130|3741352|B6||Female|Gender||Participants|Count of Participants|136|136.0||||||
3918023|NCT01443130|3741353|B5||Female|Gender||Participants|Count of Participants|143|143.0||||||
3918024|NCT01443130|3741354|B4||Female|Gender||Participants|Count of Participants|133|133.0||||||
3918025|NCT01443130|3741355|B3||Female|Gender||Participants|Count of Participants|300|300.0||||||
3918026|NCT01443130|3741356|B2||Female|Gender||Participants|Count of Participants|300|300.0||||||
3918027|NCT01443130|3741357|B1||Female|Gender||Participants|Count of Participants|300|300.0||||||
3918028|NCT01443130|3741351|B7|||Age||years|Mean|20.50|20.5|Standard Deviation|3.33|3.33|||
3918029|NCT01443130|3741352|B6|||Age||years|Mean|0|0.0|Standard Deviation|0|0.0|||
3918030|NCT01443130|3741353|B5|||Age||years|Mean|0|0.0|Standard Deviation|0|0.0|||
3918031|NCT01443130|3741354|B4|||Age||years|Mean|0|0.0|Standard Deviation|0|0.0|||
3918032|NCT01443130|3741355|B3|||Age||years|Mean|20.44|20.44|Standard Deviation|3.14|3.14|||
3918033|NCT01443130|3741356|B2|||Age||years|Mean|20.67|20.67|Standard Deviation|3.24|3.24|||
3918034|NCT01443130|3741357|B1|||Age||years|Mean|20.40|20.4|Standard Deviation|3.59|3.59|||
3918035|NCT01443130|3741351|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3918036|NCT01443130|3741352|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3918037|NCT01443130|3741353|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3918038|NCT01443130|3741354|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3918039|NCT01443130|3741355|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3918040|NCT01443130|3741356|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3918041|NCT01443130|3741357|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3918042|NCT01443130|3741351|B7||Between 18 and 65 years|Age||Participants|Count of Participants|630|630.0||||||
3918043|NCT01443130|3741352|B6||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3918044|NCT01443130|3741353|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3918045|NCT01443130|3741354|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3918046|NCT01443130|3741355|B3||Between 18 and 65 years|Age||Participants|Count of Participants|210|210.0||||||
3918047|NCT01443130|3741356|B2||Between 18 and 65 years|Age||Participants|Count of Participants|219|219.0||||||
3918048|NCT01443130|3741357|B1||Between 18 and 65 years|Age||Participants|Count of Participants|201|201.0||||||
3918049|NCT01443130|3741351|B7||<=18 years|Age||Participants|Count of Participants|1073|1073.0||||||
3918050|NCT01443130|3741352|B6||<=18 years|Age||Participants|Count of Participants|259|259.0||||||
3918051|NCT01443130|3741353|B5||<=18 years|Age||Participants|Count of Participants|274|274.0||||||
3918052|NCT01443130|3741354|B4||<=18 years|Age||Participants|Count of Participants|270|270.0||||||
3918053|NCT01443130|3741355|B3||<=18 years|Age||Participants|Count of Participants|90|90.0||||||
3918054|NCT01443130|3741356|B2||<=18 years|Age||Participants|Count of Participants|81|81.0||||||
3918055|NCT01443130|3741357|B1||<=18 years|Age||Participants|Count of Participants|99|99.0||||||
3918056|NCT01443078|3741412|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3918057|NCT01443078|3741412|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3918058|NCT01443078|3741412|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3918059|NCT01443078|3741412|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3918060|NCT01443078|3741412|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918061|NCT01443026|3741417|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
3918062|NCT01443026|3741418|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
3918063|NCT01443026|3741419|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
3918064|NCT01443026|3741417|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918065|NCT01443026|3741418|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918066|NCT01443026|3741419|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918067|NCT01443026|3741417|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918068|NCT01443026|3741418|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918069|NCT01443026|3741419|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918070|NCT01443026|3741417|B3||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3918071|NCT01443026|3741418|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3918072|NCT01443026|3741419|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3918073|NCT01443026|3741417|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3918074|NCT01443026|3741418|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3918075|NCT01443026|3741419|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3918076|NCT01443026|3741417|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918077|NCT01443026|3741418|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918078|NCT01443026|3741419|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918079|NCT01443026|3741417|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3918080|NCT01443026|3741418|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918081|NCT01443026|3741419|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3918082|NCT01443026|3741417|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918083|NCT01443026|3741418|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918084|NCT01443026|3741419|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918085|NCT01443026|3741417|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3918086|NCT01443026|3741418|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3918087|NCT01443026|3741419|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3918088|NCT01443026|3741417|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3918089|NCT01443026|3741418|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3918090|NCT01443026|3741419|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3918091|NCT01443026|3741417|B3|||Age||years|Mean|65.2|65.2|Standard Deviation|8.4|8.4|||
3918092|NCT01443026|3741418|B2|||Age||years|Mean|67.1|67.1|Standard Deviation|8.1|8.1|||
3918093|NCT01443026|3741419|B1|||Age||years|Mean|62.9|62.9|Standard Deviation|8.3|8.3|||
3918094|NCT01442844|3741426|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3918095|NCT01442844|3741427|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3918096|NCT01442844|3741428|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3918097|NCT01442844|3741426|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3918098|NCT01442844|3741427|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3918099|NCT01442844|3741428|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3918100|NCT01442844|3741426|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3918101|NCT01442844|3741427|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3918102|NCT01442844|3741428|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3918103|NCT01442844|3741426|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3918104|NCT01442844|3741427|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3918105|NCT01442844|3741428|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3918106|NCT01442844|3741426|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3918107|NCT01442844|3741427|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3918108|NCT01442844|3741428|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3918109|NCT01442844|3741426|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918110|NCT01442844|3741427|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918111|NCT01442844|3741428|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918112|NCT01442844|3741426|B3|||Age||years|Mean|69|69.0|Full Range|||63.0|74.0|
3918113|NCT01442844|3741427|B2|||Age||years|Mean|66.5|66.5|Full Range|||63.0|70.0|
3918114|NCT01442844|3741428|B1|||Age||years|Mean|74|74.0|Full Range|||||
3918115|NCT01442779|3741435|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3918116|NCT01442779|3741435|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3918117|NCT01442779|3741435|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3918118|NCT01442779|3741435|B1|||Age||years|Mean|67|67.0|Standard Deviation|8.8|8.8|||
3918119|NCT01442779|3741435|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3918120|NCT01442779|3741435|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3918121|NCT01442779|3741435|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918122|NCT01442714|3741441|B1|Not eligible||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|"ECOG PS Scale:~0 Fully active, able to carry on all pre-disease performance without restriction.~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours.~Capable of only limited self-care, confined to bed or chair more than 50% of waking hours.~Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.~Dead"|Participants|Count of Participants|5|5.0||||||
3918123|NCT01442714|3741441|B1|2||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|"ECOG PS Scale:~0 Fully active, able to carry on all pre-disease performance without restriction.~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours.~Capable of only limited self-care, confined to bed or chair more than 50% of waking hours.~Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.~Dead"|Participants|Count of Participants|3|3.0||||||
3918124|NCT01442714|3741441|B1|1||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|"ECOG PS Scale:~0 Fully active, able to carry on all pre-disease performance without restriction.~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours.~Capable of only limited self-care, confined to bed or chair more than 50% of waking hours.~Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.~Dead"|Participants|Count of Participants|6|6.0||||||
3918125|NCT01442714|3741441|B1|0||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|"ECOG PS Scale:~0 Fully active, able to carry on all pre-disease performance without restriction.~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours.~Capable of only limited self-care, confined to bed or chair more than 50% of waking hours.~Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.~Dead"|Participants|Count of Participants|24|24.0||||||
3918126|NCT01442714|3741441|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3918127|NCT01442714|3741441|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918128|NCT01442714|3741441|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3918129|NCT01442714|3741441|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3918130|NCT01442714|3741441|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918131|NCT01442714|3741441|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3918132|NCT01442714|3741441|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918133|NCT01442714|3741441|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3918134|NCT01442714|3741441|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3918135|NCT01442714|3741441|B1||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
3918136|NCT01442714|3741441|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3918137|NCT01442714|3741441|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918138|NCT01442688|3741447|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
3918139|NCT01442688|3741448|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
3918140|NCT01442688|3741449|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
3918141|NCT01442688|3741447|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3918142|NCT01442688|3741448|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3918143|NCT01442688|3741449|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3918144|NCT01442688|3741447|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3918145|NCT01442688|3741448|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3918146|NCT01442688|3741449|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3918147|NCT01442688|3741447|B3|Between 18 and 55 years||Age, Customized||participants|Number|62|62.0||||||
3918148|NCT01442688|3741448|B2|Between 18 and 55 years||Age, Customized||participants|Number|31|31.0||||||
3918149|NCT01442688|3741449|B1|Between 18 and 55 years||Age, Customized||participants|Number|31|31.0||||||
3918150|NCT01442688|3741447|B3|||Age||years|Mean|32.2|32.2|Standard Deviation|10.3|10.3|||
3918151|NCT01442688|3741448|B2|||Age||years|Mean|30.1|30.1|Standard Deviation|8.91|8.91|||
3918152|NCT01442688|3741449|B1|||Age||years|Mean|34.3|34.3|Standard Deviation|11.2|11.2|||
3918153|NCT01442675|3741458|B1|United States||Region of Enrollment||Participants|Number|834|834.0||||||
3918154|NCT01442675|3741458|B1||Male|Sex: Female, Male||Participants|Count of Participants|400|400.0||||||
3918155|NCT01442675|3741458|B1||Female|Sex: Female, Male||Participants|Count of Participants|434|434.0||||||
3918156|NCT01442675|3741458|B1|Age Continuous||Age||Years|Mean|17.8|17.8|Standard Deviation|3.2|3.2|||
3918157|NCT01442675|3741458|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3918158|NCT01442675|3741458|B1||Between 18 and 65 years|Age||Participants|Count of Participants|242|242.0||||||
3918159|NCT01442675|3741458|B1||<=18 years|Age||Participants|Count of Participants|592|592.0||||||
3918160|NCT01442493|3741468|B3|United States||Region of Enrollment||participants|Number|295|295.0||||||
3918161|NCT01442493|3741469|B2|United States||Region of Enrollment||participants|Number|149|149.0||||||
3918162|NCT01442493|3741470|B1|United States||Region of Enrollment||participants|Number|146|146.0||||||
3918163|NCT01442493|3741468|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3918164|NCT01442493|3741469|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3918165|NCT01442493|3741470|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3918166|NCT01442493|3741468|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|122|122.0||||||
3918167|NCT01442493|3741469|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|66|66.0||||||
3918168|NCT01442493|3741470|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|56|56.0||||||
3918169|NCT01442493|3741468|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|171|171.0||||||
3918170|NCT01442493|3741469|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|81|81.0||||||
3918171|NCT01442493|3741470|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|90|90.0||||||
3918172|NCT01442493|3741468|B3||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3918173|NCT01442493|3741469|B2||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3918174|NCT01442493|3741470|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3918175|NCT01442493|3741468|B3||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3918176|NCT01442493|3741469|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3918177|NCT01442493|3741470|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3918178|NCT01442493|3741468|B3|||Age||years|Mean|42.7|42.7|Standard Deviation|10.1|10.1|||
3918179|NCT01442493|3741469|B2|||Age||years|Mean|42.0|42.0|Standard Deviation|9.8|9.8|||
3918180|NCT01442493|3741470|B1|||Age||years|Mean|43.5|43.5|Standard Deviation|10.3|10.3|||
3918181|NCT01442376|3741489|B4|HEC||Emetogenicity of chemotherapy in Cycle 1||participants|Number|154|154.0||||||
3918182|NCT01442376|3741490|B3|HEC||Emetogenicity of chemotherapy in Cycle 1||participants|Number|51|51.0||||||
3918183|NCT01442376|3741491|B2|HEC||Emetogenicity of chemotherapy in Cycle 1||participants|Number|49|49.0||||||
3918184|NCT01442376|3741492|B1|HEC||Emetogenicity of chemotherapy in Cycle 1||participants|Number|54|54.0||||||
3918185|NCT01442376|3741489|B4|MEC||Emetogenicity of chemotherapy in Cycle 1||participants|Number|339|339.0||||||
3918186|NCT01442376|3741490|B3|MEC||Emetogenicity of chemotherapy in Cycle 1||participants|Number|111|111.0||||||
3918187|NCT01442376|3741491|B2|MEC||Emetogenicity of chemotherapy in Cycle 1||participants|Number|116|116.0||||||
3918188|NCT01442376|3741492|B1|MEC||Emetogenicity of chemotherapy in Cycle 1||participants|Number|112|112.0||||||
3918189|NCT01442376|3741489|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3918190|NCT01442376|3741490|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918191|NCT01442376|3741491|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918192|NCT01442376|3741492|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3918193|NCT01442376|3741489|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3918194|NCT01442376|3741490|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3918195|NCT01442376|3741491|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3918196|NCT01442376|3741492|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3918197|NCT01442376|3741489|B4||White|Race (NIH/OMB)||Participants|Count of Participants|469|469.0||||||
3918198|NCT01442376|3741490|B3||White|Race (NIH/OMB)||Participants|Count of Participants|159|159.0||||||
3918199|NCT01442376|3741491|B2||White|Race (NIH/OMB)||Participants|Count of Participants|154|154.0||||||
3918200|NCT01442376|3741492|B1||White|Race (NIH/OMB)||Participants|Count of Participants|156|156.0||||||
3918201|NCT01442376|3741489|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3918202|NCT01442376|3741490|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918203|NCT01442376|3741491|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918204|NCT01442376|3741492|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3918205|NCT01442376|3741489|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918206|NCT01442376|3741490|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918207|NCT01442376|3741491|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918208|NCT01442376|3741492|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918209|NCT01442376|3741489|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3918210|NCT01442376|3741490|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918211|NCT01442376|3741491|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918212|NCT01442376|3741492|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3918213|NCT01442376|3741489|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918214|NCT01442376|3741490|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918215|NCT01442376|3741491|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918216|NCT01442376|3741492|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918217|NCT01442376|3741489|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918218|NCT01442376|3741490|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918219|NCT01442376|3741491|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918220|NCT01442376|3741492|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918221|NCT01442376|3741489|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|429|429.0||||||
3918222|NCT01442376|3741490|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|150|150.0||||||
3918223|NCT01442376|3741491|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|139|139.0||||||
3918224|NCT01442376|3741492|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
3918225|NCT01442376|3741489|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3918226|NCT01442376|3741490|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3918227|NCT01442376|3741491|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3918228|NCT01442376|3741492|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3918229|NCT01442376|3741489|B4||Male|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
3918230|NCT01442376|3741490|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3918231|NCT01442376|3741491|B2||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3918232|NCT01442376|3741492|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3918233|NCT01442376|3741489|B4||Female|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
3918234|NCT01442376|3741490|B3||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3918235|NCT01442376|3741491|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3918236|NCT01442376|3741492|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3918237|NCT01442376|3741489|B4|12 to <17 years||Age, Customized||participants|Number|150|150.0||||||
3918238|NCT01442376|3741490|B3|12 to <17 years||Age, Customized||participants|Number|49|49.0||||||
3918239|NCT01442376|3741491|B2|12 to <17 years||Age, Customized||participants|Number|50|50.0||||||
3918240|NCT01442376|3741492|B1|12 to <17 years||Age, Customized||participants|Number|51|51.0||||||
3918241|NCT01442376|3741489|B4|6 to <12 years||Age, Customized||participants|Number|136|136.0||||||
3918242|NCT01442376|3741490|B3|6 to <12 years||Age, Customized||participants|Number|44|44.0||||||
3918243|NCT01442376|3741491|B2|6 to <12 years||Age, Customized||participants|Number|46|46.0||||||
3918244|NCT01442376|3741492|B1|6 to <12 years||Age, Customized||participants|Number|46|46.0||||||
3918245|NCT01442376|3741489|B4|2 to <6 years||Age, Customized||participants|Number|162|162.0||||||
3918246|NCT01442376|3741490|B3|2 to <6 years||Age, Customized||participants|Number|54|54.0||||||
3918247|NCT01442376|3741491|B2|2 to <6 years||Age, Customized||participants|Number|54|54.0||||||
3918248|NCT01442376|3741492|B1|2 to <6 years||Age, Customized||participants|Number|54|54.0||||||
3918249|NCT01442376|3741489|B4|<2 years||Age, Customized||participants|Number|45|45.0||||||
3918250|NCT01442376|3741490|B3|<2 years||Age, Customized||participants|Number|15|15.0||||||
3918251|NCT01442376|3741491|B2|<2 years||Age, Customized||participants|Number|15|15.0||||||
3918252|NCT01442376|3741492|B1|<2 years||Age, Customized||participants|Number|15|15.0||||||
3918253|NCT01442181|3741505|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
3918254|NCT01442181|3741506|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3918255|NCT01442181|3741507|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3918256|NCT01442181|3741505|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3918257|NCT01442181|3741506|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3918258|NCT01442181|3741507|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3918259|NCT01442181|3741505|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3918260|NCT01442181|3741506|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3918261|NCT01442181|3741507|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3918262|NCT01442181|3741505|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3918263|NCT01442181|3741506|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3918264|NCT01442181|3741507|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3918265|NCT01442181|3741505|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3918266|NCT01442181|3741506|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3918267|NCT01442181|3741507|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3918268|NCT01442181|3741505|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918269|NCT01442181|3741506|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918270|NCT01442181|3741507|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918271|NCT01442155|3741532|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3918272|NCT01442155|3741532|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3918273|NCT01442155|3741532|B1|||Age||years|Mean|58.6|58.6|Standard Deviation|10.2|10.2|||
3918274|NCT01442129|3741537|B3|Destination Therapy||Indication for LVAD|"Bridge to Transplantation indicates that the LVAD is used to help patients in end stage heart failure who are awaiting a heart transplant.~Destination Therapy indicates that the LVAD is planned for long-term use for patients in end stage heart failure who are not eligible for transplant."|participants|Number|20|20.0||||||
3918275|NCT01442129|3741538|B2|Destination Therapy||Indication for LVAD|"Bridge to Transplantation indicates that the LVAD is used to help patients in end stage heart failure who are awaiting a heart transplant.~Destination Therapy indicates that the LVAD is planned for long-term use for patients in end stage heart failure who are not eligible for transplant."|participants|Number|7|7.0||||||
3918276|NCT01442129|3741539|B1|Destination Therapy||Indication for LVAD|"Bridge to Transplantation indicates that the LVAD is used to help patients in end stage heart failure who are awaiting a heart transplant.~Destination Therapy indicates that the LVAD is planned for long-term use for patients in end stage heart failure who are not eligible for transplant."|participants|Number|13|13.0||||||
3918277|NCT01442129|3741537|B3|Bridge to Transplantation||Indication for LVAD|"Bridge to Transplantation indicates that the LVAD is used to help patients in end stage heart failure who are awaiting a heart transplant.~Destination Therapy indicates that the LVAD is planned for long-term use for patients in end stage heart failure who are not eligible for transplant."|participants|Number|10|10.0||||||
3918332|NCT01442103|3741548|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3918333|NCT01442103|3741548|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3918334|NCT01442103|3741548|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918278|NCT01442129|3741538|B2|Bridge to Transplantation||Indication for LVAD|"Bridge to Transplantation indicates that the LVAD is used to help patients in end stage heart failure who are awaiting a heart transplant.~Destination Therapy indicates that the LVAD is planned for long-term use for patients in end stage heart failure who are not eligible for transplant."|participants|Number|3|3.0||||||
3918279|NCT01442129|3741539|B1|Bridge to Transplantation||Indication for LVAD|"Bridge to Transplantation indicates that the LVAD is used to help patients in end stage heart failure who are awaiting a heart transplant.~Destination Therapy indicates that the LVAD is planned for long-term use for patients in end stage heart failure who are not eligible for transplant."|participants|Number|7|7.0||||||
3918280|NCT01442129|3741537|B3|Non-Ischemic||Cardiomyopathy||participants|Number|19|19.0||||||
3918281|NCT01442129|3741538|B2|Non-Ischemic||Cardiomyopathy||participants|Number|6|6.0||||||
3918282|NCT01442129|3741539|B1|Non-Ischemic||Cardiomyopathy||participants|Number|13|13.0||||||
3918283|NCT01442129|3741537|B3|Ischemic||Cardiomyopathy||participants|Number|11|11.0||||||
3918284|NCT01442129|3741538|B2|Ischemic||Cardiomyopathy||participants|Number|4|4.0||||||
3918285|NCT01442129|3741539|B1|Ischemic||Cardiomyopathy||participants|Number|7|7.0||||||
3918286|NCT01442129|3741537|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3918287|NCT01442129|3741538|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3918288|NCT01442129|3741539|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3918289|NCT01442129|3741537|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918290|NCT01442129|3741538|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918291|NCT01442129|3741539|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918292|NCT01442129|3741537|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918293|NCT01442129|3741538|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918294|NCT01442129|3741539|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918295|NCT01442129|3741537|B3||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3918296|NCT01442129|3741538|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3918297|NCT01442129|3741539|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3918298|NCT01442129|3741537|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3918299|NCT01442129|3741538|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3918300|NCT01442129|3741539|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3918301|NCT01442129|3741537|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918302|NCT01442129|3741538|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918303|NCT01442129|3741539|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918304|NCT01442129|3741537|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918305|NCT01442129|3741538|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918306|NCT01442129|3741539|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918307|NCT01442129|3741537|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918308|NCT01442129|3741538|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918309|NCT01442129|3741539|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918310|NCT01442129|3741537|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918311|NCT01442129|3741538|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918312|NCT01442129|3741539|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918313|NCT01442129|3741537|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3918314|NCT01442129|3741538|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3918315|NCT01442129|3741539|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3918316|NCT01442129|3741537|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3918317|NCT01442129|3741538|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918318|NCT01442129|3741539|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3918319|NCT01442129|3741537|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3918320|NCT01442129|3741538|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3918321|NCT01442129|3741539|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3918322|NCT01442129|3741537|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3918323|NCT01442129|3741538|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3918324|NCT01442129|3741539|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3918325|NCT01442129|3741537|B3|||Age||years|Mean|57.4|57.4|Standard Deviation|13.6|13.6|||
3918326|NCT01442129|3741538|B2|||Age||years|Mean|62.2|62.2|Standard Deviation|7.8|7.8|||
3918327|NCT01442129|3741539|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|15.4|15.4|||
3918328|NCT01442103|3741548|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3918329|NCT01442103|3741548|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3918330|NCT01442103|3741548|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3918331|NCT01442103|3741548|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|18.7|18.7|||
3918335|NCT01442064|3741552|B7||Male|Sex: Female, Male||Participants|Count of Participants|330|330.0||||||
3918336|NCT01442064|3741553|B6||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3918337|NCT01442064|3741554|B5||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3918338|NCT01442064|3741555|B4||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3918339|NCT01442064|3741556|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3918340|NCT01442064|3741557|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3918341|NCT01442064|3741558|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3918342|NCT01442064|3741552|B7||Female|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
3918343|NCT01442064|3741553|B6||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3918344|NCT01442064|3741554|B5||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3918345|NCT01442064|3741555|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3918346|NCT01442064|3741556|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3918347|NCT01442064|3741557|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3918348|NCT01442064|3741558|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3918349|NCT01442064|3741552|B7|≥85 years||Age, Customized||participants|Number|37|37.0||||||
3918350|NCT01442064|3741553|B6|≥85 years||Age, Customized||participants|Number|4|4.0||||||
3918351|NCT01442064|3741554|B5|≥85 years||Age, Customized||participants|Number|10|10.0||||||
3918352|NCT01442064|3741555|B4|≥85 years||Age, Customized||participants|Number|4|4.0||||||
3918353|NCT01442064|3741556|B3|≥85 years||Age, Customized||participants|Number|8|8.0||||||
3918354|NCT01442064|3741557|B2|≥85 years||Age, Customized||participants|Number|7|7.0||||||
3918355|NCT01442064|3741558|B1|≥85 years||Age, Customized||participants|Number|4|4.0||||||
3918356|NCT01442064|3741552|B7|65 to <85 years||Age, Customized||participants|Number|330|330.0||||||
3918357|NCT01442064|3741553|B6|65 to <85 years||Age, Customized||participants|Number|59|59.0||||||
3918358|NCT01442064|3741554|B5|65 to <85 years||Age, Customized||participants|Number|68|68.0||||||
3918359|NCT01442064|3741555|B4|65 to <85 years||Age, Customized||participants|Number|49|49.0||||||
3918360|NCT01442064|3741556|B3|65 to <85 years||Age, Customized||participants|Number|55|55.0||||||
3918361|NCT01442064|3741557|B2|65 to <85 years||Age, Customized||participants|Number|54|54.0||||||
3918362|NCT01442064|3741558|B1|65 to <85 years||Age, Customized||participants|Number|45|45.0||||||
3918363|NCT01442064|3741552|B7|45 to <65 years||Age, Customized||participants|Number|215|215.0||||||
3918364|NCT01442064|3741553|B6|45 to <65 years||Age, Customized||participants|Number|32|32.0||||||
3918365|NCT01442064|3741554|B5|45 to <65 years||Age, Customized||participants|Number|26|26.0||||||
3918366|NCT01442064|3741555|B4|45 to <65 years||Age, Customized||participants|Number|37|37.0||||||
3918367|NCT01442064|3741556|B3|45 to <65 years||Age, Customized||participants|Number|38|38.0||||||
3918368|NCT01442064|3741557|B2|45 to <65 years||Age, Customized||participants|Number|39|39.0||||||
3918369|NCT01442064|3741558|B1|45 to <65 years||Age, Customized||participants|Number|43|43.0||||||
3918370|NCT01442064|3741552|B7|<45 years||Age, Customized||participants|Number|26|26.0||||||
3918371|NCT01442064|3741553|B6|<45 years||Age, Customized||participants|Number|4|4.0||||||
3918372|NCT01442064|3741554|B5|<45 years||Age, Customized||participants|Number|3|3.0||||||
3918373|NCT01442064|3741555|B4|<45 years||Age, Customized||participants|Number|8|8.0||||||
3918374|NCT01442064|3741556|B3|<45 years||Age, Customized||participants|Number|3|3.0||||||
3918375|NCT01442064|3741557|B2|<45 years||Age, Customized||participants|Number|3|3.0||||||
3918376|NCT01442064|3741558|B1|<45 years||Age, Customized||participants|Number|5|5.0||||||
3918377|NCT01442038|3741598|B3|Germany||Region of Enrollment||participants|Number|61|61.0||||||
3918378|NCT01442038|3741599|B2|Germany||Region of Enrollment||participants|Number|27|27.0||||||
3918379|NCT01442038|3741600|B1|Germany||Region of Enrollment||participants|Number|34|34.0||||||
3918380|NCT01442038|3741598|B3|France||Region of Enrollment||participants|Number|37|37.0||||||
3918381|NCT01442038|3741599|B2|France||Region of Enrollment||participants|Number|15|15.0||||||
3918382|NCT01442038|3741600|B1|France||Region of Enrollment||participants|Number|22|22.0||||||
3918383|NCT01442038|3741598|B3|Israel||Region of Enrollment||participants|Number|220|220.0||||||
3918384|NCT01442038|3741599|B2|Israel||Region of Enrollment||participants|Number|109|109.0||||||
3918385|NCT01442038|3741600|B1|Israel||Region of Enrollment||participants|Number|111|111.0||||||
3918386|NCT01442038|3741598|B3|Italy||Region of Enrollment||participants|Number|61|61.0||||||
3918387|NCT01442038|3741599|B2|Italy||Region of Enrollment||participants|Number|33|33.0||||||
3918388|NCT01442038|3741600|B1|Italy||Region of Enrollment||participants|Number|28|28.0||||||
3918389|NCT01442038|3741598|B3|Poland||Region of Enrollment||participants|Number|375|375.0||||||
3918390|NCT01442038|3741599|B2|Poland||Region of Enrollment||participants|Number|172|172.0||||||
3918391|NCT01442038|3741600|B1|Poland||Region of Enrollment||participants|Number|203|203.0||||||
3918392|NCT01442038|3741598|B3|Belgium||Region of Enrollment||participants|Number|41|41.0||||||
3918393|NCT01442038|3741599|B2|Belgium||Region of Enrollment||participants|Number|21|21.0||||||
3918394|NCT01442038|3741600|B1|Belgium||Region of Enrollment||participants|Number|20|20.0||||||
3918395|NCT01442038|3741598|B3|Sweden||Region of Enrollment||participants|Number|44|44.0||||||
3918396|NCT01442038|3741599|B2|Sweden||Region of Enrollment||participants|Number|25|25.0||||||
3918397|NCT01442038|3741600|B1|Sweden||Region of Enrollment||participants|Number|19|19.0||||||
3918398|NCT01442038|3741598|B3|Netherlands||Region of Enrollment||participants|Number|26|26.0||||||
3918399|NCT01442038|3741599|B2|Netherlands||Region of Enrollment||participants|Number|13|13.0||||||
3918400|NCT01442038|3741600|B1|Netherlands||Region of Enrollment||participants|Number|13|13.0||||||
3918401|NCT01442038|3741598|B3|Czech Republic||Region of Enrollment||participants|Number|75|75.0||||||
3918402|NCT01442038|3741599|B2|Czech Republic||Region of Enrollment||participants|Number|44|44.0||||||
3918403|NCT01442038|3741600|B1|Czech Republic||Region of Enrollment||participants|Number|31|31.0||||||
3918404|NCT01442038|3741598|B3|Austria||Region of Enrollment||participants|Number|27|27.0||||||
3918405|NCT01442038|3741599|B2|Austria||Region of Enrollment||participants|Number|15|15.0||||||
3918406|NCT01442038|3741600|B1|Austria||Region of Enrollment||participants|Number|12|12.0||||||
3918407|NCT01442038|3741598|B3|Canada||Region of Enrollment||participants|Number|165|165.0||||||
3918408|NCT01442038|3741599|B2|Canada||Region of Enrollment||participants|Number|85|85.0||||||
3918409|NCT01442038|3741600|B1|Canada||Region of Enrollment||participants|Number|80|80.0||||||
3918410|NCT01442038|3741598|B3|Spain||Region of Enrollment||participants|Number|167|167.0||||||
3918411|NCT01442038|3741599|B2|Spain||Region of Enrollment||participants|Number|87|87.0||||||
3918412|NCT01442038|3741600|B1|Spain||Region of Enrollment||participants|Number|80|80.0||||||
3918413|NCT01442038|3741598|B3|United Kingdom||Region of Enrollment||participants|Number|33|33.0||||||
3918414|NCT01442038|3741599|B2|United Kingdom||Region of Enrollment||participants|Number|17|17.0||||||
3918415|NCT01442038|3741600|B1|United Kingdom||Region of Enrollment||participants|Number|16|16.0||||||
3918416|NCT01442038|3741598|B3|United States||Region of Enrollment||participants|Number|965|965.0||||||
3918417|NCT01442038|3741599|B2|United States||Region of Enrollment||participants|Number|466|466.0||||||
3918418|NCT01442038|3741600|B1|United States||Region of Enrollment||participants|Number|499|499.0||||||
3918419|NCT01442038|3741598|B3|Russian Federation||Region of Enrollment||participants|Number|322|322.0||||||
3918420|NCT01442038|3741599|B2|Russian Federation||Region of Enrollment||participants|Number|168|168.0||||||
3918421|NCT01442038|3741600|B1|Russian Federation||Region of Enrollment||participants|Number|154|154.0||||||
3918422|NCT01442038|3741598|B3|Unknown||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3918423|NCT01442038|3741599|B2|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3918424|NCT01442038|3741600|B1|Unknown||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3918425|NCT01442038|3741598|B3|Not Reported||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
3918426|NCT01442038|3741599|B2|Not Reported||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3918427|NCT01442038|3741600|B1|Not Reported||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3918428|NCT01442038|3741598|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2427|2427.0||||||
3918429|NCT01442038|3741599|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1208|1208.0||||||
3918430|NCT01442038|3741600|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1219|1219.0||||||
3918431|NCT01442038|3741598|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|136|136.0||||||
3918432|NCT01442038|3741599|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|64|64.0||||||
3918433|NCT01442038|3741600|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
3918434|NCT01442038|3741598|B3|Not Permitted||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
3918435|NCT01442038|3741599|B2|Not Permitted||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3918436|NCT01442038|3741600|B1|Not Permitted||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3918437|NCT01442038|3741598|B3|Other||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
3918438|NCT01442038|3741599|B2|Other||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3918439|NCT01442038|3741600|B1|Other||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3918440|NCT01442038|3741598|B3|White||Race/Ethnicity, Customized||participants|Number|2399|2399.0||||||
3918441|NCT01442038|3741599|B2|White||Race/Ethnicity, Customized||participants|Number|1196|1196.0||||||
3918442|NCT01442038|3741600|B1|White||Race/Ethnicity, Customized||participants|Number|1203|1203.0||||||
3918443|NCT01442038|3741598|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3918444|NCT01442038|3741599|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3918445|NCT01442038|3741600|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3918446|NCT01442038|3741598|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|92|92.0||||||
3918447|NCT01442038|3741599|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
3918448|NCT01442038|3741600|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
3918449|NCT01442038|3741598|B3|Asian||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3918450|NCT01442038|3741599|B2|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3918451|NCT01442038|3741600|B1|Asian||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3918452|NCT01442038|3741598|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3918453|NCT01442038|3741599|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3918454|NCT01442038|3741600|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3918455|NCT01442038|3741598|B3||Male|Sex: Female, Male||Participants|Count of Participants|2083|2083.0||||||
3918456|NCT01442038|3741599|B2||Male|Sex: Female, Male||Participants|Count of Participants|1037|1037.0||||||
3918457|NCT01442038|3741600|B1||Male|Sex: Female, Male||Participants|Count of Participants|1046|1046.0||||||
3918458|NCT01442038|3741598|B3||Female|Sex: Female, Male||Participants|Count of Participants|536|536.0||||||
3918459|NCT01442038|3741599|B2||Female|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
3918460|NCT01442038|3741600|B1||Female|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
3918461|NCT01442038|3741598|B3|≥ 75 Years||Age, Customized||participants|Number|401|401.0||||||
3918462|NCT01442038|3741599|B2|≥ 75 Years||Age, Customized||participants|Number|195|195.0||||||
3918463|NCT01442038|3741600|B1|≥ 75 Years||Age, Customized||participants|Number|206|206.0||||||
3918464|NCT01442038|3741598|B3|65-74 Years||Age, Customized||participants|Number|785|785.0||||||
3918465|NCT01442038|3741599|B2|65-74 Years||Age, Customized||participants|Number|383|383.0||||||
3918466|NCT01442038|3741600|B1|65-74 Years||Age, Customized||participants|Number|402|402.0||||||
3918467|NCT01442038|3741598|B3|< 65 Years||Age, Customized||participants|Number|1433|1433.0||||||
3918468|NCT01442038|3741599|B2|< 65 Years||Age, Customized||participants|Number|719|719.0||||||
3918469|NCT01442038|3741600|B1|< 65 Years||Age, Customized||participants|Number|714|714.0||||||
3918470|NCT01442038|3741598|B3|||Age||years|Mean|63.4|63.4|Standard Deviation|10.29|10.29|||
3918471|NCT01442038|3741599|B2|||Age||years|Mean|63.4|63.4|Standard Deviation|10.06|10.06|||
3918472|NCT01442038|3741600|B1|||Age||years|Mean|63.4|63.4|Standard Deviation|10.51|10.51|||
3918473|NCT01441973|3741613|B3|||Time from diagnosis to enrollment||Months|Mean|34.37|34.37|Standard Deviation|35.798|35.798|||
3918474|NCT01441973|3741614|B2|||Time from diagnosis to enrollment||Months|Mean|36.81|36.81|Standard Deviation|35.103|35.103|||
3918475|NCT01441973|3741615|B1|||Time from diagnosis to enrollment||Months|Mean|31.75|31.75|Standard Deviation|37.572|37.572|||
3918476|NCT01441973|3741613|B3|||Urine M protein||g/day|Mean|0.149|0.149|Standard Deviation|0.4532|0.4532|||
3918477|NCT01441973|3741614|B2|||Urine M protein||g/day|Mean|0.094|0.094|Standard Deviation|0.2131|0.2131|||
3918478|NCT01441973|3741615|B1|||Urine M protein||g/day|Mean|0.208|0.208|Standard Deviation|0.6199|0.6199|||
3918479|NCT01441973|3741613|B3|||Serum monoclonal (M) protein||g/L|Mean|25.6|25.6|Standard Deviation|13.72|13.72|||
3918480|NCT01441973|3741614|B2|||Serum monoclonal (M) protein||g/L|Mean|21.9|21.9|Standard Deviation|11.46|11.46|||
3918481|NCT01441973|3741615|B1|||Serum monoclonal (M) protein||g/L|Mean|29.5|29.5|Standard Deviation|15.19|15.19|||
3918482|NCT01441973|3741613|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3918483|NCT01441973|3741614|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3918484|NCT01441973|3741615|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3918485|NCT01441973|3741613|B3|White||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
3918486|NCT01441973|3741614|B2|White||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
3918487|NCT01441973|3741615|B1|White||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3918488|NCT01441973|3741613|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918489|NCT01441973|3741614|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918490|NCT01441973|3741615|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918491|NCT01441973|3741613|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3918492|NCT01441973|3741614|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3918493|NCT01441973|3741615|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3918494|NCT01441973|3741613|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3918495|NCT01441973|3741614|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3918496|NCT01441973|3741615|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918497|NCT01441973|3741613|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3918498|NCT01441973|3741614|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3918499|NCT01441973|3741615|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3918500|NCT01441973|3741613|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3918501|NCT01441973|3741614|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3918502|NCT01441973|3741615|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3918503|NCT01441973|3741613|B3|75 years and older||Age, Customized||Participants|Number|1|1.0||||||
3918504|NCT01441973|3741614|B2|75 years and older||Age, Customized||Participants|Number|1|1.0||||||
3918505|NCT01441973|3741615|B1|75 years and older||Age, Customized||Participants|Number|0|0.0||||||
3918506|NCT01441973|3741613|B3|65 years and older to younger than 75 years||Age, Customized||Participants|Number|7|7.0||||||
3918507|NCT01441973|3741614|B2|65 years and older to younger than 75 years||Age, Customized||Participants|Number|2|2.0||||||
3918508|NCT01441973|3741615|B1|65 years and older to younger than 75 years||Age, Customized||Participants|Number|5|5.0||||||
3918509|NCT01441973|3741613|B3|Younger than 65 years||Age, Customized||Participants|Number|23|23.0||||||
3918510|NCT01441973|3741614|B2|Younger than 65 years||Age, Customized||Participants|Number|13|13.0||||||
3918511|NCT01441973|3741615|B1|Younger than 65 years||Age, Customized||Participants|Number|10|10.0||||||
3918512|NCT01441973|3741613|B3|||Age||Years|Mean|59.2|59.2|Standard Deviation|9.40|9.4|||
3918513|NCT01441973|3741614|B2|||Age||Years|Mean|59.3|59.3|Standard Deviation|9.37|9.37|||
3918514|NCT01441973|3741615|B1|||Age||Years|Mean|59.0|59.0|Standard Deviation|9.75|9.75|||
3918515|NCT01441960|3741638|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
3918516|NCT01441960|3741638|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3918517|NCT01441960|3741638|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3918518|NCT01441960|3741638|B1|||Age||Years|Mean|52|52.0|Standard Deviation|8|8.0|||
3918519|NCT01441960|3741638|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3918520|NCT01441960|3741638|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3918521|NCT01441960|3741638|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918522|NCT01441882|3741649|B1|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3918523|NCT01441882|3741649|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3918524|NCT01441882|3741649|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3918525|NCT01441882|3741649|B1|||Age||years|Mean|62.6|62.6|Standard Deviation|9.8|9.8|||
3918526|NCT01441882|3741649|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3918527|NCT01441882|3741649|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3918528|NCT01441882|3741649|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918529|NCT01441843|3741653|B3|Netherlands||Region of Enrollment||participants|Number|398|398.0||||||
3918530|NCT01441843|3741654|B2|Netherlands||Region of Enrollment||participants|Number|200|200.0||||||
3918531|NCT01441843|3741655|B1|Netherlands||Region of Enrollment||participants|Number|198|198.0||||||
3918532|NCT01441843|3741653|B3||Male|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
3918533|NCT01441843|3741654|B2||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3918534|NCT01441843|3741655|B1||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3918535|NCT01441843|3741653|B3||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3918536|NCT01441843|3741654|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3918537|NCT01441843|3741655|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3918538|NCT01441843|3741653|B3|||Age||years|Mean|39.4|39.4|Standard Deviation|13.6|13.6|||
3918539|NCT01441843|3741654|B2|||Age||years|Mean|39.3|39.3|Standard Deviation|13.6|13.6|||
3918540|NCT01441843|3741655|B1|||Age||years|Mean|39.5|39.5|Standard Deviation|13.7|13.7|||
3918541|NCT01441843|3741653|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3918542|NCT01441843|3741654|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3918543|NCT01441843|3741655|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3918544|NCT01441843|3741653|B3||Between 18 and 65 years|Age||Participants|Count of Participants|381|381.0||||||
3918545|NCT01441843|3741654|B2||Between 18 and 65 years|Age||Participants|Count of Participants|191|191.0||||||
3918546|NCT01441843|3741655|B1||Between 18 and 65 years|Age||Participants|Count of Participants|190|190.0||||||
3918547|NCT01441843|3741653|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918548|NCT01441843|3741654|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918549|NCT01441843|3741655|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918550|NCT01441765|3741662|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3918551|NCT01441765|3741664|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3918552|NCT01441765|3741662|B3||Male|Gender||Participants|Count of Participants|8|8.0||||||
3918553|NCT01441765|3741664|B1||Male|Gender||Participants|Count of Participants|8|8.0||||||
3918554|NCT01441765|3741662|B3||Female|Gender||Participants|Count of Participants|3|3.0||||||
3918555|NCT01441765|3741664|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
3918556|NCT01441765|3741662|B3|||Age||years|Mean|63|63.0|Full Range|||43.0|78.0|
3918557|NCT01441765|3741664|B1|||Age||years|Mean|63|63.0|Full Range|||43.0|78.0|
3918558|NCT01441765|3741662|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3918559|NCT01441765|3741664|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3918560|NCT01441765|3741662|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3918561|NCT01441765|3741664|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3918562|NCT01441765|3741662|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918563|NCT01441765|3741664|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918564|NCT01441596|3741679|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3918565|NCT01441596|3741680|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3918566|NCT01441596|3741681|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3918567|NCT01441596|3741682|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3918568|NCT01441596|3741679|B4||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3918569|NCT01441596|3741680|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3918570|NCT01441596|3741681|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3918571|NCT01441596|3741682|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3918572|NCT01441596|3741679|B4|||Age||years|Mean|51.8|51.8|Standard Deviation|10.3|10.3|||
3918573|NCT01441596|3741680|B3|||Age||years|Mean|52.6|52.6|Standard Deviation|10.3|10.3|||
3918574|NCT01441596|3741681|B2|||Age||years|Mean|51.2|51.2|Standard Deviation|10.6|10.6|||
3918575|NCT01441596|3741682|B1|||Age||years|Mean|51.5|51.5|Standard Deviation|10.3|10.3|||
3918576|NCT01441570|3741698|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3918577|NCT01441570|3741699|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3918578|NCT01441570|3741700|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3918579|NCT01441570|3741698|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3918580|NCT01441570|3741699|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3918581|NCT01441570|3741700|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3918582|NCT01441570|3741698|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3918583|NCT01441570|3741699|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3918584|NCT01441570|3741700|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3918585|NCT01441570|3741698|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3918586|NCT01441570|3741699|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3918587|NCT01441570|3741700|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3918588|NCT01441570|3741698|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3918589|NCT01441570|3741699|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3918590|NCT01441570|3741700|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3918591|NCT01441570|3741698|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918592|NCT01441570|3741699|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918593|NCT01441570|3741700|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918594|NCT01441466|3741709|B3|Netherlands||Region of Enrollment||participants|Number|48|48.0||||||
3918595|NCT01441466|3741710|B2|Netherlands||Region of Enrollment||participants|Number|11|11.0||||||
3918596|NCT01441466|3741711|B1|Netherlands||Region of Enrollment||participants|Number|37|37.0||||||
3918597|NCT01441466|3741709|B3||Male|Gender||Participants|Count of Participants|26|26.0||||||
3918598|NCT01441466|3741710|B2||Male|Gender||Participants|Count of Participants|6|6.0||||||
3918599|NCT01441466|3741711|B1||Male|Gender||Participants|Count of Participants|20|20.0||||||
3918600|NCT01441466|3741709|B3||Female|Gender||Participants|Count of Participants|22|22.0||||||
3918601|NCT01441466|3741710|B2||Female|Gender||Participants|Count of Participants|5|5.0||||||
3918602|NCT01441466|3741711|B1||Female|Gender||Participants|Count of Participants|17|17.0||||||
3918603|NCT01441466|3741709|B3|||Age||years|Mean|0.5|0.5|Standard Deviation|0.4|0.4|||
3918604|NCT01441466|3741710|B2|||Age||years|Mean|0.6|0.6|Standard Deviation|0.5|0.5|||
3918605|NCT01441466|3741711|B1|||Age||years|Mean|0.4|0.4|Standard Deviation|0.4|0.4|||
3918606|NCT01441466|3741709|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3918607|NCT01441466|3741710|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3918608|NCT01441466|3741711|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3918609|NCT01441466|3741709|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3918610|NCT01441466|3741710|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3918611|NCT01441466|3741711|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3918612|NCT01441466|3741709|B3||<=18 years|Age||Participants|Count of Participants|48|48.0||||||
3918613|NCT01441466|3741710|B2||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
3918614|NCT01441466|3741711|B1||<=18 years|Age||Participants|Count of Participants|37|37.0||||||
3918615|NCT01441440|3741728|B4||Male|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
3918616|NCT01441440|3741729|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3918617|NCT01441440|3741730|B2||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3918618|NCT01441440|3741731|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3918619|NCT01441440|3741728|B4||Female|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
3918620|NCT01441440|3741729|B3||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3918621|NCT01441440|3741730|B2||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3918622|NCT01441440|3741731|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3918623|NCT01441440|3741728|B4|||Age||years|Mean|38.4|38.4|Standard Deviation|11.1|11.1|||
3918624|NCT01441440|3741729|B3|||Age||years|Mean|38.3|38.3|Standard Deviation|10.2|10.2|||
3918625|NCT01441440|3741730|B2|||Age||years|Mean|38.4|38.4|Standard Deviation|11.9|11.9|||
3918626|NCT01441440|3741731|B1|||Age||years|Mean|38.6|38.6|Standard Deviation|11.1|11.1|||
3918627|NCT01441414|3741756|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3918628|NCT01441414|3741756|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3918629|NCT01441414|3741756|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|10.9|10.9|||
3918630|NCT01441401|3741781|B1||Male|Sex: Female, Male|Participants taking gabapentin tablets/syrup according to the Japanese package insert.|Participants|Count of Participants|43|43.0||||||
3918631|NCT01441401|3741781|B1||Female|Sex: Female, Male|Participants taking gabapentin tablets/syrup according to the Japanese package insert.|Participants|Count of Participants|39|39.0||||||
3918632|NCT01441401|3741781|B1|13 to 15 years||Age, Customized|Participants taking gabapentin tablets/syrup according to the Japanese package insert.|Participants|Number|14|14.0||||||
3918633|NCT01441401|3741781|B1|5 to 12 years||Age, Customized|Participants taking gabapentin tablets/syrup according to the Japanese package insert.|Participants|Number|54|54.0||||||
3918634|NCT01441401|3741781|B1|3 to 4 years||Age, Customized|Participants taking gabapentin tablets/syrup according to the Japanese package insert.|Participants|Number|14|14.0||||||
3918635|NCT01441245|3741807|B3|Italy||Region of Enrollment||participants|Number|57|57.0||||||
3918636|NCT01441245|3741808|B2|Italy||Region of Enrollment||participants|Number|27|27.0||||||
3918637|NCT01441245|3741809|B1|Italy||Region of Enrollment||participants|Number|30|30.0||||||
3918638|NCT01441245|3741807|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3918639|NCT01441245|3741808|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3918640|NCT01441245|3741809|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3918641|NCT01441245|3741807|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3918642|NCT01441245|3741808|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3918643|NCT01441245|3741809|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3918644|NCT01441245|3741807|B3|||Age||years|Mean|72|72.0|Standard Deviation|8|8.0|||
3918645|NCT01441245|3741808|B2|||Age||years|Mean|73|73.0|Standard Deviation|8|8.0|||
3918646|NCT01441245|3741809|B1|||Age||years|Mean|71|71.0|Standard Deviation|7|7.0|||
3918647|NCT01441245|3741807|B3||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
3918648|NCT01441245|3741808|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3918649|NCT01441245|3741809|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3918650|NCT01441245|3741807|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3918651|NCT01441245|3741808|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3918652|NCT01441245|3741809|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3918653|NCT01441245|3741807|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918654|NCT01441245|3741808|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918655|NCT01441245|3741809|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918656|NCT01441180|3741832|B4|United States||Region of Enrollment||participants|Number|60|60.0||||||
3918657|NCT01441180|3741833|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
3918658|NCT01441180|3741834|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3918659|NCT01441180|3741835|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3918660|NCT01441180|3741832|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918661|NCT01441180|3741833|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918662|NCT01441180|3741834|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918663|NCT01441180|3741835|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918664|NCT01441180|3741832|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3918665|NCT01441180|3741833|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3918666|NCT01441180|3741834|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3918667|NCT01441180|3741835|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3918668|NCT01441180|3741832|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3918669|NCT01441180|3741833|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918670|NCT01441180|3741834|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3918671|NCT01441180|3741835|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918672|NCT01441180|3741832|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918673|NCT01441180|3741833|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918674|NCT01441180|3741834|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918675|NCT01441180|3741835|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918676|NCT01441180|3741832|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3918677|NCT01441180|3741833|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918678|NCT01441180|3741834|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3918679|NCT01441180|3741835|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918680|NCT01441180|3741832|B4||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3918681|NCT01441180|3741833|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3918682|NCT01441180|3741834|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3918683|NCT01441180|3741835|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3918684|NCT01441180|3741832|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3918685|NCT01441180|3741833|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3918686|NCT01441180|3741834|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3918687|NCT01441180|3741835|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3918688|NCT01441180|3741832|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918689|NCT01441180|3741833|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918690|NCT01441180|3741834|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918691|NCT01441180|3741835|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918692|NCT01441180|3741832|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918693|NCT01441180|3741833|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918694|NCT01441180|3741834|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918695|NCT01441180|3741835|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918696|NCT01441180|3741832|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918697|NCT01441180|3741833|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918698|NCT01441180|3741834|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918699|NCT01441180|3741835|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918700|NCT01441180|3741832|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3918701|NCT01441180|3741833|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3918702|NCT01441180|3741834|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3918703|NCT01441180|3741835|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3918704|NCT01441180|3741832|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3918705|NCT01441180|3741833|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3918706|NCT01441180|3741834|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3918707|NCT01441180|3741835|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3918708|NCT01441180|3741832|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3918709|NCT01441180|3741833|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3918710|NCT01441180|3741834|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3918711|NCT01441180|3741835|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3918712|NCT01441180|3741832|B4||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3918713|NCT01441180|3741833|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3918714|NCT01441180|3741834|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3918715|NCT01441180|3741835|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3918716|NCT01441180|3741832|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918717|NCT01441180|3741833|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918718|NCT01441180|3741834|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918719|NCT01441180|3741835|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918720|NCT01441102|3741848|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3918721|NCT01441102|3741848|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3918722|NCT01441102|3741848|B1|||Age||years|Mean|58.57|58.57|Full Range|||47.0|66.0|
3918723|NCT01441102|3741848|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3918724|NCT01441102|3741848|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3918725|NCT01441102|3741848|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918726|NCT01441076|3741868|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918727|NCT01441076|3741868|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3918728|NCT01441076|3741868|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3918729|NCT01441076|3741868|B1||Black|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3918730|NCT01441076|3741868|B1||Hawaiian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918731|NCT01441076|3741868|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918732|NCT01441076|3741868|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918733|NCT01441076|3741868|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918734|NCT01441076|3741868|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3918735|NCT01441076|3741868|B1||Hispanic|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918736|NCT01441076|3741868|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3918737|NCT01441076|3741868|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3918738|NCT01441076|3741868|B1||GTE65|Age||Participants|Count of Participants|0|0.0||||||
3918739|NCT01441076|3741868|B1||BTWN|Age||Participants|Count of Participants|6|6.0||||||
3918740|NCT01441076|3741868|B1||LTE18|Age||Participants|Count of Participants|0|0.0||||||
3918741|NCT01441037|3741886|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3918742|NCT01441037|3741886|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3918743|NCT01441037|3741886|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3918744|NCT01441037|3741886|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3918745|NCT01441037|3741886|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918746|NCT01441037|3741886|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3918747|NCT01441037|3741886|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918748|NCT01441037|3741886|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3918749|NCT01441037|3741886|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3918750|NCT01441037|3741886|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3918751|NCT01441037|3741886|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3918752|NCT01441037|3741886|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3918753|NCT01441037|3741886|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3918754|NCT01441037|3741886|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3918755|NCT01441037|3741886|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3918756|NCT01440972|3741890|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3918757|NCT01440972|3741891|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3918758|NCT01440972|3741892|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3918759|NCT01440972|3741890|B3||Female|Gender||Participants|Count of Participants|40|40.0||||||
3918760|NCT01440972|3741891|B2||Female|Gender||Participants|Count of Participants|19|19.0||||||
3918761|NCT01440972|3741892|B1||Female|Gender||Participants|Count of Participants|21|21.0||||||
3918762|NCT01440972|3741890|B3|||Age||years|Mean|55.4|55.4|Standard Deviation|6.5|6.5|||
3918763|NCT01440972|3741891|B2|||Age||years|Mean|56.1|56.1|Standard Deviation|5.9|5.9|||
3918764|NCT01440972|3741892|B1|||Age||years|Mean|54.6|54.6|Standard Deviation|6.9|6.9|||
3918765|NCT01440959|3741907|B1|Korea, Republic of||Region of Enrollment||participants|Number|30|30.0||||||
3918766|NCT01440959|3741907|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3918767|NCT01440959|3741907|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3918768|NCT01440959|3741907|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|10.4|10.4|||
3918769|NCT01440959|3741907|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3918770|NCT01440959|3741907|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3918771|NCT01440959|3741907|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918772|NCT01440946|3741915|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3918773|NCT01440946|3741916|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3918774|NCT01440946|3741917|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3918775|NCT01440946|3741915|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3918776|NCT01440946|3741916|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3918777|NCT01440946|3741917|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3918778|NCT01440946|3741915|B3|||Age||years|Mean|5.5|5.5|Standard Deviation|3.16|3.16|||
3918779|NCT01440946|3741916|B2|||Age||years|Mean|8.3|8.3|Standard Deviation|1.45|1.45|||
3918780|NCT01440946|3741917|B1|||Age||years|Mean|2.6|2.6|Standard Deviation|0.99|0.99|||
3918781|NCT01440881|3741955|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
3918782|NCT01440881|3741956|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3918783|NCT01440881|3741957|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3918784|NCT01440881|3741955|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3918785|NCT01440881|3741956|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3918786|NCT01440881|3741957|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3918787|NCT01440881|3741955|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3918788|NCT01440881|3741956|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3918789|NCT01440881|3741957|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3918790|NCT01440881|3741955|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3918791|NCT01440881|3741956|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3918792|NCT01440881|3741957|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3918793|NCT01440881|3741955|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3918794|NCT01440881|3741956|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3918795|NCT01440881|3741957|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3918796|NCT01440881|3741955|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918797|NCT01440881|3741956|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918798|NCT01440881|3741957|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918799|NCT01440816|3741970|B3|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3918800|NCT01440816|3741971|B2|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3918801|NCT01440816|3741972|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3918802|NCT01440816|3741970|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3918803|NCT01440816|3741971|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3918804|NCT01440816|3741972|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3918805|NCT01440816|3741970|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3918806|NCT01440816|3741971|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3918807|NCT01440816|3741972|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3918808|NCT01440816|3741970|B3|||Age||years|Mean|67.1|67.1|Standard Deviation|12.03|12.03|||
3918809|NCT01440816|3741971|B2|||Age||years|Mean|68.7|68.7|Standard Deviation|12.08|12.08|||
3918810|NCT01440816|3741972|B1|||Age||years|Mean|60.7|60.7|Standard Deviation|11.59|11.59|||
3918811|NCT01440764|3741987|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
3918812|NCT01440764|3741988|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3918813|NCT01440764|3741989|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3918814|NCT01440764|3741987|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3918815|NCT01440764|3741988|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3918816|NCT01440764|3741989|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3918817|NCT01440764|3741987|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3918818|NCT01440764|3741988|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3918819|NCT01440764|3741989|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3918820|NCT01440764|3741987|B3|||Age||years|Mean|27.42|27.42|Standard Deviation|10.06|10.06|||
3918821|NCT01440764|3741988|B2|||Age||years|Mean|23.58|23.58|Standard Deviation|4.42|4.42|||
3918822|NCT01440764|3741989|B1|||Age||years|Mean|31.25|31.25|Standard Deviation|12.65|12.65|||
3918823|NCT01440764|3741987|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3918824|NCT01440764|3741988|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3918825|NCT01440764|3741989|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3918826|NCT01440764|3741987|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3918827|NCT01440764|3741988|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3918828|NCT01440764|3741989|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3918829|NCT01440764|3741987|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3918830|NCT01440764|3741988|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3918831|NCT01440764|3741989|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918832|NCT01440647|3742014|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
3918833|NCT01440647|3742015|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
3918834|NCT01440647|3742016|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3918835|NCT01440647|3742014|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3918836|NCT01440647|3742015|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3918837|NCT01440647|3742016|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3918838|NCT01440647|3742014|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3918839|NCT01440647|3742015|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3918840|NCT01440647|3742016|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3918841|NCT01440647|3742014|B3|Gestational age in weeks||Age||weeks|Mean|25.9|25.9|Standard Deviation|1.1|1.1|||
3918842|NCT01440647|3742015|B2|Gestational age in weeks||Age||weeks|Mean|25.7|25.7|Standard Deviation|1.1|1.1|||
3918843|NCT01440647|3742016|B1|Gestational age in weeks||Age||weeks|Mean|26.1|26.1|Standard Deviation|1.1|1.1|||
3918844|NCT01440647|3742014|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3918845|NCT01440647|3742015|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3918846|NCT01440647|3742016|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3918847|NCT01440647|3742014|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3918848|NCT01440647|3742015|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3918849|NCT01440647|3742016|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3918850|NCT01440647|3742014|B3||<=18 years|Age||Participants|Count of Participants|34|34.0||||||
3918851|NCT01440647|3742015|B2||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
3918852|NCT01440647|3742016|B1||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
3918853|NCT01440634|3742025|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
3918854|NCT01440634|3742026|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3918855|NCT01440634|3742027|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3918856|NCT01440634|3742025|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3918857|NCT01440634|3742026|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3918858|NCT01440634|3742027|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3918859|NCT01440634|3742025|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3918860|NCT01440634|3742026|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3918861|NCT01440634|3742027|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3918862|NCT01440634|3742025|B3|||Age||years|Median|79.5|79.5|Inter-Quartile Range|11.08|11.08|70.5|86.0|
3918863|NCT01440634|3742026|B2|||Age||years|Median|79.5|79.5|Inter-Quartile Range|11.08|11.08|70.5|86.0|
3918864|NCT01440634|3742027|B1|||Age||years|Median|75|75.0|Inter-Quartile Range|||68.0|82.0|
3918865|NCT01440634|3742025|B3||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
3918866|NCT01440634|3742026|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3918867|NCT01440634|3742027|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3918868|NCT01440634|3742025|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3918869|NCT01440634|3742026|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3918870|NCT01440634|3742027|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3918871|NCT01440634|3742025|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918872|NCT01440634|3742026|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918873|NCT01440634|3742027|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918874|NCT01440595|3742034|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3918875|NCT01440595|3742035|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3918876|NCT01440595|3742036|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3918877|NCT01440595|3742034|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3918878|NCT01440595|3742035|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3918879|NCT01440595|3742036|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3918880|NCT01440595|3742034|B3|||Age||years|Mean|44.0|44.0|Standard Deviation|8.2|8.2|||
3918881|NCT01440595|3742035|B2|||Age||years|Mean|51.0|51.0|Standard Deviation|0.0|0.0|||
3918882|NCT01440595|3742036|B1|||Age||years|Mean|40.5|40.5|Standard Deviation|7.8|7.8|||
3918883|NCT01440569|3742056|B3|DDI+FTC||Background Antiretroviral Regimen|3TC, lamivudine (Epivir®); ABC, abacavir; ABC/3TC, abacavir/lamivudine coformulation; AZT, azidothymidine or zidovudine; DDI, didanosine; FTC, emtricitabine (Emtriva®); FTC/TDF, emtricitabine/tenofovir disoproxil fumarate coformulation (Truvada®); TDF, tenofovir disoproxil fumarate (Viread®)|participants|Number|1|1.0||||||
3918884|NCT01440569|3742057|B2|DDI+FTC||Background Antiretroviral Regimen|3TC, lamivudine (Epivir®); ABC, abacavir; ABC/3TC, abacavir/lamivudine coformulation; AZT, azidothymidine or zidovudine; DDI, didanosine; FTC, emtricitabine (Emtriva®); FTC/TDF, emtricitabine/tenofovir disoproxil fumarate coformulation (Truvada®); TDF, tenofovir disoproxil fumarate (Viread®)|participants|Number|1|1.0||||||
3918885|NCT01440569|3742058|B1|DDI+FTC||Background Antiretroviral Regimen|3TC, lamivudine (Epivir®); ABC, abacavir; ABC/3TC, abacavir/lamivudine coformulation; AZT, azidothymidine or zidovudine; DDI, didanosine; FTC, emtricitabine (Emtriva®); FTC/TDF, emtricitabine/tenofovir disoproxil fumarate coformulation (Truvada®); TDF, tenofovir disoproxil fumarate (Viread®)|participants|Number|0|0.0||||||
3918886|NCT01440569|3742056|B3|ABC/3TC||Background Antiretroviral Regimen|3TC, lamivudine (Epivir®); ABC, abacavir; ABC/3TC, abacavir/lamivudine coformulation; AZT, azidothymidine or zidovudine; DDI, didanosine; FTC, emtricitabine (Emtriva®); FTC/TDF, emtricitabine/tenofovir disoproxil fumarate coformulation (Truvada®); TDF, tenofovir disoproxil fumarate (Viread®)|participants|Number|1|1.0||||||
3918887|NCT01440569|3742057|B2|ABC/3TC||Background Antiretroviral Regimen|3TC, lamivudine (Epivir®); ABC, abacavir; ABC/3TC, abacavir/lamivudine coformulation; AZT, azidothymidine or zidovudine; DDI, didanosine; FTC, emtricitabine (Emtriva®); FTC/TDF, emtricitabine/tenofovir disoproxil fumarate coformulation (Truvada®); TDF, tenofovir disoproxil fumarate (Viread®)|participants|Number|0|0.0||||||
3918888|NCT01440569|3742058|B1|ABC/3TC||Background Antiretroviral Regimen|3TC, lamivudine (Epivir®); ABC, abacavir; ABC/3TC, abacavir/lamivudine coformulation; AZT, azidothymidine or zidovudine; DDI, didanosine; FTC, emtricitabine (Emtriva®); FTC/TDF, emtricitabine/tenofovir disoproxil fumarate coformulation (Truvada®); TDF, tenofovir disoproxil fumarate (Viread®)|participants|Number|1|1.0||||||
3918889|NCT01440569|3742056|B3|ABC+FTC/TDF||Background Antiretroviral Regimen|3TC, lamivudine (Epivir®); ABC, abacavir; ABC/3TC, abacavir/lamivudine coformulation; AZT, azidothymidine or zidovudine; DDI, didanosine; FTC, emtricitabine (Emtriva®); FTC/TDF, emtricitabine/tenofovir disoproxil fumarate coformulation (Truvada®); TDF, tenofovir disoproxil fumarate (Viread®)|participants|Number|2|2.0||||||
3918890|NCT01440569|3742057|B2|ABC+FTC/TDF||Background Antiretroviral Regimen|3TC, lamivudine (Epivir®); ABC, abacavir; ABC/3TC, abacavir/lamivudine coformulation; AZT, azidothymidine or zidovudine; DDI, didanosine; FTC, emtricitabine (Emtriva®); FTC/TDF, emtricitabine/tenofovir disoproxil fumarate coformulation (Truvada®); TDF, tenofovir disoproxil fumarate (Viread®)|participants|Number|1|1.0||||||
3918891|NCT01440569|3742058|B1|ABC+FTC/TDF||Background Antiretroviral Regimen|3TC, lamivudine (Epivir®); ABC, abacavir; ABC/3TC, abacavir/lamivudine coformulation; AZT, azidothymidine or zidovudine; DDI, didanosine; FTC, emtricitabine (Emtriva®); FTC/TDF, emtricitabine/tenofovir disoproxil fumarate coformulation (Truvada®); TDF, tenofovir disoproxil fumarate (Viread®)|participants|Number|1|1.0||||||
3918892|NCT01440569|3742056|B3|ABC+TDF||Background Antiretroviral Regimen|3TC, lamivudine (Epivir®); ABC, abacavir; ABC/3TC, abacavir/lamivudine coformulation; AZT, azidothymidine or zidovudine; DDI, didanosine; FTC, emtricitabine (Emtriva®); FTC/TDF, emtricitabine/tenofovir disoproxil fumarate coformulation (Truvada®); TDF, tenofovir disoproxil fumarate (Viread®)|participants|Number|3|3.0||||||
3918893|NCT01440569|3742057|B2|ABC+TDF||Background Antiretroviral Regimen|3TC, lamivudine (Epivir®); ABC, abacavir; ABC/3TC, abacavir/lamivudine coformulation; AZT, azidothymidine or zidovudine; DDI, didanosine; FTC, emtricitabine (Emtriva®); FTC/TDF, emtricitabine/tenofovir disoproxil fumarate coformulation (Truvada®); TDF, tenofovir disoproxil fumarate (Viread®)|participants|Number|1|1.0||||||
3918894|NCT01440569|3742058|B1|ABC+TDF||Background Antiretroviral Regimen|3TC, lamivudine (Epivir®); ABC, abacavir; ABC/3TC, abacavir/lamivudine coformulation; AZT, azidothymidine or zidovudine; DDI, didanosine; FTC, emtricitabine (Emtriva®); FTC/TDF, emtricitabine/tenofovir disoproxil fumarate coformulation (Truvada®); TDF, tenofovir disoproxil fumarate (Viread®)|participants|Number|2|2.0||||||
3918895|NCT01440569|3742056|B3|AZT+FTC/TDF||Background Antiretroviral Regimen|3TC, lamivudine (Epivir®); ABC, abacavir; ABC/3TC, abacavir/lamivudine coformulation; AZT, azidothymidine or zidovudine; DDI, didanosine; FTC, emtricitabine (Emtriva®); FTC/TDF, emtricitabine/tenofovir disoproxil fumarate coformulation (Truvada®); TDF, tenofovir disoproxil fumarate (Viread®)|participants|Number|5|5.0||||||
3918896|NCT01440569|3742057|B2|AZT+FTC/TDF||Background Antiretroviral Regimen|3TC, lamivudine (Epivir®); ABC, abacavir; ABC/3TC, abacavir/lamivudine coformulation; AZT, azidothymidine or zidovudine; DDI, didanosine; FTC, emtricitabine (Emtriva®); FTC/TDF, emtricitabine/tenofovir disoproxil fumarate coformulation (Truvada®); TDF, tenofovir disoproxil fumarate (Viread®)|participants|Number|5|5.0||||||
3918897|NCT01440569|3742058|B1|AZT+FTC/TDF||Background Antiretroviral Regimen|3TC, lamivudine (Epivir®); ABC, abacavir; ABC/3TC, abacavir/lamivudine coformulation; AZT, azidothymidine or zidovudine; DDI, didanosine; FTC, emtricitabine (Emtriva®); FTC/TDF, emtricitabine/tenofovir disoproxil fumarate coformulation (Truvada®); TDF, tenofovir disoproxil fumarate (Viread®)|participants|Number|0|0.0||||||
3918898|NCT01440569|3742056|B3|FTC/TDF||Background Antiretroviral Regimen|3TC, lamivudine (Epivir®); ABC, abacavir; ABC/3TC, abacavir/lamivudine coformulation; AZT, azidothymidine or zidovudine; DDI, didanosine; FTC, emtricitabine (Emtriva®); FTC/TDF, emtricitabine/tenofovir disoproxil fumarate coformulation (Truvada®); TDF, tenofovir disoproxil fumarate (Viread®)|participants|Number|301|301.0||||||
3918899|NCT01440569|3742057|B2|FTC/TDF||Background Antiretroviral Regimen|3TC, lamivudine (Epivir®); ABC, abacavir; ABC/3TC, abacavir/lamivudine coformulation; AZT, azidothymidine or zidovudine; DDI, didanosine; FTC, emtricitabine (Emtriva®); FTC/TDF, emtricitabine/tenofovir disoproxil fumarate coformulation (Truvada®); TDF, tenofovir disoproxil fumarate (Viread®)|participants|Number|10|10.0||||||
3918900|NCT01440569|3742058|B1|FTC/TDF||Background Antiretroviral Regimen|3TC, lamivudine (Epivir®); ABC, abacavir; ABC/3TC, abacavir/lamivudine coformulation; AZT, azidothymidine or zidovudine; DDI, didanosine; FTC, emtricitabine (Emtriva®); FTC/TDF, emtricitabine/tenofovir disoproxil fumarate coformulation (Truvada®); TDF, tenofovir disoproxil fumarate (Viread®)|participants|Number|291|291.0||||||
3918901|NCT01440569|3742056|B3|||HIV-1 RNA (log10 copies/mL)||log10 copies/mL|Mean|4.8|4.8|Standard Deviation|0.78|0.78|||
3918902|NCT01440569|3742057|B2|||HIV-1 RNA (log10 copies/mL)||log10 copies/mL|Mean|4.8|4.8|Standard Deviation|1.04|1.04|||
3918903|NCT01440569|3742058|B1|||HIV-1 RNA (log10 copies/mL)||log10 copies/mL|Mean|4.8|4.8|Standard Deviation|0.76|0.76|||
3918904|NCT01440569|3742056|B3|||CD4 Count (cells/mm^3)||cells/mm^3|Mean|367.8|367.8|Standard Deviation|204.79|204.79|||
3918905|NCT01440569|3742057|B2|||CD4 Count (cells/mm^3)||cells/mm^3|Mean|197.8|197.8|Standard Deviation|214.30|214.3|||
3918906|NCT01440569|3742058|B1|||CD4 Count (cells/mm^3)||cells/mm^3|Mean|378.2|378.2|Standard Deviation|199.94|199.94|||
3918907|NCT01440569|3742056|B3|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3918908|NCT01440569|3742057|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3918909|NCT01440569|3742058|B1|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3918910|NCT01440569|3742056|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3918911|NCT01440569|3742057|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3918912|NCT01440569|3742058|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3918913|NCT01440569|3742056|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3918914|NCT01440569|3742057|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3918915|NCT01440569|3742058|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3918916|NCT01440569|3742056|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3918917|NCT01440569|3742057|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3918918|NCT01440569|3742058|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3918919|NCT01440569|3742056|B3|Black or African Heritage||Race/Ethnicity, Customized||participants|Number|108|108.0||||||
3918920|NCT01440569|3742057|B2|Black or African Heritage||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3918921|NCT01440569|3742058|B1|Black or African Heritage||Race/Ethnicity, Customized||participants|Number|101|101.0||||||
3918922|NCT01440569|3742056|B3|White||Race/Ethnicity, Customized||participants|Number|187|187.0||||||
3918923|NCT01440569|3742057|B2|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3918924|NCT01440569|3742058|B1|White||Race/Ethnicity, Customized||participants|Number|176|176.0||||||
3918925|NCT01440569|3742056|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918926|NCT01440569|3742057|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918927|NCT01440569|3742058|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3918928|NCT01440569|3742056|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|245|245.0||||||
3918929|NCT01440569|3742057|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3918930|NCT01440569|3742058|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|231|231.0||||||
3918931|NCT01440569|3742056|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3918932|NCT01440569|3742057|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3918933|NCT01440569|3742058|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3918934|NCT01440569|3742056|B3||Male|Gender||Participants|Count of Participants|279|279.0||||||
3918935|NCT01440569|3742057|B2||Male|Gender||Participants|Count of Participants|13|13.0||||||
3918936|NCT01440569|3742058|B1||Male|Gender||Participants|Count of Participants|266|266.0||||||
3918937|NCT01440569|3742056|B3||Female|Gender||Participants|Count of Participants|34|34.0||||||
3918938|NCT01440569|3742057|B2||Female|Gender||Participants|Count of Participants|5|5.0||||||
3918939|NCT01440569|3742058|B1||Female|Gender||Participants|Count of Participants|29|29.0||||||
3918940|NCT01440569|3742056|B3|||Age||years|Mean|36|36.0|Standard Deviation|10.6|10.6|||
3918941|NCT01440569|3742057|B2|||Age||years|Mean|45|45.0|Standard Deviation|10.9|10.9|||
3918942|NCT01440569|3742058|B1|||Age||years|Mean|36|36.0|Standard Deviation|10.3|10.3|||
3918943|NCT01440543|3742077|B5|Czech Republic||Region of Enrollment||participants|Number|420|420.0||||||
3918944|NCT01440543|3742078|B4|Czech Republic||Region of Enrollment||participants|Number|107|107.0||||||
3918945|NCT01440543|3742079|B3|Czech Republic||Region of Enrollment||participants|Number|102|102.0||||||
3918946|NCT01440543|3742080|B2|Czech Republic||Region of Enrollment||participants|Number|105|105.0||||||
3918947|NCT01440543|3742081|B1|Czech Republic||Region of Enrollment||participants|Number|106|106.0||||||
3918948|NCT01440543|3742077|B5||Male|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
3918949|NCT01440543|3742078|B4||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3918950|NCT01440543|3742079|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3918951|NCT01440543|3742080|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3918952|NCT01440543|3742081|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3918953|NCT01440543|3742077|B5||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3918954|NCT01440543|3742078|B4||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3918955|NCT01440543|3742079|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3918956|NCT01440543|3742080|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3918957|NCT01440543|3742081|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3918958|NCT01440543|3742077|B5|||Age||years|Mean|59.2|59.2|Standard Deviation|14.1|14.1|||
3918959|NCT01440543|3742078|B4|||Age||years|Mean|58.7|58.7|Standard Deviation|13.8|13.8|||
3918960|NCT01440543|3742079|B3|||Age||years|Mean|58.2|58.2|Standard Deviation|13.4|13.4|||
3918961|NCT01440543|3742080|B2|||Age||years|Mean|59.4|59.4|Standard Deviation|14.5|14.5|||
3918962|NCT01440543|3742081|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|13.9|13.9|||
3918963|NCT01440543|3742077|B5||>=65 years|Age||Participants|Count of Participants|193|193.0||||||
3918964|NCT01440543|3742078|B4||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
3918965|NCT01440543|3742079|B3||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
3918966|NCT01440543|3742080|B2||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
3918967|NCT01440543|3742081|B1||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
3918968|NCT01440543|3742077|B5||Between 18 and 65 years|Age||Participants|Count of Participants|227|227.0||||||
3918969|NCT01440543|3742078|B4||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3918970|NCT01440543|3742079|B3||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3918971|NCT01440543|3742080|B2||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3918972|NCT01440543|3742081|B1||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
3918973|NCT01440543|3742077|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918974|NCT01440543|3742078|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918975|NCT01440543|3742079|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918976|NCT01440543|3742080|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918977|NCT01440543|3742081|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918978|NCT01440517|3742094|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3918979|NCT01440517|3742094|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3918980|NCT01440517|3742094|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3918981|NCT01440517|3742094|B1|||Age||years|Mean|63.5|63.5|Standard Deviation|4.2|4.2|||
3918982|NCT01440517|3742094|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3918983|NCT01440517|3742094|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3918984|NCT01440517|3742094|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3918985|NCT01440387|3742099|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3918986|NCT01440387|3742100|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3918987|NCT01440387|3742101|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3918988|NCT01440387|3742099|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3918989|NCT01440387|3742100|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3918990|NCT01440387|3742101|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3918991|NCT01440387|3742099|B3|||Age||Years|Mean|54.75|54.75|Standard Deviation|17.11|17.11|||
3918992|NCT01440387|3742100|B2|||Age||Years|Mean|68.6|68.6|Standard Deviation|4.72|4.72|||
3918993|NCT01440387|3742101|B1|||Age||Years|Mean|40.9|40.9|Standard Deviation|13.33|13.33|||
3918994|NCT01440374|3742122|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|134|134.0||||||
3918995|NCT01440374|3742123|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|81|81.0||||||
3918996|NCT01440374|3742124|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|39|39.0||||||
3918997|NCT01440374|3742125|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3918998|NCT01440374|3742122|B4|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3918999|NCT01440374|3742123|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3919000|NCT01440374|3742124|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3919001|NCT01440374|3742125|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3919002|NCT01440374|3742122|B4|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3919003|NCT01440374|3742123|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3919004|NCT01440374|3742124|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3919005|NCT01440374|3742125|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3919006|NCT01440374|3742122|B4|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
3919007|NCT01440374|3742123|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3919008|NCT01440374|3742124|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3919009|NCT01440374|3742125|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3919010|NCT01440374|3742122|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3919011|NCT01440374|3742123|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3919012|NCT01440374|3742124|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3919013|NCT01440374|3742125|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3919014|NCT01440374|3742122|B4||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3919015|NCT01440374|3742123|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3919016|NCT01440374|3742124|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3919017|NCT01440374|3742125|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3919018|NCT01440374|3742122|B4||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3919019|NCT01440374|3742123|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3919020|NCT01440374|3742124|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3919021|NCT01440374|3742125|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3919022|NCT01440374|3742122|B4|||Age||Years|Mean|71.8|71.8|Standard Deviation|9.56|9.56|||
3919023|NCT01440374|3742123|B3|||Age||Years|Mean|72.3|72.3|Standard Deviation|8.94|8.94|||
3919024|NCT01440374|3742124|B2|||Age||Years|Mean|70.6|70.6|Standard Deviation|10.72|10.72|||
3919025|NCT01440374|3742125|B1|||Age||Years|Mean|71.5|71.5|Standard Deviation|10.78|10.78|||
3919026|NCT01440322|3742161|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3919027|NCT01440322|3742162|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3919028|NCT01440322|3742163|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3919029|NCT01440322|3742161|B3||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3919030|NCT01440322|3742162|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3919031|NCT01440322|3742163|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3919032|NCT01440322|3742161|B3|||Age||years|Mean|31.0|31.0|Standard Deviation|10.13|10.13|||
3919033|NCT01440322|3742162|B2|||Age||years|Mean|31.0|31.0|Standard Deviation|9.91|9.91|||
3919034|NCT01440322|3742163|B1|||Age||years|Mean|31.0|31.0|Standard Deviation|10.28|10.28|||
3919035|NCT01440283|3742186|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3919036|NCT01440283|3742186|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3919037|NCT01440283|3742186|B1|||Age||years|Median|4.1|4.1|Full Range|||0.9|10.9|
3919038|NCT01440283|3742186|B1|||Age||years|Mean|4.9|4.9|Standard Deviation|3.1|3.1|||
3919039|NCT01440101|3742198|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3919040|NCT01440101|3742199|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3919041|NCT01440101|3742200|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3919042|NCT01440101|3742201|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3919043|NCT01440101|3742198|B4||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3919044|NCT01440101|3742199|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3919045|NCT01440101|3742200|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3919046|NCT01440101|3742201|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3919047|NCT01440101|3742198|B4|>/= 60 years||Age, Customized||participants|Number|2|2.0||||||
3919048|NCT01440101|3742199|B3|>/= 60 years||Age, Customized||participants|Number|1|1.0||||||
3919049|NCT01440101|3742200|B2|>/= 60 years||Age, Customized||participants|Number|0|0.0||||||
3919050|NCT01440101|3742201|B1|>/= 60 years||Age, Customized||participants|Number|1|1.0||||||
3919051|NCT01440101|3742198|B4|50 to < 60 years||Age, Customized||participants|Number|7|7.0||||||
3919052|NCT01440101|3742199|B3|50 to < 60 years||Age, Customized||participants|Number|3|3.0||||||
3919053|NCT01440101|3742200|B2|50 to < 60 years||Age, Customized||participants|Number|3|3.0||||||
3919054|NCT01440101|3742201|B1|50 to < 60 years||Age, Customized||participants|Number|1|1.0||||||
3919055|NCT01440101|3742198|B4|40 to < 50 years||Age, Customized||participants|Number|29|29.0||||||
3919056|NCT01440101|3742199|B3|40 to < 50 years||Age, Customized||participants|Number|16|16.0||||||
3919057|NCT01440101|3742200|B2|40 to < 50 years||Age, Customized||participants|Number|10|10.0||||||
3919058|NCT01440101|3742201|B1|40 to < 50 years||Age, Customized||participants|Number|3|3.0||||||
3919059|NCT01440101|3742198|B4|30 to < 40 years||Age, Customized||participants|Number|48|48.0||||||
3919060|NCT01440101|3742199|B3|30 to < 40 years||Age, Customized||participants|Number|18|18.0||||||
3919061|NCT01440101|3742200|B2|30 to < 40 years||Age, Customized||participants|Number|24|24.0||||||
3919062|NCT01440101|3742201|B1|30 to < 40 years||Age, Customized||participants|Number|6|6.0||||||
3919063|NCT01440101|3742198|B4|20 to < 30 years||Age, Customized||participants|Number|18|18.0||||||
3919064|NCT01440101|3742199|B3|20 to < 30 years||Age, Customized||participants|Number|9|9.0||||||
3919065|NCT01440101|3742200|B2|20 to < 30 years||Age, Customized||participants|Number|8|8.0||||||
3919066|NCT01440101|3742201|B1|20 to < 30 years||Age, Customized||participants|Number|1|1.0||||||
3919067|NCT01440101|3742198|B4|18 to < 20 years||Age, Customized||participants|Number|2|2.0||||||
3919068|NCT01440101|3742199|B3|18 to < 20 years||Age, Customized||participants|Number|0|0.0||||||
3919069|NCT01440101|3742200|B2|18 to < 20 years||Age, Customized||participants|Number|2|2.0||||||
3919070|NCT01440101|3742201|B1|18 to < 20 years||Age, Customized||participants|Number|0|0.0||||||
3919071|NCT01440049|3742236|B1||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3919072|NCT01440049|3742236|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3919073|NCT01440049|3742236|B1|||Age|Out of a total of 160 participants, data for baseline measure (age) was available for only 159 participants.|Years|Mean|67.70|67.7|Standard Deviation|11.72|11.72|||
3919074|NCT01439971|3742263|B6||MALE|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3919075|NCT01439971|3742264|B5||MALE|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3919076|NCT01439971|3742265|B4||MALE|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3919077|NCT01439971|3742266|B3||MALE|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3919078|NCT01439971|3742267|B2||MALE|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3919079|NCT01439971|3742268|B1||MALE|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3919080|NCT01439971|3742263|B6||FEMALE|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3919081|NCT01439971|3742264|B5||FEMALE|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3919082|NCT01439971|3742265|B4||FEMALE|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3919083|NCT01439971|3742266|B3||FEMALE|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3919084|NCT01439971|3742267|B2||FEMALE|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3919085|NCT01439971|3742268|B1||FEMALE|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3919086|NCT01439971|3742263|B6|||Age||years|Mean|37.2|37.2|Standard Deviation|13.6|13.6|||
3919087|NCT01439971|3742264|B5|||Age||years|Mean|41.0|41.0|Standard Deviation|15.7|15.7|||
3919088|NCT01439971|3742265|B4|||Age||years|Mean|32.8|32.8|Standard Deviation|12.3|12.3|||
3919089|NCT01439971|3742266|B3|||Age||years|Mean|38.5|38.5|Standard Deviation|12.1|12.1|||
3919090|NCT01439971|3742267|B2|||Age||years|Mean|32.7|32.7|Standard Deviation|13.4|13.4|||
3919091|NCT01439971|3742268|B1|||Age||years|Mean|59.0|59.0|Standard Deviation|NA||||Single participant in cohort
3919092|NCT01439945|3742449|B4|United States||Region of Enrollment||participants|Number|275|275.0||||||
3919093|NCT01439945|3742450|B3|United States||Region of Enrollment||participants|Number|91|91.0||||||
3919094|NCT01439945|3742451|B2|United States||Region of Enrollment||participants|Number|91|91.0||||||
3919095|NCT01439945|3742452|B1|United States||Region of Enrollment||participants|Number|93|93.0||||||
3919096|NCT01439945|3742449|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3919097|NCT01439945|3742450|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3919098|NCT01439945|3742451|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3919099|NCT01439945|3742452|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3919100|NCT01439945|3742449|B4||Female|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
3919101|NCT01439945|3742450|B3||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3919102|NCT01439945|3742451|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3919103|NCT01439945|3742452|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3919104|NCT01439945|3742449|B4|Age Group|>=50|Age, Customized||Participants|Count of Participants|230|230.0||||||
3919105|NCT01439945|3742450|B3|Age Group|>=50|Age, Customized||Participants|Count of Participants|76|76.0||||||
3919106|NCT01439945|3742451|B2|Age Group|>=50|Age, Customized||Participants|Count of Participants|76|76.0||||||
3919107|NCT01439945|3742452|B1|Age Group|>=50|Age, Customized||Participants|Count of Participants|78|78.0||||||
3919108|NCT01439945|3742449|B4|Age Group|18-49 years|Age, Customized||Participants|Count of Participants|45|45.0||||||
3919109|NCT01439945|3742450|B3|Age Group|18-49 years|Age, Customized||Participants|Count of Participants|15|15.0||||||
3919110|NCT01439945|3742451|B2|Age Group|18-49 years|Age, Customized||Participants|Count of Participants|15|15.0||||||
3919111|NCT01439945|3742452|B1|Age Group|18-49 years|Age, Customized||Participants|Count of Participants|15|15.0||||||
3919112|NCT01439867|3742478|B3|||Intact Parathyroid Hormone||pg/mL|Mean|1299.11|1299.11|Standard Deviation|634.18|634.18|||
3919113|NCT01439867|3742479|B2|||Intact Parathyroid Hormone||pg/mL|Mean|1206.92|1206.92|Standard Deviation|597.85|597.85|||
3919114|NCT01439867|3742480|B1|||Intact Parathyroid Hormone||pg/mL|Mean|1414.34|1414.34|Standard Deviation|699.90|699.9|||
3919115|NCT01439867|3742478|B3|||Corrected Serum Calcium||mg/dL|Mean|10.15|10.15|Standard Deviation|0.76|0.76|||
3919116|NCT01439867|3742479|B2|||Corrected Serum Calcium||mg/dL|Mean|9.82|9.82|Standard Deviation|0.61|0.61|||
3919117|NCT01439867|3742480|B1|||Corrected Serum Calcium||mg/dL|Mean|10.56|10.56|Standard Deviation|0.75|0.75|||
3919118|NCT01439867|3742478|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3919119|NCT01439867|3742479|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3919120|NCT01439867|3742480|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3919121|NCT01439867|3742478|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3919122|NCT01439867|3742479|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3919123|NCT01439867|3742480|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3919124|NCT01439867|3742478|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3919125|NCT01439867|3742479|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3919126|NCT01439867|3742480|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3919127|NCT01439867|3742478|B3|White||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3919128|NCT01439867|3742479|B2|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3919129|NCT01439867|3742480|B1|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3919130|NCT01439867|3742478|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3919131|NCT01439867|3742479|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3919132|NCT01439867|3742480|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3919133|NCT01439867|3742478|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3919134|NCT01439867|3742479|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3919135|NCT01439867|3742480|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3919136|NCT01439867|3742478|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3919137|NCT01439867|3742479|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3919138|NCT01439867|3742480|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3919139|NCT01439867|3742478|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3919140|NCT01439867|3742479|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3919141|NCT01439867|3742480|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3919142|NCT01439867|3742478|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3919143|NCT01439867|3742479|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3919144|NCT01439867|3742480|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3919145|NCT01439867|3742478|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3919146|NCT01439867|3742479|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3919147|NCT01439867|3742480|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3919148|NCT01439867|3742478|B3|2 years to < 6 years||Age, Customized||participants|Number|15|15.0||||||
3919149|NCT01439867|3742479|B2|2 years to < 6 years||Age, Customized||participants|Number|9|9.0||||||
3919150|NCT01439867|3742480|B1|2 years to < 6 years||Age, Customized||participants|Number|6|6.0||||||
3919151|NCT01439867|3742478|B3|28 days to < 2 years||Age, Customized||participants|Number|3|3.0||||||
3919152|NCT01439867|3742479|B2|28 days to < 2 years||Age, Customized||participants|Number|1|1.0||||||
3919153|NCT01439867|3742480|B1|28 days to < 2 years||Age, Customized||participants|Number|2|2.0||||||
3919154|NCT01439867|3742478|B3|||Age||months|Mean|35.9|35.9|Standard Deviation|16.8|16.8|||
3919155|NCT01439867|3742479|B2|||Age||months|Mean|35.0|35.0|Standard Deviation|15.9|15.9|||
3919156|NCT01439867|3742480|B1|||Age||months|Mean|37.1|37.1|Standard Deviation|18.9|18.9|||
3919157|NCT01439724|3742520|B3|Brazil||Region of Enrollment||participants|Number|94|94.0||||||
3919158|NCT01439724|3742521|B2|Brazil||Region of Enrollment||participants|Number|47|47.0||||||
3919159|NCT01439724|3742522|B1|Brazil||Region of Enrollment||participants|Number|47|47.0||||||
3919160|NCT01439724|3742520|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3919161|NCT01439724|3742521|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3919162|NCT01439724|3742522|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3919163|NCT01439724|3742520|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3919164|NCT01439724|3742521|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3919165|NCT01439724|3742522|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3919166|NCT01439724|3742520|B3|||Age||years|Mean|54.6|54.6|Standard Deviation|7.7|7.7|||
3919167|NCT01439724|3742521|B2|||Age||years|Mean|53.5|53.5|Standard Deviation|6.9|6.9|||
3919168|NCT01439724|3742522|B1|||Age||years|Mean|55.7|55.7|Standard Deviation|8.6|8.6|||
3919169|NCT01439711|3742529|B1|United States||Region of Enrollment||Participants|Count of Participants|68|68.0||||||
3919170|NCT01439711|3742529|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3919171|NCT01439711|3742529|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3919172|NCT01439711|3742529|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|8.03|8.03|||
3919173|NCT01439672|3742540|B1||Male|Gender||Participants|Count of Participants|7|7.0||||||
3919174|NCT01439672|3742540|B1||Female|Gender||Participants|Count of Participants|4|4.0||||||
3919175|NCT01439672|3742540|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3919176|NCT01439672|3742540|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3919177|NCT01439672|3742540|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3919178|NCT01439633|3742544|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3919179|NCT01439633|3742544|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3919180|NCT01439633|3742544|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3919181|NCT01439633|3742544|B1|||Age||years|Mean|64|64.0|Standard Deviation|11.84|11.84|||
3919182|NCT01439633|3742544|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3919183|NCT01439633|3742544|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3919184|NCT01439633|3742544|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3919185|NCT01439620|3742548|B1|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3919186|NCT01439620|3742548|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3919187|NCT01439620|3742548|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3919188|NCT01439620|3742548|B1|||Age||years|Mean|57|57.0|Standard Deviation|11.24|11.24|||
3919189|NCT01439620|3742548|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3919190|NCT01439620|3742548|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3919191|NCT01439620|3742548|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3919192|NCT01439581|3742552|B3|United States||Region of Enrollment||participants|Number|428|428.0||||||
3919193|NCT01439581|3742553|B2|United States||Region of Enrollment||participants|Number|212|212.0||||||
3919194|NCT01439581|3742554|B1|United States||Region of Enrollment||participants|Number|216|216.0||||||
3919195|NCT01439581|3742552|B3||Male|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
3919196|NCT01439581|3742553|B2||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3919197|NCT01439581|3742554|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3919198|NCT01439581|3742552|B3||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
3919199|NCT01439581|3742553|B2||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3919200|NCT01439581|3742554|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3919201|NCT01439581|3742552|B3|||Age||years|Mean|57.8|57.8|Full Range|||18.0|96.0|
3919202|NCT01439581|3742553|B2|||Age||years|Mean|56.9|56.9|Full Range|||18.0|93.0|
3919203|NCT01439581|3742554|B1|||Age||years|Mean|58.7|58.7|Full Range|||19.0|96.0|
3919204|NCT01439581|3742552|B3||>=65 years|Age||Participants|Count of Participants|147|147.0||||||
3919205|NCT01439581|3742553|B2||>=65 years|Age||Participants|Count of Participants|74|74.0||||||
3919206|NCT01439581|3742554|B1||>=65 years|Age||Participants|Count of Participants|73|73.0||||||
3919207|NCT01439581|3742552|B3||Between 18 and 65 years|Age||Participants|Count of Participants|281|281.0||||||
3919208|NCT01439581|3742553|B2||Between 18 and 65 years|Age||Participants|Count of Participants|138|138.0||||||
3919209|NCT01439581|3742554|B1||Between 18 and 65 years|Age||Participants|Count of Participants|143|143.0||||||
3919210|NCT01439581|3742552|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3919211|NCT01439581|3742553|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3919212|NCT01439581|3742554|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3919213|NCT01439373|3742561|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3919214|NCT01439373|3742562|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3919215|NCT01439373|3742563|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3919216|NCT01439373|3742561|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3919217|NCT01439373|3742562|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3919218|NCT01439373|3742563|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3919219|NCT01439373|3742561|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3919220|NCT01439373|3742562|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3919221|NCT01439373|3742563|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3919222|NCT01439373|3742561|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3919223|NCT01439373|3742562|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3919224|NCT01439373|3742563|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3919225|NCT01439373|3742561|B3|31 to 67 years||Age, Customized||Particiapnts|Number|15|15.0||||||
3919226|NCT01439373|3742562|B2|31 to 67 years||Age, Customized||Particiapnts|Number|4|4.0||||||
3919227|NCT01439373|3742563|B1|31 to 67 years||Age, Customized||Particiapnts|Number|11|11.0||||||
3919228|NCT01439360|3742605|B3|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Number|2953|2953.0||||||
3919229|NCT01439360|3742606|B2|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Number|1482|1482.0||||||
3919230|NCT01439360|3742607|B1|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Number|1471|1471.0||||||
3919231|NCT01439360|3742605|B3|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Number|291|291.0||||||
3919232|NCT01439360|3742606|B2|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Number|149|149.0||||||
3919233|NCT01439360|3742607|B1|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Number|142|142.0||||||
3919234|NCT01439360|3742605|B3|Other||Race/Ethnicity, Customized||Participants|Number|3281|3281.0||||||
3919235|NCT01439360|3742606|B2|Other||Race/Ethnicity, Customized||Participants|Number|1642|1642.0||||||
3919236|NCT01439360|3742607|B1|Other||Race/Ethnicity, Customized||Participants|Number|1639|1639.0||||||
3919237|NCT01439360|3742605|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3919238|NCT01439360|3742606|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3919239|NCT01439360|3742607|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3919240|NCT01439360|3742605|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3327|3327.0||||||
3919241|NCT01439360|3742606|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1666|1666.0||||||
3919242|NCT01439360|3742607|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1661|1661.0||||||
3919243|NCT01439360|3742605|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3919244|NCT01439360|3742606|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3919245|NCT01439360|3742607|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3919246|NCT01439360|3742605|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3919247|NCT01439360|3742606|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3919248|NCT01439360|3742607|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3919249|NCT01439360|3742605|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2115|2115.0||||||
3919250|NCT01439360|3742606|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1053|1053.0||||||
3919251|NCT01439360|3742607|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1062|1062.0||||||
3919252|NCT01439360|3742605|B3|African Heritage / African American||Race/Ethnicity, Customized||Participants|Number|44|44.0||||||
3919253|NCT01439360|3742606|B2|African Heritage / African American||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
3919254|NCT01439360|3742607|B1|African Heritage / African American||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
3919255|NCT01439360|3742605|B3||Male|Sex: Female, Male||Participants|Count of Participants|6160|6160.0||||||
3919256|NCT01439360|3742606|B2||Male|Sex: Female, Male||Participants|Count of Participants|3087|3087.0||||||
3919257|NCT01439360|3742607|B1||Male|Sex: Female, Male||Participants|Count of Participants|3073|3073.0||||||
3919258|NCT01439360|3742605|B3||Female|Sex: Female, Male||Participants|Count of Participants|5858|5858.0||||||
3919259|NCT01439360|3742606|B2||Female|Sex: Female, Male||Participants|Count of Participants|2925|2925.0||||||
3919260|NCT01439360|3742607|B1||Female|Sex: Female, Male||Participants|Count of Participants|2933|2933.0||||||
3919261|NCT01439360|3742605|B3|||Age||Months|Mean|21.9|21.9|Standard Deviation|8.0|8.0|||
3919262|NCT01439360|3742606|B2|||Age||Months|Mean|21.8|21.8|Standard Deviation|8.0|8.0|||
3919263|NCT01439360|3742607|B1|||Age||Months|Mean|21.9|21.9|Standard Deviation|8.0|8.0|||
3919264|NCT01439282|3742656|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3919265|NCT01439282|3742657|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3919266|NCT01439282|3742658|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3919267|NCT01439282|3742656|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3919268|NCT01439282|3742657|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3919269|NCT01439282|3742658|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3919270|NCT01439282|3742656|B3||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3919271|NCT01439282|3742657|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3919272|NCT01439282|3742658|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3919273|NCT01439282|3742656|B3||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
3919274|NCT01439282|3742657|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3919275|NCT01439282|3742658|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
3919276|NCT01439282|3742656|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3919277|NCT01439282|3742657|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3919278|NCT01439282|3742658|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3919279|NCT01439204|3742667|B3|||Body Weight|An inclusion criterion was that participants would weigh between 60 and 100 kilograms (kg), inclusive.|kg|Mean|79.16|79.16|Standard Deviation|11.189|11.189|||
3919280|NCT01439204|3742668|B2|||Body Weight|An inclusion criterion was that participants would weigh between 60 and 100 kilograms (kg), inclusive.|kg|Mean|79.39|79.39|Standard Deviation|11.057|11.057|||
3919281|NCT01439204|3742669|B1|||Body Weight|An inclusion criterion was that participants would weigh between 60 and 100 kilograms (kg), inclusive.|kg|Mean|78.93|78.93|Standard Deviation|11.472|11.472|||
3919282|NCT01439204|3742667|B3|United States||Region of Enrollment||participants|Number|72|72.0||||||
3919283|NCT01439204|3742668|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
3919284|NCT01439204|3742669|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
3919285|NCT01439204|3742667|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3919286|NCT01439204|3742668|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3919287|NCT01439204|3742669|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3919288|NCT01439204|3742667|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3919289|NCT01439204|3742668|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3919290|NCT01439204|3742669|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3919291|NCT01439204|3742667|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3919292|NCT01439204|3742668|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3919293|NCT01439204|3742669|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3919294|NCT01439204|3742667|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3919295|NCT01439204|3742668|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3919296|NCT01439204|3742669|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3919297|NCT01439204|3742667|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3919298|NCT01439204|3742668|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3919299|NCT01439204|3742669|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3919300|NCT01439204|3742667|B3|||Age||years|Mean|31.4|31.4|Standard Deviation|9.41|9.41|||
3919301|NCT01439204|3742668|B2|||Age||years|Mean|31.2|31.2|Standard Deviation|8.90|8.9|||
3919302|NCT01439204|3742669|B1|||Age||years|Mean|31.6|31.6|Standard Deviation|10.02|10.02|||
3919303|NCT01439165|3742702|B3|Canada||Region of Enrollment||Participants|Count of Participants|976|976.0||||||
3919304|NCT01439165|3742703|B2|Canada||Region of Enrollment||Participants|Count of Participants|244|244.0||||||
3919305|NCT01439165|3742704|B1|Canada||Region of Enrollment||Participants|Count of Participants|732|732.0||||||
3919306|NCT01439165|3742702|B3|United States||Region of Enrollment||Participants|Count of Participants|354|354.0||||||
3919307|NCT01439165|3742703|B2|United States||Region of Enrollment||Participants|Count of Participants|84|84.0||||||
3919308|NCT01439165|3742704|B1|United States||Region of Enrollment||Participants|Count of Participants|270|270.0||||||
3919309|NCT01439165|3742702|B3||Male|Sex: Female, Male||Participants|Count of Participants|472|472.0||||||
3919310|NCT01439165|3742703|B2||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3919311|NCT01439165|3742704|B1||Male|Sex: Female, Male||Participants|Count of Participants|356|356.0||||||
3919312|NCT01439165|3742702|B3||Female|Sex: Female, Male||Participants|Count of Participants|858|858.0||||||
3919313|NCT01439165|3742703|B2||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
3919314|NCT01439165|3742704|B1||Female|Sex: Female, Male||Participants|Count of Participants|646|646.0||||||
3919315|NCT01439165|3742702|B3|Age Continuous||Age||Years|Mean|29|29.0|Standard Deviation|10.3|10.3|||
3919316|NCT01439165|3742703|B2|Age Continuous||Age||Years|Mean|29.2|29.2|Standard Deviation|10.6|10.6|||
3919317|NCT01439165|3742704|B1|Age Continuous||Age||Years|Mean|28.9|28.9|Standard Deviation|10.0|10.0|||
3919318|NCT01439165|3742702|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3919319|NCT01439165|3742703|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3919320|NCT01439165|3742704|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3919321|NCT01439165|3742702|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1330|1330.0||||||
3919322|NCT01439165|3742703|B2||Between 18 and 65 years|Age||Participants|Count of Participants|328|328.0||||||
3919323|NCT01439165|3742704|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1002|1002.0||||||
3919324|NCT01439165|3742702|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3919325|NCT01439165|3742703|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3919326|NCT01439165|3742704|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3919327|NCT01439126|3742717|B3|||BMI||kg/m^2|Mean|18.54|18.54|Standard Deviation|3.203|3.203|||
3919328|NCT01439126|3742718|B2|||BMI||kg/m^2|Mean|18.79|18.79|Standard Deviation|3.485|3.485|||
3919329|NCT01439126|3742719|B1|||BMI||kg/m^2|Mean|18.29|18.29|Standard Deviation|2.921|2.921|||
3919330|NCT01439126|3742717|B3|||Height||cm|Mean|145.55|145.55|Standard Deviation|17.833|17.833|||
3919331|NCT01439126|3742718|B2|||Height||cm|Mean|145.45|145.45|Standard Deviation|17.928|17.928|||
3919332|NCT01439126|3742719|B1|||Height||cm|Mean|145.64|145.64|Standard Deviation|17.737|17.737|||
3919333|NCT01439126|3742717|B3|||Weight||kg|Mean|41.05|41.05|Standard Deviation|16.350|16.35|||
3919334|NCT01439126|3742718|B2|||Weight||kg|Mean|41.61|41.61|Standard Deviation|16.978|16.978|||
3919335|NCT01439126|3742719|B1|||Weight||kg|Mean|40.49|40.49|Standard Deviation|15.721|15.721|||
3919336|NCT01439126|3742717|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3919337|NCT01439126|3742718|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3919338|NCT01439126|3742719|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3919339|NCT01439126|3742717|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3919340|NCT01439126|3742718|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3919341|NCT01439126|3742719|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3919342|NCT01439126|3742717|B3||White|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3919343|NCT01439126|3742718|B2||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3919344|NCT01439126|3742719|B1||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3919345|NCT01439126|3742717|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3919346|NCT01439126|3742718|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3919347|NCT01439126|3742719|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3919348|NCT01439126|3742717|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3919349|NCT01439126|3742718|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3919350|NCT01439126|3742719|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3919351|NCT01439126|3742717|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3919352|NCT01439126|3742718|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3919353|NCT01439126|3742719|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3919354|NCT01439126|3742717|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3919355|NCT01439126|3742718|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3919356|NCT01439126|3742719|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3919357|NCT01439126|3742717|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3919358|NCT01439126|3742718|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3919359|NCT01439126|3742719|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3919360|NCT01439126|3742717|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
3919361|NCT01439126|3742718|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3919362|NCT01439126|3742719|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3919363|NCT01439126|3742717|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3919364|NCT01439126|3742718|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3919365|NCT01439126|3742719|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3919366|NCT01439126|3742717|B3||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3919367|NCT01439126|3742718|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3919368|NCT01439126|3742719|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3919369|NCT01439126|3742717|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3919370|NCT01439126|3742718|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3919371|NCT01439126|3742719|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3919372|NCT01439126|3742717|B3|||Age||Years|Mean|10.8|10.8|Standard Deviation|2.88|2.88|||
3919373|NCT01439126|3742718|B2|||Age||Years|Mean|10.9|10.9|Standard Deviation|2.98|2.98|||
3919374|NCT01439126|3742719|B1|||Age||Years|Mean|10.7|10.7|Standard Deviation|2.77|2.77|||
3919375|NCT01439074|3742740|B3|China||Region of Enrollment||participants|Number|153|153.0||||||
3919376|NCT01439074|3742741|B2|China||Region of Enrollment||participants|Number|82|82.0||||||
3919377|NCT01439074|3742742|B1|China||Region of Enrollment||participants|Number|71|71.0||||||
3919378|NCT01439074|3742740|B3||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3919379|NCT01439074|3742741|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3919380|NCT01439074|3742742|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3919381|NCT01439074|3742740|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3919382|NCT01439074|3742741|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3919383|NCT01439074|3742742|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3919384|NCT01439074|3742740|B3|||Age||years|Mean|36.2|36.2|Standard Deviation|12.8|12.8|||
3919385|NCT01439074|3742741|B2|||Age||years|Mean|35.4|35.4|Standard Deviation|13.2|13.2|||
3919386|NCT01439074|3742742|B1|||Age||years|Mean|37.0|37.0|Standard Deviation|12.3|12.3|||
3919387|NCT01439074|3742740|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3919388|NCT01439074|3742741|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3919389|NCT01439074|3742742|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3919390|NCT01439074|3742740|B3||Between 18 and 65 years|Age||Participants|Count of Participants|144|144.0||||||
3919391|NCT01439074|3742741|B2||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
3919392|NCT01439074|3742742|B1||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
3919393|NCT01439074|3742740|B3||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
3919394|NCT01439074|3742741|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3919395|NCT01439074|3742742|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3919396|NCT01439035|3742755|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3919397|NCT01439035|3742755|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3919398|NCT01439035|3742755|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3919399|NCT01439035|3742755|B1|||Age||years|Mean|16.3|16.3|Standard Deviation|5|5.0|||
3919400|NCT01439035|3742755|B1||>=65 years|Age|Six subjects completed this study|Participants|Count of Participants|0|0.0||||||
3919401|NCT01439035|3742755|B1||Between 18 and 65 years|Age|Six subjects completed this study|Participants|Count of Participants|2|2.0||||||
3919402|NCT01439035|3742755|B1||<=18 years|Age|Six subjects completed this study|Participants|Count of Participants|4|4.0||||||
3919403|NCT01438996|3742759|B4|Belgium||Region of Enrollment||participants|Number|51|51.0||||||
3919404|NCT01438996|3742760|B3|Belgium||Region of Enrollment||participants|Number|20|20.0||||||
3919405|NCT01438996|3742761|B2|Belgium||Region of Enrollment||participants|Number|13|13.0||||||
3919406|NCT01438996|3742762|B1|Belgium||Region of Enrollment||participants|Number|18|18.0||||||
3919407|NCT01438996|3742759|B4||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3919408|NCT01438996|3742760|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3919409|NCT01438996|3742761|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3919410|NCT01438996|3742762|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3919411|NCT01438996|3742759|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3919412|NCT01438996|3742760|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3919413|NCT01438996|3742761|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3919414|NCT01438996|3742762|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3919415|NCT01438996|3742759|B4|||Age||years|Mean|25.8|25.8|Standard Deviation|6.0|6.0|||
3919416|NCT01438996|3742760|B3|||Age||years|Mean|26.0|26.0|Standard Deviation|6.2|6.2|||
3919417|NCT01438996|3742761|B2|||Age||years|Mean|26.3|26.3|Standard Deviation|6.6|6.6|||
3919418|NCT01438996|3742762|B1|||Age||years|Mean|25.3|25.3|Standard Deviation|5.8|5.8|||
3919419|NCT01438996|3742759|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3919420|NCT01438996|3742760|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3919421|NCT01438996|3742761|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3919422|NCT01438996|3742762|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3919423|NCT01438996|3742759|B4||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3919424|NCT01438996|3742760|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3919425|NCT01438996|3742761|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3919426|NCT01438996|3742762|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3919427|NCT01438996|3742759|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3919428|NCT01438996|3742760|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3919429|NCT01438996|3742761|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3919430|NCT01438996|3742762|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3919431|NCT01438840|3742796|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3919432|NCT01438840|3742797|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3919433|NCT01438840|3742798|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3919434|NCT01438840|3742796|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3919435|NCT01438840|3742797|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3919436|NCT01438840|3742798|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3919437|NCT01438840|3742796|B3|||Age||Years|Geometric Mean|44.6|44.6|Standard Deviation|14.44|14.44|||
3919438|NCT01438840|3742797|B2|||Age||Years|Geometric Mean|46.4|46.4|Standard Deviation|14.2|14.2|||
3919439|NCT01438840|3742798|B1|||Age||Years|Geometric Mean|41.2|41.2|Standard Deviation|14.7|14.7|||
3919440|NCT01438814|3742811|B3||Male|Sex: Female, Male||Participants|Count of Participants|327|327.0||||||
3919441|NCT01438814|3742812|B2||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3919442|NCT01438814|3742813|B1||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3919443|NCT01438814|3742811|B3||Female|Sex: Female, Male||Participants|Count of Participants|362|362.0||||||
3919444|NCT01438814|3742812|B2||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
3919445|NCT01438814|3742813|B1||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
3919446|NCT01438814|3742811|B3|||Age||years|Mean|53.0|53.0|Standard Deviation|10.7|10.7|||
3919447|NCT01438814|3742812|B2|||Age||years|Mean|52.9|52.9|Standard Deviation|10.7|10.7|||
3919448|NCT01438814|3742813|B1|||Age||years|Mean|53.1|53.1|Standard Deviation|10.7|10.7|||
3919449|NCT01438710|3742844|B1|Deceased donor||Donor type for current kidney transplant, n||participants|Number|29|29.0||||||
3919450|NCT01438710|3742844|B1|Living donor||Donor type for current kidney transplant, n||participants|Number|15|15.0||||||
3919451|NCT01438710|3742844|B1|||Time from current kidney transplant to enrolment, months||Months|Mean|16.85|16.85|Standard Deviation|14.455|14.455|||
3919452|NCT01438710|3742844|B1|||BMI, kg/m2||kg/m2|Mean|29.20|29.2|Standard Deviation|5.979|5.979|||
3919453|NCT01438710|3742844|B1|||Weight, kg||kg|Mean|88.16|88.16|Standard Deviation|19.707|19.707|||
3919454|NCT01438710|3742844|B1|||Height, cm||cm|Mean|173.63|173.63|Standard Deviation|8.424|8.424|||
3919455|NCT01438710|3742844|B1|||Target Trough Range (high), ng/mL||ng/mL|Mean|8.68|8.68|Standard Deviation|1.863|1.863|||
3919456|NCT01438710|3742844|B1|||Target Trough Range (low), ng/mL||ng/mL|Mean|5.72|5.72|Standard Deviation|1.912|1.912|||
3919457|NCT01438710|3742844|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
3919458|NCT01438710|3742844|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3919459|NCT01438710|3742844|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3919460|NCT01438710|3742844|B1||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3919461|NCT01438710|3742844|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3919462|NCT01438710|3742844|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3919463|NCT01438710|3742844|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3919464|NCT01438710|3742844|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3919465|NCT01438710|3742844|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3919466|NCT01438710|3742844|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3919467|NCT01438710|3742844|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3919468|NCT01438710|3742844|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3919469|NCT01438710|3742844|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3919470|NCT01438710|3742844|B1|||Age||years|Mean|47.8|47.8|Standard Deviation|13.68|13.68|||
3919471|NCT01438710|3742844|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3919472|NCT01438710|3742844|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3919473|NCT01438710|3742844|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3919474|NCT01438541|3742850|B1|United Kingdom||Region of Enrollment||participants|Number|29|29.0||||||
3919475|NCT01438541|3742850|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3919476|NCT01438541|3742850|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3919477|NCT01438541|3742850|B1|||Age||years|Mean|68.6|68.6|Standard Deviation|16.9|16.9|||
3919478|NCT01438489|3742856|B4|||Baseline weight||kilogram|Mean|69.48|69.48|Standard Deviation|17.79|17.79|||
3919479|NCT01438489|3742857|B3|||Baseline weight||kilogram|Mean|70.74|70.74|Standard Deviation|17.29|17.29|||
3919480|NCT01438489|3742858|B2|||Baseline weight||kilogram|Mean|69.62|69.62|Standard Deviation|17.09|17.09|||
3919481|NCT01438489|3742859|B1|||Baseline weight||kilogram|Mean|68.08|68.08|Standard Deviation|18.98|18.98|||
3919482|NCT01438489|3742856|B4|UNITED STATES OF AMERICA||Region of Enrollment||Participants|Number|95|95.0||||||
3919483|NCT01438489|3742857|B3|UNITED STATES OF AMERICA||Region of Enrollment||Participants|Number|29|29.0||||||
3919484|NCT01438489|3742858|B2|UNITED STATES OF AMERICA||Region of Enrollment||Participants|Number|38|38.0||||||
3919485|NCT01438489|3742859|B1|UNITED STATES OF AMERICA||Region of Enrollment||Participants|Number|28|28.0||||||
3919486|NCT01438489|3742856|B4|UKRAINE||Region of Enrollment||Participants|Number|22|22.0||||||
3919487|NCT01438489|3742857|B3|UKRAINE||Region of Enrollment||Participants|Number|11|11.0||||||
3919488|NCT01438489|3742858|B2|UKRAINE||Region of Enrollment||Participants|Number|4|4.0||||||
3919489|NCT01438489|3742859|B1|UKRAINE||Region of Enrollment||Participants|Number|7|7.0||||||
3919490|NCT01438489|3742856|B4|TAIWAN||Region of Enrollment||Participants|Number|12|12.0||||||
3919491|NCT01438489|3742857|B3|TAIWAN||Region of Enrollment||Participants|Number|3|3.0||||||
3919492|NCT01438489|3742858|B2|TAIWAN||Region of Enrollment||Participants|Number|2|2.0||||||
3919493|NCT01438489|3742859|B1|TAIWAN||Region of Enrollment||Participants|Number|7|7.0||||||
3919494|NCT01438489|3742856|B4|SOUTH KOREA||Region of Enrollment||Participants|Number|6|6.0||||||
3919495|NCT01438489|3742857|B3|SOUTH KOREA||Region of Enrollment||Participants|Number|3|3.0||||||
3919496|NCT01438489|3742858|B2|SOUTH KOREA||Region of Enrollment||Participants|Number|0|0.0||||||
3919497|NCT01438489|3742859|B1|SOUTH KOREA||Region of Enrollment||Participants|Number|3|3.0||||||
3919498|NCT01438489|3742856|B4|ROMANIA||Region of Enrollment||Participants|Number|2|2.0||||||
3919499|NCT01438489|3742857|B3|ROMANIA||Region of Enrollment||Participants|Number|1|1.0||||||
3919500|NCT01438489|3742858|B2|ROMANIA||Region of Enrollment||Participants|Number|0|0.0||||||
3919501|NCT01438489|3742859|B1|ROMANIA||Region of Enrollment||Participants|Number|1|1.0||||||
3919502|NCT01438489|3742856|B4|POLAND||Region of Enrollment||Participants|Number|32|32.0||||||
3919503|NCT01438489|3742857|B3|POLAND||Region of Enrollment||Participants|Number|12|12.0||||||
3919504|NCT01438489|3742858|B2|POLAND||Region of Enrollment||Participants|Number|9|9.0||||||
3919505|NCT01438489|3742859|B1|POLAND||Region of Enrollment||Participants|Number|11|11.0||||||
3919506|NCT01438489|3742856|B4|PERU||Region of Enrollment||Participants|Number|50|50.0||||||
3919507|NCT01438489|3742857|B3|PERU||Region of Enrollment||Participants|Number|13|13.0||||||
3919508|NCT01438489|3742858|B2|PERU||Region of Enrollment||Participants|Number|22|22.0||||||
3919509|NCT01438489|3742859|B1|PERU||Region of Enrollment||Participants|Number|15|15.0||||||
3919510|NCT01438489|3742856|B4|MEXICO||Region of Enrollment||Participants|Number|16|16.0||||||
3919511|NCT01438489|3742857|B3|MEXICO||Region of Enrollment||Participants|Number|5|5.0||||||
3919512|NCT01438489|3742858|B2|MEXICO||Region of Enrollment||Participants|Number|7|7.0||||||
3919513|NCT01438489|3742859|B1|MEXICO||Region of Enrollment||Participants|Number|4|4.0||||||
3919514|NCT01438489|3742856|B4|INDIA||Region of Enrollment||Participants|Number|3|3.0||||||
3919515|NCT01438489|3742857|B3|INDIA||Region of Enrollment||Participants|Number|0|0.0||||||
3919516|NCT01438489|3742858|B2|INDIA||Region of Enrollment||Participants|Number|1|1.0||||||
3919517|NCT01438489|3742859|B1|INDIA||Region of Enrollment||Participants|Number|2|2.0||||||
3919518|NCT01438489|3742856|B4|HUNGARY||Region of Enrollment||Participants|Number|10|10.0||||||
3919519|NCT01438489|3742857|B3|HUNGARY||Region of Enrollment||Participants|Number|3|3.0||||||
3919520|NCT01438489|3742858|B2|HUNGARY||Region of Enrollment||Participants|Number|5|5.0||||||
3919521|NCT01438489|3742859|B1|HUNGARY||Region of Enrollment||Participants|Number|2|2.0||||||
3919522|NCT01438489|3742856|B4|CZECH REPUBLIC||Region of Enrollment||Participants|Number|3|3.0||||||
3919523|NCT01438489|3742857|B3|CZECH REPUBLIC||Region of Enrollment||Participants|Number|2|2.0||||||
3919524|NCT01438489|3742858|B2|CZECH REPUBLIC||Region of Enrollment||Participants|Number|0|0.0||||||
3919525|NCT01438489|3742859|B1|CZECH REPUBLIC||Region of Enrollment||Participants|Number|1|1.0||||||
3919526|NCT01438489|3742856|B4|COLOMBIA||Region of Enrollment||Participants|Number|44|44.0||||||
3919527|NCT01438489|3742857|B3|COLOMBIA||Region of Enrollment||Participants|Number|18|18.0||||||
3919528|NCT01438489|3742858|B2|COLOMBIA||Region of Enrollment||Participants|Number|10|10.0||||||
3919529|NCT01438489|3742859|B1|COLOMBIA||Region of Enrollment||Participants|Number|16|16.0||||||
3919530|NCT01438489|3742856|B4|BULGARIA||Region of Enrollment||Participants|Number|9|9.0||||||
3919531|NCT01438489|3742857|B3|BULGARIA||Region of Enrollment||Participants|Number|4|4.0||||||
3919532|NCT01438489|3742858|B2|BULGARIA||Region of Enrollment||Participants|Number|2|2.0||||||
3919533|NCT01438489|3742859|B1|BULGARIA||Region of Enrollment||Participants|Number|3|3.0||||||
3919534|NCT01438489|3742856|B4|BRAZIL||Region of Enrollment||Participants|Number|3|3.0||||||
3919535|NCT01438489|3742857|B3|BRAZIL||Region of Enrollment||Participants|Number|0|0.0||||||
3919536|NCT01438489|3742858|B2|BRAZIL||Region of Enrollment||Participants|Number|0|0.0||||||
3919537|NCT01438489|3742859|B1|BRAZIL||Region of Enrollment||Participants|Number|3|3.0||||||
3919538|NCT01438489|3742856|B4|Multiple category checked||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3919539|NCT01438489|3742857|B3|Multiple category checked||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3919540|NCT01438489|3742858|B2|Multiple category checked||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3919541|NCT01438489|3742859|B1|Multiple category checked||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3919542|NCT01438489|3742856|B4|Other||Race/Ethnicity, Customized||Participants|Number|109|109.0||||||
3919543|NCT01438489|3742857|B3|Other||Race/Ethnicity, Customized||Participants|Number|36|36.0||||||
3919544|NCT01438489|3742858|B2|Other||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
3919545|NCT01438489|3742859|B1|Other||Race/Ethnicity, Customized||Participants|Number|36|36.0||||||
3919546|NCT01438489|3742856|B4|White||Race/Ethnicity, Customized||Participants|Number|128|128.0||||||
3919547|NCT01438489|3742857|B3|White||Race/Ethnicity, Customized||Participants|Number|51|51.0||||||
3919548|NCT01438489|3742858|B2|White||Race/Ethnicity, Customized||Participants|Number|36|36.0||||||
3919549|NCT01438489|3742859|B1|White||Race/Ethnicity, Customized||Participants|Number|41|41.0||||||
3919550|NCT01438489|3742856|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3919551|NCT01438489|3742857|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3919552|NCT01438489|3742858|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3919553|NCT01438489|3742859|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3919554|NCT01438489|3742856|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|41|41.0||||||
3919555|NCT01438489|3742857|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
3919556|NCT01438489|3742858|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
3919557|NCT01438489|3742859|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3919558|NCT01438489|3742856|B4|Asian||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
3919559|NCT01438489|3742857|B3|Asian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3919560|NCT01438489|3742858|B2|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3919561|NCT01438489|3742859|B1|Asian||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
3919562|NCT01438489|3742856|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3919563|NCT01438489|3742857|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3919564|NCT01438489|3742858|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3919565|NCT01438489|3742859|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3919566|NCT01438489|3742856|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3919567|NCT01438489|3742857|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3919568|NCT01438489|3742858|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3919569|NCT01438489|3742859|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3919570|NCT01438489|3742856|B4||Female|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
3919571|NCT01438489|3742857|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3919572|NCT01438489|3742858|B2||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3919573|NCT01438489|3742859|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3919574|NCT01438489|3742856|B4|||Age||Years|Mean|39.8|39.8|Standard Deviation|12.2|12.2|||
3919575|NCT01438489|3742857|B3|||Age||Years|Mean|40.8|40.8|Standard Deviation|11.6|11.6|||
3919576|NCT01438489|3742858|B2|||Age||Years|Mean|39.3|39.3|Standard Deviation|12.0|12.0|||
3919577|NCT01438489|3742859|B1|||Age||Years|Mean|39.2|39.2|Standard Deviation|12.9|12.9|||
3919578|NCT01438424|3742904|B1|||Age||Years|Mean|41|41.0|Full Range|||17.0|78.0|
3919579|NCT01438424|3742904|B1|South America||Region: Continent||Participants|Number|125|125.0||||||
3919580|NCT01438424|3742904|B1|North America||Region: Continent||Participants|Number|141|141.0||||||
3919581|NCT01438424|3742904|B1|Europe||Region: Continent||Participants|Number|334|334.0||||||
3919582|NCT01438424|3742904|B1|Asia||Region: Continent||Participants|Number|451|451.0||||||
3919583|NCT01438424|3742904|B1|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3919584|NCT01438424|3742904|B1|Filipino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3919585|NCT01438424|3742904|B1|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3919586|NCT01438424|3742904|B1|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3919587|NCT01438424|3742904|B1|Missing||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3919588|NCT01438424|3742904|B1|Black/African American||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
3919589|NCT01438424|3742904|B1|White||Race/Ethnicity, Customized||Participants|Number|481|481.0||||||
3919590|NCT01438424|3742904|B1|Asian/Pacific Islander||Race/Ethnicity, Customized||Participants|Number|544|544.0||||||
3919591|NCT01438424|3742904|B1||Male|Sex: Female, Male||Participants|Count of Participants|810|810.0||||||
3919592|NCT01438424|3742904|B1||Female|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
3919593|NCT01438424|3742904|B1|||Age, Customized||Years|Median|41|41.0|Standard Deviation|13|13.0|||
3919594|NCT01438307|3742940|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
3919595|NCT01438307|3742941|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3919596|NCT01438307|3742942|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3919597|NCT01438307|3742940|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3919598|NCT01438307|3742941|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3919599|NCT01438307|3742942|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3919600|NCT01438307|3742940|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3919601|NCT01438307|3742941|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3919602|NCT01438307|3742942|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3919603|NCT01438307|3742940|B3|||Age||Years|Median|65|65.0|Full Range|||41.0|78.0|
3919604|NCT01438307|3742941|B2|||Age||Years|Median|64|64.0|Full Range|||41.0|78.0|
3919605|NCT01438307|3742942|B1|||Age||Years|Median|68|68.0|Full Range|||47.0|79.0|
3919606|NCT01438307|3742940|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3919607|NCT01438307|3742941|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3919608|NCT01438307|3742942|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3919609|NCT01438307|3742940|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3919610|NCT01438307|3742941|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3919611|NCT01438307|3742942|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3919612|NCT01438307|3742940|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3919613|NCT01438307|3742941|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3919614|NCT01438307|3742942|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3919615|NCT01438294|3742955|B3|||Walked distance||meters|Mean|580|580.0|Standard Deviation|132.4|132.4|||
3919616|NCT01438294|3742956|B2|||Walked distance||meters|Mean|561.6|561.6|Standard Deviation|126.9|126.9|||
3919617|NCT01438294|3742957|B1|||Walked distance||meters|Mean|607.6|607.6|Standard Deviation|148.5|148.5|||
3919618|NCT01438294|3742955|B3|||FeNO||ppb|Mean|33.2|33.2|Standard Deviation|18.4|18.4|||
3919619|NCT01438294|3742956|B2|||FeNO||ppb|Mean|35.5|35.5|Standard Deviation|19.7|19.7|||
3919620|NCT01438294|3742957|B1|||FeNO||ppb|Mean|31.7|31.7|Standard Deviation|15.73|15.73|||
3919621|NCT01438294|3742955|B3|||ACQ6||units on a scale|Median|1.62|1.62|Inter-Quartile Range|||0.58|2.66|
3919622|NCT01438294|3742956|B2|||ACQ6||units on a scale|Median|1.71|1.71|Inter-Quartile Range|||0.83|2.66|
3919623|NCT01438294|3742957|B1|||ACQ6||units on a scale|Median|1.16|1.16|Inter-Quartile Range|||0.58|1.66|
3919624|NCT01438294|3742955|B3|Brazil||Region of Enrollment||participants|Number|26|26.0||||||
3919625|NCT01438294|3742956|B2|Brazil||Region of Enrollment||participants|Number|13|13.0||||||
3919626|NCT01438294|3742957|B1|Brazil||Region of Enrollment||participants|Number|13|13.0||||||
3919627|NCT01438294|3742955|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3919628|NCT01438294|3742956|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3919629|NCT01438294|3742957|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3919630|NCT01438294|3742955|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3919631|NCT01438294|3742956|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3919632|NCT01438294|3742957|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3919633|NCT01438294|3742955|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3919634|NCT01438294|3742956|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3919635|NCT01438294|3742957|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3919636|NCT01438294|3742955|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3919637|NCT01438294|3742956|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3919638|NCT01438294|3742957|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3919639|NCT01438294|3742955|B3||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
3919640|NCT01438294|3742956|B2||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
3919641|NCT01438294|3742957|B1||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
3919642|NCT01438294|3742955|B3|||Age||years|Mean|7.61|7.61|Standard Deviation|2.02|2.02|||
3919643|NCT01438294|3742956|B2|||Age||years|Mean|7.5|7.5|Standard Deviation|1.9|1.9|||
3919644|NCT01438294|3742957|B1|||Age||years|Mean|8.0|8.0|Standard Deviation|2.0|2.0|||
3919645|NCT01438229|3742968|B1|||Heart Rate||beats per minute|Mean|71|71.0|Standard Deviation|12|12.0|||
3919646|NCT01438229|3742968|B1|||Office Diastolic Blood Pressure||mmHg|Mean|96|96.0|Standard Deviation|14|14.0|||
3919647|NCT01438229|3742968|B1|||Office Systolic Blood Pressure||mmHg|Mean|176|176.0|Standard Deviation|16|16.0|||
3919648|NCT01438229|3742968|B1|||Number of Anti-Hypertensive Medications||medications|Mean|4.7|4.7|Standard Deviation|1.0|1.0|||
3919649|NCT01438229|3742968|B1|||Urine Albumin-to-Creatinine Ration||mg/g|Mean|167.6|167.6|Standard Deviation|493|493.0|||
3919650|NCT01438229|3742968|B1|||Cystatin C||mg/L|Mean|1.1|1.1|Standard Deviation|0.3|0.3|||
3919651|NCT01438229|3742968|B1|||Serum Creatinine||mmol/L|Mean|78|78.0|Standard Deviation|17|17.0|||
3919652|NCT01438229|3742968|B1|||eGFR||mL/min/1.73m^2|Mean|87|87.0|Standard Deviation|19|19.0|||
3919653|NCT01438229|3742968|B1|No||Sleep Apnea||participants|Number|32|32.0||||||
3919654|NCT01438229|3742968|B1|Yes||Sleep Apnea||participants|Number|14|14.0||||||
3919655|NCT01438229|3742968|B1|No||Type II Diabetes Mellitus||participants|Number|31|31.0||||||
3919656|NCT01438229|3742968|B1|Yes||Type II Diabetes Mellitus||participants|Number|15|15.0||||||
3919657|NCT01438229|3742968|B1|No||Hyperlipidemia||participants|Number|19|19.0||||||
3919658|NCT01438229|3742968|B1|Yes||Hyperlipidemia||participants|Number|27|27.0||||||
3919659|NCT01438229|3742968|B1|No||Coronary Artery Disease||participants|Number|37|37.0||||||
3919660|NCT01438229|3742968|B1|Yes||Coronary Artery Disease||participants|Number|9|9.0||||||
3919661|NCT01438229|3742968|B1|||Body Mass Index||kg/m^2|Mean|32|32.0|Standard Deviation|5|5.0|||
3919662|NCT01438229|3742968|B1|Australia||Region of Enrollment||participants|Number|26|26.0||||||
3919663|NCT01438229|3742968|B1|Greece||Region of Enrollment||participants|Number|20|20.0||||||
3919664|NCT01438229|3742968|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3919665|NCT01438229|3742968|B1|White||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
3919666|NCT01438229|3742968|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3919667|NCT01438229|3742968|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3919668|NCT01438229|3742968|B1|||Age||years|Mean|60|60.0|Standard Deviation|10|10.0|||
3919669|NCT01438177|3743001|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3919670|NCT01438177|3743001|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3919671|NCT01438177|3743001|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3919672|NCT01438177|3743001|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3919673|NCT01438177|3743001|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3919674|NCT01438177|3743001|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3919675|NCT01438177|3743001|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3919676|NCT01438177|3743001|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3919677|NCT01438177|3743001|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3919678|NCT01438177|3743001|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3919679|NCT01438177|3743001|B1|74-83 years||Age, Customized||participants|Number|1|1.0||||||
3919680|NCT01438177|3743001|B1|64-73 years||Age, Customized||participants|Number|4|4.0||||||
3919681|NCT01438177|3743001|B1|54-63 years||Age, Customized||participants|Number|4|4.0||||||
3919682|NCT01438177|3743001|B1|45-53 years||Age, Customized||participants|Number|2|2.0||||||
3919683|NCT01438151|3743007|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3919684|NCT01438151|3743007|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3919685|NCT01438151|3743007|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3919686|NCT01438151|3743007|B1|||Age||years|Mean|34|34.0|Full Range|||10.0|55.0|
3919687|NCT01438060|3743011|B3|||Weight||kg|Median|59.0|59.0|Full Range|||33.0|102.0|
3919688|NCT01438060|3743012|B2|||Weight||kg|Median|59.0|59.0|Full Range|||35.0|100.0|
3919689|NCT01438060|3743013|B1|||Weight||kg|Median|58.8|58.8|Full Range|||33.0|102.0|
3919690|NCT01438060|3743011|B3|Asian/ Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3919691|NCT01438060|3743012|B2|Asian/ Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3919692|NCT01438060|3743013|B1|Asian/ Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3919693|NCT01438060|3743011|B3|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3919694|NCT01438060|3743012|B2|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3919695|NCT01438060|3743013|B1|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3919696|NCT01438060|3743011|B3|White||Race/Ethnicity, Customized||Participants|Number|203|203.0||||||
3919697|NCT01438060|3743012|B2|White||Race/Ethnicity, Customized||Participants|Number|105|105.0||||||
3919698|NCT01438060|3743013|B1|White||Race/Ethnicity, Customized||Participants|Number|98|98.0||||||
3919699|NCT01438060|3743011|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3919700|NCT01438060|3743012|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3919701|NCT01438060|3743013|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3919702|NCT01438060|3743011|B3||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3919703|NCT01438060|3743012|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3919704|NCT01438060|3743013|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3919705|NCT01438060|3743011|B3|||Age||years|Median|81.0|81.0|Full Range|||56.0|99.0|
3919706|NCT01438060|3743012|B2|||Age||years|Median|81.0|81.0|Full Range|||56.0|95.0|
3919707|NCT01438060|3743013|B1|||Age||years|Median|82.0|82.0|Full Range|||59.0|99.0|
3919708|NCT01437995|3743092|B4|||Euroqual EQ-5D-5L|The Euroqual EQ-5D-5L is a self-completed generic instrument for measuring quality of life over five dimensions - mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The minimum score is 0 and the maximum score is 1, with higher scores indicating better quality of life or better health state.|units on a scale|Median|1.00|1.0|Inter-Quartile Range|||0.86|1.0|
3919709|NCT01437995|3743093|B3|||Euroqual EQ-5D-5L|The Euroqual EQ-5D-5L is a self-completed generic instrument for measuring quality of life over five dimensions - mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The minimum score is 0 and the maximum score is 1, with higher scores indicating better quality of life or better health state.|units on a scale|Median|1.00|1.0|Inter-Quartile Range|||0.86|1.0|
3919710|NCT01437995|3743094|B2|||Euroqual EQ-5D-5L|The Euroqual EQ-5D-5L is a self-completed generic instrument for measuring quality of life over five dimensions - mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The minimum score is 0 and the maximum score is 1, with higher scores indicating better quality of life or better health state.|units on a scale|Median|1.00|1.0|Inter-Quartile Range|||0.86|1.0|
3919711|NCT01437995|3743095|B1|||Euroqual EQ-5D-5L|The Euroqual EQ-5D-5L is a self-completed generic instrument for measuring quality of life over five dimensions - mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The minimum score is 0 and the maximum score is 1, with higher scores indicating better quality of life or better health state.|units on a scale|Median|1.00|1.0|Inter-Quartile Range|||0.86|1.0|
3919712|NCT01437995|3743092|B4|Emotional||Children's Health Survey for Asthma - Child Version|The Children's Health Survey for Asthma - Child Version (CHSA-C) is a self-reported measure of functional impairments that are most troublesome to children 12 to 17 years of age as a results of their asthma over the past three weeks. Results are reported in Physical, Activity, and Emotion domains. For all domains, the minimum value is 0 and the maximum value is 100, with higher values indicating better health or more positive outcomes.|units on a scale|Median|93|93.0|Inter-Quartile Range|||89.0|100.0|
3919713|NCT01437995|3743093|B3|Emotional||Children's Health Survey for Asthma - Child Version|The Children's Health Survey for Asthma - Child Version (CHSA-C) is a self-reported measure of functional impairments that are most troublesome to children 12 to 17 years of age as a results of their asthma over the past three weeks. Results are reported in Physical, Activity, and Emotion domains. For all domains, the minimum value is 0 and the maximum value is 100, with higher values indicating better health or more positive outcomes.|units on a scale|Median|93|93.0|Inter-Quartile Range|||88.0|100.0|
3919714|NCT01437995|3743094|B2|Emotional||Children's Health Survey for Asthma - Child Version|The Children's Health Survey for Asthma - Child Version (CHSA-C) is a self-reported measure of functional impairments that are most troublesome to children 12 to 17 years of age as a results of their asthma over the past three weeks. Results are reported in Physical, Activity, and Emotion domains. For all domains, the minimum value is 0 and the maximum value is 100, with higher values indicating better health or more positive outcomes.|units on a scale|Median|95|95.0|Inter-Quartile Range|||91.0|100.0|
3919715|NCT01437995|3743095|B1|Emotional||Children's Health Survey for Asthma - Child Version|The Children's Health Survey for Asthma - Child Version (CHSA-C) is a self-reported measure of functional impairments that are most troublesome to children 12 to 17 years of age as a results of their asthma over the past three weeks. Results are reported in Physical, Activity, and Emotion domains. For all domains, the minimum value is 0 and the maximum value is 100, with higher values indicating better health or more positive outcomes.|units on a scale|Median|93|93.0|Inter-Quartile Range|||86.0|98.0|
3919716|NCT01437995|3743092|B4|Activity||Children's Health Survey for Asthma - Child Version|The Children's Health Survey for Asthma - Child Version (CHSA-C) is a self-reported measure of functional impairments that are most troublesome to children 12 to 17 years of age as a results of their asthma over the past three weeks. Results are reported in Physical, Activity, and Emotion domains. For all domains, the minimum value is 0 and the maximum value is 100, with higher values indicating better health or more positive outcomes.|units on a scale|Median|100|100.0|Inter-Quartile Range|||92.0|100.0|
3919731|NCT01437995|3743095|B1|||Asthma Control Test Score|The Asthma Control Test is a validated self-administered survey utilizing 5 questions to assess asthma control on a scale from 1 (poor control) to 5 (total control) in individuals 12 years and older. By answering all 5 questions a patient with asthma can obtain a score that may range between 5 and 25. Asthma control is considered a good characteristic for a person with asthma and therefore a higher score is considered a better outcome.|units on a scale|Median|23|23.0|Inter-Quartile Range|||22.0|25.0|
3919717|NCT01437995|3743093|B3|Activity||Children's Health Survey for Asthma - Child Version|The Children's Health Survey for Asthma - Child Version (CHSA-C) is a self-reported measure of functional impairments that are most troublesome to children 12 to 17 years of age as a results of their asthma over the past three weeks. Results are reported in Physical, Activity, and Emotion domains. For all domains, the minimum value is 0 and the maximum value is 100, with higher values indicating better health or more positive outcomes.|units on a scale|Median|100|100.0|Inter-Quartile Range|||96.0|100.0|
3919718|NCT01437995|3743094|B2|Activity||Children's Health Survey for Asthma - Child Version|The Children's Health Survey for Asthma - Child Version (CHSA-C) is a self-reported measure of functional impairments that are most troublesome to children 12 to 17 years of age as a results of their asthma over the past three weeks. Results are reported in Physical, Activity, and Emotion domains. For all domains, the minimum value is 0 and the maximum value is 100, with higher values indicating better health or more positive outcomes.|units on a scale|Median|100|100.0|Inter-Quartile Range|||92.0|100.0|
3919719|NCT01437995|3743095|B1|Activity||Children's Health Survey for Asthma - Child Version|The Children's Health Survey for Asthma - Child Version (CHSA-C) is a self-reported measure of functional impairments that are most troublesome to children 12 to 17 years of age as a results of their asthma over the past three weeks. Results are reported in Physical, Activity, and Emotion domains. For all domains, the minimum value is 0 and the maximum value is 100, with higher values indicating better health or more positive outcomes.|units on a scale|Median|100|100.0|Inter-Quartile Range|||92.0|100.0|
3919720|NCT01437995|3743092|B4|Physical||Children's Health Survey for Asthma - Child Version|The Children's Health Survey for Asthma - Child Version (CHSA-C) is a self-reported measure of functional impairments that are most troublesome to children 12 to 17 years of age as a results of their asthma over the past three weeks. Results are reported in Physical, Activity, and Emotion domains. For all domains, the minimum value is 0 and the maximum value is 100, with higher values indicating better health or more positive outcomes.|units on a scale|Median|93|93.0|Inter-Quartile Range|||91.0|100.0|
3919721|NCT01437995|3743093|B3|Physical||Children's Health Survey for Asthma - Child Version|The Children's Health Survey for Asthma - Child Version (CHSA-C) is a self-reported measure of functional impairments that are most troublesome to children 12 to 17 years of age as a results of their asthma over the past three weeks. Results are reported in Physical, Activity, and Emotion domains. For all domains, the minimum value is 0 and the maximum value is 100, with higher values indicating better health or more positive outcomes.|units on a scale|Median|96|96.0|Inter-Quartile Range|||93.0|100.0|
3919722|NCT01437995|3743094|B2|Physical||Children's Health Survey for Asthma - Child Version|The Children's Health Survey for Asthma - Child Version (CHSA-C) is a self-reported measure of functional impairments that are most troublesome to children 12 to 17 years of age as a results of their asthma over the past three weeks. Results are reported in Physical, Activity, and Emotion domains. For all domains, the minimum value is 0 and the maximum value is 100, with higher values indicating better health or more positive outcomes.|units on a scale|Median|93|93.0|Inter-Quartile Range|||89.0|100.0|
3919723|NCT01437995|3743095|B1|Physical||Children's Health Survey for Asthma - Child Version|The Children's Health Survey for Asthma - Child Version (CHSA-C) is a self-reported measure of functional impairments that are most troublesome to children 12 to 17 years of age as a results of their asthma over the past three weeks. Results are reported in Physical, Activity, and Emotion domains. For all domains, the minimum value is 0 and the maximum value is 100, with higher values indicating better health or more positive outcomes.|units on a scale|Median|93|93.0|Inter-Quartile Range|||93.0|100.0|
3919724|NCT01437995|3743092|B4|||Marks AQLQ|Marks Asthma Quality of Life Questionnaire (AQLQ) measures physical and emotional asthma specific quality of life during the past four weeks. The minimum score is 0 and the maximum score is 80, with lower scores indicating better quality of life. The scale is for use in adults only (individuals aged 18 or older).|units on a scale|Median|4.0|4.0|Inter-Quartile Range|||2.0|8.0|
3919725|NCT01437995|3743093|B3|||Marks AQLQ|Marks Asthma Quality of Life Questionnaire (AQLQ) measures physical and emotional asthma specific quality of life during the past four weeks. The minimum score is 0 and the maximum score is 80, with lower scores indicating better quality of life. The scale is for use in adults only (individuals aged 18 or older).|units on a scale|Median|4.0|4.0|Inter-Quartile Range|||2.0|7.0|
3919726|NCT01437995|3743094|B2|||Marks AQLQ|Marks Asthma Quality of Life Questionnaire (AQLQ) measures physical and emotional asthma specific quality of life during the past four weeks. The minimum score is 0 and the maximum score is 80, with lower scores indicating better quality of life. The scale is for use in adults only (individuals aged 18 or older).|units on a scale|Median|5.0|5.0|Inter-Quartile Range|||2.0|9.0|
3919727|NCT01437995|3743095|B1|||Marks AQLQ|Marks Asthma Quality of Life Questionnaire (AQLQ) measures physical and emotional asthma specific quality of life during the past four weeks. The minimum score is 0 and the maximum score is 80, with lower scores indicating better quality of life. The scale is for use in adults only (individuals aged 18 or older).|units on a scale|Median|4.0|4.0|Inter-Quartile Range|||1.5|8.0|
3919728|NCT01437995|3743092|B4|||Asthma Control Test Score|The Asthma Control Test is a validated self-administered survey utilizing 5 questions to assess asthma control on a scale from 1 (poor control) to 5 (total control) in individuals 12 years and older. By answering all 5 questions a patient with asthma can obtain a score that may range between 5 and 25. Asthma control is considered a good characteristic for a person with asthma and therefore a higher score is considered a better outcome.|units on a scale|Median|23|23.0|Inter-Quartile Range|||22.0|25.0|
3919729|NCT01437995|3743093|B3|||Asthma Control Test Score|The Asthma Control Test is a validated self-administered survey utilizing 5 questions to assess asthma control on a scale from 1 (poor control) to 5 (total control) in individuals 12 years and older. By answering all 5 questions a patient with asthma can obtain a score that may range between 5 and 25. Asthma control is considered a good characteristic for a person with asthma and therefore a higher score is considered a better outcome.|units on a scale|Median|23|23.0|Inter-Quartile Range|||22.0|24.0|
3919730|NCT01437995|3743094|B2|||Asthma Control Test Score|The Asthma Control Test is a validated self-administered survey utilizing 5 questions to assess asthma control on a scale from 1 (poor control) to 5 (total control) in individuals 12 years and older. By answering all 5 questions a patient with asthma can obtain a score that may range between 5 and 25. Asthma control is considered a good characteristic for a person with asthma and therefore a higher score is considered a better outcome.|units on a scale|Median|23|23.0|Inter-Quartile Range|||21.0|24.0|
3919732|NCT01437995|3743092|B4|||Pre-bronchodilator peak flow||Liters per minute|Median|430|430.0|Inter-Quartile Range|||350.0|500.0|
3919733|NCT01437995|3743093|B3|||Pre-bronchodilator peak flow||Liters per minute|Median|430|430.0|Inter-Quartile Range|||360.0|500.0|
3919734|NCT01437995|3743094|B2|||Pre-bronchodilator peak flow||Liters per minute|Median|430|430.0|Inter-Quartile Range|||350.0|500.0|
3919735|NCT01437995|3743095|B1|||Pre-bronchodilator peak flow||Liters per minute|Median|420|420.0|Inter-Quartile Range|||350.0|500.0|
3919736|NCT01437995|3743092|B4|Allergies worsen asthma||Other conditions, based upon self-report||participants|Number|358|358.0||||||
3919737|NCT01437995|3743093|B3|Allergies worsen asthma||Other conditions, based upon self-report||participants|Number|122|122.0||||||
3919738|NCT01437995|3743094|B2|Allergies worsen asthma||Other conditions, based upon self-report||participants|Number|113|113.0||||||
3919739|NCT01437995|3743095|B1|Allergies worsen asthma||Other conditions, based upon self-report||participants|Number|123|123.0||||||
3919740|NCT01437995|3743092|B4|Food allergies||Other conditions, based upon self-report||participants|Number|107|107.0||||||
3919741|NCT01437995|3743093|B3|Food allergies||Other conditions, based upon self-report||participants|Number|34|34.0||||||
3919742|NCT01437995|3743094|B2|Food allergies||Other conditions, based upon self-report||participants|Number|40|40.0||||||
3919743|NCT01437995|3743095|B1|Food allergies||Other conditions, based upon self-report||participants|Number|33|33.0||||||
3919744|NCT01437995|3743092|B4|Allergic rhinitis||Other conditions, based upon self-report||participants|Number|246|246.0||||||
3919745|NCT01437995|3743093|B3|Allergic rhinitis||Other conditions, based upon self-report||participants|Number|88|88.0||||||
3919746|NCT01437995|3743094|B2|Allergic rhinitis||Other conditions, based upon self-report||participants|Number|73|73.0||||||
3919747|NCT01437995|3743095|B1|Allergic rhinitis||Other conditions, based upon self-report||participants|Number|85|85.0||||||
3919748|NCT01437995|3743092|B4|Sinusitis||Other conditions, based upon self-report||participants|Number|125|125.0||||||
3919749|NCT01437995|3743093|B3|Sinusitis||Other conditions, based upon self-report||participants|Number|34|34.0||||||
3919750|NCT01437995|3743094|B2|Sinusitis||Other conditions, based upon self-report||participants|Number|41|41.0||||||
3919751|NCT01437995|3743095|B1|Sinusitis||Other conditions, based upon self-report||participants|Number|50|50.0||||||
3919752|NCT01437995|3743092|B4|Eczema||Other conditions, based upon self-report||participants|Number|89|89.0||||||
3919753|NCT01437995|3743093|B3|Eczema||Other conditions, based upon self-report||participants|Number|26|26.0||||||
3919754|NCT01437995|3743094|B2|Eczema||Other conditions, based upon self-report||participants|Number|28|28.0||||||
3919755|NCT01437995|3743095|B1|Eczema||Other conditions, based upon self-report||participants|Number|35|35.0||||||
3919756|NCT01437995|3743092|B4|Pre-bronchodilator peak flow||Pulmonary function measures, percent predicted||percent predicted|Median|98|98.0|Inter-Quartile Range|||88.0|110.0|
3919757|NCT01437995|3743093|B3|Pre-bronchodilator peak flow||Pulmonary function measures, percent predicted||percent predicted|Median|98|98.0|Inter-Quartile Range|||89.0|113.0|
3919758|NCT01437995|3743094|B2|Pre-bronchodilator peak flow||Pulmonary function measures, percent predicted||percent predicted|Median|100|100.0|Inter-Quartile Range|||90.0|110.0|
3919759|NCT01437995|3743095|B1|Pre-bronchodilator peak flow||Pulmonary function measures, percent predicted||percent predicted|Median|96|96.0|Inter-Quartile Range|||84.0|110.0|
3919760|NCT01437995|3743092|B4|Pre-bronchodilator FVC||Pulmonary function measures, percent predicted||percent predicted|Median|99|99.0|Inter-Quartile Range|||90.0|107.0|
3919761|NCT01437995|3743093|B3|Pre-bronchodilator FVC||Pulmonary function measures, percent predicted||percent predicted|Median|98|98.0|Inter-Quartile Range|||90.0|108.0|
3919762|NCT01437995|3743094|B2|Pre-bronchodilator FVC||Pulmonary function measures, percent predicted||percent predicted|Median|100|100.0|Inter-Quartile Range|||91.0|107.0|
3919763|NCT01437995|3743095|B1|Pre-bronchodilator FVC||Pulmonary function measures, percent predicted||percent predicted|Median|98|98.0|Inter-Quartile Range|||89.0|107.0|
3919764|NCT01437995|3743092|B4|Pre-bronchodilator FEV1||Pulmonary function measures, percent predicted||percent predicted|Median|91|91.0|Inter-Quartile Range|||83.0|101.0|
3919765|NCT01437995|3743093|B3|Pre-bronchodilator FEV1||Pulmonary function measures, percent predicted||percent predicted|Median|92|92.0|Inter-Quartile Range|||83.0|101.0|
3919766|NCT01437995|3743094|B2|Pre-bronchodilator FEV1||Pulmonary function measures, percent predicted||percent predicted|Median|91|91.0|Inter-Quartile Range|||83.0|101.0|
3919767|NCT01437995|3743095|B1|Pre-bronchodilator FEV1||Pulmonary function measures, percent predicted||percent predicted|Median|91|91.0|Inter-Quartile Range|||82.0|99.0|
3919768|NCT01437995|3743092|B4|Post-bronchodilator FVC||Pulmonary function measures||Liters|Median|3.62|3.62|Inter-Quartile Range|||3.09|4.5|
3919769|NCT01437995|3743093|B3|Post-bronchodilator FVC||Pulmonary function measures||Liters|Median|3.65|3.65|Inter-Quartile Range|||3.06|4.52|
3919770|NCT01437995|3743094|B2|Post-bronchodilator FVC||Pulmonary function measures||Liters|Median|3.72|3.72|Inter-Quartile Range|||3.11|4.63|
3919771|NCT01437995|3743095|B1|Post-bronchodilator FVC||Pulmonary function measures||Liters|Median|3.59|3.59|Inter-Quartile Range|||3.09|4.28|
3919772|NCT01437995|3743092|B4|Post-bronchodilator FEV1||Pulmonary function measures||Liters|Median|2.92|2.92|Inter-Quartile Range|||2.39|3.49|
3919773|NCT01437995|3743093|B3|Post-bronchodilator FEV1||Pulmonary function measures||Liters|Median|2.93|2.93|Inter-Quartile Range|||2.44|3.6|
3919774|NCT01437995|3743094|B2|Post-bronchodilator FEV1||Pulmonary function measures||Liters|Median|2.96|2.96|Inter-Quartile Range|||2.39|3.5|
3919775|NCT01437995|3743095|B1|Post-bronchodilator FEV1||Pulmonary function measures||Liters|Median|2.88|2.88|Inter-Quartile Range|||2.34|3.36|
3919776|NCT01437995|3743092|B4|Pre-bronchodilator FVC||Pulmonary function measures||Liters|Median|3.62|3.62|Inter-Quartile Range|||3.0|4.44|
3919777|NCT01437995|3743093|B3|Pre-bronchodilator FVC||Pulmonary function measures||Liters|Median|3.65|3.65|Inter-Quartile Range|||3.03|4.56|
3919778|NCT01437995|3743094|B2|Pre-bronchodilator FVC||Pulmonary function measures||Liters|Median|3.62|3.62|Inter-Quartile Range|||2.97|4.54|
3919779|NCT01437995|3743095|B1|Pre-bronchodilator FVC||Pulmonary function measures||Liters|Median|3.54|3.54|Inter-Quartile Range|||2.99|4.3|
3919780|NCT01437995|3743092|B4|Pre-bronchodilator FEV1||Pulmonary function measures||Liters|Median|2.83|2.83|Inter-Quartile Range|||2.3|3.43|
3919781|NCT01437995|3743093|B3|Pre-bronchodilator FEV1||Pulmonary function measures||Liters|Median|2.82|2.82|Inter-Quartile Range|||2.38|3.49|
3919782|NCT01437995|3743094|B2|Pre-bronchodilator FEV1||Pulmonary function measures||Liters|Median|2.86|2.86|Inter-Quartile Range|||2.35|3.44|
3919783|NCT01437995|3743095|B1|Pre-bronchodilator FEV1||Pulmonary function measures||Liters|Median|2.82|2.82|Inter-Quartile Range|||2.24|3.31|
3919784|NCT01437995|3743092|B4|||Asthma Symptom Utility Index|The Asthma Symptom Utility Index asks about asthma symptoms within the past 2 weeks. The scale ranges from 0 to 1 with higher scores indicating better health.|units on a scale|Median|0.95|0.95|Inter-Quartile Range|||0.89|1.0|
3919785|NCT01437995|3743093|B3|||Asthma Symptom Utility Index|The Asthma Symptom Utility Index asks about asthma symptoms within the past 2 weeks. The scale ranges from 0 to 1 with higher scores indicating better health.|units on a scale|Median|0.98|0.98|Inter-Quartile Range|||0.92|1.0|
3919786|NCT01437995|3743094|B2|||Asthma Symptom Utility Index|The Asthma Symptom Utility Index asks about asthma symptoms within the past 2 weeks. The scale ranges from 0 to 1 with higher scores indicating better health.|units on a scale|Median|0.94|0.94|Inter-Quartile Range|||0.89|1.0|
3919787|NCT01437995|3743095|B1|||Asthma Symptom Utility Index|The Asthma Symptom Utility Index asks about asthma symptoms within the past 2 weeks. The scale ranges from 0 to 1 with higher scores indicating better health.|units on a scale|Median|0.95|0.95|Inter-Quartile Range|||0.9|1.0|
3919788|NCT01437995|3743092|B4|||Atopy (phadiatop ≥ 0.35 kUA/l)||participants|Number|352|352.0||||||
3919789|NCT01437995|3743093|B3|||Atopy (phadiatop ≥ 0.35 kUA/l)||participants|Number|114|114.0||||||
3919790|NCT01437995|3743094|B2|||Atopy (phadiatop ≥ 0.35 kUA/l)||participants|Number|123|123.0||||||
3919791|NCT01437995|3743095|B1|||Atopy (phadiatop ≥ 0.35 kUA/l)||participants|Number|115|115.0||||||
3919792|NCT01437995|3743092|B4|||eNO (exhaled nitric oxide)||parts per billion|Median|17.5|17.5|Inter-Quartile Range|||12.5|26.0|
3919793|NCT01437995|3743093|B3|||eNO (exhaled nitric oxide)||parts per billion|Median|16.5|16.5|Inter-Quartile Range|||11.5|26.5|
3919794|NCT01437995|3743094|B2|||eNO (exhaled nitric oxide)||parts per billion|Median|17.5|17.5|Inter-Quartile Range|||13.8|25.3|
3919795|NCT01437995|3743095|B1|||eNO (exhaled nitric oxide)||parts per billion|Median|18.5|18.5|Inter-Quartile Range|||12.5|26.5|
3919796|NCT01437995|3743092|B4|||Age of Asthma Onset||years|Median|7|7.0|Inter-Quartile Range|||2.0|20.0|
3919797|NCT01437995|3743093|B3|||Age of Asthma Onset||years|Median|7|7.0|Inter-Quartile Range|||2.0|20.0|
3919798|NCT01437995|3743094|B2|||Age of Asthma Onset||years|Median|7|7.0|Inter-Quartile Range|||2.0|18.0|
3919799|NCT01437995|3743095|B1|||Age of Asthma Onset||years|Median|7|7.0|Inter-Quartile Range|||3.0|21.0|
3919800|NCT01437995|3743092|B4|Daily anti-leukotriene use||Asthma characteristics|Description of characteristics of recent asthma treatment. Individuals who did not have a history of the treatment were not counted.|participants|Number|92|92.0||||||
3919801|NCT01437995|3743093|B3|Daily anti-leukotriene use||Asthma characteristics|Description of characteristics of recent asthma treatment. Individuals who did not have a history of the treatment were not counted.|participants|Number|30|30.0||||||
3919802|NCT01437995|3743094|B2|Daily anti-leukotriene use||Asthma characteristics|Description of characteristics of recent asthma treatment. Individuals who did not have a history of the treatment were not counted.|participants|Number|30|30.0||||||
3919803|NCT01437995|3743095|B1|Daily anti-leukotriene use||Asthma characteristics|Description of characteristics of recent asthma treatment. Individuals who did not have a history of the treatment were not counted.|participants|Number|32|32.0||||||
3919804|NCT01437995|3743092|B4|Daily short-acting beta agonist use||Asthma characteristics|Description of characteristics of recent asthma treatment. Individuals who did not have a history of the treatment were not counted.|participants|Number|29|29.0||||||
3919805|NCT01437995|3743093|B3|Daily short-acting beta agonist use||Asthma characteristics|Description of characteristics of recent asthma treatment. Individuals who did not have a history of the treatment were not counted.|participants|Number|10|10.0||||||
3919806|NCT01437995|3743094|B2|Daily short-acting beta agonist use||Asthma characteristics|Description of characteristics of recent asthma treatment. Individuals who did not have a history of the treatment were not counted.|participants|Number|12|12.0||||||
3919807|NCT01437995|3743095|B1|Daily short-acting beta agonist use||Asthma characteristics|Description of characteristics of recent asthma treatment. Individuals who did not have a history of the treatment were not counted.|participants|Number|7|7.0||||||
3919808|NCT01437995|3743092|B4|Oral steroids in past year||Asthma characteristics|Description of characteristics of recent asthma treatment. Individuals who did not have a history of the treatment were not counted.|participants|Number|122|122.0||||||
3919809|NCT01437995|3743093|B3|Oral steroids in past year||Asthma characteristics|Description of characteristics of recent asthma treatment. Individuals who did not have a history of the treatment were not counted.|participants|Number|42|42.0||||||
3919810|NCT01437995|3743094|B2|Oral steroids in past year||Asthma characteristics|Description of characteristics of recent asthma treatment. Individuals who did not have a history of the treatment were not counted.|participants|Number|36|36.0||||||
3919811|NCT01437995|3743095|B1|Oral steroids in past year||Asthma characteristics|Description of characteristics of recent asthma treatment. Individuals who did not have a history of the treatment were not counted.|participants|Number|44|44.0||||||
3919812|NCT01437995|3743092|B4|Hospitalized for asthma in past year||Asthma characteristics|Description of characteristics of recent asthma treatment. Individuals who did not have a history of the treatment were not counted.|participants|Number|14|14.0||||||
3919813|NCT01437995|3743093|B3|Hospitalized for asthma in past year||Asthma characteristics|Description of characteristics of recent asthma treatment. Individuals who did not have a history of the treatment were not counted.|participants|Number|6|6.0||||||
3919864|NCT01437943|3743117|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3919814|NCT01437995|3743094|B2|Hospitalized for asthma in past year||Asthma characteristics|Description of characteristics of recent asthma treatment. Individuals who did not have a history of the treatment were not counted.|participants|Number|3|3.0||||||
3919815|NCT01437995|3743095|B1|Hospitalized for asthma in past year||Asthma characteristics|Description of characteristics of recent asthma treatment. Individuals who did not have a history of the treatment were not counted.|participants|Number|5|5.0||||||
3919816|NCT01437995|3743092|B4|Secondhand smoke home/work||Smoke exposure|History of cigarette smoking and current exposure to secondhand smoke. Individuals with no history of cigarette smoking and no current exposure to second hand smoke are not counted.|participants|Number|56|56.0||||||
3919817|NCT01437995|3743093|B3|Secondhand smoke home/work||Smoke exposure|History of cigarette smoking and current exposure to secondhand smoke. Individuals with no history of cigarette smoking and no current exposure to second hand smoke are not counted.|participants|Number|17|17.0||||||
3919818|NCT01437995|3743094|B2|Secondhand smoke home/work||Smoke exposure|History of cigarette smoking and current exposure to secondhand smoke. Individuals with no history of cigarette smoking and no current exposure to second hand smoke are not counted.|participants|Number|21|21.0||||||
3919819|NCT01437995|3743095|B1|Secondhand smoke home/work||Smoke exposure|History of cigarette smoking and current exposure to secondhand smoke. Individuals with no history of cigarette smoking and no current exposure to second hand smoke are not counted.|participants|Number|18|18.0||||||
3919820|NCT01437995|3743092|B4|Former smoker||Smoke exposure|History of cigarette smoking and current exposure to secondhand smoke. Individuals with no history of cigarette smoking and no current exposure to second hand smoke are not counted.|participants|Number|62|62.0||||||
3919821|NCT01437995|3743093|B3|Former smoker||Smoke exposure|History of cigarette smoking and current exposure to secondhand smoke. Individuals with no history of cigarette smoking and no current exposure to second hand smoke are not counted.|participants|Number|14|14.0||||||
3919822|NCT01437995|3743094|B2|Former smoker||Smoke exposure|History of cigarette smoking and current exposure to secondhand smoke. Individuals with no history of cigarette smoking and no current exposure to second hand smoke are not counted.|participants|Number|25|25.0||||||
3919823|NCT01437995|3743095|B1|Former smoker||Smoke exposure|History of cigarette smoking and current exposure to secondhand smoke. Individuals with no history of cigarette smoking and no current exposure to second hand smoke are not counted.|participants|Number|23|23.0||||||
3919824|NCT01437995|3743092|B4|United States||Region of Enrollment||participants|Number|455|455.0||||||
3919825|NCT01437995|3743093|B3|United States||Region of Enrollment||participants|Number|155|155.0||||||
3919826|NCT01437995|3743094|B2|United States||Region of Enrollment||participants|Number|149|149.0||||||
3919827|NCT01437995|3743095|B1|United States||Region of Enrollment||participants|Number|151|151.0||||||
3919828|NCT01437995|3743092|B4|Other||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3919829|NCT01437995|3743093|B3|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3919830|NCT01437995|3743094|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3919831|NCT01437995|3743095|B1|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3919832|NCT01437995|3743092|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
3919833|NCT01437995|3743093|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3919834|NCT01437995|3743094|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3919835|NCT01437995|3743095|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3919836|NCT01437995|3743092|B4|Black||Race/Ethnicity, Customized||participants|Number|151|151.0||||||
3919837|NCT01437995|3743093|B3|Black||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
3919838|NCT01437995|3743094|B2|Black||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
3919839|NCT01437995|3743095|B1|Black||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
3919840|NCT01437995|3743092|B4|White||Race/Ethnicity, Customized||participants|Number|221|221.0||||||
3919841|NCT01437995|3743093|B3|White||Race/Ethnicity, Customized||participants|Number|75|75.0||||||
3919842|NCT01437995|3743094|B2|White||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
3919843|NCT01437995|3743095|B1|White||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
3919844|NCT01437995|3743092|B4||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3919845|NCT01437995|3743093|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3919846|NCT01437995|3743094|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3919847|NCT01437995|3743095|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3919848|NCT01437995|3743092|B4||Female|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
3919849|NCT01437995|3743093|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3919850|NCT01437995|3743094|B2||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3919851|NCT01437995|3743095|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3919852|NCT01437995|3743092|B4|>=18||Age, Customized||participants|Number|355|355.0||||||
3919853|NCT01437995|3743093|B3|>=18||Age, Customized||participants|Number|125|125.0||||||
3919854|NCT01437995|3743094|B2|>=18||Age, Customized||participants|Number|110|110.0||||||
3919855|NCT01437995|3743095|B1|>=18||Age, Customized||participants|Number|120|120.0||||||
3919856|NCT01437995|3743092|B4|<18||Age, Customized||participants|Number|100|100.0||||||
3919857|NCT01437995|3743093|B3|<18||Age, Customized||participants|Number|30|30.0||||||
3919858|NCT01437995|3743094|B2|<18||Age, Customized||participants|Number|39|39.0||||||
3919859|NCT01437995|3743095|B1|<18||Age, Customized||participants|Number|31|31.0||||||
3919860|NCT01437995|3743092|B4|||Age||years|Median|35|35.0|Inter-Quartile Range|||20.0|50.0|
3919861|NCT01437995|3743093|B3|||Age||years|Median|35|35.0|Inter-Quartile Range|||23.0|50.0|
3919862|NCT01437995|3743094|B2|||Age||years|Median|33|33.0|Inter-Quartile Range|||17.0|49.0|
3919863|NCT01437995|3743095|B1|||Age||years|Median|36|36.0|Inter-Quartile Range|||22.0|51.0|
3919865|NCT01437943|3743118|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3919866|NCT01437943|3743119|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3919867|NCT01437943|3743117|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3919868|NCT01437943|3743118|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3919869|NCT01437943|3743119|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3919870|NCT01437943|3743117|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3919871|NCT01437943|3743118|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3919872|NCT01437943|3743119|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3919873|NCT01437943|3743117|B3|||Age||years|Mean|54|54.0|Full Range|||33.0|75.0|
3919874|NCT01437943|3743118|B2|||Age||years|Mean|48|48.0|Full Range|||33.0|64.0|
3919875|NCT01437943|3743119|B1|||Age||years|Mean|56.6|56.6|Full Range|||42.0|75.0|
3919876|NCT01437943|3743117|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3919877|NCT01437943|3743118|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3919878|NCT01437943|3743119|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3919879|NCT01437943|3743117|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3919880|NCT01437943|3743118|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3919881|NCT01437943|3743119|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3919882|NCT01437943|3743117|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3919883|NCT01437943|3743118|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3919884|NCT01437943|3743119|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3919885|NCT01437878|3743126|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3919886|NCT01437878|3743127|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3919887|NCT01437878|3743128|B1|United States||Region of Enrollment||participants|Number|0|0.0||||||
3919888|NCT01437878|3743126|B3|France||Region of Enrollment||participants|Number|1|1.0||||||
3919889|NCT01437878|3743127|B2|France||Region of Enrollment||participants|Number|0|0.0||||||
3919890|NCT01437878|3743128|B1|France||Region of Enrollment||participants|Number|1|1.0||||||
3919891|NCT01437878|3743126|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3919892|NCT01437878|3743127|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3919893|NCT01437878|3743128|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3919894|NCT01437878|3743126|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3919895|NCT01437878|3743127|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3919896|NCT01437878|3743128|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3919897|NCT01437878|3743126|B3|Age 74 years||Age, Customized||participants|Number|1|1.0||||||
3919898|NCT01437878|3743127|B2|Age 74 years||Age, Customized||participants|Number|1|1.0||||||
3919899|NCT01437878|3743128|B1|Age 74 years||Age, Customized||participants|Number|0|0.0||||||
3919900|NCT01437878|3743126|B3|Age 64 years||Age, Customized||participants|Number|1|1.0||||||
3919901|NCT01437878|3743127|B2|Age 64 years||Age, Customized||participants|Number|0|0.0||||||
3919902|NCT01437878|3743128|B1|Age 64 years||Age, Customized||participants|Number|1|1.0||||||
3919903|NCT01437852|3743169|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3919904|NCT01437852|3743169|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3919905|NCT01437852|3743169|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3919906|NCT01437852|3743169|B1|||Age||years|Mean|41.0|41.0|Standard Deviation|12.1|12.1|||
3919907|NCT01437852|3743169|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3919908|NCT01437852|3743169|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3919909|NCT01437852|3743169|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3919910|NCT01437540|3743175|B3||Male|Sex: Female, Male||Participants|Count of Participants|325|325.0||||||
3919911|NCT01437540|3743176|B2||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3919912|NCT01437540|3743177|B1||Male|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
3919913|NCT01437540|3743175|B3||Female|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
3919914|NCT01437540|3743176|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3919915|NCT01437540|3743177|B1||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
3919916|NCT01437540|3743175|B3|||Age||Years|Mean|64.2|64.2|Standard Deviation|9.4|9.4|||
3919917|NCT01437540|3743176|B2|||Age||Years|Mean|64.7|64.7|Standard Deviation|9.4|9.4|||
3919918|NCT01437540|3743177|B1|||Age||Years|Mean|63.9|63.9|Standard Deviation|9.3|9.3|||
3919919|NCT01437501|3743190|B3|China||Region of Enrollment||participants|Number|291|291.0||||||
3919920|NCT01437501|3743191|B2|China||Region of Enrollment||participants|Number|143|143.0||||||
3919921|NCT01437501|3743192|B1|China||Region of Enrollment||participants|Number|148|148.0||||||
3919922|NCT01437501|3743190|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3919923|NCT01437501|3743191|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3919924|NCT01437501|3743192|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3919925|NCT01437501|3743190|B3||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
3919926|NCT01437501|3743191|B2||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3919927|NCT01437501|3743192|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3919928|NCT01437501|3743190|B3|||Age||years|Mean|51.8|51.8|Standard Deviation|8.7|8.7|||
3919929|NCT01437501|3743191|B2|||Age||years|Mean|52.6|52.6|Standard Deviation|7.7|7.7|||
3919930|NCT01437501|3743192|B1|||Age||years|Mean|51.1|51.1|Standard Deviation|9.4|9.4|||
3919931|NCT01437501|3743190|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3919932|NCT01437501|3743191|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3919933|NCT01437501|3743192|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3919934|NCT01437501|3743190|B3||Between 18 and 65 years|Age||Participants|Count of Participants|291|291.0||||||
3919935|NCT01437501|3743191|B2||Between 18 and 65 years|Age||Participants|Count of Participants|143|143.0||||||
3919936|NCT01437501|3743192|B1||Between 18 and 65 years|Age||Participants|Count of Participants|148|148.0||||||
3919937|NCT01437501|3743190|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3919938|NCT01437501|3743191|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3919939|NCT01437501|3743192|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3919940|NCT01437488|3743201|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3919941|NCT01437488|3743201|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3919942|NCT01437488|3743201|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3919943|NCT01437488|3743201|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3919944|NCT01437488|3743201|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3919945|NCT01437488|3743201|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3919946|NCT01437488|3743201|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3919947|NCT01437488|3743201|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3919948|NCT01437488|3743201|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3919949|NCT01437488|3743201|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3919950|NCT01437488|3743201|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3919951|NCT01437488|3743201|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3919952|NCT01437488|3743201|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3919953|NCT01437488|3743201|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3919954|NCT01437488|3743201|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3919955|NCT01437488|3743201|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3919956|NCT01437423|3743208|B1|Korea, Republic of||Region of Enrollment||Participants|Number|647|647.0||||||
3919957|NCT01437423|3743208|B1||Male|Gender||Participants|Count of Participants|320|320.0||||||
3919958|NCT01437423|3743208|B1||Female|Gender||Participants|Count of Participants|327|327.0||||||
3919959|NCT01437423|3743208|B1|||Age||Months|Mean|8.16|8.16|Standard Deviation|13.43|13.43|||
3919960|NCT01437423|3743208|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3919961|NCT01437423|3743208|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3919962|NCT01437423|3743208|B1||<=18 years|Age||Participants|Count of Participants|647|647.0||||||
3919963|NCT01437397|3743215|B6||Male|Sex: Female, Male||Participants|Count of Participants|887|887.0||||||
3919964|NCT01437397|3743216|B5||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
3919965|NCT01437397|3743217|B4||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3919966|NCT01437397|3743218|B3||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3919967|NCT01437397|3743219|B2||Male|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
3919968|NCT01437397|3743220|B1||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3919969|NCT01437397|3743215|B6||Female|Sex: Female, Male||Participants|Count of Participants|782|782.0||||||
3919970|NCT01437397|3743216|B5||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3919971|NCT01437397|3743217|B4||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3919972|NCT01437397|3743218|B3||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3919973|NCT01437397|3743219|B2||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3919974|NCT01437397|3743220|B1||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3919975|NCT01437397|3743215|B6|||Age||Years|Mean|63.9|63.9|Standard Deviation|8.9|8.9|||
3919976|NCT01437397|3743216|B5|||Age||Years|Mean|63.5|63.5|Standard Deviation|8.9|8.9|||
3919977|NCT01437397|3743217|B4|||Age||Years|Mean|63.7|63.7|Standard Deviation|8.7|8.7|||
3919978|NCT01437397|3743218|B3|||Age||Years|Mean|64.4|64.4|Standard Deviation|8.7|8.7|||
3919979|NCT01437397|3743219|B2|||Age||Years|Mean|63.9|63.9|Standard Deviation|9.2|9.2|||
3919980|NCT01437397|3743220|B1|||Age||Years|Mean|64.2|64.2|Standard Deviation|8.9|8.9|||
3919981|NCT01437319|3743251|B1|United States||Region of Enrollment||participants|Number|282|282.0||||||
3919982|NCT01437319|3743251|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3919983|NCT01437319|3743251|B1||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3919984|NCT01437319|3743251|B1|||Age||years|Mean|33.8|33.8|Standard Deviation|11.6|11.6|||
3919985|NCT01437267|3743262|B7|Philippines||Region of Enrollment||participants|Number|120|120.0||||||
3919986|NCT01437267|3743263|B6|Philippines||Region of Enrollment||participants|Number|20|20.0||||||
3919987|NCT01437267|3743264|B5|Philippines||Region of Enrollment||participants|Number|20|20.0||||||
3919988|NCT01437267|3743265|B4|Philippines||Region of Enrollment||participants|Number|20|20.0||||||
3919989|NCT01437267|3743266|B3|Philippines||Region of Enrollment||participants|Number|20|20.0||||||
3919990|NCT01437267|3743267|B2|Philippines||Region of Enrollment||participants|Number|20|20.0||||||
3919991|NCT01437267|3743268|B1|Philippines||Region of Enrollment||participants|Number|20|20.0||||||
3919992|NCT01437267|3743262|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3919993|NCT01437267|3743263|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3919994|NCT01437267|3743264|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3919995|NCT01437267|3743265|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3919996|NCT01437267|3743266|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3919997|NCT01437267|3743267|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3919998|NCT01437267|3743268|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3919999|NCT01437267|3743262|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920000|NCT01437267|3743263|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920001|NCT01437267|3743264|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920002|NCT01437267|3743265|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920003|NCT01437267|3743266|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920004|NCT01437267|3743267|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920005|NCT01437267|3743268|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920006|NCT01437267|3743262|B7||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920007|NCT01437267|3743263|B6||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920008|NCT01437267|3743264|B5||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920009|NCT01437267|3743265|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920010|NCT01437267|3743266|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920011|NCT01437267|3743267|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920012|NCT01437267|3743268|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920013|NCT01437267|3743262|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920014|NCT01437267|3743263|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920015|NCT01437267|3743264|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920016|NCT01437267|3743265|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920017|NCT01437267|3743266|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920018|NCT01437267|3743267|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920019|NCT01437267|3743268|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920020|NCT01437267|3743262|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920021|NCT01437267|3743263|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920022|NCT01437267|3743264|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920023|NCT01437267|3743265|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920024|NCT01437267|3743266|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920025|NCT01437267|3743267|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920026|NCT01437267|3743268|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920027|NCT01437267|3743262|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
3920028|NCT01437267|3743263|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3920029|NCT01437267|3743264|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3920030|NCT01437267|3743265|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3920031|NCT01437267|3743266|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3920032|NCT01437267|3743267|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3920033|NCT01437267|3743268|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3920034|NCT01437267|3743262|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920035|NCT01437267|3743263|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920036|NCT01437267|3743264|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920037|NCT01437267|3743265|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920038|NCT01437267|3743266|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920039|NCT01437267|3743267|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920040|NCT01437267|3743268|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920041|NCT01437267|3743262|B7||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3920042|NCT01437267|3743263|B6||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3920043|NCT01437267|3743264|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3920044|NCT01437267|3743265|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3920045|NCT01437267|3743266|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3920046|NCT01437267|3743267|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3920047|NCT01437267|3743268|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3920048|NCT01437267|3743262|B7||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3920049|NCT01437267|3743263|B6||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3920050|NCT01437267|3743264|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3920051|NCT01437267|3743265|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3920052|NCT01437267|3743266|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3920053|NCT01437267|3743267|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3920054|NCT01437267|3743268|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3920055|NCT01437267|3743262|B7|24 months 59 months (children)||Age, Customized||participants|Number|40|40.0||||||
3920056|NCT01437267|3743263|B6|24 months 59 months (children)||Age, Customized||participants|Number|0|0.0||||||
3920057|NCT01437267|3743264|B5|24 months 59 months (children)||Age, Customized||participants|Number|0|0.0||||||
3920058|NCT01437267|3743265|B4|24 months 59 months (children)||Age, Customized||participants|Number|0|0.0||||||
3920059|NCT01437267|3743266|B3|24 months 59 months (children)||Age, Customized||participants|Number|0|0.0||||||
3920060|NCT01437267|3743267|B2|24 months 59 months (children)||Age, Customized||participants|Number|20|20.0||||||
3920061|NCT01437267|3743268|B1|24 months 59 months (children)||Age, Customized||participants|Number|20|20.0||||||
3920062|NCT01437267|3743262|B7|9 months to 12 months (older infants)||Age, Customized||participants|Number|40|40.0||||||
3920063|NCT01437267|3743263|B6|9 months to 12 months (older infants)||Age, Customized||participants|Number|0|0.0||||||
3920064|NCT01437267|3743264|B5|9 months to 12 months (older infants)||Age, Customized||participants|Number|0|0.0||||||
3920065|NCT01437267|3743265|B4|9 months to 12 months (older infants)||Age, Customized||participants|Number|20|20.0||||||
3920066|NCT01437267|3743266|B3|9 months to 12 months (older infants)||Age, Customized||participants|Number|20|20.0||||||
3920067|NCT01437267|3743267|B2|9 months to 12 months (older infants)||Age, Customized||participants|Number|0|0.0||||||
3920068|NCT01437267|3743268|B1|9 months to 12 months (older infants)||Age, Customized||participants|Number|0|0.0||||||
3920069|NCT01437267|3743262|B7|6 weeks to 8 weeks (infants)||Age, Customized||participants|Number|40|40.0||||||
3920070|NCT01437267|3743263|B6|6 weeks to 8 weeks (infants)||Age, Customized||participants|Number|20|20.0||||||
3920071|NCT01437267|3743264|B5|6 weeks to 8 weeks (infants)||Age, Customized||participants|Number|20|20.0||||||
3920072|NCT01437267|3743265|B4|6 weeks to 8 weeks (infants)||Age, Customized||participants|Number|0|0.0||||||
3920073|NCT01437267|3743266|B3|6 weeks to 8 weeks (infants)||Age, Customized||participants|Number|0|0.0||||||
3920074|NCT01437267|3743267|B2|6 weeks to 8 weeks (infants)||Age, Customized||participants|Number|0|0.0||||||
3920075|NCT01437267|3743268|B1|6 weeks to 8 weeks (infants)||Age, Customized||participants|Number|0|0.0||||||
3920076|NCT01437124|3743311|B1|United Kingdom||Region of Enrollment||participants|Number|83|83.0||||||
3920077|NCT01437124|3743311|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3920078|NCT01437124|3743311|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3920079|NCT01437124|3743311|B1|||Age||years|Mean|58|58.0|Full Range|||42.0|70.0|
3920080|NCT01437124|3743311|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3920081|NCT01437124|3743311|B1||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
3920082|NCT01437124|3743311|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3920083|NCT01437111|3743316|B1||Male|Sex: Female, Male|Gender data were not reported for 2 participants.|Participants|Count of Participants|5|5.0||||||
3920084|NCT01437111|3743316|B1||Female|Sex: Female, Male|Gender data were not reported for 2 participants.|Participants|Count of Participants|193|193.0||||||
3920085|NCT01437111|3743316|B1|||Age|Age data were not reported for 2 participants.|Years|Mean|68.81|68.81|Standard Deviation|8.39|8.39|||
3920086|NCT01437098|3743327|B1|||Aortic Valve Area (AVA)||cm²|Mean|0.6|0.6|Standard Deviation|0.1|0.1|||
3920087|NCT01437098|3743327|B1|||Logistic EuroScore|The European System for Cardiac Operative Risk Evaluation (EuroSCORE) is a method of calculating predicted operative mortality for patients undergoing cardiac surgery. If a risk factor is present, a weight/number is assigned. The weights are added to give an approximate percent of predicted mortality. A higher score indicates a higher risk. A lower score indicates a lower risk..|percent|Mean|21.5|21.5|Standard Deviation|9.9|9.9|||
3920088|NCT01437098|3743327|B1|||STS Score|The Society of Thoracic Surgeons (STS) risk model predicts the risk of operative mortality and morbidity after adult cardiac surgery on the basis of patient demographic and clinical variables. After information has been entered on a given case, the online STS risk calculator provides a risk percentage for each of the outcomes. The risk percentage estimates the chance of a specific outcome for a patient with the indicated risk factors. A higher score indicates a higher risk. A lower score indicates a lower risk.|percent|Mean|8.0|8.0|Standard Deviation|4.2|4.2|||
3920089|NCT01437098|3743327|B1|NYHA Class IV||NYHA Class|New York Heart Association Classification (NYHA) Class I Subject with cardiac disease but without resulting limitations of physical activity. Class II Subjects with cardiac disease resulting in slight limitation of physical activity. Class III Subjects with cardiac disease resulting in marked limitation of physical activity. Class IV Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort.|participants|Number|6|6.0||||||
3920090|NCT01437098|3743327|B1|NYHA Class III||NYHA Class|New York Heart Association Classification (NYHA) Class I Subject with cardiac disease but without resulting limitations of physical activity. Class II Subjects with cardiac disease resulting in slight limitation of physical activity. Class III Subjects with cardiac disease resulting in marked limitation of physical activity. Class IV Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort.|participants|Number|49|49.0||||||
3920149|NCT01436500|3743432|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3920091|NCT01437098|3743327|B1|NYHA Class II||NYHA Class|New York Heart Association Classification (NYHA) Class I Subject with cardiac disease but without resulting limitations of physical activity. Class II Subjects with cardiac disease resulting in slight limitation of physical activity. Class III Subjects with cardiac disease resulting in marked limitation of physical activity. Class IV Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort.|participants|Number|0|0.0||||||
3920092|NCT01437098|3743327|B1|Japan||Region of Enrollment||participants|Number|55|55.0||||||
3920093|NCT01437098|3743327|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3920094|NCT01437098|3743327|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3920095|NCT01437098|3743327|B1|||Age||years|Mean|82.5|82.5|Standard Deviation|5.5|5.5|||
3920096|NCT01436799|3743382|B3|Korea, Republic of||Region of Enrollment||participants|Number|40|40.0||||||
3920097|NCT01436799|3743383|B2|Korea, Republic of||Region of Enrollment||participants|Number|20|20.0||||||
3920098|NCT01436799|3743384|B1|Korea, Republic of||Region of Enrollment||participants|Number|20|20.0||||||
3920099|NCT01436799|3743382|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3920100|NCT01436799|3743383|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3920101|NCT01436799|3743384|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3920102|NCT01436799|3743382|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3920103|NCT01436799|3743383|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3920104|NCT01436799|3743384|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3920105|NCT01436799|3743382|B3|||Age||years|Mean|48|48.0|Standard Deviation|14|14.0|||
3920106|NCT01436799|3743383|B2|||Age||years|Mean|48|48.0|Standard Deviation|16|16.0|||
3920107|NCT01436799|3743384|B1|||Age||years|Mean|48|48.0|Standard Deviation|10|10.0|||
3920108|NCT01436799|3743382|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3920109|NCT01436799|3743383|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3920110|NCT01436799|3743384|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3920111|NCT01436799|3743382|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3920112|NCT01436799|3743383|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3920113|NCT01436799|3743384|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3920114|NCT01436799|3743382|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3920115|NCT01436799|3743383|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3920116|NCT01436799|3743384|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3920117|NCT01436643|3743391|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3920118|NCT01436643|3743392|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3920119|NCT01436643|3743393|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3920120|NCT01436643|3743394|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3920121|NCT01436643|3743391|B4||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3920122|NCT01436643|3743392|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3920123|NCT01436643|3743393|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3920124|NCT01436643|3743394|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3920125|NCT01436643|3743391|B4|||Age||Years|Mean|41.8|41.8|Standard Deviation|9.87|9.87|||
3920126|NCT01436643|3743392|B3|||Age||Years|Mean|41.2|41.2|Standard Deviation|10.22|10.22|||
3920127|NCT01436643|3743393|B2|||Age||Years|Mean|40.0|40.0|Standard Deviation|9.28|9.28|||
3920128|NCT01436643|3743394|B1|||Age||Years|Mean|44.2|44.2|Standard Deviation|9.22|9.22|||
3920129|NCT01436526|3743407|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3920130|NCT01436526|3743408|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3920131|NCT01436526|3743409|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3920132|NCT01436526|3743407|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3920133|NCT01436526|3743408|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3920134|NCT01436526|3743409|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3920135|NCT01436526|3743407|B3|||Age||Years|Mean|31.4|31.4|Standard Deviation|8.3|8.3|||
3920136|NCT01436526|3743408|B2|||Age||Years|Mean|31.3|31.3|Standard Deviation|10.5|10.5|||
3920137|NCT01436526|3743409|B1|||Age||Years|Mean|31.6|31.6|Standard Deviation|5.8|5.8|||
3920138|NCT01436500|3743430|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920139|NCT01436500|3743431|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920140|NCT01436500|3743432|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920141|NCT01436500|3743430|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920142|NCT01436500|3743431|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920143|NCT01436500|3743432|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920144|NCT01436500|3743430|B3||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3920145|NCT01436500|3743431|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3920146|NCT01436500|3743432|B1||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3920147|NCT01436500|3743430|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3920148|NCT01436500|3743431|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920150|NCT01436500|3743430|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920151|NCT01436500|3743431|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920152|NCT01436500|3743432|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920153|NCT01436500|3743430|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3920154|NCT01436500|3743431|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3920155|NCT01436500|3743432|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3920156|NCT01436500|3743430|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3920157|NCT01436500|3743431|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920158|NCT01436500|3743432|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3920159|NCT01436500|3743430|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920160|NCT01436500|3743431|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920161|NCT01436500|3743432|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920162|NCT01436500|3743430|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3920163|NCT01436500|3743431|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3920164|NCT01436500|3743432|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3920165|NCT01436500|3743430|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3920166|NCT01436500|3743431|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3920167|NCT01436500|3743432|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3920168|NCT01436500|3743430|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3920169|NCT01436500|3743431|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3920170|NCT01436500|3743432|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3920171|NCT01436500|3743430|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3920172|NCT01436500|3743431|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3920173|NCT01436500|3743432|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3920174|NCT01436500|3743430|B3|||Age||years|Mean|57|57.0|Standard Deviation|9.0|9.0|||
3920175|NCT01436500|3743431|B2|||Age||years|Mean|56|56.0|Standard Deviation|6.4|6.4|||
3920176|NCT01436500|3743432|B1|||Age||years|Mean|57|57.0|Standard Deviation|9.7|9.7|||
3920177|NCT01436435|3743469|B1|United States||Region of Enrollment||participants|Number|241|241.0||||||
3920178|NCT01436435|3743469|B1||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
3920179|NCT01436435|3743469|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3920180|NCT01436435|3743469|B1|||Age||years|Mean|67.1|67.1|Standard Deviation|9.8|9.8|||
3920181|NCT01436370|3743478|B9|United States||Region of Enrollment||participants|Number|102|102.0||||||
3920182|NCT01436370|3743479|B8|United States||Region of Enrollment||participants|Number|16|16.0||||||
3920183|NCT01436370|3743480|B7|United States||Region of Enrollment||participants|Number|16|16.0||||||
3920184|NCT01436370|3743481|B6|United States||Region of Enrollment||participants|Number|19|19.0||||||
3920185|NCT01436370|3743482|B5|United States||Region of Enrollment||participants|Number|19|19.0||||||
3920186|NCT01436370|3743483|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
3920187|NCT01436370|3743484|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3920188|NCT01436370|3743485|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3920189|NCT01436370|3743486|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3920190|NCT01436370|3743478|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920191|NCT01436370|3743479|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920192|NCT01436370|3743480|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920193|NCT01436370|3743481|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920194|NCT01436370|3743482|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920195|NCT01436370|3743483|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920196|NCT01436370|3743484|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920197|NCT01436370|3743485|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920198|NCT01436370|3743486|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920199|NCT01436370|3743478|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3920200|NCT01436370|3743479|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3920201|NCT01436370|3743480|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3920202|NCT01436370|3743481|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3920203|NCT01436370|3743482|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3920204|NCT01436370|3743483|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3920205|NCT01436370|3743484|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3920206|NCT01436370|3743485|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3920207|NCT01436370|3743486|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3920208|NCT01436370|3743478|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3920209|NCT01436370|3743479|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920210|NCT01436370|3743480|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3920211|NCT01436370|3743481|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920212|NCT01436370|3743482|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3920213|NCT01436370|3743483|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920214|NCT01436370|3743484|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920215|NCT01436370|3743485|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920216|NCT01436370|3743486|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3920217|NCT01436370|3743478|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920218|NCT01436370|3743479|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920219|NCT01436370|3743480|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920220|NCT01436370|3743481|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920221|NCT01436370|3743482|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920222|NCT01436370|3743483|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920223|NCT01436370|3743484|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920224|NCT01436370|3743485|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920225|NCT01436370|3743486|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920226|NCT01436370|3743478|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920227|NCT01436370|3743479|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920228|NCT01436370|3743480|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920229|NCT01436370|3743481|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920230|NCT01436370|3743482|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920231|NCT01436370|3743483|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920232|NCT01436370|3743484|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920233|NCT01436370|3743485|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920234|NCT01436370|3743486|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920235|NCT01436370|3743478|B9||White|Race (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3920236|NCT01436370|3743479|B8||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3920237|NCT01436370|3743480|B7||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3920238|NCT01436370|3743481|B6||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3920239|NCT01436370|3743482|B5||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3920240|NCT01436370|3743483|B4||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3920241|NCT01436370|3743484|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3920242|NCT01436370|3743485|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3920243|NCT01436370|3743486|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3920244|NCT01436370|3743478|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3920245|NCT01436370|3743479|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920246|NCT01436370|3743480|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3920247|NCT01436370|3743481|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920248|NCT01436370|3743482|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920249|NCT01436370|3743483|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920250|NCT01436370|3743484|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920251|NCT01436370|3743485|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920252|NCT01436370|3743486|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920253|NCT01436370|3743478|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3920254|NCT01436370|3743479|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920255|NCT01436370|3743480|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920256|NCT01436370|3743481|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920257|NCT01436370|3743482|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920258|NCT01436370|3743483|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3920259|NCT01436370|3743484|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920260|NCT01436370|3743485|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920261|NCT01436370|3743486|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920262|NCT01436370|3743478|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3920263|NCT01436370|3743479|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3920264|NCT01436370|3743480|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920265|NCT01436370|3743481|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3920266|NCT01436370|3743482|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920267|NCT01436370|3743483|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3920268|NCT01436370|3743484|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920269|NCT01436370|3743485|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3920270|NCT01436370|3743486|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920271|NCT01436370|3743478|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920272|NCT01436370|3743479|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920273|NCT01436370|3743480|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920274|NCT01436370|3743481|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920275|NCT01436370|3743482|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920276|NCT01436370|3743483|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920277|NCT01436370|3743484|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920278|NCT01436370|3743485|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920279|NCT01436370|3743486|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920280|NCT01436370|3743478|B9||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3920281|NCT01436370|3743479|B8||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3920282|NCT01436370|3743480|B7||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3920283|NCT01436370|3743481|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3920284|NCT01436370|3743482|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3920285|NCT01436370|3743483|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3920286|NCT01436370|3743484|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3920287|NCT01436370|3743485|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3920288|NCT01436370|3743486|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3920289|NCT01436370|3743478|B9||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3920290|NCT01436370|3743479|B8||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3920291|NCT01436370|3743480|B7||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3920292|NCT01436370|3743481|B6||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3920293|NCT01436370|3743482|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3920294|NCT01436370|3743483|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3920295|NCT01436370|3743484|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3920296|NCT01436370|3743485|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3920297|NCT01436370|3743486|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3920298|NCT01436370|3743478|B9|||Age||years|Mean|49.9|49.9|Standard Deviation|10.0|10.0|||
3920299|NCT01436370|3743479|B8|||Age||years|Mean|52.1|52.1|Standard Deviation|9.4|9.4|||
3920300|NCT01436370|3743480|B7|||Age||years|Mean|52.8|52.8|Standard Deviation|9.5|9.5|||
3920301|NCT01436370|3743481|B6|||Age||years|Mean|50.1|50.1|Standard Deviation|10.8|10.8|||
3920302|NCT01436370|3743482|B5|||Age||years|Mean|49.8|49.8|Standard Deviation|11.0|11.0|||
3920303|NCT01436370|3743483|B4|||Age||years|Mean|48.3|48.3|Standard Deviation|10.1|10.1|||
3920304|NCT01436370|3743484|B3|||Age||years|Mean|47.6|47.6|Standard Deviation|9.5|9.5|||
3920305|NCT01436370|3743485|B2|||Age||years|Mean|46.4|46.4|Standard Deviation|9.4|9.4|||
3920306|NCT01436370|3743486|B1|||Age||years|Mean|46.2|46.2|Standard Deviation|9.3|9.3|||
3920307|NCT01436305|3743571|B4|United States||Region of Enrollment||participants|Number|19|19.0||||||
3920308|NCT01436305|3743572|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
3920309|NCT01436305|3743573|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3920310|NCT01436305|3743574|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3920311|NCT01436305|3743571|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920312|NCT01436305|3743572|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920313|NCT01436305|3743573|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920314|NCT01436305|3743574|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920315|NCT01436305|3743571|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920316|NCT01436305|3743572|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920317|NCT01436305|3743573|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920318|NCT01436305|3743574|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920319|NCT01436305|3743571|B4||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3920320|NCT01436305|3743572|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3920321|NCT01436305|3743573|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3920322|NCT01436305|3743574|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3920323|NCT01436305|3743571|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3920324|NCT01436305|3743572|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3920325|NCT01436305|3743573|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3920326|NCT01436305|3743574|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3920327|NCT01436305|3743571|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920328|NCT01436305|3743572|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920329|NCT01436305|3743573|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920330|NCT01436305|3743574|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920331|NCT01436305|3743571|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3920332|NCT01436305|3743572|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920333|NCT01436305|3743573|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3920334|NCT01436305|3743574|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920335|NCT01436305|3743571|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920336|NCT01436305|3743572|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920337|NCT01436305|3743573|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920338|NCT01436305|3743574|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920339|NCT01436305|3743571|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3920340|NCT01436305|3743572|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3920341|NCT01436305|3743573|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920342|NCT01436305|3743574|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920343|NCT01436305|3743571|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3920344|NCT01436305|3743572|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3920345|NCT01436305|3743573|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3920346|NCT01436305|3743574|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3920347|NCT01436305|3743571|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920348|NCT01436305|3743572|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920349|NCT01436305|3743573|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920350|NCT01436305|3743574|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920351|NCT01436305|3743571|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3920352|NCT01436305|3743572|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3920353|NCT01436305|3743573|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3920354|NCT01436305|3743574|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3920355|NCT01436305|3743571|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3920356|NCT01436305|3743572|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3920357|NCT01436305|3743573|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3920358|NCT01436305|3743574|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3920359|NCT01436305|3743571|B4|||Age||years|Mean|46.6|46.6|Standard Deviation|10.3|10.3|||
3920360|NCT01436305|3743572|B3|||Age||years|Mean|49.1|49.1|Standard Deviation|9.0|9.0|||
3920361|NCT01436305|3743573|B2|||Age||years|Mean|43.3|43.3|Standard Deviation|9.5|9.5|||
3920362|NCT01436305|3743574|B1|||Age||years|Mean|46.8|46.8|Standard Deviation|13.1|13.1|||
3920363|NCT01436279|3743671|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3920364|NCT01436279|3743672|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3920365|NCT01436279|3743673|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3920366|NCT01436279|3743671|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3920367|NCT01436279|3743672|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3920368|NCT01436279|3743673|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3920369|NCT01436279|3743671|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3920370|NCT01436279|3743672|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3920371|NCT01436279|3743673|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3920372|NCT01436279|3743671|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3920373|NCT01436279|3743672|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3920374|NCT01436279|3743673|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3920375|NCT01436279|3743671|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3920376|NCT01436279|3743672|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3920377|NCT01436279|3743673|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3920378|NCT01436266|3743694|B3|Placebo Comparator: Placebo (Folic acid)|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3920379|NCT01436266|3743695|B2|Placebo Comparator: Placebo (Folic acid)|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3920380|NCT01436266|3743696|B1|Placebo Comparator: Placebo (Folic acid)|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3920381|NCT01436266|3743694|B3|Placebo Comparator: Placebo (Folic acid)|Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3920382|NCT01436266|3743695|B2|Placebo Comparator: Placebo (Folic acid)|Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3920383|NCT01436266|3743696|B1|Placebo Comparator: Placebo (Folic acid)|Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3920384|NCT01436266|3743694|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3920385|NCT01436266|3743695|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3920386|NCT01436266|3743696|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3920387|NCT01436266|3743694|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3920388|NCT01436266|3743695|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3920389|NCT01436266|3743696|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3920390|NCT01436266|3743694|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3920391|NCT01436266|3743695|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3920392|NCT01436266|3743696|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3920393|NCT01436253|3743703|B1|Unknown||Sex/Gender, Customized|Participants meeting all inclusion and exclusion criteria.|Participants|Number|85|85.0||||||
3920394|NCT01436253|3743703|B1|Male||Sex/Gender, Customized|Participants meeting all inclusion and exclusion criteria.|Participants|Number|770|770.0||||||
3920395|NCT01436253|3743703|B1|Female||Sex/Gender, Customized|Participants meeting all inclusion and exclusion criteria.|Participants|Number|1042|1042.0||||||
3920396|NCT01436253|3743703|B1|>=65 Years||Age, Customized|Participants meeting all inclusion and exclusion criteria.|Participants|Number|716|716.0||||||
3920397|NCT01436253|3743703|B1|45-64 Years||Age, Customized|Participants meeting all inclusion and exclusion criteria.|Participants|Number|1063|1063.0||||||
3920398|NCT01436253|3743703|B1|30-44 Years||Age, Customized|Participants meeting all inclusion and exclusion criteria.|Participants|Number|118|118.0||||||
3920399|NCT01436201|3743708|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3920400|NCT01436201|3743708|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920401|NCT01436201|3743708|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920402|NCT01436201|3743708|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3920403|NCT01436201|3743708|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3920404|NCT01436201|3743708|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920405|NCT01436201|3743708|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3920406|NCT01436201|3743708|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920407|NCT01436201|3743708|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920408|NCT01436201|3743708|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3920409|NCT01436201|3743708|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3920410|NCT01436201|3743708|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3920411|NCT01436201|3743708|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3920412|NCT01436201|3743708|B1|||Age||years|Mean|43.4|43.4|Standard Deviation|12.2|12.2|||
3920413|NCT01436175|3743718|B1|Croatia||Region of Enrollment||participants|Number|5|5.0||||||
3920414|NCT01436175|3743718|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3920415|NCT01436175|3743718|B1|Australia||Region of Enrollment||participants|Number|13|13.0||||||
3920416|NCT01436175|3743718|B1|Argentina||Region of Enrollment||participants|Number|27|27.0||||||
3920417|NCT01436175|3743718|B1|Germany||Region of Enrollment||participants|Number|69|69.0||||||
3920418|NCT01436175|3743718|B1|Chile||Region of Enrollment||participants|Number|33|33.0||||||
3920419|NCT01436175|3743718|B1|South Africa||Region of Enrollment||participants|Number|5|5.0||||||
3920420|NCT01436175|3743718|B1|Romania||Region of Enrollment||participants|Number|8|8.0||||||
3920421|NCT01436175|3743718|B1|Poland||Region of Enrollment||participants|Number|20|20.0||||||
3920422|NCT01436175|3743718|B1|Spain||Region of Enrollment||participants|Number|6|6.0||||||
3920423|NCT01436175|3743718|B1|Finland||Region of Enrollment||participants|Number|8|8.0||||||
3920424|NCT01436175|3743718|B1|Canada||Region of Enrollment||participants|Number|36|36.0||||||
3920425|NCT01436175|3743718|B1|Mexico||Region of Enrollment||participants|Number|27|27.0||||||
3920426|NCT01436175|3743718|B1|Czech Republic||Region of Enrollment||participants|Number|83|83.0||||||
3920427|NCT01436175|3743718|B1|Hungary||Region of Enrollment||participants|Number|4|4.0||||||
3920428|NCT01436175|3743718|B1|Estonia||Region of Enrollment||participants|Number|24|24.0||||||
3920429|NCT01436175|3743718|B1|United States||Region of Enrollment||participants|Number|1190|1190.0||||||
3920430|NCT01436175|3743718|B1||Male|Sex: Female, Male||Participants|Count of Participants|503|503.0||||||
3920431|NCT01436175|3743718|B1||Female|Sex: Female, Male||Participants|Count of Participants|1056|1056.0||||||
3920432|NCT01436175|3743718|B1|56-65 Years||Age, Customized||participants|Number|226|226.0||||||
3920433|NCT01436175|3743718|B1|18-55 Years||Age, Customized||participants|Number|1333|1333.0||||||
3920434|NCT01436175|3743718|B1|||Age||years|Mean|41.9|41.9|Standard Deviation|11.89|11.89|||
3920435|NCT01436162|3743743|B3||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3920436|NCT01436162|3743744|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3920437|NCT01436162|3743745|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3920438|NCT01436162|3743743|B3||Female|Sex: Female, Male||Participants|Count of Participants|284|284.0||||||
3920439|NCT01436162|3743744|B2||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3920440|NCT01436162|3743745|B1||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3920441|NCT01436162|3743743|B3|56-65 years||Age, Customized||Participants|Number|59|59.0||||||
3920442|NCT01436162|3743744|B2|56-65 years||Age, Customized||Participants|Number|29|29.0||||||
3920443|NCT01436162|3743745|B1|56-65 years||Age, Customized||Participants|Number|30|30.0||||||
3920444|NCT01436162|3743743|B3|18-55 years||Age, Customized||Participants|Number|365|365.0||||||
3920445|NCT01436162|3743744|B2|18-55 years||Age, Customized||Participants|Number|184|184.0||||||
3920446|NCT01436162|3743745|B1|18-55 years||Age, Customized||Participants|Number|181|181.0||||||
3920447|NCT01436162|3743743|B3|||Age||Years|Mean|42.3|42.3|Standard Deviation|11.51|11.51|||
3920448|NCT01436162|3743744|B2|||Age||Years|Mean|42.6|42.6|Standard Deviation|11.41|11.41|||
3920449|NCT01436162|3743745|B1|||Age||Years|Mean|42|42.0|Standard Deviation|11.63|11.63|||
3920450|NCT01436149|3743779|B3||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3920451|NCT01436149|3743780|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3920452|NCT01436149|3743781|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3920453|NCT01436149|3743779|B3||Female|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
3920454|NCT01436149|3743780|B2||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3920455|NCT01436149|3743781|B1||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3920456|NCT01436149|3743779|B3|56-65 years||Age, Customized||Participants|Number|59|59.0||||||
3920457|NCT01436149|3743780|B2|56-65 years||Age, Customized||Participants|Number|31|31.0||||||
3920458|NCT01436149|3743781|B1|56-65 years||Age, Customized||Participants|Number|28|28.0||||||
3920459|NCT01436149|3743779|B3|18-55 years||Age, Customized||Participants|Number|343|343.0||||||
3920460|NCT01436149|3743780|B2|18-55 years||Age, Customized||Participants|Number|170|170.0||||||
3920461|NCT01436149|3743781|B1|18-55 years||Age, Customized||Participants|Number|173|173.0||||||
3920462|NCT01436149|3743779|B3|||Age||Years|Mean|42|42.0|Standard Deviation|12.17|12.17|||
3920463|NCT01436149|3743780|B2|||Age||Years|Mean|42.2|42.2|Standard Deviation|12.32|12.32|||
3920464|NCT01436149|3743781|B1|||Age||Years|Mean|41.8|41.8|Standard Deviation|12.04|12.04|||
3920465|NCT01436110|3743811|B4|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3920466|NCT01436110|3743812|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3920467|NCT01436110|3743813|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3920468|NCT01436110|3743814|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3920469|NCT01436110|3743811|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
3920470|NCT01436110|3743812|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3920471|NCT01436110|3743813|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3920472|NCT01436110|3743814|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3920473|NCT01436110|3743811|B4|Mixed Race||Race/Ethnicity, Customized||Participants|Number|57|57.0||||||
3920474|NCT01436110|3743812|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
3920475|NCT01436110|3743813|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
3920476|NCT01436110|3743814|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
3920477|NCT01436110|3743811|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|95|95.0||||||
3920478|NCT01436110|3743812|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|34|34.0||||||
3920479|NCT01436110|3743813|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
3920480|NCT01436110|3743814|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|31|31.0||||||
3920481|NCT01436110|3743811|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|161|161.0||||||
3920482|NCT01436110|3743812|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|54|54.0||||||
3920483|NCT01436110|3743813|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|55|55.0||||||
3920484|NCT01436110|3743814|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|52|52.0||||||
3920485|NCT01436110|3743811|B4||Male|Gender||Participants|Count of Participants|118|118.0||||||
3920486|NCT01436110|3743812|B3||Male|Gender||Participants|Count of Participants|39|39.0||||||
3920487|NCT01436110|3743813|B2||Male|Gender||Participants|Count of Participants|45|45.0||||||
3920488|NCT01436110|3743814|B1||Male|Gender||Participants|Count of Participants|34|34.0||||||
3920489|NCT01436110|3743811|B4||Female|Gender||Participants|Count of Participants|229|229.0||||||
3920490|NCT01436110|3743812|B3||Female|Gender||Participants|Count of Participants|76|76.0||||||
3920491|NCT01436110|3743813|B2||Female|Gender||Participants|Count of Participants|72|72.0||||||
3920492|NCT01436110|3743814|B1||Female|Gender||Participants|Count of Participants|81|81.0||||||
3920493|NCT01436110|3743811|B4|||Age||Years|Mean|36.4|36.4|Standard Deviation|16.57|16.57|||
3920494|NCT01436110|3743812|B3|||Age||Years|Mean|36.2|36.2|Standard Deviation|16.95|16.95|||
3920495|NCT01436110|3743813|B2|||Age||Years|Mean|35.4|35.4|Standard Deviation|14.64|14.64|||
3920496|NCT01436110|3743814|B1|||Age||Years|Mean|37.6|37.6|Standard Deviation|18.03|18.03|||
3920497|NCT01436084|3743839|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3920498|NCT01436084|3743839|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3920499|NCT01436084|3743839|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3920500|NCT01436084|3743839|B1|||Age||years|Median|69|69.0|Full Range|||57.0|75.0|
3920501|NCT01436071|3743843|B3|American Indian or Alaska Native & White||Race/Ethnicity, Customized||Participants|Number|45|45.0||||||
3920502|NCT01436071|3743844|B2|American Indian or Alaska Native & White||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
3920503|NCT01436071|3743845|B1|American Indian or Alaska Native & White||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
3920504|NCT01436071|3743843|B3|African American/African Heritage & White||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3920505|NCT01436071|3743844|B2|African American/African Heritage & White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3920506|NCT01436071|3743845|B1|African American/African Heritage & White||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3920507|NCT01436071|3743843|B3|White||Race/Ethnicity, Customized||Participants|Number|76|76.0||||||
3920508|NCT01436071|3743844|B2|White||Race/Ethnicity, Customized||Participants|Number|44|44.0||||||
3920509|NCT01436071|3743845|B1|White||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
3920510|NCT01436071|3743843|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3920511|NCT01436071|3743844|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3920512|NCT01436071|3743845|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3920513|NCT01436071|3743843|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|105|105.0||||||
3920514|NCT01436071|3743844|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|46|46.0||||||
3920515|NCT01436071|3743845|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|59|59.0||||||
3920516|NCT01436071|3743843|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
3920517|NCT01436071|3743844|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3920518|NCT01436071|3743845|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3920519|NCT01436071|3743843|B3||Male|Gender||Participants|Count of Participants|97|97.0||||||
3920520|NCT01436071|3743844|B2||Male|Gender||Participants|Count of Participants|51|51.0||||||
3920521|NCT01436071|3743845|B1||Male|Gender||Participants|Count of Participants|46|46.0||||||
3920522|NCT01436071|3743843|B3||Female|Gender||Participants|Count of Participants|145|145.0||||||
3920523|NCT01436071|3743844|B2||Female|Gender||Participants|Count of Participants|70|70.0||||||
3920524|NCT01436071|3743845|B1||Female|Gender||Participants|Count of Participants|75|75.0||||||
3920525|NCT01436071|3743843|B3|||Age||Years|Mean|35.2|35.2|Standard Deviation|14.99|14.99|||
3920526|NCT01436071|3743844|B2|||Age||Years|Mean|36.8|36.8|Standard Deviation|15.98|15.98|||
3920527|NCT01436071|3743845|B1|||Age||Years|Mean|33.5|33.5|Standard Deviation|13.81|13.81|||
3920528|NCT01436045|3743862|B1|||University of Pennsylvania Smell Inventory Test (UPSIT)|UPSIT is used to test the function of an individual's olfactory system. The first 20 items (out of 40) were used. Range of 0-20. Lower scores indicate a lower functioning olfactory system. Higher scores indicate normal olfactory functioning.|units on a scale|Mean|11.8|11.8|Standard Deviation|2.52|2.52|||
3920529|NCT01436045|3743862|B1|||Mini Mental State Examination (MMSE)|MMSE scale is 0 to 30. Lower scores indicate more severe cognitive impairment. Higher scores (27-30) indicate normal cognition.|units on a scale|Mean|22.17|22.17|Standard Deviation|2.62|2.62|||
3920530|NCT01436045|3743862|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3920531|NCT01436045|3743862|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3920532|NCT01436045|3743862|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3920533|NCT01436045|3743862|B1|||Age||years|Mean|72|72.0|Standard Deviation|4.6|4.6|||
3920534|NCT01436006|3743874|B1|Italy||Region of Enrollment||participants|Number|6700|6700.0||||||
3920535|NCT01436006|3743874|B1||Male|Sex: Female, Male||Participants|Count of Participants|3736|3736.0||||||
3920536|NCT01436006|3743874|B1||Female|Sex: Female, Male||Participants|Count of Participants|2964|2964.0||||||
3920537|NCT01436006|3743874|B1||>=65 years|Age||Participants|Count of Participants|620|620.0||||||
3920538|NCT01436006|3743874|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6080|6080.0||||||
3920539|NCT01436006|3743874|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3920540|NCT01436006|3743874|B1|||Age||years|Mean|64|64.0|Standard Deviation|16|16.0|||
3920541|NCT01435928|3743886|B3|Italy||Region of Enrollment||participants|Number|1|1.0||||||
3920542|NCT01435928|3743887|B2|Italy||Region of Enrollment||participants|Number|0|0.0||||||
3920543|NCT01435928|3743888|B1|Italy||Region of Enrollment||participants|Number|1|1.0||||||
3920544|NCT01435928|3743886|B3|South Africa||Region of Enrollment||participants|Number|21|21.0||||||
3920545|NCT01435928|3743887|B2|South Africa||Region of Enrollment||participants|Number|11|11.0||||||
3920546|NCT01435928|3743888|B1|South Africa||Region of Enrollment||participants|Number|10|10.0||||||
3920547|NCT01435928|3743886|B3|Russian Federation||Region of Enrollment||participants|Number|16|16.0||||||
3920548|NCT01435928|3743887|B2|Russian Federation||Region of Enrollment||participants|Number|9|9.0||||||
3920549|NCT01435928|3743888|B1|Russian Federation||Region of Enrollment||participants|Number|7|7.0||||||
3920550|NCT01435928|3743886|B3|Slovakia||Region of Enrollment||participants|Number|22|22.0||||||
3920551|NCT01435928|3743887|B2|Slovakia||Region of Enrollment||participants|Number|11|11.0||||||
3920552|NCT01435928|3743888|B1|Slovakia||Region of Enrollment||participants|Number|11|11.0||||||
3920553|NCT01435928|3743886|B3|United States||Region of Enrollment||participants|Number|200|200.0||||||
3920554|NCT01435928|3743887|B2|United States||Region of Enrollment||participants|Number|97|97.0||||||
3920555|NCT01435928|3743888|B1|United States||Region of Enrollment||participants|Number|103|103.0||||||
3920556|NCT01435928|3743886|B3|Serbia||Region of Enrollment||participants|Number|20|20.0||||||
3920557|NCT01435928|3743887|B2|Serbia||Region of Enrollment||participants|Number|11|11.0||||||
3920558|NCT01435928|3743888|B1|Serbia||Region of Enrollment||participants|Number|9|9.0||||||
3920559|NCT01435928|3743886|B3|France||Region of Enrollment||participants|Number|5|5.0||||||
3920560|NCT01435928|3743887|B2|France||Region of Enrollment||participants|Number|2|2.0||||||
3920561|NCT01435928|3743888|B1|France||Region of Enrollment||participants|Number|3|3.0||||||
3920562|NCT01435928|3743886|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920563|NCT01435928|3743887|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920564|NCT01435928|3743888|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920565|NCT01435928|3743886|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|269|269.0||||||
3920566|NCT01435928|3743887|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
3920567|NCT01435928|3743888|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|137|137.0||||||
3920568|NCT01435928|3743886|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3920569|NCT01435928|3743887|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3920570|NCT01435928|3743888|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3920571|NCT01435928|3743886|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3920572|NCT01435928|3743887|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3920573|NCT01435928|3743888|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3920574|NCT01435928|3743886|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920575|NCT01435928|3743887|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920576|NCT01435928|3743888|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920577|NCT01435928|3743886|B3||White|Race (NIH/OMB)||Participants|Count of Participants|136|136.0||||||
3920578|NCT01435928|3743887|B2||White|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3920579|NCT01435928|3743888|B1||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3920580|NCT01435928|3743886|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
3920581|NCT01435928|3743887|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3920582|NCT01435928|3743888|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3920583|NCT01435928|3743886|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3920584|NCT01435928|3743887|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3920585|NCT01435928|3743888|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920586|NCT01435928|3743886|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3920587|NCT01435928|3743887|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3920588|NCT01435928|3743888|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920589|NCT01435928|3743886|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3920590|NCT01435928|3743887|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3920591|NCT01435928|3743888|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3920592|NCT01435928|3743886|B3||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
3920593|NCT01435928|3743887|B2||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3920594|NCT01435928|3743888|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3920595|NCT01435928|3743886|B3||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3920596|NCT01435928|3743887|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3920597|NCT01435928|3743888|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3920598|NCT01435928|3743886|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3920599|NCT01435928|3743887|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3920600|NCT01435928|3743888|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3920601|NCT01435928|3743886|B3||Between 18 and 65 years|Age||Participants|Count of Participants|282|282.0||||||
3920602|NCT01435928|3743887|B2||Between 18 and 65 years|Age||Participants|Count of Participants|140|140.0||||||
3920603|NCT01435928|3743888|B1||Between 18 and 65 years|Age||Participants|Count of Participants|142|142.0||||||
3920604|NCT01435928|3743886|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3920605|NCT01435928|3743887|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3920606|NCT01435928|3743888|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3920607|NCT01435928|3743886|B3|||Age||years|Mean|42.7|42.7|Standard Deviation|11.80|11.8|||
3920608|NCT01435928|3743887|B2|||Age||years|Mean|42.4|42.4|Standard Deviation|12.25|12.25|||
3920609|NCT01435928|3743888|B1|||Age||years|Mean|43.0|43.0|Standard Deviation|11.38|11.38|||
3920610|NCT01435798|3743917|B1|North America||Region of Enrollment||participants|Number|26|26.0||||||
3920611|NCT01435798|3743917|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3920612|NCT01435798|3743917|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3920613|NCT01435798|3743917|B1|||Age||years|Mean|46.84|46.84|Standard Deviation|11.32|11.32|||
3920614|NCT01435798|3743917|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3920615|NCT01435798|3743917|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3920616|NCT01435798|3743917|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3920617|NCT01435772|3743931|B4|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3920618|NCT01435772|3743932|B3|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3920619|NCT01435772|3743933|B2|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3920620|NCT01435772|3743934|B1|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3920621|NCT01435772|3743931|B4|United Kingdom||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3920622|NCT01435772|3743932|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3920623|NCT01435772|3743933|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3920624|NCT01435772|3743934|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3920625|NCT01435772|3743931|B4|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3920626|NCT01435772|3743932|B3|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3920627|NCT01435772|3743933|B2|Germany||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3920628|NCT01435772|3743934|B1|Germany||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3920629|NCT01435772|3743931|B4|France||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3920630|NCT01435772|3743932|B3|France||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3920631|NCT01435772|3743933|B2|France||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3920632|NCT01435772|3743934|B1|France||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3920633|NCT01435772|3743931|B4|Australia||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3920634|NCT01435772|3743932|B3|Australia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3920635|NCT01435772|3743933|B2|Australia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3920636|NCT01435772|3743934|B1|Australia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3920637|NCT01435772|3743931|B4|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3920638|NCT01435772|3743932|B3|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3920639|NCT01435772|3743933|B2|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3920640|NCT01435772|3743934|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3920641|NCT01435772|3743931|B4|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3920642|NCT01435772|3743932|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3920643|NCT01435772|3743933|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3920644|NCT01435772|3743934|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3920645|NCT01435772|3743931|B4|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3920646|NCT01435772|3743932|B3|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3920647|NCT01435772|3743933|B2|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3920648|NCT01435772|3743934|B1|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3920649|NCT01435772|3743931|B4|Race|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3920650|NCT01435772|3743932|B3|Race|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3920651|NCT01435772|3743933|B2|Race|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3920652|NCT01435772|3743934|B1|Race|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3920653|NCT01435772|3743931|B4|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3920654|NCT01435772|3743932|B3|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3920655|NCT01435772|3743933|B2|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3920656|NCT01435772|3743934|B1|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3920657|NCT01435772|3743931|B4|Race|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3920658|NCT01435772|3743932|B3|Race|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3920659|NCT01435772|3743933|B2|Race|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3920660|NCT01435772|3743934|B1|Race|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3920661|NCT01435772|3743931|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920662|NCT01435772|3743932|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920663|NCT01435772|3743933|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920664|NCT01435772|3743934|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920665|NCT01435772|3743931|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3920666|NCT01435772|3743932|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3920667|NCT01435772|3743933|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3920668|NCT01435772|3743934|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3920669|NCT01435772|3743931|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3920670|NCT01435772|3743932|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920671|NCT01435772|3743933|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3920672|NCT01435772|3743934|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920673|NCT01435772|3743931|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3920674|NCT01435772|3743932|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3920675|NCT01435772|3743933|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3920676|NCT01435772|3743934|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3920677|NCT01435772|3743931|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3920678|NCT01435772|3743932|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3920679|NCT01435772|3743933|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3920680|NCT01435772|3743934|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3920681|NCT01435772|3743931|B4|18-65 years||Age, Customized||Participants|Count of Participants|21|21.0||||||
3920682|NCT01435772|3743932|B3|18-65 years||Age, Customized||Participants|Count of Participants|15|15.0||||||
3920683|NCT01435772|3743933|B2|18-65 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
3920684|NCT01435772|3743934|B1|18-65 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
3920685|NCT01435772|3743931|B4|||Age||years|Mean|49.4|49.4|Standard Deviation|7.03|7.03|||
3920686|NCT01435772|3743932|B3|||Age||years|Mean|50.1|50.1|Standard Deviation|5.28|5.28|||
3920687|NCT01435772|3743933|B2|||Age||years|Mean|42.7|42.7|Standard Deviation|13.05|13.05|||
3920688|NCT01435772|3743934|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|6.66|6.66|||
3920689|NCT01435759|3743981|B6|UNITED STATES||Region of Enrollment||Participants|Number|333|333.0||||||
3920690|NCT01435759|3743982|B5|UNITED STATES||Region of Enrollment||Participants|Number|70|70.0||||||
3920691|NCT01435759|3743983|B4|UNITED STATES||Region of Enrollment||Participants|Number|64|64.0||||||
3920692|NCT01435759|3743984|B3|UNITED STATES||Region of Enrollment||Participants|Number|59|59.0||||||
3920693|NCT01435759|3743985|B2|UNITED STATES||Region of Enrollment||Participants|Number|68|68.0||||||
3920694|NCT01435759|3743986|B1|UNITED STATES||Region of Enrollment||Participants|Number|72|72.0||||||
3920695|NCT01435759|3743981|B6|UNITED KINGDOM||Region of Enrollment||Participants|Number|1|1.0||||||
3920696|NCT01435759|3743982|B5|UNITED KINGDOM||Region of Enrollment||Participants|Number|0|0.0||||||
3920697|NCT01435759|3743983|B4|UNITED KINGDOM||Region of Enrollment||Participants|Number|0|0.0||||||
3920698|NCT01435759|3743984|B3|UNITED KINGDOM||Region of Enrollment||Participants|Number|0|0.0||||||
3920699|NCT01435759|3743985|B2|UNITED KINGDOM||Region of Enrollment||Participants|Number|0|0.0||||||
3920700|NCT01435759|3743986|B1|UNITED KINGDOM||Region of Enrollment||Participants|Number|1|1.0||||||
3920701|NCT01435759|3743981|B6|CHILE||Region of Enrollment||Participants|Number|32|32.0||||||
3920702|NCT01435759|3743982|B5|CHILE||Region of Enrollment||Participants|Number|2|2.0||||||
3920703|NCT01435759|3743983|B4|CHILE||Region of Enrollment||Participants|Number|9|9.0||||||
3920704|NCT01435759|3743984|B3|CHILE||Region of Enrollment||Participants|Number|12|12.0||||||
3920705|NCT01435759|3743985|B2|CHILE||Region of Enrollment||Participants|Number|6|6.0||||||
3920706|NCT01435759|3743986|B1|CHILE||Region of Enrollment||Participants|Number|3|3.0||||||
3920707|NCT01435759|3743981|B6|AUSTRALIA||Region of Enrollment||Participants|Number|5|5.0||||||
3920708|NCT01435759|3743982|B5|AUSTRALIA||Region of Enrollment||Participants|Number|3|3.0||||||
3920709|NCT01435759|3743983|B4|AUSTRALIA||Region of Enrollment||Participants|Number|2|2.0||||||
3920710|NCT01435759|3743984|B3|AUSTRALIA||Region of Enrollment||Participants|Number|0|0.0||||||
3920711|NCT01435759|3743985|B2|AUSTRALIA||Region of Enrollment||Participants|Number|0|0.0||||||
3920712|NCT01435759|3743986|B1|AUSTRALIA||Region of Enrollment||Participants|Number|0|0.0||||||
3920713|NCT01435759|3743981|B6|ARGENTINA||Region of Enrollment||Participants|Number|18|18.0||||||
3920714|NCT01435759|3743982|B5|ARGENTINA||Region of Enrollment||Participants|Number|5|5.0||||||
3920715|NCT01435759|3743983|B4|ARGENTINA||Region of Enrollment||Participants|Number|3|3.0||||||
3920716|NCT01435759|3743984|B3|ARGENTINA||Region of Enrollment||Participants|Number|5|5.0||||||
3920717|NCT01435759|3743985|B2|ARGENTINA||Region of Enrollment||Participants|Number|3|3.0||||||
3920718|NCT01435759|3743986|B1|ARGENTINA||Region of Enrollment||Participants|Number|2|2.0||||||
3920719|NCT01435759|3743981|B6||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3920720|NCT01435759|3743982|B5||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3920721|NCT01435759|3743983|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3920722|NCT01435759|3743984|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3920723|NCT01435759|3743985|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3920724|NCT01435759|3743986|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3920725|NCT01435759|3743981|B6||Female|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
3920726|NCT01435759|3743982|B5||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3920727|NCT01435759|3743983|B4||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3920728|NCT01435759|3743984|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3920729|NCT01435759|3743985|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3920730|NCT01435759|3743986|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3920731|NCT01435759|3743981|B6|56-65||Age, Customized||Participants|Number|57|57.0||||||
3920732|NCT01435759|3743982|B5|56-65||Age, Customized||Participants|Number|9|9.0||||||
3920733|NCT01435759|3743983|B4|56-65||Age, Customized||Participants|Number|18|18.0||||||
3920734|NCT01435759|3743984|B3|56-65||Age, Customized||Participants|Number|14|14.0||||||
3920735|NCT01435759|3743985|B2|56-65||Age, Customized||Participants|Number|7|7.0||||||
3920736|NCT01435759|3743986|B1|56-65||Age, Customized||Participants|Number|9|9.0||||||
3920737|NCT01435759|3743981|B6|18-55||Age, Customized||Participants|Number|332|332.0||||||
3920738|NCT01435759|3743982|B5|18-55||Age, Customized||Participants|Number|71|71.0||||||
3920739|NCT01435759|3743983|B4|18-55||Age, Customized||Participants|Number|60|60.0||||||
3920740|NCT01435759|3743984|B3|18-55||Age, Customized||Participants|Number|62|62.0||||||
3920741|NCT01435759|3743985|B2|18-55||Age, Customized||Participants|Number|70|70.0||||||
3920742|NCT01435759|3743986|B1|18-55||Age, Customized||Participants|Number|69|69.0||||||
3920743|NCT01435759|3743981|B6|||Age||Years|Mean|42.3|42.3|Standard Deviation|11.61|11.61|||
3920744|NCT01435759|3743982|B5|||Age||Years|Mean|41.5|41.5|Standard Deviation|10.81|10.81|||
3920745|NCT01435759|3743983|B4|||Age||Years|Mean|43.8|43.8|Standard Deviation|12.4|12.4|||
3920746|NCT01435759|3743984|B3|||Age||Years|Mean|43.4|43.4|Standard Deviation|12.06|12.06|||
3920747|NCT01435759|3743985|B2|||Age||Years|Mean|39.1|39.1|Standard Deviation|11.83|11.83|||
3920748|NCT01435759|3743986|B1|||Age||Years|Mean|43.7|43.7|Standard Deviation|10.48|10.48|||
3920749|NCT01435655|3744018|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3920750|NCT01435655|3744018|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3920751|NCT01435655|3744018|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|13.0|13.0|||
3920752|NCT01435616|3744030|B3|Czechia||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3920753|NCT01435616|3744031|B2|Czechia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3920754|NCT01435616|3744032|B1|Czechia||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3920755|NCT01435616|3744030|B3|New Zealand||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3920756|NCT01435616|3744031|B2|New Zealand||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3920757|NCT01435616|3744032|B1|New Zealand||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3920758|NCT01435616|3744030|B3|Germany||Region of Enrollment||Participants|Count of Participants|99|99.0||||||
3920759|NCT01435616|3744031|B2|Germany||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3920760|NCT01435616|3744032|B1|Germany||Region of Enrollment||Participants|Count of Participants|63|63.0||||||
3920761|NCT01435616|3744030|B3|South Africa||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3920762|NCT01435616|3744031|B2|South Africa||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3920763|NCT01435616|3744032|B1|South Africa||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3920764|NCT01435616|3744030|B3|Australia||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3920765|NCT01435616|3744031|B2|Australia||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3920766|NCT01435616|3744032|B1|Australia||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3920767|NCT01435616|3744030|B3|Romania||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
3920768|NCT01435616|3744031|B2|Romania||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3920769|NCT01435616|3744032|B1|Romania||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3920770|NCT01435616|3744030|B3|Poland||Region of Enrollment||Participants|Count of Participants|99|99.0||||||
3920771|NCT01435616|3744031|B2|Poland||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3920772|NCT01435616|3744032|B1|Poland||Region of Enrollment||Participants|Count of Participants|67|67.0||||||
3920773|NCT01435616|3744030|B3|Brazil||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3920774|NCT01435616|3744031|B2|Brazil||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3920775|NCT01435616|3744032|B1|Brazil||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3920776|NCT01435616|3744030|B3|Argentina||Region of Enrollment||Participants|Count of Participants|101|101.0||||||
3920777|NCT01435616|3744031|B2|Argentina||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3920778|NCT01435616|3744032|B1|Argentina||Region of Enrollment||Participants|Count of Participants|67|67.0||||||
3920779|NCT01435616|3744030|B3|Canada||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3920780|NCT01435616|3744031|B2|Canada||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3920781|NCT01435616|3744032|B1|Canada||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3920782|NCT01435616|3744030|B3|Puerto Rico||Region of Enrollment||Participants|Count of Participants|58|58.0||||||
3920783|NCT01435616|3744031|B2|Puerto Rico||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3920784|NCT01435616|3744032|B1|Puerto Rico||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3920785|NCT01435616|3744030|B3|Mexico||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3920786|NCT01435616|3744031|B2|Mexico||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3920787|NCT01435616|3744032|B1|Mexico||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3920788|NCT01435616|3744030|B3|Hungary||Region of Enrollment||Participants|Count of Participants|102|102.0||||||
3920789|NCT01435616|3744031|B2|Hungary||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3920790|NCT01435616|3744032|B1|Hungary||Region of Enrollment||Participants|Count of Participants|69|69.0||||||
3920791|NCT01435616|3744030|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3920792|NCT01435616|3744031|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3920793|NCT01435616|3744032|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3920794|NCT01435616|3744030|B3|Italy||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3920795|NCT01435616|3744031|B2|Italy||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3920796|NCT01435616|3744032|B1|Italy||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3920797|NCT01435616|3744030|B3|Russia||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3920798|NCT01435616|3744031|B2|Russia||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3920799|NCT01435616|3744032|B1|Russia||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3920800|NCT01435616|3744030|B3|Israel||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3920801|NCT01435616|3744031|B2|Israel||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3920802|NCT01435616|3744032|B1|Israel||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3920803|NCT01435616|3744030|B3|Lithuania||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3920804|NCT01435616|3744031|B2|Lithuania||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3920805|NCT01435616|3744032|B1|Lithuania||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3920806|NCT01435616|3744030|B3|Turkey||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3920807|NCT01435616|3744031|B2|Turkey||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3920808|NCT01435616|3744032|B1|Turkey||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3920809|NCT01435616|3744030|B3|Spain||Region of Enrollment||Participants|Count of Participants|53|53.0||||||
3920810|NCT01435616|3744031|B2|Spain||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3920811|NCT01435616|3744032|B1|Spain||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3920812|NCT01435616|3744030|B3|Finland||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3920813|NCT01435616|3744031|B2|Finland||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3920814|NCT01435616|3744032|B1|Finland||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3920815|NCT01435616|3744030|B3|Greece||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3920816|NCT01435616|3744031|B2|Greece||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3920817|NCT01435616|3744032|B1|Greece||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3920818|NCT01435616|3744030|B3|Slovakia||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3920819|NCT01435616|3744031|B2|Slovakia||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3920820|NCT01435616|3744032|B1|Slovakia||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3920821|NCT01435616|3744030|B3|United States||Region of Enrollment||Participants|Count of Participants|559|559.0||||||
3920822|NCT01435616|3744031|B2|United States||Region of Enrollment||Participants|Count of Participants|188|188.0||||||
3920823|NCT01435616|3744032|B1|United States||Region of Enrollment||Participants|Count of Participants|371|371.0||||||
3920824|NCT01435616|3744030|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920825|NCT01435616|3744031|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920826|NCT01435616|3744032|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920827|NCT01435616|3744030|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3920828|NCT01435616|3744031|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3920829|NCT01435616|3744032|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3920830|NCT01435616|3744030|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1344|1344.0||||||
3920831|NCT01435616|3744031|B2||White|Race (NIH/OMB)||Participants|Count of Participants|469|469.0||||||
3920832|NCT01435616|3744032|B1||White|Race (NIH/OMB)||Participants|Count of Participants|875|875.0||||||
3920833|NCT01435616|3744030|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
3920834|NCT01435616|3744031|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3920835|NCT01435616|3744032|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3920836|NCT01435616|3744030|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3920837|NCT01435616|3744031|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3920838|NCT01435616|3744032|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3920839|NCT01435616|3744030|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3920840|NCT01435616|3744031|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3920841|NCT01435616|3744032|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3920842|NCT01435616|3744030|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3920843|NCT01435616|3744031|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3920844|NCT01435616|3744032|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3920845|NCT01435616|3744030|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|238|238.0||||||
3920846|NCT01435616|3744031|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3920847|NCT01435616|3744032|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|154|154.0||||||
3920848|NCT01435616|3744030|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1003|1003.0||||||
3920849|NCT01435616|3744031|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|355|355.0||||||
3920850|NCT01435616|3744032|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|648|648.0||||||
3920851|NCT01435616|3744030|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|297|297.0||||||
3920852|NCT01435616|3744031|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3920853|NCT01435616|3744032|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|201|201.0||||||
3920854|NCT01435616|3744030|B3||Male|Sex: Female, Male||Participants|Count of Participants|858|858.0||||||
3920855|NCT01435616|3744031|B2||Male|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
3920856|NCT01435616|3744032|B1||Male|Sex: Female, Male||Participants|Count of Participants|550|550.0||||||
3920857|NCT01435616|3744030|B3||Female|Sex: Female, Male||Participants|Count of Participants|680|680.0||||||
3920858|NCT01435616|3744031|B2||Female|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
3920859|NCT01435616|3744032|B1||Female|Sex: Female, Male||Participants|Count of Participants|453|453.0||||||
3920860|NCT01435616|3744030|B3|||Age||years|Mean|58.99|58.99|Standard Deviation|9.84|9.84|||
3920861|NCT01435616|3744031|B2|||Age||years|Mean|59.35|59.35|Standard Deviation|9.80|9.8|||
3920862|NCT01435616|3744032|B1|||Age||years|Mean|58.80|58.8|Standard Deviation|9.85|9.85|||
3920863|NCT01435603|3744077|B3|United States||Region of Enrollment||participants|Number|331|331.0||||||
3920864|NCT01435603|3744078|B2|United States||Region of Enrollment||participants|Number|164|164.0||||||
3920865|NCT01435603|3744079|B1|United States||Region of Enrollment||participants|Number|167|167.0||||||
3920866|NCT01435603|3744077|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
3920867|NCT01435603|3744078|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3920868|NCT01435603|3744079|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3920869|NCT01435603|3744077|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3920870|NCT01435603|3744078|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3920871|NCT01435603|3744079|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3920872|NCT01435603|3744077|B3||White|Race (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
3920873|NCT01435603|3744078|B2||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3920874|NCT01435603|3744079|B1||White|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3920875|NCT01435603|3744077|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
3920876|NCT01435603|3744078|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3920877|NCT01435603|3744079|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3920878|NCT01435603|3744077|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920879|NCT01435603|3744078|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920880|NCT01435603|3744079|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920881|NCT01435603|3744077|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3920882|NCT01435603|3744078|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3920883|NCT01435603|3744079|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3920884|NCT01435603|3744077|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920885|NCT01435603|3744078|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920886|NCT01435603|3744079|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920887|NCT01435603|3744077|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920888|NCT01435603|3744078|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920889|NCT01435603|3744079|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3920890|NCT01435603|3744077|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|240|240.0||||||
3920891|NCT01435603|3744078|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|116|116.0||||||
3920892|NCT01435603|3744079|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
3920893|NCT01435603|3744077|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3920894|NCT01435603|3744078|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3920895|NCT01435603|3744079|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3920896|NCT01435603|3744077|B3||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3920897|NCT01435603|3744078|B2||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3920898|NCT01435603|3744079|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3920899|NCT01435603|3744077|B3||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3920900|NCT01435603|3744078|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3920901|NCT01435603|3744079|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3920902|NCT01435603|3744077|B3|||Age||years|Mean|56.9|56.9|Standard Deviation|11.4|11.4|||
3920903|NCT01435603|3744078|B2|||Age||years|Mean|57.1|57.1|Standard Deviation|10.6|10.6|||
3920904|NCT01435603|3744079|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|12.2|12.2|||
3920905|NCT01435603|3744077|B3||>=65 years|Age||Participants|Count of Participants|82|82.0||||||
3920906|NCT01435603|3744078|B2||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
3920907|NCT01435603|3744079|B1||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
3920908|NCT01435603|3744077|B3||Between 18 and 65 years|Age||Participants|Count of Participants|249|249.0||||||
3920909|NCT01435603|3744078|B2||Between 18 and 65 years|Age||Participants|Count of Participants|125|125.0||||||
3920910|NCT01435603|3744079|B1||Between 18 and 65 years|Age||Participants|Count of Participants|124|124.0||||||
3920911|NCT01435603|3744077|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3920912|NCT01435603|3744078|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3920913|NCT01435603|3744079|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3920914|NCT01435577|3744086|B3|||Baseline pain intensity|"Pain intensity assessed prior to the first administration of study medication. Pain intensity is assessed by the participant using an 11-point Numeric rating scale (NRS) where a score of zero indicates no pain and a score of ten indicates pain as bad as you can imagine."|units on a scale|Mean|7.2|7.2|Standard Deviation|1.47|1.47|||
3920915|NCT01435577|3744087|B2|||Baseline pain intensity|"Pain intensity assessed prior to the first administration of study medication. Pain intensity is assessed by the participant using an 11-point Numeric rating scale (NRS) where a score of zero indicates no pain and a score of ten indicates pain as bad as you can imagine."|units on a scale|Mean|7.3|7.3|Standard Deviation|1.54|1.54|||
3920916|NCT01435577|3744088|B1|||Baseline pain intensity|"Pain intensity assessed prior to the first administration of study medication. Pain intensity is assessed by the participant using an 11-point Numeric rating scale (NRS) where a score of zero indicates no pain and a score of ten indicates pain as bad as you can imagine."|units on a scale|Mean|7.2|7.2|Standard Deviation|1.41|1.41|||
3920917|NCT01435577|3744086|B3|United States||Region of Enrollment||participants|Number|129|129.0||||||
3920918|NCT01435577|3744087|B2|United States||Region of Enrollment||participants|Number|65|65.0||||||
3920919|NCT01435577|3744088|B1|United States||Region of Enrollment||participants|Number|64|64.0||||||
3920920|NCT01435577|3744086|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3920921|NCT01435577|3744087|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3920922|NCT01435577|3744088|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3920923|NCT01435577|3744086|B3||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3920924|NCT01435577|3744087|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3920925|NCT01435577|3744088|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3920926|NCT01435577|3744086|B3|||Age||years|Mean|38.5|38.5|Standard Deviation|12.75|12.75|||
3920927|NCT01435577|3744087|B2|||Age||years|Mean|35.8|35.8|Standard Deviation|12.41|12.41|||
3920928|NCT01435577|3744088|B1|||Age||years|Mean|41.2|41.2|Standard Deviation|12.61|12.61|||
3920929|NCT01435460|3744137|B3|Chinese||Race/Ethnicity, Customized||participants|Number|300|300.0||||||
3920930|NCT01435460|3744138|B2|Chinese||Race/Ethnicity, Customized||participants|Number|149|149.0||||||
3920931|NCT01435460|3744139|B1|Chinese||Race/Ethnicity, Customized||participants|Number|151|151.0||||||
3920932|NCT01435460|3744137|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3920933|NCT01435460|3744138|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3920934|NCT01435460|3744139|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3920935|NCT01435460|3744137|B3||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3920936|NCT01435460|3744138|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3920937|NCT01435460|3744139|B1||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3920938|NCT01435460|3744137|B3|||Age||years|Mean|40.6|40.6|Standard Deviation|13.43|13.43|||
3920939|NCT01435460|3744138|B2|||Age||years|Mean|40.6|40.6|Standard Deviation|12.85|12.85|||
3920940|NCT01435460|3744139|B1|||Age||years|Mean|40.5|40.5|Standard Deviation|14.01|14.01|||
3920941|NCT01435382|3744152|B5||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3920942|NCT01435382|3744153|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3920943|NCT01435382|3744154|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3920944|NCT01435382|3744155|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3920945|NCT01435382|3744156|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3920946|NCT01435382|3744152|B5||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3920947|NCT01435382|3744153|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3920948|NCT01435382|3744154|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3920949|NCT01435382|3744155|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3920950|NCT01435382|3744156|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3920951|NCT01435382|3744152|B5|||Age||years|Mean|52.9|52.9|Standard Deviation|9.7|9.7|||
3920952|NCT01435382|3744153|B4|||Age||years|Mean|53.2|53.2|Standard Deviation|12.3|12.3|||
3920953|NCT01435382|3744154|B3|||Age||years|Mean|52.1|52.1|Standard Deviation|6.9|6.9|||
3920954|NCT01435382|3744155|B2|||Age||years|Mean|55.6|55.6|Standard Deviation|9.8|9.8|||
3920955|NCT01435382|3744156|B1|||Age||years|Mean|50.8|50.8|Standard Deviation|9.9|9.9|||
3920956|NCT01435304|3744246|B3|United States||Region of Enrollment||Participants|Count of Participants|100|100.0||||||
3920957|NCT01435304|3744247|B2|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3920958|NCT01435304|3744248|B1|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3920959|NCT01435304|3744246|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3920960|NCT01435304|3744247|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3920961|NCT01435304|3744248|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3920962|NCT01435304|3744246|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3920963|NCT01435304|3744247|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3920964|NCT01435304|3744248|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3920965|NCT01435304|3744246|B3|||Age||years|Mean|63.8|63.8|Standard Deviation|13.1|13.1|||
3920966|NCT01435304|3744247|B2|||Age||years|Mean|63.3|63.3|Standard Deviation|15.3|15.3|||
3920967|NCT01435304|3744248|B1|||Age||years|Mean|64.4|64.4|Standard Deviation|10.5|10.5|||
3920968|NCT01435265|3744265|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
3920969|NCT01435265|3744266|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3920970|NCT01435265|3744267|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3920971|NCT01435265|3744265|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3920972|NCT01435265|3744266|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3920973|NCT01435265|3744267|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3920974|NCT01435265|3744265|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3920975|NCT01435265|3744266|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3920976|NCT01435265|3744267|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3920977|NCT01435265|3744265|B3|||Age||years|Mean|51.4|51.4|Standard Deviation|10.4|10.4|||
3920978|NCT01435265|3744266|B2|||Age||years|Mean|55.0|55.0|Standard Deviation|9.3|9.3|||
3920979|NCT01435265|3744267|B1|||Age||years|Mean|46.7|46.7|Standard Deviation|12.7|12.7|||
3920980|NCT01435265|3744265|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3920981|NCT01435265|3744266|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3920982|NCT01435265|3744267|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3920983|NCT01435265|3744265|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3920984|NCT01435265|3744266|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3920985|NCT01435265|3744267|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3920986|NCT01435265|3744265|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3920987|NCT01435265|3744266|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3920988|NCT01435265|3744267|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3920989|NCT01435174|3744278|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3920990|NCT01435174|3744278|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3920991|NCT01435174|3744278|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3920992|NCT01435174|3744278|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3920993|NCT01435174|3744278|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3920994|NCT01435174|3744278|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3920995|NCT01435174|3744278|B1|||Age||years|Median|33|33.0|Full Range|||20.0|63.0|
3920996|NCT01435122|3744282|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3920997|NCT01435122|3744282|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3920998|NCT01435122|3744282|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3920999|NCT01435122|3744282|B1|||Age||years|Median|64|64.0|Full Range|||35.0|77.0|
3921000|NCT01435122|3744282|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3921001|NCT01435122|3744282|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3921002|NCT01435122|3744282|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921003|NCT01435031|3744291|B1|Triple||Number of diseased vessels||participants|Number|14|14.0||||||
3921004|NCT01435031|3744291|B1|Double||Number of diseased vessels||participants|Number|38|38.0||||||
3921005|NCT01435031|3744291|B1|Single||Number of diseased vessels||participants|Number|170|170.0||||||
3921006|NCT01435031|3744291|B1|Current or former, quit within the past month||Tobacco use|Evaluated in 208 subjects.|participants|Number|54|54.0||||||
3921007|NCT01435031|3744291|B1|Former user, quit more than 1 month ago||Tobacco use|Evaluated in 208 subjects.|participants|Number|89|89.0||||||
3921008|NCT01435031|3744291|B1|Never used tobacco||Tobacco use|Evaluated in 208 subjects.|participants|Number|65|65.0||||||
3921009|NCT01435031|3744291|B1|Mental Illness||Clinical Characteristics||participants|Number|5|5.0||||||
3921010|NCT01435031|3744291|B1|Cancer||Clinical Characteristics||participants|Number|4|4.0||||||
3921011|NCT01435031|3744291|B1|History of bleeding||Clinical Characteristics||participants|Number|18|18.0||||||
3921012|NCT01435031|3744291|B1|Atrial fibrillation||Clinical Characteristics||participants|Number|14|14.0||||||
3921013|NCT01435031|3744291|B1|Renal Insufficiency/failure||Clinical Characteristics||participants|Number|1|1.0||||||
3921014|NCT01435031|3744291|B1|Dyslipidemia||Clinical Characteristics||participants|Number|215|215.0||||||
3921015|NCT01435031|3744291|B1|Hypertension||Clinical Characteristics||participants|Number|203|203.0||||||
3921016|NCT01435031|3744291|B1|Diabetes Mellitus||Clinical Characteristics||participants|Number|89|89.0||||||
3921017|NCT01435031|3744291|B1|Congestive Heart Failure||Clinical Characteristics||participants|Number|27|27.0||||||
3921018|NCT01435031|3744291|B1|Stroke||Clinical Characteristics||participants|Number|2|2.0||||||
3921019|NCT01435031|3744291|B1|Transient Ischemic Attack (TIA)||Clinical Characteristics||participants|Number|3|3.0||||||
3921020|NCT01435031|3744291|B1|Prior Coronary Artery Bypass Graft Surgery||Clinical Characteristics||participants|Number|22|22.0||||||
3921021|NCT01435031|3744291|B1|Previous Percutaneous Intervention (PCI)||Clinical Characteristics||participants|Number|96|96.0||||||
3921022|NCT01435031|3744291|B1|Prior Myocardial Infarction (MI)||Clinical Characteristics||participants|Number|61|61.0||||||
3921023|NCT01435031|3744291|B1|United States||Region of Enrollment||participants|Number|222|222.0||||||
3921024|NCT01435031|3744291|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921025|NCT01435031|3744291|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3921026|NCT01435031|3744291|B1||White|Race (NIH/OMB)||Participants|Count of Participants|178|178.0||||||
3921027|NCT01435031|3744291|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3921028|NCT01435031|3744291|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3921029|NCT01435031|3744291|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3921030|NCT01435031|3744291|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3921031|NCT01435031|3744291|B1||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3921032|NCT01435031|3744291|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3921033|NCT01435031|3744291|B1|||Age||years|Mean|61.65|61.65|Standard Deviation|10.43|10.43|||
3921034|NCT01434823|3744389|B3|United States||Region of Enrollment||participants|Number|1598|1598.0||||||
3921035|NCT01434823|3744390|B2|United States||Region of Enrollment||participants|Number|778|778.0||||||
3921036|NCT01434823|3744391|B1|United States||Region of Enrollment||participants|Number|820|820.0||||||
3921037|NCT01434823|3744389|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|135|135.0||||||
3921038|NCT01434823|3744390|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3921039|NCT01434823|3744391|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3921040|NCT01434823|3744389|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921041|NCT01434823|3744390|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921042|NCT01434823|3744391|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921043|NCT01434823|3744389|B3||White|Race (NIH/OMB)||Participants|Count of Participants|804|804.0||||||
3921044|NCT01434823|3744390|B2||White|Race (NIH/OMB)||Participants|Count of Participants|387|387.0||||||
3921045|NCT01434823|3744391|B1||White|Race (NIH/OMB)||Participants|Count of Participants|417|417.0||||||
3921046|NCT01434823|3744389|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|643|643.0||||||
3921047|NCT01434823|3744390|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|315|315.0||||||
3921048|NCT01434823|3744391|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|328|328.0||||||
3921049|NCT01434823|3744389|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921050|NCT01434823|3744390|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921051|NCT01434823|3744391|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921052|NCT01434823|3744389|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3921053|NCT01434823|3744390|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3921054|NCT01434823|3744391|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3921055|NCT01434823|3744389|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921056|NCT01434823|3744390|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921057|NCT01434823|3744391|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921058|NCT01434823|3744389|B3||Male|Sex: Female, Male||Participants|Count of Participants|876|876.0||||||
3921059|NCT01434823|3744390|B2||Male|Sex: Female, Male||Participants|Count of Participants|422|422.0||||||
3921060|NCT01434823|3744391|B1||Male|Sex: Female, Male||Participants|Count of Participants|454|454.0||||||
3921061|NCT01434823|3744389|B3||Female|Sex: Female, Male||Participants|Count of Participants|722|722.0||||||
3921062|NCT01434823|3744390|B2||Female|Sex: Female, Male||Participants|Count of Participants|356|356.0||||||
3921063|NCT01434823|3744391|B1||Female|Sex: Female, Male||Participants|Count of Participants|366|366.0||||||
3921064|NCT01434823|3744389|B3|||Age||years|Mean|58|58.0|Standard Deviation|17|17.0|||
3921065|NCT01434823|3744390|B2|||Age||years|Mean|59|59.0|Standard Deviation|16|16.0|||
3921066|NCT01434823|3744391|B1|||Age||years|Mean|58|58.0|Standard Deviation|17|17.0|||
3921067|NCT01434693|3744408|B5|United States||Region of Enrollment||participants|Number|36|36.0||||||
3921068|NCT01434693|3744409|B4|United States||Region of Enrollment||participants|Number|9|9.0||||||
3921069|NCT01434693|3744410|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
3921070|NCT01434693|3744411|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3921071|NCT01434693|3744412|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3921072|NCT01434693|3744408|B5||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3921073|NCT01434693|3744409|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3921074|NCT01434693|3744410|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3921075|NCT01434693|3744411|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3921076|NCT01434693|3744412|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3921077|NCT01434693|3744408|B5||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3921078|NCT01434693|3744409|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3921079|NCT01434693|3744410|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3921080|NCT01434693|3744411|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3921081|NCT01434693|3744412|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3921082|NCT01434693|3744408|B5|||Age||years|Mean|32.9|32.9|Standard Deviation|1.90|1.9|||
3921083|NCT01434693|3744409|B4|||Age||years|Mean|36.9|36.9|Standard Deviation|3.27|3.27|||
3921084|NCT01434693|3744410|B3|||Age||years|Mean|31.1|31.1|Standard Deviation|3.36|3.36|||
3921085|NCT01434693|3744411|B2|||Age||years|Mean|30.8|30.8|Standard Deviation|3.19|3.19|||
3921086|NCT01434693|3744412|B1|||Age||years|Mean|43.0|43.0|Standard Deviation|3.11|3.11|||
3921087|NCT01434693|3744408|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3921088|NCT01434693|3744409|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3921089|NCT01434693|3744410|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3921090|NCT01434693|3744411|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3921091|NCT01434693|3744412|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3921092|NCT01434693|3744408|B5||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3921093|NCT01434693|3744409|B4||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3921094|NCT01434693|3744410|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3921095|NCT01434693|3744411|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3921096|NCT01434693|3744412|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3921097|NCT01434693|3744408|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921098|NCT01434693|3744409|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921099|NCT01434693|3744410|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921100|NCT01434693|3744411|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921101|NCT01434693|3744412|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921102|NCT01434680|3744425|B5||Male|Sex: Female, Male||Participants|Count of Participants|527|527.0||||||
3921103|NCT01434680|3744426|B4||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3921104|NCT01434680|3744427|B3||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3921105|NCT01434680|3744428|B2||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3921106|NCT01434680|3744429|B1||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3921107|NCT01434680|3744425|B5||Female|Sex: Female, Male||Participants|Count of Participants|465|465.0||||||
3921108|NCT01434680|3744426|B4||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3921109|NCT01434680|3744427|B3||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3921110|NCT01434680|3744428|B2||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3921111|NCT01434680|3744429|B1||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3921112|NCT01434680|3744425|B5|||Age||Months|Mean|16.5|16.5|Standard Deviation|3.3|3.3|||
3921113|NCT01434680|3744426|B4|||Age||Months|Mean|17.2|17.2|Standard Deviation|3.3|3.3|||
3921114|NCT01434680|3744427|B3|||Age||Months|Mean|16.7|16.7|Standard Deviation|3.4|3.4|||
3921115|NCT01434680|3744428|B2|||Age||Months|Mean|16.2|16.2|Standard Deviation|3.2|3.2|||
3921116|NCT01434680|3744429|B1|||Age||Months|Mean|16.4|16.4|Standard Deviation|3.4|3.4|||
3921117|NCT01434667|3744447|B3|United States||Region of Enrollment||participants|Number|125|125.0||||||
3921118|NCT01434667|3744448|B2|United States||Region of Enrollment||participants|Number|75|75.0||||||
3921119|NCT01434667|3744449|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
3921120|NCT01434667|3744447|B3||Unknown or Not Reported|Race (NIH/OMB)|Self-identified race|Participants|Count of Participants|0|0.0||||||
3921121|NCT01434667|3744448|B2||Unknown or Not Reported|Race (NIH/OMB)|Self-identified race|Participants|Count of Participants|0|0.0||||||
3921122|NCT01434667|3744449|B1||Unknown or Not Reported|Race (NIH/OMB)|Self-identified race|Participants|Count of Participants|0|0.0||||||
3921123|NCT01434667|3744447|B3||More than one race|Race (NIH/OMB)|Self-identified race|Participants|Count of Participants|0|0.0||||||
3921124|NCT01434667|3744448|B2||More than one race|Race (NIH/OMB)|Self-identified race|Participants|Count of Participants|0|0.0||||||
3921125|NCT01434667|3744449|B1||More than one race|Race (NIH/OMB)|Self-identified race|Participants|Count of Participants|0|0.0||||||
3921126|NCT01434667|3744447|B3||White|Race (NIH/OMB)|Self-identified race|Participants|Count of Participants|94|94.0||||||
3921127|NCT01434667|3744448|B2||White|Race (NIH/OMB)|Self-identified race|Participants|Count of Participants|64|64.0||||||
3921128|NCT01434667|3744449|B1||White|Race (NIH/OMB)|Self-identified race|Participants|Count of Participants|30|30.0||||||
3921129|NCT01434667|3744447|B3||Black or African American|Race (NIH/OMB)|Self-identified race|Participants|Count of Participants|20|20.0||||||
3921130|NCT01434667|3744448|B2||Black or African American|Race (NIH/OMB)|Self-identified race|Participants|Count of Participants|11|11.0||||||
3921131|NCT01434667|3744449|B1||Black or African American|Race (NIH/OMB)|Self-identified race|Participants|Count of Participants|9|9.0||||||
3921132|NCT01434667|3744447|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Self-identified race|Participants|Count of Participants|0|0.0||||||
3921133|NCT01434667|3744448|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Self-identified race|Participants|Count of Participants|0|0.0||||||
3921134|NCT01434667|3744449|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Self-identified race|Participants|Count of Participants|0|0.0||||||
3921135|NCT01434667|3744447|B3||Asian|Race (NIH/OMB)|Self-identified race|Participants|Count of Participants|0|0.0||||||
3921136|NCT01434667|3744448|B2||Asian|Race (NIH/OMB)|Self-identified race|Participants|Count of Participants|0|0.0||||||
3921137|NCT01434667|3744449|B1||Asian|Race (NIH/OMB)|Self-identified race|Participants|Count of Participants|0|0.0||||||
3921138|NCT01434667|3744447|B3||American Indian or Alaska Native|Race (NIH/OMB)|Self-identified race|Participants|Count of Participants|0|0.0||||||
3921139|NCT01434667|3744448|B2||American Indian or Alaska Native|Race (NIH/OMB)|Self-identified race|Participants|Count of Participants|0|0.0||||||
3921140|NCT01434667|3744449|B1||American Indian or Alaska Native|Race (NIH/OMB)|Self-identified race|Participants|Count of Participants|0|0.0||||||
3921141|NCT01434667|3744447|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3921142|NCT01434667|3744448|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3921143|NCT01434667|3744449|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3921144|NCT01434667|3744447|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
3921145|NCT01434667|3744448|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3921146|NCT01434667|3744449|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3921147|NCT01434667|3744447|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3921148|NCT01434667|3744448|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3921149|NCT01434667|3744449|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3921150|NCT01434667|3744447|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3921151|NCT01434667|3744448|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3921152|NCT01434667|3744449|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3921153|NCT01434667|3744447|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3921154|NCT01434667|3744448|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3921155|NCT01434667|3744449|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3921156|NCT01434667|3744447|B3|||Age||years|Mean|73.9|73.9|Standard Deviation|7.6|7.6|||
3921157|NCT01434667|3744448|B2|||Age||years|Mean|73.3|73.3|Standard Deviation|7.3|7.3|||
3921158|NCT01434667|3744449|B1|||Age||years|Mean|75.1|75.1|Standard Deviation|8.1|8.1|||
3921159|NCT01434667|3744447|B3||>=65 years|Age||Participants|Count of Participants|100|100.0||||||
3921160|NCT01434667|3744448|B2||>=65 years|Age||Participants|Count of Participants|64|64.0||||||
3921161|NCT01434667|3744449|B1||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
3921162|NCT01434667|3744447|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3921163|NCT01434667|3744448|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3921164|NCT01434667|3744449|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3921165|NCT01434667|3744447|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921166|NCT01434667|3744448|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921167|NCT01434667|3744449|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921168|NCT01434654|3744474|B3|HIV-Associated Dementia (HAD)||HIV-Associated Neurocognitive Disorder (HAND) status||participants|Number|1|1.0||||||
3921169|NCT01434654|3744475|B2|HIV-Associated Dementia (HAD)||HIV-Associated Neurocognitive Disorder (HAND) status||participants|Number|0|0.0||||||
3921170|NCT01434654|3744476|B1|HIV-Associated Dementia (HAD)||HIV-Associated Neurocognitive Disorder (HAND) status||participants|Number|1|1.0||||||
3921171|NCT01434654|3744474|B3|Mild Neurocognitive Disorder (MND)||HIV-Associated Neurocognitive Disorder (HAND) status||participants|Number|4|4.0||||||
3921172|NCT01434654|3744475|B2|Mild Neurocognitive Disorder (MND)||HIV-Associated Neurocognitive Disorder (HAND) status||participants|Number|3|3.0||||||
3921173|NCT01434654|3744476|B1|Mild Neurocognitive Disorder (MND)||HIV-Associated Neurocognitive Disorder (HAND) status||participants|Number|1|1.0||||||
3921174|NCT01434654|3744474|B3|Asymptomatic Neurocognitive Impairment (ANI)||HIV-Associated Neurocognitive Disorder (HAND) status||participants|Number|9|9.0||||||
3921175|NCT01434654|3744475|B2|Asymptomatic Neurocognitive Impairment (ANI)||HIV-Associated Neurocognitive Disorder (HAND) status||participants|Number|7|7.0||||||
3921176|NCT01434654|3744476|B1|Asymptomatic Neurocognitive Impairment (ANI)||HIV-Associated Neurocognitive Disorder (HAND) status||participants|Number|2|2.0||||||
3921177|NCT01434654|3744474|B3|Normal/Unimpaired||HIV-Associated Neurocognitive Disorder (HAND) status||participants|Number|3|3.0||||||
3921178|NCT01434654|3744475|B2|Normal/Unimpaired||HIV-Associated Neurocognitive Disorder (HAND) status||participants|Number|2|2.0||||||
3921179|NCT01434654|3744476|B1|Normal/Unimpaired||HIV-Associated Neurocognitive Disorder (HAND) status||participants|Number|1|1.0||||||
3921180|NCT01434654|3744474|B3|||Current CD4||cells/mm3|Median|684|684.0|Inter-Quartile Range|||403.25|964.75|
3921181|NCT01434654|3744475|B2|||Current CD4||cells/mm3|Median|583|583.0|Inter-Quartile Range|||386.25|979.75|
3921182|NCT01434654|3744476|B1|||Current CD4||cells/mm3|Median|943|943.0|Inter-Quartile Range|||752.5|1133.5|
3921183|NCT01434654|3744474|B3|||Nadir cluster of differentiation 4 (CD4)||cells/mm3|Median|200|200.0|Inter-Quartile Range|||70.0|330.0|
3921184|NCT01434654|3744475|B2|||Nadir cluster of differentiation 4 (CD4)||cells/mm3|Median|115|115.0|Inter-Quartile Range|||42.5|207.5|
3921185|NCT01434654|3744476|B1|||Nadir cluster of differentiation 4 (CD4)||cells/mm3|Median|400|400.0|Inter-Quartile Range|||300.25|499.75|
3921186|NCT01434654|3744474|B3|||Premorbid intelligence quotient (IQ)|Full-scale IQ based on National Adult Reading Test (NART) error score. NART is a test of reading ability that has been extensively validated for use as a proxy measure of pre-morbid intellectual functioning. Full-Scale IQ score is expressed as a Standard Score with Mean=100 and Standard Deviation=15. Possible values range from 69-131. Higher scores indicate better performance.|units on a scale|Mean|103.0|103.0|Standard Deviation|14.1|14.1|||
3921235|NCT01434342|3744512|B2||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3921187|NCT01434654|3744475|B2|||Premorbid intelligence quotient (IQ)|Full-scale IQ based on National Adult Reading Test (NART) error score. NART is a test of reading ability that has been extensively validated for use as a proxy measure of pre-morbid intellectual functioning. Full-Scale IQ score is expressed as a Standard Score with Mean=100 and Standard Deviation=15. Possible values range from 69-131. Higher scores indicate better performance.|units on a scale|Mean|102.5|102.5|Standard Deviation|12.6|12.6|||
3921188|NCT01434654|3744476|B1|||Premorbid intelligence quotient (IQ)|Full-scale IQ based on National Adult Reading Test (NART) error score. NART is a test of reading ability that has been extensively validated for use as a proxy measure of pre-morbid intellectual functioning. Full-Scale IQ score is expressed as a Standard Score with Mean=100 and Standard Deviation=15. Possible values range from 69-131. Higher scores indicate better performance.|units on a scale|Mean|104.2|104.2|Standard Deviation|18.7|18.7|||
3921189|NCT01434654|3744474|B3|||Education||years|Mean|12.8|12.8|Standard Deviation|2.7|2.7|||
3921190|NCT01434654|3744475|B2|||Education||years|Mean|12.2|12.2|Standard Deviation|2.7|2.7|||
3921191|NCT01434654|3744476|B1|||Education||years|Mean|14.4|14.4|Standard Deviation|3.4|3.4|||
3921192|NCT01434654|3744474|B3|Australia||Region of Enrollment||participants|Number|17|17.0||||||
3921193|NCT01434654|3744475|B2|Australia||Region of Enrollment||participants|Number|12|12.0||||||
3921194|NCT01434654|3744476|B1|Australia||Region of Enrollment||participants|Number|5|5.0||||||
3921195|NCT01434654|3744474|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3921196|NCT01434654|3744475|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3921197|NCT01434654|3744476|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3921198|NCT01434654|3744474|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3921199|NCT01434654|3744475|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3921200|NCT01434654|3744476|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3921201|NCT01434654|3744474|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3921202|NCT01434654|3744475|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3921203|NCT01434654|3744476|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3921204|NCT01434654|3744474|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3921205|NCT01434654|3744475|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3921206|NCT01434654|3744476|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3921207|NCT01434654|3744474|B3|||Age||years|Mean|53.9|53.9|Standard Deviation|8.5|8.5|||
3921208|NCT01434654|3744475|B2|||Age||years|Mean|55.4|55.4|Standard Deviation|8.6|8.6|||
3921209|NCT01434654|3744476|B1|||Age||years|Mean|50.2|50.2|Standard Deviation|7.8|7.8|||
3921210|NCT01434641|3744489|B1|no||Non-cardiac surgery|Patients had a low intermediate likelihood of coronary disease and were being evaluated pre-operatively for non-cardiac surgery.|participants|Number|90|90.0||||||
3921211|NCT01434641|3744489|B1|yes||Non-cardiac surgery|Patients had a low intermediate likelihood of coronary disease and were being evaluated pre-operatively for non-cardiac surgery.|participants|Number|12|12.0||||||
3921212|NCT01434641|3744489|B1|no||Risk of Coronary Artery Disease|Patients presented with risk factors for coronary artery disease and symptomatology imparting an intermediate likelihood of coronary artery disease.|participants|Number|65|65.0||||||
3921213|NCT01434641|3744489|B1|yes||Risk of Coronary Artery Disease|Patients presented with risk factors for coronary artery disease and symptomatology imparting an intermediate likelihood of coronary artery disease.|participants|Number|37|37.0||||||
3921214|NCT01434641|3744489|B1|no||Coronary Artery Disease|Patients with a history of known coronary artery disease with either prior myocardial infarction, and/or coronary revascularization, and/or a history of congestive heart failure.|participants|Number|49|49.0||||||
3921215|NCT01434641|3744489|B1|yes||Coronary Artery Disease|Patients with a history of known coronary artery disease with either prior myocardial infarction, and/or coronary revascularization, and/or a history of congestive heart failure.|participants|Number|53|53.0||||||
3921216|NCT01434641|3744489|B1|||Chest circumference||inches|Mean|41.5|41.5|Standard Deviation|4.0|4.0|||
3921217|NCT01434641|3744489|B1|||Weight||pounds|Mean|178|178.0|Standard Deviation|41|41.0|||
3921218|NCT01434641|3744489|B1|United States||Region of Enrollment||participants|Number|102|102.0||||||
3921219|NCT01434641|3744489|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3921220|NCT01434641|3744489|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3921221|NCT01434641|3744489|B1|||Age||years|Mean|55|55.0|Standard Deviation|15|15.0|||
3921222|NCT01434641|3744489|B1||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
3921223|NCT01434641|3744489|B1||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
3921224|NCT01434641|3744489|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921225|NCT01434342|3744511|B3|United States||Region of Enrollment||participants|Number|146|146.0||||||
3921226|NCT01434342|3744512|B2|United States||Region of Enrollment||participants|Number|48|48.0||||||
3921227|NCT01434342|3744513|B1|United States||Region of Enrollment||participants|Number|98|98.0||||||
3921228|NCT01434342|3744511|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921229|NCT01434342|3744512|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921230|NCT01434342|3744513|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921231|NCT01434342|3744511|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921232|NCT01434342|3744512|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921233|NCT01434342|3744513|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921234|NCT01434342|3744511|B3||White|Race (NIH/OMB)||Participants|Count of Participants|117|117.0||||||
3921236|NCT01434342|3744513|B1||White|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3921237|NCT01434342|3744511|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3921238|NCT01434342|3744512|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3921239|NCT01434342|3744513|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3921240|NCT01434342|3744511|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921241|NCT01434342|3744512|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921242|NCT01434342|3744513|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921243|NCT01434342|3744511|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921244|NCT01434342|3744512|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921245|NCT01434342|3744513|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921246|NCT01434342|3744511|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3921247|NCT01434342|3744512|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921248|NCT01434342|3744513|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3921249|NCT01434342|3744511|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3921250|NCT01434342|3744512|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921251|NCT01434342|3744513|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3921252|NCT01434342|3744511|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
3921253|NCT01434342|3744512|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3921254|NCT01434342|3744513|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3921255|NCT01434342|3744511|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3921256|NCT01434342|3744512|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921257|NCT01434342|3744513|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3921258|NCT01434342|3744511|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3921259|NCT01434342|3744512|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3921260|NCT01434342|3744513|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3921261|NCT01434342|3744511|B3||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3921262|NCT01434342|3744512|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3921263|NCT01434342|3744513|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3921264|NCT01434342|3744511|B3|||Age||years|Median|57|57.0|Full Range|||22.0|86.0|
3921265|NCT01434342|3744512|B2|||Age||years|Median|58|58.0|Full Range|||26.0|86.0|
3921266|NCT01434342|3744513|B1|||Age||years|Median|57|57.0|Full Range|||22.0|75.0|
3921267|NCT01434342|3744511|B3||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
3921268|NCT01434342|3744512|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3921269|NCT01434342|3744513|B1||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
3921270|NCT01434342|3744511|B3||Between 18 and 65 years|Age||Participants|Count of Participants|104|104.0||||||
3921271|NCT01434342|3744512|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3921272|NCT01434342|3744513|B1||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
3921273|NCT01434342|3744511|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921274|NCT01434342|3744512|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921275|NCT01434342|3744513|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921276|NCT01434290|3744522|B3||Male|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
3921277|NCT01434290|3744523|B2||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3921278|NCT01434290|3744524|B1||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3921279|NCT01434290|3744522|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3921280|NCT01434290|3744523|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3921281|NCT01434290|3744524|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3921282|NCT01434290|3744522|B3|||Age||years|Median|65|65.0|Full Range|||48.0|79.0|
3921283|NCT01434290|3744523|B2|||Age||years|Median|66|66.0|Full Range|||50.0|79.0|
3921284|NCT01434290|3744524|B1|||Age||years|Median|64|64.0|Full Range|||48.0|77.0|
3921285|NCT01434186|3744551|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3921286|NCT01434186|3744552|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3921287|NCT01434186|3744553|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3921288|NCT01434186|3744551|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3921289|NCT01434186|3744552|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3921290|NCT01434186|3744553|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3921291|NCT01434186|3744551|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3921292|NCT01434186|3744552|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3921293|NCT01434186|3744553|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3921294|NCT01434186|3744551|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3921295|NCT01434186|3744552|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3921296|NCT01434186|3744553|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3921297|NCT01434186|3744551|B3||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3921298|NCT01434186|3744552|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3921299|NCT01434186|3744553|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3921300|NCT01434121|3744560|B4|United States||Region of Enrollment||participants|Number|24|24.0||||||
3921301|NCT01434121|3744561|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3921302|NCT01434121|3744562|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3921303|NCT01434121|3744563|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3921304|NCT01434121|3744560|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3921305|NCT01434121|3744561|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3921306|NCT01434121|3744562|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3921307|NCT01434121|3744563|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3921308|NCT01434121|3744560|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3921309|NCT01434121|3744561|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3921310|NCT01434121|3744562|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3921311|NCT01434121|3744563|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3921312|NCT01434121|3744560|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921313|NCT01434121|3744561|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921314|NCT01434121|3744562|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921315|NCT01434121|3744563|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921316|NCT01434121|3744560|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921317|NCT01434121|3744561|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921318|NCT01434121|3744562|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921319|NCT01434121|3744563|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921320|NCT01434121|3744560|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921321|NCT01434121|3744561|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921322|NCT01434121|3744562|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921323|NCT01434121|3744563|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921324|NCT01434121|3744560|B4||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3921325|NCT01434121|3744561|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3921326|NCT01434121|3744562|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3921327|NCT01434121|3744563|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3921328|NCT01434121|3744560|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3921329|NCT01434121|3744561|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3921330|NCT01434121|3744562|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3921331|NCT01434121|3744563|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3921332|NCT01434121|3744560|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921333|NCT01434121|3744561|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921334|NCT01434121|3744562|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921335|NCT01434121|3744563|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921336|NCT01434121|3744560|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921337|NCT01434121|3744561|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921338|NCT01434121|3744562|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921339|NCT01434121|3744563|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921340|NCT01434121|3744560|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921341|NCT01434121|3744561|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921342|NCT01434121|3744562|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921343|NCT01434121|3744563|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921344|NCT01434121|3744560|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3921345|NCT01434121|3744561|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3921346|NCT01434121|3744562|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3921347|NCT01434121|3744563|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3921348|NCT01434121|3744560|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3921349|NCT01434121|3744561|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3921350|NCT01434121|3744562|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3921351|NCT01434121|3744563|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3921352|NCT01434121|3744560|B4||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3921353|NCT01434121|3744561|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3921354|NCT01434121|3744562|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3921355|NCT01434121|3744563|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3921356|NCT01434121|3744560|B4||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3921357|NCT01434121|3744561|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3921358|NCT01434121|3744562|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3921359|NCT01434121|3744563|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3921360|NCT01434121|3744560|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921361|NCT01434121|3744561|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921362|NCT01434121|3744562|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921363|NCT01434121|3744563|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921364|NCT01434030|3744591|B1|||Duration of Diabetes|Time since diagnosis of Type 1 Diabetes|years|Mean|24.1|24.1|Standard Deviation|11.0|11.0|||
3921365|NCT01434030|3744591|B1|||HbA1c||percent glycated hemoglobin|Mean|7.7|7.7|Standard Deviation|1.2|1.2|||
3921366|NCT01434030|3744591|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3921367|NCT01434030|3744591|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3921368|NCT01434030|3744591|B1|||Age||years|Mean|41|41.0|Standard Deviation|12.2|12.2|||
3921369|NCT01433978|3744596|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3921370|NCT01433978|3744597|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3921371|NCT01433978|3744598|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3921372|NCT01433978|3744596|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3921373|NCT01433978|3744597|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3921374|NCT01433978|3744598|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3921375|NCT01433978|3744596|B3|||Age||Years|Geometric Mean|48.2|48.2|Standard Deviation|21.36|21.36|||
3921376|NCT01433978|3744597|B2|||Age||Years|Geometric Mean|50.8|50.8|Standard Deviation|23.04|23.04|||
3921377|NCT01433978|3744598|B1|||Age||Years|Geometric Mean|45.4|45.4|Standard Deviation|20.09|20.09|||
3921378|NCT01433913|3744607|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3921379|NCT01433913|3744608|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3921380|NCT01433913|3744609|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3921381|NCT01433913|3744607|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3921382|NCT01433913|3744608|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3921383|NCT01433913|3744609|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3921384|NCT01433913|3744607|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3921385|NCT01433913|3744608|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3921386|NCT01433913|3744609|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3921387|NCT01433913|3744607|B3|||Age||years|Mean|63|63.0|Standard Deviation|8|8.0|||
3921388|NCT01433913|3744608|B2|||Age||years|Mean|61|61.0|Standard Deviation|6|6.0|||
3921389|NCT01433913|3744609|B1|||Age||years|Mean|65|65.0|Standard Deviation|10|10.0|||
3921390|NCT01433913|3744607|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3921391|NCT01433913|3744608|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3921392|NCT01433913|3744609|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3921393|NCT01433913|3744607|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3921394|NCT01433913|3744608|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3921395|NCT01433913|3744609|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3921396|NCT01433913|3744607|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921397|NCT01433913|3744608|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921398|NCT01433913|3744609|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921399|NCT01433731|3744642|B5|United States||Region of Enrollment||participants|Number|18|18.0||||||
3921400|NCT01433731|3744643|B4|United States||Region of Enrollment||participants|Number|5|5.0||||||
3921401|NCT01433731|3744644|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3921402|NCT01433731|3744645|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3921403|NCT01433731|3744646|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3921404|NCT01433731|3744642|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3921405|NCT01433731|3744643|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3921406|NCT01433731|3744644|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3921407|NCT01433731|3744645|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3921408|NCT01433731|3744646|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3921409|NCT01433731|3744642|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3921410|NCT01433731|3744643|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3921411|NCT01433731|3744644|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3921412|NCT01433731|3744645|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3921413|NCT01433731|3744646|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3921414|NCT01433731|3744642|B5||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3921415|NCT01433731|3744643|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3921416|NCT01433731|3744644|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3921417|NCT01433731|3744645|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3921418|NCT01433731|3744646|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3921419|NCT01433731|3744642|B5||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3921420|NCT01433731|3744643|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3921421|NCT01433731|3744644|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3921422|NCT01433731|3744645|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3921423|NCT01433731|3744646|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3921424|NCT01433731|3744642|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921425|NCT01433731|3744643|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921426|NCT01433731|3744644|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921427|NCT01433731|3744645|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921428|NCT01433731|3744646|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921429|NCT01433549|3744657|B1|Canada||Region of Enrollment||participants|Number|25|25.0||||||
3921430|NCT01433549|3744657|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3921431|NCT01433549|3744657|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3921432|NCT01433549|3744657|B1|||Age, Customized||years|Median|25|25.0|Full Range|||19.0|43.0|
3921433|NCT01433471|3744666|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3921434|NCT01433471|3744667|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3921435|NCT01433471|3744668|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3921436|NCT01433471|3744666|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3921437|NCT01433471|3744667|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3921438|NCT01433471|3744668|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3921439|NCT01433471|3744666|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3921440|NCT01433471|3744667|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3921441|NCT01433471|3744668|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3921442|NCT01433471|3744666|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3921443|NCT01433471|3744667|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3921444|NCT01433471|3744668|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3921445|NCT01433471|3744666|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921446|NCT01433471|3744667|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921447|NCT01433471|3744668|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921448|NCT01433354|3744685|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3921449|NCT01433354|3744685|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3921450|NCT01433354|3744685|B1|||Age||years|Mean|15.2|15.2|Standard Deviation|1.75|1.75|||
3921451|NCT01433263|3744699|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3921452|NCT01433263|3744700|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3921453|NCT01433263|3744701|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3921454|NCT01433263|3744699|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3921455|NCT01433263|3744700|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3921456|NCT01433263|3744701|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3921457|NCT01433263|3744699|B3|||Age||years|Mean|62.1|62.1|Standard Deviation|10.38|10.38|||
3921458|NCT01433263|3744700|B2|||Age||years|Mean|61.5|61.5|Standard Deviation|10.74|10.74|||
3921459|NCT01433263|3744701|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|10.17|10.17|||
3921460|NCT01433250|3744729|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3921461|NCT01433250|3744730|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3921462|NCT01433250|3744731|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3921463|NCT01433250|3744729|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3921464|NCT01433250|3744730|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3921465|NCT01433250|3744731|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3921466|NCT01433250|3744729|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3921467|NCT01433250|3744730|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921468|NCT01433250|3744731|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3921469|NCT01433250|3744729|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3921470|NCT01433250|3744730|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3921471|NCT01433250|3744731|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3921472|NCT01433250|3744729|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3921473|NCT01433250|3744730|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3921474|NCT01433250|3744731|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3921475|NCT01433250|3744729|B3|||Age||Years|Mean|35.3|35.3|Standard Deviation|9.39|9.39|||
3921476|NCT01433250|3744730|B2|||Age||Years|Mean|34.2|34.2|Standard Deviation|8.71|8.71|||
3921477|NCT01433250|3744731|B1|||Age||Years|Mean|36.1|36.1|Standard Deviation|10|10.0|||
3921478|NCT01433172|3744748|B4|United States||Region of Enrollment||Participants|Count of Participants|73|73.0||||||
3921479|NCT01433172|3744749|B3|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3921480|NCT01433172|3744750|B2|United States||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3921481|NCT01433172|3744751|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3921482|NCT01433172|3744748|B4||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3921483|NCT01433172|3744749|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3921484|NCT01433172|3744750|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3921485|NCT01433172|3744751|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3921486|NCT01433172|3744748|B4||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3921487|NCT01433172|3744749|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3921488|NCT01433172|3744750|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3921489|NCT01433172|3744751|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3921490|NCT01433172|3744748|B4|||Age||years|Median|62|62.0|Full Range|||38.0|86.0|
3921491|NCT01433172|3744749|B3|||Age||years|Median|65|65.0|Full Range|||48.0|82.0|
3921492|NCT01433172|3744750|B2|||Age||years|Median|62|62.0|Full Range|||38.0|86.0|
3921493|NCT01433172|3744751|B1|||Age||years|Median|68|68.0|Full Range|||58.0|78.0|
3921494|NCT01433172|3744748|B4||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
3921495|NCT01433172|3744749|B3||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3921496|NCT01433172|3744750|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3921497|NCT01433172|3744751|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3921498|NCT01433172|3744748|B4||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3921499|NCT01433172|3744749|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3921500|NCT01433172|3744750|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3921501|NCT01433172|3744751|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3921502|NCT01433172|3744748|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921503|NCT01433172|3744749|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921504|NCT01433172|3744750|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921505|NCT01433172|3744751|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921506|NCT01433159|3744763|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
3921507|NCT01433159|3744764|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3921508|NCT01433159|3744765|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3921509|NCT01433159|3744763|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3921510|NCT01433159|3744764|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3921511|NCT01433159|3744765|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3921512|NCT01433159|3744763|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3921513|NCT01433159|3744764|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3921514|NCT01433159|3744765|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3921515|NCT01433159|3744763|B3|||Age||years|Mean|57.4|57.4|Standard Deviation|19.0|19.0|||
3921516|NCT01433159|3744764|B2|||Age||years|Mean|58.6|58.6|Standard Deviation|18.4|18.4|||
3921517|NCT01433159|3744765|B1|||Age||years|Mean|56.0|56.0|Standard Deviation|20.7|20.7|||
3921518|NCT01433159|3744763|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3921519|NCT01433159|3744764|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3921520|NCT01433159|3744765|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3921521|NCT01433159|3744763|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3921522|NCT01433159|3744764|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3921523|NCT01433159|3744765|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3921524|NCT01433159|3744763|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921525|NCT01433159|3744764|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921526|NCT01433159|3744765|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921527|NCT01433107|3744772|B3||Male|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
3921528|NCT01433107|3744773|B2||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3921529|NCT01433107|3744774|B1||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3921530|NCT01433107|3744772|B3||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3921531|NCT01433107|3744773|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3921532|NCT01433107|3744774|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3921533|NCT01433107|3744772|B3|||Age||years|Mean|34.66|34.66|Standard Deviation|12.372|12.372|||
3921534|NCT01433107|3744773|B2|||Age||years|Mean|34.05|34.05|Standard Deviation|11.936|11.936|||
3921535|NCT01433107|3744774|B1|||Age||years|Mean|35.27|35.27|Standard Deviation|12.805|12.805|||
3921536|NCT01433081|3744785|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3921537|NCT01433081|3744786|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3921538|NCT01433081|3744787|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3921539|NCT01433081|3744785|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3921540|NCT01433081|3744786|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3921541|NCT01433081|3744787|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3921542|NCT01433081|3744785|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3921543|NCT01433081|3744786|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3921544|NCT01433081|3744787|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3921545|NCT01433081|3744785|B3|||Age||years|Mean|52|52.0|Standard Deviation|7.01|7.01|||
3921546|NCT01433081|3744786|B2|||Age||years|Mean|52|52.0|Standard Deviation|7.7|7.7|||
3921547|NCT01433081|3744787|B1|||Age||years|Mean|53|53.0|Standard Deviation|6.15|6.15|||
3921548|NCT01433081|3744785|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3921549|NCT01433081|3744786|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3921550|NCT01433081|3744787|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3921551|NCT01433081|3744785|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3921552|NCT01433081|3744786|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3921553|NCT01433081|3744787|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3921554|NCT01433081|3744785|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921555|NCT01433081|3744786|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921556|NCT01433081|3744787|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921557|NCT01433055|3744796|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3921558|NCT01433055|3744797|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
3921559|NCT01433055|3744798|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3921560|NCT01433055|3744796|B3|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3921561|NCT01433055|3744797|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3921562|NCT01433055|3744798|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3921563|NCT01433055|3744796|B3|Black||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3921564|NCT01433055|3744797|B2|Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3921565|NCT01433055|3744798|B1|Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3921566|NCT01433055|3744796|B3|White||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3921567|NCT01433055|3744797|B2|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3921568|NCT01433055|3744798|B1|White||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3921569|NCT01433055|3744796|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3921570|NCT01433055|3744797|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3921571|NCT01433055|3744798|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3921572|NCT01433055|3744796|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3921573|NCT01433055|3744797|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3921574|NCT01433055|3744798|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3921575|NCT01433055|3744796|B3|||Age||years|Mean|42.6|42.6|Standard Deviation|12.8|12.8|||
3921576|NCT01433055|3744797|B2|||Age||years|Mean|42.3|42.3|Standard Deviation|11.0|11.0|||
3921577|NCT01433055|3744798|B1|||Age||years|Mean|42.9|42.9|Standard Deviation|14.2|14.2|||
3921578|NCT01433042|3744813|B1|Sweden||Region of Enrollment||participants|Number|64|64.0||||||
3921579|NCT01433042|3744813|B1|Israel||Region of Enrollment||participants|Number|76|76.0||||||
3921580|NCT01433042|3744813|B1|Romania||Region of Enrollment||participants|Number|19|19.0||||||
3921581|NCT01433042|3744813|B1|Spain||Region of Enrollment||participants|Number|66|66.0||||||
3921582|NCT01433042|3744813|B1||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3921583|NCT01433042|3744813|B1||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3921584|NCT01433042|3744813|B1|||Age||years|Mean|52.4|52.4|Standard Deviation|18.6|18.6|||
3921585|NCT01433042|3744813|B1||>=65 years|Age||Participants|Count of Participants|67|67.0||||||
3921586|NCT01433042|3744813|B1||Between 18 and 65 years|Age||Participants|Count of Participants|157|157.0||||||
3921587|NCT01433042|3744813|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3921588|NCT01433016|3744817|B1|Israel||Region of Enrollment||participants|Number|20|20.0||||||
3921589|NCT01433016|3744817|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3921590|NCT01433016|3744817|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3921591|NCT01433016|3744817|B1|||Age||years|Mean|64|64.0|Standard Deviation|10.8|10.8|||
3921592|NCT01432938|3744821|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
3921593|NCT01432938|3744821|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921594|NCT01432938|3744821|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921595|NCT01432938|3744821|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3921596|NCT01432938|3744821|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3921597|NCT01432938|3744821|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921598|NCT01432938|3744821|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921599|NCT01432938|3744821|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921600|NCT01432938|3744821|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921601|NCT01432938|3744821|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3921602|NCT01432938|3744821|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3921603|NCT01432938|3744821|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3921604|NCT01432938|3744821|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3921605|NCT01432938|3744821|B1|||Age||years|Mean|44.2|44.2|Standard Deviation|10.9|10.9|||
3921606|NCT01432886|3744837|B3|Japanese||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3921607|NCT01432886|3744838|B2|Japanese||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3921608|NCT01432886|3744839|B1|Japanese||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3921609|NCT01432886|3744837|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3921610|NCT01432886|3744838|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3921611|NCT01432886|3744839|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3921612|NCT01432886|3744837|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3921613|NCT01432886|3744838|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3921614|NCT01432886|3744839|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3921615|NCT01432886|3744837|B3|||Age||Years|Mean|56.9|56.9|Standard Deviation|11.2|11.2|||
3921616|NCT01432886|3744838|B2|||Age||Years|Mean|49.2|49.2|Standard Deviation|10.32|10.32|||
3921617|NCT01432886|3744839|B1|||Age||Years|Mean|64.7|64.7|Standard Deviation|5.05|5.05|||
3921618|NCT01432756|3744848|B5|South Africa||Region of Enrollment||participants|Number|132|132.0||||||
3921619|NCT01432756|3744849|B4|South Africa||Region of Enrollment||participants|Number|34|34.0||||||
3921620|NCT01432756|3744850|B3|South Africa||Region of Enrollment||participants|Number|32|32.0||||||
3921621|NCT01432756|3744851|B2|South Africa||Region of Enrollment||participants|Number|34|34.0||||||
3921622|NCT01432756|3744852|B1|South Africa||Region of Enrollment||participants|Number|32|32.0||||||
3921623|NCT01432756|3744848|B5||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3921624|NCT01432756|3744849|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3921625|NCT01432756|3744850|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3921626|NCT01432756|3744851|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3921627|NCT01432756|3744852|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3921628|NCT01432756|3744848|B5||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3921629|NCT01432756|3744849|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3921630|NCT01432756|3744850|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3921631|NCT01432756|3744851|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3921632|NCT01432756|3744852|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3921633|NCT01432756|3744848|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3921634|NCT01432756|3744849|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3921635|NCT01432756|3744850|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3921636|NCT01432756|3744851|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3921637|NCT01432756|3744852|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3921638|NCT01432756|3744848|B5||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
3921639|NCT01432756|3744849|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3921640|NCT01432756|3744850|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3921641|NCT01432756|3744851|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3921642|NCT01432756|3744852|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3921643|NCT01432756|3744848|B5||<=18 years|Age||Participants|Count of Participants|66|66.0||||||
3921644|NCT01432756|3744849|B4||<=18 years|Age||Participants|Count of Participants|34|34.0||||||
3921645|NCT01432756|3744850|B3||<=18 years|Age||Participants|Count of Participants|32|32.0||||||
3921646|NCT01432756|3744851|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921647|NCT01432756|3744852|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921648|NCT01432626|3744863|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3921649|NCT01432626|3744863|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3921650|NCT01432626|3744863|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3921651|NCT01432626|3744863|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3921652|NCT01432626|3744863|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3921653|NCT01432626|3744863|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921654|NCT01432600|3744867|B4|United States||Region of Enrollment||participants|Number|80|80.0||||||
3921655|NCT01432600|3744868|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
3921656|NCT01432600|3744869|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
3921657|NCT01432600|3744870|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3921658|NCT01432600|3744867|B4||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3921659|NCT01432600|3744868|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3921660|NCT01432600|3744869|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3921661|NCT01432600|3744870|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3921662|NCT01432600|3744867|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3921663|NCT01432600|3744868|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3921664|NCT01432600|3744869|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3921665|NCT01432600|3744870|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3921666|NCT01432600|3744867|B4|||Age||years|Mean|63|63.0|Full Range|||44.0|80.0|
3921667|NCT01432600|3744868|B3|||Age||years|Mean|62|62.0|Full Range|||47.0|80.0|
3921668|NCT01432600|3744869|B2|||Age||years|Mean|64|64.0|Full Range|||50.0|78.0|
3921669|NCT01432600|3744870|B1|||Age||years|Mean|69|69.0|Full Range|||44.0|73.0|
3921670|NCT01432600|3744867|B4||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
3921671|NCT01432600|3744868|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3921672|NCT01432600|3744869|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3921673|NCT01432600|3744870|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3921674|NCT01432600|3744867|B4||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3921675|NCT01432600|3744868|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3921676|NCT01432600|3744869|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3921677|NCT01432600|3744870|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3921678|NCT01432600|3744867|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921679|NCT01432600|3744868|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921680|NCT01432600|3744869|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921681|NCT01432600|3744870|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921682|NCT01432574|3744888|B1|Mexico||Region of Enrollment||participants|Number|75|75.0||||||
3921683|NCT01432574|3744888|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
3921684|NCT01432574|3744888|B1|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3921685|NCT01432574|3744888|B1|More than one race||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
3921686|NCT01432574|3744888|B1|Native American/Alaskan||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3921687|NCT01432574|3744888|B1|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3921688|NCT01432574|3744888|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3921689|NCT01432574|3744888|B1|White||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
3921690|NCT01432574|3744888|B1||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3921691|NCT01432574|3744888|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3921692|NCT01432574|3744888|B1|||Age||years|Median|36|36.0|Full Range|||27.0|45.0|
3921693|NCT01432574|3744888|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3921694|NCT01432574|3744888|B1||Between 18 and 65 years|Age||Participants|Count of Participants|150|150.0||||||
3921695|NCT01432574|3744888|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921696|NCT01432561|3744894|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3921697|NCT01432561|3744894|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3921698|NCT01432561|3744894|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3921699|NCT01432561|3744894|B1|||Age||years|Mean|29.9|29.9|Standard Deviation|8.5|8.5|||
3921700|NCT01432561|3744894|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3921701|NCT01432561|3744894|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3921702|NCT01432561|3744894|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921703|NCT01432535|3744900|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3921704|NCT01432535|3744901|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3921705|NCT01432535|3744902|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3921706|NCT01432535|3744903|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3921707|NCT01432535|3744900|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3921708|NCT01432535|3744901|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3921709|NCT01432535|3744902|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3921710|NCT01432535|3744903|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3921711|NCT01432535|3744900|B4|||Age||Years|Mean|57.83|57.83|Standard Deviation|10.25|10.25|||
3921712|NCT01432535|3744901|B3|||Age||Years|Mean|52.67|52.67|Standard Deviation|12.74|12.74|||
3921713|NCT01432535|3744902|B2|||Age||Years|Mean|64.00|64.0|Standard Deviation|6.23|6.23|||
3921714|NCT01432535|3744903|B1|||Age||Years|Mean|57.33|57.33|Standard Deviation|9.63|9.63|||
3921715|NCT01432457|3744931|B4||Male|Sex: Female, Male||Participants|Count of Participants|399|399.0||||||
3921716|NCT01432457|3744932|B3||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3921717|NCT01432457|3744933|B2||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3921718|NCT01432457|3744934|B1||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3921719|NCT01432457|3744931|B4||Female|Sex: Female, Male||Participants|Count of Participants|510|510.0||||||
3921720|NCT01432457|3744932|B3||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3921721|NCT01432457|3744933|B2||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3921722|NCT01432457|3744934|B1||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
3921723|NCT01432457|3744931|B4|||Age||Years|Mean|41.60|41.6|Standard Deviation|12.92|12.92|||
3921724|NCT01432457|3744932|B3|||Age||Years|Mean|41.30|41.3|Standard Deviation|12.80|12.8|||
3921725|NCT01432457|3744933|B2|||Age||Years|Mean|41.78|41.78|Standard Deviation|13.56|13.56|||
3921726|NCT01432457|3744934|B1|||Age||Years|Mean|41.72|41.72|Standard Deviation|12.42|12.42|||
3921727|NCT01432444|3744965|B1||Male|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
3921728|NCT01432444|3744965|B1||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3921729|NCT01432444|3744965|B1|||Age||Years|Mean|42.1|42.1|Standard Deviation|12.0|12.0|||
3921730|NCT01432405|3744977|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
3921731|NCT01432405|3744978|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3921732|NCT01432405|3744979|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3921733|NCT01432405|3744977|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3921734|NCT01432405|3744978|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3921735|NCT01432405|3744979|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3921736|NCT01432405|3744977|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3921737|NCT01432405|3744978|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3921738|NCT01432405|3744979|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3921739|NCT01432405|3744977|B3|||Age||years|Mean|52|52.0|Standard Deviation|3|3.0|||
3921740|NCT01432405|3744978|B2|||Age||years|Mean|55|55.0|Standard Deviation|3|3.0|||
3921741|NCT01432405|3744979|B1|||Age||years|Mean|49|49.0|Standard Deviation|3|3.0|||
3921742|NCT01432405|3744977|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3921743|NCT01432405|3744978|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3921744|NCT01432405|3744979|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3921745|NCT01432405|3744977|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3921746|NCT01432405|3744978|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3921747|NCT01432405|3744979|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3921748|NCT01432405|3744977|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921749|NCT01432405|3744978|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921750|NCT01432405|3744979|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921751|NCT01432379|3744988|B1||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3921752|NCT01432379|3744988|B1||Female|Sex: Female, Male||Participants|Count of Participants|977|977.0||||||
3921753|NCT01432379|3744988|B1|||Age||Years|Mean|46.6|46.6|Standard Deviation|11.75|11.75|||
3921754|NCT01432366|3744993|B1||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3921755|NCT01432366|3744993|B1||Female|Sex: Female, Male||Participants|Count of Participants|336|336.0||||||
3921756|NCT01432366|3744993|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|12.4|12.4|||
3921757|NCT01432327|3745011|B5|Belgium||Region of Enrollment||participants|Number|227|227.0||||||
3921758|NCT01432327|3745012|B4|Belgium||Region of Enrollment||participants|Number|57|57.0||||||
3921759|NCT01432327|3745013|B3|Belgium||Region of Enrollment||participants|Number|57|57.0||||||
3921760|NCT01432327|3745014|B2|Belgium||Region of Enrollment||participants|Number|57|57.0||||||
3921761|NCT01432327|3745015|B1|Belgium||Region of Enrollment||participants|Number|56|56.0||||||
3921762|NCT01432327|3745011|B5||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3921763|NCT01432327|3745012|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3921764|NCT01432327|3745013|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3921765|NCT01432327|3745014|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3921766|NCT01432327|3745015|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3921767|NCT01432327|3745011|B5||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3921768|NCT01432327|3745012|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3921769|NCT01432327|3745013|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3921770|NCT01432327|3745014|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3921771|NCT01432327|3745015|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3921772|NCT01432327|3745011|B5|||Age||years|Mean|41|41.0|Standard Deviation|11|11.0|||
3921773|NCT01432327|3745012|B4|||Age||years|Mean|41|41.0|Standard Deviation|10|10.0|||
3921774|NCT01432327|3745013|B3|||Age||years|Mean|44|44.0|Standard Deviation|10|10.0|||
3921775|NCT01432327|3745014|B2|||Age||years|Mean|43|43.0|Standard Deviation|11|11.0|||
3921776|NCT01432327|3745015|B1|||Age||years|Mean|40|40.0|Standard Deviation|11|11.0|||
3921777|NCT01432327|3745011|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3921778|NCT01432327|3745012|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3921779|NCT01432327|3745013|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3921780|NCT01432327|3745014|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3921781|NCT01432327|3745015|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3921782|NCT01432327|3745011|B5||Between 18 and 65 years|Age||Participants|Count of Participants|227|227.0||||||
3921783|NCT01432327|3745012|B4||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
3921784|NCT01432327|3745013|B3||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
3921785|NCT01432327|3745014|B2||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
3921786|NCT01432327|3745015|B1||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
3921787|NCT01432327|3745011|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921788|NCT01432327|3745012|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921789|NCT01432327|3745013|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921790|NCT01432327|3745014|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921791|NCT01432327|3745015|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921792|NCT01432275|3745028|B1|Type 2||Type of Diabetes||participants|Number|36|36.0||||||
3921793|NCT01432275|3745028|B1|Type 1||Type of Diabetes||participants|Number|128|128.0||||||
3921794|NCT01432275|3745028|B1|United Kingdom||Region of Enrollment||participants|Number|164|164.0||||||
3921795|NCT01432275|3745028|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3921796|NCT01432275|3745028|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3921797|NCT01432275|3745028|B1|||Age||years|Mean|48.8|48.8|Standard Deviation|13.0|13.0|||
3921798|NCT01432275|3745028|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3921799|NCT01432275|3745028|B1||Between 18 and 65 years|Age||Participants|Count of Participants|145|145.0||||||
3921800|NCT01432275|3745028|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921801|NCT01432262|3745036|B3||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3921802|NCT01432262|3745037|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3921803|NCT01432262|3745038|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3921804|NCT01432262|3745036|B3||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3921805|NCT01432262|3745037|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3921806|NCT01432262|3745038|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3921807|NCT01432262|3745036|B3|||Age||years|Mean|64.5|64.5|Standard Deviation|10.1|10.1|||
3921808|NCT01432262|3745037|B2|||Age||years|Mean|73.4|73.4|Standard Deviation|5.8|5.8|||
3921809|NCT01432262|3745038|B1|||Age||years|Mean|55.7|55.7|Standard Deviation|4.0|4.0|||
3921810|NCT01432236|3745055|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3921811|NCT01432236|3745056|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3921812|NCT01432236|3745057|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3921813|NCT01432236|3745055|B3||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3921814|NCT01432236|3745056|B2||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3921815|NCT01432236|3745057|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3921816|NCT01432236|3745055|B3|>= 65 Years||Age, Customized||Participants|Number|13|13.0||||||
3921817|NCT01432236|3745056|B2|>= 65 Years||Age, Customized||Participants|Number|8|8.0||||||
3921818|NCT01432236|3745057|B1|>= 65 Years||Age, Customized||Participants|Number|5|5.0||||||
3921819|NCT01432236|3745055|B3|45-64 Years||Age, Customized||Participants|Number|129|129.0||||||
3921820|NCT01432236|3745056|B2|45-64 Years||Age, Customized||Participants|Number|60|60.0||||||
3921821|NCT01432236|3745057|B1|45-64 Years||Age, Customized||Participants|Number|69|69.0||||||
3921822|NCT01432236|3745055|B3|18-44 Years||Age, Customized||Participants|Number|51|51.0||||||
3921823|NCT01432236|3745056|B2|18-44 Years||Age, Customized||Participants|Number|29|29.0||||||
3921824|NCT01432236|3745057|B1|18-44 Years||Age, Customized||Participants|Number|22|22.0||||||
3921825|NCT01432236|3745055|B3|< 18 Years||Age, Customized||Participants|Number|0|0.0||||||
3921826|NCT01432236|3745056|B2|< 18 Years||Age, Customized||Participants|Number|0|0.0||||||
3921827|NCT01432236|3745057|B1|< 18 Years||Age, Customized||Participants|Number|0|0.0||||||
3921828|NCT01432171|3745103|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
3921829|NCT01432171|3745104|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3921830|NCT01432171|3745105|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3921831|NCT01432171|3745103|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3921832|NCT01432171|3745104|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3921833|NCT01432171|3745105|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3921834|NCT01432171|3745103|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921835|NCT01432171|3745104|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921836|NCT01432171|3745105|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921837|NCT01432171|3745103|B3||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3921838|NCT01432171|3745104|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3921839|NCT01432171|3745105|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3921840|NCT01432171|3745103|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3921841|NCT01432171|3745104|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921842|NCT01432171|3745105|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3921843|NCT01432171|3745103|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921844|NCT01432171|3745104|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921845|NCT01432171|3745105|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921846|NCT01432171|3745103|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921847|NCT01432171|3745104|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921848|NCT01432171|3745105|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921908|NCT01431989|3745123|B1|||Age||Years|Mean|34.54|34.54|Standard Deviation|7.38|7.38|||
3921849|NCT01432171|3745103|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921850|NCT01432171|3745104|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921851|NCT01432171|3745105|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921852|NCT01432171|3745103|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3921853|NCT01432171|3745104|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3921854|NCT01432171|3745105|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3921855|NCT01432171|3745103|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921856|NCT01432171|3745104|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921857|NCT01432171|3745105|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921858|NCT01432171|3745103|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921859|NCT01432171|3745104|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921860|NCT01432171|3745105|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921861|NCT01432171|3745103|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3921862|NCT01432171|3745104|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3921863|NCT01432171|3745105|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3921864|NCT01432171|3745103|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3921865|NCT01432171|3745104|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3921866|NCT01432171|3745105|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3921867|NCT01432171|3745103|B3|||Age||years|Mean|57|57.0|Standard Deviation|11|11.0|||
3921868|NCT01432171|3745104|B2|||Age||years|Mean|60|60.0|Standard Deviation|10|10.0|||
3921869|NCT01432171|3745105|B1|||Age||years|Mean|54|54.0|Standard Deviation|12|12.0|||
3921870|NCT01432171|3745103|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3921871|NCT01432171|3745104|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3921872|NCT01432171|3745105|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3921873|NCT01432171|3745103|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3921874|NCT01432171|3745104|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3921875|NCT01432171|3745105|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3921876|NCT01432171|3745103|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921877|NCT01432171|3745104|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921878|NCT01432171|3745105|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921879|NCT01432015|3745112|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3921880|NCT01432015|3745113|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3921881|NCT01432015|3745114|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3921882|NCT01432015|3745112|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921883|NCT01432015|3745113|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921884|NCT01432015|3745114|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921885|NCT01432015|3745112|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3921886|NCT01432015|3745113|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3921887|NCT01432015|3745114|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3921888|NCT01432015|3745112|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3921889|NCT01432015|3745113|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3921890|NCT01432015|3745114|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3921891|NCT01432015|3745112|B3|Female||Sex/Gender, Customized||participants|Number|20|20.0||||||
3921892|NCT01432015|3745113|B2|Female||Sex/Gender, Customized||participants|Number|10|10.0||||||
3921893|NCT01432015|3745114|B1|Female||Sex/Gender, Customized||participants|Number|10|10.0||||||
3921894|NCT01432015|3745112|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3921895|NCT01432015|3745113|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3921896|NCT01432015|3745114|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3921897|NCT01432015|3745112|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3921898|NCT01432015|3745113|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3921899|NCT01432015|3745114|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3921900|NCT01432015|3745112|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921901|NCT01432015|3745113|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921902|NCT01432015|3745114|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921903|NCT01431989|3745123|B1|Mulatto||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3921904|NCT01431989|3745123|B1|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3921905|NCT01431989|3745123|B1|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3921906|NCT01431989|3745123|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3921907|NCT01431989|3745123|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3921909|NCT01431976|3745142|B1|South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3921910|NCT01431976|3745142|B1|Japanese Heritage||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3921911|NCT01431976|3745142|B1|East Asian Heritage||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3921912|NCT01431976|3745142|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3921913|NCT01431976|3745142|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3921914|NCT01431976|3745142|B1|||Age||Years|Mean|7.7|7.7|Standard Deviation|1.95|1.95|||
3921915|NCT01431963|3745153|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized|Baseline data were collected in members of the Safety Population, comprised of all participants who had taken at least one dose of investigational product.|participants|Number|39|39.0||||||
3921916|NCT01431963|3745153|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized|Baseline data were collected in members of the Safety Population, comprised of all participants who had taken at least one dose of investigational product.|participants|Number|26|26.0||||||
3921917|NCT01431963|3745153|B1||Male|Sex: Female, Male|Baseline data were collected in members of the Safety Population, comprised of all participants who had taken at least one dose of investigational product.|Participants|Count of Participants|39|39.0||||||
3921918|NCT01431963|3745153|B1||Female|Sex: Female, Male|Baseline data were collected in members of the Safety Population, comprised of all participants who had taken at least one dose of investigational product.|Participants|Count of Participants|26|26.0||||||
3921919|NCT01431963|3745153|B1|||Age|Baseline data were collected in members of the Safety Population, comprised of all participants who had taken at least one dose of investigational product.|Years|Mean|37.3|37.3|Standard Deviation|20.20|20.2|||
3921920|NCT01431950|3745159|B3|American Indian or Alaska Native & White||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
3921921|NCT01431950|3745160|B2|American Indian or Alaska Native & White||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3921922|NCT01431950|3745161|B1|American Indian or Alaska Native & White||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3921923|NCT01431950|3745159|B3|White||Race/Ethnicity, Customized||Participants|Number|201|201.0||||||
3921924|NCT01431950|3745160|B2|White||Race/Ethnicity, Customized||Participants|Number|100|100.0||||||
3921925|NCT01431950|3745161|B1|White||Race/Ethnicity, Customized||Participants|Number|101|101.0||||||
3921926|NCT01431950|3745159|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3921927|NCT01431950|3745160|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3921928|NCT01431950|3745161|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3921929|NCT01431950|3745159|B3|Japanese/East Asian HER /South East Asian HER||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3921930|NCT01431950|3745160|B2|Japanese/East Asian HER /South East Asian HER||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3921931|NCT01431950|3745161|B1|Japanese/East Asian HER /South East Asian HER||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3921932|NCT01431950|3745159|B3|Central/South Asian HER||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3921933|NCT01431950|3745160|B2|Central/South Asian HER||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3921934|NCT01431950|3745161|B1|Central/South Asian HER||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3921935|NCT01431950|3745159|B3|African American/African Heritage (HER)||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3921936|NCT01431950|3745160|B2|African American/African Heritage (HER)||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3921937|NCT01431950|3745161|B1|African American/African Heritage (HER)||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3921938|NCT01431950|3745159|B3||Male|Gender||Participants|Count of Participants|78|78.0||||||
3921939|NCT01431950|3745160|B2||Male|Gender||Participants|Count of Participants|40|40.0||||||
3921940|NCT01431950|3745161|B1||Male|Gender||Participants|Count of Participants|38|38.0||||||
3921941|NCT01431950|3745159|B3||Female|Gender||Participants|Count of Participants|160|160.0||||||
3921942|NCT01431950|3745160|B2||Female|Gender||Participants|Count of Participants|79|79.0||||||
3921943|NCT01431950|3745161|B1||Female|Gender||Participants|Count of Participants|81|81.0||||||
3921944|NCT01431950|3745159|B3|||Age||Years|Mean|45.9|45.9|Standard Deviation|15.58|15.58|||
3921945|NCT01431950|3745160|B2|||Age||Years|Mean|45.1|45.1|Standard Deviation|15.78|15.78|||
3921946|NCT01431950|3745161|B1|||Age||Years|Mean|46.6|46.6|Standard Deviation|15.41|15.41|||
3921947|NCT01431846|3745176|B4|United States||Region of Enrollment||participants|Number|19|19.0||||||
3921948|NCT01431846|3745177|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3921949|NCT01431846|3745178|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3921950|NCT01431846|3745179|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3921951|NCT01431846|3745176|B4||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3921952|NCT01431846|3745177|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3921953|NCT01431846|3745178|B2||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||gender of provider not collected
3921954|NCT01431846|3745179|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3921955|NCT01431846|3745176|B4||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3921956|NCT01431846|3745177|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3921957|NCT01431846|3745178|B2||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||gender of provider not collected
3921958|NCT01431846|3745179|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3922063|NCT01431391|3745255|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3921959|NCT01431846|3745176|B4|>=65 years||Age||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3921960|NCT01431846|3745177|B3|>=65 years||Age||participants|Number|8|8.0||||||
3921961|NCT01431846|3745178|B2|>=65 years||Age||participants|Number|NA|||||||provider age not collected
3921962|NCT01431846|3745179|B1|>=65 years||Age||participants|Number|8|8.0||||||
3921963|NCT01431846|3745176|B4|Between 18 and 65 years||Age||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3921964|NCT01431846|3745177|B3|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
3921965|NCT01431846|3745178|B2|Between 18 and 65 years||Age||participants|Number|NA|||||||provider age not collected
3921966|NCT01431846|3745179|B1|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
3921967|NCT01431846|3745176|B4|<=18 years||Age||participants|Number|0|0.0||||||
3921968|NCT01431846|3745177|B3|<=18 years||Age||participants|Number|0|0.0||||||
3921969|NCT01431846|3745178|B2|<=18 years||Age||participants|Number|0|0.0||||||
3921970|NCT01431846|3745179|B1|<=18 years||Age||participants|Number|0|0.0||||||
3921971|NCT01431755|3745189|B1|Sweden||Region of Enrollment||participants|Number|54|54.0||||||
3921972|NCT01431755|3745189|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3921973|NCT01431755|3745189|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3921974|NCT01431755|3745189|B1|||Age||years|Mean|53|53.0|Standard Deviation|13.1|13.1|||
3921975|NCT01431755|3745189|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3921976|NCT01431755|3745189|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3921977|NCT01431755|3745189|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921978|NCT01431716|3745200|B1|Italy||Region of Enrollment||participants|Number|2|2.0||||||
3921979|NCT01431716|3745200|B1|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
3921980|NCT01431716|3745200|B1|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
3921981|NCT01431716|3745200|B1|Spain||Region of Enrollment||participants|Number|2|2.0||||||
3921982|NCT01431716|3745200|B1|Canada||Region of Enrollment||participants|Number|8|8.0||||||
3921983|NCT01431716|3745200|B1|France||Region of Enrollment||participants|Number|20|20.0||||||
3921984|NCT01431716|3745200|B1|Not Collected||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3921985|NCT01431716|3745200|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3921986|NCT01431716|3745200|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3921987|NCT01431716|3745200|B1|White/Caucasian||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3921988|NCT01431716|3745200|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3921989|NCT01431716|3745200|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3921990|NCT01431716|3745200|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3921991|NCT01431716|3745200|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3921992|NCT01431716|3745200|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3921993|NCT01431716|3745200|B1|||Age||years|Mean|44.8|44.8|Standard Deviation|13.9|13.9|||
3921994|NCT01431703|3745217|B1|China||Region of Enrollment||participants|Number|326|326.0||||||
3921995|NCT01431703|3745217|B1||Male|Gender||Participants|Count of Participants|195|195.0||||||
3921996|NCT01431703|3745217|B1||Female|Gender||Participants|Count of Participants|131|131.0||||||
3921997|NCT01431703|3745217|B1|||Age||years|Mean|57.4|57.4|Standard Deviation|10.9|10.9|||
3921998|NCT01431703|3745217|B1||>=65 years|Age||Participants|Count of Participants|97|97.0||||||
3921999|NCT01431703|3745217|B1||Between 18 and 65 years|Age||Participants|Count of Participants|229|229.0||||||
3922000|NCT01431703|3745217|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922001|NCT01431521|3745221|B5||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3922002|NCT01431521|3745222|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3922003|NCT01431521|3745223|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3922004|NCT01431521|3745224|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3922005|NCT01431521|3745225|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3922006|NCT01431521|3745221|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3922007|NCT01431521|3745222|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3922008|NCT01431521|3745223|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3922009|NCT01431521|3745224|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3922010|NCT01431521|3745225|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3922011|NCT01431521|3745221|B5|||Age||Years|Mean|42.3|42.3|Standard Deviation|10.5|10.5|||
3922012|NCT01431521|3745222|B4|||Age||Years|Mean|47.8|47.8|Standard Deviation|10.6|10.6|||
3922013|NCT01431521|3745223|B3|||Age||Years|Mean|43.7|43.7|Standard Deviation|12.1|12.1|||
3922014|NCT01431521|3745224|B2|||Age||Years|Mean|48.0|48.0|Standard Deviation|7.6|7.6|||
3922015|NCT01431521|3745225|B1|||Age||Years|Mean|35.1|35.1|Standard Deviation|5.8|5.8|||
3922016|NCT01431508|3745249|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3922017|NCT01431508|3745249|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3922018|NCT01431508|3745249|B1|||Age||years|Mean|50.5|50.5|Standard Deviation|6.7|6.7|||
3922064|NCT01431391|3745253|B3|||Age||years|Mean|65.8|65.8|Standard Deviation|0.9|0.9|||
3922065|NCT01431391|3745254|B2|||Age||years|Mean|66.2|66.2|Standard Deviation|1.1|1.1|||
3922066|NCT01431391|3745255|B1|||Age||years|Mean|65.4|65.4|Standard Deviation|1.4|1.4|||
3922019|NCT01431391|3745253|B3|Gleason Score ≥ 8||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|17|17.0||||||
3922020|NCT01431391|3745254|B2|Gleason Score ≥ 8||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|9|9.0||||||
3922021|NCT01431391|3745255|B1|Gleason Score ≥ 8||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|8|8.0||||||
3922022|NCT01431391|3745253|B3|Gleason Score = 7||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|44|44.0||||||
3922023|NCT01431391|3745254|B2|Gleason Score = 7||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|21|21.0||||||
3922024|NCT01431391|3745255|B1|Gleason Score = 7||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|23|23.0||||||
3922025|NCT01431391|3745253|B3|Gleason Score ≤ 6||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|7|7.0||||||
3922026|NCT01431391|3745254|B2|Gleason Score ≤ 6||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|4|4.0||||||
3922027|NCT01431391|3745255|B1|Gleason Score ≤ 6||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|3|3.0||||||
3922028|NCT01431391|3745253|B3|ECOG 1= Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|1|1.0||||||
3922067|NCT01431339|3745264|B3||Male|Sex: Female, Male||Participants|Count of Participants|424|424.0||||||
3922068|NCT01431339|3745265|B2||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3922069|NCT01431339|3745266|B1||Male|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
3922070|NCT01431339|3745264|B3||Female|Sex: Female, Male||Participants|Count of Participants|315|315.0||||||
3922029|NCT01431391|3745254|B2|ECOG 1= Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|0|0.0||||||
3922030|NCT01431391|3745255|B1|ECOG 1= Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|1|1.0||||||
3922031|NCT01431391|3745253|B3|ECOG 0=Fully Active; No restrictions.||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|67|67.0||||||
3922032|NCT01431391|3745254|B2|ECOG 0=Fully Active; No restrictions.||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|34|34.0||||||
3922033|NCT01431391|3745255|B1|ECOG 0=Fully Active; No restrictions.||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|33|33.0||||||
3922034|NCT01431391|3745253|B3|United States||Region of Enrollment||Participants|Count of Participants|68|68.0||||||
3922035|NCT01431391|3745254|B2|United States||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3922036|NCT01431391|3745255|B1|United States||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3922037|NCT01431391|3745253|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922038|NCT01431391|3745254|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922039|NCT01431391|3745255|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922040|NCT01431391|3745253|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922041|NCT01431391|3745254|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922042|NCT01431391|3745255|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922043|NCT01431391|3745253|B3||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3922044|NCT01431391|3745254|B2||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3922045|NCT01431391|3745255|B1||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3922046|NCT01431391|3745253|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922047|NCT01431391|3745254|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922048|NCT01431391|3745255|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922049|NCT01431391|3745253|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922050|NCT01431391|3745254|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922051|NCT01431391|3745255|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922052|NCT01431391|3745253|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922053|NCT01431391|3745254|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922054|NCT01431391|3745255|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922055|NCT01431391|3745253|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922056|NCT01431391|3745254|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922057|NCT01431391|3745255|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922058|NCT01431391|3745253|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3922059|NCT01431391|3745254|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3922060|NCT01431391|3745255|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3922061|NCT01431391|3745253|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3922062|NCT01431391|3745254|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3922071|NCT01431339|3745265|B2||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3922072|NCT01431339|3745266|B1||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3922073|NCT01431339|3745264|B3|||Age||years|Mean|50.2|50.2|Standard Deviation|16.38|16.38|||
3922074|NCT01431339|3745265|B2|||Age||years|Mean|51.4|51.4|Standard Deviation|16.16|16.16|||
3922075|NCT01431339|3745266|B1|||Age||years|Mean|49.1|49.1|Standard Deviation|16.54|16.54|||
3922076|NCT01431300|3745279|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3922077|NCT01431300|3745280|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3922078|NCT01431300|3745281|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3922079|NCT01431300|3745282|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3922080|NCT01431300|3745279|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3922081|NCT01431300|3745280|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3922082|NCT01431300|3745281|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3922083|NCT01431300|3745282|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3922084|NCT01431300|3745279|B4|||Age||years|Mean|23.4|23.4|Standard Deviation|6.8|6.8|||
3922085|NCT01431300|3745280|B3|||Age||years|Mean|24.1|24.1|Standard Deviation|7.5|7.5|||
3922086|NCT01431300|3745281|B2|||Age||years|Mean|24.6|24.6|Standard Deviation|8.1|8.1|||
3922087|NCT01431300|3745282|B1|||Age||years|Mean|22.2|22.2|Standard Deviation|5.3|5.3|||
3922088|NCT01431300|3745279|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922089|NCT01431300|3745280|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922090|NCT01431300|3745281|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922091|NCT01431300|3745282|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922092|NCT01431300|3745279|B4||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3922093|NCT01431300|3745280|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3922094|NCT01431300|3745281|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3922095|NCT01431300|3745282|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3922096|NCT01431300|3745279|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922097|NCT01431300|3745280|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922098|NCT01431300|3745281|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922099|NCT01431300|3745282|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922100|NCT01431287|3745295|B6||Male|Sex: Female, Male||Participants|Count of Participants|1828|1828.0||||||
3922101|NCT01431287|3745296|B5||Male|Sex: Female, Male||Participants|Count of Participants|349|349.0||||||
3922102|NCT01431287|3745297|B4||Male|Sex: Female, Male||Participants|Count of Participants|368|368.0||||||
3922103|NCT01431287|3745298|B3||Male|Sex: Female, Male||Participants|Count of Participants|372|372.0||||||
3922104|NCT01431287|3745299|B2||Male|Sex: Female, Male||Participants|Count of Participants|361|361.0||||||
3922105|NCT01431287|3745300|B1||Male|Sex: Female, Male||Participants|Count of Participants|378|378.0||||||
3922106|NCT01431287|3745295|B6||Female|Sex: Female, Male||Participants|Count of Participants|710|710.0||||||
3922107|NCT01431287|3745296|B5||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3922108|NCT01431287|3745297|B4||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3922109|NCT01431287|3745298|B3||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3922110|NCT01431287|3745299|B2||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3922111|NCT01431287|3745300|B1||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3922112|NCT01431287|3745295|B6|||Age||years|Mean|63.8|63.8|Standard Deviation|8.4|8.4|||
3922113|NCT01431287|3745296|B5|||Age||years|Mean|62.7|62.7|Standard Deviation|8.4|8.4|||
3922114|NCT01431287|3745297|B4|||Age||years|Mean|64.1|64.1|Standard Deviation|7.6|7.6|||
3922115|NCT01431287|3745298|B3|||Age||years|Mean|63.5|63.5|Standard Deviation|8.7|8.7|||
3922116|NCT01431287|3745299|B2|||Age||years|Mean|63.9|63.9|Standard Deviation|8.7|8.7|||
3922117|NCT01431287|3745300|B1|||Age||years|Mean|64.7|64.7|Standard Deviation|8.3|8.3|||
3922118|NCT01431274|3745461|B6||Male|Sex: Female, Male||Participants|Count of Participants|1934|1934.0||||||
3922119|NCT01431274|3745462|B5||Male|Sex: Female, Male||Participants|Count of Participants|384|384.0||||||
3922120|NCT01431274|3745463|B4||Male|Sex: Female, Male||Participants|Count of Participants|389|389.0||||||
3922121|NCT01431274|3745464|B3||Male|Sex: Female, Male||Participants|Count of Participants|383|383.0||||||
3922122|NCT01431274|3745465|B2||Male|Sex: Female, Male||Participants|Count of Participants|392|392.0||||||
3922123|NCT01431274|3745466|B1||Male|Sex: Female, Male||Participants|Count of Participants|386|386.0||||||
3922124|NCT01431274|3745461|B6||Female|Sex: Female, Male||Participants|Count of Participants|690|690.0||||||
3922125|NCT01431274|3745462|B5||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3922126|NCT01431274|3745463|B4||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3922127|NCT01431274|3745464|B3||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3922128|NCT01431274|3745465|B2||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3922129|NCT01431274|3745466|B1||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3922130|NCT01431274|3745461|B6|||Age||years|Mean|64.2|64.2|Standard Deviation|8.3|8.3|||
3922131|NCT01431274|3745462|B5|||Age||years|Mean|64.8|64.8|Standard Deviation|8.2|8.2|||
3922132|NCT01431274|3745463|B4|||Age||years|Mean|64.1|64.1|Standard Deviation|8.0|8.0|||
3922133|NCT01431274|3745464|B3|||Age||years|Mean|64.2|64.2|Standard Deviation|8.5|8.5|||
3922134|NCT01431274|3745465|B2|||Age||years|Mean|64.2|64.2|Standard Deviation|8.6|8.6|||
3922135|NCT01431274|3745466|B1|||Age||years|Mean|63.7|63.7|Standard Deviation|8.0|8.0|||
3922136|NCT01431170|3745627|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
3922137|NCT01431170|3745628|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3922138|NCT01431170|3745629|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3922139|NCT01431170|3745627|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3922140|NCT01431170|3745628|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3922141|NCT01431170|3745629|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3922142|NCT01431170|3745627|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3922143|NCT01431170|3745628|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3922144|NCT01431170|3745629|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3922145|NCT01431170|3745627|B3|||Age||days|Mean|134.71|134.71|Standard Deviation|102.90|102.9|||
3922146|NCT01431170|3745628|B2|||Age||days|Mean|158.58|158.58|Standard Deviation|110.62|110.62|||
3922147|NCT01431170|3745629|B1|||Age||days|Mean|110.83|110.83|Standard Deviation|93.05|93.05|||
3922148|NCT01431170|3745627|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922149|NCT01431170|3745628|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922150|NCT01431170|3745629|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922151|NCT01431170|3745627|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3922152|NCT01431170|3745628|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3922153|NCT01431170|3745629|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3922154|NCT01431170|3745627|B3||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
3922155|NCT01431170|3745628|B2||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
3922156|NCT01431170|3745629|B1||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
3922157|NCT01431144|3745646|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
3922158|NCT01431144|3745647|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3922159|NCT01431144|3745648|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3922160|NCT01431144|3745646|B3||Male|Gender||Participants|Count of Participants|11|11.0||||||
3922161|NCT01431144|3745647|B2||Male|Gender||Participants|Count of Participants|5|5.0||||||
3922162|NCT01431144|3745648|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
3922163|NCT01431144|3745646|B3||Female|Gender||Participants|Count of Participants|16|16.0||||||
3922164|NCT01431144|3745647|B2||Female|Gender||Participants|Count of Participants|9|9.0||||||
3922165|NCT01431144|3745648|B1||Female|Gender||Participants|Count of Participants|7|7.0||||||
3922166|NCT01431144|3745646|B3|||Age||years|Mean|52|52.0|Standard Deviation|16|16.0|||
3922167|NCT01431144|3745647|B2|||Age||years|Mean|57|57.0|Standard Deviation|10|10.0|||
3922168|NCT01431144|3745648|B1|||Age||years|Mean|46|46.0|Standard Deviation|21|21.0|||
3922169|NCT01431144|3745646|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3922170|NCT01431144|3745647|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3922171|NCT01431144|3745648|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3922172|NCT01431144|3745646|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3922173|NCT01431144|3745647|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3922174|NCT01431144|3745648|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3922175|NCT01431144|3745646|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922176|NCT01431144|3745647|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922177|NCT01431144|3745648|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922178|NCT01431131|3745655|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
3922179|NCT01431131|3745656|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3922180|NCT01431131|3745657|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3922181|NCT01431131|3745655|B3||Male|Gender||Participants|Count of Participants|11|11.0||||||
3922182|NCT01431131|3745656|B2||Male|Gender||Participants|Count of Participants|7|7.0||||||
3922183|NCT01431131|3745657|B1||Male|Gender||Participants|Count of Participants|4|4.0||||||
3922184|NCT01431131|3745655|B3||Female|Gender||Participants|Count of Participants|13|13.0||||||
3922185|NCT01431131|3745656|B2||Female|Gender||Participants|Count of Participants|5|5.0||||||
3922186|NCT01431131|3745657|B1||Female|Gender||Participants|Count of Participants|8|8.0||||||
3922187|NCT01431131|3745655|B3|||Age||years|Mean|55|55.0|Standard Deviation|14|14.0|||
3922188|NCT01431131|3745656|B2|||Age||years|Mean|58|58.0|Standard Deviation|11|11.0|||
3922189|NCT01431131|3745657|B1|||Age||years|Mean|52|52.0|Standard Deviation|16|16.0|||
3922190|NCT01431131|3745655|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3922191|NCT01431131|3745656|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3922192|NCT01431131|3745657|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3922193|NCT01431131|3745655|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3922194|NCT01431131|3745656|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3922195|NCT01431131|3745657|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3922196|NCT01431131|3745655|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922197|NCT01431131|3745656|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922198|NCT01431131|3745657|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922199|NCT01431079|3745666|B3|United States||Region of Enrollment||participants|Number|90|90.0||||||
3922200|NCT01431079|3745667|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
3922201|NCT01431079|3745668|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
3922202|NCT01431079|3745666|B3||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3922203|NCT01431079|3745667|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3922204|NCT01431079|3745668|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3922205|NCT01431079|3745666|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3922206|NCT01431079|3745667|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3922207|NCT01431079|3745668|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3922208|NCT01431079|3745666|B3|||Age||years|Mean|20.2|20.2|Standard Deviation|1.14|1.14|||
3922209|NCT01431079|3745667|B2|||Age||years|Mean|20.6|20.6|Standard Deviation|2.44|2.44|||
3922210|NCT01431079|3745668|B1|||Age||years|Mean|19.76|19.76|Standard Deviation|1.04|1.04|||
3922211|NCT01431079|3745666|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922212|NCT01431079|3745667|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922213|NCT01431079|3745668|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922214|NCT01431079|3745666|B3||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
3922215|NCT01431079|3745667|B2||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3922216|NCT01431079|3745668|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3922217|NCT01431079|3745666|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922218|NCT01431079|3745667|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922219|NCT01431079|3745668|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922220|NCT01431014|3745721|B3|Taiwan||Region of Enrollment||participants|Number|56|56.0||||||
3922221|NCT01431014|3745722|B2|Taiwan||Region of Enrollment||participants|Number|25|25.0||||||
3922222|NCT01431014|3745723|B1|Taiwan||Region of Enrollment||participants|Number|31|31.0||||||
3922223|NCT01431014|3745721|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3922224|NCT01431014|3745722|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3922225|NCT01431014|3745723|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3922226|NCT01431014|3745721|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3922227|NCT01431014|3745722|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3922228|NCT01431014|3745723|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3922229|NCT01431014|3745721|B3|||Age||years|Mean|22.16|22.16|Standard Deviation|4.6|4.6|||
3922230|NCT01431014|3745722|B2|||Age||years|Mean|20.92|20.92|Standard Deviation|4.79|4.79|||
3922231|NCT01431014|3745723|B1|||Age||years|Mean|23.16|23.16|Standard Deviation|4.19|4.19|||
3922232|NCT01431014|3745721|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922233|NCT01431014|3745722|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922234|NCT01431014|3745723|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922235|NCT01431014|3745721|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3922236|NCT01431014|3745722|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3922237|NCT01431014|3745723|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3922238|NCT01431014|3745721|B3||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3922239|NCT01431014|3745722|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3922240|NCT01431014|3745723|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3922241|NCT01430819|3745730|B3|United States||Region of Enrollment||Participants|Number|300|300.0||||||
3922242|NCT01430819|3745731|B2|United States||Region of Enrollment||Participants|Number|150|150.0||||||
3922243|NCT01430819|3745732|B1|United States||Region of Enrollment||Participants|Number|150|150.0||||||
3922244|NCT01430819|3745730|B3||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3922245|NCT01430819|3745731|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3922246|NCT01430819|3745732|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3922247|NCT01430819|3745730|B3||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3922248|NCT01430819|3745731|B2||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3922249|NCT01430819|3745732|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3922250|NCT01430819|3745730|B3|||Age||Months|Mean|72.1|72.1|Standard Deviation|5.3|5.3|||
3922251|NCT01430819|3745731|B2|||Age||Months|Mean|71.6|71.6|Standard Deviation|4.8|4.8|||
3922252|NCT01430819|3745732|B1|||Age||Months|Mean|72.6|72.6|Standard Deviation|5.8|5.8|||
3922253|NCT01430819|3745730|B3||>=65 years|Age||Participants|Count of Participants|300|300.0||||||
3922254|NCT01430819|3745731|B2||>=65 years|Age||Participants|Count of Participants|150|150.0||||||
3922255|NCT01430819|3745732|B1||>=65 years|Age||Participants|Count of Participants|150|150.0||||||
3922256|NCT01430819|3745730|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3922257|NCT01430819|3745731|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3922258|NCT01430819|3745732|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3922259|NCT01430819|3745730|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922260|NCT01430819|3745731|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922261|NCT01430819|3745732|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922262|NCT01430754|3745745|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3922263|NCT01430754|3745746|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3922264|NCT01430754|3745747|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3922265|NCT01430754|3745748|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3922266|NCT01430754|3745745|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3922267|NCT01430754|3745746|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3922268|NCT01430754|3745747|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3922269|NCT01430754|3745748|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3922270|NCT01430754|3745745|B4|||Age||years|Mean|52.1|52.1|Standard Deviation|12.71|12.71|||
3922271|NCT01430754|3745746|B3|||Age||years|Mean|52.1|52.1|Standard Deviation|12.01|12.01|||
3922272|NCT01430754|3745747|B2|||Age||years|Mean|51.3|51.3|Standard Deviation|12.87|12.87|||
3922273|NCT01430754|3745748|B1|||Age||years|Mean|52.4|52.4|Standard Deviation|13.18|13.18|||
3922274|NCT01430741|3745767|B5|Unknown||Sex/Gender, Customized||participants|Number|227|227.0||||||
3922275|NCT01430741|3745768|B4|Unknown||Sex/Gender, Customized||participants|Number|81|81.0||||||
3922276|NCT01430741|3745769|B3|Unknown||Sex/Gender, Customized||participants|Number|37|37.0||||||
3922277|NCT01430741|3745770|B2|Unknown||Sex/Gender, Customized||participants|Number|87|87.0||||||
3922278|NCT01430741|3745771|B1|Unknown||Sex/Gender, Customized||participants|Number|22|22.0||||||
3922279|NCT01430741|3745767|B5|||Age||years|Mean|52.8|52.8|Standard Deviation|10.6|10.6|||
3922280|NCT01430741|3745768|B4|||Age||years|Mean|55.9|55.9|Standard Deviation|9.5|9.5|||
3922281|NCT01430741|3745770|B2|||Age||years|Mean|49.7|49.7|Standard Deviation|10.8|10.8|||
3922282|NCT01430624|3745804|B4|United States||Region of Enrollment||participants|Number|233|233.0||||||
3922283|NCT01430624|3745805|B3|United States||Region of Enrollment||participants|Number|79|79.0||||||
3922284|NCT01430624|3745806|B2|United States||Region of Enrollment||participants|Number|77|77.0||||||
3922285|NCT01430624|3745807|B1|United States||Region of Enrollment||participants|Number|77|77.0||||||
3922286|NCT01430624|3745804|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3922287|NCT01430624|3745805|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3922288|NCT01430624|3745806|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3922289|NCT01430624|3745807|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3922290|NCT01430624|3745804|B4||Female|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
3922291|NCT01430624|3745805|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3922292|NCT01430624|3745806|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3922293|NCT01430624|3745807|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3922294|NCT01430624|3745804|B4|||Age||years|Mean|27.43|27.43|Standard Deviation|9.70|9.7|||
3922295|NCT01430624|3745805|B3|||Age||years|Mean|27.52|27.52|Standard Deviation|10.01|10.01|||
3922296|NCT01430624|3745806|B2|||Age||years|Mean|27.99|27.99|Standard Deviation|10.77|10.77|||
3922297|NCT01430624|3745807|B1|||Age||years|Mean|26.79|26.79|Standard Deviation|8.22|8.22|||
3922298|NCT01430624|3745804|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922299|NCT01430624|3745805|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922300|NCT01430624|3745806|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922301|NCT01430624|3745807|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922302|NCT01430624|3745804|B4||Between 18 and 65 years|Age||Participants|Count of Participants|223|223.0||||||
3922303|NCT01430624|3745805|B3||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
3922304|NCT01430624|3745806|B2||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
3922305|NCT01430624|3745807|B1||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
3922306|NCT01430624|3745804|B4||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
3922307|NCT01430624|3745805|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3922308|NCT01430624|3745806|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3922309|NCT01430624|3745807|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3922310|NCT01430611|3745838|B3|China||Region of Enrollment||Participants|Number|665|665.0||||||
3922311|NCT01430611|3745839|B2|China||Region of Enrollment||Participants|Number|333|333.0||||||
3922312|NCT01430611|3745840|B1|China||Region of Enrollment||Participants|Number|332|332.0||||||
3922313|NCT01430611|3745838|B3||Male|Sex: Female, Male||Participants|Count of Participants|388|388.0||||||
3922314|NCT01430611|3745839|B2||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
3922315|NCT01430611|3745840|B1||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3922316|NCT01430611|3745838|B3||Female|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
3922317|NCT01430611|3745839|B2||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3922318|NCT01430611|3745840|B1||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3922319|NCT01430611|3745838|B3|||Age||Years|Mean|3.2|3.2|Standard Deviation|1.1|1.1|||
3922320|NCT01430611|3745839|B2|||Age||Years|Mean|3.1|3.1|Standard Deviation|1.0|1.0|||
3922321|NCT01430611|3745840|B1|||Age||Years|Mean|3.2|3.2|Standard Deviation|1.1|1.1|||
3922322|NCT01430611|3745838|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922323|NCT01430611|3745839|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922324|NCT01430611|3745840|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922325|NCT01430611|3745838|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3922326|NCT01430611|3745839|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3922327|NCT01430611|3745840|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3922328|NCT01430611|3745838|B3||<=18 years|Age||Participants|Count of Participants|665|665.0||||||
3922329|NCT01430611|3745839|B2||<=18 years|Age||Participants|Count of Participants|333|333.0||||||
3922330|NCT01430611|3745840|B1||<=18 years|Age||Participants|Count of Participants|332|332.0||||||
3922331|NCT01430585|3745859|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3922332|NCT01430585|3745859|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3922333|NCT01430585|3745859|B1|||Age||years|Median|60.5|60.5|Full Range|||51.0|86.0|
3922334|NCT01430468|3745892|B3|||Pre-operative retroversion|Degrees of retroversion from 3-D CT scan|Degrees|Mean|-13.0|-13.0|Standard Deviation|11.8|11.8|||
3922335|NCT01430468|3745893|B2|||Pre-operative retroversion|Degrees of retroversion from 3-D CT scan|Degrees|Mean|-11.3|-11.3|Standard Deviation|13.3|13.3|||
3922336|NCT01430468|3745894|B1|||Pre-operative retroversion|Degrees of retroversion from 3-D CT scan|Degrees|Mean|-14.8|-14.8|Standard Deviation|10.1|10.1|||
3922337|NCT01430468|3745892|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
3922338|NCT01430468|3745893|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3922339|NCT01430468|3745894|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3922340|NCT01430468|3745892|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3922341|NCT01430468|3745893|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3922342|NCT01430468|3745894|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3922343|NCT01430468|3745892|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3922344|NCT01430468|3745893|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3922345|NCT01430468|3745894|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3922346|NCT01430468|3745892|B3|||Age||years|Mean|68.2|68.2|Standard Deviation|8.2|8.2|||
3922347|NCT01430468|3745893|B2|||Age||years|Mean|67.3|67.3|Standard Deviation|9.5|9.5|||
3922348|NCT01430468|3745894|B1|||Age||years|Mean|69.1|69.1|Standard Deviation|6.8|6.8|||
3922349|NCT01430455|3745901|B1|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3922350|NCT01430455|3745901|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3922351|NCT01430455|3745901|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3922352|NCT01430455|3745901|B1|||Age||years|Mean|41|41.0|Standard Deviation|15|15.0|||
3922353|NCT01430455|3745901|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922354|NCT01430455|3745901|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3922355|NCT01430455|3745901|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922356|NCT01430403|3745905|B4|United States||Region of Enrollment||participants|Number|478|478.0||||||
3922357|NCT01430403|3745906|B3|United States||Region of Enrollment||participants|Number|89|89.0||||||
3922358|NCT01430403|3745907|B2|United States||Region of Enrollment||participants|Number|130|130.0||||||
3922359|NCT01430403|3745908|B1|United States||Region of Enrollment||participants|Number|259|259.0||||||
3922360|NCT01430403|3745905|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3922361|NCT01430403|3745906|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3922362|NCT01430403|3745907|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3922363|NCT01430403|3745908|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3922364|NCT01430403|3745905|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3922365|NCT01430403|3745906|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3922366|NCT01430403|3745907|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3922367|NCT01430403|3745908|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3922368|NCT01430403|3745905|B4||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3922369|NCT01430403|3745906|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3922370|NCT01430403|3745907|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3922371|NCT01430403|3745908|B1||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3922372|NCT01430403|3745905|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|291|291.0||||||
3922373|NCT01430403|3745906|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3922374|NCT01430403|3745907|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3922375|NCT01430403|3745908|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|152|152.0||||||
3922376|NCT01430403|3745905|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922377|NCT01430403|3745906|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922378|NCT01430403|3745907|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922379|NCT01430403|3745908|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922380|NCT01430403|3745905|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3922381|NCT01430403|3745906|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3922382|NCT01430403|3745907|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922383|NCT01430403|3745908|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3922384|NCT01430403|3745905|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3922385|NCT01430403|3745906|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3922386|NCT01430403|3745907|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3922387|NCT01430403|3745908|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3922388|NCT01430403|3745905|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922389|NCT01430403|3745906|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922390|NCT01430403|3745907|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922391|NCT01430403|3745908|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922392|NCT01430403|3745905|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|317|317.0||||||
3922393|NCT01430403|3745906|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3922394|NCT01430403|3745907|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3922395|NCT01430403|3745908|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|171|171.0||||||
3922396|NCT01430403|3745905|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|161|161.0||||||
3922397|NCT01430403|3745906|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3922398|NCT01430403|3745907|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3922399|NCT01430403|3745908|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3922400|NCT01430403|3745905|B4||Male|Sex: Female, Male||Participants|Count of Participants|303|303.0||||||
3922401|NCT01430403|3745906|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3922402|NCT01430403|3745907|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3922403|NCT01430403|3745908|B1||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3922404|NCT01430403|3745905|B4||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
3922405|NCT01430403|3745906|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3922406|NCT01430403|3745907|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3922407|NCT01430403|3745908|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3922408|NCT01430403|3745905|B4|12-17 years||Age, Customized||participants|Number|119|119.0||||||
3922409|NCT01430403|3745906|B3|12-17 years||Age, Customized||participants|Number|22|22.0||||||
3922410|NCT01430403|3745907|B2|12-17 years||Age, Customized||participants|Number|28|28.0||||||
3922411|NCT01430403|3745908|B1|12-17 years||Age, Customized||participants|Number|69|69.0||||||
3922412|NCT01430403|3745905|B4|6-11 years||Age, Customized||participants|Number|359|359.0||||||
3922413|NCT01430403|3745906|B3|6-11 years||Age, Customized||participants|Number|67|67.0||||||
3922414|NCT01430403|3745907|B2|6-11 years||Age, Customized||participants|Number|102|102.0||||||
3922415|NCT01430403|3745908|B1|6-11 years||Age, Customized||participants|Number|190|190.0||||||
3922416|NCT01430403|3745905|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922417|NCT01430403|3745906|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922418|NCT01430403|3745907|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922419|NCT01430403|3745908|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922420|NCT01430403|3745905|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3922421|NCT01430403|3745906|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3922422|NCT01430403|3745907|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3922423|NCT01430403|3745908|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3922424|NCT01430403|3745905|B4||<=18 years|Age||Participants|Count of Participants|478|478.0||||||
3922425|NCT01430403|3745906|B3||<=18 years|Age||Participants|Count of Participants|89|89.0||||||
3922426|NCT01430403|3745907|B2||<=18 years|Age||Participants|Count of Participants|130|130.0||||||
3922427|NCT01430403|3745908|B1||<=18 years|Age||Participants|Count of Participants|259|259.0||||||
3922428|NCT01430325|3745959|B5|United States||Region of Enrollment||participants|Number|42|42.0||||||
3922429|NCT01430325|3745960|B4|United States||Region of Enrollment||participants|Number|12|12.0||||||
3922430|NCT01430325|3745961|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3922431|NCT01430325|3745962|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3922432|NCT01430325|3745963|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3922433|NCT01430325|3745959|B5||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3922434|NCT01430325|3745960|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3922435|NCT01430325|3745961|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3922436|NCT01430325|3745962|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3922437|NCT01430325|3745963|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3922438|NCT01430325|3745959|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3922439|NCT01430325|3745960|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3922440|NCT01430325|3745961|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3922441|NCT01430325|3745962|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3922442|NCT01430325|3745963|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3922443|NCT01430325|3745959|B5|||Age||years|Mean|46|46.0|Standard Deviation|10|10.0|||
3922444|NCT01430325|3745960|B4|||Age||years|Mean|45|45.0|Standard Deviation|13|13.0|||
3922445|NCT01430325|3745961|B3|||Age||years|Mean|47|47.0|Standard Deviation|9.3|9.3|||
3922446|NCT01430325|3745962|B2|||Age||years|Mean|49|49.0|Standard Deviation|7.8|7.8|||
3922447|NCT01430325|3745963|B1|||Age||years|Mean|45|45.0|Standard Deviation|10|10.0|||
3922448|NCT01430325|3745959|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922449|NCT01430325|3745960|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922450|NCT01430325|3745961|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922451|NCT01430325|3745962|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922452|NCT01430325|3745963|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922453|NCT01430325|3745959|B5||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3922454|NCT01430325|3745960|B4||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3922455|NCT01430325|3745961|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3922456|NCT01430325|3745962|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3922457|NCT01430325|3745963|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3922458|NCT01430325|3745959|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922459|NCT01430325|3745960|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922460|NCT01430325|3745961|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922461|NCT01430325|3745962|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922462|NCT01430325|3745963|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922463|NCT01430299|3745984|B3|United States||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3922464|NCT01430299|3745985|B2|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3922465|NCT01430299|3745986|B1|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3922466|NCT01430299|3745984|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3922467|NCT01430299|3745985|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3922468|NCT01430299|3745986|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3922469|NCT01430299|3745984|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3922470|NCT01430299|3745985|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3922471|NCT01430299|3745986|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3922472|NCT01430299|3745984|B3|participants over 18 years of age||Age, Customized||Participants|Count of Participants|37|37.0||||||
3922473|NCT01430299|3745985|B2|participants over 18 years of age||Age, Customized||Participants|Count of Participants|21|21.0||||||
3922474|NCT01430299|3745986|B1|participants over 18 years of age||Age, Customized||Participants|Count of Participants|16|16.0||||||
3922475|NCT01430182|3745993|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
3922476|NCT01430182|3745994|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3922477|NCT01430182|3745995|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3922478|NCT01430182|3745993|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922479|NCT01430182|3745994|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922480|NCT01430182|3745995|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922481|NCT01430182|3745993|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3922482|NCT01430182|3745994|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3922483|NCT01430182|3745995|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3922484|NCT01430182|3745993|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3922485|NCT01430182|3745994|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3922486|NCT01430182|3745995|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3922487|NCT01430182|3745993|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3922488|NCT01430182|3745994|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3922489|NCT01430182|3745995|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3922490|NCT01430182|3745993|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3922491|NCT01430182|3745994|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3922492|NCT01430182|3745995|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3922493|NCT01430182|3745993|B3|||Age||years|Mean|30.7|30.7|Standard Deviation|8.6|8.6|||
3922494|NCT01430182|3745994|B2|||Age||years|Mean|29.3|29.3|Standard Deviation|10.2|10.2|||
3922495|NCT01430182|3745995|B1|||Age||years|Mean|31.9|31.9|Standard Deviation|7.4|7.4|||
3922496|NCT01430182|3745993|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922497|NCT01430182|3745994|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922498|NCT01430182|3745995|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922499|NCT01430182|3745993|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3922500|NCT01430182|3745994|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3922501|NCT01430182|3745995|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3922502|NCT01430182|3745993|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922503|NCT01430182|3745994|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922504|NCT01430182|3745995|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922505|NCT01430169|3746002|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3922506|NCT01430169|3746002|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3922507|NCT01430169|3746002|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3922508|NCT01430169|3746002|B1|||Age||years|Mean|61.0|61.0|Standard Deviation|8.53|8.53|||
3922509|NCT01430169|3746002|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3922510|NCT01430169|3746002|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3922511|NCT01430169|3746002|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922512|NCT01430130|3746017|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3922513|NCT01430130|3746017|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3922514|NCT01430130|3746017|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3922515|NCT01430130|3746017|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922516|NCT01430130|3746017|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3922517|NCT01430130|3746017|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922518|NCT01430104|3746023|B1|||Mean Urine Calcium Excreted|Baseline calcium measures were assessed on the last day of the 14-day Lead-in Period (Day -1), after participants had been receiving Aspara-CA and Alfarol supplements. One participant was excluded from the analysis because the participant accidentally dropped the urine collection sample during baseline (N=28).|grams per day (g/day)|Mean|0.12|0.12|Standard Deviation|0.05|0.05|||
3922519|NCT01430104|3746023|B1|Urine calcium excreted ≤0.3 g/day||Number of Participants with Urine Calcium Excreted Over 0.3 Grams per Day (g/day)|Baseline calcium measures were assessed over a 24-hour period on the last day of the 14-day Lead-in Period (Day -1), after participants had been receiving Aspara-CA and Alfarol supplements, to determine the total urine calcium excreted per day.|participants|Number|29|29.0||||||
3922520|NCT01430104|3746023|B1|Urine calcium excreted >0.3 g/day||Number of Participants with Urine Calcium Excreted Over 0.3 Grams per Day (g/day)|Baseline calcium measures were assessed over a 24-hour period on the last day of the 14-day Lead-in Period (Day -1), after participants had been receiving Aspara-CA and Alfarol supplements, to determine the total urine calcium excreted per day.|participants|Number|0|0.0||||||
3922521|NCT01430104|3746023|B1|Japan||Region of Enrollment||participants|Number|29|29.0||||||
3922522|NCT01430104|3746023|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922523|NCT01430104|3746023|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922524|NCT01430104|3746023|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922525|NCT01430104|3746023|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922526|NCT01430104|3746023|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922527|NCT01430104|3746023|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3922528|NCT01430104|3746023|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922529|NCT01430104|3746023|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922530|NCT01430104|3746023|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3922531|NCT01430104|3746023|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922532|NCT01430104|3746023|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3922533|NCT01430104|3746023|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3922534|NCT01430104|3746023|B1|||Age||years|Mean|70|70.0|Standard Deviation|4.4|4.4|||
3922535|NCT01430091|3746035|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3922536|NCT01430091|3746035|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922537|NCT01430091|3746035|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3922538|NCT01430091|3746035|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3922539|NCT01430091|3746035|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922540|NCT01430091|3746035|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3922541|NCT01430091|3746035|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3922542|NCT01430091|3746035|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922543|NCT01430091|3746035|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922544|NCT01430091|3746035|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3922545|NCT01430091|3746035|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922546|NCT01430091|3746035|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3922547|NCT01430091|3746035|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3922548|NCT01430091|3746035|B1|||Age||years|Mean|37.1|37.1|Standard Deviation|13.7|13.7|||
3922549|NCT01429987|3746057|B5||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3922550|NCT01429987|3746058|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3922551|NCT01429987|3746059|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3922552|NCT01429987|3746060|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3922553|NCT01429987|3746061|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3922554|NCT01429987|3746057|B5||Female|Sex: Female, Male||Participants|Count of Participants|817|817.0||||||
3922555|NCT01429987|3746058|B4||Female|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
3922556|NCT01429987|3746059|B3||Female|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
3922557|NCT01429987|3746060|B2||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3922558|NCT01429987|3746061|B1||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
3922559|NCT01429987|3746057|B5|||Age||years|Mean|47.1|47.1|Full Range|||18.0|75.0|
3922560|NCT01429987|3746058|B4|||Age||years|Mean|46.3|46.3|Full Range|||19.0|75.0|
3922561|NCT01429987|3746059|B3|||Age||years|Mean|47.1|47.1|Full Range|||18.0|75.0|
3922562|NCT01429987|3746060|B2|||Age||years|Mean|47.1|47.1|Full Range|||18.0|75.0|
3922563|NCT01429987|3746061|B1|||Age||years|Mean|47.8|47.8|Full Range|||20.0|75.0|
3922564|NCT01429792|3746090|B1|Unknown||Sex/Gender, Customized||Participants|Number|1|1.0||||||
3922565|NCT01429792|3746090|B1|Male||Sex/Gender, Customized||Participants|Number|632|632.0||||||
3922566|NCT01429792|3746090|B1|Female||Sex/Gender, Customized||Participants|Number|380|380.0||||||
3922567|NCT01429792|3746090|B1|||Age||Years|Mean|43.6|43.6|Standard Deviation|11.3|11.3|||
3922568|NCT01429623|3746102|B3|Germany||Region of Enrollment||participants|Number|66|66.0||||||
3922569|NCT01429623|3746103|B2|Germany||Region of Enrollment||participants|Number|33|33.0||||||
3922570|NCT01429623|3746104|B1|Germany||Region of Enrollment||participants|Number|33|33.0||||||
3922571|NCT01429623|3746102|B3|Israel||Region of Enrollment||participants|Number|97|97.0||||||
3922572|NCT01429623|3746103|B2|Israel||Region of Enrollment||participants|Number|50|50.0||||||
3922573|NCT01429623|3746104|B1|Israel||Region of Enrollment||participants|Number|47|47.0||||||
3922574|NCT01429623|3746102|B3|Austria||Region of Enrollment||participants|Number|47|47.0||||||
3922575|NCT01429623|3746103|B2|Austria||Region of Enrollment||participants|Number|24|24.0||||||
3922576|NCT01429623|3746104|B1|Austria||Region of Enrollment||participants|Number|23|23.0||||||
3922577|NCT01429623|3746102|B3||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3922578|NCT01429623|3746103|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3922579|NCT01429623|3746104|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3922580|NCT01429623|3746102|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3922581|NCT01429623|3746103|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3922582|NCT01429623|3746104|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3922583|NCT01429623|3746102|B3|||Age||years|Mean|71.35|71.35|Standard Deviation|6.54|6.54|||
3922584|NCT01429623|3746103|B2|||Age||years|Mean|71.4|71.4|Standard Deviation|6.8|6.8|||
3922585|NCT01429623|3746104|B1|||Age||years|Mean|71.3|71.3|Standard Deviation|6.3|6.3|||
3922586|NCT01429623|3746102|B3||>=65 years|Age||Participants|Count of Participants|179|179.0||||||
3922587|NCT01429623|3746103|B2||>=65 years|Age||Participants|Count of Participants|91|91.0||||||
3922588|NCT01429623|3746104|B1||>=65 years|Age||Participants|Count of Participants|88|88.0||||||
3922589|NCT01429623|3746102|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3922590|NCT01429623|3746103|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3922591|NCT01429623|3746104|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3922592|NCT01429623|3746102|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922593|NCT01429623|3746103|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922594|NCT01429623|3746104|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922595|NCT01429584|3746117|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3922596|NCT01429584|3746118|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3922597|NCT01429584|3746119|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3922598|NCT01429584|3746117|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3922599|NCT01429584|3746118|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3922600|NCT01429584|3746119|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3922601|NCT01429584|3746117|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3922602|NCT01429584|3746118|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3922603|NCT01429584|3746119|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3922604|NCT01429584|3746117|B3|||Age||years|Mean|54.7|54.7|Standard Deviation|7.9|7.9|||
3922605|NCT01429584|3746118|B2|||Age||years|Mean|53.6|53.6|Standard Deviation|6.3|6.3|||
3922606|NCT01429584|3746119|B1|||Age||years|Mean|55.6|55.6|Standard Deviation|9.3|9.3|||
3922607|NCT01429532|3746130|B4|China||Region of Enrollment||participants|Number|120|120.0||||||
3922608|NCT01429532|3746131|B3|China||Region of Enrollment||participants|Number|40|40.0||||||
3922609|NCT01429532|3746132|B2|China||Region of Enrollment||participants|Number|40|40.0||||||
3922610|NCT01429532|3746133|B1|China||Region of Enrollment||participants|Number|40|40.0||||||
3922611|NCT01429532|3746130|B4||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3922612|NCT01429532|3746131|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3922613|NCT01429532|3746132|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3922614|NCT01429532|3746133|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3922615|NCT01429532|3746130|B4||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3922616|NCT01429532|3746131|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3922617|NCT01429532|3746132|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3922618|NCT01429532|3746133|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3922619|NCT01429532|3746130|B4|||Age||years|Mean|72.59|72.59|Standard Deviation|6.32|6.32|||
3922620|NCT01429532|3746131|B3|||Age||years|Mean|72.48|72.48|Standard Deviation|6.15|6.15|||
3922621|NCT01429532|3746132|B2|||Age||years|Mean|71.37|71.37|Standard Deviation|7.19|7.19|||
3922622|NCT01429532|3746133|B1|||Age||years|Mean|73.95|73.95|Standard Deviation|6.05|6.05|||
3922623|NCT01429532|3746130|B4||>=65 years|Age||Participants|Count of Participants|84|84.0||||||
3922624|NCT01429532|3746131|B3||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
3922625|NCT01429532|3746132|B2||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
3922626|NCT01429532|3746133|B1||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
3922627|NCT01429532|3746130|B4||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3922628|NCT01429532|3746131|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3922629|NCT01429532|3746132|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3922630|NCT01429532|3746133|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3922631|NCT01429532|3746130|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922632|NCT01429532|3746131|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922633|NCT01429532|3746132|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922634|NCT01429532|3746133|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922635|NCT01429441|3746149|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3922636|NCT01429441|3746150|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3922637|NCT01429441|3746151|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3922638|NCT01429441|3746149|B3||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3922639|NCT01429441|3746150|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3922640|NCT01429441|3746151|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3922641|NCT01429441|3746149|B3|||Age||years|Mean|69.1|69.1|Standard Deviation|10.30|10.3|||
3922642|NCT01429441|3746150|B2|||Age||years|Mean|68.5|68.5|Standard Deviation|10.94|10.94|||
3922643|NCT01429441|3746151|B1|||Age||years|Mean|69.4|69.4|Standard Deviation|9.99|9.99|||
3922644|NCT01429298|3746160|B3||Unknown|Nauseated or vomited before receiving opioids in the ED||Participants|Count of Participants|1|1.0||||||
3922645|NCT01429298|3746161|B2||Unknown|Nauseated or vomited before receiving opioids in the ED||Participants|Count of Participants|0|0.0||||||
3922646|NCT01429298|3746162|B1||Unknown|Nauseated or vomited before receiving opioids in the ED||Participants|Count of Participants|1|1.0||||||
3922647|NCT01429298|3746160|B3||No|Nauseated or vomited before receiving opioids in the ED||Participants|Count of Participants|129|129.0||||||
3922648|NCT01429298|3746161|B2||No|Nauseated or vomited before receiving opioids in the ED||Participants|Count of Participants|62|62.0||||||
3922649|NCT01429298|3746162|B1||No|Nauseated or vomited before receiving opioids in the ED||Participants|Count of Participants|67|67.0||||||
3922650|NCT01429298|3746160|B3||Yes|Nauseated or vomited before receiving opioids in the ED||Participants|Count of Participants|195|195.0||||||
3922651|NCT01429298|3746161|B2||Yes|Nauseated or vomited before receiving opioids in the ED||Participants|Count of Participants|99|99.0||||||
3922652|NCT01429298|3746162|B1||Yes|Nauseated or vomited before receiving opioids in the ED||Participants|Count of Participants|96|96.0||||||
3922653|NCT01429298|3746160|B3||Score of 10|Pain Intensity|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable)."|Participants|Count of Participants|206|206.0||||||
3922654|NCT01429298|3746161|B2||Score of 10|Pain Intensity|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable)."|Participants|Count of Participants|103|103.0||||||
3922655|NCT01429298|3746162|B1||Score of 10|Pain Intensity|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable)."|Participants|Count of Participants|103|103.0||||||
3922656|NCT01429298|3746160|B3||Score of 9|Pain Intensity|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable)."|Participants|Count of Participants|35|35.0||||||
3922657|NCT01429298|3746161|B2||Score of 9|Pain Intensity|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable)."|Participants|Count of Participants|15|15.0||||||
3922658|NCT01429298|3746162|B1||Score of 9|Pain Intensity|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable)."|Participants|Count of Participants|20|20.0||||||
3922659|NCT01429298|3746160|B3||Score of 8|Pain Intensity|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable)."|Participants|Count of Participants|44|44.0||||||
3922660|NCT01429298|3746161|B2||Score of 8|Pain Intensity|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable)."|Participants|Count of Participants|22|22.0||||||
3922661|NCT01429298|3746162|B1||Score of 8|Pain Intensity|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable)."|Participants|Count of Participants|22|22.0||||||
3922662|NCT01429298|3746160|B3||Score of 3-7|Pain Intensity|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable)."|Participants|Count of Participants|40|40.0||||||
3922663|NCT01429298|3746161|B2||Score of 3-7|Pain Intensity|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable)."|Participants|Count of Participants|21|21.0||||||
3922664|NCT01429298|3746162|B1||Score of 3-7|Pain Intensity|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable)."|Participants|Count of Participants|19|19.0||||||
3922665|NCT01429298|3746160|B3||Other|Location of Pain||Participants|Count of Participants|114|114.0||||||
3922666|NCT01429298|3746161|B2||Other|Location of Pain||Participants|Count of Participants|51|51.0||||||
3922667|NCT01429298|3746162|B1||Other|Location of Pain||Participants|Count of Participants|63|63.0||||||
3922668|NCT01429298|3746160|B3||Abdomen|Location of Pain||Participants|Count of Participants|211|211.0||||||
3922669|NCT01429298|3746161|B2||Abdomen|Location of Pain||Participants|Count of Participants|110|110.0||||||
3922670|NCT01429298|3746162|B1||Abdomen|Location of Pain||Participants|Count of Participants|101|101.0||||||
3922671|NCT01429298|3746160|B3|||Weight||lbs|Mean|198.4|198.4|Standard Deviation|41|41.0|||
3922672|NCT01429298|3746161|B2|||Weight||lbs|Mean|201.4|201.4|Standard Deviation|42.8|42.8|||
3922673|NCT01429298|3746162|B1|||Weight||lbs|Mean|195.4|195.4|Standard Deviation|39|39.0|||
3922674|NCT01429298|3746160|B3|United States||Region of Enrollment||Participants|Count of Participants|325|325.0||||||
3922675|NCT01429298|3746161|B2|United States||Region of Enrollment||Participants|Count of Participants|161|161.0||||||
3922676|NCT01429298|3746162|B1|United States||Region of Enrollment||Participants|Count of Participants|164|164.0||||||
3922677|NCT01429298|3746160|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3922678|NCT01429298|3746161|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3922679|NCT01429298|3746162|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3922680|NCT01429298|3746160|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3922681|NCT01429298|3746161|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3922682|NCT01429298|3746162|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3922683|NCT01429298|3746160|B3||African American|Race/Ethnicity, Customized||Participants|Count of Participants|79|79.0||||||
3922684|NCT01429298|3746161|B2||African American|Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
3922685|NCT01429298|3746162|B1||African American|Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
3922686|NCT01429298|3746160|B3||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|216|216.0||||||
3922687|NCT01429298|3746161|B2||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|103|103.0||||||
3922688|NCT01429298|3746162|B1||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|113|113.0||||||
3922689|NCT01429298|3746160|B3||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3922690|NCT01429298|3746161|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3922691|NCT01429298|3746162|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3922692|NCT01429298|3746160|B3||Female|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
3922693|NCT01429298|3746161|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3922694|NCT01429298|3746162|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3922695|NCT01429298|3746160|B3|||Age||years|Mean|41.3|41.3|Standard Deviation|12.3|12.3|||
3922696|NCT01429298|3746161|B2|||Age||years|Mean|41.2|41.2|Standard Deviation|12.3|12.3|||
3922697|NCT01429298|3746162|B1|||Age||years|Mean|41.4|41.4|Standard Deviation|12.2|12.2|||
3922698|NCT01429285|3746177|B3||Unknown|Nauseated or vomited before receiving opioids in the ED||Participants|Count of Participants|1|1.0||||||
3922699|NCT01429285|3746178|B2||Unknown|Nauseated or vomited before receiving opioids in the ED||Participants|Count of Participants|0|0.0||||||
3922700|NCT01429285|3746179|B1||Unknown|Nauseated or vomited before receiving opioids in the ED||Participants|Count of Participants|1|1.0||||||
3922701|NCT01429285|3746177|B3||No|Nauseated or vomited before receiving opioids in the ED||Participants|Count of Participants|176|176.0||||||
3922702|NCT01429285|3746178|B2||No|Nauseated or vomited before receiving opioids in the ED||Participants|Count of Participants|89|89.0||||||
3922703|NCT01429285|3746179|B1||No|Nauseated or vomited before receiving opioids in the ED||Participants|Count of Participants|87|87.0||||||
3922704|NCT01429285|3746177|B3||Yes|Nauseated or vomited before receiving opioids in the ED||Participants|Count of Participants|142|142.0||||||
3922705|NCT01429285|3746178|B2||Yes|Nauseated or vomited before receiving opioids in the ED||Participants|Count of Participants|77|77.0||||||
3922706|NCT01429285|3746179|B1||Yes|Nauseated or vomited before receiving opioids in the ED||Participants|Count of Participants|65|65.0||||||
3922707|NCT01429285|3746177|B3||NRS = 10|Pain Intensity|"Pain intensity is measured on the numerical rating scale (NRS), with scores ranging from 0 (no pain) to 10 (worst pain imaginable)."|Participants|Count of Participants|157|157.0||||||
3922708|NCT01429285|3746178|B2||NRS = 10|Pain Intensity|"Pain intensity is measured on the numerical rating scale (NRS), with scores ranging from 0 (no pain) to 10 (worst pain imaginable)."|Participants|Count of Participants|81|81.0||||||
3922709|NCT01429285|3746179|B1||NRS = 10|Pain Intensity|"Pain intensity is measured on the numerical rating scale (NRS), with scores ranging from 0 (no pain) to 10 (worst pain imaginable)."|Participants|Count of Participants|76|76.0||||||
3922710|NCT01429285|3746177|B3||NRS = 9|Pain Intensity|"Pain intensity is measured on the numerical rating scale (NRS), with scores ranging from 0 (no pain) to 10 (worst pain imaginable)."|Participants|Count of Participants|44|44.0||||||
3922711|NCT01429285|3746178|B2||NRS = 9|Pain Intensity|"Pain intensity is measured on the numerical rating scale (NRS), with scores ranging from 0 (no pain) to 10 (worst pain imaginable)."|Participants|Count of Participants|24|24.0||||||
3922712|NCT01429285|3746179|B1||NRS = 9|Pain Intensity|"Pain intensity is measured on the numerical rating scale (NRS), with scores ranging from 0 (no pain) to 10 (worst pain imaginable)."|Participants|Count of Participants|20|20.0||||||
3922713|NCT01429285|3746177|B3||NRS = 8|Pain Intensity|"Pain intensity is measured on the numerical rating scale (NRS), with scores ranging from 0 (no pain) to 10 (worst pain imaginable)."|Participants|Count of Participants|59|59.0||||||
3922714|NCT01429285|3746178|B2||NRS = 8|Pain Intensity|"Pain intensity is measured on the numerical rating scale (NRS), with scores ranging from 0 (no pain) to 10 (worst pain imaginable)."|Participants|Count of Participants|28|28.0||||||
3922715|NCT01429285|3746179|B1||NRS = 8|Pain Intensity|"Pain intensity is measured on the numerical rating scale (NRS), with scores ranging from 0 (no pain) to 10 (worst pain imaginable)."|Participants|Count of Participants|31|31.0||||||
3922716|NCT01429285|3746177|B3||NRS = 7|Pain Intensity|"Pain intensity is measured on the numerical rating scale (NRS), with scores ranging from 0 (no pain) to 10 (worst pain imaginable)."|Participants|Count of Participants|34|34.0||||||
3922717|NCT01429285|3746178|B2||NRS = 7|Pain Intensity|"Pain intensity is measured on the numerical rating scale (NRS), with scores ranging from 0 (no pain) to 10 (worst pain imaginable)."|Participants|Count of Participants|20|20.0||||||
3922718|NCT01429285|3746179|B1||NRS = 7|Pain Intensity|"Pain intensity is measured on the numerical rating scale (NRS), with scores ranging from 0 (no pain) to 10 (worst pain imaginable)."|Participants|Count of Participants|14|14.0||||||
3922719|NCT01429285|3746177|B3||NRS = 3-6|Pain Intensity|"Pain intensity is measured on the numerical rating scale (NRS), with scores ranging from 0 (no pain) to 10 (worst pain imaginable)."|Participants|Count of Participants|25|25.0||||||
3922720|NCT01429285|3746178|B2||NRS = 3-6|Pain Intensity|"Pain intensity is measured on the numerical rating scale (NRS), with scores ranging from 0 (no pain) to 10 (worst pain imaginable)."|Participants|Count of Participants|13|13.0||||||
3922721|NCT01429285|3746179|B1||NRS = 3-6|Pain Intensity|"Pain intensity is measured on the numerical rating scale (NRS), with scores ranging from 0 (no pain) to 10 (worst pain imaginable)."|Participants|Count of Participants|12|12.0||||||
3922722|NCT01429285|3746177|B3||Other (pancreatitis, perforated viscus, etc)|Diagnosis||Participants|Count of Participants|29|29.0||||||
3922723|NCT01429285|3746178|B2||Other (pancreatitis, perforated viscus, etc)|Diagnosis||Participants|Count of Participants|14|14.0||||||
3922724|NCT01429285|3746179|B1||Other (pancreatitis, perforated viscus, etc)|Diagnosis||Participants|Count of Participants|15|15.0||||||
3922725|NCT01429285|3746177|B3||Appendicitis|Diagnosis||Participants|Count of Participants|6|6.0||||||
3922726|NCT01429285|3746178|B2||Appendicitis|Diagnosis||Participants|Count of Participants|6|6.0||||||
3922727|NCT01429285|3746179|B1||Appendicitis|Diagnosis||Participants|Count of Participants|0|0.0||||||
3922728|NCT01429285|3746177|B3||Kidney stone/pyelonephritis|Diagnosis||Participants|Count of Participants|18|18.0||||||
3922729|NCT01429285|3746178|B2||Kidney stone/pyelonephritis|Diagnosis||Participants|Count of Participants|11|11.0||||||
3922730|NCT01429285|3746179|B1||Kidney stone/pyelonephritis|Diagnosis||Participants|Count of Participants|7|7.0||||||
3922731|NCT01429285|3746177|B3||biliary colic/cholecystitis|Diagnosis||Participants|Count of Participants|17|17.0||||||
3922732|NCT01429285|3746178|B2||biliary colic/cholecystitis|Diagnosis||Participants|Count of Participants|11|11.0||||||
3922733|NCT01429285|3746179|B1||biliary colic/cholecystitis|Diagnosis||Participants|Count of Participants|6|6.0||||||
3922734|NCT01429285|3746177|B3||Extremity fracture|Diagnosis||Participants|Count of Participants|18|18.0||||||
3922735|NCT01429285|3746178|B2||Extremity fracture|Diagnosis||Participants|Count of Participants|7|7.0||||||
3922736|NCT01429285|3746179|B1||Extremity fracture|Diagnosis||Participants|Count of Participants|11|11.0||||||
3922737|NCT01429285|3746177|B3||Small Bowel Obstruction|Diagnosis||Participants|Count of Participants|25|25.0||||||
3922738|NCT01429285|3746178|B2||Small Bowel Obstruction|Diagnosis||Participants|Count of Participants|13|13.0||||||
3922739|NCT01429285|3746179|B1||Small Bowel Obstruction|Diagnosis||Participants|Count of Participants|12|12.0||||||
3922740|NCT01429285|3746177|B3||Colitis/diverticulitis|Diagnosis||Participants|Count of Participants|24|24.0||||||
3922741|NCT01429285|3746178|B2||Colitis/diverticulitis|Diagnosis||Participants|Count of Participants|10|10.0||||||
3922742|NCT01429285|3746179|B1||Colitis/diverticulitis|Diagnosis||Participants|Count of Participants|14|14.0||||||
3922743|NCT01429285|3746177|B3||Back pain|Diagnosis||Participants|Count of Participants|27|27.0||||||
3922744|NCT01429285|3746178|B2||Back pain|Diagnosis||Participants|Count of Participants|13|13.0||||||
3922745|NCT01429285|3746179|B1||Back pain|Diagnosis||Participants|Count of Participants|14|14.0||||||
3922746|NCT01429285|3746177|B3||Musculoskeletal pain|Diagnosis||Participants|Count of Participants|48|48.0||||||
3922747|NCT01429285|3746178|B2||Musculoskeletal pain|Diagnosis||Participants|Count of Participants|24|24.0||||||
3922748|NCT01429285|3746179|B1||Musculoskeletal pain|Diagnosis||Participants|Count of Participants|24|24.0||||||
3922749|NCT01429285|3746177|B3||Non-specific abdominal pain|Diagnosis||Participants|Count of Participants|107|107.0||||||
3922750|NCT01429285|3746178|B2||Non-specific abdominal pain|Diagnosis||Participants|Count of Participants|57|57.0||||||
3922751|NCT01429285|3746179|B1||Non-specific abdominal pain|Diagnosis||Participants|Count of Participants|50|50.0||||||
3922752|NCT01429285|3746177|B3|||Weight||lbs|Mean|164|164.0|Standard Deviation|36|36.0|||
3922753|NCT01429285|3746178|B2|||Weight||lbs|Mean|165|165.0|Standard Deviation|38|38.0|||
3922754|NCT01429285|3746179|B1|||Weight||lbs|Mean|162|162.0|Standard Deviation|33|33.0|||
3922755|NCT01429285|3746177|B3|United States||Region of Enrollment||Participants|Count of Participants|319|319.0||||||
3922756|NCT01429285|3746178|B2|United States||Region of Enrollment||Participants|Count of Participants|166|166.0||||||
3922757|NCT01429285|3746179|B1|United States||Region of Enrollment||Participants|Count of Participants|153|153.0||||||
3922758|NCT01429285|3746177|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3922759|NCT01429285|3746178|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3922760|NCT01429285|3746179|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3922761|NCT01429285|3746177|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3922762|NCT01429285|3746178|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3922763|NCT01429285|3746179|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3922764|NCT01429285|3746177|B3||African American|Race/Ethnicity, Customized||Participants|Count of Participants|79|79.0||||||
3922765|NCT01429285|3746178|B2||African American|Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
3922766|NCT01429285|3746179|B1||African American|Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
3922964|NCT01428661|3746306|B2|||Age||years|Mean|42.0|42.0|Standard Deviation|12.46|12.46|||
3922767|NCT01429285|3746177|B3||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|200|200.0||||||
3922768|NCT01429285|3746178|B2||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|103|103.0||||||
3922769|NCT01429285|3746179|B1||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|97|97.0||||||
3922770|NCT01429285|3746177|B3||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3922771|NCT01429285|3746178|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3922772|NCT01429285|3746179|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3922773|NCT01429285|3746177|B3||Female|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
3922774|NCT01429285|3746178|B2||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3922775|NCT01429285|3746179|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3922776|NCT01429285|3746177|B3|||Age||years|Mean|74|74.0|Standard Deviation|6|6.0|||
3922777|NCT01429285|3746178|B2|||Age||years|Mean|74|74.0|Standard Deviation|6|6.0|||
3922778|NCT01429285|3746179|B1|||Age||years|Mean|75|75.0|Standard Deviation|7|7.0|||
3922779|NCT01429272|3746198|B5|||Interleukin 6 (IL-6)|Pro-inflammatory cytokine.|pg/ML|Mean|1.0|1.0|Standard Deviation|0.6|0.6|||
3922780|NCT01429272|3746199|B4|||Interleukin 6 (IL-6)|Pro-inflammatory cytokine.|pg/ML|Mean|1.1|1.1|Standard Deviation|0.7|0.7|||
3922781|NCT01429272|3746200|B3|||Interleukin 6 (IL-6)|Pro-inflammatory cytokine.|pg/ML|Mean|0.9|0.9|Standard Deviation|0.5|0.5|||
3922782|NCT01429272|3746201|B2|||Interleukin 6 (IL-6)|Pro-inflammatory cytokine.|pg/ML|Mean|1.0|1.0|Standard Deviation|0.7|0.7|||
3922783|NCT01429272|3746202|B1|||Interleukin 6 (IL-6)|Pro-inflammatory cytokine.|pg/ML|Mean|0.9|0.9|Standard Deviation|0.5|0.5|||
3922784|NCT01429272|3746198|B5|||Measure of Inflammation using the C-Reactive Protein (CRP) measurement|Measure of inflammation|mg/L|Mean|5.6|5.6|Standard Deviation|8.5|8.5|||
3922785|NCT01429272|3746199|B4|||Measure of Inflammation using the C-Reactive Protein (CRP) measurement|Measure of inflammation|mg/L|Mean|4.5|4.5|Standard Deviation|4.9|4.9|||
3922786|NCT01429272|3746200|B3|||Measure of Inflammation using the C-Reactive Protein (CRP) measurement|Measure of inflammation|mg/L|Mean|4.3|4.3|Standard Deviation|5.5|5.5|||
3922787|NCT01429272|3746201|B2|||Measure of Inflammation using the C-Reactive Protein (CRP) measurement|Measure of inflammation|mg/L|Mean|8.2|8.2|Standard Deviation|12.9|12.9|||
3922788|NCT01429272|3746202|B1|||Measure of Inflammation using the C-Reactive Protein (CRP) measurement|Measure of inflammation|mg/L|Mean|4.4|4.4|Standard Deviation|5.3|5.3|||
3922789|NCT01429272|3746198|B5|||Montgomery-Asberg Depression Rating Score|Range of scores (total) = 0-60. Higher scores indicate more depressive symptoms.|units on a scale|Mean|27.8|27.8|Standard Deviation|5.9|5.9|||
3922790|NCT01429272|3746199|B4|||Montgomery-Asberg Depression Rating Score|Range of scores (total) = 0-60. Higher scores indicate more depressive symptoms.|units on a scale|Mean|25.9|25.9|Standard Deviation|6.5|6.5|||
3922791|NCT01429272|3746200|B3|||Montgomery-Asberg Depression Rating Score|Range of scores (total) = 0-60. Higher scores indicate more depressive symptoms.|units on a scale|Mean|27.2|27.2|Standard Deviation|5.2|5.2|||
3922792|NCT01429272|3746201|B2|||Montgomery-Asberg Depression Rating Score|Range of scores (total) = 0-60. Higher scores indicate more depressive symptoms.|units on a scale|Mean|28.0|28.0|Standard Deviation|5.7|5.7|||
3922793|NCT01429272|3746202|B1|||Montgomery-Asberg Depression Rating Score|Range of scores (total) = 0-60. Higher scores indicate more depressive symptoms.|units on a scale|Mean|29.2|29.2|Standard Deviation|6.2|6.2|||
3922794|NCT01429272|3746198|B5|United States||Region of Enrollment||Participants|Count of Participants|99|99.0||||||
3922795|NCT01429272|3746199|B4|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3922796|NCT01429272|3746200|B3|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3922797|NCT01429272|3746201|B2|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3922798|NCT01429272|3746202|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3922799|NCT01429272|3746198|B5||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3922800|NCT01429272|3746199|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3922801|NCT01429272|3746200|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3922802|NCT01429272|3746201|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3922803|NCT01429272|3746202|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3922804|NCT01429272|3746198|B5||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3922805|NCT01429272|3746199|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3922806|NCT01429272|3746200|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3922807|NCT01429272|3746201|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3922808|NCT01429272|3746202|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3922809|NCT01429272|3746198|B5|||Age||Years|Mean|41.5|41.5|Standard Deviation|9.8|9.8|||
3922810|NCT01429272|3746199|B4|||Age||Years|Mean|40.6|40.6|Standard Deviation|10.2|10.2|||
3922811|NCT01429272|3746200|B3|||Age||Years|Mean|44.8|44.8|Standard Deviation|8.7|8.7|||
3922812|NCT01429272|3746201|B2|||Age||Years|Mean|40.8|40.8|Standard Deviation|9.7|9.7|||
3922813|NCT01429272|3746202|B1|||Age||Years|Mean|40.8|40.8|Standard Deviation|10.4|10.4|||
3922814|NCT01429272|3746198|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922815|NCT01429272|3746199|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922816|NCT01429272|3746200|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922817|NCT01429272|3746201|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922818|NCT01429272|3746202|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922819|NCT01429272|3746198|B5||Between 18 and 65 years|Age||Participants|Count of Participants|99|99.0||||||
3922820|NCT01429272|3746199|B4||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3922821|NCT01429272|3746200|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3922822|NCT01429272|3746201|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3922823|NCT01429272|3746202|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3922824|NCT01429272|3746198|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922825|NCT01429272|3746199|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922826|NCT01429272|3746200|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922827|NCT01429272|3746201|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922828|NCT01429272|3746202|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922829|NCT01429259|3746219|B1|||Historical Best FEV1 (% predicted)|The Historical Best FEV1 baseline measure estimates the baseline decline in pulmonary function of the population when not having an acute exacerbation. This value should be greater than the Baseline FEV1 thereby supporting that patients were having an acute pulmonary exacerbation at the start of the study.|% predicted|Mean|71|71.0|Standard Deviation|25|25.0|||
3922830|NCT01429259|3746219|B1|||Baseline Forced Expiratory Volume in 1st Second (FEV1) (% predicted)||% predicted|Mean|58|58.0|Standard Deviation|24|24.0|||
3922831|NCT01429259|3746219|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3922832|NCT01429259|3746219|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922833|NCT01429259|3746219|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922834|NCT01429259|3746219|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3922835|NCT01429259|3746219|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922836|NCT01429259|3746219|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922837|NCT01429259|3746219|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922838|NCT01429259|3746219|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3922839|NCT01429259|3746219|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3922840|NCT01429259|3746219|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3922841|NCT01429259|3746219|B1|||Age||years|Mean|12.7|12.7|Standard Deviation|2.9|2.9|||
3922842|NCT01429077|3746224|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
3922843|NCT01429077|3746225|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3922844|NCT01429077|3746226|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3922845|NCT01429077|3746224|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3922846|NCT01429077|3746225|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3922847|NCT01429077|3746226|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3922848|NCT01429077|3746224|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3922849|NCT01429077|3746225|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3922850|NCT01429077|3746226|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3922851|NCT01429077|3746224|B3|||Age||years|Mean|54.02|54.02|Standard Deviation|11.74|11.74|||
3922852|NCT01429077|3746225|B2|||Age||years|Mean|52.6|52.6|Standard Deviation|11.9|11.9|||
3922853|NCT01429077|3746226|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|11.8|11.8|||
3922854|NCT01429077|3746224|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3922855|NCT01429077|3746225|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3922856|NCT01429077|3746226|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3922857|NCT01429077|3746224|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3922858|NCT01429077|3746225|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3922859|NCT01429077|3746226|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3922860|NCT01429077|3746224|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922861|NCT01429077|3746225|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922862|NCT01429077|3746226|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922863|NCT01429064|3746233|B5||Male|Gender||Participants|Count of Participants|76|76.0||||||
3922864|NCT01429064|3746234|B4||Male|Gender||Participants|Count of Participants|16|16.0||||||
3922865|NCT01429064|3746235|B3||Male|Gender||Participants|Count of Participants|19|19.0||||||
3922866|NCT01429064|3746236|B2||Male|Gender||Participants|Count of Participants|22|22.0||||||
3922867|NCT01429064|3746237|B1||Male|Gender||Participants|Count of Participants|19|19.0||||||
3922868|NCT01429064|3746233|B5||Female|Gender||Participants|Count of Participants|0|0.0||||||
3922869|NCT01429064|3746234|B4||Female|Gender||Participants|Count of Participants|0|0.0||||||
3922870|NCT01429064|3746235|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
3922871|NCT01429064|3746236|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
3922872|NCT01429064|3746237|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3922873|NCT01429064|3746233|B5|||Age||years|Mean|69.4|69.4|Standard Deviation|7.3|7.3|||
3922874|NCT01429064|3746234|B4|||Age||years|Mean|74.6|74.6|Standard Deviation|6.3|6.3|||
3922875|NCT01429064|3746235|B3|||Age||years|Mean|68.9|68.9|Standard Deviation|8.3|8.3|||
3922876|NCT01429064|3746236|B2|||Age||years|Mean|66.5|66.5|Standard Deviation|6.6|6.6|||
3922877|NCT01429064|3746237|B1|||Age||years|Mean|68.8|68.8|Standard Deviation|6.1|6.1|||
3922878|NCT01429051|3746250|B1|Other||Site of Primary Tumour Reported in >5% Patients||participants|Number|1|1.0||||||
3922879|NCT01429051|3746250|B1|Liver||Site of Primary Tumour Reported in >5% Patients||participants|Number|1|1.0||||||
3922880|NCT01429051|3746250|B1|Unknown Primary Tumour||Site of Primary Tumour Reported in >5% Patients||participants|Number|2|2.0||||||
3922881|NCT01429051|3746250|B1|Urological||Site of Primary Tumour Reported in >5% Patients||participants|Number|7|7.0||||||
3922882|NCT01429051|3746250|B1|Prostate||Site of Primary Tumour Reported in >5% Patients||participants|Number|3|3.0||||||
3922883|NCT01429051|3746250|B1|Female genital||Site of Primary Tumour Reported in >5% Patients||participants|Number|3|3.0||||||
3922884|NCT01429051|3746250|B1|Pancreas||Site of Primary Tumour Reported in >5% Patients||participants|Number|6|6.0||||||
3922885|NCT01429051|3746250|B1|Colon/rectal||Site of Primary Tumour Reported in >5% Patients||participants|Number|3|3.0||||||
3922886|NCT01429051|3746250|B1|Gastro-oesophageal||Site of Primary Tumour Reported in >5% Patients||participants|Number|1|1.0||||||
3922887|NCT01429051|3746250|B1|Lung respiratory system||Site of Primary Tumour Reported in >5% Patients||participants|Number|5|5.0||||||
3922888|NCT01429051|3746250|B1|Breast||Site of Primary Tumour Reported in >5% Patients||participants|Number|14|14.0||||||
3922889|NCT01429051|3746250|B1|Russian Federation||Region of Enrollment||participants|Number|3|3.0||||||
3922890|NCT01429051|3746250|B1|Norway||Region of Enrollment||participants|Number|10|10.0||||||
3922891|NCT01429051|3746250|B1|Hungary||Region of Enrollment||participants|Number|33|33.0||||||
3922892|NCT01429051|3746250|B1|White||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
3922893|NCT01429051|3746250|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3922894|NCT01429051|3746250|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3922895|NCT01429051|3746250|B1|||Age||years|Mean|61.0|61.0|Standard Deviation|9.09|9.09|||
3922896|NCT01428882|3746271|B3|ASA 3||ASA class|ASA 1: a normal healthy patient (e.g., Healthy, non-smoking, no or minimal alcohol use) ASA 2: a patient with mild systemic disease (e.g., current smoker, social alcohol drinker, pregnancy, obesity, well-controlled diabetes mellitus or arterial hypertension) ASA 3: Substantive functional limitations in a patient with one or more moderate to severe diseases (e.g., poorly controlled diabetes mellitus or arterial hypertension, chronic obstructive pulmonary disease, morbid obesity, implanted pacemaker, moderate reduction of ejection fraction, patients on scheduled dialysis)|participants|Number|15|15.0||||||
3922897|NCT01428882|3746272|B2|ASA 3||ASA class|ASA 1: a normal healthy patient (e.g., Healthy, non-smoking, no or minimal alcohol use) ASA 2: a patient with mild systemic disease (e.g., current smoker, social alcohol drinker, pregnancy, obesity, well-controlled diabetes mellitus or arterial hypertension) ASA 3: Substantive functional limitations in a patient with one or more moderate to severe diseases (e.g., poorly controlled diabetes mellitus or arterial hypertension, chronic obstructive pulmonary disease, morbid obesity, implanted pacemaker, moderate reduction of ejection fraction, patients on scheduled dialysis)|participants|Number|8|8.0||||||
3922898|NCT01428882|3746273|B1|ASA 3||ASA class|ASA 1: a normal healthy patient (e.g., Healthy, non-smoking, no or minimal alcohol use) ASA 2: a patient with mild systemic disease (e.g., current smoker, social alcohol drinker, pregnancy, obesity, well-controlled diabetes mellitus or arterial hypertension) ASA 3: Substantive functional limitations in a patient with one or more moderate to severe diseases (e.g., poorly controlled diabetes mellitus or arterial hypertension, chronic obstructive pulmonary disease, morbid obesity, implanted pacemaker, moderate reduction of ejection fraction, patients on scheduled dialysis)|participants|Number|7|7.0||||||
3922899|NCT01428882|3746271|B3|ASA 2||ASA class|ASA 1: a normal healthy patient (e.g., Healthy, non-smoking, no or minimal alcohol use) ASA 2: a patient with mild systemic disease (e.g., current smoker, social alcohol drinker, pregnancy, obesity, well-controlled diabetes mellitus or arterial hypertension) ASA 3: Substantive functional limitations in a patient with one or more moderate to severe diseases (e.g., poorly controlled diabetes mellitus or arterial hypertension, chronic obstructive pulmonary disease, morbid obesity, implanted pacemaker, moderate reduction of ejection fraction, patients on scheduled dialysis)|participants|Number|51|51.0||||||
3922900|NCT01428882|3746272|B2|ASA 2||ASA class|ASA 1: a normal healthy patient (e.g., Healthy, non-smoking, no or minimal alcohol use) ASA 2: a patient with mild systemic disease (e.g., current smoker, social alcohol drinker, pregnancy, obesity, well-controlled diabetes mellitus or arterial hypertension) ASA 3: Substantive functional limitations in a patient with one or more moderate to severe diseases (e.g., poorly controlled diabetes mellitus or arterial hypertension, chronic obstructive pulmonary disease, morbid obesity, implanted pacemaker, moderate reduction of ejection fraction, patients on scheduled dialysis)|participants|Number|19|19.0||||||
3922901|NCT01428882|3746273|B1|ASA 2||ASA class|ASA 1: a normal healthy patient (e.g., Healthy, non-smoking, no or minimal alcohol use) ASA 2: a patient with mild systemic disease (e.g., current smoker, social alcohol drinker, pregnancy, obesity, well-controlled diabetes mellitus or arterial hypertension) ASA 3: Substantive functional limitations in a patient with one or more moderate to severe diseases (e.g., poorly controlled diabetes mellitus or arterial hypertension, chronic obstructive pulmonary disease, morbid obesity, implanted pacemaker, moderate reduction of ejection fraction, patients on scheduled dialysis)|participants|Number|32|32.0||||||
3922902|NCT01428882|3746271|B3|ASA 1||ASA class|ASA 1: a normal healthy patient (e.g., Healthy, non-smoking, no or minimal alcohol use) ASA 2: a patient with mild systemic disease (e.g., current smoker, social alcohol drinker, pregnancy, obesity, well-controlled diabetes mellitus or arterial hypertension) ASA 3: Substantive functional limitations in a patient with one or more moderate to severe diseases (e.g., poorly controlled diabetes mellitus or arterial hypertension, chronic obstructive pulmonary disease, morbid obesity, implanted pacemaker, moderate reduction of ejection fraction, patients on scheduled dialysis)|participants|Number|53|53.0||||||
3922903|NCT01428882|3746272|B2|ASA 1||ASA class|ASA 1: a normal healthy patient (e.g., Healthy, non-smoking, no or minimal alcohol use) ASA 2: a patient with mild systemic disease (e.g., current smoker, social alcohol drinker, pregnancy, obesity, well-controlled diabetes mellitus or arterial hypertension) ASA 3: Substantive functional limitations in a patient with one or more moderate to severe diseases (e.g., poorly controlled diabetes mellitus or arterial hypertension, chronic obstructive pulmonary disease, morbid obesity, implanted pacemaker, moderate reduction of ejection fraction, patients on scheduled dialysis)|participants|Number|31|31.0||||||
3922965|NCT01428661|3746307|B1|||Age||years|Mean|43.7|43.7|Standard Deviation|12.61|12.61|||
3922904|NCT01428882|3746273|B1|ASA 1||ASA class|ASA 1: a normal healthy patient (e.g., Healthy, non-smoking, no or minimal alcohol use) ASA 2: a patient with mild systemic disease (e.g., current smoker, social alcohol drinker, pregnancy, obesity, well-controlled diabetes mellitus or arterial hypertension) ASA 3: Substantive functional limitations in a patient with one or more moderate to severe diseases (e.g., poorly controlled diabetes mellitus or arterial hypertension, chronic obstructive pulmonary disease, morbid obesity, implanted pacemaker, moderate reduction of ejection fraction, patients on scheduled dialysis)|participants|Number|22|22.0||||||
3922905|NCT01428882|3746271|B3|Graduate degree||Educational degree||participants|Number|24|24.0||||||
3922906|NCT01428882|3746272|B2|Graduate degree||Educational degree||participants|Number|13|13.0||||||
3922907|NCT01428882|3746273|B1|Graduate degree||Educational degree||participants|Number|11|11.0||||||
3922908|NCT01428882|3746271|B3|College||Educational degree||participants|Number|21|21.0||||||
3922909|NCT01428882|3746272|B2|College||Educational degree||participants|Number|10|10.0||||||
3922910|NCT01428882|3746273|B1|College||Educational degree||participants|Number|11|11.0||||||
3922911|NCT01428882|3746271|B3|Technical||Educational degree||participants|Number|30|30.0||||||
3922912|NCT01428882|3746272|B2|Technical||Educational degree||participants|Number|10|10.0||||||
3922913|NCT01428882|3746273|B1|Technical||Educational degree||participants|Number|20|20.0||||||
3922914|NCT01428882|3746271|B3|High school||Educational degree||participants|Number|16|16.0||||||
3922915|NCT01428882|3746272|B2|High school||Educational degree||participants|Number|11|11.0||||||
3922916|NCT01428882|3746273|B1|High school||Educational degree||participants|Number|5|5.0||||||
3922917|NCT01428882|3746271|B3|No degree||Educational degree||participants|Number|28|28.0||||||
3922918|NCT01428882|3746272|B2|No degree||Educational degree||participants|Number|14|14.0||||||
3922919|NCT01428882|3746273|B1|No degree||Educational degree||participants|Number|14|14.0||||||
3922920|NCT01428882|3746271|B3|||Body Mass Index||Kg/m2|Mean|25.4|25.4|Standard Deviation|4.1|4.1|||
3922921|NCT01428882|3746272|B2|||Body Mass Index||Kg/m2|Mean|25.1|25.1|Standard Deviation|3.5|3.5|||
3922922|NCT01428882|3746273|B1|||Body Mass Index||Kg/m2|Mean|25.8|25.8|Standard Deviation|4.6|4.6|||
3922923|NCT01428882|3746271|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3922924|NCT01428882|3746272|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3922925|NCT01428882|3746273|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3922926|NCT01428882|3746271|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3922927|NCT01428882|3746272|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3922928|NCT01428882|3746273|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3922929|NCT01428882|3746271|B3|||Age||years|Mean|56|56.0|Full Range|||19.0|86.0|
3922930|NCT01428882|3746272|B2|||Age||years|Mean|55|55.0|Full Range|||20.0|86.0|
3922931|NCT01428882|3746273|B1|||Age||years|Mean|58|58.0|Full Range|||19.0|80.0|
3922932|NCT01428765|3746286|B1||Male|Sex: Female, Male||Participants|Count of Participants|577|577.0||||||
3922933|NCT01428765|3746286|B1||Female|Sex: Female, Male||Participants|Count of Participants|486|486.0||||||
3922934|NCT01428765|3746286|B1|||Age||years|Mean|68.2|68.2|Standard Deviation|11.8|11.8|||
3922935|NCT01428713|3746297|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3922936|NCT01428713|3746297|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3922937|NCT01428713|3746297|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3922938|NCT01428713|3746297|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922939|NCT01428713|3746297|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3922940|NCT01428713|3746297|B1||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
3922941|NCT01428713|3746297|B1|||Age||years|Median|14.2|14.2|Standard Deviation|1.6|1.6|||
3922942|NCT01428661|3746304|B4|Male||Gender||participants|Number|117|117.0||||||
3922943|NCT01428661|3746305|B3|Male||Gender||participants|Number|117|117.0||||||
3922944|NCT01428661|3746306|B2|Male||Gender||participants|Number|0|0.0||||||
3922945|NCT01428661|3746307|B1|Male||Gender||participants|Number|0|0.0||||||
3922946|NCT01428661|3746304|B4|Female||Gender||participants|Number|222|222.0||||||
3922947|NCT01428661|3746305|B3|Female||Gender||participants|Number|222|222.0||||||
3922948|NCT01428661|3746306|B2|Female||Gender||participants|Number|0|0.0||||||
3922949|NCT01428661|3746307|B1|Female||Gender||participants|Number|0|0.0||||||
3922950|NCT01428661|3746304|B4|Male||Gender||participants|Number|175|175.0||||||
3922951|NCT01428661|3746305|B3|Male||Gender||participants|Number|0|0.0||||||
3922952|NCT01428661|3746306|B2|Male||Gender||participants|Number|82|82.0||||||
3922953|NCT01428661|3746307|B1|Male||Gender||participants|Number|93|93.0||||||
3922954|NCT01428661|3746304|B4|Female||Gender||participants|Number|332|332.0||||||
3922955|NCT01428661|3746305|B3|Female||Gender||participants|Number|0|0.0||||||
3922956|NCT01428661|3746306|B2|Female||Gender||participants|Number|171|171.0||||||
3922957|NCT01428661|3746307|B1|Female||Gender||participants|Number|161|161.0||||||
3922958|NCT01428661|3746304|B4|||Age||years|Mean|44.1|44.1|Standard Deviation|12.19|12.19|||
3922959|NCT01428661|3746305|B3|||Age||years|Mean|44.1|44.1|Standard Deviation|12.19|12.19|||
3922960|NCT01428661|3746306|B2|||Age||years|Mean|NA||Standard Deviation|NA||||The 2 phases of the trial are being separated out so the additive total is correct for each phase.
3922961|NCT01428661|3746307|B1|||Age||years|Mean|NA||Standard Deviation|NA||||The 2 phases of the trial are being separated out so the additive total is correct for each phase.
3922962|NCT01428661|3746304|B4|||Age||years|Mean|42.9|42.9|Standard Deviation|12.54|12.54|||
3922963|NCT01428661|3746305|B3|||Age||years|Mean|NA||Standard Deviation|NA||||The 2 phases of the trial are being separated out so the additive total is correct for each phase.
3922966|NCT01428583|3746317|B1||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
3922967|NCT01428583|3746317|B1||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
3922968|NCT01428583|3746317|B1|||Age||years|Mean|53.8|53.8|Standard Deviation|12.10|12.1|||
3922969|NCT01428453|3746339|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|121|121.0||||||
3922970|NCT01428453|3746340|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|60|60.0||||||
3922971|NCT01428453|3746341|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|61|61.0||||||
3922972|NCT01428453|3746339|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3922973|NCT01428453|3746340|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3922974|NCT01428453|3746341|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3922975|NCT01428453|3746339|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3922976|NCT01428453|3746340|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3922977|NCT01428453|3746341|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3922978|NCT01428453|3746339|B3|||Age||Years|Mean|73.0|73.0|Standard Deviation|5.26|5.26|||
3922979|NCT01428453|3746340|B2|||Age||Years|Mean|72.9|72.9|Standard Deviation|5.15|5.15|||
3922980|NCT01428453|3746341|B1|||Age||Years|Mean|73.1|73.1|Standard Deviation|5.40|5.4|||
3922981|NCT01428336|3746366|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
3922982|NCT01428336|3746367|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3922983|NCT01428336|3746368|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3922984|NCT01428336|3746366|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3922985|NCT01428336|3746367|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3922986|NCT01428336|3746368|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3922987|NCT01428336|3746366|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3922988|NCT01428336|3746367|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3922989|NCT01428336|3746368|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3922990|NCT01428336|3746366|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922991|NCT01428336|3746367|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922992|NCT01428336|3746368|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3922993|NCT01428336|3746366|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3922994|NCT01428336|3746367|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3922995|NCT01428336|3746368|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3922996|NCT01428336|3746366|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922997|NCT01428336|3746367|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922998|NCT01428336|3746368|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3922999|NCT01428258|3746379|B3|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3923000|NCT01428258|3746380|B2|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3923001|NCT01428258|3746381|B1|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3923002|NCT01428258|3746379|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3923003|NCT01428258|3746380|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3923004|NCT01428258|3746381|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3923005|NCT01428258|3746379|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3923006|NCT01428258|3746380|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3923007|NCT01428258|3746381|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3923008|NCT01428258|3746379|B3|||Age||years|Mean|28|28.0|Full Range|||15.0|56.0|
3923009|NCT01428258|3746380|B2|||Age||years|Mean|28|28.0|Full Range|||15.0|56.0|
3923010|NCT01428258|3746381|B1|||Age||years|Mean|28|28.0|Full Range|||15.0|56.0|
3923011|NCT01428258|3746379|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3923012|NCT01428258|3746380|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3923013|NCT01428258|3746381|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3923014|NCT01428258|3746379|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3923015|NCT01428258|3746380|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3923016|NCT01428258|3746381|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3923017|NCT01428258|3746379|B3||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3923018|NCT01428258|3746380|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3923019|NCT01428258|3746381|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3923020|NCT01428219|3746400|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3923021|NCT01428219|3746400|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3923022|NCT01428219|3746400|B1|||Age||years|Mean|67|67.0|Full Range|||56.0|81.0|
3923023|NCT01428193|3746411|B1|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3923024|NCT01428193|3746411|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3923025|NCT01428193|3746411|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3923026|NCT01428193|3746411|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3923027|NCT01428193|3746411|B1|||Age||years|Mean|15.5|15.5|Full Range|||14.0|17.0|
3923028|NCT01428193|3746411|B1||>=65 years|Age|Age, Sex/Gender, Race, Ethnicity|Participants|Count of Participants|0|0.0||||||
3923029|NCT01428193|3746411|B1||Between 18 and 65 years|Age|Age, Sex/Gender, Race, Ethnicity|Participants|Count of Participants|0|0.0||||||
3923030|NCT01428193|3746411|B1||<=18 years|Age|Age, Sex/Gender, Race, Ethnicity|Participants|Count of Participants|4|4.0||||||
3923031|NCT01428128|3746415|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
3923032|NCT01428128|3746415|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3923033|NCT01428128|3746415|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3923034|NCT01428128|3746415|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3923035|NCT01428128|3746415|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3923036|NCT01428128|3746415|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3923037|NCT01428128|3746415|B1|||Age||years|Mean|52|52.0|Full Range|||29.0|80.0|
3923038|NCT01428115|3746420|B1|No||Participants with Comorbidities||participants|Number|65|65.0||||||
3923039|NCT01428115|3746420|B1|Yes||Participants with Comorbidities||participants|Number|18|18.0||||||
3923040|NCT01428115|3746420|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3923041|NCT01428115|3746420|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3923042|NCT01428115|3746420|B1|||Age||years|Mean|37.6|37.6|Standard Deviation|11.7|11.7|||
3923043|NCT01428076|3746433|B3|||BMI||kg/m^2|Mean|27.1|27.1|Standard Deviation|4.16|4.16|||
3923044|NCT01428076|3746434|B2|||BMI||kg/m^2|Mean|27.1|27.1|Standard Deviation|5.19|5.19|||
3923045|NCT01428076|3746435|B1|||BMI||kg/m^2|Mean|27.1|27.1|Standard Deviation|2.52|2.52|||
3923046|NCT01428076|3746433|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923047|NCT01428076|3746434|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923048|NCT01428076|3746435|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923049|NCT01428076|3746433|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923050|NCT01428076|3746434|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923051|NCT01428076|3746435|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923052|NCT01428076|3746433|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3923053|NCT01428076|3746434|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3923054|NCT01428076|3746435|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3923055|NCT01428076|3746433|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923056|NCT01428076|3746434|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923057|NCT01428076|3746435|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923058|NCT01428076|3746433|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923059|NCT01428076|3746434|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923060|NCT01428076|3746435|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923061|NCT01428076|3746433|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923062|NCT01428076|3746434|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923063|NCT01428076|3746435|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923064|NCT01428076|3746433|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923065|NCT01428076|3746434|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923066|NCT01428076|3746435|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923067|NCT01428076|3746433|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3923068|NCT01428076|3746434|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3923069|NCT01428076|3746435|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3923070|NCT01428076|3746433|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3923071|NCT01428076|3746434|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3923072|NCT01428076|3746435|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3923073|NCT01428076|3746433|B3|||Age||years|Mean|51.7|51.7|Standard Deviation|10.6|10.6|||
3923074|NCT01428076|3746434|B2|||Age||years|Mean|49.9|49.9|Standard Deviation|11.4|11.4|||
3923075|NCT01428076|3746435|B1|||Age||years|Mean|54.0|54.0|Standard Deviation|9.62|9.62|||
3923076|NCT01428063|3746444|B4||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3923077|NCT01428063|3746445|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3923078|NCT01428063|3746446|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3923079|NCT01428063|3746447|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3923080|NCT01428063|3746444|B4||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3923081|NCT01428063|3746445|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3923082|NCT01428063|3746446|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3923083|NCT01428063|3746447|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3923084|NCT01428063|3746444|B4|65 years and older||Age, Customized||Participants|Number|27|27.0||||||
3923085|NCT01428063|3746445|B3|65 years and older||Age, Customized||Participants|Number|0|0.0||||||
3923086|NCT01428063|3746446|B2|65 years and older||Age, Customized||Participants|Number|8|8.0||||||
3923087|NCT01428063|3746447|B1|65 years and older||Age, Customized||Participants|Number|19|19.0||||||
3923088|NCT01428063|3746444|B4|Younger than 65 years||Age, Customized||Participants|Number|200|200.0||||||
3923089|NCT01428063|3746445|B3|Younger than 65 years||Age, Customized||Participants|Number|6|6.0||||||
3923090|NCT01428063|3746446|B2|Younger than 65 years||Age, Customized||Participants|Number|114|114.0||||||
3923091|NCT01428063|3746447|B1|Younger than 65 years||Age, Customized||Participants|Number|80|80.0||||||
3923092|NCT01428024|3746518|B3|Sweden||Region of Enrollment||participants|Number|60|60.0||||||
3923093|NCT01428024|3746519|B2|Sweden||Region of Enrollment||participants|Number|30|30.0||||||
3923094|NCT01428024|3746520|B1|Sweden||Region of Enrollment||participants|Number|30|30.0||||||
3923095|NCT01428024|3746518|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3923096|NCT01428024|3746519|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3923097|NCT01428024|3746520|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3923098|NCT01428024|3746518|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3923099|NCT01428024|3746519|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3923100|NCT01428024|3746520|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3923101|NCT01428024|3746518|B3|||Age||years|Mean|42.8|42.8|Standard Deviation|11.9|11.9|||
3923102|NCT01428024|3746519|B2|||Age||years|Mean|49.4|49.4|Standard Deviation|6.4|6.4|||
3923103|NCT01428024|3746520|B1|||Age||years|Mean|36.1|36.1|Standard Deviation|12.5|12.5|||
3923104|NCT01428024|3746518|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3923105|NCT01428024|3746519|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3923106|NCT01428024|3746520|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3923107|NCT01428024|3746518|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3923108|NCT01428024|3746519|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3923109|NCT01428024|3746520|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3923110|NCT01428024|3746518|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3923111|NCT01428024|3746519|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3923112|NCT01428024|3746520|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3923113|NCT01427933|3746538|B3|United States||Region of Enrollment||participants|Number|141|141.0||||||
3923114|NCT01427933|3746539|B2|United States||Region of Enrollment||participants|Number|70|70.0||||||
3923115|NCT01427933|3746540|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
3923116|NCT01427933|3746538|B3|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3923117|NCT01427933|3746539|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3923118|NCT01427933|3746540|B1|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3923119|NCT01427933|3746538|B3|White||Race/Ethnicity, Customized||participants|Number|112|112.0||||||
3923120|NCT01427933|3746539|B2|White||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
3923121|NCT01427933|3746540|B1|White||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
3923122|NCT01427933|3746538|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3923123|NCT01427933|3746539|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3923124|NCT01427933|3746540|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3923125|NCT01427933|3746538|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3923126|NCT01427933|3746539|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3923127|NCT01427933|3746540|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3923128|NCT01427933|3746538|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3923129|NCT01427933|3746539|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3923130|NCT01427933|3746540|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3923131|NCT01427933|3746538|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3923132|NCT01427933|3746539|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923133|NCT01427933|3746540|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3923134|NCT01427933|3746538|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
3923135|NCT01427933|3746539|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3923136|NCT01427933|3746540|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3923137|NCT01427933|3746538|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3923138|NCT01427933|3746539|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3923139|NCT01427933|3746540|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3923140|NCT01427933|3746538|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3923141|NCT01427933|3746539|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3923142|NCT01427933|3746540|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3923143|NCT01427933|3746538|B3||Female|Gender||Participants|Count of Participants|141|141.0||||||
3923144|NCT01427933|3746539|B2||Female|Gender||Participants|Count of Participants|70|70.0||||||
3923145|NCT01427933|3746540|B1||Female|Gender||Participants|Count of Participants|71|71.0||||||
3923146|NCT01427933|3746538|B3||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
3923147|NCT01427933|3746539|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3923148|NCT01427933|3746540|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3923149|NCT01427933|3746538|B3||Between 18 and 65 years|Age||Participants|Count of Participants|115|115.0||||||
3923150|NCT01427933|3746539|B2||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
3923151|NCT01427933|3746540|B1||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
3923152|NCT01427933|3746538|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3923153|NCT01427933|3746539|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3923154|NCT01427933|3746540|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3923155|NCT01427920|3746559|B3|||Fasting Plasma Glucose||mmol/L|Mean|9.0|9.0|Standard Deviation|2.7|2.7|||
3923156|NCT01427920|3746560|B2|||Fasting Plasma Glucose||mmol/L|Mean|8.8|8.8|Standard Deviation|2.8|2.8|||
3923157|NCT01427920|3746561|B1|||Fasting Plasma Glucose||mmol/L|Mean|9.1|9.1|Standard Deviation|2.7|2.7|||
3923158|NCT01427920|3746559|B3|||Glycosylated Haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.3|8.3|Standard Deviation|0.9|0.9|||
3923159|NCT01427920|3746560|B2|||Glycosylated Haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.3|8.3|Standard Deviation|0.9|0.9|||
3923160|NCT01427920|3746561|B1|||Glycosylated Haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.3|8.3|Standard Deviation|0.9|0.9|||
3923161|NCT01427920|3746559|B3|||Body Mass Index||kg/m^2|Mean|29.4|29.4|Standard Deviation|4.7|4.7|||
3923162|NCT01427920|3746560|B2|||Body Mass Index||kg/m^2|Mean|29.2|29.2|Standard Deviation|4.7|4.7|||
3923163|NCT01427920|3746561|B1|||Body Mass Index||kg/m^2|Mean|29.7|29.7|Standard Deviation|4.8|4.8|||
3923164|NCT01427920|3746559|B3|||Body Weight||kg|Mean|79.5|79.5|Standard Deviation|15.7|15.7|||
3923165|NCT01427920|3746560|B2|||Body Weight||kg|Mean|78.0|78.0|Standard Deviation|15.0|15.0|||
3923166|NCT01427920|3746561|B1|||Body Weight||kg|Mean|81.0|81.0|Standard Deviation|16.2|16.2|||
3923167|NCT01427920|3746559|B3||Male|Gender||Participants|Count of Participants|178|178.0||||||
3923168|NCT01427920|3746560|B2||Male|Gender||Participants|Count of Participants|87|87.0||||||
3923169|NCT01427920|3746561|B1||Male|Gender||Participants|Count of Participants|91|91.0||||||
3923170|NCT01427920|3746559|B3||Female|Gender||Participants|Count of Participants|170|170.0||||||
3923171|NCT01427920|3746560|B2||Female|Gender||Participants|Count of Participants|87|87.0||||||
3923172|NCT01427920|3746561|B1||Female|Gender||Participants|Count of Participants|83|83.0||||||
3923173|NCT01427920|3746559|B3|||Age||years|Mean|58.5|58.5|Standard Deviation|9.6|9.6|||
3923174|NCT01427920|3746560|B2|||Age||years|Mean|58.0|58.0|Standard Deviation|9.5|9.5|||
3923175|NCT01427920|3746561|B1|||Age||years|Mean|58.9|58.9|Standard Deviation|9.8|9.8|||
3923176|NCT01427907|3746580|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
3923177|NCT01427907|3746581|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
3923178|NCT01427907|3746582|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3923179|NCT01427907|3746580|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3923180|NCT01427907|3746581|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3923181|NCT01427907|3746582|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3923182|NCT01427907|3746580|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3923183|NCT01427907|3746581|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3923184|NCT01427907|3746582|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3923185|NCT01427907|3746580|B3|||Age||years|Mean|59|59.0|Standard Deviation|18.0|18.0|||
3923186|NCT01427907|3746581|B2|||Age||years|Mean|57|57.0|Standard Deviation|20.2|20.2|||
3923187|NCT01427907|3746582|B1|||Age||years|Mean|60|60.0|Standard Deviation|16.3|16.3|||
3923188|NCT01427907|3746580|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3923189|NCT01427907|3746581|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3923190|NCT01427907|3746582|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3923191|NCT01427907|3746580|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3923192|NCT01427907|3746581|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3923193|NCT01427907|3746582|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3923194|NCT01427907|3746580|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3923195|NCT01427907|3746581|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3923196|NCT01427907|3746582|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3923197|NCT01427881|3746589|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3923198|NCT01427881|3746589|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3923199|NCT01427881|3746589|B1|||Age||years|Median|38|38.0|Full Range|||3.0|66.0|
3923200|NCT01427803|3746602|B3||Male|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
3923201|NCT01427803|3746603|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3923202|NCT01427803|3746604|B1||Male|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
3923203|NCT01427803|3746602|B3||Female|Sex: Female, Male||Participants|Count of Participants|363|363.0||||||
3923204|NCT01427803|3746603|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3923205|NCT01427803|3746604|B1||Female|Sex: Female, Male||Participants|Count of Participants|295|295.0||||||
3923206|NCT01427803|3746602|B3|55 Years or Older||Age, Customized||Participants|Number|257|257.0||||||
3923207|NCT01427803|3746603|B2|55 Years or Older||Age, Customized||Participants|Number|55|55.0||||||
3923208|NCT01427803|3746604|B1|55 Years or Older||Age, Customized||Participants|Number|202|202.0||||||
3923209|NCT01427803|3746602|B3|45 to 54 Years||Age, Customized||Participants|Number|172|172.0||||||
3923210|NCT01427803|3746603|B2|45 to 54 Years||Age, Customized||Participants|Number|30|30.0||||||
3923211|NCT01427803|3746604|B1|45 to 54 Years||Age, Customized||Participants|Number|142|142.0||||||
3923212|NCT01427803|3746602|B3|35 to 44 Years||Age, Customized||Participants|Number|109|109.0||||||
3923213|NCT01427803|3746603|B2|35 to 44 Years||Age, Customized||Participants|Number|28|28.0||||||
3923214|NCT01427803|3746604|B1|35 to 44 Years||Age, Customized||Participants|Number|81|81.0||||||
3923215|NCT01427803|3746602|B3|25 to 34 Years||Age, Customized||Participants|Number|76|76.0||||||
3923216|NCT01427803|3746603|B2|25 to 34 Years||Age, Customized||Participants|Number|13|13.0||||||
3923217|NCT01427803|3746604|B1|25 to 34 Years||Age, Customized||Participants|Number|63|63.0||||||
3923218|NCT01427803|3746602|B3|18 to 24 Years||Age, Customized||Participants|Number|29|29.0||||||
3923219|NCT01427803|3746603|B2|18 to 24 Years||Age, Customized||Participants|Number|4|4.0||||||
3923220|NCT01427803|3746604|B1|18 to 24 Years||Age, Customized||Participants|Number|25|25.0||||||
3923221|NCT01427803|3746602|B3|12 to 17 Years||Age, Customized||Participants|Number|3|3.0||||||
3923222|NCT01427803|3746603|B2|12 to 17 Years||Age, Customized||Participants|Number|0|0.0||||||
3923223|NCT01427803|3746604|B1|12 to 17 Years||Age, Customized||Participants|Number|3|3.0||||||
3923224|NCT01427751|3746617|B3||Male|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
3923225|NCT01427751|3746618|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3923226|NCT01427751|3746619|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3923227|NCT01427751|3746617|B3||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3923228|NCT01427751|3746618|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3923229|NCT01427751|3746619|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3923230|NCT01427751|3746617|B3|||Age||years|Mean|67.0|67.0|Standard Deviation|11.41|11.41|||
3923231|NCT01427751|3746618|B2|||Age||years|Mean|65.5|65.5|Standard Deviation|12.04|12.04|||
3923232|NCT01427751|3746619|B1|||Age||years|Mean|68.4|68.4|Standard Deviation|10.58|10.58|||
3923233|NCT01427738|3746638|B3|||HIV RNA Viral Load||log10(copies/ml)|Mean|4.96|4.96|Standard Deviation|1.26|1.26|||
3923234|NCT01427738|3746639|B2|||HIV RNA Viral Load||log10(copies/ml)|Mean|5.03|5.03|Standard Deviation|1.21|1.21|||
3923235|NCT01427738|3746640|B1|||HIV RNA Viral Load||log10(copies/ml)|Mean|4.89|4.89|Standard Deviation|1.31|1.31|||
3923236|NCT01427738|3746638|B3|> 200 cells/microliter||CD4 Count||participants|Number|46|46.0||||||
3923237|NCT01427738|3746639|B2|> 200 cells/microliter||CD4 Count||participants|Number|23|23.0||||||
3923238|NCT01427738|3746640|B1|> 200 cells/microliter||CD4 Count||participants|Number|23|23.0||||||
3923239|NCT01427738|3746638|B3|0-200 cells/microliter||CD4 Count||participants|Number|175|175.0||||||
3923240|NCT01427738|3746639|B2|0-200 cells/microliter||CD4 Count||participants|Number|88|88.0||||||
3923241|NCT01427738|3746640|B1|0-200 cells/microliter||CD4 Count||participants|Number|87|87.0||||||
3923242|NCT01427738|3746638|B3|Not on ART||Antiretroviral Therapy Usage||participants|Number|166|166.0||||||
3923243|NCT01427738|3746639|B2|Not on ART||Antiretroviral Therapy Usage||participants|Number|83|83.0||||||
3923244|NCT01427738|3746640|B1|Not on ART||Antiretroviral Therapy Usage||participants|Number|83|83.0||||||
3923245|NCT01427738|3746638|B3|On ART||Antiretroviral Therapy Usage||participants|Number|55|55.0||||||
3923246|NCT01427738|3746639|B2|On ART||Antiretroviral Therapy Usage||participants|Number|28|28.0||||||
3923247|NCT01427738|3746640|B1|On ART||Antiretroviral Therapy Usage||participants|Number|27|27.0||||||
3923248|NCT01427738|3746638|B3|Asian, Pacific Islander||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3923249|NCT01427738|3746639|B2|Asian, Pacific Islander||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3923250|NCT01427738|3746640|B1|Asian, Pacific Islander||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3923251|NCT01427738|3746638|B3|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|203|203.0||||||
3923252|NCT01427738|3746639|B2|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|106|106.0||||||
3923253|NCT01427738|3746640|B1|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|97|97.0||||||
3923254|NCT01427738|3746638|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3923255|NCT01427738|3746639|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3923256|NCT01427738|3746640|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3923257|NCT01427738|3746638|B3||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3923258|NCT01427738|3746639|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3923259|NCT01427738|3746640|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3923260|NCT01427738|3746638|B3|Over 60 years||Age, Customized||participants|Number|4|4.0||||||
3923261|NCT01427738|3746639|B2|Over 60 years||Age, Customized||participants|Number|2|2.0||||||
3923262|NCT01427738|3746640|B1|Over 60 years||Age, Customized||participants|Number|2|2.0||||||
3923263|NCT01427738|3746638|B3|50-59 years||Age, Customized||participants|Number|25|25.0||||||
3923264|NCT01427738|3746639|B2|50-59 years||Age, Customized||participants|Number|9|9.0||||||
3923265|NCT01427738|3746640|B1|50-59 years||Age, Customized||participants|Number|16|16.0||||||
3923266|NCT01427738|3746638|B3|40-49 years||Age, Customized||participants|Number|38|38.0||||||
3923267|NCT01427738|3746639|B2|40-49 years||Age, Customized||participants|Number|17|17.0||||||
3923268|NCT01427738|3746640|B1|40-49 years||Age, Customized||participants|Number|21|21.0||||||
3923269|NCT01427738|3746638|B3|30-39 years||Age, Customized||participants|Number|106|106.0||||||
3923270|NCT01427738|3746639|B2|30-39 years||Age, Customized||participants|Number|52|52.0||||||
3923271|NCT01427738|3746640|B1|30-39 years||Age, Customized||participants|Number|54|54.0||||||
3923272|NCT01427738|3746638|B3|20-29 years||Age, Customized||participants|Number|47|47.0||||||
3923273|NCT01427738|3746639|B2|20-29 years||Age, Customized||participants|Number|30|30.0||||||
3923274|NCT01427738|3746640|B1|20-29 years||Age, Customized||participants|Number|17|17.0||||||
3923275|NCT01427738|3746638|B3|10-19 years||Age, Customized||participants|Number|1|1.0||||||
3923276|NCT01427738|3746639|B2|10-19 years||Age, Customized||participants|Number|1|1.0||||||
3923277|NCT01427738|3746640|B1|10-19 years||Age, Customized||participants|Number|0|0.0||||||
3923278|NCT01427517|3746659|B4|United States||Region of Enrollment||participants|Number|9|9.0||||||
3923279|NCT01427517|3746660|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3923280|NCT01427517|3746661|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3923281|NCT01427517|3746662|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3923282|NCT01427517|3746659|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3923283|NCT01427517|3746660|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3923284|NCT01427517|3746661|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3923285|NCT01427517|3746662|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3923286|NCT01427517|3746659|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3923287|NCT01427517|3746660|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3923288|NCT01427517|3746661|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3923289|NCT01427517|3746662|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3923290|NCT01427517|3746659|B4|||Age||years|Mean|52.11|52.11|Standard Deviation|13.46|13.46|||
3923291|NCT01427517|3746660|B3|||Age||years|Mean|58|58.0|Standard Deviation|0|0.0|||
3923292|NCT01427517|3746661|B2|||Age||years|Mean|44|44.0|Standard Deviation|23.58|23.58|||
3923293|NCT01427517|3746662|B1|||Age||years|Mean|54.33|54.33|Standard Deviation|3.21|3.21|||
3923294|NCT01427517|3746659|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3923295|NCT01427517|3746660|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3923296|NCT01427517|3746661|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3923297|NCT01427517|3746662|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3923298|NCT01427517|3746659|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3923299|NCT01427517|3746660|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3923300|NCT01427517|3746661|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3923301|NCT01427517|3746662|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3923302|NCT01427517|3746659|B4||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3923303|NCT01427517|3746660|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3923304|NCT01427517|3746661|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3923305|NCT01427517|3746662|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3923306|NCT01427504|3746672|B7|United States||Region of Enrollment||participants|Number|26|26.0||||||
3923307|NCT01427504|3746673|B6|United States||Region of Enrollment||participants|Number|6|6.0||||||
3923308|NCT01427504|3746674|B5|United States||Region of Enrollment||participants|Number|3|3.0||||||
3923309|NCT01427504|3746675|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
3923310|NCT01427504|3746676|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3923311|NCT01427504|3746677|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3923312|NCT01427504|3746678|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3923313|NCT01427504|3746672|B7||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3923314|NCT01427504|3746673|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3923315|NCT01427504|3746674|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3923316|NCT01427504|3746675|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3923317|NCT01427504|3746676|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3923318|NCT01427504|3746677|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3923319|NCT01427504|3746678|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3923320|NCT01427504|3746672|B7||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3923321|NCT01427504|3746673|B6||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3923322|NCT01427504|3746674|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3923323|NCT01427504|3746675|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3923324|NCT01427504|3746676|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3923325|NCT01427504|3746677|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3923326|NCT01427504|3746678|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3923327|NCT01427504|3746672|B7|||Age||years|Mean|34.2|34.2|Standard Deviation|10.9|10.9|||
3923328|NCT01427504|3746673|B6|||Age||years|Mean|32.4|32.4|Standard Deviation|9.3|9.3|||
3923329|NCT01427504|3746674|B5|||Age||years|Mean|42.7|42.7|Standard Deviation|16.8|16.8|||
3923330|NCT01427504|3746675|B4|||Age||years|Mean|25.9|25.9|Standard Deviation|3.8|3.8|||
3923331|NCT01427504|3746676|B3|||Age||years|Mean|33.3|33.3|Standard Deviation|9.8|9.8|||
3923332|NCT01427504|3746677|B2|||Age||years|Mean|35.6|35.6|Standard Deviation|8.0|8.0|||
3923333|NCT01427504|3746678|B1|||Age||years|Mean|42.7|42.7|Standard Deviation|13.4|13.4|||
3923334|NCT01427504|3746672|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3923335|NCT01427504|3746673|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3923336|NCT01427504|3746674|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3923337|NCT01427504|3746675|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3923338|NCT01427504|3746676|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3923339|NCT01427504|3746677|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3923340|NCT01427504|3746678|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3923341|NCT01427504|3746672|B7||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3923342|NCT01427504|3746673|B6||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3923343|NCT01427504|3746674|B5||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3923344|NCT01427504|3746675|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3923345|NCT01427504|3746676|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3923346|NCT01427504|3746677|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3923347|NCT01427504|3746678|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3923348|NCT01427504|3746672|B7||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3923349|NCT01427504|3746673|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3923350|NCT01427504|3746674|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3923351|NCT01427504|3746675|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3923352|NCT01427504|3746676|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3923353|NCT01427504|3746677|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3923354|NCT01427504|3746678|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3923355|NCT01427309|3746700|B5|Canada||Region of Enrollment||Participants|Number|1445|1445.0||||||
3923356|NCT01427309|3746701|B4|Canada||Region of Enrollment||Participants|Number|423|423.0||||||
3923357|NCT01427309|3746702|B3|Canada||Region of Enrollment||Participants|Number|422|422.0||||||
3923358|NCT01427309|3746703|B2|Canada||Region of Enrollment||Participants|Number|300|300.0||||||
3923359|NCT01427309|3746704|B1|Canada||Region of Enrollment||Participants|Number|300|300.0||||||
3923360|NCT01427309|3746700|B5|United States||Region of Enrollment||Participants|Number|30538|30538.0||||||
3923361|NCT01427309|3746701|B4|United States||Region of Enrollment||Participants|Number|8326|8326.0||||||
3923362|NCT01427309|3746702|B3|United States||Region of Enrollment||Participants|Number|8315|8315.0||||||
3923363|NCT01427309|3746703|B2|United States||Region of Enrollment||Participants|Number|6944|6944.0||||||
3923364|NCT01427309|3746704|B1|United States||Region of Enrollment||Participants|Number|6953|6953.0||||||
3923365|NCT01427309|3746700|B5||Male|Sex: Female, Male||Participants|Count of Participants|13889|13889.0||||||
3923366|NCT01427309|3746701|B4||Male|Sex: Female, Male||Participants|Count of Participants|3827|3827.0||||||
3923367|NCT01427309|3746702|B3||Male|Sex: Female, Male||Participants|Count of Participants|3691|3691.0||||||
3923368|NCT01427309|3746703|B2||Male|Sex: Female, Male||Participants|Count of Participants|3203|3203.0||||||
3923369|NCT01427309|3746704|B1||Male|Sex: Female, Male||Participants|Count of Participants|3168|3168.0||||||
3923370|NCT01427309|3746700|B5||Female|Sex: Female, Male||Participants|Count of Participants|18094|18094.0||||||
3923371|NCT01427309|3746701|B4||Female|Sex: Female, Male||Participants|Count of Participants|4922|4922.0||||||
3923372|NCT01427309|3746702|B3||Female|Sex: Female, Male||Participants|Count of Participants|5046|5046.0||||||
3923373|NCT01427309|3746703|B2||Female|Sex: Female, Male||Participants|Count of Participants|4041|4041.0||||||
3923374|NCT01427309|3746704|B1||Female|Sex: Female, Male||Participants|Count of Participants|4085|4085.0||||||
3923375|NCT01427309|3746700|B5|||Age||Years|Mean|73.3|73.3|Standard Deviation|5.82|5.82|||
3923376|NCT01427309|3746701|B4|||Age||Years|Mean|73.4|73.4|Standard Deviation|5.85|5.85|||
3923377|NCT01427309|3746702|B3|||Age||Years|Mean|73.3|73.3|Standard Deviation|5.74|5.74|||
3923378|NCT01427309|3746703|B2|||Age||Years|Mean|73.2|73.2|Standard Deviation|5.82|5.82|||
3923379|NCT01427309|3746704|B1|||Age||Years|Mean|73.3|73.3|Standard Deviation|5.88|5.88|||
3923380|NCT01427309|3746700|B5||>=65 years|Age||Participants|Count of Participants|31983|31983.0||||||
3923381|NCT01427309|3746701|B4||>=65 years|Age||Participants|Count of Participants|8749|8749.0||||||
3923382|NCT01427309|3746702|B3||>=65 years|Age||Participants|Count of Participants|8737|8737.0||||||
3923383|NCT01427309|3746703|B2||>=65 years|Age||Participants|Count of Participants|7244|7244.0||||||
3923384|NCT01427309|3746704|B1||>=65 years|Age||Participants|Count of Participants|7253|7253.0||||||
3923385|NCT01427309|3746700|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3923386|NCT01427309|3746701|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3923387|NCT01427309|3746702|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3923388|NCT01427309|3746703|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3923389|NCT01427309|3746704|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3923390|NCT01427309|3746700|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3923391|NCT01427309|3746701|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3923392|NCT01427309|3746702|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3923393|NCT01427309|3746703|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3923394|NCT01427309|3746704|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3923395|NCT01427296|3746745|B3||Male|Sex: Female, Male||Participants|Count of Participants|831|831.0||||||
3923396|NCT01427296|3746746|B2||Male|Sex: Female, Male||Participants|Count of Participants|406|406.0||||||
3923397|NCT01427296|3746747|B1||Male|Sex: Female, Male||Participants|Count of Participants|425|425.0||||||
3923398|NCT01427296|3746745|B3||Female|Sex: Female, Male||Participants|Count of Participants|1261|1261.0||||||
3923399|NCT01427296|3746746|B2||Female|Sex: Female, Male||Participants|Count of Participants|645|645.0||||||
3923400|NCT01427296|3746747|B1||Female|Sex: Female, Male||Participants|Count of Participants|616|616.0||||||
3923401|NCT01427296|3746745|B3|>=65||Age, Customized||Participants|Count of Participants|254|254.0||||||
3923402|NCT01427296|3746746|B2|>=65||Age, Customized||Participants|Count of Participants|119|119.0||||||
3923403|NCT01427296|3746747|B1|>=65||Age, Customized||Participants|Count of Participants|135|135.0||||||
3923404|NCT01427296|3746745|B3|<65||Age, Customized||Participants|Count of Participants|1838|1838.0||||||
3923405|NCT01427296|3746746|B2|<65||Age, Customized||Participants|Count of Participants|932|932.0||||||
3923406|NCT01427296|3746747|B1|<65||Age, Customized||Participants|Count of Participants|906|906.0||||||
3923407|NCT01426958|3746754|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3923408|NCT01426958|3746754|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3923409|NCT01426958|3746754|B1|||Age||years|Mean|38.0|38.0|Standard Deviation|8.3|8.3|||
3923410|NCT01426867|3746768|B4|United States||Region of Enrollment||participants|Number|101|101.0||||||
3923411|NCT01426867|3746769|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
3923412|NCT01426867|3746770|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
3923413|NCT01426867|3746771|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
3923414|NCT01426867|3746768|B4||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3923415|NCT01426867|3746769|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3923416|NCT01426867|3746770|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3923417|NCT01426867|3746771|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3923418|NCT01426867|3746768|B4||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3923419|NCT01426867|3746769|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3923420|NCT01426867|3746770|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3923421|NCT01426867|3746771|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3923422|NCT01426867|3746768|B4|≥65 years||Age, Customized||participants|Number|70|70.0||||||
3923423|NCT01426867|3746769|B3|≥65 years||Age, Customized||participants|Number|23|23.0||||||
3923424|NCT01426867|3746770|B2|≥65 years||Age, Customized||participants|Number|22|22.0||||||
3923425|NCT01426867|3746771|B1|≥65 years||Age, Customized||participants|Number|25|25.0||||||
3923426|NCT01426867|3746768|B4|18 to 64 years||Age, Customized||participants|Number|31|31.0||||||
3923427|NCT01426867|3746769|B3|18 to 64 years||Age, Customized||participants|Number|11|11.0||||||
3923428|NCT01426867|3746770|B2|18 to 64 years||Age, Customized||participants|Number|12|12.0||||||
3923429|NCT01426867|3746771|B1|18 to 64 years||Age, Customized||participants|Number|8|8.0||||||
3923430|NCT01426854|3746781|B3|China||Region of Enrollment||participants|Number|248|248.0||||||
3923431|NCT01426854|3746782|B2|China||Region of Enrollment||participants|Number|123|123.0||||||
3923432|NCT01426854|3746783|B1|China||Region of Enrollment||participants|Number|125|125.0||||||
3923433|NCT01426854|3746781|B3||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3923434|NCT01426854|3746782|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3923435|NCT01426854|3746783|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3923436|NCT01426854|3746781|B3||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3923437|NCT01426854|3746782|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3923438|NCT01426854|3746783|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3923439|NCT01426854|3746781|B3|85 to <95 years||Age, Customized||participants|Number|8|8.0||||||
3923440|NCT01426854|3746782|B2|85 to <95 years||Age, Customized||participants|Number|3|3.0||||||
3923441|NCT01426854|3746783|B1|85 to <95 years||Age, Customized||participants|Number|5|5.0||||||
3923442|NCT01426854|3746781|B3|75 to <85 years||Age, Customized||participants|Number|85|85.0||||||
3923443|NCT01426854|3746782|B2|75 to <85 years||Age, Customized||participants|Number|43|43.0||||||
3923444|NCT01426854|3746783|B1|75 to <85 years||Age, Customized||participants|Number|42|42.0||||||
3923445|NCT01426854|3746781|B3|65 to <75 years||Age, Customized||participants|Number|87|87.0||||||
3923446|NCT01426854|3746782|B2|65 to <75 years||Age, Customized||participants|Number|44|44.0||||||
3923447|NCT01426854|3746783|B1|65 to <75 years||Age, Customized||participants|Number|43|43.0||||||
3923448|NCT01426854|3746781|B3|18 to <65 years||Age, Customized||participants|Number|68|68.0||||||
3923449|NCT01426854|3746782|B2|18 to <65 years||Age, Customized||participants|Number|33|33.0||||||
3923450|NCT01426854|3746783|B1|18 to <65 years||Age, Customized||participants|Number|35|35.0||||||
3923451|NCT01426854|3746781|B3|||Age||years|Mean|69.3|69.3|Standard Deviation|10.40|10.4|||
3923452|NCT01426854|3746782|B2|||Age||years|Mean|69.8|69.8|Standard Deviation|10.19|10.19|||
3923453|NCT01426854|3746783|B1|||Age||years|Mean|68.8|68.8|Standard Deviation|10.62|10.62|||
3923454|NCT01426789|3746792|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3923455|NCT01426789|3746793|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3923456|NCT01426789|3746794|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3923457|NCT01426789|3746792|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3923458|NCT01426789|3746793|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3923459|NCT01426789|3746794|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3923460|NCT01426789|3746792|B3|||Age||Years|Mean|51.1|51.1|Standard Deviation|11.29|11.29|||
3923461|NCT01426789|3746793|B2|||Age||Years|Mean|54.5|54.5|Standard Deviation|10.30|10.3|||
3923462|NCT01426789|3746794|B1|||Age||Years|Mean|49.5|49.5|Standard Deviation|11.45|11.45|||
3923463|NCT01426763|3746813|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3923464|NCT01426763|3746814|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3923465|NCT01426763|3746815|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3923466|NCT01426763|3746813|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3923467|NCT01426763|3746814|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3923468|NCT01426763|3746815|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3923469|NCT01426763|3746813|B3|||Age||years|Mean|32.6|32.6|Standard Deviation|8.76|8.76|||
3923470|NCT01426763|3746814|B2|||Age||years|Mean|33.7|33.7|Standard Deviation|10.27|10.27|||
3923471|NCT01426763|3746815|B1|||Age||years|Mean|31.5|31.5|Standard Deviation|7.79|7.79|||
3923472|NCT01426555|3746822|B3|United States||Region of Enrollment||participants|Number|70|70.0||||||
3923473|NCT01426555|3746823|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
3923474|NCT01426555|3746824|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3923475|NCT01426555|3746822|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3923476|NCT01426555|3746823|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3923477|NCT01426555|3746824|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3923478|NCT01426555|3746822|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3923479|NCT01426555|3746823|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3923480|NCT01426555|3746824|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3923481|NCT01426555|3746822|B3|||Age||Years|Mean|38.1|38.1|Full Range|||20.7|65.0|
3923482|NCT01426555|3746823|B2|||Age||Years|Mean|39.0|39.0|Full Range|||21.1|65.0|
3923483|NCT01426555|3746824|B1|||Age||Years|Mean|37.2|37.2|Full Range|||20.7|63.5|
3923484|NCT01426555|3746822|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3923485|NCT01426555|3746823|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3923486|NCT01426555|3746824|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3923487|NCT01426555|3746822|B3||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
3923488|NCT01426555|3746823|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3923489|NCT01426555|3746824|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3923490|NCT01426555|3746822|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3923491|NCT01426555|3746823|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3923492|NCT01426555|3746824|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3923493|NCT01426516|3746833|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923494|NCT01426516|3746834|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923495|NCT01426516|3746835|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923496|NCT01426516|3746833|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3923497|NCT01426516|3746834|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3923498|NCT01426516|3746835|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3923499|NCT01426516|3746833|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3923500|NCT01426516|3746834|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923501|NCT01426516|3746835|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3923502|NCT01426516|3746833|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3923503|NCT01426516|3746834|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3923504|NCT01426516|3746835|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3923505|NCT01426516|3746833|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3923506|NCT01426516|3746834|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3923507|NCT01426516|3746835|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3923508|NCT01426516|3746833|B3|||Age||Years|Mean|45|45.0|Full Range|||23.0|65.0|
3923509|NCT01426516|3746834|B2|||Age||Years|Mean|46|46.0|Full Range|||23.0|65.0|
3923510|NCT01426516|3746835|B1|||Age||Years|Mean|44|44.0|Full Range|||24.0|59.0|
3923511|NCT01426516|3746833|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3923512|NCT01426516|3746834|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3923513|NCT01426516|3746835|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3923514|NCT01426516|3746833|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3923515|NCT01426516|3746834|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3923516|NCT01426516|3746835|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3923517|NCT01426516|3746833|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3923518|NCT01426516|3746834|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3923519|NCT01426516|3746835|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3923520|NCT01426438|3746842|B3|||D-Dimer||ug/ml|Median|0.29|0.29|Inter-Quartile Range|||0.19|0.42|
3923521|NCT01426438|3746843|B2|||D-Dimer||ug/ml|Median|0.25|0.25|Inter-Quartile Range|||0.19|0.46|
3923522|NCT01426438|3746844|B1|||D-Dimer||ug/ml|Median|0.30|0.3|Inter-Quartile Range|||0.22|0.37|
3923523|NCT01426438|3746842|B3|||C-reactive protein||ug/ml|Median|1.7|1.7|Inter-Quartile Range|||0.8|4.3|
3923524|NCT01426438|3746843|B2|||C-reactive protein||ug/ml|Median|1.5|1.5|Inter-Quartile Range|||0.7|3.9|
3923525|NCT01426438|3746844|B1|||C-reactive protein||ug/ml|Median|1.9|1.9|Inter-Quartile Range|||1.0|5.4|
3923526|NCT01426438|3746842|B3|||Interleukin(IL)-6|Niacin + Aspirin N=34; Fenofibrate N=35.|pg/ml|Median|1.3|1.3|Inter-Quartile Range|||0.8|2.2|
3923527|NCT01426438|3746843|B2|||Interleukin(IL)-6|Niacin + Aspirin N=34; Fenofibrate N=35.|pg/ml|Median|1.5|1.5|Inter-Quartile Range|||0.8|2.2|
3923528|NCT01426438|3746844|B1|||Interleukin(IL)-6|Niacin + Aspirin N=34; Fenofibrate N=35.|pg/ml|Median|1.1|1.1|Inter-Quartile Range|||0.8|2.2|
3923529|NCT01426438|3746842|B3|||HOMA-IR (Homeostatic model assessment - Insulin Resistance)|Niacin + Aspirin N=34; Fenofibrate N=39.|HOMA IR Score|Median|3.1|3.1|Inter-Quartile Range|||2.1|4.8|
3923530|NCT01426438|3746843|B2|||HOMA-IR (Homeostatic model assessment - Insulin Resistance)|Niacin + Aspirin N=34; Fenofibrate N=39.|HOMA IR Score|Median|3.2|3.2|Inter-Quartile Range|||2.6|5.3|
3923531|NCT01426438|3746844|B1|||HOMA-IR (Homeostatic model assessment - Insulin Resistance)|Niacin + Aspirin N=34; Fenofibrate N=39.|HOMA IR Score|Median|2.5|2.5|Inter-Quartile Range|||1.9|4.5|
3923532|NCT01426438|3746842|B3|||Large HDL Particles||nmol/L|Median|2.5|2.5|Inter-Quartile Range|||1.5|3.3|
3923533|NCT01426438|3746843|B2|||Large HDL Particles||nmol/L|Median|2.6|2.6|Inter-Quartile Range|||1.5|3.7|
3923534|NCT01426438|3746844|B1|||Large HDL Particles||nmol/L|Median|2.1|2.1|Inter-Quartile Range|||1.4|3.2|
3923535|NCT01426438|3746842|B3|||Small LDL Particles||nmol/L|Median|1022|1022.0|Inter-Quartile Range|||816.0|1161.0|
3923536|NCT01426438|3746843|B2|||Small LDL Particles||nmol/L|Median|1052|1052.0|Inter-Quartile Range|||823.0|1222.0|
3923537|NCT01426438|3746844|B1|||Small LDL Particles||nmol/L|Median|1018|1018.0|Inter-Quartile Range|||803.0|1133.0|
3923538|NCT01426438|3746842|B3|||Low Density Lipoprotein (LDL) Cholesterol|Niacin + Aspirin N=29; Fenofibrate N=36.|mg/dL|Median|103|103.0|Inter-Quartile Range|||86.0|119.0|
3923539|NCT01426438|3746843|B2|||Low Density Lipoprotein (LDL) Cholesterol|Niacin + Aspirin N=29; Fenofibrate N=36.|mg/dL|Median|101|101.0|Inter-Quartile Range|||84.0|120.0|
3923540|NCT01426438|3746844|B1|||Low Density Lipoprotein (LDL) Cholesterol|Niacin + Aspirin N=29; Fenofibrate N=36.|mg/dL|Median|103|103.0|Inter-Quartile Range|||88.0|117.0|
3923541|NCT01426438|3746842|B3|||Non-HDL Cholesterol|Niacin + Aspirin N=34; Fenofibrate N=39.|mg/dL|Median|150|150.0|Inter-Quartile Range|||128.0|169.0|
3923542|NCT01426438|3746843|B2|||Non-HDL Cholesterol|Niacin + Aspirin N=34; Fenofibrate N=39.|mg/dL|Median|153|153.0|Inter-Quartile Range|||123.0|175.0|
3923543|NCT01426438|3746844|B1|||Non-HDL Cholesterol|Niacin + Aspirin N=34; Fenofibrate N=39.|mg/dL|Median|150|150.0|Inter-Quartile Range|||135.0|169.0|
3923544|NCT01426438|3746842|B3|||HDL Particles||nmol/L|Median|31.3|31.3|Inter-Quartile Range|||27.2|34.8|
3923545|NCT01426438|3746843|B2|||HDL Particles||nmol/L|Median|30.2|30.2|Inter-Quartile Range|||26.7|33.2|
3923546|NCT01426438|3746844|B1|||HDL Particles||nmol/L|Median|31.8|31.8|Inter-Quartile Range|||28.4|35.4|
3923547|NCT01426438|3746842|B3|||Women: HDL Cholesterol|"Since the eligibility requirements for HDL cholesterol differed for men and women, HDL cholesterol is reported separately for men and women.~Niacin + Aspirin N=7; Fenofibrate N=9."|mg/dL|Median|38|38.0|Inter-Quartile Range|||36.0|46.0|
3923548|NCT01426438|3746843|B2|||Women: HDL Cholesterol|"Since the eligibility requirements for HDL cholesterol differed for men and women, HDL cholesterol is reported separately for men and women.~Niacin + Aspirin N=7; Fenofibrate N=9."|mg/dL|Median|38|38.0|Inter-Quartile Range|||35.0|42.0|
3923549|NCT01426438|3746844|B1|||Women: HDL Cholesterol|"Since the eligibility requirements for HDL cholesterol differed for men and women, HDL cholesterol is reported separately for men and women.~Niacin + Aspirin N=7; Fenofibrate N=9."|mg/dL|Median|37|37.0|Inter-Quartile Range|||36.0|49.0|
3923550|NCT01426438|3746842|B3|||Men: HDL Cholesterol|"Since the eligibility requirements for HDL cholesterol differed for men and women, HDL cholesterol is reported separately for men and women.~Niacin + Aspirin N=27; Fenofibrate N=30."|mg/dL|Median|33|33.0|Inter-Quartile Range|||30.0|37.0|
3923551|NCT01426438|3746843|B2|||Men: HDL Cholesterol|"Since the eligibility requirements for HDL cholesterol differed for men and women, HDL cholesterol is reported separately for men and women.~Niacin + Aspirin N=27; Fenofibrate N=30."|mg/dL|Median|36|36.0|Inter-Quartile Range|||29.0|39.0|
3923552|NCT01426438|3746844|B1|||Men: HDL Cholesterol|"Since the eligibility requirements for HDL cholesterol differed for men and women, HDL cholesterol is reported separately for men and women.~Niacin + Aspirin N=27; Fenofibrate N=30."|mg/dL|Median|32|32.0|Inter-Quartile Range|||30.0|35.0|
3923553|NCT01426438|3746842|B3|Low HDL-C (30-40 mg/dL (Men)/40-50 mg/dL (Women))||High Density Lipoprotein (HDL)-Cholesterol||participants|Number|52|52.0||||||
3923554|NCT01426438|3746843|B2|Low HDL-C (30-40 mg/dL (Men)/40-50 mg/dL (Women))||High Density Lipoprotein (HDL)-Cholesterol||participants|Number|27|27.0||||||
3923555|NCT01426438|3746844|B1|Low HDL-C (30-40 mg/dL (Men)/40-50 mg/dL (Women))||High Density Lipoprotein (HDL)-Cholesterol||participants|Number|25|25.0||||||
3923556|NCT01426438|3746842|B3|Very low HDL-C (< 30 mg/dL (Men)/< 40 mg/dL (W))||High Density Lipoprotein (HDL)-Cholesterol||participants|Number|22|22.0||||||
3923557|NCT01426438|3746843|B2|Very low HDL-C (< 30 mg/dL (Men)/< 40 mg/dL (W))||High Density Lipoprotein (HDL)-Cholesterol||participants|Number|12|12.0||||||
3923558|NCT01426438|3746844|B1|Very low HDL-C (< 30 mg/dL (Men)/< 40 mg/dL (W))||High Density Lipoprotein (HDL)-Cholesterol||participants|Number|10|10.0||||||
3923559|NCT01426438|3746842|B3|||Triglycerides|Niacin + Aspirin N=34; Fenofibrate N=39.|mg/dL|Median|232|232.0|Inter-Quartile Range|||176.0|308.0|
3923560|NCT01426438|3746843|B2|||Triglycerides|Niacin + Aspirin N=34; Fenofibrate N=39.|mg/dL|Median|206|206.0|Inter-Quartile Range|||171.0|293.0|
3923561|NCT01426438|3746844|B1|||Triglycerides|Niacin + Aspirin N=34; Fenofibrate N=39.|mg/dL|Median|254|254.0|Inter-Quartile Range|||198.0|360.0|
3923562|NCT01426438|3746842|B3|||Baseline Cholesterol|Niacin + Aspirin N=34; Fenofibrate N=39.|mg/dL|Median|184|184.0|Inter-Quartile Range|||165.0|211.0|
3923563|NCT01426438|3746843|B2|||Baseline Cholesterol|Niacin + Aspirin N=34; Fenofibrate N=39.|mg/dL|Median|184|184.0|Inter-Quartile Range|||159.0|211.0|
3923564|NCT01426438|3746844|B1|||Baseline Cholesterol|Niacin + Aspirin N=34; Fenofibrate N=39.|mg/dL|Median|185|185.0|Inter-Quartile Range|||171.0|212.0|
3923565|NCT01426438|3746842|B3|||Relative FMD||%|Median|4.21|4.21|Inter-Quartile Range|||2.76|6.76|
3923566|NCT01426438|3746843|B2|||Relative FMD||%|Median|3.93|3.93|Inter-Quartile Range|||2.61|8.05|
3923567|NCT01426438|3746844|B1|||Relative FMD||%|Median|4.38|4.38|Inter-Quartile Range|||2.88|6.76|
3923568|NCT01426438|3746842|B3|||10 year Coronary Heart Disease (CHD) risk||10yr Framingham CHD risk (%)|Median|3|3.0|Inter-Quartile Range|||1.0|8.0|
3923569|NCT01426438|3746843|B2|||10 year Coronary Heart Disease (CHD) risk||10yr Framingham CHD risk (%)|Median|3|3.0|Inter-Quartile Range|||1.0|10.0|
3923570|NCT01426438|3746844|B1|||10 year Coronary Heart Disease (CHD) risk||10yr Framingham CHD risk (%)|Median|3|3.0|Inter-Quartile Range|||1.0|6.0|
3923571|NCT01426438|3746842|B3|No||Current Smoker||participants|Number|48|48.0||||||
3923572|NCT01426438|3746843|B2|No||Current Smoker||participants|Number|23|23.0||||||
3923573|NCT01426438|3746844|B1|No||Current Smoker||participants|Number|25|25.0||||||
3923574|NCT01426438|3746842|B3|Yes||Current Smoker||participants|Number|26|26.0||||||
3923575|NCT01426438|3746843|B2|Yes||Current Smoker||participants|Number|16|16.0||||||
3923576|NCT01426438|3746844|B1|Yes||Current Smoker||participants|Number|10|10.0||||||
3923577|NCT01426438|3746842|B3|United States||Region of Enrollment||participants|Number|74|74.0||||||
3923578|NCT01426438|3746843|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
3923579|NCT01426438|3746844|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3923580|NCT01426438|3746842|B3|American Indian, Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3923581|NCT01426438|3746843|B2|American Indian, Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3923582|NCT01426438|3746844|B1|American Indian, Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3923583|NCT01426438|3746842|B3|Hispanic, regardless of race||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3923584|NCT01426438|3746843|B2|Hispanic, regardless of race||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3923585|NCT01426438|3746844|B1|Hispanic, regardless of race||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3923586|NCT01426438|3746842|B3|Black, non-Hispanic||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3923587|NCT01426438|3746843|B2|Black, non-Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3923588|NCT01426438|3746844|B1|Black, non-Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3923589|NCT01426438|3746842|B3|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3923590|NCT01426438|3746843|B2|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3923591|NCT01426438|3746844|B1|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3923592|NCT01426438|3746842|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3923593|NCT01426438|3746843|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3923594|NCT01426438|3746844|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3923595|NCT01426438|3746842|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3923596|NCT01426438|3746843|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3923597|NCT01426438|3746844|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3923598|NCT01426438|3746842|B3|||Age||years|Median|45|45.0|Inter-Quartile Range|||38.0|51.0|
3923599|NCT01426438|3746843|B2|||Age||years|Median|45|45.0|Inter-Quartile Range|||38.0|51.0|
3923600|NCT01426438|3746844|B1|||Age||years|Median|46|46.0|Inter-Quartile Range|||37.0|50.0|
3923601|NCT01426438|3746842|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3923602|NCT01426438|3746843|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3923603|NCT01426438|3746844|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3923604|NCT01426438|3746842|B3||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
3923605|NCT01426438|3746843|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3923606|NCT01426438|3746844|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3923607|NCT01426438|3746842|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3923608|NCT01426438|3746843|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3923609|NCT01426438|3746844|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3923610|NCT01426425|3746877|B1|Other race||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3923611|NCT01426425|3746877|B1|Two or more races||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3923612|NCT01426425|3746877|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|353|353.0||||||
3923613|NCT01426425|3746877|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3923614|NCT01426425|3746877|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3923615|NCT01426425|3746877|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3923616|NCT01426425|3746877|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3923617|NCT01426425|3746877|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3923618|NCT01426425|3746877|B1|Not reportable per local laws or regulations||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3923619|NCT01426425|3746877|B1|Subject/physician chose not to provide information||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3923620|NCT01426425|3746877|B1||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3923621|NCT01426425|3746877|B1||Female|Sex: Female, Male||Participants|Count of Participants|279|279.0||||||
3923622|NCT01426425|3746877|B1|||Age||years|Mean|52.6|52.6|Standard Deviation|13.9|13.9|||
3923623|NCT01426386|3746883|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3923624|NCT01426386|3746884|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3923625|NCT01426386|3746885|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3923626|NCT01426386|3746886|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3923627|NCT01426386|3746887|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3923628|NCT01426386|3746888|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3923629|NCT01426386|3746889|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3923630|NCT01426386|3746883|B7||Female|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
3923631|NCT01426386|3746884|B6||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3923632|NCT01426386|3746885|B5||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3923633|NCT01426386|3746886|B4||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3923634|NCT01426386|3746887|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3923635|NCT01426386|3746888|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3923636|NCT01426386|3746889|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3923637|NCT01426386|3746883|B7|||Age||years|Mean|32.7|32.7|Standard Deviation|2.95|2.95|||
3923638|NCT01426386|3746884|B6|||Age||years|Mean|32.4|32.4|Standard Deviation|3.04|3.04|||
3923639|NCT01426386|3746885|B5|||Age||years|Mean|32.6|32.6|Standard Deviation|2.97|2.97|||
3923640|NCT01426386|3746886|B4|||Age||years|Mean|32.3|32.3|Standard Deviation|3.21|3.21|||
3923641|NCT01426386|3746887|B3|||Age||years|Mean|32.8|32.8|Standard Deviation|2.44|2.44|||
3923642|NCT01426386|3746888|B2|||Age||years|Mean|32.3|32.3|Standard Deviation|3.51|3.51|||
3923643|NCT01426386|3746889|B1|||Age||years|Mean|33.6|33.6|Standard Deviation|2.24|2.24|||
3923644|NCT01426373|3746950|B1|4||Clinician-Reported Submental Fat Rating Scale (CR-SMFRS) Rating|"CR-SMFRS Ratings:~0 = Absent submental convexity: No localized submental fat evident~1 = Mild submental convexity: Minimal, localized submental fat~2 = Moderate submental convexity: Prominent, localized submental fat~3 = Severe submental convexity: Marked, localized submental fat~4 = Extreme submental convexity"|participants|Number|13|13.0||||||
3923645|NCT01426373|3746950|B1|3||Clinician-Reported Submental Fat Rating Scale (CR-SMFRS) Rating|"CR-SMFRS Ratings:~0 = Absent submental convexity: No localized submental fat evident~1 = Mild submental convexity: Minimal, localized submental fat~2 = Moderate submental convexity: Prominent, localized submental fat~3 = Severe submental convexity: Marked, localized submental fat~4 = Extreme submental convexity"|participants|Number|66|66.0||||||
3923646|NCT01426373|3746950|B1|2||Clinician-Reported Submental Fat Rating Scale (CR-SMFRS) Rating|"CR-SMFRS Ratings:~0 = Absent submental convexity: No localized submental fat evident~1 = Mild submental convexity: Minimal, localized submental fat~2 = Moderate submental convexity: Prominent, localized submental fat~3 = Severe submental convexity: Marked, localized submental fat~4 = Extreme submental convexity"|participants|Number|86|86.0||||||
3923647|NCT01426373|3746950|B1|IV - VI||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair, always burns, does not tan~Type II: Fair skin, blue eyes, burns easily, tans poorly~Type III: Darker white skin, tans after initial burn~Type IV: Light brown skin, burns minimally, tans easily~Type V: Brown skin, rarely burns, tans darkly easily~Type VI: Dark brown or black skin, never burns, always tans darkly"|participants|Number|42|42.0||||||
3923648|NCT01426373|3746950|B1|I - III||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair, always burns, does not tan~Type II: Fair skin, blue eyes, burns easily, tans poorly~Type III: Darker white skin, tans after initial burn~Type IV: Light brown skin, burns minimally, tans easily~Type V: Brown skin, rarely burns, tans darkly easily~Type VI: Dark brown or black skin, never burns, always tans darkly"|participants|Number|123|123.0||||||
3923649|NCT01426373|3746950|B1|||Body Mass Index (BMI)||kg/m²|Mean|28.88|28.88|Standard Deviation|4.311|4.311|||
3923650|NCT01426373|3746950|B1|||Weight||kg|Mean|80.37|80.37|Standard Deviation|15.111|15.111|||
3923651|NCT01426373|3746950|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|135|135.0||||||
3923652|NCT01426373|3746950|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3923653|NCT01426373|3746950|B1|White||Race/Ethnicity, Customized||participants|Number|129|129.0||||||
3923654|NCT01426373|3746950|B1|Other||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3923655|NCT01426373|3746950|B1|Multiple||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3923656|NCT01426373|3746950|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3923657|NCT01426373|3746950|B1|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3923658|NCT01426373|3746950|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3923659|NCT01426373|3746950|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3923660|NCT01426373|3746950|B1||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3923661|NCT01426373|3746950|B1|> 65 years||Age, Customized||participants|Number|4|4.0||||||
3923662|NCT01426373|3746950|B1|51 - 65 years||Age, Customized||participants|Number|63|63.0||||||
3923663|NCT01426373|3746950|B1|18 - 50 years||Age, Customized||participants|Number|98|98.0||||||
3923664|NCT01426373|3746950|B1|||Age||years|Mean|46.9|46.9|Standard Deviation|10.89|10.89|||
3923699|NCT01426347|3746982|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3923700|NCT01426347|3746983|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3923665|NCT01426360|3746966|B3|||Baseline air blast hypersensitivity score|"The tooth was isolated. Air was delivered from a standard dental unit air syringe and directed at the exposed buccal surface of the hypersensitive tooth for 1 second. The Schiff Cold Air Sensitivity Scale was used to assess the subjects’ response.~0 - Subject does not respond to air stimulus;~- Subject responds to air stimulus, but does not request discontinuation of stimulus;~- Subject responds to air stimulus and requests discontinuation or moves from stimulus;~- Subject responds to air stimulus, considers stimulus to be painful, and requests discontinuation of the stimulus."|Scores on a scale|Mean|2.44|2.44|Standard Deviation|0.41|0.41|||
3923666|NCT01426360|3746967|B2|||Baseline air blast hypersensitivity score|"The tooth was isolated. Air was delivered from a standard dental unit air syringe and directed at the exposed buccal surface of the hypersensitive tooth for 1 second. The Schiff Cold Air Sensitivity Scale was used to assess the subjects’ response.~0 - Subject does not respond to air stimulus;~- Subject responds to air stimulus, but does not request discontinuation of stimulus;~- Subject responds to air stimulus and requests discontinuation or moves from stimulus;~- Subject responds to air stimulus, considers stimulus to be painful, and requests discontinuation of the stimulus."|Scores on a scale|Mean|2.46|2.46|Standard Deviation|0.41|0.41|||
3923667|NCT01426360|3746968|B1|||Baseline air blast hypersensitivity score|"The tooth was isolated. Air was delivered from a standard dental unit air syringe and directed at the exposed buccal surface of the hypersensitive tooth for 1 second. The Schiff Cold Air Sensitivity Scale was used to assess the subjects’ response.~0 - Subject does not respond to air stimulus;~- Subject responds to air stimulus, but does not request discontinuation of stimulus;~- Subject responds to air stimulus and requests discontinuation or moves from stimulus;~- Subject responds to air stimulus, considers stimulus to be painful, and requests discontinuation of the stimulus."|Scores on a scale|Mean|2.42|2.42|Standard Deviation|0.41|0.41|||
3923668|NCT01426360|3746966|B3|||Baseline tactile hypersensitivity score|Tactile hypersensitivity assessments were done using an Electronic Force Sensing Probe (Yeaple Probe Model 200A, Xinix Research Inc., USA). Scores were recorded in terms of a quantified, reproducible force applied by a #19 explorer tip. After presetting the probe to 10 grams, the tip of the probe was run across the exposed dentin perpendicular to the examined surface. Subsequent passes were made, each time the applied force was increased by 10 grams, until the subject indicated that he/she was experiencing discomfort, or until the maximum force of 50 grams had been reached.|gram|Mean|12.41|12.41|Standard Deviation|4.45|4.45|||
3923669|NCT01426360|3746967|B2|||Baseline tactile hypersensitivity score|Tactile hypersensitivity assessments were done using an Electronic Force Sensing Probe (Yeaple Probe Model 200A, Xinix Research Inc., USA). Scores were recorded in terms of a quantified, reproducible force applied by a #19 explorer tip. After presetting the probe to 10 grams, the tip of the probe was run across the exposed dentin perpendicular to the examined surface. Subsequent passes were made, each time the applied force was increased by 10 grams, until the subject indicated that he/she was experiencing discomfort, or until the maximum force of 50 grams had been reached.|gram|Mean|12.2|12.2|Standard Deviation|3.72|3.72|||
3923670|NCT01426360|3746968|B1|||Baseline tactile hypersensitivity score|Tactile hypersensitivity assessments were done using an Electronic Force Sensing Probe (Yeaple Probe Model 200A, Xinix Research Inc., USA). Scores were recorded in terms of a quantified, reproducible force applied by a #19 explorer tip. After presetting the probe to 10 grams, the tip of the probe was run across the exposed dentin perpendicular to the examined surface. Subsequent passes were made, each time the applied force was increased by 10 grams, until the subject indicated that he/she was experiencing discomfort, or until the maximum force of 50 grams had been reached.|gram|Mean|12.63|12.63|Standard Deviation|5.16|5.16|||
3923671|NCT01426360|3746966|B3|China||Region of Enrollment||participants|Number|79|79.0||||||
3923672|NCT01426360|3746967|B2|China||Region of Enrollment||participants|Number|41|41.0||||||
3923673|NCT01426360|3746968|B1|China||Region of Enrollment||participants|Number|38|38.0||||||
3923674|NCT01426360|3746966|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3923675|NCT01426360|3746967|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3923676|NCT01426360|3746968|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3923677|NCT01426360|3746966|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3923678|NCT01426360|3746967|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3923679|NCT01426360|3746968|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3923680|NCT01426360|3746966|B3|||Age||years|Mean|42.9|42.9|Standard Deviation|8.7|8.7|||
3923681|NCT01426360|3746967|B2|||Age||years|Mean|43.39|43.39|Standard Deviation|8.8|8.8|||
3923682|NCT01426360|3746968|B1|||Age||years|Mean|42.37|42.37|Standard Deviation|8.8|8.8|||
3923683|NCT01426360|3746966|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3923684|NCT01426360|3746967|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3923685|NCT01426360|3746968|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3923686|NCT01426360|3746966|B3||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
3923687|NCT01426360|3746967|B2||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3923688|NCT01426360|3746968|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3923689|NCT01426360|3746966|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3923690|NCT01426360|3746967|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3923691|NCT01426360|3746968|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3923692|NCT01426347|3746981|B3|Non-caucasian||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3923693|NCT01426347|3746982|B2|Non-caucasian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3923694|NCT01426347|3746983|B1|Non-caucasian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3923695|NCT01426347|3746981|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
3923696|NCT01426347|3746982|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3923697|NCT01426347|3746983|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3923698|NCT01426347|3746981|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3923701|NCT01426347|3746981|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3923702|NCT01426347|3746982|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3923703|NCT01426347|3746983|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3923704|NCT01426347|3746981|B3|||Age||years|Mean|52.5|52.5|Standard Deviation|12.8|12.8|||
3923705|NCT01426347|3746982|B2|||Age||years|Mean|52.2|52.2|Standard Deviation|12.2|12.2|||
3923706|NCT01426347|3746983|B1|||Age||years|Mean|52.7|52.7|Standard Deviation|13.5|13.5|||
3923707|NCT01426269|3746992|B1|||Weight||pounds|Mean|180.2|180.2|Standard Deviation|45.0|45.0|||
3923708|NCT01426269|3746992|B1|||Height||inches|Mean|66.0|66.0|Standard Deviation|3.8|3.8|||
3923709|NCT01426269|3746992|B1|||History of Rosacea||years|Mean|4.4|4.4|Standard Deviation|7.7|7.7|||
3923710|NCT01426269|3746992|B1|VI||FItzpatrick Skin Type|Fitzpatrick Skin Type Classification Scale I, always burns easily; never tans II, always burns easily; tans minimally and with difficulty III, burns minimally; tans gradually and uniformly (light brown) IV, burns minimally; always tans well (moderate brown) V, rarely burns; tans very easily (dark brown) VI, never burns, tans very easily (black)|participants|Number|0|0.0||||||
3923711|NCT01426269|3746992|B1|V||FItzpatrick Skin Type|Fitzpatrick Skin Type Classification Scale I, always burns easily; never tans II, always burns easily; tans minimally and with difficulty III, burns minimally; tans gradually and uniformly (light brown) IV, burns minimally; always tans well (moderate brown) V, rarely burns; tans very easily (dark brown) VI, never burns, tans very easily (black)|participants|Number|15|15.0||||||
3923712|NCT01426269|3746992|B1|IV||FItzpatrick Skin Type|Fitzpatrick Skin Type Classification Scale I, always burns easily; never tans II, always burns easily; tans minimally and with difficulty III, burns minimally; tans gradually and uniformly (light brown) IV, burns minimally; always tans well (moderate brown) V, rarely burns; tans very easily (dark brown) VI, never burns, tans very easily (black)|participants|Number|42|42.0||||||
3923713|NCT01426269|3746992|B1|III||FItzpatrick Skin Type|Fitzpatrick Skin Type Classification Scale I, always burns easily; never tans II, always burns easily; tans minimally and with difficulty III, burns minimally; tans gradually and uniformly (light brown) IV, burns minimally; always tans well (moderate brown) V, rarely burns; tans very easily (dark brown) VI, never burns, tans very easily (black)|participants|Number|64|64.0||||||
3923714|NCT01426269|3746992|B1|II||FItzpatrick Skin Type|Fitzpatrick Skin Type Classification Scale I, always burns easily; never tans II, always burns easily; tans minimally and with difficulty III, burns minimally; tans gradually and uniformly (light brown) IV, burns minimally; always tans well (moderate brown) V, rarely burns; tans very easily (dark brown) VI, never burns, tans very easily (black)|participants|Number|93|93.0||||||
3923715|NCT01426269|3746992|B1|I||FItzpatrick Skin Type|Fitzpatrick Skin Type Classification Scale I, always burns easily; never tans II, always burns easily; tans minimally and with difficulty III, burns minimally; tans gradually and uniformly (light brown) IV, burns minimally; always tans well (moderate brown) V, rarely burns; tans very easily (dark brown) VI, never burns, tans very easily (black)|participants|Number|16|16.0||||||
3923716|NCT01426269|3746992|B1|Combination||Skin Type||participants|Number|102|102.0||||||
3923717|NCT01426269|3746992|B1|Oily||Skin Type||participants|Number|38|38.0||||||
3923718|NCT01426269|3746992|B1|Normal||Skin Type||participants|Number|50|50.0||||||
3923719|NCT01426269|3746992|B1|Dry||Skin Type||participants|Number|40|40.0||||||
3923720|NCT01426269|3746992|B1|United States||Region of Enrollment||participants|Number|230|230.0||||||
3923721|NCT01426269|3746992|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923722|NCT01426269|3746992|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|186|186.0||||||
3923723|NCT01426269|3746992|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3923724|NCT01426269|3746992|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923725|NCT01426269|3746992|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3923726|NCT01426269|3746992|B1||White|Race (NIH/OMB)||Participants|Count of Participants|217|217.0||||||
3923727|NCT01426269|3746992|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3923728|NCT01426269|3746992|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923729|NCT01426269|3746992|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3923730|NCT01426269|3746992|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923731|NCT01426269|3746992|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3923732|NCT01426269|3746992|B1||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3923733|NCT01426269|3746992|B1|||Age||years|Mean|47.4|47.4|Standard Deviation|12.9|12.9|||
3923734|NCT01426230|3747019|B3|United States||Region of Enrollment||participants|Number|197|197.0||||||
3923735|NCT01426230|3747020|B2|United States||Region of Enrollment||participants|Number|111|111.0||||||
3923736|NCT01426230|3747021|B1|United States||Region of Enrollment||participants|Number|86|86.0||||||
3923737|NCT01426230|3747019|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3923738|NCT01426230|3747020|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3923739|NCT01426230|3747021|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3923740|NCT01426230|3747019|B3||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3923741|NCT01426230|3747020|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3923742|NCT01426230|3747021|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3923743|NCT01426230|3747019|B3|||Age||years|Mean|67.4|67.4|Standard Deviation|12.79|12.79|||
3923744|NCT01426230|3747020|B2|||Age||years|Mean|59.0|59.0|Standard Deviation|10.42|10.42|||
3923745|NCT01426230|3747021|B1|||Age||years|Mean|78.2|78.2|Standard Deviation|5.28|5.28|||
3923746|NCT01426230|3747019|B3||>=65 years|Age||Participants|Count of Participants|131|131.0||||||
3923747|NCT01426230|3747020|B2||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
3923748|NCT01426230|3747021|B1||>=65 years|Age||Participants|Count of Participants|86|86.0||||||
3923749|NCT01426230|3747019|B3||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
3923750|NCT01426230|3747020|B2||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
3923751|NCT01426230|3747021|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3923752|NCT01426230|3747019|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3923753|NCT01426230|3747020|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3923754|NCT01426230|3747021|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3923755|NCT01426217|3747027|B3|United States||Region of Enrollment||participants|Number|572|572.0||||||
3923756|NCT01426217|3747028|B2|United States||Region of Enrollment||participants|Number|266|266.0||||||
3923757|NCT01426217|3747029|B1|United States||Region of Enrollment||participants|Number|306|306.0||||||
3923758|NCT01426217|3747027|B3||Male|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
3923759|NCT01426217|3747028|B2||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3923760|NCT01426217|3747029|B1||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3923761|NCT01426217|3747027|B3||Female|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
3923762|NCT01426217|3747028|B2||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3923763|NCT01426217|3747029|B1||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3923764|NCT01426217|3747027|B3|||Age||years|Mean|57.6|57.6|Standard Deviation|16|16.0|||
3923765|NCT01426217|3747028|B2|||Age||years|Mean|57.5|57.5|Standard Deviation|15.7|15.7|||
3923766|NCT01426217|3747029|B1|||Age||years|Mean|57.7|57.7|Standard Deviation|16.3|16.3|||
3923767|NCT01426113|3747036|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3923768|NCT01426113|3747037|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3923769|NCT01426113|3747038|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3923770|NCT01426113|3747036|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3923771|NCT01426113|3747037|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3923772|NCT01426113|3747038|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3923773|NCT01426113|3747036|B3|12 to 15 years||Age, Customized||Participants|Number|6|6.0||||||
3923774|NCT01426113|3747037|B2|12 to 15 years||Age, Customized||Participants|Number|3|3.0||||||
3923775|NCT01426113|3747038|B1|12 to 15 years||Age, Customized||Participants|Number|3|3.0||||||
3923776|NCT01426009|3747045|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3923777|NCT01426009|3747045|B1|United States||Region of Enrollment||Participants|Count of Participants|120|120.0||||||
3923778|NCT01426009|3747045|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923779|NCT01426009|3747045|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923780|NCT01426009|3747045|B1||White|Race (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
3923781|NCT01426009|3747045|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3923782|NCT01426009|3747045|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923783|NCT01426009|3747045|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923784|NCT01426009|3747045|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3923785|NCT01426009|3747045|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923786|NCT01426009|3747045|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
3923787|NCT01426009|3747045|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3923788|NCT01426009|3747045|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3923789|NCT01426009|3747045|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3923790|NCT01426009|3747045|B1|||Age||years|Mean|61.4|61.4|Standard Deviation|8.11|8.11|||
3923791|NCT01426009|3747045|B1||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
3923792|NCT01426009|3747045|B1||Between 18 and 65 years|Age||Participants|Count of Participants|88|88.0||||||
3923793|NCT01426009|3747045|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3923794|NCT01425879|3747101|B1|PS 1||ECOG Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)~PS 0 defined as Normal activity. Fully active, able to carry on all pre-disease performance without restriction.~PS 1 defined as Symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g. light housework, office work)."|patients|Number|6|6.0||||||
3923795|NCT01425879|3747101|B1|PS 0||ECOG Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)~PS 0 defined as Normal activity. Fully active, able to carry on all pre-disease performance without restriction.~PS 1 defined as Symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g. light housework, office work)."|patients|Number|2|2.0||||||
3923796|NCT01425879|3747101|B1|Extrahepatic||Disease site||patients|Number|2|2.0||||||
3923797|NCT01425879|3747101|B1|Gallbladder||Disease site||patients|Number|0|0.0||||||
3923798|NCT01425879|3747101|B1|Intrahepatic||Disease site||patients|Number|6|6.0||||||
3923799|NCT01425879|3747101|B1|United States||Region of Enrollment||patients|Number|8|8.0||||||
3923800|NCT01425879|3747101|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923801|NCT01425879|3747101|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923802|NCT01425879|3747101|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3923803|NCT01425879|3747101|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923804|NCT01425879|3747101|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923805|NCT01425879|3747101|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3923806|NCT01425879|3747101|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923807|NCT01425879|3747101|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3923808|NCT01425879|3747101|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3923809|NCT01425879|3747101|B1|||Age||years|Median|58|58.0|Full Range|||40.0|83.0|
3923810|NCT01425853|3747108|B3|||WOMAC Pain Subscale|Western Ontario & McMaster Universities Osteoarthritis Index, from 0 No Pain to 500 Maximum Pain|units on a scale|Mean|371.29|371.29|Standard Deviation|41.57|41.57|||
3923811|NCT01425853|3747109|B2|||WOMAC Pain Subscale|Western Ontario & McMaster Universities Osteoarthritis Index, from 0 No Pain to 500 Maximum Pain|units on a scale|Mean|370.60|370.6|Standard Deviation|41.15|41.15|||
3923812|NCT01425853|3747110|B1|||WOMAC Pain Subscale|Western Ontario & McMaster Universities Osteoarthritis Index, from 0 No Pain to 500 Maximum Pain|units on a scale|Mean|371.97|371.97|Standard Deviation|41.76|41.76|||
3923813|NCT01425853|3747108|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3923814|NCT01425853|3747109|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3923815|NCT01425853|3747110|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3923816|NCT01425853|3747108|B3||Female|Sex: Female, Male||Participants|Count of Participants|438|438.0||||||
3923817|NCT01425853|3747109|B2||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
3923818|NCT01425853|3747110|B1||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
3923819|NCT01425853|3747108|B3|||Age||Years|Mean|62.68|62.68|Standard Deviation|8.92|8.92|||
3923820|NCT01425853|3747109|B2|||Age||Years|Mean|63.16|63.16|Standard Deviation|9.02|9.02|||
3923821|NCT01425853|3747110|B1|||Age||Years|Mean|62.22|62.22|Standard Deviation|8.81|8.81|||
3923822|NCT01425814|3747141|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3923823|NCT01425814|3747141|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3923824|NCT01425814|3747141|B1|||Age||Years|Mean|61.2|61.2|Standard Deviation|7.7|7.7|||
3923825|NCT01425801|3747238|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3923826|NCT01425801|3747238|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3923827|NCT01425801|3747238|B1|||Age||Years|Mean|40.9|40.9|Standard Deviation|11.2|11.2|||
3923828|NCT01425749|3747347|B3|Stage IV||Stage of Melanoma|AJCC staging, version 7|participants|Number|9|9.0||||||
3923829|NCT01425749|3747348|B2|Stage IV||Stage of Melanoma|AJCC staging, version 7|participants|Number|4|4.0||||||
3923830|NCT01425749|3747349|B1|Stage IV||Stage of Melanoma|AJCC staging, version 7|participants|Number|5|5.0||||||
3923831|NCT01425749|3747347|B3|Stage IIIC||Stage of Melanoma|AJCC staging, version 7|participants|Number|8|8.0||||||
3923832|NCT01425749|3747348|B2|Stage IIIC||Stage of Melanoma|AJCC staging, version 7|participants|Number|3|3.0||||||
3923833|NCT01425749|3747349|B1|Stage IIIC||Stage of Melanoma|AJCC staging, version 7|participants|Number|5|5.0||||||
3923834|NCT01425749|3747347|B3|Stage IIIB||Stage of Melanoma|AJCC staging, version 7|participants|Number|8|8.0||||||
3923835|NCT01425749|3747348|B2|Stage IIIB||Stage of Melanoma|AJCC staging, version 7|participants|Number|5|5.0||||||
3923836|NCT01425749|3747349|B1|Stage IIIB||Stage of Melanoma|AJCC staging, version 7|participants|Number|3|3.0||||||
3923837|NCT01425749|3747347|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
3923838|NCT01425749|3747348|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3923839|NCT01425749|3747349|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3923840|NCT01425749|3747347|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923841|NCT01425749|3747348|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923842|NCT01425749|3747349|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923843|NCT01425749|3747347|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923844|NCT01425749|3747348|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923845|NCT01425749|3747349|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923846|NCT01425749|3747347|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3923847|NCT01425749|3747348|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3923848|NCT01425749|3747349|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3923849|NCT01425749|3747347|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923850|NCT01425749|3747348|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923851|NCT01425749|3747349|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923852|NCT01425749|3747347|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923853|NCT01425749|3747348|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923854|NCT01425749|3747349|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923855|NCT01425749|3747347|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923856|NCT01425749|3747348|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923857|NCT01425749|3747349|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923858|NCT01425749|3747347|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3923859|NCT01425749|3747348|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3923860|NCT01425749|3747349|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923861|NCT01425749|3747347|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923862|NCT01425749|3747348|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923863|NCT01425749|3747349|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923864|NCT01425749|3747347|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3923865|NCT01425749|3747348|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3923866|NCT01425749|3747349|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3923867|NCT01425749|3747347|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923868|NCT01425749|3747348|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923869|NCT01425749|3747349|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923870|NCT01425749|3747347|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3923871|NCT01425749|3747348|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3923872|NCT01425749|3747349|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3923873|NCT01425749|3747347|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3923874|NCT01425749|3747348|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3923875|NCT01425749|3747349|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3923876|NCT01425749|3747347|B3|||Age||years|Mean|55|55.0|Full Range|||39.0|82.0|
3923877|NCT01425749|3747348|B2|||Age||years|Mean|54|54.0|Full Range|||40.0|69.0|
3923878|NCT01425749|3747349|B1|||Age||years|Mean|56|56.0|Full Range|||39.0|82.0|
3923879|NCT01425723|3747365|B3|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3923880|NCT01425723|3747366|B2|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3923881|NCT01425723|3747367|B1|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3923882|NCT01425723|3747365|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3923883|NCT01425723|3747366|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3923884|NCT01425723|3747367|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3923885|NCT01425723|3747365|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3923886|NCT01425723|3747366|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3923887|NCT01425723|3747367|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3923888|NCT01425723|3747365|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3923889|NCT01425723|3747366|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3923890|NCT01425723|3747367|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3923891|NCT01425723|3747365|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3923892|NCT01425723|3747366|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3923893|NCT01425723|3747367|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3923894|NCT01425723|3747365|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3923895|NCT01425723|3747366|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3923896|NCT01425723|3747367|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3923897|NCT01425723|3747365|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|66|66.0||||||
3923898|NCT01425723|3747366|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
3923899|NCT01425723|3747367|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3923900|NCT01425723|3747365|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3923901|NCT01425723|3747366|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3923902|NCT01425723|3747367|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923903|NCT01425723|3747365|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
3923904|NCT01425723|3747366|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3923905|NCT01425723|3747367|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3923906|NCT01425723|3747365|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3923907|NCT01425723|3747366|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3923908|NCT01425723|3747367|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923909|NCT01425723|3747365|B3||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3923910|NCT01425723|3747366|B2||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3923911|NCT01425723|3747367|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3923912|NCT01425723|3747365|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3923913|NCT01425723|3747366|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3923914|NCT01425723|3747367|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3923915|NCT01425723|3747365|B3|> 65 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3923916|NCT01425723|3747366|B2|> 65 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3923917|NCT01425723|3747367|B1|> 65 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3923918|NCT01425723|3747365|B3|Between 18 and 65 years||Age, Customized||Participants|Count of Participants|85|85.0||||||
3923919|NCT01425723|3747366|B2|Between 18 and 65 years||Age, Customized||Participants|Count of Participants|85|85.0||||||
3923920|NCT01425723|3747367|B1|Between 18 and 65 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3923921|NCT01425723|3747365|B3|<18 years||Age, Customized||Participants|Count of Participants|35|35.0||||||
3923922|NCT01425723|3747366|B2|<18 years||Age, Customized||Participants|Count of Participants|8|8.0||||||
3923923|NCT01425723|3747367|B1|<18 years||Age, Customized||Participants|Count of Participants|27|27.0||||||
3923924|NCT01425632|3747395|B4||Male|Sex: Female, Male||Participants|Count of Participants|292|292.0||||||
3923925|NCT01425632|3747396|B3||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3923926|NCT01425632|3747397|B2||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3923927|NCT01425632|3747398|B1||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3923928|NCT01425632|3747395|B4||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
3923929|NCT01425632|3747396|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3923930|NCT01425632|3747397|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3923931|NCT01425632|3747398|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3923932|NCT01425632|3747395|B4|||Age||years|Mean|11.2|11.2|Standard Deviation|2.4|2.4|||
3923933|NCT01425632|3747396|B3|||Age||years|Mean|11.2|11.2|Standard Deviation|2.5|2.5|||
3923934|NCT01425632|3747397|B2|||Age||years|Mean|11.4|11.4|Standard Deviation|2.3|2.3|||
3923935|NCT01425632|3747398|B1|||Age||years|Mean|11.2|11.2|Standard Deviation|2.5|2.5|||
3923936|NCT01425528|3747408|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3923937|NCT01425528|3747409|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3923938|NCT01425528|3747410|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3923939|NCT01425528|3747408|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923940|NCT01425528|3747409|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923941|NCT01425528|3747410|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923942|NCT01425528|3747408|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3923943|NCT01425528|3747409|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3923944|NCT01425528|3747410|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3923945|NCT01425528|3747408|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923946|NCT01425528|3747409|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923947|NCT01425528|3747410|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923948|NCT01425528|3747408|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923949|NCT01425528|3747409|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923950|NCT01425528|3747410|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923951|NCT01425528|3747408|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923952|NCT01425528|3747409|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923953|NCT01425528|3747410|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923954|NCT01425528|3747408|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3923955|NCT01425528|3747409|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3923956|NCT01425528|3747410|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3923957|NCT01425528|3747408|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923958|NCT01425528|3747409|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923959|NCT01425528|3747410|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923960|NCT01425528|3747408|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923961|NCT01425528|3747409|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923962|NCT01425528|3747410|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923963|NCT01425528|3747408|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923964|NCT01425528|3747409|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923965|NCT01425528|3747410|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923966|NCT01425528|3747408|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923967|NCT01425528|3747409|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923968|NCT01425528|3747410|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923969|NCT01425528|3747408|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3923970|NCT01425528|3747409|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3923971|NCT01425528|3747410|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3923972|NCT01425528|3747408|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3923973|NCT01425528|3747409|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3923974|NCT01425528|3747410|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3923975|NCT01425528|3747408|B3|||Age||years|Mean|35|35.0|Full Range|||18.0|62.0|
3923976|NCT01425528|3747409|B2|||Age||years|Mean|28|28.0|Full Range|||18.0|37.0|
3923977|NCT01425528|3747410|B1|||Age||years|Mean|42|42.0|Full Range|||29.0|62.0|
3923978|NCT01425463|3747417|B3|||Height||centimeter (cm)|Mean|161.2|161.2|Standard Deviation|4.5|4.5|||
3923979|NCT01425463|3747418|B2|||Height||centimeter (cm)|Mean|161.2|161.2|Standard Deviation|4.6|4.6|||
3923980|NCT01425463|3747419|B1|||Height||centimeter (cm)|Mean|161.2|161.2|Standard Deviation|4.4|4.4|||
3923981|NCT01425463|3747417|B3|||Weight||kilogram (kg)|Mean|58.1|58.1|Standard Deviation|7.7|7.7|||
3923982|NCT01425463|3747418|B2|||Weight||kilogram (kg)|Mean|58.1|58.1|Standard Deviation|7.6|7.6|||
3923983|NCT01425463|3747419|B1|||Weight||kilogram (kg)|Mean|58.2|58.2|Standard Deviation|7.8|7.8|||
3923984|NCT01425463|3747417|B3|China||Region of Enrollment||participants|Number|238|238.0||||||
3923985|NCT01425463|3747418|B2|China||Region of Enrollment||participants|Number|116|116.0||||||
3923986|NCT01425463|3747419|B1|China||Region of Enrollment||participants|Number|122|122.0||||||
3923987|NCT01425463|3747417|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923988|NCT01425463|3747418|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923989|NCT01425463|3747419|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923990|NCT01425463|3747417|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923991|NCT01425463|3747418|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923992|NCT01425463|3747419|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923993|NCT01425463|3747417|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923994|NCT01425463|3747418|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923995|NCT01425463|3747419|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923996|NCT01425463|3747417|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923997|NCT01425463|3747418|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923998|NCT01425463|3747419|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3923999|NCT01425463|3747417|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924000|NCT01425463|3747418|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924001|NCT01425463|3747419|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924002|NCT01425463|3747417|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|238|238.0||||||
3924003|NCT01425463|3747418|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|116|116.0||||||
3924004|NCT01425463|3747419|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
3924005|NCT01425463|3747417|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924006|NCT01425463|3747418|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924007|NCT01425463|3747419|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924008|NCT01425463|3747417|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3924009|NCT01425463|3747418|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3924010|NCT01425463|3747419|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3924011|NCT01425463|3747417|B3||Female|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
3924012|NCT01425463|3747418|B2||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3924013|NCT01425463|3747419|B1||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3924014|NCT01425463|3747417|B3|||Age||years|Mean|37.5|37.5|Standard Deviation|8.2|8.2|||
3924015|NCT01425463|3747418|B2|||Age||years|Mean|37.8|37.8|Standard Deviation|7.9|7.9|||
3924016|NCT01425463|3747419|B1|||Age||years|Mean|37.2|37.2|Standard Deviation|8.5|8.5|||
3924017|NCT01425359|3747434|B3|||Glycosylated hemoglobin (HbA1c)||percent HbA1c in blood|Mean|7.3|7.3|Standard Deviation|1.52|1.52|||
3924018|NCT01425359|3747435|B2|||Glycosylated hemoglobin (HbA1c)||percent HbA1c in blood|Mean|7.3|7.3|Standard Deviation|1.50|1.5|||
3924019|NCT01425359|3747436|B1|||Glycosylated hemoglobin (HbA1c)||percent HbA1c in blood|Mean|7.3|7.3|Standard Deviation|1.53|1.53|||
3924020|NCT01425359|3747434|B3|||Body Mass Index||kg/m^2|Mean|31.2|31.2|Standard Deviation|4.96|4.96|||
3924021|NCT01425359|3747435|B2|||Body Mass Index||kg/m^2|Mean|31.3|31.3|Standard Deviation|5.01|5.01|||
3924022|NCT01425359|3747436|B1|||Body Mass Index||kg/m^2|Mean|31.1|31.1|Standard Deviation|4.90|4.9|||
3924023|NCT01425359|3747434|B3|Germany||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|3|3.0||||||
3924024|NCT01425359|3747435|B2|Germany||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|2|2.0||||||
3924025|NCT01425359|3747436|B1|Germany||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|1|1.0||||||
3924026|NCT01425359|3747434|B3|Georgia||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|76|76.0||||||
3924027|NCT01425359|3747435|B2|Georgia||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|40|40.0||||||
3924028|NCT01425359|3747436|B1|Georgia||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|36|36.0||||||
3924029|NCT01425359|3747434|B3|Bulgaria||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|20|20.0||||||
3924030|NCT01425359|3747435|B2|Bulgaria||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|11|11.0||||||
3924031|NCT01425359|3747436|B1|Bulgaria||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|9|9.0||||||
3924032|NCT01425359|3747434|B3|Poland||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|93|93.0||||||
3924033|NCT01425359|3747435|B2|Poland||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|40|40.0||||||
3924034|NCT01425359|3747436|B1|Poland||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|53|53.0||||||
3924035|NCT01425359|3747434|B3|Canada||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|3|3.0||||||
3924036|NCT01425359|3747435|B2|Canada||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|1|1.0||||||
3924037|NCT01425359|3747436|B1|Canada||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|2|2.0||||||
3924038|NCT01425359|3747434|B3|Czech Republic||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|9|9.0||||||
3924039|NCT01425359|3747435|B2|Czech Republic||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|6|6.0||||||
3924040|NCT01425359|3747436|B1|Czech Republic||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|3|3.0||||||
3924041|NCT01425359|3747434|B3|Russian Federation||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|544|544.0||||||
3924042|NCT01425359|3747435|B2|Russian Federation||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|263|263.0||||||
3924043|NCT01425359|3747436|B1|Russian Federation||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|281|281.0||||||
3924044|NCT01425359|3747434|B3|Israel||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|24|24.0||||||
3924045|NCT01425359|3747435|B2|Israel||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|14|14.0||||||
3924046|NCT01425359|3747436|B1|Israel||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|10|10.0||||||
3924047|NCT01425359|3747434|B3|Ukraine||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|122|122.0||||||
3924048|NCT01425359|3747435|B2|Ukraine||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|69|69.0||||||
3924049|NCT01425359|3747436|B1|Ukraine||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|53|53.0||||||
3924050|NCT01425359|3747434|B3|Slovakia||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|21|21.0||||||
3924051|NCT01425359|3747435|B2|Slovakia||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|9|9.0||||||
3924052|NCT01425359|3747436|B1|Slovakia||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|12|12.0||||||
3924053|NCT01425359|3747434|B3|Slovenia||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|1|1.0||||||
3924054|NCT01425359|3747435|B2|Slovenia||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|1|1.0||||||
3924055|NCT01425359|3747436|B1|Slovenia||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|0|0.0||||||
3924056|NCT01425359|3747434|B3|Serbia||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|5|5.0||||||
3924057|NCT01425359|3747435|B2|Serbia||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|2|2.0||||||
3924058|NCT01425359|3747436|B1|Serbia||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|3|3.0||||||
3924059|NCT01425359|3747434|B3|Belarus||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|1|1.0||||||
3924060|NCT01425359|3747435|B2|Belarus||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|0|0.0||||||
3924061|NCT01425359|3747436|B1|Belarus||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|1|1.0||||||
3924062|NCT01425359|3747434|B3|United States||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|27|27.0||||||
3924063|NCT01425359|3747435|B2|United States||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|15|15.0||||||
3924064|NCT01425359|3747436|B1|United States||Region of Enrollment|All randomized participants were analyzed for region of enrollment (placebo, n = 476; ranolazine, n = 473).|participants|Number|12|12.0||||||
3924065|NCT01425359|3747434|B3|Unknown||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3924066|NCT01425359|3747435|B2|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3924067|NCT01425359|3747436|B1|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3924068|NCT01425359|3747434|B3|Not Reported||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3924069|NCT01425359|3747435|B2|Not Reported||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3924070|NCT01425359|3747436|B1|Not Reported||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3924071|NCT01425359|3747434|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|926|926.0||||||
3924072|NCT01425359|3747435|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|462|462.0||||||
3924073|NCT01425359|3747436|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|464|464.0||||||
3924074|NCT01425359|3747434|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3924075|NCT01425359|3747435|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3924076|NCT01425359|3747436|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3924077|NCT01425359|3747434|B3|White||Race/Ethnicity, Customized||participants|Number|935|935.0||||||
3924078|NCT01425359|3747435|B2|White||Race/Ethnicity, Customized||participants|Number|464|464.0||||||
3924079|NCT01425359|3747436|B1|White||Race/Ethnicity, Customized||participants|Number|471|471.0||||||
3924080|NCT01425359|3747434|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3924081|NCT01425359|3747435|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3924082|NCT01425359|3747436|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3924083|NCT01425359|3747434|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3924084|NCT01425359|3747435|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3924085|NCT01425359|3747436|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3924086|NCT01425359|3747434|B3||Male|Sex: Female, Male||Participants|Count of Participants|582|582.0||||||
3924087|NCT01425359|3747435|B2||Male|Sex: Female, Male||Participants|Count of Participants|290|290.0||||||
3924088|NCT01425359|3747436|B1||Male|Sex: Female, Male||Participants|Count of Participants|292|292.0||||||
3924089|NCT01425359|3747434|B3||Female|Sex: Female, Male||Participants|Count of Participants|362|362.0||||||
3924090|NCT01425359|3747435|B2||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3924091|NCT01425359|3747436|B1||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3924092|NCT01425359|3747434|B3|≥ 75 years||Age, Customized||participants|Number|101|101.0||||||
3924093|NCT01425359|3747435|B2|≥ 75 years||Age, Customized||participants|Number|46|46.0||||||
3924094|NCT01425359|3747436|B1|≥ 75 years||Age, Customized||participants|Number|55|55.0||||||
3924095|NCT01425359|3747434|B3|65 - 74 years||Age, Customized||participants|Number|330|330.0||||||
3924096|NCT01425359|3747435|B2|65 - 74 years||Age, Customized||participants|Number|160|160.0||||||
3924097|NCT01425359|3747436|B1|65 - 74 years||Age, Customized||participants|Number|170|170.0||||||
3924098|NCT01425359|3747434|B3|< 65 years||Age, Customized||participants|Number|513|513.0||||||
3924099|NCT01425359|3747435|B2|< 65 years||Age, Customized||participants|Number|264|264.0||||||
3924100|NCT01425359|3747436|B1|< 65 years||Age, Customized||participants|Number|249|249.0||||||
3924101|NCT01425359|3747434|B3|||Age||years|Mean|64|64.0|Standard Deviation|8.5|8.5|||
3924102|NCT01425359|3747435|B2|||Age||years|Mean|63|63.0|Standard Deviation|8.6|8.6|||
3924103|NCT01425359|3747436|B1|||Age||years|Mean|64|64.0|Standard Deviation|8.5|8.5|||
3924104|NCT01425307|3747453|B3|||Duration of Transfusions|Duration of Transfusions refers to the duration of chronic transfusion therapy (either simple, partial exchange or erythrocytapheresis) for primary stroke prevention.|years|Mean|4.1|4.1|Standard Deviation|2.4|2.4|||
3924105|NCT01425307|3747454|B2|||Duration of Transfusions|Duration of Transfusions refers to the duration of chronic transfusion therapy (either simple, partial exchange or erythrocytapheresis) for primary stroke prevention.|years|Mean|4.5|4.5|Standard Deviation|2.8|2.8|||
3924106|NCT01425307|3747455|B1|||Duration of Transfusions|Duration of Transfusions refers to the duration of chronic transfusion therapy (either simple, partial exchange or erythrocytapheresis) for primary stroke prevention.|years|Mean|3.8|3.8|Standard Deviation|1.8|1.8|||
3924107|NCT01425307|3747453|B3|||Age at Index TCD|The index TCD is the documented first abnormal TCD examination. This TCD examination was at least 12 months prior to eligibility for TWiTCH.|years|Mean|5.4|5.4|Standard Deviation|1.9|1.9|||
3924108|NCT01425307|3747454|B2|||Age at Index TCD|The index TCD is the documented first abnormal TCD examination. This TCD examination was at least 12 months prior to eligibility for TWiTCH.|years|Mean|5.0|5.0|Standard Deviation|1.8|1.8|||
3924109|NCT01425307|3747455|B1|||Age at Index TCD|The index TCD is the documented first abnormal TCD examination. This TCD examination was at least 12 months prior to eligibility for TWiTCH.|years|Mean|5.7|5.7|Standard Deviation|2.0|2.0|||
3924110|NCT01425307|3747453|B3|United States||Region of Enrollment||participants|Number|112|112.0||||||
3924111|NCT01425307|3747454|B2|United States||Region of Enrollment||participants|Number|55|55.0||||||
3924112|NCT01425307|3747455|B1|United States||Region of Enrollment||participants|Number|57|57.0||||||
3924113|NCT01425307|3747453|B3|Canada||Region of Enrollment||participants|Number|9|9.0||||||
3924114|NCT01425307|3747454|B2|Canada||Region of Enrollment||participants|Number|5|5.0||||||
3924115|NCT01425307|3747455|B1|Canada||Region of Enrollment||participants|Number|4|4.0||||||
3924116|NCT01425307|3747453|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924117|NCT01425307|3747454|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924118|NCT01425307|3747455|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924119|NCT01425307|3747453|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3924120|NCT01425307|3747454|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3924121|NCT01425307|3747455|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3924122|NCT01425307|3747453|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3924123|NCT01425307|3747454|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3924124|NCT01425307|3747455|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924125|NCT01425307|3747453|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
3924126|NCT01425307|3747454|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3924127|NCT01425307|3747455|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3924128|NCT01425307|3747453|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924129|NCT01425307|3747454|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924130|NCT01425307|3747455|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924131|NCT01425307|3747453|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924132|NCT01425307|3747454|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924133|NCT01425307|3747455|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924134|NCT01425307|3747453|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924135|NCT01425307|3747454|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924136|NCT01425307|3747455|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924137|NCT01425307|3747453|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924138|NCT01425307|3747454|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924139|NCT01425307|3747455|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924140|NCT01425307|3747453|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
3924141|NCT01425307|3747454|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3924142|NCT01425307|3747455|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3924143|NCT01425307|3747453|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3924144|NCT01425307|3747454|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3924145|NCT01425307|3747455|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3924146|NCT01425307|3747453|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3924147|NCT01425307|3747454|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3924148|NCT01425307|3747455|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3924149|NCT01425307|3747453|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3924150|NCT01425307|3747454|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3924151|NCT01425307|3747455|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3924152|NCT01425307|3747453|B3|||Age||years|Mean|9.6|9.6|Standard Deviation|2.9|2.9|||
3924153|NCT01425307|3747454|B2|||Age||years|Mean|9.7|9.7|Standard Deviation|3.2|3.2|||
3924154|NCT01425307|3747455|B1|||Age||years|Mean|9.5|9.5|Standard Deviation|2.6|2.6|||
3924155|NCT01425307|3747453|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3924156|NCT01425307|3747454|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3924157|NCT01425307|3747455|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3924158|NCT01425307|3747453|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3924159|NCT01425307|3747454|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3924160|NCT01425307|3747455|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3924161|NCT01425307|3747453|B3||<=18 years|Age||Participants|Count of Participants|121|121.0||||||
3924162|NCT01425307|3747454|B2||<=18 years|Age||Participants|Count of Participants|60|60.0||||||
3924163|NCT01425307|3747455|B1||<=18 years|Age||Participants|Count of Participants|61|61.0||||||
3924164|NCT01425268|3747466|B3|United States||Region of Enrollment||participants|Number|150|150.0||||||
3924165|NCT01425268|3747467|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
3924166|NCT01425268|3747468|B1|United States||Region of Enrollment||participants|Number|98|98.0||||||
3924167|NCT01425268|3747466|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3924168|NCT01425268|3747467|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3924169|NCT01425268|3747468|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3924170|NCT01425268|3747466|B3||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3924171|NCT01425268|3747467|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3924172|NCT01425268|3747468|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3924173|NCT01425268|3747466|B3|||Age||years|Mean|49.7|49.7|Standard Deviation|9.87|9.87|||
3924174|NCT01425268|3747467|B2|||Age||years|Mean|51.1|51.1|Standard Deviation|9.88|9.88|||
3924175|NCT01425268|3747468|B1|||Age||years|Mean|48.9|48.9|Standard Deviation|9.83|9.83|||
3924176|NCT01425268|3747466|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3924177|NCT01425268|3747467|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3924178|NCT01425268|3747468|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3924179|NCT01425268|3747466|B3||Between 18 and 65 years|Age||Participants|Count of Participants|141|141.0||||||
3924180|NCT01425268|3747467|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3924181|NCT01425268|3747468|B1||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
3924182|NCT01425268|3747466|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3924183|NCT01425268|3747467|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3924184|NCT01425268|3747468|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3924185|NCT01425229|3747477|B1|Germany||Region of Enrollment||participants|Number|16|16.0||||||
3924186|NCT01425229|3747477|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3924187|NCT01425229|3747477|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3924188|NCT01425229|3747477|B1|||Age||years|Mean|31.6|31.6|Standard Deviation|7.8|7.8|||
3924189|NCT01425203|3747488|B3||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3924190|NCT01425203|3747489|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3924191|NCT01425203|3747490|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3924192|NCT01425203|3747488|B3||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3924193|NCT01425203|3747489|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3924194|NCT01425203|3747490|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3924195|NCT01425203|3747488|B3|||Age||years|Mean|38.4|38.4|Standard Deviation|9.8|9.8|||
3924196|NCT01425203|3747489|B2|||Age||years|Mean|38.1|38.1|Standard Deviation|10.0|10.0|||
3924197|NCT01425203|3747490|B1|||Age||years|Mean|38.6|38.6|Standard Deviation|9.8|9.8|||
3924198|NCT01425190|3747506|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3924199|NCT01425190|3747509|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3924200|NCT01425190|3747506|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3924201|NCT01425190|3747509|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3924202|NCT01425190|3747506|B4|Age||Age||Years|Mean|14.9|14.9|Standard Deviation|1.2|1.2|||
3924203|NCT01425190|3747509|B1|Age||Age||Years|Mean|14.9|14.9|Standard Deviation|1.2|1.2|||
3924204|NCT01424943|3747528|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
3924205|NCT01424943|3747529|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
3924206|NCT01424943|3747530|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3924207|NCT01424943|3747528|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3924208|NCT01424943|3747529|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3924209|NCT01424943|3747530|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3924210|NCT01424943|3747528|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3924211|NCT01424943|3747529|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3924212|NCT01424943|3747530|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3924213|NCT01424943|3747528|B3||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3924214|NCT01424943|3747529|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3924215|NCT01424943|3747530|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3924216|NCT01424943|3747528|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3924217|NCT01424943|3747529|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3924218|NCT01424943|3747530|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3924219|NCT01424943|3747528|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3924220|NCT01424943|3747529|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3924221|NCT01424943|3747530|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924222|NCT01424943|3747528|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924223|NCT01424943|3747529|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924224|NCT01424943|3747530|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924225|NCT01424943|3747528|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924226|NCT01424943|3747529|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924227|NCT01424943|3747530|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924228|NCT01424943|3747528|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3924229|NCT01424943|3747529|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3924230|NCT01424943|3747530|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3924231|NCT01424943|3747528|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3924232|NCT01424943|3747529|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3924233|NCT01424943|3747530|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3924234|NCT01424943|3747528|B3|||Age||months|Mean|19.00|19.0|Standard Deviation|3.76|3.76|||
3924235|NCT01424943|3747529|B2|||Age||months|Mean|19.25|19.25|Standard Deviation|3.13|3.13|||
3924236|NCT01424943|3747530|B1|||Age||months|Mean|18.77|18.77|Standard Deviation|3.64|3.64|||
3924237|NCT01424930|3747545|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3924238|NCT01424930|3747546|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3924239|NCT01424930|3747547|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3924240|NCT01424930|3747545|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3924241|NCT01424930|3747546|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3924242|NCT01424930|3747547|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3924243|NCT01424930|3747545|B3|||Age||years|Mean|70.8|70.8|Standard Deviation|8.67|8.67|||
3924244|NCT01424930|3747546|B2|||Age||years|Mean|69.1|69.1|Standard Deviation|7.26|7.26|||
3924245|NCT01424930|3747547|B1|||Age||years|Mean|75.1|75.1|Standard Deviation|11.01|11.01|||
3924246|NCT01424813|3747560|B3|||Body Mass Index||kg/m^2|Mean|28.9|28.9|Standard Deviation|7.58|7.58|||
3924247|NCT01424813|3747561|B2|||Body Mass Index||kg/m^2|Mean|29.2|29.2|Standard Deviation|8.22|8.22|||
3924248|NCT01424813|3747562|B1|||Body Mass Index||kg/m^2|Mean|28.6|28.6|Standard Deviation|6.92|6.92|||
3924249|NCT01424813|3747560|B3|||Height||cm|Mean|169.2|169.2|Standard Deviation|9.35|9.35|||
3924250|NCT01424813|3747561|B2|||Height||cm|Mean|168.9|168.9|Standard Deviation|9.27|9.27|||
3924251|NCT01424813|3747562|B1|||Height||cm|Mean|169.5|169.5|Standard Deviation|9.47|9.47|||
3924252|NCT01424813|3747560|B3|||Weight||kg|Mean|82.9|82.9|Standard Deviation|22.75|22.75|||
3924253|NCT01424813|3747561|B2|||Weight||kg|Mean|83.4|83.4|Standard Deviation|24.20|24.2|||
3924254|NCT01424813|3747562|B1|||Weight||kg|Mean|82.4|82.4|Standard Deviation|21.34|21.34|||
3924255|NCT01424813|3747560|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|149|149.0||||||
3924256|NCT01424813|3747561|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|73|73.0||||||
3924257|NCT01424813|3747562|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
3924258|NCT01424813|3747560|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3924259|NCT01424813|3747561|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3924260|NCT01424813|3747562|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3924261|NCT01424813|3747560|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3924262|NCT01424813|3747561|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3924263|NCT01424813|3747562|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3924264|NCT01424813|3747560|B3|Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3924265|NCT01424813|3747561|B2|Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3924266|NCT01424813|3747562|B1|Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3924267|NCT01424813|3747560|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3924268|NCT01424813|3747561|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3924269|NCT01424813|3747562|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3924270|NCT01424813|3747560|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3924271|NCT01424813|3747561|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3924272|NCT01424813|3747562|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3924273|NCT01424813|3747560|B3|Black||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
3924274|NCT01424813|3747561|B2|Black||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3924275|NCT01424813|3747562|B1|Black||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3924276|NCT01424813|3747560|B3|White||Race/Ethnicity, Customized||participants|Number|114|114.0||||||
3924277|NCT01424813|3747561|B2|White||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
3924278|NCT01424813|3747562|B1|White||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
3924279|NCT01424813|3747560|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3924280|NCT01424813|3747561|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3924281|NCT01424813|3747562|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3924282|NCT01424813|3747560|B3||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3924283|NCT01424813|3747561|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3924284|NCT01424813|3747562|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3924285|NCT01424813|3747560|B3|65+ years||Age, Customized||participants|Number|5|5.0||||||
3924286|NCT01424813|3747561|B2|65+ years||Age, Customized||participants|Number|3|3.0||||||
3924287|NCT01424813|3747562|B1|65+ years||Age, Customized||participants|Number|2|2.0||||||
3924288|NCT01424813|3747560|B3|18-64 years||Age, Customized||participants|Number|123|123.0||||||
3924289|NCT01424813|3747561|B2|18-64 years||Age, Customized||participants|Number|60|60.0||||||
3924290|NCT01424813|3747562|B1|18-64 years||Age, Customized||participants|Number|63|63.0||||||
3924291|NCT01424813|3747560|B3|12-17 years||Age, Customized||participants|Number|30|30.0||||||
3924292|NCT01424813|3747561|B2|12-17 years||Age, Customized||participants|Number|16|16.0||||||
3924293|NCT01424813|3747562|B1|12-17 years||Age, Customized||participants|Number|14|14.0||||||
3924294|NCT01424813|3747560|B3|||Age||years|Mean|38.8|38.8|Standard Deviation|16.88|16.88|||
3924295|NCT01424813|3747561|B2|||Age||years|Mean|37.3|37.3|Standard Deviation|16.89|16.89|||
3924296|NCT01424813|3747562|B1|||Age||years|Mean|40.3|40.3|Standard Deviation|16.84|16.84|||
3924297|NCT01424644|3747581|B3||Male|Sex: Female, Male||Participants|Count of Participants|477|477.0||||||
3924298|NCT01424644|3747582|B2||Male|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
3924299|NCT01424644|3747583|B1||Male|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
3924300|NCT01424644|3747581|B3||Female|Sex: Female, Male||Participants|Count of Participants|324|324.0||||||
3924301|NCT01424644|3747582|B2||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3924302|NCT01424644|3747583|B1||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3924303|NCT01424644|3747581|B3|||Age||years|Mean|11.9|11.9|Standard Deviation|1.6|1.6|||
3924304|NCT01424644|3747582|B2|||Age||years|Mean|11.8|11.8|Standard Deviation|1.5|1.5|||
3924305|NCT01424644|3747583|B1|||Age||years|Mean|11.9|11.9|Standard Deviation|1.7|1.7|||
3924306|NCT01424566|3747598|B1||Male|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
3924307|NCT01424566|3747598|B1||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
3924308|NCT01424566|3747598|B1|||Age||years|Mean|61.2|61.2|Standard Deviation|11.2|11.2|||
3924309|NCT01424514|3747627|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3924310|NCT01424514|3747627|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
3924311|NCT01424514|3747627|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3924312|NCT01424514|3747627|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3924313|NCT01424514|3747627|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3924314|NCT01424514|3747627|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3924315|NCT01424514|3747627|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3924316|NCT01424514|3747627|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3924317|NCT01424514|3747627|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3924318|NCT01424514|3747627|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3924319|NCT01424514|3747627|B1|||Age||Years|Mean|40.6|40.6|Standard Deviation|11.48|11.48|||
3924320|NCT01424501|3747667|B7|Geographic ancestry|White - Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3924321|NCT01424501|3747668|B6|Geographic ancestry|White - Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3924322|NCT01424501|3747669|B5|Geographic ancestry|White - Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3924323|NCT01424501|3747670|B4|Geographic ancestry|White - Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3924324|NCT01424501|3747671|B3|Geographic ancestry|White - Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3924325|NCT01424501|3747672|B2|Geographic ancestry|White - Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3924326|NCT01424501|3747673|B1|Geographic ancestry|White - Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3924327|NCT01424501|3747667|B7|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|106|106.0||||||
3924328|NCT01424501|3747668|B6|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3924329|NCT01424501|3747669|B5|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3924330|NCT01424501|3747670|B4|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3924331|NCT01424501|3747671|B3|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3924332|NCT01424501|3747672|B2|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3924333|NCT01424501|3747673|B1|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3924334|NCT01424501|3747667|B7||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3924335|NCT01424501|3747668|B6||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3924336|NCT01424501|3747669|B5||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3924337|NCT01424501|3747670|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3924338|NCT01424501|3747671|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3924339|NCT01424501|3747672|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3924340|NCT01424501|3747673|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3924341|NCT01424501|3747667|B7||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3924342|NCT01424501|3747668|B6||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3924343|NCT01424501|3747669|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3924344|NCT01424501|3747670|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3924345|NCT01424501|3747671|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3924346|NCT01424501|3747672|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3924347|NCT01424501|3747673|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3924348|NCT01424501|3747667|B7|||Age||Years|Mean|38.7|38.7|Standard Deviation|9.98|9.98|||
3924349|NCT01424501|3747668|B6|||Age||Years|Mean|33.3|33.3|Standard Deviation|9.8|9.8|||
3924350|NCT01424501|3747669|B5|||Age||Years|Mean|33.8|33.8|Standard Deviation|8.5|8.5|||
3924351|NCT01424501|3747670|B4|||Age||Years|Mean|47|47.0|Standard Deviation|9.8|9.8|||
3924352|NCT01424501|3747671|B3|||Age||Years|Mean|44.5|44.5|Standard Deviation|10.3|10.3|||
3924353|NCT01424501|3747672|B2|||Age||Years|Mean|44.7|44.7|Standard Deviation|11.8|11.8|||
3924354|NCT01424501|3747673|B1|||Age||Years|Mean|42.9|42.9|Standard Deviation|11.5|11.5|||
3924355|NCT01424306|3747842|B1|||Estimated total calorie requirement||kcal/d|Mean|2560|2560.0|Standard Deviation|370|370.0|||
3924356|NCT01424306|3747842|B1|||Physical activity||MET-hr/wk|Mean|68.7|68.7|Standard Deviation|45.9|45.9|||
3924357|NCT01424306|3747842|B1|||Fasting glucose||mg/dL|Mean|92|92.0|Standard Deviation|10|10.0|||
3924358|NCT01424306|3747842|B1|||BMI||kg/m^2|Mean|27.4|27.4|Standard Deviation|4.8|4.8|||
3924359|NCT01424306|3747842|B1|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3924360|NCT01424306|3747842|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3924361|NCT01424306|3747842|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3924362|NCT01424306|3747842|B1|||Age||years|Mean|36|36.0|Standard Deviation|12|12.0|||
3924363|NCT01424228|3747894|B3|Czech Republic||Region of Enrollment|This includes all randomized subjects (n = 364).|participants|Number|14|14.0||||||
3924364|NCT01424228|3747895|B2|Czech Republic||Region of Enrollment|This includes all randomized subjects (n = 364).|participants|Number|8|8.0||||||
3924365|NCT01424228|3747896|B1|Czech Republic||Region of Enrollment|This includes all randomized subjects (n = 364).|participants|Number|6|6.0||||||
3924366|NCT01424228|3747894|B3|Sweden||Region of Enrollment|This includes all randomized subjects (n = 364).|participants|Number|18|18.0||||||
3924367|NCT01424228|3747895|B2|Sweden||Region of Enrollment|This includes all randomized subjects (n = 364).|participants|Number|9|9.0||||||
3924368|NCT01424228|3747896|B1|Sweden||Region of Enrollment|This includes all randomized subjects (n = 364).|participants|Number|9|9.0||||||
3924369|NCT01424228|3747894|B3|Belgium||Region of Enrollment|This includes all randomized subjects (n = 364).|participants|Number|19|19.0||||||
3924370|NCT01424228|3747895|B2|Belgium||Region of Enrollment|This includes all randomized subjects (n = 364).|participants|Number|11|11.0||||||
3924371|NCT01424228|3747896|B1|Belgium||Region of Enrollment|This includes all randomized subjects (n = 364).|participants|Number|8|8.0||||||
3924372|NCT01424228|3747894|B3|Spain||Region of Enrollment|This includes all randomized subjects (n = 364).|participants|Number|19|19.0||||||
3924373|NCT01424228|3747895|B2|Spain||Region of Enrollment|This includes all randomized subjects (n = 364).|participants|Number|8|8.0||||||
3924374|NCT01424228|3747896|B1|Spain||Region of Enrollment|This includes all randomized subjects (n = 364).|participants|Number|11|11.0||||||
3924375|NCT01424228|3747894|B3|Italy||Region of Enrollment|This includes all randomized subjects (n = 364).|participants|Number|37|37.0||||||
3924376|NCT01424228|3747895|B2|Italy||Region of Enrollment|This includes all randomized subjects (n = 364).|participants|Number|18|18.0||||||
3924377|NCT01424228|3747896|B1|Italy||Region of Enrollment|This includes all randomized subjects (n = 364).|participants|Number|19|19.0||||||
3924378|NCT01424228|3747894|B3|Slovakia||Region of Enrollment|This includes all randomized subjects (n = 364).|participants|Number|57|57.0||||||
3924379|NCT01424228|3747895|B2|Slovakia||Region of Enrollment|This includes all randomized subjects (n = 364).|participants|Number|29|29.0||||||
3924380|NCT01424228|3747896|B1|Slovakia||Region of Enrollment|This includes all randomized subjects (n = 364).|participants|Number|28|28.0||||||
3924381|NCT01424228|3747894|B3|Hungary||Region of Enrollment|This includes all randomized subjects (n = 364).|participants|Number|60|60.0||||||
3924382|NCT01424228|3747895|B2|Hungary||Region of Enrollment|This includes all randomized subjects (n = 364).|participants|Number|31|31.0||||||
3924383|NCT01424228|3747896|B1|Hungary||Region of Enrollment|This includes all randomized subjects (n = 364).|participants|Number|29|29.0||||||
3924384|NCT01424228|3747894|B3|Poland||Region of Enrollment|This includes all randomized subjects (n = 364).|participants|Number|65|65.0||||||
3924385|NCT01424228|3747895|B2|Poland||Region of Enrollment|This includes all randomized subjects (n = 364).|participants|Number|31|31.0||||||
3924386|NCT01424228|3747896|B1|Poland||Region of Enrollment|This includes all randomized subjects (n = 364).|participants|Number|34|34.0||||||
3924387|NCT01424228|3747894|B3|Romania||Region of Enrollment|This includes all randomized subjects (n = 364).|participants|Number|75|75.0||||||
3924388|NCT01424228|3747895|B2|Romania||Region of Enrollment|This includes all randomized subjects (n = 364).|participants|Number|37|37.0||||||
3924389|NCT01424228|3747896|B1|Romania||Region of Enrollment|This includes all randomized subjects (n = 364).|participants|Number|38|38.0||||||
3924390|NCT01424228|3747894|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3924391|NCT01424228|3747895|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3924392|NCT01424228|3747896|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3924393|NCT01424228|3747894|B3||Female|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
3924394|NCT01424228|3747895|B2||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3924395|NCT01424228|3747896|B1||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3924396|NCT01424228|3747894|B3|>=75 years||Age, Customized||participants|Number|20|20.0||||||
3924397|NCT01424228|3747895|B2|>=75 years||Age, Customized||participants|Number|9|9.0||||||
3924398|NCT01424228|3747896|B1|>=75 years||Age, Customized||participants|Number|11|11.0||||||
3924399|NCT01424228|3747894|B3|> = 65 years to <75 years||Age, Customized||participants|Number|46|46.0||||||
3924400|NCT01424228|3747895|B2|> = 65 years to <75 years||Age, Customized||participants|Number|26|26.0||||||
3924401|NCT01424228|3747896|B1|> = 65 years to <75 years||Age, Customized||participants|Number|20|20.0||||||
3924402|NCT01424228|3747894|B3|<65 years||Age, Customized||participants|Number|295|295.0||||||
3924403|NCT01424228|3747895|B2|<65 years||Age, Customized||participants|Number|146|146.0||||||
3924404|NCT01424228|3747896|B1|<65 years||Age, Customized||participants|Number|149|149.0||||||
3924405|NCT01424228|3747894|B3|||Age||years|Mean|48.9|48.9|Standard Deviation|16.00|16.0|||
3924406|NCT01424228|3747895|B2|||Age||years|Mean|49.4|49.4|Standard Deviation|15.78|15.78|||
3924407|NCT01424228|3747896|B1|||Age||years|Mean|48.3|48.3|Standard Deviation|16.25|16.25|||
3924408|NCT01424189|3747935|B3||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
3924409|NCT01424189|3747936|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3924410|NCT01424189|3747937|B1||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3924411|NCT01424189|3747935|B3||Female|Sex: Female, Male||Participants|Count of Participants|376|376.0||||||
3924412|NCT01424189|3747936|B2||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3924413|NCT01424189|3747937|B1||Female|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
3924414|NCT01424189|3747935|B3|||Age||years|Mean|67.38|67.38|Standard Deviation|8.88|8.88|||
3924415|NCT01424189|3747936|B2|||Age||years|Mean|68.36|68.36|Standard Deviation|8.13|8.13|||
3924416|NCT01424189|3747937|B1|||Age||years|Mean|66.91|66.91|Standard Deviation|9.20|9.2|||
3924417|NCT01424072|3747950|B4|Brazil||Region of Enrollment||participants|Number|75|75.0||||||
3924418|NCT01424072|3747951|B3|Brazil||Region of Enrollment||participants|Number|22|22.0||||||
3924419|NCT01424072|3747952|B2|Brazil||Region of Enrollment||participants|Number|26|26.0||||||
3924420|NCT01424072|3747953|B1|Brazil||Region of Enrollment||participants|Number|27|27.0||||||
3924421|NCT01424072|3747950|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3924422|NCT01424072|3747951|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3924423|NCT01424072|3747952|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3924424|NCT01424072|3747953|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3924425|NCT01424072|3747950|B4||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3924426|NCT01424072|3747951|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3924427|NCT01424072|3747952|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3924428|NCT01424072|3747953|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3924429|NCT01424072|3747950|B4|||Age||years|Mean|42.06|42.06|Standard Deviation|9.27|9.27|||
3924430|NCT01424072|3747951|B3|||Age||years|Mean|39.25|39.25|Standard Deviation|13.17|13.17|||
3924431|NCT01424072|3747952|B2|||Age||years|Mean|45.57|45.57|Standard Deviation|6.40|6.4|||
3924432|NCT01424072|3747953|B1|||Age||years|Mean|41.37|41.37|Standard Deviation|8.23|8.23|||
3924433|NCT01424072|3747950|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3924434|NCT01424072|3747951|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3924435|NCT01424072|3747952|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3924436|NCT01424072|3747953|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3924437|NCT01424072|3747950|B4||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
3924438|NCT01424072|3747951|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3924439|NCT01424072|3747952|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3924440|NCT01424072|3747953|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3924441|NCT01424072|3747950|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3924442|NCT01424072|3747951|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3924443|NCT01424072|3747952|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3924444|NCT01424072|3747953|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3924445|NCT01424033|3747972|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3924446|NCT01424033|3747972|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3924447|NCT01424033|3747972|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3924448|NCT01424033|3747972|B1|||Age||years|Mean|50|50.0|Standard Deviation|5|5.0|||
3924449|NCT01424033|3747972|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3924450|NCT01424033|3747972|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3924451|NCT01424033|3747972|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3924452|NCT01423916|3747976|B4||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3924453|NCT01423916|3747977|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3924454|NCT01423916|3747978|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3924455|NCT01423916|3747979|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3924456|NCT01423916|3747976|B4||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3924457|NCT01423916|3747977|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3924458|NCT01423916|3747978|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3924459|NCT01423916|3747979|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3924460|NCT01423916|3747976|B4|||Age||Years|Mean|38.1|38.1|Standard Deviation|9.4|9.4|||
3924461|NCT01423916|3747977|B3|||Age||Years|Mean|38.2|38.2|Standard Deviation|9.6|9.6|||
3924462|NCT01423916|3747978|B2|||Age||Years|Mean|37.5|37.5|Standard Deviation|9.0|9.0|||
3924463|NCT01423916|3747979|B1|||Age||Years|Mean|38.5|38.5|Standard Deviation|9.6|9.6|||
3924464|NCT01423812|3748035|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
3924465|NCT01423812|3748036|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3924466|NCT01423812|3748037|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3924467|NCT01423812|3748035|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3924468|NCT01423812|3748036|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3924469|NCT01423812|3748037|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3924470|NCT01423812|3748035|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3924471|NCT01423812|3748036|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3924472|NCT01423812|3748037|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3924473|NCT01423812|3748035|B3|||Age||years|Mean|48|48.0|Full Range|||36.0|66.0|
3924474|NCT01423812|3748036|B2|||Age||years|Mean|49|49.0|Full Range|||38.0|66.0|
3924475|NCT01423812|3748037|B1|||Age||years|Mean|48|48.0|Full Range|||36.0|65.0|
3924476|NCT01423812|3748035|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3924477|NCT01423812|3748036|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3924478|NCT01423812|3748037|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3924479|NCT01423812|3748035|B3||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
3924480|NCT01423812|3748036|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3924481|NCT01423812|3748037|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3924482|NCT01423812|3748035|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3924483|NCT01423812|3748036|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3924484|NCT01423812|3748037|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3924485|NCT01423773|3748046|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3924486|NCT01423773|3748046|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3924487|NCT01423773|3748046|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3924488|NCT01423773|3748046|B1|||Age||years|Mean|36.0|36.0|Standard Deviation|10.0|10.0|||
3924489|NCT01423760|3748053|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3924490|NCT01423760|3748054|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3924491|NCT01423760|3748055|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3924492|NCT01423760|3748053|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3924493|NCT01423760|3748054|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3924494|NCT01423760|3748055|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3924495|NCT01423760|3748053|B3|||Age||Years|Mean|66.5|66.5|Standard Deviation|9.30|9.3|||
3924496|NCT01423760|3748054|B2|||Age||Years|Mean|65.2|65.2|Standard Deviation|9.81|9.81|||
3924497|NCT01423760|3748055|B1|||Age||Years|Mean|67.7|67.7|Standard Deviation|8.98|8.98|||
3924498|NCT01423617|3748064|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3924499|NCT01423617|3748065|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3924500|NCT01423617|3748066|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3924501|NCT01423617|3748064|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3924502|NCT01423617|3748065|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3924503|NCT01423617|3748066|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3924504|NCT01423617|3748064|B3|||Age||years|Mean|42.8|42.8|Standard Deviation|11.2|11.2|||
3924505|NCT01423617|3748065|B2|||Age||years|Mean|42.5|42.5|Standard Deviation|11.6|11.6|||
3924506|NCT01423617|3748066|B1|||Age||years|Mean|43.1|43.1|Standard Deviation|10.9|10.9|||
3924507|NCT01423604|3748081|B4|||Body surface area|Treatment Group Ruxolitinib (N = 60); Placebo (N = 60)|m^2|Mean|1.827|1.827|Standard Deviation|0.275|0.275|||
3924508|NCT01423604|3748082|B3|||Body surface area|Treatment Group Ruxolitinib (N = 60); Placebo (N = 60)|m^2|Mean|1.791|1.791|Standard Deviation|0.248|0.248|||
3924509|NCT01423604|3748083|B2|||Body surface area|Treatment Group Ruxolitinib (N = 60); Placebo (N = 60)|m^2|Mean|1.863|1.863|Standard Deviation|0.297|0.297|||
3924510|NCT01423604|3748084|B1|||Body surface area|Treatment Group Ruxolitinib (N = 60); Placebo (N = 60)|m^2|Mean|1.869|1.869|Standard Deviation|0.287|0.287|||
3924511|NCT01423604|3748081|B4|||Body mass index (BMI)|Treatment Group Ruxolitinib (N = 60); Placebo (N = 60)|kg/m^2|Mean|24.789|24.789|Standard Deviation|5.394|5.394|||
3924512|NCT01423604|3748082|B3|||Body mass index (BMI)|Treatment Group Ruxolitinib (N = 60); Placebo (N = 60)|kg/m^2|Mean|24.243|24.243|Standard Deviation|4.237|4.237|||
3924513|NCT01423604|3748083|B2|||Body mass index (BMI)|Treatment Group Ruxolitinib (N = 60); Placebo (N = 60)|kg/m^2|Mean|25.354|25.354|Standard Deviation|6.332|6.332|||
3924514|NCT01423604|3748084|B1|||Body mass index (BMI)|Treatment Group Ruxolitinib (N = 60); Placebo (N = 60)|kg/m^2|Mean|25.3|25.3|Standard Deviation|4.209|4.209|||
3924515|NCT01423604|3748081|B4|||Weight|Treatment Group Ruxolitinib (N = 60); Placebo (N = 60)|kg|Mean|72.156|72.156|Standard Deviation|19.427|19.427|||
3924516|NCT01423604|3748082|B3|||Weight|Treatment Group Ruxolitinib (N = 60); Placebo (N = 60)|kg|Mean|69.299|69.299|Standard Deviation|16.260|16.26|||
3924517|NCT01423604|3748083|B2|||Weight|Treatment Group Ruxolitinib (N = 60); Placebo (N = 60)|kg|Mean|75.014|75.014|Standard Deviation|21.914|21.914|||
3924518|NCT01423604|3748084|B1|||Weight|Treatment Group Ruxolitinib (N = 60); Placebo (N = 60)|kg|Mean|75.051|75.051|Standard Deviation|17.317|17.317|||
3924519|NCT01423604|3748081|B4|||Height|Treatment Group Ruxolitinib (N = 60); Placebo (N = 60)|cm|Mean|169.78|169.78|Standard Deviation|11.18|11.18|||
3924520|NCT01423604|3748082|B3|||Height|Treatment Group Ruxolitinib (N = 60); Placebo (N = 60)|cm|Mean|168.27|168.27|Standard Deviation|10.25|10.25|||
3924521|NCT01423604|3748083|B2|||Height|Treatment Group Ruxolitinib (N = 60); Placebo (N = 60)|cm|Mean|171.29|171.29|Standard Deviation|11.93|11.93|||
3924522|NCT01423604|3748084|B1|||Height|Treatment Group Ruxolitinib (N = 60); Placebo (N = 60)|cm|Mean|171.67|171.67|Standard Deviation|14.11|14.11|||
3924523|NCT01423604|3748081|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3924524|NCT01423604|3748082|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3924525|NCT01423604|3748083|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3924526|NCT01423604|3748084|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924527|NCT01423604|3748081|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924528|NCT01423604|3748082|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924529|NCT01423604|3748083|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924530|NCT01423604|3748084|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924531|NCT01423604|3748081|B4||White|Race (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
3924532|NCT01423604|3748082|B3||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3924533|NCT01423604|3748083|B2||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3924534|NCT01423604|3748084|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3924535|NCT01423604|3748081|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3924536|NCT01423604|3748082|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3924537|NCT01423604|3748083|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3924538|NCT01423604|3748084|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3924539|NCT01423604|3748081|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924540|NCT01423604|3748082|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924541|NCT01423604|3748083|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924542|NCT01423604|3748084|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924543|NCT01423604|3748081|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3924544|NCT01423604|3748082|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3924545|NCT01423604|3748083|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924546|NCT01423604|3748084|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3924547|NCT01423604|3748081|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924548|NCT01423604|3748082|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924549|NCT01423604|3748083|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924550|NCT01423604|3748084|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924551|NCT01423604|3748081|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3924552|NCT01423604|3748082|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924553|NCT01423604|3748083|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3924554|NCT01423604|3748084|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924555|NCT01423604|3748081|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
3924556|NCT01423604|3748082|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3924557|NCT01423604|3748083|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3924558|NCT01423604|3748084|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3924559|NCT01423604|3748081|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3924560|NCT01423604|3748082|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3924561|NCT01423604|3748083|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3924562|NCT01423604|3748084|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924563|NCT01423604|3748081|B4||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3924564|NCT01423604|3748082|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3924565|NCT01423604|3748083|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3924566|NCT01423604|3748084|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3924567|NCT01423604|3748081|B4||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3924568|NCT01423604|3748082|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3924569|NCT01423604|3748083|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3924570|NCT01423604|3748084|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3924571|NCT01423604|3748081|B4|||Age||years|Mean|66.0|66.0|Standard Deviation|9.5|9.5|||
3924572|NCT01423604|3748082|B3|||Age||years|Mean|66.3|66.3|Standard Deviation|9.8|9.8|||
3924573|NCT01423604|3748083|B2|||Age||years|Mean|65.7|65.7|Standard Deviation|9.3|9.3|||
3924574|NCT01423604|3748084|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|9.4|9.4|||
3924575|NCT01423253|3748100|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
3924576|NCT01423253|3748100|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3924577|NCT01423253|3748100|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924578|NCT01423253|3748100|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3924579|NCT01423253|3748100|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3924580|NCT01423253|3748100|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924581|NCT01423253|3748100|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3924582|NCT01423253|3748100|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924583|NCT01423253|3748100|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3924584|NCT01423253|3748100|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3924585|NCT01423253|3748100|B1|||Age||Years|Mean|42.5|42.5|Standard Deviation|13.42|13.42|||
3924586|NCT01423253|3748100|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3924587|NCT01423253|3748100|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3924588|NCT01423253|3748100|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3924589|NCT01423162|3748111|B3|Philippines||Region of Enrollment||participants|Number|20|20.0||||||
3924590|NCT01423162|3748112|B2|Philippines||Region of Enrollment||participants|Number|9|9.0||||||
3924591|NCT01423162|3748113|B1|Philippines||Region of Enrollment||participants|Number|11|11.0||||||
3924592|NCT01423162|3748111|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3924593|NCT01423162|3748112|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3924594|NCT01423162|3748113|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3924595|NCT01423162|3748111|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3924596|NCT01423162|3748112|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3924597|NCT01423162|3748113|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3924598|NCT01423162|3748111|B3|years||Age, Customized||years|Mean|6.3|6.3|Full Range|||6.0|6.6|
3924599|NCT01423162|3748112|B2|years||Age, Customized||years|Mean|6.4|6.4|Full Range|||6.2|6.6|
3924600|NCT01423162|3748113|B1|years||Age, Customized||years|Mean|6.3|6.3|Full Range|||6.0|6.6|
3924601|NCT01423162|3748111|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3924602|NCT01423162|3748112|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3924603|NCT01423162|3748113|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3924604|NCT01423162|3748111|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3924605|NCT01423162|3748112|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3924606|NCT01423162|3748113|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3924607|NCT01423162|3748111|B3||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
3924608|NCT01423162|3748112|B2||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
3924609|NCT01423162|3748113|B1||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
3924610|NCT01423084|3748120|B3||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
3924611|NCT01423084|3748121|B2||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3924612|NCT01423084|3748122|B1||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3924613|NCT01423084|3748120|B3||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3924614|NCT01423084|3748121|B2||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3924615|NCT01423084|3748122|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3924616|NCT01423084|3748120|B3|||Age||years|Mean|13.7|13.7|Standard Deviation|1.9|1.9|||
3924617|NCT01423084|3748121|B2|||Age||years|Mean|13.8|13.8|Standard Deviation|1.8|1.8|||
3924618|NCT01423084|3748122|B1|||Age||years|Mean|13.6|13.6|Standard Deviation|1.9|1.9|||
3924619|NCT01422915|3748153|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3924620|NCT01422915|3748153|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3924621|NCT01422915|3748153|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3924622|NCT01422915|3748153|B1|>=65 years||Age, Customized|For baseline in Period 1 and Period 2: ~monthly completion of sun sensitivity questionnaire; donate whole blood for RBC and plasma protoporphyrin|participants|Number|0|0.0||||||
3924623|NCT01422915|3748153|B1|Between 18 and 65 years||Age, Customized|For baseline in Period 1 and Period 2: ~monthly completion of sun sensitivity questionnaire; donate whole blood for RBC and plasma protoporphyrin|participants|Number|4|4.0||||||
3924624|NCT01422915|3748153|B1|<=18 years||Age, Customized|For baseline in Period 1 and Period 2: ~monthly completion of sun sensitivity questionnaire; donate whole blood for RBC and plasma protoporphyrin|participants|Number|0|0.0||||||
3924625|NCT01422915|3748153|B1|||Age||years|Mean|43|43.0|Standard Deviation|15|15.0|||
3924626|NCT01422915|3748153|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3924627|NCT01422915|3748153|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3924628|NCT01422915|3748153|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3924629|NCT01422889|3748158|B1|Severe Calcification||Lesion Characteristics:Lesion Based|N=1111 subjects; N=1562 Lesions|Lesions|Number|79|79.0||||||
3924630|NCT01422889|3748158|B1|Culprit for STEMI||Lesion Characteristics:Lesion Based|N=1111 subjects; N=1562 Lesions|Lesions|Number|108|108.0||||||
3924631|NCT01422889|3748158|B1|Bifurcation||Lesion Characteristics|The same participant may be included in more than one category therefore the number of participants does not equal the total number of participants in the group.|participants|Number|116|116.0||||||
3924632|NCT01422889|3748158|B1|Long Lesions (>=28mm)||Lesion Characteristics|The same participant may be included in more than one category therefore the number of participants does not equal the total number of participants in the group.|participants|Number|235|235.0||||||
3924633|NCT01422889|3748158|B1|RVD<=2.5mm||Lesion Characteristics|The same participant may be included in more than one category therefore the number of participants does not equal the total number of participants in the group.|participants|Number|387|387.0||||||
3924634|NCT01422889|3748158|B1|Prior PCI||Cardiac Risk Factors|The same participant may be included in more than one category therefore the number of participants does not equal the total number of participants in the group.|participants|Number|522|522.0||||||
3924635|NCT01422889|3748158|B1|Unstable Angina||Cardiac Risk Factors|The same participant may be included in more than one category therefore the number of participants does not equal the total number of participants in the group.|participants|Number|485|485.0||||||
3924636|NCT01422889|3748158|B1|Hyperlipidemia||Cardiac Risk Factors|The same participant may be included in more than one category therefore the number of participants does not equal the total number of participants in the group.|participants|Number|869|869.0||||||
3924637|NCT01422889|3748158|B1|Hypertension||Cardiac Risk Factors|The same participant may be included in more than one category therefore the number of participants does not equal the total number of participants in the group.|participants|Number|905|905.0||||||
3924638|NCT01422889|3748158|B1|Current Smoker||Cardiac Risk Factors|The same participant may be included in more than one category therefore the number of participants does not equal the total number of participants in the group.|participants|Number|275|275.0||||||
3924639|NCT01422889|3748158|B1|Diabetes||Cardiac Risk Factors|The same participant may be included in more than one category therefore the number of participants does not equal the total number of participants in the group.|participants|Number|376|376.0||||||
3924640|NCT01422889|3748158|B1|United States||Region of Enrollment||participants|Number|1111|1111.0||||||
3924641|NCT01422889|3748158|B1||Male|Sex: Female, Male||Participants|Count of Participants|781|781.0||||||
3924642|NCT01422889|3748158|B1||Female|Sex: Female, Male||Participants|Count of Participants|330|330.0||||||
3924643|NCT01422889|3748158|B1|||Age||years|Mean|64.1|64.1|Standard Deviation|10.98|10.98|||
3924644|NCT01422876|3748163|B11||Male|Sex: Female, Male||Participants|Count of Participants|721|721.0||||||
3924645|NCT01422876|3748164|B10||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3924646|NCT01422876|3748165|B9||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3924647|NCT01422876|3748166|B8||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3924648|NCT01422876|3748167|B7||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3924649|NCT01422876|3748168|B6||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3924650|NCT01422876|3748169|B5||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3924651|NCT01422876|3748170|B4||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3924652|NCT01422876|3748171|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3924653|NCT01422876|3748172|B2||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3924654|NCT01422876|3748173|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3924655|NCT01422876|3748163|B11||Female|Sex: Female, Male||Participants|Count of Participants|620|620.0||||||
3924656|NCT01422876|3748164|B10||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3924657|NCT01422876|3748165|B9||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3924658|NCT01422876|3748166|B8||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3924659|NCT01422876|3748167|B7||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3924660|NCT01422876|3748168|B6||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3924661|NCT01422876|3748169|B5||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3924662|NCT01422876|3748170|B4||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3924663|NCT01422876|3748171|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3924664|NCT01422876|3748172|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3924665|NCT01422876|3748173|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3924666|NCT01422876|3748163|B11|||Age||years|Mean|55.4|55.4|Standard Deviation|10.2|10.2|||
3924667|NCT01422876|3748164|B10|||Age||years|Mean|53.8|53.8|Standard Deviation|11.5|11.5|||
3924668|NCT01422876|3748165|B9|||Age||years|Mean|53.9|53.9|Standard Deviation|10.5|10.5|||
3924669|NCT01422876|3748166|B8|||Age||years|Mean|56.0|56.0|Standard Deviation|9.3|9.3|||
3924670|NCT01422876|3748167|B7|||Age||years|Mean|55.2|55.2|Standard Deviation|9.8|9.8|||
3924671|NCT01422876|3748168|B6|||Age||years|Mean|54.2|54.2|Standard Deviation|10.0|10.0|||
3924672|NCT01422876|3748169|B5|||Age||years|Mean|56.2|56.2|Standard Deviation|10.0|10.0|||
3924673|NCT01422876|3748170|B4|||Age||years|Mean|56.1|56.1|Standard Deviation|10.5|10.5|||
3924674|NCT01422876|3748171|B3|||Age||years|Mean|55.5|55.5|Standard Deviation|10.0|10.0|||
3924675|NCT01422876|3748172|B2|||Age||years|Mean|56.2|56.2|Standard Deviation|10.3|10.3|||
3924676|NCT01422876|3748173|B1|||Age||years|Mean|57.1|57.1|Standard Deviation|10.2|10.2|||
3924677|NCT01422850|3748229|B1|Denmark||Region of Enrollment||participants|Number|21|21.0||||||
3924678|NCT01422850|3748229|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3924679|NCT01422850|3748229|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3924680|NCT01422850|3748229|B1|Mean age||Age||years|Mean|71|71.0|Full Range|||56.0|83.0|
3924681|NCT01422850|3748229|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3924682|NCT01422850|3748229|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3924683|NCT01422850|3748229|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3924684|NCT01422824|3748235|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3924685|NCT01422824|3748235|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3924686|NCT01422824|3748235|B1|||Age||years|Mean|58.0|58.0|Standard Deviation|10.9|10.9|||
3924687|NCT01422720|3748240|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3924688|NCT01422720|3748240|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3924689|NCT01422720|3748240|B1|80-84 years||Age, Customized||participants|Number|4|4.0||||||
3924690|NCT01422720|3748240|B1|75-79 years||Age, Customized||participants|Number|19|19.0||||||
3924691|NCT01422720|3748240|B1|70-74 years||Age, Customized||participants|Number|19|19.0||||||
3924692|NCT01422720|3748240|B1|65-69 years||Age, Customized||participants|Number|30|30.0||||||
3924693|NCT01422538|3748248|B4|Type VI||Fitzpatrick Skin Type|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|1|1.0||||||
3924694|NCT01422538|3748249|B3|Type VI||Fitzpatrick Skin Type|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|0|0.0||||||
3924695|NCT01422538|3748250|B2|Type VI||Fitzpatrick Skin Type|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|0|0.0||||||
3924696|NCT01422538|3748251|B1|Type VI||Fitzpatrick Skin Type|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|1|1.0||||||
3924697|NCT01422538|3748248|B4|Type V||Fitzpatrick Skin Type|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|0|0.0||||||
3924698|NCT01422538|3748249|B3|Type V||Fitzpatrick Skin Type|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|0|0.0||||||
3924699|NCT01422538|3748250|B2|Type V||Fitzpatrick Skin Type|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|0|0.0||||||
3924700|NCT01422538|3748251|B1|Type V||Fitzpatrick Skin Type|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|0|0.0||||||
3924701|NCT01422538|3748248|B4|Type IV||Fitzpatrick Skin Type|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|0|0.0||||||
3924702|NCT01422538|3748249|B3|Type IV||Fitzpatrick Skin Type|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|0|0.0||||||
3924703|NCT01422538|3748250|B2|Type IV||Fitzpatrick Skin Type|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|0|0.0||||||
3924916|NCT01422213|3748395|B4|||Age||years|Mean|45.7|45.7|Standard Deviation|12.0|12.0|||
3924704|NCT01422538|3748251|B1|Type IV||Fitzpatrick Skin Type|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|0|0.0||||||
3924705|NCT01422538|3748248|B4|Type III||Fitzpatrick Skin Type|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|12|12.0||||||
3924706|NCT01422538|3748249|B3|Type III||Fitzpatrick Skin Type|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|3|3.0||||||
3924707|NCT01422538|3748250|B2|Type III||Fitzpatrick Skin Type|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|4|4.0||||||
3924708|NCT01422538|3748251|B1|Type III||Fitzpatrick Skin Type|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|5|5.0||||||
3924709|NCT01422538|3748248|B4|Type II||Fitzpatrick Skin Type|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|16|16.0||||||
3924710|NCT01422538|3748249|B3|Type II||Fitzpatrick Skin Type|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|6|6.0||||||
3924711|NCT01422538|3748250|B2|Type II||Fitzpatrick Skin Type|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|6|6.0||||||
3924712|NCT01422538|3748251|B1|Type II||Fitzpatrick Skin Type|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|4|4.0||||||
3924713|NCT01422538|3748248|B4|Type 1||Fitzpatrick Skin Type|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|1|1.0||||||
3924714|NCT01422538|3748249|B3|Type 1||Fitzpatrick Skin Type|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|1|1.0||||||
3924715|NCT01422538|3748250|B2|Type 1||Fitzpatrick Skin Type|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|0|0.0||||||
3924773|NCT01422408|3748297|B1||Not severe|Severe baseline symptoms, Itching|Severe symptoms indicated by a score of 3 or 4. Measured at study baseline|Participants|Count of Participants|33|33.0||||||
3924716|NCT01422538|3748251|B1|Type 1||Fitzpatrick Skin Type|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|0|0.0||||||
3924717|NCT01422538|3748248|B4|United States||Region of Enrollment||participants|Number|30|30.0||||||
3924718|NCT01422538|3748249|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3924719|NCT01422538|3748250|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3924720|NCT01422538|3748251|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3924721|NCT01422538|3748248|B4|Native Amer. Indian/ Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3924722|NCT01422538|3748249|B3|Native Amer. Indian/ Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3924723|NCT01422538|3748250|B2|Native Amer. Indian/ Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3924724|NCT01422538|3748251|B1|Native Amer. Indian/ Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3924725|NCT01422538|3748248|B4|African American/Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3924726|NCT01422538|3748249|B3|African American/Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3924727|NCT01422538|3748250|B2|African American/Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3924728|NCT01422538|3748251|B1|African American/Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3924729|NCT01422538|3748248|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3924730|NCT01422538|3748249|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3924731|NCT01422538|3748250|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3924732|NCT01422538|3748251|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3924733|NCT01422538|3748248|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3924734|NCT01422538|3748249|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3924735|NCT01422538|3748250|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3924736|NCT01422538|3748251|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3924737|NCT01422538|3748248|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3924738|NCT01422538|3748249|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3924739|NCT01422538|3748250|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3924740|NCT01422538|3748251|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3924741|NCT01422538|3748248|B4|||Age||years|Mean|48|48.0|Full Range|||37.0|58.0|
3924742|NCT01422538|3748249|B3|||Age||years|Mean|50|50.0|Full Range|||43.0|58.0|
3924743|NCT01422538|3748250|B2|||Age||years|Mean|47|47.0|Full Range|||38.0|56.0|
3924744|NCT01422538|3748251|B1|||Age||years|Mean|47|47.0|Full Range|||37.0|56.0|
3924745|NCT01422434|3748275|B4|Japan||Region of Enrollment||participants|Number|676|676.0||||||
3924746|NCT01422434|3748276|B3|Japan||Region of Enrollment||participants|Number|223|223.0||||||
3924747|NCT01422434|3748277|B2|Japan||Region of Enrollment||participants|Number|226|226.0||||||
3924748|NCT01422434|3748278|B1|Japan||Region of Enrollment||participants|Number|227|227.0||||||
3924749|NCT01422434|3748275|B4||Male|Sex: Female, Male||Participants|Count of Participants|489|489.0||||||
3924750|NCT01422434|3748276|B3||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3924751|NCT01422434|3748277|B2||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
3924752|NCT01422434|3748278|B1||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3924753|NCT01422434|3748275|B4||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
3924754|NCT01422434|3748276|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3924755|NCT01422434|3748277|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3924756|NCT01422434|3748278|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3924757|NCT01422434|3748275|B4|||Age||years|Mean|54.2|54.2|Standard Deviation|15.5|15.5|||
3924758|NCT01422434|3748276|B3|||Age||years|Mean|53.7|53.7|Standard Deviation|15.6|15.6|||
3924759|NCT01422434|3748277|B2|||Age||years|Mean|54.9|54.9|Standard Deviation|15.5|15.5|||
3924760|NCT01422434|3748278|B1|||Age||years|Mean|53.9|53.9|Standard Deviation|15.4|15.4|||
3924761|NCT01422434|3748275|B4||>=65 years|Age||Participants|Count of Participants|200|200.0||||||
3924762|NCT01422434|3748276|B3||>=65 years|Age||Participants|Count of Participants|60|60.0||||||
3924763|NCT01422434|3748277|B2||>=65 years|Age||Participants|Count of Participants|71|71.0||||||
3924764|NCT01422434|3748278|B1||>=65 years|Age||Participants|Count of Participants|69|69.0||||||
3924765|NCT01422434|3748275|B4||Between 18 and 65 years|Age||Participants|Count of Participants|476|476.0||||||
3924766|NCT01422434|3748276|B3||Between 18 and 65 years|Age||Participants|Count of Participants|163|163.0||||||
3924767|NCT01422434|3748277|B2||Between 18 and 65 years|Age||Participants|Count of Participants|155|155.0||||||
3924768|NCT01422434|3748278|B1||Between 18 and 65 years|Age||Participants|Count of Participants|158|158.0||||||
3924769|NCT01422434|3748275|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3924770|NCT01422434|3748276|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3924771|NCT01422434|3748277|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3924772|NCT01422434|3748278|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3924910|NCT01422213|3748397|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3924774|NCT01422408|3748297|B1||Severe|Severe baseline symptoms, Itching|Severe symptoms indicated by a score of 3 or 4. Measured at study baseline|Participants|Count of Participants|1|1.0||||||
3924775|NCT01422408|3748297|B1||Missing/not reported|Severe baseline symptoms, Dyspareunia|Severe symptoms indicated by a score of 3 or 4. Measured at study baseline|Participants|Count of Participants|9|9.0||||||
3924776|NCT01422408|3748297|B1||Not severe|Severe baseline symptoms, Dyspareunia|Severe symptoms indicated by a score of 3 or 4. Measured at study baseline|Participants|Count of Participants|10|10.0||||||
3924777|NCT01422408|3748297|B1||Severe|Severe baseline symptoms, Dyspareunia|Severe symptoms indicated by a score of 3 or 4. Measured at study baseline|Participants|Count of Participants|15|15.0||||||
3924778|NCT01422408|3748297|B1||Not severe|Severe baseline symptoms, Dryness|Severe symptoms indicated by a score of 3 or 4. Measured at study baseline|Participants|Count of Participants|19|19.0||||||
3924779|NCT01422408|3748297|B1||Severe|Severe baseline symptoms, Dryness|Severe symptoms indicated by a score of 3 or 4. Measured at study baseline|Participants|Count of Participants|15|15.0||||||
3924780|NCT01422408|3748297|B1||Prophylaxis|Indications for endocrine therapy|use of endocrine therapy for preventative treatment with an increased risk for breast cancer vs. adjuvant treatment for a history of invasive breast cancer|Participants|Count of Participants|1|1.0||||||
3924781|NCT01422408|3748297|B1||Adjuvant|Indications for endocrine therapy|use of endocrine therapy for preventative treatment with an increased risk for breast cancer vs. adjuvant treatment for a history of invasive breast cancer|Participants|Count of Participants|33|33.0||||||
3924782|NCT01422408|3748297|B1||No prior cytotoxic chemotherapy|Prior cytotoxic chemotherapy received|Whether the subject has received prior cytotoxic chemotherapy for breast cancer: prior cytotoxic chemotherapy versus no prior cytotoxic chemotherapy for breast cancer|Participants|Count of Participants|20|20.0||||||
3924783|NCT01422408|3748297|B1||Prior cytotoxic chemotherapy|Prior cytotoxic chemotherapy received|Whether the subject has received prior cytotoxic chemotherapy for breast cancer: prior cytotoxic chemotherapy versus no prior cytotoxic chemotherapy for breast cancer|Participants|Count of Participants|14|14.0||||||
3924784|NCT01422408|3748297|B1||Tamoxifen|Current endocrine therapy|"type of endocrine therapy currently taken by the subject~tamoxifen vs. anastrazole vs. letrozole vs. exemestane"|Participants|Count of Participants|11|11.0||||||
3924785|NCT01422408|3748297|B1||Letrozole|Current endocrine therapy|"type of endocrine therapy currently taken by the subject~tamoxifen vs. anastrazole vs. letrozole vs. exemestane"|Participants|Count of Participants|13|13.0||||||
3924786|NCT01422408|3748297|B1||Exemestane|Current endocrine therapy|"type of endocrine therapy currently taken by the subject~tamoxifen vs. anastrazole vs. letrozole vs. exemestane"|Participants|Count of Participants|3|3.0||||||
3924787|NCT01422408|3748297|B1||Anastrazole|Current endocrine therapy|"type of endocrine therapy currently taken by the subject~tamoxifen vs. anastrazole vs. letrozole vs. exemestane"|Participants|Count of Participants|7|7.0||||||
3924788|NCT01422408|3748297|B1||Post-menopausal|Menopause status|"Pre-menopausal versus post-menopausal (defined as either no menses ≥ 12 months, medical ovarian suppression with leuprolide or goserelin, bilateral ovarian ablation with radiation, or bilateral oophorectomy)~The subject’s menopausal status will be classified according to the menopausal status at the time of enrollment on study."|Participants|Count of Participants|33|33.0||||||
3924789|NCT01422408|3748297|B1||Pre-menopausal|Menopause status|"Pre-menopausal versus post-menopausal (defined as either no menses ≥ 12 months, medical ovarian suppression with leuprolide or goserelin, bilateral ovarian ablation with radiation, or bilateral oophorectomy)~The subject’s menopausal status will be classified according to the menopausal status at the time of enrollment on study."|Participants|Count of Participants|1|1.0||||||
3924790|NCT01422408|3748297|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3924791|NCT01422408|3748297|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3924792|NCT01422408|3748297|B1|||Age||years|Mean|55.44|55.44|Standard Deviation|9.39|9.39|||
3924793|NCT01422408|3748297|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3924794|NCT01422408|3748297|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3924795|NCT01422408|3748297|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3924796|NCT01422382|3748326|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
3924797|NCT01422382|3748326|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3924798|NCT01422382|3748326|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3924799|NCT01422382|3748326|B1|||Age||years|Mean|29.2|29.2|Standard Deviation|7.63|7.63|||
3924800|NCT01422382|3748326|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3924801|NCT01422382|3748326|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3924802|NCT01422382|3748326|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3924803|NCT01422369|3748331|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
3924804|NCT01422369|3748331|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3924805|NCT01422369|3748331|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3924806|NCT01422369|3748331|B1|||Age||years|Mean|30.5|30.5|Standard Deviation|6.61|6.61|||
3924807|NCT01422369|3748331|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3924808|NCT01422369|3748331|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3924809|NCT01422369|3748331|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3924810|NCT01422356|3748336|B1|Australia||Region of Enrollment||participants|Number|200|200.0||||||
3924811|NCT01422356|3748336|B1||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
3924812|NCT01422356|3748336|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3924813|NCT01422356|3748336|B1|||Age||years|Median|19|19.0|Full Range|||16.0|20.0|
3924814|NCT01422304|3748340|B3|||Prothrombin Time (International Normalized Ratio) (PT[INR])|n=557, 535, 1092 for Sugammadex, Usual Care and Total, respectively|ratio|Mean|1.117|1.117|Standard Deviation|0.147|0.147|||
3924815|NCT01422304|3748341|B2|||Prothrombin Time (International Normalized Ratio) (PT[INR])|n=557, 535, 1092 for Sugammadex, Usual Care and Total, respectively|ratio|Mean|1.114|1.114|Standard Deviation|0.132|0.132|||
3924816|NCT01422304|3748342|B1|||Prothrombin Time (International Normalized Ratio) (PT[INR])|n=557, 535, 1092 for Sugammadex, Usual Care and Total, respectively|ratio|Mean|1.121|1.121|Standard Deviation|0.159|0.159|||
3924817|NCT01422304|3748340|B3|||Activated Partial Thromboplastin Time (aPTT)|n=556, 535, 1091 for Sugammadex, Usual Care and Total, respectively|seconds|Mean|31.08|31.08|Standard Deviation|4.26|4.26|||
3924818|NCT01422304|3748341|B2|||Activated Partial Thromboplastin Time (aPTT)|n=556, 535, 1091 for Sugammadex, Usual Care and Total, respectively|seconds|Mean|31.01|31.01|Standard Deviation|4.14|4.14|||
3924819|NCT01422304|3748342|B1|||Activated Partial Thromboplastin Time (aPTT)|n=556, 535, 1091 for Sugammadex, Usual Care and Total, respectively|seconds|Mean|31.14|31.14|Standard Deviation|4.38|4.38|||
3924820|NCT01422304|3748340|B3||Male|Sex: Female, Male||Participants|Count of Participants|518|518.0||||||
3924821|NCT01422304|3748341|B2||Male|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
3924822|NCT01422304|3748342|B1||Male|Sex: Female, Male||Participants|Count of Participants|270|270.0||||||
3924823|NCT01422304|3748340|B3||Female|Sex: Female, Male||Participants|Count of Participants|666|666.0||||||
3924824|NCT01422304|3748341|B2||Female|Sex: Female, Male||Participants|Count of Participants|340|340.0||||||
3924825|NCT01422304|3748342|B1||Female|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
3924826|NCT01422304|3748340|B3|||Age||years|Mean|66.7|66.7|Standard Deviation|11.7|11.7|||
3924827|NCT01422304|3748341|B2|||Age||years|Mean|66.6|66.6|Standard Deviation|11.3|11.3|||
3924828|NCT01422304|3748342|B1|||Age||years|Mean|66.7|66.7|Standard Deviation|12.0|12.0|||
3924829|NCT01422239|3748373|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3924830|NCT01422239|3748374|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3924831|NCT01422239|3748375|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3924832|NCT01422239|3748373|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3924833|NCT01422239|3748374|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3924834|NCT01422239|3748375|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3924835|NCT01422239|3748373|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3924836|NCT01422239|3748374|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3924837|NCT01422239|3748375|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3924838|NCT01422239|3748373|B3|||Age||years|Mean|44.5|44.5|Standard Deviation|9.8|9.8|||
3924839|NCT01422239|3748374|B2|||Age||years|Mean|45.8|45.8|Standard Deviation|13.3|13.3|||
3924840|NCT01422239|3748375|B1|||Age||years|Mean|43.9|43.9|Standard Deviation|8.4|8.4|||
3924841|NCT01422239|3748373|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3924842|NCT01422239|3748374|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3924843|NCT01422239|3748375|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3924844|NCT01422239|3748373|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3924845|NCT01422239|3748374|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3924846|NCT01422239|3748375|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3924847|NCT01422239|3748373|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3924848|NCT01422239|3748374|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3924849|NCT01422239|3748375|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3924850|NCT01422226|3748386|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3924851|NCT01422226|3748387|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3924852|NCT01422226|3748388|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3924853|NCT01422226|3748386|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3924854|NCT01422226|3748387|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3924855|NCT01422226|3748388|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3924856|NCT01422226|3748386|B3||Female|Gender||Participants|Count of Participants|3|3.0||||||
3924857|NCT01422226|3748387|B2||Female|Gender||Participants|Count of Participants|2|2.0||||||
3924858|NCT01422226|3748388|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
3924859|NCT01422226|3748386|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3924860|NCT01422226|3748387|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3924861|NCT01422226|3748388|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3924862|NCT01422226|3748386|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3924863|NCT01422226|3748387|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3924864|NCT01422226|3748388|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3924865|NCT01422226|3748386|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3924866|NCT01422226|3748387|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3924867|NCT01422226|3748388|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3924868|NCT01422213|3748395|B4|||CGI-S: Baseline Total Score|The Clinical Global Impression - Severity of Illness (CGI-S) is a 7-point scale rated from 1 (normal, not at all ill) to 7 (among the most extremely ill patients). The investigator should use his/her total clinical experience with this patient population to judge how mentally ill the patient is at the time of rating.|units on a scale|Mean|4.59|4.59|Standard Deviation|0.61|0.61|||
3924911|NCT01422213|3748398|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3924912|NCT01422213|3748395|B4||Female|Sex: Female, Male||Participants|Count of Participants|396|396.0||||||
3924869|NCT01422213|3748396|B3|||CGI-S: Baseline Total Score|The Clinical Global Impression - Severity of Illness (CGI-S) is a 7-point scale rated from 1 (normal, not at all ill) to 7 (among the most extremely ill patients). The investigator should use his/her total clinical experience with this patient population to judge how mentally ill the patient is at the time of rating.|units on a scale|Mean|4.62|4.62|Standard Deviation|0.58|0.58|||
3924870|NCT01422213|3748397|B2|||CGI-S: Baseline Total Score|The Clinical Global Impression - Severity of Illness (CGI-S) is a 7-point scale rated from 1 (normal, not at all ill) to 7 (among the most extremely ill patients). The investigator should use his/her total clinical experience with this patient population to judge how mentally ill the patient is at the time of rating.|units on a scale|Mean|4.60|4.6|Standard Deviation|0.62|0.62|||
3924871|NCT01422213|3748398|B1|||CGI-S: Baseline Total Score|The Clinical Global Impression - Severity of Illness (CGI-S) is a 7-point scale rated from 1 (normal, not at all ill) to 7 (among the most extremely ill patients). The investigator should use his/her total clinical experience with this patient population to judge how mentally ill the patient is at the time of rating.|units on a scale|Mean|4.55|4.55|Standard Deviation|0.63|0.63|||
3924872|NCT01422213|3748395|B4|||MADRS: Baseline Total Score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 (no symptom) to 6 (severe symptom). The 10 items represent the core symptoms of depressive illness. The rating should be based on a clinical interview with the patient, moving from broadly phrased questions about symptoms to more detailed ones, which allow a precise rating of severity, covering the last 7 days. Total score from 0 to 60. The higher the score, the more severe.|units on a scale|Least Squares Mean|31.57|31.57|Standard Deviation|3.68|3.68|||
3924873|NCT01422213|3748396|B3|||MADRS: Baseline Total Score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 (no symptom) to 6 (severe symptom). The 10 items represent the core symptoms of depressive illness. The rating should be based on a clinical interview with the patient, moving from broadly phrased questions about symptoms to more detailed ones, which allow a precise rating of severity, covering the last 7 days. Total score from 0 to 60. The higher the score, the more severe.|units on a scale|Least Squares Mean|31.74|31.74|Standard Deviation|3.53|3.53|||
3924874|NCT01422213|3748397|B2|||MADRS: Baseline Total Score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 (no symptom) to 6 (severe symptom). The 10 items represent the core symptoms of depressive illness. The rating should be based on a clinical interview with the patient, moving from broadly phrased questions about symptoms to more detailed ones, which allow a precise rating of severity, covering the last 7 days. Total score from 0 to 60. The higher the score, the more severe.|units on a scale|Least Squares Mean|31.62|31.62|Standard Deviation|3.77|3.77|||
3924875|NCT01422213|3748398|B1|||MADRS: Baseline Total Score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 (no symptom) to 6 (severe symptom). The 10 items represent the core symptoms of depressive illness. The rating should be based on a clinical interview with the patient, moving from broadly phrased questions about symptoms to more detailed ones, which allow a precise rating of severity, covering the last 7 days. Total score from 0 to 60. The higher the score, the more severe.|units on a scale|Least Squares Mean|31.34|31.34|Standard Deviation|3.75|3.75|||
3924876|NCT01422213|3748395|B4|||CRT: Baseline Total Score|"SRT is designed to assess psychomotor speed, and CRT is designed to assess visual attention. Two computerised tests, part of the CogState battery were used to measure SRT and CRT in milliseconds:~The detection task measures SRT: the patient presses a yes button, whenever an onscreen playing card is turned over.~The identification task measures CRT: the patient presses a yes button whenever an onscreen playing card is turned over and is red, or a no button if the card is not red."|log10 (ms)|Mean|2.78|2.78|Standard Deviation|0.14|0.14|||
3924877|NCT01422213|3748396|B3|||CRT: Baseline Total Score|"SRT is designed to assess psychomotor speed, and CRT is designed to assess visual attention. Two computerised tests, part of the CogState battery were used to measure SRT and CRT in milliseconds:~The detection task measures SRT: the patient presses a yes button, whenever an onscreen playing card is turned over.~The identification task measures CRT: the patient presses a yes button whenever an onscreen playing card is turned over and is red, or a no button if the card is not red."|log10 (ms)|Mean|2.78|2.78|Standard Deviation|0.14|0.14|||
3924878|NCT01422213|3748397|B2|||CRT: Baseline Total Score|"SRT is designed to assess psychomotor speed, and CRT is designed to assess visual attention. Two computerised tests, part of the CogState battery were used to measure SRT and CRT in milliseconds:~The detection task measures SRT: the patient presses a yes button, whenever an onscreen playing card is turned over.~The identification task measures CRT: the patient presses a yes button whenever an onscreen playing card is turned over and is red, or a no button if the card is not red."|log10 (ms)|Mean|2.78|2.78|Standard Deviation|0.14|0.14|||
3924879|NCT01422213|3748398|B1|||CRT: Baseline Total Score|"SRT is designed to assess psychomotor speed, and CRT is designed to assess visual attention. Two computerised tests, part of the CogState battery were used to measure SRT and CRT in milliseconds:~The detection task measures SRT: the patient presses a yes button, whenever an onscreen playing card is turned over.~The identification task measures CRT: the patient presses a yes button whenever an onscreen playing card is turned over and is red, or a no button if the card is not red."|log10 (ms)|Mean|2.78|2.78|Standard Deviation|0.14|0.14|||
3924880|NCT01422213|3748395|B4|||SRT: Baseline Total Score|"Simple Reaction Time (SRT) is designed to assess psychomotor speed, and Choice Reaction Time (CRT) is designed to assess visual attention. Two computerised tests, part of the CogState battery were used to measure SRT and CRT in milliseconds:~The detection task measures SRT: the patient presses a yes button, whenever an onscreen playing card is turned over.~The identification task measures CRT: the patient presses a yes button whenever an onscreen playing card is turned over and is red, or a no button if the card is not red."|log10 (ms)|Mean|2.64|2.64|Standard Deviation|0.20|0.2|||
3924881|NCT01422213|3748396|B3|||SRT: Baseline Total Score|"Simple Reaction Time (SRT) is designed to assess psychomotor speed, and Choice Reaction Time (CRT) is designed to assess visual attention. Two computerised tests, part of the CogState battery were used to measure SRT and CRT in milliseconds:~The detection task measures SRT: the patient presses a yes button, whenever an onscreen playing card is turned over.~The identification task measures CRT: the patient presses a yes button whenever an onscreen playing card is turned over and is red, or a no button if the card is not red."|log10 (ms)|Mean|2.63|2.63|Standard Deviation|0.20|0.2|||
3924882|NCT01422213|3748397|B2|||SRT: Baseline Total Score|"Simple Reaction Time (SRT) is designed to assess psychomotor speed, and Choice Reaction Time (CRT) is designed to assess visual attention. Two computerised tests, part of the CogState battery were used to measure SRT and CRT in milliseconds:~The detection task measures SRT: the patient presses a yes button, whenever an onscreen playing card is turned over.~The identification task measures CRT: the patient presses a yes button whenever an onscreen playing card is turned over and is red, or a no button if the card is not red."|log10 (ms)|Mean|2.64|2.64|Standard Deviation|0.20|0.2|||
3924883|NCT01422213|3748398|B1|||SRT: Baseline Total Score|"Simple Reaction Time (SRT) is designed to assess psychomotor speed, and Choice Reaction Time (CRT) is designed to assess visual attention. Two computerised tests, part of the CogState battery were used to measure SRT and CRT in milliseconds:~The detection task measures SRT: the patient presses a yes button, whenever an onscreen playing card is turned over.~The identification task measures CRT: the patient presses a yes button whenever an onscreen playing card is turned over and is red, or a no button if the card is not red."|log10 (ms)|Mean|2.64|2.64|Standard Deviation|0.20|0.2|||
3924884|NCT01422213|3748395|B4|||STROOP Incongruent: Baseline Total Score||seconds|Mean|84.75|84.75|Standard Deviation|40.51|40.51|||
3924885|NCT01422213|3748396|B3|||STROOP Incongruent: Baseline Total Score||seconds|Mean|83.62|83.62|Standard Deviation|41.40|41.4|||
3924886|NCT01422213|3748397|B2|||STROOP Incongruent: Baseline Total Score||seconds|Mean|85.03|85.03|Standard Deviation|41.09|41.09|||
3924887|NCT01422213|3748398|B1|||STROOP Incongruent: Baseline Total Score||seconds|Mean|85.66|85.66|Standard Deviation|39.15|39.15|||
3924888|NCT01422213|3748395|B4|||STROOP Congruent: Baseline Total Score|Stroop Colour Naming Test (STROOP) is a cognitive test designed to assess the ability to inhibit a prepotent response to reading words while performing a task that requires attention control. It comprises two sheets with 50 words on each, and each word is the name of a colour. On the Congruent STROOP Sheet, the word and ink colour match; on the Incongruent STROOP Sheet, the word and ink colour do not match. The patient has 4 minutes to name the ink colour of each word. The clinician notes the time taken and counts the number of correct and incorrect responses.|seconds|Mean|49.86|49.86|Standard Deviation|25.72|25.72|||
3924889|NCT01422213|3748396|B3|||STROOP Congruent: Baseline Total Score|Stroop Colour Naming Test (STROOP) is a cognitive test designed to assess the ability to inhibit a prepotent response to reading words while performing a task that requires attention control. It comprises two sheets with 50 words on each, and each word is the name of a colour. On the Congruent STROOP Sheet, the word and ink colour match; on the Incongruent STROOP Sheet, the word and ink colour do not match. The patient has 4 minutes to name the ink colour of each word. The clinician notes the time taken and counts the number of correct and incorrect responses.|seconds|Mean|50.01|50.01|Standard Deviation|27.58|27.58|||
3924890|NCT01422213|3748397|B2|||STROOP Congruent: Baseline Total Score|Stroop Colour Naming Test (STROOP) is a cognitive test designed to assess the ability to inhibit a prepotent response to reading words while performing a task that requires attention control. It comprises two sheets with 50 words on each, and each word is the name of a colour. On the Congruent STROOP Sheet, the word and ink colour match; on the Incongruent STROOP Sheet, the word and ink colour do not match. The patient has 4 minutes to name the ink colour of each word. The clinician notes the time taken and counts the number of correct and incorrect responses.|seconds|Mean|49.59|49.59|Standard Deviation|24.65|24.65|||
3924891|NCT01422213|3748398|B1|||STROOP Congruent: Baseline Total Score|Stroop Colour Naming Test (STROOP) is a cognitive test designed to assess the ability to inhibit a prepotent response to reading words while performing a task that requires attention control. It comprises two sheets with 50 words on each, and each word is the name of a colour. On the Congruent STROOP Sheet, the word and ink colour match; on the Incongruent STROOP Sheet, the word and ink colour do not match. The patient has 4 minutes to name the ink colour of each word. The clinician notes the time taken and counts the number of correct and incorrect responses.|seconds|Mean|49.97|49.97|Standard Deviation|24.86|24.86|||
3924892|NCT01422213|3748395|B4|||TMT B: Baseline Total Score|TMT is a cognitive test designed to assess scanning, visuomotor tracking, executive function, and cognitive flexibility. It consists of two parts, A and B: the patient must draw lines to connect consecutively numbered circles (part A) and then connect consecutively numbered and lettered circles alternating between the two sequences (part B). The time taken to complete the two parts is recorded. Part B examines executive functioning and ability to shift cognitive set. The lower the score the faster the ability to shift cognitive set.|seconds|Mean|103.27|103.27|Standard Deviation|52.30|52.3|||
3924893|NCT01422213|3748396|B3|||TMT B: Baseline Total Score|TMT is a cognitive test designed to assess scanning, visuomotor tracking, executive function, and cognitive flexibility. It consists of two parts, A and B: the patient must draw lines to connect consecutively numbered circles (part A) and then connect consecutively numbered and lettered circles alternating between the two sequences (part B). The time taken to complete the two parts is recorded. Part B examines executive functioning and ability to shift cognitive set. The lower the score the faster the ability to shift cognitive set.|seconds|Mean|102.94|102.94|Standard Deviation|52.43|52.43|||
3924894|NCT01422213|3748397|B2|||TMT B: Baseline Total Score|TMT is a cognitive test designed to assess scanning, visuomotor tracking, executive function, and cognitive flexibility. It consists of two parts, A and B: the patient must draw lines to connect consecutively numbered circles (part A) and then connect consecutively numbered and lettered circles alternating between the two sequences (part B). The time taken to complete the two parts is recorded. Part B examines executive functioning and ability to shift cognitive set. The lower the score the faster the ability to shift cognitive set.|seconds|Mean|101.82|101.82|Standard Deviation|51.68|51.68|||
3924895|NCT01422213|3748398|B1|||TMT B: Baseline Total Score|TMT is a cognitive test designed to assess scanning, visuomotor tracking, executive function, and cognitive flexibility. It consists of two parts, A and B: the patient must draw lines to connect consecutively numbered circles (part A) and then connect consecutively numbered and lettered circles alternating between the two sequences (part B). The time taken to complete the two parts is recorded. Part B examines executive functioning and ability to shift cognitive set. The lower the score the faster the ability to shift cognitive set.|seconds|Mean|105.05|105.05|Standard Deviation|52.99|52.99|||
3924913|NCT01422213|3748396|B3||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3924914|NCT01422213|3748397|B2||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3924915|NCT01422213|3748398|B1||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3924896|NCT01422213|3748395|B4|||TMT A: Baseline Total Score|Trail Making Test (TMT) is a cognitive test designed to assess scanning, visuomotor tracking, executive function, and cognitive flexibility. It consists of two parts, A and B: the patient must draw lines to connect consecutively numbered circles (part A) and then connect consecutively numbered and lettered circles alternating between the two sequences (part B). The time taken to complete the two parts is recorded. Part A assesses cognitive processing speed. The lower the score the faster the processing speed.|seconds|Mean|47.13|47.13|Standard Deviation|25.20|25.2|||
3924897|NCT01422213|3748396|B3|||TMT A: Baseline Total Score|Trail Making Test (TMT) is a cognitive test designed to assess scanning, visuomotor tracking, executive function, and cognitive flexibility. It consists of two parts, A and B: the patient must draw lines to connect consecutively numbered circles (part A) and then connect consecutively numbered and lettered circles alternating between the two sequences (part B). The time taken to complete the two parts is recorded. Part A assesses cognitive processing speed. The lower the score the faster the processing speed.|seconds|Mean|46.23|46.23|Standard Deviation|26.66|26.66|||
3924898|NCT01422213|3748397|B2|||TMT A: Baseline Total Score|Trail Making Test (TMT) is a cognitive test designed to assess scanning, visuomotor tracking, executive function, and cognitive flexibility. It consists of two parts, A and B: the patient must draw lines to connect consecutively numbered circles (part A) and then connect consecutively numbered and lettered circles alternating between the two sequences (part B). The time taken to complete the two parts is recorded. Part A assesses cognitive processing speed. The lower the score the faster the processing speed.|seconds|Mean|46.51|46.51|Standard Deviation|24.12|24.12|||
3924899|NCT01422213|3748398|B1|||TMT A: Baseline Total Score|Trail Making Test (TMT) is a cognitive test designed to assess scanning, visuomotor tracking, executive function, and cognitive flexibility. It consists of two parts, A and B: the patient must draw lines to connect consecutively numbered circles (part A) and then connect consecutively numbered and lettered circles alternating between the two sequences (part B). The time taken to complete the two parts is recorded. Part A assesses cognitive processing speed. The lower the score the faster the processing speed.|seconds|Mean|48.71|48.71|Standard Deviation|24.73|24.73|||
3924900|NCT01422213|3748395|B4|||RAVLT: Baseline Total Score|Rey Auditory Verbal Learning Task (RAVLT) is a cognitive test designed to assess verbal learning and memory, including immediate memory, efficiency of learning, retroactive and proactive interference effects, and encoding versus retrieval. It consists of a number of tasks, including immediate recall and delayed recall. The number of words correctly recalled on each task is recorded. The number of correct words could range from 0 to 45. No categorization of the number of correct words is possible.|correct words|Mean|22.38|22.38|Standard Deviation|5.77|5.77|||
3924901|NCT01422213|3748396|B3|||RAVLT: Baseline Total Score|Rey Auditory Verbal Learning Task (RAVLT) is a cognitive test designed to assess verbal learning and memory, including immediate memory, efficiency of learning, retroactive and proactive interference effects, and encoding versus retrieval. It consists of a number of tasks, including immediate recall and delayed recall. The number of words correctly recalled on each task is recorded. The number of correct words could range from 0 to 45. No categorization of the number of correct words is possible.|correct words|Mean|22.64|22.64|Standard Deviation|5.88|5.88|||
3924902|NCT01422213|3748397|B2|||RAVLT: Baseline Total Score|Rey Auditory Verbal Learning Task (RAVLT) is a cognitive test designed to assess verbal learning and memory, including immediate memory, efficiency of learning, retroactive and proactive interference effects, and encoding versus retrieval. It consists of a number of tasks, including immediate recall and delayed recall. The number of words correctly recalled on each task is recorded. The number of correct words could range from 0 to 45. No categorization of the number of correct words is possible.|correct words|Mean|22.34|22.34|Standard Deviation|5.76|5.76|||
3924903|NCT01422213|3748398|B1|||RAVLT: Baseline Total Score|Rey Auditory Verbal Learning Task (RAVLT) is a cognitive test designed to assess verbal learning and memory, including immediate memory, efficiency of learning, retroactive and proactive interference effects, and encoding versus retrieval. It consists of a number of tasks, including immediate recall and delayed recall. The number of words correctly recalled on each task is recorded. The number of correct words could range from 0 to 45. No categorization of the number of correct words is possible.|correct words|Mean|22.14|22.14|Standard Deviation|5.70|5.7|||
3924904|NCT01422213|3748395|B4|||DSST: Baseline Total Score|Digit Symbol Substitution Test (DSST) is a cognitive test designed to assess psychomotor speed of performance requiring visual perception, spatial decision-making, and motor skills. It consists of 133 digits and requires the patient to substitute each digit with a simple symbol in a 90-second period. Each correct symbol is counted, and the total score ranges from 0 (less than normal functioning) to 133 (greater than normal functioning).|units on a scale|Mean|41.98|41.98|Standard Deviation|13.00|13.0|||
3924905|NCT01422213|3748396|B3|||DSST: Baseline Total Score|Digit Symbol Substitution Test (DSST) is a cognitive test designed to assess psychomotor speed of performance requiring visual perception, spatial decision-making, and motor skills. It consists of 133 digits and requires the patient to substitute each digit with a simple symbol in a 90-second period. Each correct symbol is counted, and the total score ranges from 0 (less than normal functioning) to 133 (greater than normal functioning).|units on a scale|Mean|41.61|41.61|Standard Deviation|12.72|12.72|||
3924906|NCT01422213|3748397|B2|||DSST: Baseline Total Score|Digit Symbol Substitution Test (DSST) is a cognitive test designed to assess psychomotor speed of performance requiring visual perception, spatial decision-making, and motor skills. It consists of 133 digits and requires the patient to substitute each digit with a simple symbol in a 90-second period. Each correct symbol is counted, and the total score ranges from 0 (less than normal functioning) to 133 (greater than normal functioning).|units on a scale|Mean|41.96|41.96|Standard Deviation|12.56|12.56|||
3924907|NCT01422213|3748398|B1|||DSST: Baseline Total Score|Digit Symbol Substitution Test (DSST) is a cognitive test designed to assess psychomotor speed of performance requiring visual perception, spatial decision-making, and motor skills. It consists of 133 digits and requires the patient to substitute each digit with a simple symbol in a 90-second period. Each correct symbol is counted, and the total score ranges from 0 (less than normal functioning) to 133 (greater than normal functioning).|units on a scale|Mean|42.38|42.38|Standard Deviation|13.76|13.76|||
3924908|NCT01422213|3748395|B4||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3924909|NCT01422213|3748396|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3924917|NCT01422213|3748396|B3|||Age||years|Mean|46.1|46.1|Standard Deviation|11.8|11.8|||
3924918|NCT01422213|3748397|B2|||Age||years|Mean|45.4|45.4|Standard Deviation|12.2|12.2|||
3924919|NCT01422213|3748398|B1|||Age||years|Mean|45.6|45.6|Standard Deviation|12.1|12.1|||
3924920|NCT01422187|3748458|B4|Spain||Region of Enrollment||participants|Number|2|2.0||||||
3924921|NCT01422187|3748459|B3|Spain||Region of Enrollment||participants|Number|0|0.0||||||
3924922|NCT01422187|3748460|B2|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3924923|NCT01422187|3748461|B1|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3924924|NCT01422187|3748458|B4|Chile||Region of Enrollment||participants|Number|2|2.0||||||
3924925|NCT01422187|3748459|B3|Chile||Region of Enrollment||participants|Number|1|1.0||||||
3924926|NCT01422187|3748460|B2|Chile||Region of Enrollment||participants|Number|1|1.0||||||
3924927|NCT01422187|3748461|B1|Chile||Region of Enrollment||participants|Number|0|0.0||||||
3924928|NCT01422187|3748458|B4|Mexico||Region of Enrollment||participants|Number|5|5.0||||||
3924929|NCT01422187|3748459|B3|Mexico||Region of Enrollment||participants|Number|0|0.0||||||
3924930|NCT01422187|3748460|B2|Mexico||Region of Enrollment||participants|Number|2|2.0||||||
3924931|NCT01422187|3748461|B1|Mexico||Region of Enrollment||participants|Number|3|3.0||||||
3924932|NCT01422187|3748458|B4|Serbia||Region of Enrollment||participants|Number|4|4.0||||||
3924933|NCT01422187|3748459|B3|Serbia||Region of Enrollment||participants|Number|0|0.0||||||
3924934|NCT01422187|3748460|B2|Serbia||Region of Enrollment||participants|Number|2|2.0||||||
3924935|NCT01422187|3748461|B1|Serbia||Region of Enrollment||participants|Number|2|2.0||||||
3924936|NCT01422187|3748458|B4|Italy||Region of Enrollment||participants|Number|1|1.0||||||
3924937|NCT01422187|3748459|B3|Italy||Region of Enrollment||participants|Number|0|0.0||||||
3924938|NCT01422187|3748460|B2|Italy||Region of Enrollment||participants|Number|1|1.0||||||
3924939|NCT01422187|3748461|B1|Italy||Region of Enrollment||participants|Number|0|0.0||||||
3924940|NCT01422187|3748458|B4|South Africa||Region of Enrollment||participants|Number|1|1.0||||||
3924941|NCT01422187|3748459|B3|South Africa||Region of Enrollment||participants|Number|1|1.0||||||
3924942|NCT01422187|3748460|B2|South Africa||Region of Enrollment||participants|Number|0|0.0||||||
3924943|NCT01422187|3748461|B1|South Africa||Region of Enrollment||participants|Number|0|0.0||||||
3924944|NCT01422187|3748458|B4|Israel||Region of Enrollment||participants|Number|4|4.0||||||
3924945|NCT01422187|3748459|B3|Israel||Region of Enrollment||participants|Number|0|0.0||||||
3924946|NCT01422187|3748460|B2|Israel||Region of Enrollment||participants|Number|2|2.0||||||
3924947|NCT01422187|3748461|B1|Israel||Region of Enrollment||participants|Number|2|2.0||||||
3924948|NCT01422187|3748458|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924949|NCT01422187|3748459|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924950|NCT01422187|3748460|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924951|NCT01422187|3748461|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924952|NCT01422187|3748458|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924953|NCT01422187|3748459|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924954|NCT01422187|3748460|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924955|NCT01422187|3748461|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924956|NCT01422187|3748458|B4||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3924957|NCT01422187|3748459|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3924958|NCT01422187|3748460|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3924959|NCT01422187|3748461|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3924960|NCT01422187|3748458|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924961|NCT01422187|3748459|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924962|NCT01422187|3748460|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924963|NCT01422187|3748461|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924964|NCT01422187|3748458|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924965|NCT01422187|3748459|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924966|NCT01422187|3748460|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924967|NCT01422187|3748461|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924968|NCT01422187|3748458|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924969|NCT01422187|3748459|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924970|NCT01422187|3748460|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924971|NCT01422187|3748461|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924972|NCT01422187|3748458|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924973|NCT01422187|3748459|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924974|NCT01422187|3748460|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924975|NCT01422187|3748461|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3924976|NCT01422187|3748458|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3924977|NCT01422187|3748459|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3924978|NCT01422187|3748460|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3924979|NCT01422187|3748461|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3924980|NCT01422187|3748458|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3924981|NCT01422187|3748459|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3924982|NCT01422187|3748460|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3924983|NCT01422187|3748461|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3924984|NCT01422187|3748458|B4|||Age||years|Mean|41.8|41.8|Standard Deviation|11.8|11.8|||
3924985|NCT01422187|3748459|B3|||Age||years|Mean|38.5|38.5|Standard Deviation|0.7|0.7|||
3924986|NCT01422187|3748460|B2|||Age||years|Mean|39.9|39.9|Standard Deviation|12.0|12.0|||
3924987|NCT01422187|3748461|B1|||Age||years|Mean|44.8|44.8|Standard Deviation|13.4|13.4|||
3924988|NCT01422135|3748480|B1|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3924989|NCT01422135|3748480|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3924990|NCT01422135|3748480|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3924991|NCT01422135|3748480|B1|||Age||years|Mean|32.2|32.2|Standard Deviation|8.32|8.32|||
3924992|NCT01422135|3748480|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3924993|NCT01422135|3748480|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3924994|NCT01422135|3748480|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3924995|NCT01422070|3748494|B3||Male|Sex: Female, Male||Participants|Count of Participants|3500|3500.0||||||
3924996|NCT01422070|3748495|B2||Male|Sex: Female, Male||Participants|Count of Participants|471|471.0||||||
3924997|NCT01422070|3748496|B1||Male|Sex: Female, Male||Participants|Count of Participants|3029|3029.0||||||
3924998|NCT01422070|3748494|B3||Female|Sex: Female, Male||Participants|Count of Participants|2334|2334.0||||||
3924999|NCT01422070|3748495|B2||Female|Sex: Female, Male||Participants|Count of Participants|332|332.0||||||
3925000|NCT01422070|3748496|B1||Female|Sex: Female, Male||Participants|Count of Participants|2002|2002.0||||||
3925001|NCT01422070|3748494|B3|||Age||years|Median|65|65.0|Inter-Quartile Range|||53.0|75.0|
3925002|NCT01422070|3748495|B2|||Age||years|Median|68|68.0|Inter-Quartile Range|||55.0|77.0|
3925003|NCT01422070|3748496|B1|||Age||years|Median|65|65.0|Inter-Quartile Range|||52.0|75.0|
3925004|NCT01421719|3748508|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3925005|NCT01421719|3748508|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3925006|NCT01421719|3748508|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3925007|NCT01421719|3748508|B1|||Age||years|Mean|70.95|70.95|Standard Deviation|8.22|8.22|||
3925008|NCT01421719|3748508|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3925009|NCT01421719|3748508|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3925010|NCT01421719|3748508|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3925011|NCT01421667|3748513|B5|Missing||Disease Status Relative to Most Recent Prior Therapy||participants|Number|1|1.0||||||
3925012|NCT01421667|3748514|B4|Missing||Disease Status Relative to Most Recent Prior Therapy||participants|Number|0|0.0||||||
3925013|NCT01421667|3748515|B3|Missing||Disease Status Relative to Most Recent Prior Therapy||participants|Number|0|0.0||||||
3925014|NCT01421667|3748516|B2|Missing||Disease Status Relative to Most Recent Prior Therapy||participants|Number|1|1.0||||||
3925015|NCT01421667|3748517|B1|Missing||Disease Status Relative to Most Recent Prior Therapy||participants|Number|0|0.0||||||
3925016|NCT01421667|3748513|B5|Relapsed||Disease Status Relative to Most Recent Prior Therapy||participants|Number|48|48.0||||||
3925017|NCT01421667|3748514|B4|Relapsed||Disease Status Relative to Most Recent Prior Therapy||participants|Number|7|7.0||||||
3925018|NCT01421667|3748515|B3|Relapsed||Disease Status Relative to Most Recent Prior Therapy||participants|Number|16|16.0||||||
3925019|NCT01421667|3748516|B2|Relapsed||Disease Status Relative to Most Recent Prior Therapy||participants|Number|12|12.0||||||
3925020|NCT01421667|3748517|B1|Relapsed||Disease Status Relative to Most Recent Prior Therapy||participants|Number|13|13.0||||||
3925021|NCT01421667|3748513|B5|Refractory||Disease Status Relative to Most Recent Prior Therapy||participants|Number|123|123.0||||||
3925022|NCT01421667|3748514|B4|Refractory||Disease Status Relative to Most Recent Prior Therapy||participants|Number|9|9.0||||||
3925023|NCT01421667|3748515|B3|Refractory||Disease Status Relative to Most Recent Prior Therapy||participants|Number|37|37.0||||||
3925024|NCT01421667|3748516|B2|Refractory||Disease Status Relative to Most Recent Prior Therapy||participants|Number|55|55.0||||||
3925025|NCT01421667|3748517|B1|Refractory||Disease Status Relative to Most Recent Prior Therapy||participants|Number|22|22.0||||||
3925026|NCT01421667|3748513|B5|Missing/Unknown||Refractory to Frontline Therapy||participants|Number|2|2.0||||||
3925027|NCT01421667|3748514|B4|Missing/Unknown||Refractory to Frontline Therapy||participants|Number|0|0.0||||||
3925028|NCT01421667|3748515|B3|Missing/Unknown||Refractory to Frontline Therapy||participants|Number|0|0.0||||||
3925029|NCT01421667|3748516|B2|Missing/Unknown||Refractory to Frontline Therapy||participants|Number|2|2.0||||||
3925030|NCT01421667|3748517|B1|Missing/Unknown||Refractory to Frontline Therapy||participants|Number|0|0.0||||||
3925031|NCT01421667|3748513|B5|No||Refractory to Frontline Therapy||participants|Number|50|50.0||||||
3925032|NCT01421667|3748514|B4|No||Refractory to Frontline Therapy||participants|Number|6|6.0||||||
3925033|NCT01421667|3748515|B3|No||Refractory to Frontline Therapy||participants|Number|19|19.0||||||
3925034|NCT01421667|3748516|B2|No||Refractory to Frontline Therapy||participants|Number|15|15.0||||||
3925035|NCT01421667|3748517|B1|No||Refractory to Frontline Therapy||participants|Number|10|10.0||||||
3925036|NCT01421667|3748513|B5|Yes||Refractory to Frontline Therapy||participants|Number|120|120.0||||||
3925037|NCT01421667|3748514|B4|Yes||Refractory to Frontline Therapy||participants|Number|10|10.0||||||
3925038|NCT01421667|3748515|B3|Yes||Refractory to Frontline Therapy||participants|Number|34|34.0||||||
3925039|NCT01421667|3748516|B2|Yes||Refractory to Frontline Therapy||participants|Number|51|51.0||||||
3925040|NCT01421667|3748517|B1|Yes||Refractory to Frontline Therapy||participants|Number|25|25.0||||||
3925041|NCT01421667|3748513|B5|||% CD30 Expression by Visual Immunohistochemistry (vIHC)|Percent CD30 expression by standard immunohistochemistry assessed visually by central laboratory (vIHC)|percentage|Median|8|8.0|Full Range|||0.0|100.0|
3925042|NCT01421667|3748514|B4|||% CD30 Expression by Visual Immunohistochemistry (vIHC)|Percent CD30 expression by standard immunohistochemistry assessed visually by central laboratory (vIHC)|percentage|Median|50|50.0|Full Range|||1.0|100.0|
3925043|NCT01421667|3748515|B3|||% CD30 Expression by Visual Immunohistochemistry (vIHC)|Percent CD30 expression by standard immunohistochemistry assessed visually by central laboratory (vIHC)|percentage|Median|0|0.0|Full Range|||0.0|10.0|
3925044|NCT01421667|3748516|B2|||% CD30 Expression by Visual Immunohistochemistry (vIHC)|Percent CD30 expression by standard immunohistochemistry assessed visually by central laboratory (vIHC)|percentage|Median|35|35.0|Full Range|||0.0|100.0|
3925045|NCT01421667|3748517|B1|||% CD30 Expression by Visual Immunohistochemistry (vIHC)|Percent CD30 expression by standard immunohistochemistry assessed visually by central laboratory (vIHC)|percentage|Median|15|15.0|Full Range|||0.0|95.0|
3925046|NCT01421667|3748513|B5|Missing||Eastern Cooperative Oncology Group Performance Status (ECOG)|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|1|1.0||||||
3925047|NCT01421667|3748514|B4|Missing||Eastern Cooperative Oncology Group Performance Status (ECOG)|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|0|0.0||||||
3925048|NCT01421667|3748515|B3|Missing||Eastern Cooperative Oncology Group Performance Status (ECOG)|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|0|0.0||||||
3925049|NCT01421667|3748516|B2|Missing||Eastern Cooperative Oncology Group Performance Status (ECOG)|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|1|1.0||||||
3925050|NCT01421667|3748517|B1|Missing||Eastern Cooperative Oncology Group Performance Status (ECOG)|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|0|0.0||||||
3925051|NCT01421667|3748513|B5|3-5||Eastern Cooperative Oncology Group Performance Status (ECOG)|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|0|0.0||||||
3925052|NCT01421667|3748514|B4|3-5||Eastern Cooperative Oncology Group Performance Status (ECOG)|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|0|0.0||||||
3925053|NCT01421667|3748515|B3|3-5||Eastern Cooperative Oncology Group Performance Status (ECOG)|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|0|0.0||||||
3925054|NCT01421667|3748516|B2|3-5||Eastern Cooperative Oncology Group Performance Status (ECOG)|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|0|0.0||||||
3925055|NCT01421667|3748517|B1|3-5||Eastern Cooperative Oncology Group Performance Status (ECOG)|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|0|0.0||||||
3925056|NCT01421667|3748513|B5|2||Eastern Cooperative Oncology Group Performance Status (ECOG)|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|24|24.0||||||
3925057|NCT01421667|3748514|B4|2||Eastern Cooperative Oncology Group Performance Status (ECOG)|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|0|0.0||||||
3925058|NCT01421667|3748515|B3|2||Eastern Cooperative Oncology Group Performance Status (ECOG)|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|12|12.0||||||
3925059|NCT01421667|3748516|B2|2||Eastern Cooperative Oncology Group Performance Status (ECOG)|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|7|7.0||||||
3925060|NCT01421667|3748517|B1|2||Eastern Cooperative Oncology Group Performance Status (ECOG)|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|5|5.0||||||
3925061|NCT01421667|3748513|B5|1||Eastern Cooperative Oncology Group Performance Status (ECOG)|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|96|96.0||||||
3925062|NCT01421667|3748514|B4|1||Eastern Cooperative Oncology Group Performance Status (ECOG)|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|7|7.0||||||
3925063|NCT01421667|3748515|B3|1||Eastern Cooperative Oncology Group Performance Status (ECOG)|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|31|31.0||||||
3925064|NCT01421667|3748516|B2|1||Eastern Cooperative Oncology Group Performance Status (ECOG)|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|35|35.0||||||
3925065|NCT01421667|3748517|B1|1||Eastern Cooperative Oncology Group Performance Status (ECOG)|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|23|23.0||||||
3925120|NCT01421667|3748517|B1|Peripheral T-Cell Lymphoma Not Otherwise Specified||Pathological Diagnosis||participants|Number|22|22.0||||||
3925066|NCT01421667|3748513|B5|0||Eastern Cooperative Oncology Group Performance Status (ECOG)|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|51|51.0||||||
3925067|NCT01421667|3748514|B4|0||Eastern Cooperative Oncology Group Performance Status (ECOG)|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|9|9.0||||||
3925068|NCT01421667|3748515|B3|0||Eastern Cooperative Oncology Group Performance Status (ECOG)|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|10|10.0||||||
3925069|NCT01421667|3748516|B2|0||Eastern Cooperative Oncology Group Performance Status (ECOG)|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|25|25.0||||||
3925070|NCT01421667|3748517|B1|0||Eastern Cooperative Oncology Group Performance Status (ECOG)|0 = Normal activity; 1 = Symptoms but ambulatory; 2 = In bed <50% of the time; 3 = In bed >50% of the time; 4 = 100% bedridden; 5 = Dead|participants|Number|7|7.0||||||
3925071|NCT01421667|3748513|B5|No||Bulky Disease (≥5 cm on at least one baseline index lesion)||participants|Number|101|101.0||||||
3925072|NCT01421667|3748514|B4|No||Bulky Disease (≥5 cm on at least one baseline index lesion)||participants|Number|12|12.0||||||
3925073|NCT01421667|3748515|B3|No||Bulky Disease (≥5 cm on at least one baseline index lesion)||participants|Number|18|18.0||||||
3925074|NCT01421667|3748516|B2|No||Bulky Disease (≥5 cm on at least one baseline index lesion)||participants|Number|41|41.0||||||
3925075|NCT01421667|3748517|B1|No||Bulky Disease (≥5 cm on at least one baseline index lesion)||participants|Number|30|30.0||||||
3925076|NCT01421667|3748513|B5|Yes||Bulky Disease (≥5 cm on at least one baseline index lesion)||participants|Number|71|71.0||||||
3925077|NCT01421667|3748514|B4|Yes||Bulky Disease (≥5 cm on at least one baseline index lesion)||participants|Number|4|4.0||||||
3925078|NCT01421667|3748515|B3|Yes||Bulky Disease (≥5 cm on at least one baseline index lesion)||participants|Number|35|35.0||||||
3925079|NCT01421667|3748516|B2|Yes||Bulky Disease (≥5 cm on at least one baseline index lesion)||participants|Number|27|27.0||||||
3925080|NCT01421667|3748517|B1|Yes||Bulky Disease (≥5 cm on at least one baseline index lesion)||participants|Number|5|5.0||||||
3925081|NCT01421667|3748513|B5|Unknown||Disease Stage||participants|Number|9|9.0||||||
3925082|NCT01421667|3748514|B4|Unknown||Disease Stage||participants|Number|0|0.0||||||
3925083|NCT01421667|3748515|B3|Unknown||Disease Stage||participants|Number|1|1.0||||||
3925084|NCT01421667|3748516|B2|Unknown||Disease Stage||participants|Number|4|4.0||||||
3925085|NCT01421667|3748517|B1|Unknown||Disease Stage||participants|Number|4|4.0||||||
3925086|NCT01421667|3748513|B5|Stage IV||Disease Stage||participants|Number|84|84.0||||||
3925087|NCT01421667|3748514|B4|Stage IV||Disease Stage||participants|Number|6|6.0||||||
3925088|NCT01421667|3748515|B3|Stage IV||Disease Stage||participants|Number|33|33.0||||||
3925089|NCT01421667|3748516|B2|Stage IV||Disease Stage||participants|Number|31|31.0||||||
3925090|NCT01421667|3748517|B1|Stage IV||Disease Stage||participants|Number|14|14.0||||||
3925091|NCT01421667|3748513|B5|Stage III||Disease Stage||participants|Number|47|47.0||||||
3925092|NCT01421667|3748514|B4|Stage III||Disease Stage||participants|Number|6|6.0||||||
3925093|NCT01421667|3748515|B3|Stage III||Disease Stage||participants|Number|11|11.0||||||
3925094|NCT01421667|3748516|B2|Stage III||Disease Stage||participants|Number|17|17.0||||||
3925095|NCT01421667|3748517|B1|Stage III||Disease Stage||participants|Number|13|13.0||||||
3925096|NCT01421667|3748513|B5|Stage II||Disease Stage||participants|Number|24|24.0||||||
3925097|NCT01421667|3748514|B4|Stage II||Disease Stage||participants|Number|3|3.0||||||
3925098|NCT01421667|3748515|B3|Stage II||Disease Stage||participants|Number|7|7.0||||||
3925099|NCT01421667|3748516|B2|Stage II||Disease Stage||participants|Number|12|12.0||||||
3925100|NCT01421667|3748517|B1|Stage II||Disease Stage||participants|Number|2|2.0||||||
3925101|NCT01421667|3748513|B5|Stage I||Disease Stage||participants|Number|8|8.0||||||
3925102|NCT01421667|3748514|B4|Stage I||Disease Stage||participants|Number|1|1.0||||||
3925103|NCT01421667|3748515|B3|Stage I||Disease Stage||participants|Number|1|1.0||||||
3925104|NCT01421667|3748516|B2|Stage I||Disease Stage||participants|Number|4|4.0||||||
3925105|NCT01421667|3748517|B1|Stage I||Disease Stage||participants|Number|2|2.0||||||
3925106|NCT01421667|3748513|B5|No||Transformed Disease from Prior Non-Hodgkin Lymphoma||participants|Number|141|141.0||||||
3925107|NCT01421667|3748514|B4|No||Transformed Disease from Prior Non-Hodgkin Lymphoma||participants|Number|11|11.0||||||
3925108|NCT01421667|3748515|B3|No||Transformed Disease from Prior Non-Hodgkin Lymphoma||participants|Number|42|42.0||||||
3925109|NCT01421667|3748516|B2|No||Transformed Disease from Prior Non-Hodgkin Lymphoma||participants|Number|54|54.0||||||
3925110|NCT01421667|3748517|B1|No||Transformed Disease from Prior Non-Hodgkin Lymphoma||participants|Number|34|34.0||||||
3925111|NCT01421667|3748513|B5|Yes||Transformed Disease from Prior Non-Hodgkin Lymphoma||participants|Number|31|31.0||||||
3925112|NCT01421667|3748514|B4|Yes||Transformed Disease from Prior Non-Hodgkin Lymphoma||participants|Number|5|5.0||||||
3925113|NCT01421667|3748515|B3|Yes||Transformed Disease from Prior Non-Hodgkin Lymphoma||participants|Number|11|11.0||||||
3925114|NCT01421667|3748516|B2|Yes||Transformed Disease from Prior Non-Hodgkin Lymphoma||participants|Number|14|14.0||||||
3925115|NCT01421667|3748517|B1|Yes||Transformed Disease from Prior Non-Hodgkin Lymphoma||participants|Number|1|1.0||||||
3925116|NCT01421667|3748513|B5|Peripheral T-Cell Lymphoma Not Otherwise Specified||Pathological Diagnosis||participants|Number|22|22.0||||||
3925117|NCT01421667|3748514|B4|Peripheral T-Cell Lymphoma Not Otherwise Specified||Pathological Diagnosis||participants|Number|0|0.0||||||
3925118|NCT01421667|3748515|B3|Peripheral T-Cell Lymphoma Not Otherwise Specified||Pathological Diagnosis||participants|Number|0|0.0||||||
3925119|NCT01421667|3748516|B2|Peripheral T-Cell Lymphoma Not Otherwise Specified||Pathological Diagnosis||participants|Number|0|0.0||||||
3925121|NCT01421667|3748513|B5|Angioimmunoblastic T-cell Lymphoma||Pathological Diagnosis||participants|Number|13|13.0||||||
3925122|NCT01421667|3748514|B4|Angioimmunoblastic T-cell Lymphoma||Pathological Diagnosis||participants|Number|0|0.0||||||
3925123|NCT01421667|3748515|B3|Angioimmunoblastic T-cell Lymphoma||Pathological Diagnosis||participants|Number|0|0.0||||||
3925124|NCT01421667|3748516|B2|Angioimmunoblastic T-cell Lymphoma||Pathological Diagnosis||participants|Number|0|0.0||||||
3925125|NCT01421667|3748517|B1|Angioimmunoblastic T-cell Lymphoma||Pathological Diagnosis||participants|Number|13|13.0||||||
3925126|NCT01421667|3748513|B5|T-Cell Rich B-Cell Lymphoma||Pathological Diagnosis||participants|Number|1|1.0||||||
3925127|NCT01421667|3748514|B4|T-Cell Rich B-Cell Lymphoma||Pathological Diagnosis||participants|Number|0|0.0||||||
3925128|NCT01421667|3748515|B3|T-Cell Rich B-Cell Lymphoma||Pathological Diagnosis||participants|Number|0|0.0||||||
3925129|NCT01421667|3748516|B2|T-Cell Rich B-Cell Lymphoma||Pathological Diagnosis||participants|Number|1|1.0||||||
3925130|NCT01421667|3748517|B1|T-Cell Rich B-Cell Lymphoma||Pathological Diagnosis||participants|Number|0|0.0||||||
3925131|NCT01421667|3748513|B5|Plasmablastic Lymphoma||Pathological Diagnosis||participants|Number|1|1.0||||||
3925132|NCT01421667|3748514|B4|Plasmablastic Lymphoma||Pathological Diagnosis||participants|Number|0|0.0||||||
3925133|NCT01421667|3748515|B3|Plasmablastic Lymphoma||Pathological Diagnosis||participants|Number|0|0.0||||||
3925134|NCT01421667|3748516|B2|Plasmablastic Lymphoma||Pathological Diagnosis||participants|Number|1|1.0||||||
3925135|NCT01421667|3748517|B1|Plasmablastic Lymphoma||Pathological Diagnosis||participants|Number|0|0.0||||||
3925136|NCT01421667|3748513|B5|Post-Transplant Lymphoproliferative Disorder||Pathological Diagnosis||participants|Number|3|3.0||||||
3925137|NCT01421667|3748514|B4|Post-Transplant Lymphoproliferative Disorder||Pathological Diagnosis||participants|Number|0|0.0||||||
3925138|NCT01421667|3748515|B3|Post-Transplant Lymphoproliferative Disorder||Pathological Diagnosis||participants|Number|0|0.0||||||
3925139|NCT01421667|3748516|B2|Post-Transplant Lymphoproliferative Disorder||Pathological Diagnosis||participants|Number|3|3.0||||||
3925140|NCT01421667|3748517|B1|Post-Transplant Lymphoproliferative Disorder||Pathological Diagnosis||participants|Number|0|0.0||||||
3925141|NCT01421667|3748513|B5|Primary Mediastinal B-Cell Lymphoma||Pathological Diagnosis||participants|Number|6|6.0||||||
3925142|NCT01421667|3748514|B4|Primary Mediastinal B-Cell Lymphoma||Pathological Diagnosis||participants|Number|0|0.0||||||
3925143|NCT01421667|3748515|B3|Primary Mediastinal B-Cell Lymphoma||Pathological Diagnosis||participants|Number|0|0.0||||||
3925144|NCT01421667|3748516|B2|Primary Mediastinal B-Cell Lymphoma||Pathological Diagnosis||participants|Number|6|6.0||||||
3925145|NCT01421667|3748517|B1|Primary Mediastinal B-Cell Lymphoma||Pathological Diagnosis||participants|Number|0|0.0||||||
3925146|NCT01421667|3748513|B5|Gray Zone Lymphoma||Pathological Diagnosis||participants|Number|6|6.0||||||
3925147|NCT01421667|3748514|B4|Gray Zone Lymphoma||Pathological Diagnosis||participants|Number|0|0.0||||||
3925148|NCT01421667|3748515|B3|Gray Zone Lymphoma||Pathological Diagnosis||participants|Number|0|0.0||||||
3925149|NCT01421667|3748516|B2|Gray Zone Lymphoma||Pathological Diagnosis||participants|Number|6|6.0||||||
3925150|NCT01421667|3748517|B1|Gray Zone Lymphoma||Pathological Diagnosis||participants|Number|0|0.0||||||
3925151|NCT01421667|3748513|B5|Follicular Lymphoma||Pathological Diagnosis||participants|Number|3|3.0||||||
3925152|NCT01421667|3748514|B4|Follicular Lymphoma||Pathological Diagnosis||participants|Number|0|0.0||||||
3925153|NCT01421667|3748515|B3|Follicular Lymphoma||Pathological Diagnosis||participants|Number|0|0.0||||||
3925154|NCT01421667|3748516|B2|Follicular Lymphoma||Pathological Diagnosis||participants|Number|3|3.0||||||
3925155|NCT01421667|3748517|B1|Follicular Lymphoma||Pathological Diagnosis||participants|Number|0|0.0||||||
3925156|NCT01421667|3748513|B5|Epstein-Barr Virus-Associated DLBCL of Elderly||Pathological Diagnosis||participants|Number|5|5.0||||||
3925157|NCT01421667|3748514|B4|Epstein-Barr Virus-Associated DLBCL of Elderly||Pathological Diagnosis||participants|Number|0|0.0||||||
3925158|NCT01421667|3748515|B3|Epstein-Barr Virus-Associated DLBCL of Elderly||Pathological Diagnosis||participants|Number|0|0.0||||||
3925159|NCT01421667|3748516|B2|Epstein-Barr Virus-Associated DLBCL of Elderly||Pathological Diagnosis||participants|Number|5|5.0||||||
3925160|NCT01421667|3748517|B1|Epstein-Barr Virus-Associated DLBCL of Elderly||Pathological Diagnosis||participants|Number|0|0.0||||||
3925161|NCT01421667|3748513|B5|Diffuse Large B-Cell Lymphoma (DLBCL)||Pathological Diagnosis||participants|Number|112|112.0||||||
3925162|NCT01421667|3748514|B4|Diffuse Large B-Cell Lymphoma (DLBCL)||Pathological Diagnosis||participants|Number|16|16.0||||||
3925163|NCT01421667|3748515|B3|Diffuse Large B-Cell Lymphoma (DLBCL)||Pathological Diagnosis||participants|Number|53|53.0||||||
3925164|NCT01421667|3748516|B2|Diffuse Large B-Cell Lymphoma (DLBCL)||Pathological Diagnosis||participants|Number|43|43.0||||||
3925165|NCT01421667|3748517|B1|Diffuse Large B-Cell Lymphoma (DLBCL)||Pathological Diagnosis||participants|Number|0|0.0||||||
3925166|NCT01421667|3748513|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925167|NCT01421667|3748514|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925168|NCT01421667|3748515|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925169|NCT01421667|3748516|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925170|NCT01421667|3748517|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925171|NCT01421667|3748513|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3925172|NCT01421667|3748514|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3925173|NCT01421667|3748515|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3925174|NCT01421667|3748516|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3925175|NCT01421667|3748517|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925176|NCT01421667|3748513|B5||White|Race (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
3925177|NCT01421667|3748514|B4||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3925178|NCT01421667|3748515|B3||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3925179|NCT01421667|3748516|B2||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3925180|NCT01421667|3748517|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3925181|NCT01421667|3748513|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3925182|NCT01421667|3748514|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925183|NCT01421667|3748515|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3925184|NCT01421667|3748516|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3925185|NCT01421667|3748517|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3925186|NCT01421667|3748513|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3925187|NCT01421667|3748514|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925188|NCT01421667|3748515|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3925189|NCT01421667|3748516|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925190|NCT01421667|3748517|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925191|NCT01421667|3748513|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3925192|NCT01421667|3748514|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925193|NCT01421667|3748515|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3925194|NCT01421667|3748516|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3925195|NCT01421667|3748517|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3925196|NCT01421667|3748513|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3925197|NCT01421667|3748514|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925198|NCT01421667|3748515|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3925199|NCT01421667|3748516|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3925200|NCT01421667|3748517|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925201|NCT01421667|3748513|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925202|NCT01421667|3748514|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925203|NCT01421667|3748515|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925204|NCT01421667|3748516|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925205|NCT01421667|3748517|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925206|NCT01421667|3748513|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|158|158.0||||||
3925207|NCT01421667|3748514|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3925208|NCT01421667|3748515|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3925209|NCT01421667|3748516|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3925210|NCT01421667|3748517|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3925211|NCT01421667|3748513|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3925212|NCT01421667|3748514|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3925213|NCT01421667|3748515|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3925214|NCT01421667|3748516|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3925215|NCT01421667|3748517|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3925216|NCT01421667|3748513|B5||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3925217|NCT01421667|3748514|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3925218|NCT01421667|3748515|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3925219|NCT01421667|3748516|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3925220|NCT01421667|3748517|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3925221|NCT01421667|3748513|B5||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3925222|NCT01421667|3748514|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3925223|NCT01421667|3748515|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3925224|NCT01421667|3748516|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3925225|NCT01421667|3748517|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3925226|NCT01421667|3748513|B5|||Age||years|Median|63|63.0|Full Range|||16.0|91.0|
3925227|NCT01421667|3748514|B4|||Age||years|Median|62|62.0|Full Range|||22.0|78.0|
3925228|NCT01421667|3748515|B3|||Age||years|Median|65|65.0|Full Range|||21.0|91.0|
3925229|NCT01421667|3748516|B2|||Age||years|Median|57|57.0|Full Range|||16.0|85.0|
3925230|NCT01421667|3748517|B1|||Age||years|Median|64|64.0|Full Range|||33.0|83.0|
3925231|NCT01421654|3748570|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3925232|NCT01421654|3748571|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3925233|NCT01421654|3748572|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3925234|NCT01421654|3748570|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3925235|NCT01421654|3748571|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3925236|NCT01421654|3748572|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3925237|NCT01421654|3748570|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3925238|NCT01421654|3748571|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3925239|NCT01421654|3748572|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3925240|NCT01421654|3748570|B3|||Age||years|Mean|55.1|55.1|Standard Deviation|10.1|10.1|||
3925241|NCT01421654|3748571|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|9.2|9.2|||
3925242|NCT01421654|3748572|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|11.2|11.2|||
3925243|NCT01421654|3748570|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3925244|NCT01421654|3748571|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3925245|NCT01421654|3748572|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3925246|NCT01421654|3748570|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3925247|NCT01421654|3748571|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3925248|NCT01421654|3748572|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3925249|NCT01421654|3748570|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3925250|NCT01421654|3748571|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3925251|NCT01421654|3748572|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3925252|NCT01421641|3748579|B3|United States||Region of Enrollment||participants|Number|74|74.0||||||
3925253|NCT01421641|3748580|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
3925254|NCT01421641|3748581|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
3925255|NCT01421641|3748579|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3925256|NCT01421641|3748580|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3925257|NCT01421641|3748581|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3925258|NCT01421641|3748579|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3925259|NCT01421641|3748580|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3925260|NCT01421641|3748581|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3925261|NCT01421641|3748579|B3|||Age||years|Mean|34.5|34.5|Standard Deviation|9.9|9.9|||
3925262|NCT01421641|3748580|B2|||Age||years|Mean|33.7|33.7|Standard Deviation|7.3|7.3|||
3925263|NCT01421641|3748581|B1|||Age||years|Mean|34.6|34.6|Standard Deviation|12.2|12.2|||
3925264|NCT01421641|3748579|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3925265|NCT01421641|3748580|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3925266|NCT01421641|3748581|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3925267|NCT01421641|3748579|B3||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
3925268|NCT01421641|3748580|B2||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3925269|NCT01421641|3748581|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3925270|NCT01421641|3748579|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3925271|NCT01421641|3748580|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3925272|NCT01421641|3748581|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3925273|NCT01421589|3748592|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3925274|NCT01421589|3748592|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925275|NCT01421589|3748592|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3925276|NCT01421589|3748592|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3925277|NCT01421589|3748592|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3925278|NCT01421589|3748592|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925279|NCT01421589|3748592|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3925280|NCT01421589|3748592|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3925281|NCT01421589|3748592|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925282|NCT01421589|3748592|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925283|NCT01421589|3748592|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925284|NCT01421589|3748592|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3925285|NCT01421589|3748592|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3925286|NCT01421589|3748592|B1|||Age||years|Mean|47.9|47.9|Standard Deviation|8.4|8.4|||
3925287|NCT01421511|3748602|B3||Male|Sex: Female, Male||Participants|Count of Participants|439|439.0||||||
3925288|NCT01421511|3748603|B2||Male|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
3925289|NCT01421511|3748604|B1||Male|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
3925290|NCT01421511|3748602|B3||Female|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
3925291|NCT01421511|3748603|B2||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3925292|NCT01421511|3748604|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3925293|NCT01421511|3748602|B3|||Age||years|Mean|45.6|45.6|Standard Deviation|15.67|15.67|||
3925294|NCT01421511|3748603|B2|||Age||years|Mean|45.6|45.6|Standard Deviation|15.57|15.57|||
3925295|NCT01421511|3748604|B1|||Age||years|Mean|45.6|45.6|Standard Deviation|15.79|15.79|||
3925296|NCT01421498|3748625|B3||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3925297|NCT01421498|3748626|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3925298|NCT01421498|3748627|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3925299|NCT01421498|3748625|B3||Female|Sex: Female, Male||Participants|Count of Participants|446|446.0||||||
3925300|NCT01421498|3748626|B2||Female|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
3925301|NCT01421498|3748627|B1||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
3925302|NCT01421498|3748625|B3|||Age||years|Mean|60.6|60.6|Standard Deviation|11.99|11.99|||
3925303|NCT01421498|3748626|B2|||Age||years|Mean|61.1|61.1|Standard Deviation|11.77|11.77|||
3925304|NCT01421498|3748627|B1|||Age||years|Mean|60.2|60.2|Standard Deviation|12.21|12.21|||
3925305|NCT01421472|3748636|B5|No||Subject of Child-Bearing Potential (Y/N)||participants|Number|106|106.0||||||
3925306|NCT01421472|3748637|B4|No||Subject of Child-Bearing Potential (Y/N)||participants|Number|20|20.0||||||
3925307|NCT01421472|3748638|B3|No||Subject of Child-Bearing Potential (Y/N)||participants|Number|37|37.0||||||
3925308|NCT01421472|3748639|B2|No||Subject of Child-Bearing Potential (Y/N)||participants|Number|14|14.0||||||
3925309|NCT01421472|3748640|B1|No||Subject of Child-Bearing Potential (Y/N)||participants|Number|35|35.0||||||
3925310|NCT01421472|3748636|B5|Yes||Subject of Child-Bearing Potential (Y/N)||participants|Number|90|90.0||||||
3925311|NCT01421472|3748637|B4|Yes||Subject of Child-Bearing Potential (Y/N)||participants|Number|12|12.0||||||
3925312|NCT01421472|3748638|B3|Yes||Subject of Child-Bearing Potential (Y/N)||participants|Number|27|27.0||||||
3925313|NCT01421472|3748639|B2|Yes||Subject of Child-Bearing Potential (Y/N)||participants|Number|19|19.0||||||
3925314|NCT01421472|3748640|B1|Yes||Subject of Child-Bearing Potential (Y/N)||participants|Number|32|32.0||||||
3925315|NCT01421472|3748636|B5|United States||Region of Enrollment||participants|Number|196|196.0||||||
3925316|NCT01421472|3748637|B4|United States||Region of Enrollment||participants|Number|32|32.0||||||
3925317|NCT01421472|3748638|B3|United States||Region of Enrollment||participants|Number|64|64.0||||||
3925318|NCT01421472|3748639|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
3925319|NCT01421472|3748640|B1|United States||Region of Enrollment||participants|Number|67|67.0||||||
3925320|NCT01421472|3748636|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3925321|NCT01421472|3748637|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3925322|NCT01421472|3748638|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3925323|NCT01421472|3748639|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3925324|NCT01421472|3748640|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3925325|NCT01421472|3748636|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925326|NCT01421472|3748637|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925327|NCT01421472|3748638|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925328|NCT01421472|3748639|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925329|NCT01421472|3748640|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925330|NCT01421472|3748636|B5||White|Race (NIH/OMB)||Participants|Count of Participants|157|157.0||||||
3925331|NCT01421472|3748637|B4||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3925332|NCT01421472|3748638|B3||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3925333|NCT01421472|3748639|B2||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3925334|NCT01421472|3748640|B1||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3925335|NCT01421472|3748636|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3925336|NCT01421472|3748637|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3925337|NCT01421472|3748638|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3925338|NCT01421472|3748639|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3925339|NCT01421472|3748640|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3925340|NCT01421472|3748636|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3925341|NCT01421472|3748637|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925342|NCT01421472|3748638|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925343|NCT01421472|3748639|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3925344|NCT01421472|3748640|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925345|NCT01421472|3748636|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3925346|NCT01421472|3748637|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925347|NCT01421472|3748638|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925348|NCT01421472|3748639|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925349|NCT01421472|3748640|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3925350|NCT01421472|3748636|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925351|NCT01421472|3748637|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925352|NCT01421472|3748638|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925353|NCT01421472|3748639|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925354|NCT01421472|3748640|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925355|NCT01421472|3748636|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3925356|NCT01421472|3748637|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925357|NCT01421472|3748638|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925358|NCT01421472|3748639|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3925359|NCT01421472|3748640|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925360|NCT01421472|3748636|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|159|159.0||||||
3925361|NCT01421472|3748637|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3925362|NCT01421472|3748638|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3925363|NCT01421472|3748639|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3925364|NCT01421472|3748640|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3925365|NCT01421472|3748636|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3925366|NCT01421472|3748637|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3925367|NCT01421472|3748638|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3925368|NCT01421472|3748639|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3925369|NCT01421472|3748640|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3925370|NCT01421472|3748636|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3925371|NCT01421472|3748637|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3925372|NCT01421472|3748638|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3925373|NCT01421472|3748639|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3925374|NCT01421472|3748640|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3925375|NCT01421472|3748636|B5||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
3925376|NCT01421472|3748637|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3925377|NCT01421472|3748638|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3925378|NCT01421472|3748639|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3925379|NCT01421472|3748640|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3925380|NCT01421472|3748636|B5|||Age||years|Mean|50.25|50.25|Standard Deviation|11.12|11.12|||
3925381|NCT01421472|3748637|B4|||Age||years|Mean|52.5|52.5|Standard Deviation|13.45|13.45|||
3925382|NCT01421472|3748638|B3|||Age||years|Mean|49.3|49.3|Standard Deviation|10.89|10.89|||
3925383|NCT01421472|3748639|B2|||Age||years|Mean|48.9|48.9|Standard Deviation|10.53|10.53|||
3925384|NCT01421472|3748640|B1|||Age||years|Mean|50.7|50.7|Standard Deviation|10.35|10.35|||
3925385|NCT01421459|3748653|B3|||Body Weight||kilograms (kg)|Mean|90.09|90.09|Standard Deviation|19.62|19.62|||
3925386|NCT01421459|3748654|B2|||Body Weight||kilograms (kg)|Mean|89.83|89.83|Standard Deviation|19.25|19.25|||
3925387|NCT01421459|3748655|B1|||Body Weight||kilograms (kg)|Mean|90.35|90.35|Standard Deviation|20.02|20.02|||
3925388|NCT01421459|3748653|B3|Evening/Bedtime||Time of Basal Insulin Injection|Number of participants who administered a basal insulin injection during the Daytime and Evening/Bedtime.|participants|Number|381|381.0||||||
3925389|NCT01421459|3748654|B2|Evening/Bedtime||Time of Basal Insulin Injection|Number of participants who administered a basal insulin injection during the Daytime and Evening/Bedtime.|participants|Number|192|192.0||||||
3925390|NCT01421459|3748655|B1|Evening/Bedtime||Time of Basal Insulin Injection|Number of participants who administered a basal insulin injection during the Daytime and Evening/Bedtime.|participants|Number|189|189.0||||||
3925391|NCT01421459|3748653|B3|Daytime||Time of Basal Insulin Injection|Number of participants who administered a basal insulin injection during the Daytime and Evening/Bedtime.|participants|Number|375|375.0||||||
3925392|NCT01421459|3748654|B2|Daytime||Time of Basal Insulin Injection|Number of participants who administered a basal insulin injection during the Daytime and Evening/Bedtime.|participants|Number|188|188.0||||||
3925393|NCT01421459|3748655|B1|Daytime||Time of Basal Insulin Injection|Number of participants who administered a basal insulin injection during the Daytime and Evening/Bedtime.|participants|Number|187|187.0||||||
3925394|NCT01421459|3748653|B3|No, did not use sulfonylurea||Sulfonylurea Use|Number of participants who used or did not use sulfonylurea.|participants|Number|126|126.0||||||
3925395|NCT01421459|3748654|B2|No, did not use sulfonylurea||Sulfonylurea Use|Number of participants who used or did not use sulfonylurea.|participants|Number|65|65.0||||||
3925396|NCT01421459|3748655|B1|No, did not use sulfonylurea||Sulfonylurea Use|Number of participants who used or did not use sulfonylurea.|participants|Number|61|61.0||||||
3925397|NCT01421459|3748653|B3|Yes, did use sulfonylurea||Sulfonylurea Use|Number of participants who used or did not use sulfonylurea.|participants|Number|630|630.0||||||
3925398|NCT01421459|3748654|B2|Yes, did use sulfonylurea||Sulfonylurea Use|Number of participants who used or did not use sulfonylurea.|participants|Number|315|315.0||||||
3925399|NCT01421459|3748655|B1|Yes, did use sulfonylurea||Sulfonylurea Use|Number of participants who used or did not use sulfonylurea.|participants|Number|315|315.0||||||
3925400|NCT01421459|3748653|B3|||Baseline Hemoglobin A1c (HbA1c)|HbA1c is the glycosylated fraction of hemoglobin A. HbA1c is measured primarily to identify average plasma glucose concentration over prolonged periods of time.|percentage of glycosylated hemoglobin|Mean|8.33|8.33|Standard Deviation|1.08|1.08|||
3925401|NCT01421459|3748654|B2|||Baseline Hemoglobin A1c (HbA1c)|HbA1c is the glycosylated fraction of hemoglobin A. HbA1c is measured primarily to identify average plasma glucose concentration over prolonged periods of time.|percentage of glycosylated hemoglobin|Mean|8.31|8.31|Standard Deviation|1.06|1.06|||
3925402|NCT01421459|3748655|B1|||Baseline Hemoglobin A1c (HbA1c)|HbA1c is the glycosylated fraction of hemoglobin A. HbA1c is measured primarily to identify average plasma glucose concentration over prolonged periods of time.|percentage of glycosylated hemoglobin|Mean|8.34|8.34|Standard Deviation|1.09|1.09|||
3925403|NCT01421459|3748653|B3|United States||Region of Enrollment||participants|Number|355|355.0||||||
3925404|NCT01421459|3748654|B2|United States||Region of Enrollment||participants|Number|184|184.0||||||
3925405|NCT01421459|3748655|B1|United States||Region of Enrollment||participants|Number|171|171.0||||||
3925406|NCT01421459|3748653|B3|Taiwan||Region of Enrollment||participants|Number|21|21.0||||||
3925407|NCT01421459|3748654|B2|Taiwan||Region of Enrollment||participants|Number|12|12.0||||||
3925408|NCT01421459|3748655|B1|Taiwan||Region of Enrollment||participants|Number|9|9.0||||||
3925409|NCT01421459|3748653|B3|Spain||Region of Enrollment||participants|Number|22|22.0||||||
3925410|NCT01421459|3748654|B2|Spain||Region of Enrollment||participants|Number|12|12.0||||||
3925411|NCT01421459|3748655|B1|Spain||Region of Enrollment||participants|Number|10|10.0||||||
3925412|NCT01421459|3748653|B3|Puerto Rico||Region of Enrollment||participants|Number|70|70.0||||||
3925413|NCT01421459|3748654|B2|Puerto Rico||Region of Enrollment||participants|Number|31|31.0||||||
3925414|NCT01421459|3748655|B1|Puerto Rico||Region of Enrollment||participants|Number|39|39.0||||||
3925415|NCT01421459|3748653|B3|Poland||Region of Enrollment||participants|Number|23|23.0||||||
3925416|NCT01421459|3748654|B2|Poland||Region of Enrollment||participants|Number|11|11.0||||||
3925417|NCT01421459|3748655|B1|Poland||Region of Enrollment||participants|Number|12|12.0||||||
3925418|NCT01421459|3748653|B3|Mexico||Region of Enrollment||participants|Number|58|58.0||||||
3925419|NCT01421459|3748654|B2|Mexico||Region of Enrollment||participants|Number|29|29.0||||||
3925420|NCT01421459|3748655|B1|Mexico||Region of Enrollment||participants|Number|29|29.0||||||
3925421|NCT01421459|3748653|B3|Korea, Republic of||Region of Enrollment||participants|Number|32|32.0||||||
3925422|NCT01421459|3748654|B2|Korea, Republic of||Region of Enrollment||participants|Number|15|15.0||||||
3925423|NCT01421459|3748655|B1|Korea, Republic of||Region of Enrollment||participants|Number|17|17.0||||||
3925424|NCT01421459|3748653|B3|Italy||Region of Enrollment||participants|Number|11|11.0||||||
3925425|NCT01421459|3748654|B2|Italy||Region of Enrollment||participants|Number|5|5.0||||||
3925426|NCT01421459|3748655|B1|Italy||Region of Enrollment||participants|Number|6|6.0||||||
3925427|NCT01421459|3748653|B3|Hungary||Region of Enrollment||participants|Number|62|62.0||||||
3925428|NCT01421459|3748654|B2|Hungary||Region of Enrollment||participants|Number|30|30.0||||||
3925429|NCT01421459|3748655|B1|Hungary||Region of Enrollment||participants|Number|32|32.0||||||
3925430|NCT01421459|3748653|B3|Greece||Region of Enrollment||participants|Number|22|22.0||||||
3925431|NCT01421459|3748654|B2|Greece||Region of Enrollment||participants|Number|12|12.0||||||
3925432|NCT01421459|3748655|B1|Greece||Region of Enrollment||participants|Number|10|10.0||||||
3925433|NCT01421459|3748653|B3|Germany||Region of Enrollment||participants|Number|28|28.0||||||
3925434|NCT01421459|3748654|B2|Germany||Region of Enrollment||participants|Number|13|13.0||||||
3925435|NCT01421459|3748655|B1|Germany||Region of Enrollment||participants|Number|15|15.0||||||
3925436|NCT01421459|3748653|B3|France||Region of Enrollment||participants|Number|16|16.0||||||
3925437|NCT01421459|3748654|B2|France||Region of Enrollment||participants|Number|8|8.0||||||
3925438|NCT01421459|3748655|B1|France||Region of Enrollment||participants|Number|8|8.0||||||
3925439|NCT01421459|3748653|B3|Czech Republic||Region of Enrollment||participants|Number|36|36.0||||||
3925440|NCT01421459|3748654|B2|Czech Republic||Region of Enrollment||participants|Number|18|18.0||||||
3925441|NCT01421459|3748655|B1|Czech Republic||Region of Enrollment||participants|Number|18|18.0||||||
3925442|NCT01421459|3748653|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925443|NCT01421459|3748654|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925444|NCT01421459|3748655|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925445|NCT01421459|3748653|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3925446|NCT01421459|3748654|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3925447|NCT01421459|3748655|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3925448|NCT01421459|3748653|B3||White|Race (NIH/OMB)||Participants|Count of Participants|593|593.0||||||
3925449|NCT01421459|3748654|B2||White|Race (NIH/OMB)||Participants|Count of Participants|291|291.0||||||
3925450|NCT01421459|3748655|B1||White|Race (NIH/OMB)||Participants|Count of Participants|302|302.0||||||
3925451|NCT01421459|3748653|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3925452|NCT01421459|3748654|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3925453|NCT01421459|3748655|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3925454|NCT01421459|3748653|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925455|NCT01421459|3748654|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925456|NCT01421459|3748655|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925457|NCT01421459|3748653|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3925458|NCT01421459|3748654|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3925459|NCT01421459|3748655|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3925460|NCT01421459|3748653|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3925461|NCT01421459|3748654|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3925462|NCT01421459|3748655|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3925463|NCT01421459|3748653|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3925464|NCT01421459|3748654|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3925465|NCT01421459|3748655|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3925466|NCT01421459|3748653|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|500|500.0||||||
3925467|NCT01421459|3748654|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|256|256.0||||||
3925468|NCT01421459|3748655|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|244|244.0||||||
3925469|NCT01421459|3748653|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|210|210.0||||||
3925470|NCT01421459|3748654|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
3925471|NCT01421459|3748655|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
3925472|NCT01421459|3748653|B3||Male|Sex: Female, Male||Participants|Count of Participants|378|378.0||||||
3925473|NCT01421459|3748654|B2||Male|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
3925474|NCT01421459|3748655|B1||Male|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
3925475|NCT01421459|3748653|B3||Female|Sex: Female, Male||Participants|Count of Participants|378|378.0||||||
3925476|NCT01421459|3748654|B2||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
3925477|NCT01421459|3748655|B1||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
3925478|NCT01421459|3748653|B3|||Age||years|Mean|58.82|58.82|Standard Deviation|10.09|10.09|||
3925479|NCT01421459|3748654|B2|||Age||years|Mean|58.67|58.67|Standard Deviation|10.02|10.02|||
3925480|NCT01421459|3748655|B1|||Age||years|Mean|58.98|58.98|Standard Deviation|10.17|10.17|||
3925481|NCT01421355|3748690|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3925482|NCT01421355|3748690|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3925483|NCT01421355|3748690|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3925484|NCT01421355|3748690|B1|||Age||years|Mean|44|44.0|Standard Deviation|8|8.0|||
3925485|NCT01421342|3748694|B4|||Cumulative Illness Rating Scale (CIRS) Severity Index|Standard questionnaire to assess comorbidities (range 0-56; 0 indicates least comorbidities [none], 56 greatest severity of comorbidities)|units on a scale|Mean|11.2|11.2|Standard Deviation|5.2|5.2|||
3925486|NCT01421342|3748695|B3|||Cumulative Illness Rating Scale (CIRS) Severity Index|Standard questionnaire to assess comorbidities (range 0-56; 0 indicates least comorbidities [none], 56 greatest severity of comorbidities)|units on a scale|Mean|11.0|11.0|Standard Deviation|5.1|5.1|||
3925487|NCT01421342|3748696|B2|||Cumulative Illness Rating Scale (CIRS) Severity Index|Standard questionnaire to assess comorbidities (range 0-56; 0 indicates least comorbidities [none], 56 greatest severity of comorbidities)|units on a scale|Mean|11.1|11.1|Standard Deviation|4.9|4.9|||
3925488|NCT01421342|3748697|B1|||Cumulative Illness Rating Scale (CIRS) Severity Index|Standard questionnaire to assess comorbidities (range 0-56; 0 indicates least comorbidities [none], 56 greatest severity of comorbidities)|units on a scale|Mean|11.4|11.4|Standard Deviation|5.5|5.5|||
3925489|NCT01421342|3748694|B4|||Quality of Life Enjoyment and Satisfaction Score|Quality of Life Enjoyment and Satisfaction (Q_LES_Q) Score - adjusted for percent of maximum score - measures general quality of life (percent of raw score ranges 0 - 100; 0 indicates worse quality, 100 indicates best quality)|units on a scale|Mean|40.6|40.6|Standard Deviation|14.5|14.5|||
3925490|NCT01421342|3748695|B3|||Quality of Life Enjoyment and Satisfaction Score|Quality of Life Enjoyment and Satisfaction (Q_LES_Q) Score - adjusted for percent of maximum score - measures general quality of life (percent of raw score ranges 0 - 100; 0 indicates worse quality, 100 indicates best quality)|units on a scale|Mean|40.1|40.1|Standard Deviation|14.8|14.8|||
3925491|NCT01421342|3748696|B2|||Quality of Life Enjoyment and Satisfaction Score|Quality of Life Enjoyment and Satisfaction (Q_LES_Q) Score - adjusted for percent of maximum score - measures general quality of life (percent of raw score ranges 0 - 100; 0 indicates worse quality, 100 indicates best quality)|units on a scale|Mean|40.3|40.3|Standard Deviation|14.8|14.8|||
3925492|NCT01421342|3748697|B1|||Quality of Life Enjoyment and Satisfaction Score|Quality of Life Enjoyment and Satisfaction (Q_LES_Q) Score - adjusted for percent of maximum score - measures general quality of life (percent of raw score ranges 0 - 100; 0 indicates worse quality, 100 indicates best quality)|units on a scale|Mean|41.4|41.4|Standard Deviation|13.8|13.8|||
3925493|NCT01421342|3748694|B4|||EuroQol Health State Score|General health-related quality of life (range 0 - 100; 0 indicates worse health state, 100 indicates best possible health state)|units on a scale|Mean|53.8|53.8|Standard Deviation|20.4|20.4|||
3925494|NCT01421342|3748695|B3|||EuroQol Health State Score|General health-related quality of life (range 0 - 100; 0 indicates worse health state, 100 indicates best possible health state)|units on a scale|Mean|54.0|54.0|Standard Deviation|20.8|20.8|||
3925495|NCT01421342|3748696|B2|||EuroQol Health State Score|General health-related quality of life (range 0 - 100; 0 indicates worse health state, 100 indicates best possible health state)|units on a scale|Mean|52.7|52.7|Standard Deviation|19.8|19.8|||
3925496|NCT01421342|3748697|B1|||EuroQol Health State Score|General health-related quality of life (range 0 - 100; 0 indicates worse health state, 100 indicates best possible health state)|units on a scale|Mean|54.7|54.7|Standard Deviation|20.5|20.5|||
3925497|NCT01421342|3748694|B4|||PTSD|Post-traumatic stress disorder (PTSD) determined by PTSD panel on MINI International Neuropsychiatric Interview (MINI) V6.0.0 following the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria, administered prior to randomization - current diagnosis.|Participants|Count of Participants|717|717.0||||||
3925498|NCT01421342|3748695|B3|||PTSD|Post-traumatic stress disorder (PTSD) determined by PTSD panel on MINI International Neuropsychiatric Interview (MINI) V6.0.0 following the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria, administered prior to randomization - current diagnosis.|Participants|Count of Participants|225|225.0||||||
3925499|NCT01421342|3748696|B2|||PTSD|Post-traumatic stress disorder (PTSD) determined by PTSD panel on MINI International Neuropsychiatric Interview (MINI) V6.0.0 following the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria, administered prior to randomization - current diagnosis.|Participants|Count of Participants|244|244.0||||||
3925500|NCT01421342|3748697|B1|||PTSD|Post-traumatic stress disorder (PTSD) determined by PTSD panel on MINI International Neuropsychiatric Interview (MINI) V6.0.0 following the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria, administered prior to randomization - current diagnosis.|Participants|Count of Participants|248|248.0||||||
3925501|NCT01421342|3748694|B4|||Arizona Sexual Experiences Scale (male)|This is a standard questionnaire for quantification of sexual dysfunction. Mean and standard deviation of total score are presented here (range 5-30; 5 indicates better experiences, 30 indicates worse experiences) - this version specific to males. Not all males completed the questionnaire, number of responders is lower than number of males due to missing responses.|participants|Mean|4.1|4.1|Standard Deviation|1.1|1.1|||
3925502|NCT01421342|3748695|B3|||Arizona Sexual Experiences Scale (male)|This is a standard questionnaire for quantification of sexual dysfunction. Mean and standard deviation of total score are presented here (range 5-30; 5 indicates better experiences, 30 indicates worse experiences) - this version specific to males. Not all males completed the questionnaire, number of responders is lower than number of males due to missing responses.|participants|Mean|4.1|4.1|Standard Deviation|1.2|1.2|||
3925503|NCT01421342|3748696|B2|||Arizona Sexual Experiences Scale (male)|This is a standard questionnaire for quantification of sexual dysfunction. Mean and standard deviation of total score are presented here (range 5-30; 5 indicates better experiences, 30 indicates worse experiences) - this version specific to males. Not all males completed the questionnaire, number of responders is lower than number of males due to missing responses.|participants|Mean|4.1|4.1|Standard Deviation|1.1|1.1|||
3925504|NCT01421342|3748697|B1|||Arizona Sexual Experiences Scale (male)|This is a standard questionnaire for quantification of sexual dysfunction. Mean and standard deviation of total score are presented here (range 5-30; 5 indicates better experiences, 30 indicates worse experiences) - this version specific to males. Not all males completed the questionnaire, number of responders is lower than number of males due to missing responses.|participants|Mean|4.1|4.1|Standard Deviation|1.1|1.1|||
3925505|NCT01421342|3748694|B4|||Arizona Sexual Experiences Scale (Female)|This is a standard questionnaire for quantification of sexual dysfunction. The mean and standard deviation of the total score are presented here (range 5-30; 5 indicates better experiences, 30 indicates worse experiences) - this version is specific to females.|participants|Mean|4.2|4.2|Standard Deviation|1.1|1.1|||
3925506|NCT01421342|3748695|B3|||Arizona Sexual Experiences Scale (Female)|This is a standard questionnaire for quantification of sexual dysfunction. The mean and standard deviation of the total score are presented here (range 5-30; 5 indicates better experiences, 30 indicates worse experiences) - this version is specific to females.|participants|Mean|4.2|4.2|Standard Deviation|1.2|1.2|||
3925507|NCT01421342|3748696|B2|||Arizona Sexual Experiences Scale (Female)|This is a standard questionnaire for quantification of sexual dysfunction. The mean and standard deviation of the total score are presented here (range 5-30; 5 indicates better experiences, 30 indicates worse experiences) - this version is specific to females.|participants|Mean|4.2|4.2|Standard Deviation|1.1|1.1|||
3925508|NCT01421342|3748697|B1|||Arizona Sexual Experiences Scale (Female)|This is a standard questionnaire for quantification of sexual dysfunction. The mean and standard deviation of the total score are presented here (range 5-30; 5 indicates better experiences, 30 indicates worse experiences) - this version is specific to females.|participants|Mean|4.2|4.2|Standard Deviation|1.1|1.1|||
3925509|NCT01421342|3748694|B4|||Beck Anxiety Inventory|Beck Anxiety Inventory (BAI) - This is a standard questionnaire to assess anxiety of participant. The mean and standard deviation of the total score (range: 0 [low anxiety - better], 63 [higher anxiety - worse] ), https://www.beckinstitute.org/get-informed/tools-and-resources/professionals/patient-assessment-tools/|units on a scale|Mean|19.1|19.1|Standard Deviation|11.3|11.3|||
3925510|NCT01421342|3748695|B3|||Beck Anxiety Inventory|Beck Anxiety Inventory (BAI) - This is a standard questionnaire to assess anxiety of participant. The mean and standard deviation of the total score (range: 0 [low anxiety - better], 63 [higher anxiety - worse] ), https://www.beckinstitute.org/get-informed/tools-and-resources/professionals/patient-assessment-tools/|units on a scale|Mean|19.7|19.7|Standard Deviation|11.3|11.3|||
3925511|NCT01421342|3748696|B2|||Beck Anxiety Inventory|Beck Anxiety Inventory (BAI) - This is a standard questionnaire to assess anxiety of participant. The mean and standard deviation of the total score (range: 0 [low anxiety - better], 63 [higher anxiety - worse] ), https://www.beckinstitute.org/get-informed/tools-and-resources/professionals/patient-assessment-tools/|units on a scale|Mean|19.0|19.0|Standard Deviation|11.4|11.4|||
3925512|NCT01421342|3748697|B1|||Beck Anxiety Inventory|Beck Anxiety Inventory (BAI) - This is a standard questionnaire to assess anxiety of participant. The mean and standard deviation of the total score (range: 0 [low anxiety - better], 63 [higher anxiety - worse] ), https://www.beckinstitute.org/get-informed/tools-and-resources/professionals/patient-assessment-tools/|units on a scale|Mean|18.6|18.6|Standard Deviation|11.1|11.1|||
3925513|NCT01421342|3748694|B4|||CGI - Severity Score|Clinical Global Impression (CGI) - Severity score - standard questionnaire for severity of depression symptoms (range: 1 [less severe],7 [more severe]), https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2880930/|units on a scale|Mean|4.6|4.6|Standard Deviation|1.0|1.0|||
3925514|NCT01421342|3748695|B3|||CGI - Severity Score|Clinical Global Impression (CGI) - Severity score - standard questionnaire for severity of depression symptoms (range: 1 [less severe],7 [more severe]), https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2880930/|units on a scale|Mean|4.6|4.6|Standard Deviation|1.0|1.0|||
3925515|NCT01421342|3748696|B2|||CGI - Severity Score|Clinical Global Impression (CGI) - Severity score - standard questionnaire for severity of depression symptoms (range: 1 [less severe],7 [more severe]), https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2880930/|units on a scale|Mean|4.6|4.6|Standard Deviation|0.9|0.9|||
3925516|NCT01421342|3748697|B1|||CGI - Severity Score|Clinical Global Impression (CGI) - Severity score - standard questionnaire for severity of depression symptoms (range: 1 [less severe],7 [more severe]), https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2880930/|units on a scale|Mean|4.5|4.5|Standard Deviation|1.0|1.0|||
3925517|NCT01421342|3748694|B4|||Patient Health Questionnaire (PHQ-9)|Patient Health Questionnaire (PHQ-9) score is a standard assessment of severity of depression symptoms. (range: 0 [better], 27 [worse]). http://www.apa.org/pi/about/publications/caregivers/practice-settings/assessment/tools/patient-health.aspx|units on a scale|Mean|16.2|16.2|Standard Deviation|5.2|5.2|||
3925518|NCT01421342|3748695|B3|||Patient Health Questionnaire (PHQ-9)|Patient Health Questionnaire (PHQ-9) score is a standard assessment of severity of depression symptoms. (range: 0 [better], 27 [worse]). http://www.apa.org/pi/about/publications/caregivers/practice-settings/assessment/tools/patient-health.aspx|units on a scale|Mean|16.3|16.3|Standard Deviation|5.2|5.2|||
3925519|NCT01421342|3748696|B2|||Patient Health Questionnaire (PHQ-9)|Patient Health Questionnaire (PHQ-9) score is a standard assessment of severity of depression symptoms. (range: 0 [better], 27 [worse]). http://www.apa.org/pi/about/publications/caregivers/practice-settings/assessment/tools/patient-health.aspx|units on a scale|Mean|16.3|16.3|Standard Deviation|5.2|5.2|||
3925520|NCT01421342|3748697|B1|||Patient Health Questionnaire (PHQ-9)|Patient Health Questionnaire (PHQ-9) score is a standard assessment of severity of depression symptoms. (range: 0 [better], 27 [worse]). http://www.apa.org/pi/about/publications/caregivers/practice-settings/assessment/tools/patient-health.aspx|units on a scale|Mean|15.9|15.9|Standard Deviation|5.2|5.2|||
3925521|NCT01421342|3748694|B4|||QIDS-C16 Score|Quick Inventory of Depression Symptomatology - Clinician rated (QIDS-C16) score: summary score of severity of depression symptoms. (range: 0 [better],27 [worse]), www.ids-qids.org|units on a scale|Mean|16.7|16.7|Standard Deviation|3.3|3.3|||
3925522|NCT01421342|3748695|B3|||QIDS-C16 Score|Quick Inventory of Depression Symptomatology - Clinician rated (QIDS-C16) score: summary score of severity of depression symptoms. (range: 0 [better],27 [worse]), www.ids-qids.org|units on a scale|Mean|16.9|16.9|Standard Deviation|3.3|3.3|||
3925523|NCT01421342|3748696|B2|||QIDS-C16 Score|Quick Inventory of Depression Symptomatology - Clinician rated (QIDS-C16) score: summary score of severity of depression symptoms. (range: 0 [better],27 [worse]), www.ids-qids.org|units on a scale|Mean|16.6|16.6|Standard Deviation|3.2|3.2|||
3925524|NCT01421342|3748697|B1|||QIDS-C16 Score|Quick Inventory of Depression Symptomatology - Clinician rated (QIDS-C16) score: summary score of severity of depression symptoms. (range: 0 [better],27 [worse]), www.ids-qids.org|units on a scale|Mean|16.6|16.6|Standard Deviation|3.3|3.3|||
3925525|NCT01421342|3748694|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3925526|NCT01421342|3748695|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3925527|NCT01421342|3748696|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3925528|NCT01421342|3748697|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3925529|NCT01421342|3748694|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3925530|NCT01421342|3748695|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3925531|NCT01421342|3748696|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3925532|NCT01421342|3748697|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3925533|NCT01421342|3748694|B4||White|Race (NIH/OMB)||Participants|Count of Participants|1022|1022.0||||||
3925534|NCT01421342|3748695|B3||White|Race (NIH/OMB)||Participants|Count of Participants|338|338.0||||||
3925535|NCT01421342|3748696|B2||White|Race (NIH/OMB)||Participants|Count of Participants|343|343.0||||||
3925536|NCT01421342|3748697|B1||White|Race (NIH/OMB)||Participants|Count of Participants|341|341.0||||||
3925537|NCT01421342|3748694|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|370|370.0||||||
3925538|NCT01421342|3748695|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
3925539|NCT01421342|3748696|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
3925540|NCT01421342|3748697|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
3925541|NCT01421342|3748694|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3925542|NCT01421342|3748695|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3925543|NCT01421342|3748696|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3925544|NCT01421342|3748697|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3925545|NCT01421342|3748694|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3925546|NCT01421342|3748695|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3925547|NCT01421342|3748696|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3925548|NCT01421342|3748697|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3925549|NCT01421342|3748694|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3925550|NCT01421342|3748695|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3925551|NCT01421342|3748696|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3925552|NCT01421342|3748697|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3925553|NCT01421342|3748694|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|157|157.0||||||
3925554|NCT01421342|3748695|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3925555|NCT01421342|3748696|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3925556|NCT01421342|3748697|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3925557|NCT01421342|3748694|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1362|1362.0||||||
3925558|NCT01421342|3748695|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|459|459.0||||||
3925559|NCT01421342|3748696|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|449|449.0||||||
3925560|NCT01421342|3748697|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|454|454.0||||||
3925561|NCT01421342|3748694|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3925562|NCT01421342|3748695|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3925563|NCT01421342|3748696|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3925564|NCT01421342|3748697|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925565|NCT01421342|3748694|B4||Male|Sex: Female, Male||Participants|Count of Participants|1296|1296.0||||||
3925566|NCT01421342|3748695|B3||Male|Sex: Female, Male||Participants|Count of Participants|428|428.0||||||
3925567|NCT01421342|3748696|B2||Male|Sex: Female, Male||Participants|Count of Participants|425|425.0||||||
3925568|NCT01421342|3748697|B1||Male|Sex: Female, Male||Participants|Count of Participants|443|443.0||||||
3925569|NCT01421342|3748694|B4||Female|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
3925570|NCT01421342|3748695|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3925571|NCT01421342|3748696|B2||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3925572|NCT01421342|3748697|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3925573|NCT01421342|3748694|B4|||Age||years|Mean|54.4|54.4|Standard Deviation|12.2|12.2|||
3925574|NCT01421342|3748695|B3|||Age||years|Mean|54.2|54.2|Standard Deviation|12.3|12.3|||
3925575|NCT01421342|3748696|B2|||Age||years|Mean|54.4|54.4|Standard Deviation|12.2|12.2|||
3925576|NCT01421342|3748697|B1|||Age||years|Mean|54.5|54.5|Standard Deviation|12.2|12.2|||
3925577|NCT01421303|3748716|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3925578|NCT01421303|3748716|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3925579|NCT01421303|3748716|B1|||Age||years|Mean|38.1|38.1|Standard Deviation|9.1|9.1|||
3925580|NCT01421277|3748741|B3|Not reported||Sex/Gender, Customized||Participants|Number|2|2.0||||||
3925581|NCT01421277|3748742|B2|Not reported||Sex/Gender, Customized||Participants|Number|2|2.0||||||
3925582|NCT01421277|3748743|B1|Not reported||Sex/Gender, Customized||Participants|Number|0|0.0||||||
3925583|NCT01421277|3748741|B3|Male||Sex/Gender, Customized||Participants|Number|37|37.0||||||
3925584|NCT01421277|3748742|B2|Male||Sex/Gender, Customized||Participants|Number|32|32.0||||||
3925585|NCT01421277|3748743|B1|Male||Sex/Gender, Customized||Participants|Number|5|5.0||||||
3925586|NCT01421277|3748741|B3|Female||Sex/Gender, Customized||Participants|Number|177|177.0||||||
3925587|NCT01421277|3748742|B2|Female||Sex/Gender, Customized||Participants|Number|157|157.0||||||
3925588|NCT01421277|3748743|B1|Female||Sex/Gender, Customized||Participants|Number|20|20.0||||||
3925589|NCT01421277|3748741|B3|||Age||Years|Mean|39.9|39.9|Standard Deviation|13.65|13.65|||
3925590|NCT01421277|3748742|B2|||Age||Years|Mean|39.8|39.8|Standard Deviation|13.39|13.39|||
3925591|NCT01421277|3748743|B1|||Age||Years|Mean|41.0|41.0|Standard Deviation|15.77|15.77|||
3925592|NCT01421225|3748754|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3925593|NCT01421225|3748755|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3925594|NCT01421225|3748756|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3925595|NCT01421225|3748754|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3925596|NCT01421225|3748755|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3925597|NCT01421225|3748756|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3925598|NCT01421225|3748754|B3|age||Age||years|Mean|5.1|5.1|Standard Deviation|1.4|1.4|||
3925599|NCT01421225|3748755|B2|age||Age||years|Mean|5.5|5.5|Standard Deviation|0.9|0.9|||
3925600|NCT01421225|3748756|B1|age||Age||years|Mean|3.7|3.7|Standard Deviation|1.3|1.3|||
3925601|NCT01421147|3748769|B3|||Body Weight||kilograms (kg)|Mean|75.29|75.29|Standard Deviation|16.07|16.07|||
3925602|NCT01421147|3748770|B2|||Body Weight||kilograms (kg)|Mean|74.77|74.77|Standard Deviation|15.36|15.36|||
3925603|NCT01421147|3748771|B1|||Body Weight||kilograms (kg)|Mean|75.80|75.8|Standard Deviation|16.76|16.76|||
3925604|NCT01421147|3748769|B3|Evening/Bedtime||Time of Basal Insulin Injection|Number of participants who administered a basal insulin injection during the Daytime and Evening/Bedtime.|participants|Number|436|436.0||||||
3925605|NCT01421147|3748770|B2|Evening/Bedtime||Time of Basal Insulin Injection|Number of participants who administered a basal insulin injection during the Daytime and Evening/Bedtime.|participants|Number|219|219.0||||||
3925606|NCT01421147|3748771|B1|Evening/Bedtime||Time of Basal Insulin Injection|Number of participants who administered a basal insulin injection during the Daytime and Evening/Bedtime.|participants|Number|217|217.0||||||
3925607|NCT01421147|3748769|B3|Daytime||Time of Basal Insulin Injection|Number of participants who administered a basal insulin injection during the Daytime and Evening/Bedtime.|participants|Number|99|99.0||||||
3925608|NCT01421147|3748770|B2|Daytime||Time of Basal Insulin Injection|Number of participants who administered a basal insulin injection during the Daytime and Evening/Bedtime.|participants|Number|48|48.0||||||
3925609|NCT01421147|3748771|B1|Daytime||Time of Basal Insulin Injection|Number of participants who administered a basal insulin injection during the Daytime and Evening/Bedtime.|participants|Number|51|51.0||||||
3925610|NCT01421147|3748769|B3|||Baseline Hemoglobin A1c (HbA1c)|HbA1c is the glycosylated fraction of hemoglobin A which provides an estimate of a participant's blood sugar control over a 6- to 12-week period.|percentage of glycosylated hemoglobin|Mean|7.77|7.77|Standard Deviation|1.08|1.08|||
3925667|NCT01421147|3748769|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3925787|NCT01420848|3748840|B4|||Age||years|Mean|28.93|28.93|Standard Deviation|6.96|6.96|||
3925611|NCT01421147|3748770|B2|||Baseline Hemoglobin A1c (HbA1c)|HbA1c is the glycosylated fraction of hemoglobin A which provides an estimate of a participant's blood sugar control over a 6- to 12-week period.|percentage of glycosylated hemoglobin|Mean|7.79|7.79|Standard Deviation|1.03|1.03|||
3925612|NCT01421147|3748771|B1|||Baseline Hemoglobin A1c (HbA1c)|HbA1c is the glycosylated fraction of hemoglobin A which provides an estimate of a participant's blood sugar control over a 6- to 12-week period.|percentage of glycosylated hemoglobin|Mean|7.75|7.75|Standard Deviation|1.13|1.13|||
3925613|NCT01421147|3748769|B3|Japan||Region of Enrollment||participants|Number|100|100.0||||||
3925614|NCT01421147|3748770|B2|Japan||Region of Enrollment||participants|Number|51|51.0||||||
3925615|NCT01421147|3748771|B1|Japan||Region of Enrollment||participants|Number|49|49.0||||||
3925616|NCT01421147|3748769|B3|Germany||Region of Enrollment||participants|Number|54|54.0||||||
3925617|NCT01421147|3748770|B2|Germany||Region of Enrollment||participants|Number|28|28.0||||||
3925618|NCT01421147|3748771|B1|Germany||Region of Enrollment||participants|Number|26|26.0||||||
3925619|NCT01421147|3748769|B3|Romania||Region of Enrollment||participants|Number|34|34.0||||||
3925620|NCT01421147|3748770|B2|Romania||Region of Enrollment||participants|Number|16|16.0||||||
3925621|NCT01421147|3748771|B1|Romania||Region of Enrollment||participants|Number|18|18.0||||||
3925622|NCT01421147|3748769|B3|Poland||Region of Enrollment||participants|Number|35|35.0||||||
3925623|NCT01421147|3748770|B2|Poland||Region of Enrollment||participants|Number|17|17.0||||||
3925624|NCT01421147|3748771|B1|Poland||Region of Enrollment||participants|Number|18|18.0||||||
3925625|NCT01421147|3748769|B3|Belgium||Region of Enrollment||participants|Number|23|23.0||||||
3925626|NCT01421147|3748770|B2|Belgium||Region of Enrollment||participants|Number|11|11.0||||||
3925627|NCT01421147|3748771|B1|Belgium||Region of Enrollment||participants|Number|12|12.0||||||
3925628|NCT01421147|3748769|B3|Greece||Region of Enrollment||participants|Number|28|28.0||||||
3925629|NCT01421147|3748770|B2|Greece||Region of Enrollment||participants|Number|13|13.0||||||
3925630|NCT01421147|3748771|B1|Greece||Region of Enrollment||participants|Number|15|15.0||||||
3925631|NCT01421147|3748769|B3|Mexico||Region of Enrollment||participants|Number|36|36.0||||||
3925632|NCT01421147|3748770|B2|Mexico||Region of Enrollment||participants|Number|19|19.0||||||
3925633|NCT01421147|3748771|B1|Mexico||Region of Enrollment||participants|Number|17|17.0||||||
3925634|NCT01421147|3748769|B3|Hungary||Region of Enrollment||participants|Number|30|30.0||||||
3925635|NCT01421147|3748770|B2|Hungary||Region of Enrollment||participants|Number|16|16.0||||||
3925636|NCT01421147|3748771|B1|Hungary||Region of Enrollment||participants|Number|14|14.0||||||
3925637|NCT01421147|3748769|B3|United States||Region of Enrollment||participants|Number|195|195.0||||||
3925638|NCT01421147|3748770|B2|United States||Region of Enrollment||participants|Number|96|96.0||||||
3925639|NCT01421147|3748771|B1|United States||Region of Enrollment||participants|Number|99|99.0||||||
3925640|NCT01421147|3748769|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3925641|NCT01421147|3748770|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925642|NCT01421147|3748771|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3925643|NCT01421147|3748769|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3925644|NCT01421147|3748770|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3925645|NCT01421147|3748771|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3925646|NCT01421147|3748769|B3||White|Race (NIH/OMB)||Participants|Count of Participants|398|398.0||||||
3925647|NCT01421147|3748770|B2||White|Race (NIH/OMB)||Participants|Count of Participants|201|201.0||||||
3925648|NCT01421147|3748771|B1||White|Race (NIH/OMB)||Participants|Count of Participants|197|197.0||||||
3925649|NCT01421147|3748769|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3925650|NCT01421147|3748770|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3925651|NCT01421147|3748771|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3925652|NCT01421147|3748769|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925653|NCT01421147|3748770|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925654|NCT01421147|3748771|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925655|NCT01421147|3748769|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3925656|NCT01421147|3748770|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3925657|NCT01421147|3748771|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3925658|NCT01421147|3748769|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3925659|NCT01421147|3748770|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3925660|NCT01421147|3748771|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3925661|NCT01421147|3748769|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
3925662|NCT01421147|3748770|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3925663|NCT01421147|3748771|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3925664|NCT01421147|3748769|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|347|347.0||||||
3925665|NCT01421147|3748770|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|170|170.0||||||
3925666|NCT01421147|3748771|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|177|177.0||||||
3925786|NCT01420848|3748843|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3925668|NCT01421147|3748770|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3925669|NCT01421147|3748771|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3925670|NCT01421147|3748769|B3||Male|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
3925671|NCT01421147|3748770|B2||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3925672|NCT01421147|3748771|B1||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3925673|NCT01421147|3748769|B3||Female|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
3925674|NCT01421147|3748770|B2||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3925675|NCT01421147|3748771|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3925676|NCT01421147|3748769|B3|||Age||years|Mean|41.16|41.16|Standard Deviation|13.44|13.44|||
3925677|NCT01421147|3748770|B2|||Age||years|Mean|41.37|41.37|Standard Deviation|13.25|13.25|||
3925678|NCT01421147|3748771|B1|||Age||years|Mean|40.96|40.96|Standard Deviation|13.65|13.65|||
3925679|NCT01421134|3748802|B3|Serbia||Region of Enrollment||participants|Number|52|52.0||||||
3925680|NCT01421134|3748803|B2|Serbia||Region of Enrollment||participants|Number|26|26.0||||||
3925681|NCT01421134|3748804|B1|Serbia||Region of Enrollment||participants|Number|26|26.0||||||
3925682|NCT01421134|3748802|B3|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3925683|NCT01421134|3748803|B2|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3925684|NCT01421134|3748804|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3925685|NCT01421134|3748802|B3|Ukraine||Region of Enrollment||participants|Number|62|62.0||||||
3925686|NCT01421134|3748803|B2|Ukraine||Region of Enrollment||participants|Number|32|32.0||||||
3925687|NCT01421134|3748804|B1|Ukraine||Region of Enrollment||participants|Number|30|30.0||||||
3925688|NCT01421134|3748802|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
3925689|NCT01421134|3748803|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
3925690|NCT01421134|3748804|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
3925691|NCT01421134|3748802|B3|Russian Federation||Region of Enrollment||participants|Number|31|31.0||||||
3925692|NCT01421134|3748803|B2|Russian Federation||Region of Enrollment||participants|Number|13|13.0||||||
3925693|NCT01421134|3748804|B1|Russian Federation||Region of Enrollment||participants|Number|18|18.0||||||
3925694|NCT01421134|3748802|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3925695|NCT01421134|3748803|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3925696|NCT01421134|3748804|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3925697|NCT01421134|3748802|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925698|NCT01421134|3748803|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925699|NCT01421134|3748804|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925700|NCT01421134|3748802|B3||White|Race (NIH/OMB)||Participants|Count of Participants|180|180.0||||||
3925701|NCT01421134|3748803|B2||White|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
3925702|NCT01421134|3748804|B1||White|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3925703|NCT01421134|3748802|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3925704|NCT01421134|3748803|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3925705|NCT01421134|3748804|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3925706|NCT01421134|3748802|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925707|NCT01421134|3748803|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925708|NCT01421134|3748804|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925709|NCT01421134|3748802|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3925710|NCT01421134|3748803|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3925711|NCT01421134|3748804|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925712|NCT01421134|3748802|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925713|NCT01421134|3748803|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925714|NCT01421134|3748804|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925715|NCT01421134|3748802|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3925716|NCT01421134|3748803|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3925717|NCT01421134|3748804|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3925718|NCT01421134|3748802|B3||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3925719|NCT01421134|3748803|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3925720|NCT01421134|3748804|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3925721|NCT01421134|3748802|B3|||Age||years|Mean|44.9|44.9|Standard Deviation|12.10|12.1|||
3925722|NCT01421134|3748803|B2|||Age||years|Mean|46.4|46.4|Standard Deviation|12.01|12.01|||
3925723|NCT01421134|3748804|B1|||Age||years|Mean|43.6|43.6|Standard Deviation|12.08|12.08|||
3925724|NCT01421134|3748802|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3925725|NCT01421134|3748803|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3925726|NCT01421134|3748804|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3925727|NCT01421134|3748802|B3||Between 18 and 65 years|Age||Participants|Count of Participants|202|202.0||||||
3925728|NCT01421134|3748803|B2||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
3925729|NCT01421134|3748804|B1||Between 18 and 65 years|Age||Participants|Count of Participants|106|106.0||||||
3925730|NCT01421134|3748802|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3925731|NCT01421134|3748803|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3925732|NCT01421134|3748804|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3925733|NCT01420926|3748823|B3|United States||Region of Enrollment||participants|Number|163|163.0||||||
3925734|NCT01420926|3748824|B2|United States||Region of Enrollment||participants|Number|81|81.0||||||
3925735|NCT01420926|3748825|B1|United States||Region of Enrollment||participants|Number|82|82.0||||||
3925736|NCT01420926|3748823|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3925737|NCT01420926|3748824|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3925738|NCT01420926|3748825|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3925739|NCT01420926|3748823|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3925740|NCT01420926|3748824|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3925741|NCT01420926|3748825|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925742|NCT01420926|3748823|B3||White|Race (NIH/OMB)||Participants|Count of Participants|147|147.0||||||
3925743|NCT01420926|3748824|B2||White|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3925744|NCT01420926|3748825|B1||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3925745|NCT01420926|3748823|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3925746|NCT01420926|3748824|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3925747|NCT01420926|3748825|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3925748|NCT01420926|3748823|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3925749|NCT01420926|3748824|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925750|NCT01420926|3748825|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3925751|NCT01420926|3748823|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3925752|NCT01420926|3748824|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3925753|NCT01420926|3748825|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925754|NCT01420926|3748823|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925755|NCT01420926|3748824|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925756|NCT01420926|3748825|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925757|NCT01420926|3748823|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3925758|NCT01420926|3748824|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3925759|NCT01420926|3748825|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3925760|NCT01420926|3748823|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|154|154.0||||||
3925761|NCT01420926|3748824|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3925762|NCT01420926|3748825|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3925763|NCT01420926|3748823|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925764|NCT01420926|3748824|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925765|NCT01420926|3748825|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925766|NCT01420926|3748823|B3||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3925767|NCT01420926|3748824|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3925768|NCT01420926|3748825|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3925769|NCT01420926|3748823|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3925770|NCT01420926|3748824|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3925771|NCT01420926|3748825|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3925772|NCT01420926|3748823|B3|||Age||years|Median|72.4|72.4|Full Range|||60.5|92.3|
3925773|NCT01420926|3748824|B2|||Age||years|Median|72.9|72.9|Full Range|||60.5|90.0|
3925774|NCT01420926|3748825|B1|||Age||years|Median|72.4|72.4|Full Range|||60.7|92.3|
3925775|NCT01420848|3748840|B4|Brazil||Region of Enrollment||participants|Number|71|71.0||||||
3925776|NCT01420848|3748841|B3|Brazil||Region of Enrollment||participants|Number|22|22.0||||||
3925777|NCT01420848|3748842|B2|Brazil||Region of Enrollment||participants|Number|25|25.0||||||
3925778|NCT01420848|3748843|B1|Brazil||Region of Enrollment||participants|Number|24|24.0||||||
3925779|NCT01420848|3748840|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3925780|NCT01420848|3748841|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3925781|NCT01420848|3748842|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3925782|NCT01420848|3748843|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3925783|NCT01420848|3748840|B4||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3925784|NCT01420848|3748841|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3925785|NCT01420848|3748842|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3925788|NCT01420848|3748841|B3|||Age||years|Mean|30.91|30.91|Standard Deviation|8.34|8.34|||
3925789|NCT01420848|3748842|B2|||Age||years|Mean|28.68|28.68|Standard Deviation|6.57|6.57|||
3925790|NCT01420848|3748843|B1|||Age||years|Mean|27.21|27.21|Standard Deviation|5.97|5.97|||
3925791|NCT01420848|3748840|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3925792|NCT01420848|3748841|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3925793|NCT01420848|3748842|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3925794|NCT01420848|3748843|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3925795|NCT01420848|3748840|B4||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
3925796|NCT01420848|3748841|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3925797|NCT01420848|3748842|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3925798|NCT01420848|3748843|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3925799|NCT01420848|3748840|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3925800|NCT01420848|3748841|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3925801|NCT01420848|3748842|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3925802|NCT01420848|3748843|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3925803|NCT01420653|3748856|B5|United States||Region of Enrollment||participants|Number|135|135.0||||||
3925804|NCT01420653|3748857|B4|United States||Region of Enrollment||participants|Number|25|25.0||||||
3925805|NCT01420653|3748858|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
3925806|NCT01420653|3748859|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
3925807|NCT01420653|3748860|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
3925808|NCT01420653|3748856|B5|New Zealand||Region of Enrollment||participants|Number|273|273.0||||||
3925809|NCT01420653|3748857|B4|New Zealand||Region of Enrollment||participants|Number|50|50.0||||||
3925810|NCT01420653|3748858|B3|New Zealand||Region of Enrollment||participants|Number|75|75.0||||||
3925811|NCT01420653|3748859|B2|New Zealand||Region of Enrollment||participants|Number|75|75.0||||||
3925812|NCT01420653|3748860|B1|New Zealand||Region of Enrollment||participants|Number|73|73.0||||||
3925813|NCT01420653|3748856|B5||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3925814|NCT01420653|3748857|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3925815|NCT01420653|3748858|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3925816|NCT01420653|3748859|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3925817|NCT01420653|3748860|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3925818|NCT01420653|3748856|B5||Female|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
3925819|NCT01420653|3748857|B4||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3925820|NCT01420653|3748858|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3925821|NCT01420653|3748859|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3925822|NCT01420653|3748860|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3925823|NCT01420653|3748856|B5|||Age||years|Mean|24.8|24.8|Standard Deviation|6.6|6.6|||
3925824|NCT01420653|3748857|B4|||Age||years|Mean|24.3|24.3|Standard Deviation|6.3|6.3|||
3925825|NCT01420653|3748858|B3|||Age||years|Mean|24.3|24.3|Standard Deviation|5.9|5.9|||
3925826|NCT01420653|3748859|B2|||Age||years|Mean|25.0|25.0|Standard Deviation|6.9|6.9|||
3925827|NCT01420653|3748860|B1|||Age||years|Mean|25.4|25.4|Standard Deviation|7.0|7.0|||
3925828|NCT01420289|3748873|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
3925829|NCT01420289|3748874|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3925830|NCT01420289|3748875|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3925831|NCT01420289|3748873|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3925832|NCT01420289|3748874|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3925833|NCT01420289|3748875|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3925834|NCT01420289|3748873|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3925835|NCT01420289|3748874|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3925836|NCT01420289|3748875|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3925837|NCT01420289|3748873|B3|||Age||years|Mean|63|63.0|Standard Deviation|12|12.0|||
3925838|NCT01420289|3748874|B2|||Age||years|Mean|62|62.0|Standard Deviation|11|11.0|||
3925839|NCT01420289|3748875|B1|||Age||years|Mean|64|64.0|Standard Deviation|12|12.0|||
3925840|NCT01420289|3748873|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3925841|NCT01420289|3748874|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3925842|NCT01420289|3748875|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3925843|NCT01420289|3748873|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3925844|NCT01420289|3748874|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3925845|NCT01420289|3748875|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3925846|NCT01420289|3748873|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3925847|NCT01420289|3748874|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3925848|NCT01420289|3748875|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3925849|NCT01420146|3748888|B1|Belgium||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3925850|NCT01420146|3748888|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3925851|NCT01420146|3748888|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3925852|NCT01420146|3748888|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3925853|NCT01420146|3748888|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3925854|NCT01420146|3748888|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3925855|NCT01420081|3748892|B10||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3925856|NCT01420081|3748893|B9||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3925857|NCT01420081|3748894|B8||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3925858|NCT01420081|3748895|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3925859|NCT01420081|3748896|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3925860|NCT01420081|3748897|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3925861|NCT01420081|3748898|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3925862|NCT01420081|3748899|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3925863|NCT01420081|3748900|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3925864|NCT01420081|3748901|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3925865|NCT01420081|3748892|B10||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3925866|NCT01420081|3748893|B9||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3925867|NCT01420081|3748894|B8||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3925868|NCT01420081|3748895|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3925869|NCT01420081|3748896|B6||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3925870|NCT01420081|3748897|B5||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3925871|NCT01420081|3748898|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3925872|NCT01420081|3748899|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3925873|NCT01420081|3748900|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3925874|NCT01420081|3748901|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3925875|NCT01420081|3748892|B10|>= 65 years||Age, Customized||participants|Number|38|38.0||||||
3925876|NCT01420081|3748893|B9|>= 65 years||Age, Customized||participants|Number|1|1.0||||||
3925877|NCT01420081|3748894|B8|>= 65 years||Age, Customized||participants|Number|1|1.0||||||
3925878|NCT01420081|3748895|B7|>= 65 years||Age, Customized||participants|Number|1|1.0||||||
3925879|NCT01420081|3748896|B6|>= 65 years||Age, Customized||participants|Number|16|16.0||||||
3925880|NCT01420081|3748897|B5|>= 65 years||Age, Customized||participants|Number|11|11.0||||||
3925881|NCT01420081|3748898|B4|>= 65 years||Age, Customized||participants|Number|0|0.0||||||
3925882|NCT01420081|3748899|B3|>= 65 years||Age, Customized||participants|Number|7|7.0||||||
3925883|NCT01420081|3748900|B2|>= 65 years||Age, Customized||participants|Number|0|0.0||||||
3925884|NCT01420081|3748901|B1|>= 65 years||Age, Customized||participants|Number|1|1.0||||||
3925885|NCT01420081|3748892|B10|45 - 64 years||Age, Customized||participants|Number|28|28.0||||||
3925886|NCT01420081|3748893|B9|45 - 64 years||Age, Customized||participants|Number|2|2.0||||||
3925887|NCT01420081|3748894|B8|45 - 64 years||Age, Customized||participants|Number|1|1.0||||||
3925888|NCT01420081|3748895|B7|45 - 64 years||Age, Customized||participants|Number|2|2.0||||||
3925889|NCT01420081|3748896|B6|45 - 64 years||Age, Customized||participants|Number|4|4.0||||||
3925890|NCT01420081|3748897|B5|45 - 64 years||Age, Customized||participants|Number|9|9.0||||||
3925891|NCT01420081|3748898|B4|45 - 64 years||Age, Customized||participants|Number|3|3.0||||||
3925892|NCT01420081|3748899|B3|45 - 64 years||Age, Customized||participants|Number|4|4.0||||||
3925893|NCT01420081|3748900|B2|45 - 64 years||Age, Customized||participants|Number|1|1.0||||||
3925894|NCT01420081|3748901|B1|45 - 64 years||Age, Customized||participants|Number|2|2.0||||||
3925895|NCT01420081|3748892|B10|18 - 44 years||Age, Customized||participants|Number|1|1.0||||||
3925896|NCT01420081|3748893|B9|18 - 44 years||Age, Customized||participants|Number|0|0.0||||||
3925897|NCT01420081|3748894|B8|18 - 44 years||Age, Customized||participants|Number|1|1.0||||||
3925898|NCT01420081|3748895|B7|18 - 44 years||Age, Customized||participants|Number|0|0.0||||||
3925899|NCT01420081|3748896|B6|18 - 44 years||Age, Customized||participants|Number|0|0.0||||||
3925900|NCT01420081|3748897|B5|18 - 44 years||Age, Customized||participants|Number|0|0.0||||||
3925901|NCT01420081|3748898|B4|18 - 44 years||Age, Customized||participants|Number|0|0.0||||||
3925902|NCT01420081|3748899|B3|18 - 44 years||Age, Customized||participants|Number|0|0.0||||||
3925903|NCT01420081|3748900|B2|18 - 44 years||Age, Customized||participants|Number|0|0.0||||||
3925904|NCT01420081|3748901|B1|18 - 44 years||Age, Customized||participants|Number|0|0.0||||||
3925905|NCT01420081|3748892|B10|< 18 years||Age, Customized||participants|Number|0|0.0||||||
3925906|NCT01420081|3748893|B9|< 18 years||Age, Customized||participants|Number|0|0.0||||||
3925907|NCT01420081|3748894|B8|< 18 years||Age, Customized||participants|Number|0|0.0||||||
3925908|NCT01420081|3748895|B7|< 18 years||Age, Customized||participants|Number|0|0.0||||||
3925909|NCT01420081|3748896|B6|< 18 years||Age, Customized||participants|Number|0|0.0||||||
3925910|NCT01420081|3748897|B5|< 18 years||Age, Customized||participants|Number|0|0.0||||||
3925911|NCT01420081|3748898|B4|< 18 years||Age, Customized||participants|Number|0|0.0||||||
3925912|NCT01420081|3748899|B3|< 18 years||Age, Customized||participants|Number|0|0.0||||||
3925913|NCT01420081|3748900|B2|< 18 years||Age, Customized||participants|Number|0|0.0||||||
3925914|NCT01420081|3748901|B1|< 18 years||Age, Customized||participants|Number|0|0.0||||||
3925969|NCT01420016|3748988|B3|||Age||years|Mean|58.6|58.6|Standard Deviation|8.5|8.5|||
3925915|NCT01420016|3748988|B3|||Body Mass Index (BMI)|Body Mass Index (BMI) at index visit|kg/m2|Mean|30.3|30.3|Standard Deviation|6.3|6.3|||
3925916|NCT01420016|3748989|B2|||Body Mass Index (BMI)|Body Mass Index (BMI) at index visit|kg/m2|Mean|30.4|30.4|Standard Deviation|6.4|6.4|||
3925917|NCT01420016|3748990|B1|||Body Mass Index (BMI)|Body Mass Index (BMI) at index visit|kg/m2|Mean|30.1|30.1|Standard Deviation|6.2|6.2|||
3925918|NCT01420016|3748988|B3|||LDL Cholesterol|Mean of LDL cholesterol value as of index date.|mg/dL|Mean|126.4|126.4|Standard Deviation|36.8|36.8|||
3925919|NCT01420016|3748989|B2|||LDL Cholesterol|Mean of LDL cholesterol value as of index date.|mg/dL|Mean|127.7|127.7|Standard Deviation|36.9|36.9|||
3925920|NCT01420016|3748990|B1|||LDL Cholesterol|Mean of LDL cholesterol value as of index date.|mg/dL|Mean|125.0|125.0|Standard Deviation|36.7|36.7|||
3925921|NCT01420016|3748988|B3|||Aspirin use|Aspirin use when indicated|Participants|Count of Participants|1511|1511.0||||||
3925922|NCT01420016|3748989|B2|||Aspirin use|Aspirin use when indicated|Participants|Count of Participants|744|744.0||||||
3925923|NCT01420016|3748990|B1|||Aspirin use|Aspirin use when indicated|Participants|Count of Participants|767|767.0||||||
3925924|NCT01420016|3748988|B3|||Smoking status|Current smoker at index visit|Participants|Count of Participants|4357|4357.0||||||
3925925|NCT01420016|3748989|B2|||Smoking status|Current smoker at index visit|Participants|Count of Participants|2061|2061.0||||||
3925926|NCT01420016|3748990|B1|||Smoking status|Current smoker at index visit|Participants|Count of Participants|2296|2296.0||||||
3925927|NCT01420016|3748988|B3|||Diastolic Blood Pressure||mmHg|Mean|86.0|86.0|Standard Deviation|13.1|13.1|||
3925928|NCT01420016|3748989|B2|||Diastolic Blood Pressure||mmHg|Mean|85.8|85.8|Standard Deviation|13.4|13.4|||
3925929|NCT01420016|3748990|B1|||Diastolic Blood Pressure||mmHg|Mean|86.2|86.2|Standard Deviation|12.8|12.8|||
3925930|NCT01420016|3748988|B3|||Systolic Blood Pressure||mmHg|Mean|144.9|144.9|Standard Deviation|21.4|21.4|||
3925931|NCT01420016|3748989|B2|||Systolic Blood Pressure||mmHg|Mean|145.3|145.3|Standard Deviation|21.7|21.7|||
3925932|NCT01420016|3748990|B1|||Systolic Blood Pressure||mmHg|Mean|144.6|144.6|Standard Deviation|21.1|21.1|||
3925933|NCT01420016|3748988|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|392|392.0||||||
3925934|NCT01420016|3748989|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|137|137.0||||||
3925935|NCT01420016|3748990|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|255|255.0||||||
3925936|NCT01420016|3748988|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3925937|NCT01420016|3748989|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3925938|NCT01420016|3748990|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3925939|NCT01420016|3748988|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6271|6271.0||||||
3925940|NCT01420016|3748989|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3210|3210.0||||||
3925941|NCT01420016|3748990|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3061|3061.0||||||
3925942|NCT01420016|3748988|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|956|956.0||||||
3925943|NCT01420016|3748989|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|355|355.0||||||
3925944|NCT01420016|3748990|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|601|601.0||||||
3925945|NCT01420016|3748988|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3925946|NCT01420016|3748989|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3925947|NCT01420016|3748990|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3925948|NCT01420016|3748988|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|232|232.0||||||
3925949|NCT01420016|3748989|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|145|145.0||||||
3925950|NCT01420016|3748990|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3925951|NCT01420016|3748988|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3925952|NCT01420016|3748989|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3925953|NCT01420016|3748990|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3925954|NCT01420016|3748988|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925955|NCT01420016|3748989|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925956|NCT01420016|3748990|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925957|NCT01420016|3748988|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7782|7782.0||||||
3925958|NCT01420016|3748989|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3822|3822.0||||||
3925959|NCT01420016|3748990|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3960|3960.0||||||
3925960|NCT01420016|3748988|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
3925961|NCT01420016|3748989|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3925962|NCT01420016|3748990|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3925963|NCT01420016|3748988|B3||Male|Sex: Female, Male||Participants|Count of Participants|5834|5834.0||||||
3925964|NCT01420016|3748989|B2||Male|Sex: Female, Male||Participants|Count of Participants|2858|2858.0||||||
3925965|NCT01420016|3748990|B1||Male|Sex: Female, Male||Participants|Count of Participants|2976|2976.0||||||
3925966|NCT01420016|3748988|B3||Female|Sex: Female, Male||Participants|Count of Participants|2080|2080.0||||||
3925967|NCT01420016|3748989|B2||Female|Sex: Female, Male||Participants|Count of Participants|1013|1013.0||||||
3925968|NCT01420016|3748990|B1||Female|Sex: Female, Male||Participants|Count of Participants|1067|1067.0||||||
3925970|NCT01420016|3748989|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|8.6|8.6|||
3925971|NCT01420016|3748990|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|8.5|8.5|||
3925972|NCT01419977|3748999|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
3925973|NCT01419977|3749000|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3925974|NCT01419977|3749001|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3925975|NCT01419977|3748999|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3925976|NCT01419977|3749000|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3925977|NCT01419977|3749001|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3925978|NCT01419977|3748999|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3925979|NCT01419977|3749000|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3925980|NCT01419977|3749001|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3925981|NCT01419977|3748999|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3925982|NCT01419977|3749000|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3925983|NCT01419977|3749001|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3925984|NCT01419977|3748999|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3925985|NCT01419977|3749000|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3925986|NCT01419977|3749001|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3925987|NCT01419977|3748999|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3925988|NCT01419977|3749000|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3925989|NCT01419977|3749001|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3925990|NCT01419795|3749014|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925991|NCT01419795|3749016|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925992|NCT01419795|3749014|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925993|NCT01419795|3749016|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925994|NCT01419795|3749014|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3925995|NCT01419795|3749016|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3925996|NCT01419795|3749014|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925997|NCT01419795|3749016|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925998|NCT01419795|3749014|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3925999|NCT01419795|3749016|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926000|NCT01419795|3749014|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926001|NCT01419795|3749016|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926002|NCT01419795|3749014|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926003|NCT01419795|3749016|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926004|NCT01419795|3749014|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3926005|NCT01419795|3749016|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3926006|NCT01419795|3749014|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926007|NCT01419795|3749016|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926008|NCT01419795|3749014|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926009|NCT01419795|3749016|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926010|NCT01419795|3749014|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3926011|NCT01419795|3749016|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3926012|NCT01419795|3749014|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3926013|NCT01419795|3749016|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3926014|NCT01419795|3749014|B3|||Age||years|Median|57|57.0|Full Range|||48.0|62.0|
3926015|NCT01419795|3749016|B1|||Age||years|Median|57|57.0|Full Range|||48.0|62.0|
3926016|NCT01419769|3749039|B1|||Weight||pounds|Mean|169.5|169.5|Standard Deviation|43.5|43.5|||
3926017|NCT01419769|3749039|B1|||Height||inches|Mean|67.4|67.4|Standard Deviation|3.9|3.9|||
3926018|NCT01419769|3749039|B1|Spain||Region of Enrollment||participants|Number|3|3.0||||||
3926019|NCT01419769|3749039|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3926020|NCT01419769|3749039|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3926021|NCT01419769|3749039|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3926022|NCT01419769|3749039|B1|||Age||Years|Mean|52.6|52.6|Standard Deviation|14.0|14.0|||
3926023|NCT01419639|3749052|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3926024|NCT01419639|3749052|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3926025|NCT01419639|3749052|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3926026|NCT01419639|3749052|B1|||Age||years|Median|27|27.0|Full Range|||12.0|44.0|
3926027|NCT01419639|3749052|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3926028|NCT01419639|3749052|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3926029|NCT01419639|3749052|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3926030|NCT01419314|3749058|B3|||Function-Walking Distance|The 6 minute walk distance was collected on all participants. Longer walking distances represent decreased impact on function. Non-HIV cohorts typically are able to walk 400-600m in six-minutes.|Meters (m)|Mean|243.99|243.99|Standard Deviation|141.04|141.04|||
3926031|NCT01419314|3749059|B2|||Function-Walking Distance|The 6 minute walk distance was collected on all participants. Longer walking distances represent decreased impact on function. Non-HIV cohorts typically are able to walk 400-600m in six-minutes.|Meters (m)|Mean|241.89|241.89|Standard Deviation|151.46|151.46|||
3926032|NCT01419314|3749060|B1|||Function-Walking Distance|The 6 minute walk distance was collected on all participants. Longer walking distances represent decreased impact on function. Non-HIV cohorts typically are able to walk 400-600m in six-minutes.|Meters (m)|Mean|246.00|246.0|Standard Deviation|133.71|133.71|||
3926033|NCT01419314|3749058|B3|||Function- Forward reach|The average of 3 reaching trials are reported. One participant in the liner group had extreme reaching values (>3 standard deviation from the mean) and was excluded from the report (n=22). Longer distances in this test represent better volitional control of balance in the sagittal plane. Reaching distances >30 cm are considered to be within normal limits.|Centimeters (cm)|Mean|36.07|36.07|Standard Deviation|7.37|7.37|||
3926034|NCT01419314|3749059|B2|||Function- Forward reach|The average of 3 reaching trials are reported. One participant in the liner group had extreme reaching values (>3 standard deviation from the mean) and was excluded from the report (n=22). Longer distances in this test represent better volitional control of balance in the sagittal plane. Reaching distances >30 cm are considered to be within normal limits.|Centimeters (cm)|Mean|36.88|36.88|Standard Deviation|8.36|8.36|||
3926035|NCT01419314|3749060|B1|||Function- Forward reach|The average of 3 reaching trials are reported. One participant in the liner group had extreme reaching values (>3 standard deviation from the mean) and was excluded from the report (n=22). Longer distances in this test represent better volitional control of balance in the sagittal plane. Reaching distances >30 cm are considered to be within normal limits.|Centimeters (cm)|Mean|35.31|35.31|Standard Deviation|6.45|6.45|||
3926036|NCT01419314|3749058|B3|||Sleep Scores|"Pittsburgh Sleep Quality Index (PSQI),this is a 0-21 score scale with 21/21 denoting maximum sleep disturbances. The PSQI is scored by adding all seven sub-scales, each with a maximum score of three. A score greater than 5/21 characterizes the individual as a poor sleeper."|Scores on a 0-21 scale|Mean|14.62|14.62|Standard Deviation|4.28|4.28|||
3926037|NCT01419314|3749059|B2|||Sleep Scores|"Pittsburgh Sleep Quality Index (PSQI),this is a 0-21 score scale with 21/21 denoting maximum sleep disturbances. The PSQI is scored by adding all seven sub-scales, each with a maximum score of three. A score greater than 5/21 characterizes the individual as a poor sleeper."|Scores on a 0-21 scale|Mean|15.14|15.14|Standard Deviation|4.68|4.68|||
3926038|NCT01419314|3749060|B1|||Sleep Scores|"Pittsburgh Sleep Quality Index (PSQI),this is a 0-21 score scale with 21/21 denoting maximum sleep disturbances. The PSQI is scored by adding all seven sub-scales, each with a maximum score of three. A score greater than 5/21 characterizes the individual as a poor sleeper."|Scores on a 0-21 scale|Mean|14.13|14.13|Standard Deviation|3.89|3.89|||
3926039|NCT01419314|3749058|B3|||Pain scores|"Neuropathic Pain Scale (NPS) score, where a score of 0 equates to no pain and 100 is the maximum neuropathic pain score possible. The scale score is computed by totaling all 10 pain sub-scales, each individually scored from 0-10."|Scores on a 0-100 scale.|Mean|60.77|60.77|Standard Deviation|17.85|17.85|||
3926040|NCT01419314|3749059|B2|||Pain scores|"Neuropathic Pain Scale (NPS) score, where a score of 0 equates to no pain and 100 is the maximum neuropathic pain score possible. The scale score is computed by totaling all 10 pain sub-scales, each individually scored from 0-10."|Scores on a 0-100 scale.|Mean|60.16|60.16|Standard Deviation|14.35|14.35|||
3926041|NCT01419314|3749060|B1|||Pain scores|"Neuropathic Pain Scale (NPS) score, where a score of 0 equates to no pain and 100 is the maximum neuropathic pain score possible. The scale score is computed by totaling all 10 pain sub-scales, each individually scored from 0-10."|Scores on a 0-100 scale.|Mean|61.35|61.35|Standard Deviation|20.98|20.98|||
3926042|NCT01419314|3749058|B3|||Years living with HIV|The number of years living with HIV was calculated by subtracting the year of diagnosis to the year of sutdy enrollment.|years|Mean|10.82|10.82|Standard Deviation|6.79|6.79|||
3926043|NCT01419314|3749059|B2|||Years living with HIV|The number of years living with HIV was calculated by subtracting the year of diagnosis to the year of sutdy enrollment.|years|Mean|10.32|10.32|Standard Deviation|7.62|7.62|||
3926044|NCT01419314|3749060|B1|||Years living with HIV|The number of years living with HIV was calculated by subtracting the year of diagnosis to the year of sutdy enrollment.|years|Mean|11.30|11.3|Standard Deviation|6.01|6.01|||
3926045|NCT01419314|3749058|B3|||Log Viral load|The most recent measured HIV viral load (log viral load) was extracted from the medical record. Measured in viral copies/ml on a logarithmic scale with 1.48 log/ml representing undetectable viral load levels for the viral load test conducted in our site (less than 50 copies/ml)|Log (copies/ml)|Log Mean|2.10|2.1|Standard Deviation|0.93|0.93|||
3926046|NCT01419314|3749059|B2|||Log Viral load|The most recent measured HIV viral load (log viral load) was extracted from the medical record. Measured in viral copies/ml on a logarithmic scale with 1.48 log/ml representing undetectable viral load levels for the viral load test conducted in our site (less than 50 copies/ml)|Log (copies/ml)|Log Mean|1.96|1.96|Standard Deviation|0.75|0.75|||
3926047|NCT01419314|3749060|B1|||Log Viral load|The most recent measured HIV viral load (log viral load) was extracted from the medical record. Measured in viral copies/ml on a logarithmic scale with 1.48 log/ml representing undetectable viral load levels for the viral load test conducted in our site (less than 50 copies/ml)|Log (copies/ml)|Log Mean|2.25|2.25|Standard Deviation|1.08|1.08|||
3926048|NCT01419314|3749058|B3|||CD4|The most recent CD4 cell counts were extracted from the medical record.|cells/mm3|Mean|517.67|517.67|Standard Deviation|241.07|241.07|||
3926049|NCT01419314|3749059|B2|||CD4|The most recent CD4 cell counts were extracted from the medical record.|cells/mm3|Mean|446.09|446.09|Standard Deviation|232.54|232.54|||
3926050|NCT01419314|3749060|B1|||CD4|The most recent CD4 cell counts were extracted from the medical record.|cells/mm3|Mean|586.13|586.13|Standard Deviation|233.64|233.64|||
3926051|NCT01419314|3749058|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3926052|NCT01419314|3749059|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3926114|NCT01419236|3749102|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
3926053|NCT01419314|3749060|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3926054|NCT01419314|3749058|B3|Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3926055|NCT01419314|3749059|B2|Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3926056|NCT01419314|3749060|B1|Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3926057|NCT01419314|3749058|B3|White||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3926058|NCT01419314|3749059|B2|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3926059|NCT01419314|3749060|B1|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3926060|NCT01419314|3749058|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3926061|NCT01419314|3749059|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3926062|NCT01419314|3749060|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3926063|NCT01419314|3749058|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3926064|NCT01419314|3749059|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3926065|NCT01419314|3749060|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3926066|NCT01419314|3749058|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3926067|NCT01419314|3749059|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3926068|NCT01419314|3749060|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3926069|NCT01419314|3749058|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3926070|NCT01419314|3749059|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3926071|NCT01419314|3749060|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3926072|NCT01419314|3749058|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3926073|NCT01419314|3749059|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3926074|NCT01419314|3749060|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3926075|NCT01419314|3749058|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3926076|NCT01419314|3749059|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3926077|NCT01419314|3749060|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3926078|NCT01419314|3749058|B3|||Age||years|Mean|48.42|48.42|Standard Deviation|8.13|8.13|||
3926079|NCT01419314|3749059|B2|||Age||years|Mean|46.09|46.09|Standard Deviation|7.71|7.71|||
3926080|NCT01419314|3749060|B1|||Age||years|Mean|50.65|50.65|Standard Deviation|8.04|8.04|||
3926081|NCT01419314|3749058|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3926082|NCT01419314|3749059|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3926083|NCT01419314|3749060|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3926084|NCT01419314|3749058|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3926085|NCT01419314|3749059|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3926086|NCT01419314|3749060|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3926087|NCT01419314|3749058|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3926088|NCT01419314|3749059|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3926089|NCT01419314|3749060|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3926090|NCT01419275|3749081|B1|United States||Region of Enrollment||participants|Number|126|126.0||||||
3926091|NCT01419275|3749081|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3926092|NCT01419275|3749081|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3926093|NCT01419275|3749081|B1|||Age||years|Mean|41.3|41.3|Standard Deviation|11.0|11.0|||
3926094|NCT01419249|3749085|B3||Male|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
3926095|NCT01419249|3749086|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3926096|NCT01419249|3749087|B1||Male|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
3926097|NCT01419249|3749085|B3||Female|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
3926098|NCT01419249|3749086|B2||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3926099|NCT01419249|3749087|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3926100|NCT01419249|3749085|B3|greater than (>) 12 years||Age, Customized||participants|Number|18|18.0||||||
3926101|NCT01419249|3749086|B2|greater than (>) 12 years||Age, Customized||participants|Number|6|6.0||||||
3926102|NCT01419249|3749087|B1|greater than (>) 12 years||Age, Customized||participants|Number|12|12.0||||||
3926103|NCT01419249|3749085|B3|Between 8 to 12 years||Age, Customized||participants|Number|115|115.0||||||
3926104|NCT01419249|3749086|B2|Between 8 to 12 years||Age, Customized||participants|Number|31|31.0||||||
3926105|NCT01419249|3749087|B1|Between 8 to 12 years||Age, Customized||participants|Number|84|84.0||||||
3926106|NCT01419249|3749085|B3|less than (<) 8 years||Age, Customized||participants|Number|292|292.0||||||
3926107|NCT01419249|3749086|B2|less than (<) 8 years||Age, Customized||participants|Number|95|95.0||||||
3926108|NCT01419249|3749087|B1|less than (<) 8 years||Age, Customized||participants|Number|197|197.0||||||
3926109|NCT01419236|3749100|B3|Mexico||Region of Enrollment||participants|Number|6|6.0||||||
3926110|NCT01419236|3749101|B2|Mexico||Region of Enrollment||participants|Number|3|3.0||||||
3926111|NCT01419236|3749102|B1|Mexico||Region of Enrollment||participants|Number|3|3.0||||||
3926112|NCT01419236|3749100|B3|Canada||Region of Enrollment||participants|Number|10|10.0||||||
3926113|NCT01419236|3749101|B2|Canada||Region of Enrollment||participants|Number|7|7.0||||||
3926115|NCT01419236|3749100|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
3926116|NCT01419236|3749101|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3926117|NCT01419236|3749102|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3926118|NCT01419236|3749100|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926119|NCT01419236|3749101|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926120|NCT01419236|3749102|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926121|NCT01419236|3749100|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3926122|NCT01419236|3749101|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3926123|NCT01419236|3749102|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926124|NCT01419236|3749100|B3||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3926125|NCT01419236|3749101|B2||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3926126|NCT01419236|3749102|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3926127|NCT01419236|3749100|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3926128|NCT01419236|3749101|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3926129|NCT01419236|3749102|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3926130|NCT01419236|3749100|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926131|NCT01419236|3749101|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926132|NCT01419236|3749102|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926133|NCT01419236|3749100|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926134|NCT01419236|3749101|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926135|NCT01419236|3749102|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926136|NCT01419236|3749100|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3926137|NCT01419236|3749101|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3926138|NCT01419236|3749102|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926139|NCT01419236|3749100|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926140|NCT01419236|3749101|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926141|NCT01419236|3749102|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926142|NCT01419236|3749100|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3926143|NCT01419236|3749101|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3926144|NCT01419236|3749102|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3926145|NCT01419236|3749100|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3926146|NCT01419236|3749101|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3926147|NCT01419236|3749102|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3926148|NCT01419236|3749100|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3926149|NCT01419236|3749101|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3926150|NCT01419236|3749102|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3926151|NCT01419236|3749100|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3926152|NCT01419236|3749101|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3926153|NCT01419236|3749102|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3926154|NCT01419236|3749100|B3|||Age||years|Mean|50.7|50.7|Standard Deviation|9.76|9.76|||
3926155|NCT01419236|3749101|B2|||Age||years|Mean|52.7|52.7|Standard Deviation|9.34|9.34|||
3926156|NCT01419236|3749102|B1|||Age||years|Mean|48.4|48.4|Standard Deviation|9.83|9.83|||
3926157|NCT01419197|3749125|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3926158|NCT01419197|3749126|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3926159|NCT01419197|3749127|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3926160|NCT01419197|3749125|B3||Female|Sex: Female, Male||Participants|Count of Participants|598|598.0||||||
3926161|NCT01419197|3749126|B2||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
3926162|NCT01419197|3749127|B1||Female|Sex: Female, Male||Participants|Count of Participants|401|401.0||||||
3926163|NCT01419197|3749125|B3|||Age||years|Mean|53.6|53.6|Standard Deviation|10.5|10.5|||
3926164|NCT01419197|3749126|B2|||Age||years|Mean|54.3|54.3|Standard Deviation|10.8|10.8|||
3926165|NCT01419197|3749127|B1|||Age||years|Mean|53.3|53.3|Standard Deviation|10.4|10.4|||
3926166|NCT01419184|3749151|B3||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3926167|NCT01419184|3749152|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3926168|NCT01419184|3749153|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3926169|NCT01419184|3749151|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3926170|NCT01419184|3749152|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3926171|NCT01419184|3749153|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3926172|NCT01419184|3749151|B3|70+ Years Old||Age, Customized||participants|Number|15|15.0||||||
3926173|NCT01419184|3749152|B2|70+ Years Old||Age, Customized||participants|Number|5|5.0||||||
3926174|NCT01419184|3749153|B1|70+ Years Old||Age, Customized||participants|Number|10|10.0||||||
3926175|NCT01419184|3749151|B3|60-69 Years Old||Age, Customized||participants|Number|35|35.0||||||
3926176|NCT01419184|3749152|B2|60-69 Years Old||Age, Customized||participants|Number|21|21.0||||||
3926177|NCT01419184|3749153|B1|60-69 Years Old||Age, Customized||participants|Number|14|14.0||||||
3926178|NCT01419184|3749151|B3|50-59 Years Old||Age, Customized||participants|Number|58|58.0||||||
3926179|NCT01419184|3749152|B2|50-59 Years Old||Age, Customized||participants|Number|32|32.0||||||
3926180|NCT01419184|3749153|B1|50-59 Years Old||Age, Customized||participants|Number|26|26.0||||||
3926181|NCT01419184|3749151|B3|40-49 Years Old||Age, Customized||participants|Number|51|51.0||||||
3926182|NCT01419184|3749152|B2|40-49 Years Old||Age, Customized||participants|Number|21|21.0||||||
3926183|NCT01419184|3749153|B1|40-49 Years Old||Age, Customized||participants|Number|30|30.0||||||
3926184|NCT01419184|3749151|B3|30-39 Years Old||Age, Customized||participants|Number|39|39.0||||||
3926185|NCT01419184|3749152|B2|30-39 Years Old||Age, Customized||participants|Number|17|17.0||||||
3926186|NCT01419184|3749153|B1|30-39 Years Old||Age, Customized||participants|Number|22|22.0||||||
3926187|NCT01419184|3749151|B3|18-29 Years Old||Age, Customized||participants|Number|26|26.0||||||
3926188|NCT01419184|3749152|B2|18-29 Years Old||Age, Customized||participants|Number|10|10.0||||||
3926189|NCT01419184|3749153|B1|18-29 Years Old||Age, Customized||participants|Number|16|16.0||||||
3926190|NCT01419171|3749170|B1|||Lesion Characteristic: Percent Diameter Stenosis by QCA||Percent|Mean|67.41|67.41|Standard Deviation|11.34|11.34|||
3926191|NCT01419171|3749170|B1|Lesion Length||Lesion Characteristics by Quantitative Cornary Angiography||Millimeters|Mean|12.49|12.49|Standard Deviation|5.15|5.15|||
3926192|NCT01419171|3749170|B1|Minimum Lumen Diameter||Lesion Characteristics by Quantitative Cornary Angiography||Millimeters|Mean|0.9|0.9|Standard Deviation|0.38|0.38|||
3926193|NCT01419171|3749170|B1|Reference Vessel Diameter||Lesion Characteristics by Quantitative Cornary Angiography||Millimeters|Mean|2.77|2.77|Standard Deviation|0.53|0.53|||
3926194|NCT01419171|3749170|B1|3 (complete perfusion)||Lesion Characteristic: Pre-Procedure Thrombolysis in Myocardial Infarction (TIMI) Flow|Note: A single participant could potentially experience multiple categories listed below.|Lesions|Number|319|319.0||||||
3926195|NCT01419171|3749170|B1|2 (partial perfusion)||Lesion Characteristic: Pre-Procedure Thrombolysis in Myocardial Infarction (TIMI) Flow|Note: A single participant could potentially experience multiple categories listed below.|Lesions|Number|6|6.0||||||
3926196|NCT01419171|3749170|B1|1 (penetration with minimal perfusion)||Lesion Characteristic: Pre-Procedure Thrombolysis in Myocardial Infarction (TIMI) Flow|Note: A single participant could potentially experience multiple categories listed below.|Lesions|Number|2|2.0||||||
3926197|NCT01419171|3749170|B1|0 (no perfusion)||Lesion Characteristic: Pre-Procedure Thrombolysis in Myocardial Infarction (TIMI) Flow|Note: A single participant could potentially experience multiple categories listed below.|Lesions|Number|0|0.0||||||
3926198|NCT01419171|3749170|B1|Aneurysm||Lesion Characteristics|Note: A single participant could potentially experience multiple categories listed below.|Lesions|Number|7|7.0||||||
3926199|NCT01419171|3749170|B1|Ulcer||Lesion Characteristics|Note: A single participant could potentially experience multiple categories listed below.|Lesions|Number|21|21.0||||||
3926200|NCT01419171|3749170|B1|Calcification, Any||Lesion Characteristics|Note: A single participant could potentially experience multiple categories listed below.|Lesions|Number|111|111.0||||||
3926201|NCT01419171|3749170|B1|Thrombus||Lesion Characteristics|Note: A single participant could potentially experience multiple categories listed below.|Lesions|Number|4|4.0||||||
3926202|NCT01419171|3749170|B1|Tortuosity, Any||Lesion Characteristics|Note: A single participant could potentially experience multiple categories listed below.|Lesions|Number|32|32.0||||||
3926203|NCT01419171|3749170|B1|Greater than 20 mm||Lesion Characteristic: Lesion Length|Note: A single participant could potentially experience multiple categories listed below.|Lesions|Number|32|32.0||||||
3926204|NCT01419171|3749170|B1|10 to 20 mm||Lesion Characteristic: Lesion Length|Note: A single participant could potentially experience multiple categories listed below.|Lesions|Number|172|172.0||||||
3926205|NCT01419171|3749170|B1|Less than 10 mm||Lesion Characteristic: Lesion Length|Note: A single participant could potentially experience multiple categories listed below.|Lesions|Number|123|123.0||||||
3926206|NCT01419171|3749170|B1|Ostial||Lesion Characteristic: Lesion Location|Note: A single participant could potentially experience multiple categories listed below.|Lesions|Number|14|14.0||||||
3926207|NCT01419171|3749170|B1|Distal||Lesion Characteristic: Lesion Location|Note: A single participant could potentially experience multiple categories listed below.|Lesions|Number|37|37.0||||||
3926208|NCT01419171|3749170|B1|Mid||Lesion Characteristic: Lesion Location|Note: A single participant could potentially experience multiple categories listed below.|Lesions|Number|155|155.0||||||
3926209|NCT01419171|3749170|B1|Proximal||Lesion Characteristic: Lesion Location|Note: A single participant could potentially experience multiple categories listed below.|Lesions|Number|122|122.0||||||
3926210|NCT01419171|3749170|B1|Right Coronary Artery||Lesion Characteristics: Target Lesion Vessel|Note: A single participant could potentially experience multiple categories listed below.|participants|Number|137|137.0||||||
3926211|NCT01419171|3749170|B1|Circumflex Artery||Lesion Characteristics: Target Lesion Vessel|Note: A single participant could potentially experience multiple categories listed below.|participants|Number|79|79.0||||||
3926212|NCT01419171|3749170|B1|Left Anterior Descending Artery||Lesion Characteristics: Target Lesion Vessel|Note: A single participant could potentially experience multiple categories listed below.|participants|Number|112|112.0||||||
3926213|NCT01419171|3749170|B1|Family History of CAD||Cardiac Risk Factors|Note: A single participant could potentially experience multiple categories listed below.|participants|Number|131|131.0||||||
3926214|NCT01419171|3749170|B1|Hypertension Requiring Medication||Cardiac Risk Factors|Note: A single participant could potentially experience multiple categories listed below.|participants|Number|243|243.0||||||
3926215|NCT01419171|3749170|B1|Hyperlipidemia Requiring Medication||Cardiac Risk Factors|Note: A single participant could potentially experience multiple categories listed below.|participants|Number|230|230.0||||||
3926216|NCT01419171|3749170|B1|Medically Treated Diabetes||Cardiac Risk Factors|Note: A single participant could potentially experience multiple categories listed below.|participants|Number|57|57.0||||||
3926217|NCT01419171|3749170|B1|Smoking, Ever||Cardiac Risk Factors|Note: A single participant could potentially experience multiple categories listed below.|participants|Number|211|211.0||||||
3926218|NCT01419171|3749170|B1|Silent Ischemia||Cardiac History|Note: A single participant could potentially experience multiple categories listed below.|participants|Number|54|54.0||||||
3926219|NCT01419171|3749170|B1|Unstable Angina||Cardiac History|Note: A single participant could potentially experience multiple categories listed below.|participants|Number|111|111.0||||||
3926220|NCT01419171|3749170|B1|Stable Angina||Cardiac History|Note: A single participant could potentially experience multiple categories listed below.|participants|Number|182|182.0||||||
3926221|NCT01419171|3749170|B1|History of CHF||Cardiac History|Note: A single participant could potentially experience multiple categories listed below.|participants|Number|21|21.0||||||
3926222|NCT01419171|3749170|B1|History of PCI||Cardiac History|Note: A single participant could potentially experience multiple categories listed below.|participants|Number|95|95.0||||||
3926223|NCT01419171|3749170|B1|History of CABG||Cardiac History|Note: A single participant could potentially experience multiple categories listed below.|participants|Number|15|15.0||||||
3926224|NCT01419171|3749170|B1|Previous Myocardial Infarction||Cardiac History|Note: A single participant could potentially experience multiple categories listed below.|participants|Number|96|96.0||||||
3926225|NCT01419171|3749170|B1|Germany||Region of Enrollment||participants|Number|31|31.0||||||
3926226|NCT01419171|3749170|B1|Latvia||Region of Enrollment||participants|Number|23|23.0||||||
3926227|NCT01419171|3749170|B1|Netherlands||Region of Enrollment||participants|Number|39|39.0||||||
3926228|NCT01419171|3749170|B1|Belgium||Region of Enrollment||participants|Number|37|37.0||||||
3926229|NCT01419171|3749170|B1|Spain||Region of Enrollment||participants|Number|39|39.0||||||
3926230|NCT01419171|3749170|B1|United States||Region of Enrollment||participants|Number|104|104.0||||||
3926231|NCT01419171|3749170|B1|France||Region of Enrollment||participants|Number|55|55.0||||||
3926232|NCT01419171|3749170|B1|Not disclosed||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
3926233|NCT01419171|3749170|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3926234|NCT01419171|3749170|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3926235|NCT01419171|3749170|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|254|254.0||||||
3926236|NCT01419171|3749170|B1|Black, of African heritage||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3926237|NCT01419171|3749170|B1||Male|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
3926238|NCT01419171|3749170|B1||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3926239|NCT01419171|3749170|B1|||Age||years|Mean|65.46|65.46|Standard Deviation|11.23|11.23|||
3926240|NCT01419028|3749187|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
3926241|NCT01419028|3749187|B1|Taiwan||Region of Enrollment||participants|Number|1|1.0||||||
3926242|NCT01419028|3749187|B1|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
3926243|NCT01419028|3749187|B1|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3926244|NCT01419028|3749187|B1|Germany||Region of Enrollment||participants|Number|6|6.0||||||
3926245|NCT01419028|3749187|B1|Canada||Region of Enrollment||participants|Number|11|11.0||||||
3926246|NCT01419028|3749187|B1|Australia||Region of Enrollment||participants|Number|2|2.0||||||
3926247|NCT01419028|3749187|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3926248|NCT01419028|3749187|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3926249|NCT01419028|3749187|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3926250|NCT01419028|3749187|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3926251|NCT01419028|3749187|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926252|NCT01419028|3749187|B1||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3926253|NCT01419028|3749187|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3926254|NCT01419028|3749187|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926255|NCT01419028|3749187|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3926256|NCT01419028|3749187|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3926257|NCT01419028|3749187|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3926258|NCT01419028|3749187|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3926259|NCT01419028|3749187|B1|>=65 years||Age|Age is only for subjects who are alive at the time of data abstraction|weeks|Number|0|0.0||||||
3926260|NCT01419028|3749187|B1|Between 18 and 65 years||Age|Age is only for subjects who are alive at the time of data abstraction|weeks|Number|3|3.0||||||
3926261|NCT01419028|3749187|B1|<=18 years||Age|Age is only for subjects who are alive at the time of data abstraction|weeks|Number|10|10.0||||||
3926262|NCT01419028|3749187|B1|||Age|Age is only for subjects who are alive at the time of data abstraction|weeks|Mean|506.9|506.9|Standard Deviation|319.24|319.24|||
3926263|NCT01418937|3749192|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3926264|NCT01418937|3749192|B1||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3926265|NCT01418937|3749192|B1|||Age||Years|Mean|30.8|30.8|Standard Deviation|2.9|2.9|||
3926266|NCT01418703|3749199|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3926267|NCT01418703|3749200|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3926268|NCT01418703|3749201|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3926269|NCT01418703|3749199|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3926270|NCT01418703|3749200|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3926271|NCT01418703|3749201|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3926272|NCT01418703|3749199|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3926273|NCT01418703|3749200|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3926274|NCT01418703|3749201|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3926275|NCT01418703|3749199|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3926276|NCT01418703|3749200|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3926277|NCT01418703|3749201|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3926278|NCT01418703|3749199|B3||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
3926279|NCT01418703|3749200|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3926280|NCT01418703|3749201|B1||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
3926281|NCT01418482|3749215|B1|Sweden||Region of Enrollment||participants|Number|15|15.0||||||
3926282|NCT01418482|3749215|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3926283|NCT01418482|3749215|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3926284|NCT01418482|3749215|B1|||Age||years|Mean|44.5|44.5|Standard Deviation|14.5|14.5|||
3926285|NCT01418365|3749221|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3926286|NCT01418365|3749222|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3926287|NCT01418365|3749223|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3926288|NCT01418365|3749221|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3926289|NCT01418365|3749222|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3926290|NCT01418365|3749223|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3926291|NCT01418365|3749221|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3926292|NCT01418365|3749222|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3926293|NCT01418365|3749223|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3926294|NCT01418365|3749221|B3|Between 18 and 55 years||Age, Customized||participants|Number|30|30.0||||||
3926295|NCT01418365|3749222|B2|Between 18 and 55 years||Age, Customized||participants|Number|15|15.0||||||
3926296|NCT01418365|3749223|B1|Between 18 and 55 years||Age, Customized||participants|Number|15|15.0||||||
3926297|NCT01418365|3749221|B3|||Age||years|Mean|33.6|33.6|Standard Deviation|10.1|10.1|||
3926298|NCT01418365|3749222|B2|||Age||years|Mean|31.2|31.2|Standard Deviation|11.0|11.0|||
3926299|NCT01418365|3749223|B1|||Age||years|Mean|35.9|35.9|Standard Deviation|8.84|8.84|||
3926300|NCT01418209|3749232|B4|||Perceived Hot Flash Interference (Hot Flash Related Daily Interference Scale; HFRDIS)|The perceived hot flash related daily interference scale (HFRDIS) is a tool for assessing the impact of hot flashes on quality of life. There are 10 questions with each having a score ranging from 0 to 10. The scores from each question are summed for a total score ranging from 0 to 100. Lower numbers indicate less interference and higher numbers indicate more interference.|units on a scale|Mean|35.1|35.1|Standard Deviation|22.6|22.6|||
3926301|NCT01418209|3749233|B3|||Perceived Hot Flash Interference (Hot Flash Related Daily Interference Scale; HFRDIS)|The perceived hot flash related daily interference scale (HFRDIS) is a tool for assessing the impact of hot flashes on quality of life. There are 10 questions with each having a score ranging from 0 to 10. The scores from each question are summed for a total score ranging from 0 to 100. Lower numbers indicate less interference and higher numbers indicate more interference.|units on a scale|Mean|32.8|32.8|Standard Deviation|21.3|21.3|||
3926302|NCT01418209|3749234|B2|||Perceived Hot Flash Interference (Hot Flash Related Daily Interference Scale; HFRDIS)|The perceived hot flash related daily interference scale (HFRDIS) is a tool for assessing the impact of hot flashes on quality of life. There are 10 questions with each having a score ranging from 0 to 10. The scores from each question are summed for a total score ranging from 0 to 100. Lower numbers indicate less interference and higher numbers indicate more interference.|units on a scale|Mean|36.8|36.8|Standard Deviation|23.4|23.4|||
3926303|NCT01418209|3749235|B1|||Perceived Hot Flash Interference (Hot Flash Related Daily Interference Scale; HFRDIS)|The perceived hot flash related daily interference scale (HFRDIS) is a tool for assessing the impact of hot flashes on quality of life. There are 10 questions with each having a score ranging from 0 to 10. The scores from each question are summed for a total score ranging from 0 to 100. Lower numbers indicate less interference and higher numbers indicate more interference.|units on a scale|Mean|36.9|36.9|Standard Deviation|23.8|23.8|||
3926304|NCT01418209|3749232|B4|||Bothersomeness of Hot Flashes|Bothersomeness of hot flashes is measured on a scale from 0 to 3. Lower numbers indicate less bother and higher numbers indicate more bother.|units on a scale|Mean|2.0|2.0|Standard Deviation|0.5|0.5|||
3926305|NCT01418209|3749233|B3|||Bothersomeness of Hot Flashes|Bothersomeness of hot flashes is measured on a scale from 0 to 3. Lower numbers indicate less bother and higher numbers indicate more bother.|units on a scale|Mean|2.0|2.0|Standard Deviation|0.5|0.5|||
3926306|NCT01418209|3749234|B2|||Bothersomeness of Hot Flashes|Bothersomeness of hot flashes is measured on a scale from 0 to 3. Lower numbers indicate less bother and higher numbers indicate more bother.|units on a scale|Mean|2.0|2.0|Standard Deviation|0.5|0.5|||
3926307|NCT01418209|3749235|B1|||Bothersomeness of Hot Flashes|Bothersomeness of hot flashes is measured on a scale from 0 to 3. Lower numbers indicate less bother and higher numbers indicate more bother.|units on a scale|Mean|2.1|2.1|Standard Deviation|0.5|0.5|||
3926308|NCT01418209|3749232|B4|||Severity of Hot Flashes|Severity of hot flashes is measured as a scale from 0 to 3. Lower numbers indicate less severity and higher numbers indicate more severity.|units on a scale|Mean|1.0|1.0|Standard Deviation|0.5|0.5|||
3926309|NCT01418209|3749233|B3|||Severity of Hot Flashes|Severity of hot flashes is measured as a scale from 0 to 3. Lower numbers indicate less severity and higher numbers indicate more severity.|units on a scale|Mean|1.0|1.0|Standard Deviation|0.4|0.4|||
3926310|NCT01418209|3749234|B2|||Severity of Hot Flashes|Severity of hot flashes is measured as a scale from 0 to 3. Lower numbers indicate less severity and higher numbers indicate more severity.|units on a scale|Mean|1.0|1.0|Standard Deviation|0.5|0.5|||
3926311|NCT01418209|3749235|B1|||Severity of Hot Flashes|Severity of hot flashes is measured as a scale from 0 to 3. Lower numbers indicate less severity and higher numbers indicate more severity.|units on a scale|Mean|1.1|1.1|Standard Deviation|0.5|0.5|||
3926312|NCT01418209|3749232|B4|||Vasomotor Symptoms (VMS) as number of hot flashes|Vasomotor Symptoms (VMS) frequency measures the number of hot flashes during the day and during the night. The day and night frequencies are summed for a 24-hour score.|Number of hot flashes per day|Mean|8.1|8.1|Standard Deviation|5.3|5.3|||
3926313|NCT01418209|3749233|B3|||Vasomotor Symptoms (VMS) as number of hot flashes|Vasomotor Symptoms (VMS) frequency measures the number of hot flashes during the day and during the night. The day and night frequencies are summed for a 24-hour score.|Number of hot flashes per day|Mean|7.7|7.7|Standard Deviation|4.8|4.8|||
3926314|NCT01418209|3749234|B2|||Vasomotor Symptoms (VMS) as number of hot flashes|Vasomotor Symptoms (VMS) frequency measures the number of hot flashes during the day and during the night. The day and night frequencies are summed for a 24-hour score.|Number of hot flashes per day|Mean|8.2|8.2|Standard Deviation|5.5|5.5|||
3926315|NCT01418209|3749235|B1|||Vasomotor Symptoms (VMS) as number of hot flashes|Vasomotor Symptoms (VMS) frequency measures the number of hot flashes during the day and during the night. The day and night frequencies are summed for a 24-hour score.|Number of hot flashes per day|Mean|8.5|8.5|Standard Deviation|5.7|5.7|||
3926316|NCT01418209|3749232|B4|Moderate anxiety (>= 10)||Generalized Anxiety Disorder 7 (GAD-7) Score||participants|Number|23|23.0||||||
3926317|NCT01418209|3749233|B3|Moderate anxiety (>= 10)||Generalized Anxiety Disorder 7 (GAD-7) Score||participants|Number|11|11.0||||||
3926318|NCT01418209|3749234|B2|Moderate anxiety (>= 10)||Generalized Anxiety Disorder 7 (GAD-7) Score||participants|Number|3|3.0||||||
3926319|NCT01418209|3749235|B1|Moderate anxiety (>= 10)||Generalized Anxiety Disorder 7 (GAD-7) Score||participants|Number|9|9.0||||||
3926320|NCT01418209|3749232|B4|Mild anxiety (5 - 9)||Generalized Anxiety Disorder 7 (GAD-7) Score||participants|Number|51|51.0||||||
3926321|NCT01418209|3749233|B3|Mild anxiety (5 - 9)||Generalized Anxiety Disorder 7 (GAD-7) Score||participants|Number|19|19.0||||||
3926322|NCT01418209|3749234|B2|Mild anxiety (5 - 9)||Generalized Anxiety Disorder 7 (GAD-7) Score||participants|Number|17|17.0||||||
3926323|NCT01418209|3749235|B1|Mild anxiety (5 - 9)||Generalized Anxiety Disorder 7 (GAD-7) Score||participants|Number|15|15.0||||||
3926324|NCT01418209|3749232|B4|No anxiety (0 - 4)||Generalized Anxiety Disorder 7 (GAD-7) Score||participants|Number|265|265.0||||||
3926325|NCT01418209|3749233|B3|No anxiety (0 - 4)||Generalized Anxiety Disorder 7 (GAD-7) Score||participants|Number|116|116.0||||||
3926326|NCT01418209|3749234|B2|No anxiety (0 - 4)||Generalized Anxiety Disorder 7 (GAD-7) Score||participants|Number|76|76.0||||||
3926327|NCT01418209|3749235|B1|No anxiety (0 - 4)||Generalized Anxiety Disorder 7 (GAD-7) Score||participants|Number|73|73.0||||||
3926328|NCT01418209|3749232|B4|||Generalized Anxiety Disorder 7 (GAD-7) Score|Generalized Anxiety Disorder 7 (GAD-7) assesses generalized anxiety. There are 7 questions with each scored from 0 to 3. The scores from each question are summed to a total score ranging from 0 to 21. Lower scores are better.|units on a scale|Mean|2.5|2.5|Standard Deviation|3.6|3.6|||
3926329|NCT01418209|3749233|B3|||Generalized Anxiety Disorder 7 (GAD-7) Score|Generalized Anxiety Disorder 7 (GAD-7) assesses generalized anxiety. There are 7 questions with each scored from 0 to 3. The scores from each question are summed to a total score ranging from 0 to 21. Lower scores are better.|units on a scale|Mean|2.4|2.4|Standard Deviation|3.4|3.4|||
3926330|NCT01418209|3749234|B2|||Generalized Anxiety Disorder 7 (GAD-7) Score|Generalized Anxiety Disorder 7 (GAD-7) assesses generalized anxiety. There are 7 questions with each scored from 0 to 3. The scores from each question are summed to a total score ranging from 0 to 21. Lower scores are better.|units on a scale|Mean|2.2|2.2|Standard Deviation|3.0|3.0|||
3926331|NCT01418209|3749235|B1|||Generalized Anxiety Disorder 7 (GAD-7) Score|Generalized Anxiety Disorder 7 (GAD-7) assesses generalized anxiety. There are 7 questions with each scored from 0 to 3. The scores from each question are summed to a total score ranging from 0 to 21. Lower scores are better.|units on a scale|Mean|3.0|3.0|Standard Deviation|4.3|4.3|||
3926332|NCT01418209|3749232|B4|Moderate depression (>= 10)||PHQ-9 Depression Score||participants|Number|29|29.0||||||
3926333|NCT01418209|3749233|B3|Moderate depression (>= 10)||PHQ-9 Depression Score||participants|Number|15|15.0||||||
3926334|NCT01418209|3749234|B2|Moderate depression (>= 10)||PHQ-9 Depression Score||participants|Number|3|3.0||||||
3926335|NCT01418209|3749235|B1|Moderate depression (>= 10)||PHQ-9 Depression Score||participants|Number|11|11.0||||||
3926336|NCT01418209|3749232|B4|Mild depression (5 - 9)||PHQ-9 Depression Score||participants|Number|64|64.0||||||
3926337|NCT01418209|3749233|B3|Mild depression (5 - 9)||PHQ-9 Depression Score||participants|Number|23|23.0||||||
3926338|NCT01418209|3749234|B2|Mild depression (5 - 9)||PHQ-9 Depression Score||participants|Number|23|23.0||||||
3926339|NCT01418209|3749235|B1|Mild depression (5 - 9)||PHQ-9 Depression Score||participants|Number|18|18.0||||||
3926340|NCT01418209|3749232|B4|No depression (0 - 4)||PHQ-9 Depression Score||participants|Number|246|246.0||||||
3926341|NCT01418209|3749233|B3|No depression (0 - 4)||PHQ-9 Depression Score||participants|Number|108|108.0||||||
3926342|NCT01418209|3749234|B2|No depression (0 - 4)||PHQ-9 Depression Score||participants|Number|70|70.0||||||
3926343|NCT01418209|3749235|B1|No depression (0 - 4)||PHQ-9 Depression Score||participants|Number|68|68.0||||||
3926344|NCT01418209|3749232|B4|||Patient Health Questionnaire (PHQ-9) Depression Score|The Patient Health Questionnaire (PHQ-9) assesses severity of depression. There are 10 questions with the first nine questions each scored from 0 to 3. The individual scores are summed to create a total score ranging from 0 to 45. Scores from 5 to >20 provisionally indicate, from lower to higher numbers, minimal symptoms to severe depression.|units on a scale|Mean|3.4|3.4|Standard Deviation|3.7|3.7|||
3926381|NCT01418209|3749233|B3|Subthreshold insomnia (8 - 14)||Insomnia Severity Index (ISI) Score||participants|Number|54|54.0||||||
3926482|NCT01418209|3749234|B2|<7||Alcohol use (drinks/week)||participants|Number|77|77.0||||||
3926345|NCT01418209|3749233|B3|||Patient Health Questionnaire (PHQ-9) Depression Score|The Patient Health Questionnaire (PHQ-9) assesses severity of depression. There are 10 questions with the first nine questions each scored from 0 to 3. The individual scores are summed to create a total score ranging from 0 to 45. Scores from 5 to >20 provisionally indicate, from lower to higher numbers, minimal symptoms to severe depression.|units on a scale|Mean|3.4|3.4|Standard Deviation|3.7|3.7|||
3926346|NCT01418209|3749234|B2|||Patient Health Questionnaire (PHQ-9) Depression Score|The Patient Health Questionnaire (PHQ-9) assesses severity of depression. There are 10 questions with the first nine questions each scored from 0 to 3. The individual scores are summed to create a total score ranging from 0 to 45. Scores from 5 to >20 provisionally indicate, from lower to higher numbers, minimal symptoms to severe depression.|units on a scale|Mean|3.0|3.0|Standard Deviation|2.9|2.9|||
3926347|NCT01418209|3749235|B1|||Patient Health Questionnaire (PHQ-9) Depression Score|The Patient Health Questionnaire (PHQ-9) assesses severity of depression. There are 10 questions with the first nine questions each scored from 0 to 3. The individual scores are summed to create a total score ranging from 0 to 45. Scores from 5 to >20 provisionally indicate, from lower to higher numbers, minimal symptoms to severe depression.|units on a scale|Mean|3.9|3.9|Standard Deviation|4.4|4.4|||
3926348|NCT01418209|3749232|B4|Missing||Pittsburgh Sleep Quality Index (PSQI) Score||participants|Number|19|19.0||||||
3926349|NCT01418209|3749233|B3|Missing||Pittsburgh Sleep Quality Index (PSQI) Score||participants|Number|5|5.0||||||
3926350|NCT01418209|3749234|B2|Missing||Pittsburgh Sleep Quality Index (PSQI) Score||participants|Number|7|7.0||||||
3926351|NCT01418209|3749235|B1|Missing||Pittsburgh Sleep Quality Index (PSQI) Score||participants|Number|7|7.0||||||
3926352|NCT01418209|3749232|B4|Poor sleep quality (>= 8)||Pittsburgh Sleep Quality Index (PSQI) Score||participants|Number|151|151.0||||||
3926353|NCT01418209|3749233|B3|Poor sleep quality (>= 8)||Pittsburgh Sleep Quality Index (PSQI) Score||participants|Number|65|65.0||||||
3926354|NCT01418209|3749234|B2|Poor sleep quality (>= 8)||Pittsburgh Sleep Quality Index (PSQI) Score||participants|Number|40|40.0||||||
3926355|NCT01418209|3749235|B1|Poor sleep quality (>= 8)||Pittsburgh Sleep Quality Index (PSQI) Score||participants|Number|46|46.0||||||
3926356|NCT01418209|3749232|B4|Moderate sleep quality (5 - < 8)||Pittsburgh Sleep Quality Index (PSQI) Score||participants|Number|102|102.0||||||
3926357|NCT01418209|3749233|B3|Moderate sleep quality (5 - < 8)||Pittsburgh Sleep Quality Index (PSQI) Score||participants|Number|46|46.0||||||
3926358|NCT01418209|3749234|B2|Moderate sleep quality (5 - < 8)||Pittsburgh Sleep Quality Index (PSQI) Score||participants|Number|35|35.0||||||
3926359|NCT01418209|3749235|B1|Moderate sleep quality (5 - < 8)||Pittsburgh Sleep Quality Index (PSQI) Score||participants|Number|21|21.0||||||
3926360|NCT01418209|3749232|B4|Good quality sleep (< 5)||Pittsburgh Sleep Quality Index (PSQI) Score||participants|Number|67|67.0||||||
3926361|NCT01418209|3749233|B3|Good quality sleep (< 5)||Pittsburgh Sleep Quality Index (PSQI) Score||participants|Number|30|30.0||||||
3926362|NCT01418209|3749234|B2|Good quality sleep (< 5)||Pittsburgh Sleep Quality Index (PSQI) Score||participants|Number|14|14.0||||||
3926363|NCT01418209|3749235|B1|Good quality sleep (< 5)||Pittsburgh Sleep Quality Index (PSQI) Score||participants|Number|23|23.0||||||
3926364|NCT01418209|3749232|B4|||Pittsburgh Sleep Quality Index (PSQI) Score|The Pittsburgh Sleep Quality Index (PSQI) assesses quality of sleep. There are 7 questions. Each question is scored 0 (better quality sleep) to 3 (worse quality sleep). The scores from each question are summed to a total score, ranging from 0 (better quality sleep) to 21 (worse quality sleep).|units on a scale|Mean|7.5|7.5|Standard Deviation|3.4|3.4|||
3926365|NCT01418209|3749233|B3|||Pittsburgh Sleep Quality Index (PSQI) Score|The Pittsburgh Sleep Quality Index (PSQI) assesses quality of sleep. There are 7 questions. Each question is scored 0 (better quality sleep) to 3 (worse quality sleep). The scores from each question are summed to a total score, ranging from 0 (better quality sleep) to 21 (worse quality sleep).|units on a scale|Mean|7.3|7.3|Standard Deviation|3.5|3.5|||
3926366|NCT01418209|3749234|B2|||Pittsburgh Sleep Quality Index (PSQI) Score|The Pittsburgh Sleep Quality Index (PSQI) assesses quality of sleep. There are 7 questions. Each question is scored 0 (better quality sleep) to 3 (worse quality sleep). The scores from each question are summed to a total score, ranging from 0 (better quality sleep) to 21 (worse quality sleep).|units on a scale|Mean|7.6|7.6|Standard Deviation|3.2|3.2|||
3926367|NCT01418209|3749235|B1|||Pittsburgh Sleep Quality Index (PSQI) Score|The Pittsburgh Sleep Quality Index (PSQI) assesses quality of sleep. There are 7 questions. Each question is scored 0 (better quality sleep) to 3 (worse quality sleep). The scores from each question are summed to a total score, ranging from 0 (better quality sleep) to 21 (worse quality sleep).|units on a scale|Mean|7.6|7.6|Standard Deviation|3.6|3.6|||
3926368|NCT01418209|3749232|B4|Missing||Insomnia Severity Index (ISI) Score||participants|Number|8|8.0||||||
3926369|NCT01418209|3749233|B3|Missing||Insomnia Severity Index (ISI) Score||participants|Number|4|4.0||||||
3926370|NCT01418209|3749234|B2|Missing||Insomnia Severity Index (ISI) Score||participants|Number|1|1.0||||||
3926371|NCT01418209|3749235|B1|Missing||Insomnia Severity Index (ISI) Score||participants|Number|3|3.0||||||
3926372|NCT01418209|3749232|B4|Clinical insomnia (severe, >= 22)||Insomnia Severity Index (ISI) Score||participants|Number|14|14.0||||||
3926373|NCT01418209|3749233|B3|Clinical insomnia (severe, >= 22)||Insomnia Severity Index (ISI) Score||participants|Number|4|4.0||||||
3926374|NCT01418209|3749234|B2|Clinical insomnia (severe, >= 22)||Insomnia Severity Index (ISI) Score||participants|Number|5|5.0||||||
3926375|NCT01418209|3749235|B1|Clinical insomnia (severe, >= 22)||Insomnia Severity Index (ISI) Score||participants|Number|5|5.0||||||
3926376|NCT01418209|3749232|B4|Clinical insomnia (moderate, 15 - 21)||Insomnia Severity Index (ISI) Score||participants|Number|78|78.0||||||
3926377|NCT01418209|3749233|B3|Clinical insomnia (moderate, 15 - 21)||Insomnia Severity Index (ISI) Score||participants|Number|32|32.0||||||
3926378|NCT01418209|3749234|B2|Clinical insomnia (moderate, 15 - 21)||Insomnia Severity Index (ISI) Score||participants|Number|25|25.0||||||
3926379|NCT01418209|3749235|B1|Clinical insomnia (moderate, 15 - 21)||Insomnia Severity Index (ISI) Score||participants|Number|21|21.0||||||
3926380|NCT01418209|3749232|B4|Subthreshold insomnia (8 - 14)||Insomnia Severity Index (ISI) Score||participants|Number|133|133.0||||||
3926382|NCT01418209|3749234|B2|Subthreshold insomnia (8 - 14)||Insomnia Severity Index (ISI) Score||participants|Number|39|39.0||||||
3926383|NCT01418209|3749235|B1|Subthreshold insomnia (8 - 14)||Insomnia Severity Index (ISI) Score||participants|Number|40|40.0||||||
3926384|NCT01418209|3749232|B4|No clinically significant insomnia (<= 7)||Insomnia Severity Index (ISI) Score||participants|Number|106|106.0||||||
3926385|NCT01418209|3749233|B3|No clinically significant insomnia (<= 7)||Insomnia Severity Index (ISI) Score||participants|Number|52|52.0||||||
3926386|NCT01418209|3749234|B2|No clinically significant insomnia (<= 7)||Insomnia Severity Index (ISI) Score||participants|Number|26|26.0||||||
3926387|NCT01418209|3749235|B1|No clinically significant insomnia (<= 7)||Insomnia Severity Index (ISI) Score||participants|Number|28|28.0||||||
3926388|NCT01418209|3749232|B4|||Insomnia Severity Index (ISI) Score|The Insomnia Severity Index (ISI) assesses level of insomnia, an inability to sleep. There are 7 questions, each ranging in a numerical rating from 0 (zero) to 4 with 0 indicating less insomnia and 4 indicating more insomnia. The numbers from each question are summed for a total score ranging from 0 to 28 with 0 indicating less insomnia and 28 indicating more insomnia.|units on a scale|Mean|11.0|11.0|Standard Deviation|6.0|6.0|||
3926389|NCT01418209|3749233|B3|||Insomnia Severity Index (ISI) Score|The Insomnia Severity Index (ISI) assesses level of insomnia, an inability to sleep. There are 7 questions, each ranging in a numerical rating from 0 (zero) to 4 with 0 indicating less insomnia and 4 indicating more insomnia. The numbers from each question are summed for a total score ranging from 0 to 28 with 0 indicating less insomnia and 28 indicating more insomnia.|units on a scale|Mean|10.4|10.4|Standard Deviation|5.8|5.8|||
3926390|NCT01418209|3749234|B2|||Insomnia Severity Index (ISI) Score|The Insomnia Severity Index (ISI) assesses level of insomnia, an inability to sleep. There are 7 questions, each ranging in a numerical rating from 0 (zero) to 4 with 0 indicating less insomnia and 4 indicating more insomnia. The numbers from each question are summed for a total score ranging from 0 to 28 with 0 indicating less insomnia and 28 indicating more insomnia.|units on a scale|Mean|11.7|11.7|Standard Deviation|6.0|6.0|||
3926391|NCT01418209|3749235|B1|||Insomnia Severity Index (ISI) Score|The Insomnia Severity Index (ISI) assesses level of insomnia, an inability to sleep. There are 7 questions, each ranging in a numerical rating from 0 (zero) to 4 with 0 indicating less insomnia and 4 indicating more insomnia. The numbers from each question are summed for a total score ranging from 0 to 28 with 0 indicating less insomnia and 28 indicating more insomnia.|units on a scale|Mean|11.0|11.0|Standard Deviation|6.3|6.3|||
3926392|NCT01418209|3749232|B4|Missing||Age at starting vasomotor symptoms (VMS), years of age||participants|Number|5|5.0||||||
3926393|NCT01418209|3749233|B3|Missing||Age at starting vasomotor symptoms (VMS), years of age||participants|Number|2|2.0||||||
3926394|NCT01418209|3749234|B2|Missing||Age at starting vasomotor symptoms (VMS), years of age||participants|Number|1|1.0||||||
3926395|NCT01418209|3749235|B1|Missing||Age at starting vasomotor symptoms (VMS), years of age||participants|Number|2|2.0||||||
3926396|NCT01418209|3749232|B4|>= 50||Age at starting vasomotor symptoms (VMS), years of age||participants|Number|163|163.0||||||
3926397|NCT01418209|3749233|B3|>= 50||Age at starting vasomotor symptoms (VMS), years of age||participants|Number|71|71.0||||||
3926398|NCT01418209|3749234|B2|>= 50||Age at starting vasomotor symptoms (VMS), years of age||participants|Number|44|44.0||||||
3926399|NCT01418209|3749235|B1|>= 50||Age at starting vasomotor symptoms (VMS), years of age||participants|Number|48|48.0||||||
3926400|NCT01418209|3749232|B4|< 50||Age at starting vasomotor symptoms (VMS), years of age||participants|Number|171|171.0||||||
3926401|NCT01418209|3749233|B3|< 50||Age at starting vasomotor symptoms (VMS), years of age||participants|Number|73|73.0||||||
3926402|NCT01418209|3749234|B2|< 50||Age at starting vasomotor symptoms (VMS), years of age||participants|Number|51|51.0||||||
3926403|NCT01418209|3749235|B1|< 50||Age at starting vasomotor symptoms (VMS), years of age||participants|Number|47|47.0||||||
3926404|NCT01418209|3749232|B4|>= 12||Vasomotor symptom (VMS) number of participants with number of hot flashes / day||participants|Number|53|53.0||||||
3926405|NCT01418209|3749233|B3|>= 12||Vasomotor symptom (VMS) number of participants with number of hot flashes / day||participants|Number|21|21.0||||||
3926406|NCT01418209|3749234|B2|>= 12||Vasomotor symptom (VMS) number of participants with number of hot flashes / day||participants|Number|14|14.0||||||
3926407|NCT01418209|3749235|B1|>= 12||Vasomotor symptom (VMS) number of participants with number of hot flashes / day||participants|Number|18|18.0||||||
3926408|NCT01418209|3749232|B4|9 - < 12||Vasomotor symptom (VMS) number of participants with number of hot flashes / day||participants|Number|45|45.0||||||
3926409|NCT01418209|3749233|B3|9 - < 12||Vasomotor symptom (VMS) number of participants with number of hot flashes / day||participants|Number|19|19.0||||||
3926410|NCT01418209|3749234|B2|9 - < 12||Vasomotor symptom (VMS) number of participants with number of hot flashes / day||participants|Number|15|15.0||||||
3926411|NCT01418209|3749235|B1|9 - < 12||Vasomotor symptom (VMS) number of participants with number of hot flashes / day||participants|Number|11|11.0||||||
3926412|NCT01418209|3749232|B4|6 - < 9||Vasomotor symptom (VMS) number of participants with number of hot flashes / day||participants|Number|102|102.0||||||
3926413|NCT01418209|3749233|B3|6 - < 9||Vasomotor symptom (VMS) number of participants with number of hot flashes / day||participants|Number|39|39.0||||||
3926414|NCT01418209|3749234|B2|6 - < 9||Vasomotor symptom (VMS) number of participants with number of hot flashes / day||participants|Number|31|31.0||||||
3926415|NCT01418209|3749235|B1|6 - < 9||Vasomotor symptom (VMS) number of participants with number of hot flashes / day||participants|Number|32|32.0||||||
3926416|NCT01418209|3749232|B4|< 6||Vasomotor symptom (VMS) number of participants with number of hot flashes / day||participants|Number|139|139.0||||||
3926417|NCT01418209|3749233|B3|< 6||Vasomotor symptom (VMS) number of participants with number of hot flashes / day||participants|Number|67|67.0||||||
3926418|NCT01418209|3749234|B2|< 6||Vasomotor symptom (VMS) number of participants with number of hot flashes / day||participants|Number|36|36.0||||||
3926419|NCT01418209|3749235|B1|< 6||Vasomotor symptom (VMS) number of participants with number of hot flashes / day||participants|Number|36|36.0||||||
3926420|NCT01418209|3749232|B4|Not postmenopausal||Years since final menstrual period (postmenopausal only)||participants|Number|83|83.0||||||
3926421|NCT01418209|3749233|B3|Not postmenopausal||Years since final menstrual period (postmenopausal only)||participants|Number|36|36.0||||||
3926422|NCT01418209|3749234|B2|Not postmenopausal||Years since final menstrual period (postmenopausal only)||participants|Number|24|24.0||||||
3926423|NCT01418209|3749235|B1|Not postmenopausal||Years since final menstrual period (postmenopausal only)||participants|Number|23|23.0||||||
3926424|NCT01418209|3749232|B4|> 10||Years since final menstrual period (postmenopausal only)||participants|Number|42|42.0||||||
3926425|NCT01418209|3749233|B3|> 10||Years since final menstrual period (postmenopausal only)||participants|Number|13|13.0||||||
3926426|NCT01418209|3749234|B2|> 10||Years since final menstrual period (postmenopausal only)||participants|Number|13|13.0||||||
3926427|NCT01418209|3749235|B1|> 10||Years since final menstrual period (postmenopausal only)||participants|Number|16|16.0||||||
3926428|NCT01418209|3749232|B4|6 - 10||Years since final menstrual period (postmenopausal only)||participants|Number|72|72.0||||||
3926429|NCT01418209|3749233|B3|6 - 10||Years since final menstrual period (postmenopausal only)||participants|Number|29|29.0||||||
3926430|NCT01418209|3749234|B2|6 - 10||Years since final menstrual period (postmenopausal only)||participants|Number|20|20.0||||||
3926431|NCT01418209|3749235|B1|6 - 10||Years since final menstrual period (postmenopausal only)||participants|Number|23|23.0||||||
3926432|NCT01418209|3749232|B4|0 - 5||Years since final menstrual period (postmenopausal only)||participants|Number|142|142.0||||||
3926433|NCT01418209|3749233|B3|0 - 5||Years since final menstrual period (postmenopausal only)||participants|Number|68|68.0||||||
3926434|NCT01418209|3749234|B2|0 - 5||Years since final menstrual period (postmenopausal only)||participants|Number|39|39.0||||||
3926435|NCT01418209|3749235|B1|0 - 5||Years since final menstrual period (postmenopausal only)||participants|Number|35|35.0||||||
3926436|NCT01418209|3749232|B4|Indeterminate||Menopause status||participants|Number|31|31.0||||||
3926437|NCT01418209|3749233|B3|Indeterminate||Menopause status||participants|Number|14|14.0||||||
3926438|NCT01418209|3749234|B2|Indeterminate||Menopause status||participants|Number|8|8.0||||||
3926439|NCT01418209|3749235|B1|Indeterminate||Menopause status||participants|Number|9|9.0||||||
3926440|NCT01418209|3749232|B4|Postmenopausal||Menopause status||participants|Number|256|256.0||||||
3926441|NCT01418209|3749233|B3|Postmenopausal||Menopause status||participants|Number|110|110.0||||||
3926442|NCT01418209|3749234|B2|Postmenopausal||Menopause status||participants|Number|72|72.0||||||
3926443|NCT01418209|3749235|B1|Postmenopausal||Menopause status||participants|Number|74|74.0||||||
3926444|NCT01418209|3749232|B4|Perimenopausal||Menopause status||participants|Number|52|52.0||||||
3926445|NCT01418209|3749233|B3|Perimenopausal||Menopause status||participants|Number|22|22.0||||||
3926446|NCT01418209|3749234|B2|Perimenopausal||Menopause status||participants|Number|16|16.0||||||
3926447|NCT01418209|3749235|B1|Perimenopausal||Menopause status||participants|Number|14|14.0||||||
3926448|NCT01418209|3749232|B4|Missing||Education||participants|Number|1|1.0||||||
3926449|NCT01418209|3749233|B3|Missing||Education||participants|Number|1|1.0||||||
3926450|NCT01418209|3749234|B2|Missing||Education||participants|Number|0|0.0||||||
3926451|NCT01418209|3749235|B1|Missing||Education||participants|Number|0|0.0||||||
3926452|NCT01418209|3749232|B4|College graduate||Education||participants|Number|172|172.0||||||
3926453|NCT01418209|3749233|B3|College graduate||Education||participants|Number|75|75.0||||||
3926454|NCT01418209|3749234|B2|College graduate||Education||participants|Number|48|48.0||||||
3926455|NCT01418209|3749235|B1|College graduate||Education||participants|Number|49|49.0||||||
3926456|NCT01418209|3749232|B4|<College graduate||Education||participants|Number|166|166.0||||||
3926457|NCT01418209|3749233|B3|<College graduate||Education||participants|Number|70|70.0||||||
3926458|NCT01418209|3749234|B2|<College graduate||Education||participants|Number|48|48.0||||||
3926459|NCT01418209|3749235|B1|<College graduate||Education||participants|Number|48|48.0||||||
3926460|NCT01418209|3749232|B4|Missing||Marital status||participants|Number|2|2.0||||||
3926461|NCT01418209|3749233|B3|Missing||Marital status||participants|Number|1|1.0||||||
3926462|NCT01418209|3749234|B2|Missing||Marital status||participants|Number|0|0.0||||||
3926463|NCT01418209|3749235|B1|Missing||Marital status||participants|Number|1|1.0||||||
3926464|NCT01418209|3749232|B4|Married / living with partner||Marital status||participants|Number|210|210.0||||||
3926465|NCT01418209|3749233|B3|Married / living with partner||Marital status||participants|Number|96|96.0||||||
3926466|NCT01418209|3749234|B2|Married / living with partner||Marital status||participants|Number|56|56.0||||||
3926467|NCT01418209|3749235|B1|Married / living with partner||Marital status||participants|Number|58|58.0||||||
3926468|NCT01418209|3749232|B4|Never married / Divorced / Widowed||Marital status||participants|Number|127|127.0||||||
3926469|NCT01418209|3749233|B3|Never married / Divorced / Widowed||Marital status||participants|Number|49|49.0||||||
3926470|NCT01418209|3749234|B2|Never married / Divorced / Widowed||Marital status||participants|Number|40|40.0||||||
3926471|NCT01418209|3749235|B1|Never married / Divorced / Widowed||Marital status||participants|Number|38|38.0||||||
3926472|NCT01418209|3749232|B4|Missing||Alcohol use (drinks/week)||participants|Number|13|13.0||||||
3926473|NCT01418209|3749233|B3|Missing||Alcohol use (drinks/week)||participants|Number|2|2.0||||||
3926474|NCT01418209|3749234|B2|Missing||Alcohol use (drinks/week)||participants|Number|6|6.0||||||
3926475|NCT01418209|3749235|B1|Missing||Alcohol use (drinks/week)||participants|Number|5|5.0||||||
3926476|NCT01418209|3749232|B4|>=7||Alcohol use (drinks/week)||participants|Number|61|61.0||||||
3926477|NCT01418209|3749233|B3|>=7||Alcohol use (drinks/week)||participants|Number|27|27.0||||||
3926478|NCT01418209|3749234|B2|>=7||Alcohol use (drinks/week)||participants|Number|13|13.0||||||
3926479|NCT01418209|3749235|B1|>=7||Alcohol use (drinks/week)||participants|Number|21|21.0||||||
3926480|NCT01418209|3749232|B4|<7||Alcohol use (drinks/week)||participants|Number|265|265.0||||||
3926481|NCT01418209|3749233|B3|<7||Alcohol use (drinks/week)||participants|Number|117|117.0||||||
3926483|NCT01418209|3749235|B1|<7||Alcohol use (drinks/week)||participants|Number|71|71.0||||||
3926484|NCT01418209|3749232|B4|Missing||Smoking||participants|Number|3|3.0||||||
3926485|NCT01418209|3749233|B3|Missing||Smoking||participants|Number|2|2.0||||||
3926486|NCT01418209|3749234|B2|Missing||Smoking||participants|Number|1|1.0||||||
3926487|NCT01418209|3749235|B1|Missing||Smoking||participants|Number|0|0.0||||||
3926488|NCT01418209|3749232|B4|Current||Smoking||participants|Number|55|55.0||||||
3926489|NCT01418209|3749233|B3|Current||Smoking||participants|Number|24|24.0||||||
3926490|NCT01418209|3749234|B2|Current||Smoking||participants|Number|14|14.0||||||
3926491|NCT01418209|3749235|B1|Current||Smoking||participants|Number|17|17.0||||||
3926492|NCT01418209|3749232|B4|Past||Smoking||participants|Number|107|107.0||||||
3926493|NCT01418209|3749233|B3|Past||Smoking||participants|Number|50|50.0||||||
3926494|NCT01418209|3749234|B2|Past||Smoking||participants|Number|27|27.0||||||
3926495|NCT01418209|3749235|B1|Past||Smoking||participants|Number|30|30.0||||||
3926496|NCT01418209|3749232|B4|Never||Smoking||participants|Number|174|174.0||||||
3926497|NCT01418209|3749233|B3|Never||Smoking||participants|Number|70|70.0||||||
3926498|NCT01418209|3749234|B2|Never||Smoking||participants|Number|54|54.0||||||
3926499|NCT01418209|3749235|B1|Never||Smoking||participants|Number|50|50.0||||||
3926500|NCT01418209|3749232|B4|||Body Mass Index (BMI)||kg/m^2|Mean|28.3|28.3|Standard Deviation|6.8|6.8|||
3926501|NCT01418209|3749233|B3|||Body Mass Index (BMI)||kg/m^2|Mean|27.6|27.6|Standard Deviation|6.8|6.8|||
3926502|NCT01418209|3749234|B2|||Body Mass Index (BMI)||kg/m^2|Mean|29.3|29.3|Standard Deviation|6.9|6.9|||
3926503|NCT01418209|3749235|B1|||Body Mass Index (BMI)||kg/m^2|Mean|28.5|28.5|Standard Deviation|6.5|6.5|||
3926504|NCT01418209|3749232|B4|United States||Region of Enrollment||participants|Number|339|339.0||||||
3926505|NCT01418209|3749233|B3|United States||Region of Enrollment||participants|Number|146|146.0||||||
3926506|NCT01418209|3749234|B2|United States||Region of Enrollment||participants|Number|96|96.0||||||
3926507|NCT01418209|3749235|B1|United States||Region of Enrollment||participants|Number|97|97.0||||||
3926508|NCT01418209|3749232|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3926509|NCT01418209|3749233|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3926510|NCT01418209|3749234|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3926511|NCT01418209|3749235|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3926512|NCT01418209|3749232|B4||Female|Sex: Female, Male||Participants|Count of Participants|339|339.0||||||
3926513|NCT01418209|3749233|B3||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3926514|NCT01418209|3749234|B2||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3926515|NCT01418209|3749235|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3926516|NCT01418209|3749232|B4|||Age||years|Mean|54.6|54.6|Standard Deviation|3.8|3.8|||
3926517|NCT01418209|3749233|B3|||Age||years|Mean|54.3|54.3|Standard Deviation|3.8|3.8|||
3926518|NCT01418209|3749234|B2|||Age||years|Mean|54.8|54.8|Standard Deviation|3.7|3.7|||
3926519|NCT01418209|3749235|B1|||Age||years|Mean|54.9|54.9|Standard Deviation|4.1|4.1|||
3926520|NCT01418001|3749266|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3926521|NCT01418001|3749266|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3926522|NCT01418001|3749266|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3926523|NCT01418001|3749266|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3926524|NCT01418001|3749266|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3926525|NCT01417936|3749271|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3926526|NCT01417936|3749271|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3926527|NCT01417936|3749271|B1|||Age||years|Mean|62.0|62.0|Standard Deviation|10.0|10.0|||
3926528|NCT01417481|3749290|B3|Mexico||Region of Enrollment||participants|Number|15|15.0||||||
3926529|NCT01417481|3749291|B2|Mexico||Region of Enrollment||participants|Number|7|7.0||||||
3926530|NCT01417481|3749292|B1|Mexico||Region of Enrollment||participants|Number|8|8.0||||||
3926531|NCT01417481|3749290|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3926532|NCT01417481|3749291|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3926533|NCT01417481|3749292|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3926534|NCT01417481|3749290|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3926535|NCT01417481|3749291|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3926536|NCT01417481|3749292|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3926537|NCT01417481|3749290|B3|||Age||years|Mean|12.81|12.81|Standard Deviation|5.19|5.19|||
3926538|NCT01417481|3749291|B2|||Age||years|Mean|11.00|11.0|Standard Deviation|4.01|4.01|||
3926539|NCT01417481|3749292|B1|||Age||years|Mean|14.39|14.39|Standard Deviation|5.82|5.82|||
3926540|NCT01417481|3749290|B3||>=65 years|Age|During the course of the study, inclusion criteria was expanded to include subjects older than 15 years of age.|Participants|Count of Participants|0|0.0||||||
3926541|NCT01417481|3749291|B2||>=65 years|Age|During the course of the study, inclusion criteria was expanded to include subjects older than 15 years of age.|Participants|Count of Participants|0|0.0||||||
3926542|NCT01417481|3749292|B1||>=65 years|Age|During the course of the study, inclusion criteria was expanded to include subjects older than 15 years of age.|Participants|Count of Participants|0|0.0||||||
3926543|NCT01417481|3749290|B3||Between 18 and 65 years|Age|During the course of the study, inclusion criteria was expanded to include subjects older than 15 years of age.|Participants|Count of Participants|2|2.0||||||
3926625|NCT01417195|3749366|B2|No||Ever Smoked?||participants|Number|56|56.0||||||
3926544|NCT01417481|3749291|B2||Between 18 and 65 years|Age|During the course of the study, inclusion criteria was expanded to include subjects older than 15 years of age.|Participants|Count of Participants|0|0.0||||||
3926545|NCT01417481|3749292|B1||Between 18 and 65 years|Age|During the course of the study, inclusion criteria was expanded to include subjects older than 15 years of age.|Participants|Count of Participants|2|2.0||||||
3926546|NCT01417481|3749290|B3||<=18 years|Age|During the course of the study, inclusion criteria was expanded to include subjects older than 15 years of age.|Participants|Count of Participants|13|13.0||||||
3926547|NCT01417481|3749291|B2||<=18 years|Age|During the course of the study, inclusion criteria was expanded to include subjects older than 15 years of age.|Participants|Count of Participants|7|7.0||||||
3926548|NCT01417481|3749292|B1||<=18 years|Age|During the course of the study, inclusion criteria was expanded to include subjects older than 15 years of age.|Participants|Count of Participants|6|6.0||||||
3926549|NCT01417455|3749317|B9|||Symptoms duration (years)||years|Median|NA||Inter-Quartile Range|||0.0|0.0|Total Symptom duration is not a valid measure because we are measuring patients with different therapies (that is the study purpose) and Healthy donors have no measure of symptom duration.
3926550|NCT01417455|3749318|B8|||Symptoms duration (years)||years|Median|NA||Inter-Quartile Range|||0.0|0.0|Healthy donors have no measurement for this parameter
3926551|NCT01417455|3749319|B7|||Symptoms duration (years)||years|Median|11|11.0|Inter-Quartile Range|||8.0|22.0|
3926552|NCT01417455|3749320|B6|||Symptoms duration (years)||years|Median|10|10.0|Inter-Quartile Range|||7.0|21.0|
3926553|NCT01417455|3749321|B5|||Symptoms duration (years)||years|Median|11|11.0|Inter-Quartile Range|||8.0|21.0|
3926554|NCT01417455|3749322|B4|||Symptoms duration (years)||years|Median|7|7.0|Inter-Quartile Range|||5.0|8.0|
3926555|NCT01417455|3749323|B3|||Symptoms duration (years)||years|Median|6|6.0|Inter-Quartile Range|||4.0|7.0|
3926556|NCT01417455|3749324|B2|||Symptoms duration (years)||years|Median|1.3|1.3|Inter-Quartile Range|||0.8|1.5|
3926557|NCT01417455|3749325|B1|||Symptoms duration (years)||years|Median|0.8|0.8|Inter-Quartile Range|||0.2|1.0|
3926558|NCT01417455|3749317|B9|||CRP (mg/dl)||mg/dl|Median|NA||Inter-Quartile Range|||0.0|0.0|Total CRP is not a valid measure because we are measuring patients with different therapies (that is the study purpose) and Healthy donors have no measure of CRP.
3926559|NCT01417455|3749318|B8|||CRP (mg/dl)||mg/dl|Median|NA||Inter-Quartile Range|||0.0|0.0|Healthy donors have no measurement for this parameter
3926560|NCT01417455|3749319|B7|||CRP (mg/dl)||mg/dl|Median|0.1|0.1|Inter-Quartile Range|||0.0|0.6|
3926561|NCT01417455|3749320|B6|||CRP (mg/dl)||mg/dl|Median|1.4|1.4|Inter-Quartile Range|||0.1|3.0|
3926562|NCT01417455|3749321|B5|||CRP (mg/dl)||mg/dl|Median|0.8|0.8|Inter-Quartile Range|||0.2|1.7|
3926563|NCT01417455|3749322|B4|||CRP (mg/dl)||mg/dl|Median|0.3|0.3|Inter-Quartile Range|||0.0|0.7|
3926564|NCT01417455|3749323|B3|||CRP (mg/dl)||mg/dl|Median|1.4|1.4|Inter-Quartile Range|||0.7|1.8|
3926565|NCT01417455|3749324|B2|||CRP (mg/dl)||mg/dl|Median|0.2|0.2|Inter-Quartile Range|||0.1|0.3|
3926566|NCT01417455|3749325|B1|||CRP (mg/dl)||mg/dl|Median|0.3|0.3|Inter-Quartile Range|||0.1|2.7|
3926567|NCT01417455|3749317|B9|||ESR (mm/hr)||mm/hr|Median|NA||Inter-Quartile Range|||0.0|0.0|Total ESR is not a valid measure because we are measuring patients with different therapies (that is the study purpose) and Healthy donors have no measure of ESR.
3926568|NCT01417455|3749318|B8|||ESR (mm/hr)||mm/hr|Median|NA||Inter-Quartile Range|||0.0|0.0|Healthy donors did not measure this parameter
3926569|NCT01417455|3749319|B7|||ESR (mm/hr)||mm/hr|Median|7|7.0|Inter-Quartile Range|||4.0|17.0|
3926570|NCT01417455|3749320|B6|||ESR (mm/hr)||mm/hr|Median|30|30.0|Inter-Quartile Range|||14.0|54.0|
3926571|NCT01417455|3749321|B5|||ESR (mm/hr)||mm/hr|Median|23|23.0|Inter-Quartile Range|||11.0|28.0|
3926572|NCT01417455|3749322|B4|||ESR (mm/hr)||mm/hr|Median|21|21.0|Inter-Quartile Range|||15.0|26.0|
3926573|NCT01417455|3749323|B3|||ESR (mm/hr)||mm/hr|Median|25|25.0|Inter-Quartile Range|||19.0|41.0|
3926574|NCT01417455|3749324|B2|||ESR (mm/hr)||mm/hr|Median|13|13.0|Inter-Quartile Range|||9.0|27.0|
3926575|NCT01417455|3749325|B1|||ESR (mm/hr)||mm/hr|Median|22|22.0|Inter-Quartile Range|||11.0|44.0|
3926576|NCT01417455|3749317|B9|||Disease activity|"DAS28 for RA. 28 joints included. tender and swollen joint count (TEN28, SWO28). Erythrocyte sedimentation rate (ESR) is measured. The patient makes a subjective assessment (SA) of disease activity.~DAS28 ≤ 3.2 Inactive > 3.2 but ≤ 5.1 Moderate > 5.1 Very active~ASDAS for AS. Combines five disease activity variables in one single score~ASDAS~≤ 3.1Inactive > 3.1 but ≤ 2.1 Moderate > 2.1 but ≤ 3.5 Moderate > 3.5 Very active"|units on a scale|Median|NA||Inter-Quartile Range|||0.0|0.0|Total Disease activity is not a valid measure because we are measuring patients with different therapies (that is the study purpose) and Healthy donors have no Disease activity.
3926577|NCT01417455|3749318|B8|||Disease activity|"DAS28 for RA. 28 joints included. tender and swollen joint count (TEN28, SWO28). Erythrocyte sedimentation rate (ESR) is measured. The patient makes a subjective assessment (SA) of disease activity.~DAS28 ≤ 3.2 Inactive > 3.2 but ≤ 5.1 Moderate > 5.1 Very active~ASDAS for AS. Combines five disease activity variables in one single score~ASDAS~≤ 3.1Inactive > 3.1 but ≤ 2.1 Moderate > 2.1 but ≤ 3.5 Moderate > 3.5 Very active"|units on a scale|Median|NA||Inter-Quartile Range|||0.0|0.0|Healthy donors have no disease activity
3926578|NCT01417455|3749319|B7|||Disease activity|"DAS28 for RA. 28 joints included. tender and swollen joint count (TEN28, SWO28). Erythrocyte sedimentation rate (ESR) is measured. The patient makes a subjective assessment (SA) of disease activity.~DAS28 ≤ 3.2 Inactive > 3.2 but ≤ 5.1 Moderate > 5.1 Very active~ASDAS for AS. Combines five disease activity variables in one single score~ASDAS~≤ 3.1Inactive > 3.1 but ≤ 2.1 Moderate > 2.1 but ≤ 3.5 Moderate > 3.5 Very active"|units on a scale|Median|1.7|1.7|Inter-Quartile Range|||1.4|1.9|
3926579|NCT01417455|3749320|B6|||Disease activity|"DAS28 for RA. 28 joints included. tender and swollen joint count (TEN28, SWO28). Erythrocyte sedimentation rate (ESR) is measured. The patient makes a subjective assessment (SA) of disease activity.~DAS28 ≤ 3.2 Inactive > 3.2 but ≤ 5.1 Moderate > 5.1 Very active~ASDAS for AS. Combines five disease activity variables in one single score~ASDAS~≤ 3.1Inactive > 3.1 but ≤ 2.1 Moderate > 2.1 but ≤ 3.5 Moderate > 3.5 Very active"|units on a scale|Median|3.8|3.8|Inter-Quartile Range|||2.2|4.3|
3926580|NCT01417455|3749321|B5|||Disease activity|"DAS28 for RA. 28 joints included. tender and swollen joint count (TEN28, SWO28). Erythrocyte sedimentation rate (ESR) is measured. The patient makes a subjective assessment (SA) of disease activity.~DAS28 ≤ 3.2 Inactive > 3.2 but ≤ 5.1 Moderate > 5.1 Very active~ASDAS for AS. Combines five disease activity variables in one single score~ASDAS~≤ 3.1Inactive > 3.1 but ≤ 2.1 Moderate > 2.1 but ≤ 3.5 Moderate > 3.5 Very active"|units on a scale|Median|5.8|5.8|Inter-Quartile Range|||3.7|7.3|
3926581|NCT01417455|3749322|B4|||Disease activity|"DAS28 for RA. 28 joints included. tender and swollen joint count (TEN28, SWO28). Erythrocyte sedimentation rate (ESR) is measured. The patient makes a subjective assessment (SA) of disease activity.~DAS28 ≤ 3.2 Inactive > 3.2 but ≤ 5.1 Moderate > 5.1 Very active~ASDAS for AS. Combines five disease activity variables in one single score~ASDAS~≤ 3.1Inactive > 3.1 but ≤ 2.1 Moderate > 2.1 but ≤ 3.5 Moderate > 3.5 Very active"|units on a scale|Median|2.9|2.9|Inter-Quartile Range|||2.3|3.2|
3926582|NCT01417455|3749323|B3|||Disease activity|"DAS28 for RA. 28 joints included. tender and swollen joint count (TEN28, SWO28). Erythrocyte sedimentation rate (ESR) is measured. The patient makes a subjective assessment (SA) of disease activity.~DAS28 ≤ 3.2 Inactive > 3.2 but ≤ 5.1 Moderate > 5.1 Very active~ASDAS for AS. Combines five disease activity variables in one single score~ASDAS~≤ 3.1Inactive > 3.1 but ≤ 2.1 Moderate > 2.1 but ≤ 3.5 Moderate > 3.5 Very active"|units on a scale|Median|5.7|5.7|Inter-Quartile Range|||5.3|6.0|
3926583|NCT01417455|3749324|B2|||Disease activity|"DAS28 for RA. 28 joints included. tender and swollen joint count (TEN28, SWO28). Erythrocyte sedimentation rate (ESR) is measured. The patient makes a subjective assessment (SA) of disease activity.~DAS28 ≤ 3.2 Inactive > 3.2 but ≤ 5.1 Moderate > 5.1 Very active~ASDAS for AS. Combines five disease activity variables in one single score~ASDAS~≤ 3.1Inactive > 3.1 but ≤ 2.1 Moderate > 2.1 but ≤ 3.5 Moderate > 3.5 Very active"|units on a scale|Median|2.4|2.4|Inter-Quartile Range|||2.1|3.6|
3926584|NCT01417455|3749325|B1|||Disease activity|"DAS28 for RA. 28 joints included. tender and swollen joint count (TEN28, SWO28). Erythrocyte sedimentation rate (ESR) is measured. The patient makes a subjective assessment (SA) of disease activity.~DAS28 ≤ 3.2 Inactive > 3.2 but ≤ 5.1 Moderate > 5.1 Very active~ASDAS for AS. Combines five disease activity variables in one single score~ASDAS~≤ 3.1Inactive > 3.1 but ≤ 2.1 Moderate > 2.1 but ≤ 3.5 Moderate > 3.5 Very active"|units on a scale|Median|4.7|4.7|Inter-Quartile Range|||4.2|5.4|
3926585|NCT01417455|3749317|B9||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3926586|NCT01417455|3749318|B8||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3926587|NCT01417455|3749319|B7||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3926588|NCT01417455|3749320|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3926589|NCT01417455|3749321|B5||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3926590|NCT01417455|3749322|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3926591|NCT01417455|3749323|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3926592|NCT01417455|3749324|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3926593|NCT01417455|3749325|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3926594|NCT01417455|3749317|B9||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3926595|NCT01417455|3749318|B8||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3926596|NCT01417455|3749319|B7||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3926597|NCT01417455|3749320|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3926598|NCT01417455|3749321|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3926599|NCT01417455|3749322|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3926600|NCT01417455|3749323|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3926601|NCT01417455|3749324|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3926602|NCT01417455|3749325|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3926603|NCT01417455|3749317|B9|||Age||years|Median|45|45.0|Inter-Quartile Range|||35.0|55.0|
3926604|NCT01417455|3749318|B8|||Age||years|Median|45|45.0|Inter-Quartile Range|||36.0|53.0|
3926605|NCT01417455|3749319|B7|||Age||years|Median|37|37.0|Inter-Quartile Range|||33.0|43.0|
3926606|NCT01417455|3749320|B6|||Age||years|Median|37|37.0|Inter-Quartile Range|||33.0|43.0|
3926607|NCT01417455|3749321|B5|||Age||years|Median|40|40.0|Inter-Quartile Range|||33.0|51.0|
3926608|NCT01417455|3749322|B4|||Age||years|Median|50|50.0|Inter-Quartile Range|||42.0|63.0|
3926609|NCT01417455|3749323|B3|||Age||years|Median|50|50.0|Inter-Quartile Range|||42.0|63.0|
3926610|NCT01417455|3749324|B2|||Age||years|Median|50|50.0|Inter-Quartile Range|||32.0|60.0|
3926611|NCT01417455|3749325|B1|||Age||years|Median|50|50.0|Inter-Quartile Range|||32.0|60.0|
3926612|NCT01417377|3749358|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3926613|NCT01417377|3749358|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3926614|NCT01417377|3749358|B1|||Age|Number of participants analyzed for this baseline characteristic were 21, as the age data were available only for treated participants.|years|Mean|55.2|55.2|Standard Deviation|16.8|16.8|||
3926615|NCT01417195|3749365|B3|Yes||Current Drinkers||participants|Number|96|96.0||||||
3926616|NCT01417195|3749366|B2|Yes||Current Drinkers||participants|Number|51|51.0||||||
3926617|NCT01417195|3749367|B1|Yes||Current Drinkers||participants|Number|45|45.0||||||
3926618|NCT01417195|3749365|B3|No||Current Drinkers||participants|Number|26|26.0||||||
3926619|NCT01417195|3749366|B2|No||Current Drinkers||participants|Number|11|11.0||||||
3926620|NCT01417195|3749367|B1|No||Current Drinkers||participants|Number|15|15.0||||||
3926621|NCT01417195|3749365|B3|Yes||Ever Smoked?||participants|Number|14|14.0||||||
3926622|NCT01417195|3749366|B2|Yes||Ever Smoked?||participants|Number|6|6.0||||||
3926623|NCT01417195|3749367|B1|Yes||Ever Smoked?||participants|Number|8|8.0||||||
3926624|NCT01417195|3749365|B3|No||Ever Smoked?||participants|Number|108|108.0||||||
3926626|NCT01417195|3749367|B1|No||Ever Smoked?||participants|Number|52|52.0||||||
3926627|NCT01417195|3749365|B3|Yes||Current Smokers||participants|Number|9|9.0||||||
3926628|NCT01417195|3749366|B2|Yes||Current Smokers||participants|Number|5|5.0||||||
3926629|NCT01417195|3749367|B1|Yes||Current Smokers||participants|Number|4|4.0||||||
3926630|NCT01417195|3749365|B3|No||Current Smokers||participants|Number|113|113.0||||||
3926631|NCT01417195|3749366|B2|No||Current Smokers||participants|Number|57|57.0||||||
3926632|NCT01417195|3749367|B1|No||Current Smokers||participants|Number|56|56.0||||||
3926633|NCT01417195|3749365|B3|>30 to <=35 kg/m^2||Body Mass Index||participants|Number|18|18.0||||||
3926634|NCT01417195|3749366|B2|>30 to <=35 kg/m^2||Body Mass Index||participants|Number|10|10.0||||||
3926635|NCT01417195|3749367|B1|>30 to <=35 kg/m^2||Body Mass Index||participants|Number|8|8.0||||||
3926636|NCT01417195|3749365|B3|>25 to <=30 kg/m^2||Body Mass Index||participants|Number|42|42.0||||||
3926637|NCT01417195|3749366|B2|>25 to <=30 kg/m^2||Body Mass Index||participants|Number|23|23.0||||||
3926638|NCT01417195|3749367|B1|>25 to <=30 kg/m^2||Body Mass Index||participants|Number|19|19.0||||||
3926639|NCT01417195|3749365|B3|18 to <=25 kg/m^2||Body Mass Index||participants|Number|62|62.0||||||
3926640|NCT01417195|3749366|B2|18 to <=25 kg/m^2||Body Mass Index||participants|Number|29|29.0||||||
3926641|NCT01417195|3749367|B1|18 to <=25 kg/m^2||Body Mass Index||participants|Number|33|33.0||||||
3926642|NCT01417195|3749365|B3|United States||Region of Enrollment||participants|Number|122|122.0||||||
3926643|NCT01417195|3749366|B2|United States||Region of Enrollment||participants|Number|62|62.0||||||
3926644|NCT01417195|3749367|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
3926645|NCT01417195|3749365|B3|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|113|113.0||||||
3926646|NCT01417195|3749366|B2|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
3926647|NCT01417195|3749367|B1|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
3926648|NCT01417195|3749365|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3926649|NCT01417195|3749366|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3926650|NCT01417195|3749367|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3926651|NCT01417195|3749365|B3|Asian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3926652|NCT01417195|3749366|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3926653|NCT01417195|3749367|B1|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3926654|NCT01417195|3749365|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3926655|NCT01417195|3749366|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3926656|NCT01417195|3749367|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3926657|NCT01417195|3749365|B3|White/Caucasian||Race/Ethnicity, Customized||participants|Number|89|89.0||||||
3926658|NCT01417195|3749366|B2|White/Caucasian||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
3926659|NCT01417195|3749367|B1|White/Caucasian||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
3926660|NCT01417195|3749365|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3926661|NCT01417195|3749366|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3926662|NCT01417195|3749367|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3926663|NCT01417195|3749365|B3||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3926664|NCT01417195|3749366|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3926665|NCT01417195|3749367|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3926666|NCT01417195|3749365|B3|>40 years||Age, Customized||participants|Number|4|4.0||||||
3926667|NCT01417195|3749366|B2|>40 years||Age, Customized||participants|Number|1|1.0||||||
3926668|NCT01417195|3749367|B1|>40 years||Age, Customized||participants|Number|3|3.0||||||
3926669|NCT01417195|3749365|B3|38 to 40 years||Age, Customized||participants|Number|15|15.0||||||
3926670|NCT01417195|3749366|B2|38 to 40 years||Age, Customized||participants|Number|6|6.0||||||
3926671|NCT01417195|3749367|B1|38 to 40 years||Age, Customized||participants|Number|9|9.0||||||
3926672|NCT01417195|3749365|B3|35 to 37 years||Age, Customized||participants|Number|28|28.0||||||
3926673|NCT01417195|3749366|B2|35 to 37 years||Age, Customized||participants|Number|15|15.0||||||
3926674|NCT01417195|3749367|B1|35 to 37 years||Age, Customized||participants|Number|13|13.0||||||
3926675|NCT01417195|3749365|B3|<35 years||Age, Customized||participants|Number|75|75.0||||||
3926676|NCT01417195|3749366|B2|<35 years||Age, Customized||participants|Number|40|40.0||||||
3926677|NCT01417195|3749367|B1|<35 years||Age, Customized||participants|Number|35|35.0||||||
3926678|NCT01417156|3749384|B1||Male|Gender||Participants|Count of Participants|14|14.0||||||
3926679|NCT01417156|3749384|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
3926680|NCT01417156|3749384|B1|||Age||Years|Mean|65.8|65.8|Standard Deviation|9.5|9.5|||
3926681|NCT01417104|3749392|B3|United States||Region of Enrollment||participants|Number|71|71.0||||||
3926682|NCT01417104|3749393|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
3926683|NCT01417104|3749394|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
3926684|NCT01417104|3749392|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3926685|NCT01417104|3749393|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3926686|NCT01417104|3749394|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3926687|NCT01417104|3749392|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3926688|NCT01417104|3749393|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3926689|NCT01417104|3749394|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3926690|NCT01417104|3749392|B3|||Age||years|Mean|64.18|64.18|Standard Deviation|10.17|10.17|||
3926691|NCT01417104|3749393|B2|||Age||years|Mean|64.5|64.5|Standard Deviation|8.9|8.9|||
3926692|NCT01417104|3749394|B1|||Age||years|Mean|63.9|63.9|Standard Deviation|11.5|11.5|||
3926693|NCT01417104|3749392|B3||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
3926694|NCT01417104|3749393|B2||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3926695|NCT01417104|3749394|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3926696|NCT01417104|3749392|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3926697|NCT01417104|3749393|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3926698|NCT01417104|3749394|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3926699|NCT01417104|3749392|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3926700|NCT01417104|3749393|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3926701|NCT01417104|3749394|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3926702|NCT01417078|3749405|B1|||Body Mass Index (BMI)||(kg/m^2)|Mean|26.3|26.3|Standard Deviation|4.08|4.08|||
3926703|NCT01417078|3749405|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3926704|NCT01417078|3749405|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3926705|NCT01417078|3749405|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3926706|NCT01417078|3749405|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3926707|NCT01417078|3749405|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3926708|NCT01417078|3749405|B1|||Age||years|Mean|35.2|35.2|Standard Deviation|12.80|12.8|||
3926709|NCT01417026|3749415|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
3926710|NCT01417026|3749416|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3926711|NCT01417026|3749417|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3926712|NCT01417026|3749415|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3926713|NCT01417026|3749416|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3926714|NCT01417026|3749417|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3926715|NCT01417026|3749415|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3926716|NCT01417026|3749416|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3926717|NCT01417026|3749417|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3926718|NCT01417026|3749415|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3926719|NCT01417026|3749416|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3926720|NCT01417026|3749417|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3926721|NCT01417026|3749415|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3926722|NCT01417026|3749416|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3926723|NCT01417026|3749417|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3926724|NCT01417026|3749415|B3||<=18 years|Age||Participants|Count of Participants|27|27.0||||||
3926725|NCT01417026|3749416|B2||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
3926726|NCT01417026|3749417|B1||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
3926727|NCT01417000|3749428|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3926728|NCT01417000|3749429|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3926729|NCT01417000|3749430|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3926730|NCT01417000|3749428|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3926731|NCT01417000|3749429|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3926732|NCT01417000|3749430|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3926733|NCT01417000|3749428|B3|||Age||years|Median|63.8|63.8|Standard Deviation|9.13|9.13|||
3926734|NCT01417000|3749429|B2|||Age||years|Median|63.9|63.9|Standard Deviation|9.29|9.29|||
3926735|NCT01417000|3749430|B1|||Age||years|Median|63.7|63.7|Standard Deviation|9.14|9.14|||
3926736|NCT01416610|3749439|B1|Austria||Region of Enrollment||participants|Number|88|88.0||||||
3926737|NCT01416610|3749439|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3926738|NCT01416610|3749439|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3926739|NCT01416610|3749439|B1|||Age||years|Mean|34.6|34.6|Standard Deviation|8.5|8.5|||
3926740|NCT01416584|3749453|B4|United States||Region of Enrollment||participants|Number|98|98.0||||||
3926741|NCT01416584|3749454|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
3926742|NCT01416584|3749455|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
3926743|NCT01416584|3749456|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3926744|NCT01416584|3749453|B4||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3926745|NCT01416584|3749454|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3926746|NCT01416584|3749455|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3926747|NCT01416584|3749456|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3926748|NCT01416584|3749453|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3926749|NCT01416584|3749454|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3926750|NCT01416584|3749455|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3926751|NCT01416584|3749456|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3926752|NCT01416584|3749453|B4|||Age||years|Mean|44|44.0|Standard Deviation|9|9.0|||
3926753|NCT01416584|3749454|B3|||Age||years|Mean|44|44.0|Standard Deviation|9|9.0|||
3926754|NCT01416584|3749455|B2|||Age||years|Mean|42|42.0|Standard Deviation|10|10.0|||
3926755|NCT01416584|3749456|B1|||Age||years|Mean|44|44.0|Standard Deviation|9|9.0|||
3926756|NCT01416584|3749453|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3926757|NCT01416584|3749454|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3926758|NCT01416584|3749455|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3926759|NCT01416584|3749456|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3926760|NCT01416584|3749453|B4||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
3926761|NCT01416584|3749454|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3926762|NCT01416584|3749455|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3926763|NCT01416584|3749456|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3926764|NCT01416584|3749453|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3926765|NCT01416584|3749454|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3926766|NCT01416584|3749455|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3926767|NCT01416584|3749456|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3926768|NCT01416571|3749493|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3926769|NCT01416571|3749493|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3926770|NCT01416571|3749493|B1|||Age||Years|Mean|40.6|40.6|Standard Deviation|13.05|13.05|||
3926771|NCT01416389|3749520|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
3926772|NCT01416389|3749521|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3926773|NCT01416389|3749522|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
3926774|NCT01416389|3749520|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926775|NCT01416389|3749521|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926776|NCT01416389|3749522|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926777|NCT01416389|3749520|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926778|NCT01416389|3749521|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926779|NCT01416389|3749522|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926780|NCT01416389|3749520|B3||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3926781|NCT01416389|3749521|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3926782|NCT01416389|3749522|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3926783|NCT01416389|3749520|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3926784|NCT01416389|3749521|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3926785|NCT01416389|3749522|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3926786|NCT01416389|3749520|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926787|NCT01416389|3749521|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926788|NCT01416389|3749522|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926789|NCT01416389|3749520|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926790|NCT01416389|3749521|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926791|NCT01416389|3749522|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926792|NCT01416389|3749520|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926793|NCT01416389|3749521|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926794|NCT01416389|3749522|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926795|NCT01416389|3749520|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926796|NCT01416389|3749521|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926797|NCT01416389|3749522|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926798|NCT01416389|3749520|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3926799|NCT01416389|3749521|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3926800|NCT01416389|3749522|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3926801|NCT01416389|3749520|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926802|NCT01416389|3749521|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926803|NCT01416389|3749522|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926804|NCT01416389|3749520|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3926805|NCT01416389|3749521|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3926806|NCT01416389|3749522|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3926807|NCT01416389|3749520|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3926808|NCT01416389|3749521|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3926809|NCT01416389|3749522|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3926810|NCT01416389|3749520|B3|||Age||years|Mean|60.8|60.8|Standard Deviation|10|10.0|||
3926811|NCT01416389|3749521|B2|||Age||years|Mean|57.8|57.8|Standard Deviation|9.9|9.9|||
3926812|NCT01416389|3749522|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|9.9|9.9|||
3926813|NCT01416272|3749540|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3926814|NCT01416272|3749540|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3926815|NCT01416272|3749540|B1|||Age||years|Mean|48|48.0|Full Range|||33.0|63.0|
3926816|NCT01416181|3749546|B3||Male|Sex: Female, Male||Participants|Count of Participants|338|338.0||||||
3926817|NCT01416181|3749547|B2||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3926818|NCT01416181|3749548|B1||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3926819|NCT01416181|3749546|B3||Female|Sex: Female, Male||Participants|Count of Participants|550|550.0||||||
3926820|NCT01416181|3749547|B2||Female|Sex: Female, Male||Participants|Count of Participants|270|270.0||||||
3926821|NCT01416181|3749548|B1||Female|Sex: Female, Male||Participants|Count of Participants|280|280.0||||||
3926822|NCT01416181|3749546|B3|≥ 50 years||Age, Customized||participants|Number|389|389.0||||||
3926823|NCT01416181|3749547|B2|≥ 50 years||Age, Customized||participants|Number|185|185.0||||||
3926824|NCT01416181|3749548|B1|≥ 50 years||Age, Customized||participants|Number|204|204.0||||||
3926825|NCT01416181|3749546|B3|40 - 49 years||Age, Customized||participants|Number|356|356.0||||||
3926826|NCT01416181|3749547|B2|40 - 49 years||Age, Customized||participants|Number|194|194.0||||||
3926827|NCT01416181|3749548|B1|40 - 49 years||Age, Customized||participants|Number|162|162.0||||||
3926828|NCT01416181|3749546|B3|30 - 39 years||Age, Customized||participants|Number|123|123.0||||||
3926829|NCT01416181|3749547|B2|30 - 39 years||Age, Customized||participants|Number|50|50.0||||||
3926830|NCT01416181|3749548|B1|30 - 39 years||Age, Customized||participants|Number|73|73.0||||||
3926831|NCT01416181|3749546|B3|20 - 29 years||Age, Customized||participants|Number|20|20.0||||||
3926832|NCT01416181|3749547|B2|20 - 29 years||Age, Customized||participants|Number|10|10.0||||||
3926833|NCT01416181|3749548|B1|20 - 29 years||Age, Customized||participants|Number|10|10.0||||||
3926834|NCT01416155|3749611|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3926835|NCT01416155|3749611|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3926836|NCT01416155|3749611|B1|>= 60 years||Age, Customized||participants|Number|1|1.0||||||
3926837|NCT01416155|3749611|B1|50 to 59 years||Age, Customized||participants|Number|7|7.0||||||
3926838|NCT01416155|3749611|B1|40 to 49 years||Age, Customized||participants|Number|28|28.0||||||
3926839|NCT01416155|3749611|B1|30 to 39 years||Age, Customized||participants|Number|44|44.0||||||
3926840|NCT01416155|3749611|B1|20 to 29 years||Age, Customized||participants|Number|16|16.0||||||
3926841|NCT01416155|3749611|B1|18 to 19 years||Age, Customized||participants|Number|1|1.0||||||
3926842|NCT01416155|3749611|B1|||Age||years|Mean|37.2|37.2|Standard Deviation|8.67|8.67|||
3926843|NCT01416142|3749618|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3926844|NCT01416142|3749618|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3926845|NCT01416142|3749618|B1|||Age||years|Mean|19.5|19.5|Standard Deviation|4.2|4.2|||
3926846|NCT01416129|3749629|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3926847|NCT01416129|3749630|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3926848|NCT01416129|3749631|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3926849|NCT01416129|3749629|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3926850|NCT01416129|3749630|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3926851|NCT01416129|3749631|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3926852|NCT01416129|3749629|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3926853|NCT01416129|3749630|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3926854|NCT01416129|3749631|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3926855|NCT01416129|3749629|B3|||Age||years|Mean|42.9|42.9|Standard Deviation|14.7|14.7|||
3926856|NCT01416129|3749630|B2|||Age||years|Mean|42.9|42.9|Standard Deviation|14.7|14.7|||
3926857|NCT01416129|3749631|B1|||Age||years|Mean|42.9|42.9|Standard Deviation|14.7|14.7|||
3926858|NCT01416129|3749629|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3926859|NCT01416129|3749630|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3926860|NCT01416129|3749631|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3926861|NCT01416129|3749629|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3926862|NCT01416129|3749630|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3926863|NCT01416129|3749631|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3926864|NCT01416129|3749629|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3926865|NCT01416129|3749630|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3926866|NCT01416129|3749631|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3926867|NCT01416025|3749638|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
3926868|NCT01416025|3749639|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3926869|NCT01416025|3749640|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3926870|NCT01416025|3749638|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3926871|NCT01416025|3749639|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3926872|NCT01416025|3749640|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3926873|NCT01416025|3749638|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3926874|NCT01416025|3749639|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3926875|NCT01416025|3749640|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3926876|NCT01416025|3749638|B3|||Age||years|Mean|62.5|62.5|Full Range|||28.0|84.0|
3926877|NCT01416025|3749639|B2|||Age||years|Mean|59.1|59.1|Full Range|||28.0|84.0|
3926878|NCT01416025|3749640|B1|||Age||years|Mean|63.4|63.4|Full Range|||49.0|83.0|
3926879|NCT01416025|3749638|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3926880|NCT01416025|3749639|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3926881|NCT01416025|3749640|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3926882|NCT01416025|3749638|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3926883|NCT01416025|3749639|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3926884|NCT01416025|3749640|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3926885|NCT01416025|3749638|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3926886|NCT01416025|3749639|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3926887|NCT01416025|3749640|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3926888|NCT01415986|3749647|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3926889|NCT01415986|3749647|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3926890|NCT01415986|3749647|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3926891|NCT01415986|3749647|B1|||Age||years|Mean|65|65.0|Standard Deviation|0|0.0|||
3926892|NCT01415986|3749647|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3926893|NCT01415986|3749647|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3926894|NCT01415986|3749647|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3926895|NCT01415960|3749652|B1|United States||Region of Enrollment||participants|Number|161|161.0||||||
3926896|NCT01415960|3749652|B1||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3926897|NCT01415960|3749652|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3926898|NCT01415960|3749652|B1|||Age||years|Mean|71|71.0|Standard Deviation|9.02|9.02|||
3926899|NCT01415960|3749652|B1||>=65 years|Age||Participants|Count of Participants|119|119.0||||||
3926900|NCT01415960|3749652|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3926901|NCT01415960|3749652|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3926902|NCT01415934|3749662|B3|United States||Region of Enrollment||participants|Number|381|381.0||||||
3926903|NCT01415934|3749663|B2|United States||Region of Enrollment||participants|Number|189|189.0||||||
3926904|NCT01415934|3749664|B1|United States||Region of Enrollment||participants|Number|192|192.0||||||
3926905|NCT01415934|3749662|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3926906|NCT01415934|3749663|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3926907|NCT01415934|3749664|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3926908|NCT01415934|3749662|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3926909|NCT01415934|3749663|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3926910|NCT01415934|3749664|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3926911|NCT01415934|3749662|B3||White|Race (NIH/OMB)||Participants|Count of Participants|315|315.0||||||
3926912|NCT01415934|3749663|B2||White|Race (NIH/OMB)||Participants|Count of Participants|153|153.0||||||
3926913|NCT01415934|3749664|B1||White|Race (NIH/OMB)||Participants|Count of Participants|162|162.0||||||
3926914|NCT01415934|3749662|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3926915|NCT01415934|3749663|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3926916|NCT01415934|3749664|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3926917|NCT01415934|3749662|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3926918|NCT01415934|3749663|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926919|NCT01415934|3749664|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3926920|NCT01415934|3749662|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3926921|NCT01415934|3749663|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926922|NCT01415934|3749664|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3926923|NCT01415934|3749662|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926924|NCT01415934|3749663|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926925|NCT01415934|3749664|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926926|NCT01415934|3749662|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926927|NCT01415934|3749663|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926928|NCT01415934|3749664|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926929|NCT01415934|3749662|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|365|365.0||||||
3926930|NCT01415934|3749663|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|183|183.0||||||
3926931|NCT01415934|3749664|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|182|182.0||||||
3926932|NCT01415934|3749662|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3926933|NCT01415934|3749663|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3926934|NCT01415934|3749664|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3926935|NCT01415934|3749662|B3||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
3926936|NCT01415934|3749663|B2||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3926937|NCT01415934|3749664|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3926938|NCT01415934|3749662|B3||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3926939|NCT01415934|3749663|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3926940|NCT01415934|3749664|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3926941|NCT01415934|3749662|B3|||Age||Years|Mean|74.1|74.1|Standard Deviation|11.6|11.6|||
3926942|NCT01415934|3749663|B2|||Age||Years|Mean|74.8|74.8|Standard Deviation|11.7|11.7|||
3926943|NCT01415934|3749664|B1|||Age||Years|Mean|73.5|73.5|Standard Deviation|11.5|11.5|||
3926944|NCT01415934|3749662|B3||>=65 years|Age||Participants|Count of Participants|308|308.0||||||
3926945|NCT01415934|3749663|B2||>=65 years|Age||Participants|Count of Participants|154|154.0||||||
3926946|NCT01415934|3749664|B1||>=65 years|Age||Participants|Count of Participants|154|154.0||||||
3926947|NCT01415934|3749662|B3||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
3926948|NCT01415934|3749663|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3926949|NCT01415934|3749664|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3926950|NCT01415934|3749662|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3926951|NCT01415934|3749663|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3926952|NCT01415934|3749664|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3926953|NCT01415921|3749671|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
3926954|NCT01415921|3749672|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3926955|NCT01415921|3749673|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3926956|NCT01415921|3749671|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926957|NCT01415921|3749672|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926958|NCT01415921|3749673|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926959|NCT01415921|3749671|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3926960|NCT01415921|3749672|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3926961|NCT01415921|3749673|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3926962|NCT01415921|3749671|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3926963|NCT01415921|3749672|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926964|NCT01415921|3749673|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3926965|NCT01415921|3749671|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3926966|NCT01415921|3749672|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3926967|NCT01415921|3749673|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3926968|NCT01415921|3749671|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926969|NCT01415921|3749672|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926970|NCT01415921|3749673|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926971|NCT01415921|3749671|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3926972|NCT01415921|3749672|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3926973|NCT01415921|3749673|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3926974|NCT01415921|3749671|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926975|NCT01415921|3749672|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926976|NCT01415921|3749673|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3926977|NCT01415921|3749671|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3926978|NCT01415921|3749672|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3926979|NCT01415921|3749673|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3926980|NCT01415921|3749671|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3926981|NCT01415921|3749672|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3926982|NCT01415921|3749673|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3926983|NCT01415921|3749671|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3926984|NCT01415921|3749672|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3926985|NCT01415921|3749673|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3926986|NCT01415921|3749671|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3926987|NCT01415921|3749672|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3926988|NCT01415921|3749673|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3926989|NCT01415921|3749671|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3926990|NCT01415921|3749672|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3926991|NCT01415921|3749673|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3926992|NCT01415908|3749682|B3|||Weight||lbs|Mean|180.7|180.7|Standard Deviation|36.13|36.13|||
3926993|NCT01415908|3749683|B2|||Weight||lbs|Mean|183.5|183.5|Standard Deviation|38.10|38.1|||
3926994|NCT01415908|3749684|B1|||Weight||lbs|Mean|179.7|179.7|Standard Deviation|37.25|37.25|||
3926995|NCT01415908|3749682|B3|||Height||Inches|Mean|67.9|67.9|Standard Deviation|3.38|3.38|||
3926996|NCT01415908|3749683|B2|||Height||Inches|Mean|68.5|68.5|Standard Deviation|3.87|3.87|||
3926997|NCT01415908|3749684|B1|||Height||Inches|Mean|67.6|67.6|Standard Deviation|3.35|3.35|||
3926998|NCT01415908|3749682|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3926999|NCT01415908|3749683|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3927000|NCT01415908|3749684|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3927001|NCT01415908|3749682|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3927002|NCT01415908|3749683|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3927003|NCT01415908|3749684|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3927004|NCT01415908|3749682|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3927005|NCT01415908|3749683|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3927006|NCT01415908|3749684|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3927007|NCT01415908|3749682|B3|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3927008|NCT01415908|3749683|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3927009|NCT01415908|3749684|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3927010|NCT01415908|3749682|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3927011|NCT01415908|3749683|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3927012|NCT01415908|3749684|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3927013|NCT01415908|3749682|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3927014|NCT01415908|3749683|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3927015|NCT01415908|3749684|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3927016|NCT01415908|3749682|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3927017|NCT01415908|3749683|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3927018|NCT01415908|3749684|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3927019|NCT01415908|3749682|B3|||Age||years|Mean|52.0|52.0|Standard Deviation|11.83|11.83|||
3927020|NCT01415908|3749683|B2|||Age||years|Mean|56.2|56.2|Standard Deviation|12.26|12.26|||
3927021|NCT01415908|3749684|B1|||Age||years|Mean|50.5|50.5|Standard Deviation|11.88|11.88|||
3927022|NCT01415583|3749711|B3||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
3927023|NCT01415583|3749712|B2||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3927024|NCT01415583|3749713|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3927025|NCT01415583|3749711|B3||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3927026|NCT01415583|3749712|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3927027|NCT01415583|3749713|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3927028|NCT01415583|3749711|B3|||Age||years|Median|6|6.0|Inter-Quartile Range|||4.0|9.0|
3927029|NCT01415583|3749712|B2|||Age||years|Median|6|6.0|Inter-Quartile Range|||4.0|8.0|
3927030|NCT01415583|3749713|B1|||Age||years|Median|6|6.0|Inter-Quartile Range|||4.0|9.0|
3927031|NCT01415531|3749720|B3|United States||Region of Enrollment||participants|Number|641|641.0||||||
3927032|NCT01415531|3749721|B2|United States||Region of Enrollment||participants|Number|427|427.0||||||
3927033|NCT01415531|3749722|B1|United States||Region of Enrollment||participants|Number|214|214.0||||||
3927034|NCT01415531|3749720|B3||Male|Sex: Female, Male||Participants|Count of Participants|356|356.0||||||
3927035|NCT01415531|3749721|B2||Male|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
3927036|NCT01415531|3749722|B1||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3927037|NCT01415531|3749720|B3||Female|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
3927038|NCT01415531|3749721|B2||Female|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
3927039|NCT01415531|3749722|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3927040|NCT01415531|3749720|B3|18 to 54||Age||years|Mean|45.3|45.3|Standard Deviation|6.9|6.9|||
3927041|NCT01415531|3749721|B2|18 to 54||Age||years|Mean|44.9|44.9|Standard Deviation|6.9|6.9|||
3927042|NCT01415531|3749722|B1|18 to 54||Age||years|Mean|46.0|46.0|Standard Deviation|6.9|6.9|||
3927043|NCT01415518|3749731|B3||Male|Sex: Female, Male||Participants|Count of Participants|503|503.0||||||
3927044|NCT01415518|3749732|B2||Male|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
3927045|NCT01415518|3749733|B1||Male|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
3927046|NCT01415518|3749731|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3927047|NCT01415518|3749732|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3927048|NCT01415518|3749733|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3927049|NCT01415518|3749731|B3|||Age||years|Mean|64.1|64.1|Standard Deviation|8.77|8.77|||
3927050|NCT01415518|3749732|B2|||Age||years|Mean|64.4|64.4|Standard Deviation|8.76|8.76|||
3927051|NCT01415518|3749733|B1|||Age||years|Mean|63.8|63.8|Standard Deviation|8.79|8.79|||
3927052|NCT01415453|3749786|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3927053|NCT01415453|3749786|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3927054|NCT01415453|3749786|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3927055|NCT01415453|3749786|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3927056|NCT01415453|3749786|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3927057|NCT01415453|3749786|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3927058|NCT01415427|3749790|B5|United States||Region of Enrollment||participants|Number|32|32.0||||||
3927059|NCT01415427|3749791|B4|United States||Region of Enrollment||participants|Number|9|9.0||||||
3927060|NCT01415427|3749792|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3927061|NCT01415427|3749793|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3927062|NCT01415427|3749794|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3927063|NCT01415427|3749790|B5|United Kingdom||Region of Enrollment||participants|Number|22|22.0||||||
3927064|NCT01415427|3749791|B4|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
3927065|NCT01415427|3749792|B3|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3927066|NCT01415427|3749793|B2|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3927067|NCT01415427|3749794|B1|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3927068|NCT01415427|3749790|B5|Taiwan||Region of Enrollment||participants|Number|5|5.0||||||
3927069|NCT01415427|3749791|B4|Taiwan||Region of Enrollment||participants|Number|1|1.0||||||
3927070|NCT01415427|3749792|B3|Taiwan||Region of Enrollment||participants|Number|3|3.0||||||
3927071|NCT01415427|3749793|B2|Taiwan||Region of Enrollment||participants|Number|1|1.0||||||
3927072|NCT01415427|3749794|B1|Taiwan||Region of Enrollment||participants|Number|0|0.0||||||
3927073|NCT01415427|3749790|B5|Saudi Arabia||Region of Enrollment||participants|Number|7|7.0||||||
3927074|NCT01415427|3749791|B4|Saudi Arabia||Region of Enrollment||participants|Number|4|4.0||||||
3927075|NCT01415427|3749792|B3|Saudi Arabia||Region of Enrollment||participants|Number|1|1.0||||||
3927076|NCT01415427|3749793|B2|Saudi Arabia||Region of Enrollment||participants|Number|2|2.0||||||
3927077|NCT01415427|3749794|B1|Saudi Arabia||Region of Enrollment||participants|Number|0|0.0||||||
3927078|NCT01415427|3749790|B5|Qatar||Region of Enrollment||participants|Number|2|2.0||||||
3927079|NCT01415427|3749791|B4|Qatar||Region of Enrollment||participants|Number|1|1.0||||||
3927080|NCT01415427|3749792|B3|Qatar||Region of Enrollment||participants|Number|0|0.0||||||
3927081|NCT01415427|3749793|B2|Qatar||Region of Enrollment||participants|Number|1|1.0||||||
3927082|NCT01415427|3749794|B1|Qatar||Region of Enrollment||participants|Number|0|0.0||||||
3927083|NCT01415427|3749790|B5|Portugal||Region of Enrollment||participants|Number|3|3.0||||||
3927084|NCT01415427|3749791|B4|Portugal||Region of Enrollment||participants|Number|0|0.0||||||
3927085|NCT01415427|3749792|B3|Portugal||Region of Enrollment||participants|Number|1|1.0||||||
3927086|NCT01415427|3749793|B2|Portugal||Region of Enrollment||participants|Number|1|1.0||||||
3927087|NCT01415427|3749794|B1|Portugal||Region of Enrollment||participants|Number|1|1.0||||||
3927088|NCT01415427|3749790|B5|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
3927089|NCT01415427|3749791|B4|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
3927090|NCT01415427|3749792|B3|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
3927091|NCT01415427|3749793|B2|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
3927092|NCT01415427|3749794|B1|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
3927093|NCT01415427|3749790|B5|Korea, South||Region of Enrollment||participants|Number|7|7.0||||||
3927094|NCT01415427|3749791|B4|Korea, South||Region of Enrollment||participants|Number|3|3.0||||||
3927095|NCT01415427|3749792|B3|Korea, South||Region of Enrollment||participants|Number|1|1.0||||||
3927096|NCT01415427|3749793|B2|Korea, South||Region of Enrollment||participants|Number|1|1.0||||||
3927097|NCT01415427|3749794|B1|Korea, South||Region of Enrollment||participants|Number|2|2.0||||||
3927098|NCT01415427|3749790|B5|Japan||Region of Enrollment||participants|Number|6|6.0||||||
3927099|NCT01415427|3749791|B4|Japan||Region of Enrollment||participants|Number|2|2.0||||||
3927100|NCT01415427|3749792|B3|Japan||Region of Enrollment||participants|Number|4|4.0||||||
3927101|NCT01415427|3749793|B2|Japan||Region of Enrollment||participants|Number|0|0.0||||||
3927102|NCT01415427|3749794|B1|Japan||Region of Enrollment||participants|Number|0|0.0||||||
3927103|NCT01415427|3749790|B5|Italy||Region of Enrollment||participants|Number|10|10.0||||||
3927104|NCT01415427|3749791|B4|Italy||Region of Enrollment||participants|Number|2|2.0||||||
3927105|NCT01415427|3749792|B3|Italy||Region of Enrollment||participants|Number|4|4.0||||||
3927106|NCT01415427|3749793|B2|Italy||Region of Enrollment||participants|Number|1|1.0||||||
3927107|NCT01415427|3749794|B1|Italy||Region of Enrollment||participants|Number|3|3.0||||||
3927108|NCT01415427|3749790|B5|Germany||Region of Enrollment||participants|Number|10|10.0||||||
3927109|NCT01415427|3749791|B4|Germany||Region of Enrollment||participants|Number|1|1.0||||||
3927110|NCT01415427|3749792|B3|Germany||Region of Enrollment||participants|Number|5|5.0||||||
3927111|NCT01415427|3749793|B2|Germany||Region of Enrollment||participants|Number|2|2.0||||||
3927112|NCT01415427|3749794|B1|Germany||Region of Enrollment||participants|Number|2|2.0||||||
3927113|NCT01415427|3749790|B5|France||Region of Enrollment||participants|Number|20|20.0||||||
3927114|NCT01415427|3749791|B4|France||Region of Enrollment||participants|Number|8|8.0||||||
3927115|NCT01415427|3749792|B3|France||Region of Enrollment||participants|Number|5|5.0||||||
3927116|NCT01415427|3749793|B2|France||Region of Enrollment||participants|Number|5|5.0||||||
3927117|NCT01415427|3749794|B1|France||Region of Enrollment||participants|Number|2|2.0||||||
3927118|NCT01415427|3749790|B5|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
3927119|NCT01415427|3749791|B4|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
3927120|NCT01415427|3749792|B3|Denmark||Region of Enrollment||participants|Number|0|0.0||||||
3927121|NCT01415427|3749793|B2|Denmark||Region of Enrollment||participants|Number|0|0.0||||||
3927122|NCT01415427|3749794|B1|Denmark||Region of Enrollment||participants|Number|0|0.0||||||
3927123|NCT01415427|3749790|B5|Colombia||Region of Enrollment||participants|Number|6|6.0||||||
3927124|NCT01415427|3749791|B4|Colombia||Region of Enrollment||participants|Number|2|2.0||||||
3927125|NCT01415427|3749792|B3|Colombia||Region of Enrollment||participants|Number|2|2.0||||||
3927126|NCT01415427|3749793|B2|Colombia||Region of Enrollment||participants|Number|2|2.0||||||
3927127|NCT01415427|3749794|B1|Colombia||Region of Enrollment||participants|Number|0|0.0||||||
3927128|NCT01415427|3749790|B5|Canada||Region of Enrollment||participants|Number|14|14.0||||||
3927129|NCT01415427|3749791|B4|Canada||Region of Enrollment||participants|Number|5|5.0||||||
3927130|NCT01415427|3749792|B3|Canada||Region of Enrollment||participants|Number|5|5.0||||||
3927131|NCT01415427|3749793|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3927132|NCT01415427|3749794|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
3927133|NCT01415427|3749790|B5|Brazil||Region of Enrollment||participants|Number|20|20.0||||||
3927134|NCT01415427|3749791|B4|Brazil||Region of Enrollment||participants|Number|5|5.0||||||
3927135|NCT01415427|3749792|B3|Brazil||Region of Enrollment||participants|Number|10|10.0||||||
3927136|NCT01415427|3749793|B2|Brazil||Region of Enrollment||participants|Number|3|3.0||||||
3927137|NCT01415427|3749794|B1|Brazil||Region of Enrollment||participants|Number|2|2.0||||||
3927138|NCT01415427|3749790|B5|Argentina||Region of Enrollment||participants|Number|2|2.0||||||
3927139|NCT01415427|3749791|B4|Argentina||Region of Enrollment||participants|Number|0|0.0||||||
3927140|NCT01415427|3749792|B3|Argentina||Region of Enrollment||participants|Number|1|1.0||||||
3927141|NCT01415427|3749793|B2|Argentina||Region of Enrollment||participants|Number|1|1.0||||||
3927142|NCT01415427|3749794|B1|Argentina||Region of Enrollment||participants|Number|0|0.0||||||
3927143|NCT01415427|3749790|B5|Other||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3927144|NCT01415427|3749791|B4|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3927145|NCT01415427|3749792|B3|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3927146|NCT01415427|3749793|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3927147|NCT01415427|3749794|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3927148|NCT01415427|3749790|B5|White||Race/Ethnicity, Customized||participants|Number|113|113.0||||||
3927149|NCT01415427|3749791|B4|White||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3927150|NCT01415427|3749792|B3|White||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3927151|NCT01415427|3749793|B2|White||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3927152|NCT01415427|3749794|B1|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3927153|NCT01415427|3749790|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3927154|NCT01415427|3749791|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3927155|NCT01415427|3749792|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3927156|NCT01415427|3749793|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3927157|NCT01415427|3749794|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3927158|NCT01415427|3749790|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3927159|NCT01415427|3749791|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3927160|NCT01415427|3749792|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3927161|NCT01415427|3749793|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3927162|NCT01415427|3749794|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3927163|NCT01415427|3749790|B5|Asian||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
3927164|NCT01415427|3749791|B4|Asian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3927165|NCT01415427|3749792|B3|Asian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3927166|NCT01415427|3749793|B2|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3927167|NCT01415427|3749794|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3927168|NCT01415427|3749790|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3927169|NCT01415427|3749791|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3927170|NCT01415427|3749792|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3927171|NCT01415427|3749793|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3927172|NCT01415427|3749794|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3927173|NCT01415427|3749790|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927174|NCT01415427|3749791|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927175|NCT01415427|3749792|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927176|NCT01415427|3749793|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927177|NCT01415427|3749794|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927178|NCT01415427|3749790|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|136|136.0||||||
3927179|NCT01415427|3749791|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3927180|NCT01415427|3749792|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3927181|NCT01415427|3749793|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3927182|NCT01415427|3749794|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3927183|NCT01415427|3749790|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3927184|NCT01415427|3749791|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3927185|NCT01415427|3749792|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3927186|NCT01415427|3749793|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3927187|NCT01415427|3749794|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3927188|NCT01415427|3749790|B5||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3927189|NCT01415427|3749791|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3927190|NCT01415427|3749792|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3927191|NCT01415427|3749793|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3927192|NCT01415427|3749794|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3927193|NCT01415427|3749790|B5||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3927194|NCT01415427|3749791|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3927195|NCT01415427|3749792|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3927196|NCT01415427|3749793|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3927197|NCT01415427|3749794|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3927198|NCT01415427|3749790|B5|>=19||Age, Customized||participants|Number|34|34.0||||||
3927199|NCT01415427|3749791|B4|>=19||Age, Customized||participants|Number|8|8.0||||||
3927200|NCT01415427|3749792|B3|>=19||Age, Customized||participants|Number|12|12.0||||||
3927201|NCT01415427|3749793|B2|>=19||Age, Customized||participants|Number|7|7.0||||||
3927202|NCT01415427|3749794|B1|>=19||Age, Customized||participants|Number|7|7.0||||||
3927203|NCT01415427|3749790|B5|12 - 18||Age, Customized||participants|Number|46|46.0||||||
3927204|NCT01415427|3749791|B4|12 - 18||Age, Customized||participants|Number|16|16.0||||||
3927205|NCT01415427|3749792|B3|12 - 18||Age, Customized||participants|Number|16|16.0||||||
3927206|NCT01415427|3749793|B2|12 - 18||Age, Customized||participants|Number|7|7.0||||||
3927207|NCT01415427|3749794|B1|12 - 18||Age, Customized||participants|Number|7|7.0||||||
3927208|NCT01415427|3749790|B5|5 - 11||Age, Customized||participants|Number|93|93.0||||||
3927209|NCT01415427|3749791|B4|5 - 11||Age, Customized||participants|Number|32|32.0||||||
3927210|NCT01415427|3749792|B3|5 - 11||Age, Customized||participants|Number|31|31.0||||||
3927211|NCT01415427|3749793|B2|5 - 11||Age, Customized||participants|Number|15|15.0||||||
3927212|NCT01415427|3749794|B1|5 - 11||Age, Customized||participants|Number|15|15.0||||||
3927213|NCT01415427|3749790|B5|||Age||years|Mean|14.4|14.4|Standard Deviation|10.20|10.2|||
3927214|NCT01415427|3749791|B4|||Age||years|Mean|12.8|12.8|Standard Deviation|8.01|8.01|||
3927215|NCT01415427|3749792|B3|||Age||years|Mean|15.3|15.3|Standard Deviation|10.79|10.79|||
3927216|NCT01415427|3749793|B2|||Age||years|Mean|13.5|13.5|Standard Deviation|8.50|8.5|||
3927217|NCT01415427|3749794|B1|||Age||years|Mean|16.7|16.7|Standard Deviation|13.66|13.66|||
3927218|NCT01415401|3749834|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3927219|NCT01415401|3749834|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3927220|NCT01415401|3749834|B1|||Age||years|Mean|69.6|69.6|Standard Deviation|10.37|10.37|||
3927221|NCT01415349|3749839|B1|Netherlands||Region of Enrollment||participants|Number|42|42.0||||||
3927222|NCT01415349|3749839|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3927223|NCT01415349|3749839|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3927224|NCT01415349|3749839|B1|Between 18 and 55 years||Age, Customized||participants|Number|42|42.0||||||
3927225|NCT01415349|3749839|B1|||Age||years|Mean|27.4|27.4|Standard Deviation|10.52|10.52|||
3927226|NCT01415232|3749848|B1|United States||Region of Enrollment||participants|Number|160|160.0||||||
3927227|NCT01415232|3749848|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3927228|NCT01415232|3749848|B1||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3927229|NCT01415232|3749848|B1|||Age||years|Mean|28.9|28.9|Standard Deviation|6.4|6.4|||
3927230|NCT01415232|3749848|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3927231|NCT01415232|3749848|B1||Between 18 and 65 years|Age||Participants|Count of Participants|160|160.0||||||
3927232|NCT01415232|3749848|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3927233|NCT01414855|3749852|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3927234|NCT01414855|3749852|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3927235|NCT01414855|3749852|B1|||Age||years|Mean|57.9|57.9|Standard Deviation|14.4|14.4|||
3927236|NCT01414634|3749868|B1|Germany||Region of Enrollment||participants|Number|9|9.0||||||
3927237|NCT01414634|3749868|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3927238|NCT01414634|3749868|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3927239|NCT01414634|3749868|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3927240|NCT01414634|3749868|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3927241|NCT01414634|3749868|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3927242|NCT01414634|3749868|B1|||Age||years|Median|42|42.0|Full Range|||27.0|49.0|
3927243|NCT01414413|3749886|B3||Male|Sex: Female, Male||Participants|Count of Participants|8651|8651.0||||||
3927244|NCT01414413|3749887|B2||Male|Sex: Female, Male||Participants|Count of Participants|4399|4399.0||||||
3927245|NCT01414413|3749888|B1||Male|Sex: Female, Male||Participants|Count of Participants|4252|4252.0||||||
3927246|NCT01414413|3749886|B3||Female|Sex: Female, Male||Participants|Count of Participants|8009|8009.0||||||
3927247|NCT01414413|3749887|B2||Female|Sex: Female, Male||Participants|Count of Participants|4067|4067.0||||||
3927248|NCT01414413|3749888|B1||Female|Sex: Female, Male||Participants|Count of Participants|3942|3942.0||||||
3927249|NCT01414413|3749886|B3|||Age||years|Mean|30.3|30.3|Standard Deviation|11.6|11.6|||
3927250|NCT01414413|3749887|B2|||Age||years|Mean|30.2|30.2|Standard Deviation|11.4|11.4|||
3927251|NCT01414413|3749888|B1|||Age||years|Mean|30.4|30.4|Standard Deviation|11.8|11.8|||
3927252|NCT01414257|3749901|B1|Not used Methotrexate Previously||History of Methotrexate Therapy||Participants|Number|10|10.0||||||
3927253|NCT01414257|3749901|B1|Unknown||History of Methotrexate Therapy||Participants|Number|554|554.0||||||
3927254|NCT01414257|3749901|B1|≥5 years||History of Methotrexate Therapy||Participants|Number|436|436.0||||||
3927255|NCT01414257|3749901|B1|3 to ˂5 years||History of Methotrexate Therapy||Participants|Number|300|300.0||||||
3927256|NCT01414257|3749901|B1|1 to ˂3 years||History of Methotrexate Therapy||Participants|Number|547|547.0||||||
3927257|NCT01414257|3749901|B1|0.5 to ˂1 year||History of Methotrexate Therapy||Participants|Number|254|254.0||||||
3927258|NCT01414257|3749901|B1|˂0.5 year||History of Methotrexate Therapy||Participants|Number|737|737.0||||||
3927259|NCT01414257|3749901|B1|Unknown||Morbidity Period||Participants|Number|422|422.0||||||
3927260|NCT01414257|3749901|B1|≥5 years||Morbidity Period||Participants|Number|1148|1148.0||||||
3927261|NCT01414257|3749901|B1|3 to ˂5 years||Morbidity Period||Participants|Number|313|313.0||||||
3927262|NCT01414257|3749901|B1|1 to ˂3 years||Morbidity Period||Participants|Number|512|512.0||||||
3927263|NCT01414257|3749901|B1|<1 year||Morbidity Period||Participants|Number|443|443.0||||||
3927264|NCT01414257|3749901|B1|Unknown||Steinbrocker Class|"Class was classified into four-grade based on below criteria by doctor at beginning.~Class1:Complete ability to carry out all the usual duties without handicaps Class2:Adequate for normal activities despite handicap of discomfort or limited motion of one of the joints Class3:Limited to little or none of the duties of usual occupation or self-care Class4:Incapacitated, largely or wholly bed-ridden or confined to a wheelchair with little or no self-care"|Participants|Number|86|86.0||||||
3927265|NCT01414257|3749901|B1|Class 4||Steinbrocker Class|"Class was classified into four-grade based on below criteria by doctor at beginning.~Class1:Complete ability to carry out all the usual duties without handicaps Class2:Adequate for normal activities despite handicap of discomfort or limited motion of one of the joints Class3:Limited to little or none of the duties of usual occupation or self-care Class4:Incapacitated, largely or wholly bed-ridden or confined to a wheelchair with little or no self-care"|Participants|Number|16|16.0||||||
3927266|NCT01414257|3749901|B1|Class 3||Steinbrocker Class|"Class was classified into four-grade based on below criteria by doctor at beginning.~Class1:Complete ability to carry out all the usual duties without handicaps Class2:Adequate for normal activities despite handicap of discomfort or limited motion of one of the joints Class3:Limited to little or none of the duties of usual occupation or self-care Class4:Incapacitated, largely or wholly bed-ridden or confined to a wheelchair with little or no self-care"|Participants|Number|301|301.0||||||
3927267|NCT01414257|3749901|B1|Class 2||Steinbrocker Class|"Class was classified into four-grade based on below criteria by doctor at beginning.~Class1:Complete ability to carry out all the usual duties without handicaps Class2:Adequate for normal activities despite handicap of discomfort or limited motion of one of the joints Class3:Limited to little or none of the duties of usual occupation or self-care Class4:Incapacitated, largely or wholly bed-ridden or confined to a wheelchair with little or no self-care"|Participants|Number|1641|1641.0||||||
3927268|NCT01414257|3749901|B1|Class 1||Steinbrocker Class|"Class was classified into four-grade based on below criteria by doctor at beginning.~Class1:Complete ability to carry out all the usual duties without handicaps Class2:Adequate for normal activities despite handicap of discomfort or limited motion of one of the joints Class3:Limited to little or none of the duties of usual occupation or self-care Class4:Incapacitated, largely or wholly bed-ridden or confined to a wheelchair with little or no self-care"|Participants|Number|794|794.0||||||
3927269|NCT01414257|3749901|B1|Unknown||Steinbrocker Stage|"Stage was classified into four-grade based on below criteria by doctor at beginning. StageI:No radiological finding of osteolysis. StageII:1.Radiological finding of osteoporosis with or without mild fracture of subchondral bone. There may be mild cartilage destruction.~2. Articular movement may be restricted, but no joint deformity StageIII:1.Osteoporosis and radiological finding of bone and cartilage destruction 2.Joint deformity such as subluxation, ulnar malposition or extension is present. There is no fibrous or osseous ankylosis.~StageIV:Fibrous or osseous ankylosis is present."|Participants|Number|58|58.0||||||
3927270|NCT01414257|3749901|B1|Stage IV (Terminal)||Steinbrocker Stage|"Stage was classified into four-grade based on below criteria by doctor at beginning. StageI:No radiological finding of osteolysis. StageII:1.Radiological finding of osteoporosis with or without mild fracture of subchondral bone. There may be mild cartilage destruction.~2. Articular movement may be restricted, but no joint deformity StageIII:1.Osteoporosis and radiological finding of bone and cartilage destruction 2.Joint deformity such as subluxation, ulnar malposition or extension is present. There is no fibrous or osseous ankylosis.~StageIV:Fibrous or osseous ankylosis is present."|Participants|Number|524|524.0||||||
3927271|NCT01414257|3749901|B1|Stage III (Progressive)||Steinbrocker Stage|"Stage was classified into four-grade based on below criteria by doctor at beginning. StageI:No radiological finding of osteolysis. StageII:1.Radiological finding of osteoporosis with or without mild fracture of subchondral bone. There may be mild cartilage destruction.~2. Articular movement may be restricted, but no joint deformity StageIII:1.Osteoporosis and radiological finding of bone and cartilage destruction 2.Joint deformity such as subluxation, ulnar malposition or extension is present. There is no fibrous or osseous ankylosis.~StageIV:Fibrous or osseous ankylosis is present."|Participants|Number|613|613.0||||||
3927325|NCT01414153|3750022|B5|Missing||Choroidal neovascularization (CNV) Lesion Type||percentage of participants|Number|15|15.0||||||
3927272|NCT01414257|3749901|B1|Stage II (Medium)||Steinbrocker Stage|"Stage was classified into four-grade based on below criteria by doctor at beginning. StageI:No radiological finding of osteolysis. StageII:1.Radiological finding of osteoporosis with or without mild fracture of subchondral bone. There may be mild cartilage destruction.~2. Articular movement may be restricted, but no joint deformity StageIII:1.Osteoporosis and radiological finding of bone and cartilage destruction 2.Joint deformity such as subluxation, ulnar malposition or extension is present. There is no fibrous or osseous ankylosis.~StageIV:Fibrous or osseous ankylosis is present."|Participants|Number|948|948.0||||||
3927273|NCT01414257|3749901|B1|Stage I (Initial)||Steinbrocker Stage|"Stage was classified into four-grade based on below criteria by doctor at beginning. StageI:No radiological finding of osteolysis. StageII:1.Radiological finding of osteoporosis with or without mild fracture of subchondral bone. There may be mild cartilage destruction.~2. Articular movement may be restricted, but no joint deformity StageIII:1.Osteoporosis and radiological finding of bone and cartilage destruction 2.Joint deformity such as subluxation, ulnar malposition or extension is present. There is no fibrous or osseous ankylosis.~StageIV:Fibrous or osseous ankylosis is present."|Participants|Number|695|695.0||||||
3927274|NCT01414257|3749901|B1|Unknown||Sex/Gender, Customized||Participants|Number|3|3.0||||||
3927275|NCT01414257|3749901|B1|Male||Sex/Gender, Customized||Participants|Number|659|659.0||||||
3927276|NCT01414257|3749901|B1|Female||Sex/Gender, Customized||Participants|Number|2176|2176.0||||||
3927277|NCT01414257|3749901|B1|Unknown||Age, Customized||Participants|Number|20|20.0||||||
3927278|NCT01414257|3749901|B1|≥65 years||Age, Customized||Participants|Number|804|804.0||||||
3927279|NCT01414257|3749901|B1|≥15 to <65 years||Age, Customized||Participants|Number|2014|2014.0||||||
3927280|NCT01414244|3749912|B3|United States||Region of Enrollment||Participants|Count of Participants|106|106.0||||||
3927281|NCT01414244|3749913|B2|United States||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
3927282|NCT01414244|3749914|B1|United States||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
3927283|NCT01414244|3749912|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3927284|NCT01414244|3749913|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3927285|NCT01414244|3749914|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3927286|NCT01414244|3749912|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3927287|NCT01414244|3749913|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3927288|NCT01414244|3749914|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3927289|NCT01414244|3749912|B3|||Age||years|Mean|31.7|31.7|Standard Deviation|8.3|8.3|||
3927290|NCT01414244|3749913|B2|||Age||years|Mean|30.9|30.9|Standard Deviation|7.1|7.1|||
3927291|NCT01414244|3749914|B1|||Age||years|Mean|32.4|32.4|Standard Deviation|9.5|9.5|||
3927292|NCT01414205|3749927|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3927293|NCT01414205|3749928|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3927294|NCT01414205|3749929|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3927295|NCT01414205|3749927|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3927296|NCT01414205|3749928|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3927297|NCT01414205|3749929|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3927298|NCT01414205|3749927|B3|||Age||years|Mean|65.7|65.7|Standard Deviation|11.2|11.2|||
3927299|NCT01414205|3749928|B2|||Age||years|Mean|64.3|64.3|Standard Deviation|12.4|12.4|||
3927300|NCT01414205|3749929|B1|||Age||years|Mean|67.0|67.0|Standard Deviation|10.0|10.0|||
3927301|NCT01414192|3749962|B5||Male|Sex: Female, Male||Participants|Count of Participants|1756|1756.0||||||
3927302|NCT01414192|3749963|B4||Male|Sex: Female, Male||Participants|Count of Participants|998|998.0||||||
3927303|NCT01414192|3749964|B3||Male|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
3927304|NCT01414192|3749965|B2||Male|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
3927305|NCT01414192|3749966|B1||Male|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
3927306|NCT01414192|3749962|B5||Female|Sex: Female, Male||Participants|Count of Participants|1459|1459.0||||||
3927307|NCT01414192|3749963|B4||Female|Sex: Female, Male||Participants|Count of Participants|728|728.0||||||
3927308|NCT01414192|3749964|B3||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3927309|NCT01414192|3749965|B2||Female|Sex: Female, Male||Participants|Count of Participants|284|284.0||||||
3927310|NCT01414192|3749966|B1||Female|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
3927311|NCT01414192|3749962|B5|||Age||years|Mean|61.5|61.5|Standard Deviation|10.7|10.7|||
3927312|NCT01414192|3749963|B4|||Age||years|Mean|61.4|61.4|Standard Deviation|10.6|10.6|||
3927313|NCT01414192|3749964|B3|||Age||years|Mean|60.8|60.8|Standard Deviation|10.8|10.8|||
3927314|NCT01414192|3749965|B2|||Age||years|Mean|63.3|63.3|Standard Deviation|9.7|9.7|||
3927315|NCT01414192|3749966|B1|||Age||years|Mean|60.3|60.3|Standard Deviation|11.5|11.5|||
3927316|NCT01414166|3749997|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3927317|NCT01414166|3749998|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3927318|NCT01414166|3749999|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3927319|NCT01414166|3749997|B3||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3927320|NCT01414166|3749998|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3927321|NCT01414166|3749999|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3927322|NCT01414166|3749997|B3|||Age||Years|Mean|45.5|45.5|Standard Deviation|9.73|9.73|||
3927323|NCT01414166|3749998|B2|||Age||Years|Mean|45.3|45.3|Standard Deviation|10.18|10.18|||
3927324|NCT01414166|3749999|B1|||Age||Years|Mean|45.8|45.8|Standard Deviation|9.30|9.3|||
3927326|NCT01414153|3750023|B4|Missing||Choroidal neovascularization (CNV) Lesion Type||percentage of participants|Number|7.3|7.3||||||
3927327|NCT01414153|3750024|B3|Missing||Choroidal neovascularization (CNV) Lesion Type||percentage of participants|Number|2.6|2.6||||||
3927328|NCT01414153|3750025|B2|Missing||Choroidal neovascularization (CNV) Lesion Type||percentage of participants|Number|2.5|2.5||||||
3927329|NCT01414153|3750026|B1|Missing||Choroidal neovascularization (CNV) Lesion Type||percentage of participants|Number|2.6|2.6||||||
3927330|NCT01414153|3750022|B5|Unreadable||Choroidal neovascularization (CNV) Lesion Type||percentage of participants|Number|7.7|7.7||||||
3927331|NCT01414153|3750023|B4|Unreadable||Choroidal neovascularization (CNV) Lesion Type||percentage of participants|Number|2.4|2.4||||||
3927332|NCT01414153|3750024|B3|Unreadable||Choroidal neovascularization (CNV) Lesion Type||percentage of participants|Number|0.0|0.0||||||
3927333|NCT01414153|3750025|B2|Unreadable||Choroidal neovascularization (CNV) Lesion Type||percentage of participants|Number|0.0|0.0||||||
3927334|NCT01414153|3750026|B1|Unreadable||Choroidal neovascularization (CNV) Lesion Type||percentage of participants|Number|5.3|5.3||||||
3927335|NCT01414153|3750022|B5|Occult||Choroidal neovascularization (CNV) Lesion Type||percentage of participants|Number|294.3|294.3||||||
3927336|NCT01414153|3750023|B4|Occult||Choroidal neovascularization (CNV) Lesion Type||percentage of participants|Number|61.0|61.0||||||
3927337|NCT01414153|3750024|B3|Occult||Choroidal neovascularization (CNV) Lesion Type||percentage of participants|Number|79.5|79.5||||||
3927338|NCT01414153|3750025|B2|Occult||Choroidal neovascularization (CNV) Lesion Type||percentage of participants|Number|77.5|77.5||||||
3927339|NCT01414153|3750026|B1|Occult||Choroidal neovascularization (CNV) Lesion Type||percentage of participants|Number|76.3|76.3||||||
3927340|NCT01414153|3750022|B5|Minimally Classic||Choroidal neovascularization (CNV) Lesion Type||percentage of participants|Number|22.7|22.7||||||
3927341|NCT01414153|3750023|B4|Minimally Classic||Choroidal neovascularization (CNV) Lesion Type||percentage of participants|Number|7.3|7.3||||||
3927342|NCT01414153|3750024|B3|Minimally Classic||Choroidal neovascularization (CNV) Lesion Type||percentage of participants|Number|5.1|5.1||||||
3927343|NCT01414153|3750025|B2|Minimally Classic||Choroidal neovascularization (CNV) Lesion Type||percentage of participants|Number|5.0|5.0||||||
3927344|NCT01414153|3750026|B1|Minimally Classic||Choroidal neovascularization (CNV) Lesion Type||percentage of participants|Number|5.3|5.3||||||
3927345|NCT01414153|3750022|B5|Predominantly Classic||Choroidal neovascularization (CNV) Lesion Type||percentage of participants|Number|60.3|60.3||||||
3927346|NCT01414153|3750023|B4|Predominantly Classic||Choroidal neovascularization (CNV) Lesion Type||percentage of participants|Number|22.0|22.0||||||
3927347|NCT01414153|3750024|B3|Predominantly Classic||Choroidal neovascularization (CNV) Lesion Type||percentage of participants|Number|12.8|12.8||||||
3927348|NCT01414153|3750025|B2|Predominantly Classic||Choroidal neovascularization (CNV) Lesion Type||percentage of participants|Number|15.0|15.0||||||
3927349|NCT01414153|3750026|B1|Predominantly Classic||Choroidal neovascularization (CNV) Lesion Type||percentage of participants|Number|10.5|10.5||||||
3927350|NCT01414153|3750022|B5|||Best Corrected Visual Acuity (ETDRS)|Visual function was assessed using the ETDRS protocol, for which numerical scores range from 0 to 100 (roughly equivalent to 20/10 vision as measured by Snellen). A higher score (more letters read) represents better functioning.|letters|Mean|59|59.0|Standard Deviation|11.45|11.45|||
3927351|NCT01414153|3750023|B4|||Best Corrected Visual Acuity (ETDRS)|Visual function was assessed using the ETDRS protocol, for which numerical scores range from 0 to 100 (roughly equivalent to 20/10 vision as measured by Snellen). A higher score (more letters read) represents better functioning.|letters|Mean|63.2|63.2|Standard Deviation|7.88|7.88|||
3927352|NCT01414153|3750024|B3|||Best Corrected Visual Acuity (ETDRS)|Visual function was assessed using the ETDRS protocol, for which numerical scores range from 0 to 100 (roughly equivalent to 20/10 vision as measured by Snellen). A higher score (more letters read) represents better functioning.|letters|Mean|61.3|61.3|Standard Deviation|9.20|9.2|||
3927353|NCT01414153|3750025|B2|||Best Corrected Visual Acuity (ETDRS)|Visual function was assessed using the ETDRS protocol, for which numerical scores range from 0 to 100 (roughly equivalent to 20/10 vision as measured by Snellen). A higher score (more letters read) represents better functioning.|letters|Mean|58.7|58.7|Standard Deviation|10.75|10.75|||
3927354|NCT01414153|3750026|B1|||Best Corrected Visual Acuity (ETDRS)|Visual function was assessed using the ETDRS protocol, for which numerical scores range from 0 to 100 (roughly equivalent to 20/10 vision as measured by Snellen). A higher score (more letters read) represents better functioning.|letters|Mean|56.2|56.2|Standard Deviation|15.84|15.84|||
3927355|NCT01414153|3750022|B5|United States||Region of Enrollment||participants|Number|158|158.0||||||
3927356|NCT01414153|3750023|B4|United States||Region of Enrollment||participants|Number|41|41.0||||||
3927357|NCT01414153|3750024|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
3927358|NCT01414153|3750025|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
3927359|NCT01414153|3750026|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
3927360|NCT01414153|3750022|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3927361|NCT01414153|3750023|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927362|NCT01414153|3750024|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927363|NCT01414153|3750025|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3927364|NCT01414153|3750026|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927365|NCT01414153|3750022|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927366|NCT01414153|3750023|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927367|NCT01414153|3750024|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927368|NCT01414153|3750025|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927369|NCT01414153|3750026|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927370|NCT01414153|3750022|B5||White|Race (NIH/OMB)||Participants|Count of Participants|154|154.0||||||
3927371|NCT01414153|3750023|B4||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3927372|NCT01414153|3750024|B3||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3927373|NCT01414153|3750025|B2||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3927374|NCT01414153|3750026|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3927375|NCT01414153|3750022|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3927376|NCT01414153|3750023|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927377|NCT01414153|3750024|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927378|NCT01414153|3750025|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927379|NCT01414153|3750026|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3927380|NCT01414153|3750022|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927381|NCT01414153|3750023|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927382|NCT01414153|3750024|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927383|NCT01414153|3750025|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927384|NCT01414153|3750026|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927385|NCT01414153|3750022|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3927386|NCT01414153|3750023|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3927387|NCT01414153|3750024|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927388|NCT01414153|3750025|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927389|NCT01414153|3750026|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927390|NCT01414153|3750022|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927391|NCT01414153|3750023|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927392|NCT01414153|3750024|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927393|NCT01414153|3750025|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927394|NCT01414153|3750026|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927395|NCT01414153|3750022|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927396|NCT01414153|3750023|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927397|NCT01414153|3750024|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927398|NCT01414153|3750025|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927399|NCT01414153|3750026|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927400|NCT01414153|3750022|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|148|148.0||||||
3927401|NCT01414153|3750023|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3927402|NCT01414153|3750024|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3927403|NCT01414153|3750025|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3927404|NCT01414153|3750026|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3927405|NCT01414153|3750022|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3927406|NCT01414153|3750023|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3927407|NCT01414153|3750024|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3927408|NCT01414153|3750025|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3927409|NCT01414153|3750026|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3927410|NCT01414153|3750022|B5||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3927411|NCT01414153|3750023|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3927412|NCT01414153|3750024|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3927413|NCT01414153|3750025|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3927414|NCT01414153|3750026|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3927415|NCT01414153|3750022|B5||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3927416|NCT01414153|3750023|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3927417|NCT01414153|3750024|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3927418|NCT01414153|3750025|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3927419|NCT01414153|3750026|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3927420|NCT01414153|3750022|B5|||Age||years|Mean|76.8|76.8|Standard Deviation|7.65|7.65|||
3927421|NCT01414153|3750023|B4|||Age||years|Mean|76.5|76.5|Standard Deviation|7.95|7.95|||
3927422|NCT01414153|3750024|B3|||Age||years|Mean|77.6|77.6|Standard Deviation|7.86|7.86|||
3927423|NCT01414153|3750025|B2|||Age||years|Mean|77.2|77.2|Standard Deviation|7.43|7.43|||
3927424|NCT01414153|3750026|B1|||Age||years|Mean|76.1|76.1|Standard Deviation|7.53|7.53|||
3927425|NCT01414114|3750063|B1|||Phosphorus||mg/dL|Mean|5.7|5.7|Standard Deviation|1.38|1.38|||
3927426|NCT01414114|3750063|B1|||Corrected Calcium||mg/dL|Mean|10.1|10.1|Standard Deviation|0.62|0.62|||
3927427|NCT01414114|3750063|B1||> 700 pg/mL|Parathyroid Hormone Category||Participants|Count of Participants|15|15.0||||||
3927428|NCT01414114|3750063|B1||≤ 700 pg/mL|Parathyroid Hormone Category||Participants|Count of Participants|22|22.0||||||
3927429|NCT01414114|3750063|B1|||Parathyroid Hormone (PTH)||pg/mL|Mean|853.4|853.4|Standard Deviation|644.25|644.25|||
3927430|NCT01414114|3750063|B1||Not Hispanic or Latino|Ethnicity||Participants|Count of Participants|26|26.0||||||
3927431|NCT01414114|3750063|B1||Hispanic or Latino|Ethnicity||Participants|Count of Participants|11|11.0||||||
3927432|NCT01414114|3750063|B1||Black or African American|Race||Participants|Count of Participants|19|19.0||||||
3927433|NCT01414114|3750063|B1||White|Race||Participants|Count of Participants|18|18.0||||||
3927434|NCT01414114|3750063|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3927435|NCT01414114|3750063|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3927436|NCT01414114|3750063|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|13.30|13.3|||
3927437|NCT01414036|3750081|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3927438|NCT01414036|3750082|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3927439|NCT01414036|3750083|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3927440|NCT01414036|3750081|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3927441|NCT01414036|3750082|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3927442|NCT01414036|3750083|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3927443|NCT01414036|3750081|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3927444|NCT01414036|3750082|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3927445|NCT01414036|3750083|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3927446|NCT01414036|3750081|B3||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3927447|NCT01414036|3750082|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3927448|NCT01414036|3750083|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3927449|NCT01414036|3750081|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3927450|NCT01414036|3750082|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3927451|NCT01414036|3750083|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3927452|NCT01414010|3750094|B5|United States||Region of Enrollment||participants|Number|32|32.0||||||
3927453|NCT01414010|3750095|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
3927454|NCT01414010|3750096|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3927455|NCT01414010|3750097|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3927456|NCT01414010|3750098|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3927457|NCT01414010|3750094|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3927458|NCT01414010|3750095|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3927459|NCT01414010|3750096|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3927460|NCT01414010|3750097|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3927461|NCT01414010|3750098|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3927462|NCT01414010|3750094|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3927463|NCT01414010|3750095|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3927464|NCT01414010|3750096|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3927465|NCT01414010|3750097|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3927466|NCT01414010|3750098|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3927467|NCT01414010|3750094|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3927468|NCT01414010|3750095|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3927469|NCT01414010|3750096|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3927470|NCT01414010|3750097|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3927471|NCT01414010|3750098|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3927472|NCT01414010|3750094|B5||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3927473|NCT01414010|3750095|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3927474|NCT01414010|3750096|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3927475|NCT01414010|3750097|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3927476|NCT01414010|3750098|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3927477|NCT01414010|3750094|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3927478|NCT01414010|3750095|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3927479|NCT01414010|3750096|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3927480|NCT01414010|3750097|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3927481|NCT01414010|3750098|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3927482|NCT01414010|3750094|B5|||Age||years|Mean|32|32.0|Standard Deviation|10.1|10.1|||
3927483|NCT01414010|3750095|B4|||Age||years|Mean|29.9|29.9|Standard Deviation|10.3|10.3|||
3927484|NCT01414010|3750096|B3|||Age||years|Mean|32.1|32.1|Standard Deviation|8.9|8.9|||
3927485|NCT01414010|3750097|B2|||Age||years|Mean|32.9|32.9|Standard Deviation|9.8|9.8|||
3927486|NCT01414010|3750098|B1|||Age||years|Mean|33.5|33.5|Standard Deviation|13.7|13.7|||
3927487|NCT01413958|3750117|B3||Male|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
3927488|NCT01413958|3750118|B2||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3927489|NCT01413958|3750119|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3927490|NCT01413958|3750117|B3||Female|Sex: Female, Male||Participants|Count of Participants|353|353.0||||||
3927491|NCT01413958|3750118|B2||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
3927492|NCT01413958|3750119|B1||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
3927493|NCT01413958|3750117|B3|||Age||years|Mean|40.1|40.1|Standard Deviation|11.62|11.62|||
3927494|NCT01413958|3750118|B2|||Age||years|Mean|40.1|40.1|Standard Deviation|11.62|11.62|||
3927495|NCT01413958|3750119|B1|||Age||years|Mean|40.1|40.1|Standard Deviation|11.64|11.64|||
3927496|NCT01413750|3750151|B5|United States||Region of Enrollment||participants|Number|23|23.0||||||
3927497|NCT01413750|3750152|B4|United States||Region of Enrollment||participants|Number|7|7.0||||||
3927498|NCT01413750|3750153|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3927499|NCT01413750|3750154|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3927500|NCT01413750|3750155|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3927501|NCT01413750|3750151|B5||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3927502|NCT01413750|3750152|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3927503|NCT01413750|3750153|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3927504|NCT01413750|3750154|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3927505|NCT01413750|3750155|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3927506|NCT01413750|3750151|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3927507|NCT01413750|3750152|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3927508|NCT01413750|3750153|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3927509|NCT01413750|3750154|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3927510|NCT01413750|3750155|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3927511|NCT01413750|3750151|B5|||Age||years|Median|63|63.0|Full Range|||24.0|79.0|
3927512|NCT01413750|3750152|B4|||Age||years|Median|65|65.0|Full Range|||52.0|72.0|
3927513|NCT01413750|3750153|B3|||Age||years|Median|72|72.0|Full Range|||62.0|77.0|
3927514|NCT01413750|3750154|B2|||Age||years|Median|59|59.0|Full Range|||24.0|79.0|
3927515|NCT01413750|3750155|B1|||Age||years|Median|61|61.0|Full Range|||53.0|64.0|
3927516|NCT01413542|3750169|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
3927517|NCT01413542|3750170|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3927518|NCT01413542|3750171|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3927519|NCT01413542|3750169|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927520|NCT01413542|3750170|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927521|NCT01413542|3750171|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927522|NCT01413542|3750169|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927523|NCT01413542|3750170|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927524|NCT01413542|3750171|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927525|NCT01413542|3750169|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3927526|NCT01413542|3750170|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3927527|NCT01413542|3750171|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3927528|NCT01413542|3750169|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3927529|NCT01413542|3750170|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3927530|NCT01413542|3750171|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3927531|NCT01413542|3750169|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927532|NCT01413542|3750170|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927533|NCT01413542|3750171|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927534|NCT01413542|3750169|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927535|NCT01413542|3750170|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927536|NCT01413542|3750171|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927537|NCT01413542|3750169|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927538|NCT01413542|3750170|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927539|NCT01413542|3750171|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927540|NCT01413542|3750169|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3927541|NCT01413542|3750170|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3927542|NCT01413542|3750171|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3927543|NCT01413542|3750169|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3927544|NCT01413542|3750170|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3927545|NCT01413542|3750171|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3927546|NCT01413542|3750169|B3|||Age||years|Mean|36.5|36.5|Standard Deviation|10.7|10.7|||
3927547|NCT01413542|3750170|B2|||Age||years|Mean|35.4|35.4|Standard Deviation|10.0|10.0|||
3927548|NCT01413542|3750171|B1|||Age||years|Mean|38.1|38.1|Standard Deviation|12.0|12.0|||
3927549|NCT01413516|3750187|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
3927550|NCT01413516|3750188|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3927551|NCT01413516|3750189|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3927552|NCT01413516|3750187|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3927553|NCT01413516|3750188|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3927554|NCT01413516|3750189|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3927555|NCT01413516|3750187|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3927556|NCT01413516|3750188|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3927557|NCT01413516|3750189|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3927558|NCT01413516|3750187|B3|||Age||years|Mean|50|50.0|Standard Deviation|13|13.0|||
3927559|NCT01413516|3750188|B2|||Age||years|Mean|48|48.0|Standard Deviation|13|13.0|||
3927560|NCT01413516|3750189|B1|||Age||years|Mean|52|52.0|Standard Deviation|14|14.0|||
3927561|NCT01413516|3750187|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3927562|NCT01413516|3750188|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3927563|NCT01413516|3750189|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3927564|NCT01413516|3750187|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3927565|NCT01413516|3750188|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3927566|NCT01413516|3750189|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3927567|NCT01413516|3750187|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3927568|NCT01413516|3750188|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3927569|NCT01413516|3750189|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3927570|NCT01413503|3750196|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
3927571|NCT01413503|3750196|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3927572|NCT01413503|3750196|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3927573|NCT01413503|3750196|B1|||Age||years|Mean|42.6|42.6|Full Range|||10.3|64.4|
3927574|NCT01413360|3750200|B1|||ALT||IU/L|Median|65|65.0|Full Range|||41.0|142.0|
3927575|NCT01413360|3750200|B1|Alcohol||Etiology||participants|Number|3|3.0||||||
3927576|NCT01413360|3750200|B1|HCV||Etiology||participants|Number|7|7.0||||||
3927577|NCT01413360|3750200|B1|Korea, Republic of||Region of Enrollment||participants|Number|10|10.0||||||
3927578|NCT01413360|3750200|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3927579|NCT01413360|3750200|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3927580|NCT01413360|3750200|B1|||Age||years|Median|62|62.0|Full Range|||39.0|70.0|
3927581|NCT01413204|3750205|B4||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
3927582|NCT01413204|3750206|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3927583|NCT01413204|3750207|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3927584|NCT01413204|3750208|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3927585|NCT01413204|3750205|B4||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3927586|NCT01413204|3750206|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3927587|NCT01413204|3750207|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3927588|NCT01413204|3750208|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3927589|NCT01413204|3750205|B4|||Age||years|Mean|58|58.0|Standard Deviation|10.8|10.8|||
3927590|NCT01413204|3750206|B3|||Age||years|Mean|58.2|58.2|Standard Deviation|11|11.0|||
3927591|NCT01413204|3750207|B2|||Age||years|Mean|57.3|57.3|Standard Deviation|11.1|11.1|||
3927592|NCT01413204|3750208|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|10.4|10.4|||
3927593|NCT01413191|3750218|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3927594|NCT01413191|3750218|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3927595|NCT01413191|3750218|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3927596|NCT01413191|3750218|B1|||Age||years|Median|67|67.0|Full Range|||41.0|85.0|
3927597|NCT01412983|3750222|B1|United States||Region of Enrollment||participants|Number|99|99.0||||||
3927598|NCT01412983|3750222|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927599|NCT01412983|3750222|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927600|NCT01412983|3750222|B1||White|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3927601|NCT01412983|3750222|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3927602|NCT01412983|3750222|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927603|NCT01412983|3750222|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3927604|NCT01412983|3750222|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927605|NCT01412983|3750222|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3927606|NCT01412983|3750222|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3927607|NCT01412983|3750222|B1|||Age||years|Mean|29.9|29.9|Standard Deviation|7.6|7.6|||
3927608|NCT01412957|3750231|B3|Missing||Location of Primary Tumor||participants|Number|1|1.0||||||
3927609|NCT01412957|3750232|B2|Missing||Location of Primary Tumor||participants|Number|1|1.0||||||
3927610|NCT01412957|3750233|B1|Missing||Location of Primary Tumor||participants|Number|0|0.0||||||
3927611|NCT01412957|3750231|B3|Rectum||Location of Primary Tumor||participants|Number|162|162.0||||||
3927612|NCT01412957|3750232|B2|Rectum||Location of Primary Tumor||participants|Number|81|81.0||||||
3927613|NCT01412957|3750233|B1|Rectum||Location of Primary Tumor||participants|Number|81|81.0||||||
3927614|NCT01412957|3750231|B3|Colon||Location of Primary Tumor||participants|Number|214|214.0||||||
3927615|NCT01412957|3750232|B2|Colon||Location of Primary Tumor||participants|Number|106|106.0||||||
3927616|NCT01412957|3750233|B1|Colon||Location of Primary Tumor||participants|Number|108|108.0||||||
3927617|NCT01412957|3750231|B3|Grade 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|34|34.0||||||
3927618|NCT01412957|3750232|B2|Grade 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|16|16.0||||||
3927619|NCT01412957|3750233|B1|Grade 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|18|18.0||||||
3927620|NCT01412957|3750231|B3|Grade 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|207|207.0||||||
3927621|NCT01412957|3750232|B2|Grade 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|107|107.0||||||
3927622|NCT01412957|3750233|B1|Grade 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|100|100.0||||||
3927623|NCT01412957|3750231|B3|Grade 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|136|136.0||||||
3927624|NCT01412957|3750232|B2|Grade 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|65|65.0||||||
3927625|NCT01412957|3750233|B1|Grade 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|71|71.0||||||
3927626|NCT01412957|3750231|B3|Rest of world||Geographic Region||participants|Number|44|44.0||||||
3927627|NCT01412957|3750232|B2|Rest of world||Geographic Region||participants|Number|21|21.0||||||
3927628|NCT01412957|3750233|B1|Rest of world||Geographic Region||participants|Number|23|23.0||||||
3927629|NCT01412957|3750231|B3|Asia||Geographic Region||participants|Number|162|162.0||||||
3927630|NCT01412957|3750232|B2|Asia||Geographic Region||participants|Number|82|82.0||||||
3927631|NCT01412957|3750233|B1|Asia||Geographic Region||participants|Number|80|80.0||||||
3927632|NCT01412957|3750231|B3|Europe||Geographic Region||participants|Number|171|171.0||||||
3927633|NCT01412957|3750232|B2|Europe||Geographic Region||participants|Number|85|85.0||||||
3927634|NCT01412957|3750233|B1|Europe||Geographic Region||participants|Number|86|86.0||||||
3927635|NCT01412957|3750231|B3|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3927636|NCT01412957|3750232|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3927637|NCT01412957|3750233|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3927638|NCT01412957|3750231|B3|White||Race/Ethnicity, Customized||participants|Number|209|209.0||||||
3927639|NCT01412957|3750232|B2|White||Race/Ethnicity, Customized||participants|Number|102|102.0||||||
3927640|NCT01412957|3750233|B1|White||Race/Ethnicity, Customized||participants|Number|107|107.0||||||
3927641|NCT01412957|3750231|B3|Asian||Race/Ethnicity, Customized||participants|Number|161|161.0||||||
3927642|NCT01412957|3750232|B2|Asian||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
3927643|NCT01412957|3750233|B1|Asian||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
3927644|NCT01412957|3750231|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3927645|NCT01412957|3750232|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3927646|NCT01412957|3750233|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3927647|NCT01412957|3750231|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|332|332.0||||||
3927648|NCT01412957|3750232|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|166|166.0||||||
3927649|NCT01412957|3750233|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|166|166.0||||||
3927650|NCT01412957|3750231|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
3927651|NCT01412957|3750232|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3927652|NCT01412957|3750233|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3927653|NCT01412957|3750231|B3||Male|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
3927654|NCT01412957|3750232|B2||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3927655|NCT01412957|3750233|B1||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3927656|NCT01412957|3750231|B3||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3927657|NCT01412957|3750232|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3927658|NCT01412957|3750233|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3927659|NCT01412957|3750231|B3|||Age||years|Mean|59.4|59.4|Standard Deviation|10.9|10.9|||
3927660|NCT01412957|3750232|B2|||Age||years|Mean|58.7|58.7|Standard Deviation|11.1|11.1|||
3927661|NCT01412957|3750233|B1|||Age||years|Mean|60.2|60.2|Standard Deviation|10.7|10.7|||
3927662|NCT01412944|3750254|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3927663|NCT01412944|3750255|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3927664|NCT01412944|3750256|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3927665|NCT01412944|3750254|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3927666|NCT01412944|3750255|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3927667|NCT01412944|3750256|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3927668|NCT01412944|3750254|B3|||Age||Years|Mean|46.6|46.6|Standard Deviation|13.24|13.24|||
3927669|NCT01412944|3750255|B2|||Age||Years|Mean|45.7|45.7|Standard Deviation|12.14|12.14|||
3927670|NCT01412944|3750256|B1|||Age||Years|Mean|47.6|47.6|Standard Deviation|14.53|14.53|||
3927671|NCT01412918|3750295|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3927672|NCT01412918|3750296|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3927673|NCT01412918|3750297|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3927674|NCT01412918|3750295|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3927675|NCT01412918|3750296|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3927676|NCT01412918|3750297|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3927677|NCT01412918|3750295|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3927678|NCT01412918|3750296|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3927679|NCT01412918|3750297|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3927680|NCT01412918|3750295|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3927681|NCT01412918|3750296|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3927682|NCT01412918|3750297|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3927683|NCT01412918|3750295|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3927684|NCT01412918|3750296|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3927685|NCT01412918|3750297|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3927686|NCT01412879|3750305|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3927687|NCT01412879|3750306|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3927688|NCT01412879|3750307|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3927689|NCT01412879|3750305|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927690|NCT01412879|3750306|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927691|NCT01412879|3750307|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927692|NCT01412879|3750305|B3||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3927693|NCT01412879|3750306|B2||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3927694|NCT01412879|3750307|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3927695|NCT01412879|3750305|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3927696|NCT01412879|3750306|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3927697|NCT01412879|3750307|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3927698|NCT01412879|3750305|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927699|NCT01412879|3750306|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927700|NCT01412879|3750307|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927701|NCT01412879|3750305|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3927702|NCT01412879|3750306|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927703|NCT01412879|3750307|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3927704|NCT01412879|3750305|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927705|NCT01412879|3750306|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927706|NCT01412879|3750307|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927707|NCT01412879|3750305|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3927708|NCT01412879|3750306|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927709|NCT01412879|3750307|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3927710|NCT01412879|3750305|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3927711|NCT01412879|3750306|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3927712|NCT01412879|3750307|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3927713|NCT01412879|3750305|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927714|NCT01412879|3750306|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927715|NCT01412879|3750307|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927716|NCT01412879|3750305|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3927717|NCT01412879|3750306|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3927718|NCT01412879|3750307|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3927719|NCT01412879|3750305|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3927720|NCT01412879|3750306|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3927721|NCT01412879|3750307|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3927722|NCT01412879|3750305|B3|||Age||years|Median|57.2|57.2|Full Range|||33.0|65.7|
3927723|NCT01412879|3750306|B2|||Age||years|Median|56.6|56.6|Full Range|||33.0|64.1|
3927724|NCT01412879|3750307|B1|||Age||years|Median|58.8|58.8|Full Range|||43.6|65.7|
3927725|NCT01412866|3750323|B3|||Cigarettes smoked per day||Cigarettes|Mean|15.0|15.0|Standard Deviation|11.2|11.2|||
3927726|NCT01412866|3750324|B2|||Cigarettes smoked per day||Cigarettes|Mean|15.1|15.1|Standard Deviation|10.8|10.8|||
3927727|NCT01412866|3750325|B1|||Cigarettes smoked per day||Cigarettes|Mean|15.0|15.0|Standard Deviation|11.8|11.8|||
3927728|NCT01412866|3750323|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3927729|NCT01412866|3750324|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3927730|NCT01412866|3750325|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3927731|NCT01412866|3750323|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3927732|NCT01412866|3750324|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3927733|NCT01412866|3750325|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3927734|NCT01412866|3750323|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|60|60.0||||||
3927735|NCT01412866|3750324|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3927736|NCT01412866|3750325|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3927737|NCT01412866|3750323|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3927738|NCT01412866|3750324|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3927739|NCT01412866|3750325|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3927740|NCT01412866|3750323|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3927741|NCT01412866|3750324|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3927742|NCT01412866|3750325|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3927743|NCT01412866|3750323|B3|||Age||years|Mean|46.5|46.5|Standard Deviation|10.1|10.1|||
3927744|NCT01412866|3750324|B2|||Age||years|Mean|46.3|46.3|Standard Deviation|10.8|10.8|||
3927745|NCT01412866|3750325|B1|||Age||years|Mean|46.7|46.7|Standard Deviation|9.3|9.3|||
3927746|NCT01412801|3750332|B7||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3927747|NCT01412801|3750333|B6||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3927748|NCT01412801|3750334|B5||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3927749|NCT01412801|3750335|B4||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3927750|NCT01412801|3750336|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3927751|NCT01412801|3750337|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3927752|NCT01412801|3750338|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3927753|NCT01412801|3750332|B7||Female|Sex: Female, Male||Participants|Count of Participants|393|393.0||||||
3927754|NCT01412801|3750333|B6||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3927755|NCT01412801|3750334|B5||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3927756|NCT01412801|3750335|B4||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3927757|NCT01412801|3750336|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3927758|NCT01412801|3750337|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3927759|NCT01412801|3750338|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3927760|NCT01412801|3750332|B7|Infants||Age, Customized||days|Mean|1.6|1.6|Standard Deviation|1.0|1.0|||
3927761|NCT01412801|3750333|B6|Infants||Age, Customized||days|Mean|1.3|1.3|Standard Deviation|1.1|1.1|||
3927762|NCT01412801|3750334|B5|Infants||Age, Customized||days|Mean|6.7|6.7|Standard Deviation|2.5|2.5|||
3927763|NCT01412801|3750335|B4|Infants||Age, Customized||days|Mean|4.1|4.1|Standard Deviation|1.6|1.6|||
3927764|NCT01412801|3750336|B3|Infants||Age, Customized||days|Mean|NA||Standard Deviation|NA||||"Infants' ages only provided here"
3927765|NCT01412801|3750337|B2|Infants||Age, Customized||days|Mean|NA||Standard Deviation|NA||||"Infants' ages only provided here"
3927766|NCT01412801|3750338|B1|Infants||Age, Customized||days|Mean|NA||Standard Deviation|NA||||"Infants' ages only provided here"
3927767|NCT01412801|3750332|B7|Maternal Subjects||Age, Customized||years|Mean|27.1|27.1|Standard Deviation|5.0|5.0|||
3927768|NCT01412801|3750333|B6|Maternal Subjects||Age, Customized||years|Mean|NA||Standard Deviation|NA||||"Mothers' ages only provided Here"
3927769|NCT01412801|3750334|B5|Maternal Subjects||Age, Customized||years|Mean|NA||Standard Deviation|NA||||"Mothers' ages only provided Here"
3927770|NCT01412801|3750335|B4|Maternal Subjects||Age, Customized||years|Mean|NA||Standard Deviation|NA||||"Mothers' ages only provided Here"
3927771|NCT01412801|3750336|B3|Maternal Subjects||Age, Customized||years|Mean|24.7|24.7|Standard Deviation|4.4|4.4|||
3927772|NCT01412801|3750337|B2|Maternal Subjects||Age, Customized||years|Mean|28.1|28.1|Standard Deviation|5.2|5.2|||
3927773|NCT01412801|3750338|B1|Maternal Subjects||Age, Customized||years|Mean|28.3|28.3|Standard Deviation|4.8|4.8|||
3927774|NCT01412710|3750380|B3|United States||Region of Enrollment||Participants|Count of Participants|77|77.0||||||
3927775|NCT01412710|3750381|B2|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3927776|NCT01412710|3750382|B1|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3927777|NCT01412710|3750380|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927778|NCT01412710|3750381|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927779|NCT01412710|3750382|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927780|NCT01412710|3750380|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3927781|NCT01412710|3750381|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3927782|NCT01412710|3750382|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3927783|NCT01412710|3750380|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3927784|NCT01412710|3750381|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3927785|NCT01412710|3750382|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3927786|NCT01412710|3750380|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3927787|NCT01412710|3750381|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3927788|NCT01412710|3750382|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3927789|NCT01412710|3750380|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3927790|NCT01412710|3750381|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3927791|NCT01412710|3750382|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3927792|NCT01412710|3750380|B3|||Age||years|Mean|54.46|54.46|Standard Deviation|9.77|9.77|||
3927793|NCT01412710|3750381|B2|||Age||years|Mean|54.17|54.17|Standard Deviation|10.99|10.99|||
3927794|NCT01412710|3750382|B1|||Age||years|Mean|54.76|54.76|Standard Deviation|8.56|8.56|||
3927795|NCT01412710|3750380|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3927796|NCT01412710|3750381|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3927797|NCT01412710|3750382|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3927798|NCT01412710|3750380|B3||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
3927799|NCT01412710|3750381|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3927800|NCT01412710|3750382|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3927801|NCT01412710|3750380|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3927802|NCT01412710|3750381|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3927803|NCT01412710|3750382|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3927804|NCT01412541|3750391|B3||Male|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
3927805|NCT01412541|3750392|B2||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3927806|NCT01412541|3750393|B1||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
3927807|NCT01412541|3750391|B3||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
3927808|NCT01412541|3750392|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3927809|NCT01412541|3750393|B1||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3927810|NCT01412541|3750391|B3|||Age||years|Mean|68.2|68.2|Standard Deviation|9.7|9.7|||
3927811|NCT01412541|3750392|B2|||Age||years|Mean|69.0|69.0|Standard Deviation|9.0|9.0|||
3927812|NCT01412541|3750393|B1|||Age||years|Mean|67.8|67.8|Standard Deviation|10.0|10.0|||
3927813|NCT01412424|3750502|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3927814|NCT01412424|3750502|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927815|NCT01412424|3750502|B1||White|Race (NIH/OMB)||Participants|Count of Participants|137|137.0||||||
3927816|NCT01412424|3750502|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927817|NCT01412424|3750502|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927818|NCT01412424|3750502|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3927819|NCT01412424|3750502|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927820|NCT01412424|3750502|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927821|NCT01412424|3750502|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|135|135.0||||||
3927822|NCT01412424|3750502|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3927823|NCT01412424|3750502|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3927824|NCT01412424|3750502|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3927825|NCT01412424|3750502|B1|||Age||Years|Mean|54.2|54.2|Standard Deviation|11.54|11.54|||
3927826|NCT01412333|3750518|B3||Male|Sex: Female, Male||Participants|Count of Participants|284|284.0||||||
3927827|NCT01412333|3750519|B2||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3927828|NCT01412333|3750520|B1||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3927829|NCT01412333|3750518|B3||Female|Sex: Female, Male||Participants|Count of Participants|551|551.0||||||
3927830|NCT01412333|3750519|B2||Female|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
3927831|NCT01412333|3750520|B1||Female|Sex: Female, Male||Participants|Count of Participants|280|280.0||||||
3927832|NCT01412333|3750518|B3|||Age||years|Mean|37.3|37.3|Standard Deviation|9.0|9.0|||
3927833|NCT01412333|3750519|B2|||Age||years|Mean|37.2|37.2|Standard Deviation|9.1|9.1|||
3927834|NCT01412333|3750520|B1|||Age||years|Mean|37.4|37.4|Standard Deviation|9.0|9.0|||
3927835|NCT01412281|3750552|B5|Switzerland||Region of Enrollment||participants|Number|440|440.0||||||
3927836|NCT01412281|3750553|B4|Switzerland||Region of Enrollment||participants|Number|110|110.0||||||
3927837|NCT01412281|3750554|B3|Switzerland||Region of Enrollment||participants|Number|110|110.0||||||
3927838|NCT01412281|3750555|B2|Switzerland||Region of Enrollment||participants|Number|110|110.0||||||
3927839|NCT01412281|3750556|B1|Switzerland||Region of Enrollment||participants|Number|110|110.0||||||
3927840|NCT01412281|3750552|B5||Male|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
3927841|NCT01412281|3750553|B4||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3927842|NCT01412281|3750554|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3927843|NCT01412281|3750555|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3927844|NCT01412281|3750556|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3927845|NCT01412281|3750552|B5||Female|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
3927846|NCT01412281|3750553|B4||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3927847|NCT01412281|3750554|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3927848|NCT01412281|3750555|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3927849|NCT01412281|3750556|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3927850|NCT01412281|3750552|B5|||Age||years|Mean|54.6|54.6|Standard Deviation|16.56|16.56|||
3927851|NCT01412281|3750553|B4|||Age||years|Mean|67.8|67.8|Standard Deviation|5.31|5.31|||
3927852|NCT01412281|3750554|B3|||Age||years|Mean|68.4|68.4|Standard Deviation|5.86|5.86|||
3927853|NCT01412281|3750555|B2|||Age||years|Mean|42.5|42.5|Standard Deviation|11.98|11.98|||
3927854|NCT01412281|3750556|B1|||Age||years|Mean|39.6|39.6|Standard Deviation|12.46|12.46|||
3927855|NCT01412281|3750552|B5||>=65 years|Age||Participants|Count of Participants|149|149.0||||||
3927856|NCT01412281|3750553|B4||>=65 years|Age||Participants|Count of Participants|72|72.0||||||
3927857|NCT01412281|3750554|B3||>=65 years|Age||Participants|Count of Participants|77|77.0||||||
3927858|NCT01412281|3750555|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3927859|NCT01412281|3750556|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3927860|NCT01412281|3750552|B5||Between 18 and 65 years|Age||Participants|Count of Participants|291|291.0||||||
3927861|NCT01412281|3750553|B4||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3927862|NCT01412281|3750554|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3927863|NCT01412281|3750555|B2||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
3927864|NCT01412281|3750556|B1||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
3927865|NCT01412281|3750552|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3927866|NCT01412281|3750553|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3927867|NCT01412281|3750554|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3927868|NCT01412281|3750555|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3927869|NCT01412281|3750556|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3927870|NCT01412229|3750581|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
3927871|NCT01412229|3750581|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3927872|NCT01412229|3750581|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927873|NCT01412229|3750581|B1||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3927874|NCT01412229|3750581|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3927875|NCT01412229|3750581|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927876|NCT01412229|3750581|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927877|NCT01412229|3750581|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927878|NCT01412229|3750581|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3927879|NCT01412229|3750581|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3927880|NCT01412229|3750581|B1|||Age||years|Median|62|62.0|Full Range|||46.0|82.0|
3927881|NCT01412164|3750593|B1|China||Region of Enrollment||participants|Number|730|730.0||||||
3927882|NCT01412164|3750593|B1||Male|Sex: Female, Male||Participants|Count of Participants|517|517.0||||||
3927883|NCT01412164|3750593|B1||Female|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
3927884|NCT01412164|3750593|B1|||Age||years|Mean|58.71|58.71|Standard Deviation|8.90|8.9|||
3927885|NCT01412151|3750597|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3927886|NCT01412151|3750597|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3927887|NCT01412151|3750597|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3927888|NCT01412151|3750597|B1|||Age||years|Mean|48.2|48.2|Standard Deviation|8.4|8.4|||
3927889|NCT01412151|3750597|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3927890|NCT01412151|3750597|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3927891|NCT01412151|3750597|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3927892|NCT01412086|3750603|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3927893|NCT01412086|3750603|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3927894|NCT01412086|3750603|B1|||Age||Years|Mean|44.3|44.3|Full Range|||18.0|67.0|
3927895|NCT01412060|3750608|B1|||Waist circumference||cm|Mean|90.39|90.39|Standard Deviation|15.34|15.34|||
3927896|NCT01412060|3750608|B1|||Body Mass Index (BMI)||kg/m^2|Mean|26.50|26.5|Standard Deviation|5.63|5.63|||
3927897|NCT01412060|3750608|B1|||Height||cm|Mean|170.98|170.98|Standard Deviation|9.95|9.95|||
3927898|NCT01412060|3750608|B1|||Weight||kg|Mean|78.07|78.07|Standard Deviation|20.10|20.1|||
3927899|NCT01412060|3750608|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927900|NCT01412060|3750608|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3927901|NCT01412060|3750608|B1||White|Race (NIH/OMB)||Participants|Count of Participants|299|299.0||||||
3927902|NCT01412060|3750608|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|313|313.0||||||
3927903|NCT01412060|3750608|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3927904|NCT01412060|3750608|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|149|149.0||||||
3927905|NCT01412060|3750608|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927906|NCT01412060|3750608|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927907|NCT01412060|3750608|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|728|728.0||||||
3927908|NCT01412060|3750608|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3927909|NCT01412060|3750608|B1||Male|Sex: Female, Male||Participants|Count of Participants|544|544.0||||||
3927910|NCT01412060|3750608|B1||Female|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
3927911|NCT01412060|3750608|B1|||Age||years|Mean|38.4|38.4|Standard Deviation|10.4|10.4|||
3927912|NCT01411995|3750620|B3|Resident||Clinician inserter||participants|Number|15|15.0||||||
3927913|NCT01411995|3750621|B2|Resident||Clinician inserter||participants|Number|9|9.0||||||
3927914|NCT01411995|3750622|B1|Resident||Clinician inserter||participants|Number|6|6.0||||||
3927915|NCT01411995|3750620|B3|Nurse Practioner||Clinician inserter||participants|Number|94|94.0||||||
3927916|NCT01411995|3750621|B2|Nurse Practioner||Clinician inserter||participants|Number|46|46.0||||||
3927917|NCT01411995|3750622|B1|Nurse Practioner||Clinician inserter||participants|Number|48|48.0||||||
3927918|NCT01411995|3750620|B3|Physician||Clinician inserter||participants|Number|90|90.0||||||
3927919|NCT01411995|3750621|B2|Physician||Clinician inserter||participants|Number|44|44.0||||||
3927920|NCT01411995|3750622|B1|Physician||Clinician inserter||participants|Number|46|46.0||||||
3927921|NCT01411995|3750620|B3|Cu-IUD||IUD type||participants|Number|47|47.0||||||
3927922|NCT01411995|3750621|B2|Cu-IUD||IUD type||participants|Number|24|24.0||||||
3927923|NCT01411995|3750622|B1|Cu-IUD||IUD type||participants|Number|23|23.0||||||
3927924|NCT01411995|3750620|B3|LNG-IUD||IUD type||participants|Number|152|152.0||||||
3927925|NCT01411995|3750621|B2|LNG-IUD||IUD type||participants|Number|75|75.0||||||
3927926|NCT01411995|3750622|B1|LNG-IUD||IUD type||participants|Number|77|77.0||||||
3927927|NCT01411995|3750620|B3|Yes||History of abortion||participants|Number|73|73.0||||||
3927928|NCT01411995|3750621|B2|Yes||History of abortion||participants|Number|32|32.0||||||
3927929|NCT01411995|3750622|B1|Yes||History of abortion||participants|Number|41|41.0||||||
3927930|NCT01411995|3750620|B3|No||History of abortion||participants|Number|126|126.0||||||
3927931|NCT01411995|3750621|B2|No||History of abortion||participants|Number|67|67.0||||||
3927932|NCT01411995|3750622|B1|No||History of abortion||participants|Number|59|59.0||||||
3927933|NCT01411995|3750620|B3|College graduate||Education||participants|Number|74|74.0||||||
3927934|NCT01411995|3750621|B2|College graduate||Education||participants|Number|41|41.0||||||
3927935|NCT01411995|3750622|B1|College graduate||Education||participants|Number|33|33.0||||||
3927936|NCT01411995|3750620|B3|Some College||Education||participants|Number|92|92.0||||||
3927937|NCT01411995|3750621|B2|Some College||Education||participants|Number|40|40.0||||||
3927938|NCT01411995|3750622|B1|Some College||Education||participants|Number|52|52.0||||||
3927939|NCT01411995|3750620|B3|Less than or equal to HS||Education||participants|Number|33|33.0||||||
3927940|NCT01411995|3750621|B2|Less than or equal to HS||Education||participants|Number|18|18.0||||||
3927941|NCT01411995|3750622|B1|Less than or equal to HS||Education||participants|Number|15|15.0||||||
3927942|NCT01411995|3750620|B3|greater than or equal to 3||Parity||participants|Number|19|19.0||||||
3927943|NCT01411995|3750621|B2|greater than or equal to 3||Parity||participants|Number|11|11.0||||||
3927944|NCT01411995|3750622|B1|greater than or equal to 3||Parity||participants|Number|8|8.0||||||
3927945|NCT01411995|3750620|B3|1-2||Parity||participants|Number|80|80.0||||||
3927946|NCT01411995|3750621|B2|1-2||Parity||participants|Number|38|38.0||||||
3927947|NCT01411995|3750622|B1|1-2||Parity||participants|Number|42|42.0||||||
3927948|NCT01411995|3750620|B3|0||Parity||participants|Number|100|100.0||||||
3927949|NCT01411995|3750621|B2|0||Parity||participants|Number|50|50.0||||||
3927950|NCT01411995|3750622|B1|0||Parity||participants|Number|50|50.0||||||
3927951|NCT01411995|3750620|B3|greater than 30.0||BMI|kg/m^2|participants|Number|52|52.0||||||
3927952|NCT01411995|3750621|B2|greater than 30.0||BMI|kg/m^2|participants|Number|28|28.0||||||
3927953|NCT01411995|3750622|B1|greater than 30.0||BMI|kg/m^2|participants|Number|24|24.0||||||
3927954|NCT01411995|3750620|B3|25.1-30.0||BMI|kg/m^2|participants|Number|56|56.0||||||
3927955|NCT01411995|3750621|B2|25.1-30.0||BMI|kg/m^2|participants|Number|28|28.0||||||
3927956|NCT01411995|3750622|B1|25.1-30.0||BMI|kg/m^2|participants|Number|28|28.0||||||
3927957|NCT01411995|3750620|B3|18.5-25||BMI|kg/m^2|participants|Number|86|86.0||||||
3927958|NCT01411995|3750621|B2|18.5-25||BMI|kg/m^2|participants|Number|41|41.0||||||
3927959|NCT01411995|3750622|B1|18.5-25||BMI|kg/m^2|participants|Number|45|45.0||||||
3927960|NCT01411995|3750620|B3|Less than 18.5||BMI|kg/m^2|participants|Number|5|5.0||||||
3927961|NCT01411995|3750621|B2|Less than 18.5||BMI|kg/m^2|participants|Number|2|2.0||||||
3927962|NCT01411995|3750622|B1|Less than 18.5||BMI|kg/m^2|participants|Number|3|3.0||||||
3927963|NCT01411995|3750620|B3|United States||Region of Enrollment||participants|Number|199|199.0||||||
3927964|NCT01411995|3750621|B2|United States||Region of Enrollment||participants|Number|99|99.0||||||
3927965|NCT01411995|3750622|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
3927966|NCT01411995|3750620|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927967|NCT01411995|3750621|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927968|NCT01411995|3750622|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927969|NCT01411995|3750620|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3927970|NCT01411995|3750621|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3927971|NCT01411995|3750622|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3927972|NCT01411995|3750620|B3||White|Race (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
3927973|NCT01411995|3750621|B2||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3927974|NCT01411995|3750622|B1||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3927975|NCT01411995|3750620|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3927976|NCT01411995|3750621|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3927977|NCT01411995|3750622|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3927978|NCT01411995|3750620|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927979|NCT01411995|3750621|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927980|NCT01411995|3750622|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927981|NCT01411995|3750620|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927982|NCT01411995|3750621|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927983|NCT01411995|3750622|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927984|NCT01411995|3750620|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927985|NCT01411995|3750621|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927986|NCT01411995|3750622|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3927987|NCT01411995|3750620|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3927988|NCT01411995|3750621|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3927989|NCT01411995|3750622|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3927990|NCT01411995|3750620|B3||Female|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
3927991|NCT01411995|3750621|B2||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3927992|NCT01411995|3750622|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3927993|NCT01411995|3750620|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3927994|NCT01411995|3750621|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3927995|NCT01411995|3750622|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3927996|NCT01411995|3750620|B3||Between 18 and 65 years|Age||Participants|Count of Participants|199|199.0||||||
3927997|NCT01411995|3750621|B2||Between 18 and 65 years|Age||Participants|Count of Participants|99|99.0||||||
3927998|NCT01411995|3750622|B1||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
3927999|NCT01411995|3750620|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3928000|NCT01411995|3750621|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3928001|NCT01411995|3750622|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3928002|NCT01411891|3750629|B3|United States||Region of Enrollment||participants|Number|95|95.0||||||
3928003|NCT01411891|3750630|B2|United States||Region of Enrollment||participants|Number|48|48.0||||||
3928004|NCT01411891|3750631|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
3928005|NCT01411891|3750629|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3928006|NCT01411891|3750630|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3928007|NCT01411891|3750631|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3928008|NCT01411891|3750629|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3928009|NCT01411891|3750630|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3928010|NCT01411891|3750631|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3928011|NCT01411891|3750629|B3|||Age||years|Mean|63|63.0|Standard Deviation|9.4|9.4|||
3928012|NCT01411891|3750630|B2|||Age||years|Mean|61.2|61.2|Standard Deviation|8.6|8.6|||
3928013|NCT01411891|3750631|B1|||Age||years|Mean|63.5|63.5|Standard Deviation|9.6|9.6|||
3928014|NCT01411891|3750629|B3||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
3928015|NCT01411891|3750630|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3928016|NCT01411891|3750631|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3928017|NCT01411891|3750629|B3||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
3928018|NCT01411891|3750630|B2||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3928019|NCT01411891|3750631|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3928020|NCT01411891|3750629|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3928021|NCT01411891|3750630|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3928022|NCT01411891|3750631|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3928023|NCT01411852|3750640|B3|||Total out-of-hospital time|Total number of minutes from estimated time of injury to time of hospital arrival|minutes|Mean|41.9|41.9|Standard Deviation|15.2|15.2|||
3928024|NCT01411852|3750641|B2|||Total out-of-hospital time|Total number of minutes from estimated time of injury to time of hospital arrival|minutes|Mean|42.7|42.7|Standard Deviation|16.5|16.5|||
3928025|NCT01411852|3750642|B1|||Total out-of-hospital time|Total number of minutes from estimated time of injury to time of hospital arrival|minutes|Mean|41|41.0|Standard Deviation|13.8|13.8|||
3928026|NCT01411852|3750640|B3|||Time from dispatch call to first intravenous/intraosseous access (IV/IO)|Number of minutes from time of call to dispatch to the recorded time of the first successful intravenous catheter (IV) insertion and intraosseous needle (IO) insertion|minutes|Mean|21.5|21.5|Standard Deviation|9.3|9.3|||
3928027|NCT01411852|3750641|B2|||Time from dispatch call to first intravenous/intraosseous access (IV/IO)|Number of minutes from time of call to dispatch to the recorded time of the first successful intravenous catheter (IV) insertion and intraosseous needle (IO) insertion|minutes|Mean|21|21.0|Standard Deviation|8.7|8.7|||
3928028|NCT01411852|3750642|B1|||Time from dispatch call to first intravenous/intraosseous access (IV/IO)|Number of minutes from time of call to dispatch to the recorded time of the first successful intravenous catheter (IV) insertion and intraosseous needle (IO) insertion|minutes|Mean|22.1|22.1|Standard Deviation|9.9|9.9|||
3928029|NCT01411852|3750640|B3|Number died prior to transport||Air transport|Number of patients who required air transport by helicopter accompanied by paramedic, registered nurse or physician. Criteria for transporting the patient by air include severity of injury and geographical barriers to transport by ground vehicle|participants|Number|1|1.0||||||
3928030|NCT01411852|3750641|B2|Number died prior to transport||Air transport|Number of patients who required air transport by helicopter accompanied by paramedic, registered nurse or physician. Criteria for transporting the patient by air include severity of injury and geographical barriers to transport by ground vehicle|participants|Number|0|0.0||||||
3928031|NCT01411852|3750642|B1|Number died prior to transport||Air transport|Number of patients who required air transport by helicopter accompanied by paramedic, registered nurse or physician. Criteria for transporting the patient by air include severity of injury and geographical barriers to transport by ground vehicle|participants|Number|1|1.0||||||
3928032|NCT01411852|3750640|B3|Number transported by ground||Air transport|Number of patients who required air transport by helicopter accompanied by paramedic, registered nurse or physician. Criteria for transporting the patient by air include severity of injury and geographical barriers to transport by ground vehicle|participants|Number|179|179.0||||||
3928033|NCT01411852|3750641|B2|Number transported by ground||Air transport|Number of patients who required air transport by helicopter accompanied by paramedic, registered nurse or physician. Criteria for transporting the patient by air include severity of injury and geographical barriers to transport by ground vehicle|participants|Number|91|91.0||||||
3928034|NCT01411852|3750642|B1|Number transported by ground||Air transport|Number of patients who required air transport by helicopter accompanied by paramedic, registered nurse or physician. Criteria for transporting the patient by air include severity of injury and geographical barriers to transport by ground vehicle|participants|Number|88|88.0||||||
3928035|NCT01411852|3750640|B3|Number transported by air||Air transport|Number of patients who required air transport by helicopter accompanied by paramedic, registered nurse or physician. Criteria for transporting the patient by air include severity of injury and geographical barriers to transport by ground vehicle|participants|Number|11|11.0||||||
3928036|NCT01411852|3750641|B2|Number transported by air||Air transport|Number of patients who required air transport by helicopter accompanied by paramedic, registered nurse or physician. Criteria for transporting the patient by air include severity of injury and geographical barriers to transport by ground vehicle|participants|Number|5|5.0||||||
3928133|NCT01411774|3750701|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3928037|NCT01411852|3750642|B1|Number transported by air||Air transport|Number of patients who required air transport by helicopter accompanied by paramedic, registered nurse or physician. Criteria for transporting the patient by air include severity of injury and geographical barriers to transport by ground vehicle|participants|Number|6|6.0||||||
3928038|NCT01411852|3750640|B3|||Initial heart rate (HR)||number of heart beats per minute|Mean|93.3|93.3|Standard Deviation|23.5|23.5|||
3928039|NCT01411852|3750641|B2|||Initial heart rate (HR)||number of heart beats per minute|Mean|94.7|94.7|Standard Deviation|22.9|22.9|||
3928040|NCT01411852|3750642|B1|||Initial heart rate (HR)||number of heart beats per minute|Mean|91.9|91.9|Standard Deviation|24.2|24.2|||
3928041|NCT01411852|3750640|B3|||Qualifying SBP||mmHg|Median|80|80.0|Inter-Quartile Range|||70.0|87.0|
3928042|NCT01411852|3750641|B2|||Qualifying SBP||mmHg|Median|78|78.0|Inter-Quartile Range|||69.8|85.0|
3928043|NCT01411852|3750642|B1|||Qualifying SBP||mmHg|Median|82|82.0|Inter-Quartile Range|||72.0|89.0|
3928044|NCT01411852|3750640|B3|||Initial SBP|Time of first recorded SBP by paramedic upon arrival at injured patient's side|mmHg|Median|84|84.0|Inter-Quartile Range|||72.0|93.0|
3928045|NCT01411852|3750641|B2|||Initial SBP|Time of first recorded SBP by paramedic upon arrival at injured patient's side|mmHg|Median|81.5|81.5|Inter-Quartile Range|||72.0|92.0|
3928046|NCT01411852|3750642|B1|||Initial SBP|Time of first recorded SBP by paramedic upon arrival at injured patient's side|mmHg|Median|84|84.0|Inter-Quartile Range|||74.5|94.0|
3928047|NCT01411852|3750640|B3|||Revised Trauma Score (RTS)|"The first GCS, SBP and Respiratory Rate (RR) are coded 4 to 0.~4 = GCS 13-15, SBP>89, RR 10-29; 3 = GCS 9-12, SBP 26-89, RR>29; 2 = GCS 6-8, SBP 50-75, RR 6-9;~1 = GCS 4-5, SBP 1-49, RR 1-5; 0 = GCS 3, SBP 0, RR 0~Enter GCS, SBP, RR codes:~RTS = 0.9368 GCS + 0.7326 SBP + 0.2908 RR~The RTS range is 0 to 7.8408. The RTS is heavily weighted towards the GCS to compensate for major head injury without multisystem injury or major physiological changes. A threshold of RTS < 4 has been proposed to identify those patients who are severely injured and should be treated in a trauma center."|units on a scale|Mean|6.5|6.5|Standard Deviation|1.6|1.6|||
3928048|NCT01411852|3750641|B2|||Revised Trauma Score (RTS)|"The first GCS, SBP and Respiratory Rate (RR) are coded 4 to 0.~4 = GCS 13-15, SBP>89, RR 10-29; 3 = GCS 9-12, SBP 26-89, RR>29; 2 = GCS 6-8, SBP 50-75, RR 6-9;~1 = GCS 4-5, SBP 1-49, RR 1-5; 0 = GCS 3, SBP 0, RR 0~Enter GCS, SBP, RR codes:~RTS = 0.9368 GCS + 0.7326 SBP + 0.2908 RR~The RTS range is 0 to 7.8408. The RTS is heavily weighted towards the GCS to compensate for major head injury without multisystem injury or major physiological changes. A threshold of RTS < 4 has been proposed to identify those patients who are severely injured and should be treated in a trauma center."|units on a scale|Mean|6.5|6.5|Standard Deviation|1.4|1.4|||
3928049|NCT01411852|3750642|B1|||Revised Trauma Score (RTS)|"The first GCS, SBP and Respiratory Rate (RR) are coded 4 to 0.~4 = GCS 13-15, SBP>89, RR 10-29; 3 = GCS 9-12, SBP 26-89, RR>29; 2 = GCS 6-8, SBP 50-75, RR 6-9;~1 = GCS 4-5, SBP 1-49, RR 1-5; 0 = GCS 3, SBP 0, RR 0~Enter GCS, SBP, RR codes:~RTS = 0.9368 GCS + 0.7326 SBP + 0.2908 RR~The RTS range is 0 to 7.8408. The RTS is heavily weighted towards the GCS to compensate for major head injury without multisystem injury or major physiological changes. A threshold of RTS < 4 has been proposed to identify those patients who are severely injured and should be treated in a trauma center."|units on a scale|Mean|6.4|6.4|Standard Deviation|1.7|1.7|||
3928050|NCT01411852|3750640|B3|Number of patients with no advanced airway||Advanced airway|Insertion of an advanced airway by paramedics prior to hospital arrival|participants|Number|172|172.0||||||
3928051|NCT01411852|3750641|B2|Number of patients with no advanced airway||Advanced airway|Insertion of an advanced airway by paramedics prior to hospital arrival|participants|Number|89|89.0||||||
3928052|NCT01411852|3750642|B1|Number of patients with no advanced airway||Advanced airway|Insertion of an advanced airway by paramedics prior to hospital arrival|participants|Number|83|83.0||||||
3928053|NCT01411852|3750640|B3|Number of patients with advanced airway inserted||Advanced airway|Insertion of an advanced airway by paramedics prior to hospital arrival|participants|Number|19|19.0||||||
3928054|NCT01411852|3750641|B2|Number of patients with advanced airway inserted||Advanced airway|Insertion of an advanced airway by paramedics prior to hospital arrival|participants|Number|7|7.0||||||
3928055|NCT01411852|3750642|B1|Number of patients with advanced airway inserted||Advanced airway|Insertion of an advanced airway by paramedics prior to hospital arrival|participants|Number|12|12.0||||||
3928056|NCT01411852|3750640|B3|||Glasgow Coma Score (GCS) prior to enrollment|"GCS is a reliable, objective way of recording the conscious state of a person. A patient is given a score between 3 (deep unconsciousness) and 15 (opens eyes spontaneously, alert & oriented, and obeys commands).~Eye: 1 - no eye opening; 2 - eye opening to pain stimulus; 3 - eye opening to speech; 4 - eye opening spontaneously~Verbal: 1 - no verbal; 2 - incomprehensible sounds; 3 - inappropriate words; 4 - confused; 5 - oriented~Motor: 1 - no moving; 2 - decerebrate posture; 3 - decorticate posture; 4 - withdraws from pain; 5 - localizes to pain; 6 - obeys commands"|units on a scale|Mean|12.7|12.7|Standard Deviation|3.9|3.9|||
3928057|NCT01411852|3750641|B2|||Glasgow Coma Score (GCS) prior to enrollment|"GCS is a reliable, objective way of recording the conscious state of a person. A patient is given a score between 3 (deep unconsciousness) and 15 (opens eyes spontaneously, alert & oriented, and obeys commands).~Eye: 1 - no eye opening; 2 - eye opening to pain stimulus; 3 - eye opening to speech; 4 - eye opening spontaneously~Verbal: 1 - no verbal; 2 - incomprehensible sounds; 3 - inappropriate words; 4 - confused; 5 - oriented~Motor: 1 - no moving; 2 - decerebrate posture; 3 - decorticate posture; 4 - withdraws from pain; 5 - localizes to pain; 6 - obeys commands"|units on a scale|Mean|13|13.0|Standard Deviation|3.6|3.6|||
3928058|NCT01411852|3750642|B1|||Glasgow Coma Score (GCS) prior to enrollment|"GCS is a reliable, objective way of recording the conscious state of a person. A patient is given a score between 3 (deep unconsciousness) and 15 (opens eyes spontaneously, alert & oriented, and obeys commands).~Eye: 1 - no eye opening; 2 - eye opening to pain stimulus; 3 - eye opening to speech; 4 - eye opening spontaneously~Verbal: 1 - no verbal; 2 - incomprehensible sounds; 3 - inappropriate words; 4 - confused; 5 - oriented~Motor: 1 - no moving; 2 - decerebrate posture; 3 - decorticate posture; 4 - withdraws from pain; 5 - localizes to pain; 6 - obeys commands"|units on a scale|Mean|12.4|12.4|Standard Deviation|4.1|4.1|||
3928134|NCT01411774|3750699|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3928135|NCT01411774|3750700|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3928059|NCT01411852|3750640|B3|Died in field with no AIS available||Injury Severity Score (ISS): Number of Severely Injured|"An ISS > 15 is considered severely injured. One patient died prior to hospital arrival and could not be scored.~The ISS is an anatomical scoring system with values from 0 to 75. Each injury is assigned an Abbreviated Injury Scale (AIS) score and is allocated to one of six body regions (Head, Face, Chest, Abdomen, Extremities (including Pelvis), External). Only the highest AIS score in each region is used. The 3 most severely injured body regions have their score squared and added together to produce the ISS score. If an AIS is 6 (unsurvivable injury), the ISS is automatically scored as 75."|participants|Number|1|1.0||||||
3928060|NCT01411852|3750641|B2|Died in field with no AIS available||Injury Severity Score (ISS): Number of Severely Injured|"An ISS > 15 is considered severely injured. One patient died prior to hospital arrival and could not be scored.~The ISS is an anatomical scoring system with values from 0 to 75. Each injury is assigned an Abbreviated Injury Scale (AIS) score and is allocated to one of six body regions (Head, Face, Chest, Abdomen, Extremities (including Pelvis), External). Only the highest AIS score in each region is used. The 3 most severely injured body regions have their score squared and added together to produce the ISS score. If an AIS is 6 (unsurvivable injury), the ISS is automatically scored as 75."|participants|Number|0|0.0||||||
3928061|NCT01411852|3750642|B1|Died in field with no AIS available||Injury Severity Score (ISS): Number of Severely Injured|"An ISS > 15 is considered severely injured. One patient died prior to hospital arrival and could not be scored.~The ISS is an anatomical scoring system with values from 0 to 75. Each injury is assigned an Abbreviated Injury Scale (AIS) score and is allocated to one of six body regions (Head, Face, Chest, Abdomen, Extremities (including Pelvis), External). Only the highest AIS score in each region is used. The 3 most severely injured body regions have their score squared and added together to produce the ISS score. If an AIS is 6 (unsurvivable injury), the ISS is automatically scored as 75."|participants|Number|1|1.0||||||
3928062|NCT01411852|3750640|B3|Mildly injured with ISS ≤ 15||Injury Severity Score (ISS): Number of Severely Injured|"An ISS > 15 is considered severely injured. One patient died prior to hospital arrival and could not be scored.~The ISS is an anatomical scoring system with values from 0 to 75. Each injury is assigned an Abbreviated Injury Scale (AIS) score and is allocated to one of six body regions (Head, Face, Chest, Abdomen, Extremities (including Pelvis), External). Only the highest AIS score in each region is used. The 3 most severely injured body regions have their score squared and added together to produce the ISS score. If an AIS is 6 (unsurvivable injury), the ISS is automatically scored as 75."|participants|Number|125|125.0||||||
3928063|NCT01411852|3750641|B2|Mildly injured with ISS ≤ 15||Injury Severity Score (ISS): Number of Severely Injured|"An ISS > 15 is considered severely injured. One patient died prior to hospital arrival and could not be scored.~The ISS is an anatomical scoring system with values from 0 to 75. Each injury is assigned an Abbreviated Injury Scale (AIS) score and is allocated to one of six body regions (Head, Face, Chest, Abdomen, Extremities (including Pelvis), External). Only the highest AIS score in each region is used. The 3 most severely injured body regions have their score squared and added together to produce the ISS score. If an AIS is 6 (unsurvivable injury), the ISS is automatically scored as 75."|participants|Number|63|63.0||||||
3928064|NCT01411852|3750642|B1|Mildly injured with ISS ≤ 15||Injury Severity Score (ISS): Number of Severely Injured|"An ISS > 15 is considered severely injured. One patient died prior to hospital arrival and could not be scored.~The ISS is an anatomical scoring system with values from 0 to 75. Each injury is assigned an Abbreviated Injury Scale (AIS) score and is allocated to one of six body regions (Head, Face, Chest, Abdomen, Extremities (including Pelvis), External). Only the highest AIS score in each region is used. The 3 most severely injured body regions have their score squared and added together to produce the ISS score. If an AIS is 6 (unsurvivable injury), the ISS is automatically scored as 75."|participants|Number|62|62.0||||||
3928065|NCT01411852|3750640|B3|Severely injured with ISS > 15||Injury Severity Score (ISS): Number of Severely Injured|"An ISS > 15 is considered severely injured. One patient died prior to hospital arrival and could not be scored.~The ISS is an anatomical scoring system with values from 0 to 75. Each injury is assigned an Abbreviated Injury Scale (AIS) score and is allocated to one of six body regions (Head, Face, Chest, Abdomen, Extremities (including Pelvis), External). Only the highest AIS score in each region is used. The 3 most severely injured body regions have their score squared and added together to produce the ISS score. If an AIS is 6 (unsurvivable injury), the ISS is automatically scored as 75."|participants|Number|65|65.0||||||
3928066|NCT01411852|3750641|B2|Severely injured with ISS > 15||Injury Severity Score (ISS): Number of Severely Injured|"An ISS > 15 is considered severely injured. One patient died prior to hospital arrival and could not be scored.~The ISS is an anatomical scoring system with values from 0 to 75. Each injury is assigned an Abbreviated Injury Scale (AIS) score and is allocated to one of six body regions (Head, Face, Chest, Abdomen, Extremities (including Pelvis), External). Only the highest AIS score in each region is used. The 3 most severely injured body regions have their score squared and added together to produce the ISS score. If an AIS is 6 (unsurvivable injury), the ISS is automatically scored as 75."|participants|Number|33|33.0||||||
3928067|NCT01411852|3750642|B1|Severely injured with ISS > 15||Injury Severity Score (ISS): Number of Severely Injured|"An ISS > 15 is considered severely injured. One patient died prior to hospital arrival and could not be scored.~The ISS is an anatomical scoring system with values from 0 to 75. Each injury is assigned an Abbreviated Injury Scale (AIS) score and is allocated to one of six body regions (Head, Face, Chest, Abdomen, Extremities (including Pelvis), External). Only the highest AIS score in each region is used. The 3 most severely injured body regions have their score squared and added together to produce the ISS score. If an AIS is 6 (unsurvivable injury), the ISS is automatically scored as 75."|participants|Number|32|32.0||||||
3928068|NCT01411852|3750640|B3|||Injury Severity Score (ISS)|The ISS is an anatomical scoring system that provides an overall score for patients with multiple injuries. Each injury is assigned an Abbreviated Injury Scale (AIS) score and is allocated to one of six body regions (Head, Face, Chest, Abdomen, Extremities (including Pelvis), External). The highest AIS score in each body region is used. The 3 most severely injured body regions have their score squared and added together to produce the ISS score. The ISS score takes values from 0 to 75. If an injury is assigned an AIS of 6 (unsurvivable injury), the ISS score is automatically assigned to 75.|units on a scale|Median|9|9.0|Inter-Quartile Range|||2.0|20.0|
3928136|NCT01411774|3750701|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3928137|NCT01411774|3750699|B3||White|Race (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
3928069|NCT01411852|3750641|B2|||Injury Severity Score (ISS)|The ISS is an anatomical scoring system that provides an overall score for patients with multiple injuries. Each injury is assigned an Abbreviated Injury Scale (AIS) score and is allocated to one of six body regions (Head, Face, Chest, Abdomen, Extremities (including Pelvis), External). The highest AIS score in each body region is used. The 3 most severely injured body regions have their score squared and added together to produce the ISS score. The ISS score takes values from 0 to 75. If an injury is assigned an AIS of 6 (unsurvivable injury), the ISS score is automatically assigned to 75.|units on a scale|Median|9.5|9.5|Inter-Quartile Range|||1.8|19.2|
3928070|NCT01411852|3750642|B1|||Injury Severity Score (ISS)|The ISS is an anatomical scoring system that provides an overall score for patients with multiple injuries. Each injury is assigned an Abbreviated Injury Scale (AIS) score and is allocated to one of six body regions (Head, Face, Chest, Abdomen, Extremities (including Pelvis), External). The highest AIS score in each body region is used. The 3 most severely injured body regions have their score squared and added together to produce the ISS score. The ISS score takes values from 0 to 75. If an injury is assigned an AIS of 6 (unsurvivable injury), the ISS score is automatically assigned to 75.|units on a scale|Median|9|9.0|Inter-Quartile Range|||2.0|24.2|
3928071|NCT01411852|3750640|B3|Neither penetrating or blunt force||Penetrating trauma||participants|Number|1|1.0||||||
3928072|NCT01411852|3750641|B2|Neither penetrating or blunt force||Penetrating trauma||participants|Number|1|1.0||||||
3928073|NCT01411852|3750642|B1|Neither penetrating or blunt force||Penetrating trauma||participants|Number|0|0.0||||||
3928074|NCT01411852|3750640|B3|Blunt force primary mechanism of injury||Penetrating trauma||participants|Number|125|125.0||||||
3928075|NCT01411852|3750641|B2|Blunt force primary mechanism of injury||Penetrating trauma||participants|Number|63|63.0||||||
3928076|NCT01411852|3750642|B1|Blunt force primary mechanism of injury||Penetrating trauma||participants|Number|62|62.0||||||
3928077|NCT01411852|3750640|B3|Penetrating primary mechanism of injury||Penetrating trauma||participants|Number|65|65.0||||||
3928078|NCT01411852|3750641|B2|Penetrating primary mechanism of injury||Penetrating trauma||participants|Number|32|32.0||||||
3928079|NCT01411852|3750642|B1|Penetrating primary mechanism of injury||Penetrating trauma||participants|Number|33|33.0||||||
3928080|NCT01411852|3750640|B3||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3928081|NCT01411852|3750641|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3928082|NCT01411852|3750642|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3928083|NCT01411852|3750640|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3928084|NCT01411852|3750641|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3928085|NCT01411852|3750642|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3928086|NCT01411852|3750640|B3|||Age||years|Mean|41.8|41.8|Standard Deviation|19.7|19.7|||
3928087|NCT01411852|3750641|B2|||Age||years|Mean|41.9|41.9|Standard Deviation|20.2|20.2|||
3928088|NCT01411852|3750642|B1|||Age||years|Mean|41.8|41.8|Standard Deviation|19.2|19.2|||
3928089|NCT01411839|3750686|B3|||Montgomery-Asberg Depression Rating Scale (MADRS)|The MADRS is a 10-item clinician administered scripted rating scale of depressive symptoms (each of the ten items is scored from 0-6, with total scores ranging from 0 to 60). The scale was developed to capture current depressive symptoms within the past seven days. The areas covered include: apparent and reported sadness, inner tension, reduced sleep and appetite, concentration difficulties, lassitude, inability to feel, pessimistic and suicidal thoughts. Higher scores indicate the presence of more depressive symptoms.|units on a scale|Mean|23.6|23.6|Standard Deviation|9.7|9.7|||
3928090|NCT01411839|3750687|B2|||Montgomery-Asberg Depression Rating Scale (MADRS)|The MADRS is a 10-item clinician administered scripted rating scale of depressive symptoms (each of the ten items is scored from 0-6, with total scores ranging from 0 to 60). The scale was developed to capture current depressive symptoms within the past seven days. The areas covered include: apparent and reported sadness, inner tension, reduced sleep and appetite, concentration difficulties, lassitude, inability to feel, pessimistic and suicidal thoughts. Higher scores indicate the presence of more depressive symptoms.|units on a scale|Mean|22.1|22.1|Standard Deviation|9.8|9.8|||
3928091|NCT01411839|3750688|B1|||Montgomery-Asberg Depression Rating Scale (MADRS)|The MADRS is a 10-item clinician administered scripted rating scale of depressive symptoms (each of the ten items is scored from 0-6, with total scores ranging from 0 to 60). The scale was developed to capture current depressive symptoms within the past seven days. The areas covered include: apparent and reported sadness, inner tension, reduced sleep and appetite, concentration difficulties, lassitude, inability to feel, pessimistic and suicidal thoughts. Higher scores indicate the presence of more depressive symptoms.|units on a scale|Mean|25.1|25.1|Standard Deviation|9.7|9.7|||
3928092|NCT01411839|3750686|B3|||Electronic Drug Adherence Monitoring|The MedSignals electronic pill-box is a storage bin that allows participants to store medications. In the treatment condition, the pill-box provides audio commands to alarm participants that it is time to take their medication. The pill-box stores adherence data (time, number of openings). In the control condition, the pill-box does not alarm participants but serves in the same capacity otherwise. All data is uploaded electronically. Higher numbers indicate better adherence that correspond to pill-box openings corresponding the designated time of taking their medication.|Percent Adherence|Mean|49.4|49.4|Standard Deviation|40.6|40.6|||
3928093|NCT01411839|3750687|B2|||Electronic Drug Adherence Monitoring|The MedSignals electronic pill-box is a storage bin that allows participants to store medications. In the treatment condition, the pill-box provides audio commands to alarm participants that it is time to take their medication. The pill-box stores adherence data (time, number of openings). In the control condition, the pill-box does not alarm participants but serves in the same capacity otherwise. All data is uploaded electronically. Higher numbers indicate better adherence that correspond to pill-box openings corresponding the designated time of taking their medication.|Percent Adherence|Mean|55.6|55.6|Standard Deviation|47.6|47.6|||
3928138|NCT01411774|3750700|B2||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3928139|NCT01411774|3750701|B1||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3928140|NCT01411774|3750699|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3928094|NCT01411839|3750688|B1|||Electronic Drug Adherence Monitoring|The MedSignals electronic pill-box is a storage bin that allows participants to store medications. In the treatment condition, the pill-box provides audio commands to alarm participants that it is time to take their medication. The pill-box stores adherence data (time, number of openings). In the control condition, the pill-box does not alarm participants but serves in the same capacity otherwise. All data is uploaded electronically. Higher numbers indicate better adherence that correspond to pill-box openings corresponding the designated time of taking their medication.|Percent Adherence|Mean|43.2|43.2|Standard Deviation|43.5|43.5|||
3928095|NCT01411839|3750686|B3|||Visual Analog Scale 30-day Adherence|Self-reported adherence was assessed with the visual analog scale. This is a 10cm line that is shown to patients who then mark on the line (from 0 to 100% in 1cm intervals) how much medication they have taken. Higher scores indicate better adherence.|Percent of doses taken|Mean|87.2|87.2|Standard Deviation|19.5|19.5|||
3928096|NCT01411839|3750687|B2|||Visual Analog Scale 30-day Adherence|Self-reported adherence was assessed with the visual analog scale. This is a 10cm line that is shown to patients who then mark on the line (from 0 to 100% in 1cm intervals) how much medication they have taken. Higher scores indicate better adherence.|Percent of doses taken|Mean|90.6|90.6|Standard Deviation|11.1|11.1|||
3928097|NCT01411839|3750688|B1|||Visual Analog Scale 30-day Adherence|Self-reported adherence was assessed with the visual analog scale. This is a 10cm line that is shown to patients who then mark on the line (from 0 to 100% in 1cm intervals) how much medication they have taken. Higher scores indicate better adherence.|Percent of doses taken|Mean|84.4|84.4|Standard Deviation|24.4|24.4|||
3928098|NCT01411839|3750686|B3|||Beck Depression Inventory 1a|Self-reported depressive symptoms were assessed at each time point using the revised Beck Depression Inventory-Ia (BDI-Ia), which consists of 21 items, each with a 4-point response scale anchored with descriptive statements. Scores can range from 0-63, and scores of 10 or higher are presumptive of mild depressive severity. The BDI scores presented were added up and higher scores indicate worse depression.|units on a scale|Mean|19.4|19.4|Standard Deviation|8.2|8.2|||
3928099|NCT01411839|3750687|B2|||Beck Depression Inventory 1a|Self-reported depressive symptoms were assessed at each time point using the revised Beck Depression Inventory-Ia (BDI-Ia), which consists of 21 items, each with a 4-point response scale anchored with descriptive statements. Scores can range from 0-63, and scores of 10 or higher are presumptive of mild depressive severity. The BDI scores presented were added up and higher scores indicate worse depression.|units on a scale|Mean|16.8|16.8|Standard Deviation|6.3|6.3|||
3928100|NCT01411839|3750688|B1|||Beck Depression Inventory 1a|Self-reported depressive symptoms were assessed at each time point using the revised Beck Depression Inventory-Ia (BDI-Ia), which consists of 21 items, each with a 4-point response scale anchored with descriptive statements. Scores can range from 0-63, and scores of 10 or higher are presumptive of mild depressive severity. The BDI scores presented were added up and higher scores indicate worse depression.|units on a scale|Mean|22|22.0|Standard Deviation|9.2|9.2|||
3928101|NCT01411839|3750686|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928102|NCT01411839|3750687|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928103|NCT01411839|3750688|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928104|NCT01411839|3750686|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928105|NCT01411839|3750687|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928106|NCT01411839|3750688|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928107|NCT01411839|3750686|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3928108|NCT01411839|3750687|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3928109|NCT01411839|3750688|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3928110|NCT01411839|3750686|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3928111|NCT01411839|3750687|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3928112|NCT01411839|3750688|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3928113|NCT01411839|3750686|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3928114|NCT01411839|3750687|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3928115|NCT01411839|3750688|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3928116|NCT01411839|3750686|B3|||Age||years|Mean|46|46.0|Standard Deviation|10.6|10.6|||
3928117|NCT01411839|3750687|B2|||Age||years|Mean|44.8|44.8|Standard Deviation|10.7|10.7|||
3928118|NCT01411839|3750688|B1|||Age||years|Mean|47.3|47.3|Standard Deviation|10.7|10.7|||
3928119|NCT01411839|3750686|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3928120|NCT01411839|3750687|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3928121|NCT01411839|3750688|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3928122|NCT01411839|3750686|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3928123|NCT01411839|3750687|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3928124|NCT01411839|3750688|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3928125|NCT01411839|3750686|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3928126|NCT01411839|3750687|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3928127|NCT01411839|3750688|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3928128|NCT01411774|3750699|B3|United States||Region of Enrollment||Participants|Count of Participants|142|142.0||||||
3928129|NCT01411774|3750700|B2|United States||Region of Enrollment||Participants|Count of Participants|70|70.0||||||
3928130|NCT01411774|3750701|B1|United States||Region of Enrollment||Participants|Count of Participants|72|72.0||||||
3928131|NCT01411774|3750699|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3928132|NCT01411774|3750700|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3928141|NCT01411774|3750700|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3928142|NCT01411774|3750701|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3928143|NCT01411774|3750699|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928144|NCT01411774|3750700|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928145|NCT01411774|3750701|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928146|NCT01411774|3750699|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3928147|NCT01411774|3750700|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3928148|NCT01411774|3750701|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928149|NCT01411774|3750699|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3928150|NCT01411774|3750700|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928151|NCT01411774|3750701|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3928152|NCT01411774|3750699|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3928153|NCT01411774|3750700|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3928154|NCT01411774|3750701|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3928155|NCT01411774|3750699|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3928156|NCT01411774|3750700|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3928157|NCT01411774|3750701|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3928158|NCT01411774|3750699|B3|||Age||years|Mean|12.93|12.93|Standard Deviation|2.92|2.92|||
3928159|NCT01411774|3750700|B2|||Age||years|Mean|13.05|13.05|Standard Deviation|2.93|2.93|||
3928160|NCT01411774|3750701|B1|||Age||years|Mean|12.54|12.54|Standard Deviation|3.04|3.04|||
3928161|NCT01411774|3750699|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3928162|NCT01411774|3750700|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3928163|NCT01411774|3750701|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3928164|NCT01411774|3750699|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3928165|NCT01411774|3750700|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3928166|NCT01411774|3750701|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3928167|NCT01411774|3750699|B3||<=18 years|Age||Participants|Count of Participants|142|142.0||||||
3928168|NCT01411774|3750700|B2||<=18 years|Age||Participants|Count of Participants|70|70.0||||||
3928169|NCT01411774|3750701|B1||<=18 years|Age||Participants|Count of Participants|72|72.0||||||
3928170|NCT01411696|3750710|B1||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3928171|NCT01411696|3750710|B1||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3928172|NCT01411696|3750710|B1|||Age||Years|Mean|71.9|71.9|Standard Deviation|10.95|10.95|||
3928173|NCT01411592|3750717|B3|Germany||Region of Enrollment||participants|Number|30|30.0||||||
3928174|NCT01411592|3750718|B2|Germany||Region of Enrollment||participants|Number|16|16.0||||||
3928175|NCT01411592|3750719|B1|Germany||Region of Enrollment||participants|Number|14|14.0||||||
3928176|NCT01411592|3750717|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3928177|NCT01411592|3750718|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3928178|NCT01411592|3750719|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3928179|NCT01411592|3750717|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3928180|NCT01411592|3750718|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3928181|NCT01411592|3750719|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3928182|NCT01411592|3750717|B3|||Age||years|Mean|33.3|33.3|Standard Deviation|18.82|18.82|||
3928183|NCT01411592|3750718|B2|||Age||years|Mean|36.56|36.56|Standard Deviation|20.36|20.36|||
3928184|NCT01411592|3750719|B1|||Age||years|Mean|29.57|29.57|Standard Deviation|16.84|16.84|||
3928185|NCT01411501|3750728|B5|no defecation||Degree of straining during defecation|This outcome describes how much effort the patients with while defecating. It ranges from 0 to 3. Zero means defecating with no effort and 3 means defecating with great effort. A 0 score is considered a better than 3 for outcome. Patients score for themselves according to their own feelings.|participants|Number|7|7.0||||||
3928186|NCT01411501|3750729|B4|no defecation||Degree of straining during defecation|This outcome describes how much effort the patients with while defecating. It ranges from 0 to 3. Zero means defecating with no effort and 3 means defecating with great effort. A 0 score is considered a better than 3 for outcome. Patients score for themselves according to their own feelings.|participants|Number|3|3.0||||||
3928187|NCT01411501|3750730|B3|no defecation||Degree of straining during defecation|This outcome describes how much effort the patients with while defecating. It ranges from 0 to 3. Zero means defecating with no effort and 3 means defecating with great effort. A 0 score is considered a better than 3 for outcome. Patients score for themselves according to their own feelings.|participants|Number|2|2.0||||||
3928188|NCT01411501|3750731|B2|no defecation||Degree of straining during defecation|This outcome describes how much effort the patients with while defecating. It ranges from 0 to 3. Zero means defecating with no effort and 3 means defecating with great effort. A 0 score is considered a better than 3 for outcome. Patients score for themselves according to their own feelings.|participants|Number|0|0.0||||||
3928189|NCT01411501|3750732|B1|no defecation||Degree of straining during defecation|This outcome describes how much effort the patients with while defecating. It ranges from 0 to 3. Zero means defecating with no effort and 3 means defecating with great effort. A 0 score is considered a better than 3 for outcome. Patients score for themselves according to their own feelings.|participants|Number|2|2.0||||||
3928190|NCT01411501|3750728|B5|3||Degree of straining during defecation|This outcome describes how much effort the patients with while defecating. It ranges from 0 to 3. Zero means defecating with no effort and 3 means defecating with great effort. A 0 score is considered a better than 3 for outcome. Patients score for themselves according to their own feelings.|participants|Number|124|124.0||||||
3928191|NCT01411501|3750729|B4|3||Degree of straining during defecation|This outcome describes how much effort the patients with while defecating. It ranges from 0 to 3. Zero means defecating with no effort and 3 means defecating with great effort. A 0 score is considered a better than 3 for outcome. Patients score for themselves according to their own feelings.|participants|Number|31|31.0||||||
3928192|NCT01411501|3750730|B3|3||Degree of straining during defecation|This outcome describes how much effort the patients with while defecating. It ranges from 0 to 3. Zero means defecating with no effort and 3 means defecating with great effort. A 0 score is considered a better than 3 for outcome. Patients score for themselves according to their own feelings.|participants|Number|28|28.0||||||
3928193|NCT01411501|3750731|B2|3||Degree of straining during defecation|This outcome describes how much effort the patients with while defecating. It ranges from 0 to 3. Zero means defecating with no effort and 3 means defecating with great effort. A 0 score is considered a better than 3 for outcome. Patients score for themselves according to their own feelings.|participants|Number|35|35.0||||||
3928194|NCT01411501|3750732|B1|3||Degree of straining during defecation|This outcome describes how much effort the patients with while defecating. It ranges from 0 to 3. Zero means defecating with no effort and 3 means defecating with great effort. A 0 score is considered a better than 3 for outcome. Patients score for themselves according to their own feelings.|participants|Number|30|30.0||||||
3928195|NCT01411501|3750728|B5|2||Degree of straining during defecation|This outcome describes how much effort the patients with while defecating. It ranges from 0 to 3. Zero means defecating with no effort and 3 means defecating with great effort. A 0 score is considered a better than 3 for outcome. Patients score for themselves according to their own feelings.|participants|Number|267|267.0||||||
3928196|NCT01411501|3750729|B4|2||Degree of straining during defecation|This outcome describes how much effort the patients with while defecating. It ranges from 0 to 3. Zero means defecating with no effort and 3 means defecating with great effort. A 0 score is considered a better than 3 for outcome. Patients score for themselves according to their own feelings.|participants|Number|72|72.0||||||
3928197|NCT01411501|3750730|B3|2||Degree of straining during defecation|This outcome describes how much effort the patients with while defecating. It ranges from 0 to 3. Zero means defecating with no effort and 3 means defecating with great effort. A 0 score is considered a better than 3 for outcome. Patients score for themselves according to their own feelings.|participants|Number|58|58.0||||||
3928198|NCT01411501|3750731|B2|2||Degree of straining during defecation|This outcome describes how much effort the patients with while defecating. It ranges from 0 to 3. Zero means defecating with no effort and 3 means defecating with great effort. A 0 score is considered a better than 3 for outcome. Patients score for themselves according to their own feelings.|participants|Number|69|69.0||||||
3928199|NCT01411501|3750732|B1|2||Degree of straining during defecation|This outcome describes how much effort the patients with while defecating. It ranges from 0 to 3. Zero means defecating with no effort and 3 means defecating with great effort. A 0 score is considered a better than 3 for outcome. Patients score for themselves according to their own feelings.|participants|Number|68|68.0||||||
3928200|NCT01411501|3750728|B5|1||Degree of straining during defecation|This outcome describes how much effort the patients with while defecating. It ranges from 0 to 3. Zero means defecating with no effort and 3 means defecating with great effort. A 0 score is considered a better than 3 for outcome. Patients score for themselves according to their own feelings.|participants|Number|250|250.0||||||
3928201|NCT01411501|3750729|B4|1||Degree of straining during defecation|This outcome describes how much effort the patients with while defecating. It ranges from 0 to 3. Zero means defecating with no effort and 3 means defecating with great effort. A 0 score is considered a better than 3 for outcome. Patients score for themselves according to their own feelings.|participants|Number|59|59.0||||||
3928202|NCT01411501|3750730|B3|1||Degree of straining during defecation|This outcome describes how much effort the patients with while defecating. It ranges from 0 to 3. Zero means defecating with no effort and 3 means defecating with great effort. A 0 score is considered a better than 3 for outcome. Patients score for themselves according to their own feelings.|participants|Number|68|68.0||||||
3928203|NCT01411501|3750731|B2|1||Degree of straining during defecation|This outcome describes how much effort the patients with while defecating. It ranges from 0 to 3. Zero means defecating with no effort and 3 means defecating with great effort. A 0 score is considered a better than 3 for outcome. Patients score for themselves according to their own feelings.|participants|Number|60|60.0||||||
3928204|NCT01411501|3750732|B1|1||Degree of straining during defecation|This outcome describes how much effort the patients with while defecating. It ranges from 0 to 3. Zero means defecating with no effort and 3 means defecating with great effort. A 0 score is considered a better than 3 for outcome. Patients score for themselves according to their own feelings.|participants|Number|63|63.0||||||
3928205|NCT01411501|3750728|B5|0||Degree of straining during defecation|This outcome describes how much effort the patients with while defecating. It ranges from 0 to 3. Zero means defecating with no effort and 3 means defecating with great effort. A 0 score is considered a better than 3 for outcome. Patients score for themselves according to their own feelings.|participants|Number|27|27.0||||||
3928206|NCT01411501|3750729|B4|0||Degree of straining during defecation|This outcome describes how much effort the patients with while defecating. It ranges from 0 to 3. Zero means defecating with no effort and 3 means defecating with great effort. A 0 score is considered a better than 3 for outcome. Patients score for themselves according to their own feelings.|participants|Number|5|5.0||||||
3928207|NCT01411501|3750730|B3|0||Degree of straining during defecation|This outcome describes how much effort the patients with while defecating. It ranges from 0 to 3. Zero means defecating with no effort and 3 means defecating with great effort. A 0 score is considered a better than 3 for outcome. Patients score for themselves according to their own feelings.|participants|Number|9|9.0||||||
3928208|NCT01411501|3750731|B2|0||Degree of straining during defecation|This outcome describes how much effort the patients with while defecating. It ranges from 0 to 3. Zero means defecating with no effort and 3 means defecating with great effort. A 0 score is considered a better than 3 for outcome. Patients score for themselves according to their own feelings.|participants|Number|8|8.0||||||
3928209|NCT01411501|3750732|B1|0||Degree of straining during defecation|This outcome describes how much effort the patients with while defecating. It ranges from 0 to 3. Zero means defecating with no effort and 3 means defecating with great effort. A 0 score is considered a better than 3 for outcome. Patients score for themselves according to their own feelings.|participants|Number|5|5.0||||||
3928210|NCT01411501|3750728|B5|||Bristol scale|Bristol stool scale provides illustration of seven stool types. It ranges from 1 to 7 with the meaning that 1 referring to separate hard lumps and 7 referring to watery, no solid pieces. For patients with constipation, a higher score means a better outcome.|units on a scale|Mean|2.9|2.9|Standard Deviation|1.8|1.8|||
3928211|NCT01411501|3750729|B4|||Bristol scale|Bristol stool scale provides illustration of seven stool types. It ranges from 1 to 7 with the meaning that 1 referring to separate hard lumps and 7 referring to watery, no solid pieces. For patients with constipation, a higher score means a better outcome.|units on a scale|Mean|2.7|2.7|Standard Deviation|1.4|1.4|||
3928212|NCT01411501|3750730|B3|||Bristol scale|Bristol stool scale provides illustration of seven stool types. It ranges from 1 to 7 with the meaning that 1 referring to separate hard lumps and 7 referring to watery, no solid pieces. For patients with constipation, a higher score means a better outcome.|units on a scale|Mean|3.0|3.0|Standard Deviation|1.5|1.5|||
3928213|NCT01411501|3750731|B2|||Bristol scale|Bristol stool scale provides illustration of seven stool types. It ranges from 1 to 7 with the meaning that 1 referring to separate hard lumps and 7 referring to watery, no solid pieces. For patients with constipation, a higher score means a better outcome.|units on a scale|Mean|2.9|2.9|Standard Deviation|1.4|1.4|||
3928214|NCT01411501|3750732|B1|||Bristol scale|Bristol stool scale provides illustration of seven stool types. It ranges from 1 to 7 with the meaning that 1 referring to separate hard lumps and 7 referring to watery, no solid pieces. For patients with constipation, a higher score means a better outcome.|units on a scale|Mean|2.8|2.8|Standard Deviation|1.3|1.3|||
3928215|NCT01411501|3750728|B5|||SBMs|SBMs, spontaneous bowel movements.|times per week|Mean|2.8|2.8|Standard Deviation|2.1|2.1|||
3928216|NCT01411501|3750729|B4|||SBMs|SBMs, spontaneous bowel movements.|times per week|Mean|2.9|2.9|Standard Deviation|2.8|2.8|||
3928217|NCT01411501|3750730|B3|||SBMs|SBMs, spontaneous bowel movements.|times per week|Mean|2.9|2.9|Standard Deviation|2.0|2.0|||
3928218|NCT01411501|3750731|B2|||SBMs|SBMs, spontaneous bowel movements.|times per week|Mean|2.5|2.5|Standard Deviation|1.7|1.7|||
3928219|NCT01411501|3750732|B1|||SBMs|SBMs, spontaneous bowel movements.|times per week|Mean|2.7|2.7|Standard Deviation|1.9|1.9|||
3928220|NCT01411501|3750728|B5|Neither||Received Traditional Chinese Medicine therapies||participants|Number|451|451.0||||||
3928221|NCT01411501|3750729|B4|Neither||Received Traditional Chinese Medicine therapies||participants|Number|118|118.0||||||
3928222|NCT01411501|3750730|B3|Neither||Received Traditional Chinese Medicine therapies||participants|Number|107|107.0||||||
3928223|NCT01411501|3750731|B2|Neither||Received Traditional Chinese Medicine therapies||participants|Number|110|110.0||||||
3928224|NCT01411501|3750732|B1|Neither||Received Traditional Chinese Medicine therapies||participants|Number|116|116.0||||||
3928225|NCT01411501|3750728|B5|Both||Received Traditional Chinese Medicine therapies||participants|Number|25|25.0||||||
3928226|NCT01411501|3750729|B4|Both||Received Traditional Chinese Medicine therapies||participants|Number|5|5.0||||||
3928227|NCT01411501|3750730|B3|Both||Received Traditional Chinese Medicine therapies||participants|Number|8|8.0||||||
3928228|NCT01411501|3750731|B2|Both||Received Traditional Chinese Medicine therapies||participants|Number|5|5.0||||||
3928229|NCT01411501|3750732|B1|Both||Received Traditional Chinese Medicine therapies||participants|Number|7|7.0||||||
3928230|NCT01411501|3750728|B5|Herbs||Received Traditional Chinese Medicine therapies||participants|Number|173|173.0||||||
3928231|NCT01411501|3750729|B4|Herbs||Received Traditional Chinese Medicine therapies||participants|Number|44|44.0||||||
3928232|NCT01411501|3750730|B3|Herbs||Received Traditional Chinese Medicine therapies||participants|Number|43|43.0||||||
3928233|NCT01411501|3750731|B2|Herbs||Received Traditional Chinese Medicine therapies||participants|Number|48|48.0||||||
3928234|NCT01411501|3750732|B1|Herbs||Received Traditional Chinese Medicine therapies||participants|Number|38|38.0||||||
3928235|NCT01411501|3750728|B5|Acupuncture||Received Traditional Chinese Medicine therapies||participants|Number|26|26.0||||||
3928236|NCT01411501|3750729|B4|Acupuncture||Received Traditional Chinese Medicine therapies||participants|Number|3|3.0||||||
3928237|NCT01411501|3750730|B3|Acupuncture||Received Traditional Chinese Medicine therapies||participants|Number|7|7.0||||||
3928238|NCT01411501|3750731|B2|Acupuncture||Received Traditional Chinese Medicine therapies||participants|Number|9|9.0||||||
3928239|NCT01411501|3750732|B1|Acupuncture||Received Traditional Chinese Medicine therapies||participants|Number|7|7.0||||||
3928240|NCT01411501|3750728|B5|||Duration of functional constipation||months|Mean|6.2|6.2|Standard Deviation|5.56|5.56|||
3928241|NCT01411501|3750729|B4|||Duration of functional constipation||months|Mean|5.8|5.8|Standard Deviation|4.6|4.6|||
3928242|NCT01411501|3750730|B3|||Duration of functional constipation||months|Mean|5.6|5.6|Standard Deviation|4.3|4.3|||
3928243|NCT01411501|3750731|B2|||Duration of functional constipation||months|Mean|6.3|6.3|Standard Deviation|6.5|6.5|||
3928244|NCT01411501|3750732|B1|||Duration of functional constipation||months|Mean|7.0|7.0|Standard Deviation|6.8|6.8|||
3928245|NCT01411501|3750728|B5|China||Region of Enrollment||participants|Number|675|675.0||||||
3928246|NCT01411501|3750729|B4|China||Region of Enrollment||participants|Number|170|170.0||||||
3928247|NCT01411501|3750730|B3|China||Region of Enrollment||participants|Number|165|165.0||||||
3928248|NCT01411501|3750731|B2|China||Region of Enrollment||participants|Number|172|172.0||||||
3928249|NCT01411501|3750732|B1|China||Region of Enrollment||participants|Number|168|168.0||||||
3928250|NCT01411501|3750728|B5||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3928251|NCT01411501|3750729|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3928252|NCT01411501|3750730|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3928253|NCT01411501|3750731|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3928254|NCT01411501|3750732|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3928255|NCT01411501|3750728|B5||Female|Sex: Female, Male||Participants|Count of Participants|548|548.0||||||
3928256|NCT01411501|3750729|B4||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3928257|NCT01411501|3750730|B3||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3928258|NCT01411501|3750731|B2||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3928259|NCT01411501|3750732|B1||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3928260|NCT01411501|3750728|B5|||Age||years|Mean|40.1|40.1|Standard Deviation|16.9|16.9|||
3928261|NCT01411501|3750729|B4|||Age||years|Mean|40.6|40.6|Standard Deviation|16.7|16.7|||
3928262|NCT01411501|3750730|B3|||Age||years|Mean|40.7|40.7|Standard Deviation|16.8|16.8|||
3928263|NCT01411501|3750731|B2|||Age||years|Mean|39.9|39.9|Standard Deviation|16.8|16.8|||
3928264|NCT01411501|3750732|B1|||Age||years|Mean|38.9|38.9|Standard Deviation|17.4|17.4|||
3928265|NCT01411488|3750765|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3928266|NCT01411488|3750766|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3928267|NCT01411488|3750767|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3928268|NCT01411488|3750765|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3928269|NCT01411488|3750766|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3928270|NCT01411488|3750767|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3928271|NCT01411488|3750765|B3|||Age||years|Mean|64.0|64.0|Standard Deviation|13.6|13.6|||
3928272|NCT01411488|3750766|B2|||Age||years|Mean|64.7|64.7|Standard Deviation|12.3|12.3|||
3928273|NCT01411488|3750767|B1|||Age||years|Mean|63.3|63.3|Standard Deviation|15.0|15.0|||
3928274|NCT01411228|3750774|B4|Singapore||Region of Enrollment||participants|Number|1|1.0||||||
3928275|NCT01411228|3750775|B3|Singapore||Region of Enrollment||participants|Number|1|1.0||||||
3928276|NCT01411228|3750776|B2|Singapore||Region of Enrollment||participants|Number|0|0.0||||||
3928277|NCT01411228|3750777|B1|Singapore||Region of Enrollment||participants|Number|0|0.0||||||
3928278|NCT01411228|3750774|B4|Paraguay||Region of Enrollment||participants|Number|4|4.0||||||
3928279|NCT01411228|3750775|B3|Paraguay||Region of Enrollment||participants|Number|0|0.0||||||
3928280|NCT01411228|3750776|B2|Paraguay||Region of Enrollment||participants|Number|3|3.0||||||
3928281|NCT01411228|3750777|B1|Paraguay||Region of Enrollment||participants|Number|1|1.0||||||
3928282|NCT01411228|3750774|B4|Serbia||Region of Enrollment||participants|Number|2|2.0||||||
3928283|NCT01411228|3750775|B3|Serbia||Region of Enrollment||participants|Number|2|2.0||||||
3928284|NCT01411228|3750776|B2|Serbia||Region of Enrollment||participants|Number|0|0.0||||||
3928285|NCT01411228|3750777|B1|Serbia||Region of Enrollment||participants|Number|0|0.0||||||
3928286|NCT01411228|3750774|B4|Spain||Region of Enrollment||participants|Number|2|2.0||||||
3928287|NCT01411228|3750775|B3|Spain||Region of Enrollment||participants|Number|2|2.0||||||
3928288|NCT01411228|3750776|B2|Spain||Region of Enrollment||participants|Number|0|0.0||||||
3928289|NCT01411228|3750777|B1|Spain||Region of Enrollment||participants|Number|0|0.0||||||
3928290|NCT01411228|3750774|B4|Israel||Region of Enrollment||participants|Number|3|3.0||||||
3928291|NCT01411228|3750775|B3|Israel||Region of Enrollment||participants|Number|0|0.0||||||
3928292|NCT01411228|3750776|B2|Israel||Region of Enrollment||participants|Number|1|1.0||||||
3928293|NCT01411228|3750777|B1|Israel||Region of Enrollment||participants|Number|2|2.0||||||
3928294|NCT01411228|3750774|B4|South Africa||Region of Enrollment||participants|Number|3|3.0||||||
3928295|NCT01411228|3750775|B3|South Africa||Region of Enrollment||participants|Number|0|0.0||||||
3928296|NCT01411228|3750776|B2|South Africa||Region of Enrollment||participants|Number|1|1.0||||||
3928297|NCT01411228|3750777|B1|South Africa||Region of Enrollment||participants|Number|2|2.0||||||
3928298|NCT01411228|3750774|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3928299|NCT01411228|3750775|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928300|NCT01411228|3750776|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928301|NCT01411228|3750777|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3928302|NCT01411228|3750774|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928303|NCT01411228|3750775|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928304|NCT01411228|3750776|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928305|NCT01411228|3750777|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928306|NCT01411228|3750774|B4||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3928307|NCT01411228|3750775|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3928308|NCT01411228|3750776|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3928309|NCT01411228|3750777|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3928310|NCT01411228|3750774|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928311|NCT01411228|3750775|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928312|NCT01411228|3750776|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928313|NCT01411228|3750777|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928314|NCT01411228|3750774|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3928315|NCT01411228|3750775|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3928316|NCT01411228|3750776|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928317|NCT01411228|3750777|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928318|NCT01411228|3750774|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928319|NCT01411228|3750775|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928320|NCT01411228|3750776|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928321|NCT01411228|3750777|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928322|NCT01411228|3750774|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928323|NCT01411228|3750775|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928324|NCT01411228|3750776|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928325|NCT01411228|3750777|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928326|NCT01411228|3750774|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3928327|NCT01411228|3750775|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3928328|NCT01411228|3750776|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3928329|NCT01411228|3750777|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3928330|NCT01411228|3750774|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3928331|NCT01411228|3750775|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3928332|NCT01411228|3750776|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3928333|NCT01411228|3750777|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3928334|NCT01411228|3750774|B4|||Age||years|Mean|9.4|9.4|Standard Deviation|4.4|4.4|||
3928335|NCT01411228|3750775|B3|||Age||years|Mean|13.0|13.0|Standard Deviation|4.1|4.1|||
3928336|NCT01411228|3750776|B2|||Age||years|Mean|8.6|8.6|Standard Deviation|3.8|3.8|||
3928337|NCT01411228|3750777|B1|||Age||years|Mean|6.6|6.6|Standard Deviation|3.1|3.1|||
3928338|NCT01411215|3750799|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3928339|NCT01411215|3750800|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3928340|NCT01411215|3750801|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3928341|NCT01411215|3750799|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3928342|NCT01411215|3750800|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3928343|NCT01411215|3750801|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3928344|NCT01411215|3750799|B3|>=50 years||Age, Customized||Participants|Number|43|43.0||||||
3928345|NCT01411215|3750800|B2|>=50 years||Age, Customized||Participants|Number|9|9.0||||||
3928346|NCT01411215|3750801|B1|>=50 years||Age, Customized||Participants|Number|34|34.0||||||
3928347|NCT01411215|3750799|B3|>=40 and <50 years||Age, Customized||Participants|Number|40|40.0||||||
3928348|NCT01411215|3750800|B2|>=40 and <50 years||Age, Customized||Participants|Number|18|18.0||||||
3928349|NCT01411215|3750801|B1|>=40 and <50 years||Age, Customized||Participants|Number|22|22.0||||||
3928350|NCT01411215|3750799|B3|>=30 and <40 years||Age, Customized||Participants|Number|28|28.0||||||
3928351|NCT01411215|3750800|B2|>=30 and <40 years||Age, Customized||Participants|Number|21|21.0||||||
3928352|NCT01411215|3750801|B1|>=30 and <40 years||Age, Customized||Participants|Number|7|7.0||||||
3928353|NCT01411215|3750799|B3|greater than or equal to (>=) 20 and <30 years||Age, Customized||Participants|Number|30|30.0||||||
3928354|NCT01411215|3750800|B2|greater than or equal to (>=) 20 and <30 years||Age, Customized||Participants|Number|27|27.0||||||
3928355|NCT01411215|3750801|B1|greater than or equal to (>=) 20 and <30 years||Age, Customized||Participants|Number|3|3.0||||||
3928356|NCT01411215|3750799|B3|less than (<) 20 years||Age, Customized||Participants|Number|18|18.0||||||
3928357|NCT01411215|3750800|B2|less than (<) 20 years||Age, Customized||Participants|Number|15|15.0||||||
3928358|NCT01411215|3750801|B1|less than (<) 20 years||Age, Customized||Participants|Number|3|3.0||||||
3928359|NCT01411137|3750835|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
3928360|NCT01411137|3750835|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928361|NCT01411137|3750835|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928362|NCT01411137|3750835|B1||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3928363|NCT01411137|3750835|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928364|NCT01411137|3750835|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928365|NCT01411137|3750835|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3928366|NCT01411137|3750835|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928367|NCT01411137|3750835|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928368|NCT01411137|3750835|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3928369|NCT01411137|3750835|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928370|NCT01411137|3750835|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3928371|NCT01411137|3750835|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3928372|NCT01411137|3750835|B1|||Age||years|Mean|66.4|66.4|Standard Deviation|10.49|10.49|||
3928373|NCT01411137|3750835|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3928374|NCT01411137|3750835|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3928375|NCT01411137|3750835|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3928376|NCT01411085|3750854|B1|United States||Region of Enrollment|Timeline Followback assessment of drinks per week|Participants|Count of Participants|10|10.0||||||
3928377|NCT01411085|3750854|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3928378|NCT01411085|3750854|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3928379|NCT01411085|3750854|B1|||Age||years|Mean|46|46.0|Standard Deviation|9.82|9.82|||
3928380|NCT01411085|3750854|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3928381|NCT01411085|3750854|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3928382|NCT01411085|3750854|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3928383|NCT01410812|3750858|B4||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3928384|NCT01410812|3750859|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3928385|NCT01410812|3750860|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3928386|NCT01410812|3750861|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3928387|NCT01410812|3750858|B4||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3928388|NCT01410812|3750859|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3928389|NCT01410812|3750860|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3928390|NCT01410812|3750861|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3928391|NCT01410812|3750858|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3928392|NCT01410812|3750859|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3928393|NCT01410812|3750860|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3928394|NCT01410812|3750861|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3928395|NCT01410812|3750858|B4||Between 18 and 65 years|Age||Participants|Count of Participants|226|226.0||||||
3928396|NCT01410812|3750859|B3||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
3928397|NCT01410812|3750860|B2||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
3928398|NCT01410812|3750861|B1||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
3928399|NCT01410812|3750858|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3928400|NCT01410812|3750859|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3928401|NCT01410812|3750860|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3928402|NCT01410812|3750861|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3928403|NCT01410773|3750874|B1|United States||Region of Enrollment||participants|Number|110|110.0||||||
3928404|NCT01410773|3750874|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3928405|NCT01410773|3750874|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3928406|NCT01410773|3750874|B1|Mean (Full range of ages)||Age, Customized||years|Mean|53.1|53.1|Full Range|||19.0|86.0|
3928407|NCT01410604|3750879|B3|Mexico||Region of Enrollment||participants|Number|31|31.0||||||
3928408|NCT01410604|3750880|B2|Mexico||Region of Enrollment||participants|Number|16|16.0||||||
3928409|NCT01410604|3750881|B1|Mexico||Region of Enrollment||participants|Number|15|15.0||||||
3928410|NCT01410604|3750879|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3928411|NCT01410604|3750880|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3928412|NCT01410604|3750881|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3928413|NCT01410604|3750879|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3928414|NCT01410604|3750880|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3928415|NCT01410604|3750881|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3928416|NCT01410604|3750879|B3|||Age||years|Mean|13.37|13.37|Standard Deviation|1.92|1.92|||
3928417|NCT01410604|3750880|B2|||Age||years|Mean|14.12|14.12|Standard Deviation|1.20|1.2|||
3928418|NCT01410604|3750881|B1|||Age||years|Mean|12.56|12.56|Standard Deviation|2.25|2.25|||
3928419|NCT01410604|3750879|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3928420|NCT01410604|3750880|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3928421|NCT01410604|3750881|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3928422|NCT01410604|3750879|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3928423|NCT01410604|3750880|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3928424|NCT01410604|3750881|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3928425|NCT01410604|3750879|B3||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
3928426|NCT01410604|3750880|B2||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
3928427|NCT01410604|3750881|B1||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
3928428|NCT01410565|3750902|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928429|NCT01410565|3750903|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928430|NCT01410565|3750904|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928431|NCT01410565|3750902|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928432|NCT01410565|3750903|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928433|NCT01410565|3750904|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928434|NCT01410565|3750902|B3||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3928435|NCT01410565|3750903|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3928436|NCT01410565|3750904|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3928437|NCT01410565|3750902|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928438|NCT01410565|3750903|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928439|NCT01410565|3750904|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928440|NCT01410565|3750902|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928441|NCT01410565|3750903|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928442|NCT01410565|3750904|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928443|NCT01410565|3750902|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928444|NCT01410565|3750903|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928445|NCT01410565|3750904|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928446|NCT01410565|3750902|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928447|NCT01410565|3750903|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928448|NCT01410565|3750904|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928449|NCT01410565|3750902|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928450|NCT01410565|3750903|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928451|NCT01410565|3750904|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928452|NCT01410565|3750902|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3928453|NCT01410565|3750903|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3928454|NCT01410565|3750904|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3928455|NCT01410565|3750902|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3928456|NCT01410565|3750903|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3928457|NCT01410565|3750904|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928458|NCT01410565|3750902|B3||Male|Gender||Participants|Count of Participants|24|24.0||||||
3928459|NCT01410565|3750903|B2||Male|Gender||Participants|Count of Participants|13|13.0||||||
3928460|NCT01410565|3750904|B1||Male|Gender||Participants|Count of Participants|11|11.0||||||
3928461|NCT01410565|3750902|B3||Female|Gender||Participants|Count of Participants|4|4.0||||||
3928462|NCT01410565|3750903|B2||Female|Gender||Participants|Count of Participants|2|2.0||||||
3928463|NCT01410565|3750904|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
3928464|NCT01410565|3750902|B3|||Age||years|Mean|68.2|68.2|Standard Deviation|12.30|12.3|||
3928465|NCT01410565|3750903|B2|||Age||years|Mean|70.5|70.5|Standard Deviation|12.66|12.66|||
3928466|NCT01410565|3750904|B1|||Age||years|Mean|65.5|65.5|Standard Deviation|11.77|11.77|||
3928467|NCT01410565|3750902|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3928468|NCT01410565|3750903|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3928469|NCT01410565|3750904|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3928470|NCT01410565|3750902|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3928471|NCT01410565|3750903|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3928472|NCT01410565|3750904|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3928473|NCT01410565|3750902|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3928474|NCT01410565|3750903|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3928475|NCT01410565|3750904|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3928476|NCT01410552|3750916|B1||Male|Sex: Female, Male||Participants|Count of Participants|789|789.0||||||
3928477|NCT01410552|3750916|B1||Female|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
3928478|NCT01410552|3750916|B1|||Age||years|Median|68.0|68.0|Inter-Quartile Range|||60.0|76.0|
3928479|NCT01410474|3750921|B3||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3928480|NCT01410474|3750922|B2||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3928481|NCT01410474|3750923|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3928482|NCT01410474|3750921|B3||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3928483|NCT01410474|3750922|B2||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3928484|NCT01410474|3750923|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3928485|NCT01410474|3750921|B3|||Age||Years|Mean|10.1|10.1|Standard Deviation|4.5|4.5|||
3928486|NCT01410474|3750922|B2|||Age||Years|Mean|14.0|14.0|Standard Deviation|2.2|2.2|||
3928487|NCT01410474|3750923|B1|||Age||Years|Mean|6.3|6.3|Standard Deviation|2.6|2.6|||
3928488|NCT01410448|3750945|B3||Male|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
3928489|NCT01410448|3750946|B2||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3928490|NCT01410448|3750947|B1||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3928491|NCT01410448|3750945|B3||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3928492|NCT01410448|3750946|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3928493|NCT01410448|3750947|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3928494|NCT01410448|3750945|B3|||Age||Years|Mean|51.32|51.32|Standard Deviation|11.82|11.82|||
3928495|NCT01410448|3750946|B2|||Age||Years|Mean|51.19|51.19|Standard Deviation|12.29|12.29|||
3928496|NCT01410448|3750947|B1|||Age||Years|Mean|51.46|51.46|Standard Deviation|11.37|11.37|||
3928497|NCT01410409|3750986|B3|||Body Mass Index||kg/m^2|Mean|32.0|32.0|Standard Deviation|6.0|6.0|||
3928498|NCT01410409|3750987|B2|||Body Mass Index||kg/m^2|Mean|32.3|32.3|Standard Deviation|6.2|6.2|||
3928499|NCT01410409|3750988|B1|||Body Mass Index||kg/m^2|Mean|32.0|32.0|Standard Deviation|5.8|5.8|||
3928500|NCT01410409|3750986|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3928501|NCT01410409|3750987|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3928502|NCT01410409|3750988|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3928503|NCT01410409|3750986|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3928504|NCT01410409|3750987|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3928505|NCT01410409|3750988|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3928506|NCT01410409|3750986|B3|||Age||years|Mean|66.4|66.4|Standard Deviation|8.7|8.7|||
3928507|NCT01410409|3750987|B2|||Age||years|Mean|65.8|65.8|Standard Deviation|8.7|8.7|||
3928508|NCT01410409|3750988|B1|||Age||years|Mean|67.0|67.0|Standard Deviation|8.7|8.7|||
3928509|NCT01410357|3751011|B3|||Body Mass Index||kg/m^2|Mean|36.0|36.0|Standard Deviation|8.7|8.7|||
3928510|NCT01410357|3751012|B2|||Body Mass Index||kg/m^2|Mean|36.6|36.6|Standard Deviation|9.4|9.4|||
3928511|NCT01410357|3751013|B1|||Body Mass Index||kg/m^2|Mean|35.4|35.4|Standard Deviation|8.0|8.0|||
3928512|NCT01410357|3751011|B3|||Systolic blood pressure||mmHg|Mean|134.8|134.8|Standard Deviation|21.2|21.2|||
3928513|NCT01410357|3751012|B2|||Systolic blood pressure||mmHg|Mean|134.5|134.5|Standard Deviation|21.7|21.7|||
3928514|NCT01410357|3751013|B1|||Systolic blood pressure||mmHg|Mean|135.0|135.0|Standard Deviation|20.7|20.7|||
3928515|NCT01410357|3751011|B3|||Glycosylated hemoglobin (HbA1c)||mmol/mol|Mean|8.2|8.2|Standard Deviation|2.3|2.3|||
3928516|NCT01410357|3751012|B2|||Glycosylated hemoglobin (HbA1c)||mmol/mol|Mean|8.0|8.0|Standard Deviation|2.4|2.4|||
3928517|NCT01410357|3751013|B1|||Glycosylated hemoglobin (HbA1c)||mmol/mol|Mean|8.2|8.2|Standard Deviation|2.0|2.0|||
3928518|NCT01410357|3751011|B3|Mental||Short-form 36 (general health status)|The Short Form 36 Health Survey (SF-36) is a self-report of general health divided into a physical component summary (PCS) and mental component summary (MCS). Norm-based scores are placed on the same metric with a mean of 50 and standard deviation of 10. Scores above 50 reflect higher functional status than the average population and scores below 50 reflect lower than average function. Both the physical and mental are separate subscales with their own scoring as determined by the process above.|scores on a scale|Mean|36.4|36.4|Standard Deviation|11.4|11.4|||
3928519|NCT01410357|3751012|B2|Mental||Short-form 36 (general health status)|The Short Form 36 Health Survey (SF-36) is a self-report of general health divided into a physical component summary (PCS) and mental component summary (MCS). Norm-based scores are placed on the same metric with a mean of 50 and standard deviation of 10. Scores above 50 reflect higher functional status than the average population and scores below 50 reflect lower than average function. Both the physical and mental are separate subscales with their own scoring as determined by the process above.|scores on a scale|Mean|35.6|35.6|Standard Deviation|12.1|12.1|||
3928520|NCT01410357|3751013|B1|Mental||Short-form 36 (general health status)|The Short Form 36 Health Survey (SF-36) is a self-report of general health divided into a physical component summary (PCS) and mental component summary (MCS). Norm-based scores are placed on the same metric with a mean of 50 and standard deviation of 10. Scores above 50 reflect higher functional status than the average population and scores below 50 reflect lower than average function. Both the physical and mental are separate subscales with their own scoring as determined by the process above.|scores on a scale|Mean|37.2|37.2|Standard Deviation|10.6|10.6|||
3928521|NCT01410357|3751011|B3|Physical||Short-form 36 (general health status)|The Short Form 36 Health Survey (SF-36) is a self-report of general health divided into a physical component summary (PCS) and mental component summary (MCS). Norm-based scores are placed on the same metric with a mean of 50 and standard deviation of 10. Scores above 50 reflect higher functional status than the average population and scores below 50 reflect lower than average function. Both the physical and mental are separate subscales with their own scoring as determined by the process above.|scores on a scale|Mean|39.6|39.6|Standard Deviation|10.5|10.5|||
3928522|NCT01410357|3751012|B2|Physical||Short-form 36 (general health status)|The Short Form 36 Health Survey (SF-36) is a self-report of general health divided into a physical component summary (PCS) and mental component summary (MCS). Norm-based scores are placed on the same metric with a mean of 50 and standard deviation of 10. Scores above 50 reflect higher functional status than the average population and scores below 50 reflect lower than average function. Both the physical and mental are separate subscales with their own scoring as determined by the process above.|scores on a scale|Mean|39.8|39.8|Standard Deviation|10.9|10.9|||
3928523|NCT01410357|3751013|B1|Physical||Short-form 36 (general health status)|The Short Form 36 Health Survey (SF-36) is a self-report of general health divided into a physical component summary (PCS) and mental component summary (MCS). Norm-based scores are placed on the same metric with a mean of 50 and standard deviation of 10. Scores above 50 reflect higher functional status than the average population and scores below 50 reflect lower than average function. Both the physical and mental are separate subscales with their own scoring as determined by the process above.|scores on a scale|Mean|39.4|39.4|Standard Deviation|10.1|10.1|||
3928524|NCT01410357|3751011|B3|||Sheehan Disability Scale|The SDS measures role impairment in three domains (work/school; family life/home; social life). Possible total scores range from 0 to 30, with higher scores indicating greater disability. Only the total score was reported in our analyses, and is denoted here. The total score is calculated by summing the three domain scores, each which range from 0-10.|scores on a scale|Mean|17.9|17.9|Standard Deviation|6.2|6.2|||
3928543|NCT01410357|3751012|B2|||Charlson Index|The self-reported Charlson Index evaluates medical comorbidity. Possible scores range from 0 to 9, with higher scores indicating higher comorbidity. There are no subscales for this measure, just a total score that is summed.|scores on a scale|Mean|2.1|2.1|Standard Deviation|1.5|1.5|||
3928525|NCT01410357|3751012|B2|||Sheehan Disability Scale|The SDS measures role impairment in three domains (work/school; family life/home; social life). Possible total scores range from 0 to 30, with higher scores indicating greater disability. Only the total score was reported in our analyses, and is denoted here. The total score is calculated by summing the three domain scores, each which range from 0-10.|scores on a scale|Mean|17.8|17.8|Standard Deviation|6.5|6.5|||
3928526|NCT01410357|3751013|B1|||Sheehan Disability Scale|The SDS measures role impairment in three domains (work/school; family life/home; social life). Possible total scores range from 0 to 30, with higher scores indicating greater disability. Only the total score was reported in our analyses, and is denoted here. The total score is calculated by summing the three domain scores, each which range from 0-10.|scores on a scale|Mean|18.0|18.0|Standard Deviation|5.8|5.8|||
3928527|NCT01410357|3751011|B3|||Global Assessment of Functioning|The GAF is a 100-point single-item scale that measures global functioning. Possible scores range from 1 to 100, with higher scores indicating better functioning.|scores on a scale|Mean|51.6|51.6|Standard Deviation|11.5|11.5|||
3928528|NCT01410357|3751012|B2|||Global Assessment of Functioning|The GAF is a 100-point single-item scale that measures global functioning. Possible scores range from 1 to 100, with higher scores indicating better functioning.|scores on a scale|Mean|51.4|51.4|Standard Deviation|11.9|11.9|||
3928529|NCT01410357|3751013|B1|||Global Assessment of Functioning|The GAF is a 100-point single-item scale that measures global functioning. Possible scores range from 1 to 100, with higher scores indicating better functioning.|scores on a scale|Mean|51.8|51.8|Standard Deviation|11.0|11.0|||
3928530|NCT01410357|3751011|B3|||Brief Psychiatry Rating Scale|The BPRS measures psychotic and non-psychotic symptoms in serious mental illness. Possible total scores range from 7 to 126, with higher scores indicating greater symptom severity. For this study, the BPRS with 18 items was used. Each symptom measured ranges from 1-7, and all 18 items/symptoms are summed to create the total score. Only the BPRS total score was utilized in the analyses.|scores on a scale|Mean|40.0|40.0|Standard Deviation|9.3|9.3|||
3928531|NCT01410357|3751012|B2|||Brief Psychiatry Rating Scale|The BPRS measures psychotic and non-psychotic symptoms in serious mental illness. Possible total scores range from 7 to 126, with higher scores indicating greater symptom severity. For this study, the BPRS with 18 items was used. Each symptom measured ranges from 1-7, and all 18 items/symptoms are summed to create the total score. Only the BPRS total score was utilized in the analyses.|scores on a scale|Mean|41.3|41.3|Standard Deviation|8.9|8.9|||
3928532|NCT01410357|3751013|B1|||Brief Psychiatry Rating Scale|The BPRS measures psychotic and non-psychotic symptoms in serious mental illness. Possible total scores range from 7 to 126, with higher scores indicating greater symptom severity. For this study, the BPRS with 18 items was used. Each symptom measured ranges from 1-7, and all 18 items/symptoms are summed to create the total score. Only the BPRS total score was utilized in the analyses.|scores on a scale|Mean|38.7|38.7|Standard Deviation|9.8|9.8|||
3928533|NCT01410357|3751011|B3|||Montgomery Asberg Depression Rating Scale|The MADRS is a 10-item depression severity scale widely utilized in studies with patients with serious mental illness. Possible scores range from 0 to 60 with higher scores indicating worse depression.|scores on a scale|Mean|24.1|24.1|Standard Deviation|9.1|9.1|||
3928534|NCT01410357|3751012|B2|||Montgomery Asberg Depression Rating Scale|The MADRS is a 10-item depression severity scale widely utilized in studies with patients with serious mental illness. Possible scores range from 0 to 60 with higher scores indicating worse depression.|scores on a scale|Mean|25.0|25.0|Standard Deviation|8.8|8.8|||
3928535|NCT01410357|3751013|B1|||Montgomery Asberg Depression Rating Scale|The MADRS is a 10-item depression severity scale widely utilized in studies with patients with serious mental illness. Possible scores range from 0 to 60 with higher scores indicating worse depression.|scores on a scale|Mean|23.1|23.1|Standard Deviation|9.4|9.4|||
3928536|NCT01410357|3751011|B3|||Clinical Global Impression|The Clinical Global Impression (CGI) is a broad measure of global psychopathology that evaluates illness severity on a 1 to 7 point continuum. Possible scores range from 0 to 7, with higher scores indicating greater psychopathology.|scores on a scale|Mean|4.3|4.3|Standard Deviation|0.9|0.9|||
3928537|NCT01410357|3751012|B2|||Clinical Global Impression|The Clinical Global Impression (CGI) is a broad measure of global psychopathology that evaluates illness severity on a 1 to 7 point continuum. Possible scores range from 0 to 7, with higher scores indicating greater psychopathology.|scores on a scale|Mean|4.3|4.3|Standard Deviation|0.9|0.9|||
3928538|NCT01410357|3751013|B1|||Clinical Global Impression|The Clinical Global Impression (CGI) is a broad measure of global psychopathology that evaluates illness severity on a 1 to 7 point continuum. Possible scores range from 0 to 7, with higher scores indicating greater psychopathology.|scores on a scale|Mean|4.3|4.3|Standard Deviation|1.0|1.0|||
3928539|NCT01410357|3751011|B3|||Basic Health Literacy Screen|The Basic Health Literacy Scale is comprised of three items on a 5-point response scale, ranging from 1-5. After reverse-scoring the item addressing confidence with forms (item #2), responses to the three items are summed. Total scores range between 3 and 15, with higher scores indicating higher subjective health literacy.|scores on a scale|Mean|12.5|12.5|Standard Deviation|3.2|3.2|||
3928540|NCT01410357|3751012|B2|||Basic Health Literacy Screen|The Basic Health Literacy Scale is comprised of three items on a 5-point response scale, ranging from 1-5. After reverse-scoring the item addressing confidence with forms (item #2), responses to the three items are summed. Total scores range between 3 and 15, with higher scores indicating higher subjective health literacy.|scores on a scale|Mean|12.4|12.4|Standard Deviation|3.3|3.3|||
3928541|NCT01410357|3751013|B1|||Basic Health Literacy Screen|The Basic Health Literacy Scale is comprised of three items on a 5-point response scale, ranging from 1-5. After reverse-scoring the item addressing confidence with forms (item #2), responses to the three items are summed. Total scores range between 3 and 15, with higher scores indicating higher subjective health literacy.|scores on a scale|Mean|12.5|12.5|Standard Deviation|3.0|3.0|||
3928542|NCT01410357|3751011|B3|||Charlson Index|The self-reported Charlson Index evaluates medical comorbidity. Possible scores range from 0 to 9, with higher scores indicating higher comorbidity. There are no subscales for this measure, just a total score that is summed.|scores on a scale|Mean|2.2|2.2|Standard Deviation|1.6|1.6|||
3928597|NCT01410357|3751012|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3928598|NCT01410357|3751013|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
3928544|NCT01410357|3751013|B1|||Charlson Index|The self-reported Charlson Index evaluates medical comorbidity. Possible scores range from 0 to 9, with higher scores indicating higher comorbidity. There are no subscales for this measure, just a total score that is summed.|scores on a scale|Mean|2.4|2.4|Standard Deviation|1.7|1.7|||
3928545|NCT01410357|3751011|B3|||Insulin user||Participants|Count of Participants|88|88.0||||||
3928546|NCT01410357|3751012|B2|||Insulin user||Participants|Count of Participants|45|45.0||||||
3928547|NCT01410357|3751013|B1|||Insulin user||Participants|Count of Participants|43|43.0||||||
3928548|NCT01410357|3751011|B3|||On second generation antipsychotic medication||Participants|Count of Participants|73|73.0||||||
3928549|NCT01410357|3751012|B2|||On second generation antipsychotic medication||Participants|Count of Participants|33|33.0||||||
3928550|NCT01410357|3751013|B1|||On second generation antipsychotic medication||Participants|Count of Participants|40|40.0||||||
3928551|NCT01410357|3751011|B3|||AHA-defined hypertension||Participants|Count of Participants|87|87.0||||||
3928552|NCT01410357|3751012|B2|||AHA-defined hypertension||Participants|Count of Participants|42|42.0||||||
3928553|NCT01410357|3751013|B1|||AHA-defined hypertension||Participants|Count of Participants|45|45.0||||||
3928554|NCT01410357|3751011|B3|||Diabetes mellitus duration||years|Mean|10.1|10.1|Standard Deviation|7.8|7.8|||
3928555|NCT01410357|3751012|B2|||Diabetes mellitus duration||years|Mean|10.3|10.3|Standard Deviation|8.1|8.1|||
3928556|NCT01410357|3751013|B1|||Diabetes mellitus duration||years|Mean|9.8|9.8|Standard Deviation|7.5|7.5|||
3928557|NCT01410357|3751011|B3|||Serious Mental Illness duration||years|Mean|18.5|18.5|Standard Deviation|12.6|12.6|||
3928558|NCT01410357|3751012|B2|||Serious Mental Illness duration||years|Mean|17.8|17.8|Standard Deviation|12.4|12.4|||
3928559|NCT01410357|3751013|B1|||Serious Mental Illness duration||years|Mean|19.1|19.1|Standard Deviation|12.9|12.9|||
3928560|NCT01410357|3751011|B3||Major Depressive Disorder|Mini-International Neuropsychiatric Interview (MINI)||Participants|Count of Participants|95|95.0||||||
3928561|NCT01410357|3751012|B2||Major Depressive Disorder|Mini-International Neuropsychiatric Interview (MINI)||Participants|Count of Participants|46|46.0||||||
3928562|NCT01410357|3751013|B1||Major Depressive Disorder|Mini-International Neuropsychiatric Interview (MINI)||Participants|Count of Participants|49|49.0||||||
3928563|NCT01410357|3751011|B3||Bipolar Disorder|Mini-International Neuropsychiatric Interview (MINI)||Participants|Count of Participants|56|56.0||||||
3928564|NCT01410357|3751012|B2||Bipolar Disorder|Mini-International Neuropsychiatric Interview (MINI)||Participants|Count of Participants|34|34.0||||||
3928565|NCT01410357|3751013|B1||Bipolar Disorder|Mini-International Neuropsychiatric Interview (MINI)||Participants|Count of Participants|22|22.0||||||
3928566|NCT01410357|3751011|B3||Schizophrenia|Mini-International Neuropsychiatric Interview (MINI)||Participants|Count of Participants|49|49.0||||||
3928567|NCT01410357|3751012|B2||Schizophrenia|Mini-International Neuropsychiatric Interview (MINI)||Participants|Count of Participants|20|20.0||||||
3928568|NCT01410357|3751013|B1||Schizophrenia|Mini-International Neuropsychiatric Interview (MINI)||Participants|Count of Participants|29|29.0||||||
3928569|NCT01410357|3751011|B3||Other/None|Health Insurance Type||Participants|Count of Participants|29|29.0||||||
3928570|NCT01410357|3751012|B2||Other/None|Health Insurance Type||Participants|Count of Participants|17|17.0||||||
3928571|NCT01410357|3751013|B1||Other/None|Health Insurance Type||Participants|Count of Participants|12|12.0||||||
3928572|NCT01410357|3751011|B3||Medicaid|Health Insurance Type||Participants|Count of Participants|95|95.0||||||
3928573|NCT01410357|3751012|B2||Medicaid|Health Insurance Type||Participants|Count of Participants|47|47.0||||||
3928574|NCT01410357|3751013|B1||Medicaid|Health Insurance Type||Participants|Count of Participants|48|48.0||||||
3928575|NCT01410357|3751011|B3||Medicare|Health Insurance Type||Participants|Count of Participants|69|69.0||||||
3928576|NCT01410357|3751012|B2||Medicare|Health Insurance Type||Participants|Count of Participants|34|34.0||||||
3928577|NCT01410357|3751013|B1||Medicare|Health Insurance Type||Participants|Count of Participants|35|35.0||||||
3928578|NCT01410357|3751011|B3||Private|Health Insurance Type||Participants|Count of Participants|7|7.0||||||
3928579|NCT01410357|3751012|B2||Private|Health Insurance Type||Participants|Count of Participants|2|2.0||||||
3928580|NCT01410357|3751013|B1||Private|Health Insurance Type||Participants|Count of Participants|5|5.0||||||
3928581|NCT01410357|3751011|B3|||Education||years|Mean|12.6|12.6|Standard Deviation|2.7|2.7|||
3928582|NCT01410357|3751012|B2|||Education||years|Mean|12.5|12.5|Standard Deviation|2.9|2.9|||
3928583|NCT01410357|3751013|B1|||Education||years|Mean|12.7|12.7|Standard Deviation|2.5|2.5|||
3928584|NCT01410357|3751011|B3|United States||Region of Enrollment||Participants|Count of Participants|200|200.0||||||
3928585|NCT01410357|3751012|B2|United States||Region of Enrollment||Participants|Count of Participants|100|100.0||||||
3928586|NCT01410357|3751013|B1|United States||Region of Enrollment||Participants|Count of Participants|100|100.0||||||
3928587|NCT01410357|3751011|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3928588|NCT01410357|3751012|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3928589|NCT01410357|3751013|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3928590|NCT01410357|3751011|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3928591|NCT01410357|3751012|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3928592|NCT01410357|3751013|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3928593|NCT01410357|3751011|B3|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|107|107.0||||||
3928594|NCT01410357|3751012|B2|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|55|55.0||||||
3928595|NCT01410357|3751013|B1|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|52|52.0||||||
3928596|NCT01410357|3751011|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|74|74.0||||||
3928599|NCT01410357|3751011|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3928600|NCT01410357|3751012|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3928601|NCT01410357|3751013|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3928602|NCT01410357|3751011|B3||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3928603|NCT01410357|3751012|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3928604|NCT01410357|3751013|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3928605|NCT01410357|3751011|B3|||Age||years|Mean|52.7|52.7|Standard Deviation|9.5|9.5|||
3928606|NCT01410357|3751012|B2|||Age||years|Mean|52.6|52.6|Standard Deviation|9.7|9.7|||
3928607|NCT01410357|3751013|B1|||Age||years|Mean|52.8|52.8|Standard Deviation|9.7|9.7|||
3928608|NCT01410344|3751068|B1|||CD4 T-cell Count||cells/microliter|Median|224|224.0|Full Range|||55.0|833.0|
3928609|NCT01410344|3751068|B1||Mismatched Unrelated|Donor Type|Donor/recipient matching described by relatedness and HLA matching. A matched donor corresponds to matching on 8/8 HLA loci, while mismatched donor indicates 7/8 matching.|Participants|Count of Participants|1|1.0||||||
3928610|NCT01410344|3751068|B1||Mismatched Related|Donor Type|Donor/recipient matching described by relatedness and HLA matching. A matched donor corresponds to matching on 8/8 HLA loci, while mismatched donor indicates 7/8 matching.|Participants|Count of Participants|3|3.0||||||
3928611|NCT01410344|3751068|B1||Matched Unrelated|Donor Type|Donor/recipient matching described by relatedness and HLA matching. A matched donor corresponds to matching on 8/8 HLA loci, while mismatched donor indicates 7/8 matching.|Participants|Count of Participants|9|9.0||||||
3928612|NCT01410344|3751068|B1||Matched Related|Donor Type|Donor/recipient matching described by relatedness and HLA matching. A matched donor corresponds to matching on 8/8 HLA loci, while mismatched donor indicates 7/8 matching.|Participants|Count of Participants|4|4.0||||||
3928613|NCT01410344|3751068|B1||3|Number of Regimens of Salvage Chemotherapy||Participants|Count of Participants|1|1.0||||||
3928614|NCT01410344|3751068|B1||1|Number of Regimens of Salvage Chemotherapy||Participants|Count of Participants|6|6.0||||||
3928615|NCT01410344|3751068|B1||0|Number of Regimens of Salvage Chemotherapy||Participants|Count of Participants|10|10.0||||||
3928616|NCT01410344|3751068|B1||3|Number of Regimens of Induction Chemotherapy||Participants|Count of Participants|1|1.0||||||
3928617|NCT01410344|3751068|B1||2|Number of Regimens of Induction Chemotherapy||Participants|Count of Participants|6|6.0||||||
3928618|NCT01410344|3751068|B1||1|Number of Regimens of Induction Chemotherapy||Participants|Count of Participants|10|10.0||||||
3928619|NCT01410344|3751068|B1||Negative|Recipient Cytomegalovirus Status||Participants|Count of Participants|5|5.0||||||
3928620|NCT01410344|3751068|B1||Positive|Recipient Cytomegalovirus Status||Participants|Count of Participants|12|12.0||||||
3928621|NCT01410344|3751068|B1||Detectable by Assay|HIV Viral Load||Participants|Count of Participants|2|2.0||||||
3928622|NCT01410344|3751068|B1||Undetectable by Assay|HIV Viral Load||Participants|Count of Participants|15|15.0||||||
3928623|NCT01410344|3751068|B1||Partial Remission|Lymphoma Stage||Participants|Count of Participants|1|1.0||||||
3928624|NCT01410344|3751068|B1||Complete Remission|Lymphoma Stage||Participants|Count of Participants|3|3.0||||||
3928625|NCT01410344|3751068|B1||Second Complete Remission|Leukemia Stage||Participants|Count of Participants|3|3.0||||||
3928626|NCT01410344|3751068|B1||First Complete Remission|Leukemia Stage||Participants|Count of Participants|8|8.0||||||
3928627|NCT01410344|3751068|B1||Non-Hodgkin's Lymphoma|Primary Malignancy||Participants|Count of Participants|3|3.0||||||
3928628|NCT01410344|3751068|B1||Hodgkin's Lymphoma|Primary Malignancy||Participants|Count of Participants|1|1.0||||||
3928629|NCT01410344|3751068|B1||Myelodysplastic Syndromes (MDS)|Primary Malignancy||Participants|Count of Participants|2|2.0||||||
3928630|NCT01410344|3751068|B1||Acute Lymphocytic Leukemia (ALL)|Primary Malignancy||Participants|Count of Participants|2|2.0||||||
3928631|NCT01410344|3751068|B1||Acute Myeloid Leukemia (AML)|Primary Malignancy||Participants|Count of Participants|9|9.0||||||
3928632|NCT01410344|3751068|B1||70|Karnofsky Performance Score|Assesses patient self-perceived global quality of life and functioning, where 100 equals perfect quality of life.|Participants|Count of Participants|1|1.0||||||
3928633|NCT01410344|3751068|B1||80|Karnofsky Performance Score|Assesses patient self-perceived global quality of life and functioning, where 100 equals perfect quality of life.|Participants|Count of Participants|3|3.0||||||
3928634|NCT01410344|3751068|B1||90|Karnofsky Performance Score|Assesses patient self-perceived global quality of life and functioning, where 100 equals perfect quality of life.|Participants|Count of Participants|9|9.0||||||
3928635|NCT01410344|3751068|B1||100|Karnofsky Performance Score|Assesses patient self-perceived global quality of life and functioning, where 100 equals perfect quality of life.|Participants|Count of Participants|4|4.0||||||
3928636|NCT01410344|3751068|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3928637|NCT01410344|3751068|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928638|NCT01410344|3751068|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3928639|NCT01410344|3751068|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3928640|NCT01410344|3751068|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928641|NCT01410344|3751068|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928642|NCT01410344|3751068|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3928643|NCT01410344|3751068|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3928644|NCT01410344|3751068|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3928645|NCT01410344|3751068|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3928646|NCT01410344|3751068|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3928647|NCT01410344|3751068|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3928648|NCT01410344|3751068|B1|||Age||years|Median|47|47.0|Full Range|||25.0|64.0|
3928649|NCT01410240|3751082|B4|United States||Region of Enrollment||participants|Number|118|118.0||||||
3928650|NCT01410240|3751083|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3928651|NCT01410240|3751084|B2|United States||Region of Enrollment||participants|Number|53|53.0||||||
3928652|NCT01410240|3751085|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
3928653|NCT01410240|3751082|B4||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3928654|NCT01410240|3751083|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3928655|NCT01410240|3751084|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3928656|NCT01410240|3751085|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3928657|NCT01410240|3751082|B4||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3928658|NCT01410240|3751083|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3928659|NCT01410240|3751084|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3928660|NCT01410240|3751085|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3928661|NCT01410240|3751082|B4|||Age||years|Mean|64.8|64.8|Standard Deviation|8.14|8.14|||
3928662|NCT01410240|3751083|B3|||Age||years|Mean|59.4|59.4|Standard Deviation|8.49|8.49|||
3928663|NCT01410240|3751084|B2|||Age||years|Mean|64.8|64.8|Standard Deviation|7.73|7.73|||
3928664|NCT01410240|3751085|B1|||Age||years|Mean|66.2|66.2|Standard Deviation|8.09|8.09|||
3928665|NCT01410227|3751158|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3928666|NCT01410227|3751158|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3928667|NCT01410227|3751158|B1|||Age||Years|Median|37|37.0|Full Range|||18.0|64.0|
3928668|NCT01410110|3751231|B3|||Global Assessment of Function (GAF)|The Global Assessment of Function Scale range is from 1 to 100. Higher scores indicate better functioning.|units on a scale|Mean|46.42|46.42|Standard Deviation|4.75|4.75|||
3928669|NCT01410110|3751232|B2|||Global Assessment of Function (GAF)|The Global Assessment of Function Scale range is from 1 to 100. Higher scores indicate better functioning.|units on a scale|Mean|47.67|47.67|Standard Deviation|5.9|5.9|||
3928670|NCT01410110|3751233|B1|||Global Assessment of Function (GAF)|The Global Assessment of Function Scale range is from 1 to 100. Higher scores indicate better functioning.|units on a scale|Mean|45.17|45.17|Standard Deviation|3.6|3.6|||
3928671|NCT01410110|3751231|B3|No||Disability (SSDI or VA Service Connected)||participants|Number|43|43.0||||||
3928672|NCT01410110|3751232|B2|No||Disability (SSDI or VA Service Connected)||participants|Number|21|21.0||||||
3928673|NCT01410110|3751233|B1|No||Disability (SSDI or VA Service Connected)||participants|Number|22|22.0||||||
3928674|NCT01410110|3751231|B3|Yes||Disability (SSDI or VA Service Connected)||participants|Number|5|5.0||||||
3928675|NCT01410110|3751232|B2|Yes||Disability (SSDI or VA Service Connected)||participants|Number|3|3.0||||||
3928676|NCT01410110|3751233|B1|Yes||Disability (SSDI or VA Service Connected)||participants|Number|2|2.0||||||
3928677|NCT01410110|3751231|B3|No||Felony Convictions||participants|Number|25|25.0||||||
3928678|NCT01410110|3751232|B2|No||Felony Convictions||participants|Number|12|12.0||||||
3928679|NCT01410110|3751233|B1|No||Felony Convictions||participants|Number|13|13.0||||||
3928680|NCT01410110|3751231|B3|Yes||Felony Convictions||participants|Number|23|23.0||||||
3928681|NCT01410110|3751232|B2|Yes||Felony Convictions||participants|Number|12|12.0||||||
3928682|NCT01410110|3751233|B1|Yes||Felony Convictions||participants|Number|11|11.0||||||
3928683|NCT01410110|3751231|B3|||Education||years|Mean|12.71|12.71|Standard Deviation|1.55|1.55|||
3928684|NCT01410110|3751232|B2|||Education||years|Mean|12.21|12.21|Standard Deviation|1.5|1.5|||
3928685|NCT01410110|3751233|B1|||Education||years|Mean|13.2|13.2|Standard Deviation|1.6|1.6|||
3928686|NCT01410110|3751231|B3|Other||Axis 1 Primary Diagnosis||participants|Number|4|4.0||||||
3928687|NCT01410110|3751232|B2|Other||Axis 1 Primary Diagnosis||participants|Number|2|2.0||||||
3928688|NCT01410110|3751233|B1|Other||Axis 1 Primary Diagnosis||participants|Number|2|2.0||||||
3928689|NCT01410110|3751231|B3|Opiods||Axis 1 Primary Diagnosis||participants|Number|6|6.0||||||
3928690|NCT01410110|3751232|B2|Opiods||Axis 1 Primary Diagnosis||participants|Number|0|0.0||||||
3928691|NCT01410110|3751233|B1|Opiods||Axis 1 Primary Diagnosis||participants|Number|6|6.0||||||
3928692|NCT01410110|3751231|B3|Cocaine||Axis 1 Primary Diagnosis||participants|Number|10|10.0||||||
3928693|NCT01410110|3751232|B2|Cocaine||Axis 1 Primary Diagnosis||participants|Number|7|7.0||||||
3928694|NCT01410110|3751233|B1|Cocaine||Axis 1 Primary Diagnosis||participants|Number|3|3.0||||||
3928695|NCT01410110|3751231|B3|Alcohol Use Disorder||Axis 1 Primary Diagnosis||participants|Number|28|28.0||||||
3928696|NCT01410110|3751232|B2|Alcohol Use Disorder||Axis 1 Primary Diagnosis||participants|Number|15|15.0||||||
3928697|NCT01410110|3751233|B1|Alcohol Use Disorder||Axis 1 Primary Diagnosis||participants|Number|13|13.0||||||
3928698|NCT01410110|3751231|B3|Divorced/Widowed||Marital Status||participants|Number|26|26.0||||||
3928699|NCT01410110|3751232|B2|Divorced/Widowed||Marital Status||participants|Number|10|10.0||||||
3928700|NCT01410110|3751233|B1|Divorced/Widowed||Marital Status||participants|Number|16|16.0||||||
3928701|NCT01410110|3751231|B3|Never Married||Marital Status||participants|Number|13|13.0||||||
3928702|NCT01410110|3751232|B2|Never Married||Marital Status||participants|Number|8|8.0||||||
3928703|NCT01410110|3751233|B1|Never Married||Marital Status||participants|Number|5|5.0||||||
3928704|NCT01410110|3751231|B3|Married||Marital Status||participants|Number|9|9.0||||||
3928705|NCT01410110|3751232|B2|Married||Marital Status||participants|Number|6|6.0||||||
3928706|NCT01410110|3751233|B1|Married||Marital Status||participants|Number|3|3.0||||||
3928707|NCT01410110|3751231|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928708|NCT01410110|3751232|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928709|NCT01410110|3751233|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928710|NCT01410110|3751231|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3928711|NCT01410110|3751232|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3928712|NCT01410110|3751233|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928713|NCT01410110|3751231|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3928714|NCT01410110|3751232|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3928715|NCT01410110|3751233|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3928716|NCT01410110|3751231|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3928717|NCT01410110|3751232|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3928718|NCT01410110|3751233|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3928719|NCT01410110|3751231|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928720|NCT01410110|3751232|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928721|NCT01410110|3751233|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928722|NCT01410110|3751231|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928723|NCT01410110|3751232|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928724|NCT01410110|3751233|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928725|NCT01410110|3751231|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3928726|NCT01410110|3751232|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3928727|NCT01410110|3751233|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928728|NCT01410110|3751231|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928729|NCT01410110|3751232|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928730|NCT01410110|3751233|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928731|NCT01410110|3751231|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3928732|NCT01410110|3751232|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3928733|NCT01410110|3751233|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3928734|NCT01410110|3751231|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928735|NCT01410110|3751232|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928736|NCT01410110|3751233|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928737|NCT01410110|3751231|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3928738|NCT01410110|3751232|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3928739|NCT01410110|3751233|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3928740|NCT01410110|3751231|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3928741|NCT01410110|3751232|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3928742|NCT01410110|3751233|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3928743|NCT01410110|3751231|B3|||Age||years|Mean|52.55|52.55|Standard Deviation|8.55|8.55|||
3928744|NCT01410110|3751232|B2|||Age||years|Mean|53.8|53.8|Standard Deviation|7.4|7.4|||
3928745|NCT01410110|3751233|B1|||Age||years|Mean|51.3|51.3|Standard Deviation|9.7|9.7|||
3928746|NCT01410097|3751256|B3|Other/multiple||Race/Ethnicity, Customized||Participants|Count of Participants|84|84.0||||||
3928747|NCT01410097|3751257|B2|Other/multiple||Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3928748|NCT01410097|3751258|B1|Other/multiple||Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3928749|NCT01410097|3751256|B3|Non Hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|779|779.0||||||
3928750|NCT01410097|3751257|B2|Non Hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|378|378.0||||||
3928751|NCT01410097|3751258|B1|Non Hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|401|401.0||||||
3928752|NCT01410097|3751256|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|218|218.0||||||
3928753|NCT01410097|3751257|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|108|108.0||||||
3928754|NCT01410097|3751258|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|110|110.0||||||
3928755|NCT01410097|3751256|B3||Male|Sex: Female, Male||Participants|Count of Participants|463|463.0||||||
3928756|NCT01410097|3751257|B2||Male|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
3928757|NCT01410097|3751258|B1||Male|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
3928758|NCT01410097|3751256|B3||Female|Sex: Female, Male||Participants|Count of Participants|618|618.0||||||
3928759|NCT01410097|3751257|B2||Female|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
3928760|NCT01410097|3751258|B1||Female|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
3928761|NCT01410097|3751256|B3|||Age||years|Mean|59.0|59.0|Standard Deviation|6.8|6.8|||
3928762|NCT01410097|3751257|B2|||Age||years|Mean|59.1|59.1|Standard Deviation|6.7|6.7|||
3928763|NCT01410097|3751258|B1|||Age||years|Mean|58.9|58.9|Standard Deviation|6.8|6.8|||
3928764|NCT01409993|3751281|B3|United States||Region of Enrollment||participants|Number|78|78.0||||||
3928765|NCT01409993|3751282|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
3928766|NCT01409993|3751283|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
3928767|NCT01409993|3751281|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928768|NCT01409993|3751282|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928769|NCT01409993|3751283|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928770|NCT01409993|3751281|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928771|NCT01409993|3751282|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928772|NCT01409993|3751283|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928773|NCT01409993|3751281|B3||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3928774|NCT01409993|3751282|B2||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3928775|NCT01409993|3751283|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3928776|NCT01409993|3751281|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3928777|NCT01409993|3751282|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3928778|NCT01409993|3751283|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3928779|NCT01409993|3751281|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928780|NCT01409993|3751282|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928781|NCT01409993|3751283|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928782|NCT01409993|3751281|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3928783|NCT01409993|3751282|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928784|NCT01409993|3751283|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3928785|NCT01409993|3751281|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928786|NCT01409993|3751282|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928787|NCT01409993|3751283|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3928788|NCT01409993|3751281|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3928789|NCT01409993|3751282|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3928790|NCT01409993|3751283|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3928791|NCT01409993|3751281|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3928792|NCT01409993|3751282|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3928793|NCT01409993|3751283|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3928794|NCT01409993|3751281|B3|||Age||years|Mean|49.58|49.58|Standard Deviation|10.80|10.8|||
3928795|NCT01409993|3751282|B2|||Age||years|Mean|51.0|51.0|Standard Deviation|10.6|10.6|||
3928796|NCT01409993|3751283|B1|||Age||years|Mean|48.4|48.4|Standard Deviation|10.6|10.6|||
3928797|NCT01409837|3751304|B3|||Sperm cells with abnormal morphology (%)||Per cent|Geometric Mean|43.52|43.52|Standard Deviation|3.85|3.85|||
3928798|NCT01409837|3751305|B2|||Sperm cells with abnormal morphology (%)||Per cent|Geometric Mean|44.12|44.12|Standard Deviation|2.6|2.6|||
3928799|NCT01409837|3751306|B1|||Sperm cells with abnormal morphology (%)||Per cent|Geometric Mean|42.91|42.91|Standard Deviation|5.1|5.1|||
3928800|NCT01409837|3751304|B3|||Sperm cell motility (%)||Per cent|Geometric Mean|19.73|19.73|Standard Deviation|3.8|3.8|||
3928801|NCT01409837|3751305|B2|||Sperm cell motility (%)||Per cent|Geometric Mean|22.12|22.12|Standard Deviation|4.4|4.4|||
3928802|NCT01409837|3751306|B1|||Sperm cell motility (%)||Per cent|Geometric Mean|17.33|17.33|Standard Deviation|3.2|3.2|||
3928803|NCT01409837|3751304|B3|||Sperm cell count||Millions/ml|Geometric Mean|6.36|6.36|Standard Deviation|3.29|3.29|||
3928804|NCT01409837|3751305|B2|||Sperm cell count||Millions/ml|Geometric Mean|7.43|7.43|Standard Deviation|3.97|3.97|||
3928805|NCT01409837|3751306|B1|||Sperm cell count||Millions/ml|Geometric Mean|5.29|5.29|Standard Deviation|2.6|2.6|||
3928806|NCT01409837|3751304|B3|||Ejaculate volume||ml|Geometric Mean|3.05|3.05|Standard Deviation|0.29|0.29|||
3928807|NCT01409837|3751305|B2|||Ejaculate volume||ml|Geometric Mean|3.01|3.01|Standard Deviation|0.23|0.23|||
3928808|NCT01409837|3751306|B1|||Ejaculate volume||ml|Geometric Mean|3.09|3.09|Standard Deviation|0.34|0.34|||
3928809|NCT01409837|3751304|B3|||Duration of infertility||Years|Mean|7.789|7.789|Standard Deviation|3.7|3.7|||
3928810|NCT01409837|3751305|B2|||Duration of infertility||Years|Mean|7.77|7.77|Standard Deviation|3.1|3.1|||
3928811|NCT01409837|3751306|B1|||Duration of infertility||Years|Mean|8.20|8.2|Standard Deviation|4.3|4.3|||
3928812|NCT01409837|3751304|B3|||Weight||Kg|Mean|65.225|65.225|Standard Deviation|10.75|10.75|||
3928813|NCT01409837|3751305|B2|||Weight||Kg|Mean|64.26|64.26|Standard Deviation|10.3|10.3|||
3928814|NCT01409837|3751306|B1|||Weight||Kg|Mean|66.19|66.19|Standard Deviation|11.2|11.2|||
3928815|NCT01409837|3751304|B3|||Height||metres|Mean|1.495|1.495|Standard Deviation|0.45|0.45|||
3928816|NCT01409837|3751305|B2|||Height||metres|Mean|1.48|1.48|Standard Deviation|0.5|0.5|||
3928817|NCT01409837|3751306|B1|||Height||metres|Mean|1.51|1.51|Standard Deviation|0.4|0.4|||
3928818|NCT01409837|3751304|B3|Nigeria||Region of Enrollment||participants|Number|33|33.0||||||
3928819|NCT01409837|3751305|B2|Nigeria||Region of Enrollment||participants|Number|16|16.0||||||
3928820|NCT01409837|3751306|B1|Nigeria||Region of Enrollment||participants|Number|17|17.0||||||
3928821|NCT01409837|3751304|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3928822|NCT01409837|3751305|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3928823|NCT01409837|3751306|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3928824|NCT01409837|3751304|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3928825|NCT01409837|3751305|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3928826|NCT01409837|3751306|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3928827|NCT01409837|3751304|B3|Between 18 and 65 years||Age||Years|Mean|28.895|28.895|Standard Deviation|8.05|8.05|||
3928828|NCT01409837|3751305|B2|Between 18 and 65 years||Age||Years|Mean|26.93|26.93|Standard Deviation|7.3|7.3|||
3928829|NCT01409837|3751306|B1|Between 18 and 65 years||Age||Years|Mean|30.86|30.86|Standard Deviation|8.8|8.8|||
3928830|NCT01409707|3751329|B4|United States||Region of Enrollment||participants|Number|126|126.0||||||
3928831|NCT01409707|3751330|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3928832|NCT01409707|3751331|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
3928833|NCT01409707|3751332|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
3928834|NCT01409707|3751329|B4||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3928835|NCT01409707|3751330|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3928836|NCT01409707|3751331|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3928837|NCT01409707|3751332|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3928838|NCT01409707|3751329|B4||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3928839|NCT01409707|3751330|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3928840|NCT01409707|3751331|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3928841|NCT01409707|3751332|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3928842|NCT01409707|3751329|B4|||Age||years|Mean|33.72|33.72|Standard Deviation|10.25|10.25|||
3928843|NCT01409707|3751330|B3|||Age||years|Mean|34.40|34.4|Standard Deviation|10.65|10.65|||
3928844|NCT01409707|3751331|B2|||Age||years|Mean|34.67|34.67|Standard Deviation|10.33|10.33|||
3928845|NCT01409707|3751332|B1|||Age||years|Mean|32.85|32.85|Standard Deviation|10.67|10.67|||
3928846|NCT01409707|3751329|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3928847|NCT01409707|3751330|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3928848|NCT01409707|3751331|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3928849|NCT01409707|3751332|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3928850|NCT01409707|3751329|B4||Between 18 and 65 years|Age||Participants|Count of Participants|126|126.0||||||
3928851|NCT01409707|3751330|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3928852|NCT01409707|3751331|B2||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3928853|NCT01409707|3751332|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3928854|NCT01409707|3751329|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3928855|NCT01409707|3751330|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3928856|NCT01409707|3751331|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3928857|NCT01409707|3751332|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3928858|NCT01409564|3751344|B3|Korea, Republic of||Region of Enrollment||participants|Number|36|36.0||||||
3928859|NCT01409564|3751345|B2|Korea, Republic of||Region of Enrollment||participants|Number|18|18.0||||||
3928860|NCT01409564|3751346|B1|Korea, Republic of||Region of Enrollment||participants|Number|18|18.0||||||
3928861|NCT01409564|3751344|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3928862|NCT01409564|3751345|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3928863|NCT01409564|3751346|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3928864|NCT01409564|3751344|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3928865|NCT01409564|3751345|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3928866|NCT01409564|3751346|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3928867|NCT01409564|3751344|B3|||Age||years|Mean|78.53|78.53|Standard Deviation|6.11|6.11|||
3928868|NCT01409564|3751345|B2|||Age||years|Mean|78.05|78.05|Standard Deviation|6.09|6.09|||
3928869|NCT01409564|3751346|B1|||Age||years|Mean|79.00|79.0|Standard Deviation|6.26|6.26|||
3928870|NCT01409564|3751344|B3||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
3928871|NCT01409564|3751345|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3928872|NCT01409564|3751346|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3928873|NCT01409564|3751344|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3928874|NCT01409564|3751345|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3928875|NCT01409564|3751346|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3928876|NCT01409564|3751344|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3928877|NCT01409564|3751345|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3928878|NCT01409564|3751346|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3928879|NCT01409434|3751365|B1|||Fasting Glucose||mg/dL|Mean|91|91.0|Standard Deviation|12|12.0|||
3928880|NCT01409434|3751365|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
3928881|NCT01409434|3751365|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3928882|NCT01409434|3751365|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3928883|NCT01409434|3751365|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3928884|NCT01409434|3751365|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3928885|NCT01409434|3751365|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3928886|NCT01409434|3751365|B1|||Age||years|Mean|49|49.0|Standard Deviation|10|10.0|||
3928887|NCT01409382|3751373|B3|Brazil||Region of Enrollment||participants|Number|480|480.0||||||
3928888|NCT01409382|3751374|B2|Brazil||Region of Enrollment||participants|Number|240|240.0||||||
3928889|NCT01409382|3751375|B1|Brazil||Region of Enrollment||participants|Number|240|240.0||||||
3928890|NCT01409382|3751373|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3928891|NCT01409382|3751374|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3928892|NCT01409382|3751375|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3928893|NCT01409382|3751373|B3||Female|Sex: Female, Male||Participants|Count of Participants|480|480.0||||||
3928894|NCT01409382|3751374|B2||Female|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
3928895|NCT01409382|3751375|B1||Female|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
3928896|NCT01409382|3751373|B3|||Age||years|Mean|33|33.0|Standard Deviation|7|7.0|||
3928897|NCT01409382|3751374|B2|||Age||years|Mean|33|33.0|Standard Deviation|8|8.0|||
3928898|NCT01409382|3751375|B1|||Age||years|Mean|34|34.0|Standard Deviation|6|6.0|||
3928899|NCT01409382|3751373|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3928900|NCT01409382|3751374|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3928901|NCT01409382|3751375|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3928902|NCT01409382|3751373|B3||Between 18 and 65 years|Age||Participants|Count of Participants|480|480.0||||||
3928903|NCT01409382|3751374|B2||Between 18 and 65 years|Age||Participants|Count of Participants|240|240.0||||||
3928904|NCT01409382|3751375|B1||Between 18 and 65 years|Age||Participants|Count of Participants|240|240.0||||||
3928905|NCT01409382|3751373|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3928906|NCT01409382|3751374|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3928907|NCT01409382|3751375|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3928908|NCT01409291|3751388|B3|United States||Region of Enrollment||participants|Number|64|64.0||||||
3928909|NCT01409291|3751389|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
3928910|NCT01409291|3751390|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
3928911|NCT01409291|3751388|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3928912|NCT01409291|3751389|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3928913|NCT01409291|3751390|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3928914|NCT01409291|3751388|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3928915|NCT01409291|3751389|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3928916|NCT01409291|3751390|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3928917|NCT01409291|3751388|B3|||Age||years|Mean|23.5|23.5|Standard Deviation|6.7|6.7|||
3928918|NCT01409291|3751389|B2|||Age||years|Mean|7.9|7.9|Standard Deviation|3.5|3.5|||
3928919|NCT01409291|3751390|B1|||Age||years|Mean|35.8|35.8|Standard Deviation|6.1|6.1|||
3928920|NCT01409239|3751399|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
3928921|NCT01409239|3751400|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3928922|NCT01409239|3751401|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3928923|NCT01409239|3751399|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3928924|NCT01409239|3751400|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3928925|NCT01409239|3751401|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3928926|NCT01409239|3751399|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3928927|NCT01409239|3751400|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3928928|NCT01409239|3751401|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3928929|NCT01409239|3751399|B3|||Age||years|Mean|54|54.0|Standard Deviation|10|10.0|||
3928930|NCT01409239|3751400|B2|||Age||years|Mean|54|54.0|Standard Deviation|11|11.0|||
3928931|NCT01409239|3751401|B1|||Age||years|Mean|55|55.0|Standard Deviation|11|11.0|||
3928932|NCT01409239|3751399|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3928933|NCT01409239|3751400|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3928934|NCT01409239|3751401|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3928935|NCT01409239|3751399|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3928936|NCT01409239|3751400|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3928937|NCT01409239|3751401|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3928938|NCT01409239|3751399|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3928939|NCT01409239|3751400|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3928940|NCT01409239|3751401|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3928941|NCT01409213|3751408|B1|||Fasting blood glucose (FBG)|Population for this baseline characteristic consists of participants with available data, n=1366|mg/dL|Mean|146.9|146.9|Standard Deviation|42.0|42.0|||
3928942|NCT01409213|3751408|B1|||Hemoglobin A1c (HbA1c)|Population for this baseline characteristic consists of participants with available data, n=1519|Percent of glycosylated hemoglobin|Mean|7.4|7.4|Standard Deviation|1.1|1.1|||
3928943|NCT01409213|3751408|B1|Germany||Region of Enrollment||participants|Number|1522|1522.0||||||
3928944|NCT01409213|3751408|B1|Missing||Sex/Gender, Customized||Participants|Number|1|1.0||||||
3928945|NCT01409213|3751408|B1|Male||Sex/Gender, Customized||Participants|Number|680|680.0||||||
3928946|NCT01409213|3751408|B1|Female||Sex/Gender, Customized||Participants|Number|841|841.0||||||
3928947|NCT01409213|3751408|B1|||Age||years|Mean|64.0|64.0|Standard Deviation|10.8|10.8|||
3928948|NCT01409096|3751413|B3|||Hamilton Rating Scale for Anxiety (HRSA)|Minimum: 0 Maximum: 56 Better outcome: lower|units on a scale|Mean|21.1|21.1|Standard Deviation|9.2|9.2|||
3928949|NCT01409096|3751414|B2|||Hamilton Rating Scale for Anxiety (HRSA)|Minimum: 0 Maximum: 56 Better outcome: lower|units on a scale|Mean|22.8|22.8|Standard Deviation|8.1|8.1|||
3928950|NCT01409096|3751415|B1|||Hamilton Rating Scale for Anxiety (HRSA)|Minimum: 0 Maximum: 56 Better outcome: lower|units on a scale|Mean|19.4|19.4|Standard Deviation|9.8|9.8|||
3928951|NCT01409096|3751413|B3|||Young Mania Rating Scale (YMRS)|Minimum: 0 Maximum: 60 Better outcome: lower|units on a scale|Mean|10.1|10.1|Standard Deviation|4.3|4.3|||
3928952|NCT01409096|3751414|B2|||Young Mania Rating Scale (YMRS)|Minimum: 0 Maximum: 60 Better outcome: lower|units on a scale|Mean|10.4|10.4|Standard Deviation|4.3|4.3|||
3928953|NCT01409096|3751415|B1|||Young Mania Rating Scale (YMRS)|Minimum: 0 Maximum: 60 Better outcome: lower|units on a scale|Mean|10.1|10.1|Standard Deviation|4.7|4.7|||
3928954|NCT01409096|3751413|B3|||Inventory of Depressive Symtomatology-Self Report (IDS-SR)|Minimum: 0 Maximum: 84 Better outcome: Lower Normal: 7 or less|units on a scale|Mean|42.7|42.7|Standard Deviation|15.2|15.2|||
3928955|NCT01409096|3751414|B2|||Inventory of Depressive Symtomatology-Self Report (IDS-SR)|Minimum: 0 Maximum: 84 Better outcome: Lower Normal: 7 or less|units on a scale|Mean|47.5|47.5|Standard Deviation|14.5|14.5|||
3928956|NCT01409096|3751415|B1|||Inventory of Depressive Symtomatology-Self Report (IDS-SR)|Minimum: 0 Maximum: 84 Better outcome: Lower Normal: 7 or less|units on a scale|Mean|38.0|38.0|Standard Deviation|14.5|14.5|||
3928957|NCT01409096|3751413|B3|||Hamilton Rating Scale for Depression (HRSD)|Minimum: 0 Maximum: 50 Better outcome: lower Normal= 7 or less|units on a scale|Mean|22.4|22.4|Standard Deviation|4.3|4.3|||
3928958|NCT01409096|3751414|B2|||Hamilton Rating Scale for Depression (HRSD)|Minimum: 0 Maximum: 50 Better outcome: lower Normal= 7 or less|units on a scale|Mean|23.5|23.5|Standard Deviation|4.6|4.6|||
3928959|NCT01409096|3751415|B1|||Hamilton Rating Scale for Depression (HRSD)|Minimum: 0 Maximum: 50 Better outcome: lower Normal= 7 or less|units on a scale|Mean|21.3|21.3|Standard Deviation|4.0|4.0|||
3928960|NCT01409096|3751413|B3|Concomitant medication||Concomitant medications: None||participants|Number|60|60.0||||||
3928961|NCT01409096|3751414|B2|Concomitant medication||Concomitant medications: None||participants|Number|29|29.0||||||
3928962|NCT01409096|3751415|B1|Concomitant medication||Concomitant medications: None||participants|Number|31|31.0||||||
3928963|NCT01409096|3751413|B3|No concomitant medications||Concomitant medications: None||participants|Number|13|13.0||||||
3928964|NCT01409096|3751414|B2|No concomitant medications||Concomitant medications: None||participants|Number|6|6.0||||||
3928965|NCT01409096|3751415|B1|No concomitant medications||Concomitant medications: None||participants|Number|7|7.0||||||
3928966|NCT01409096|3751413|B3|No stimulant||Concomitant medications: Stimulant||participants|Number|72|72.0||||||
3928967|NCT01409096|3751414|B2|No stimulant||Concomitant medications: Stimulant||participants|Number|34|34.0||||||
3928968|NCT01409096|3751415|B1|No stimulant||Concomitant medications: Stimulant||participants|Number|38|38.0||||||
3928969|NCT01409096|3751413|B3|Stimulant||Concomitant medications: Stimulant||participants|Number|1|1.0||||||
3928970|NCT01409096|3751414|B2|Stimulant||Concomitant medications: Stimulant||participants|Number|1|1.0||||||
3928971|NCT01409096|3751415|B1|Stimulant||Concomitant medications: Stimulant||participants|Number|0|0.0||||||
3928972|NCT01409096|3751413|B3|No Sedative/hypnotic/anxiolytic||Concomitant Medications: Sedative/hypnotic/anxiolytic||participants|Number|37|37.0||||||
3928973|NCT01409096|3751414|B2|No Sedative/hypnotic/anxiolytic||Concomitant Medications: Sedative/hypnotic/anxiolytic||participants|Number|15|15.0||||||
3928974|NCT01409096|3751415|B1|No Sedative/hypnotic/anxiolytic||Concomitant Medications: Sedative/hypnotic/anxiolytic||participants|Number|22|22.0||||||
3928975|NCT01409096|3751413|B3|Sedative/hypnotic/anxiolytic||Concomitant Medications: Sedative/hypnotic/anxiolytic||participants|Number|36|36.0||||||
3928976|NCT01409096|3751414|B2|Sedative/hypnotic/anxiolytic||Concomitant Medications: Sedative/hypnotic/anxiolytic||participants|Number|20|20.0||||||
3928977|NCT01409096|3751415|B1|Sedative/hypnotic/anxiolytic||Concomitant Medications: Sedative/hypnotic/anxiolytic||participants|Number|16|16.0||||||
3928978|NCT01409096|3751413|B3|No antipsychotic||Concomitant Medications: Antipsychotic||participants|Number|38|38.0||||||
3928979|NCT01409096|3751414|B2|No antipsychotic||Concomitant Medications: Antipsychotic||participants|Number|17|17.0||||||
3928980|NCT01409096|3751415|B1|No antipsychotic||Concomitant Medications: Antipsychotic||participants|Number|21|21.0||||||
3928981|NCT01409096|3751413|B3|Antipsychotic||Concomitant Medications: Antipsychotic||participants|Number|35|35.0||||||
3928982|NCT01409096|3751414|B2|Antipsychotic||Concomitant Medications: Antipsychotic||participants|Number|18|18.0||||||
3928983|NCT01409096|3751415|B1|Antipsychotic||Concomitant Medications: Antipsychotic||participants|Number|17|17.0||||||
3928984|NCT01409096|3751413|B3|No antidepressants||Concomitant Medications: Antidepressant||participants|Number|30|30.0||||||
3928985|NCT01409096|3751414|B2|No antidepressants||Concomitant Medications: Antidepressant||participants|Number|13|13.0||||||
3928986|NCT01409096|3751415|B1|No antidepressants||Concomitant Medications: Antidepressant||participants|Number|17|17.0||||||
3928987|NCT01409096|3751413|B3|Antidepressants||Concomitant Medications: Antidepressant||participants|Number|43|43.0||||||
3928988|NCT01409096|3751414|B2|Antidepressants||Concomitant Medications: Antidepressant||participants|Number|22|22.0||||||
3928989|NCT01409096|3751415|B1|Antidepressants||Concomitant Medications: Antidepressant||participants|Number|21|21.0||||||
3928990|NCT01409096|3751413|B3|No anticonvulsants||Concomitant Medications: Anticonvulsant||participants|Number|53|53.0||||||
3928991|NCT01409096|3751414|B2|No anticonvulsants||Concomitant Medications: Anticonvulsant||participants|Number|25|25.0||||||
3928992|NCT01409096|3751415|B1|No anticonvulsants||Concomitant Medications: Anticonvulsant||participants|Number|28|28.0||||||
3928993|NCT01409096|3751413|B3|Anticonvulsants||Concomitant Medications: Anticonvulsant||participants|Number|20|20.0||||||
3928994|NCT01409096|3751414|B2|Anticonvulsants||Concomitant Medications: Anticonvulsant||participants|Number|10|10.0||||||
3928995|NCT01409096|3751415|B1|Anticonvulsants||Concomitant Medications: Anticonvulsant||participants|Number|10|10.0||||||
3928996|NCT01409096|3751413|B3|No Lithium||Concomitant Medications: Lithium||participants|Number|64|64.0||||||
3928997|NCT01409096|3751414|B2|No Lithium||Concomitant Medications: Lithium||participants|Number|31|31.0||||||
3928998|NCT01409096|3751415|B1|No Lithium||Concomitant Medications: Lithium||participants|Number|33|33.0||||||
3928999|NCT01409096|3751413|B3|Lithium||Concomitant Medications: Lithium||participants|Number|9|9.0||||||
3929000|NCT01409096|3751414|B2|Lithium||Concomitant Medications: Lithium||participants|Number|4|4.0||||||
3929001|NCT01409096|3751415|B1|Lithium||Concomitant Medications: Lithium||participants|Number|5|5.0||||||
3929002|NCT01409096|3751413|B3|||Age of onset of mood symptoms||years|Mean|26.7|26.7|Standard Deviation|8.22|8.22|||
3929003|NCT01409096|3751414|B2|||Age of onset of mood symptoms||years|Mean|26.7|26.7|Standard Deviation|7.3|7.3|||
3929004|NCT01409096|3751415|B1|||Age of onset of mood symptoms||years|Mean|26.4|26.4|Standard Deviation|9.0|9.0|||
3929005|NCT01409096|3751413|B3|Bipolar Not Otherwise Specified||Bipolar Diagnosis|Participants were graded clinically by using the Diagnostic and Statistical Manual of Mental Disorders (DSM) guidelines for criteria from a structured clinical interview.|participants|Number|4|4.0||||||
3929006|NCT01409096|3751414|B2|Bipolar Not Otherwise Specified||Bipolar Diagnosis|Participants were graded clinically by using the Diagnostic and Statistical Manual of Mental Disorders (DSM) guidelines for criteria from a structured clinical interview.|participants|Number|3|3.0||||||
3929007|NCT01409096|3751415|B1|Bipolar Not Otherwise Specified||Bipolar Diagnosis|Participants were graded clinically by using the Diagnostic and Statistical Manual of Mental Disorders (DSM) guidelines for criteria from a structured clinical interview.|participants|Number|1|1.0||||||
3929008|NCT01409096|3751413|B3|Bipolar II||Bipolar Diagnosis|Participants were graded clinically by using the Diagnostic and Statistical Manual of Mental Disorders (DSM) guidelines for criteria from a structured clinical interview.|participants|Number|38|38.0||||||
3929009|NCT01409096|3751414|B2|Bipolar II||Bipolar Diagnosis|Participants were graded clinically by using the Diagnostic and Statistical Manual of Mental Disorders (DSM) guidelines for criteria from a structured clinical interview.|participants|Number|17|17.0||||||
3929010|NCT01409096|3751415|B1|Bipolar II||Bipolar Diagnosis|Participants were graded clinically by using the Diagnostic and Statistical Manual of Mental Disorders (DSM) guidelines for criteria from a structured clinical interview.|participants|Number|21|21.0||||||
3929011|NCT01409096|3751413|B3|Bipolar I||Bipolar Diagnosis|Participants were graded clinically by using the Diagnostic and Statistical Manual of Mental Disorders (DSM) guidelines for criteria from a structured clinical interview.|participants|Number|31|31.0||||||
3929012|NCT01409096|3751414|B2|Bipolar I||Bipolar Diagnosis|Participants were graded clinically by using the Diagnostic and Statistical Manual of Mental Disorders (DSM) guidelines for criteria from a structured clinical interview.|participants|Number|15|15.0||||||
3929013|NCT01409096|3751415|B1|Bipolar I||Bipolar Diagnosis|Participants were graded clinically by using the Diagnostic and Statistical Manual of Mental Disorders (DSM) guidelines for criteria from a structured clinical interview.|participants|Number|16|16.0||||||
3929014|NCT01409096|3751413|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3929015|NCT01409096|3751414|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3929016|NCT01409096|3751415|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3929017|NCT01409096|3751413|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
3929018|NCT01409096|3751414|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3929019|NCT01409096|3751415|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3929020|NCT01409096|3751413|B3|African-American||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
3929021|NCT01409096|3751414|B2|African-American||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3929022|NCT01409096|3751415|B1|African-American||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3929023|NCT01409096|3751413|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3929024|NCT01409096|3751414|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3929025|NCT01409096|3751415|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3929026|NCT01409096|3751413|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3929027|NCT01409096|3751414|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3929028|NCT01409096|3751415|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3929029|NCT01409096|3751413|B3|||Age||years|Mean|43.6|43.6|Standard Deviation|9.5|9.5|||
3929030|NCT01409096|3751414|B2|||Age||years|Mean|44.1|44.1|Standard Deviation|10.4|10.4|||
3929031|NCT01409096|3751415|B1|||Age||years|Mean|43.2|43.2|Standard Deviation|8.5|8.5|||
3929032|NCT01408992|3751428|B1||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
3929033|NCT01408992|3751428|B1||Female|Sex: Female, Male||Participants|Count of Participants|382|382.0||||||
3929034|NCT01408992|3751428|B1|>,= 80 years||Age, Customized||participants|Number|17|17.0||||||
3929035|NCT01408992|3751428|B1|Between 70 and 79 years||Age, Customized||participants|Number|86|86.0||||||
3929036|NCT01408992|3751428|B1|Between 60 and 69 years||Age, Customized||participants|Number|123|123.0||||||
3929037|NCT01408992|3751428|B1|Between 50 and 59 years||Age, Customized||participants|Number|128|128.0||||||
3929038|NCT01408992|3751428|B1|Between 40 and 49 years||Age, Customized||participants|Number|109|109.0||||||
3929039|NCT01408992|3751428|B1|Between 30 and 39 years||Age, Customized||participants|Number|53|53.0||||||
3929040|NCT01408992|3751428|B1|Between 20 and 29 years||Age, Customized||participants|Number|40|40.0||||||
3929041|NCT01408992|3751428|B1|18-19 years||Age, Customized||participants|Number|2|2.0||||||
3929042|NCT01408914|3751440|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3929043|NCT01408914|3751441|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3929044|NCT01408914|3751442|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3929045|NCT01408914|3751443|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3929046|NCT01408914|3751440|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|162|162.0||||||
3929047|NCT01408914|3751441|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3929048|NCT01408914|3751442|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3929049|NCT01408914|3751443|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3929050|NCT01408914|3751440|B4||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3929051|NCT01408914|3751441|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3929052|NCT01408914|3751442|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3929053|NCT01408914|3751443|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929054|NCT01408914|3751440|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929055|NCT01408914|3751441|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929056|NCT01408914|3751442|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929057|NCT01408914|3751443|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929058|NCT01408914|3751440|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929059|NCT01408914|3751441|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929060|NCT01408914|3751442|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929061|NCT01408914|3751443|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929062|NCT01408914|3751440|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929063|NCT01408914|3751441|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929064|NCT01408914|3751442|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929065|NCT01408914|3751443|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929066|NCT01408914|3751440|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3929067|NCT01408914|3751441|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3929068|NCT01408914|3751442|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3929069|NCT01408914|3751443|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3929070|NCT01408914|3751440|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929071|NCT01408914|3751441|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929072|NCT01408914|3751442|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929073|NCT01408914|3751443|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929074|NCT01408914|3751440|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3929075|NCT01408914|3751441|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3929076|NCT01408914|3751442|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929077|NCT01408914|3751443|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929078|NCT01408914|3751440|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|179|179.0||||||
3929079|NCT01408914|3751441|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3929080|NCT01408914|3751442|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3929081|NCT01408914|3751443|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3929082|NCT01408914|3751440|B4||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3929083|NCT01408914|3751441|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3929084|NCT01408914|3751442|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3929085|NCT01408914|3751443|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3929086|NCT01408914|3751440|B4||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3929087|NCT01408914|3751441|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3929088|NCT01408914|3751442|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3929089|NCT01408914|3751443|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3929090|NCT01408914|3751440|B4|||Age||years|Median|25|25.0|Inter-Quartile Range|||21.0|37.0|
3929091|NCT01408914|3751441|B3|||Age||years|Median|27|27.0|Inter-Quartile Range|||22.0|37.0|
3929092|NCT01408914|3751442|B2|||Age||years|Median|25|25.0|Inter-Quartile Range|||20.0|35.0|
3929093|NCT01408914|3751443|B1|||Age||years|Median|24|24.0|Inter-Quartile Range|||21.0|37.0|
3929094|NCT01408888|3751459|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3929095|NCT01408888|3751459|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929096|NCT01408888|3751459|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929097|NCT01408888|3751459|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3929098|NCT01408888|3751459|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3929099|NCT01408888|3751459|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929100|NCT01408888|3751459|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3929101|NCT01408888|3751459|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929102|NCT01408888|3751459|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929103|NCT01408888|3751459|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3929104|NCT01408888|3751459|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3929105|NCT01408888|3751459|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3929106|NCT01408888|3751459|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3929107|NCT01408888|3751459|B1|||Age||years|Mean|52.7|52.7|Standard Deviation|11.1|11.1|||
3929108|NCT01408862|3751483|B1|Argentina||Region of Enrollment|Ciudad Autonoma de Buenos Aires, Argentina|participants|Number|20|20.0||||||
3929109|NCT01408862|3751483|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3929110|NCT01408862|3751483|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3929111|NCT01408862|3751483|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3929112|NCT01408862|3751483|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3929113|NCT01408862|3751483|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3929114|NCT01408862|3751483|B1|||Age||years|Mean|42|42.0|Standard Deviation|10|10.0|||
3929115|NCT01408732|3751488|B1|Cautery||Prior Treatment||participants|Number|3|3.0||||||
3929116|NCT01408732|3751488|B1|Packing||Prior Treatment||participants|Number|4|4.0||||||
3929117|NCT01408732|3751488|B1|Moisturization||Prior Treatment||participants|Number|11|11.0||||||
3929118|NCT01408732|3751488|B1|Type 3||Telangiectasia type|"(I) isolated punctate telangiectasias or individual small arteriovenous malformation; (II) diffuse interconnecting vasculature with feeder vessels; and (III) large solitary arteriovenous malformation, which may be associated with scattered telangiectasia (Mahoney and Shapshay)"|participants|Number|1|1.0||||||
3929119|NCT01408732|3751488|B1|Type 2||Telangiectasia type|"(I) isolated punctate telangiectasias or individual small arteriovenous malformation; (II) diffuse interconnecting vasculature with feeder vessels; and (III) large solitary arteriovenous malformation, which may be associated with scattered telangiectasia (Mahoney and Shapshay)"|participants|Number|13|13.0||||||
3929120|NCT01408732|3751488|B1|Type 1||Telangiectasia type|"(I) isolated punctate telangiectasias or individual small arteriovenous malformation; (II) diffuse interconnecting vasculature with feeder vessels; and (III) large solitary arteriovenous malformation, which may be associated with scattered telangiectasia (Mahoney and Shapshay)"|participants|Number|4|4.0||||||
3929121|NCT01408732|3751488|B1|||Number of Telangiectasia||Telangiectasia|Mean|7|7.0|Full Range|||3.0|12.0|
3929122|NCT01408732|3751488|B1|Family history:||Curacao criteria|"1. Epistaxis;: spontaneous, recurrent nose bleeds 2. Telangiectases: multiple, at characteristic sites (lips, oral cavity, fingers, nose) 3. Visceral Lesions such as gastrointestinal telangiectasia (with or without bleeding), pulmonary arteriovenous malformation (AVM), hepatic AVM, cerebral AVMs, spinal AVM 4. Family history: a first degree relative with HHT according to these criteria~Diagnosis of HHT Define: 3 criteria are present Possible or suspected: 2 criteria are present Unlikely: <2 criteria are present~(Shovlin et al)"|participants|Number|9|9.0||||||
3929123|NCT01408732|3751488|B1|Visceral Lesions||Curacao criteria|"1. Epistaxis;: spontaneous, recurrent nose bleeds 2. Telangiectases: multiple, at characteristic sites (lips, oral cavity, fingers, nose) 3. Visceral Lesions such as gastrointestinal telangiectasia (with or without bleeding), pulmonary arteriovenous malformation (AVM), hepatic AVM, cerebral AVMs, spinal AVM 4. Family history: a first degree relative with HHT according to these criteria~Diagnosis of HHT Define: 3 criteria are present Possible or suspected: 2 criteria are present Unlikely: <2 criteria are present~(Shovlin et al)"|participants|Number|9|9.0||||||
3929124|NCT01408732|3751488|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3929125|NCT01408732|3751488|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3929126|NCT01408732|3751488|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3929127|NCT01408732|3751488|B1|||Age||years|Mean|51.8|51.8|Full Range|||31.0|70.0|
3929128|NCT01408719|3751495|B21||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3929129|NCT01408719|3751496|B20||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3929130|NCT01408719|3751497|B19||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3929131|NCT01408719|3751498|B18||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3929132|NCT01408719|3751499|B17||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3929133|NCT01408719|3751500|B16||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3929134|NCT01408719|3751501|B15||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3929135|NCT01408719|3751502|B14||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3929136|NCT01408719|3751503|B13||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3929137|NCT01408719|3751504|B12||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3929138|NCT01408719|3751505|B11||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3929139|NCT01408719|3751506|B10||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3929140|NCT01408719|3751507|B9||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3929141|NCT01408719|3751508|B8||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3929142|NCT01408719|3751509|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3929143|NCT01408719|3751510|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3929144|NCT01408719|3751511|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3929145|NCT01408719|3751512|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3929146|NCT01408719|3751513|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3929147|NCT01408719|3751514|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3929148|NCT01408719|3751515|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3929149|NCT01408719|3751495|B21||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3929150|NCT01408719|3751496|B20||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3929151|NCT01408719|3751497|B19||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3929152|NCT01408719|3751498|B18||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3929153|NCT01408719|3751499|B17||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3929154|NCT01408719|3751500|B16||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3929155|NCT01408719|3751501|B15||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3929156|NCT01408719|3751502|B14||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3929157|NCT01408719|3751503|B13||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3929158|NCT01408719|3751504|B12||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3929159|NCT01408719|3751505|B11||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3929160|NCT01408719|3751506|B10||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3929161|NCT01408719|3751507|B9||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3929162|NCT01408719|3751508|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3929163|NCT01408719|3751509|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3929164|NCT01408719|3751510|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3929165|NCT01408719|3751511|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3929166|NCT01408719|3751512|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3929167|NCT01408719|3751513|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3929168|NCT01408719|3751514|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3929169|NCT01408719|3751515|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3929170|NCT01408719|3751495|B21|||Age||years|Mean|57.9|57.9|Standard Deviation|10.6|10.6|||
3929171|NCT01408719|3751496|B20|||Age||years|Mean|59|59.0|Standard Deviation|0|0.0|||
3929172|NCT01408719|3751497|B19|||Age||years|Mean|65|65.0|Standard Deviation|0|0.0|||
3929173|NCT01408719|3751498|B18|||Age||years|Mean|59|59.0|Standard Deviation|0|0.0|||
3929174|NCT01408719|3751499|B17|||Age||years|Mean|53|53.0|Standard Deviation|8.5|8.5|||
3929175|NCT01408719|3751500|B16|||Age||years|Mean|58|58.0|Standard Deviation|0|0.0|||
3929176|NCT01408719|3751501|B15|||Age||years|Mean|76|76.0|Standard Deviation|0|0.0|||
3929177|NCT01408719|3751502|B14|||Age||years|Mean|59.3|59.3|Standard Deviation|3.8|3.8|||
3929178|NCT01408719|3751503|B13|||Age||years|Mean|62|62.0|Standard Deviation|0|0.0|||
3929179|NCT01408719|3751504|B12|||Age||years|Mean|59.5|59.5|Standard Deviation|4.9|4.9|||
3929180|NCT01408719|3751505|B11|||Age||years|Mean|62.5|62.5|Standard Deviation|0.7|0.7|||
3929181|NCT01408719|3751506|B10|||Age||years|Mean|27|27.0|Standard Deviation|0|0.0|||
3929182|NCT01408719|3751507|B9|||Age||years|Mean|57|57.0|Standard Deviation|0|0.0|||
3929183|NCT01408719|3751508|B8|||Age||years|Mean|67|67.0|Standard Deviation|1.4|1.4|||
3929184|NCT01408719|3751509|B7|||Age||years|Mean|55.5|55.5|Standard Deviation|2.12|2.12|||
3929185|NCT01408719|3751510|B6|||Age||years|Mean|55|55.0|Standard Deviation|14|14.0|||
3929186|NCT01408719|3751511|B5|||Age||years|Mean|70|70.0|Standard Deviation|10.6|10.6|||
3929187|NCT01408719|3751512|B4|||Age||years|Mean|63|63.0|Standard Deviation|1.4|1.4|||
3929188|NCT01408719|3751513|B3|||Age||years|Mean|40|40.0|Standard Deviation|0|0.0|||
3929189|NCT01408719|3751514|B2|||Age||years|Mean|52.7|52.7|Standard Deviation|3.5|3.5|||
3929190|NCT01408719|3751515|B1|||Age||years|Mean|46|46.0|Standard Deviation|15.6|15.6|||
3929191|NCT01408706|3751544|B3|||Clinically localized T1-3, NO, MO adenocarcinoma of the prostate||participants|Number|60|60.0||||||
3929192|NCT01408706|3751545|B2|||Clinically localized T1-3, NO, MO adenocarcinoma of the prostate||participants|Number|30|30.0||||||
3929193|NCT01408706|3751546|B1|||Clinically localized T1-3, NO, MO adenocarcinoma of the prostate||participants|Number|30|30.0||||||
3929194|NCT01408706|3751544|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
3929195|NCT01408706|3751545|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3929196|NCT01408706|3751546|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3929197|NCT01408706|3751544|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3929198|NCT01408706|3751545|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3929199|NCT01408706|3751546|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3929200|NCT01408706|3751544|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3929201|NCT01408706|3751545|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3929202|NCT01408706|3751546|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3929203|NCT01408706|3751544|B3||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
3929204|NCT01408706|3751545|B2||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3929205|NCT01408706|3751546|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3929206|NCT01408706|3751544|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3929207|NCT01408706|3751545|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3929208|NCT01408706|3751546|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3929209|NCT01408706|3751544|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3929210|NCT01408706|3751545|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3929211|NCT01408706|3751546|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3929212|NCT01408641|3751557|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3929213|NCT01408641|3751559|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3929214|NCT01408641|3751557|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929215|NCT01408641|3751559|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929216|NCT01408641|3751557|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929217|NCT01408641|3751559|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929218|NCT01408641|3751557|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929219|NCT01408641|3751559|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929220|NCT01408641|3751557|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3929221|NCT01408641|3751559|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3929222|NCT01408641|3751557|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929223|NCT01408641|3751559|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929224|NCT01408641|3751557|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929225|NCT01408641|3751559|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929226|NCT01408641|3751557|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929227|NCT01408641|3751559|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929228|NCT01408641|3751557|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929229|NCT01408641|3751559|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929230|NCT01408641|3751557|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3929231|NCT01408641|3751559|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3929232|NCT01408641|3751557|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929233|NCT01408641|3751559|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929234|NCT01408641|3751557|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3929235|NCT01408641|3751559|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3929236|NCT01408641|3751557|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3929237|NCT01408641|3751559|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3929238|NCT01408641|3751557|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3929239|NCT01408641|3751559|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3929240|NCT01408641|3751557|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3929241|NCT01408641|3751559|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3929242|NCT01408641|3751557|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3929243|NCT01408641|3751559|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3929244|NCT01408628|3751568|B1|||A1c Baseline||Percentage (glycosolated hemoglobin)|Mean|8.61|8.61|Standard Deviation|1.63|1.63|||
3929245|NCT01408628|3751568|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
3929246|NCT01408628|3751568|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3929247|NCT01408628|3751568|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3929248|NCT01408628|3751568|B1|||Age||years|Mean|58.67|58.67|Standard Deviation|10.54|10.54|||
3929249|NCT01408628|3751568|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3929250|NCT01408628|3751568|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3929251|NCT01408628|3751568|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3929252|NCT01408576|3751574|B4||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3929253|NCT01408576|3751575|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3929254|NCT01408576|3751576|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3929255|NCT01408576|3751577|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3929256|NCT01408576|3751574|B4||Female|Sex: Female, Male||Participants|Count of Participants|1171|1171.0||||||
3929257|NCT01408576|3751575|B3||Female|Sex: Female, Male||Participants|Count of Participants|478|478.0||||||
3929258|NCT01408576|3751576|B2||Female|Sex: Female, Male||Participants|Count of Participants|467|467.0||||||
3929259|NCT01408576|3751577|B1||Female|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
3929260|NCT01408576|3751574|B4|||Age||years|Mean|42.0|42.0|Standard Deviation|11.7|11.7|||
3929261|NCT01408576|3751575|B3|||Age||years|Mean|42.5|42.5|Standard Deviation|11.9|11.9|||
3929262|NCT01408576|3751576|B2|||Age||years|Mean|41.9|41.9|Standard Deviation|11.5|11.5|||
3929263|NCT01408576|3751577|B1|||Age||years|Mean|41.0|41.0|Standard Deviation|12.0|12.0|||
3929264|NCT01408576|3751574|B4||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
3929265|NCT01408576|3751575|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3929266|NCT01408576|3751576|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3929267|NCT01408576|3751577|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3929268|NCT01408576|3751574|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1218|1218.0||||||
3929269|NCT01408576|3751575|B3||Between 18 and 65 years|Age||Participants|Count of Participants|490|490.0||||||
3929270|NCT01408576|3751576|B2||Between 18 and 65 years|Age||Participants|Count of Participants|489|489.0||||||
3929271|NCT01408576|3751577|B1||Between 18 and 65 years|Age||Participants|Count of Participants|239|239.0||||||
3929272|NCT01408576|3751574|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3929273|NCT01408576|3751575|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3929274|NCT01408576|3751576|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3929275|NCT01408576|3751577|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3929276|NCT01408563|3751626|B1||Non-Hodgkin Lymphoma (NHL)|Disease||Participants|Count of Participants|7|7.0||||||
3929277|NCT01408563|3751626|B1||Myeloproliferative Disorder (MPD)|Disease||Participants|Count of Participants|2|2.0||||||
3929278|NCT01408563|3751626|B1||Myelodysplastic Syndromes (MDS)|Disease||Participants|Count of Participants|8|8.0||||||
3929279|NCT01408563|3751626|B1||Hodgkin's Disease (HD)|Disease||Participants|Count of Participants|1|1.0||||||
3929280|NCT01408563|3751626|B1||Acute Myeloid Leukemia (AML)|Disease||Participants|Count of Participants|11|11.0||||||
3929281|NCT01408563|3751626|B1||Acute Lymphoblastic Leukemia (ALL)|Disease||Participants|Count of Participants|2|2.0||||||
3929282|NCT01408563|3751626|B1||2|Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status:~0 - Asymptomatic (Fully active, able to carry on all predisease activities without restriction)~1 - Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. For example, light housework, office work)~2 - Symptomatic, <50% in bed during the day (Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours)"|Participants|Count of Participants|2|2.0||||||
3929283|NCT01408563|3751626|B1||1|Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status:~0 - Asymptomatic (Fully active, able to carry on all predisease activities without restriction)~1 - Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. For example, light housework, office work)~2 - Symptomatic, <50% in bed during the day (Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours)"|Participants|Count of Participants|19|19.0||||||
3929284|NCT01408563|3751626|B1||0|Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status:~0 - Asymptomatic (Fully active, able to carry on all predisease activities without restriction)~1 - Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. For example, light housework, office work)~2 - Symptomatic, <50% in bed during the day (Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours)"|Participants|Count of Participants|10|10.0||||||
3929285|NCT01408563|3751626|B1|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3929286|NCT01408563|3751626|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3929287|NCT01408563|3751626|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3929288|NCT01408563|3751626|B1|||Age||years|Median|57|57.0|Full Range|||21.0|68.0|
3929289|NCT01408537|3751637|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3929290|NCT01408537|3751637|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3929291|NCT01408537|3751637|B1|||Age||years|Mean|1.2|1.2|Standard Deviation|0.32|0.32|||
3929292|NCT01408537|3751637|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3929293|NCT01408537|3751637|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3929294|NCT01408537|3751637|B1||<=18 years|Age||Participants|Count of Participants|152|152.0||||||
3929295|NCT01408485|3751653|B1|Canada||Region of Enrollment||participants|Number|18|18.0||||||
3929296|NCT01408485|3751653|B1|United States||Region of Enrollment||participants|Number|182|182.0||||||
3929297|NCT01408485|3751653|B1||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3929298|NCT01408485|3751653|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3929299|NCT01408485|3751653|B1||>=65 years|Age||Participants|Count of Participants|111|111.0||||||
3929300|NCT01408485|3751653|B1||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
3929301|NCT01408485|3751653|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3929302|NCT01408485|3751653|B1|||Age||years|Mean|66.28|66.28|Standard Deviation|10.18|10.18|||
3929303|NCT01408329|3751659|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
3929304|NCT01408329|3751660|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3929305|NCT01408329|3751661|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3929306|NCT01408329|3751659|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3929307|NCT01408329|3751660|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3929308|NCT01408329|3751661|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3929309|NCT01408329|3751659|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3929310|NCT01408329|3751660|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3929311|NCT01408329|3751661|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3929312|NCT01408329|3751659|B3|||Age||years|Mean|49|49.0|Standard Deviation|6|6.0|||
3929313|NCT01408329|3751660|B2|||Age||years|Mean|48|48.0|Standard Deviation|6|6.0|||
3929314|NCT01408329|3751661|B1|||Age||years|Mean|50|50.0|Standard Deviation|4|4.0|||
3929315|NCT01408329|3751659|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3929316|NCT01408329|3751660|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3929317|NCT01408329|3751661|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3929318|NCT01408329|3751659|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3929319|NCT01408329|3751660|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3929320|NCT01408329|3751661|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3929321|NCT01408329|3751659|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3929322|NCT01408329|3751660|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3929323|NCT01408329|3751661|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3929324|NCT01408303|3751668|B4|United States||Region of Enrollment||participants|Number|646|646.0||||||
3929325|NCT01408303|3751669|B3|United States||Region of Enrollment||participants|Number|215|215.0||||||
3929326|NCT01408303|3751670|B2|United States||Region of Enrollment||participants|Number|216|216.0||||||
3929327|NCT01408303|3751671|B1|United States||Region of Enrollment||participants|Number|215|215.0||||||
3929328|NCT01408303|3751668|B4||Male|Sex: Female, Male||Participants|Count of Participants|382|382.0||||||
3929329|NCT01408303|3751669|B3||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3929330|NCT01408303|3751670|B2||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3929331|NCT01408303|3751671|B1||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3929332|NCT01408303|3751668|B4||Female|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
3929333|NCT01408303|3751669|B3||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3929334|NCT01408303|3751670|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3929335|NCT01408303|3751671|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3929336|NCT01408303|3751668|B4|||Age||years|Mean|60.8|60.8|Standard Deviation|9.61|9.61|||
3929337|NCT01408303|3751669|B3|||Age||years|Mean|61.5|61.5|Standard Deviation|9.64|9.64|||
3929338|NCT01408303|3751670|B2|||Age||years|Mean|60.1|60.1|Standard Deviation|9.23|9.23|||
3929339|NCT01408303|3751671|B1|||Age||years|Mean|60.9|60.9|Standard Deviation|9.95|9.95|||
3929340|NCT01408303|3751668|B4||>=65 years|Age||Participants|Count of Participants|243|243.0||||||
3929341|NCT01408303|3751669|B3||>=65 years|Age||Participants|Count of Participants|91|91.0||||||
3929342|NCT01408303|3751670|B2||>=65 years|Age||Participants|Count of Participants|75|75.0||||||
3929343|NCT01408303|3751671|B1||>=65 years|Age||Participants|Count of Participants|77|77.0||||||
3929344|NCT01408303|3751668|B4||Between 18 and 65 years|Age||Participants|Count of Participants|403|403.0||||||
3929345|NCT01408303|3751669|B3||Between 18 and 65 years|Age||Participants|Count of Participants|124|124.0||||||
3929346|NCT01408303|3751670|B2||Between 18 and 65 years|Age||Participants|Count of Participants|141|141.0||||||
3929347|NCT01408303|3751671|B1||Between 18 and 65 years|Age||Participants|Count of Participants|138|138.0||||||
3929348|NCT01408303|3751668|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3929349|NCT01408303|3751669|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3929350|NCT01408303|3751670|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3929351|NCT01408303|3751671|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3929352|NCT01408277|3751681|B3|United States||Region of Enrollment||participants|Number|55|55.0||||||
3929353|NCT01408277|3751682|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
3929354|NCT01408277|3751683|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
3929355|NCT01408277|3751681|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929356|NCT01408277|3751682|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929357|NCT01408277|3751683|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929358|NCT01408277|3751681|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929359|NCT01408277|3751682|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929360|NCT01408277|3751683|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929361|NCT01408277|3751681|B3||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3929362|NCT01408277|3751682|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3929363|NCT01408277|3751683|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3929364|NCT01408277|3751681|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3929365|NCT01408277|3751682|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3929366|NCT01408277|3751683|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3929367|NCT01408277|3751681|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929368|NCT01408277|3751682|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929369|NCT01408277|3751683|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929370|NCT01408277|3751681|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929371|NCT01408277|3751682|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929372|NCT01408277|3751683|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929373|NCT01408277|3751681|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929374|NCT01408277|3751682|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929375|NCT01408277|3751683|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929376|NCT01408277|3751681|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929377|NCT01408277|3751682|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929378|NCT01408277|3751683|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929379|NCT01408277|3751681|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3929380|NCT01408277|3751682|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3929381|NCT01408277|3751683|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3929382|NCT01408277|3751681|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3929383|NCT01408277|3751682|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3929384|NCT01408277|3751683|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3929385|NCT01408277|3751681|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3929386|NCT01408277|3751682|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3929387|NCT01408277|3751683|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3929388|NCT01408277|3751681|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3929389|NCT01408277|3751682|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3929390|NCT01408277|3751683|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3929391|NCT01408277|3751681|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3929392|NCT01408277|3751682|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3929393|NCT01408277|3751683|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3929394|NCT01408277|3751681|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3929395|NCT01408277|3751682|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3929396|NCT01408277|3751683|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3929397|NCT01408277|3751681|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3929398|NCT01408277|3751682|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3929399|NCT01408277|3751683|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3929400|NCT01408030|3751690|B5|||Epistaxis severity score||units on a scale|Mean|5.37|5.37|Full Range|||4.71|6.38|
3929401|NCT01408030|3751691|B4|||Epistaxis severity score||units on a scale|Mean|5.71|5.71|Full Range|||5.04|6.38|
3929402|NCT01408030|3751692|B3|||Epistaxis severity score||units on a scale|Mean|5.43|5.43|Full Range|||4.94|5.91|
3929403|NCT01408030|3751693|B2|||Epistaxis severity score||units on a scale|Mean|5.19|5.19|Full Range|||4.71|5.68|
3929404|NCT01408030|3751694|B1|||Epistaxis severity score||units on a scale|Mean|5.16|5.16|Full Range|||4.75|5.57|
3929405|NCT01408030|3751690|B5|||Epistaxis history||bleeding episodes per week|Median|7.0|7.0|Inter-Quartile Range|||3.0|14.0|
3929406|NCT01408030|3751691|B4|||Epistaxis history||bleeding episodes per week|Median|7.0|7.0|Inter-Quartile Range|||5.0|15.0|
3929407|NCT01408030|3751692|B3|||Epistaxis history||bleeding episodes per week|Median|7.8|7.8|Inter-Quartile Range|||5.5|14.5|
3929408|NCT01408030|3751693|B2|||Epistaxis history||bleeding episodes per week|Median|7.0|7.0|Inter-Quartile Range|||7.0|14.0|
3929409|NCT01408030|3751694|B1|||Epistaxis history||bleeding episodes per week|Median|10.0|10.0|Inter-Quartile Range|||5.0|14.0|
3929410|NCT01408030|3751690|B5|||Definite HHT||Participants|Count of Participants|113|113.0||||||
3929411|NCT01408030|3751691|B4|||Definite HHT||Participants|Count of Participants|26|26.0||||||
3929412|NCT01408030|3751692|B3|||Definite HHT||Participants|Count of Participants|32|32.0||||||
3929413|NCT01408030|3751693|B2|||Definite HHT||Participants|Count of Participants|29|29.0||||||
3929414|NCT01408030|3751694|B1|||Definite HHT||Participants|Count of Participants|26|26.0||||||
3929415|NCT01408030|3751690|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3929416|NCT01408030|3751691|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929417|NCT01408030|3751692|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929418|NCT01408030|3751693|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929419|NCT01408030|3751694|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3929420|NCT01408030|3751690|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929421|NCT01408030|3751691|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929422|NCT01408030|3751692|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929423|NCT01408030|3751693|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929424|NCT01408030|3751694|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929425|NCT01408030|3751690|B5||White|Race (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
3929426|NCT01408030|3751691|B4||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3929427|NCT01408030|3751692|B3||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3929428|NCT01408030|3751693|B2||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3929429|NCT01408030|3751694|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3929430|NCT01408030|3751690|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929431|NCT01408030|3751691|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929432|NCT01408030|3751692|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929433|NCT01408030|3751693|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929434|NCT01408030|3751694|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929435|NCT01408030|3751690|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929529|NCT01407367|3751759|B2||>=65 years|Age||Participants|Count of Participants|152|152.0||||||
3929436|NCT01408030|3751691|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929437|NCT01408030|3751692|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929438|NCT01408030|3751693|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929439|NCT01408030|3751694|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929440|NCT01408030|3751690|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929441|NCT01408030|3751691|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929442|NCT01408030|3751692|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929443|NCT01408030|3751693|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929444|NCT01408030|3751694|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929445|NCT01408030|3751690|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929446|NCT01408030|3751691|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929447|NCT01408030|3751692|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929448|NCT01408030|3751693|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929449|NCT01408030|3751694|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929450|NCT01408030|3751690|B5||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3929451|NCT01408030|3751691|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3929452|NCT01408030|3751692|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3929453|NCT01408030|3751693|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3929454|NCT01408030|3751694|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3929455|NCT01408030|3751690|B5||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3929456|NCT01408030|3751691|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3929457|NCT01408030|3751692|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3929458|NCT01408030|3751693|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3929459|NCT01408030|3751694|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3929460|NCT01408030|3751690|B5|||Age||years|Mean|52.8|52.8|Inter-Quartile Range|||39.9|65.7|
3929461|NCT01408030|3751691|B4|||Age||years|Mean|53|53.0|Inter-Quartile Range|||48.6|57.3|
3929462|NCT01408030|3751692|B3|||Age||years|Mean|53|53.0|Inter-Quartile Range|||48.2|57.8|
3929463|NCT01408030|3751693|B2|||Age||years|Mean|56.6|56.6|Inter-Quartile Range|||52.0|61.2|
3929464|NCT01408030|3751694|B1|||Age||years|Mean|47.8|47.8|Inter-Quartile Range|||42.8|52.9|
3929465|NCT01407575|3751727|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3929466|NCT01407575|3751728|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3929467|NCT01407575|3751729|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3929468|NCT01407575|3751727|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3929469|NCT01407575|3751728|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3929470|NCT01407575|3751729|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3929471|NCT01407575|3751727|B3|||Age||years|Mean|59.66|59.66|Standard Deviation|12.17|12.17|||
3929472|NCT01407575|3751728|B2|||Age||years|Mean|64.59|64.59|Standard Deviation|5.01|5.01|||
3929473|NCT01407575|3751729|B1|||Age||years|Mean|53.92|53.92|Standard Deviation|15.88|15.88|||
3929474|NCT01407523|3751748|B1|||Height||centimeter|Mean|163.40|163.4|Standard Deviation|8.95|8.95|||
3929475|NCT01407523|3751748|B1|||Weight||kilogram|Mean|68.82|68.82|Standard Deviation|12.38|12.38|||
3929476|NCT01407523|3751748|B1|Japan||Region of Enrollment||participants|Number|16|16.0||||||
3929477|NCT01407523|3751748|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3929478|NCT01407523|3751748|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3929479|NCT01407523|3751748|B1|||Age||years|Mean|32.9|32.9|Standard Deviation|10.6|10.6|||
3929480|NCT01407523|3751748|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3929481|NCT01407523|3751748|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3929482|NCT01407523|3751748|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3929483|NCT01407367|3751758|B3||Stage 5 (eGFR< 15 mL/min/1.73 m²,)|eGFR|Estimated Glomerular Filtration Rate (eGFR) mL/min/1.73 m², baseline measure of kidney function, Stage 5 being the most severe stage of CKD (prior to ESRD) and Stage 2 being the most mild stage of CKD.|Participants|Count of Participants|13|13.0||||||
3929484|NCT01407367|3751759|B2||Stage 5 (eGFR< 15 mL/min/1.73 m²,)|eGFR|Estimated Glomerular Filtration Rate (eGFR) mL/min/1.73 m², baseline measure of kidney function, Stage 5 being the most severe stage of CKD (prior to ESRD) and Stage 2 being the most mild stage of CKD.|Participants|Count of Participants|10|10.0||||||
3929485|NCT01407367|3751760|B1||Stage 5 (eGFR< 15 mL/min/1.73 m²,)|eGFR|Estimated Glomerular Filtration Rate (eGFR) mL/min/1.73 m², baseline measure of kidney function, Stage 5 being the most severe stage of CKD (prior to ESRD) and Stage 2 being the most mild stage of CKD.|Participants|Count of Participants|3|3.0||||||
3929486|NCT01407367|3751758|B3||Stage 4 (15 ≤ eGFR ≤ 29 mL/min/1.73 m²,)|eGFR|Estimated Glomerular Filtration Rate (eGFR) mL/min/1.73 m², baseline measure of kidney function, Stage 5 being the most severe stage of CKD (prior to ESRD) and Stage 2 being the most mild stage of CKD.|Participants|Count of Participants|50|50.0||||||
3929487|NCT01407367|3751759|B2||Stage 4 (15 ≤ eGFR ≤ 29 mL/min/1.73 m²,)|eGFR|Estimated Glomerular Filtration Rate (eGFR) mL/min/1.73 m², baseline measure of kidney function, Stage 5 being the most severe stage of CKD (prior to ESRD) and Stage 2 being the most mild stage of CKD.|Participants|Count of Participants|35|35.0||||||
3929488|NCT01407367|3751760|B1||Stage 4 (15 ≤ eGFR ≤ 29 mL/min/1.73 m²,)|eGFR|Estimated Glomerular Filtration Rate (eGFR) mL/min/1.73 m², baseline measure of kidney function, Stage 5 being the most severe stage of CKD (prior to ESRD) and Stage 2 being the most mild stage of CKD.|Participants|Count of Participants|15|15.0||||||
3929489|NCT01407367|3751758|B3||Stage 3b (30 ≤ eGFR ≤ 44 mL/min/1.73 m²,)|eGFR|Estimated Glomerular Filtration Rate (eGFR) mL/min/1.73 m², baseline measure of kidney function, Stage 5 being the most severe stage of CKD (prior to ESRD) and Stage 2 being the most mild stage of CKD.|Participants|Count of Participants|137|137.0||||||
3929490|NCT01407367|3751759|B2||Stage 3b (30 ≤ eGFR ≤ 44 mL/min/1.73 m²,)|eGFR|Estimated Glomerular Filtration Rate (eGFR) mL/min/1.73 m², baseline measure of kidney function, Stage 5 being the most severe stage of CKD (prior to ESRD) and Stage 2 being the most mild stage of CKD.|Participants|Count of Participants|91|91.0||||||
3929491|NCT01407367|3751760|B1||Stage 3b (30 ≤ eGFR ≤ 44 mL/min/1.73 m²,)|eGFR|Estimated Glomerular Filtration Rate (eGFR) mL/min/1.73 m², baseline measure of kidney function, Stage 5 being the most severe stage of CKD (prior to ESRD) and Stage 2 being the most mild stage of CKD.|Participants|Count of Participants|46|46.0||||||
3929492|NCT01407367|3751758|B3||Stage 3a (45 ≤ eGFR ≤ 59 mL/min/1.73 m²,)|eGFR|Estimated Glomerular Filtration Rate (eGFR) mL/min/1.73 m², baseline measure of kidney function, Stage 5 being the most severe stage of CKD (prior to ESRD) and Stage 2 being the most mild stage of CKD.|Participants|Count of Participants|115|115.0||||||
3929493|NCT01407367|3751759|B2||Stage 3a (45 ≤ eGFR ≤ 59 mL/min/1.73 m²,)|eGFR|Estimated Glomerular Filtration Rate (eGFR) mL/min/1.73 m², baseline measure of kidney function, Stage 5 being the most severe stage of CKD (prior to ESRD) and Stage 2 being the most mild stage of CKD.|Participants|Count of Participants|83|83.0||||||
3929494|NCT01407367|3751760|B1||Stage 3a (45 ≤ eGFR ≤ 59 mL/min/1.73 m²,)|eGFR|Estimated Glomerular Filtration Rate (eGFR) mL/min/1.73 m², baseline measure of kidney function, Stage 5 being the most severe stage of CKD (prior to ESRD) and Stage 2 being the most mild stage of CKD.|Participants|Count of Participants|32|32.0||||||
3929495|NCT01407367|3751758|B3||Stage 2 (60 ≤ eGFR ≤ 89 mL/min/1.73 m²)|eGFR|Estimated Glomerular Filtration Rate (eGFR) mL/min/1.73 m², baseline measure of kidney function, Stage 5 being the most severe stage of CKD (prior to ESRD) and Stage 2 being the most mild stage of CKD.|Participants|Count of Participants|35|35.0||||||
3929496|NCT01407367|3751759|B2||Stage 2 (60 ≤ eGFR ≤ 89 mL/min/1.73 m²)|eGFR|Estimated Glomerular Filtration Rate (eGFR) mL/min/1.73 m², baseline measure of kidney function, Stage 5 being the most severe stage of CKD (prior to ESRD) and Stage 2 being the most mild stage of CKD.|Participants|Count of Participants|23|23.0||||||
3929497|NCT01407367|3751760|B1||Stage 2 (60 ≤ eGFR ≤ 89 mL/min/1.73 m²)|eGFR|Estimated Glomerular Filtration Rate (eGFR) mL/min/1.73 m², baseline measure of kidney function, Stage 5 being the most severe stage of CKD (prior to ESRD) and Stage 2 being the most mild stage of CKD.|Participants|Count of Participants|12|12.0||||||
3929498|NCT01407367|3751758|B3|United States||Region of Enrollment||Participants|Count of Participants|350|350.0||||||
3929499|NCT01407367|3751759|B2|United States||Region of Enrollment||Participants|Count of Participants|242|242.0||||||
3929500|NCT01407367|3751760|B1|United States||Region of Enrollment||Participants|Count of Participants|108|108.0||||||
3929501|NCT01407367|3751758|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929502|NCT01407367|3751759|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929503|NCT01407367|3751760|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929504|NCT01407367|3751758|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929505|NCT01407367|3751759|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929506|NCT01407367|3751760|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929507|NCT01407367|3751758|B3||White|Race (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
3929508|NCT01407367|3751759|B2||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3929509|NCT01407367|3751760|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3929510|NCT01407367|3751758|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|243|243.0||||||
3929511|NCT01407367|3751759|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|165|165.0||||||
3929512|NCT01407367|3751760|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3929513|NCT01407367|3751758|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929514|NCT01407367|3751759|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929515|NCT01407367|3751760|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929516|NCT01407367|3751758|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3929517|NCT01407367|3751759|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3929518|NCT01407367|3751760|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929519|NCT01407367|3751758|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3929520|NCT01407367|3751759|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3929521|NCT01407367|3751760|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929522|NCT01407367|3751758|B3||Male|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
3929523|NCT01407367|3751759|B2||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
3929524|NCT01407367|3751760|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3929525|NCT01407367|3751758|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3929526|NCT01407367|3751759|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3929527|NCT01407367|3751760|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3929528|NCT01407367|3751758|B3||>=65 years|Age||Participants|Count of Participants|204|204.0||||||
3929530|NCT01407367|3751760|B1||>=65 years|Age||Participants|Count of Participants|52|52.0||||||
3929531|NCT01407367|3751758|B3||Between 18 and 65 years|Age||Participants|Count of Participants|146|146.0||||||
3929532|NCT01407367|3751759|B2||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
3929533|NCT01407367|3751760|B1||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
3929534|NCT01407367|3751758|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3929535|NCT01407367|3751759|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3929536|NCT01407367|3751760|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3929537|NCT01407354|3751775|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929538|NCT01407354|3751775|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929539|NCT01407354|3751775|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3929540|NCT01407354|3751775|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3929541|NCT01407354|3751775|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3929542|NCT01407354|3751775|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3929543|NCT01407354|3751775|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3929544|NCT01407354|3751775|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3929545|NCT01407354|3751775|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3929546|NCT01407354|3751775|B1|||Age||years|Mean|44.7|44.7|Standard Deviation|12.1|12.1|||
3929547|NCT01407276|3751784|B9||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3929548|NCT01407276|3751785|B8||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3929549|NCT01407276|3751786|B7||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3929550|NCT01407276|3751787|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3929551|NCT01407276|3751788|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3929552|NCT01407276|3751789|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3929553|NCT01407276|3751790|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3929554|NCT01407276|3751791|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3929555|NCT01407276|3751792|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3929556|NCT01407276|3751784|B9||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3929557|NCT01407276|3751785|B8||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3929558|NCT01407276|3751786|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3929559|NCT01407276|3751787|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3929560|NCT01407276|3751788|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3929561|NCT01407276|3751789|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3929562|NCT01407276|3751790|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3929563|NCT01407276|3751791|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3929564|NCT01407276|3751792|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3929565|NCT01407276|3751784|B9|||Age||Years|Mean|59|59.0|Full Range|||33.0|75.0|
3929566|NCT01407276|3751785|B8|||Age||Years|Mean|43|43.0|Full Range|||33.0|57.0|
3929567|NCT01407276|3751786|B7|||Age||Years|Mean|46|46.0|Full Range|||36.0|60.0|
3929568|NCT01407276|3751787|B6|||Age||Years|Mean|60|60.0|Full Range|||51.0|69.0|
3929569|NCT01407276|3751788|B5|||Age||Years|Mean|64|64.0|Full Range|||54.0|72.0|
3929570|NCT01407276|3751789|B4|||Age||Years|Mean|60|60.0|Full Range|||51.0|74.0|
3929571|NCT01407276|3751790|B3|||Age||Years|Mean|62|62.0|Full Range|||50.0|74.0|
3929572|NCT01407276|3751791|B2|||Age||Years|Mean|68|68.0|Full Range|||64.0|74.0|
3929573|NCT01407276|3751792|B1|||Age||Years|Mean|71|71.0|Full Range|||67.0|75.0|
3929574|NCT01407094|3751923|B4|United States||Region of Enrollment||participants|Number|296|296.0||||||
3929575|NCT01407094|3751925|B2|United States||Region of Enrollment||participants|Number|150|150.0||||||
3929576|NCT01407094|3751926|B1|United States||Region of Enrollment||participants|Number|146|146.0||||||
3929577|NCT01407094|3751923|B4||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3929578|NCT01407094|3751925|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3929579|NCT01407094|3751926|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3929580|NCT01407094|3751923|B4||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
3929581|NCT01407094|3751925|B2||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3929582|NCT01407094|3751926|B1||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3929583|NCT01407094|3751923|B4|||Age||years|Mean|37.05|37.05|Standard Deviation|13.3|13.3|||
3929584|NCT01407094|3751925|B2|||Age||years|Mean|36.9|36.9|Standard Deviation|12.8|12.8|||
3929585|NCT01407094|3751926|B1|||Age||years|Mean|37.2|37.2|Standard Deviation|13.8|13.8|||
3929586|NCT01407094|3751923|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3929587|NCT01407094|3751925|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3929588|NCT01407094|3751926|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3929589|NCT01407094|3751923|B4||Between 18 and 65 years|Age||Participants|Count of Participants|284|284.0||||||
3929590|NCT01407094|3751925|B2||Between 18 and 65 years|Age||Participants|Count of Participants|145|145.0||||||
3929591|NCT01407094|3751926|B1||Between 18 and 65 years|Age||Participants|Count of Participants|139|139.0||||||
3929592|NCT01407094|3751923|B4||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
3929593|NCT01407094|3751925|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3929594|NCT01407094|3751926|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3929595|NCT01407068|3751936|B1|Australia||Region of Enrollment||participants|Number|39|39.0||||||
3929596|NCT01407068|3751936|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3929597|NCT01407068|3751936|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3929598|NCT01407068|3751936|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3929599|NCT01407068|3751936|B1|||Age||years|Mean|63.7|63.7|Standard Deviation|10.59|10.59|||
3929600|NCT01407068|3751936|B1||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
3929601|NCT01407068|3751936|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3929602|NCT01407068|3751936|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3929603|NCT01406990|3751945|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3929604|NCT01406990|3751945|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3929605|NCT01406990|3751945|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3929606|NCT01406990|3751945|B1|||Age||years|Mean|71.8|71.8|Standard Deviation|6.13|6.13|||
3929607|NCT01406990|3751945|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3929608|NCT01406990|3751945|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3929609|NCT01406990|3751945|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3929610|NCT01406938|3751949|B3||Male|Sex: Female, Male||Participants|Count of Participants|638|638.0||||||
3929611|NCT01406938|3751950|B2||Male|Sex: Female, Male||Participants|Count of Participants|333|333.0||||||
3929612|NCT01406938|3751951|B1||Male|Sex: Female, Male||Participants|Count of Participants|305|305.0||||||
3929613|NCT01406938|3751949|B3||Female|Sex: Female, Male||Participants|Count of Participants|328|328.0||||||
3929614|NCT01406938|3751950|B2||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3929615|NCT01406938|3751951|B1||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
3929616|NCT01406938|3751949|B3|||Age||Years|Mean|46.0|46.0|Standard Deviation|12.84|12.84|||
3929617|NCT01406938|3751950|B2|||Age||Years|Mean|46.7|46.7|Standard Deviation|12.83|12.83|||
3929618|NCT01406938|3751951|B1|||Age||Years|Mean|45.3|45.3|Standard Deviation|12.83|12.83|||
3929619|NCT01406873|3752072|B3|United States||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3929620|NCT01406873|3752073|B2|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3929621|NCT01406873|3752074|B1|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3929622|NCT01406873|3752072|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929623|NCT01406873|3752073|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929624|NCT01406873|3752074|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929625|NCT01406873|3752072|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3929626|NCT01406873|3752073|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3929627|NCT01406873|3752074|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3929628|NCT01406873|3752072|B3||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3929629|NCT01406873|3752073|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3929630|NCT01406873|3752074|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3929631|NCT01406873|3752072|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929632|NCT01406873|3752073|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929633|NCT01406873|3752074|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929634|NCT01406873|3752072|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929635|NCT01406873|3752073|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929636|NCT01406873|3752074|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929637|NCT01406873|3752072|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929638|NCT01406873|3752073|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929639|NCT01406873|3752074|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929640|NCT01406873|3752072|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929641|NCT01406873|3752073|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929642|NCT01406873|3752074|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929643|NCT01406873|3752072|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929644|NCT01406873|3752073|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929645|NCT01406873|3752074|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929646|NCT01406873|3752072|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3929647|NCT01406873|3752073|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3929648|NCT01406873|3752074|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3929649|NCT01406873|3752072|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3929650|NCT01406873|3752073|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3929651|NCT01406873|3752074|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3929652|NCT01406873|3752072|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3929653|NCT01406873|3752073|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3929654|NCT01406873|3752074|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3929655|NCT01406873|3752072|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3929656|NCT01406873|3752073|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3929657|NCT01406873|3752074|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3929658|NCT01406873|3752072|B3|||Age||Years|Mean|40.10|40.1|Standard Deviation|10.75|10.75|||
3929659|NCT01406873|3752073|B2|||Age||Years|Mean|38.14|38.14|Standard Deviation|9.78|9.78|||
3929660|NCT01406873|3752074|B1|||Age||Years|Mean|42.05|42.05|Standard Deviation|11.54|11.54|||
3929661|NCT01406873|3752072|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3929662|NCT01406873|3752073|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3929663|NCT01406873|3752074|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3929664|NCT01406873|3752072|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3929665|NCT01406873|3752073|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3929666|NCT01406873|3752074|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3929667|NCT01406873|3752072|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3929668|NCT01406873|3752073|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3929669|NCT01406873|3752074|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3929670|NCT01406860|3752091|B3|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3929671|NCT01406860|3752092|B2|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3929672|NCT01406860|3752093|B1|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3929673|NCT01406860|3752091|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3929674|NCT01406860|3752092|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3929675|NCT01406860|3752093|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3929676|NCT01406860|3752091|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3929677|NCT01406860|3752092|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3929678|NCT01406860|3752093|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3929679|NCT01406860|3752091|B3|||Age||years|Mean|32.6|32.6|Standard Deviation|7.85|7.85|||
3929680|NCT01406860|3752092|B2|||Age||years|Mean|30.6|30.6|Standard Deviation|5.31|5.31|||
3929681|NCT01406860|3752093|B1|||Age||years|Mean|33.6|33.6|Standard Deviation|9.01|9.01|||
3929682|NCT01406795|3752106|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3929683|NCT01406795|3752106|B1||Male|Gender||Participants|Count of Participants|1|1.0||||||
3929684|NCT01406795|3752106|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3929685|NCT01406795|3752106|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3929686|NCT01406795|3752106|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3929687|NCT01406795|3752106|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3929688|NCT01406574|3752120|B1|Japan||Region of Enrollment||participants|Number|23|23.0||||||
3929689|NCT01406574|3752120|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3929690|NCT01406574|3752120|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3929691|NCT01406574|3752120|B1|||Age||years|Mean|64.0|64.0|Standard Deviation|7.3|7.3|||
3929692|NCT01406574|3752120|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3929693|NCT01406574|3752120|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3929694|NCT01406574|3752120|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3929695|NCT01406223|3752135|B5|United States||Region of Enrollment||participants|Number|76|76.0||||||
3929696|NCT01406223|3752136|B4|United States||Region of Enrollment||participants|Number|19|19.0||||||
3929697|NCT01406223|3752137|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3929698|NCT01406223|3752138|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3929699|NCT01406223|3752139|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3929700|NCT01406223|3752135|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929701|NCT01406223|3752136|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929702|NCT01406223|3752137|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929703|NCT01406223|3752138|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929704|NCT01406223|3752139|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929705|NCT01406223|3752135|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3929706|NCT01406223|3752136|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929707|NCT01406223|3752137|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3929708|NCT01406223|3752138|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3929709|NCT01406223|3752139|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3929710|NCT01406223|3752135|B5||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3929711|NCT01406223|3752136|B4||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3929712|NCT01406223|3752137|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3929713|NCT01406223|3752138|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3929714|NCT01406223|3752139|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3929715|NCT01406223|3752135|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3929716|NCT01406223|3752136|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3929717|NCT01406223|3752137|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3929718|NCT01406223|3752138|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3929719|NCT01406223|3752139|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3929720|NCT01406223|3752135|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929721|NCT01406223|3752136|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929722|NCT01406223|3752137|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929723|NCT01406223|3752138|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929724|NCT01406223|3752139|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929725|NCT01406223|3752135|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929726|NCT01406223|3752136|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929727|NCT01406223|3752137|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929728|NCT01406223|3752138|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929729|NCT01406223|3752139|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929730|NCT01406223|3752135|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3929731|NCT01406223|3752136|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929732|NCT01406223|3752137|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929733|NCT01406223|3752138|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3929734|NCT01406223|3752139|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929735|NCT01406223|3752135|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929736|NCT01406223|3752136|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929737|NCT01406223|3752137|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929738|NCT01406223|3752138|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929739|NCT01406223|3752139|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929740|NCT01406223|3752135|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3929741|NCT01406223|3752136|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3929742|NCT01406223|3752137|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3929743|NCT01406223|3752138|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3929744|NCT01406223|3752139|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3929745|NCT01406223|3752135|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3929746|NCT01406223|3752136|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929747|NCT01406223|3752137|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3929748|NCT01406223|3752138|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3929749|NCT01406223|3752139|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3929750|NCT01406223|3752135|B5||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3929751|NCT01406223|3752136|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3929752|NCT01406223|3752137|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3929753|NCT01406223|3752138|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3929754|NCT01406223|3752139|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3929755|NCT01406223|3752135|B5||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3929756|NCT01406223|3752136|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3929757|NCT01406223|3752137|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3929758|NCT01406223|3752138|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3929759|NCT01406223|3752139|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3929760|NCT01406223|3752135|B5|||Age||years|Mean|38.75|38.75|Standard Deviation|11.19|11.19|||
3929761|NCT01406223|3752136|B4|||Age||years|Mean|37.16|37.16|Standard Deviation|10.59|10.59|||
3929762|NCT01406223|3752137|B3|||Age||years|Mean|38.35|38.35|Standard Deviation|11.42|11.42|||
3929763|NCT01406223|3752138|B2|||Age||years|Mean|41.89|41.89|Standard Deviation|12.22|12.22|||
3929764|NCT01406223|3752139|B1|||Age||years|Mean|37.56|37.56|Standard Deviation|10.68|10.68|||
3929765|NCT01406223|3752135|B5||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3929766|NCT01406223|3752136|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3929767|NCT01406223|3752137|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3929768|NCT01406223|3752138|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3929769|NCT01406223|3752139|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3929770|NCT01406223|3752135|B5||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
3929771|NCT01406223|3752136|B4||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3929772|NCT01406223|3752137|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3929773|NCT01406223|3752138|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3929774|NCT01406223|3752139|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3929775|NCT01406223|3752135|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3929776|NCT01406223|3752136|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3929777|NCT01406223|3752137|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3929778|NCT01406223|3752138|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3929779|NCT01406223|3752139|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3929780|NCT01406015|3752156|B3|||Body Mass Index (BMI)||kg/m^2|Mean|36.8|36.8|Standard Deviation|5.8|5.8|||
3929781|NCT01406015|3752157|B2|||Body Mass Index (BMI)||kg/m^2|Mean|36|36.0|Standard Deviation|4.6|4.6|||
3929782|NCT01406015|3752158|B1|||Body Mass Index (BMI)||kg/m^2|Mean|38|38.0|Standard Deviation|6.6|6.6|||
3929783|NCT01406015|3752156|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3929784|NCT01406015|3752157|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3929785|NCT01406015|3752158|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3929786|NCT01406015|3752156|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3929787|NCT01406015|3752157|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3929788|NCT01406015|3752158|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3929789|NCT01406015|3752156|B3|||Age||years|Mean|43.4|43.4|Standard Deviation|12.3|12.3|||
3929790|NCT01406015|3752157|B2|||Age||years|Mean|40|40.0|Standard Deviation|12.3|12.3|||
3929791|NCT01406015|3752158|B1|||Age||years|Mean|47|47.0|Standard Deviation|11.6|11.6|||
3929792|NCT01405950|3752173|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929793|NCT01405950|3752174|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929794|NCT01405950|3752175|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929795|NCT01405950|3752173|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3929796|NCT01405950|3752174|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3929797|NCT01405950|3752175|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3929798|NCT01405950|3752173|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929799|NCT01405950|3752174|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929800|NCT01405950|3752175|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3929801|NCT01405950|3752173|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3929802|NCT01405950|3752174|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3929803|NCT01405950|3752175|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3929804|NCT01405950|3752173|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3929805|NCT01405950|3752174|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3929806|NCT01405950|3752175|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3929807|NCT01405950|3752173|B3|13-16 years||Age, Customized||participants|Number|1|1.0||||||
3929808|NCT01405950|3752174|B2|13-16 years||Age, Customized||participants|Number|0|0.0||||||
3929809|NCT01405950|3752175|B1|13-16 years||Age, Customized||participants|Number|1|1.0||||||
3929810|NCT01405950|3752173|B3|6-12 years||Age, Customized||participants|Number|5|5.0||||||
3929811|NCT01405950|3752174|B2|6-12 years||Age, Customized||participants|Number|2|2.0||||||
3929812|NCT01405950|3752175|B1|6-12 years||Age, Customized||participants|Number|3|3.0||||||
3929813|NCT01405950|3752173|B3|4-5 years||Age, Customized||participants|Number|1|1.0||||||
3929814|NCT01405950|3752174|B2|4-5 years||Age, Customized||participants|Number|0|0.0||||||
3929815|NCT01405950|3752175|B1|4-5 years||Age, Customized||participants|Number|1|1.0||||||
3929816|NCT01405950|3752173|B3|2-3 years||Age, Customized||participants|Number|3|3.0||||||
3929817|NCT01405950|3752174|B2|2-3 years||Age, Customized||participants|Number|0|0.0||||||
3929818|NCT01405950|3752175|B1|2-3 years||Age, Customized||participants|Number|3|3.0||||||
3929819|NCT01405937|3752190|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3929820|NCT01405937|3752191|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3929821|NCT01405937|3752192|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3929822|NCT01405937|3752190|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3929823|NCT01405937|3752191|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3929824|NCT01405937|3752192|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3929825|NCT01405937|3752190|B3|||Age||years|Mean|59.1|59.1|Standard Deviation|8.3|8.3|||
3929826|NCT01405937|3752191|B2|||Age||years|Mean|60.3|60.3|Standard Deviation|7.5|7.5|||
3929827|NCT01405937|3752192|B1|||Age||years|Mean|57.8|57.8|Standard Deviation|9.0|9.0|||
3929828|NCT01405924|3752213|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3929829|NCT01405924|3752213|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3929830|NCT01405924|3752213|B1|||Age||Years|Mean|52.83|52.83|Standard Deviation|12.60|12.6|||
3929831|NCT01405898|3752223|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3929832|NCT01405898|3752224|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3929833|NCT01405898|3752225|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3929834|NCT01405898|3752223|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3929835|NCT01405898|3752224|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3929836|NCT01405898|3752225|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3929837|NCT01405898|3752223|B3|||Age||years|Mean|56.9|56.9|Standard Deviation|15.1|15.1|||
3929838|NCT01405898|3752224|B2|||Age||years|Mean|56.3|56.3|Standard Deviation|16.4|16.4|||
3929839|NCT01405898|3752225|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|13.9|13.9|||
3929840|NCT01405820|3752244|B7||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3929841|NCT01405820|3752245|B6||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3929842|NCT01405820|3752246|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3929843|NCT01405820|3752247|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3929844|NCT01405820|3752248|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3929845|NCT01405820|3752249|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3929846|NCT01405820|3752250|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3929847|NCT01405820|3752244|B7||Female|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
3929848|NCT01405820|3752245|B6||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3929849|NCT01405820|3752246|B5||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3929850|NCT01405820|3752247|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3929851|NCT01405820|3752248|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3929852|NCT01405820|3752249|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3929853|NCT01405820|3752250|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3929854|NCT01405820|3752244|B7|50 to 56 years||Age, Customized||participants|Number|29|29.0||||||
3929855|NCT01405820|3752245|B6|50 to 56 years||Age, Customized||participants|Number|4|4.0||||||
3929856|NCT01405820|3752246|B5|50 to 56 years||Age, Customized||participants|Number|5|5.0||||||
3929857|NCT01405820|3752247|B4|50 to 56 years||Age, Customized||participants|Number|6|6.0||||||
3929858|NCT01405820|3752248|B3|50 to 56 years||Age, Customized||participants|Number|7|7.0||||||
3929859|NCT01405820|3752249|B2|50 to 56 years||Age, Customized||participants|Number|2|2.0||||||
3929860|NCT01405820|3752250|B1|50 to 56 years||Age, Customized||participants|Number|5|5.0||||||
3929861|NCT01405820|3752244|B7|40 to 49 years||Age, Customized||participants|Number|95|95.0||||||
3929862|NCT01405820|3752245|B6|40 to 49 years||Age, Customized||participants|Number|9|9.0||||||
3929863|NCT01405820|3752246|B5|40 to 49 years||Age, Customized||participants|Number|16|16.0||||||
3929864|NCT01405820|3752247|B4|40 to 49 years||Age, Customized||participants|Number|17|17.0||||||
3929865|NCT01405820|3752248|B3|40 to 49 years||Age, Customized||participants|Number|17|17.0||||||
3929866|NCT01405820|3752249|B2|40 to 49 years||Age, Customized||participants|Number|16|16.0||||||
3929867|NCT01405820|3752250|B1|40 to 49 years||Age, Customized||participants|Number|20|20.0||||||
3929868|NCT01405820|3752244|B7|30 to 39 years||Age, Customized||participants|Number|117|117.0||||||
3929869|NCT01405820|3752245|B6|30 to 39 years||Age, Customized||participants|Number|14|14.0||||||
3929870|NCT01405820|3752246|B5|30 to 39 years||Age, Customized||participants|Number|21|21.0||||||
3929871|NCT01405820|3752247|B4|30 to 39 years||Age, Customized||participants|Number|24|24.0||||||
3929872|NCT01405820|3752248|B3|30 to 39 years||Age, Customized||participants|Number|21|21.0||||||
3929873|NCT01405820|3752249|B2|30 to 39 years||Age, Customized||participants|Number|15|15.0||||||
3929874|NCT01405820|3752250|B1|30 to 39 years||Age, Customized||participants|Number|22|22.0||||||
3929875|NCT01405820|3752244|B7|20 to 29 years||Age, Customized||participants|Number|48|48.0||||||
3929876|NCT01405820|3752245|B6|20 to 29 years||Age, Customized||participants|Number|11|11.0||||||
3929877|NCT01405820|3752246|B5|20 to 29 years||Age, Customized||participants|Number|5|5.0||||||
3929878|NCT01405820|3752247|B4|20 to 29 years||Age, Customized||participants|Number|7|7.0||||||
3929879|NCT01405820|3752248|B3|20 to 29 years||Age, Customized||participants|Number|7|7.0||||||
3929880|NCT01405820|3752249|B2|20 to 29 years||Age, Customized||participants|Number|11|11.0||||||
3929881|NCT01405820|3752250|B1|20 to 29 years||Age, Customized||participants|Number|7|7.0||||||
3929882|NCT01405820|3752244|B7|18 to 19 years||Age, Customized||participants|Number|1|1.0||||||
3929883|NCT01405820|3752245|B6|18 to 19 years||Age, Customized||participants|Number|0|0.0||||||
3929884|NCT01405820|3752246|B5|18 to 19 years||Age, Customized||participants|Number|0|0.0||||||
3929885|NCT01405820|3752247|B4|18 to 19 years||Age, Customized||participants|Number|0|0.0||||||
3929886|NCT01405820|3752248|B3|18 to 19 years||Age, Customized||participants|Number|0|0.0||||||
3929887|NCT01405820|3752249|B2|18 to 19 years||Age, Customized||participants|Number|1|1.0||||||
3929888|NCT01405820|3752250|B1|18 to 19 years||Age, Customized||participants|Number|0|0.0||||||
3929889|NCT01405820|3752244|B7|||Age||years|Mean|37.9|37.9|Standard Deviation|8.41|8.41|||
3929890|NCT01405820|3752245|B6|||Age||years|Mean|36.0|36.0|Standard Deviation|9.03|9.03|||
3929891|NCT01405820|3752246|B5|||Age||years|Mean|38.7|38.7|Standard Deviation|8.61|8.61|||
3929892|NCT01405820|3752247|B4|||Age||years|Mean|38.7|38.7|Standard Deviation|7.85|7.85|||
3929893|NCT01405820|3752248|B3|||Age||years|Mean|38.7|38.7|Standard Deviation|8.43|8.43|||
3929894|NCT01405820|3752249|B2|||Age||years|Mean|36.3|36.3|Standard Deviation|8.92|8.92|||
3929895|NCT01405820|3752250|B1|||Age||years|Mean|38.4|38.4|Standard Deviation|7.84|7.84|||
3929896|NCT01405794|3752275|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3929897|NCT01405794|3752275|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3929898|NCT01405794|3752275|B1|||Age||years|Mean|28.8|28.8|Full Range|||20.0|50.0|
3929899|NCT01405768|3752349|B3|>10 mL||Anesthetic volume (in mL)||participants|Number|3|3.0||||||
3929900|NCT01405768|3752350|B2|>10 mL||Anesthetic volume (in mL)||participants|Number|2|2.0||||||
3929901|NCT01405768|3752351|B1|>10 mL||Anesthetic volume (in mL)||participants|Number|1|1.0||||||
3929902|NCT01405768|3752349|B3|10 mL||Anesthetic volume (in mL)||participants|Number|26|26.0||||||
3929903|NCT01405768|3752350|B2|10 mL||Anesthetic volume (in mL)||participants|Number|15|15.0||||||
3929904|NCT01405768|3752351|B1|10 mL||Anesthetic volume (in mL)||participants|Number|11|11.0||||||
3929905|NCT01405768|3752349|B3|6-9 mL||Anesthetic volume (in mL)||participants|Number|23|23.0||||||
3929906|NCT01405768|3752350|B2|6-9 mL||Anesthetic volume (in mL)||participants|Number|11|11.0||||||
3929907|NCT01405768|3752351|B1|6-9 mL||Anesthetic volume (in mL)||participants|Number|12|12.0||||||
3929908|NCT01405768|3752349|B3|>10 mL||Estimated blood loss (in mL)||participants|Number|10|10.0||||||
3929909|NCT01405768|3752350|B2|>10 mL||Estimated blood loss (in mL)||participants|Number|5|5.0||||||
3929910|NCT01405768|3752351|B1|>10 mL||Estimated blood loss (in mL)||participants|Number|5|5.0||||||
3929911|NCT01405768|3752349|B3|6-10 mL||Estimated blood loss (in mL)||participants|Number|16|16.0||||||
3929912|NCT01405768|3752350|B2|6-10 mL||Estimated blood loss (in mL)||participants|Number|9|9.0||||||
3929913|NCT01405768|3752351|B1|6-10 mL||Estimated blood loss (in mL)||participants|Number|7|7.0||||||
3929914|NCT01405768|3752349|B3|1-5 mL||Estimated blood loss (in mL)||participants|Number|17|17.0||||||
3929915|NCT01405768|3752350|B2|1-5 mL||Estimated blood loss (in mL)||participants|Number|8|8.0||||||
3929916|NCT01405768|3752351|B1|1-5 mL||Estimated blood loss (in mL)||participants|Number|9|9.0||||||
3929917|NCT01405768|3752349|B3|0 mL||Estimated blood loss (in mL)||participants|Number|9|9.0||||||
3929918|NCT01405768|3752350|B2|0 mL||Estimated blood loss (in mL)||participants|Number|6|6.0||||||
3929919|NCT01405768|3752351|B1|0 mL||Estimated blood loss (in mL)||participants|Number|3|3.0||||||
3929920|NCT01405768|3752349|B3|10 x 8||Endocervical loop size (in mm)|"8 patients in the Lidocaine arm had the endocervical loop used.~11 patients in the Buffered Lidocaine arm had the endocervical loop used."|participants|Number|1|1.0||||||
3929921|NCT01405768|3752350|B2|10 x 8||Endocervical loop size (in mm)|"8 patients in the Lidocaine arm had the endocervical loop used.~11 patients in the Buffered Lidocaine arm had the endocervical loop used."|participants|Number|0|0.0||||||
3929922|NCT01405768|3752351|B1|10 x 8||Endocervical loop size (in mm)|"8 patients in the Lidocaine arm had the endocervical loop used.~11 patients in the Buffered Lidocaine arm had the endocervical loop used."|participants|Number|1|1.0||||||
3929923|NCT01405768|3752349|B3|15 x 12||Endocervical loop size (in mm)|"8 patients in the Lidocaine arm had the endocervical loop used.~11 patients in the Buffered Lidocaine arm had the endocervical loop used."|participants|Number|2|2.0||||||
3929924|NCT01405768|3752350|B2|15 x 12||Endocervical loop size (in mm)|"8 patients in the Lidocaine arm had the endocervical loop used.~11 patients in the Buffered Lidocaine arm had the endocervical loop used."|participants|Number|0|0.0||||||
3929925|NCT01405768|3752351|B1|15 x 12||Endocervical loop size (in mm)|"8 patients in the Lidocaine arm had the endocervical loop used.~11 patients in the Buffered Lidocaine arm had the endocervical loop used."|participants|Number|2|2.0||||||
3929926|NCT01405768|3752349|B3|10 x 10||Endocervical loop size (in mm)|"8 patients in the Lidocaine arm had the endocervical loop used.~11 patients in the Buffered Lidocaine arm had the endocervical loop used."|participants|Number|16|16.0||||||
3929927|NCT01405768|3752350|B2|10 x 10||Endocervical loop size (in mm)|"8 patients in the Lidocaine arm had the endocervical loop used.~11 patients in the Buffered Lidocaine arm had the endocervical loop used."|participants|Number|11|11.0||||||
3929928|NCT01405768|3752351|B1|10 x 10||Endocervical loop size (in mm)|"8 patients in the Lidocaine arm had the endocervical loop used.~11 patients in the Buffered Lidocaine arm had the endocervical loop used."|participants|Number|5|5.0||||||
3929929|NCT01405768|3752349|B3|Other||Ectocervical loop size (in mm)||participants|Number|13|13.0||||||
3929930|NCT01405768|3752350|B2|Other||Ectocervical loop size (in mm)||participants|Number|5|5.0||||||
3929931|NCT01405768|3752351|B1|Other||Ectocervical loop size (in mm)||participants|Number|8|8.0||||||
3929932|NCT01405768|3752349|B3|20 x 12||Ectocervical loop size (in mm)||participants|Number|29|29.0||||||
3929933|NCT01405768|3752350|B2|20 x 12||Ectocervical loop size (in mm)||participants|Number|16|16.0||||||
3929934|NCT01405768|3752351|B1|20 x 12||Ectocervical loop size (in mm)||participants|Number|13|13.0||||||
3929935|NCT01405768|3752349|B3|15 x 12||Ectocervical loop size (in mm)||participants|Number|10|10.0||||||
3929936|NCT01405768|3752350|B2|15 x 12||Ectocervical loop size (in mm)||participants|Number|7|7.0||||||
3929937|NCT01405768|3752351|B1|15 x 12||Ectocervical loop size (in mm)||participants|Number|3|3.0||||||
3929938|NCT01405768|3752349|B3|3+||Number of passes||participants|Number|11|11.0||||||
3929939|NCT01405768|3752350|B2|3+||Number of passes||participants|Number|5|5.0||||||
3929940|NCT01405768|3752351|B1|3+||Number of passes||participants|Number|6|6.0||||||
3929941|NCT01405768|3752349|B3|2||Number of passes||participants|Number|24|24.0||||||
3929942|NCT01405768|3752350|B2|2||Number of passes||participants|Number|12|12.0||||||
3929943|NCT01405768|3752351|B1|2||Number of passes||participants|Number|12|12.0||||||
3929944|NCT01405768|3752349|B3|1||Number of passes||participants|Number|17|17.0||||||
3929945|NCT01405768|3752350|B2|1||Number of passes||participants|Number|11|11.0||||||
3929946|NCT01405768|3752351|B1|1||Number of passes||participants|Number|6|6.0||||||
3929947|NCT01405768|3752349|B3|Ectocervix and endocervix||Procedure type||participants|Number|19|19.0||||||
3929948|NCT01405768|3752350|B2|Ectocervix and endocervix||Procedure type||participants|Number|11|11.0||||||
3929949|NCT01405768|3752351|B1|Ectocervix and endocervix||Procedure type||participants|Number|8|8.0||||||
3929950|NCT01405768|3752349|B3|Ectocervix only||Procedure type||participants|Number|33|33.0||||||
3929951|NCT01405768|3752350|B2|Ectocervix only||Procedure type||participants|Number|17|17.0||||||
3929952|NCT01405768|3752351|B1|Ectocervix only||Procedure type||participants|Number|16|16.0||||||
3929953|NCT01405768|3752349|B3|Persistent CIN 1||Indication|"HSIL = High grade squamous intraepithelial lesion~CIN 2 = Cervical squamous intraepithelial neoplasia 2~CIN 3 = Cervical squamous intraepithelial neoplasia 2~AIS = Adenocarcinoma in situ~Persistent CIN 1 = Persistent cervical squamous intraepithelial neoplasia 1"|participants|Number|1|1.0||||||
3929954|NCT01405768|3752350|B2|Persistent CIN 1||Indication|"HSIL = High grade squamous intraepithelial lesion~CIN 2 = Cervical squamous intraepithelial neoplasia 2~CIN 3 = Cervical squamous intraepithelial neoplasia 2~AIS = Adenocarcinoma in situ~Persistent CIN 1 = Persistent cervical squamous intraepithelial neoplasia 1"|participants|Number|1|1.0||||||
3929955|NCT01405768|3752351|B1|Persistent CIN 1||Indication|"HSIL = High grade squamous intraepithelial lesion~CIN 2 = Cervical squamous intraepithelial neoplasia 2~CIN 3 = Cervical squamous intraepithelial neoplasia 2~AIS = Adenocarcinoma in situ~Persistent CIN 1 = Persistent cervical squamous intraepithelial neoplasia 1"|participants|Number|0|0.0||||||
3929956|NCT01405768|3752349|B3|AIS||Indication|"HSIL = High grade squamous intraepithelial lesion~CIN 2 = Cervical squamous intraepithelial neoplasia 2~CIN 3 = Cervical squamous intraepithelial neoplasia 2~AIS = Adenocarcinoma in situ~Persistent CIN 1 = Persistent cervical squamous intraepithelial neoplasia 1"|participants|Number|2|2.0||||||
3929957|NCT01405768|3752350|B2|AIS||Indication|"HSIL = High grade squamous intraepithelial lesion~CIN 2 = Cervical squamous intraepithelial neoplasia 2~CIN 3 = Cervical squamous intraepithelial neoplasia 2~AIS = Adenocarcinoma in situ~Persistent CIN 1 = Persistent cervical squamous intraepithelial neoplasia 1"|participants|Number|1|1.0||||||
3929958|NCT01405768|3752351|B1|AIS||Indication|"HSIL = High grade squamous intraepithelial lesion~CIN 2 = Cervical squamous intraepithelial neoplasia 2~CIN 3 = Cervical squamous intraepithelial neoplasia 2~AIS = Adenocarcinoma in situ~Persistent CIN 1 = Persistent cervical squamous intraepithelial neoplasia 1"|participants|Number|1|1.0||||||
3929959|NCT01405768|3752349|B3|CIN 3||Indication|"HSIL = High grade squamous intraepithelial lesion~CIN 2 = Cervical squamous intraepithelial neoplasia 2~CIN 3 = Cervical squamous intraepithelial neoplasia 2~AIS = Adenocarcinoma in situ~Persistent CIN 1 = Persistent cervical squamous intraepithelial neoplasia 1"|participants|Number|26|26.0||||||
3929960|NCT01405768|3752350|B2|CIN 3||Indication|"HSIL = High grade squamous intraepithelial lesion~CIN 2 = Cervical squamous intraepithelial neoplasia 2~CIN 3 = Cervical squamous intraepithelial neoplasia 2~AIS = Adenocarcinoma in situ~Persistent CIN 1 = Persistent cervical squamous intraepithelial neoplasia 1"|participants|Number|15|15.0||||||
3929961|NCT01405768|3752351|B1|CIN 3||Indication|"HSIL = High grade squamous intraepithelial lesion~CIN 2 = Cervical squamous intraepithelial neoplasia 2~CIN 3 = Cervical squamous intraepithelial neoplasia 2~AIS = Adenocarcinoma in situ~Persistent CIN 1 = Persistent cervical squamous intraepithelial neoplasia 1"|participants|Number|11|11.0||||||
3929962|NCT01405768|3752349|B3|CIN 2||Indication|"HSIL = High grade squamous intraepithelial lesion~CIN 2 = Cervical squamous intraepithelial neoplasia 2~CIN 3 = Cervical squamous intraepithelial neoplasia 2~AIS = Adenocarcinoma in situ~Persistent CIN 1 = Persistent cervical squamous intraepithelial neoplasia 1"|participants|Number|11|11.0||||||
3929963|NCT01405768|3752350|B2|CIN 2||Indication|"HSIL = High grade squamous intraepithelial lesion~CIN 2 = Cervical squamous intraepithelial neoplasia 2~CIN 3 = Cervical squamous intraepithelial neoplasia 2~AIS = Adenocarcinoma in situ~Persistent CIN 1 = Persistent cervical squamous intraepithelial neoplasia 1"|participants|Number|7|7.0||||||
3929964|NCT01405768|3752351|B1|CIN 2||Indication|"HSIL = High grade squamous intraepithelial lesion~CIN 2 = Cervical squamous intraepithelial neoplasia 2~CIN 3 = Cervical squamous intraepithelial neoplasia 2~AIS = Adenocarcinoma in situ~Persistent CIN 1 = Persistent cervical squamous intraepithelial neoplasia 1"|participants|Number|4|4.0||||||
3929965|NCT01405768|3752349|B3|HSIL||Indication|"HSIL = High grade squamous intraepithelial lesion~CIN 2 = Cervical squamous intraepithelial neoplasia 2~CIN 3 = Cervical squamous intraepithelial neoplasia 2~AIS = Adenocarcinoma in situ~Persistent CIN 1 = Persistent cervical squamous intraepithelial neoplasia 1"|participants|Number|12|12.0||||||
3929966|NCT01405768|3752350|B2|HSIL||Indication|"HSIL = High grade squamous intraepithelial lesion~CIN 2 = Cervical squamous intraepithelial neoplasia 2~CIN 3 = Cervical squamous intraepithelial neoplasia 2~AIS = Adenocarcinoma in situ~Persistent CIN 1 = Persistent cervical squamous intraepithelial neoplasia 1"|participants|Number|4|4.0||||||
3929967|NCT01405768|3752351|B1|HSIL||Indication|"HSIL = High grade squamous intraepithelial lesion~CIN 2 = Cervical squamous intraepithelial neoplasia 2~CIN 3 = Cervical squamous intraepithelial neoplasia 2~AIS = Adenocarcinoma in situ~Persistent CIN 1 = Persistent cervical squamous intraepithelial neoplasia 1"|participants|Number|8|8.0||||||
3929968|NCT01405768|3752349|B3|2+||Parity|Parity indicates the number of >20-week births (including viable and non-viable; i.e., stillbirths). Pregnancies consisting of multiples, such as twins or triplets, count as one birth for the purpose of this notation.|participants|Number|31|31.0||||||
3929969|NCT01405768|3752350|B2|2+||Parity|Parity indicates the number of >20-week births (including viable and non-viable; i.e., stillbirths). Pregnancies consisting of multiples, such as twins or triplets, count as one birth for the purpose of this notation.|participants|Number|15|15.0||||||
3929970|NCT01405768|3752351|B1|2+||Parity|Parity indicates the number of >20-week births (including viable and non-viable; i.e., stillbirths). Pregnancies consisting of multiples, such as twins or triplets, count as one birth for the purpose of this notation.|participants|Number|16|16.0||||||
3929971|NCT01405768|3752349|B3|1||Parity|Parity indicates the number of >20-week births (including viable and non-viable; i.e., stillbirths). Pregnancies consisting of multiples, such as twins or triplets, count as one birth for the purpose of this notation.|participants|Number|12|12.0||||||
3929972|NCT01405768|3752350|B2|1||Parity|Parity indicates the number of >20-week births (including viable and non-viable; i.e., stillbirths). Pregnancies consisting of multiples, such as twins or triplets, count as one birth for the purpose of this notation.|participants|Number|7|7.0||||||
3929973|NCT01405768|3752351|B1|1||Parity|Parity indicates the number of >20-week births (including viable and non-viable; i.e., stillbirths). Pregnancies consisting of multiples, such as twins or triplets, count as one birth for the purpose of this notation.|participants|Number|5|5.0||||||
3929974|NCT01405768|3752349|B3|0||Parity|Parity indicates the number of >20-week births (including viable and non-viable; i.e., stillbirths). Pregnancies consisting of multiples, such as twins or triplets, count as one birth for the purpose of this notation.|participants|Number|9|9.0||||||
3929975|NCT01405768|3752350|B2|0||Parity|Parity indicates the number of >20-week births (including viable and non-viable; i.e., stillbirths). Pregnancies consisting of multiples, such as twins or triplets, count as one birth for the purpose of this notation.|participants|Number|6|6.0||||||
3929976|NCT01405768|3752351|B1|0||Parity|Parity indicates the number of >20-week births (including viable and non-viable; i.e., stillbirths). Pregnancies consisting of multiples, such as twins or triplets, count as one birth for the purpose of this notation.|participants|Number|3|3.0||||||
3929977|NCT01405768|3752349|B3|United States||Region of Enrollment||participants|Number|52|52.0||||||
3929978|NCT01405768|3752350|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
3929979|NCT01405768|3752351|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3929980|NCT01405768|3752349|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3929981|NCT01405768|3752350|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3929982|NCT01405768|3752351|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3929983|NCT01405768|3752349|B3|Hispanic/Latina||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3929984|NCT01405768|3752350|B2|Hispanic/Latina||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3929985|NCT01405768|3752351|B1|Hispanic/Latina||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3929986|NCT01405768|3752349|B3|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3929987|NCT01405768|3752350|B2|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3929988|NCT01405768|3752351|B1|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3929989|NCT01405768|3752349|B3|African American||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3929990|NCT01405768|3752350|B2|African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3929991|NCT01405768|3752351|B1|African American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3929992|NCT01405768|3752349|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3929993|NCT01405768|3752350|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3929994|NCT01405768|3752351|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3929995|NCT01405768|3752349|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3929996|NCT01405768|3752350|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3929997|NCT01405768|3752351|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3929998|NCT01405768|3752349|B3|||Age||years|Mean|32.4|32.4|Standard Deviation|9.2|9.2|||
3929999|NCT01405768|3752350|B2|||Age||years|Mean|32.3|32.3|Standard Deviation|7.6|7.6|||
3930000|NCT01405768|3752351|B1|||Age||years|Mean|32.4|32.4|Standard Deviation|10.3|10.3|||
3930001|NCT01405768|3752349|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3930002|NCT01405768|3752350|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3930003|NCT01405768|3752351|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3930004|NCT01405768|3752349|B3||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3930005|NCT01405768|3752350|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3930006|NCT01405768|3752351|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3930007|NCT01405768|3752349|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3930008|NCT01405768|3752350|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3930009|NCT01405768|3752351|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3930010|NCT01405742|3752364|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3930011|NCT01405742|3752364|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3930012|NCT01405742|3752364|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3930013|NCT01405742|3752364|B1|||Age||year|Median|25.5|25.5|Full Range|||19.0|33.0|
3930014|NCT01405742|3752364|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3930015|NCT01405742|3752364|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3930016|NCT01405742|3752364|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3930017|NCT01405560|3752375|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3930018|NCT01405560|3752375|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3930019|NCT01405560|3752375|B1|||Age||years|Mean|57.4|57.4|Standard Deviation|9.2|9.2|||
3930020|NCT01405508|3752386|B5||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3930021|NCT01405508|3752387|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3930022|NCT01405508|3752388|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3930023|NCT01405508|3752389|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3930024|NCT01405508|3752390|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3930025|NCT01405508|3752386|B5||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3930026|NCT01405508|3752387|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3930027|NCT01405508|3752388|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3930028|NCT01405508|3752389|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3930029|NCT01405508|3752390|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3930030|NCT01405508|3752386|B5|||Age||years|Mean|41.6|41.6|Standard Deviation|12.2|12.2|||
3930031|NCT01405508|3752387|B4|||Age||years|Mean|44.4|44.4|Standard Deviation|12.6|12.6|||
3930032|NCT01405508|3752388|B3|||Age||years|Mean|42.0|42.0|Standard Deviation|9.2|9.2|||
3930033|NCT01405508|3752389|B2|||Age||years|Mean|39.5|39.5|Standard Deviation|14.4|14.4|||
3930034|NCT01405508|3752390|B1|||Age||years|Mean|40.6|40.6|Standard Deviation|12.2|12.2|||
3930035|NCT01405508|3752386|B5||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3930036|NCT01405508|3752387|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3930037|NCT01405508|3752388|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3930038|NCT01405508|3752389|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3930039|NCT01405508|3752390|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3930040|NCT01405508|3752386|B5||Between 18 and 65 years|Age||Participants|Count of Participants|103|103.0||||||
3930041|NCT01405508|3752387|B4||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3930042|NCT01405508|3752388|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3930043|NCT01405508|3752389|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3930044|NCT01405508|3752390|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3930045|NCT01405508|3752386|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3930046|NCT01405508|3752387|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3930047|NCT01405508|3752388|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3930048|NCT01405508|3752389|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3930049|NCT01405508|3752390|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3930050|NCT01405469|3752411|B1|Germany||Region of Enrollment||participants|Number|16|16.0||||||
3930051|NCT01405469|3752411|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3930052|NCT01405469|3752411|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3930053|NCT01405469|3752411|B1|||Age||years|Mean|45|45.0|Standard Deviation|16.22|16.22|||
3930054|NCT01405469|3752411|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3930055|NCT01405469|3752411|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3930056|NCT01405469|3752411|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3930057|NCT01405456|3752423|B3|||Markers of Immune Activation|MCP-1|pg/mL|Mean|198|198.0|Standard Deviation|66|66.0|||
3930058|NCT01405456|3752424|B2|||Markers of Immune Activation|MCP-1|pg/mL|Mean|191|191.0|Standard Deviation|51|51.0|||
3930059|NCT01405456|3752425|B1|||Markers of Immune Activation|MCP-1|pg/mL|Mean|205|205.0|Standard Deviation|78|78.0|||
3930060|NCT01405456|3752423|B3|||Markers of Systemic Inflammation|IL-6|pg/mL|Median|9.1|9.1|Inter-Quartile Range|||5.9|19.3|
3930061|NCT01405456|3752424|B2|||Markers of Systemic Inflammation|IL-6|pg/mL|Median|7.9|7.9|Inter-Quartile Range|||6.1|18.3|
3930062|NCT01405456|3752425|B1|||Markers of Systemic Inflammation|IL-6|pg/mL|Median|10.2|10.2|Inter-Quartile Range|||5.2|19.8|
3930063|NCT01405456|3752423|B3|||Adiponectin||pg/mL|Median|4527|4527.0|Inter-Quartile Range|||3373.0|5484.0|
3930064|NCT01405456|3752424|B2|||Adiponectin||pg/mL|Median|4673|4673.0|Inter-Quartile Range|||3302.0|6042.0|
3930065|NCT01405456|3752425|B1|||Adiponectin||pg/mL|Median|4016|4016.0|Inter-Quartile Range|||3439.0|5360.0|
3930066|NCT01405456|3752423|B3|||Plasminogen Activator Inhibitor 1||ng/mL|Mean|36.9|36.9|Standard Deviation|18.3|18.3|||
3930067|NCT01405456|3752424|B2|||Plasminogen Activator Inhibitor 1||ng/mL|Mean|37.0|37.0|Standard Deviation|18.7|18.7|||
3930068|NCT01405456|3752425|B1|||Plasminogen Activator Inhibitor 1||ng/mL|Mean|36.7|36.7|Standard Deviation|18.3|18.3|||
3930069|NCT01405456|3752423|B3|||C-reactive Protein||mg/L|Median|3.4|3.4|Inter-Quartile Range|||1.3|9.6|
3930070|NCT01405456|3752424|B2|||C-reactive Protein||mg/L|Median|3.7|3.7|Inter-Quartile Range|||1.6|9.8|
3930071|NCT01405456|3752425|B1|||C-reactive Protein||mg/L|Median|3.3|3.3|Inter-Quartile Range|||1.2|9.4|
3930072|NCT01405456|3752423|B3|||Hemoglobin A1c||percentage|Median|5.7|5.7|Inter-Quartile Range|||5.5|6.0|
3930073|NCT01405456|3752424|B2|||Hemoglobin A1c||percentage|Median|5.8|5.8|Inter-Quartile Range|||5.3|6.1|
3930074|NCT01405456|3752425|B1|||Hemoglobin A1c||percentage|Median|5.7|5.7|Inter-Quartile Range|||5.5|6.0|
3930075|NCT01405456|3752423|B3|||Potassium||mEq/L|Mean|4.1|4.1|Standard Deviation|0.2|0.2|||
3930076|NCT01405456|3752424|B2|||Potassium||mEq/L|Mean|4.0|4.0|Standard Deviation|0.2|0.2|||
3930077|NCT01405456|3752425|B1|||Potassium||mEq/L|Mean|4.1|4.1|Standard Deviation|0.2|0.2|||
3930078|NCT01405456|3752423|B3|||Flow Mediated Vasodilation|Flow mediated vasodilation obtained at the brachial artery.|percentage of maximum change|Median|13.0|13.0|Inter-Quartile Range|||10.7|17.6|
3930079|NCT01405456|3752424|B2|||Flow Mediated Vasodilation|Flow mediated vasodilation obtained at the brachial artery.|percentage of maximum change|Median|13.4|13.4|Inter-Quartile Range|||10.8|17.6|
3930080|NCT01405456|3752425|B1|||Flow Mediated Vasodilation|Flow mediated vasodilation obtained at the brachial artery.|percentage of maximum change|Median|13.0|13.0|Inter-Quartile Range|||9.7|19.3|
3930081|NCT01405456|3752423|B3|||Intramyocellular Lipid|Intramyocellular lipid of the tibialis anterior muscle obtained by MRS.|percentage of intramyocellular lipid|Median|0.4|0.4|Inter-Quartile Range|||0.2|0.5|
3930082|NCT01405456|3752424|B2|||Intramyocellular Lipid|Intramyocellular lipid of the tibialis anterior muscle obtained by MRS.|percentage of intramyocellular lipid|Median|0.3|0.3|Inter-Quartile Range|||0.2|0.5|
3930083|NCT01405456|3752425|B1|||Intramyocellular Lipid|Intramyocellular lipid of the tibialis anterior muscle obtained by MRS.|percentage of intramyocellular lipid|Median|0.5|0.5|Inter-Quartile Range|||0.2|0.6|
3930084|NCT01405456|3752423|B3|||Liver Fat|Intrahepatic lipid obtained by MRS.|percentage of intrahepatic lipid|Median|5|5.0|Inter-Quartile Range|||3.0|12.0|
3930085|NCT01405456|3752424|B2|||Liver Fat|Intrahepatic lipid obtained by MRS.|percentage of intrahepatic lipid|Median|5|5.0|Inter-Quartile Range|||2.0|12.0|
3930086|NCT01405456|3752425|B1|||Liver Fat|Intrahepatic lipid obtained by MRS.|percentage of intrahepatic lipid|Median|5|5.0|Inter-Quartile Range|||3.0|12.0|
3930087|NCT01405456|3752423|B3|||Visceral Adipose Tissue|Abdominal visceral fat obtained by MRI.|cm^2|Median|230|230.0|Inter-Quartile Range|||154.0|308.0|
3930088|NCT01405456|3752424|B2|||Visceral Adipose Tissue|Abdominal visceral fat obtained by MRI.|cm^2|Median|241|241.0|Inter-Quartile Range|||147.0|295.0|
3930089|NCT01405456|3752425|B1|||Visceral Adipose Tissue|Abdominal visceral fat obtained by MRI.|cm^2|Median|215|215.0|Inter-Quartile Range|||154.0|324.0|
3930090|NCT01405456|3752423|B3|||Insulin Stimulated Glucose Uptake|Insulin stimulated glucose uptake at steady state using the euglycemic hyperinsulinemic clamp technique normalized to insulin and lean body mass.|mg/min per μIU/ml|Median|7.44|7.44|Inter-Quartile Range|||5.64|9.87|
3930091|NCT01405456|3752424|B2|||Insulin Stimulated Glucose Uptake|Insulin stimulated glucose uptake at steady state using the euglycemic hyperinsulinemic clamp technique normalized to insulin and lean body mass.|mg/min per μIU/ml|Median|7.52|7.52|Inter-Quartile Range|||5.12|10.43|
3930092|NCT01405456|3752425|B1|||Insulin Stimulated Glucose Uptake|Insulin stimulated glucose uptake at steady state using the euglycemic hyperinsulinemic clamp technique normalized to insulin and lean body mass.|mg/min per μIU/ml|Median|7.26|7.26|Inter-Quartile Range|||5.74|9.55|
3930093|NCT01405456|3752423|B3|United States||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
3930094|NCT01405456|3752424|B2|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3930095|NCT01405456|3752425|B1|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3930096|NCT01405456|3752423|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3930097|NCT01405456|3752424|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3930098|NCT01405456|3752425|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930099|NCT01405456|3752423|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3930100|NCT01405456|3752424|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930101|NCT01405456|3752425|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3930102|NCT01405456|3752423|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3930103|NCT01405456|3752424|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3930104|NCT01405456|3752425|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3930105|NCT01405456|3752423|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3930106|NCT01405456|3752424|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3930107|NCT01405456|3752425|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3930108|NCT01405456|3752423|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930109|NCT01405456|3752424|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930110|NCT01405456|3752425|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930111|NCT01405456|3752423|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930112|NCT01405456|3752424|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930113|NCT01405456|3752425|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930114|NCT01405456|3752423|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930115|NCT01405456|3752424|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930116|NCT01405456|3752425|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930117|NCT01405456|3752423|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3930118|NCT01405456|3752424|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3930119|NCT01405456|3752425|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3930120|NCT01405456|3752423|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3930121|NCT01405456|3752424|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3930122|NCT01405456|3752425|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3930123|NCT01405456|3752423|B3|||Age||years|Mean|51|51.0|Standard Deviation|6|6.0|||
3930124|NCT01405456|3752424|B2|||Age||years|Mean|52|52.0|Standard Deviation|6|6.0|||
3930125|NCT01405456|3752425|B1|||Age||years|Mean|49|49.0|Standard Deviation|6|6.0|||
3930126|NCT01405313|3752454|B1|Germany||Region of Enrollment||participants|Number|21|21.0||||||
3930127|NCT01405313|3752454|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3930128|NCT01405313|3752454|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3930129|NCT01405313|3752454|B1|||Age||years|Mean|69.9|69.9|Standard Deviation|8.7|8.7|||
3930130|NCT01405313|3752454|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3930131|NCT01405313|3752454|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3930132|NCT01405313|3752454|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3930133|NCT01405196|3752462|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3930134|NCT01405196|3752463|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3930135|NCT01405196|3752464|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3930136|NCT01405196|3752465|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3930137|NCT01405196|3752466|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3930138|NCT01405196|3752462|B5||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3930139|NCT01405196|3752463|B4||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3930140|NCT01405196|3752464|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3930141|NCT01405196|3752465|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3930142|NCT01405196|3752466|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3930143|NCT01405196|3752462|B5|||Age||Years|Mean|40.4|40.4|Standard Deviation|11.60|11.6|||
3930144|NCT01405196|3752463|B4|||Age||Years|Mean|42.3|42.3|Standard Deviation|13.04|13.04|||
3930145|NCT01405196|3752464|B3|||Age||Years|Mean|41.3|41.3|Standard Deviation|11.29|11.29|||
3930146|NCT01405196|3752465|B2|||Age||Years|Mean|38.3|38.3|Standard Deviation|10.49|10.49|||
3930147|NCT01405196|3752466|B1|||Age||Years|Mean|39.9|39.9|Standard Deviation|11.48|11.48|||
3930148|NCT01405027|3752554|B3|Missing||Hepatitis C Virus Genotype||participants|Number|2|2.0||||||
3930149|NCT01405027|3752555|B2|Missing||Hepatitis C Virus Genotype||participants|Number|2|2.0||||||
3930150|NCT01405027|3752556|B1|Missing||Hepatitis C Virus Genotype||participants|Number|0|0.0||||||
3930151|NCT01405027|3752554|B3|1b||Hepatitis C Virus Genotype||participants|Number|57|57.0||||||
3930152|NCT01405027|3752555|B2|1b||Hepatitis C Virus Genotype||participants|Number|35|35.0||||||
3930153|NCT01405027|3752556|B1|1b||Hepatitis C Virus Genotype||participants|Number|22|22.0||||||
3930154|NCT01405027|3752554|B3|1a||Hepatitis C Virus Genotype||participants|Number|138|138.0||||||
3930155|NCT01405027|3752555|B2|1a||Hepatitis C Virus Genotype||participants|Number|76|76.0||||||
3930156|NCT01405027|3752556|B1|1a||Hepatitis C Virus Genotype||participants|Number|62|62.0||||||
3930157|NCT01405027|3752554|B3|Historic Null Responder||Patient Status||participants|Number|25|25.0||||||
3930158|NCT01405027|3752555|B2|Historic Null Responder||Patient Status||participants|Number|9|9.0||||||
3930159|NCT01405027|3752556|B1|Historic Null Responder||Patient Status||participants|Number|16|16.0||||||
3930160|NCT01405027|3752554|B3|Compensated Cirrhotic||Patient Status||participants|Number|17|17.0||||||
3930161|NCT01405027|3752555|B2|Compensated Cirrhotic||Patient Status||participants|Number|8|8.0||||||
3930162|NCT01405027|3752556|B1|Compensated Cirrhotic||Patient Status||participants|Number|9|9.0||||||
3930163|NCT01405027|3752554|B3|Relapsed||Patient Status||participants|Number|39|39.0||||||
3930164|NCT01405027|3752555|B2|Relapsed||Patient Status||participants|Number|22|22.0||||||
3930165|NCT01405027|3752556|B1|Relapsed||Patient Status||participants|Number|17|17.0||||||
3930166|NCT01405027|3752554|B3|Previous Partial Responder||Patient Status||participants|Number|17|17.0||||||
3930167|NCT01405027|3752555|B2|Previous Partial Responder||Patient Status||participants|Number|5|5.0||||||
3930168|NCT01405027|3752556|B1|Previous Partial Responder||Patient Status||participants|Number|12|12.0||||||
3930169|NCT01405027|3752554|B3|Treatment Naive||Patient Status||participants|Number|99|99.0||||||
3930170|NCT01405027|3752555|B2|Treatment Naive||Patient Status||participants|Number|69|69.0||||||
3930171|NCT01405027|3752556|B1|Treatment Naive||Patient Status||participants|Number|30|30.0||||||
3930172|NCT01405027|3752554|B3|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3930173|NCT01405027|3752555|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3930174|NCT01405027|3752556|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3930175|NCT01405027|3752554|B3|Latino||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3930176|NCT01405027|3752555|B2|Latino||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3930177|NCT01405027|3752556|B1|Latino||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3930178|NCT01405027|3752554|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3930179|NCT01405027|3752555|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3930180|NCT01405027|3752556|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3930181|NCT01405027|3752554|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
3930182|NCT01405027|3752555|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3930183|NCT01405027|3752556|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3930184|NCT01405027|3752554|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|125|125.0||||||
3930185|NCT01405027|3752555|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|75|75.0||||||
3930186|NCT01405027|3752556|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
3930187|NCT01405027|3752554|B3||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3930188|NCT01405027|3752555|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3930189|NCT01405027|3752556|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3930190|NCT01405027|3752554|B3||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3930191|NCT01405027|3752555|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3930192|NCT01405027|3752556|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3930193|NCT01405027|3752554|B3|||Age||years|Mean|52.0|52.0|Standard Deviation|11.29|11.29|||
3930194|NCT01405027|3752555|B2|||Age||years|Mean|51.7|51.7|Standard Deviation|11.27|11.27|||
3930195|NCT01405027|3752556|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|11.37|11.37|||
3930196|NCT01404988|3752571|B4|Not prescribed Beta Blockers||Prescribed Beta Blockers||participants|Number|8|8.0||||||
3930197|NCT01404988|3752572|B3|Not prescribed Beta Blockers||Prescribed Beta Blockers||participants|Number|5|5.0||||||
3930198|NCT01404988|3752573|B2|Not prescribed Beta Blockers||Prescribed Beta Blockers||participants|Number|2|2.0||||||
3930199|NCT01404988|3752574|B1|Not prescribed Beta Blockers||Prescribed Beta Blockers||participants|Number|1|1.0||||||
3930200|NCT01404988|3752571|B4|Prescribed Beta Blockers||Prescribed Beta Blockers||participants|Number|91|91.0||||||
3930201|NCT01404988|3752572|B3|Prescribed Beta Blockers||Prescribed Beta Blockers||participants|Number|28|28.0||||||
3930202|NCT01404988|3752573|B2|Prescribed Beta Blockers||Prescribed Beta Blockers||participants|Number|31|31.0||||||
3930203|NCT01404988|3752574|B1|Prescribed Beta Blockers||Prescribed Beta Blockers||participants|Number|32|32.0||||||
3930204|NCT01404988|3752571|B4|Not prescribed ACE and/or ARB||Prescribed ACE inhibitors or Angiotensin II Receptor Blockers (ABRs)||participants|Number|20|20.0||||||
3930205|NCT01404988|3752572|B3|Not prescribed ACE and/or ARB||Prescribed ACE inhibitors or Angiotensin II Receptor Blockers (ABRs)||participants|Number|2|2.0||||||
3930206|NCT01404988|3752573|B2|Not prescribed ACE and/or ARB||Prescribed ACE inhibitors or Angiotensin II Receptor Blockers (ABRs)||participants|Number|8|8.0||||||
3930207|NCT01404988|3752574|B1|Not prescribed ACE and/or ARB||Prescribed ACE inhibitors or Angiotensin II Receptor Blockers (ABRs)||participants|Number|10|10.0||||||
3930208|NCT01404988|3752571|B4|Prescribed ACE and/or ARB||Prescribed ACE inhibitors or Angiotensin II Receptor Blockers (ABRs)||participants|Number|79|79.0||||||
3930209|NCT01404988|3752572|B3|Prescribed ACE and/or ARB||Prescribed ACE inhibitors or Angiotensin II Receptor Blockers (ABRs)||participants|Number|31|31.0||||||
3930210|NCT01404988|3752573|B2|Prescribed ACE and/or ARB||Prescribed ACE inhibitors or Angiotensin II Receptor Blockers (ABRs)||participants|Number|25|25.0||||||
3930211|NCT01404988|3752574|B1|Prescribed ACE and/or ARB||Prescribed ACE inhibitors or Angiotensin II Receptor Blockers (ABRs)||participants|Number|23|23.0||||||
3930212|NCT01404988|3752571|B4|||Number of Heart Failure Medications||number of heart failure medications|Median|3.0|3.0|Inter-Quartile Range|||3.0|4.0|
3930213|NCT01404988|3752572|B3|||Number of Heart Failure Medications||number of heart failure medications|Median|3.0|3.0|Inter-Quartile Range|||3.0|4.0|
3930214|NCT01404988|3752573|B2|||Number of Heart Failure Medications||number of heart failure medications|Median|3.0|3.0|Inter-Quartile Range|||3.0|4.0|
3930215|NCT01404988|3752574|B1|||Number of Heart Failure Medications||number of heart failure medications|Median|3.0|3.0|Inter-Quartile Range|||2.0|4.0|
3930216|NCT01404988|3752571|B4|High Adherence||Medication Adherence|Self-reported adherence assessed using the Morisky Scale. A score of 0 was classified as high adherence, scores ranging from 1-2 were classified as medium adherence, and scores ranging from 3-8 were classified as low adherence.|participants|Number|36|36.0||||||
3930217|NCT01404988|3752572|B3|High Adherence||Medication Adherence|Self-reported adherence assessed using the Morisky Scale. A score of 0 was classified as high adherence, scores ranging from 1-2 were classified as medium adherence, and scores ranging from 3-8 were classified as low adherence.|participants|Number|14|14.0||||||
3930218|NCT01404988|3752573|B2|High Adherence||Medication Adherence|Self-reported adherence assessed using the Morisky Scale. A score of 0 was classified as high adherence, scores ranging from 1-2 were classified as medium adherence, and scores ranging from 3-8 were classified as low adherence.|participants|Number|9|9.0||||||
3930219|NCT01404988|3752574|B1|High Adherence||Medication Adherence|Self-reported adherence assessed using the Morisky Scale. A score of 0 was classified as high adherence, scores ranging from 1-2 were classified as medium adherence, and scores ranging from 3-8 were classified as low adherence.|participants|Number|13|13.0||||||
3930220|NCT01404988|3752571|B4|Medium Adherence||Medication Adherence|Self-reported adherence assessed using the Morisky Scale. A score of 0 was classified as high adherence, scores ranging from 1-2 were classified as medium adherence, and scores ranging from 3-8 were classified as low adherence.|participants|Number|45|45.0||||||
3930221|NCT01404988|3752572|B3|Medium Adherence||Medication Adherence|Self-reported adherence assessed using the Morisky Scale. A score of 0 was classified as high adherence, scores ranging from 1-2 were classified as medium adherence, and scores ranging from 3-8 were classified as low adherence.|participants|Number|15|15.0||||||
3930222|NCT01404988|3752573|B2|Medium Adherence||Medication Adherence|Self-reported adherence assessed using the Morisky Scale. A score of 0 was classified as high adherence, scores ranging from 1-2 were classified as medium adherence, and scores ranging from 3-8 were classified as low adherence.|participants|Number|15|15.0||||||
3930223|NCT01404988|3752574|B1|Medium Adherence||Medication Adherence|Self-reported adherence assessed using the Morisky Scale. A score of 0 was classified as high adherence, scores ranging from 1-2 were classified as medium adherence, and scores ranging from 3-8 were classified as low adherence.|participants|Number|15|15.0||||||
3930224|NCT01404988|3752571|B4|Low adherence||Medication Adherence|Self-reported adherence assessed using the Morisky Scale. A score of 0 was classified as high adherence, scores ranging from 1-2 were classified as medium adherence, and scores ranging from 3-8 were classified as low adherence.|participants|Number|18|18.0||||||
3930225|NCT01404988|3752572|B3|Low adherence||Medication Adherence|Self-reported adherence assessed using the Morisky Scale. A score of 0 was classified as high adherence, scores ranging from 1-2 were classified as medium adherence, and scores ranging from 3-8 were classified as low adherence.|participants|Number|4|4.0||||||
3930226|NCT01404988|3752573|B2|Low adherence||Medication Adherence|Self-reported adherence assessed using the Morisky Scale. A score of 0 was classified as high adherence, scores ranging from 1-2 were classified as medium adherence, and scores ranging from 3-8 were classified as low adherence.|participants|Number|9|9.0||||||
3930227|NCT01404988|3752574|B1|Low adherence||Medication Adherence|Self-reported adherence assessed using the Morisky Scale. A score of 0 was classified as high adherence, scores ranging from 1-2 were classified as medium adherence, and scores ranging from 3-8 were classified as low adherence.|participants|Number|5|5.0||||||
3930228|NCT01404988|3752571|B4|No History of IHD||Ischemic Heart Disease (IHD)|Self-reported history|participants|Number|97|97.0||||||
3930229|NCT01404988|3752572|B3|No History of IHD||Ischemic Heart Disease (IHD)|Self-reported history|participants|Number|32|32.0||||||
3930230|NCT01404988|3752573|B2|No History of IHD||Ischemic Heart Disease (IHD)|Self-reported history|participants|Number|32|32.0||||||
3930231|NCT01404988|3752574|B1|No History of IHD||Ischemic Heart Disease (IHD)|Self-reported history|participants|Number|33|33.0||||||
3930232|NCT01404988|3752571|B4|History of IHD||Ischemic Heart Disease (IHD)|Self-reported history|participants|Number|2|2.0||||||
3930233|NCT01404988|3752572|B3|History of IHD||Ischemic Heart Disease (IHD)|Self-reported history|participants|Number|1|1.0||||||
3930234|NCT01404988|3752573|B2|History of IHD||Ischemic Heart Disease (IHD)|Self-reported history|participants|Number|1|1.0||||||
3930235|NCT01404988|3752574|B1|History of IHD||Ischemic Heart Disease (IHD)|Self-reported history|participants|Number|0|0.0||||||
3930236|NCT01404988|3752571|B4|Brooklyn||Campus||participants|Number|60|60.0||||||
3930237|NCT01404988|3752572|B3|Brooklyn||Campus||participants|Number|20|20.0||||||
3930238|NCT01404988|3752573|B2|Brooklyn||Campus||participants|Number|21|21.0||||||
3930239|NCT01404988|3752574|B1|Brooklyn||Campus||participants|Number|19|19.0||||||
3930240|NCT01404988|3752571|B4|Manhattan||Campus||participants|Number|39|39.0||||||
3930241|NCT01404988|3752572|B3|Manhattan||Campus||participants|Number|13|13.0||||||
3930242|NCT01404988|3752573|B2|Manhattan||Campus||participants|Number|12|12.0||||||
3930243|NCT01404988|3752574|B1|Manhattan||Campus||participants|Number|14|14.0||||||
3930244|NCT01404988|3752571|B4|Not Employed||Employment Status||participants|Number|87|87.0||||||
3930245|NCT01404988|3752572|B3|Not Employed||Employment Status||participants|Number|28|28.0||||||
3930246|NCT01404988|3752573|B2|Not Employed||Employment Status||participants|Number|28|28.0||||||
3930247|NCT01404988|3752574|B1|Not Employed||Employment Status||participants|Number|31|31.0||||||
3930248|NCT01404988|3752571|B4|Employed||Employment Status||participants|Number|12|12.0||||||
3930249|NCT01404988|3752572|B3|Employed||Employment Status||participants|Number|5|5.0||||||
3930250|NCT01404988|3752573|B2|Employed||Employment Status||participants|Number|5|5.0||||||
3930251|NCT01404988|3752574|B1|Employed||Employment Status||participants|Number|2|2.0||||||
3930252|NCT01404988|3752571|B4|Some College or Higher||Education||participants|Number|90|90.0||||||
3930253|NCT01404988|3752572|B3|Some College or Higher||Education||participants|Number|31|31.0||||||
3930254|NCT01404988|3752573|B2|Some College or Higher||Education||participants|Number|29|29.0||||||
3930255|NCT01404988|3752574|B1|Some College or Higher||Education||participants|Number|30|30.0||||||
3930256|NCT01404988|3752571|B4|High School Graduate or Below||Education||participants|Number|9|9.0||||||
3930257|NCT01404988|3752572|B3|High School Graduate or Below||Education||participants|Number|2|2.0||||||
3930258|NCT01404988|3752573|B2|High School Graduate or Below||Education||participants|Number|4|4.0||||||
3930259|NCT01404988|3752574|B1|High School Graduate or Below||Education||participants|Number|3|3.0||||||
3930260|NCT01404988|3752571|B4|Not Married||Marital Status||participants|Number|33|33.0||||||
3930261|NCT01404988|3752572|B3|Not Married||Marital Status||participants|Number|8|8.0||||||
3930262|NCT01404988|3752573|B2|Not Married||Marital Status||participants|Number|17|17.0||||||
3930263|NCT01404988|3752574|B1|Not Married||Marital Status||participants|Number|8|8.0||||||
3930264|NCT01404988|3752571|B4|Married||Marital Status||participants|Number|66|66.0||||||
3930265|NCT01404988|3752572|B3|Married||Marital Status||participants|Number|25|25.0||||||
3930266|NCT01404988|3752573|B2|Married||Marital Status||participants|Number|16|16.0||||||
3930267|NCT01404988|3752574|B1|Married||Marital Status||participants|Number|25|25.0||||||
3930268|NCT01404988|3752571|B4|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3930269|NCT01404988|3752572|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3930270|NCT01404988|3752573|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3930271|NCT01404988|3752574|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3930272|NCT01404988|3752571|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3930273|NCT01404988|3752572|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3930274|NCT01404988|3752573|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3930275|NCT01404988|3752574|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3930276|NCT01404988|3752571|B4|Black (Non-Hispanic)||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3930277|NCT01404988|3752572|B3|Black (Non-Hispanic)||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3930278|NCT01404988|3752573|B2|Black (Non-Hispanic)||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3930279|NCT01404988|3752574|B1|Black (Non-Hispanic)||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3930280|NCT01404988|3752571|B4|White (Non-Hispanic)||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
3930281|NCT01404988|3752572|B3|White (Non-Hispanic)||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3930282|NCT01404988|3752573|B2|White (Non-Hispanic)||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3930283|NCT01404988|3752574|B1|White (Non-Hispanic)||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3930284|NCT01404988|3752571|B4||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3930285|NCT01404988|3752572|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3930286|NCT01404988|3752573|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3930287|NCT01404988|3752574|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3930288|NCT01404988|3752571|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3930289|NCT01404988|3752572|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3930290|NCT01404988|3752573|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3930291|NCT01404988|3752574|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3930292|NCT01404988|3752571|B4|||Age||years|Median|67.0|67.0|Inter-Quartile Range|||62.3|77.1|
3930293|NCT01404988|3752572|B3|||Age||years|Median|67.6|67.6|Inter-Quartile Range|||64.1|75.8|
3930294|NCT01404988|3752573|B2|||Age||years|Median|67.7|67.7|Inter-Quartile Range|||64.5|79.1|
3930295|NCT01404988|3752574|B1|||Age||years|Median|65.9|65.9|Inter-Quartile Range|||54.7|69.9|
3930296|NCT01404936|3752593|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3930297|NCT01404936|3752593|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3930298|NCT01404936|3752593|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3930299|NCT01404936|3752593|B1|||Age||years|Median|30|30.0|Full Range|||18.0|62.0|
3930300|NCT01404923|3752597|B3|France||Region of Enrollment||participants|Number|436|436.0||||||
3930301|NCT01404923|3752598|B2|France||Region of Enrollment||participants|Number|214|214.0||||||
3930302|NCT01404923|3752599|B1|France||Region of Enrollment||participants|Number|222|222.0||||||
3930303|NCT01404923|3752597|B3||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3930304|NCT01404923|3752598|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3930305|NCT01404923|3752599|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3930306|NCT01404923|3752597|B3||Female|Sex: Female, Male||Participants|Count of Participants|320|320.0||||||
3930307|NCT01404923|3752598|B2||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3930308|NCT01404923|3752599|B1||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3930309|NCT01404923|3752597|B3|||Age||years|Mean|54.4|54.4|Standard Deviation|15.6|15.6|||
3930310|NCT01404923|3752598|B2|||Age||years|Mean|55.1|55.1|Standard Deviation|16.2|16.2|||
3930311|NCT01404923|3752599|B1|||Age||years|Mean|53.8|53.8|Standard Deviation|14.9|14.9|||
3930312|NCT01404832|3752608|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3930313|NCT01404832|3752608|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3930314|NCT01404832|3752608|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3930315|NCT01404832|3752608|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3930316|NCT01404832|3752608|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3930317|NCT01404832|3752608|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3930318|NCT01404650|3752613|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3930319|NCT01404650|3752613|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930320|NCT01404650|3752613|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930321|NCT01404650|3752613|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3930322|NCT01404650|3752613|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3930323|NCT01404650|3752613|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930324|NCT01404650|3752613|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930325|NCT01404650|3752613|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930326|NCT01404650|3752613|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3930327|NCT01404650|3752613|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3930328|NCT01404650|3752613|B1|||Age||years|Median|63|63.0|Full Range|||20.0|79.0|
3930329|NCT01404650|3752613|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3930330|NCT01404650|3752613|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3930331|NCT01404650|3752613|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3930332|NCT01404611|3752620|B4||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
3930333|NCT01404611|3752621|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3930334|NCT01404611|3752622|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3930335|NCT01404611|3752623|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3930336|NCT01404611|3752620|B4||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3930337|NCT01404611|3752621|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3930338|NCT01404611|3752622|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3930339|NCT01404611|3752623|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3930340|NCT01404611|3752620|B4|||Age||years|Mean|3.2|3.2|Standard Deviation|2.4|2.4|||
3930341|NCT01404611|3752621|B3|||Age||years|Mean|3.2|3.2|Standard Deviation|2.5|2.5|||
3930342|NCT01404611|3752622|B2|||Age||years|Mean|3.2|3.2|Standard Deviation|2.3|2.3|||
3930343|NCT01404611|3752623|B1|||Age||years|Mean|3.3|3.3|Standard Deviation|2.4|2.4|||
3930344|NCT01404611|3752620|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3930345|NCT01404611|3752621|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3930346|NCT01404611|3752622|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3930347|NCT01404611|3752623|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3930348|NCT01404611|3752620|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3930349|NCT01404611|3752621|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3930350|NCT01404611|3752622|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3930351|NCT01404611|3752623|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3930352|NCT01404611|3752620|B4||<=18 years|Age||Participants|Count of Participants|331|331.0||||||
3930353|NCT01404611|3752621|B3||<=18 years|Age||Participants|Count of Participants|111|111.0||||||
3930354|NCT01404611|3752622|B2||<=18 years|Age||Participants|Count of Participants|108|108.0||||||
3930355|NCT01404611|3752623|B1||<=18 years|Age||Participants|Count of Participants|112|112.0||||||
3930356|NCT01404572|3752633|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3930357|NCT01404572|3752633|B1|Native Hawaiian or other Pacfic Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3930358|NCT01404572|3752633|B1|American Indian or Alaska native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3930359|NCT01404572|3752633|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3930360|NCT01404572|3752633|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3930361|NCT01404572|3752633|B1|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3930362|NCT01404572|3752633|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930363|NCT01404572|3752633|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3930364|NCT01404572|3752633|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930365|NCT01404572|3752633|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3930366|NCT01404572|3752633|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3930367|NCT01404572|3752633|B1|||Age||years|Mean|30.7|30.7|Standard Deviation|8.56|8.56|||
3930368|NCT01404559|3752664|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
3930369|NCT01404559|3752665|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3930370|NCT01404559|3752666|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3930371|NCT01404559|3752664|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3930372|NCT01404559|3752665|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3930373|NCT01404559|3752666|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3930374|NCT01404559|3752664|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3930375|NCT01404559|3752665|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3930376|NCT01404559|3752666|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3930377|NCT01404559|3752664|B3|||Age||years|Mean|33.2|33.2|Standard Deviation|5.7|5.7|||
3930378|NCT01404559|3752665|B2|||Age||years|Mean|38.5|38.5|Standard Deviation|5.1|5.1|||
3930379|NCT01404559|3752666|B1|||Age||years|Mean|31.4|31.4|Standard Deviation|5.9|5.9|||
3930380|NCT01404429|3752680|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3930381|NCT01404429|3752681|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3930382|NCT01404429|3752682|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3930383|NCT01404429|3752680|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3930384|NCT01404429|3752681|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3930385|NCT01404429|3752682|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3930386|NCT01404429|3752680|B3|||Age||years|Mean|43.6|43.6|Standard Deviation|10.8|10.8|||
3930387|NCT01404429|3752681|B2|||Age||years|Mean|42.8|42.8|Standard Deviation|11.2|11.2|||
3930388|NCT01404429|3752682|B1|||Age||years|Mean|44.5|44.5|Standard Deviation|10.3|10.3|||
3930389|NCT01404312|3752695|B3||Not Reported|HIV-1 RNA Viral load among participants on ART at entry|Undetectable defined as HIV-1 RNA < 40 copies/mL|Participants|Count of Participants|53|53.0||||||
3930390|NCT01404312|3752696|B2||Not Reported|HIV-1 RNA Viral load among participants on ART at entry|Undetectable defined as HIV-1 RNA < 40 copies/mL|Participants|Count of Participants|26|26.0||||||
3930391|NCT01404312|3752697|B1||Not Reported|HIV-1 RNA Viral load among participants on ART at entry|Undetectable defined as HIV-1 RNA < 40 copies/mL|Participants|Count of Participants|27|27.0||||||
3930392|NCT01404312|3752695|B3||Undetectable|HIV-1 RNA Viral load among participants on ART at entry|Undetectable defined as HIV-1 RNA < 40 copies/mL|Participants|Count of Participants|1155|1155.0||||||
3930393|NCT01404312|3752696|B2||Undetectable|HIV-1 RNA Viral load among participants on ART at entry|Undetectable defined as HIV-1 RNA < 40 copies/mL|Participants|Count of Participants|586|586.0||||||
3930394|NCT01404312|3752697|B1||Undetectable|HIV-1 RNA Viral load among participants on ART at entry|Undetectable defined as HIV-1 RNA < 40 copies/mL|Participants|Count of Participants|569|569.0||||||
3930395|NCT01404312|3752695|B3||Detectable|HIV-1 RNA Viral load among participants on ART at entry|Undetectable defined as HIV-1 RNA < 40 copies/mL|Participants|Count of Participants|297|297.0||||||
3930396|NCT01404312|3752696|B2||Detectable|HIV-1 RNA Viral load among participants on ART at entry|Undetectable defined as HIV-1 RNA < 40 copies/mL|Participants|Count of Participants|143|143.0||||||
3930397|NCT01404312|3752697|B1||Detectable|HIV-1 RNA Viral load among participants on ART at entry|Undetectable defined as HIV-1 RNA < 40 copies/mL|Participants|Count of Participants|154|154.0||||||
3930398|NCT01404312|3752695|B3||Not on ART|Antiretroviral Therapy (ART) at Entry||Participants|Count of Participants|1495|1495.0||||||
3930399|NCT01404312|3752696|B2||Not on ART|Antiretroviral Therapy (ART) at Entry||Participants|Count of Participants|749|749.0||||||
3930400|NCT01404312|3752697|B1||Not on ART|Antiretroviral Therapy (ART) at Entry||Participants|Count of Participants|746|746.0||||||
3930401|NCT01404312|3752695|B3||Neither Efavirenz nor Nevirapine-based|Antiretroviral Therapy (ART) at Entry||Participants|Count of Participants|9|9.0||||||
3930402|NCT01404312|3752696|B2||Neither Efavirenz nor Nevirapine-based|Antiretroviral Therapy (ART) at Entry||Participants|Count of Participants|6|6.0||||||
3930403|NCT01404312|3752697|B1||Neither Efavirenz nor Nevirapine-based|Antiretroviral Therapy (ART) at Entry||Participants|Count of Participants|3|3.0||||||
3930404|NCT01404312|3752695|B3||Nevirapine-based|Antiretroviral Therapy (ART) at Entry||Participants|Count of Participants|197|197.0||||||
3930405|NCT01404312|3752696|B2||Nevirapine-based|Antiretroviral Therapy (ART) at Entry||Participants|Count of Participants|100|100.0||||||
3930406|NCT01404312|3752697|B1||Nevirapine-based|Antiretroviral Therapy (ART) at Entry||Participants|Count of Participants|97|97.0||||||
3930407|NCT01404312|3752695|B3||Efavirenz-based|Antiretroviral Therapy (ART) at Entry||Participants|Count of Participants|1299|1299.0||||||
3930408|NCT01404312|3752696|B2||Efavirenz-based|Antiretroviral Therapy (ART) at Entry||Participants|Count of Participants|649|649.0||||||
3930409|NCT01404312|3752697|B1||Efavirenz-based|Antiretroviral Therapy (ART) at Entry||Participants|Count of Participants|650|650.0||||||
3930410|NCT01404312|3752695|B3||>250 cells/mm^3|Screening CD4 counts||Participants|Count of Participants|2601|2601.0||||||
3930411|NCT01404312|3752696|B2||>250 cells/mm^3|Screening CD4 counts||Participants|Count of Participants|1302|1302.0||||||
3930412|NCT01404312|3752697|B1||>250 cells/mm^3|Screening CD4 counts||Participants|Count of Participants|1299|1299.0||||||
3930413|NCT01404312|3752695|B3||>=100,<=250 cells/mm^3|Screening CD4 counts||Participants|Count of Participants|325|325.0||||||
3930414|NCT01404312|3752696|B2||>=100,<=250 cells/mm^3|Screening CD4 counts||Participants|Count of Participants|165|165.0||||||
3930415|NCT01404312|3752697|B1||>=100,<=250 cells/mm^3|Screening CD4 counts||Participants|Count of Participants|160|160.0||||||
3930416|NCT01404312|3752695|B3||<100 cells/mm^3|Screening CD4 counts||Participants|Count of Participants|74|74.0||||||
3930417|NCT01404312|3752696|B2||<100 cells/mm^3|Screening CD4 counts||Participants|Count of Participants|37|37.0||||||
3930418|NCT01404312|3752697|B1||<100 cells/mm^3|Screening CD4 counts||Participants|Count of Participants|37|37.0||||||
3930419|NCT01404312|3752695|B3||No|Prior Tuberculosis History||Participants|Count of Participants|2829|2829.0||||||
3930420|NCT01404312|3752696|B2||No|Prior Tuberculosis History||Participants|Count of Participants|1415|1415.0||||||
3930421|NCT01404312|3752697|B1||No|Prior Tuberculosis History||Participants|Count of Participants|1414|1414.0||||||
3930422|NCT01404312|3752695|B3||Yes|Prior Tuberculosis History||Participants|Count of Participants|171|171.0||||||
3930423|NCT01404312|3752696|B2||Yes|Prior Tuberculosis History||Participants|Count of Participants|89|89.0||||||
3930424|NCT01404312|3752697|B1||Yes|Prior Tuberculosis History||Participants|Count of Participants|82|82.0||||||
3930425|NCT01404312|3752695|B3||Previously|IV Drug Use||Participants|Count of Participants|11|11.0||||||
3930426|NCT01404312|3752696|B2||Previously|IV Drug Use||Participants|Count of Participants|6|6.0||||||
3930427|NCT01404312|3752697|B1||Previously|IV Drug Use||Participants|Count of Participants|5|5.0||||||
3930428|NCT01404312|3752695|B3||Currently|IV Drug Use||Participants|Count of Participants|3|3.0||||||
3930429|NCT01404312|3752696|B2||Currently|IV Drug Use||Participants|Count of Participants|1|1.0||||||
3930430|NCT01404312|3752697|B1||Currently|IV Drug Use||Participants|Count of Participants|2|2.0||||||
3930431|NCT01404312|3752695|B3||Never|IV Drug Use||Participants|Count of Participants|2986|2986.0||||||
3930432|NCT01404312|3752696|B2||Never|IV Drug Use||Participants|Count of Participants|1497|1497.0||||||
3930433|NCT01404312|3752697|B1||Never|IV Drug Use||Participants|Count of Participants|1489|1489.0||||||
3930434|NCT01404312|3752695|B3|||Body Mass Index (BMI)||kg/m^2|Mean|24.5|24.5|Standard Deviation|5.2|5.2|||
3930435|NCT01404312|3752696|B2|||Body Mass Index (BMI)||kg/m^2|Mean|24.5|24.5|Standard Deviation|5.3|5.3|||
3930436|NCT01404312|3752697|B1|||Body Mass Index (BMI)||kg/m^2|Mean|24.6|24.6|Standard Deviation|5.2|5.2|||
3930437|NCT01404312|3752695|B3|Peru||Region of Enrollment||participants|Number|515|515.0||||||
3930438|NCT01404312|3752696|B2|Peru||Region of Enrollment||participants|Number|257|257.0||||||
3930439|NCT01404312|3752697|B1|Peru||Region of Enrollment||participants|Number|258|258.0||||||
3930440|NCT01404312|3752695|B3|Thailand||Region of Enrollment||participants|Number|245|245.0||||||
3930441|NCT01404312|3752696|B2|Thailand||Region of Enrollment||participants|Number|124|124.0||||||
3930442|NCT01404312|3752697|B1|Thailand||Region of Enrollment||participants|Number|121|121.0||||||
3930443|NCT01404312|3752695|B3|Kenya||Region of Enrollment||participants|Number|187|187.0||||||
3930444|NCT01404312|3752696|B2|Kenya||Region of Enrollment||participants|Number|94|94.0||||||
3930445|NCT01404312|3752697|B1|Kenya||Region of Enrollment||participants|Number|93|93.0||||||
3930446|NCT01404312|3752695|B3|Zimbabwe||Region of Enrollment||participants|Number|114|114.0||||||
3930447|NCT01404312|3752696|B2|Zimbabwe||Region of Enrollment||participants|Number|58|58.0||||||
3930448|NCT01404312|3752697|B1|Zimbabwe||Region of Enrollment||participants|Number|56|56.0||||||
3930449|NCT01404312|3752695|B3|South Africa||Region of Enrollment||participants|Number|616|616.0||||||
3930450|NCT01404312|3752696|B2|South Africa||Region of Enrollment||participants|Number|309|309.0||||||
3930451|NCT01404312|3752697|B1|South Africa||Region of Enrollment||participants|Number|307|307.0||||||
3930452|NCT01404312|3752695|B3|Brazil||Region of Enrollment||participants|Number|200|200.0||||||
3930453|NCT01404312|3752696|B2|Brazil||Region of Enrollment||participants|Number|98|98.0||||||
3930454|NCT01404312|3752697|B1|Brazil||Region of Enrollment||participants|Number|102|102.0||||||
3930455|NCT01404312|3752695|B3|Botswana||Region of Enrollment||participants|Number|422|422.0||||||
3930456|NCT01404312|3752696|B2|Botswana||Region of Enrollment||participants|Number|212|212.0||||||
3930457|NCT01404312|3752697|B1|Botswana||Region of Enrollment||participants|Number|210|210.0||||||
3930458|NCT01404312|3752695|B3|Malawi||Region of Enrollment||participants|Number|214|214.0||||||
3930459|NCT01404312|3752696|B2|Malawi||Region of Enrollment||participants|Number|108|108.0||||||
3930460|NCT01404312|3752697|B1|Malawi||Region of Enrollment||participants|Number|106|106.0||||||
3930461|NCT01404312|3752695|B3|United States||Region of Enrollment||participants|Number|91|91.0||||||
3930462|NCT01404312|3752696|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
3930463|NCT01404312|3752697|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
3930464|NCT01404312|3752695|B3|Haiti||Region of Enrollment||participants|Number|396|396.0||||||
3930465|NCT01404312|3752696|B2|Haiti||Region of Enrollment||participants|Number|198|198.0||||||
3930466|NCT01404312|3752697|B1|Haiti||Region of Enrollment||participants|Number|198|198.0||||||
3930467|NCT01404312|3752695|B3|Race/Ethnicity|Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3930468|NCT01404312|3752696|B2|Race/Ethnicity|Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3930469|NCT01404312|3752697|B1|Race/Ethnicity|Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3930470|NCT01404312|3752695|B3|Race/Ethnicity|Asian, Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|250|250.0||||||
3930471|NCT01404312|3752696|B2|Race/Ethnicity|Asian, Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|128|128.0||||||
3930472|NCT01404312|3752697|B1|Race/Ethnicity|Asian, Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|122|122.0||||||
3930473|NCT01404312|3752695|B3|Race/Ethnicity|Hispanic (Regardless of Race)|Race/Ethnicity, Customized||Participants|Count of Participants|730|730.0||||||
3930474|NCT01404312|3752696|B2|Race/Ethnicity|Hispanic (Regardless of Race)|Race/Ethnicity, Customized||Participants|Count of Participants|369|369.0||||||
3930475|NCT01404312|3752697|B1|Race/Ethnicity|Hispanic (Regardless of Race)|Race/Ethnicity, Customized||Participants|Count of Participants|361|361.0||||||
3930476|NCT01404312|3752695|B3|Race/Ethnicity|Black Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1983|1983.0||||||
3930477|NCT01404312|3752696|B2|Race/Ethnicity|Black Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|991|991.0||||||
3930478|NCT01404312|3752697|B1|Race/Ethnicity|Black Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|992|992.0||||||
3930479|NCT01404312|3752695|B3|Race/Ethnicity|White Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3930480|NCT01404312|3752696|B2|Race/Ethnicity|White Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3930481|NCT01404312|3752697|B1|Race/Ethnicity|White Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3930482|NCT01404312|3752695|B3||Male|Sex: Female, Male||Participants|Count of Participants|1386|1386.0||||||
3930483|NCT01404312|3752696|B2||Male|Sex: Female, Male||Participants|Count of Participants|692|692.0||||||
3930484|NCT01404312|3752697|B1||Male|Sex: Female, Male||Participants|Count of Participants|694|694.0||||||
3930485|NCT01404312|3752695|B3||Female|Sex: Female, Male||Participants|Count of Participants|1614|1614.0||||||
3930486|NCT01404312|3752696|B2||Female|Sex: Female, Male||Participants|Count of Participants|812|812.0||||||
3930487|NCT01404312|3752697|B1||Female|Sex: Female, Male||Participants|Count of Participants|802|802.0||||||
3930488|NCT01404312|3752695|B3|Age at Entry|>50 years|Age, Customized||Participants|Count of Participants|267|267.0||||||
3930489|NCT01404312|3752696|B2|Age at Entry|>50 years|Age, Customized||Participants|Count of Participants|134|134.0||||||
3930490|NCT01404312|3752697|B1|Age at Entry|>50 years|Age, Customized||Participants|Count of Participants|133|133.0||||||
3930491|NCT01404312|3752695|B3|Age at Entry|>40, <=50 years|Age, Customized||Participants|Count of Participants|673|673.0||||||
3930492|NCT01404312|3752696|B2|Age at Entry|>40, <=50 years|Age, Customized||Participants|Count of Participants|331|331.0||||||
3930493|NCT01404312|3752697|B1|Age at Entry|>40, <=50 years|Age, Customized||Participants|Count of Participants|342|342.0||||||
3930494|NCT01404312|3752695|B3|Age at Entry|>30, <=40 years|Age, Customized||Participants|Count of Participants|1037|1037.0||||||
3930495|NCT01404312|3752696|B2|Age at Entry|>30, <=40 years|Age, Customized||Participants|Count of Participants|514|514.0||||||
3930496|NCT01404312|3752697|B1|Age at Entry|>30, <=40 years|Age, Customized||Participants|Count of Participants|523|523.0||||||
3930497|NCT01404312|3752695|B3|Age at Entry|>20, <=30 years|Age, Customized||Participants|Count of Participants|876|876.0||||||
3930498|NCT01404312|3752696|B2|Age at Entry|>20, <=30 years|Age, Customized||Participants|Count of Participants|455|455.0||||||
3930499|NCT01404312|3752697|B1|Age at Entry|>20, <=30 years|Age, Customized||Participants|Count of Participants|421|421.0||||||
3930500|NCT01404312|3752695|B3|Age at Entry|<=20 years|Age, Customized||Participants|Count of Participants|147|147.0||||||
3930501|NCT01404312|3752696|B2|Age at Entry|<=20 years|Age, Customized||Participants|Count of Participants|70|70.0||||||
3930502|NCT01404312|3752697|B1|Age at Entry|<=20 years|Age, Customized||Participants|Count of Participants|77|77.0||||||
3930503|NCT01404312|3752695|B3|||Age||years|Mean|35.7|35.7|Standard Deviation|10.3|10.3|||
3930504|NCT01404312|3752696|B2|||Age||years|Mean|35.6|35.6|Standard Deviation|10.3|10.3|||
3930505|NCT01404312|3752697|B1|||Age||years|Mean|35.7|35.7|Standard Deviation|10.3|10.3|||
3930506|NCT01404260|3752718|B3|China||Region of Enrollment||participants|Number|219|219.0||||||
3930507|NCT01404260|3752719|B2|China||Region of Enrollment||participants|Number|110|110.0||||||
3930508|NCT01404260|3752720|B1|China||Region of Enrollment||participants|Number|109|109.0||||||
3930509|NCT01404260|3752718|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930510|NCT01404260|3752719|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930511|NCT01404260|3752720|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930512|NCT01404260|3752718|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930513|NCT01404260|3752719|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930514|NCT01404260|3752720|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930515|NCT01404260|3752718|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930516|NCT01404260|3752719|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930517|NCT01404260|3752720|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930518|NCT01404260|3752718|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930519|NCT01404260|3752719|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930520|NCT01404260|3752720|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930521|NCT01404260|3752718|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930522|NCT01404260|3752719|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930523|NCT01404260|3752720|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930524|NCT01404260|3752718|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|219|219.0||||||
3930525|NCT01404260|3752719|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
3930526|NCT01404260|3752720|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|109|109.0||||||
3930527|NCT01404260|3752718|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930528|NCT01404260|3752719|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930529|NCT01404260|3752720|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930530|NCT01404260|3752718|B3||Male|Gender||Participants|Count of Participants|48|48.0||||||
3930531|NCT01404260|3752719|B2||Male|Gender||Participants|Count of Participants|27|27.0||||||
3930532|NCT01404260|3752720|B1||Male|Gender||Participants|Count of Participants|21|21.0||||||
3930533|NCT01404260|3752718|B3||Female|Gender||Participants|Count of Participants|171|171.0||||||
3930534|NCT01404260|3752719|B2||Female|Gender||Participants|Count of Participants|83|83.0||||||
3930535|NCT01404260|3752720|B1||Female|Gender||Participants|Count of Participants|88|88.0||||||
3930536|NCT01404260|3752718|B3|||Age||Years|Median|57|57.0|Full Range|||49.0|63.0|
3930537|NCT01404260|3752719|B2|||Age||Years|Median|58|58.0|Full Range|||50.0|63.0|
3930538|NCT01404260|3752720|B1|||Age||Years|Median|56|56.0|Full Range|||49.0|62.0|
3930539|NCT01404234|3752727|B1|Absent||Presence of Pseudomonas aeruginosa (PA)||participants|Number|3|3.0||||||
3930540|NCT01404234|3752727|B1|Present||Presence of Pseudomonas aeruginosa (PA)||participants|Number|58|58.0||||||
3930541|NCT01404234|3752727|B1|||CFQ-R RSS Score|Respiratory symptoms (eg, coughing, congestion, wheezing) were assessed with the Cystic Fibrosis Questionnaire – Revised (CFQ-R) Respiratory Symptoms Scale (RSS). The range of scores (units) was 0 to 100 with higher scores indicating fewer symptoms. Participants ≥ 6 years of age were analyzed at baseline for CFQ-R RSS (n = 51; data was missing for one participant).|units on a scale|Mean|71.73|71.73|Standard Deviation|17.327|17.327|||
3930542|NCT01404234|3752727|B1|||FEV25-75|FEF25-75 is defined as the forced expiratory flow from 25% to 75% of the FVC. Participants ≥ 6 years of age were analyzed at baseline for FEV25-75 (n = 52).|liters/sec|Mean|1.82|1.82|Standard Deviation|1.169|1.169|||
3930543|NCT01404234|3752727|B1|||Forced vital capacity (FVC)|FVC is defined as the volume of air that can forcibly be blown out after taking a full breath. Participants ≥ 6 years of age were analyzed at baseline for FVC (n = 52).|liters|Mean|2.11|2.11|Standard Deviation|0.687|0.687|||
3930544|NCT01404234|3752727|B1|||FEV1|FEV1 is defined as the maximal volume of air that can be exhaled in 1 second. Participants ≥ 6 years of age were analyzed at baseline for FEV1 (n = 52).|liters|Mean|1.67|1.67|Standard Deviation|0.627|0.627|||
3930545|NCT01404234|3752727|B1|||Forced expiratory volume in 1 second (FEV1) % predicted|FEV1 % predicted is defined as FEV1 of the patient divided by the average FEV1 in the population for any person of similar age, sex, race, and body composition. Participants ≥ 6 years of age were analyzed at baseline for FEV1 % predicted (n = 52).|percentage of FEV1 % predicted|Mean|80.31|80.31|Standard Deviation|19.494|19.494|||
3930546|NCT01404234|3752727|B1|||Body Mass Index (BMI)||kg/m^2|Mean|16.3|16.3|Standard Deviation|1.66|1.66|||
3930547|NCT01404234|3752727|B1|Italy||Region of Enrollment||participants|Number|6|6.0||||||
3930548|NCT01404234|3752727|B1|Germany||Region of Enrollment||participants|Number|5|5.0||||||
3930549|NCT01404234|3752727|B1|Poland||Region of Enrollment||participants|Number|11|11.0||||||
3930550|NCT01404234|3752727|B1|Spain||Region of Enrollment||participants|Number|5|5.0||||||
3930551|NCT01404234|3752727|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3930552|NCT01404234|3752727|B1|France||Region of Enrollment||participants|Number|5|5.0||||||
3930553|NCT01404234|3752727|B1|Not Permitted||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3930554|NCT01404234|3752727|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3930555|NCT01404234|3752727|B1|White||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
3930556|NCT01404234|3752727|B1|Black or African Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3930557|NCT01404234|3752727|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3930558|NCT01404234|3752727|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3930559|NCT01404234|3752727|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3930560|NCT01404234|3752727|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3930561|NCT01404234|3752727|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3930562|NCT01404234|3752727|B1|≥ 6 years to ≤ 12 years||Age, Customized||participants|Number|52|52.0||||||
3930563|NCT01404234|3752727|B1|≥ 2 years to < 6 years||Age, Customized||participants|Number|7|7.0||||||
3930564|NCT01404234|3752727|B1|< 2 years||Age, Customized||participants|Number|2|2.0||||||
3930565|NCT01404234|3752727|B1|||Age||years|Mean|9.0|9.0|Standard Deviation|2.94|2.94|||
3930566|NCT01404208|3752741|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3930567|NCT01404208|3752742|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3930568|NCT01404208|3752743|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3930569|NCT01404208|3752741|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930570|NCT01404208|3752742|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930571|NCT01404208|3752743|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930572|NCT01404208|3752741|B3||White|Race (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
3930573|NCT01404208|3752742|B2||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3930574|NCT01404208|3752743|B1||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3930575|NCT01404208|3752741|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3930576|NCT01404208|3752742|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3930577|NCT01404208|3752743|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3930578|NCT01404208|3752741|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930579|NCT01404208|3752742|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930580|NCT01404208|3752743|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930581|NCT01404208|3752741|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3930582|NCT01404208|3752742|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930583|NCT01404208|3752743|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3930584|NCT01404208|3752741|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930585|NCT01404208|3752742|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930586|NCT01404208|3752743|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930587|NCT01404208|3752741|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930588|NCT01404208|3752742|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930589|NCT01404208|3752743|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930590|NCT01404208|3752741|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
3930591|NCT01404208|3752742|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3930592|NCT01404208|3752743|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3930593|NCT01404208|3752741|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3930594|NCT01404208|3752742|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3930595|NCT01404208|3752743|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3930596|NCT01404208|3752741|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3930597|NCT01404208|3752742|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3930598|NCT01404208|3752743|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3930599|NCT01404208|3752741|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3930600|NCT01404208|3752742|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3930601|NCT01404208|3752743|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3930602|NCT01404208|3752741|B3|||Age||Years|Mean|12.40|12.4|Standard Deviation|2.95|2.95|||
3930603|NCT01404208|3752742|B2|||Age||Years|Mean|12.14|12.14|Standard Deviation|2.97|2.97|||
3930604|NCT01404208|3752743|B1|||Age||Years|Mean|12.67|12.67|Standard Deviation|2.94|2.94|||
3930605|NCT01404078|3752752|B3|India||Region of Enrollment||participants|Number|518|518.0||||||
3930606|NCT01404078|3752753|B2|India||Region of Enrollment||participants|Number|261|261.0||||||
3930607|NCT01404078|3752754|B1|India||Region of Enrollment||participants|Number|257|257.0||||||
3930608|NCT01404078|3752752|B3||Male|Sex: Female, Male||Participants|Count of Participants|307|307.0||||||
3930609|NCT01404078|3752753|B2||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3930610|NCT01404078|3752754|B1||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3930611|NCT01404078|3752752|B3||Female|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
3930612|NCT01404078|3752753|B2||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3930613|NCT01404078|3752754|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3930614|NCT01404078|3752752|B3|||Age||years|Mean|57.6|57.6|Standard Deviation|19.5|19.5|||
3930615|NCT01404078|3752753|B2|||Age||years|Mean|57.9|57.9|Standard Deviation|19.2|19.2|||
3930616|NCT01404078|3752754|B1|||Age||years|Mean|57.2|57.2|Standard Deviation|19.4|19.4|||
3930617|NCT01404039|3752761|B10||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3930618|NCT01404039|3752762|B9||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3930619|NCT01404039|3752763|B8||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3930620|NCT01404039|3752764|B7||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3930621|NCT01404039|3752765|B6||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3930622|NCT01404039|3752766|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3930623|NCT01404039|3752767|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3930624|NCT01404039|3752768|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3930625|NCT01404039|3752769|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3930626|NCT01404039|3752770|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3930627|NCT01404039|3752761|B10||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3930628|NCT01404039|3752762|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3930629|NCT01404039|3752763|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3930630|NCT01404039|3752764|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3930631|NCT01404039|3752765|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3930632|NCT01404039|3752766|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3930633|NCT01404039|3752767|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3930634|NCT01404039|3752768|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3930635|NCT01404039|3752769|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3930636|NCT01404039|3752770|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3930637|NCT01404039|3752761|B10||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3930638|NCT01404039|3752762|B9||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3930639|NCT01404039|3752763|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3930640|NCT01404039|3752764|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3930641|NCT01404039|3752765|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3930642|NCT01404039|3752766|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3930643|NCT01404039|3752767|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3930644|NCT01404039|3752768|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3930645|NCT01404039|3752769|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3930646|NCT01404039|3752770|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3930647|NCT01404039|3752761|B10||Between 18 and 65 years|Age||Participants|Count of Participants|115|115.0||||||
3930648|NCT01404039|3752762|B9||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3930649|NCT01404039|3752763|B8||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3930650|NCT01404039|3752764|B7||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3930651|NCT01404039|3752765|B6||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3930652|NCT01404039|3752766|B5||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3930653|NCT01404039|3752767|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3930654|NCT01404039|3752768|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3930655|NCT01404039|3752769|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3930656|NCT01404039|3752770|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3930657|NCT01404039|3752761|B10||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3930658|NCT01404039|3752762|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3930659|NCT01404039|3752763|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3930660|NCT01404039|3752764|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3930661|NCT01404039|3752765|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3930662|NCT01404039|3752766|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3930663|NCT01404039|3752767|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3930664|NCT01404039|3752768|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3930665|NCT01404039|3752769|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3930666|NCT01404039|3752770|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3930667|NCT01403987|3752806|B4|United States||Region of Enrollment||participants|Number|136|136.0||||||
3930668|NCT01403987|3752807|B3|United States||Region of Enrollment||participants|Number|68|68.0||||||
3930669|NCT01403987|3752808|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
3930670|NCT01403987|3752809|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
3930671|NCT01403987|3752806|B4|||Sex/Gender, Customized|Gender was not captured as a requirement of our IRB to limit ability to identify participants.|Number of participants|Number|0|0.0||||||
3930672|NCT01403987|3752807|B3|||Sex/Gender, Customized|Gender was not captured as a requirement of our IRB to limit ability to identify participants.|Number of participants|Number|NA|||||||IRB would not allow capture of data
3930673|NCT01403987|3752808|B2|||Sex/Gender, Customized|Gender was not captured as a requirement of our IRB to limit ability to identify participants.|Number of participants|Number|NA|||||||IRB would not allow capture of data
3930674|NCT01403987|3752809|B1|||Sex/Gender, Customized|Gender was not captured as a requirement of our IRB to limit ability to identify participants.|Number of participants|Number|NA|||||||IRB would not allow capture of data
3930675|NCT01403987|3752806|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3930676|NCT01403987|3752807|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3930677|NCT01403987|3752808|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3930678|NCT01403987|3752809|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3930679|NCT01403987|3752806|B4||Between 18 and 65 years|Age||Participants|Count of Participants|136|136.0||||||
3930680|NCT01403987|3752807|B3||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
3930681|NCT01403987|3752808|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3930682|NCT01403987|3752809|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3930683|NCT01403987|3752806|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3930684|NCT01403987|3752807|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3930685|NCT01403987|3752808|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3930686|NCT01403987|3752809|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3930687|NCT01403805|3752825|B3|Japan||Region of Enrollment||participants|Number|199|199.0||||||
3930688|NCT01403805|3752826|B2|Japan||Region of Enrollment||participants|Number|105|105.0||||||
3930689|NCT01403805|3752827|B1|Japan||Region of Enrollment||participants|Number|94|94.0||||||
3930690|NCT01403805|3752825|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3930691|NCT01403805|3752826|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3930692|NCT01403805|3752827|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3930693|NCT01403805|3752825|B3||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3930694|NCT01403805|3752826|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3930695|NCT01403805|3752827|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3930696|NCT01403805|3752825|B3|||Age||years|Mean|85.5|85.5|Standard Deviation|7.56|7.56|||
3930697|NCT01403805|3752826|B2|||Age||years|Mean|86.0|86.0|Standard Deviation|7.64|7.64|||
3930698|NCT01403805|3752827|B1|||Age||years|Mean|85.0|85.0|Standard Deviation|7.48|7.48|||
3930699|NCT01403805|3752825|B3||>=65 years|Age||Participants|Count of Participants|197|197.0||||||
3930700|NCT01403805|3752826|B2||>=65 years|Age||Participants|Count of Participants|105|105.0||||||
3930701|NCT01403805|3752827|B1||>=65 years|Age||Participants|Count of Participants|92|92.0||||||
3930702|NCT01403805|3752825|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3930703|NCT01403805|3752826|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3930704|NCT01403805|3752827|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3930705|NCT01403805|3752825|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3930706|NCT01403805|3752826|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3930707|NCT01403805|3752827|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3930708|NCT01403441|3752840|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3930709|NCT01403441|3752840|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3930710|NCT01403441|3752840|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3930711|NCT01403441|3752840|B1|||Age||years|Mean|50.3|50.3|Standard Deviation|10.3|10.3|||
3930712|NCT01403441|3752840|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3930713|NCT01403441|3752840|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3930714|NCT01403441|3752840|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3930715|NCT01403376|3752847|B4|≥40||pre-vaccination antibody titer - B strain||participants|Number|82|82.0||||||
3930716|NCT01403376|3752848|B3|≥40||pre-vaccination antibody titer - B strain||participants|Number|25|25.0||||||
3930717|NCT01403376|3752849|B2|≥40||pre-vaccination antibody titer - B strain||participants|Number|28|28.0||||||
3930718|NCT01403376|3752850|B1|≥40||pre-vaccination antibody titer - B strain||participants|Number|29|29.0||||||
3930719|NCT01403376|3752847|B4|Between 10 and 40 (<)||pre-vaccination antibody titer - B strain||participants|Number|46|46.0||||||
3930720|NCT01403376|3752848|B3|Between 10 and 40 (<)||pre-vaccination antibody titer - B strain||participants|Number|21|21.0||||||
3930721|NCT01403376|3752849|B2|Between 10 and 40 (<)||pre-vaccination antibody titer - B strain||participants|Number|13|13.0||||||
3930722|NCT01403376|3752850|B1|Between 10 and 40 (<)||pre-vaccination antibody titer - B strain||participants|Number|12|12.0||||||
3930723|NCT01403376|3752847|B4|<10||pre-vaccination antibody titer - B strain||participants|Number|0|0.0||||||
3930724|NCT01403376|3752848|B3|<10||pre-vaccination antibody titer - B strain||participants|Number|0|0.0||||||
3930725|NCT01403376|3752849|B2|<10||pre-vaccination antibody titer - B strain||participants|Number|0|0.0||||||
3930726|NCT01403376|3752850|B1|<10||pre-vaccination antibody titer - B strain||participants|Number|0|0.0||||||
3930727|NCT01403376|3752847|B4|≥40||pre-vaccination antibody titer - H3N2 strain||participants|Number|68|68.0||||||
3930728|NCT01403376|3752848|B3|≥40||pre-vaccination antibody titer - H3N2 strain||participants|Number|22|22.0||||||
3930729|NCT01403376|3752849|B2|≥40||pre-vaccination antibody titer - H3N2 strain||participants|Number|23|23.0||||||
3930730|NCT01403376|3752850|B1|≥40||pre-vaccination antibody titer - H3N2 strain||participants|Number|23|23.0||||||
3930731|NCT01403376|3752847|B4|Between 10 and 40 (<)||pre-vaccination antibody titer - H3N2 strain||participants|Number|53|53.0||||||
3930732|NCT01403376|3752848|B3|Between 10 and 40 (<)||pre-vaccination antibody titer - H3N2 strain||participants|Number|22|22.0||||||
3930733|NCT01403376|3752849|B2|Between 10 and 40 (<)||pre-vaccination antibody titer - H3N2 strain||participants|Number|15|15.0||||||
3930734|NCT01403376|3752850|B1|Between 10 and 40 (<)||pre-vaccination antibody titer - H3N2 strain||participants|Number|16|16.0||||||
3930735|NCT01403376|3752847|B4|<10||pre-vaccination antibody titer - H3N2 strain||participants|Number|7|7.0||||||
3930736|NCT01403376|3752848|B3|<10||pre-vaccination antibody titer - H3N2 strain||participants|Number|2|2.0||||||
3930737|NCT01403376|3752849|B2|<10||pre-vaccination antibody titer - H3N2 strain||participants|Number|3|3.0||||||
3930738|NCT01403376|3752850|B1|<10||pre-vaccination antibody titer - H3N2 strain||participants|Number|2|2.0||||||
3930739|NCT01403376|3752847|B4|≥40||pre-vaccination antibody titer - H1N1 strain|H1N1, H3N2 and B were the strains contained in the seasonal influenza vaccine used.|participants|Number|111|111.0||||||
3930740|NCT01403376|3752848|B3|≥40||pre-vaccination antibody titer - H1N1 strain|H1N1, H3N2 and B were the strains contained in the seasonal influenza vaccine used.|participants|Number|41|41.0||||||
3930741|NCT01403376|3752849|B2|≥40||pre-vaccination antibody titer - H1N1 strain|H1N1, H3N2 and B were the strains contained in the seasonal influenza vaccine used.|participants|Number|36|36.0||||||
3930742|NCT01403376|3752850|B1|≥40||pre-vaccination antibody titer - H1N1 strain|H1N1, H3N2 and B were the strains contained in the seasonal influenza vaccine used.|participants|Number|34|34.0||||||
3930743|NCT01403376|3752847|B4|Between 10 and 40 (<)||pre-vaccination antibody titer - H1N1 strain|H1N1, H3N2 and B were the strains contained in the seasonal influenza vaccine used.|participants|Number|16|16.0||||||
3930744|NCT01403376|3752848|B3|Between 10 and 40 (<)||pre-vaccination antibody titer - H1N1 strain|H1N1, H3N2 and B were the strains contained in the seasonal influenza vaccine used.|participants|Number|5|5.0||||||
3930745|NCT01403376|3752849|B2|Between 10 and 40 (<)||pre-vaccination antibody titer - H1N1 strain|H1N1, H3N2 and B were the strains contained in the seasonal influenza vaccine used.|participants|Number|4|4.0||||||
3930746|NCT01403376|3752850|B1|Between 10 and 40 (<)||pre-vaccination antibody titer - H1N1 strain|H1N1, H3N2 and B were the strains contained in the seasonal influenza vaccine used.|participants|Number|7|7.0||||||
3930747|NCT01403376|3752847|B4|<10||pre-vaccination antibody titer - H1N1 strain|H1N1, H3N2 and B were the strains contained in the seasonal influenza vaccine used.|participants|Number|1|1.0||||||
3930806|NCT01403051|3752892|B3|United States||Region of Enrollment||participants|Number|165|165.0||||||
3930748|NCT01403376|3752848|B3|<10||pre-vaccination antibody titer - H1N1 strain|H1N1, H3N2 and B were the strains contained in the seasonal influenza vaccine used.|participants|Number|0|0.0||||||
3930749|NCT01403376|3752849|B2|<10||pre-vaccination antibody titer - H1N1 strain|H1N1, H3N2 and B were the strains contained in the seasonal influenza vaccine used.|participants|Number|1|1.0||||||
3930750|NCT01403376|3752850|B1|<10||pre-vaccination antibody titer - H1N1 strain|H1N1, H3N2 and B were the strains contained in the seasonal influenza vaccine used.|participants|Number|0|0.0||||||
3930751|NCT01403376|3752847|B4||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3930752|NCT01403376|3752848|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3930753|NCT01403376|3752849|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3930754|NCT01403376|3752850|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3930755|NCT01403376|3752847|B4||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3930756|NCT01403376|3752848|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3930757|NCT01403376|3752849|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3930758|NCT01403376|3752850|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3930759|NCT01403376|3752847|B4|||Age||years|Mean|45.0|45.0|Standard Deviation|9.2|9.2|||
3930760|NCT01403376|3752848|B3|||Age||years|Mean|45.1|45.1|Standard Deviation|10.8|10.8|||
3930761|NCT01403376|3752849|B2|||Age||years|Mean|43.8|43.8|Standard Deviation|8.5|8.5|||
3930762|NCT01403376|3752850|B1|||Age||years|Mean|46.1|46.1|Standard Deviation|7.9|7.9|||
3930763|NCT01403194|3752872|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3930764|NCT01403194|3752872|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3930765|NCT01403194|3752872|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3930766|NCT01403194|3752872|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3930767|NCT01403194|3752872|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3930768|NCT01403194|3752872|B1||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
3930769|NCT01403116|3752878|B3|Germany||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3930770|NCT01403116|3752879|B2|Germany||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3930771|NCT01403116|3752880|B1|Germany||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3930772|NCT01403116|3752878|B3|United States||Region of Enrollment||Participants|Count of Participants|284|284.0||||||
3930773|NCT01403116|3752879|B2|United States||Region of Enrollment||Participants|Count of Participants|143|143.0||||||
3930774|NCT01403116|3752880|B1|United States||Region of Enrollment||Participants|Count of Participants|141|141.0||||||
3930775|NCT01403116|3752878|B3||Male|Sex: Female, Male||Participants|Count of Participants|321|321.0||||||
3930776|NCT01403116|3752879|B2||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3930777|NCT01403116|3752880|B1||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3930778|NCT01403116|3752878|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3930779|NCT01403116|3752879|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3930780|NCT01403116|3752880|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3930781|NCT01403116|3752878|B3|||Age||years|Mean|54.9|54.9|Standard Deviation|11.10|11.1|||
3930782|NCT01403116|3752879|B2|||Age||years|Mean|54.7|54.7|Standard Deviation|11.18|11.18|||
3930783|NCT01403116|3752880|B1|||Age||years|Mean|55|55.0|Standard Deviation|11.06|11.06|||
3930784|NCT01403116|3752878|B3||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
3930785|NCT01403116|3752879|B2||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3930786|NCT01403116|3752880|B1||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
3930787|NCT01403116|3752878|B3||Between 18 and 65 years|Age||Participants|Count of Participants|270|270.0||||||
3930788|NCT01403116|3752879|B2||Between 18 and 65 years|Age||Participants|Count of Participants|136|136.0||||||
3930789|NCT01403116|3752880|B1||Between 18 and 65 years|Age||Participants|Count of Participants|134|134.0||||||
3930790|NCT01403116|3752878|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3930791|NCT01403116|3752879|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3930792|NCT01403116|3752880|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3930793|NCT01403090|3752888|B1|Colombia||Region of Enrollment||participants|Number|8|8.0||||||
3930794|NCT01403090|3752888|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3930795|NCT01403090|3752888|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3930796|NCT01403090|3752888|B1|||Age||years|Mean|35.4|35.4|Standard Deviation|16.2|16.2|||
3930797|NCT01403090|3752888|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3930798|NCT01403090|3752888|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3930799|NCT01403090|3752888|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3930800|NCT01403051|3752892|B3|||CD4 count|Entry total CD4 count (cells/mm3)|cells/mm3|Median|341|341.0|Inter-Quartile Range|||230.0|490.0|
3930801|NCT01403051|3752893|B2|||CD4 count|Entry total CD4 count (cells/mm3)|cells/mm3|Median|342|342.0|Inter-Quartile Range|||232.0|454.0|
3930802|NCT01403051|3752894|B1|||CD4 count|Entry total CD4 count (cells/mm3)|cells/mm3|Median|339|339.0|Inter-Quartile Range|||230.0|500.0|
3930803|NCT01403051|3752892|B3|||HIV-1 RNA level|Entry HIV-RNA level (log10 copies/mL)|log10 copies/mL|Median|4.5|4.5|Inter-Quartile Range|||4.1|5.1|
3930804|NCT01403051|3752893|B2|||HIV-1 RNA level|Entry HIV-RNA level (log10 copies/mL)|log10 copies/mL|Median|4.5|4.5|Inter-Quartile Range|||4.0|5.1|
3930805|NCT01403051|3752894|B1|||HIV-1 RNA level|Entry HIV-RNA level (log10 copies/mL)|log10 copies/mL|Median|4.5|4.5|Inter-Quartile Range|||4.1|5.1|
3930807|NCT01403051|3752893|B2|United States||Region of Enrollment||participants|Number|86|86.0||||||
3930808|NCT01403051|3752894|B1|United States||Region of Enrollment||participants|Number|79|79.0||||||
3930809|NCT01403051|3752892|B3|American Indian, Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3930810|NCT01403051|3752893|B2|American Indian, Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3930811|NCT01403051|3752894|B1|American Indian, Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3930812|NCT01403051|3752892|B3|Asian, Pacific Islander||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3930813|NCT01403051|3752893|B2|Asian, Pacific Islander||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3930814|NCT01403051|3752894|B1|Asian, Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3930815|NCT01403051|3752892|B3|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
3930816|NCT01403051|3752893|B2|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3930817|NCT01403051|3752894|B1|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3930818|NCT01403051|3752892|B3|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
3930819|NCT01403051|3752893|B2|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3930820|NCT01403051|3752894|B1|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3930821|NCT01403051|3752892|B3|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
3930822|NCT01403051|3752893|B2|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
3930823|NCT01403051|3752894|B1|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3930824|NCT01403051|3752892|B3||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3930825|NCT01403051|3752893|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3930826|NCT01403051|3752894|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3930827|NCT01403051|3752892|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3930828|NCT01403051|3752893|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3930829|NCT01403051|3752894|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3930830|NCT01403051|3752892|B3|||Age||years|Median|33|33.0|Inter-Quartile Range|||26.0|46.0|
3930831|NCT01403051|3752893|B2|||Age||years|Median|31|31.0|Inter-Quartile Range|||25.0|44.0|
3930832|NCT01403051|3752894|B1|||Age||years|Median|36|36.0|Inter-Quartile Range|||28.0|47.0|
3930833|NCT01403051|3752892|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3930834|NCT01403051|3752893|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3930835|NCT01403051|3752894|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3930836|NCT01403051|3752892|B3||Between 18 and 65 years|Age||Participants|Count of Participants|161|161.0||||||
3930837|NCT01403051|3752893|B2||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
3930838|NCT01403051|3752894|B1||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
3930839|NCT01403051|3752892|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3930840|NCT01403051|3752893|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3930841|NCT01403051|3752894|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3930842|NCT01402986|3752927|B5||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3930843|NCT01402986|3752928|B4||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3930844|NCT01402986|3752929|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3930845|NCT01402986|3752930|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3930846|NCT01402986|3752931|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3930847|NCT01402986|3752927|B5||Female|Sex: Female, Male||Participants|Count of Participants|297|297.0||||||
3930848|NCT01402986|3752928|B4||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3930849|NCT01402986|3752929|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3930850|NCT01402986|3752930|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3930851|NCT01402986|3752931|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3930852|NCT01402986|3752927|B5|||Age||years|Mean|50.1|50.1|Standard Deviation|12.0|12.0|||
3930853|NCT01402986|3752928|B4|||Age||years|Mean|50.5|50.5|Standard Deviation|11.8|11.8|||
3930854|NCT01402986|3752929|B3|||Age||years|Mean|51.7|51.7|Standard Deviation|13.6|13.6|||
3930855|NCT01402986|3752930|B2|||Age||years|Mean|49.7|49.7|Standard Deviation|12.2|12.2|||
3930856|NCT01402986|3752931|B1|||Age||years|Mean|48.8|48.8|Standard Deviation|12.1|12.1|||
3930857|NCT01402947|3753067|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3930858|NCT01402947|3753068|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3930859|NCT01402947|3753069|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3930860|NCT01402947|3753067|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3930861|NCT01402947|3753068|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3930862|NCT01402947|3753069|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3930863|NCT01402947|3753067|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3930864|NCT01402947|3753068|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3930865|NCT01402947|3753069|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3930866|NCT01402947|3753067|B3|18 to 55 years||Age, Customized||participants|Number|30|30.0||||||
3930867|NCT01402947|3753068|B2|18 to 55 years||Age, Customized||participants|Number|15|15.0||||||
3930868|NCT01402947|3753069|B1|18 to 55 years||Age, Customized||participants|Number|15|15.0||||||
3930869|NCT01402947|3753067|B3|||Age||years|Mean|31.6|31.6|Standard Deviation|11.16|11.16|||
3930870|NCT01402947|3753068|B2|||Age||years|Mean|31.3|31.3|Standard Deviation|10.95|10.95|||
3930871|NCT01402947|3753069|B1|||Age||years|Mean|31.9|31.9|Standard Deviation|11.73|11.73|||
3930872|NCT01402869|3753078|B4|||Baseline Methemoglobin Blood Level|Methemoglobin blood level recorded non-invasively by the Masimo Radical-7 Pulse Co-Oximeter prior to the administration of local anesthetic or start of restorative dental procedures.|percentage|Mean|0.83|0.83|Standard Deviation|0.39|0.39|||
3930873|NCT01402869|3753079|B3|||Baseline Methemoglobin Blood Level|Methemoglobin blood level recorded non-invasively by the Masimo Radical-7 Pulse Co-Oximeter prior to the administration of local anesthetic or start of restorative dental procedures.|percentage|Mean|0.84|0.84|Standard Deviation|0.43|0.43|||
3930874|NCT01402869|3753080|B2|||Baseline Methemoglobin Blood Level|Methemoglobin blood level recorded non-invasively by the Masimo Radical-7 Pulse Co-Oximeter prior to the administration of local anesthetic or start of restorative dental procedures.|percentage|Mean|0.85|0.85|Standard Deviation|0.35|0.35|||
3930875|NCT01402869|3753081|B1|||Baseline Methemoglobin Blood Level|Methemoglobin blood level recorded non-invasively by the Masimo Radical-7 Pulse Co-Oximeter prior to the administration of local anesthetic or start of restorative dental procedures.|percentage|Mean|0.82|0.82|Standard Deviation|0.39|0.39|||
3930876|NCT01402869|3753078|B4|>65th and <=95th percentiles||Body Mass Index Percentile||participants|Number|35|35.0||||||
3930877|NCT01402869|3753079|B3|>65th and <=95th percentiles||Body Mass Index Percentile||participants|Number|12|12.0||||||
3930878|NCT01402869|3753080|B2|>65th and <=95th percentiles||Body Mass Index Percentile||participants|Number|10|10.0||||||
3930879|NCT01402869|3753081|B1|>65th and <=95th percentiles||Body Mass Index Percentile||participants|Number|13|13.0||||||
3930880|NCT01402869|3753078|B4|>35th and <=65th percentiles||Body Mass Index Percentile||participants|Number|32|32.0||||||
3930881|NCT01402869|3753079|B3|>35th and <=65th percentiles||Body Mass Index Percentile||participants|Number|12|12.0||||||
3930882|NCT01402869|3753080|B2|>35th and <=65th percentiles||Body Mass Index Percentile||participants|Number|14|14.0||||||
3930883|NCT01402869|3753081|B1|>35th and <=65th percentiles||Body Mass Index Percentile||participants|Number|6|6.0||||||
3930884|NCT01402869|3753078|B4|>=5th and <=35th percentiles||Body Mass Index Percentile||participants|Number|23|23.0||||||
3930885|NCT01402869|3753079|B3|>=5th and <=35th percentiles||Body Mass Index Percentile||participants|Number|6|6.0||||||
3930886|NCT01402869|3753080|B2|>=5th and <=35th percentiles||Body Mass Index Percentile||participants|Number|6|6.0||||||
3930887|NCT01402869|3753081|B1|>=5th and <=35th percentiles||Body Mass Index Percentile||participants|Number|11|11.0||||||
3930888|NCT01402869|3753078|B4|||Body Mass Index Numerical Value||kg/m^2|Mean|15.64|15.64|Standard Deviation|1.07|1.07|||
3930889|NCT01402869|3753079|B3|||Body Mass Index Numerical Value||kg/m^2|Mean|15.60|15.6|Standard Deviation|1.03|1.03|||
3930890|NCT01402869|3753080|B2|||Body Mass Index Numerical Value||kg/m^2|Mean|15.69|15.69|Standard Deviation|1.08|1.08|||
3930891|NCT01402869|3753081|B1|||Body Mass Index Numerical Value||kg/m^2|Mean|15.62|15.62|Standard Deviation|1.12|1.12|||
3930892|NCT01402869|3753078|B4|II-Patients with mild, systemic disease||ASA Health Classification||participants|Number|15|15.0||||||
3930893|NCT01402869|3753079|B3|II-Patients with mild, systemic disease||ASA Health Classification||participants|Number|6|6.0||||||
3930894|NCT01402869|3753080|B2|II-Patients with mild, systemic disease||ASA Health Classification||participants|Number|5|5.0||||||
3930895|NCT01402869|3753081|B1|II-Patients with mild, systemic disease||ASA Health Classification||participants|Number|4|4.0||||||
3930896|NCT01402869|3753078|B4|I-Healthy patients; no systemic disease||ASA Health Classification||participants|Number|75|75.0||||||
3930897|NCT01402869|3753079|B3|I-Healthy patients; no systemic disease||ASA Health Classification||participants|Number|24|24.0||||||
3930898|NCT01402869|3753080|B2|I-Healthy patients; no systemic disease||ASA Health Classification||participants|Number|25|25.0||||||
3930899|NCT01402869|3753081|B1|I-Healthy patients; no systemic disease||ASA Health Classification||participants|Number|26|26.0||||||
3930900|NCT01402869|3753078|B4|||Weight Continuous||kilograms|Mean|17.20|17.2|Standard Deviation|2.86|2.86|||
3930901|NCT01402869|3753079|B3|||Weight Continuous||kilograms|Mean|17.19|17.19|Standard Deviation|2.96|2.96|||
3930902|NCT01402869|3753080|B2|||Weight Continuous||kilograms|Mean|17.24|17.24|Standard Deviation|2.78|2.78|||
3930903|NCT01402869|3753081|B1|||Weight Continuous||kilograms|Mean|17.17|17.17|Standard Deviation|2.94|2.94|||
3930904|NCT01402869|3753078|B4||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3930905|NCT01402869|3753079|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3930906|NCT01402869|3753080|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3930907|NCT01402869|3753081|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3930908|NCT01402869|3753078|B4||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3930909|NCT01402869|3753079|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3930910|NCT01402869|3753080|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3930911|NCT01402869|3753081|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3930912|NCT01402869|3753078|B4|||Age||months|Mean|50.79|50.79|Standard Deviation|9.41|9.41|||
3930913|NCT01402869|3753079|B3|||Age||months|Mean|50.63|50.63|Standard Deviation|8.43|8.43|||
3930914|NCT01402869|3753080|B2|||Age||months|Mean|50.77|50.77|Standard Deviation|10.19|10.19|||
3930915|NCT01402869|3753081|B1|||Age||months|Mean|50.97|50.97|Standard Deviation|9.84|9.84|||
3930916|NCT01402817|3753097|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3930917|NCT01402817|3753097|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930918|NCT01402817|3753097|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3930919|NCT01402817|3753097|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3930920|NCT01402817|3753097|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3930921|NCT01402817|3753097|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930922|NCT01402817|3753097|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930923|NCT01402817|3753097|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3930924|NCT01402817|3753097|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930925|NCT01402817|3753097|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3930926|NCT01402817|3753097|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930927|NCT01402817|3753097|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3930928|NCT01402817|3753097|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3930929|NCT01402817|3753097|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3930930|NCT01402817|3753097|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3930931|NCT01402817|3753097|B1||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
3930932|NCT01402700|3753102|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3930933|NCT01402700|3753102|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3930934|NCT01402700|3753102|B1|||Age||years|Mean|64.2|64.2|Standard Deviation|8.9|8.9|||
3930935|NCT01402570|3753106|B1|||Physical activity, number of steps daily|Refers to cumulative steps per day (24 hours period). 10,000 or more steps per day is considered optimal.|steps/day|Mean|4004.1|4004.1|Standard Deviation|3357.9|3357.9|||
3930936|NCT01402570|3753106|B1|||PROMIS Fatigue|Assesses fatigue from mild subjective feelings to an overwhelming, debilitating, and sustained sense of exhaustion that is likely to decrease one’s ability to carry out daily activities, including the ability to work effectively and to function at one’s usual level in family or social roles. Fatigue is divided conceptually into the experience of fatigue (e.g., frequency, duration, and intensity), and the impact of fatigue upon physical, mental and social activities.Scores are standardized T-scores with mean of 50 and standard deviation of 10; higher scores indicate greater fatigue.|units on a scale|Mean|56.0|56.0|Standard Deviation|8.7|8.7|||
3930937|NCT01402570|3753106|B1|||Subjective sleep efficiency|Sleep efficiency is defined as the ratio of time sleeping and time in bed. Using a sleep diary, participants recorded bedtime the night before, amount of time it took to fall asleep, number and total duration of awakenings, time of final awakening, and time of rising. Efficiency ranges from 0 to 100; higher values indicate higher sleep efficiency or more time sleeping when in bed.|percentage|Mean|82.0|82.0|Standard Deviation|14.6|14.6|||
3930938|NCT01402570|3753106|B1|||PROMIS Physical Functioning|Assesses the ability to carry out activities that require physical actions, ranging from self-care (activities of daily living) to more complex activities that require a combination of skills, often within a social context. Scores are standardized T-scores with mean of 50 and standard deviation of 10; higher scores indicate better physical function.|units on a scale|Mean|37.8|37.8|Standard Deviation|4.6|4.6|||
3930939|NCT01402570|3753106|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3930940|NCT01402570|3753106|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930941|NCT01402570|3753106|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930942|NCT01402570|3753106|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3930943|NCT01402570|3753106|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3930944|NCT01402570|3753106|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930945|NCT01402570|3753106|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930946|NCT01402570|3753106|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3930947|NCT01402570|3753106|B1||Male|Gender||Participants|Count of Participants|11|11.0||||||
3930948|NCT01402570|3753106|B1||Female|Gender||Participants|Count of Participants|9|9.0||||||
3930949|NCT01402570|3753106|B1|||Age||years|Mean|60.85|60.85|Standard Deviation|3.89|3.89|||
3930950|NCT01402427|3753113|B3|Hungary||Region of Enrollment||participants|Number|591|591.0||||||
3930951|NCT01402427|3753114|B2|Hungary||Region of Enrollment||participants|Number|294|294.0||||||
3930952|NCT01402427|3753115|B1|Hungary||Region of Enrollment||participants|Number|297|297.0||||||
3930953|NCT01402427|3753113|B3||Male|Sex: Female, Male||Participants|Count of Participants|376|376.0||||||
3930954|NCT01402427|3753114|B2||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
3930955|NCT01402427|3753115|B1||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
3930956|NCT01402427|3753113|B3||Female|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
3930957|NCT01402427|3753114|B2||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3930958|NCT01402427|3753115|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3930959|NCT01402427|3753113|B3|||Age||years|Mean|62.1|62.1|Standard Deviation|10.7|10.7|||
3930960|NCT01402427|3753114|B2|||Age||years|Mean|62.5|62.5|Standard Deviation|10.8|10.8|||
3930961|NCT01402427|3753115|B1|||Age||years|Mean|61.8|61.8|Standard Deviation|10.5|10.5|||
3930962|NCT01402375|3753134|B7|Unknown||Took analgesic prior to presentation||Participants|Count of Participants|12|12.0||||||
3930963|NCT01402375|3753135|B6|Unknown||Took analgesic prior to presentation||Participants|Count of Participants|3|3.0||||||
3930964|NCT01402375|3753136|B5|Unknown||Took analgesic prior to presentation||Participants|Count of Participants|2|2.0||||||
3930965|NCT01402375|3753137|B4|Unknown||Took analgesic prior to presentation||Participants|Count of Participants|1|1.0||||||
3930966|NCT01402375|3753138|B3|Unknown||Took analgesic prior to presentation||Participants|Count of Participants|2|2.0||||||
3930967|NCT01402375|3753139|B2|Unknown||Took analgesic prior to presentation||Participants|Count of Participants|3|3.0||||||
3930968|NCT01402375|3753140|B1|Unknown||Took analgesic prior to presentation||Participants|Count of Participants|1|1.0||||||
3930969|NCT01402375|3753134|B7|Yes||Took analgesic prior to presentation||Participants|Count of Participants|186|186.0||||||
3930970|NCT01402375|3753135|B6|Yes||Took analgesic prior to presentation||Participants|Count of Participants|36|36.0||||||
3930971|NCT01402375|3753136|B5|Yes||Took analgesic prior to presentation||Participants|Count of Participants|29|29.0||||||
3930972|NCT01402375|3753137|B4|Yes||Took analgesic prior to presentation||Participants|Count of Participants|33|33.0||||||
3930973|NCT01402375|3753138|B3|Yes||Took analgesic prior to presentation||Participants|Count of Participants|37|37.0||||||
3930974|NCT01402375|3753139|B2|Yes||Took analgesic prior to presentation||Participants|Count of Participants|27|27.0||||||
3930975|NCT01402375|3753140|B1|Yes||Took analgesic prior to presentation||Participants|Count of Participants|24|24.0||||||
3930976|NCT01402375|3753134|B7|No||Took analgesic prior to presentation||Participants|Count of Participants|418|418.0||||||
3930977|NCT01402375|3753135|B6|No||Took analgesic prior to presentation||Participants|Count of Participants|74|74.0||||||
3930978|NCT01402375|3753136|B5|No||Took analgesic prior to presentation||Participants|Count of Participants|76|76.0||||||
3930979|NCT01402375|3753137|B4|No||Took analgesic prior to presentation||Participants|Count of Participants|70|70.0||||||
3930980|NCT01402375|3753138|B3|No||Took analgesic prior to presentation||Participants|Count of Participants|72|72.0||||||
3930981|NCT01402375|3753139|B2|No||Took analgesic prior to presentation||Participants|Count of Participants|63|63.0||||||
3930982|NCT01402375|3753140|B1|No||Took analgesic prior to presentation||Participants|Count of Participants|63|63.0||||||
3930983|NCT01402375|3753134|B7|Other||Diagnosis||Participants|Count of Participants|105|105.0||||||
3930984|NCT01402375|3753135|B6|Other||Diagnosis||Participants|Count of Participants|13|13.0||||||
3930985|NCT01402375|3753136|B5|Other||Diagnosis||Participants|Count of Participants|5|5.0||||||
3930986|NCT01402375|3753137|B4|Other||Diagnosis||Participants|Count of Participants|18|18.0||||||
3930987|NCT01402375|3753138|B3|Other||Diagnosis||Participants|Count of Participants|19|19.0||||||
3930988|NCT01402375|3753139|B2|Other||Diagnosis||Participants|Count of Participants|22|22.0||||||
3930989|NCT01402375|3753140|B1|Other||Diagnosis||Participants|Count of Participants|28|28.0||||||
3930990|NCT01402375|3753134|B7|Extremity Fracture||Diagnosis||Participants|Count of Participants|228|228.0||||||
3930991|NCT01402375|3753135|B6|Extremity Fracture||Diagnosis||Participants|Count of Participants|58|58.0||||||
3930992|NCT01402375|3753136|B5|Extremity Fracture||Diagnosis||Participants|Count of Participants|63|63.0||||||
3930993|NCT01402375|3753137|B4|Extremity Fracture||Diagnosis||Participants|Count of Participants|37|37.0||||||
3930994|NCT01402375|3753138|B3|Extremity Fracture||Diagnosis||Participants|Count of Participants|33|33.0||||||
3930995|NCT01402375|3753139|B2|Extremity Fracture||Diagnosis||Participants|Count of Participants|17|17.0||||||
3930996|NCT01402375|3753140|B1|Extremity Fracture||Diagnosis||Participants|Count of Participants|20|20.0||||||
3930997|NCT01402375|3753134|B7|Sprain/strain||Diagnosis||Participants|Count of Participants|283|283.0||||||
3930998|NCT01402375|3753135|B6|Sprain/strain||Diagnosis||Participants|Count of Participants|42|42.0||||||
3930999|NCT01402375|3753136|B5|Sprain/strain||Diagnosis||Participants|Count of Participants|39|39.0||||||
3931000|NCT01402375|3753137|B4|Sprain/strain||Diagnosis||Participants|Count of Participants|49|49.0||||||
3931001|NCT01402375|3753138|B3|Sprain/strain||Diagnosis||Participants|Count of Participants|59|59.0||||||
3931002|NCT01402375|3753139|B2|Sprain/strain||Diagnosis||Participants|Count of Participants|54|54.0||||||
3931003|NCT01402375|3753140|B1|Sprain/strain||Diagnosis||Participants|Count of Participants|40|40.0||||||
3931004|NCT01402375|3753134|B7|||NRS pain intensity score on discharge|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable).~The study involved patients taking study medications AFTER emergency department discharge, and the primary outcome also involved NRS pain scores 24 hours AFTER ED discharge. Thus, any data collected while in the ED is considered baseline."|units on a scale|Median|7|7.0|Inter-Quartile Range|||5.0|9.0|
3931005|NCT01402375|3753135|B6|||NRS pain intensity score on discharge|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable).~The study involved patients taking study medications AFTER emergency department discharge, and the primary outcome also involved NRS pain scores 24 hours AFTER ED discharge. Thus, any data collected while in the ED is considered baseline."|units on a scale|Median|8|8.0|Inter-Quartile Range|||6.0|9.0|
3931006|NCT01402375|3753136|B5|||NRS pain intensity score on discharge|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable).~The study involved patients taking study medications AFTER emergency department discharge, and the primary outcome also involved NRS pain scores 24 hours AFTER ED discharge. Thus, any data collected while in the ED is considered baseline."|units on a scale|Median|8|8.0|Inter-Quartile Range|||6.0|9.0|
3931007|NCT01402375|3753137|B4|||NRS pain intensity score on discharge|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable).~The study involved patients taking study medications AFTER emergency department discharge, and the primary outcome also involved NRS pain scores 24 hours AFTER ED discharge. Thus, any data collected while in the ED is considered baseline."|units on a scale|Median|7|7.0|Inter-Quartile Range|||5.0|9.0|
3931008|NCT01402375|3753138|B3|||NRS pain intensity score on discharge|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable).~The study involved patients taking study medications AFTER emergency department discharge, and the primary outcome also involved NRS pain scores 24 hours AFTER ED discharge. Thus, any data collected while in the ED is considered baseline."|units on a scale|Median|7|7.0|Inter-Quartile Range|||6.0|9.0|
3931053|NCT01402375|3753134|B7||Female|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
3931054|NCT01402375|3753135|B6||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3931009|NCT01402375|3753139|B2|||NRS pain intensity score on discharge|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable).~The study involved patients taking study medications AFTER emergency department discharge, and the primary outcome also involved NRS pain scores 24 hours AFTER ED discharge. Thus, any data collected while in the ED is considered baseline."|units on a scale|Median|7|7.0|Inter-Quartile Range|||5.0|8.0|
3931010|NCT01402375|3753140|B1|||NRS pain intensity score on discharge|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable).~The study involved patients taking study medications AFTER emergency department discharge, and the primary outcome also involved NRS pain scores 24 hours AFTER ED discharge. Thus, any data collected while in the ED is considered baseline."|units on a scale|Median|7|7.0|Inter-Quartile Range|||5.0|8.0|
3931011|NCT01402375|3753134|B7|||NRS pain intensity score on ED arrival|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable)"|units on a scale|Median|10|10.0|Inter-Quartile Range|||8.0|10.0|
3931012|NCT01402375|3753135|B6|||NRS pain intensity score on ED arrival|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable)"|units on a scale|Median|10|10.0|Inter-Quartile Range|||8.0|10.0|
3931013|NCT01402375|3753136|B5|||NRS pain intensity score on ED arrival|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable)"|units on a scale|Median|10|10.0|Inter-Quartile Range|||8.0|10.0|
3931014|NCT01402375|3753137|B4|||NRS pain intensity score on ED arrival|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable)"|units on a scale|Median|10|10.0|Inter-Quartile Range|||8.0|10.0|
3931015|NCT01402375|3753138|B3|||NRS pain intensity score on ED arrival|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable)"|units on a scale|Median|10|10.0|Inter-Quartile Range|||8.0|10.0|
3931016|NCT01402375|3753139|B2|||NRS pain intensity score on ED arrival|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable)"|units on a scale|Median|9|9.0|Inter-Quartile Range|||8.0|10.0|
3931017|NCT01402375|3753140|B1|||NRS pain intensity score on ED arrival|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable)"|units on a scale|Median|9|9.0|Inter-Quartile Range|||8.0|10.0|
3931018|NCT01402375|3753134|B7|United States||Region of Enrollment||Participants|Count of Participants|616|616.0||||||
3931019|NCT01402375|3753135|B6|United States||Region of Enrollment||Participants|Count of Participants|113|113.0||||||
3931020|NCT01402375|3753136|B5|United States||Region of Enrollment||Participants|Count of Participants|107|107.0||||||
3931021|NCT01402375|3753137|B4|United States||Region of Enrollment||Participants|Count of Participants|104|104.0||||||
3931022|NCT01402375|3753138|B3|United States||Region of Enrollment||Participants|Count of Participants|111|111.0||||||
3931023|NCT01402375|3753139|B2|United States||Region of Enrollment||Participants|Count of Participants|93|93.0||||||
3931024|NCT01402375|3753140|B1|United States||Region of Enrollment||Participants|Count of Participants|88|88.0||||||
3931025|NCT01402375|3753134|B7|Other||Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
3931026|NCT01402375|3753135|B6|Other||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3931027|NCT01402375|3753136|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3931028|NCT01402375|3753137|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3931029|NCT01402375|3753138|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3931030|NCT01402375|3753139|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3931031|NCT01402375|3753140|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3931032|NCT01402375|3753134|B7|African American||Race/Ethnicity, Customized||Participants|Count of Participants|167|167.0||||||
3931033|NCT01402375|3753135|B6|African American||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3931034|NCT01402375|3753136|B5|African American||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3931035|NCT01402375|3753137|B4|African American||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3931036|NCT01402375|3753138|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
3931037|NCT01402375|3753139|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3931038|NCT01402375|3753140|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3931039|NCT01402375|3753134|B7|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|402|402.0||||||
3931040|NCT01402375|3753135|B6|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|73|73.0||||||
3931041|NCT01402375|3753136|B5|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|67|67.0||||||
3931042|NCT01402375|3753137|B4|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|71|71.0||||||
3931043|NCT01402375|3753138|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|66|66.0||||||
3931044|NCT01402375|3753139|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|69|69.0||||||
3931045|NCT01402375|3753140|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|56|56.0||||||
3931046|NCT01402375|3753134|B7||Male|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
3931047|NCT01402375|3753135|B6||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3931048|NCT01402375|3753136|B5||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3931049|NCT01402375|3753137|B4||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3931050|NCT01402375|3753138|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3931051|NCT01402375|3753139|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3931052|NCT01402375|3753140|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3931055|NCT01402375|3753136|B5||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3931056|NCT01402375|3753137|B4||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3931057|NCT01402375|3753138|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3931058|NCT01402375|3753139|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3931059|NCT01402375|3753140|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3931060|NCT01402375|3753134|B7|||Age||years|Mean|38|38.0|Standard Deviation|12|12.0|||
3931061|NCT01402375|3753135|B6|||Age||years|Mean|38|38.0|Standard Deviation|13|13.0|||
3931062|NCT01402375|3753136|B5|||Age||years|Mean|39|39.0|Standard Deviation|12|12.0|||
3931063|NCT01402375|3753137|B4|||Age||years|Mean|38|38.0|Standard Deviation|11|11.0|||
3931064|NCT01402375|3753138|B3|||Age||years|Mean|39|39.0|Standard Deviation|12|12.0|||
3931065|NCT01402375|3753139|B2|||Age||years|Mean|37|37.0|Standard Deviation|11|11.0|||
3931066|NCT01402375|3753140|B1|||Age||years|Mean|34|34.0|Standard Deviation|12|12.0|||
3931067|NCT01402284|3753177|B1|Free lambda||Isotypes|Measure Description: IgA Kappa, IgG Kappa, IgG Lambda, Free Kappa and Free lambda were measured in the urine to determine changes in renal function. Measurable is defined as any of the following: Serum monoclonal protein greater than or equal to 1.0 g/dL, urine monoclonal protein greater than 200 mg/24 hour, and serum immunoglobulin free light chain greater than 10mg/dL AND abnormal kappa/lambda ratio.|percentage of participants|Number|4|4.0||||||
3931068|NCT01402284|3753177|B1|Free kappa||Isotypes|Measure Description: IgA Kappa, IgG Kappa, IgG Lambda, Free Kappa and Free lambda were measured in the urine to determine changes in renal function. Measurable is defined as any of the following: Serum monoclonal protein greater than or equal to 1.0 g/dL, urine monoclonal protein greater than 200 mg/24 hour, and serum immunoglobulin free light chain greater than 10mg/dL AND abnormal kappa/lambda ratio.|percentage of participants|Number|9|9.0||||||
3931069|NCT01402284|3753177|B1|IgA lambda||Isotypes|Measure Description: IgA Kappa, IgG Kappa, IgG Lambda, Free Kappa and Free lambda were measured in the urine to determine changes in renal function. Measurable is defined as any of the following: Serum monoclonal protein greater than or equal to 1.0 g/dL, urine monoclonal protein greater than 200 mg/24 hour, and serum immunoglobulin free light chain greater than 10mg/dL AND abnormal kappa/lambda ratio.|percentage of participants|Number|9|9.0||||||
3931070|NCT01402284|3753177|B1|IgA kappa||Isotypes|Measure Description: IgA Kappa, IgG Kappa, IgG Lambda, Free Kappa and Free lambda were measured in the urine to determine changes in renal function. Measurable is defined as any of the following: Serum monoclonal protein greater than or equal to 1.0 g/dL, urine monoclonal protein greater than 200 mg/24 hour, and serum immunoglobulin free light chain greater than 10mg/dL AND abnormal kappa/lambda ratio.|percentage of participants|Number|9|9.0||||||
3931071|NCT01402284|3753177|B1|IgG lambda||Isotypes|Measure Description: IgA Kappa, IgG Kappa, IgG Lambda, Free Kappa and Free lambda were measured in the urine to determine changes in renal function. Measurable is defined as any of the following: Serum monoclonal protein greater than or equal to 1.0 g/dL, urine monoclonal protein greater than 200 mg/24 hour, and serum immunoglobulin free light chain greater than 10mg/dL AND abnormal kappa/lambda ratio.|percentage of participants|Number|16|16.0||||||
3931072|NCT01402284|3753177|B1|IgG kappa||Isotypes|Measure Description: IgA Kappa, IgG Kappa, IgG Lambda, Free Kappa and Free lambda were measured in the urine to determine changes in renal function. Measurable is defined as any of the following: Serum monoclonal protein greater than or equal to 1.0 g/dL, urine monoclonal protein greater than 200 mg/24 hour, and serum immunoglobulin free light chain greater than 10mg/dL AND abnormal kappa/lambda ratio.|percentage of participants|Number|51|51.0||||||
3931073|NCT01402284|3753177|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
3931074|NCT01402284|3753177|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931075|NCT01402284|3753177|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931076|NCT01402284|3753177|B1||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3931077|NCT01402284|3753177|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3931078|NCT01402284|3753177|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931079|NCT01402284|3753177|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3931080|NCT01402284|3753177|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931081|NCT01402284|3753177|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931082|NCT01402284|3753177|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3931083|NCT01402284|3753177|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931084|NCT01402284|3753177|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3931085|NCT01402284|3753177|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3931086|NCT01402284|3753177|B1|||Age||years|Median|60|60.0|Full Range|||40.0|89.0|
3931087|NCT01402284|3753177|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3931088|NCT01402284|3753177|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3931089|NCT01402284|3753177|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931090|NCT01402141|3753188|B3|Korea, Republic of||Region of Enrollment||participants|Number|60|60.0||||||
3931091|NCT01402141|3753189|B2|Korea, Republic of||Region of Enrollment||participants|Number|30|30.0||||||
3931092|NCT01402141|3753190|B1|Korea, Republic of||Region of Enrollment||participants|Number|30|30.0||||||
3931093|NCT01402141|3753188|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3931094|NCT01402141|3753189|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3931095|NCT01402141|3753190|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3931096|NCT01402141|3753188|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3931097|NCT01402141|3753189|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3931098|NCT01402141|3753190|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3931099|NCT01402141|3753188|B3|||Age||years|Mean|34.9|34.9|Standard Deviation|12.3|12.3|||
3931100|NCT01402141|3753189|B2|||Age||years|Mean|34.2|34.2|Standard Deviation|12.9|12.9|||
3931101|NCT01402141|3753190|B1|||Age||years|Mean|35.5|35.5|Standard Deviation|11.9|11.9|||
3931102|NCT01402141|3753188|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3931103|NCT01402141|3753189|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3931104|NCT01402141|3753190|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3931105|NCT01402141|3753188|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3931106|NCT01402141|3753189|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3931107|NCT01402141|3753190|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3931108|NCT01402141|3753188|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931109|NCT01402141|3753189|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931110|NCT01402141|3753190|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931111|NCT01402128|3753211|B3|Korea, Republic of||Region of Enrollment||participants|Number|80|80.0||||||
3931112|NCT01402128|3753212|B2|Korea, Republic of||Region of Enrollment||participants|Number|40|40.0||||||
3931113|NCT01402128|3753213|B1|Korea, Republic of||Region of Enrollment||participants|Number|40|40.0||||||
3931114|NCT01402128|3753211|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3931115|NCT01402128|3753212|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3931116|NCT01402128|3753213|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3931117|NCT01402128|3753211|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3931118|NCT01402128|3753212|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3931119|NCT01402128|3753213|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3931120|NCT01402128|3753211|B3|||Age||years|Mean|48.2|48.2|Standard Deviation|9.8|9.8|||
3931121|NCT01402128|3753212|B2|||Age||years|Mean|48.5|48.5|Standard Deviation|10.8|10.8|||
3931122|NCT01402128|3753213|B1|||Age||years|Mean|47.9|47.9|Standard Deviation|8.7|8.7|||
3931123|NCT01402128|3753211|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3931124|NCT01402128|3753212|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3931125|NCT01402128|3753213|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3931126|NCT01402128|3753211|B3||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
3931127|NCT01402128|3753212|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3931128|NCT01402128|3753213|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3931129|NCT01402128|3753211|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931130|NCT01402128|3753212|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931131|NCT01402128|3753213|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931132|NCT01402115|3753240|B3|Korea, Republic of||Region of Enrollment||participants|Number|60|60.0||||||
3931133|NCT01402115|3753241|B2|Korea, Republic of||Region of Enrollment||participants|Number|30|30.0||||||
3931134|NCT01402115|3753242|B1|Korea, Republic of||Region of Enrollment||participants|Number|30|30.0||||||
3931135|NCT01402115|3753240|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3931136|NCT01402115|3753241|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3931137|NCT01402115|3753242|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3931138|NCT01402115|3753240|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3931139|NCT01402115|3753241|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3931140|NCT01402115|3753242|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3931141|NCT01402115|3753240|B3|||Age||years|Mean|52.8|52.8|Standard Deviation|5.8|5.8|||
3931142|NCT01402115|3753241|B2|||Age||years|Mean|52.9|52.9|Standard Deviation|5.8|5.8|||
3931143|NCT01402115|3753242|B1|||Age||years|Mean|52.8|52.8|Standard Deviation|6.3|6.3|||
3931144|NCT01402115|3753240|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3931145|NCT01402115|3753241|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3931146|NCT01402115|3753242|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3931147|NCT01402115|3753240|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3931148|NCT01402115|3753241|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3931149|NCT01402115|3753242|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3931150|NCT01402115|3753240|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931151|NCT01402115|3753241|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931152|NCT01402115|3753242|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931153|NCT01402102|3753257|B3|Korea, Republic of||Region of Enrollment||participants|Number|60|60.0||||||
3931154|NCT01402102|3753258|B2|Korea, Republic of||Region of Enrollment||participants|Number|30|30.0||||||
3931155|NCT01402102|3753259|B1|Korea, Republic of||Region of Enrollment||participants|Number|30|30.0||||||
3931156|NCT01402102|3753257|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3931157|NCT01402102|3753258|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3931158|NCT01402102|3753259|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3931159|NCT01402102|3753257|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3931160|NCT01402102|3753258|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3931161|NCT01402102|3753259|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3931162|NCT01402102|3753257|B3|||Age||years|Mean|50.5|50.5|Standard Deviation|8.6|8.6|||
3931163|NCT01402102|3753258|B2|||Age||years|Mean|50.8|50.8|Standard Deviation|8|8.0|||
3931164|NCT01402102|3753259|B1|||Age||years|Mean|50.1|50.1|Standard Deviation|9.2|9.2|||
3931165|NCT01402102|3753257|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3931166|NCT01402102|3753258|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3931167|NCT01402102|3753259|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3931168|NCT01402102|3753257|B3||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
3931169|NCT01402102|3753258|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3931170|NCT01402102|3753259|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3931171|NCT01402102|3753257|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931172|NCT01402102|3753258|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931173|NCT01402102|3753259|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931174|NCT01402063|3753278|B3|United States||Region of Enrollment||participants|Number|63|63.0||||||
3931175|NCT01402063|3753279|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
3931176|NCT01402063|3753280|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
3931177|NCT01402063|3753278|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3931178|NCT01402063|3753279|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3931179|NCT01402063|3753280|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3931180|NCT01402063|3753278|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3931181|NCT01402063|3753279|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3931182|NCT01402063|3753280|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3931183|NCT01402063|3753278|B3|||Age||years|Mean|62|62.0|Full Range|||21.0|82.0|
3931184|NCT01402063|3753279|B2|||Age||years|Mean|62|62.0|Full Range|||49.0|82.0|
3931185|NCT01402063|3753280|B1|||Age||years|Mean|62|62.0|Full Range|||21.0|79.0|
3931186|NCT01402063|3753278|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3931187|NCT01402063|3753279|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3931188|NCT01402063|3753280|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3931189|NCT01402063|3753278|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3931190|NCT01402063|3753279|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3931191|NCT01402063|3753280|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3931192|NCT01402063|3753278|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931193|NCT01402063|3753279|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931194|NCT01402063|3753280|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931195|NCT01402011|3753287|B4|||Shoulder symptom duration||months|Mean|76|76.0|Standard Deviation|166|166.0|||
3931196|NCT01402011|3753288|B3|||Shoulder symptom duration||months|Mean|101|101.0|Standard Deviation|115|115.0|||
3931197|NCT01402011|3753289|B2|||Shoulder symptom duration||months|Mean|131|131.0|Standard Deviation|155|155.0|||
3931198|NCT01402011|3753290|B1|||Shoulder symptom duration||months|Mean|61|61.0|Standard Deviation|81|81.0|||
3931199|NCT01402011|3753287|B4||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3931200|NCT01402011|3753288|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3931201|NCT01402011|3753289|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3931202|NCT01402011|3753290|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3931203|NCT01402011|3753287|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3931204|NCT01402011|3753288|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3931205|NCT01402011|3753289|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3931206|NCT01402011|3753290|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3931207|NCT01402011|3753287|B4|||Age||years|Mean|51|51.0|Standard Deviation|11.78|11.78|||
3931208|NCT01402011|3753288|B3|||Age||years|Mean|49.0|49.0|Standard Deviation|11.9|11.9|||
3931209|NCT01402011|3753289|B2|||Age||years|Mean|51.1|51.1|Standard Deviation|9.2|9.2|||
3931210|NCT01402011|3753290|B1|||Age||years|Mean|53.8|53.8|Standard Deviation|13.5|13.5|||
3931211|NCT01401959|3753318|B4|United States||Region of Enrollment||Participants|Count of Participants|126|126.0||||||
3931212|NCT01401959|3753319|B3|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3931213|NCT01401959|3753320|B2|United States||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3931214|NCT01401959|3753321|B1|United States||Region of Enrollment||Participants|Count of Participants|53|53.0||||||
3931215|NCT01401959|3753318|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3931216|NCT01401959|3753319|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3931217|NCT01401959|3753320|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3931218|NCT01401959|3753321|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3931219|NCT01401959|3753318|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931220|NCT01401959|3753319|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931221|NCT01401959|3753320|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931222|NCT01401959|3753321|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931223|NCT01401959|3753318|B4||White|Race (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
3931224|NCT01401959|3753319|B3||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3931225|NCT01401959|3753320|B2||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3931226|NCT01401959|3753321|B1||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3931227|NCT01401959|3753318|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3931228|NCT01401959|3753319|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3931229|NCT01401959|3753320|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3931230|NCT01401959|3753321|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3931231|NCT01401959|3753318|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931232|NCT01401959|3753319|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931233|NCT01401959|3753320|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931234|NCT01401959|3753321|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931235|NCT01401959|3753318|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931236|NCT01401959|3753319|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931237|NCT01401959|3753320|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931238|NCT01401959|3753321|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931239|NCT01401959|3753318|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931240|NCT01401959|3753319|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931241|NCT01401959|3753320|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931242|NCT01401959|3753321|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931243|NCT01401959|3753318|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3931244|NCT01401959|3753319|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3931245|NCT01401959|3753320|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3931246|NCT01401959|3753321|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3931247|NCT01401959|3753318|B4||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3931248|NCT01401959|3753319|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3931249|NCT01401959|3753320|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3931250|NCT01401959|3753321|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3931251|NCT01401959|3753318|B4|||Age||years|Median|52|52.0|Full Range|||27.0|78.0|
3931252|NCT01401959|3753319|B3|||Age||years|Median|52|52.0|Full Range|||38.0|78.0|
3931253|NCT01401959|3753320|B2|||Age||years|Median|55|55.0|Full Range|||27.0|71.0|
3931254|NCT01401959|3753321|B1|||Age||years|Median|49|49.0|Full Range|||28.0|74.0|
3931255|NCT01401907|3753337|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3931256|NCT01401907|3753338|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3931257|NCT01401907|3753339|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3931258|NCT01401907|3753337|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3931259|NCT01401907|3753338|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931260|NCT01401907|3753339|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3931261|NCT01401907|3753337|B3||White|Race (NIH/OMB)||Participants|Count of Participants|323|323.0||||||
3931262|NCT01401907|3753338|B2||White|Race (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
3931263|NCT01401907|3753339|B1||White|Race (NIH/OMB)||Participants|Count of Participants|156|156.0||||||
3931264|NCT01401907|3753337|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3931265|NCT01401907|3753338|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3931266|NCT01401907|3753339|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3931267|NCT01401907|3753337|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931268|NCT01401907|3753338|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931269|NCT01401907|3753339|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931270|NCT01401907|3753337|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3931271|NCT01401907|3753338|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3931272|NCT01401907|3753339|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3931273|NCT01401907|3753337|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3931274|NCT01401907|3753338|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931275|NCT01401907|3753339|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3931276|NCT01401907|3753337|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931277|NCT01401907|3753338|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931278|NCT01401907|3753339|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931279|NCT01401907|3753337|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|341|341.0||||||
3931280|NCT01401907|3753338|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|173|173.0||||||
3931281|NCT01401907|3753339|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|168|168.0||||||
3931282|NCT01401907|3753337|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3931283|NCT01401907|3753338|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3931284|NCT01401907|3753339|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3931285|NCT01401907|3753337|B3||Male|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
3931286|NCT01401907|3753338|B2||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3931287|NCT01401907|3753339|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3931288|NCT01401907|3753337|B3||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3931289|NCT01401907|3753338|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3931290|NCT01401907|3753339|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3931291|NCT01401907|3753337|B3|||Age||years|Mean|64.85|64.85|Standard Deviation|10.88|10.88|||
3931292|NCT01401907|3753338|B2|||Age||years|Mean|64.03|64.03|Standard Deviation|10.46|10.46|||
3931293|NCT01401907|3753339|B1|||Age||years|Mean|65.64|65.64|Standard Deviation|11.26|11.26|||
3931294|NCT01401842|3753358|B3|||Dynamic Lumbar Extension Muscular Endurance|Dynamic lumbar extension muscular endurance (# repetitions at 50% peak torque) as assessed by a validated physical performance test on the lumbar dynamometer. Strengthening Exercise: n = 285; Stabilization Exercise: n = 271.|repetitions|Mean|21.9|21.9|Standard Deviation|7.9|7.9|||
3931295|NCT01401842|3753359|B2|||Dynamic Lumbar Extension Muscular Endurance|Dynamic lumbar extension muscular endurance (# repetitions at 50% peak torque) as assessed by a validated physical performance test on the lumbar dynamometer. Strengthening Exercise: n = 285; Stabilization Exercise: n = 271.|repetitions|Mean|22.0|22.0|Standard Deviation|8.0|8.0|||
3931296|NCT01401842|3753360|B1|||Dynamic Lumbar Extension Muscular Endurance|Dynamic lumbar extension muscular endurance (# repetitions at 50% peak torque) as assessed by a validated physical performance test on the lumbar dynamometer. Strengthening Exercise: n = 285; Stabilization Exercise: n = 271.|repetitions|Mean|21.8|21.8|Standard Deviation|7.7|7.7|||
3931297|NCT01401842|3753358|B3|||Isometric Core Muscular Endurance|Isometric core muscular endurance as assessed by a validated physical performance test (prone static plank test). Strengthening Exercise: n = 296; Stabilization Exercise: n = 279.|seconds|Mean|170.8|170.8|Standard Deviation|63.2|63.2|||
3931298|NCT01401842|3753359|B2|||Isometric Core Muscular Endurance|Isometric core muscular endurance as assessed by a validated physical performance test (prone static plank test). Strengthening Exercise: n = 296; Stabilization Exercise: n = 279.|seconds|Mean|172.8|172.8|Standard Deviation|64.1|64.1|||
3931299|NCT01401842|3753360|B1|||Isometric Core Muscular Endurance|Isometric core muscular endurance as assessed by a validated physical performance test (prone static plank test). Strengthening Exercise: n = 296; Stabilization Exercise: n = 279.|seconds|Mean|169.0|169.0|Standard Deviation|62.4|62.4|||
3931300|NCT01401842|3753358|B3|||Isometric Lumbar Extension Muscular Strength|Isometric lumbar extension muscular strength (torque - Nm) as assessed by a validated physical performance test on the lumbar dynamometer|Nm|Mean|273.7|273.7|Standard Deviation|89.9|89.9|||
3931301|NCT01401842|3753359|B2|||Isometric Lumbar Extension Muscular Strength|Isometric lumbar extension muscular strength (torque - Nm) as assessed by a validated physical performance test on the lumbar dynamometer|Nm|Mean|271.7|271.7|Standard Deviation|92.8|92.8|||
3931302|NCT01401842|3753360|B1|||Isometric Lumbar Extension Muscular Strength|Isometric lumbar extension muscular strength (torque - Nm) as assessed by a validated physical performance test on the lumbar dynamometer|Nm|Mean|275.4|275.4|Standard Deviation|87.0|87.0|||
3931303|NCT01401842|3753358|B3|United States||Region of Enrollment|All participants were enrolled from Fort Sam Houston, TX, USA|participants|Number|582|582.0||||||
3931304|NCT01401842|3753359|B2|United States||Region of Enrollment|All participants were enrolled from Fort Sam Houston, TX, USA|participants|Number|284|284.0||||||
3931305|NCT01401842|3753360|B1|United States||Region of Enrollment|All participants were enrolled from Fort Sam Houston, TX, USA|participants|Number|298|298.0||||||
3931306|NCT01401842|3753358|B3|White or Caucasian||Race/Ethnicity, Customized||participants|Number|360|360.0||||||
3931307|NCT01401842|3753359|B2|White or Caucasian||Race/Ethnicity, Customized||participants|Number|172|172.0||||||
3931308|NCT01401842|3753360|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|188|188.0||||||
3931309|NCT01401842|3753358|B3|Pacific Islander, White or Caucasian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3931310|NCT01401842|3753359|B2|Pacific Islander, White or Caucasian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3931311|NCT01401842|3753360|B1|Pacific Islander, White or Caucasian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3931312|NCT01401842|3753358|B3|Pacific Islander||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3931313|NCT01401842|3753359|B2|Pacific Islander||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3931314|NCT01401842|3753360|B1|Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3931315|NCT01401842|3753358|B3|Other, White or Caucasian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3931316|NCT01401842|3753359|B2|Other, White or Caucasian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3931317|NCT01401842|3753360|B1|Other, White or Caucasian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3931318|NCT01401842|3753358|B3|Other/unknown||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3931319|NCT01401842|3753359|B2|Other/unknown||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3931320|NCT01401842|3753360|B1|Other/unknown||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3931321|NCT01401842|3753358|B3|Hispanic, White or Caucasian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3931322|NCT01401842|3753359|B2|Hispanic, White or Caucasian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3931323|NCT01401842|3753360|B1|Hispanic, White or Caucasian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3931324|NCT01401842|3753358|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|87|87.0||||||
3931325|NCT01401842|3753359|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
3931326|NCT01401842|3753360|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
3931327|NCT01401842|3753358|B3|Black or African American, White or Caucasian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3931328|NCT01401842|3753359|B2|Black or African American, White or Caucasian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3931329|NCT01401842|3753360|B1|Black or African American, White or Caucasian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3931330|NCT01401842|3753358|B3|Black or African American, Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3931331|NCT01401842|3753359|B2|Black or African American, Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3931332|NCT01401842|3753360|B1|Black or African American, Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3931333|NCT01401842|3753358|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
3931334|NCT01401842|3753359|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3931335|NCT01401842|3753360|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
3931336|NCT01401842|3753358|B3|Asian, White or Caucasian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3931337|NCT01401842|3753359|B2|Asian, White or Caucasian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3931338|NCT01401842|3753360|B1|Asian, White or Caucasian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3931339|NCT01401842|3753358|B3|Asian, Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3931340|NCT01401842|3753359|B2|Asian, Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3931341|NCT01401842|3753360|B1|Asian, Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3931342|NCT01401842|3753358|B3|Asian, Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3931343|NCT01401842|3753359|B2|Asian, Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3931344|NCT01401842|3753360|B1|Asian, Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3931345|NCT01401842|3753358|B3|Asian, Black or African American, Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3931346|NCT01401842|3753359|B2|Asian, Black or African American, Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3931347|NCT01401842|3753360|B1|Asian, Black or African American, Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3931348|NCT01401842|3753358|B3|Asian, Black/African American, Hispanic, White/Cau||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3931349|NCT01401842|3753359|B2|Asian, Black/African American, Hispanic, White/Cau||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3931350|NCT01401842|3753360|B1|Asian, Black/African American, Hispanic, White/Cau||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3931351|NCT01401842|3753358|B3|Asian||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3931352|NCT01401842|3753359|B2|Asian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3931353|NCT01401842|3753360|B1|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3931354|NCT01401842|3753358|B3|American Indian, White or Caucasian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3931355|NCT01401842|3753359|B2|American Indian, White or Caucasian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3931356|NCT01401842|3753360|B1|American Indian, White or Caucasian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3931357|NCT01401842|3753358|B3|American Indian, Black/African American, White/Cau||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3931358|NCT01401842|3753359|B2|American Indian, Black/African American, White/Cau||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3931359|NCT01401842|3753360|B1|American Indian, Black/African American, White/Cau||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3931360|NCT01401842|3753358|B3|American Indian, Asian, Hispanic, White/Cau||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3931361|NCT01401842|3753359|B2|American Indian, Asian, Hispanic, White/Cau||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3931362|NCT01401842|3753360|B1|American Indian, Asian, Hispanic, White/Cau||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3931363|NCT01401842|3753358|B3|American Indian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3931364|NCT01401842|3753359|B2|American Indian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3931365|NCT01401842|3753360|B1|American Indian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3931366|NCT01401842|3753358|B3||Male|Sex: Female, Male||Participants|Count of Participants|447|447.0||||||
3931367|NCT01401842|3753359|B2||Male|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
3931368|NCT01401842|3753360|B1||Male|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
3931369|NCT01401842|3753358|B3||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3931370|NCT01401842|3753359|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3931371|NCT01401842|3753360|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3931372|NCT01401842|3753358|B3|||Age||years|Mean|21.7|21.7|Standard Deviation|3.7|3.7|||
3931373|NCT01401842|3753359|B2|||Age||years|Mean|21.5|21.5|Standard Deviation|3.6|3.6|||
3931374|NCT01401842|3753360|B1|||Age||years|Mean|21.8|21.8|Standard Deviation|3.8|3.8|||
3931375|NCT01401699|3753371|B1|United States||Region of Enrollment||Participants|Count of Participants|110|110.0||||||
3931376|NCT01401699|3753371|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3931377|NCT01401699|3753371|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3931378|NCT01401699|3753371|B1|||Age||years|Mean|63|63.0|Standard Deviation|11|11.0|||
3931379|NCT01401699|3753371|B1||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
3931380|NCT01401699|3753371|B1||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
3931381|NCT01401699|3753371|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931382|NCT01401647|3753375|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1664|1664.0||||||
3931383|NCT01401647|3753376|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|587|587.0||||||
3931384|NCT01401647|3753377|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|559|559.0||||||
3931385|NCT01401647|3753378|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|518|518.0||||||
3931386|NCT01401647|3753375|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3931387|NCT01401647|3753376|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3931388|NCT01401647|3753377|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931389|NCT01401647|3753378|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931390|NCT01401647|3753375|B4||White|Race (NIH/OMB)||Participants|Count of Participants|989|989.0||||||
3931391|NCT01401647|3753376|B3||White|Race (NIH/OMB)||Participants|Count of Participants|340|340.0||||||
3931392|NCT01401647|3753377|B2||White|Race (NIH/OMB)||Participants|Count of Participants|315|315.0||||||
3931393|NCT01401647|3753378|B1||White|Race (NIH/OMB)||Participants|Count of Participants|334|334.0||||||
3931394|NCT01401647|3753375|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|288|288.0||||||
3931395|NCT01401647|3753376|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
3931396|NCT01401647|3753377|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3931397|NCT01401647|3753378|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3931398|NCT01401647|3753375|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3931399|NCT01401647|3753376|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3931400|NCT01401647|3753377|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3931401|NCT01401647|3753378|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3931402|NCT01401647|3753375|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3931403|NCT01401647|3753376|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3931404|NCT01401647|3753377|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3931405|NCT01401647|3753378|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3931406|NCT01401647|3753375|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3931407|NCT01401647|3753376|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3931408|NCT01401647|3753377|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3931409|NCT01401647|3753378|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3931410|NCT01401647|3753375|B4||Male|Sex: Female, Male||Participants|Count of Participants|2421|2421.0||||||
3931411|NCT01401647|3753376|B3||Male|Sex: Female, Male||Participants|Count of Participants|844|844.0||||||
3931412|NCT01401647|3753377|B2||Male|Sex: Female, Male||Participants|Count of Participants|816|816.0||||||
3931413|NCT01401647|3753378|B1||Male|Sex: Female, Male||Participants|Count of Participants|761|761.0||||||
3931414|NCT01401647|3753375|B4||Female|Sex: Female, Male||Participants|Count of Participants|603|603.0||||||
3931415|NCT01401647|3753376|B3||Female|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
3931416|NCT01401647|3753377|B2||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
3931417|NCT01401647|3753378|B1||Female|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
3931418|NCT01401647|3753375|B4|||Age||years|Mean|63.5|63.5|Standard Deviation|14.4|14.4|||
3931419|NCT01401647|3753376|B3|||Age||years|Mean|63.1|63.1|Standard Deviation|14.6|14.6|||
3931420|NCT01401647|3753377|B2|||Age||years|Mean|63.4|63.4|Standard Deviation|14.7|14.7|||
3931421|NCT01401647|3753378|B1|||Age||years|Mean|64.0|64.0|Standard Deviation|14.0|14.0|||
3931422|NCT01401595|3753391|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
3931423|NCT01401595|3753392|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3931424|NCT01401595|3753393|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
3931425|NCT01401595|3753391|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3931426|NCT01401595|3753392|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3931427|NCT01401595|3753393|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3931428|NCT01401595|3753391|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3931429|NCT01401595|3753392|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3931430|NCT01401595|3753393|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3931431|NCT01401595|3753391|B3||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3931432|NCT01401595|3753392|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3931433|NCT01401595|3753393|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3931434|NCT01401595|3753391|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3931435|NCT01401595|3753392|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3931436|NCT01401595|3753393|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3931437|NCT01401595|3753391|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931438|NCT01401595|3753392|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931439|NCT01401595|3753393|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931440|NCT01401595|3753391|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3931441|NCT01401595|3753392|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931442|NCT01401595|3753393|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3931443|NCT01401595|3753391|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931444|NCT01401595|3753392|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931445|NCT01401595|3753393|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931446|NCT01401595|3753391|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3931447|NCT01401595|3753392|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3931448|NCT01401595|3753393|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3931449|NCT01401595|3753391|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3931450|NCT01401595|3753392|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3931451|NCT01401595|3753393|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3931452|NCT01401595|3753391|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3931453|NCT01401595|3753392|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3931454|NCT01401595|3753393|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3931455|NCT01401595|3753391|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3931456|NCT01401595|3753392|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3931457|NCT01401595|3753393|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3931458|NCT01401595|3753391|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3931459|NCT01401595|3753392|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3931460|NCT01401595|3753393|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3931461|NCT01401595|3753391|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3931462|NCT01401595|3753392|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3931463|NCT01401595|3753393|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3931464|NCT01401595|3753391|B3||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3931465|NCT01401595|3753392|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3931466|NCT01401595|3753393|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3931467|NCT01401595|3753391|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931468|NCT01401595|3753392|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931469|NCT01401595|3753393|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931470|NCT01401582|3753403|B3||Male|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
3931471|NCT01401582|3753404|B2||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3931472|NCT01401582|3753405|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3931473|NCT01401582|3753403|B3||Female|Sex: Female, Male||Participants|Count of Participants|307|307.0||||||
3931474|NCT01401582|3753404|B2||Female|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
3931475|NCT01401582|3753405|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3931476|NCT01401582|3753403|B3|||Age||years|Mean|80.0|80.0|Standard Deviation|5.5|5.5|||
3931477|NCT01401582|3753404|B2|||Age||years|Mean|80.2|80.2|Standard Deviation|5.7|5.7|||
3931478|NCT01401582|3753405|B1|||Age||years|Mean|79.6|79.6|Standard Deviation|5.3|5.3|||
3931479|NCT01401530|3753422|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3931480|NCT01401530|3753423|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3931481|NCT01401530|3753424|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3931482|NCT01401530|3753425|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3931483|NCT01401530|3753422|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3931484|NCT01401530|3753423|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3931485|NCT01401530|3753424|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3931486|NCT01401530|3753425|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3931487|NCT01401530|3753422|B4|||Age||Years|Mean|58.2|58.2|Standard Deviation|15.98|15.98|||
3931488|NCT01401530|3753423|B3|||Age||Years|Mean|66.3|66.3|Standard Deviation|4.16|4.16|||
3931489|NCT01401530|3753424|B2|||Age||Years|Mean|49.9|49.9|Standard Deviation|17.74|17.74|||
3931490|NCT01401530|3753425|B1|||Age||Years|Mean|69.7|69.7|Standard Deviation|5.51|5.51|||
3931491|NCT01401517|3753464|B4|United States||Region of Enrollment||participants|Number|55|55.0||||||
3931492|NCT01401517|3753465|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
3931493|NCT01401517|3753466|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3931494|NCT01401517|3753467|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3931495|NCT01401517|3753464|B4||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3931496|NCT01401517|3753465|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3931497|NCT01401517|3753466|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3931498|NCT01401517|3753467|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3931499|NCT01401517|3753464|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3931500|NCT01401517|3753465|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3931501|NCT01401517|3753466|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3931502|NCT01401517|3753467|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3931503|NCT01401517|3753464|B4||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
3931504|NCT01401517|3753465|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3931505|NCT01401517|3753466|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3931506|NCT01401517|3753467|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3931507|NCT01401517|3753464|B4||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3931508|NCT01401517|3753465|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3931509|NCT01401517|3753466|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3931510|NCT01401517|3753467|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3931511|NCT01401517|3753464|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931512|NCT01401517|3753465|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931513|NCT01401517|3753466|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931514|NCT01401517|3753467|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931515|NCT01401517|3753464|B4|||Age||years|Mean|66.0|66.0|Standard Deviation|9.21|9.21|||
3931516|NCT01401517|3753465|B3|||Age||years|Mean|67.9|67.9|Standard Deviation|9.99|9.99|||
3931517|NCT01401517|3753466|B2|||Age||years|Mean|65.3|65.3|Standard Deviation|8.86|8.86|||
3931518|NCT01401517|3753467|B1|||Age||years|Mean|64.9|64.9|Standard Deviation|8.98|8.98|||
3931519|NCT01401478|3753477|B1|Russian Federation||Region of Enrollment||participants|Number|86|86.0||||||
3931520|NCT01401478|3753477|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3931521|NCT01401478|3753477|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3931522|NCT01401478|3753477|B1|||Age||Participants|Mean|45.4|45.4|Standard Deviation|12.6|12.6|||
3931523|NCT01401478|3753477|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3931524|NCT01401478|3753477|B1||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
3931525|NCT01401478|3753477|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931526|NCT01401465|3753488|B3|United States||Region of Enrollment||participants|Number|327|327.0||||||
3931527|NCT01401465|3753489|B2|United States||Region of Enrollment||participants|Number|162|162.0||||||
3931528|NCT01401465|3753490|B1|United States||Region of Enrollment||participants|Number|165|165.0||||||
3931529|NCT01401465|3753488|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3931530|NCT01401465|3753489|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931531|NCT01401465|3753490|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3931532|NCT01401465|3753488|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3931533|NCT01401465|3753489|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3931534|NCT01401465|3753490|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3931535|NCT01401465|3753488|B3||White|Race (NIH/OMB)||Participants|Count of Participants|278|278.0||||||
3931536|NCT01401465|3753489|B2||White|Race (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
3931537|NCT01401465|3753490|B1||White|Race (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
3931538|NCT01401465|3753488|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3931539|NCT01401465|3753489|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3931540|NCT01401465|3753490|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3931541|NCT01401465|3753488|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3931542|NCT01401465|3753489|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3931543|NCT01401465|3753490|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931544|NCT01401465|3753488|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3931545|NCT01401465|3753489|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3931546|NCT01401465|3753490|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3931547|NCT01401465|3753488|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3931548|NCT01401465|3753489|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931549|NCT01401465|3753490|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3931550|NCT01401465|3753488|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931551|NCT01401465|3753489|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931675|NCT01401153|3753644|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3931552|NCT01401465|3753490|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931553|NCT01401465|3753488|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|259|259.0||||||
3931554|NCT01401465|3753489|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
3931555|NCT01401465|3753490|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|135|135.0||||||
3931556|NCT01401465|3753488|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3931557|NCT01401465|3753489|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3931558|NCT01401465|3753490|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3931559|NCT01401465|3753488|B3||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3931560|NCT01401465|3753489|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3931561|NCT01401465|3753490|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3931562|NCT01401465|3753488|B3||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3931563|NCT01401465|3753489|B2||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3931564|NCT01401465|3753490|B1||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3931565|NCT01401465|3753488|B3|||Age||years|Mean|36.6|36.6|Standard Deviation|14.76|14.76|||
3931566|NCT01401465|3753489|B2|||Age||years|Mean|35.7|35.7|Standard Deviation|14.72|14.72|||
3931567|NCT01401465|3753490|B1|||Age||years|Mean|37.5|37.5|Standard Deviation|14.78|14.78|||
3931568|NCT01401465|3753488|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3931569|NCT01401465|3753489|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3931570|NCT01401465|3753490|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3931571|NCT01401465|3753488|B3||Between 18 and 65 years|Age||Participants|Count of Participants|277|277.0||||||
3931572|NCT01401465|3753489|B2||Between 18 and 65 years|Age||Participants|Count of Participants|134|134.0||||||
3931573|NCT01401465|3753490|B1||Between 18 and 65 years|Age||Participants|Count of Participants|143|143.0||||||
3931574|NCT01401465|3753488|B3||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
3931575|NCT01401465|3753489|B2||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
3931576|NCT01401465|3753490|B1||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
3931577|NCT01401452|3753554|B1|Diabetes||Most prevalent co-morbidities among participants in the study||participants|Number|31|31.0||||||
3931578|NCT01401452|3753554|B1|Obesity||Most prevalent co-morbidities among participants in the study||participants|Number|64|64.0||||||
3931579|NCT01401452|3753554|B1|Metabolic syndrome||Most prevalent co-morbidities among participants in the study||participants|Number|72|72.0||||||
3931580|NCT01401452|3753554|B1|Hypertension||Most prevalent co-morbidities among participants in the study||participants|Number|79|79.0||||||
3931581|NCT01401452|3753554|B1|Psoriatic arthritis||Most prevalent co-morbidities among participants in the study||participants|Number|114|114.0||||||
3931582|NCT01401452|3753554|B1|Male||Number of participants with comorbidities||participants|Number|152|152.0||||||
3931583|NCT01401452|3753554|B1|Female||Number of participants with comorbidities||participants|Number|93|93.0||||||
3931584|NCT01401452|3753554|B1|||Duration of psoriasis||years|Mean|18.6|18.6|Standard Deviation|13.6|13.6|||
3931585|NCT01401452|3753554|B1||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3931586|NCT01401452|3753554|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3931587|NCT01401452|3753554|B1|||Age||years|Mean|48.8|48.8|Standard Deviation|13.6|13.6|||
3931588|NCT01401361|3753566|B1|Canada||Region of Enrollment||participants|Number|10|10.0||||||
3931589|NCT01401361|3753566|B1|United States||Region of Enrollment||participants|Number|140|140.0||||||
3931590|NCT01401361|3753566|B1||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3931591|NCT01401361|3753566|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3931592|NCT01401361|3753566|B1|||Age||years|Mean|64.82|64.82|Standard Deviation|11.97|11.97|||
3931593|NCT01401361|3753566|B1||>=65 years|Age||Participants|Count of Participants|82|82.0||||||
3931594|NCT01401361|3753566|B1||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
3931595|NCT01401361|3753566|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931596|NCT01401322|3753572|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3931597|NCT01401322|3753572|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3931598|NCT01401322|3753572|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3931599|NCT01401322|3753572|B1|||Age||years|Median|39.7|39.7|Full Range|||32.4|69.8|
3931600|NCT01401283|3753576|B3|Germany||Region of Enrollment||participants|Number|180|180.0||||||
3931601|NCT01401283|3753577|B2|Germany||Region of Enrollment||participants|Number|91|91.0||||||
3931602|NCT01401283|3753578|B1|Germany||Region of Enrollment||participants|Number|89|89.0||||||
3931603|NCT01401283|3753576|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3931604|NCT01401283|3753577|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3931605|NCT01401283|3753578|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3931606|NCT01401283|3753576|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3931607|NCT01401283|3753577|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3931608|NCT01401283|3753578|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3931609|NCT01401283|3753576|B3||>=65 years|Age||Participants|Count of Participants|61|61.0||||||
3931610|NCT01401283|3753577|B2||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
3931611|NCT01401283|3753578|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3931612|NCT01401283|3753576|B3||Between 18 and 65 years|Age||Participants|Count of Participants|119|119.0||||||
3931613|NCT01401283|3753577|B2||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
3931614|NCT01401283|3753578|B1||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
3931615|NCT01401283|3753576|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931616|NCT01401283|3753577|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931617|NCT01401283|3753578|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931618|NCT01401257|3753587|B5|France||Region of Enrollment||participants|Number|80|80.0||||||
3931619|NCT01401257|3753588|B4|France||Region of Enrollment||participants|Number|19|19.0||||||
3931620|NCT01401257|3753589|B3|France||Region of Enrollment||participants|Number|19|19.0||||||
3931621|NCT01401257|3753590|B2|France||Region of Enrollment||participants|Number|21|21.0||||||
3931622|NCT01401257|3753591|B1|France||Region of Enrollment||participants|Number|21|21.0||||||
3931623|NCT01401257|3753587|B5||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3931624|NCT01401257|3753588|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3931625|NCT01401257|3753589|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3931626|NCT01401257|3753590|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3931627|NCT01401257|3753591|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3931628|NCT01401257|3753587|B5||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3931629|NCT01401257|3753588|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3931630|NCT01401257|3753589|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3931631|NCT01401257|3753590|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3931632|NCT01401257|3753591|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3931633|NCT01401257|3753587|B5|||Age||years|Mean|45.1|45.1|Full Range|||18.0|65.0|
3931634|NCT01401257|3753588|B4|||Age||years|Mean|43.2|43.2|Full Range|||21.0|65.0|
3931635|NCT01401257|3753589|B3|||Age||years|Mean|44.6|44.6|Full Range|||24.0|63.0|
3931636|NCT01401257|3753590|B2|||Age||years|Mean|44.3|44.3|Full Range|||23.0|64.0|
3931637|NCT01401257|3753591|B1|||Age||years|Mean|47.9|47.9|Full Range|||18.0|63.0|
3931638|NCT01401257|3753587|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3931639|NCT01401257|3753588|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3931640|NCT01401257|3753589|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3931641|NCT01401257|3753590|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3931642|NCT01401257|3753591|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3931643|NCT01401257|3753587|B5||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
3931644|NCT01401257|3753588|B4||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3931645|NCT01401257|3753589|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3931646|NCT01401257|3753590|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3931647|NCT01401257|3753591|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3931648|NCT01401257|3753587|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931649|NCT01401257|3753588|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931650|NCT01401257|3753589|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931651|NCT01401257|3753590|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931652|NCT01401257|3753591|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931653|NCT01401166|3753604|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3931654|NCT01401166|3753605|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3931655|NCT01401166|3753606|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3931656|NCT01401166|3753604|B3||Female|Sex: Female, Male||Participants|Count of Participants|483|483.0||||||
3931657|NCT01401166|3753605|B2||Female|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
3931658|NCT01401166|3753606|B1||Female|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
3931659|NCT01401166|3753604|B3|||Age||years|Mean|53.1|53.1|Standard Deviation|11.13|11.13|||
3931660|NCT01401166|3753605|B2|||Age||years|Mean|52.9|52.9|Standard Deviation|10.87|10.87|||
3931661|NCT01401166|3753606|B1|||Age||years|Mean|53.3|53.3|Standard Deviation|11.40|11.4|||
3931662|NCT01401153|3753643|B3|Germany||Region of Enrollment||participants|Number|121|121.0||||||
3931663|NCT01401153|3753644|B2|Germany||Region of Enrollment||participants|Number|55|55.0||||||
3931664|NCT01401153|3753645|B1|Germany||Region of Enrollment||participants|Number|66|66.0||||||
3931665|NCT01401153|3753643|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3931666|NCT01401153|3753644|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3931667|NCT01401153|3753645|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3931668|NCT01401153|3753643|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3931669|NCT01401153|3753644|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3931670|NCT01401153|3753645|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3931671|NCT01401153|3753643|B3|||Age||years|Mean|12.7|12.7|Standard Deviation|0.6|0.6|||
3931672|NCT01401153|3753644|B2|||Age||years|Mean|12.7|12.7|Standard Deviation|0.6|0.6|||
3931673|NCT01401153|3753645|B1|||Age||years|Mean|12.7|12.7|Standard Deviation|0.6|0.6|||
3931674|NCT01401153|3753643|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3931676|NCT01401153|3753645|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3931677|NCT01401153|3753643|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3931678|NCT01401153|3753644|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3931679|NCT01401153|3753645|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3931680|NCT01401153|3753643|B3||<=18 years|Age||Participants|Count of Participants|121|121.0||||||
3931681|NCT01401153|3753644|B2||<=18 years|Age||Participants|Count of Participants|55|55.0||||||
3931682|NCT01401153|3753645|B1||<=18 years|Age||Participants|Count of Participants|66|66.0||||||
3931683|NCT01401101|3753678|B3|United States||Region of Enrollment||participants|Number|355|355.0||||||
3931684|NCT01401101|3753679|B2|United States||Region of Enrollment||participants|Number|171|171.0||||||
3931685|NCT01401101|3753680|B1|United States||Region of Enrollment||participants|Number|184|184.0||||||
3931686|NCT01401101|3753678|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3931687|NCT01401101|3753679|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3931688|NCT01401101|3753680|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3931689|NCT01401101|3753678|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3931690|NCT01401101|3753679|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3931691|NCT01401101|3753680|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3931692|NCT01401101|3753678|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3931693|NCT01401101|3753679|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3931694|NCT01401101|3753680|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931695|NCT01401101|3753678|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3931696|NCT01401101|3753679|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3931697|NCT01401101|3753680|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3931698|NCT01401101|3753678|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3931699|NCT01401101|3753679|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3931700|NCT01401101|3753680|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931701|NCT01401101|3753678|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
3931702|NCT01401101|3753679|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3931703|NCT01401101|3753680|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3931704|NCT01401101|3753678|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|183|183.0||||||
3931705|NCT01401101|3753679|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3931706|NCT01401101|3753680|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3931707|NCT01401101|3753678|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3931708|NCT01401101|3753679|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3931709|NCT01401101|3753680|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3931710|NCT01401101|3753678|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
3931711|NCT01401101|3753679|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3931712|NCT01401101|3753680|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3931713|NCT01401101|3753678|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|185|185.0||||||
3931714|NCT01401101|3753679|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
3931715|NCT01401101|3753680|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3931716|NCT01401101|3753678|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3931717|NCT01401101|3753679|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3931718|NCT01401101|3753680|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3931719|NCT01401101|3753678|B3||Female|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
3931720|NCT01401101|3753679|B2||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3931721|NCT01401101|3753680|B1||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3931722|NCT01401101|3753678|B3|||Age||years|Mean|42.4|42.4|Standard Deviation|12.2|12.2|||
3931723|NCT01401101|3753679|B2|||Age||years|Mean|42.2|42.2|Standard Deviation|12.0|12.0|||
3931724|NCT01401101|3753680|B1|||Age||years|Mean|42.5|42.5|Standard Deviation|12.4|12.4|||
3931725|NCT01401062|3753691|B3|Other/Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3931726|NCT01401062|3753692|B2|Other/Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3931727|NCT01401062|3753693|B1|Other/Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3931728|NCT01401062|3753691|B3|White, not of Hispanic-American origin||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3931729|NCT01401062|3753692|B2|White, not of Hispanic-American origin||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3931730|NCT01401062|3753693|B1|White, not of Hispanic-American origin||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3931731|NCT01401062|3753691|B3|Black, not of Hispanic-American Origin||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3931732|NCT01401062|3753692|B2|Black, not of Hispanic-American Origin||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3931733|NCT01401062|3753693|B1|Black, not of Hispanic-American Origin||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3931734|NCT01401062|3753691|B3|Asian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3931735|NCT01401062|3753692|B2|Asian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3931736|NCT01401062|3753693|B1|Asian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3931737|NCT01401062|3753691|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3931738|NCT01401062|3753692|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3931739|NCT01401062|3753693|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3931740|NCT01401062|3753691|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3931741|NCT01401062|3753692|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3931742|NCT01401062|3753693|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3931743|NCT01401062|3753691|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3931744|NCT01401062|3753692|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3931745|NCT01401062|3753693|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3931746|NCT01401062|3753691|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3931747|NCT01401062|3753692|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3931748|NCT01401062|3753693|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3931749|NCT01401062|3753691|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931750|NCT01401062|3753692|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931751|NCT01401062|3753693|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931752|NCT01401023|3753711|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3931753|NCT01401023|3753711|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3931754|NCT01401023|3753711|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3931755|NCT01401023|3753711|B1|||Age||years|Mean|63|63.0|Standard Deviation|16|16.0|||
3931756|NCT01401023|3753711|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3931757|NCT01401023|3753711|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3931758|NCT01401023|3753711|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931759|NCT01401010|3753719|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3931760|NCT01401010|3753720|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3931761|NCT01401010|3753721|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3931762|NCT01401010|3753719|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3931763|NCT01401010|3753720|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3931764|NCT01401010|3753721|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3931765|NCT01401010|3753719|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3931766|NCT01401010|3753720|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3931767|NCT01401010|3753721|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3931768|NCT01401010|3753719|B3|||Age||years|Mean|49|49.0|Standard Deviation|17.5|17.5|||
3931769|NCT01401010|3753720|B2|||Age||years|Mean|49|49.0|Standard Deviation|18|18.0|||
3931770|NCT01401010|3753721|B1|||Age||years|Mean|49|49.0|Standard Deviation|17|17.0|||
3931771|NCT01401010|3753719|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3931772|NCT01401010|3753720|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3931773|NCT01401010|3753721|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3931774|NCT01401010|3753719|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3931775|NCT01401010|3753720|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3931776|NCT01401010|3753721|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3931777|NCT01401010|3753719|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931778|NCT01401010|3753720|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931779|NCT01401010|3753721|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931780|NCT01400958|3753745|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3931781|NCT01400958|3753746|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3931782|NCT01400958|3753747|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3931783|NCT01400958|3753745|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3931784|NCT01400958|3753746|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3931785|NCT01400958|3753747|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3931786|NCT01400958|3753745|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3931787|NCT01400958|3753746|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3931788|NCT01400958|3753747|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3931789|NCT01400958|3753745|B3|||Age||years|Mean|62|62.0|Full Range|||48.0|72.0|
3931790|NCT01400958|3753746|B2|||Age||years|Mean|65|65.0|Full Range|||53.0|72.0|
3931791|NCT01400958|3753747|B1|||Age||years|Mean|59|59.0|Full Range|||48.0|66.0|
3931792|NCT01400958|3753745|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3931793|NCT01400958|3753746|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3931794|NCT01400958|3753747|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3931795|NCT01400958|3753745|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3931796|NCT01400958|3753746|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3931797|NCT01400958|3753747|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3931798|NCT01400958|3753745|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931799|NCT01400958|3753746|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931800|NCT01400958|3753747|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931801|NCT01400932|3753756|B3|5: Very Severe||Participants with the Indicated Investigational's Static Global Assessment (ISGA) Score at Baseline|Investigators evaluated the acne severity of the participants' face using the ISGA scale, ranging from 0 to 5: 0=clear skin with no ILs or NILs; 1=almost clear: rare NILs with no more than rare papules; 2=mild acne: greater than Grade 1, some NILs with no more than a few ILs (papules/pustules only, no NLs); 3=moderate acne: greater than Grade 2, up to many NILs and had some ILs, but no more than one small NL; 4=severe acne: greater than Grade 3, up to many NILs and ILs, but no more than a few NLs; 5=very severe acne: many NILs and ILs and more than a few NLs, had cystic lesions.|participants|Number|0|0.0||||||
3931802|NCT01400932|3753757|B2|5: Very Severe||Participants with the Indicated Investigational's Static Global Assessment (ISGA) Score at Baseline|Investigators evaluated the acne severity of the participants' face using the ISGA scale, ranging from 0 to 5: 0=clear skin with no ILs or NILs; 1=almost clear: rare NILs with no more than rare papules; 2=mild acne: greater than Grade 1, some NILs with no more than a few ILs (papules/pustules only, no NLs); 3=moderate acne: greater than Grade 2, up to many NILs and had some ILs, but no more than one small NL; 4=severe acne: greater than Grade 3, up to many NILs and ILs, but no more than a few NLs; 5=very severe acne: many NILs and ILs and more than a few NLs, had cystic lesions.|participants|Number|0|0.0||||||
3931803|NCT01400932|3753758|B1|5: Very Severe||Participants with the Indicated Investigational's Static Global Assessment (ISGA) Score at Baseline|Investigators evaluated the acne severity of the participants' face using the ISGA scale, ranging from 0 to 5: 0=clear skin with no ILs or NILs; 1=almost clear: rare NILs with no more than rare papules; 2=mild acne: greater than Grade 1, some NILs with no more than a few ILs (papules/pustules only, no NLs); 3=moderate acne: greater than Grade 2, up to many NILs and had some ILs, but no more than one small NL; 4=severe acne: greater than Grade 3, up to many NILs and ILs, but no more than a few NLs; 5=very severe acne: many NILs and ILs and more than a few NLs, had cystic lesions.|participants|Number|0|0.0||||||
3931804|NCT01400932|3753756|B3|4: Severe||Participants with the Indicated Investigational's Static Global Assessment (ISGA) Score at Baseline|Investigators evaluated the acne severity of the participants' face using the ISGA scale, ranging from 0 to 5: 0=clear skin with no ILs or NILs; 1=almost clear: rare NILs with no more than rare papules; 2=mild acne: greater than Grade 1, some NILs with no more than a few ILs (papules/pustules only, no NLs); 3=moderate acne: greater than Grade 2, up to many NILs and had some ILs, but no more than one small NL; 4=severe acne: greater than Grade 3, up to many NILs and ILs, but no more than a few NLs; 5=very severe acne: many NILs and ILs and more than a few NLs, had cystic lesions.|participants|Number|39|39.0||||||
3931805|NCT01400932|3753757|B2|4: Severe||Participants with the Indicated Investigational's Static Global Assessment (ISGA) Score at Baseline|Investigators evaluated the acne severity of the participants' face using the ISGA scale, ranging from 0 to 5: 0=clear skin with no ILs or NILs; 1=almost clear: rare NILs with no more than rare papules; 2=mild acne: greater than Grade 1, some NILs with no more than a few ILs (papules/pustules only, no NLs); 3=moderate acne: greater than Grade 2, up to many NILs and had some ILs, but no more than one small NL; 4=severe acne: greater than Grade 3, up to many NILs and ILs, but no more than a few NLs; 5=very severe acne: many NILs and ILs and more than a few NLs, had cystic lesions.|participants|Number|19|19.0||||||
3931806|NCT01400932|3753758|B1|4: Severe||Participants with the Indicated Investigational's Static Global Assessment (ISGA) Score at Baseline|Investigators evaluated the acne severity of the participants' face using the ISGA scale, ranging from 0 to 5: 0=clear skin with no ILs or NILs; 1=almost clear: rare NILs with no more than rare papules; 2=mild acne: greater than Grade 1, some NILs with no more than a few ILs (papules/pustules only, no NLs); 3=moderate acne: greater than Grade 2, up to many NILs and had some ILs, but no more than one small NL; 4=severe acne: greater than Grade 3, up to many NILs and ILs, but no more than a few NLs; 5=very severe acne: many NILs and ILs and more than a few NLs, had cystic lesions.|participants|Number|20|20.0||||||
3931807|NCT01400932|3753756|B3|3: Moderate Severity||Participants with the Indicated Investigational's Static Global Assessment (ISGA) Score at Baseline|Investigators evaluated the acne severity of the participants' face using the ISGA scale, ranging from 0 to 5: 0=clear skin with no ILs or NILs; 1=almost clear: rare NILs with no more than rare papules; 2=mild acne: greater than Grade 1, some NILs with no more than a few ILs (papules/pustules only, no NLs); 3=moderate acne: greater than Grade 2, up to many NILs and had some ILs, but no more than one small NL; 4=severe acne: greater than Grade 3, up to many NILs and ILs, but no more than a few NLs; 5=very severe acne: many NILs and ILs and more than a few NLs, had cystic lesions.|participants|Number|235|235.0||||||
3931808|NCT01400932|3753757|B2|3: Moderate Severity||Participants with the Indicated Investigational's Static Global Assessment (ISGA) Score at Baseline|Investigators evaluated the acne severity of the participants' face using the ISGA scale, ranging from 0 to 5: 0=clear skin with no ILs or NILs; 1=almost clear: rare NILs with no more than rare papules; 2=mild acne: greater than Grade 1, some NILs with no more than a few ILs (papules/pustules only, no NLs); 3=moderate acne: greater than Grade 2, up to many NILs and had some ILs, but no more than one small NL; 4=severe acne: greater than Grade 3, up to many NILs and ILs, but no more than a few NLs; 5=very severe acne: many NILs and ILs and more than a few NLs, had cystic lesions.|participants|Number|118|118.0||||||
3931809|NCT01400932|3753758|B1|3: Moderate Severity||Participants with the Indicated Investigational's Static Global Assessment (ISGA) Score at Baseline|Investigators evaluated the acne severity of the participants' face using the ISGA scale, ranging from 0 to 5: 0=clear skin with no ILs or NILs; 1=almost clear: rare NILs with no more than rare papules; 2=mild acne: greater than Grade 1, some NILs with no more than a few ILs (papules/pustules only, no NLs); 3=moderate acne: greater than Grade 2, up to many NILs and had some ILs, but no more than one small NL; 4=severe acne: greater than Grade 3, up to many NILs and ILs, but no more than a few NLs; 5=very severe acne: many NILs and ILs and more than a few NLs, had cystic lesions.|participants|Number|117|117.0||||||
3931857|NCT01400893|3753824|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931810|NCT01400932|3753756|B3|2: Mild Severity||Participants with the Indicated Investigational's Static Global Assessment (ISGA) Score at Baseline|Investigators evaluated the acne severity of the participants' face using the ISGA scale, ranging from 0 to 5: 0=clear skin with no ILs or NILs; 1=almost clear: rare NILs with no more than rare papules; 2=mild acne: greater than Grade 1, some NILs with no more than a few ILs (papules/pustules only, no NLs); 3=moderate acne: greater than Grade 2, up to many NILs and had some ILs, but no more than one small NL; 4=severe acne: greater than Grade 3, up to many NILs and ILs, but no more than a few NLs; 5=very severe acne: many NILs and ILs and more than a few NLs, had cystic lesions.|participants|Number|86|86.0||||||
3931811|NCT01400932|3753757|B2|2: Mild Severity||Participants with the Indicated Investigational's Static Global Assessment (ISGA) Score at Baseline|Investigators evaluated the acne severity of the participants' face using the ISGA scale, ranging from 0 to 5: 0=clear skin with no ILs or NILs; 1=almost clear: rare NILs with no more than rare papules; 2=mild acne: greater than Grade 1, some NILs with no more than a few ILs (papules/pustules only, no NLs); 3=moderate acne: greater than Grade 2, up to many NILs and had some ILs, but no more than one small NL; 4=severe acne: greater than Grade 3, up to many NILs and ILs, but no more than a few NLs; 5=very severe acne: many NILs and ILs and more than a few NLs, had cystic lesions.|participants|Number|45|45.0||||||
3931812|NCT01400932|3753758|B1|2: Mild Severity||Participants with the Indicated Investigational's Static Global Assessment (ISGA) Score at Baseline|Investigators evaluated the acne severity of the participants' face using the ISGA scale, ranging from 0 to 5: 0=clear skin with no ILs or NILs; 1=almost clear: rare NILs with no more than rare papules; 2=mild acne: greater than Grade 1, some NILs with no more than a few ILs (papules/pustules only, no NLs); 3=moderate acne: greater than Grade 2, up to many NILs and had some ILs, but no more than one small NL; 4=severe acne: greater than Grade 3, up to many NILs and ILs, but no more than a few NLs; 5=very severe acne: many NILs and ILs and more than a few NLs, had cystic lesions.|participants|Number|41|41.0||||||
3931813|NCT01400932|3753756|B3|1: Almost Clear||Participants with the Indicated Investigational's Static Global Assessment (ISGA) Score at Baseline|Investigators evaluated the acne severity of the participants' face using the ISGA scale, ranging from 0 to 5: 0=clear skin with no ILs or NILs; 1=almost clear: rare NILs with no more than rare papules; 2=mild acne: greater than Grade 1, some NILs with no more than a few ILs (papules/pustules only, no NLs); 3=moderate acne: greater than Grade 2, up to many NILs and had some ILs, but no more than one small NL; 4=severe acne: greater than Grade 3, up to many NILs and ILs, but no more than a few NLs; 5=very severe acne: many NILs and ILs and more than a few NLs, had cystic lesions.|participants|Number|0|0.0||||||
3931814|NCT01400932|3753757|B2|1: Almost Clear||Participants with the Indicated Investigational's Static Global Assessment (ISGA) Score at Baseline|Investigators evaluated the acne severity of the participants' face using the ISGA scale, ranging from 0 to 5: 0=clear skin with no ILs or NILs; 1=almost clear: rare NILs with no more than rare papules; 2=mild acne: greater than Grade 1, some NILs with no more than a few ILs (papules/pustules only, no NLs); 3=moderate acne: greater than Grade 2, up to many NILs and had some ILs, but no more than one small NL; 4=severe acne: greater than Grade 3, up to many NILs and ILs, but no more than a few NLs; 5=very severe acne: many NILs and ILs and more than a few NLs, had cystic lesions.|participants|Number|0|0.0||||||
3931815|NCT01400932|3753758|B1|1: Almost Clear||Participants with the Indicated Investigational's Static Global Assessment (ISGA) Score at Baseline|Investigators evaluated the acne severity of the participants' face using the ISGA scale, ranging from 0 to 5: 0=clear skin with no ILs or NILs; 1=almost clear: rare NILs with no more than rare papules; 2=mild acne: greater than Grade 1, some NILs with no more than a few ILs (papules/pustules only, no NLs); 3=moderate acne: greater than Grade 2, up to many NILs and had some ILs, but no more than one small NL; 4=severe acne: greater than Grade 3, up to many NILs and ILs, but no more than a few NLs; 5=very severe acne: many NILs and ILs and more than a few NLs, had cystic lesions.|participants|Number|0|0.0||||||
3931816|NCT01400932|3753756|B3|0: Clear||Participants with the Indicated Investigational's Static Global Assessment (ISGA) Score at Baseline|Investigators evaluated the acne severity of the participants' face using the ISGA scale, ranging from 0 to 5: 0=clear skin with no ILs or NILs; 1=almost clear: rare NILs with no more than rare papules; 2=mild acne: greater than Grade 1, some NILs with no more than a few ILs (papules/pustules only, no NLs); 3=moderate acne: greater than Grade 2, up to many NILs and had some ILs, but no more than one small NL; 4=severe acne: greater than Grade 3, up to many NILs and ILs, but no more than a few NLs; 5=very severe acne: many NILs and ILs and more than a few NLs, had cystic lesions.|participants|Number|0|0.0||||||
3931817|NCT01400932|3753757|B2|0: Clear||Participants with the Indicated Investigational's Static Global Assessment (ISGA) Score at Baseline|Investigators evaluated the acne severity of the participants' face using the ISGA scale, ranging from 0 to 5: 0=clear skin with no ILs or NILs; 1=almost clear: rare NILs with no more than rare papules; 2=mild acne: greater than Grade 1, some NILs with no more than a few ILs (papules/pustules only, no NLs); 3=moderate acne: greater than Grade 2, up to many NILs and had some ILs, but no more than one small NL; 4=severe acne: greater than Grade 3, up to many NILs and ILs, but no more than a few NLs; 5=very severe acne: many NILs and ILs and more than a few NLs, had cystic lesions.|participants|Number|0|0.0||||||
3931818|NCT01400932|3753758|B1|0: Clear||Participants with the Indicated Investigational's Static Global Assessment (ISGA) Score at Baseline|Investigators evaluated the acne severity of the participants' face using the ISGA scale, ranging from 0 to 5: 0=clear skin with no ILs or NILs; 1=almost clear: rare NILs with no more than rare papules; 2=mild acne: greater than Grade 1, some NILs with no more than a few ILs (papules/pustules only, no NLs); 3=moderate acne: greater than Grade 2, up to many NILs and had some ILs, but no more than one small NL; 4=severe acne: greater than Grade 3, up to many NILs and ILs, but no more than a few NLs; 5=very severe acne: many NILs and ILs and more than a few NLs, had cystic lesions.|participants|Number|0|0.0||||||
3931819|NCT01400932|3753756|B3|||Inflammatory Lesion (IL) Counts at Baseline|The investigator/subinvestigator counted all inflammatory lesions (papules, pustules, and nodular lesions [NL]) on the face at each study visit. A papule is a small, raised, red, dome-shaped palpable lesion. A pustule is a raised, dome-shaped palpable lesion containing yellow fluid (pus). A nodule may be a raised or deep-seated, dome-shaped palpable lesion of at least 5 millimeters in diameter.|lesion counts|Mean|27.7|27.7|Standard Deviation|10.41|10.41|||
3931858|NCT01400893|3753822|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3931859|NCT01400893|3753823|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3931860|NCT01400893|3753824|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3931820|NCT01400932|3753757|B2|||Inflammatory Lesion (IL) Counts at Baseline|The investigator/subinvestigator counted all inflammatory lesions (papules, pustules, and nodular lesions [NL]) on the face at each study visit. A papule is a small, raised, red, dome-shaped palpable lesion. A pustule is a raised, dome-shaped palpable lesion containing yellow fluid (pus). A nodule may be a raised or deep-seated, dome-shaped palpable lesion of at least 5 millimeters in diameter.|lesion counts|Mean|27.5|27.5|Standard Deviation|10.09|10.09|||
3931821|NCT01400932|3753758|B1|||Inflammatory Lesion (IL) Counts at Baseline|The investigator/subinvestigator counted all inflammatory lesions (papules, pustules, and nodular lesions [NL]) on the face at each study visit. A papule is a small, raised, red, dome-shaped palpable lesion. A pustule is a raised, dome-shaped palpable lesion containing yellow fluid (pus). A nodule may be a raised or deep-seated, dome-shaped palpable lesion of at least 5 millimeters in diameter.|lesion counts|Mean|28.0|28.0|Standard Deviation|10.76|10.76|||
3931822|NCT01400932|3753756|B3|||Non-inflammatory Lesion (NIL) Counts at Baseline|The investigator/subinvestigator counted all non-inflammatory lesions (open and closed comedo) on the face at each study visit. An open comedo is an open, widely dilated follicle with black-colored sebum, due to melanin and oxidation, and keratinous material that forms a plug, thereby obstructing the pilosebaceous duct. A closed comedo is a closed follicle filled with impacted sebum covered by keratin that has a whitish color.|lesion counts|Mean|43.4|43.4|Standard Deviation|27.14|27.14|||
3931823|NCT01400932|3753757|B2|||Non-inflammatory Lesion (NIL) Counts at Baseline|The investigator/subinvestigator counted all non-inflammatory lesions (open and closed comedo) on the face at each study visit. An open comedo is an open, widely dilated follicle with black-colored sebum, due to melanin and oxidation, and keratinous material that forms a plug, thereby obstructing the pilosebaceous duct. A closed comedo is a closed follicle filled with impacted sebum covered by keratin that has a whitish color.|lesion counts|Mean|42.7|42.7|Standard Deviation|26.28|26.28|||
3931824|NCT01400932|3753758|B1|||Non-inflammatory Lesion (NIL) Counts at Baseline|The investigator/subinvestigator counted all non-inflammatory lesions (open and closed comedo) on the face at each study visit. An open comedo is an open, widely dilated follicle with black-colored sebum, due to melanin and oxidation, and keratinous material that forms a plug, thereby obstructing the pilosebaceous duct. A closed comedo is a closed follicle filled with impacted sebum covered by keratin that has a whitish color.|lesion counts|Mean|44.2|44.2|Standard Deviation|28.03|28.03|||
3931825|NCT01400932|3753756|B3|||Total Lesion Counts at Baseline|The investigator (or subinvestigator) counted all inflammatory lesions (papules, pustules, and nodular lesions) and non-inflammatory lesions (open and closed comedos; diagnosis based on palpation) on the face at each study visit.|lesion counts|Mean|71.2|71.2|Standard Deviation|32.12|32.12|||
3931826|NCT01400932|3753757|B2|||Total Lesion Counts at Baseline|The investigator (or subinvestigator) counted all inflammatory lesions (papules, pustules, and nodular lesions) and non-inflammatory lesions (open and closed comedos; diagnosis based on palpation) on the face at each study visit.|lesion counts|Mean|70.3|70.3|Standard Deviation|30.89|30.89|||
3931827|NCT01400932|3753758|B1|||Total Lesion Counts at Baseline|The investigator (or subinvestigator) counted all inflammatory lesions (papules, pustules, and nodular lesions) and non-inflammatory lesions (open and closed comedos; diagnosis based on palpation) on the face at each study visit.|lesion counts|Mean|72.1|72.1|Standard Deviation|33.40|33.4|||
3931828|NCT01400932|3753756|B3|Asian-Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|360|360.0||||||
3931829|NCT01400932|3753757|B2|Asian-Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|182|182.0||||||
3931830|NCT01400932|3753758|B1|Asian-Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|178|178.0||||||
3931831|NCT01400932|3753756|B3||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3931832|NCT01400932|3753757|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3931833|NCT01400932|3753758|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3931834|NCT01400932|3753756|B3||Female|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
3931835|NCT01400932|3753757|B2||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3931836|NCT01400932|3753758|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3931837|NCT01400932|3753756|B3|||Age||Years|Mean|21.9|21.9|Standard Deviation|6.38|6.38|||
3931838|NCT01400932|3753757|B2|||Age||Years|Mean|22.4|22.4|Standard Deviation|6.76|6.76|||
3931839|NCT01400932|3753758|B1|||Age||Years|Mean|21.3|21.3|Standard Deviation|5.93|5.93|||
3931840|NCT01400919|3753781|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3931841|NCT01400919|3753781|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3931842|NCT01400919|3753781|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|8.9|8.9|||
3931843|NCT01400906|3753785|B1|White||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3931844|NCT01400906|3753785|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3931845|NCT01400906|3753785|B1|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3931846|NCT01400906|3753785|B1|Central/South Asian HER||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3931847|NCT01400906|3753785|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3931848|NCT01400906|3753785|B1|African American/African Heritage (HER)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3931849|NCT01400906|3753785|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3931850|NCT01400906|3753785|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3931851|NCT01400906|3753785|B1|||Age||Years|Mean|30.0|30.0|Standard Deviation|7.85|7.85|||
3931852|NCT01400893|3753822|B3|United States||Region of Enrollment||participants|Number|134|134.0||||||
3931853|NCT01400893|3753823|B2|United States||Region of Enrollment||participants|Number|65|65.0||||||
3931854|NCT01400893|3753824|B1|United States||Region of Enrollment||participants|Number|69|69.0||||||
3931855|NCT01400893|3753822|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3931856|NCT01400893|3753823|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3931861|NCT01400893|3753822|B3||White|Race (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
3931862|NCT01400893|3753823|B2||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3931863|NCT01400893|3753824|B1||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3931864|NCT01400893|3753822|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3931865|NCT01400893|3753823|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3931866|NCT01400893|3753824|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3931867|NCT01400893|3753822|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931868|NCT01400893|3753823|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931869|NCT01400893|3753824|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931870|NCT01400893|3753822|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931871|NCT01400893|3753823|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931872|NCT01400893|3753824|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931873|NCT01400893|3753822|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931874|NCT01400893|3753823|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931875|NCT01400893|3753824|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3931876|NCT01400893|3753822|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3931877|NCT01400893|3753823|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3931878|NCT01400893|3753824|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3931879|NCT01400893|3753822|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3931880|NCT01400893|3753823|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3931881|NCT01400893|3753824|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3931882|NCT01400893|3753822|B3|||Age||years|Mean|55.4|55.4|Standard Deviation|14|14.0|||
3931883|NCT01400893|3753823|B2|||Age||years|Mean|53.5|53.5|Standard Deviation|14.7|14.7|||
3931884|NCT01400893|3753824|B1|||Age||years|Mean|57.2|57.2|Standard Deviation|13.1|13.1|||
3931885|NCT01400880|3753833|B1|Pregnant Women||Sex/Gender, Customized||participants|Number|101|101.0||||||
3931886|NCT01400880|3753833|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3931887|NCT01400880|3753833|B1||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
3931888|NCT01400880|3753833|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931889|NCT01400841|3753837|B1|||Cardiac index|Cardiac index is the cardiac output divided by body surface area. n=9 (7 unavailable or not evaluable)|l/min/m^2|Mean|3.41|3.41|Standard Deviation|0.90|0.9|||
3931890|NCT01400841|3753837|B1|||Cardiac output|Echocardiographic parameter determined by core laboratory. n=9 (7 unavailable or not evaluable)|l/min|Mean|6.77|6.77|Standard Deviation|1.60|1.6|||
3931891|NCT01400841|3753837|B1|||Left ventricular ejection fraction (LVEF)|Left ventricular ejection fraction. Echocardiographic parameter determined by core laboratory. n=10 (6 unavailable or not evaluable)|%|Mean|53.2|53.2|Standard Deviation|6.7|6.7|||
3931892|NCT01400841|3753837|B1|||LV systolic volume|Left ventricular systolic volume. Echocardiographic parameter determined by core laboratory. n=10 (6 unavailable or not evaluable)|ml|Mean|84.7|84.7|Standard Deviation|25.4|25.4|||
3931893|NCT01400841|3753837|B1|||LV diastolic volume|Left ventricular diastolic volume. Echocardiographic parameter determined by core laboratory. n=10 (6 unavailable or not evaluable)|ml|Mean|180.7|180.7|Standard Deviation|50.2|50.2|||
3931894|NCT01400841|3753837|B1|||LVID systole|Left ventricular internal dimension. Echocardiographic parameter determined by core laboratory. n=7 (9 unavailable or not evaluable)|cm|Mean|4.09|4.09|Standard Deviation|0.76|0.76|||
3931895|NCT01400841|3753837|B1|||Left ventricular internal dimension (LVID) diastole|Left ventricular internal dimension. Echocardiographic parameter determined by core laboratory. n=11 (5 unavailable or not evaluable)|cm|Mean|5.44|5.44|Standard Deviation|0.60|0.6|||
3931896|NCT01400841|3753837|B1|||Left ventricular (LV) mass|Left ventricular mass. Echocardiographic parameter determined by core laboratory. n=11 (5 unavailable or not evaluable)|g|Mean|260.0|260.0|Standard Deviation|57.1|57.1|||
3931897|NCT01400841|3753837|B1|||Mean gradient|Echocardiographic parameter determined by core laboratory. n=14 (2 unavailable or not evaluable)|mm Hg|Mean|6.8|6.8|Standard Deviation|3.0|3.0|||
3931898|NCT01400841|3753837|B1|||Peak gradient|Echocardiographic parameter determined by core laboratory. n=14 (2 unavailable or not evaluable)|mm Hg|Mean|13.3|13.3|Standard Deviation|6.2|6.2|||
3931899|NCT01400841|3753837|B1|IV||NYHA Classification|"New York Heart Association Functional Capacity~Class I: no limitation of activity. Ordinary activity - no undue fatigue, palpitation, dyspnea, or anginal pain.~Class II: slight limitation of activity. Comfortable at rest. Ordinary activity - fatigue, palpitation, dyspnea, or anginal pain.~Class III: marked limitation of activity. Comfortable at rest. Less than ordinary activity - fatigue, palpitation, dyspnea, or anginal pain.~Class IV: no activity without discomfort. Symptoms of heart failure or the anginal syndrome may be present even at rest. Increased discomfort upon activity."|participants|Number|0|0.0||||||
3931900|NCT01400841|3753837|B1|III||NYHA Classification|"New York Heart Association Functional Capacity~Class I: no limitation of activity. Ordinary activity - no undue fatigue, palpitation, dyspnea, or anginal pain.~Class II: slight limitation of activity. Comfortable at rest. Ordinary activity - fatigue, palpitation, dyspnea, or anginal pain.~Class III: marked limitation of activity. Comfortable at rest. Less than ordinary activity - fatigue, palpitation, dyspnea, or anginal pain.~Class IV: no activity without discomfort. Symptoms of heart failure or the anginal syndrome may be present even at rest. Increased discomfort upon activity."|participants|Number|6|6.0||||||
3931949|NCT01400698|3753873|B3|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3931950|NCT01400698|3753874|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3931901|NCT01400841|3753837|B1|II||NYHA Classification|"New York Heart Association Functional Capacity~Class I: no limitation of activity. Ordinary activity - no undue fatigue, palpitation, dyspnea, or anginal pain.~Class II: slight limitation of activity. Comfortable at rest. Ordinary activity - fatigue, palpitation, dyspnea, or anginal pain.~Class III: marked limitation of activity. Comfortable at rest. Less than ordinary activity - fatigue, palpitation, dyspnea, or anginal pain.~Class IV: no activity without discomfort. Symptoms of heart failure or the anginal syndrome may be present even at rest. Increased discomfort upon activity."|participants|Number|10|10.0||||||
3931902|NCT01400841|3753837|B1|I||NYHA Classification|"New York Heart Association Functional Capacity~Class I: no limitation of activity. Ordinary activity - no undue fatigue, palpitation, dyspnea, or anginal pain.~Class II: slight limitation of activity. Comfortable at rest. Ordinary activity - fatigue, palpitation, dyspnea, or anginal pain.~Class III: marked limitation of activity. Comfortable at rest. Less than ordinary activity - fatigue, palpitation, dyspnea, or anginal pain.~Class IV: no activity without discomfort. Symptoms of heart failure or the anginal syndrome may be present even at rest. Increased discomfort upon activity."|participants|Number|0|0.0||||||
3931903|NCT01400841|3753837|B1|4+||Aortic Valvular Regurgitation|Grade assigned to degree of aortic regurgitation determined by core laboratory analysis of echocardiogram: 0=None/trace, 1+=Mild, 2+=Moderate, 3+=Moderate-to-Severe, 4+=Severe|participants|Number|3|3.0||||||
3931904|NCT01400841|3753837|B1|3+||Aortic Valvular Regurgitation|Grade assigned to degree of aortic regurgitation determined by core laboratory analysis of echocardiogram: 0=None/trace, 1+=Mild, 2+=Moderate, 3+=Moderate-to-Severe, 4+=Severe|participants|Number|7|7.0||||||
3931905|NCT01400841|3753837|B1|2+||Aortic Valvular Regurgitation|Grade assigned to degree of aortic regurgitation determined by core laboratory analysis of echocardiogram: 0=None/trace, 1+=Mild, 2+=Moderate, 3+=Moderate-to-Severe, 4+=Severe|participants|Number|6|6.0||||||
3931906|NCT01400841|3753837|B1|1+||Aortic Valvular Regurgitation|Grade assigned to degree of aortic regurgitation determined by core laboratory analysis of echocardiogram: 0=None/trace, 1+=Mild, 2+=Moderate, 3+=Moderate-to-Severe, 4+=Severe|participants|Number|0|0.0||||||
3931907|NCT01400841|3753837|B1|0||Aortic Valvular Regurgitation|Grade assigned to degree of aortic regurgitation determined by core laboratory analysis of echocardiogram: 0=None/trace, 1+=Mild, 2+=Moderate, 3+=Moderate-to-Severe, 4+=Severe|participants|Number|0|0.0||||||
3931908|NCT01400841|3753837|B1|Germany||Region of Enrollment||participants|Number|13|13.0||||||
3931909|NCT01400841|3753837|B1|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
3931910|NCT01400841|3753837|B1|Czech Republic||Region of Enrollment||participants|Number|2|2.0||||||
3931911|NCT01400841|3753837|B1||Male|Gender||Participants|Count of Participants|13|13.0||||||
3931912|NCT01400841|3753837|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
3931913|NCT01400841|3753837|B1|||Age||years|Mean|68.1|68.1|Standard Deviation|9.3|9.3|||
3931914|NCT01400841|3753837|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3931915|NCT01400841|3753837|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3931916|NCT01400841|3753837|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3931917|NCT01400698|3753871|B5|||Length of Gestation||weeks|Mean|37.9|37.9|Standard Deviation|2.6|2.6|||
3931918|NCT01400698|3753872|B4|||Length of Gestation||weeks|Mean|37.9|37.9|Standard Deviation|2.8|2.8|||
3931919|NCT01400698|3753873|B3|||Length of Gestation||weeks|Mean|38.9|38.9|Standard Deviation|1.5|1.5|||
3931920|NCT01400698|3753874|B2|||Length of Gestation||weeks|Mean|37.3|37.3|Standard Deviation|2.6|2.6|||
3931921|NCT01400698|3753875|B1|||Length of Gestation||weeks|Mean|37|37.0|Standard Deviation|2.9|2.9|||
3931922|NCT01400698|3753871|B5|||Birth Weight||g|Mean|2085.3|2085.3|Standard Deviation|551.8|551.8|||
3931923|NCT01400698|3753872|B4|||Birth Weight||g|Mean|2030.9|2030.9|Standard Deviation|573.4|573.4|||
3931924|NCT01400698|3753873|B3|||Birth Weight||g|Mean|2312|2312.0|Standard Deviation|451.1|451.1|||
3931925|NCT01400698|3753874|B2|||Birth Weight||g|Mean|2076.9|2076.9|Standard Deviation|520.9|520.9|||
3931926|NCT01400698|3753875|B1|||Birth Weight||g|Mean|1848|1848.0|Standard Deviation|601.2|601.2|||
3931927|NCT01400698|3753871|B5|||Birth Height||cm|Mean|42.8|42.8|Standard Deviation|3.7|3.7|||
3931928|NCT01400698|3753872|B4|||Birth Height||cm|Mean|42.3|42.3|Standard Deviation|3.5|3.5|||
3931929|NCT01400698|3753873|B3|||Birth Height||cm|Mean|44.8|44.8|Standard Deviation|3.4|3.4|||
3931930|NCT01400698|3753874|B2|||Birth Height||cm|Mean|42.2|42.2|Standard Deviation|3.5|3.5|||
3931931|NCT01400698|3753875|B1|||Birth Height||cm|Mean|41.8|41.8|Standard Deviation|4.3|4.3|||
3931932|NCT01400698|3753871|B5|GF6283||Original Study||participants|Number|39|39.0||||||
3931933|NCT01400698|3753872|B4|GF6283||Original Study||participants|Number|24|24.0||||||
3931934|NCT01400698|3753873|B3|GF6283||Original Study||participants|Number|4|4.0||||||
3931935|NCT01400698|3753874|B2|GF6283||Original Study||participants|Number|7|7.0||||||
3931936|NCT01400698|3753875|B1|GF6283||Original Study||participants|Number|4|4.0||||||
3931937|NCT01400698|3753871|B5|GF4001||Original Study||participants|Number|52|52.0||||||
3931938|NCT01400698|3753872|B4|GF4001||Original Study||participants|Number|22|22.0||||||
3931939|NCT01400698|3753873|B3|GF4001||Original Study||participants|Number|18|18.0||||||
3931940|NCT01400698|3753874|B2|GF4001||Original Study||participants|Number|6|6.0||||||
3931941|NCT01400698|3753875|B1|GF4001||Original Study||participants|Number|6|6.0||||||
3931942|NCT01400698|3753871|B5|White||Race/Ethnicity, Customized||participants|Number|88|88.0||||||
3931943|NCT01400698|3753872|B4|White||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
3931944|NCT01400698|3753873|B3|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3931945|NCT01400698|3753874|B2|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3931946|NCT01400698|3753875|B1|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3931947|NCT01400698|3753871|B5|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3931948|NCT01400698|3753872|B4|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3931951|NCT01400698|3753875|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3931952|NCT01400698|3753871|B5|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3931953|NCT01400698|3753872|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3931954|NCT01400698|3753873|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3931955|NCT01400698|3753874|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3931956|NCT01400698|3753875|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3931957|NCT01400698|3753871|B5||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3931958|NCT01400698|3753872|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3931959|NCT01400698|3753873|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3931960|NCT01400698|3753874|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3931961|NCT01400698|3753875|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3931962|NCT01400698|3753871|B5||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3931963|NCT01400698|3753872|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3931964|NCT01400698|3753873|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3931965|NCT01400698|3753874|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3931966|NCT01400698|3753875|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3931967|NCT01400698|3753871|B5|||Age||years|Mean|10.3|10.3|Standard Deviation|3.0|3.0|||
3931968|NCT01400698|3753872|B4|||Age||years|Mean|9.5|9.5|Standard Deviation|2.6|2.6|||
3931969|NCT01400698|3753873|B3|||Age||years|Mean|12.5|12.5|Standard Deviation|3.1|3.1|||
3931970|NCT01400698|3753874|B2|||Age||years|Mean|9.2|9.2|Standard Deviation|2.4|2.4|||
3931971|NCT01400698|3753875|B1|||Age||years|Mean|10.6|10.6|Standard Deviation|3.0|3.0|||
3931972|NCT01400516|3753902|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3931973|NCT01400516|3753903|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3931974|NCT01400516|3753904|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3931975|NCT01400516|3753902|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3931976|NCT01400516|3753903|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3931977|NCT01400516|3753904|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3931978|NCT01400516|3753902|B3|||Age||years|Median|62|62.0|Inter-Quartile Range|||56.0|66.0|
3931979|NCT01400516|3753903|B2|||Age||years|Median|63|63.0|Inter-Quartile Range|||56.0|69.0|
3931980|NCT01400516|3753904|B1|||Age||years|Median|61|61.0|Inter-Quartile Range|||56.0|65.0|
3931981|NCT01400503|3753915|B1|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3931982|NCT01400503|3753915|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3931983|NCT01400503|3753915|B1|Taiwan, Province Of China||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3931984|NCT01400503|3753915|B1|Spain||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3931985|NCT01400503|3753915|B1|Korea, Republic Of||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3931986|NCT01400503|3753915|B1|Singapore||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3931987|NCT01400503|3753915|B1|Norway||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3931988|NCT01400503|3753915|B1|New Zealand||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3931989|NCT01400503|3753915|B1|Hong Kong||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3931990|NCT01400503|3753915|B1|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3931991|NCT01400503|3753915|B1|France||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3931992|NCT01400503|3753915|B1|Egypt||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3931993|NCT01400503|3753915|B1|China||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3931994|NCT01400503|3753915|B1|Canada||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3931995|NCT01400503|3753915|B1|Brazil||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3931996|NCT01400503|3753915|B1|Belgium||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3931997|NCT01400503|3753915|B1|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3931998|NCT01400503|3753915|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3931999|NCT01400503|3753915|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3932000|NCT01400503|3753915|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3932001|NCT01400503|3753915|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3932002|NCT01400503|3753915|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932003|NCT01400503|3753915|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932004|NCT01400503|3753915|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3932005|NCT01400503|3753915|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3932006|NCT01400503|3753915|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3932007|NCT01400503|3753915|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3932008|NCT01400503|3753915|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3932009|NCT01400503|3753915|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932069|NCT01400425|3753943|B1||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3932010|NCT01400503|3753915|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3932011|NCT01400503|3753915|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3932012|NCT01400503|3753915|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3932013|NCT01400503|3753915|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3932014|NCT01400503|3753915|B1|||Age||years|Mean|45.1|45.1|Standard Deviation|14.51|14.51|||
3932015|NCT01400451|3753924|B4|United States||Region of Enrollment||participants|Number|12|12.0||||||
3932016|NCT01400451|3753925|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3932017|NCT01400451|3753926|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3932018|NCT01400451|3753927|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3932019|NCT01400451|3753924|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932020|NCT01400451|3753925|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932021|NCT01400451|3753926|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932022|NCT01400451|3753927|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932023|NCT01400451|3753924|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932024|NCT01400451|3753925|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932025|NCT01400451|3753926|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932026|NCT01400451|3753927|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932027|NCT01400451|3753924|B4||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3932028|NCT01400451|3753925|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3932029|NCT01400451|3753926|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3932030|NCT01400451|3753927|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3932031|NCT01400451|3753924|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3932032|NCT01400451|3753925|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932033|NCT01400451|3753926|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932034|NCT01400451|3753927|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3932035|NCT01400451|3753924|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932036|NCT01400451|3753925|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932037|NCT01400451|3753926|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932038|NCT01400451|3753927|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932039|NCT01400451|3753924|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932040|NCT01400451|3753925|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932041|NCT01400451|3753926|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932042|NCT01400451|3753927|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932043|NCT01400451|3753924|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932044|NCT01400451|3753925|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932045|NCT01400451|3753926|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932046|NCT01400451|3753927|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932047|NCT01400451|3753924|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3932048|NCT01400451|3753925|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3932049|NCT01400451|3753926|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3932050|NCT01400451|3753927|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3932051|NCT01400451|3753924|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3932052|NCT01400451|3753925|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3932053|NCT01400451|3753926|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3932054|NCT01400451|3753927|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3932055|NCT01400451|3753924|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3932056|NCT01400451|3753925|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3932057|NCT01400451|3753926|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3932058|NCT01400451|3753927|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3932059|NCT01400451|3753924|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3932060|NCT01400451|3753925|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3932061|NCT01400451|3753926|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3932062|NCT01400451|3753927|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3932063|NCT01400451|3753924|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3932064|NCT01400451|3753925|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3932065|NCT01400451|3753926|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3932066|NCT01400451|3753927|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3932067|NCT01400425|3753943|B1|United States||Region of Enrollment||participants|Number|229|229.0||||||
3932068|NCT01400425|3753943|B1||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3932070|NCT01400425|3753943|B1|||Age||years|Mean|74.1|74.1|Standard Deviation|8.1|8.1|||
3932071|NCT01400425|3753943|B1||>=65 years|Age||Participants|Count of Participants|205|205.0||||||
3932072|NCT01400425|3753943|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3932073|NCT01400425|3753943|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3932074|NCT01400412|3753954|B3|||HIV-1 RNA||log10 copies/mL|Median|4.50|4.5|Inter-Quartile Range|||3.97|5.0|
3932075|NCT01400412|3753955|B2|||HIV-1 RNA||log10 copies/mL|Median|4.47|4.47|Inter-Quartile Range|||4.02|4.91|
3932076|NCT01400412|3753956|B1|||HIV-1 RNA||log10 copies/mL|Median|4.59|4.59|Inter-Quartile Range|||3.91|5.07|
3932077|NCT01400412|3753954|B3|||CD4 count||cells/mm^3|Median|390|390.0|Inter-Quartile Range|||294.0|517.0|
3932078|NCT01400412|3753955|B2|||CD4 count||cells/mm^3|Median|392|392.0|Inter-Quartile Range|||290.0|518.0|
3932079|NCT01400412|3753956|B1|||CD4 count||cells/mm^3|Median|389|389.0|Inter-Quartile Range|||295.0|496.0|
3932080|NCT01400412|3753954|B3|Puerto Rico||Region of Enrollment||participants|Number|5|5.0||||||
3932081|NCT01400412|3753955|B2|Puerto Rico||Region of Enrollment||participants|Number|2|2.0||||||
3932082|NCT01400412|3753956|B1|Puerto Rico||Region of Enrollment||participants|Number|3|3.0||||||
3932083|NCT01400412|3753954|B3|United States||Region of Enrollment||participants|Number|254|254.0||||||
3932084|NCT01400412|3753955|B2|United States||Region of Enrollment||participants|Number|127|127.0||||||
3932085|NCT01400412|3753956|B1|United States||Region of Enrollment||participants|Number|127|127.0||||||
3932086|NCT01400412|3753954|B3|More than one race||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3932087|NCT01400412|3753955|B2|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3932088|NCT01400412|3753956|B1|More than one race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3932089|NCT01400412|3753954|B3|American Indian, Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3932090|NCT01400412|3753955|B2|American Indian, Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3932091|NCT01400412|3753956|B1|American Indian, Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3932092|NCT01400412|3753954|B3|Asian, Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3932093|NCT01400412|3753955|B2|Asian, Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3932094|NCT01400412|3753956|B1|Asian, Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3932095|NCT01400412|3753954|B3|Hispanic (regardless of race)||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
3932096|NCT01400412|3753955|B2|Hispanic (regardless of race)||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
3932097|NCT01400412|3753956|B1|Hispanic (regardless of race)||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3932098|NCT01400412|3753954|B3|Black non-Hispanic||Race/Ethnicity, Customized||participants|Number|78|78.0||||||
3932099|NCT01400412|3753955|B2|Black non-Hispanic||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
3932100|NCT01400412|3753956|B1|Black non-Hispanic||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
3932101|NCT01400412|3753954|B3|White non-Hispanic||Race/Ethnicity, Customized||participants|Number|116|116.0||||||
3932102|NCT01400412|3753955|B2|White non-Hispanic||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
3932103|NCT01400412|3753956|B1|White non-Hispanic||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
3932104|NCT01400412|3753954|B3||Male|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
3932105|NCT01400412|3753955|B2||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3932106|NCT01400412|3753956|B1||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3932107|NCT01400412|3753954|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3932108|NCT01400412|3753955|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3932109|NCT01400412|3753956|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3932110|NCT01400412|3753954|B3|>=50 Years||Age, Customized||participants|Number|31|31.0||||||
3932111|NCT01400412|3753955|B2|>=50 Years||Age, Customized||participants|Number|16|16.0||||||
3932112|NCT01400412|3753956|B1|>=50 Years||Age, Customized||participants|Number|15|15.0||||||
3932113|NCT01400412|3753954|B3|40-49 Years||Age, Customized||participants|Number|50|50.0||||||
3932114|NCT01400412|3753955|B2|40-49 Years||Age, Customized||participants|Number|24|24.0||||||
3932115|NCT01400412|3753956|B1|40-49 Years||Age, Customized||participants|Number|26|26.0||||||
3932116|NCT01400412|3753954|B3|30-39 Years||Age, Customized||participants|Number|81|81.0||||||
3932117|NCT01400412|3753955|B2|30-39 Years||Age, Customized||participants|Number|41|41.0||||||
3932118|NCT01400412|3753956|B1|30-39 Years||Age, Customized||participants|Number|40|40.0||||||
3932119|NCT01400412|3753954|B3|18-29 Years||Age, Customized||participants|Number|97|97.0||||||
3932120|NCT01400412|3753955|B2|18-29 Years||Age, Customized||participants|Number|48|48.0||||||
3932121|NCT01400412|3753956|B1|18-29 Years||Age, Customized||participants|Number|49|49.0||||||
3932122|NCT01400412|3753954|B3|||Age||years|Median|33|33.0|Inter-Quartile Range|||26.0|42.0|
3932123|NCT01400412|3753955|B2|||Age||years|Median|33|33.0|Inter-Quartile Range|||26.0|42.0|
3932124|NCT01400412|3753956|B1|||Age||years|Median|33|33.0|Inter-Quartile Range|||26.0|42.0|
3932125|NCT01400243|3754001|B3|United States||Region of Enrollment||participants|Number|127|127.0||||||
3932126|NCT01400243|3754002|B2|United States||Region of Enrollment||participants|Number|63|63.0||||||
3932127|NCT01400243|3754003|B1|United States||Region of Enrollment||participants|Number|64|64.0||||||
3932128|NCT01400243|3754001|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3932129|NCT01400243|3754002|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3932130|NCT01400243|3754003|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3932131|NCT01400243|3754001|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3932132|NCT01400243|3754002|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3932133|NCT01400243|3754003|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3932134|NCT01400243|3754001|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3932135|NCT01400243|3754002|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3932136|NCT01400243|3754003|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3932137|NCT01400243|3754001|B3||Between 18 and 65 years|Age||Participants|Count of Participants|127|127.0||||||
3932138|NCT01400243|3754002|B2||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
3932139|NCT01400243|3754003|B1||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
3932140|NCT01400243|3754001|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3932141|NCT01400243|3754002|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3932142|NCT01400243|3754003|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3932143|NCT01400243|3754001|B3|Age||Age||years|Mean|20.87|20.87|Standard Deviation|3.20|3.2|||
3932144|NCT01400243|3754002|B2|Age||Age||years|Mean|21.19|21.19|Standard Deviation|3.86|3.86|||
3932145|NCT01400243|3754003|B1|Age||Age||years|Mean|20.57|20.57|Standard Deviation|2.43|2.43|||
3932146|NCT01400139|3754026|B1|||Screening Baseline Pain Over the Last 24 Hours|"Average pain over the last 24 hours score (on an 11-point numerical rating scale where 0 = no pain and 10 = pain as bad as you can imagine)."|units on a scale|Mean|6.4|6.4|Standard Deviation|1.60|1.6|||
3932147|NCT01400139|3754026|B1|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3932148|NCT01400139|3754026|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3932149|NCT01400139|3754026|B1|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3932150|NCT01400139|3754026|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3932151|NCT01400139|3754026|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|141|141.0||||||
3932152|NCT01400139|3754026|B1|White||Race/Ethnicity, Customized||participants|Number|761|761.0||||||
3932153|NCT01400139|3754026|B1||Male|Sex: Female, Male||Participants|Count of Participants|396|396.0||||||
3932154|NCT01400139|3754026|B1||Female|Sex: Female, Male||Participants|Count of Participants|526|526.0||||||
3932155|NCT01400139|3754026|B1|||Age||years|Mean|51.8|51.8|Standard Deviation|12.53|12.53|||
3932156|NCT01400113|3754034|B3|United States||Region of Enrollment||participants|Number|120|120.0||||||
3932157|NCT01400113|3754035|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
3932158|NCT01400113|3754036|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
3932159|NCT01400113|3754034|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3932160|NCT01400113|3754035|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3932161|NCT01400113|3754036|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3932162|NCT01400113|3754034|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3932163|NCT01400113|3754035|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3932164|NCT01400113|3754036|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3932165|NCT01400113|3754034|B3|||Age||years|Mean|36.4|36.4|Standard Deviation|11.75|11.75|||
3932166|NCT01400113|3754035|B2|||Age||years|Mean|36.4|36.4|Standard Deviation|12.4|12.4|||
3932167|NCT01400113|3754036|B1|||Age||years|Mean|36.3|36.3|Standard Deviation|11.1|11.1|||
3932168|NCT01400113|3754034|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3932169|NCT01400113|3754035|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3932170|NCT01400113|3754036|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3932171|NCT01400113|3754034|B3||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
3932172|NCT01400113|3754035|B2||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3932173|NCT01400113|3754036|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3932174|NCT01400113|3754034|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3932175|NCT01400113|3754035|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3932176|NCT01400113|3754036|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3932177|NCT01399866|3754043|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3932178|NCT01399866|3754044|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3932179|NCT01399866|3754045|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3932180|NCT01399866|3754043|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3932181|NCT01399866|3754044|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3932182|NCT01399866|3754045|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3932183|NCT01399866|3754043|B3|||Age||years|Mean|47.7|47.7|Standard Deviation|11.8|11.8|||
3932184|NCT01399866|3754044|B2|||Age||years|Mean|48.4|48.4|Standard Deviation|12.4|12.4|||
3932185|NCT01399866|3754045|B1|||Age||years|Mean|47.1|47.1|Standard Deviation|11.4|11.4|||
3932186|NCT01399827|3754062|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3932187|NCT01399827|3754063|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3932188|NCT01399827|3754064|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3932189|NCT01399827|3754062|B3|Race|Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3932190|NCT01399827|3754063|B2|Race|Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3932191|NCT01399827|3754064|B1|Race|Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3932192|NCT01399827|3754062|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3932193|NCT01399827|3754063|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3932194|NCT01399827|3754064|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3932195|NCT01399827|3754062|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3932196|NCT01399827|3754063|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3932197|NCT01399827|3754064|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3932198|NCT01399827|3754062|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3932199|NCT01399827|3754063|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3932200|NCT01399827|3754064|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3932201|NCT01399827|3754062|B3|||Age||years|Mean|34.5|34.5|Standard Deviation|19.09|19.09|||
3932202|NCT01399827|3754063|B2|||Age||years|Mean|21|21.0|Standard Deviation|NA||||There is no standard deviation because there was only one participant.
3932203|NCT01399827|3754064|B1|||Age||years|Mean|48|48.0|Standard Deviation|NA||||There is no standard deviation because there was only one participant.
3932204|NCT01399827|3754062|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3932205|NCT01399827|3754063|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3932206|NCT01399827|3754064|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3932207|NCT01399827|3754062|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3932208|NCT01399827|3754063|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3932209|NCT01399827|3754064|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3932210|NCT01399827|3754062|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3932211|NCT01399827|3754063|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3932212|NCT01399827|3754064|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3932213|NCT01399788|3754079|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3932214|NCT01399788|3754079|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3932215|NCT01399788|3754079|B1|||Age||years|Mean|32.6|32.6|Standard Deviation|8.8|8.8|||
3932216|NCT01399723|3754100|B3|Kenya||Region of Enrollment||participants|Number|527|527.0||||||
3932217|NCT01399723|3754101|B2|Kenya||Region of Enrollment||participants|Number|264|264.0||||||
3932218|NCT01399723|3754102|B1|Kenya||Region of Enrollment||participants|Number|263|263.0||||||
3932219|NCT01399723|3754100|B3||Male|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
3932220|NCT01399723|3754101|B2||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3932221|NCT01399723|3754102|B1||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3932222|NCT01399723|3754100|B3||Female|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
3932223|NCT01399723|3754101|B2||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3932224|NCT01399723|3754102|B1||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3932225|NCT01399723|3754100|B3|||Age||years|Median|13|13.0|Inter-Quartile Range|||7.0|24.0|
3932226|NCT01399723|3754101|B2|||Age||years|Median|13|13.0|Inter-Quartile Range|||7.0|24.0|
3932227|NCT01399723|3754102|B1|||Age||years|Median|14|14.0|Inter-Quartile Range|||7.0|25.0|
3932228|NCT01399697|3754113|B4||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3932229|NCT01399697|3754114|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3932230|NCT01399697|3754115|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3932231|NCT01399697|3754116|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3932232|NCT01399697|3754113|B4||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
3932233|NCT01399697|3754114|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3932234|NCT01399697|3754115|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3932235|NCT01399697|3754116|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3932236|NCT01399697|3754113|B4|||Age||years|Mean|51.2|51.2|Standard Deviation|12.6|12.6|||
3932237|NCT01399697|3754114|B3|||Age||years|Mean|51.0|51.0|Standard Deviation|12.2|12.2|||
3932238|NCT01399697|3754115|B2|||Age||years|Mean|50.2|50.2|Standard Deviation|12.5|12.5|||
3932239|NCT01399697|3754116|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|13.2|13.2|||
3932240|NCT01399619|3754143|B3||Male|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
3932241|NCT01399619|3754144|B2||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3932242|NCT01399619|3754145|B1||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3932243|NCT01399619|3754143|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3932244|NCT01399619|3754144|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3932245|NCT01399619|3754145|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3932246|NCT01399619|3754143|B3|||Age||years|Mean|46.9|46.9|Standard Deviation|8.08|8.08|||
3932247|NCT01399619|3754144|B2|||Age||years|Mean|46.5|46.5|Standard Deviation|8.36|8.36|||
3932248|NCT01399619|3754145|B1|||Age||years|Mean|47.6|47.6|Standard Deviation|7.63|7.63|||
3932289|NCT01399593|3754210|B2||More than one race|Race (NIH/OMB)|"Patients appearing under Unknown or Not Reported were categorized as Other by the investigator."|Participants|Count of Participants|0|0.0||||||
3932249|NCT01399593|3754209|B3|||Highest Single Donor-Specific Antibodies (DSA)|The presence of donor-specific antibodies (DSA) indicates that a patient has become sensitized, i.e., has preformed antibodies against donor specific human leukocyte antigens (HLAs). A higher DSA level indicates greater sensitization and greater risk of antibody-mediated rejection (AMR).|mean fluorescence intensity (MFI)|Mean|8431.7|8431.7|Standard Deviation|4157.87|4157.87|||
3932250|NCT01399593|3754210|B2|||Highest Single Donor-Specific Antibodies (DSA)|The presence of donor-specific antibodies (DSA) indicates that a patient has become sensitized, i.e., has preformed antibodies against donor specific human leukocyte antigens (HLAs). A higher DSA level indicates greater sensitization and greater risk of antibody-mediated rejection (AMR).|mean fluorescence intensity (MFI)|Mean|8740.7|8740.7|Standard Deviation|4289.97|4289.97|||
3932251|NCT01399593|3754211|B1|||Highest Single Donor-Specific Antibodies (DSA)|The presence of donor-specific antibodies (DSA) indicates that a patient has become sensitized, i.e., has preformed antibodies against donor specific human leukocyte antigens (HLAs). A higher DSA level indicates greater sensitization and greater risk of antibody-mediated rejection (AMR).|mean fluorescence intensity (MFI)|Mean|8135|8135.0|Standard Deviation|4048.08|4048.08|||
3932252|NCT01399593|3754209|B3|||Total Donor-Specific Antibodies (DSA)|The presence of donor-specific antibodies (DSA) indicates that a patient has become sensitized, i.e., has preformed antibodies against donor specific human leukocyte antigens (HLAs). A higher DSA level indicates greater sensitization and greater risk of antibody-mediated rejection (AMR).|mean fluorescence intensity (MFI)|Mean|16411.1|16411.1|Standard Deviation|13380.16|13380.16|||
3932253|NCT01399593|3754210|B2|||Total Donor-Specific Antibodies (DSA)|The presence of donor-specific antibodies (DSA) indicates that a patient has become sensitized, i.e., has preformed antibodies against donor specific human leukocyte antigens (HLAs). A higher DSA level indicates greater sensitization and greater risk of antibody-mediated rejection (AMR).|mean fluorescence intensity (MFI)|Mean|17469.8|17469.8|Standard Deviation|12573.44|12573.44|||
3932254|NCT01399593|3754211|B1|||Total Donor-Specific Antibodies (DSA)|The presence of donor-specific antibodies (DSA) indicates that a patient has become sensitized, i.e., has preformed antibodies against donor specific human leukocyte antigens (HLAs). A higher DSA level indicates greater sensitization and greater risk of antibody-mediated rejection (AMR).|mean fluorescence intensity (MFI)|Mean|15394.7|15394.7|Standard Deviation|14163.78|14163.78|||
3932255|NCT01399593|3754209|B3|United States||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
3932256|NCT01399593|3754210|B2|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3932257|NCT01399593|3754211|B1|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3932258|NCT01399593|3754209|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3932259|NCT01399593|3754210|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3932260|NCT01399593|3754211|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3932261|NCT01399593|3754209|B3|Sweden||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3932262|NCT01399593|3754210|B2|Sweden||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3932263|NCT01399593|3754211|B1|Sweden||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3932264|NCT01399593|3754209|B3|Spain||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3932265|NCT01399593|3754210|B2|Spain||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3932266|NCT01399593|3754211|B1|Spain||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3932267|NCT01399593|3754209|B3|Norway||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3932268|NCT01399593|3754210|B2|Norway||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3932269|NCT01399593|3754211|B1|Norway||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3932270|NCT01399593|3754209|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3932271|NCT01399593|3754210|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3932272|NCT01399593|3754211|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3932273|NCT01399593|3754209|B3|Italy||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3932274|NCT01399593|3754210|B2|Italy||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3932275|NCT01399593|3754211|B1|Italy||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3932276|NCT01399593|3754209|B3|Germany||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3932277|NCT01399593|3754210|B2|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3932278|NCT01399593|3754211|B1|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3932279|NCT01399593|3754209|B3|France||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3932280|NCT01399593|3754210|B2|France||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3932281|NCT01399593|3754211|B1|France||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3932282|NCT01399593|3754209|B3|Australia||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3932283|NCT01399593|3754210|B2|Australia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3932284|NCT01399593|3754211|B1|Australia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3932285|NCT01399593|3754209|B3||Unknown or Not Reported|Race (NIH/OMB)|"Patients appearing under Unknown or Not Reported were categorized as Other by the investigator."|Participants|Count of Participants|12|12.0||||||
3932286|NCT01399593|3754210|B2||Unknown or Not Reported|Race (NIH/OMB)|"Patients appearing under Unknown or Not Reported were categorized as Other by the investigator."|Participants|Count of Participants|6|6.0||||||
3932287|NCT01399593|3754211|B1||Unknown or Not Reported|Race (NIH/OMB)|"Patients appearing under Unknown or Not Reported were categorized as Other by the investigator."|Participants|Count of Participants|6|6.0||||||
3932288|NCT01399593|3754209|B3||More than one race|Race (NIH/OMB)|"Patients appearing under Unknown or Not Reported were categorized as Other by the investigator."|Participants|Count of Participants|0|0.0||||||
3932290|NCT01399593|3754211|B1||More than one race|Race (NIH/OMB)|"Patients appearing under Unknown or Not Reported were categorized as Other by the investigator."|Participants|Count of Participants|0|0.0||||||
3932291|NCT01399593|3754209|B3||White|Race (NIH/OMB)|"Patients appearing under Unknown or Not Reported were categorized as Other by the investigator."|Participants|Count of Participants|73|73.0||||||
3932292|NCT01399593|3754210|B2||White|Race (NIH/OMB)|"Patients appearing under Unknown or Not Reported were categorized as Other by the investigator."|Participants|Count of Participants|36|36.0||||||
3932293|NCT01399593|3754211|B1||White|Race (NIH/OMB)|"Patients appearing under Unknown or Not Reported were categorized as Other by the investigator."|Participants|Count of Participants|37|37.0||||||
3932294|NCT01399593|3754209|B3||Black or African American|Race (NIH/OMB)|"Patients appearing under Unknown or Not Reported were categorized as Other by the investigator."|Participants|Count of Participants|12|12.0||||||
3932295|NCT01399593|3754210|B2||Black or African American|Race (NIH/OMB)|"Patients appearing under Unknown or Not Reported were categorized as Other by the investigator."|Participants|Count of Participants|6|6.0||||||
3932296|NCT01399593|3754211|B1||Black or African American|Race (NIH/OMB)|"Patients appearing under Unknown or Not Reported were categorized as Other by the investigator."|Participants|Count of Participants|6|6.0||||||
3932297|NCT01399593|3754209|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|"Patients appearing under Unknown or Not Reported were categorized as Other by the investigator."|Participants|Count of Participants|0|0.0||||||
3932298|NCT01399593|3754210|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|"Patients appearing under Unknown or Not Reported were categorized as Other by the investigator."|Participants|Count of Participants|0|0.0||||||
3932299|NCT01399593|3754211|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|"Patients appearing under Unknown or Not Reported were categorized as Other by the investigator."|Participants|Count of Participants|0|0.0||||||
3932300|NCT01399593|3754209|B3||Asian|Race (NIH/OMB)|"Patients appearing under Unknown or Not Reported were categorized as Other by the investigator."|Participants|Count of Participants|5|5.0||||||
3932301|NCT01399593|3754210|B2||Asian|Race (NIH/OMB)|"Patients appearing under Unknown or Not Reported were categorized as Other by the investigator."|Participants|Count of Participants|3|3.0||||||
3932302|NCT01399593|3754211|B1||Asian|Race (NIH/OMB)|"Patients appearing under Unknown or Not Reported were categorized as Other by the investigator."|Participants|Count of Participants|2|2.0||||||
3932303|NCT01399593|3754209|B3||American Indian or Alaska Native|Race (NIH/OMB)|"Patients appearing under Unknown or Not Reported were categorized as Other by the investigator."|Participants|Count of Participants|0|0.0||||||
3932304|NCT01399593|3754210|B2||American Indian or Alaska Native|Race (NIH/OMB)|"Patients appearing under Unknown or Not Reported were categorized as Other by the investigator."|Participants|Count of Participants|0|0.0||||||
3932305|NCT01399593|3754211|B1||American Indian or Alaska Native|Race (NIH/OMB)|"Patients appearing under Unknown or Not Reported were categorized as Other by the investigator."|Participants|Count of Participants|0|0.0||||||
3932306|NCT01399593|3754209|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3932307|NCT01399593|3754210|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3932308|NCT01399593|3754211|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3932309|NCT01399593|3754209|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3932310|NCT01399593|3754210|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3932311|NCT01399593|3754211|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3932312|NCT01399593|3754209|B3|85 years and over||Age, Customized||Participants|Count of Participants|0|0.0||||||
3932313|NCT01399593|3754210|B2|85 years and over||Age, Customized||Participants|Count of Participants|0|0.0||||||
3932314|NCT01399593|3754211|B1|85 years and over||Age, Customized||Participants|Count of Participants|0|0.0||||||
3932315|NCT01399593|3754209|B3|From 65 to 84 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
3932316|NCT01399593|3754210|B2|From 65 to 84 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
3932317|NCT01399593|3754211|B1|From 65 to 84 years||Age, Customized||Participants|Count of Participants|4|4.0||||||
3932318|NCT01399593|3754209|B3|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|96|96.0||||||
3932319|NCT01399593|3754210|B2|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|49|49.0||||||
3932320|NCT01399593|3754211|B1|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|47|47.0||||||
3932321|NCT01399593|3754209|B3|Adolescents (12-17 years)||Age, Customized||Participants|Count of Participants|0|0.0||||||
3932322|NCT01399593|3754210|B2|Adolescents (12-17 years)||Age, Customized||Participants|Count of Participants|0|0.0||||||
3932323|NCT01399593|3754211|B1|Adolescents (12-17 years)||Age, Customized||Participants|Count of Participants|0|0.0||||||
3932324|NCT01399593|3754209|B3|Children (2-11 years)||Age, Customized||Participants|Count of Participants|0|0.0||||||
3932325|NCT01399593|3754210|B2|Children (2-11 years)||Age, Customized||Participants|Count of Participants|0|0.0||||||
3932326|NCT01399593|3754211|B1|Children (2-11 years)||Age, Customized||Participants|Count of Participants|0|0.0||||||
3932327|NCT01399593|3754209|B3|Infants and toddlers (28 days-23 months)||Age, Customized||Participants|Count of Participants|0|0.0||||||
3932328|NCT01399593|3754210|B2|Infants and toddlers (28 days-23 months)||Age, Customized||Participants|Count of Participants|0|0.0||||||
3932329|NCT01399593|3754211|B1|Infants and toddlers (28 days-23 months)||Age, Customized||Participants|Count of Participants|0|0.0||||||
3932330|NCT01399593|3754209|B3|Newborns (0-27 days)||Age, Customized||Participants|Count of Participants|0|0.0||||||
3932331|NCT01399593|3754210|B2|Newborns (0-27 days)||Age, Customized||Participants|Count of Participants|0|0.0||||||
3932332|NCT01399593|3754211|B1|Newborns (0-27 days)||Age, Customized||Participants|Count of Participants|0|0.0||||||
3932333|NCT01399593|3754209|B3|Preterm newborn - gestational age < 37 wk||Age, Customized||Participants|Count of Participants|0|0.0||||||
3932334|NCT01399593|3754210|B2|Preterm newborn - gestational age < 37 wk||Age, Customized||Participants|Count of Participants|0|0.0||||||
3932335|NCT01399593|3754211|B1|Preterm newborn - gestational age < 37 wk||Age, Customized||Participants|Count of Participants|0|0.0||||||
3932336|NCT01399593|3754209|B3|In utero||Age, Customized||Participants|Count of Participants|0|0.0||||||
3932337|NCT01399593|3754210|B2|In utero||Age, Customized||Participants|Count of Participants|0|0.0||||||
3932338|NCT01399593|3754211|B1|In utero||Age, Customized||Participants|Count of Participants|0|0.0||||||
3932339|NCT01399268|3754218|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3932340|NCT01399268|3754219|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3932341|NCT01399268|3754220|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3932342|NCT01399268|3754218|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3932343|NCT01399268|3754218|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3932344|NCT01399268|3754219|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3932345|NCT01399268|3754220|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3932346|NCT01399268|3754218|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3932347|NCT01399268|3754219|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3932348|NCT01399268|3754220|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3932349|NCT01399268|3754218|B3|||Age||years|Mean|67.5|67.5|Standard Deviation|8|8.0|||
3932350|NCT01399268|3754219|B2|||Age||years|Mean|71|71.0|Standard Deviation|9|9.0|||
3932351|NCT01399268|3754220|B1|||Age||years|Mean|64|64.0|Standard Deviation|7|7.0|||
3932352|NCT01399229|3754239|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3932353|NCT01399229|3754239|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3932354|NCT01399229|3754239|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3932355|NCT01399229|3754239|B1|||Age||years|Mean|29.50|29.5|Standard Deviation|6.75|6.75|||
3932356|NCT01399229|3754239|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3932357|NCT01399229|3754239|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3932358|NCT01399229|3754239|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3932359|NCT01399190|3754245|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3932360|NCT01399190|3754245|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3932361|NCT01399190|3754245|B1|||Age||years|Mean|60.08|60.08|Standard Deviation|10.38|10.38|||
3932362|NCT01399125|3754251|B3||Male|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
3932363|NCT01399125|3754252|B2||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3932364|NCT01399125|3754253|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3932365|NCT01399125|3754251|B3||Female|Sex: Female, Male||Participants|Count of Participants|279|279.0||||||
3932366|NCT01399125|3754252|B2||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3932367|NCT01399125|3754253|B1||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3932368|NCT01399125|3754251|B3|||Age||years|Mean|70.1|70.1|Standard Deviation|8.11|8.11|||
3932369|NCT01399125|3754252|B2|||Age||years|Mean|69.8|69.8|Standard Deviation|8.20|8.2|||
3932370|NCT01399125|3754253|B1|||Age||years|Mean|70.4|70.4|Standard Deviation|8.02|8.02|||
3932371|NCT01399099|3754268|B1|United States||Region of Enrollment||participants|Number|67|67.0||||||
3932372|NCT01399099|3754268|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932373|NCT01399099|3754268|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3932374|NCT01399099|3754268|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3932375|NCT01399099|3754268|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3932376|NCT01399099|3754268|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932377|NCT01399099|3754268|B1||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3932378|NCT01399099|3754268|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3932379|NCT01399099|3754268|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932380|NCT01399099|3754268|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3932381|NCT01399099|3754268|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932382|NCT01399099|3754268|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3932383|NCT01399099|3754268|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3932384|NCT01399099|3754268|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3932385|NCT01399099|3754268|B1||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
3932386|NCT01399099|3754268|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3932387|NCT01399047|3754273|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
3932388|NCT01399047|3754274|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3932389|NCT01399047|3754275|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3932390|NCT01399047|3754273|B3|Race|More than one Race|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3932391|NCT01399047|3754274|B2|Race|More than one Race|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3932392|NCT01399047|3754275|B1|Race|More than one Race|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3932393|NCT01399047|3754273|B3|Race|White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3932394|NCT01399047|3754274|B2|Race|White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3932395|NCT01399047|3754275|B1|Race|White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3932396|NCT01399047|3754273|B3||Male|Gender||Participants|Count of Participants|15|15.0||||||
3932397|NCT01399047|3754274|B2||Male|Gender||Participants|Count of Participants|7|7.0||||||
3932398|NCT01399047|3754275|B1||Male|Gender||Participants|Count of Participants|8|8.0||||||
3932399|NCT01399047|3754273|B3||Female|Gender||Participants|Count of Participants|4|4.0||||||
3932400|NCT01399047|3754274|B2||Female|Gender||Participants|Count of Participants|2|2.0||||||
3932401|NCT01399047|3754275|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
3932402|NCT01399047|3754273|B3|||Age||years|Mean|12.53|12.53|Standard Deviation|5.04|5.04|||
3932403|NCT01399047|3754274|B2|||Age||years|Mean|14.78|14.78|Standard Deviation|2.44|2.44|||
3932404|NCT01399047|3754275|B1|||Age||years|Mean|10.50|10.5|Standard Deviation|5.99|5.99|||
3932405|NCT01399008|3754282|B4||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3932406|NCT01399008|3754283|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3932407|NCT01399008|3754284|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3932408|NCT01399008|3754285|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3932409|NCT01399008|3754282|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3932410|NCT01399008|3754283|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3932411|NCT01399008|3754284|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3932412|NCT01399008|3754285|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3932413|NCT01399008|3754282|B4|||Age||years|Mean|51.4|51.4|Standard Deviation|10.6|10.6|||
3932414|NCT01399008|3754283|B3|||Age||years|Mean|50.4|50.4|Standard Deviation|11.0|11.0|||
3932415|NCT01399008|3754284|B2|||Age||years|Mean|50.6|50.6|Standard Deviation|10.2|10.2|||
3932416|NCT01399008|3754285|B1|||Age||years|Mean|52.0|52.0|Standard Deviation|10.9|10.9|||
3932417|NCT01398982|3754295|B3|Canada||Region of Enrollment||participants|Number|93|93.0||||||
3932418|NCT01398982|3754296|B2|Canada||Region of Enrollment||participants|Number|49|49.0||||||
3932419|NCT01398982|3754297|B1|Canada||Region of Enrollment||participants|Number|44|44.0||||||
3932420|NCT01398982|3754295|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3932421|NCT01398982|3754296|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3932422|NCT01398982|3754297|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3932423|NCT01398982|3754295|B3||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3932424|NCT01398982|3754296|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3932425|NCT01398982|3754297|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3932426|NCT01398982|3754295|B3|||Age||years|Mean|51.4|51.4|Standard Deviation|8.3|8.3|||
3932427|NCT01398982|3754296|B2|||Age||years|Mean|52.1|52.1|Standard Deviation|8.3|8.3|||
3932428|NCT01398982|3754297|B1|||Age||years|Mean|50.5|50.5|Standard Deviation|8.4|8.4|||
3932429|NCT01398956|3754304|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3932430|NCT01398956|3754304|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3932431|NCT01398956|3754304|B1|||Age||years|Mean|26.1|26.1|Standard Deviation|13.9|13.9|||
3932432|NCT01398956|3754304|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3932433|NCT01398956|3754304|B1||Between 18 and 65 Years|Age||Participants|Count of Participants|28|28.0||||||
3932434|NCT01398956|3754304|B1||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
3932435|NCT01398943|3754310|B3|||Height||cm|Mean|168|168.0|Standard Deviation|2|2.0|||
3932436|NCT01398943|3754311|B2|||Height||cm|Mean|166|166.0|Standard Deviation|2|2.0|||
3932437|NCT01398943|3754312|B1|||Height||cm|Mean|169|169.0|Standard Deviation|2|2.0|||
3932438|NCT01398943|3754310|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3932439|NCT01398943|3754311|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3932440|NCT01398943|3754312|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3932441|NCT01398943|3754310|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3932442|NCT01398943|3754311|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3932443|NCT01398943|3754312|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3932444|NCT01398943|3754310|B3|Age||Age, Customized||years|Mean|66|66.0|Standard Deviation|2|2.0|||
3932445|NCT01398943|3754311|B2|Age||Age, Customized||years|Mean|66|66.0|Standard Deviation|2|2.0|||
3932446|NCT01398943|3754312|B1|Age||Age, Customized||years|Mean|66|66.0|Standard Deviation|2|2.0|||
3932447|NCT01398852|3754323|B1|United States||Region of Enrollment||participants|Number|372|372.0||||||
3932448|NCT01398852|3754323|B1||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||The study was terminated prior to data analysis.
3932449|NCT01398852|3754323|B1||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||The study was terminated prior to data analysis.
3932450|NCT01398852|3754323|B1|||Age||years|Mean|NA||Standard Deviation|NA||||The study was terminated prior to data analysis.
3932451|NCT01398852|3754323|B1||>=65 years|Age||Participants|Count of Participants|NA|||||||The study was terminated prior to data analysis.
3932452|NCT01398852|3754323|B1||Between 18 and 65 years|Age||Participants|Count of Participants|NA|||||||The study was terminated prior to data analysis.
3932453|NCT01398852|3754323|B1||<=18 years|Age||Participants|Count of Participants|NA|||||||The study was terminated prior to data analysis.
3932454|NCT01398839|3754327|B3|United States||Region of Enrollment||participants|Number|72|72.0||||||
3932455|NCT01398839|3754328|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
3932456|NCT01398839|3754329|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3932457|NCT01398839|3754327|B3||Male|Gender||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3932458|NCT01398839|3754328|B2||Male|Gender||Participants|Count of Participants|NA|||||||The study was terminated prior to data analysis.
3932459|NCT01398839|3754329|B1||Male|Gender||Participants|Count of Participants|NA|||||||The study was terminated prior to data analysis.
3932460|NCT01398839|3754327|B3||Female|Gender||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3932461|NCT01398839|3754328|B2||Female|Gender||Participants|Count of Participants|NA|||||||The study was terminated prior to data analysis.
3932462|NCT01398839|3754329|B1||Female|Gender||Participants|Count of Participants|NA|||||||The study was terminated prior to data analysis.
3932463|NCT01398839|3754327|B3|||Age||years|Mean|NA||Standard Deviation|NA||||The sponsor terminated the study prior to data analysis for financial reasons.
3932464|NCT01398839|3754328|B2|||Age||years|Mean|NA||Standard Deviation|NA||||The study was terminated prior to data analysis.
3932465|NCT01398839|3754329|B1|||Age||years|Mean|NA||Standard Deviation|NA||||The study was terminated prior to data analysis.
3932466|NCT01398839|3754327|B3||>=65 years|Age||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3932467|NCT01398839|3754328|B2||>=65 years|Age||Participants|Count of Participants|NA|||||||The study was terminated prior to data analysis.
3932468|NCT01398839|3754329|B1||>=65 years|Age||Participants|Count of Participants|NA|||||||The study was terminated prior to data analysis.
3932469|NCT01398839|3754327|B3||Between 18 and 65 years|Age||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3932470|NCT01398839|3754328|B2||Between 18 and 65 years|Age||Participants|Count of Participants|NA|||||||The study was terminated prior to data analysis.
3932471|NCT01398839|3754329|B1||Between 18 and 65 years|Age||Participants|Count of Participants|NA|||||||The study was terminated prior to data analysis.
3932472|NCT01398839|3754327|B3||<=18 years|Age||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3932473|NCT01398839|3754328|B2||<=18 years|Age||Participants|Count of Participants|NA|||||||The study was terminated prior to data analysis.
3932474|NCT01398839|3754329|B1||<=18 years|Age||Participants|Count of Participants|NA|||||||The study was terminated prior to data analysis.
3932475|NCT01398787|3754336|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3932476|NCT01398787|3754336|B1||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3932477|NCT01398787|3754336|B1|||Age||years|Mean|33.9|33.9|Standard Deviation|12.9|12.9|||
3932478|NCT01398514|3754352|B3|United States||Region of Enrollment||participants|Number|52|52.0||||||
3932479|NCT01398514|3754353|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
3932480|NCT01398514|3754354|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
3932481|NCT01398514|3754352|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3932482|NCT01398514|3754353|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3932483|NCT01398514|3754354|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3932484|NCT01398514|3754352|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3932485|NCT01398514|3754353|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3932486|NCT01398514|3754354|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3932487|NCT01398514|3754352|B3|||Age||years|Mean|32.25|32.25|Standard Deviation|11.54|11.54|||
3932488|NCT01398514|3754353|B2|||Age||years|Mean|30.46|30.46|Standard Deviation|11.46|11.46|||
3932489|NCT01398514|3754354|B1|||Age||years|Mean|34.04|34.04|Standard Deviation|11.56|11.56|||
3932490|NCT01398514|3754352|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3932491|NCT01398514|3754353|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3932492|NCT01398514|3754354|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3932493|NCT01398514|3754352|B3||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3932494|NCT01398514|3754353|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3932495|NCT01398514|3754354|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3932496|NCT01398514|3754352|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3932497|NCT01398514|3754353|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3932498|NCT01398514|3754354|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3932499|NCT01398475|3754367|B1|Singapore||Region of Enrollment||participants|Number|15|15.0||||||
3932500|NCT01398475|3754367|B1|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3932501|NCT01398475|3754367|B1|Asian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3932502|NCT01398475|3754367|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3932503|NCT01398475|3754367|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3932504|NCT01398475|3754367|B1|||Age||years|Mean|38.0|38.0|Standard Deviation|9.6|9.6|||
3932505|NCT01398410|3754388|B3||Male|Sex: Female, Male||Participants|Count of Participants|305|305.0||||||
3932506|NCT01398410|3754389|B2||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3932507|NCT01398410|3754390|B1||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3932508|NCT01398410|3754388|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3932509|NCT01398410|3754389|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3932510|NCT01398410|3754390|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3932511|NCT01398410|3754388|B3|||Age||Years|Mean|69.8|69.8|Standard Deviation|8.9|8.9|||
3932512|NCT01398410|3754389|B2|||Age||Years|Mean|70.1|70.1|Standard Deviation|9.3|9.3|||
3932513|NCT01398410|3754390|B1|||Age||Years|Mean|69.4|69.4|Standard Deviation|8.5|8.5|||
3932514|NCT01398358|3754399|B4|||Body Mass Index Z-score (BMI z-score)||z-score|Mean|0.61|0.61|Standard Deviation|1.17|1.17|||
3932515|NCT01398358|3754400|B3|||Body Mass Index Z-score (BMI z-score)||z-score|Mean|0.64|0.64|Standard Deviation|1.28|1.28|||
3932516|NCT01398358|3754401|B2|||Body Mass Index Z-score (BMI z-score)||z-score|Mean|0.62|0.62|Standard Deviation|1.20|1.2|||
3932517|NCT01398358|3754402|B1|||Body Mass Index Z-score (BMI z-score)||z-score|Mean|0.57|0.57|Standard Deviation|1.03|1.03|||
3932518|NCT01398358|3754399|B4|United States||Region of Enrollment||participants|Number|697|697.0||||||
3932519|NCT01398358|3754400|B3|United States||Region of Enrollment||participants|Number|255|255.0||||||
3932520|NCT01398358|3754401|B2|United States||Region of Enrollment||participants|Number|224|224.0||||||
3932521|NCT01398358|3754402|B1|United States||Region of Enrollment||participants|Number|218|218.0||||||
3932522|NCT01398358|3754399|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3932523|NCT01398358|3754400|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3932524|NCT01398358|3754401|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3932525|NCT01398358|3754402|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3932526|NCT01398358|3754399|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3932527|NCT01398358|3754400|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3932528|NCT01398358|3754401|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3932529|NCT01398358|3754402|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3932530|NCT01398358|3754399|B4||White|Race (NIH/OMB)||Participants|Count of Participants|387|387.0||||||
3932531|NCT01398358|3754400|B3||White|Race (NIH/OMB)||Participants|Count of Participants|159|159.0||||||
3932532|NCT01398358|3754401|B2||White|Race (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3932533|NCT01398358|3754402|B1||White|Race (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
3932534|NCT01398358|3754399|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|219|219.0||||||
3932535|NCT01398358|3754400|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3932536|NCT01398358|3754401|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
3932537|NCT01398358|3754402|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3932538|NCT01398358|3754399|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932539|NCT01398358|3754400|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932540|NCT01398358|3754401|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932541|NCT01398358|3754402|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932542|NCT01398358|3754399|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932543|NCT01398358|3754400|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932544|NCT01398358|3754401|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932545|NCT01398358|3754402|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932546|NCT01398358|3754399|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3932547|NCT01398358|3754400|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932548|NCT01398358|3754401|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3932549|NCT01398358|3754402|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3932550|NCT01398358|3754399|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3932551|NCT01398358|3754400|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3932552|NCT01398358|3754401|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3932553|NCT01398358|3754402|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3932554|NCT01398358|3754399|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|608|608.0||||||
3932555|NCT01398358|3754400|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|227|227.0||||||
3932556|NCT01398358|3754401|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|192|192.0||||||
3932557|NCT01398358|3754402|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|189|189.0||||||
3932558|NCT01398358|3754399|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3932559|NCT01398358|3754400|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3932560|NCT01398358|3754401|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3932561|NCT01398358|3754402|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3932562|NCT01398358|3754399|B4||Male|Sex: Female, Male||Participants|Count of Participants|339|339.0||||||
3932563|NCT01398358|3754400|B3||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3932564|NCT01398358|3754401|B2||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3932565|NCT01398358|3754402|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3932566|NCT01398358|3754399|B4||Female|Sex: Female, Male||Participants|Count of Participants|358|358.0||||||
3932567|NCT01398358|3754400|B3||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3932568|NCT01398358|3754401|B2||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3932569|NCT01398358|3754402|B1||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3932570|NCT01398358|3754399|B4|||Age||years|Mean|4.10|4.1|Standard Deviation|0.50|0.5|||
3932571|NCT01398358|3754400|B3|||Age||years|Mean|4.12|4.12|Standard Deviation|0.52|0.52|||
3932572|NCT01398358|3754401|B2|||Age||years|Mean|4.10|4.1|Standard Deviation|0.52|0.52|||
3932573|NCT01398358|3754402|B1|||Age||years|Mean|4.12|4.12|Standard Deviation|0.53|0.53|||
3932574|NCT01398358|3754399|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3932575|NCT01398358|3754400|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3932576|NCT01398358|3754401|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3932577|NCT01398358|3754402|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3932578|NCT01398358|3754399|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3932579|NCT01398358|3754400|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3932580|NCT01398358|3754401|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3932581|NCT01398358|3754402|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3932582|NCT01398358|3754399|B4||<=18 years|Age||Participants|Count of Participants|697|697.0||||||
3932583|NCT01398358|3754400|B3||<=18 years|Age||Participants|Count of Participants|255|255.0||||||
3932584|NCT01398358|3754401|B2||<=18 years|Age||Participants|Count of Participants|224|224.0||||||
3932585|NCT01398358|3754402|B1||<=18 years|Age||Participants|Count of Participants|218|218.0||||||
3932586|NCT01398176|3754415|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
3932587|NCT01398176|3754416|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3932588|NCT01398176|3754417|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
3932589|NCT01398176|3754415|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3932590|NCT01398176|3754416|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3932591|NCT01398176|3754417|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3932592|NCT01398176|3754415|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3932593|NCT01398176|3754416|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3932594|NCT01398176|3754417|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3932595|NCT01398176|3754415|B3|||Age||years|Mean|24.2|24.2|Standard Deviation|4.9|4.9|||
3932596|NCT01398176|3754416|B2|||Age||years|Mean|25.6|25.6|Standard Deviation|6.4|6.4|||
3932597|NCT01398176|3754417|B1|||Age||years|Mean|22.8|22.8|Standard Deviation|2.14|2.14|||
3932598|NCT01398176|3754415|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3932599|NCT01398176|3754416|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3932600|NCT01398176|3754417|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3932601|NCT01398176|3754415|B3||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3932602|NCT01398176|3754416|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3932603|NCT01398176|3754417|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3932604|NCT01398176|3754415|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3932605|NCT01398176|3754416|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3932606|NCT01398176|3754417|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3932607|NCT01397890|3754424|B3||Male|Sex: Female, Male||Participants|Count of Participants|552|552.0||||||
3932608|NCT01397890|3754425|B2||Male|Sex: Female, Male||Participants|Count of Participants|273|273.0||||||
3932609|NCT01397890|3754426|B1||Male|Sex: Female, Male||Participants|Count of Participants|279|279.0||||||
3932610|NCT01397890|3754424|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3932611|NCT01397890|3754425|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3932612|NCT01397890|3754426|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3932613|NCT01397890|3754424|B3|||Age||Years|Mean|66.8|66.8|Standard Deviation|8.25|8.25|||
3932614|NCT01397890|3754425|B2|||Age||Years|Mean|66.9|66.9|Standard Deviation|8.50|8.5|||
3932615|NCT01397890|3754426|B1|||Age||Years|Mean|66.6|66.6|Standard Deviation|7.99|7.99|||
3932616|NCT01397851|3754479|B3|Zambia||Region of Enrollment||participants|Number|81597|81597.0||||||
3932617|NCT01397851|3754480|B2|Zambia||Region of Enrollment||participants|Number|41634|41634.0||||||
3932618|NCT01397851|3754481|B1|Zambia||Region of Enrollment||participants|Number|39963|39963.0||||||
3932619|NCT01397851|3754479|B3||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3932620|NCT01397851|3754480|B2||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||not collected
3932621|NCT01397851|3754481|B1||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||not collected
3932622|NCT01397851|3754479|B3||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3932623|NCT01397851|3754480|B2||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||not collected
3932624|NCT01397851|3754481|B1||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||not collected
3932625|NCT01397851|3754479|B3|||Age|||Mean|NA||Standard Deviation|NA||||not collected
3932626|NCT01397851|3754480|B2|||Age|||Mean|NA||Standard Deviation|NA||||not collected
3932627|NCT01397851|3754481|B1|||Age|||Mean|NA||Standard Deviation|NA||||not collected
3932628|NCT01397825|3754494|B5|||Body Surface Area|Body surface area (m^²)=square root [height (cm)×weight (kg)/3600].|m^2|Mean|1.910|1.91|Standard Deviation|0.25|0.25|||
3932629|NCT01397825|3754495|B4|||Body Surface Area|Body surface area (m^²)=square root [height (cm)×weight (kg)/3600].|m^2|Mean|1.823|1.823|Standard Deviation|0.21|0.21|||
3932630|NCT01397825|3754496|B3|||Body Surface Area|Body surface area (m^²)=square root [height (cm)×weight (kg)/3600].|m^2|Mean|1.940|1.94|Standard Deviation|0.23|0.23|||
3932631|NCT01397825|3754497|B2|||Body Surface Area|Body surface area (m^²)=square root [height (cm)×weight (kg)/3600].|m^2|Mean|2.093|2.093|Standard Deviation|0.31|0.31|||
3932632|NCT01397825|3754498|B1|||Body Surface Area|Body surface area (m^²)=square root [height (cm)×weight (kg)/3600].|m^2|Mean|1.815|1.815|Standard Deviation|0.25|0.25|||
3932633|NCT01397825|3754494|B5|||Weight||kg|Mean|78.93|78.93|Standard Deviation|17.46|17.46|||
3932634|NCT01397825|3754495|B4|||Weight||kg|Mean|71.94|71.94|Standard Deviation|14.55|14.55|||
3932635|NCT01397825|3754496|B3|||Weight||kg|Mean|82.21|82.21|Standard Deviation|16.4|16.4|||
3932636|NCT01397825|3754497|B2|||Weight||kg|Mean|89.51|89.51|Standard Deviation|23.89|23.89|||
3932637|NCT01397825|3754498|B1|||Weight||kg|Mean|70.98|70.98|Standard Deviation|16.18|16.18|||
3932638|NCT01397825|3754494|B5|||Height||cm|Mean|169.0|169.0|Standard Deviation|10.44|10.44|||
3932639|NCT01397825|3754495|B4|||Height||cm|Mean|166.5|166.5|Standard Deviation|5.32|5.32|||
3932640|NCT01397825|3754496|B3|||Height||cm|Mean|168.4|168.4|Standard Deviation|10.76|10.76|||
3932641|NCT01397825|3754497|B2|||Height||cm|Mean|178.2|178.2|Standard Deviation|7.15|7.15|||
3932642|NCT01397825|3754498|B1|||Height||cm|Mean|167.9|167.9|Standard Deviation|10.90|10.9|||
3932643|NCT01397825|3754494|B5|United States||Region of Enrollment||participants|Number|45|45.0||||||
3932644|NCT01397825|3754495|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
3932645|NCT01397825|3754496|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
3932646|NCT01397825|3754497|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3932647|NCT01397825|3754498|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3932648|NCT01397825|3754494|B5|Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3932649|NCT01397825|3754495|B4|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3932650|NCT01397825|3754496|B3|Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3932651|NCT01397825|3754497|B2|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3932652|NCT01397825|3754498|B1|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3932653|NCT01397825|3754494|B5|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3932654|NCT01397825|3754495|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3932655|NCT01397825|3754496|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3932656|NCT01397825|3754497|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3932657|NCT01397825|3754498|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3932658|NCT01397825|3754494|B5|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3932659|NCT01397825|3754495|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3932660|NCT01397825|3754496|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3932661|NCT01397825|3754497|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3932662|NCT01397825|3754498|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3932663|NCT01397825|3754494|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3932664|NCT01397825|3754495|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3932665|NCT01397825|3754496|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3932666|NCT01397825|3754497|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3932667|NCT01397825|3754498|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3932668|NCT01397825|3754494|B5|White||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
3932669|NCT01397825|3754495|B4|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3932670|NCT01397825|3754496|B3|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3932671|NCT01397825|3754497|B2|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3932672|NCT01397825|3754498|B1|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3932673|NCT01397825|3754494|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3932674|NCT01397825|3754495|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3932675|NCT01397825|3754496|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3932676|NCT01397825|3754497|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3932677|NCT01397825|3754498|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3932678|NCT01397825|3754494|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3932679|NCT01397825|3754495|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3932680|NCT01397825|3754496|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3932681|NCT01397825|3754497|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3932682|NCT01397825|3754498|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3932683|NCT01397825|3754494|B5||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3932684|NCT01397825|3754495|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3932685|NCT01397825|3754496|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3932686|NCT01397825|3754497|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3932687|NCT01397825|3754498|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3932688|NCT01397825|3754494|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3932689|NCT01397825|3754495|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3932690|NCT01397825|3754496|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3932691|NCT01397825|3754497|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3932692|NCT01397825|3754498|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3932693|NCT01397825|3754494|B5|||Age||years|Mean|61.3|61.3|Standard Deviation|12.89|12.89|||
3932694|NCT01397825|3754495|B4|||Age||years|Mean|66.7|66.7|Standard Deviation|12.86|12.86|||
3932695|NCT01397825|3754496|B3|||Age||years|Mean|62.8|62.8|Standard Deviation|10.51|10.51|||
3932696|NCT01397825|3754497|B2|||Age||years|Mean|51.3|51.3|Standard Deviation|21.65|21.65|||
3932697|NCT01397825|3754498|B1|||Age||years|Mean|60.3|60.3|Standard Deviation|14.06|14.06|||
3932698|NCT01397786|3754569|B4||Male|Sex: Female, Male||Participants|Count of Participants|663|663.0||||||
3932699|NCT01397786|3754570|B3||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3932700|NCT01397786|3754571|B2||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3932701|NCT01397786|3754572|B1||Male|Sex: Female, Male||Participants|Count of Participants|366|366.0||||||
3932702|NCT01397786|3754569|B4||Female|Sex: Female, Male||Participants|Count of Participants|409|409.0||||||
3932703|NCT01397786|3754570|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3932704|NCT01397786|3754571|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3932705|NCT01397786|3754572|B1||Female|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
3932706|NCT01397786|3754569|B4|||Age||participants|Mean|40.0|40.0|Standard Deviation|11.1|11.1|||
3932707|NCT01397786|3754570|B3|||Age||participants|Mean|44.1|44.1|Standard Deviation|11.1|11.1|||
3932708|NCT01397786|3754571|B2|||Age||participants|Mean|39.6|39.6|Standard Deviation|10.8|10.8|||
3932709|NCT01397786|3754572|B1|||Age||participants|Mean|38.5|38.5|Standard Deviation|10.8|10.8|||
3932710|NCT01397747|3754640|B1|Current Smoker||Smoking History||participants|Number|903|903.0||||||
3932711|NCT01397747|3754640|B1|Former Smoker||Smoking History||participants|Number|3589|3589.0||||||
3932712|NCT01397747|3754640|B1|Never Smoked||Smoking History||participants|Number|5531|5531.0||||||
3932713|NCT01397747|3754640|B1|||BMI||kg/m^2|Mean|28.83|28.83|Standard Deviation|5.836|5.836|||
3932714|NCT01397747|3754640|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3932715|NCT01397747|3754640|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|206|206.0||||||
3932716|NCT01397747|3754640|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8422|8422.0||||||
3932717|NCT01397747|3754640|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1071|1071.0||||||
3932718|NCT01397747|3754640|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3932719|NCT01397747|3754640|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|259|259.0||||||
3932720|NCT01397747|3754640|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3932721|NCT01397747|3754640|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3932722|NCT01397747|3754640|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9028|9028.0||||||
3932723|NCT01397747|3754640|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|991|991.0||||||
3932724|NCT01397747|3754640|B1||Male|Sex: Female, Male||Participants|Count of Participants|4645|4645.0||||||
3932725|NCT01397747|3754640|B1||Female|Sex: Female, Male||Participants|Count of Participants|5378|5378.0||||||
3932726|NCT01397747|3754640|B1|||Age||years|Mean|64.2|64.2|Standard Deviation|8.42|8.42|||
3932727|NCT01397656|3754645|B3|||CPR Experience|Prior experience delivering CPR|Participants|Count of Participants|6|6.0||||||
3932728|NCT01397656|3754646|B2|||CPR Experience|Prior experience delivering CPR|Participants|Count of Participants|3|3.0||||||
3932729|NCT01397656|3754647|B1|||CPR Experience|Prior experience delivering CPR|Participants|Count of Participants|3|3.0||||||
3932730|NCT01397656|3754645|B3|||CPR Training||Participants|Count of Participants|38|38.0||||||
3932731|NCT01397656|3754646|B2|||CPR Training||Participants|Count of Participants|20|20.0||||||
3932732|NCT01397656|3754647|B1|||CPR Training||Participants|Count of Participants|18|18.0||||||
3932733|NCT01397656|3754645|B3|Canada||Region of Enrollment||participants|Number|63|63.0||||||
3932734|NCT01397656|3754646|B2|Canada||Region of Enrollment||participants|Number|30|30.0||||||
3932735|NCT01397656|3754647|B1|Canada||Region of Enrollment||participants|Number|33|33.0||||||
3932736|NCT01397656|3754645|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3932737|NCT01397656|3754646|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3932738|NCT01397656|3754647|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3932739|NCT01397656|3754645|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3932740|NCT01397656|3754646|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3932741|NCT01397656|3754647|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3932742|NCT01397656|3754645|B3|||Age||years|Mean|70.8|70.8|Standard Deviation|6.4|6.4|||
3932743|NCT01397656|3754646|B2|||Age||years|Mean|69.9|69.9|Standard Deviation|6.3|6.3|||
3932744|NCT01397656|3754647|B1|||Age||years|Mean|71.6|71.6|Standard Deviation|6.5|6.5|||
3932745|NCT01397617|3754660|B4||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3932746|NCT01397617|3754661|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3932747|NCT01397617|3754662|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3932748|NCT01397617|3754663|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3932749|NCT01397617|3754660|B4||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3932750|NCT01397617|3754661|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3932751|NCT01397617|3754662|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3932752|NCT01397617|3754663|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3932753|NCT01397617|3754660|B4|||Age||years|Mean|48.2|48.2|Standard Deviation|13.8|13.8|||
3932754|NCT01397617|3754661|B3|||Age||years|Mean|46.9|46.9|Standard Deviation|14.6|14.6|||
3932755|NCT01397617|3754662|B2|||Age||years|Mean|49.9|49.9|Standard Deviation|13.6|13.6|||
3932756|NCT01397617|3754663|B1|||Age||years|Mean|49.5|49.5|Standard Deviation|13.1|13.1|||
3932757|NCT01397591|3754676|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3932758|NCT01397591|3754676|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3932759|NCT01397591|3754676|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3932760|NCT01397591|3754676|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3932761|NCT01397591|3754676|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3932762|NCT01397591|3754676|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3932763|NCT01397591|3754676|B1|||Age||years|Mean|63.5|63.5|Standard Deviation|10.6|10.6|||
3932764|NCT01397461|3754693|B4|American Indian or Alaska native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3932765|NCT01397461|3754694|B3|American Indian or Alaska native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3932766|NCT01397461|3754695|B2|American Indian or Alaska native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3932767|NCT01397461|3754696|B1|American Indian or Alaska native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3932768|NCT01397461|3754693|B4|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3932769|NCT01397461|3754694|B3|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3932770|NCT01397461|3754695|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3932771|NCT01397461|3754696|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3932772|NCT01397461|3754693|B4|Mixed race||Race/Ethnicity, Customized||Participants|Number|56|56.0||||||
3932773|NCT01397461|3754694|B3|Mixed race||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
3932774|NCT01397461|3754695|B2|Mixed race||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
3932775|NCT01397461|3754696|B1|Mixed race||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
3932776|NCT01397461|3754693|B4|White||Race/Ethnicity, Customized||Participants|Number|170|170.0||||||
3932777|NCT01397461|3754694|B3|White||Race/Ethnicity, Customized||Participants|Number|50|50.0||||||
3932778|NCT01397461|3754695|B2|White||Race/Ethnicity, Customized||Participants|Number|62|62.0||||||
3932779|NCT01397461|3754696|B1|White||Race/Ethnicity, Customized||Participants|Number|58|58.0||||||
3932780|NCT01397461|3754693|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|233|233.0||||||
3932781|NCT01397461|3754694|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|78|78.0||||||
3932782|NCT01397461|3754695|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|77|77.0||||||
3932783|NCT01397461|3754696|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|78|78.0||||||
3932784|NCT01397461|3754693|B4||Male|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
3932785|NCT01397461|3754694|B3||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3932786|NCT01397461|3754695|B2||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3932787|NCT01397461|3754696|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3932788|NCT01397461|3754693|B4||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
3932789|NCT01397461|3754694|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3932790|NCT01397461|3754695|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3932791|NCT01397461|3754696|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3932792|NCT01397461|3754693|B4|>=65||Age, Customized||Participants|Number|13|13.0||||||
3932793|NCT01397461|3754694|B3|>=65||Age, Customized||Participants|Number|3|3.0||||||
3932794|NCT01397461|3754695|B2|>=65||Age, Customized||Participants|Number|4|4.0||||||
3932795|NCT01397461|3754696|B1|>=65||Age, Customized||Participants|Number|6|6.0||||||
3932796|NCT01397461|3754693|B4|>=18 years to <65 years||Age, Customized||Participants|Number|116|116.0||||||
3932797|NCT01397461|3754694|B3|>=18 years to <65 years||Age, Customized||Participants|Number|40|40.0||||||
3932798|NCT01397461|3754695|B2|>=18 years to <65 years||Age, Customized||Participants|Number|40|40.0||||||
3932799|NCT01397461|3754696|B1|>=18 years to <65 years||Age, Customized||Participants|Number|36|36.0||||||
3932800|NCT01397461|3754693|B4|>=12 years to <18 years||Age, Customized||Participants|Number|52|52.0||||||
3932801|NCT01397461|3754694|B3|>=12 years to <18 years||Age, Customized||Participants|Number|15|15.0||||||
3932802|NCT01397461|3754695|B2|>=12 years to <18 years||Age, Customized||Participants|Number|18|18.0||||||
3932803|NCT01397461|3754696|B1|>=12 years to <18 years||Age, Customized||Participants|Number|19|19.0||||||
3932804|NCT01397461|3754693|B4|2>=years to <12 years||Age, Customized||Participants|Number|283|283.0||||||
3932805|NCT01397461|3754694|B3|2>=years to <12 years||Age, Customized||Participants|Number|94|94.0||||||
3932806|NCT01397461|3754695|B2|2>=years to <12 years||Age, Customized||Participants|Number|94|94.0||||||
3932807|NCT01397461|3754696|B1|2>=years to <12 years||Age, Customized||Participants|Number|95|95.0||||||
3932808|NCT01397448|3754706|B4|Other (No)||Primary Disease|Percutaneous Transluminal Coronary Angioplasty is represented as PTCA.|Participants|Number|446|446.0||||||
3932809|NCT01397448|3754707|B3|Other (No)||Primary Disease|Percutaneous Transluminal Coronary Angioplasty is represented as PTCA.|Participants|Number|149|149.0||||||
3932810|NCT01397448|3754708|B2|Other (No)||Primary Disease|Percutaneous Transluminal Coronary Angioplasty is represented as PTCA.|Participants|Number|147|147.0||||||
3932811|NCT01397448|3754709|B1|Other (No)||Primary Disease|Percutaneous Transluminal Coronary Angioplasty is represented as PTCA.|Participants|Number|150|150.0||||||
3932812|NCT01397448|3754706|B4|Other (Yes)||Primary Disease|Percutaneous Transluminal Coronary Angioplasty is represented as PTCA.|Participants|Number|25|25.0||||||
3932813|NCT01397448|3754707|B3|Other (Yes)||Primary Disease|Percutaneous Transluminal Coronary Angioplasty is represented as PTCA.|Participants|Number|9|9.0||||||
3932814|NCT01397448|3754708|B2|Other (Yes)||Primary Disease|Percutaneous Transluminal Coronary Angioplasty is represented as PTCA.|Participants|Number|10|10.0||||||
3932815|NCT01397448|3754709|B1|Other (Yes)||Primary Disease|Percutaneous Transluminal Coronary Angioplasty is represented as PTCA.|Participants|Number|6|6.0||||||
3932816|NCT01397448|3754706|B4|Coronary Arterial Bypass Grafting or PTCA (No)||Primary Disease|Percutaneous Transluminal Coronary Angioplasty is represented as PTCA.|Participants|Number|320|320.0||||||
3932817|NCT01397448|3754707|B3|Coronary Arterial Bypass Grafting or PTCA (No)||Primary Disease|Percutaneous Transluminal Coronary Angioplasty is represented as PTCA.|Participants|Number|110|110.0||||||
3932818|NCT01397448|3754708|B2|Coronary Arterial Bypass Grafting or PTCA (No)||Primary Disease|Percutaneous Transluminal Coronary Angioplasty is represented as PTCA.|Participants|Number|106|106.0||||||
3932819|NCT01397448|3754709|B1|Coronary Arterial Bypass Grafting or PTCA (No)||Primary Disease|Percutaneous Transluminal Coronary Angioplasty is represented as PTCA.|Participants|Number|104|104.0||||||
3932820|NCT01397448|3754706|B4|Coronary Arterial Bypass Grafting or PTCA (Yes)||Primary Disease|Percutaneous Transluminal Coronary Angioplasty is represented as PTCA.|Participants|Number|151|151.0||||||
3932821|NCT01397448|3754707|B3|Coronary Arterial Bypass Grafting or PTCA (Yes)||Primary Disease|Percutaneous Transluminal Coronary Angioplasty is represented as PTCA.|Participants|Number|48|48.0||||||
3932822|NCT01397448|3754708|B2|Coronary Arterial Bypass Grafting or PTCA (Yes)||Primary Disease|Percutaneous Transluminal Coronary Angioplasty is represented as PTCA.|Participants|Number|51|51.0||||||
3932823|NCT01397448|3754709|B1|Coronary Arterial Bypass Grafting or PTCA (Yes)||Primary Disease|Percutaneous Transluminal Coronary Angioplasty is represented as PTCA.|Participants|Number|52|52.0||||||
3932824|NCT01397448|3754706|B4|Ischemic Cerebrovascular Disease (No)||Primary Disease|Percutaneous Transluminal Coronary Angioplasty is represented as PTCA.|Participants|Number|237|237.0||||||
3932825|NCT01397448|3754707|B3|Ischemic Cerebrovascular Disease (No)||Primary Disease|Percutaneous Transluminal Coronary Angioplasty is represented as PTCA.|Participants|Number|80|80.0||||||
3932826|NCT01397448|3754708|B2|Ischemic Cerebrovascular Disease (No)||Primary Disease|Percutaneous Transluminal Coronary Angioplasty is represented as PTCA.|Participants|Number|80|80.0||||||
3932827|NCT01397448|3754709|B1|Ischemic Cerebrovascular Disease (No)||Primary Disease|Percutaneous Transluminal Coronary Angioplasty is represented as PTCA.|Participants|Number|77|77.0||||||
3932828|NCT01397448|3754706|B4|Ischemic Cerebrovascular Disease (Yes)||Primary Disease|Percutaneous Transluminal Coronary Angioplasty is represented as PTCA.|Participants|Number|234|234.0||||||
3932829|NCT01397448|3754707|B3|Ischemic Cerebrovascular Disease (Yes)||Primary Disease|Percutaneous Transluminal Coronary Angioplasty is represented as PTCA.|Participants|Number|78|78.0||||||
3932830|NCT01397448|3754708|B2|Ischemic Cerebrovascular Disease (Yes)||Primary Disease|Percutaneous Transluminal Coronary Angioplasty is represented as PTCA.|Participants|Number|77|77.0||||||
3932831|NCT01397448|3754709|B1|Ischemic Cerebrovascular Disease (Yes)||Primary Disease|Percutaneous Transluminal Coronary Angioplasty is represented as PTCA.|Participants|Number|79|79.0||||||
3932832|NCT01397448|3754706|B4|Myocardial Infarction (No)||Primary Disease|Percutaneous Transluminal Coronary Angioplasty is represented as PTCA.|Participants|Number|380|380.0||||||
3932833|NCT01397448|3754707|B3|Myocardial Infarction (No)||Primary Disease|Percutaneous Transluminal Coronary Angioplasty is represented as PTCA.|Participants|Number|125|125.0||||||
3932834|NCT01397448|3754708|B2|Myocardial Infarction (No)||Primary Disease|Percutaneous Transluminal Coronary Angioplasty is represented as PTCA.|Participants|Number|126|126.0||||||
3932835|NCT01397448|3754709|B1|Myocardial Infarction (No)||Primary Disease|Percutaneous Transluminal Coronary Angioplasty is represented as PTCA.|Participants|Number|129|129.0||||||
3932836|NCT01397448|3754706|B4|Myocardial Infarction (Yes)||Primary Disease|Percutaneous Transluminal Coronary Angioplasty is represented as PTCA.|Participants|Number|91|91.0||||||
3932837|NCT01397448|3754707|B3|Myocardial Infarction (Yes)||Primary Disease|Percutaneous Transluminal Coronary Angioplasty is represented as PTCA.|Participants|Number|33|33.0||||||
3932838|NCT01397448|3754708|B2|Myocardial Infarction (Yes)||Primary Disease|Percutaneous Transluminal Coronary Angioplasty is represented as PTCA.|Participants|Number|31|31.0||||||
3932839|NCT01397448|3754709|B1|Myocardial Infarction (Yes)||Primary Disease|Percutaneous Transluminal Coronary Angioplasty is represented as PTCA.|Participants|Number|27|27.0||||||
3932840|NCT01397448|3754706|B4|Angina Pectoris (No)||Primary Disease|Percutaneous Transluminal Coronary Angioplasty is represented as PTCA.|Participants|Number|274|274.0||||||
3932841|NCT01397448|3754707|B3|Angina Pectoris (No)||Primary Disease|Percutaneous Transluminal Coronary Angioplasty is represented as PTCA.|Participants|Number|92|92.0||||||
3932842|NCT01397448|3754708|B2|Angina Pectoris (No)||Primary Disease|Percutaneous Transluminal Coronary Angioplasty is represented as PTCA.|Participants|Number|94|94.0||||||
3932843|NCT01397448|3754709|B1|Angina Pectoris (No)||Primary Disease|Percutaneous Transluminal Coronary Angioplasty is represented as PTCA.|Participants|Number|88|88.0||||||
3932844|NCT01397448|3754706|B4|Angina Pectoris (Yes)||Primary Disease|Percutaneous Transluminal Coronary Angioplasty is represented as PTCA.|Participants|Number|197|197.0||||||
3932845|NCT01397448|3754707|B3|Angina Pectoris (Yes)||Primary Disease|Percutaneous Transluminal Coronary Angioplasty is represented as PTCA.|Participants|Number|66|66.0||||||
3932846|NCT01397448|3754708|B2|Angina Pectoris (Yes)||Primary Disease|Percutaneous Transluminal Coronary Angioplasty is represented as PTCA.|Participants|Number|63|63.0||||||
3932847|NCT01397448|3754709|B1|Angina Pectoris (Yes)||Primary Disease|Percutaneous Transluminal Coronary Angioplasty is represented as PTCA.|Participants|Number|68|68.0||||||
3932848|NCT01397448|3754706|B4|Negative||Diagnostic Test of H.pylori. (IgG Antibody)||Participants|Number|255|255.0||||||
3932849|NCT01397448|3754707|B3|Negative||Diagnostic Test of H.pylori. (IgG Antibody)||Participants|Number|81|81.0||||||
3932850|NCT01397448|3754708|B2|Negative||Diagnostic Test of H.pylori. (IgG Antibody)||Participants|Number|90|90.0||||||
3932851|NCT01397448|3754709|B1|Negative||Diagnostic Test of H.pylori. (IgG Antibody)||Participants|Number|84|84.0||||||
3932852|NCT01397448|3754706|B4|Positive||Diagnostic Test of H.pylori. (IgG Antibody)||Participants|Number|216|216.0||||||
3932853|NCT01397448|3754707|B3|Positive||Diagnostic Test of H.pylori. (IgG Antibody)||Participants|Number|77|77.0||||||
3932854|NCT01397448|3754708|B2|Positive||Diagnostic Test of H.pylori. (IgG Antibody)||Participants|Number|67|67.0||||||
3932855|NCT01397448|3754709|B1|Positive||Diagnostic Test of H.pylori. (IgG Antibody)||Participants|Number|72|72.0||||||
3932856|NCT01397448|3754706|B4|100 mg||Daily Dose of Low-Dose Aspirin||Participants|Number|429|429.0||||||
3932857|NCT01397448|3754707|B3|100 mg||Daily Dose of Low-Dose Aspirin||Participants|Number|142|142.0||||||
3932858|NCT01397448|3754708|B2|100 mg||Daily Dose of Low-Dose Aspirin||Participants|Number|143|143.0||||||
3932859|NCT01397448|3754709|B1|100 mg||Daily Dose of Low-Dose Aspirin||Participants|Number|144|144.0||||||
3932860|NCT01397448|3754706|B4|81 mg||Daily Dose of Low-Dose Aspirin||Participants|Number|42|42.0||||||
3932861|NCT01397448|3754707|B3|81 mg||Daily Dose of Low-Dose Aspirin||Participants|Number|16|16.0||||||
3932862|NCT01397448|3754708|B2|81 mg||Daily Dose of Low-Dose Aspirin||Participants|Number|14|14.0||||||
3932863|NCT01397448|3754709|B1|81 mg||Daily Dose of Low-Dose Aspirin||Participants|Number|12|12.0||||||
3932864|NCT01397448|3754706|B4|No||Antiplatelet Drug or Anticoagulant Drug||Participants|Number|372|372.0||||||
3932865|NCT01397448|3754707|B3|No||Antiplatelet Drug or Anticoagulant Drug||Participants|Number|123|123.0||||||
3932866|NCT01397448|3754708|B2|No||Antiplatelet Drug or Anticoagulant Drug||Participants|Number|123|123.0||||||
3932867|NCT01397448|3754709|B1|No||Antiplatelet Drug or Anticoagulant Drug||Participants|Number|126|126.0||||||
3932868|NCT01397448|3754706|B4|Yes||Antiplatelet Drug or Anticoagulant Drug||Participants|Number|99|99.0||||||
3932869|NCT01397448|3754707|B3|Yes||Antiplatelet Drug or Anticoagulant Drug||Participants|Number|35|35.0||||||
3932870|NCT01397448|3754708|B2|Yes||Antiplatelet Drug or Anticoagulant Drug||Participants|Number|34|34.0||||||
3932871|NCT01397448|3754709|B1|Yes||Antiplatelet Drug or Anticoagulant Drug||Participants|Number|30|30.0||||||
3932872|NCT01397448|3754706|B4||Male|Sex: Female, Male||Participants|Count of Participants|359|359.0||||||
3932873|NCT01397448|3754707|B3||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3932874|NCT01397448|3754708|B2||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3932875|NCT01397448|3754709|B1||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3932876|NCT01397448|3754706|B4||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3932877|NCT01397448|3754707|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3932878|NCT01397448|3754708|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3932879|NCT01397448|3754709|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3932880|NCT01397448|3754706|B4|||Age||Years|Mean|69.6|69.6|Standard Deviation|8.8|8.8|||
3932881|NCT01397448|3754707|B3|||Age||Years|Mean|69.4|69.4|Standard Deviation|7.9|7.9|||
3932882|NCT01397448|3754708|B2|||Age||Years|Mean|70.1|70.1|Standard Deviation|9.6|9.6|||
3932883|NCT01397448|3754709|B1|||Age||Years|Mean|69.3|69.3|Standard Deviation|8.9|8.9|||
3932884|NCT01397422|3754722|B5|Anticholinergic||Subjects taking Antiparkinson Medication|Participants may have been taking more than 1 antiparkinson medication at baseline.|Participants|Count of Participants|2|2.0||||||
3932885|NCT01397422|3754723|B4|Anticholinergic||Subjects taking Antiparkinson Medication|Participants may have been taking more than 1 antiparkinson medication at baseline.|Participants|Count of Participants|1|1.0||||||
3932886|NCT01397422|3754724|B3|Anticholinergic||Subjects taking Antiparkinson Medication|Participants may have been taking more than 1 antiparkinson medication at baseline.|Participants|Count of Participants|0|0.0||||||
3932887|NCT01397422|3754725|B2|Anticholinergic||Subjects taking Antiparkinson Medication|Participants may have been taking more than 1 antiparkinson medication at baseline.|Participants|Count of Participants|0|0.0||||||
3932888|NCT01397422|3754726|B1|Anticholinergic||Subjects taking Antiparkinson Medication|Participants may have been taking more than 1 antiparkinson medication at baseline.|Participants|Count of Participants|1|1.0||||||
3932889|NCT01397422|3754722|B5|COMT Inhibitor||Subjects taking Antiparkinson Medication|Participants may have been taking more than 1 antiparkinson medication at baseline.|Participants|Count of Participants|14|14.0||||||
3932890|NCT01397422|3754723|B4|COMT Inhibitor||Subjects taking Antiparkinson Medication|Participants may have been taking more than 1 antiparkinson medication at baseline.|Participants|Count of Participants|4|4.0||||||
3932891|NCT01397422|3754724|B3|COMT Inhibitor||Subjects taking Antiparkinson Medication|Participants may have been taking more than 1 antiparkinson medication at baseline.|Participants|Count of Participants|6|6.0||||||
3932892|NCT01397422|3754725|B2|COMT Inhibitor||Subjects taking Antiparkinson Medication|Participants may have been taking more than 1 antiparkinson medication at baseline.|Participants|Count of Participants|1|1.0||||||
3932893|NCT01397422|3754726|B1|COMT Inhibitor||Subjects taking Antiparkinson Medication|Participants may have been taking more than 1 antiparkinson medication at baseline.|Participants|Count of Participants|3|3.0||||||
3932894|NCT01397422|3754722|B5|MAO-B Inhibitor||Subjects taking Antiparkinson Medication|Participants may have been taking more than 1 antiparkinson medication at baseline.|Participants|Count of Participants|49|49.0||||||
3932895|NCT01397422|3754723|B4|MAO-B Inhibitor||Subjects taking Antiparkinson Medication|Participants may have been taking more than 1 antiparkinson medication at baseline.|Participants|Count of Participants|12|12.0||||||
3932896|NCT01397422|3754724|B3|MAO-B Inhibitor||Subjects taking Antiparkinson Medication|Participants may have been taking more than 1 antiparkinson medication at baseline.|Participants|Count of Participants|12|12.0||||||
3932897|NCT01397422|3754725|B2|MAO-B Inhibitor||Subjects taking Antiparkinson Medication|Participants may have been taking more than 1 antiparkinson medication at baseline.|Participants|Count of Participants|11|11.0||||||
3932898|NCT01397422|3754726|B1|MAO-B Inhibitor||Subjects taking Antiparkinson Medication|Participants may have been taking more than 1 antiparkinson medication at baseline.|Participants|Count of Participants|14|14.0||||||
3932899|NCT01397422|3754722|B5|Dopamine Agonist||Subjects taking Antiparkinson Medication|Participants may have been taking more than 1 antiparkinson medication at baseline.|Participants|Count of Participants|54|54.0||||||
3932900|NCT01397422|3754723|B4|Dopamine Agonist||Subjects taking Antiparkinson Medication|Participants may have been taking more than 1 antiparkinson medication at baseline.|Participants|Count of Participants|16|16.0||||||
3932901|NCT01397422|3754724|B3|Dopamine Agonist||Subjects taking Antiparkinson Medication|Participants may have been taking more than 1 antiparkinson medication at baseline.|Participants|Count of Participants|10|10.0||||||
3932902|NCT01397422|3754725|B2|Dopamine Agonist||Subjects taking Antiparkinson Medication|Participants may have been taking more than 1 antiparkinson medication at baseline.|Participants|Count of Participants|14|14.0||||||
3932903|NCT01397422|3754726|B1|Dopamine Agonist||Subjects taking Antiparkinson Medication|Participants may have been taking more than 1 antiparkinson medication at baseline.|Participants|Count of Participants|14|14.0||||||
3932904|NCT01397422|3754722|B5|Levodopa (Sinemet or Stalevo)||Subjects taking Antiparkinson Medication|Participants may have been taking more than 1 antiparkinson medication at baseline.|Participants|Count of Participants|83|83.0||||||
3932905|NCT01397422|3754723|B4|Levodopa (Sinemet or Stalevo)||Subjects taking Antiparkinson Medication|Participants may have been taking more than 1 antiparkinson medication at baseline.|Participants|Count of Participants|20|20.0||||||
3932906|NCT01397422|3754724|B3|Levodopa (Sinemet or Stalevo)||Subjects taking Antiparkinson Medication|Participants may have been taking more than 1 antiparkinson medication at baseline.|Participants|Count of Participants|21|21.0||||||
3932907|NCT01397422|3754725|B2|Levodopa (Sinemet or Stalevo)||Subjects taking Antiparkinson Medication|Participants may have been taking more than 1 antiparkinson medication at baseline.|Participants|Count of Participants|20|20.0||||||
3932908|NCT01397422|3754726|B1|Levodopa (Sinemet or Stalevo)||Subjects taking Antiparkinson Medication|Participants may have been taking more than 1 antiparkinson medication at baseline.|Participants|Count of Participants|22|22.0||||||
3932909|NCT01397422|3754722|B5|||Duration of LID||years|Mean|3.85|3.85|Standard Deviation|3.106|3.106|||
3932910|NCT01397422|3754723|B4|||Duration of LID||years|Mean|3.57|3.57|Standard Deviation|2.049|2.049|||
3932911|NCT01397422|3754724|B3|||Duration of LID||years|Mean|4.37|4.37|Standard Deviation|3.364|3.364|||
3932912|NCT01397422|3754725|B2|||Duration of LID||years|Mean|3.35|3.35|Standard Deviation|2.585|2.585|||
3932913|NCT01397422|3754726|B1|||Duration of LID||years|Mean|4.08|4.08|Standard Deviation|4.051|4.051|||
3932914|NCT01397422|3754722|B5|||Levodopa daily dose||mg|Mean|768.6|768.6|Standard Deviation|444.41|444.41|||
3932915|NCT01397422|3754723|B4|||Levodopa daily dose||mg|Mean|862.5|862.5|Standard Deviation|585.94|585.94|||
3932916|NCT01397422|3754724|B3|||Levodopa daily dose||mg|Mean|694.0|694.0|Standard Deviation|278.33|278.33|||
3932917|NCT01397422|3754725|B2|||Levodopa daily dose||mg|Mean|714.5|714.5|Standard Deviation|449.33|449.33|||
3932918|NCT01397422|3754726|B1|||Levodopa daily dose||mg|Mean|801.1|801.1|Standard Deviation|431.94|431.94|||
3932919|NCT01397422|3754722|B5|||Time since PD diagnosis||years|Mean|9.51|9.51|Standard Deviation|4.964|4.964|||
3932920|NCT01397422|3754723|B4|||Time since PD diagnosis||years|Mean|9.00|9.0|Standard Deviation|3.484|3.484|||
3932921|NCT01397422|3754724|B3|||Time since PD diagnosis||years|Mean|9.33|9.33|Standard Deviation|4.913|4.913|||
3932922|NCT01397422|3754725|B2|||Time since PD diagnosis||years|Mean|8.94|8.94|Standard Deviation|3.395|3.395|||
3932923|NCT01397422|3754726|B1|||Time since PD diagnosis||years|Mean|10.66|10.66|Standard Deviation|7.057|7.057|||
3932924|NCT01397422|3754722|B5|||Hoehn and Yahr Score|Hoehn and Yahr assessed at screening only. The scale, from 1-5, describes the patient's PD progression. The higher the score the more severe the symptoms of PD.|units on a scale|Mean|2.5|2.5|Standard Deviation|0.7|0.7|||
3932925|NCT01397422|3754723|B4|||Hoehn and Yahr Score|Hoehn and Yahr assessed at screening only. The scale, from 1-5, describes the patient's PD progression. The higher the score the more severe the symptoms of PD.|units on a scale|Mean|2.4|2.4|Standard Deviation|0.8|0.8|||
3932926|NCT01397422|3754724|B3|||Hoehn and Yahr Score|Hoehn and Yahr assessed at screening only. The scale, from 1-5, describes the patient's PD progression. The higher the score the more severe the symptoms of PD.|units on a scale|Mean|2.5|2.5|Standard Deviation|0.6|0.6|||
3932927|NCT01397422|3754725|B2|||Hoehn and Yahr Score|Hoehn and Yahr assessed at screening only. The scale, from 1-5, describes the patient's PD progression. The higher the score the more severe the symptoms of PD.|units on a scale|Mean|2.5|2.5|Standard Deviation|0.9|0.9|||
3932928|NCT01397422|3754726|B1|||Hoehn and Yahr Score|Hoehn and Yahr assessed at screening only. The scale, from 1-5, describes the patient's PD progression. The higher the score the more severe the symptoms of PD.|units on a scale|Mean|2.5|2.5|Standard Deviation|0.7|0.7|||
3932929|NCT01397422|3754722|B5|||Fatigue Severity Score (FSS)|The FSS is a 9-item self-reported scale, rating subject experience of fatigue during the previous 7 days. The total score, on a scale from 1-7, is represented by the mean of all answered items. The higher the score, the greater the fatigue severity.|units on a scale|Mean|4.71|4.71|Standard Deviation|1.307|1.307|||
3932930|NCT01397422|3754723|B4|||Fatigue Severity Score (FSS)|The FSS is a 9-item self-reported scale, rating subject experience of fatigue during the previous 7 days. The total score, on a scale from 1-7, is represented by the mean of all answered items. The higher the score, the greater the fatigue severity.|units on a scale|Mean|4.78|4.78|Standard Deviation|1.120|1.12|||
3932931|NCT01397422|3754724|B3|||Fatigue Severity Score (FSS)|The FSS is a 9-item self-reported scale, rating subject experience of fatigue during the previous 7 days. The total score, on a scale from 1-7, is represented by the mean of all answered items. The higher the score, the greater the fatigue severity.|units on a scale|Mean|4.80|4.8|Standard Deviation|1.425|1.425|||
3932984|NCT01397422|3754722|B5||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3932932|NCT01397422|3754725|B2|||Fatigue Severity Score (FSS)|The FSS is a 9-item self-reported scale, rating subject experience of fatigue during the previous 7 days. The total score, on a scale from 1-7, is represented by the mean of all answered items. The higher the score, the greater the fatigue severity.|units on a scale|Mean|4.40|4.4|Standard Deviation|1.488|1.488|||
3932933|NCT01397422|3754726|B1|||Fatigue Severity Score (FSS)|The FSS is a 9-item self-reported scale, rating subject experience of fatigue during the previous 7 days. The total score, on a scale from 1-7, is represented by the mean of all answered items. The higher the score, the greater the fatigue severity.|units on a scale|Mean|4.86|4.86|Standard Deviation|1.211|1.211|||
3932934|NCT01397422|3754722|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932935|NCT01397422|3754723|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932936|NCT01397422|3754724|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932937|NCT01397422|3754725|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932938|NCT01397422|3754726|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932939|NCT01397422|3754722|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932940|NCT01397422|3754723|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932941|NCT01397422|3754724|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932942|NCT01397422|3754725|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932943|NCT01397422|3754726|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932944|NCT01397422|3754722|B5||White|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3932945|NCT01397422|3754723|B4||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3932946|NCT01397422|3754724|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3932947|NCT01397422|3754725|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3932948|NCT01397422|3754726|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3932949|NCT01397422|3754722|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3932950|NCT01397422|3754723|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932951|NCT01397422|3754724|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3932952|NCT01397422|3754725|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932953|NCT01397422|3754726|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3932954|NCT01397422|3754722|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932955|NCT01397422|3754723|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932956|NCT01397422|3754724|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932957|NCT01397422|3754725|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932958|NCT01397422|3754726|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932959|NCT01397422|3754722|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3932960|NCT01397422|3754723|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3932961|NCT01397422|3754724|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932962|NCT01397422|3754725|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932963|NCT01397422|3754726|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3932964|NCT01397422|3754722|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3932965|NCT01397422|3754723|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932966|NCT01397422|3754724|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932967|NCT01397422|3754725|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3932968|NCT01397422|3754726|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932969|NCT01397422|3754722|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932970|NCT01397422|3754723|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932971|NCT01397422|3754724|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932972|NCT01397422|3754725|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932973|NCT01397422|3754726|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932974|NCT01397422|3754722|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3932975|NCT01397422|3754723|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3932976|NCT01397422|3754724|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3932977|NCT01397422|3754725|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3932978|NCT01397422|3754726|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3932979|NCT01397422|3754722|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3932980|NCT01397422|3754723|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3932981|NCT01397422|3754724|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3932982|NCT01397422|3754725|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3932983|NCT01397422|3754726|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3932985|NCT01397422|3754723|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3932986|NCT01397422|3754724|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3932987|NCT01397422|3754725|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3932988|NCT01397422|3754726|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3932989|NCT01397422|3754722|B5||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3932990|NCT01397422|3754723|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3932991|NCT01397422|3754724|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3932992|NCT01397422|3754725|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3932993|NCT01397422|3754726|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3932994|NCT01397422|3754722|B5|||Age||years|Mean|66.0|66.0|Standard Deviation|9.47|9.47|||
3932995|NCT01397422|3754723|B4|||Age||years|Mean|66.4|66.4|Standard Deviation|9.38|9.38|||
3932996|NCT01397422|3754724|B3|||Age||years|Mean|64.7|64.7|Standard Deviation|10.03|10.03|||
3932997|NCT01397422|3754725|B2|||Age||years|Mean|67.5|67.5|Standard Deviation|8.59|8.59|||
3932998|NCT01397422|3754726|B1|||Age||years|Mean|65.5|65.5|Standard Deviation|10.17|10.17|||
3932999|NCT01397409|3754759|B11||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3933000|NCT01397409|3754760|B10||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3933001|NCT01397409|3754761|B9||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3933002|NCT01397409|3754762|B8||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3933003|NCT01397409|3754763|B7||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3933004|NCT01397409|3754764|B6||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3933005|NCT01397409|3754765|B5||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3933006|NCT01397409|3754766|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3933007|NCT01397409|3754767|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3933008|NCT01397409|3754768|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3933009|NCT01397409|3754769|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3933010|NCT01397409|3754759|B11||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
3933011|NCT01397409|3754760|B10||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3933012|NCT01397409|3754761|B9||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3933013|NCT01397409|3754762|B8||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3933014|NCT01397409|3754763|B7||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3933015|NCT01397409|3754764|B6||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3933016|NCT01397409|3754765|B5||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3933017|NCT01397409|3754766|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3933018|NCT01397409|3754767|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3933019|NCT01397409|3754768|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3933020|NCT01397409|3754769|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3933021|NCT01397409|3754759|B11|||Age||Years|Mean|77.2|77.2|Full Range|||53.0|95.0|
3933022|NCT01397409|3754760|B10|||Age||Years|Mean|76.5|76.5|Full Range|||53.0|86.0|
3933023|NCT01397409|3754761|B9|||Age||Years|Mean|75.5|75.5|Full Range|||54.0|91.0|
3933024|NCT01397409|3754762|B8|||Age||Years|Mean|77.9|77.9|Full Range|||67.0|89.0|
3933025|NCT01397409|3754763|B7|||Age||Years|Mean|78.5|78.5|Full Range|||59.0|92.0|
3933026|NCT01397409|3754764|B6|||Age||Years|Mean|78.6|78.6|Full Range|||63.0|94.0|
3933027|NCT01397409|3754765|B5|||Age||Years|Mean|80.4|80.4|Full Range|||58.0|95.0|
3933028|NCT01397409|3754766|B4|||Age||Years|Mean|67.7|67.7|Full Range|||64.0|71.0|
3933029|NCT01397409|3754767|B3|||Age||Years|Mean|79.3|79.3|Full Range|||72.0|91.0|
3933030|NCT01397409|3754768|B2|||Age||Years|Mean|75.3|75.3|Full Range|||62.0|86.0|
3933031|NCT01397409|3754769|B1|||Age||Years|Mean|82.3|82.3|Full Range|||68.0|89.0|
3933032|NCT01397253|3754816|B3|United States||Region of Enrollment||participants|Number|560|560.0||||||
3933033|NCT01397253|3754817|B2|United States||Region of Enrollment||participants|Number|243|243.0||||||
3933034|NCT01397253|3754818|B1|United States||Region of Enrollment||participants|Number|317|317.0||||||
3933035|NCT01397253|3754816|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3933036|NCT01397253|3754817|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3933037|NCT01397253|3754818|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933038|NCT01397253|3754816|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3933039|NCT01397253|3754817|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933040|NCT01397253|3754818|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3933041|NCT01397253|3754816|B3||White|Race (NIH/OMB)||Participants|Count of Participants|367|367.0||||||
3933042|NCT01397253|3754817|B2||White|Race (NIH/OMB)||Participants|Count of Participants|151|151.0||||||
3933043|NCT01397253|3754818|B1||White|Race (NIH/OMB)||Participants|Count of Participants|216|216.0||||||
3933044|NCT01397253|3754816|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|182|182.0||||||
3933045|NCT01397253|3754817|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
3933046|NCT01397253|3754818|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3933047|NCT01397253|3754816|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933048|NCT01397253|3754817|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933049|NCT01397253|3754818|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933050|NCT01397253|3754816|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3933051|NCT01397253|3754817|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3933052|NCT01397253|3754818|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3933053|NCT01397253|3754816|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3933054|NCT01397253|3754817|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3933055|NCT01397253|3754818|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3933056|NCT01397253|3754816|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3933057|NCT01397253|3754817|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3933058|NCT01397253|3754818|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933059|NCT01397253|3754816|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|558|558.0||||||
3933060|NCT01397253|3754817|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|242|242.0||||||
3933061|NCT01397253|3754818|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|316|316.0||||||
3933062|NCT01397253|3754816|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3933063|NCT01397253|3754817|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933064|NCT01397253|3754818|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3933065|NCT01397253|3754816|B3||Male|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
3933066|NCT01397253|3754817|B2||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3933067|NCT01397253|3754818|B1||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3933068|NCT01397253|3754816|B3||Female|Sex: Female, Male||Participants|Count of Participants|328|328.0||||||
3933069|NCT01397253|3754817|B2||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3933070|NCT01397253|3754818|B1||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
3933071|NCT01397253|3754816|B3|||Age||years|Median|63|63.0|Inter-Quartile Range|||54.0|75.0|
3933072|NCT01397253|3754817|B2|||Age||years|Median|63|63.0|Inter-Quartile Range|||54.0|73.0|
3933073|NCT01397253|3754818|B1|||Age||years|Median|63|63.0|Inter-Quartile Range|||53.0|76.0|
3933074|NCT01397084|3754825|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3933075|NCT01397084|3754825|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3933076|NCT01397084|3754825|B1|||Age||years|Mean|50.9|50.9|Standard Deviation|12.2|12.2|||
3933077|NCT01396525|3754832|B1|United States||Region of Enrollment||participants|Number|153|153.0||||||
3933078|NCT01396525|3754832|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3933079|NCT01396525|3754832|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3933080|NCT01396525|3754832|B1|||Age||years|Mean|63.9|63.9|Standard Deviation|9.0|9.0|||
3933081|NCT01396525|3754832|B1||>=65 years|Age||Participants|Count of Participants|66|66.0||||||
3933082|NCT01396525|3754832|B1||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
3933083|NCT01396525|3754832|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3933084|NCT01396512|3754930|B3|South Korea||Region of Enrollment||Participants|Number|274|274.0||||||
3933085|NCT01396512|3754931|B2|South Korea||Region of Enrollment||Participants|Number|137|137.0||||||
3933086|NCT01396512|3754932|B1|South Korea||Region of Enrollment||Participants|Number|137|137.0||||||
3933087|NCT01396512|3754930|B3||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
3933088|NCT01396512|3754931|B2||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3933089|NCT01396512|3754932|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3933090|NCT01396512|3754930|B3||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3933091|NCT01396512|3754931|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3933092|NCT01396512|3754932|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3933093|NCT01396512|3754930|B3|||Age||Months|Mean|14.2|14.2|Standard Deviation|2.1|2.1|||
3933094|NCT01396512|3754931|B2|||Age||Months|Mean|14.3|14.3|Standard Deviation|2.2|2.2|||
3933095|NCT01396512|3754932|B1|||Age||Months|Mean|14.0|14.0|Standard Deviation|2.0|2.0|||
3933096|NCT01396512|3754930|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3933097|NCT01396512|3754931|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3933098|NCT01396512|3754932|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3933099|NCT01396512|3754930|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3933100|NCT01396512|3754931|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3933101|NCT01396512|3754932|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3933102|NCT01396512|3754930|B3||<=18 years|Age||Participants|Count of Participants|274|274.0||||||
3933103|NCT01396512|3754931|B2||<=18 years|Age||Participants|Count of Participants|137|137.0||||||
3933104|NCT01396512|3754932|B1||<=18 years|Age||Participants|Count of Participants|137|137.0||||||
3933105|NCT01396447|3754945|B5|||Waist circumference||cm|Mean|92.83|92.83|Standard Deviation|14.90|14.9|||
3933106|NCT01396447|3754946|B4|||Waist circumference||cm|Mean|93.24|93.24|Standard Deviation|15.40|15.4|||
3933107|NCT01396447|3754947|B3|||Waist circumference||cm|Mean|93.38|93.38|Standard Deviation|14.55|14.55|||
3933108|NCT01396447|3754948|B2|||Waist circumference||cm|Mean|93.32|93.32|Standard Deviation|15.45|15.45|||
3933109|NCT01396447|3754949|B1|||Waist circumference||cm|Mean|91.40|91.4|Standard Deviation|14.24|14.24|||
3933110|NCT01396447|3754945|B5|||Body Mass Index (BMI)||kg/m^2|Mean|28.24|28.24|Standard Deviation|5.50|5.5|||
3933111|NCT01396447|3754946|B4|||Body Mass Index (BMI)||kg/m^2|Mean|28.28|28.28|Standard Deviation|5.64|5.64|||
3933112|NCT01396447|3754947|B3|||Body Mass Index (BMI)||kg/m^2|Mean|28.44|28.44|Standard Deviation|5.39|5.39|||
3933113|NCT01396447|3754948|B2|||Body Mass Index (BMI)||kg/m^2|Mean|28.42|28.42|Standard Deviation|5.71|5.71|||
3933114|NCT01396447|3754949|B1|||Body Mass Index (BMI)||kg/m^2|Mean|27.81|27.81|Standard Deviation|5.27|5.27|||
3933115|NCT01396447|3754945|B5|||Weight||kg|Mean|80.92|80.92|Standard Deviation|17.49|17.49|||
3933116|NCT01396447|3754946|B4|||Weight||kg|Mean|81.45|81.45|Standard Deviation|17.86|17.86|||
3933117|NCT01396447|3754947|B3|||Weight||kg|Mean|81.43|81.43|Standard Deviation|16.79|16.79|||
3933118|NCT01396447|3754948|B2|||Weight||kg|Mean|80.81|80.81|Standard Deviation|18.36|18.36|||
3933119|NCT01396447|3754949|B1|||Weight||kg|Mean|79.98|79.98|Standard Deviation|17.08|17.08|||
3933120|NCT01396447|3754945|B5||Other|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3933121|NCT01396447|3754946|B4||Other|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3933122|NCT01396447|3754947|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3933123|NCT01396447|3754948|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3933124|NCT01396447|3754949|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3933125|NCT01396447|3754945|B5||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3933126|NCT01396447|3754946|B4||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3933127|NCT01396447|3754947|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3933128|NCT01396447|3754948|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3933129|NCT01396447|3754949|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3933130|NCT01396447|3754945|B5||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3933131|NCT01396447|3754946|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3933132|NCT01396447|3754947|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3933133|NCT01396447|3754948|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3933134|NCT01396447|3754949|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3933135|NCT01396447|3754945|B5||Black or African-American|Race/Ethnicity, Customized||Participants|Count of Participants|112|112.0||||||
3933136|NCT01396447|3754946|B4||Black or African-American|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3933137|NCT01396447|3754947|B3||Black or African-American|Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3933138|NCT01396447|3754948|B2||Black or African-American|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3933139|NCT01396447|3754949|B1||Black or African-American|Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3933140|NCT01396447|3754945|B5||White|Race/Ethnicity, Customized||Participants|Count of Participants|443|443.0||||||
3933141|NCT01396447|3754946|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|113|113.0||||||
3933142|NCT01396447|3754947|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|109|109.0||||||
3933143|NCT01396447|3754948|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|111|111.0||||||
3933144|NCT01396447|3754949|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|110|110.0||||||
3933145|NCT01396447|3754945|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933146|NCT01396447|3754946|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933147|NCT01396447|3754947|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933148|NCT01396447|3754948|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933149|NCT01396447|3754949|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933150|NCT01396447|3754945|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|530|530.0||||||
3933151|NCT01396447|3754946|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
3933152|NCT01396447|3754947|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|135|135.0||||||
3933153|NCT01396447|3754948|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
3933154|NCT01396447|3754949|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|133|133.0||||||
3933155|NCT01396447|3754945|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3933156|NCT01396447|3754946|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3933157|NCT01396447|3754947|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3933158|NCT01396447|3754948|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3933159|NCT01396447|3754949|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3933160|NCT01396447|3754945|B5||Male|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
3933161|NCT01396447|3754946|B4||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3933162|NCT01396447|3754947|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3933163|NCT01396447|3754948|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3933164|NCT01396447|3754949|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3933165|NCT01396447|3754945|B5||Female|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
3933166|NCT01396447|3754946|B4||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3933167|NCT01396447|3754947|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3933168|NCT01396447|3754948|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3933169|NCT01396447|3754949|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3933170|NCT01396447|3754945|B5|||Age||years|Mean|41.9|41.9|Standard Deviation|11.4|11.4|||
3933171|NCT01396447|3754946|B4|||Age||years|Mean|42.8|42.8|Standard Deviation|10.8|10.8|||
3933172|NCT01396447|3754947|B3|||Age||years|Mean|40.9|40.9|Standard Deviation|11.4|11.4|||
3933173|NCT01396447|3754948|B2|||Age||years|Mean|40.1|40.1|Standard Deviation|11.2|11.2|||
3933174|NCT01396447|3754949|B1|||Age||years|Mean|43.6|43.6|Standard Deviation|12.0|12.0|||
3933175|NCT01396434|3754966|B4|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3933176|NCT01396434|3754967|B3|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3933177|NCT01396434|3754968|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3933178|NCT01396434|3754969|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3933179|NCT01396434|3754966|B4|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3933180|NCT01396434|3754967|B3|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3933181|NCT01396434|3754968|B2|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3933182|NCT01396434|3754969|B1|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3933183|NCT01396434|3754966|B4|Other||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3933184|NCT01396434|3754967|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3933185|NCT01396434|3754968|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3933186|NCT01396434|3754969|B1|Other||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3933187|NCT01396434|3754966|B4|Asian||Race/Ethnicity, Customized||participants|Number|2972|2972.0||||||
3933188|NCT01396434|3754967|B3|Asian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3933189|NCT01396434|3754968|B2|Asian||Race/Ethnicity, Customized||participants|Number|175|175.0||||||
3933190|NCT01396434|3754969|B1|Asian||Race/Ethnicity, Customized||participants|Number|2783|2783.0||||||
3933191|NCT01396434|3754966|B4||Male|Gender||Participants|Count of Participants|1483|1483.0||||||
3933192|NCT01396434|3754967|B3||Male|Gender||Participants|Count of Participants|8|8.0||||||
3933193|NCT01396434|3754968|B2||Male|Gender||Participants|Count of Participants|60|60.0||||||
3933194|NCT01396434|3754969|B1||Male|Gender||Participants|Count of Participants|1415|1415.0||||||
3933195|NCT01396434|3754966|B4||Female|Gender||Participants|Count of Participants|1523|1523.0||||||
3933196|NCT01396434|3754967|B3||Female|Gender||Participants|Count of Participants|6|6.0||||||
3933197|NCT01396434|3754968|B2||Female|Gender||Participants|Count of Participants|115|115.0||||||
3933198|NCT01396434|3754969|B1||Female|Gender||Participants|Count of Participants|1402|1402.0||||||
3933199|NCT01396434|3754966|B4|Age at enrollment (years)||Age||years|Mean|4.3|4.3|Standard Deviation|15.37|15.37|||
3933200|NCT01396434|3754967|B3|Age at enrollment (years)||Age||years|Mean|0.7|0.7|Standard Deviation|1.54|1.54|||
3933201|NCT01396434|3754968|B2|Age at enrollment (years)||Age||years|Mean|65.1|65.1|Standard Deviation|10.60|10.6|||
3933202|NCT01396434|3754969|B1|Age at enrollment (years)||Age||years|Mean|0.5|0.5|Standard Deviation|0.94|0.94|||
3933203|NCT01396421|3754979|B5||Male|Sex: Female, Male||Participants|Count of Participants|401|401.0||||||
3933204|NCT01396421|3754980|B4||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3933205|NCT01396421|3754981|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3933206|NCT01396421|3754982|B2||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3933207|NCT01396421|3754983|B1||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3933208|NCT01396421|3754979|B5||Female|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
3933209|NCT01396421|3754980|B4||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3933210|NCT01396421|3754981|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3933211|NCT01396421|3754982|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3933212|NCT01396421|3754983|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3933213|NCT01396421|3754979|B5|||Age||Years|Mean|40.1|40.1|Standard Deviation|10.8|10.8|||
3933214|NCT01396421|3754980|B4|||Age||Years|Mean|39.7|39.7|Standard Deviation|10.8|10.8|||
3933215|NCT01396421|3754981|B3|||Age||Years|Mean|40.5|40.5|Standard Deviation|11.4|11.4|||
3933216|NCT01396421|3754982|B2|||Age||Years|Mean|39.6|39.6|Standard Deviation|10.2|10.2|||
3933217|NCT01396421|3754983|B1|||Age||Years|Mean|40.8|40.8|Standard Deviation|11.0|11.0|||
3933218|NCT01396395|3755056|B3||Male|Sex: Female, Male||Participants|Count of Participants|270|270.0||||||
3933219|NCT01396395|3755057|B2||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3933220|NCT01396395|3755058|B1||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3933221|NCT01396395|3755056|B3||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3933222|NCT01396395|3755057|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3933223|NCT01396395|3755058|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3933224|NCT01396395|3755056|B3|||Age||years|Mean|61.1|61.1|Standard Deviation|10.04|10.04|||
3933225|NCT01396395|3755057|B2|||Age||years|Mean|60.8|60.8|Standard Deviation|9.94|9.94|||
3933226|NCT01396395|3755058|B1|||Age||years|Mean|61.4|61.4|Standard Deviation|10.16|10.16|||
3933227|NCT01396382|3755094|B1|United States||Region of Enrollment||participants|Number|97|97.0||||||
3933228|NCT01396382|3755094|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3933229|NCT01396382|3755094|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3933230|NCT01396382|3755094|B1|||Age||years|Mean|53.7|53.7|Standard Deviation|28.4|28.4|||
3933231|NCT01396317|3755099|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3933232|NCT01396317|3755100|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3933233|NCT01396317|3755101|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3933234|NCT01396317|3755099|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3933235|NCT01396317|3755100|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3933236|NCT01396317|3755101|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3933237|NCT01396317|3755099|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3933238|NCT01396317|3755100|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3933239|NCT01396317|3755101|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3933240|NCT01396317|3755099|B3|||Age||years|Mean|70|70.0|Standard Deviation|9.6|9.6|||
3933241|NCT01396317|3755100|B2|||Age||years|Mean|72|72.0|Standard Deviation|10.7|10.7|||
3933242|NCT01396317|3755101|B1|||Age||years|Mean|68|68.0|Standard Deviation|8.5|8.5|||
3933243|NCT01396265|3755116|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3933244|NCT01396265|3755116|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3933245|NCT01396265|3755116|B1|||Age||years|Mean|32.7|32.7|Standard Deviation|8.3|8.3|||
3933246|NCT01396239|3755140|B4|United States||Region of Enrollment||participants|Number|12|12.0||||||
3933247|NCT01396239|3755141|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3933248|NCT01396239|3755142|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3933249|NCT01396239|3755143|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3933250|NCT01396239|3755140|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3933251|NCT01396239|3755141|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3933252|NCT01396239|3755142|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3933253|NCT01396239|3755143|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3933254|NCT01396239|3755140|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3933255|NCT01396239|3755141|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3933256|NCT01396239|3755142|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3933257|NCT01396239|3755143|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3933258|NCT01396239|3755140|B4|||Age||years|Mean|8.8|8.8|Standard Deviation|1.22|1.22|||
3933259|NCT01396239|3755141|B3|||Age||years|Mean|8.5|8.5|Standard Deviation|1.73|1.73|||
3933260|NCT01396239|3755142|B2|||Age||years|Mean|8.5|8.5|Standard Deviation|1.29|1.29|||
3933261|NCT01396239|3755143|B1|||Age||years|Mean|9.3|9.3|Standard Deviation|0.50|0.5|||
3933262|NCT01396239|3755140|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3933263|NCT01396239|3755141|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3933264|NCT01396239|3755142|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3933265|NCT01396239|3755143|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3933266|NCT01396239|3755140|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3933267|NCT01396239|3755141|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3933268|NCT01396239|3755142|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3933269|NCT01396239|3755143|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3933270|NCT01396239|3755140|B4||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
3933271|NCT01396239|3755141|B3||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3933272|NCT01396239|3755142|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3933273|NCT01396239|3755143|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3933274|NCT01396226|3755167|B3|White||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
3933275|NCT01396226|3755168|B2|White||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3933276|NCT01396226|3755169|B1|White||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3933277|NCT01396226|3755167|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3933278|NCT01396226|3755168|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3933279|NCT01396226|3755169|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3933280|NCT01396226|3755167|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3933281|NCT01396226|3755168|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3933282|NCT01396226|3755169|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3933283|NCT01396226|3755167|B3|||Age||Years|Mean|59.9|59.9|Standard Deviation|8.2|8.2|||
3933284|NCT01396226|3755168|B2|||Age||Years|Mean|63.8|63.8|Standard Deviation|8.3|8.3|||
3933285|NCT01396226|3755169|B1|||Age||Years|Mean|57.9|57.9|Standard Deviation|7.7|7.7|||
3933286|NCT01396187|3755200|B6||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3933287|NCT01396187|3755201|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3933288|NCT01396187|3755202|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3933289|NCT01396187|3755203|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3933290|NCT01396187|3755204|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3933291|NCT01396187|3755205|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3933292|NCT01396187|3755200|B6||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3933293|NCT01396187|3755201|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3933294|NCT01396187|3755202|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3933295|NCT01396187|3755203|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3933296|NCT01396187|3755204|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3933297|NCT01396187|3755205|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3933298|NCT01396187|3755200|B6|||Age||years|Mean|55.7|55.7|Standard Deviation|8.2|8.2|||
3933299|NCT01396187|3755201|B5|||Age||years|Mean|57.6|57.6|Standard Deviation|9.1|9.1|||
3933300|NCT01396187|3755202|B4|||Age||years|Mean|59.0|59.0|Standard Deviation|6.3|6.3|||
3933301|NCT01396187|3755203|B3|||Age||years|Mean|56.9|56.9|Standard Deviation|6.9|6.9|||
3933302|NCT01396187|3755204|B2|||Age||years|Mean|50.2|50.2|Standard Deviation|10.0|10.0|||
3933303|NCT01396187|3755205|B1|||Age||years|Mean|55.8|55.8|Standard Deviation|4.3|4.3|||
3933304|NCT01396161|3755302|B8||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3933305|NCT01396161|3755303|B7||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3933306|NCT01396161|3755304|B6||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3933307|NCT01396161|3755305|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3933308|NCT01396161|3755306|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3933309|NCT01396161|3755307|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3933310|NCT01396161|3755308|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3933311|NCT01396161|3755309|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3933312|NCT01396161|3755302|B8||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3933313|NCT01396161|3755303|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3933314|NCT01396161|3755304|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3933315|NCT01396161|3755305|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3933316|NCT01396161|3755306|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3933317|NCT01396161|3755307|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3933318|NCT01396161|3755308|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3933319|NCT01396161|3755309|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3933320|NCT01396161|3755302|B8|45 to 64 years||Age, Customized||participants|Number|20|20.0||||||
3933321|NCT01396161|3755303|B7|45 to 64 years||Age, Customized||participants|Number|9|9.0||||||
3933322|NCT01396161|3755304|B6|45 to 64 years||Age, Customized||participants|Number|2|2.0||||||
3933323|NCT01396161|3755305|B5|45 to 64 years||Age, Customized||participants|Number|1|1.0||||||
3933324|NCT01396161|3755306|B4|45 to 64 years||Age, Customized||participants|Number|2|2.0||||||
3933325|NCT01396161|3755307|B3|45 to 64 years||Age, Customized||participants|Number|0|0.0||||||
3933326|NCT01396161|3755308|B2|45 to 64 years||Age, Customized||participants|Number|3|3.0||||||
3933327|NCT01396161|3755309|B1|45 to 64 years||Age, Customized||participants|Number|3|3.0||||||
3933328|NCT01396161|3755302|B8|18 to 44 years||Age, Customized||participants|Number|44|44.0||||||
3933329|NCT01396161|3755303|B7|18 to 44 years||Age, Customized||participants|Number|2|2.0||||||
3933330|NCT01396161|3755304|B6|18 to 44 years||Age, Customized||participants|Number|7|7.0||||||
3933331|NCT01396161|3755305|B5|18 to 44 years||Age, Customized||participants|Number|8|8.0||||||
3933332|NCT01396161|3755306|B4|18 to 44 years||Age, Customized||participants|Number|7|7.0||||||
3933333|NCT01396161|3755307|B3|18 to 44 years||Age, Customized||participants|Number|9|9.0||||||
3933334|NCT01396161|3755308|B2|18 to 44 years||Age, Customized||participants|Number|2|2.0||||||
3933335|NCT01396161|3755309|B1|18 to 44 years||Age, Customized||participants|Number|9|9.0||||||
3933336|NCT01396148|3755368|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3933337|NCT01396148|3755368|B1|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3933338|NCT01396148|3755368|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3933339|NCT01396148|3755368|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3933340|NCT01396148|3755368|B1|||Age||years|Mean|14.3|14.3|Standard Deviation|1.4|1.4|||
3933341|NCT01396083|3755393|B3||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3933342|NCT01396083|3755394|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3933343|NCT01396083|3755395|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3933344|NCT01396083|3755393|B3||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3933345|NCT01396083|3755394|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3933346|NCT01396083|3755395|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3933347|NCT01396083|3755393|B3|||Age||Years|Mean|66.1|66.1|Standard Deviation|11.9|11.9|||
3933348|NCT01396083|3755394|B2|||Age||Years|Mean|66.9|66.9|Standard Deviation|12.4|12.4|||
3933349|NCT01396083|3755395|B1|||Age||Years|Mean|65.3|65.3|Standard Deviation|11.4|11.4|||
3933400|NCT01396044|3755456|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3933350|NCT01396070|3755420|B1|Stage IV/SS (includes IVA, IVA/SS and III)||Clinical Stage|"MF/SS staging is based on a tumor-node-metastasis-blood (TNMB) classification system. The most important prognostic factors include overall clinical stage, T-classification, and extracutaneous disease.~Early stage includes MF IA, IB, and IIA. Advanced stage includes MF IIB and higher, including MF/SS IVA."|Participants|Count of Participants|14|14.0||||||
3933351|NCT01396070|3755420|B1|Stage IIB||Clinical Stage|"MF/SS staging is based on a tumor-node-metastasis-blood (TNMB) classification system. The most important prognostic factors include overall clinical stage, T-classification, and extracutaneous disease.~Early stage includes MF IA, IB, and IIA. Advanced stage includes MF IIB and higher, including MF/SS IVA."|Participants|Count of Participants|16|16.0||||||
3933352|NCT01396070|3755420|B1|Stage IB||Clinical Stage|"MF/SS staging is based on a tumor-node-metastasis-blood (TNMB) classification system. The most important prognostic factors include overall clinical stage, T-classification, and extracutaneous disease.~Early stage includes MF IA, IB, and IIA. Advanced stage includes MF IIB and higher, including MF/SS IVA."|Participants|Count of Participants|6|6.0||||||
3933353|NCT01396070|3755420|B1|> 50% CD30 positivity||CD30 grouping at screening|Level of CD30 expression was defined at the % CD30 positivity in the total lymphocytic infiltrate, stratified as 0 to < 10% ; 10% to 50%; or over 50%.|participants|Number|4|4.0||||||
3933354|NCT01396070|3755420|B1|10% to 50% CD30 positivity||CD30 grouping at screening|Level of CD30 expression was defined at the % CD30 positivity in the total lymphocytic infiltrate, stratified as 0 to < 10% ; 10% to 50%; or over 50%.|participants|Number|15|15.0||||||
3933355|NCT01396070|3755420|B1|< 10% CD30 positivity||CD30 grouping at screening|Level of CD30 expression was defined at the % CD30 positivity in the total lymphocytic infiltrate, stratified as 0 to < 10% ; 10% to 50%; or over 50%.|participants|Number|17|17.0||||||
3933356|NCT01396070|3755420|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3933357|NCT01396070|3755420|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933358|NCT01396070|3755420|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3933359|NCT01396070|3755420|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3933360|NCT01396070|3755420|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933361|NCT01396070|3755420|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933362|NCT01396070|3755420|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933363|NCT01396070|3755420|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3933364|NCT01396070|3755420|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3933365|NCT01396070|3755420|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3933366|NCT01396070|3755420|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3933367|NCT01396070|3755420|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3933368|NCT01396070|3755420|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3933369|NCT01396070|3755420|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3933370|NCT01396070|3755420|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3933371|NCT01396057|3755427|B3||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3933372|NCT01396057|3755428|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3933373|NCT01396057|3755429|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3933374|NCT01396057|3755427|B3||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3933375|NCT01396057|3755428|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3933376|NCT01396057|3755429|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3933377|NCT01396057|3755427|B3|||Age||Years|Mean|65.6|65.6|Standard Deviation|10.5|10.5|||
3933378|NCT01396057|3755428|B2|||Age||Years|Mean|65.6|65.6|Standard Deviation|10.0|10.0|||
3933379|NCT01396057|3755429|B1|||Age||Years|Mean|65.7|65.7|Standard Deviation|10.9|10.9|||
3933380|NCT01396044|3755454|B3|United States||Region of Enrollment||participants|Number|296|296.0||||||
3933381|NCT01396044|3755455|B2|United States||Region of Enrollment||participants|Number|171|171.0||||||
3933382|NCT01396044|3755456|B1|United States||Region of Enrollment||participants|Number|125|125.0||||||
3933383|NCT01396044|3755454|B3||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3933384|NCT01396044|3755455|B2||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3933385|NCT01396044|3755456|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3933386|NCT01396044|3755454|B3||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3933387|NCT01396044|3755455|B2||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3933388|NCT01396044|3755456|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3933389|NCT01396044|3755454|B3|||Age||years|Mean|61.1|61.1|Standard Deviation|17.8|17.8|||
3933390|NCT01396044|3755455|B2|||Age||years|Mean|60.0|60.0|Standard Deviation|17.8|17.8|||
3933391|NCT01396044|3755456|B1|||Age||years|Mean|62.6|62.6|Standard Deviation|17.6|17.6|||
3933392|NCT01396044|3755454|B3||>=65 years|Age||Participants|Count of Participants|131|131.0||||||
3933393|NCT01396044|3755455|B2||>=65 years|Age||Participants|Count of Participants|70|70.0||||||
3933394|NCT01396044|3755456|B1||>=65 years|Age||Participants|Count of Participants|61|61.0||||||
3933395|NCT01396044|3755454|B3||Between 18 and 65 years|Age||Participants|Count of Participants|165|165.0||||||
3933396|NCT01396044|3755455|B2||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
3933397|NCT01396044|3755456|B1||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
3933398|NCT01396044|3755454|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3933399|NCT01396044|3755455|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3933401|NCT01396005|3755477|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3933402|NCT01396005|3755478|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3933403|NCT01396005|3755479|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3933404|NCT01396005|3755477|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3933405|NCT01396005|3755478|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3933406|NCT01396005|3755479|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3933407|NCT01396005|3755477|B3|||Age||years|Mean|33.7|33.7|Standard Deviation|10.1|10.1|||
3933408|NCT01396005|3755478|B2|||Age||years|Mean|33.2|33.2|Standard Deviation|29.0|29.0|||
3933409|NCT01396005|3755479|B1|||Age||years|Mean|34.2|34.2|Standard Deviation|10.2|10.2|||
3933410|NCT01395966|3755496|B4||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3933411|NCT01395966|3755497|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3933412|NCT01395966|3755498|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3933413|NCT01395966|3755499|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3933414|NCT01395966|3755496|B4||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
3933415|NCT01395966|3755497|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3933416|NCT01395966|3755498|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3933417|NCT01395966|3755499|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3933418|NCT01395966|3755496|B4|||Age||years|Mean|3.4|3.4|Standard Deviation|2.6|2.6|||
3933419|NCT01395966|3755497|B3|||Age||years|Mean|3.2|3.2|Standard Deviation|2.5|2.5|||
3933420|NCT01395966|3755498|B2|||Age||years|Mean|3.5|3.5|Standard Deviation|2.6|2.6|||
3933421|NCT01395966|3755499|B1|||Age||years|Mean|3.5|3.5|Standard Deviation|2.7|2.7|||
3933422|NCT01395966|3755496|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3933423|NCT01395966|3755497|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3933424|NCT01395966|3755498|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3933425|NCT01395966|3755499|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3933426|NCT01395966|3755496|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3933427|NCT01395966|3755497|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3933428|NCT01395966|3755498|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3933429|NCT01395966|3755499|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3933430|NCT01395966|3755496|B4||<=18 years|Age||Participants|Count of Participants|331|331.0||||||
3933431|NCT01395966|3755497|B3||<=18 years|Age||Participants|Count of Participants|112|112.0||||||
3933432|NCT01395966|3755498|B2||<=18 years|Age||Participants|Count of Participants|110|110.0||||||
3933433|NCT01395966|3755499|B1||<=18 years|Age||Participants|Count of Participants|109|109.0||||||
3933434|NCT01395914|3755509|B3|Australia||Region of Enrollment||participants|Number|10|10.0||||||
3933435|NCT01395914|3755510|B2|Australia||Region of Enrollment||participants|Number|3|3.0||||||
3933436|NCT01395914|3755511|B1|Australia||Region of Enrollment||participants|Number|7|7.0||||||
3933437|NCT01395914|3755509|B3|Russian Federation||Region of Enrollment||participants|Number|100|100.0||||||
3933438|NCT01395914|3755510|B2|Russian Federation||Region of Enrollment||participants|Number|31|31.0||||||
3933439|NCT01395914|3755511|B1|Russian Federation||Region of Enrollment||participants|Number|69|69.0||||||
3933440|NCT01395914|3755509|B3|Ukraine||Region of Enrollment||participants|Number|97|97.0||||||
3933441|NCT01395914|3755510|B2|Ukraine||Region of Enrollment||participants|Number|33|33.0||||||
3933442|NCT01395914|3755511|B1|Ukraine||Region of Enrollment||participants|Number|64|64.0||||||
3933443|NCT01395914|3755509|B3|Serbia||Region of Enrollment||participants|Number|6|6.0||||||
3933444|NCT01395914|3755510|B2|Serbia||Region of Enrollment||participants|Number|2|2.0||||||
3933445|NCT01395914|3755511|B1|Serbia||Region of Enrollment||participants|Number|4|4.0||||||
3933446|NCT01395914|3755509|B3|Israel||Region of Enrollment||participants|Number|6|6.0||||||
3933447|NCT01395914|3755510|B2|Israel||Region of Enrollment||participants|Number|2|2.0||||||
3933448|NCT01395914|3755511|B1|Israel||Region of Enrollment||participants|Number|4|4.0||||||
3933449|NCT01395914|3755509|B3|Belarus||Region of Enrollment||participants|Number|14|14.0||||||
3933450|NCT01395914|3755510|B2|Belarus||Region of Enrollment||participants|Number|6|6.0||||||
3933451|NCT01395914|3755511|B1|Belarus||Region of Enrollment||participants|Number|8|8.0||||||
3933452|NCT01395914|3755509|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3933453|NCT01395914|3755510|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3933454|NCT01395914|3755511|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3933455|NCT01395914|3755509|B3|Canada||Region of Enrollment||participants|Number|4|4.0||||||
3933456|NCT01395914|3755510|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3933457|NCT01395914|3755511|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
3933458|NCT01395914|3755509|B3|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
3933459|NCT01395914|3755510|B2|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
3933460|NCT01395914|3755511|B1|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
3933461|NCT01395914|3755509|B3|Italy||Region of Enrollment||participants|Number|1|1.0||||||
3933462|NCT01395914|3755510|B2|Italy||Region of Enrollment||participants|Number|0|0.0||||||
3933463|NCT01395914|3755511|B1|Italy||Region of Enrollment||participants|Number|1|1.0||||||
3933464|NCT01395914|3755509|B3|Hungary||Region of Enrollment||participants|Number|55|55.0||||||
3933465|NCT01395914|3755510|B2|Hungary||Region of Enrollment||participants|Number|16|16.0||||||
3933466|NCT01395914|3755511|B1|Hungary||Region of Enrollment||participants|Number|39|39.0||||||
3933467|NCT01395914|3755509|B3|Germany||Region of Enrollment||participants|Number|3|3.0||||||
3933468|NCT01395914|3755510|B2|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3933469|NCT01395914|3755511|B1|Germany||Region of Enrollment||participants|Number|3|3.0||||||
3933470|NCT01395914|3755509|B3|France||Region of Enrollment||participants|Number|3|3.0||||||
3933471|NCT01395914|3755510|B2|France||Region of Enrollment||participants|Number|2|2.0||||||
3933472|NCT01395914|3755511|B1|France||Region of Enrollment||participants|Number|1|1.0||||||
3933473|NCT01395914|3755509|B3|Czech Republic||Region of Enrollment||participants|Number|14|14.0||||||
3933474|NCT01395914|3755510|B2|Czech Republic||Region of Enrollment||participants|Number|3|3.0||||||
3933475|NCT01395914|3755511|B1|Czech Republic||Region of Enrollment||participants|Number|11|11.0||||||
3933476|NCT01395914|3755509|B3|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
3933477|NCT01395914|3755510|B2|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
3933478|NCT01395914|3755511|B1|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
3933479|NCT01395914|3755509|B3|Spain||Region of Enrollment||participants|Number|7|7.0||||||
3933480|NCT01395914|3755510|B2|Spain||Region of Enrollment||participants|Number|2|2.0||||||
3933481|NCT01395914|3755511|B1|Spain||Region of Enrollment||participants|Number|5|5.0||||||
3933482|NCT01395914|3755509|B3|Slovenia||Region of Enrollment||participants|Number|1|1.0||||||
3933483|NCT01395914|3755510|B2|Slovenia||Region of Enrollment||participants|Number|1|1.0||||||
3933484|NCT01395914|3755511|B1|Slovenia||Region of Enrollment||participants|Number|0|0.0||||||
3933485|NCT01395914|3755509|B3|Poland||Region of Enrollment||participants|Number|167|167.0||||||
3933486|NCT01395914|3755510|B2|Poland||Region of Enrollment||participants|Number|60|60.0||||||
3933487|NCT01395914|3755511|B1|Poland||Region of Enrollment||participants|Number|107|107.0||||||
3933488|NCT01395914|3755509|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3933489|NCT01395914|3755510|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3933490|NCT01395914|3755511|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933491|NCT01395914|3755509|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933492|NCT01395914|3755510|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933493|NCT01395914|3755511|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933494|NCT01395914|3755509|B3||White|Race (NIH/OMB)||Participants|Count of Participants|510|510.0||||||
3933495|NCT01395914|3755510|B2||White|Race (NIH/OMB)||Participants|Count of Participants|166|166.0||||||
3933496|NCT01395914|3755511|B1||White|Race (NIH/OMB)||Participants|Count of Participants|344|344.0||||||
3933497|NCT01395914|3755509|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933498|NCT01395914|3755510|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933499|NCT01395914|3755511|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933500|NCT01395914|3755509|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3933501|NCT01395914|3755510|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933502|NCT01395914|3755511|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3933503|NCT01395914|3755509|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3933504|NCT01395914|3755510|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3933505|NCT01395914|3755511|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933506|NCT01395914|3755509|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933507|NCT01395914|3755510|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933508|NCT01395914|3755511|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933509|NCT01395914|3755509|B3||Male|Sex: Female, Male||Participants|Count of Participants|387|387.0||||||
3933510|NCT01395914|3755510|B2||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3933511|NCT01395914|3755511|B1||Male|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
3933512|NCT01395914|3755509|B3||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3933513|NCT01395914|3755510|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3933514|NCT01395914|3755511|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3933515|NCT01395914|3755509|B3||>=65 years|Age||Participants|Count of Participants|157|157.0||||||
3933516|NCT01395914|3755510|B2||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
3933517|NCT01395914|3755511|B1||>=65 years|Age||Participants|Count of Participants|109|109.0||||||
3933518|NCT01395914|3755509|B3||Between 18 and 65 years|Age||Participants|Count of Participants|356|356.0||||||
3933519|NCT01395914|3755510|B2||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
3933520|NCT01395914|3755511|B1||Between 18 and 65 years|Age||Participants|Count of Participants|236|236.0||||||
3933521|NCT01395914|3755509|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3933522|NCT01395914|3755510|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3933523|NCT01395914|3755511|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3933524|NCT01395901|3755524|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3933644|NCT01395810|3755564|B1|||Age||Years|Mean|32.2|32.2|Standard Deviation|13.6|13.6|||
3933525|NCT01395901|3755525|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3933526|NCT01395901|3755526|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3933527|NCT01395901|3755524|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3933528|NCT01395901|3755525|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3933529|NCT01395901|3755526|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933530|NCT01395901|3755524|B3||White|Race (NIH/OMB)||Participants|Count of Participants|627|627.0||||||
3933531|NCT01395901|3755525|B2||White|Race (NIH/OMB)||Participants|Count of Participants|312|312.0||||||
3933532|NCT01395901|3755526|B1||White|Race (NIH/OMB)||Participants|Count of Participants|315|315.0||||||
3933533|NCT01395901|3755524|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3933534|NCT01395901|3755525|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3933535|NCT01395901|3755526|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3933536|NCT01395901|3755524|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933537|NCT01395901|3755525|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933538|NCT01395901|3755526|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933539|NCT01395901|3755524|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3933540|NCT01395901|3755525|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3933541|NCT01395901|3755526|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3933542|NCT01395901|3755524|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3933543|NCT01395901|3755525|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3933544|NCT01395901|3755526|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933545|NCT01395901|3755524|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933546|NCT01395901|3755525|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933547|NCT01395901|3755526|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933548|NCT01395901|3755524|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|616|616.0||||||
3933549|NCT01395901|3755525|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|309|309.0||||||
3933550|NCT01395901|3755526|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|307|307.0||||||
3933551|NCT01395901|3755524|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3933552|NCT01395901|3755525|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3933553|NCT01395901|3755526|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3933554|NCT01395901|3755524|B3||Male|Sex: Female, Male||Participants|Count of Participants|400|400.0||||||
3933555|NCT01395901|3755525|B2||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3933556|NCT01395901|3755526|B1||Male|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
3933557|NCT01395901|3755524|B3||Female|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
3933558|NCT01395901|3755525|B2||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3933559|NCT01395901|3755526|B1||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3933560|NCT01395901|3755524|B3|12 <17 years||Age, Customized||participants|Number|134|134.0||||||
3933561|NCT01395901|3755525|B2|12 <17 years||Age, Customized||participants|Number|66|66.0||||||
3933562|NCT01395901|3755526|B1|12 <17 years||Age, Customized||participants|Number|68|68.0||||||
3933563|NCT01395901|3755524|B3|6 <12 years||Age, Customized||participants|Number|234|234.0||||||
3933564|NCT01395901|3755525|B2|6 <12 years||Age, Customized||participants|Number|117|117.0||||||
3933565|NCT01395901|3755526|B1|6 <12 years||Age, Customized||participants|Number|117|117.0||||||
3933566|NCT01395901|3755524|B3|2 <6 years||Age, Customized||participants|Number|247|247.0||||||
3933567|NCT01395901|3755525|B2|2 <6 years||Age, Customized||participants|Number|123|123.0||||||
3933568|NCT01395901|3755526|B1|2 <6 years||Age, Customized||participants|Number|124|124.0||||||
3933569|NCT01395901|3755524|B3|<2 years||Age, Customized||participants|Number|46|46.0||||||
3933570|NCT01395901|3755525|B2|<2 years||Age, Customized||participants|Number|24|24.0||||||
3933571|NCT01395901|3755526|B1|<2 years||Age, Customized||participants|Number|22|22.0||||||
3933572|NCT01395888|3755541|B3|White - White/Caucasian/European||Race/Ethnicity, Customized||participants|Number|257|257.0||||||
3933573|NCT01395888|3755542|B2|White - White/Caucasian/European||Race/Ethnicity, Customized||participants|Number|130|130.0||||||
3933574|NCT01395888|3755543|B1|White - White/Caucasian/European||Race/Ethnicity, Customized||participants|Number|127|127.0||||||
3933575|NCT01395888|3755541|B3||Male|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
3933576|NCT01395888|3755542|B2||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3933577|NCT01395888|3755543|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3933578|NCT01395888|3755541|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3933579|NCT01395888|3755542|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3933580|NCT01395888|3755543|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3933581|NCT01395888|3755541|B3|||Age||Years|Mean|67.3|67.3|Standard Deviation|7.28|7.28|||
3933582|NCT01395888|3755542|B2|||Age||Years|Mean|67.7|67.7|Standard Deviation|7.34|7.34|||
3933583|NCT01395888|3755543|B1|||Age||Years|Mean|66.7|66.7|Standard Deviation|7.20|7.2|||
3933584|NCT01395823|3755551|B3|||Epogen Dose, units/week||units/week|Median|5550|5550.0|Inter-Quartile Range|||2500.0|11900.0|
3933585|NCT01395823|3755552|B2|||Epogen Dose, units/week||units/week|Median|5400|5400.0|Inter-Quartile Range|||2400.0|11500.0|
3933586|NCT01395823|3755553|B1|||Epogen Dose, units/week||units/week|Median|5800|5800.0|Inter-Quartile Range|||2600.0|12200.0|
3933587|NCT01395823|3755551|B3|||25Vit D (ng/mL)||ng/mL|Mean|16.4|16.4|Standard Deviation|6.2|6.2|||
3933588|NCT01395823|3755552|B2|||25Vit D (ng/mL)||ng/mL|Mean|16.9|16.9|Standard Deviation|6.4|6.4|||
3933589|NCT01395823|3755553|B1|||25Vit D (ng/mL)||ng/mL|Mean|16.0|16.0|Standard Deviation|5.9|5.9|||
3933590|NCT01395823|3755551|B3|United States||Region of Enrollment||participants|Number|276|276.0||||||
3933591|NCT01395823|3755552|B2|United States||Region of Enrollment||participants|Number|139|139.0||||||
3933592|NCT01395823|3755553|B1|United States||Region of Enrollment||participants|Number|137|137.0||||||
3933593|NCT01395823|3755551|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3933594|NCT01395823|3755552|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3933595|NCT01395823|3755553|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3933596|NCT01395823|3755551|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933597|NCT01395823|3755552|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933598|NCT01395823|3755553|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933599|NCT01395823|3755551|B3||White|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
3933600|NCT01395823|3755552|B2||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3933601|NCT01395823|3755553|B1||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3933602|NCT01395823|3755551|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|166|166.0||||||
3933603|NCT01395823|3755552|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
3933604|NCT01395823|3755553|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
3933605|NCT01395823|3755551|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933606|NCT01395823|3755552|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933607|NCT01395823|3755553|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933608|NCT01395823|3755551|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3933609|NCT01395823|3755552|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3933610|NCT01395823|3755553|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3933611|NCT01395823|3755551|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933612|NCT01395823|3755552|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933613|NCT01395823|3755553|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933614|NCT01395823|3755551|B3||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3933615|NCT01395823|3755552|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3933616|NCT01395823|3755553|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3933617|NCT01395823|3755551|B3||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3933618|NCT01395823|3755552|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3933619|NCT01395823|3755553|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3933620|NCT01395823|3755551|B3|||Age||years|Mean|61.1|61.1|Standard Deviation|13.6|13.6|||
3933621|NCT01395823|3755552|B2|||Age||years|Mean|60.8|60.8|Standard Deviation|13.9|13.9|||
3933622|NCT01395823|3755553|B1|||Age||years|Mean|61.4|61.4|Standard Deviation|13.3|13.3|||
3933623|NCT01395810|3755560|B5||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3933624|NCT01395810|3755561|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3933625|NCT01395810|3755562|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3933626|NCT01395810|3755563|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3933627|NCT01395810|3755564|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3933628|NCT01395810|3755560|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3933629|NCT01395810|3755561|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3933630|NCT01395810|3755562|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3933631|NCT01395810|3755563|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3933632|NCT01395810|3755564|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3933633|NCT01395810|3755560|B5|18 - 70 years||Age, Customized||Participants|Number|56|56.0||||||
3933634|NCT01395810|3755561|B4|18 - 70 years||Age, Customized||Participants|Number|5|5.0||||||
3933635|NCT01395810|3755563|B2|18 - 70 years||Age, Customized||Participants|Number|36|36.0||||||
3933636|NCT01395810|3755564|B1|18 - 70 years||Age, Customized||Participants|Number|15|15.0||||||
3933637|NCT01395810|3755560|B5|13 - 17 years||Age, Customized||Participants|Number|15|15.0||||||
3933638|NCT01395810|3755561|B4|13 - 17 years||Age, Customized||Participants|Number|0|0.0||||||
3933639|NCT01395810|3755563|B2|13 - 17 years||Age, Customized||Participants|Number|12|12.0||||||
3933640|NCT01395810|3755564|B1|13 - 17 years||Age, Customized||Participants|Number|3|3.0||||||
3933641|NCT01395810|3755560|B5|||Age||Years|Mean|32.0|32.0|Standard Deviation|14.2|14.2|||
3933642|NCT01395810|3755561|B4|||Age||Years|Mean|37.6|37.6|Standard Deviation|15.4|15.4|||
3933643|NCT01395810|3755563|B2|||Age||Years|Mean|31.4|31.4|Standard Deviation|14.4|14.4|||
3933645|NCT01395797|3755595|B7|United States||Region of Enrollment||participants|Number|82|82.0||||||
3933646|NCT01395797|3755596|B6|United States||Region of Enrollment||participants|Number|17|17.0||||||
3933647|NCT01395797|3755597|B5|United States||Region of Enrollment||participants|Number|9|9.0||||||
3933648|NCT01395797|3755598|B4|United States||Region of Enrollment||participants|Number|15|15.0||||||
3933649|NCT01395797|3755599|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
3933650|NCT01395797|3755600|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3933651|NCT01395797|3755601|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3933652|NCT01395797|3755595|B7||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3933653|NCT01395797|3755596|B6||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3933654|NCT01395797|3755597|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3933655|NCT01395797|3755598|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3933656|NCT01395797|3755599|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3933657|NCT01395797|3755600|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3933658|NCT01395797|3755601|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3933659|NCT01395797|3755595|B7||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3933660|NCT01395797|3755596|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3933661|NCT01395797|3755597|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3933662|NCT01395797|3755598|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3933663|NCT01395797|3755599|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3933664|NCT01395797|3755600|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3933665|NCT01395797|3755601|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3933666|NCT01395797|3755595|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3933667|NCT01395797|3755596|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3933668|NCT01395797|3755597|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3933669|NCT01395797|3755598|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3933670|NCT01395797|3755599|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3933671|NCT01395797|3755600|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3933672|NCT01395797|3755601|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3933673|NCT01395797|3755595|B7||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
3933674|NCT01395797|3755596|B6||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3933675|NCT01395797|3755597|B5||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3933676|NCT01395797|3755598|B4||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3933677|NCT01395797|3755599|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3933678|NCT01395797|3755600|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3933679|NCT01395797|3755601|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3933680|NCT01395797|3755595|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3933681|NCT01395797|3755596|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3933682|NCT01395797|3755597|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3933683|NCT01395797|3755598|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3933684|NCT01395797|3755599|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3933685|NCT01395797|3755600|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3933686|NCT01395797|3755601|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3933687|NCT01395784|3755626|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3933688|NCT01395784|3755626|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3933689|NCT01395784|3755626|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3933690|NCT01395784|3755626|B1|||Age||years|Mean|35|35.0|Standard Deviation|9|9.0|||
3933691|NCT01395784|3755626|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3933692|NCT01395784|3755626|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3933693|NCT01395784|3755626|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3933694|NCT01395758|3755631|B3||No|Confirmation of Kirsten rat sarcoma (KRAS) Mutation||Participants|Count of Participants|0|0.0||||||
3933695|NCT01395758|3755632|B2||No|Confirmation of Kirsten rat sarcoma (KRAS) Mutation||Participants|Count of Participants|0|0.0||||||
3933696|NCT01395758|3755633|B1||No|Confirmation of Kirsten rat sarcoma (KRAS) Mutation||Participants|Count of Participants|0|0.0||||||
3933697|NCT01395758|3755631|B3||Yes|Confirmation of Kirsten rat sarcoma (KRAS) Mutation||Participants|Count of Participants|96|96.0||||||
3933698|NCT01395758|3755632|B2||Yes|Confirmation of Kirsten rat sarcoma (KRAS) Mutation||Participants|Count of Participants|45|45.0||||||
3933699|NCT01395758|3755633|B1||Yes|Confirmation of Kirsten rat sarcoma (KRAS) Mutation||Participants|Count of Participants|51|51.0||||||
3933700|NCT01395758|3755631|B3||Grade 2|Eastern Cooperative Oncology Group (ECOG) Performance Status Score|"Grade 0: Normal activity, fully active. Able to carry on all pre-disease performance without restriction.~Grade 1: Symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work) Grade 2: In bed < 50% of the time. Ambulatory and capable of all self-care, but unable to carry out work activities. Up and about more than 50% of waking hours."|Participants|Count of Participants|11|11.0||||||
3933731|NCT01395758|3755632|B2||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3933701|NCT01395758|3755632|B2||Grade 2|Eastern Cooperative Oncology Group (ECOG) Performance Status Score|"Grade 0: Normal activity, fully active. Able to carry on all pre-disease performance without restriction.~Grade 1: Symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work) Grade 2: In bed < 50% of the time. Ambulatory and capable of all self-care, but unable to carry out work activities. Up and about more than 50% of waking hours."|Participants|Count of Participants|4|4.0||||||
3933702|NCT01395758|3755633|B1||Grade 2|Eastern Cooperative Oncology Group (ECOG) Performance Status Score|"Grade 0: Normal activity, fully active. Able to carry on all pre-disease performance without restriction.~Grade 1: Symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work) Grade 2: In bed < 50% of the time. Ambulatory and capable of all self-care, but unable to carry out work activities. Up and about more than 50% of waking hours."|Participants|Count of Participants|7|7.0||||||
3933703|NCT01395758|3755631|B3||Grade 1|Eastern Cooperative Oncology Group (ECOG) Performance Status Score|"Grade 0: Normal activity, fully active. Able to carry on all pre-disease performance without restriction.~Grade 1: Symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work) Grade 2: In bed < 50% of the time. Ambulatory and capable of all self-care, but unable to carry out work activities. Up and about more than 50% of waking hours."|Participants|Count of Participants|65|65.0||||||
3933704|NCT01395758|3755632|B2||Grade 1|Eastern Cooperative Oncology Group (ECOG) Performance Status Score|"Grade 0: Normal activity, fully active. Able to carry on all pre-disease performance without restriction.~Grade 1: Symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work) Grade 2: In bed < 50% of the time. Ambulatory and capable of all self-care, but unable to carry out work activities. Up and about more than 50% of waking hours."|Participants|Count of Participants|33|33.0||||||
3933705|NCT01395758|3755633|B1||Grade 1|Eastern Cooperative Oncology Group (ECOG) Performance Status Score|"Grade 0: Normal activity, fully active. Able to carry on all pre-disease performance without restriction.~Grade 1: Symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work) Grade 2: In bed < 50% of the time. Ambulatory and capable of all self-care, but unable to carry out work activities. Up and about more than 50% of waking hours."|Participants|Count of Participants|32|32.0||||||
3933706|NCT01395758|3755631|B3||Grade 0|Eastern Cooperative Oncology Group (ECOG) Performance Status Score|"Grade 0: Normal activity, fully active. Able to carry on all pre-disease performance without restriction.~Grade 1: Symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work) Grade 2: In bed < 50% of the time. Ambulatory and capable of all self-care, but unable to carry out work activities. Up and about more than 50% of waking hours."|Participants|Count of Participants|20|20.0||||||
3933707|NCT01395758|3755632|B2||Grade 0|Eastern Cooperative Oncology Group (ECOG) Performance Status Score|"Grade 0: Normal activity, fully active. Able to carry on all pre-disease performance without restriction.~Grade 1: Symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work) Grade 2: In bed < 50% of the time. Ambulatory and capable of all self-care, but unable to carry out work activities. Up and about more than 50% of waking hours."|Participants|Count of Participants|8|8.0||||||
3933708|NCT01395758|3755633|B1||Grade 0|Eastern Cooperative Oncology Group (ECOG) Performance Status Score|"Grade 0: Normal activity, fully active. Able to carry on all pre-disease performance without restriction.~Grade 1: Symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work) Grade 2: In bed < 50% of the time. Ambulatory and capable of all self-care, but unable to carry out work activities. Up and about more than 50% of waking hours."|Participants|Count of Participants|12|12.0||||||
3933709|NCT01395758|3755631|B3|||Height||centimeters|Mean|165.68|165.68|Standard Deviation|9.86|9.86|||
3933710|NCT01395758|3755632|B2|||Height||centimeters|Mean|164.88|164.88|Standard Deviation|9.42|9.42|||
3933711|NCT01395758|3755633|B1|||Height||centimeters|Mean|166.38|166.38|Standard Deviation|10.28|10.28|||
3933712|NCT01395758|3755631|B3|||Weight||kilograms|Mean|70.79|70.79|Standard Deviation|16.37|16.37|||
3933713|NCT01395758|3755632|B2|||Weight||kilograms|Mean|68.86|68.86|Standard Deviation|15.19|15.19|||
3933714|NCT01395758|3755633|B1|||Weight||kilograms|Mean|72.50|72.5|Standard Deviation|17.31|17.31|||
3933715|NCT01395758|3755631|B3||No|Cigarette Use||Participants|Count of Participants|8|8.0||||||
3933716|NCT01395758|3755632|B2||No|Cigarette Use||Participants|Count of Participants|3|3.0||||||
3933717|NCT01395758|3755633|B1||No|Cigarette Use||Participants|Count of Participants|5|5.0||||||
3933718|NCT01395758|3755631|B3||Yes|Cigarette Use||Participants|Count of Participants|88|88.0||||||
3933719|NCT01395758|3755632|B2||Yes|Cigarette Use||Participants|Count of Participants|42|42.0||||||
3933720|NCT01395758|3755633|B1||Yes|Cigarette Use||Participants|Count of Participants|46|46.0||||||
3933721|NCT01395758|3755631|B3|United States||Region of Enrollment||participants|Number|96|96.0||||||
3933722|NCT01395758|3755632|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
3933723|NCT01395758|3755633|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
3933724|NCT01395758|3755631|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3933725|NCT01395758|3755632|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933726|NCT01395758|3755633|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3933727|NCT01395758|3755631|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933728|NCT01395758|3755632|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933729|NCT01395758|3755633|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933730|NCT01395758|3755631|B3||White|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3933732|NCT01395758|3755633|B1||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3933733|NCT01395758|3755631|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3933734|NCT01395758|3755632|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3933735|NCT01395758|3755633|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3933736|NCT01395758|3755631|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933737|NCT01395758|3755632|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933738|NCT01395758|3755633|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933739|NCT01395758|3755631|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3933740|NCT01395758|3755632|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3933741|NCT01395758|3755633|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3933742|NCT01395758|3755631|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933743|NCT01395758|3755632|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933744|NCT01395758|3755633|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933745|NCT01395758|3755631|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933746|NCT01395758|3755632|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933747|NCT01395758|3755633|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933748|NCT01395758|3755631|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3933749|NCT01395758|3755632|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3933750|NCT01395758|3755633|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3933751|NCT01395758|3755631|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3933752|NCT01395758|3755632|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933753|NCT01395758|3755633|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3933754|NCT01395758|3755631|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3933755|NCT01395758|3755632|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3933756|NCT01395758|3755633|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3933757|NCT01395758|3755631|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3933758|NCT01395758|3755632|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3933759|NCT01395758|3755633|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3933760|NCT01395758|3755631|B3|||Age||years|Mean|63.8|63.8|Standard Deviation|9.43|9.43|||
3933761|NCT01395758|3755632|B2|||Age||years|Mean|65.2|65.2|Standard Deviation|9.55|9.55|||
3933762|NCT01395758|3755633|B1|||Age||years|Mean|62.6|62.6|Standard Deviation|9.23|9.23|||
3933763|NCT01395758|3755631|B3||>=65 years|Age||Participants|Count of Participants|52|52.0||||||
3933764|NCT01395758|3755632|B2||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
3933765|NCT01395758|3755633|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3933766|NCT01395758|3755631|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3933767|NCT01395758|3755632|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3933768|NCT01395758|3755633|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3933769|NCT01395758|3755631|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3933770|NCT01395758|3755632|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3933771|NCT01395758|3755633|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3933772|NCT01395524|3755646|B4|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3933773|NCT01395524|3755647|B3|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3933774|NCT01395524|3755648|B2|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3933775|NCT01395524|3755649|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3933776|NCT01395524|3755646|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3933777|NCT01395524|3755647|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3933778|NCT01395524|3755648|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3933779|NCT01395524|3755649|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3933780|NCT01395524|3755646|B4|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3933781|NCT01395524|3755647|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3933782|NCT01395524|3755648|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3933783|NCT01395524|3755649|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3933784|NCT01395524|3755646|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|69|69.0||||||
3933785|NCT01395524|3755647|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
3933786|NCT01395524|3755648|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
3933787|NCT01395524|3755649|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
3933788|NCT01395524|3755646|B4|White||Race/Ethnicity, Customized||Participants|Number|221|221.0||||||
3933789|NCT01395524|3755647|B3|White||Race/Ethnicity, Customized||Participants|Number|76|76.0||||||
3933790|NCT01395524|3755648|B2|White||Race/Ethnicity, Customized||Participants|Number|74|74.0||||||
3933791|NCT01395524|3755649|B1|White||Race/Ethnicity, Customized||Participants|Number|71|71.0||||||
3933792|NCT01395524|3755646|B4||Male|Gender||Participants|Count of Participants|116|116.0||||||
3933793|NCT01395524|3755647|B3||Male|Gender||Participants|Count of Participants|42|42.0||||||
3933794|NCT01395524|3755648|B2||Male|Gender||Participants|Count of Participants|41|41.0||||||
3933795|NCT01395524|3755649|B1||Male|Gender||Participants|Count of Participants|33|33.0||||||
3933796|NCT01395524|3755646|B4||Female|Gender||Participants|Count of Participants|180|180.0||||||
3933797|NCT01395524|3755647|B3||Female|Gender||Participants|Count of Participants|61|61.0||||||
3933798|NCT01395524|3755648|B2||Female|Gender||Participants|Count of Participants|57|57.0||||||
3933799|NCT01395524|3755649|B1||Female|Gender||Participants|Count of Participants|62|62.0||||||
3933800|NCT01395524|3755646|B4|||Age||Years|Mean|52.3|52.3|Standard Deviation|9.89|9.89|||
3933801|NCT01395524|3755647|B3|||Age||Years|Mean|52.6|52.6|Standard Deviation|10.00|10.0|||
3933802|NCT01395524|3755648|B2|||Age||Years|Mean|52.6|52.6|Standard Deviation|10.19|10.19|||
3933803|NCT01395524|3755649|B1|||Age||Years|Mean|51.8|51.8|Standard Deviation|9.51|9.51|||
3933804|NCT01395394|3755671|B4|||high-sensitivity CRP||mg/L|Mean|1.06|1.06|Standard Deviation|1.19|1.19|||
3933805|NCT01395394|3755672|B3|||high-sensitivity CRP||mg/L|Mean|1.04|1.04|Standard Deviation|1.48|1.48|||
3933806|NCT01395394|3755673|B2|||high-sensitivity CRP||mg/L|Mean|0.61|0.61|Standard Deviation|0.14|0.14|||
3933807|NCT01395394|3755674|B1|||high-sensitivity CRP||mg/L|Mean|1.3|1.3|Standard Deviation|1.2|1.2|||
3933808|NCT01395394|3755671|B4|United States||Region of Enrollment||participants|Number|12|12.0||||||
3933809|NCT01395394|3755672|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3933810|NCT01395394|3755673|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3933811|NCT01395394|3755674|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3933812|NCT01395394|3755671|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3933813|NCT01395394|3755672|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3933814|NCT01395394|3755673|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3933815|NCT01395394|3755674|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3933816|NCT01395394|3755671|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3933817|NCT01395394|3755672|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3933818|NCT01395394|3755673|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3933819|NCT01395394|3755674|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3933820|NCT01395394|3755671|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3933821|NCT01395394|3755672|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3933822|NCT01395394|3755673|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3933823|NCT01395394|3755674|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3933824|NCT01395394|3755671|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3933825|NCT01395394|3755672|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3933826|NCT01395394|3755673|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3933827|NCT01395394|3755674|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3933828|NCT01395394|3755671|B4||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3933829|NCT01395394|3755672|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3933830|NCT01395394|3755673|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3933831|NCT01395394|3755674|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3933832|NCT01395394|3755671|B4|||Age||years|Mean|27.4|27.4|Standard Deviation|12.6|12.6|||
3933833|NCT01395394|3755672|B3|||Age||years|Mean|18.5|18.5|Standard Deviation|3.8|3.8|||
3933834|NCT01395394|3755673|B2|||Age||years|Mean|33.5|33.5|Standard Deviation|15.7|15.7|||
3933835|NCT01395394|3755674|B1|||Age||years|Mean|33.9|33.9|Standard Deviation|13.4|13.4|||
3933836|NCT01395368|3755687|B1|United States||Region of Enrollment||participants|Number|92|92.0||||||
3933837|NCT01395368|3755687|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3933838|NCT01395368|3755687|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3933839|NCT01395368|3755687|B1|||Age||years|Mean|53|53.0|Standard Deviation|8|8.0|||
3933840|NCT01395368|3755687|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3933841|NCT01395368|3755687|B1||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
3933842|NCT01395368|3755687|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3933843|NCT01395329|3755691|B4|United States||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3933844|NCT01395329|3755692|B3|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3933845|NCT01395329|3755693|B2|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3933846|NCT01395329|3755694|B1|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3933847|NCT01395329|3755691|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3933848|NCT01395329|3755692|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3933849|NCT01395329|3755693|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3933850|NCT01395329|3755694|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3933851|NCT01395329|3755691|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3933852|NCT01395329|3755692|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3933853|NCT01395329|3755693|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3933854|NCT01395329|3755694|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3933855|NCT01395329|3755691|B4|||Age||years|Mean|56|56.0|Standard Deviation|5.1|5.1|||
3933856|NCT01395329|3755692|B3|||Age||years|Mean|56|56.0|Standard Deviation|5.9|5.9|||
3933857|NCT01395329|3755693|B2|||Age||years|Mean|55|55.0|Standard Deviation|4.1|4.1|||
3933858|NCT01395329|3755694|B1|||Age||years|Mean|57|57.0|Standard Deviation|5.3|5.3|||
3933859|NCT01395329|3755691|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3933860|NCT01395329|3755692|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3933861|NCT01395329|3755693|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3933862|NCT01395329|3755694|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3933863|NCT01395329|3755691|B4||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3933864|NCT01395329|3755692|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3933865|NCT01395329|3755693|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3933866|NCT01395329|3755694|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3933867|NCT01395329|3755691|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3933868|NCT01395329|3755692|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3933869|NCT01395329|3755693|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3933870|NCT01395329|3755694|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3933871|NCT01395316|3755743|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3933872|NCT01395316|3755743|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3933873|NCT01395316|3755743|B1|||Age||years|Mean|32.6|32.6|Standard Deviation|7.7|7.7|||
3933874|NCT01395277|3755747|B3|||Mean Blood Pressure||mmHg|Mean|87|87.0|Standard Deviation|6|6.0|||
3933875|NCT01395277|3755748|B2|||Mean Blood Pressure||mmHg|Mean|88|88.0|Standard Deviation|7|7.0|||
3933876|NCT01395277|3755749|B1|||Mean Blood Pressure||mmHg|Mean|85|85.0|Standard Deviation|8|8.0|||
3933877|NCT01395277|3755747|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3933878|NCT01395277|3755748|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3933879|NCT01395277|3755749|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3933880|NCT01395277|3755747|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3933881|NCT01395277|3755748|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3933882|NCT01395277|3755749|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3933883|NCT01395277|3755747|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3933884|NCT01395277|3755748|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3933885|NCT01395277|3755749|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3933886|NCT01395277|3755747|B3|||Age||years|Mean|68.0|68.0|Standard Deviation|2.7|2.7|||
3933887|NCT01395277|3755748|B2|||Age||years|Mean|67.5|67.5|Standard Deviation|2.9|2.9|||
3933888|NCT01395277|3755749|B1|||Age||years|Mean|68.4|68.4|Standard Deviation|2.8|2.8|||
3933889|NCT01395277|3755747|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3933890|NCT01395277|3755748|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3933891|NCT01395277|3755749|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3933892|NCT01395277|3755747|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3933893|NCT01395277|3755748|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3933894|NCT01395277|3755749|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3933895|NCT01395277|3755747|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3933896|NCT01395277|3755748|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3933897|NCT01395277|3755749|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3933898|NCT01395043|3755758|B1|Denmark||Region of Enrollment||participants|Number|15|15.0||||||
3933899|NCT01395043|3755758|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3933900|NCT01395043|3755758|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3933901|NCT01395043|3755758|B1|||Age||years|Mean|66|66.0|Standard Deviation|9|9.0|||
3933902|NCT01395043|3755758|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3933903|NCT01395043|3755758|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3933904|NCT01395043|3755758|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3933905|NCT01395030|3755763|B1||Sarcoma|Tumor Diagnosis||Participants|Count of Participants|1|1.0||||||
3933906|NCT01395030|3755763|B1||Cholangiocarcinoma|Tumor Diagnosis||Participants|Count of Participants|8|8.0||||||
3933907|NCT01395030|3755763|B1||Hepatocellular carcinoma|Tumor Diagnosis||Participants|Count of Participants|48|48.0||||||
3933908|NCT01395030|3755763|B1|United States||Region of Enrollment||Participants|Count of Participants|57|57.0||||||
3933909|NCT01395030|3755763|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933910|NCT01395030|3755763|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933911|NCT01395030|3755763|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3933912|NCT01395030|3755763|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3933913|NCT01395030|3755763|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3933914|NCT01395030|3755763|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3933915|NCT01395030|3755763|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933916|NCT01395030|3755763|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3933917|NCT01395030|3755763|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3933918|NCT01395030|3755763|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3933919|NCT01395030|3755763|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3933920|NCT01395030|3755763|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3933921|NCT01395030|3755763|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3933922|NCT01395030|3755763|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3933923|NCT01395030|3755763|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3933924|NCT01395017|3755771|B3||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3933925|NCT01395017|3755772|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3933926|NCT01395017|3755773|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3933927|NCT01395017|3755771|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3933928|NCT01395017|3755772|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3933929|NCT01395017|3755773|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3933930|NCT01395017|3755771|B3|||Age||Years|Mean|64.8|64.8|Standard Deviation|9.4|9.4|||
3933931|NCT01395017|3755772|B2|||Age||Years|Mean|64.7|64.7|Standard Deviation|9.6|9.6|||
3933932|NCT01395017|3755773|B1|||Age||Years|Mean|64.8|64.8|Standard Deviation|9.1|9.1|||
3933933|NCT01394991|3755782|B3|Ukraine||Region of Enrollment||participants|Number|66|66.0||||||
3933934|NCT01394991|3755783|B2|Ukraine||Region of Enrollment||participants|Number|35|35.0||||||
3933935|NCT01394991|3755784|B1|Ukraine||Region of Enrollment||participants|Number|31|31.0||||||
3933936|NCT01394991|3755782|B3|Slovakia||Region of Enrollment||participants|Number|20|20.0||||||
3933937|NCT01394991|3755783|B2|Slovakia||Region of Enrollment||participants|Number|11|11.0||||||
3933938|NCT01394991|3755784|B1|Slovakia||Region of Enrollment||participants|Number|9|9.0||||||
3933939|NCT01394991|3755782|B3|Russia||Region of Enrollment||participants|Number|181|181.0||||||
3933940|NCT01394991|3755783|B2|Russia||Region of Enrollment||participants|Number|93|93.0||||||
3933941|NCT01394991|3755784|B1|Russia||Region of Enrollment||participants|Number|88|88.0||||||
3933942|NCT01394991|3755782|B3|Romania||Region of Enrollment||participants|Number|41|41.0||||||
3933943|NCT01394991|3755783|B2|Romania||Region of Enrollment||participants|Number|20|20.0||||||
3933944|NCT01394991|3755784|B1|Romania||Region of Enrollment||participants|Number|21|21.0||||||
3933945|NCT01394991|3755782|B3|Poland||Region of Enrollment||participants|Number|13|13.0||||||
3933946|NCT01394991|3755783|B2|Poland||Region of Enrollment||participants|Number|6|6.0||||||
3933947|NCT01394991|3755784|B1|Poland||Region of Enrollment||participants|Number|7|7.0||||||
3933948|NCT01394991|3755782|B3|Italy||Region of Enrollment||participants|Number|26|26.0||||||
3933949|NCT01394991|3755783|B2|Italy||Region of Enrollment||participants|Number|13|13.0||||||
3933950|NCT01394991|3755784|B1|Italy||Region of Enrollment||participants|Number|13|13.0||||||
3933951|NCT01394991|3755782|B3|Greece||Region of Enrollment||participants|Number|20|20.0||||||
3933952|NCT01394991|3755783|B2|Greece||Region of Enrollment||participants|Number|12|12.0||||||
3933953|NCT01394991|3755784|B1|Greece||Region of Enrollment||participants|Number|8|8.0||||||
3933954|NCT01394991|3755782|B3|Great Britain||Region of Enrollment||participants|Number|5|5.0||||||
3933955|NCT01394991|3755783|B2|Great Britain||Region of Enrollment||participants|Number|4|4.0||||||
3933956|NCT01394991|3755784|B1|Great Britain||Region of Enrollment||participants|Number|1|1.0||||||
3933957|NCT01394991|3755782|B3|Germany||Region of Enrollment||participants|Number|106|106.0||||||
3933958|NCT01394991|3755783|B2|Germany||Region of Enrollment||participants|Number|55|55.0||||||
3933959|NCT01394991|3755784|B1|Germany||Region of Enrollment||participants|Number|51|51.0||||||
3933960|NCT01394991|3755782|B3|France||Region of Enrollment||participants|Number|13|13.0||||||
3933961|NCT01394991|3755783|B2|France||Region of Enrollment||participants|Number|6|6.0||||||
3933962|NCT01394991|3755784|B1|France||Region of Enrollment||participants|Number|7|7.0||||||
3933963|NCT01394991|3755782|B3|Bulgaria||Region of Enrollment||participants|Number|13|13.0||||||
3933964|NCT01394991|3755783|B2|Bulgaria||Region of Enrollment||participants|Number|7|7.0||||||
3933965|NCT01394991|3755784|B1|Bulgaria||Region of Enrollment||participants|Number|6|6.0||||||
3933966|NCT01394991|3755782|B3||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3933967|NCT01394991|3755783|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3933968|NCT01394991|3755784|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3933969|NCT01394991|3755782|B3||Female|Sex: Female, Male||Participants|Count of Participants|337|337.0||||||
3933970|NCT01394991|3755783|B2||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
3933971|NCT01394991|3755784|B1||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3933972|NCT01394991|3755782|B3|||Age||years|Mean|58.1|58.1|Standard Deviation|13.44|13.44|||
3933973|NCT01394991|3755783|B2|||Age||years|Mean|57.5|57.5|Standard Deviation|13.53|13.53|||
3933974|NCT01394991|3755784|B1|||Age||years|Mean|58.8|58.8|Standard Deviation|13.35|13.35|||
3933975|NCT01394991|3755782|B3||>=65 years|Age||Participants|Count of Participants|169|169.0||||||
3933976|NCT01394991|3755783|B2||>=65 years|Age||Participants|Count of Participants|88|88.0||||||
3933977|NCT01394991|3755784|B1||>=65 years|Age||Participants|Count of Participants|81|81.0||||||
3933978|NCT01394991|3755782|B3||Between 18 and 65 years|Age||Participants|Count of Participants|333|333.0||||||
3933979|NCT01394991|3755783|B2||Between 18 and 65 years|Age||Participants|Count of Participants|173|173.0||||||
3933980|NCT01394991|3755784|B1||Between 18 and 65 years|Age||Participants|Count of Participants|160|160.0||||||
3933981|NCT01394991|3755782|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3933982|NCT01394991|3755783|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3933983|NCT01394991|3755784|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3933984|NCT01394978|3755805|B3||>= 30 kg/sq. meters|BMI Category at Baseline||Participants|Count of Participants|130|130.0||||||
3933985|NCT01394978|3755806|B2||>= 30 kg/sq. meters|BMI Category at Baseline||Participants|Count of Participants|79|79.0||||||
3933986|NCT01394978|3755807|B1||>= 30 kg/sq. meters|BMI Category at Baseline||Participants|Count of Participants|51|51.0||||||
3933987|NCT01394978|3755805|B3||<30 kg/sq. meters|BMI Category at Baseline||Participants|Count of Participants|314|314.0||||||
3933988|NCT01394978|3755806|B2||<30 kg/sq. meters|BMI Category at Baseline||Participants|Count of Participants|197|197.0||||||
3933989|NCT01394978|3755807|B1||<30 kg/sq. meters|BMI Category at Baseline||Participants|Count of Participants|117|117.0||||||
3933990|NCT01394978|3755805|B3|||Body Mass Index (BMI)||kg/m^2|Mean|27.7|27.7|Standard Deviation|6.11|6.11|||
3933991|NCT01394978|3755806|B2|||Body Mass Index (BMI)||kg/m^2|Mean|27.7|27.7|Standard Deviation|6.10|6.1|||
3933992|NCT01394978|3755807|B1|||Body Mass Index (BMI)||kg/m^2|Mean|27.8|27.8|Standard Deviation|6.16|6.16|||
3933993|NCT01394978|3755805|B3|||Weight||kilograms|Mean|80.3|80.3|Standard Deviation|20.22|20.22|||
3933994|NCT01394978|3755806|B2|||Weight||kilograms|Mean|80.5|80.5|Standard Deviation|20.54|20.54|||
3933995|NCT01394978|3755807|B1|||Weight||kilograms|Mean|79.9|79.9|Standard Deviation|19.75|19.75|||
3933996|NCT01394978|3755805|B3|||Height||centimeters|Mean|169.8|169.8|Standard Deviation|9.74|9.74|||
3933997|NCT01394978|3755806|B2|||Height||centimeters|Mean|170.1|170.1|Standard Deviation|9.63|9.63|||
3933998|NCT01394978|3755807|B1|||Height||centimeters|Mean|169.3|169.3|Standard Deviation|9.93|9.93|||
3933999|NCT01394978|3755805|B3|United States||Region of Enrollment||participants|Number|444|444.0||||||
3934000|NCT01394978|3755806|B2|United States||Region of Enrollment||participants|Number|276|276.0||||||
3934001|NCT01394978|3755807|B1|United States||Region of Enrollment||participants|Number|168|168.0||||||
3934002|NCT01394978|3755805|B3|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3934003|NCT01394978|3755806|B2|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3934004|NCT01394978|3755807|B1|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3934005|NCT01394978|3755805|B3|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3934006|NCT01394978|3755806|B2|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3934007|NCT01394978|3755807|B1|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3934008|NCT01394978|3755805|B3|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3934009|NCT01394978|3755806|B2|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3934010|NCT01394978|3755807|B1|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3934011|NCT01394978|3755805|B3|Race/Ethnicity|Black|Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3934012|NCT01394978|3755806|B2|Race/Ethnicity|Black|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3934013|NCT01394978|3755807|B1|Race/Ethnicity|Black|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3934014|NCT01394978|3755805|B3|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|414|414.0||||||
3934015|NCT01394978|3755806|B2|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|258|258.0||||||
3934016|NCT01394978|3755807|B1|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|156|156.0||||||
3934017|NCT01394978|3755805|B3||Male|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
3934018|NCT01394978|3755806|B2||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3934019|NCT01394978|3755807|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3934020|NCT01394978|3755805|B3||Female|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
3934021|NCT01394978|3755806|B2||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3934022|NCT01394978|3755807|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3934023|NCT01394978|3755805|B3|||Age||years|Mean|65.6|65.6|Standard Deviation|10.87|10.87|||
3934024|NCT01394978|3755806|B2|||Age||years|Mean|65.6|65.6|Standard Deviation|10.52|10.52|||
3934025|NCT01394978|3755807|B1|||Age||years|Mean|65.7|65.7|Standard Deviation|11.46|11.46|||
3934026|NCT01394978|3755805|B3||>=65 years|Age||Participants|Count of Participants|253|253.0||||||
3934027|NCT01394978|3755806|B2||>=65 years|Age||Participants|Count of Participants|154|154.0||||||
3934028|NCT01394978|3755807|B1||>=65 years|Age||Participants|Count of Participants|99|99.0||||||
3934029|NCT01394978|3755805|B3||Between 18 and 65 years|Age||Participants|Count of Participants|191|191.0||||||
3934030|NCT01394978|3755806|B2||Between 18 and 65 years|Age||Participants|Count of Participants|122|122.0||||||
3934031|NCT01394978|3755807|B1||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
3934032|NCT01394978|3755805|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3934033|NCT01394978|3755806|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3934034|NCT01394978|3755807|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3934035|NCT01394926|3755814|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3934036|NCT01394926|3755814|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3934037|NCT01394926|3755814|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3934038|NCT01394926|3755814|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3934039|NCT01394926|3755814|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3934040|NCT01394926|3755814|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3934041|NCT01394926|3755814|B1|||Age||years|Mean|67.3|67.3|Standard Deviation|9.40|9.4|||
3934042|NCT01394718|3755823|B3|||Intra-operative methadone||milligrams/kilograms (mg/kg)|Median|0.1|0.1|Full Range|||0.0|0.2|
3934043|NCT01394718|3755824|B2|||Intra-operative methadone||milligrams/kilograms (mg/kg)|Median|0.1|0.1|Full Range|||0.0|0.2|
3934044|NCT01394718|3755825|B1|||Intra-operative methadone||milligrams/kilograms (mg/kg)|Median|0.1|0.1|Full Range|||0.0|0.2|
3934045|NCT01394718|3755823|B3|||Intra-operative methadone||milligrams (mg)|Median|6.0|6.0|Full Range|||0.0|10.0|
3934046|NCT01394718|3755824|B2|||Intra-operative methadone||milligrams (mg)|Median|6.0|6.0|Full Range|||0.0|10.0|
3934047|NCT01394718|3755825|B1|||Intra-operative methadone||milligrams (mg)|Median|6.3|6.3|Full Range|||0.0|10.0|
3934048|NCT01394718|3755823|B3|||Estimated Blood Loss (EBL)||milliliter (ml)|Median|700|700.0|Full Range|||150.0|2200.0|
3934049|NCT01394718|3755824|B2|||Estimated Blood Loss (EBL)||milliliter (ml)|Median|600|600.0|Full Range|||150.0|1400.0|
3934050|NCT01394718|3755825|B1|||Estimated Blood Loss (EBL)||milliliter (ml)|Median|775|775.0|Full Range|||450.0|2200.0|
3934051|NCT01394718|3755823|B3|||Surgery Duration||hours (hr)|Mean|5.15|5.15|Standard Deviation|1.08|1.08|||
3934052|NCT01394718|3755824|B2|||Surgery Duration||hours (hr)|Mean|5.09|5.09|Standard Deviation|1.14|1.14|||
3934053|NCT01394718|3755825|B1|||Surgery Duration||hours (hr)|Mean|5.21|5.21|Standard Deviation|1.03|1.03|||
3934054|NCT01394718|3755823|B3|||Weight||kilograms (kg)|Mean|56.56|56.56|Standard Deviation|12.83|12.83|||
3934055|NCT01394718|3755824|B2|||Weight||kilograms (kg)|Mean|53.44|53.44|Standard Deviation|11.32|11.32|||
3934056|NCT01394718|3755825|B1|||Weight||kilograms (kg)|Mean|59.79|59.79|Standard Deviation|13.69|13.69|||
3934057|NCT01394718|3755823|B3|United States||Region of Enrollment||participants|Number|57|57.0||||||
3934058|NCT01394718|3755824|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
3934059|NCT01394718|3755825|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
3934060|NCT01394718|3755823|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3934061|NCT01394718|3755824|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3934062|NCT01394718|3755825|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3934063|NCT01394718|3755823|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3934064|NCT01394718|3755824|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3934065|NCT01394718|3755825|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3934066|NCT01394718|3755823|B3|||Age||years|Mean|14.30|14.3|Standard Deviation|1.77|1.77|||
3934067|NCT01394718|3755824|B2|||Age||years|Mean|14.17|14.17|Standard Deviation|1.87|1.87|||
3934068|NCT01394718|3755825|B1|||Age||years|Mean|14.43|14.43|Standard Deviation|1.69|1.69|||
3934069|NCT01394692|3755838|B3|Germany||Region of Enrollment||participants|Number|58|58.0||||||
3934070|NCT01394692|3755839|B2|Germany||Region of Enrollment||participants|Number|29|29.0||||||
3934071|NCT01394692|3755840|B1|Germany||Region of Enrollment||participants|Number|29|29.0||||||
3934072|NCT01394692|3755838|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3934073|NCT01394692|3755839|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3934074|NCT01394692|3755840|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3934075|NCT01394692|3755838|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3934076|NCT01394692|3755839|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3934077|NCT01394692|3755840|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3934078|NCT01394692|3755838|B3|||Age||years|Mean|58|58.0|Standard Deviation|13|13.0|||
3934079|NCT01394692|3755839|B2|||Age||years|Mean|58|58.0|Standard Deviation|13|13.0|||
3934080|NCT01394692|3755840|B1|||Age||years|Mean|57|57.0|Standard Deviation|13|13.0|||
3934081|NCT01394692|3755838|B3||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3934082|NCT01394692|3755839|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3934083|NCT01394692|3755840|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3934084|NCT01394692|3755838|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3934085|NCT01394692|3755839|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3934086|NCT01394692|3755840|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3934087|NCT01394692|3755838|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3934088|NCT01394692|3755839|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3934089|NCT01394692|3755840|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3934090|NCT01394627|3755847|B1|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3934091|NCT01394627|3755847|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934092|NCT01394627|3755847|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3934093|NCT01394627|3755847|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3934094|NCT01394627|3755847|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3934095|NCT01394627|3755847|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934096|NCT01394627|3755847|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3934097|NCT01394627|3755847|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934098|NCT01394627|3755847|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3934099|NCT01394627|3755847|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3934100|NCT01394627|3755847|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3934101|NCT01394627|3755847|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3934102|NCT01394627|3755847|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3934103|NCT01394627|3755847|B1|||Age||years|Mean|26.5|26.5|Standard Deviation|5.6|5.6|||
3934104|NCT01394627|3755847|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3934105|NCT01394627|3755847|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3934106|NCT01394627|3755847|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3934107|NCT01394614|3755856|B3|Canada||Region of Enrollment||participants|Number|24|24.0||||||
3934108|NCT01394614|3755857|B2|Canada||Region of Enrollment||participants|Number|16|16.0||||||
3934109|NCT01394614|3755858|B1|Canada||Region of Enrollment||participants|Number|8|8.0||||||
3934110|NCT01394614|3755856|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3934111|NCT01394614|3755857|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3934112|NCT01394614|3755858|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3934113|NCT01394614|3755856|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3934114|NCT01394614|3755857|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3934115|NCT01394614|3755858|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3934116|NCT01394614|3755856|B3|||Age||years|Mean|24.0|24.0|Full Range|||6.0|55.0|
3934117|NCT01394614|3755857|B2|||Age||years|Mean|26.1|26.1|Full Range|||8.0|55.0|
3934118|NCT01394614|3755858|B1|||Age||years|Mean|19.9|19.9|Full Range|||6.0|50.0|
3934119|NCT01394614|3755856|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3934120|NCT01394614|3755857|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3934121|NCT01394614|3755858|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3934122|NCT01394614|3755856|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3934123|NCT01394614|3755857|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3934124|NCT01394614|3755858|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3934125|NCT01394614|3755856|B3||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
3934126|NCT01394614|3755857|B2||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
3934127|NCT01394614|3755858|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3934128|NCT01394523|3755865|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3934129|NCT01394523|3755866|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3934130|NCT01394523|3755867|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3934131|NCT01394523|3755868|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3934132|NCT01394523|3755865|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3934133|NCT01394523|3755866|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3934134|NCT01394523|3755867|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3934135|NCT01394523|3755868|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3934136|NCT01394523|3755865|B4|||Age||years|Mean|4.4|4.4|Standard Deviation|1.4|1.4|||
3934137|NCT01394523|3755866|B3|||Age||years|Mean|4.6|4.6|Standard Deviation|1.2|1.2|||
3934138|NCT01394523|3755867|B2|||Age||years|Mean|4.3|4.3|Standard Deviation|1.6|1.6|||
3934139|NCT01394523|3755868|B1|||Age||years|Mean|4.2|4.2|Standard Deviation|1.5|1.5|||
3934140|NCT01394510|3755878|B1|||metformin|number of patients taking metformin|participants|Number|6|6.0||||||
3934141|NCT01394510|3755878|B1|||HbA1c||%|Mean|6.17|6.17|Standard Deviation|2.05|2.05|||
3934142|NCT01394510|3755878|B1|||body mass index|Body mass index|kg/m2|Mean|37.3|37.3|Standard Deviation|10.1|10.1|||
3934143|NCT01394510|3755878|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3934144|NCT01394510|3755878|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3934145|NCT01394510|3755878|B1|||Age||years|Mean|53.9|53.9|Standard Deviation|11.7|11.7|||
3934146|NCT01394276|3755884|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3934147|NCT01394276|3755884|B1||Female|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
3934148|NCT01394276|3755884|B1|||Age||years|Mean|55.8|55.8|Standard Deviation|11.6|11.6|||
3934149|NCT01394250|3755906|B3|United States||Region of Enrollment||participants|Number|224|224.0||||||
3934150|NCT01394250|3755907|B2|United States||Region of Enrollment||participants|Number|110|110.0||||||
3934151|NCT01394250|3755908|B1|United States||Region of Enrollment||participants|Number|114|114.0||||||
3934152|NCT01394250|3755906|B3||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3934153|NCT01394250|3755907|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3934154|NCT01394250|3755908|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3934155|NCT01394250|3755906|B3||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3934156|NCT01394250|3755907|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3934157|NCT01394250|3755908|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3934158|NCT01394250|3755906|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3934159|NCT01394250|3755907|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3934160|NCT01394250|3755908|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3934161|NCT01394250|3755906|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3934162|NCT01394250|3755907|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3934163|NCT01394250|3755908|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3934164|NCT01394250|3755906|B3||<=18 years|Age||Participants|Count of Participants|224|224.0||||||
3934165|NCT01394250|3755907|B2||<=18 years|Age||Participants|Count of Participants|110|110.0||||||
3934166|NCT01394250|3755908|B1||<=18 years|Age||Participants|Count of Participants|114|114.0||||||
3934167|NCT01394211|3755917|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3934168|NCT01394211|3755917|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3934169|NCT01394211|3755917|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3934170|NCT01394211|3755917|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3934171|NCT01394211|3755917|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3934172|NCT01394211|3755917|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3934173|NCT01394185|3755923|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3934174|NCT01394185|3755923|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934175|NCT01394185|3755923|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3934176|NCT01394185|3755923|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3934177|NCT01394185|3755923|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3934178|NCT01394185|3755923|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934179|NCT01394185|3755923|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934180|NCT01394185|3755923|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934181|NCT01394185|3755923|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934182|NCT01394185|3755923|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3934183|NCT01394185|3755923|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934184|NCT01394185|3755923|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3934185|NCT01394185|3755923|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3934186|NCT01394185|3755923|B1|||Age||years|Mean|25|25.0|Standard Deviation|5|5.0|||
3934187|NCT01394159|3755939|B3|United States||Region of Enrollment||participants|Number|56|56.0||||||
3934188|NCT01394159|3755940|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
3934189|NCT01394159|3755941|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
3934190|NCT01394159|3755939|B3|Black||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3934191|NCT01394159|3755940|B2|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3934192|NCT01394159|3755941|B1|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3934193|NCT01394159|3755939|B3|White||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
3934194|NCT01394159|3755940|B2|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3934195|NCT01394159|3755941|B1|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3934196|NCT01394159|3755939|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3934197|NCT01394159|3755940|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3934198|NCT01394159|3755941|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3934199|NCT01394159|3755939|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3934200|NCT01394159|3755940|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3934201|NCT01394159|3755941|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3934202|NCT01394159|3755939|B3|||Age||years|Mean|65.2|65.2|Standard Deviation|13.3|13.3|||
3934203|NCT01394159|3755940|B2|||Age||years|Mean|65.4|65.4|Standard Deviation|11.1|11.1|||
3934204|NCT01394159|3755941|B1|||Age||years|Mean|65.0|65.0|Standard Deviation|15.4|15.4|||
3934205|NCT01394081|3755952|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934206|NCT01394081|3755953|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934207|NCT01394081|3755954|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934208|NCT01394081|3755952|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934209|NCT01394081|3755953|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934210|NCT01394081|3755954|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934211|NCT01394081|3755952|B3||White|Race (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
3934212|NCT01394081|3755953|B2||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3934213|NCT01394081|3755954|B1||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3934214|NCT01394081|3755952|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3934215|NCT01394081|3755953|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3934216|NCT01394081|3755954|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3934217|NCT01394081|3755952|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934218|NCT01394081|3755953|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934219|NCT01394081|3755954|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934220|NCT01394081|3755952|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3934221|NCT01394081|3755953|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3934222|NCT01394081|3755954|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934223|NCT01394081|3755952|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934224|NCT01394081|3755953|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934225|NCT01394081|3755954|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934226|NCT01394081|3755952|B3||Male|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
3934227|NCT01394081|3755953|B2||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3934228|NCT01394081|3755954|B1||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3934229|NCT01394081|3755952|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3934230|NCT01394081|3755953|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3934231|NCT01394081|3755954|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3934232|NCT01394081|3755952|B3|||Age||years|Mean|55.6|55.6|Standard Deviation|14.4|14.4|||
3934233|NCT01394081|3755953|B2|||Age||years|Mean|55.39|55.39|Standard Deviation|14.60|14.6|||
3934234|NCT01394081|3755954|B1|||Age||years|Mean|55.72|55.72|Standard Deviation|14.24|14.24|||
3934235|NCT01393964|3755963|B4|United States||Region of Enrollment||participants|Number|26|26.0||||||
3934236|NCT01393964|3755964|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
3934237|NCT01393964|3755965|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3934238|NCT01393964|3755966|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3934239|NCT01393964|3755963|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3934240|NCT01393964|3755964|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3934241|NCT01393964|3755965|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3934242|NCT01393964|3755966|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3934243|NCT01393964|3755963|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3934244|NCT01393964|3755964|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3934245|NCT01393964|3755965|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3934246|NCT01393964|3755966|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3934247|NCT01393964|3755963|B4|>= 75 years||Age, Customized||participants|Number|6|6.0||||||
3934248|NCT01393964|3755964|B3|>= 75 years||Age, Customized||participants|Number|1|1.0||||||
3934249|NCT01393964|3755965|B2|>= 75 years||Age, Customized||participants|Number|5|5.0||||||
3934250|NCT01393964|3755966|B1|>= 75 years||Age, Customized||participants|Number|0|0.0||||||
3934251|NCT01393964|3755963|B4|>=65 and < 75 years||Age, Customized||participants|Number|4|4.0||||||
3934252|NCT01393964|3755964|B3|>=65 and < 75 years||Age, Customized||participants|Number|0|0.0||||||
3934253|NCT01393964|3755965|B2|>=65 and < 75 years||Age, Customized||participants|Number|3|3.0||||||
3934254|NCT01393964|3755966|B1|>=65 and < 75 years||Age, Customized||participants|Number|1|1.0||||||
3934255|NCT01393964|3755963|B4|< 65 years||Age, Customized||participants|Number|16|16.0||||||
3934256|NCT01393964|3755964|B3|< 65 years||Age, Customized||participants|Number|8|8.0||||||
3934257|NCT01393964|3755965|B2|< 65 years||Age, Customized||participants|Number|1|1.0||||||
3934258|NCT01393964|3755966|B1|< 65 years||Age, Customized||participants|Number|7|7.0||||||
3934259|NCT01393964|3755963|B4|||Age||years|Mean|63.3|63.3|Standard Deviation|13.02|13.02|||
3934260|NCT01393964|3755964|B3|||Age||years|Mean|55.6|55.6|Standard Deviation|11.70|11.7|||
3934261|NCT01393964|3755965|B2|||Age||years|Mean|75.9|75.9|Standard Deviation|7.70|7.7|||
3934262|NCT01393964|3755966|B1|||Age||years|Mean|57.8|57.8|Standard Deviation|8.05|8.05|||
3934263|NCT01393899|3756006|B4||Male|Gender||Participants|Count of Participants|94|94.0||||||
3934264|NCT01393899|3756007|B3||Male|Gender||Participants|Count of Participants|37|37.0||||||
3934265|NCT01393899|3756008|B2||Male|Gender||Participants|Count of Participants|30|30.0||||||
3934266|NCT01393899|3756009|B1||Male|Gender||Participants|Count of Participants|27|27.0||||||
3934267|NCT01393899|3756006|B4||Female|Gender||Participants|Count of Participants|86|86.0||||||
3934268|NCT01393899|3756007|B3||Female|Gender||Participants|Count of Participants|24|24.0||||||
3934269|NCT01393899|3756008|B2||Female|Gender||Participants|Count of Participants|30|30.0||||||
3934270|NCT01393899|3756009|B1||Female|Gender||Participants|Count of Participants|32|32.0||||||
3934271|NCT01393899|3756006|B4|More than or equal to (>=)65 years||Age, Customized||Participants|Number|4|4.0||||||
3934272|NCT01393899|3756007|B3|More than or equal to (>=)65 years||Age, Customized||Participants|Number|1|1.0||||||
3934273|NCT01393899|3756008|B2|More than or equal to (>=)65 years||Age, Customized||Participants|Number|1|1.0||||||
3934274|NCT01393899|3756009|B1|More than or equal to (>=)65 years||Age, Customized||Participants|Number|2|2.0||||||
3934275|NCT01393899|3756006|B4|Between 45 and 64 years||Age, Customized||Participants|Number|58|58.0||||||
3934276|NCT01393899|3756007|B3|Between 45 and 64 years||Age, Customized||Participants|Number|20|20.0||||||
3934277|NCT01393899|3756008|B2|Between 45 and 64 years||Age, Customized||Participants|Number|15|15.0||||||
3934278|NCT01393899|3756009|B1|Between 45 and 64 years||Age, Customized||Participants|Number|23|23.0||||||
3934279|NCT01393899|3756006|B4|Between 18 and 44 years||Age, Customized||Participants|Number|118|118.0||||||
3934280|NCT01393899|3756007|B3|Between 18 and 44 years||Age, Customized||Participants|Number|40|40.0||||||
3934281|NCT01393899|3756008|B2|Between 18 and 44 years||Age, Customized||Participants|Number|44|44.0||||||
3934282|NCT01393899|3756009|B1|Between 18 and 44 years||Age, Customized||Participants|Number|34|34.0||||||
3934283|NCT01393899|3756006|B4|Less than or equal to (<=)18 years||Age, Customized||Participants|Number|0|0.0||||||
3934284|NCT01393899|3756007|B3|Less than or equal to (<=)18 years||Age, Customized||Participants|Number|0|0.0||||||
3934285|NCT01393899|3756008|B2|Less than or equal to (<=)18 years||Age, Customized||Participants|Number|0|0.0||||||
3934286|NCT01393899|3756009|B1|Less than or equal to (<=)18 years||Age, Customized||Participants|Number|0|0.0||||||
3934287|NCT01393743|3756063|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3934288|NCT01393743|3756064|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3934289|NCT01393743|3756065|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3934290|NCT01393743|3756063|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3934291|NCT01393743|3756064|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3934292|NCT01393743|3756065|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3934293|NCT01393743|3756063|B3|||Age||Years|Median|26|26.0|Full Range|||12.0|70.0|
3934294|NCT01393743|3756064|B2|||Age||Years|Median|26|26.0|Full Range|||12.0|58.0|
3934295|NCT01393743|3756065|B1|||Age||Years|Median|26|26.0|Full Range|||14.0|70.0|
3934296|NCT01393730|3756090|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3934297|NCT01393730|3756090|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3934298|NCT01393730|3756090|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3934299|NCT01393730|3756090|B1|||Age||years|Median|61|61.0|Inter-Quartile Range|||59.0|65.0|
3934300|NCT01393717|3756102|B1|United States||Region of Enrollment||Participants|Count of Participants|57|57.0||||||
3934301|NCT01393717|3756102|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3934302|NCT01393717|3756102|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934303|NCT01393717|3756102|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3934304|NCT01393717|3756102|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3934305|NCT01393717|3756102|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934306|NCT01393717|3756102|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3934307|NCT01393717|3756102|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934308|NCT01393717|3756102|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3934309|NCT01393717|3756102|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3934310|NCT01393717|3756102|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3934311|NCT01393717|3756102|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3934312|NCT01393717|3756102|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3934313|NCT01393717|3756102|B1|||Age||years|Median|32|32.0|Full Range|||11.0|67.0|
3934314|NCT01393704|3756115|B3|United States||Region of Enrollment||participants|Number|152|152.0||||||
3934315|NCT01393704|3756116|B2|United States||Region of Enrollment||participants|Number|76|76.0||||||
3934316|NCT01393704|3756117|B1|United States||Region of Enrollment||participants|Number|76|76.0||||||
3934317|NCT01393704|3756115|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3934318|NCT01393704|3756116|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3934319|NCT01393704|3756117|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3934320|NCT01393704|3756115|B3||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3934321|NCT01393704|3756116|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3934322|NCT01393704|3756117|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3934323|NCT01393704|3756115|B3|||Age||years|Mean|37.49|37.49|Standard Deviation|6.39|6.39|||
3934324|NCT01393704|3756116|B2|||Age||years|Mean|37.87|37.87|Standard Deviation|7.11|7.11|||
3934325|NCT01393704|3756117|B1|||Age||years|Mean|37.39|37.39|Standard Deviation|5.68|5.68|||
3934326|NCT01393704|3756115|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3934327|NCT01393704|3756116|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3934328|NCT01393704|3756117|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3934329|NCT01393704|3756115|B3||Between 18 and 65 years|Age||Participants|Count of Participants|152|152.0||||||
3934330|NCT01393704|3756116|B2||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
3934331|NCT01393704|3756117|B1||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
3934332|NCT01393704|3756115|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3934333|NCT01393704|3756116|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3934334|NCT01393704|3756117|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3934335|NCT01393626|3756132|B5||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3934336|NCT01393626|3756133|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3934337|NCT01393626|3756134|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3934338|NCT01393626|3756135|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3934339|NCT01393626|3756136|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3934340|NCT01393626|3756132|B5||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3934341|NCT01393626|3756133|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3934342|NCT01393626|3756134|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3934343|NCT01393626|3756135|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3934344|NCT01393626|3756136|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3934345|NCT01393626|3756132|B5|||Age||Years|Mean|39.0|39.0|Standard Deviation|12.4|12.4|||
3934346|NCT01393626|3756133|B4|||Age||Years|Mean|41.3|41.3|Standard Deviation|14.3|14.3|||
3934347|NCT01393626|3756134|B3|||Age||Years|Mean|39.3|39.3|Standard Deviation|13.7|13.7|||
3934348|NCT01393626|3756135|B2|||Age||Years|Mean|40.2|40.2|Standard Deviation|11.5|11.5|||
3934349|NCT01393626|3756136|B1|||Age||Years|Mean|37.2|37.2|Standard Deviation|11.7|11.7|||
3934350|NCT01393613|3756215|B5||Male|Sex: Female, Male||Participants|Count of Participants|423|423.0||||||
3934351|NCT01393613|3756216|B4||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3934352|NCT01393613|3756217|B3||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3934353|NCT01393613|3756218|B2||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3934354|NCT01393613|3756219|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3934355|NCT01393613|3756215|B5||Female|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
3934356|NCT01393613|3756216|B4||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3934357|NCT01393613|3756217|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3934358|NCT01393613|3756218|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3934359|NCT01393613|3756219|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3934360|NCT01393613|3756215|B5|||Age||Years|Mean|38.4|38.4|Standard Deviation|11.1|11.1|||
3934361|NCT01393613|3756216|B4|||Age||Years|Mean|39.3|39.3|Standard Deviation|10.8|10.8|||
3934362|NCT01393613|3756217|B3|||Age||Years|Mean|38.6|38.6|Standard Deviation|11.0|11.0|||
3934363|NCT01393613|3756218|B2|||Age||Years|Mean|36.9|36.9|Standard Deviation|10.9|10.9|||
3934364|NCT01393613|3756219|B1|||Age||Years|Mean|39.1|39.1|Standard Deviation|11.9|11.9|||
3934365|NCT01393600|3756284|B1|||Age at TD Diagnosis||years|Mean|41.7|41.7|Full Range|||18.0|63.0|
3934366|NCT01393600|3756284|B1|||Age of Schizophrenia/Schizoaffective Disorder Diagnosis||years|Mean|25.8|25.8|Full Range|||8.0|54.0|
3934367|NCT01393600|3756284|B1|||Body Mass Index||kg/m^2|Mean|29.9|29.9|Full Range|||18.1|42.0|
3934368|NCT01393600|3756284|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3934369|NCT01393600|3756284|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3934370|NCT01393600|3756284|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3934371|NCT01393600|3756284|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3934372|NCT01393600|3756284|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3934373|NCT01393600|3756284|B1|||Age||years|Mean|51.1|51.1|Full Range|||29.0|65.0|
3934374|NCT01393457|3756302|B5|||Number of days of cocaine use over the last 30 days||days|Mean|16.13|16.13|Standard Deviation|8.65|8.65|||
3934375|NCT01393457|3756303|B4|||Number of days of cocaine use over the last 30 days||days|Mean|14.74|14.74|Standard Deviation|8.69|8.69|||
3934376|NCT01393457|3756304|B3|||Number of days of cocaine use over the last 30 days||days|Mean|17.19|17.19|Standard Deviation|8.46|8.46|||
3934377|NCT01393457|3756305|B2|||Number of days of cocaine use over the last 30 days||days|Mean|16.31|16.31|Standard Deviation|9.64|9.64|||
3934378|NCT01393457|3756306|B1|||Number of days of cocaine use over the last 30 days||days|Mean|16.12|16.12|Standard Deviation|8.08|8.08|||
3934379|NCT01393457|3756302|B5|United States||Region of Enrollment||Participants|Count of Participants|110|110.0||||||
3934380|NCT01393457|3756303|B4|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3934381|NCT01393457|3756304|B3|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3934382|NCT01393457|3756305|B2|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3934383|NCT01393457|3756306|B1|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3934384|NCT01393457|3756302|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3934385|NCT01393457|3756303|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3934386|NCT01393457|3756304|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3934387|NCT01393457|3756305|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3934388|NCT01393457|3756306|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3934389|NCT01393457|3756302|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3934390|NCT01393457|3756303|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3934391|NCT01393457|3756304|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934392|NCT01393457|3756305|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934393|NCT01393457|3756306|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3934394|NCT01393457|3756302|B5||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3934395|NCT01393457|3756303|B4||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3934396|NCT01393457|3756304|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3934397|NCT01393457|3756305|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3934398|NCT01393457|3756306|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3934399|NCT01393457|3756302|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3934400|NCT01393457|3756303|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3934401|NCT01393457|3756304|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3934402|NCT01393457|3756305|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3934403|NCT01393457|3756306|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3934404|NCT01393457|3756302|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934405|NCT01393457|3756303|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934406|NCT01393457|3756304|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934407|NCT01393457|3756305|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934408|NCT01393457|3756306|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934409|NCT01393457|3756302|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934410|NCT01393457|3756303|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934411|NCT01393457|3756304|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934412|NCT01393457|3756305|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934413|NCT01393457|3756306|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934414|NCT01393457|3756302|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934415|NCT01393457|3756303|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934416|NCT01393457|3756304|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934417|NCT01393457|3756305|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934418|NCT01393457|3756306|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934419|NCT01393457|3756302|B5||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3934420|NCT01393457|3756303|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3934421|NCT01393457|3756304|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3934422|NCT01393457|3756305|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3934423|NCT01393457|3756306|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3934424|NCT01393457|3756302|B5||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3934425|NCT01393457|3756303|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3934426|NCT01393457|3756304|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3934427|NCT01393457|3756305|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3934428|NCT01393457|3756306|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3934429|NCT01393457|3756302|B5|||Age||years|Mean|46.6|46.6|Standard Deviation|7.93|7.93|||
3934430|NCT01393457|3756303|B4|||Age||years|Mean|47.11|47.11|Standard Deviation|8.56|8.56|||
3934431|NCT01393457|3756304|B3|||Age||years|Mean|48|48.0|Standard Deviation|7.87|7.87|||
3934432|NCT01393457|3756305|B2|||Age||years|Mean|46.04|46.04|Standard Deviation|8.70|8.7|||
3934433|NCT01393457|3756306|B1|||Age||years|Mean|44.96|44.96|Standard Deviation|6.50|6.5|||
3934434|NCT01393444|3756323|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3934435|NCT01393444|3756323|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3934436|NCT01393444|3756323|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3934437|NCT01393444|3756323|B1|||Age||years|Mean|39|39.0|Full Range|||20.0|54.0|
3934438|NCT01393444|3756323|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3934439|NCT01393444|3756323|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3934440|NCT01393444|3756323|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3934441|NCT01393405|3756328|B1||Pancolitis|Site of disease||Participants|Count of Participants|93|93.0||||||
3934442|NCT01393405|3756328|B1||Left colon|Site of disease||Participants|Count of Participants|86|86.0||||||
3934443|NCT01393405|3756328|B1|||Calprotectin week 0 (Induction period) or week 16 (Maintenance period)||mg/kg|Mean|612|612.0|Standard Deviation|524|524.0|||
3934444|NCT01393405|3756328|B1|United States||Region of Enrollment||Participants|Count of Participants|179|179.0||||||
3934445|NCT01393405|3756328|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3934446|NCT01393405|3756328|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934447|NCT01393405|3756328|B1||White|Race (NIH/OMB)||Participants|Count of Participants|155|155.0||||||
3934448|NCT01393405|3756328|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3934449|NCT01393405|3756328|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934450|NCT01393405|3756328|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3934451|NCT01393405|3756328|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934452|NCT01393405|3756328|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934453|NCT01393405|3756328|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|169|169.0||||||
3934454|NCT01393405|3756328|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3934455|NCT01393405|3756328|B1||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3934456|NCT01393405|3756328|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3934457|NCT01393405|3756328|B1|||Age||years|Mean|42|42.0|Full Range|||19.0|74.0|
3934458|NCT01393392|3756347|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3934459|NCT01393392|3756348|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3934460|NCT01393392|3756349|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934461|NCT01393392|3756347|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934462|NCT01393392|3756348|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934463|NCT01393392|3756349|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934464|NCT01393392|3756347|B3||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3934465|NCT01393392|3756348|B2||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3934466|NCT01393392|3756349|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3934467|NCT01393392|3756347|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3934468|NCT01393392|3756348|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3934469|NCT01393392|3756349|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3934470|NCT01393392|3756347|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934471|NCT01393392|3756348|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934472|NCT01393392|3756349|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934473|NCT01393392|3756347|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934474|NCT01393392|3756348|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934475|NCT01393392|3756349|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934476|NCT01393392|3756347|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934477|NCT01393392|3756348|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934478|NCT01393392|3756349|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934479|NCT01393392|3756347|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934480|NCT01393392|3756348|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934481|NCT01393392|3756349|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934482|NCT01393392|3756347|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3934483|NCT01393392|3756348|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3934484|NCT01393392|3756349|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3934485|NCT01393392|3756347|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3934486|NCT01393392|3756348|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3934487|NCT01393392|3756349|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3934488|NCT01393392|3756347|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3934489|NCT01393392|3756348|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3934490|NCT01393392|3756349|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3934491|NCT01393392|3756347|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3934492|NCT01393392|3756348|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3934493|NCT01393392|3756349|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3934494|NCT01393392|3756347|B3|||Age||years|Mean|43|43.0|Standard Deviation|10|10.0|||
3934495|NCT01393392|3756348|B2|||Age||years|Mean|42|42.0|Standard Deviation|10|10.0|||
3934496|NCT01393392|3756349|B1|||Age||years|Mean|44|44.0|Standard Deviation|11|11.0|||
3934497|NCT01393132|3756366|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
3934498|NCT01393132|3756367|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3934499|NCT01393132|3756368|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3934500|NCT01393132|3756366|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3934501|NCT01393132|3756367|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3934502|NCT01393132|3756368|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3934503|NCT01393132|3756366|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3934504|NCT01393132|3756367|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3934505|NCT01393132|3756368|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3934506|NCT01393132|3756366|B3|||Age||Years|Mean|57.33|57.33|Standard Deviation|11.18|11.18|||
3934507|NCT01393132|3756367|B2|||Age||Years|Mean|63.7|63.7|Standard Deviation|6.65|6.65|||
3934508|NCT01393132|3756368|B1|||Age||Years|Mean|54.2|54.2|Standard Deviation|11.6|11.6|||
3934509|NCT01393132|3756366|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3934510|NCT01393132|3756367|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3934511|NCT01393132|3756368|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3934512|NCT01393132|3756366|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3934513|NCT01393132|3756367|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3934514|NCT01393132|3756368|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3934515|NCT01393132|3756366|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3934516|NCT01393132|3756367|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3934517|NCT01393132|3756368|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3934518|NCT01393106|3756381|B1|||Karnofsky Performance Status|Classifies patients according to their functional impairment. Scores range from 0-100; the lower the score, the worse the survival for most serious illnesses.|units on a scale|Mean|83|83.0|Standard Deviation|7.1|7.1|||
3934519|NCT01393106|3756381|B1|Stage IV||Disease Stage at Screening|"Disease stage was based on the Ann Arbor Lymphoma Staging System:~Stage I: Single lymph node group or lymph node region; Stage II: Two or more node regions on same side of diaphragm; Stage III: Lymph node regions on both sides of the diaphragm; Stage IV: Multiple extranodal sites or lymph nodes and extranodal sites"|participants|Number|10|10.0||||||
3934520|NCT01393106|3756381|B1|Stage III||Disease Stage at Screening|"Disease stage was based on the Ann Arbor Lymphoma Staging System:~Stage I: Single lymph node group or lymph node region; Stage II: Two or more node regions on same side of diaphragm; Stage III: Lymph node regions on both sides of the diaphragm; Stage IV: Multiple extranodal sites or lymph nodes and extranodal sites"|participants|Number|6|6.0||||||
3934521|NCT01393106|3756381|B1|Stage II||Disease Stage at Screening|"Disease stage was based on the Ann Arbor Lymphoma Staging System:~Stage I: Single lymph node group or lymph node region; Stage II: Two or more node regions on same side of diaphragm; Stage III: Lymph node regions on both sides of the diaphragm; Stage IV: Multiple extranodal sites or lymph nodes and extranodal sites"|participants|Number|8|8.0||||||
3934522|NCT01393106|3756381|B1|Stage I||Disease Stage at Screening|"Disease stage was based on the Ann Arbor Lymphoma Staging System:~Stage I: Single lymph node group or lymph node region; Stage II: Two or more node regions on same side of diaphragm; Stage III: Lymph node regions on both sides of the diaphragm; Stage IV: Multiple extranodal sites or lymph nodes and extranodal sites"|participants|Number|1|1.0||||||
3934523|NCT01393106|3756381|B1|Lymphocyte Rich||Classical Hodgkin Lymphoma Pathologic Subtype||participants|Number|2|2.0||||||
3934524|NCT01393106|3756381|B1|Nodular Sclerosis||Classical Hodgkin Lymphoma Pathologic Subtype||participants|Number|23|23.0||||||
3934525|NCT01393106|3756381|B1|||Time Since Diagnosis (years)||years|Mean|3.9|3.9|Standard Deviation|4.26|4.26|||
3934526|NCT01393106|3756381|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3934527|NCT01393106|3756381|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3934528|NCT01393106|3756381|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3934529|NCT01393106|3756381|B1|White||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3934530|NCT01393106|3756381|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3934531|NCT01393106|3756381|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3934532|NCT01393106|3756381|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3934533|NCT01393106|3756381|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3934534|NCT01393106|3756381|B1|||Age||years|Mean|43|43.0|Standard Deviation|16.1|16.1|||
3934535|NCT01392963|3756398|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3934536|NCT01392963|3756398|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3934537|NCT01392963|3756399|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3934538|NCT01392963|3756400|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3934539|NCT01392963|3756398|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3934540|NCT01392963|3756399|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3934541|NCT01392963|3756400|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3934542|NCT01392963|3756398|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3934543|NCT01392963|3756399|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3934544|NCT01392963|3756400|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3934545|NCT01392963|3756398|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3934546|NCT01392963|3756399|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3934547|NCT01392963|3756400|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3934548|NCT01392963|3756398|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3934549|NCT01392963|3756399|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3934550|NCT01392963|3756400|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3934551|NCT01392742|3756409|B1||Male|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
3934552|NCT01392742|3756409|B1||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3934553|NCT01392742|3756409|B1|||Age||years|Mean|40.61|40.61|Standard Deviation|12.32|12.32|||
3934554|NCT01392703|3756424|B1|Not Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|39|39.0||||||
3934555|NCT01392703|3756424|B1|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|39|39.0||||||
3934556|NCT01392703|3756424|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3934557|NCT01392703|3756424|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3934558|NCT01392703|3756424|B1|Younger than 65 years||Age, Customized||Participants|Number|78|78.0||||||
3934559|NCT01392703|3756424|B1|||Age||years|Mean|36.5|36.5|Standard Deviation|8.75|8.75|||
3934560|NCT01392677|3756453|B3|||Fasting C-Peptide||ng/mL|Mean|2.5|2.5|Standard Deviation|1.02|1.02|||
3934561|NCT01392677|3756454|B2|||Fasting C-Peptide||ng/mL|Mean|2.5|2.5|Standard Deviation|1.06|1.06|||
3934562|NCT01392677|3756455|B1|||Fasting C-Peptide||ng/mL|Mean|2.5|2.5|Standard Deviation|0.98|0.98|||
3934563|NCT01392677|3756453|B3|||Fasting Plasma Glucose||mg/dL|Mean|173.8|173.8|Standard Deviation|43.61|43.61|||
3934564|NCT01392677|3756454|B2|||Fasting Plasma Glucose||mg/dL|Mean|167.4|167.4|Standard Deviation|43.32|43.32|||
3934565|NCT01392677|3756455|B1|||Fasting Plasma Glucose||mg/dL|Mean|180.2|180.2|Standard Deviation|43.13|43.13|||
3934566|NCT01392677|3756453|B3|||Glycosylated hemoglobin A1c (HbA1c)||Percent|Mean|8.16|8.16|Standard Deviation|0.890|0.89|||
3934567|NCT01392677|3756454|B2|||Glycosylated hemoglobin A1c (HbA1c)||Percent|Mean|8.08|8.08|Standard Deviation|0.912|0.912|||
3934568|NCT01392677|3756455|B1|||Glycosylated hemoglobin A1c (HbA1c)||Percent|Mean|8.24|8.24|Standard Deviation|0.865|0.865|||
3934569|NCT01392677|3756453|B3|||Body Mass Index||kg/m^2|Mean|31.97|31.97|Standard Deviation|4.702|4.702|||
3934570|NCT01392677|3756454|B2|||Body Mass Index||kg/m^2|Mean|31.93|31.93|Standard Deviation|4.840|4.84|||
3934571|NCT01392677|3756455|B1|||Body Mass Index||kg/m^2|Mean|32.02|32.02|Standard Deviation|4.581|4.581|||
3934572|NCT01392677|3756453|B3|||Body Weight||kg|Mean|89.32|89.32|Standard Deviation|16.872|16.872|||
3934573|NCT01392677|3756454|B2|||Body Weight||kg|Mean|88.57|88.57|Standard Deviation|17.584|17.584|||
3934574|NCT01392677|3756455|B1|||Body Weight||kg|Mean|90.07|90.07|Standard Deviation|16.175|16.175|||
3934575|NCT01392677|3756453|B3|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3934576|NCT01392677|3756454|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3934577|NCT01392677|3756455|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3934578|NCT01392677|3756453|B3|Asian||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3934579|NCT01392677|3756454|B2|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3934580|NCT01392677|3756455|B1|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3934581|NCT01392677|3756453|B3|Black/African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3934582|NCT01392677|3756454|B2|Black/African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3934583|NCT01392677|3756455|B1|Black/African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3934584|NCT01392677|3756453|B3|White||Race/Ethnicity, Customized||Participants|Number|206|206.0||||||
3934585|NCT01392677|3756454|B2|White||Race/Ethnicity, Customized||Participants|Number|104|104.0||||||
3934586|NCT01392677|3756455|B1|White||Race/Ethnicity, Customized||Participants|Number|102|102.0||||||
3934587|NCT01392677|3756453|B3||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3934588|NCT01392677|3756454|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3934589|NCT01392677|3756455|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3934590|NCT01392677|3756453|B3||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3934591|NCT01392677|3756454|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3934592|NCT01392677|3756455|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3934593|NCT01392677|3756453|B3|||Age||Years|Mean|61.0|61.0|Standard Deviation|9.42|9.42|||
3934594|NCT01392677|3756454|B2|||Age||Years|Mean|61.1|61.1|Standard Deviation|9.65|9.65|||
3934595|NCT01392677|3756455|B1|||Age||Years|Mean|60.9|60.9|Standard Deviation|9.24|9.24|||
3934596|NCT01392625|3756470|B3||Class IV -Inability to carry on physical activity|New York Heart Association Class||Participants|Count of Participants|0|0.0||||||
3934597|NCT01392625|3756471|B2||Class IV -Inability to carry on physical activity|New York Heart Association Class||Participants|Count of Participants|0|0.0||||||
3934598|NCT01392625|3756472|B1||Class IV -Inability to carry on physical activity|New York Heart Association Class||Participants|Count of Participants|0|0.0||||||
3934599|NCT01392625|3756470|B3||Class III - Marked Limitation of Physical Activity|New York Heart Association Class||Participants|Count of Participants|7|7.0||||||
3934600|NCT01392625|3756471|B2||Class III - Marked Limitation of Physical Activity|New York Heart Association Class||Participants|Count of Participants|5|5.0||||||
3934601|NCT01392625|3756472|B1||Class III - Marked Limitation of Physical Activity|New York Heart Association Class||Participants|Count of Participants|2|2.0||||||
3934602|NCT01392625|3756470|B3||Class II - Slight Limitation of Physical Activity|New York Heart Association Class||Participants|Count of Participants|17|17.0||||||
3934603|NCT01392625|3756471|B2||Class II - Slight Limitation of Physical Activity|New York Heart Association Class||Participants|Count of Participants|9|9.0||||||
3934604|NCT01392625|3756472|B1||Class II - Slight Limitation of Physical Activity|New York Heart Association Class||Participants|Count of Participants|8|8.0||||||
3934605|NCT01392625|3756470|B3||Class I - no limitation|New York Heart Association Class||Participants|Count of Participants|10|10.0||||||
3934606|NCT01392625|3756471|B2||Class I - no limitation|New York Heart Association Class||Participants|Count of Participants|4|4.0||||||
3934607|NCT01392625|3756472|B1||Class I - no limitation|New York Heart Association Class||Participants|Count of Participants|6|6.0||||||
3934608|NCT01392625|3756470|B3|||Enrollment End Diastolic diameter (CM)||centimeters|Mean|7.1|7.1|Standard Deviation|1.4|1.4|||
3934609|NCT01392625|3756471|B2|||Enrollment End Diastolic diameter (CM)||centimeters|Mean|7.2|7.2|Standard Deviation|1.2|1.2|||
3934610|NCT01392625|3756472|B1|||Enrollment End Diastolic diameter (CM)||centimeters|Mean|7.0|7.0|Standard Deviation|1.6|1.6|||
3934611|NCT01392625|3756470|B3|||Participants Ejection Fraction % in the trial||percentage|Mean|22.1|22.1|Standard Deviation|6.3|6.3|||
3934612|NCT01392625|3756471|B2|||Participants Ejection Fraction % in the trial||percentage|Mean|22.5|22.5|Standard Deviation|6.5|6.5|||
3934613|NCT01392625|3756472|B1|||Participants Ejection Fraction % in the trial||percentage|Mean|21.7|21.7|Standard Deviation|6.2|6.2|||
3934614|NCT01392625|3756470|B3|Yes||Participants Injection status in the trial||Participants|Count of Participants|34|34.0||||||
3934615|NCT01392625|3756471|B2|Yes||Participants Injection status in the trial||Participants|Count of Participants|18|18.0||||||
3934616|NCT01392625|3756472|B1|Yes||Participants Injection status in the trial||Participants|Count of Participants|16|16.0||||||
3934617|NCT01392625|3756470|B3|No||Participants Injection status in the trial||Participants|Count of Participants|3|3.0||||||
3934618|NCT01392625|3756471|B2|No||Participants Injection status in the trial||Participants|Count of Participants|1|1.0||||||
3934619|NCT01392625|3756472|B1|No||Participants Injection status in the trial||Participants|Count of Participants|2|2.0||||||
3934620|NCT01392625|3756470|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3934621|NCT01392625|3756471|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934622|NCT01392625|3756472|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3934623|NCT01392625|3756470|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934624|NCT01392625|3756471|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934625|NCT01392625|3756472|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934626|NCT01392625|3756470|B3||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3934627|NCT01392625|3756471|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3934628|NCT01392625|3756472|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3934629|NCT01392625|3756470|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3934630|NCT01392625|3756471|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3934631|NCT01392625|3756472|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3934632|NCT01392625|3756470|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934633|NCT01392625|3756471|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934634|NCT01392625|3756472|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934635|NCT01392625|3756470|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934636|NCT01392625|3756471|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934637|NCT01392625|3756472|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934638|NCT01392625|3756470|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934639|NCT01392625|3756471|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934640|NCT01392625|3756472|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934641|NCT01392625|3756470|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934642|NCT01392625|3756471|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934643|NCT01392625|3756472|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934644|NCT01392625|3756470|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3934645|NCT01392625|3756471|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3934646|NCT01392625|3756472|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3934647|NCT01392625|3756470|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3934648|NCT01392625|3756471|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3934649|NCT01392625|3756472|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3934650|NCT01392625|3756470|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3934651|NCT01392625|3756471|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3934652|NCT01392625|3756472|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3934653|NCT01392625|3756470|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3934654|NCT01392625|3756471|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3934655|NCT01392625|3756472|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3934656|NCT01392625|3756470|B3|||Age||years|Mean|55.8|55.8|Standard Deviation|11.2|11.2|||
3934657|NCT01392625|3756471|B2|||Age||years|Mean|54.4|54.4|Standard Deviation|11.5|11.5|||
3934658|NCT01392625|3756472|B1|||Age||years|Mean|57.4|57.4|Standard Deviation|11.0|11.0|||
3934659|NCT01392573|3756489|B3|||Body Weight||kg|Mean|94.5|94.5|Standard Deviation|19.7|19.7|||
3934660|NCT01392573|3756490|B2|||Body Weight||kg|Mean|93.5|93.5|Standard Deviation|20.0|20.0|||
3934661|NCT01392573|3756491|B1|||Body Weight||kg|Mean|95.4|95.4|Standard Deviation|19.4|19.4|||
3934662|NCT01392573|3756489|B3|||HbA1c (glycosylated haemoglobin)||percentage of glycosylated haemoglobin|Mean|8.8|8.8|Standard Deviation|0.7|0.7|||
3934663|NCT01392573|3756490|B2|||HbA1c (glycosylated haemoglobin)||percentage of glycosylated haemoglobin|Mean|8.8|8.8|Standard Deviation|0.7|0.7|||
3934664|NCT01392573|3756491|B1|||HbA1c (glycosylated haemoglobin)||percentage of glycosylated haemoglobin|Mean|8.7|8.7|Standard Deviation|0.7|0.7|||
3934665|NCT01392573|3756489|B3||Male|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
3934666|NCT01392573|3756490|B2||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3934667|NCT01392573|3756491|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3934668|NCT01392573|3756489|B3||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3934669|NCT01392573|3756490|B2||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3934670|NCT01392573|3756491|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3934671|NCT01392573|3756489|B3|||Age||years|Mean|57.2|57.2|Standard Deviation|9.7|9.7|||
3934672|NCT01392573|3756490|B2|||Age||years|Mean|57.5|57.5|Standard Deviation|10.5|10.5|||
3934673|NCT01392573|3756491|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|8.9|8.9|||
3934674|NCT01392560|3756500|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3934675|NCT01392560|3756500|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3934676|NCT01392560|3756500|B1|||Age||years|Mean|24.1|24.1|Standard Deviation|5.0|5.0|||
3934677|NCT01392547|3756506|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3934678|NCT01392547|3756506|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3934679|NCT01392547|3756506|B1|||Age||years|Mean|30.19|30.19|Standard Deviation|13.84|13.84|||
3934680|NCT01392495|3756520|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3934681|NCT01392495|3756520|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3934682|NCT01392495|3756520|B1|||Age||Years|Mean|53.5|53.5|Standard Deviation|14.3|14.3|||
3934683|NCT01392378|3756532|B6||Male|Sex: Female, Male||Participants|Count of Participants|480|480.0||||||
3934684|NCT01392378|3756533|B5||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3934685|NCT01392378|3756534|B4||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3934686|NCT01392378|3756535|B3||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3934687|NCT01392378|3756536|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3934688|NCT01392378|3756537|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3934689|NCT01392378|3756532|B6||Female|Sex: Female, Male||Participants|Count of Participants|428|428.0||||||
3934690|NCT01392378|3756533|B5||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3934691|NCT01392378|3756534|B4||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3934692|NCT01392378|3756535|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3934693|NCT01392378|3756536|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3934694|NCT01392378|3756537|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3934695|NCT01392378|3756532|B6|||Age||days|Mean|65.8|65.8|Standard Deviation|9.8|9.8|||
3934696|NCT01392378|3756533|B5|||Age||days|Mean|65.6|65.6|Standard Deviation|9.4|9.4|||
3934697|NCT01392378|3756534|B4|||Age||days|Mean|66.4|66.4|Standard Deviation|10.3|10.3|||
3934698|NCT01392378|3756535|B3|||Age||days|Mean|65.6|65.6|Standard Deviation|9.7|9.7|||
3934699|NCT01392378|3756536|B2|||Age||days|Mean|66.5|66.5|Standard Deviation|10.1|10.1|||
3934700|NCT01392378|3756537|B1|||Age||days|Mean|65.1|65.1|Standard Deviation|9.5|9.5|||
3934701|NCT01392326|3756678|B4||Male|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
3934702|NCT01392326|3756679|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3934703|NCT01392326|3756680|B2||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3934704|NCT01392326|3756681|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3934705|NCT01392326|3756678|B4||Female|Sex: Female, Male||Participants|Count of Participants|330|330.0||||||
3934706|NCT01392326|3756679|B3||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3934707|NCT01392326|3756680|B2||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3934708|NCT01392326|3756681|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3934709|NCT01392326|3756678|B4||>=65 years|Age||Participants|Count of Participants|54|54.0||||||
3934710|NCT01392326|3756679|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3934711|NCT01392326|3756680|B2||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3934712|NCT01392326|3756681|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3934713|NCT01392326|3756678|B4||Between 18 and 65 years|Age||Participants|Count of Participants|552|552.0||||||
3934714|NCT01392326|3756679|B3||Between 18 and 65 years|Age||Participants|Count of Participants|192|192.0||||||
3934715|NCT01392326|3756680|B2||Between 18 and 65 years|Age||Participants|Count of Participants|180|180.0||||||
3934716|NCT01392326|3756681|B1||Between 18 and 65 years|Age||Participants|Count of Participants|180|180.0||||||
3934717|NCT01392326|3756678|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3934718|NCT01392326|3756679|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3934719|NCT01392326|3756680|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3934720|NCT01392326|3756681|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3934721|NCT01392300|3756718|B3|India||Region of Enrollment||participants|Number|39|39.0||||||
3934722|NCT01392300|3756719|B2|India||Region of Enrollment||participants|Number|13|13.0||||||
3934723|NCT01392300|3756720|B1|India||Region of Enrollment||participants|Number|26|26.0||||||
3934724|NCT01392300|3756718|B3|Germany||Region of Enrollment||participants|Number|1|1.0||||||
3934725|NCT01392300|3756719|B2|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3934726|NCT01392300|3756720|B1|Germany||Region of Enrollment||participants|Number|1|1.0||||||
3934727|NCT01392300|3756718|B3|Russian Federation||Region of Enrollment||participants|Number|32|32.0||||||
3934728|NCT01392300|3756719|B2|Russian Federation||Region of Enrollment||participants|Number|10|10.0||||||
3934729|NCT01392300|3756720|B1|Russian Federation||Region of Enrollment||participants|Number|22|22.0||||||
3934730|NCT01392300|3756718|B3|Poland||Region of Enrollment||participants|Number|104|104.0||||||
3934731|NCT01392300|3756719|B2|Poland||Region of Enrollment||participants|Number|38|38.0||||||
3934732|NCT01392300|3756720|B1|Poland||Region of Enrollment||participants|Number|66|66.0||||||
3934733|NCT01392300|3756718|B3|Hungary||Region of Enrollment||participants|Number|32|32.0||||||
3934734|NCT01392300|3756719|B2|Hungary||Region of Enrollment||participants|Number|9|9.0||||||
3934735|NCT01392300|3756720|B1|Hungary||Region of Enrollment||participants|Number|23|23.0||||||
3934736|NCT01392300|3756718|B3|Czech Republic||Region of Enrollment||participants|Number|71|71.0||||||
3934737|NCT01392300|3756719|B2|Czech Republic||Region of Enrollment||participants|Number|25|25.0||||||
3934738|NCT01392300|3756720|B1|Czech Republic||Region of Enrollment||participants|Number|46|46.0||||||
3934739|NCT01392300|3756718|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
3934740|NCT01392300|3756719|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3934741|NCT01392300|3756720|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
3934742|NCT01392300|3756718|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3934743|NCT01392300|3756719|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934744|NCT01392300|3756720|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3934745|NCT01392300|3756718|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934746|NCT01392300|3756719|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934747|NCT01392300|3756720|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934748|NCT01392300|3756718|B3||White|Race (NIH/OMB)||Participants|Count of Participants|266|266.0||||||
3934749|NCT01392300|3756719|B2||White|Race (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3934750|NCT01392300|3756720|B1||White|Race (NIH/OMB)||Participants|Count of Participants|175|175.0||||||
3934751|NCT01392300|3756718|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3934752|NCT01392300|3756719|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3934753|NCT01392300|3756720|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3934754|NCT01392300|3756718|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3934755|NCT01392300|3756719|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934756|NCT01392300|3756720|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3934757|NCT01392300|3756718|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3934758|NCT01392300|3756719|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3934759|NCT01392300|3756720|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3934760|NCT01392300|3756718|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934761|NCT01392300|3756719|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934762|NCT01392300|3756720|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934763|NCT01392300|3756718|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|279|279.0||||||
3934764|NCT01392300|3756719|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3934765|NCT01392300|3756720|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|184|184.0||||||
3934766|NCT01392300|3756718|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3934767|NCT01392300|3756719|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3934768|NCT01392300|3756720|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3934769|NCT01392300|3756718|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3934770|NCT01392300|3756719|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934771|NCT01392300|3756720|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3934772|NCT01392300|3756718|B3||Male|Gender||Participants|Count of Participants|136|136.0||||||
3934773|NCT01392300|3756719|B2||Male|Gender||Participants|Count of Participants|46|46.0||||||
3934774|NCT01392300|3756720|B1||Male|Gender||Participants|Count of Participants|90|90.0||||||
3934775|NCT01392300|3756718|B3||Female|Gender||Participants|Count of Participants|181|181.0||||||
3934776|NCT01392300|3756719|B2||Female|Gender||Participants|Count of Participants|61|61.0||||||
3934777|NCT01392300|3756720|B1||Female|Gender||Participants|Count of Participants|120|120.0||||||
3934778|NCT01392300|3756718|B3|||Age||years|Mean|56.1|56.1|Standard Deviation|11.6|11.6|||
3934779|NCT01392300|3756719|B2|||Age||years|Mean|57.8|57.8|Standard Deviation|10.9|10.9|||
3934780|NCT01392300|3756720|B1|||Age||years|Mean|55.3|55.3|Standard Deviation|11.9|11.9|||
3934781|NCT01392170|3756827|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3934782|NCT01392170|3756827|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3934783|NCT01392170|3756827|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3934784|NCT01392170|3756827|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3934785|NCT01392170|3756827|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3934786|NCT01392170|3756827|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3934787|NCT01392053|3756831|B3|Brazil||Region of Enrollment||participants|Number|46|46.0||||||
3934788|NCT01392053|3756832|B2|Brazil||Region of Enrollment||participants|Number|23|23.0||||||
3934789|NCT01392053|3756833|B1|Brazil||Region of Enrollment||participants|Number|23|23.0||||||
3934790|NCT01392053|3756831|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3934791|NCT01392053|3756832|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3934792|NCT01392053|3756833|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3934793|NCT01392053|3756831|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3934794|NCT01392053|3756832|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3934795|NCT01392053|3756833|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3934796|NCT01392053|3756831|B3|||Age||years|Mean|19|19.0|Standard Deviation|3.5|3.5|||
3934797|NCT01392053|3756832|B2|||Age||years|Mean|19|19.0|Standard Deviation|3.2|3.2|||
3934798|NCT01392053|3756833|B1|||Age||years|Mean|19|19.0|Standard Deviation|3.7|3.7|||
3934799|NCT01392053|3756831|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3934800|NCT01392053|3756832|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3934801|NCT01392053|3756833|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3934802|NCT01392053|3756831|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3934803|NCT01392053|3756832|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3934804|NCT01392053|3756833|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3934805|NCT01392053|3756831|B3||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
3934806|NCT01392053|3756832|B2||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
3934807|NCT01392053|3756833|B1||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
3934808|NCT01391858|3756852|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
3934809|NCT01391858|3756853|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
3934810|NCT01391858|3756854|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
3934811|NCT01391858|3756852|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3934812|NCT01391858|3756853|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3934813|NCT01391858|3756854|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3934814|NCT01391858|3756852|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3934815|NCT01391858|3756853|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3934816|NCT01391858|3756854|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3934817|NCT01391858|3756852|B3|||Age||years|Mean|49|49.0|Standard Deviation|7|7.0|||
3934818|NCT01391858|3756853|B2|||Age||years|Mean|47|47.0|Standard Deviation|8|8.0|||
3934819|NCT01391858|3756854|B1|||Age||years|Mean|50|50.0|Standard Deviation|9|9.0|||
3934820|NCT01391819|3756875|B1||Male|Sex: Female, Male||Participants|Count of Participants|1020|1020.0||||||
3934821|NCT01391819|3756875|B1||Female|Sex: Female, Male||Participants|Count of Participants|1096|1096.0||||||
3934822|NCT01391819|3756875|B1|||Age||Years|Mean|8.997|8.997|Standard Deviation|2.4637|2.4637|||
3934823|NCT01391663|3756902|B5|||Body Mass Index (BMI)||kg/m2|Mean|21.59|21.59|Standard Deviation|1.94|1.94|||
3934824|NCT01391663|3756903|B4|||Body Mass Index (BMI)||kg/m2|Mean|21.00|21.0|Standard Deviation|1.525|1.525|||
3934825|NCT01391663|3756904|B3|||Body Mass Index (BMI)||kg/m2|Mean|21.53|21.53|Standard Deviation|2.41|2.41|||
3934826|NCT01391663|3756905|B2|||Body Mass Index (BMI)||kg/m2|Mean|21.67|21.67|Standard Deviation|2.31|2.31|||
3934827|NCT01391663|3756906|B1|||Body Mass Index (BMI)||kg/m2|Mean|22.17|22.17|Standard Deviation|1.35|1.35|||
3934828|NCT01391663|3756902|B5|||Weight||kg|Mean|63.10|63.1|Standard Deviation|9.34|9.34|||
3934829|NCT01391663|3756903|B4|||Weight||kg|Mean|60.85|60.85|Standard Deviation|8.891|8.891|||
3934830|NCT01391663|3756904|B3|||Weight||kg|Mean|62.84|62.84|Standard Deviation|9.78|9.78|||
3934831|NCT01391663|3756905|B2|||Weight||kg|Mean|63.37|63.37|Standard Deviation|10.49|10.49|||
3934832|NCT01391663|3756906|B1|||Weight||kg|Mean|65.33|65.33|Standard Deviation|8.76|8.76|||
3934833|NCT01391663|3756902|B5|||Height||cm|Mean|170.5|170.5|Standard Deviation|8.37|8.37|||
3934834|NCT01391663|3756903|B4|||Height||cm|Mean|168.9|168.9|Standard Deviation|8.11|8.11|||
3934835|NCT01391663|3756904|B3|||Height||cm|Mean|171.2|171.2|Standard Deviation|8.62|8.62|||
3934836|NCT01391663|3756905|B2|||Height||cm|Mean|170.3|170.3|Standard Deviation|8.52|8.52|||
3934837|NCT01391663|3756906|B1|||Height||cm|Mean|171.7|171.7|Standard Deviation|9.05|9.05|||
3934838|NCT01391663|3756902|B5|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3934839|NCT01391663|3756903|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3934840|NCT01391663|3756904|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3934841|NCT01391663|3756905|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3934842|NCT01391663|3756906|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3934843|NCT01391663|3756902|B5|Korean||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
3934844|NCT01391663|3756903|B4|Korean||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3934845|NCT01391663|3756904|B3|Korean||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3934846|NCT01391663|3756905|B2|Korean||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3934847|NCT01391663|3756906|B1|Korean||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3934848|NCT01391663|3756902|B5||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3934849|NCT01391663|3756903|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3934850|NCT01391663|3756904|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3934851|NCT01391663|3756905|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3934852|NCT01391663|3756906|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3934853|NCT01391663|3756902|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3934854|NCT01391663|3756903|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3934855|NCT01391663|3756904|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3934856|NCT01391663|3756905|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3934857|NCT01391663|3756906|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3934858|NCT01391663|3756902|B5|||Age||Years|Mean|25.3|25.3|Standard Deviation|4.97|4.97|||
3934859|NCT01391663|3756903|B4|||Age||Years|Mean|25.8|25.8|Standard Deviation|2.17|2.17|||
3934860|NCT01391663|3756904|B3|||Age||Years|Mean|25.3|25.3|Standard Deviation|7.88|7.88|||
3934861|NCT01391663|3756905|B2|||Age||Years|Mean|23.5|23.5|Standard Deviation|2.75|2.75|||
3934862|NCT01391663|3756906|B1|||Age||Years|Mean|26.6|26.6|Standard Deviation|5.05|5.05|||
3934863|NCT01391611|3756939|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3934864|NCT01391611|3756939|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3934865|NCT01391611|3756939|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934866|NCT01391611|3756939|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3934867|NCT01391611|3756939|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3934868|NCT01391611|3756939|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934869|NCT01391611|3756939|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3934870|NCT01391611|3756939|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3934871|NCT01391611|3756939|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3934872|NCT01391611|3756939|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3934873|NCT01391611|3756939|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3934874|NCT01391611|3756939|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3934875|NCT01391611|3756939|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3934876|NCT01391611|3756939|B1|||Age||years|Median|59|59.0|Full Range|||27.0|72.0|
3934877|NCT01391559|3756944|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3934878|NCT01391559|3756944|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3934879|NCT01391559|3756944|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3934880|NCT01391559|3756944|B1|||Age||years|Mean|71|71.0|Standard Deviation|7|7.0|||
3934881|NCT01391559|3756944|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3934882|NCT01391559|3756944|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3934883|NCT01391559|3756944|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3934884|NCT01391546|3756951|B3|||Age at Vaccination|Age of all vaccinated participants at Day 0 (time of vaccination)|Years of Age|Mean|62.6|62.6|Standard Deviation|8.4|8.4|||
3934885|NCT01391546|3756952|B2|||Age at Vaccination|Age of all vaccinated participants at Day 0 (time of vaccination)|Years of Age|Mean|62.6|62.6|Standard Deviation|8.5|8.5|||
3934886|NCT01391546|3756953|B1|||Age at Vaccination|Age of all vaccinated participants at Day 0 (time of vaccination)|Years of Age|Mean|62.6|62.6|Standard Deviation|8.3|8.3|||
3934887|NCT01391546|3756951|B3||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
3934888|NCT01391546|3756952|B2||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3934889|NCT01391546|3756953|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3934890|NCT01391546|3756951|B3||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
3934891|NCT01391546|3756952|B2||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3934892|NCT01391546|3756953|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3934893|NCT01391546|3756951|B3|≥70 years of age||Age, Customized||Participants|Number|80|80.0||||||
3934894|NCT01391546|3756952|B2|≥70 years of age||Age, Customized||Participants|Number|40|40.0||||||
3934895|NCT01391546|3756953|B1|≥70 years of age||Age, Customized||Participants|Number|40|40.0||||||
3934896|NCT01391546|3756951|B3|60-69 years of age||Age, Customized||Participants|Number|111|111.0||||||
3934897|NCT01391546|3756952|B2|60-69 years of age||Age, Customized||Participants|Number|55|55.0||||||
3934898|NCT01391546|3756953|B1|60-69 years of age||Age, Customized||Participants|Number|56|56.0||||||
3934899|NCT01391546|3756951|B3|50-59 years of age||Age, Customized||Participants|Number|163|163.0||||||
3934900|NCT01391546|3756952|B2|50-59 years of age||Age, Customized||Participants|Number|82|82.0||||||
3934901|NCT01391546|3756953|B1|50-59 years of age||Age, Customized||Participants|Number|81|81.0||||||
3934902|NCT01391507|3756972|B5|Germany||Region of Enrollment||participants|Number|36|36.0||||||
3934903|NCT01391507|3756973|B4|Germany||Region of Enrollment||participants|Number|12|12.0||||||
3934904|NCT01391507|3756974|B3|Germany||Region of Enrollment||participants|Number|6|6.0||||||
3934905|NCT01391507|3756975|B2|Germany||Region of Enrollment||participants|Number|8|8.0||||||
3934906|NCT01391507|3756976|B1|Germany||Region of Enrollment||participants|Number|10|10.0||||||
3934907|NCT01391507|3756972|B5||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3934908|NCT01391507|3756973|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3934909|NCT01391507|3756974|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3934910|NCT01391507|3756975|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3934911|NCT01391507|3756976|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3934912|NCT01391507|3756972|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3934913|NCT01391507|3756973|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3934914|NCT01391507|3756974|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3934915|NCT01391507|3756975|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3934916|NCT01391507|3756976|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3934917|NCT01391507|3756972|B5|||Age||years|Mean|59.6|59.6|Standard Deviation|10.97|10.97|||
3934918|NCT01391507|3756973|B4|||Age||years|Mean|59.8|59.8|Standard Deviation|11.88|11.88|||
3934919|NCT01391507|3756974|B3|||Age||years|Mean|62|62.0|Standard Deviation|13.59|13.59|||
3934920|NCT01391507|3756975|B2|||Age||years|Mean|57.5|57.5|Standard Deviation|10.92|10.92|||
3934921|NCT01391507|3756976|B1|||Age||years|Mean|59.4|59.4|Standard Deviation|9.61|9.61|||
3934922|NCT01391468|3757025|B3|||IL-6|inflammatory cytokine|pg/ml|Mean|5.90|5.9|Standard Deviation|11.71|11.71|||
3934923|NCT01391468|3757026|B2|||IL-6|inflammatory cytokine|pg/ml|Mean|6.55|6.55|Standard Deviation|10.72|10.72|||
3934924|NCT01391468|3757027|B1|||IL-6|inflammatory cytokine|pg/ml|Mean|5.27|5.27|Standard Deviation|12.78|12.78|||
3934925|NCT01391468|3757025|B3|Taiwan||Region of Enrollment||participants|Number|47|47.0||||||
3934926|NCT01391468|3757026|B2|Taiwan||Region of Enrollment||participants|Number|23|23.0||||||
3934927|NCT01391468|3757027|B1|Taiwan||Region of Enrollment||participants|Number|24|24.0||||||
3934928|NCT01391468|3757025|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3934929|NCT01391468|3757026|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3934930|NCT01391468|3757027|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3934931|NCT01391468|3757025|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3934932|NCT01391468|3757026|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3934933|NCT01391468|3757027|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3934934|NCT01391468|3757025|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3934935|NCT01391468|3757026|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3934936|NCT01391468|3757027|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3934937|NCT01391468|3757025|B3||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3934938|NCT01391468|3757026|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3934939|NCT01391468|3757027|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3934940|NCT01391468|3757025|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3934941|NCT01391468|3757026|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3934942|NCT01391468|3757027|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3934943|NCT01391325|3757040|B1|New Zealand||Region of Enrollment||participants|Number|84|84.0||||||
3934944|NCT01391325|3757040|B1|Germany||Region of Enrollment||participants|Number|14|14.0||||||
3934945|NCT01391325|3757040|B1|South Africa||Region of Enrollment||participants|Number|242|242.0||||||
3934946|NCT01391325|3757040|B1|Australia||Region of Enrollment||participants|Number|104|104.0||||||
3934947|NCT01391325|3757040|B1|Belgium||Region of Enrollment||participants|Number|11|11.0||||||
3934948|NCT01391325|3757040|B1|Canada||Region of Enrollment||participants|Number|74|74.0||||||
3934949|NCT01391325|3757040|B1|United States||Region of Enrollment||participants|Number|1203|1203.0||||||
3934950|NCT01391325|3757040|B1||Male|Sex: Female, Male||Participants|Count of Participants|1614|1614.0||||||
3934951|NCT01391325|3757040|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3934952|NCT01391325|3757040|B1||>=65 years|Age||Participants|Count of Participants|249|249.0||||||
3934953|NCT01391325|3757040|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1483|1483.0||||||
3934954|NCT01391325|3757040|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3934955|NCT01391325|3757040|B1|||Age|Age in years at enrollment.|years|Mean|51.4|51.4|Standard Deviation|11.93|11.93|||
3934956|NCT01391312|3757047|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3934957|NCT01391312|3757048|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3934958|NCT01391312|3757049|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3934959|NCT01391312|3757047|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3934960|NCT01391312|3757048|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3934961|NCT01391312|3757049|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3934962|NCT01391312|3757047|B3|||Age||Years|Mean|50.4|50.4|Standard Deviation|11.0|11.0|||
3934963|NCT01391312|3757048|B2|||Age||Years|Mean|54.5|54.5|Standard Deviation|7.1|7.1|||
3934964|NCT01391312|3757049|B1|||Age||Years|Mean|46.3|46.3|Standard Deviation|12.8|12.8|||
3934965|NCT01391299|3757060|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3934966|NCT01391299|3757061|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3934967|NCT01391299|3757062|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3934968|NCT01391299|3757063|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3934969|NCT01391299|3757060|B4||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3934970|NCT01391299|3757061|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3934971|NCT01391299|3757062|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3934972|NCT01391299|3757063|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3934973|NCT01391299|3757060|B4|>65 years||Age, Customized||Participants|Number|8|8.0||||||
3934974|NCT01391299|3757061|B3|>65 years||Age, Customized||Participants|Number|1|1.0||||||
3934975|NCT01391299|3757062|B2|>65 years||Age, Customized||Participants|Number|4|4.0||||||
3934976|NCT01391299|3757063|B1|>65 years||Age, Customized||Participants|Number|3|3.0||||||
3934977|NCT01391299|3757060|B4|45 to 65 years||Age, Customized||Participants|Number|92|92.0||||||
3934978|NCT01391299|3757061|B3|45 to 65 years||Age, Customized||Participants|Number|35|35.0||||||
3934979|NCT01391299|3757062|B2|45 to 65 years||Age, Customized||Participants|Number|31|31.0||||||
3934980|NCT01391299|3757063|B1|45 to 65 years||Age, Customized||Participants|Number|26|26.0||||||
3934981|NCT01391299|3757060|B4|<45 years||Age, Customized||Participants|Number|75|75.0||||||
3934982|NCT01391299|3757061|B3|<45 years||Age, Customized||Participants|Number|22|22.0||||||
3934983|NCT01391299|3757062|B2|<45 years||Age, Customized||Participants|Number|25|25.0||||||
3934984|NCT01391299|3757063|B1|<45 years||Age, Customized||Participants|Number|28|28.0||||||
3934985|NCT01391286|3757085|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3934986|NCT01391286|3757086|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3934987|NCT01391286|3757087|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3934988|NCT01391286|3757085|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3934989|NCT01391286|3757086|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3934990|NCT01391286|3757087|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3934991|NCT01391286|3757085|B3|> 65 Years||Age, Customized||Participants|Number|3|3.0||||||
3934992|NCT01391286|3757086|B2|> 65 Years||Age, Customized||Participants|Number|3|3.0||||||
3934993|NCT01391286|3757087|B1|> 65 Years||Age, Customized||Participants|Number|0|0.0||||||
3934994|NCT01391286|3757085|B3|45 to 65 Years||Age, Customized||Participants|Number|22|22.0||||||
3934995|NCT01391286|3757086|B2|45 to 65 Years||Age, Customized||Participants|Number|12|12.0||||||
3934996|NCT01391286|3757087|B1|45 to 65 Years||Age, Customized||Participants|Number|10|10.0||||||
3934997|NCT01391286|3757085|B3|< 45 Years||Age, Customized||Participants|Number|11|11.0||10.20|10.2|||
3934998|NCT01391286|3757086|B2|< 45 Years||Age, Customized||Participants|Number|3|3.0||10.49|10.49|||
3934999|NCT01391286|3757087|B1|< 45 Years||Age, Customized||Participants|Number|8|8.0||8.10|8.1|||
3935000|NCT01391273|3757100|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3935001|NCT01391273|3757101|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3935002|NCT01391273|3757102|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3935003|NCT01391273|3757100|B3||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3935004|NCT01391273|3757101|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3935005|NCT01391273|3757102|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3935006|NCT01391273|3757100|B3|>65 Years||Age, Customized||Participants|Number|1|1.0||||||
3935007|NCT01391273|3757101|B2|>65 Years||Age, Customized||Participants|Number|0|0.0||||||
3935008|NCT01391273|3757102|B1|>65 Years||Age, Customized||Participants|Number|1|1.0||||||
3935009|NCT01391273|3757100|B3|45 to 65 Years||Age, Customized||Participants|Number|66|66.0||||||
3935010|NCT01391273|3757101|B2|45 to 65 Years||Age, Customized||Participants|Number|37|37.0||||||
3935011|NCT01391273|3757102|B1|45 to 65 Years||Age, Customized||Participants|Number|29|29.0||||||
3935012|NCT01391273|3757100|B3|< 45 Years||Age, Customized||Participants|Number|106|106.0||11.95|11.95|||
3935013|NCT01391273|3757101|B2|< 45 Years||Age, Customized||Participants|Number|48|48.0||12.53|12.53|||
3935014|NCT01391273|3757102|B1|< 45 Years||Age, Customized||Participants|Number|58|58.0||11.40|11.4|||
3935015|NCT01391013|3757115|B3|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3935016|NCT01391013|3757116|B2|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3935017|NCT01391013|3757117|B1|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3935018|NCT01391013|3757115|B3|White||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
3935019|NCT01391013|3757116|B2|White||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
3935020|NCT01391013|3757117|B1|White||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3935021|NCT01391013|3757115|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3935022|NCT01391013|3757116|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3935023|NCT01391013|3757117|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3935024|NCT01391013|3757115|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3935025|NCT01391013|3757116|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3935026|NCT01391013|3757117|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3935027|NCT01391013|3757115|B3|||Age||Years|Median|44.6|44.6|Inter-Quartile Range|||35.0|47.4|
3935028|NCT01391013|3757116|B2|||Age||Years|Median|43.0|43.0|Inter-Quartile Range|||35.0|46.8|
3935029|NCT01391013|3757117|B1|||Age||Years|Median|44.8|44.8|Inter-Quartile Range|||34.5|55.1|
3935030|NCT01391000|3757156|B3|||Number of participants with Traumatic Lesion||Participants|Count of Participants|30|30.0||||||
3935031|NCT01391000|3757157|B2|||Number of participants with Traumatic Lesion||Participants|Count of Participants|12|12.0||||||
3935032|NCT01391000|3757158|B1|||Number of participants with Traumatic Lesion||Participants|Count of Participants|18|18.0||||||
3935033|NCT01391000|3757156|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3935034|NCT01391000|3757157|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3935035|NCT01391000|3757158|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3935036|NCT01391000|3757156|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3935037|NCT01391000|3757157|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3935038|NCT01391000|3757158|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3935039|NCT01391000|3757156|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|7.8|7.8|||
3935040|NCT01391000|3757157|B2|||Age||years|Mean|61.6|61.6|Standard Deviation|6.5|6.5|||
3935041|NCT01391000|3757158|B1|||Age||years|Mean|58|58.0|Standard Deviation|9.2|9.2|||
3935042|NCT01390948|3757169|B4||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3935043|NCT01390948|3757170|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3935044|NCT01390948|3757171|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3935045|NCT01390948|3757172|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3935046|NCT01390948|3757169|B4||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3935047|NCT01390948|3757170|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3935048|NCT01390948|3757171|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3935049|NCT01390948|3757172|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3935050|NCT01390948|3757169|B4|>/= 13 years and < 18 years||Age, Customized||participants|Number|40|40.0||||||
3935051|NCT01390948|3757170|B3|>/= 13 years and < 18 years||Age, Customized||participants|Number|0|0.0||||||
3935052|NCT01390948|3757171|B2|>/= 13 years and < 18 years||Age, Customized||participants|Number|17|17.0||||||
3935053|NCT01390948|3757172|B1|>/= 13 years and < 18 years||Age, Customized||participants|Number|23|23.0||||||
3935054|NCT01390948|3757169|B4|>/= 6 years and < 13 years||Age, Customized||participants|Number|65|65.0||||||
3935055|NCT01390948|3757170|B3|>/= 6 years and < 13 years||Age, Customized||participants|Number|0|0.0||||||
3935056|NCT01390948|3757171|B2|>/= 6 years and < 13 years||Age, Customized||participants|Number|35|35.0||||||
3935057|NCT01390948|3757172|B1|>/= 6 years and < 13 years||Age, Customized||participants|Number|30|30.0||||||
3935058|NCT01390948|3757169|B4|>/= 3 years and < 6 years||Age, Customized||participants|Number|16|16.0||||||
3935059|NCT01390948|3757170|B3|>/= 3 years and < 6 years||Age, Customized||participants|Number|0|0.0||||||
3935060|NCT01390948|3757171|B2|>/= 3 years and < 6 years||Age, Customized||participants|Number|10|10.0||||||
3935061|NCT01390948|3757172|B1|>/= 3 years and < 6 years||Age, Customized||participants|Number|6|6.0||||||
3935062|NCT01390948|3757169|B4|< 3 years||Age, Customized||participants|Number|3|3.0||||||
3935063|NCT01390948|3757170|B3|< 3 years||Age, Customized||participants|Number|3|3.0||||||
3935064|NCT01390948|3757171|B2|< 3 years||Age, Customized||participants|Number|0|0.0||||||
3935065|NCT01390948|3757172|B1|< 3 years||Age, Customized||participants|Number|0|0.0||||||
3935066|NCT01390909|3757207|B7|Mental Retardation, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|323|323.0||||||
3935067|NCT01390909|3757208|B6|Mental Retardation, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935068|NCT01390909|3757209|B5|Mental Retardation, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|11|11.0||||||
3935069|NCT01390909|3757210|B4|Mental Retardation, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935070|NCT01390909|3757211|B3|Mental Retardation, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935071|NCT01390909|3757212|B2|Mental Retardation, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|312|312.0||||||
3935072|NCT01390909|3757213|B1|Mental Retardation, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935073|NCT01390909|3757207|B7|Mental Retardation, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|1262|1262.0||||||
3935074|NCT01390909|3757208|B6|Mental Retardation, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|8|8.0||||||
3935075|NCT01390909|3757209|B5|Mental Retardation, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|11|11.0||||||
3935076|NCT01390909|3757210|B4|Mental Retardation, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|5|5.0||||||
3935077|NCT01390909|3757211|B3|Mental Retardation, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|434|434.0||||||
3935078|NCT01390909|3757212|B2|Mental Retardation, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|322|322.0||||||
3935079|NCT01390909|3757213|B1|Mental Retardation, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|482|482.0||||||
3935080|NCT01390909|3757207|B7|Personality Disorder, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|1068|1068.0||||||
3935081|NCT01390909|3757208|B6|Personality Disorder, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935082|NCT01390909|3757209|B5|Personality Disorder, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|67|67.0||||||
3935083|NCT01390909|3757210|B4|Personality Disorder, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935084|NCT01390909|3757211|B3|Personality Disorder, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935085|NCT01390909|3757212|B2|Personality Disorder, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|1001|1001.0||||||
3935086|NCT01390909|3757213|B1|Personality Disorder, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935087|NCT01390909|3757207|B7|Personality Disorder, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|3214|3214.0||||||
3935088|NCT01390909|3757208|B6|Personality Disorder, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|58|58.0||||||
3935089|NCT01390909|3757209|B5|Personality Disorder, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|68|68.0||||||
3935090|NCT01390909|3757210|B4|Personality Disorder, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|51|51.0||||||
3935091|NCT01390909|3757211|B3|Personality Disorder, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|1024|1024.0||||||
3935092|NCT01390909|3757212|B2|Personality Disorder, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|1062|1062.0||||||
3935093|NCT01390909|3757213|B1|Personality Disorder, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|951|951.0||||||
3935094|NCT01390909|3757207|B7|Psychosis, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|819|819.0||||||
3935095|NCT01390909|3757208|B6|Psychosis, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935096|NCT01390909|3757209|B5|Psychosis, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|65|65.0||||||
3935097|NCT01390909|3757210|B4|Psychosis, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935098|NCT01390909|3757211|B3|Psychosis, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935099|NCT01390909|3757212|B2|Psychosis, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|754|754.0||||||
3935100|NCT01390909|3757213|B1|Psychosis, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935101|NCT01390909|3757207|B7|Psychosis, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|2611|2611.0||||||
3935102|NCT01390909|3757208|B6|Psychosis, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|65|65.0||||||
3935103|NCT01390909|3757209|B5|Psychosis, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|65|65.0||||||
3935104|NCT01390909|3757210|B4|Psychosis, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|62|62.0||||||
3935105|NCT01390909|3757211|B3|Psychosis, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|816|816.0||||||
3935106|NCT01390909|3757212|B2|Psychosis, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|794|794.0||||||
3935107|NCT01390909|3757213|B1|Psychosis, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|809|809.0||||||
3935108|NCT01390909|3757207|B7|Depression, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|923|923.0||||||
3935109|NCT01390909|3757208|B6|Depression, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935110|NCT01390909|3757209|B5|Depression, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|90|90.0||||||
3935111|NCT01390909|3757210|B4|Depression, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935112|NCT01390909|3757211|B3|Depression, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935113|NCT01390909|3757212|B2|Depression, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|833|833.0||||||
3935114|NCT01390909|3757213|B1|Depression, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935115|NCT01390909|3757207|B7|Depression, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|2895|2895.0||||||
3935116|NCT01390909|3757208|B6|Depression, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|102|102.0||||||
3935117|NCT01390909|3757209|B5|Depression, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|95|95.0||||||
3935118|NCT01390909|3757210|B4|Depression, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|90|90.0||||||
3935119|NCT01390909|3757211|B3|Depression, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|897|897.0||||||
3935120|NCT01390909|3757212|B2|Depression, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|890|890.0||||||
3935121|NCT01390909|3757213|B1|Depression, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|821|821.0||||||
3935122|NCT01390909|3757207|B7|Bipolar Disorder, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|414|414.0||||||
3935123|NCT01390909|3757208|B6|Bipolar Disorder, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935124|NCT01390909|3757209|B5|Bipolar Disorder, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|17|17.0||||||
3935125|NCT01390909|3757210|B4|Bipolar Disorder, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935126|NCT01390909|3757211|B3|Bipolar Disorder, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935127|NCT01390909|3757212|B2|Bipolar Disorder, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|397|397.0||||||
3935128|NCT01390909|3757213|B1|Bipolar Disorder, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935129|NCT01390909|3757207|B7|Bipolar Disorder, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|1394|1394.0||||||
3935130|NCT01390909|3757208|B6|Bipolar Disorder, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|15|15.0||||||
3935131|NCT01390909|3757209|B5|Bipolar Disorder, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|18|18.0||||||
3935132|NCT01390909|3757210|B4|Bipolar Disorder, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|22|22.0||||||
3935133|NCT01390909|3757211|B3|Bipolar Disorder, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|472|472.0||||||
3935134|NCT01390909|3757212|B2|Bipolar Disorder, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|439|439.0||||||
3935135|NCT01390909|3757213|B1|Bipolar Disorder, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|428|428.0||||||
3935136|NCT01390909|3757207|B7|Anxiety Disorders, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|448|448.0||||||
3935137|NCT01390909|3757208|B6|Anxiety Disorders, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935138|NCT01390909|3757209|B5|Anxiety Disorders, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|38|38.0||||||
3935139|NCT01390909|3757210|B4|Anxiety Disorders, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935140|NCT01390909|3757211|B3|Anxiety Disorders, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935141|NCT01390909|3757212|B2|Anxiety Disorders, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|410|410.0||||||
3935142|NCT01390909|3757213|B1|Anxiety Disorders, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935143|NCT01390909|3757207|B7|Anxiety Disorders, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|1344|1344.0||||||
3935144|NCT01390909|3757208|B6|Anxiety Disorders, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|28|28.0||||||
3935145|NCT01390909|3757209|B5|Anxiety Disorders, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|41|41.0||||||
3935146|NCT01390909|3757210|B4|Anxiety Disorders, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|32|32.0||||||
3935147|NCT01390909|3757211|B3|Anxiety Disorders, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|440|440.0||||||
3935148|NCT01390909|3757212|B2|Anxiety Disorders, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|447|447.0||||||
3935149|NCT01390909|3757213|B1|Anxiety Disorders, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|356|356.0||||||
3935150|NCT01390909|3757207|B7|Stroke, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|430|430.0||||||
3935151|NCT01390909|3757208|B6|Stroke, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935152|NCT01390909|3757209|B5|Stroke, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|128|128.0||||||
3935153|NCT01390909|3757210|B4|Stroke, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935154|NCT01390909|3757211|B3|Stroke, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935155|NCT01390909|3757212|B2|Stroke, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|302|302.0||||||
3935156|NCT01390909|3757213|B1|Stroke, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935157|NCT01390909|3757207|B7|Stroke, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|1245|1245.0||||||
3935158|NCT01390909|3757208|B6|Stroke, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|154|154.0||||||
3935159|NCT01390909|3757209|B5|Stroke, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|134|134.0||||||
3935160|NCT01390909|3757210|B4|Stroke, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|123|123.0||||||
3935161|NCT01390909|3757211|B3|Stroke, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|264|264.0||||||
3935162|NCT01390909|3757212|B2|Stroke, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|303|303.0||||||
3935163|NCT01390909|3757213|B1|Stroke, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|267|267.0||||||
3935164|NCT01390909|3757207|B7|Migraine, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|280|280.0||||||
3935165|NCT01390909|3757208|B6|Migraine, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935166|NCT01390909|3757209|B5|Migraine, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|41|41.0||||||
3935167|NCT01390909|3757210|B4|Migraine, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935168|NCT01390909|3757211|B3|Migraine, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935169|NCT01390909|3757212|B2|Migraine, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|239|239.0||||||
3935170|NCT01390909|3757213|B1|Migraine, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935171|NCT01390909|3757207|B7|Migraine, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|840|840.0||||||
3935172|NCT01390909|3757208|B6|Migraine, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|35|35.0||||||
3935173|NCT01390909|3757209|B5|Migraine, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|42|42.0||||||
3935174|NCT01390909|3757210|B4|Migraine, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|41|41.0||||||
3935175|NCT01390909|3757211|B3|Migraine, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|262|262.0||||||
3935176|NCT01390909|3757212|B2|Migraine, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|262|262.0||||||
3935177|NCT01390909|3757213|B1|Migraine, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|198|198.0||||||
3935178|NCT01390909|3757207|B7|Meningitis, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|24|24.0||||||
3935179|NCT01390909|3757208|B6|Meningitis, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935180|NCT01390909|3757209|B5|Meningitis, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|9|9.0||||||
3935181|NCT01390909|3757210|B4|Meningitis, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935182|NCT01390909|3757211|B3|Meningitis, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935183|NCT01390909|3757212|B2|Meningitis, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|15|15.0||||||
3935184|NCT01390909|3757213|B1|Meningitis, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935185|NCT01390909|3757207|B7|Meningitis, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|68|68.0||||||
3935186|NCT01390909|3757208|B6|Meningitis, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|6|6.0||||||
3935187|NCT01390909|3757209|B5|Meningitis, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|10|10.0||||||
3935188|NCT01390909|3757210|B4|Meningitis, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|11|11.0||||||
3935189|NCT01390909|3757211|B3|Meningitis, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|13|13.0||||||
3935190|NCT01390909|3757212|B2|Meningitis, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|16|16.0||||||
3935191|NCT01390909|3757213|B1|Meningitis, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|12|12.0||||||
3935192|NCT01390909|3757207|B7|Brain Tumor, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|106|106.0||||||
3935193|NCT01390909|3757208|B6|Brain Tumor, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935194|NCT01390909|3757209|B5|Brain Tumor, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|44|44.0||||||
3935195|NCT01390909|3757210|B4|Brain Tumor, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935196|NCT01390909|3757211|B3|Brain Tumor, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935197|NCT01390909|3757212|B2|Brain Tumor, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|62|62.0||||||
3935198|NCT01390909|3757213|B1|Brain Tumor, Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935199|NCT01390909|3757207|B7|Brain Tumor, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|287|287.0||||||
3935200|NCT01390909|3757208|B6|Brain Tumor, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|43|43.0||||||
3935201|NCT01390909|3757209|B5|Brain Tumor, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|50|50.0||||||
3935202|NCT01390909|3757210|B4|Brain Tumor, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|38|38.0||||||
3935203|NCT01390909|3757211|B3|Brain Tumor, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|40|40.0||||||
3935204|NCT01390909|3757212|B2|Brain Tumor, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|63|63.0||||||
3935205|NCT01390909|3757213|B1|Brain Tumor, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|53|53.0||||||
3935206|NCT01390909|3757207|B7|Alzheimer's Disease Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|113|113.0||||||
3935207|NCT01390909|3757208|B6|Alzheimer's Disease Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935208|NCT01390909|3757209|B5|Alzheimer's Disease Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|20|20.0||||||
3935209|NCT01390909|3757210|B4|Alzheimer's Disease Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935210|NCT01390909|3757211|B3|Alzheimer's Disease Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935211|NCT01390909|3757212|B2|Alzheimer's Disease Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|93|93.0||||||
3935212|NCT01390909|3757213|B1|Alzheimer's Disease Subgroup||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|NA|||||||There are no subgroup participants.
3935213|NCT01390909|3757207|B7|Alzheimer’s Disease, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|322|322.0||||||
3935214|NCT01390909|3757208|B6|Alzheimer’s Disease, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|19|19.0||||||
3935215|NCT01390909|3757209|B5|Alzheimer’s Disease, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|20|20.0||||||
3935216|NCT01390909|3757210|B4|Alzheimer’s Disease, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|12|12.0||||||
3935217|NCT01390909|3757211|B3|Alzheimer’s Disease, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|84|84.0||||||
3935218|NCT01390909|3757212|B2|Alzheimer’s Disease, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|93|93.0||||||
3935219|NCT01390909|3757213|B1|Alzheimer’s Disease, Overall Study||Number of participant records with diagnosis codes for the indicated diseases or disorders||participant records|Number|94|94.0||||||
3935220|NCT01390909|3757207|B7|Subgroup||Charlson Comorbidity Index (CCI) Scores|The Charlson Comorbidity Index estimates 10-year mortality risk. Scores range from 0 - 37, with a lower score indicating a higher chance of survival. For the total population and the subgroup, a weighted average of the study group means was used. The standard deviation (SD) is the SD of the study group means.|scores on a scale|Mean|1.11|1.11|Standard Deviation|1.66|1.66|||
3935221|NCT01390909|3757208|B6|Subgroup||Charlson Comorbidity Index (CCI) Scores|The Charlson Comorbidity Index estimates 10-year mortality risk. Scores range from 0 - 37, with a lower score indicating a higher chance of survival. For the total population and the subgroup, a weighted average of the study group means was used. The standard deviation (SD) is the SD of the study group means.|scores on a scale|Mean|NA||Standard Deviation|NA||||There are no subgroup participants.
3935222|NCT01390909|3757209|B5|Subgroup||Charlson Comorbidity Index (CCI) Scores|The Charlson Comorbidity Index estimates 10-year mortality risk. Scores range from 0 - 37, with a lower score indicating a higher chance of survival. For the total population and the subgroup, a weighted average of the study group means was used. The standard deviation (SD) is the SD of the study group means.|scores on a scale|Mean|1.29|1.29|Standard Deviation|1.88|1.88|||
3935223|NCT01390909|3757210|B4|Subgroup||Charlson Comorbidity Index (CCI) Scores|The Charlson Comorbidity Index estimates 10-year mortality risk. Scores range from 0 - 37, with a lower score indicating a higher chance of survival. For the total population and the subgroup, a weighted average of the study group means was used. The standard deviation (SD) is the SD of the study group means.|scores on a scale|Mean|NA||Standard Deviation|NA||||There are no subgroup participants.
3935224|NCT01390909|3757211|B3|Subgroup||Charlson Comorbidity Index (CCI) Scores|The Charlson Comorbidity Index estimates 10-year mortality risk. Scores range from 0 - 37, with a lower score indicating a higher chance of survival. For the total population and the subgroup, a weighted average of the study group means was used. The standard deviation (SD) is the SD of the study group means.|scores on a scale|Mean|NA||Standard Deviation|NA||||There are no subgroup participants.
3935225|NCT01390909|3757212|B2|Subgroup||Charlson Comorbidity Index (CCI) Scores|The Charlson Comorbidity Index estimates 10-year mortality risk. Scores range from 0 - 37, with a lower score indicating a higher chance of survival. For the total population and the subgroup, a weighted average of the study group means was used. The standard deviation (SD) is the SD of the study group means.|scores on a scale|Mean|1.08|1.08|Standard Deviation|1.83|1.83|||
3935226|NCT01390909|3757213|B1|Subgroup||Charlson Comorbidity Index (CCI) Scores|The Charlson Comorbidity Index estimates 10-year mortality risk. Scores range from 0 - 37, with a lower score indicating a higher chance of survival. For the total population and the subgroup, a weighted average of the study group means was used. The standard deviation (SD) is the SD of the study group means.|scores on a scale|Mean|NA||Standard Deviation|NA||||There are no subgroup participants.
3935227|NCT01390909|3757207|B7|Overall Study||Charlson Comorbidity Index (CCI) Scores|The Charlson Comorbidity Index estimates 10-year mortality risk. Scores range from 0 - 37, with a lower score indicating a higher chance of survival. For the total population and the subgroup, a weighted average of the study group means was used. The standard deviation (SD) is the SD of the study group means.|scores on a scale|Mean|1.05|1.05|Standard Deviation|0.11|0.11|||
3935228|NCT01390909|3757208|B6|Overall Study||Charlson Comorbidity Index (CCI) Scores|The Charlson Comorbidity Index estimates 10-year mortality risk. Scores range from 0 - 37, with a lower score indicating a higher chance of survival. For the total population and the subgroup, a weighted average of the study group means was used. The standard deviation (SD) is the SD of the study group means.|scores on a scale|Mean|1.20|1.2|Standard Deviation|1.82|1.82|||
3935229|NCT01390909|3757209|B5|Overall Study||Charlson Comorbidity Index (CCI) Scores|The Charlson Comorbidity Index estimates 10-year mortality risk. Scores range from 0 - 37, with a lower score indicating a higher chance of survival. For the total population and the subgroup, a weighted average of the study group means was used. The standard deviation (SD) is the SD of the study group means.|scores on a scale|Mean|1.32|1.32|Standard Deviation|1.91|1.91|||
3935230|NCT01390909|3757210|B4|Overall Study||Charlson Comorbidity Index (CCI) Scores|The Charlson Comorbidity Index estimates 10-year mortality risk. Scores range from 0 - 37, with a lower score indicating a higher chance of survival. For the total population and the subgroup, a weighted average of the study group means was used. The standard deviation (SD) is the SD of the study group means.|scores on a scale|Mean|1.13|1.13|Standard Deviation|1.65|1.65|||
3935231|NCT01390909|3757211|B3|Overall Study||Charlson Comorbidity Index (CCI) Scores|The Charlson Comorbidity Index estimates 10-year mortality risk. Scores range from 0 - 37, with a lower score indicating a higher chance of survival. For the total population and the subgroup, a weighted average of the study group means was used. The standard deviation (SD) is the SD of the study group means.|scores on a scale|Mean|1.00|1.0|Standard Deviation|1.78|1.78|||
3935232|NCT01390909|3757212|B2|Overall Study||Charlson Comorbidity Index (CCI) Scores|The Charlson Comorbidity Index estimates 10-year mortality risk. Scores range from 0 - 37, with a lower score indicating a higher chance of survival. For the total population and the subgroup, a weighted average of the study group means was used. The standard deviation (SD) is the SD of the study group means.|scores on a scale|Mean|1.09|1.09|Standard Deviation|1.84|1.84|||
3935233|NCT01390909|3757213|B1|Overall Study||Charlson Comorbidity Index (CCI) Scores|The Charlson Comorbidity Index estimates 10-year mortality risk. Scores range from 0 - 37, with a lower score indicating a higher chance of survival. For the total population and the subgroup, a weighted average of the study group means was used. The standard deviation (SD) is the SD of the study group means.|scores on a scale|Mean|0.98|0.98|Standard Deviation|1.83|1.83|||
3935234|NCT01390909|3757207|B7|Subgroup||Number of Days of Observation|For the total population and subgroups, a weighted average of the individual study group means and number of participants was used. The SDs reflect the SDs of the study group means.|days of observation|Mean|2170.5|2170.5|Standard Deviation|402.5|402.5|||
3935235|NCT01390909|3757208|B6|Subgroup||Number of Days of Observation|For the total population and subgroups, a weighted average of the individual study group means and number of participants was used. The SDs reflect the SDs of the study group means.|days of observation|Mean|NA||Standard Deviation|NA||||There are no subgroup participants.
3935236|NCT01390909|3757209|B5|Subgroup||Number of Days of Observation|For the total population and subgroups, a weighted average of the individual study group means and number of participants was used. The SDs reflect the SDs of the study group means.|days of observation|Mean|1485|1485.0|Standard Deviation|751|751.0|||
3935237|NCT01390909|3757210|B4|Subgroup||Number of Days of Observation|For the total population and subgroups, a weighted average of the individual study group means and number of participants was used. The SDs reflect the SDs of the study group means.|days of observation|Mean|NA||Standard Deviation|NA||||There are no subgroup participants.
3935238|NCT01390909|3757211|B3|Subgroup||Number of Days of Observation|For the total population and subgroups, a weighted average of the individual study group means and number of participants was used. The SDs reflect the SDs of the study group means.|days of observation|Mean|NA||Standard Deviation|NA||||There are no subgroup participants.
3935239|NCT01390909|3757212|B2|Subgroup||Number of Days of Observation|For the total population and subgroups, a weighted average of the individual study group means and number of participants was used. The SDs reflect the SDs of the study group means.|days of observation|Mean|2290|2290.0|Standard Deviation|1133|1133.0|||
3935240|NCT01390909|3757213|B1|Subgroup||Number of Days of Observation|For the total population and subgroups, a weighted average of the individual study group means and number of participants was used. The SDs reflect the SDs of the study group means.|days of observation|Mean|NA||Standard Deviation|NA||||There are no subgroup participants.
3935241|NCT01390909|3757207|B7|Overall Study||Number of Days of Observation|For the total population and subgroups, a weighted average of the individual study group means and number of participants was used. The SDs reflect the SDs of the study group means.|days of observation|Mean|2221|2221.0|Standard Deviation|385|385.0|||
3935242|NCT01390909|3757208|B6|Overall Study||Number of Days of Observation|For the total population and subgroups, a weighted average of the individual study group means and number of participants was used. The SDs reflect the SDs of the study group means.|days of observation|Mean|1739|1739.0|Standard Deviation|792|792.0|||
3935243|NCT01390909|3757209|B5|Overall Study||Number of Days of Observation|For the total population and subgroups, a weighted average of the individual study group means and number of participants was used. The SDs reflect the SDs of the study group means.|days of observation|Mean|1478|1478.0|Standard Deviation|749|749.0|||
3935244|NCT01390909|3757210|B4|Overall Study||Number of Days of Observation|For the total population and subgroups, a weighted average of the individual study group means and number of participants was used. The SDs reflect the SDs of the study group means.|days of observation|Mean|1572|1572.0|Standard Deviation|847|847.0|||
3935245|NCT01390909|3757211|B3|Overall Study||Number of Days of Observation|For the total population and subgroups, a weighted average of the individual study group means and number of participants was used. The SDs reflect the SDs of the study group means.|days of observation|Mean|2502|2502.0|Standard Deviation|1124|1124.0|||
3935246|NCT01390909|3757212|B2|Overall Study||Number of Days of Observation|For the total population and subgroups, a weighted average of the individual study group means and number of participants was used. The SDs reflect the SDs of the study group means.|days of observation|Mean|2296|2296.0|Standard Deviation|1132|1132.0|||
3935247|NCT01390909|3757213|B1|Overall Study||Number of Days of Observation|For the total population and subgroups, a weighted average of the individual study group means and number of participants was used. The SDs reflect the SDs of the study group means.|days of observation|Mean|2184|2184.0|Standard Deviation|1181|1181.0|||
3935248|NCT01390909|3757207|B7|Male, Subgroup||Sex/Gender, Customized||Participants|Number|602|602.0||||||
3935249|NCT01390909|3757208|B6|Male, Subgroup||Sex/Gender, Customized||Participants|Number|NA|||||||There are no subgroup participants.
3935250|NCT01390909|3757209|B5|Male, Subgroup||Sex/Gender, Customized||Participants|Number|257|257.0||||||
3935251|NCT01390909|3757210|B4|Male, Subgroup||Sex/Gender, Customized||Participants|Number|NA|||||||There are no subgroup participants.
3935252|NCT01390909|3757211|B3|Male, Subgroup||Sex/Gender, Customized||Participants|Number|NA|||||||There are no subgroup participants.
3935253|NCT01390909|3757212|B2|Male, Subgroup||Sex/Gender, Customized||Participants|Number|345|345.0||||||
3935254|NCT01390909|3757213|B1|Male, Subgroup||Sex/Gender, Customized||Participants|Number|NA|||||||There are no subgroup participants.
3935255|NCT01390909|3757207|B7|Female, Subgroup||Sex/Gender, Customized||Participants|Number|2436|2436.0||||||
3935256|NCT01390909|3757208|B6|Female, Subgroup||Sex/Gender, Customized||Participants|Number|NA|||||||There are no subgroup participants.
3935257|NCT01390909|3757209|B5|Female, Subgroup||Sex/Gender, Customized||Participants|Number|345|345.0||||||
3935258|NCT01390909|3757210|B4|Female, Subgroup||Sex/Gender, Customized||Participants|Number|NA|||||||There are no subgroup participants.
3935259|NCT01390909|3757211|B3|Female, Subgroup||Sex/Gender, Customized||Participants|Number|NA|||||||There are no subgroup participants.
3935260|NCT01390909|3757212|B2|Female, Subgroup||Sex/Gender, Customized||Participants|Number|2091|2091.0||||||
3935261|NCT01390909|3757213|B1|Female, Subgroup||Sex/Gender, Customized||Participants|Number|NA|||||||There are no subgroup participants.
3935262|NCT01390909|3757207|B7|Male, Overall Study||Sex/Gender, Customized||Participants|Number|4926|4926.0||||||
3935263|NCT01390909|3757208|B6|Male, Overall Study||Sex/Gender, Customized||Participants|Number|281|281.0||||||
3935264|NCT01390909|3757209|B5|Male, Overall Study||Sex/Gender, Customized||Participants|Number|262|262.0||||||
3935265|NCT01390909|3757210|B4|Male, Overall Study||Sex/Gender, Customized||Participants|Number|261|261.0||||||
3935266|NCT01390909|3757211|B3|Male, Overall Study||Sex/Gender, Customized||Participants|Number|1393|1393.0||||||
3935267|NCT01390909|3757212|B2|Male, Overall Study||Sex/Gender, Customized||Participants|Number|1381|1381.0||||||
3935268|NCT01390909|3757213|B1|Male, Overall Study||Sex/Gender, Customized||Participants|Number|1348|1348.0||||||
3935269|NCT01390909|3757207|B7|Female, Overall Study||Sex/Gender, Customized||Participants|Number|7460|7460.0||||||
3935270|NCT01390909|3757208|B6|Female, Overall Study||Sex/Gender, Customized||Participants|Number|332|332.0||||||
3935271|NCT01390909|3757209|B5|Female, Overall Study||Sex/Gender, Customized||Participants|Number|351|351.0||||||
3935272|NCT01390909|3757210|B4|Female, Overall Study||Sex/Gender, Customized||Participants|Number|341|341.0||||||
3935273|NCT01390909|3757211|B3|Female, Overall Study||Sex/Gender, Customized||Participants|Number|2159|2159.0||||||
3935274|NCT01390909|3757212|B2|Female, Overall Study||Sex/Gender, Customized||Participants|Number|2171|2171.0||||||
3935275|NCT01390909|3757213|B1|Female, Overall Study||Sex/Gender, Customized||Participants|Number|2106|2106.0||||||
3935276|NCT01390909|3757207|B7|Subgroup||Age|For the total population and the subgroup total population, a weighted average of the individual study group means and number of participants was used. The standard deviation (SD) is the SD of the study group means.|Years|Mean|43.3|43.3|Standard Deviation|6.3|6.3|||
3935277|NCT01390909|3757208|B6|Subgroup||Age|For the total population and the subgroup total population, a weighted average of the individual study group means and number of participants was used. The standard deviation (SD) is the SD of the study group means.|Years|Mean|NA||Standard Deviation|NA||||There are no subgroup participants.
3935278|NCT01390909|3757209|B5|Subgroup||Age|For the total population and the subgroup total population, a weighted average of the individual study group means and number of participants was used. The standard deviation (SD) is the SD of the study group means.|Years|Mean|54.0|54.0|Standard Deviation|17.4|17.4|||
3935279|NCT01390909|3757210|B4|Subgroup||Age|For the total population and the subgroup total population, a weighted average of the individual study group means and number of participants was used. The standard deviation (SD) is the SD of the study group means.|Years|Mean|NA||Standard Deviation|NA||||There are no subgroup participants.
3935280|NCT01390909|3757211|B3|Subgroup||Age|For the total population and the subgroup total population, a weighted average of the individual study group means and number of participants was used. The standard deviation (SD) is the SD of the study group means.|Years|Mean|NA||Standard Deviation|NA||||There are no subgroup participants.
3935281|NCT01390909|3757212|B2|Subgroup||Age|For the total population and the subgroup total population, a weighted average of the individual study group means and number of participants was used. The standard deviation (SD) is the SD of the study group means.|Years|Mean|41.4|41.4|Standard Deviation|14.2|14.2|||
3935282|NCT01390909|3757213|B1|Subgroup||Age|For the total population and the subgroup total population, a weighted average of the individual study group means and number of participants was used. The standard deviation (SD) is the SD of the study group means.|Years|Mean|NA||Standard Deviation|NA||||There are no subgroup participants.
3935283|NCT01390909|3757207|B7|Overall Study||Age|For the total population and the subgroup total population, a weighted average of the individual study group means and number of participants was used. The standard deviation (SD) is the SD of the study group means.|Years|Mean|43.2|43.2|Standard Deviation|6.5|6.5|||
3935284|NCT01390909|3757208|B6|Overall Study||Age|For the total population and the subgroup total population, a weighted average of the individual study group means and number of participants was used. The standard deviation (SD) is the SD of the study group means.|Years|Mean|54.6|54.6|Standard Deviation|16.7|16.7|||
3935285|NCT01390909|3757209|B5|Overall Study||Age|For the total population and the subgroup total population, a weighted average of the individual study group means and number of participants was used. The standard deviation (SD) is the SD of the study group means.|Years|Mean|54.1|54.1|Standard Deviation|17.3|17.3|||
3935286|NCT01390909|3757210|B4|Overall Study||Age|For the total population and the subgroup total population, a weighted average of the individual study group means and number of participants was used. The standard deviation (SD) is the SD of the study group means.|Years|Mean|54.2|54.2|Standard Deviation|17.1|17.1|||
3935287|NCT01390909|3757211|B3|Overall Study||Age|For the total population and the subgroup total population, a weighted average of the individual study group means and number of participants was used. The standard deviation (SD) is the SD of the study group means.|Years|Mean|41.2|41.2|Standard Deviation|14.6|14.6|||
3935288|NCT01390909|3757212|B2|Overall Study||Age|For the total population and the subgroup total population, a weighted average of the individual study group means and number of participants was used. The standard deviation (SD) is the SD of the study group means.|Years|Mean|41.3|41.3|Standard Deviation|14.1|14.1|||
3935289|NCT01390909|3757213|B1|Overall Study||Age|For the total population and the subgroup total population, a weighted average of the individual study group means and number of participants was used. The standard deviation (SD) is the SD of the study group means.|Years|Mean|41.5|41.5|Standard Deviation|15.4|15.4|||
3935290|NCT01390870|3757236|B1|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3935291|NCT01390870|3757236|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3935292|NCT01390870|3757236|B1|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3935293|NCT01390870|3757236|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|391|391.0||||||
3935294|NCT01390870|3757236|B1||Male|Sex: Female, Male||Participants|Count of Participants|400|400.0||||||
3935295|NCT01390870|3757236|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3935296|NCT01390870|3757236|B1|less than 50 years old||Age, Customized|The number of participants who were aged 50 and older and those aged 49 and younger are presented.|Participants|Number|0|0.0||||||
3935297|NCT01390870|3757236|B1|at least 50 years old||Age, Customized|The number of participants who were aged 50 and older and those aged 49 and younger are presented.|Participants|Number|400|400.0||||||
3935298|NCT01390857|3757240|B1|Japanese||Race/Ethnicity, Customized|Baseline characteristics were collected in members of the Intent-to-Treat Safety Population, comprised of all participants to whom the drug was administered, excluding 10 withdrawal participants.|participants|Number|369|369.0||||||
3935299|NCT01390857|3757240|B1||Male|Sex: Female, Male|Baseline characteristics were collected in members of the Intent-to-Treat Safety Population, comprised of all participants to whom the drug was administered, excluding 10 withdrawal participants.|Participants|Count of Participants|213|213.0||||||
3935300|NCT01390857|3757240|B1||Female|Sex: Female, Male|Baseline characteristics were collected in members of the Intent-to-Treat Safety Population, comprised of all participants to whom the drug was administered, excluding 10 withdrawal participants.|Participants|Count of Participants|156|156.0||||||
3935301|NCT01390857|3757240|B1|>=7 to <=13 years||Age, Customized|The number of participants in the indicated age groups was recorded. Baseline characteristics were collected in members of the Intent-to-Treat Safety Population, comprised of all participants to whom the drug was administered, excluding 10 withdrawal participants.|Participants|Number|42|42.0||||||
3935302|NCT01390857|3757240|B1|>=1 to <7 years||Age, Customized|The number of participants in the indicated age groups was recorded. Baseline characteristics were collected in members of the Intent-to-Treat Safety Population, comprised of all participants to whom the drug was administered, excluding 10 withdrawal participants.|Participants|Number|311|311.0||||||
3935303|NCT01390857|3757240|B1|>=1 month to <1 year||Age, Customized|The number of participants in the indicated age groups was recorded. Baseline characteristics were collected in members of the Intent-to-Treat Safety Population, comprised of all participants to whom the drug was administered, excluding 10 withdrawal participants.|Participants|Number|16|16.0||||||
3935304|NCT01390844|3757247|B5||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3935305|NCT01390844|3757248|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3935306|NCT01390844|3757249|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3935307|NCT01390844|3757250|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3935308|NCT01390844|3757251|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3935309|NCT01390844|3757247|B5||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3935310|NCT01390844|3757248|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3935311|NCT01390844|3757249|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3935312|NCT01390844|3757250|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3935313|NCT01390844|3757251|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3935314|NCT01390844|3757247|B5|||Age||Years|Mean|51.6|51.6|Standard Deviation|10.63|10.63|||
3935315|NCT01390844|3757248|B4|||Age||Years|Mean|45.2|45.2|Standard Deviation|12.27|12.27|||
3935316|NCT01390844|3757249|B3|||Age||Years|Mean|47.9|47.9|Standard Deviation|9.83|9.83|||
3935317|NCT01390844|3757250|B2|||Age||Years|Mean|52.4|52.4|Standard Deviation|9.80|9.8|||
3935318|NCT01390844|3757251|B1|||Age||Years|Mean|54.0|54.0|Standard Deviation|10.15|10.15|||
3935319|NCT01390818|3757280|B16||Male|Gender||Participants|Count of Participants|59|59.0||||||
3935320|NCT01390818|3757281|B15||Male|Gender||Participants|Count of Participants|11|11.0||||||
3935321|NCT01390818|3757282|B14||Male|Gender||Participants|Count of Participants|7|7.0||||||
3935322|NCT01390818|3757283|B13||Male|Gender||Participants|Count of Participants|9|9.0||||||
3935323|NCT01390818|3757284|B12||Male|Gender||Participants|Count of Participants|0|0.0||||||
3935324|NCT01390818|3757285|B11||Male|Gender||Participants|Count of Participants|4|4.0||||||
3935325|NCT01390818|3757286|B10||Male|Gender||Participants|Count of Participants|1|1.0||||||
3935326|NCT01390818|3757287|B9||Male|Gender||Participants|Count of Participants|2|2.0||||||
3935327|NCT01390818|3757288|B8||Male|Gender||Participants|Count of Participants|1|1.0||||||
3935328|NCT01390818|3757289|B7||Male|Gender||Participants|Count of Participants|13|13.0||||||
3935329|NCT01390818|3757290|B6||Male|Gender||Participants|Count of Participants|2|2.0||||||
3935330|NCT01390818|3757291|B5||Male|Gender||Participants|Count of Participants|3|3.0||||||
3935331|NCT01390818|3757292|B4||Male|Gender||Participants|Count of Participants|3|3.0||||||
3935332|NCT01390818|3757293|B3||Male|Gender||Participants|Count of Participants|1|1.0||||||
3935333|NCT01390818|3757294|B2||Male|Gender||Participants|Count of Participants|2|2.0||||||
3935334|NCT01390818|3757295|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3935335|NCT01390818|3757280|B16||Female|Gender||Participants|Count of Participants|87|87.0||||||
3935336|NCT01390818|3757281|B15||Female|Gender||Participants|Count of Participants|4|4.0||||||
3935337|NCT01390818|3757282|B14||Female|Gender||Participants|Count of Participants|11|11.0||||||
3935338|NCT01390818|3757283|B13||Female|Gender||Participants|Count of Participants|15|15.0||||||
3935339|NCT01390818|3757284|B12||Female|Gender||Participants|Count of Participants|26|26.0||||||
3935340|NCT01390818|3757285|B11||Female|Gender||Participants|Count of Participants|0|0.0||||||
3935341|NCT01390818|3757286|B10||Female|Gender||Participants|Count of Participants|2|2.0||||||
3935342|NCT01390818|3757287|B9||Female|Gender||Participants|Count of Participants|1|1.0||||||
3935343|NCT01390818|3757288|B8||Female|Gender||Participants|Count of Participants|13|13.0||||||
3935344|NCT01390818|3757289|B7||Female|Gender||Participants|Count of Participants|6|6.0||||||
3935345|NCT01390818|3757290|B6||Female|Gender||Participants|Count of Participants|1|1.0||||||
3935346|NCT01390818|3757291|B5||Female|Gender||Participants|Count of Participants|1|1.0||||||
3935347|NCT01390818|3757292|B4||Female|Gender||Participants|Count of Participants|1|1.0||||||
3935348|NCT01390818|3757293|B3||Female|Gender||Participants|Count of Participants|2|2.0||||||
3935349|NCT01390818|3757294|B2||Female|Gender||Participants|Count of Participants|1|1.0||||||
3935350|NCT01390818|3757295|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
3935351|NCT01390818|3757280|B16||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
3935352|NCT01390818|3757281|B15||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3935353|NCT01390818|3757282|B14||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3935354|NCT01390818|3757283|B13||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3935355|NCT01390818|3757284|B12||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3935356|NCT01390818|3757285|B11||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3935357|NCT01390818|3757286|B10||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3935358|NCT01390818|3757287|B9||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3935359|NCT01390818|3757288|B8||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3935360|NCT01390818|3757289|B7||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3935361|NCT01390818|3757290|B6||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3935362|NCT01390818|3757291|B5||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3935363|NCT01390818|3757292|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3935364|NCT01390818|3757293|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3935365|NCT01390818|3757294|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3935366|NCT01390818|3757295|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3935367|NCT01390818|3757280|B16||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
3935368|NCT01390818|3757281|B15||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3935369|NCT01390818|3757282|B14||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3935370|NCT01390818|3757283|B13||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3935371|NCT01390818|3757284|B12||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3935372|NCT01390818|3757285|B11||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3935373|NCT01390818|3757286|B10||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3935374|NCT01390818|3757287|B9||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3935375|NCT01390818|3757288|B8||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3935376|NCT01390818|3757289|B7||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3935377|NCT01390818|3757290|B6||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3935378|NCT01390818|3757291|B5||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3935379|NCT01390818|3757292|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3935380|NCT01390818|3757293|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3935381|NCT01390818|3757294|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3935382|NCT01390818|3757295|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3935383|NCT01390818|3757280|B16||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3935384|NCT01390818|3757281|B15||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3935385|NCT01390818|3757282|B14||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3935386|NCT01390818|3757283|B13||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3935387|NCT01390818|3757284|B12||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3935388|NCT01390818|3757285|B11||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3935389|NCT01390818|3757286|B10||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3935390|NCT01390818|3757287|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3935391|NCT01390818|3757288|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3935392|NCT01390818|3757289|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3935393|NCT01390818|3757290|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3935394|NCT01390818|3757291|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3935395|NCT01390818|3757292|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3935396|NCT01390818|3757293|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3935397|NCT01390818|3757294|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3935398|NCT01390818|3757295|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3935399|NCT01390779|3757581|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
3935400|NCT01390779|3757581|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3935401|NCT01390779|3757581|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3935402|NCT01390779|3757581|B1|||Age||years|Mean|35|35.0|Standard Deviation|14.4|14.4|||
3935403|NCT01390779|3757581|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3935404|NCT01390779|3757581|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3935405|NCT01390779|3757581|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3935406|NCT01390649|3757586|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3935407|NCT01390649|3757586|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3935408|NCT01390649|3757586|B1|||Age||years|Mean|43.5|43.5|Standard Deviation|13.10|13.1|||
3935409|NCT01390649|3757586|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3935410|NCT01390649|3757586|B1||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
3935411|NCT01390649|3757586|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3935412|NCT01390441|3757591|B6||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3935413|NCT01390441|3757592|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3935414|NCT01390441|3757593|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3935415|NCT01390441|3757594|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3935416|NCT01390441|3757595|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3935417|NCT01390441|3757596|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3935418|NCT01390441|3757591|B6||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3935419|NCT01390441|3757592|B5||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3935420|NCT01390441|3757593|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3935421|NCT01390441|3757594|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3935422|NCT01390441|3757595|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3935423|NCT01390441|3757596|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3935424|NCT01390441|3757591|B6|||Age||years|Mean|49.1|49.1|Standard Deviation|9.9|9.9|||
3935425|NCT01390441|3757592|B5|||Age||years|Mean|46.2|46.2|Standard Deviation|10.5|10.5|||
3935426|NCT01390441|3757593|B4|||Age||years|Mean|48.7|48.7|Standard Deviation|12.4|12.4|||
3935427|NCT01390441|3757594|B3|||Age||years|Mean|46.4|46.4|Standard Deviation|10.9|10.9|||
3935428|NCT01390441|3757595|B2|||Age||years|Mean|51.5|51.5|Standard Deviation|8.4|8.4|||
3935429|NCT01390441|3757596|B1|||Age||years|Mean|51.7|51.7|Standard Deviation|6.7|6.7|||
3935430|NCT01390428|3757659|B7||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3935431|NCT01390428|3757660|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3935432|NCT01390428|3757661|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3935433|NCT01390428|3757662|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3935434|NCT01390428|3757663|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3935435|NCT01390428|3757664|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3935436|NCT01390428|3757665|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3935437|NCT01390428|3757659|B7||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3935438|NCT01390428|3757660|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3935439|NCT01390428|3757661|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3935440|NCT01390428|3757662|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3935441|NCT01390428|3757663|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3935442|NCT01390428|3757664|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3935443|NCT01390428|3757665|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3935444|NCT01390428|3757659|B7|||Age||Years|Mean|53.1|53.1|Standard Deviation|6.9|6.9|||
3935445|NCT01390428|3757660|B6|||Age||Years|Mean|52.0|52.0|Standard Deviation|9.9|9.9|||
3935446|NCT01390428|3757661|B5|||Age||Years|Mean|52.1|52.1|Standard Deviation|8.4|8.4|||
3935447|NCT01390428|3757662|B4|||Age||Years|Mean|52.3|52.3|Standard Deviation|6.8|6.8|||
3935448|NCT01390428|3757663|B3|||Age||Years|Mean|53.3|53.3|Standard Deviation|6.7|6.7|||
3935449|NCT01390428|3757664|B2|||Age||Years|Mean|54.5|54.5|Standard Deviation|5.8|5.8|||
3935450|NCT01390428|3757665|B1|||Age||Years|Mean|54.1|54.1|Standard Deviation|4.1|4.1|||
3935451|NCT01390415|3757720|B3||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3935452|NCT01390415|3757721|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3935453|NCT01390415|3757722|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3935454|NCT01390415|3757720|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3935455|NCT01390415|3757721|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3935456|NCT01390415|3757722|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3935457|NCT01390415|3757720|B3|||Age||years|Mean|59.0|59.0|Standard Deviation|7.5|7.5|||
3935458|NCT01390415|3757721|B2|||Age||years|Mean|59.7|59.7|Standard Deviation|6.0|6.0|||
3935459|NCT01390415|3757722|B1|||Age||years|Mean|58.8|58.8|Standard Deviation|8.1|8.1|||
3935460|NCT01390402|3757733|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3935461|NCT01390402|3757733|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3935462|NCT01390402|3757733|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3935463|NCT01390402|3757733|B1|||Age||years|Median|46|46.0|Full Range|||25.0|55.0|
3935464|NCT01390389|3757737|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
3935465|NCT01390389|3757738|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3935466|NCT01390389|3757739|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3935467|NCT01390389|3757737|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3935468|NCT01390389|3757738|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3935469|NCT01390389|3757739|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3935470|NCT01390389|3757737|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3935471|NCT01390389|3757738|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3935472|NCT01390389|3757739|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3935473|NCT01390389|3757737|B3|||Age||years|Mean|62.21|62.21|Standard Deviation|5.48|5.48|||
3935474|NCT01390389|3757738|B2|||Age||years|Mean|63|63.0|Standard Deviation|50.05|50.05|||
3935475|NCT01390389|3757739|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|60.2|60.2|||
3935476|NCT01390389|3757737|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3935477|NCT01390389|3757738|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3935478|NCT01390389|3757739|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3935479|NCT01390389|3757737|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3935480|NCT01390389|3757738|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3935481|NCT01390389|3757739|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3935482|NCT01390389|3757737|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3935483|NCT01390389|3757738|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3935484|NCT01390389|3757739|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3935485|NCT01390259|3757750|B1|||HbA1c|Glycated hemoglobin|percent|Mean|8.6|8.6|Standard Deviation|0.8|0.8|||
3935486|NCT01390259|3757750|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3935487|NCT01390259|3757750|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3935488|NCT01390259|3757750|B1|||Age||years|Mean|14.5|14.5|Standard Deviation|1.5|1.5|||
3935489|NCT01390246|3757760|B3|United States||Region of Enrollment||Participants|Count of Participants|65|65.0||||||
3935490|NCT01390246|3757761|B2|United States||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3935491|NCT01390246|3757762|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3935492|NCT01390246|3757760|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935493|NCT01390246|3757761|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935494|NCT01390246|3757762|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935495|NCT01390246|3757760|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935496|NCT01390246|3757761|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935497|NCT01390246|3757762|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935498|NCT01390246|3757760|B3||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3935499|NCT01390246|3757761|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3935500|NCT01390246|3757762|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3935501|NCT01390246|3757760|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3935502|NCT01390246|3757761|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3935503|NCT01390246|3757762|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3935504|NCT01390246|3757760|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935505|NCT01390246|3757761|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935506|NCT01390246|3757762|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935507|NCT01390246|3757760|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935508|NCT01390246|3757761|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935509|NCT01390246|3757762|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935510|NCT01390246|3757760|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935511|NCT01390246|3757761|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935512|NCT01390246|3757762|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935513|NCT01390246|3757760|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3935514|NCT01390246|3757761|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935515|NCT01390246|3757762|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3935516|NCT01390246|3757760|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3935517|NCT01390246|3757761|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3935518|NCT01390246|3757762|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3935519|NCT01390246|3757760|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3935520|NCT01390246|3757761|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3935521|NCT01390246|3757762|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3935522|NCT01390246|3757760|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3935523|NCT01390246|3757761|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3935524|NCT01390246|3757762|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3935525|NCT01390246|3757760|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3935526|NCT01390246|3757761|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3935527|NCT01390246|3757762|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3935528|NCT01390246|3757760|B3|||Age||years|Mean|26.2|26.2|Standard Deviation|6.2|6.2|||
3935529|NCT01390246|3757761|B2|||Age||years|Mean|27.5|27.5|Standard Deviation|6.52|6.52|||
3935530|NCT01390246|3757762|B1|||Age||years|Mean|24.5|24.5|Standard Deviation|5.56|5.56|||
3935531|NCT01390246|3757760|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3935532|NCT01390246|3757761|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3935533|NCT01390246|3757762|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3935534|NCT01390246|3757760|B3||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
3935535|NCT01390246|3757761|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3935536|NCT01390246|3757762|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3935537|NCT01390246|3757760|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3935538|NCT01390246|3757761|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3935539|NCT01390246|3757762|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3935540|NCT01390233|3757775|B4|United States||Region of Enrollment||participants|Number|101|101.0||||||
3935541|NCT01390233|3757776|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
3935542|NCT01390233|3757777|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
3935543|NCT01390233|3757778|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
3935544|NCT01390233|3757775|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3935545|NCT01390233|3757776|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3935546|NCT01390233|3757777|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3935547|NCT01390233|3757778|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3935548|NCT01390233|3757775|B4||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3935549|NCT01390233|3757776|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3935550|NCT01390233|3757777|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3935551|NCT01390233|3757778|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3935552|NCT01390233|3757775|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3935553|NCT01390233|3757776|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3935554|NCT01390233|3757777|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3935555|NCT01390233|3757778|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3935556|NCT01390233|3757775|B4||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
3935557|NCT01390233|3757776|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3935558|NCT01390233|3757777|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3935559|NCT01390233|3757778|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3935560|NCT01390233|3757775|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3935561|NCT01390233|3757776|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3935562|NCT01390233|3757777|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3935563|NCT01390233|3757778|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3935564|NCT01390233|3757775|B4|||Age||years|Mean|25|25.0|Full Range|||18.0|44.0|
3935565|NCT01390233|3757776|B3|||Age||years|Mean|26|26.0|Full Range|||18.0|44.0|
3935566|NCT01390233|3757777|B2|||Age||years|Mean|25|25.0|Full Range|||18.0|38.0|
3935567|NCT01390233|3757778|B1|||Age||years|Mean|25|25.0|Full Range|||18.0|37.0|
3935568|NCT01390181|3757788|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3935569|NCT01390181|3757788|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3935570|NCT01390181|3757788|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3935571|NCT01390181|3757788|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3935572|NCT01390181|3757788|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3935573|NCT01390181|3757788|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3935574|NCT01390038|3757792|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3935575|NCT01390038|3757792|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3935576|NCT01390038|3757792|B1|||Age||years|Mean|65.5|65.5|Standard Deviation|8.6|8.6|||
3935577|NCT01389973|3757802|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3935578|NCT01389973|3757802|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3935579|NCT01389973|3757802|B1|||Age||years|Mean|48.8|48.8|Standard Deviation|10.13|10.13|||
3935580|NCT01389882|3757810|B3|||Capillary Blood HCO3||mmol/L|Mean|23.02|23.02|Standard Deviation|6.78|6.78|||
3935581|NCT01389882|3757811|B2|||Capillary Blood HCO3||mmol/L|Mean|21.62|21.62|Standard Deviation|9.34|9.34|||
3935582|NCT01389882|3757812|B1|||Capillary Blood HCO3||mmol/L|Mean|24.20|24.2|Standard Deviation|3.45|3.45|||
3935583|NCT01389882|3757810|B3|||Capillary Blood pO2||mmHg|Mean|37.42|37.42|Standard Deviation|7.72|7.72|||
3935584|NCT01389882|3757811|B2|||Capillary Blood pO2||mmHg|Mean|37.00|37.0|Standard Deviation|8.80|8.8|||
3935585|NCT01389882|3757812|B1|||Capillary Blood pO2||mmHg|Mean|37.77|37.77|Standard Deviation|7.03|7.03|||
3935586|NCT01389882|3757810|B3|||Capillary Blood pCO2||mmHg|Mean|46.8|46.8|Standard Deviation|8.00|8.0|||
3935587|NCT01389882|3757811|B2|||Capillary Blood pCO2||mmHg|Mean|44.45|44.45|Standard Deviation|6.34|6.34|||
3935588|NCT01389882|3757812|B1|||Capillary Blood pCO2||mmHg|Mean|48.83|48.83|Standard Deviation|8.93|8.93|||
3935589|NCT01389882|3757810|B3|||Capillary Blood pH||pH|Mean|7.32|7.32|Standard Deviation|0.05|0.05|||
3935590|NCT01389882|3757811|B2|||Capillary Blood pH||pH|Mean|7.34|7.34|Standard Deviation|0.06|0.06|||
3935591|NCT01389882|3757812|B1|||Capillary Blood pH||pH|Mean|7.31|7.31|Standard Deviation|0.04|0.04|||
3935592|NCT01389882|3757810|B3|||Study Day Body Weight||g|Median|1355|1355.0|Full Range|||670.0|2580.0|
3935593|NCT01389882|3757811|B2|||Study Day Body Weight||g|Median|1530|1530.0|Full Range|||750.0|2580.0|
3935594|NCT01389882|3757812|B1|||Study Day Body Weight||g|Median|1210|1210.0|Full Range|||670.0|2530.0|
3935595|NCT01389882|3757810|B3|||Study Day Postmenstrual Age||days|Mean|221|221.0|Standard Deviation|18|18.0|||
3935596|NCT01389882|3757811|B2|||Study Day Postmenstrual Age||days|Mean|222|222.0|Standard Deviation|15|15.0|||
3935597|NCT01389882|3757812|B1|||Study Day Postmenstrual Age||days|Mean|220|220.0|Standard Deviation|20|20.0|||
3935598|NCT01389882|3757810|B3|||Birth Height||cm|Mean|37.7|37.7|Standard Deviation|6.2|6.2|||
3935599|NCT01389882|3757811|B2|||Birth Height||cm|Mean|38.3|38.3|Standard Deviation|6.7|6.7|||
3935600|NCT01389882|3757812|B1|||Birth Height||cm|Mean|37.2|37.2|Standard Deviation|5.9|5.9|||
3935601|NCT01389882|3757810|B3|||Birth Weight||g|Median|1075|1075.0|Full Range|||370.0|2510.0|
3935602|NCT01389882|3757811|B2|||Birth Weight||g|Median|1630|1630.0|Full Range|||710.0|2510.0|
3935603|NCT01389882|3757812|B1|||Birth Weight||g|Median|990|990.0|Full Range|||370.0|2510.0|
3935604|NCT01389882|3757810|B3|||Gestational Age||days|Mean|209|209.0|Standard Deviation|24|24.0|||
3935605|NCT01389882|3757811|B2|||Gestational Age||days|Mean|212|212.0|Standard Deviation|20|20.0|||
3935606|NCT01389882|3757812|B1|||Gestational Age||days|Mean|206|206.0|Standard Deviation|28|28.0|||
3935607|NCT01389882|3757810|B3|Korea, Republic of||Region of Enrollment||participants|Number|24|24.0||||||
3935608|NCT01389882|3757811|B2|Korea, Republic of||Region of Enrollment||participants|Number|11|11.0||||||
3935609|NCT01389882|3757812|B1|Korea, Republic of||Region of Enrollment||participants|Number|13|13.0||||||
3935610|NCT01389882|3757810|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3935611|NCT01389882|3757811|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3935612|NCT01389882|3757812|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3935613|NCT01389882|3757810|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3935614|NCT01389882|3757811|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3935615|NCT01389882|3757812|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3935616|NCT01389882|3757810|B3|||Age||days|Median|5|5.0|Full Range|||2.0|70.0|
3935617|NCT01389882|3757811|B2|||Age||days|Median|5|5.0|Full Range|||2.0|70.0|
3935618|NCT01389882|3757812|B1|||Age||days|Median|7|7.0|Full Range|||2.0|57.0|
3935619|NCT01389856|3757841|B3|||Gestational age||weeks|Median|39.0|39.0|Full Range|||36.0|42.0|
3935620|NCT01389856|3757842|B2|||Gestational age||weeks|Median|38.5|38.5|Full Range|||36.0|42.0|
3935621|NCT01389856|3757843|B1|||Gestational age||weeks|Median|40.0|40.0|Full Range|||36.0|41.0|
3935622|NCT01389856|3757841|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3935623|NCT01389856|3757842|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3935624|NCT01389856|3757843|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3935625|NCT01389856|3757841|B3|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3935626|NCT01389856|3757842|B2|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
3935627|NCT01389856|3757843|B1|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3935628|NCT01389856|3757841|B3|Poland||Region of Enrollment||participants|Number|8|8.0||||||
3935629|NCT01389856|3757842|B2|Poland||Region of Enrollment||participants|Number|3|3.0||||||
3935630|NCT01389856|3757843|B1|Poland||Region of Enrollment||participants|Number|5|5.0||||||
3935631|NCT01389856|3757841|B3|Korea, Republic of||Region of Enrollment||participants|Number|1|1.0||||||
3935632|NCT01389856|3757842|B2|Korea, Republic of||Region of Enrollment||participants|Number|0|0.0||||||
3935633|NCT01389856|3757843|B1|Korea, Republic of||Region of Enrollment||participants|Number|1|1.0||||||
3935634|NCT01389856|3757841|B3|France||Region of Enrollment||participants|Number|1|1.0||||||
3935635|NCT01389856|3757842|B2|France||Region of Enrollment||participants|Number|0|0.0||||||
3935636|NCT01389856|3757843|B1|France||Region of Enrollment||participants|Number|1|1.0||||||
3935637|NCT01389856|3757841|B3|Czech Republic||Region of Enrollment||participants|Number|2|2.0||||||
3935638|NCT01389856|3757842|B2|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
3935639|NCT01389856|3757843|B1|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
3935640|NCT01389856|3757841|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3935641|NCT01389856|3757842|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3935642|NCT01389856|3757843|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3935643|NCT01389856|3757841|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3935644|NCT01389856|3757842|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3935645|NCT01389856|3757843|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3935646|NCT01389856|3757841|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3935647|NCT01389856|3757842|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3935648|NCT01389856|3757843|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3935649|NCT01389856|3757841|B3|Caucasian/white||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3935650|NCT01389856|3757842|B2|Caucasian/white||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3935651|NCT01389856|3757843|B1|Caucasian/white||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3935652|NCT01389856|3757841|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3935653|NCT01389856|3757842|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3935654|NCT01389856|3757843|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3935655|NCT01389856|3757841|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3935656|NCT01389856|3757842|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3935657|NCT01389856|3757843|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3935658|NCT01389856|3757841|B3|||Age||days|Median|1.4|1.4|Full Range|||0.6|5.9|
3935659|NCT01389856|3757842|B2|||Age||days|Median|1.7|1.7|Full Range|||0.6|5.9|
3935660|NCT01389856|3757843|B1|||Age||days|Median|1.4|1.4|Full Range|||0.6|5.6|
3935661|NCT01389817|3757899|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3935662|NCT01389817|3757901|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3935663|NCT01389817|3757899|B3|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
3935664|NCT01389817|3757901|B1|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
3935665|NCT01389817|3757899|B3|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
3935666|NCT01389817|3757901|B1|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
3935667|NCT01389817|3757899|B3|White||Race (NIH/OMB)||participants|Number|4|4.0||||||
3935668|NCT01389817|3757901|B1|White||Race (NIH/OMB)||participants|Number|4|4.0||||||
3935669|NCT01389817|3757899|B3|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
3935670|NCT01389817|3757901|B1|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
3935671|NCT01389817|3757899|B3|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
3935672|NCT01389817|3757901|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
3935673|NCT01389817|3757899|B3|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
3935674|NCT01389817|3757901|B1|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
3935675|NCT01389817|3757899|B3|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
3935676|NCT01389817|3757901|B1|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
3935677|NCT01389817|3757899|B3|Male||Gender||participants|Number|4|4.0||||||
3935678|NCT01389817|3757901|B1|Male||Gender||participants|Number|4|4.0||||||
3935679|NCT01389817|3757899|B3|Female||Gender||participants|Number|0|0.0||||||
3935680|NCT01389817|3757901|B1|Female||Gender||participants|Number|0|0.0||||||
3935681|NCT01389817|3757899|B3|>=65 years||Age||participants|Number|0|0.0||||||
3935682|NCT01389817|3757901|B1|>=65 years||Age||participants|Number|0|0.0||||||
3935683|NCT01389817|3757899|B3|Between 18 and 65 years||Age||participants|Number|4|4.0||||||
3935684|NCT01389817|3757901|B1|Between 18 and 65 years||Age||participants|Number|4|4.0||||||
3935685|NCT01389817|3757899|B3|<=18 years||Age||participants|Number|0|0.0||||||
3935686|NCT01389817|3757901|B1|<=18 years||Age||participants|Number|0|0.0||||||
3935687|NCT01389765|3757908|B1|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3935688|NCT01389765|3757908|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935689|NCT01389765|3757908|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3935690|NCT01389765|3757908|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3935691|NCT01389765|3757908|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3935692|NCT01389765|3757908|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935693|NCT01389765|3757908|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935694|NCT01389765|3757908|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935695|NCT01389765|3757908|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935696|NCT01389765|3757908|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3935697|NCT01389765|3757908|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3935698|NCT01389765|3757908|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3935699|NCT01389765|3757908|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3935700|NCT01389765|3757908|B1|||Age||years|Mean|39.0|39.0|Standard Deviation|12.8|12.8|||
3935701|NCT01389752|3757919|B1|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3935702|NCT01389752|3757919|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935703|NCT01389752|3757919|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3935704|NCT01389752|3757919|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3935705|NCT01389752|3757919|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3935706|NCT01389752|3757919|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935707|NCT01389752|3757919|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935708|NCT01389752|3757919|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935709|NCT01389752|3757919|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3935710|NCT01389752|3757919|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3935711|NCT01389752|3757919|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3935712|NCT01389752|3757919|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3935713|NCT01389752|3757919|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3935714|NCT01389752|3757919|B1|||Age||years|Mean|35.2|35.2|Standard Deviation|9.3|9.3|||
3935715|NCT01389596|3757930|B4||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3935716|NCT01389596|3757931|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3935717|NCT01389596|3757932|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3935718|NCT01389596|3757933|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3935719|NCT01389596|3757930|B4||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3935720|NCT01389596|3757931|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3935721|NCT01389596|3757932|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3935722|NCT01389596|3757933|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3935723|NCT01389596|3757930|B4|||Age||years|Mean|10.2|10.2|Standard Deviation|3.7|3.7|||
3935724|NCT01389596|3757931|B3|||Age||years|Mean|10.3|10.3|Standard Deviation|3.7|3.7|||
3935725|NCT01389596|3757932|B2|||Age||years|Mean|10.1|10.1|Standard Deviation|3.5|3.5|||
3935726|NCT01389596|3757933|B1|||Age||years|Mean|10.2|10.2|Standard Deviation|3.9|3.9|||
3935727|NCT01389323|3757994|B1|Minor Homozygous (TT)||rs12979860 Single Nucleotide Polymorphism in the Interleukin-28B Gene||participants|Number|62|62.0||||||
3935728|NCT01389323|3757994|B1|Heterozygous (CT)||rs12979860 Single Nucleotide Polymorphism in the Interleukin-28B Gene||participants|Number|134|134.0||||||
3935729|NCT01389323|3757994|B1|Wild Type (CC)||rs12979860 Single Nucleotide Polymorphism in the Interleukin-28B Gene||participants|Number|50|50.0||||||
3935730|NCT01389323|3757994|B1|Subtype 1||Hepatitis C Virus Genotype||participants|Number|1|1.0||||||
3935731|NCT01389323|3757994|B1|Subtype 1B||Hepatitis C Virus Genotype||participants|Number|54|54.0||||||
3935732|NCT01389323|3757994|B1|Subtype 1A||Hepatitis C Virus Genotype||participants|Number|191|191.0||||||
3935733|NCT01389323|3757994|B1|≥800,000 IU/mL||Hepatitis C Virus RNA Distribution||participants|Number|182|182.0||||||
3935734|NCT01389323|3757994|B1|<800,000 IU/mL||Hepatitis C Virus RNA Distribution||participants|Number|64|64.0||||||
3935735|NCT01389323|3757994|B1|||Hepatitis C Virus RNA Levels||Log10 IU/mL|Mean|6.21|6.21|Standard Deviation|0.684|0.684|||
3935736|NCT01389323|3757994|B1|White/Caucasian Non-Latino||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3935737|NCT01389323|3757994|B1|White Latino||Race/Ethnicity, Customized||participants|Number|88|88.0||||||
3935738|NCT01389323|3757994|B1|Black/African American Non-Latino||Race/Ethnicity, Customized||participants|Number|109|109.0||||||
3935739|NCT01389323|3757994|B1|Black/African American Latino||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3935740|NCT01389323|3757994|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935741|NCT01389323|3757994|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935742|NCT01389323|3757994|B1||White|Race (NIH/OMB)||Participants|Count of Participants|118|118.0||||||
3935743|NCT01389323|3757994|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
3935744|NCT01389323|3757994|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935745|NCT01389323|3757994|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935746|NCT01389323|3757994|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935747|NCT01389323|3757994|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935748|NCT01389323|3757994|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|139|139.0||||||
3935749|NCT01389323|3757994|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
3935750|NCT01389323|3757994|B1||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
3935751|NCT01389323|3757994|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3935752|NCT01389323|3757994|B1|||Age||years|Mean|51.8|51.8|Standard Deviation|9.94|9.94|||
3935753|NCT01389284|3758014|B4|3 = Severe||Pain Intensity Score|Pain intensity was evaluated using a 4-point Categorical Pain Intensity Rating Scale: 0 = none, 1 = mild, 2 = moderate, 3 = severe|Participants|Number|54|54.0||||||
3935754|NCT01389284|3758015|B3|3 = Severe||Pain Intensity Score|Pain intensity was evaluated using a 4-point Categorical Pain Intensity Rating Scale: 0 = none, 1 = mild, 2 = moderate, 3 = severe|Participants|Number|7|7.0||||||
3935755|NCT01389284|3758016|B2|3 = Severe||Pain Intensity Score|Pain intensity was evaluated using a 4-point Categorical Pain Intensity Rating Scale: 0 = none, 1 = mild, 2 = moderate, 3 = severe|Participants|Number|23|23.0||||||
3935756|NCT01389284|3758017|B1|3 = Severe||Pain Intensity Score|Pain intensity was evaluated using a 4-point Categorical Pain Intensity Rating Scale: 0 = none, 1 = mild, 2 = moderate, 3 = severe|Participants|Number|24|24.0||||||
3935757|NCT01389284|3758014|B4|2 = Moderate||Pain Intensity Score|Pain intensity was evaluated using a 4-point Categorical Pain Intensity Rating Scale: 0 = none, 1 = mild, 2 = moderate, 3 = severe|Participants|Number|246|246.0||||||
3935758|NCT01389284|3758015|B3|2 = Moderate||Pain Intensity Score|Pain intensity was evaluated using a 4-point Categorical Pain Intensity Rating Scale: 0 = none, 1 = mild, 2 = moderate, 3 = severe|Participants|Number|53|53.0||||||
3935759|NCT01389284|3758016|B2|2 = Moderate||Pain Intensity Score|Pain intensity was evaluated using a 4-point Categorical Pain Intensity Rating Scale: 0 = none, 1 = mild, 2 = moderate, 3 = severe|Participants|Number|97|97.0||||||
3935760|NCT01389284|3758017|B1|2 = Moderate||Pain Intensity Score|Pain intensity was evaluated using a 4-point Categorical Pain Intensity Rating Scale: 0 = none, 1 = mild, 2 = moderate, 3 = severe|Participants|Number|96|96.0||||||
3935761|NCT01389284|3758014|B4|1 = Mild||Pain Intensity Score|Pain intensity was evaluated using a 4-point Categorical Pain Intensity Rating Scale: 0 = none, 1 = mild, 2 = moderate, 3 = severe|Participants|Number|0|0.0||||||
3935762|NCT01389284|3758015|B3|1 = Mild||Pain Intensity Score|Pain intensity was evaluated using a 4-point Categorical Pain Intensity Rating Scale: 0 = none, 1 = mild, 2 = moderate, 3 = severe|Participants|Number|0|0.0||||||
3935763|NCT01389284|3758016|B2|1 = Mild||Pain Intensity Score|Pain intensity was evaluated using a 4-point Categorical Pain Intensity Rating Scale: 0 = none, 1 = mild, 2 = moderate, 3 = severe|Participants|Number|0|0.0||||||
3935764|NCT01389284|3758017|B1|1 = Mild||Pain Intensity Score|Pain intensity was evaluated using a 4-point Categorical Pain Intensity Rating Scale: 0 = none, 1 = mild, 2 = moderate, 3 = severe|Participants|Number|0|0.0||||||
3935765|NCT01389284|3758014|B4|0 = None||Pain Intensity Score|Pain intensity was evaluated using a 4-point Categorical Pain Intensity Rating Scale: 0 = none, 1 = mild, 2 = moderate, 3 = severe|Participants|Number|0|0.0||||||
3935766|NCT01389284|3758015|B3|0 = None||Pain Intensity Score|Pain intensity was evaluated using a 4-point Categorical Pain Intensity Rating Scale: 0 = none, 1 = mild, 2 = moderate, 3 = severe|Participants|Number|0|0.0||||||
3935767|NCT01389284|3758016|B2|0 = None||Pain Intensity Score|Pain intensity was evaluated using a 4-point Categorical Pain Intensity Rating Scale: 0 = none, 1 = mild, 2 = moderate, 3 = severe|Participants|Number|0|0.0||||||
3935768|NCT01389284|3758017|B1|0 = None||Pain Intensity Score|Pain intensity was evaluated using a 4-point Categorical Pain Intensity Rating Scale: 0 = none, 1 = mild, 2 = moderate, 3 = severe|Participants|Number|0|0.0||||||
3935769|NCT01389284|3758014|B4||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3935770|NCT01389284|3758015|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3935771|NCT01389284|3758016|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3935772|NCT01389284|3758017|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3935773|NCT01389284|3758014|B4||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3935774|NCT01389284|3758015|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3935775|NCT01389284|3758016|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3935776|NCT01389284|3758017|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3935777|NCT01389284|3758014|B4|||Age||Years|Mean|23.8|23.8|Standard Deviation|5.28|5.28|||
3935778|NCT01389284|3758015|B3|||Age||Years|Mean|25.0|25.0|Standard Deviation|6.56|6.56|||
3935779|NCT01389284|3758016|B2|||Age||Years|Mean|23.0|23.0|Standard Deviation|4.67|4.67|||
3935780|NCT01389284|3758017|B1|||Age||Years|Mean|24.0|24.0|Standard Deviation|5.05|5.05|||
3935781|NCT01389102|3758051|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3935782|NCT01389102|3758052|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3935783|NCT01389102|3758053|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3935784|NCT01389102|3758054|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3935785|NCT01389102|3758055|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3935786|NCT01389102|3758056|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3935787|NCT01389102|3758057|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3935788|NCT01389102|3758051|B7||Female|Sex: Female, Male||Participants|Count of Participants|454|454.0||||||
3935789|NCT01389102|3758052|B6||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3935790|NCT01389102|3758053|B5||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3935791|NCT01389102|3758054|B4||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3935792|NCT01389102|3758055|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3935793|NCT01389102|3758056|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3935794|NCT01389102|3758057|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3935795|NCT01389102|3758051|B7|||Age||years|Mean|52.7|52.7|Standard Deviation|6.5|6.5|||
3935796|NCT01389102|3758052|B6|||Age||years|Mean|53.5|53.5|Standard Deviation|6.8|6.8|||
3935797|NCT01389102|3758053|B5|||Age||years|Mean|52.2|52.2|Standard Deviation|6.8|6.8|||
3935798|NCT01389102|3758054|B4|||Age||years|Mean|52.3|52.3|Standard Deviation|5.7|5.7|||
3935799|NCT01389102|3758055|B3|||Age||years|Mean|52.8|52.8|Standard Deviation|6.9|6.9|||
3935800|NCT01389102|3758056|B2|||Age||years|Mean|52.0|52.0|Standard Deviation|7.0|7.0|||
3935801|NCT01389102|3758057|B1|||Age||years|Mean|52.0|52.0|Standard Deviation|6.3|6.3|||
3935802|NCT01389076|3758082|B1||Male|Gender||Participants|Count of Participants|13|13.0||||||
3935803|NCT01389076|3758082|B1||Female|Gender||Participants|Count of Participants|9|9.0||||||
3935804|NCT01389076|3758082|B1|||Age||years|Median|56|56.0|Full Range|||36.0|74.0|
3935805|NCT01388946|3758090|B3|Greece||Region of Enrollment||participants|Number|110|110.0||||||
3935806|NCT01388946|3758091|B2|Greece||Region of Enrollment||participants|Number|55|55.0||||||
3935807|NCT01388946|3758092|B1|Greece||Region of Enrollment||participants|Number|55|55.0||||||
3935808|NCT01388946|3758090|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3935809|NCT01388946|3758091|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3935810|NCT01388946|3758092|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3935811|NCT01388946|3758090|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3935812|NCT01388946|3758091|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3935813|NCT01388946|3758092|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3935814|NCT01388946|3758090|B3|||Age||years|Mean|50|50.0|Standard Deviation|11.9|11.9|||
3935815|NCT01388946|3758091|B2|||Age||years|Mean|48|48.0|Standard Deviation|12.5|12.5|||
3935816|NCT01388946|3758092|B1|||Age||years|Mean|51|51.0|Standard Deviation|11.2|11.2|||
3935817|NCT01388946|3758090|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3935818|NCT01388946|3758091|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3935819|NCT01388946|3758092|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3935820|NCT01388946|3758090|B3||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
3935821|NCT01388946|3758091|B2||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
3935822|NCT01388946|3758092|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3935823|NCT01388946|3758090|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3935824|NCT01388946|3758091|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3935825|NCT01388946|3758092|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3935826|NCT01388920|3758125|B4|United States||Region of Enrollment||participants|Number|2|2.0||||||
3935827|NCT01388920|3758127|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3935828|NCT01388920|3758128|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3935829|NCT01388920|3758125|B4|Male||Gender||participants|Number|1|1.0||||||
3935830|NCT01388920|3758127|B2|Male||Gender||participants|Number|0|0.0||||||
3935831|NCT01388920|3758128|B1|Male||Gender||participants|Number|1|1.0||||||
3935832|NCT01388920|3758125|B4|Female||Gender||participants|Number|1|1.0||||||
3935833|NCT01388920|3758127|B2|Female||Gender||participants|Number|1|1.0||||||
3935834|NCT01388920|3758128|B1|Female||Gender||participants|Number|0|0.0||||||
3935835|NCT01388920|3758125|B4|||Age||years|Mean|55|55.0|Standard Deviation|0|0.0|||
3935836|NCT01388920|3758127|B2|||Age||years|Mean|51|51.0|Standard Deviation|0|0.0|||
3935837|NCT01388920|3758128|B1|||Age||years|Mean|59|59.0|Standard Deviation|0|0.0|||
3935838|NCT01388907|3758138|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3935839|NCT01388907|3758139|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3935840|NCT01388907|3758140|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3935841|NCT01388907|3758138|B3||Female|Gender||Participants|Count of Participants|61|61.0||||||
3935842|NCT01388907|3758139|B2||Female|Gender||Participants|Count of Participants|28|28.0||||||
3935843|NCT01388907|3758140|B1||Female|Gender||Participants|Count of Participants|33|33.0||||||
3935844|NCT01388907|3758138|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3935845|NCT01388907|3758139|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3935846|NCT01388907|3758140|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3935847|NCT01388907|3758138|B3||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
3935848|NCT01388907|3758139|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3935849|NCT01388907|3758140|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3935850|NCT01388907|3758138|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3935851|NCT01388907|3758139|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3935852|NCT01388907|3758140|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3935853|NCT01388816|3758153|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935854|NCT01388816|3758154|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935855|NCT01388816|3758155|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935856|NCT01388816|3758156|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935857|NCT01388816|3758157|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935858|NCT01388816|3758153|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935859|NCT01388816|3758154|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935860|NCT01388816|3758155|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935861|NCT01388816|3758156|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935862|NCT01388816|3758157|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935863|NCT01388816|3758153|B5||White|Race (NIH/OMB)||Participants|Count of Participants|175|175.0||||||
3935864|NCT01388816|3758154|B4||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3935865|NCT01388816|3758155|B3||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3935866|NCT01388816|3758156|B2||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3935867|NCT01388816|3758157|B1||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3935868|NCT01388816|3758153|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935869|NCT01388816|3758154|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935870|NCT01388816|3758155|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935871|NCT01388816|3758156|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935872|NCT01388816|3758157|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935873|NCT01388816|3758153|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935874|NCT01388816|3758154|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935875|NCT01388816|3758155|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935876|NCT01388816|3758156|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935877|NCT01388816|3758157|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935878|NCT01388816|3758153|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3935879|NCT01388816|3758154|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935880|NCT01388816|3758155|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3935881|NCT01388816|3758156|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935882|NCT01388816|3758157|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935883|NCT01388816|3758153|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935884|NCT01388816|3758154|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935885|NCT01388816|3758155|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935886|NCT01388816|3758156|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935887|NCT01388816|3758157|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935888|NCT01388816|3758153|B5||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3935889|NCT01388816|3758154|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3935890|NCT01388816|3758155|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3935891|NCT01388816|3758156|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3935892|NCT01388816|3758157|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3935893|NCT01388816|3758153|B5||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3935894|NCT01388816|3758154|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3935895|NCT01388816|3758155|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3935896|NCT01388816|3758156|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3935897|NCT01388816|3758157|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3935898|NCT01388816|3758153|B5|||Age||Years|Mean|55.8|55.8|Standard Deviation|9.91|9.91|||
3935899|NCT01388816|3758154|B4|||Age||Years|Mean|56.2|56.2|Standard Deviation|10.74|10.74|||
3935900|NCT01388816|3758155|B3|||Age||Years|Mean|54.2|54.2|Standard Deviation|10.48|10.48|||
3935901|NCT01388816|3758156|B2|||Age||Years|Mean|55.8|55.8|Standard Deviation|9.93|9.93|||
3935902|NCT01388816|3758157|B1|||Age||Years|Mean|57.0|57.0|Standard Deviation|8.49|8.49|||
3935903|NCT01388790|3758189|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3935904|NCT01388790|3758189|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3935905|NCT01388790|3758189|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|10.09|10.09|||
3935906|NCT01388777|3758194|B1|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3935907|NCT01388777|3758194|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935908|NCT01388777|3758194|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935909|NCT01388777|3758194|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935910|NCT01388777|3758194|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3935911|NCT01388777|3758194|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935912|NCT01388777|3758194|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935913|NCT01388777|3758194|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3935914|NCT01388777|3758194|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3935915|NCT01388777|3758194|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3935916|NCT01388777|3758194|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3935917|NCT01388777|3758194|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3935918|NCT01388777|3758194|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3935919|NCT01388647|3758198|B3|||Body Mass Index||kg/m^2|Mean|32.4|32.4|Standard Deviation|5.52|5.52|||
3935920|NCT01388647|3758199|B2|||Body Mass Index||kg/m^2|Mean|32.4|32.4|Standard Deviation|4.59|4.59|||
3935921|NCT01388647|3758200|B1|||Body Mass Index||kg/m^2|Mean|32.4|32.4|Standard Deviation|6.79|6.79|||
3935922|NCT01388647|3758198|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3935923|NCT01388647|3758199|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3935924|NCT01388647|3758200|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3935925|NCT01388647|3758198|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3935926|NCT01388647|3758199|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3935927|NCT01388647|3758200|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3935928|NCT01388647|3758198|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3935929|NCT01388647|3758199|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3935930|NCT01388647|3758200|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3935931|NCT01388647|3758198|B3|||Age||years|Mean|53.1|53.1|Standard Deviation|7.96|7.96|||
3935932|NCT01388647|3758199|B2|||Age||years|Mean|53.0|53.0|Standard Deviation|9.14|9.14|||
3935933|NCT01388647|3758200|B1|||Age||years|Mean|53.2|53.2|Standard Deviation|7.47|7.47|||
3935934|NCT01388647|3758198|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3935935|NCT01388647|3758199|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3935936|NCT01388647|3758200|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3935937|NCT01388647|3758198|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3935938|NCT01388647|3758199|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3935939|NCT01388647|3758200|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3935940|NCT01388647|3758198|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3935941|NCT01388647|3758199|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3935942|NCT01388647|3758200|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3935943|NCT01388530|3758212|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3935944|NCT01388530|3758212|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3935945|NCT01388530|3758212|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3935946|NCT01388530|3758212|B1|||Age||years|Mean|10.14|10.14|Standard Deviation|1.98|1.98|||
3935947|NCT01388530|3758212|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3935948|NCT01388530|3758212|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3935949|NCT01388530|3758212|B1||<=18 years|Age||Participants|Count of Participants|25|25.0||||||
3935950|NCT01388491|3758219|B3|||Body Mass Index (BMI)||kg/m^2|Mean|22.6|22.6|Standard Deviation|3.36|3.36|||
3935951|NCT01388491|3758220|B2|||Body Mass Index (BMI)||kg/m^2|Mean|22.4|22.4|Standard Deviation|3.06|3.06|||
3935952|NCT01388491|3758221|B1|||Body Mass Index (BMI)||kg/m^2|Mean|22.9|22.9|Standard Deviation|3.62|3.62|||
3935953|NCT01388491|3758219|B3|||Weight||kg|Mean|60.9|60.9|Standard Deviation|9.89|9.89|||
3935954|NCT01388491|3758220|B2|||Weight||kg|Mean|60.1|60.1|Standard Deviation|9.36|9.36|||
3935955|NCT01388491|3758221|B1|||Weight||kg|Mean|61.6|61.6|Standard Deviation|10.35|10.35|||
3935956|NCT01388491|3758219|B3|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3935957|NCT01388491|3758220|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3935958|NCT01388491|3758221|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3935959|NCT01388491|3758219|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3935960|NCT01388491|3758220|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3935961|NCT01388491|3758221|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3935962|NCT01388491|3758219|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3935963|NCT01388491|3758220|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3935964|NCT01388491|3758221|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3935965|NCT01388491|3758219|B3|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3935966|NCT01388491|3758220|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3935967|NCT01388491|3758221|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3935968|NCT01388491|3758219|B3|White||Race/Ethnicity, Customized||participants|Number|276|276.0||||||
3935969|NCT01388491|3758220|B2|White||Race/Ethnicity, Customized||participants|Number|136|136.0||||||
3935970|NCT01388491|3758221|B1|White||Race/Ethnicity, Customized||participants|Number|140|140.0||||||
3935971|NCT01388491|3758219|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3935972|NCT01388491|3758220|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3935973|NCT01388491|3758221|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3935974|NCT01388491|3758219|B3||Female|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
3935975|NCT01388491|3758220|B2||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3935976|NCT01388491|3758221|B1||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3935977|NCT01388491|3758219|B3|||Age||years|Mean|26.7|26.7|Standard Deviation|5.12|5.12|||
3935978|NCT01388491|3758220|B2|||Age||years|Mean|27.0|27.0|Standard Deviation|5.26|5.26|||
3935979|NCT01388491|3758221|B1|||Age||years|Mean|26.4|26.4|Standard Deviation|4.98|4.98|||
3935980|NCT01388361|3758254|B4|||Fasting plasma glucose (FPG)|Randomised population.|mmol/L|Mean|6.3|6.3|Standard Deviation|2.1|2.1|||
3935981|NCT01388361|3758255|B3|||Fasting plasma glucose (FPG)|Randomised population.|mmol/L|Mean|6.1|6.1|Standard Deviation|1.7|1.7|||
3935982|NCT01388361|3758256|B2|||Fasting plasma glucose (FPG)|Randomised population.|mmol/L|Mean|6.4|6.4|Standard Deviation|2.4|2.4|||
3935983|NCT01388361|3758257|B1|||Fasting plasma glucose (FPG)|Randomised population.|mmol/L|Mean|NA||Standard Deviation|NA||||Values available in the previous row, baseline values for non-randomised arm IDeg.
3935984|NCT01388361|3758254|B4|||Fasting plasma glucose (FPG)|Non-randomised population.|mmol/L|Mean|6.7|6.7|Standard Deviation|1.8|1.8|||
3935985|NCT01388361|3758255|B3|||Fasting plasma glucose (FPG)|Non-randomised population.|mmol/L|Mean|NA||Standard Deviation|NA||||Values available in the next row, baseline values for IDeg + Liraglutide vs. IDeg + IAsp OD.
3935986|NCT01388361|3758256|B2|||Fasting plasma glucose (FPG)|Non-randomised population.|mmol/L|Mean|NA||Standard Deviation|NA||||Values available in the next row, baseline values for IDeg + Liraglutide vs. IDeg + IAsp OD.
3935987|NCT01388361|3758257|B1|||Fasting plasma glucose (FPG)|Non-randomised population.|mmol/L|Mean|6.7|6.7|Standard Deviation|1.8|1.8|||
3935988|NCT01388361|3758254|B4|||Glycosylated haemoglobin (HbA1c)|Randomised population.|percentage of glycosylated haemoglobin|Mean|7.7|7.7|Standard Deviation|0.7|0.7|||
3935989|NCT01388361|3758255|B3|||Glycosylated haemoglobin (HbA1c)|Randomised population.|percentage of glycosylated haemoglobin|Mean|7.7|7.7|Standard Deviation|0.8|0.8|||
3935990|NCT01388361|3758256|B2|||Glycosylated haemoglobin (HbA1c)|Randomised population.|percentage of glycosylated haemoglobin|Mean|7.7|7.7|Standard Deviation|0.6|0.6|||
3935991|NCT01388361|3758257|B1|||Glycosylated haemoglobin (HbA1c)|Randomised population.|percentage of glycosylated haemoglobin|Mean|NA||Standard Deviation|NA||||Values available in the previous row, baseline values for non-randomised arm IDeg.
3935992|NCT01388361|3758254|B4|||Glycosylated haemoglobin (HbA1c)|Non-randomised population.|percentage of glycosylated haemoglobin|Mean|6.4|6.4|Standard Deviation|0.4|0.4|||
3935993|NCT01388361|3758255|B3|||Glycosylated haemoglobin (HbA1c)|Non-randomised population.|percentage of glycosylated haemoglobin|Mean|NA||Standard Deviation|NA||||Values available in the next row, baseline values for IDeg + Liraglutide vs. IDeg + IAsp OD.
3935994|NCT01388361|3758256|B2|||Glycosylated haemoglobin (HbA1c)|Non-randomised population.|percentage of glycosylated haemoglobin|Mean|NA||Standard Deviation|NA||||Values available in the next row, baseline values for IDeg + Liraglutide vs. IDeg + IAsp OD.
3935995|NCT01388361|3758257|B1|||Glycosylated haemoglobin (HbA1c)|Non-randomised population.|percentage of glycosylated haemoglobin|Mean|6.4|6.4|Standard Deviation|0.4|0.4|||
3935996|NCT01388361|3758254|B4||Male|Sex: Female, Male|Randomised population.|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3935997|NCT01388361|3758255|B3||Male|Sex: Female, Male|Randomised population.|Participants|Count of Participants|53|53.0||||||
3935998|NCT01388361|3758256|B2||Male|Sex: Female, Male|Randomised population.|Participants|Count of Participants|63|63.0||||||
3935999|NCT01388361|3758257|B1||Male|Sex: Female, Male|Randomised population.|Participants|Count of Participants|NA|||||||Values available in the previous row, baseline values for non-randomised arm IDeg.
3936000|NCT01388361|3758254|B4||Female|Sex: Female, Male|Randomised population.|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3936001|NCT01388361|3758255|B3||Female|Sex: Female, Male|Randomised population.|Participants|Count of Participants|36|36.0||||||
3936002|NCT01388361|3758256|B2||Female|Sex: Female, Male|Randomised population.|Participants|Count of Participants|25|25.0||||||
3936003|NCT01388361|3758257|B1||Female|Sex: Female, Male|Randomised population.|Participants|Count of Participants|NA|||||||Values available in the previous row, baseline values for non-randomised arm IDeg.
3936004|NCT01388361|3758254|B4||Male|Sex: Female, Male|Non-randomised population.|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3936005|NCT01388361|3758255|B3||Male|Sex: Female, Male|Non-randomised population.|Participants|Count of Participants|NA|||||||Values available in the next row, baseline values for IDeg + Liraglutide vs. IDeg + IAsp OD.
3936006|NCT01388361|3758256|B2||Male|Sex: Female, Male|Non-randomised population.|Participants|Count of Participants|NA|||||||Values available in the next row, baseline values for IDeg + Liraglutide vs. IDeg + IAsp OD.
3936007|NCT01388361|3758257|B1||Male|Sex: Female, Male|Non-randomised population.|Participants|Count of Participants|146|146.0||||||
3936008|NCT01388361|3758254|B4||Female|Sex: Female, Male|Non-randomised population.|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3936009|NCT01388361|3758255|B3||Female|Sex: Female, Male|Non-randomised population.|Participants|Count of Participants|NA|||||||Values available in the next row, baseline values for IDeg + Liraglutide vs. IDeg + IAsp OD.
3936010|NCT01388361|3758256|B2||Female|Sex: Female, Male|Non-randomised population.|Participants|Count of Participants|NA|||||||Values available in the next row, baseline values for IDeg + Liraglutide vs. IDeg + IAsp OD.
3936011|NCT01388361|3758257|B1||Female|Sex: Female, Male|Non-randomised population.|Participants|Count of Participants|90|90.0||||||
3936012|NCT01388361|3758254|B4|||Age|Randomised population.|years|Mean|61.0|61.0|Standard Deviation|9.2|9.2|||
3936013|NCT01388361|3758255|B3|||Age|Randomised population.|years|Mean|60.9|60.9|Standard Deviation|8.8|8.8|||
3936014|NCT01388361|3758256|B2|||Age|Randomised population.|years|Mean|61.1|61.1|Standard Deviation|9.5|9.5|||
3936015|NCT01388361|3758257|B1|||Age|Randomised population.|years|Mean|NA||Standard Deviation|NA||||Values available in the previous row, baseline values for non-randomised arm IDeg.
3936016|NCT01388361|3758254|B4|||Age|Non-randomised population.|years|Mean|61.9|61.9|Standard Deviation|9.3|9.3|||
3936017|NCT01388361|3758255|B3|||Age|Non-randomised population.|years|Mean|NA||Standard Deviation|NA||||Values available in the next row, baseline values for IDeg + Liraglutide vs. IDeg + IAsp OD.
3936018|NCT01388361|3758256|B2|||Age|Non-randomised population.|years|Mean|NA||Standard Deviation|NA||||Values available in the next row, baseline values for IDeg + Liraglutide vs. IDeg + IAsp OD.
3936081|NCT01387672|3758303|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3936019|NCT01388361|3758257|B1|||Age|Non-randomised population.|years|Mean|61.9|61.9|Standard Deviation|9.3|9.3|||
3936020|NCT01388166|3758276|B1||Male|Sex: Female, Male||Participants|Count of Participants|773|773.0||||||
3936021|NCT01388166|3758276|B1||Female|Sex: Female, Male||Participants|Count of Participants|480|480.0||||||
3936022|NCT01388166|3758276|B1|||Age||years|Mean|63.7|63.7|Standard Deviation|9.95|9.95|||
3936023|NCT01387789|3758282|B1|Malaysia||Region of Enrollment||participants|Number|71|71.0||||||
3936024|NCT01387789|3758282|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3936025|NCT01387789|3758282|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3936026|NCT01387789|3758282|B1|60-69 years of age||Age, Customized||participants|Number|7|7.0||||||
3936027|NCT01387789|3758282|B1|50-59 years of age||Age, Customized||participants|Number|26|26.0||||||
3936028|NCT01387789|3758282|B1|40-49 years of age||Age, Customized||participants|Number|16|16.0||||||
3936029|NCT01387789|3758282|B1|30-39 years of age||Age, Customized||participants|Number|18|18.0||||||
3936030|NCT01387789|3758282|B1|<30 years of age||Age, Customized||participants|Number|4|4.0||||||
3936031|NCT01387737|3758294|B3||Male|Sex: Female, Male||Participants|Count of Participants|924|924.0||||||
3936032|NCT01387737|3758295|B2||Male|Sex: Female, Male||Participants|Count of Participants|503|503.0||||||
3936033|NCT01387737|3758296|B1||Male|Sex: Female, Male||Participants|Count of Participants|421|421.0||||||
3936034|NCT01387737|3758294|B3||Female|Sex: Female, Male||Participants|Count of Participants|375|375.0||||||
3936035|NCT01387737|3758295|B2||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
3936036|NCT01387737|3758296|B1||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3936037|NCT01387737|3758294|B3||>=65 years|Age||Participants|Count of Participants|343|343.0||||||
3936038|NCT01387737|3758295|B2||>=65 years|Age||Participants|Count of Participants|195|195.0||||||
3936039|NCT01387737|3758296|B1||>=65 years|Age||Participants|Count of Participants|148|148.0||||||
3936040|NCT01387737|3758294|B3||Between 18 and 65 years|Age||Participants|Count of Participants|956|956.0||||||
3936041|NCT01387737|3758295|B2||Between 18 and 65 years|Age||Participants|Count of Participants|520|520.0||||||
3936042|NCT01387737|3758296|B1||Between 18 and 65 years|Age||Participants|Count of Participants|436|436.0||||||
3936043|NCT01387737|3758294|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3936044|NCT01387737|3758295|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3936045|NCT01387737|3758296|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3936046|NCT01387672|3758303|B7|Canada||Region of Enrollment||participants|Number|229|229.0||||||
3936047|NCT01387672|3758304|B6|Canada||Region of Enrollment||participants|Number|37|37.0||||||
3936048|NCT01387672|3758305|B5|Canada||Region of Enrollment||participants|Number|38|38.0||||||
3936049|NCT01387672|3758306|B4|Canada||Region of Enrollment||participants|Number|39|39.0||||||
3936050|NCT01387672|3758307|B3|Canada||Region of Enrollment||participants|Number|38|38.0||||||
3936051|NCT01387672|3758308|B2|Canada||Region of Enrollment||participants|Number|38|38.0||||||
3936052|NCT01387672|3758309|B1|Canada||Region of Enrollment||participants|Number|39|39.0||||||
3936053|NCT01387672|3758303|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3936054|NCT01387672|3758304|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3936055|NCT01387672|3758305|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3936056|NCT01387672|3758306|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3936057|NCT01387672|3758307|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3936058|NCT01387672|3758308|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3936059|NCT01387672|3758309|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3936060|NCT01387672|3758303|B7||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
3936061|NCT01387672|3758304|B6||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3936062|NCT01387672|3758305|B5||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3936063|NCT01387672|3758306|B4||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3936064|NCT01387672|3758307|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3936065|NCT01387672|3758308|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3936066|NCT01387672|3758309|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3936067|NCT01387672|3758303|B7||>=65 years|Age||Participants|Count of Participants|103|103.0||||||
3936068|NCT01387672|3758304|B6||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3936069|NCT01387672|3758305|B5||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3936070|NCT01387672|3758306|B4||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3936071|NCT01387672|3758307|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3936072|NCT01387672|3758308|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3936073|NCT01387672|3758309|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3936074|NCT01387672|3758303|B7||Between 18 and 65 years|Age||Participants|Count of Participants|126|126.0||||||
3936075|NCT01387672|3758304|B6||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3936076|NCT01387672|3758305|B5||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3936077|NCT01387672|3758306|B4||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3936078|NCT01387672|3758307|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3936079|NCT01387672|3758308|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3936080|NCT01387672|3758309|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3936082|NCT01387672|3758304|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3936083|NCT01387672|3758305|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3936084|NCT01387672|3758306|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3936085|NCT01387672|3758307|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3936086|NCT01387672|3758308|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3936087|NCT01387672|3758309|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3936088|NCT01387607|3758329|B3|Fibromyalgia duration since diagnosis||Primary Diagnoses and Durations||years|Mean|0.3|0.3|Standard Deviation|1.1|1.1|||
3936089|NCT01387607|3758330|B2|Fibromyalgia duration since diagnosis||Primary Diagnoses and Durations||years|Mean|0.4|0.4|Standard Deviation|1.2|1.2|||
3936090|NCT01387607|3758331|B1|Fibromyalgia duration since diagnosis||Primary Diagnoses and Durations||years|Mean|0.3|0.3|Standard Deviation|1.0|1.0|||
3936091|NCT01387607|3758329|B3|Fibromyalgia duration since onset of symptoms||Primary Diagnoses and Durations||years|Mean|5.8|5.8|Standard Deviation|6.7|6.7|||
3936092|NCT01387607|3758330|B2|Fibromyalgia duration since onset of symptoms||Primary Diagnoses and Durations||years|Mean|5.6|5.6|Standard Deviation|6.4|6.4|||
3936093|NCT01387607|3758331|B1|Fibromyalgia duration since onset of symptoms||Primary Diagnoses and Durations||years|Mean|6.0|6.0|Standard Deviation|7.0|7.0|||
3936094|NCT01387607|3758329|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3936095|NCT01387607|3758330|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3936096|NCT01387607|3758331|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3936097|NCT01387607|3758329|B3||Female|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
3936098|NCT01387607|3758330|B2||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3936099|NCT01387607|3758331|B1||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3936100|NCT01387607|3758329|B3|||Age||years|Mean|44.0|44.0|Standard Deviation|11.1|11.1|||
3936101|NCT01387607|3758330|B2|||Age||years|Mean|43.5|43.5|Standard Deviation|10.6|10.6|||
3936102|NCT01387607|3758331|B1|||Age||years|Mean|44.5|44.5|Standard Deviation|11.5|11.5|||
3936103|NCT01387594|3758384|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3936104|NCT01387594|3758385|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3936105|NCT01387594|3758386|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3936106|NCT01387594|3758384|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3936107|NCT01387594|3758385|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3936108|NCT01387594|3758386|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3936109|NCT01387594|3758384|B3|More than or equal to (>=) 65 years||Age, Customized||participants|Number|0|0.0||||||
3936110|NCT01387594|3758385|B2|More than or equal to (>=) 65 years||Age, Customized||participants|Number|0|0.0||||||
3936111|NCT01387594|3758386|B1|More than or equal to (>=) 65 years||Age, Customized||participants|Number|0|0.0||||||
3936112|NCT01387594|3758384|B3|45-64 years||Age, Customized||participants|Number|16|16.0||||||
3936113|NCT01387594|3758385|B2|45-64 years||Age, Customized||participants|Number|12|12.0||||||
3936114|NCT01387594|3758386|B1|45-64 years||Age, Customized||participants|Number|4|4.0||||||
3936115|NCT01387594|3758384|B3|18-44 years||Age, Customized||participants|Number|33|33.0||||||
3936116|NCT01387594|3758385|B2|18-44 years||Age, Customized||participants|Number|27|27.0||||||
3936117|NCT01387594|3758386|B1|18-44 years||Age, Customized||participants|Number|6|6.0||||||
3936118|NCT01387594|3758384|B3|||Age||years|Mean|38.1|38.1|Standard Deviation|11.8|11.8|||
3936119|NCT01387594|3758385|B2|||Age||years|Mean|37.4|37.4|Standard Deviation|10.6|10.6|||
3936120|NCT01387594|3758386|B1|||Age||years|Mean|40.9|40.9|Standard Deviation|15.9|15.9|||
3936121|NCT01387581|3758399|B4|> 60 years||Years in Practice||participants|Number|77|77.0||||||
3936122|NCT01387581|3758400|B3|> 60 years||Years in Practice||participants|Number|2|2.0||||||
3936123|NCT01387581|3758401|B2|> 60 years||Years in Practice||participants|Number|36|36.0||||||
3936124|NCT01387581|3758402|B1|> 60 years||Years in Practice||participants|Number|39|39.0||||||
3936125|NCT01387581|3758399|B4|16 - 20 years||Years in Practice||participants|Number|56|56.0||||||
3936126|NCT01387581|3758400|B3|16 - 20 years||Years in Practice||participants|Number|4|4.0||||||
3936127|NCT01387581|3758401|B2|16 - 20 years||Years in Practice||participants|Number|25|25.0||||||
3936128|NCT01387581|3758402|B1|16 - 20 years||Years in Practice||participants|Number|27|27.0||||||
3936129|NCT01387581|3758399|B4|11 - 15 years||Years in Practice||participants|Number|51|51.0||||||
3936130|NCT01387581|3758400|B3|11 - 15 years||Years in Practice||participants|Number|2|2.0||||||
3936131|NCT01387581|3758401|B2|11 - 15 years||Years in Practice||participants|Number|23|23.0||||||
3936132|NCT01387581|3758402|B1|11 - 15 years||Years in Practice||participants|Number|26|26.0||||||
3936133|NCT01387581|3758399|B4|5 - 10 years||Years in Practice||participants|Number|26|26.0||||||
3936134|NCT01387581|3758400|B3|5 - 10 years||Years in Practice||participants|Number|1|1.0||||||
3936135|NCT01387581|3758401|B2|5 - 10 years||Years in Practice||participants|Number|17|17.0||||||
3936136|NCT01387581|3758402|B1|5 - 10 years||Years in Practice||participants|Number|8|8.0||||||
3936137|NCT01387581|3758399|B4|< 5 years||Years in Practice||participants|Number|1|1.0||||||
3936138|NCT01387581|3758400|B3|< 5 years||Years in Practice||participants|Number|0|0.0||||||
3936139|NCT01387581|3758401|B2|< 5 years||Years in Practice||participants|Number|0|0.0||||||
3936140|NCT01387581|3758402|B1|< 5 years||Years in Practice||participants|Number|1|1.0||||||
3936141|NCT01387581|3758399|B4|Always||Dermoscopy use||participants|Number|93|93.0||||||
3936142|NCT01387581|3758400|B3|Always||Dermoscopy use||participants|Number|3|3.0||||||
3936143|NCT01387581|3758401|B2|Always||Dermoscopy use||participants|Number|38|38.0||||||
3936144|NCT01387581|3758402|B1|Always||Dermoscopy use||participants|Number|52|52.0||||||
3936145|NCT01387581|3758399|B4|Almost all||Dermoscopy use||participants|Number|60|60.0||||||
3936146|NCT01387581|3758400|B3|Almost all||Dermoscopy use||participants|Number|1|1.0||||||
3936147|NCT01387581|3758401|B2|Almost all||Dermoscopy use||participants|Number|31|31.0||||||
3936148|NCT01387581|3758402|B1|Almost all||Dermoscopy use||participants|Number|28|28.0||||||
3936149|NCT01387581|3758399|B4|> half of pigmented skin lesions||Dermoscopy use||participants|Number|35|35.0||||||
3936150|NCT01387581|3758400|B3|> half of pigmented skin lesions||Dermoscopy use||participants|Number|2|2.0||||||
3936151|NCT01387581|3758401|B2|> half of pigmented skin lesions||Dermoscopy use||participants|Number|16|16.0||||||
3936152|NCT01387581|3758402|B1|> half of pigmented skin lesions||Dermoscopy use||participants|Number|17|17.0||||||
3936153|NCT01387581|3758399|B4|< half of pigmented skin lesions||Dermoscopy use||participants|Number|23|23.0||||||
3936154|NCT01387581|3758400|B3|< half of pigmented skin lesions||Dermoscopy use||participants|Number|3|3.0||||||
3936155|NCT01387581|3758401|B2|< half of pigmented skin lesions||Dermoscopy use||participants|Number|16|16.0||||||
3936156|NCT01387581|3758402|B1|< half of pigmented skin lesions||Dermoscopy use||participants|Number|4|4.0||||||
3936157|NCT01387581|3758399|B4|Rarely||Dermoscopy use||participants|Number|0|0.0||||||
3936158|NCT01387581|3758400|B3|Rarely||Dermoscopy use||participants|Number|0|0.0||||||
3936159|NCT01387581|3758401|B2|Rarely||Dermoscopy use||participants|Number|0|0.0||||||
3936160|NCT01387581|3758402|B1|Rarely||Dermoscopy use||participants|Number|0|0.0||||||
3936161|NCT01387581|3758399|B4|Never||Dermoscopy use||participants|Number|0|0.0||||||
3936162|NCT01387581|3758400|B3|Never||Dermoscopy use||participants|Number|0|0.0||||||
3936163|NCT01387581|3758401|B2|Never||Dermoscopy use||participants|Number|0|0.0||||||
3936164|NCT01387581|3758402|B1|Never||Dermoscopy use||participants|Number|0|0.0||||||
3936165|NCT01387581|3758399|B4|Germany||Region of Enrollment||participants|Number|211|211.0||||||
3936166|NCT01387581|3758400|B3|Germany||Region of Enrollment||participants|Number|9|9.0||||||
3936167|NCT01387581|3758401|B2|Germany||Region of Enrollment||participants|Number|101|101.0||||||
3936168|NCT01387581|3758402|B1|Germany||Region of Enrollment||participants|Number|101|101.0||||||
3936169|NCT01387581|3758399|B4||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3936170|NCT01387581|3758400|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3936171|NCT01387581|3758401|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3936172|NCT01387581|3758402|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3936173|NCT01387581|3758399|B4||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3936174|NCT01387581|3758400|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3936175|NCT01387581|3758401|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3936176|NCT01387581|3758402|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3936177|NCT01387581|3758399|B4|> 60 years||Age, Customized||participants|Number|11|11.0||||||
3936178|NCT01387581|3758400|B3|> 60 years||Age, Customized||participants|Number|0|0.0||||||
3936179|NCT01387581|3758401|B2|> 60 years||Age, Customized||participants|Number|5|5.0||||||
3936180|NCT01387581|3758402|B1|> 60 years||Age, Customized||participants|Number|6|6.0||||||
3936181|NCT01387581|3758399|B4|51-60 years||Age, Customized||participants|Number|61|61.0||||||
3936182|NCT01387581|3758400|B3|51-60 years||Age, Customized||participants|Number|2|2.0||||||
3936183|NCT01387581|3758401|B2|51-60 years||Age, Customized||participants|Number|30|30.0||||||
3936184|NCT01387581|3758402|B1|51-60 years||Age, Customized||participants|Number|29|29.0||||||
3936185|NCT01387581|3758399|B4|41-50 years||Age, Customized||participants|Number|97|97.0||||||
3936186|NCT01387581|3758400|B3|41-50 years||Age, Customized||participants|Number|5|5.0||||||
3936187|NCT01387581|3758401|B2|41-50 years||Age, Customized||participants|Number|44|44.0||||||
3936188|NCT01387581|3758402|B1|41-50 years||Age, Customized||participants|Number|48|48.0||||||
3936189|NCT01387581|3758399|B4|31-40 years||Age, Customized||participants|Number|42|42.0||||||
3936190|NCT01387581|3758400|B3|31-40 years||Age, Customized||participants|Number|2|2.0||||||
3936191|NCT01387581|3758401|B2|31-40 years||Age, Customized||participants|Number|22|22.0||||||
3936192|NCT01387581|3758402|B1|31-40 years||Age, Customized||participants|Number|18|18.0||||||
3936193|NCT01387542|3758415|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3936194|NCT01387542|3758415|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3936195|NCT01387542|3758415|B1|||Age||Years|Mean|41.13|41.13|Standard Deviation|12.314|12.314|||
3936196|NCT01387464|3758422|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3936197|NCT01387464|3758423|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3936198|NCT01387464|3758424|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3936199|NCT01387464|3758422|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3936200|NCT01387464|3758423|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3936201|NCT01387464|3758424|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3936202|NCT01387464|3758422|B3|>70 years||Age, Customized||participants|Number|31|31.0||||||
3936203|NCT01387464|3758423|B2|>70 years||Age, Customized||participants|Number|12|12.0||||||
3936204|NCT01387464|3758424|B1|>70 years||Age, Customized||participants|Number|19|19.0||||||
3936205|NCT01387464|3758422|B3|51-70 years||Age, Customized||participants|Number|28|28.0||||||
3936206|NCT01387464|3758423|B2|51-70 years||Age, Customized||participants|Number|18|18.0||||||
3936207|NCT01387464|3758424|B1|51-70 years||Age, Customized||participants|Number|10|10.0||||||
3936208|NCT01387464|3758422|B3|31-50 years||Age, Customized||participants|Number|1|1.0||||||
3936209|NCT01387464|3758423|B2|31-50 years||Age, Customized||participants|Number|0|0.0||||||
3936210|NCT01387464|3758424|B1|31-50 years||Age, Customized||participants|Number|1|1.0||||||
3936211|NCT01387464|3758422|B3|18-30 years||Age, Customized||participants|Number|0|0.0||||||
3936212|NCT01387464|3758423|B2|18-30 years||Age, Customized||participants|Number|0|0.0||||||
3936213|NCT01387464|3758424|B1|18-30 years||Age, Customized||participants|Number|0|0.0||||||
3936214|NCT01387464|3758422|B3|||Age||years|Mean|69.4|69.4|Standard Deviation|9.8|9.8|||
3936215|NCT01387464|3758423|B2|||Age||years|Mean|68.2|68.2|Standard Deviation|9.5|9.5|||
3936216|NCT01387464|3758424|B1|||Age||years|Mean|70.6|70.6|Standard Deviation|10.14|10.14|||
3936217|NCT01387347|3758431|B3|United States||Region of Enrollment||participants|Number|72|72.0||||||
3936218|NCT01387347|3758432|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
3936219|NCT01387347|3758433|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
3936220|NCT01387347|3758431|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3936221|NCT01387347|3758432|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3936222|NCT01387347|3758433|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3936223|NCT01387347|3758431|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3936224|NCT01387347|3758432|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3936225|NCT01387347|3758433|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3936226|NCT01387347|3758431|B3|||Age||years|Mean|56.02|56.02|Standard Deviation|12.37|12.37|||
3936227|NCT01387347|3758432|B2|||Age||years|Mean|57.1|57.1|Standard Deviation|12.07|12.07|||
3936228|NCT01387347|3758433|B1|||Age||years|Mean|55.3|55.3|Standard Deviation|12.76|12.76|||
3936229|NCT01387347|3758431|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3936230|NCT01387347|3758432|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3936231|NCT01387347|3758433|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3936232|NCT01387347|3758431|B3||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3936233|NCT01387347|3758432|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3936234|NCT01387347|3758433|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3936235|NCT01387347|3758431|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3936236|NCT01387347|3758432|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3936237|NCT01387347|3758433|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3936238|NCT01387282|3758444|B3||Australia|Geographic region||Participants|Count of Participants|22|22.0||||||
3936239|NCT01387282|3758445|B2||Australia|Geographic region||Participants|Count of Participants|8|8.0||||||
3936240|NCT01387282|3758446|B1||Australia|Geographic region||Participants|Count of Participants|14|14.0||||||
3936241|NCT01387282|3758444|B3||East Europe + Russia|Geographic region||Participants|Count of Participants|241|241.0||||||
3936242|NCT01387282|3758445|B2||East Europe + Russia|Geographic region||Participants|Count of Participants|77|77.0||||||
3936243|NCT01387282|3758446|B1||East Europe + Russia|Geographic region||Participants|Count of Participants|164|164.0||||||
3936244|NCT01387282|3758444|B3||West Europe|Geographic region||Participants|Count of Participants|217|217.0||||||
3936245|NCT01387282|3758445|B2||West Europe|Geographic region||Participants|Count of Participants|75|75.0||||||
3936246|NCT01387282|3758446|B1||West Europe|Geographic region||Participants|Count of Participants|142|142.0||||||
3936247|NCT01387282|3758444|B3||North America|Geographic region||Participants|Count of Participants|15|15.0||||||
3936248|NCT01387282|3758445|B2||North America|Geographic region||Participants|Count of Participants|5|5.0||||||
3936249|NCT01387282|3758446|B1||North America|Geographic region||Participants|Count of Participants|10|10.0||||||
3936250|NCT01387282|3758444|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
3936251|NCT01387282|3758445|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3936252|NCT01387282|3758446|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3936253|NCT01387282|3758444|B3|Russian Federation||Region of Enrollment||participants|Number|133|133.0||||||
3936254|NCT01387282|3758445|B2|Russian Federation||Region of Enrollment||participants|Number|41|41.0||||||
3936255|NCT01387282|3758446|B1|Russian Federation||Region of Enrollment||participants|Number|92|92.0||||||
3936256|NCT01387282|3758444|B3|Israel||Region of Enrollment||participants|Number|13|13.0||||||
3936257|NCT01387282|3758445|B2|Israel||Region of Enrollment||participants|Number|5|5.0||||||
3936258|NCT01387282|3758446|B1|Israel||Region of Enrollment||participants|Number|8|8.0||||||
3936259|NCT01387282|3758444|B3|Australia||Region of Enrollment||participants|Number|22|22.0||||||
3936260|NCT01387282|3758445|B2|Australia||Region of Enrollment||participants|Number|8|8.0||||||
3936261|NCT01387282|3758446|B1|Australia||Region of Enrollment||participants|Number|14|14.0||||||
3936262|NCT01387282|3758444|B3|Hungary||Region of Enrollment||participants|Number|108|108.0||||||
3936263|NCT01387282|3758445|B2|Hungary||Region of Enrollment||participants|Number|36|36.0||||||
3936264|NCT01387282|3758446|B1|Hungary||Region of Enrollment||participants|Number|72|72.0||||||
3936265|NCT01387282|3758444|B3|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3936266|NCT01387282|3758445|B2|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3936267|NCT01387282|3758446|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3936268|NCT01387282|3758444|B3|Poland||Region of Enrollment||participants|Number|203|203.0||||||
3936269|NCT01387282|3758445|B2|Poland||Region of Enrollment||participants|Number|70|70.0||||||
3936270|NCT01387282|3758446|B1|Poland||Region of Enrollment||participants|Number|133|133.0||||||
3936271|NCT01387282|3758444|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3936272|NCT01387282|3758445|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3936273|NCT01387282|3758446|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3936274|NCT01387282|3758444|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936275|NCT01387282|3758445|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936276|NCT01387282|3758446|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936277|NCT01387282|3758444|B3||White|Race (NIH/OMB)||Participants|Count of Participants|488|488.0||||||
3936278|NCT01387282|3758445|B2||White|Race (NIH/OMB)||Participants|Count of Participants|162|162.0||||||
3936279|NCT01387282|3758446|B1||White|Race (NIH/OMB)||Participants|Count of Participants|326|326.0||||||
3936280|NCT01387282|3758444|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3936281|NCT01387282|3758445|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3936282|NCT01387282|3758446|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3936283|NCT01387282|3758444|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3936284|NCT01387282|3758445|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936285|NCT01387282|3758446|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3936286|NCT01387282|3758444|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3936287|NCT01387282|3758445|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3936288|NCT01387282|3758446|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936289|NCT01387282|3758444|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936290|NCT01387282|3758445|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936291|NCT01387282|3758446|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936292|NCT01387282|3758444|B3||Male|Sex: Female, Male||Participants|Count of Participants|362|362.0||||||
3936293|NCT01387282|3758445|B2||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3936294|NCT01387282|3758446|B1||Male|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
3936295|NCT01387282|3758444|B3||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3936296|NCT01387282|3758445|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3936297|NCT01387282|3758446|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3936298|NCT01387282|3758444|B3||>=65 years|Age||Participants|Count of Participants|178|178.0||||||
3936299|NCT01387282|3758445|B2||>=65 years|Age||Participants|Count of Participants|57|57.0||||||
3936300|NCT01387282|3758446|B1||>=65 years|Age||Participants|Count of Participants|121|121.0||||||
3936301|NCT01387282|3758444|B3||Between 18 and 65 years|Age||Participants|Count of Participants|317|317.0||||||
3936302|NCT01387282|3758445|B2||Between 18 and 65 years|Age||Participants|Count of Participants|108|108.0||||||
3936303|NCT01387282|3758446|B1||Between 18 and 65 years|Age||Participants|Count of Participants|209|209.0||||||
3936304|NCT01387282|3758444|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3936305|NCT01387282|3758445|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3936306|NCT01387282|3758446|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3936307|NCT01387269|3758461|B3||Australia|Geographic region||Participants|Count of Participants|0|0.0||||||
3936308|NCT01387269|3758462|B2||Australia|Geographic region||Participants|Count of Participants|0|0.0||||||
3936309|NCT01387269|3758463|B1||Australia|Geographic region||Participants|Count of Participants|0|0.0||||||
3936310|NCT01387269|3758461|B3||East Europe + Russia|Geographic region||Participants|Count of Participants|248|248.0||||||
3936311|NCT01387269|3758462|B2||East Europe + Russia|Geographic region||Participants|Count of Participants|82|82.0||||||
3936312|NCT01387269|3758463|B1||East Europe + Russia|Geographic region||Participants|Count of Participants|166|166.0||||||
3936313|NCT01387269|3758461|B3||West Europe|Geographic region||Participants|Count of Participants|184|184.0||||||
3936314|NCT01387269|3758462|B2||West Europe|Geographic region||Participants|Count of Participants|62|62.0||||||
3936315|NCT01387269|3758463|B1||West Europe|Geographic region||Participants|Count of Participants|122|122.0||||||
3936316|NCT01387269|3758461|B3||North America|Geographic region||Participants|Count of Participants|52|52.0||||||
3936317|NCT01387269|3758462|B2||North America|Geographic region||Participants|Count of Participants|17|17.0||||||
3936318|NCT01387269|3758463|B1||North America|Geographic region||Participants|Count of Participants|35|35.0||||||
3936319|NCT01387269|3758461|B3|Italy||Region of Enrollment||participants|Number|14|14.0||||||
3936320|NCT01387269|3758462|B2|Italy||Region of Enrollment||participants|Number|5|5.0||||||
3936321|NCT01387269|3758463|B1|Italy||Region of Enrollment||participants|Number|9|9.0||||||
3936322|NCT01387269|3758461|B3|Germany||Region of Enrollment||participants|Number|13|13.0||||||
3936323|NCT01387269|3758462|B2|Germany||Region of Enrollment||participants|Number|3|3.0||||||
3936324|NCT01387269|3758463|B1|Germany||Region of Enrollment||participants|Number|10|10.0||||||
3936325|NCT01387269|3758461|B3|France||Region of Enrollment||participants|Number|14|14.0||||||
3936326|NCT01387269|3758462|B2|France||Region of Enrollment||participants|Number|6|6.0||||||
3936327|NCT01387269|3758463|B1|France||Region of Enrollment||participants|Number|8|8.0||||||
3936328|NCT01387269|3758461|B3|Czech Republic||Region of Enrollment||participants|Number|27|27.0||||||
3936329|NCT01387269|3758462|B2|Czech Republic||Region of Enrollment||participants|Number|11|11.0||||||
3936330|NCT01387269|3758463|B1|Czech Republic||Region of Enrollment||participants|Number|16|16.0||||||
3936331|NCT01387269|3758461|B3|Belgium||Region of Enrollment||participants|Number|15|15.0||||||
3936332|NCT01387269|3758462|B2|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
3936333|NCT01387269|3758463|B1|Belgium||Region of Enrollment||participants|Number|11|11.0||||||
3936334|NCT01387269|3758461|B3|Spain||Region of Enrollment||participants|Number|16|16.0||||||
3936335|NCT01387269|3758462|B2|Spain||Region of Enrollment||participants|Number|3|3.0||||||
3936336|NCT01387269|3758463|B1|Spain||Region of Enrollment||participants|Number|13|13.0||||||
3936337|NCT01387269|3758461|B3|Slovenia||Region of Enrollment||participants|Number|9|9.0||||||
3936338|NCT01387269|3758462|B2|Slovenia||Region of Enrollment||participants|Number|4|4.0||||||
3936339|NCT01387269|3758463|B1|Slovenia||Region of Enrollment||participants|Number|5|5.0||||||
3936340|NCT01387269|3758461|B3|Poland||Region of Enrollment||participants|Number|74|74.0||||||
3936341|NCT01387269|3758462|B2|Poland||Region of Enrollment||participants|Number|26|26.0||||||
3936342|NCT01387269|3758463|B1|Poland||Region of Enrollment||participants|Number|48|48.0||||||
3936343|NCT01387269|3758461|B3|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
3936344|NCT01387269|3758462|B2|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
3936345|NCT01387269|3758463|B1|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
3936346|NCT01387269|3758461|B3|Canada||Region of Enrollment||participants|Number|15|15.0||||||
3936347|NCT01387269|3758462|B2|Canada||Region of Enrollment||participants|Number|6|6.0||||||
3936348|NCT01387269|3758463|B1|Canada||Region of Enrollment||participants|Number|9|9.0||||||
3936349|NCT01387269|3758461|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
3936350|NCT01387269|3758462|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3936351|NCT01387269|3758463|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
3936352|NCT01387269|3758461|B3|Belarus||Region of Enrollment||participants|Number|24|24.0||||||
3936353|NCT01387269|3758462|B2|Belarus||Region of Enrollment||participants|Number|9|9.0||||||
3936354|NCT01387269|3758463|B1|Belarus||Region of Enrollment||participants|Number|15|15.0||||||
3936355|NCT01387269|3758461|B3|Ukraine||Region of Enrollment||participants|Number|199|199.0||||||
3936356|NCT01387269|3758462|B2|Ukraine||Region of Enrollment||participants|Number|66|66.0||||||
3936357|NCT01387269|3758463|B1|Ukraine||Region of Enrollment||participants|Number|133|133.0||||||
3936358|NCT01387269|3758461|B3|Serbia||Region of Enrollment||participants|Number|13|13.0||||||
3936359|NCT01387269|3758462|B2|Serbia||Region of Enrollment||participants|Number|3|3.0||||||
3936360|NCT01387269|3758463|B1|Serbia||Region of Enrollment||participants|Number|10|10.0||||||
3936361|NCT01387269|3758461|B3|Russian Federation||Region of Enrollment||participants|Number|12|12.0||||||
3936362|NCT01387269|3758462|B2|Russian Federation||Region of Enrollment||participants|Number|4|4.0||||||
3936363|NCT01387269|3758463|B1|Russian Federation||Region of Enrollment||participants|Number|8|8.0||||||
3936364|NCT01387269|3758461|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3936365|NCT01387269|3758462|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3936366|NCT01387269|3758463|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3936367|NCT01387269|3758461|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936368|NCT01387269|3758462|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936369|NCT01387269|3758463|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936370|NCT01387269|3758461|B3||White|Race (NIH/OMB)||Participants|Count of Participants|478|478.0||||||
3936371|NCT01387269|3758462|B2||White|Race (NIH/OMB)||Participants|Count of Participants|159|159.0||||||
3936372|NCT01387269|3758463|B1||White|Race (NIH/OMB)||Participants|Count of Participants|319|319.0||||||
3936373|NCT01387269|3758461|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3936374|NCT01387269|3758462|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936375|NCT01387269|3758463|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3936376|NCT01387269|3758461|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936377|NCT01387269|3758462|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936378|NCT01387269|3758463|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936379|NCT01387269|3758461|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3936380|NCT01387269|3758462|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936381|NCT01387269|3758463|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3936382|NCT01387269|3758461|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936383|NCT01387269|3758462|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936384|NCT01387269|3758463|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936385|NCT01387269|3758461|B3||Male|Sex: Female, Male||Participants|Count of Participants|368|368.0||||||
3936386|NCT01387269|3758462|B2||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3936387|NCT01387269|3758463|B1||Male|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
3936388|NCT01387269|3758461|B3||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3936389|NCT01387269|3758462|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3936390|NCT01387269|3758463|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3936391|NCT01387269|3758461|B3||>=65 years|Age||Participants|Count of Participants|164|164.0||||||
3936392|NCT01387269|3758462|B2||>=65 years|Age||Participants|Count of Participants|56|56.0||||||
3936393|NCT01387269|3758463|B1||>=65 years|Age||Participants|Count of Participants|108|108.0||||||
3936394|NCT01387269|3758461|B3||Between 18 and 65 years|Age||Participants|Count of Participants|320|320.0||||||
3936395|NCT01387269|3758462|B2||Between 18 and 65 years|Age||Participants|Count of Participants|105|105.0||||||
3936396|NCT01387269|3758463|B1||Between 18 and 65 years|Age||Participants|Count of Participants|215|215.0||||||
3936397|NCT01387269|3758461|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3936398|NCT01387269|3758462|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3936399|NCT01387269|3758463|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3936400|NCT01387230|3758478|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|179|179.0||||||
3936401|NCT01387230|3758479|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|61|61.0||||||
3936402|NCT01387230|3758480|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|60|60.0||||||
3936403|NCT01387230|3758481|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|58|58.0||||||
3936404|NCT01387230|3758478|B4|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3936405|NCT01387230|3758479|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3936406|NCT01387230|3758480|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3936407|NCT01387230|3758481|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3936408|NCT01387230|3758478|B4|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
3936409|NCT01387230|3758479|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3936410|NCT01387230|3758480|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3936411|NCT01387230|3758481|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3936412|NCT01387230|3758478|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3936413|NCT01387230|3758479|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3936414|NCT01387230|3758480|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3936415|NCT01387230|3758481|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3936416|NCT01387230|3758478|B4||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3936417|NCT01387230|3758479|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3936418|NCT01387230|3758480|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3936419|NCT01387230|3758481|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3936420|NCT01387230|3758478|B4||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3936421|NCT01387230|3758479|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3936422|NCT01387230|3758480|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3936423|NCT01387230|3758481|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3936424|NCT01387230|3758478|B4|||Age||Years|Mean|63.1|63.1|Standard Deviation|8.77|8.77|||
3936425|NCT01387230|3758479|B3|||Age||Years|Mean|64.6|64.6|Standard Deviation|7.96|7.96|||
3936426|NCT01387230|3758480|B2|||Age||Years|Mean|62.3|62.3|Standard Deviation|9.50|9.5|||
3936427|NCT01387230|3758481|B1|||Age||Years|Mean|62.5|62.5|Standard Deviation|8.72|8.72|||
3936428|NCT01387178|3758497|B3|Severe||Number of Participants with the Indicated COPD Severity|Mild, moderate, and severe COPD were defined by an algorithm for retrospective data analyses that is based on COPD-related healthcare encounters such as intensive care unit stays, hospitalizations, emergency department/urgent care visits, and the use of oxygen.|participants|Number|3035|3035.0||||||
3936429|NCT01387178|3758498|B2|Severe||Number of Participants with the Indicated COPD Severity|Mild, moderate, and severe COPD were defined by an algorithm for retrospective data analyses that is based on COPD-related healthcare encounters such as intensive care unit stays, hospitalizations, emergency department/urgent care visits, and the use of oxygen.|participants|Number|1645|1645.0||||||
3936430|NCT01387178|3758499|B1|Severe||Number of Participants with the Indicated COPD Severity|Mild, moderate, and severe COPD were defined by an algorithm for retrospective data analyses that is based on COPD-related healthcare encounters such as intensive care unit stays, hospitalizations, emergency department/urgent care visits, and the use of oxygen.|participants|Number|1390|1390.0||||||
3936431|NCT01387178|3758497|B3|Moderate||Number of Participants with the Indicated COPD Severity|Mild, moderate, and severe COPD were defined by an algorithm for retrospective data analyses that is based on COPD-related healthcare encounters such as intensive care unit stays, hospitalizations, emergency department/urgent care visits, and the use of oxygen.|participants|Number|1270|1270.0||||||
3936432|NCT01387178|3758498|B2|Moderate||Number of Participants with the Indicated COPD Severity|Mild, moderate, and severe COPD were defined by an algorithm for retrospective data analyses that is based on COPD-related healthcare encounters such as intensive care unit stays, hospitalizations, emergency department/urgent care visits, and the use of oxygen.|participants|Number|520|520.0||||||
3936433|NCT01387178|3758499|B1|Moderate||Number of Participants with the Indicated COPD Severity|Mild, moderate, and severe COPD were defined by an algorithm for retrospective data analyses that is based on COPD-related healthcare encounters such as intensive care unit stays, hospitalizations, emergency department/urgent care visits, and the use of oxygen.|participants|Number|750|750.0||||||
3936434|NCT01387178|3758497|B3|Mild||Number of Participants with the Indicated COPD Severity|Mild, moderate, and severe COPD were defined by an algorithm for retrospective data analyses that is based on COPD-related healthcare encounters such as intensive care unit stays, hospitalizations, emergency department/urgent care visits, and the use of oxygen.|participants|Number|17918|17918.0||||||
3936435|NCT01387178|3758498|B2|Mild||Number of Participants with the Indicated COPD Severity|Mild, moderate, and severe COPD were defined by an algorithm for retrospective data analyses that is based on COPD-related healthcare encounters such as intensive care unit stays, hospitalizations, emergency department/urgent care visits, and the use of oxygen.|participants|Number|8476|8476.0||||||
3936436|NCT01387178|3758499|B1|Mild||Number of Participants with the Indicated COPD Severity|Mild, moderate, and severe COPD were defined by an algorithm for retrospective data analyses that is based on COPD-related healthcare encounters such as intensive care unit stays, hospitalizations, emergency department/urgent care visits, and the use of oxygen.|participants|Number|9442|9442.0||||||
3936437|NCT01387178|3758497|B3|Oxygen use||Number of the Indicated Pre-Index Period Treatments||number of treatments|Number|2727|2727.0||||||
3936438|NCT01387178|3758498|B2|Oxygen use||Number of the Indicated Pre-Index Period Treatments||number of treatments|Number|1517|1517.0||||||
3936439|NCT01387178|3758499|B1|Oxygen use||Number of the Indicated Pre-Index Period Treatments||number of treatments|Number|1210|1210.0||||||
3936440|NCT01387178|3758497|B3|Long-acting beta-agonist use||Number of the Indicated Pre-Index Period Treatments||number of treatments|Number|798|798.0||||||
3936441|NCT01387178|3758498|B2|Long-acting beta-agonist use||Number of the Indicated Pre-Index Period Treatments||number of treatments|Number|556|556.0||||||
3936442|NCT01387178|3758499|B1|Long-acting beta-agonist use||Number of the Indicated Pre-Index Period Treatments||number of treatments|Number|242|242.0||||||
3936443|NCT01387178|3758497|B3|Lower respiratory infection||Number of the Indicated Pre-Index Period COPD-related comorbidities|The pre-index period was defined as the 12 months prior to the index date, which corresponded with the start of the study medication.|number of comorbidities|Number|1006|1006.0||||||
3936444|NCT01387178|3758498|B2|Lower respiratory infection||Number of the Indicated Pre-Index Period COPD-related comorbidities|The pre-index period was defined as the 12 months prior to the index date, which corresponded with the start of the study medication.|number of comorbidities|Number|475|475.0||||||
3936445|NCT01387178|3758499|B1|Lower respiratory infection||Number of the Indicated Pre-Index Period COPD-related comorbidities|The pre-index period was defined as the 12 months prior to the index date, which corresponded with the start of the study medication.|number of comorbidities|Number|531|531.0||||||
3936446|NCT01387178|3758497|B3|Upper respiratory infection||Number of the Indicated Pre-Index Period COPD-related comorbidities|The pre-index period was defined as the 12 months prior to the index date, which corresponded with the start of the study medication.|number of comorbidities|Number|7347|7347.0||||||
3936447|NCT01387178|3758498|B2|Upper respiratory infection||Number of the Indicated Pre-Index Period COPD-related comorbidities|The pre-index period was defined as the 12 months prior to the index date, which corresponded with the start of the study medication.|number of comorbidities|Number|2952|2952.0||||||
3936448|NCT01387178|3758499|B1|Upper respiratory infection||Number of the Indicated Pre-Index Period COPD-related comorbidities|The pre-index period was defined as the 12 months prior to the index date, which corresponded with the start of the study medication.|number of comorbidities|Number|4395|4395.0||||||
3936449|NCT01387178|3758497|B3|Congestive heart failure||Number of the Indicated Pre-Index Period COPD-related comorbidities|The pre-index period was defined as the 12 months prior to the index date, which corresponded with the start of the study medication.|number of comorbidities|Number|3096|3096.0||||||
3936450|NCT01387178|3758498|B2|Congestive heart failure||Number of the Indicated Pre-Index Period COPD-related comorbidities|The pre-index period was defined as the 12 months prior to the index date, which corresponded with the start of the study medication.|number of comorbidities|Number|1624|1624.0||||||
3936451|NCT01387178|3758499|B1|Congestive heart failure||Number of the Indicated Pre-Index Period COPD-related comorbidities|The pre-index period was defined as the 12 months prior to the index date, which corresponded with the start of the study medication.|number of comorbidities|Number|1472|1472.0||||||
3936452|NCT01387178|3758497|B3|Asthma||Number of the Indicated Pre-Index Period COPD-related comorbidities|The pre-index period was defined as the 12 months prior to the index date, which corresponded with the start of the study medication.|number of comorbidities|Number|4977|4977.0||||||
3936453|NCT01387178|3758498|B2|Asthma||Number of the Indicated Pre-Index Period COPD-related comorbidities|The pre-index period was defined as the 12 months prior to the index date, which corresponded with the start of the study medication.|number of comorbidities|Number|1651|1651.0||||||
3936454|NCT01387178|3758499|B1|Asthma||Number of the Indicated Pre-Index Period COPD-related comorbidities|The pre-index period was defined as the 12 months prior to the index date, which corresponded with the start of the study medication.|number of comorbidities|Number|3326|3326.0||||||
3936455|NCT01387178|3758497|B3|||Charlson Comorbidity Score|The Charlson Comorbidity Index estimates 10-year mortality risk. Scores range from 0 - 37, with a lower score indicating a higher chance of survival.|scores on a scale|Mean|1.6|1.6|Standard Deviation|2.1|2.1|||
3936456|NCT01387178|3758498|B2|||Charlson Comorbidity Score|The Charlson Comorbidity Index estimates 10-year mortality risk. Scores range from 0 - 37, with a lower score indicating a higher chance of survival.|scores on a scale|Mean|1.6|1.6|Standard Deviation|2.2|2.2|||
3936457|NCT01387178|3758499|B1|||Charlson Comorbidity Score|The Charlson Comorbidity Index estimates 10-year mortality risk. Scores range from 0 - 37, with a lower score indicating a higher chance of survival.|scores on a scale|Mean|1.6|1.6|Standard Deviation|2.1|2.1|||
3936458|NCT01387178|3758497|B3|Medicare||Number of participants with the indicated payer source|Participants were classified according to the type of healthcare payer with which they were associated.|participants|Number|2592|2592.0||||||
3936459|NCT01387178|3758498|B2|Medicare||Number of participants with the indicated payer source|Participants were classified according to the type of healthcare payer with which they were associated.|participants|Number|1364|1364.0||||||
3936460|NCT01387178|3758499|B1|Medicare||Number of participants with the indicated payer source|Participants were classified according to the type of healthcare payer with which they were associated.|participants|Number|1228|1228.0||||||
3936461|NCT01387178|3758497|B3|Medicaid||Number of participants with the indicated payer source|Participants were classified according to the type of healthcare payer with which they were associated.|participants|Number|171|171.0||||||
3936462|NCT01387178|3758498|B2|Medicaid||Number of participants with the indicated payer source|Participants were classified according to the type of healthcare payer with which they were associated.|participants|Number|50|50.0||||||
3936463|NCT01387178|3758499|B1|Medicaid||Number of participants with the indicated payer source|Participants were classified according to the type of healthcare payer with which they were associated.|participants|Number|121|121.0||||||
3936464|NCT01387178|3758497|B3|Commercial||Number of participants with the indicated payer source|Participants were classified according to the type of healthcare payer with which they were associated.|participants|Number|19460|19460.0||||||
3936465|NCT01387178|3758498|B2|Commercial||Number of participants with the indicated payer source|Participants were classified according to the type of healthcare payer with which they were associated.|participants|Number|9227|9227.0||||||
3936466|NCT01387178|3758499|B1|Commercial||Number of participants with the indicated payer source|Participants were classified according to the type of healthcare payer with which they were associated.|participants|Number|10233|10233.0||||||
3936467|NCT01387178|3758497|B3|National or Unknown||Region of Enrollment|Some participants are grouped into the “National” region to protect their identities because the combination of their medical and demographic information is considered “infrequent” and could potentially be used to identify the participants.|Participants|Number|670|670.0||||||
3936468|NCT01387178|3758498|B2|National or Unknown||Region of Enrollment|Some participants are grouped into the “National” region to protect their identities because the combination of their medical and demographic information is considered “infrequent” and could potentially be used to identify the participants.|Participants|Number|304|304.0||||||
3936469|NCT01387178|3758499|B1|National or Unknown||Region of Enrollment|Some participants are grouped into the “National” region to protect their identities because the combination of their medical and demographic information is considered “infrequent” and could potentially be used to identify the participants.|Participants|Number|366|366.0||||||
3936470|NCT01387178|3758497|B3|West||Region of Enrollment|Some participants are grouped into the “National” region to protect their identities because the combination of their medical and demographic information is considered “infrequent” and could potentially be used to identify the participants.|Participants|Number|1912|1912.0||||||
3936471|NCT01387178|3758498|B2|West||Region of Enrollment|Some participants are grouped into the “National” region to protect their identities because the combination of their medical and demographic information is considered “infrequent” and could potentially be used to identify the participants.|Participants|Number|827|827.0||||||
3936472|NCT01387178|3758499|B1|West||Region of Enrollment|Some participants are grouped into the “National” region to protect their identities because the combination of their medical and demographic information is considered “infrequent” and could potentially be used to identify the participants.|Participants|Number|1085|1085.0||||||
3936473|NCT01387178|3758497|B3|Midwest||Region of Enrollment|Some participants are grouped into the “National” region to protect their identities because the combination of their medical and demographic information is considered “infrequent” and could potentially be used to identify the participants.|Participants|Number|3521|3521.0||||||
3936474|NCT01387178|3758498|B2|Midwest||Region of Enrollment|Some participants are grouped into the “National” region to protect their identities because the combination of their medical and demographic information is considered “infrequent” and could potentially be used to identify the participants.|Participants|Number|1731|1731.0||||||
3936475|NCT01387178|3758499|B1|Midwest||Region of Enrollment|Some participants are grouped into the “National” region to protect their identities because the combination of their medical and demographic information is considered “infrequent” and could potentially be used to identify the participants.|Participants|Number|1790|1790.0||||||
3936476|NCT01387178|3758497|B3|South||Region of Enrollment|Some participants are grouped into the “National” region to protect their identities because the combination of their medical and demographic information is considered “infrequent” and could potentially be used to identify the participants.|Participants|Number|7448|7448.0||||||
3936477|NCT01387178|3758498|B2|South||Region of Enrollment|Some participants are grouped into the “National” region to protect their identities because the combination of their medical and demographic information is considered “infrequent” and could potentially be used to identify the participants.|Participants|Number|3630|3630.0||||||
3936478|NCT01387178|3758499|B1|South||Region of Enrollment|Some participants are grouped into the “National” region to protect their identities because the combination of their medical and demographic information is considered “infrequent” and could potentially be used to identify the participants.|Participants|Number|3818|3818.0||||||
3936479|NCT01387178|3758497|B3|Northeast||Region of Enrollment|Some participants are grouped into the “National” region to protect their identities because the combination of their medical and demographic information is considered “infrequent” and could potentially be used to identify the participants.|Participants|Number|8672|8672.0||||||
3936480|NCT01387178|3758498|B2|Northeast||Region of Enrollment|Some participants are grouped into the “National” region to protect their identities because the combination of their medical and demographic information is considered “infrequent” and could potentially be used to identify the participants.|Participants|Number|4149|4149.0||||||
3936481|NCT01387178|3758499|B1|Northeast||Region of Enrollment|Some participants are grouped into the “National” region to protect their identities because the combination of their medical and demographic information is considered “infrequent” and could potentially be used to identify the participants.|Participants|Number|4523|4523.0||||||
3936482|NCT01387178|3758497|B3||Male|Sex: Female, Male||Participants|Count of Participants|11144|11144.0||||||
3936483|NCT01387178|3758498|B2||Male|Sex: Female, Male||Participants|Count of Participants|5683|5683.0||||||
3936484|NCT01387178|3758499|B1||Male|Sex: Female, Male||Participants|Count of Participants|5461|5461.0||||||
3936485|NCT01387178|3758497|B3||Female|Sex: Female, Male||Participants|Count of Participants|11079|11079.0||||||
3936486|NCT01387178|3758498|B2||Female|Sex: Female, Male||Participants|Count of Participants|4958|4958.0||||||
3936487|NCT01387178|3758499|B1||Female|Sex: Female, Male||Participants|Count of Participants|6121|6121.0||||||
3936488|NCT01387178|3758497|B3|||Age||Years|Mean|61.9|61.9|Standard Deviation|10.4|10.4|||
3936489|NCT01387178|3758498|B2|||Age||Years|Mean|63.1|63.1|Standard Deviation|10.0|10.0|||
3936490|NCT01387178|3758499|B1|||Age||Years|Mean|60.8|60.8|Standard Deviation|10.6|10.6|||
3936491|NCT01387139|3758510|B3|United States||Region of Enrollment||participants|Number|183|183.0||||||
3936492|NCT01387139|3758511|B2|United States||Region of Enrollment||participants|Number|84|84.0||||||
3936493|NCT01387139|3758512|B1|United States||Region of Enrollment||participants|Number|99|99.0||||||
3936494|NCT01387139|3758510|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3936495|NCT01387139|3758511|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3936496|NCT01387139|3758512|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3936497|NCT01387139|3758510|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936498|NCT01387139|3758511|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936499|NCT01387139|3758512|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936500|NCT01387139|3758510|B3||White|Race (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
3936501|NCT01387139|3758511|B2||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3936502|NCT01387139|3758512|B1||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3936503|NCT01387139|3758510|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3936504|NCT01387139|3758511|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3936505|NCT01387139|3758512|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3936506|NCT01387139|3758510|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936507|NCT01387139|3758511|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936508|NCT01387139|3758512|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936509|NCT01387139|3758510|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3936510|NCT01387139|3758511|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936511|NCT01387139|3758512|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3936512|NCT01387139|3758510|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936513|NCT01387139|3758511|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936514|NCT01387139|3758512|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936515|NCT01387139|3758510|B3||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3936516|NCT01387139|3758511|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3936517|NCT01387139|3758512|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3936518|NCT01387139|3758510|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3936519|NCT01387139|3758511|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3936520|NCT01387139|3758512|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3936521|NCT01387139|3758510|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3936522|NCT01387139|3758511|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3936523|NCT01387139|3758512|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3936524|NCT01387139|3758510|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3936525|NCT01387139|3758511|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3936526|NCT01387139|3758512|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3936527|NCT01387139|3758510|B3||<=18 years|Age||Participants|Count of Participants|183|183.0||||||
3936528|NCT01387139|3758511|B2||<=18 years|Age||Participants|Count of Participants|84|84.0||||||
3936529|NCT01387139|3758512|B1||<=18 years|Age||Participants|Count of Participants|99|99.0||||||
3936530|NCT01387074|3758529|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3936531|NCT01387074|3758529|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3936532|NCT01387074|3758529|B1|81-90 Years||Age, Customized||Participants|Number|4|4.0||||||
3936533|NCT01387074|3758529|B1|71-80 Years||Age, Customized||Participants|Number|14|14.0||||||
3936534|NCT01387074|3758529|B1|61-70 Years||Age, Customized||Participants|Number|24|24.0||||||
3936535|NCT01387074|3758529|B1|51-60 Years||Age, Customized||Participants|Number|23|23.0||||||
3936536|NCT01387074|3758529|B1|41-50 Years||Age, Customized||Participants|Number|22|22.0||||||
3936537|NCT01387074|3758529|B1|31-40 Years||Age, Customized||Participants|Number|13|13.0||||||
3936538|NCT01387074|3758529|B1|18-30 Years||Age, Customized||Participants|Number|8|8.0||||||
3936539|NCT01387022|3758540|B3|||Viral load||log10 copies/ml|Mean|4.5|4.5|Standard Deviation|0.79|0.79|||
3936540|NCT01387022|3758541|B2|||Viral load||log10 copies/ml|Mean|4.6|4.6|Standard Deviation|0.80|0.8|||
3936541|NCT01387022|3758542|B1|||Viral load||log10 copies/ml|Mean|4.4|4.4|Standard Deviation|0.79|0.79|||
3936542|NCT01387022|3758540|B3|||CD4+ T cell count||cells/uL|Median|345|345.0|Inter-Quartile Range|||280.0|423.0|
3936543|NCT01387022|3758541|B2|||CD4+ T cell count||cells/uL|Median|335|335.0|Inter-Quartile Range|||280.0|411.0|
3936544|NCT01387022|3758542|B1|||CD4+ T cell count||cells/uL|Median|345|345.0|Inter-Quartile Range|||289.0|431.0|
3936545|NCT01387022|3758540|B3|South Africa||Region of Enrollment||participants|Number|59|59.0||||||
3936546|NCT01387022|3758541|B2|South Africa||Region of Enrollment||participants|Number|30|30.0||||||
3936547|NCT01387022|3758542|B1|South Africa||Region of Enrollment||participants|Number|29|29.0||||||
3936548|NCT01387022|3758540|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936549|NCT01387022|3758541|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936550|NCT01387022|3758542|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936551|NCT01387022|3758540|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936552|NCT01387022|3758541|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936553|NCT01387022|3758542|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936554|NCT01387022|3758540|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936555|NCT01387022|3758541|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936556|NCT01387022|3758542|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936557|NCT01387022|3758540|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3936558|NCT01387022|3758541|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3936559|NCT01387022|3758542|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3936560|NCT01387022|3758540|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936561|NCT01387022|3758541|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936562|NCT01387022|3758542|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936563|NCT01387022|3758540|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936564|NCT01387022|3758541|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936565|NCT01387022|3758542|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936566|NCT01387022|3758540|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936567|NCT01387022|3758541|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936568|NCT01387022|3758542|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936569|NCT01387022|3758540|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3936570|NCT01387022|3758541|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3936571|NCT01387022|3758542|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3936572|NCT01387022|3758540|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3936573|NCT01387022|3758541|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3936574|NCT01387022|3758542|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3936575|NCT01387022|3758540|B3|||Age||years|Median|28|28.0|Inter-Quartile Range|||25.0|32.0|
3936576|NCT01387022|3758541|B2|||Age||years|Median|28|28.0|Inter-Quartile Range|||26.0|30.0|
3936577|NCT01387022|3758542|B1|||Age||years|Median|28|28.0|Inter-Quartile Range|||25.0|33.0|
3936578|NCT01386983|3758559|B3||Male|Sex: Female, Male||Participants|Count of Participants|332|332.0||||||
3936579|NCT01386983|3758560|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3936580|NCT01386983|3758561|B1||Male|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
3936581|NCT01386983|3758559|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3936582|NCT01386983|3758560|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3936583|NCT01386983|3758561|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3936584|NCT01386983|3758559|B3|<50 years old||Age, Customized||participants|Number|0|0.0||||||
3936585|NCT01386983|3758560|B2|<50 years old||Age, Customized||participants|Number|0|0.0||||||
3936586|NCT01386983|3758561|B1|<50 years old||Age, Customized||participants|Number|0|0.0||||||
3936587|NCT01386983|3758559|B3|>=50 years old||Age, Customized||participants|Number|332|332.0||||||
3936588|NCT01386983|3758560|B2|>=50 years old||Age, Customized||participants|Number|68|68.0||||||
3936589|NCT01386983|3758561|B1|>=50 years old||Age, Customized||participants|Number|264|264.0||||||
3936590|NCT01386944|3758570|B1|||Weight||kilogram|Mean|81.69|81.69|Standard Deviation|15.93|15.93|||
3936591|NCT01386944|3758570|B1|||Height||centimeter|Mean|168.43|168.43|Standard Deviation|9.48|9.48|||
3936592|NCT01386944|3758570|B1|Missing||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3936593|NCT01386944|3758570|B1|Southern European||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3936594|NCT01386944|3758570|B1|Scandinavian/Central European||Race/Ethnicity, Customized||participants|Number|90|90.0||||||
3936595|NCT01386944|3758570|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3936596|NCT01386944|3758570|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3936597|NCT01386944|3758570|B1||>=65 years|Age||Participants|Count of Participants|52|52.0||||||
3936598|NCT01386944|3758570|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3936599|NCT01386944|3758570|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3936600|NCT01386944|3758570|B1|||Age||years|Mean|64.2|64.2|Standard Deviation|11.1|11.1|||
3936601|NCT01386788|3758580|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3936602|NCT01386788|3758580|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3936603|NCT01386788|3758580|B1|||Age||years|Mean|49.4|49.4|Full Range|19|19.0|20.0|95.0|
3936604|NCT01386684|3758585|B1||Male|Sex: Female, Male||Participants|Count of Participants|552|552.0||||||
3936605|NCT01386684|3758585|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3936606|NCT01386684|3758585|B1|||Age||years|Mean|76.3|76.3|Standard Deviation|8.7|8.7|||
3936607|NCT01386632|3758624|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3936608|NCT01386632|3758625|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3936609|NCT01386632|3758626|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3936610|NCT01386632|3758624|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936611|NCT01386632|3758625|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936612|NCT01386632|3758626|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936613|NCT01386632|3758624|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936614|NCT01386632|3758625|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936615|NCT01386632|3758626|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936616|NCT01386632|3758624|B3||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3936617|NCT01386632|3758625|B2||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3936618|NCT01386632|3758626|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3936619|NCT01386632|3758624|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936620|NCT01386632|3758625|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936621|NCT01386632|3758626|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936622|NCT01386632|3758624|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936623|NCT01386632|3758625|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936624|NCT01386632|3758626|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936625|NCT01386632|3758624|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3936626|NCT01386632|3758625|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3936627|NCT01386632|3758626|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936628|NCT01386632|3758624|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936629|NCT01386632|3758625|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936630|NCT01386632|3758626|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936631|NCT01386632|3758624|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3936632|NCT01386632|3758625|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936633|NCT01386632|3758626|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3936634|NCT01386632|3758624|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3936635|NCT01386632|3758625|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3936636|NCT01386632|3758626|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3936637|NCT01386632|3758624|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3936638|NCT01386632|3758625|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3936639|NCT01386632|3758626|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936640|NCT01386632|3758624|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3936641|NCT01386632|3758625|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3936642|NCT01386632|3758626|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3936643|NCT01386632|3758624|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3936644|NCT01386632|3758625|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3936645|NCT01386632|3758626|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3936646|NCT01386632|3758624|B3|||Age||years|Mean|59.62|59.62|Standard Deviation|8.71|8.71|||
3936647|NCT01386632|3758625|B2|||Age||years|Mean|58.35|58.35|Standard Deviation|8.33|8.33|||
3936648|NCT01386632|3758626|B1|||Age||years|Mean|60.89|60.89|Standard Deviation|9.06|9.06|||
3936649|NCT01386606|3758635|B5|||BMI||Kg/m^2|Mean|31.8|31.8|Standard Deviation|6.1|6.1|||
3936650|NCT01386606|3758636|B4|||BMI||Kg/m^2|Mean|31.0|31.0|Standard Deviation|6.1|6.1|||
3936651|NCT01386606|3758637|B3|||BMI||Kg/m^2|Mean|31.6|31.6|Standard Deviation|6.3|6.3|||
3936652|NCT01386606|3758638|B2|||BMI||Kg/m^2|Mean|31.2|31.2|Standard Deviation|6.6|6.6|||
3936653|NCT01386606|3758639|B1|||BMI||Kg/m^2|Mean|33.3|33.3|Standard Deviation|5.9|5.9|||
3936654|NCT01386606|3758635|B5|United States||Region of Enrollment||participants|Number|60|60.0||||||
3936655|NCT01386606|3758636|B4|United States||Region of Enrollment||participants|Number|14|14.0||||||
3936656|NCT01386606|3758637|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
3936657|NCT01386606|3758638|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3936658|NCT01386606|3758639|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3936659|NCT01386606|3758635|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936660|NCT01386606|3758636|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936661|NCT01386606|3758637|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936662|NCT01386606|3758638|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936663|NCT01386606|3758639|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936664|NCT01386606|3758635|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936665|NCT01386606|3758636|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936666|NCT01386606|3758637|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936667|NCT01386606|3758638|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936668|NCT01386606|3758639|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936669|NCT01386606|3758635|B5||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3936670|NCT01386606|3758636|B4||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3936671|NCT01386606|3758637|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3936672|NCT01386606|3758638|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3936673|NCT01386606|3758639|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3936674|NCT01386606|3758635|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3936675|NCT01386606|3758636|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3936676|NCT01386606|3758637|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3936677|NCT01386606|3758638|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3936678|NCT01386606|3758639|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3936679|NCT01386606|3758635|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936680|NCT01386606|3758636|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936681|NCT01386606|3758637|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936682|NCT01386606|3758638|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936683|NCT01386606|3758639|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936684|NCT01386606|3758635|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936685|NCT01386606|3758636|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936686|NCT01386606|3758637|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936687|NCT01386606|3758638|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936688|NCT01386606|3758639|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936689|NCT01386606|3758635|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936690|NCT01386606|3758636|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936691|NCT01386606|3758637|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936692|NCT01386606|3758638|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936693|NCT01386606|3758639|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3936694|NCT01386606|3758635|B5||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3936695|NCT01386606|3758636|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3936696|NCT01386606|3758637|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3936697|NCT01386606|3758638|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3936698|NCT01386606|3758639|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3936699|NCT01386606|3758635|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3936700|NCT01386606|3758636|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3936701|NCT01386606|3758637|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3936702|NCT01386606|3758638|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3936703|NCT01386606|3758639|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3936704|NCT01386606|3758635|B5|||Age||years|Mean|52.6|52.6|Standard Deviation|10.2|10.2|||
3936705|NCT01386606|3758636|B4|||Age||years|Mean|53.5|53.5|Standard Deviation|9.8|9.8|||
3936706|NCT01386606|3758637|B3|||Age||years|Mean|51.8|51.8|Standard Deviation|13.0|13.0|||
3936707|NCT01386606|3758638|B2|||Age||years|Mean|51.7|51.7|Standard Deviation|9.2|9.2|||
3936708|NCT01386606|3758639|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|8.8|8.8|||
3936709|NCT01386554|3758670|B4|Colombia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3936710|NCT01386554|3758671|B3|Colombia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3936711|NCT01386554|3758672|B2|Colombia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3936712|NCT01386554|3758673|B1|Colombia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3936713|NCT01386554|3758670|B4|Argentina||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3936714|NCT01386554|3758671|B3|Argentina||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3936715|NCT01386554|3758672|B2|Argentina||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3936716|NCT01386554|3758673|B1|Argentina||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3936717|NCT01386554|3758670|B4|Chile||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3936718|NCT01386554|3758671|B3|Chile||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3936719|NCT01386554|3758672|B2|Chile||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3936720|NCT01386554|3758673|B1|Chile||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3936721|NCT01386554|3758670|B4|Mexico||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3936722|NCT01386554|3758671|B3|Mexico||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3936723|NCT01386554|3758672|B2|Mexico||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3936724|NCT01386554|3758673|B1|Mexico||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3936725|NCT01386554|3758670|B4|United States||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3936726|NCT01386554|3758671|B3|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3936727|NCT01386554|3758672|B2|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3936728|NCT01386554|3758673|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3936729|NCT01386554|3758670|B4|Turkey||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3936730|NCT01386554|3758671|B3|Turkey||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3936731|NCT01386554|3758672|B2|Turkey||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3936732|NCT01386554|3758673|B1|Turkey||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3936733|NCT01386554|3758670|B4|Canada||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3936734|NCT01386554|3758671|B3|Canada||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3936735|NCT01386554|3758672|B2|Canada||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3936736|NCT01386554|3758673|B1|Canada||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3936737|NCT01386554|3758670|B4||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3936738|NCT01386554|3758671|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3936739|NCT01386554|3758672|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3936740|NCT01386554|3758673|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3936741|NCT01386554|3758670|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3936742|NCT01386554|3758671|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3936743|NCT01386554|3758672|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3936744|NCT01386554|3758673|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3936745|NCT01386554|3758670|B4|||Age||Years|Mean|48.7|48.7|Standard Deviation|12.65|12.65|||
3936746|NCT01386554|3758671|B3|||Age||Years|Mean|45.4|45.4|Standard Deviation|12.24|12.24|||
3936747|NCT01386554|3758672|B2|||Age||Years|Mean|49.9|49.9|Standard Deviation|13.18|13.18|||
3936748|NCT01386554|3758673|B1|||Age||Years|Mean|55.0|55.0|Standard Deviation|5.72|5.72|||
3936749|NCT01386528|3758689|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3936750|NCT01386528|3758689|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3936751|NCT01386528|3758689|B1|||Age||years|Median|39|39.0|Full Range|12.6|12.6|15.0|56.0|
3936752|NCT01386528|3758689|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3936753|NCT01386528|3758689|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3936754|NCT01386528|3758689|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3936755|NCT01386125|3758699|B3||Male|Sex: Female, Male||Participants|Count of Participants|463|463.0||||||
3936756|NCT01386125|3758700|B2||Male|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
3936757|NCT01386125|3758701|B1||Male|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
3936758|NCT01386125|3758699|B3||Female|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
3936759|NCT01386125|3758700|B2||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3936760|NCT01386125|3758701|B1||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3936761|NCT01386125|3758699|B3|||Age||years|Mean|46.8|46.8|Standard Deviation|13.61|13.61|||
3936762|NCT01386125|3758700|B2|||Age||years|Mean|46.8|46.8|Standard Deviation|13.75|13.75|||
3936763|NCT01386125|3758701|B1|||Age||years|Mean|46.8|46.8|Standard Deviation|13.49|13.49|||
3936764|NCT01386008|3758710|B1|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3936765|NCT01386008|3758710|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3936766|NCT01386008|3758710|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3936767|NCT01386008|3758710|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3936768|NCT01386008|3758710|B1|||Age||Years|Mean|23|23.0|Standard Deviation|3|3.0|||
3936769|NCT01386008|3758710|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3936770|NCT01386008|3758710|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3936771|NCT01386008|3758710|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3936772|NCT01385995|3758717|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3936773|NCT01385995|3758718|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3936774|NCT01385995|3758719|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3936775|NCT01385995|3758717|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3936776|NCT01385995|3758718|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3936777|NCT01385995|3758719|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3936778|NCT01385995|3758717|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3936779|NCT01385995|3758718|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3936780|NCT01385995|3758719|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3936781|NCT01385995|3758717|B3|||Age||years|Mean|53.6|53.6|Standard Deviation|9.9|9.9|||
3936782|NCT01385995|3758718|B2|||Age||years|Mean|53|53.0|Standard Deviation|8|8.0|||
3936783|NCT01385995|3758719|B1|||Age||years|Mean|54|54.0|Standard Deviation|10|10.0|||
3936784|NCT01385995|3758717|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3936785|NCT01385995|3758718|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3936786|NCT01385995|3758719|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3936787|NCT01385995|3758717|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3936788|NCT01385995|3758718|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3936789|NCT01385995|3758719|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3936790|NCT01385995|3758717|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3936791|NCT01385995|3758718|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3936792|NCT01385995|3758719|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3936793|NCT01385748|3758734|B4|||Disease duration|Duration of the squamous cell carcinoma at baseline.|months|Median|2|2.0|Full Range|||0.0|99.0|
3936794|NCT01385748|3758735|B3|||Disease duration|Duration of the squamous cell carcinoma at baseline.|months|Median|2|2.0|Full Range|||0.0|7.0|
3936795|NCT01385748|3758736|B2|||Disease duration|Duration of the squamous cell carcinoma at baseline.|months|Median|2|2.0|Full Range|||1.0|99.0|
3936796|NCT01385748|3758737|B1|||Disease duration|Duration of the squamous cell carcinoma at baseline.|months|Median|2|2.0|Full Range|||1.0|14.0|
3936797|NCT01385748|3758734|B4|||Body Mass Index (BMI)||kg/m^2|Median|23.59|23.59|Full Range|||16.1|44.4|
3936798|NCT01385748|3758735|B3|||Body Mass Index (BMI)||kg/m^2|Median|23.33|23.33|Full Range|||16.9|43.8|
3936799|NCT01385748|3758736|B2|||Body Mass Index (BMI)||kg/m^2|Median|23.66|23.66|Full Range|||16.8|40.3|
3936800|NCT01385748|3758737|B1|||Body Mass Index (BMI)||kg/m^2|Median|23.7|23.7|Full Range|||16.1|44.4|
3936801|NCT01385748|3758734|B4|||Weight||kg|Median|69|69.0|Full Range|||43.0|130.0|
3936802|NCT01385748|3758735|B3|||Weight||kg|Median|69|69.0|Full Range|||48.0|115.0|
3936803|NCT01385748|3758736|B2|||Weight||kg|Median|66|66.0|Full Range|||43.0|123.0|
3936804|NCT01385748|3758737|B1|||Weight||kg|Median|71.3|71.3|Full Range|||44.0|130.0|
3936805|NCT01385748|3758734|B4|||Height||cm|Median|171|171.0|Full Range|||145.0|190.0|
3936806|NCT01385748|3758735|B3|||Height||cm|Median|172|172.0|Full Range|||145.0|190.0|
3936807|NCT01385748|3758736|B2|||Height||cm|Median|170|170.0|Full Range|||147.0|186.0|
3936808|NCT01385748|3758737|B1|||Height||cm|Median|171|171.0|Full Range|||153.0|182.0|
3936809|NCT01385748|3758734|B4|No||Prior radiotherapy and/or chemotherapy|The number of participants previously treated with radiotherapy and/or chemotherapy.|participants|Number|6|6.0||||||
3936810|NCT01385748|3758735|B3|No||Prior radiotherapy and/or chemotherapy|The number of participants previously treated with radiotherapy and/or chemotherapy.|participants|Number|1|1.0||||||
3936811|NCT01385748|3758736|B2|No||Prior radiotherapy and/or chemotherapy|The number of participants previously treated with radiotherapy and/or chemotherapy.|participants|Number|3|3.0||||||
3936812|NCT01385748|3758737|B1|No||Prior radiotherapy and/or chemotherapy|The number of participants previously treated with radiotherapy and/or chemotherapy.|participants|Number|2|2.0||||||
3936813|NCT01385748|3758734|B4|Yes||Prior radiotherapy and/or chemotherapy|The number of participants previously treated with radiotherapy and/or chemotherapy.|participants|Number|177|177.0||||||
3936814|NCT01385748|3758735|B3|Yes||Prior radiotherapy and/or chemotherapy|The number of participants previously treated with radiotherapy and/or chemotherapy.|participants|Number|61|61.0||||||
3936815|NCT01385748|3758736|B2|Yes||Prior radiotherapy and/or chemotherapy|The number of participants previously treated with radiotherapy and/or chemotherapy.|participants|Number|62|62.0||||||
3936816|NCT01385748|3758737|B1|Yes||Prior radiotherapy and/or chemotherapy|The number of participants previously treated with radiotherapy and/or chemotherapy.|participants|Number|54|54.0||||||
3936817|NCT01385748|3758734|B4|No||Prior surgery|The number of participants having undergone prior surgery.|participants|Number|3|3.0||||||
3936818|NCT01385748|3758735|B3|No||Prior surgery|The number of participants having undergone prior surgery.|participants|Number|1|1.0||||||
3936819|NCT01385748|3758736|B2|No||Prior surgery|The number of participants having undergone prior surgery.|participants|Number|1|1.0||||||
3936820|NCT01385748|3758737|B1|No||Prior surgery|The number of participants having undergone prior surgery.|participants|Number|1|1.0||||||
3936821|NCT01385748|3758734|B4|Yes||Prior surgery|The number of participants having undergone prior surgery.|participants|Number|180|180.0||||||
3936822|NCT01385748|3758735|B3|Yes||Prior surgery|The number of participants having undergone prior surgery.|participants|Number|61|61.0||||||
3936823|NCT01385748|3758736|B2|Yes||Prior surgery|The number of participants having undergone prior surgery.|participants|Number|64|64.0||||||
3936824|NCT01385748|3758737|B1|Yes||Prior surgery|The number of participants having undergone prior surgery.|participants|Number|55|55.0||||||
3936825|NCT01385748|3758734|B4|Missing||Oral infection|The number of participants presenting with oral infection at baseline.|participants|Number|1|1.0||||||
3936826|NCT01385748|3758735|B3|Missing||Oral infection|The number of participants presenting with oral infection at baseline.|participants|Number|0|0.0||||||
3936827|NCT01385748|3758736|B2|Missing||Oral infection|The number of participants presenting with oral infection at baseline.|participants|Number|0|0.0||||||
3936828|NCT01385748|3758737|B1|Missing||Oral infection|The number of participants presenting with oral infection at baseline.|participants|Number|1|1.0||||||
3936829|NCT01385748|3758734|B4|No||Oral infection|The number of participants presenting with oral infection at baseline.|participants|Number|181|181.0||||||
3936830|NCT01385748|3758735|B3|No||Oral infection|The number of participants presenting with oral infection at baseline.|participants|Number|62|62.0||||||
3936831|NCT01385748|3758736|B2|No||Oral infection|The number of participants presenting with oral infection at baseline.|participants|Number|64|64.0||||||
3936832|NCT01385748|3758737|B1|No||Oral infection|The number of participants presenting with oral infection at baseline.|participants|Number|55|55.0||||||
3936833|NCT01385748|3758734|B4|Yes||Oral infection|The number of participants presenting with oral infection at baseline.|participants|Number|1|1.0||||||
3936834|NCT01385748|3758735|B3|Yes||Oral infection|The number of participants presenting with oral infection at baseline.|participants|Number|0|0.0||||||
3936835|NCT01385748|3758736|B2|Yes||Oral infection|The number of participants presenting with oral infection at baseline.|participants|Number|1|1.0||||||
3936836|NCT01385748|3758737|B1|Yes||Oral infection|The number of participants presenting with oral infection at baseline.|participants|Number|0|0.0||||||
3936837|NCT01385748|3758734|B4|Missing||Tooth extraction|The number of participants having undergone tooth extraction at baseline.|participants|Number|2|2.0||||||
3936838|NCT01385748|3758735|B3|Missing||Tooth extraction|The number of participants having undergone tooth extraction at baseline.|participants|Number|0|0.0||||||
3936839|NCT01385748|3758736|B2|Missing||Tooth extraction|The number of participants having undergone tooth extraction at baseline.|participants|Number|1|1.0||||||
3936840|NCT01385748|3758737|B1|Missing||Tooth extraction|The number of participants having undergone tooth extraction at baseline.|participants|Number|1|1.0||||||
3936841|NCT01385748|3758734|B4|No||Tooth extraction|The number of participants having undergone tooth extraction at baseline.|participants|Number|87|87.0||||||
3936842|NCT01385748|3758735|B3|No||Tooth extraction|The number of participants having undergone tooth extraction at baseline.|participants|Number|30|30.0||||||
3936843|NCT01385748|3758736|B2|No||Tooth extraction|The number of participants having undergone tooth extraction at baseline.|participants|Number|32|32.0||||||
3936844|NCT01385748|3758737|B1|No||Tooth extraction|The number of participants having undergone tooth extraction at baseline.|participants|Number|25|25.0||||||
3936845|NCT01385748|3758734|B4|Yes||Tooth extraction|The number of participants having undergone tooth extraction at baseline.|participants|Number|94|94.0||||||
3936846|NCT01385748|3758735|B3|Yes||Tooth extraction|The number of participants having undergone tooth extraction at baseline.|participants|Number|32|32.0||||||
3936847|NCT01385748|3758736|B2|Yes||Tooth extraction|The number of participants having undergone tooth extraction at baseline.|participants|Number|32|32.0||||||
3936848|NCT01385748|3758737|B1|Yes||Tooth extraction|The number of participants having undergone tooth extraction at baseline.|participants|Number|30|30.0||||||
3936849|NCT01385748|3758734|B4|Missing||Mucosal irritation|The number of participants with mucosal irritation at baseline.|participants|Number|1|1.0||||||
3936850|NCT01385748|3758735|B3|Missing||Mucosal irritation|The number of participants with mucosal irritation at baseline.|participants|Number|0|0.0||||||
3936851|NCT01385748|3758736|B2|Missing||Mucosal irritation|The number of participants with mucosal irritation at baseline.|participants|Number|0|0.0||||||
3936852|NCT01385748|3758737|B1|Missing||Mucosal irritation|The number of participants with mucosal irritation at baseline.|participants|Number|1|1.0||||||
3936853|NCT01385748|3758734|B4|No||Mucosal irritation|The number of participants with mucosal irritation at baseline.|participants|Number|177|177.0||||||
3936854|NCT01385748|3758735|B3|No||Mucosal irritation|The number of participants with mucosal irritation at baseline.|participants|Number|61|61.0||||||
3936855|NCT01385748|3758736|B2|No||Mucosal irritation|The number of participants with mucosal irritation at baseline.|participants|Number|63|63.0||||||
3936856|NCT01385748|3758737|B1|No||Mucosal irritation|The number of participants with mucosal irritation at baseline.|participants|Number|53|53.0||||||
3936857|NCT01385748|3758734|B4|Yes||Mucosal irritation|The number of participants with mucosal irritation at baseline.|participants|Number|5|5.0||||||
3936858|NCT01385748|3758735|B3|Yes||Mucosal irritation|The number of participants with mucosal irritation at baseline.|participants|Number|1|1.0||||||
3936859|NCT01385748|3758736|B2|Yes||Mucosal irritation|The number of participants with mucosal irritation at baseline.|participants|Number|2|2.0||||||
3936860|NCT01385748|3758737|B1|Yes||Mucosal irritation|The number of participants with mucosal irritation at baseline.|participants|Number|2|2.0||||||
3936861|NCT01385748|3758734|B4|No||Disease location in oral cavity or oropharynx|Location of the squamous cell carcinoma (in oral cavity or oropharynx).|participants|Number|23|23.0||||||
3936862|NCT01385748|3758735|B3|No||Disease location in oral cavity or oropharynx|Location of the squamous cell carcinoma (in oral cavity or oropharynx).|participants|Number|7|7.0||||||
3936863|NCT01385748|3758736|B2|No||Disease location in oral cavity or oropharynx|Location of the squamous cell carcinoma (in oral cavity or oropharynx).|participants|Number|8|8.0||||||
3936864|NCT01385748|3758737|B1|No||Disease location in oral cavity or oropharynx|Location of the squamous cell carcinoma (in oral cavity or oropharynx).|participants|Number|8|8.0||||||
3936865|NCT01385748|3758734|B4|Yes||Disease location in oral cavity or oropharynx|Location of the squamous cell carcinoma (in oral cavity or oropharynx).|participants|Number|160|160.0||||||
3936866|NCT01385748|3758735|B3|Yes||Disease location in oral cavity or oropharynx|Location of the squamous cell carcinoma (in oral cavity or oropharynx).|participants|Number|55|55.0||||||
3936867|NCT01385748|3758736|B2|Yes||Disease location in oral cavity or oropharynx|Location of the squamous cell carcinoma (in oral cavity or oropharynx).|participants|Number|57|57.0||||||
3936868|NCT01385748|3758737|B1|Yes||Disease location in oral cavity or oropharynx|Location of the squamous cell carcinoma (in oral cavity or oropharynx).|participants|Number|48|48.0||||||
3936869|NCT01385748|3758734|B4|Oropharynx/larynx||Disease location|The location of the squamous cell carcinoma.|participants|Number|1|1.0||||||
3936870|NCT01385748|3758735|B3|Oropharynx/larynx||Disease location|The location of the squamous cell carcinoma.|participants|Number|1|1.0||||||
3936871|NCT01385748|3758736|B2|Oropharynx/larynx||Disease location|The location of the squamous cell carcinoma.|participants|Number|0|0.0||||||
3936872|NCT01385748|3758737|B1|Oropharynx/larynx||Disease location|The location of the squamous cell carcinoma.|participants|Number|0|0.0||||||
3936873|NCT01385748|3758734|B4|Oropharynx/hypopharynx||Disease location|The location of the squamous cell carcinoma.|participants|Number|4|4.0||||||
3936874|NCT01385748|3758735|B3|Oropharynx/hypopharynx||Disease location|The location of the squamous cell carcinoma.|participants|Number|1|1.0||||||
3936875|NCT01385748|3758736|B2|Oropharynx/hypopharynx||Disease location|The location of the squamous cell carcinoma.|participants|Number|1|1.0||||||
3936876|NCT01385748|3758737|B1|Oropharynx/hypopharynx||Disease location|The location of the squamous cell carcinoma.|participants|Number|2|2.0||||||
3936877|NCT01385748|3758734|B4|Oral cavity/larynx||Disease location|The location of the squamous cell carcinoma.|participants|Number|1|1.0||||||
3936878|NCT01385748|3758735|B3|Oral cavity/larynx||Disease location|The location of the squamous cell carcinoma.|participants|Number|0|0.0||||||
3936879|NCT01385748|3758736|B2|Oral cavity/larynx||Disease location|The location of the squamous cell carcinoma.|participants|Number|0|0.0||||||
3936880|NCT01385748|3758737|B1|Oral cavity/larynx||Disease location|The location of the squamous cell carcinoma.|participants|Number|1|1.0||||||
3936881|NCT01385748|3758734|B4|Oral cavity/hypopharynx||Disease location|The location of the squamous cell carcinoma.|participants|Number|2|2.0||||||
3936882|NCT01385748|3758735|B3|Oral cavity/hypopharynx||Disease location|The location of the squamous cell carcinoma.|participants|Number|1|1.0||||||
3936883|NCT01385748|3758736|B2|Oral cavity/hypopharynx||Disease location|The location of the squamous cell carcinoma.|participants|Number|1|1.0||||||
3936884|NCT01385748|3758737|B1|Oral cavity/hypopharynx||Disease location|The location of the squamous cell carcinoma.|participants|Number|0|0.0||||||
3936885|NCT01385748|3758734|B4|Oral cavity/oropharynx||Disease location|The location of the squamous cell carcinoma.|participants|Number|2|2.0||||||
3936886|NCT01385748|3758735|B3|Oral cavity/oropharynx||Disease location|The location of the squamous cell carcinoma.|participants|Number|1|1.0||||||
3936887|NCT01385748|3758736|B2|Oral cavity/oropharynx||Disease location|The location of the squamous cell carcinoma.|participants|Number|1|1.0||||||
3936888|NCT01385748|3758737|B1|Oral cavity/oropharynx||Disease location|The location of the squamous cell carcinoma.|participants|Number|0|0.0||||||
3936889|NCT01385748|3758734|B4|Larynx||Disease location|The location of the squamous cell carcinoma.|participants|Number|15|15.0||||||
3936890|NCT01385748|3758735|B3|Larynx||Disease location|The location of the squamous cell carcinoma.|participants|Number|5|5.0||||||
3936891|NCT01385748|3758736|B2|Larynx||Disease location|The location of the squamous cell carcinoma.|participants|Number|6|6.0||||||
3936892|NCT01385748|3758737|B1|Larynx||Disease location|The location of the squamous cell carcinoma.|participants|Number|4|4.0||||||
3936893|NCT01385748|3758734|B4|Hypopharynx||Disease location|The location of the squamous cell carcinoma.|participants|Number|8|8.0||||||
3936894|NCT01385748|3758735|B3|Hypopharynx||Disease location|The location of the squamous cell carcinoma.|participants|Number|2|2.0||||||
3936895|NCT01385748|3758736|B2|Hypopharynx||Disease location|The location of the squamous cell carcinoma.|participants|Number|2|2.0||||||
3936896|NCT01385748|3758737|B1|Hypopharynx||Disease location|The location of the squamous cell carcinoma.|participants|Number|4|4.0||||||
3936897|NCT01385748|3758734|B4|Oropharynx||Disease location|The location of the squamous cell carcinoma.|participants|Number|57|57.0||||||
3936898|NCT01385748|3758735|B3|Oropharynx||Disease location|The location of the squamous cell carcinoma.|participants|Number|21|21.0||||||
3936899|NCT01385748|3758736|B2|Oropharynx||Disease location|The location of the squamous cell carcinoma.|participants|Number|17|17.0||||||
3936900|NCT01385748|3758737|B1|Oropharynx||Disease location|The location of the squamous cell carcinoma.|participants|Number|19|19.0||||||
3936901|NCT01385748|3758734|B4|Oral cavity||Disease location|The location of the squamous cell carcinoma.|participants|Number|93|93.0||||||
3936902|NCT01385748|3758735|B3|Oral cavity||Disease location|The location of the squamous cell carcinoma.|participants|Number|30|30.0||||||
3936903|NCT01385748|3758736|B2|Oral cavity||Disease location|The location of the squamous cell carcinoma.|participants|Number|37|37.0||||||
3936904|NCT01385748|3758737|B1|Oral cavity||Disease location|The location of the squamous cell carcinoma.|participants|Number|26|26.0||||||
3936905|NCT01385748|3758734|B4|Score 2||Eastern Cooperative Oncology Group (ECOG) Score|ECOG performance status measured on 6 point scale to assess participant's performance status. 0=Fully active, able to carry on all pre-disease activities without restriction; 1=Restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=Ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=Capable of only limited self care, confined to bed/chair >50% of waking hours; 4=Completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=Dead.|participants|Number|2|2.0||||||
3936906|NCT01385748|3758735|B3|Score 2||Eastern Cooperative Oncology Group (ECOG) Score|ECOG performance status measured on 6 point scale to assess participant's performance status. 0=Fully active, able to carry on all pre-disease activities without restriction; 1=Restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=Ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=Capable of only limited self care, confined to bed/chair >50% of waking hours; 4=Completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=Dead.|participants|Number|0|0.0||||||
3936907|NCT01385748|3758736|B2|Score 2||Eastern Cooperative Oncology Group (ECOG) Score|ECOG performance status measured on 6 point scale to assess participant's performance status. 0=Fully active, able to carry on all pre-disease activities without restriction; 1=Restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=Ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=Capable of only limited self care, confined to bed/chair >50% of waking hours; 4=Completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=Dead.|participants|Number|2|2.0||||||
3936908|NCT01385748|3758737|B1|Score 2||Eastern Cooperative Oncology Group (ECOG) Score|ECOG performance status measured on 6 point scale to assess participant's performance status. 0=Fully active, able to carry on all pre-disease activities without restriction; 1=Restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=Ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=Capable of only limited self care, confined to bed/chair >50% of waking hours; 4=Completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=Dead.|participants|Number|0|0.0||||||
3936909|NCT01385748|3758734|B4|Score 1||Eastern Cooperative Oncology Group (ECOG) Score|ECOG performance status measured on 6 point scale to assess participant's performance status. 0=Fully active, able to carry on all pre-disease activities without restriction; 1=Restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=Ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=Capable of only limited self care, confined to bed/chair >50% of waking hours; 4=Completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=Dead.|participants|Number|56|56.0||||||
3936910|NCT01385748|3758735|B3|Score 1||Eastern Cooperative Oncology Group (ECOG) Score|ECOG performance status measured on 6 point scale to assess participant's performance status. 0=Fully active, able to carry on all pre-disease activities without restriction; 1=Restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=Ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=Capable of only limited self care, confined to bed/chair >50% of waking hours; 4=Completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=Dead.|participants|Number|20|20.0||||||
3936911|NCT01385748|3758736|B2|Score 1||Eastern Cooperative Oncology Group (ECOG) Score|ECOG performance status measured on 6 point scale to assess participant's performance status. 0=Fully active, able to carry on all pre-disease activities without restriction; 1=Restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=Ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=Capable of only limited self care, confined to bed/chair >50% of waking hours; 4=Completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=Dead.|participants|Number|22|22.0||||||
3936912|NCT01385748|3758737|B1|Score 1||Eastern Cooperative Oncology Group (ECOG) Score|ECOG performance status measured on 6 point scale to assess participant's performance status. 0=Fully active, able to carry on all pre-disease activities without restriction; 1=Restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=Ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=Capable of only limited self care, confined to bed/chair >50% of waking hours; 4=Completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=Dead.|participants|Number|14|14.0||||||
3936913|NCT01385748|3758734|B4|Score 0||Eastern Cooperative Oncology Group (ECOG) Score|ECOG performance status measured on 6 point scale to assess participant's performance status. 0=Fully active, able to carry on all pre-disease activities without restriction; 1=Restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=Ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=Capable of only limited self care, confined to bed/chair >50% of waking hours; 4=Completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=Dead.|participants|Number|125|125.0||||||
3936914|NCT01385748|3758735|B3|Score 0||Eastern Cooperative Oncology Group (ECOG) Score|ECOG performance status measured on 6 point scale to assess participant's performance status. 0=Fully active, able to carry on all pre-disease activities without restriction; 1=Restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=Ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=Capable of only limited self care, confined to bed/chair >50% of waking hours; 4=Completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=Dead.|participants|Number|42|42.0||||||
3936915|NCT01385748|3758736|B2|Score 0||Eastern Cooperative Oncology Group (ECOG) Score|ECOG performance status measured on 6 point scale to assess participant's performance status. 0=Fully active, able to carry on all pre-disease activities without restriction; 1=Restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=Ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=Capable of only limited self care, confined to bed/chair >50% of waking hours; 4=Completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=Dead.|participants|Number|41|41.0||||||
3936916|NCT01385748|3758737|B1|Score 0||Eastern Cooperative Oncology Group (ECOG) Score|ECOG performance status measured on 6 point scale to assess participant's performance status. 0=Fully active, able to carry on all pre-disease activities without restriction; 1=Restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=Ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=Capable of only limited self care, confined to bed/chair >50% of waking hours; 4=Completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=Dead.|participants|Number|42|42.0||||||
3936917|NCT01385748|3758734|B4|Spain||Region of Enrollment||participants|Number|52|52.0||||||
3936918|NCT01385748|3758735|B3|Spain||Region of Enrollment||participants|Number|18|18.0||||||
3936919|NCT01385748|3758736|B2|Spain||Region of Enrollment||participants|Number|20|20.0||||||
3936920|NCT01385748|3758737|B1|Spain||Region of Enrollment||participants|Number|14|14.0||||||
3936921|NCT01385748|3758734|B4|Germany||Region of Enrollment||participants|Number|31|31.0||||||
3936922|NCT01385748|3758735|B3|Germany||Region of Enrollment||participants|Number|10|10.0||||||
3936923|NCT01385748|3758736|B2|Germany||Region of Enrollment||participants|Number|11|11.0||||||
3936924|NCT01385748|3758737|B1|Germany||Region of Enrollment||participants|Number|10|10.0||||||
3936925|NCT01385748|3758734|B4|Switzerland||Region of Enrollment||participants|Number|2|2.0||||||
3936926|NCT01385748|3758735|B3|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
3936927|NCT01385748|3758736|B2|Switzerland||Region of Enrollment||participants|Number|2|2.0||||||
3936928|NCT01385748|3758737|B1|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
3936929|NCT01385748|3758734|B4|France||Region of Enrollment||participants|Number|88|88.0||||||
3936930|NCT01385748|3758735|B3|France||Region of Enrollment||participants|Number|30|30.0||||||
3936931|NCT01385748|3758736|B2|France||Region of Enrollment||participants|Number|27|27.0||||||
3936932|NCT01385748|3758737|B1|France||Region of Enrollment||participants|Number|31|31.0||||||
3936933|NCT01385748|3758734|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
3936934|NCT01385748|3758735|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3936935|NCT01385748|3758736|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3936936|NCT01385748|3758737|B1|United States||Region of Enrollment||participants|Number|0|0.0||||||
3936937|NCT01385748|3758734|B4|Hungary||Region of Enrollment||participants|Number|4|4.0||||||
3936938|NCT01385748|3758735|B3|Hungary||Region of Enrollment||participants|Number|0|0.0||||||
3936939|NCT01385748|3758736|B2|Hungary||Region of Enrollment||participants|Number|3|3.0||||||
3936940|NCT01385748|3758737|B1|Hungary||Region of Enrollment||participants|Number|1|1.0||||||
3936941|NCT01385748|3758734|B4|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3936942|NCT01385748|3758735|B3|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3936943|NCT01385748|3758736|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3936944|NCT01385748|3758737|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3936945|NCT01385748|3758734|B4|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3936946|NCT01385748|3758735|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3936947|NCT01385748|3758736|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3936948|NCT01385748|3758737|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3936949|NCT01385748|3758734|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|173|173.0||||||
3936950|NCT01385748|3758735|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
3936951|NCT01385748|3758736|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
3936952|NCT01385748|3758737|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
3936953|NCT01385748|3758734|B4||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3936954|NCT01385748|3758735|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3936955|NCT01385748|3758736|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3936956|NCT01385748|3758737|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3936957|NCT01385748|3758734|B4||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3936958|NCT01385748|3758735|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3936959|NCT01385748|3758736|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3936960|NCT01385748|3758737|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3936961|NCT01385748|3758734|B4|85 years and over||Age, Customized||participants|Number|0|0.0||||||
3936962|NCT01385748|3758735|B3|85 years and over||Age, Customized||participants|Number|0|0.0||||||
3936963|NCT01385748|3758736|B2|85 years and over||Age, Customized||participants|Number|0|0.0||||||
3936964|NCT01385748|3758737|B1|85 years and over||Age, Customized||participants|Number|0|0.0||||||
3936965|NCT01385748|3758734|B4|65 to 84 years||Age, Customized||participants|Number|32|32.0||||||
3936966|NCT01385748|3758735|B3|65 to 84 years||Age, Customized||participants|Number|12|12.0||||||
3936967|NCT01385748|3758736|B2|65 to 84 years||Age, Customized||participants|Number|7|7.0||||||
3936968|NCT01385748|3758737|B1|65 to 84 years||Age, Customized||participants|Number|13|13.0||||||
3936969|NCT01385748|3758734|B4|18 to 64 years||Age, Customized||participants|Number|151|151.0||||||
3936970|NCT01385748|3758735|B3|18 to 64 years||Age, Customized||participants|Number|50|50.0||||||
3936971|NCT01385748|3758736|B2|18 to 64 years||Age, Customized||participants|Number|58|58.0||||||
3936972|NCT01385748|3758737|B1|18 to 64 years||Age, Customized||participants|Number|43|43.0||||||
3936973|NCT01385748|3758734|B4|||Age||years|Median|57.3|57.3|Full Range|||22.0|79.0|
3936974|NCT01385748|3758735|B3|||Age||years|Median|56.6|56.6|Full Range|||33.0|72.0|
3936975|NCT01385748|3758736|B2|||Age||years|Median|55.7|55.7|Full Range|||22.0|75.0|
3936976|NCT01385748|3758737|B1|||Age||years|Median|58.8|58.8|Full Range|||30.0|79.0|
3936977|NCT01385696|3758784|B1|Netherlands||Region of Enrollment||participants|Number|44|44.0||||||
3936978|NCT01385696|3758784|B1|Germany||Region of Enrollment||participants|Number|85|85.0||||||
3936979|NCT01385696|3758784|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3936980|NCT01385696|3758784|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3936981|NCT01385696|3758784|B1|||Age||years|Mean|65.9|65.9|Standard Deviation|8.6|8.6|||
3936982|NCT01385644|3758794|B3|Australia||Region of Enrollment||participants|Number|8|8.0||||||
3936983|NCT01385644|3758795|B2|Australia||Region of Enrollment||participants|Number|4|4.0||||||
3936984|NCT01385644|3758796|B1|Australia||Region of Enrollment||participants|Number|4|4.0||||||
3936985|NCT01385644|3758794|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3936986|NCT01385644|3758795|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3936987|NCT01385644|3758796|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3936988|NCT01385644|3758794|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3936989|NCT01385644|3758795|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3936990|NCT01385644|3758796|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3936991|NCT01385644|3758794|B3|||Age||years|Median|64.1|64.1|Inter-Quartile Range|||62.0|70.0|
3936992|NCT01385644|3758795|B2|||Age||years|Median|66.2|66.2|Inter-Quartile Range|||61.1|71.5|
3936993|NCT01385644|3758796|B1|||Age||years|Median|64.1|64.1|Inter-Quartile Range|||62.4|66.5|
3936994|NCT01385644|3758794|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3936995|NCT01385644|3758795|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3936996|NCT01385644|3758796|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3936997|NCT01385644|3758794|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3936998|NCT01385644|3758795|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3936999|NCT01385644|3758796|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3937000|NCT01385644|3758794|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3937001|NCT01385644|3758795|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3937002|NCT01385644|3758796|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3937003|NCT01385579|3758809|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3937004|NCT01385579|3758810|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3937005|NCT01385579|3758811|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3937006|NCT01385579|3758809|B3||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3937007|NCT01385579|3758810|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3937008|NCT01385579|3758811|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3937009|NCT01385579|3758809|B3|||Age||years|Mean|60|60.0|Standard Deviation|8|8.0|||
3937010|NCT01385579|3758810|B2|||Age||years|Mean|60|60.0|Standard Deviation|7|7.0|||
3937011|NCT01385579|3758811|B1|||Age||years|Mean|60|60.0|Standard Deviation|8|8.0|||
3937012|NCT01385566|3758818|B7||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3937013|NCT01385566|3758819|B6||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3937014|NCT01385566|3758820|B5||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3937015|NCT01385566|3758821|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3937016|NCT01385566|3758822|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3937017|NCT01385566|3758823|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3937018|NCT01385566|3758824|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3937019|NCT01385566|3758818|B7||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3937020|NCT01385566|3758819|B6||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3937021|NCT01385566|3758820|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3937022|NCT01385566|3758821|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3937023|NCT01385566|3758822|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3937024|NCT01385566|3758823|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3937025|NCT01385566|3758824|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3937026|NCT01385566|3758818|B7|||Age||years|Mean|60.8|60.8|Standard Deviation|7.9|7.9|||
3937027|NCT01385566|3758819|B6|||Age||years|Mean|60.1|60.1|Standard Deviation|7.1|7.1|||
3937028|NCT01385566|3758820|B5|||Age||years|Mean|61.6|61.6|Standard Deviation|8.1|8.1|||
3937029|NCT01385566|3758821|B4|||Age||years|Mean|61.2|61.2|Standard Deviation|8.7|8.7|||
3937030|NCT01385566|3758822|B3|||Age||years|Mean|62.1|62.1|Standard Deviation|8.5|8.5|||
3937031|NCT01385566|3758823|B2|||Age||years|Mean|60.5|60.5|Standard Deviation|7.5|7.5|||
3937032|NCT01385566|3758824|B1|||Age||years|Mean|59.9|59.9|Standard Deviation|7.7|7.7|||
3937033|NCT01385371|3758881|B3||Male|Gender||Participants|Count of Participants|787|787.0||||||
3937034|NCT01385371|3758882|B2||Male|Gender||Participants|Count of Participants|416|416.0||||||
3937035|NCT01385371|3758883|B1||Male|Gender||Participants|Count of Participants|371|371.0||||||
3937036|NCT01385371|3758881|B3||Female|Gender||Participants|Count of Participants|714|714.0||||||
3937037|NCT01385371|3758882|B2||Female|Gender||Participants|Count of Participants|333|333.0||||||
3937038|NCT01385371|3758883|B1||Female|Gender||Participants|Count of Participants|381|381.0||||||
3937039|NCT01385371|3758881|B3|||Age||years|Mean|33.2|33.2|Standard Deviation|14.5|14.5|||
3937040|NCT01385371|3758882|B2|||Age||years|Mean|33.5|33.5|Standard Deviation|14.5|14.5|||
3937041|NCT01385371|3758883|B1|||Age||years|Mean|32.9|32.9|Standard Deviation|14.5|14.5|||
3937042|NCT01385306|3758904|B1|South Africa||Region of Enrollment||participants|Number|6|6.0||||||
3937043|NCT01385306|3758904|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3937044|NCT01385306|3758904|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3937045|NCT01385306|3758904|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3937046|NCT01385306|3758904|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3937047|NCT01385306|3758904|B1|||Age||years|Mean|41|41.0|Full Range|||32.0|58.0|
3937048|NCT01385293|3758912|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937049|NCT01385293|3758912|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937050|NCT01385293|3758912|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3937051|NCT01385293|3758912|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3937052|NCT01385293|3758912|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3937053|NCT01385293|3758912|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937054|NCT01385293|3758912|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3937055|NCT01385293|3758912|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3937056|NCT01385293|3758912|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3937057|NCT01385293|3758912|B1|||Age||years|Median|67|67.0|Full Range|||48.0|94.0|
3937058|NCT01385280|3758922|B1|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3937059|NCT01385280|3758922|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937060|NCT01385280|3758922|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937061|NCT01385280|3758922|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3937062|NCT01385280|3758922|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937063|NCT01385280|3758922|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937064|NCT01385280|3758922|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3937065|NCT01385280|3758922|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937066|NCT01385280|3758922|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3937067|NCT01385280|3758922|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3937068|NCT01385280|3758922|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3937069|NCT01385280|3758922|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3937070|NCT01385280|3758922|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3937071|NCT01385202|3758932|B1|United States||Region of Enrollment||participants|Number|172|172.0||||||
3937072|NCT01385202|3758932|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937073|NCT01385202|3758932|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|168|168.0||||||
3937074|NCT01385202|3758932|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3937075|NCT01385202|3758932|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3937076|NCT01385202|3758932|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937077|NCT01385202|3758932|B1||White|Race (NIH/OMB)||Participants|Count of Participants|165|165.0||||||
3937078|NCT01385202|3758932|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3937079|NCT01385202|3758932|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937080|NCT01385202|3758932|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937081|NCT01385202|3758932|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937082|NCT01385202|3758932|B1||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3937083|NCT01385202|3758932|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3937084|NCT01385202|3758932|B1|||Age||Years|Mean|58.8|58.8|Standard Deviation|11.0|11.0|||
3937085|NCT01385189|3758939|B6||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3937086|NCT01385189|3758940|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3937087|NCT01385189|3758941|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3937088|NCT01385189|3758942|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3937089|NCT01385189|3758943|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3937090|NCT01385189|3758944|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3937091|NCT01385189|3758939|B6||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3937092|NCT01385189|3758940|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3937093|NCT01385189|3758941|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3937094|NCT01385189|3758942|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3937095|NCT01385189|3758943|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3937096|NCT01385189|3758944|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3937097|NCT01385189|3758939|B6|||Age||years|Mean|32.9|32.9|Full Range|||18.0|45.0|
3937098|NCT01385189|3758940|B5|||Age||years|Mean|35.0|35.0|Full Range|||26.0|45.0|
3937099|NCT01385189|3758941|B4|||Age||years|Mean|23.3|23.3|Full Range|||18.0|39.0|
3937100|NCT01385189|3758942|B3|||Age||years|Mean|26.3|26.3|Full Range|||18.0|33.0|
3937101|NCT01385189|3758943|B2|||Age||years|Mean|33.8|33.8|Full Range|||18.0|45.0|
3937102|NCT01385189|3758944|B1|||Age||years|Mean|34.3|34.3|Full Range|||18.0|45.0|
3937103|NCT01385137|3758967|B3|No||Osteoarthritis||Participants|Count of Participants|192|192.0||||||
3937104|NCT01385137|3758968|B2|No||Osteoarthritis||Participants|Count of Participants|98|98.0||||||
3937105|NCT01385137|3758969|B1|No||Osteoarthritis||Participants|Count of Participants|94|94.0||||||
3937106|NCT01385137|3758967|B3|Yes||Osteoarthritis||Participants|Count of Participants|57|57.0||||||
3937107|NCT01385137|3758968|B2|Yes||Osteoarthritis||Participants|Count of Participants|29|29.0||||||
3937108|NCT01385137|3758969|B1|Yes||Osteoarthritis||Participants|Count of Participants|28|28.0||||||
3937109|NCT01385137|3758967|B3|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3937110|NCT01385137|3758968|B2|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3937111|NCT01385137|3758969|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3937112|NCT01385137|3758967|B3|Multiracial||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3937113|NCT01385137|3758968|B2|Multiracial||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3937114|NCT01385137|3758969|B1|Multiracial||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3937115|NCT01385137|3758967|B3|Native American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3937116|NCT01385137|3758968|B2|Native American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3937117|NCT01385137|3758969|B1|Native American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3937118|NCT01385137|3758967|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3937119|NCT01385137|3758968|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3937120|NCT01385137|3758969|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3937121|NCT01385137|3758967|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3937122|NCT01385137|3758968|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3937123|NCT01385137|3758969|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3937124|NCT01385137|3758967|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|217|217.0||||||
3937125|NCT01385137|3758968|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|104|104.0||||||
3937126|NCT01385137|3758969|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|113|113.0||||||
3937127|NCT01385137|3758967|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3937128|NCT01385137|3758968|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3937129|NCT01385137|3758969|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3937130|NCT01385137|3758967|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|225|225.0||||||
3937131|NCT01385137|3758968|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
3937132|NCT01385137|3758969|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|112|112.0||||||
3937133|NCT01385137|3758967|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3937134|NCT01385137|3758968|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3937135|NCT01385137|3758969|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3937136|NCT01385137|3758967|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3937137|NCT01385137|3758968|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3937138|NCT01385137|3758969|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3937139|NCT01385137|3758967|B3||Female|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
3937140|NCT01385137|3758968|B2||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3937141|NCT01385137|3758969|B1||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3937142|NCT01385137|3758967|B3|||Age||years|Median|59.2|59.2|Full Range|||40.0|84.0|
3937143|NCT01385137|3758968|B2|||Age||years|Median|59.1|59.1|Full Range|||43.0|83.0|
3937144|NCT01385137|3758969|B1|||Age||years|Median|59.5|59.5|Full Range|||40.0|84.0|
3937145|NCT01385098|3758984|B1||Roux-Y Gastric Bypass|Surgery type||Participants|Count of Participants|12|12.0||||||
3937146|NCT01385098|3758984|B1||Sleeve Gastrectomy|Surgery type||Participants|Count of Participants|11|11.0||||||
3937147|NCT01385098|3758984|B1|||Excess body weight, lb||lb|Mean|128|128.0|Standard Deviation|47|47.0|||
3937148|NCT01385098|3758984|B1|||Body weight, lb||lb|Mean|278|278.0|Standard Deviation|52|52.0|||
3937149|NCT01385098|3758984|B1|||BMI, kg/m^2||kg/m^2|Mean|46.3|46.3|Standard Deviation|8.1|8.1|||
3937150|NCT01385098|3758984|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
3937151|NCT01385098|3758984|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937152|NCT01385098|3758984|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937153|NCT01385098|3758984|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3937154|NCT01385098|3758984|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3937155|NCT01385098|3758984|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937156|NCT01385098|3758984|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937157|NCT01385098|3758984|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937158|NCT01385098|3758984|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937159|NCT01385098|3758984|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3937160|NCT01385098|3758984|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3937161|NCT01385098|3758984|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3937162|NCT01385098|3758984|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3937163|NCT01385098|3758984|B1|||Age||years|Mean|41|41.0|Standard Deviation|11|11.0|||
3937164|NCT01385033|3758990|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3937165|NCT01385033|3758991|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3937166|NCT01385033|3758992|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3937167|NCT01385033|3758990|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3937168|NCT01385033|3758991|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3937169|NCT01385033|3758992|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3937170|NCT01385033|3758990|B3|||Age||years|Mean|69.5|69.5|Standard Deviation|6.8|6.8|||
3937171|NCT01385033|3758991|B2|||Age||years|Mean|71.9|71.9|Standard Deviation|5.8|5.8|||
3937172|NCT01385033|3758992|B1|||Age||years|Mean|63.8|63.8|Standard Deviation|5.8|5.8|||
3937173|NCT01384760|3759004|B3|||Score on Epworth Sleepiness Scale (ESS)|"The Epworth Sleepiness Scale (ESS) is a self-reporting questionnaire to assess subjective sleepiness and relies on dosing behavior in eight different situations of relatively low soporific nature, asking the respondent to rate the likelihood of falling asleep on a scale from 0 to 3, were 0 indicates no chance and 3 being the greatest chance of dosing. The scores for the eight questions are added together to obtain a single number.~A number in the 0–9 range is considered to be normal while a number of >10 indicates pathological sleepiness."|units on a scale|Mean|11.0|11.0|Standard Deviation|5.0|5.0|||
3937174|NCT01384760|3759005|B2|||Score on Epworth Sleepiness Scale (ESS)|"The Epworth Sleepiness Scale (ESS) is a self-reporting questionnaire to assess subjective sleepiness and relies on dosing behavior in eight different situations of relatively low soporific nature, asking the respondent to rate the likelihood of falling asleep on a scale from 0 to 3, were 0 indicates no chance and 3 being the greatest chance of dosing. The scores for the eight questions are added together to obtain a single number.~A number in the 0–9 range is considered to be normal while a number of >10 indicates pathological sleepiness."|units on a scale|Mean|10.2|10.2|Standard Deviation|4.7|4.7|||
3937229|NCT01384734|3759020|B1||American Indian Or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3937230|NCT01384734|3759015|B6||African American/African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|76|76.0||||||
3937175|NCT01384760|3759006|B1|||Score on Epworth Sleepiness Scale (ESS)|"The Epworth Sleepiness Scale (ESS) is a self-reporting questionnaire to assess subjective sleepiness and relies on dosing behavior in eight different situations of relatively low soporific nature, asking the respondent to rate the likelihood of falling asleep on a scale from 0 to 3, were 0 indicates no chance and 3 being the greatest chance of dosing. The scores for the eight questions are added together to obtain a single number.~A number in the 0–9 range is considered to be normal while a number of >10 indicates pathological sleepiness."|units on a scale|Mean|11.4|11.4|Standard Deviation|5.7|5.7|||
3937176|NCT01384760|3759004|B3|||minSaO2||percentage|Mean|67.2|67.2|Standard Deviation|10.2|10.2|||
3937177|NCT01384760|3759005|B2|||minSaO2||percentage|Mean|65.1|65.1|Standard Deviation|17.9|17.9|||
3937178|NCT01384760|3759006|B1|||minSaO2||percentage|Mean|69.6|69.6|Standard Deviation|9.7|9.7|||
3937179|NCT01384760|3759004|B3|||AHI - events/hour||events per hour|Mean|43|43.0|Standard Deviation|19.8|19.8|||
3937180|NCT01384760|3759005|B2|||AHI - events/hour||events per hour|Mean|42.5|42.5|Standard Deviation|20|20.0|||
3937181|NCT01384760|3759006|B1|||AHI - events/hour||events per hour|Mean|43.4|43.4|Standard Deviation|20|20.0|||
3937182|NCT01384760|3759004|B3|current smoking||smoking status||participants|Number|17|17.0||||||
3937183|NCT01384760|3759005|B2|current smoking||smoking status||participants|Number|6|6.0||||||
3937184|NCT01384760|3759006|B1|current smoking||smoking status||participants|Number|11|11.0||||||
3937185|NCT01384760|3759004|B3|quitted smoking||smoking status||participants|Number|12|12.0||||||
3937186|NCT01384760|3759005|B2|quitted smoking||smoking status||participants|Number|6|6.0||||||
3937187|NCT01384760|3759006|B1|quitted smoking||smoking status||participants|Number|6|6.0||||||
3937188|NCT01384760|3759004|B3|never smoke||smoking status||participants|Number|75|75.0||||||
3937189|NCT01384760|3759005|B2|never smoke||smoking status||participants|Number|31|31.0||||||
3937190|NCT01384760|3759006|B1|never smoke||smoking status||participants|Number|44|44.0||||||
3937191|NCT01384760|3759004|B3|||Neck circumference (cm)||cm|Mean|40.1|40.1|Standard Deviation|3.5|3.5|||
3937192|NCT01384760|3759005|B2|||Neck circumference (cm)||cm|Mean|40.3|40.3|Standard Deviation|3.7|3.7|||
3937193|NCT01384760|3759006|B1|||Neck circumference (cm)||cm|Mean|39.9|39.9|Standard Deviation|3.3|3.3|||
3937194|NCT01384760|3759004|B3|||Body mass index (BMI)||kg/m^2|Mean|30.3|30.3|Standard Deviation|4.0|4.0|||
3937195|NCT01384760|3759005|B2|||Body mass index (BMI)||kg/m^2|Mean|30.5|30.5|Standard Deviation|4.2|4.2|||
3937196|NCT01384760|3759006|B1|||Body mass index (BMI)||kg/m^2|Mean|30.2|30.2|Standard Deviation|3.9|3.9|||
3937197|NCT01384760|3759004|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3937198|NCT01384760|3759005|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3937199|NCT01384760|3759006|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3937200|NCT01384760|3759004|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3937201|NCT01384760|3759005|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3937202|NCT01384760|3759006|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3937203|NCT01384760|3759004|B3|||Age||years|Mean|51.8|51.8|Standard Deviation|7.8|7.8|||
3937204|NCT01384760|3759005|B2|||Age||years|Mean|52|52.0|Standard Deviation|9.3|9.3|||
3937205|NCT01384760|3759006|B1|||Age||years|Mean|51.4|51.4|Standard Deviation|9.1|9.1|||
3937206|NCT01384734|3759015|B6||Other/Mixed|Race/Ethnicity, Customized||Participants|Count of Participants|75|75.0||||||
3937207|NCT01384734|3759016|B5||Other/Mixed|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3937208|NCT01384734|3759017|B4||Other/Mixed|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3937209|NCT01384734|3759018|B3||Other/Mixed|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3937210|NCT01384734|3759019|B2||Other/Mixed|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3937211|NCT01384734|3759020|B1||Other/Mixed|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3937212|NCT01384734|3759015|B6||White|Race/Ethnicity, Customized||Participants|Count of Participants|95|95.0||||||
3937213|NCT01384734|3759016|B5||White|Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3937214|NCT01384734|3759017|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3937215|NCT01384734|3759018|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3937216|NCT01384734|3759019|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3937217|NCT01384734|3759020|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3937218|NCT01384734|3759015|B6||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3937219|NCT01384734|3759016|B5||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3937220|NCT01384734|3759017|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3937221|NCT01384734|3759018|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3937222|NCT01384734|3759019|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3937223|NCT01384734|3759020|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3937224|NCT01384734|3759015|B6||American Indian Or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3937225|NCT01384734|3759016|B5||American Indian Or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3937226|NCT01384734|3759017|B4||American Indian Or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3937227|NCT01384734|3759018|B3||American Indian Or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3937228|NCT01384734|3759019|B2||American Indian Or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3937231|NCT01384734|3759016|B5||African American/African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3937232|NCT01384734|3759017|B4||African American/African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3937233|NCT01384734|3759018|B3||African American/African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3937234|NCT01384734|3759019|B2||African American/African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3937235|NCT01384734|3759020|B1||African American/African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3937236|NCT01384734|3759015|B6||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3937237|NCT01384734|3759016|B5||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3937238|NCT01384734|3759017|B4||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3937239|NCT01384734|3759018|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3937240|NCT01384734|3759019|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3937241|NCT01384734|3759020|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3937242|NCT01384734|3759015|B6||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3937243|NCT01384734|3759016|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3937244|NCT01384734|3759017|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3937245|NCT01384734|3759018|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3937246|NCT01384734|3759019|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3937247|NCT01384734|3759020|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3937248|NCT01384734|3759015|B6|||Age||Years|Mean|39.1|39.1|Standard Deviation|9.84|9.84|||
3937249|NCT01384734|3759016|B5|||Age||Years|Mean|39.7|39.7|Standard Deviation|10.63|10.63|||
3937250|NCT01384734|3759017|B4|||Age||Years|Mean|39.2|39.2|Standard Deviation|11.41|11.41|||
3937251|NCT01384734|3759018|B3|||Age||Years|Mean|40.1|40.1|Standard Deviation|9.45|9.45|||
3937252|NCT01384734|3759019|B2|||Age||Years|Mean|38.4|38.4|Standard Deviation|9.49|9.49|||
3937253|NCT01384734|3759020|B1|||Age||Years|Mean|38.1|38.1|Standard Deviation|8.17|8.17|||
3937254|NCT01384591|3759104|B4|||Fat Mass||kilograms|Mean|19.1|19.1|Standard Deviation|3.90|3.9|||
3937255|NCT01384591|3759105|B3|||Fat Mass||kilograms|Mean|16.8|16.8|Standard Deviation|0.490|0.49|||
3937256|NCT01384591|3759106|B2|||Fat Mass||kilograms|Mean|16.6|16.6|Standard Deviation|3.2|3.2|||
3937257|NCT01384591|3759107|B1|||Fat Mass||kilograms|Mean|23.7|23.7|Standard Deviation|0.98|0.98|||
3937258|NCT01384591|3759104|B4|||Lean Body Mass||kilograms|Mean|46.7|46.7|Standard Deviation|9.7|9.7|||
3937259|NCT01384591|3759105|B3|||Lean Body Mass||kilograms|Mean|45.9|45.9|Standard Deviation|2.4|2.4|||
3937260|NCT01384591|3759106|B2|||Lean Body Mass||kilograms|Mean|52.9|52.9|Standard Deviation|14.2|14.2|||
3937261|NCT01384591|3759107|B1|||Lean Body Mass||kilograms|Mean|41.2|41.2|Standard Deviation|11.1|11.1|||
3937262|NCT01384591|3759104|B4|||Total Mass||kilograms|Mean|68.5|68.5|Standard Deviation|7.8|7.8|||
3937263|NCT01384591|3759105|B3|||Total Mass||kilograms|Mean|65.7|65.7|Standard Deviation|3.5|3.5|||
3937264|NCT01384591|3759106|B2|||Total Mass||kilograms|Mean|72.7|72.7|Standard Deviation|11.4|11.4|||
3937265|NCT01384591|3759107|B1|||Total Mass||kilograms|Mean|67.1|67.1|Standard Deviation|10.2|10.2|||
3937266|NCT01384591|3759104|B4|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3937267|NCT01384591|3759105|B3|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3937268|NCT01384591|3759106|B2|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3937269|NCT01384591|3759107|B1|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3937270|NCT01384591|3759104|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3937271|NCT01384591|3759105|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3937272|NCT01384591|3759106|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3937273|NCT01384591|3759107|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3937274|NCT01384591|3759104|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3937275|NCT01384591|3759105|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3937276|NCT01384591|3759106|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3937277|NCT01384591|3759107|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3937278|NCT01384591|3759104|B4|||Age||years|Mean|72|72.0|Standard Deviation|3.6|3.6|||
3937279|NCT01384591|3759105|B3|||Age||years|Mean|68.5|68.5|Standard Deviation|1.3|1.3|||
3937280|NCT01384591|3759106|B2|||Age||years|Mean|72.3|72.3|Standard Deviation|2.1|2.1|||
3937281|NCT01384591|3759107|B1|||Age||years|Mean|75.2|75.2|Standard Deviation|3.6|3.6|||
3937282|NCT01384591|3759104|B4||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3937283|NCT01384591|3759105|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3937284|NCT01384591|3759106|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3937285|NCT01384591|3759107|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3937286|NCT01384591|3759104|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3937287|NCT01384591|3759105|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3937288|NCT01384591|3759106|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3937289|NCT01384591|3759107|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3937290|NCT01384591|3759104|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3937291|NCT01384591|3759105|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3937292|NCT01384591|3759106|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3937293|NCT01384591|3759107|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3937294|NCT01384539|3759237|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
3937295|NCT01384539|3759238|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3937296|NCT01384539|3759239|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3937297|NCT01384539|3759237|B3|Non-Hispanic Black||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3937298|NCT01384539|3759238|B2|Non-Hispanic Black||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3937299|NCT01384539|3759239|B1|Non-Hispanic Black||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3937300|NCT01384539|3759237|B3|Non-Hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
3937301|NCT01384539|3759238|B2|Non-Hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3937302|NCT01384539|3759239|B1|Non-Hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3937303|NCT01384539|3759237|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3937304|NCT01384539|3759238|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3937305|NCT01384539|3759239|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3937306|NCT01384539|3759237|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3937307|NCT01384539|3759238|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3937308|NCT01384539|3759239|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3937309|NCT01384539|3759237|B3|||Age||years|Mean|58|58.0|Standard Deviation|12|12.0|||
3937310|NCT01384539|3759238|B2|||Age||years|Mean|59|59.0|Standard Deviation|12|12.0|||
3937311|NCT01384539|3759239|B1|||Age||years|Mean|58|58.0|Standard Deviation|13|13.0|||
3937312|NCT01384292|3759250|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3937313|NCT01384292|3759251|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3937314|NCT01384292|3759252|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3937315|NCT01384292|3759253|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3937316|NCT01384292|3759250|B4|White||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3937317|NCT01384292|3759251|B3|White||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3937318|NCT01384292|3759252|B2|White||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3937319|NCT01384292|3759253|B1|White||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3937320|NCT01384292|3759250|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3937321|NCT01384292|3759251|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3937322|NCT01384292|3759252|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3937323|NCT01384292|3759253|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3937324|NCT01384292|3759250|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3937325|NCT01384292|3759251|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3937326|NCT01384292|3759252|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3937327|NCT01384292|3759253|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3937328|NCT01384292|3759250|B4|||Age||Years|Mean|54.1|54.1|Standard Deviation|8.70|8.7|||
3937329|NCT01384292|3759251|B3|||Age||Years|Mean|52.5|52.5|Standard Deviation|4.93|4.93|||
3937330|NCT01384292|3759252|B2|||Age||Years|Mean|53.8|53.8|Standard Deviation|11.69|11.69|||
3937331|NCT01384292|3759253|B1|||Age||Years|Mean|55.8|55.8|Standard Deviation|9.20|9.2|||
3937332|NCT01384019|3759265|B3|Korea, Republic of||Region of Enrollment||participants|Number|126|126.0||||||
3937333|NCT01384019|3759266|B2|Korea, Republic of||Region of Enrollment||participants|Number|61|61.0||||||
3937334|NCT01384019|3759267|B1|Korea, Republic of||Region of Enrollment||participants|Number|65|65.0||||||
3937335|NCT01384019|3759265|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3937336|NCT01384019|3759266|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3937337|NCT01384019|3759267|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3937338|NCT01384019|3759265|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3937339|NCT01384019|3759266|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3937340|NCT01384019|3759267|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3937341|NCT01384019|3759265|B3|||Age||years|Mean|58|58.0|Standard Deviation|12|12.0|||
3937342|NCT01384019|3759266|B2|||Age||years|Mean|58|58.0|Standard Deviation|11|11.0|||
3937343|NCT01384019|3759267|B1|||Age||years|Mean|58|58.0|Standard Deviation|12|12.0|||
3937344|NCT01383993|3759274|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3937345|NCT01383993|3759275|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3937346|NCT01383993|3759276|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3937347|NCT01383993|3759277|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3937348|NCT01383993|3759274|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3937349|NCT01383993|3759275|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3937350|NCT01383993|3759276|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3937351|NCT01383993|3759277|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3937352|NCT01383993|3759274|B4|||Age||years|Mean|9.2|9.2|Standard Deviation|3.4|3.4|||
3937353|NCT01383993|3759275|B3|||Age||years|Mean|14.0|14.0|Standard Deviation|0.0|0.0|||
3937354|NCT01383993|3759276|B2|||Age||years|Mean|12.5|12.5|Standard Deviation|0.6|0.6|||
3937355|NCT01383993|3759277|B1|||Age||years|Mean|7.7|7.7|Standard Deviation|2.8|2.8|||
3937356|NCT01383954|3759326|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3937357|NCT01383954|3759326|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3937358|NCT01383954|3759326|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|11.2|11.2|||
3937359|NCT01383928|3759331|B4|Not Reported||Participants with Extramedullary Plasmacytomas|Participants who performed magnetic resonance imaging (MRI)/computed tomography (CT) scan were eligible for this baseline measure.|participants|Number|36|36.0||||||
3937360|NCT01383928|3759332|B3|Not Reported||Participants with Extramedullary Plasmacytomas|Participants who performed magnetic resonance imaging (MRI)/computed tomography (CT) scan were eligible for this baseline measure.|participants|Number|28|28.0||||||
3937361|NCT01383928|3759333|B2|Not Reported||Participants with Extramedullary Plasmacytomas|Participants who performed magnetic resonance imaging (MRI)/computed tomography (CT) scan were eligible for this baseline measure.|participants|Number|4|4.0||||||
3937362|NCT01383928|3759334|B1|Not Reported||Participants with Extramedullary Plasmacytomas|Participants who performed magnetic resonance imaging (MRI)/computed tomography (CT) scan were eligible for this baseline measure.|participants|Number|4|4.0||||||
3937363|NCT01383928|3759331|B4|Plasmacytomas Not Present||Participants with Extramedullary Plasmacytomas|Participants who performed magnetic resonance imaging (MRI)/computed tomography (CT) scan were eligible for this baseline measure.|participants|Number|8|8.0||||||
3937364|NCT01383928|3759332|B3|Plasmacytomas Not Present||Participants with Extramedullary Plasmacytomas|Participants who performed magnetic resonance imaging (MRI)/computed tomography (CT) scan were eligible for this baseline measure.|participants|Number|4|4.0||||||
3937365|NCT01383928|3759333|B2|Plasmacytomas Not Present||Participants with Extramedullary Plasmacytomas|Participants who performed magnetic resonance imaging (MRI)/computed tomography (CT) scan were eligible for this baseline measure.|participants|Number|2|2.0||||||
3937366|NCT01383928|3759334|B1|Plasmacytomas Not Present||Participants with Extramedullary Plasmacytomas|Participants who performed magnetic resonance imaging (MRI)/computed tomography (CT) scan were eligible for this baseline measure.|participants|Number|2|2.0||||||
3937367|NCT01383928|3759331|B4|Plasmacytomas Present||Participants with Extramedullary Plasmacytomas|Participants who performed magnetic resonance imaging (MRI)/computed tomography (CT) scan were eligible for this baseline measure.|participants|Number|20|20.0||||||
3937368|NCT01383928|3759332|B3|Plasmacytomas Present||Participants with Extramedullary Plasmacytomas|Participants who performed magnetic resonance imaging (MRI)/computed tomography (CT) scan were eligible for this baseline measure.|participants|Number|18|18.0||||||
3937369|NCT01383928|3759333|B2|Plasmacytomas Present||Participants with Extramedullary Plasmacytomas|Participants who performed magnetic resonance imaging (MRI)/computed tomography (CT) scan were eligible for this baseline measure.|participants|Number|1|1.0||||||
3937370|NCT01383928|3759334|B1|Plasmacytomas Present||Participants with Extramedullary Plasmacytomas|Participants who performed magnetic resonance imaging (MRI)/computed tomography (CT) scan were eligible for this baseline measure.|participants|Number|1|1.0||||||
3937371|NCT01383928|3759331|B4|Missing||Participants with Lytic Bone Lesions Present||participants|Number|8|8.0||||||
3937372|NCT01383928|3759332|B3|Missing||Participants with Lytic Bone Lesions Present||participants|Number|5|5.0||||||
3937373|NCT01383928|3759333|B2|Missing||Participants with Lytic Bone Lesions Present||participants|Number|2|2.0||||||
3937374|NCT01383928|3759334|B1|Missing||Participants with Lytic Bone Lesions Present||participants|Number|1|1.0||||||
3937375|NCT01383928|3759331|B4|Indeterminate||Participants with Lytic Bone Lesions Present||participants|Number|1|1.0||||||
3937376|NCT01383928|3759332|B3|Indeterminate||Participants with Lytic Bone Lesions Present||participants|Number|1|1.0||||||
3937377|NCT01383928|3759333|B2|Indeterminate||Participants with Lytic Bone Lesions Present||participants|Number|0|0.0||||||
3937378|NCT01383928|3759334|B1|Indeterminate||Participants with Lytic Bone Lesions Present||participants|Number|0|0.0||||||
3937379|NCT01383928|3759331|B4|Not Present||Participants with Lytic Bone Lesions Present||participants|Number|10|10.0||||||
3937380|NCT01383928|3759332|B3|Not Present||Participants with Lytic Bone Lesions Present||participants|Number|7|7.0||||||
3937381|NCT01383928|3759333|B2|Not Present||Participants with Lytic Bone Lesions Present||participants|Number|2|2.0||||||
3937382|NCT01383928|3759334|B1|Not Present||Participants with Lytic Bone Lesions Present||participants|Number|1|1.0||||||
3937383|NCT01383928|3759331|B4|Present||Participants with Lytic Bone Lesions Present||participants|Number|45|45.0||||||
3937384|NCT01383928|3759332|B3|Present||Participants with Lytic Bone Lesions Present||participants|Number|37|37.0||||||
3937385|NCT01383928|3759333|B2|Present||Participants with Lytic Bone Lesions Present||participants|Number|3|3.0||||||
3937386|NCT01383928|3759334|B1|Present||Participants with Lytic Bone Lesions Present||participants|Number|5|5.0||||||
3937387|NCT01383928|3759331|B4|Abnormal, clinically significant||Participants with skeletal survey results|Participants who performed skeletal survey were eligible for this baseline measure.|participants|Number|28|28.0||||||
3937388|NCT01383928|3759332|B3|Abnormal, clinically significant||Participants with skeletal survey results|Participants who performed skeletal survey were eligible for this baseline measure.|participants|Number|22|22.0||||||
3937389|NCT01383928|3759333|B2|Abnormal, clinically significant||Participants with skeletal survey results|Participants who performed skeletal survey were eligible for this baseline measure.|participants|Number|2|2.0||||||
3937390|NCT01383928|3759334|B1|Abnormal, clinically significant||Participants with skeletal survey results|Participants who performed skeletal survey were eligible for this baseline measure.|participants|Number|4|4.0||||||
3937391|NCT01383928|3759331|B4|Abnormal, not clinically significant||Participants with skeletal survey results|Participants who performed skeletal survey were eligible for this baseline measure.|participants|Number|26|26.0||||||
3937392|NCT01383928|3759332|B3|Abnormal, not clinically significant||Participants with skeletal survey results|Participants who performed skeletal survey were eligible for this baseline measure.|participants|Number|21|21.0||||||
3937393|NCT01383928|3759333|B2|Abnormal, not clinically significant||Participants with skeletal survey results|Participants who performed skeletal survey were eligible for this baseline measure.|participants|Number|3|3.0||||||
3937394|NCT01383928|3759334|B1|Abnormal, not clinically significant||Participants with skeletal survey results|Participants who performed skeletal survey were eligible for this baseline measure.|participants|Number|2|2.0||||||
3937395|NCT01383928|3759331|B4|Within Normal Limits||Participants with skeletal survey results|Participants who performed skeletal survey were eligible for this baseline measure.|participants|Number|3|3.0||||||
3937396|NCT01383928|3759332|B3|Within Normal Limits||Participants with skeletal survey results|Participants who performed skeletal survey were eligible for this baseline measure.|participants|Number|3|3.0||||||
3937397|NCT01383928|3759333|B2|Within Normal Limits||Participants with skeletal survey results|Participants who performed skeletal survey were eligible for this baseline measure.|participants|Number|0|0.0||||||
3937398|NCT01383928|3759334|B1|Within Normal Limits||Participants with skeletal survey results|Participants who performed skeletal survey were eligible for this baseline measure.|participants|Number|0|0.0||||||
3937399|NCT01383928|3759331|B4|Did not Performed Skeletal Survey||Skeletal Survey||participants|Number|7|7.0||||||
3937400|NCT01383928|3759332|B3|Did not Performed Skeletal Survey||Skeletal Survey||participants|Number|4|4.0||||||
3937401|NCT01383928|3759333|B2|Did not Performed Skeletal Survey||Skeletal Survey||participants|Number|2|2.0||||||
3937402|NCT01383928|3759334|B1|Did not Performed Skeletal Survey||Skeletal Survey||participants|Number|1|1.0||||||
3937403|NCT01383928|3759331|B4|Performed Skeletal Survey||Skeletal Survey||participants|Number|57|57.0||||||
3937404|NCT01383928|3759332|B3|Performed Skeletal Survey||Skeletal Survey||participants|Number|46|46.0||||||
3937405|NCT01383928|3759333|B2|Performed Skeletal Survey||Skeletal Survey||participants|Number|5|5.0||||||
3937406|NCT01383928|3759334|B1|Performed Skeletal Survey||Skeletal Survey||participants|Number|6|6.0||||||
3937407|NCT01383928|3759331|B4|||Hemoglobin||gram per liter (g/L)|Mean|108.6|108.6|Standard Deviation|15.32|15.32|||
3937408|NCT01383928|3759332|B3|||Hemoglobin||gram per liter (g/L)|Mean|108.9|108.9|Standard Deviation|14.36|14.36|||
3937409|NCT01383928|3759333|B2|||Hemoglobin||gram per liter (g/L)|Mean|112.0|112.0|Standard Deviation|16.42|16.42|||
3937410|NCT01383928|3759334|B1|||Hemoglobin||gram per liter (g/L)|Mean|103.4|103.4|Standard Deviation|21.59|21.59|||
3937411|NCT01383928|3759331|B4|||Corrected Calcium|Corrected calcium was calculated using the following formula: serum calcium (mg/dL)+0.98*[4-serum albumin (gram per deciliter [g/dL])]|mg/dL|Mean|9.96|9.96|Standard Deviation|0.583|0.583|||
3937412|NCT01383928|3759332|B3|||Corrected Calcium|Corrected calcium was calculated using the following formula: serum calcium (mg/dL)+0.98*[4-serum albumin (gram per deciliter [g/dL])]|mg/dL|Mean|10.01|10.01|Standard Deviation|0.617|0.617|||
3937413|NCT01383928|3759333|B2|||Corrected Calcium|Corrected calcium was calculated using the following formula: serum calcium (mg/dL)+0.98*[4-serum albumin (gram per deciliter [g/dL])]|mg/dL|Mean|9.79|9.79|Standard Deviation|0.561|0.561|||
3937414|NCT01383928|3759334|B1|||Corrected Calcium|Corrected calcium was calculated using the following formula: serum calcium (mg/dL)+0.98*[4-serum albumin (gram per deciliter [g/dL])]|mg/dL|Mean|9.83|9.83|Standard Deviation|0.275|0.275|||
3937415|NCT01383928|3759331|B4|>60 mL/min||Creatinine Clearance Category||participants|Number|52|52.0||||||
3937416|NCT01383928|3759332|B3|>60 mL/min||Creatinine Clearance Category||participants|Number|42|42.0||||||
3937417|NCT01383928|3759333|B2|>60 mL/min||Creatinine Clearance Category||participants|Number|5|5.0||||||
3937418|NCT01383928|3759334|B1|>60 mL/min||Creatinine Clearance Category||participants|Number|5|5.0||||||
3937419|NCT01383928|3759331|B4|30 - 60 mL/min||Creatinine Clearance Category||participants|Number|12|12.0||||||
3937420|NCT01383928|3759332|B3|30 - 60 mL/min||Creatinine Clearance Category||participants|Number|8|8.0||||||
3937421|NCT01383928|3759333|B2|30 - 60 mL/min||Creatinine Clearance Category||participants|Number|2|2.0||||||
3937422|NCT01383928|3759334|B1|30 - 60 mL/min||Creatinine Clearance Category||participants|Number|2|2.0||||||
3937423|NCT01383928|3759331|B4|||Creatinine Clearance|Creatinine clearance was calculated using the Cockcroft-Gault formula: C*[140-Age(years)]*Weight (kg)/[72 x serum creatinine (mg/dL)], where multiplication factor C = 1 for males, and C = 0.85 for females.|milliliter per minute (mL/min)|Mean|83.813|83.813|Standard Deviation|29.1122|29.1122|||
3937424|NCT01383928|3759332|B3|||Creatinine Clearance|Creatinine clearance was calculated using the Cockcroft-Gault formula: C*[140-Age(years)]*Weight (kg)/[72 x serum creatinine (mg/dL)], where multiplication factor C = 1 for males, and C = 0.85 for females.|milliliter per minute (mL/min)|Mean|84.128|84.128|Standard Deviation|27.8796|27.8796|||
3937425|NCT01383928|3759333|B2|||Creatinine Clearance|Creatinine clearance was calculated using the Cockcroft-Gault formula: C*[140-Age(years)]*Weight (kg)/[72 x serum creatinine (mg/dL)], where multiplication factor C = 1 for males, and C = 0.85 for females.|milliliter per minute (mL/min)|Mean|83.527|83.527|Standard Deviation|31.9197|31.9197|||
3937426|NCT01383928|3759334|B1|||Creatinine Clearance|Creatinine clearance was calculated using the Cockcroft-Gault formula: C*[140-Age(years)]*Weight (kg)/[72 x serum creatinine (mg/dL)], where multiplication factor C = 1 for males, and C = 0.85 for females.|milliliter per minute (mL/min)|Mean|81.847|81.847|Standard Deviation|39.0758|39.0758|||
3937427|NCT01383928|3759331|B4|Greater than (>) 2 mg/dL||Serum Creatinine Category||participants|Number|0|0.0||||||
3937428|NCT01383928|3759332|B3|Greater than (>) 2 mg/dL||Serum Creatinine Category||participants|Number|0|0.0||||||
3937429|NCT01383928|3759333|B2|Greater than (>) 2 mg/dL||Serum Creatinine Category||participants|Number|0|0.0||||||
3937430|NCT01383928|3759334|B1|Greater than (>) 2 mg/dL||Serum Creatinine Category||participants|Number|0|0.0||||||
3937431|NCT01383928|3759331|B4|Less than or equal to (<=) 2 mg/dL||Serum Creatinine Category||participants|Number|64|64.0||||||
3937432|NCT01383928|3759332|B3|Less than or equal to (<=) 2 mg/dL||Serum Creatinine Category||participants|Number|50|50.0||||||
3937433|NCT01383928|3759333|B2|Less than or equal to (<=) 2 mg/dL||Serum Creatinine Category||participants|Number|7|7.0||||||
3937434|NCT01383928|3759334|B1|Less than or equal to (<=) 2 mg/dL||Serum Creatinine Category||participants|Number|7|7.0||||||
3937435|NCT01383928|3759331|B4|||Serum Creatinine||milligram per deciliter (mg/dL)|Mean|1.07|1.07|Standard Deviation|0.291|0.291|||
3937436|NCT01383928|3759332|B3|||Serum Creatinine||milligram per deciliter (mg/dL)|Mean|1.04|1.04|Standard Deviation|0.257|0.257|||
3937437|NCT01383928|3759333|B2|||Serum Creatinine||milligram per deciliter (mg/dL)|Mean|1.07|1.07|Standard Deviation|0.269|0.269|||
3937438|NCT01383928|3759334|B1|||Serum Creatinine||milligram per deciliter (mg/dL)|Mean|1.33|1.33|Standard Deviation|0.435|0.435|||
3937439|NCT01383928|3759331|B4|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|3|3.0||||||
3937440|NCT01383928|3759332|B3|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|2|2.0||||||
3937441|NCT01383928|3759333|B2|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|1|1.0||||||
3937442|NCT01383928|3759334|B1|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|0|0.0||||||
3937443|NCT01383928|3759331|B4|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|26|26.0||||||
3937444|NCT01383928|3759332|B3|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|21|21.0||||||
3937445|NCT01383928|3759333|B2|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|1|1.0||||||
3937446|NCT01383928|3759334|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|4|4.0||||||
3937447|NCT01383928|3759331|B4|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|35|35.0||||||
3937448|NCT01383928|3759332|B3|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|27|27.0||||||
3937449|NCT01383928|3759333|B2|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|5|5.0||||||
3937450|NCT01383928|3759334|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|3|3.0||||||
3937451|NCT01383928|3759331|B4|Unknown||Type of Myeloma|Types of Myeloma was described on the basis of antibodies produced by cancerous plasma cells.|participants|Number|1|1.0||||||
3937452|NCT01383928|3759332|B3|Unknown||Type of Myeloma|Types of Myeloma was described on the basis of antibodies produced by cancerous plasma cells.|participants|Number|1|1.0||||||
3937453|NCT01383928|3759333|B2|Unknown||Type of Myeloma|Types of Myeloma was described on the basis of antibodies produced by cancerous plasma cells.|participants|Number|0|0.0||||||
3937454|NCT01383928|3759334|B1|Unknown||Type of Myeloma|Types of Myeloma was described on the basis of antibodies produced by cancerous plasma cells.|participants|Number|0|0.0||||||
3937455|NCT01383928|3759331|B4|Kappa Free Light Chains||Type of Myeloma|Types of Myeloma was described on the basis of antibodies produced by cancerous plasma cells.|participants|Number|3|3.0||||||
3937456|NCT01383928|3759332|B3|Kappa Free Light Chains||Type of Myeloma|Types of Myeloma was described on the basis of antibodies produced by cancerous plasma cells.|participants|Number|1|1.0||||||
3937457|NCT01383928|3759333|B2|Kappa Free Light Chains||Type of Myeloma|Types of Myeloma was described on the basis of antibodies produced by cancerous plasma cells.|participants|Number|1|1.0||||||
3937458|NCT01383928|3759334|B1|Kappa Free Light Chains||Type of Myeloma|Types of Myeloma was described on the basis of antibodies produced by cancerous plasma cells.|participants|Number|1|1.0||||||
3937459|NCT01383928|3759331|B4|Lambda Free Light Chains||Type of Myeloma|Types of Myeloma was described on the basis of antibodies produced by cancerous plasma cells.|participants|Number|4|4.0||||||
3937460|NCT01383928|3759332|B3|Lambda Free Light Chains||Type of Myeloma|Types of Myeloma was described on the basis of antibodies produced by cancerous plasma cells.|participants|Number|3|3.0||||||
3937461|NCT01383928|3759333|B2|Lambda Free Light Chains||Type of Myeloma|Types of Myeloma was described on the basis of antibodies produced by cancerous plasma cells.|participants|Number|0|0.0||||||
3937462|NCT01383928|3759334|B1|Lambda Free Light Chains||Type of Myeloma|Types of Myeloma was described on the basis of antibodies produced by cancerous plasma cells.|participants|Number|1|1.0||||||
3937463|NCT01383928|3759331|B4|Biclonal||Type of Myeloma|Types of Myeloma was described on the basis of antibodies produced by cancerous plasma cells.|participants|Number|2|2.0||||||
3937464|NCT01383928|3759332|B3|Biclonal||Type of Myeloma|Types of Myeloma was described on the basis of antibodies produced by cancerous plasma cells.|participants|Number|1|1.0||||||
3937465|NCT01383928|3759333|B2|Biclonal||Type of Myeloma|Types of Myeloma was described on the basis of antibodies produced by cancerous plasma cells.|participants|Number|1|1.0||||||
3937466|NCT01383928|3759334|B1|Biclonal||Type of Myeloma|Types of Myeloma was described on the basis of antibodies produced by cancerous plasma cells.|participants|Number|0|0.0||||||
3937467|NCT01383928|3759331|B4|IgA Lambda||Type of Myeloma|Types of Myeloma was described on the basis of antibodies produced by cancerous plasma cells.|participants|Number|4|4.0||||||
3937468|NCT01383928|3759332|B3|IgA Lambda||Type of Myeloma|Types of Myeloma was described on the basis of antibodies produced by cancerous plasma cells.|participants|Number|3|3.0||||||
3937469|NCT01383928|3759333|B2|IgA Lambda||Type of Myeloma|Types of Myeloma was described on the basis of antibodies produced by cancerous plasma cells.|participants|Number|0|0.0||||||
3937470|NCT01383928|3759334|B1|IgA Lambda||Type of Myeloma|Types of Myeloma was described on the basis of antibodies produced by cancerous plasma cells.|participants|Number|1|1.0||||||
3937471|NCT01383928|3759331|B4|IgA Kappa||Type of Myeloma|Types of Myeloma was described on the basis of antibodies produced by cancerous plasma cells.|participants|Number|12|12.0||||||
3937472|NCT01383928|3759332|B3|IgA Kappa||Type of Myeloma|Types of Myeloma was described on the basis of antibodies produced by cancerous plasma cells.|participants|Number|10|10.0||||||
3937473|NCT01383928|3759333|B2|IgA Kappa||Type of Myeloma|Types of Myeloma was described on the basis of antibodies produced by cancerous plasma cells.|participants|Number|1|1.0||||||
3937474|NCT01383928|3759334|B1|IgA Kappa||Type of Myeloma|Types of Myeloma was described on the basis of antibodies produced by cancerous plasma cells.|participants|Number|1|1.0||||||
3937475|NCT01383928|3759331|B4|IgG Lambda||Type of Myeloma|Types of Myeloma was described on the basis of antibodies produced by cancerous plasma cells.|participants|Number|9|9.0||||||
3937476|NCT01383928|3759332|B3|IgG Lambda||Type of Myeloma|Types of Myeloma was described on the basis of antibodies produced by cancerous plasma cells.|participants|Number|7|7.0||||||
3937477|NCT01383928|3759333|B2|IgG Lambda||Type of Myeloma|Types of Myeloma was described on the basis of antibodies produced by cancerous plasma cells.|participants|Number|1|1.0||||||
3937478|NCT01383928|3759334|B1|IgG Lambda||Type of Myeloma|Types of Myeloma was described on the basis of antibodies produced by cancerous plasma cells.|participants|Number|1|1.0||||||
3937479|NCT01383928|3759331|B4|IgG Kappa||Type of Myeloma|Types of Myeloma was described on the basis of antibodies produced by cancerous plasma cells.|participants|Number|29|29.0||||||
3937480|NCT01383928|3759332|B3|IgG Kappa||Type of Myeloma|Types of Myeloma was described on the basis of antibodies produced by cancerous plasma cells.|participants|Number|24|24.0||||||
3937481|NCT01383928|3759333|B2|IgG Kappa||Type of Myeloma|Types of Myeloma was described on the basis of antibodies produced by cancerous plasma cells.|participants|Number|3|3.0||||||
3937482|NCT01383928|3759334|B1|IgG Kappa||Type of Myeloma|Types of Myeloma was described on the basis of antibodies produced by cancerous plasma cells.|participants|Number|2|2.0||||||
3937483|NCT01383928|3759331|B4|||Body Surface Area (BSA)|For this baseline measure, number of participants evaluable were 7, 6 and 49 for each arm, respectively.|square meter (m^2)|Mean|1.975|1.975|Standard Deviation|0.2390|0.239|||
3937484|NCT01383928|3759332|B3|||Body Surface Area (BSA)|For this baseline measure, number of participants evaluable were 7, 6 and 49 for each arm, respectively.|square meter (m^2)|Mean|1.958|1.958|Standard Deviation|0.2373|0.2373|||
3937485|NCT01383928|3759333|B2|||Body Surface Area (BSA)|For this baseline measure, number of participants evaluable were 7, 6 and 49 for each arm, respectively.|square meter (m^2)|Mean|1.960|1.96|Standard Deviation|0.2657|0.2657|||
3937486|NCT01383928|3759334|B1|||Body Surface Area (BSA)|For this baseline measure, number of participants evaluable were 7, 6 and 49 for each arm, respectively.|square meter (m^2)|Mean|2.109|2.109|Standard Deviation|0.2192|0.2192|||
3937487|NCT01383928|3759331|B4|||Weight||kilogram (kg)|Mean|82.80|82.8|Standard Deviation|17.228|17.228|||
3937488|NCT01383928|3759332|B3|||Weight||kilogram (kg)|Mean|81.22|81.22|Standard Deviation|16.701|16.701|||
3937489|NCT01383928|3759333|B2|||Weight||kilogram (kg)|Mean|82.56|82.56|Standard Deviation|19.295|19.295|||
3937490|NCT01383928|3759334|B1|||Weight||kilogram (kg)|Mean|94.29|94.29|Standard Deviation|17.083|17.083|||
3937491|NCT01383928|3759331|B4|||Height|For this baseline measure, number of participants evaluable were 7, 6 and 49 for each arm, respectively.|centimeter (cm)|Mean|171.1|171.1|Standard Deviation|9.43|9.43|||
3937492|NCT01383928|3759332|B3|||Height|For this baseline measure, number of participants evaluable were 7, 6 and 49 for each arm, respectively.|centimeter (cm)|Mean|171.2|171.2|Standard Deviation|9.30|9.3|||
3937493|NCT01383928|3759333|B2|||Height|For this baseline measure, number of participants evaluable were 7, 6 and 49 for each arm, respectively.|centimeter (cm)|Mean|170.9|170.9|Standard Deviation|7.10|7.1|||
3937494|NCT01383928|3759334|B1|||Height|For this baseline measure, number of participants evaluable were 7, 6 and 49 for each arm, respectively.|centimeter (cm)|Mean|171.1|171.1|Standard Deviation|13.09|13.09|||
3937495|NCT01383928|3759331|B4|United States||Region of Enrollment||participants|Number|64|64.0||||||
3937496|NCT01383928|3759332|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3937497|NCT01383928|3759333|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3937498|NCT01383928|3759334|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3937499|NCT01383928|3759331|B4|Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3937500|NCT01383928|3759332|B3|Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3937501|NCT01383928|3759333|B2|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3937502|NCT01383928|3759334|B1|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3937503|NCT01383928|3759331|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3937504|NCT01383928|3759332|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3937505|NCT01383928|3759333|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3937506|NCT01383928|3759334|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3937507|NCT01383928|3759331|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3937508|NCT01383928|3759332|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3937509|NCT01383928|3759333|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3937510|NCT01383928|3759334|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3937511|NCT01383928|3759331|B4|White||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
3937512|NCT01383928|3759332|B3|White||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
3937513|NCT01383928|3759333|B2|White||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3937514|NCT01383928|3759334|B1|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3937515|NCT01383928|3759331|B4|Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3937516|NCT01383928|3759332|B3|Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3937517|NCT01383928|3759333|B2|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3937518|NCT01383928|3759334|B1|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3937519|NCT01383928|3759331|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
3937520|NCT01383928|3759332|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
3937521|NCT01383928|3759333|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3937522|NCT01383928|3759334|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3937523|NCT01383928|3759331|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3937524|NCT01383928|3759332|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3937525|NCT01383928|3759333|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3937526|NCT01383928|3759334|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3937527|NCT01383928|3759331|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3937528|NCT01383928|3759332|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3937529|NCT01383928|3759333|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3937530|NCT01383928|3759334|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3937531|NCT01383928|3759331|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3937532|NCT01383928|3759332|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3937533|NCT01383928|3759333|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3937534|NCT01383928|3759334|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3937535|NCT01383928|3759331|B4|||Age||years|Mean|61.8|61.8|Standard Deviation|9.82|9.82|||
3937536|NCT01383928|3759332|B3|||Age||years|Mean|61.5|61.5|Standard Deviation|10.03|10.03|||
3937537|NCT01383928|3759333|B2|||Age||years|Mean|61.1|61.1|Standard Deviation|6.20|6.2|||
3937538|NCT01383928|3759334|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|12.04|12.04|||
3937539|NCT01383720|3759378|B1|||EuroScore|"European System for Cardiac Operative Risk Evaluation. EuroSCORE is a method of calculating predicted operative mortality for patients undergoing cardiac surgery.~The patient is considered at high risk for surgical aortic valve replacement with an STS score ≥8% or a EuroSCORE ≥20%, or documented multidisciplinary heart team agreement that the patient is at high risk for surgery due to frailty and/or coexisting comorbidities. EuroScore II is a risk model that calculates the risk of death after a heart operation through 30 days."|units on a scale|Mean|9.5|9.5|Standard Deviation|4.4|4.4|||
3937540|NCT01383720|3759378|B1|||Society of Thoracic Surgeons (STS) Score|The Society of Thoracic Surgeons’ risk models predict the risk of operative mortality and morbidity after adult cardiac surgery on the basis of patient demographic and clinical variables. The patient is considered at high risk for surgical aortic valve replacement with an STS score ≥8% or a EuroSCORE ≥20%, or documented multidisciplinary heart team agreement that the patient is at high risk for surgery due to frailty and/or coexisting comorbidities. For example, an STS score of 10% means predicted operative mortality or serious, irreversible morbidity risk of 10% at 30 days.|units on a scale|Mean|4.9|4.9|Standard Deviation|2.5|2.5|||
3937541|NCT01383720|3759378|B1|||Charlson Comorbidity Index Score|"Charlson Comorbidity Index contains 19 categories of comorbidity and assigns a weighted value to each subject’s comorbidity based on the risk of 1-year mortality.~A score of 0 reflects no comorbidities and 19 reveals severe comorbidities."|units on a scale|Mean|1.8|1.8|Standard Deviation|1.7|1.7|||
3937542|NCT01383720|3759378|B1|||Mini-Cognitive Assessment for Dementia|Mini-Cognitive Assessment for Dementia scores range from 5 (normal cognition) to 0 (impaired cognition).|units on a scale|Mean|3.3|3.3|Standard Deviation|1.5|1.5|||
3937621|NCT01383447|3759499|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937622|NCT01383447|3759499|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3937543|NCT01383720|3759378|B1|||Katz Index|"Katz Index of Independence in Activities of Daily Living (ADL) is an instrument to assess functional status as a measurement of the client’s ability to perform activities of daily living independently.~The Index ranks adequacy of performance in the six functions of bathing, dressing, toileting, transferring, continence, and feeding. A score of 6 indicates full function, 4 indicates moderate impairment, and 2 or less indicates severe functional impairment."|units on a scale|Mean|5.9|5.9|Standard Deviation|0.3|0.3|||
3937544|NCT01383720|3759378|B1|||Maximum Grip Strength Average||kg|Mean|15.3|15.3|Standard Deviation|5.7|5.7|||
3937545|NCT01383720|3759378|B1|||5-Meter Gait Speed||seconds|Mean|8.2|8.2|Standard Deviation|4.9|4.9|||
3937546|NCT01383720|3759378|B1|||Serum Albumin||g/dL|Mean|3.9|3.9|Standard Deviation|0.4|0.4|||
3937547|NCT01383720|3759378|B1|||Body mass index||kg/m2|Mean|27.6|27.6|Standard Deviation|6.0|6.0|||
3937548|NCT01383720|3759378|B1|||Mitral Regurgitation (moderate or severe)|A patient may or may not belong to a category or may belong to more than one category. Therefore the sum may not equal the overall number of patients in the study.|participants|Number|3|3.0||||||
3937549|NCT01383720|3759378|B1|||Aortic regurgitation (moderate or severe)|A patient may or may not belong to a category or may belong to more than one category. Therefore the sum may not equal the overall number of patients in the study.|participants|Number|4|4.0||||||
3937550|NCT01383720|3759378|B1|||Left Ventricular Ejection Fraction|This measure represents the percent of Left Ventricular Ejection Fraction.|percent of LVEF|Mean|62.3|62.3|Standard Deviation|7.6|7.6|||
3937551|NCT01383720|3759378|B1|||Mean Aortic Valve Gradient||mmHg|Mean|53.9|53.9|Standard Deviation|20.9|20.9|||
3937552|NCT01383720|3759378|B1|||Aortic valve area (effective orifice area)||cm^2|Mean|0.68|0.68|Standard Deviation|0.19|0.19|||
3937553|NCT01383720|3759378|B1|Cerebrovascular Accident||Neurological History|A patient may or may not belong to a category or may belong to more than one category. Therefore the sum may not equal the overall number of patients in the study.|participants|Number|2|2.0||||||
3937554|NCT01383720|3759378|B1|Transient Ischemic Attack||Neurological History|A patient may or may not belong to a category or may belong to more than one category. Therefore the sum may not equal the overall number of patients in the study.|participants|Number|1|1.0||||||
3937555|NCT01383720|3759378|B1|3 or higher||Modified Rankin Scale|Higher score equals a worse condition with zero meaning no symptoms, 2 meaning slight disability and 6 meaning death.|participants|Number|0|0.0||||||
3937556|NCT01383720|3759378|B1|2||Modified Rankin Scale|Higher score equals a worse condition with zero meaning no symptoms, 2 meaning slight disability and 6 meaning death.|participants|Number|1|1.0||||||
3937557|NCT01383720|3759378|B1|1||Modified Rankin Scale|Higher score equals a worse condition with zero meaning no symptoms, 2 meaning slight disability and 6 meaning death.|participants|Number|0|0.0||||||
3937558|NCT01383720|3759378|B1|0||Modified Rankin Scale|Higher score equals a worse condition with zero meaning no symptoms, 2 meaning slight disability and 6 meaning death.|participants|Number|10|10.0||||||
3937559|NCT01383720|3759378|B1|Class IV||New York Heart Association Class|"New York Heart Association (NYHA) functional classification system relates symptoms to everyday activities and the patient's quality of life.~Class I (Mild): No limitation of physical activity. Class II (Mild): Slight limitation of physical activity. Class III (Moderate): Marked limitation of physical activity. Class IV (Severe): Unable to carry out any physical activity without discomfort.~Symptomatic aortic valve stenosis is related to NYHA Functional Class ≥ II."|participants|Number|0|0.0||||||
3937560|NCT01383720|3759378|B1|Class III||New York Heart Association Class|"New York Heart Association (NYHA) functional classification system relates symptoms to everyday activities and the patient's quality of life.~Class I (Mild): No limitation of physical activity. Class II (Mild): Slight limitation of physical activity. Class III (Moderate): Marked limitation of physical activity. Class IV (Severe): Unable to carry out any physical activity without discomfort.~Symptomatic aortic valve stenosis is related to NYHA Functional Class ≥ II."|participants|Number|5|5.0||||||
3937561|NCT01383720|3759378|B1|Class II||New York Heart Association Class|"New York Heart Association (NYHA) functional classification system relates symptoms to everyday activities and the patient's quality of life.~Class I (Mild): No limitation of physical activity. Class II (Mild): Slight limitation of physical activity. Class III (Moderate): Marked limitation of physical activity. Class IV (Severe): Unable to carry out any physical activity without discomfort.~Symptomatic aortic valve stenosis is related to NYHA Functional Class ≥ II."|participants|Number|6|6.0||||||
3937562|NCT01383720|3759378|B1|Class I||New York Heart Association Class|"New York Heart Association (NYHA) functional classification system relates symptoms to everyday activities and the patient's quality of life.~Class I (Mild): No limitation of physical activity. Class II (Mild): Slight limitation of physical activity. Class III (Moderate): Marked limitation of physical activity. Class IV (Severe): Unable to carry out any physical activity without discomfort.~Symptomatic aortic valve stenosis is related to NYHA Functional Class ≥ II."|participants|Number|0|0.0||||||
3937563|NCT01383720|3759378|B1|History of atrial fibrillation||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|5|5.0||||||
3937564|NCT01383720|3759378|B1|Previous coronary artery bypass graft surgery||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|0|0.0||||||
3937565|NCT01383720|3759378|B1|Previous percutaneous coronary intervention||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|2|2.0||||||
3937566|NCT01383720|3759378|B1|Coronary artery disease||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|5|5.0||||||
3937567|NCT01383720|3759378|B1|Chronic obstructive pulmonary disease||General Medical History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|1|1.0||||||
3937623|NCT01383447|3759499|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937568|NCT01383720|3759378|B1|Dialysis dependent renal failure||General Medical History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|0|0.0||||||
3937569|NCT01383720|3759378|B1|History of peripheral vascular disease||General Medical History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|1|1.0||||||
3937570|NCT01383720|3759378|B1|Hypertension (medically treated)||General Medical History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|10|10.0||||||
3937571|NCT01383720|3759378|B1|Hyperlipidemia (medically treated)||General Medical History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|8|8.0||||||
3937572|NCT01383720|3759378|B1|Diabetes mellitus (current)||General Medical History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|5|5.0||||||
3937573|NCT01383720|3759378|B1|Australia||Region of Enrollment||participants|Number|11|11.0||||||
3937574|NCT01383720|3759378|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3937575|NCT01383720|3759378|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3937576|NCT01383720|3759378|B1|||Age||years|Mean|83.0|83.0|Standard Deviation|3.6|3.6|||
3937577|NCT01383720|3759378|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3937578|NCT01383720|3759378|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3937579|NCT01383720|3759378|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3937580|NCT01383707|3759400|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3937581|NCT01383707|3759400|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3937582|NCT01383707|3759400|B1|||Age||years|Mean|63.7|63.7|Standard Deviation|10.6|10.6|||
3937583|NCT01383681|3759409|B1||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3937584|NCT01383681|3759409|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3937585|NCT01383681|3759409|B1|>65 years||Age, Customized||Participants|Number|45|45.0||||||
3937586|NCT01383681|3759409|B1|56 to 65 years||Age, Customized||Participants|Number|57|57.0||||||
3937587|NCT01383681|3759409|B1|46 to 55 years||Age, Customized||Participants|Number|48|48.0||||||
3937588|NCT01383681|3759409|B1|36 to 45 years||Age, Customized||Participants|Number|43|43.0||||||
3937589|NCT01383681|3759409|B1|26 to 35 years||Age, Customized||Participants|Number|21|21.0||||||
3937590|NCT01383681|3759409|B1|18 to 25 years||Age, Customized||Participants|Number|21|21.0||||||
3937591|NCT01383616|3759414|B3|United States||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3937592|NCT01383616|3759415|B2|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3937593|NCT01383616|3759416|B1|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3937594|NCT01383616|3759414|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3937595|NCT01383616|3759415|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3937596|NCT01383616|3759416|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3937597|NCT01383616|3759414|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3937598|NCT01383616|3759415|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3937599|NCT01383616|3759416|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3937600|NCT01383616|3759414|B3|||Age||years|Mean|79|79.0|Standard Deviation|7.1|7.1|||
3937601|NCT01383616|3759415|B2|||Age||years|Mean|79.3|79.3|Standard Deviation|6.5|6.5|||
3937602|NCT01383616|3759416|B1|||Age||years|Mean|78.7|78.7|Standard Deviation|7.8|7.8|||
3937603|NCT01383616|3759414|B3||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
3937604|NCT01383616|3759415|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3937605|NCT01383616|3759416|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3937606|NCT01383616|3759414|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3937607|NCT01383616|3759415|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3937608|NCT01383616|3759416|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3937609|NCT01383616|3759414|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3937610|NCT01383616|3759415|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3937611|NCT01383616|3759416|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3937612|NCT01383499|3759440|B1|||Forced expiratory volume in 1s (FEV1)||Litre|Mean|1.640|1.64|Standard Deviation|0.386|0.386|||
3937613|NCT01383499|3759440|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3937614|NCT01383499|3759440|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3937615|NCT01383499|3759440|B1|||Age||years|Mean|8.8|8.8|Standard Deviation|1.7|1.7|||
3937616|NCT01383486|3759493|B1|Male||Gender|119 females; 115 males; 1 subject refused to provide gender information|Participants|Number|115|115.0||||||
3937617|NCT01383486|3759493|B1|Female||Gender|119 females; 115 males; 1 subject refused to provide gender information|Participants|Number|119|119.0||||||
3937618|NCT01383486|3759493|B1|||Age||Years|Mean|51.4|51.4|Standard Deviation|14.3|14.3|||
3937619|NCT01383447|3759499|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3937620|NCT01383447|3759499|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937624|NCT01383447|3759499|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937625|NCT01383447|3759499|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937626|NCT01383447|3759499|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937627|NCT01383447|3759499|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3937628|NCT01383447|3759499|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3937629|NCT01383447|3759499|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3937630|NCT01383447|3759499|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3937631|NCT01383447|3759499|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3937632|NCT01383421|3759507|B1||Male|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
3937633|NCT01383421|3759507|B1||Female|Sex: Female, Male||Participants|Count of Participants|790|790.0||||||
3937634|NCT01383421|3759507|B1|||Age||years|Mean|54.3|54.3|Standard Deviation|13.33|13.33|||
3937635|NCT01383356|3759570|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3937636|NCT01383356|3759570|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3937637|NCT01383356|3759570|B1|||Age||years|Mean|35|35.0|Standard Deviation|9|9.0|||
3937638|NCT01383317|3759581|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3937639|NCT01383317|3759582|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3937640|NCT01383317|3759583|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3937641|NCT01383317|3759581|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937642|NCT01383317|3759582|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937643|NCT01383317|3759583|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937644|NCT01383317|3759581|B3||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3937645|NCT01383317|3759582|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3937646|NCT01383317|3759583|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3937647|NCT01383317|3759581|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3937648|NCT01383317|3759582|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3937649|NCT01383317|3759583|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3937650|NCT01383317|3759581|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937651|NCT01383317|3759582|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937652|NCT01383317|3759583|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937653|NCT01383317|3759581|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937654|NCT01383317|3759582|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937655|NCT01383317|3759583|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937656|NCT01383317|3759581|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937657|NCT01383317|3759582|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937658|NCT01383317|3759583|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937659|NCT01383317|3759581|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3937660|NCT01383317|3759582|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3937661|NCT01383317|3759583|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3937662|NCT01383317|3759581|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3937663|NCT01383317|3759582|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3937664|NCT01383317|3759583|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3937665|NCT01383317|3759581|B3|||Age||years|Mean|55.52|55.52|Standard Deviation|11.6|11.6|||
3937666|NCT01383317|3759582|B2|||Age||years|Mean|59.82|59.82|Standard Deviation|10.62|10.62|||
3937667|NCT01383317|3759583|B1|||Age||years|Mean|51.03|51.03|Standard Deviation|11.43|11.43|||
3937668|NCT01383213|3759606|B3|Italy||Region of Enrollment||participants|Number|81|81.0||||||
3937669|NCT01383213|3759607|B2|Italy||Region of Enrollment||participants|Number|41|41.0||||||
3937670|NCT01383213|3759608|B1|Italy||Region of Enrollment||participants|Number|40|40.0||||||
3937671|NCT01383213|3759606|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3937672|NCT01383213|3759607|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3937673|NCT01383213|3759608|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3937674|NCT01383213|3759606|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3937675|NCT01383213|3759607|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3937676|NCT01383213|3759608|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3937677|NCT01383213|3759606|B3|||Age||years|Mean|67.2|67.2|Standard Deviation|16|16.0|||
3937678|NCT01383213|3759607|B2|||Age||years|Mean|69.5|69.5|Standard Deviation|15.8|15.8|||
3937679|NCT01383213|3759608|B1|||Age||years|Mean|64.9|64.9|Standard Deviation|16.1|16.1|||
3937680|NCT01383213|3759606|B3||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
3937681|NCT01383213|3759607|B2||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
3937682|NCT01383213|3759608|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3937683|NCT01383213|3759606|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3937684|NCT01383213|3759607|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3937685|NCT01383213|3759608|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3937686|NCT01383213|3759606|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3937687|NCT01383213|3759607|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3937688|NCT01383213|3759608|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3937689|NCT01383200|3759615|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3937690|NCT01383200|3759616|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3937691|NCT01383200|3759617|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3937692|NCT01383200|3759615|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3937693|NCT01383200|3759616|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3937694|NCT01383200|3759617|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3937695|NCT01383200|3759615|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3937696|NCT01383200|3759616|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3937697|NCT01383200|3759617|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3937698|NCT01383200|3759615|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3937699|NCT01383200|3759616|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3937700|NCT01383200|3759617|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3937701|NCT01383200|3759615|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3937702|NCT01383200|3759616|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3937703|NCT01383200|3759617|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3937704|NCT01383200|3759615|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3937705|NCT01383200|3759616|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3937706|NCT01383200|3759617|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3937707|NCT01383174|3759624|B3|No treatment||Adjuvant treatment||participants|Number|24|24.0||||||
3937708|NCT01383174|3759625|B2|No treatment||Adjuvant treatment||participants|Number|13|13.0||||||
3937709|NCT01383174|3759626|B1|No treatment||Adjuvant treatment||participants|Number|11|11.0||||||
3937710|NCT01383174|3759624|B3|Only chemotherapy||Adjuvant treatment||participants|Number|25|25.0||||||
3937711|NCT01383174|3759625|B2|Only chemotherapy||Adjuvant treatment||participants|Number|11|11.0||||||
3937712|NCT01383174|3759626|B1|Only chemotherapy||Adjuvant treatment||participants|Number|14|14.0||||||
3937713|NCT01383174|3759624|B3|Only radiation||Adjuvant treatment||participants|Number|42|42.0||||||
3937714|NCT01383174|3759625|B2|Only radiation||Adjuvant treatment||participants|Number|24|24.0||||||
3937715|NCT01383174|3759626|B1|Only radiation||Adjuvant treatment||participants|Number|18|18.0||||||
3937716|NCT01383174|3759624|B3|Both chemotherapy and radiation||Adjuvant treatment||participants|Number|60|60.0||||||
3937717|NCT01383174|3759625|B2|Both chemotherapy and radiation||Adjuvant treatment||participants|Number|27|27.0||||||
3937718|NCT01383174|3759626|B1|Both chemotherapy and radiation||Adjuvant treatment||participants|Number|33|33.0||||||
3937719|NCT01383174|3759624|B3|Mastectomy||Surgery||participants|Number|67|67.0||||||
3937720|NCT01383174|3759625|B2|Mastectomy||Surgery||participants|Number|34|34.0||||||
3937721|NCT01383174|3759626|B1|Mastectomy||Surgery||participants|Number|33|33.0||||||
3937722|NCT01383174|3759624|B3|Breast conserving||Surgery||participants|Number|84|84.0||||||
3937723|NCT01383174|3759625|B2|Breast conserving||Surgery||participants|Number|41|41.0||||||
3937724|NCT01383174|3759626|B1|Breast conserving||Surgery||participants|Number|43|43.0||||||
3937725|NCT01383174|3759624|B3|III (3)||Stage|"Stage 0-Carcinoma in situ;~Stage I, Stage II, and Stage III-Higher numbers indicate more extensive disease: Larger tumor size and/or spread of the cancer beyond the organ in which it first developed to nearby lymph nodes and/or tissues or organs adjacent to the location of the primary tumor"|participants|Number|31|31.0||||||
3937726|NCT01383174|3759625|B2|III (3)||Stage|"Stage 0-Carcinoma in situ;~Stage I, Stage II, and Stage III-Higher numbers indicate more extensive disease: Larger tumor size and/or spread of the cancer beyond the organ in which it first developed to nearby lymph nodes and/or tissues or organs adjacent to the location of the primary tumor"|participants|Number|18|18.0||||||
3937727|NCT01383174|3759626|B1|III (3)||Stage|"Stage 0-Carcinoma in situ;~Stage I, Stage II, and Stage III-Higher numbers indicate more extensive disease: Larger tumor size and/or spread of the cancer beyond the organ in which it first developed to nearby lymph nodes and/or tissues or organs adjacent to the location of the primary tumor"|participants|Number|13|13.0||||||
3937728|NCT01383174|3759624|B3|II (2)||Stage|"Stage 0-Carcinoma in situ;~Stage I, Stage II, and Stage III-Higher numbers indicate more extensive disease: Larger tumor size and/or spread of the cancer beyond the organ in which it first developed to nearby lymph nodes and/or tissues or organs adjacent to the location of the primary tumor"|participants|Number|57|57.0||||||
3937729|NCT01383174|3759625|B2|II (2)||Stage|"Stage 0-Carcinoma in situ;~Stage I, Stage II, and Stage III-Higher numbers indicate more extensive disease: Larger tumor size and/or spread of the cancer beyond the organ in which it first developed to nearby lymph nodes and/or tissues or organs adjacent to the location of the primary tumor"|participants|Number|26|26.0||||||
3937730|NCT01383174|3759626|B1|II (2)||Stage|"Stage 0-Carcinoma in situ;~Stage I, Stage II, and Stage III-Higher numbers indicate more extensive disease: Larger tumor size and/or spread of the cancer beyond the organ in which it first developed to nearby lymph nodes and/or tissues or organs adjacent to the location of the primary tumor"|participants|Number|31|31.0||||||
3937731|NCT01383174|3759624|B3|I (1)||Stage|"Stage 0-Carcinoma in situ;~Stage I, Stage II, and Stage III-Higher numbers indicate more extensive disease: Larger tumor size and/or spread of the cancer beyond the organ in which it first developed to nearby lymph nodes and/or tissues or organs adjacent to the location of the primary tumor"|participants|Number|23|23.0||||||
3937732|NCT01383174|3759625|B2|I (1)||Stage|"Stage 0-Carcinoma in situ;~Stage I, Stage II, and Stage III-Higher numbers indicate more extensive disease: Larger tumor size and/or spread of the cancer beyond the organ in which it first developed to nearby lymph nodes and/or tissues or organs adjacent to the location of the primary tumor"|participants|Number|11|11.0||||||
3937733|NCT01383174|3759626|B1|I (1)||Stage|"Stage 0-Carcinoma in situ;~Stage I, Stage II, and Stage III-Higher numbers indicate more extensive disease: Larger tumor size and/or spread of the cancer beyond the organ in which it first developed to nearby lymph nodes and/or tissues or organs adjacent to the location of the primary tumor"|participants|Number|12|12.0||||||
3937734|NCT01383174|3759624|B3|0 (in situ)||Stage|"Stage 0-Carcinoma in situ;~Stage I, Stage II, and Stage III-Higher numbers indicate more extensive disease: Larger tumor size and/or spread of the cancer beyond the organ in which it first developed to nearby lymph nodes and/or tissues or organs adjacent to the location of the primary tumor"|participants|Number|40|40.0||||||
3937735|NCT01383174|3759625|B2|0 (in situ)||Stage|"Stage 0-Carcinoma in situ;~Stage I, Stage II, and Stage III-Higher numbers indicate more extensive disease: Larger tumor size and/or spread of the cancer beyond the organ in which it first developed to nearby lymph nodes and/or tissues or organs adjacent to the location of the primary tumor"|participants|Number|20|20.0||||||
3937736|NCT01383174|3759626|B1|0 (in situ)||Stage|"Stage 0-Carcinoma in situ;~Stage I, Stage II, and Stage III-Higher numbers indicate more extensive disease: Larger tumor size and/or spread of the cancer beyond the organ in which it first developed to nearby lymph nodes and/or tissues or organs adjacent to the location of the primary tumor"|participants|Number|20|20.0||||||
3937737|NCT01383174|3759624|B3|Invasive||Breast cancer||participants|Number|111|111.0||||||
3937738|NCT01383174|3759625|B2|Invasive||Breast cancer||participants|Number|55|55.0||||||
3937739|NCT01383174|3759626|B1|Invasive||Breast cancer||participants|Number|56|56.0||||||
3937740|NCT01383174|3759624|B3|Ductal Carcinoma In Situ (DCIS)||Breast cancer||participants|Number|40|40.0||||||
3937741|NCT01383174|3759625|B2|Ductal Carcinoma In Situ (DCIS)||Breast cancer||participants|Number|20|20.0||||||
3937742|NCT01383174|3759626|B1|Ductal Carcinoma In Situ (DCIS)||Breast cancer||participants|Number|20|20.0||||||
3937743|NCT01383174|3759624|B3|Missing data||Health insurance||participants|Number|7|7.0||||||
3937744|NCT01383174|3759625|B2|Missing data||Health insurance||participants|Number|7|7.0||||||
3937745|NCT01383174|3759626|B1|Missing data||Health insurance||participants|Number|0|0.0||||||
3937746|NCT01383174|3759624|B3|None||Health insurance||participants|Number|5|5.0||||||
3937747|NCT01383174|3759625|B2|None||Health insurance||participants|Number|2|2.0||||||
3937748|NCT01383174|3759626|B1|None||Health insurance||participants|Number|3|3.0||||||
3937749|NCT01383174|3759624|B3|Public insurance only||Health insurance||participants|Number|118|118.0||||||
3937750|NCT01383174|3759625|B2|Public insurance only||Health insurance||participants|Number|56|56.0||||||
3937751|NCT01383174|3759626|B1|Public insurance only||Health insurance||participants|Number|62|62.0||||||
3937752|NCT01383174|3759624|B3|Any private||Health insurance||participants|Number|21|21.0||||||
3937753|NCT01383174|3759625|B2|Any private||Health insurance||participants|Number|10|10.0||||||
3937754|NCT01383174|3759626|B1|Any private||Health insurance||participants|Number|11|11.0||||||
3937755|NCT01383174|3759624|B3|High school graduate||Educational attainment||participants|Number|24|24.0||||||
3937756|NCT01383174|3759625|B2|High school graduate||Educational attainment||participants|Number|13|13.0||||||
3937757|NCT01383174|3759626|B1|High school graduate||Educational attainment||participants|Number|11|11.0||||||
3937758|NCT01383174|3759624|B3|6th grade to less than high school||Educational attainment||participants|Number|27|27.0||||||
3937759|NCT01383174|3759625|B2|6th grade to less than high school||Educational attainment||participants|Number|12|12.0||||||
3937760|NCT01383174|3759626|B1|6th grade to less than high school||Educational attainment||participants|Number|15|15.0||||||
3937761|NCT01383174|3759624|B3|Less than 6th grade||Educational attainment||participants|Number|100|100.0||||||
3937762|NCT01383174|3759625|B2|Less than 6th grade||Educational attainment||participants|Number|50|50.0||||||
3937763|NCT01383174|3759626|B1|Less than 6th grade||Educational attainment||participants|Number|50|50.0||||||
3937764|NCT01383174|3759624|B3|United States||Region of Enrollment||participants|Number|151|151.0||||||
3937765|NCT01383174|3759625|B2|United States||Region of Enrollment||participants|Number|75|75.0||||||
3937766|NCT01383174|3759626|B1|United States||Region of Enrollment||participants|Number|76|76.0||||||
3937767|NCT01383174|3759624|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937768|NCT01383174|3759625|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937769|NCT01383174|3759626|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937770|NCT01383174|3759624|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937771|NCT01383174|3759625|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937772|NCT01383174|3759626|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937773|NCT01383174|3759624|B3||White|Race (NIH/OMB)||Participants|Count of Participants|151|151.0||||||
3937774|NCT01383174|3759625|B2||White|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3937775|NCT01383174|3759626|B1||White|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
3937776|NCT01383174|3759624|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937777|NCT01383174|3759625|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937778|NCT01383174|3759626|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937779|NCT01383174|3759624|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937780|NCT01383174|3759625|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937900|NCT01382901|3759754|B2|||Age||years|Mean|54.1|54.1|Standard Deviation|13.68|13.68|||
3937781|NCT01383174|3759626|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937782|NCT01383174|3759624|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937783|NCT01383174|3759625|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937784|NCT01383174|3759626|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937785|NCT01383174|3759624|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937786|NCT01383174|3759625|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937787|NCT01383174|3759626|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937788|NCT01383174|3759624|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937789|NCT01383174|3759625|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937790|NCT01383174|3759626|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937791|NCT01383174|3759624|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937792|NCT01383174|3759625|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937793|NCT01383174|3759626|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937794|NCT01383174|3759624|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|151|151.0||||||
3937795|NCT01383174|3759625|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3937796|NCT01383174|3759626|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
3937797|NCT01383174|3759624|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3937798|NCT01383174|3759625|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3937799|NCT01383174|3759626|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3937800|NCT01383174|3759624|B3||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3937801|NCT01383174|3759625|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3937802|NCT01383174|3759626|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3937803|NCT01383174|3759624|B3|||Age||years|Mean|50.5|50.5|Standard Deviation|10.9|10.9|||
3937804|NCT01383174|3759625|B2|||Age||years|Mean|50.2|50.2|Standard Deviation|9.9|9.9|||
3937805|NCT01383174|3759626|B1|||Age||years|Mean|50.8|50.8|Standard Deviation|11.9|11.9|||
3937806|NCT01383174|3759624|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3937807|NCT01383174|3759625|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3937808|NCT01383174|3759626|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3937809|NCT01383174|3759624|B3||Between 18 and 65 years|Age||Participants|Count of Participants|136|136.0||||||
3937810|NCT01383174|3759625|B2||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
3937811|NCT01383174|3759626|B1||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
3937812|NCT01383174|3759624|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3937813|NCT01383174|3759625|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3937814|NCT01383174|3759626|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3937815|NCT01383161|3759651|B3|United States||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
3937816|NCT01383161|3759652|B2|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3937817|NCT01383161|3759653|B1|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3937818|NCT01383161|3759651|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937819|NCT01383161|3759652|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937820|NCT01383161|3759653|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937821|NCT01383161|3759651|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937822|NCT01383161|3759652|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937823|NCT01383161|3759653|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937824|NCT01383161|3759651|B3||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3937825|NCT01383161|3759652|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3937826|NCT01383161|3759653|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3937827|NCT01383161|3759651|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3937828|NCT01383161|3759652|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3937829|NCT01383161|3759653|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3937830|NCT01383161|3759651|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937831|NCT01383161|3759652|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937832|NCT01383161|3759653|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937833|NCT01383161|3759651|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3937834|NCT01383161|3759652|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3937835|NCT01383161|3759653|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3937836|NCT01383161|3759651|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937837|NCT01383161|3759652|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937838|NCT01383161|3759653|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937839|NCT01383161|3759651|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937840|NCT01383161|3759652|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937841|NCT01383161|3759653|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937842|NCT01383161|3759651|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3937843|NCT01383161|3759652|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3937844|NCT01383161|3759653|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3937845|NCT01383161|3759651|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3937846|NCT01383161|3759652|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3937847|NCT01383161|3759653|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3937848|NCT01383161|3759651|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3937849|NCT01383161|3759652|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3937850|NCT01383161|3759653|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3937851|NCT01383161|3759651|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3937852|NCT01383161|3759652|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3937853|NCT01383161|3759653|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3937854|NCT01383161|3759651|B3|||Age||years|Mean|63.6|63.6|Standard Deviation|8.8|8.8|||
3937855|NCT01383161|3759652|B2|||Age||years|Mean|62.5|62.5|Standard Deviation|9.0|9.0|||
3937856|NCT01383161|3759653|B1|||Age||years|Mean|64.5|64.5|Standard Deviation|8.6|8.6|||
3937857|NCT01383161|3759651|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3937858|NCT01383161|3759652|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3937859|NCT01383161|3759653|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3937860|NCT01383161|3759651|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3937861|NCT01383161|3759652|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3937862|NCT01383161|3759653|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3937863|NCT01383161|3759651|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3937864|NCT01383161|3759652|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3937865|NCT01383161|3759653|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3937866|NCT01383096|3759670|B4||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3937867|NCT01383096|3759671|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3937868|NCT01383096|3759672|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3937869|NCT01383096|3759673|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3937870|NCT01383096|3759670|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3937871|NCT01383096|3759671|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3937872|NCT01383096|3759672|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3937873|NCT01383096|3759673|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3937874|NCT01383096|3759670|B4|||Age||years|Mean|27.4|27.4|Standard Deviation|5.6|5.6|||
3937875|NCT01383096|3759671|B3|||Age||years|Mean|25.4|25.4|Standard Deviation|4.4|4.4|||
3937876|NCT01383096|3759672|B2|||Age||years|Mean|27.2|27.2|Standard Deviation|5.7|5.7|||
3937877|NCT01383096|3759673|B1|||Age||years|Mean|29.3|29.3|Standard Deviation|6.2|6.2|||
3937878|NCT01383005|3759721|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3937879|NCT01383005|3759722|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3937880|NCT01383005|3759723|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3937881|NCT01383005|3759721|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3937882|NCT01383005|3759722|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3937883|NCT01383005|3759723|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3937884|NCT01383005|3759721|B3|||Age||years|Mean|38.6|38.6|Standard Deviation|9.2|9.2|||
3937885|NCT01383005|3759722|B2|||Age||years|Mean|39.9|39.9|Standard Deviation|8.8|8.8|||
3937886|NCT01383005|3759723|B1|||Age||years|Mean|36.2|36.2|Standard Deviation|9.4|9.4|||
3937887|NCT01382940|3759743|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3937888|NCT01382940|3759743|B1||Female|Sex: Female, Male||Participants|Count of Participants|279|279.0||||||
3937889|NCT01382940|3759743|B1|||Age||years|Mean|55.5|55.5|Standard Deviation|11.5|11.5|||
3937890|NCT01382901|3759753|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
3937891|NCT01382901|3759754|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
3937892|NCT01382901|3759755|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3937893|NCT01382901|3759753|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3937894|NCT01382901|3759754|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3937895|NCT01382901|3759755|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3937896|NCT01382901|3759753|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3937897|NCT01382901|3759754|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3937898|NCT01382901|3759755|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3937899|NCT01382901|3759753|B3|||Age||years|Mean|51.7|51.7|Standard Deviation|12.59|12.59|||
3937901|NCT01382901|3759755|B1|||Age||years|Mean|49.5|49.5|Standard Deviation|11.42|11.42|||
3937902|NCT01382901|3759753|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3937903|NCT01382901|3759754|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3937904|NCT01382901|3759755|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3937905|NCT01382901|3759753|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3937906|NCT01382901|3759754|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3937907|NCT01382901|3759755|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3937908|NCT01382901|3759753|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3937909|NCT01382901|3759754|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3937910|NCT01382901|3759755|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3937911|NCT01382719|3759762|B5|No||Oral Contraceptive Use within 30 Days of Visit 1||Participants|Number|341|341.0||||||
3937912|NCT01382719|3759763|B4|No||Oral Contraceptive Use within 30 Days of Visit 1||Participants|Number|83|83.0||||||
3937913|NCT01382719|3759764|B3|No||Oral Contraceptive Use within 30 Days of Visit 1||Participants|Number|88|88.0||||||
3937914|NCT01382719|3759765|B2|No||Oral Contraceptive Use within 30 Days of Visit 1||Participants|Number|85|85.0||||||
3937915|NCT01382719|3759766|B1|No||Oral Contraceptive Use within 30 Days of Visit 1||Participants|Number|85|85.0||||||
3937916|NCT01382719|3759762|B5|Yes||Oral Contraceptive Use within 30 Days of Visit 1||Participants|Number|53|53.0||||||
3937917|NCT01382719|3759763|B4|Yes||Oral Contraceptive Use within 30 Days of Visit 1||Participants|Number|15|15.0||||||
3937918|NCT01382719|3759764|B3|Yes||Oral Contraceptive Use within 30 Days of Visit 1||Participants|Number|11|11.0||||||
3937919|NCT01382719|3759765|B2|Yes||Oral Contraceptive Use within 30 Days of Visit 1||Participants|Number|15|15.0||||||
3937920|NCT01382719|3759766|B1|Yes||Oral Contraceptive Use within 30 Days of Visit 1||Participants|Number|12|12.0||||||
3937921|NCT01382719|3759762|B5|Mixed FSAD/HSDD||Diagnosis||Participants|Number|290|290.0||||||
3937922|NCT01382719|3759763|B4|Mixed FSAD/HSDD||Diagnosis||Participants|Number|72|72.0||||||
3937923|NCT01382719|3759764|B3|Mixed FSAD/HSDD||Diagnosis||Participants|Number|72|72.0||||||
3937924|NCT01382719|3759765|B2|Mixed FSAD/HSDD||Diagnosis||Participants|Number|77|77.0||||||
3937925|NCT01382719|3759766|B1|Mixed FSAD/HSDD||Diagnosis||Participants|Number|69|69.0||||||
3937926|NCT01382719|3759762|B5|HSDD||Diagnosis||Participants|Number|92|92.0||||||
3937927|NCT01382719|3759763|B4|HSDD||Diagnosis||Participants|Number|24|24.0||||||
3937928|NCT01382719|3759764|B3|HSDD||Diagnosis||Participants|Number|24|24.0||||||
3937929|NCT01382719|3759765|B2|HSDD||Diagnosis||Participants|Number|20|20.0||||||
3937930|NCT01382719|3759766|B1|HSDD||Diagnosis||Participants|Number|24|24.0||||||
3937931|NCT01382719|3759762|B5|FSAD||Diagnosis||Participants|Number|12|12.0||||||
3937932|NCT01382719|3759763|B4|FSAD||Diagnosis||Participants|Number|2|2.0||||||
3937933|NCT01382719|3759764|B3|FSAD||Diagnosis||Participants|Number|3|3.0||||||
3937934|NCT01382719|3759765|B2|FSAD||Diagnosis||Participants|Number|3|3.0||||||
3937935|NCT01382719|3759766|B1|FSAD||Diagnosis||Participants|Number|4|4.0||||||
3937936|NCT01382719|3759762|B5|Other Than Red||Natural Hair Color||Participants|Number|371|371.0||||||
3937937|NCT01382719|3759763|B4|Other Than Red||Natural Hair Color||Participants|Number|92|92.0||||||
3937938|NCT01382719|3759764|B3|Other Than Red||Natural Hair Color||Participants|Number|93|93.0||||||
3937939|NCT01382719|3759765|B2|Other Than Red||Natural Hair Color||Participants|Number|95|95.0||||||
3937940|NCT01382719|3759766|B1|Other Than Red||Natural Hair Color||Participants|Number|91|91.0||||||
3937941|NCT01382719|3759762|B5|Red||Natural Hair Color||Participants|Number|23|23.0||||||
3937942|NCT01382719|3759763|B4|Red||Natural Hair Color||Participants|Number|6|6.0||||||
3937943|NCT01382719|3759764|B3|Red||Natural Hair Color||Participants|Number|6|6.0||||||
3937944|NCT01382719|3759765|B2|Red||Natural Hair Color||Participants|Number|5|5.0||||||
3937945|NCT01382719|3759766|B1|Red||Natural Hair Color||Participants|Number|6|6.0||||||
3937946|NCT01382719|3759762|B5|N.A.||Menses Frequency||Participants|Number|44|44.0||||||
3937947|NCT01382719|3759763|B4|N.A.||Menses Frequency||Participants|Number|12|12.0||||||
3937948|NCT01382719|3759764|B3|N.A.||Menses Frequency||Participants|Number|6|6.0||||||
3937949|NCT01382719|3759765|B2|N.A.||Menses Frequency||Participants|Number|13|13.0||||||
3937950|NCT01382719|3759766|B1|N.A.||Menses Frequency||Participants|Number|13|13.0||||||
3937951|NCT01382719|3759762|B5|2 or more skipped cycles, and amenorrhea for 60 or||Menses Frequency||Participants|Number|11|11.0||||||
3937952|NCT01382719|3759763|B4|2 or more skipped cycles, and amenorrhea for 60 or||Menses Frequency||Participants|Number|1|1.0||||||
3937953|NCT01382719|3759764|B3|2 or more skipped cycles, and amenorrhea for 60 or||Menses Frequency||Participants|Number|2|2.0||||||
3937954|NCT01382719|3759765|B2|2 or more skipped cycles, and amenorrhea for 60 or||Menses Frequency||Participants|Number|6|6.0||||||
3937955|NCT01382719|3759766|B1|2 or more skipped cycles, and amenorrhea for 60 or||Menses Frequency||Participants|Number|2|2.0||||||
3937956|NCT01382719|3759762|B5|Variable cycle length (>7 days different from nor||Menses Frequency||Participants|Number|12|12.0||||||
3937957|NCT01382719|3759763|B4|Variable cycle length (>7 days different from nor||Menses Frequency||Participants|Number|2|2.0||||||
3937958|NCT01382719|3759764|B3|Variable cycle length (>7 days different from nor||Menses Frequency||Participants|Number|1|1.0||||||
3937959|NCT01382719|3759765|B2|Variable cycle length (>7 days different from nor||Menses Frequency||Participants|Number|2|2.0||||||
3937960|NCT01382719|3759766|B1|Variable cycle length (>7 days different from nor||Menses Frequency||Participants|Number|7|7.0||||||
3937961|NCT01382719|3759762|B5|Regular||Menses Frequency||Participants|Number|312|312.0||||||
3937962|NCT01382719|3759763|B4|Regular||Menses Frequency||Participants|Number|79|79.0||||||
3937963|NCT01382719|3759764|B3|Regular||Menses Frequency||Participants|Number|86|86.0||||||
3937964|NCT01382719|3759765|B2|Regular||Menses Frequency||Participants|Number|75|75.0||||||
3937965|NCT01382719|3759766|B1|Regular||Menses Frequency||Participants|Number|72|72.0||||||
3937966|NCT01382719|3759762|B5|Variable cycle length (<7 days different from nor||Menses Frequency||Participants|Number|15|15.0||||||
3937967|NCT01382719|3759763|B4|Variable cycle length (<7 days different from nor||Menses Frequency||Participants|Number|4|4.0||||||
3937968|NCT01382719|3759764|B3|Variable cycle length (<7 days different from nor||Menses Frequency||Participants|Number|4|4.0||||||
3937969|NCT01382719|3759765|B2|Variable cycle length (<7 days different from nor||Menses Frequency||Participants|Number|4|4.0||||||
3937970|NCT01382719|3759766|B1|Variable cycle length (<7 days different from nor||Menses Frequency||Participants|Number|3|3.0||||||
3937971|NCT01382719|3759762|B5|Data Missing||Weight Quartile||Pound|Number|1|1.0||||||
3937972|NCT01382719|3759763|B4|Data Missing||Weight Quartile||Pound|Number|1|1.0||||||
3937973|NCT01382719|3759764|B3|Data Missing||Weight Quartile||Pound|Number|0|0.0||||||
3937974|NCT01382719|3759765|B2|Data Missing||Weight Quartile||Pound|Number|0|0.0||||||
3937975|NCT01382719|3759766|B1|Data Missing||Weight Quartile||Pound|Number|0|0.0||||||
3937976|NCT01382719|3759762|B5|>200.6 - 350 pounds||Weight Quartile||Pound|Number|87|87.0||||||
3937977|NCT01382719|3759763|B4|>200.6 - 350 pounds||Weight Quartile||Pound|Number|28|28.0||||||
3937978|NCT01382719|3759764|B3|>200.6 - 350 pounds||Weight Quartile||Pound|Number|23|23.0||||||
3937979|NCT01382719|3759765|B2|>200.6 - 350 pounds||Weight Quartile||Pound|Number|17|17.0||||||
3937980|NCT01382719|3759766|B1|>200.6 - 350 pounds||Weight Quartile||Pound|Number|19|19.0||||||
3937981|NCT01382719|3759762|B5|>165 - 200.6 pounds||Weight Quartile||Pound|Number|101|101.0||||||
3937982|NCT01382719|3759763|B4|>165 - 200.6 pounds||Weight Quartile||Pound|Number|24|24.0||||||
3937983|NCT01382719|3759764|B3|>165 - 200.6 pounds||Weight Quartile||Pound|Number|28|28.0||||||
3937984|NCT01382719|3759765|B2|>165 - 200.6 pounds||Weight Quartile||Pound|Number|26|26.0||||||
3937985|NCT01382719|3759766|B1|>165 - 200.6 pounds||Weight Quartile||Pound|Number|23|23.0||||||
3937986|NCT01382719|3759762|B5|>143 - 165 pounds||Weight Quartile||Pound|Number|103|103.0||||||
3937987|NCT01382719|3759763|B4|>143 - 165 pounds||Weight Quartile||Pound|Number|24|24.0||||||
3937988|NCT01382719|3759764|B3|>143 - 165 pounds||Weight Quartile||Pound|Number|25|25.0||||||
3937989|NCT01382719|3759765|B2|>143 - 165 pounds||Weight Quartile||Pound|Number|36|36.0||||||
3937990|NCT01382719|3759766|B1|>143 - 165 pounds||Weight Quartile||Pound|Number|18|18.0||||||
3937991|NCT01382719|3759762|B5|95 - 143 pounds||Weight Quartile||Pound|Number|102|102.0||||||
3937992|NCT01382719|3759763|B4|95 - 143 pounds||Weight Quartile||Pound|Number|21|21.0||||||
3937993|NCT01382719|3759764|B3|95 - 143 pounds||Weight Quartile||Pound|Number|23|23.0||||||
3937994|NCT01382719|3759765|B2|95 - 143 pounds||Weight Quartile||Pound|Number|21|21.0||||||
3937995|NCT01382719|3759766|B1|95 - 143 pounds||Weight Quartile||Pound|Number|37|37.0||||||
3937996|NCT01382719|3759762|B5|Data Missing||Of Childbearing Potential||Participants|Number|1|1.0||||||
3937997|NCT01382719|3759763|B4|Data Missing||Of Childbearing Potential||Participants|Number|1|1.0||||||
3937998|NCT01382719|3759764|B3|Data Missing||Of Childbearing Potential||Participants|Number|0|0.0||||||
3937999|NCT01382719|3759765|B2|Data Missing||Of Childbearing Potential||Participants|Number|0|0.0||||||
3938000|NCT01382719|3759766|B1|Data Missing||Of Childbearing Potential||Participants|Number|0|0.0||||||
3938001|NCT01382719|3759762|B5|Surgically Sterile||Of Childbearing Potential||Participants|Number|110|110.0||||||
3938002|NCT01382719|3759763|B4|Surgically Sterile||Of Childbearing Potential||Participants|Number|32|32.0||||||
3938003|NCT01382719|3759764|B3|Surgically Sterile||Of Childbearing Potential||Participants|Number|29|29.0||||||
3938004|NCT01382719|3759765|B2|Surgically Sterile||Of Childbearing Potential||Participants|Number|24|24.0||||||
3938005|NCT01382719|3759766|B1|Surgically Sterile||Of Childbearing Potential||Participants|Number|25|25.0||||||
3938006|NCT01382719|3759762|B5|Of Childbearing Potential||Of Childbearing Potential||Participants|Number|283|283.0||||||
3938007|NCT01382719|3759763|B4|Of Childbearing Potential||Of Childbearing Potential||Participants|Number|65|65.0||||||
3938008|NCT01382719|3759764|B3|Of Childbearing Potential||Of Childbearing Potential||Participants|Number|70|70.0||||||
3938009|NCT01382719|3759765|B2|Of Childbearing Potential||Of Childbearing Potential||Participants|Number|76|76.0||||||
3938010|NCT01382719|3759766|B1|Of Childbearing Potential||Of Childbearing Potential||Participants|Number|72|72.0||||||
3938011|NCT01382719|3759762|B5|||Body Mass Index||kg/m2|Mean|28.82|28.82|Standard Deviation|6.802|6.802|||
3938012|NCT01382719|3759763|B4|||Body Mass Index||kg/m2|Mean|29.92|29.92|Standard Deviation|7.181|7.181|||
3938013|NCT01382719|3759764|B3|||Body Mass Index||kg/m2|Mean|29.17|29.17|Standard Deviation|7.096|7.096|||
3938014|NCT01382719|3759765|B2|||Body Mass Index||kg/m2|Mean|28.47|28.47|Standard Deviation|6.616|6.616|||
3938015|NCT01382719|3759766|B1|||Body Mass Index||kg/m2|Mean|27.73|27.73|Standard Deviation|6.171|6.171|||
3938016|NCT01382719|3759762|B5|||Weight||Pound|Mean|171.41|171.41|Standard Deviation|42.532|42.532|||
3938017|NCT01382719|3759763|B4|||Weight||Pound|Mean|179.15|179.15|Standard Deviation|45.872|45.872|||
3938018|NCT01382719|3759764|B3|||Weight||Pound|Mean|173.97|173.97|Standard Deviation|43.229|43.229|||
3938019|NCT01382719|3759765|B2|||Weight||Pound|Mean|168.17|168.17|Standard Deviation|37.867|37.867|||
3938020|NCT01382719|3759766|B1|||Weight||Pound|Mean|164.40|164.4|Standard Deviation|42.050|42.05|||
3938021|NCT01382719|3759762|B5|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3938022|NCT01382719|3759763|B4|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3938023|NCT01382719|3759764|B3|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3938024|NCT01382719|3759765|B2|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3938025|NCT01382719|3759766|B1|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3938026|NCT01382719|3759762|B5|Other||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3938027|NCT01382719|3759763|B4|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3938028|NCT01382719|3759764|B3|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3938029|NCT01382719|3759765|B2|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3938030|NCT01382719|3759766|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3938031|NCT01382719|3759762|B5|White||Race/Ethnicity, Customized||Participants|Number|281|281.0||||||
3938032|NCT01382719|3759763|B4|White||Race/Ethnicity, Customized||Participants|Number|70|70.0||||||
3938033|NCT01382719|3759764|B3|White||Race/Ethnicity, Customized||Participants|Number|65|65.0||||||
3938034|NCT01382719|3759765|B2|White||Race/Ethnicity, Customized||Participants|Number|71|71.0||||||
3938035|NCT01382719|3759766|B1|White||Race/Ethnicity, Customized||Participants|Number|75|75.0||||||
3938036|NCT01382719|3759762|B5|Black or African American||Race/Ethnicity, Customized||Participants|Number|99|99.0||||||
3938037|NCT01382719|3759763|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
3938038|NCT01382719|3759764|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
3938039|NCT01382719|3759765|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
3938040|NCT01382719|3759766|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
3938041|NCT01382719|3759762|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3938042|NCT01382719|3759763|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3938043|NCT01382719|3759764|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3938044|NCT01382719|3759765|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3938045|NCT01382719|3759766|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3938046|NCT01382719|3759762|B5|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3938047|NCT01382719|3759763|B4|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3938048|NCT01382719|3759764|B3|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3938049|NCT01382719|3759765|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3938050|NCT01382719|3759766|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3938051|NCT01382719|3759762|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3938052|NCT01382719|3759763|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3938053|NCT01382719|3759764|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3938054|NCT01382719|3759765|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3938055|NCT01382719|3759766|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3938056|NCT01382719|3759762|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3938057|NCT01382719|3759763|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3938058|NCT01382719|3759764|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3938059|NCT01382719|3759765|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3938060|NCT01382719|3759766|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3938061|NCT01382719|3759762|B5||Female|Sex: Female, Male||Participants|Count of Participants|394|394.0||||||
3938062|NCT01382719|3759763|B4||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3938063|NCT01382719|3759764|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3938064|NCT01382719|3759765|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3938065|NCT01382719|3759766|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3938066|NCT01382719|3759762|B5|||Age||years|Mean|36.9|36.9|Standard Deviation|7.57|7.57|||
3938067|NCT01382719|3759763|B4|||Age||years|Mean|37.0|37.0|Standard Deviation|7.56|7.56|||
3938068|NCT01382719|3759764|B3|||Age||years|Mean|35.7|35.7|Standard Deviation|7.22|7.22|||
3938069|NCT01382719|3759765|B2|||Age||years|Mean|37.6|37.6|Standard Deviation|7.76|7.76|||
3938070|NCT01382719|3759766|B1|||Age||years|Mean|37.0|37.0|Standard Deviation|7.70|7.7|||
3938071|NCT01382602|3759803|B3|Germany||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3938072|NCT01382602|3759804|B2|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3938073|NCT01382602|3759805|B1|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3938074|NCT01382602|3759803|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3938075|NCT01382602|3759804|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3938076|NCT01382602|3759805|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3938077|NCT01382602|3759803|B3|Canada||Region of Enrollment||Participants|Count of Participants|140|140.0||||||
3938078|NCT01382602|3759804|B2|Canada||Region of Enrollment||Participants|Count of Participants|49|49.0||||||
3938079|NCT01382602|3759805|B1|Canada||Region of Enrollment||Participants|Count of Participants|91|91.0||||||
3938080|NCT01382602|3759803|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938081|NCT01382602|3759804|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938082|NCT01382602|3759805|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938083|NCT01382602|3759803|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3938084|NCT01382602|3759804|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938085|NCT01382602|3759805|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3938086|NCT01382602|3759803|B3||White|Race (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
3938087|NCT01382602|3759804|B2||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3938088|NCT01382602|3759805|B1||White|Race (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3938089|NCT01382602|3759803|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3938090|NCT01382602|3759804|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3938091|NCT01382602|3759805|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938092|NCT01382602|3759803|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938093|NCT01382602|3759804|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938094|NCT01382602|3759805|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938095|NCT01382602|3759803|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3938096|NCT01382602|3759804|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3938097|NCT01382602|3759805|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3938098|NCT01382602|3759803|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938099|NCT01382602|3759804|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938100|NCT01382602|3759805|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938101|NCT01382602|3759803|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3938102|NCT01382602|3759804|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3938103|NCT01382602|3759805|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3938104|NCT01382602|3759803|B3||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3938105|NCT01382602|3759804|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3938106|NCT01382602|3759805|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3938107|NCT01382602|3759803|B3|||Age||Years|Mean|51.5|51.5|Standard Deviation|10.6|10.6|||
3938108|NCT01382602|3759804|B2|||Age||Years|Mean|51.7|51.7|Standard Deviation|9.9|9.9|||
3938109|NCT01382602|3759805|B1|||Age||Years|Mean|51.4|51.4|Standard Deviation|11.1|11.1|||
3938110|NCT01382602|3759803|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3938111|NCT01382602|3759804|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3938112|NCT01382602|3759805|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3938113|NCT01382602|3759803|B3||Between 18 and 65 years|Age||Participants|Count of Participants|125|125.0||||||
3938114|NCT01382602|3759804|B2||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
3938115|NCT01382602|3759805|B1||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
3938116|NCT01382602|3759803|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3938117|NCT01382602|3759804|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3938118|NCT01382602|3759805|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3938119|NCT01382446|3759812|B3|United States||Region of Enrollment||participants|Number|66|66.0||||||
3938120|NCT01382446|3759813|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
3938121|NCT01382446|3759814|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
3938122|NCT01382446|3759812|B3||Male|Gender||Participants|Count of Participants|47|47.0||||||
3938123|NCT01382446|3759813|B2||Male|Gender||Participants|Count of Participants|25|25.0||||||
3938124|NCT01382446|3759814|B1||Male|Gender||Participants|Count of Participants|22|22.0||||||
3938125|NCT01382446|3759812|B3||Female|Gender||Participants|Count of Participants|19|19.0||||||
3938126|NCT01382446|3759813|B2||Female|Gender||Participants|Count of Participants|8|8.0||||||
3938127|NCT01382446|3759814|B1||Female|Gender||Participants|Count of Participants|11|11.0||||||
3938128|NCT01382446|3759812|B3|||Age||years|Mean|43.88|43.88|Standard Deviation|18.355|18.355|||
3938129|NCT01382446|3759813|B2|||Age||years|Mean|45.5|45.5|Standard Deviation|19.96|19.96|||
3938130|NCT01382446|3759814|B1|||Age||years|Mean|41.5|41.5|Standard Deviation|16.279|16.279|||
3938131|NCT01382446|3759812|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3938132|NCT01382446|3759813|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3938133|NCT01382446|3759814|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3938134|NCT01382446|3759812|B3||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
3938135|NCT01382446|3759813|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3938136|NCT01382446|3759814|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3938137|NCT01382446|3759812|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3938138|NCT01382446|3759813|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3938139|NCT01382446|3759814|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3938140|NCT01382303|3759821|B3|Korea, Republic of||Region of Enrollment||participants|Number|174|174.0||||||
3938141|NCT01382303|3759822|B2|Korea, Republic of||Region of Enrollment||participants|Number|87|87.0||||||
3938142|NCT01382303|3759823|B1|Korea, Republic of||Region of Enrollment||participants|Number|87|87.0||||||
3938143|NCT01382303|3759821|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3938144|NCT01382303|3759821|B3||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3938145|NCT01382303|3759822|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3938146|NCT01382303|3759823|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3938147|NCT01382303|3759821|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3938148|NCT01382303|3759822|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3938149|NCT01382303|3759823|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3938150|NCT01382303|3759821|B3|||Age||years|Mean|63.8|63.8|Standard Deviation|9|9.0|||
3938151|NCT01382303|3759822|B2|||Age||years|Mean|63.8|63.8|Standard Deviation|9.4|9.4|||
3938152|NCT01382303|3759823|B1|||Age||years|Mean|63.7|63.7|Standard Deviation|10.1|10.1|||
3938153|NCT01382251|3759840|B3|Canada||Region of Enrollment||participants|Number|204|204.0||||||
3938154|NCT01382251|3759841|B2|Canada||Region of Enrollment||participants|Number|102|102.0||||||
3938155|NCT01382251|3759842|B1|Canada||Region of Enrollment||participants|Number|102|102.0||||||
3938156|NCT01382251|3759840|B3||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3938157|NCT01382251|3759841|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3938158|NCT01382251|3759842|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3938159|NCT01382251|3759840|B3||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3938160|NCT01382251|3759841|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3938161|NCT01382251|3759842|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3938162|NCT01382251|3759840|B3||>=65 years|Age||Participants|Count of Participants|174|174.0||||||
3938163|NCT01382251|3759841|B2||>=65 years|Age||Participants|Count of Participants|72|72.0||||||
3938164|NCT01382251|3759842|B1||>=65 years|Age||Participants|Count of Participants|102|102.0||||||
3938165|NCT01382251|3759840|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3938166|NCT01382251|3759841|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3938167|NCT01382251|3759842|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3938168|NCT01382251|3759840|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3938169|NCT01382251|3759841|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3938170|NCT01382251|3759842|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3938171|NCT01382225|3759854|B3|United States||Region of Enrollment||participants|Number|1450|1450.0||||||
3938172|NCT01382225|3759855|B2|United States||Region of Enrollment||participants|Number|727|727.0||||||
3938173|NCT01382225|3759856|B1|United States||Region of Enrollment||participants|Number|723|723.0||||||
3938174|NCT01382225|3759854|B3||Male|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
3938175|NCT01382225|3759855|B2||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3938176|NCT01382225|3759856|B1||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3938177|NCT01382225|3759854|B3||Female|Sex: Female, Male||Participants|Count of Participants|1184|1184.0||||||
3938178|NCT01382225|3759855|B2||Female|Sex: Female, Male||Participants|Count of Participants|594|594.0||||||
3938179|NCT01382225|3759856|B1||Female|Sex: Female, Male||Participants|Count of Participants|590|590.0||||||
3938180|NCT01382225|3759854|B3|≥65 years||Age, Customized||participants|Number|656|656.0||||||
3938181|NCT01382225|3759855|B2|≥65 years||Age, Customized||participants|Number|335|335.0||||||
3938182|NCT01382225|3759856|B1|≥65 years||Age, Customized||participants|Number|321|321.0||||||
3938183|NCT01382225|3759854|B3|18-64 years||Age, Customized||participants|Number|794|794.0||||||
3938184|NCT01382225|3759855|B2|18-64 years||Age, Customized||participants|Number|392|392.0||||||
3938185|NCT01382225|3759856|B1|18-64 years||Age, Customized||participants|Number|402|402.0||||||
3938186|NCT01382212|3759879|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3938187|NCT01382212|3759879|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3938188|NCT01382212|3759879|B1|||Age||years|Mean|14.5|14.5|Standard Deviation|1.76|1.76|||
3938189|NCT01382186|3759903|B3|||Number of participants with annual income of $35,001 or more||participants|Number|455|455.0||||||
3938190|NCT01382186|3759904|B2|||Number of participants with annual income of $35,001 or more||participants|Number|434|434.0||||||
3938191|NCT01382186|3759905|B1|||Number of participants with annual income of $35,001 or more||participants|Number|21|21.0||||||
3938192|NCT01382186|3759903|B3|||Number of particpants with greater than or equal to high school education||participants|Number|850|850.0||||||
3938193|NCT01382186|3759904|B2|||Number of particpants with greater than or equal to high school education||participants|Number|817|817.0||||||
3938194|NCT01382186|3759905|B1|||Number of particpants with greater than or equal to high school education||participants|Number|33|33.0||||||
3938195|NCT01382186|3759903|B3|United States||Region of Enrollment||participants|Number|852|852.0||||||
3938196|NCT01382186|3759904|B2|United States||Region of Enrollment||participants|Number|819|819.0||||||
3938197|NCT01382186|3759905|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
3938198|NCT01382186|3759903|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3938199|NCT01382186|3759904|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3938200|NCT01382186|3759905|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3938201|NCT01382186|3759903|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|734|734.0||||||
3938202|NCT01382186|3759904|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|706|706.0||||||
3938203|NCT01382186|3759905|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3938204|NCT01382186|3759903|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3938205|NCT01382186|3759904|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3938206|NCT01382186|3759905|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3938207|NCT01382186|3759903|B3||Male|Sex: Female, Male||Participants|Count of Participants|738|738.0||||||
3938208|NCT01382186|3759904|B2||Male|Sex: Female, Male||Participants|Count of Participants|712|712.0||||||
3938209|NCT01382186|3759905|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3938210|NCT01382186|3759903|B3||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3938211|NCT01382186|3759904|B2||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3938212|NCT01382186|3759905|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3938213|NCT01382186|3759903|B3|||Age||years|Mean|60.75|60.75|Standard Deviation|12.5|12.5|||
3938214|NCT01382186|3759904|B2|||Age||years|Mean|62|62.0|Standard Deviation|13|13.0|||
3938215|NCT01382186|3759905|B1|||Age||years|Mean|59.5|59.5|Standard Deviation|12|12.0|||
3938216|NCT01382108|3759920|B3|Canada||Region of Enrollment||participants|Number|39|39.0||||||
3938217|NCT01382108|3759921|B2|Canada||Region of Enrollment||participants|Number|19|19.0||||||
3938218|NCT01382108|3759922|B1|Canada||Region of Enrollment||participants|Number|20|20.0||||||
3938219|NCT01382108|3759920|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3938220|NCT01382108|3759921|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3938221|NCT01382108|3759922|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3938222|NCT01382108|3759920|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3938223|NCT01382108|3759921|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3938224|NCT01382108|3759922|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3938225|NCT01382108|3759920|B3|||Age||years|Mean|58.4|58.4|Standard Deviation|11.4|11.4|||
3938226|NCT01382108|3759921|B2|||Age||years|Mean|59.5|59.5|Standard Deviation|10.8|10.8|||
3938227|NCT01382108|3759922|B1|||Age||years|Mean|57.3|57.3|Standard Deviation|6.1|6.1|||
3938228|NCT01382108|3759920|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3938229|NCT01382108|3759921|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3938230|NCT01382108|3759922|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3938231|NCT01382108|3759920|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3938232|NCT01382108|3759921|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3938233|NCT01382108|3759922|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3938234|NCT01382108|3759920|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3938235|NCT01382108|3759921|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3938236|NCT01382108|3759922|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3938237|NCT01381952|3759933|B1|Sweden||Region of Enrollment||participants|Number|20|20.0||||||
3938238|NCT01381952|3759933|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3938239|NCT01381952|3759933|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3938240|NCT01381952|3759933|B1|||Age||years|Mean|56|56.0|Standard Deviation|11|11.0|||
3938241|NCT01381926|3759940|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3938242|NCT01381926|3759941|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3938243|NCT01381926|3759942|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3938244|NCT01381926|3759940|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938245|NCT01381926|3759941|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938246|NCT01381926|3759942|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938247|NCT01381926|3759940|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938248|NCT01381926|3759941|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938249|NCT01381926|3759942|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938250|NCT01381926|3759940|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3938251|NCT01381926|3759941|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3938252|NCT01381926|3759942|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3938253|NCT01381926|3759940|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3938254|NCT01381926|3759941|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3938255|NCT01381926|3759942|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3938256|NCT01381926|3759940|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938257|NCT01381926|3759941|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938258|NCT01381926|3759942|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938259|NCT01381926|3759940|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938260|NCT01381926|3759941|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938261|NCT01381926|3759942|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938262|NCT01381926|3759940|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938263|NCT01381926|3759941|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938264|NCT01381926|3759942|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938265|NCT01381926|3759940|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3938266|NCT01381926|3759941|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3938267|NCT01381926|3759942|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3938268|NCT01381926|3759940|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3938269|NCT01381926|3759941|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3938270|NCT01381926|3759942|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3938271|NCT01381926|3759940|B3|||Age||years|Median|61|61.0|Standard Deviation|4.0|4.0|||
3938272|NCT01381926|3759941|B2|||Age||years|Median|61|61.0|Standard Deviation|3.8|3.8|||
3938273|NCT01381926|3759942|B1|||Age||years|Median|61|61.0|Standard Deviation|4.2|4.2|||
3938274|NCT01381900|3759953|B4|Vietnam||Region Enroll||participants|Number|28|28.0||||||
3938275|NCT01381900|3759954|B3|Vietnam||Region Enroll||participants|Number|10|10.0||||||
3938276|NCT01381900|3759955|B2|Vietnam||Region Enroll||participants|Number|8|8.0||||||
3938277|NCT01381900|3759956|B1|Vietnam||Region Enroll||participants|Number|10|10.0||||||
3938278|NCT01381900|3759953|B4|Malaysia||Region Enroll||participants|Number|12|12.0||||||
3938279|NCT01381900|3759954|B3|Malaysia||Region Enroll||participants|Number|4|4.0||||||
3938280|NCT01381900|3759955|B2|Malaysia||Region Enroll||participants|Number|5|5.0||||||
3938281|NCT01381900|3759956|B1|Malaysia||Region Enroll||participants|Number|3|3.0||||||
3938282|NCT01381900|3759953|B4|China||Region Enroll||participants|Number|636|636.0||||||
3938283|NCT01381900|3759954|B3|China||Region Enroll||participants|Number|213|213.0||||||
3938284|NCT01381900|3759955|B2|China||Region Enroll||participants|Number|210|210.0||||||
3938285|NCT01381900|3759956|B1|China||Region Enroll||participants|Number|213|213.0||||||
3938286|NCT01381900|3759953|B4||Male|Sex: Female, Male||Participants|Count of Participants|362|362.0||||||
3938287|NCT01381900|3759954|B3||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3938288|NCT01381900|3759955|B2||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3938289|NCT01381900|3759956|B1||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3938290|NCT01381900|3759953|B4||Female|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
3938291|NCT01381900|3759954|B3||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3938292|NCT01381900|3759955|B2||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3938293|NCT01381900|3759956|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3938294|NCT01381900|3759953|B4|||Age||years|Mean|56.3|56.3|Standard Deviation|8.94|8.94|||
3938295|NCT01381900|3759954|B3|||Age||years|Mean|56.4|56.4|Standard Deviation|9.21|9.21|||
3938296|NCT01381900|3759955|B2|||Age||years|Mean|56.5|56.5|Standard Deviation|8.25|8.25|||
3938297|NCT01381900|3759956|B1|||Age||years|Mean|55.8|55.8|Standard Deviation|9.35|9.35|||
3938298|NCT01381900|3759953|B4||>=65 years|Age||Participants|Count of Participants|119|119.0||||||
3938299|NCT01381900|3759954|B3||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
3938300|NCT01381900|3759955|B2||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
3938301|NCT01381900|3759956|B1||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
3938302|NCT01381900|3759953|B4||Between 18 and 65 years|Age||Participants|Count of Participants|557|557.0||||||
3938303|NCT01381900|3759954|B3||Between 18 and 65 years|Age||Participants|Count of Participants|186|186.0||||||
3938304|NCT01381900|3759955|B2||Between 18 and 65 years|Age||Participants|Count of Participants|187|187.0||||||
3938305|NCT01381900|3759956|B1||Between 18 and 65 years|Age||Participants|Count of Participants|184|184.0||||||
3938306|NCT01381900|3759953|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3938307|NCT01381900|3759954|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3938308|NCT01381900|3759955|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3938309|NCT01381900|3759956|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3938310|NCT01381874|3759978|B4|Ukraine||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3938311|NCT01381874|3759979|B3|Ukraine||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3938312|NCT01381874|3759980|B2|Ukraine||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3938313|NCT01381874|3759981|B1|Ukraine||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3938314|NCT01381874|3759978|B4|Russia||Region of Enrollment||Participants|Count of Participants|51|51.0||||||
3938315|NCT01381874|3759979|B3|Russia||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3938316|NCT01381874|3759980|B2|Russia||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3938317|NCT01381874|3759981|B1|Russia||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3938318|NCT01381874|3759978|B4|Netherlands||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3938319|NCT01381874|3759979|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3938320|NCT01381874|3759980|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3938321|NCT01381874|3759981|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3938322|NCT01381874|3759978|B4|Korea, Republic Of||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3938323|NCT01381874|3759979|B3|Korea, Republic Of||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3938324|NCT01381874|3759980|B2|Korea, Republic Of||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3938325|NCT01381874|3759981|B1|Korea, Republic Of||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3938326|NCT01381874|3759978|B4|Italy||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3938327|NCT01381874|3759979|B3|Italy||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3938328|NCT01381874|3759980|B2|Italy||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3938329|NCT01381874|3759981|B1|Italy||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3938330|NCT01381874|3759978|B4|United Kingdom||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3938331|NCT01381874|3759979|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3938332|NCT01381874|3759980|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3938333|NCT01381874|3759981|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3938334|NCT01381874|3759978|B4|Spain||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3938335|NCT01381874|3759979|B3|Spain||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3938336|NCT01381874|3759980|B2|Spain||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3938337|NCT01381874|3759981|B1|Spain||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3938338|NCT01381874|3759978|B4|France||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3938339|NCT01381874|3759979|B3|France||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3938340|NCT01381874|3759980|B2|France||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3938341|NCT01381874|3759981|B1|France||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3938342|NCT01381874|3759978|B4|Belgium||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3938343|NCT01381874|3759979|B3|Belgium||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3938344|NCT01381874|3759980|B2|Belgium||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3938345|NCT01381874|3759981|B1|Belgium||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3938346|NCT01381874|3759978|B4|USA||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3938347|NCT01381874|3759979|B3|USA||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3938348|NCT01381874|3759980|B2|USA||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3938349|NCT01381874|3759981|B1|USA||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3938350|NCT01381874|3759978|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3938351|NCT01381874|3759979|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3938352|NCT01381874|3759980|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3938353|NCT01381874|3759981|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3938354|NCT01381874|3759978|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3938355|NCT01381874|3759979|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3938356|NCT01381874|3759980|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3938357|NCT01381874|3759981|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938358|NCT01381874|3759978|B4||White|Race (NIH/OMB)||Participants|Count of Participants|264|264.0||||||
3938359|NCT01381874|3759979|B3||White|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3938360|NCT01381874|3759980|B2||White|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
3938361|NCT01381874|3759981|B1||White|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
3938362|NCT01381874|3759978|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938363|NCT01381874|3759979|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938364|NCT01381874|3759980|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938365|NCT01381874|3759981|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938366|NCT01381874|3759978|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938367|NCT01381874|3759979|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938368|NCT01381874|3759980|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938369|NCT01381874|3759981|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938370|NCT01381874|3759978|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3938371|NCT01381874|3759979|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3938372|NCT01381874|3759980|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3938373|NCT01381874|3759981|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3938374|NCT01381874|3759978|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938375|NCT01381874|3759979|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938376|NCT01381874|3759980|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938377|NCT01381874|3759981|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938378|NCT01381874|3759978|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3938379|NCT01381874|3759979|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3938380|NCT01381874|3759980|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3938381|NCT01381874|3759981|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3938438|NCT01381562|3760083|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3938382|NCT01381874|3759978|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|251|251.0||||||
3938383|NCT01381874|3759979|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3938384|NCT01381874|3759980|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3938385|NCT01381874|3759981|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3938386|NCT01381874|3759978|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3938387|NCT01381874|3759979|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3938388|NCT01381874|3759980|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3938389|NCT01381874|3759981|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938390|NCT01381874|3759978|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3938391|NCT01381874|3759979|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3938392|NCT01381874|3759980|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3938393|NCT01381874|3759981|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3938394|NCT01381874|3759978|B4||Female|Sex: Female, Male||Participants|Count of Participants|297|297.0||||||
3938395|NCT01381874|3759979|B3||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3938396|NCT01381874|3759980|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3938397|NCT01381874|3759981|B1||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3938398|NCT01381874|3759978|B4|||Age||years|Mean|62.9|62.9|Standard Deviation|9.63|9.63|||
3938399|NCT01381874|3759979|B3|||Age||years|Mean|63.8|63.8|Standard Deviation|10.91|10.91|||
3938400|NCT01381874|3759980|B2|||Age||years|Mean|63.1|63.1|Standard Deviation|9.17|9.17|||
3938401|NCT01381874|3759981|B1|||Age||years|Mean|61.9|61.9|Standard Deviation|8.55|8.55|||
3938402|NCT01381679|3760009|B1|Austria||Region of Enrollment||participants|Number|1682|1682.0||||||
3938403|NCT01381679|3760009|B1|Not Reported||Sex/Gender, Customized||Participants|Number|24|24.0||||||
3938404|NCT01381679|3760009|B1|Females||Sex/Gender, Customized||Participants|Number|655|655.0||||||
3938405|NCT01381679|3760009|B1|Males||Sex/Gender, Customized||Participants|Number|1003|1003.0||||||
3938406|NCT01381679|3760009|B1|||Age||years|Mean|64.58|64.58|Standard Deviation|10.4|10.4|||
3938407|NCT01381575|3760021|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3938408|NCT01381575|3760022|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3938409|NCT01381575|3760023|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3938410|NCT01381575|3760024|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3938411|NCT01381575|3760021|B4||Female|Sex: Female, Male||Participants|Count of Participants|1447|1447.0||||||
3938412|NCT01381575|3760022|B3||Female|Sex: Female, Male||Participants|Count of Participants|415|415.0||||||
3938413|NCT01381575|3760023|B2||Female|Sex: Female, Male||Participants|Count of Participants|482|482.0||||||
3938414|NCT01381575|3760024|B1||Female|Sex: Female, Male||Participants|Count of Participants|550|550.0||||||
3938415|NCT01381575|3760021|B4|||Age||Years|Mean|13.83|13.83|Standard Deviation|4.22|4.22|||
3938416|NCT01381575|3760022|B3|||Age||Years|Mean|11.4|11.4|Standard Deviation|1.55|1.55|||
3938417|NCT01381575|3760023|B2|||Age||Years|Mean|19.6|19.6|Standard Deviation|3.05|3.05|||
3938418|NCT01381575|3760024|B1|||Age||Years|Mean|11.6|11.6|Standard Deviation|1.59|1.59|||
3938419|NCT01381562|3760080|B4|White - White/Caucasian/European||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3938420|NCT01381562|3760081|B3|White - White/Caucasian/European||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3938421|NCT01381562|3760082|B2|White - White/Caucasian/European||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3938422|NCT01381562|3760083|B1|White - White/Caucasian/European||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3938423|NCT01381562|3760080|B4|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3938424|NCT01381562|3760081|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3938425|NCT01381562|3760082|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3938426|NCT01381562|3760083|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3938427|NCT01381562|3760080|B4|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3938428|NCT01381562|3760081|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3938429|NCT01381562|3760082|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3938430|NCT01381562|3760083|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3938431|NCT01381562|3760080|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3938432|NCT01381562|3760081|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3938433|NCT01381562|3760082|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3938434|NCT01381562|3760083|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3938435|NCT01381562|3760080|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3938436|NCT01381562|3760081|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3938437|NCT01381562|3760082|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3938439|NCT01381562|3760080|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3938440|NCT01381562|3760081|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3938441|NCT01381562|3760082|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3938442|NCT01381562|3760083|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3938443|NCT01381562|3760080|B4|||Age||Years|Mean|36.3|36.3|Standard Deviation|12.49|12.49|||
3938444|NCT01381562|3760081|B3|||Age||Years|Mean|34.6|34.6|Standard Deviation|10.31|10.31|||
3938445|NCT01381562|3760082|B2|||Age||Years|Mean|41.3|41.3|Standard Deviation|13.65|13.65|||
3938446|NCT01381562|3760083|B1|||Age||Years|Mean|34.0|34.0|Standard Deviation|15.05|15.05|||
3938447|NCT01381549|3760150|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938448|NCT01381549|3760151|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938449|NCT01381549|3760152|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938450|NCT01381549|3760153|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938451|NCT01381549|3760150|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938452|NCT01381549|3760151|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938453|NCT01381549|3760152|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938454|NCT01381549|3760153|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938455|NCT01381549|3760150|B4||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3938456|NCT01381549|3760151|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3938457|NCT01381549|3760152|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3938458|NCT01381549|3760153|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3938459|NCT01381549|3760150|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3938460|NCT01381549|3760151|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938461|NCT01381549|3760152|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3938462|NCT01381549|3760153|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938463|NCT01381549|3760150|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938464|NCT01381549|3760151|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938465|NCT01381549|3760152|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938466|NCT01381549|3760153|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938467|NCT01381549|3760150|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938468|NCT01381549|3760151|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938469|NCT01381549|3760152|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938470|NCT01381549|3760153|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938471|NCT01381549|3760150|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3938472|NCT01381549|3760151|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3938473|NCT01381549|3760152|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3938474|NCT01381549|3760153|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938475|NCT01381549|3760150|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3938476|NCT01381549|3760151|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3938477|NCT01381549|3760152|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3938478|NCT01381549|3760153|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3938479|NCT01381549|3760150|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3938480|NCT01381549|3760151|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3938481|NCT01381549|3760152|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3938482|NCT01381549|3760153|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3938483|NCT01381549|3760150|B4|||Age||Years|Mean|51.3|51.3|Standard Deviation|18.95|18.95|||
3938484|NCT01381549|3760151|B3|||Age||Years|Mean|48.0|48.0|Standard Deviation|17.48|17.48|||
3938485|NCT01381549|3760152|B2|||Age||Years|Mean|50.4|50.4|Standard Deviation|24.45|24.45|||
3938486|NCT01381549|3760153|B1|||Age||Years|Mean|55.7|55.7|Standard Deviation|13.60|13.6|||
3938487|NCT01381471|3760250|B1|High adherence||Number of Participants with the Indicated Level of Adherence to FSC|Adherence levels were defined by the number of pharmacy claims for each participant in the year following the index date (an FSC claim from (July 1, 2005 to June 30, 2006). Three or fewer claims for FSC was considered low adherence, medium adherence was defined as 4 to 8 claims, and high adherence was defined as nine or more pharmacy claims.|participants|Number|4855|4855.0||||||
3938488|NCT01381471|3760250|B1|Medium adherence||Number of Participants with the Indicated Level of Adherence to FSC|Adherence levels were defined by the number of pharmacy claims for each participant in the year following the index date (an FSC claim from (July 1, 2005 to June 30, 2006). Three or fewer claims for FSC was considered low adherence, medium adherence was defined as 4 to 8 claims, and high adherence was defined as nine or more pharmacy claims.|participants|Number|3479|3479.0||||||
3938531|NCT01381120|3760270|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3938532|NCT01381120|3760268|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3938533|NCT01381120|3760269|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3938489|NCT01381471|3760250|B1|Low adherence||Number of Participants with the Indicated Level of Adherence to FSC|Adherence levels were defined by the number of pharmacy claims for each participant in the year following the index date (an FSC claim from (July 1, 2005 to June 30, 2006). Three or fewer claims for FSC was considered low adherence, medium adherence was defined as 4 to 8 claims, and high adherence was defined as nine or more pharmacy claims.|participants|Number|2726|2726.0||||||
3938490|NCT01381471|3760250|B1||Male|Sex: Female, Male||Participants|Count of Participants|4957|4957.0||||||
3938491|NCT01381471|3760250|B1||Female|Sex: Female, Male||Participants|Count of Participants|6103|6103.0||||||
3938492|NCT01381471|3760250|B1|||Age||Years|Mean|61.6|61.6|Standard Deviation|9.4|9.4|||
3938493|NCT01381406|3760255|B3|Number of physician visits for COPD||Mean number of health care encounters, as a measure of resource utilization|The mean number of health care encounters for each participant group was measured. COPD = Chronic Obstructive Pulmonary Disease. SABA = Short Acting Beta Agonist.|number of encounters|Mean|3.2|3.2|Standard Deviation|3.6|3.6|||
3938494|NCT01381406|3760256|B2|Number of physician visits for COPD||Mean number of health care encounters, as a measure of resource utilization|The mean number of health care encounters for each participant group was measured. COPD = Chronic Obstructive Pulmonary Disease. SABA = Short Acting Beta Agonist.|number of encounters|Mean|2.9|2.9|Standard Deviation|3.4|3.4|||
3938495|NCT01381406|3760257|B1|Number of physician visits for COPD||Mean number of health care encounters, as a measure of resource utilization|The mean number of health care encounters for each participant group was measured. COPD = Chronic Obstructive Pulmonary Disease. SABA = Short Acting Beta Agonist.|number of encounters|Mean|3.3|3.3|Standard Deviation|3.6|3.6|||
3938496|NCT01381406|3760255|B3|Oral corticosteriod prescriptions||Mean number of health care encounters, as a measure of resource utilization|The mean number of health care encounters for each participant group was measured. COPD = Chronic Obstructive Pulmonary Disease. SABA = Short Acting Beta Agonist.|number of encounters|Mean|2.0|2.0|Standard Deviation|2.8|2.8|||
3938497|NCT01381406|3760256|B2|Oral corticosteriod prescriptions||Mean number of health care encounters, as a measure of resource utilization|The mean number of health care encounters for each participant group was measured. COPD = Chronic Obstructive Pulmonary Disease. SABA = Short Acting Beta Agonist.|number of encounters|Mean|1.9|1.9|Standard Deviation|2.3|2.3|||
3938498|NCT01381406|3760257|B1|Oral corticosteriod prescriptions||Mean number of health care encounters, as a measure of resource utilization|The mean number of health care encounters for each participant group was measured. COPD = Chronic Obstructive Pulmonary Disease. SABA = Short Acting Beta Agonist.|number of encounters|Mean|2.1|2.1|Standard Deviation|2.9|2.9|||
3938499|NCT01381406|3760255|B3|SABA containers||Mean number of health care encounters, as a measure of resource utilization|The mean number of health care encounters for each participant group was measured. COPD = Chronic Obstructive Pulmonary Disease. SABA = Short Acting Beta Agonist.|number of encounters|Mean|2.4|2.4|Standard Deviation|5.1|5.1|||
3938500|NCT01381406|3760256|B2|SABA containers||Mean number of health care encounters, as a measure of resource utilization|The mean number of health care encounters for each participant group was measured. COPD = Chronic Obstructive Pulmonary Disease. SABA = Short Acting Beta Agonist.|number of encounters|Mean|2.2|2.2|Standard Deviation|5.4|5.4|||
3938501|NCT01381406|3760257|B1|SABA containers||Mean number of health care encounters, as a measure of resource utilization|The mean number of health care encounters for each participant group was measured. COPD = Chronic Obstructive Pulmonary Disease. SABA = Short Acting Beta Agonist.|number of encounters|Mean|2.4|2.4|Standard Deviation|5.0|5.0|||
3938502|NCT01381406|3760255|B3|Emergency department visit for COPD||Number of health care encounters, as a measure of resource utilization|The number of health care encounters for each participant group was measured. COPD = Chronic Obstructive Pulmonary Disease. An exacerbation of COPD is defined as an emergency department visit and a primary COPD diagnosis code or a physician visit plus COPD prescription (moderate) or hospitalization with a primary diagnosis of COPD (severe).|number of encounters|Number|769|769.0||||||
3938503|NCT01381406|3760256|B2|Emergency department visit for COPD||Number of health care encounters, as a measure of resource utilization|The number of health care encounters for each participant group was measured. COPD = Chronic Obstructive Pulmonary Disease. An exacerbation of COPD is defined as an emergency department visit and a primary COPD diagnosis code or a physician visit plus COPD prescription (moderate) or hospitalization with a primary diagnosis of COPD (severe).|number of encounters|Number|199|199.0||||||
3938504|NCT01381406|3760257|B1|Emergency department visit for COPD||Number of health care encounters, as a measure of resource utilization|The number of health care encounters for each participant group was measured. COPD = Chronic Obstructive Pulmonary Disease. An exacerbation of COPD is defined as an emergency department visit and a primary COPD diagnosis code or a physician visit plus COPD prescription (moderate) or hospitalization with a primary diagnosis of COPD (severe).|number of encounters|Number|570|570.0||||||
3938505|NCT01381406|3760255|B3|Hospitalization for COPD||Number of health care encounters, as a measure of resource utilization|The number of health care encounters for each participant group was measured. COPD = Chronic Obstructive Pulmonary Disease. An exacerbation of COPD is defined as an emergency department visit and a primary COPD diagnosis code or a physician visit plus COPD prescription (moderate) or hospitalization with a primary diagnosis of COPD (severe).|number of encounters|Number|695|695.0||||||
3938506|NCT01381406|3760256|B2|Hospitalization for COPD||Number of health care encounters, as a measure of resource utilization|The number of health care encounters for each participant group was measured. COPD = Chronic Obstructive Pulmonary Disease. An exacerbation of COPD is defined as an emergency department visit and a primary COPD diagnosis code or a physician visit plus COPD prescription (moderate) or hospitalization with a primary diagnosis of COPD (severe).|number of encounters|Number|228|228.0||||||
3938507|NCT01381406|3760257|B1|Hospitalization for COPD||Number of health care encounters, as a measure of resource utilization|The number of health care encounters for each participant group was measured. COPD = Chronic Obstructive Pulmonary Disease. An exacerbation of COPD is defined as an emergency department visit and a primary COPD diagnosis code or a physician visit plus COPD prescription (moderate) or hospitalization with a primary diagnosis of COPD (severe).|number of encounters|Number|467|467.0||||||
3938534|NCT01381120|3760270|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3938535|NCT01381120|3760268|B3|||Age||years|Mean|53|53.0|Standard Deviation|15.52|15.52|||
3938508|NCT01381406|3760255|B3|Moderate exacerbation of COPD||Number of health care encounters, as a measure of resource utilization|The number of health care encounters for each participant group was measured. COPD = Chronic Obstructive Pulmonary Disease. An exacerbation of COPD is defined as an emergency department visit and a primary COPD diagnosis code or a physician visit plus COPD prescription (moderate) or hospitalization with a primary diagnosis of COPD (severe).|number of encounters|Number|3021|3021.0||||||
3938509|NCT01381406|3760256|B2|Moderate exacerbation of COPD||Number of health care encounters, as a measure of resource utilization|The number of health care encounters for each participant group was measured. COPD = Chronic Obstructive Pulmonary Disease. An exacerbation of COPD is defined as an emergency department visit and a primary COPD diagnosis code or a physician visit plus COPD prescription (moderate) or hospitalization with a primary diagnosis of COPD (severe).|number of encounters|Number|747|747.0||||||
3938510|NCT01381406|3760257|B1|Moderate exacerbation of COPD||Number of health care encounters, as a measure of resource utilization|The number of health care encounters for each participant group was measured. COPD = Chronic Obstructive Pulmonary Disease. An exacerbation of COPD is defined as an emergency department visit and a primary COPD diagnosis code or a physician visit plus COPD prescription (moderate) or hospitalization with a primary diagnosis of COPD (severe).|number of encounters|Number|2274|2274.0||||||
3938511|NCT01381406|3760255|B3|Severe exacerbation of COPD||Number of health care encounters, as a measure of resource utilization|The number of health care encounters for each participant group was measured. COPD = Chronic Obstructive Pulmonary Disease. An exacerbation of COPD is defined as an emergency department visit and a primary COPD diagnosis code or a physician visit plus COPD prescription (moderate) or hospitalization with a primary diagnosis of COPD (severe).|number of encounters|Number|535|535.0||||||
3938512|NCT01381406|3760256|B2|Severe exacerbation of COPD||Number of health care encounters, as a measure of resource utilization|The number of health care encounters for each participant group was measured. COPD = Chronic Obstructive Pulmonary Disease. An exacerbation of COPD is defined as an emergency department visit and a primary COPD diagnosis code or a physician visit plus COPD prescription (moderate) or hospitalization with a primary diagnosis of COPD (severe).|number of encounters|Number|175|175.0||||||
3938513|NCT01381406|3760257|B1|Severe exacerbation of COPD||Number of health care encounters, as a measure of resource utilization|The number of health care encounters for each participant group was measured. COPD = Chronic Obstructive Pulmonary Disease. An exacerbation of COPD is defined as an emergency department visit and a primary COPD diagnosis code or a physician visit plus COPD prescription (moderate) or hospitalization with a primary diagnosis of COPD (severe).|number of encounters|Number|360|360.0||||||
3938514|NCT01381406|3760255|B3|Intensive care unit stays for COPD||Number of health care encounters, as a measure of resource utilization|The number of health care encounters for each participant group was measured. COPD = Chronic Obstructive Pulmonary Disease. An exacerbation of COPD is defined as an emergency department visit and a primary COPD diagnosis code or a physician visit plus COPD prescription (moderate) or hospitalization with a primary diagnosis of COPD (severe).|number of encounters|Number|110|110.0||||||
3938515|NCT01381406|3760256|B2|Intensive care unit stays for COPD||Number of health care encounters, as a measure of resource utilization|The number of health care encounters for each participant group was measured. COPD = Chronic Obstructive Pulmonary Disease. An exacerbation of COPD is defined as an emergency department visit and a primary COPD diagnosis code or a physician visit plus COPD prescription (moderate) or hospitalization with a primary diagnosis of COPD (severe).|number of encounters|Number|29|29.0||||||
3938516|NCT01381406|3760257|B1|Intensive care unit stays for COPD||Number of health care encounters, as a measure of resource utilization|The number of health care encounters for each participant group was measured. COPD = Chronic Obstructive Pulmonary Disease. An exacerbation of COPD is defined as an emergency department visit and a primary COPD diagnosis code or a physician visit plus COPD prescription (moderate) or hospitalization with a primary diagnosis of COPD (severe).|number of encounters|Number|81|81.0||||||
3938517|NCT01381406|3760255|B3|Home oxygen therapy||Number of health care encounters, as a measure of resource utilization|The number of health care encounters for each participant group was measured. COPD = Chronic Obstructive Pulmonary Disease. An exacerbation of COPD is defined as an emergency department visit and a primary COPD diagnosis code or a physician visit plus COPD prescription (moderate) or hospitalization with a primary diagnosis of COPD (severe).|number of encounters|Number|1049|1049.0||||||
3938518|NCT01381406|3760256|B2|Home oxygen therapy||Number of health care encounters, as a measure of resource utilization|The number of health care encounters for each participant group was measured. COPD = Chronic Obstructive Pulmonary Disease. An exacerbation of COPD is defined as an emergency department visit and a primary COPD diagnosis code or a physician visit plus COPD prescription (moderate) or hospitalization with a primary diagnosis of COPD (severe).|number of encounters|Number|248|248.0||||||
3938519|NCT01381406|3760257|B1|Home oxygen therapy||Number of health care encounters, as a measure of resource utilization|The number of health care encounters for each participant group was measured. COPD = Chronic Obstructive Pulmonary Disease. An exacerbation of COPD is defined as an emergency department visit and a primary COPD diagnosis code or a physician visit plus COPD prescription (moderate) or hospitalization with a primary diagnosis of COPD (severe).|number of encounters|Number|801|801.0||||||
3938520|NCT01381406|3760255|B3||Male|Sex: Female, Male||Participants|Count of Participants|1768|1768.0||||||
3938521|NCT01381406|3760256|B2||Male|Sex: Female, Male||Participants|Count of Participants|453|453.0||||||
3938522|NCT01381406|3760257|B1||Male|Sex: Female, Male||Participants|Count of Participants|1315|1315.0||||||
3938523|NCT01381406|3760255|B3||Female|Sex: Female, Male||Participants|Count of Participants|1565|1565.0||||||
3938524|NCT01381406|3760256|B2||Female|Sex: Female, Male||Participants|Count of Participants|399|399.0||||||
3938525|NCT01381406|3760257|B1||Female|Sex: Female, Male||Participants|Count of Participants|1166|1166.0||||||
3938526|NCT01381406|3760255|B3|||Age||Years|Mean|65.7|65.7|Standard Deviation|10.9|10.9|||
3938527|NCT01381406|3760256|B2|||Age||Years|Mean|64.6|64.6|Standard Deviation|11.0|11.0|||
3938528|NCT01381406|3760257|B1|||Age||Years|Mean|66.1|66.1|Standard Deviation|10.9|10.9|||
3938529|NCT01381120|3760268|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3938530|NCT01381120|3760269|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3938536|NCT01381120|3760269|B2|||Age||years|Mean|57.54|57.54|Standard Deviation|18.73|18.73|||
3938537|NCT01381120|3760270|B1|||Age||years|Mean|50.81|50.81|Standard Deviation|12.36|12.36|||
3938538|NCT01381016|3760279|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3938539|NCT01381016|3760280|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3938540|NCT01381016|3760281|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3938541|NCT01381016|3760279|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3938542|NCT01381016|3760280|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3938543|NCT01381016|3760281|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3938544|NCT01381016|3760279|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3938545|NCT01381016|3760280|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3938546|NCT01381016|3760281|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3938547|NCT01381016|3760279|B3|||Age||years|Mean|30.57|30.57|Full Range|||19.0|41.0|
3938548|NCT01381016|3760280|B2|||Age||years|Mean|31.76|31.76|Full Range|||19.0|39.0|
3938549|NCT01381016|3760281|B1|||Age||years|Mean|29|29.0|Full Range|||23.0|41.0|
3938550|NCT01381016|3760279|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3938551|NCT01381016|3760280|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3938552|NCT01381016|3760281|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3938553|NCT01381016|3760279|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3938554|NCT01381016|3760280|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3938555|NCT01381016|3760281|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3938556|NCT01381016|3760279|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3938557|NCT01381016|3760280|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3938558|NCT01381016|3760281|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3938559|NCT01380834|3760290|B3|United States||Region of Enrollment||participants|Number|84|84.0||||||
3938560|NCT01380834|3760291|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
3938561|NCT01380834|3760292|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
3938562|NCT01380834|3760290|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3938563|NCT01380834|3760291|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3938564|NCT01380834|3760292|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3938565|NCT01380834|3760290|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3938566|NCT01380834|3760291|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3938567|NCT01380834|3760292|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3938568|NCT01380834|3760290|B3|||Age||years|Median|14|14.0|Inter-Quartile Range|||12.0|16.0|
3938569|NCT01380834|3760291|B2|||Age||years|Median|14|14.0|Inter-Quartile Range|||12.0|15.0|
3938570|NCT01380834|3760292|B1|||Age||years|Median|14.5|14.5|Inter-Quartile Range|||12.0|16.0|
3938571|NCT01380834|3760290|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3938572|NCT01380834|3760291|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3938573|NCT01380834|3760292|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3938574|NCT01380834|3760290|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3938575|NCT01380834|3760291|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3938576|NCT01380834|3760292|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3938577|NCT01380834|3760290|B3||<=18 years|Age||Participants|Count of Participants|84|84.0||||||
3938578|NCT01380834|3760291|B2||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
3938579|NCT01380834|3760292|B1||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
3938580|NCT01380782|3760303|B3|||Karnofsky Performance Status|Karnofsky Performance Status ranges from 0 (Dead) to 100 (Normal, no complaints, no evidence of disease) in increments of 10. This was measured at baseline, prior to any treatment on study.|Units on a scale|Median|90|90.0|Full Range|||60.0|100.0|
3938581|NCT01380782|3760304|B2|||Karnofsky Performance Status|Karnofsky Performance Status ranges from 0 (Dead) to 100 (Normal, no complaints, no evidence of disease) in increments of 10. This was measured at baseline, prior to any treatment on study.|Units on a scale|Median|90|90.0|Full Range|||60.0|100.0|
3938582|NCT01380782|3760305|B1|||Karnofsky Performance Status|Karnofsky Performance Status ranges from 0 (Dead) to 100 (Normal, no complaints, no evidence of disease) in increments of 10. This was measured at baseline, prior to any treatment on study.|Units on a scale|Median|90|90.0|Full Range|||60.0|100.0|
3938583|NCT01380782|3760303|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3938584|NCT01380782|3760304|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3938585|NCT01380782|3760305|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3938586|NCT01380782|3760303|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3938587|NCT01380782|3760304|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3938588|NCT01380782|3760305|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3938589|NCT01380782|3760303|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3938590|NCT01380782|3760304|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3938591|NCT01380782|3760305|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938592|NCT01380782|3760303|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3938593|NCT01380782|3760304|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3938594|NCT01380782|3760305|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3938595|NCT01380782|3760303|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3938596|NCT01380782|3760304|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938597|NCT01380782|3760305|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3938598|NCT01380782|3760303|B3||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3938599|NCT01380782|3760304|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3938600|NCT01380782|3760305|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3938601|NCT01380782|3760303|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938602|NCT01380782|3760304|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938603|NCT01380782|3760305|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938604|NCT01380782|3760303|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938605|NCT01380782|3760304|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938606|NCT01380782|3760305|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938607|NCT01380782|3760303|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3938608|NCT01380782|3760304|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938609|NCT01380782|3760305|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3938610|NCT01380782|3760303|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938611|NCT01380782|3760304|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938612|NCT01380782|3760305|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938613|NCT01380782|3760303|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3938614|NCT01380782|3760304|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3938615|NCT01380782|3760305|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3938616|NCT01380782|3760303|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3938617|NCT01380782|3760304|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3938618|NCT01380782|3760305|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3938619|NCT01380782|3760303|B3|||Age||years|Median|52|52.0|Full Range|||28.0|75.0|
3938620|NCT01380782|3760304|B2|||Age||years|Median|52|52.0|Full Range|||32.0|70.0|
3938621|NCT01380782|3760305|B1|||Age||years|Median|54|54.0|Full Range|||28.0|75.0|
3938622|NCT01380769|3760329|B3|Ukraine||Region of Enrollment||participants|Number|62|62.0||||||
3938623|NCT01380769|3760330|B2|Ukraine||Region of Enrollment||participants|Number|21|21.0||||||
3938624|NCT01380769|3760331|B1|Ukraine||Region of Enrollment||participants|Number|41|41.0||||||
3938625|NCT01380769|3760329|B3|Russian Federation||Region of Enrollment||participants|Number|85|85.0||||||
3938626|NCT01380769|3760330|B2|Russian Federation||Region of Enrollment||participants|Number|29|29.0||||||
3938627|NCT01380769|3760331|B1|Russian Federation||Region of Enrollment||participants|Number|56|56.0||||||
3938628|NCT01380769|3760329|B3||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3938629|NCT01380769|3760330|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3938630|NCT01380769|3760331|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3938631|NCT01380769|3760329|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3938632|NCT01380769|3760330|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3938633|NCT01380769|3760331|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3938634|NCT01380769|3760329|B3|||Age||Years|Mean|59.4|59.4|Standard Deviation|7.68|7.68|||
3938635|NCT01380769|3760330|B2|||Age||Years|Mean|60.6|60.6|Standard Deviation|6.42|6.42|||
3938636|NCT01380769|3760331|B1|||Age||Years|Mean|58|58.0|Standard Deviation|8.22|8.22|||
3938637|NCT01380743|3760340|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3938638|NCT01380743|3760341|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3938639|NCT01380743|3760342|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3938640|NCT01380743|3760343|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3938641|NCT01380743|3760344|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3938642|NCT01380743|3760340|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3938643|NCT01380743|3760341|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3938644|NCT01380743|3760342|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3938645|NCT01380743|3760343|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3938646|NCT01380743|3760344|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3938647|NCT01380743|3760340|B5|||Age||years|Mean|47.3|47.3|Standard Deviation|9.13|9.13|||
3938648|NCT01380743|3760341|B4|||Age||years|Mean|40.0|40.0|Standard Deviation|6.61|6.61|||
3938649|NCT01380743|3760342|B3|||Age||years|Mean|50.0|50.0|Standard Deviation|12.90|12.9|||
3938650|NCT01380743|3760343|B2|||Age||years|Mean|52.8|52.8|Standard Deviation|5.71|5.71|||
3938651|NCT01380743|3760344|B1|||Age||years|Mean|47.7|47.7|Standard Deviation|5.35|5.35|||
3938652|NCT01380730|3760385|B9|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|0.670|0.67|Standard Deviation|0.184|0.184|||
3938653|NCT01380730|3760386|B8|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|0.653|0.653|Standard Deviation|0.177|0.177|||
3938654|NCT01380730|3760387|B7|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|0.687|0.687|Standard Deviation|0.175|0.175|||
3938655|NCT01380730|3760388|B6|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|0.662|0.662|Standard Deviation|0.199|0.199|||
3938656|NCT01380730|3760389|B5|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|0.649|0.649|Standard Deviation|0.155|0.155|||
3938657|NCT01380730|3760390|B4|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|0.695|0.695|Standard Deviation|0.219|0.219|||
3938658|NCT01380730|3760391|B3|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|0.675|0.675|Standard Deviation|0.191|0.191|||
3938659|NCT01380730|3760392|B2|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|0.676|0.676|Standard Deviation|0.194|0.194|||
3938660|NCT01380730|3760393|B1|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|0.660|0.66|Standard Deviation|0.155|0.155|||
3938661|NCT01380730|3760385|B9|||Total Cholesterol/HDL-C ratio||ratio|Mean|4.008|4.008|Standard Deviation|1.184|1.184|||
3938662|NCT01380730|3760386|B8|||Total Cholesterol/HDL-C ratio||ratio|Mean|3.885|3.885|Standard Deviation|1.090|1.09|||
3938663|NCT01380730|3760387|B7|||Total Cholesterol/HDL-C ratio||ratio|Mean|4.118|4.118|Standard Deviation|0.963|0.963|||
3938664|NCT01380730|3760388|B6|||Total Cholesterol/HDL-C ratio||ratio|Mean|4.007|4.007|Standard Deviation|1.300|1.3|||
3938665|NCT01380730|3760389|B5|||Total Cholesterol/HDL-C ratio||ratio|Mean|3.932|3.932|Standard Deviation|1.022|1.022|||
3938666|NCT01380730|3760390|B4|||Total Cholesterol/HDL-C ratio||ratio|Mean|4.128|4.128|Standard Deviation|1.473|1.473|||
3938667|NCT01380730|3760391|B3|||Total Cholesterol/HDL-C ratio||ratio|Mean|4.002|4.002|Standard Deviation|1.243|1.243|||
3938668|NCT01380730|3760392|B2|||Total Cholesterol/HDL-C ratio||ratio|Mean|4.057|4.057|Standard Deviation|1.303|1.303|||
3938669|NCT01380730|3760393|B1|||Total Cholesterol/HDL-C ratio||ratio|Mean|3.940|3.94|Standard Deviation|1.016|1.016|||
3938670|NCT01380730|3760385|B9|||Apolipoprotein B Concentration||mg/dL|Mean|100.9|100.9|Standard Deviation|19.0|19.0|||
3938671|NCT01380730|3760386|B8|||Apolipoprotein B Concentration||mg/dL|Mean|99.9|99.9|Standard Deviation|18.6|18.6|||
3938672|NCT01380730|3760387|B7|||Apolipoprotein B Concentration||mg/dL|Mean|102.6|102.6|Standard Deviation|18.9|18.9|||
3938673|NCT01380730|3760388|B6|||Apolipoprotein B Concentration||mg/dL|Mean|101.3|101.3|Standard Deviation|21.2|21.2|||
3938674|NCT01380730|3760389|B5|||Apolipoprotein B Concentration||mg/dL|Mean|98.8|98.8|Standard Deviation|16.6|16.6|||
3938675|NCT01380730|3760390|B4|||Apolipoprotein B Concentration||mg/dL|Mean|103.6|103.6|Standard Deviation|22.3|22.3|||
3938676|NCT01380730|3760391|B3|||Apolipoprotein B Concentration||mg/dL|Mean|99.9|99.9|Standard Deviation|16.8|16.8|||
3938677|NCT01380730|3760392|B2|||Apolipoprotein B Concentration||mg/dL|Mean|101.6|101.6|Standard Deviation|20.0|20.0|||
3938678|NCT01380730|3760393|B1|||Apolipoprotein B Concentration||mg/dL|Mean|99.9|99.9|Standard Deviation|17.0|17.0|||
3938679|NCT01380730|3760385|B9|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|147.4|147.4|Standard Deviation|31.8|31.8|||
3938680|NCT01380730|3760386|B8|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|144.4|144.4|Standard Deviation|31.2|31.2|||
3938681|NCT01380730|3760387|B7|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|150.0|150.0|Standard Deviation|29.1|29.1|||
3938682|NCT01380730|3760388|B6|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|146.3|146.3|Standard Deviation|33.3|33.3|||
3938683|NCT01380730|3760389|B5|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|145.3|145.3|Standard Deviation|26.2|26.2|||
3938684|NCT01380730|3760390|B4|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|151.2|151.2|Standard Deviation|37.2|37.2|||
3938685|NCT01380730|3760391|B3|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|145.3|145.3|Standard Deviation|29.9|29.9|||
3938686|NCT01380730|3760392|B2|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|150.2|150.2|Standard Deviation|36.5|36.5|||
3938687|NCT01380730|3760393|B1|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|146.9|146.9|Standard Deviation|29.9|29.9|||
3938688|NCT01380730|3760385|B9|||LDL-C Concentration|LDL-C was measured using ultracentrifugation.|mg/dL|Mean|122.8|122.8|Standard Deviation|27.7|27.7|||
3938689|NCT01380730|3760386|B8|||LDL-C Concentration|LDL-C was measured using ultracentrifugation.|mg/dL|Mean|120.8|120.8|Standard Deviation|26.5|26.5|||
3938690|NCT01380730|3760387|B7|||LDL-C Concentration|LDL-C was measured using ultracentrifugation.|mg/dL|Mean|123.2|123.2|Standard Deviation|27.1|27.1|||
3938691|NCT01380730|3760388|B6|||LDL-C Concentration|LDL-C was measured using ultracentrifugation.|mg/dL|Mean|122.0|122.0|Standard Deviation|28.8|28.8|||
3938692|NCT01380730|3760389|B5|||LDL-C Concentration|LDL-C was measured using ultracentrifugation.|mg/dL|Mean|120.9|120.9|Standard Deviation|25.1|25.1|||
3938693|NCT01380730|3760390|B4|||LDL-C Concentration|LDL-C was measured using ultracentrifugation.|mg/dL|Mean|127.4|127.4|Standard Deviation|32.1|32.1|||
3938694|NCT01380730|3760391|B3|||LDL-C Concentration|LDL-C was measured using ultracentrifugation.|mg/dL|Mean|121.4|121.4|Standard Deviation|24.4|24.4|||
3938695|NCT01380730|3760392|B2|||LDL-C Concentration|LDL-C was measured using ultracentrifugation.|mg/dL|Mean|124.9|124.9|Standard Deviation|30.6|30.6|||
3938696|NCT01380730|3760393|B1|||LDL-C Concentration|LDL-C was measured using ultracentrifugation.|mg/dL|Mean|122.2|122.2|Standard Deviation|27.1|27.1|||
3938697|NCT01380730|3760385|B9|Yes||Stratification Factor: Baseline Ezetimibe Use||participants|Number|57|57.0||||||
3938698|NCT01380730|3760386|B8|Yes||Stratification Factor: Baseline Ezetimibe Use||participants|Number|7|7.0||||||
3938699|NCT01380730|3760387|B7|Yes||Stratification Factor: Baseline Ezetimibe Use||participants|Number|7|7.0||||||
3938700|NCT01380730|3760388|B6|Yes||Stratification Factor: Baseline Ezetimibe Use||participants|Number|7|7.0||||||
3938701|NCT01380730|3760389|B5|Yes||Stratification Factor: Baseline Ezetimibe Use||participants|Number|7|7.0||||||
3938702|NCT01380730|3760390|B4|Yes||Stratification Factor: Baseline Ezetimibe Use||participants|Number|7|7.0||||||
3938703|NCT01380730|3760391|B3|Yes||Stratification Factor: Baseline Ezetimibe Use||participants|Number|7|7.0||||||
3938704|NCT01380730|3760392|B2|Yes||Stratification Factor: Baseline Ezetimibe Use||participants|Number|8|8.0||||||
3938705|NCT01380730|3760393|B1|Yes||Stratification Factor: Baseline Ezetimibe Use||participants|Number|7|7.0||||||
3938706|NCT01380730|3760385|B9|No||Stratification Factor: Baseline Ezetimibe Use||participants|Number|572|572.0||||||
3938707|NCT01380730|3760386|B8|No||Stratification Factor: Baseline Ezetimibe Use||participants|Number|73|73.0||||||
3938708|NCT01380730|3760387|B7|No||Stratification Factor: Baseline Ezetimibe Use||participants|Number|72|72.0||||||
3938709|NCT01380730|3760388|B6|No||Stratification Factor: Baseline Ezetimibe Use||participants|Number|72|72.0||||||
3938710|NCT01380730|3760389|B5|No||Stratification Factor: Baseline Ezetimibe Use||participants|Number|71|71.0||||||
3938711|NCT01380730|3760390|B4|No||Stratification Factor: Baseline Ezetimibe Use||participants|Number|72|72.0||||||
3938712|NCT01380730|3760391|B3|No||Stratification Factor: Baseline Ezetimibe Use||participants|Number|72|72.0||||||
3938713|NCT01380730|3760392|B2|No||Stratification Factor: Baseline Ezetimibe Use||participants|Number|69|69.0||||||
3938714|NCT01380730|3760393|B1|No||Stratification Factor: Baseline Ezetimibe Use||participants|Number|71|71.0||||||
3938715|NCT01380730|3760385|B9|≥ 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|217|217.0||||||
3938716|NCT01380730|3760386|B8|≥ 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|27|27.0||||||
3938717|NCT01380730|3760387|B7|≥ 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|27|27.0||||||
3938718|NCT01380730|3760388|B6|≥ 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|28|28.0||||||
3938719|NCT01380730|3760389|B5|≥ 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|26|26.0||||||
3938720|NCT01380730|3760390|B4|≥ 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|28|28.0||||||
3938721|NCT01380730|3760391|B3|≥ 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|28|28.0||||||
3938722|NCT01380730|3760392|B2|≥ 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|26|26.0||||||
3938723|NCT01380730|3760393|B1|≥ 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|27|27.0||||||
3938724|NCT01380730|3760385|B9|< 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|412|412.0||||||
3938725|NCT01380730|3760386|B8|< 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|53|53.0||||||
3938726|NCT01380730|3760387|B7|< 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|52|52.0||||||
3938727|NCT01380730|3760388|B6|< 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|51|51.0||||||
3938728|NCT01380730|3760389|B5|< 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|52|52.0||||||
3938729|NCT01380730|3760390|B4|< 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|51|51.0||||||
3938730|NCT01380730|3760391|B3|< 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|51|51.0||||||
3938731|NCT01380730|3760392|B2|< 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|51|51.0||||||
3938732|NCT01380730|3760393|B1|< 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|51|51.0||||||
3938733|NCT01380730|3760385|B9|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|608|608.0||||||
3938734|NCT01380730|3760386|B8|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|78|78.0||||||
3938735|NCT01380730|3760387|B7|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
3938736|NCT01380730|3760388|B6|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|78|78.0||||||
3938737|NCT01380730|3760389|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
3938738|NCT01380730|3760390|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
3938739|NCT01380730|3760391|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
3938740|NCT01380730|3760392|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|71|71.0||||||
3938741|NCT01380730|3760393|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
3938742|NCT01380730|3760385|B9|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3938743|NCT01380730|3760386|B8|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3938744|NCT01380730|3760387|B7|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3938745|NCT01380730|3760388|B6|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3938746|NCT01380730|3760389|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3938747|NCT01380730|3760390|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3938748|NCT01380730|3760391|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3938749|NCT01380730|3760392|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3938750|NCT01380730|3760393|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3938751|NCT01380730|3760385|B9|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3938752|NCT01380730|3760386|B8|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3938753|NCT01380730|3760387|B7|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3938754|NCT01380730|3760388|B6|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3938755|NCT01380730|3760389|B5|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3938756|NCT01380730|3760390|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3938757|NCT01380730|3760391|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3938758|NCT01380730|3760392|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3938759|NCT01380730|3760393|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3938760|NCT01380730|3760385|B9|White||Race/Ethnicity, Customized||participants|Number|558|558.0||||||
3938761|NCT01380730|3760386|B8|White||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
3938762|NCT01380730|3760387|B7|White||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
3938763|NCT01380730|3760388|B6|White||Race/Ethnicity, Customized||participants|Number|64|64.0||||||
3938764|NCT01380730|3760389|B5|White||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
3938765|NCT01380730|3760390|B4|White||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
3938766|NCT01380730|3760391|B3|White||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
3938767|NCT01380730|3760392|B2|White||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
3938768|NCT01380730|3760393|B1|White||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
3938769|NCT01380730|3760385|B9|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3938770|NCT01380730|3760386|B8|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3938771|NCT01380730|3760387|B7|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3938772|NCT01380730|3760388|B6|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3938773|NCT01380730|3760389|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3938774|NCT01380730|3760390|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3938775|NCT01380730|3760391|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3938776|NCT01380730|3760392|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3938777|NCT01380730|3760393|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3938778|NCT01380730|3760385|B9|Black or African American||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
3938779|NCT01380730|3760386|B8|Black or African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3938780|NCT01380730|3760387|B7|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3938781|NCT01380730|3760388|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3938782|NCT01380730|3760389|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3938783|NCT01380730|3760390|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3938784|NCT01380730|3760391|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3938785|NCT01380730|3760392|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3938786|NCT01380730|3760393|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3938787|NCT01380730|3760385|B9|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3938788|NCT01380730|3760386|B8|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3938789|NCT01380730|3760387|B7|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3938790|NCT01380730|3760388|B6|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3938791|NCT01380730|3760389|B5|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3938792|NCT01380730|3760390|B4|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3938793|NCT01380730|3760391|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3938794|NCT01380730|3760392|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3938795|NCT01380730|3760393|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3938796|NCT01380730|3760385|B9|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3938797|NCT01380730|3760386|B8|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3938798|NCT01380730|3760387|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3938799|NCT01380730|3760388|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3938800|NCT01380730|3760389|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3938801|NCT01380730|3760390|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3938802|NCT01380730|3760391|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3938803|NCT01380730|3760392|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3938804|NCT01380730|3760393|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3938805|NCT01380730|3760385|B9||Male|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
3938806|NCT01380730|3760386|B8||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3938807|NCT01380730|3760387|B7||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3938808|NCT01380730|3760388|B6||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3938809|NCT01380730|3760389|B5||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3938810|NCT01380730|3760390|B4||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3938811|NCT01380730|3760391|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3938812|NCT01380730|3760392|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3938813|NCT01380730|3760393|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3938814|NCT01380730|3760385|B9||Female|Sex: Female, Male||Participants|Count of Participants|319|319.0||||||
3938815|NCT01380730|3760386|B8||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3938816|NCT01380730|3760387|B7||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3938817|NCT01380730|3760388|B6||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3938818|NCT01380730|3760389|B5||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3938819|NCT01380730|3760390|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3938820|NCT01380730|3760391|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3938821|NCT01380730|3760392|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3938822|NCT01380730|3760393|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3938823|NCT01380730|3760385|B9|||Age||years|Mean|60.5|60.5|Standard Deviation|9.5|9.5|||
3938824|NCT01380730|3760386|B8|||Age||years|Mean|60.9|60.9|Standard Deviation|10.3|10.3|||
3938825|NCT01380730|3760387|B7|||Age||years|Mean|61.9|61.9|Standard Deviation|8.8|8.8|||
3938826|NCT01380730|3760388|B6|||Age||years|Mean|60.3|60.3|Standard Deviation|8.4|8.4|||
3938827|NCT01380730|3760389|B5|||Age||years|Mean|62.4|62.4|Standard Deviation|10.2|10.2|||
3938828|NCT01380730|3760390|B4|||Age||years|Mean|58.8|58.8|Standard Deviation|9.7|9.7|||
3938829|NCT01380730|3760391|B3|||Age||years|Mean|59.4|59.4|Standard Deviation|9.9|9.9|||
3938830|NCT01380730|3760392|B2|||Age||years|Mean|60.1|60.1|Standard Deviation|9.6|9.6|||
3938831|NCT01380730|3760393|B1|||Age||years|Mean|60.2|60.2|Standard Deviation|8.8|8.8|||
3938832|NCT01380639|3760458|B3|Germany||Region of Enrollment||participants|Number|82|82.0||||||
3938833|NCT01380639|3760459|B2|Germany||Region of Enrollment||participants|Number|40|40.0||||||
3938834|NCT01380639|3760460|B1|Germany||Region of Enrollment||participants|Number|42|42.0||||||
3938835|NCT01380639|3760458|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3938836|NCT01380639|3760459|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3938837|NCT01380639|3760460|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3938838|NCT01380639|3760458|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3938839|NCT01380639|3760459|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3938840|NCT01380639|3760460|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3938841|NCT01380639|3760458|B3|||Age||years|Mean|64|64.0|Standard Deviation|9|9.0|||
3938842|NCT01380639|3760459|B2|||Age||years|Mean|65|65.0|Standard Deviation|7|7.0|||
3938843|NCT01380639|3760460|B1|||Age||years|Mean|64|64.0|Standard Deviation|11|11.0|||
3938844|NCT01380639|3760458|B3||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
3938845|NCT01380639|3760459|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3938846|NCT01380639|3760460|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3938847|NCT01380639|3760458|B3||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3938848|NCT01380639|3760459|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3938849|NCT01380639|3760460|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3938850|NCT01380639|3760458|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3938851|NCT01380639|3760459|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3938852|NCT01380639|3760460|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3938853|NCT01380379|3760467|B1|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3938854|NCT01380379|3760467|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938855|NCT01380379|3760467|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938856|NCT01380379|3760467|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3938857|NCT01380379|3760467|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938858|NCT01380379|3760467|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938859|NCT01380379|3760467|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3938860|NCT01380379|3760467|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938861|NCT01380379|3760467|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3938862|NCT01380379|3760467|B1||Female|Gender||Participants|Count of Participants|9|9.0||||||
3938863|NCT01380379|3760467|B1|||Age||years|Mean|46.38|46.38|Standard Deviation|9.6|9.6|||
3938864|NCT01380366|3760472|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3938865|NCT01380366|3760472|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3938866|NCT01380366|3760472|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3938867|NCT01380366|3760472|B1|||Age||years|Mean|50.1|50.1|Standard Deviation|15.16|15.16|||
3938868|NCT01380366|3760472|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3938869|NCT01380366|3760472|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3938870|NCT01380366|3760472|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3938871|NCT01380327|3760477|B4|||German Cockroach Prick Skin Test Wheal Size||mm|Median|5.3|5.3|Full Range|||3.0|12.0|
3938872|NCT01380327|3760478|B3|||German Cockroach Prick Skin Test Wheal Size||mm|Median|5.8|5.8|Full Range|||4.0|11.5|
3938873|NCT01380327|3760479|B2|||German Cockroach Prick Skin Test Wheal Size||mm|Median|5.0|5.0|Full Range|||3.5|12.0|
3938874|NCT01380327|3760480|B1|||German Cockroach Prick Skin Test Wheal Size||mm|Median|5.0|5.0|Full Range|||3.0|12.0|
3938875|NCT01380327|3760477|B4|||German Cockroach-Specific IgE Fragment Antibody Binding (FAB) Activity||Percent antibody binding|Median|81.5|81.5|Full Range|||5.0|426.4|
3938983|NCT01380080|3760821|B1|Asian, Pacific Islander||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3938876|NCT01380327|3760478|B3|||German Cockroach-Specific IgE Fragment Antibody Binding (FAB) Activity||Percent antibody binding|Median|80.8|80.8|Full Range|||16.9|201.5|
3938877|NCT01380327|3760479|B2|||German Cockroach-Specific IgE Fragment Antibody Binding (FAB) Activity||Percent antibody binding|Median|78.3|78.3|Full Range|||6.2|421.7|
3938878|NCT01380327|3760480|B1|||German Cockroach-Specific IgE Fragment Antibody Binding (FAB) Activity||Percent antibody binding|Median|84.9|84.9|Full Range|||5.0|426.4|
3938879|NCT01380327|3760477|B4|||German Cockroach-Specific Serum Immunoglobulin Subclass 4 (IgG4) Levels||mg/mL|Median|0.2|0.2|Full Range|||0.0|7.5|
3938880|NCT01380327|3760478|B3|||German Cockroach-Specific Serum Immunoglobulin Subclass 4 (IgG4) Levels||mg/mL|Median|0.5|0.5|Full Range|||0.0|2.6|
3938881|NCT01380327|3760479|B2|||German Cockroach-Specific Serum Immunoglobulin Subclass 4 (IgG4) Levels||mg/mL|Median|0.1|0.1|Full Range|||0.0|3.5|
3938882|NCT01380327|3760480|B1|||German Cockroach-Specific Serum Immunoglobulin Subclass 4 (IgG4) Levels||mg/mL|Median|0.1|0.1|Full Range|||0.0|7.5|
3938883|NCT01380327|3760477|B4|||German Cockroach-Specific Serum Immunoglobulin G (IgG) Levels||mg/mL|Median|4.5|4.5|Full Range|||2.0|33.8|
3938884|NCT01380327|3760478|B3|||German Cockroach-Specific Serum Immunoglobulin G (IgG) Levels||mg/mL|Median|5.1|5.1|Full Range|||2.0|24.9|
3938885|NCT01380327|3760479|B2|||German Cockroach-Specific Serum Immunoglobulin G (IgG) Levels||mg/mL|Median|4.3|4.3|Full Range|||2.0|20.6|
3938886|NCT01380327|3760480|B1|||German Cockroach-Specific Serum Immunoglobulin G (IgG) Levels||mg/mL|Median|4.1|4.1|Full Range|||2.0|33.8|
3938887|NCT01380327|3760477|B4|||German Cockroach-Specific Serum Immunoglobulin E (IgE) Levels||kU/L|Median|6.4|6.4|Full Range|||0.4|349.0|
3938888|NCT01380327|3760478|B3|||German Cockroach-Specific Serum Immunoglobulin E (IgE) Levels||kU/L|Median|9.2|9.2|Full Range|||0.4|98.6|
3938889|NCT01380327|3760479|B2|||German Cockroach-Specific Serum Immunoglobulin E (IgE) Levels||kU/L|Median|4.9|4.9|Full Range|||0.4|174.0|
3938890|NCT01380327|3760480|B1|||German Cockroach-Specific Serum Immunoglobulin E (IgE) Levels||kU/L|Median|6.7|6.7|Full Range|||0.4|349.0|
3938891|NCT01380327|3760477|B4|United States||Region of Enrollment||participants|Number|89|89.0||||||
3938892|NCT01380327|3760478|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
3938893|NCT01380327|3760479|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
3938894|NCT01380327|3760480|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3938895|NCT01380327|3760477|B4||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3938896|NCT01380327|3760478|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3938897|NCT01380327|3760479|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3938898|NCT01380327|3760480|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3938899|NCT01380327|3760477|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3938900|NCT01380327|3760478|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3938901|NCT01380327|3760479|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3938902|NCT01380327|3760480|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3938903|NCT01380327|3760477|B4|||Age||years|Mean|10.7|10.7|Standard Deviation|3.5|3.5|||
3938904|NCT01380327|3760478|B3|||Age||years|Mean|10.8|10.8|Standard Deviation|3.7|3.7|||
3938905|NCT01380327|3760479|B2|||Age||years|Mean|11.0|11.0|Standard Deviation|3.3|3.3|||
3938906|NCT01380327|3760480|B1|||Age||years|Mean|10.2|10.2|Standard Deviation|3.6|3.6|||
3938907|NCT01380197|3760502|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3938908|NCT01380197|3760503|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3938909|NCT01380197|3760504|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3938910|NCT01380197|3760502|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3938911|NCT01380197|3760503|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3938912|NCT01380197|3760504|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3938913|NCT01380197|3760502|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3938914|NCT01380197|3760503|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3938915|NCT01380197|3760504|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3938916|NCT01380197|3760502|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3938917|NCT01380197|3760503|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3938918|NCT01380197|3760504|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3938919|NCT01380197|3760502|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3938920|NCT01380197|3760503|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3938921|NCT01380197|3760504|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3938922|NCT01380197|3760502|B3||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
3938923|NCT01380197|3760503|B2||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
3938924|NCT01380197|3760504|B1||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
3938925|NCT01380145|3760513|B1|Very Good Partial Response||Response to Prior Induction Therapy|"Complete Response (CR): negative immunofixation on serum/urine, disappearance of soft tissue plasmacytomas, <5% plasma cells in bone marrow~Stringent CR (sCR): CR + normal free light chain (FLC) ratio and absence of clonal cells in bone marrow~Very Good Partial Response (VGPR): Serum/urine M-component detectable by immunofixation but not electropheresis OR ≥90% reduction in serum M-component + urine M-component <100 mg/24 hrs~PR: ≥50% reduction of serum M-protein and reduction in 24-hr urinary M-protein by ≥90% or to <200 mg/24 hrs~Stable disease: not response or progression"|participants|Number|12|12.0||||||
3938984|NCT01380080|3760819|B3|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
3938985|NCT01380080|3760820|B2|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3938926|NCT01380145|3760513|B1|Complete Response||Response to Prior Induction Therapy|"Complete Response (CR): negative immunofixation on serum/urine, disappearance of soft tissue plasmacytomas, <5% plasma cells in bone marrow~Stringent CR (sCR): CR + normal free light chain (FLC) ratio and absence of clonal cells in bone marrow~Very Good Partial Response (VGPR): Serum/urine M-component detectable by immunofixation but not electropheresis OR ≥90% reduction in serum M-component + urine M-component <100 mg/24 hrs~PR: ≥50% reduction of serum M-protein and reduction in 24-hr urinary M-protein by ≥90% or to <200 mg/24 hrs~Stable disease: not response or progression"|participants|Number|1|1.0||||||
3938927|NCT01380145|3760513|B1|||Body Mass Index||kg/m^2|Mean|30.2|30.2|Standard Deviation|4.74|4.74|||
3938928|NCT01380145|3760513|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3938929|NCT01380145|3760513|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3938930|NCT01380145|3760513|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938931|NCT01380145|3760513|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3938932|NCT01380145|3760513|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3938933|NCT01380145|3760513|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938934|NCT01380145|3760513|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938935|NCT01380145|3760513|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938936|NCT01380145|3760513|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3938937|NCT01380145|3760513|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3938938|NCT01380145|3760513|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3938939|NCT01380145|3760513|B1||Male|Gender||Participants|Count of Participants|9|9.0||||||
3938940|NCT01380145|3760513|B1||Female|Gender||Participants|Count of Participants|4|4.0||||||
3938941|NCT01380145|3760513|B1|||Age||years|Mean|54.3|54.3|Standard Deviation|10.33|10.33|||
3938942|NCT01380093|3760521|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3938943|NCT01380093|3760521|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3938944|NCT01380093|3760521|B1|||Age||years|Mean|24.7|24.7|Standard Deviation|4.52|4.52|||
3938945|NCT01380080|3760819|B3|||CD4+ T-cell count||cells/mm^3|Median|18|18.0|Inter-Quartile Range|||9.0|32.0|
3938946|NCT01380080|3760820|B2|||CD4+ T-cell count||cells/mm^3|Median|19|19.0|Inter-Quartile Range|||9.0|33.0|
3938947|NCT01380080|3760821|B1|||CD4+ T-cell count||cells/mm^3|Median|18|18.0|Inter-Quartile Range|||9.0|31.0|
3938948|NCT01380080|3760819|B3|||HIV-1 RNA||log10 copies/mL|Median|5.3|5.3|Inter-Quartile Range|||4.9|5.7|
3938949|NCT01380080|3760820|B2|||HIV-1 RNA||log10 copies/mL|Median|5.3|5.3|Inter-Quartile Range|||4.9|5.7|
3938950|NCT01380080|3760821|B1|||HIV-1 RNA||log10 copies/mL|Median|5.4|5.4|Inter-Quartile Range|||5.0|5.7|
3938951|NCT01380080|3760819|B3|India||Region of Enrollment||participants|Number|29|29.0||||||
3938952|NCT01380080|3760820|B2|India||Region of Enrollment||participants|Number|12|12.0||||||
3938953|NCT01380080|3760821|B1|India||Region of Enrollment||participants|Number|17|17.0||||||
3938954|NCT01380080|3760819|B3|Peru||Region of Enrollment||participants|Number|39|39.0||||||
3938955|NCT01380080|3760820|B2|Peru||Region of Enrollment||participants|Number|19|19.0||||||
3938956|NCT01380080|3760821|B1|Peru||Region of Enrollment||participants|Number|20|20.0||||||
3938957|NCT01380080|3760819|B3|Kenya||Region of Enrollment||participants|Number|152|152.0||||||
3938958|NCT01380080|3760820|B2|Kenya||Region of Enrollment||participants|Number|75|75.0||||||
3938959|NCT01380080|3760821|B1|Kenya||Region of Enrollment||participants|Number|77|77.0||||||
3938960|NCT01380080|3760819|B3|Zambia||Region of Enrollment||participants|Number|36|36.0||||||
3938961|NCT01380080|3760820|B2|Zambia||Region of Enrollment||participants|Number|19|19.0||||||
3938962|NCT01380080|3760821|B1|Zambia||Region of Enrollment||participants|Number|17|17.0||||||
3938963|NCT01380080|3760819|B3|Uganda||Region of Enrollment||participants|Number|49|49.0||||||
3938964|NCT01380080|3760820|B2|Uganda||Region of Enrollment||participants|Number|24|24.0||||||
3938965|NCT01380080|3760821|B1|Uganda||Region of Enrollment||participants|Number|25|25.0||||||
3938966|NCT01380080|3760819|B3|Zimbabwe||Region of Enrollment||participants|Number|52|52.0||||||
3938967|NCT01380080|3760820|B2|Zimbabwe||Region of Enrollment||participants|Number|27|27.0||||||
3938968|NCT01380080|3760821|B1|Zimbabwe||Region of Enrollment||participants|Number|25|25.0||||||
3938969|NCT01380080|3760819|B3|South Africa||Region of Enrollment||participants|Number|176|176.0||||||
3938970|NCT01380080|3760820|B2|South Africa||Region of Enrollment||participants|Number|90|90.0||||||
3938971|NCT01380080|3760821|B1|South Africa||Region of Enrollment||participants|Number|86|86.0||||||
3938972|NCT01380080|3760819|B3|Brazil||Region of Enrollment||participants|Number|15|15.0||||||
3938973|NCT01380080|3760820|B2|Brazil||Region of Enrollment||participants|Number|6|6.0||||||
3938974|NCT01380080|3760821|B1|Brazil||Region of Enrollment||participants|Number|9|9.0||||||
3938975|NCT01380080|3760819|B3|Malawi||Region of Enrollment||participants|Number|193|193.0||||||
3938976|NCT01380080|3760820|B2|Malawi||Region of Enrollment||participants|Number|98|98.0||||||
3938977|NCT01380080|3760821|B1|Malawi||Region of Enrollment||participants|Number|95|95.0||||||
3938978|NCT01380080|3760819|B3|Haiti||Region of Enrollment||participants|Number|109|109.0||||||
3938979|NCT01380080|3760820|B2|Haiti||Region of Enrollment||participants|Number|56|56.0||||||
3938980|NCT01380080|3760821|B1|Haiti||Region of Enrollment||participants|Number|53|53.0||||||
3938981|NCT01380080|3760819|B3|Asian, Pacific Islander||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3938982|NCT01380080|3760820|B2|Asian, Pacific Islander||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3938986|NCT01380080|3760821|B1|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3938987|NCT01380080|3760819|B3|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|759|759.0||||||
3938988|NCT01380080|3760820|B2|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|384|384.0||||||
3938989|NCT01380080|3760821|B1|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|375|375.0||||||
3938990|NCT01380080|3760819|B3||Male|Sex: Female, Male||Participants|Count of Participants|450|450.0||||||
3938991|NCT01380080|3760820|B2||Male|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
3938992|NCT01380080|3760821|B1||Male|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
3938993|NCT01380080|3760819|B3||Female|Sex: Female, Male||Participants|Count of Participants|400|400.0||||||
3938994|NCT01380080|3760820|B2||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
3938995|NCT01380080|3760821|B1||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
3938996|NCT01380080|3760819|B3|||Age||years|Median|36|36.0|Inter-Quartile Range|||30.0|42.0|
3938997|NCT01380080|3760820|B2|||Age||years|Median|35|35.0|Inter-Quartile Range|||30.0|42.0|
3938998|NCT01380080|3760821|B1|||Age||years|Median|36|36.0|Inter-Quartile Range|||30.0|42.0|
3938999|NCT01379963|3760838|B1|Missing||Sex/Gender, Customized||Participants|Number|13|13.0||||||
3939000|NCT01379963|3760838|B1|Male||Sex/Gender, Customized||Participants|Number|325|325.0||||||
3939001|NCT01379963|3760838|B1|Female||Sex/Gender, Customized||Participants|Number|442|442.0||||||
3939002|NCT01379963|3760838|B1|||Age|Here, 773 participants were analyzed for this baseline measure (age). Since this is a non-interventional retrospective study participants with missing data were excluded from the analysis.|Years|Mean|68.64|68.64|Standard Deviation|14.10|14.1|||
3939003|NCT01379937|3760843|B5||Male|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
3939004|NCT01379937|3760844|B4||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3939005|NCT01379937|3760845|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3939006|NCT01379937|3760846|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3939007|NCT01379937|3760847|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3939008|NCT01379937|3760843|B5||Female|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
3939009|NCT01379937|3760844|B4||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3939010|NCT01379937|3760845|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3939011|NCT01379937|3760846|B2||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3939012|NCT01379937|3760847|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3939013|NCT01379937|3760843|B5|||Age||Years|Mean|9.51|9.51|Standard Deviation|4.06|4.06|||
3939014|NCT01379937|3760844|B4|||Age||Years|Mean|9.6|9.6|Standard Deviation|4.23|4.23|||
3939015|NCT01379937|3760845|B3|||Age||Years|Mean|9.3|9.3|Standard Deviation|3.87|3.87|||
3939016|NCT01379937|3760846|B2|||Age||Years|Mean|9.40|9.4|Standard Deviation|3.88|3.88|||
3939017|NCT01379937|3760847|B1|||Age||Years|Mean|9.70|9.7|Standard Deviation|4.26|4.26|||
3939018|NCT01379781|3760930|B3|||Hamilton Rating Scales of Depression|"Assessing severity of depression; clinician rated~24 questions~13 items are scored on a 5 point scale ranging from 0=not present to 4=severe~11 items are scored from 0-2~A composite score is created by the sum of the scores from all items. Scores can range from 0-74~0-7: normal~8-13: mild depression~14-18: moderate depression~19-23: severe depression~24: very severe depression~Higher summed values indicate a greater severity of depression"|units on a scale|Mean|16.16|16.16|Standard Deviation|15.00|15.0|||
3939019|NCT01379781|3760931|B2|||Hamilton Rating Scales of Depression|"Assessing severity of depression; clinician rated~24 questions~13 items are scored on a 5 point scale ranging from 0=not present to 4=severe~11 items are scored from 0-2~A composite score is created by the sum of the scores from all items. Scores can range from 0-74~0-7: normal~8-13: mild depression~14-18: moderate depression~19-23: severe depression~24: very severe depression~Higher summed values indicate a greater severity of depression"|units on a scale|Mean|13.83|13.83|Standard Deviation|17.17|17.17|||
3939020|NCT01379781|3760932|B1|||Hamilton Rating Scales of Depression|"Assessing severity of depression; clinician rated~24 questions~13 items are scored on a 5 point scale ranging from 0=not present to 4=severe~11 items are scored from 0-2~A composite score is created by the sum of the scores from all items. Scores can range from 0-74~0-7: normal~8-13: mild depression~14-18: moderate depression~19-23: severe depression~24: very severe depression~Higher summed values indicate a greater severity of depression"|units on a scale|Mean|18.48|18.48|Standard Deviation|12.82|12.82|||
3939021|NCT01379781|3760930|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
3939022|NCT01379781|3760931|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
3939023|NCT01379781|3760932|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3939024|NCT01379781|3760930|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3939025|NCT01379781|3760931|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3939026|NCT01379781|3760932|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3939027|NCT01379781|3760930|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3939028|NCT01379781|3760931|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939029|NCT01379781|3760932|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3939030|NCT01379781|3760930|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3939031|NCT01379781|3760931|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3939032|NCT01379781|3760932|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3939033|NCT01379781|3760930|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3939093|NCT01379703|3760967|B1|Romania||Region of Enrollment||participants|Number|422|422.0||||||
3939034|NCT01379781|3760931|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3939035|NCT01379781|3760932|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3939036|NCT01379781|3760930|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939037|NCT01379781|3760931|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939038|NCT01379781|3760932|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939039|NCT01379781|3760930|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3939040|NCT01379781|3760931|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3939041|NCT01379781|3760932|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3939042|NCT01379781|3760930|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939043|NCT01379781|3760931|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939044|NCT01379781|3760932|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939045|NCT01379781|3760930|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3939046|NCT01379781|3760931|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3939047|NCT01379781|3760932|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3939048|NCT01379781|3760930|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3939049|NCT01379781|3760931|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3939050|NCT01379781|3760932|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3939051|NCT01379781|3760930|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3939052|NCT01379781|3760931|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3939053|NCT01379781|3760932|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3939054|NCT01379781|3760930|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3939055|NCT01379781|3760931|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3939056|NCT01379781|3760932|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3939057|NCT01379781|3760930|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3939058|NCT01379781|3760931|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3939059|NCT01379781|3760932|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3939060|NCT01379781|3760930|B3|||Age||years|Mean|30.24|30.24|Standard Deviation|6.09|6.09|||
3939061|NCT01379781|3760931|B2|||Age||years|Mean|29.60|29.6|Standard Deviation|5.67|5.67|||
3939062|NCT01379781|3760932|B1|||Age||years|Mean|30.87|30.87|Standard Deviation|6.51|6.51|||
3939063|NCT01379781|3760930|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3939064|NCT01379781|3760931|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3939065|NCT01379781|3760932|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3939066|NCT01379781|3760930|B3||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3939067|NCT01379781|3760931|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3939068|NCT01379781|3760932|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3939069|NCT01379781|3760930|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3939070|NCT01379781|3760931|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3939071|NCT01379781|3760932|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3939072|NCT01379768|3760939|B4|Canada||Region of Enrollment||participants|Number|65|65.0||||||
3939073|NCT01379768|3760940|B3|Canada||Region of Enrollment||participants|Number|20|20.0||||||
3939074|NCT01379768|3760941|B2|Canada||Region of Enrollment||participants|Number|22|22.0||||||
3939075|NCT01379768|3760942|B1|Canada||Region of Enrollment||participants|Number|23|23.0||||||
3939076|NCT01379768|3760939|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3939077|NCT01379768|3760940|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3939078|NCT01379768|3760941|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3939079|NCT01379768|3760942|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3939080|NCT01379768|3760939|B4||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3939081|NCT01379768|3760940|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3939082|NCT01379768|3760941|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3939083|NCT01379768|3760942|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3939084|NCT01379768|3760939|B4|||Age, Customized||years|Median|23|23.0|Full Range|||19.0|50.0|
3939085|NCT01379768|3760940|B3|||Age, Customized||years|Median|23.5|23.5|Full Range|||20.0|41.0|
3939086|NCT01379768|3760941|B2|||Age, Customized||years|Median|23.5|23.5|Full Range|||19.0|50.0|
3939087|NCT01379768|3760942|B1|||Age, Customized||years|Median|22|22.0|Full Range|||19.0|50.0|
3939088|NCT01379703|3760967|B1|Latvia||Region of Enrollment||participants|Number|18|18.0||||||
3939089|NCT01379703|3760967|B1|Georgia||Region of Enrollment||participants|Number|10|10.0||||||
3939090|NCT01379703|3760967|B1|Israel||Region of Enrollment||participants|Number|139|139.0||||||
3939091|NCT01379703|3760967|B1|Russian Federation||Region of Enrollment||participants|Number|644|644.0||||||
3939092|NCT01379703|3760967|B1|Lithuania||Region of Enrollment||participants|Number|3|3.0||||||
3939094|NCT01379703|3760967|B1|Ukraine||Region of Enrollment||participants|Number|266|266.0||||||
3939095|NCT01379703|3760967|B1|Poland||Region of Enrollment||participants|Number|381|381.0||||||
3939096|NCT01379703|3760967|B1|Slovakia||Region of Enrollment||participants|Number|26|26.0||||||
3939097|NCT01379703|3760967|B1|Slovenia||Region of Enrollment||participants|Number|123|123.0||||||
3939098|NCT01379703|3760967|B1|Czech Republic||Region of Enrollment||participants|Number|107|107.0||||||
3939099|NCT01379703|3760967|B1|Serbia||Region of Enrollment||participants|Number|149|149.0||||||
3939100|NCT01379703|3760967|B1|Data not reported||Sex/Gender, Customized||Participants|Number|2|2.0||||||
3939101|NCT01379703|3760967|B1|Male||Sex/Gender, Customized||Participants|Number|1419|1419.0||||||
3939102|NCT01379703|3760967|B1|Female||Sex/Gender, Customized||Participants|Number|867|867.0||||||
3939103|NCT01379703|3760967|B1|||Age||years|Mean|32.6|32.6|Standard Deviation|11.0|11.0|||
3939104|NCT01379664|3761030|B3||Male|Sex: Female, Male||Participants|Count of Participants|674|674.0||||||
3939105|NCT01379664|3761031|B2||Male|Sex: Female, Male||Participants|Count of Participants|368|368.0||||||
3939106|NCT01379664|3761032|B1||Male|Sex: Female, Male||Participants|Count of Participants|306|306.0||||||
3939107|NCT01379664|3761030|B3||Female|Sex: Female, Male||Participants|Count of Participants|910|910.0||||||
3939108|NCT01379664|3761031|B2||Female|Sex: Female, Male||Participants|Count of Participants|502|502.0||||||
3939109|NCT01379664|3761032|B1||Female|Sex: Female, Male||Participants|Count of Participants|408|408.0||||||
3939110|NCT01379664|3761030|B3|||Age||years|Mean|53.5|53.5|Standard Deviation|16.6|16.6|||
3939111|NCT01379664|3761031|B2|||Age||years|Mean|53.6|53.6|Standard Deviation|16.6|16.6|||
3939112|NCT01379664|3761032|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|16.5|16.5|||
3939113|NCT01379651|3761043|B3|Italy||Region of Enrollment||participants|Number|20|20.0||||||
3939114|NCT01379651|3761044|B2|Italy||Region of Enrollment||participants|Number|10|10.0||||||
3939115|NCT01379651|3761045|B1|Italy||Region of Enrollment||participants|Number|10|10.0||||||
3939116|NCT01379651|3761043|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3939117|NCT01379651|3761044|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3939118|NCT01379651|3761045|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3939119|NCT01379651|3761043|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3939120|NCT01379651|3761044|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3939121|NCT01379651|3761045|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3939122|NCT01379651|3761043|B3|||Age||years|Mean|7.354|7.354|Standard Deviation|2.607|2.607|||
3939123|NCT01379651|3761044|B2|||Age||years|Mean|7.676|7.676|Standard Deviation|3.203|3.203|||
3939124|NCT01379651|3761045|B1|||Age||years|Mean|7.033|7.033|Standard Deviation|1.768|1.768|||
3939125|NCT01379651|3761043|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3939126|NCT01379651|3761044|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3939127|NCT01379651|3761045|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3939128|NCT01379651|3761043|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3939129|NCT01379651|3761044|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3939130|NCT01379651|3761045|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3939131|NCT01379651|3761043|B3||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
3939132|NCT01379651|3761044|B2||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
3939133|NCT01379651|3761045|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
3939134|NCT01379625|3761054|B3|||Total Energy Expenditure|Total energy expenditure in kcal/day was measured by doubly labled water in 12 subjects in the MCT group and in 13 of the subjects in the Triheptanoin group.|kcal/day|Mean|2392|2392.0|Standard Deviation|572|572.0|||
3939135|NCT01379625|3761055|B2|||Total Energy Expenditure|Total energy expenditure in kcal/day was measured by doubly labled water in 12 subjects in the MCT group and in 13 of the subjects in the Triheptanoin group.|kcal/day|Mean|2230|2230.0|Standard Deviation|512|512.0|||
3939136|NCT01379625|3761056|B1|||Total Energy Expenditure|Total energy expenditure in kcal/day was measured by doubly labled water in 12 subjects in the MCT group and in 13 of the subjects in the Triheptanoin group.|kcal/day|Mean|2567|2567.0|Standard Deviation|604|604.0|||
3939137|NCT01379625|3761054|B3|||Exercise Heart Rate|All participants performed a moderate intensity exercise treadmill walking at an estimated 60% of their estimated max heart rate for 40 minutes. The exercise heart rate at minute 30 when the exercise was steady is reported.|beats per minute|Mean|128|128.0|Standard Deviation|10|10.0|||
3939138|NCT01379625|3761055|B2|||Exercise Heart Rate|All participants performed a moderate intensity exercise treadmill walking at an estimated 60% of their estimated max heart rate for 40 minutes. The exercise heart rate at minute 30 when the exercise was steady is reported.|beats per minute|Mean|125|125.0|Standard Deviation|12|12.0|||
3939139|NCT01379625|3761056|B1|||Exercise Heart Rate|All participants performed a moderate intensity exercise treadmill walking at an estimated 60% of their estimated max heart rate for 40 minutes. The exercise heart rate at minute 30 when the exercise was steady is reported.|beats per minute|Mean|132|132.0|Standard Deviation|7|7.0|||
3939140|NCT01379625|3761054|B3|||Ejection Fraction|Echocardiogram ejection fraction as a %. This was not completed for all the participant. There were 11 participants in the MCT group and 10 participants in the Triheptanoin group who are included in this baseline measure.|percent|Mean|59.7|59.7|Standard Deviation|8.0|8.0|||
3939141|NCT01379625|3761055|B2|||Ejection Fraction|Echocardiogram ejection fraction as a %. This was not completed for all the participant. There were 11 participants in the MCT group and 10 participants in the Triheptanoin group who are included in this baseline measure.|percent|Mean|57|57.0|Standard Deviation|9.2|9.2|||
3939199|NCT01379521|3761090|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3939200|NCT01379521|3761088|B3|||Age||years|Mean|59.6|59.6|Standard Deviation|10.85|10.85|||
3939142|NCT01379625|3761056|B1|||Ejection Fraction|Echocardiogram ejection fraction as a %. This was not completed for all the participant. There were 11 participants in the MCT group and 10 participants in the Triheptanoin group who are included in this baseline measure.|percent|Mean|63|63.0|Standard Deviation|5.3|5.3|||
3939143|NCT01379625|3761054|B3|||Body Weight||kilograms|Mean|64.6|64.6|Standard Deviation|24.9|24.9|||
3939144|NCT01379625|3761055|B2|||Body Weight||kilograms|Mean|62.1|62.1|Standard Deviation|23.5|23.5|||
3939145|NCT01379625|3761056|B1|||Body Weight||kilograms|Mean|67.1|67.1|Standard Deviation|26.8|26.8|||
3939146|NCT01379625|3761054|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
3939147|NCT01379625|3761055|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3939148|NCT01379625|3761056|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3939149|NCT01379625|3761054|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939150|NCT01379625|3761055|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939151|NCT01379625|3761056|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939152|NCT01379625|3761054|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939153|NCT01379625|3761055|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939154|NCT01379625|3761056|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939155|NCT01379625|3761054|B3||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3939156|NCT01379625|3761055|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3939157|NCT01379625|3761056|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3939158|NCT01379625|3761054|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939159|NCT01379625|3761055|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939160|NCT01379625|3761056|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939161|NCT01379625|3761054|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939162|NCT01379625|3761055|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939163|NCT01379625|3761056|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939164|NCT01379625|3761054|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939165|NCT01379625|3761055|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939166|NCT01379625|3761056|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939167|NCT01379625|3761054|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939168|NCT01379625|3761055|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939169|NCT01379625|3761056|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939170|NCT01379625|3761054|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939171|NCT01379625|3761055|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939172|NCT01379625|3761056|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939173|NCT01379625|3761054|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3939174|NCT01379625|3761055|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3939175|NCT01379625|3761056|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3939176|NCT01379625|3761054|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3939177|NCT01379625|3761055|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939178|NCT01379625|3761056|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3939179|NCT01379625|3761054|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3939180|NCT01379625|3761055|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3939181|NCT01379625|3761056|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3939182|NCT01379625|3761054|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3939183|NCT01379625|3761055|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3939184|NCT01379625|3761056|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3939185|NCT01379625|3761054|B3|||Age||years|Mean|24.8|24.8|Standard Deviation|14.4|14.4|||
3939186|NCT01379625|3761055|B2|||Age||years|Mean|27.2|27.2|Standard Deviation|15.9|15.9|||
3939187|NCT01379625|3761056|B1|||Age||years|Mean|22.3|22.3|Standard Deviation|12.7|12.7|||
3939188|NCT01379534|3761067|B3|||Sex/Gender, Customized|Females only|Participants|Number|53|53.0||||||
3939189|NCT01379534|3761068|B2|||Sex/Gender, Customized|Females only|Participants|Number|31|31.0||||||
3939190|NCT01379534|3761069|B1|||Sex/Gender, Customized|Females only|Participants|Number|22|22.0||||||
3939191|NCT01379534|3761067|B3|||Age||Years|Mean|63.4|63.4|Standard Deviation|9.45|9.45|||
3939192|NCT01379534|3761068|B2|||Age||Years|Mean|64.4|64.4|Standard Deviation|8.63|8.63|||
3939193|NCT01379534|3761069|B1|||Age||Years|Mean|61.9|61.9|Standard Deviation|10.54|10.54|||
3939194|NCT01379521|3761088|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3939195|NCT01379521|3761089|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3939196|NCT01379521|3761090|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3939197|NCT01379521|3761088|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3939198|NCT01379521|3761089|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3939201|NCT01379521|3761089|B2|||Age||years|Mean|61.0|61.0|Standard Deviation|10.32|10.32|||
3939202|NCT01379521|3761090|B1|||Age||years|Mean|58.5|58.5|Standard Deviation|11.29|11.29|||
3939203|NCT01379508|3761109|B5||5 × or more ULN|Participants with aspartate aminotransferase (AST) - Multiples of upper limits of normal (ULN)|Measurment at baseline.|Participants|Count of Participants|6|6.0||||||
3939204|NCT01379508|3761110|B4||5 × or more ULN|Participants with aspartate aminotransferase (AST) - Multiples of upper limits of normal (ULN)|Measurment at baseline.|Participants|Count of Participants|1|1.0||||||
3939205|NCT01379508|3761111|B3||5 × or more ULN|Participants with aspartate aminotransferase (AST) - Multiples of upper limits of normal (ULN)|Measurment at baseline.|Participants|Count of Participants|1|1.0||||||
3939206|NCT01379508|3761112|B2||5 × or more ULN|Participants with aspartate aminotransferase (AST) - Multiples of upper limits of normal (ULN)|Measurment at baseline.|Participants|Count of Participants|1|1.0||||||
3939207|NCT01379508|3761113|B1||5 × or more ULN|Participants with aspartate aminotransferase (AST) - Multiples of upper limits of normal (ULN)|Measurment at baseline.|Participants|Count of Participants|3|3.0||||||
3939208|NCT01379508|3761109|B5||2 × - < 5 × ULN|Participants with aspartate aminotransferase (AST) - Multiples of upper limits of normal (ULN)|Measurment at baseline.|Participants|Count of Participants|33|33.0||||||
3939209|NCT01379508|3761110|B4||2 × - < 5 × ULN|Participants with aspartate aminotransferase (AST) - Multiples of upper limits of normal (ULN)|Measurment at baseline.|Participants|Count of Participants|1|1.0||||||
3939210|NCT01379508|3761111|B3||2 × - < 5 × ULN|Participants with aspartate aminotransferase (AST) - Multiples of upper limits of normal (ULN)|Measurment at baseline.|Participants|Count of Participants|16|16.0||||||
3939211|NCT01379508|3761112|B2||2 × - < 5 × ULN|Participants with aspartate aminotransferase (AST) - Multiples of upper limits of normal (ULN)|Measurment at baseline.|Participants|Count of Participants|4|4.0||||||
3939212|NCT01379508|3761113|B1||2 × - < 5 × ULN|Participants with aspartate aminotransferase (AST) - Multiples of upper limits of normal (ULN)|Measurment at baseline.|Participants|Count of Participants|12|12.0||||||
3939213|NCT01379508|3761109|B5||> 1 × - < 2 × ULN|Participants with aspartate aminotransferase (AST) - Multiples of upper limits of normal (ULN)|Measurment at baseline.|Participants|Count of Participants|51|51.0||||||
3939214|NCT01379508|3761110|B4||> 1 × - < 2 × ULN|Participants with aspartate aminotransferase (AST) - Multiples of upper limits of normal (ULN)|Measurment at baseline.|Participants|Count of Participants|7|7.0||||||
3939215|NCT01379508|3761111|B3||> 1 × - < 2 × ULN|Participants with aspartate aminotransferase (AST) - Multiples of upper limits of normal (ULN)|Measurment at baseline.|Participants|Count of Participants|23|23.0||||||
3939216|NCT01379508|3761112|B2||> 1 × - < 2 × ULN|Participants with aspartate aminotransferase (AST) - Multiples of upper limits of normal (ULN)|Measurment at baseline.|Participants|Count of Participants|7|7.0||||||
3939217|NCT01379508|3761113|B1||> 1 × - < 2 × ULN|Participants with aspartate aminotransferase (AST) - Multiples of upper limits of normal (ULN)|Measurment at baseline.|Participants|Count of Participants|14|14.0||||||
3939218|NCT01379508|3761109|B5||≤ 1 × ULN|Participants with aspartate aminotransferase (AST) - Multiples of upper limits of normal (ULN)|Measurment at baseline.|Participants|Count of Participants|151|151.0||||||
3939219|NCT01379508|3761110|B4||≤ 1 × ULN|Participants with aspartate aminotransferase (AST) - Multiples of upper limits of normal (ULN)|Measurment at baseline.|Participants|Count of Participants|2|2.0||||||
3939220|NCT01379508|3761111|B3||≤ 1 × ULN|Participants with aspartate aminotransferase (AST) - Multiples of upper limits of normal (ULN)|Measurment at baseline.|Participants|Count of Participants|69|69.0||||||
3939221|NCT01379508|3761112|B2||≤ 1 × ULN|Participants with aspartate aminotransferase (AST) - Multiples of upper limits of normal (ULN)|Measurment at baseline.|Participants|Count of Participants|10|10.0||||||
3939222|NCT01379508|3761113|B1||≤ 1 × ULN|Participants with aspartate aminotransferase (AST) - Multiples of upper limits of normal (ULN)|Measurment at baseline.|Participants|Count of Participants|70|70.0||||||
3939223|NCT01379508|3761109|B5||5 × or more ULN|Participants with alanine aminotransferase (ALT) - Multiples of upper limits of normal (ULN)|Serum ALT normalization is an important clinically relevant efficacy endpoint. Elevated serum ALT levels are thought to reflect underlying hepatitis disease activity (i.e. active liver inflammation). Correspondingly, ALT normalization is an accepted therapeutic goal in hepatitis studies as it is thought to reflect a substantial reduction in hepatic disease activity.Measurement at baseline.|Participants|Count of Participants|11|11.0||||||
3939224|NCT01379508|3761110|B4||5 × or more ULN|Participants with alanine aminotransferase (ALT) - Multiples of upper limits of normal (ULN)|Serum ALT normalization is an important clinically relevant efficacy endpoint. Elevated serum ALT levels are thought to reflect underlying hepatitis disease activity (i.e. active liver inflammation). Correspondingly, ALT normalization is an accepted therapeutic goal in hepatitis studies as it is thought to reflect a substantial reduction in hepatic disease activity.Measurement at baseline.|Participants|Count of Participants|1|1.0||||||
3939225|NCT01379508|3761111|B3||5 × or more ULN|Participants with alanine aminotransferase (ALT) - Multiples of upper limits of normal (ULN)|Serum ALT normalization is an important clinically relevant efficacy endpoint. Elevated serum ALT levels are thought to reflect underlying hepatitis disease activity (i.e. active liver inflammation). Correspondingly, ALT normalization is an accepted therapeutic goal in hepatitis studies as it is thought to reflect a substantial reduction in hepatic disease activity.Measurement at baseline.|Participants|Count of Participants|4|4.0||||||
3939226|NCT01379508|3761112|B2||5 × or more ULN|Participants with alanine aminotransferase (ALT) - Multiples of upper limits of normal (ULN)|Serum ALT normalization is an important clinically relevant efficacy endpoint. Elevated serum ALT levels are thought to reflect underlying hepatitis disease activity (i.e. active liver inflammation). Correspondingly, ALT normalization is an accepted therapeutic goal in hepatitis studies as it is thought to reflect a substantial reduction in hepatic disease activity.Measurement at baseline.|Participants|Count of Participants|1|1.0||||||
3939285|NCT01379183|3761144|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3939286|NCT01379183|3761142|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3939287|NCT01379183|3761143|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3939288|NCT01379183|3761144|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3939227|NCT01379508|3761113|B1||5 × or more ULN|Participants with alanine aminotransferase (ALT) - Multiples of upper limits of normal (ULN)|Serum ALT normalization is an important clinically relevant efficacy endpoint. Elevated serum ALT levels are thought to reflect underlying hepatitis disease activity (i.e. active liver inflammation). Correspondingly, ALT normalization is an accepted therapeutic goal in hepatitis studies as it is thought to reflect a substantial reduction in hepatic disease activity.Measurement at baseline.|Participants|Count of Participants|5|5.0||||||
3939228|NCT01379508|3761109|B5||2 × - < 5 × ULN|Participants with alanine aminotransferase (ALT) - Multiples of upper limits of normal (ULN)|Serum ALT normalization is an important clinically relevant efficacy endpoint. Elevated serum ALT levels are thought to reflect underlying hepatitis disease activity (i.e. active liver inflammation). Correspondingly, ALT normalization is an accepted therapeutic goal in hepatitis studies as it is thought to reflect a substantial reduction in hepatic disease activity.Measurement at baseline.|Participants|Count of Participants|51|51.0||||||
3939229|NCT01379508|3761110|B4||2 × - < 5 × ULN|Participants with alanine aminotransferase (ALT) - Multiples of upper limits of normal (ULN)|Serum ALT normalization is an important clinically relevant efficacy endpoint. Elevated serum ALT levels are thought to reflect underlying hepatitis disease activity (i.e. active liver inflammation). Correspondingly, ALT normalization is an accepted therapeutic goal in hepatitis studies as it is thought to reflect a substantial reduction in hepatic disease activity.Measurement at baseline.|Participants|Count of Participants|1|1.0||||||
3939230|NCT01379508|3761111|B3||2 × - < 5 × ULN|Participants with alanine aminotransferase (ALT) - Multiples of upper limits of normal (ULN)|Serum ALT normalization is an important clinically relevant efficacy endpoint. Elevated serum ALT levels are thought to reflect underlying hepatitis disease activity (i.e. active liver inflammation). Correspondingly, ALT normalization is an accepted therapeutic goal in hepatitis studies as it is thought to reflect a substantial reduction in hepatic disease activity.Measurement at baseline.|Participants|Count of Participants|26|26.0||||||
3939231|NCT01379508|3761112|B2||2 × - < 5 × ULN|Participants with alanine aminotransferase (ALT) - Multiples of upper limits of normal (ULN)|Serum ALT normalization is an important clinically relevant efficacy endpoint. Elevated serum ALT levels are thought to reflect underlying hepatitis disease activity (i.e. active liver inflammation). Correspondingly, ALT normalization is an accepted therapeutic goal in hepatitis studies as it is thought to reflect a substantial reduction in hepatic disease activity.Measurement at baseline.|Participants|Count of Participants|11|11.0||||||
3939232|NCT01379508|3761113|B1||2 × - < 5 × ULN|Participants with alanine aminotransferase (ALT) - Multiples of upper limits of normal (ULN)|Serum ALT normalization is an important clinically relevant efficacy endpoint. Elevated serum ALT levels are thought to reflect underlying hepatitis disease activity (i.e. active liver inflammation). Correspondingly, ALT normalization is an accepted therapeutic goal in hepatitis studies as it is thought to reflect a substantial reduction in hepatic disease activity.Measurement at baseline.|Participants|Count of Participants|13|13.0||||||
3939233|NCT01379508|3761109|B5||> 1 × - < 2 × ULN|Participants with alanine aminotransferase (ALT) - Multiples of upper limits of normal (ULN)|Serum ALT normalization is an important clinically relevant efficacy endpoint. Elevated serum ALT levels are thought to reflect underlying hepatitis disease activity (i.e. active liver inflammation). Correspondingly, ALT normalization is an accepted therapeutic goal in hepatitis studies as it is thought to reflect a substantial reduction in hepatic disease activity.Measurement at baseline.|Participants|Count of Participants|74|74.0||||||
3939234|NCT01379508|3761110|B4||> 1 × - < 2 × ULN|Participants with alanine aminotransferase (ALT) - Multiples of upper limits of normal (ULN)|Serum ALT normalization is an important clinically relevant efficacy endpoint. Elevated serum ALT levels are thought to reflect underlying hepatitis disease activity (i.e. active liver inflammation). Correspondingly, ALT normalization is an accepted therapeutic goal in hepatitis studies as it is thought to reflect a substantial reduction in hepatic disease activity.Measurement at baseline.|Participants|Count of Participants|5|5.0||||||
3939235|NCT01379508|3761111|B3||> 1 × - < 2 × ULN|Participants with alanine aminotransferase (ALT) - Multiples of upper limits of normal (ULN)|Serum ALT normalization is an important clinically relevant efficacy endpoint. Elevated serum ALT levels are thought to reflect underlying hepatitis disease activity (i.e. active liver inflammation). Correspondingly, ALT normalization is an accepted therapeutic goal in hepatitis studies as it is thought to reflect a substantial reduction in hepatic disease activity.Measurement at baseline.|Participants|Count of Participants|27|27.0||||||
3939236|NCT01379508|3761112|B2||> 1 × - < 2 × ULN|Participants with alanine aminotransferase (ALT) - Multiples of upper limits of normal (ULN)|Serum ALT normalization is an important clinically relevant efficacy endpoint. Elevated serum ALT levels are thought to reflect underlying hepatitis disease activity (i.e. active liver inflammation). Correspondingly, ALT normalization is an accepted therapeutic goal in hepatitis studies as it is thought to reflect a substantial reduction in hepatic disease activity.Measurement at baseline.|Participants|Count of Participants|7|7.0||||||
3939237|NCT01379508|3761113|B1||> 1 × - < 2 × ULN|Participants with alanine aminotransferase (ALT) - Multiples of upper limits of normal (ULN)|Serum ALT normalization is an important clinically relevant efficacy endpoint. Elevated serum ALT levels are thought to reflect underlying hepatitis disease activity (i.e. active liver inflammation). Correspondingly, ALT normalization is an accepted therapeutic goal in hepatitis studies as it is thought to reflect a substantial reduction in hepatic disease activity.Measurement at baseline.|Participants|Count of Participants|35|35.0||||||
3939238|NCT01379508|3761109|B5||≤ 1 × ULN|Participants with alanine aminotransferase (ALT) - Multiples of upper limits of normal (ULN)|Serum ALT normalization is an important clinically relevant efficacy endpoint. Elevated serum ALT levels are thought to reflect underlying hepatitis disease activity (i.e. active liver inflammation). Correspondingly, ALT normalization is an accepted therapeutic goal in hepatitis studies as it is thought to reflect a substantial reduction in hepatic disease activity.Measurement at baseline.|Participants|Count of Participants|105|105.0||||||
3939239|NCT01379508|3761110|B4||≤ 1 × ULN|Participants with alanine aminotransferase (ALT) - Multiples of upper limits of normal (ULN)|Serum ALT normalization is an important clinically relevant efficacy endpoint. Elevated serum ALT levels are thought to reflect underlying hepatitis disease activity (i.e. active liver inflammation). Correspondingly, ALT normalization is an accepted therapeutic goal in hepatitis studies as it is thought to reflect a substantial reduction in hepatic disease activity.Measurement at baseline.|Participants|Count of Participants|4|4.0||||||
3939289|NCT01379183|3761142|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3939240|NCT01379508|3761111|B3||≤ 1 × ULN|Participants with alanine aminotransferase (ALT) - Multiples of upper limits of normal (ULN)|Serum ALT normalization is an important clinically relevant efficacy endpoint. Elevated serum ALT levels are thought to reflect underlying hepatitis disease activity (i.e. active liver inflammation). Correspondingly, ALT normalization is an accepted therapeutic goal in hepatitis studies as it is thought to reflect a substantial reduction in hepatic disease activity.Measurement at baseline.|Participants|Count of Participants|52|52.0||||||
3939241|NCT01379508|3761112|B2||≤ 1 × ULN|Participants with alanine aminotransferase (ALT) - Multiples of upper limits of normal (ULN)|Serum ALT normalization is an important clinically relevant efficacy endpoint. Elevated serum ALT levels are thought to reflect underlying hepatitis disease activity (i.e. active liver inflammation). Correspondingly, ALT normalization is an accepted therapeutic goal in hepatitis studies as it is thought to reflect a substantial reduction in hepatic disease activity.Measurement at baseline.|Participants|Count of Participants|3|3.0||||||
3939242|NCT01379508|3761113|B1||≤ 1 × ULN|Participants with alanine aminotransferase (ALT) - Multiples of upper limits of normal (ULN)|Serum ALT normalization is an important clinically relevant efficacy endpoint. Elevated serum ALT levels are thought to reflect underlying hepatitis disease activity (i.e. active liver inflammation). Correspondingly, ALT normalization is an accepted therapeutic goal in hepatitis studies as it is thought to reflect a substantial reduction in hepatic disease activity.Measurement at baseline.|Participants|Count of Participants|46|46.0||||||
3939243|NCT01379508|3761109|B5||≥ 7 log 10 copies/mL|HBV DNA levels < or ≥ 7 log 10 copies/mL at baseline.||Participants|Count of Participants|70|70.0||||||
3939244|NCT01379508|3761110|B4||≥ 7 log 10 copies/mL|HBV DNA levels < or ≥ 7 log 10 copies/mL at baseline.||Participants|Count of Participants|8|8.0||||||
3939245|NCT01379508|3761111|B3||≥ 7 log 10 copies/mL|HBV DNA levels < or ≥ 7 log 10 copies/mL at baseline.||Participants|Count of Participants|26|26.0||||||
3939246|NCT01379508|3761112|B2||≥ 7 log 10 copies/mL|HBV DNA levels < or ≥ 7 log 10 copies/mL at baseline.||Participants|Count of Participants|18|18.0||||||
3939247|NCT01379508|3761113|B1||≥ 7 log 10 copies/mL|HBV DNA levels < or ≥ 7 log 10 copies/mL at baseline.||Participants|Count of Participants|18|18.0||||||
3939248|NCT01379508|3761109|B5||< 7 log 10 copies/mL|HBV DNA levels < or ≥ 7 log 10 copies/mL at baseline.||Participants|Count of Participants|171|171.0||||||
3939249|NCT01379508|3761110|B4||< 7 log 10 copies/mL|HBV DNA levels < or ≥ 7 log 10 copies/mL at baseline.||Participants|Count of Participants|3|3.0||||||
3939250|NCT01379508|3761111|B3||< 7 log 10 copies/mL|HBV DNA levels < or ≥ 7 log 10 copies/mL at baseline.||Participants|Count of Participants|83|83.0||||||
3939251|NCT01379508|3761112|B2||< 7 log 10 copies/mL|HBV DNA levels < or ≥ 7 log 10 copies/mL at baseline.||Participants|Count of Participants|4|4.0||||||
3939252|NCT01379508|3761113|B1||< 7 log 10 copies/mL|HBV DNA levels < or ≥ 7 log 10 copies/mL at baseline.||Participants|Count of Participants|81|81.0||||||
3939253|NCT01379508|3761109|B5|||HBV DNA||log10 copies/mL)|Mean|5.887|5.887|Standard Deviation|1.2862|1.2862|||
3939254|NCT01379508|3761110|B4|||HBV DNA||log10 copies/mL)|Mean|7.938|7.938|Standard Deviation|1.0709|1.0709|||
3939255|NCT01379508|3761111|B3|||HBV DNA||log10 copies/mL)|Mean|5.838|5.838|Standard Deviation|1.2464|1.2464|||
3939256|NCT01379508|3761112|B2|||HBV DNA||log10 copies/mL)|Mean|7.769|7.769|Standard Deviation|1.2502|1.2502|||
3939257|NCT01379508|3761113|B1|||HBV DNA||log10 copies/mL)|Mean|5.887|5.887|Standard Deviation|1.2862|1.2862|||
3939258|NCT01379508|3761109|B5||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3939259|NCT01379508|3761110|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3939260|NCT01379508|3761111|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3939261|NCT01379508|3761112|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3939262|NCT01379508|3761113|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3939263|NCT01379508|3761109|B5||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3939264|NCT01379508|3761110|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3939265|NCT01379508|3761111|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3939266|NCT01379508|3761112|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3939267|NCT01379508|3761113|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3939268|NCT01379508|3761109|B5||> 50 years|Age, Customized||Participants|Count of Participants|67|67.0||||||
3939269|NCT01379508|3761110|B4||> 50 years|Age, Customized||Participants|Count of Participants|4|4.0||||||
3939270|NCT01379508|3761111|B3||> 50 years|Age, Customized||Participants|Count of Participants|32|32.0||||||
3939271|NCT01379508|3761112|B2||> 50 years|Age, Customized||Participants|Count of Participants|5|5.0||||||
3939272|NCT01379508|3761113|B1||> 50 years|Age, Customized||Participants|Count of Participants|26|26.0||||||
3939273|NCT01379508|3761109|B5||Between 30 and 50 years|Age, Customized||Participants|Count of Participants|135|135.0||||||
3939274|NCT01379508|3761110|B4||Between 30 and 50 years|Age, Customized||Participants|Count of Participants|7|7.0||||||
3939275|NCT01379508|3761111|B3||Between 30 and 50 years|Age, Customized||Participants|Count of Participants|59|59.0||||||
3939276|NCT01379508|3761112|B2||Between 30 and 50 years|Age, Customized||Participants|Count of Participants|13|13.0||||||
3939277|NCT01379508|3761113|B1||Between 30 and 50 years|Age, Customized||Participants|Count of Participants|56|56.0||||||
3939278|NCT01379508|3761109|B5||< 30 years|Age, Customized||Participants|Count of Participants|39|39.0||||||
3939279|NCT01379508|3761110|B4||< 30 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3939280|NCT01379508|3761111|B3||< 30 years|Age, Customized||Participants|Count of Participants|18|18.0||||||
3939281|NCT01379508|3761112|B2||< 30 years|Age, Customized||Participants|Count of Participants|4|4.0||||||
3939282|NCT01379508|3761113|B1||< 30 years|Age, Customized||Participants|Count of Participants|17|17.0||||||
3939283|NCT01379183|3761142|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3939284|NCT01379183|3761143|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
3939290|NCT01379183|3761143|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3939291|NCT01379183|3761144|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3939292|NCT01379183|3761142|B3|||Age||years|Mean|35|35.0|Standard Deviation|13|13.0|||
3939293|NCT01379183|3761143|B2|||Age||years|Mean|35|35.0|Standard Deviation|13|13.0|||
3939294|NCT01379183|3761144|B1|||Age||years|Mean|34|34.0|Standard Deviation|12.6|12.6|||
3939295|NCT01378988|3761161|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3939296|NCT01378988|3761162|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939297|NCT01378988|3761163|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3939298|NCT01378988|3761161|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939299|NCT01378988|3761162|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939300|NCT01378988|3761163|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939301|NCT01378988|3761161|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3939302|NCT01378988|3761162|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3939303|NCT01378988|3761163|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3939304|NCT01378988|3761161|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939305|NCT01378988|3761162|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939306|NCT01378988|3761163|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939307|NCT01378988|3761161|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939308|NCT01378988|3761162|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939309|NCT01378988|3761163|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939310|NCT01378988|3761161|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939311|NCT01378988|3761162|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939312|NCT01378988|3761163|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939313|NCT01378988|3761161|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939314|NCT01378988|3761162|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939315|NCT01378988|3761163|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939316|NCT01378988|3761161|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3939317|NCT01378988|3761162|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3939318|NCT01378988|3761163|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3939319|NCT01378988|3761161|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3939320|NCT01378988|3761162|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3939321|NCT01378988|3761163|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3939322|NCT01378988|3761161|B3|||Age||years|Mean|1.44|1.44|Standard Deviation|0.249|0.249|||
3939323|NCT01378988|3761162|B2|||Age||years|Mean|1.45|1.45|Standard Deviation|0.274|0.274|||
3939324|NCT01378988|3761163|B1|||Age||years|Mean|1.43|1.43|Standard Deviation|0.312|0.312|||
3939325|NCT01378975|3761192|B3||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3939326|NCT01378975|3761193|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3939327|NCT01378975|3761194|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3939328|NCT01378975|3761192|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3939329|NCT01378975|3761193|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3939330|NCT01378975|3761194|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3939331|NCT01378975|3761192|B3|||Age||years|Mean|54.5|54.5|Standard Deviation|13.20|13.2|||
3939332|NCT01378975|3761193|B2|||Age||years|Mean|52.7|52.7|Standard Deviation|13.85|13.85|||
3939333|NCT01378975|3761194|B1|||Age||years|Mean|55.7|55.7|Standard Deviation|12.73|12.73|||
3939334|NCT01378962|3761221|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3939335|NCT01378962|3761221|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3939336|NCT01378962|3761221|B1|||Age||years|Mean|62.86|62.86|Standard Deviation|11.42|11.42|||
3939337|NCT01378520|3761234|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3939338|NCT01378520|3761234|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3939339|NCT01378520|3761234|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3939340|NCT01378520|3761234|B1|||Age||years|Mean|69.6|69.6|Standard Deviation|6.9|6.9|||
3939341|NCT01378429|3761245|B3|United States||Region of Enrollment||participants|Number|89|89.0||||||
3939342|NCT01378429|3761246|B2|United States||Region of Enrollment||participants|Number|47|47.0||||||
3939343|NCT01378429|3761247|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
3939344|NCT01378429|3761245|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939345|NCT01378429|3761246|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939346|NCT01378429|3761247|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939347|NCT01378429|3761245|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3939348|NCT01378429|3761246|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3939349|NCT01378429|3761247|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3939350|NCT01378429|3761245|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3939351|NCT01378429|3761246|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3939352|NCT01378429|3761247|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3939353|NCT01378429|3761245|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939354|NCT01378429|3761246|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939355|NCT01378429|3761247|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939356|NCT01378429|3761245|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3939357|NCT01378429|3761246|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3939358|NCT01378429|3761247|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939359|NCT01378429|3761245|B3||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3939360|NCT01378429|3761246|B2||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3939361|NCT01378429|3761247|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3939362|NCT01378429|3761245|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3939363|NCT01378429|3761246|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3939364|NCT01378429|3761247|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3939365|NCT01378429|3761245|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939366|NCT01378429|3761246|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939367|NCT01378429|3761247|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939368|NCT01378429|3761245|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3939369|NCT01378429|3761246|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3939370|NCT01378429|3761247|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3939371|NCT01378429|3761245|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939372|NCT01378429|3761246|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939373|NCT01378429|3761247|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939374|NCT01378429|3761245|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3939375|NCT01378429|3761246|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3939376|NCT01378429|3761247|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3939377|NCT01378429|3761245|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3939378|NCT01378429|3761246|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3939379|NCT01378429|3761247|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3939380|NCT01378429|3761245|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3939381|NCT01378429|3761246|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3939382|NCT01378429|3761247|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3939383|NCT01378429|3761245|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3939384|NCT01378429|3761246|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3939385|NCT01378429|3761247|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3939386|NCT01378429|3761245|B3||<=18 years|Age||Participants|Count of Participants|89|89.0||||||
3939387|NCT01378429|3761246|B2||<=18 years|Age||Participants|Count of Participants|47|47.0||||||
3939388|NCT01378429|3761247|B1||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
3939389|NCT01378429|3761245|B3|||Age||years|Mean|8.9|8.9|Standard Deviation|1.70|1.7|||
3939390|NCT01378429|3761246|B2|||Age||years|Mean|8.6|8.6|Standard Deviation|1.65|1.65|||
3939391|NCT01378429|3761247|B1|||Age||years|Mean|9.2|9.2|Standard Deviation|1.74|1.74|||
3939392|NCT01378416|3761280|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3939393|NCT01378416|3761280|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3939394|NCT01378416|3761280|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3939395|NCT01378416|3761280|B1|||Age||years|Mean|68.2|68.2|Standard Deviation|11.12|11.12|||
3939396|NCT01378377|3761288|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3939397|NCT01378377|3761289|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3939398|NCT01378377|3761290|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3939399|NCT01378377|3761291|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3939400|NCT01378377|3761288|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3939401|NCT01378377|3761289|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3939402|NCT01378377|3761290|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3939403|NCT01378377|3761291|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3939404|NCT01378377|3761288|B4|||Age||years|Mean|58.1|58.1|Standard Deviation|12.61|12.61|||
3939405|NCT01378377|3761289|B3|||Age||years|Mean|55.5|55.5|Standard Deviation|6.19|6.19|||
3939406|NCT01378377|3761290|B2|||Age||years|Mean|57.9|57.9|Standard Deviation|14.09|14.09|||
3939407|NCT01378377|3761291|B1|||Age||years|Mean|63.3|63.3|Standard Deviation|11.30|11.3|||
3939470|NCT01378117|3761392|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3939408|NCT01378325|3761359|B3|Number of Female Participants||Sex/Gender, Customized|Gender, female|participants|Number|79|79.0||||||
3939409|NCT01378325|3761360|B2|Number of Female Participants||Sex/Gender, Customized|Gender, female|participants|Number|40|40.0||||||
3939410|NCT01378325|3761361|B1|Number of Female Participants||Sex/Gender, Customized|Gender, female|participants|Number|39|39.0||||||
3939411|NCT01378325|3761359|B3|||Age||years|Mean|33|33.0|Standard Deviation|5|5.0|||
3939412|NCT01378325|3761360|B2|||Age||years|Mean|32.5|32.5|Standard Deviation|5|5.0|||
3939413|NCT01378325|3761361|B1|||Age||years|Mean|33.5|33.5|Standard Deviation|5|5.0|||
3939414|NCT01378221|3761368|B3|Germany||Region of Enrollment||participants|Number|59|59.0||||||
3939415|NCT01378221|3761369|B2|Germany||Region of Enrollment||participants|Number|30|30.0||||||
3939416|NCT01378221|3761370|B1|Germany||Region of Enrollment||participants|Number|29|29.0||||||
3939417|NCT01378221|3761368|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3939418|NCT01378221|3761369|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3939419|NCT01378221|3761370|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3939420|NCT01378221|3761368|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3939421|NCT01378221|3761369|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3939422|NCT01378221|3761370|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3939423|NCT01378221|3761368|B3|Age||Age||years|Mean|68.05|68.05|Standard Deviation|5.14|5.14|||
3939424|NCT01378221|3761369|B2|Age||Age||years|Mean|77.0|77.0|Standard Deviation|4.38|4.38|||
3939425|NCT01378221|3761370|B1|Age||Age||years|Mean|58.8|58.8|Standard Deviation|5.92|5.92|||
3939426|NCT01378195|3761377|B3|United States||Region of Enrollment||participants|Number|150|150.0||||||
3939427|NCT01378195|3761378|B2|United States||Region of Enrollment||participants|Number|75|75.0||||||
3939428|NCT01378195|3761379|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
3939429|NCT01378195|3761377|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3939430|NCT01378195|3761378|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3939431|NCT01378195|3761379|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3939432|NCT01378195|3761377|B3||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3939433|NCT01378195|3761378|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3939434|NCT01378195|3761379|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3939435|NCT01378195|3761377|B3||>=65 years|Age||Participants|Count of Participants|55|55.0||||||
3939436|NCT01378195|3761378|B2||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
3939437|NCT01378195|3761379|B1||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
3939438|NCT01378195|3761377|B3||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
3939439|NCT01378195|3761378|B2||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
3939440|NCT01378195|3761379|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3939441|NCT01378195|3761377|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3939442|NCT01378195|3761378|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3939443|NCT01378195|3761379|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3939444|NCT01378117|3761390|B4|United States||Region of Enrollment||participants|Number|82|82.0||||||
3939445|NCT01378117|3761391|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
3939446|NCT01378117|3761392|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
3939447|NCT01378117|3761393|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3939448|NCT01378117|3761390|B4||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3939449|NCT01378117|3761391|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3939450|NCT01378117|3761392|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3939451|NCT01378117|3761393|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3939452|NCT01378117|3761390|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3939453|NCT01378117|3761391|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3939454|NCT01378117|3761392|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3939455|NCT01378117|3761393|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3939456|NCT01378117|3761390|B4|||Age||years|Mean|58|58.0|Standard Deviation|11|11.0|||
3939457|NCT01378117|3761391|B3|||Age||years|Mean|57|57.0|Standard Deviation|10|10.0|||
3939458|NCT01378117|3761392|B2|||Age||years|Mean|58|58.0|Standard Deviation|12|12.0|||
3939459|NCT01378117|3761393|B1|||Age||years|Mean|59|59.0|Standard Deviation|11|11.0|||
3939460|NCT01378117|3761390|B4||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3939461|NCT01378117|3761391|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3939462|NCT01378117|3761392|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3939463|NCT01378117|3761393|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3939464|NCT01378117|3761390|B4||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
3939465|NCT01378117|3761391|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3939466|NCT01378117|3761392|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3939467|NCT01378117|3761393|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3939468|NCT01378117|3761390|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3939469|NCT01378117|3761391|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3939471|NCT01378117|3761393|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3939472|NCT01378104|3761427|B3|Korea, Republic of||Region of Enrollment||participants|Number|178|178.0||||||
3939473|NCT01378104|3761428|B2|Korea, Republic of||Region of Enrollment||participants|Number|86|86.0||||||
3939474|NCT01378104|3761429|B1|Korea, Republic of||Region of Enrollment||participants|Number|92|92.0||||||
3939475|NCT01378104|3761427|B3||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3939476|NCT01378104|3761428|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3939477|NCT01378104|3761429|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3939478|NCT01378104|3761427|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3939479|NCT01378104|3761428|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3939480|NCT01378104|3761429|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3939481|NCT01378104|3761427|B3|||Age||years|Mean|48.6|48.6|Standard Deviation|11.0|11.0|||
3939482|NCT01378104|3761428|B2|||Age||years|Mean|48.7|48.7|Standard Deviation|11.5|11.5|||
3939483|NCT01378104|3761429|B1|||Age||years|Mean|48.5|48.5|Standard Deviation|10.6|10.6|||
3939484|NCT01378104|3761427|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3939485|NCT01378104|3761428|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3939486|NCT01378104|3761429|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3939487|NCT01378104|3761427|B3||Between 18 and 65 years|Age||Participants|Count of Participants|169|169.0||||||
3939488|NCT01378104|3761428|B2||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
3939489|NCT01378104|3761429|B1||Between 18 and 65 years|Age||Participants|Count of Participants|88|88.0||||||
3939490|NCT01378104|3761427|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3939491|NCT01378104|3761428|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3939492|NCT01378104|3761429|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3939493|NCT01378065|3761438|B1|||Height||Inches|Mean|64.3|64.3|Standard Deviation|2.9|2.9|||
3939494|NCT01378065|3761438|B1|||Weight||pound|Mean|164.7|164.7|Standard Deviation|36.8|36.8|||
3939495|NCT01378065|3761438|B1|||Body Mass Index (BMI)||Kg/m^2|Mean|27.9|27.9|Standard Deviation|5.6|5.6|||
3939496|NCT01378065|3761438|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3939497|NCT01378065|3761438|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3939498|NCT01378065|3761438|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3939499|NCT01378065|3761438|B1|||Age||years|Mean|62.1|62.1|Standard Deviation|12.8|12.8|||
3939500|NCT01377987|3761475|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939501|NCT01377987|3761475|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939502|NCT01377987|3761475|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3939503|NCT01377987|3761475|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3939504|NCT01377987|3761475|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939505|NCT01377987|3761475|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939506|NCT01377987|3761475|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939507|NCT01377987|3761475|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3939508|NCT01377987|3761475|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3939509|NCT01377987|3761475|B1|||Age||years|Mean|60|60.0|Standard Deviation|13|13.0|||
3939510|NCT01377922|3761492|B3|||If yes, number of continuous days of amifampridine exposure immediately prior to enrollment||days|Mean|1544.0|1544.0|Standard Deviation|1957.36|1957.36|||
3939511|NCT01377922|3761493|B2|||If yes, number of continuous days of amifampridine exposure immediately prior to enrollment||days|Mean|2143.3|2143.3|Standard Deviation|3080.16|3080.16|||
3939512|NCT01377922|3761494|B1|||If yes, number of continuous days of amifampridine exposure immediately prior to enrollment||days|Mean|1287.1|1287.1|Standard Deviation|1525.73|1525.73|||
3939513|NCT01377922|3761492|B3||No|Was the patient taking amifampridine (base or phosphate) immediately prior to enrollment?||Participants|Count of Participants|28|28.0||||||
3939514|NCT01377922|3761493|B2||No|Was the patient taking amifampridine (base or phosphate) immediately prior to enrollment?||Participants|Count of Participants|13|13.0||||||
3939515|NCT01377922|3761494|B1||No|Was the patient taking amifampridine (base or phosphate) immediately prior to enrollment?||Participants|Count of Participants|15|15.0||||||
3939516|NCT01377922|3761492|B3||Yes|Was the patient taking amifampridine (base or phosphate) immediately prior to enrollment?||Participants|Count of Participants|10|10.0||||||
3939517|NCT01377922|3761493|B2||Yes|Was the patient taking amifampridine (base or phosphate) immediately prior to enrollment?||Participants|Count of Participants|3|3.0||||||
3939518|NCT01377922|3761494|B1||Yes|Was the patient taking amifampridine (base or phosphate) immediately prior to enrollment?||Participants|Count of Participants|7|7.0||||||
3939519|NCT01377922|3761492|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3939520|NCT01377922|3761493|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3939521|NCT01377922|3761494|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3939522|NCT01377922|3761492|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3939523|NCT01377922|3761493|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3939524|NCT01377922|3761494|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939525|NCT01377922|3761492|B3||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3939526|NCT01377922|3761493|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3939527|NCT01377922|3761494|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3939528|NCT01377922|3761492|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939529|NCT01377922|3761493|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939530|NCT01377922|3761494|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939531|NCT01377922|3761492|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939532|NCT01377922|3761493|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939533|NCT01377922|3761494|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939534|NCT01377922|3761492|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939535|NCT01377922|3761493|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939536|NCT01377922|3761494|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939537|NCT01377922|3761492|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939538|NCT01377922|3761493|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939539|NCT01377922|3761494|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939540|NCT01377922|3761492|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3939541|NCT01377922|3761493|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3939542|NCT01377922|3761494|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939543|NCT01377922|3761492|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3939544|NCT01377922|3761493|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3939545|NCT01377922|3761494|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3939546|NCT01377922|3761492|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3939547|NCT01377922|3761493|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3939548|NCT01377922|3761494|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939549|NCT01377922|3761492|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3939550|NCT01377922|3761493|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3939551|NCT01377922|3761494|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3939552|NCT01377922|3761492|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3939553|NCT01377922|3761493|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3939554|NCT01377922|3761494|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3939555|NCT01377922|3761492|B3|||Age||years|Mean|51.5|51.5|Standard Deviation|15.30|15.3|||
3939556|NCT01377922|3761493|B2|||Age||years|Mean|51.6|51.6|Standard Deviation|12.05|12.05|||
3939557|NCT01377922|3761494|B1|||Age||years|Mean|51.5|51.5|Standard Deviation|17.57|17.57|||
3939558|NCT01377636|3761507|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3939559|NCT01377636|3761507|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3939560|NCT01377636|3761507|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3939561|NCT01377636|3761507|B1|||Age||years|Mean|62|62.0|Standard Deviation|8.2|8.2|||
3939562|NCT01377636|3761507|B1||>=65 years|Age|Demographics and BIS were measured|Participants|Count of Participants|9|9.0||||||
3939563|NCT01377636|3761507|B1||Between 18 and 65 years|Age|Demographics and BIS were measured|Participants|Count of Participants|11|11.0||||||
3939564|NCT01377636|3761507|B1||<=18 years|Age|Demographics and BIS were measured|Participants|Count of Participants|0|0.0||||||
3939565|NCT01377623|3761519|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3939566|NCT01377623|3761520|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3939567|NCT01377623|3761521|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3939568|NCT01377623|3761519|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3939569|NCT01377623|3761520|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3939570|NCT01377623|3761521|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3939571|NCT01377623|3761519|B3|||Age||years|Mean|56.18|56.18|Standard Deviation|11.69|11.69|||
3939572|NCT01377623|3761520|B2|||Age||years|Mean|55.3|55.3|Standard Deviation|12.3|12.3|||
3939573|NCT01377623|3761521|B1|||Age||years|Mean|57|57.0|Standard Deviation|11.1|11.1|||
3939574|NCT01377584|3761536|B7|||Apnea–Hypopnea Index|Apnea-Hypopnea Index is a measure of the total number of apnea and hypopnea events per hour of sleep.|Events per hour of sleep|Mean|37|37.0|Standard Deviation|31|31.0|||
3939575|NCT01377584|3761537|B6|||Apnea–Hypopnea Index|Apnea-Hypopnea Index is a measure of the total number of apnea and hypopnea events per hour of sleep.|Events per hour of sleep|Mean|NA||Standard Deviation|NA||||Data not collected for partners.
3939576|NCT01377584|3761538|B5|||Apnea–Hypopnea Index|Apnea-Hypopnea Index is a measure of the total number of apnea and hypopnea events per hour of sleep.|Events per hour of sleep|Mean|40|40.0|Standard Deviation|28|28.0|||
3939577|NCT01377584|3761539|B4|||Apnea–Hypopnea Index|Apnea-Hypopnea Index is a measure of the total number of apnea and hypopnea events per hour of sleep.|Events per hour of sleep|Mean|NA||Standard Deviation|NA||||Data not collected for partners.
3939578|NCT01377584|3761540|B3|||Apnea–Hypopnea Index|Apnea-Hypopnea Index is a measure of the total number of apnea and hypopnea events per hour of sleep.|Events per hour of sleep|Mean|30|30.0|Standard Deviation|32|32.0|||
3939634|NCT01377584|3761540|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3939579|NCT01377584|3761541|B2|||Apnea–Hypopnea Index|Apnea-Hypopnea Index is a measure of the total number of apnea and hypopnea events per hour of sleep.|Events per hour of sleep|Mean|NA||Standard Deviation|NA||||Data not collected for partners.
3939580|NCT01377584|3761542|B1|||Apnea–Hypopnea Index|Apnea-Hypopnea Index is a measure of the total number of apnea and hypopnea events per hour of sleep.|Events per hour of sleep|Mean|40|40.0|Standard Deviation|40|40.0|||
3939581|NCT01377584|3761536|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939582|NCT01377584|3761537|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939583|NCT01377584|3761538|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939584|NCT01377584|3761539|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939585|NCT01377584|3761540|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939586|NCT01377584|3761541|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939587|NCT01377584|3761542|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939588|NCT01377584|3761536|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3939589|NCT01377584|3761537|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3939590|NCT01377584|3761538|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3939591|NCT01377584|3761539|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3939592|NCT01377584|3761540|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3939593|NCT01377584|3761541|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939594|NCT01377584|3761542|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939595|NCT01377584|3761536|B7||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3939596|NCT01377584|3761537|B6||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3939597|NCT01377584|3761538|B5||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3939598|NCT01377584|3761539|B4||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3939599|NCT01377584|3761540|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3939600|NCT01377584|3761541|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3939601|NCT01377584|3761542|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3939602|NCT01377584|3761536|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3939603|NCT01377584|3761537|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3939604|NCT01377584|3761538|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3939605|NCT01377584|3761539|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3939606|NCT01377584|3761540|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3939607|NCT01377584|3761541|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939608|NCT01377584|3761542|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939609|NCT01377584|3761536|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939610|NCT01377584|3761537|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939611|NCT01377584|3761538|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939612|NCT01377584|3761539|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939613|NCT01377584|3761540|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939614|NCT01377584|3761541|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939615|NCT01377584|3761542|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939616|NCT01377584|3761536|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939617|NCT01377584|3761537|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939618|NCT01377584|3761538|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939619|NCT01377584|3761539|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939620|NCT01377584|3761540|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939621|NCT01377584|3761541|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939622|NCT01377584|3761542|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939623|NCT01377584|3761536|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939624|NCT01377584|3761537|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939625|NCT01377584|3761538|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939626|NCT01377584|3761539|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939627|NCT01377584|3761540|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939628|NCT01377584|3761541|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939629|NCT01377584|3761542|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939630|NCT01377584|3761536|B7||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3939631|NCT01377584|3761537|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3939632|NCT01377584|3761538|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3939633|NCT01377584|3761539|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3939635|NCT01377584|3761541|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3939636|NCT01377584|3761542|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3939637|NCT01377584|3761536|B7||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3939638|NCT01377584|3761537|B6||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3939639|NCT01377584|3761538|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3939640|NCT01377584|3761539|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3939641|NCT01377584|3761540|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3939642|NCT01377584|3761541|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3939643|NCT01377584|3761542|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3939644|NCT01377584|3761536|B7|||Age||years|Mean|52|52.0|Standard Deviation|10|10.0|||
3939645|NCT01377584|3761537|B6|||Age||years|Mean|54|54.0|Standard Deviation|7|7.0|||
3939646|NCT01377584|3761538|B5|||Age||years|Mean|54|54.0|Standard Deviation|7|7.0|||
3939647|NCT01377584|3761539|B4|||Age||years|Mean|54|54.0|Standard Deviation|14|14.0|||
3939648|NCT01377584|3761540|B3|||Age||years|Mean|50|50.0|Standard Deviation|11|11.0|||
3939649|NCT01377584|3761541|B2|||Age||years|Mean|43|43.0|Standard Deviation|3|3.0|||
3939650|NCT01377584|3761542|B1|||Age||years|Mean|49|49.0|Standard Deviation|14|14.0|||
3939651|NCT01377480|3761576|B5||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3939652|NCT01377480|3761577|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3939653|NCT01377480|3761578|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3939654|NCT01377480|3761579|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3939655|NCT01377480|3761580|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3939656|NCT01377480|3761576|B5||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3939657|NCT01377480|3761577|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3939658|NCT01377480|3761578|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3939659|NCT01377480|3761579|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3939660|NCT01377480|3761580|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3939661|NCT01377480|3761576|B5|||Age||years|Mean|40.8|40.8|Standard Deviation|8.1|8.1|||
3939662|NCT01377480|3761577|B4|||Age||years|Mean|40.4|40.4|Standard Deviation|7.7|7.7|||
3939663|NCT01377480|3761578|B3|||Age||years|Mean|40.2|40.2|Standard Deviation|8.4|8.4|||
3939664|NCT01377480|3761579|B2|||Age||years|Mean|42.2|42.2|Standard Deviation|7.8|7.8|||
3939665|NCT01377480|3761580|B1|||Age||years|Mean|40.3|40.3|Standard Deviation|8.6|8.6|||
3939666|NCT01377467|3761593|B3|No||Number of osteoporotic patients||participants|Number|81|81.0||||||
3939667|NCT01377467|3761594|B2|No||Number of osteoporotic patients||participants|Number|38|38.0||||||
3939668|NCT01377467|3761595|B1|No||Number of osteoporotic patients||participants|Number|43|43.0||||||
3939669|NCT01377467|3761593|B3|Yes||Number of osteoporotic patients||participants|Number|9|9.0||||||
3939670|NCT01377467|3761594|B2|Yes||Number of osteoporotic patients||participants|Number|6|6.0||||||
3939671|NCT01377467|3761595|B1|Yes||Number of osteoporotic patients||participants|Number|3|3.0||||||
3939672|NCT01377467|3761593|B3|No||Number of osteopenic patients||participants|Number|49|49.0||||||
3939673|NCT01377467|3761594|B2|No||Number of osteopenic patients||participants|Number|19|19.0||||||
3939674|NCT01377467|3761595|B1|No||Number of osteopenic patients||participants|Number|30|30.0||||||
3939675|NCT01377467|3761593|B3|Yes||Number of osteopenic patients||participants|Number|41|41.0||||||
3939676|NCT01377467|3761594|B2|Yes||Number of osteopenic patients||participants|Number|25|25.0||||||
3939677|NCT01377467|3761595|B1|Yes||Number of osteopenic patients||participants|Number|16|16.0||||||
3939678|NCT01377467|3761593|B3|Switzerland||Region of Enrollment||participants|Number|90|90.0||||||
3939679|NCT01377467|3761594|B2|Switzerland||Region of Enrollment||participants|Number|44|44.0||||||
3939680|NCT01377467|3761595|B1|Switzerland||Region of Enrollment||participants|Number|46|46.0||||||
3939681|NCT01377467|3761593|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3939682|NCT01377467|3761594|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3939683|NCT01377467|3761595|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3939684|NCT01377467|3761593|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3939685|NCT01377467|3761594|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3939686|NCT01377467|3761595|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3939687|NCT01377467|3761593|B3|||Age||years|Mean|50.9|50.9|Standard Deviation|15.1|15.1|||
3939688|NCT01377467|3761594|B2|||Age||years|Mean|52.9|52.9|Standard Deviation|14.0|14.0|||
3939689|NCT01377467|3761595|B1|||Age||years|Mean|48.9|48.9|Standard Deviation|16.0|16.0|||
3939690|NCT01377402|3761653|B1|Argentina||Region of Enrollment||participants|Number|982|982.0||||||
3939691|NCT01377402|3761653|B1||Male|Sex: Female, Male||Participants|Count of Participants|588|588.0||||||
3939692|NCT01377402|3761653|B1||Female|Sex: Female, Male||Participants|Count of Participants|394|394.0||||||
3939693|NCT01377402|3761653|B1|||Age||years|Median|62|62.0|Inter-Quartile Range|||53.0|72.0|
3939694|NCT01377402|3761653|B1||>=65 years|Age||Participants|Count of Participants|438|438.0||||||
3939695|NCT01377402|3761653|B1||Between 18 and 65 years|Age||Participants|Count of Participants|544|544.0||||||
3939696|NCT01377402|3761653|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3939697|NCT01377233|3761659|B6|||Waist circumference||cm|Mean|103.3|103.3|Standard Deviation|13.2|13.2|||
3939698|NCT01377233|3761660|B5|||Waist circumference||cm|Mean|106.5|106.5|Standard Deviation|12.5|12.5|||
3939699|NCT01377233|3761661|B4|||Waist circumference||cm|Mean|101.1|101.1|Standard Deviation|13.1|13.1|||
3939700|NCT01377233|3761662|B3|||Waist circumference||cm|Mean|101.8|101.8|Standard Deviation|14.1|14.1|||
3939701|NCT01377233|3761663|B2|||Waist circumference||cm|Mean|99.8|99.8|Standard Deviation|16.4|16.4|||
3939702|NCT01377233|3761664|B1|||Waist circumference||cm|Mean|98.7|98.7|Standard Deviation|16.2|16.2|||
3939703|NCT01377233|3761659|B6|||BMI||kg/m2|Mean|30.4|30.4|Standard Deviation|5.3|5.3|||
3939704|NCT01377233|3761660|B5|||BMI||kg/m2|Mean|32.2|32.2|Standard Deviation|5.2|5.2|||
3939705|NCT01377233|3761661|B4|||BMI||kg/m2|Mean|28.6|28.6|Standard Deviation|4.2|4.2|||
3939706|NCT01377233|3761662|B3|||BMI||kg/m2|Mean|31.6|31.6|Standard Deviation|5.9|5.9|||
3939707|NCT01377233|3761663|B2|||BMI||kg/m2|Mean|31.3|31.3|Standard Deviation|7.1|7.1|||
3939708|NCT01377233|3761664|B1|||BMI||kg/m2|Mean|30.0|30.0|Standard Deviation|5.5|5.5|||
3939709|NCT01377233|3761659|B6|||Weight||kg|Mean|89.7|89.7|Standard Deviation|18.0|18.0|||
3939710|NCT01377233|3761660|B5|||Weight||kg|Mean|93.8|93.8|Standard Deviation|16.8|16.8|||
3939711|NCT01377233|3761661|B4|||Weight||kg|Mean|87.5|87.5|Standard Deviation|17.5|17.5|||
3939712|NCT01377233|3761662|B3|||Weight||kg|Mean|91.5|91.5|Standard Deviation|19.2|19.2|||
3939713|NCT01377233|3761663|B2|||Weight||kg|Mean|90.0|90.0|Standard Deviation|21.1|21.1|||
3939714|NCT01377233|3761664|B1|||Weight||kg|Mean|94.7|94.7|Standard Deviation|27.5|27.5|||
3939715|NCT01377233|3761659|B6|||Height||cm|Mean|171.8|171.8|Standard Deviation|9.8|9.8|||
3939716|NCT01377233|3761660|B5|||Height||cm|Mean|170.9|170.9|Standard Deviation|11.7|11.7|||
3939717|NCT01377233|3761661|B4|||Height||cm|Mean|174.6|174.6|Standard Deviation|10.3|10.3|||
3939718|NCT01377233|3761662|B3|||Height||cm|Mean|170.1|170.1|Standard Deviation|9.7|9.7|||
3939719|NCT01377233|3761663|B2|||Height||cm|Mean|169.5|169.5|Standard Deviation|8.3|8.3|||
3939720|NCT01377233|3761664|B1|||Height||cm|Mean|176.3|176.3|Standard Deviation|9.4|9.4|||
3939721|NCT01377233|3761659|B6|United States||Region of Enrollment||participants|Number|46|46.0||||||
3939722|NCT01377233|3761660|B5|United States||Region of Enrollment||participants|Number|10|10.0||||||
3939723|NCT01377233|3761661|B4|United States||Region of Enrollment||participants|Number|11|11.0||||||
3939724|NCT01377233|3761662|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3939725|NCT01377233|3761663|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3939726|NCT01377233|3761664|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3939727|NCT01377233|3761659|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939728|NCT01377233|3761660|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939729|NCT01377233|3761661|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939730|NCT01377233|3761662|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939731|NCT01377233|3761663|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939732|NCT01377233|3761664|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939733|NCT01377233|3761659|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939734|NCT01377233|3761660|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939735|NCT01377233|3761661|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939736|NCT01377233|3761662|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939737|NCT01377233|3761663|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939738|NCT01377233|3761664|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939739|NCT01377233|3761659|B6||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3939740|NCT01377233|3761660|B5||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3939741|NCT01377233|3761661|B4||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3939742|NCT01377233|3761662|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3939743|NCT01377233|3761663|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3939744|NCT01377233|3761664|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3939745|NCT01377233|3761659|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3939746|NCT01377233|3761660|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3939747|NCT01377233|3761661|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3939748|NCT01377233|3761662|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3939749|NCT01377233|3761663|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3939750|NCT01377233|3761664|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3939751|NCT01377233|3761659|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3939752|NCT01377233|3761660|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939753|NCT01377233|3761661|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939754|NCT01377233|3761662|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3939755|NCT01377233|3761663|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939756|NCT01377233|3761664|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939757|NCT01377233|3761659|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939758|NCT01377233|3761660|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939759|NCT01377233|3761661|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939760|NCT01377233|3761662|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939761|NCT01377233|3761663|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939762|NCT01377233|3761664|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939763|NCT01377233|3761659|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3939764|NCT01377233|3761660|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939765|NCT01377233|3761661|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939766|NCT01377233|3761662|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939767|NCT01377233|3761663|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939768|NCT01377233|3761664|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3939769|NCT01377233|3761659|B6||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3939770|NCT01377233|3761660|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3939771|NCT01377233|3761661|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3939772|NCT01377233|3761662|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3939773|NCT01377233|3761663|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3939774|NCT01377233|3761664|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3939775|NCT01377233|3761659|B6||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3939776|NCT01377233|3761660|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3939777|NCT01377233|3761661|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3939778|NCT01377233|3761662|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3939779|NCT01377233|3761663|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3939780|NCT01377233|3761664|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3939781|NCT01377233|3761659|B6|||Age||years|Mean|47.0|47.0|Standard Deviation|8.3|8.3|||
3939782|NCT01377233|3761660|B5|||Age||years|Mean|50.1|50.1|Standard Deviation|4.8|4.8|||
3939783|NCT01377233|3761661|B4|||Age||years|Mean|50.8|50.8|Standard Deviation|5.0|5.0|||
3939784|NCT01377233|3761662|B3|||Age||years|Mean|47.8|47.8|Standard Deviation|6.4|6.4|||
3939785|NCT01377233|3761663|B2|||Age||years|Mean|42.7|42.7|Standard Deviation|11.7|11.7|||
3939786|NCT01377233|3761664|B1|||Age||years|Mean|38.5|38.5|Standard Deviation|6.6|6.6|||
3939787|NCT01377194|3761692|B4|||Body Mass Index (BMI)||Kilograms Per Meter Squared|Mean|28.54|28.54|Standard Deviation|5.35|5.35|||
3939788|NCT01377194|3761693|B3|||Body Mass Index (BMI)||Kilograms Per Meter Squared|Mean|28.71|28.71|Standard Deviation|5.68|5.68|||
3939789|NCT01377194|3761694|B2|||Body Mass Index (BMI)||Kilograms Per Meter Squared|Mean|28.25|28.25|Standard Deviation|5.17|5.17|||
3939790|NCT01377194|3761695|B1|||Body Mass Index (BMI)||Kilograms Per Meter Squared|Mean|28.67|28.67|Standard Deviation|5.19|5.19|||
3939791|NCT01377194|3761692|B4|||Height||cm|Mean|168.84|168.84|Standard Deviation|9.47|9.47|||
3939792|NCT01377194|3761693|B3|||Height||cm|Mean|168.63|168.63|Standard Deviation|8.91|8.91|||
3939793|NCT01377194|3761694|B2|||Height||cm|Mean|169.48|169.48|Standard Deviation|9.79|9.79|||
3939794|NCT01377194|3761695|B1|||Height||cm|Mean|168.41|168.41|Standard Deviation|9.69|9.69|||
3939795|NCT01377194|3761692|B4|||Weight||kg|Mean|81.56|81.56|Standard Deviation|17.45|17.45|||
3939796|NCT01377194|3761693|B3|||Weight||kg|Mean|81.73|81.73|Standard Deviation|17.57|17.57|||
3939797|NCT01377194|3761694|B2|||Weight||kg|Mean|81.35|81.35|Standard Deviation|17.09|17.09|||
3939798|NCT01377194|3761695|B1|||Weight||kg|Mean|81.60|81.6|Standard Deviation|17.77|17.77|||
3939799|NCT01377194|3761692|B4|Canada||Region of Enrollment||participants|Number|22|22.0||||||
3939800|NCT01377194|3761693|B3|Canada||Region of Enrollment||participants|Number|8|8.0||||||
3939801|NCT01377194|3761694|B2|Canada||Region of Enrollment||participants|Number|5|5.0||||||
3939802|NCT01377194|3761695|B1|Canada||Region of Enrollment||participants|Number|9|9.0||||||
3939803|NCT01377194|3761692|B4|United States||Region of Enrollment||participants|Number|540|540.0||||||
3939804|NCT01377194|3761693|B3|United States||Region of Enrollment||participants|Number|180|180.0||||||
3939805|NCT01377194|3761694|B2|United States||Region of Enrollment||participants|Number|183|183.0||||||
3939806|NCT01377194|3761695|B1|United States||Region of Enrollment||participants|Number|177|177.0||||||
3939807|NCT01377194|3761692|B4|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|500|500.0||||||
3939808|NCT01377194|3761693|B3|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|173|173.0||||||
3939809|NCT01377194|3761694|B2|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|164|164.0||||||
3939810|NCT01377194|3761695|B1|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|163|163.0||||||
3939811|NCT01377194|3761692|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
3939812|NCT01377194|3761693|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3939813|NCT01377194|3761694|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3939814|NCT01377194|3761695|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3939815|NCT01377194|3761692|B4|Other Race||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3939816|NCT01377194|3761693|B3|Other Race||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3939817|NCT01377194|3761694|B2|Other Race||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3939818|NCT01377194|3761695|B1|Other Race||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3939819|NCT01377194|3761692|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3939820|NCT01377194|3761693|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3939821|NCT01377194|3761694|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3939822|NCT01377194|3761695|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3939823|NCT01377194|3761692|B4|American Indian of Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3939824|NCT01377194|3761693|B3|American Indian of Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3939825|NCT01377194|3761694|B2|American Indian of Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3939826|NCT01377194|3761695|B1|American Indian of Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3939827|NCT01377194|3761692|B4|Asian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3939828|NCT01377194|3761693|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3939829|NCT01377194|3761694|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3939830|NCT01377194|3761695|B1|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3939831|NCT01377194|3761692|B4|Black or African-American||Race/Ethnicity, Customized||participants|Number|108|108.0||||||
3939832|NCT01377194|3761693|B3|Black or African-American||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3939833|NCT01377194|3761694|B2|Black or African-American||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
3939834|NCT01377194|3761695|B1|Black or African-American||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3939835|NCT01377194|3761692|B4|White||Race/Ethnicity, Customized||participants|Number|416|416.0||||||
3939836|NCT01377194|3761693|B3|White||Race/Ethnicity, Customized||participants|Number|139|139.0||||||
3939837|NCT01377194|3761694|B2|White||Race/Ethnicity, Customized||participants|Number|142|142.0||||||
3939838|NCT01377194|3761695|B1|White||Race/Ethnicity, Customized||participants|Number|135|135.0||||||
3939839|NCT01377194|3761692|B4||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
3939840|NCT01377194|3761693|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3939841|NCT01377194|3761694|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3939842|NCT01377194|3761695|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3939843|NCT01377194|3761692|B4||Female|Sex: Female, Male||Participants|Count of Participants|357|357.0||||||
3939844|NCT01377194|3761693|B3||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3939845|NCT01377194|3761694|B2||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3939846|NCT01377194|3761695|B1||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3939847|NCT01377194|3761692|B4|≥ 60||Age, Customized||participants|Number|60|60.0||||||
3939848|NCT01377194|3761693|B3|≥ 60||Age, Customized||participants|Number|22|22.0||||||
3939849|NCT01377194|3761694|B2|≥ 60||Age, Customized||participants|Number|21|21.0||||||
3939850|NCT01377194|3761695|B1|≥ 60||Age, Customized||participants|Number|17|17.0||||||
3939851|NCT01377194|3761692|B4|≥ 50-59||Age, Customized||participants|Number|121|121.0||||||
3939852|NCT01377194|3761693|B3|≥ 50-59||Age, Customized||participants|Number|36|36.0||||||
3939853|NCT01377194|3761694|B2|≥ 50-59||Age, Customized||participants|Number|42|42.0||||||
3939854|NCT01377194|3761695|B1|≥ 50-59||Age, Customized||participants|Number|43|43.0||||||
3939855|NCT01377194|3761692|B4|≥ 40-49||Age, Customized||participants|Number|147|147.0||||||
3939856|NCT01377194|3761693|B3|≥ 40-49||Age, Customized||participants|Number|53|53.0||||||
3939857|NCT01377194|3761694|B2|≥ 40-49||Age, Customized||participants|Number|49|49.0||||||
3939858|NCT01377194|3761695|B1|≥ 40-49||Age, Customized||participants|Number|45|45.0||||||
3939859|NCT01377194|3761692|B4|≥ 30-39||Age, Customized||participants|Number|127|127.0||||||
3939860|NCT01377194|3761693|B3|≥ 30-39||Age, Customized||participants|Number|44|44.0||||||
3939861|NCT01377194|3761694|B2|≥ 30-39||Age, Customized||participants|Number|40|40.0||||||
3939862|NCT01377194|3761695|B1|≥ 30-39||Age, Customized||participants|Number|43|43.0||||||
3939863|NCT01377194|3761692|B4|≥ 20-29||Age, Customized||participants|Number|98|98.0||||||
3939864|NCT01377194|3761693|B3|≥ 20-29||Age, Customized||participants|Number|28|28.0||||||
3939865|NCT01377194|3761694|B2|≥ 20-29||Age, Customized||participants|Number|35|35.0||||||
3939866|NCT01377194|3761695|B1|≥ 20-29||Age, Customized||participants|Number|35|35.0||||||
3939867|NCT01377194|3761692|B4|< 20||Age, Customized||participants|Number|9|9.0||||||
3939868|NCT01377194|3761693|B3|< 20||Age, Customized||participants|Number|5|5.0||||||
3939869|NCT01377194|3761694|B2|< 20||Age, Customized||participants|Number|1|1.0||||||
3939870|NCT01377194|3761695|B1|< 20||Age, Customized||participants|Number|3|3.0||||||
3939871|NCT01377194|3761692|B4|||Age||years|Mean|42.8|42.8|Standard Deviation|13.1|13.1|||
3939872|NCT01377194|3761693|B3|||Age||years|Mean|43.1|43.1|Standard Deviation|12.8|12.8|||
3939873|NCT01377194|3761694|B2|||Age||years|Mean|42.9|42.9|Standard Deviation|13.4|13.4|||
3939874|NCT01377194|3761695|B1|||Age||years|Mean|42.3|42.3|Standard Deviation|13.2|13.2|||
3939875|NCT01377012|3761708|B4||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3939876|NCT01377012|3761709|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3939877|NCT01377012|3761710|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3939878|NCT01377012|3761711|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3939879|NCT01377012|3761708|B4||Female|Sex: Female, Male||Participants|Count of Participants|556|556.0||||||
3939880|NCT01377012|3761709|B3||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3939881|NCT01377012|3761710|B2||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3939882|NCT01377012|3761711|B1||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
3939883|NCT01377012|3761708|B4|>=65 years||Age, Customized||Particpants|Number|102|102.0||||||
3939884|NCT01377012|3761709|B3|>=65 years||Age, Customized||Particpants|Number|32|32.0||||||
3939885|NCT01377012|3761710|B2|>=65 years||Age, Customized||Particpants|Number|37|37.0||||||
3939886|NCT01377012|3761711|B1|>=65 years||Age, Customized||Particpants|Number|33|33.0||||||
3939887|NCT01377012|3761708|B4|<65 years||Age, Customized||Particpants|Number|535|535.0||||||
3939888|NCT01377012|3761709|B3|<65 years||Age, Customized||Particpants|Number|182|182.0||||||
3939889|NCT01377012|3761710|B2|<65 years||Age, Customized||Particpants|Number|176|176.0||||||
3939890|NCT01377012|3761711|B1|<65 years||Age, Customized||Particpants|Number|177|177.0||||||
3939891|NCT01376908|3761748|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3939892|NCT01376908|3761749|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3939893|NCT01376908|3761750|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3939894|NCT01376908|3761748|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3939895|NCT01376908|3761749|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3939896|NCT01376908|3761750|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3939897|NCT01376908|3761748|B3|||Age||months|Mean|21.2|21.2|Standard Deviation|12.1|12.1|||
3939898|NCT01376908|3761749|B2|||Age||months|Mean|21.2|21.2|Standard Deviation|12.0|12.0|||
3939899|NCT01376908|3761750|B1|||Age||months|Mean|21.1|21.1|Standard Deviation|12.3|12.3|||
3939900|NCT01376804|3761784|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3939901|NCT01376804|3761784|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3939902|NCT01376804|3761784|B1|≥ 12 Years||Age, Customized||Participants|Number|32|32.0||1.3|1.3|||
3939903|NCT01376804|3761784|B1|> 2 to < 12 Years||Age, Customized||Participants|Number|18|18.0||2.5|2.5|||
3939904|NCT01376804|3761784|B1|≤ 2 Years||Age, Customized||Participants|Number|6|6.0||0.5|0.5|||
3939905|NCT01376700|3761795|B1|Germany||Region of Enrollment||participants|Number|2|2.0||||||
3939906|NCT01376700|3761795|B1|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
3939907|NCT01376700|3761795|B1|Bulgaria||Region of Enrollment||participants|Number|1|1.0||||||
3939908|NCT01376700|3761795|B1|Russian Federation||Region of Enrollment||participants|Number|3|3.0||||||
3939909|NCT01376700|3761795|B1|Austria||Region of Enrollment||participants|Number|1|1.0||||||
3939910|NCT01376700|3761795|B1|Poland||Region of Enrollment||participants|Number|4|4.0||||||
3939911|NCT01376700|3761795|B1|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3939912|NCT01376700|3761795|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3939913|NCT01376700|3761795|B1|Czech Republic||Region of Enrollment||participants|Number|2|2.0||||||
3939914|NCT01376700|3761795|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3939915|NCT01376700|3761795|B1|Serbia||Region of Enrollment||participants|Number|1|1.0||||||
3939916|NCT01376700|3761795|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3939917|NCT01376700|3761795|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3939918|NCT01376700|3761795|B1|||Age||weeks|Mean|43.3|43.3|Standard Deviation|10.2|10.2|||
3939919|NCT01376557|3761811|B6|||Body Mass index (BMI)||kg/m^2|Mean|33.08|33.08|Standard Deviation|5.658|5.658|||
3939920|NCT01376557|3761812|B5|||Body Mass index (BMI)||kg/m^2|Mean|32.17|32.17|Standard Deviation|5.796|5.796|||
3939921|NCT01376557|3761813|B4|||Body Mass index (BMI)||kg/m^2|Mean|32.85|32.85|Standard Deviation|5.626|5.626|||
3939922|NCT01376557|3761814|B3|||Body Mass index (BMI)||kg/m^2|Mean|32.69|32.69|Standard Deviation|5.757|5.757|||
3939923|NCT01376557|3761815|B2|||Body Mass index (BMI)||kg/m^2|Mean|34.23|34.23|Standard Deviation|5.816|5.816|||
3939924|NCT01376557|3761816|B1|||Body Mass index (BMI)||kg/m^2|Mean|33.44|33.44|Standard Deviation|5.237|5.237|||
3939925|NCT01376557|3761811|B6|||Weight||kg|Mean|93.73|93.73|Standard Deviation|20.093|20.093|||
3939926|NCT01376557|3761812|B5|||Weight||kg|Mean|90.57|90.57|Standard Deviation|20.726|20.726|||
3939927|NCT01376557|3761813|B4|||Weight||kg|Mean|95.01|95.01|Standard Deviation|22.202|22.202|||
3939928|NCT01376557|3761814|B3|||Weight||kg|Mean|91.38|91.38|Standard Deviation|18.643|18.643|||
3939929|NCT01376557|3761815|B2|||Weight||kg|Mean|95.59|95.59|Standard Deviation|19.368|19.368|||
3939930|NCT01376557|3761816|B1|||Weight||kg|Mean|96.16|96.16|Standard Deviation|19.328|19.328|||
3939931|NCT01376557|3761811|B6|||Height||cm|Mean|167.96|167.96|Standard Deviation|10.486|10.486|||
3939932|NCT01376557|3761812|B5|||Height||cm|Mean|167.18|167.18|Standard Deviation|10.240|10.24|||
3939933|NCT01376557|3761813|B4|||Height||cm|Mean|169.39|169.39|Standard Deviation|11.171|11.171|||
3939934|NCT01376557|3761814|B3|||Height||cm|Mean|167.04|167.04|Standard Deviation|9.849|9.849|||
3939935|NCT01376557|3761815|B2|||Height||cm|Mean|166.99|166.99|Standard Deviation|10.764|10.764|||
3939936|NCT01376557|3761816|B1|||Height||cm|Mean|169.25|169.25|Standard Deviation|10.419|10.419|||
3939937|NCT01376557|3761811|B6|United States||Region of Enrollment||participants|Number|299|299.0||||||
3939938|NCT01376557|3761812|B5|United States||Region of Enrollment||participants|Number|60|60.0||||||
3939939|NCT01376557|3761813|B4|United States||Region of Enrollment||participants|Number|60|60.0||||||
3939940|NCT01376557|3761814|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
3939941|NCT01376557|3761815|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
3939942|NCT01376557|3761816|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
3939943|NCT01376557|3761811|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939944|NCT01376557|3761812|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939945|NCT01376557|3761813|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939946|NCT01376557|3761814|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939947|NCT01376557|3761815|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939948|NCT01376557|3761816|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939949|NCT01376557|3761811|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|217|217.0||||||
3939950|NCT01376557|3761812|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3939951|NCT01376557|3761813|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3939952|NCT01376557|3761814|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3939953|NCT01376557|3761815|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3939954|NCT01376557|3761816|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3939955|NCT01376557|3761811|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3939956|NCT01376557|3761812|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3939957|NCT01376557|3761813|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3939958|NCT01376557|3761814|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3939959|NCT01376557|3761815|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3939960|NCT01376557|3761816|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3939961|NCT01376557|3761811|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3939962|NCT01376557|3761812|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3939963|NCT01376557|3761813|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939964|NCT01376557|3761814|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3939965|NCT01376557|3761815|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939966|NCT01376557|3761816|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3939967|NCT01376557|3761811|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3939968|NCT01376557|3761812|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3939969|NCT01376557|3761813|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939970|NCT01376557|3761814|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3939971|NCT01376557|3761815|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939972|NCT01376557|3761816|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3939973|NCT01376557|3761811|B6||White|Race (NIH/OMB)||Participants|Count of Participants|252|252.0||||||
3939974|NCT01376557|3761812|B5||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3939975|NCT01376557|3761813|B4||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3939976|NCT01376557|3761814|B3||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3939977|NCT01376557|3761815|B2||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3939978|NCT01376557|3761816|B1||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3939979|NCT01376557|3761811|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3939980|NCT01376557|3761812|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3939981|NCT01376557|3761813|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3939982|NCT01376557|3761814|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3939983|NCT01376557|3761815|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3939984|NCT01376557|3761816|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3939985|NCT01376557|3761811|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939986|NCT01376557|3761812|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939987|NCT01376557|3761813|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939988|NCT01376557|3761814|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939989|NCT01376557|3761815|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939990|NCT01376557|3761816|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939991|NCT01376557|3761811|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3939992|NCT01376557|3761812|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3939993|NCT01376557|3761813|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3939994|NCT01376557|3761814|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3939995|NCT01376557|3761815|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939996|NCT01376557|3761816|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3940116|NCT01376297|3761999|B1|White||Race/Ethnicity, Customized||participants|Number|258|258.0||||||
3939997|NCT01376557|3761811|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3939998|NCT01376557|3761812|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3939999|NCT01376557|3761813|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940000|NCT01376557|3761814|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940001|NCT01376557|3761815|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940002|NCT01376557|3761816|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3940003|NCT01376557|3761811|B6||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3940004|NCT01376557|3761812|B5||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3940005|NCT01376557|3761813|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3940006|NCT01376557|3761814|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3940007|NCT01376557|3761815|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3940008|NCT01376557|3761816|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3940009|NCT01376557|3761811|B6||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3940010|NCT01376557|3761812|B5||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3940011|NCT01376557|3761813|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3940012|NCT01376557|3761814|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3940013|NCT01376557|3761815|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3940014|NCT01376557|3761816|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3940015|NCT01376557|3761811|B6|||Age||years|Mean|55.9|55.9|Standard Deviation|9.34|9.34|||
3940016|NCT01376557|3761812|B5|||Age||years|Mean|55.1|55.1|Standard Deviation|9.79|9.79|||
3940017|NCT01376557|3761813|B4|||Age||years|Mean|56.4|56.4|Standard Deviation|8.76|8.76|||
3940018|NCT01376557|3761814|B3|||Age||years|Mean|56.1|56.1|Standard Deviation|9.51|9.51|||
3940019|NCT01376557|3761815|B2|||Age||years|Mean|55.6|55.6|Standard Deviation|9.25|9.25|||
3940020|NCT01376557|3761816|B1|||Age||years|Mean|56.1|56.1|Standard Deviation|9.61|9.61|||
3940021|NCT01376388|3761857|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|130|130.0||||||
3940022|NCT01376388|3761857|B1||Male|Gender||Participants|Count of Participants|120|120.0||||||
3940023|NCT01376388|3761857|B1||Female|Gender||Participants|Count of Participants|10|10.0||||||
3940024|NCT01376388|3761857|B1|||Age||Years|Mean|70.4|70.4|Standard Deviation|7.86|7.86|||
3940025|NCT01376362|3761872|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3940026|NCT01376362|3761872|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3940027|NCT01376362|3761872|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3940028|NCT01376362|3761872|B1|||Age||years|Median|55|55.0|Full Range|12.51|12.51|32.0|63.0|
3940029|NCT01376362|3761872|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3940030|NCT01376362|3761872|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3940031|NCT01376362|3761872|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3940032|NCT01376349|3761892|B4|United States||Region of Enrollment||participants|Number|443|443.0||||||
3940033|NCT01376349|3761893|B3|United States||Region of Enrollment||participants|Number|147|147.0||||||
3940034|NCT01376349|3761894|B2|United States||Region of Enrollment||participants|Number|149|149.0||||||
3940035|NCT01376349|3761895|B1|United States||Region of Enrollment||participants|Number|147|147.0||||||
3940036|NCT01376349|3761892|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3940037|NCT01376349|3761893|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3940038|NCT01376349|3761894|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3940039|NCT01376349|3761895|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3940040|NCT01376349|3761892|B4||Female|Sex: Female, Male||Participants|Count of Participants|443|443.0||||||
3940041|NCT01376349|3761893|B3||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3940042|NCT01376349|3761894|B2||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3940043|NCT01376349|3761895|B1||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3940044|NCT01376349|3761892|B4|||Age||years|Mean|57.3|57.3|Standard Deviation|7.4|7.4|||
3940045|NCT01376349|3761893|B3|||Age||years|Mean|58|58.0|Standard Deviation|7.3|7.3|||
3940046|NCT01376349|3761894|B2|||Age||years|Mean|57.3|57.3|Standard Deviation|8.2|8.2|||
3940047|NCT01376349|3761895|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|6.7|6.7|||
3940048|NCT01376323|3761906|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940049|NCT01376323|3761907|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940050|NCT01376323|3761908|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940051|NCT01376323|3761909|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940052|NCT01376323|3761910|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940053|NCT01376323|3761911|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940054|NCT01376323|3761906|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3940055|NCT01376323|3761907|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940056|NCT01376323|3761908|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3940057|NCT01376323|3761909|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940058|NCT01376323|3761910|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940059|NCT01376323|3761911|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940060|NCT01376323|3761906|B6||White|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3940061|NCT01376323|3761907|B5||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3940062|NCT01376323|3761908|B4||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3940063|NCT01376323|3761909|B3||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3940064|NCT01376323|3761910|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3940065|NCT01376323|3761911|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3940066|NCT01376323|3761906|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3940067|NCT01376323|3761907|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940068|NCT01376323|3761908|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3940069|NCT01376323|3761909|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940070|NCT01376323|3761910|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940071|NCT01376323|3761911|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3940072|NCT01376323|3761906|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940073|NCT01376323|3761907|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940074|NCT01376323|3761908|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940075|NCT01376323|3761909|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940076|NCT01376323|3761910|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940077|NCT01376323|3761911|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940078|NCT01376323|3761906|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3940079|NCT01376323|3761907|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940080|NCT01376323|3761908|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940081|NCT01376323|3761909|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940082|NCT01376323|3761910|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940083|NCT01376323|3761911|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3940084|NCT01376323|3761906|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940085|NCT01376323|3761907|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940086|NCT01376323|3761908|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940087|NCT01376323|3761909|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940088|NCT01376323|3761910|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940089|NCT01376323|3761911|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940090|NCT01376323|3761906|B6||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3940091|NCT01376323|3761907|B5||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3940092|NCT01376323|3761908|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3940093|NCT01376323|3761909|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3940094|NCT01376323|3761910|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3940095|NCT01376323|3761911|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3940096|NCT01376323|3761906|B6||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3940097|NCT01376323|3761907|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3940098|NCT01376323|3761908|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3940099|NCT01376323|3761909|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3940100|NCT01376323|3761910|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3940101|NCT01376323|3761911|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3940102|NCT01376323|3761906|B6|||Age||Years|Mean|58.8|58.8|Standard Deviation|7.01|7.01|||
3940103|NCT01376323|3761907|B5|||Age||Years|Mean|57.1|57.1|Standard Deviation|7.30|7.3|||
3940104|NCT01376323|3761908|B4|||Age||Years|Mean|60.2|60.2|Standard Deviation|6.21|6.21|||
3940105|NCT01376323|3761909|B3|||Age||Years|Mean|59.6|59.6|Standard Deviation|8.07|8.07|||
3940106|NCT01376323|3761910|B2|||Age||Years|Mean|60.0|60.0|Standard Deviation|6.24|6.24|||
3940107|NCT01376323|3761911|B1|||Age||Years|Mean|57.0|57.0|Standard Deviation|7.01|7.01|||
3940108|NCT01376297|3761997|B3|Asian||Race/Ethnicity, Customized||participants|Number|64|64.0||||||
3940109|NCT01376297|3761998|B2|Asian||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3940110|NCT01376297|3761999|B1|Asian||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
3940111|NCT01376297|3761997|B3|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3940112|NCT01376297|3761998|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940113|NCT01376297|3761999|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3940114|NCT01376297|3761997|B3|White||Race/Ethnicity, Customized||participants|Number|345|345.0||||||
3940115|NCT01376297|3761998|B2|White||Race/Ethnicity, Customized||participants|Number|87|87.0||||||
3940117|NCT01376297|3761997|B3||Male|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
3940118|NCT01376297|3761998|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3940119|NCT01376297|3761999|B1||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3940120|NCT01376297|3761997|B3||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
3940121|NCT01376297|3761998|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3940122|NCT01376297|3761999|B1||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3940123|NCT01376297|3761997|B3|||Age||years|Mean|56.6|56.6|Standard Deviation|10.76|10.76|||
3940124|NCT01376297|3761998|B2|||Age||years|Mean|56.9|56.9|Standard Deviation|11.70|11.7|||
3940125|NCT01376297|3761999|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|10.44|10.44|||
3940126|NCT01376245|3762006|B5|Asian - South East Asian||Race/Ethnicity, Customized||Participants|Number|45|45.0||||||
3940127|NCT01376245|3762007|B4|Asian - South East Asian||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3940128|NCT01376245|3762008|B3|Asian - South East Asian||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3940129|NCT01376245|3762009|B2|Asian - South East Asian||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3940130|NCT01376245|3762010|B1|Asian - South East Asian||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3940131|NCT01376245|3762006|B5|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|598|598.0||||||
3940132|NCT01376245|3762007|B4|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|148|148.0||||||
3940133|NCT01376245|3762008|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|150|150.0||||||
3940134|NCT01376245|3762009|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|149|149.0||||||
3940135|NCT01376245|3762010|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|151|151.0||||||
3940136|NCT01376245|3762006|B5||Male|Gender||Participants|Count of Participants|584|584.0||||||
3940137|NCT01376245|3762007|B4||Male|Gender||Participants|Count of Participants|145|145.0||||||
3940138|NCT01376245|3762008|B3||Male|Gender||Participants|Count of Participants|149|149.0||||||
3940139|NCT01376245|3762009|B2||Male|Gender||Participants|Count of Participants|144|144.0||||||
3940140|NCT01376245|3762010|B1||Male|Gender||Participants|Count of Participants|146|146.0||||||
3940141|NCT01376245|3762006|B5||Female|Gender||Participants|Count of Participants|59|59.0||||||
3940142|NCT01376245|3762007|B4||Female|Gender||Participants|Count of Participants|15|15.0||||||
3940143|NCT01376245|3762008|B3||Female|Gender||Participants|Count of Participants|12|12.0||||||
3940144|NCT01376245|3762009|B2||Female|Gender||Participants|Count of Participants|16|16.0||||||
3940145|NCT01376245|3762010|B1||Female|Gender||Participants|Count of Participants|16|16.0||||||
3940146|NCT01376245|3762006|B5|||Age||Years|Mean|64.4|64.4|Standard Deviation|8.80|8.8|||
3940147|NCT01376245|3762007|B4|||Age||Years|Mean|62.7|62.7|Standard Deviation|8.65|8.65|||
3940148|NCT01376245|3762008|B3|||Age||Years|Mean|65.1|65.1|Standard Deviation|9.19|9.19|||
3940149|NCT01376245|3762009|B2|||Age||Years|Mean|65.2|65.2|Standard Deviation|8.41|8.41|||
3940150|NCT01376245|3762010|B1|||Age||Years|Mean|64.7|64.7|Standard Deviation|8.78|8.78|||
3940151|NCT01376167|3762028|B4|Multiple-Amer Ind or Al N/A-Central/South A Her||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3940152|NCT01376167|3762029|B3|Multiple-Amer Ind or Al N/A-Central/South A Her||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3940153|NCT01376167|3762030|B2|Multiple-Amer Ind or Al N/A-Central/South A Her||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3940154|NCT01376167|3762031|B1|Multiple-Amer Ind or Al N/A-Central/South A Her||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3940155|NCT01376167|3762028|B4|Multiple-Afr Amer/Afr Her/White-White/Cau/Eur Her||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3940156|NCT01376167|3762029|B3|Multiple-Afr Amer/Afr Her/White-White/Cau/Eur Her||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3940157|NCT01376167|3762030|B2|Multiple-Afr Amer/Afr Her/White-White/Cau/Eur Her||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3940158|NCT01376167|3762031|B1|Multiple-Afr Amer/Afr Her/White-White/Cau/Eur Her||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3940159|NCT01376167|3762028|B4|Multiple-Afr Amer/Afr Her/Amer Ind or Al N||Race/Ethnicity, Customized||Participants|Count of Participants|189|189.0||||||
3940160|NCT01376167|3762029|B3|Multiple-Afr Amer/Afr Her/Amer Ind or Al N||Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
3940161|NCT01376167|3762030|B2|Multiple-Afr Amer/Afr Her/Amer Ind or Al N||Race/Ethnicity, Customized||Participants|Count of Participants|95|95.0||||||
3940162|NCT01376167|3762031|B1|Multiple-Afr Amer/Afr Her/Amer Ind or Al N||Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
3940163|NCT01376167|3762028|B4|White-White/Caucasian(Cau)/European(Eur) Her||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3940164|NCT01376167|3762029|B3|White-White/Caucasian(Cau)/European(Eur) Her||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3940165|NCT01376167|3762030|B2|White-White/Caucasian(Cau)/European(Eur) Her||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3940166|NCT01376167|3762031|B1|White-White/Caucasian(Cau)/European(Eur) Her||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3940167|NCT01376167|3762028|B4|Black or African (Afr) Amer||Race/Ethnicity, Customized||Participants|Count of Participants|55|55.0||||||
3940168|NCT01376167|3762029|B3|Black or African (Afr) Amer||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3940169|NCT01376167|3762030|B2|Black or African (Afr) Amer||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3940170|NCT01376167|3762031|B1|Black or African (Afr) Amer||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3940171|NCT01376167|3762028|B4|Asian-South East Asian (A) Heritage (Her)||Race/Ethnicity, Customized||Participants|Count of Participants|102|102.0||||||
3940172|NCT01376167|3762029|B3|Asian-South East Asian (A) Heritage (Her)||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3940173|NCT01376167|3762030|B2|Asian-South East Asian (A) Heritage (Her)||Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
3940174|NCT01376167|3762031|B1|Asian-South East Asian (A) Heritage (Her)||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3940175|NCT01376167|3762028|B4|American(Amer) Indian(Ind) or Alaska(Al) Native(N)||Race/Ethnicity, Customized||Participants|Count of Participants|165|165.0||||||
3940176|NCT01376167|3762029|B3|American(Amer) Indian(Ind) or Alaska(Al) Native(N)||Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
3940177|NCT01376167|3762030|B2|American(Amer) Indian(Ind) or Alaska(Al) Native(N)||Race/Ethnicity, Customized||Participants|Count of Participants|81|81.0||||||
3940178|NCT01376167|3762031|B1|American(Amer) Indian(Ind) or Alaska(Al) Native(N)||Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
3940179|NCT01376167|3762028|B4||Male|Sex: Female, Male||Participants|Count of Participants|392|392.0||||||
3940180|NCT01376167|3762029|B3||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3940181|NCT01376167|3762030|B2||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
3940182|NCT01376167|3762031|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3940183|NCT01376167|3762028|B4||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3940184|NCT01376167|3762029|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3940185|NCT01376167|3762030|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3940186|NCT01376167|3762031|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3940187|NCT01376167|3762028|B4|||Age||Years|Mean|35.0|35.0|Standard Deviation|14.29|14.29|||
3940188|NCT01376167|3762029|B3|||Age||Years|Mean|34.7|34.7|Standard Deviation|14.26|14.26|||
3940189|NCT01376167|3762030|B2|||Age||Years|Mean|35.0|35.0|Standard Deviation|14.39|14.39|||
3940190|NCT01376167|3762031|B1|||Age||Years|Mean|35.3|35.3|Standard Deviation|14.23|14.23|||
3940191|NCT01376089|3762102|B3|United Kingdom||Region of Enrollment||participants|Number|14|14.0||||||
3940192|NCT01376089|3762103|B2|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3940193|NCT01376089|3762104|B1|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3940194|NCT01376089|3762102|B3|Spain||Region of Enrollment||participants|Number|70|70.0||||||
3940195|NCT01376089|3762103|B2|Spain||Region of Enrollment||participants|Number|35|35.0||||||
3940196|NCT01376089|3762104|B1|Spain||Region of Enrollment||participants|Number|35|35.0||||||
3940197|NCT01376089|3762102|B3|Germany||Region of Enrollment||participants|Number|88|88.0||||||
3940198|NCT01376089|3762103|B2|Germany||Region of Enrollment||participants|Number|43|43.0||||||
3940199|NCT01376089|3762104|B1|Germany||Region of Enrollment||participants|Number|45|45.0||||||
3940200|NCT01376089|3762102|B3|United States||Region of Enrollment||participants|Number|127|127.0||||||
3940201|NCT01376089|3762103|B2|United States||Region of Enrollment||participants|Number|62|62.0||||||
3940202|NCT01376089|3762104|B1|United States||Region of Enrollment||participants|Number|65|65.0||||||
3940203|NCT01376089|3762102|B3||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3940204|NCT01376089|3762103|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3940205|NCT01376089|3762104|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3940206|NCT01376089|3762102|B3||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3940207|NCT01376089|3762103|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3940208|NCT01376089|3762104|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3940209|NCT01376089|3762102|B3|||Age||years|Mean|58.1|58.1|Standard Deviation|15.10|15.1|||
3940210|NCT01376089|3762103|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|15.02|15.02|||
3940211|NCT01376089|3762104|B1|||Age||years|Mean|57.8|57.8|Standard Deviation|15.23|15.23|||
3940212|NCT01376089|3762102|B3||>=65 years|Age||Participants|Count of Participants|117|117.0||||||
3940213|NCT01376089|3762103|B2||>=65 years|Age||Participants|Count of Participants|57|57.0||||||
3940214|NCT01376089|3762104|B1||>=65 years|Age||Participants|Count of Participants|60|60.0||||||
3940215|NCT01376089|3762102|B3||Between 18 and 65 years|Age||Participants|Count of Participants|182|182.0||||||
3940216|NCT01376089|3762103|B2||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
3940217|NCT01376089|3762104|B1||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
3940218|NCT01376089|3762102|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3940219|NCT01376089|3762103|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3940220|NCT01376089|3762104|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3940221|NCT01376050|3762115|B3|||Visual Analog Scale (VAS) Degree of Ulcer Pain Rating|The Visual Analog Pain Scale (VAS) is one of the three most commonly used scales for assessing pain. The VAS scale ranges from 0 to 100 mm, with 0 indicating no pain and 100 indicating worst pain imaginable. The subject marks on the line the spot for the pain intensity, which is then measured. Subjects in this study were asked to mark the spot on the line that best represented the degree of pain they felt at the study ulcer site at that time.|units on a scale|Mean|38.17|38.17|Standard Deviation|22.93|22.93|||
3940222|NCT01376050|3762116|B2|||Visual Analog Scale (VAS) Degree of Ulcer Pain Rating|The Visual Analog Pain Scale (VAS) is one of the three most commonly used scales for assessing pain. The VAS scale ranges from 0 to 100 mm, with 0 indicating no pain and 100 indicating worst pain imaginable. The subject marks on the line the spot for the pain intensity, which is then measured. Subjects in this study were asked to mark the spot on the line that best represented the degree of pain they felt at the study ulcer site at that time.|units on a scale|Mean|30.45|30.45|Standard Deviation|20.04|20.04|||
3940223|NCT01376050|3762117|B1|||Visual Analog Scale (VAS) Degree of Ulcer Pain Rating|The Visual Analog Pain Scale (VAS) is one of the three most commonly used scales for assessing pain. The VAS scale ranges from 0 to 100 mm, with 0 indicating no pain and 100 indicating worst pain imaginable. The subject marks on the line the spot for the pain intensity, which is then measured. Subjects in this study were asked to mark the spot on the line that best represented the degree of pain they felt at the study ulcer site at that time.|units on a scale|Mean|44.69|44.69|Standard Deviation|23.93|23.93|||
3940224|NCT01376050|3762115|B3|||Ulcer Size|The study ulcer was digitally photographed, and the ulcer size/area calculated in centimeters squared (cm²) using the Aranz Medical SilhouetteMobile™ System, a portable handheld computer device with custom camera and software that enables capturing of a wound image at the point of care.|cm²|Mean|10.53|10.53|Standard Deviation|6.64|6.64|||
3940225|NCT01376050|3762116|B2|||Ulcer Size|The study ulcer was digitally photographed, and the ulcer size/area calculated in centimeters squared (cm²) using the Aranz Medical SilhouetteMobile™ System, a portable handheld computer device with custom camera and software that enables capturing of a wound image at the point of care.|cm²|Mean|11.30|11.3|Standard Deviation|7.55|7.55|||
3940226|NCT01376050|3762117|B1|||Ulcer Size|The study ulcer was digitally photographed, and the ulcer size/area calculated in centimeters squared (cm²) using the Aranz Medical SilhouetteMobile™ System, a portable handheld computer device with custom camera and software that enables capturing of a wound image at the point of care.|cm²|Mean|10.13|10.13|Standard Deviation|6.23|6.23|||
3940227|NCT01376050|3762115|B3|France||Region of Enrollment||participants|Number|24|24.0||||||
3940228|NCT01376050|3762116|B2|France||Region of Enrollment||participants|Number|11|11.0||||||
3940229|NCT01376050|3762117|B1|France||Region of Enrollment||participants|Number|13|13.0||||||
3940230|NCT01376050|3762115|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940231|NCT01376050|3762116|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940232|NCT01376050|3762117|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940233|NCT01376050|3762115|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940234|NCT01376050|3762116|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940235|NCT01376050|3762117|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940236|NCT01376050|3762115|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3940237|NCT01376050|3762116|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3940238|NCT01376050|3762117|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3940239|NCT01376050|3762115|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940240|NCT01376050|3762116|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940241|NCT01376050|3762117|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940242|NCT01376050|3762115|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940243|NCT01376050|3762116|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940244|NCT01376050|3762117|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940245|NCT01376050|3762115|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940246|NCT01376050|3762116|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940247|NCT01376050|3762117|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940248|NCT01376050|3762115|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940249|NCT01376050|3762116|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940250|NCT01376050|3762117|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940251|NCT01376050|3762115|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3940252|NCT01376050|3762116|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3940253|NCT01376050|3762117|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3940254|NCT01376050|3762115|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3940255|NCT01376050|3762116|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3940256|NCT01376050|3762117|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3940257|NCT01376050|3762115|B3|||Age||years|Mean|67.00|67.0|Standard Deviation|13.09|13.09|||
3940258|NCT01376050|3762116|B2|||Age||years|Mean|65.80|65.8|Standard Deviation|11.17|11.17|||
3940259|NCT01376050|3762117|B1|||Age||years|Mean|67.92|67.92|Standard Deviation|14.78|14.78|||
3940260|NCT01376037|3762126|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
3940261|NCT01376037|3762127|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
3940262|NCT01376037|3762128|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
3940263|NCT01376037|3762126|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3940264|NCT01376037|3762127|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3940265|NCT01376037|3762128|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3940266|NCT01376037|3762126|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3940267|NCT01376037|3762127|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3940268|NCT01376037|3762128|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3940269|NCT01376037|3762126|B3|||Age||years|Mean|46.29|46.29|Standard Deviation|11.82|11.82|||
3940270|NCT01376037|3762127|B2|||Age||years|Mean|46.68|46.68|Standard Deviation|13.11|13.11|||
3940271|NCT01376037|3762128|B1|||Age||years|Mean|45.90|45.9|Standard Deviation|10.59|10.59|||
3940272|NCT01376037|3762126|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3940273|NCT01376037|3762127|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3940274|NCT01376037|3762128|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3940275|NCT01376037|3762126|B3||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
3940276|NCT01376037|3762127|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3940277|NCT01376037|3762128|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3940278|NCT01376037|3762126|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3940279|NCT01376037|3762127|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3940280|NCT01376037|3762128|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3940281|NCT01375946|3762135|B1|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3940282|NCT01375946|3762135|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3940283|NCT01375946|3762135|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3940284|NCT01375946|3762135|B1|||Age||years|Mean|35.13|35.13|Standard Deviation|6.469|6.469|||
3940285|NCT01375946|3762135|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3940286|NCT01375946|3762135|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3940287|NCT01375946|3762135|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3940288|NCT01375777|3762148|B10|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|0.738|0.738|Standard Deviation|0.196|0.196|||
3940289|NCT01375777|3762149|B9|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|0.758|0.758|Standard Deviation|0.191|0.191|||
3940290|NCT01375777|3762150|B8|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|0.706|0.706|Standard Deviation|0.185|0.185|||
3940291|NCT01375777|3762151|B7|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|0.751|0.751|Standard Deviation|0.161|0.161|||
3940292|NCT01375777|3762152|B6|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|0.709|0.709|Standard Deviation|0.175|0.175|||
3940293|NCT01375777|3762153|B5|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|0.744|0.744|Standard Deviation|0.168|0.168|||
3940294|NCT01375777|3762154|B4|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|0.705|0.705|Standard Deviation|0.161|0.161|||
3940295|NCT01375777|3762155|B3|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|0.752|0.752|Standard Deviation|0.176|0.176|||
3940296|NCT01375777|3762156|B2|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|0.785|0.785|Standard Deviation|0.322|0.322|||
3940297|NCT01375777|3762157|B1|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|0.729|0.729|Standard Deviation|0.180|0.18|||
3940298|NCT01375777|3762148|B10|||Total Cholesterol/HDL-C Ratio||ratio|Mean|4.512|4.512|Standard Deviation|1.351|1.351|||
3940299|NCT01375777|3762149|B9|||Total Cholesterol/HDL-C Ratio||ratio|Mean|4.741|4.741|Standard Deviation|1.656|1.656|||
3940300|NCT01375777|3762150|B8|||Total Cholesterol/HDL-C Ratio||ratio|Mean|4.335|4.335|Standard Deviation|1.282|1.282|||
3940301|NCT01375777|3762151|B7|||Total Cholesterol/HDL-C Ratio||ratio|Mean|4.500|4.5|Standard Deviation|1.154|1.154|||
3940302|NCT01375777|3762152|B6|||Total Cholesterol/HDL-C Ratio||ratio|Mean|4.181|4.181|Standard Deviation|1.131|1.131|||
3940303|NCT01375777|3762153|B5|||Total Cholesterol/HDL-C Ratio||ratio|Mean|4.571|4.571|Standard Deviation|1.269|1.269|||
3940304|NCT01375777|3762154|B4|||Total Cholesterol/HDL-C Ratio||ratio|Mean|4.335|4.335|Standard Deviation|1.090|1.09|||
3940305|NCT01375777|3762155|B3|||Total Cholesterol/HDL-C Ratio||ratio|Mean|4.670|4.67|Standard Deviation|1.258|1.258|||
3940306|NCT01375777|3762156|B2|||Total Cholesterol/HDL-C Ratio||ratio|Mean|4.793|4.793|Standard Deviation|1.836|1.836|||
3940307|NCT01375777|3762157|B1|||Total Cholesterol/HDL-C Ratio||ratio|Mean|4.477|4.477|Standard Deviation|1.293|1.293|||
3940308|NCT01375777|3762148|B10|||Apolipoprotein B Concentration||mg/dL|Mean|109.1|109.1|Standard Deviation|16.5|16.5|||
3940309|NCT01375777|3762149|B9|||Apolipoprotein B Concentration||mg/dL|Mean|110.2|110.2|Standard Deviation|18.4|18.4|||
3940310|NCT01375777|3762150|B8|||Apolipoprotein B Concentration||mg/dL|Mean|105.8|105.8|Standard Deviation|15.9|15.9|||
3940311|NCT01375777|3762151|B7|||Apolipoprotein B Concentration||mg/dL|Mean|109.2|109.2|Standard Deviation|15.7|15.7|||
3940312|NCT01375777|3762152|B6|||Apolipoprotein B Concentration||mg/dL|Mean|107.2|107.2|Standard Deviation|16.3|16.3|||
3940313|NCT01375777|3762153|B5|||Apolipoprotein B Concentration||mg/dL|Mean|108.5|108.5|Standard Deviation|15.2|15.2|||
3940314|NCT01375777|3762154|B4|||Apolipoprotein B Concentration||mg/dL|Mean|108.7|108.7|Standard Deviation|15.7|15.7|||
3940315|NCT01375777|3762155|B3|||Apolipoprotein B Concentration||mg/dL|Mean|109.9|109.9|Standard Deviation|17.7|17.7|||
3940316|NCT01375777|3762156|B2|||Apolipoprotein B Concentration||mg/dL|Mean|110.4|110.4|Standard Deviation|17.2|17.2|||
3940317|NCT01375777|3762157|B1|||Apolipoprotein B Concentration||mg/dL|Mean|111.7|111.7|Standard Deviation|17.1|17.1|||
3940318|NCT01375777|3762148|B10|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|167.8|167.8|Standard Deviation|27.4|27.4|||
3940319|NCT01375777|3762149|B9|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|167.9|167.9|Standard Deviation|29.6|29.6|||
3940320|NCT01375777|3762150|B8|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|161.1|161.1|Standard Deviation|26.1|26.1|||
3940321|NCT01375777|3762151|B7|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|166.3|166.3|Standard Deviation|27.8|27.8|||
3940322|NCT01375777|3762152|B6|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|163.8|163.8|Standard Deviation|23.7|23.7|||
3940323|NCT01375777|3762153|B5|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|169.2|169.2|Standard Deviation|24.3|24.3|||
3940324|NCT01375777|3762154|B4|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|169.0|169.0|Standard Deviation|24.5|24.5|||
3940325|NCT01375777|3762155|B3|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|170.0|170.0|Standard Deviation|32.0|32.0|||
3940326|NCT01375777|3762156|B2|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|169.1|169.1|Standard Deviation|27.7|27.7|||
3940327|NCT01375777|3762157|B1|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|173.8|173.8|Standard Deviation|30.5|30.5|||
3940328|NCT01375777|3762148|B10|||LDL-C Concentration||mg/dL|Mean|141.6|141.6|Standard Deviation|22.3|22.3|||
3940329|NCT01375777|3762149|B9|||LDL-C Concentration||mg/dL|Mean|138.9|138.9|Standard Deviation|21.9|21.9|||
3940330|NCT01375777|3762150|B8|||LDL-C Concentration||mg/dL|Mean|136.6|136.6|Standard Deviation|20.8|20.8|||
3940331|NCT01375777|3762151|B7|||LDL-C Concentration||mg/dL|Mean|141.1|141.1|Standard Deviation|21.8|21.8|||
3940332|NCT01375777|3762152|B6|||LDL-C Concentration||mg/dL|Mean|139.8|139.8|Standard Deviation|21.1|21.1|||
3940333|NCT01375777|3762153|B5|||LDL-C Concentration||mg/dL|Mean|141.5|141.5|Standard Deviation|22.3|22.3|||
3940334|NCT01375777|3762154|B4|||LDL-C Concentration||mg/dL|Mean|143.1|143.1|Standard Deviation|21.7|21.7|||
3940335|NCT01375777|3762155|B3|||LDL-C Concentration||mg/dL|Mean|144.2|144.2|Standard Deviation|25.8|25.8|||
3940336|NCT01375777|3762156|B2|||LDL-C Concentration||mg/dL|Mean|142.3|142.3|Standard Deviation|24.3|24.3|||
3940337|NCT01375777|3762157|B1|||LDL-C Concentration||mg/dL|Mean|147.0|147.0|Standard Deviation|21.0|21.0|||
3940338|NCT01375777|3762148|B10|≥ 130 mg/dL||Stratification Factor: LDL-C level||participants|Number|275|275.0||||||
3940339|NCT01375777|3762149|B9|≥ 130 mg/dL||Stratification Factor: LDL-C level||participants|Number|31|31.0||||||
3940340|NCT01375777|3762150|B8|≥ 130 mg/dL||Stratification Factor: LDL-C level||participants|Number|30|30.0||||||
3940341|NCT01375777|3762151|B7|≥ 130 mg/dL||Stratification Factor: LDL-C level||participants|Number|30|30.0||||||
3940342|NCT01375777|3762152|B6|≥ 130 mg/dL||Stratification Factor: LDL-C level||participants|Number|31|31.0||||||
3940343|NCT01375777|3762153|B5|≥ 130 mg/dL||Stratification Factor: LDL-C level||participants|Number|31|31.0||||||
3940344|NCT01375777|3762154|B4|≥ 130 mg/dL||Stratification Factor: LDL-C level||participants|Number|31|31.0||||||
3940345|NCT01375777|3762155|B3|≥ 130 mg/dL||Stratification Factor: LDL-C level||participants|Number|30|30.0||||||
3940346|NCT01375777|3762156|B2|≥ 130 mg/dL||Stratification Factor: LDL-C level||participants|Number|31|31.0||||||
3940347|NCT01375777|3762157|B1|≥ 130 mg/dL||Stratification Factor: LDL-C level||participants|Number|30|30.0||||||
3940348|NCT01375777|3762148|B10|< 130 mg/dL||Stratification Factor: LDL-C level||participants|Number|131|131.0||||||
3940349|NCT01375777|3762149|B9|< 130 mg/dL||Stratification Factor: LDL-C level||participants|Number|14|14.0||||||
3940350|NCT01375777|3762150|B8|< 130 mg/dL||Stratification Factor: LDL-C level||participants|Number|15|15.0||||||
3940351|NCT01375777|3762151|B7|< 130 mg/dL||Stratification Factor: LDL-C level||participants|Number|15|15.0||||||
3940352|NCT01375777|3762152|B6|< 130 mg/dL||Stratification Factor: LDL-C level||participants|Number|14|14.0||||||
3940353|NCT01375777|3762153|B5|< 130 mg/dL||Stratification Factor: LDL-C level||participants|Number|15|15.0||||||
3940354|NCT01375777|3762154|B4|< 130 mg/dL||Stratification Factor: LDL-C level||participants|Number|14|14.0||||||
3940355|NCT01375777|3762155|B3|< 130 mg/dL||Stratification Factor: LDL-C level||participants|Number|15|15.0||||||
3940356|NCT01375777|3762156|B2|< 130 mg/dL||Stratification Factor: LDL-C level||participants|Number|14|14.0||||||
3940357|NCT01375777|3762157|B1|< 130 mg/dL||Stratification Factor: LDL-C level||participants|Number|15|15.0||||||
3940358|NCT01375777|3762148|B10|ot Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|350|350.0||||||
3940359|NCT01375777|3762149|B9|ot Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3940360|NCT01375777|3762150|B8|ot Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
3940361|NCT01375777|3762151|B7|ot Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
3940362|NCT01375777|3762152|B6|ot Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
3940363|NCT01375777|3762153|B5|ot Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
3940364|NCT01375777|3762154|B4|ot Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
3940365|NCT01375777|3762155|B3|ot Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
3940366|NCT01375777|3762156|B2|ot Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
3940367|NCT01375777|3762157|B1|ot Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
3940368|NCT01375777|3762148|B10|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
3940369|NCT01375777|3762149|B9|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3940370|NCT01375777|3762150|B8|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3940371|NCT01375777|3762151|B7|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3940372|NCT01375777|3762152|B6|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3940373|NCT01375777|3762153|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3940374|NCT01375777|3762154|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3940375|NCT01375777|3762155|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3940376|NCT01375777|3762156|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3940377|NCT01375777|3762157|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3940378|NCT01375777|3762148|B10|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3940379|NCT01375777|3762149|B9|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940380|NCT01375777|3762150|B8|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940381|NCT01375777|3762151|B7|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940382|NCT01375777|3762152|B6|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940383|NCT01375777|3762153|B5|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940384|NCT01375777|3762154|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3940385|NCT01375777|3762155|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940386|NCT01375777|3762156|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940387|NCT01375777|3762157|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940388|NCT01375777|3762148|B10|White||Race/Ethnicity, Customized||participants|Number|319|319.0||||||
3940389|NCT01375777|3762149|B9|White||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
3940390|NCT01375777|3762150|B8|White||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3940391|NCT01375777|3762151|B7|White||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3940392|NCT01375777|3762152|B6|White||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
3940393|NCT01375777|3762153|B5|White||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
3940394|NCT01375777|3762154|B4|White||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
3940395|NCT01375777|3762155|B3|White||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3940396|NCT01375777|3762156|B2|White||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3940397|NCT01375777|3762157|B1|White||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3940398|NCT01375777|3762148|B10|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3940399|NCT01375777|3762149|B9|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940400|NCT01375777|3762150|B8|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940401|NCT01375777|3762151|B7|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940402|NCT01375777|3762152|B6|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940403|NCT01375777|3762153|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3940404|NCT01375777|3762154|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940405|NCT01375777|3762155|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940406|NCT01375777|3762156|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3940407|NCT01375777|3762157|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940408|NCT01375777|3762148|B10|Black or African American||Race/Ethnicity, Customized||participants|Number|64|64.0||||||
3940409|NCT01375777|3762149|B9|Black or African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3940410|NCT01375777|3762150|B8|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3940411|NCT01375777|3762151|B7|Black or African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3940412|NCT01375777|3762152|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3940413|NCT01375777|3762153|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3940414|NCT01375777|3762154|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3940415|NCT01375777|3762155|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3940416|NCT01375777|3762156|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3940417|NCT01375777|3762157|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3940418|NCT01375777|3762148|B10|Asian||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3940419|NCT01375777|3762149|B9|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3940420|NCT01375777|3762150|B8|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3940421|NCT01375777|3762151|B7|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3940422|NCT01375777|3762152|B6|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3940423|NCT01375777|3762153|B5|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3940424|NCT01375777|3762154|B4|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3940425|NCT01375777|3762155|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3940426|NCT01375777|3762156|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3940427|NCT01375777|3762157|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3940428|NCT01375777|3762148|B10|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3940429|NCT01375777|3762149|B9|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940430|NCT01375777|3762150|B8|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3940431|NCT01375777|3762151|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3940432|NCT01375777|3762152|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940433|NCT01375777|3762153|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940434|NCT01375777|3762154|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3940435|NCT01375777|3762155|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940436|NCT01375777|3762156|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940437|NCT01375777|3762157|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940438|NCT01375777|3762148|B10||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3940439|NCT01375777|3762149|B9||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3940440|NCT01375777|3762150|B8||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3940441|NCT01375777|3762151|B7||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3940442|NCT01375777|3762152|B6||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3940443|NCT01375777|3762153|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3940444|NCT01375777|3762154|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3940445|NCT01375777|3762155|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3940446|NCT01375777|3762156|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3940447|NCT01375777|3762157|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3940448|NCT01375777|3762148|B10||Female|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
3940449|NCT01375777|3762149|B9||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3940450|NCT01375777|3762150|B8||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3940451|NCT01375777|3762151|B7||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3940452|NCT01375777|3762152|B6||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3940453|NCT01375777|3762153|B5||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3940454|NCT01375777|3762154|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3940455|NCT01375777|3762155|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3940456|NCT01375777|3762156|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3940457|NCT01375777|3762157|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3940458|NCT01375777|3762148|B10|||Age||years|Mean|50.6|50.6|Standard Deviation|11.8|11.8|||
3940459|NCT01375777|3762149|B9|||Age||years|Mean|50.1|50.1|Standard Deviation|12.0|12.0|||
3940460|NCT01375777|3762150|B8|||Age||years|Mean|50.9|50.9|Standard Deviation|13.1|13.1|||
3940461|NCT01375777|3762151|B7|||Age||years|Mean|49.3|49.3|Standard Deviation|10.3|10.3|||
3940462|NCT01375777|3762152|B6|||Age||years|Mean|52.8|52.8|Standard Deviation|11.6|11.6|||
3940463|NCT01375777|3762153|B5|||Age||years|Mean|48.3|48.3|Standard Deviation|11.8|11.8|||
3940464|NCT01375777|3762154|B4|||Age||years|Mean|50.9|50.9|Standard Deviation|12.9|12.9|||
3940465|NCT01375777|3762155|B3|||Age||years|Mean|50.0|50.0|Standard Deviation|12.0|12.0|||
3940466|NCT01375777|3762156|B2|||Age||years|Mean|50.7|50.7|Standard Deviation|12.6|12.6|||
3940467|NCT01375777|3762157|B1|||Age||years|Mean|52.5|52.5|Standard Deviation|9.8|9.8|||
3940468|NCT01375764|3762230|B6|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|0.921|0.921|Standard Deviation|0.319|0.319|||
3940469|NCT01375764|3762231|B5|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|1.055|1.055|Standard Deviation|0.388|0.388|||
3940470|NCT01375764|3762232|B4|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|0.916|0.916|Standard Deviation|0.332|0.332|||
3940471|NCT01375764|3762233|B3|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|0.906|0.906|Standard Deviation|0.265|0.265|||
3940472|NCT01375764|3762234|B2|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|0.882|0.882|Standard Deviation|0.332|0.332|||
3940473|NCT01375764|3762235|B1|||Apolipoprotein B/Apolipoprotein A-1 Ratio||ratio|Mean|0.841|0.841|Standard Deviation|0.230|0.23|||
3940474|NCT01375764|3762230|B6|||Total Cholesterol/HDL-C Ratio||ratio|Mean|5.438|5.438|Standard Deviation|2.265|2.265|||
3940475|NCT01375764|3762231|B5|||Total Cholesterol/HDL-C Ratio||ratio|Mean|6.438|6.438|Standard Deviation|2.834|2.834|||
3940476|NCT01375764|3762232|B4|||Total Cholesterol/HDL-C Ratio||ratio|Mean|5.444|5.444|Standard Deviation|2.308|2.308|||
3940477|NCT01375764|3762233|B3|||Total Cholesterol/HDL-C Ratio||ratio|Mean|5.287|5.287|Standard Deviation|1.816|1.816|||
3940478|NCT01375764|3762234|B2|||Total Cholesterol/HDL-C Ratio||ratio|Mean|5.093|5.093|Standard Deviation|2.416|2.416|||
3940479|NCT01375764|3762235|B1|||Total Cholesterol/HDL-C Ratio||ratio|Mean|4.907|4.907|Standard Deviation|1.553|1.553|||
3940480|NCT01375764|3762230|B6|||Apolipoprotein B Concentration||mg/dL|Mean|143.2|143.2|Standard Deviation|30.9|30.9|||
3940481|NCT01375764|3762231|B5|||Apolipoprotein B Concentration||mg/dL|Mean|150.8|150.8|Standard Deviation|34.1|34.1|||
3940482|NCT01375764|3762232|B4|||Apolipoprotein B Concentration||mg/dL|Mean|144.9|144.9|Standard Deviation|33.9|33.9|||
3940483|NCT01375764|3762233|B3|||Apolipoprotein B Concentration||mg/dL|Mean|143.0|143.0|Standard Deviation|30.6|30.6|||
3940484|NCT01375764|3762234|B2|||Apolipoprotein B Concentration||mg/dL|Mean|138.8|138.8|Standard Deviation|33.1|33.1|||
3940485|NCT01375764|3762235|B1|||Apolipoprotein B Concentration||mg/dL|Mean|138.0|138.0|Standard Deviation|21.7|21.7|||
3940486|NCT01375764|3762230|B6|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|224.6|224.6|Standard Deviation|55.3|55.3|||
3940487|NCT01375764|3762231|B5|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|240.6|240.6|Standard Deviation|63.9|63.9|||
3940488|NCT01375764|3762232|B4|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|222.9|222.9|Standard Deviation|55.8|55.8|||
3940489|NCT01375764|3762233|B3|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|225.5|225.5|Standard Deviation|53.3|53.3|||
3940490|NCT01375764|3762234|B2|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|219.8|219.8|Standard Deviation|60.5|60.5|||
3940491|NCT01375764|3762235|B1|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|213.7|213.7|Standard Deviation|40.4|40.4|||
3940492|NCT01375764|3762230|B6|||LDL-C Concentration||mg/dL|Mean|193.2|193.2|Standard Deviation|51.0|51.0|||
3940493|NCT01375764|3762231|B5|||LDL-C Concentration||mg/dL|Mean|203.5|203.5|Standard Deviation|60.3|60.3|||
3940494|NCT01375764|3762232|B4|||LDL-C Concentration||mg/dL|Mean|190.3|190.3|Standard Deviation|47.8|47.8|||
3940495|NCT01375764|3762233|B3|||LDL-C Concentration||mg/dL|Mean|194.8|194.8|Standard Deviation|48.1|48.1|||
3940496|NCT01375764|3762234|B2|||LDL-C Concentration||mg/dL|Mean|194.4|194.4|Standard Deviation|60.1|60.1|||
3940497|NCT01375764|3762235|B1|||LDL-C Concentration||mg/dL|Mean|182.9|182.9|Standard Deviation|36.4|36.4|||
3940498|NCT01375764|3762230|B6|Yes||Stratification Factor: Baseline Use of Statin||participants|Number|24|24.0||||||
3940499|NCT01375764|3762231|B5|Yes||Stratification Factor: Baseline Use of Statin||participants|Number|5|5.0||||||
3940500|NCT01375764|3762232|B4|Yes||Stratification Factor: Baseline Use of Statin||participants|Number|4|4.0||||||
3940501|NCT01375764|3762233|B3|Yes||Stratification Factor: Baseline Use of Statin||participants|Number|5|5.0||||||
3940502|NCT01375764|3762234|B2|Yes||Stratification Factor: Baseline Use of Statin||participants|Number|4|4.0||||||
3940503|NCT01375764|3762235|B1|Yes||Stratification Factor: Baseline Use of Statin||participants|Number|6|6.0||||||
3940504|NCT01375764|3762230|B6|No||Stratification Factor: Baseline Use of Statin||participants|Number|133|133.0||||||
3940505|NCT01375764|3762231|B5|No||Stratification Factor: Baseline Use of Statin||participants|Number|27|27.0||||||
3940506|NCT01375764|3762232|B4|No||Stratification Factor: Baseline Use of Statin||participants|Number|27|27.0||||||
3940507|NCT01375764|3762233|B3|No||Stratification Factor: Baseline Use of Statin||participants|Number|27|27.0||||||
3940508|NCT01375764|3762234|B2|No||Stratification Factor: Baseline Use of Statin||participants|Number|26|26.0||||||
3940509|NCT01375764|3762235|B1|No||Stratification Factor: Baseline Use of Statin||participants|Number|26|26.0||||||
3940510|NCT01375764|3762230|B6|≥ 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|148|148.0||||||
3940511|NCT01375764|3762231|B5|≥ 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|30|30.0||||||
3940512|NCT01375764|3762232|B4|≥ 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|29|29.0||||||
3940513|NCT01375764|3762233|B3|≥ 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|30|30.0||||||
3940514|NCT01375764|3762234|B2|≥ 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|29|29.0||||||
3940515|NCT01375764|3762235|B1|≥ 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|30|30.0||||||
3940516|NCT01375764|3762230|B6|< 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|9|9.0||||||
3940517|NCT01375764|3762231|B5|< 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|2|2.0||||||
3940518|NCT01375764|3762232|B4|< 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|2|2.0||||||
3940519|NCT01375764|3762233|B3|< 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|2|2.0||||||
3940520|NCT01375764|3762234|B2|< 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|1|1.0||||||
3940521|NCT01375764|3762235|B1|< 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|2|2.0||||||
3940522|NCT01375764|3762230|B6|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|155|155.0||||||
3940523|NCT01375764|3762231|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3940524|NCT01375764|3762232|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3940525|NCT01375764|3762233|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3940526|NCT01375764|3762234|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3940527|NCT01375764|3762235|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3940528|NCT01375764|3762230|B6|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3940529|NCT01375764|3762231|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940530|NCT01375764|3762232|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940531|NCT01375764|3762233|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940532|NCT01375764|3762234|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940533|NCT01375764|3762235|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3940534|NCT01375764|3762230|B6|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3940535|NCT01375764|3762231|B5|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940536|NCT01375764|3762232|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940537|NCT01375764|3762233|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3940538|NCT01375764|3762234|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940539|NCT01375764|3762235|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940540|NCT01375764|3762230|B6|White||Race/Ethnicity, Customized||participants|Number|139|139.0||||||
3940541|NCT01375764|3762231|B5|White||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3940542|NCT01375764|3762232|B4|White||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3940543|NCT01375764|3762233|B3|White||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3940544|NCT01375764|3762234|B2|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3940545|NCT01375764|3762235|B1|White||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3940546|NCT01375764|3762230|B6|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3940547|NCT01375764|3762231|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3940548|NCT01375764|3762232|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940549|NCT01375764|3762233|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940550|NCT01375764|3762234|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940551|NCT01375764|3762235|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940552|NCT01375764|3762230|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3940553|NCT01375764|3762231|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3940554|NCT01375764|3762232|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3940555|NCT01375764|3762233|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3940556|NCT01375764|3762234|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3940557|NCT01375764|3762235|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3940558|NCT01375764|3762230|B6|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3940559|NCT01375764|3762231|B5|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940560|NCT01375764|3762232|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940561|NCT01375764|3762233|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3940562|NCT01375764|3762234|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3940563|NCT01375764|3762235|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3940564|NCT01375764|3762230|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940565|NCT01375764|3762231|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940566|NCT01375764|3762232|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940567|NCT01375764|3762233|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940568|NCT01375764|3762234|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940569|NCT01375764|3762235|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940570|NCT01375764|3762230|B6||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3940571|NCT01375764|3762231|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3940572|NCT01375764|3762232|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3940573|NCT01375764|3762233|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3940574|NCT01375764|3762234|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3940575|NCT01375764|3762235|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3940576|NCT01375764|3762230|B6||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3940577|NCT01375764|3762231|B5||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3940578|NCT01375764|3762232|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3940579|NCT01375764|3762233|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3940580|NCT01375764|3762234|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3940581|NCT01375764|3762235|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3940582|NCT01375764|3762230|B6|||Age||years|Mean|61.8|61.8|Standard Deviation|8.4|8.4|||
3940583|NCT01375764|3762231|B5|||Age||years|Mean|60.0|60.0|Standard Deviation|8.6|8.6|||
3940584|NCT01375764|3762232|B4|||Age||years|Mean|62.3|62.3|Standard Deviation|9.1|9.1|||
3940585|NCT01375764|3762233|B3|||Age||years|Mean|62.2|62.2|Standard Deviation|10.1|10.1|||
3940586|NCT01375764|3762234|B2|||Age||years|Mean|62.0|62.0|Standard Deviation|7.2|7.2|||
3940587|NCT01375764|3762235|B1|||Age||years|Mean|62.4|62.4|Standard Deviation|6.6|6.6|||
3940588|NCT01375751|3762282|B4|||Apolipoprotein B/Apolipoprotein A1 Ratio||ratio|Mean|0.899|0.899|Standard Deviation|0.274|0.274|||
3940589|NCT01375751|3762283|B3|||Apolipoprotein B/Apolipoprotein A1 Ratio||ratio|Mean|0.867|0.867|Standard Deviation|0.264|0.264|||
3940590|NCT01375751|3762284|B2|||Apolipoprotein B/Apolipoprotein A1 Ratio||ratio|Mean|0.901|0.901|Standard Deviation|0.286|0.286|||
3940591|NCT01375751|3762285|B1|||Apolipoprotein B/Apolipoprotein A1 Ratio||ratio|Mean|0.899|0.899|Standard Deviation|0.277|0.277|||
3940592|NCT01375751|3762282|B4|||Total Cholesterol/HDL-C Ratio||ratio|Mean|4.956|4.956|Standard Deviation|1.795|1.795|||
3940593|NCT01375751|3762283|B3|||Total Cholesterol/HDL-C Ratio||ratio|Mean|4.857|4.857|Standard Deviation|1.688|1.688|||
3940594|NCT01375751|3762284|B2|||Total Cholesterol/HDL-C Ratio||ratio|Mean|5.119|5.119|Standard Deviation|1.923|1.923|||
3940595|NCT01375751|3762285|B1|||Total Cholesterol/HDL-C Ratio||ratio|Mean|4.895|4.895|Standard Deviation|1.790|1.79|||
3940596|NCT01375751|3762282|B4|||Apolipoprotein B Concentration||mg/dL|Mean|121.8|121.8|Standard Deviation|29.0|29.0|||
3940597|NCT01375751|3762283|B3|||Apolipoprotein B Concentration||mg/dL|Mean|119.3|119.3|Standard Deviation|27.6|27.6|||
3940598|NCT01375751|3762284|B2|||Apolipoprotein B Concentration||mg/dL|Mean|120.9|120.9|Standard Deviation|29.3|29.3|||
3940599|NCT01375751|3762285|B1|||Apolipoprotein B Concentration||mg/dL|Mean|125.2|125.2|Standard Deviation|30.3|30.3|||
3940600|NCT01375751|3762282|B4|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|177.2|177.2|Standard Deviation|49.4|49.4|||
3940601|NCT01375751|3762283|B3|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|171.0|171.0|Standard Deviation|43.6|43.6|||
3940602|NCT01375751|3762284|B2|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|178.0|178.0|Standard Deviation|51.7|51.7|||
3940603|NCT01375751|3762285|B1|||Non-High-Density Lipoprotein Cholesterol (non-HDL-C) Concentration||mg/dL|Mean|182.7|182.7|Standard Deviation|52.6|52.6|||
3940604|NCT01375751|3762282|B4|||LDL-C Concentration|LDL-C was measured using ultacentrifugation|mg/dL|Mean|155.7|155.7|Standard Deviation|42.3|42.3|||
3940605|NCT01375751|3762283|B3|||LDL-C Concentration|LDL-C was measured using ultacentrifugation|mg/dL|Mean|149.5|149.5|Standard Deviation|36.3|36.3|||
3940606|NCT01375751|3762284|B2|||LDL-C Concentration|LDL-C was measured using ultacentrifugation|mg/dL|Mean|156.8|156.8|Standard Deviation|46.1|46.1|||
3940607|NCT01375751|3762285|B1|||LDL-C Concentration|LDL-C was measured using ultacentrifugation|mg/dL|Mean|160.8|160.8|Standard Deviation|44.0|44.0|||
3940608|NCT01375751|3762282|B4|Yes||Stratification Factor: Baseline Use Of Ezetimibe||participants|Number|108|108.0||||||
3940609|NCT01375751|3762283|B3|Yes||Stratification Factor: Baseline Use Of Ezetimibe||participants|Number|36|36.0||||||
3940610|NCT01375751|3762284|B2|Yes||Stratification Factor: Baseline Use Of Ezetimibe||participants|Number|36|36.0||||||
3940611|NCT01375751|3762285|B1|Yes||Stratification Factor: Baseline Use Of Ezetimibe||participants|Number|36|36.0||||||
3940612|NCT01375751|3762282|B4|No||Stratification Factor: Baseline Use Of Ezetimibe||participants|Number|59|59.0||||||
3940613|NCT01375751|3762283|B3|No||Stratification Factor: Baseline Use Of Ezetimibe||participants|Number|20|20.0||||||
3940614|NCT01375751|3762284|B2|No||Stratification Factor: Baseline Use Of Ezetimibe||participants|Number|19|19.0||||||
3940615|NCT01375751|3762285|B1|No||Stratification Factor: Baseline Use Of Ezetimibe||participants|Number|20|20.0||||||
3940616|NCT01375751|3762282|B4|≥ 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|112|112.0||||||
3940617|NCT01375751|3762283|B3|≥ 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|37|37.0||||||
3940618|NCT01375751|3762284|B2|≥ 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|38|38.0||||||
3940619|NCT01375751|3762285|B1|≥ 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|37|37.0||||||
3940620|NCT01375751|3762282|B4|< 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|55|55.0||||||
3940621|NCT01375751|3762283|B3|< 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|19|19.0||||||
3940622|NCT01375751|3762284|B2|< 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|17|17.0||||||
3940623|NCT01375751|3762285|B1|< 130 mg/dL||Stratification Factor: LDL-C Level||participants|Number|19|19.0||||||
3940624|NCT01375751|3762282|B4|Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3940625|NCT01375751|3762283|B3|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940626|NCT01375751|3762284|B2|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940627|NCT01375751|3762285|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3940628|NCT01375751|3762282|B4|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3940629|NCT01375751|3762283|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940630|NCT01375751|3762284|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3940631|NCT01375751|3762285|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3940632|NCT01375751|3762282|B4|White||Race/Ethnicity, Customized||participants|Number|148|148.0||||||
3940633|NCT01375751|3762283|B3|White||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
3940634|NCT01375751|3762284|B2|White||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
3940635|NCT01375751|3762285|B1|White||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
3940636|NCT01375751|3762282|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3940637|NCT01375751|3762283|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3940638|NCT01375751|3762284|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3940639|NCT01375751|3762285|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940640|NCT01375751|3762282|B4|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3940641|NCT01375751|3762283|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3940642|NCT01375751|3762284|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3940643|NCT01375751|3762285|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3940644|NCT01375751|3762282|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|165|165.0||||||
3940645|NCT01375751|3762283|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
3940646|NCT01375751|3762284|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
3940647|NCT01375751|3762285|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
3940648|NCT01375751|3762282|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3940649|NCT01375751|3762283|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940650|NCT01375751|3762284|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940651|NCT01375751|3762285|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3940652|NCT01375751|3762282|B4||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3940653|NCT01375751|3762283|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3940654|NCT01375751|3762284|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3940655|NCT01375751|3762285|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3940656|NCT01375751|3762282|B4||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3940657|NCT01375751|3762283|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3940658|NCT01375751|3762284|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3940659|NCT01375751|3762285|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3940660|NCT01375751|3762282|B4|||Age||years|Mean|49.6|49.6|Standard Deviation|12.7|12.7|||
3940661|NCT01375751|3762283|B3|||Age||years|Mean|51.8|51.8|Standard Deviation|13.0|13.0|||
3940662|NCT01375751|3762284|B2|||Age||years|Mean|47.6|47.6|Standard Deviation|13.6|13.6|||
3940663|NCT01375751|3762285|B1|||Age||years|Mean|49.3|49.3|Standard Deviation|11.3|11.3|||
3940664|NCT01375660|3762310|B3|||Vit D||ng/ml|Mean|14.3|14.3|Standard Deviation|4.8|4.8|||
3940665|NCT01375660|3762311|B2|||Vit D||ng/ml|Mean|14.7|14.7|Standard Deviation|4.7|4.7|||
3940666|NCT01375660|3762312|B1|||Vit D||ng/ml|Mean|14.0|14.0|Standard Deviation|4.8|4.8|||
3940667|NCT01375660|3762310|B3|||HbA1c||Percentage of A1C|Mean|6.1|6.1|Standard Deviation|0.26|0.26|||
3940668|NCT01375660|3762311|B2|||HbA1c||Percentage of A1C|Mean|6.1|6.1|Standard Deviation|0.26|0.26|||
3940669|NCT01375660|3762312|B1|||HbA1c||Percentage of A1C|Mean|6.1|6.1|Standard Deviation|0.20|0.2|||
3940670|NCT01375660|3762310|B3|||BMI||Kg/m2|Mean|31.9|31.9|Standard Deviation|2.65|2.65|||
3940671|NCT01375660|3762311|B2|||BMI||Kg/m2|Mean|32.4|32.4|Standard Deviation|2.9|2.9|||
3940672|NCT01375660|3762312|B1|||BMI||Kg/m2|Mean|31.5|31.5|Standard Deviation|2.4|2.4|||
3940673|NCT01375660|3762310|B3|United States||Region of Enrollment||participants|Number|173|173.0||||||
3940674|NCT01375660|3762311|B2|United States||Region of Enrollment||participants|Number|87|87.0||||||
3940675|NCT01375660|3762312|B1|United States||Region of Enrollment||participants|Number|86|86.0||||||
3940676|NCT01375660|3762310|B3|African American Male Veterans||Race/Ethnicity, Customized||participants|Number|173|173.0||||||
3940677|NCT01375660|3762311|B2|African American Male Veterans||Race/Ethnicity, Customized||participants|Number|87|87.0||||||
3940678|NCT01375660|3762312|B1|African American Male Veterans||Race/Ethnicity, Customized||participants|Number|86|86.0||||||
3940679|NCT01375660|3762310|B3|Male||Sex/Gender, Customized||participants|Number|173|173.0||||||
3940680|NCT01375660|3762311|B2|Male||Sex/Gender, Customized||participants|Number|87|87.0||||||
3940681|NCT01375660|3762312|B1|Male||Sex/Gender, Customized||participants|Number|86|86.0||||||
3940682|NCT01375660|3762310|B3|35-85 Years||Age, Customized||participants|Number|173|173.0||||||
3940683|NCT01375660|3762311|B2|35-85 Years||Age, Customized||participants|Number|87|87.0||||||
3940684|NCT01375660|3762312|B1|35-85 Years||Age, Customized||participants|Number|86|86.0||||||
3940685|NCT01375608|3762331|B1|||fetal hemoglobin||%|Mean|4.8|4.8|Full Range|||1.0|13.5|
3940686|NCT01375608|3762331|B1|||total hemoglobin||g/dL|Mean|8.14|8.14|Full Range|||4.9|12.0|
3940687|NCT01375608|3762331|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940688|NCT01375608|3762331|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940689|NCT01375608|3762331|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940690|NCT01375608|3762331|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3940691|NCT01375608|3762331|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940692|NCT01375608|3762331|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940693|NCT01375608|3762331|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940694|NCT01375608|3762331|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
3940695|NCT01375608|3762331|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
3940696|NCT01375608|3762331|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3940697|NCT01375608|3762331|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3940698|NCT01375608|3762331|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3940699|NCT01375569|3762335|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3940700|NCT01375569|3762335|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940701|NCT01375569|3762335|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940702|NCT01375569|3762335|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3940703|NCT01375569|3762335|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3940704|NCT01375569|3762335|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940705|NCT01375569|3762335|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3940706|NCT01375569|3762335|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940707|NCT01375569|3762335|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940708|NCT01375569|3762335|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3940709|NCT01375569|3762335|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940710|NCT01375569|3762335|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3940711|NCT01375569|3762335|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3940712|NCT01375569|3762335|B1|||Age||years|Mean|54.46|54.46|Standard Deviation|12.8|12.8|||
3940713|NCT01375569|3762335|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3940714|NCT01375569|3762335|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3940715|NCT01375569|3762335|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3940716|NCT01375374|3762340|B1|||Body Mass Index||kilogram per square meter|Mean|25.89|25.89|Standard Deviation|3.01|3.01|||
3940717|NCT01375374|3762340|B1|||Height||centimeters|Mean|178.05|178.05|Standard Deviation|10.14|10.14|||
3940718|NCT01375374|3762340|B1|||Weight||kilograms|Mean|82.81|82.81|Standard Deviation|16.25|16.25|||
3940719|NCT01375374|3762340|B1|Other/Mixed||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3940720|NCT01375374|3762340|B1|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3940721|NCT01375374|3762340|B1|Native Hawaiin or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940722|NCT01375374|3762340|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940723|NCT01375374|3762340|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3940724|NCT01375374|3762340|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3940725|NCT01375374|3762340|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3940726|NCT01375374|3762340|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3940727|NCT01375374|3762340|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3940728|NCT01375374|3762340|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3940729|NCT01375374|3762340|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3940730|NCT01375374|3762340|B1|||Age||years|Mean|31.5|31.5|Standard Deviation|5.9|5.9|||
3940731|NCT01375127|3762347|B7||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3940732|NCT01375127|3762348|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3940733|NCT01375127|3762349|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3940734|NCT01375127|3762350|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3940735|NCT01375127|3762351|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3940736|NCT01375127|3762352|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3940737|NCT01375127|3762353|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3940738|NCT01375127|3762347|B7||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3940739|NCT01375127|3762348|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3940740|NCT01375127|3762349|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3940741|NCT01375127|3762350|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3940742|NCT01375127|3762351|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3940743|NCT01375127|3762352|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3940744|NCT01375127|3762353|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3940745|NCT01375127|3762347|B7|||Age||years|Mean|45.8|45.8|Standard Deviation|13.0|13.0|||
3940746|NCT01375127|3762348|B6|||Age||years|Mean|36.7|36.7|Standard Deviation|3.1|3.1|||
3940747|NCT01375127|3762349|B5|||Age||years|Mean|46.8|46.8|Standard Deviation|8.5|8.5|||
3940748|NCT01375127|3762350|B4|||Age||years|Mean|45.3|45.3|Standard Deviation|13.1|13.1|||
3940749|NCT01375127|3762351|B3|||Age||years|Mean|46.8|46.8|Standard Deviation|13.2|13.2|||
3940750|NCT01375127|3762352|B2|||Age||years|Mean|26.0|26.0|Standard Deviation|||||
3940751|NCT01375127|3762353|B1|||Age||years|Mean|67.0|67.0|Standard Deviation|||||
3940752|NCT01375075|3762390|B7|||Pulse Rate||beats per minute (bpm)|Mean|68.8|68.8|Standard Deviation|9.26|9.26|||
3940753|NCT01375075|3762391|B6|||Pulse Rate||beats per minute (bpm)|Mean|72.4|72.4|Standard Deviation|8.90|8.9|||
3940754|NCT01375075|3762392|B5|||Pulse Rate||beats per minute (bpm)|Mean|68.4|68.4|Standard Deviation|8.14|8.14|||
3940755|NCT01375075|3762393|B4|||Pulse Rate||beats per minute (bpm)|Mean|67.3|67.3|Standard Deviation|11.15|11.15|||
3940756|NCT01375075|3762394|B3|||Pulse Rate||beats per minute (bpm)|Mean|68.2|68.2|Standard Deviation|10.41|10.41|||
3940757|NCT01375075|3762395|B2|||Pulse Rate||beats per minute (bpm)|Mean|67.7|67.7|Standard Deviation|7.45|7.45|||
3940758|NCT01375075|3762396|B1|||Pulse Rate||beats per minute (bpm)|Mean|68.4|68.4|Standard Deviation|8.90|8.9|||
3940759|NCT01375075|3762390|B7|||Diastolic Blood Pressure||millimeters of mercury (mm Hg)|Mean|74.0|74.0|Standard Deviation|8.37|8.37|||
3940760|NCT01375075|3762391|B6|||Diastolic Blood Pressure||millimeters of mercury (mm Hg)|Mean|71.8|71.8|Standard Deviation|8.52|8.52|||
3940761|NCT01375075|3762392|B5|||Diastolic Blood Pressure||millimeters of mercury (mm Hg)|Mean|75.4|75.4|Standard Deviation|7.58|7.58|||
3940762|NCT01375075|3762393|B4|||Diastolic Blood Pressure||millimeters of mercury (mm Hg)|Mean|75.1|75.1|Standard Deviation|7.32|7.32|||
3940763|NCT01375075|3762394|B3|||Diastolic Blood Pressure||millimeters of mercury (mm Hg)|Mean|74.3|74.3|Standard Deviation|9.77|9.77|||
3940764|NCT01375075|3762395|B2|||Diastolic Blood Pressure||millimeters of mercury (mm Hg)|Mean|74.0|74.0|Standard Deviation|9.57|9.57|||
3940765|NCT01375075|3762396|B1|||Diastolic Blood Pressure||millimeters of mercury (mm Hg)|Mean|73.7|73.7|Standard Deviation|7.32|7.32|||
3940766|NCT01375075|3762390|B7|||Systolic Blood Pressure||millimeters of mercury (mm Hg)|Mean|118.5|118.5|Standard Deviation|11.84|11.84|||
3940767|NCT01375075|3762391|B6|||Systolic Blood Pressure||millimeters of mercury (mm Hg)|Mean|116.9|116.9|Standard Deviation|13.31|13.31|||
3940768|NCT01375075|3762392|B5|||Systolic Blood Pressure||millimeters of mercury (mm Hg)|Mean|119.6|119.6|Standard Deviation|9.82|9.82|||
3940769|NCT01375075|3762393|B4|||Systolic Blood Pressure||millimeters of mercury (mm Hg)|Mean|119.5|119.5|Standard Deviation|11.67|11.67|||
3940770|NCT01375075|3762394|B3|||Systolic Blood Pressure||millimeters of mercury (mm Hg)|Mean|118.4|118.4|Standard Deviation|12.61|12.61|||
3940771|NCT01375075|3762395|B2|||Systolic Blood Pressure||millimeters of mercury (mm Hg)|Mean|117.7|117.7|Standard Deviation|12.41|12.41|||
3940772|NCT01375075|3762396|B1|||Systolic Blood Pressure||millimeters of mercury (mm Hg)|Mean|118.8|118.8|Standard Deviation|11.75|11.75|||
3940773|NCT01375075|3762390|B7|||Fasting Triglycerides (TG)||milligrams per deciliter (mg/dL)|Mean|143.4|143.4|Standard Deviation|69.27|69.27|||
3940774|NCT01375075|3762391|B6|||Fasting Triglycerides (TG)||milligrams per deciliter (mg/dL)|Mean|144.3|144.3|Standard Deviation|75.32|75.32|||
3940775|NCT01375075|3762392|B5|||Fasting Triglycerides (TG)||milligrams per deciliter (mg/dL)|Mean|143.1|143.1|Standard Deviation|60.02|60.02|||
3940776|NCT01375075|3762393|B4|||Fasting Triglycerides (TG)||milligrams per deciliter (mg/dL)|Mean|138.9|138.9|Standard Deviation|64.56|64.56|||
3940777|NCT01375075|3762394|B3|||Fasting Triglycerides (TG)||milligrams per deciliter (mg/dL)|Mean|145.4|145.4|Standard Deviation|79.14|79.14|||
3940778|NCT01375075|3762395|B2|||Fasting Triglycerides (TG)||milligrams per deciliter (mg/dL)|Mean|133.1|133.1|Standard Deviation|64.75|64.75|||
3940779|NCT01375075|3762396|B1|||Fasting Triglycerides (TG)||milligrams per deciliter (mg/dL)|Mean|156.1|156.1|Standard Deviation|74.31|74.31|||
3940780|NCT01375075|3762390|B7|||High-Density Lipoprotein Cholesterol (HDL-C)||milligrams per deciliter (mg/dL)|Mean|50.5|50.5|Standard Deviation|13.77|13.77|||
3940781|NCT01375075|3762391|B6|||High-Density Lipoprotein Cholesterol (HDL-C)||milligrams per deciliter (mg/dL)|Mean|51.7|51.7|Standard Deviation|14.47|14.47|||
3940782|NCT01375075|3762392|B5|||High-Density Lipoprotein Cholesterol (HDL-C)||milligrams per deciliter (mg/dL)|Mean|48.9|48.9|Standard Deviation|13.70|13.7|||
3940783|NCT01375075|3762393|B4|||High-Density Lipoprotein Cholesterol (HDL-C)||milligrams per deciliter (mg/dL)|Mean|50.7|50.7|Standard Deviation|14.39|14.39|||
3940784|NCT01375075|3762394|B3|||High-Density Lipoprotein Cholesterol (HDL-C)||milligrams per deciliter (mg/dL)|Mean|49.2|49.2|Standard Deviation|11.41|11.41|||
3940785|NCT01375075|3762395|B2|||High-Density Lipoprotein Cholesterol (HDL-C)||milligrams per deciliter (mg/dL)|Mean|52.1|52.1|Standard Deviation|16.15|16.15|||
3940786|NCT01375075|3762396|B1|||High-Density Lipoprotein Cholesterol (HDL-C)||milligrams per deciliter (mg/dL)|Mean|50.2|50.2|Standard Deviation|12.88|12.88|||
3940787|NCT01375075|3762390|B7|||Low-Density Lipoprotein Cholesterol (LDL-C)||milligrams per deciliter (mg/dL)|Mean|140.7|140.7|Standard Deviation|26.12|26.12|||
3940788|NCT01375075|3762391|B6|||Low-Density Lipoprotein Cholesterol (LDL-C)||milligrams per deciliter (mg/dL)|Mean|139.6|139.6|Standard Deviation|19.84|19.84|||
3940789|NCT01375075|3762392|B5|||Low-Density Lipoprotein Cholesterol (LDL-C)||milligrams per deciliter (mg/dL)|Mean|134.3|134.3|Standard Deviation|31.78|31.78|||
3940790|NCT01375075|3762393|B4|||Low-Density Lipoprotein Cholesterol (LDL-C)||milligrams per deciliter (mg/dL)|Mean|140.1|140.1|Standard Deviation|27.37|27.37|||
3940791|NCT01375075|3762394|B3|||Low-Density Lipoprotein Cholesterol (LDL-C)||milligrams per deciliter (mg/dL)|Mean|142.6|142.6|Standard Deviation|30.16|30.16|||
3940792|NCT01375075|3762395|B2|||Low-Density Lipoprotein Cholesterol (LDL-C)||milligrams per deciliter (mg/dL)|Mean|143.6|143.6|Standard Deviation|23.05|23.05|||
3940793|NCT01375075|3762396|B1|||Low-Density Lipoprotein Cholesterol (LDL-C)||milligrams per deciliter (mg/dL)|Mean|143.9|143.9|Standard Deviation|24.02|24.02|||
3940794|NCT01375075|3762390|B7|||Body Mass Index (BMI)||kilograms per square meter (kg/m²)|Mean|24.7|24.7|Standard Deviation|3.93|3.93|||
3940795|NCT01375075|3762391|B6|||Body Mass Index (BMI)||kilograms per square meter (kg/m²)|Mean|25.5|25.5|Standard Deviation|5.49|5.49|||
3940796|NCT01375075|3762392|B5|||Body Mass Index (BMI)||kilograms per square meter (kg/m²)|Mean|24.1|24.1|Standard Deviation|3.35|3.35|||
3940797|NCT01375075|3762393|B4|||Body Mass Index (BMI)||kilograms per square meter (kg/m²)|Mean|25.1|25.1|Standard Deviation|3.70|3.7|||
3940798|NCT01375075|3762394|B3|||Body Mass Index (BMI)||kilograms per square meter (kg/m²)|Mean|24.5|24.5|Standard Deviation|4.10|4.1|||
3940799|NCT01375075|3762395|B2|||Body Mass Index (BMI)||kilograms per square meter (kg/m²)|Mean|24.0|24.0|Standard Deviation|3.15|3.15|||
3940800|NCT01375075|3762396|B1|||Body Mass Index (BMI)||kilograms per square meter (kg/m²)|Mean|24.9|24.9|Standard Deviation|3.38|3.38|||
3940801|NCT01375075|3762390|B7|||Height||centimeters (cm)|Mean|165.7|165.7|Standard Deviation|8.68|8.68|||
3940802|NCT01375075|3762391|B6|||Height||centimeters (cm)|Mean|165.2|165.2|Standard Deviation|8.34|8.34|||
3940803|NCT01375075|3762392|B5|||Height||centimeters (cm)|Mean|166.7|166.7|Standard Deviation|6.76|6.76|||
3940804|NCT01375075|3762393|B4|||Height||centimeters (cm)|Mean|165.6|165.6|Standard Deviation|8.56|8.56|||
3940805|NCT01375075|3762394|B3|||Height||centimeters (cm)|Mean|166.5|166.5|Standard Deviation|9.27|9.27|||
3940806|NCT01375075|3762395|B2|||Height||centimeters (cm)|Mean|165.4|165.4|Standard Deviation|9.95|9.95|||
3940807|NCT01375075|3762396|B1|||Height||centimeters (cm)|Mean|165.1|165.1|Standard Deviation|9.48|9.48|||
3940808|NCT01375075|3762390|B7|||Weight||kilograms (kg)|Mean|68.3|68.3|Standard Deviation|14.34|14.34|||
3940809|NCT01375075|3762391|B6|||Weight||kilograms (kg)|Mean|70.3|70.3|Standard Deviation|18.33|18.33|||
3940810|NCT01375075|3762392|B5|||Weight||kilograms (kg)|Mean|67.4|67.4|Standard Deviation|12.77|12.77|||
3940811|NCT01375075|3762393|B4|||Weight||kilograms (kg)|Mean|69.3|69.3|Standard Deviation|13.51|13.51|||
3940812|NCT01375075|3762394|B3|||Weight||kilograms (kg)|Mean|68.5|68.5|Standard Deviation|15.71|15.71|||
3940813|NCT01375075|3762395|B2|||Weight||kilograms (kg)|Mean|65.9|65.9|Standard Deviation|11.58|11.58|||
3940814|NCT01375075|3762396|B1|||Weight||kilograms (kg)|Mean|68.5|68.5|Standard Deviation|14.04|14.04|||
3940815|NCT01375075|3762390|B7|Japan||Region of Enrollment||Participants|Count of Participants|165|165.0||||||
3940816|NCT01375075|3762391|B6|Japan||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3940817|NCT01375075|3762392|B5|Japan||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3940818|NCT01375075|3762393|B4|Japan||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3940819|NCT01375075|3762394|B3|Japan||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3940820|NCT01375075|3762395|B2|Japan||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3940821|NCT01375075|3762396|B1|Japan||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3940822|NCT01375075|3762390|B7|Japanese||Race/Ethnicity, Customized||Participants|Count of Participants|165|165.0||||||
3940823|NCT01375075|3762391|B6|Japanese||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3940824|NCT01375075|3762392|B5|Japanese||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3940825|NCT01375075|3762393|B4|Japanese||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3940826|NCT01375075|3762394|B3|Japanese||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3940827|NCT01375075|3762395|B2|Japanese||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3940828|NCT01375075|3762396|B1|Japanese||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3940829|NCT01375075|3762390|B7||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3940830|NCT01375075|3762391|B6||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3940831|NCT01375075|3762392|B5||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3940832|NCT01375075|3762393|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3940833|NCT01375075|3762394|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3940834|NCT01375075|3762395|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3940835|NCT01375075|3762396|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3940836|NCT01375075|3762390|B7||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3940837|NCT01375075|3762391|B6||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3940838|NCT01375075|3762392|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3940839|NCT01375075|3762393|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3940840|NCT01375075|3762394|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3940841|NCT01375075|3762395|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3940842|NCT01375075|3762396|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3940843|NCT01375075|3762390|B7|||Age||years|Mean|49.2|49.2|Standard Deviation|9.88|9.88|||
3940844|NCT01375075|3762391|B6|||Age||years|Mean|50.0|50.0|Standard Deviation|10.01|10.01|||
3940845|NCT01375075|3762392|B5|||Age||years|Mean|49.4|49.4|Standard Deviation|8.76|8.76|||
3940846|NCT01375075|3762393|B4|||Age||years|Mean|50.3|50.3|Standard Deviation|9.63|9.63|||
3940847|NCT01375075|3762394|B3|||Age||years|Mean|49.4|49.4|Standard Deviation|8.10|8.1|||
3940848|NCT01375075|3762395|B2|||Age||years|Mean|47.6|47.6|Standard Deviation|11.94|11.94|||
3940849|NCT01375075|3762396|B1|||Age||years|Mean|48.6|48.6|Standard Deviation|10.95|10.95|||
3940850|NCT01375049|3762485|B1|Absent at baseline||Presence of Pseudomonas aeruginosa (PA)|Of the 105 participants in the safety analysis set, 3 participants did not provide baseline samples (ie, oropharyngeal swab sample). All participants had a positive PA culture within 30 days of baseline.|participants|Number|57|57.0||||||
3940851|NCT01375049|3762485|B1|Present at baseline||Presence of Pseudomonas aeruginosa (PA)|Of the 105 participants in the safety analysis set, 3 participants did not provide baseline samples (ie, oropharyngeal swab sample). All participants had a positive PA culture within 30 days of baseline.|participants|Number|45|45.0||||||
3940852|NCT01375049|3762485|B1|||BMI||kg/m^2|Mean|17.1|17.1|Standard Deviation|2.57|2.57|||
3940853|NCT01375049|3762485|B1|||Height||cm|Mean|113.9|113.9|Standard Deviation|33.02|33.02|||
3940854|NCT01375049|3762485|B1|||Weight||kg|Mean|24.8|24.8|Standard Deviation|15.69|15.69|||
3940855|NCT01375049|3762485|B1|Italy||Region of Enrollment||participants|Number|5|5.0||||||
3940856|NCT01375049|3762485|B1|Germany||Region of Enrollment||participants|Number|4|4.0||||||
3940857|NCT01375049|3762485|B1|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
3940858|NCT01375049|3762485|B1|Austria||Region of Enrollment||participants|Number|3|3.0||||||
3940859|NCT01375049|3762485|B1|Belgium||Region of Enrollment||participants|Number|11|11.0||||||
3940860|NCT01375049|3762485|B1|Poland||Region of Enrollment||participants|Number|3|3.0||||||
3940861|NCT01375049|3762485|B1|Spain||Region of Enrollment||participants|Number|6|6.0||||||
3940862|NCT01375049|3762485|B1|United States||Region of Enrollment||participants|Number|56|56.0||||||
3940863|NCT01375049|3762485|B1|France||Region of Enrollment||participants|Number|12|12.0||||||
3940864|NCT01375049|3762485|B1|Not Permitted to be Recorded||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3940865|NCT01375049|3762485|B1|Not Hispanic||Race/Ethnicity, Customized||participants|Number|93|93.0||||||
3940866|NCT01375049|3762485|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3940867|NCT01375049|3762485|B1|Not Permitted to be Recorded||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3940868|NCT01375049|3762485|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3940869|NCT01375049|3762485|B1|White||Race/Ethnicity, Customized||participants|Number|99|99.0||||||
3940870|NCT01375049|3762485|B1|Black or African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3940871|NCT01375049|3762485|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3940872|NCT01375049|3762485|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3940873|NCT01375049|3762485|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3940874|NCT01375049|3762485|B1|≥ 6 years to < 18 years||Age, Customized||participants|Number|56|56.0||||||
3940875|NCT01375049|3762485|B1|≥ 2 years to < 6 years||Age, Customized||participants|Number|25|25.0||||||
3940876|NCT01375049|3762485|B1|3 months to < 2 years||Age, Customized||participants|Number|24|24.0||||||
3940877|NCT01375049|3762485|B1|||Age||years|Mean|6.26|6.26|Standard Deviation|4.743|4.743|||
3940878|NCT01374971|3762500|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3940879|NCT01374971|3762500|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3940880|NCT01374971|3762500|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3940881|NCT01374971|3762500|B1|>18 years of age||Age, Customized||years|Number|12|12.0||||||
3940882|NCT01374919|3762505|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
3940883|NCT01374919|3762505|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3940884|NCT01374919|3762505|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3940885|NCT01374919|3762505|B1|||Age||years|Mean|53.4|53.4|Full Range|67|67.0|22.0|89.0|
3940886|NCT01374919|3762505|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3940887|NCT01374919|3762505|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3940888|NCT01374919|3762505|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3940889|NCT01374906|3762510|B3|Other||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3940890|NCT01374906|3762511|B2|Other||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3940891|NCT01374906|3762512|B1|Other||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3940892|NCT01374906|3762510|B3|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3940893|NCT01374906|3762511|B2|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3940894|NCT01374906|3762512|B1|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3940895|NCT01374906|3762510|B3|Asian||Race/Ethnicity, Customized||Participants|Number|51|51.0||||||
3940896|NCT01374906|3762511|B2|Asian||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
3940897|NCT01374906|3762512|B1|Asian||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
3940898|NCT01374906|3762510|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|83|83.0||||||
3940899|NCT01374906|3762511|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|44|44.0||||||
3940900|NCT01374906|3762512|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|39|39.0||||||
3940901|NCT01374906|3762510|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3940902|NCT01374906|3762511|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3940903|NCT01374906|3762512|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3940904|NCT01374906|3762510|B3||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3940905|NCT01374906|3762511|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3940906|NCT01374906|3762512|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3940907|NCT01374906|3762510|B3|||Age||years|Mean|38.5|38.5|Standard Deviation|12.72|12.72|||
3940908|NCT01374906|3762511|B2|||Age||years|Mean|38.6|38.6|Standard Deviation|12.99|12.99|||
3940909|NCT01374906|3762512|B1|||Age||years|Mean|38.3|38.3|Standard Deviation|12.52|12.52|||
3940910|NCT01374802|3762580|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3940911|NCT01374802|3762580|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3940912|NCT01374802|3762580|B1|||Age||years|Mean|40.4|40.4|Standard Deviation|9.9|9.9|||
3940913|NCT01374568|3762592|B3|||Diastolic Blood Pressure||mmHg|Median|78|78.0|Standard Deviation|7.0|7.0|||
3940914|NCT01374568|3762593|B2|||Diastolic Blood Pressure||mmHg|Median|78|78.0|Standard Deviation|6.2|6.2|||
3940915|NCT01374568|3762594|B1|||Diastolic Blood Pressure||mmHg|Median|82|82.0|Standard Deviation|8|8.0|||
3940916|NCT01374568|3762592|B3|||Systolic Blood Pressure||mmHg|Median|130|130.0|Standard Deviation|12.4|12.4|||
3940917|NCT01374568|3762593|B2|||Systolic Blood Pressure||mmHg|Median|130|130.0|Standard Deviation|10.0|10.0|||
3940918|NCT01374568|3762594|B1|||Systolic Blood Pressure||mmHg|Median|119|119.0|Standard Deviation|11.0|11.0|||
3940919|NCT01374568|3762592|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3940920|NCT01374568|3762593|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3940921|NCT01374568|3762594|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3940922|NCT01374568|3762592|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940923|NCT01374568|3762593|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940924|NCT01374568|3762594|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940925|NCT01374568|3762592|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940926|NCT01374568|3762593|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940927|NCT01374568|3762594|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940928|NCT01374568|3762592|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3940929|NCT01374568|3762593|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940930|NCT01374568|3762594|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3940931|NCT01374568|3762592|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3940932|NCT01374568|3762593|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3940933|NCT01374568|3762594|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3940934|NCT01374568|3762592|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940935|NCT01374568|3762593|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940936|NCT01374568|3762594|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940937|NCT01374568|3762592|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940938|NCT01374568|3762593|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940939|NCT01374568|3762594|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940940|NCT01374568|3762592|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940941|NCT01374568|3762593|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940942|NCT01374568|3762594|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940943|NCT01374568|3762592|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3940944|NCT01374568|3762593|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3940945|NCT01374568|3762594|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3940946|NCT01374568|3762592|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3940947|NCT01374568|3762593|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3940948|NCT01374568|3762594|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3940949|NCT01374568|3762592|B3|||Age||years|Median|61.0|61.0|Standard Deviation|8.6|8.6|||
3940950|NCT01374568|3762593|B2|||Age||years|Median|61.0|61.0|Standard Deviation|8.3|8.3|||
3940951|NCT01374568|3762594|B1|||Age||years|Median|57.5|57.5|Standard Deviation|6.5|6.5|||
3940952|NCT01374451|3762603|B3||Male|Gender||Participants|Count of Participants|86|86.0||||||
3940953|NCT01374451|3762604|B2||Male|Gender||Participants|Count of Participants|47|47.0||||||
3940954|NCT01374451|3762605|B1||Male|Gender||Participants|Count of Participants|39|39.0||||||
3940955|NCT01374451|3762603|B3||Female|Gender||Participants|Count of Participants|74|74.0||||||
3940956|NCT01374451|3762604|B2||Female|Gender||Participants|Count of Participants|34|34.0||||||
3940957|NCT01374451|3762605|B1||Female|Gender||Participants|Count of Participants|40|40.0||||||
3940958|NCT01374451|3762603|B3|||Age||Years|Mean|57.38|57.38|Standard Deviation|12.314|12.314|||
3940959|NCT01374451|3762604|B2|||Age||Years|Mean|58.22|58.22|Standard Deviation|12.650|12.65|||
3940960|NCT01374451|3762605|B1|||Age||Years|Mean|56.52|56.52|Standard Deviation|11.978|11.978|||
3940961|NCT01374438|3762633|B3|||Mini-Mental State Examination Score|Screening Mini-Mental State Examination Score, Mean (SD). Possible scores range between 0 and 30. Scores ≥27 indicate normal cognition, 19-24 indicate mild impairment, 10-18 indicate moderate impairment, and scores ≤9 indicate severe impairment.|units on a scale|Mean|23.9|23.9|Standard Deviation|2.6|2.6|||
3940962|NCT01374438|3762634|B2|||Mini-Mental State Examination Score|Screening Mini-Mental State Examination Score, Mean (SD). Possible scores range between 0 and 30. Scores ≥27 indicate normal cognition, 19-24 indicate mild impairment, 10-18 indicate moderate impairment, and scores ≤9 indicate severe impairment.|units on a scale|Mean|25.2|25.2|Standard Deviation|2.1|2.1|||
3940963|NCT01374438|3762635|B1|||Mini-Mental State Examination Score|Screening Mini-Mental State Examination Score, Mean (SD). Possible scores range between 0 and 30. Scores ≥27 indicate normal cognition, 19-24 indicate mild impairment, 10-18 indicate moderate impairment, and scores ≤9 indicate severe impairment.|units on a scale|Mean|22.8|22.8|Standard Deviation|2.4|2.4|||
3940964|NCT01374438|3762633|B3|Apo E e4 allelle absent||Presence of an Apolipoprotein E e4 allele||participants|Number|10|10.0||||||
3940965|NCT01374438|3762634|B2|Apo E e4 allelle absent||Presence of an Apolipoprotein E e4 allele||participants|Number|4|4.0||||||
3940966|NCT01374438|3762635|B1|Apo E e4 allelle absent||Presence of an Apolipoprotein E e4 allele||participants|Number|6|6.0||||||
3940967|NCT01374438|3762633|B3|Apo E e4 allele present||Presence of an Apolipoprotein E e4 allele||participants|Number|19|19.0||||||
3940968|NCT01374438|3762634|B2|Apo E e4 allele present||Presence of an Apolipoprotein E e4 allele||participants|Number|9|9.0||||||
3940969|NCT01374438|3762635|B1|Apo E e4 allele present||Presence of an Apolipoprotein E e4 allele||participants|Number|10|10.0||||||
3940970|NCT01374438|3762633|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940971|NCT01374438|3762634|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940972|NCT01374438|3762635|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940973|NCT01374438|3762633|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940974|NCT01374438|3762634|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940975|NCT01374438|3762635|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940976|NCT01374438|3762633|B3||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3940977|NCT01374438|3762634|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3940978|NCT01374438|3762635|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3940979|NCT01374438|3762633|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3940980|NCT01374438|3762634|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3940981|NCT01374438|3762635|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3940982|NCT01374438|3762633|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940983|NCT01374438|3762634|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940984|NCT01374438|3762635|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940985|NCT01374438|3762633|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940986|NCT01374438|3762634|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940987|NCT01374438|3762635|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940988|NCT01374438|3762633|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940989|NCT01374438|3762634|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940990|NCT01374438|3762635|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3940991|NCT01374438|3762633|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3940992|NCT01374438|3762634|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3940993|NCT01374438|3762635|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3940994|NCT01374438|3762633|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3940995|NCT01374438|3762634|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3940996|NCT01374438|3762635|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3940997|NCT01374438|3762633|B3|||Age||years|Mean|71.7|71.7|Standard Deviation|8.3|8.3|||
3940998|NCT01374438|3762634|B2|||Age||years|Mean|71.0|71.0|Standard Deviation|8.0|8.0|||
3940999|NCT01374438|3762635|B1|||Age||years|Mean|72.3|72.3|Standard Deviation|8.8|8.8|||
3941000|NCT01374425|3762650|B3||Male|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
3941001|NCT01374425|3762651|B2||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3941002|NCT01374425|3762652|B1||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3941003|NCT01374425|3762650|B3||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3941004|NCT01374425|3762651|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3941005|NCT01374425|3762652|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3941006|NCT01374425|3762650|B3|||Age||years|Mean|59.9|59.9|Standard Deviation|10.78|10.78|||
3941007|NCT01374425|3762651|B2|||Age||years|Mean|60.7|60.7|Standard Deviation|10.66|10.66|||
3941008|NCT01374425|3762652|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|10.88|10.88|||
3941009|NCT01374269|3762731|B3|Colombia||Region of Enrollment||participants|Number|90|90.0||||||
3941010|NCT01374269|3762732|B2|Colombia||Region of Enrollment||participants|Number|44|44.0||||||
3941011|NCT01374269|3762733|B1|Colombia||Region of Enrollment||participants|Number|46|46.0||||||
3941012|NCT01374269|3762731|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3941013|NCT01374269|3762732|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3941014|NCT01374269|3762733|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3941015|NCT01374269|3762731|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3941016|NCT01374269|3762732|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3941017|NCT01374269|3762733|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3941018|NCT01374269|3762731|B3|||Age||years|Mean|39.4|39.4|Standard Deviation|12.74|12.74|||
3941019|NCT01374269|3762732|B2|||Age||years|Mean|40.3|40.3|Standard Deviation|13.2|13.2|||
3941020|NCT01374269|3762733|B1|||Age||years|Mean|38.5|38.5|Standard Deviation|12.3|12.3|||
3941021|NCT01374217|3762862|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3941022|NCT01374217|3762862|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3941023|NCT01374217|3762862|B1|||Age||years|Median|63|63.0|Full Range|||52.0|74.0|
3941024|NCT01374217|3762862|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3941025|NCT01374217|3762862|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3941026|NCT01374217|3762862|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3941027|NCT01374178|3762870|B1|Singapore||Region of Enrollment||participants|Number|16|16.0||||||
3941028|NCT01374178|3762870|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941029|NCT01374178|3762870|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941030|NCT01374178|3762870|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3941031|NCT01374178|3762870|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941032|NCT01374178|3762870|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941033|NCT01374178|3762870|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3941034|NCT01374178|3762870|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941035|NCT01374178|3762870|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941036|NCT01374178|3762870|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3941037|NCT01374178|3762870|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941038|NCT01374178|3762870|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3941039|NCT01374178|3762870|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3941040|NCT01374178|3762870|B1|||Age||years|Mean|31.1|31.1|Standard Deviation|7.6|7.6|||
3941041|NCT01374087|3762887|B3|Spain||Region of Enrollment||participants|Number|31|31.0||||||
3941042|NCT01374087|3762888|B2|Spain||Region of Enrollment||participants|Number|16|16.0||||||
3941043|NCT01374087|3762889|B1|Spain||Region of Enrollment||participants|Number|15|15.0||||||
3941044|NCT01374087|3762887|B3|Caucasian/White||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3941045|NCT01374087|3762888|B2|Caucasian/White||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3941046|NCT01374087|3762889|B1|Caucasian/White||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3941047|NCT01374087|3762887|B3||Male|Gender||Participants|Count of Participants|31|31.0||||||
3941048|NCT01374087|3762888|B2||Male|Gender||Participants|Count of Participants|16|16.0||||||
3941049|NCT01374087|3762889|B1||Male|Gender||Participants|Count of Participants|15|15.0||||||
3941050|NCT01374087|3762887|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
3941051|NCT01374087|3762888|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
3941052|NCT01374087|3762889|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3941053|NCT01374087|3762887|B3|||Age||years|Median|68.00|68.0|Full Range|||58.0|76.0|
3941054|NCT01374087|3762888|B2|||Age||years|Median|67.50|67.5|Full Range|||59.0|76.0|
3941055|NCT01374087|3762889|B1|||Age||years|Median|70.00|70.0|Full Range|||58.0|76.0|
3941056|NCT01373931|3762898|B3|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3941057|NCT01373931|3762899|B2|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3941058|NCT01373931|3762900|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3941059|NCT01373931|3762898|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941060|NCT01373931|3762899|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941061|NCT01373931|3762900|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941062|NCT01373931|3762898|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3941063|NCT01373931|3762899|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3941064|NCT01373931|3762900|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941065|NCT01373931|3762898|B3||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3941066|NCT01373931|3762899|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3941067|NCT01373931|3762900|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3941068|NCT01373931|3762898|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3941069|NCT01373931|3762899|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3941070|NCT01373931|3762900|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3941071|NCT01373931|3762898|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941072|NCT01373931|3762899|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941073|NCT01373931|3762900|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941074|NCT01373931|3762898|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941075|NCT01373931|3762899|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941076|NCT01373931|3762900|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941077|NCT01373931|3762898|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941078|NCT01373931|3762899|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941079|NCT01373931|3762900|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941080|NCT01373931|3762898|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941081|NCT01373931|3762899|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941082|NCT01373931|3762900|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941083|NCT01373931|3762898|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3941084|NCT01373931|3762899|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3941085|NCT01373931|3762900|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3941086|NCT01373931|3762898|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3941087|NCT01373931|3762899|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3941088|NCT01373931|3762900|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3941089|NCT01373931|3762898|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3941090|NCT01373931|3762899|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3941091|NCT01373931|3762900|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3941092|NCT01373931|3762898|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3941093|NCT01373931|3762899|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3941094|NCT01373931|3762900|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3941095|NCT01373931|3762898|B3|||Age||years|Mean|30.2|30.2|Standard Deviation|9.2|9.2|||
3941096|NCT01373931|3762899|B2|||Age||years|Mean|30.7|30.7|Standard Deviation|10.0|10.0|||
3941097|NCT01373931|3762900|B1|||Age||years|Mean|29.6|29.6|Standard Deviation|8.9|8.9|||
3941098|NCT01373918|3762912|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
3941099|NCT01373918|3762913|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3941100|NCT01373918|3762914|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3941101|NCT01373918|3762912|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941102|NCT01373918|3762913|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941103|NCT01373918|3762914|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941104|NCT01373918|3762912|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941105|NCT01373918|3762913|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941106|NCT01373918|3762914|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941107|NCT01373918|3762912|B3||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3941108|NCT01373918|3762913|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3941109|NCT01373918|3762914|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3941110|NCT01373918|3762912|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3941111|NCT01373918|3762913|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3941112|NCT01373918|3762914|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3941113|NCT01373918|3762912|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941114|NCT01373918|3762913|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941115|NCT01373918|3762914|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941116|NCT01373918|3762912|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941117|NCT01373918|3762913|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941118|NCT01373918|3762914|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941119|NCT01373918|3762912|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941120|NCT01373918|3762913|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941121|NCT01373918|3762914|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941122|NCT01373918|3762912|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941123|NCT01373918|3762913|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941124|NCT01373918|3762914|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941125|NCT01373918|3762912|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3941126|NCT01373918|3762913|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3941127|NCT01373918|3762914|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3941128|NCT01373918|3762912|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3941129|NCT01373918|3762913|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3941130|NCT01373918|3762914|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3941131|NCT01373918|3762912|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3941132|NCT01373918|3762913|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3941133|NCT01373918|3762914|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3941134|NCT01373918|3762912|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3941135|NCT01373918|3762913|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3941136|NCT01373918|3762914|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3941137|NCT01373918|3762912|B3|||Age||days|Mean|1.3|1.3|Standard Deviation|1.3|1.3|||
3941138|NCT01373918|3762913|B2|||Age||days|Mean|1.3|1.3|Standard Deviation|1.1|1.1|||
3941139|NCT01373918|3762914|B1|||Age||days|Mean|1.3|1.3|Standard Deviation|1.4|1.4|||
3941140|NCT01373671|3762927|B1|United States||Region of Enrollment||participants|Number|764|764.0||||||
3941141|NCT01373671|3762927|B1|Female||Sex/Gender, Customized|Female|participants|Number|764|764.0||||||
3941142|NCT01373671|3762927|B1|>= 30 years old < 40||Age, Customized|>= 40 years >= 30 years if presenting for biopsy|participants|Number|12|12.0||||||
3941143|NCT01373671|3762927|B1|>= 40 years old||Age, Customized|>= 40 years >= 30 years if presenting for biopsy|participants|Number|752|752.0||||||
3941144|NCT01373580|3762932|B1|United States||Region of Enrollment||Participants|Count of Participants|373|373.0||||||
3941145|NCT01373580|3762932|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3941146|NCT01373580|3762932|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|52|52.0||||||
3941147|NCT01373580|3762932|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3941148|NCT01373580|3762932|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3941149|NCT01373580|3762932|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|290|290.0||||||
3941150|NCT01373580|3762932|B1||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3941151|NCT01373580|3762932|B1||Female|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
3941152|NCT01373580|3762932|B1|||Age||Years|Mean|51.3|51.3|Standard Deviation|4.3|4.3|||
3941153|NCT01373489|3762938|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3941154|NCT01373489|3762939|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3941155|NCT01373489|3762940|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941156|NCT01373489|3762938|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941157|NCT01373489|3762939|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941158|NCT01373489|3762940|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941159|NCT01373489|3762938|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3941160|NCT01373489|3762939|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3941161|NCT01373489|3762940|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3941162|NCT01373489|3762938|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3941163|NCT01373489|3762939|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3941164|NCT01373489|3762940|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3941165|NCT01373489|3762938|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941166|NCT01373489|3762939|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941167|NCT01373489|3762940|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941168|NCT01373489|3762938|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941169|NCT01373489|3762939|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941170|NCT01373489|3762940|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941171|NCT01373489|3762938|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941172|NCT01373489|3762939|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941173|NCT01373489|3762940|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941174|NCT01373489|3762938|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3941175|NCT01373489|3762939|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3941176|NCT01373489|3762940|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3941177|NCT01373489|3762938|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3941178|NCT01373489|3762939|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3941179|NCT01373489|3762940|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3941180|NCT01373489|3762938|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3941181|NCT01373489|3762939|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3941182|NCT01373489|3762940|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3941183|NCT01373489|3762938|B3||Between 18 and 65 years|Age||Participants|Count of Participants|113|113.0||||||
3941184|NCT01373489|3762939|B2||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3941185|NCT01373489|3762940|B1||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
3941186|NCT01373489|3762938|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3941187|NCT01373489|3762939|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3941188|NCT01373489|3762940|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3941189|NCT01373450|3762947|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3941190|NCT01373450|3762947|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3941191|NCT01373450|3762947|B1|||Age||years|Mean|58.8|58.8|Standard Deviation|3.8|3.8|||
3941192|NCT01373346|3762974|B1|Korea, Republic of||Region of Enrollment||participants|Number|15|15.0||||||
3941193|NCT01373346|3762974|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3941194|NCT01373346|3762974|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3941195|NCT01373346|3762974|B1|||Age||years|Mean|62.1|62.1|Standard Deviation|8.7|8.7|||
3941196|NCT01373346|3762974|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3941197|NCT01373346|3762974|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3941198|NCT01373346|3762974|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3941199|NCT01373294|3762995|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
3941200|NCT01373294|3762996|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3941201|NCT01373294|3762997|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3941202|NCT01373294|3762995|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3941203|NCT01373294|3762996|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3941204|NCT01373294|3762997|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3941205|NCT01373294|3762995|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3941206|NCT01373294|3762996|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3941207|NCT01373294|3762997|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3941208|NCT01373294|3762995|B3|||Age||years|Mean|71.8|71.8|Full Range|||52.0|85.0|
3941209|NCT01373294|3762996|B2|||Age||years|Mean|70|70.0|Full Range|||66.0|74.0|
3941210|NCT01373294|3762997|B1|||Age||years|Mean|72|72.0|Full Range|||52.0|85.0|
3941211|NCT01373294|3762995|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3941212|NCT01373294|3762996|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3941213|NCT01373294|3762997|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3941214|NCT01373294|3762995|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3941215|NCT01373294|3762996|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3941216|NCT01373294|3762997|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3941217|NCT01373294|3762995|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3941218|NCT01373294|3762996|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3941219|NCT01373294|3762997|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3941220|NCT01373281|3763005|B3|Vietnam||Region of Enrollment||Participants|Count of Participants|2333|2333.0||||||
3941221|NCT01373281|3763006|B2|Vietnam||Region of Enrollment||Participants|Count of Participants|778|778.0||||||
3941222|NCT01373281|3763007|B1|Vietnam||Region of Enrollment||Participants|Count of Participants|1555|1555.0||||||
3941223|NCT01373281|3763005|B3|Thailand||Region of Enrollment||Participants|Count of Participants|1170|1170.0||||||
3941224|NCT01373281|3763006|B2|Thailand||Region of Enrollment||Participants|Count of Participants|392|392.0||||||
3941225|NCT01373281|3763007|B1|Thailand||Region of Enrollment||Participants|Count of Participants|778|778.0||||||
3941226|NCT01373281|3763005|B3|Indonesia||Region of Enrollment||Participants|Count of Participants|1870|1870.0||||||
3941227|NCT01373281|3763006|B2|Indonesia||Region of Enrollment||Participants|Count of Participants|624|624.0||||||
3941228|NCT01373281|3763007|B1|Indonesia||Region of Enrollment||Participants|Count of Participants|1246|1246.0||||||
3941229|NCT01373281|3763005|B3|Malaysia||Region of Enrollment||Participants|Count of Participants|1401|1401.0||||||
3941230|NCT01373281|3763006|B2|Malaysia||Region of Enrollment||Participants|Count of Participants|464|464.0||||||
3941231|NCT01373281|3763007|B1|Malaysia||Region of Enrollment||Participants|Count of Participants|937|937.0||||||
3941232|NCT01373281|3763005|B3|Philippines||Region of Enrollment||Participants|Count of Participants|3501|3501.0||||||
3941233|NCT01373281|3763006|B2|Philippines||Region of Enrollment||Participants|Count of Participants|1166|1166.0||||||
3941234|NCT01373281|3763007|B1|Philippines||Region of Enrollment||Participants|Count of Participants|2335|2335.0||||||
3941235|NCT01373281|3763005|B3||Male|Sex: Female, Male||Participants|Count of Participants|4984|4984.0||||||
3941236|NCT01373281|3763006|B2||Male|Sex: Female, Male||Participants|Count of Participants|1657|1657.0||||||
3941237|NCT01373281|3763007|B1||Male|Sex: Female, Male||Participants|Count of Participants|3327|3327.0||||||
3941238|NCT01373281|3763005|B3||Female|Sex: Female, Male||Participants|Count of Participants|5291|5291.0||||||
3941239|NCT01373281|3763006|B2||Female|Sex: Female, Male||Participants|Count of Participants|1767|1767.0||||||
3941240|NCT01373281|3763007|B1||Female|Sex: Female, Male||Participants|Count of Participants|3524|3524.0||||||
3941241|NCT01373281|3763005|B3|Age Continuous||Age||Years|Mean|8.8|8.8|Standard Deviation|3.44|3.44|||
3941242|NCT01373281|3763006|B2|Age Continuous||Age||Years|Mean|8.8|8.8|Standard Deviation|3.42|3.42|||
3941243|NCT01373281|3763007|B1|Age Continuous||Age||Years|Mean|8.8|8.8|Standard Deviation|3.45|3.45|||
3941244|NCT01373281|3763005|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3941245|NCT01373281|3763006|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3941246|NCT01373281|3763007|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3941247|NCT01373281|3763005|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3941248|NCT01373281|3763006|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3941249|NCT01373281|3763007|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3941250|NCT01373281|3763005|B3||<=18 years|Age||Participants|Count of Participants|10275|10275.0||||||
3941251|NCT01373281|3763006|B2||<=18 years|Age||Participants|Count of Participants|3424|3424.0||||||
3941252|NCT01373281|3763007|B1||<=18 years|Age||Participants|Count of Participants|6851|6851.0||||||
3941253|NCT01373229|3763040|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3941254|NCT01373229|3763040|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941255|NCT01373229|3763040|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941256|NCT01373229|3763040|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3941257|NCT01373229|3763040|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3941258|NCT01373229|3763040|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941259|NCT01373229|3763040|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941260|NCT01373229|3763040|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941261|NCT01373229|3763040|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941262|NCT01373229|3763040|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3941263|NCT01373229|3763040|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941264|NCT01373229|3763040|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3941265|NCT01373229|3763040|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3941266|NCT01373229|3763040|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3941267|NCT01373229|3763040|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3941268|NCT01373229|3763040|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3941269|NCT01373164|3763049|B6|Spain||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3941270|NCT01373164|3763050|B5|Spain||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3941271|NCT01373164|3763051|B4|Spain||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3941272|NCT01373164|3763052|B3|Spain||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3941273|NCT01373164|3763053|B2|Spain||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3941274|NCT01373164|3763054|B1|Spain||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3941275|NCT01373164|3763049|B6|Germany||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3941276|NCT01373164|3763050|B5|Germany||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3941277|NCT01373164|3763051|B4|Germany||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3941278|NCT01373164|3763052|B3|Germany||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3941279|NCT01373164|3763053|B2|Germany||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3941280|NCT01373164|3763054|B1|Germany||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3941281|NCT01373164|3763049|B6|France||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3941282|NCT01373164|3763050|B5|France||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3941283|NCT01373164|3763051|B4|France||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3941284|NCT01373164|3763052|B3|France||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3941285|NCT01373164|3763053|B2|France||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3941286|NCT01373164|3763054|B1|France||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3941287|NCT01373164|3763049|B6|Italy||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3941288|NCT01373164|3763050|B5|Italy||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3941289|NCT01373164|3763051|B4|Italy||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3941290|NCT01373164|3763052|B3|Italy||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3941291|NCT01373164|3763053|B2|Italy||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3941292|NCT01373164|3763054|B1|Italy||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3941293|NCT01373164|3763049|B6|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3941294|NCT01373164|3763050|B5|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3941295|NCT01373164|3763051|B4|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3941296|NCT01373164|3763052|B3|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3941297|NCT01373164|3763053|B2|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3941298|NCT01373164|3763054|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3941299|NCT01373164|3763049|B6|Belgium||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3941300|NCT01373164|3763050|B5|Belgium||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3941301|NCT01373164|3763051|B4|Belgium||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3941302|NCT01373164|3763052|B3|Belgium||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3941303|NCT01373164|3763053|B2|Belgium||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3941304|NCT01373164|3763054|B1|Belgium||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3941305|NCT01373164|3763049|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3941306|NCT01373164|3763050|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3941307|NCT01373164|3763051|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3941308|NCT01373164|3763052|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941309|NCT01373164|3763053|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941310|NCT01373164|3763054|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941311|NCT01373164|3763049|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941312|NCT01373164|3763050|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941313|NCT01373164|3763051|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941314|NCT01373164|3763052|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941315|NCT01373164|3763053|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941316|NCT01373164|3763054|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941317|NCT01373164|3763049|B6||White|Race (NIH/OMB)||Participants|Count of Participants|157|157.0||||||
3941318|NCT01373164|3763050|B5||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3941319|NCT01373164|3763051|B4||White|Race (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
3941320|NCT01373164|3763052|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3941321|NCT01373164|3763053|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3941322|NCT01373164|3763054|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3941323|NCT01373164|3763049|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3941324|NCT01373164|3763050|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941325|NCT01373164|3763051|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941326|NCT01373164|3763052|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941327|NCT01373164|3763053|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941328|NCT01373164|3763054|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3941329|NCT01373164|3763049|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941330|NCT01373164|3763050|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941331|NCT01373164|3763051|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941332|NCT01373164|3763052|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941333|NCT01373164|3763053|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941334|NCT01373164|3763054|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941335|NCT01373164|3763049|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941336|NCT01373164|3763050|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941337|NCT01373164|3763051|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941338|NCT01373164|3763052|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941339|NCT01373164|3763053|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941340|NCT01373164|3763054|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941341|NCT01373164|3763049|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941342|NCT01373164|3763050|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941343|NCT01373164|3763051|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941344|NCT01373164|3763052|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941345|NCT01373164|3763053|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941346|NCT01373164|3763054|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941347|NCT01373164|3763049|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3941348|NCT01373164|3763050|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3941349|NCT01373164|3763051|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3941350|NCT01373164|3763052|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941351|NCT01373164|3763053|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941352|NCT01373164|3763054|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941353|NCT01373164|3763049|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3941354|NCT01373164|3763050|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3941355|NCT01373164|3763051|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3941356|NCT01373164|3763052|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3941357|NCT01373164|3763053|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3941358|NCT01373164|3763054|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3941359|NCT01373164|3763049|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3941360|NCT01373164|3763050|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941361|NCT01373164|3763051|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941362|NCT01373164|3763052|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3941363|NCT01373164|3763053|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941364|NCT01373164|3763054|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941365|NCT01373164|3763049|B6||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3941366|NCT01373164|3763050|B5||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3941367|NCT01373164|3763051|B4||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3941368|NCT01373164|3763052|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3941369|NCT01373164|3763053|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3941370|NCT01373164|3763054|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3941371|NCT01373164|3763049|B6||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3941372|NCT01373164|3763050|B5||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3941373|NCT01373164|3763051|B4||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3941374|NCT01373164|3763052|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3941375|NCT01373164|3763053|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3941376|NCT01373164|3763054|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3941377|NCT01373164|3763049|B6|||Age||Years|Mean|63.5|63.5|Standard Deviation|9.7|9.7|||
3941378|NCT01373164|3763050|B5|||Age||Years|Mean|66.3|66.3|Standard Deviation|8.9|8.9|||
3941379|NCT01373164|3763051|B4|||Age||Years|Mean|67.3|67.3|Standard Deviation|8.2|8.2|||
3941380|NCT01373164|3763052|B3|||Age||Years|Mean|56.6|56.6|Standard Deviation|9.2|9.2|||
3941381|NCT01373164|3763053|B2|||Age||Years|Mean|63.8|63.8|Standard Deviation|9.0|9.0|||
3941382|NCT01373164|3763054|B1|||Age||Years|Mean|63.2|63.2|Standard Deviation|12.9|12.9|||
3941383|NCT01372995|3763089|B4|No Asthma||Asthma||participants|Number|28|28.0||||||
3941384|NCT01372995|3763090|B3|No Asthma||Asthma||participants|Number|11|11.0||||||
3941385|NCT01372995|3763091|B2|No Asthma||Asthma||participants|Number|8|8.0||||||
3941386|NCT01372995|3763092|B1|No Asthma||Asthma||participants|Number|9|9.0||||||
3941387|NCT01372995|3763089|B4|Asthma Present||Asthma||participants|Number|2|2.0||||||
3941388|NCT01372995|3763090|B3|Asthma Present||Asthma||participants|Number|0|0.0||||||
3941389|NCT01372995|3763091|B2|Asthma Present||Asthma||participants|Number|1|1.0||||||
3941390|NCT01372995|3763092|B1|Asthma Present||Asthma||participants|Number|1|1.0||||||
3941391|NCT01372995|3763089|B4|No COPD||Chronic Obstructive Pulmonary Disease (COPD)||participants|Number|23|23.0||||||
3941392|NCT01372995|3763090|B3|No COPD||Chronic Obstructive Pulmonary Disease (COPD)||participants|Number|7|7.0||||||
3941393|NCT01372995|3763091|B2|No COPD||Chronic Obstructive Pulmonary Disease (COPD)||participants|Number|8|8.0||||||
3941394|NCT01372995|3763092|B1|No COPD||Chronic Obstructive Pulmonary Disease (COPD)||participants|Number|8|8.0||||||
3941395|NCT01372995|3763089|B4|COPD Present||Chronic Obstructive Pulmonary Disease (COPD)||participants|Number|7|7.0||||||
3941396|NCT01372995|3763090|B3|COPD Present||Chronic Obstructive Pulmonary Disease (COPD)||participants|Number|4|4.0||||||
3941397|NCT01372995|3763091|B2|COPD Present||Chronic Obstructive Pulmonary Disease (COPD)||participants|Number|1|1.0||||||
3941398|NCT01372995|3763092|B1|COPD Present||Chronic Obstructive Pulmonary Disease (COPD)||participants|Number|2|2.0||||||
3941399|NCT01372995|3763089|B4|No Diabetes||Diabetes||participants|Number|23|23.0||||||
3941400|NCT01372995|3763090|B3|No Diabetes||Diabetes||participants|Number|9|9.0||||||
3941401|NCT01372995|3763091|B2|No Diabetes||Diabetes||participants|Number|8|8.0||||||
3941402|NCT01372995|3763092|B1|No Diabetes||Diabetes||participants|Number|6|6.0||||||
3941403|NCT01372995|3763089|B4|Diabetes Present||Diabetes||participants|Number|7|7.0||||||
3941404|NCT01372995|3763090|B3|Diabetes Present||Diabetes||participants|Number|2|2.0||||||
3941405|NCT01372995|3763091|B2|Diabetes Present||Diabetes||participants|Number|1|1.0||||||
3941406|NCT01372995|3763092|B1|Diabetes Present||Diabetes||participants|Number|4|4.0||||||
3941407|NCT01372995|3763089|B4|No Congestive Heart Failure||Congestive Heart Failure||participants|Number|22|22.0||||||
3941408|NCT01372995|3763090|B3|No Congestive Heart Failure||Congestive Heart Failure||participants|Number|6|6.0||||||
3941409|NCT01372995|3763091|B2|No Congestive Heart Failure||Congestive Heart Failure||participants|Number|7|7.0||||||
3941410|NCT01372995|3763092|B1|No Congestive Heart Failure||Congestive Heart Failure||participants|Number|9|9.0||||||
3941411|NCT01372995|3763089|B4|Congestive Heart Failure Present||Congestive Heart Failure||participants|Number|8|8.0||||||
3941412|NCT01372995|3763090|B3|Congestive Heart Failure Present||Congestive Heart Failure||participants|Number|5|5.0||||||
3941413|NCT01372995|3763091|B2|Congestive Heart Failure Present||Congestive Heart Failure||participants|Number|2|2.0||||||
3941414|NCT01372995|3763092|B1|Congestive Heart Failure Present||Congestive Heart Failure||participants|Number|1|1.0||||||
3941415|NCT01372995|3763089|B4|No Coronary Artery Disease||Coronary Artery Disease||participants|Number|20|20.0||||||
3941416|NCT01372995|3763090|B3|No Coronary Artery Disease||Coronary Artery Disease||participants|Number|4|4.0||||||
3941417|NCT01372995|3763091|B2|No Coronary Artery Disease||Coronary Artery Disease||participants|Number|7|7.0||||||
3941418|NCT01372995|3763092|B1|No Coronary Artery Disease||Coronary Artery Disease||participants|Number|9|9.0||||||
3941419|NCT01372995|3763089|B4|Coronary Artery Disease Present||Coronary Artery Disease||participants|Number|10|10.0||||||
3941420|NCT01372995|3763090|B3|Coronary Artery Disease Present||Coronary Artery Disease||participants|Number|7|7.0||||||
3941421|NCT01372995|3763091|B2|Coronary Artery Disease Present||Coronary Artery Disease||participants|Number|2|2.0||||||
3941422|NCT01372995|3763092|B1|Coronary Artery Disease Present||Coronary Artery Disease||participants|Number|1|1.0||||||
3941423|NCT01372995|3763089|B4|Sufficient (>30 ng/mL)||Vitamin D at baseline||participants|Number|5|5.0||||||
3941424|NCT01372995|3763090|B3|Sufficient (>30 ng/mL)||Vitamin D at baseline||participants|Number|1|1.0||||||
3941425|NCT01372995|3763091|B2|Sufficient (>30 ng/mL)||Vitamin D at baseline||participants|Number|2|2.0||||||
3941426|NCT01372995|3763092|B1|Sufficient (>30 ng/mL)||Vitamin D at baseline||participants|Number|2|2.0||||||
3941427|NCT01372995|3763089|B4|Insufficient (20-30 ng/mL)||Vitamin D at baseline||participants|Number|12|12.0||||||
3941428|NCT01372995|3763090|B3|Insufficient (20-30 ng/mL)||Vitamin D at baseline||participants|Number|5|5.0||||||
3941429|NCT01372995|3763091|B2|Insufficient (20-30 ng/mL)||Vitamin D at baseline||participants|Number|4|4.0||||||
3941430|NCT01372995|3763092|B1|Insufficient (20-30 ng/mL)||Vitamin D at baseline||participants|Number|3|3.0||||||
3941431|NCT01372995|3763089|B4|Deficient (<20 ng/mL)||Vitamin D at baseline||participants|Number|13|13.0||||||
3941432|NCT01372995|3763090|B3|Deficient (<20 ng/mL)||Vitamin D at baseline||participants|Number|5|5.0||||||
3941433|NCT01372995|3763091|B2|Deficient (<20 ng/mL)||Vitamin D at baseline||participants|Number|3|3.0||||||
3941434|NCT01372995|3763092|B1|Deficient (<20 ng/mL)||Vitamin D at baseline||participants|Number|5|5.0||||||
3941435|NCT01372995|3763089|B4|United States||Region of Enrollment||participants|Number|30|30.0||||||
3941436|NCT01372995|3763090|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3941437|NCT01372995|3763091|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3941438|NCT01372995|3763092|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3941439|NCT01372995|3763089|B4|American Indian/Alaskan||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3941440|NCT01372995|3763090|B3|American Indian/Alaskan||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3941441|NCT01372995|3763091|B2|American Indian/Alaskan||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3941442|NCT01372995|3763092|B1|American Indian/Alaskan||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3941443|NCT01372995|3763089|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3941444|NCT01372995|3763090|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3941445|NCT01372995|3763091|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3941446|NCT01372995|3763092|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3941447|NCT01372995|3763089|B4|African American||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3941448|NCT01372995|3763090|B3|African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3941449|NCT01372995|3763091|B2|African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3941450|NCT01372995|3763092|B1|African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3941451|NCT01372995|3763089|B4||Male|Gender||Participants|Count of Participants|19|19.0||||||
3941452|NCT01372995|3763090|B3||Male|Gender||Participants|Count of Participants|8|8.0||||||
3941453|NCT01372995|3763091|B2||Male|Gender||Participants|Count of Participants|5|5.0||||||
3941454|NCT01372995|3763092|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
3941455|NCT01372995|3763089|B4||Female|Gender||Participants|Count of Participants|11|11.0||||||
3941456|NCT01372995|3763090|B3||Female|Gender||Participants|Count of Participants|3|3.0||||||
3941457|NCT01372995|3763091|B2||Female|Gender||Participants|Count of Participants|4|4.0||||||
3941458|NCT01372995|3763092|B1||Female|Gender||Participants|Count of Participants|4|4.0||||||
3941459|NCT01372995|3763089|B4||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3941460|NCT01372995|3763090|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3941461|NCT01372995|3763091|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3941462|NCT01372995|3763092|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3941463|NCT01372995|3763089|B4||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3941464|NCT01372995|3763090|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3941465|NCT01372995|3763091|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3941466|NCT01372995|3763092|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3941467|NCT01372995|3763089|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3941468|NCT01372995|3763090|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3941469|NCT01372995|3763091|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3941470|NCT01372995|3763092|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3941471|NCT01372878|3763141|B1|Israel||Region of Enrollment||participants|Number|326|326.0||||||
3941472|NCT01372878|3763141|B1|United States||Region of Enrollment||participants|Number|558|558.0||||||
3941473|NCT01372878|3763141|B1||Male|Sex: Female, Male||Participants|Count of Participants|397|397.0||||||
3941474|NCT01372878|3763141|B1||Female|Sex: Female, Male||Participants|Count of Participants|487|487.0||||||
3941475|NCT01372878|3763141|B1|||Age||years|Mean|57.29|57.29|Standard Deviation|5.84|5.84|||
3941476|NCT01372813|3763146|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3941477|NCT01372813|3763146|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941478|NCT01372813|3763146|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941479|NCT01372813|3763146|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3941480|NCT01372813|3763146|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941481|NCT01372813|3763146|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941482|NCT01372813|3763146|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941483|NCT01372813|3763146|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941484|NCT01372813|3763146|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941485|NCT01372813|3763146|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3941486|NCT01372813|3763146|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941487|NCT01372813|3763146|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3941488|NCT01372813|3763146|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3941489|NCT01372813|3763146|B1|||Age||years|Mean|58.8|58.8|Standard Deviation|5.43|5.43|||
3941490|NCT01372813|3763146|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3941491|NCT01372813|3763146|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3941492|NCT01372813|3763146|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3941493|NCT01372774|3763159|B3|North America||Region of Enrollment||participants|Number|194|194.0||||||
3941494|NCT01372774|3763160|B2|North America||Region of Enrollment||participants|Number|98|98.0||||||
3941495|NCT01372774|3763161|B1|North America||Region of Enrollment||participants|Number|96|96.0||||||
3941496|NCT01372774|3763159|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3941497|NCT01372774|3763160|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3941498|NCT01372774|3763161|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3941499|NCT01372774|3763159|B3||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3941500|NCT01372774|3763160|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3941501|NCT01372774|3763161|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3941502|NCT01372774|3763159|B3|||Age||years|Median|61|61.0|Inter-Quartile Range|||54.0|68.0|
3941503|NCT01372774|3763160|B2|||Age||years|Median|61|61.0|Inter-Quartile Range|||54.0|66.0|
3941504|NCT01372774|3763161|B1|||Age||years|Median|62|62.0|Inter-Quartile Range|||54.0|68.0|
3941505|NCT01372748|3763176|B3|United States||Region of Enrollment||participants|Number|8966|8966.0||||||
3941506|NCT01372748|3763177|B2|United States||Region of Enrollment||participants|Number|4632|4632.0||||||
3941507|NCT01372748|3763178|B1|United States||Region of Enrollment||participants|Number|4334|4334.0||||||
3941508|NCT01372748|3763176|B3|Canada||Region of Enrollment||participants|Number|14721|14721.0||||||
3941509|NCT01372748|3763177|B2|Canada||Region of Enrollment||participants|Number|8010|8010.0||||||
3941510|NCT01372748|3763178|B1|Canada||Region of Enrollment||participants|Number|6711|6711.0||||||
3941511|NCT01372748|3763176|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17021|17021.0||||||
3941512|NCT01372748|3763177|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9180|9180.0||||||
3941513|NCT01372748|3763178|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7841|7841.0||||||
3941514|NCT01372748|3763176|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3941515|NCT01372748|3763177|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3941516|NCT01372748|3763178|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3941517|NCT01372748|3763176|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3726|3726.0||||||
3941518|NCT01372748|3763177|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1931|1931.0||||||
3941519|NCT01372748|3763178|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1795|1795.0||||||
3941520|NCT01372748|3763176|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2596|2596.0||||||
3941521|NCT01372748|3763177|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1350|1350.0||||||
3941522|NCT01372748|3763178|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1246|1246.0||||||
3941523|NCT01372748|3763176|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3941524|NCT01372748|3763177|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3941525|NCT01372748|3763178|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3941526|NCT01372748|3763176|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|263|263.0||||||
3941527|NCT01372748|3763177|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
3941528|NCT01372748|3763178|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
3941529|NCT01372748|3763176|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3941530|NCT01372748|3763177|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3941531|NCT01372748|3763178|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3941532|NCT01372748|3763176|B3||Male|Gender||Participants|Count of Participants|15143|15143.0||||||
3941533|NCT01372748|3763177|B2||Male|Gender||Participants|Count of Participants|8024|8024.0||||||
3941534|NCT01372748|3763178|B1||Male|Gender||Participants|Count of Participants|7119|7119.0||||||
3941535|NCT01372748|3763176|B3||Female|Gender||Participants|Count of Participants|8544|8544.0||||||
3941536|NCT01372748|3763177|B2||Female|Gender||Participants|Count of Participants|4618|4618.0||||||
3941537|NCT01372748|3763178|B1||Female|Gender||Participants|Count of Participants|3926|3926.0||||||
3941538|NCT01372748|3763176|B3|||Age||years|Mean|66.3|66.3|Standard Deviation|17.1|17.1|||
3941539|NCT01372748|3763177|B2|||Age||years|Mean|66.4|66.4|Standard Deviation|17.2|17.2|||
3941540|NCT01372748|3763178|B1|||Age||years|Mean|66.2|66.2|Standard Deviation|17.0|17.0|||
3941541|NCT01372618|3763187|B1|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3941542|NCT01372618|3763187|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3941543|NCT01372618|3763187|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3941544|NCT01372618|3763187|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3941545|NCT01372618|3763187|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3941546|NCT01372618|3763187|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3941547|NCT01372605|3763193|B3|United States||Region of Enrollment||participants|Number|304|304.0||||||
3941548|NCT01372605|3763194|B2|United States||Region of Enrollment||participants|Number|155|155.0||||||
3941549|NCT01372605|3763195|B1|United States||Region of Enrollment||participants|Number|149|149.0||||||
3941550|NCT01372605|3763193|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3941551|NCT01372605|3763194|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3941552|NCT01372605|3763195|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3941553|NCT01372605|3763193|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3941554|NCT01372605|3763194|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3941555|NCT01372605|3763195|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3941556|NCT01372605|3763193|B3||White|Race (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
3941557|NCT01372605|3763194|B2||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3941558|NCT01372605|3763195|B1||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3941559|NCT01372605|3763193|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|193|193.0||||||
3941560|NCT01372605|3763194|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
3941561|NCT01372605|3763195|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
3941562|NCT01372605|3763193|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941563|NCT01372605|3763194|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941564|NCT01372605|3763195|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941565|NCT01372605|3763193|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3941566|NCT01372605|3763194|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3941567|NCT01372605|3763195|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941568|NCT01372605|3763193|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3941569|NCT01372605|3763194|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3941570|NCT01372605|3763195|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3941571|NCT01372605|3763193|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941572|NCT01372605|3763194|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941573|NCT01372605|3763195|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941574|NCT01372605|3763193|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|291|291.0||||||
3941575|NCT01372605|3763194|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|151|151.0||||||
3941576|NCT01372605|3763195|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
3941577|NCT01372605|3763193|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3941578|NCT01372605|3763194|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3941579|NCT01372605|3763195|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3941580|NCT01372605|3763193|B3|Transgender||Sex/Gender, Customized||participants|Number|5|5.0||||||
3941581|NCT01372605|3763194|B2|Transgender||Sex/Gender, Customized||participants|Number|3|3.0||||||
3941582|NCT01372605|3763195|B1|Transgender||Sex/Gender, Customized||participants|Number|2|2.0||||||
3941583|NCT01372605|3763193|B3|Female||Sex/Gender, Customized||participants|Number|87|87.0||||||
3941584|NCT01372605|3763194|B2|Female||Sex/Gender, Customized||participants|Number|52|52.0||||||
3941585|NCT01372605|3763195|B1|Female||Sex/Gender, Customized||participants|Number|35|35.0||||||
3941586|NCT01372605|3763193|B3|Male||Sex/Gender, Customized||participants|Number|212|212.0||||||
3941587|NCT01372605|3763194|B2|Male||Sex/Gender, Customized||participants|Number|100|100.0||||||
3941588|NCT01372605|3763195|B1|Male||Sex/Gender, Customized||participants|Number|112|112.0||||||
3941589|NCT01372605|3763193|B3|||Age||years|Mean|43.9|43.9|Standard Deviation|10.1|10.1|||
3941590|NCT01372605|3763194|B2|||Age||years|Mean|44.9|44.9|Standard Deviation|9.9|9.9|||
3941591|NCT01372605|3763195|B1|||Age||years|Mean|42.8|42.8|Standard Deviation|10.3|10.3|||
3941592|NCT01372501|3763222|B1|Chile||Region of Enrollment||participants|Number|19|19.0||||||
3941593|NCT01372501|3763222|B1||Male|Gender||Participants|Count of Participants|4|4.0||||||
3941594|NCT01372501|3763222|B1||Female|Gender||Participants|Count of Participants|15|15.0||||||
3941595|NCT01372501|3763222|B1|||Age||years|Mean|38.5|38.5|Standard Deviation|11.32|11.32|||
3941596|NCT01372462|3763227|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3941597|NCT01372462|3763227|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941598|NCT01372462|3763227|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941599|NCT01372462|3763227|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3941600|NCT01372462|3763227|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941601|NCT01372462|3763227|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941602|NCT01372462|3763227|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941603|NCT01372462|3763227|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941604|NCT01372462|3763227|B1||Male|Sex: Female, Male|Only male subjects were recruited due to need for placement of sensors on an exposed chest area.|Participants|Count of Participants|15|15.0||||||
3941605|NCT01372462|3763227|B1||Female|Sex: Female, Male|Only male subjects were recruited due to need for placement of sensors on an exposed chest area.|Participants|Count of Participants|0|0.0||||||
3941606|NCT01372462|3763227|B1|||Age||years|Mean|65.5|65.5|Standard Deviation|9.1|9.1|||
3941607|NCT01372410|3763245|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3941608|NCT01372410|3763245|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|145|145.0||||||
3941609|NCT01372410|3763245|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3941610|NCT01372410|3763245|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3941611|NCT01372410|3763245|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3941612|NCT01372410|3763245|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3941613|NCT01372410|3763245|B1|||Age||Years|Mean|59.5|59.5|Standard Deviation|9.21|9.21|||
3941614|NCT01372384|3763289|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3941615|NCT01372384|3763289|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3941616|NCT01372384|3763289|B1|||Age||years|Mean|66.5|66.5|Standard Deviation|6.19|6.19|||
3941617|NCT01372202|3763296|B4|United States||Region of Enrollment||participants|Number|31|31.0||||||
3941618|NCT01372202|3763297|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
3941619|NCT01372202|3763298|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3941620|NCT01372202|3763299|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3941621|NCT01372202|3763296|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3941622|NCT01372202|3763297|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3941623|NCT01372202|3763298|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3941624|NCT01372202|3763299|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3941625|NCT01372202|3763296|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3941626|NCT01372202|3763297|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3941627|NCT01372202|3763298|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3941628|NCT01372202|3763299|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3941629|NCT01372202|3763296|B4|||Age||years|Mean|62|62.0|Full Range|||47.0|76.0|
3941630|NCT01372202|3763297|B3|||Age||years|Mean|60|60.0|Full Range|||47.0|73.0|
3941631|NCT01372202|3763298|B2|||Age||years|Mean|67|67.0|Full Range|||57.0|76.0|
3941632|NCT01372202|3763299|B1|||Age||years|Mean|63|63.0|Full Range|||54.0|72.0|
3941633|NCT01372202|3763296|B4||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3941634|NCT01372202|3763297|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3941635|NCT01372202|3763298|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3941636|NCT01372202|3763299|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3941637|NCT01372202|3763296|B4||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3941638|NCT01372202|3763297|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3941639|NCT01372202|3763298|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3941640|NCT01372202|3763299|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3941641|NCT01372202|3763296|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3941642|NCT01372202|3763297|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3941643|NCT01372202|3763298|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3941644|NCT01372202|3763299|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3941645|NCT01372150|3763309|B4||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3941646|NCT01372150|3763310|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3941647|NCT01372150|3763311|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3941648|NCT01372150|3763312|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3941649|NCT01372150|3763309|B4||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3941650|NCT01372150|3763310|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3941651|NCT01372150|3763311|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3941652|NCT01372150|3763312|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3941653|NCT01372150|3763309|B4|||Age||Years|Mean|12.7|12.7|Standard Deviation|2.96|2.96|||
3941654|NCT01372150|3763310|B3|||Age||Years|Mean|12.9|12.9|Standard Deviation|3.12|3.12|||
3941655|NCT01372150|3763311|B2|||Age||Years|Mean|12.6|12.6|Standard Deviation|2.89|2.89|||
3941656|NCT01372150|3763312|B1|||Age||Years|Mean|12.6|12.6|Standard Deviation|2.89|2.89|||
3941657|NCT01371994|3763331|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
3941658|NCT01371994|3763332|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3941659|NCT01371994|3763333|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3941660|NCT01371994|3763331|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|568|568.0||||||
3941661|NCT01371994|3763332|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|284|284.0||||||
3941662|NCT01371994|3763333|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|284|284.0||||||
3941663|NCT01371994|3763331|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3941664|NCT01371994|3763332|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3941665|NCT01371994|3763333|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3941666|NCT01371994|3763331|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3941667|NCT01371994|3763332|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3941668|NCT01371994|3763333|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3941669|NCT01371994|3763331|B3|Black||Race/Ethnicity, Customized||participants|Number|87|87.0||||||
3941670|NCT01371994|3763332|B2|Black||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
3941671|NCT01371994|3763333|B1|Black||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
3941672|NCT01371994|3763331|B3|White||Race/Ethnicity, Customized||participants|Number|529|529.0||||||
3941673|NCT01371994|3763332|B2|White||Race/Ethnicity, Customized||participants|Number|266|266.0||||||
3941674|NCT01371994|3763333|B1|White||Race/Ethnicity, Customized||participants|Number|263|263.0||||||
3941675|NCT01371994|3763331|B3||Male|Sex: Female, Male||Participants|Count of Participants|623|623.0||||||
3941676|NCT01371994|3763332|B2||Male|Sex: Female, Male||Participants|Count of Participants|313|313.0||||||
3941677|NCT01371994|3763333|B1||Male|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
3941678|NCT01371994|3763331|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3941679|NCT01371994|3763332|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3941680|NCT01371994|3763333|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3941681|NCT01371994|3763331|B3|||Age||years|Mean|60.9|60.9|Standard Deviation|6.98|6.98|||
3941682|NCT01371994|3763332|B2|||Age||years|Mean|60.5|60.5|Standard Deviation|7.21|7.21|||
3941683|NCT01371994|3763333|B1|||Age||years|Mean|61.2|61.2|Standard Deviation|6.72|6.72|||
3941684|NCT01371877|3763376|B3|||Baseline vitamin D level||ng/mL|Mean|33.0|33.0|Standard Deviation|13.6|13.6|||
3941685|NCT01371877|3763377|B2|||Baseline vitamin D level||ng/mL|Mean|37.2|37.2|Standard Deviation|15.5|15.5|||
3941686|NCT01371877|3763378|B1|||Baseline vitamin D level||ng/mL|Mean|28.86|28.86|Standard Deviation|10.1|10.1|||
3941687|NCT01371877|3763376|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
3941688|NCT01371877|3763377|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
3941689|NCT01371877|3763378|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3941690|NCT01371877|3763376|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941691|NCT01371877|3763377|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941692|NCT01371877|3763378|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941693|NCT01371877|3763376|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941694|NCT01371877|3763377|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941695|NCT01371877|3763378|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941696|NCT01371877|3763376|B3||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3941697|NCT01371877|3763377|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3941698|NCT01371877|3763378|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3941699|NCT01371877|3763376|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3941700|NCT01371877|3763377|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3941701|NCT01371877|3763378|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3941702|NCT01371877|3763376|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941703|NCT01371877|3763377|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941704|NCT01371877|3763378|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941705|NCT01371877|3763376|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3941706|NCT01371877|3763377|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3941707|NCT01371877|3763378|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941708|NCT01371877|3763376|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941709|NCT01371877|3763377|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941710|NCT01371877|3763378|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941711|NCT01371877|3763376|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3941712|NCT01371877|3763377|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3941713|NCT01371877|3763378|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3941714|NCT01371877|3763376|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3941715|NCT01371877|3763377|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3941716|NCT01371877|3763378|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3941717|NCT01371877|3763376|B3|||Age||years|Mean|43.5|43.5|Full Range|||19.0|79.0|
3941718|NCT01371877|3763377|B2|||Age||years|Mean|43.1|43.1|Full Range|||20.0|72.0|
3941719|NCT01371877|3763378|B1|||Age||years|Mean|43.9|43.9|Full Range|||19.0|79.0|
3941720|NCT01371851|3763389|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
3941721|NCT01371851|3763390|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3941722|NCT01371851|3763391|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3941723|NCT01371851|3763389|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941724|NCT01371851|3763390|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941725|NCT01371851|3763391|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941726|NCT01371851|3763389|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941727|NCT01371851|3763390|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941728|NCT01371851|3763391|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941729|NCT01371851|3763389|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3941730|NCT01371851|3763390|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3941731|NCT01371851|3763391|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3941732|NCT01371851|3763389|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3941733|NCT01371851|3763390|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3941734|NCT01371851|3763391|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3941735|NCT01371851|3763389|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941736|NCT01371851|3763390|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941737|NCT01371851|3763391|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941738|NCT01371851|3763389|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941739|NCT01371851|3763390|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941740|NCT01371851|3763391|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941741|NCT01371851|3763389|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941742|NCT01371851|3763390|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941743|NCT01371851|3763391|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941744|NCT01371851|3763389|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3941745|NCT01371851|3763390|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3941746|NCT01371851|3763391|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3941747|NCT01371851|3763389|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3941748|NCT01371851|3763390|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3941749|NCT01371851|3763391|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3941750|NCT01371851|3763389|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3941751|NCT01371851|3763390|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3941752|NCT01371851|3763391|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3941753|NCT01371851|3763389|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3941754|NCT01371851|3763390|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3941755|NCT01371851|3763391|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3941756|NCT01371851|3763389|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3941757|NCT01371851|3763390|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3941758|NCT01371851|3763391|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3941759|NCT01371838|3763398|B3|Asian||Race/Ethnicity, Customized||Participants|Number|763|763.0||||||
3941760|NCT01371838|3763399|B2|Asian||Race/Ethnicity, Customized||Participants|Number|382|382.0||||||
3941761|NCT01371838|3763400|B1|Asian||Race/Ethnicity, Customized||Participants|Number|381|381.0||||||
3941762|NCT01371838|3763398|B3||Male|Sex: Female, Male||Participants|Count of Participants|537|537.0||||||
3941763|NCT01371838|3763399|B2||Male|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
3941764|NCT01371838|3763400|B1||Male|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
3941765|NCT01371838|3763398|B3||Female|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
3941766|NCT01371838|3763399|B2||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3941767|NCT01371838|3763400|B1||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3941768|NCT01371838|3763398|B3|>=65 years||Age, Customized||Participants|Number|462|462.0||||||
3941769|NCT01371838|3763399|B2|>=65 years||Age, Customized||Participants|Number|236|236.0||||||
3941770|NCT01371838|3763400|B1|>=65 years||Age, Customized||Participants|Number|226|226.0||||||
3941771|NCT01371838|3763398|B3|<65 years||Age, Customized||Participants|Number|301|301.0||||||
3941772|NCT01371838|3763399|B2|<65 years||Age, Customized||Participants|Number|146|146.0||||||
3941773|NCT01371838|3763400|B1|<65 years||Age, Customized||Participants|Number|155|155.0||||||
3941774|NCT01371838|3763398|B3|||Age||Years|Mean|66.0|66.0|Standard Deviation|14.28|14.28|19.0|94.0|
3941775|NCT01371838|3763399|B2|||Age||Years|Mean|65.8|65.8|Standard Deviation|13.86|13.86|19.0|92.0|
3941776|NCT01371838|3763400|B1|||Age||Years|Mean|66.1|66.1|Standard Deviation|14.70|14.7|21.0|94.0|
3941777|NCT01371825|3763437|B1|India||Region of Enrollment||participants|Number|0|0.0||||||
3941778|NCT01371825|3763437|B1|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3941779|NCT01371825|3763437|B1|France||Region of Enrollment||participants|Number|3|3.0||||||
3941780|NCT01371825|3763437|B1|Italy||Region of Enrollment||participants|Number|0|0.0||||||
3941781|NCT01371825|3763437|B1|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
3941782|NCT01371825|3763437|B1|Egypt||Region of Enrollment||participants|Number|1|1.0||||||
3941783|NCT01371825|3763437|B1|Taiwan||Region of Enrollment||participants|Number|0|0.0||||||
3941784|NCT01371825|3763437|B1|Ireland||Region of Enrollment||participants|Number|1|1.0||||||
3941785|NCT01371825|3763437|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3941786|NCT01371825|3763437|B1|Turkey||Region of Enrollment||participants|Number|1|1.0||||||
3941787|NCT01371825|3763437|B1|Saudi Arabia||Region of Enrollment||participants|Number|0|0.0||||||
3941788|NCT01371825|3763437|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3941789|NCT01371825|3763437|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941790|NCT01371825|3763437|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3941791|NCT01371825|3763437|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3941792|NCT01371825|3763437|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941793|NCT01371825|3763437|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3941794|NCT01371825|3763437|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941795|NCT01371825|3763437|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3941796|NCT01371825|3763437|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3941797|NCT01371825|3763437|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941798|NCT01371825|3763437|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3941799|NCT01371825|3763437|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3941800|NCT01371825|3763437|B1|||Age||months|Median|3|3.0|Full Range|||1.1|5.8|
3941801|NCT01371825|3763437|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3941802|NCT01371825|3763437|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3941803|NCT01371825|3763437|B1||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
3941804|NCT01371786|3763449|B3|United Kingdom||Region of Enrollment||participants|Number|14|14.0||||||
3941805|NCT01371786|3763450|B2|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
3941806|NCT01371786|3763451|B1|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
3941807|NCT01371786|3763449|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3941808|NCT01371786|3763450|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3941809|NCT01371786|3763451|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3941810|NCT01371786|3763449|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3941811|NCT01371786|3763450|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3941812|NCT01371786|3763451|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3941813|NCT01371786|3763449|B3|||Age||years|Mean|35.4|35.4|Standard Deviation|12.34|12.34|||
3941814|NCT01371786|3763450|B2|||Age||years|Mean|34.6|34.6|Standard Deviation|11.96|11.96|||
3941815|NCT01371786|3763451|B1|||Age||years|Mean|36.1|36.1|Standard Deviation|13.62|13.62|||
3941816|NCT01371786|3763449|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3941817|NCT01371786|3763450|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3941818|NCT01371786|3763451|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3941819|NCT01371786|3763449|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3941820|NCT01371786|3763450|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3941821|NCT01371786|3763451|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3941822|NCT01371786|3763449|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3941823|NCT01371786|3763450|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3941824|NCT01371786|3763451|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3941825|NCT01371747|3763466|B7||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
3941826|NCT01371747|3763467|B6||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3941827|NCT01371747|3763468|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3941828|NCT01371747|3763469|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3941829|NCT01371747|3763470|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3941830|NCT01371747|3763471|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3941831|NCT01371747|3763472|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3941832|NCT01371747|3763466|B7||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3941833|NCT01371747|3763467|B6||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3941834|NCT01371747|3763468|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3941835|NCT01371747|3763469|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3941836|NCT01371747|3763470|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3941837|NCT01371747|3763471|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3941838|NCT01371747|3763472|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3941839|NCT01371747|3763466|B7|||Age||years|Median|67.5|67.5|Full Range|||37.0|80.0|
3941840|NCT01371747|3763467|B6|||Age||years|Median|65|65.0|Full Range|||44.0|78.0|
3941841|NCT01371747|3763468|B5|||Age||years|Median|68.5|68.5|Full Range|||39.0|80.0|
3941842|NCT01371747|3763469|B4|||Age||years|Median|66.5|66.5|Full Range|||56.0|76.0|
3941843|NCT01371747|3763470|B3|||Age||years|Median|68|68.0|Full Range|||40.0|79.0|
3941844|NCT01371747|3763471|B2|||Age||years|Median|70|70.0|Full Range|||37.0|79.0|
3941845|NCT01371747|3763472|B1|||Age||years|Median|67|67.0|Full Range|||46.0|80.0|
3941846|NCT01371747|3763466|B7||>=65 years|Age||Participants|Count of Participants|182|182.0||||||
3941847|NCT01371747|3763467|B6||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3941848|NCT01371747|3763468|B5||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3941849|NCT01371747|3763469|B4||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3941850|NCT01371747|3763470|B3||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
3941851|NCT01371747|3763471|B2||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
3941852|NCT01371747|3763472|B1||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
3941853|NCT01371747|3763466|B7||Between 18 and 65 years|Age||Participants|Count of Participants|122|122.0||||||
3941854|NCT01371747|3763467|B6||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3941855|NCT01371747|3763468|B5||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3941856|NCT01371747|3763469|B4||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3941857|NCT01371747|3763470|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3941858|NCT01371747|3763471|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3941859|NCT01371747|3763472|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3941860|NCT01371747|3763466|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3941861|NCT01371747|3763467|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3941862|NCT01371747|3763468|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3941863|NCT01371747|3763469|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3941864|NCT01371747|3763470|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3941865|NCT01371747|3763471|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3941866|NCT01371747|3763472|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3941867|NCT01371734|3763539|B4||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3941868|NCT01371734|3763540|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3941869|NCT01371734|3763541|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3941870|NCT01371734|3763542|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3941871|NCT01371734|3763539|B4||Female|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
3941872|NCT01371734|3763540|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3941873|NCT01371734|3763541|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3941874|NCT01371734|3763542|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3941875|NCT01371734|3763539|B4|||Age||Years|Mean|13.0|13.0|Standard Deviation|2.83|2.83|||
3941876|NCT01371734|3763540|B3|||Age||Years|Mean|12.9|12.9|Standard Deviation|3.01|3.01|||
3941877|NCT01371734|3763541|B2|||Age||Years|Mean|13.1|13.1|Standard Deviation|2.80|2.8|||
3941878|NCT01371734|3763542|B1|||Age||Years|Mean|13.2|13.2|Standard Deviation|2.68|2.68|||
3941879|NCT01371721|3763561|B4||Male|Gender||Participants|Count of Participants|133|133.0||||||
3941880|NCT01371721|3763562|B3||Male|Gender||Participants|Count of Participants|43|43.0||||||
3941881|NCT01371721|3763563|B2||Male|Gender||Participants|Count of Participants|50|50.0||||||
3941882|NCT01371721|3763564|B1||Male|Gender||Participants|Count of Participants|40|40.0||||||
3941883|NCT01371721|3763561|B4||Female|Gender||Participants|Count of Participants|135|135.0||||||
3941884|NCT01371721|3763562|B3||Female|Gender||Participants|Count of Participants|49|49.0||||||
3941885|NCT01371721|3763563|B2||Female|Gender||Participants|Count of Participants|39|39.0||||||
3941886|NCT01371721|3763564|B1||Female|Gender||Participants|Count of Participants|47|47.0||||||
3941887|NCT01371721|3763561|B4|||Age||Years|Mean|12.6|12.6|Standard Deviation|3.01|3.01|||
3941888|NCT01371721|3763562|B3|||Age||Years|Mean|12.8|12.8|Standard Deviation|3.14|3.14|||
3941889|NCT01371721|3763563|B2|||Age||Years|Mean|12.4|12.4|Standard Deviation|3.01|3.01|||
3941890|NCT01371721|3763564|B1|||Age||Years|Mean|12.5|12.5|Standard Deviation|2.90|2.9|||
3941891|NCT01371708|3763596|B4|Other||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
3941892|NCT01371708|3763597|B3|Other||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3941893|NCT01371708|3763598|B2|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3941894|NCT01371708|3763599|B1|Other||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3941895|NCT01371708|3763596|B4|White||Race/Ethnicity, Customized||Participants|Number|187|187.0||||||
3941896|NCT01371708|3763597|B3|White||Race/Ethnicity, Customized||Participants|Number|60|60.0||||||
3941897|NCT01371708|3763598|B2|White||Race/Ethnicity, Customized||Participants|Number|65|65.0||||||
3941898|NCT01371708|3763599|B1|White||Race/Ethnicity, Customized||Participants|Number|62|62.0||||||
3941899|NCT01371708|3763596|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|71|71.0||||||
3941900|NCT01371708|3763597|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|28|28.0||||||
3941901|NCT01371708|3763598|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
3941902|NCT01371708|3763599|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
3941903|NCT01371708|3763596|B4|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3941904|NCT01371708|3763597|B3|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3941905|NCT01371708|3763598|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3941906|NCT01371708|3763599|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3941907|NCT01371708|3763596|B4||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3941908|NCT01371708|3763597|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3941909|NCT01371708|3763598|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3941910|NCT01371708|3763599|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3941911|NCT01371708|3763596|B4||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3941912|NCT01371708|3763597|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3941913|NCT01371708|3763598|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3941914|NCT01371708|3763599|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3941915|NCT01371708|3763596|B4|12 to 17 years||Age, Customized||Participants|Number|194|194.0||||||
3941916|NCT01371708|3763597|B3|12 to 17 years||Age, Customized||Participants|Number|64|64.0||||||
3941917|NCT01371708|3763598|B2|12 to 17 years||Age, Customized||Participants|Number|67|67.0||||||
3941918|NCT01371708|3763599|B1|12 to 17 years||Age, Customized||Participants|Number|63|63.0||||||
3941919|NCT01371708|3763596|B4|7 to 11 years||Age, Customized||Participants|Number|87|87.0||||||
3941920|NCT01371708|3763597|B3|7 to 11 years||Age, Customized||Participants|Number|33|33.0||||||
3941921|NCT01371708|3763598|B2|7 to 11 years||Age, Customized||Participants|Number|26|26.0||||||
3941922|NCT01371708|3763599|B1|7 to 11 years||Age, Customized||Participants|Number|28|28.0||||||
3941923|NCT01371656|3763631|B3|Ireland||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3941924|NCT01371656|3763632|B2|Ireland||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3941925|NCT01371656|3763633|B1|Ireland||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3941926|NCT01371656|3763631|B3|Mexico||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3941927|NCT01371656|3763632|B2|Mexico||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3941928|NCT01371656|3763633|B1|Mexico||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3941929|NCT01371656|3763631|B3|India||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3941930|NCT01371656|3763632|B2|India||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3941931|NCT01371656|3763633|B1|India||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3941932|NCT01371656|3763631|B3|Canada||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
3941933|NCT01371656|3763632|B2|Canada||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3941934|NCT01371656|3763633|B1|Canada||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3941935|NCT01371656|3763631|B3|United States||Region of Enrollment||Participants|Count of Participants|559|559.0||||||
3941936|NCT01371656|3763632|B2|United States||Region of Enrollment||Participants|Count of Participants|272|272.0||||||
3941937|NCT01371656|3763633|B1|United States||Region of Enrollment||Participants|Count of Participants|287|287.0||||||
3941938|NCT01371656|3763631|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3941939|NCT01371656|3763632|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3941940|NCT01371656|3763633|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3941941|NCT01371656|3763631|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941942|NCT01371656|3763632|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941943|NCT01371656|3763633|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941944|NCT01371656|3763631|B3||White|Race (NIH/OMB)||Participants|Count of Participants|433|433.0||||||
3941945|NCT01371656|3763632|B2||White|Race (NIH/OMB)||Participants|Count of Participants|216|216.0||||||
3941946|NCT01371656|3763633|B1||White|Race (NIH/OMB)||Participants|Count of Participants|217|217.0||||||
3941947|NCT01371656|3763631|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3941948|NCT01371656|3763632|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3941949|NCT01371656|3763633|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3941950|NCT01371656|3763631|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941951|NCT01371656|3763632|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941952|NCT01371656|3763633|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941953|NCT01371656|3763631|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3941954|NCT01371656|3763632|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3941955|NCT01371656|3763633|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3941956|NCT01371656|3763631|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941957|NCT01371656|3763632|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941958|NCT01371656|3763633|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3941959|NCT01371656|3763631|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3941960|NCT01371656|3763632|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3941961|NCT01371656|3763633|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3941962|NCT01371656|3763631|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|454|454.0||||||
3941963|NCT01371656|3763632|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|246|246.0||||||
3941964|NCT01371656|3763633|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|208|208.0||||||
3941965|NCT01371656|3763631|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|145|145.0||||||
3941966|NCT01371656|3763632|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3941967|NCT01371656|3763633|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
3941968|NCT01371656|3763631|B3||Male|Sex: Female, Male||Participants|Count of Participants|377|377.0||||||
3941969|NCT01371656|3763632|B2||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3941970|NCT01371656|3763633|B1||Male|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
3941971|NCT01371656|3763631|B3||Female|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
3941972|NCT01371656|3763632|B2||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3941973|NCT01371656|3763633|B1||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3941974|NCT01371656|3763631|B3|||Age||Years|Median|9.31|9.31|Standard Deviation|6.03|6.03|||
3941975|NCT01371656|3763632|B2|||Age||Years|Median|9.18|9.18|Standard Deviation|5.89|5.89|||
3941976|NCT01371656|3763633|B1|||Age||Years|Median|9.44|9.44|Standard Deviation|6.18|6.18|||
3941977|NCT01371656|3763631|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3941978|NCT01371656|3763632|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3941979|NCT01371656|3763633|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3941980|NCT01371656|3763631|B3||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
3941981|NCT01371656|3763632|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3941982|NCT01371656|3763633|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3941983|NCT01371656|3763631|B3||<=18 years|Age||Participants|Count of Participants|559|559.0||||||
3941984|NCT01371656|3763632|B2||<=18 years|Age||Participants|Count of Participants|284|284.0||||||
3941985|NCT01371656|3763633|B1||<=18 years|Age||Participants|Count of Participants|275|275.0||||||
3941986|NCT01371643|3763652|B3|Italy||Region of Enrollment||participants|Number|6|6.0||||||
3941987|NCT01371643|3763653|B2|Italy||Region of Enrollment||participants|Number|4|4.0||||||
3941988|NCT01371643|3763654|B1|Italy||Region of Enrollment||participants|Number|2|2.0||||||
3941989|NCT01371643|3763652|B3|Germany||Region of Enrollment||participants|Number|13|13.0||||||
3941990|NCT01371643|3763653|B2|Germany||Region of Enrollment||participants|Number|8|8.0||||||
3941991|NCT01371643|3763654|B1|Germany||Region of Enrollment||participants|Number|5|5.0||||||
3941992|NCT01371643|3763652|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
3941993|NCT01371643|3763653|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3941994|NCT01371643|3763654|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3941995|NCT01371643|3763652|B3|Other or Unknown||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3941996|NCT01371643|3763653|B2|Other or Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3941997|NCT01371643|3763654|B1|Other or Unknown||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3941998|NCT01371643|3763652|B3|White, not of Hispanic-American Origin||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3941999|NCT01371643|3763653|B2|White, not of Hispanic-American Origin||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3942000|NCT01371643|3763654|B1|White, not of Hispanic-American Origin||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3942001|NCT01371643|3763652|B3|Hispanic-American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3942002|NCT01371643|3763653|B2|Hispanic-American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3942003|NCT01371643|3763654|B1|Hispanic-American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3942004|NCT01371643|3763652|B3|Black, Not of Hispanic-American Origin||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3942005|NCT01371643|3763653|B2|Black, Not of Hispanic-American Origin||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3942006|NCT01371643|3763654|B1|Black, Not of Hispanic-American Origin||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3942007|NCT01371643|3763652|B3|Asian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3942008|NCT01371643|3763653|B2|Asian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3942009|NCT01371643|3763654|B1|Asian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3942010|NCT01371643|3763652|B3|American Indian or Alaskan||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3942011|NCT01371643|3763653|B2|American Indian or Alaskan||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3942012|NCT01371643|3763654|B1|American Indian or Alaskan||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3942013|NCT01371643|3763652|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3942014|NCT01371643|3763653|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3942015|NCT01371643|3763654|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3942016|NCT01371643|3763652|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3942017|NCT01371643|3763653|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3942018|NCT01371643|3763654|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3942019|NCT01371643|3763652|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3942020|NCT01371643|3763653|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3942021|NCT01371643|3763654|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3942022|NCT01371643|3763652|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3942023|NCT01371643|3763653|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3942024|NCT01371643|3763654|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3942025|NCT01371643|3763652|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3942026|NCT01371643|3763653|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3942027|NCT01371643|3763654|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3942028|NCT01371565|3763665|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3942029|NCT01371565|3763665|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3942030|NCT01371565|3763665|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3942031|NCT01371565|3763665|B1|||Age||years|Mean|44.8|44.8|Standard Deviation|17.9|17.9|||
3942032|NCT01371565|3763665|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3942033|NCT01371565|3763665|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3942034|NCT01371565|3763665|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3942035|NCT01371552|3763669|B1|Canada||Region of Enrollment||participants|Number|119|119.0||||||
3942036|NCT01371552|3763669|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3942037|NCT01371552|3763669|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3942038|NCT01371552|3763669|B1|||Age||years|Mean|27|27.0|Standard Deviation|9|9.0|||
3942039|NCT01371539|3763701|B1|United States||Region of Enrollment||participants|Number|104|104.0||||||
3942040|NCT01371539|3763701|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3942041|NCT01371539|3763701|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3942042|NCT01371539|3763701|B1|||Age||years|Mean|49.0|49.0|Standard Deviation|6.3|6.3|||
3942043|NCT01371110|3763710|B3|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3942044|NCT01371110|3763711|B2|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3942045|NCT01371110|3763712|B1|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3942046|NCT01371110|3763710|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3942047|NCT01371110|3763711|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3942048|NCT01371110|3763712|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3942049|NCT01371110|3763710|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942050|NCT01371110|3763711|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942051|NCT01371110|3763712|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942052|NCT01371110|3763710|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942053|NCT01371110|3763711|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942054|NCT01371110|3763712|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942055|NCT01371110|3763710|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942056|NCT01371110|3763711|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942057|NCT01371110|3763712|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942058|NCT01371110|3763710|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942059|NCT01371110|3763711|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942060|NCT01371110|3763712|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942061|NCT01371110|3763710|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942062|NCT01371110|3763711|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942063|NCT01371110|3763712|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942064|NCT01371110|3763710|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942065|NCT01371110|3763711|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942066|NCT01371110|3763712|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942067|NCT01371110|3763710|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3942068|NCT01371110|3763711|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3942069|NCT01371110|3763712|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3942070|NCT01371110|3763710|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3942071|NCT01371110|3763711|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3942072|NCT01371110|3763712|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3942073|NCT01371110|3763710|B3|||Age||years|Mean|48.6|48.6|Full Range|||34.0|63.0|
3942074|NCT01371110|3763711|B2|||Age||years|Mean|48.5|48.5|Full Range|||34.0|63.0|
3942075|NCT01371110|3763712|B1|||Age||years|Mean|49|49.0|Full Range|||49.0|49.0|
3942076|NCT01371110|3763710|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3942077|NCT01371110|3763711|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3942078|NCT01371110|3763712|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3942079|NCT01371110|3763710|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3942080|NCT01371110|3763711|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3942081|NCT01371110|3763712|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3942082|NCT01371110|3763710|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3942083|NCT01371110|3763711|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3942084|NCT01371110|3763712|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3942085|NCT01371006|3763721|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3942086|NCT01371006|3763722|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3942087|NCT01371006|3763723|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3942088|NCT01371006|3763721|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3942089|NCT01371006|3763722|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3942090|NCT01371006|3763723|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3942091|NCT01371006|3763721|B3|||Age||years|Mean|36.1|36.1|Standard Deviation|11.5|11.5|||
3942092|NCT01371006|3763722|B2|||Age||years|Mean|33.1|33.1|Standard Deviation|11.6|11.6|||
3942093|NCT01371006|3763723|B1|||Age||years|Mean|39.4|39.4|Standard Deviation|10.7|10.7|||
3942094|NCT01370863|3763763|B3|Switzerland||Region of Enrollment|All randomized subjects (n = 67).|participants|Number|6|6.0||||||
3942095|NCT01370863|3763764|B2|Switzerland||Region of Enrollment|All randomized subjects (n = 67).|participants|Number|2|2.0||||||
3942096|NCT01370863|3763765|B1|Switzerland||Region of Enrollment|All randomized subjects (n = 67).|participants|Number|4|4.0||||||
3942097|NCT01370863|3763763|B3|United Kingdom||Region of Enrollment|All randomized subjects (n = 67).|participants|Number|7|7.0||||||
3942098|NCT01370863|3763764|B2|United Kingdom||Region of Enrollment|All randomized subjects (n = 67).|participants|Number|4|4.0||||||
3942099|NCT01370863|3763765|B1|United Kingdom||Region of Enrollment|All randomized subjects (n = 67).|participants|Number|3|3.0||||||
3942100|NCT01370863|3763763|B3|Germany||Region of Enrollment|All randomized subjects (n = 67).|participants|Number|8|8.0||||||
3942101|NCT01370863|3763764|B2|Germany||Region of Enrollment|All randomized subjects (n = 67).|participants|Number|4|4.0||||||
3942102|NCT01370863|3763765|B1|Germany||Region of Enrollment|All randomized subjects (n = 67).|participants|Number|4|4.0||||||
3942103|NCT01370863|3763763|B3|Netherlands||Region of Enrollment|All randomized subjects (n = 67).|participants|Number|5|5.0||||||
3942104|NCT01370863|3763764|B2|Netherlands||Region of Enrollment|All randomized subjects (n = 67).|participants|Number|3|3.0||||||
3942105|NCT01370863|3763765|B1|Netherlands||Region of Enrollment|All randomized subjects (n = 67).|participants|Number|2|2.0||||||
3942106|NCT01370863|3763763|B3|Belgium||Region of Enrollment|All randomized subjects (n = 67).|participants|Number|15|15.0||||||
3942107|NCT01370863|3763764|B2|Belgium||Region of Enrollment|All randomized subjects (n = 67).|participants|Number|7|7.0||||||
3942108|NCT01370863|3763765|B1|Belgium||Region of Enrollment|All randomized subjects (n = 67).|participants|Number|8|8.0||||||
3942109|NCT01370863|3763763|B3|France||Region of Enrollment|All randomized subjects (n = 67).|participants|Number|26|26.0||||||
3942110|NCT01370863|3763764|B2|France||Region of Enrollment|All randomized subjects (n = 67).|participants|Number|13|13.0||||||
3942111|NCT01370863|3763765|B1|France||Region of Enrollment|All randomized subjects (n = 67).|participants|Number|13|13.0||||||
3942112|NCT01370863|3763763|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3942113|NCT01370863|3763764|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3942114|NCT01370863|3763765|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3942115|NCT01370863|3763763|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3942116|NCT01370863|3763764|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3942117|NCT01370863|3763765|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3942118|NCT01370863|3763763|B3|Between 18 and 70 years inclusive||Age, Customized||participants|Number|65|65.0||||||
3942119|NCT01370863|3763764|B2|Between 18 and 70 years inclusive||Age, Customized||participants|Number|31|31.0||||||
3942120|NCT01370863|3763765|B1|Between 18 and 70 years inclusive||Age, Customized||participants|Number|34|34.0||||||
3942121|NCT01370863|3763763|B3|||Age||years|Mean|44.8|44.8|Standard Deviation|15.24|15.24|||
3942122|NCT01370863|3763764|B2|||Age||years|Mean|45.8|45.8|Standard Deviation|14.50|14.5|||
3942123|NCT01370863|3763765|B1|||Age||years|Mean|43.8|43.8|Standard Deviation|16.04|16.04|||
3942124|NCT01370837|3763776|B4|Netherlands||Region of Enrollment||participants|Number|41|41.0||||||
3942125|NCT01370837|3763777|B3|Netherlands||Region of Enrollment||participants|Number|17|17.0||||||
3942126|NCT01370837|3763778|B2|Netherlands||Region of Enrollment||participants|Number|12|12.0||||||
3942127|NCT01370837|3763779|B1|Netherlands||Region of Enrollment||participants|Number|12|12.0||||||
3942128|NCT01370837|3763776|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3942129|NCT01370837|3763777|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3942130|NCT01370837|3763778|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3942131|NCT01370837|3763779|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3942132|NCT01370837|3763776|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3942133|NCT01370837|3763777|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3942134|NCT01370837|3763778|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3942135|NCT01370837|3763779|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3942136|NCT01370837|3763776|B4|||Age||years|Mean|64|64.0|Standard Deviation|7.3|7.3|||
3942137|NCT01370837|3763777|B3|||Age||years|Mean|66|66.0|Standard Deviation|5.2|5.2|||
3942138|NCT01370837|3763778|B2|||Age||years|Mean|65|65.0|Standard Deviation|6.7|6.7|||
3942139|NCT01370837|3763779|B1|||Age||years|Mean|59|59.0|Standard Deviation|8.8|8.8|||
3942140|NCT01370733|3763789|B3|Unknown||Education Level||participants|Number|2|2.0||||||
3942141|NCT01370733|3763790|B2|Unknown||Education Level||participants|Number|1|1.0||||||
3942142|NCT01370733|3763791|B1|Unknown||Education Level||participants|Number|1|1.0||||||
3942143|NCT01370733|3763789|B3|Professional or Graduate degree||Education Level||participants|Number|36|36.0||||||
3942144|NCT01370733|3763790|B2|Professional or Graduate degree||Education Level||participants|Number|15|15.0||||||
3942145|NCT01370733|3763791|B1|Professional or Graduate degree||Education Level||participants|Number|21|21.0||||||
3942146|NCT01370733|3763789|B3|College degree||Education Level||participants|Number|84|84.0||||||
3942147|NCT01370733|3763790|B2|College degree||Education Level||participants|Number|42|42.0||||||
3942148|NCT01370733|3763791|B1|College degree||Education Level||participants|Number|42|42.0||||||
3942149|NCT01370733|3763789|B3|Some college||Education Level||participants|Number|48|48.0||||||
3942150|NCT01370733|3763790|B2|Some college||Education Level||participants|Number|31|31.0||||||
3942151|NCT01370733|3763791|B1|Some college||Education Level||participants|Number|17|17.0||||||
3942152|NCT01370733|3763789|B3|Vocational school||Education Level||participants|Number|3|3.0||||||
3942153|NCT01370733|3763790|B2|Vocational school||Education Level||participants|Number|2|2.0||||||
3942154|NCT01370733|3763791|B1|Vocational school||Education Level||participants|Number|1|1.0||||||
3942155|NCT01370733|3763789|B3|High school diploma||Education Level||participants|Number|26|26.0||||||
3942156|NCT01370733|3763790|B2|High school diploma||Education Level||participants|Number|7|7.0||||||
3942157|NCT01370733|3763791|B1|High school diploma||Education Level||participants|Number|19|19.0||||||
3942158|NCT01370733|3763789|B3|Some high school or less||Education Level||participants|Number|3|3.0||||||
3942159|NCT01370733|3763790|B2|Some high school or less||Education Level||participants|Number|1|1.0||||||
3942160|NCT01370733|3763791|B1|Some high school or less||Education Level||participants|Number|2|2.0||||||
3942161|NCT01370733|3763789|B3|Adequate Trial of >= 1 Medication||Antidepressant Exposure in Current Episode|Subjects were asked about previous antidepressant exposure in the current episode. It was possible to select more than one correct response in assessing antidepressant history.|participants|Number|126|126.0||||||
3942162|NCT01370733|3763790|B2|Adequate Trial of >= 1 Medication||Antidepressant Exposure in Current Episode|Subjects were asked about previous antidepressant exposure in the current episode. It was possible to select more than one correct response in assessing antidepressant history.|participants|Number|65|65.0||||||
3942163|NCT01370733|3763791|B1|Adequate Trial of >= 1 Medication||Antidepressant Exposure in Current Episode|Subjects were asked about previous antidepressant exposure in the current episode. It was possible to select more than one correct response in assessing antidepressant history.|participants|Number|61|61.0||||||
3942164|NCT01370733|3763789|B3|Treatment Naive (ATHF 0)||Antidepressant Exposure in Current Episode|Subjects were asked about previous antidepressant exposure in the current episode. It was possible to select more than one correct response in assessing antidepressant history.|participants|Number|77|77.0||||||
3942165|NCT01370733|3763790|B2|Treatment Naive (ATHF 0)||Antidepressant Exposure in Current Episode|Subjects were asked about previous antidepressant exposure in the current episode. It was possible to select more than one correct response in assessing antidepressant history.|participants|Number|37|37.0||||||
3942166|NCT01370733|3763791|B1|Treatment Naive (ATHF 0)||Antidepressant Exposure in Current Episode|Subjects were asked about previous antidepressant exposure in the current episode. It was possible to select more than one correct response in assessing antidepressant history.|participants|Number|40|40.0||||||
3942167|NCT01370733|3763789|B3|Intolerant of >= 1 Medication||Antidepressant Exposure in Current Episode|Subjects were asked about previous antidepressant exposure in the current episode. It was possible to select more than one correct response in assessing antidepressant history.|participants|Number|15|15.0||||||
3942168|NCT01370733|3763790|B2|Intolerant of >= 1 Medication||Antidepressant Exposure in Current Episode|Subjects were asked about previous antidepressant exposure in the current episode. It was possible to select more than one correct response in assessing antidepressant history.|participants|Number|5|5.0||||||
3942169|NCT01370733|3763791|B1|Intolerant of >= 1 Medication||Antidepressant Exposure in Current Episode|Subjects were asked about previous antidepressant exposure in the current episode. It was possible to select more than one correct response in assessing antidepressant history.|participants|Number|10|10.0||||||
3942170|NCT01370733|3763789|B3|Inadequate Dose/Duration of >= 1 Medication||Antidepressant Exposure in Current Episode|Subjects were asked about previous antidepressant exposure in the current episode. It was possible to select more than one correct response in assessing antidepressant history.|participants|Number|24|24.0||||||
3942171|NCT01370733|3763790|B2|Inadequate Dose/Duration of >= 1 Medication||Antidepressant Exposure in Current Episode|Subjects were asked about previous antidepressant exposure in the current episode. It was possible to select more than one correct response in assessing antidepressant history.|participants|Number|13|13.0||||||
3942172|NCT01370733|3763791|B1|Inadequate Dose/Duration of >= 1 Medication||Antidepressant Exposure in Current Episode|Subjects were asked about previous antidepressant exposure in the current episode. It was possible to select more than one correct response in assessing antidepressant history.|participants|Number|11|11.0||||||
3942173|NCT01370733|3763789|B3|||Length of Current Episode in Months||months|Mean|10.85|10.85|Standard Deviation|6.73|6.73|||
3942174|NCT01370733|3763790|B2|||Length of Current Episode in Months||months|Mean|10.8|10.8|Standard Deviation|6.7|6.7|||
3942175|NCT01370733|3763791|B1|||Length of Current Episode in Months||months|Mean|10.9|10.9|Standard Deviation|6.8|6.8|||
3942176|NCT01370733|3763789|B3|||Baseline Mean Hamilton Rating Scale for Depression (HAM-D17)|"For this trial, the Hamilton Rating Scale for Depression (HAM-D28) was performed as a baseline assessment. A subset of the HAM-D28, the HAM-D17, was utilized as both a baseline and efficacy measure. It's considered the gold standard for rating depression severity and used frequently in clinical trials.~The HAM-D17 score ranges from 0-52; a score of 0–7 is generally accepted to be within the normal range (or in clinical remission), while a score of 20 or higher indicates at least moderate severity. A reduction of 50% or more in total score from Baseline indicates clinical response."|units on a scale|Mean|21.55|21.55|Standard Deviation|3.37|3.37|||
3942177|NCT01370733|3763790|B2|||Baseline Mean Hamilton Rating Scale for Depression (HAM-D17)|"For this trial, the Hamilton Rating Scale for Depression (HAM-D28) was performed as a baseline assessment. A subset of the HAM-D28, the HAM-D17, was utilized as both a baseline and efficacy measure. It's considered the gold standard for rating depression severity and used frequently in clinical trials.~The HAM-D17 score ranges from 0-52; a score of 0–7 is generally accepted to be within the normal range (or in clinical remission), while a score of 20 or higher indicates at least moderate severity. A reduction of 50% or more in total score from Baseline indicates clinical response."|units on a scale|Mean|21.15|21.15|Standard Deviation|3.25|3.25|||
3942178|NCT01370733|3763791|B1|||Baseline Mean Hamilton Rating Scale for Depression (HAM-D17)|"For this trial, the Hamilton Rating Scale for Depression (HAM-D28) was performed as a baseline assessment. A subset of the HAM-D28, the HAM-D17, was utilized as both a baseline and efficacy measure. It's considered the gold standard for rating depression severity and used frequently in clinical trials.~The HAM-D17 score ranges from 0-52; a score of 0–7 is generally accepted to be within the normal range (or in clinical remission), while a score of 20 or higher indicates at least moderate severity. A reduction of 50% or more in total score from Baseline indicates clinical response."|units on a scale|Mean|21.94|21.94|Standard Deviation|3.46|3.46|||
3942179|NCT01370733|3763789|B3|United States||Region of Enrollment||participants|Number|202|202.0||||||
3942180|NCT01370733|3763790|B2|United States||Region of Enrollment||participants|Number|99|99.0||||||
3942181|NCT01370733|3763791|B1|United States||Region of Enrollment||participants|Number|103|103.0||||||
3942182|NCT01370733|3763789|B3|Other or Unknown||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3942183|NCT01370733|3763790|B2|Other or Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3942184|NCT01370733|3763791|B1|Other or Unknown||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3942185|NCT01370733|3763789|B3|White||Race/Ethnicity, Customized||participants|Number|161|161.0||||||
3942186|NCT01370733|3763790|B2|White||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
3942187|NCT01370733|3763791|B1|White||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
3942188|NCT01370733|3763789|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3942189|NCT01370733|3763790|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3942190|NCT01370733|3763791|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3942191|NCT01370733|3763789|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3942192|NCT01370733|3763790|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3942193|NCT01370733|3763791|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3942194|NCT01370733|3763789|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3942195|NCT01370733|3763790|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3942196|NCT01370733|3763791|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3942197|NCT01370733|3763789|B3|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3942198|NCT01370733|3763790|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3942199|NCT01370733|3763791|B1|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3942200|NCT01370733|3763789|B3|American Indian / Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3942201|NCT01370733|3763790|B2|American Indian / Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3942202|NCT01370733|3763791|B1|American Indian / Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3942203|NCT01370733|3763789|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3942204|NCT01370733|3763790|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3942205|NCT01370733|3763791|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3942206|NCT01370733|3763789|B3||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3942207|NCT01370733|3763790|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3942208|NCT01370733|3763791|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3942209|NCT01370733|3763789|B3|||Age||years|Mean|45.9|45.9|Standard Deviation|11.7|11.7|||
3942210|NCT01370733|3763790|B2|||Age||years|Mean|45.7|45.7|Standard Deviation|12.2|12.2|||
3942211|NCT01370733|3763791|B1|||Age||years|Mean|46.1|46.1|Standard Deviation|11.3|11.3|||
3942212|NCT01370694|3763814|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3942213|NCT01370694|3763814|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3942214|NCT01370694|3763814|B1|||Age||Years|Mean|56.1|56.1|Standard Deviation|16.4|16.4|||
3942215|NCT01370655|3763824|B13||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3942216|NCT01370655|3763825|B12||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3942217|NCT01370655|3763826|B11||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3942218|NCT01370655|3763827|B10||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3942219|NCT01370655|3763828|B9||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3942220|NCT01370655|3763829|B8||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3942221|NCT01370655|3763830|B7||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3942222|NCT01370655|3763831|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3942223|NCT01370655|3763832|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3942224|NCT01370655|3763833|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3942225|NCT01370655|3763834|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3942226|NCT01370655|3763835|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3942227|NCT01370655|3763836|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3942228|NCT01370655|3763824|B13||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3942229|NCT01370655|3763825|B12||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3942230|NCT01370655|3763826|B11||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3942231|NCT01370655|3763827|B10||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3942232|NCT01370655|3763828|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3942233|NCT01370655|3763829|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3942234|NCT01370655|3763830|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3942235|NCT01370655|3763831|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3942236|NCT01370655|3763832|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3942237|NCT01370655|3763833|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3942238|NCT01370655|3763834|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3942239|NCT01370655|3763835|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3942240|NCT01370655|3763836|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3942241|NCT01370655|3763824|B13|||Age||years|Mean|54.4|54.4|Standard Deviation|9.2|9.2|||
3942242|NCT01370655|3763825|B12|||Age||years|Mean|49.0|49.0|Standard Deviation|9.2|9.2|||
3942243|NCT01370655|3763826|B11|||Age||years|Mean|50.0|50.0|Standard Deviation|1.0|1.0|||
3942244|NCT01370655|3763827|B10|||Age||years|Mean|60.5|60.5|Standard Deviation|6.4|6.4|||
3942245|NCT01370655|3763828|B9|||Age||years|Mean|48.3|48.3|Standard Deviation|12.6|12.6|||
3942246|NCT01370655|3763829|B8|||Age||years|Mean|52.0|52.0|Standard Deviation|9.6|9.6|||
3942247|NCT01370655|3763830|B7|||Age||years|Mean|60.0|60.0|Standard Deviation|6.7|6.7|||
3942248|NCT01370655|3763831|B6|||Age||years|Mean|54.8|54.8|Standard Deviation|14.7|14.7|||
3942249|NCT01370655|3763832|B5|||Age||years|Mean|59.3|59.3|Standard Deviation|8.3|8.3|||
3942250|NCT01370655|3763833|B4|||Age||years|Mean|60.7|60.7|Standard Deviation|3.2|3.2|||
3942251|NCT01370655|3763834|B3|||Age||years|Mean|58.3|58.3|Standard Deviation|4.5|4.5|||
3942252|NCT01370655|3763835|B2|||Age||years|Mean|56.1|56.1|Standard Deviation|10.9|10.9|||
3942253|NCT01370655|3763836|B1|||Age||years|Mean|49.1|49.1|Standard Deviation|8.1|8.1|||
3942254|NCT01370642|3763881|B4||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3942255|NCT01370642|3763882|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3942256|NCT01370642|3763883|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3942257|NCT01370642|3763884|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3942258|NCT01370642|3763881|B4||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3942259|NCT01370642|3763882|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3942260|NCT01370642|3763883|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3942261|NCT01370642|3763884|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3942262|NCT01370642|3763881|B4|||Age||years|Mean|54.5|54.5|Standard Deviation|10.6|10.6|||
3942263|NCT01370642|3763882|B3|||Age||years|Mean|54.8|54.8|Standard Deviation|9.9|9.9|||
3942264|NCT01370642|3763883|B2|||Age||years|Mean|55.5|55.5|Standard Deviation|9.7|9.7|||
3942265|NCT01370642|3763884|B1|||Age||years|Mean|53.2|53.2|Standard Deviation|12.0|12.0|||
3942266|NCT01370616|3763915|B3||Male|Sex: Female, Male||Participants|Count of Participants|364|364.0||||||
3942267|NCT01370616|3763916|B2||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3942268|NCT01370616|3763917|B1||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
3942269|NCT01370616|3763915|B3||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3942270|NCT01370616|3763916|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3942271|NCT01370616|3763917|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3942272|NCT01370616|3763915|B3|||Age||Years|Mean|60.9|60.9|Standard Deviation|10.5|10.5|||
3942273|NCT01370616|3763916|B2|||Age||Years|Mean|60.4|60.4|Standard Deviation|10.1|10.1|||
3942274|NCT01370616|3763917|B1|||Age||Years|Mean|61.4|61.4|Standard Deviation|10.9|10.9|||
3942275|NCT01370603|3763940|B3||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3942276|NCT01370603|3763941|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3942277|NCT01370603|3763942|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3942278|NCT01370603|3763940|B3||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
3942279|NCT01370603|3763941|B2||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3942280|NCT01370603|3763942|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3942281|NCT01370603|3763940|B3|≥ 65 years||Age, Customized||Participants|Number|55|55.0||||||
3942282|NCT01370603|3763941|B2|≥ 65 years||Age, Customized||Participants|Number|30|30.0||||||
3942283|NCT01370603|3763942|B1|≥ 65 years||Age, Customized||Participants|Number|25|25.0||||||
3942284|NCT01370603|3763940|B3|60 to 64 years||Age, Customized||Participants|Number|55|55.0||||||
3942285|NCT01370603|3763941|B2|60 to 64 years||Age, Customized||Participants|Number|35|35.0||||||
3942286|NCT01370603|3763942|B1|60 to 64 years||Age, Customized||Participants|Number|20|20.0||||||
3942287|NCT01370603|3763940|B3|50 to 59 years||Age, Customized||Participants|Number|135|135.0||||||
3942288|NCT01370603|3763941|B2|50 to 59 years||Age, Customized||Participants|Number|61|61.0||||||
3942289|NCT01370603|3763942|B1|50 to 59 years||Age, Customized||Participants|Number|74|74.0||||||
3942290|NCT01370603|3763940|B3|40 to 49 years||Age, Customized||Participants|Number|64|64.0||||||
3942291|NCT01370603|3763941|B2|40 to 49 years||Age, Customized||Participants|Number|29|29.0||||||
3942292|NCT01370603|3763942|B1|40 to 49 years||Age, Customized||Participants|Number|35|35.0||||||
3942293|NCT01370603|3763940|B3|30 to 39 years||Age, Customized||Participants|Number|19|19.0||||||
3942294|NCT01370603|3763941|B2|30 to 39 years||Age, Customized||Participants|Number|9|9.0||||||
3942295|NCT01370603|3763942|B1|30 to 39 years||Age, Customized||Participants|Number|10|10.0||||||
3942296|NCT01370590|3763959|B3||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3942297|NCT01370590|3763960|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3942298|NCT01370590|3763961|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3942299|NCT01370590|3763959|B3||Female|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
3942300|NCT01370590|3763960|B2||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3942301|NCT01370590|3763961|B1||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3942302|NCT01370590|3763959|B3|≥65 years||Age, Customized||Participants|Number|69|69.0||||||
3942303|NCT01370590|3763960|B2|≥65 years||Age, Customized||Participants|Number|33|33.0||||||
3942304|NCT01370590|3763961|B1|≥65 years||Age, Customized||Participants|Number|36|36.0||||||
3942305|NCT01370590|3763959|B3|60 to 64 years||Age, Customized||Participants|Number|91|91.0||||||
3942306|NCT01370590|3763960|B2|60 to 64 years||Age, Customized||Participants|Number|51|51.0||||||
3942307|NCT01370590|3763961|B1|60 to 64 years||Age, Customized||Participants|Number|40|40.0||||||
3942308|NCT01370590|3763959|B3|50 to 59 years||Age, Customized||Participants|Number|159|159.0||||||
3942309|NCT01370590|3763960|B2|50 to 59 years||Age, Customized||Participants|Number|81|81.0||||||
3942310|NCT01370590|3763961|B1|50 to 59 years||Age, Customized||Participants|Number|78|78.0||||||
3942311|NCT01370590|3763959|B3|40 to 49 years||Age, Customized||Participants|Number|63|63.0||||||
3942312|NCT01370590|3763960|B2|40 to 49 years||Age, Customized||Participants|Number|28|28.0||||||
3942313|NCT01370590|3763961|B1|40 to 49 years||Age, Customized||Participants|Number|35|35.0||||||
3942314|NCT01370590|3763959|B3|30 to 39 years||Age, Customized||Participants|Number|24|24.0||||||
3942315|NCT01370590|3763960|B2|30 to 39 years||Age, Customized||Participants|Number|10|10.0||||||
3942316|NCT01370590|3763961|B1|30 to 39 years||Age, Customized||Participants|Number|14|14.0||||||
3942317|NCT01370564|3763978|B1||Class IV|New York Heart Association Classification|"The New York Heart Association (NYHA) Functional Classification classifies the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity.~Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bedbound patients."|Participants|Count of Participants|0|0.0||||||
3942318|NCT01370564|3763978|B1||Class III|New York Heart Association Classification|"The New York Heart Association (NYHA) Functional Classification classifies the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity.~Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bedbound patients."|Participants|Count of Participants|5|5.0||||||
3942319|NCT01370564|3763978|B1||Class II|New York Heart Association Classification|"The New York Heart Association (NYHA) Functional Classification classifies the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity.~Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bedbound patients."|Participants|Count of Participants|12|12.0||||||
3942320|NCT01370564|3763978|B1||Class I|New York Heart Association Classification|"The New York Heart Association (NYHA) Functional Classification classifies the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity.~Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bedbound patients."|Participants|Count of Participants|4|4.0||||||
3942321|NCT01370564|3763978|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3942322|NCT01370564|3763978|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3942323|NCT01370564|3763978|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3942324|NCT01370564|3763978|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|12.7|12.7|||
3942325|NCT01370538|3763988|B3|NOT REPORTED||Race/Ethnicity, Customized||Participants|Number|191|191.0||||||
3942326|NCT01370538|3763989|B2|NOT REPORTED||Race/Ethnicity, Customized||Participants|Number|100|100.0||||||
3942327|NCT01370538|3763990|B1|NOT REPORTED||Race/Ethnicity, Customized||Participants|Number|91|91.0||||||
3942328|NCT01370538|3763988|B3|NOT HISPANIC OR LATINO||Race/Ethnicity, Customized||Participants|Number|101|101.0||||||
3942329|NCT01370538|3763989|B2|NOT HISPANIC OR LATINO||Race/Ethnicity, Customized||Participants|Number|46|46.0||||||
3942330|NCT01370538|3763990|B1|NOT HISPANIC OR LATINO||Race/Ethnicity, Customized||Participants|Number|55|55.0||||||
3942331|NCT01370538|3763988|B3|HISPANIC OR LATINO||Race/Ethnicity, Customized||Participants|Number|49|49.0||||||
3942332|NCT01370538|3763989|B2|HISPANIC OR LATINO||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
3942333|NCT01370538|3763990|B1|HISPANIC OR LATINO||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
3942334|NCT01370538|3763988|B3|OTHER||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3942335|NCT01370538|3763989|B2|OTHER||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3942336|NCT01370538|3763990|B1|OTHER||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3942337|NCT01370538|3763988|B3|AMERICAN INDIAN/ALASKA NATIVE||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3942338|NCT01370538|3763989|B2|AMERICAN INDIAN/ALASKA NATIVE||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3942339|NCT01370538|3763990|B1|AMERICAN INDIAN/ALASKA NATIVE||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3942340|NCT01370538|3763988|B3|NATIVE HAWAIIAN/PACIFIC ISLANDER||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3942341|NCT01370538|3763989|B2|NATIVE HAWAIIAN/PACIFIC ISLANDER||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3942342|NCT01370538|3763990|B1|NATIVE HAWAIIAN/PACIFIC ISLANDER||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3942343|NCT01370538|3763988|B3|BLACK OR AFRICAN AMERICAN||Race/Ethnicity, Customized||Participants|Number|102|102.0||||||
3942344|NCT01370538|3763989|B2|BLACK OR AFRICAN AMERICAN||Race/Ethnicity, Customized||Participants|Number|50|50.0||||||
3942345|NCT01370538|3763990|B1|BLACK OR AFRICAN AMERICAN||Race/Ethnicity, Customized||Participants|Number|52|52.0||||||
3942346|NCT01370538|3763988|B3|WHITE||Race/Ethnicity, Customized||Participants|Number|231|231.0||||||
3942347|NCT01370538|3763989|B2|WHITE||Race/Ethnicity, Customized||Participants|Number|120|120.0||||||
3942348|NCT01370538|3763990|B1|WHITE||Race/Ethnicity, Customized||Participants|Number|111|111.0||||||
3942349|NCT01370538|3763988|B3||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3942350|NCT01370538|3763989|B2||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3942351|NCT01370538|3763990|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3942352|NCT01370538|3763988|B3||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
3942353|NCT01370538|3763989|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3942354|NCT01370538|3763990|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3942355|NCT01370538|3763988|B3|All||Age||Years|Mean|42.2|42.2|Standard Deviation|13.6|13.6|||
3942356|NCT01370538|3763989|B2|All||Age||Years|Mean|42.8|42.8|Standard Deviation|13.2|13.2|||
3942357|NCT01370538|3763990|B1|All||Age||Years|Mean|41.6|41.6|Standard Deviation|14.0|14.0|||
3942358|NCT01370525|3764005|B3|NOT REPORTED||Race/Ethnicity, Customized|Randomized population was analyzed using criteria of hispanic or latino/ not hispanic or latino/ not reported.|Participants|Number|165|165.0||||||
3942359|NCT01370525|3764006|B2|NOT REPORTED||Race/Ethnicity, Customized|Randomized population was analyzed using criteria of hispanic or latino/ not hispanic or latino/ not reported.|Participants|Number|84|84.0||||||
3942360|NCT01370525|3764007|B1|NOT REPORTED||Race/Ethnicity, Customized|Randomized population was analyzed using criteria of hispanic or latino/ not hispanic or latino/ not reported.|Participants|Number|81|81.0||||||
3942361|NCT01370525|3764005|B3|NOT HISPANIC OR LATINO||Race/Ethnicity, Customized|Randomized population was analyzed using criteria of hispanic or latino/ not hispanic or latino/ not reported.|Participants|Number|115|115.0||||||
3942362|NCT01370525|3764006|B2|NOT HISPANIC OR LATINO||Race/Ethnicity, Customized|Randomized population was analyzed using criteria of hispanic or latino/ not hispanic or latino/ not reported.|Participants|Number|59|59.0||||||
3942363|NCT01370525|3764007|B1|NOT HISPANIC OR LATINO||Race/Ethnicity, Customized|Randomized population was analyzed using criteria of hispanic or latino/ not hispanic or latino/ not reported.|Participants|Number|56|56.0||||||
3942364|NCT01370525|3764005|B3|HISPANIC OR LATINO||Race/Ethnicity, Customized|Randomized population was analyzed using criteria of hispanic or latino/ not hispanic or latino/ not reported.|Participants|Number|60|60.0||||||
3942365|NCT01370525|3764006|B2|HISPANIC OR LATINO||Race/Ethnicity, Customized|Randomized population was analyzed using criteria of hispanic or latino/ not hispanic or latino/ not reported.|Participants|Number|26|26.0||||||
3942366|NCT01370525|3764007|B1|HISPANIC OR LATINO||Race/Ethnicity, Customized|Randomized population was analyzed using criteria of hispanic or latino/ not hispanic or latino/ not reported.|Participants|Number|34|34.0||||||
3942367|NCT01370525|3764005|B3|OTHER||Race/Ethnicity, Customized|Randomized population was analyzed using criteria of white/ black or african american/ asian/ american indian or alaska native /white.|Participants|Number|3|3.0||||||
3942368|NCT01370525|3764006|B2|OTHER||Race/Ethnicity, Customized|Randomized population was analyzed using criteria of white/ black or african american/ asian/ american indian or alaska native /white.|Participants|Number|1|1.0||||||
3942369|NCT01370525|3764007|B1|OTHER||Race/Ethnicity, Customized|Randomized population was analyzed using criteria of white/ black or african american/ asian/ american indian or alaska native /white.|Participants|Number|2|2.0||||||
3942370|NCT01370525|3764005|B3|AMERICAN INDIAN/ALASKA NATIVE||Race/Ethnicity, Customized|Randomized population was analyzed using criteria of white/ black or african american/ asian/ american indian or alaska native /white.|Participants|Number|1|1.0||||||
3942371|NCT01370525|3764006|B2|AMERICAN INDIAN/ALASKA NATIVE||Race/Ethnicity, Customized|Randomized population was analyzed using criteria of white/ black or african american/ asian/ american indian or alaska native /white.|Participants|Number|0|0.0||||||
3942372|NCT01370525|3764007|B1|AMERICAN INDIAN/ALASKA NATIVE||Race/Ethnicity, Customized|Randomized population was analyzed using criteria of white/ black or african american/ asian/ american indian or alaska native /white.|Participants|Number|1|1.0||||||
3942425|NCT01370460|3764058|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3942426|NCT01370460|3764059|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3942373|NCT01370525|3764005|B3|ASIAN||Race/Ethnicity, Customized|Randomized population was analyzed using criteria of white/ black or african american/ asian/ american indian or alaska native /white.|Participants|Number|1|1.0||||||
3942374|NCT01370525|3764006|B2|ASIAN||Race/Ethnicity, Customized|Randomized population was analyzed using criteria of white/ black or african american/ asian/ american indian or alaska native /white.|Participants|Number|1|1.0||||||
3942375|NCT01370525|3764007|B1|ASIAN||Race/Ethnicity, Customized|Randomized population was analyzed using criteria of white/ black or african american/ asian/ american indian or alaska native /white.|Participants|Number|0|0.0||||||
3942376|NCT01370525|3764005|B3|BLACK OR AFRICAN AMERICAN||Race/Ethnicity, Customized|Randomized population was analyzed using criteria of white/ black or african american/ asian/ american indian or alaska native /white.|Participants|Number|120|120.0||||||
3942377|NCT01370525|3764006|B2|BLACK OR AFRICAN AMERICAN||Race/Ethnicity, Customized|Randomized population was analyzed using criteria of white/ black or african american/ asian/ american indian or alaska native /white.|Participants|Number|55|55.0||||||
3942378|NCT01370525|3764007|B1|BLACK OR AFRICAN AMERICAN||Race/Ethnicity, Customized|Randomized population was analyzed using criteria of white/ black or african american/ asian/ american indian or alaska native /white.|Participants|Number|65|65.0||||||
3942379|NCT01370525|3764005|B3|WHITE||Race/Ethnicity, Customized|Randomized population was analyzed using criteria of white/ black or african american/ asian/ american indian or alaska native /white.|Participants|Number|215|215.0||||||
3942380|NCT01370525|3764006|B2|WHITE||Race/Ethnicity, Customized|Randomized population was analyzed using criteria of white/ black or african american/ asian/ american indian or alaska native /white.|Participants|Number|112|112.0||||||
3942381|NCT01370525|3764007|B1|WHITE||Race/Ethnicity, Customized|Randomized population was analyzed using criteria of white/ black or african american/ asian/ american indian or alaska native /white.|Participants|Number|103|103.0||||||
3942382|NCT01370525|3764005|B3||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3942383|NCT01370525|3764006|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3942384|NCT01370525|3764007|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3942385|NCT01370525|3764005|B3||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3942386|NCT01370525|3764006|B2||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3942387|NCT01370525|3764007|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3942388|NCT01370525|3764005|B3|||Age||Years|Mean|44.75|44.75|Standard Deviation|12.4|12.4|||
3942389|NCT01370525|3764006|B2|||Age||Years|Mean|45.9|45.9|Standard Deviation|12.6|12.6|||
3942390|NCT01370525|3764007|B1|||Age||Years|Mean|43.6|43.6|Standard Deviation|12.2|12.2|||
3942391|NCT01370499|3764022|B3|Japan||Region of Enrollment||Participants|Count of Participants|288|288.0||||||
3942392|NCT01370499|3764023|B2|Japan||Region of Enrollment||Participants|Count of Participants|93|93.0||||||
3942393|NCT01370499|3764024|B1|Japan||Region of Enrollment||Participants|Count of Participants|195|195.0||||||
3942394|NCT01370499|3764022|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|288|288.0||||||
3942395|NCT01370499|3764023|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|93|93.0||||||
3942396|NCT01370499|3764024|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|195|195.0||||||
3942397|NCT01370499|3764022|B3||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3942398|NCT01370499|3764023|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3942399|NCT01370499|3764024|B1||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3942400|NCT01370499|3764022|B3||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3942401|NCT01370499|3764023|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3942402|NCT01370499|3764024|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3942403|NCT01370499|3764022|B3|||Age||years|Mean|38.68|38.68|Standard Deviation|9.36|9.36|||
3942404|NCT01370499|3764023|B2|||Age||years|Mean|37.40|37.4|Standard Deviation|9.18|9.18|||
3942405|NCT01370499|3764024|B1|||Age||years|Mean|39.28|39.28|Standard Deviation|9.41|9.41|||
3942406|NCT01370460|3764057|B3|United States||Region of Enrollment||participants|Number|101|101.0||||||
3942407|NCT01370460|3764058|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
3942408|NCT01370460|3764059|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3942409|NCT01370460|3764057|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3942410|NCT01370460|3764058|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3942411|NCT01370460|3764059|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3942412|NCT01370460|3764057|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3942413|NCT01370460|3764058|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3942414|NCT01370460|3764059|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3942415|NCT01370460|3764057|B3|||Age||years|Mean|65.75|65.75|Standard Deviation|8.6|8.6|||
3942416|NCT01370460|3764058|B2|||Age||years|Mean|64.5|64.5|Standard Deviation|8.2|8.2|||
3942417|NCT01370460|3764059|B1|||Age||years|Mean|67|67.0|Standard Deviation|9|9.0|||
3942418|NCT01370460|3764057|B3||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
3942419|NCT01370460|3764058|B2||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3942420|NCT01370460|3764059|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3942421|NCT01370460|3764057|B3||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3942422|NCT01370460|3764058|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3942423|NCT01370460|3764059|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3942424|NCT01370460|3764057|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3942427|NCT01370408|3764067|B1|United States||Region of Enrollment||participants|Number|85|85.0||||||
3942428|NCT01370408|3764067|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3942429|NCT01370408|3764067|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3942430|NCT01370408|3764067|B1|||Age||years|Median|57|57.0|Full Range|||20.0|74.0|
3942431|NCT01370408|3764067|B1||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
3942432|NCT01370408|3764067|B1||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
3942433|NCT01370408|3764067|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3942434|NCT01370369|3764078|B1|||Weight||lbs|Mean|196.2|196.2|Standard Deviation|23.3|23.3|||
3942435|NCT01370369|3764078|B1|||Height||Inch|Mean|69.7|69.7|Standard Deviation|3.2|3.2|||
3942436|NCT01370369|3764078|B1|||Body Mass Index (BMI)||Kg/m^2|Mean|28.3|28.3|Standard Deviation|2.3|2.3|||
3942437|NCT01370369|3764078|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942438|NCT01370369|3764078|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942439|NCT01370369|3764078|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3942440|NCT01370369|3764078|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3942441|NCT01370369|3764078|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942442|NCT01370369|3764078|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3942443|NCT01370369|3764078|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942444|NCT01370369|3764078|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942445|NCT01370369|3764078|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3942446|NCT01370369|3764078|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3942447|NCT01370369|3764078|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3942448|NCT01370369|3764078|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3942449|NCT01370369|3764078|B1|||Age||year|Mean|47.9|47.9|Standard Deviation|9.9|9.9|||
3942450|NCT01370356|3764125|B3||Male|Sex: Female, Male||Participants|Count of Participants|842|842.0||||||
3942451|NCT01370356|3764126|B2||Male|Sex: Female, Male||Participants|Count of Participants|421|421.0||||||
3942452|NCT01370356|3764127|B1||Male|Sex: Female, Male||Participants|Count of Participants|421|421.0||||||
3942453|NCT01370356|3764125|B3||Female|Sex: Female, Male||Participants|Count of Participants|651|651.0||||||
3942454|NCT01370356|3764126|B2||Female|Sex: Female, Male||Participants|Count of Participants|321|321.0||||||
3942455|NCT01370356|3764127|B1||Female|Sex: Female, Male||Participants|Count of Participants|330|330.0||||||
3942456|NCT01370356|3764125|B3|||Age||Years|Mean|44.6|44.6|Standard Deviation|11.9|11.9|||
3942457|NCT01370356|3764126|B2|||Age||Years|Mean|44.4|44.4|Standard Deviation|12.0|12.0|||
3942458|NCT01370356|3764127|B1|||Age||Years|Mean|44.7|44.7|Standard Deviation|11.8|11.8|||
3942459|NCT01370265|3764142|B1|||Body Mass Index||kg/m^2|Mean|26.1|26.1|Standard Deviation|4.3|4.3|||
3942460|NCT01370265|3764142|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3942461|NCT01370265|3764142|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3942462|NCT01370265|3764142|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3942463|NCT01370265|3764142|B1|||Age||years|Mean|44|44.0|Standard Deviation|8|8.0|||
3942464|NCT01370083|3764160|B3|Normal Scores (1 or 2)||Penetration-Aspiration, Categorical|The 8-point Penetration-Aspiration Scale is an ordinal rating scale used to rate the severity of airway invasion during swallowing. Scores of 1 and 2 are considered normal. Here we report the number of participants displaying abnormal scores (i.e. of 3 and higher) vs normal scores (1 or 2) on thin liquid swallows in videofluoroscopy.|participants|Number|6|6.0||||||
3942465|NCT01370083|3764161|B2|Normal Scores (1 or 2)||Penetration-Aspiration, Categorical|The 8-point Penetration-Aspiration Scale is an ordinal rating scale used to rate the severity of airway invasion during swallowing. Scores of 1 and 2 are considered normal. Here we report the number of participants displaying abnormal scores (i.e. of 3 and higher) vs normal scores (1 or 2) on thin liquid swallows in videofluoroscopy.|participants|Number|3|3.0||||||
3942466|NCT01370083|3764162|B1|Normal Scores (1 or 2)||Penetration-Aspiration, Categorical|The 8-point Penetration-Aspiration Scale is an ordinal rating scale used to rate the severity of airway invasion during swallowing. Scores of 1 and 2 are considered normal. Here we report the number of participants displaying abnormal scores (i.e. of 3 and higher) vs normal scores (1 or 2) on thin liquid swallows in videofluoroscopy.|participants|Number|3|3.0||||||
3942467|NCT01370083|3764160|B3|Abnormal Scores (3 or higher)||Penetration-Aspiration, Categorical|The 8-point Penetration-Aspiration Scale is an ordinal rating scale used to rate the severity of airway invasion during swallowing. Scores of 1 and 2 are considered normal. Here we report the number of participants displaying abnormal scores (i.e. of 3 and higher) vs normal scores (1 or 2) on thin liquid swallows in videofluoroscopy.|participants|Number|8|8.0||||||
3942468|NCT01370083|3764161|B2|Abnormal Scores (3 or higher)||Penetration-Aspiration, Categorical|The 8-point Penetration-Aspiration Scale is an ordinal rating scale used to rate the severity of airway invasion during swallowing. Scores of 1 and 2 are considered normal. Here we report the number of participants displaying abnormal scores (i.e. of 3 and higher) vs normal scores (1 or 2) on thin liquid swallows in videofluoroscopy.|participants|Number|4|4.0||||||
3942469|NCT01370083|3764162|B1|Abnormal Scores (3 or higher)||Penetration-Aspiration, Categorical|The 8-point Penetration-Aspiration Scale is an ordinal rating scale used to rate the severity of airway invasion during swallowing. Scores of 1 and 2 are considered normal. Here we report the number of participants displaying abnormal scores (i.e. of 3 and higher) vs normal scores (1 or 2) on thin liquid swallows in videofluoroscopy.|participants|Number|4|4.0||||||
3942512|NCT01369888|3764231|B5|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
3942470|NCT01370083|3764160|B3|||Swallow Response Time (thin liquids), Categorical|This is a categorical measure (within vs.above normal limits) of the time interval between a thin liquid bolus entering the pharynx (passing the shadow of the ramus of mandible) and onset of upward-anterior hyolaryngeal excursion for the swallow. The continuous parameter is measured in milliseconds from videofluoroscopy. Durations < 350 ms are considered within normal limits; those > 350 ms are considered prolonged. Prolonged swallow response time on thin liquid swallows at baseline was an inclusion criterion for this study. We report the # of participants with values > 350 ms.|participants|Number|14|14.0||||||
3942471|NCT01370083|3764161|B2|||Swallow Response Time (thin liquids), Categorical|This is a categorical measure (within vs.above normal limits) of the time interval between a thin liquid bolus entering the pharynx (passing the shadow of the ramus of mandible) and onset of upward-anterior hyolaryngeal excursion for the swallow. The continuous parameter is measured in milliseconds from videofluoroscopy. Durations < 350 ms are considered within normal limits; those > 350 ms are considered prolonged. Prolonged swallow response time on thin liquid swallows at baseline was an inclusion criterion for this study. We report the # of participants with values > 350 ms.|participants|Number|7|7.0||||||
3942472|NCT01370083|3764162|B1|||Swallow Response Time (thin liquids), Categorical|This is a categorical measure (within vs.above normal limits) of the time interval between a thin liquid bolus entering the pharynx (passing the shadow of the ramus of mandible) and onset of upward-anterior hyolaryngeal excursion for the swallow. The continuous parameter is measured in milliseconds from videofluoroscopy. Durations < 350 ms are considered within normal limits; those > 350 ms are considered prolonged. Prolonged swallow response time on thin liquid swallows at baseline was an inclusion criterion for this study. We report the # of participants with values > 350 ms.|participants|Number|7|7.0||||||
3942473|NCT01370083|3764160|B3|||Tongue Strength, Continuous|1 Repetition Maximum Isometric Tongue-Palate Pressure measured across 3 repetitions of maximum isometric tongue pressure generation using the Iowa Oral Performance Instrument, with the bulb located in a posterior position in the mouth (with the flat edge of the bulb aligned with the first molar tooth).|Kilopascals|Mean|19|19.0|Standard Deviation|10|10.0|||
3942474|NCT01370083|3764161|B2|||Tongue Strength, Continuous|1 Repetition Maximum Isometric Tongue-Palate Pressure measured across 3 repetitions of maximum isometric tongue pressure generation using the Iowa Oral Performance Instrument, with the bulb located in a posterior position in the mouth (with the flat edge of the bulb aligned with the first molar tooth).|Kilopascals|Mean|25.71|25.71|Standard Deviation|8.36|8.36|||
3942475|NCT01370083|3764162|B1|||Tongue Strength, Continuous|1 Repetition Maximum Isometric Tongue-Palate Pressure measured across 3 repetitions of maximum isometric tongue pressure generation using the Iowa Oral Performance Instrument, with the bulb located in a posterior position in the mouth (with the flat edge of the bulb aligned with the first molar tooth).|Kilopascals|Mean|12.71|12.71|Standard Deviation|7.48|7.48|||
3942476|NCT01370083|3764160|B3|Canada||Region of Enrollment||participants|Number|14|14.0||||||
3942477|NCT01370083|3764161|B2|Canada||Region of Enrollment||participants|Number|7|7.0||||||
3942478|NCT01370083|3764162|B1|Canada||Region of Enrollment||participants|Number|7|7.0||||||
3942479|NCT01370083|3764160|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3942480|NCT01370083|3764161|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3942481|NCT01370083|3764162|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3942482|NCT01370083|3764160|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3942483|NCT01370083|3764161|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3942484|NCT01370083|3764162|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3942485|NCT01370083|3764160|B3|||Age||years|Mean|71|71.0|Full Range|||49.0|89.0|
3942486|NCT01370083|3764161|B2|||Age||years|Mean|67|67.0|Full Range|||49.0|89.0|
3942487|NCT01370083|3764162|B1|||Age||years|Mean|75|75.0|Full Range|||56.0|84.0|
3942488|NCT01370005|3764173|B4||Male|Sex: Female, Male||Participants|Count of Participants|495|495.0||||||
3942489|NCT01370005|3764174|B3||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3942490|NCT01370005|3764175|B2||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3942491|NCT01370005|3764176|B1||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3942492|NCT01370005|3764173|B4||Female|Sex: Female, Male||Participants|Count of Participants|328|328.0||||||
3942493|NCT01370005|3764174|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3942494|NCT01370005|3764175|B2||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3942495|NCT01370005|3764176|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3942496|NCT01370005|3764173|B4|||Age||years|Mean|60.2|60.2|Standard Deviation|9.0|9.0|||
3942497|NCT01370005|3764174|B3|||Age||years|Mean|59.9|59.9|Standard Deviation|9.7|9.7|||
3942498|NCT01370005|3764175|B2|||Age||years|Mean|60.6|60.6|Standard Deviation|8.5|8.5|||
3942499|NCT01370005|3764176|B1|||Age||years|Mean|60.3|60.3|Standard Deviation|8.8|8.8|||
3942500|NCT01369888|3764231|B5|United States||Region of Enrollment||participants|Number|3|3.0||||||
3942501|NCT01369888|3764234|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3942502|NCT01369888|3764235|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3942503|NCT01369888|3764231|B5|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
3942504|NCT01369888|3764234|B2|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
3942505|NCT01369888|3764235|B1|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
3942506|NCT01369888|3764231|B5|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
3942507|NCT01369888|3764234|B2|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
3942508|NCT01369888|3764235|B1|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
3942509|NCT01369888|3764231|B5|White||Race (NIH/OMB)||participants|Number|3|3.0||||||
3942510|NCT01369888|3764234|B2|White||Race (NIH/OMB)||participants|Number|2|2.0||||||
3942511|NCT01369888|3764235|B1|White||Race (NIH/OMB)||participants|Number|1|1.0||||||
3942513|NCT01369888|3764234|B2|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
3942514|NCT01369888|3764235|B1|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
3942515|NCT01369888|3764231|B5|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
3942516|NCT01369888|3764234|B2|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
3942517|NCT01369888|3764235|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
3942518|NCT01369888|3764231|B5|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
3942519|NCT01369888|3764234|B2|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
3942520|NCT01369888|3764235|B1|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
3942521|NCT01369888|3764231|B5|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
3942522|NCT01369888|3764234|B2|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
3942523|NCT01369888|3764235|B1|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
3942524|NCT01369888|3764231|B5|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
3942525|NCT01369888|3764234|B2|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
3942526|NCT01369888|3764235|B1|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
3942527|NCT01369888|3764231|B5|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|3|3.0||||||
3942528|NCT01369888|3764234|B2|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|2|2.0||||||
3942529|NCT01369888|3764235|B1|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|1|1.0||||||
3942530|NCT01369888|3764231|B5|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
3942531|NCT01369888|3764234|B2|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
3942532|NCT01369888|3764235|B1|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
3942533|NCT01369888|3764231|B5|Male||Gender||participants|Number|3|3.0||||||
3942534|NCT01369888|3764234|B2|Male||Gender||participants|Number|2|2.0||||||
3942535|NCT01369888|3764235|B1|Male||Gender||participants|Number|1|1.0||||||
3942536|NCT01369888|3764231|B5|Female||Gender||participants|Number|0|0.0||||||
3942537|NCT01369888|3764234|B2|Female||Gender||participants|Number|0|0.0||||||
3942538|NCT01369888|3764235|B1|Female||Gender||participants|Number|0|0.0||||||
3942539|NCT01369888|3764231|B5|||Age||years|Mean|45.7|45.7|Standard Deviation|13.9|13.9|||
3942540|NCT01369888|3764234|B2|||Age||years|Mean|38.|0.0|Standard Deviation|5.7|5.7|||
3942541|NCT01369888|3764235|B1|||Age||years|Mean|61.0|61.0|Standard Deviation|||||
3942542|NCT01369888|3764231|B5|>=65 years||Age||participants|Number|0|0.0||||||
3942543|NCT01369888|3764234|B2|>=65 years||Age||participants|Number|0|0.0||||||
3942544|NCT01369888|3764235|B1|>=65 years||Age||participants|Number|0|0.0||||||
3942545|NCT01369888|3764231|B5|Between 18 and 65 years||Age||participants|Number|3|3.0||||||
3942546|NCT01369888|3764234|B2|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
3942547|NCT01369888|3764235|B1|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
3942548|NCT01369888|3764231|B5|<=18 years||Age||participants|Number|0|0.0||||||
3942549|NCT01369888|3764234|B2|<=18 years||Age||participants|Number|0|0.0||||||
3942550|NCT01369888|3764235|B1|<=18 years||Age||participants|Number|0|0.0||||||
3942551|NCT01369875|3764246|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3942552|NCT01369875|3764247|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3942553|NCT01369875|3764248|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3942554|NCT01369875|3764246|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942555|NCT01369875|3764247|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942556|NCT01369875|3764248|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942557|NCT01369875|3764246|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942558|NCT01369875|3764247|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942559|NCT01369875|3764248|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942560|NCT01369875|3764246|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3942561|NCT01369875|3764247|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942562|NCT01369875|3764248|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3942563|NCT01369875|3764246|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3942564|NCT01369875|3764247|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3942565|NCT01369875|3764248|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942566|NCT01369875|3764246|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942567|NCT01369875|3764247|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942568|NCT01369875|3764248|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942569|NCT01369875|3764246|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942570|NCT01369875|3764247|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942571|NCT01369875|3764248|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942572|NCT01369875|3764246|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942573|NCT01369875|3764247|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942574|NCT01369875|3764248|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942575|NCT01369875|3764246|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942576|NCT01369875|3764247|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942577|NCT01369875|3764248|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942578|NCT01369875|3764246|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3942579|NCT01369875|3764247|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3942580|NCT01369875|3764248|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3942581|NCT01369875|3764246|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942582|NCT01369875|3764247|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942583|NCT01369875|3764248|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942584|NCT01369875|3764246|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3942585|NCT01369875|3764247|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3942586|NCT01369875|3764248|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3942587|NCT01369875|3764246|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3942588|NCT01369875|3764247|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3942589|NCT01369875|3764248|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3942590|NCT01369875|3764246|B3|||Age||years|Mean|48.0|48.0|Standard Deviation|2.8|2.8|||
3942591|NCT01369875|3764247|B2|||Age||years|Mean|46.0|46.0|Standard Deviation|||||
3942592|NCT01369875|3764248|B1|||Age||years|Mean|50.0|50.0|Standard Deviation|||||
3942593|NCT01369875|3764246|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3942594|NCT01369875|3764247|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3942595|NCT01369875|3764248|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3942596|NCT01369875|3764246|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3942597|NCT01369875|3764247|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3942598|NCT01369875|3764248|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3942599|NCT01369875|3764246|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3942600|NCT01369875|3764247|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3942601|NCT01369875|3764248|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3942602|NCT01369849|3764257|B4|United States||Region of Enrollment||participants|Number|14|14.0||||||
3942603|NCT01369849|3764258|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3942604|NCT01369849|3764259|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3942605|NCT01369849|3764260|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3942606|NCT01369849|3764257|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3942607|NCT01369849|3764258|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3942608|NCT01369849|3764259|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3942609|NCT01369849|3764260|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3942610|NCT01369849|3764257|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3942611|NCT01369849|3764258|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3942612|NCT01369849|3764259|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3942613|NCT01369849|3764260|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3942614|NCT01369849|3764257|B4|||Age||years|Median|67|67.0|Full Range|||44.0|75.0|
3942615|NCT01369849|3764258|B3|||Age||years|Median|65|65.0|Full Range|||54.0|75.0|
3942616|NCT01369849|3764259|B2|||Age||years|Median|66.5|66.5|Full Range|||61.0|71.0|
3942617|NCT01369849|3764260|B1|||Age||years|Median|67.5|67.5|Full Range|||44.0|74.0|
3942618|NCT01369784|3764284|B1|ECOG 4||ECOG Performance Status (Eastern Cooperative Oncology Group Performance Status)|ECOG=0: Fully active, able to carry on all pre-disease performance without restriction ECOG=5: Exitus|participants|Number|3|3.0||||||
3942619|NCT01369784|3764284|B1|ECOG 3||ECOG Performance Status (Eastern Cooperative Oncology Group Performance Status)|ECOG=0: Fully active, able to carry on all pre-disease performance without restriction ECOG=5: Exitus|participants|Number|15|15.0||||||
3942620|NCT01369784|3764284|B1|ECOG 2||ECOG Performance Status (Eastern Cooperative Oncology Group Performance Status)|ECOG=0: Fully active, able to carry on all pre-disease performance without restriction ECOG=5: Exitus|participants|Number|25|25.0||||||
3942621|NCT01369784|3764284|B1|ECOG 1||ECOG Performance Status (Eastern Cooperative Oncology Group Performance Status)|ECOG=0: Fully active, able to carry on all pre-disease performance without restriction ECOG=5: Exitus|participants|Number|55|55.0||||||
3942622|NCT01369784|3764284|B1|ECOG 0||ECOG Performance Status (Eastern Cooperative Oncology Group Performance Status)|ECOG=0: Fully active, able to carry on all pre-disease performance without restriction ECOG=5: Exitus|participants|Number|48|48.0||||||
3942623|NCT01369784|3764284|B1|IV||Ann Arbor Staging|Ann Arbor=I: Best condition Ann Arbor=IV: Worst condition|participants|Number|83|83.0||||||
3942624|NCT01369784|3764284|B1|III||Ann Arbor Staging|Ann Arbor=I: Best condition Ann Arbor=IV: Worst condition|participants|Number|37|37.0||||||
3942625|NCT01369784|3764284|B1|II||Ann Arbor Staging|Ann Arbor=I: Best condition Ann Arbor=IV: Worst condition|participants|Number|20|20.0||||||
3942626|NCT01369784|3764284|B1|I||Ann Arbor Staging|Ann Arbor=I: Best condition Ann Arbor=IV: Worst condition|participants|Number|6|6.0||||||
3942627|NCT01369784|3764284|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3942628|NCT01369784|3764284|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3942629|NCT01369784|3764284|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|14.1|14.1|||
3942630|NCT01369758|3764309|B1|United States||Region of Enrollment||participants|Number|278|278.0||||||
3942631|NCT01369758|3764309|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3942632|NCT01369758|3764309|B1||Female|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
3942633|NCT01369758|3764309|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3942634|NCT01369758|3764309|B1||Between 18 and 65 years|Age||Participants|Count of Participants|278|278.0||||||
3942635|NCT01369758|3764309|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3942636|NCT01369745|3764314|B6||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3942637|NCT01369745|3764315|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3942638|NCT01369745|3764316|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3942639|NCT01369745|3764317|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3942640|NCT01369745|3764318|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3942641|NCT01369745|3764319|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3942642|NCT01369745|3764314|B6||Female|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
3942643|NCT01369745|3764315|B5||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3942644|NCT01369745|3764316|B4||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3942645|NCT01369745|3764317|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3942646|NCT01369745|3764318|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3942647|NCT01369745|3764319|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3942648|NCT01369745|3764314|B6|||Age||years|Mean|54.6|54.6|Standard Deviation|11.5|11.5|||
3942649|NCT01369745|3764315|B5|||Age||years|Mean|53.7|53.7|Standard Deviation|12.44|12.44|||
3942650|NCT01369745|3764316|B4|||Age||years|Mean|54.5|54.5|Standard Deviation|11.53|11.53|||
3942651|NCT01369745|3764317|B3|||Age||years|Mean|55.5|55.5|Standard Deviation|9.82|9.82|||
3942652|NCT01369745|3764318|B2|||Age||years|Mean|55.9|55.9|Standard Deviation|9.35|9.35|||
3942653|NCT01369745|3764319|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|12.69|12.69|||
3942654|NCT01369732|3764355|B3|Korea, Republic of||Region of Enrollment||participants|Number|66|66.0||||||
3942655|NCT01369732|3764356|B2|Korea, Republic of||Region of Enrollment||participants|Number|33|33.0||||||
3942656|NCT01369732|3764357|B1|Korea, Republic of||Region of Enrollment||participants|Number|33|33.0||||||
3942657|NCT01369732|3764355|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3942658|NCT01369732|3764356|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3942659|NCT01369732|3764357|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3942660|NCT01369732|3764355|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3942661|NCT01369732|3764356|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3942662|NCT01369732|3764357|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3942663|NCT01369732|3764355|B3|||Age||years|Mean|63|63.0|Standard Deviation|13|13.0|||
3942664|NCT01369732|3764356|B2|||Age||years|Mean|61|61.0|Standard Deviation|13|13.0|||
3942665|NCT01369732|3764357|B1|||Age||years|Mean|65|65.0|Standard Deviation|12|12.0|||
3942666|NCT01369732|3764355|B3||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
3942667|NCT01369732|3764356|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3942668|NCT01369732|3764357|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3942669|NCT01369732|3764355|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3942670|NCT01369732|3764356|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3942671|NCT01369732|3764357|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3942672|NCT01369732|3764355|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3942673|NCT01369732|3764356|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3942674|NCT01369732|3764357|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3942675|NCT01369706|3764364|B1|Germany||Region of Enrollment||participants|Number|317|317.0||||||
3942676|NCT01369706|3764364|B1|Greece||Region of Enrollment||participants|Number|71|71.0||||||
3942677|NCT01369706|3764364|B1||Male|Sex: Female, Male||Participants|Count of Participants|295|295.0||||||
3942678|NCT01369706|3764364|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3942679|NCT01369706|3764364|B1|||Age||years|Mean|66|66.0|Standard Deviation|15|15.0|||
3942680|NCT01369680|3764368|B5|United States||Region of Enrollment||participants|Number|12|12.0||||||
3942681|NCT01369680|3764369|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
3942682|NCT01369680|3764370|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3942683|NCT01369680|3764371|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3942684|NCT01369680|3764372|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3942685|NCT01369680|3764368|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3942686|NCT01369680|3764369|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3942687|NCT01369680|3764370|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3942688|NCT01369680|3764371|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3942689|NCT01369680|3764372|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3942690|NCT01369680|3764368|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3942691|NCT01369680|3764369|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3942692|NCT01369680|3764370|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3942693|NCT01369680|3764371|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3942694|NCT01369680|3764372|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3942695|NCT01369680|3764368|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3942696|NCT01369680|3764369|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3942697|NCT01369680|3764370|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3942698|NCT01369680|3764371|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3942699|NCT01369680|3764372|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3942700|NCT01369680|3764368|B5||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3942701|NCT01369680|3764369|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3942702|NCT01369680|3764370|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3942703|NCT01369680|3764371|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3942704|NCT01369680|3764372|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3942705|NCT01369680|3764368|B5||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
3942706|NCT01369680|3764369|B4||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3942707|NCT01369680|3764370|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3942708|NCT01369680|3764371|B2||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3942709|NCT01369680|3764372|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3942710|NCT01369641|3764396|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3942711|NCT01369641|3764396|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942712|NCT01369641|3764396|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3942713|NCT01369641|3764396|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942714|NCT01369641|3764396|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942715|NCT01369641|3764396|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942716|NCT01369641|3764396|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3942717|NCT01369641|3764396|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942718|NCT01369641|3764396|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942719|NCT01369641|3764396|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942720|NCT01369641|3764396|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942721|NCT01369641|3764396|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3942722|NCT01369641|3764396|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3942723|NCT01369641|3764396|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3942724|NCT01369641|3764396|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3942725|NCT01369641|3764396|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3942726|NCT01369641|3764396|B1|||Age||years|Mean|69.26|69.26|Standard Deviation|0|0.0|||
3942727|NCT01369615|3764400|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3942728|NCT01369615|3764401|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3942729|NCT01369615|3764402|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3942730|NCT01369615|3764400|B3|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3942731|NCT01369615|3764401|B2|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3942732|NCT01369615|3764402|B1|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3942733|NCT01369615|3764400|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3942734|NCT01369615|3764401|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3942735|NCT01369615|3764402|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3942736|NCT01369615|3764400|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3942737|NCT01369615|3764401|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3942738|NCT01369615|3764402|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3942739|NCT01369615|3764400|B3|||Age||years|Mean|12.6|12.6|Standard Deviation|2.69|2.69|||
3942740|NCT01369615|3764401|B2|||Age||years|Mean|14.3|14.3|Standard Deviation|1.49|1.49|||
3942741|NCT01369615|3764402|B1|||Age||years|Mean|9.9|9.9|Standard Deviation|1.76|1.76|||
3942742|NCT01369511|3764409|B5|||Body Mass Index (BMI)|BMI was calculated by weight in kilograms divided by height in meters squared.|kilograms per meter squared (kg/m^2)|Mean|28.51|28.51|Standard Deviation|4.63|4.63|||
3942743|NCT01369511|3764410|B4|||Body Mass Index (BMI)|BMI was calculated by weight in kilograms divided by height in meters squared.|kilograms per meter squared (kg/m^2)|Mean|28.51|28.51|Standard Deviation|4.47|4.47|||
3942744|NCT01369511|3764411|B3|||Body Mass Index (BMI)|BMI was calculated by weight in kilograms divided by height in meters squared.|kilograms per meter squared (kg/m^2)|Mean|28.14|28.14|Standard Deviation|4.31|4.31|||
3942745|NCT01369511|3764412|B2|||Body Mass Index (BMI)|BMI was calculated by weight in kilograms divided by height in meters squared.|kilograms per meter squared (kg/m^2)|Mean|28.78|28.78|Standard Deviation|4.94|4.94|||
3942746|NCT01369511|3764413|B1|||Body Mass Index (BMI)|BMI was calculated by weight in kilograms divided by height in meters squared.|kilograms per meter squared (kg/m^2)|Mean|28.58|28.58|Standard Deviation|4.82|4.82|||
3942747|NCT01369511|3764409|B5|Sweden||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3942748|NCT01369511|3764410|B4|Sweden||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3942749|NCT01369511|3764411|B3|Sweden||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3942750|NCT01369511|3764412|B2|Sweden||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3942751|NCT01369511|3764413|B1|Sweden||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3942752|NCT01369511|3764409|B5|Japan||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3942753|NCT01369511|3764410|B4|Japan||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3942754|NCT01369511|3764411|B3|Japan||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3942755|NCT01369511|3764412|B2|Japan||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3942756|NCT01369511|3764413|B1|Japan||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3942757|NCT01369511|3764409|B5|Denmark||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3942758|NCT01369511|3764410|B4|Denmark||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3942759|NCT01369511|3764411|B3|Denmark||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3942760|NCT01369511|3764412|B2|Denmark||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3942761|NCT01369511|3764413|B1|Denmark||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3942762|NCT01369511|3764409|B5|Austria||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3942763|NCT01369511|3764410|B4|Austria||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3942764|NCT01369511|3764411|B3|Austria||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3942765|NCT01369511|3764412|B2|Austria||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3942766|NCT01369511|3764413|B1|Austria||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3942767|NCT01369511|3764409|B5|Spain||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3942768|NCT01369511|3764410|B4|Spain||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3942769|NCT01369511|3764411|B3|Spain||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3942770|NCT01369511|3764412|B2|Spain||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3942771|NCT01369511|3764413|B1|Spain||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3942772|NCT01369511|3764409|B5|Belgium||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3942773|NCT01369511|3764410|B4|Belgium||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3942774|NCT01369511|3764411|B3|Belgium||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3942775|NCT01369511|3764412|B2|Belgium||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3942776|NCT01369511|3764413|B1|Belgium||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3942777|NCT01369511|3764409|B5|Finland||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3942778|NCT01369511|3764410|B4|Finland||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3942779|NCT01369511|3764411|B3|Finland||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3942780|NCT01369511|3764412|B2|Finland||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3942781|NCT01369511|3764413|B1|Finland||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3942782|NCT01369511|3764409|B5|Canada||Region of Enrollment||Participants|Count of Participants|74|74.0||||||
3942783|NCT01369511|3764410|B4|Canada||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3942784|NCT01369511|3764411|B3|Canada||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3942785|NCT01369511|3764412|B2|Canada||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3942786|NCT01369511|3764413|B1|Canada||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3942787|NCT01369511|3764409|B5|Estonia||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3942788|NCT01369511|3764410|B4|Estonia||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3942789|NCT01369511|3764411|B3|Estonia||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3942790|NCT01369511|3764412|B2|Estonia||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3942791|NCT01369511|3764413|B1|Estonia||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3942792|NCT01369511|3764409|B5|United States||Region of Enrollment||Participants|Count of Participants|113|113.0||||||
3942793|NCT01369511|3764410|B4|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3942794|NCT01369511|3764411|B3|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3942795|NCT01369511|3764412|B2|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3942796|NCT01369511|3764413|B1|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3942797|NCT01369511|3764409|B5|France||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3942798|NCT01369511|3764410|B4|France||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3942799|NCT01369511|3764411|B3|France||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3942800|NCT01369511|3764412|B2|France||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3942801|NCT01369511|3764413|B1|France||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3942802|NCT01369511|3764409|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942803|NCT01369511|3764410|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942804|NCT01369511|3764411|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942805|NCT01369511|3764412|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942806|NCT01369511|3764413|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942807|NCT01369511|3764409|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942808|NCT01369511|3764410|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942809|NCT01369511|3764411|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942810|NCT01369511|3764412|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942811|NCT01369511|3764413|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942812|NCT01369511|3764409|B5||White|Race (NIH/OMB)||Participants|Count of Participants|349|349.0||||||
3942813|NCT01369511|3764410|B4||White|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3942814|NCT01369511|3764411|B3||White|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3942815|NCT01369511|3764412|B2||White|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
3942816|NCT01369511|3764413|B1||White|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3942817|NCT01369511|3764409|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3942818|NCT01369511|3764410|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3942819|NCT01369511|3764411|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3942820|NCT01369511|3764412|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3942821|NCT01369511|3764413|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3942822|NCT01369511|3764409|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942823|NCT01369511|3764410|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942824|NCT01369511|3764411|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942825|NCT01369511|3764412|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942826|NCT01369511|3764413|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942827|NCT01369511|3764409|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3942828|NCT01369511|3764410|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3942829|NCT01369511|3764411|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3942830|NCT01369511|3764412|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3942831|NCT01369511|3764413|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3942832|NCT01369511|3764409|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942833|NCT01369511|3764410|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942834|NCT01369511|3764411|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942835|NCT01369511|3764412|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942836|NCT01369511|3764413|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942837|NCT01369511|3764409|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|184|184.0||||||
3942838|NCT01369511|3764410|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3942839|NCT01369511|3764411|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3942840|NCT01369511|3764412|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3942841|NCT01369511|3764413|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3942842|NCT01369511|3764409|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|214|214.0||||||
3942843|NCT01369511|3764410|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3942844|NCT01369511|3764411|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3942845|NCT01369511|3764412|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3942846|NCT01369511|3764413|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3942847|NCT01369511|3764409|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3942848|NCT01369511|3764410|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942849|NCT01369511|3764411|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3942850|NCT01369511|3764412|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3942851|NCT01369511|3764413|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3942852|NCT01369511|3764409|B5||Male|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3942853|NCT01369511|3764410|B4||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3942854|NCT01369511|3764411|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3942855|NCT01369511|3764412|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3942856|NCT01369511|3764413|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3942857|NCT01369511|3764409|B5||Female|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
3942858|NCT01369511|3764410|B4||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3942859|NCT01369511|3764411|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3942860|NCT01369511|3764412|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3942861|NCT01369511|3764413|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3942862|NCT01369511|3764409|B5|||Age||years|Mean|68.65|68.65|Standard Deviation|8.26|8.26|||
3942863|NCT01369511|3764410|B4|||Age||years|Mean|68.71|68.71|Standard Deviation|7.95|7.95|||
3942864|NCT01369511|3764411|B3|||Age||years|Mean|67.85|67.85|Standard Deviation|8.14|8.14|||
3942865|NCT01369511|3764412|B2|||Age||years|Mean|68.66|68.66|Standard Deviation|8.09|8.09|||
3942866|NCT01369511|3764413|B1|||Age||years|Mean|69.38|69.38|Standard Deviation|8.90|8.9|||
3942867|NCT01369485|3764430|B3|United States||Region of Enrollment||participants|Number|163|163.0||||||
3942868|NCT01369485|3764431|B2|United States||Region of Enrollment||participants|Number|83|83.0||||||
3942869|NCT01369485|3764432|B1|United States||Region of Enrollment||participants|Number|80|80.0||||||
3942870|NCT01369485|3764430|B3|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3942871|NCT01369485|3764431|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3942872|NCT01369485|3764432|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3942873|NCT01369485|3764430|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|131|131.0||||||
3942874|NCT01369485|3764431|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
3942875|NCT01369485|3764432|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
3942876|NCT01369485|3764430|B3|African American||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3942877|NCT01369485|3764431|B2|African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3942878|NCT01369485|3764432|B1|African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3942879|NCT01369485|3764430|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3942880|NCT01369485|3764431|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3942881|NCT01369485|3764432|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3942882|NCT01369485|3764430|B3|Native American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3942883|NCT01369485|3764431|B2|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3942884|NCT01369485|3764432|B1|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3942885|NCT01369485|3764430|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3942886|NCT01369485|3764431|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3942887|NCT01369485|3764432|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3942888|NCT01369485|3764430|B3||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3942889|NCT01369485|3764431|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3942890|NCT01369485|3764432|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3942891|NCT01369485|3764430|B3|||Age||years|Mean|61.6|61.6|Standard Deviation|14.1|14.1|||
3942892|NCT01369485|3764431|B2|||Age||years|Mean|62.4|62.4|Standard Deviation|13.8|13.8|||
3942893|NCT01369485|3764432|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|14.3|14.3|||
3942894|NCT01369355|3764473|B7|Germany||Region of Enrollment||Participants|Count of Participants|84|84.0||||||
3942895|NCT01369355|3764474|B6|Germany||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3942896|NCT01369355|3764475|B5|Germany||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3942897|NCT01369355|3764476|B4|Germany||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3942898|NCT01369355|3764477|B3|Germany||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3942899|NCT01369355|3764478|B2|Germany||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3942900|NCT01369355|3764479|B1|Germany||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3942901|NCT01369355|3764473|B7|Czech Republic||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3942902|NCT01369355|3764474|B6|Czech Republic||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3942903|NCT01369355|3764475|B5|Czech Republic||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3942904|NCT01369355|3764476|B4|Czech Republic||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3942905|NCT01369355|3764477|B3|Czech Republic||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3942906|NCT01369355|3764478|B2|Czech Republic||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3942907|NCT01369355|3764479|B1|Czech Republic||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3942908|NCT01369355|3764473|B7|South Africa||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3942909|NCT01369355|3764474|B6|South Africa||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3942910|NCT01369355|3764475|B5|South Africa||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3942911|NCT01369355|3764476|B4|South Africa||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3942912|NCT01369355|3764477|B3|South Africa||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3942913|NCT01369355|3764478|B2|South Africa||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3942914|NCT01369355|3764479|B1|South Africa||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3942915|NCT01369355|3764473|B7|United States||Region of Enrollment||Participants|Count of Participants|495|495.0||||||
3942916|NCT01369355|3764474|B6|United States||Region of Enrollment||Participants|Count of Participants|198|198.0||||||
3942917|NCT01369355|3764475|B5|United States||Region of Enrollment||Participants|Count of Participants|124|124.0||||||
3942918|NCT01369355|3764476|B4|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3942919|NCT01369355|3764477|B3|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3942920|NCT01369355|3764478|B2|United States||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3942921|NCT01369355|3764479|B1|United States||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3942922|NCT01369355|3764473|B7|Serbia||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3942923|NCT01369355|3764474|B6|Serbia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3942924|NCT01369355|3764475|B5|Serbia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3942925|NCT01369355|3764476|B4|Serbia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3942926|NCT01369355|3764477|B3|Serbia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3942927|NCT01369355|3764478|B2|Serbia||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3942928|NCT01369355|3764479|B1|Serbia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3942929|NCT01369355|3764473|B7|Russia||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3942930|NCT01369355|3764474|B6|Russia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3942931|NCT01369355|3764475|B5|Russia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3942932|NCT01369355|3764476|B4|Russia||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3942933|NCT01369355|3764477|B3|Russia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3942934|NCT01369355|3764478|B2|Russia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3942935|NCT01369355|3764479|B1|Russia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3942936|NCT01369355|3764473|B7|Poland||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3942937|NCT01369355|3764474|B6|Poland||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3942938|NCT01369355|3764475|B5|Poland||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3942939|NCT01369355|3764476|B4|Poland||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3942940|NCT01369355|3764477|B3|Poland||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3942941|NCT01369355|3764478|B2|Poland||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3942942|NCT01369355|3764479|B1|Poland||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3942943|NCT01369355|3764473|B7|New Zealand||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3942944|NCT01369355|3764474|B6|New Zealand||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3942945|NCT01369355|3764475|B5|New Zealand||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3942946|NCT01369355|3764476|B4|New Zealand||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3942947|NCT01369355|3764477|B3|New Zealand||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3942948|NCT01369355|3764478|B2|New Zealand||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3942949|NCT01369355|3764479|B1|New Zealand||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3942950|NCT01369355|3764473|B7|Netherlands||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3942951|NCT01369355|3764474|B6|Netherlands||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3942952|NCT01369355|3764475|B5|Netherlands||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3942953|NCT01369355|3764476|B4|Netherlands||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3942954|NCT01369355|3764477|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3942955|NCT01369355|3764478|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3942956|NCT01369355|3764479|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3942957|NCT01369355|3764473|B7|Korea, Democratic People'S Republic Of||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3942958|NCT01369355|3764474|B6|Korea, Democratic People'S Republic Of||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3942959|NCT01369355|3764475|B5|Korea, Democratic People'S Republic Of||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3942960|NCT01369355|3764476|B4|Korea, Democratic People'S Republic Of||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3942961|NCT01369355|3764477|B3|Korea, Democratic People'S Republic Of||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3942962|NCT01369355|3764478|B2|Korea, Democratic People'S Republic Of||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3942963|NCT01369355|3764479|B1|Korea, Democratic People'S Republic Of||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3942964|NCT01369355|3764473|B7|Japan||Region of Enrollment||Participants|Count of Participants|74|74.0||||||
3942965|NCT01369355|3764474|B6|Japan||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3942966|NCT01369355|3764475|B5|Japan||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3942967|NCT01369355|3764476|B4|Japan||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3942968|NCT01369355|3764477|B3|Japan||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3942969|NCT01369355|3764478|B2|Japan||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3942970|NCT01369355|3764479|B1|Japan||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3942971|NCT01369355|3764473|B7|Italy||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3942972|NCT01369355|3764474|B6|Italy||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3942973|NCT01369355|3764475|B5|Italy||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3942974|NCT01369355|3764476|B4|Italy||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3942975|NCT01369355|3764477|B3|Italy||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3942976|NCT01369355|3764478|B2|Italy||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3942977|NCT01369355|3764479|B1|Italy||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3942978|NCT01369355|3764473|B7|Israel||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3942979|NCT01369355|3764474|B6|Israel||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3942980|NCT01369355|3764475|B5|Israel||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3942981|NCT01369355|3764476|B4|Israel||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3942982|NCT01369355|3764477|B3|Israel||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3942983|NCT01369355|3764478|B2|Israel||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3942984|NCT01369355|3764479|B1|Israel||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3942985|NCT01369355|3764473|B7|Iceland||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3942986|NCT01369355|3764474|B6|Iceland||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3942987|NCT01369355|3764475|B5|Iceland||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3942988|NCT01369355|3764476|B4|Iceland||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3942989|NCT01369355|3764477|B3|Iceland||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3942990|NCT01369355|3764478|B2|Iceland||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3942991|NCT01369355|3764479|B1|Iceland||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3942992|NCT01369355|3764473|B7|Ireland||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3942993|NCT01369355|3764474|B6|Ireland||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3942994|NCT01369355|3764475|B5|Ireland||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3942995|NCT01369355|3764476|B4|Ireland||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3942996|NCT01369355|3764477|B3|Ireland||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3942997|NCT01369355|3764478|B2|Ireland||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3942998|NCT01369355|3764479|B1|Ireland||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3942999|NCT01369355|3764473|B7|Hungary||Region of Enrollment||Participants|Count of Participants|64|64.0||||||
3943000|NCT01369355|3764474|B6|Hungary||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3943001|NCT01369355|3764475|B5|Hungary||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3943002|NCT01369355|3764476|B4|Hungary||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3943003|NCT01369355|3764477|B3|Hungary||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3943004|NCT01369355|3764478|B2|Hungary||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3943005|NCT01369355|3764479|B1|Hungary||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3943006|NCT01369355|3764473|B7|Croatia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3943007|NCT01369355|3764474|B6|Croatia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3943008|NCT01369355|3764475|B5|Croatia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3943009|NCT01369355|3764476|B4|Croatia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3943010|NCT01369355|3764477|B3|Croatia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3943011|NCT01369355|3764478|B2|Croatia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3943012|NCT01369355|3764479|B1|Croatia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3943013|NCT01369355|3764473|B7|United Kingdom||Region of Enrollment||Participants|Count of Participants|67|67.0||||||
3943014|NCT01369355|3764474|B6|United Kingdom||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3943015|NCT01369355|3764475|B5|United Kingdom||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3943016|NCT01369355|3764476|B4|United Kingdom||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3943017|NCT01369355|3764477|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3943018|NCT01369355|3764478|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3943019|NCT01369355|3764479|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3943020|NCT01369355|3764473|B7|France||Region of Enrollment||Participants|Count of Participants|64|64.0||||||
3943021|NCT01369355|3764474|B6|France||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3943022|NCT01369355|3764475|B5|France||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3943023|NCT01369355|3764476|B4|France||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3943024|NCT01369355|3764477|B3|France||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3943025|NCT01369355|3764478|B2|France||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3943026|NCT01369355|3764479|B1|France||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3943027|NCT01369355|3764473|B7|Spain||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3943028|NCT01369355|3764474|B6|Spain||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3943029|NCT01369355|3764475|B5|Spain||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3943030|NCT01369355|3764476|B4|Spain||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3943031|NCT01369355|3764477|B3|Spain||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3943032|NCT01369355|3764478|B2|Spain||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3943033|NCT01369355|3764479|B1|Spain||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3943034|NCT01369355|3764473|B7|Denmark||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3943035|NCT01369355|3764474|B6|Denmark||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3943036|NCT01369355|3764475|B5|Denmark||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3943037|NCT01369355|3764476|B4|Denmark||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3943038|NCT01369355|3764477|B3|Denmark||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3943039|NCT01369355|3764478|B2|Denmark||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3943040|NCT01369355|3764479|B1|Denmark||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3943041|NCT01369355|3764473|B7|Canada||Region of Enrollment||Participants|Count of Participants|92|92.0||||||
3943042|NCT01369355|3764474|B6|Canada||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3943043|NCT01369355|3764475|B5|Canada||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3943044|NCT01369355|3764476|B4|Canada||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3943045|NCT01369355|3764477|B3|Canada||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3943046|NCT01369355|3764478|B2|Canada||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3943047|NCT01369355|3764479|B1|Canada||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3943048|NCT01369355|3764473|B7|Brazil||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3943049|NCT01369355|3764474|B6|Brazil||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3943050|NCT01369355|3764475|B5|Brazil||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3943051|NCT01369355|3764476|B4|Brazil||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3943052|NCT01369355|3764477|B3|Brazil||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3943053|NCT01369355|3764478|B2|Brazil||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3943054|NCT01369355|3764479|B1|Brazil||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3943055|NCT01369355|3764473|B7|Bulgaria||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3943056|NCT01369355|3764474|B6|Bulgaria||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3943057|NCT01369355|3764475|B5|Bulgaria||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3943058|NCT01369355|3764476|B4|Bulgaria||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3943059|NCT01369355|3764477|B3|Bulgaria||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3943060|NCT01369355|3764478|B2|Bulgaria||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3943061|NCT01369355|3764479|B1|Bulgaria||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3943062|NCT01369355|3764473|B7|Belgium||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3943063|NCT01369355|3764474|B6|Belgium||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3943064|NCT01369355|3764475|B5|Belgium||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3943065|NCT01369355|3764476|B4|Belgium||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3943066|NCT01369355|3764477|B3|Belgium||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3943067|NCT01369355|3764478|B2|Belgium||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3943068|NCT01369355|3764479|B1|Belgium||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3943069|NCT01369355|3764473|B7|Austria||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3943070|NCT01369355|3764474|B6|Austria||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3943071|NCT01369355|3764475|B5|Austria||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3943072|NCT01369355|3764476|B4|Austria||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3943073|NCT01369355|3764477|B3|Austria||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3943074|NCT01369355|3764478|B2|Austria||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3943075|NCT01369355|3764479|B1|Austria||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3943076|NCT01369355|3764473|B7|Australia||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
3943077|NCT01369355|3764474|B6|Australia||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3943078|NCT01369355|3764475|B5|Australia||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3943079|NCT01369355|3764476|B4|Australia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3943080|NCT01369355|3764477|B3|Australia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3943081|NCT01369355|3764478|B2|Australia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3943082|NCT01369355|3764479|B1|Australia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3943083|NCT01369355|3764473|B7||Male|Sex: Female, Male||Participants|Count of Participants|569|569.0||||||
3943084|NCT01369355|3764474|B6||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3943085|NCT01369355|3764475|B5||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3943086|NCT01369355|3764476|B4||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3943087|NCT01369355|3764477|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3943088|NCT01369355|3764478|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3943089|NCT01369355|3764479|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3943090|NCT01369355|3764473|B7||Female|Sex: Female, Male||Participants|Count of Participants|712|712.0||||||
3943091|NCT01369355|3764474|B6||Female|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
3943092|NCT01369355|3764475|B5||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3943093|NCT01369355|3764476|B4||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3943094|NCT01369355|3764477|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3943095|NCT01369355|3764478|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3943096|NCT01369355|3764479|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3943097|NCT01369355|3764473|B7|||Age||years|Mean|38.3|38.3|Standard Deviation|12.68|12.68|||
3943098|NCT01369355|3764474|B6|||Age||years|Mean|37.4|37.4|Standard Deviation|12.5|12.5|||
3943099|NCT01369355|3764475|B5|||Age||years|Mean|39|39.0|Standard Deviation|12.33|12.33|||
3943100|NCT01369355|3764476|B4|||Age||years|Mean|39.1|39.1|Standard Deviation|12.46|12.46|||
3943101|NCT01369355|3764477|B3|||Age||years|Mean|37.9|37.9|Standard Deviation|13.2|13.2|||
3943102|NCT01369355|3764478|B2|||Age||years|Mean|38.6|38.6|Standard Deviation|13.65|13.65|||
3943103|NCT01369355|3764479|B1|||Age||years|Mean|39.5|39.5|Standard Deviation|12.69|12.69|||
3943104|NCT01369342|3764510|B4|South Africa||Region of Enrollment||participants|Number|33|33.0||||||
3943105|NCT01369342|3764511|B3|South Africa||Region of Enrollment||participants|Number|14|14.0||||||
3943106|NCT01369342|3764512|B2|South Africa||Region of Enrollment||participants|Number|5|5.0||||||
3943107|NCT01369342|3764513|B1|South Africa||Region of Enrollment||participants|Number|14|14.0||||||
3943108|NCT01369342|3764510|B4|United States||Region of Enrollment||participants|Number|220|220.0||||||
3943109|NCT01369342|3764511|B3|United States||Region of Enrollment||participants|Number|76|76.0||||||
3943110|NCT01369342|3764512|B2|United States||Region of Enrollment||participants|Number|72|72.0||||||
3943111|NCT01369342|3764513|B1|United States||Region of Enrollment||participants|Number|72|72.0||||||
3943112|NCT01369342|3764510|B4|Serbia||Region of Enrollment||participants|Number|15|15.0||||||
3943113|NCT01369342|3764511|B3|Serbia||Region of Enrollment||participants|Number|3|3.0||||||
3943114|NCT01369342|3764512|B2|Serbia||Region of Enrollment||participants|Number|8|8.0||||||
3943115|NCT01369342|3764513|B1|Serbia||Region of Enrollment||participants|Number|4|4.0||||||
3943116|NCT01369342|3764510|B4|Russia||Region of Enrollment||participants|Number|17|17.0||||||
3943117|NCT01369342|3764511|B3|Russia||Region of Enrollment||participants|Number|5|5.0||||||
3943118|NCT01369342|3764512|B2|Russia||Region of Enrollment||participants|Number|6|6.0||||||
3943119|NCT01369342|3764513|B1|Russia||Region of Enrollment||participants|Number|6|6.0||||||
3943120|NCT01369342|3764510|B4|Poland||Region of Enrollment||participants|Number|26|26.0||||||
3943121|NCT01369342|3764511|B3|Poland||Region of Enrollment||participants|Number|10|10.0||||||
3943122|NCT01369342|3764512|B2|Poland||Region of Enrollment||participants|Number|8|8.0||||||
3943123|NCT01369342|3764513|B1|Poland||Region of Enrollment||participants|Number|8|8.0||||||
3943124|NCT01369342|3764510|B4|New Zealand||Region of Enrollment||participants|Number|14|14.0||||||
3943125|NCT01369342|3764511|B3|New Zealand||Region of Enrollment||participants|Number|4|4.0||||||
3943126|NCT01369342|3764512|B2|New Zealand||Region of Enrollment||participants|Number|8|8.0||||||
3943127|NCT01369342|3764513|B1|New Zealand||Region of Enrollment||participants|Number|2|2.0||||||
3943128|NCT01369342|3764510|B4|Netherland||Region of Enrollment||participants|Number|4|4.0||||||
3943129|NCT01369342|3764511|B3|Netherland||Region of Enrollment||participants|Number|2|2.0||||||
3943130|NCT01369342|3764512|B2|Netherland||Region of Enrollment||participants|Number|1|1.0||||||
3943131|NCT01369342|3764513|B1|Netherland||Region of Enrollment||participants|Number|1|1.0||||||
3943132|NCT01369342|3764510|B4|Korea||Region of Enrollment||participants|Number|20|20.0||||||
3943133|NCT01369342|3764511|B3|Korea||Region of Enrollment||participants|Number|6|6.0||||||
3943134|NCT01369342|3764512|B2|Korea||Region of Enrollment||participants|Number|7|7.0||||||
3943135|NCT01369342|3764513|B1|Korea||Region of Enrollment||participants|Number|7|7.0||||||
3943136|NCT01369342|3764510|B4|Japan||Region of Enrollment||participants|Number|26|26.0||||||
3943137|NCT01369342|3764511|B3|Japan||Region of Enrollment||participants|Number|9|9.0||||||
3943138|NCT01369342|3764512|B2|Japan||Region of Enrollment||participants|Number|8|8.0||||||
3943139|NCT01369342|3764513|B1|Japan||Region of Enrollment||participants|Number|9|9.0||||||
3943140|NCT01369342|3764510|B4|Italy||Region of Enrollment||participants|Number|9|9.0||||||
3943141|NCT01369342|3764511|B3|Italy||Region of Enrollment||participants|Number|5|5.0||||||
3943142|NCT01369342|3764512|B2|Italy||Region of Enrollment||participants|Number|2|2.0||||||
3943143|NCT01369342|3764513|B1|Italy||Region of Enrollment||participants|Number|2|2.0||||||
3943144|NCT01369342|3764510|B4|Israel||Region of Enrollment||participants|Number|11|11.0||||||
3943145|NCT01369342|3764511|B3|Israel||Region of Enrollment||participants|Number|6|6.0||||||
3943146|NCT01369342|3764512|B2|Israel||Region of Enrollment||participants|Number|3|3.0||||||
3943147|NCT01369342|3764513|B1|Israel||Region of Enrollment||participants|Number|2|2.0||||||
3943148|NCT01369342|3764510|B4|Iceland||Region of Enrollment||participants|Number|2|2.0||||||
3943149|NCT01369342|3764511|B3|Iceland||Region of Enrollment||participants|Number|1|1.0||||||
3943150|NCT01369342|3764512|B2|Iceland||Region of Enrollment||participants|Number|1|1.0||||||
3943151|NCT01369342|3764513|B1|Iceland||Region of Enrollment||participants|Number|0|0.0||||||
3943152|NCT01369342|3764510|B4|Hungary||Region of Enrollment||participants|Number|61|61.0||||||
3943153|NCT01369342|3764511|B3|Hungary||Region of Enrollment||participants|Number|18|18.0||||||
3943154|NCT01369342|3764512|B2|Hungary||Region of Enrollment||participants|Number|20|20.0||||||
3943155|NCT01369342|3764513|B1|Hungary||Region of Enrollment||participants|Number|23|23.0||||||
3943156|NCT01369342|3764510|B4|Croatia||Region of Enrollment||participants|Number|4|4.0||||||
3943157|NCT01369342|3764511|B3|Croatia||Region of Enrollment||participants|Number|1|1.0||||||
3943158|NCT01369342|3764512|B2|Croatia||Region of Enrollment||participants|Number|2|2.0||||||
3943159|NCT01369342|3764513|B1|Croatia||Region of Enrollment||participants|Number|1|1.0||||||
3943160|NCT01369342|3764510|B4|United Kingdom||Region of Enrollment||participants|Number|21|21.0||||||
3943161|NCT01369342|3764511|B3|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
3943162|NCT01369342|3764512|B2|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3943163|NCT01369342|3764513|B1|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3943164|NCT01369342|3764510|B4|France||Region of Enrollment||participants|Number|10|10.0||||||
3943165|NCT01369342|3764511|B3|France||Region of Enrollment||participants|Number|5|5.0||||||
3943166|NCT01369342|3764512|B2|France||Region of Enrollment||participants|Number|2|2.0||||||
3943167|NCT01369342|3764513|B1|France||Region of Enrollment||participants|Number|3|3.0||||||
3943168|NCT01369342|3764510|B4|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3943169|NCT01369342|3764511|B3|Spain||Region of Enrollment||participants|Number|0|0.0||||||
3943170|NCT01369342|3764512|B2|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3943171|NCT01369342|3764513|B1|Spain||Region of Enrollment||participants|Number|0|0.0||||||
3943172|NCT01369342|3764510|B4|Germany||Region of Enrollment||participants|Number|47|47.0||||||
3943173|NCT01369342|3764511|B3|Germany||Region of Enrollment||participants|Number|13|13.0||||||
3943174|NCT01369342|3764512|B2|Germany||Region of Enrollment||participants|Number|15|15.0||||||
3943175|NCT01369342|3764513|B1|Germany||Region of Enrollment||participants|Number|19|19.0||||||
3943176|NCT01369342|3764510|B4|Canada||Region of Enrollment||participants|Number|42|42.0||||||
3943177|NCT01369342|3764511|B3|Canada||Region of Enrollment||participants|Number|10|10.0||||||
3943178|NCT01369342|3764512|B2|Canada||Region of Enrollment||participants|Number|18|18.0||||||
3943179|NCT01369342|3764513|B1|Canada||Region of Enrollment||participants|Number|14|14.0||||||
3943180|NCT01369342|3764510|B4|Brazil||Region of Enrollment||participants|Number|9|9.0||||||
3943181|NCT01369342|3764511|B3|Brazil||Region of Enrollment||participants|Number|2|2.0||||||
3943182|NCT01369342|3764512|B2|Brazil||Region of Enrollment||participants|Number|5|5.0||||||
3943183|NCT01369342|3764513|B1|Brazil||Region of Enrollment||participants|Number|2|2.0||||||
3943184|NCT01369342|3764510|B4|Bulgaria||Region of Enrollment||participants|Number|24|24.0||||||
3943185|NCT01369342|3764511|B3|Bulgaria||Region of Enrollment||participants|Number|11|11.0||||||
3943186|NCT01369342|3764512|B2|Bulgaria||Region of Enrollment||participants|Number|5|5.0||||||
3943187|NCT01369342|3764513|B1|Bulgaria||Region of Enrollment||participants|Number|8|8.0||||||
3943188|NCT01369342|3764510|B4|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
3943189|NCT01369342|3764511|B3|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
3943190|NCT01369342|3764512|B2|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
3943191|NCT01369342|3764513|B1|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
3943192|NCT01369342|3764510|B4|Australia||Region of Enrollment||participants|Number|20|20.0||||||
3943193|NCT01369342|3764511|B3|Australia||Region of Enrollment||participants|Number|5|5.0||||||
3943194|NCT01369342|3764512|B2|Australia||Region of Enrollment||participants|Number|7|7.0||||||
3943195|NCT01369342|3764513|B1|Australia||Region of Enrollment||participants|Number|8|8.0||||||
3943196|NCT01369342|3764510|B4||Male|Gender||Participants|Count of Participants|298|298.0||||||
3943197|NCT01369342|3764511|B3||Male|Gender||Participants|Count of Participants|91|91.0||||||
3943198|NCT01369342|3764512|B2||Male|Gender||Participants|Count of Participants|106|106.0||||||
3943199|NCT01369342|3764513|B1||Male|Gender||Participants|Count of Participants|101|101.0||||||
3943200|NCT01369342|3764510|B4||Female|Gender||Participants|Count of Participants|342|342.0||||||
3943201|NCT01369342|3764511|B3||Female|Gender||Participants|Count of Participants|122|122.0||||||
3943202|NCT01369342|3764512|B2||Female|Gender||Participants|Count of Participants|107|107.0||||||
3943203|NCT01369342|3764513|B1||Female|Gender||Participants|Count of Participants|113|113.0||||||
3943204|NCT01369342|3764510|B4|||Age||years|Mean|39.4|39.4|Standard Deviation|13.48|13.48|||
3943205|NCT01369342|3764511|B3|||Age||years|Mean|38.8|38.8|Standard Deviation|13.65|13.65|||
3943206|NCT01369342|3764512|B2|||Age||years|Mean|39.2|39.2|Standard Deviation|13.74|13.74|||
3943207|NCT01369342|3764513|B1|||Age||years|Mean|40.1|40.1|Standard Deviation|13.09|13.09|||
3943208|NCT01369329|3764535|B4|South Africa||Region of Enrollment||participants|Number|2|2.0||||||
3943209|NCT01369329|3764536|B3|South Africa||Region of Enrollment||participants|Number|0|0.0||||||
3943210|NCT01369329|3764537|B2|South Africa||Region of Enrollment||participants|Number|1|1.0||||||
3943211|NCT01369329|3764538|B1|South Africa||Region of Enrollment||participants|Number|1|1.0||||||
3943212|NCT01369329|3764535|B4|United States||Region of Enrollment||participants|Number|331|331.0||||||
3943213|NCT01369329|3764536|B3|United States||Region of Enrollment||participants|Number|97|97.0||||||
3943214|NCT01369329|3764537|B2|United States||Region of Enrollment||participants|Number|108|108.0||||||
3943215|NCT01369329|3764538|B1|United States||Region of Enrollment||participants|Number|126|126.0||||||
3943216|NCT01369329|3764535|B4|Serbia||Region of Enrollment||participants|Number|4|4.0||||||
3943217|NCT01369329|3764536|B3|Serbia||Region of Enrollment||participants|Number|1|1.0||||||
3943218|NCT01369329|3764537|B2|Serbia||Region of Enrollment||participants|Number|2|2.0||||||
3943219|NCT01369329|3764538|B1|Serbia||Region of Enrollment||participants|Number|1|1.0||||||
3943220|NCT01369329|3764535|B4|Poland||Region of Enrollment||participants|Number|11|11.0||||||
3943221|NCT01369329|3764536|B3|Poland||Region of Enrollment||participants|Number|4|4.0||||||
3943222|NCT01369329|3764537|B2|Poland||Region of Enrollment||participants|Number|3|3.0||||||
3943223|NCT01369329|3764538|B1|Poland||Region of Enrollment||participants|Number|4|4.0||||||
3943224|NCT01369329|3764535|B4|New Zealand||Region of Enrollment||participants|Number|2|2.0||||||
3943225|NCT01369329|3764536|B3|New Zealand||Region of Enrollment||participants|Number|0|0.0||||||
3943226|NCT01369329|3764537|B2|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
3943227|NCT01369329|3764538|B1|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
3943228|NCT01369329|3764535|B4|Netherlands||Region of Enrollment||participants|Number|32|32.0||||||
3943229|NCT01369329|3764536|B3|Netherlands||Region of Enrollment||participants|Number|14|14.0||||||
3943230|NCT01369329|3764537|B2|Netherlands||Region of Enrollment||participants|Number|9|9.0||||||
3943231|NCT01369329|3764538|B1|Netherlands||Region of Enrollment||participants|Number|9|9.0||||||
3943232|NCT01369329|3764535|B4|South Korea||Region of Enrollment||participants|Number|3|3.0||||||
3943233|NCT01369329|3764536|B3|South Korea||Region of Enrollment||participants|Number|2|2.0||||||
3943234|NCT01369329|3764537|B2|South Korea||Region of Enrollment||participants|Number|0|0.0||||||
3943235|NCT01369329|3764538|B1|South Korea||Region of Enrollment||participants|Number|1|1.0||||||
3943236|NCT01369329|3764535|B4|Japan||Region of Enrollment||participants|Number|56|56.0||||||
3943237|NCT01369329|3764536|B3|Japan||Region of Enrollment||participants|Number|19|19.0||||||
3943238|NCT01369329|3764537|B2|Japan||Region of Enrollment||participants|Number|19|19.0||||||
3943239|NCT01369329|3764538|B1|Japan||Region of Enrollment||participants|Number|18|18.0||||||
3943240|NCT01369329|3764535|B4|Italy||Region of Enrollment||participants|Number|19|19.0||||||
3943241|NCT01369329|3764536|B3|Italy||Region of Enrollment||participants|Number|8|8.0||||||
3943242|NCT01369329|3764537|B2|Italy||Region of Enrollment||participants|Number|7|7.0||||||
3943243|NCT01369329|3764538|B1|Italy||Region of Enrollment||participants|Number|4|4.0||||||
3943244|NCT01369329|3764535|B4|Israel||Region of Enrollment||participants|Number|6|6.0||||||
3943245|NCT01369329|3764536|B3|Israel||Region of Enrollment||participants|Number|3|3.0||||||
3943246|NCT01369329|3764537|B2|Israel||Region of Enrollment||participants|Number|2|2.0||||||
3943247|NCT01369329|3764538|B1|Israel||Region of Enrollment||participants|Number|1|1.0||||||
3943248|NCT01369329|3764535|B4|Ireland||Region of Enrollment||participants|Number|1|1.0||||||
3943249|NCT01369329|3764536|B3|Ireland||Region of Enrollment||participants|Number|1|1.0||||||
3943250|NCT01369329|3764537|B2|Ireland||Region of Enrollment||participants|Number|0|0.0||||||
3943251|NCT01369329|3764538|B1|Ireland||Region of Enrollment||participants|Number|0|0.0||||||
3943252|NCT01369329|3764535|B4|Hungary||Region of Enrollment||participants|Number|4|4.0||||||
3943253|NCT01369329|3764536|B3|Hungary||Region of Enrollment||participants|Number|2|2.0||||||
3943254|NCT01369329|3764537|B2|Hungary||Region of Enrollment||participants|Number|1|1.0||||||
3943255|NCT01369329|3764538|B1|Hungary||Region of Enrollment||participants|Number|1|1.0||||||
3943256|NCT01369329|3764535|B4|United Kingdom||Region of Enrollment||participants|Number|58|58.0||||||
3943257|NCT01369329|3764536|B3|United Kingdom||Region of Enrollment||participants|Number|16|16.0||||||
3943258|NCT01369329|3764537|B2|United Kingdom||Region of Enrollment||participants|Number|21|21.0||||||
3943259|NCT01369329|3764538|B1|United Kingdom||Region of Enrollment||participants|Number|21|21.0||||||
3943260|NCT01369329|3764535|B4|France||Region of Enrollment||participants|Number|67|67.0||||||
3943261|NCT01369329|3764536|B3|France||Region of Enrollment||participants|Number|29|29.0||||||
3943262|NCT01369329|3764537|B2|France||Region of Enrollment||participants|Number|21|21.0||||||
3943263|NCT01369329|3764538|B1|France||Region of Enrollment||participants|Number|17|17.0||||||
3943264|NCT01369329|3764535|B4|Spain||Region of Enrollment||participants|Number|2|2.0||||||
3943265|NCT01369329|3764536|B3|Spain||Region of Enrollment||participants|Number|2|2.0||||||
3943266|NCT01369329|3764537|B2|Spain||Region of Enrollment||participants|Number|0|0.0||||||
3943267|NCT01369329|3764538|B1|Spain||Region of Enrollment||participants|Number|0|0.0||||||
3943268|NCT01369329|3764535|B4|Denmark||Region of Enrollment||participants|Number|6|6.0||||||
3943269|NCT01369329|3764536|B3|Denmark||Region of Enrollment||participants|Number|2|2.0||||||
3943270|NCT01369329|3764537|B2|Denmark||Region of Enrollment||participants|Number|3|3.0||||||
3943271|NCT01369329|3764538|B1|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
3943272|NCT01369329|3764535|B4|Germany||Region of Enrollment||participants|Number|50|50.0||||||
3943273|NCT01369329|3764536|B3|Germany||Region of Enrollment||participants|Number|14|14.0||||||
3943274|NCT01369329|3764537|B2|Germany||Region of Enrollment||participants|Number|14|14.0||||||
3943275|NCT01369329|3764538|B1|Germany||Region of Enrollment||participants|Number|22|22.0||||||
3943276|NCT01369329|3764535|B4|Czech Republic||Region of Enrollment||participants|Number|5|5.0||||||
3943277|NCT01369329|3764536|B3|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
3943278|NCT01369329|3764537|B2|Czech Republic||Region of Enrollment||participants|Number|2|2.0||||||
3943279|NCT01369329|3764538|B1|Czech Republic||Region of Enrollment||participants|Number|2|2.0||||||
3943280|NCT01369329|3764535|B4|Canada||Region of Enrollment||participants|Number|52|52.0||||||
3943281|NCT01369329|3764536|B3|Canada||Region of Enrollment||participants|Number|21|21.0||||||
3943282|NCT01369329|3764537|B2|Canada||Region of Enrollment||participants|Number|21|21.0||||||
3943283|NCT01369329|3764538|B1|Canada||Region of Enrollment||participants|Number|10|10.0||||||
3943284|NCT01369329|3764535|B4|Brazil||Region of Enrollment||participants|Number|3|3.0||||||
3943285|NCT01369329|3764536|B3|Brazil||Region of Enrollment||participants|Number|1|1.0||||||
3943286|NCT01369329|3764537|B2|Brazil||Region of Enrollment||participants|Number|0|0.0||||||
3943287|NCT01369329|3764538|B1|Brazil||Region of Enrollment||participants|Number|2|2.0||||||
3943288|NCT01369329|3764535|B4|Belgium||Region of Enrollment||participants|Number|28|28.0||||||
3943289|NCT01369329|3764536|B3|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
3943290|NCT01369329|3764537|B2|Belgium||Region of Enrollment||participants|Number|12|12.0||||||
3943291|NCT01369329|3764538|B1|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
3943292|NCT01369329|3764535|B4|Austria||Region of Enrollment||participants|Number|6|6.0||||||
3943293|NCT01369329|3764536|B3|Austria||Region of Enrollment||participants|Number|6|6.0||||||
3943294|NCT01369329|3764537|B2|Austria||Region of Enrollment||participants|Number|0|0.0||||||
3943295|NCT01369329|3764538|B1|Austria||Region of Enrollment||participants|Number|0|0.0||||||
3943296|NCT01369329|3764535|B4|Australia||Region of Enrollment||participants|Number|21|21.0||||||
3943297|NCT01369329|3764536|B3|Australia||Region of Enrollment||participants|Number|8|8.0||||||
3943298|NCT01369329|3764537|B2|Australia||Region of Enrollment||participants|Number|7|7.0||||||
3943299|NCT01369329|3764538|B1|Australia||Region of Enrollment||participants|Number|6|6.0||||||
3943300|NCT01369329|3764535|B4||Male|Sex: Female, Male||Participants|Count of Participants|329|329.0||||||
3943301|NCT01369329|3764536|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3943302|NCT01369329|3764537|B2||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3943303|NCT01369329|3764538|B1||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3943304|NCT01369329|3764535|B4||Female|Sex: Female, Male||Participants|Count of Participants|440|440.0||||||
3943305|NCT01369329|3764536|B3||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3943306|NCT01369329|3764537|B2||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3943307|NCT01369329|3764538|B1||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3943308|NCT01369329|3764535|B4|||Age||years|Mean|37.4|37.4|Standard Deviation|12.05|12.05|||
3943309|NCT01369329|3764536|B3|||Age||years|Mean|37.2|37.2|Standard Deviation|12.57|12.57|||
3943310|NCT01369329|3764537|B2|||Age||years|Mean|37.4|37.4|Standard Deviation|11.74|11.74|||
3943311|NCT01369329|3764538|B1|||Age||years|Mean|37.6|37.6|Standard Deviation|11.86|11.86|||
3943312|NCT01369225|3764560|B7||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3943313|NCT01369225|3764561|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3943314|NCT01369225|3764562|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3943315|NCT01369225|3764563|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3943316|NCT01369225|3764564|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3943317|NCT01369225|3764565|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3943318|NCT01369225|3764566|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3943319|NCT01369225|3764560|B7||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3943320|NCT01369225|3764561|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3943321|NCT01369225|3764562|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3943322|NCT01369225|3764563|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3943323|NCT01369225|3764564|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3943324|NCT01369225|3764565|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3943325|NCT01369225|3764566|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3943326|NCT01369225|3764560|B7|||Age||years|Mean|67.1|67.1|Standard Deviation|9.0|9.0|||
3943327|NCT01369225|3764561|B6|||Age||years|Mean|71.7|71.7|Standard Deviation|7.9|7.9|||
3943328|NCT01369225|3764562|B5|||Age||years|Mean|60.7|60.7|Standard Deviation|5.8|5.8|||
3943329|NCT01369225|3764563|B4|||Age||years|Mean|71.3|71.3|Standard Deviation|8.8|8.8|||
3943330|NCT01369225|3764564|B3|||Age||years|Mean|68.8|68.8|Standard Deviation|10.6|10.6|||
3943331|NCT01369225|3764565|B2|||Age||years|Mean|63.0|63.0|Standard Deviation|7.8|7.8|||
3943332|NCT01369225|3764566|B1|||Age||years|Mean|65.2|65.2|Standard Deviation|6.5|6.5|||
3943333|NCT01369199|3764663|B1|||Hepatitis B Virus (HBV) DNA||log10 IU/mL|Median|8.2|8.2|Full Range|||7.2|8.8|
3943334|NCT01369199|3764663|B1|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3943335|NCT01369199|3764663|B1|Canada||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3943336|NCT01369199|3764663|B1|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3943337|NCT01369199|3764663|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3943338|NCT01369199|3764663|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3943339|NCT01369199|3764663|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3943340|NCT01369199|3764663|B1|||Age||years|Median|37.2|37.2|Full Range|||22.2|61.2|
3943341|NCT01369108|3764685|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
3943342|NCT01369108|3764685|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3943343|NCT01369108|3764685|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3943344|NCT01369108|3764685|B1|||Age||years|Mean|52|52.0|Full Range|||19.0|63.0|
3943345|NCT01369108|3764685|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3943346|NCT01369108|3764685|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3943347|NCT01369108|3764685|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3943348|NCT01369030|3764692|B1|United States||Region of Enrollment||participants|Number|554|554.0||||||
3943349|NCT01369030|3764692|B1|Male||Gender|Baseline gender characteristic categories include female, male, and unknown. 16 enrolled subjects were listed as unknown.|participants|Number|114|114.0||||||
3943350|NCT01369030|3764692|B1|Female||Gender|Baseline gender characteristic categories include female, male, and unknown. 16 enrolled subjects were listed as unknown.|participants|Number|424|424.0||||||
3943351|NCT01369030|3764692|B1|||Age||years|Mean|49.9|49.9|Standard Deviation|14.1|14.1|||
3943352|NCT01369030|3764692|B1||>=65 years|Age||Participants|Count of Participants|84|84.0||||||
3943353|NCT01369030|3764692|B1||Between 18 and 65 years|Age||Participants|Count of Participants|470|470.0||||||
3943354|NCT01369030|3764692|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3943355|NCT01368965|3764698|B1|Type VI||Fitzpatrick Skin Type|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|3|3.0||||||
3943356|NCT01368965|3764698|B1|Type V||Fitzpatrick Skin Type|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|15|15.0||||||
3943357|NCT01368965|3764698|B1|Type IV||Fitzpatrick Skin Type|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|25|25.0||||||
3943358|NCT01368965|3764698|B1|Type III||Fitzpatrick Skin Type|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|9|9.0||||||
3943359|NCT01368965|3764698|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
3943360|NCT01368965|3764698|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3943361|NCT01368965|3764698|B1|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3943362|NCT01368965|3764698|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3943363|NCT01368965|3764698|B1|African American/Black||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3943364|NCT01368965|3764698|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3943365|NCT01368965|3764698|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3943366|NCT01368965|3764698|B1|||Age||years|Mean|53|53.0|Full Range|||32.0|64.0|
3943367|NCT01368900|3764707|B1|Skin Type VI||Fitzpatrick Skin Type|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|0|0.0||||||
3943368|NCT01368900|3764707|B1|Skin Type V||Fitzpatrick Skin Type|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|1|1.0||||||
3943369|NCT01368900|3764707|B1|Skin Type IV||Fitzpatrick Skin Type|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|1|1.0||||||
3943370|NCT01368900|3764707|B1|Skin Type III||Fitzpatrick Skin Type|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|48|48.0||||||
3943371|NCT01368900|3764707|B1|Skin Type II||Fitzpatrick Skin Type|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|18|18.0||||||
3943372|NCT01368900|3764707|B1|Skin Type I||Fitzpatrick Skin Type|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|participants|Number|0|0.0||||||
3943373|NCT01368900|3764707|B1|United States||Region of Enrollment||participants|Number|68|68.0||||||
3943374|NCT01368900|3764707|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3943375|NCT01368900|3764707|B1|African American/Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3943376|NCT01368900|3764707|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
3943377|NCT01368900|3764707|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3943378|NCT01368900|3764707|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3943379|NCT01368900|3764707|B1|Mean (Full Range)||Age||years|Mean|51|51.0|Full Range|||36.0|64.0|
3943380|NCT01368874|3764717|B4|||BMI||Kg/m^2|Mean|25.60|25.6|Full Range|||18.47|36.44|
3943381|NCT01368874|3764718|B3|||BMI||Kg/m^2|Mean|26.32|26.32|Full Range|||18.47|36.44|
3943382|NCT01368874|3764719|B2|||BMI||Kg/m^2|Mean|22.49|22.49|Full Range|||19.58|27.1|
3943383|NCT01368874|3764720|B1|||BMI||Kg/m^2|Mean|25.53|25.53|Full Range|||19.04|32.76|
3943384|NCT01368874|3764717|B4|Type V||Fitzpatrick Skin Type Score|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|Participants|Number|1|1.0||||||
3943385|NCT01368874|3764718|B3|Type V||Fitzpatrick Skin Type Score|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|Participants|Number|1|1.0||||||
3943386|NCT01368874|3764719|B2|Type V||Fitzpatrick Skin Type Score|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|Participants|Number|0|0.0||||||
3943387|NCT01368874|3764720|B1|Type V||Fitzpatrick Skin Type Score|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|Participants|Number|0|0.0||||||
3943388|NCT01368874|3764717|B4|Type IV||Fitzpatrick Skin Type Score|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|Participants|Number|0|0.0||||||
3943389|NCT01368874|3764718|B3|Type IV||Fitzpatrick Skin Type Score|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|Participants|Number|0|0.0||||||
3943390|NCT01368874|3764719|B2|Type IV||Fitzpatrick Skin Type Score|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|Participants|Number|0|0.0||||||
3943391|NCT01368874|3764720|B1|Type IV||Fitzpatrick Skin Type Score|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|Participants|Number|0|0.0||||||
3943392|NCT01368874|3764717|B4|Type III||Fitzpatrick Skin Type Score|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|Participants|Number|22|22.0||||||
3943393|NCT01368874|3764718|B3|Type III||Fitzpatrick Skin Type Score|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|Participants|Number|12|12.0||||||
3943414|NCT01368874|3764719|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3943415|NCT01368874|3764720|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3943394|NCT01368874|3764719|B2|Type III||Fitzpatrick Skin Type Score|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|Participants|Number|0|0.0||||||
3943395|NCT01368874|3764720|B1|Type III||Fitzpatrick Skin Type Score|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|Participants|Number|10|10.0||||||
3943396|NCT01368874|3764717|B4|Type II||Fitzpatrick Skin Type Score|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|Participants|Number|31|31.0||||||
3943397|NCT01368874|3764718|B3|Type II||Fitzpatrick Skin Type Score|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|Participants|Number|8|8.0||||||
3943398|NCT01368874|3764719|B2|Type II||Fitzpatrick Skin Type Score|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|Participants|Number|5|5.0||||||
3943399|NCT01368874|3764720|B1|Type II||Fitzpatrick Skin Type Score|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|Participants|Number|18|18.0||||||
3943400|NCT01368874|3764717|B4|Type I||Fitzpatrick Skin Type Score|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|Participants|Number|10|10.0||||||
3943401|NCT01368874|3764718|B3|Type I||Fitzpatrick Skin Type Score|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|Participants|Number|4|4.0||||||
3943402|NCT01368874|3764719|B2|Type I||Fitzpatrick Skin Type Score|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|Participants|Number|0|0.0||||||
3943403|NCT01368874|3764720|B1|Type I||Fitzpatrick Skin Type Score|"Skin Type I = White;very fair,red or blonde hair blue eyes;freckles;Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes;Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|Participants|Number|6|6.0||||||
3943404|NCT01368874|3764717|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3943405|NCT01368874|3764718|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3943406|NCT01368874|3764719|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3943407|NCT01368874|3764720|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3943408|NCT01368874|3764717|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3943409|NCT01368874|3764718|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3943410|NCT01368874|3764719|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3943411|NCT01368874|3764720|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3943412|NCT01368874|3764717|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3943413|NCT01368874|3764718|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3943416|NCT01368874|3764717|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3943417|NCT01368874|3764718|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3943418|NCT01368874|3764719|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3943419|NCT01368874|3764720|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3943420|NCT01368874|3764717|B4||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3943421|NCT01368874|3764718|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3943422|NCT01368874|3764719|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3943423|NCT01368874|3764720|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3943424|NCT01368874|3764717|B4|||Age||years|Mean|55.3|55.3|Full Range|||39.0|65.0|
3943425|NCT01368874|3764718|B3|||Age||years|Mean|55.2|55.2|Full Range|||39.0|65.0|
3943426|NCT01368874|3764719|B2|||Age||years|Mean|57.4|57.4|Full Range|||49.0|62.0|
3943427|NCT01368874|3764720|B1|||Age||years|Mean|55.06|55.06|Full Range|NA||43.0|65.0|
3943428|NCT01368835|3764782|B1|Skin Type V||Fitzpatrick Skin Type|"Skin Type I = White; very fair, red or blonde hair blue eyes; freckles; Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes; Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|# of Participants|Number|1|1.0||||||
3943429|NCT01368835|3764782|B1|Skin Type IV||Fitzpatrick Skin Type|"Skin Type I = White; very fair, red or blonde hair blue eyes; freckles; Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes; Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|# of Participants|Number|2|2.0||||||
3943430|NCT01368835|3764782|B1|Skin Type III||Fitzpatrick Skin Type|"Skin Type I = White; very fair, red or blonde hair blue eyes; freckles; Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes; Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|# of Participants|Number|12|12.0||||||
3943431|NCT01368835|3764782|B1|Skin Type II||Fitzpatrick Skin Type|"Skin Type I = White; very fair, red or blonde hair blue eyes; freckles; Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes; Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|# of Participants|Number|46|46.0||||||
3943432|NCT01368835|3764782|B1|Skin Type I||Fitzpatrick Skin Type|"Skin Type I = White; very fair, red or blonde hair blue eyes; freckles; Always burns, never tans~Skin Type II = White, fair, red or blond hair; blue, hazel or green eyes; Usually burns, tans with difficulty~Skin Type III = Cream white; fair with any eye or hair color (common); Sometimes mild burn, gradually tans~Skin Type IV = Brown; typical Mediterranean Caucasian skin; Rarely burns, tans with ease~Skin Type V = Dark Brown; mid-eastern skin types; Very rarely burns, tans easily~Skin Type VI = Black; Never burns, tans very easily"|# of Participants|Number|9|9.0||||||
3943433|NCT01368835|3764782|B1|United States||Region of Enrollment||participants|Number|70|70.0||||||
3943434|NCT01368835|3764782|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3943435|NCT01368835|3764782|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3943436|NCT01368835|3764782|B1|||Age|Average patient age|years|Mean|49.5|49.5|Full Range|||35.0|58.0|
3943437|NCT01368809|3764789|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
3943438|NCT01368809|3764790|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
3943439|NCT01368809|3764791|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3943440|NCT01368809|3764789|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3943441|NCT01368809|3764790|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3943442|NCT01368809|3764791|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3943443|NCT01368809|3764789|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3943444|NCT01368809|3764790|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3943445|NCT01368809|3764791|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3943446|NCT01368809|3764789|B3|||Age||years|Mean|48|48.0|Standard Deviation|15|15.0|||
3943447|NCT01368809|3764790|B2|||Age||years|Mean|48|48.0|Standard Deviation|16|16.0|||
3943448|NCT01368809|3764791|B1|||Age||years|Mean|48|48.0|Standard Deviation|14|14.0|||
3943449|NCT01368653|3764802|B3|United States||Region of Enrollment||participants|Number|93|93.0||||||
3943450|NCT01368653|3764803|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
3943451|NCT01368653|3764804|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
3943452|NCT01368653|3764802|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3943453|NCT01368653|3764803|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3943454|NCT01368653|3764804|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3943455|NCT01368653|3764802|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3943456|NCT01368653|3764803|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3943457|NCT01368653|3764804|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3943458|NCT01368653|3764802|B3|||Age||years|Mean|47.76|47.76|Standard Deviation|12.44|12.44|||
3943459|NCT01368653|3764803|B2|||Age||years|Mean|48.41|48.41|Standard Deviation|10.36|10.36|||
3943460|NCT01368653|3764804|B1|||Age||years|Mean|47.13|47.13|Standard Deviation|14.27|14.27|||
3943461|NCT01368653|3764802|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3943462|NCT01368653|3764803|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3943463|NCT01368653|3764804|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3943464|NCT01368653|3764802|B3||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
3943465|NCT01368653|3764803|B2||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3943466|NCT01368653|3764804|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3943467|NCT01368653|3764802|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3943468|NCT01368653|3764803|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3943469|NCT01368653|3764804|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3943470|NCT01368536|3764821|B4||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
3943471|NCT01368536|3764822|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3943472|NCT01368536|3764823|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3943473|NCT01368536|3764824|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3943474|NCT01368536|3764821|B4||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
3943475|NCT01368536|3764822|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3943476|NCT01368536|3764823|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3943477|NCT01368536|3764824|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3943478|NCT01368536|3764821|B4|||Age||Years|Mean|55.1|55.1|Standard Deviation|9.20|9.2|||
3943479|NCT01368536|3764822|B3|||Age||Years|Mean|54.6|54.6|Standard Deviation|9.35|9.35|||
3943480|NCT01368536|3764823|B2|||Age||Years|Mean|56.0|56.0|Standard Deviation|9.56|9.56|||
3943481|NCT01368536|3764824|B1|||Age||Years|Mean|54.7|54.7|Standard Deviation|8.65|8.65|||
3943482|NCT01368497|3764847|B1|||HBV DNA||log10 IU/mL|Median|8.2|8.2|Full Range|||7.5|9.1|
3943483|NCT01368497|3764847|B1|United States||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
3943484|NCT01368497|3764847|B1|Canada||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3943485|NCT01368497|3764847|B1|Mixed||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3943486|NCT01368497|3764847|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|54|54.0||||||
3943487|NCT01368497|3764847|B1|Black/African-American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3943488|NCT01368497|3764847|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3943489|NCT01368497|3764847|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3943490|NCT01368497|3764847|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3943491|NCT01368497|3764847|B1|||Age||years|Median|10.9|10.9|Full Range|||3.4|17.9|
3943492|NCT01368432|3764873|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
3943493|NCT01368432|3764874|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3943494|NCT01368432|3764875|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3943495|NCT01368432|3764873|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3943496|NCT01368432|3764874|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3943497|NCT01368432|3764875|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3943498|NCT01368432|3764873|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3943499|NCT01368432|3764874|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3943500|NCT01368432|3764875|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3943501|NCT01368432|3764873|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3943502|NCT01368432|3764874|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3943503|NCT01368432|3764875|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3943504|NCT01368432|3764873|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3943505|NCT01368432|3764874|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3943506|NCT01368432|3764875|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3943507|NCT01368432|3764873|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3943508|NCT01368432|3764874|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3943509|NCT01368432|3764875|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3943510|NCT01368406|3764908|B3|Brazil||Region of Enrollment||participants|Number|160|160.0||||||
3943511|NCT01368406|3764909|B2|Brazil||Region of Enrollment||participants|Number|79|79.0||||||
3943512|NCT01368406|3764910|B1|Brazil||Region of Enrollment||participants|Number|81|81.0||||||
3943513|NCT01368406|3764908|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3943514|NCT01368406|3764909|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3943515|NCT01368406|3764910|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3943516|NCT01368406|3764908|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3943517|NCT01368406|3764909|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3943518|NCT01368406|3764910|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3943519|NCT01368406|3764908|B3|||Age||years|Mean|37.3|37.3|Standard Deviation|10.4|10.4|||
3943520|NCT01368406|3764909|B2|||Age||years|Mean|38.3|38.3|Standard Deviation|10.7|10.7|||
3943521|NCT01368406|3764910|B1|||Age||years|Mean|36.2|36.2|Standard Deviation|9.9|9.9|||
3943522|NCT01368406|3764908|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3943523|NCT01368406|3764909|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3943524|NCT01368406|3764910|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3943525|NCT01368406|3764908|B3||Between 18 and 65 years|Age||Participants|Count of Participants|160|160.0||||||
3943526|NCT01368406|3764909|B2||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
3943527|NCT01368406|3764910|B1||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
3943528|NCT01368406|3764908|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3943529|NCT01368406|3764909|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3943530|NCT01368406|3764910|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3943531|NCT01368276|3764917|B3|Stage IV M1c||Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥ 4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs; normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|5|5.0||||||
3943532|NCT01368276|3764918|B2|Stage IV M1c||Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥ 4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs; normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|4|4.0||||||
3943533|NCT01368276|3764919|B1|Stage IV M1c||Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥ 4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs; normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|1|1.0||||||
3943534|NCT01368276|3764917|B3|Stage IV M1b||Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥ 4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs; normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|9|9.0||||||
3943535|NCT01368276|3764918|B2|Stage IV M1b||Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥ 4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs; normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|8|8.0||||||
3943536|NCT01368276|3764919|B1|Stage IV M1b||Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥ 4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs; normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|1|1.0||||||
3943537|NCT01368276|3764917|B3|Stage IV M1a||Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥ 4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs; normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|10|10.0||||||
3943538|NCT01368276|3764918|B2|Stage IV M1a||Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥ 4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs; normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|9|9.0||||||
3943539|NCT01368276|3764919|B1|Stage IV M1a||Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥ 4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs; normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|1|1.0||||||
3943609|NCT01368081|3764973|B14||Female|Sex: Female, Male||Participants|Count of Participants|325|325.0||||||
3943540|NCT01368276|3764917|B3|Stage IIIC||Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥ 4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs; normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|6|6.0||||||
3943541|NCT01368276|3764918|B2|Stage IIIC||Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥ 4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs; normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|6|6.0||||||
3943542|NCT01368276|3764919|B1|Stage IIIC||Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥ 4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs; normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|0|0.0||||||
3943543|NCT01368276|3764917|B3|Stage IIIB||Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥ 4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs; normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|1|1.0||||||
3943544|NCT01368276|3764918|B2|Stage IIIB||Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥ 4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs; normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|1|1.0||||||
3943545|NCT01368276|3764919|B1|Stage IIIB||Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥ 4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs; normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|0|0.0||||||
3943546|NCT01368276|3764917|B3|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|8|8.0||||||
3943547|NCT01368276|3764918|B2|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|8|8.0||||||
3943548|NCT01368276|3764919|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
3943549|NCT01368276|3764917|B3|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|23|23.0||||||
3943550|NCT01368276|3764918|B2|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|20|20.0||||||
3943551|NCT01368276|3764919|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|3|3.0||||||
3943552|NCT01368276|3764917|B3|White||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3943553|NCT01368276|3764918|B2|White||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3943554|NCT01368276|3764919|B1|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3943555|NCT01368276|3764917|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3943556|NCT01368276|3764918|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3943557|NCT01368276|3764919|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3943558|NCT01368276|3764917|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3943559|NCT01368276|3764918|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3943560|NCT01368276|3764919|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3943561|NCT01368276|3764917|B3|||Age||years|Mean|63.3|63.3|Standard Deviation|14.4|14.4|||
3943562|NCT01368276|3764918|B2|||Age||years|Mean|64.2|64.2|Standard Deviation|13.2|13.2|||
3943563|NCT01368276|3764919|B1|||Age||years|Mean|54.7|54.7|Standard Deviation|25.0|25.0|||
3943564|NCT01368263|3764930|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
3943565|NCT01368263|3764931|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3943566|NCT01368263|3764932|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3943567|NCT01368263|3764933|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3943568|NCT01368263|3764930|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3943569|NCT01368263|3764931|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3943570|NCT01368263|3764932|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3943571|NCT01368263|3764933|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3943572|NCT01368263|3764930|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3943573|NCT01368263|3764931|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3943574|NCT01368263|3764932|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3943575|NCT01368263|3764933|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3943576|NCT01368263|3764930|B4|||Age||years|Median|38.5|38.5|Full Range|||29.0|53.0|
3943577|NCT01368263|3764931|B3|||Age||years|Median|35|35.0|Full Range|||35.0|35.0|
3943578|NCT01368263|3764932|B2|||Age||years|Median|29|29.0|Full Range|||29.0|29.0|
3943579|NCT01368263|3764933|B1|||Age||years|Median|43|43.0|Full Range|||35.0|53.0|
3943580|NCT01368211|3764955|B3|Denmark||Region of Enrollment||participants|Number|15|15.0||||||
3943581|NCT01368211|3764956|B2|Denmark||Region of Enrollment||participants|Number|7|7.0||||||
3943582|NCT01368211|3764957|B1|Denmark||Region of Enrollment||participants|Number|8|8.0||||||
3943583|NCT01368211|3764955|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3943584|NCT01368211|3764956|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3943585|NCT01368211|3764957|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3943586|NCT01368211|3764955|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3943587|NCT01368211|3764956|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3943588|NCT01368211|3764957|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3943589|NCT01368211|3764955|B3|||Age||Years|Mean|57.33|57.33|Standard Deviation|15.99|15.99|||
3943590|NCT01368211|3764956|B2|||Age||Years|Mean|55.29|55.29|Standard Deviation|19.95|19.95|||
3943591|NCT01368211|3764957|B1|||Age||Years|Mean|59.13|59.13|Standard Deviation|12.76|12.76|||
3943592|NCT01368185|3764966|B1||Male|Sex: Female, Male||Participants|Count of Participants|910|910.0||||||
3943593|NCT01368185|3764966|B1||Female|Sex: Female, Male||Participants|Count of Participants|795|795.0||||||
3943594|NCT01368185|3764966|B1|||Age||years|Mean|57.9|57.9|Standard Deviation|10.4|10.4|||
3943595|NCT01368081|3764973|B14||Male|Sex: Female, Male||Participants|Count of Participants|835|835.0||||||
3943596|NCT01368081|3764974|B13||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3943597|NCT01368081|3764975|B12||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3943598|NCT01368081|3764976|B11||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3943599|NCT01368081|3764977|B10||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3943600|NCT01368081|3764978|B9||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3943601|NCT01368081|3764979|B8||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3943602|NCT01368081|3764980|B7||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3943603|NCT01368081|3764981|B6||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3943604|NCT01368081|3764982|B5||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3943605|NCT01368081|3764983|B4||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3943606|NCT01368081|3764984|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3943607|NCT01368081|3764985|B2||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3943608|NCT01368081|3764986|B1||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3943610|NCT01368081|3764974|B13||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3943611|NCT01368081|3764975|B12||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3943612|NCT01368081|3764976|B11||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3943613|NCT01368081|3764977|B10||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3943614|NCT01368081|3764978|B9||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3943615|NCT01368081|3764979|B8||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3943616|NCT01368081|3764980|B7||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3943617|NCT01368081|3764981|B6||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3943618|NCT01368081|3764982|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3943619|NCT01368081|3764983|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3943620|NCT01368081|3764984|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3943621|NCT01368081|3764985|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3943622|NCT01368081|3764986|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3943623|NCT01368081|3764973|B14|||Age||years|Mean|60.3|60.3|Standard Deviation|10.4|10.4|||
3943624|NCT01368081|3764974|B13|||Age||years|Mean|57.7|57.7|Standard Deviation|11.8|11.8|||
3943625|NCT01368081|3764975|B12|||Age||years|Mean|59.2|59.2|Standard Deviation|12.1|12.1|||
3943626|NCT01368081|3764976|B11|||Age||years|Mean|59.1|59.1|Standard Deviation|10.3|10.3|||
3943627|NCT01368081|3764977|B10|||Age||years|Mean|63.3|63.3|Standard Deviation|9.9|9.9|||
3943628|NCT01368081|3764978|B9|||Age||years|Mean|61.9|61.9|Standard Deviation|11.7|11.7|||
3943629|NCT01368081|3764979|B8|||Age||years|Mean|63.5|63.5|Standard Deviation|8.8|8.8|||
3943630|NCT01368081|3764980|B7|||Age||years|Mean|59.7|59.7|Standard Deviation|9.9|9.9|||
3943631|NCT01368081|3764981|B6|||Age||years|Mean|60.4|60.4|Standard Deviation|10.1|10.1|||
3943632|NCT01368081|3764982|B5|||Age||years|Mean|57.3|57.3|Standard Deviation|11.4|11.4|||
3943633|NCT01368081|3764983|B4|||Age||years|Mean|56.9|56.9|Standard Deviation|9.5|9.5|||
3943634|NCT01368081|3764984|B3|||Age||years|Mean|60.0|60.0|Standard Deviation|10.2|10.2|||
3943635|NCT01368081|3764985|B2|||Age||years|Mean|61.8|61.8|Standard Deviation|9.6|9.6|||
3943636|NCT01368081|3764986|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|9.9|9.9|||
3943637|NCT01368042|3765052|B1||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
3943638|NCT01368042|3765052|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3943639|NCT01368042|3765052|B1|||Age||years|Mean|67.8|67.8|Standard Deviation|12.0|12.0|||
3943640|NCT01367886|3765072|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3943641|NCT01367886|3765072|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3943642|NCT01367886|3765072|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3943643|NCT01367886|3765072|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3943644|NCT01367886|3765072|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3943645|NCT01367886|3765072|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3943646|NCT01367860|3765079|B3|||ODI preoperatively|"Oswestry Disability Index (ODI) -> The Oswestry Disability Index (ODI) is one of the principal condition-specific outcome measures used in the management of spinal disorders. The ODI is the most commonly outcome measures in patients with low back pain.~Each of the 10 items is scored from 0 - 5. The maximum score is therefore 50. If the FIRST statement is marked, the section score = 0, If the LAST statement is marked, it = 5.~0 is the best outcome and 50 is the worst outcome."|units on a scale|Mean|30|30.0|Standard Deviation|8.8|8.8|||
3943647|NCT01367860|3765080|B2|||ODI preoperatively|"Oswestry Disability Index (ODI) -> The Oswestry Disability Index (ODI) is one of the principal condition-specific outcome measures used in the management of spinal disorders. The ODI is the most commonly outcome measures in patients with low back pain.~Each of the 10 items is scored from 0 - 5. The maximum score is therefore 50. If the FIRST statement is marked, the section score = 0, If the LAST statement is marked, it = 5.~0 is the best outcome and 50 is the worst outcome."|units on a scale|Mean|26.35|26.35|Standard Deviation|6.6|6.6|||
3943648|NCT01367860|3765081|B1|||ODI preoperatively|"Oswestry Disability Index (ODI) -> The Oswestry Disability Index (ODI) is one of the principal condition-specific outcome measures used in the management of spinal disorders. The ODI is the most commonly outcome measures in patients with low back pain.~Each of the 10 items is scored from 0 - 5. The maximum score is therefore 50. If the FIRST statement is marked, the section score = 0, If the LAST statement is marked, it = 5.~0 is the best outcome and 50 is the worst outcome."|units on a scale|Mean|33.65|33.65|Standard Deviation|9.33|9.33|||
3943649|NCT01367860|3765079|B3|||VAS for leg pain preoperatively|Visual Analog Scale (VAS) -> minimum value=0 and maximum value=100, higher values represent a worse outcome and zero is a better outcome.|units on a scale|Mean|78.9|78.9|Standard Deviation|22|22.0|||
3943650|NCT01367860|3765080|B2|||VAS for leg pain preoperatively|Visual Analog Scale (VAS) -> minimum value=0 and maximum value=100, higher values represent a worse outcome and zero is a better outcome.|units on a scale|Mean|73.6|73.6|Standard Deviation|22|22.0|||
3943651|NCT01367860|3765081|B1|||VAS for leg pain preoperatively|Visual Analog Scale (VAS) -> minimum value=0 and maximum value=100, higher values represent a worse outcome and zero is a better outcome.|units on a scale|Mean|84.2|84.2|Standard Deviation|23|23.0|||
3943652|NCT01367860|3765079|B3|||VAS for lumbar pain preoperatively|Visual Analog Scale (VAS) -> minimum value=0 and maximum value=100, higher values represent a worse outcome and zero is a better outcome.|units on a scale|Mean|69.2|69.2|Standard Deviation|29|29.0|||
3943653|NCT01367860|3765080|B2|||VAS for lumbar pain preoperatively|Visual Analog Scale (VAS) -> minimum value=0 and maximum value=100, higher values represent a worse outcome and zero is a better outcome.|units on a scale|Mean|63|63.0|Standard Deviation|30|30.0|||
3943716|NCT01367860|3765080|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3943654|NCT01367860|3765081|B1|||VAS for lumbar pain preoperatively|Visual Analog Scale (VAS) -> minimum value=0 and maximum value=100, higher values represent a worse outcome and zero is a better outcome.|units on a scale|Mean|77.2|77.2|Standard Deviation|27|27.0|||
3943655|NCT01367860|3765079|B3|||Months feeling pain||Months|Mean|24.87|24.87|Standard Deviation|36.96|36.96|||
3943656|NCT01367860|3765080|B2|||Months feeling pain||Months|Mean|33.5|33.5|Standard Deviation|47.3|47.3|||
3943657|NCT01367860|3765081|B1|||Months feeling pain||Months|Mean|16.25|16.25|Standard Deviation|20.2|20.2|||
3943658|NCT01367860|3765079|B3|||Months away from work||Months|Mean|5.8|5.8|Standard Deviation|9.14|9.14|||
3943659|NCT01367860|3765080|B2|||Months away from work||Months|Mean|8.67|8.67|Standard Deviation|14.4|14.4|||
3943660|NCT01367860|3765081|B1|||Months away from work||Months|Mean|4.65|4.65|Standard Deviation|6.52|6.52|||
3943661|NCT01367860|3765079|B3|no||Receiving government benefit||participants|Number|17|17.0||||||
3943662|NCT01367860|3765080|B2|no||Receiving government benefit||participants|Number|10|10.0||||||
3943663|NCT01367860|3765081|B1|no||Receiving government benefit||participants|Number|7|7.0||||||
3943664|NCT01367860|3765079|B3|yes||Receiving government benefit||participants|Number|23|23.0||||||
3943665|NCT01367860|3765080|B2|yes||Receiving government benefit||participants|Number|10|10.0||||||
3943666|NCT01367860|3765081|B1|yes||Receiving government benefit||participants|Number|13|13.0||||||
3943667|NCT01367860|3765079|B3|no||Working currently||participants|Number|24|24.0||||||
3943668|NCT01367860|3765080|B2|no||Working currently||participants|Number|10|10.0||||||
3943669|NCT01367860|3765081|B1|no||Working currently||participants|Number|14|14.0||||||
3943670|NCT01367860|3765079|B3|yes||Working currently||participants|Number|16|16.0||||||
3943671|NCT01367860|3765080|B2|yes||Working currently||participants|Number|10|10.0||||||
3943672|NCT01367860|3765081|B1|yes||Working currently||participants|Number|6|6.0||||||
3943673|NCT01367860|3765079|B3|no||Opioid use||participants|Number|16|16.0||||||
3943674|NCT01367860|3765080|B2|no||Opioid use||participants|Number|9|9.0||||||
3943675|NCT01367860|3765081|B1|no||Opioid use||participants|Number|7|7.0||||||
3943676|NCT01367860|3765079|B3|yes||Opioid use||participants|Number|24|24.0||||||
3943677|NCT01367860|3765080|B2|yes||Opioid use||participants|Number|11|11.0||||||
3943678|NCT01367860|3765081|B1|yes||Opioid use||participants|Number|13|13.0||||||
3943679|NCT01367860|3765079|B3|no||Manual labor||participants|Number|15|15.0||||||
3943680|NCT01367860|3765080|B2|no||Manual labor||participants|Number|8|8.0||||||
3943681|NCT01367860|3765081|B1|no||Manual labor||participants|Number|7|7.0||||||
3943682|NCT01367860|3765079|B3|yes||Manual labor||participants|Number|25|25.0||||||
3943683|NCT01367860|3765080|B2|yes||Manual labor||participants|Number|12|12.0||||||
3943684|NCT01367860|3765081|B1|yes||Manual labor||participants|Number|13|13.0||||||
3943685|NCT01367860|3765079|B3|No||Married||participants|Number|9|9.0||||||
3943686|NCT01367860|3765080|B2|No||Married||participants|Number|7|7.0||||||
3943687|NCT01367860|3765081|B1|No||Married||participants|Number|2|2.0||||||
3943688|NCT01367860|3765079|B3|Yes||Married||participants|Number|31|31.0||||||
3943689|NCT01367860|3765080|B2|Yes||Married||participants|Number|13|13.0||||||
3943690|NCT01367860|3765081|B1|Yes||Married||participants|Number|18|18.0||||||
3943691|NCT01367860|3765079|B3|<8 years||Schooling|Schooling (>=8 years and <8 years)|participants|Number|20|20.0||||||
3943692|NCT01367860|3765080|B2|<8 years||Schooling|Schooling (>=8 years and <8 years)|participants|Number|10|10.0||||||
3943693|NCT01367860|3765081|B1|<8 years||Schooling|Schooling (>=8 years and <8 years)|participants|Number|10|10.0||||||
3943694|NCT01367860|3765079|B3|>=8 years||Schooling|Schooling (>=8 years and <8 years)|participants|Number|20|20.0||||||
3943695|NCT01367860|3765080|B2|>=8 years||Schooling|Schooling (>=8 years and <8 years)|participants|Number|10|10.0||||||
3943696|NCT01367860|3765081|B1|>=8 years||Schooling|Schooling (>=8 years and <8 years)|participants|Number|10|10.0||||||
3943697|NCT01367860|3765079|B3|Brazil||Region of Enrollment||participants|Number|40|40.0||||||
3943698|NCT01367860|3765080|B2|Brazil||Region of Enrollment||participants|Number|20|20.0||||||
3943699|NCT01367860|3765081|B1|Brazil||Region of Enrollment||participants|Number|20|20.0||||||
3943700|NCT01367860|3765079|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3943701|NCT01367860|3765080|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3943702|NCT01367860|3765081|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3943703|NCT01367860|3765079|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3943704|NCT01367860|3765080|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3943705|NCT01367860|3765081|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3943706|NCT01367860|3765079|B3||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3943707|NCT01367860|3765080|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3943708|NCT01367860|3765081|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3943709|NCT01367860|3765079|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3943710|NCT01367860|3765080|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3943711|NCT01367860|3765081|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3943712|NCT01367860|3765079|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3943713|NCT01367860|3765080|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3943714|NCT01367860|3765081|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3943715|NCT01367860|3765079|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3943717|NCT01367860|3765081|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3943718|NCT01367860|3765079|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3943719|NCT01367860|3765080|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3943720|NCT01367860|3765081|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3943721|NCT01367860|3765079|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3943722|NCT01367860|3765080|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3943723|NCT01367860|3765081|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3943724|NCT01367860|3765079|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3943725|NCT01367860|3765080|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3943726|NCT01367860|3765081|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3943727|NCT01367860|3765079|B3|||Age||years|Mean|43|43.0|Standard Deviation|9.4|9.4|||
3943728|NCT01367860|3765080|B2|||Age||years|Mean|44.9|44.9|Standard Deviation|9.4|9.4|||
3943729|NCT01367860|3765081|B1|||Age||years|Mean|41.2|41.2|Standard Deviation|9.3|9.3|||
3943730|NCT01367847|3765120|B3|Minority (Racial and/or Ethnic)||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3943731|NCT01367847|3765121|B2|Minority (Racial and/or Ethnic)||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3943732|NCT01367847|3765122|B1|Minority (Racial and/or Ethnic)||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3943733|NCT01367847|3765120|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3943734|NCT01367847|3765121|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3943735|NCT01367847|3765122|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3943736|NCT01367847|3765120|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3943737|NCT01367847|3765121|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3943738|NCT01367847|3765122|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3943739|NCT01367847|3765120|B3|||Age||Years|Mean|5.67|5.67|Standard Deviation|1.72|1.72|||
3943740|NCT01367847|3765121|B2|||Age||Years|Mean|5.57|5.57|Standard Deviation|1.27|1.27|||
3943741|NCT01367847|3765122|B1|||Age||Years|Mean|5.75|5.75|Standard Deviation|2.12|2.12|||
3943742|NCT01367834|3765137|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
3943743|NCT01367834|3765138|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3943744|NCT01367834|3765139|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3943745|NCT01367834|3765137|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3943746|NCT01367834|3765138|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3943747|NCT01367834|3765139|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3943748|NCT01367834|3765137|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3943749|NCT01367834|3765138|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3943750|NCT01367834|3765139|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3943751|NCT01367834|3765137|B3|||Age||months|Mean|12.96|12.96|Standard Deviation|0.73|0.73|||
3943752|NCT01367834|3765138|B2|||Age||months|Mean|12.73|12.73|Standard Deviation|0.50|0.5|||
3943753|NCT01367834|3765139|B1|||Age||months|Mean|13.12|13.12|Standard Deviation|0.82|0.82|||
3943754|NCT01367834|3765137|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3943755|NCT01367834|3765138|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3943756|NCT01367834|3765139|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3943757|NCT01367834|3765137|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3943758|NCT01367834|3765138|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3943759|NCT01367834|3765139|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3943760|NCT01367834|3765137|B3||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
3943761|NCT01367834|3765138|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3943762|NCT01367834|3765139|B1||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
3943763|NCT01367704|3765162|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3943764|NCT01367704|3765163|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3943765|NCT01367704|3765164|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3943766|NCT01367704|3765162|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|193|193.0||||||
3943767|NCT01367704|3765163|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
3943768|NCT01367704|3765164|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
3943769|NCT01367704|3765162|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1069|1069.0||||||
3943770|NCT01367704|3765163|B2||White|Race (NIH/OMB)||Participants|Count of Participants|502|502.0||||||
3943771|NCT01367704|3765164|B1||White|Race (NIH/OMB)||Participants|Count of Participants|567|567.0||||||
3943772|NCT01367704|3765162|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|439|439.0||||||
3943773|NCT01367704|3765163|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|248|248.0||||||
3943774|NCT01367704|3765164|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|191|191.0||||||
3943775|NCT01367704|3765162|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3943776|NCT01367704|3765163|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3943777|NCT01367704|3765164|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3943778|NCT01367704|3765162|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|192|192.0||||||
3943779|NCT01367704|3765163|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3943780|NCT01367704|3765164|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|114|114.0||||||
3943781|NCT01367704|3765162|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3943782|NCT01367704|3765163|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3943783|NCT01367704|3765164|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3943784|NCT01367704|3765162|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3943785|NCT01367704|3765163|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3943786|NCT01367704|3765164|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3943787|NCT01367704|3765162|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1598|1598.0||||||
3943788|NCT01367704|3765163|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|776|776.0||||||
3943789|NCT01367704|3765164|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|822|822.0||||||
3943790|NCT01367704|3765162|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|389|389.0||||||
3943791|NCT01367704|3765163|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|220|220.0||||||
3943792|NCT01367704|3765164|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|169|169.0||||||
3943793|NCT01367704|3765162|B3||Male|Sex: Female, Male||Participants|Count of Participants|2006|2006.0||||||
3943794|NCT01367704|3765163|B2||Male|Sex: Female, Male||Participants|Count of Participants|1008|1008.0||||||
3943795|NCT01367704|3765164|B1||Male|Sex: Female, Male||Participants|Count of Participants|998|998.0||||||
3943796|NCT01367704|3765162|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3943797|NCT01367704|3765163|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3943798|NCT01367704|3765164|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3943799|NCT01367704|3765162|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3943800|NCT01367704|3765163|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3943801|NCT01367704|3765164|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3943802|NCT01367704|3765162|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3943803|NCT01367704|3765163|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3943804|NCT01367704|3765164|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3943805|NCT01367704|3765162|B3||<=18 years|Age||Participants|Count of Participants|2006|2006.0||||||
3943806|NCT01367704|3765163|B2||<=18 years|Age||Participants|Count of Participants|1008|1008.0||||||
3943807|NCT01367704|3765164|B1||<=18 years|Age||Participants|Count of Participants|998|998.0||||||
3943808|NCT01367704|3765162|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3943809|NCT01367704|3765163|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3943810|NCT01367704|3765164|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3943811|NCT01367704|3765162|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3943812|NCT01367704|3765163|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3943813|NCT01367704|3765164|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3943814|NCT01367704|3765162|B3||<=18 years|Age||Participants|Count of Participants|2006|2006.0||||||
3943815|NCT01367704|3765163|B2||<=18 years|Age||Participants|Count of Participants|1008|1008.0||||||
3943816|NCT01367704|3765164|B1||<=18 years|Age||Participants|Count of Participants|998|998.0||||||
3943817|NCT01367457|3765175|B4||Male|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
3943818|NCT01367457|3765176|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3943819|NCT01367457|3765177|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3943820|NCT01367457|3765178|B1||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3943821|NCT01367457|3765175|B4||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3943822|NCT01367457|3765176|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3943823|NCT01367457|3765177|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3943824|NCT01367457|3765178|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3943825|NCT01367457|3765175|B4|||Age||years|Mean|66.54|66.54|Standard Deviation|11.04|11.04|||
3943826|NCT01367457|3765176|B3|||Age||years|Mean|72.34|72.34|Standard Deviation|7.11|7.11|||
3943827|NCT01367457|3765177|B2|||Age||years|Mean|70.56|70.56|Standard Deviation|11.07|11.07|||
3943828|NCT01367457|3765178|B1|||Age||years|Mean|65.27|65.27|Standard Deviation|11.14|11.14|||
3943829|NCT01367249|3765200|B3|Other||Iris Color (Study Eye)||participants|Number|1|1.0||||||
3943830|NCT01367249|3765201|B2|Other||Iris Color (Study Eye)||participants|Number|1|1.0||||||
3943831|NCT01367249|3765202|B1|Other||Iris Color (Study Eye)||participants|Number|0|0.0||||||
3943832|NCT01367249|3765200|B3|Hazel||Iris Color (Study Eye)||participants|Number|64|64.0||||||
3943833|NCT01367249|3765201|B2|Hazel||Iris Color (Study Eye)||participants|Number|33|33.0||||||
3943834|NCT01367249|3765202|B1|Hazel||Iris Color (Study Eye)||participants|Number|31|31.0||||||
3943835|NCT01367249|3765200|B3|Green||Iris Color (Study Eye)||participants|Number|45|45.0||||||
3943836|NCT01367249|3765201|B2|Green||Iris Color (Study Eye)||participants|Number|21|21.0||||||
3943837|NCT01367249|3765202|B1|Green||Iris Color (Study Eye)||participants|Number|24|24.0||||||
3943838|NCT01367249|3765200|B3|Gray||Iris Color (Study Eye)||participants|Number|6|6.0||||||
3943839|NCT01367249|3765201|B2|Gray||Iris Color (Study Eye)||participants|Number|5|5.0||||||
3943840|NCT01367249|3765202|B1|Gray||Iris Color (Study Eye)||participants|Number|1|1.0||||||
3943841|NCT01367249|3765200|B3|Brown||Iris Color (Study Eye)||participants|Number|202|202.0||||||
3943842|NCT01367249|3765201|B2|Brown||Iris Color (Study Eye)||participants|Number|93|93.0||||||
3943843|NCT01367249|3765202|B1|Brown||Iris Color (Study Eye)||participants|Number|109|109.0||||||
3943844|NCT01367249|3765200|B3|Blue||Iris Color (Study Eye)||participants|Number|122|122.0||||||
3943845|NCT01367249|3765201|B2|Blue||Iris Color (Study Eye)||participants|Number|65|65.0||||||
3943846|NCT01367249|3765202|B1|Blue||Iris Color (Study Eye)||participants|Number|57|57.0||||||
3943847|NCT01367249|3765200|B3|United States||Region of Enrollment||participants|Number|440|440.0||||||
3943848|NCT01367249|3765201|B2|United States||Region of Enrollment||participants|Number|218|218.0||||||
3943849|NCT01367249|3765202|B1|United States||Region of Enrollment||participants|Number|222|222.0||||||
3943850|NCT01367249|3765200|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3943851|NCT01367249|3765201|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3943852|NCT01367249|3765202|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3943853|NCT01367249|3765200|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3943854|NCT01367249|3765201|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3943855|NCT01367249|3765202|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3943856|NCT01367249|3765200|B3||White|Race (NIH/OMB)||Participants|Count of Participants|329|329.0||||||
3943857|NCT01367249|3765201|B2||White|Race (NIH/OMB)||Participants|Count of Participants|162|162.0||||||
3943858|NCT01367249|3765202|B1||White|Race (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
3943859|NCT01367249|3765200|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3943860|NCT01367249|3765201|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3943861|NCT01367249|3765202|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3943862|NCT01367249|3765200|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3943863|NCT01367249|3765201|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3943864|NCT01367249|3765202|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3943865|NCT01367249|3765200|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3943866|NCT01367249|3765201|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3943867|NCT01367249|3765202|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3943868|NCT01367249|3765200|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3943869|NCT01367249|3765201|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3943870|NCT01367249|3765202|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3943871|NCT01367249|3765200|B3||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3943872|NCT01367249|3765201|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3943873|NCT01367249|3765202|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3943874|NCT01367249|3765200|B3||Female|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
3943875|NCT01367249|3765201|B2||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3943876|NCT01367249|3765202|B1||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3943877|NCT01367249|3765200|B3|||Age||years|Mean|68.5|68.5|Standard Deviation|10.19|10.19|||
3943878|NCT01367249|3765201|B2|||Age||years|Mean|68.5|68.5|Standard Deviation|9.68|9.68|||
3943879|NCT01367249|3765202|B1|||Age||years|Mean|68.4|68.4|Standard Deviation|10.70|10.7|||
3943880|NCT01367158|3765211|B12||Male|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
3943881|NCT01367158|3765212|B11||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3943882|NCT01367158|3765213|B10||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3943883|NCT01367158|3765214|B9||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3943884|NCT01367158|3765215|B8||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3943885|NCT01367158|3765216|B7||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3943886|NCT01367158|3765217|B6||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3943887|NCT01367158|3765218|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3943888|NCT01367158|3765219|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3943889|NCT01367158|3765220|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3943890|NCT01367158|3765221|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3943891|NCT01367158|3765222|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3943892|NCT01367158|3765211|B12||Female|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
3943893|NCT01367158|3765212|B11||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3943894|NCT01367158|3765213|B10||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3943895|NCT01367158|3765214|B9||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3943896|NCT01367158|3765215|B8||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3943897|NCT01367158|3765216|B7||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3943898|NCT01367158|3765217|B6||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3943899|NCT01367158|3765218|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3943900|NCT01367158|3765219|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3943901|NCT01367158|3765220|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3943902|NCT01367158|3765221|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3943903|NCT01367158|3765222|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3943904|NCT01367158|3765211|B12|||Age||years|Mean|14.5|14.5|Standard Deviation|2.1|2.1|||
3943905|NCT01367158|3765212|B11|||Age||years|Mean|14.8|14.8|Standard Deviation|2.1|2.1|||
3943906|NCT01367158|3765213|B10|||Age||years|Mean|15.0|15.0|Standard Deviation|2.0|2.0|||
3943907|NCT01367158|3765214|B9|||Age||years|Mean|14.8|14.8|Standard Deviation|2.5|2.5|||
3943908|NCT01367158|3765215|B8|||Age||years|Mean|14.4|14.4|Standard Deviation|2.1|2.1|||
3943909|NCT01367158|3765216|B7|||Age||years|Mean|14.3|14.3|Standard Deviation|2.0|2.0|||
3943910|NCT01367158|3765217|B6|||Age||years|Mean|14.2|14.2|Standard Deviation|2.1|2.1|||
3943911|NCT01367158|3765218|B5|||Age||years|Mean|14.9|14.9|Standard Deviation|2.6|2.6|||
3943912|NCT01367158|3765219|B4|||Age||years|Mean|14.4|14.4|Standard Deviation|2.1|2.1|||
3943913|NCT01367158|3765220|B3|||Age||years|Mean|14.4|14.4|Standard Deviation|2.1|2.1|||
3943914|NCT01367158|3765221|B2|||Age||years|Mean|14.2|14.2|Standard Deviation|2.0|2.0|||
3943915|NCT01367158|3765222|B1|||Age||years|Mean|14.3|14.3|Standard Deviation|2.2|2.2|||
3943916|NCT01367119|3765374|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
3943917|NCT01367119|3765375|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3943918|NCT01367119|3765376|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3943919|NCT01367119|3765374|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3943920|NCT01367119|3765375|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3943921|NCT01367119|3765376|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3943922|NCT01367119|3765374|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3943923|NCT01367119|3765375|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3943924|NCT01367119|3765376|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3943925|NCT01367119|3765374|B3|||Age||years|Mean|47.7|47.7|Standard Deviation|10.8|10.8|||
3943926|NCT01367119|3765375|B2|||Age||years|Mean|48.65|48.65|Standard Deviation|7.20|7.2|||
3943927|NCT01367119|3765376|B1|||Age||years|Mean|46.95|46.95|Standard Deviation|13.17|13.17|||
3943928|NCT01367080|3765387|B3|Korea, Republic of||Region of Enrollment||participants|Number|12|12.0||||||
3943929|NCT01367080|3765388|B2|Korea, Republic of||Region of Enrollment||participants|Number|6|6.0||||||
3943930|NCT01367080|3765389|B1|Korea, Republic of||Region of Enrollment||participants|Number|6|6.0||||||
3943931|NCT01367080|3765387|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3943932|NCT01367080|3765388|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3943933|NCT01367080|3765389|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3943934|NCT01367080|3765387|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3943935|NCT01367080|3765388|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3943936|NCT01367080|3765389|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3943937|NCT01367080|3765387|B3|||Age||years|Mean|21.7|21.7|Standard Deviation|1.9|1.9|||
3943938|NCT01367080|3765388|B2|||Age||years|Mean|21.2|21.2|Standard Deviation|2.1|2.1|||
3943939|NCT01367080|3765389|B1|||Age||years|Mean|22.2|22.2|Standard Deviation|2.1|2.1|||
3943940|NCT01367080|3765387|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3943941|NCT01367080|3765388|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3943942|NCT01367080|3765389|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3943943|NCT01367080|3765387|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3943944|NCT01367080|3765388|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3943945|NCT01367080|3765389|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3943946|NCT01367080|3765387|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3943947|NCT01367080|3765388|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3943948|NCT01367080|3765389|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3943949|NCT01366976|3765402|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
3943950|NCT01366976|3765403|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3943951|NCT01366976|3765404|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3943952|NCT01366976|3765402|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3943953|NCT01366976|3765403|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3943954|NCT01366976|3765404|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3943955|NCT01366976|3765402|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3943956|NCT01366976|3765403|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3943957|NCT01366976|3765404|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3943958|NCT01366976|3765402|B3|||Age||years|Median|63|63.0|Inter-Quartile Range|||51.75|67.75|
3943959|NCT01366976|3765403|B2|||Age||years|Median|61.0|61.0|Inter-Quartile Range|||54.0|67.8|
3943960|NCT01366976|3765404|B1|||Age||years|Median|64.5|64.5|Inter-Quartile Range|||49.0|68.4|
3943961|NCT01366885|3765417|B1|||Mothers with at least one child with autism, and pregnant before the third trimester||participants|Number|20|20.0||||||
3943962|NCT01366885|3765417|B1|Israel||Region of Enrollment||participants|Number|1|1.0||||||
3943963|NCT01366885|3765417|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3943964|NCT01366885|3765417|B1|Females||Sex/Gender, Customized||participants|Number|20|20.0||||||
3943965|NCT01366885|3765417|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3943966|NCT01366885|3765417|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3943967|NCT01366885|3765417|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3943968|NCT01366872|3765422|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3943969|NCT01366872|3765422|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3943970|NCT01366872|3765422|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3943971|NCT01366872|3765422|B1|||Age||years|Mean|62.1|62.1|Standard Deviation|4.36|4.36|||
3943972|NCT01366872|3765422|B1||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
3943973|NCT01366872|3765422|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3943974|NCT01366872|3765422|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3943975|NCT01366846|3765428|B5|United Kingdom||Region of Enrollment||participants|Number|556|556.0||||||
3943976|NCT01366846|3765429|B4|United Kingdom||Region of Enrollment||participants|Number|46|46.0||||||
3943977|NCT01366846|3765430|B3|United Kingdom||Region of Enrollment||participants|Number|47|47.0||||||
3943978|NCT01366846|3765431|B2|United Kingdom||Region of Enrollment||participants|Number|228|228.0||||||
3943979|NCT01366846|3765432|B1|United Kingdom||Region of Enrollment||participants|Number|235|235.0||||||
3943980|NCT01366846|3765428|B5||Male|Sex: Female, Male||Participants|Count of Participants|337|337.0||||||
3943981|NCT01366846|3765429|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3943982|NCT01366846|3765430|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3943983|NCT01366846|3765431|B2||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3943984|NCT01366846|3765432|B1||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3943985|NCT01366846|3765428|B5||Female|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
3943986|NCT01366846|3765429|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3943987|NCT01366846|3765430|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3943988|NCT01366846|3765431|B2||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3943989|NCT01366846|3765432|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3943990|NCT01366846|3765428|B5|Age in Months||Age, Customized||Months|Mean|61.3|61.3|Standard Deviation|3.93|3.93|||
3943991|NCT01366846|3765429|B4|Age in Months||Age, Customized||Months|Mean|61.4|61.4|Standard Deviation|4.98|4.98|||
3943992|NCT01366846|3765430|B3|Age in Months||Age, Customized||Months|Mean|60.6|60.6|Standard Deviation|3.76|3.76|||
3943993|NCT01366846|3765431|B2|Age in Months||Age, Customized||Months|Mean|61.7|61.7|Standard Deviation|4.19|4.19|||
3943994|NCT01366846|3765432|B1|Age in Months||Age, Customized||Months|Mean|61.0|61.0|Standard Deviation|3.44|3.44|||
3943995|NCT01366638|3765455|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3943996|NCT01366638|3765456|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3943997|NCT01366638|3765457|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3943998|NCT01366638|3765458|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3943999|NCT01366638|3765455|B4||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3944000|NCT01366638|3765456|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3944001|NCT01366638|3765457|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3944002|NCT01366638|3765458|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3944003|NCT01366638|3765455|B4|||Age||years|Median|60|60.0|Full Range|||37.0|70.0|
3944004|NCT01366638|3765456|B3|||Age||years|Median|53|53.0|Full Range|||45.0|69.0|
3944005|NCT01366638|3765457|B2|||Age||years|Median|60|60.0|Full Range|||38.0|70.0|
3944006|NCT01366638|3765458|B1|||Age||years|Median|60|60.0|Full Range|||37.0|68.0|
3944007|NCT01366534|3765494|B4|Races|Mixed Origin|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3944008|NCT01366534|3765495|B3|Races|Mixed Origin|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3944009|NCT01366534|3765496|B2|Races|Mixed Origin|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3944010|NCT01366534|3765497|B1|Races|Mixed Origin|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3944011|NCT01366534|3765494|B4|Races|White - Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3944012|NCT01366534|3765495|B3|Races|White - Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3944013|NCT01366534|3765496|B2|Races|White - Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3944014|NCT01366534|3765497|B1|Races|White - Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3944015|NCT01366534|3765494|B4|Races|Asian - Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3944016|NCT01366534|3765495|B3|Races|Asian - Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3944017|NCT01366534|3765496|B2|Races|Asian - Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3944018|NCT01366534|3765497|B1|Races|Asian - Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3944019|NCT01366534|3765494|B4|Races|American Indian or Alaskan native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3944020|NCT01366534|3765495|B3|Races|American Indian or Alaskan native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3944021|NCT01366534|3765496|B2|Races|American Indian or Alaskan native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3944022|NCT01366534|3765497|B1|Races|American Indian or Alaskan native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3944023|NCT01366534|3765494|B4|Races|African heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3944024|NCT01366534|3765495|B3|Races|African heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3944025|NCT01366534|3765496|B2|Races|African heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3944026|NCT01366534|3765497|B1|Races|African heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3944027|NCT01366534|3765494|B4||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3944028|NCT01366534|3765495|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3944029|NCT01366534|3765496|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3944030|NCT01366534|3765497|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3944031|NCT01366534|3765494|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3944032|NCT01366534|3765495|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3944033|NCT01366534|3765496|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3944034|NCT01366534|3765497|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3944035|NCT01366534|3765494|B4|||Age||Years|Mean|30.04|30.04|Standard Deviation|7.23|7.23|||
3944036|NCT01366534|3765495|B3|||Age||Years|Mean|29.8|29.8|Standard Deviation|6.86|6.86|||
3944037|NCT01366534|3765496|B2|||Age||Years|Mean|30.3|30.3|Standard Deviation|7.83|7.83|||
3944038|NCT01366534|3765497|B1|||Age||Years|Mean|29.9|29.9|Standard Deviation|7.03|7.03|||
3944039|NCT01366521|3765545|B5|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|66|66.0||||||
3944040|NCT01366521|3765546|B4|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3944041|NCT01366521|3765547|B3|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
3944042|NCT01366521|3765548|B2|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3944043|NCT01366521|3765549|B1|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
3944044|NCT01366521|3765545|B5|Asian-South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3944045|NCT01366521|3765546|B4|Asian-South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3944046|NCT01366521|3765547|B3|Asian-South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3944047|NCT01366521|3765548|B2|Asian-South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3944048|NCT01366521|3765549|B1|Asian-South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3944049|NCT01366521|3765545|B5|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3944050|NCT01366521|3765546|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3944051|NCT01366521|3765547|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3944052|NCT01366521|3765548|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3944053|NCT01366521|3765549|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3944054|NCT01366521|3765545|B5||Male|Gender||Participants|Count of Participants|33|33.0||||||
3944055|NCT01366521|3765546|B4||Male|Gender||Participants|Count of Participants|6|6.0||||||
3944056|NCT01366521|3765547|B3||Male|Gender||Participants|Count of Participants|9|9.0||||||
3944057|NCT01366521|3765548|B2||Male|Gender||Participants|Count of Participants|10|10.0||||||
3944058|NCT01366521|3765549|B1||Male|Gender||Participants|Count of Participants|8|8.0||||||
3944059|NCT01366521|3765545|B5||Female|Gender||Participants|Count of Participants|37|37.0||||||
3944060|NCT01366521|3765546|B4||Female|Gender||Participants|Count of Participants|5|5.0||||||
3944061|NCT01366521|3765547|B3||Female|Gender||Participants|Count of Participants|14|14.0||||||
3944062|NCT01366521|3765548|B2||Female|Gender||Participants|Count of Participants|5|5.0||||||
3944063|NCT01366521|3765549|B1||Female|Gender||Participants|Count of Participants|13|13.0||||||
3944064|NCT01366521|3765545|B5|||Age||Years|Mean|42.3|42.3|Standard Deviation|13.83|13.83|||
3944065|NCT01366521|3765546|B4|||Age||Years|Mean|44.8|44.8|Standard Deviation|12.55|12.55|||
3944066|NCT01366521|3765547|B3|||Age||Years|Mean|43.9|43.9|Standard Deviation|13.42|13.42|||
3944067|NCT01366521|3765548|B2|||Age||Years|Mean|37.0|37.0|Standard Deviation|17.80|17.8|||
3944068|NCT01366521|3765549|B1|||Age||Years|Mean|43.1|43.1|Standard Deviation|11.53|11.53|||
3944069|NCT01366443|3765627|B1|United States||Region of Enrollment||participants|Number|288|288.0||||||
3944070|NCT01366443|3765627|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3944071|NCT01366443|3765627|B1||Female|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
3944072|NCT01366443|3765627|B1|||Age||years|Mean|27.26|27.26|Standard Deviation|5.81|5.81|||
3944073|NCT01366443|3765627|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3944074|NCT01366443|3765627|B1||Between 18 and 65 years|Age||Participants|Count of Participants|287|287.0||||||
3944075|NCT01366443|3765627|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3944076|NCT01366417|3765632|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
3944077|NCT01366417|3765632|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3944078|NCT01366417|3765632|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3944079|NCT01366417|3765632|B1|||Age||years|Mean|36|36.0|Standard Deviation|16.71105|16.71105|||
3944080|NCT01366417|3765632|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3944081|NCT01366417|3765632|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3944082|NCT01366417|3765632|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3944083|NCT01366209|3765639|B3|Singapore||Region of Enrollment||participants|Number|2|2.0||||||
3944084|NCT01366209|3765640|B2|Singapore||Region of Enrollment||participants|Number|2|2.0||||||
3944085|NCT01366209|3765641|B1|Singapore||Region of Enrollment||participants|Number|0|0.0||||||
3944086|NCT01366209|3765639|B3|Peru||Region of Enrollment||participants|Number|44|44.0||||||
3944087|NCT01366209|3765640|B2|Peru||Region of Enrollment||participants|Number|26|26.0||||||
3944088|NCT01366209|3765641|B1|Peru||Region of Enrollment||participants|Number|18|18.0||||||
3944089|NCT01366209|3765639|B3|New Zealand||Region of Enrollment||participants|Number|4|4.0||||||
3944090|NCT01366209|3765640|B2|New Zealand||Region of Enrollment||participants|Number|3|3.0||||||
3944091|NCT01366209|3765641|B1|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
3944092|NCT01366209|3765639|B3|Mexico||Region of Enrollment||participants|Number|17|17.0||||||
3944093|NCT01366209|3765640|B2|Mexico||Region of Enrollment||participants|Number|5|5.0||||||
3944094|NCT01366209|3765641|B1|Mexico||Region of Enrollment||participants|Number|12|12.0||||||
3944095|NCT01366209|3765639|B3|Israel||Region of Enrollment||participants|Number|20|20.0||||||
3944096|NCT01366209|3765640|B2|Israel||Region of Enrollment||participants|Number|9|9.0||||||
3944097|NCT01366209|3765641|B1|Israel||Region of Enrollment||participants|Number|11|11.0||||||
3944098|NCT01366209|3765639|B3|Croatia||Region of Enrollment||participants|Number|2|2.0||||||
3944099|NCT01366209|3765640|B2|Croatia||Region of Enrollment||participants|Number|1|1.0||||||
3944100|NCT01366209|3765641|B1|Croatia||Region of Enrollment||participants|Number|1|1.0||||||
3944101|NCT01366209|3765639|B3|Brazil||Region of Enrollment||participants|Number|31|31.0||||||
3944102|NCT01366209|3765640|B2|Brazil||Region of Enrollment||participants|Number|16|16.0||||||
3944103|NCT01366209|3765641|B1|Brazil||Region of Enrollment||participants|Number|15|15.0||||||
3944104|NCT01366209|3765639|B3|Australia||Region of Enrollment||participants|Number|64|64.0||||||
3944105|NCT01366209|3765640|B2|Australia||Region of Enrollment||participants|Number|31|31.0||||||
3944106|NCT01366209|3765641|B1|Australia||Region of Enrollment||participants|Number|33|33.0||||||
3944107|NCT01366209|3765639|B3|United States||Region of Enrollment||participants|Number|371|371.0||||||
3944108|NCT01366209|3765640|B2|United States||Region of Enrollment||participants|Number|184|184.0||||||
3944109|NCT01366209|3765641|B1|United States||Region of Enrollment||participants|Number|187|187.0||||||
3944110|NCT01366209|3765639|B3||Male|Sex: Female, Male||Participants|Count of Participants|435|435.0||||||
3944111|NCT01366209|3765640|B2||Male|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
3944112|NCT01366209|3765641|B1||Male|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
3944113|NCT01366209|3765639|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3944114|NCT01366209|3765640|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3944115|NCT01366209|3765641|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3944116|NCT01366209|3765639|B3||>=65 years|Age||Participants|Count of Participants|394|394.0||||||
3944117|NCT01366209|3765640|B2||>=65 years|Age||Participants|Count of Participants|189|189.0||||||
3944118|NCT01366209|3765641|B1||>=65 years|Age||Participants|Count of Participants|205|205.0||||||
3944119|NCT01366209|3765639|B3||Between 18 and 65 years|Age||Participants|Count of Participants|161|161.0||||||
3944120|NCT01366209|3765640|B2||Between 18 and 65 years|Age||Participants|Count of Participants|88|88.0||||||
3944121|NCT01366209|3765641|B1||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
3944122|NCT01366209|3765639|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3944123|NCT01366209|3765640|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3944124|NCT01366209|3765641|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3944125|NCT01366196|3765648|B3|United States||Region of Enrollment||Participants|Count of Participants|86|86.0||||||
3944126|NCT01366196|3765649|B2|United States||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
3944127|NCT01366196|3765650|B1|United States||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
3944128|NCT01366196|3765648|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3944129|NCT01366196|3765649|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3944130|NCT01366196|3765650|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3944131|NCT01366196|3765648|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3944132|NCT01366196|3765649|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3944133|NCT01366196|3765650|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3944134|NCT01366196|3765648|B3|||Age||years|Mean|56.849|56.849|Standard Deviation|12.993|12.993|||
3944135|NCT01366196|3765649|B2|||Age||years|Mean|57.511|57.511|Standard Deviation|13.491|13.491|||
3944136|NCT01366196|3765650|B1|||Age||years|Mean|56.186|56.186|Standard Deviation|12.599|12.599|||
3944137|NCT01366092|3765665|B1|||Baseline Corticosteroid (Prednisone) dose||milligrams per day|Median|20|20.0|Full Range|||2.5|50.0|
3944251|NCT01365624|3765763|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3944138|NCT01366092|3765665|B1|||Number of concurrent cGVHD therapies||therapies|Median|2|2.0|Full Range|||1.0|3.0|
3944139|NCT01366092|3765665|B1|||Number of cGVHD organ sites||organs affected by cGVHD|Median|4|4.0|Full Range|||1.0|7.0|
3944140|NCT01366092|3765665|B1|||Time from chronic GVHD onsent||days|Median|252|252.0|Full Range|||28.0|1880.0|
3944141|NCT01366092|3765665|B1|||Time from Allogeneic Stem Cell Transplant||days|Median|616|616.0|Full Range|||270.0|2145.0|
3944142|NCT01366092|3765665|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3944143|NCT01366092|3765665|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3944144|NCT01366092|3765665|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3944145|NCT01366092|3765665|B1|||Age||years|Median|51|51.0|Full Range|||22.0|72.0|
3944146|NCT01365910|3765674|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3944147|NCT01365910|3765674|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3944148|NCT01365910|3765674|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3944149|NCT01365910|3765674|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3944150|NCT01365910|3765674|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3944151|NCT01365910|3765674|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3944152|NCT01365910|3765674|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3944153|NCT01365910|3765674|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3944154|NCT01365910|3765674|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3944155|NCT01365910|3765674|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3944156|NCT01365910|3765674|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3944157|NCT01365910|3765674|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3944158|NCT01365910|3765674|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3944159|NCT01365910|3765674|B1|Age 70-79||Age, Customized||participants|Number|5|5.0||||||
3944160|NCT01365910|3765674|B1|Age 60-69||Age, Customized||participants|Number|10|10.0||||||
3944161|NCT01365910|3765674|B1|Age 50-59||Age, Customized||participants|Number|10|10.0||||||
3944162|NCT01365910|3765674|B1|Age 40-49||Age, Customized||participants|Number|4|4.0||||||
3944163|NCT01365910|3765674|B1|Age 20-29||Age, Customized||participants|Number|1|1.0||||||
3944164|NCT01365845|3765681|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3944165|NCT01365845|3765681|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3944166|NCT01365845|3765681|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3944167|NCT01365845|3765681|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3944168|NCT01365845|3765681|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3944169|NCT01365845|3765681|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3944170|NCT01365845|3765681|B1|||Age||Years|Median|52|52.0|Full Range|||37.0|73.0|
3944171|NCT01365819|3765688|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3944172|NCT01365819|3765689|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3944173|NCT01365819|3765690|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3944174|NCT01365819|3765688|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3944175|NCT01365819|3765689|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3944176|NCT01365819|3765690|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3944177|NCT01365819|3765688|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3944178|NCT01365819|3765689|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3944179|NCT01365819|3765690|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3944180|NCT01365819|3765688|B3||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3944181|NCT01365819|3765689|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3944182|NCT01365819|3765690|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3944183|NCT01365819|3765688|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3944184|NCT01365819|3765689|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3944185|NCT01365819|3765690|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3944186|NCT01365793|3765705|B5|Ethnicity|Not Hispanic or Latino, Other, or Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|1161|1161.0||||||
3944187|NCT01365793|3765706|B4|Ethnicity|Not Hispanic or Latino, Other, or Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|280|280.0||||||
3944188|NCT01365793|3765707|B3|Ethnicity|Not Hispanic or Latino, Other, or Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|296|296.0||||||
3944189|NCT01365793|3765708|B2|Ethnicity|Not Hispanic or Latino, Other, or Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|289|289.0||||||
3944190|NCT01365793|3765709|B1|Ethnicity|Not Hispanic or Latino, Other, or Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|296|296.0||||||
3944191|NCT01365793|3765705|B5|Ethnicity|Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|228|228.0||||||
3944192|NCT01365793|3765706|B4|Ethnicity|Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|69|69.0||||||
3944193|NCT01365793|3765707|B3|Ethnicity|Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|49|49.0||||||
3944194|NCT01365793|3765708|B2|Ethnicity|Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|62|62.0||||||
3944252|NCT01365624|3765761|B3|||Age||years|Mean|58.1|58.1|Standard Deviation|16.3|16.3|||
3944195|NCT01365793|3765709|B1|Ethnicity|Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
3944196|NCT01365793|3765705|B5|Race|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|74|74.0||||||
3944197|NCT01365793|3765706|B4|Race|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3944198|NCT01365793|3765707|B3|Race|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3944199|NCT01365793|3765708|B2|Race|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3944200|NCT01365793|3765709|B1|Race|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3944201|NCT01365793|3765705|B5|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|72|72.0||||||
3944202|NCT01365793|3765706|B4|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3944203|NCT01365793|3765707|B3|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3944204|NCT01365793|3765708|B2|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3944205|NCT01365793|3765709|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3944206|NCT01365793|3765705|B5|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|286|286.0||||||
3944207|NCT01365793|3765706|B4|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|63|63.0||||||
3944208|NCT01365793|3765707|B3|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|68|68.0||||||
3944209|NCT01365793|3765708|B2|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|82|82.0||||||
3944210|NCT01365793|3765709|B1|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|73|73.0||||||
3944211|NCT01365793|3765705|B5|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|957|957.0||||||
3944212|NCT01365793|3765706|B4|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|243|243.0||||||
3944213|NCT01365793|3765707|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|247|247.0||||||
3944214|NCT01365793|3765708|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|232|232.0||||||
3944215|NCT01365793|3765709|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|235|235.0||||||
3944216|NCT01365793|3765705|B5||Male|Sex: Female, Male||Participants|Count of Participants|650|650.0||||||
3944217|NCT01365793|3765706|B4||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3944218|NCT01365793|3765707|B3||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3944219|NCT01365793|3765708|B2||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3944220|NCT01365793|3765709|B1||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3944221|NCT01365793|3765705|B5||Female|Sex: Female, Male||Participants|Count of Participants|739|739.0||||||
3944222|NCT01365793|3765706|B4||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
3944223|NCT01365793|3765707|B3||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
3944224|NCT01365793|3765708|B2||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
3944225|NCT01365793|3765709|B1||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
3944226|NCT01365793|3765705|B5|6 to less than 18 years old||Age, Customized||Participants|Count of Participants|1227|1227.0||||||
3944227|NCT01365793|3765706|B4|6 to less than 18 years old||Age, Customized||Participants|Count of Participants|314|314.0||||||
3944228|NCT01365793|3765707|B3|6 to less than 18 years old||Age, Customized||Participants|Count of Participants|303|303.0||||||
3944229|NCT01365793|3765708|B2|6 to less than 18 years old||Age, Customized||Participants|Count of Participants|309|309.0||||||
3944230|NCT01365793|3765709|B1|6 to less than 18 years old||Age, Customized||Participants|Count of Participants|301|301.0||||||
3944231|NCT01365793|3765705|B5|0 to less than 6 years old||Age, Customized||Participants|Count of Participants|162|162.0||||||
3944232|NCT01365793|3765706|B4|0 to less than 6 years old||Age, Customized||Participants|Count of Participants|35|35.0||||||
3944233|NCT01365793|3765707|B3|0 to less than 6 years old||Age, Customized||Participants|Count of Participants|42|42.0||||||
3944234|NCT01365793|3765708|B2|0 to less than 6 years old||Age, Customized||Participants|Count of Participants|42|42.0||||||
3944235|NCT01365793|3765709|B1|0 to less than 6 years old||Age, Customized||Participants|Count of Participants|43|43.0||||||
3944236|NCT01365650|3765738|B1|Australia||Region of Enrollment||participants|Number|24|24.0||||||
3944237|NCT01365650|3765738|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3944238|NCT01365650|3765738|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3944239|NCT01365650|3765738|B1|||Age||years|Mean|42.6|42.6|Standard Deviation|16.3|16.3|||
3944240|NCT01365650|3765738|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3944241|NCT01365650|3765738|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3944242|NCT01365650|3765738|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3944243|NCT01365624|3765761|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3944244|NCT01365624|3765762|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3944245|NCT01365624|3765763|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3944246|NCT01365624|3765761|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3944247|NCT01365624|3765762|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3944248|NCT01365624|3765763|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3944249|NCT01365624|3765761|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3944250|NCT01365624|3765762|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3944253|NCT01365624|3765762|B2|||Age||years|Mean|44.2|44.2|Standard Deviation|10.3|10.3|||
3944254|NCT01365624|3765763|B1|||Age||years|Mean|71.9|71.9|Standard Deviation|5.9|5.9|||
3944255|NCT01365624|3765761|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3944256|NCT01365624|3765762|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3944257|NCT01365624|3765763|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3944258|NCT01365624|3765761|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3944259|NCT01365624|3765762|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3944260|NCT01365624|3765763|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3944261|NCT01365624|3765761|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3944262|NCT01365624|3765762|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3944263|NCT01365624|3765763|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3944264|NCT01365611|3765780|B1|United Kingdom||Region of Enrollment||participants|Number|36|36.0||||||
3944265|NCT01365611|3765780|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3944266|NCT01365611|3765780|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3944267|NCT01365611|3765780|B1|||Age||years|Mean|33.7|33.7|Standard Deviation|13.2|13.2|||
3944268|NCT01365611|3765780|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3944269|NCT01365611|3765780|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3944270|NCT01365611|3765780|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3944271|NCT01365585|3765796|B1|||Borg Dyspnea Index|Borg dyspnea scale: 10-point scale where following scores stands for severity of dyspnea: 0=no breathlessness at all; 0.5=very very slight (just noticeable); 1=very slight; 2=slight breathlessness; 3=moderate; 4=some what severe; 5=severe; 7=very severe breathlessness; 9=very very severe (almost maximum) and 10=maximum. Participants evaluable=158.|units on a scale|Mean|3.7|3.7|Standard Deviation|1.91|1.91|||
3944272|NCT01365585|3765796|B1|||Pulmonary Capillary Wedge Pressure (PCWP)|PCWP was measured by pulmonary artery catheterization and provided an indirect measure of left atrial pressure. Number of participants evaluable for this measure was 44.|mmHg|Mean|7.6|7.6|Standard Deviation|3.84|3.84|||
3944273|NCT01365585|3765796|B1|||Cardiac Index (CI)|CI: calculated as cardiac output in systemic circulation (COsys) divided by body surface area (BSA). Number of participants evaluable for this measure was 44.|(Liter/minute)/square meter([L/min]/m^2)|Mean|2.5|2.5|Standard Deviation|1.51|1.51|||
3944274|NCT01365585|3765796|B1|||Pulmonary Vascular Resistance (PVR)|PVR: calculated by subtracting PCWP from mPAP and dividing by cardiac output in pulmonary circulation (COpulm). Number of participants evaluable for this measure was 48.|dynes*second/centimeter^5|Mean|612.8|612.8|Standard Deviation|250.54|250.54|||
3944275|NCT01365585|3765796|B1|||Mean Pulmonary Arterial Pressure (mPAP) at rest|mPAP was measured using a pressure transducer positioned at the mid-axillary line with the participant in the supine position. Number of participants evaluable for this measure was 56.|mmHg|Mean|44.8|44.8|Standard Deviation|12.37|12.37|||
3944276|NCT01365585|3765796|B1|||Right Atrial Pressure (RAP)|RAP was measured using a pressure transducer positioned at the mid-axillary line with the participant in the supine position. Number of participants evaluable for this measure was 50.|millimeters of mercury (mmHg)|Mean|6.6|6.6|Standard Deviation|4.85|4.85|||
3944277|NCT01365585|3765796|B1|Class IV||New York Heart Association, World Health Organization (NYHA/WHO) Functional Class|NYHA/WHO functional classification for PAH range from Class I (no limitation in physical activity, no dyspnea with normal activity) to Class IV (can not perform a physical activity without any symptoms, dyspnea at rest). Number of participants in each functional class was reported. Number of participants evaluable for this measure was 216.|participants|Number|13|13.0||||||
3944278|NCT01365585|3765796|B1|Class III||New York Heart Association, World Health Organization (NYHA/WHO) Functional Class|NYHA/WHO functional classification for PAH range from Class I (no limitation in physical activity, no dyspnea with normal activity) to Class IV (can not perform a physical activity without any symptoms, dyspnea at rest). Number of participants in each functional class was reported. Number of participants evaluable for this measure was 216.|participants|Number|163|163.0||||||
3944279|NCT01365585|3765796|B1|Class II||New York Heart Association, World Health Organization (NYHA/WHO) Functional Class|NYHA/WHO functional classification for PAH range from Class I (no limitation in physical activity, no dyspnea with normal activity) to Class IV (can not perform a physical activity without any symptoms, dyspnea at rest). Number of participants in each functional class was reported. Number of participants evaluable for this measure was 216.|participants|Number|39|39.0||||||
3944280|NCT01365585|3765796|B1|Class I||New York Heart Association, World Health Organization (NYHA/WHO) Functional Class|NYHA/WHO functional classification for PAH range from Class I (no limitation in physical activity, no dyspnea with normal activity) to Class IV (can not perform a physical activity without any symptoms, dyspnea at rest). Number of participants in each functional class was reported. Number of participants evaluable for this measure was 216.|participants|Number|1|1.0||||||
3944281|NCT01365585|3765796|B1|||Six-Minute Walk Distance (6MWD)|6MWD was the distance that a participant could walk in 6 minutes. Participants were asked to perform the test at a pace that was comfortable to them, with as many breaks as they needed. Number of participants evaluable for this measure was 176.|meter|Mean|331.7|331.7|Standard Deviation|117.42|117.42|||
3944282|NCT01365585|3765796|B1|Male||Sex/Gender, Customized|For baseline characteristic gender, number of participants evaluable was 226.|participants|Number|81|81.0||||||
3944283|NCT01365585|3765796|B1|Female||Sex/Gender, Customized|For baseline characteristic gender, number of participants evaluable was 226.|participants|Number|145|145.0||||||
3944284|NCT01365585|3765796|B1|||Age||years|Mean|60.5|60.5|Standard Deviation|14.37|14.37|||
3944285|NCT01365546|3765810|B1|India||Region of Enrollment||participants|Number|13|13.0||||||
3944286|NCT01365546|3765810|B1|Italy||Region of Enrollment||participants|Number|5|5.0||||||
3944287|NCT01365546|3765810|B1|South Africa||Region of Enrollment||participants|Number|2|2.0||||||
3944288|NCT01365546|3765810|B1|Bulgaria||Region of Enrollment||participants|Number|1|1.0||||||
3944289|NCT01365546|3765810|B1|Turkey||Region of Enrollment||participants|Number|1|1.0||||||
3944290|NCT01365546|3765810|B1|Romania||Region of Enrollment||participants|Number|8|8.0||||||
3944291|NCT01365546|3765810|B1|Oman||Region of Enrollment||participants|Number|2|2.0||||||
3944292|NCT01365546|3765810|B1|Poland||Region of Enrollment||participants|Number|2|2.0||||||
3944293|NCT01365546|3765810|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3944294|NCT01365546|3765810|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3944295|NCT01365546|3765810|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3944296|NCT01365546|3765810|B1|||Age||years|Mean|39.7|39.7|Standard Deviation|18.1|18.1|||
3944297|NCT01365507|3765818|B3|||Fasting plasma glucose (FPG)||mmol/L|Mean|8.9|8.9|Standard Deviation|2.4|2.4|||
3944298|NCT01365507|3765819|B2|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.0|9.0|Standard Deviation|2.3|2.3|||
3944299|NCT01365507|3765820|B1|||Fasting plasma glucose (FPG)||mmol/L|Mean|8.9|8.9|Standard Deviation|2.4|2.4|||
3944300|NCT01365507|3765818|B3|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.3|8.3|Standard Deviation|0.8|0.8|||
3944301|NCT01365507|3765819|B2|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.2|8.2|Standard Deviation|0.8|0.8|||
3944302|NCT01365507|3765820|B1|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.3|8.3|Standard Deviation|0.8|0.8|||
3944303|NCT01365507|3765818|B3||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3944304|NCT01365507|3765819|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3944305|NCT01365507|3765820|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3944306|NCT01365507|3765818|B3||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3944307|NCT01365507|3765819|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3944308|NCT01365507|3765820|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3944309|NCT01365507|3765818|B3|||Age||years|Mean|56.4|56.4|Standard Deviation|9.5|9.5|||
3944310|NCT01365507|3765819|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|9.7|9.7|||
3944311|NCT01365507|3765820|B1|||Age||years|Mean|57.0|57.0|Standard Deviation|9.4|9.4|||
3944312|NCT01365494|3765835|B3||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3944313|NCT01365494|3765836|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3944314|NCT01365494|3765837|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3944315|NCT01365494|3765835|B3||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3944316|NCT01365494|3765836|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3944317|NCT01365494|3765837|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3944318|NCT01365494|3765835|B3|||Age||years|Mean|28.2|28.2|Standard Deviation|8.1|8.1|||
3944319|NCT01365494|3765836|B2|||Age||years|Mean|27.2|27.2|Standard Deviation|7.3|7.3|||
3944320|NCT01365494|3765837|B1|||Age||years|Mean|29.1|29.1|Standard Deviation|8.8|8.8|||
3944321|NCT01365481|3765850|B5||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3944322|NCT01365481|3765851|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3944323|NCT01365481|3765852|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3944324|NCT01365481|3765853|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3944325|NCT01365481|3765854|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3944326|NCT01365481|3765850|B5||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3944327|NCT01365481|3765851|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3944328|NCT01365481|3765852|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3944329|NCT01365481|3765853|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3944330|NCT01365481|3765854|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3944331|NCT01365481|3765850|B5|12 – 17 years||Age, Customized||participants|Number|105|105.0||||||
3944332|NCT01365481|3765851|B4|12 – 17 years||Age, Customized||participants|Number|47|47.0||||||
3944333|NCT01365481|3765852|B3|12 – 17 years||Age, Customized||participants|Number|15|15.0||||||
3944334|NCT01365481|3765853|B2|12 – 17 years||Age, Customized||participants|Number|30|30.0||||||
3944335|NCT01365481|3765854|B1|12 – 17 years||Age, Customized||participants|Number|13|13.0||||||
3944336|NCT01365481|3765850|B5|6 – 11 years||Age, Customized||participants|Number|45|45.0||||||
3944337|NCT01365481|3765851|B4|6 – 11 years||Age, Customized||participants|Number|10|10.0||||||
3944338|NCT01365481|3765852|B3|6 – 11 years||Age, Customized||participants|Number|3|3.0||||||
3944339|NCT01365481|3765853|B2|6 – 11 years||Age, Customized||participants|Number|22|22.0||||||
3944340|NCT01365481|3765854|B1|6 – 11 years||Age, Customized||participants|Number|10|10.0||||||
3944341|NCT01365481|3765850|B5|||Age||years|Mean|13.36|13.36|Standard Deviation|3.130|3.13|||
3944342|NCT01365481|3765851|B4|||Age||years|Mean|14.37|14.37|Standard Deviation|2.83|2.83|||
3944343|NCT01365481|3765852|B3|||Age||years|Mean|13.79|13.79|Standard Deviation|2.64|2.64|||
3944344|NCT01365481|3765853|B2|||Age||years|Mean|12.30|12.3|Standard Deviation|3.20|3.2|||
3944345|NCT01365481|3765854|B1|||Age||years|Mean|12.90|12.9|Standard Deviation|3.35|3.35|||
3944346|NCT01365468|3765875|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3944347|NCT01365468|3765876|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3944348|NCT01365468|3765877|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3944349|NCT01365468|3765875|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3944350|NCT01365468|3765876|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3944351|NCT01365468|3765877|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3944352|NCT01365468|3765875|B3|||Age||Years|Mean|19.5|19.5|Standard Deviation|11.6|11.6|||
3944353|NCT01365468|3765876|B2|||Age||Years|Mean|16.9|16.9|Standard Deviation|9.8|9.8|||
3944354|NCT01365468|3765877|B1|||Age||Years|Mean|22.7|22.7|Standard Deviation|14.3|14.3|||
3944355|NCT01365455|3765890|B4||Male|Sex: Female, Male||Participants|Count of Participants|509|509.0||||||
3944356|NCT01365455|3765891|B3||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3944357|NCT01365455|3765892|B2||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3944358|NCT01365455|3765893|B1||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3944359|NCT01365455|3765890|B4||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
3944360|NCT01365455|3765891|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3944361|NCT01365455|3765892|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3944362|NCT01365455|3765893|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3944363|NCT01365455|3765890|B4|||Age||years|Mean|45.1|45.1|Standard Deviation|13.13|13.13|||
3944364|NCT01365455|3765891|B3|||Age||years|Mean|45.4|45.4|Standard Deviation|12.63|12.63|||
3944365|NCT01365455|3765892|B2|||Age||years|Mean|44.9|44.9|Standard Deviation|13.46|13.46|||
3944366|NCT01365455|3765893|B1|||Age||years|Mean|44.9|44.9|Standard Deviation|13.33|13.33|||
3944367|NCT01365273|3765985|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3944368|NCT01365273|3765986|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3944369|NCT01365273|3765987|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3944370|NCT01365273|3765985|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3944371|NCT01365273|3765986|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3944372|NCT01365273|3765987|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3944373|NCT01365273|3765985|B3|||Age||years|Mean|40.15|40.15|Standard Deviation|17|17.0|||
3944374|NCT01365273|3765986|B2|||Age||years|Mean|38.0|38.0|Standard Deviation|18.0|18.0|||
3944375|NCT01365273|3765987|B1|||Age||years|Mean|42.3|42.3|Standard Deviation|16.0|16.0|||
3944376|NCT01365130|3765998|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3944377|NCT01365130|3765998|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3944378|NCT01365130|3765998|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3944379|NCT01365130|3765998|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3944380|NCT01365130|3765998|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3944381|NCT01365130|3765998|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3944382|NCT01365130|3765998|B1|||Age||years|Mean|67|67.0|Standard Deviation|7.9|7.9|||
3944383|NCT01365091|3766003|B5|Both genders||Sex/Gender, Customized|The clinical study report (CSR) stated only that participants of both genders were enrolled. The CSR did not report the number of each gender enrolled.|Participants|Number|112|112.0||||||
3944384|NCT01365091|3766004|B4|Both genders||Sex/Gender, Customized|The clinical study report (CSR) stated only that participants of both genders were enrolled. The CSR did not report the number of each gender enrolled.|Participants|Number|28|28.0||||||
3944385|NCT01365091|3766005|B3|Both genders||Sex/Gender, Customized|The clinical study report (CSR) stated only that participants of both genders were enrolled. The CSR did not report the number of each gender enrolled.|Participants|Number|28|28.0||||||
3944386|NCT01365091|3766006|B2|Both genders||Sex/Gender, Customized|The clinical study report (CSR) stated only that participants of both genders were enrolled. The CSR did not report the number of each gender enrolled.|Participants|Number|28|28.0||||||
3944387|NCT01365091|3766007|B1|Both genders||Sex/Gender, Customized|The clinical study report (CSR) stated only that participants of both genders were enrolled. The CSR did not report the number of each gender enrolled.|Participants|Number|28|28.0||||||
3944388|NCT01365091|3766003|B5|>=55 years||Age, Customized||Participants|Number|0|0.0||||||
3944389|NCT01365091|3766004|B4|>=55 years||Age, Customized||Participants|Number|0|0.0||||||
3944390|NCT01365091|3766005|B3|>=55 years||Age, Customized||Participants|Number|0|0.0||||||
3944391|NCT01365091|3766006|B2|>=55 years||Age, Customized||Participants|Number|0|0.0||||||
3944392|NCT01365091|3766007|B1|>=55 years||Age, Customized||Participants|Number|0|0.0||||||
3944393|NCT01365091|3766003|B5|Between 18 and 55 years||Age, Customized||Participants|Number|112|112.0||||||
3944394|NCT01365091|3766004|B4|Between 18 and 55 years||Age, Customized||Participants|Number|28|28.0||||||
3944395|NCT01365091|3766005|B3|Between 18 and 55 years||Age, Customized||Participants|Number|28|28.0||||||
3944396|NCT01365091|3766006|B2|Between 18 and 55 years||Age, Customized||Participants|Number|28|28.0||||||
3944397|NCT01365091|3766007|B1|Between 18 and 55 years||Age, Customized||Participants|Number|28|28.0||||||
3944398|NCT01365091|3766003|B5|<=18 years||Age, Customized||Participants|Number|0|0.0||||||
3944399|NCT01365091|3766004|B4|<=18 years||Age, Customized||Participants|Number|0|0.0||||||
3944400|NCT01365091|3766005|B3|<=18 years||Age, Customized||Participants|Number|0|0.0||||||
3944401|NCT01365091|3766006|B2|<=18 years||Age, Customized||Participants|Number|0|0.0||||||
3944402|NCT01365091|3766007|B1|<=18 years||Age, Customized||Participants|Number|0|0.0||||||
3944403|NCT01365052|3766036|B3||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3944404|NCT01365052|3766037|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3944405|NCT01365052|3766038|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3944406|NCT01365052|3766036|B3||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
3944407|NCT01365052|3766037|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3944408|NCT01365052|3766038|B1||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3944409|NCT01365052|3766036|B3|>65 years||Age, Customized|Some categories will have overlapping samples|Participants|Number|74|74.0||||||
3944410|NCT01365052|3766037|B2|>65 years||Age, Customized|Some categories will have overlapping samples|Participants|Number|28|28.0||25.7|25.7|||
3944411|NCT01365052|3766038|B1|>65 years||Age, Customized|Some categories will have overlapping samples|Participants|Number|46|46.0||21.2|21.2|||
3944412|NCT01365052|3766036|B3|Greater than or equal to 60 years||Age, Customized|Some categories will have overlapping samples|Participants|Number|102|102.0||||||
3944413|NCT01365052|3766037|B2|Greater than or equal to 60 years||Age, Customized|Some categories will have overlapping samples|Participants|Number|37|37.0||33.9|33.9|||
3944414|NCT01365052|3766038|B1|Greater than or equal to 60 years||Age, Customized|Some categories will have overlapping samples|Participants|Number|65|65.0||30.0|30.0|||
3944415|NCT01365052|3766036|B3|<60 years||Age, Customized|Some categories will have overlapping samples|Participants|Number|224|224.0||||||
3944416|NCT01365052|3766037|B2|<60 years||Age, Customized|Some categories will have overlapping samples|Participants|Number|72|72.0||66.1|66.1|||
3944417|NCT01365052|3766038|B1|<60 years||Age, Customized|Some categories will have overlapping samples|Participants|Number|152|152.0||70.0|70.0|||
3944418|NCT01365052|3766036|B3|||Age||years|Mean|47.0|47.0|Standard Deviation|18.49|18.49|||
3944419|NCT01365052|3766037|B2|||Age||years|Mean|47.1|47.1|Standard Deviation|19.26|19.26|||
3944420|NCT01365052|3766038|B1|||Age||years|Mean|46.9|46.9|Standard Deviation|18.14|18.14|||
3944421|NCT01365039|3766053|B3|United States||Region of Enrollment||participants|Number|173|173.0||||||
3944422|NCT01365039|3766054|B2|United States||Region of Enrollment||participants|Number|87|87.0||||||
3944423|NCT01365039|3766055|B1|United States||Region of Enrollment||participants|Number|86|86.0||||||
3944424|NCT01365039|3766053|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3944425|NCT01365039|3766054|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3944426|NCT01365039|3766055|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3944427|NCT01365039|3766053|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3944428|NCT01365039|3766054|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3944429|NCT01365039|3766055|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3944430|NCT01365039|3766053|B3|Between 18 and 40 years||Age, Customized||participants|Number|173|173.0||||||
3944431|NCT01365039|3766054|B2|Between 18 and 40 years||Age, Customized||participants|Number|87|87.0||||||
3944432|NCT01365039|3766055|B1|Between 18 and 40 years||Age, Customized||participants|Number|86|86.0||||||
3944433|NCT01364922|3766064|B4|Very Good||Double-blind Participant's Global Assessment of Back Pain Status|"Participant answered the question Considering all the ways your chronic low back pain affects you, how are you doing today? on a 5-point scale: very good (no symptoms and no limitation of normal activities); good (mild symptoms and no limitation of normal activities); fair (moderate symptoms and limitation of some normal activities); poor (severe symptoms and inability to carry out most normal activities); very poor (very severe symptoms which are intolerable and inability to carry out all normal activities). Values presented for all participants with double-blind baseline data."|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3944434|NCT01364922|3766065|B3|Very Good||Double-blind Participant's Global Assessment of Back Pain Status|"Participant answered the question Considering all the ways your chronic low back pain affects you, how are you doing today? on a 5-point scale: very good (no symptoms and no limitation of normal activities); good (mild symptoms and no limitation of normal activities); fair (moderate symptoms and limitation of some normal activities); poor (severe symptoms and inability to carry out most normal activities); very poor (very severe symptoms which are intolerable and inability to carry out all normal activities). Values presented for all participants with double-blind baseline data."|participants|Number|3|3.0||||||
3944435|NCT01364922|3766066|B2|Very Good||Double-blind Participant's Global Assessment of Back Pain Status|"Participant answered the question Considering all the ways your chronic low back pain affects you, how are you doing today? on a 5-point scale: very good (no symptoms and no limitation of normal activities); good (mild symptoms and no limitation of normal activities); fair (moderate symptoms and limitation of some normal activities); poor (severe symptoms and inability to carry out most normal activities); very poor (very severe symptoms which are intolerable and inability to carry out all normal activities). Values presented for all participants with double-blind baseline data."|participants|Number|15|15.0||||||
3944436|NCT01364922|3766067|B1|Very Good||Double-blind Participant's Global Assessment of Back Pain Status|"Participant answered the question Considering all the ways your chronic low back pain affects you, how are you doing today? on a 5-point scale: very good (no symptoms and no limitation of normal activities); good (mild symptoms and no limitation of normal activities); fair (moderate symptoms and limitation of some normal activities); poor (severe symptoms and inability to carry out most normal activities); very poor (very severe symptoms which are intolerable and inability to carry out all normal activities). Values presented for all participants with double-blind baseline data."|participants|Number|NA|||||||These subjects were not randomized to the double-blind period.
3944437|NCT01364922|3766064|B4|Poor||Double-blind Participant's Global Assessment of Back Pain Status|"Participant answered the question Considering all the ways your chronic low back pain affects you, how are you doing today? on a 5-point scale: very good (no symptoms and no limitation of normal activities); good (mild symptoms and no limitation of normal activities); fair (moderate symptoms and limitation of some normal activities); poor (severe symptoms and inability to carry out most normal activities); very poor (very severe symptoms which are intolerable and inability to carry out all normal activities). Values presented for all participants with double-blind baseline data."|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3944495|NCT01364870|3766088|B4|||Pressure Pain Threshold||kilopascal (kPa)|Mean|255.16|255.16|Full Range|||28.0|853.3|
3944496|NCT01364870|3766089|B3|||Pressure Pain Threshold||kilopascal (kPa)|Mean|247|247.0|Full Range|||28.0|681.5|
3944497|NCT01364870|3766090|B2|||Pressure Pain Threshold||kilopascal (kPa)|Mean|251.02|251.02|Full Range|||36.3|770.0|
3944438|NCT01364922|3766065|B3|Poor||Double-blind Participant's Global Assessment of Back Pain Status|"Participant answered the question Considering all the ways your chronic low back pain affects you, how are you doing today? on a 5-point scale: very good (no symptoms and no limitation of normal activities); good (mild symptoms and no limitation of normal activities); fair (moderate symptoms and limitation of some normal activities); poor (severe symptoms and inability to carry out most normal activities); very poor (very severe symptoms which are intolerable and inability to carry out all normal activities). Values presented for all participants with double-blind baseline data."|participants|Number|0|0.0||||||
3944439|NCT01364922|3766066|B2|Poor||Double-blind Participant's Global Assessment of Back Pain Status|"Participant answered the question Considering all the ways your chronic low back pain affects you, how are you doing today? on a 5-point scale: very good (no symptoms and no limitation of normal activities); good (mild symptoms and no limitation of normal activities); fair (moderate symptoms and limitation of some normal activities); poor (severe symptoms and inability to carry out most normal activities); very poor (very severe symptoms which are intolerable and inability to carry out all normal activities). Values presented for all participants with double-blind baseline data."|participants|Number|2|2.0||||||
3944440|NCT01364922|3766067|B1|Poor||Double-blind Participant's Global Assessment of Back Pain Status|"Participant answered the question Considering all the ways your chronic low back pain affects you, how are you doing today? on a 5-point scale: very good (no symptoms and no limitation of normal activities); good (mild symptoms and no limitation of normal activities); fair (moderate symptoms and limitation of some normal activities); poor (severe symptoms and inability to carry out most normal activities); very poor (very severe symptoms which are intolerable and inability to carry out all normal activities). Values presented for all participants with double-blind baseline data."|participants|Number|NA|||||||These subjects were not randomized to the double-blind period.
3944441|NCT01364922|3766064|B4|Good||Double-blind Participant's Global Assessment of Back Pain Status|"Participant answered the question Considering all the ways your chronic low back pain affects you, how are you doing today? on a 5-point scale: very good (no symptoms and no limitation of normal activities); good (mild symptoms and no limitation of normal activities); fair (moderate symptoms and limitation of some normal activities); poor (severe symptoms and inability to carry out most normal activities); very poor (very severe symptoms which are intolerable and inability to carry out all normal activities). Values presented for all participants with double-blind baseline data."|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3944442|NCT01364922|3766065|B3|Good||Double-blind Participant's Global Assessment of Back Pain Status|"Participant answered the question Considering all the ways your chronic low back pain affects you, how are you doing today? on a 5-point scale: very good (no symptoms and no limitation of normal activities); good (mild symptoms and no limitation of normal activities); fair (moderate symptoms and limitation of some normal activities); poor (severe symptoms and inability to carry out most normal activities); very poor (very severe symptoms which are intolerable and inability to carry out all normal activities). Values presented for all participants with double-blind baseline data."|participants|Number|29|29.0||||||
3944443|NCT01364922|3766066|B2|Good||Double-blind Participant's Global Assessment of Back Pain Status|"Participant answered the question Considering all the ways your chronic low back pain affects you, how are you doing today? on a 5-point scale: very good (no symptoms and no limitation of normal activities); good (mild symptoms and no limitation of normal activities); fair (moderate symptoms and limitation of some normal activities); poor (severe symptoms and inability to carry out most normal activities); very poor (very severe symptoms which are intolerable and inability to carry out all normal activities). Values presented for all participants with double-blind baseline data."|participants|Number|57|57.0||||||
3944444|NCT01364922|3766067|B1|Good||Double-blind Participant's Global Assessment of Back Pain Status|"Participant answered the question Considering all the ways your chronic low back pain affects you, how are you doing today? on a 5-point scale: very good (no symptoms and no limitation of normal activities); good (mild symptoms and no limitation of normal activities); fair (moderate symptoms and limitation of some normal activities); poor (severe symptoms and inability to carry out most normal activities); very poor (very severe symptoms which are intolerable and inability to carry out all normal activities). Values presented for all participants with double-blind baseline data."|participants|Number|NA|||||||These subjects were not randomized to the double-blind period.
3944445|NCT01364922|3766064|B4|Fair||Double-blind Participant's Global Assessment of Back Pain Status|"Participant answered the question Considering all the ways your chronic low back pain affects you, how are you doing today? on a 5-point scale: very good (no symptoms and no limitation of normal activities); good (mild symptoms and no limitation of normal activities); fair (moderate symptoms and limitation of some normal activities); poor (severe symptoms and inability to carry out most normal activities); very poor (very severe symptoms which are intolerable and inability to carry out all normal activities). Values presented for all participants with double-blind baseline data."|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3944446|NCT01364922|3766065|B3|Fair||Double-blind Participant's Global Assessment of Back Pain Status|"Participant answered the question Considering all the ways your chronic low back pain affects you, how are you doing today? on a 5-point scale: very good (no symptoms and no limitation of normal activities); good (mild symptoms and no limitation of normal activities); fair (moderate symptoms and limitation of some normal activities); poor (severe symptoms and inability to carry out most normal activities); very poor (very severe symptoms which are intolerable and inability to carry out all normal activities). Values presented for all participants with double-blind baseline data."|participants|Number|14|14.0||||||
3944447|NCT01364922|3766066|B2|Fair||Double-blind Participant's Global Assessment of Back Pain Status|"Participant answered the question Considering all the ways your chronic low back pain affects you, how are you doing today? on a 5-point scale: very good (no symptoms and no limitation of normal activities); good (mild symptoms and no limitation of normal activities); fair (moderate symptoms and limitation of some normal activities); poor (severe symptoms and inability to carry out most normal activities); very poor (very severe symptoms which are intolerable and inability to carry out all normal activities). Values presented for all participants with double-blind baseline data."|participants|Number|21|21.0||||||
3944498|NCT01364870|3766091|B1|||Pressure Pain Threshold||kilopascal (kPa)|Mean|264.08|264.08|Full Range|||51.0|853.3|
3944541|NCT01364870|3766090|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3944448|NCT01364922|3766067|B1|Fair||Double-blind Participant's Global Assessment of Back Pain Status|"Participant answered the question Considering all the ways your chronic low back pain affects you, how are you doing today? on a 5-point scale: very good (no symptoms and no limitation of normal activities); good (mild symptoms and no limitation of normal activities); fair (moderate symptoms and limitation of some normal activities); poor (severe symptoms and inability to carry out most normal activities); very poor (very severe symptoms which are intolerable and inability to carry out all normal activities). Values presented for all participants with double-blind baseline data."|participants|Number|NA|||||||These subjects were not randomized to the double-blind period.
3944449|NCT01364922|3766064|B4|||Double-blind Baseline Chronic Lower Back Pain (CLBP) Intensity VAS|The last assessment using the CLBP Intensity Visual Analog Scale (VAS) (0 mm = No Pain and 100 mm = Worst Pain Imaginable) conducted before the first dose in the double blind period.|scores on a scale|Mean|28.5|28.5|Standard Deviation|13.14|13.14|||
3944450|NCT01364922|3766065|B3|||Double-blind Baseline Chronic Lower Back Pain (CLBP) Intensity VAS|The last assessment using the CLBP Intensity Visual Analog Scale (VAS) (0 mm = No Pain and 100 mm = Worst Pain Imaginable) conducted before the first dose in the double blind period.|scores on a scale|Mean|31.7|31.7|Standard Deviation|11.17|11.17|||
3944451|NCT01364922|3766066|B2|||Double-blind Baseline Chronic Lower Back Pain (CLBP) Intensity VAS|The last assessment using the CLBP Intensity Visual Analog Scale (VAS) (0 mm = No Pain and 100 mm = Worst Pain Imaginable) conducted before the first dose in the double blind period.|scores on a scale|Mean|26.9|26.9|Standard Deviation|13.78|13.78|||
3944452|NCT01364922|3766067|B1|||Double-blind Baseline Chronic Lower Back Pain (CLBP) Intensity VAS|The last assessment using the CLBP Intensity Visual Analog Scale (VAS) (0 mm = No Pain and 100 mm = Worst Pain Imaginable) conducted before the first dose in the double blind period.|scores on a scale|Mean|NA||Standard Deviation|NA||||These subjects were not randomized to the double-blind period.
3944453|NCT01364922|3766064|B4||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3944454|NCT01364922|3766065|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3944455|NCT01364922|3766066|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3944456|NCT01364922|3766067|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3944457|NCT01364922|3766064|B4||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3944458|NCT01364922|3766065|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3944459|NCT01364922|3766066|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3944460|NCT01364922|3766067|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3944461|NCT01364922|3766064|B4|||Age||years|Mean|49.7|49.7|Standard Deviation|13.79|13.79|||
3944462|NCT01364922|3766065|B3|||Age||years|Mean|52.7|52.7|Standard Deviation|13.82|13.82|||
3944463|NCT01364922|3766066|B2|||Age||years|Mean|47.9|47.9|Standard Deviation|13.62|13.62|||
3944464|NCT01364922|3766067|B1|||Age||years|Mean|51.0|51.0|Standard Deviation|13.82|13.82|||
3944465|NCT01364896|3766080|B1|||Number of participants with Indeterminate Colitis||participants|Number|1|1.0||||||
3944466|NCT01364896|3766080|B1|||Number of participants with Ulcerative Colitis||participants|Number|14|14.0||||||
3944467|NCT01364896|3766080|B1|||Number of participants with Crohn's Disease||participants|Number|31|31.0||||||
3944468|NCT01364896|3766080|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
3944469|NCT01364896|3766080|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3944470|NCT01364896|3766080|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3944471|NCT01364896|3766080|B1|||Age||years|Mean|32|32.0|Standard Deviation|8|8.0|||
3944472|NCT01364896|3766080|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3944473|NCT01364896|3766080|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
3944474|NCT01364896|3766080|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3944475|NCT01364870|3766088|B4|||Range of motion: Flextion||Degrees|Mean|113|113.0|Full Range|||35.0|142.0|
3944476|NCT01364870|3766089|B3|||Range of motion: Flextion||Degrees|Mean|109.8|109.8|Full Range|||58.0|142.0|
3944477|NCT01364870|3766090|B2|||Range of motion: Flextion||Degrees|Mean|115.4|115.4|Full Range|||35.0|140.0|
3944478|NCT01364870|3766091|B1|||Range of motion: Flextion||Degrees|Mean|112.5|112.5|Full Range|||61.0|140.0|
3944479|NCT01364870|3766088|B4|||Gait Speed Test||feet in 15 seconds|Mean|61.9|61.9|Full Range|||8.8|122.5|
3944480|NCT01364870|3766089|B3|||Gait Speed Test||feet in 15 seconds|Mean|60.5|60.5|Full Range|||15.4|122.5|
3944481|NCT01364870|3766090|B2|||Gait Speed Test||feet in 15 seconds|Mean|62.7|62.7|Full Range|||13.8|120.0|
3944482|NCT01364870|3766091|B1|||Gait Speed Test||feet in 15 seconds|Mean|61.9|61.9|Full Range|||8.8|117.0|
3944483|NCT01364870|3766088|B4|||Knee Range of Motion: Extension||Degrees|Mean|-5.3|-5.3|Full Range|||-30.0|10.0|
3944484|NCT01364870|3766089|B3|||Knee Range of Motion: Extension||Degrees|Mean|-6.5|-6.5|Full Range|||-26.0|4.0|
3944485|NCT01364870|3766090|B2|||Knee Range of Motion: Extension||Degrees|Mean|-4.8|-4.8|Full Range|||-24.0|8.0|
3944486|NCT01364870|3766091|B1|||Knee Range of Motion: Extension||Degrees|Mean|-5|-5.0|Full Range|||-30.0|10.0|
3944487|NCT01364870|3766088|B4|||Heat Pain Tolerance||Degrees Celsius|Mean|47.1|47.1|Full Range|||35.9|52.0|
3944488|NCT01364870|3766089|B3|||Heat Pain Tolerance||Degrees Celsius|Mean|47.1|47.1|Full Range|||38.3|51.0|
3944489|NCT01364870|3766090|B2|||Heat Pain Tolerance||Degrees Celsius|Mean|46.8|46.8|Full Range|||35.9|50.0|
3944490|NCT01364870|3766091|B1|||Heat Pain Tolerance||Degrees Celsius|Mean|47.4|47.4|Full Range|||42.5|52.0|
3944491|NCT01364870|3766088|B4|||Heat Pain Threshold||Degrees Celsius|Mean|43.4|43.4|Full Range|||35.7|49.8|
3944492|NCT01364870|3766089|B3|||Heat Pain Threshold||Degrees Celsius|Mean|43.6|43.6|Full Range|||35.8|48.0|
3944493|NCT01364870|3766090|B2|||Heat Pain Threshold||Degrees Celsius|Mean|43.3|43.3|Full Range|||35.8|49.8|
3944494|NCT01364870|3766091|B1|||Heat Pain Threshold||Degrees Celsius|Mean|43.3|43.3|Full Range|||35.7|49.6|
3944499|NCT01364870|3766088|B4|||Pain at rest|"While subject is sitting and not moving, they report their pain on 0-20 Numeric Rating Scale (where 0 is no pain and 20 is pain as bad as you can imagine)."|scores on a scale|Mean|3.28|3.28|Full Range|||0.0|19.0|
3944500|NCT01364870|3766089|B3|||Pain at rest|"While subject is sitting and not moving, they report their pain on 0-20 Numeric Rating Scale (where 0 is no pain and 20 is pain as bad as you can imagine)."|scores on a scale|Mean|3.76|3.76|Full Range|||0.0|19.0|
3944501|NCT01364870|3766090|B2|||Pain at rest|"While subject is sitting and not moving, they report their pain on 0-20 Numeric Rating Scale (where 0 is no pain and 20 is pain as bad as you can imagine)."|scores on a scale|Mean|3.35|3.35|Full Range|||0.0|18.0|
3944502|NCT01364870|3766091|B1|||Pain at rest|"While subject is sitting and not moving, they report their pain on 0-20 Numeric Rating Scale (where 0 is no pain and 20 is pain as bad as you can imagine)."|scores on a scale|Mean|2.92|2.92|Full Range|||0.0|15.0|
3944503|NCT01364870|3766088|B4|||Pain with walking|"While subject was walking, they report their pain on 0-20 Numeric Rating Scale (where 0 is no pain and 20 is pain as bad as you can imagine)."|scores on a scale|Mean|6.52|6.52|Full Range|||0.0|20.0|
3944504|NCT01364870|3766089|B3|||Pain with walking|"While subject was walking, they report their pain on 0-20 Numeric Rating Scale (where 0 is no pain and 20 is pain as bad as you can imagine)."|scores on a scale|Mean|7.65|7.65|Full Range|||0.0|20.0|
3944505|NCT01364870|3766090|B2|||Pain with walking|"While subject was walking, they report their pain on 0-20 Numeric Rating Scale (where 0 is no pain and 20 is pain as bad as you can imagine)."|scores on a scale|Mean|6.29|6.29|Full Range|||0.0|20.0|
3944506|NCT01364870|3766091|B1|||Pain with walking|"While subject was walking, they report their pain on 0-20 Numeric Rating Scale (where 0 is no pain and 20 is pain as bad as you can imagine)."|scores on a scale|Mean|6.1|6.1|Full Range|||0.0|20.0|
3944507|NCT01364870|3766088|B4|||Pain with knee range of motion: Extension|"While subject's knee extension is measured, they report their pain on 0-20 Numeric Rating Scale (where 0 is no pain and 20 is pain as bad as you can imagine)."|scores on a scale|Mean|7.13|7.13|Full Range|||0.0|20.0|
3944508|NCT01364870|3766089|B3|||Pain with knee range of motion: Extension|"While subject's knee extension is measured, they report their pain on 0-20 Numeric Rating Scale (where 0 is no pain and 20 is pain as bad as you can imagine)."|scores on a scale|Mean|8.03|8.03|Full Range|||0.0|20.0|
3944509|NCT01364870|3766090|B2|||Pain with knee range of motion: Extension|"While subject's knee extension is measured, they report their pain on 0-20 Numeric Rating Scale (where 0 is no pain and 20 is pain as bad as you can imagine)."|scores on a scale|Mean|7.03|7.03|Full Range|||0.0|20.0|
3944510|NCT01364870|3766091|B1|||Pain with knee range of motion: Extension|"While subject's knee extension is measured, they report their pain on 0-20 Numeric Rating Scale (where 0 is no pain and 20 is pain as bad as you can imagine)."|scores on a scale|Mean|6.69|6.69|Full Range|||0.0|20.0|
3944511|NCT01364870|3766088|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3944512|NCT01364870|3766089|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3944513|NCT01364870|3766090|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3944514|NCT01364870|3766091|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3944515|NCT01364870|3766088|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3944516|NCT01364870|3766089|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3944517|NCT01364870|3766090|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3944518|NCT01364870|3766091|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3944519|NCT01364870|3766088|B4||White|Race (NIH/OMB)||Participants|Count of Participants|299|299.0||||||
3944520|NCT01364870|3766089|B3||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3944521|NCT01364870|3766090|B2||White|Race (NIH/OMB)||Participants|Count of Participants|117|117.0||||||
3944522|NCT01364870|3766091|B1||White|Race (NIH/OMB)||Participants|Count of Participants|114|114.0||||||
3944523|NCT01364870|3766088|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3944524|NCT01364870|3766089|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3944525|NCT01364870|3766090|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3944526|NCT01364870|3766091|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3944527|NCT01364870|3766088|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3944528|NCT01364870|3766089|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3944529|NCT01364870|3766090|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3944530|NCT01364870|3766091|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3944531|NCT01364870|3766088|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3944532|NCT01364870|3766089|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3944533|NCT01364870|3766090|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3944534|NCT01364870|3766091|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3944535|NCT01364870|3766088|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3944536|NCT01364870|3766089|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3944537|NCT01364870|3766090|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3944538|NCT01364870|3766091|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3944539|NCT01364870|3766088|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3944540|NCT01364870|3766089|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3944668|NCT01364649|3766120|B1|>41 years||Age, Customized||participants|Number|103|103.0||||||
3944542|NCT01364870|3766091|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3944543|NCT01364870|3766088|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|310|310.0||||||
3944544|NCT01364870|3766089|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3944545|NCT01364870|3766090|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|121|121.0||||||
3944546|NCT01364870|3766091|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|118|118.0||||||
3944547|NCT01364870|3766088|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3944548|NCT01364870|3766089|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3944549|NCT01364870|3766090|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3944550|NCT01364870|3766091|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3944551|NCT01364870|3766088|B4||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3944552|NCT01364870|3766089|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3944553|NCT01364870|3766090|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3944554|NCT01364870|3766091|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3944555|NCT01364870|3766088|B4||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3944556|NCT01364870|3766089|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3944557|NCT01364870|3766090|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3944558|NCT01364870|3766091|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3944559|NCT01364870|3766088|B4|||Age||Years|Mean|62.3|62.3|Full Range|||40.0|90.0|
3944560|NCT01364870|3766089|B3|||Age||Years|Mean|62.2|62.2|Full Range|||42.0|86.0|
3944561|NCT01364870|3766090|B2|||Age||Years|Mean|61.9|61.9|Full Range|||40.0|82.0|
3944562|NCT01364870|3766091|B1|||Age||Years|Mean|62.7|62.7|Full Range|||41.0|90.0|
3944563|NCT01364740|3766104|B1|||Epworth Sleepiness Scale score|Subjective measure of daytime sleepiness, 0-24 points, where higher numbers indicate greater levels of subjective daytime sleepiness|units on a scale|Mean|6.9|6.9|Standard Deviation|5.61|5.61|||
3944564|NCT01364740|3766104|B1|Women||Body Mass Index||kg/m^2|Mean|30.8|30.8|Standard Deviation|11.76|11.76|||
3944565|NCT01364740|3766104|B1|Men||Body Mass Index||kg/m^2|Mean|29.5|29.5|Standard Deviation|9.54|9.54|||
3944566|NCT01364740|3766104|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
3944567|NCT01364740|3766104|B1||Female|Gender||Participants|Count of Participants|4|4.0||||||
3944568|NCT01364740|3766104|B1|Women||Age, Customized||years|Mean|56.8|56.8|Standard Deviation|14.24|14.24|||
3944569|NCT01364740|3766104|B1|Men||Age, Customized||years|Mean|54.3|54.3|Standard Deviation|15.46|15.46|||
3944570|NCT01364727|3766112|B1|Unknown||Histology||Participants|Count of Participants|1|1.0||||||
3944571|NCT01364727|3766112|B1|Thymoma||Histology||Participants|Count of Participants|14|14.0||||||
3944572|NCT01364727|3766112|B1|Thymic Carcinoma||Histology||Participants|Count of Participants|20|20.0||||||
3944573|NCT01364727|3766112|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3944574|NCT01364727|3766112|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3944575|NCT01364727|3766112|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3944576|NCT01364727|3766112|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3944577|NCT01364727|3766112|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3944578|NCT01364727|3766112|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3944579|NCT01364727|3766112|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3944580|NCT01364727|3766112|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3944581|NCT01364727|3766112|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3944582|NCT01364727|3766112|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3944583|NCT01364727|3766112|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3944584|NCT01364727|3766112|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3944585|NCT01364727|3766112|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3944586|NCT01364727|3766112|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3944587|NCT01364727|3766112|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3944588|NCT01364649|3766118|B3|||Profile of Mood States (POMS) Brief Total Score|POMS brief is a rating scale, which comprises of 30 items that are evaluated in a 0-4 scale (0=not at all and 4=extremely). The scores for the 30 items are added in various combinations to throw six validated factors which are used to calculate total POMS score: (tension-anxiety) + (depression-dejection) + (anger-hostility)+ (fatigue-Inertia) + (confusion-bewilderment) - (vigor-activity). Score range (-40 to 192). Score -40 denotes the best score and score 192 denotes the worst score. The number of participants with available data were 224 and 219 in each treatment arm respectively.|scores on a scale|Mean|19.2|19.2|Standard Deviation|19.39|19.39|||
3944589|NCT01364649|3766119|B2|||Profile of Mood States (POMS) Brief Total Score|POMS brief is a rating scale, which comprises of 30 items that are evaluated in a 0-4 scale (0=not at all and 4=extremely). The scores for the 30 items are added in various combinations to throw six validated factors which are used to calculate total POMS score: (tension-anxiety) + (depression-dejection) + (anger-hostility)+ (fatigue-Inertia) + (confusion-bewilderment) - (vigor-activity). Score range (-40 to 192). Score -40 denotes the best score and score 192 denotes the worst score. The number of participants with available data were 224 and 219 in each treatment arm respectively.|scores on a scale|Mean|19.7|19.7|Standard Deviation|19.45|19.45|||
3944590|NCT01364649|3766120|B1|||Profile of Mood States (POMS) Brief Total Score|POMS brief is a rating scale, which comprises of 30 items that are evaluated in a 0-4 scale (0=not at all and 4=extremely). The scores for the 30 items are added in various combinations to throw six validated factors which are used to calculate total POMS score: (tension-anxiety) + (depression-dejection) + (anger-hostility)+ (fatigue-Inertia) + (confusion-bewilderment) - (vigor-activity). Score range (-40 to 192). Score -40 denotes the best score and score 192 denotes the worst score. The number of participants with available data were 224 and 219 in each treatment arm respectively.|scores on a scale|Mean|18.8|18.8|Standard Deviation|19.36|19.36|||
3944591|NCT01364649|3766118|B3|||Clinical Global Impression - Severity scale (CGI-S) score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill. The number of participants with available data were 224 and 221 in each treatment arm respectively.|scores on a scale|Mean|2.0|2.0|Standard Deviation|0.82|0.82|||
3944592|NCT01364649|3766119|B2|||Clinical Global Impression - Severity scale (CGI-S) score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill. The number of participants with available data were 224 and 221 in each treatment arm respectively.|scores on a scale|Mean|2.0|2.0|Standard Deviation|0.84|0.84|||
3944593|NCT01364649|3766120|B1|||Clinical Global Impression - Severity scale (CGI-S) score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill. The number of participants with available data were 224 and 221 in each treatment arm respectively.|scores on a scale|Mean|2.0|2.0|Standard Deviation|0.81|0.81|||
3944594|NCT01364649|3766118|B3|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression). The number of participants with available data were 224 and 221 in each treatment arm respectively.|scores on a scale|Mean|8.1|8.1|Standard Deviation|6.40|6.4|||
3944595|NCT01364649|3766119|B2|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression). The number of participants with available data were 224 and 221 in each treatment arm respectively.|scores on a scale|Mean|8.3|8.3|Standard Deviation|6.53|6.53|||
3944596|NCT01364649|3766120|B1|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression). The number of participants with available data were 224 and 221 in each treatment arm respectively.|scores on a scale|Mean|7.9|7.9|Standard Deviation|6.28|6.28|||
3944597|NCT01364649|3766118|B3|||Changes in Sexual Functioning Questionnaire Short-Form (CSFQ-14) Total Score|The CSFQ-14 is a structured self reported questionnaire designed to measure illness- and medication-related changes in sexual functioning consisting of 14 items that measure sexual functioning as a total score (14 items) and on the subscales of pleasure (1 item), desire/frequency (2 items), desire/interest (3 items), arousal (3 items), and orgasm (3 items), rated on an 5 point scale from 1 to 5 with a total score range from 14 to 70. Higher scores reflect higher sexual functioning. The number of participants with available data were 220 and 216 in each treatment arm respectively.|scores on a scale|Mean|36.4|36.4|Standard Deviation|5.71|5.71|||
3944598|NCT01364649|3766119|B2|||Changes in Sexual Functioning Questionnaire Short-Form (CSFQ-14) Total Score|The CSFQ-14 is a structured self reported questionnaire designed to measure illness- and medication-related changes in sexual functioning consisting of 14 items that measure sexual functioning as a total score (14 items) and on the subscales of pleasure (1 item), desire/frequency (2 items), desire/interest (3 items), arousal (3 items), and orgasm (3 items), rated on an 5 point scale from 1 to 5 with a total score range from 14 to 70. Higher scores reflect higher sexual functioning. The number of participants with available data were 220 and 216 in each treatment arm respectively.|scores on a scale|Mean|36.3|36.3|Standard Deviation|5.62|5.62|||
3944599|NCT01364649|3766120|B1|||Changes in Sexual Functioning Questionnaire Short-Form (CSFQ-14) Total Score|The CSFQ-14 is a structured self reported questionnaire designed to measure illness- and medication-related changes in sexual functioning consisting of 14 items that measure sexual functioning as a total score (14 items) and on the subscales of pleasure (1 item), desire/frequency (2 items), desire/interest (3 items), arousal (3 items), and orgasm (3 items), rated on an 5 point scale from 1 to 5 with a total score range from 14 to 70. Higher scores reflect higher sexual functioning. The number of participants with available data were 220 and 216 in each treatment arm respectively.|scores on a scale|Mean|36.5|36.5|Standard Deviation|5.81|5.81|||
3944600|NCT01364649|3766118|B3|Daily||Alcohol Consumption||participants|Number|3|3.0||||||
3944601|NCT01364649|3766119|B2|Daily||Alcohol Consumption||participants|Number|2|2.0||||||
3944602|NCT01364649|3766120|B1|Daily||Alcohol Consumption||participants|Number|1|1.0||||||
3944603|NCT01364649|3766118|B3|2 to 6 times per week||Alcohol Consumption||participants|Number|69|69.0||||||
3944604|NCT01364649|3766119|B2|2 to 6 times per week||Alcohol Consumption||participants|Number|36|36.0||||||
3944605|NCT01364649|3766120|B1|2 to 6 times per week||Alcohol Consumption||participants|Number|33|33.0||||||
3944606|NCT01364649|3766118|B3|Once a week||Alcohol Consumption||participants|Number|77|77.0||||||
3944607|NCT01364649|3766119|B2|Once a week||Alcohol Consumption||participants|Number|37|37.0||||||
3944608|NCT01364649|3766120|B1|Once a week||Alcohol Consumption||participants|Number|40|40.0||||||
3944609|NCT01364649|3766118|B3|Once monthly or less often||Alcohol Consumption||participants|Number|168|168.0||||||
3944610|NCT01364649|3766119|B2|Once monthly or less often||Alcohol Consumption||participants|Number|82|82.0||||||
3944611|NCT01364649|3766120|B1|Once monthly or less often||Alcohol Consumption||participants|Number|86|86.0||||||
3944612|NCT01364649|3766118|B3|Never||Alcohol Consumption||participants|Number|130|130.0||||||
3944613|NCT01364649|3766119|B2|Never||Alcohol Consumption||participants|Number|65|65.0||||||
3944614|NCT01364649|3766120|B1|Never||Alcohol Consumption||participants|Number|65|65.0||||||
3944615|NCT01364649|3766118|B3|Ex-smoker||Smoking Classification||participants|Number|85|85.0||||||
3944616|NCT01364649|3766119|B2|Ex-smoker||Smoking Classification||participants|Number|41|41.0||||||
3944617|NCT01364649|3766120|B1|Ex-smoker||Smoking Classification||participants|Number|44|44.0||||||
3944618|NCT01364649|3766118|B3|Current smoker||Smoking Classification||participants|Number|124|124.0||||||
3944619|NCT01364649|3766119|B2|Current smoker||Smoking Classification||participants|Number|55|55.0||||||
3944620|NCT01364649|3766120|B1|Current smoker||Smoking Classification||participants|Number|69|69.0||||||
3944621|NCT01364649|3766118|B3|Never smoked||Smoking Classification||participants|Number|238|238.0||||||
3944622|NCT01364649|3766119|B2|Never smoked||Smoking Classification||participants|Number|126|126.0||||||
3944623|NCT01364649|3766120|B1|Never smoked||Smoking Classification||participants|Number|112|112.0||||||
3944624|NCT01364649|3766118|B3|||Waist Circumference||cm|Mean|92.07|92.07|Standard Deviation|13.218|13.218|||
3944625|NCT01364649|3766119|B2|||Waist Circumference||cm|Mean|93.31|93.31|Standard Deviation|13.074|13.074|||
3944626|NCT01364649|3766120|B1|||Waist Circumference||cm|Mean|90.85|90.85|Standard Deviation|13.274|13.274|||
3944627|NCT01364649|3766118|B3|||Body Mass Index (BMI)||kg/m^2|Mean|27.72|27.72|Standard Deviation|4.395|4.395|||
3944628|NCT01364649|3766119|B2|||Body Mass Index (BMI)||kg/m^2|Mean|27.90|27.9|Standard Deviation|4.440|4.44|||
3944629|NCT01364649|3766120|B1|||Body Mass Index (BMI)||kg/m^2|Mean|27.54|27.54|Standard Deviation|4.352|4.352|||
3944630|NCT01364649|3766118|B3|||Weight||kg|Mean|80.41|80.41|Standard Deviation|16.110|16.11|||
3944631|NCT01364649|3766119|B2|||Weight||kg|Mean|81.22|81.22|Standard Deviation|16.012|16.012|||
3944632|NCT01364649|3766120|B1|||Weight||kg|Mean|79.62|79.62|Standard Deviation|16.202|16.202|||
3944633|NCT01364649|3766118|B3|||Height||cm|Mean|169.9|169.9|Standard Deviation|9.28|9.28|||
3944634|NCT01364649|3766119|B2|||Height||cm|Mean|170.3|170.3|Standard Deviation|8.81|8.81|||
3944635|NCT01364649|3766120|B1|||Height||cm|Mean|169.6|169.6|Standard Deviation|9.73|9.73|||
3944636|NCT01364649|3766118|B3|North America||Region of Enrollment||participants|Number|447|447.0||||||
3944637|NCT01364649|3766119|B2|North America||Region of Enrollment||participants|Number|222|222.0||||||
3944638|NCT01364649|3766120|B1|North America||Region of Enrollment||participants|Number|225|225.0||||||
3944639|NCT01364649|3766118|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3944640|NCT01364649|3766119|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3944641|NCT01364649|3766120|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3944642|NCT01364649|3766118|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3944643|NCT01364649|3766119|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3944644|NCT01364649|3766120|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3944645|NCT01364649|3766118|B3|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3944646|NCT01364649|3766119|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3944647|NCT01364649|3766120|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3944648|NCT01364649|3766118|B3|Black of African American||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
3944649|NCT01364649|3766119|B2|Black of African American||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3944650|NCT01364649|3766120|B1|Black of African American||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
3944651|NCT01364649|3766118|B3|Caucasian (or White, including Hispanic)||Race/Ethnicity, Customized||participants|Number|359|359.0||||||
3944652|NCT01364649|3766119|B2|Caucasian (or White, including Hispanic)||Race/Ethnicity, Customized||participants|Number|181|181.0||||||
3944653|NCT01364649|3766120|B1|Caucasian (or White, including Hispanic)||Race/Ethnicity, Customized||participants|Number|178|178.0||||||
3944654|NCT01364649|3766118|B3|Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||participants|Number|397|397.0||||||
3944655|NCT01364649|3766119|B2|Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||participants|Number|186|186.0||||||
3944656|NCT01364649|3766120|B1|Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||participants|Number|211|211.0||||||
3944657|NCT01364649|3766118|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
3944658|NCT01364649|3766119|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3944659|NCT01364649|3766120|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3944660|NCT01364649|3766118|B3||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3944661|NCT01364649|3766119|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3944662|NCT01364649|3766120|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3944663|NCT01364649|3766118|B3||Female|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
3944664|NCT01364649|3766119|B2||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3944665|NCT01364649|3766120|B1||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3944666|NCT01364649|3766118|B3|>41 years||Age, Customized||participants|Number|213|213.0||||||
3944667|NCT01364649|3766119|B2|>41 years||Age, Customized||participants|Number|110|110.0||||||
3944669|NCT01364649|3766118|B3|≤41 years||Age, Customized||participants|Number|234|234.0||||||
3944670|NCT01364649|3766119|B2|≤41 years||Age, Customized||participants|Number|112|112.0||||||
3944671|NCT01364649|3766120|B1|≤41 years||Age, Customized||participants|Number|122|122.0||||||
3944672|NCT01364649|3766118|B3|||Age||years|Mean|39.8|39.8|Standard Deviation|9.98|9.98|||
3944673|NCT01364649|3766119|B2|||Age||years|Mean|40.2|40.2|Standard Deviation|10.01|10.01|||
3944674|NCT01364649|3766120|B1|||Age||years|Mean|39.3|39.3|Standard Deviation|9.96|9.96|||
3944675|NCT01364584|3766131|B3|||Stroke Volume (ml/beat)||milliliters per beat|Mean|81.5|81.5|Standard Deviation|23.1|23.1|||
3944676|NCT01364584|3766132|B2|||Stroke Volume (ml/beat)||milliliters per beat|Mean|82.5|82.5|Standard Deviation|23.1|23.1|||
3944677|NCT01364584|3766133|B1|||Stroke Volume (ml/beat)||milliliters per beat|Mean|79.2|79.2|Standard Deviation|22.7|22.7|||
3944678|NCT01364584|3766131|B3|||Longitudinal Strain|Measured via echocardiography, longitudinal strain is calculated as the change in length of both the endocardium and the epicardium as compared to the relaxed length of those regions.|percentage difference in lengths|Mean|-18.2|-18.2|Standard Deviation|3.4|3.4|||
3944679|NCT01364584|3766132|B2|||Longitudinal Strain|Measured via echocardiography, longitudinal strain is calculated as the change in length of both the endocardium and the epicardium as compared to the relaxed length of those regions.|percentage difference in lengths|Mean|-19.3|-19.3|Standard Deviation|2.3|2.3|||
3944680|NCT01364584|3766133|B1|||Longitudinal Strain|Measured via echocardiography, longitudinal strain is calculated as the change in length of both the endocardium and the epicardium as compared to the relaxed length of those regions.|percentage difference in lengths|Mean|-17.1|-17.1|Standard Deviation|3.9|3.9|||
3944681|NCT01364584|3766131|B3|||Circumferential Strain|Measured via echocardiography, circumferential strain is calculated as the change in circumference of both the endocardium and the epicardium as compared to the relaxed circumference of those regions.|percentage difference in circumferences|Mean|-23.6|-23.6|Standard Deviation|5.3|5.3|||
3944682|NCT01364584|3766132|B2|||Circumferential Strain|Measured via echocardiography, circumferential strain is calculated as the change in circumference of both the endocardium and the epicardium as compared to the relaxed circumference of those regions.|percentage difference in circumferences|Mean|-23.5|-23.5|Standard Deviation|5.0|5.0|||
3944683|NCT01364584|3766133|B1|||Circumferential Strain|Measured via echocardiography, circumferential strain is calculated as the change in circumference of both the endocardium and the epicardium as compared to the relaxed circumference of those regions.|percentage difference in circumferences|Mean|-23.7|-23.7|Standard Deviation|5.5|5.5|||
3944684|NCT01364584|3766131|B3|||VO2 kinetics tau (sec)||seconds|Mean|71.9|71.9|Standard Deviation|19.1|19.1|||
3944685|NCT01364584|3766132|B2|||VO2 kinetics tau (sec)||seconds|Mean|63.3|63.3|Standard Deviation|5.9|5.9|||
3944686|NCT01364584|3766133|B1|||VO2 kinetics tau (sec)||seconds|Mean|78.2|78.2|Standard Deviation|6.8|6.8|||
3944687|NCT01364584|3766131|B3|||VO2peak (ml/min)||milliliters per minute|Mean|1554|1554.0|Standard Deviation|415|415.0|||
3944688|NCT01364584|3766132|B2|||VO2peak (ml/min)||milliliters per minute|Mean|1363|1363.0|Standard Deviation|95|95.0|||
3944689|NCT01364584|3766133|B1|||VO2peak (ml/min)||milliliters per minute|Mean|1783|1783.0|Standard Deviation|129|129.0|||
3944690|NCT01364584|3766131|B3|||VO2peak (ml/kg/min)||milliliters per kilogram per minute|Mean|16.4|16.4|Standard Deviation|3.1|3.1|||
3944691|NCT01364584|3766132|B2|||VO2peak (ml/kg/min)||milliliters per kilogram per minute|Mean|15.4|15.4|Standard Deviation|0.9|0.9|||
3944692|NCT01364584|3766133|B1|||VO2peak (ml/kg/min)||milliliters per kilogram per minute|Mean|17.5|17.5|Standard Deviation|1.0|1.0|||
3944693|NCT01364584|3766131|B3|||Free Fatty Acids (mmol/L)||millimoles per liter|Mean|546.3|546.3|Standard Deviation|228.2|228.2|||
3944694|NCT01364584|3766132|B2|||Free Fatty Acids (mmol/L)||millimoles per liter|Mean|500.5|500.5|Standard Deviation|67.8|67.8|||
3944695|NCT01364584|3766133|B1|||Free Fatty Acids (mmol/L)||millimoles per liter|Mean|580.8|580.8|Standard Deviation|76.3|76.3|||
3944696|NCT01364584|3766131|B3|||Glycerol (mg/dl)||milligrams per deciliter|Mean|1.16|1.16|Standard Deviation|0.5|0.5|||
3944697|NCT01364584|3766132|B2|||Glycerol (mg/dl)||milligrams per deciliter|Mean|1.14|1.14|Standard Deviation|0.5|0.5|||
3944698|NCT01364584|3766133|B1|||Glycerol (mg/dl)||milligrams per deciliter|Mean|1.21|1.21|Standard Deviation|0.5|0.5|||
3944699|NCT01364584|3766131|B3|||Triglycerides (mg/dl)||milligrams per deciliter|Mean|190.1|190.1|Standard Deviation|136.9|136.9|||
3944700|NCT01364584|3766132|B2|||Triglycerides (mg/dl)||milligrams per deciliter|Mean|217.8|217.8|Standard Deviation|58.0|58.0|||
3944701|NCT01364584|3766133|B1|||Triglycerides (mg/dl)||milligrams per deciliter|Mean|156.8|156.8|Standard Deviation|18.3|18.3|||
3944702|NCT01364584|3766131|B3|||LDL Cholesterol (mg/dl)||milligrams per deciliter|Mean|94.4|94.4|Standard Deviation|22.1|22.1|||
3944703|NCT01364584|3766132|B2|||LDL Cholesterol (mg/dl)||milligrams per deciliter|Mean|97.6|97.6|Standard Deviation|7.4|7.4|||
3944704|NCT01364584|3766133|B1|||LDL Cholesterol (mg/dl)||milligrams per deciliter|Mean|93.8|93.8|Standard Deviation|6.2|6.2|||
3944705|NCT01364584|3766131|B3|||Total Cholesterol (mg/dl)||milligrams per deciliter|Mean|165.2|165.2|Standard Deviation|34.9|34.9|||
3944706|NCT01364584|3766132|B2|||Total Cholesterol (mg/dl)||milligrams per deciliter|Mean|175.3|175.3|Standard Deviation|11.7|11.7|||
3944707|NCT01364584|3766133|B1|||Total Cholesterol (mg/dl)||milligrams per deciliter|Mean|156.3|156.3|Standard Deviation|9.8|9.8|||
3944708|NCT01364584|3766131|B3|||HbA1c (%)||percentage of glycated hemoglobin|Mean|7.2|7.2|Standard Deviation|1.1|1.1|||
3944709|NCT01364584|3766132|B2|||HbA1c (%)||percentage of glycated hemoglobin|Mean|7.2|7.2|Standard Deviation|0.4|0.4|||
3944710|NCT01364584|3766133|B1|||HbA1c (%)||percentage of glycated hemoglobin|Mean|7.3|7.3|Standard Deviation|1.1|1.1|||
3944711|NCT01364584|3766131|B3|||Fasting Insulin (μU/ml)||microunits per milliliter|Mean|31.0|31.0|Standard Deviation|15.1|15.1|||
3944712|NCT01364584|3766132|B2|||Fasting Insulin (μU/ml)||microunits per milliliter|Mean|34.6|34.6|Standard Deviation|6.4|6.4|||
3944713|NCT01364584|3766133|B1|||Fasting Insulin (μU/ml)||microunits per milliliter|Mean|29.0|29.0|Standard Deviation|3.7|3.7|||
3944714|NCT01364584|3766131|B3|||Fasting Glucose (mg/dl)||milligrams per deciliter|Mean|147.6|147.6|Standard Deviation|59.9|59.9|||
3944715|NCT01364584|3766132|B2|||Fasting Glucose (mg/dl)||milligrams per deciliter|Mean|127.9|127.9|Standard Deviation|8.0|8.0|||
3944716|NCT01364584|3766133|B1|||Fasting Glucose (mg/dl)||milligrams per deciliter|Mean|170.5|170.5|Standard Deviation|24.2|24.2|||
3944717|NCT01364584|3766131|B3|||Lean Mass (kg)||kilograms|Mean|58.1|58.1|Standard Deviation|11.6|11.6|||
3944718|NCT01364584|3766132|B2|||Lean Mass (kg)||kilograms|Mean|55.8|55.8|Standard Deviation|2.8|2.8|||
3944719|NCT01364584|3766133|B1|||Lean Mass (kg)||kilograms|Mean|61.9|61.9|Standard Deviation|3.9|3.9|||
3944720|NCT01364584|3766131|B3|||Body Fat (%)||percentage|Mean|36.7|36.7|Standard Deviation|7.15|7.15|||
3944721|NCT01364584|3766132|B2|||Body Fat (%)||percentage|Mean|35.7|35.7|Standard Deviation|2.2|2.2|||
3944722|NCT01364584|3766133|B1|||Body Fat (%)||percentage|Mean|37.7|37.7|Standard Deviation|2.3|2.3|||
3944723|NCT01364584|3766131|B3|||Body Mass Index (kg/m2)||kilograms per meter squared|Mean|32.3|32.3|Standard Deviation|3.9|3.9|||
3944724|NCT01364584|3766132|B2|||Body Mass Index (kg/m2)||kilograms per meter squared|Mean|31.3|31.3|Standard Deviation|1.2|1.2|||
3944725|NCT01364584|3766133|B1|||Body Mass Index (kg/m2)||kilograms per meter squared|Mean|33.9|33.9|Standard Deviation|1.0|1.0|||
3944726|NCT01364584|3766131|B3|||Body Mass (kg)||kilograms|Mean|93.4|93.4|Standard Deviation|16.1|16.1|||
3944727|NCT01364584|3766132|B2|||Body Mass (kg)||kilograms|Mean|87.9|87.9|Standard Deviation|3.3|3.3|||
3944728|NCT01364584|3766133|B1|||Body Mass (kg)||kilograms|Mean|101.7|101.7|Standard Deviation|5.3|5.3|||
3944729|NCT01364584|3766131|B3|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3944730|NCT01364584|3766132|B2|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3944731|NCT01364584|3766133|B1|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3944732|NCT01364584|3766131|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3944733|NCT01364584|3766132|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3944734|NCT01364584|3766133|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3944735|NCT01364584|3766131|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3944736|NCT01364584|3766132|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3944737|NCT01364584|3766133|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3944738|NCT01364584|3766131|B3|||Age||years|Mean|64|64.0|Standard Deviation|4|4.0|||
3944739|NCT01364584|3766132|B2|||Age||years|Mean|64|64.0|Standard Deviation|1|1.0|||
3944740|NCT01364584|3766133|B1|||Age||years|Mean|64|64.0|Standard Deviation|7|7.0|||
3944741|NCT01364558|3766168|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3944742|NCT01364558|3766168|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3944743|NCT01364558|3766168|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3944744|NCT01364558|3766168|B1|||Age||years|Mean|32.2|32.2|Standard Deviation|7.84|7.84|||
3944745|NCT01364558|3766168|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3944746|NCT01364558|3766168|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3944747|NCT01364558|3766168|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3944748|NCT01364428|3766178|B3|||Fasting plasma glucose (FPG)||mmol/L|Mean|8.3|8.3|Standard Deviation|3.2|3.2|||
3944749|NCT01364428|3766179|B2|||Fasting plasma glucose (FPG)||mmol/L|Mean|8.3|8.3|Standard Deviation|3.4|3.4|||
3944750|NCT01364428|3766180|B1|||Fasting plasma glucose (FPG)||mmol/L|Mean|8.3|8.3|Standard Deviation|3.0|3.0|||
3944751|NCT01364428|3766178|B3|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.2|8.2|Standard Deviation|0.9|0.9|||
3944752|NCT01364428|3766179|B2|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.2|8.2|Standard Deviation|0.9|0.9|||
3944753|NCT01364428|3766180|B1|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.1|8.1|Standard Deviation|0.9|0.9|||
3944754|NCT01364428|3766178|B3||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
3944755|NCT01364428|3766179|B2||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3944756|NCT01364428|3766180|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3944757|NCT01364428|3766178|B3||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3944758|NCT01364428|3766179|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3944759|NCT01364428|3766180|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3944760|NCT01364428|3766178|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|10.1|10.1|||
3944761|NCT01364428|3766179|B2|||Age||years|Mean|60.3|60.3|Standard Deviation|10.2|10.2|||
3944762|NCT01364428|3766180|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|10.0|10.0|||
3944763|NCT01364389|3766195|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3944764|NCT01364389|3766196|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3944765|NCT01364389|3766197|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3944766|NCT01364389|3766198|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3944767|NCT01364389|3766195|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3944768|NCT01364389|3766196|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3944769|NCT01364389|3766197|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3944770|NCT01364389|3766198|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3944771|NCT01364389|3766195|B4|||Age||years|Mean|68.5|68.5|Standard Deviation|8.02|8.02|||
3944772|NCT01364389|3766196|B3|||Age||years|Mean|69.4|69.4|Standard Deviation|7.89|7.89|||
3944773|NCT01364389|3766197|B2|||Age||years|Mean|68.8|68.8|Standard Deviation|8.61|8.61|||
3944774|NCT01364389|3766198|B1|||Age||years|Mean|67.2|67.2|Standard Deviation|9.09|9.09|||
3944775|NCT01364298|3766217|B3||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3944776|NCT01364298|3766218|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3944777|NCT01364298|3766219|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3944778|NCT01364298|3766217|B3||Female|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
3944779|NCT01364298|3766218|B2||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3944780|NCT01364298|3766219|B1||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3944781|NCT01364298|3766217|B3|||Age||years|Mean|53.8|53.8|Standard Deviation|9.9|9.9|||
3944782|NCT01364298|3766218|B2|||Age||years|Mean|54.3|54.3|Standard Deviation|9.4|9.4|||
3944783|NCT01364298|3766219|B1|||Age||years|Mean|53.2|53.2|Standard Deviation|10.5|10.5|||
3944784|NCT01364259|3766242|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
3944785|NCT01364259|3766243|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3944786|NCT01364259|3766244|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3944787|NCT01364259|3766242|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3944788|NCT01364259|3766243|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3944789|NCT01364259|3766244|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3944790|NCT01364259|3766242|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3944791|NCT01364259|3766243|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3944792|NCT01364259|3766244|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3944793|NCT01364259|3766242|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3944794|NCT01364259|3766243|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3944795|NCT01364259|3766244|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3944796|NCT01364259|3766242|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3944797|NCT01364259|3766243|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3944798|NCT01364259|3766244|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3944799|NCT01364259|3766242|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3944800|NCT01364259|3766243|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3944801|NCT01364259|3766244|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3944802|NCT01364233|3766253|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3944803|NCT01364233|3766253|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3944804|NCT01364233|3766253|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3944805|NCT01364233|3766253|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3944806|NCT01364233|3766253|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3944807|NCT01364207|3766257|B1|||Baseline Intraocular Pressure on Decaffeinated Coffee Visit|The intraocular pressure measured at baseline prior to ingestion of decaffeinated coffee on the decaffeinated coffee visit.|mmHg|Mean|16.01|16.01|Standard Deviation|2.72|2.72|||
3944808|NCT01364207|3766257|B1|||Baseline Intraocular Pressure on Caffeinated Coffee Visit|The intraocular pressure measured at baseline prior to ingestion of caffeinated coffee on the caffeinated coffee visit.|mmHg|Mean|15.90|15.9|Standard Deviation|2.78|2.78|||
3944809|NCT01364207|3766257|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3944810|NCT01364207|3766257|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3944811|NCT01364207|3766257|B1|||Age||years|Mean|64.4|64.4|Standard Deviation|11.7|11.7|||
3944812|NCT01364090|3766266|B4||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3944813|NCT01364090|3766267|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3944814|NCT01364090|3766268|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3944815|NCT01364090|3766269|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3944816|NCT01364090|3766266|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3944817|NCT01364090|3766267|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3944818|NCT01364090|3766268|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3944819|NCT01364090|3766269|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3944820|NCT01364090|3766266|B4|||Age||years|Median|41|41.0|Inter-Quartile Range|||35.0|49.0|
3944821|NCT01364090|3766267|B3|||Age||years|Median|50|50.0|Inter-Quartile Range|||41.0|56.0|
3944822|NCT01364090|3766268|B2|||Age||years|Median|41|41.0|Inter-Quartile Range|||34.0|49.0|
3944823|NCT01364090|3766269|B1|||Age||years|Median|40|40.0|Inter-Quartile Range|||35.0|48.0|
3944824|NCT01363986|3766279|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3944825|NCT01363986|3766279|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3944826|NCT01363986|3766279|B1|||Age||years|Median|60|60.0|Full Range|||37.0|74.0|
3944827|NCT01363908|3766287|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3944828|NCT01363908|3766288|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3944829|NCT01363908|3766289|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3944830|NCT01363908|3766287|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3944831|NCT01363908|3766288|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3944832|NCT01363908|3766289|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3944833|NCT01363908|3766287|B3|||Age||years|Mean|11.8|11.8|Standard Deviation|3.42|3.42|||
3944834|NCT01363908|3766288|B2|||Age||years|Mean|14.4|14.4|Standard Deviation|1.78|1.78|||
3944835|NCT01363908|3766289|B1|||Age||years|Mean|8.6|8.6|Standard Deviation|1.85|1.85|||
3944836|NCT01363843|3766320|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
3944837|NCT01363843|3766320|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3944838|NCT01363843|3766320|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3944839|NCT01363843|3766320|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3944840|NCT01363843|3766320|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3944841|NCT01363843|3766320|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3944842|NCT01363843|3766320|B1|||Age||years|Median|61|61.0|Full Range|||30.0|79.0|
3944843|NCT01363765|3766324|B3|Brazil||Region of Enrollment||participants|Number|4660|4660.0||||||
3944844|NCT01363765|3766325|B2|Brazil||Region of Enrollment||participants|Number|2050|2050.0||||||
3944845|NCT01363765|3766326|B1|Brazil||Region of Enrollment||participants|Number|2610|2610.0||||||
3944846|NCT01363765|3766324|B3||Male|Sex: Female, Male||Participants|Count of Participants|2996|2996.0||||||
3944847|NCT01363765|3766325|B2||Male|Sex: Female, Male||Participants|Count of Participants|1314|1314.0||||||
3944848|NCT01363765|3766326|B1||Male|Sex: Female, Male||Participants|Count of Participants|1682|1682.0||||||
3944849|NCT01363765|3766324|B3||Female|Sex: Female, Male||Participants|Count of Participants|1664|1664.0||||||
3944850|NCT01363765|3766325|B2||Female|Sex: Female, Male||Participants|Count of Participants|736|736.0||||||
3944851|NCT01363765|3766326|B1||Female|Sex: Female, Male||Participants|Count of Participants|928|928.0||||||
3944852|NCT01363765|3766324|B3|<=14 years||Age, Customized||participants|Number|112|112.0||||||
3944853|NCT01363765|3766325|B2|<=14 years||Age, Customized||participants|Number|56|56.0||||||
3944854|NCT01363765|3766326|B1|<=14 years||Age, Customized||participants|Number|56|56.0||||||
3944855|NCT01363765|3766324|B3|>=60 years||Age, Customized||participants|Number|568|568.0||||||
3944856|NCT01363765|3766325|B2|>=60 years||Age, Customized||participants|Number|244|244.0||||||
3944857|NCT01363765|3766326|B1|>=60 years||Age, Customized||participants|Number|324|324.0||||||
3944858|NCT01363765|3766324|B3|Between 40 and 59 years||Age, Customized||participants|Number|1517|1517.0||||||
3944859|NCT01363765|3766325|B2|Between 40 and 59 years||Age, Customized||participants|Number|682|682.0||||||
3944860|NCT01363765|3766326|B1|Between 40 and 59 years||Age, Customized||participants|Number|835|835.0||||||
3944861|NCT01363765|3766324|B3|Between 15 and 39 years||Age, Customized||participants|Number|2463|2463.0||||||
3944862|NCT01363765|3766325|B2|Between 15 and 39 years||Age, Customized||participants|Number|1068|1068.0||||||
3944863|NCT01363765|3766326|B1|Between 15 and 39 years||Age, Customized||participants|Number|1395|1395.0||||||
3944864|NCT01363713|3766339|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3944865|NCT01363713|3766339|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3944866|NCT01363713|3766339|B1|||Age||years|Mean|40.2|40.2|Standard Deviation|13.0|13.0|||
3944867|NCT01363700|3766345|B4||Male|Sex: Female, Male|"After “Epinastine vs Placebo”, allocate subjects to Olopatadine / Placebo or Epinastine / Placebo for “Epinastine vs Olopatadine”.~Demographic statistics in whole periods were not analyzed."|Participants|Count of Participants|48|48.0||||||
3944868|NCT01363700|3766346|B3||Male|Sex: Female, Male|"After “Epinastine vs Placebo”, allocate subjects to Olopatadine / Placebo or Epinastine / Placebo for “Epinastine vs Olopatadine”.~Demographic statistics in whole periods were not analyzed."|Participants|Count of Participants|11|11.0||||||
3944869|NCT01363700|3766347|B2||Male|Sex: Female, Male|"After “Epinastine vs Placebo”, allocate subjects to Olopatadine / Placebo or Epinastine / Placebo for “Epinastine vs Olopatadine”.~Demographic statistics in whole periods were not analyzed."|Participants|Count of Participants|11|11.0||||||
3944870|NCT01363700|3766348|B1||Male|Sex: Female, Male|"After “Epinastine vs Placebo”, allocate subjects to Olopatadine / Placebo or Epinastine / Placebo for “Epinastine vs Olopatadine”.~Demographic statistics in whole periods were not analyzed."|Participants|Count of Participants|26|26.0||||||
3944871|NCT01363700|3766345|B4||Female|Sex: Female, Male|"After “Epinastine vs Placebo”, allocate subjects to Olopatadine / Placebo or Epinastine / Placebo for “Epinastine vs Olopatadine”.~Demographic statistics in whole periods were not analyzed."|Participants|Count of Participants|39|39.0||||||
3944872|NCT01363700|3766346|B3||Female|Sex: Female, Male|"After “Epinastine vs Placebo”, allocate subjects to Olopatadine / Placebo or Epinastine / Placebo for “Epinastine vs Olopatadine”.~Demographic statistics in whole periods were not analyzed."|Participants|Count of Participants|11|11.0||||||
3944873|NCT01363700|3766347|B2||Female|Sex: Female, Male|"After “Epinastine vs Placebo”, allocate subjects to Olopatadine / Placebo or Epinastine / Placebo for “Epinastine vs Olopatadine”.~Demographic statistics in whole periods were not analyzed."|Participants|Count of Participants|11|11.0||||||
3944874|NCT01363700|3766348|B1||Female|Sex: Female, Male|"After “Epinastine vs Placebo”, allocate subjects to Olopatadine / Placebo or Epinastine / Placebo for “Epinastine vs Olopatadine”.~Demographic statistics in whole periods were not analyzed."|Participants|Count of Participants|17|17.0||||||
3944875|NCT01363700|3766345|B4|||Age||years|Mean|39.4|39.4|Standard Deviation|10.8|10.8|||
3944876|NCT01363700|3766346|B3|||Age||years|Mean|39.7|39.7|Standard Deviation|11.7|11.7|||
3944877|NCT01363700|3766347|B2|||Age||years|Mean|39.0|39.0|Standard Deviation|10.0|10.0|||
3944878|NCT01363700|3766348|B1|||Age||years|Mean|39.5|39.5|Standard Deviation|11.0|11.0|||
3944879|NCT01363661|3766369|B3|Belgium||Region of Enrollment||participants|Number|46|46.0||||||
3944880|NCT01363661|3766370|B2|Belgium||Region of Enrollment||participants|Number|28|28.0||||||
3944881|NCT01363661|3766371|B1|Belgium||Region of Enrollment||participants|Number|18|18.0||||||
3944882|NCT01363661|3766369|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3944883|NCT01363661|3766370|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3944884|NCT01363661|3766371|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3944885|NCT01363661|3766369|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3944886|NCT01363661|3766370|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3944887|NCT01363661|3766371|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3944888|NCT01363661|3766369|B3|||Age||Years|Mean|63.5|63.5|Standard Deviation|9.9|9.9|||
3944889|NCT01363661|3766370|B2|||Age||Years|Mean|64.1|64.1|Standard Deviation|9.9|9.9|||
3944890|NCT01363661|3766371|B1|||Age||Years|Mean|62.4|62.4|Standard Deviation|10.2|10.2|||
3944891|NCT01363492|3766388|B1|||Urine Gb3||(nmol/g creatinine)|Mean|1775.08|1775.08|Standard Deviation|3691.087|3691.087|||
3944892|NCT01363492|3766388|B1|||Plasma Gb3||(nmol/mL)|Mean|14.79|14.79|Standard Deviation|12.228|12.228|||
3944893|NCT01363492|3766388|B1|||Midwall Fractional Shortening (MFS)||(%)|Mean|18.63|18.63|Standard Deviation|2.891|2.891|||
3944894|NCT01363492|3766388|B1|||Left Ventricular Mass Index (LVMI)||(g/m^2.7)|Mean|35.37|35.37|Standard Deviation|10.129|10.129|||
3944895|NCT01363492|3766388|B1|||Heart rate variability parameter pNN50||msec|Mean|32.79|32.79|Standard Deviation|19.997|19.997|||
3944896|NCT01363492|3766388|B1|||Heart rate variability parameter rMSSD||msec|Mean|75.92|75.92|Standard Deviation|45.747|45.747|||
3944897|NCT01363492|3766388|B1|||Heart rate variability parameter SDNN||msec|Mean|103.46|103.46|Standard Deviation|32.928|32.928|||
3944898|NCT01363492|3766388|B1|UNITED STATES||Region of Enrollment||Participants|Number|14|14.0||||||
3944899|NCT01363492|3766388|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3944900|NCT01363492|3766388|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3944901|NCT01363492|3766388|B1|<=18 years||Age, Customized|Age at informed consent|Participants|Number|14|14.0||||||
3944902|NCT01363492|3766388|B1|||Age||Years|Mean|12.16|12.16|Standard Deviation|2.992|2.992|||
3944903|NCT01363479|3766401|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3944904|NCT01363479|3766402|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3944905|NCT01363479|3766403|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3944906|NCT01363479|3766401|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3944907|NCT01363479|3766402|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3944908|NCT01363479|3766403|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3944909|NCT01363479|3766401|B3|Asian||Race/Ethnicity, Customized||participants|Number|96|96.0||||||
3944910|NCT01363479|3766402|B2|Asian||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
3944911|NCT01363479|3766403|B1|Asian||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
3944912|NCT01363479|3766401|B3|White||Race/Ethnicity, Customized||participants|Number|641|641.0||||||
3944913|NCT01363479|3766402|B2|White||Race/Ethnicity, Customized||participants|Number|320|320.0||||||
3944914|NCT01363479|3766403|B1|White||Race/Ethnicity, Customized||participants|Number|321|321.0||||||
3944915|NCT01363479|3766401|B3||Male|Sex: Female, Male||Participants|Count of Participants|436|436.0||||||
3944916|NCT01363479|3766402|B2||Male|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
3944917|NCT01363479|3766403|B1||Male|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
3944918|NCT01363479|3766401|B3||Female|Sex: Female, Male||Participants|Count of Participants|303|303.0||||||
3944919|NCT01363479|3766402|B2||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3944920|NCT01363479|3766403|B1||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3944921|NCT01363479|3766401|B3|||Age||years|Mean|57.9|57.9|Standard Deviation|9.66|9.66|||
3944922|NCT01363479|3766402|B2|||Age||years|Mean|57.7|57.7|Standard Deviation|9.92|9.92|||
3944923|NCT01363479|3766403|B1|||Age||years|Mean|58.0|58.0|Standard Deviation|9.41|9.41|||
3944924|NCT01363440|3766410|B4||Male|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
3944925|NCT01363440|3766411|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3944926|NCT01363440|3766412|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3944927|NCT01363440|3766413|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3944928|NCT01363440|3766410|B4||Female|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
3944929|NCT01363440|3766411|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3944930|NCT01363440|3766412|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3944931|NCT01363440|3766413|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3944932|NCT01363440|3766410|B4|||Age||years|Mean|62.2|62.2|Standard Deviation|9.7|9.7|||
3944933|NCT01363440|3766411|B3|||Age||years|Mean|63.1|63.1|Standard Deviation|9.36|9.36|||
3944934|NCT01363440|3766412|B2|||Age||years|Mean|62|62.0|Standard Deviation|11.16|11.16|||
3944935|NCT01363440|3766413|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|8.65|8.65|||
3944936|NCT01363401|3766444|B3|Not on Riluzole||Riluzole use||participants|Number|0|0.0||||||
3944937|NCT01363401|3766445|B2|Not on Riluzole||Riluzole use||participants|Number|0|0.0||||||
3944938|NCT01363401|3766446|B1|Not on Riluzole||Riluzole use||participants|Number|0|0.0||||||
3944939|NCT01363401|3766444|B3|on Riluzole||Riluzole use||participants|Number|72|72.0||||||
3944940|NCT01363401|3766445|B2|on Riluzole||Riluzole use||participants|Number|31|31.0||||||
3944941|NCT01363401|3766446|B1|on Riluzole||Riluzole use||participants|Number|41|41.0||||||
3944942|NCT01363401|3766444|B3|Korea, Republic of||Region of Enrollment||participants|Number|72|72.0||||||
3944943|NCT01363401|3766445|B2|Korea, Republic of||Region of Enrollment||participants|Number|31|31.0||||||
3944944|NCT01363401|3766446|B1|Korea, Republic of||Region of Enrollment||participants|Number|41|41.0||||||
3944945|NCT01363401|3766444|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3944946|NCT01363401|3766445|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3944947|NCT01363401|3766446|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3944948|NCT01363401|3766444|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3944949|NCT01363401|3766445|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3944950|NCT01363401|3766446|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3944951|NCT01363401|3766444|B3|||Age||years|Mean|52.61|52.61|Standard Deviation|8.61|8.61|||
3944952|NCT01363401|3766445|B2|||Age||years|Mean|52.65|52.65|Standard Deviation|8.93|8.93|||
3944953|NCT01363401|3766446|B1|||Age||years|Mean|52.59|52.59|Standard Deviation|8.59|8.59|||
3944954|NCT01363349|3766459|B3|India||Region of Enrollment||participants|Number|186|186.0||||||
3944955|NCT01363349|3766460|B2|India||Region of Enrollment||participants|Number|94|94.0||||||
3944956|NCT01363349|3766461|B1|India||Region of Enrollment||participants|Number|92|92.0||||||
3944957|NCT01363349|3766459|B3|Romania||Region of Enrollment||participants|Number|83|83.0||||||
3944958|NCT01363349|3766460|B2|Romania||Region of Enrollment||participants|Number|42|42.0||||||
3944959|NCT01363349|3766461|B1|Romania||Region of Enrollment||participants|Number|41|41.0||||||
3944960|NCT01363349|3766459|B3|caucasian||Race/Ethnicity, Customized||number of participants|Number|83|83.0||||||
3944961|NCT01363349|3766460|B2|caucasian||Race/Ethnicity, Customized||number of participants|Number|42|42.0||||||
3944962|NCT01363349|3766461|B1|caucasian||Race/Ethnicity, Customized||number of participants|Number|41|41.0||||||
3944963|NCT01363349|3766459|B3|asian||Race/Ethnicity, Customized||number of participants|Number|186|186.0||||||
3944964|NCT01363349|3766460|B2|asian||Race/Ethnicity, Customized||number of participants|Number|94|94.0||||||
3944965|NCT01363349|3766461|B1|asian||Race/Ethnicity, Customized||number of participants|Number|92|92.0||||||
3944966|NCT01363349|3766459|B3||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3944967|NCT01363349|3766460|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3944968|NCT01363349|3766461|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3944969|NCT01363349|3766459|B3||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3944970|NCT01363349|3766460|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3944971|NCT01363349|3766461|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3944972|NCT01363349|3766459|B3|||Age||years|Mean|32.8|32.8|Standard Deviation|8.37|8.37|||
3944973|NCT01363349|3766460|B2|||Age||years|Mean|32.3|32.3|Standard Deviation|7.97|7.97|||
3944974|NCT01363349|3766461|B1|||Age||years|Mean|33.3|33.3|Standard Deviation|8.76|8.76|||
3944975|NCT01363297|3766468|B6||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3944976|NCT01363297|3766469|B5||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3944977|NCT01363297|3766470|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3944978|NCT01363297|3766471|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3944979|NCT01363297|3766472|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3944980|NCT01363297|3766473|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3944981|NCT01363297|3766468|B6||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3944982|NCT01363297|3766469|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3944983|NCT01363297|3766470|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3944984|NCT01363297|3766471|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3944985|NCT01363297|3766472|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3944986|NCT01363297|3766473|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3944987|NCT01363297|3766468|B6|||Age||Years|Mean|44.9|44.9|Standard Deviation|17.26|17.26|||
3944988|NCT01363297|3766469|B5|||Age||Years|Mean|40.7|40.7|Standard Deviation|17.08|17.08|||
3944989|NCT01363297|3766470|B4|||Age||Years|Mean|53.4|53.4|Standard Deviation|13.82|13.82|||
3944990|NCT01363297|3766471|B3|||Age||Years|Mean|43.1|43.1|Standard Deviation|18.37|18.37|||
3944991|NCT01363297|3766472|B2|||Age||Years|Mean|44.9|44.9|Standard Deviation|18.06|18.06|||
3944992|NCT01363297|3766473|B1|||Age||Years|Mean|63.7|63.7|Standard Deviation|1.53|1.53|||
3944993|NCT01363258|3766567|B3|||Charlson Comorbidity Index|"The Charlson Comorbidity Index assigns weighted values to specific medical conditions, for example, a diagnosis of hypertension may receive a 1 while a diagnosis of uncontrolled diabetes may receive a 2. The higher the number, the more severe the accompanying medical conditions."|units on a scale|Mean|2.50|2.5|Standard Deviation|2.06|2.06|||
3944994|NCT01363258|3766568|B2|||Charlson Comorbidity Index|"The Charlson Comorbidity Index assigns weighted values to specific medical conditions, for example, a diagnosis of hypertension may receive a 1 while a diagnosis of uncontrolled diabetes may receive a 2. The higher the number, the more severe the accompanying medical conditions."|units on a scale|Mean|2.60|2.6|Standard Deviation|2.56|2.56|||
3944995|NCT01363258|3766569|B1|||Charlson Comorbidity Index|"The Charlson Comorbidity Index assigns weighted values to specific medical conditions, for example, a diagnosis of hypertension may receive a 1 while a diagnosis of uncontrolled diabetes may receive a 2. The higher the number, the more severe the accompanying medical conditions."|units on a scale|Mean|2.40|2.4|Standard Deviation|1.53|1.53|||
3945043|NCT01363258|3766569|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3945044|NCT01363258|3766567|B3|||Age||years|Mean|81.55|81.55|Standard Deviation|9.91|9.91|||
3944996|NCT01363258|3766567|B3|||Katz Index of ADLs|The Katz Index of Activities of Daily Living is an ordinal measure of functional abilities. Higher numbers denote greater impairment, where 0 is completely independent and 18 is completely dependent on others for care.|units on a scale|Mean|9.53|9.53|Standard Deviation|3.16|3.16|||
3944997|NCT01363258|3766568|B2|||Katz Index of ADLs|The Katz Index of Activities of Daily Living is an ordinal measure of functional abilities. Higher numbers denote greater impairment, where 0 is completely independent and 18 is completely dependent on others for care.|units on a scale|Mean|9.76|9.76|Standard Deviation|3.63|3.63|||
3944998|NCT01363258|3766569|B1|||Katz Index of ADLs|The Katz Index of Activities of Daily Living is an ordinal measure of functional abilities. Higher numbers denote greater impairment, where 0 is completely independent and 18 is completely dependent on others for care.|units on a scale|Mean|9.33|9.33|Standard Deviation|2.67|2.67|||
3944999|NCT01363258|3766567|B3|||Global Deterioration Scale|The Global Deterioration Scales is an ordinal measure that captures the severity of the dementia based on cognitive and functional abilities. Ranges from 1 (normal) to 7 (severe dementia).|units on a scale|Mean|5.71|5.71|Standard Deviation|0.89|0.89|||
3945000|NCT01363258|3766568|B2|||Global Deterioration Scale|The Global Deterioration Scales is an ordinal measure that captures the severity of the dementia based on cognitive and functional abilities. Ranges from 1 (normal) to 7 (severe dementia).|units on a scale|Mean|5.73|5.73|Standard Deviation|0.71|0.71|||
3945001|NCT01363258|3766569|B1|||Global Deterioration Scale|The Global Deterioration Scales is an ordinal measure that captures the severity of the dementia based on cognitive and functional abilities. Ranges from 1 (normal) to 7 (severe dementia).|units on a scale|Mean|5.69|5.69|Standard Deviation|1.03|1.03|||
3945002|NCT01363258|3766567|B3|||Months in nursing home||months|Mean|22.66|22.66|Standard Deviation|23.63|23.63|||
3945003|NCT01363258|3766568|B2|||Months in nursing home||months|Mean|28.74|28.74|Standard Deviation|29.16|29.16|||
3945004|NCT01363258|3766569|B1|||Months in nursing home||months|Mean|17.39|17.39|Standard Deviation|15.99|15.99|||
3945005|NCT01363258|3766567|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
3945006|NCT01363258|3766568|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
3945007|NCT01363258|3766569|B1|United States||Region of Enrollment||participants|Number|54|54.0||||||
3945008|NCT01363258|3766567|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945009|NCT01363258|3766568|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945010|NCT01363258|3766569|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945011|NCT01363258|3766567|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945012|NCT01363258|3766568|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945013|NCT01363258|3766569|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945014|NCT01363258|3766567|B3||White|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3945015|NCT01363258|3766568|B2||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3945016|NCT01363258|3766569|B1||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3945017|NCT01363258|3766567|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3945018|NCT01363258|3766568|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3945019|NCT01363258|3766569|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3945020|NCT01363258|3766567|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945021|NCT01363258|3766568|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945022|NCT01363258|3766569|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945023|NCT01363258|3766567|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945024|NCT01363258|3766568|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945025|NCT01363258|3766569|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945026|NCT01363258|3766567|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945027|NCT01363258|3766568|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945028|NCT01363258|3766569|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945029|NCT01363258|3766567|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945030|NCT01363258|3766568|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945031|NCT01363258|3766569|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945032|NCT01363258|3766567|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3945033|NCT01363258|3766568|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3945034|NCT01363258|3766569|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3945035|NCT01363258|3766567|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945036|NCT01363258|3766568|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945037|NCT01363258|3766569|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945038|NCT01363258|3766567|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3945039|NCT01363258|3766568|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3945040|NCT01363258|3766569|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3945041|NCT01363258|3766567|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3945042|NCT01363258|3766568|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3945045|NCT01363258|3766568|B2|||Age||years|Mean|82.80|82.8|Standard Deviation|8.92|8.92|||
3945046|NCT01363258|3766569|B1|||Age||years|Mean|80.48|80.48|Standard Deviation|11.54|11.54|||
3945047|NCT01363076|3766578|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3945048|NCT01363076|3766579|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3945049|NCT01363076|3766580|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3945050|NCT01363076|3766578|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3945051|NCT01363076|3766579|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3945052|NCT01363076|3766580|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3945053|NCT01363076|3766578|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3945054|NCT01363076|3766579|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3945055|NCT01363076|3766580|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3945056|NCT01363076|3766578|B3|||Age||years|Mean|15.0|15.0|Standard Deviation|1.5|1.5|||
3945057|NCT01363076|3766579|B2|||Age||years|Mean|15.4|15.4|Standard Deviation|1.6|1.6|||
3945058|NCT01363076|3766580|B1|||Age||years|Mean|14.1|14.1|Standard Deviation|0.7|0.7|||
3945059|NCT01363076|3766578|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3945060|NCT01363076|3766579|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3945061|NCT01363076|3766580|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3945062|NCT01363076|3766578|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3945063|NCT01363076|3766579|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3945064|NCT01363076|3766580|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3945065|NCT01363076|3766578|B3||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
3945066|NCT01363076|3766579|B2||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
3945067|NCT01363076|3766580|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
3945068|NCT01363050|3766599|B1|United Kingdom||Region of Enrollment||participants|Number|15|15.0||||||
3945069|NCT01363050|3766599|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3945070|NCT01363050|3766599|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3945071|NCT01363050|3766599|B1|||Age||years|Mean|31.7|31.7|Standard Deviation|10.4|10.4|||
3945072|NCT01363050|3766599|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3945073|NCT01363050|3766599|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3945074|NCT01363050|3766599|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3945075|NCT01363011|3766611|B3|> 500 cells/µL||CD4 Cell Count||participants|Number|55|55.0||||||
3945076|NCT01363011|3766612|B2|> 500 cells/µL||CD4 Cell Count||participants|Number|49|49.0||||||
3945077|NCT01363011|3766613|B1|> 500 cells/µL||CD4 Cell Count||participants|Number|6|6.0||||||
3945078|NCT01363011|3766611|B3|351 to ≤ 500 cells/µL||CD4 Cell Count||participants|Number|26|26.0||||||
3945079|NCT01363011|3766612|B2|351 to ≤ 500 cells/µL||CD4 Cell Count||participants|Number|16|16.0||||||
3945080|NCT01363011|3766613|B1|351 to ≤ 500 cells/µL||CD4 Cell Count||participants|Number|10|10.0||||||
3945081|NCT01363011|3766611|B3|201 to ≤ 350 cells/µL||CD4 Cell Count||participants|Number|18|18.0||||||
3945082|NCT01363011|3766612|B2|201 to ≤ 350 cells/µL||CD4 Cell Count||participants|Number|5|5.0||||||
3945083|NCT01363011|3766613|B1|201 to ≤ 350 cells/µL||CD4 Cell Count||participants|Number|13|13.0||||||
3945084|NCT01363011|3766611|B3|51 to ≤ 200 cells/µL||CD4 Cell Count||participants|Number|6|6.0||||||
3945085|NCT01363011|3766612|B2|51 to ≤ 200 cells/µL||CD4 Cell Count||participants|Number|3|3.0||||||
3945086|NCT01363011|3766613|B1|51 to ≤ 200 cells/µL||CD4 Cell Count||participants|Number|3|3.0||||||
3945087|NCT01363011|3766611|B3|≤ 50 cells/µL||CD4 Cell Count||participants|Number|1|1.0||||||
3945088|NCT01363011|3766612|B2|≤ 50 cells/µL||CD4 Cell Count||participants|Number|0|0.0||||||
3945089|NCT01363011|3766613|B1|≤ 50 cells/µL||CD4 Cell Count||participants|Number|1|1.0||||||
3945090|NCT01363011|3766611|B3|> 100,000 copies/mL||HIV-1 RNA Category||participants|Number|9|9.0||||||
3945091|NCT01363011|3766612|B2|> 100,000 copies/mL||HIV-1 RNA Category||participants|Number|0|0.0||||||
3945092|NCT01363011|3766613|B1|> 100,000 copies/mL||HIV-1 RNA Category||participants|Number|9|9.0||||||
3945093|NCT01363011|3766611|B3|≥ 1,000 to ≤ 100,000 copies/mL||HIV-1 RNA Category||participants|Number|24|24.0||||||
3945094|NCT01363011|3766612|B2|≥ 1,000 to ≤ 100,000 copies/mL||HIV-1 RNA Category||participants|Number|0|0.0||||||
3945095|NCT01363011|3766613|B1|≥ 1,000 to ≤ 100,000 copies/mL||HIV-1 RNA Category||participants|Number|24|24.0||||||
3945096|NCT01363011|3766611|B3|≥ 50 to < 1,000 copies/mL||HIV-1 RNA Category||participants|Number|0|0.0||||||
3945097|NCT01363011|3766612|B2|≥ 50 to < 1,000 copies/mL||HIV-1 RNA Category||participants|Number|0|0.0||||||
3945098|NCT01363011|3766613|B1|≥ 50 to < 1,000 copies/mL||HIV-1 RNA Category||participants|Number|0|0.0||||||
3945099|NCT01363011|3766611|B3|< 50 copies/mL||HIV-1 RNA Category||participants|Number|73|73.0||||||
3945100|NCT01363011|3766612|B2|< 50 copies/mL||HIV-1 RNA Category||participants|Number|73|73.0||||||
3945101|NCT01363011|3766613|B1|< 50 copies/mL||HIV-1 RNA Category||participants|Number|0|0.0||||||
3945102|NCT01363011|3766611|B3|Indeterminate||Hepatitis C Virus (HCV) Antibody Status||participants|Number|1|1.0||||||
3945103|NCT01363011|3766612|B2|Indeterminate||Hepatitis C Virus (HCV) Antibody Status||participants|Number|0|0.0||||||
3945104|NCT01363011|3766613|B1|Indeterminate||Hepatitis C Virus (HCV) Antibody Status||participants|Number|1|1.0||||||
3945105|NCT01363011|3766611|B3|Negative||Hepatitis C Virus (HCV) Antibody Status||participants|Number|93|93.0||||||
3945106|NCT01363011|3766612|B2|Negative||Hepatitis C Virus (HCV) Antibody Status||participants|Number|63|63.0||||||
3945107|NCT01363011|3766613|B1|Negative||Hepatitis C Virus (HCV) Antibody Status||participants|Number|30|30.0||||||
3945108|NCT01363011|3766611|B3|Positive||Hepatitis C Virus (HCV) Antibody Status||participants|Number|12|12.0||||||
3945109|NCT01363011|3766612|B2|Positive||Hepatitis C Virus (HCV) Antibody Status||participants|Number|10|10.0||||||
3945110|NCT01363011|3766613|B1|Positive||Hepatitis C Virus (HCV) Antibody Status||participants|Number|2|2.0||||||
3945111|NCT01363011|3766611|B3|Negative||Hepatitis B Virus (HBV) Surface Antigen Status||participants|Number|101|101.0||||||
3945112|NCT01363011|3766612|B2|Negative||Hepatitis B Virus (HBV) Surface Antigen Status||participants|Number|69|69.0||||||
3945113|NCT01363011|3766613|B1|Negative||Hepatitis B Virus (HBV) Surface Antigen Status||participants|Number|32|32.0||||||
3945114|NCT01363011|3766611|B3|Positive||Hepatitis B Virus (HBV) Surface Antigen Status||participants|Number|5|5.0||||||
3945115|NCT01363011|3766612|B2|Positive||Hepatitis B Virus (HBV) Surface Antigen Status||participants|Number|4|4.0||||||
3945116|NCT01363011|3766613|B1|Positive||Hepatitis B Virus (HBV) Surface Antigen Status||participants|Number|1|1.0||||||
3945117|NCT01363011|3766611|B3|AIDS||HIV Disease Status||participants|Number|20|20.0||||||
3945118|NCT01363011|3766612|B2|AIDS||HIV Disease Status||participants|Number|18|18.0||||||
3945119|NCT01363011|3766613|B1|AIDS||HIV Disease Status||participants|Number|2|2.0||||||
3945120|NCT01363011|3766611|B3|Symptomatic HIV Infection||HIV Disease Status||participants|Number|21|21.0||||||
3945121|NCT01363011|3766612|B2|Symptomatic HIV Infection||HIV Disease Status||participants|Number|18|18.0||||||
3945122|NCT01363011|3766613|B1|Symptomatic HIV Infection||HIV Disease Status||participants|Number|3|3.0||||||
3945123|NCT01363011|3766611|B3|Asymptomatic||HIV Disease Status||participants|Number|65|65.0||||||
3945124|NCT01363011|3766612|B2|Asymptomatic||HIV Disease Status||participants|Number|37|37.0||||||
3945125|NCT01363011|3766613|B1|Asymptomatic||HIV Disease Status||participants|Number|28|28.0||||||
3945126|NCT01363011|3766611|B3|United Kingdom||Region of Enrollment||participants|Number|22|22.0||||||
3945127|NCT01363011|3766612|B2|United Kingdom||Region of Enrollment||participants|Number|18|18.0||||||
3945128|NCT01363011|3766613|B1|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3945129|NCT01363011|3766611|B3|Germany||Region of Enrollment||participants|Number|3|3.0||||||
3945130|NCT01363011|3766612|B2|Germany||Region of Enrollment||participants|Number|3|3.0||||||
3945131|NCT01363011|3766613|B1|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3945132|NCT01363011|3766611|B3|Australia||Region of Enrollment||participants|Number|6|6.0||||||
3945133|NCT01363011|3766612|B2|Australia||Region of Enrollment||participants|Number|5|5.0||||||
3945134|NCT01363011|3766613|B1|Australia||Region of Enrollment||participants|Number|1|1.0||||||
3945135|NCT01363011|3766611|B3|Austria||Region of Enrollment||participants|Number|2|2.0||||||
3945136|NCT01363011|3766612|B2|Austria||Region of Enrollment||participants|Number|2|2.0||||||
3945137|NCT01363011|3766613|B1|Austria||Region of Enrollment||participants|Number|0|0.0||||||
3945138|NCT01363011|3766611|B3|Dominican Republic||Region of Enrollment||participants|Number|6|6.0||||||
3945139|NCT01363011|3766612|B2|Dominican Republic||Region of Enrollment||participants|Number|1|1.0||||||
3945140|NCT01363011|3766613|B1|Dominican Republic||Region of Enrollment||participants|Number|5|5.0||||||
3945141|NCT01363011|3766611|B3|Canada||Region of Enrollment||participants|Number|6|6.0||||||
3945142|NCT01363011|3766612|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
3945143|NCT01363011|3766613|B1|Canada||Region of Enrollment||participants|Number|4|4.0||||||
3945144|NCT01363011|3766611|B3|Mexico||Region of Enrollment||participants|Number|9|9.0||||||
3945145|NCT01363011|3766612|B2|Mexico||Region of Enrollment||participants|Number|9|9.0||||||
3945146|NCT01363011|3766613|B1|Mexico||Region of Enrollment||participants|Number|0|0.0||||||
3945147|NCT01363011|3766611|B3|United States||Region of Enrollment||participants|Number|52|52.0||||||
3945148|NCT01363011|3766612|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
3945149|NCT01363011|3766613|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3945150|NCT01363011|3766611|B3|Non-Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|78|78.0||||||
3945151|NCT01363011|3766612|B2|Non-Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
3945152|NCT01363011|3766613|B1|Non-Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3945153|NCT01363011|3766611|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3945154|NCT01363011|3766612|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3945155|NCT01363011|3766613|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3945156|NCT01363011|3766611|B3|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3945157|NCT01363011|3766612|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3945158|NCT01363011|3766613|B1|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3945159|NCT01363011|3766611|B3|White||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
3945160|NCT01363011|3766612|B2|White||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
3945161|NCT01363011|3766613|B1|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3945162|NCT01363011|3766611|B3|Black or African Heritage||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
3945163|NCT01363011|3766612|B2|Black or African Heritage||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3945164|NCT01363011|3766613|B1|Black or African Heritage||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3945165|NCT01363011|3766611|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3945166|NCT01363011|3766612|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3945167|NCT01363011|3766613|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3945229|NCT01362608|3766754|B3||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3945168|NCT01363011|3766611|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3945169|NCT01363011|3766612|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3945170|NCT01363011|3766613|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3945171|NCT01363011|3766611|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3945172|NCT01363011|3766612|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3945173|NCT01363011|3766613|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3945174|NCT01363011|3766611|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3945175|NCT01363011|3766612|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3945176|NCT01363011|3766613|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3945177|NCT01363011|3766611|B3|||Age||years|Mean|53|53.0|Standard Deviation|10.5|10.5|||
3945178|NCT01363011|3766612|B2|||Age||years|Mean|54|54.0|Standard Deviation|9.5|9.5|||
3945179|NCT01363011|3766613|B1|||Age||years|Mean|50|50.0|Standard Deviation|12.1|12.1|||
3945180|NCT01362959|3766654|B3|Netherlands||Region of Enrollment||participants|Number|47|47.0||||||
3945181|NCT01362959|3766655|B2|Netherlands||Region of Enrollment||participants|Number|26|26.0||||||
3945182|NCT01362959|3766656|B1|Netherlands||Region of Enrollment||participants|Number|21|21.0||||||
3945183|NCT01362959|3766654|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3945184|NCT01362959|3766655|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3945185|NCT01362959|3766656|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3945186|NCT01362959|3766654|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3945187|NCT01362959|3766655|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3945188|NCT01362959|3766656|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3945189|NCT01362959|3766654|B3|||Age|Years|years|Mean|62.9|62.9|Standard Deviation|10.0|10.0|||
3945190|NCT01362959|3766655|B2|||Age|Years|years|Mean|65.2|65.2|Standard Deviation|9.13|9.13|||
3945191|NCT01362959|3766656|B1|||Age|Years|years|Mean|60.1|60.1|Standard Deviation|10.55|10.55|||
3945192|NCT01362946|3766671|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
3945193|NCT01362946|3766671|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945194|NCT01362946|3766671|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3945195|NCT01362946|3766671|B1||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3945196|NCT01362946|3766671|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3945197|NCT01362946|3766671|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945198|NCT01362946|3766671|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3945199|NCT01362946|3766671|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3945200|NCT01362946|3766671|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945201|NCT01362946|3766671|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3945202|NCT01362946|3766671|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3945203|NCT01362946|3766671|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3945204|NCT01362946|3766671|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3945205|NCT01362946|3766671|B1|||Age||years|Mean|9.29|9.29|Standard Deviation|1.37|1.37|||
3945206|NCT01362946|3766671|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3945207|NCT01362946|3766671|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3945208|NCT01362946|3766671|B1||<=18 years|Age||Participants|Count of Participants|48|48.0||||||
3945209|NCT01362907|3766705|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3945210|NCT01362907|3766705|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3945211|NCT01362907|3766705|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3945212|NCT01362907|3766705|B1|||Age||years|Mean|32.7|32.7|Standard Deviation|9.5|9.5|||
3945213|NCT01362894|3766720|B1|Germany||Region of Enrollment||participants|Number|238|238.0||||||
3945214|NCT01362894|3766720|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3945215|NCT01362894|3766720|B1||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
3945216|NCT01362894|3766720|B1|||Age||years|Mean|31.4|31.4|Standard Deviation|9.7|9.7|||
3945217|NCT01362686|3766735|B4||Male|Gender||Participants|Count of Participants|145|145.0||||||
3945218|NCT01362686|3766736|B3||Male|Gender||Participants|Count of Participants|51|51.0||||||
3945219|NCT01362686|3766737|B2||Male|Gender||Participants|Count of Participants|46|46.0||||||
3945220|NCT01362686|3766738|B1||Male|Gender||Participants|Count of Participants|48|48.0||||||
3945221|NCT01362686|3766735|B4||Female|Gender||Participants|Count of Participants|51|51.0||||||
3945222|NCT01362686|3766736|B3||Female|Gender||Participants|Count of Participants|12|12.0||||||
3945223|NCT01362686|3766737|B2||Female|Gender||Participants|Count of Participants|20|20.0||||||
3945224|NCT01362686|3766738|B1||Female|Gender||Participants|Count of Participants|19|19.0||||||
3945225|NCT01362686|3766735|B4|||Age||years|Mean|80.2|80.2|Standard Deviation|8.4|8.4|||
3945226|NCT01362686|3766736|B3|||Age||years|Mean|81.6|81.6|Standard Deviation|7.8|7.8|||
3945227|NCT01362686|3766737|B2|||Age||years|Mean|80.1|80.1|Standard Deviation|9.6|9.6|||
3945228|NCT01362686|3766738|B1|||Age||years|Mean|79.1|79.1|Standard Deviation|7.6|7.6|||
3945230|NCT01362608|3766755|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3945231|NCT01362608|3766756|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3945232|NCT01362608|3766754|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3945233|NCT01362608|3766755|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3945234|NCT01362608|3766756|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3945235|NCT01362608|3766754|B3|||Age||years|Mean|49.7|49.7|Standard Deviation|11.64|11.64|||
3945236|NCT01362608|3766755|B2|||Age||years|Mean|49.2|49.2|Standard Deviation|11.37|11.37|||
3945237|NCT01362608|3766756|B1|||Age||years|Mean|50.2|50.2|Standard Deviation|11.98|11.98|||
3945238|NCT01362608|3766754|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3945239|NCT01362608|3766755|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3945240|NCT01362608|3766756|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3945241|NCT01362608|3766754|B3||Between 18 and 65 years|Age||Participants|Count of Participants|124|124.0||||||
3945242|NCT01362608|3766755|B2||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
3945243|NCT01362608|3766756|B1||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3945244|NCT01362608|3766754|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3945245|NCT01362608|3766755|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3945246|NCT01362608|3766756|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3945247|NCT01362530|3766793|B3||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3945248|NCT01362530|3766794|B2||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3945249|NCT01362530|3766795|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3945250|NCT01362530|3766793|B3||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3945251|NCT01362530|3766794|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3945252|NCT01362530|3766795|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3945253|NCT01362530|3766793|B3|||Age||Months|Mean|98.5|98.5|Standard Deviation|62.0|62.0|||
3945254|NCT01362530|3766794|B2|||Age||Months|Mean|99.4|99.4|Standard Deviation|60.9|60.9|||
3945255|NCT01362530|3766795|B1|||Age||Months|Mean|97.7|97.7|Standard Deviation|63.2|63.2|||
3945256|NCT01362517|3766809|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3945257|NCT01362517|3766809|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3945258|NCT01362517|3766809|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3945259|NCT01362517|3766809|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3945260|NCT01362517|3766809|B1||<=18 years|Age||Participants|Count of Participants|131|131.0||||||
3945261|NCT01362491|3766817|B4|Severe||Pain Severity Score|Pain severity score was assessed on a 4-point categorical scale. Total possible pain severity was 0 to 3, where 0 = none, 1 = mild, 2 = moderately severe and 3 = severe.|participants|Number|47|47.0||||||
3945262|NCT01362491|3766818|B3|Severe||Pain Severity Score|Pain severity score was assessed on a 4-point categorical scale. Total possible pain severity was 0 to 3, where 0 = none, 1 = mild, 2 = moderately severe and 3 = severe.|participants|Number|10|10.0||||||
3945263|NCT01362491|3766819|B2|Severe||Pain Severity Score|Pain severity score was assessed on a 4-point categorical scale. Total possible pain severity was 0 to 3, where 0 = none, 1 = mild, 2 = moderately severe and 3 = severe.|participants|Number|19|19.0||||||
3945264|NCT01362491|3766820|B1|Severe||Pain Severity Score|Pain severity score was assessed on a 4-point categorical scale. Total possible pain severity was 0 to 3, where 0 = none, 1 = mild, 2 = moderately severe and 3 = severe.|participants|Number|18|18.0||||||
3945265|NCT01362491|3766817|B4|Moderately Severe||Pain Severity Score|Pain severity score was assessed on a 4-point categorical scale. Total possible pain severity was 0 to 3, where 0 = none, 1 = mild, 2 = moderately severe and 3 = severe.|participants|Number|179|179.0||||||
3945266|NCT01362491|3766818|B3|Moderately Severe||Pain Severity Score|Pain severity score was assessed on a 4-point categorical scale. Total possible pain severity was 0 to 3, where 0 = none, 1 = mild, 2 = moderately severe and 3 = severe.|participants|Number|36|36.0||||||
3945267|NCT01362491|3766819|B2|Moderately Severe||Pain Severity Score|Pain severity score was assessed on a 4-point categorical scale. Total possible pain severity was 0 to 3, where 0 = none, 1 = mild, 2 = moderately severe and 3 = severe.|participants|Number|70|70.0||||||
3945268|NCT01362491|3766820|B1|Moderately Severe||Pain Severity Score|Pain severity score was assessed on a 4-point categorical scale. Total possible pain severity was 0 to 3, where 0 = none, 1 = mild, 2 = moderately severe and 3 = severe.|participants|Number|73|73.0||||||
3945269|NCT01362491|3766817|B4||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3945270|NCT01362491|3766818|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3945271|NCT01362491|3766819|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3945272|NCT01362491|3766820|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3945273|NCT01362491|3766817|B4||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3945274|NCT01362491|3766818|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3945275|NCT01362491|3766819|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3945276|NCT01362491|3766820|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3945277|NCT01362491|3766817|B4|||Age||years|Mean|42.8|42.8|Standard Deviation|14.2|14.2|||
3945278|NCT01362491|3766818|B3|||Age||years|Mean|39.9|39.9|Standard Deviation|15.2|15.2|||
3945279|NCT01362491|3766819|B2|||Age||years|Mean|44.8|44.8|Standard Deviation|13.5|13.5|||
3945280|NCT01362491|3766820|B1|||Age||years|Mean|42.3|42.3|Standard Deviation|14.3|14.3|||
3945335|NCT01362244|3766988|B1|Japanese/East Asian Heritage/ South East Asian Htg||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3945281|NCT01362439|3766870|B1||Male|Sex: Female, Male|Out of a total of 133 participants, Baseline characteristic (Gender) was available for only 132 participants who were included in ITT population.|Participants|Count of Participants|91|91.0||||||
3945282|NCT01362439|3766870|B1||Female|Sex: Female, Male|Out of a total of 133 participants, Baseline characteristic (Gender) was available for only 132 participants who were included in ITT population.|Participants|Count of Participants|41|41.0||||||
3945283|NCT01362439|3766870|B1|||Age|Out of a total of 133 participants, Baseline characteristic (Age) was available for only 132 participants who were included in intent to treat (ITT) population.|years|Mean|35.3|35.3|Standard Deviation|6.76|6.76|||
3945284|NCT01362348|3766885|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945285|NCT01362348|3766885|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945286|NCT01362348|3766885|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3945287|NCT01362348|3766885|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945288|NCT01362348|3766885|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945289|NCT01362348|3766885|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945290|NCT01362348|3766885|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945291|NCT01362348|3766885|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3945292|NCT01362348|3766885|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3945293|NCT01362348|3766885|B1|||Age||Years|Mean|76.3|76.3|Standard Deviation|6.65|6.65|||
3945294|NCT01362322|3766902|B3||Male|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
3945295|NCT01362322|3766903|B2||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3945296|NCT01362322|3766904|B1||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3945297|NCT01362322|3766902|B3||Female|Sex: Female, Male||Participants|Count of Participants|357|357.0||||||
3945298|NCT01362322|3766903|B2||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
3945299|NCT01362322|3766904|B1||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
3945300|NCT01362322|3766902|B3|||Age||Years|Mean|11.9|11.9|Standard Deviation|1.6|1.6|||
3945301|NCT01362322|3766903|B2|||Age||Years|Mean|11.9|11.9|Standard Deviation|1.61|1.61|||
3945302|NCT01362322|3766904|B1|||Age||Years|Mean|11.9|11.9|Standard Deviation|1.59|1.59|||
3945303|NCT01362296|3766935|B3|Missing||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3945304|NCT01362296|3766936|B2|Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3945305|NCT01362296|3766937|B1|Missing||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3945306|NCT01362296|3766935|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3945307|NCT01362296|3766936|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3945308|NCT01362296|3766937|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3945309|NCT01362296|3766935|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3945310|NCT01362296|3766936|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3945311|NCT01362296|3766937|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3945312|NCT01362296|3766935|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3945313|NCT01362296|3766936|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3945314|NCT01362296|3766937|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3945315|NCT01362296|3766935|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
3945316|NCT01362296|3766936|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3945317|NCT01362296|3766937|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3945318|NCT01362296|3766935|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|105|105.0||||||
3945319|NCT01362296|3766936|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
3945320|NCT01362296|3766937|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|73|73.0||||||
3945321|NCT01362296|3766935|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3945322|NCT01362296|3766936|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3945323|NCT01362296|3766937|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3945324|NCT01362296|3766935|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3945325|NCT01362296|3766936|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3945326|NCT01362296|3766937|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3945327|NCT01362296|3766935|B3|||Age||Years|Mean|61.2|61.2|Standard Deviation|9.32|9.32|||
3945328|NCT01362296|3766936|B2|||Age||Years|Mean|60.9|60.9|Standard Deviation|10.06|10.06|||
3945329|NCT01362296|3766937|B1|||Age||Years|Mean|61.4|61.4|Standard Deviation|8.97|8.97|||
3945330|NCT01362244|3766986|B3|White||Race/Ethnicity, Customized||Participants|Number|102|102.0||||||
3945331|NCT01362244|3766987|B2|White||Race/Ethnicity, Customized||Participants|Number|50|50.0||||||
3945332|NCT01362244|3766988|B1|White||Race/Ethnicity, Customized||Participants|Number|52|52.0||||||
3945333|NCT01362244|3766986|B3|Japanese/East Asian Heritage/ South East Asian Htg||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3945334|NCT01362244|3766987|B2|Japanese/East Asian Heritage/ South East Asian Htg||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3945336|NCT01362244|3766986|B3|Central/South Asian Heritage (Htg)||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3945337|NCT01362244|3766987|B2|Central/South Asian Heritage (Htg)||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3945338|NCT01362244|3766988|B1|Central/South Asian Heritage (Htg)||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3945339|NCT01362244|3766986|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3945340|NCT01362244|3766987|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3945341|NCT01362244|3766988|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3945342|NCT01362244|3766986|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3945343|NCT01362244|3766987|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3945344|NCT01362244|3766988|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3945345|NCT01362244|3766986|B3|||Age||Years|Mean|50.2|50.2|Standard Deviation|10.52|10.52|||
3945346|NCT01362244|3766987|B2|||Age||Years|Mean|49.7|49.7|Standard Deviation|10.38|10.38|||
3945347|NCT01362244|3766988|B1|||Age||Years|Mean|50.6|50.6|Standard Deviation|10.73|10.73|||
3945348|NCT01362205|3767060|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
3945349|NCT01362205|3767061|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
3945350|NCT01362205|3767062|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3945351|NCT01362205|3767060|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945352|NCT01362205|3767061|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945353|NCT01362205|3767062|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945354|NCT01362205|3767060|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945355|NCT01362205|3767061|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945356|NCT01362205|3767062|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945357|NCT01362205|3767060|B3||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3945358|NCT01362205|3767061|B2||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3945359|NCT01362205|3767062|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3945360|NCT01362205|3767060|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3945361|NCT01362205|3767061|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3945362|NCT01362205|3767062|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3945363|NCT01362205|3767060|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945364|NCT01362205|3767061|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945365|NCT01362205|3767062|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945366|NCT01362205|3767060|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945367|NCT01362205|3767061|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945368|NCT01362205|3767062|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945369|NCT01362205|3767060|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3945370|NCT01362205|3767061|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3945371|NCT01362205|3767062|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945372|NCT01362205|3767060|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945373|NCT01362205|3767061|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945374|NCT01362205|3767062|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945375|NCT01362205|3767060|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3945376|NCT01362205|3767061|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3945377|NCT01362205|3767062|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3945378|NCT01362205|3767060|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3945379|NCT01362205|3767061|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3945380|NCT01362205|3767062|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3945381|NCT01362205|3767060|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3945382|NCT01362205|3767061|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3945383|NCT01362205|3767062|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3945384|NCT01362205|3767060|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3945385|NCT01362205|3767061|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3945386|NCT01362205|3767062|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3945387|NCT01362205|3767060|B3|||Age||years|Mean|47.4|47.4|Standard Deviation|11.61|11.61|||
3945388|NCT01362205|3767061|B2|||Age||years|Mean|48.2|48.2|Standard Deviation|11.82|11.82|||
3945389|NCT01362205|3767062|B1|||Age||years|Mean|46.5|46.5|Standard Deviation|11.54|11.54|||
3945390|NCT01362192|3767089|B1|III||Fitzpatrick Skin Type|The Fitzpatrick Skin Type is a skin classification system based on color, genetics and reaction to sun exposure. Types range from the I to VI, where type I represents very fair-skinned individuals and type VI represents very dark-skinned individuals.|participants|Number|4|4.0||||||
3945465|NCT01362062|3767126|B1|||Age||years|Mean|51.19|51.19|Standard Deviation|10.44|10.44|||
3945391|NCT01362192|3767089|B1|II||Fitzpatrick Skin Type|The Fitzpatrick Skin Type is a skin classification system based on color, genetics and reaction to sun exposure. Types range from the I to VI, where type I represents very fair-skinned individuals and type VI represents very dark-skinned individuals.|participants|Number|15|15.0||||||
3945392|NCT01362192|3767089|B1|I||Fitzpatrick Skin Type|The Fitzpatrick Skin Type is a skin classification system based on color, genetics and reaction to sun exposure. Types range from the I to VI, where type I represents very fair-skinned individuals and type VI represents very dark-skinned individuals.|participants|Number|1|1.0||||||
3945393|NCT01362192|3767089|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3945394|NCT01362192|3767089|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3945395|NCT01362192|3767089|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3945396|NCT01362192|3767089|B1|||Age||years|Mean|48|48.0|Full Range|||32.0|66.0|
3945397|NCT01362192|3767089|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3945398|NCT01362192|3767089|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3945399|NCT01362192|3767089|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3945400|NCT01362140|3767099|B3|||Hemoglobin|Data available for 35 and 75 participants in each treatment group respectively|g/dL|Mean|9.19|9.19|Standard Deviation|0.76|0.76|||
3945401|NCT01362140|3767100|B2|||Hemoglobin|Data available for 35 and 75 participants in each treatment group respectively|g/dL|Mean|9.23|9.23|Standard Deviation|0.70|0.7|||
3945402|NCT01362140|3767101|B1|||Hemoglobin|Data available for 35 and 75 participants in each treatment group respectively|g/dL|Mean|9.10|9.1|Standard Deviation|0.87|0.87|||
3945403|NCT01362140|3767099|B3|||Time since MDS Diagnosis|Data available for 43 and 88 participants in each treatment group respectively|months|Mean|12.2|12.2|Standard Deviation|16.9|16.9|||
3945404|NCT01362140|3767100|B2|||Time since MDS Diagnosis|Data available for 43 and 88 participants in each treatment group respectively|months|Mean|12.4|12.4|Standard Deviation|16.7|16.7|||
3945405|NCT01362140|3767101|B1|||Time since MDS Diagnosis|Data available for 43 and 88 participants in each treatment group respectively|months|Mean|11.7|11.7|Standard Deviation|17.6|17.6|||
3945406|NCT01362140|3767099|B3|Unknown||World Health Organization (WHO) Classification of MDS|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|1|1.0||||||
3945407|NCT01362140|3767100|B2|Unknown||World Health Organization (WHO) Classification of MDS|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|1|1.0||||||
3945408|NCT01362140|3767101|B1|Unknown||World Health Organization (WHO) Classification of MDS|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|0|0.0||||||
3945409|NCT01362140|3767099|B3|Refractory anemia with excess blasts-2 (RAEB-2)||World Health Organization (WHO) Classification of MDS|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|0|0.0||||||
3945410|NCT01362140|3767100|B2|Refractory anemia with excess blasts-2 (RAEB-2)||World Health Organization (WHO) Classification of MDS|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|0|0.0||||||
3945411|NCT01362140|3767101|B1|Refractory anemia with excess blasts-2 (RAEB-2)||World Health Organization (WHO) Classification of MDS|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|0|0.0||||||
3945412|NCT01362140|3767099|B3|Refractory anemia with excess blasts-1 (RAEB-1)||World Health Organization (WHO) Classification of MDS|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|23|23.0||||||
3945413|NCT01362140|3767100|B2|Refractory anemia with excess blasts-1 (RAEB-1)||World Health Organization (WHO) Classification of MDS|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|13|13.0||||||
3945414|NCT01362140|3767101|B1|Refractory anemia with excess blasts-1 (RAEB-1)||World Health Organization (WHO) Classification of MDS|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|10|10.0||||||
3945415|NCT01362140|3767099|B3|MDS associated with isolated del(5q)||World Health Organization (WHO) Classification of MDS|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|13|13.0||||||
3945466|NCT01362049|3767144|B5|United States||Region of Enrollment||participants|Number|102|102.0||||||
3945467|NCT01362049|3767145|B4|United States||Region of Enrollment||participants|Number|25|25.0||||||
3945416|NCT01362140|3767100|B2|MDS associated with isolated del(5q)||World Health Organization (WHO) Classification of MDS|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|11|11.0||||||
3945417|NCT01362140|3767101|B1|MDS associated with isolated del(5q)||World Health Organization (WHO) Classification of MDS|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|2|2.0||||||
3945418|NCT01362140|3767099|B3|MDS, unclassified (MDS-U)||World Health Organization (WHO) Classification of MDS|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|2|2.0||||||
3945419|NCT01362140|3767100|B2|MDS, unclassified (MDS-U)||World Health Organization (WHO) Classification of MDS|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|1|1.0||||||
3945420|NCT01362140|3767101|B1|MDS, unclassified (MDS-U)||World Health Organization (WHO) Classification of MDS|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|1|1.0||||||
3945421|NCT01362140|3767099|B3|Refractory cytopenia multilineage dysplasia (RCMD)||World Health Organization (WHO) Classification of MDS|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|64|64.0||||||
3945422|NCT01362140|3767100|B2|Refractory cytopenia multilineage dysplasia (RCMD)||World Health Organization (WHO) Classification of MDS|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|45|45.0||||||
3945423|NCT01362140|3767101|B1|Refractory cytopenia multilineage dysplasia (RCMD)||World Health Organization (WHO) Classification of MDS|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|19|19.0||||||
3945424|NCT01362140|3767099|B3|RA with ringed sideroblasts (RARS)||World Health Organization (WHO) Classification of MDS|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|21|21.0||||||
3945425|NCT01362140|3767100|B2|RA with ringed sideroblasts (RARS)||World Health Organization (WHO) Classification of MDS|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|17|17.0||||||
3945426|NCT01362140|3767101|B1|RA with ringed sideroblasts (RARS)||World Health Organization (WHO) Classification of MDS|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|4|4.0||||||
3945427|NCT01362140|3767099|B3|Refractory anemia (RA)||World Health Organization (WHO) Classification of MDS|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|22|22.0||||||
3945428|NCT01362140|3767100|B2|Refractory anemia (RA)||World Health Organization (WHO) Classification of MDS|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|9|9.0||||||
3945429|NCT01362140|3767101|B1|Refractory anemia (RA)||World Health Organization (WHO) Classification of MDS|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|13|13.0||||||
3945430|NCT01362140|3767099|B3|Intermediate-1||IPSS Risk Category|The Myelodysplastic Syndrome (MDS) IPSS score assesses the severity of MDS based on 3 prognostic factors each assigned a score: the percentage of bone marrow blasts, chromosome changes in the marrow cells (karyotype) and the presence of one or more low blood cell counts (cytopenias). The IPSS score is the sum of the bone marrow blast + karyotype + cytopenia score and ranges from 0 (low risk) to 3.5 (high risk). Prognosis is categorized as Low risk (score = 0), Intermediate-1 (score 0.5 to 1.0), Intermediate-2 (score 1.5 to 2.0) or High risk (score ≥ 2.5).|participants|Number|72|72.0||||||
3945468|NCT01362049|3767146|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
3945469|NCT01362049|3767147|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3945470|NCT01362049|3767148|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
3945471|NCT01362049|3767144|B5||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3945431|NCT01362140|3767100|B2|Intermediate-1||IPSS Risk Category|The Myelodysplastic Syndrome (MDS) IPSS score assesses the severity of MDS based on 3 prognostic factors each assigned a score: the percentage of bone marrow blasts, chromosome changes in the marrow cells (karyotype) and the presence of one or more low blood cell counts (cytopenias). The IPSS score is the sum of the bone marrow blast + karyotype + cytopenia score and ranges from 0 (low risk) to 3.5 (high risk). Prognosis is categorized as Low risk (score = 0), Intermediate-1 (score 0.5 to 1.0), Intermediate-2 (score 1.5 to 2.0) or High risk (score ≥ 2.5).|participants|Number|48|48.0||||||
3945432|NCT01362140|3767101|B1|Intermediate-1||IPSS Risk Category|The Myelodysplastic Syndrome (MDS) IPSS score assesses the severity of MDS based on 3 prognostic factors each assigned a score: the percentage of bone marrow blasts, chromosome changes in the marrow cells (karyotype) and the presence of one or more low blood cell counts (cytopenias). The IPSS score is the sum of the bone marrow blast + karyotype + cytopenia score and ranges from 0 (low risk) to 3.5 (high risk). Prognosis is categorized as Low risk (score = 0), Intermediate-1 (score 0.5 to 1.0), Intermediate-2 (score 1.5 to 2.0) or High risk (score ≥ 2.5).|participants|Number|24|24.0||||||
3945433|NCT01362140|3767099|B3|Low||IPSS Risk Category|The Myelodysplastic Syndrome (MDS) IPSS score assesses the severity of MDS based on 3 prognostic factors each assigned a score: the percentage of bone marrow blasts, chromosome changes in the marrow cells (karyotype) and the presence of one or more low blood cell counts (cytopenias). The IPSS score is the sum of the bone marrow blast + karyotype + cytopenia score and ranges from 0 (low risk) to 3.5 (high risk). Prognosis is categorized as Low risk (score = 0), Intermediate-1 (score 0.5 to 1.0), Intermediate-2 (score 1.5 to 2.0) or High risk (score ≥ 2.5).|participants|Number|74|74.0||||||
3945434|NCT01362140|3767100|B2|Low||IPSS Risk Category|The Myelodysplastic Syndrome (MDS) IPSS score assesses the severity of MDS based on 3 prognostic factors each assigned a score: the percentage of bone marrow blasts, chromosome changes in the marrow cells (karyotype) and the presence of one or more low blood cell counts (cytopenias). The IPSS score is the sum of the bone marrow blast + karyotype + cytopenia score and ranges from 0 (low risk) to 3.5 (high risk). Prognosis is categorized as Low risk (score = 0), Intermediate-1 (score 0.5 to 1.0), Intermediate-2 (score 1.5 to 2.0) or High risk (score ≥ 2.5).|participants|Number|49|49.0||||||
3945435|NCT01362140|3767101|B1|Low||IPSS Risk Category|The Myelodysplastic Syndrome (MDS) IPSS score assesses the severity of MDS based on 3 prognostic factors each assigned a score: the percentage of bone marrow blasts, chromosome changes in the marrow cells (karyotype) and the presence of one or more low blood cell counts (cytopenias). The IPSS score is the sum of the bone marrow blast + karyotype + cytopenia score and ranges from 0 (low risk) to 3.5 (high risk). Prognosis is categorized as Low risk (score = 0), Intermediate-1 (score 0.5 to 1.0), Intermediate-2 (score 1.5 to 2.0) or High risk (score ≥ 2.5).|participants|Number|25|25.0||||||
3945436|NCT01362140|3767099|B3|White||Race/Ethnicity, Customized||participants|Number|146|146.0||||||
3945437|NCT01362140|3767100|B2|White||Race/Ethnicity, Customized||participants|Number|97|97.0||||||
3945438|NCT01362140|3767101|B1|White||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
3945439|NCT01362140|3767099|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)|French clinical sites, per regulation, did not complete the ethnicity question.|Participants|Count of Participants|8|8.0||||||
3945440|NCT01362140|3767100|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)|French clinical sites, per regulation, did not complete the ethnicity question.|Participants|Count of Participants|5|5.0||||||
3945441|NCT01362140|3767101|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|French clinical sites, per regulation, did not complete the ethnicity question.|Participants|Count of Participants|3|3.0||||||
3945442|NCT01362140|3767099|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)|French clinical sites, per regulation, did not complete the ethnicity question.|Participants|Count of Participants|135|135.0||||||
3945443|NCT01362140|3767100|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)|French clinical sites, per regulation, did not complete the ethnicity question.|Participants|Count of Participants|90|90.0||||||
3945444|NCT01362140|3767101|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|French clinical sites, per regulation, did not complete the ethnicity question.|Participants|Count of Participants|45|45.0||||||
3945445|NCT01362140|3767099|B3||Hispanic or Latino|Ethnicity (NIH/OMB)|French clinical sites, per regulation, did not complete the ethnicity question.|Participants|Count of Participants|3|3.0||||||
3945446|NCT01362140|3767100|B2||Hispanic or Latino|Ethnicity (NIH/OMB)|French clinical sites, per regulation, did not complete the ethnicity question.|Participants|Count of Participants|2|2.0||||||
3945447|NCT01362140|3767101|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|French clinical sites, per regulation, did not complete the ethnicity question.|Participants|Count of Participants|1|1.0||||||
3945448|NCT01362140|3767099|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3945449|NCT01362140|3767100|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3945450|NCT01362140|3767101|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3945451|NCT01362140|3767099|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3945452|NCT01362140|3767100|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3945453|NCT01362140|3767101|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3945454|NCT01362140|3767099|B3|||Age||years|Mean|72.4|72.4|Standard Deviation|9.4|9.4|||
3945455|NCT01362140|3767100|B2|||Age||years|Mean|72.4|72.4|Standard Deviation|9.4|9.4|||
3945456|NCT01362140|3767101|B1|||Age||years|Mean|72.4|72.4|Standard Deviation|9.3|9.3|||
3945457|NCT01362062|3767124|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3945458|NCT01362062|3767125|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3945459|NCT01362062|3767126|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3945460|NCT01362062|3767124|B3||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3945461|NCT01362062|3767125|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3945462|NCT01362062|3767126|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3945463|NCT01362062|3767124|B3|||Age||years|Mean|50.74|50.74|Standard Deviation|11.64|11.64|||
3945464|NCT01362062|3767125|B2|||Age||years|Mean|50.39|50.39|Standard Deviation|12.56|12.56|||
3945472|NCT01362049|3767145|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3945473|NCT01362049|3767146|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3945474|NCT01362049|3767147|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3945475|NCT01362049|3767148|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3945476|NCT01362049|3767144|B5||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3945477|NCT01362049|3767145|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3945478|NCT01362049|3767146|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3945479|NCT01362049|3767147|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3945480|NCT01362049|3767148|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3945481|NCT01362049|3767144|B5|||Age||years|Mean|41.5|41.5|Standard Deviation|10.8|10.8|||
3945482|NCT01362049|3767145|B4|||Age||years|Mean|45.9|45.9|Standard Deviation|8.8|8.8|||
3945483|NCT01362049|3767146|B3|||Age||years|Mean|44.1|44.1|Standard Deviation|9.4|9.4|||
3945484|NCT01362049|3767147|B2|||Age||years|Mean|37.1|37.1|Standard Deviation|11.4|11.4|||
3945485|NCT01362049|3767148|B1|||Age||years|Mean|37.5|37.5|Standard Deviation|11.4|11.4|||
3945486|NCT01362049|3767144|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3945487|NCT01362049|3767145|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3945488|NCT01362049|3767146|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3945489|NCT01362049|3767147|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3945490|NCT01362049|3767148|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3945491|NCT01362049|3767144|B5||Between 18 and 65 years|Age||Participants|Count of Participants|102|102.0||||||
3945492|NCT01362049|3767145|B4||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3945493|NCT01362049|3767146|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3945494|NCT01362049|3767147|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3945495|NCT01362049|3767148|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3945496|NCT01362049|3767144|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3945497|NCT01362049|3767145|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3945498|NCT01362049|3767146|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3945499|NCT01362049|3767147|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3945500|NCT01362049|3767148|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3945501|NCT01361867|3767189|B1|||Step Height|Please notice that step height was defined as the distance between the foot and the belt of the treadmill during the midswing phase of the gait cycle. This definition of step height allowed us to measure it where the effect of the perturbation led to a maximum deviation from the baseline value|cm|Mean|9.7|9.7|Standard Deviation|0.2|0.2|||
3945502|NCT01361867|3767189|B1|||Step Length|Please notice that step length was defined as the maximum value of the foot position in the anteroposterior direction in a coordinate system positioned at the center of rotation of the robotic joint connecting the pelvis and thigh components of the exoskeleton system. In other words, this measure differs from standard measures of step length during overground walking.|cm|Mean|25.0|25.0|Standard Deviation|0.3|0.3|||
3945503|NCT01361867|3767189|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3945504|NCT01361867|3767189|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945505|NCT01361867|3767189|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945506|NCT01361867|3767189|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3945507|NCT01361867|3767189|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945508|NCT01361867|3767189|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945509|NCT01361867|3767189|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945510|NCT01361867|3767189|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945511|NCT01361867|3767189|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945512|NCT01361867|3767189|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3945513|NCT01361867|3767189|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3945514|NCT01361867|3767189|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3945515|NCT01361867|3767189|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3945516|NCT01361867|3767189|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3945517|NCT01361867|3767189|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3945518|NCT01361867|3767189|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3945519|NCT01361854|3767194|B1|Belgium||Region of Enrollment||participants|Number|102|102.0||||||
3945520|NCT01361854|3767194|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3945521|NCT01361854|3767194|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3945522|NCT01361854|3767194|B1|||Age||years|Mean|48|48.0|Standard Deviation|12|12.0|||
3945523|NCT01361854|3767194|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3945524|NCT01361854|3767194|B1||Between 18 and 65 years|Age||Participants|Count of Participants|102|102.0||||||
3945525|NCT01361854|3767194|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3945526|NCT01361633|3767201|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
3945527|NCT01361633|3767202|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
3945528|NCT01361633|3767203|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3945529|NCT01361633|3767201|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3945530|NCT01361633|3767202|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3945531|NCT01361633|3767203|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3945532|NCT01361633|3767201|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3945533|NCT01361633|3767202|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3945534|NCT01361633|3767203|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3945535|NCT01361633|3767201|B3|||Age||years|Mean|69|69.0|Standard Deviation|7.66|7.66|||
3945536|NCT01361633|3767202|B2|||Age||years|Mean|70|70.0|Standard Deviation|8.44|8.44|||
3945537|NCT01361633|3767203|B1|||Age||years|Mean|68|68.0|Standard Deviation|6.73|6.73|||
3945538|NCT01361633|3767201|B3||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
3945539|NCT01361633|3767202|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3945540|NCT01361633|3767203|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3945541|NCT01361633|3767201|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3945542|NCT01361633|3767202|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3945543|NCT01361633|3767203|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3945544|NCT01361633|3767201|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3945545|NCT01361633|3767202|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3945546|NCT01361633|3767203|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3945547|NCT01361620|3767210|B1|United States||Region of Enrollment||participants|Number|132|132.0||||||
3945548|NCT01361620|3767210|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3945549|NCT01361620|3767210|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3945550|NCT01361620|3767210|B1|||Age||years|Mean|61|61.0|Standard Deviation|10.2|10.2|||
3945551|NCT01361620|3767210|B1||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
3945552|NCT01361620|3767210|B1||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
3945553|NCT01361620|3767210|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3945554|NCT01361607|3767214|B3||Male|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
3945555|NCT01361607|3767215|B2||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3945556|NCT01361607|3767216|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3945557|NCT01361607|3767214|B3||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
3945558|NCT01361607|3767215|B2||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3945559|NCT01361607|3767216|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3945560|NCT01361607|3767214|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|11.0|11.0|||
3945561|NCT01361607|3767215|B2|||Age||years|Mean|59.6|59.6|Standard Deviation|11.0|11.0|||
3945562|NCT01361607|3767216|B1|||Age||years|Mean|60.0|60.0|Standard Deviation|11.0|11.0|||
3945563|NCT01361594|3767243|B3||Male|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
3945564|NCT01361594|3767244|B2||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3945565|NCT01361594|3767245|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3945566|NCT01361594|3767243|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3945567|NCT01361594|3767244|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3945568|NCT01361594|3767245|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3945569|NCT01361594|3767243|B3||>=65 years|Age||Participants|Count of Participants|143|143.0||||||
3945570|NCT01361594|3767244|B2||>=65 years|Age||Participants|Count of Participants|71|71.0||||||
3945571|NCT01361594|3767245|B1||>=65 years|Age||Participants|Count of Participants|72|72.0||||||
3945572|NCT01361594|3767243|B3||Between 18 and 65 years|Age||Participants|Count of Participants|159|159.0||||||
3945573|NCT01361594|3767244|B2||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
3945574|NCT01361594|3767245|B1||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
3945575|NCT01361594|3767243|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3945576|NCT01361594|3767244|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3945577|NCT01361594|3767245|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3945578|NCT01361568|3767254|B7|United States||Region of Enrollment||participants|Number|203|203.0||||||
3945579|NCT01361568|3767255|B6|United States||Region of Enrollment||participants|Number|13|13.0||||||
3945580|NCT01361568|3767256|B5|United States||Region of Enrollment||participants|Number|7|7.0||||||
3945581|NCT01361568|3767257|B4|United States||Region of Enrollment||participants|Number|21|21.0||||||
3945582|NCT01361568|3767258|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3945583|NCT01361568|3767259|B2|United States||Region of Enrollment||participants|Number|71|71.0||||||
3945584|NCT01361568|3767260|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
3945585|NCT01361568|3767254|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3945586|NCT01361568|3767255|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3945587|NCT01361568|3767256|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3945588|NCT01361568|3767257|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3945589|NCT01361568|3767258|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3945590|NCT01361568|3767259|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3945591|NCT01361568|3767260|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3945592|NCT01361568|3767254|B7||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
3945593|NCT01361568|3767255|B6||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3945594|NCT01361568|3767256|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3945595|NCT01361568|3767257|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3945596|NCT01361568|3767258|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3945597|NCT01361568|3767259|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3945598|NCT01361568|3767260|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3945599|NCT01361568|3767254|B7|||Age||years|Mean|43.7|43.7|Standard Deviation|8.97|8.97|||
3945600|NCT01361568|3767255|B6|||Age||years|Mean|45.3|45.3|Standard Deviation|7.93|7.93|||
3945601|NCT01361568|3767256|B5|||Age||years|Mean|55.9|55.9|Standard Deviation|7.84|7.84|||
3945602|NCT01361568|3767257|B4|||Age||years|Mean|40.0|40.0|Standard Deviation|6.88|6.88|||
3945603|NCT01361568|3767258|B3|||Age||years|Mean|43.8|43.8|Standard Deviation|7.14|7.14|||
3945604|NCT01361568|3767259|B2|||Age||years|Mean|44.3|44.3|Standard Deviation|9.69|9.69|||
3945605|NCT01361568|3767260|B1|||Age||years|Mean|42.7|42.7|Standard Deviation|8.60|8.6|||
3945606|NCT01361568|3767254|B7||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3945607|NCT01361568|3767255|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3945608|NCT01361568|3767256|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3945609|NCT01361568|3767257|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3945610|NCT01361568|3767258|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3945611|NCT01361568|3767259|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3945612|NCT01361568|3767260|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3945613|NCT01361568|3767254|B7||Between 18 and 65 years|Age||Participants|Count of Participants|202|202.0||||||
3945614|NCT01361568|3767255|B6||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3945615|NCT01361568|3767256|B5||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3945616|NCT01361568|3767257|B4||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3945617|NCT01361568|3767258|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3945618|NCT01361568|3767259|B2||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
3945619|NCT01361568|3767260|B1||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
3945620|NCT01361568|3767254|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3945621|NCT01361568|3767255|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3945622|NCT01361568|3767256|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3945623|NCT01361568|3767257|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3945624|NCT01361568|3767258|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3945625|NCT01361568|3767259|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3945626|NCT01361568|3767260|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3945627|NCT01361464|3767295|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3945628|NCT01361464|3767295|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3945629|NCT01361464|3767295|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3945630|NCT01361464|3767295|B1|||Age||years|Median|75|75.0|Full Range|||66.0|84.0|
3945631|NCT01361464|3767295|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3945632|NCT01361464|3767295|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3945633|NCT01361464|3767295|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3945634|NCT01361308|3767302|B3|United States||Region of Enrollment||participants|Number|614|614.0||||||
3945635|NCT01361308|3767303|B2|United States||Region of Enrollment||participants|Number|308|308.0||||||
3945636|NCT01361308|3767304|B1|United States||Region of Enrollment||participants|Number|306|306.0||||||
3945637|NCT01361308|3767302|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3945638|NCT01361308|3767303|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3945639|NCT01361308|3767304|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3945640|NCT01361308|3767302|B3||Female|Sex: Female, Male||Participants|Count of Participants|614|614.0||||||
3945641|NCT01361308|3767303|B2||Female|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
3945642|NCT01361308|3767304|B1||Female|Sex: Female, Male||Participants|Count of Participants|306|306.0||||||
3945643|NCT01361308|3767302|B3|||Age||years|Mean|54.7|54.7|Standard Deviation|6.11|6.11|||
3945644|NCT01361308|3767303|B2|||Age||years|Mean|54.5|54.5|Standard Deviation|6.27|6.27|||
3945645|NCT01361308|3767304|B1|||Age||years|Mean|54.9|54.9|Standard Deviation|5.95|5.95|||
3945646|NCT01361308|3767302|B3||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
3945647|NCT01361308|3767303|B2||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3945648|NCT01361308|3767304|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3945649|NCT01361308|3767302|B3||Between 18 and 65 years|Age||Participants|Count of Participants|565|565.0||||||
3945650|NCT01361308|3767303|B2||Between 18 and 65 years|Age||Participants|Count of Participants|284|284.0||||||
3945651|NCT01361308|3767304|B1||Between 18 and 65 years|Age||Participants|Count of Participants|281|281.0||||||
3945652|NCT01361308|3767302|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3945653|NCT01361308|3767303|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3945654|NCT01361308|3767304|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3945655|NCT01361217|3767345|B1|||weight||kg|Mean|72|72.0|Standard Deviation|14|14.0|||
3945656|NCT01361217|3767345|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3945657|NCT01361217|3767345|B1|chicano||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3945658|NCT01361217|3767345|B1|hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3945659|NCT01361217|3767345|B1|caucasian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3945660|NCT01361217|3767345|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3945661|NCT01361217|3767345|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3945662|NCT01361217|3767345|B1|||Age||years|Mean|30|30.0|Standard Deviation|10|10.0|||
3945663|NCT01361217|3767345|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3945664|NCT01361217|3767345|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3945665|NCT01361217|3767345|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3945666|NCT01361178|3767351|B3|Basiliximab||Induction Agent||Participants|Count of Participants|44|44.0||||||
3945667|NCT01361178|3767352|B2|Basiliximab||Induction Agent||Participants|Count of Participants|6|6.0||||||
3945668|NCT01361178|3767353|B1|Basiliximab||Induction Agent||Participants|Count of Participants|38|38.0||||||
3945669|NCT01361178|3767351|B3|Alemtuzamab||Induction Agent||Participants|Count of Participants|89|89.0||||||
3945670|NCT01361178|3767352|B2|Alemtuzamab||Induction Agent||Participants|Count of Participants|5|5.0||||||
3945671|NCT01361178|3767353|B1|Alemtuzamab||Induction Agent||Participants|Count of Participants|84|84.0||||||
3945672|NCT01361178|3767351|B3|Other||Diagnosis||Participants|Count of Participants|15|15.0||||||
3945673|NCT01361178|3767352|B2|Other||Diagnosis||Participants|Count of Participants|1|1.0||||||
3945674|NCT01361178|3767353|B1|Other||Diagnosis||Participants|Count of Participants|14|14.0||||||
3945675|NCT01361178|3767351|B3|Pulmonary Hypertension||Diagnosis||Participants|Count of Participants|3|3.0||||||
3945676|NCT01361178|3767352|B2|Pulmonary Hypertension||Diagnosis||Participants|Count of Participants|0|0.0||||||
3945677|NCT01361178|3767353|B1|Pulmonary Hypertension||Diagnosis||Participants|Count of Participants|3|3.0||||||
3945678|NCT01361178|3767351|B3|Sarcoidosis||Diagnosis||Participants|Count of Participants|4|4.0||||||
3945679|NCT01361178|3767352|B2|Sarcoidosis||Diagnosis||Participants|Count of Participants|1|1.0||||||
3945680|NCT01361178|3767353|B1|Sarcoidosis||Diagnosis||Participants|Count of Participants|3|3.0||||||
3945681|NCT01361178|3767351|B3|Scleroderma||Diagnosis||Participants|Count of Participants|12|12.0||||||
3945682|NCT01361178|3767352|B2|Scleroderma||Diagnosis||Participants|Count of Participants|1|1.0||||||
3945683|NCT01361178|3767353|B1|Scleroderma||Diagnosis||Participants|Count of Participants|11|11.0||||||
3945684|NCT01361178|3767351|B3|Cystic Fibrosis||Diagnosis||Participants|Count of Participants|13|13.0||||||
3945685|NCT01361178|3767352|B2|Cystic Fibrosis||Diagnosis||Participants|Count of Participants|3|3.0||||||
3945686|NCT01361178|3767353|B1|Cystic Fibrosis||Diagnosis||Participants|Count of Participants|10|10.0||||||
3945687|NCT01361178|3767351|B3|COPD||Diagnosis||Participants|Count of Participants|40|40.0||||||
3945688|NCT01361178|3767352|B2|COPD||Diagnosis||Participants|Count of Participants|3|3.0||||||
3945689|NCT01361178|3767353|B1|COPD||Diagnosis||Participants|Count of Participants|37|37.0||||||
3945690|NCT01361178|3767351|B3|IPF||Diagnosis||Participants|Count of Participants|46|46.0||||||
3945691|NCT01361178|3767352|B2|IPF||Diagnosis||Participants|Count of Participants|2|2.0||||||
3945692|NCT01361178|3767353|B1|IPF||Diagnosis||Participants|Count of Participants|44|44.0||||||
3945693|NCT01361178|3767351|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945694|NCT01361178|3767352|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945695|NCT01361178|3767353|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945696|NCT01361178|3767351|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945697|NCT01361178|3767352|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945698|NCT01361178|3767353|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945699|NCT01361178|3767351|B3||White|Race (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
3945700|NCT01361178|3767352|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3945701|NCT01361178|3767353|B1||White|Race (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
3945702|NCT01361178|3767351|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3945703|NCT01361178|3767352|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945704|NCT01361178|3767353|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3945705|NCT01361178|3767351|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945706|NCT01361178|3767352|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945707|NCT01361178|3767353|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945708|NCT01361178|3767351|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3945709|NCT01361178|3767352|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945710|NCT01361178|3767353|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3945711|NCT01361178|3767351|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945712|NCT01361178|3767352|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945713|NCT01361178|3767353|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945714|NCT01361178|3767351|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3945715|NCT01361178|3767352|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3945716|NCT01361178|3767353|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3945717|NCT01361178|3767351|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3945718|NCT01361178|3767352|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3945719|NCT01361178|3767353|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3945720|NCT01361178|3767351|B3|||Age||years|Median|61|61.0|Full Range|||18.0|75.0|
3945721|NCT01361178|3767352|B2|||Age||years|Median|52|52.0|Full Range|||26.0|70.0|
3945722|NCT01361178|3767353|B1|||Age||years|Median|62|62.0|Full Range|||18.0|75.0|
3945723|NCT01361126|3767360|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3945724|NCT01361126|3767361|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3945725|NCT01361126|3767362|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3945726|NCT01361126|3767360|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3945727|NCT01361126|3767361|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3945728|NCT01361126|3767362|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3945729|NCT01361126|3767360|B3|≥ 18 years||Age, Customized||participants|Number|14|14.0||||||
3945730|NCT01361126|3767361|B2|≥ 18 years||Age, Customized||participants|Number|4|4.0||||||
3945731|NCT01361126|3767362|B1|≥ 18 years||Age, Customized||participants|Number|10|10.0||||||
3945732|NCT01361126|3767360|B3|< 18 years||Age, Customized||participants|Number|3|3.0||||||
3945733|NCT01361126|3767361|B2|< 18 years||Age, Customized||participants|Number|0|0.0||||||
3945734|NCT01361126|3767362|B1|< 18 years||Age, Customized||participants|Number|3|3.0||||||
3945735|NCT01361126|3767360|B3|||Age||years|Mean|26.1|26.1|Standard Deviation|10.7|10.7|||
3945736|NCT01361126|3767361|B2|||Age||years|Mean|35.8|35.8|Standard Deviation|9.7|9.7|||
3945737|NCT01361126|3767362|B1|||Age||years|Mean|23.2|23.2|Standard Deviation|9.4|9.4|||
3945738|NCT01361113|3767378|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3945739|NCT01361113|3767378|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3945740|NCT01361113|3767378|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945741|NCT01361113|3767378|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3945742|NCT01361113|3767378|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3945743|NCT01361113|3767378|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945744|NCT01361113|3767378|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945745|NCT01361113|3767378|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945746|NCT01361113|3767378|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945747|NCT01361113|3767378|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3945748|NCT01361113|3767378|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3945749|NCT01361113|3767378|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3945750|NCT01361113|3767378|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3945751|NCT01361113|3767378|B1|||Age||years|Median|61.57|61.57|Full Range|||39.0|80.0|
3945752|NCT01361048|3767386|B4|United States||Region of Enrollment||participants|Number|40|40.0||||||
3945753|NCT01361048|3767387|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3945754|NCT01361048|3767388|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3945755|NCT01361048|3767389|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3945756|NCT01361048|3767386|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3945757|NCT01361048|3767387|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3945758|NCT01361048|3767388|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3945759|NCT01361048|3767389|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3945760|NCT01361048|3767386|B4||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3945761|NCT01361048|3767387|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3945762|NCT01361048|3767388|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3945763|NCT01361048|3767389|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3945764|NCT01361048|3767386|B4|||Age||years|Mean|30.5|30.5|Standard Deviation|10.5|10.5|||
3945765|NCT01361048|3767387|B3|||Age||years|Mean|28.3|28.3|Standard Deviation|6.7|6.7|||
3945766|NCT01361048|3767388|B2|||Age||years|Mean|31.5|31.5|Standard Deviation|9.8|9.8|||
3945767|NCT01361048|3767389|B1|||Age||years|Mean|31.9|31.9|Standard Deviation|11.8|11.8|||
3945768|NCT01361048|3767386|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3945769|NCT01361048|3767387|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3945770|NCT01361048|3767388|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3945771|NCT01361048|3767389|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3945772|NCT01361048|3767386|B4||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3945773|NCT01361048|3767387|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3945774|NCT01361048|3767388|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3945775|NCT01361048|3767389|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3945776|NCT01361048|3767386|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3945777|NCT01361048|3767387|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3945778|NCT01361048|3767388|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3945779|NCT01361048|3767389|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3945780|NCT01361009|3767402|B1|||Course of Parkinson's disease|Course of Parkinson's disease is the length of time that participants had Parkinson’s Disease prior to study enrollment.|years|Median|3|3.0|Inter-Quartile Range|2.5|2.5|2.0|5.0|
3945781|NCT01361009|3767402|B1|Male||Gender|The data of gender in three patients was missing|Number of participants|Number|1174|1174.0||||||
3945782|NCT01361009|3767402|B1|Female||Gender|The data of gender in three patients was missing|Number of participants|Number|840|840.0||||||
3945783|NCT01361009|3767402|B1|||Age||years|Mean|62.09|62.09|Standard Deviation|9.67|9.67|||
3945784|NCT01360996|3767409|B4|United States||Region of Enrollment||participants|Number|64|64.0||||||
3945785|NCT01360996|3767410|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
3945786|NCT01360996|3767411|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
3945787|NCT01360996|3767412|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3945788|NCT01360996|3767409|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3945789|NCT01360996|3767410|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3945790|NCT01360996|3767411|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3945791|NCT01360996|3767412|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3945792|NCT01360996|3767409|B4||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3945793|NCT01360996|3767410|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3945794|NCT01360996|3767411|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3945795|NCT01360996|3767412|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3945796|NCT01360996|3767409|B4||>=65 years|Age|Healthy, premenopausal women (n=64) with polycystic ovary syndrome (PCOS), aged between 16 and 35 years inclusive with a body mass index (BMI) of >18 to <35kg/ m2,|Participants|Count of Participants|0|0.0||||||
3945797|NCT01360996|3767410|B3||>=65 years|Age|Healthy, premenopausal women (n=64) with polycystic ovary syndrome (PCOS), aged between 16 and 35 years inclusive with a body mass index (BMI) of >18 to <35kg/ m2,|Participants|Count of Participants|0|0.0||||||
3945798|NCT01360996|3767411|B2||>=65 years|Age|Healthy, premenopausal women (n=64) with polycystic ovary syndrome (PCOS), aged between 16 and 35 years inclusive with a body mass index (BMI) of >18 to <35kg/ m2,|Participants|Count of Participants|0|0.0||||||
3945799|NCT01360996|3767412|B1||>=65 years|Age|Healthy, premenopausal women (n=64) with polycystic ovary syndrome (PCOS), aged between 16 and 35 years inclusive with a body mass index (BMI) of >18 to <35kg/ m2,|Participants|Count of Participants|0|0.0||||||
3945800|NCT01360996|3767409|B4||Between 18 and 65 years|Age|Healthy, premenopausal women (n=64) with polycystic ovary syndrome (PCOS), aged between 16 and 35 years inclusive with a body mass index (BMI) of >18 to <35kg/ m2,|Participants|Count of Participants|55|55.0||||||
3945801|NCT01360996|3767410|B3||Between 18 and 65 years|Age|Healthy, premenopausal women (n=64) with polycystic ovary syndrome (PCOS), aged between 16 and 35 years inclusive with a body mass index (BMI) of >18 to <35kg/ m2,|Participants|Count of Participants|19|19.0||||||
3945802|NCT01360996|3767411|B2||Between 18 and 65 years|Age|Healthy, premenopausal women (n=64) with polycystic ovary syndrome (PCOS), aged between 16 and 35 years inclusive with a body mass index (BMI) of >18 to <35kg/ m2,|Participants|Count of Participants|19|19.0||||||
3945803|NCT01360996|3767412|B1||Between 18 and 65 years|Age|Healthy, premenopausal women (n=64) with polycystic ovary syndrome (PCOS), aged between 16 and 35 years inclusive with a body mass index (BMI) of >18 to <35kg/ m2,|Participants|Count of Participants|17|17.0||||||
3945804|NCT01360996|3767409|B4||<=18 years|Age|Healthy, premenopausal women (n=64) with polycystic ovary syndrome (PCOS), aged between 16 and 35 years inclusive with a body mass index (BMI) of >18 to <35kg/ m2,|Participants|Count of Participants|9|9.0||||||
3945805|NCT01360996|3767410|B3||<=18 years|Age|Healthy, premenopausal women (n=64) with polycystic ovary syndrome (PCOS), aged between 16 and 35 years inclusive with a body mass index (BMI) of >18 to <35kg/ m2,|Participants|Count of Participants|4|4.0||||||
3945806|NCT01360996|3767411|B2||<=18 years|Age|Healthy, premenopausal women (n=64) with polycystic ovary syndrome (PCOS), aged between 16 and 35 years inclusive with a body mass index (BMI) of >18 to <35kg/ m2,|Participants|Count of Participants|2|2.0||||||
3945807|NCT01360996|3767412|B1||<=18 years|Age|Healthy, premenopausal women (n=64) with polycystic ovary syndrome (PCOS), aged between 16 and 35 years inclusive with a body mass index (BMI) of >18 to <35kg/ m2,|Participants|Count of Participants|3|3.0||||||
3945808|NCT01360866|3767433|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3945809|NCT01360866|3767434|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3945810|NCT01360866|3767435|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3945811|NCT01360866|3767436|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3945812|NCT01360866|3767437|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3945813|NCT01360866|3767433|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3945814|NCT01360866|3767434|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3945815|NCT01360866|3767435|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3945816|NCT01360866|3767436|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3945817|NCT01360866|3767437|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3945818|NCT01360866|3767433|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3945819|NCT01360866|3767434|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3945820|NCT01360866|3767435|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3945821|NCT01360866|3767436|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3945822|NCT01360866|3767437|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3945823|NCT01360866|3767433|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3945824|NCT01360866|3767434|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3945825|NCT01360866|3767435|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3945826|NCT01360866|3767436|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3945827|NCT01360866|3767437|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3945828|NCT01360866|3767433|B5|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|288|288.0||||||
3945829|NCT01360866|3767434|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3945830|NCT01360866|3767435|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|149|149.0||||||
3945831|NCT01360866|3767436|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|76|76.0||||||
3945832|NCT01360866|3767437|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|55|55.0||||||
3945833|NCT01360866|3767433|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|2588|2588.0||||||
3945834|NCT01360866|3767434|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|68|68.0||||||
3945835|NCT01360866|3767435|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|1459|1459.0||||||
3945836|NCT01360866|3767436|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|609|609.0||||||
3945837|NCT01360866|3767437|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|452|452.0||||||
3945838|NCT01360866|3767433|B5||Male|Sex: Female, Male||Participants|Count of Participants|939|939.0||||||
3945839|NCT01360866|3767434|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3945840|NCT01360866|3767435|B3||Male|Sex: Female, Male||Participants|Count of Participants|537|537.0||||||
3945841|NCT01360866|3767436|B2||Male|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
3945842|NCT01360866|3767437|B1||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3945843|NCT01360866|3767433|B5||Female|Sex: Female, Male||Participants|Count of Participants|2005|2005.0||||||
3945844|NCT01360866|3767434|B4||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3945845|NCT01360866|3767435|B3||Female|Sex: Female, Male||Participants|Count of Participants|1108|1108.0||||||
3945846|NCT01360866|3767436|B2||Female|Sex: Female, Male||Participants|Count of Participants|479|479.0||||||
3945847|NCT01360866|3767437|B1||Female|Sex: Female, Male||Participants|Count of Participants|367|367.0||||||
3945848|NCT01360866|3767433|B5|||Age||years|Mean|45.0|45.0|Standard Deviation|12.0|12.0|||
3945849|NCT01360866|3767434|B4|||Age||years|Mean|44.0|44.0|Standard Deviation|11.0|11.0|||
3945850|NCT01360866|3767435|B3|||Age||years|Mean|44.0|44.0|Standard Deviation|12.0|12.0|||
3945851|NCT01360866|3767436|B2|||Age||years|Mean|45.0|45.0|Standard Deviation|11.0|11.0|||
3945852|NCT01360866|3767437|B1|||Age||years|Mean|45.0|45.0|Standard Deviation|11.0|11.0|||
3945853|NCT01360840|3767466|B4||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3945854|NCT01360840|3767467|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3945855|NCT01360840|3767468|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3945856|NCT01360840|3767469|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3945857|NCT01360840|3767466|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3945858|NCT01360840|3767467|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3945859|NCT01360840|3767468|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3945860|NCT01360840|3767469|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3945861|NCT01360840|3767466|B4|||Age||years|Mean|69.6|69.6|Standard Deviation|8.20|8.2|||
3945862|NCT01360840|3767467|B3|||Age||years|Mean|70.0|70.0|Standard Deviation|8.88|8.88|||
3945863|NCT01360840|3767468|B2|||Age||years|Mean|69.0|69.0|Standard Deviation|7.31|7.31|||
3945864|NCT01360840|3767469|B1|||Age||years|Mean|69.9|69.9|Standard Deviation|8.43|8.43|||
3945865|NCT01360645|3767521|B3||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3945866|NCT01360645|3767522|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3945867|NCT01360645|3767523|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3945868|NCT01360645|3767521|B3||Female|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
3945869|NCT01360645|3767522|B2||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3945870|NCT01360645|3767523|B1||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3945871|NCT01360645|3767521|B3|||Age||Years|Mean|44.6|44.6|Standard Deviation|11.5|11.5|||
3945872|NCT01360645|3767522|B2|||Age||Years|Mean|45.2|45.2|Standard Deviation|11.3|11.3|||
3945873|NCT01360645|3767523|B1|||Age||Years|Mean|44.1|44.1|Standard Deviation|11.6|11.6|||
3945874|NCT01360632|3767578|B4||Male|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
3945875|NCT01360632|3767579|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3945876|NCT01360632|3767580|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3945877|NCT01360632|3767581|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3945878|NCT01360632|3767578|B4||Female|Sex: Female, Male||Participants|Count of Participants|460|460.0||||||
3945879|NCT01360632|3767579|B3||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3945880|NCT01360632|3767580|B2||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3945881|NCT01360632|3767581|B1||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3945882|NCT01360632|3767578|B4|||Age||Years|Mean|45.6|45.6|Standard Deviation|11.3|11.3|||
3945883|NCT01360632|3767579|B3|||Age||Years|Mean|46.6|46.6|Standard Deviation|11.0|11.0|||
3945884|NCT01360632|3767580|B2|||Age||Years|Mean|44.5|44.5|Standard Deviation|11.2|11.2|||
3945885|NCT01360632|3767581|B1|||Age||Years|Mean|45.7|45.7|Standard Deviation|11.6|11.6|||
3945886|NCT01360554|3767662|B3||Male|Sex: Female, Male||Participants|Count of Participants|561|561.0||||||
3945887|NCT01360554|3767663|B2||Male|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
3945888|NCT01360554|3767664|B1||Male|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
3945889|NCT01360554|3767662|B3||Female|Sex: Female, Male||Participants|Count of Participants|311|311.0||||||
3945890|NCT01360554|3767663|B2||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3945891|NCT01360554|3767664|B1||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3945892|NCT01360554|3767662|B3|||Age||Years|Mean|62.5|62.5|Standard Deviation|9.67|9.67|||
3945893|NCT01360554|3767663|B2|||Age||Years|Mean|61.7|61.7|Standard Deviation|9.71|9.71|||
3945894|NCT01360554|3767664|B1|||Age||Years|Mean|63.3|63.3|Standard Deviation|9.57|9.57|||
3945895|NCT01360450|3767701|B3|||Birth Weight||grams|Mean|3160|3160.0|Standard Deviation|0.76|0.76|||
3945896|NCT01360450|3767702|B2|||Birth Weight||grams|Mean|3250|3250.0|Standard Deviation|0.9|0.9|||
3945897|NCT01360450|3767703|B1|||Birth Weight||grams|Mean|3084|3084.0|Standard Deviation|0.59|0.59|||
3945898|NCT01360450|3767701|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3945899|NCT01360450|3767702|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3945900|NCT01360450|3767703|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3945901|NCT01360450|3767701|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3945902|NCT01360450|3767702|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3945903|NCT01360450|3767703|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945904|NCT01360450|3767701|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945905|NCT01360450|3767702|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945906|NCT01360450|3767703|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945907|NCT01360450|3767701|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3945908|NCT01360450|3767702|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3945909|NCT01360450|3767703|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3945910|NCT01360450|3767701|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3945911|NCT01360450|3767702|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3945912|NCT01360450|3767703|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945913|NCT01360450|3767701|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945914|NCT01360450|3767702|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945915|NCT01360450|3767703|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945916|NCT01360450|3767701|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3945917|NCT01360450|3767702|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3945918|NCT01360450|3767703|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945919|NCT01360450|3767701|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945920|NCT01360450|3767702|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945921|NCT01360450|3767703|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945922|NCT01360450|3767701|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3945923|NCT01360450|3767702|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3945924|NCT01360450|3767703|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3945925|NCT01360450|3767701|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3945926|NCT01360450|3767702|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3945927|NCT01360450|3767703|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3945928|NCT01360450|3767701|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3945929|NCT01360450|3767702|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3945930|NCT01360450|3767703|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3945931|NCT01360450|3767701|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3945932|NCT01360450|3767702|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3945933|NCT01360450|3767703|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3945934|NCT01360450|3767701|B3||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
3945935|NCT01360450|3767702|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3945936|NCT01360450|3767703|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3945937|NCT01360021|3767714|B4|||Baseline % Predicted FEV1 (Visit 4)||%|Mean|67.79|67.79|Standard Deviation|10.898|10.898|||
3945938|NCT01360021|3767715|B3|||Baseline % Predicted FEV1 (Visit 4)||%|Mean|68.27|68.27|Standard Deviation|11.078|11.078|||
3945939|NCT01360021|3767716|B2|||Baseline % Predicted FEV1 (Visit 4)||%|Mean|67.31|67.31|Standard Deviation|10.683|10.683|||
3945940|NCT01360021|3767717|B1|||Baseline % Predicted FEV1 (Visit 4)||%|Mean|67.78|67.78|Standard Deviation|11.059|11.059|||
3945941|NCT01360021|3767714|B4|||% Reversibility in FEV1 (Visit 3)||%|Mean|26.51|26.51|Standard Deviation|15.692|15.692|||
3945942|NCT01360021|3767715|B3|||% Reversibility in FEV1 (Visit 3)||%|Mean|24.88|24.88|Standard Deviation|14.235|14.235|||
3945943|NCT01360021|3767716|B2|||% Reversibility in FEV1 (Visit 3)||%|Mean|28.22|28.22|Standard Deviation|16.118|16.118|||
3945944|NCT01360021|3767717|B1|||% Reversibility in FEV1 (Visit 3)||%|Mean|26.43|26.43|Standard Deviation|16.662|16.662|||
3945945|NCT01360021|3767714|B4|||% Reversibility in FEV1 (Visit 2)|Reversibility is defined as a change of ≥12% in FEV1 from pre-bronchodilator values (for patients ≥12 and <18 years of age), and for patients ≥18 years of age, a change of ≥12% and 200 mL in FEV1 from pre-bronchodilator values. Percent reversibility of FEV1 was calculated as follows: (Post-bronchodilator FEV1 - pre-bronchodilator FEV1)/pre-bronchodilator FEV1 x 100.|%|Mean|25.20|25.2|Standard Deviation|14.491|14.491|||
3945946|NCT01360021|3767715|B3|||% Reversibility in FEV1 (Visit 2)|Reversibility is defined as a change of ≥12% in FEV1 from pre-bronchodilator values (for patients ≥12 and <18 years of age), and for patients ≥18 years of age, a change of ≥12% and 200 mL in FEV1 from pre-bronchodilator values. Percent reversibility of FEV1 was calculated as follows: (Post-bronchodilator FEV1 - pre-bronchodilator FEV1)/pre-bronchodilator FEV1 x 100.|%|Mean|23.64|23.64|Standard Deviation|12.692|12.692|||
3945947|NCT01360021|3767716|B2|||% Reversibility in FEV1 (Visit 2)|Reversibility is defined as a change of ≥12% in FEV1 from pre-bronchodilator values (for patients ≥12 and <18 years of age), and for patients ≥18 years of age, a change of ≥12% and 200 mL in FEV1 from pre-bronchodilator values. Percent reversibility of FEV1 was calculated as follows: (Post-bronchodilator FEV1 - pre-bronchodilator FEV1)/pre-bronchodilator FEV1 x 100.|%|Mean|28.04|28.04|Standard Deviation|14.712|14.712|||
3945948|NCT01360021|3767717|B1|||% Reversibility in FEV1 (Visit 2)|Reversibility is defined as a change of ≥12% in FEV1 from pre-bronchodilator values (for patients ≥12 and <18 years of age), and for patients ≥18 years of age, a change of ≥12% and 200 mL in FEV1 from pre-bronchodilator values. Percent reversibility of FEV1 was calculated as follows: (Post-bronchodilator FEV1 - pre-bronchodilator FEV1)/pre-bronchodilator FEV1 x 100.|%|Mean|23.93|23.93|Standard Deviation|15.728|15.728|||
3945949|NCT01360021|3767714|B4|||% Predicted FEV1 (Visit 2)||%|Mean|66.93|66.93|Standard Deviation|10.434|10.434|||
3945950|NCT01360021|3767715|B3|||% Predicted FEV1 (Visit 2)||%|Mean|68.49|68.49|Standard Deviation|9.924|9.924|||
3945951|NCT01360021|3767716|B2|||% Predicted FEV1 (Visit 2)||%|Mean|65.02|65.02|Standard Deviation|11.135|11.135|||
3945952|NCT01360021|3767717|B1|||% Predicted FEV1 (Visit 2)||%|Mean|67.27|67.27|Standard Deviation|10.048|10.048|||
3945953|NCT01360021|3767714|B4|||Years since asthma diagnosis||Years|Mean|24.25|24.25|Standard Deviation|14.998|14.998|||
3945954|NCT01360021|3767715|B3|||Years since asthma diagnosis||Years|Mean|24.38|24.38|Standard Deviation|15.183|15.183|||
3945955|NCT01360021|3767716|B2|||Years since asthma diagnosis||Years|Mean|24.12|24.12|Standard Deviation|15.128|15.128|||
3945956|NCT01360021|3767717|B1|||Years since asthma diagnosis||Years|Mean|24.26|24.26|Standard Deviation|14.891|14.891|||
3945957|NCT01360021|3767714|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3945958|NCT01360021|3767715|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3945959|NCT01360021|3767716|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945960|NCT01360021|3767717|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3945961|NCT01360021|3767714|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945962|NCT01360021|3767715|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945963|NCT01360021|3767716|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945964|NCT01360021|3767717|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945965|NCT01360021|3767714|B4||White|Race (NIH/OMB)||Participants|Count of Participants|177|177.0||||||
3945966|NCT01360021|3767715|B3||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3945967|NCT01360021|3767716|B2||White|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3945968|NCT01360021|3767717|B1||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3945969|NCT01360021|3767714|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3945970|NCT01360021|3767715|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3945971|NCT01360021|3767716|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3945972|NCT01360021|3767717|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3945973|NCT01360021|3767714|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3945974|NCT01360021|3767715|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3945975|NCT01360021|3767716|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945976|NCT01360021|3767717|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945977|NCT01360021|3767714|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3945978|NCT01360021|3767715|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3945979|NCT01360021|3767716|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3945980|NCT01360021|3767717|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3945981|NCT01360021|3767714|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945982|NCT01360021|3767715|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945983|NCT01360021|3767716|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945984|NCT01360021|3767717|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3945985|NCT01360021|3767714|B4||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3945986|NCT01360021|3767715|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3945987|NCT01360021|3767716|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3945988|NCT01360021|3767717|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3945989|NCT01360021|3767714|B4||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3945990|NCT01360021|3767715|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3945991|NCT01360021|3767716|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3945992|NCT01360021|3767717|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3945993|NCT01360021|3767714|B4|>= 75 years||Age, Customized||Participants|Number|5|5.0||||||
3945994|NCT01360021|3767715|B3|>= 75 years||Age, Customized||Participants|Number|1|1.0||||||
3945995|NCT01360021|3767716|B2|>= 75 years||Age, Customized||Participants|Number|3|3.0||||||
3945996|NCT01360021|3767717|B1|>= 75 years||Age, Customized||Participants|Number|1|1.0||||||
3945997|NCT01360021|3767714|B4|65 - <75 years||Age, Customized||Participants|Number|10|10.0||||||
3945998|NCT01360021|3767715|B3|65 - <75 years||Age, Customized||Participants|Number|2|2.0||||||
3945999|NCT01360021|3767716|B2|65 - <75 years||Age, Customized||Participants|Number|4|4.0||||||
3946000|NCT01360021|3767717|B1|65 - <75 years||Age, Customized||Participants|Number|4|4.0||||||
3946001|NCT01360021|3767714|B4|18 - <65 years||Age, Customized||Participants|Number|178|178.0||||||
3946002|NCT01360021|3767715|B3|18 - <65 years||Age, Customized||Participants|Number|62|62.0||||||
3946003|NCT01360021|3767716|B2|18 - <65 years||Age, Customized||Participants|Number|56|56.0||||||
3946004|NCT01360021|3767717|B1|18 - <65 years||Age, Customized||Participants|Number|60|60.0||||||
3946005|NCT01360021|3767714|B4|12 - <18 years||Age, Customized||Participants|Number|21|21.0||||||
3946006|NCT01360021|3767715|B3|12 - <18 years||Age, Customized||Participants|Number|7|7.0||||||
3946007|NCT01360021|3767716|B2|12 - <18 years||Age, Customized||Participants|Number|8|8.0||||||
3946008|NCT01360021|3767717|B1|12 - <18 years||Age, Customized||Participants|Number|6|6.0||||||
3946009|NCT01360021|3767714|B4|||Age||Years|Mean|42.72|42.72|Standard Deviation|15.770|15.77|||
3946010|NCT01360021|3767715|B3|||Age||Years|Mean|42.72|42.72|Standard Deviation|14.424|14.424|||
3946011|NCT01360021|3767716|B2|||Age||Years|Mean|42.62|42.62|Standard Deviation|16.873|16.873|||
3946012|NCT01360021|3767717|B1|||Age||Years|Mean|42.83|42.83|Standard Deviation|16.156|16.156|||
3946013|NCT01359943|3767742|B4||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3946014|NCT01359943|3767743|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3946015|NCT01359943|3767744|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3946016|NCT01359943|3767745|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3946017|NCT01359943|3767742|B4||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
3946018|NCT01359943|3767743|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3946019|NCT01359943|3767744|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3946020|NCT01359943|3767745|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3946021|NCT01359943|3767742|B4|||Age||Years|Mean|54.0|54.0|Standard Deviation|11.51|11.51|||
3946022|NCT01359943|3767743|B3|||Age||Years|Mean|53.5|53.5|Standard Deviation|9.33|9.33|||
3946023|NCT01359943|3767744|B2|||Age||Years|Mean|54.5|54.5|Standard Deviation|12.26|12.26|||
3946024|NCT01359943|3767745|B1|||Age||Years|Mean|53.8|53.8|Standard Deviation|11.81|11.81|||
3946025|NCT01359904|3767793|B3|Canada||Region of Enrollment||participants|Number|34|34.0||||||
3946026|NCT01359904|3767794|B2|Canada||Region of Enrollment||participants|Number|19|19.0||||||
3946027|NCT01359904|3767795|B1|Canada||Region of Enrollment||participants|Number|15|15.0||||||
3946028|NCT01359904|3767793|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3946029|NCT01359904|3767794|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3946030|NCT01359904|3767795|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3946031|NCT01359904|3767793|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3946032|NCT01359904|3767794|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3946033|NCT01359904|3767795|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3946034|NCT01359904|3767793|B3|||Age||years|Median|71|71.0|Full Range|||35.0|88.0|
3946035|NCT01359904|3767794|B2|||Age||years|Median|65|65.0|Full Range|||35.0|87.0|
3946036|NCT01359904|3767795|B1|||Age||years|Median|73|73.0|Full Range|||45.0|88.0|
3946037|NCT01359748|3767808|B5||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3946038|NCT01359748|3767809|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3946039|NCT01359748|3767810|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3946040|NCT01359748|3767811|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3946041|NCT01359748|3767812|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3946042|NCT01359748|3767808|B5||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3946043|NCT01359748|3767809|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3946044|NCT01359748|3767810|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3946045|NCT01359748|3767811|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3946046|NCT01359748|3767812|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3946047|NCT01359748|3767808|B5||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3946048|NCT01359748|3767809|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3946049|NCT01359748|3767810|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3946050|NCT01359748|3767811|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3946051|NCT01359748|3767812|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3946052|NCT01359748|3767808|B5||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
3946053|NCT01359748|3767809|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3946054|NCT01359748|3767810|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3946055|NCT01359748|3767811|B2||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
3946056|NCT01359748|3767812|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3946057|NCT01359748|3767808|B5||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3946058|NCT01359748|3767809|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3946059|NCT01359748|3767810|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3946060|NCT01359748|3767811|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3946061|NCT01359748|3767812|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3946062|NCT01359735|3767823|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946063|NCT01359735|3767824|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946064|NCT01359735|3767825|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946065|NCT01359735|3767823|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946066|NCT01359735|3767824|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946067|NCT01359735|3767825|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946068|NCT01359735|3767823|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3946069|NCT01359735|3767824|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3946070|NCT01359735|3767825|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3946071|NCT01359735|3767823|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946072|NCT01359735|3767824|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946073|NCT01359735|3767825|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946074|NCT01359735|3767823|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946075|NCT01359735|3767824|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946076|NCT01359735|3767825|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946077|NCT01359735|3767823|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946078|NCT01359735|3767824|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946079|NCT01359735|3767825|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946080|NCT01359735|3767823|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946081|NCT01359735|3767824|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946082|NCT01359735|3767825|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946083|NCT01359735|3767823|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946084|NCT01359735|3767824|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946085|NCT01359735|3767825|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946086|NCT01359735|3767823|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3946087|NCT01359735|3767824|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3946088|NCT01359735|3767825|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3946089|NCT01359735|3767823|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946090|NCT01359735|3767824|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946091|NCT01359735|3767825|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946092|NCT01359735|3767823|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3946093|NCT01359735|3767824|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3946094|NCT01359735|3767825|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3946095|NCT01359735|3767823|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3946096|NCT01359735|3767824|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3946097|NCT01359735|3767825|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3946098|NCT01359735|3767823|B3|70+ yrs||Age, Customized||participants|Number|4|4.0||||||
3946099|NCT01359735|3767824|B2|70+ yrs||Age, Customized||participants|Number|2|2.0||||||
3946100|NCT01359735|3767825|B1|70+ yrs||Age, Customized||participants|Number|2|2.0||||||
3946101|NCT01359735|3767823|B3|50-69 yrs||Age, Customized||participants|Number|4|4.0||||||
3946102|NCT01359735|3767824|B2|50-69 yrs||Age, Customized||participants|Number|2|2.0||||||
3946103|NCT01359735|3767825|B1|50-69 yrs||Age, Customized||participants|Number|2|2.0||||||
3946104|NCT01359735|3767823|B3|||Age||years|Mean|70.4|70.4|Standard Deviation|11|11.0|||
3946105|NCT01359735|3767824|B2|||Age||years|Mean|66.8|66.8|Standard Deviation|10.7|10.7|||
3946106|NCT01359735|3767825|B1|||Age||years|Mean|74|74.0|Standard Deviation|11.6|11.6|||
3946107|NCT01359644|3767840|B11||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3946108|NCT01359644|3767841|B10||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3946109|NCT01359644|3767842|B9||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3946110|NCT01359644|3767843|B8||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3946111|NCT01359644|3767844|B7||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3946112|NCT01359644|3767845|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3946113|NCT01359644|3767846|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3946114|NCT01359644|3767847|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3946115|NCT01359644|3767848|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3946116|NCT01359644|3767849|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3946117|NCT01359644|3767850|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3946118|NCT01359644|3767840|B11||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3946119|NCT01359644|3767841|B10||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3946120|NCT01359644|3767842|B9||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3946121|NCT01359644|3767843|B8||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3946122|NCT01359644|3767844|B7||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3946123|NCT01359644|3767845|B6||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3946124|NCT01359644|3767846|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3946125|NCT01359644|3767847|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3946126|NCT01359644|3767848|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3946127|NCT01359644|3767849|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3946128|NCT01359644|3767850|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3946129|NCT01359644|3767840|B11|>= 65 years||Age, Customized||participants|Number|12|12.0||||||
3946130|NCT01359644|3767841|B10|>= 65 years||Age, Customized||participants|Number|1|1.0||||||
3946131|NCT01359644|3767842|B9|>= 65 years||Age, Customized||participants|Number|3|3.0||||||
3946132|NCT01359644|3767843|B8|>= 65 years||Age, Customized||participants|Number|3|3.0||||||
3946133|NCT01359644|3767844|B7|>= 65 years||Age, Customized||participants|Number|2|2.0||||||
3946134|NCT01359644|3767845|B6|>= 65 years||Age, Customized||participants|Number|1|1.0||||||
3946135|NCT01359644|3767846|B5|>= 65 years||Age, Customized||participants|Number|0|0.0||||||
3946136|NCT01359644|3767847|B4|>= 65 years||Age, Customized||participants|Number|1|1.0||||||
3946137|NCT01359644|3767848|B3|>= 65 years||Age, Customized||participants|Number|0|0.0||||||
3946138|NCT01359644|3767849|B2|>= 65 years||Age, Customized||participants|Number|1|1.0||||||
3946139|NCT01359644|3767850|B1|>= 65 years||Age, Customized||participants|Number|0|0.0||||||
3946140|NCT01359644|3767840|B11|<65 years||Age, Customized||participants|Number|199|199.0||||||
3946141|NCT01359644|3767841|B10|<65 years||Age, Customized||participants|Number|19|19.0||||||
3946142|NCT01359644|3767842|B9|<65 years||Age, Customized||participants|Number|18|18.0||||||
3946143|NCT01359644|3767843|B8|<65 years||Age, Customized||participants|Number|38|38.0||||||
3946144|NCT01359644|3767844|B7|<65 years||Age, Customized||participants|Number|39|39.0||||||
3946145|NCT01359644|3767845|B6|<65 years||Age, Customized||participants|Number|13|13.0||||||
3946146|NCT01359644|3767846|B5|<65 years||Age, Customized||participants|Number|15|15.0||||||
3946147|NCT01359644|3767847|B4|<65 years||Age, Customized||participants|Number|13|13.0||||||
3946148|NCT01359644|3767848|B3|<65 years||Age, Customized||participants|Number|14|14.0||||||
3946149|NCT01359644|3767849|B2|<65 years||Age, Customized||participants|Number|15|15.0||||||
3946150|NCT01359644|3767850|B1|<65 years||Age, Customized||participants|Number|15|15.0||||||
3946151|NCT01359644|3767840|B11|||Age||years|Mean|52.0|52.0|Standard Deviation|10.37|10.37|||
3946152|NCT01359644|3767841|B10|||Age||years|Mean|52.6|52.6|Standard Deviation|10.89|10.89|||
3946153|NCT01359644|3767842|B9|||Age||years|Mean|56.6|56.6|Standard Deviation|9.89|9.89|||
3946154|NCT01359644|3767843|B8|||Age||years|Mean|53.1|53.1|Standard Deviation|9.53|9.53|||
3946155|NCT01359644|3767844|B7|||Age||years|Mean|50.9|50.9|Standard Deviation|11.56|11.56|||
3946156|NCT01359644|3767845|B6|||Age||years|Mean|48.8|48.8|Standard Deviation|12.27|12.27|||
3946157|NCT01359644|3767846|B5|||Age||years|Mean|50.9|50.9|Standard Deviation|11.72|11.72|||
3946158|NCT01359644|3767847|B4|||Age||years|Mean|49.7|49.7|Standard Deviation|10.49|10.49|||
3946159|NCT01359644|3767848|B3|||Age||years|Mean|52.7|52.7|Standard Deviation|7.39|7.39|||
3946160|NCT01359644|3767849|B2|||Age||years|Mean|50.6|50.6|Standard Deviation|8.53|8.53|||
3946161|NCT01359644|3767850|B1|||Age||years|Mean|52.1|52.1|Standard Deviation|10.18|10.18|||
3946162|NCT01359449|3767901|B3|Canada||Region of Enrollment||Participants|Number|123|123.0||||||
3946163|NCT01359449|3767902|B2|Canada||Region of Enrollment||Participants|Number|62|62.0||||||
3946164|NCT01359449|3767903|B1|Canada||Region of Enrollment||Participants|Number|61|61.0||||||
3946165|NCT01359449|3767901|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3946166|NCT01359449|3767902|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3946167|NCT01359449|3767903|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3946168|NCT01359449|3767901|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3946169|NCT01359449|3767902|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3946170|NCT01359449|3767903|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3946171|NCT01359449|3767901|B3|||Age||Months|Mean|12.4|12.4|Standard Deviation|0.3|0.3|||
3946172|NCT01359449|3767902|B2|||Age||Months|Mean|12.4|12.4|Standard Deviation|0.3|0.3|||
3946173|NCT01359449|3767903|B1|||Age||Months|Mean|12.4|12.4|Standard Deviation|0.3|0.3|||
3946174|NCT01359449|3767901|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3946175|NCT01359449|3767902|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3946176|NCT01359449|3767903|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3946177|NCT01359449|3767901|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3946178|NCT01359449|3767902|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3946179|NCT01359449|3767903|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3946180|NCT01359449|3767901|B3||<=18 years|Age||Participants|Count of Participants|123|123.0||||||
3946181|NCT01359449|3767902|B2||<=18 years|Age||Participants|Count of Participants|62|62.0||||||
3946182|NCT01359449|3767903|B1||<=18 years|Age||Participants|Count of Participants|61|61.0||||||
3946183|NCT01359410|3767926|B3||Smoker|Smoking history||Participants|Count of Participants|40|40.0||||||
3946184|NCT01359410|3767927|B2||Smoker|Smoking history||Participants|Count of Participants|20|20.0||||||
3946185|NCT01359410|3767928|B1||Smoker|Smoking history||Participants|Count of Participants|20|20.0||||||
3946186|NCT01359410|3767926|B3||Nonsmoker|Smoking history||Participants|Count of Participants|60|60.0||||||
3946187|NCT01359410|3767927|B2||Nonsmoker|Smoking history||Participants|Count of Participants|26|26.0||||||
3946188|NCT01359410|3767928|B1||Nonsmoker|Smoking history||Participants|Count of Participants|34|34.0||||||
3946189|NCT01359410|3767926|B3||Normal pancreas|Indication for operation||Participants|Count of Participants|6|6.0||||||
3946190|NCT01359410|3767927|B2||Normal pancreas|Indication for operation||Participants|Count of Participants|2|2.0||||||
3946191|NCT01359410|3767928|B1||Normal pancreas|Indication for operation||Participants|Count of Participants|4|4.0||||||
3946192|NCT01359410|3767926|B3||Chronic pancreatitis|Indication for operation||Participants|Count of Participants|7|7.0||||||
3946193|NCT01359410|3767927|B2||Chronic pancreatitis|Indication for operation||Participants|Count of Participants|4|4.0||||||
3946194|NCT01359410|3767928|B1||Chronic pancreatitis|Indication for operation||Participants|Count of Participants|3|3.0||||||
3946195|NCT01359410|3767926|B3||Benign pancreatic tumor|Indication for operation||Participants|Count of Participants|37|37.0||||||
3946196|NCT01359410|3767927|B2||Benign pancreatic tumor|Indication for operation||Participants|Count of Participants|13|13.0||||||
3946197|NCT01359410|3767928|B1||Benign pancreatic tumor|Indication for operation||Participants|Count of Participants|24|24.0||||||
3946198|NCT01359410|3767926|B3||Metastatic tumor to pancreas|Indication for operation||Participants|Count of Participants|6|6.0||||||
3946199|NCT01359410|3767927|B2||Metastatic tumor to pancreas|Indication for operation||Participants|Count of Participants|3|3.0||||||
3946200|NCT01359410|3767928|B1||Metastatic tumor to pancreas|Indication for operation||Participants|Count of Participants|3|3.0||||||
3946201|NCT01359410|3767926|B3||Neuroendocrine tumor|Indication for operation||Participants|Count of Participants|26|26.0||||||
3946202|NCT01359410|3767927|B2||Neuroendocrine tumor|Indication for operation||Participants|Count of Participants|14|14.0||||||
3946203|NCT01359410|3767928|B1||Neuroendocrine tumor|Indication for operation||Participants|Count of Participants|12|12.0||||||
3946204|NCT01359410|3767926|B3||Adenocarcinoma|Indication for operation||Participants|Count of Participants|18|18.0||||||
3946205|NCT01359410|3767927|B2||Adenocarcinoma|Indication for operation||Participants|Count of Participants|10|10.0||||||
3946206|NCT01359410|3767928|B1||Adenocarcinoma|Indication for operation||Participants|Count of Participants|8|8.0||||||
3946207|NCT01359410|3767926|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
3946208|NCT01359410|3767927|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
3946209|NCT01359410|3767928|B1|United States||Region of Enrollment||participants|Number|54|54.0||||||
3946210|NCT01359410|3767926|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3946211|NCT01359410|3767927|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3946212|NCT01359410|3767928|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3946213|NCT01359410|3767926|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3946214|NCT01359410|3767927|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3946215|NCT01359410|3767928|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3946216|NCT01359410|3767926|B3|||Age||years|Mean|58.0|58.0|Standard Deviation|14.7|14.7|||
3946217|NCT01359410|3767927|B2|||Age||years|Mean|58.6|58.6|Standard Deviation|13.4|13.4|||
3946218|NCT01359410|3767928|B1|||Age||years|Mean|57.5|57.5|Standard Deviation|15.6|15.6|||
3946219|NCT01359371|3767943|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946220|NCT01359371|3767943|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946221|NCT01359371|3767943|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3946222|NCT01359371|3767943|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3946223|NCT01359371|3767943|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946224|NCT01359371|3767943|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946284|NCT01358968|3767999|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3946225|NCT01359371|3767943|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3946226|NCT01359371|3767943|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3946227|NCT01359371|3767943|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3946228|NCT01359371|3767943|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|10.5|10.5|||
3946229|NCT01359254|3767948|B3|Male||Gender||participants|Number|1|1.0||||||
3946230|NCT01359254|3767950|B1|Male||Gender||participants|Number|1|1.0||||||
3946231|NCT01359254|3767948|B3|Female||Gender||participants|Number|0|0.0||||||
3946232|NCT01359254|3767950|B1|Female||Gender||participants|Number|0|0.0||||||
3946233|NCT01359254|3767948|B3|>=65 years||Age||participants|Number|0|0.0||||||
3946234|NCT01359254|3767950|B1|>=65 years||Age||participants|Number|0|0.0||||||
3946235|NCT01359254|3767948|B3|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
3946236|NCT01359254|3767950|B1|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
3946237|NCT01359254|3767948|B3|<=18 years||Age||participants|Number|0|0.0||||||
3946238|NCT01359254|3767950|B1|<=18 years||Age||participants|Number|0|0.0||||||
3946239|NCT01359150|3767959|B3|Without Background MTX use||Number of Participants With Background (BG) Methotrexate (MTX) use||participants|Number|99|99.0||||||
3946240|NCT01359150|3767960|B2|Without Background MTX use||Number of Participants With Background (BG) Methotrexate (MTX) use||participants|Number|49|49.0||||||
3946241|NCT01359150|3767961|B1|Without Background MTX use||Number of Participants With Background (BG) Methotrexate (MTX) use||participants|Number|50|50.0||||||
3946242|NCT01359150|3767959|B3|With Background MTX use||Number of Participants With Background (BG) Methotrexate (MTX) use||participants|Number|124|124.0||||||
3946243|NCT01359150|3767960|B2|With Background MTX use||Number of Participants With Background (BG) Methotrexate (MTX) use||participants|Number|62|62.0||||||
3946244|NCT01359150|3767961|B1|With Background MTX use||Number of Participants With Background (BG) Methotrexate (MTX) use||participants|Number|62|62.0||||||
3946245|NCT01359150|3767959|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3946246|NCT01359150|3767960|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3946247|NCT01359150|3767961|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3946248|NCT01359150|3767959|B3||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3946249|NCT01359150|3767960|B2||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3946250|NCT01359150|3767961|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3946251|NCT01359150|3767959|B3|||Age||years|Mean|52.4|52.4|Standard Deviation|10.8|10.8|||
3946252|NCT01359150|3767960|B2|||Age||years|Mean|52.2|52.2|Standard Deviation|11.1|11.1|||
3946253|NCT01359150|3767961|B1|||Age||years|Mean|52.7|52.7|Standard Deviation|10.4|10.4|||
3946254|NCT01359111|3767984|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3946255|NCT01359111|3767984|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3946256|NCT01359111|3767984|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3946257|NCT01359111|3767984|B1|||Age||years|Mean|35.4|35.4|Standard Deviation|9.3|9.3|||
3946258|NCT01359111|3767984|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3946259|NCT01359111|3767984|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3946260|NCT01359111|3767984|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3946261|NCT01359007|3767991|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3946262|NCT01359007|3767991|B1|Race|Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946263|NCT01359007|3767991|B1|Race|More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3946264|NCT01359007|3767991|B1|Race|White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3946265|NCT01359007|3767991|B1|Race|Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3946266|NCT01359007|3767991|B1|Race|Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946267|NCT01359007|3767991|B1|Race|Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946268|NCT01359007|3767991|B1|Race|American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946269|NCT01359007|3767991|B1|sex|Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3946270|NCT01359007|3767991|B1|sex|Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3946271|NCT01359007|3767991|B1|||Age||years|Mean|60|60.0|Full Range|||52.0|67.0|
3946272|NCT01358968|3767999|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3946273|NCT01358968|3767999|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946274|NCT01358968|3767999|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3946275|NCT01358968|3767999|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3946276|NCT01358968|3767999|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3946277|NCT01358968|3767999|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946278|NCT01358968|3767999|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946279|NCT01358968|3767999|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946280|NCT01358968|3767999|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946281|NCT01358968|3767999|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3946282|NCT01358968|3767999|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946283|NCT01358968|3767999|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3946285|NCT01358968|3767999|B1|||Age||years|Mean|58.3|58.3|Standard Deviation|9.9|9.9|||
3946286|NCT01358877|3768016|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3946287|NCT01358877|3768017|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3946288|NCT01358877|3768018|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3946289|NCT01358877|3768016|B3||Female|Sex: Female, Male||Participants|Count of Participants|4793|4793.0||||||
3946290|NCT01358877|3768017|B2||Female|Sex: Female, Male||Participants|Count of Participants|2396|2396.0||||||
3946291|NCT01358877|3768018|B1||Female|Sex: Female, Male||Participants|Count of Participants|2397|2397.0||||||
3946292|NCT01358877|3768016|B3|||Age||years|Mean|51.5|51.5|Standard Deviation|10.8|10.8|||
3946293|NCT01358877|3768017|B2|||Age||years|Mean|51.4|51.4|Standard Deviation|10.7|10.7|||
3946294|NCT01358877|3768018|B1|||Age||years|Mean|51.7|51.7|Standard Deviation|10.9|10.9|||
3946295|NCT01358864|3768081|B9||Male|Sex: Female, Male||Participants|Count of Participants|403|403.0||||||
3946296|NCT01358864|3768082|B8||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3946297|NCT01358864|3768083|B7||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3946298|NCT01358864|3768084|B6||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3946299|NCT01358864|3768085|B5||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3946300|NCT01358864|3768086|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3946301|NCT01358864|3768087|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3946302|NCT01358864|3768088|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3946303|NCT01358864|3768089|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3946304|NCT01358864|3768081|B9||Female|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
3946305|NCT01358864|3768082|B8||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3946306|NCT01358864|3768083|B7||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3946307|NCT01358864|3768084|B6||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3946308|NCT01358864|3768085|B5||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3946309|NCT01358864|3768086|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3946310|NCT01358864|3768087|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3946311|NCT01358864|3768088|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3946312|NCT01358864|3768089|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3946313|NCT01358864|3768081|B9|||Age||years|Mean|53.4|53.4|Standard Deviation|8.48|8.48|||
3946314|NCT01358864|3768082|B8|||Age||years|Mean|53.6|53.6|Standard Deviation|8.13|8.13|||
3946315|NCT01358864|3768083|B7|||Age||years|Mean|53.2|53.2|Standard Deviation|8.76|8.76|||
3946316|NCT01358864|3768084|B6|||Age||years|Mean|52.0|52.0|Standard Deviation|10.32|10.32|||
3946317|NCT01358864|3768085|B5|||Age||years|Mean|52.7|52.7|Standard Deviation|7.90|7.9|||
3946318|NCT01358864|3768086|B4|||Age||years|Mean|55.7|55.7|Standard Deviation|7.50|7.5|||
3946319|NCT01358864|3768087|B3|||Age||years|Mean|53.7|53.7|Standard Deviation|8.14|8.14|||
3946320|NCT01358864|3768088|B2|||Age||years|Mean|53.5|53.5|Standard Deviation|8.57|8.57|||
3946321|NCT01358864|3768089|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|8.29|8.29|||
3946322|NCT01358825|3768185|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3946323|NCT01358825|3768186|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3946324|NCT01358825|3768187|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3946325|NCT01358825|3768185|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3946326|NCT01358825|3768186|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3946327|NCT01358825|3768187|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3946328|NCT01358825|3768185|B3|||Age||Years|Mean|5.0|5.0|Standard Deviation|0.0|0.0|||
3946329|NCT01358825|3768186|B2|||Age||Years|Mean|5.0|5.0|Standard Deviation|0.0|0.0|||
3946330|NCT01358825|3768187|B1|||Age||Years|Mean|5.0|5.0|Standard Deviation|0.0|0.0|||
3946331|NCT01358760|3768209|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3946332|NCT01358760|3768210|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3946333|NCT01358760|3768211|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3946334|NCT01358760|3768212|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3946335|NCT01358760|3768209|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3946336|NCT01358760|3768210|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3946337|NCT01358760|3768211|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3946338|NCT01358760|3768212|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3946339|NCT01358760|3768209|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3946340|NCT01358760|3768210|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3946341|NCT01358760|3768211|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3946342|NCT01358760|3768212|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3946343|NCT01358760|3768209|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3946344|NCT01358760|3768210|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3946345|NCT01358760|3768211|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3946346|NCT01358760|3768212|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3946347|NCT01358760|3768209|B4|White caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|398|398.0||||||
3946348|NCT01358760|3768210|B3|White caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|131|131.0||||||
3946349|NCT01358760|3768211|B2|White caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|132|132.0||||||
3946350|NCT01358760|3768212|B1|White caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|135|135.0||||||
3946351|NCT01358760|3768209|B4|Female||Sex/Gender, Customized||Participants|Count of Participants|441|441.0||||||
3946352|NCT01358760|3768210|B3|Female||Sex/Gender, Customized||Participants|Count of Participants|148|148.0||||||
3946353|NCT01358760|3768211|B2|Female||Sex/Gender, Customized||Participants|Count of Participants|143|143.0||||||
3946354|NCT01358760|3768212|B1|Female||Sex/Gender, Customized||Participants|Count of Participants|150|150.0||||||
3946355|NCT01358760|3768209|B4|||Age||years|Mean|58.11|58.11|Standard Deviation|6.22|6.22|||
3946356|NCT01358760|3768210|B3|||Age||years|Mean|58.33|58.33|Standard Deviation|6.16|6.16|||
3946357|NCT01358760|3768211|B2|||Age||years|Mean|58.41|58.41|Standard Deviation|6.02|6.02|||
3946358|NCT01358760|3768212|B1|||Age||years|Mean|57.59|57.59|Standard Deviation|6.47|6.47|||
3946359|NCT01358734|3768246|B4|≥1 X 10^9L||Peripheral Blast Blood Count||participants|Number|19|19.0||||||
3946360|NCT01358734|3768247|B3|≥1 X 10^9L||Peripheral Blast Blood Count||participants|Number|7|7.0||||||
3946361|NCT01358734|3768248|B2|≥1 X 10^9L||Peripheral Blast Blood Count||participants|Number|8|8.0||||||
3946362|NCT01358734|3768249|B1|≥1 X 10^9L||Peripheral Blast Blood Count||participants|Number|4|4.0||||||
3946363|NCT01358734|3768246|B4|<1 X 10^9L||Peripheral Blast Blood Count||participants|Number|69|69.0||||||
3946364|NCT01358734|3768247|B3|<1 X 10^9L||Peripheral Blast Blood Count||participants|Number|27|27.0||||||
3946365|NCT01358734|3768248|B2|<1 X 10^9L||Peripheral Blast Blood Count||participants|Number|31|31.0||||||
3946366|NCT01358734|3768249|B1|<1 X 10^9L||Peripheral Blast Blood Count||participants|Number|11|11.0||||||
3946367|NCT01358734|3768246|B4|Missing||Eastern Cooperative Oncology Group|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|1|1.0||||||
3946368|NCT01358734|3768247|B3|Missing||Eastern Cooperative Oncology Group|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|1|1.0||||||
3946369|NCT01358734|3768248|B2|Missing||Eastern Cooperative Oncology Group|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|0|0.0||||||
3946370|NCT01358734|3768249|B1|Missing||Eastern Cooperative Oncology Group|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|0|0.0||||||
3946371|NCT01358734|3768246|B4|4 = (Completely Disabled)||Eastern Cooperative Oncology Group|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|0|0.0||||||
3946372|NCT01358734|3768247|B3|4 = (Completely Disabled)||Eastern Cooperative Oncology Group|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|0|0.0||||||
3946373|NCT01358734|3768248|B2|4 = (Completely Disabled)||Eastern Cooperative Oncology Group|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|0|0.0||||||
3946428|NCT01358578|3768294|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946429|NCT01358578|3768290|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3946430|NCT01358578|3768291|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3946374|NCT01358734|3768249|B1|4 = (Completely Disabled)||Eastern Cooperative Oncology Group|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|0|0.0||||||
3946375|NCT01358734|3768246|B4|3 = (Limited self care)||Eastern Cooperative Oncology Group|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|0|0.0||||||
3946376|NCT01358734|3768247|B3|3 = (Limited self care)||Eastern Cooperative Oncology Group|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|0|0.0||||||
3946377|NCT01358734|3768248|B2|3 = (Limited self care)||Eastern Cooperative Oncology Group|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|0|0.0||||||
3946378|NCT01358734|3768249|B1|3 = (Limited self care)||Eastern Cooperative Oncology Group|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|0|0.0||||||
3946379|NCT01358734|3768246|B4|(Ambulatory but unable to work)||Eastern Cooperative Oncology Group|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|15|15.0||||||
3946380|NCT01358734|3768247|B3|(Ambulatory but unable to work)||Eastern Cooperative Oncology Group|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|6|6.0||||||
3946381|NCT01358734|3768248|B2|(Ambulatory but unable to work)||Eastern Cooperative Oncology Group|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|7|7.0||||||
3946382|NCT01358734|3768249|B1|(Ambulatory but unable to work)||Eastern Cooperative Oncology Group|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|2|2.0||||||
3946383|NCT01358734|3768246|B4|1 = (Restrictive but ambulatory)||Eastern Cooperative Oncology Group|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|54|54.0||||||
3946384|NCT01358734|3768247|B3|1 = (Restrictive but ambulatory)||Eastern Cooperative Oncology Group|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|17|17.0||||||
3946385|NCT01358734|3768248|B2|1 = (Restrictive but ambulatory)||Eastern Cooperative Oncology Group|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|28|28.0||||||
3946431|NCT01358578|3768292|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3946386|NCT01358734|3768249|B1|1 = (Restrictive but ambulatory)||Eastern Cooperative Oncology Group|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|9|9.0||||||
3946387|NCT01358734|3768246|B4|0 = (Fully Active)||Eastern Cooperative Oncology Group|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|18|18.0||||||
3946388|NCT01358734|3768247|B3|0 = (Fully Active)||Eastern Cooperative Oncology Group|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|10|10.0||||||
3946389|NCT01358734|3768248|B2|0 = (Fully Active)||Eastern Cooperative Oncology Group|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|4|4.0||||||
3946390|NCT01358734|3768249|B1|0 = (Fully Active)||Eastern Cooperative Oncology Group|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|4|4.0||||||
3946391|NCT01358734|3768246|B4||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3946392|NCT01358734|3768247|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3946393|NCT01358734|3768248|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3946394|NCT01358734|3768249|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3946395|NCT01358734|3768246|B4||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3946396|NCT01358734|3768247|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3946397|NCT01358734|3768248|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3946398|NCT01358734|3768249|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3946399|NCT01358734|3768246|B4|||Age||years|Mean|75.97|75.97|Standard Deviation|5.44|5.44|||
3946400|NCT01358734|3768247|B3|||Age||years|Mean|74.8|74.8|Standard Deviation|4.96|4.96|||
3946401|NCT01358734|3768248|B2|||Age||years|Mean|75.5|75.5|Standard Deviation|5.88|5.88|||
3946402|NCT01358734|3768249|B1|||Age||years|Mean|77.6|77.6|Standard Deviation|5.47|5.47|||
3946403|NCT01358708|3768268|B3|Germany||Region of Enrollment||participants|Number|14|14.0||||||
3946404|NCT01358708|3768269|B2|Germany||Region of Enrollment||participants|Number|7|7.0||||||
3946405|NCT01358708|3768270|B1|Germany||Region of Enrollment||participants|Number|7|7.0||||||
3946406|NCT01358708|3768268|B3|France||Region of Enrollment||participants|Number|12|12.0||||||
3946407|NCT01358708|3768269|B2|France||Region of Enrollment||participants|Number|6|6.0||||||
3946408|NCT01358708|3768270|B1|France||Region of Enrollment||participants|Number|6|6.0||||||
3946409|NCT01358708|3768268|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3946410|NCT01358708|3768269|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3946411|NCT01358708|3768270|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3946412|NCT01358708|3768268|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3946413|NCT01358708|3768269|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3946414|NCT01358708|3768270|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3946415|NCT01358708|3768268|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3946416|NCT01358708|3768269|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3946417|NCT01358708|3768270|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3946418|NCT01358708|3768268|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3946419|NCT01358708|3768269|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3946420|NCT01358708|3768270|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3946421|NCT01358708|3768268|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3946422|NCT01358708|3768269|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3946423|NCT01358708|3768270|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3946424|NCT01358578|3768290|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3946425|NCT01358578|3768291|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3946426|NCT01358578|3768292|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3946427|NCT01358578|3768293|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946432|NCT01358578|3768293|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3946433|NCT01358578|3768294|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3946434|NCT01358578|3768290|B5||White|Race (NIH/OMB)||Participants|Count of Participants|880|880.0||||||
3946435|NCT01358578|3768291|B4||White|Race (NIH/OMB)||Participants|Count of Participants|219|219.0||||||
3946436|NCT01358578|3768292|B3||White|Race (NIH/OMB)||Participants|Count of Participants|218|218.0||||||
3946437|NCT01358578|3768293|B2||White|Race (NIH/OMB)||Participants|Count of Participants|224|224.0||||||
3946438|NCT01358578|3768294|B1||White|Race (NIH/OMB)||Participants|Count of Participants|219|219.0||||||
3946439|NCT01358578|3768290|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3946440|NCT01358578|3768291|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946441|NCT01358578|3768292|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3946442|NCT01358578|3768293|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3946443|NCT01358578|3768294|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3946444|NCT01358578|3768290|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3946445|NCT01358578|3768291|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3946446|NCT01358578|3768292|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3946447|NCT01358578|3768293|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3946448|NCT01358578|3768294|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946449|NCT01358578|3768290|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|291|291.0||||||
3946450|NCT01358578|3768291|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3946451|NCT01358578|3768292|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3946452|NCT01358578|3768293|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3946453|NCT01358578|3768294|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3946454|NCT01358578|3768290|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
3946455|NCT01358578|3768291|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3946456|NCT01358578|3768292|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3946457|NCT01358578|3768293|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3946458|NCT01358578|3768294|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3946459|NCT01358578|3768290|B5||Male|Sex: Female, Male||Participants|Count of Participants|929|929.0||||||
3946460|NCT01358578|3768291|B4||Male|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
3946461|NCT01358578|3768292|B3||Male|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
3946462|NCT01358578|3768293|B2||Male|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
3946463|NCT01358578|3768294|B1||Male|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
3946464|NCT01358578|3768290|B5||Female|Sex: Female, Male||Participants|Count of Participants|377|377.0||||||
3946465|NCT01358578|3768291|B4||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3946466|NCT01358578|3768292|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3946467|NCT01358578|3768293|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3946468|NCT01358578|3768294|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3946469|NCT01358578|3768290|B5|||Age||years|Mean|44.4|44.4|Standard Deviation|12.93|12.93|||
3946470|NCT01358578|3768291|B4|||Age||years|Mean|43.8|43.8|Standard Deviation|12.95|12.95|||
3946471|NCT01358578|3768292|B3|||Age||years|Mean|44.1|44.1|Standard Deviation|12.64|12.64|||
3946472|NCT01358578|3768293|B2|||Age||years|Mean|44.5|44.5|Standard Deviation|13.19|13.19|||
3946473|NCT01358578|3768294|B1|||Age||years|Mean|45.4|45.4|Standard Deviation|12.92|12.92|||
3946474|NCT01358578|3768290|B5||>=65 years|Age||Participants|Count of Participants|78|78.0||||||
3946475|NCT01358578|3768291|B4||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3946476|NCT01358578|3768292|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3946477|NCT01358578|3768293|B2||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3946478|NCT01358578|3768294|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3946479|NCT01358578|3768290|B5||Between 18 and 65 years|Age||Participants|Count of Participants|1228|1228.0||||||
3946480|NCT01358578|3768291|B4||Between 18 and 65 years|Age||Participants|Count of Participants|308|308.0||||||
3946481|NCT01358578|3768292|B3||Between 18 and 65 years|Age||Participants|Count of Participants|311|311.0||||||
3946482|NCT01358578|3768293|B2||Between 18 and 65 years|Age||Participants|Count of Participants|305|305.0||||||
3946483|NCT01358578|3768294|B1||Between 18 and 65 years|Age||Participants|Count of Participants|304|304.0||||||
3946484|NCT01358578|3768290|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3946485|NCT01358578|3768291|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3946486|NCT01358578|3768292|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3946487|NCT01358578|3768293|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3946488|NCT01358578|3768294|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3946489|NCT01358526|3768349|B3|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3946490|NCT01358526|3768350|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3946491|NCT01358526|3768351|B1|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3946492|NCT01358526|3768349|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3946493|NCT01358526|3768350|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3946494|NCT01358526|3768351|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3946495|NCT01358526|3768349|B3|Asian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3946496|NCT01358526|3768350|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3946497|NCT01358526|3768351|B1|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3946498|NCT01358526|3768349|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|114|114.0||||||
3946499|NCT01358526|3768350|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
3946500|NCT01358526|3768351|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
3946501|NCT01358526|3768349|B3|White||Race/Ethnicity, Customized||participants|Number|462|462.0||||||
3946502|NCT01358526|3768350|B2|White||Race/Ethnicity, Customized||participants|Number|233|233.0||||||
3946503|NCT01358526|3768351|B1|White||Race/Ethnicity, Customized||participants|Number|229|229.0||||||
3946504|NCT01358526|3768349|B3||Male|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
3946505|NCT01358526|3768350|B2||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3946506|NCT01358526|3768351|B1||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3946507|NCT01358526|3768349|B3||Female|Sex: Female, Male||Participants|Count of Participants|338|338.0||||||
3946508|NCT01358526|3768350|B2||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
3946509|NCT01358526|3768351|B1||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3946510|NCT01358526|3768349|B3|||Age||years|Mean|53.2|53.2|Standard Deviation|11.33|11.33|||
3946511|NCT01358526|3768350|B2|||Age||years|Mean|53.0|53.0|Standard Deviation|10.97|10.97|||
3946512|NCT01358526|3768351|B1|||Age||years|Mean|53.5|53.5|Standard Deviation|11.69|11.69|||
3946513|NCT01358357|3768368|B3|Serbia||Region of Enrollment||participants|Number|39|39.0||||||
3946514|NCT01358357|3768369|B2|Serbia||Region of Enrollment||participants|Number|19|19.0||||||
3946515|NCT01358357|3768370|B1|Serbia||Region of Enrollment||participants|Number|20|20.0||||||
3946516|NCT01358357|3768368|B3|France||Region of Enrollment||participants|Number|14|14.0||||||
3946517|NCT01358357|3768369|B2|France||Region of Enrollment||participants|Number|6|6.0||||||
3946518|NCT01358357|3768370|B1|France||Region of Enrollment||participants|Number|8|8.0||||||
3946519|NCT01358357|3768368|B3|Chile||Region of Enrollment||participants|Number|20|20.0||||||
3946520|NCT01358357|3768369|B2|Chile||Region of Enrollment||participants|Number|11|11.0||||||
3946521|NCT01358357|3768370|B1|Chile||Region of Enrollment||participants|Number|9|9.0||||||
3946522|NCT01358357|3768368|B3|Bulgaria||Region of Enrollment||participants|Number|40|40.0||||||
3946523|NCT01358357|3768369|B2|Bulgaria||Region of Enrollment||participants|Number|20|20.0||||||
3946524|NCT01358357|3768370|B1|Bulgaria||Region of Enrollment||participants|Number|20|20.0||||||
3946525|NCT01358357|3768368|B3|Slovakia||Region of Enrollment||participants|Number|7|7.0||||||
3946526|NCT01358357|3768369|B2|Slovakia||Region of Enrollment||participants|Number|3|3.0||||||
3946527|NCT01358357|3768370|B1|Slovakia||Region of Enrollment||participants|Number|4|4.0||||||
3946528|NCT01358357|3768368|B3|Poland||Region of Enrollment||participants|Number|43|43.0||||||
3946529|NCT01358357|3768369|B2|Poland||Region of Enrollment||participants|Number|21|21.0||||||
3946530|NCT01358357|3768370|B1|Poland||Region of Enrollment||participants|Number|22|22.0||||||
3946531|NCT01358357|3768368|B3|Czech Republic||Region of Enrollment||participants|Number|47|47.0||||||
3946532|NCT01358357|3768369|B2|Czech Republic||Region of Enrollment||participants|Number|24|24.0||||||
3946533|NCT01358357|3768370|B1|Czech Republic||Region of Enrollment||participants|Number|23|23.0||||||
3946534|NCT01358357|3768368|B3|Japan||Region of Enrollment||participants|Number|10|10.0||||||
3946535|NCT01358357|3768369|B2|Japan||Region of Enrollment||participants|Number|5|5.0||||||
3946536|NCT01358357|3768370|B1|Japan||Region of Enrollment||participants|Number|5|5.0||||||
3946537|NCT01358357|3768368|B3|United States||Region of Enrollment||participants|Number|149|149.0||||||
3946538|NCT01358357|3768369|B2|United States||Region of Enrollment||participants|Number|76|76.0||||||
3946539|NCT01358357|3768370|B1|United States||Region of Enrollment||participants|Number|73|73.0||||||
3946540|NCT01358357|3768368|B3|Hungary||Region of Enrollment||participants|Number|28|28.0||||||
3946541|NCT01358357|3768369|B2|Hungary||Region of Enrollment||participants|Number|15|15.0||||||
3946542|NCT01358357|3768370|B1|Hungary||Region of Enrollment||participants|Number|13|13.0||||||
3946543|NCT01358357|3768368|B3|Russian Federation||Region of Enrollment||participants|Number|61|61.0||||||
3946544|NCT01358357|3768369|B2|Russian Federation||Region of Enrollment||participants|Number|31|31.0||||||
3946545|NCT01358357|3768370|B1|Russian Federation||Region of Enrollment||participants|Number|30|30.0||||||
3946546|NCT01358357|3768368|B3|Argentina||Region of Enrollment||participants|Number|38|38.0||||||
3946547|NCT01358357|3768369|B2|Argentina||Region of Enrollment||participants|Number|19|19.0||||||
3946548|NCT01358357|3768370|B1|Argentina||Region of Enrollment||participants|Number|19|19.0||||||
3946549|NCT01358357|3768368|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3946550|NCT01358357|3768369|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3946551|NCT01358357|3768370|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3946552|NCT01358357|3768368|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946553|NCT01358357|3768369|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946554|NCT01358357|3768370|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946555|NCT01358357|3768368|B3||White|Race (NIH/OMB)||Participants|Count of Participants|429|429.0||||||
3946556|NCT01358357|3768369|B2||White|Race (NIH/OMB)||Participants|Count of Participants|216|216.0||||||
3946557|NCT01358357|3768370|B1||White|Race (NIH/OMB)||Participants|Count of Participants|213|213.0||||||
3946558|NCT01358357|3768368|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3946559|NCT01358357|3768369|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3946560|NCT01358357|3768370|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3946561|NCT01358357|3768368|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946562|NCT01358357|3768369|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946563|NCT01358357|3768370|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946564|NCT01358357|3768368|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3946565|NCT01358357|3768369|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3946566|NCT01358357|3768370|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3946567|NCT01358357|3768368|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3946568|NCT01358357|3768369|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3946569|NCT01358357|3768370|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946570|NCT01358357|3768368|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946571|NCT01358357|3768369|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946572|NCT01358357|3768370|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946573|NCT01358357|3768368|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|417|417.0||||||
3946574|NCT01358357|3768369|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|212|212.0||||||
3946575|NCT01358357|3768370|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|205|205.0||||||
3946576|NCT01358357|3768368|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3946577|NCT01358357|3768369|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3946578|NCT01358357|3768370|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3946579|NCT01358357|3768368|B3||Male|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
3946580|NCT01358357|3768369|B2||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3946581|NCT01358357|3768370|B1||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3946582|NCT01358357|3768368|B3||Female|Sex: Female, Male||Participants|Count of Participants|279|279.0||||||
3946583|NCT01358357|3768369|B2||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3946584|NCT01358357|3768370|B1||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3946585|NCT01358357|3768368|B3|||Age||years|Mean|44.4|44.4|Standard Deviation|12.36|12.36|||
3946586|NCT01358357|3768369|B2|||Age||years|Mean|43.2|43.2|Standard Deviation|12.18|12.18|||
3946587|NCT01358357|3768370|B1|||Age||years|Mean|45.7|45.7|Standard Deviation|12.43|12.43|||
3946588|NCT01358357|3768368|B3||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3946589|NCT01358357|3768369|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3946590|NCT01358357|3768370|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3946591|NCT01358357|3768368|B3||Between 18 and 65 years|Age||Participants|Count of Participants|474|474.0||||||
3946592|NCT01358357|3768369|B2||Between 18 and 65 years|Age||Participants|Count of Participants|242|242.0||||||
3946593|NCT01358357|3768370|B1||Between 18 and 65 years|Age||Participants|Count of Participants|232|232.0||||||
3946594|NCT01358357|3768368|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3946595|NCT01358357|3768369|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3946596|NCT01358357|3768370|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3946597|NCT01358175|3768405|B4||Male|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
3946598|NCT01358175|3768406|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3946599|NCT01358175|3768407|B2||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3946600|NCT01358175|3768408|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3946601|NCT01358175|3768405|B4||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3946602|NCT01358175|3768406|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3946603|NCT01358175|3768407|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3946604|NCT01358175|3768408|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3946605|NCT01358175|3768405|B4||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3946606|NCT01358175|3768406|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3946607|NCT01358175|3768407|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3946608|NCT01358175|3768408|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3946609|NCT01358175|3768405|B4||Between 18 and 65 years|Age||Participants|Count of Participants|354|354.0||||||
3946610|NCT01358175|3768406|B3||Between 18 and 65 years|Age||Participants|Count of Participants|115|115.0||||||
3946611|NCT01358175|3768407|B2||Between 18 and 65 years|Age||Participants|Count of Participants|122|122.0||||||
3946612|NCT01358175|3768408|B1||Between 18 and 65 years|Age||Participants|Count of Participants|117|117.0||||||
3946613|NCT01358175|3768405|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3946614|NCT01358175|3768406|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3946615|NCT01358175|3768407|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3946616|NCT01358175|3768408|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3946617|NCT01357980|3768443|B5|||Number of Subjects Using Anticholinergics||participants|Number|28|28.0||||||
3946618|NCT01357980|3768444|B4|||Number of Subjects Using Anticholinergics||participants|Number|5|5.0||||||
3946619|NCT01357980|3768445|B3|||Number of Subjects Using Anticholinergics||participants|Number|9|9.0||||||
3946620|NCT01357980|3768446|B2|||Number of Subjects Using Anticholinergics||participants|Number|5|5.0||||||
3946621|NCT01357980|3768447|B1|||Number of Subjects Using Anticholinergics||participants|Number|9|9.0||||||
3946622|NCT01357980|3768443|B5|MS||Number of subjects with Spinal Cord Injury (SCI) or Multiple Sclerosis (MS)||participants|Number|20|20.0||||||
3946623|NCT01357980|3768444|B4|MS||Number of subjects with Spinal Cord Injury (SCI) or Multiple Sclerosis (MS)||participants|Number|4|4.0||||||
3946624|NCT01357980|3768445|B3|MS||Number of subjects with Spinal Cord Injury (SCI) or Multiple Sclerosis (MS)||participants|Number|9|9.0||||||
3946625|NCT01357980|3768446|B2|MS||Number of subjects with Spinal Cord Injury (SCI) or Multiple Sclerosis (MS)||participants|Number|2|2.0||||||
3946626|NCT01357980|3768447|B1|MS||Number of subjects with Spinal Cord Injury (SCI) or Multiple Sclerosis (MS)||participants|Number|5|5.0||||||
3946627|NCT01357980|3768443|B5|SCI||Number of subjects with Spinal Cord Injury (SCI) or Multiple Sclerosis (MS)||participants|Number|22|22.0||||||
3946628|NCT01357980|3768444|B4|SCI||Number of subjects with Spinal Cord Injury (SCI) or Multiple Sclerosis (MS)||participants|Number|2|2.0||||||
3946629|NCT01357980|3768445|B3|SCI||Number of subjects with Spinal Cord Injury (SCI) or Multiple Sclerosis (MS)||participants|Number|7|7.0||||||
3946630|NCT01357980|3768446|B2|SCI||Number of subjects with Spinal Cord Injury (SCI) or Multiple Sclerosis (MS)||participants|Number|4|4.0||||||
3946631|NCT01357980|3768447|B1|SCI||Number of subjects with Spinal Cord Injury (SCI) or Multiple Sclerosis (MS)||participants|Number|9|9.0||||||
3946632|NCT01357980|3768443|B5||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3946633|NCT01357980|3768444|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3946634|NCT01357980|3768445|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3946635|NCT01357980|3768446|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3946636|NCT01357980|3768447|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3946637|NCT01357980|3768443|B5||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3946638|NCT01357980|3768444|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3946639|NCT01357980|3768445|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3946640|NCT01357980|3768446|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3946641|NCT01357980|3768447|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3946642|NCT01357980|3768443|B5|||Age||years|Mean|47.9|47.9|Standard Deviation|11.6|11.6|||
3946643|NCT01357980|3768444|B4|||Age||years|Mean|40.8|40.8|Standard Deviation|10.6|10.6|||
3946644|NCT01357980|3768445|B3|||Age||years|Mean|50.5|50.5|Standard Deviation|11.1|11.1|||
3946645|NCT01357980|3768446|B2|||Age||years|Mean|46.5|46.5|Standard Deviation|10.7|10.7|||
3946646|NCT01357980|3768447|B1|||Age||years|Mean|41.1|41.1|Standard Deviation|12.1|12.1|||
3946647|NCT01357915|3768492|B3|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
3946648|NCT01357915|3768493|B2|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3946649|NCT01357915|3768494|B1|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3946650|NCT01357915|3768492|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3946651|NCT01357915|3768493|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3946652|NCT01357915|3768494|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3946653|NCT01357915|3768492|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3946654|NCT01357915|3768493|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3946655|NCT01357915|3768494|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3946656|NCT01357915|3768492|B3|||Age||Years|Mean|34.73|34.73|Standard Deviation|6.63|6.63|||
3946657|NCT01357915|3768493|B2|||Age||Years|Mean|35.5|35.5|Standard Deviation|7.20|7.2|||
3946658|NCT01357915|3768494|B1|||Age||Years|Mean|34.3|34.3|Standard Deviation|6.37|6.37|||
3946659|NCT01357889|3768508|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants randomized to the Single- and Multiple-dose Phases (Overall).|Participants|Number|237|237.0||||||
3946660|NCT01357889|3768509|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants randomized to the Single- and Multiple-dose Phases (Overall).|Participants|Number|117|117.0||||||
3946661|NCT01357889|3768510|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants randomized to the Single- and Multiple-dose Phases (Overall).|Participants|Number|120|120.0||||||
3946662|NCT01357889|3768508|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Baseline data are reported for participants randomized to the Single- and Multiple-dose Phases (Overall).|Participants|Number|1|1.0||||||
3946663|NCT01357889|3768509|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Baseline data are reported for participants randomized to the Single- and Multiple-dose Phases (Overall).|Participants|Number|1|1.0||||||
3946760|NCT01357655|3768648|B2|<=18 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3946664|NCT01357889|3768510|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Baseline data are reported for participants randomized to the Single- and Multiple-dose Phases (Overall).|Participants|Number|0|0.0||||||
3946665|NCT01357889|3768508|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants randomized to the Single- and Multiple-dose Phases (Overall).|Participants|Number|4|4.0||||||
3946666|NCT01357889|3768509|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants randomized to the Single- and Multiple-dose Phases (Overall).|Participants|Number|1|1.0||||||
3946667|NCT01357889|3768510|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants randomized to the Single- and Multiple-dose Phases (Overall).|Participants|Number|3|3.0||||||
3946668|NCT01357889|3768508|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants randomized to the Single- and Multiple-dose Phases (Overall).|Participants|Number|3|3.0||||||
3946669|NCT01357889|3768509|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants randomized to the Single- and Multiple-dose Phases (Overall).|Participants|Number|2|2.0||||||
3946670|NCT01357889|3768510|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants randomized to the Single- and Multiple-dose Phases (Overall).|Participants|Number|1|1.0||||||
3946671|NCT01357889|3768508|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants randomized to the Single- and Multiple-dose Phases (Overall).|Participants|Number|2|2.0||||||
3946672|NCT01357889|3768509|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants randomized to the Single- and Multiple-dose Phases (Overall).|Participants|Number|0|0.0||||||
3946673|NCT01357889|3768510|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants randomized to the Single- and Multiple-dose Phases (Overall).|Participants|Number|2|2.0||||||
3946674|NCT01357889|3768508|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized|Baseline data are reported for participants randomized to the Single- and Multiple-dose Phases (Overall).|Participants|Number|1|1.0||||||
3946675|NCT01357889|3768509|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized|Baseline data are reported for participants randomized to the Single- and Multiple-dose Phases (Overall).|Participants|Number|1|1.0||||||
3946676|NCT01357889|3768510|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized|Baseline data are reported for participants randomized to the Single- and Multiple-dose Phases (Overall).|Participants|Number|0|0.0||||||
3946677|NCT01357889|3768508|B3|African American/African Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants randomized to the Single- and Multiple-dose Phases (Overall).|Participants|Number|35|35.0||||||
3946678|NCT01357889|3768509|B2|African American/African Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants randomized to the Single- and Multiple-dose Phases (Overall).|Participants|Number|20|20.0||||||
3946679|NCT01357889|3768510|B1|African American/African Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants randomized to the Single- and Multiple-dose Phases (Overall).|Participants|Number|15|15.0||||||
3946680|NCT01357889|3768508|B3||Male|Gender|Baseline data are reported for participants randomized to the Single- and Multiple-dose Phases (Overall).|Participants|Count of Participants|129|129.0||||||
3946681|NCT01357889|3768509|B2||Male|Gender|Baseline data are reported for participants randomized to the Single- and Multiple-dose Phases (Overall).|Participants|Count of Participants|66|66.0||||||
3946682|NCT01357889|3768510|B1||Male|Gender|Baseline data are reported for participants randomized to the Single- and Multiple-dose Phases (Overall).|Participants|Count of Participants|63|63.0||||||
3946683|NCT01357889|3768508|B3||Female|Gender|Baseline data are reported for participants randomized to the Single- and Multiple-dose Phases (Overall).|Participants|Count of Participants|154|154.0||||||
3946684|NCT01357889|3768509|B2||Female|Gender|Baseline data are reported for participants randomized to the Single- and Multiple-dose Phases (Overall).|Participants|Count of Participants|76|76.0||||||
3946685|NCT01357889|3768510|B1||Female|Gender|Baseline data are reported for participants randomized to the Single- and Multiple-dose Phases (Overall).|Participants|Count of Participants|78|78.0||||||
3946686|NCT01357889|3768508|B3|||Age|Baseline data are reported for participants randomized to the Single- and Multiple-dose Phases (Overall).|Years|Mean|53.5|53.5|Standard Deviation|10.88|10.88|||
3946687|NCT01357889|3768509|B2|||Age|Baseline data are reported for participants randomized to the Single- and Multiple-dose Phases (Overall).|Years|Mean|54.4|54.4|Standard Deviation|10.53|10.53|||
3946688|NCT01357889|3768510|B1|||Age|Baseline data are reported for participants randomized to the Single- and Multiple-dose Phases (Overall).|Years|Mean|52.6|52.6|Standard Deviation|11.18|11.18|||
3946689|NCT01357850|3768551|B5|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3946690|NCT01357850|3768552|B4|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3946691|NCT01357850|3768553|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3946692|NCT01357850|3768554|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3946693|NCT01357850|3768555|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3946694|NCT01357850|3768551|B5|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|63|63.0||||||
3946695|NCT01357850|3768552|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
3946696|NCT01357850|3768553|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3946697|NCT01357850|3768554|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3946698|NCT01357850|3768555|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|26|26.0||||||
3946699|NCT01357850|3768551|B5|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3946700|NCT01357850|3768552|B4|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3946701|NCT01357850|3768553|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3946702|NCT01357850|3768554|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3946703|NCT01357850|3768555|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3946704|NCT01357850|3768551|B5|Native Hawaiian Or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3946705|NCT01357850|3768552|B4|Native Hawaiian Or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3946706|NCT01357850|3768553|B3|Native Hawaiian Or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3946707|NCT01357850|3768554|B2|Native Hawaiian Or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3946708|NCT01357850|3768555|B1|Native Hawaiian Or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3946709|NCT01357850|3768551|B5|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
3946710|NCT01357850|3768552|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3946711|NCT01357850|3768553|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3946712|NCT01357850|3768554|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3946713|NCT01357850|3768555|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3946714|NCT01357850|3768551|B5||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3946715|NCT01357850|3768552|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3946716|NCT01357850|3768553|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3946717|NCT01357850|3768554|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3946718|NCT01357850|3768555|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3946719|NCT01357850|3768551|B5||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3946720|NCT01357850|3768552|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3946721|NCT01357850|3768553|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3946722|NCT01357850|3768554|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3946723|NCT01357850|3768555|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3946724|NCT01357850|3768551|B5|||Age||Years|Mean|56.1|56.1|Standard Deviation|10.53|10.53|||
3946725|NCT01357850|3768552|B4|||Age||Years|Mean|58.2|58.2|Standard Deviation|10.23|10.23|||
3946726|NCT01357850|3768553|B3|||Age||Years|Mean|57.2|57.2|Standard Deviation|11.02|11.02|||
3946727|NCT01357850|3768554|B2|||Age||Years|Mean|51.3|51.3|Standard Deviation|12.44|12.44|||
3946728|NCT01357850|3768555|B1|||Age||Years|Mean|55.6|55.6|Standard Deviation|9.60|9.6|||
3946729|NCT01357720|3768630|B3||Male|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
3946730|NCT01357720|3768631|B2||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3946731|NCT01357720|3768632|B1||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3946732|NCT01357720|3768630|B3||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
3946733|NCT01357720|3768631|B2||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3946734|NCT01357720|3768632|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3946735|NCT01357720|3768630|B3|||Age||weeks|Mean|6.7|6.7|Standard Deviation|0.89|0.89|||
3946736|NCT01357720|3768631|B2|||Age||weeks|Mean|6.7|6.7|Standard Deviation|0.86|0.86|||
3946737|NCT01357720|3768632|B1|||Age||weeks|Mean|6.8|6.8|Standard Deviation|0.91|0.91|||
3946738|NCT01357720|3768630|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3946739|NCT01357720|3768631|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3946740|NCT01357720|3768632|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3946741|NCT01357720|3768630|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3946742|NCT01357720|3768631|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3946743|NCT01357720|3768632|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3946744|NCT01357720|3768630|B3||<=18 years|Age||Participants|Count of Participants|400|400.0||||||
3946745|NCT01357720|3768631|B2||<=18 years|Age||Participants|Count of Participants|200|200.0||||||
3946746|NCT01357720|3768632|B1||<=18 years|Age||Participants|Count of Participants|200|200.0||||||
3946747|NCT01357655|3768647|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3946748|NCT01357655|3768648|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3946749|NCT01357655|3768649|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3946750|NCT01357655|3768647|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3946751|NCT01357655|3768648|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3946752|NCT01357655|3768649|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3946753|NCT01357655|3768647|B3|>=65 years||Age, Customized||Participants|Count of Participants|12|12.0||||||
3946754|NCT01357655|3768648|B2|>=65 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3946755|NCT01357655|3768649|B1|>=65 years||Age, Customized||Participants|Count of Participants|12|12.0||||||
3946756|NCT01357655|3768647|B3|Between 18 and 64 years||Age, Customized||Participants|Count of Participants|54|54.0||||||
3946757|NCT01357655|3768648|B2|Between 18 and 64 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3946758|NCT01357655|3768649|B1|Between 18 and 64 years||Age, Customized||Participants|Count of Participants|54|54.0||||||
3946759|NCT01357655|3768647|B3|<=18 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3946761|NCT01357655|3768649|B1|<=18 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3946762|NCT01357616|3768665|B3||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3946763|NCT01357616|3768666|B2||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3946764|NCT01357616|3768667|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3946765|NCT01357616|3768665|B3||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3946766|NCT01357616|3768666|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3946767|NCT01357616|3768667|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3946768|NCT01357616|3768665|B3|≥65 Years||Age, Customized||participants|Number|29|29.0||||||
3946769|NCT01357616|3768666|B2|≥65 Years||Age, Customized||participants|Number|20|20.0||||||
3946770|NCT01357616|3768667|B1|≥65 Years||Age, Customized||participants|Number|9|9.0||||||
3946771|NCT01357616|3768665|B3|<65 Years||Age, Customized||participants|Number|283|283.0||||||
3946772|NCT01357616|3768666|B2|<65 Years||Age, Customized||participants|Number|135|135.0||||||
3946773|NCT01357616|3768667|B1|<65 Years||Age, Customized||participants|Number|148|148.0||||||
3946774|NCT01357551|3768680|B3|missing||Employment status||participants|Number|2|2.0||||||
3946775|NCT01357551|3768681|B2|missing||Employment status||participants|Number|1|1.0||||||
3946776|NCT01357551|3768682|B1|missing||Employment status||participants|Number|1|1.0||||||
3946777|NCT01357551|3768680|B3|other/disabled||Employment status||participants|Number|35|35.0||||||
3946778|NCT01357551|3768681|B2|other/disabled||Employment status||participants|Number|18|18.0||||||
3946779|NCT01357551|3768682|B1|other/disabled||Employment status||participants|Number|17|17.0||||||
3946780|NCT01357551|3768680|B3|retired||Employment status||participants|Number|124|124.0||||||
3946781|NCT01357551|3768681|B2|retired||Employment status||participants|Number|65|65.0||||||
3946782|NCT01357551|3768682|B1|retired||Employment status||participants|Number|59|59.0||||||
3946783|NCT01357551|3768680|B3|working full time or part-time||Employment status||participants|Number|61|61.0||||||
3946784|NCT01357551|3768681|B2|working full time or part-time||Employment status||participants|Number|28|28.0||||||
3946785|NCT01357551|3768682|B1|working full time or part-time||Employment status||participants|Number|33|33.0||||||
3946786|NCT01357551|3768680|B3|missing||Current tobacco user||participants|Number|1|1.0||||||
3946787|NCT01357551|3768681|B2|missing||Current tobacco user||participants|Number|1|1.0||||||
3946788|NCT01357551|3768682|B1|missing||Current tobacco user||participants|Number|0|0.0||||||
3946789|NCT01357551|3768680|B3|no||Current tobacco user||participants|Number|207|207.0||||||
3946790|NCT01357551|3768681|B2|no||Current tobacco user||participants|Number|102|102.0||||||
3946791|NCT01357551|3768682|B1|no||Current tobacco user||participants|Number|105|105.0||||||
3946792|NCT01357551|3768680|B3|yes||Current tobacco user||participants|Number|14|14.0||||||
3946793|NCT01357551|3768681|B2|yes||Current tobacco user||participants|Number|9|9.0||||||
3946794|NCT01357551|3768682|B1|yes||Current tobacco user||participants|Number|5|5.0||||||
3946795|NCT01357551|3768680|B3|missing||Education||participants|Number|1|1.0||||||
3946796|NCT01357551|3768681|B2|missing||Education||participants|Number|0|0.0||||||
3946797|NCT01357551|3768682|B1|missing||Education||participants|Number|1|1.0||||||
3946798|NCT01357551|3768680|B3|not high school graduate||Education||participants|Number|4|4.0||||||
3946799|NCT01357551|3768681|B2|not high school graduate||Education||participants|Number|1|1.0||||||
3946800|NCT01357551|3768682|B1|not high school graduate||Education||participants|Number|3|3.0||||||
3946801|NCT01357551|3768680|B3|high school graduate||Education||participants|Number|217|217.0||||||
3946802|NCT01357551|3768681|B2|high school graduate||Education||participants|Number|111|111.0||||||
3946803|NCT01357551|3768682|B1|high school graduate||Education||participants|Number|106|106.0||||||
3946804|NCT01357551|3768680|B3|||Body mass index||kilograms per meter squared|Mean|34.0|34.0|Standard Deviation|6.1|6.1|||
3946805|NCT01357551|3768681|B2|||Body mass index||kilograms per meter squared|Mean|34.6|34.6|Standard Deviation|6.4|6.4|||
3946806|NCT01357551|3768682|B1|||Body mass index||kilograms per meter squared|Mean|33.3|33.3|Standard Deviation|5.7|5.7|||
3946807|NCT01357551|3768680|B3|||Weight||kilograms|Mean|103.6|103.6|Standard Deviation|20.4|20.4|||
3946808|NCT01357551|3768681|B2|||Weight||kilograms|Mean|105.0|105.0|Standard Deviation|21.0|21.0|||
3946809|NCT01357551|3768682|B1|||Weight||kilograms|Mean|102.1|102.1|Standard Deviation|19.8|19.8|||
3946810|NCT01357551|3768680|B3|||Weight loss during initiation phase||kilograms|Mean|7.2|7.2|Standard Deviation|3.1|3.1|||
3946811|NCT01357551|3768681|B2|||Weight loss during initiation phase||kilograms|Mean|7.2|7.2|Standard Deviation|3.4|3.4|||
3946812|NCT01357551|3768682|B1|||Weight loss during initiation phase||kilograms|Mean|7.2|7.2|Standard Deviation|2.8|2.8|||
3946813|NCT01357551|3768680|B3|United States||Region of Enrollment||participants|Number|222|222.0||||||
3946814|NCT01357551|3768681|B2|United States||Region of Enrollment||participants|Number|112|112.0||||||
3946815|NCT01357551|3768682|B1|United States||Region of Enrollment||participants|Number|110|110.0||||||
3946816|NCT01357551|3768680|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3946817|NCT01357551|3768681|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3946818|NCT01357551|3768682|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3946819|NCT01357551|3768680|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3946820|NCT01357551|3768681|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3946821|NCT01357551|3768682|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3946822|NCT01357551|3768680|B3||White|Race (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
3946823|NCT01357551|3768681|B2||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3946824|NCT01357551|3768682|B1||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3946825|NCT01357551|3768680|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3946826|NCT01357551|3768681|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3946827|NCT01357551|3768682|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3946828|NCT01357551|3768680|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946829|NCT01357551|3768681|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946830|NCT01357551|3768682|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946831|NCT01357551|3768680|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946832|NCT01357551|3768681|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946833|NCT01357551|3768682|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946834|NCT01357551|3768680|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3946835|NCT01357551|3768681|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3946836|NCT01357551|3768682|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946837|NCT01357551|3768680|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3946838|NCT01357551|3768681|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946839|NCT01357551|3768682|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3946840|NCT01357551|3768680|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|216|216.0||||||
3946841|NCT01357551|3768681|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
3946842|NCT01357551|3768682|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
3946843|NCT01357551|3768680|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3946844|NCT01357551|3768681|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3946845|NCT01357551|3768682|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3946846|NCT01357551|3768680|B3||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3946847|NCT01357551|3768681|B2||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3946848|NCT01357551|3768682|B1||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3946849|NCT01357551|3768680|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3946850|NCT01357551|3768681|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3946851|NCT01357551|3768682|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3946852|NCT01357551|3768680|B3|||Age||years|Mean|61.8|61.8|Standard Deviation|8.3|8.3|||
3946853|NCT01357551|3768681|B2|||Age||years|Mean|62.0|62.0|Standard Deviation|8.3|8.3|||
3946854|NCT01357551|3768682|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|8.3|8.3|||
3946855|NCT01357512|3768695|B3|||Serum prostate-specific antigen level||ng/ml|Median|6.1|6.1|Inter-Quartile Range|||4.1|10.2|
3946856|NCT01357512|3768696|B2|||Serum prostate-specific antigen level||ng/ml|Median|6.2|6.2|Inter-Quartile Range|||4.0|10.7|
3946857|NCT01357512|3768697|B1|||Serum prostate-specific antigen level||ng/ml|Median|6.1|6.1|Inter-Quartile Range|||4.2|9.9|
3946858|NCT01357512|3768695|B3|Finland||Region of Enrollment||participants|Number|113|113.0||||||
3946859|NCT01357512|3768696|B2|Finland||Region of Enrollment||participants|Number|60|60.0||||||
3946860|NCT01357512|3768697|B1|Finland||Region of Enrollment||participants|Number|53|53.0||||||
3946861|NCT01357512|3768695|B3||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3946862|NCT01357512|3768696|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3946863|NCT01357512|3768697|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3946864|NCT01357512|3768695|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3946865|NCT01357512|3768696|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3946866|NCT01357512|3768697|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3946867|NCT01357512|3768695|B3|||Age||years|Median|62|62.0|Inter-Quartile Range|||58.0|66.0|
3946868|NCT01357512|3768696|B2|||Age||years|Median|62|62.0|Inter-Quartile Range|||56.0|67.0|
3946869|NCT01357512|3768697|B1|||Age||years|Median|63|63.0|Inter-Quartile Range|||60.0|66.0|
3946870|NCT01357239|3768706|B5||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3946871|NCT01357239|3768707|B4||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3946872|NCT01357239|3768708|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3946873|NCT01357239|3768709|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3946874|NCT01357239|3768710|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3946875|NCT01357239|3768706|B5||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3946876|NCT01357239|3768707|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3946877|NCT01357239|3768708|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3946878|NCT01357239|3768709|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3946879|NCT01357239|3768710|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3946880|NCT01357239|3768706|B5|||Age||Years|Mean|14.5|14.5|Standard Deviation|1.72|1.72|||
3946881|NCT01357239|3768707|B4|||Age||Years|Mean|14.4|14.4|Standard Deviation|1.85|1.85|||
3946882|NCT01357239|3768708|B3|||Age||Years|Mean|14.6|14.6|Standard Deviation|1.77|1.77|||
3946883|NCT01357239|3768709|B2|||Age||Years|Mean|14.6|14.6|Standard Deviation|1.58|1.58|||
3946884|NCT01357239|3768710|B1|||Age||Years|Mean|14.4|14.4|Standard Deviation|1.70|1.7|||
3946885|NCT01357161|3768768|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3946886|NCT01357161|3768769|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3946887|NCT01357161|3768770|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3946888|NCT01357161|3768771|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3946889|NCT01357161|3768768|B4||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3946890|NCT01357161|3768769|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3946891|NCT01357161|3768770|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3946892|NCT01357161|3768771|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3946893|NCT01357161|3768768|B4|||Age||years|Mean|59.3|59.3|Standard Deviation|9.9|9.9|||
3946894|NCT01357161|3768769|B3|||Age||years|Mean|60.4|60.4|Standard Deviation|9.8|9.8|||
3946895|NCT01357161|3768770|B2|||Age||years|Mean|58.3|58.3|Standard Deviation|10.1|10.1|||
3946896|NCT01357161|3768771|B1|||Age||years|Mean|58.2|58.2|Standard Deviation|9.9|9.9|||
3946897|NCT01357148|3768802|B1|Unspecified||Sex/Gender, Customized||participants|Number|3|3.0||||||
3946898|NCT01357148|3768802|B1|Male||Sex/Gender, Customized||participants|Number|66|66.0||||||
3946899|NCT01357148|3768802|B1|Female||Sex/Gender, Customized||participants|Number|74|74.0||||||
3946900|NCT01357148|3768802|B1|||Age||years|Mean|51|51.0|Standard Deviation|13.2|13.2|||
3946901|NCT01357135|3768809|B4|Missing||Sex/Gender, Customized||Participants|Number|8|8.0||||||
3946902|NCT01357135|3768810|B3|Missing||Sex/Gender, Customized||Participants|Number|0|0.0||||||
3946903|NCT01357135|3768811|B2|Missing||Sex/Gender, Customized||Participants|Number|0|0.0||||||
3946904|NCT01357135|3768812|B1|Missing||Sex/Gender, Customized||Participants|Number|8|8.0||||||
3946905|NCT01357135|3768809|B4|Male||Sex/Gender, Customized||Participants|Number|2004|2004.0||||||
3946906|NCT01357135|3768810|B3|Male||Sex/Gender, Customized||Participants|Number|474|474.0||||||
3946907|NCT01357135|3768811|B2|Male||Sex/Gender, Customized||Participants|Number|422|422.0||||||
3946908|NCT01357135|3768812|B1|Male||Sex/Gender, Customized||Participants|Number|1108|1108.0||||||
3946909|NCT01357135|3768809|B4|Female||Sex/Gender, Customized||Participants|Number|1441|1441.0||||||
3946910|NCT01357135|3768810|B3|Female||Sex/Gender, Customized||Participants|Number|372|372.0||||||
3946911|NCT01357135|3768811|B2|Female||Sex/Gender, Customized||Participants|Number|311|311.0||||||
3946912|NCT01357135|3768812|B1|Female||Sex/Gender, Customized||Participants|Number|758|758.0||||||
3946913|NCT01357135|3768809|B4|||Age||Years|Mean|63.5|63.5|Standard Deviation|11.2|11.2|||
3946914|NCT01357135|3768810|B3|||Age||Years|Mean|65.5|65.5|Standard Deviation|11.3|11.3|||
3946915|NCT01357135|3768811|B2|||Age||Years|Mean|64.2|64.2|Standard Deviation|11.5|11.5|||
3946916|NCT01357135|3768812|B1|||Age||Years|Mean|62.4|62.4|Standard Deviation|10.8|10.8|||
3946917|NCT01356966|3768823|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3946918|NCT01356966|3768824|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3946919|NCT01356966|3768825|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3946920|NCT01356966|3768823|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3946921|NCT01356966|3768824|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3946922|NCT01356966|3768825|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3946923|NCT01356966|3768823|B3|||Age||years|Mean|56.4|56.4|Standard Deviation|1.8|1.8|||
3946924|NCT01356966|3768824|B2|||Age||years|Mean|55.2|55.2|Standard Deviation|2.2|2.2|||
3946925|NCT01356966|3768825|B1|||Age||years|Mean|57.5|57.5|Standard Deviation|1.3|1.3|||
3946926|NCT01356940|3768836|B3|male patients||Sex/Gender, Customized||participants|Number|13|13.0||||||
3946927|NCT01356940|3768837|B2|male patients||Sex/Gender, Customized||participants|Number|10|10.0||||||
3946928|NCT01356940|3768838|B1|male patients||Sex/Gender, Customized||participants|Number|3|3.0||||||
3946929|NCT01356940|3768836|B3|female patients||Sex/Gender, Customized||participants|Number|30|30.0||||||
3946930|NCT01356940|3768837|B2|female patients||Sex/Gender, Customized||participants|Number|11|11.0||||||
3946931|NCT01356940|3768838|B1|female patients||Sex/Gender, Customized||participants|Number|19|19.0||||||
3946932|NCT01356940|3768836|B3|||Age||years|Mean|54.2|54.2|Standard Deviation|2.3|2.3|||
3946933|NCT01356940|3768837|B2|||Age||years|Mean|53.3|53.3|Standard Deviation|2.2|2.2|||
3946934|NCT01356940|3768838|B1|||Age||years|Mean|55.0|55.0|Standard Deviation|2.5|2.5|||
3946935|NCT01356667|3768847|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3946936|NCT01356667|3768848|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3946937|NCT01356667|3768849|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3946938|NCT01356667|3768847|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3946939|NCT01356667|3768848|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3946940|NCT01356667|3768849|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3946941|NCT01356667|3768847|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3946942|NCT01356667|3768848|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3946943|NCT01356667|3768849|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3946944|NCT01356667|3768847|B3|||Age||years|Mean|44.3|44.3|Standard Deviation|9.5|9.5|||
3946945|NCT01356667|3768848|B2|||Age||years|Mean|50.3|50.3|Standard Deviation|3.9|3.9|||
3946946|NCT01356667|3768849|B1|||Age||years|Mean|35.3|35.3|Standard Deviation|9.0|9.0|||
3946947|NCT01356667|3768847|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3946948|NCT01356667|3768848|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3946949|NCT01356667|3768849|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3946950|NCT01356667|3768847|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3946951|NCT01356667|3768848|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3946952|NCT01356667|3768849|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3946953|NCT01356667|3768847|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3946954|NCT01356667|3768848|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3946955|NCT01356667|3768849|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3946956|NCT01356628|3768860|B1|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3946957|NCT01356628|3768860|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946958|NCT01356628|3768860|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946959|NCT01356628|3768860|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3946960|NCT01356628|3768860|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3946961|NCT01356628|3768860|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946962|NCT01356628|3768860|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3946963|NCT01356628|3768860|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946964|NCT01356628|3768860|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3946965|NCT01356628|3768860|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3946966|NCT01356628|3768860|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3946967|NCT01356628|3768860|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3946968|NCT01356628|3768860|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3946969|NCT01356628|3768860|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3946970|NCT01356628|3768860|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3946971|NCT01356628|3768860|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3946972|NCT01356602|3768865|B4||Male|Sex: Female, Male||Participants|Count of Participants|364|364.0||||||
3946973|NCT01356602|3768866|B3||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3946974|NCT01356602|3768867|B2||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3946975|NCT01356602|3768868|B1||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3946976|NCT01356602|3768865|B4||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3946977|NCT01356602|3768866|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3946978|NCT01356602|3768867|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3946979|NCT01356602|3768868|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3946980|NCT01356602|3768865|B4|||Age||Years|Mean|53.5|53.5|Standard Deviation|11.44|11.44|||
3946981|NCT01356602|3768866|B3|||Age||Years|Mean|53.7|53.7|Standard Deviation|11.33|11.33|||
3946982|NCT01356602|3768867|B2|||Age||Years|Mean|53|53.0|Standard Deviation|11.84|11.84|||
3946983|NCT01356602|3768868|B1|||Age||Years|Mean|53.4|53.4|Standard Deviation|11.21|11.21|||
3946984|NCT01356589|3768929|B1||Male|Sex: Female, Male||Participants|Count of Participants|715|715.0||||||
3946985|NCT01356589|3768929|B1||Female|Sex: Female, Male||Participants|Count of Participants|570|570.0||||||
3946986|NCT01356589|3768929|B1|||Age|Data for this baseline characteristic were available for 1276 participants only.|years|Mean|70.13|70.13|Standard Deviation|13.75|13.75|||
3946987|NCT01356498|3768935|B7|Mexico||Region of Enrollment||participants|Number|14|14.0||||||
3946988|NCT01356498|3768936|B6|Mexico||Region of Enrollment||participants|Number|3|3.0||||||
3946989|NCT01356498|3768937|B5|Mexico||Region of Enrollment||participants|Number|1|1.0||||||
3946990|NCT01356498|3768938|B4|Mexico||Region of Enrollment||participants|Number|5|5.0||||||
3946991|NCT01356498|3768939|B3|Mexico||Region of Enrollment||participants|Number|0|0.0||||||
3946992|NCT01356498|3768940|B2|Mexico||Region of Enrollment||participants|Number|2|2.0||||||
3946993|NCT01356498|3768941|B1|Mexico||Region of Enrollment||participants|Number|3|3.0||||||
3946994|NCT01356498|3768935|B7|Canada||Region of Enrollment||participants|Number|2|2.0||||||
3946995|NCT01356498|3768936|B6|Canada||Region of Enrollment||participants|Number|0|0.0||||||
3946996|NCT01356498|3768937|B5|Canada||Region of Enrollment||participants|Number|0|0.0||||||
3946997|NCT01356498|3768938|B4|Canada||Region of Enrollment||participants|Number|0|0.0||||||
3946998|NCT01356498|3768939|B3|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3946999|NCT01356498|3768940|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3947000|NCT01356498|3768941|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
3947001|NCT01356498|3768935|B7|United States||Region of Enrollment||participants|Number|133|133.0||||||
3947002|NCT01356498|3768936|B6|United States||Region of Enrollment||participants|Number|13|13.0||||||
3947003|NCT01356498|3768937|B5|United States||Region of Enrollment||participants|Number|27|27.0||||||
3947004|NCT01356498|3768938|B4|United States||Region of Enrollment||participants|Number|17|17.0||||||
3947005|NCT01356498|3768939|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
3947006|NCT01356498|3768940|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
3947007|NCT01356498|3768941|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
3947008|NCT01356498|3768935|B7||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3947009|NCT01356498|3768936|B6||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3947010|NCT01356498|3768937|B5||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3947011|NCT01356498|3768938|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3947012|NCT01356498|3768939|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3947013|NCT01356498|3768940|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3947014|NCT01356498|3768941|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3947015|NCT01356498|3768935|B7||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3947016|NCT01356498|3768936|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3947017|NCT01356498|3768937|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3947018|NCT01356498|3768938|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3947019|NCT01356498|3768939|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3947020|NCT01356498|3768940|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3947021|NCT01356498|3768941|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3947022|NCT01356498|3768935|B7|||Age||years|Mean|56.8|56.8|Standard Deviation|13.19|13.19|||
3947023|NCT01356498|3768936|B6|||Age||years|Mean|54.6|54.6|Standard Deviation|13.62|13.62|||
3947024|NCT01356498|3768937|B5|||Age||years|Mean|53.5|53.5|Standard Deviation|12.25|12.25|||
3947025|NCT01356498|3768938|B4|||Age||years|Mean|52.0|52.0|Standard Deviation|13.12|13.12|||
3947026|NCT01356498|3768939|B3|||Age||years|Mean|56.6|56.6|Standard Deviation|10.53|10.53|||
3947027|NCT01356498|3768940|B2|||Age||years|Mean|58.6|58.6|Standard Deviation|13.59|13.59|||
3947028|NCT01356498|3768941|B1|||Age||years|Mean|62.4|62.4|Standard Deviation|13.66|13.66|||
3947029|NCT01356498|3768935|B7||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
3947030|NCT01356498|3768936|B6||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3947031|NCT01356498|3768937|B5||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3947032|NCT01356498|3768938|B4||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3947033|NCT01356498|3768939|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3947034|NCT01356498|3768940|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3947035|NCT01356498|3768941|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3947036|NCT01356498|3768935|B7||Between 18 and 65 years|Age||Participants|Count of Participants|105|105.0||||||
3947037|NCT01356498|3768936|B6||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3947038|NCT01356498|3768937|B5||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3947039|NCT01356498|3768938|B4||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3947040|NCT01356498|3768939|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3947041|NCT01356498|3768940|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3947042|NCT01356498|3768941|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3947043|NCT01356498|3768935|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3947044|NCT01356498|3768936|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3947045|NCT01356498|3768937|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3947046|NCT01356498|3768938|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3947047|NCT01356498|3768939|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3947048|NCT01356498|3768940|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3947049|NCT01356498|3768941|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3947050|NCT01356407|3768984|B3|||BMI||kg/m2|Mean|22.99|22.99|Standard Deviation|2.75|2.75|||
3947051|NCT01356407|3768985|B2|||BMI||kg/m2|Mean|23.07|23.07|Standard Deviation|2.83|2.83|||
3947052|NCT01356407|3768986|B1|||BMI||kg/m2|Mean|22.91|22.91|Standard Deviation|2.67|2.67|||
3947053|NCT01356407|3768984|B3|||Weight||kilograms|Mean|62.65|62.65|Standard Deviation|10.52|10.52|||
3947054|NCT01356407|3768985|B2|||Weight||kilograms|Mean|62.95|62.95|Standard Deviation|10.86|10.86|||
3947055|NCT01356407|3768986|B1|||Weight||kilograms|Mean|62.35|62.35|Standard Deviation|10.20|10.2|||
3947056|NCT01356407|3768984|B3||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3947057|NCT01356407|3768985|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3947058|NCT01356407|3768986|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3947059|NCT01356407|3768984|B3||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
3947060|NCT01356407|3768985|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3947061|NCT01356407|3768986|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3947062|NCT01356407|3768984|B3|||Age||years|Mean|46.80|46.8|Standard Deviation|12.74|12.74|||
3947063|NCT01356407|3768985|B2|||Age||years|Mean|47.15|47.15|Standard Deviation|12.63|12.63|||
3947064|NCT01356407|3768986|B1|||Age||years|Mean|46.44|46.44|Standard Deviation|12.88|12.88|||
3947065|NCT01356277|3769003|B3|||Total Adolescent Medication Barriers scale score|A higher Adolescent medication Barriers Scale (AMBS) represents a greater burden of barriers. The possible range for total score is 17-85.|units on a scale|Mean|37.7|37.7|Standard Deviation|10.5|10.5|||
3947066|NCT01356277|3769004|B2|||Total Adolescent Medication Barriers scale score|A higher Adolescent medication Barriers Scale (AMBS) represents a greater burden of barriers. The possible range for total score is 17-85.|units on a scale|Mean|38.1|38.1|Standard Deviation|9.8|9.8|||
3947067|NCT01356277|3769005|B1|||Total Adolescent Medication Barriers scale score|A higher Adolescent medication Barriers Scale (AMBS) represents a greater burden of barriers. The possible range for total score is 17-85.|units on a scale|Mean|37.5|37.5|Standard Deviation|11.2|11.2|||
3947068|NCT01356277|3769003|B3|||pre-intervention taking adherence||% days with 100% taking adherence|Number|73.8|73.8||||||
3947069|NCT01356277|3769004|B2|||pre-intervention taking adherence||% days with 100% taking adherence|Number|74.7|74.7||||||
3947070|NCT01356277|3769005|B1|||pre-intervention taking adherence||% days with 100% taking adherence|Number|72.8|72.8||||||
3947071|NCT01356277|3769003|B3|||number of doses of immunosuppressives per day||number of doses per day|Median|7|7.0|Inter-Quartile Range|||5.0|9.0|
3947072|NCT01356277|3769004|B2|||number of doses of immunosuppressives per day||number of doses per day|Median|7|7.0|Inter-Quartile Range|||5.0|9.0|
3947073|NCT01356277|3769005|B1|||number of doses of immunosuppressives per day||number of doses per day|Median|7|7.0|Inter-Quartile Range|||5.0|9.0|
3947074|NCT01356277|3769003|B3||at least 1|number of comorbidities||Participants|Count of Participants|85|85.0||||||
3947075|NCT01356277|3769004|B2||at least 1|number of comorbidities||Participants|Count of Participants|45|45.0||||||
3947076|NCT01356277|3769005|B1||at least 1|number of comorbidities||Participants|Count of Participants|40|40.0||||||
3947077|NCT01356277|3769003|B3||0|number of comorbidities||Participants|Count of Participants|84|84.0||||||
3947078|NCT01356277|3769004|B2||0|number of comorbidities||Participants|Count of Participants|43|43.0||||||
3947079|NCT01356277|3769005|B1||0|number of comorbidities||Participants|Count of Participants|41|41.0||||||
3947080|NCT01356277|3769003|B3||2 or more|number of past acute rejections||Participants|Count of Participants|10|10.0||||||
3947081|NCT01356277|3769004|B2||2 or more|number of past acute rejections||Participants|Count of Participants|4|4.0||||||
3947082|NCT01356277|3769005|B1||2 or more|number of past acute rejections||Participants|Count of Participants|6|6.0||||||
3947083|NCT01356277|3769003|B3||1|number of past acute rejections||Participants|Count of Participants|24|24.0||||||
3947084|NCT01356277|3769004|B2||1|number of past acute rejections||Participants|Count of Participants|8|8.0||||||
3947085|NCT01356277|3769005|B1||1|number of past acute rejections||Participants|Count of Participants|16|16.0||||||
3947086|NCT01356277|3769003|B3||0|number of past acute rejections||Participants|Count of Participants|135|135.0||||||
3947087|NCT01356277|3769004|B2||0|number of past acute rejections||Participants|Count of Participants|76|76.0||||||
3947088|NCT01356277|3769005|B1||0|number of past acute rejections||Participants|Count of Participants|59|59.0||||||
3947089|NCT01356277|3769003|B3||other|primary disease||Participants|Count of Participants|65|65.0||||||
3947090|NCT01356277|3769004|B2||other|primary disease||Participants|Count of Participants|36|36.0||||||
3947091|NCT01356277|3769005|B1||other|primary disease||Participants|Count of Participants|29|29.0||||||
3947092|NCT01356277|3769003|B3||Focal segmental glomerulosclerosis|primary disease||Participants|Count of Participants|20|20.0||||||
3947093|NCT01356277|3769004|B2||Focal segmental glomerulosclerosis|primary disease||Participants|Count of Participants|6|6.0||||||
3947094|NCT01356277|3769005|B1||Focal segmental glomerulosclerosis|primary disease||Participants|Count of Participants|14|14.0||||||
3947095|NCT01356277|3769003|B3||glomerulonephritis|primary disease||Participants|Count of Participants|14|14.0||||||
3947096|NCT01356277|3769004|B2||glomerulonephritis|primary disease||Participants|Count of Participants|5|5.0||||||
3947097|NCT01356277|3769005|B1||glomerulonephritis|primary disease||Participants|Count of Participants|9|9.0||||||
3947098|NCT01356277|3769003|B3||Congenital anomalies of the kidneys/ urinary tract|primary disease||Participants|Count of Participants|70|70.0||||||
3947099|NCT01356277|3769004|B2||Congenital anomalies of the kidneys/ urinary tract|primary disease||Participants|Count of Participants|41|41.0||||||
3947100|NCT01356277|3769005|B1||Congenital anomalies of the kidneys/ urinary tract|primary disease||Participants|Count of Participants|29|29.0||||||
3947101|NCT01356277|3769003|B3|||median total lifetime duration of dialysis||Months|Median|6.0|6.0|Inter-Quartile Range|||0.0|15.0|
3947102|NCT01356277|3769004|B2|||median total lifetime duration of dialysis||Months|Median|5.0|5.0|Inter-Quartile Range|||0.0|12.0|
3947103|NCT01356277|3769005|B1|||median total lifetime duration of dialysis||Months|Median|10.0|10.0|Inter-Quartile Range|||0.1|19.0|
3947104|NCT01356277|3769003|B3||Deceased|donor source||Participants|Count of Participants|81|81.0||||||
3947105|NCT01356277|3769004|B2||Deceased|donor source||Participants|Count of Participants|37|37.0||||||
3947106|NCT01356277|3769005|B1||Deceased|donor source||Participants|Count of Participants|44|44.0||||||
3947107|NCT01356277|3769003|B3||Living|donor source||Participants|Count of Participants|88|88.0||||||
3947108|NCT01356277|3769004|B2||Living|donor source||Participants|Count of Participants|51|51.0||||||
3947109|NCT01356277|3769005|B1||Living|donor source||Participants|Count of Participants|37|37.0||||||
3947110|NCT01356277|3769003|B3|||median years post-transplant||years|Median|3.1|3.1|Inter-Quartile Range|||0.7|7.5|
3947111|NCT01356277|3769004|B2|||median years post-transplant||years|Median|3.0|3.0|Inter-Quartile Range|||0.8|7.2|
3947112|NCT01356277|3769005|B1|||median years post-transplant||years|Median|3.7|3.7|Inter-Quartile Range|||0.7|7.9|
3947113|NCT01356277|3769003|B3||unknown|household income||Participants|Count of Participants|14|14.0||||||
3947114|NCT01356277|3769004|B2||unknown|household income||Participants|Count of Participants|9|9.0||||||
3947115|NCT01356277|3769005|B1||unknown|household income||Participants|Count of Participants|5|5.0||||||
3947116|NCT01356277|3769003|B3||prefer not to answer|household income||Participants|Count of Participants|7|7.0||||||
3947117|NCT01356277|3769004|B2||prefer not to answer|household income||Participants|Count of Participants|2|2.0||||||
3947118|NCT01356277|3769005|B1||prefer not to answer|household income||Participants|Count of Participants|5|5.0||||||
3947119|NCT01356277|3769003|B3||>$100,000|household income||Participants|Count of Participants|28|28.0||||||
3947120|NCT01356277|3769004|B2||>$100,000|household income||Participants|Count of Participants|16|16.0||||||
3947121|NCT01356277|3769005|B1||>$100,000|household income||Participants|Count of Participants|12|12.0||||||
3947122|NCT01356277|3769003|B3||$76,000- $100,000|household income||Participants|Count of Participants|15|15.0||||||
3947123|NCT01356277|3769004|B2||$76,000- $100,000|household income||Participants|Count of Participants|9|9.0||||||
3947124|NCT01356277|3769005|B1||$76,000- $100,000|household income||Participants|Count of Participants|6|6.0||||||
3947125|NCT01356277|3769003|B3||$51,000- $75,000|household income||Participants|Count of Participants|39|39.0||||||
3947126|NCT01356277|3769004|B2||$51,000- $75,000|household income||Participants|Count of Participants|22|22.0||||||
3947127|NCT01356277|3769005|B1||$51,000- $75,000|household income||Participants|Count of Participants|17|17.0||||||
3947128|NCT01356277|3769003|B3||$25,000- $50,000|household income||Participants|Count of Participants|37|37.0||||||
3947129|NCT01356277|3769004|B2||$25,000- $50,000|household income||Participants|Count of Participants|20|20.0||||||
3947130|NCT01356277|3769005|B1||$25,000- $50,000|household income||Participants|Count of Participants|17|17.0||||||
3947131|NCT01356277|3769003|B3||< $25,000|household income||Participants|Count of Participants|29|29.0||||||
3947132|NCT01356277|3769004|B2||< $25,000|household income||Participants|Count of Participants|10|10.0||||||
3947133|NCT01356277|3769005|B1||< $25,000|household income||Participants|Count of Participants|19|19.0||||||
3947134|NCT01356277|3769003|B3||Canada provincial|medication insurer||Participants|Count of Participants|59|59.0||||||
3947135|NCT01356277|3769004|B2||Canada provincial|medication insurer||Participants|Count of Participants|32|32.0||||||
3947136|NCT01356277|3769005|B1||Canada provincial|medication insurer||Participants|Count of Participants|27|27.0||||||
3947137|NCT01356277|3769003|B3||Private|medication insurer||Participants|Count of Participants|64|64.0||||||
3947138|NCT01356277|3769004|B2||Private|medication insurer||Participants|Count of Participants|36|36.0||||||
3947139|NCT01356277|3769005|B1||Private|medication insurer||Participants|Count of Participants|28|28.0||||||
3947140|NCT01356277|3769003|B3||U.S. Public|medication insurer||Participants|Count of Participants|46|46.0||||||
3947141|NCT01356277|3769004|B2||U.S. Public|medication insurer||Participants|Count of Participants|20|20.0||||||
3947142|NCT01356277|3769005|B1||U.S. Public|medication insurer||Participants|Count of Participants|26|26.0||||||
3947143|NCT01356277|3769003|B3|United States||Region of Enrollment||Participants|Count of Participants|110|110.0||||||
3947144|NCT01356277|3769004|B2|United States||Region of Enrollment||Participants|Count of Participants|56|56.0||||||
3947145|NCT01356277|3769005|B1|United States||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
3947146|NCT01356277|3769003|B3|Canada||Region of Enrollment||Participants|Count of Participants|59|59.0||||||
3947147|NCT01356277|3769004|B2|Canada||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3947148|NCT01356277|3769005|B1|Canada||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3947149|NCT01356277|3769003|B3|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3947150|NCT01356277|3769004|B2|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3947151|NCT01356277|3769005|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3947152|NCT01356277|3769003|B3|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3947153|NCT01356277|3769004|B2|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3947154|NCT01356277|3769005|B1|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3947155|NCT01356277|3769003|B3|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3947156|NCT01356277|3769004|B2|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3947157|NCT01356277|3769005|B1|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3947158|NCT01356277|3769003|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|114|114.0||||||
3947159|NCT01356277|3769004|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|57|57.0||||||
3947160|NCT01356277|3769005|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|57|57.0||||||
3947161|NCT01356277|3769003|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947162|NCT01356277|3769004|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947163|NCT01356277|3769005|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947164|NCT01356277|3769003|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|155|155.0||||||
3947165|NCT01356277|3769004|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3947166|NCT01356277|3769005|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3947167|NCT01356277|3769003|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3947168|NCT01356277|3769004|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3947169|NCT01356277|3769005|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3947170|NCT01356277|3769003|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3947171|NCT01356277|3769004|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3947172|NCT01356277|3769005|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3947173|NCT01356277|3769003|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3947174|NCT01356277|3769004|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3947175|NCT01356277|3769005|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3947176|NCT01356277|3769003|B3|||Age||years|Median|15.8|15.8|Inter-Quartile Range|||13.2|17.4|
3947177|NCT01356277|3769004|B2|||Age||years|Median|15.8|15.8|Inter-Quartile Range|||13.3|17.4|
3947178|NCT01356277|3769005|B1|||Age||years|Median|15.5|15.5|Inter-Quartile Range|||13.2|17.4|
3947179|NCT01356147|3769024|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3947180|NCT01356147|3769025|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3947181|NCT01356147|3769026|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3947182|NCT01356147|3769024|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3947183|NCT01356147|3769025|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3947184|NCT01356147|3769026|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3947185|NCT01356147|3769024|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3947186|NCT01356147|3769025|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3947187|NCT01356147|3769026|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3947188|NCT01356147|3769024|B3|||Age||days|Mean|31|31.0|Full Range|||18.0|68.0|
3947189|NCT01356147|3769025|B2|||Age||days|Mean|33|33.0|Full Range|||18.0|68.0|
3947190|NCT01356147|3769026|B1|||Age||days|Mean|29|29.0|Full Range|||18.0|39.0|
3947191|NCT01356147|3769024|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3947192|NCT01356147|3769025|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3947193|NCT01356147|3769026|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3947194|NCT01356147|3769024|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3947195|NCT01356147|3769025|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3947196|NCT01356147|3769026|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3947197|NCT01356147|3769024|B3||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
3947198|NCT01356147|3769025|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3947199|NCT01356147|3769026|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3947200|NCT01355978|3769037|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3947201|NCT01355978|3769037|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947202|NCT01355978|3769037|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947203|NCT01355978|3769037|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3947204|NCT01355978|3769037|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947205|NCT01355978|3769037|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947206|NCT01355978|3769037|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947207|NCT01355978|3769037|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947208|NCT01355978|3769037|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3947209|NCT01355978|3769037|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3947210|NCT01355978|3769037|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3947211|NCT01355978|3769037|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3947212|NCT01355978|3769037|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3947213|NCT01355796|3769043|B1|||FEV1||% of predicted|Mean|71|71.0|Inter-Quartile Range|||64.0|78.0|
3947214|NCT01355796|3769043|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3947215|NCT01355796|3769043|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3947216|NCT01355796|3769043|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3947217|NCT01355796|3769043|B1|||Age||years|Mean|31|31.0|Standard Deviation|12.56|12.56|||
3947218|NCT01355796|3769043|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3947219|NCT01355796|3769043|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3947220|NCT01355796|3769043|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3947221|NCT01355705|3769052|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3947222|NCT01355705|3769052|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3947223|NCT01355705|3769052|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3947224|NCT01355705|3769052|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3947225|NCT01355705|3769052|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3947226|NCT01355705|3769052|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3947227|NCT01355679|3769059|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3947228|NCT01355679|3769059|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3947229|NCT01355679|3769059|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947230|NCT01355679|3769059|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3947231|NCT01355679|3769059|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3947232|NCT01355679|3769059|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947233|NCT01355679|3769059|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947234|NCT01355679|3769059|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947235|NCT01355679|3769059|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3947236|NCT01355679|3769059|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3947237|NCT01355679|3769059|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3947238|NCT01355679|3769059|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3947239|NCT01355679|3769059|B1||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
3947240|NCT01355627|3769066|B3|Not Applicable||Fertility Status||participants|Number|282|282.0||||||
3947241|NCT01355627|3769067|B2|Not Applicable||Fertility Status||participants|Number|154|154.0||||||
3947242|NCT01355627|3769068|B1|Not Applicable||Fertility Status||participants|Number|128|128.0||||||
3947243|NCT01355627|3769066|B3|Surgically Sterile||Fertility Status||participants|Number|45|45.0||||||
3947244|NCT01355627|3769067|B2|Surgically Sterile||Fertility Status||participants|Number|26|26.0||||||
3947245|NCT01355627|3769068|B1|Surgically Sterile||Fertility Status||participants|Number|19|19.0||||||
3947246|NCT01355627|3769066|B3|Post-Menopausal||Fertility Status||participants|Number|251|251.0||||||
3947247|NCT01355627|3769067|B2|Post-Menopausal||Fertility Status||participants|Number|111|111.0||||||
3947248|NCT01355627|3769068|B1|Post-Menopausal||Fertility Status||participants|Number|140|140.0||||||
3947249|NCT01355627|3769066|B3|Fertile||Fertility Status||participants|Number|148|148.0||||||
3947250|NCT01355627|3769067|B2|Fertile||Fertility Status||participants|Number|74|74.0||||||
3947251|NCT01355627|3769068|B1|Fertile||Fertility Status||participants|Number|74|74.0||||||
3947252|NCT01355627|3769066|B3|||Body Mass Index (BMI)||kg/m^2|Mean|26.31|26.31|Standard Deviation|4.79|4.79|||
3947253|NCT01355627|3769067|B2|||Body Mass Index (BMI)||kg/m^2|Mean|26.42|26.42|Standard Deviation|5.10|5.1|||
3947254|NCT01355627|3769068|B1|||Body Mass Index (BMI)||kg/m^2|Mean|26.20|26.2|Standard Deviation|4.44|4.44|||
3947255|NCT01355627|3769066|B3|||Weight||kg|Mean|74.4|74.4|Standard Deviation|15.65|15.65|||
3947256|NCT01355627|3769067|B2|||Weight||kg|Mean|75.2|75.2|Standard Deviation|16.79|16.79|||
3947257|NCT01355627|3769068|B1|||Weight||kg|Mean|73.6|73.6|Standard Deviation|14.40|14.4|||
3947258|NCT01355627|3769066|B3|||Height||cm|Mean|168.0|168.0|Standard Deviation|9.32|9.32|||
3947259|NCT01355627|3769067|B2|||Height||cm|Mean|168.5|168.5|Standard Deviation|9.18|9.18|||
3947260|NCT01355627|3769068|B1|||Height||cm|Mean|167.4|167.4|Standard Deviation|9.44|9.44|||
3947261|NCT01355627|3769066|B3|Sweden||Region of Enrollment||participants|Number|90|90.0||||||
3947262|NCT01355627|3769067|B2|Sweden||Region of Enrollment||participants|Number|46|46.0||||||
3947263|NCT01355627|3769068|B1|Sweden||Region of Enrollment||participants|Number|44|44.0||||||
3947264|NCT01355627|3769066|B3|Russian Federation||Region of Enrollment||participants|Number|17|17.0||||||
3947265|NCT01355627|3769067|B2|Russian Federation||Region of Enrollment||participants|Number|8|8.0||||||
3947266|NCT01355627|3769068|B1|Russian Federation||Region of Enrollment||participants|Number|9|9.0||||||
3947267|NCT01355627|3769066|B3|Poland||Region of Enrollment||participants|Number|120|120.0||||||
3947268|NCT01355627|3769067|B2|Poland||Region of Enrollment||participants|Number|61|61.0||||||
3947269|NCT01355627|3769068|B1|Poland||Region of Enrollment||participants|Number|59|59.0||||||
3947270|NCT01355627|3769066|B3|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
3947271|NCT01355627|3769067|B2|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
3947272|NCT01355627|3769068|B1|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
3947273|NCT01355627|3769066|B3|Italy||Region of Enrollment||participants|Number|28|28.0||||||
3947274|NCT01355627|3769067|B2|Italy||Region of Enrollment||participants|Number|14|14.0||||||
3947275|NCT01355627|3769068|B1|Italy||Region of Enrollment||participants|Number|14|14.0||||||
3947276|NCT01355627|3769066|B3|Greece||Region of Enrollment||participants|Number|72|72.0||||||
3947277|NCT01355627|3769067|B2|Greece||Region of Enrollment||participants|Number|38|38.0||||||
3947278|NCT01355627|3769068|B1|Greece||Region of Enrollment||participants|Number|34|34.0||||||
3947279|NCT01355627|3769066|B3|France||Region of Enrollment||participants|Number|50|50.0||||||
3947280|NCT01355627|3769067|B2|France||Region of Enrollment||participants|Number|26|26.0||||||
3947281|NCT01355627|3769068|B1|France||Region of Enrollment||participants|Number|24|24.0||||||
3947282|NCT01355627|3769066|B3|Spain||Region of Enrollment||participants|Number|108|108.0||||||
3947283|NCT01355627|3769067|B2|Spain||Region of Enrollment||participants|Number|54|54.0||||||
3947284|NCT01355627|3769068|B1|Spain||Region of Enrollment||participants|Number|54|54.0||||||
3947285|NCT01355627|3769066|B3|Germany||Region of Enrollment||participants|Number|62|62.0||||||
3947286|NCT01355627|3769067|B2|Germany||Region of Enrollment||participants|Number|29|29.0||||||
3947287|NCT01355627|3769068|B1|Germany||Region of Enrollment||participants|Number|33|33.0||||||
3947288|NCT01355627|3769066|B3|Belgium||Region of Enrollment||participants|Number|174|174.0||||||
3947289|NCT01355627|3769067|B2|Belgium||Region of Enrollment||participants|Number|87|87.0||||||
3947290|NCT01355627|3769068|B1|Belgium||Region of Enrollment||participants|Number|87|87.0||||||
3947291|NCT01355627|3769066|B3|Unknown||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3947292|NCT01355627|3769067|B2|Unknown||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3947293|NCT01355627|3769068|B1|Unknown||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3947294|NCT01355627|3769066|B3|Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||participants|Number|584|584.0||||||
3947295|NCT01355627|3769067|B2|Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||participants|Number|289|289.0||||||
3947296|NCT01355627|3769068|B1|Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||participants|Number|295|295.0||||||
3947297|NCT01355627|3769066|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|117|117.0||||||
3947298|NCT01355627|3769067|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
3947299|NCT01355627|3769068|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
3947300|NCT01355627|3769066|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3947301|NCT01355627|3769067|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3947302|NCT01355627|3769068|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3947303|NCT01355627|3769066|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3947304|NCT01355627|3769067|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3947305|NCT01355627|3769068|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3947306|NCT01355627|3769066|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3947307|NCT01355627|3769067|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3947308|NCT01355627|3769068|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3947309|NCT01355627|3769066|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3947310|NCT01355627|3769067|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3947311|NCT01355627|3769068|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3947312|NCT01355627|3769066|B3|White/Caucasian||Race/Ethnicity, Customized||participants|Number|716|716.0||||||
3947313|NCT01355627|3769067|B2|White/Caucasian||Race/Ethnicity, Customized||participants|Number|361|361.0||||||
3947314|NCT01355627|3769068|B1|White/Caucasian||Race/Ethnicity, Customized||participants|Number|355|355.0||||||
3947315|NCT01355627|3769066|B3||Male|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
3947316|NCT01355627|3769067|B2||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3947317|NCT01355627|3769068|B1||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3947318|NCT01355627|3769066|B3||Female|Sex: Female, Male||Participants|Count of Participants|444|444.0||||||
3947319|NCT01355627|3769067|B2||Female|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
3947320|NCT01355627|3769068|B1||Female|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
3947321|NCT01355627|3769066|B3|>65 years||Age, Customized||participants|Number|145|145.0||||||
3947322|NCT01355627|3769067|B2|>65 years||Age, Customized||participants|Number|72|72.0||||||
3947323|NCT01355627|3769068|B1|>65 years||Age, Customized||participants|Number|73|73.0||||||
3947324|NCT01355627|3769066|B3|18-65 years||Age, Customized||participants|Number|581|581.0||||||
3947325|NCT01355627|3769067|B2|18-65 years||Age, Customized||participants|Number|293|293.0||||||
3947326|NCT01355627|3769068|B1|18-65 years||Age, Customized||participants|Number|288|288.0||||||
3947327|NCT01355627|3769066|B3|||Age||years|Mean|53.1|53.1|Standard Deviation|14.00|14.0|||
3947328|NCT01355627|3769067|B2|||Age||years|Mean|53.2|53.2|Standard Deviation|14.22|14.22|||
3947329|NCT01355627|3769068|B1|||Age||years|Mean|53.1|53.1|Standard Deviation|13.80|13.8|||
3947330|NCT01355588|3769077|B5|United Kingdom||Region of Enrollment||participants|Number|16|16.0||||||
3947331|NCT01355588|3769078|B4|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3947332|NCT01355588|3769079|B3|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3947333|NCT01355588|3769080|B2|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3947334|NCT01355588|3769081|B1|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3947335|NCT01355588|3769077|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3947336|NCT01355588|3769078|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3947337|NCT01355588|3769079|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3947338|NCT01355588|3769080|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3947339|NCT01355588|3769081|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3947340|NCT01355588|3769077|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3947341|NCT01355588|3769078|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3947342|NCT01355588|3769079|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3947343|NCT01355588|3769080|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3947344|NCT01355588|3769081|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3947345|NCT01355588|3769077|B5|||Age||years|Mean|39.8|39.8|Standard Deviation|16.0|16.0|||
3947346|NCT01355588|3769078|B4|||Age||years|Mean|50.25|50.25|Standard Deviation|10.31|10.31|||
3947347|NCT01355588|3769079|B3|||Age||years|Mean|34.0|34.0|Standard Deviation|15.90|15.9|||
3947348|NCT01355588|3769080|B2|||Age||years|Mean|40.75|40.75|Standard Deviation|19.97|19.97|||
3947349|NCT01355588|3769081|B1|||Age||years|Mean|34.25|34.25|Standard Deviation|17.21|17.21|||
3947350|NCT01355588|3769077|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3947351|NCT01355588|3769078|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3947352|NCT01355588|3769079|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3947353|NCT01355588|3769080|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3947354|NCT01355588|3769081|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3947355|NCT01355588|3769077|B5||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3947356|NCT01355588|3769078|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3947357|NCT01355588|3769079|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3947358|NCT01355588|3769080|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3947359|NCT01355588|3769081|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3947360|NCT01355588|3769077|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3947361|NCT01355588|3769078|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3947362|NCT01355588|3769079|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3947363|NCT01355588|3769080|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3947364|NCT01355588|3769081|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3947365|NCT01355523|3769106|B3|Postmenopausal||Menopausal status||Participants|Number|30|30.0||||||
3947366|NCT01355523|3769107|B2|Postmenopausal||Menopausal status||Participants|Number|16|16.0||||||
3947367|NCT01355523|3769108|B1|Postmenopausal||Menopausal status||Participants|Number|14|14.0||||||
3947368|NCT01355523|3769106|B3|Premenopausal||Menopausal status||Participants|Number|24|24.0||||||
3947369|NCT01355523|3769107|B2|Premenopausal||Menopausal status||Participants|Number|10|10.0||||||
3947370|NCT01355523|3769108|B1|Premenopausal||Menopausal status||Participants|Number|14|14.0||||||
3947371|NCT01355523|3769106|B3|||MDI - Major Depression Inventory|The MDI is a self-rating scale including 12 questions and has been validated in a Danish population. The MDI assesses information on depressive symptoms that have been present continuously during the previous 2 weeks. The individual items are measured on a 6-point Likert scale, ranging from 0 to 5, with graduations depending on the extent of the symptom the previous 14 days. Accordingly, the theoretical score ranges from 0 to 50.|Scores on a scale|Median|7|7.0|Inter-Quartile Range|||4.0|11.0|
3947372|NCT01355523|3769107|B2|||MDI - Major Depression Inventory|The MDI is a self-rating scale including 12 questions and has been validated in a Danish population. The MDI assesses information on depressive symptoms that have been present continuously during the previous 2 weeks. The individual items are measured on a 6-point Likert scale, ranging from 0 to 5, with graduations depending on the extent of the symptom the previous 14 days. Accordingly, the theoretical score ranges from 0 to 50.|Scores on a scale|Median|7|7.0|Inter-Quartile Range|||4.5|10.0|
3947373|NCT01355523|3769108|B1|||MDI - Major Depression Inventory|The MDI is a self-rating scale including 12 questions and has been validated in a Danish population. The MDI assesses information on depressive symptoms that have been present continuously during the previous 2 weeks. The individual items are measured on a 6-point Likert scale, ranging from 0 to 5, with graduations depending on the extent of the symptom the previous 14 days. Accordingly, the theoretical score ranges from 0 to 50.|Scores on a scale|Median|6.5|6.5|Inter-Quartile Range|||4.0|12.5|
3947374|NCT01355523|3769106|B3|Drop-out before anti-hormone therapy||Anti-hormone therapy|Only registered as which anti-hormone therapy (if any at all) the patients received during their participation in the MELODY trial|Participants|Number|10|10.0||||||
3947375|NCT01355523|3769107|B2|Drop-out before anti-hormone therapy||Anti-hormone therapy|Only registered as which anti-hormone therapy (if any at all) the patients received during their participation in the MELODY trial|Participants|Number|9|9.0||||||
3947376|NCT01355523|3769108|B1|Drop-out before anti-hormone therapy||Anti-hormone therapy|Only registered as which anti-hormone therapy (if any at all) the patients received during their participation in the MELODY trial|Participants|Number|1|1.0||||||
3947377|NCT01355523|3769106|B3|YES||Anti-hormone therapy|Only registered as which anti-hormone therapy (if any at all) the patients received during their participation in the MELODY trial|Participants|Number|14|14.0||||||
3947378|NCT01355523|3769107|B2|YES||Anti-hormone therapy|Only registered as which anti-hormone therapy (if any at all) the patients received during their participation in the MELODY trial|Participants|Number|7|7.0||||||
3947379|NCT01355523|3769108|B1|YES||Anti-hormone therapy|Only registered as which anti-hormone therapy (if any at all) the patients received during their participation in the MELODY trial|Participants|Number|7|7.0||||||
3947380|NCT01355523|3769106|B3|NO||Anti-hormone therapy|Only registered as which anti-hormone therapy (if any at all) the patients received during their participation in the MELODY trial|Participants|Number|30|30.0||||||
3947381|NCT01355523|3769107|B2|NO||Anti-hormone therapy|Only registered as which anti-hormone therapy (if any at all) the patients received during their participation in the MELODY trial|Participants|Number|10|10.0||||||
3947382|NCT01355523|3769108|B1|NO||Anti-hormone therapy|Only registered as which anti-hormone therapy (if any at all) the patients received during their participation in the MELODY trial|Participants|Number|20|20.0||||||
3947383|NCT01355523|3769106|B3|Drop-out before chemo/radiation||Oncological treatment|Only registered as which oncological treatment (if any at all) the patients received during their participation in the MELODY trial|Participants|Number|10|10.0||||||
3947384|NCT01355523|3769107|B2|Drop-out before chemo/radiation||Oncological treatment|Only registered as which oncological treatment (if any at all) the patients received during their participation in the MELODY trial|Participants|Number|9|9.0||||||
3947385|NCT01355523|3769108|B1|Drop-out before chemo/radiation||Oncological treatment|Only registered as which oncological treatment (if any at all) the patients received during their participation in the MELODY trial|Participants|Number|1|1.0||||||
3947386|NCT01355523|3769106|B3|Radiation x 1 only||Oncological treatment|Only registered as which oncological treatment (if any at all) the patients received during their participation in the MELODY trial|Participants|Number|4|4.0||||||
3947387|NCT01355523|3769107|B2|Radiation x 1 only||Oncological treatment|Only registered as which oncological treatment (if any at all) the patients received during their participation in the MELODY trial|Participants|Number|1|1.0||||||
3947388|NCT01355523|3769108|B1|Radiation x 1 only||Oncological treatment|Only registered as which oncological treatment (if any at all) the patients received during their participation in the MELODY trial|Participants|Number|3|3.0||||||
3947389|NCT01355523|3769106|B3|Chemotherapy + radiation||Oncological treatment|Only registered as which oncological treatment (if any at all) the patients received during their participation in the MELODY trial|Participants|Number|0|0.0||||||
3947390|NCT01355523|3769107|B2|Chemotherapy + radiation||Oncological treatment|Only registered as which oncological treatment (if any at all) the patients received during their participation in the MELODY trial|Participants|Number|0|0.0||||||
3947391|NCT01355523|3769108|B1|Chemotherapy + radiation||Oncological treatment|Only registered as which oncological treatment (if any at all) the patients received during their participation in the MELODY trial|Participants|Number|0|0.0||||||
3947392|NCT01355523|3769106|B3|Chemotherapy||Oncological treatment|Only registered as which oncological treatment (if any at all) the patients received during their participation in the MELODY trial|Participants|Number|23|23.0||||||
3947393|NCT01355523|3769107|B2|Chemotherapy||Oncological treatment|Only registered as which oncological treatment (if any at all) the patients received during their participation in the MELODY trial|Participants|Number|7|7.0||||||
3947394|NCT01355523|3769108|B1|Chemotherapy||Oncological treatment|Only registered as which oncological treatment (if any at all) the patients received during their participation in the MELODY trial|Participants|Number|16|16.0||||||
3947395|NCT01355523|3769106|B3|Radiation||Oncological treatment|Only registered as which oncological treatment (if any at all) the patients received during their participation in the MELODY trial|Participants|Number|11|11.0||||||
3947396|NCT01355523|3769107|B2|Radiation||Oncological treatment|Only registered as which oncological treatment (if any at all) the patients received during their participation in the MELODY trial|Participants|Number|6|6.0||||||
3947397|NCT01355523|3769108|B1|Radiation||Oncological treatment|Only registered as which oncological treatment (if any at all) the patients received during their participation in the MELODY trial|Participants|Number|5|5.0||||||
3947398|NCT01355523|3769106|B3|None||Oncological treatment|Only registered as which oncological treatment (if any at all) the patients received during their participation in the MELODY trial|Participants|Number|6|6.0||||||
3947399|NCT01355523|3769107|B2|None||Oncological treatment|Only registered as which oncological treatment (if any at all) the patients received during their participation in the MELODY trial|Participants|Number|3|3.0||||||
3947400|NCT01355523|3769108|B1|None||Oncological treatment|Only registered as which oncological treatment (if any at all) the patients received during their participation in the MELODY trial|Participants|Number|3|3.0||||||
3947401|NCT01355523|3769106|B3|||Anaesthesia duration||Minutes|Median|171|171.0|Inter-Quartile Range|||139.25|196.25|
3947402|NCT01355523|3769107|B2|||Anaesthesia duration||Minutes|Median|190|190.0|Inter-Quartile Range|||155.0|225.0|
3947403|NCT01355523|3769108|B1|||Anaesthesia duration||Minutes|Median|155|155.0|Inter-Quartile Range|||130.0|187.0|
3947404|NCT01355523|3769106|B3|||Surgery duration||Minutes|Median|110|110.0|Inter-Quartile Range|||85.0|141.0|
3947405|NCT01355523|3769107|B2|||Surgery duration||Minutes|Median|125|125.0|Inter-Quartile Range|||104.5|156.5|
3947406|NCT01355523|3769108|B1|||Surgery duration||Minutes|Median|92|92.0|Inter-Quartile Range|||74.5|125.0|
3947407|NCT01355523|3769106|B3|Bilateral lumpectomy + axillary dissection + SN||Type of surgery|SN: sentinel node|Participants|Number|2|2.0||||||
3947408|NCT01355523|3769107|B2|Bilateral lumpectomy + axillary dissection + SN||Type of surgery|SN: sentinel node|Participants|Number|2|2.0||||||
3947409|NCT01355523|3769108|B1|Bilateral lumpectomy + axillary dissection + SN||Type of surgery|SN: sentinel node|Participants|Number|0|0.0||||||
3947410|NCT01355523|3769106|B3|Lumpectomy converted to mastectomy + SN||Type of surgery|SN: sentinel node|Participants|Number|1|1.0||||||
3947411|NCT01355523|3769107|B2|Lumpectomy converted to mastectomy + SN||Type of surgery|SN: sentinel node|Participants|Number|0|0.0||||||
3947412|NCT01355523|3769108|B1|Lumpectomy converted to mastectomy + SN||Type of surgery|SN: sentinel node|Participants|Number|1|1.0||||||
3947413|NCT01355523|3769106|B3|Lumpectomy + SN||Type of surgery|SN: sentinel node|Participants|Number|28|28.0||||||
3947414|NCT01355523|3769107|B2|Lumpectomy + SN||Type of surgery|SN: sentinel node|Participants|Number|12|12.0||||||
3947415|NCT01355523|3769108|B1|Lumpectomy + SN||Type of surgery|SN: sentinel node|Participants|Number|16|16.0||||||
3947416|NCT01355523|3769106|B3|Lumpectomy + axillary dissection +/- SN||Type of surgery|SN: sentinel node|Participants|Number|12|12.0||||||
3947417|NCT01355523|3769107|B2|Lumpectomy + axillary dissection +/- SN||Type of surgery|SN: sentinel node|Participants|Number|6|6.0||||||
3947418|NCT01355523|3769108|B1|Lumpectomy + axillary dissection +/- SN||Type of surgery|SN: sentinel node|Participants|Number|6|6.0||||||
3947419|NCT01355523|3769106|B3|Mastectomy + SN||Type of surgery|SN: sentinel node|Participants|Number|7|7.0||||||
3947420|NCT01355523|3769107|B2|Mastectomy + SN||Type of surgery|SN: sentinel node|Participants|Number|3|3.0||||||
3947421|NCT01355523|3769108|B1|Mastectomy + SN||Type of surgery|SN: sentinel node|Participants|Number|4|4.0||||||
3947422|NCT01355523|3769106|B3|Mastectomy + axillary dissection +/- SN||Type of surgery|SN: sentinel node|Participants|Number|4|4.0||||||
3947423|NCT01355523|3769107|B2|Mastectomy + axillary dissection +/- SN||Type of surgery|SN: sentinel node|Participants|Number|3|3.0||||||
3947424|NCT01355523|3769108|B1|Mastectomy + axillary dissection +/- SN||Type of surgery|SN: sentinel node|Participants|Number|1|1.0||||||
3947425|NCT01355523|3769106|B3|Denmark||Region of Enrollment||participants|Number|54|54.0||||||
3947426|NCT01355523|3769107|B2|Denmark||Region of Enrollment||participants|Number|26|26.0||||||
3947427|NCT01355523|3769108|B1|Denmark||Region of Enrollment||participants|Number|28|28.0||||||
3947428|NCT01355523|3769106|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3947429|NCT01355523|3769107|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3947430|NCT01355523|3769108|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3947431|NCT01355523|3769106|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3947432|NCT01355523|3769107|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3947433|NCT01355523|3769108|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3947434|NCT01355523|3769106|B3|||Age||years|Mean|56.30|56.3|Standard Deviation|11.07|11.07|||
3947435|NCT01355523|3769107|B2|||Age||years|Mean|58.23|58.23|Standard Deviation|11.36|11.36|||
3947436|NCT01355523|3769108|B1|||Age||years|Mean|54.50|54.5|Standard Deviation|10.69|10.69|||
3947437|NCT01355523|3769106|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3947438|NCT01355523|3769107|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3947439|NCT01355523|3769108|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3947440|NCT01355523|3769106|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3947441|NCT01355523|3769107|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3947442|NCT01355523|3769108|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3947443|NCT01355523|3769106|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3947444|NCT01355523|3769107|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3947445|NCT01355523|3769108|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3947446|NCT01355484|3769151|B3||Male|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
3947447|NCT01355484|3769152|B2||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3947448|NCT01355484|3769153|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3947449|NCT01355484|3769151|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3947450|NCT01355484|3769152|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3947451|NCT01355484|3769153|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3947452|NCT01355484|3769151|B3|||Age||years|Median|61.0|61.0|Full Range|||34.0|88.0|
3947453|NCT01355484|3769152|B2|||Age||years|Median|62.0|62.0|Full Range|||34.0|88.0|
3947454|NCT01355484|3769153|B1|||Age||years|Median|60.5|60.5|Full Range|||36.0|84.0|
3947455|NCT01355471|3769162|B3|Canada||Region of Enrollment||participants|Number|15|15.0||||||
3947456|NCT01355471|3769163|B2|Canada||Region of Enrollment||participants|Number|7|7.0||||||
3947457|NCT01355471|3769164|B1|Canada||Region of Enrollment||participants|Number|8|8.0||||||
3947458|NCT01355471|3769162|B3|United States||Region of Enrollment||participants|Number|278|278.0||||||
3947459|NCT01355471|3769163|B2|United States||Region of Enrollment||participants|Number|138|138.0||||||
3947460|NCT01355471|3769164|B1|United States||Region of Enrollment||participants|Number|140|140.0||||||
3947461|NCT01355471|3769162|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3947462|NCT01355471|3769163|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3947463|NCT01355471|3769164|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3947464|NCT01355471|3769162|B3||Female|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
3947465|NCT01355471|3769163|B2||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3947466|NCT01355471|3769164|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3947467|NCT01355471|3769162|B3|||Age||years|Mean|47.5|47.5|Standard Deviation|12.04|12.04|||
3947468|NCT01355471|3769163|B2|||Age||years|Mean|46.5|46.5|Standard Deviation|12.10|12.1|||
3947469|NCT01355471|3769164|B1|||Age||years|Mean|48.5|48.5|Standard Deviation|11.94|11.94|||
3947470|NCT01355471|3769162|B3||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3947471|NCT01355471|3769163|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3947472|NCT01355471|3769164|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3947473|NCT01355471|3769162|B3||Between 18 and 65 years|Age||Participants|Count of Participants|270|270.0||||||
3947474|NCT01355471|3769163|B2||Between 18 and 65 years|Age||Participants|Count of Participants|134|134.0||||||
3947475|NCT01355471|3769164|B1||Between 18 and 65 years|Age||Participants|Count of Participants|136|136.0||||||
3947476|NCT01355471|3769162|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3947477|NCT01355471|3769163|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3947478|NCT01355471|3769164|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3947479|NCT01355458|3769171|B3|Canada||Region of Enrollment||participants|Number|29|29.0||||||
3947480|NCT01355458|3769172|B2|Canada||Region of Enrollment||participants|Number|15|15.0||||||
3947481|NCT01355458|3769173|B1|Canada||Region of Enrollment||participants|Number|14|14.0||||||
3947482|NCT01355458|3769171|B3|United States||Region of Enrollment||participants|Number|231|231.0||||||
3947483|NCT01355458|3769172|B2|United States||Region of Enrollment||participants|Number|116|116.0||||||
3947484|NCT01355458|3769173|B1|United States||Region of Enrollment||participants|Number|115|115.0||||||
3947485|NCT01355458|3769171|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3947486|NCT01355458|3769172|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3947487|NCT01355458|3769173|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3947488|NCT01355458|3769171|B3||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
3947489|NCT01355458|3769172|B2||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3947490|NCT01355458|3769173|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3947491|NCT01355458|3769171|B3|||Age||years|Mean|48.8|48.8|Standard Deviation|12.30|12.3|||
3947492|NCT01355458|3769172|B2|||Age||years|Mean|48.1|48.1|Standard Deviation|12.81|12.81|||
3947493|NCT01355458|3769173|B1|||Age||years|Mean|49.5|49.5|Standard Deviation|11.76|11.76|||
3947494|NCT01355458|3769171|B3||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
3947495|NCT01355458|3769172|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3947496|NCT01355458|3769173|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3947497|NCT01355458|3769171|B3||Between 18 and 65 years|Age||Participants|Count of Participants|234|234.0||||||
3947498|NCT01355458|3769172|B2||Between 18 and 65 years|Age||Participants|Count of Participants|117|117.0||||||
3947499|NCT01355458|3769173|B1||Between 18 and 65 years|Age||Participants|Count of Participants|117|117.0||||||
3947500|NCT01355458|3769171|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3947501|NCT01355458|3769172|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3947502|NCT01355458|3769173|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3947503|NCT01355419|3769180|B1|Belgium||Region of Enrollment||participants|Number|150|150.0||||||
3947504|NCT01355419|3769180|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3947505|NCT01355419|3769180|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3947506|NCT01355419|3769180|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3947507|NCT01355419|3769180|B1||Between 18 and 65 years|Age||Participants|Count of Participants|150|150.0||||||
3947508|NCT01355419|3769180|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3947509|NCT01355419|3769180|B1|||Age||years|Mean|51|51.0|Standard Deviation|10|10.0|||
3947510|NCT01355302|3769185|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3947511|NCT01355302|3769185|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3947512|NCT01355302|3769185|B1|Age range 47 to 80 years||Age, Customized||Participants|Number|7|7.0||||||
3947513|NCT01355289|3769198|B5||Male|Sex: Female, Male|Full analysis set (FAS), the group of all randomized participants of core study.|Participants|Count of Participants|48|48.0||||||
3947514|NCT01355289|3769199|B4||Male|Sex: Female, Male|Full analysis set (FAS), the group of all randomized participants of core study.|Participants|Count of Participants|9|9.0||||||
3947515|NCT01355289|3769200|B3||Male|Sex: Female, Male|Full analysis set (FAS), the group of all randomized participants of core study.|Participants|Count of Participants|13|13.0||||||
3947516|NCT01355289|3769201|B2||Male|Sex: Female, Male|Full analysis set (FAS), the group of all randomized participants of core study.|Participants|Count of Participants|12|12.0||||||
3947517|NCT01355289|3769202|B1||Male|Sex: Female, Male|Full analysis set (FAS), the group of all randomized participants of core study.|Participants|Count of Participants|14|14.0||||||
3947518|NCT01355289|3769198|B5||Female|Sex: Female, Male|Full analysis set (FAS), the group of all randomized participants of core study.|Participants|Count of Participants|17|17.0||||||
3947519|NCT01355289|3769199|B4||Female|Sex: Female, Male|Full analysis set (FAS), the group of all randomized participants of core study.|Participants|Count of Participants|5|5.0||||||
3947520|NCT01355289|3769200|B3||Female|Sex: Female, Male|Full analysis set (FAS), the group of all randomized participants of core study.|Participants|Count of Participants|5|5.0||||||
3947521|NCT01355289|3769201|B2||Female|Sex: Female, Male|Full analysis set (FAS), the group of all randomized participants of core study.|Participants|Count of Participants|4|4.0||||||
3947522|NCT01355289|3769202|B1||Female|Sex: Female, Male|Full analysis set (FAS), the group of all randomized participants of core study.|Participants|Count of Participants|3|3.0||||||
3947523|NCT01355289|3769198|B5|||Age||Years|Mean|53.5|53.5|Standard Deviation|7.78|7.78|||
3947524|NCT01355289|3769199|B4|||Age||Years|Mean|53.6|53.6|Standard Deviation|7.26|7.26|||
3947525|NCT01355289|3769200|B3|||Age||Years|Mean|54.9|54.9|Standard Deviation|7.38|7.38|||
3947526|NCT01355289|3769201|B2|||Age||Years|Mean|55.3|55.3|Standard Deviation|8.06|8.06|||
3947527|NCT01355289|3769202|B1|||Age||Years|Mean|50.2|50.2|Standard Deviation|7.96|7.96|||
3947528|NCT01355224|3769229|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3947529|NCT01355224|3769230|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3947530|NCT01355224|3769231|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3947531|NCT01355224|3769232|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3947532|NCT01355224|3769233|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3947533|NCT01355224|3769229|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3947534|NCT01355224|3769230|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3947535|NCT01355224|3769231|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3947536|NCT01355224|3769232|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3947537|NCT01355224|3769233|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3947538|NCT01355224|3769229|B5||White|Race (NIH/OMB)||Participants|Count of Participants|636|636.0||||||
3947539|NCT01355224|3769230|B4||White|Race (NIH/OMB)||Participants|Count of Participants|154|154.0||||||
3947540|NCT01355224|3769231|B3||White|Race (NIH/OMB)||Participants|Count of Participants|161|161.0||||||
3947541|NCT01355224|3769232|B2||White|Race (NIH/OMB)||Participants|Count of Participants|166|166.0||||||
3947542|NCT01355224|3769233|B1||White|Race (NIH/OMB)||Participants|Count of Participants|155|155.0||||||
3947543|NCT01355224|3769229|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3947544|NCT01355224|3769230|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3947545|NCT01355224|3769231|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3947546|NCT01355224|3769232|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3947547|NCT01355224|3769233|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3947548|NCT01355224|3769229|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947549|NCT01355224|3769230|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947550|NCT01355224|3769231|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947551|NCT01355224|3769232|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947552|NCT01355224|3769233|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947553|NCT01355224|3769229|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3947554|NCT01355224|3769230|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3947555|NCT01355224|3769231|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3947556|NCT01355224|3769232|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3947557|NCT01355224|3769233|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3947558|NCT01355224|3769229|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947559|NCT01355224|3769230|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947560|NCT01355224|3769231|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947561|NCT01355224|3769232|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947562|NCT01355224|3769233|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947563|NCT01355224|3769229|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3947564|NCT01355224|3769230|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947565|NCT01355224|3769231|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947566|NCT01355224|3769232|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3947567|NCT01355224|3769233|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3947568|NCT01355224|3769229|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|678|678.0||||||
3947569|NCT01355224|3769230|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|169|169.0||||||
3947570|NCT01355224|3769231|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|170|170.0||||||
3947571|NCT01355224|3769232|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|176|176.0||||||
3947572|NCT01355224|3769233|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|163|163.0||||||
3947573|NCT01355224|3769229|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3947574|NCT01355224|3769230|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3947575|NCT01355224|3769231|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3947576|NCT01355224|3769232|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3947577|NCT01355224|3769233|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3947578|NCT01355224|3769229|B5||Male|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
3947579|NCT01355224|3769230|B4||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3947580|NCT01355224|3769231|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3947581|NCT01355224|3769232|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3947582|NCT01355224|3769233|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3947583|NCT01355224|3769229|B5||Female|Sex: Female, Male||Participants|Count of Participants|472|472.0||||||
3947584|NCT01355224|3769230|B4||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3947585|NCT01355224|3769231|B3||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3947586|NCT01355224|3769232|B2||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3947587|NCT01355224|3769233|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3947588|NCT01355224|3769229|B5|||Age||years|Mean|50|50.0|Full Range|||20.0|82.0|
3947589|NCT01355224|3769230|B4|||Age||years|Mean|48|48.0|Full Range|||20.0|81.0|
3947590|NCT01355224|3769231|B3|||Age||years|Mean|51|51.0|Full Range|||21.0|81.0|
3947591|NCT01355224|3769232|B2|||Age||years|Mean|51|51.0|Full Range|||20.0|77.0|
3947592|NCT01355224|3769233|B1|||Age||years|Mean|51|51.0|Full Range|||21.0|82.0|
3947593|NCT01355081|3769256|B4|||Sheehan Disability Scale (SDS) - Total Score|The Sheehan Disability Scale assesses functional impairment in 3 domains: work/school, social life or leisure activities, and home life or family responsibilities. The participant rates the extent to which each aspect is impaired on a 10-point visual analog scale, from 0 (not at all) to 10 (extremely). The 3 scores are added together to calculate the total score, which ranges from 0 to 30, with higher scores indicating more impairment.|scores on a scale|Mean|15.4|15.4|Standard Deviation|5.83|5.83|||
3947594|NCT01355081|3769257|B3|||Sheehan Disability Scale (SDS) - Total Score|The Sheehan Disability Scale assesses functional impairment in 3 domains: work/school, social life or leisure activities, and home life or family responsibilities. The participant rates the extent to which each aspect is impaired on a 10-point visual analog scale, from 0 (not at all) to 10 (extremely). The 3 scores are added together to calculate the total score, which ranges from 0 to 30, with higher scores indicating more impairment.|scores on a scale|Mean|15.4|15.4|Standard Deviation|5.45|5.45|||
3947595|NCT01355081|3769258|B2|||Sheehan Disability Scale (SDS) - Total Score|The Sheehan Disability Scale assesses functional impairment in 3 domains: work/school, social life or leisure activities, and home life or family responsibilities. The participant rates the extent to which each aspect is impaired on a 10-point visual analog scale, from 0 (not at all) to 10 (extremely). The 3 scores are added together to calculate the total score, which ranges from 0 to 30, with higher scores indicating more impairment.|scores on a scale|Mean|15.2|15.2|Standard Deviation|5.97|5.97|||
3947596|NCT01355081|3769259|B1|||Sheehan Disability Scale (SDS) - Total Score|The Sheehan Disability Scale assesses functional impairment in 3 domains: work/school, social life or leisure activities, and home life or family responsibilities. The participant rates the extent to which each aspect is impaired on a 10-point visual analog scale, from 0 (not at all) to 10 (extremely). The 3 scores are added together to calculate the total score, which ranges from 0 to 30, with higher scores indicating more impairment.|scores on a scale|Mean|15.5|15.5|Standard Deviation|6.12|6.12|||
3947597|NCT01355081|3769256|B4|||Clinical Global Impression - Severity Scale Score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|scores on a scale|Mean|4.5|4.5|Standard Deviation|0.66|0.66|||
3947598|NCT01355081|3769257|B3|||Clinical Global Impression - Severity Scale Score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|scores on a scale|Mean|4.6|4.6|Standard Deviation|0.69|0.69|||
3947599|NCT01355081|3769258|B2|||Clinical Global Impression - Severity Scale Score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|scores on a scale|Mean|4.5|4.5|Standard Deviation|0.64|0.64|||
3947600|NCT01355081|3769259|B1|||Clinical Global Impression - Severity Scale Score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|scores on a scale|Mean|4.5|4.5|Standard Deviation|0.65|0.65|||
3947601|NCT01355081|3769256|B4|||Hamilton Depression Scale (HAM-D17) Total Score|The HAM-D17 is a clinician-rated scale for assessing the severity of depression symptoms. The scores for each item range from 0 to 4 or 0 to 2, where 0 represents no symptoms. The rating is based on the past 7 days prior to the time of assessment. The total score ranges from 0 to 52 where a higher score indicates a greater depressive state.|scores on a scale|Mean|21.2|21.2|Standard Deviation|4.34|4.34|||
3947602|NCT01355081|3769257|B3|||Hamilton Depression Scale (HAM-D17) Total Score|The HAM-D17 is a clinician-rated scale for assessing the severity of depression symptoms. The scores for each item range from 0 to 4 or 0 to 2, where 0 represents no symptoms. The rating is based on the past 7 days prior to the time of assessment. The total score ranges from 0 to 52 where a higher score indicates a greater depressive state.|scores on a scale|Mean|21.5|21.5|Standard Deviation|4.48|4.48|||
3947603|NCT01355081|3769258|B2|||Hamilton Depression Scale (HAM-D17) Total Score|The HAM-D17 is a clinician-rated scale for assessing the severity of depression symptoms. The scores for each item range from 0 to 4 or 0 to 2, where 0 represents no symptoms. The rating is based on the past 7 days prior to the time of assessment. The total score ranges from 0 to 52 where a higher score indicates a greater depressive state.|scores on a scale|Mean|21.2|21.2|Standard Deviation|4.43|4.43|||
3947604|NCT01355081|3769259|B1|||Hamilton Depression Scale (HAM-D17) Total Score|The HAM-D17 is a clinician-rated scale for assessing the severity of depression symptoms. The scores for each item range from 0 to 4 or 0 to 2, where 0 represents no symptoms. The rating is based on the past 7 days prior to the time of assessment. The total score ranges from 0 to 52 where a higher score indicates a greater depressive state.|scores on a scale|Mean|20.9|20.9|Standard Deviation|4.12|4.12|||
3947605|NCT01355081|3769256|B4|||Montgomery Åsberg Depression Rating Scale (MADRS) Total Score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|32.4|32.4|Standard Deviation|4.74|4.74|||
3947606|NCT01355081|3769257|B3|||Montgomery Åsberg Depression Rating Scale (MADRS) Total Score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|32.5|32.5|Standard Deviation|4.50|4.5|||
3947607|NCT01355081|3769258|B2|||Montgomery Åsberg Depression Rating Scale (MADRS) Total Score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|32.5|32.5|Standard Deviation|4.93|4.93|||
3947608|NCT01355081|3769259|B1|||Montgomery Åsberg Depression Rating Scale (MADRS) Total Score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|32.2|32.2|Standard Deviation|4.81|4.81|||
3947609|NCT01355081|3769256|B4|No||Pharmacotherapy for Current Major Depressive Episode||participants|Number|156|156.0||||||
3947610|NCT01355081|3769257|B3|No||Pharmacotherapy for Current Major Depressive Episode||participants|Number|50|50.0||||||
3947611|NCT01355081|3769258|B2|No||Pharmacotherapy for Current Major Depressive Episode||participants|Number|55|55.0||||||
3947612|NCT01355081|3769259|B1|No||Pharmacotherapy for Current Major Depressive Episode||participants|Number|51|51.0||||||
3947613|NCT01355081|3769256|B4|Yes||Pharmacotherapy for Current Major Depressive Episode||participants|Number|210|210.0||||||
3947614|NCT01355081|3769257|B3|Yes||Pharmacotherapy for Current Major Depressive Episode||participants|Number|74|74.0||||||
3947615|NCT01355081|3769258|B2|Yes||Pharmacotherapy for Current Major Depressive Episode||participants|Number|68|68.0||||||
3947616|NCT01355081|3769259|B1|Yes||Pharmacotherapy for Current Major Depressive Episode||participants|Number|68|68.0||||||
3947617|NCT01355081|3769256|B4|Recurrent episode||Status of Major Depressive Episode (MDE)|An MDE is a period marked by depressed mood, loss of interest or pleasure, disturbed sleep or appetite, low energy, feelings of guilt or low self-worth, and poor concentration.|participants|Number|152|152.0||||||
3947618|NCT01355081|3769257|B3|Recurrent episode||Status of Major Depressive Episode (MDE)|An MDE is a period marked by depressed mood, loss of interest or pleasure, disturbed sleep or appetite, low energy, feelings of guilt or low self-worth, and poor concentration.|participants|Number|48|48.0||||||
3947619|NCT01355081|3769258|B2|Recurrent episode||Status of Major Depressive Episode (MDE)|An MDE is a period marked by depressed mood, loss of interest or pleasure, disturbed sleep or appetite, low energy, feelings of guilt or low self-worth, and poor concentration.|participants|Number|55|55.0||||||
3947671|NCT01355081|3769258|B2|Extensive Metabolizer (EM)||Cytochrome p450 (CYP)2D6 Phenotype||participants|Number|97|97.0||||||
3947620|NCT01355081|3769259|B1|Recurrent episode||Status of Major Depressive Episode (MDE)|An MDE is a period marked by depressed mood, loss of interest or pleasure, disturbed sleep or appetite, low energy, feelings of guilt or low self-worth, and poor concentration.|participants|Number|49|49.0||||||
3947621|NCT01355081|3769256|B4|Single episode||Status of Major Depressive Episode (MDE)|An MDE is a period marked by depressed mood, loss of interest or pleasure, disturbed sleep or appetite, low energy, feelings of guilt or low self-worth, and poor concentration.|participants|Number|214|214.0||||||
3947622|NCT01355081|3769257|B3|Single episode||Status of Major Depressive Episode (MDE)|An MDE is a period marked by depressed mood, loss of interest or pleasure, disturbed sleep or appetite, low energy, feelings of guilt or low self-worth, and poor concentration.|participants|Number|76|76.0||||||
3947623|NCT01355081|3769258|B2|Single episode||Status of Major Depressive Episode (MDE)|An MDE is a period marked by depressed mood, loss of interest or pleasure, disturbed sleep or appetite, low energy, feelings of guilt or low self-worth, and poor concentration.|participants|Number|68|68.0||||||
3947624|NCT01355081|3769259|B1|Single episode||Status of Major Depressive Episode (MDE)|An MDE is a period marked by depressed mood, loss of interest or pleasure, disturbed sleep or appetite, low energy, feelings of guilt or low self-worth, and poor concentration.|participants|Number|70|70.0||||||
3947625|NCT01355081|3769256|B4|Daily||History of Alcohol Consumption||participants|Number|34|34.0||||||
3947626|NCT01355081|3769257|B3|Daily||History of Alcohol Consumption||participants|Number|8|8.0||||||
3947627|NCT01355081|3769258|B2|Daily||History of Alcohol Consumption||participants|Number|11|11.0||||||
3947628|NCT01355081|3769259|B1|Daily||History of Alcohol Consumption||participants|Number|15|15.0||||||
3947629|NCT01355081|3769256|B4|2 to 6 Times/Week||History of Alcohol Consumption||participants|Number|56|56.0||||||
3947630|NCT01355081|3769257|B3|2 to 6 Times/Week||History of Alcohol Consumption||participants|Number|15|15.0||||||
3947631|NCT01355081|3769258|B2|2 to 6 Times/Week||History of Alcohol Consumption||participants|Number|20|20.0||||||
3947632|NCT01355081|3769259|B1|2 to 6 Times/Week||History of Alcohol Consumption||participants|Number|21|21.0||||||
3947633|NCT01355081|3769256|B4|Once a Week||History of Alcohol Consumption||participants|Number|56|56.0||||||
3947634|NCT01355081|3769257|B3|Once a Week||History of Alcohol Consumption||participants|Number|20|20.0||||||
3947635|NCT01355081|3769258|B2|Once a Week||History of Alcohol Consumption||participants|Number|20|20.0||||||
3947636|NCT01355081|3769259|B1|Once a Week||History of Alcohol Consumption||participants|Number|16|16.0||||||
3947637|NCT01355081|3769256|B4|Once Monthly or Less Often||History of Alcohol Consumption||participants|Number|113|113.0||||||
3947638|NCT01355081|3769257|B3|Once Monthly or Less Often||History of Alcohol Consumption||participants|Number|40|40.0||||||
3947639|NCT01355081|3769258|B2|Once Monthly or Less Often||History of Alcohol Consumption||participants|Number|40|40.0||||||
3947640|NCT01355081|3769259|B1|Once Monthly or Less Often||History of Alcohol Consumption||participants|Number|33|33.0||||||
3947641|NCT01355081|3769256|B4|Never||History of Alcohol Consumption||participants|Number|107|107.0||||||
3947642|NCT01355081|3769257|B3|Never||History of Alcohol Consumption||participants|Number|41|41.0||||||
3947643|NCT01355081|3769258|B2|Never||History of Alcohol Consumption||participants|Number|32|32.0||||||
3947644|NCT01355081|3769259|B1|Never||History of Alcohol Consumption||participants|Number|34|34.0||||||
3947645|NCT01355081|3769256|B4|Never Smoked||Smoking Classification||participants|Number|172|172.0||||||
3947646|NCT01355081|3769257|B3|Never Smoked||Smoking Classification||participants|Number|60|60.0||||||
3947647|NCT01355081|3769258|B2|Never Smoked||Smoking Classification||participants|Number|58|58.0||||||
3947648|NCT01355081|3769259|B1|Never Smoked||Smoking Classification||participants|Number|54|54.0||||||
3947649|NCT01355081|3769256|B4|Ex-smoker||Smoking Classification||participants|Number|74|74.0||||||
3947650|NCT01355081|3769257|B3|Ex-smoker||Smoking Classification||participants|Number|24|24.0||||||
3947651|NCT01355081|3769258|B2|Ex-smoker||Smoking Classification||participants|Number|24|24.0||||||
3947652|NCT01355081|3769259|B1|Ex-smoker||Smoking Classification||participants|Number|26|26.0||||||
3947653|NCT01355081|3769256|B4|Current smoker||Smoking Classification||participants|Number|120|120.0||||||
3947654|NCT01355081|3769257|B3|Current smoker||Smoking Classification||participants|Number|40|40.0||||||
3947655|NCT01355081|3769258|B2|Current smoker||Smoking Classification||participants|Number|41|41.0||||||
3947656|NCT01355081|3769259|B1|Current smoker||Smoking Classification||participants|Number|39|39.0||||||
3947657|NCT01355081|3769256|B4|Unknown||Cytochrome p450 (CYP)2D6 Phenotype||participants|Number|11|11.0||||||
3947658|NCT01355081|3769257|B3|Unknown||Cytochrome p450 (CYP)2D6 Phenotype||participants|Number|5|5.0||||||
3947659|NCT01355081|3769258|B2|Unknown||Cytochrome p450 (CYP)2D6 Phenotype||participants|Number|4|4.0||||||
3947660|NCT01355081|3769259|B1|Unknown||Cytochrome p450 (CYP)2D6 Phenotype||participants|Number|2|2.0||||||
3947661|NCT01355081|3769256|B4|Poor Metabolizer (PM)||Cytochrome p450 (CYP)2D6 Phenotype||participants|Number|1|1.0||||||
3947662|NCT01355081|3769257|B3|Poor Metabolizer (PM)||Cytochrome p450 (CYP)2D6 Phenotype||participants|Number|0|0.0||||||
3947663|NCT01355081|3769258|B2|Poor Metabolizer (PM)||Cytochrome p450 (CYP)2D6 Phenotype||participants|Number|1|1.0||||||
3947664|NCT01355081|3769259|B1|Poor Metabolizer (PM)||Cytochrome p450 (CYP)2D6 Phenotype||participants|Number|0|0.0||||||
3947665|NCT01355081|3769256|B4|Intermediate Metabolizer (IM)||Cytochrome p450 (CYP)2D6 Phenotype||participants|Number|66|66.0||||||
3947666|NCT01355081|3769257|B3|Intermediate Metabolizer (IM)||Cytochrome p450 (CYP)2D6 Phenotype||participants|Number|21|21.0||||||
3947667|NCT01355081|3769258|B2|Intermediate Metabolizer (IM)||Cytochrome p450 (CYP)2D6 Phenotype||participants|Number|20|20.0||||||
3947668|NCT01355081|3769259|B1|Intermediate Metabolizer (IM)||Cytochrome p450 (CYP)2D6 Phenotype||participants|Number|25|25.0||||||
3947669|NCT01355081|3769256|B4|Extensive Metabolizer (EM)||Cytochrome p450 (CYP)2D6 Phenotype||participants|Number|284|284.0||||||
3947670|NCT01355081|3769257|B3|Extensive Metabolizer (EM)||Cytochrome p450 (CYP)2D6 Phenotype||participants|Number|96|96.0||||||
3947672|NCT01355081|3769259|B1|Extensive Metabolizer (EM)||Cytochrome p450 (CYP)2D6 Phenotype||participants|Number|91|91.0||||||
3947673|NCT01355081|3769256|B4|Ultra-rapid Metabolizer (UM)||Cytochrome p450 (CYP)2D6 Phenotype||participants|Number|4|4.0||||||
3947674|NCT01355081|3769257|B3|Ultra-rapid Metabolizer (UM)||Cytochrome p450 (CYP)2D6 Phenotype||participants|Number|2|2.0||||||
3947675|NCT01355081|3769258|B2|Ultra-rapid Metabolizer (UM)||Cytochrome p450 (CYP)2D6 Phenotype||participants|Number|1|1.0||||||
3947676|NCT01355081|3769259|B1|Ultra-rapid Metabolizer (UM)||Cytochrome p450 (CYP)2D6 Phenotype||participants|Number|1|1.0||||||
3947677|NCT01355081|3769256|B4|||Body Mass Index (BMI)||kg/m^2|Mean|22.53|22.53|Standard Deviation|3.911|3.911|||
3947678|NCT01355081|3769257|B3|||Body Mass Index (BMI)||kg/m^2|Mean|22.57|22.57|Standard Deviation|4.016|4.016|||
3947679|NCT01355081|3769258|B2|||Body Mass Index (BMI)||kg/m^2|Mean|22.42|22.42|Standard Deviation|4.306|4.306|||
3947680|NCT01355081|3769259|B1|||Body Mass Index (BMI)||kg/m^2|Mean|22.59|22.59|Standard Deviation|3.366|3.366|||
3947681|NCT01355081|3769256|B4|||Weight||kg|Mean|61.71|61.71|Standard Deviation|13.441|13.441|||
3947682|NCT01355081|3769257|B3|||Weight||kg|Mean|60.86|60.86|Standard Deviation|12.690|12.69|||
3947683|NCT01355081|3769258|B2|||Weight||kg|Mean|62.11|62.11|Standard Deviation|15.883|15.883|||
3947684|NCT01355081|3769259|B1|||Weight||kg|Mean|62.18|62.18|Standard Deviation|11.357|11.357|||
3947685|NCT01355081|3769256|B4|||Height||cm|Mean|165.1|165.1|Standard Deviation|8.49|8.49|||
3947686|NCT01355081|3769257|B3|||Height||cm|Mean|163.9|163.9|Standard Deviation|8.46|8.46|||
3947687|NCT01355081|3769258|B2|||Height||cm|Mean|165.6|165.6|Standard Deviation|8.51|8.51|||
3947688|NCT01355081|3769259|B1|||Height||cm|Mean|165.7|165.7|Standard Deviation|8.45|8.45|||
3947689|NCT01355081|3769256|B4|Japan||Region of Enrollment||participants|Number|366|366.0||||||
3947690|NCT01355081|3769257|B3|Japan||Region of Enrollment||participants|Number|124|124.0||||||
3947691|NCT01355081|3769258|B2|Japan||Region of Enrollment||participants|Number|123|123.0||||||
3947692|NCT01355081|3769259|B1|Japan||Region of Enrollment||participants|Number|119|119.0||||||
3947693|NCT01355081|3769256|B4||Male|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
3947694|NCT01355081|3769257|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3947695|NCT01355081|3769258|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3947696|NCT01355081|3769259|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3947697|NCT01355081|3769256|B4||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3947698|NCT01355081|3769257|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3947699|NCT01355081|3769258|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3947700|NCT01355081|3769259|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3947701|NCT01355081|3769256|B4|||Age||years|Mean|38.4|38.4|Standard Deviation|10.83|10.83|||
3947702|NCT01355081|3769257|B3|||Age||years|Mean|37.6|37.6|Standard Deviation|10.67|10.67|||
3947703|NCT01355081|3769258|B2|||Age||years|Mean|38.8|38.8|Standard Deviation|10.99|10.99|||
3947704|NCT01355081|3769259|B1|||Age||years|Mean|38.8|38.8|Standard Deviation|10.85|10.85|||
3947705|NCT01355068|3769284|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3947706|NCT01355068|3769284|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3947707|NCT01355068|3769284|B1|||Age||years|Mean|31.8|31.8|Standard Deviation|8.3|8.3|||
3947708|NCT01354990|3769301|B1|Unspecified||Sex/Gender, Customized||participants|Number|46|46.0||||||
3947709|NCT01354990|3769301|B1|Male||Sex/Gender, Customized||participants|Number|1351|1351.0||||||
3947710|NCT01354990|3769301|B1|Female||Sex/Gender, Customized||participants|Number|1577|1577.0||||||
3947711|NCT01354990|3769301|B1|Unspecified||Age, Customized||participants|Number|48|48.0||||||
3947712|NCT01354990|3769301|B1|20 - 99||Age, Customized||participants|Number|2926|2926.0||||||
3947713|NCT01354990|3769301|B1|0 - 19||Age, Customized||participants|Number|0|0.0||12.2|12.2|||
3947714|NCT01354951|3769308|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3947715|NCT01354951|3769308|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947716|NCT01354951|3769308|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947717|NCT01354951|3769308|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3947718|NCT01354951|3769308|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947719|NCT01354951|3769308|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947720|NCT01354951|3769308|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947721|NCT01354951|3769308|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947722|NCT01354951|3769308|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947723|NCT01354951|3769308|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3947724|NCT01354951|3769308|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947725|NCT01354951|3769308|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3947726|NCT01354951|3769308|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3947727|NCT01354951|3769308|B1|||Age||years|Median|57|57.0|Full Range|||50.0|64.0|
3947728|NCT01354938|3769315|B1|Pakistan||Region of Enrollment||participants|Number|220|220.0||||||
3947729|NCT01354938|3769315|B1||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
3947730|NCT01354938|3769315|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3947731|NCT01354938|3769315|B1|||Age||years|Mean|56.35|56.35|Standard Deviation|12|12.0|||
3947732|NCT01354899|3769321|B1|Sweden||Region of Enrollment||participants|Number|24|24.0||||||
3947733|NCT01354899|3769321|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3947734|NCT01354899|3769321|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3947735|NCT01354899|3769321|B1|||Age||years|Mean|62.1|62.1|Standard Deviation|17.1|17.1|||
3947736|NCT01354652|3769326|B4|Korea, Republic of||Region of Enrollment||participants|Number|5|5.0||||||
3947737|NCT01354652|3769328|B2|Korea, Republic of||Region of Enrollment||participants|Number|2|2.0||||||
3947738|NCT01354652|3769329|B1|Korea, Republic of||Region of Enrollment||participants|Number|3|3.0||||||
3947739|NCT01354652|3769326|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947740|NCT01354652|3769328|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947741|NCT01354652|3769329|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947742|NCT01354652|3769326|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947743|NCT01354652|3769328|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947744|NCT01354652|3769329|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947745|NCT01354652|3769326|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947746|NCT01354652|3769328|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947747|NCT01354652|3769329|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947748|NCT01354652|3769326|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947749|NCT01354652|3769328|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947750|NCT01354652|3769329|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947751|NCT01354652|3769326|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947752|NCT01354652|3769328|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947753|NCT01354652|3769329|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947754|NCT01354652|3769326|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3947755|NCT01354652|3769328|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3947756|NCT01354652|3769329|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3947757|NCT01354652|3769326|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947758|NCT01354652|3769328|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947759|NCT01354652|3769329|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947760|NCT01354652|3769326|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947761|NCT01354652|3769328|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947762|NCT01354652|3769329|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947763|NCT01354652|3769326|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3947764|NCT01354652|3769328|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3947765|NCT01354652|3769329|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3947766|NCT01354652|3769326|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947767|NCT01354652|3769328|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947768|NCT01354652|3769329|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947769|NCT01354652|3769326|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3947770|NCT01354652|3769328|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3947771|NCT01354652|3769329|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3947772|NCT01354652|3769326|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3947773|NCT01354652|3769328|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3947774|NCT01354652|3769329|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3947775|NCT01354652|3769326|B4|||Age||years|Mean|46.6|46.6|Standard Deviation|9.9|9.9|||
3947776|NCT01354652|3769328|B2|||Age||years|Mean|38.0|38.0|Standard Deviation|7.1|7.1|||
3947777|NCT01354652|3769329|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|6.8|6.8|||
3947778|NCT01354652|3769326|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3947779|NCT01354652|3769328|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3947780|NCT01354652|3769329|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3947781|NCT01354652|3769326|B4||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3947782|NCT01354652|3769328|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3947783|NCT01354652|3769329|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3947784|NCT01354652|3769326|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3947785|NCT01354652|3769328|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3947786|NCT01354652|3769329|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3947787|NCT01354444|3769354|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947788|NCT01354444|3769355|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947789|NCT01354444|3769356|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947790|NCT01354444|3769354|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947791|NCT01354444|3769355|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947792|NCT01354444|3769356|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947793|NCT01354444|3769354|B3||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3947794|NCT01354444|3769355|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3947795|NCT01354444|3769356|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3947796|NCT01354444|3769354|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3947797|NCT01354444|3769355|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3947798|NCT01354444|3769356|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3947799|NCT01354444|3769354|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947800|NCT01354444|3769355|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947801|NCT01354444|3769356|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947802|NCT01354444|3769354|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947803|NCT01354444|3769355|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947804|NCT01354444|3769356|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947805|NCT01354444|3769354|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947806|NCT01354444|3769355|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947807|NCT01354444|3769356|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947808|NCT01354444|3769354|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3947809|NCT01354444|3769355|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3947810|NCT01354444|3769356|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3947811|NCT01354444|3769354|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3947812|NCT01354444|3769355|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3947813|NCT01354444|3769356|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3947814|NCT01354444|3769354|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3947815|NCT01354444|3769355|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3947816|NCT01354444|3769356|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3947817|NCT01354444|3769354|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3947818|NCT01354444|3769355|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3947819|NCT01354444|3769356|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3947820|NCT01354444|3769354|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3947821|NCT01354444|3769355|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3947822|NCT01354444|3769356|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3947823|NCT01354431|3769367|B4||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3947824|NCT01354431|3769368|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3947825|NCT01354431|3769369|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3947826|NCT01354431|3769370|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3947827|NCT01354431|3769367|B4||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3947828|NCT01354431|3769368|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3947829|NCT01354431|3769369|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3947830|NCT01354431|3769370|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3947831|NCT01354431|3769367|B4|Greater than, equal to (>=)75 years||Age, Customized||participants|Number|11|11.0||||||
3947832|NCT01354431|3769368|B3|Greater than, equal to (>=)75 years||Age, Customized||participants|Number|4|4.0||||||
3947833|NCT01354431|3769369|B2|Greater than, equal to (>=)75 years||Age, Customized||participants|Number|4|4.0||||||
3947834|NCT01354431|3769370|B1|Greater than, equal to (>=)75 years||Age, Customized||participants|Number|3|3.0||||||
3947835|NCT01354431|3769367|B4|65 to < 75 years||Age, Customized||participants|Number|44|44.0||||||
3947836|NCT01354431|3769368|B3|65 to < 75 years||Age, Customized||participants|Number|15|15.0||||||
3947837|NCT01354431|3769369|B2|65 to < 75 years||Age, Customized||participants|Number|9|9.0||||||
3947838|NCT01354431|3769370|B1|65 to < 75 years||Age, Customized||participants|Number|20|20.0||||||
3947839|NCT01354431|3769367|B4|Less than (<) 65 years||Age, Customized||participants|Number|113|113.0||||||
3947840|NCT01354431|3769368|B3|Less than (<) 65 years||Age, Customized||participants|Number|35|35.0||||||
3947841|NCT01354431|3769369|B2|Less than (<) 65 years||Age, Customized||participants|Number|41|41.0||||||
3947842|NCT01354431|3769370|B1|Less than (<) 65 years||Age, Customized||participants|Number|37|37.0||||||
3947843|NCT01354431|3769367|B4|||Age||years|Mean|60.8|60.8|Standard Deviation|8.85|8.85|||
3947844|NCT01354431|3769368|B3|||Age||years|Mean|60.6|60.6|Standard Deviation|9.61|9.61|||
3947845|NCT01354431|3769369|B2|||Age||years|Mean|60.8|60.8|Standard Deviation|8.23|8.23|||
3947846|NCT01354431|3769370|B1|||Age||years|Mean|61.0|61.0|Standard Deviation|8.82|8.82|||
3947847|NCT01354314|3769392|B5|Negative History||Hepatitis C Infection Status||participants|Number|21|21.0||||||
3947848|NCT01354314|3769393|B4|Negative History||Hepatitis C Infection Status||participants|Number|3|3.0||||||
3947849|NCT01354314|3769394|B3|Negative History||Hepatitis C Infection Status||participants|Number|4|4.0||||||
3947850|NCT01354314|3769395|B2|Negative History||Hepatitis C Infection Status||participants|Number|8|8.0||||||
3947851|NCT01354314|3769396|B1|Negative History||Hepatitis C Infection Status||participants|Number|6|6.0||||||
3947852|NCT01354314|3769392|B5|Positive History||Hepatitis C Infection Status||participants|Number|24|24.0||||||
3947853|NCT01354314|3769393|B4|Positive History||Hepatitis C Infection Status||participants|Number|8|8.0||||||
3947854|NCT01354314|3769394|B3|Positive History||Hepatitis C Infection Status||participants|Number|7|7.0||||||
3947855|NCT01354314|3769395|B2|Positive History||Hepatitis C Infection Status||participants|Number|3|3.0||||||
3947856|NCT01354314|3769396|B1|Positive History||Hepatitis C Infection Status||participants|Number|6|6.0||||||
3947857|NCT01354314|3769392|B5|Detectable: 250-499 copies/mL||Plasma HIV Viral Load||participants|Number|2|2.0||||||
3947858|NCT01354314|3769393|B4|Detectable: 250-499 copies/mL||Plasma HIV Viral Load||participants|Number|0|0.0||||||
3947859|NCT01354314|3769394|B3|Detectable: 250-499 copies/mL||Plasma HIV Viral Load||participants|Number|0|0.0||||||
3947860|NCT01354314|3769395|B2|Detectable: 250-499 copies/mL||Plasma HIV Viral Load||participants|Number|0|0.0||||||
3947861|NCT01354314|3769396|B1|Detectable: 250-499 copies/mL||Plasma HIV Viral Load||participants|Number|2|2.0||||||
3947862|NCT01354314|3769392|B5|Detectable: 100-249 copies/mL||Plasma HIV Viral Load||participants|Number|2|2.0||||||
3947863|NCT01354314|3769393|B4|Detectable: 100-249 copies/mL||Plasma HIV Viral Load||participants|Number|0|0.0||||||
3947864|NCT01354314|3769394|B3|Detectable: 100-249 copies/mL||Plasma HIV Viral Load||participants|Number|0|0.0||||||
3947865|NCT01354314|3769395|B2|Detectable: 100-249 copies/mL||Plasma HIV Viral Load||participants|Number|2|2.0||||||
3947866|NCT01354314|3769396|B1|Detectable: 100-249 copies/mL||Plasma HIV Viral Load||participants|Number|0|0.0||||||
3947867|NCT01354314|3769392|B5|Detectable: 50-99 copies/mL||Plasma HIV Viral Load||participants|Number|4|4.0||||||
3947868|NCT01354314|3769393|B4|Detectable: 50-99 copies/mL||Plasma HIV Viral Load||participants|Number|1|1.0||||||
3947869|NCT01354314|3769394|B3|Detectable: 50-99 copies/mL||Plasma HIV Viral Load||participants|Number|0|0.0||||||
3947870|NCT01354314|3769395|B2|Detectable: 50-99 copies/mL||Plasma HIV Viral Load||participants|Number|0|0.0||||||
3947871|NCT01354314|3769396|B1|Detectable: 50-99 copies/mL||Plasma HIV Viral Load||participants|Number|3|3.0||||||
3947872|NCT01354314|3769392|B5|Undetectable (<50 copies/mL)||Plasma HIV Viral Load||participants|Number|37|37.0||||||
3947873|NCT01354314|3769393|B4|Undetectable (<50 copies/mL)||Plasma HIV Viral Load||participants|Number|10|10.0||||||
3947874|NCT01354314|3769394|B3|Undetectable (<50 copies/mL)||Plasma HIV Viral Load||participants|Number|11|11.0||||||
3947875|NCT01354314|3769395|B2|Undetectable (<50 copies/mL)||Plasma HIV Viral Load||participants|Number|9|9.0||||||
3947876|NCT01354314|3769396|B1|Undetectable (<50 copies/mL)||Plasma HIV Viral Load||participants|Number|7|7.0||||||
3947877|NCT01354314|3769392|B5|||Absolute CD4 Count||Cells per cubic mm|Mean|553.9|553.9|Standard Deviation|248.2|248.2|||
3947878|NCT01354314|3769393|B4|||Absolute CD4 Count||Cells per cubic mm|Mean|510.4|510.4|Standard Deviation|235.1|235.1|||
3947879|NCT01354314|3769394|B3|||Absolute CD4 Count||Cells per cubic mm|Mean|555.2|555.2|Standard Deviation|282.8|282.8|||
3947880|NCT01354314|3769395|B2|||Absolute CD4 Count||Cells per cubic mm|Mean|637.3|637.3|Standard Deviation|241.7|241.7|||
3947881|NCT01354314|3769396|B1|||Absolute CD4 Count||Cells per cubic mm|Mean|516.1|516.1|Standard Deviation|244.8|244.8|||
3947882|NCT01354314|3769392|B5|||Years Since HIV Diagnosis|Based on self-report from participants.|Years|Mean|16.11|16.11|Standard Deviation|7.14|7.14|||
3947883|NCT01354314|3769393|B4|||Years Since HIV Diagnosis|Based on self-report from participants.|Years|Mean|17.36|17.36|Standard Deviation|7.93|7.93|||
3947884|NCT01354314|3769394|B3|||Years Since HIV Diagnosis|Based on self-report from participants.|Years|Mean|15.45|15.45|Standard Deviation|6.76|6.76|||
3947885|NCT01354314|3769395|B2|||Years Since HIV Diagnosis|Based on self-report from participants.|Years|Mean|16.36|16.36|Standard Deviation|7.90|7.9|||
3947886|NCT01354314|3769396|B1|||Years Since HIV Diagnosis|Based on self-report from participants.|Years|Mean|15.33|15.33|Standard Deviation|6.77|6.77|||
3947887|NCT01354314|3769392|B5|||Education||Years Completed|Mean|12.36|12.36|Standard Deviation|1.94|1.94|||
3947888|NCT01354314|3769393|B4|||Education||Years Completed|Mean|12.36|12.36|Standard Deviation|2.11|2.11|||
3947889|NCT01354314|3769394|B3|||Education||Years Completed|Mean|12.91|12.91|Standard Deviation|1.87|1.87|||
3947890|NCT01354314|3769395|B2|||Education||Years Completed|Mean|12.36|12.36|Standard Deviation|1.80|1.8|||
3947891|NCT01354314|3769396|B1|||Education||Years Completed|Mean|11.83|11.83|Standard Deviation|2.08|2.08|||
3947892|NCT01354314|3769392|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947893|NCT01354314|3769393|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947894|NCT01354314|3769394|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947895|NCT01354314|3769395|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947896|NCT01354314|3769396|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947897|NCT01354314|3769392|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947898|NCT01354314|3769393|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947899|NCT01354314|3769394|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947900|NCT01354314|3769395|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947901|NCT01354314|3769396|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947902|NCT01354314|3769392|B5||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3947903|NCT01354314|3769393|B4||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3947904|NCT01354314|3769394|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3947905|NCT01354314|3769395|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3947906|NCT01354314|3769396|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3947907|NCT01354314|3769392|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3947908|NCT01354314|3769393|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3947909|NCT01354314|3769394|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3947910|NCT01354314|3769395|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3947911|NCT01354314|3769396|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3947912|NCT01354314|3769392|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947913|NCT01354314|3769393|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947914|NCT01354314|3769394|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947915|NCT01354314|3769395|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947916|NCT01354314|3769396|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947917|NCT01354314|3769392|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3947918|NCT01354314|3769393|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3947919|NCT01354314|3769394|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947920|NCT01354314|3769395|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947921|NCT01354314|3769396|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947922|NCT01354314|3769392|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947923|NCT01354314|3769393|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947924|NCT01354314|3769394|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947925|NCT01354314|3769395|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947926|NCT01354314|3769396|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947927|NCT01354314|3769392|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947928|NCT01354314|3769393|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947929|NCT01354314|3769394|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947930|NCT01354314|3769395|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947931|NCT01354314|3769396|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947932|NCT01354314|3769392|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3947933|NCT01354314|3769393|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3947934|NCT01354314|3769394|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3947935|NCT01354314|3769395|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3947936|NCT01354314|3769396|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3947937|NCT01354314|3769392|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3947938|NCT01354314|3769393|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947939|NCT01354314|3769394|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947940|NCT01354314|3769395|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3947941|NCT01354314|3769396|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3947942|NCT01354314|3769392|B5|Transgender (Male to Female)||Sex/Gender, Customized||participants|Number|2|2.0||||||
3947943|NCT01354314|3769393|B4|Transgender (Male to Female)||Sex/Gender, Customized||participants|Number|1|1.0||||||
3947944|NCT01354314|3769394|B3|Transgender (Male to Female)||Sex/Gender, Customized||participants|Number|0|0.0||||||
3947945|NCT01354314|3769395|B2|Transgender (Male to Female)||Sex/Gender, Customized||participants|Number|0|0.0||||||
3947946|NCT01354314|3769396|B1|Transgender (Male to Female)||Sex/Gender, Customized||participants|Number|1|1.0||||||
3947947|NCT01354314|3769392|B5|Female||Sex/Gender, Customized||participants|Number|11|11.0||||||
3947948|NCT01354314|3769393|B4|Female||Sex/Gender, Customized||participants|Number|1|1.0||||||
3947949|NCT01354314|3769394|B3|Female||Sex/Gender, Customized||participants|Number|1|1.0||||||
3947950|NCT01354314|3769395|B2|Female||Sex/Gender, Customized||participants|Number|2|2.0||||||
3947951|NCT01354314|3769396|B1|Female||Sex/Gender, Customized||participants|Number|7|7.0||||||
3947952|NCT01354314|3769392|B5|Male||Sex/Gender, Customized||participants|Number|32|32.0||||||
3947953|NCT01354314|3769393|B4|Male||Sex/Gender, Customized||participants|Number|9|9.0||||||
3947954|NCT01354314|3769394|B3|Male||Sex/Gender, Customized||participants|Number|10|10.0||||||
3947955|NCT01354314|3769395|B2|Male||Sex/Gender, Customized||participants|Number|9|9.0||||||
3947956|NCT01354314|3769396|B1|Male||Sex/Gender, Customized||participants|Number|4|4.0||||||
3947957|NCT01354314|3769392|B5|55 to 64||Age, Customized||Years|Number|12|12.0||||||
3947958|NCT01354314|3769393|B4|55 to 64||Age, Customized||Years|Number|4|4.0||||||
3947959|NCT01354314|3769394|B3|55 to 64||Age, Customized||Years|Number|3|3.0||||||
3947960|NCT01354314|3769395|B2|55 to 64||Age, Customized||Years|Number|3|3.0||||||
3947961|NCT01354314|3769396|B1|55 to 64||Age, Customized||Years|Number|2|2.0||||||
3947962|NCT01354314|3769392|B5|45 to 54||Age, Customized||Years|Number|27|27.0||||||
3947963|NCT01354314|3769393|B4|45 to 54||Age, Customized||Years|Number|5|5.0||||||
3947964|NCT01354314|3769394|B3|45 to 54||Age, Customized||Years|Number|7|7.0||||||
3947965|NCT01354314|3769395|B2|45 to 54||Age, Customized||Years|Number|7|7.0||||||
3947966|NCT01354314|3769396|B1|45 to 54||Age, Customized||Years|Number|8|8.0||||||
3947967|NCT01354314|3769392|B5|35 to 44||Age, Customized||Years|Number|5|5.0||||||
3947968|NCT01354314|3769393|B4|35 to 44||Age, Customized||Years|Number|1|1.0||||||
3947969|NCT01354314|3769394|B3|35 to 44||Age, Customized||Years|Number|1|1.0||||||
3947970|NCT01354314|3769395|B2|35 to 44||Age, Customized||Years|Number|1|1.0||||||
3947971|NCT01354314|3769396|B1|35 to 44||Age, Customized||Years|Number|2|2.0||||||
3947972|NCT01354314|3769392|B5|25 to 34||Age, Customized||Years|Number|1|1.0||||||
3947973|NCT01354314|3769393|B4|25 to 34||Age, Customized||Years|Number|1|1.0||||||
3947974|NCT01354314|3769394|B3|25 to 34||Age, Customized||Years|Number|0|0.0||||||
3947975|NCT01354314|3769395|B2|25 to 34||Age, Customized||Years|Number|0|0.0||||||
3947976|NCT01354314|3769396|B1|25 to 34||Age, Customized||Years|Number|0|0.0||||||
3947977|NCT01354314|3769392|B5|||Age||Years|Mean|50.56|50.56|Standard Deviation|7.17|7.17|||
3947978|NCT01354314|3769393|B4|||Age||Years|Mean|48.73|48.73|Standard Deviation|10.23|10.23|||
3947979|NCT01354314|3769394|B3|||Age||Years|Mean|51.73|51.73|Standard Deviation|5.76|5.76|||
3947980|NCT01354314|3769395|B2|||Age||Years|Mean|52.00|52.0|Standard Deviation|6.62|6.62|||
3947981|NCT01354314|3769396|B1|||Age||Years|Mean|49.83|49.83|Standard Deviation|5.77|5.77|||
3947982|NCT01354223|3769533|B3|United States||Region of Enrollment||participants|Number|90|90.0||||||
3947983|NCT01354223|3769534|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3947984|NCT01354223|3769535|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
3947985|NCT01354223|3769533|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3947986|NCT01354223|3769534|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3947987|NCT01354223|3769535|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3947988|NCT01354223|3769533|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3947989|NCT01354223|3769534|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3947990|NCT01354223|3769535|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3947991|NCT01354223|3769533|B3|||Age||years|Mean|31.7|31.7|Standard Deviation|8.822|8.822|||
3947992|NCT01354223|3769534|B2|||Age||years|Mean|29.8|29.8|Standard Deviation|8.550|8.55|||
3947993|NCT01354223|3769535|B1|||Age||years|Mean|32.6|32.6|Standard Deviation|8.884|8.884|||
3947994|NCT01354223|3769533|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3947995|NCT01354223|3769534|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3947996|NCT01354223|3769535|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3947997|NCT01354223|3769533|B3||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
3947998|NCT01354223|3769534|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3947999|NCT01354223|3769535|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3948000|NCT01354223|3769533|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3948001|NCT01354223|3769534|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3948002|NCT01354223|3769535|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3948003|NCT01354197|3769550|B3|Thailand||Region of Enrollment||participants|Number|4652|4652.0||||||
3948004|NCT01354197|3769551|B2|Thailand||Region of Enrollment||participants|Number|642|642.0||||||
3948005|NCT01354197|3769552|B1|Thailand||Region of Enrollment||participants|Number|4010|4010.0||||||
3948006|NCT01354197|3769550|B3|Thai||Race/Ethnicity, Customized||participants|Number|4652|4652.0||||||
3948007|NCT01354197|3769551|B2|Thai||Race/Ethnicity, Customized||participants|Number|642|642.0||||||
3948008|NCT01354197|3769552|B1|Thai||Race/Ethnicity, Customized||participants|Number|4010|4010.0||||||
3948009|NCT01354197|3769550|B3||Male|Sex: Female, Male||Participants|Count of Participants|2729|2729.0||||||
3948010|NCT01354197|3769551|B2||Male|Sex: Female, Male||Participants|Count of Participants|411|411.0||||||
3948011|NCT01354197|3769552|B1||Male|Sex: Female, Male||Participants|Count of Participants|2318|2318.0||||||
3948012|NCT01354197|3769550|B3||Female|Sex: Female, Male||Participants|Count of Participants|1923|1923.0||||||
3948013|NCT01354197|3769551|B2||Female|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
3948014|NCT01354197|3769552|B1||Female|Sex: Female, Male||Participants|Count of Participants|1692|1692.0||||||
3948015|NCT01354197|3769550|B3|||Age||years|Mean|61.7|61.7|Standard Deviation|17.3|17.3|||
3948016|NCT01354197|3769551|B2|||Age||years|Mean|63.7|63.7|Standard Deviation|17.4|17.4|||
3948017|NCT01354197|3769552|B1|||Age||years|Mean|61.4|61.4|Standard Deviation|17.3|17.3|||
3948018|NCT01354145|3769558|B3|||Cartilage Volume in the Global Knee||cubic milimeters|Mean|12356|12356.0|Standard Deviation|3674|3674.0|||
3948019|NCT01354145|3769559|B2|||Cartilage Volume in the Global Knee||cubic milimeters|Mean|12048|12048.0|Standard Deviation|2969|2969.0|||
3948020|NCT01354145|3769560|B1|||Cartilage Volume in the Global Knee||cubic milimeters|Mean|12665|12665.0|Standard Deviation|4259|4259.0|||
3948021|NCT01354145|3769558|B3|||Cartilage Volume in the Medial Compartment||cubic milimeters|Mean|5882|5882.0|Standard Deviation|1820|1820.0|||
3948022|NCT01354145|3769559|B2|||Cartilage Volume in the Medial Compartment||cubic milimeters|Mean|5705|5705.0|Standard Deviation|1572|1572.0|||
3948023|NCT01354145|3769560|B1|||Cartilage Volume in the Medial Compartment||cubic milimeters|Mean|6059|6059.0|Standard Deviation|2031|2031.0|||
3948024|NCT01354145|3769558|B3|||Cartilage Volume in the Lateral Compartment||cubic milimeters|Mean|6475|6475.0|Standard Deviation|1985|1985.0|||
3948025|NCT01354145|3769559|B2|||Cartilage Volume in the Lateral Compartment||cubic milimeters|Mean|6343|6343.0|Standard Deviation|1565|1565.0|||
3948026|NCT01354145|3769560|B1|||Cartilage Volume in the Lateral Compartment||cubic milimeters|Mean|6606|6606.0|Standard Deviation|2332|2332.0|||
3948027|NCT01354145|3769558|B3||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3948028|NCT01354145|3769559|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3948029|NCT01354145|3769560|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3948030|NCT01354145|3769558|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3948031|NCT01354145|3769559|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3948032|NCT01354145|3769560|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3948033|NCT01354145|3769558|B3|||Age||years|Mean|61.3|61.3|Standard Deviation|8.9|8.9|||
3948034|NCT01354145|3769559|B2|||Age||years|Mean|61.3|61.3|Standard Deviation|8.5|8.5|||
3948035|NCT01354145|3769560|B1|||Age||years|Mean|61.4|61.4|Standard Deviation|9.3|9.3|||
3948036|NCT01354145|3769558|B3||>=65 years|Age||Participants|Count of Participants|79|79.0||||||
3948037|NCT01354145|3769559|B2||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
3948038|NCT01354145|3769560|B1||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
3948039|NCT01354145|3769558|B3||Between 18 and 65 years|Age||Participants|Count of Participants|115|115.0||||||
3948040|NCT01354145|3769559|B2||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
3948041|NCT01354145|3769560|B1||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
3948042|NCT01354145|3769558|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3948043|NCT01354145|3769559|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3948044|NCT01354145|3769560|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3948045|NCT01354132|3769593|B3|Glutamate||Brain Marker - Glutathione and Glutamate|Brain markers, glutathione and glutamate were measured using Magnetic Resonance Spectroscopy (H-MRS) in the medial prefrontal cortex. Glutathione is a tripeptide comprised of three amino acids (cysteine, glutamic acid, and glycine) and acts as an antioxidant, a free radical scavanger and a detoxifying agent. Glutathione is an important co-factor for the enzyme glutathione peroxidase used in the uptake of amino acids. Glutamate is an excitatory neurotransmitter in the brain.|mM (millimolar)|Mean|10.37|10.37|Standard Deviation|1.01|1.01|||
3948046|NCT01354132|3769594|B2|Glutamate||Brain Marker - Glutathione and Glutamate|Brain markers, glutathione and glutamate were measured using Magnetic Resonance Spectroscopy (H-MRS) in the medial prefrontal cortex. Glutathione is a tripeptide comprised of three amino acids (cysteine, glutamic acid, and glycine) and acts as an antioxidant, a free radical scavanger and a detoxifying agent. Glutathione is an important co-factor for the enzyme glutathione peroxidase used in the uptake of amino acids. Glutamate is an excitatory neurotransmitter in the brain.|mM (millimolar)|Mean|10.64|10.64|Standard Deviation|1.23|1.23|||
3948047|NCT01354132|3769595|B1|Glutamate||Brain Marker - Glutathione and Glutamate|Brain markers, glutathione and glutamate were measured using Magnetic Resonance Spectroscopy (H-MRS) in the medial prefrontal cortex. Glutathione is a tripeptide comprised of three amino acids (cysteine, glutamic acid, and glycine) and acts as an antioxidant, a free radical scavanger and a detoxifying agent. Glutathione is an important co-factor for the enzyme glutathione peroxidase used in the uptake of amino acids. Glutamate is an excitatory neurotransmitter in the brain.|mM (millimolar)|Mean|10.12|10.12|Standard Deviation|0.80|0.8|||
3948048|NCT01354132|3769593|B3|Glutathione||Brain Marker - Glutathione and Glutamate|Brain markers, glutathione and glutamate were measured using Magnetic Resonance Spectroscopy (H-MRS) in the medial prefrontal cortex. Glutathione is a tripeptide comprised of three amino acids (cysteine, glutamic acid, and glycine) and acts as an antioxidant, a free radical scavanger and a detoxifying agent. Glutathione is an important co-factor for the enzyme glutathione peroxidase used in the uptake of amino acids. Glutamate is an excitatory neurotransmitter in the brain.|mM (millimolar)|Mean|0.99|0.99|Standard Deviation|0.21|0.21|||
3948049|NCT01354132|3769594|B2|Glutathione||Brain Marker - Glutathione and Glutamate|Brain markers, glutathione and glutamate were measured using Magnetic Resonance Spectroscopy (H-MRS) in the medial prefrontal cortex. Glutathione is a tripeptide comprised of three amino acids (cysteine, glutamic acid, and glycine) and acts as an antioxidant, a free radical scavanger and a detoxifying agent. Glutathione is an important co-factor for the enzyme glutathione peroxidase used in the uptake of amino acids. Glutamate is an excitatory neurotransmitter in the brain.|mM (millimolar)|Mean|1.12|1.12|Standard Deviation|0.18|0.18|||
3948050|NCT01354132|3769595|B1|Glutathione||Brain Marker - Glutathione and Glutamate|Brain markers, glutathione and glutamate were measured using Magnetic Resonance Spectroscopy (H-MRS) in the medial prefrontal cortex. Glutathione is a tripeptide comprised of three amino acids (cysteine, glutamic acid, and glycine) and acts as an antioxidant, a free radical scavanger and a detoxifying agent. Glutathione is an important co-factor for the enzyme glutathione peroxidase used in the uptake of amino acids. Glutamate is an excitatory neurotransmitter in the brain.|mM (millimolar)|Mean|0.87|0.87|Standard Deviation|0.23|0.23|||
3948051|NCT01354132|3769593|B3|Myo-Inositol||Brain Marker - Glutamine and myo-Inositol|Brain levels of glutamine and myo-Inositol were measured using Magnetic ResonanceSpectroscopy (H-MRS), both are chemicals that work to protect the brain from high levels of excitatory chemicals such as glutamate.|mM (millimolar)|Mean|6.26|6.26|Standard Deviation|0.84|0.84|||
3948052|NCT01354132|3769594|B2|Myo-Inositol||Brain Marker - Glutamine and myo-Inositol|Brain levels of glutamine and myo-Inositol were measured using Magnetic ResonanceSpectroscopy (H-MRS), both are chemicals that work to protect the brain from high levels of excitatory chemicals such as glutamate.|mM (millimolar)|Mean|6.28|6.28|Standard Deviation|0.62|0.62|||
3948053|NCT01354132|3769595|B1|Myo-Inositol||Brain Marker - Glutamine and myo-Inositol|Brain levels of glutamine and myo-Inositol were measured using Magnetic ResonanceSpectroscopy (H-MRS), both are chemicals that work to protect the brain from high levels of excitatory chemicals such as glutamate.|mM (millimolar)|Mean|6.25|6.25|Standard Deviation|1.05|1.05|||
3948054|NCT01354132|3769593|B3|Glutamine||Brain Marker - Glutamine and myo-Inositol|Brain levels of glutamine and myo-Inositol were measured using Magnetic ResonanceSpectroscopy (H-MRS), both are chemicals that work to protect the brain from high levels of excitatory chemicals such as glutamate.|mM (millimolar)|Mean|3.10|3.1|Standard Deviation|0.50|0.5|||
3948055|NCT01354132|3769594|B2|Glutamine||Brain Marker - Glutamine and myo-Inositol|Brain levels of glutamine and myo-Inositol were measured using Magnetic ResonanceSpectroscopy (H-MRS), both are chemicals that work to protect the brain from high levels of excitatory chemicals such as glutamate.|mM (millimolar)|Mean|2.93|2.93|Standard Deviation|0.48|0.48|||
3948056|NCT01354132|3769595|B1|Glutamine||Brain Marker - Glutamine and myo-Inositol|Brain levels of glutamine and myo-Inositol were measured using Magnetic ResonanceSpectroscopy (H-MRS), both are chemicals that work to protect the brain from high levels of excitatory chemicals such as glutamate.|mM (millimolar)|Mean|3.25|3.25|Standard Deviation|0.51|0.51|||
3948057|NCT01354132|3769593|B3|||Blood Marker - Glutathione|Glutathione is a tripeptide comprised of three amino acids (cysteine, glutamic acid, and glycine) and acts as an antioxidant, a free radical scavanger and a detoxifying agent. Glutathione is an important co-factor for the enzyme glutathione peroxidase used in the uptake of amino acids. The level of glutathione is measured in blood cells.|mM (millimolar) in blood cells|Mean|0.81|0.81|Standard Deviation|0.24|0.24|||
3948058|NCT01354132|3769594|B2|||Blood Marker - Glutathione|Glutathione is a tripeptide comprised of three amino acids (cysteine, glutamic acid, and glycine) and acts as an antioxidant, a free radical scavanger and a detoxifying agent. Glutathione is an important co-factor for the enzyme glutathione peroxidase used in the uptake of amino acids. The level of glutathione is measured in blood cells.|mM (millimolar) in blood cells|Mean|0.84|0.84|Standard Deviation|0.27|0.27|||
3948059|NCT01354132|3769595|B1|||Blood Marker - Glutathione|Glutathione is a tripeptide comprised of three amino acids (cysteine, glutamic acid, and glycine) and acts as an antioxidant, a free radical scavanger and a detoxifying agent. Glutathione is an important co-factor for the enzyme glutathione peroxidase used in the uptake of amino acids. The level of glutathione is measured in blood cells.|mM (millimolar) in blood cells|Mean|0.77|0.77|Standard Deviation|0.21|0.21|||
3948060|NCT01354132|3769593|B3|||Blood Marker - GPxbc- Glutathione peroxidase|GPxBC is a measurement of glutathiione peroxidase enzymatic activity in glutathione synthesis and the redox system in blood cells. Measured as umol/min/gHb from blood cells.|umol/min/gHb|Mean|21.13|21.13|Standard Deviation|7.17|7.17|||
3948061|NCT01354132|3769594|B2|||Blood Marker - GPxbc- Glutathione peroxidase|GPxBC is a measurement of glutathiione peroxidase enzymatic activity in glutathione synthesis and the redox system in blood cells. Measured as umol/min/gHb from blood cells.|umol/min/gHb|Mean|21.01|21.01|Standard Deviation|6.93|6.93|||
3948062|NCT01354132|3769595|B1|||Blood Marker - GPxbc- Glutathione peroxidase|GPxBC is a measurement of glutathiione peroxidase enzymatic activity in glutathione synthesis and the redox system in blood cells. Measured as umol/min/gHb from blood cells.|umol/min/gHb|Mean|21.24|21.24|Standard Deviation|7.5|7.5|||
3948063|NCT01354132|3769593|B3|||Blood Marker - Cysteine|Cysteine is an amino acid, a building block for proteins and is used throughout the body and was measured in blood plasma.|uM (micrometer)|Mean|257.7|257.7|Standard Deviation|35.7|35.7|||
3948064|NCT01354132|3769594|B2|||Blood Marker - Cysteine|Cysteine is an amino acid, a building block for proteins and is used throughout the body and was measured in blood plasma.|uM (micrometer)|Mean|254.0|254.0|Standard Deviation|33.6|33.6|||
3948065|NCT01354132|3769595|B1|||Blood Marker - Cysteine|Cysteine is an amino acid, a building block for proteins and is used throughout the body and was measured in blood plasma.|uM (micrometer)|Mean|261.3|261.3|Standard Deviation|37.6|37.6|||
3948066|NCT01354132|3769593|B3|||Antipsychotic Medication Chlorpromazine Equivalents|Dose of current antipsychotic medication in chlorpromazine equivalents|milligrams|Mean|309|309.0|Standard Deviation|220|220.0|||
3948067|NCT01354132|3769594|B2|||Antipsychotic Medication Chlorpromazine Equivalents|Dose of current antipsychotic medication in chlorpromazine equivalents|milligrams|Mean|309|309.0|Standard Deviation|188|188.0|||
3948068|NCT01354132|3769595|B1|||Antipsychotic Medication Chlorpromazine Equivalents|Dose of current antipsychotic medication in chlorpromazine equivalents|milligrams|Mean|309|309.0|Standard Deviation|252|252.0|||
3948069|NCT01354132|3769593|B3|Problem Solving||MATRICS Consensus Cognitive Battery (MCCB) excluding MISCEIT managing emotions test)|The MCCB has 6 cognitive factors including: 1) processing speed (Trail Making Test, BACS: Symbol Coding, Category Fluency: Animal Naming), 2) sustained attention (Continuous Performance Test –Identical Pairs), 3) working memory (WMS-III Spatial Span and Letter-Number Span), 4) verbal learning (Hopkins Verbal Learning Test-Revised: Immediate Recall), 5) visual learning (Brief Visuospatial Memory test – Revised: Immediate Recall) and 6) problem solving (NAB Mazes). The T-score of 50 is an average score. Scores below 50 indicates cognitive processing lower than age matched healthy populations.|Standardized T Scores|Mean|44.41|44.41|Standard Deviation|12.17|12.17|||
3948070|NCT01354132|3769594|B2|Problem Solving||MATRICS Consensus Cognitive Battery (MCCB) excluding MISCEIT managing emotions test)|The MCCB has 6 cognitive factors including: 1) processing speed (Trail Making Test, BACS: Symbol Coding, Category Fluency: Animal Naming), 2) sustained attention (Continuous Performance Test –Identical Pairs), 3) working memory (WMS-III Spatial Span and Letter-Number Span), 4) verbal learning (Hopkins Verbal Learning Test-Revised: Immediate Recall), 5) visual learning (Brief Visuospatial Memory test – Revised: Immediate Recall) and 6) problem solving (NAB Mazes). The T-score of 50 is an average score. Scores below 50 indicates cognitive processing lower than age matched healthy populations.|Standardized T Scores|Mean|39.93|39.93|Standard Deviation|12.76|12.76|||
3948071|NCT01354132|3769595|B1|Problem Solving||MATRICS Consensus Cognitive Battery (MCCB) excluding MISCEIT managing emotions test)|The MCCB has 6 cognitive factors including: 1) processing speed (Trail Making Test, BACS: Symbol Coding, Category Fluency: Animal Naming), 2) sustained attention (Continuous Performance Test –Identical Pairs), 3) working memory (WMS-III Spatial Span and Letter-Number Span), 4) verbal learning (Hopkins Verbal Learning Test-Revised: Immediate Recall), 5) visual learning (Brief Visuospatial Memory test – Revised: Immediate Recall) and 6) problem solving (NAB Mazes). The T-score of 50 is an average score. Scores below 50 indicates cognitive processing lower than age matched healthy populations.|Standardized T Scores|Mean|48.00|48.0|Standard Deviation|11.69|11.69|||
3948119|NCT01354132|3769595|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3948120|NCT01354132|3769593|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3948121|NCT01354132|3769594|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3948122|NCT01354132|3769595|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3948072|NCT01354132|3769593|B3|Visual Learning||MATRICS Consensus Cognitive Battery (MCCB) excluding MISCEIT managing emotions test)|The MCCB has 6 cognitive factors including: 1) processing speed (Trail Making Test, BACS: Symbol Coding, Category Fluency: Animal Naming), 2) sustained attention (Continuous Performance Test –Identical Pairs), 3) working memory (WMS-III Spatial Span and Letter-Number Span), 4) verbal learning (Hopkins Verbal Learning Test-Revised: Immediate Recall), 5) visual learning (Brief Visuospatial Memory test – Revised: Immediate Recall) and 6) problem solving (NAB Mazes). The T-score of 50 is an average score. Scores below 50 indicates cognitive processing lower than age matched healthy populations.|Standardized T Scores|Mean|42.75|42.75|Standard Deviation|11.97|11.97|||
3948073|NCT01354132|3769594|B2|Visual Learning||MATRICS Consensus Cognitive Battery (MCCB) excluding MISCEIT managing emotions test)|The MCCB has 6 cognitive factors including: 1) processing speed (Trail Making Test, BACS: Symbol Coding, Category Fluency: Animal Naming), 2) sustained attention (Continuous Performance Test –Identical Pairs), 3) working memory (WMS-III Spatial Span and Letter-Number Span), 4) verbal learning (Hopkins Verbal Learning Test-Revised: Immediate Recall), 5) visual learning (Brief Visuospatial Memory test – Revised: Immediate Recall) and 6) problem solving (NAB Mazes). The T-score of 50 is an average score. Scores below 50 indicates cognitive processing lower than age matched healthy populations.|Standardized T Scores|Mean|44.86|44.86|Standard Deviation|14.42|14.42|||
3948074|NCT01354132|3769595|B1|Visual Learning||MATRICS Consensus Cognitive Battery (MCCB) excluding MISCEIT managing emotions test)|The MCCB has 6 cognitive factors including: 1) processing speed (Trail Making Test, BACS: Symbol Coding, Category Fluency: Animal Naming), 2) sustained attention (Continuous Performance Test –Identical Pairs), 3) working memory (WMS-III Spatial Span and Letter-Number Span), 4) verbal learning (Hopkins Verbal Learning Test-Revised: Immediate Recall), 5) visual learning (Brief Visuospatial Memory test – Revised: Immediate Recall) and 6) problem solving (NAB Mazes). The T-score of 50 is an average score. Scores below 50 indicates cognitive processing lower than age matched healthy populations.|Standardized T Scores|Mean|41.06|41.06|Standard Deviation|10.01|10.01|||
3948075|NCT01354132|3769593|B3|Verbal Learning||MATRICS Consensus Cognitive Battery (MCCB) excluding MISCEIT managing emotions test)|The MCCB has 6 cognitive factors including: 1) processing speed (Trail Making Test, BACS: Symbol Coding, Category Fluency: Animal Naming), 2) sustained attention (Continuous Performance Test –Identical Pairs), 3) working memory (WMS-III Spatial Span and Letter-Number Span), 4) verbal learning (Hopkins Verbal Learning Test-Revised: Immediate Recall), 5) visual learning (Brief Visuospatial Memory test – Revised: Immediate Recall) and 6) problem solving (NAB Mazes). The T-score of 50 is an average score. Scores below 50 indicates cognitive processing lower than age matched healthy populations.|Standardized T Scores|Mean|40.94|40.94|Standard Deviation|11.71|11.71|||
3948076|NCT01354132|3769594|B2|Verbal Learning||MATRICS Consensus Cognitive Battery (MCCB) excluding MISCEIT managing emotions test)|The MCCB has 6 cognitive factors including: 1) processing speed (Trail Making Test, BACS: Symbol Coding, Category Fluency: Animal Naming), 2) sustained attention (Continuous Performance Test –Identical Pairs), 3) working memory (WMS-III Spatial Span and Letter-Number Span), 4) verbal learning (Hopkins Verbal Learning Test-Revised: Immediate Recall), 5) visual learning (Brief Visuospatial Memory test – Revised: Immediate Recall) and 6) problem solving (NAB Mazes). The T-score of 50 is an average score. Scores below 50 indicates cognitive processing lower than age matched healthy populations.|Standardized T Scores|Mean|40.93|40.93|Standard Deviation|13.73|13.73|||
3948077|NCT01354132|3769595|B1|Verbal Learning||MATRICS Consensus Cognitive Battery (MCCB) excluding MISCEIT managing emotions test)|The MCCB has 6 cognitive factors including: 1) processing speed (Trail Making Test, BACS: Symbol Coding, Category Fluency: Animal Naming), 2) sustained attention (Continuous Performance Test –Identical Pairs), 3) working memory (WMS-III Spatial Span and Letter-Number Span), 4) verbal learning (Hopkins Verbal Learning Test-Revised: Immediate Recall), 5) visual learning (Brief Visuospatial Memory test – Revised: Immediate Recall) and 6) problem solving (NAB Mazes). The T-score of 50 is an average score. Scores below 50 indicates cognitive processing lower than age matched healthy populations.|Standardized T Scores|Mean|40.94|40.94|Standard Deviation|10.09|10.09|||
3948078|NCT01354132|3769593|B3|Working Memory||MATRICS Consensus Cognitive Battery (MCCB) excluding MISCEIT managing emotions test)|The MCCB has 6 cognitive factors including: 1) processing speed (Trail Making Test, BACS: Symbol Coding, Category Fluency: Animal Naming), 2) sustained attention (Continuous Performance Test –Identical Pairs), 3) working memory (WMS-III Spatial Span and Letter-Number Span), 4) verbal learning (Hopkins Verbal Learning Test-Revised: Immediate Recall), 5) visual learning (Brief Visuospatial Memory test – Revised: Immediate Recall) and 6) problem solving (NAB Mazes). The T-score of 50 is an average score. Scores below 50 indicates cognitive processing lower than age matched healthy populations.|Standardized T Scores|Mean|43.70|43.7|Standard Deviation|12.10|12.1|||
3948079|NCT01354132|3769594|B2|Working Memory||MATRICS Consensus Cognitive Battery (MCCB) excluding MISCEIT managing emotions test)|The MCCB has 6 cognitive factors including: 1) processing speed (Trail Making Test, BACS: Symbol Coding, Category Fluency: Animal Naming), 2) sustained attention (Continuous Performance Test –Identical Pairs), 3) working memory (WMS-III Spatial Span and Letter-Number Span), 4) verbal learning (Hopkins Verbal Learning Test-Revised: Immediate Recall), 5) visual learning (Brief Visuospatial Memory test – Revised: Immediate Recall) and 6) problem solving (NAB Mazes). The T-score of 50 is an average score. Scores below 50 indicates cognitive processing lower than age matched healthy populations.|Standardized T Scores|Mean|38.87|38.87|Standard Deviation|15.09|15.09|||
3948080|NCT01354132|3769595|B1|Working Memory||MATRICS Consensus Cognitive Battery (MCCB) excluding MISCEIT managing emotions test)|The MCCB has 6 cognitive factors including: 1) processing speed (Trail Making Test, BACS: Symbol Coding, Category Fluency: Animal Naming), 2) sustained attention (Continuous Performance Test –Identical Pairs), 3) working memory (WMS-III Spatial Span and Letter-Number Span), 4) verbal learning (Hopkins Verbal Learning Test-Revised: Immediate Recall), 5) visual learning (Brief Visuospatial Memory test – Revised: Immediate Recall) and 6) problem solving (NAB Mazes). The T-score of 50 is an average score. Scores below 50 indicates cognitive processing lower than age matched healthy populations.|Standardized T Scores|Mean|47.56|47.56|Standard Deviation|9.70|9.7|||
3948123|NCT01354132|3769593|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3948124|NCT01354132|3769594|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3948125|NCT01354132|3769595|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3948126|NCT01354132|3769593|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3948081|NCT01354132|3769593|B3|Sustained Attention||MATRICS Consensus Cognitive Battery (MCCB) excluding MISCEIT managing emotions test)|The MCCB has 6 cognitive factors including: 1) processing speed (Trail Making Test, BACS: Symbol Coding, Category Fluency: Animal Naming), 2) sustained attention (Continuous Performance Test –Identical Pairs), 3) working memory (WMS-III Spatial Span and Letter-Number Span), 4) verbal learning (Hopkins Verbal Learning Test-Revised: Immediate Recall), 5) visual learning (Brief Visuospatial Memory test – Revised: Immediate Recall) and 6) problem solving (NAB Mazes). The T-score of 50 is an average score. Scores below 50 indicates cognitive processing lower than age matched healthy populations.|Standardized T Scores|Mean|36.87|36.87|Standard Deviation|12.35|12.35|||
3948082|NCT01354132|3769594|B2|Sustained Attention||MATRICS Consensus Cognitive Battery (MCCB) excluding MISCEIT managing emotions test)|The MCCB has 6 cognitive factors including: 1) processing speed (Trail Making Test, BACS: Symbol Coding, Category Fluency: Animal Naming), 2) sustained attention (Continuous Performance Test –Identical Pairs), 3) working memory (WMS-III Spatial Span and Letter-Number Span), 4) verbal learning (Hopkins Verbal Learning Test-Revised: Immediate Recall), 5) visual learning (Brief Visuospatial Memory test – Revised: Immediate Recall) and 6) problem solving (NAB Mazes). The T-score of 50 is an average score. Scores below 50 indicates cognitive processing lower than age matched healthy populations.|Standardized T Scores|Mean|32.67|32.67|Standard Deviation|13.15|13.15|||
3948083|NCT01354132|3769595|B1|Sustained Attention||MATRICS Consensus Cognitive Battery (MCCB) excluding MISCEIT managing emotions test)|The MCCB has 6 cognitive factors including: 1) processing speed (Trail Making Test, BACS: Symbol Coding, Category Fluency: Animal Naming), 2) sustained attention (Continuous Performance Test –Identical Pairs), 3) working memory (WMS-III Spatial Span and Letter-Number Span), 4) verbal learning (Hopkins Verbal Learning Test-Revised: Immediate Recall), 5) visual learning (Brief Visuospatial Memory test – Revised: Immediate Recall) and 6) problem solving (NAB Mazes). The T-score of 50 is an average score. Scores below 50 indicates cognitive processing lower than age matched healthy populations.|Standardized T Scores|Mean|40.23|40.23|Standard Deviation|11.71|11.71|||
3948084|NCT01354132|3769593|B3|Processing Speed||MATRICS Consensus Cognitive Battery (MCCB) excluding MISCEIT managing emotions test)|The MCCB has 6 cognitive factors including: 1) processing speed (Trail Making Test, BACS: Symbol Coding, Category Fluency: Animal Naming), 2) sustained attention (Continuous Performance Test –Identical Pairs), 3) working memory (WMS-III Spatial Span and Letter-Number Span), 4) verbal learning (Hopkins Verbal Learning Test-Revised: Immediate Recall), 5) visual learning (Brief Visuospatial Memory test – Revised: Immediate Recall) and 6) problem solving (NAB Mazes). The T-score of 50 is an average score. Scores below 50 indicates cognitive processing lower than age matched healthy populations.|Standardized T Scores|Mean|36.75|36.75|Standard Deviation|13.48|13.48|||
3948085|NCT01354132|3769594|B2|Processing Speed||MATRICS Consensus Cognitive Battery (MCCB) excluding MISCEIT managing emotions test)|The MCCB has 6 cognitive factors including: 1) processing speed (Trail Making Test, BACS: Symbol Coding, Category Fluency: Animal Naming), 2) sustained attention (Continuous Performance Test –Identical Pairs), 3) working memory (WMS-III Spatial Span and Letter-Number Span), 4) verbal learning (Hopkins Verbal Learning Test-Revised: Immediate Recall), 5) visual learning (Brief Visuospatial Memory test – Revised: Immediate Recall) and 6) problem solving (NAB Mazes). The T-score of 50 is an average score. Scores below 50 indicates cognitive processing lower than age matched healthy populations.|Standardized T Scores|Mean|35.53|35.53|Standard Deviation|16.31|16.31|||
3948086|NCT01354132|3769595|B1|Processing Speed||MATRICS Consensus Cognitive Battery (MCCB) excluding MISCEIT managing emotions test)|The MCCB has 6 cognitive factors including: 1) processing speed (Trail Making Test, BACS: Symbol Coding, Category Fluency: Animal Naming), 2) sustained attention (Continuous Performance Test –Identical Pairs), 3) working memory (WMS-III Spatial Span and Letter-Number Span), 4) verbal learning (Hopkins Verbal Learning Test-Revised: Immediate Recall), 5) visual learning (Brief Visuospatial Memory test – Revised: Immediate Recall) and 6) problem solving (NAB Mazes). The T-score of 50 is an average score. Scores below 50 indicates cognitive processing lower than age matched healthy populations.|Standardized T Scores|Mean|37.72|37.72|Standard Deviation|11.22|11.22|||
3948087|NCT01354132|3769593|B3|||Social and Occupational Functioning Assessment Scale (SOFAS)|"Rating of Overall Social and Occupational Functioning on a scale of 1 (worst) to 100 (best) in groups of 10:~100–91: Superior functioning 90–81: Good functioning 80–71: Slight impairment 70–61: Some difficulty 60–51: Moderate difficulty 50–41: Serious impairment 40–31: Major impairment 30–21: Inability to function in almost all areas 20–11: Unable to function independently 10–1: Unable to function without harming self or others"|units on a scale|Mean|54.7|54.7|Standard Deviation|12.0|12.0|||
3948088|NCT01354132|3769594|B2|||Social and Occupational Functioning Assessment Scale (SOFAS)|"Rating of Overall Social and Occupational Functioning on a scale of 1 (worst) to 100 (best) in groups of 10:~100–91: Superior functioning 90–81: Good functioning 80–71: Slight impairment 70–61: Some difficulty 60–51: Moderate difficulty 50–41: Serious impairment 40–31: Major impairment 30–21: Inability to function in almost all areas 20–11: Unable to function independently 10–1: Unable to function without harming self or others"|units on a scale|Mean|53.5|53.5|Standard Deviation|13.0|13.0|||
3948089|NCT01354132|3769595|B1|||Social and Occupational Functioning Assessment Scale (SOFAS)|"Rating of Overall Social and Occupational Functioning on a scale of 1 (worst) to 100 (best) in groups of 10:~100–91: Superior functioning 90–81: Good functioning 80–71: Slight impairment 70–61: Some difficulty 60–51: Moderate difficulty 50–41: Serious impairment 40–31: Major impairment 30–21: Inability to function in almost all areas 20–11: Unable to function independently 10–1: Unable to function without harming self or others"|units on a scale|Mean|55.8|55.8|Standard Deviation|11.0|11.0|||
3948090|NCT01354132|3769593|B3|||Duration of Psychosis|Duration of time in days since onset of psychosis|days|Mean|796|796.0|Standard Deviation|726|726.0|||
3948091|NCT01354132|3769594|B2|||Duration of Psychosis|Duration of time in days since onset of psychosis|days|Mean|747|747.0|Standard Deviation|693|693.0|||
3948092|NCT01354132|3769595|B1|||Duration of Psychosis|Duration of time in days since onset of psychosis|days|Mean|848|848.0|Standard Deviation|767|767.0|||
3948127|NCT01354132|3769594|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3948128|NCT01354132|3769595|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3948129|NCT01354132|3769593|B3|||Age||years|Mean|25.4|25.4|Standard Deviation|6.0|6.0|||
3948130|NCT01354132|3769594|B2|||Age||years|Mean|24.7|24.7|Standard Deviation|5.9|5.9|||
3948093|NCT01354132|3769593|B3|||Global Assessment of Functioning (GAF)|"Clinical Measure of Global level of Symptoms (Sx) and Functioning from 1 (Worst) to 100 (Best) in groups of 10:~100 – 91: Superior functioning 90 – 81: Absent or minimal Sx 80 – 71: If symptoms are present and expected 70 – 61:Some mild Sx 60 – 51: Moderate Sx 50 – 41: Serious Sx 40 – 31: Some impairment in reality testing or communication 30 – 21: Behavior is considerably influenced by delusions or hallucinations 20 – 11: Some danger of hurting self or others 10 – 1: Persistent danger of severely hurting self or others"|units on a scale|Mean|52.8|52.8|Standard Deviation|11.8|11.8|||
3948094|NCT01354132|3769594|B2|||Global Assessment of Functioning (GAF)|"Clinical Measure of Global level of Symptoms (Sx) and Functioning from 1 (Worst) to 100 (Best) in groups of 10:~100 – 91: Superior functioning 90 – 81: Absent or minimal Sx 80 – 71: If symptoms are present and expected 70 – 61:Some mild Sx 60 – 51: Moderate Sx 50 – 41: Serious Sx 40 – 31: Some impairment in reality testing or communication 30 – 21: Behavior is considerably influenced by delusions or hallucinations 20 – 11: Some danger of hurting self or others 10 – 1: Persistent danger of severely hurting self or others"|units on a scale|Mean|51.6|51.6|Standard Deviation|12.8|12.8|||
3948095|NCT01354132|3769595|B1|||Global Assessment of Functioning (GAF)|"Clinical Measure of Global level of Symptoms (Sx) and Functioning from 1 (Worst) to 100 (Best) in groups of 10:~100 – 91: Superior functioning 90 – 81: Absent or minimal Sx 80 – 71: If symptoms are present and expected 70 – 61:Some mild Sx 60 – 51: Moderate Sx 50 – 41: Serious Sx 40 – 31: Some impairment in reality testing or communication 30 – 21: Behavior is considerably influenced by delusions or hallucinations 20 – 11: Some danger of hurting self or others 10 – 1: Persistent danger of severely hurting self or others"|units on a scale|Mean|54|54.0|Standard Deviation|10.8|10.8|||
3948096|NCT01354132|3769593|B3|Negative Symptoms||Positive and Negative Symptom Scale (PANSS)|"Clinical Measure of Positive (7 items P1-P7) Negative Symptoms (7 items N1-N7) General Psychopathology Symptoms (G1-G16) total of 30 items~Assessed in the previous week:~RATING SCALE~1: Absent 2: Minimal 3: Mild 4: Moderate 5: Moderate Severe 6: Severe 7: Extreme The higher the score the worse the symptoms. The lowest possible score is 30 and the highesr possible score is 210."|units on a scale|Mean|16.4|16.4|Standard Deviation|5.7|5.7|||
3948097|NCT01354132|3769594|B2|Negative Symptoms||Positive and Negative Symptom Scale (PANSS)|"Clinical Measure of Positive (7 items P1-P7) Negative Symptoms (7 items N1-N7) General Psychopathology Symptoms (G1-G16) total of 30 items~Assessed in the previous week:~RATING SCALE~1: Absent 2: Minimal 3: Mild 4: Moderate 5: Moderate Severe 6: Severe 7: Extreme The higher the score the worse the symptoms. The lowest possible score is 30 and the highesr possible score is 210."|units on a scale|Mean|17.3|17.3|Standard Deviation|6.3|6.3|||
3948098|NCT01354132|3769595|B1|Negative Symptoms||Positive and Negative Symptom Scale (PANSS)|"Clinical Measure of Positive (7 items P1-P7) Negative Symptoms (7 items N1-N7) General Psychopathology Symptoms (G1-G16) total of 30 items~Assessed in the previous week:~RATING SCALE~1: Absent 2: Minimal 3: Mild 4: Moderate 5: Moderate Severe 6: Severe 7: Extreme The higher the score the worse the symptoms. The lowest possible score is 30 and the highesr possible score is 210."|units on a scale|Mean|15.6|15.6|Standard Deviation|5.0|5.0|||
3948099|NCT01354132|3769593|B3|Positive PANSS Symptoms||Positive and Negative Symptom Scale (PANSS)|"Clinical Measure of Positive (7 items P1-P7) Negative Symptoms (7 items N1-N7) General Psychopathology Symptoms (G1-G16) total of 30 items~Assessed in the previous week:~RATING SCALE~1: Absent 2: Minimal 3: Mild 4: Moderate 5: Moderate Severe 6: Severe 7: Extreme The higher the score the worse the symptoms. The lowest possible score is 30 and the highesr possible score is 210."|units on a scale|Mean|14.7|14.7|Standard Deviation|16.4|16.4|||
3948100|NCT01354132|3769594|B2|Positive PANSS Symptoms||Positive and Negative Symptom Scale (PANSS)|"Clinical Measure of Positive (7 items P1-P7) Negative Symptoms (7 items N1-N7) General Psychopathology Symptoms (G1-G16) total of 30 items~Assessed in the previous week:~RATING SCALE~1: Absent 2: Minimal 3: Mild 4: Moderate 5: Moderate Severe 6: Severe 7: Extreme The higher the score the worse the symptoms. The lowest possible score is 30 and the highesr possible score is 210."|units on a scale|Mean|15.0|15.0|Standard Deviation|5.6|5.6|||
3948101|NCT01354132|3769595|B1|Positive PANSS Symptoms||Positive and Negative Symptom Scale (PANSS)|"Clinical Measure of Positive (7 items P1-P7) Negative Symptoms (7 items N1-N7) General Psychopathology Symptoms (G1-G16) total of 30 items~Assessed in the previous week:~RATING SCALE~1: Absent 2: Minimal 3: Mild 4: Moderate 5: Moderate Severe 6: Severe 7: Extreme The higher the score the worse the symptoms. The lowest possible score is 30 and the highesr possible score is 210."|units on a scale|Mean|14.3|14.3|Standard Deviation|5.4|5.4|||
3948102|NCT01354132|3769593|B3|Switzerland||Region of Enrollment||Participants|Count of Participants|53|53.0||||||
3948103|NCT01354132|3769594|B2|Switzerland||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3948104|NCT01354132|3769595|B1|Switzerland||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3948105|NCT01354132|3769593|B3|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3948106|NCT01354132|3769594|B2|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3948107|NCT01354132|3769595|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3948108|NCT01354132|3769593|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|60|60.0||||||
3948109|NCT01354132|3769594|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3948110|NCT01354132|3769595|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3948111|NCT01354132|3769593|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3948112|NCT01354132|3769594|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3948113|NCT01354132|3769595|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3948114|NCT01354132|3769593|B3|Maghreb||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3948115|NCT01354132|3769594|B2|Maghreb||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3948116|NCT01354132|3769595|B1|Maghreb||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3948117|NCT01354132|3769593|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
3948118|NCT01354132|3769594|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3948131|NCT01354132|3769595|B1|||Age||years|Mean|26.1|26.1|Standard Deviation|6.1|6.1|||
3948132|NCT01354106|3769634|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
3948133|NCT01354106|3769634|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3948134|NCT01354106|3769634|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3948135|NCT01354106|3769634|B1|||Age||years|Mean|2.88|2.88|Standard Deviation|0.87|0.87|||
3948136|NCT01354106|3769634|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3948137|NCT01354106|3769634|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3948138|NCT01354106|3769634|B1||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
3948139|NCT01354028|3769640|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3948140|NCT01354028|3769640|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3948141|NCT01354028|3769640|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3948142|NCT01354028|3769640|B1|newborn infant >3 days||Age, Customized||participants|Number|30|30.0||||||
3948143|NCT01354015|3769653|B3|Unknown or Not Reported||Race/Ethnicity, Customized|self reported|participants|Number|3|3.0||||||
3948144|NCT01354015|3769654|B2|Unknown or Not Reported||Race/Ethnicity, Customized|self reported|participants|Number|3|3.0||||||
3948145|NCT01354015|3769655|B1|Unknown or Not Reported||Race/Ethnicity, Customized|self reported|participants|Number|0|0.0||||||
3948146|NCT01354015|3769653|B3|More than one race||Race/Ethnicity, Customized|self reported|participants|Number|0|0.0||||||
3948147|NCT01354015|3769654|B2|More than one race||Race/Ethnicity, Customized|self reported|participants|Number|0|0.0||||||
3948148|NCT01354015|3769655|B1|More than one race||Race/Ethnicity, Customized|self reported|participants|Number|0|0.0||||||
3948149|NCT01354015|3769653|B3|White||Race/Ethnicity, Customized|self reported|participants|Number|30|30.0||||||
3948150|NCT01354015|3769654|B2|White||Race/Ethnicity, Customized|self reported|participants|Number|17|17.0||||||
3948151|NCT01354015|3769655|B1|White||Race/Ethnicity, Customized|self reported|participants|Number|13|13.0||||||
3948152|NCT01354015|3769653|B3|Black or African American||Race/Ethnicity, Customized|self reported|participants|Number|64|64.0||||||
3948153|NCT01354015|3769654|B2|Black or African American||Race/Ethnicity, Customized|self reported|participants|Number|27|27.0||||||
3948154|NCT01354015|3769655|B1|Black or African American||Race/Ethnicity, Customized|self reported|participants|Number|37|37.0||||||
3948155|NCT01354015|3769653|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|self reported|participants|Number|0|0.0||||||
3948156|NCT01354015|3769654|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|self reported|participants|Number|0|0.0||||||
3948157|NCT01354015|3769655|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|self reported|participants|Number|0|0.0||||||
3948158|NCT01354015|3769653|B3|Asian||Race/Ethnicity, Customized|self reported|participants|Number|1|1.0||||||
3948159|NCT01354015|3769654|B2|Asian||Race/Ethnicity, Customized|self reported|participants|Number|1|1.0||||||
3948160|NCT01354015|3769655|B1|Asian||Race/Ethnicity, Customized|self reported|participants|Number|0|0.0||||||
3948161|NCT01354015|3769653|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|self reported|participants|Number|0|0.0||||||
3948162|NCT01354015|3769654|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|self reported|participants|Number|0|0.0||||||
3948163|NCT01354015|3769655|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|self reported|participants|Number|0|0.0||||||
3948164|NCT01354015|3769653|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3948165|NCT01354015|3769654|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3948166|NCT01354015|3769655|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3948167|NCT01354015|3769653|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3948168|NCT01354015|3769654|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3948169|NCT01354015|3769655|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3948170|NCT01354015|3769653|B3|||Age||years|Mean|59.1|59.1|Standard Deviation|9.5|9.5|||
3948171|NCT01354015|3769654|B2|||Age||years|Mean|59.3|59.3|Standard Deviation|8.7|8.7|||
3948172|NCT01354015|3769655|B1|||Age||years|Mean|58.9|58.9|Standard Deviation|10.3|10.3|||
3948173|NCT01353976|3769664|B3|Dominican Republic||Region of Enrollment||participants|Number|81|81.0||||||
3948174|NCT01353976|3769665|B2|Dominican Republic||Region of Enrollment||participants|Number|42|42.0||||||
3948175|NCT01353976|3769666|B1|Dominican Republic||Region of Enrollment||participants|Number|39|39.0||||||
3948176|NCT01353976|3769664|B3|United States||Region of Enrollment||participants|Number|183|183.0||||||
3948177|NCT01353976|3769665|B2|United States||Region of Enrollment||participants|Number|92|92.0||||||
3948178|NCT01353976|3769666|B1|United States||Region of Enrollment||participants|Number|91|91.0||||||
3948179|NCT01353976|3769664|B3||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3948180|NCT01353976|3769665|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3948181|NCT01353976|3769666|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3948182|NCT01353976|3769664|B3||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3948183|NCT01353976|3769665|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3948184|NCT01353976|3769666|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3948185|NCT01353976|3769664|B3|||Age||years|Mean|42.1|42.1|Standard Deviation|12.65|12.65|||
3948186|NCT01353976|3769665|B2|||Age||years|Mean|42.5|42.5|Standard Deviation|12.85|12.85|||
3948187|NCT01353976|3769666|B1|||Age||years|Mean|41.7|41.7|Standard Deviation|12.48|12.48|||
3948188|NCT01353976|3769664|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3948189|NCT01353976|3769665|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3948190|NCT01353976|3769666|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3948191|NCT01353976|3769664|B3||Between 18 and 65 years|Age||Participants|Count of Participants|246|246.0||||||
3948192|NCT01353976|3769665|B2||Between 18 and 65 years|Age||Participants|Count of Participants|125|125.0||||||
3948193|NCT01353976|3769666|B1||Between 18 and 65 years|Age||Participants|Count of Participants|121|121.0||||||
3948194|NCT01353976|3769664|B3||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
3948195|NCT01353976|3769665|B2||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3948196|NCT01353976|3769666|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3948197|NCT01353963|3769677|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3948198|NCT01353963|3769677|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3948199|NCT01353963|3769677|B1|||Age||years|Mean|46.5|46.5|Standard Deviation|13.5|13.5|||
3948200|NCT01353911|3769687|B9||Male|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
3948201|NCT01353911|3769688|B8||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3948202|NCT01353911|3769689|B7||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3948203|NCT01353911|3769690|B6||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3948204|NCT01353911|3769691|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3948205|NCT01353911|3769692|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3948206|NCT01353911|3769693|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3948207|NCT01353911|3769694|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3948208|NCT01353911|3769695|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3948209|NCT01353911|3769687|B9||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3948210|NCT01353911|3769688|B8||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3948211|NCT01353911|3769689|B7||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3948212|NCT01353911|3769690|B6||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3948213|NCT01353911|3769691|B5||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3948214|NCT01353911|3769692|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3948215|NCT01353911|3769693|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3948216|NCT01353911|3769694|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3948217|NCT01353911|3769695|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3948218|NCT01353911|3769687|B9|||Age||years|Mean|48.7|48.7|Standard Deviation|11.2|11.2|||
3948219|NCT01353911|3769688|B8|||Age||years|Mean|48.3|48.3|Standard Deviation|11.2|11.2|||
3948220|NCT01353911|3769689|B7|||Age||years|Mean|50.3|50.3|Standard Deviation|11.2|11.2|||
3948221|NCT01353911|3769690|B6|||Age||years|Mean|48.3|48.3|Standard Deviation|11.4|11.4|||
3948222|NCT01353911|3769691|B5|||Age||years|Mean|50.4|50.4|Standard Deviation|13.4|13.4|||
3948223|NCT01353911|3769692|B4|||Age||years|Mean|44.6|44.6|Standard Deviation|12.5|12.5|||
3948224|NCT01353911|3769693|B3|||Age||years|Mean|48.3|48.3|Standard Deviation|10.6|10.6|||
3948225|NCT01353911|3769694|B2|||Age||years|Mean|46.4|46.4|Standard Deviation|11.3|11.3|||
3948226|NCT01353911|3769695|B1|||Age||years|Mean|54.4|54.4|Standard Deviation|6.9|6.9|||
3948227|NCT01353898|3769776|B7||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3948228|NCT01353898|3769777|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3948229|NCT01353898|3769778|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3948230|NCT01353898|3769779|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3948231|NCT01353898|3769780|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3948232|NCT01353898|3769781|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3948233|NCT01353898|3769782|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3948234|NCT01353898|3769776|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3948235|NCT01353898|3769777|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3948236|NCT01353898|3769778|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3948237|NCT01353898|3769779|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3948238|NCT01353898|3769780|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3948239|NCT01353898|3769781|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3948240|NCT01353898|3769782|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3948241|NCT01353898|3769776|B7|||Age||Years|Mean|34.9|34.9|Standard Deviation|10.6|10.6|||
3948242|NCT01353898|3769777|B6|||Age||Years|Mean|37.0|37.0|Standard Deviation|17.0|17.0|||
3948243|NCT01353898|3769778|B5|||Age||Years|Mean|37.0|37.0|Standard Deviation|1.4|1.4|||
3948244|NCT01353898|3769779|B4|||Age||Years|Mean|47.5|47.5|Standard Deviation|10.6|10.6|||
3948245|NCT01353898|3769780|B3|||Age||Years|Mean|32.5|32.5|Standard Deviation|0.7|0.7|||
3948246|NCT01353898|3769781|B2|||Age||Years|Mean|24.0|24.0|Standard Deviation|2.8|2.8|||
3948247|NCT01353898|3769782|B1|||Age||Years|Mean|31.5|31.5|Standard Deviation|14.8|14.8|||
3948248|NCT01353859|3769813|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3948249|NCT01353859|3769813|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3948250|NCT01353859|3769813|B1|||Age||years|Median|53|53.0|Full Range|||19.0|75.0|
3948388|NCT01353144|3769951|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3948251|NCT01353664|3769826|B1|||Weight|The number of participants with weight measured was 15; 3 were missing.|Kilograms|Mean|75.1|75.1|Standard Deviation|20.06|20.06|||
3948252|NCT01353664|3769826|B1|||Height|The total number for this baseline characteristic was 18; 1 participants' height was missing.|Centimeters|Mean|170.4|170.4|Standard Deviation|11.02|11.02|||
3948253|NCT01353664|3769826|B1|4 = Completely Disabled||ECOG-Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a particpant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.|Participants|Number|0|0.0||||||
3948254|NCT01353664|3769826|B1|3 = Limited Self-Care||ECOG-Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a particpant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.|Participants|Number|0|0.0||||||
3948255|NCT01353664|3769826|B1|2 = Ambulatory; unable to carry out activities||ECOG-Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a particpant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.|Participants|Number|0|0.0||||||
3948256|NCT01353664|3769826|B1|1 = Restricted activity but ambulatory||ECOG-Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a particpant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.|Participants|Number|10|10.0||||||
3948257|NCT01353664|3769826|B1|0 = Fully Active (Most Favorable Activity)||ECOG-Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a particpant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.|Participants|Number|9|9.0||||||
3948258|NCT01353664|3769826|B1|Other (unspecified)||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3948259|NCT01353664|3769826|B1|White||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
3948260|NCT01353664|3769826|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3948261|NCT01353664|3769826|B1|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3948262|NCT01353664|3769826|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
3948263|NCT01353664|3769826|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3948264|NCT01353664|3769826|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3948265|NCT01353664|3769826|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3948266|NCT01353664|3769826|B1|> 65||Age, Customized||Participants|Number|9|9.0||||||
3948267|NCT01353664|3769826|B1|≤ 65||Age, Customized||Participants|Number|10|10.0||||||
3948268|NCT01353664|3769826|B1|||Age||Years|Mean|62.3|62.3|Standard Deviation|12.69|12.69|||
3948269|NCT01353586|3769830|B3||Unknown or Not Reported|Race (NIH/OMB)|"Fifty-three subjects in nMARQ arm and 3 subjects in SNA Control Group didn't report ethnicity and race data because of French privacy law restrictions. These subjects are reported in Race category, Unknown or Not Reported."|Participants|Count of Participants|56|56.0||||||
3948270|NCT01353586|3769831|B2||Unknown or Not Reported|Race (NIH/OMB)|"Fifty-three subjects in nMARQ arm and 3 subjects in SNA Control Group didn't report ethnicity and race data because of French privacy law restrictions. These subjects are reported in Race category, Unknown or Not Reported."|Participants|Count of Participants|3|3.0||||||
3948271|NCT01353586|3769832|B1||Unknown or Not Reported|Race (NIH/OMB)|"Fifty-three subjects in nMARQ arm and 3 subjects in SNA Control Group didn't report ethnicity and race data because of French privacy law restrictions. These subjects are reported in Race category, Unknown or Not Reported."|Participants|Count of Participants|53|53.0||||||
3948272|NCT01353586|3769830|B3||More than one race|Race (NIH/OMB)|"Fifty-three subjects in nMARQ arm and 3 subjects in SNA Control Group didn't report ethnicity and race data because of French privacy law restrictions. These subjects are reported in Race category, Unknown or Not Reported."|Participants|Count of Participants|0|0.0||||||
3948273|NCT01353586|3769831|B2||More than one race|Race (NIH/OMB)|"Fifty-three subjects in nMARQ arm and 3 subjects in SNA Control Group didn't report ethnicity and race data because of French privacy law restrictions. These subjects are reported in Race category, Unknown or Not Reported."|Participants|Count of Participants|0|0.0||||||
3948274|NCT01353586|3769832|B1||More than one race|Race (NIH/OMB)|"Fifty-three subjects in nMARQ arm and 3 subjects in SNA Control Group didn't report ethnicity and race data because of French privacy law restrictions. These subjects are reported in Race category, Unknown or Not Reported."|Participants|Count of Participants|0|0.0||||||
3948275|NCT01353586|3769830|B3||White|Race (NIH/OMB)|"Fifty-three subjects in nMARQ arm and 3 subjects in SNA Control Group didn't report ethnicity and race data because of French privacy law restrictions. These subjects are reported in Race category, Unknown or Not Reported."|Participants|Count of Participants|124|124.0||||||
3948276|NCT01353586|3769831|B2||White|Race (NIH/OMB)|"Fifty-three subjects in nMARQ arm and 3 subjects in SNA Control Group didn't report ethnicity and race data because of French privacy law restrictions. These subjects are reported in Race category, Unknown or Not Reported."|Participants|Count of Participants|14|14.0||||||
3948277|NCT01353586|3769832|B1||White|Race (NIH/OMB)|"Fifty-three subjects in nMARQ arm and 3 subjects in SNA Control Group didn't report ethnicity and race data because of French privacy law restrictions. These subjects are reported in Race category, Unknown or Not Reported."|Participants|Count of Participants|110|110.0||||||
3948278|NCT01353586|3769830|B3||Black or African American|Race (NIH/OMB)|"Fifty-three subjects in nMARQ arm and 3 subjects in SNA Control Group didn't report ethnicity and race data because of French privacy law restrictions. These subjects are reported in Race category, Unknown or Not Reported."|Participants|Count of Participants|0|0.0||||||
3948389|NCT01353144|3769949|B3|||Age||years|Mean|69.9|69.9|Standard Deviation|11.6|11.6|||
3948279|NCT01353586|3769831|B2||Black or African American|Race (NIH/OMB)|"Fifty-three subjects in nMARQ arm and 3 subjects in SNA Control Group didn't report ethnicity and race data because of French privacy law restrictions. These subjects are reported in Race category, Unknown or Not Reported."|Participants|Count of Participants|0|0.0||||||
3948280|NCT01353586|3769832|B1||Black or African American|Race (NIH/OMB)|"Fifty-three subjects in nMARQ arm and 3 subjects in SNA Control Group didn't report ethnicity and race data because of French privacy law restrictions. These subjects are reported in Race category, Unknown or Not Reported."|Participants|Count of Participants|0|0.0||||||
3948281|NCT01353586|3769830|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|"Fifty-three subjects in nMARQ arm and 3 subjects in SNA Control Group didn't report ethnicity and race data because of French privacy law restrictions. These subjects are reported in Race category, Unknown or Not Reported."|Participants|Count of Participants|0|0.0||||||
3948282|NCT01353586|3769831|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|"Fifty-three subjects in nMARQ arm and 3 subjects in SNA Control Group didn't report ethnicity and race data because of French privacy law restrictions. These subjects are reported in Race category, Unknown or Not Reported."|Participants|Count of Participants|0|0.0||||||
3948283|NCT01353586|3769832|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|"Fifty-three subjects in nMARQ arm and 3 subjects in SNA Control Group didn't report ethnicity and race data because of French privacy law restrictions. These subjects are reported in Race category, Unknown or Not Reported."|Participants|Count of Participants|0|0.0||||||
3948284|NCT01353586|3769830|B3||Asian|Race (NIH/OMB)|"Fifty-three subjects in nMARQ arm and 3 subjects in SNA Control Group didn't report ethnicity and race data because of French privacy law restrictions. These subjects are reported in Race category, Unknown or Not Reported."|Participants|Count of Participants|0|0.0||||||
3948285|NCT01353586|3769831|B2||Asian|Race (NIH/OMB)|"Fifty-three subjects in nMARQ arm and 3 subjects in SNA Control Group didn't report ethnicity and race data because of French privacy law restrictions. These subjects are reported in Race category, Unknown or Not Reported."|Participants|Count of Participants|0|0.0||||||
3948286|NCT01353586|3769832|B1||Asian|Race (NIH/OMB)|"Fifty-three subjects in nMARQ arm and 3 subjects in SNA Control Group didn't report ethnicity and race data because of French privacy law restrictions. These subjects are reported in Race category, Unknown or Not Reported."|Participants|Count of Participants|0|0.0||||||
3948287|NCT01353586|3769830|B3||American Indian or Alaska Native|Race (NIH/OMB)|"Fifty-three subjects in nMARQ arm and 3 subjects in SNA Control Group didn't report ethnicity and race data because of French privacy law restrictions. These subjects are reported in Race category, Unknown or Not Reported."|Participants|Count of Participants|0|0.0||||||
3948288|NCT01353586|3769831|B2||American Indian or Alaska Native|Race (NIH/OMB)|"Fifty-three subjects in nMARQ arm and 3 subjects in SNA Control Group didn't report ethnicity and race data because of French privacy law restrictions. These subjects are reported in Race category, Unknown or Not Reported."|Participants|Count of Participants|0|0.0||||||
3948289|NCT01353586|3769832|B1||American Indian or Alaska Native|Race (NIH/OMB)|"Fifty-three subjects in nMARQ arm and 3 subjects in SNA Control Group didn't report ethnicity and race data because of French privacy law restrictions. These subjects are reported in Race category, Unknown or Not Reported."|Participants|Count of Participants|0|0.0||||||
3948290|NCT01353586|3769830|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3948291|NCT01353586|3769831|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3948292|NCT01353586|3769832|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3948293|NCT01353586|3769830|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
3948294|NCT01353586|3769831|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3948295|NCT01353586|3769832|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
3948296|NCT01353586|3769830|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948297|NCT01353586|3769831|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948298|NCT01353586|3769832|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948299|NCT01353586|3769830|B3||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3948300|NCT01353586|3769831|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3948301|NCT01353586|3769832|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3948302|NCT01353586|3769830|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3948303|NCT01353586|3769831|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3948304|NCT01353586|3769832|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3948305|NCT01353586|3769830|B3|||Age||years|Mean|58.49|58.49|Standard Deviation|10.0|10.0|||
3948306|NCT01353586|3769831|B2|||Age||years|Mean|56.5|56.5|Standard Deviation|9.86|9.86|||
3948307|NCT01353586|3769832|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|10.24|10.24|||
3948308|NCT01353508|3769847|B5||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3948309|NCT01353508|3769848|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3948310|NCT01353508|3769849|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3948311|NCT01353508|3769850|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3948312|NCT01353508|3769851|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3948313|NCT01353508|3769847|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3948314|NCT01353508|3769848|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3948315|NCT01353508|3769849|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3948316|NCT01353508|3769850|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3948317|NCT01353508|3769851|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3948390|NCT01353144|3769950|B2|||Age||years|Mean|69.9|69.9|Standard Deviation|12.4|12.4|||
3948318|NCT01353508|3769847|B5|||Age|Age mean and standard deviation (SD) for HF cohort was 65.4 (9.57); age mean and SD for HTN cohort was 58.8 (8.15)|Years|Mean|62.6|62.6|Standard Deviation|8.86|8.86|||
3948319|NCT01353508|3769848|B4|||Age|Age mean and standard deviation (SD) for HF cohort was 65.4 (9.57); age mean and SD for HTN cohort was 58.8 (8.15)|Years|Mean|61.6|61.6|Standard Deviation|8.40|8.4|||
3948320|NCT01353508|3769849|B3|||Age|Age mean and standard deviation (SD) for HF cohort was 65.4 (9.57); age mean and SD for HTN cohort was 58.8 (8.15)|Years|Mean|58.0|58.0|Standard Deviation|8.02|8.02|||
3948321|NCT01353508|3769850|B2|||Age|Age mean and standard deviation (SD) for HF cohort was 65.4 (9.57); age mean and SD for HTN cohort was 58.8 (8.15)|Years|Mean|67.6|67.6|Standard Deviation|9.07|9.07|||
3948322|NCT01353508|3769851|B1|||Age|Age mean and standard deviation (SD) for HF cohort was 65.4 (9.57); age mean and SD for HTN cohort was 58.8 (8.15)|Years|Mean|63.3|63.3|Standard Deviation|10.15|10.15|||
3948323|NCT01353274|3769932|B1||Male|Sex: Female, Male||Participants|Count of Participants|595|595.0||||||
3948324|NCT01353274|3769932|B1||Female|Sex: Female, Male||Participants|Count of Participants|514|514.0||||||
3948325|NCT01353274|3769932|B1|||Age||years|Mean|66.6|66.6|Standard Deviation|12.6|12.6|||
3948326|NCT01353222|3769940|B3|ECOG 2=Ambulatory, capable of self-care; no work||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|5|5.0||||||
3948327|NCT01353222|3769941|B2|ECOG 2=Ambulatory, capable of self-care; no work||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|2|2.0||||||
3948328|NCT01353222|3769942|B1|ECOG 2=Ambulatory, capable of self-care; no work||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|3|3.0||||||
3948329|NCT01353222|3769940|B3|ECOG 1= Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|55|55.0||||||
3948330|NCT01353222|3769941|B2|ECOG 1= Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|31|31.0||||||
3948331|NCT01353222|3769942|B1|ECOG 1= Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|24|24.0||||||
3948332|NCT01353222|3769940|B3|ECOG 0=Fully Active; No restrictions||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|80|80.0||||||
3948333|NCT01353222|3769941|B2|ECOG 0=Fully Active; No restrictions||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|38|38.0||||||
3948391|NCT01353144|3769951|B1|||Age||years|Mean|70.0|70.0|Standard Deviation|11.0|11.0|||
3948334|NCT01353222|3769942|B1|ECOG 0=Fully Active; No restrictions||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|42|42.0||||||
3948335|NCT01353222|3769940|B3|||Body weight||kilograms|Mean|81.448|81.448|Standard Deviation|18.0679|18.0679|||
3948336|NCT01353222|3769941|B2|||Body weight||kilograms|Mean|82.115|82.115|Standard Deviation|17.9330|17.933|||
3948337|NCT01353222|3769942|B1|||Body weight||kilograms|Mean|80.770|80.77|Standard Deviation|18.3080|18.308|||
3948338|NCT01353222|3769940|B3|United States||Region of Enrollment||Participants|Count of Participants|142|142.0||||||
3948339|NCT01353222|3769941|B2|United States||Region of Enrollment||Participants|Count of Participants|72|72.0||||||
3948340|NCT01353222|3769942|B1|United States||Region of Enrollment||Participants|Count of Participants|70|70.0||||||
3948341|NCT01353222|3769940|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948342|NCT01353222|3769941|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948343|NCT01353222|3769942|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948344|NCT01353222|3769940|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948345|NCT01353222|3769941|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948346|NCT01353222|3769942|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948347|NCT01353222|3769940|B3||White|Race (NIH/OMB)||Participants|Count of Participants|135|135.0||||||
3948348|NCT01353222|3769941|B2||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3948349|NCT01353222|3769942|B1||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3948350|NCT01353222|3769940|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3948351|NCT01353222|3769941|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948352|NCT01353222|3769942|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3948353|NCT01353222|3769940|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948354|NCT01353222|3769941|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948355|NCT01353222|3769942|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948356|NCT01353222|3769940|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3948357|NCT01353222|3769941|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3948358|NCT01353222|3769942|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3948359|NCT01353222|3769940|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948360|NCT01353222|3769941|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948361|NCT01353222|3769942|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948362|NCT01353222|3769940|B3||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3948363|NCT01353222|3769941|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3948364|NCT01353222|3769942|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3948365|NCT01353222|3769940|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3948366|NCT01353222|3769941|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3948367|NCT01353222|3769942|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3948368|NCT01353222|3769940|B3|||Age||years|Mean|66.0|66.0|Standard Deviation|10.42|10.42|||
3948369|NCT01353222|3769941|B2|||Age||years|Mean|66.4|66.4|Standard Deviation|10.09|10.09|||
3948370|NCT01353222|3769942|B1|||Age||years|Mean|65.6|65.6|Standard Deviation|10.81|10.81|||
3948371|NCT01353222|3769940|B3||>=65 years|Age||Participants|Count of Participants|74|74.0||||||
3948372|NCT01353222|3769941|B2||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
3948373|NCT01353222|3769942|B1||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
3948374|NCT01353222|3769940|B3||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
3948375|NCT01353222|3769941|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3948376|NCT01353222|3769942|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3948377|NCT01353222|3769940|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3948378|NCT01353222|3769941|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3948379|NCT01353222|3769942|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3948380|NCT01353144|3769949|B3|Taiwan||Region of Enrollment||participants|Number|178|178.0||||||
3948381|NCT01353144|3769950|B2|Taiwan||Region of Enrollment||participants|Number|89|89.0||||||
3948382|NCT01353144|3769951|B1|Taiwan||Region of Enrollment||participants|Number|89|89.0||||||
3948383|NCT01353144|3769949|B3||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3948384|NCT01353144|3769950|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3948385|NCT01353144|3769951|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3948386|NCT01353144|3769949|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3948387|NCT01353144|3769950|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3948392|NCT01353144|3769949|B3||>=65 years|Age||Participants|Count of Participants|131|131.0||||||
3948393|NCT01353144|3769950|B2||>=65 years|Age||Participants|Count of Participants|63|63.0||||||
3948394|NCT01353144|3769951|B1||>=65 years|Age||Participants|Count of Participants|68|68.0||||||
3948395|NCT01353144|3769949|B3||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3948396|NCT01353144|3769950|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3948397|NCT01353144|3769951|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3948398|NCT01353144|3769949|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3948399|NCT01353144|3769950|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3948400|NCT01353144|3769951|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3948401|NCT01353079|3769960|B3||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
3948402|NCT01353079|3769961|B2||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3948403|NCT01353079|3769962|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3948404|NCT01353079|3769960|B3||Female|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
3948405|NCT01353079|3769961|B2||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3948406|NCT01353079|3769962|B1||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3948407|NCT01353079|3769960|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3948408|NCT01353079|3769961|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3948409|NCT01353079|3769962|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3948410|NCT01353079|3769960|B3||Between 18 and 65 years|Age||Participants|Count of Participants|429|429.0||||||
3948411|NCT01353079|3769961|B2||Between 18 and 65 years|Age||Participants|Count of Participants|211|211.0||||||
3948412|NCT01353079|3769962|B1||Between 18 and 65 years|Age||Participants|Count of Participants|218|218.0||||||
3948413|NCT01353079|3769960|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3948414|NCT01353079|3769961|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3948415|NCT01353079|3769962|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3948416|NCT01352845|3769975|B3||Male|Sex: Female, Male||Participants|Count of Participants|1359|1359.0||||||
3948417|NCT01352845|3769976|B2||Male|Sex: Female, Male||Participants|Count of Participants|340|340.0||||||
3948418|NCT01352845|3769977|B1||Male|Sex: Female, Male||Participants|Count of Participants|1019|1019.0||||||
3948419|NCT01352845|3769975|B3||Female|Sex: Female, Male||Participants|Count of Participants|1934|1934.0||||||
3948420|NCT01352845|3769976|B2||Female|Sex: Female, Male||Participants|Count of Participants|482|482.0||||||
3948421|NCT01352845|3769977|B1||Female|Sex: Female, Male||Participants|Count of Participants|1452|1452.0||||||
3948422|NCT01352845|3769975|B3|||Age||Years|Mean|21.48|21.48|Standard Deviation|2.15|2.15|||
3948423|NCT01352845|3769976|B2|||Age||Years|Mean|21.52|21.52|Standard Deviation|2.20|2.2|||
3948424|NCT01352845|3769977|B1|||Age||Years|Mean|21.47|21.47|Standard Deviation|2.14|2.14|||
3948425|NCT01352793|3770065|B3||Male|Sex: Female, Male||Participants|Count of Participants|2756|2756.0||||||
3948426|NCT01352793|3770066|B2||Male|Sex: Female, Male||Participants|Count of Participants|914|914.0||||||
3948427|NCT01352793|3770067|B1||Male|Sex: Female, Male||Participants|Count of Participants|1842|1842.0||||||
3948428|NCT01352793|3770065|B3||Female|Sex: Female, Male||Participants|Count of Participants|2956|2956.0||||||
3948429|NCT01352793|3770066|B2||Female|Sex: Female, Male||Participants|Count of Participants|994|994.0||||||
3948430|NCT01352793|3770067|B1||Female|Sex: Female, Male||Participants|Count of Participants|1962|1962.0||||||
3948431|NCT01352793|3770065|B3|||Age||years|Mean|17.4|17.4|Standard Deviation|4.6|4.6|||
3948432|NCT01352793|3770066|B2|||Age||years|Mean|17.4|17.4|Standard Deviation|4.6|4.6|||
3948433|NCT01352793|3770067|B1|||Age||years|Mean|17.4|17.4|Standard Deviation|4.6|4.6|||
3948434|NCT01352741|3770092|B1|Missing||Subject's satisfaction with previous treatment||participants|Number|7|7.0||||||
3948435|NCT01352741|3770092|B1|Excellent||Subject's satisfaction with previous treatment||participants|Number|1|1.0||||||
3948436|NCT01352741|3770092|B1|Very Good||Subject's satisfaction with previous treatment||participants|Number|10|10.0||||||
3948437|NCT01352741|3770092|B1|Good||Subject's satisfaction with previous treatment||participants|Number|68|68.0||||||
3948438|NCT01352741|3770092|B1|Fair||Subject's satisfaction with previous treatment||participants|Number|233|233.0||||||
3948439|NCT01352741|3770092|B1|Poor||Subject's satisfaction with previous treatment||participants|Number|126|126.0||||||
3948440|NCT01352741|3770092|B1|||History of low back pain|Participants were asked since when they suffer from their current pain.|years|Median|6.3|6.3|Full Range|||2.1|11.7|
3948441|NCT01352741|3770092|B1|Missing||Diagnosis of Lumbar Radiculopathy|Number of participants with dermatomal pain present as assessed by the investigator. For a participant to have diagnosed lumbar radiculopathy pain, they must have answered ‘yes’ to all three dermatomal pain questions and ‘yes’ to at least one of the three root dysfunction questions|participants|Number|1|1.0||||||
3948442|NCT01352741|3770092|B1|No||Diagnosis of Lumbar Radiculopathy|Number of participants with dermatomal pain present as assessed by the investigator. For a participant to have diagnosed lumbar radiculopathy pain, they must have answered ‘yes’ to all three dermatomal pain questions and ‘yes’ to at least one of the three root dysfunction questions|participants|Number|134|134.0||||||
3948443|NCT01352741|3770092|B1|Yes||Diagnosis of Lumbar Radiculopathy|Number of participants with dermatomal pain present as assessed by the investigator. For a participant to have diagnosed lumbar radiculopathy pain, they must have answered ‘yes’ to all three dermatomal pain questions and ‘yes’ to at least one of the three root dysfunction questions|participants|Number|310|310.0||||||
3948444|NCT01352741|3770092|B1|||Body Mass Index (BMI)|Data available for 441 participants.|kg/m²|Mean|29.57|29.57|Standard Deviation|5.616|5.616|||
3948445|NCT01352741|3770092|B1|||Weight||kg|Mean|83.61|83.61|Standard Deviation|17.542|17.542|||
3948446|NCT01352741|3770092|B1|||Height|Data available for 441 participants|cm|Mean|168.2|168.2|Standard Deviation|9.97|9.97|||
3948447|NCT01352741|3770092|B1|Germany||Region of Enrollment||participants|Number|122|122.0||||||
3948448|NCT01352741|3770092|B1|Netherlands||Region of Enrollment||participants|Number|26|26.0||||||
3948449|NCT01352741|3770092|B1|Austria||Region of Enrollment||participants|Number|55|55.0||||||
3948450|NCT01352741|3770092|B1|Denmark||Region of Enrollment||participants|Number|41|41.0||||||
3948451|NCT01352741|3770092|B1|Poland||Region of Enrollment||participants|Number|102|102.0||||||
3948452|NCT01352741|3770092|B1|Belgium||Region of Enrollment||participants|Number|45|45.0||||||
3948453|NCT01352741|3770092|B1|Spain||Region of Enrollment||participants|Number|54|54.0||||||
3948454|NCT01352741|3770092|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3948455|NCT01352741|3770092|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3948456|NCT01352741|3770092|B1|White||Race/Ethnicity, Customized||participants|Number|441|441.0||||||
3948457|NCT01352741|3770092|B1||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3948458|NCT01352741|3770092|B1||Female|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
3948459|NCT01352741|3770092|B1|||Age||years|Mean|57.9|57.9|Standard Deviation|11.30|11.3|||
3948460|NCT01352715|3770185|B3|||CD4+ T-cell count||cells/mm^3|Mean|180|180.0|Standard Deviation|165|165.0|||
3948461|NCT01352715|3770186|B2|||CD4+ T-cell count||cells/mm^3|Mean|182|182.0|Standard Deviation|160|160.0|||
3948462|NCT01352715|3770187|B1|||CD4+ T-cell count||cells/mm^3|Mean|178|178.0|Standard Deviation|170|170.0|||
3948463|NCT01352715|3770185|B3|||HIV-1 RNA||log10 copies/mL|Mean|4.5|4.5|Standard Deviation|0.8|0.8|||
3948464|NCT01352715|3770186|B2|||HIV-1 RNA||log10 copies/mL|Mean|4.5|4.5|Standard Deviation|0.9|0.9|||
3948465|NCT01352715|3770187|B1|||HIV-1 RNA||log10 copies/mL|Mean|4.6|4.6|Standard Deviation|0.8|0.8|||
3948466|NCT01352715|3770185|B3|Thailand||Region of Enrollment||participants|Number|7|7.0||||||
3948467|NCT01352715|3770186|B2|Thailand||Region of Enrollment||participants|Number|4|4.0||||||
3948468|NCT01352715|3770187|B1|Thailand||Region of Enrollment||participants|Number|3|3.0||||||
3948469|NCT01352715|3770185|B3|Tanzania||Region of Enrollment||participants|Number|17|17.0||||||
3948470|NCT01352715|3770186|B2|Tanzania||Region of Enrollment||participants|Number|9|9.0||||||
3948471|NCT01352715|3770187|B1|Tanzania||Region of Enrollment||participants|Number|8|8.0||||||
3948472|NCT01352715|3770185|B3|Brazil||Region of Enrollment||participants|Number|12|12.0||||||
3948473|NCT01352715|3770186|B2|Brazil||Region of Enrollment||participants|Number|6|6.0||||||
3948474|NCT01352715|3770187|B1|Brazil||Region of Enrollment||participants|Number|6|6.0||||||
3948475|NCT01352715|3770185|B3|Peru||Region of Enrollment||participants|Number|9|9.0||||||
3948476|NCT01352715|3770186|B2|Peru||Region of Enrollment||participants|Number|4|4.0||||||
3948477|NCT01352715|3770187|B1|Peru||Region of Enrollment||participants|Number|5|5.0||||||
3948478|NCT01352715|3770185|B3|Kenya||Region of Enrollment||participants|Number|48|48.0||||||
3948479|NCT01352715|3770186|B2|Kenya||Region of Enrollment||participants|Number|24|24.0||||||
3948480|NCT01352715|3770187|B1|Kenya||Region of Enrollment||participants|Number|24|24.0||||||
3948481|NCT01352715|3770185|B3|Zimbabwe||Region of Enrollment||participants|Number|47|47.0||||||
3948482|NCT01352715|3770186|B2|Zimbabwe||Region of Enrollment||participants|Number|23|23.0||||||
3948483|NCT01352715|3770187|B1|Zimbabwe||Region of Enrollment||participants|Number|24|24.0||||||
3948484|NCT01352715|3770185|B3|India||Region of Enrollment||participants|Number|158|158.0||||||
3948485|NCT01352715|3770186|B2|India||Region of Enrollment||participants|Number|78|78.0||||||
3948486|NCT01352715|3770187|B1|India||Region of Enrollment||participants|Number|80|80.0||||||
3948487|NCT01352715|3770185|B3|South Africa||Region of Enrollment||participants|Number|103|103.0||||||
3948488|NCT01352715|3770186|B2|South Africa||Region of Enrollment||participants|Number|51|51.0||||||
3948489|NCT01352715|3770187|B1|South Africa||Region of Enrollment||participants|Number|52|52.0||||||
3948490|NCT01352715|3770185|B3|Malawi||Region of Enrollment||participants|Number|111|111.0||||||
3948491|NCT01352715|3770186|B2|Malawi||Region of Enrollment||participants|Number|55|55.0||||||
3948492|NCT01352715|3770187|B1|Malawi||Region of Enrollment||participants|Number|56|56.0||||||
3948493|NCT01352715|3770185|B3|Asian, Pacific Islander||Race/Ethnicity, Customized||participants|Number|165|165.0||||||
3948494|NCT01352715|3770186|B2|Asian, Pacific Islander||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
3948495|NCT01352715|3770187|B1|Asian, Pacific Islander||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
3948496|NCT01352715|3770185|B3|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3948497|NCT01352715|3770186|B2|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3948498|NCT01352715|3770187|B1|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3948499|NCT01352715|3770185|B3|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|326|326.0||||||
3948500|NCT01352715|3770186|B2|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|162|162.0||||||
3948501|NCT01352715|3770187|B1|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|164|164.0||||||
3948502|NCT01352715|3770185|B3|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3948503|NCT01352715|3770186|B2|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3948504|NCT01352715|3770187|B1|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3948505|NCT01352715|3770185|B3||Male|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
3948506|NCT01352715|3770186|B2||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3948507|NCT01352715|3770187|B1||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3948508|NCT01352715|3770185|B3||Female|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
3948509|NCT01352715|3770186|B2||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3948510|NCT01352715|3770187|B1||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3948511|NCT01352715|3770185|B3|||Age||years|Mean|39|39.0|Standard Deviation|8|8.0|||
3948512|NCT01352715|3770186|B2|||Age||years|Mean|38|38.0|Standard Deviation|8|8.0|||
3948513|NCT01352715|3770187|B1|||Age||years|Mean|40|40.0|Standard Deviation|8|8.0|||
3948514|NCT01352715|3770185|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3948515|NCT01352715|3770186|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3948516|NCT01352715|3770187|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3948517|NCT01352715|3770185|B3||Between 18 and 65 years|Age||Participants|Count of Participants|512|512.0||||||
3948518|NCT01352715|3770186|B2||Between 18 and 65 years|Age||Participants|Count of Participants|254|254.0||||||
3948519|NCT01352715|3770187|B1||Between 18 and 65 years|Age||Participants|Count of Participants|258|258.0||||||
3948520|NCT01352715|3770185|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3948521|NCT01352715|3770186|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3948522|NCT01352715|3770187|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3948523|NCT01352585|3770210|B1|Italy||Region of Enrollment||participants|Number|47|47.0||||||
3948524|NCT01352585|3770210|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3948525|NCT01352585|3770210|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3948526|NCT01352585|3770210|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3948527|NCT01352585|3770210|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3948528|NCT01352585|3770210|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3948529|NCT01352585|3770210|B1|||Age||years|Mean|58.0|58.0|Standard Deviation|14.87|14.87|||
3948530|NCT01352546|3770221|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
3948531|NCT01352546|3770221|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3948532|NCT01352546|3770221|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3948533|NCT01352546|3770221|B1|||Age||years|Mean|27.3|27.3|Full Range|||20.0|37.0|
3948534|NCT01352507|3770225|B3|Mixed||ED Etiology||participants|Number|272|272.0||||||
3948535|NCT01352507|3770226|B2|Mixed||ED Etiology||participants|Number|139|139.0||||||
3948536|NCT01352507|3770227|B1|Mixed||ED Etiology||participants|Number|133|133.0||||||
3948537|NCT01352507|3770225|B3|Organic||ED Etiology||participants|Number|24|24.0||||||
3948538|NCT01352507|3770226|B2|Organic||ED Etiology||participants|Number|13|13.0||||||
3948539|NCT01352507|3770227|B1|Organic||ED Etiology||participants|Number|11|11.0||||||
3948540|NCT01352507|3770225|B3|Psychogenic||ED Etiology||participants|Number|87|87.0||||||
3948541|NCT01352507|3770226|B2|Psychogenic||ED Etiology||participants|Number|41|41.0||||||
3948542|NCT01352507|3770227|B1|Psychogenic||ED Etiology||participants|Number|46|46.0||||||
3948543|NCT01352507|3770225|B3|≥1 year||ED Duration||participants|Number|219|219.0||||||
3948544|NCT01352507|3770226|B2|≥1 year||ED Duration||participants|Number|106|106.0||||||
3948545|NCT01352507|3770227|B1|≥1 year||ED Duration||participants|Number|113|113.0||||||
3948546|NCT01352507|3770225|B3|≥3 months to <1 year||ED Duration||participants|Number|164|164.0||||||
3948547|NCT01352507|3770226|B2|≥3 months to <1 year||ED Duration||participants|Number|87|87.0||||||
3948548|NCT01352507|3770227|B1|≥3 months to <1 year||ED Duration||participants|Number|77|77.0||||||
3948549|NCT01352507|3770225|B3|Severe||Erectile Dysfunction (ED) Severity|Investigator-reported severity of a participant's ED. ED was defined as a consistent change in the quality of erection adversely affecting participant satisfaction with sexual intercourse. Severity was based on investigator opinion.|participants|Number|119|119.0||||||
3948550|NCT01352507|3770226|B2|Severe||Erectile Dysfunction (ED) Severity|Investigator-reported severity of a participant's ED. ED was defined as a consistent change in the quality of erection adversely affecting participant satisfaction with sexual intercourse. Severity was based on investigator opinion.|participants|Number|60|60.0||||||
3948551|NCT01352507|3770227|B1|Severe||Erectile Dysfunction (ED) Severity|Investigator-reported severity of a participant's ED. ED was defined as a consistent change in the quality of erection adversely affecting participant satisfaction with sexual intercourse. Severity was based on investigator opinion.|participants|Number|59|59.0||||||
3948552|NCT01352507|3770225|B3|Moderate||Erectile Dysfunction (ED) Severity|Investigator-reported severity of a participant's ED. ED was defined as a consistent change in the quality of erection adversely affecting participant satisfaction with sexual intercourse. Severity was based on investigator opinion.|participants|Number|133|133.0||||||
3948553|NCT01352507|3770226|B2|Moderate||Erectile Dysfunction (ED) Severity|Investigator-reported severity of a participant's ED. ED was defined as a consistent change in the quality of erection adversely affecting participant satisfaction with sexual intercourse. Severity was based on investigator opinion.|participants|Number|65|65.0||||||
3948554|NCT01352507|3770227|B1|Moderate||Erectile Dysfunction (ED) Severity|Investigator-reported severity of a participant's ED. ED was defined as a consistent change in the quality of erection adversely affecting participant satisfaction with sexual intercourse. Severity was based on investigator opinion.|participants|Number|68|68.0||||||
3948555|NCT01352507|3770225|B3|Mild||Erectile Dysfunction (ED) Severity|Investigator-reported severity of a participant's ED. ED was defined as a consistent change in the quality of erection adversely affecting participant satisfaction with sexual intercourse. Severity was based on investigator opinion.|participants|Number|131|131.0||||||
3948556|NCT01352507|3770226|B2|Mild||Erectile Dysfunction (ED) Severity|Investigator-reported severity of a participant's ED. ED was defined as a consistent change in the quality of erection adversely affecting participant satisfaction with sexual intercourse. Severity was based on investigator opinion.|participants|Number|68|68.0||||||
3948557|NCT01352507|3770227|B1|Mild||Erectile Dysfunction (ED) Severity|Investigator-reported severity of a participant's ED. ED was defined as a consistent change in the quality of erection adversely affecting participant satisfaction with sexual intercourse. Severity was based on investigator opinion.|participants|Number|63|63.0||||||
3948558|NCT01352507|3770225|B3|||International Index of Erectile Function (IIEF) Erectile Function (EF) Domain|IIEF-EF was the sum of Questions (Q)1 through 5 and Q15 of the IIEF. Q1 to Q5 were scored 0 (low/no erectile function) to 5 (high erectile function) and Q15 was scored 1 (no/low confidence) to 5 (high confidence). IIEF-EF domain scores ranged from 1 to 30. Higher scores represented better erectile function.|units on a scale|Mean|13.98|13.98|Standard Deviation|5.73|5.73|||
3948559|NCT01352507|3770226|B2|||International Index of Erectile Function (IIEF) Erectile Function (EF) Domain|IIEF-EF was the sum of Questions (Q)1 through 5 and Q15 of the IIEF. Q1 to Q5 were scored 0 (low/no erectile function) to 5 (high erectile function) and Q15 was scored 1 (no/low confidence) to 5 (high confidence). IIEF-EF domain scores ranged from 1 to 30. Higher scores represented better erectile function.|units on a scale|Mean|14.19|14.19|Standard Deviation|6.08|6.08|||
3948560|NCT01352507|3770227|B1|||International Index of Erectile Function (IIEF) Erectile Function (EF) Domain|IIEF-EF was the sum of Questions (Q)1 through 5 and Q15 of the IIEF. Q1 to Q5 were scored 0 (low/no erectile function) to 5 (high erectile function) and Q15 was scored 1 (no/low confidence) to 5 (high confidence). IIEF-EF domain scores ranged from 1 to 30. Higher scores represented better erectile function.|units on a scale|Mean|13.77|13.77|Standard Deviation|5.37|5.37|||
3948561|NCT01352507|3770225|B3|China||Region of Enrollment||participants|Number|383|383.0||||||
3948562|NCT01352507|3770226|B2|China||Region of Enrollment||participants|Number|193|193.0||||||
3948563|NCT01352507|3770227|B1|China||Region of Enrollment||participants|Number|190|190.0||||||
3948564|NCT01352507|3770225|B3|Chinese||Race/Ethnicity, Customized||participants|Number|383|383.0||||||
3948565|NCT01352507|3770226|B2|Chinese||Race/Ethnicity, Customized||participants|Number|193|193.0||||||
3948566|NCT01352507|3770227|B1|Chinese||Race/Ethnicity, Customized||participants|Number|190|190.0||||||
3948567|NCT01352507|3770225|B3||Male|Sex: Female, Male||Participants|Count of Participants|383|383.0||||||
3948568|NCT01352507|3770226|B2||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
3948569|NCT01352507|3770227|B1||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
3948570|NCT01352507|3770225|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3948571|NCT01352507|3770226|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3948572|NCT01352507|3770227|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3948573|NCT01352507|3770225|B3|||Age||years|Mean|39.94|39.94|Standard Deviation|11.00|11.0|||
3948574|NCT01352507|3770226|B2|||Age||years|Mean|40.66|40.66|Standard Deviation|11.44|11.44|||
3948575|NCT01352507|3770227|B1|||Age||years|Mean|39.20|39.2|Standard Deviation|10.52|10.52|||
3948576|NCT01352468|3770259|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
3948577|NCT01352468|3770260|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
3948578|NCT01352468|3770261|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3948579|NCT01352468|3770259|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948580|NCT01352468|3770260|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948581|NCT01352468|3770261|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948582|NCT01352468|3770259|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948583|NCT01352468|3770260|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948584|NCT01352468|3770261|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948585|NCT01352468|3770259|B3||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3948586|NCT01352468|3770260|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3948587|NCT01352468|3770261|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3948588|NCT01352468|3770259|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3948589|NCT01352468|3770260|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3948590|NCT01352468|3770261|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3948591|NCT01352468|3770259|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3948592|NCT01352468|3770260|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948593|NCT01352468|3770261|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3948594|NCT01352468|3770259|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948595|NCT01352468|3770260|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948596|NCT01352468|3770261|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948597|NCT01352468|3770259|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948598|NCT01352468|3770260|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948599|NCT01352468|3770261|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948600|NCT01352468|3770259|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948601|NCT01352468|3770260|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948602|NCT01352468|3770261|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948603|NCT01352468|3770259|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3948604|NCT01352468|3770260|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3948605|NCT01352468|3770261|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3948606|NCT01352468|3770259|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3948607|NCT01352468|3770260|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3948608|NCT01352468|3770261|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948609|NCT01352468|3770259|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3948610|NCT01352468|3770260|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3948611|NCT01352468|3770261|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3948612|NCT01352468|3770259|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3948613|NCT01352468|3770260|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3948614|NCT01352468|3770261|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3948615|NCT01352468|3770259|B3|||Age||years|Mean|9.14|9.14|Standard Deviation|1.68|1.68|||
3948616|NCT01352468|3770260|B2|||Age||years|Mean|9.22|9.22|Standard Deviation|1.65|1.65|||
3948617|NCT01352468|3770261|B1|||Age||years|Mean|9.05|9.05|Standard Deviation|1.73|1.73|||
3948618|NCT01352468|3770259|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3948619|NCT01352468|3770260|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3948620|NCT01352468|3770261|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3948621|NCT01352468|3770259|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3948622|NCT01352468|3770260|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3948623|NCT01352468|3770261|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3948624|NCT01352468|3770259|B3||<=18 years|Age||Participants|Count of Participants|44|44.0||||||
3948625|NCT01352468|3770260|B2||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
3948626|NCT01352468|3770261|B1||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
3948627|NCT01352442|3770272|B1|France||Region of Enrollment||participants|Number|12|12.0||||||
3948628|NCT01352442|3770272|B1|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
3948629|NCT01352442|3770272|B1|Spain||Region of Enrollment||participants|Number|3|3.0||||||
3948630|NCT01352442|3770272|B1|Australia||Region of Enrollment||participants|Number|26|26.0||||||
3948631|NCT01352442|3770272|B1|New Zealand||Region of Enrollment||participants|Number|16|16.0||||||
3948632|NCT01352442|3770272|B1|Turkey||Region of Enrollment||participants|Number|36|36.0||||||
3948633|NCT01352442|3770272|B1|Philippines||Region of Enrollment||participants|Number|26|26.0||||||
3948634|NCT01352442|3770272|B1|Singapore||Region of Enrollment||participants|Number|8|8.0||||||
3948635|NCT01352442|3770272|B1|Japan||Region of Enrollment||participants|Number|9|9.0||||||
3948636|NCT01352442|3770272|B1|Austria||Region of Enrollment||participants|Number|9|9.0||||||
3948637|NCT01352442|3770272|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3948638|NCT01352442|3770272|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3948639|NCT01352442|3770272|B1|||Age||years|Mean|51|51.0|Standard Deviation|4|4.0|||
3948640|NCT01352442|3770272|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3948641|NCT01352442|3770272|B1||Between 18 and 65 years|Age||Participants|Count of Participants|151|151.0||||||
3948642|NCT01352442|3770272|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3948643|NCT01352416|3770277|B5|United States||Region of Enrollment||participants|Number|15|15.0||||||
3948644|NCT01352416|3770278|B4|United States||Region of Enrollment||participants|Number|2|2.0||||||
3948645|NCT01352416|3770279|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3948646|NCT01352416|3770280|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3948647|NCT01352416|3770281|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3948648|NCT01352416|3770277|B5||Male|Gender||Participants|Count of Participants|15|15.0||||||
3948649|NCT01352416|3770278|B4||Male|Gender||Participants|Count of Participants|2|2.0||||||
3948650|NCT01352416|3770279|B3||Male|Gender||Participants|Count of Participants|2|2.0||||||
3948651|NCT01352416|3770280|B2||Male|Gender||Participants|Count of Participants|7|7.0||||||
3948652|NCT01352416|3770281|B1||Male|Gender||Participants|Count of Participants|4|4.0||||||
3948653|NCT01352416|3770277|B5||Female|Gender||Participants|Count of Participants|0|0.0||||||
3948654|NCT01352416|3770278|B4||Female|Gender||Participants|Count of Participants|0|0.0||||||
3948655|NCT01352416|3770279|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
3948656|NCT01352416|3770280|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
3948657|NCT01352416|3770281|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3948658|NCT01352416|3770277|B5|||Age||years|Mean|63.4|63.4|Standard Deviation|12.1|12.1|||
3948659|NCT01352416|3770278|B4|||Age||years|Mean|71.0|71.0|Standard Deviation|9.9|9.9|||
3948660|NCT01352416|3770279|B3|||Age||years|Mean|48.0|48.0|Standard Deviation|25.5|25.5|||
3948661|NCT01352416|3770280|B2|||Age||years|Mean|63.4|63.4|Standard Deviation|9.9|9.9|||
3948662|NCT01352416|3770281|B1|||Age||years|Mean|67.3|67.3|Standard Deviation|4.6|4.6|||
3948663|NCT01352416|3770277|B5||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3948664|NCT01352416|3770278|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3948665|NCT01352416|3770279|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3948666|NCT01352416|3770280|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3948667|NCT01352416|3770281|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3948668|NCT01352416|3770277|B5||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3948669|NCT01352416|3770278|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3948670|NCT01352416|3770279|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3948671|NCT01352416|3770280|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3948672|NCT01352416|3770281|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3948673|NCT01352416|3770277|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3948674|NCT01352416|3770278|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3948675|NCT01352416|3770279|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3948676|NCT01352416|3770280|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3948677|NCT01352416|3770281|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3948678|NCT01352221|3770294|B3|||Irritable Bowel Disease Questionnaire (IBDQ) score at baseline|"Irritable Bowel Disease Questionnaire (IBDQ) score at baseline (randomisation) of the 12 week double-blind phase.~The IBDQ was developed as an activity index for determining the effect of Crohn's disease symptoms on perceived quality of life. It is a 32-item questionnaire with four dimensions: bowel function, emotional status, systemic symptoms and social function. Total IBDQ score ranges from 32 to 224, with higher scores indicating better quality of life. The score of patients in remission usually is between 170 and 190."|score on a scale|Mean|173.02|173.02|Standard Deviation|32.23|32.23|||
3948679|NCT01352221|3770295|B2|||Irritable Bowel Disease Questionnaire (IBDQ) score at baseline|"Irritable Bowel Disease Questionnaire (IBDQ) score at baseline (randomisation) of the 12 week double-blind phase.~The IBDQ was developed as an activity index for determining the effect of Crohn's disease symptoms on perceived quality of life. It is a 32-item questionnaire with four dimensions: bowel function, emotional status, systemic symptoms and social function. Total IBDQ score ranges from 32 to 224, with higher scores indicating better quality of life. The score of patients in remission usually is between 170 and 190."|score on a scale|Mean|171.0|171.0|Standard Deviation|33.56|33.56|||
3948680|NCT01352221|3770296|B1|||Irritable Bowel Disease Questionnaire (IBDQ) score at baseline|"Irritable Bowel Disease Questionnaire (IBDQ) score at baseline (randomisation) of the 12 week double-blind phase.~The IBDQ was developed as an activity index for determining the effect of Crohn's disease symptoms on perceived quality of life. It is a 32-item questionnaire with four dimensions: bowel function, emotional status, systemic symptoms and social function. Total IBDQ score ranges from 32 to 224, with higher scores indicating better quality of life. The score of patients in remission usually is between 170 and 190."|score on a scale|Mean|175.0|175.0|Standard Deviation|30.92|30.92|||
3948681|NCT01352221|3770294|B3|||Crohn’s Disease Activity Index (CDAI) score at baseline|"Crohn’s Disease Activity Index (CDAI) score at baseline (randomisation) of the 12-week double-blind phase (in study subjects with CD only).~The CDAI is a research tool used to quantify the symptoms of patients with Crohn's disease. CDAI score can range from 0 to approximately 600. Traditionally, for clinical trials, clinical remission is defined as a CDAI score <150, clinical response is a decrease in CDAI score of 70-100. Mildly active Crohn's disease is defined as a CDAI score 150–220, moderate–severe Crohn's is typically a CDAI 220–450, and severe disease is defined as a CDAI >450."|score on a scale|Mean|95.85|95.85|Full Range|||10.0|220.0|
3948682|NCT01352221|3770295|B2|||Crohn’s Disease Activity Index (CDAI) score at baseline|"Crohn’s Disease Activity Index (CDAI) score at baseline (randomisation) of the 12-week double-blind phase (in study subjects with CD only).~The CDAI is a research tool used to quantify the symptoms of patients with Crohn's disease. CDAI score can range from 0 to approximately 600. Traditionally, for clinical trials, clinical remission is defined as a CDAI score <150, clinical response is a decrease in CDAI score of 70-100. Mildly active Crohn's disease is defined as a CDAI score 150–220, moderate–severe Crohn's is typically a CDAI 220–450, and severe disease is defined as a CDAI >450."|score on a scale|Mean|105.3|105.3|Full Range|||10.0|220.0|
3948683|NCT01352221|3770296|B1|||Crohn’s Disease Activity Index (CDAI) score at baseline|"Crohn’s Disease Activity Index (CDAI) score at baseline (randomisation) of the 12-week double-blind phase (in study subjects with CD only).~The CDAI is a research tool used to quantify the symptoms of patients with Crohn's disease. CDAI score can range from 0 to approximately 600. Traditionally, for clinical trials, clinical remission is defined as a CDAI score <150, clinical response is a decrease in CDAI score of 70-100. Mildly active Crohn's disease is defined as a CDAI score 150–220, moderate–severe Crohn's is typically a CDAI 220–450, and severe disease is defined as a CDAI >450."|score on a scale|Mean|86.4|86.4|Full Range|||14.0|199.0|
3948684|NCT01352221|3770294|B3|||TSAT% at baseline|TSAT% (transferrin saturation %) at baseline of the 12 week double-blind phase|percentage|Mean|10.05|10.05|Standard Deviation|9.6|9.6|||
3948685|NCT01352221|3770295|B2|||TSAT% at baseline|TSAT% (transferrin saturation %) at baseline of the 12 week double-blind phase|percentage|Mean|9.5|9.5|Standard Deviation|7.5|7.5|||
3948686|NCT01352221|3770296|B1|||TSAT% at baseline|TSAT% (transferrin saturation %) at baseline of the 12 week double-blind phase|percentage|Mean|10.6|10.6|Standard Deviation|11.7|11.7|||
3948687|NCT01352221|3770294|B3|||Serum Ferritin concentration at baseline|Serum Ferritin concentration at baseline of the 12 week double-blind phase|μg/L|Mean|8.4|8.4|Standard Deviation|6.6|6.6|||
3948688|NCT01352221|3770295|B2|||Serum Ferritin concentration at baseline|Serum Ferritin concentration at baseline of the 12 week double-blind phase|μg/L|Mean|8.2|8.2|Standard Deviation|6.5|6.5|||
3948689|NCT01352221|3770296|B1|||Serum Ferritin concentration at baseline|Serum Ferritin concentration at baseline of the 12 week double-blind phase|μg/L|Mean|8.6|8.6|Standard Deviation|6.8|6.8|||
3948690|NCT01352221|3770294|B3|||Haemoglobin concentration at baseline|Haemoglobin concentration at baseline of the 12 week double-blind phase|g/dL|Mean|11.05|11.05|Standard Deviation|0.93|0.93|||
3948691|NCT01352221|3770295|B2|||Haemoglobin concentration at baseline|Haemoglobin concentration at baseline of the 12 week double-blind phase|g/dL|Mean|11.1|11.1|Standard Deviation|0.85|0.85|||
3948692|NCT01352221|3770296|B1|||Haemoglobin concentration at baseline|Haemoglobin concentration at baseline of the 12 week double-blind phase|g/dL|Mean|11|11.0|Standard Deviation|1.03|1.03|||
3948693|NCT01352221|3770294|B3|||Time since last OFP dose (months)|Time since last prior oral ferrous product (OFP) dose (months)|months|Mean|34.76|34.76|Standard Deviation|41.7|41.7|||
3948694|NCT01352221|3770295|B2|||Time since last OFP dose (months)|Time since last prior oral ferrous product (OFP) dose (months)|months|Mean|33.34|33.34|Standard Deviation|44.04|44.04|||
3948695|NCT01352221|3770296|B1|||Time since last OFP dose (months)|Time since last prior oral ferrous product (OFP) dose (months)|months|Mean|36.17|36.17|Standard Deviation|40.1|40.1|||
3948696|NCT01352221|3770294|B3|||Time since last IBD flare-up (months)|Time since last IBD flare-up (months) recorded at baseline|months|Mean|23.2|23.2|Standard Deviation|48.4|48.4|||
3948697|NCT01352221|3770295|B2|||Time since last IBD flare-up (months)|Time since last IBD flare-up (months) recorded at baseline|months|Mean|21.51|21.51|Standard Deviation|38.46|38.46|||
3948698|NCT01352221|3770296|B1|||Time since last IBD flare-up (months)|Time since last IBD flare-up (months) recorded at baseline|months|Mean|24.8|24.8|Standard Deviation|59.16|59.16|||
3948699|NCT01352221|3770294|B3|||Duration of Crohn’s disease (years)|Duration of Crohn’s disease (years); for participants with CD|years|Mean|11.13|11.13|Standard Deviation|8.6|8.6|||
3948700|NCT01352221|3770295|B2|||Duration of Crohn’s disease (years)|Duration of Crohn’s disease (years); for participants with CD|years|Mean|11.01|11.01|Standard Deviation|8.09|8.09|||
3948701|NCT01352221|3770296|B1|||Duration of Crohn’s disease (years)|Duration of Crohn’s disease (years); for participants with CD|years|Mean|11.25|11.25|Standard Deviation|9.296|9.296|||
3948702|NCT01352221|3770294|B3|Austria||Region of Enrollment||participants|Number|10|10.0||||||
3948703|NCT01352221|3770295|B2|Austria||Region of Enrollment||participants|Number|6|6.0||||||
3948704|NCT01352221|3770296|B1|Austria||Region of Enrollment||participants|Number|4|4.0||||||
3948705|NCT01352221|3770294|B3|Germany||Region of Enrollment||participants|Number|67|67.0||||||
3948706|NCT01352221|3770295|B2|Germany||Region of Enrollment||participants|Number|32|32.0||||||
3948707|NCT01352221|3770296|B1|Germany||Region of Enrollment||participants|Number|35|35.0||||||
3948708|NCT01352221|3770294|B3|Hungary||Region of Enrollment||participants|Number|26|26.0||||||
3948709|NCT01352221|3770295|B2|Hungary||Region of Enrollment||participants|Number|15|15.0||||||
3948710|NCT01352221|3770296|B1|Hungary||Region of Enrollment||participants|Number|11|11.0||||||
3948711|NCT01352221|3770294|B3|United Kingdom||Region of Enrollment||participants|Number|25|25.0||||||
3948712|NCT01352221|3770295|B2|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
3948713|NCT01352221|3770296|B1|United Kingdom||Region of Enrollment||participants|Number|15|15.0||||||
3948714|NCT01352221|3770294|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3948715|NCT01352221|3770295|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3948716|NCT01352221|3770296|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3948717|NCT01352221|3770294|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3948718|NCT01352221|3770295|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3948719|NCT01352221|3770296|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3948720|NCT01352221|3770294|B3|||Age||years|Mean|39.2|39.2|Standard Deviation|12.9|12.9|||
3948721|NCT01352221|3770295|B2|||Age||years|Mean|38.5|38.5|Standard Deviation|12.3|12.3|||
3948722|NCT01352221|3770296|B1|||Age||years|Mean|40.1|40.1|Standard Deviation|13.52|13.52|||
3948723|NCT01352221|3770294|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3948724|NCT01352221|3770295|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3948725|NCT01352221|3770296|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3948726|NCT01352221|3770294|B3||Between 18 and 65 years|Age||Participants|Count of Participants|125|125.0||||||
3948727|NCT01352221|3770295|B2||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
3948728|NCT01352221|3770296|B1||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
3948729|NCT01352221|3770294|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3948730|NCT01352221|3770295|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3948731|NCT01352221|3770296|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3948732|NCT01352117|3770357|B3||ART-naive|ART experience||Participants|Count of Participants|189|189.0||||||
3948733|NCT01352117|3770358|B2||ART-naive|ART experience||Participants|Count of Participants|95|95.0||||||
3948734|NCT01352117|3770359|B1||ART-naive|ART experience||Participants|Count of Participants|94|94.0||||||
3948735|NCT01352117|3770357|B3||ART-experienced|ART experience||Participants|Count of Participants|1|1.0||||||
3948736|NCT01352117|3770358|B2||ART-experienced|ART experience||Participants|Count of Participants|1|1.0||||||
3948737|NCT01352117|3770359|B1||ART-experienced|ART experience||Participants|Count of Participants|0|0.0||||||
3948738|NCT01352117|3770357|B3||KS tumor Stage T1|KS stage|KS tumor stage was determined by the ACTG criteria (refer to Protocol Section, References) where Stage T0 (good risk) is defined as KS confined to skin and/or lymph nodes and/or minimal oral KS and Stage T1 (poor risk) as presence of tumor-associated edema and/or presence of oral KS beyond flat lesions confined to the palate and/or presence of asymptomatic gastrointestinal KS.|Participants|Count of Participants|115|115.0||||||
3948739|NCT01352117|3770358|B2||KS tumor Stage T1|KS stage|KS tumor stage was determined by the ACTG criteria (refer to Protocol Section, References) where Stage T0 (good risk) is defined as KS confined to skin and/or lymph nodes and/or minimal oral KS and Stage T1 (poor risk) as presence of tumor-associated edema and/or presence of oral KS beyond flat lesions confined to the palate and/or presence of asymptomatic gastrointestinal KS.|Participants|Count of Participants|56|56.0||||||
3948740|NCT01352117|3770359|B1||KS tumor Stage T1|KS stage|KS tumor stage was determined by the ACTG criteria (refer to Protocol Section, References) where Stage T0 (good risk) is defined as KS confined to skin and/or lymph nodes and/or minimal oral KS and Stage T1 (poor risk) as presence of tumor-associated edema and/or presence of oral KS beyond flat lesions confined to the palate and/or presence of asymptomatic gastrointestinal KS.|Participants|Count of Participants|59|59.0||||||
3948780|NCT01352117|3770357|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3948741|NCT01352117|3770357|B3||KS tumor Stage T0|KS stage|KS tumor stage was determined by the ACTG criteria (refer to Protocol Section, References) where Stage T0 (good risk) is defined as KS confined to skin and/or lymph nodes and/or minimal oral KS and Stage T1 (poor risk) as presence of tumor-associated edema and/or presence of oral KS beyond flat lesions confined to the palate and/or presence of asymptomatic gastrointestinal KS.|Participants|Count of Participants|75|75.0||||||
3948742|NCT01352117|3770358|B2||KS tumor Stage T0|KS stage|KS tumor stage was determined by the ACTG criteria (refer to Protocol Section, References) where Stage T0 (good risk) is defined as KS confined to skin and/or lymph nodes and/or minimal oral KS and Stage T1 (poor risk) as presence of tumor-associated edema and/or presence of oral KS beyond flat lesions confined to the palate and/or presence of asymptomatic gastrointestinal KS.|Participants|Count of Participants|40|40.0||||||
3948743|NCT01352117|3770359|B1||KS tumor Stage T0|KS stage|KS tumor stage was determined by the ACTG criteria (refer to Protocol Section, References) where Stage T0 (good risk) is defined as KS confined to skin and/or lymph nodes and/or minimal oral KS and Stage T1 (poor risk) as presence of tumor-associated edema and/or presence of oral KS beyond flat lesions confined to the palate and/or presence of asymptomatic gastrointestinal KS.|Participants|Count of Participants|35|35.0||||||
3948744|NCT01352117|3770357|B3||100|Karnofsky score|Karnofsky performance scale is from 0 (dead) to 100 (normal; no complaint; no evidence of disease) by 10.|Participants|Count of Participants|10|10.0||||||
3948745|NCT01352117|3770358|B2||100|Karnofsky score|Karnofsky performance scale is from 0 (dead) to 100 (normal; no complaint; no evidence of disease) by 10.|Participants|Count of Participants|5|5.0||||||
3948746|NCT01352117|3770359|B1||100|Karnofsky score|Karnofsky performance scale is from 0 (dead) to 100 (normal; no complaint; no evidence of disease) by 10.|Participants|Count of Participants|5|5.0||||||
3948747|NCT01352117|3770357|B3||90|Karnofsky score|Karnofsky performance scale is from 0 (dead) to 100 (normal; no complaint; no evidence of disease) by 10.|Participants|Count of Participants|114|114.0||||||
3948748|NCT01352117|3770358|B2||90|Karnofsky score|Karnofsky performance scale is from 0 (dead) to 100 (normal; no complaint; no evidence of disease) by 10.|Participants|Count of Participants|60|60.0||||||
3948749|NCT01352117|3770359|B1||90|Karnofsky score|Karnofsky performance scale is from 0 (dead) to 100 (normal; no complaint; no evidence of disease) by 10.|Participants|Count of Participants|54|54.0||||||
3948750|NCT01352117|3770357|B3||80|Karnofsky score|Karnofsky performance scale is from 0 (dead) to 100 (normal; no complaint; no evidence of disease) by 10.|Participants|Count of Participants|52|52.0||||||
3948751|NCT01352117|3770358|B2||80|Karnofsky score|Karnofsky performance scale is from 0 (dead) to 100 (normal; no complaint; no evidence of disease) by 10.|Participants|Count of Participants|26|26.0||||||
3948752|NCT01352117|3770359|B1||80|Karnofsky score|Karnofsky performance scale is from 0 (dead) to 100 (normal; no complaint; no evidence of disease) by 10.|Participants|Count of Participants|26|26.0||||||
3948753|NCT01352117|3770357|B3||70|Karnofsky score|Karnofsky performance scale is from 0 (dead) to 100 (normal; no complaint; no evidence of disease) by 10.|Participants|Count of Participants|13|13.0||||||
3948754|NCT01352117|3770358|B2||70|Karnofsky score|Karnofsky performance scale is from 0 (dead) to 100 (normal; no complaint; no evidence of disease) by 10.|Participants|Count of Participants|5|5.0||||||
3948755|NCT01352117|3770359|B1||70|Karnofsky score|Karnofsky performance scale is from 0 (dead) to 100 (normal; no complaint; no evidence of disease) by 10.|Participants|Count of Participants|8|8.0||||||
3948756|NCT01352117|3770357|B3||60|Karnofsky score|Karnofsky performance scale is from 0 (dead) to 100 (normal; no complaint; no evidence of disease) by 10.|Participants|Count of Participants|1|1.0||||||
3948757|NCT01352117|3770358|B2||60|Karnofsky score|Karnofsky performance scale is from 0 (dead) to 100 (normal; no complaint; no evidence of disease) by 10.|Participants|Count of Participants|0|0.0||||||
3948758|NCT01352117|3770359|B1||60|Karnofsky score|Karnofsky performance scale is from 0 (dead) to 100 (normal; no complaint; no evidence of disease) by 10.|Participants|Count of Participants|1|1.0||||||
3948759|NCT01352117|3770357|B3||>=200 cells/mm^3|CD4 cell count, categorized||Participants|Count of Participants|87|87.0||||||
3948760|NCT01352117|3770358|B2||>=200 cells/mm^3|CD4 cell count, categorized||Participants|Count of Participants|43|43.0||||||
3948761|NCT01352117|3770359|B1||>=200 cells/mm^3|CD4 cell count, categorized||Participants|Count of Participants|44|44.0||||||
3948762|NCT01352117|3770357|B3||<200 cells/mm^3|CD4 cell count, categorized||Participants|Count of Participants|103|103.0||||||
3948763|NCT01352117|3770358|B2||<200 cells/mm^3|CD4 cell count, categorized||Participants|Count of Participants|53|53.0||||||
3948764|NCT01352117|3770359|B1||<200 cells/mm^3|CD4 cell count, categorized||Participants|Count of Participants|50|50.0||||||
3948765|NCT01352117|3770357|B3|||CD4 cell count, continuous||cells/mm^3|Median|184|184.0|Inter-Quartile Range|||78.0|325.0|
3948766|NCT01352117|3770358|B2|||CD4 cell count, continuous||cells/mm^3|Median|165|165.0|Inter-Quartile Range|||63.0|327.0|
3948767|NCT01352117|3770359|B1|||CD4 cell count, continuous||cells/mm^3|Median|190|190.0|Inter-Quartile Range|||88.0|325.0|
3948768|NCT01352117|3770357|B3|||HIV-1 RNA||log10 copies/mL|Median|5.11|5.11|Inter-Quartile Range|||4.53|5.5|
3948769|NCT01352117|3770358|B2|||HIV-1 RNA||log10 copies/mL|Median|5.10|5.1|Inter-Quartile Range|||4.59|5.47|
3948770|NCT01352117|3770359|B1|||HIV-1 RNA||log10 copies/mL|Median|5.11|5.11|Inter-Quartile Range|||4.48|5.62|
3948771|NCT01352117|3770357|B3||Other|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3948772|NCT01352117|3770358|B2||Other|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3948773|NCT01352117|3770359|B1||Other|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3948774|NCT01352117|3770357|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3948775|NCT01352117|3770358|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3948776|NCT01352117|3770359|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3948777|NCT01352117|3770357|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|177|177.0||||||
3948778|NCT01352117|3770358|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3948779|NCT01352117|3770359|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
3948781|NCT01352117|3770358|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3948782|NCT01352117|3770359|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948783|NCT01352117|3770357|B3|Peru||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3948784|NCT01352117|3770358|B2|Peru||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3948785|NCT01352117|3770359|B1|Peru||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3948786|NCT01352117|3770357|B3|Kenya||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3948787|NCT01352117|3770358|B2|Kenya||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3948788|NCT01352117|3770359|B1|Kenya||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3948789|NCT01352117|3770357|B3|South Africa||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3948790|NCT01352117|3770358|B2|South Africa||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3948791|NCT01352117|3770359|B1|South Africa||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3948792|NCT01352117|3770357|B3|Zimbabwe||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3948793|NCT01352117|3770358|B2|Zimbabwe||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3948794|NCT01352117|3770359|B1|Zimbabwe||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3948795|NCT01352117|3770357|B3|Uganda||Region of Enrollment||Participants|Count of Participants|58|58.0||||||
3948796|NCT01352117|3770358|B2|Uganda||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3948797|NCT01352117|3770359|B1|Uganda||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3948798|NCT01352117|3770357|B3|Brazil||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3948799|NCT01352117|3770358|B2|Brazil||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3948800|NCT01352117|3770359|B1|Brazil||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3948801|NCT01352117|3770357|B3|Malawi||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
3948802|NCT01352117|3770358|B2|Malawi||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3948803|NCT01352117|3770359|B1|Malawi||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3948804|NCT01352117|3770357|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3948805|NCT01352117|3770358|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3948806|NCT01352117|3770359|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3948807|NCT01352117|3770357|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|169|169.0||||||
3948808|NCT01352117|3770358|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
3948809|NCT01352117|3770359|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3948810|NCT01352117|3770357|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3948811|NCT01352117|3770358|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3948812|NCT01352117|3770359|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3948813|NCT01352117|3770357|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3948814|NCT01352117|3770358|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3948815|NCT01352117|3770359|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3948816|NCT01352117|3770357|B3||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3948817|NCT01352117|3770358|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3948818|NCT01352117|3770359|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3948819|NCT01352117|3770357|B3|||Age||years|Median|34|34.0|Inter-Quartile Range|||29.0|41.0|
3948820|NCT01352117|3770358|B2|||Age||years|Median|35|35.0|Inter-Quartile Range|||30.0|41.0|
3948821|NCT01352117|3770359|B1|||Age||years|Median|34|34.0|Inter-Quartile Range|||28.0|41.0|
3948822|NCT01351740|3770412|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3948823|NCT01351740|3770413|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3948824|NCT01351740|3770414|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3948825|NCT01351740|3770412|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3948826|NCT01351740|3770413|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3948827|NCT01351740|3770414|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3948828|NCT01351740|3770412|B3|||Age||years|Median|47|47.0|Inter-Quartile Range|||40.0|53.0|
3948829|NCT01351740|3770413|B2|||Age||years|Median|46|46.0|Inter-Quartile Range|||39.0|53.0|
3948830|NCT01351740|3770414|B1|||Age||years|Median|48|48.0|Inter-Quartile Range|||42.0|52.0|
3948831|NCT01351623|3770423|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
3948832|NCT01351623|3770423|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3948833|NCT01351623|3770423|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948834|NCT01351623|3770423|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3948835|NCT01351623|3770423|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3948836|NCT01351623|3770423|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948837|NCT01351623|3770423|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3948838|NCT01351623|3770423|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948901|NCT01351090|3770476|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3948839|NCT01351623|3770423|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3948840|NCT01351623|3770423|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3948841|NCT01351623|3770423|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3948842|NCT01351623|3770423|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3948843|NCT01351623|3770423|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3948844|NCT01351623|3770423|B1|||Age||years|Median|63|63.0|Full Range|||45.0|86.0|
3948845|NCT01351506|3770427|B3||Male|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
3948846|NCT01351506|3770428|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3948847|NCT01351506|3770429|B1||Male|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
3948848|NCT01351506|3770427|B3||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
3948849|NCT01351506|3770428|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3948850|NCT01351506|3770429|B1||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3948851|NCT01351506|3770427|B3|||Age||years|Median|60|60.0|Inter-Quartile Range|||49.0|74.0|
3948852|NCT01351506|3770428|B2|||Age||years|Median|53|53.0|Inter-Quartile Range|||45.0|74.0|
3948853|NCT01351506|3770429|B1|||Age||years|Median|60|60.0|Inter-Quartile Range|||49.0|72.0|
3948854|NCT01351480|3770439|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
3948855|NCT01351480|3770439|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3948856|NCT01351480|3770439|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3948857|NCT01351480|3770439|B1|||Age||years|Mean|57|57.0|Full Range|||32.0|83.0|
3948858|NCT01351480|3770439|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3948859|NCT01351480|3770439|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3948860|NCT01351480|3770439|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3948861|NCT01351415|3770447|B3||Male|Sex: Female, Male||Participants|Count of Participants|293|293.0||||||
3948862|NCT01351415|3770448|B2||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3948863|NCT01351415|3770449|B1||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3948864|NCT01351415|3770447|B3||Female|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
3948865|NCT01351415|3770448|B2||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3948866|NCT01351415|3770449|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3948867|NCT01351415|3770447|B3|||Age||Years|Mean|61.6|61.6|Standard Deviation|9.44|9.44|26.0|84.0|
3948868|NCT01351415|3770448|B2|||Age||Years|Mean|61.8|61.8|Standard Deviation|9.29|9.29|35.0|82.0|
3948869|NCT01351415|3770449|B1|||Age||Years|Mean|61.5|61.5|Standard Deviation|9.61|9.61|26.0|84.0|
3948870|NCT01351337|3770470|B1|Temporal lobe||Study Specific Measure [Tumor Location]||participants|Number|11|11.0||||||
3948871|NCT01351337|3770470|B1|Insular lobe||Study Specific Measure [Tumor Location]||participants|Number|12|12.0||||||
3948872|NCT01351337|3770470|B1|Parietal lobe||Study Specific Measure [Tumor Location]||participants|Number|13|13.0||||||
3948873|NCT01351337|3770470|B1|Frontal lobe||Study Specific Measure [Tumor Location]||participants|Number|22|22.0||||||
3948874|NCT01351337|3770470|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3948875|NCT01351337|3770470|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3948876|NCT01351337|3770470|B1|Patients enrolled||Age||years|Mean|44|44.0|Full Range|||10.0|72.0|
3948877|NCT01351090|3770476|B4|New Zealand||Region of Enrollment||participants|Number|127|127.0||||||
3948878|NCT01351090|3770477|B3|New Zealand||Region of Enrollment||participants|Number|42|42.0||||||
3948879|NCT01351090|3770478|B2|New Zealand||Region of Enrollment||participants|Number|42|42.0||||||
3948880|NCT01351090|3770479|B1|New Zealand||Region of Enrollment||participants|Number|43|43.0||||||
3948881|NCT01351090|3770476|B4||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3948882|NCT01351090|3770477|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3948883|NCT01351090|3770478|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3948884|NCT01351090|3770479|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3948885|NCT01351090|3770476|B4||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3948886|NCT01351090|3770477|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3948887|NCT01351090|3770478|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3948888|NCT01351090|3770479|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3948889|NCT01351090|3770476|B4|||Age||years|Mean|53.0|53.0|Standard Deviation|1.4|1.4|||
3948890|NCT01351090|3770477|B3|||Age||years|Mean|56.7|56.7|Standard Deviation|2.5|2.5|||
3948891|NCT01351090|3770478|B2|||Age||years|Mean|52.8|52.8|Standard Deviation|2.5|2.5|||
3948892|NCT01351090|3770479|B1|||Age||years|Mean|49.7|49.7|Standard Deviation|2.1|2.1|||
3948893|NCT01351090|3770476|B4||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
3948894|NCT01351090|3770477|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3948895|NCT01351090|3770478|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3948896|NCT01351090|3770479|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3948897|NCT01351090|3770476|B4||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
3948898|NCT01351090|3770477|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3948899|NCT01351090|3770478|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3948900|NCT01351090|3770479|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3948902|NCT01351090|3770477|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3948903|NCT01351090|3770478|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3948904|NCT01351090|3770479|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3948905|NCT01351077|3770498|B3|Medicaid||Insurance||Participants|Count of Participants|331|331.0||||||
3948906|NCT01351077|3770499|B2|Medicaid||Insurance||Participants|Count of Participants|171|171.0||||||
3948907|NCT01351077|3770500|B1|Medicaid||Insurance||Participants|Count of Participants|160|160.0||||||
3948908|NCT01351077|3770498|B3|Self-pay||Insurance||Participants|Count of Participants|14|14.0||||||
3948909|NCT01351077|3770499|B2|Self-pay||Insurance||Participants|Count of Participants|2|2.0||||||
3948910|NCT01351077|3770500|B1|Self-pay||Insurance||Participants|Count of Participants|12|12.0||||||
3948911|NCT01351077|3770498|B3|Advantage/Commercial||Insurance||Participants|Count of Participants|14|14.0||||||
3948912|NCT01351077|3770499|B2|Advantage/Commercial||Insurance||Participants|Count of Participants|6|6.0||||||
3948913|NCT01351077|3770500|B1|Advantage/Commercial||Insurance||Participants|Count of Participants|8|8.0||||||
3948914|NCT01351077|3770498|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3948915|NCT01351077|3770499|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3948916|NCT01351077|3770500|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3948917|NCT01351077|3770498|B3|White/Asian||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3948918|NCT01351077|3770499|B2|White/Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3948919|NCT01351077|3770500|B1|White/Asian||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3948920|NCT01351077|3770498|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|128|128.0||||||
3948921|NCT01351077|3770499|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3948922|NCT01351077|3770500|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|117|117.0||||||
3948923|NCT01351077|3770498|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|215|215.0||||||
3948924|NCT01351077|3770499|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|164|164.0||||||
3948925|NCT01351077|3770500|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
3948926|NCT01351077|3770498|B3||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3948927|NCT01351077|3770499|B2||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3948928|NCT01351077|3770500|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3948929|NCT01351077|3770498|B3||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3948930|NCT01351077|3770499|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3948931|NCT01351077|3770500|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3948932|NCT01351077|3770498|B3|||Age||months|Mean|21.8|21.8|Standard Deviation|5.8|5.8|||
3948933|NCT01351077|3770499|B2|||Age||months|Mean|23.7|23.7|Standard Deviation|6.5|6.5|||
3948934|NCT01351077|3770500|B1|||Age||months|Mean|19.8|19.8|Standard Deviation|5.1|5.1|||
3948935|NCT01351064|3770515|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3948936|NCT01351064|3770516|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3948937|NCT01351064|3770517|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3948938|NCT01351064|3770515|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948939|NCT01351064|3770516|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948940|NCT01351064|3770517|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948941|NCT01351064|3770515|B3||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3948942|NCT01351064|3770516|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3948943|NCT01351064|3770517|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3948944|NCT01351064|3770515|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3948945|NCT01351064|3770516|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3948946|NCT01351064|3770517|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3948947|NCT01351064|3770515|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948948|NCT01351064|3770516|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948949|NCT01351064|3770517|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948950|NCT01351064|3770515|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948951|NCT01351064|3770516|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948952|NCT01351064|3770517|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948953|NCT01351064|3770515|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948954|NCT01351064|3770516|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948955|NCT01351064|3770517|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3948956|NCT01351064|3770515|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3948957|NCT01351064|3770516|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3948958|NCT01351064|3770517|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3948959|NCT01351064|3770515|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3948960|NCT01351064|3770516|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3948961|NCT01351064|3770517|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3948962|NCT01351064|3770515|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3948963|NCT01351064|3770516|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3948964|NCT01351064|3770517|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3948965|NCT01351064|3770515|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3948966|NCT01351064|3770516|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3948967|NCT01351064|3770517|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3948968|NCT01351064|3770515|B3||<=18 years|Age||Participants|Count of Participants|84|84.0||||||
3948969|NCT01351064|3770516|B2||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
3948970|NCT01351064|3770517|B1||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
3948971|NCT01351025|3770526|B3|||CD4 count||cells/mm^3|Median|552|552.0|Inter-Quartile Range|||412.0|714.0|
3948972|NCT01351025|3770527|B2|||CD4 count||cells/mm^3|Median|545|545.0|Inter-Quartile Range|||424.0|689.0|
3948973|NCT01351025|3770528|B1|||CD4 count||cells/mm^3|Median|587|587.0|Inter-Quartile Range|||373.0|732.0|
3948974|NCT01351025|3770526|B3|>= assay lower limit||HIV-1 RNA||participants|Number|1|1.0||||||
3948975|NCT01351025|3770527|B2|>= assay lower limit||HIV-1 RNA||participants|Number|1|1.0||||||
3948976|NCT01351025|3770528|B1|>= assay lower limit||HIV-1 RNA||participants|Number|0|0.0||||||
3948977|NCT01351025|3770526|B3|< assay lower limit||HIV-1 RNA||participants|Number|93|93.0||||||
3948978|NCT01351025|3770527|B2|< assay lower limit||HIV-1 RNA||participants|Number|47|47.0||||||
3948979|NCT01351025|3770528|B1|< assay lower limit||HIV-1 RNA||participants|Number|46|46.0||||||
3948980|NCT01351025|3770526|B3|United States||Region of Enrollment||participants|Number|94|94.0||||||
3948981|NCT01351025|3770527|B2|United States||Region of Enrollment||participants|Number|48|48.0||||||
3948982|NCT01351025|3770528|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
3948983|NCT01351025|3770526|B3|Asian, Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3948984|NCT01351025|3770527|B2|Asian, Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3948985|NCT01351025|3770528|B1|Asian, Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3948986|NCT01351025|3770526|B3|Hispanic (regardless of race)||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
3948987|NCT01351025|3770527|B2|Hispanic (regardless of race)||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3948988|NCT01351025|3770528|B1|Hispanic (regardless of race)||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3948989|NCT01351025|3770526|B3|Black non-Hispanic||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
3948990|NCT01351025|3770527|B2|Black non-Hispanic||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3948991|NCT01351025|3770528|B1|Black non-Hispanic||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3948992|NCT01351025|3770526|B3|White non-Hispanic||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3948993|NCT01351025|3770527|B2|White non-Hispanic||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3948994|NCT01351025|3770528|B1|White non-Hispanic||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3948995|NCT01351025|3770526|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3948996|NCT01351025|3770527|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3948997|NCT01351025|3770528|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3948998|NCT01351025|3770526|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3948999|NCT01351025|3770527|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3949000|NCT01351025|3770528|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3949001|NCT01351025|3770526|B3|>=60 Years||Age, Customized||participants|Number|7|7.0||||||
3949002|NCT01351025|3770527|B2|>=60 Years||Age, Customized||participants|Number|3|3.0||||||
3949003|NCT01351025|3770528|B1|>=60 Years||Age, Customized||participants|Number|4|4.0||||||
3949004|NCT01351025|3770526|B3|50-59 Years||Age, Customized||participants|Number|35|35.0||||||
3949005|NCT01351025|3770527|B2|50-59 Years||Age, Customized||participants|Number|21|21.0||||||
3949006|NCT01351025|3770528|B1|50-59 Years||Age, Customized||participants|Number|14|14.0||||||
3949007|NCT01351025|3770526|B3|40-49 Years||Age, Customized||participants|Number|32|32.0||||||
3949008|NCT01351025|3770527|B2|40-49 Years||Age, Customized||participants|Number|16|16.0||||||
3949009|NCT01351025|3770528|B1|40-49 Years||Age, Customized||participants|Number|16|16.0||||||
3949010|NCT01351025|3770526|B3|30-39 Years||Age, Customized||participants|Number|15|15.0||||||
3949011|NCT01351025|3770527|B2|30-39 Years||Age, Customized||participants|Number|6|6.0||||||
3949012|NCT01351025|3770528|B1|30-39 Years||Age, Customized||participants|Number|9|9.0||||||
3949013|NCT01351025|3770526|B3|18-29 Years||Age, Customized||participants|Number|5|5.0||||||
3949014|NCT01351025|3770527|B2|18-29 Years||Age, Customized||participants|Number|2|2.0||||||
3949015|NCT01351025|3770528|B1|18-29 Years||Age, Customized||participants|Number|3|3.0||||||
3949016|NCT01351025|3770526|B3|||Age||years|Median|48|48.0|Inter-Quartile Range|||41.0|55.0|
3949017|NCT01351025|3770527|B2|||Age||years|Median|50|50.0|Inter-Quartile Range|||42.0|55.0|
3949018|NCT01351025|3770528|B1|||Age||years|Median|47|47.0|Inter-Quartile Range|||39.0|55.0|
3949019|NCT01350999|3770559|B4|||Low Density Lipoprotein - Cholesterol (LDL-C)||mg/dL|Mean|130.5|130.5|Standard Deviation|31.06|31.06|||
3949020|NCT01350999|3770560|B3|||Low Density Lipoprotein - Cholesterol (LDL-C)||mg/dL|Mean|129.3|129.3|Standard Deviation|33.00|33.0|||
3949021|NCT01350999|3770561|B2|||Low Density Lipoprotein - Cholesterol (LDL-C)||mg/dL|Mean|129.0|129.0|Standard Deviation|30.26|30.26|||
3949022|NCT01350999|3770562|B1|||Low Density Lipoprotein - Cholesterol (LDL-C)||mg/dL|Mean|133.2|133.2|Standard Deviation|29.85|29.85|||
3949023|NCT01350999|3770559|B4|≥140 mg/dL||Low Density Lipoprotein - Cholesterol (LDL-C), Categorical||participants|Number|184|184.0||||||
3949024|NCT01350999|3770560|B3|≥140 mg/dL||Low Density Lipoprotein - Cholesterol (LDL-C), Categorical||participants|Number|65|65.0||||||
3949025|NCT01350999|3770561|B2|≥140 mg/dL||Low Density Lipoprotein - Cholesterol (LDL-C), Categorical||participants|Number|55|55.0||||||
3949026|NCT01350999|3770562|B1|≥140 mg/dL||Low Density Lipoprotein - Cholesterol (LDL-C), Categorical||participants|Number|64|64.0||||||
3949027|NCT01350999|3770559|B4|<140 mg/dL||Low Density Lipoprotein - Cholesterol (LDL-C), Categorical||participants|Number|319|319.0||||||
3949028|NCT01350999|3770560|B3|<140 mg/dL||Low Density Lipoprotein - Cholesterol (LDL-C), Categorical||participants|Number|102|102.0||||||
3949029|NCT01350999|3770561|B2|<140 mg/dL||Low Density Lipoprotein - Cholesterol (LDL-C), Categorical||participants|Number|116|116.0||||||
3949030|NCT01350999|3770562|B1|<140 mg/dL||Low Density Lipoprotein - Cholesterol (LDL-C), Categorical||participants|Number|101|101.0||||||
3949031|NCT01350999|3770559|B4|||Triglycerides|The number of participants with available triglyceride data are 164, 169 and 167 in each treatment arm, respectively.|mg/dL|Mean|263.0|263.0|Standard Deviation|103.71|103.71|||
3949032|NCT01350999|3770560|B3|||Triglycerides|The number of participants with available triglyceride data are 164, 169 and 167 in each treatment arm, respectively.|mg/dL|Mean|264.2|264.2|Standard Deviation|111.62|111.62|||
3949033|NCT01350999|3770561|B2|||Triglycerides|The number of participants with available triglyceride data are 164, 169 and 167 in each treatment arm, respectively.|mg/dL|Mean|270.0|270.0|Standard Deviation|101.19|101.19|||
3949034|NCT01350999|3770562|B1|||Triglycerides|The number of participants with available triglyceride data are 164, 169 and 167 in each treatment arm, respectively.|mg/dL|Mean|254.7|254.7|Standard Deviation|97.80|97.8|||
3949035|NCT01350999|3770559|B4|≥500 mg/dL||Triglycerides, Categorical|The number of participants with available triglyceride data are 164, 169 and 167 in each treatment arm, respectively.|participants|Number|21|21.0||||||
3949036|NCT01350999|3770560|B3|≥500 mg/dL||Triglycerides, Categorical|The number of participants with available triglyceride data are 164, 169 and 167 in each treatment arm, respectively.|participants|Number|7|7.0||||||
3949037|NCT01350999|3770561|B2|≥500 mg/dL||Triglycerides, Categorical|The number of participants with available triglyceride data are 164, 169 and 167 in each treatment arm, respectively.|participants|Number|7|7.0||||||
3949038|NCT01350999|3770562|B1|≥500 mg/dL||Triglycerides, Categorical|The number of participants with available triglyceride data are 164, 169 and 167 in each treatment arm, respectively.|participants|Number|7|7.0||||||
3949039|NCT01350999|3770559|B4|≥300 - <500 mg/dL||Triglycerides, Categorical|The number of participants with available triglyceride data are 164, 169 and 167 in each treatment arm, respectively.|participants|Number|118|118.0||||||
3949040|NCT01350999|3770560|B3|≥300 - <500 mg/dL||Triglycerides, Categorical|The number of participants with available triglyceride data are 164, 169 and 167 in each treatment arm, respectively.|participants|Number|37|37.0||||||
3949041|NCT01350999|3770561|B2|≥300 - <500 mg/dL||Triglycerides, Categorical|The number of participants with available triglyceride data are 164, 169 and 167 in each treatment arm, respectively.|participants|Number|43|43.0||||||
3949042|NCT01350999|3770562|B1|≥300 - <500 mg/dL||Triglycerides, Categorical|The number of participants with available triglyceride data are 164, 169 and 167 in each treatment arm, respectively.|participants|Number|38|38.0||||||
3949043|NCT01350999|3770559|B4|≥150 - <300 mg/dL||Triglycerides, Categorical|The number of participants with available triglyceride data are 164, 169 and 167 in each treatment arm, respectively.|participants|Number|319|319.0||||||
3949044|NCT01350999|3770560|B3|≥150 - <300 mg/dL||Triglycerides, Categorical|The number of participants with available triglyceride data are 164, 169 and 167 in each treatment arm, respectively.|participants|Number|109|109.0||||||
3949045|NCT01350999|3770561|B2|≥150 - <300 mg/dL||Triglycerides, Categorical|The number of participants with available triglyceride data are 164, 169 and 167 in each treatment arm, respectively.|participants|Number|107|107.0||||||
3949046|NCT01350999|3770562|B1|≥150 - <300 mg/dL||Triglycerides, Categorical|The number of participants with available triglyceride data are 164, 169 and 167 in each treatment arm, respectively.|participants|Number|103|103.0||||||
3949047|NCT01350999|3770559|B4|<150 mg/dL||Triglycerides, Categorical|The number of participants with available triglyceride data are 164, 169 and 167 in each treatment arm, respectively.|participants|Number|42|42.0||||||
3949048|NCT01350999|3770560|B3|<150 mg/dL||Triglycerides, Categorical|The number of participants with available triglyceride data are 164, 169 and 167 in each treatment arm, respectively.|participants|Number|14|14.0||||||
3949049|NCT01350999|3770561|B2|<150 mg/dL||Triglycerides, Categorical|The number of participants with available triglyceride data are 164, 169 and 167 in each treatment arm, respectively.|participants|Number|12|12.0||||||
3949050|NCT01350999|3770562|B1|<150 mg/dL||Triglycerides, Categorical|The number of participants with available triglyceride data are 164, 169 and 167 in each treatment arm, respectively.|participants|Number|16|16.0||||||
3949051|NCT01350999|3770559|B4|No||Administration of 3-hydroxy 3-methylglutaryl coenzyme A (HMGCoA) Reductase Inhibitor||participants|Number|308|308.0||||||
3949052|NCT01350999|3770560|B3|No||Administration of 3-hydroxy 3-methylglutaryl coenzyme A (HMGCoA) Reductase Inhibitor||participants|Number|102|102.0||||||
3949053|NCT01350999|3770561|B2|No||Administration of 3-hydroxy 3-methylglutaryl coenzyme A (HMGCoA) Reductase Inhibitor||participants|Number|105|105.0||||||
3949054|NCT01350999|3770562|B1|No||Administration of 3-hydroxy 3-methylglutaryl coenzyme A (HMGCoA) Reductase Inhibitor||participants|Number|101|101.0||||||
3949055|NCT01350999|3770559|B4|Yes||Administration of 3-hydroxy 3-methylglutaryl coenzyme A (HMGCoA) Reductase Inhibitor||participants|Number|195|195.0||||||
3949056|NCT01350999|3770560|B3|Yes||Administration of 3-hydroxy 3-methylglutaryl coenzyme A (HMGCoA) Reductase Inhibitor||participants|Number|65|65.0||||||
3949057|NCT01350999|3770561|B2|Yes||Administration of 3-hydroxy 3-methylglutaryl coenzyme A (HMGCoA) Reductase Inhibitor||participants|Number|66|66.0||||||
3949058|NCT01350999|3770562|B1|Yes||Administration of 3-hydroxy 3-methylglutaryl coenzyme A (HMGCoA) Reductase Inhibitor||participants|Number|64|64.0||||||
3949124|NCT01350999|3770560|B3|Current Smoker||Smoking Classification||participants|Number|58|58.0||||||
3949059|NCT01350999|3770559|B4|No||Low High Density Lipoprotein - Cholesterol (HDL-C)||participants|Number|377|377.0||||||
3949060|NCT01350999|3770560|B3|No||Low High Density Lipoprotein - Cholesterol (HDL-C)||participants|Number|122|122.0||||||
3949061|NCT01350999|3770561|B2|No||Low High Density Lipoprotein - Cholesterol (HDL-C)||participants|Number|132|132.0||||||
3949062|NCT01350999|3770562|B1|No||Low High Density Lipoprotein - Cholesterol (HDL-C)||participants|Number|123|123.0||||||
3949063|NCT01350999|3770559|B4|Yes||Low High Density Lipoprotein - Cholesterol (HDL-C)||participants|Number|126|126.0||||||
3949064|NCT01350999|3770560|B3|Yes||Low High Density Lipoprotein - Cholesterol (HDL-C)||participants|Number|45|45.0||||||
3949065|NCT01350999|3770561|B2|Yes||Low High Density Lipoprotein - Cholesterol (HDL-C)||participants|Number|39|39.0||||||
3949066|NCT01350999|3770562|B1|Yes||Low High Density Lipoprotein - Cholesterol (HDL-C)||participants|Number|42|42.0||||||
3949067|NCT01350999|3770559|B4|No||Diabetes Mellitus (Including Impaired Glucose Tolerance)||participants|Number|319|319.0||||||
3949068|NCT01350999|3770560|B3|No||Diabetes Mellitus (Including Impaired Glucose Tolerance)||participants|Number|96|96.0||||||
3949069|NCT01350999|3770561|B2|No||Diabetes Mellitus (Including Impaired Glucose Tolerance)||participants|Number|108|108.0||||||
3949070|NCT01350999|3770562|B1|No||Diabetes Mellitus (Including Impaired Glucose Tolerance)||participants|Number|115|115.0||||||
3949071|NCT01350999|3770559|B4|Yes||Diabetes Mellitus (Including Impaired Glucose Tolerance)||participants|Number|184|184.0||||||
3949072|NCT01350999|3770560|B3|Yes||Diabetes Mellitus (Including Impaired Glucose Tolerance)||participants|Number|71|71.0||||||
3949073|NCT01350999|3770561|B2|Yes||Diabetes Mellitus (Including Impaired Glucose Tolerance)||participants|Number|63|63.0||||||
3949074|NCT01350999|3770562|B1|Yes||Diabetes Mellitus (Including Impaired Glucose Tolerance)||participants|Number|50|50.0||||||
3949075|NCT01350999|3770559|B4|No||Hypertension||participants|Number|163|163.0||||||
3949076|NCT01350999|3770560|B3|No||Hypertension||participants|Number|52|52.0||||||
3949077|NCT01350999|3770561|B2|No||Hypertension||participants|Number|56|56.0||||||
3949078|NCT01350999|3770562|B1|No||Hypertension||participants|Number|55|55.0||||||
3949079|NCT01350999|3770559|B4|Yes||Hypertension||participants|Number|340|340.0||||||
3949080|NCT01350999|3770560|B3|Yes||Hypertension||participants|Number|115|115.0||||||
3949081|NCT01350999|3770561|B2|Yes||Hypertension||participants|Number|115|115.0||||||
3949082|NCT01350999|3770562|B1|Yes||Hypertension||participants|Number|110|110.0||||||
3949083|NCT01350999|3770559|B4|History of CAD||Coronary Artery Disease (CAD) Category|CAD Patient Categories define the degree of risk of CAD according to Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases. Categories are classified by the degree of risks in the patient [e.g, smoking, hypertension, excluding level of low density lipoprotein cholesterol (LDL-C)]. Category I=Low risk (best), Category II=Middle risk, Category III=High Risk and History of CAD.|participants|Number|13|13.0||||||
3949084|NCT01350999|3770560|B3|History of CAD||Coronary Artery Disease (CAD) Category|CAD Patient Categories define the degree of risk of CAD according to Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases. Categories are classified by the degree of risks in the patient [e.g, smoking, hypertension, excluding level of low density lipoprotein cholesterol (LDL-C)]. Category I=Low risk (best), Category II=Middle risk, Category III=High Risk and History of CAD.|participants|Number|6|6.0||||||
3949085|NCT01350999|3770561|B2|History of CAD||Coronary Artery Disease (CAD) Category|CAD Patient Categories define the degree of risk of CAD according to Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases. Categories are classified by the degree of risks in the patient [e.g, smoking, hypertension, excluding level of low density lipoprotein cholesterol (LDL-C)]. Category I=Low risk (best), Category II=Middle risk, Category III=High Risk and History of CAD.|participants|Number|5|5.0||||||
3949086|NCT01350999|3770562|B1|History of CAD||Coronary Artery Disease (CAD) Category|CAD Patient Categories define the degree of risk of CAD according to Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases. Categories are classified by the degree of risks in the patient [e.g, smoking, hypertension, excluding level of low density lipoprotein cholesterol (LDL-C)]. Category I=Low risk (best), Category II=Middle risk, Category III=High Risk and History of CAD.|participants|Number|2|2.0||||||
3949087|NCT01350999|3770559|B4|Category III||Coronary Artery Disease (CAD) Category|CAD Patient Categories define the degree of risk of CAD according to Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases. Categories are classified by the degree of risks in the patient [e.g, smoking, hypertension, excluding level of low density lipoprotein cholesterol (LDL-C)]. Category I=Low risk (best), Category II=Middle risk, Category III=High Risk and History of CAD.|participants|Number|274|274.0||||||
3949088|NCT01350999|3770560|B3|Category III||Coronary Artery Disease (CAD) Category|CAD Patient Categories define the degree of risk of CAD according to Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases. Categories are classified by the degree of risks in the patient [e.g, smoking, hypertension, excluding level of low density lipoprotein cholesterol (LDL-C)]. Category I=Low risk (best), Category II=Middle risk, Category III=High Risk and History of CAD.|participants|Number|102|102.0||||||
3949089|NCT01350999|3770561|B2|Category III||Coronary Artery Disease (CAD) Category|CAD Patient Categories define the degree of risk of CAD according to Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases. Categories are classified by the degree of risks in the patient [e.g, smoking, hypertension, excluding level of low density lipoprotein cholesterol (LDL-C)]. Category I=Low risk (best), Category II=Middle risk, Category III=High Risk and History of CAD.|participants|Number|86|86.0||||||
3949090|NCT01350999|3770562|B1|Category III||Coronary Artery Disease (CAD) Category|CAD Patient Categories define the degree of risk of CAD according to Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases. Categories are classified by the degree of risks in the patient [e.g, smoking, hypertension, excluding level of low density lipoprotein cholesterol (LDL-C)]. Category I=Low risk (best), Category II=Middle risk, Category III=High Risk and History of CAD.|participants|Number|86|86.0||||||
3949125|NCT01350999|3770561|B2|Current Smoker||Smoking Classification||participants|Number|47|47.0||||||
3949091|NCT01350999|3770559|B4|Category II||Coronary Artery Disease (CAD) Category|CAD Patient Categories define the degree of risk of CAD according to Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases. Categories are classified by the degree of risks in the patient [e.g, smoking, hypertension, excluding level of low density lipoprotein cholesterol (LDL-C)]. Category I=Low risk (best), Category II=Middle risk, Category III=High Risk and History of CAD.|participants|Number|197|197.0||||||
3949092|NCT01350999|3770560|B3|Category II||Coronary Artery Disease (CAD) Category|CAD Patient Categories define the degree of risk of CAD according to Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases. Categories are classified by the degree of risks in the patient [e.g, smoking, hypertension, excluding level of low density lipoprotein cholesterol (LDL-C)]. Category I=Low risk (best), Category II=Middle risk, Category III=High Risk and History of CAD.|participants|Number|56|56.0||||||
3949093|NCT01350999|3770561|B2|Category II||Coronary Artery Disease (CAD) Category|CAD Patient Categories define the degree of risk of CAD according to Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases. Categories are classified by the degree of risks in the patient [e.g, smoking, hypertension, excluding level of low density lipoprotein cholesterol (LDL-C)]. Category I=Low risk (best), Category II=Middle risk, Category III=High Risk and History of CAD.|participants|Number|71|71.0||||||
3949094|NCT01350999|3770562|B1|Category II||Coronary Artery Disease (CAD) Category|CAD Patient Categories define the degree of risk of CAD according to Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases. Categories are classified by the degree of risks in the patient [e.g, smoking, hypertension, excluding level of low density lipoprotein cholesterol (LDL-C)]. Category I=Low risk (best), Category II=Middle risk, Category III=High Risk and History of CAD.|participants|Number|70|70.0||||||
3949095|NCT01350999|3770559|B4|Category I||Coronary Artery Disease (CAD) Category|CAD Patient Categories define the degree of risk of CAD according to Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases. Categories are classified by the degree of risks in the patient [e.g, smoking, hypertension, excluding level of low density lipoprotein cholesterol (LDL-C)]. Category I=Low risk (best), Category II=Middle risk, Category III=High Risk and History of CAD.|participants|Number|19|19.0||||||
3949096|NCT01350999|3770560|B3|Category I||Coronary Artery Disease (CAD) Category|CAD Patient Categories define the degree of risk of CAD according to Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases. Categories are classified by the degree of risks in the patient [e.g, smoking, hypertension, excluding level of low density lipoprotein cholesterol (LDL-C)]. Category I=Low risk (best), Category II=Middle risk, Category III=High Risk and History of CAD.|participants|Number|3|3.0||||||
3949097|NCT01350999|3770561|B2|Category I||Coronary Artery Disease (CAD) Category|CAD Patient Categories define the degree of risk of CAD according to Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases. Categories are classified by the degree of risks in the patient [e.g, smoking, hypertension, excluding level of low density lipoprotein cholesterol (LDL-C)]. Category I=Low risk (best), Category II=Middle risk, Category III=High Risk and History of CAD.|participants|Number|9|9.0||||||
3949098|NCT01350999|3770562|B1|Category I||Coronary Artery Disease (CAD) Category|CAD Patient Categories define the degree of risk of CAD according to Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases. Categories are classified by the degree of risks in the patient [e.g, smoking, hypertension, excluding level of low density lipoprotein cholesterol (LDL-C)]. Category I=Low risk (best), Category II=Middle risk, Category III=High Risk and History of CAD.|participants|Number|7|7.0||||||
3949099|NCT01350999|3770559|B4|||Waist Circumference||cm|Mean|90.77|90.77|Standard Deviation|9.015|9.015|||
3949100|NCT01350999|3770560|B3|||Waist Circumference||cm|Mean|91.16|91.16|Standard Deviation|9.284|9.284|||
3949101|NCT01350999|3770561|B2|||Waist Circumference||cm|Mean|90.75|90.75|Standard Deviation|9.169|9.169|||
3949102|NCT01350999|3770562|B1|||Waist Circumference||cm|Mean|90.39|90.39|Standard Deviation|8.607|8.607|||
3949103|NCT01350999|3770559|B4|Female ≥90.0 cm||Waist Circumference, Categorical||participants|Number|63|63.0||||||
3949104|NCT01350999|3770560|B3|Female ≥90.0 cm||Waist Circumference, Categorical||participants|Number|22|22.0||||||
3949105|NCT01350999|3770561|B2|Female ≥90.0 cm||Waist Circumference, Categorical||participants|Number|20|20.0||||||
3949106|NCT01350999|3770562|B1|Female ≥90.0 cm||Waist Circumference, Categorical||participants|Number|21|21.0||||||
3949107|NCT01350999|3770559|B4|Female <90.0 cm||Waist Circumference, Categorical||participants|Number|82|82.0||||||
3949108|NCT01350999|3770560|B3|Female <90.0 cm||Waist Circumference, Categorical||participants|Number|26|26.0||||||
3949109|NCT01350999|3770561|B2|Female <90.0 cm||Waist Circumference, Categorical||participants|Number|30|30.0||||||
3949110|NCT01350999|3770562|B1|Female <90.0 cm||Waist Circumference, Categorical||participants|Number|26|26.0||||||
3949111|NCT01350999|3770559|B4|Male ≥85.0 cm||Waist Circumference, Categorical||participants|Number|288|288.0||||||
3949112|NCT01350999|3770560|B3|Male ≥85.0 cm||Waist Circumference, Categorical||participants|Number|100|100.0||||||
3949113|NCT01350999|3770561|B2|Male ≥85.0 cm||Waist Circumference, Categorical||participants|Number|92|92.0||||||
3949114|NCT01350999|3770562|B1|Male ≥85.0 cm||Waist Circumference, Categorical||participants|Number|96|96.0||||||
3949115|NCT01350999|3770559|B4|Male <85.0 cm||Waist Circumference, Categorical||participants|Number|70|70.0||||||
3949116|NCT01350999|3770560|B3|Male <85.0 cm||Waist Circumference, Categorical||participants|Number|19|19.0||||||
3949117|NCT01350999|3770561|B2|Male <85.0 cm||Waist Circumference, Categorical||participants|Number|29|29.0||||||
3949118|NCT01350999|3770562|B1|Male <85.0 cm||Waist Circumference, Categorical||participants|Number|22|22.0||||||
3949119|NCT01350999|3770559|B4|Ex-Smoker||Smoking Classification||participants|Number|184|184.0||||||
3949120|NCT01350999|3770560|B3|Ex-Smoker||Smoking Classification||participants|Number|62|62.0||||||
3949121|NCT01350999|3770561|B2|Ex-Smoker||Smoking Classification||participants|Number|68|68.0||||||
3949122|NCT01350999|3770562|B1|Ex-Smoker||Smoking Classification||participants|Number|54|54.0||||||
3949123|NCT01350999|3770559|B4|Current Smoker||Smoking Classification||participants|Number|157|157.0||||||
3949126|NCT01350999|3770562|B1|Current Smoker||Smoking Classification||participants|Number|52|52.0||||||
3949127|NCT01350999|3770559|B4|Never Smoked||Smoking Classification||participants|Number|162|162.0||||||
3949128|NCT01350999|3770560|B3|Never Smoked||Smoking Classification||participants|Number|47|47.0||||||
3949129|NCT01350999|3770561|B2|Never Smoked||Smoking Classification||participants|Number|56|56.0||||||
3949130|NCT01350999|3770562|B1|Never Smoked||Smoking Classification||participants|Number|59|59.0||||||
3949131|NCT01350999|3770559|B4|||Body Mass Index||kg/m^2|Mean|26.12|26.12|Standard Deviation|3.500|3.5|||
3949132|NCT01350999|3770560|B3|||Body Mass Index||kg/m^2|Mean|26.33|26.33|Standard Deviation|3.301|3.301|||
3949133|NCT01350999|3770561|B2|||Body Mass Index||kg/m^2|Mean|26.11|26.11|Standard Deviation|3.526|3.526|||
3949134|NCT01350999|3770562|B1|||Body Mass Index||kg/m^2|Mean|25.90|25.9|Standard Deviation|3.673|3.673|||
3949135|NCT01350999|3770559|B4|≥30.0 kg/m^2||Body Mass Index, Categorical||participants|Number|66|66.0||||||
3949136|NCT01350999|3770560|B3|≥30.0 kg/m^2||Body Mass Index, Categorical||participants|Number|24|24.0||||||
3949137|NCT01350999|3770561|B2|≥30.0 kg/m^2||Body Mass Index, Categorical||participants|Number|25|25.0||||||
3949138|NCT01350999|3770562|B1|≥30.0 kg/m^2||Body Mass Index, Categorical||participants|Number|17|17.0||||||
3949139|NCT01350999|3770559|B4|≥25.0 - <30.0 kg/m^2||Body Mass Index, Categorical||participants|Number|228|228.0||||||
3949140|NCT01350999|3770560|B3|≥25.0 - <30.0 kg/m^2||Body Mass Index, Categorical||participants|Number|83|83.0||||||
3949141|NCT01350999|3770561|B2|≥25.0 - <30.0 kg/m^2||Body Mass Index, Categorical||participants|Number|74|74.0||||||
3949142|NCT01350999|3770562|B1|≥25.0 - <30.0 kg/m^2||Body Mass Index, Categorical||participants|Number|71|71.0||||||
3949143|NCT01350999|3770559|B4|<25.0 kg/m^2||Body Mass Index, Categorical||participants|Number|209|209.0||||||
3949144|NCT01350999|3770560|B3|<25.0 kg/m^2||Body Mass Index, Categorical||participants|Number|60|60.0||||||
3949145|NCT01350999|3770561|B2|<25.0 kg/m^2||Body Mass Index, Categorical||participants|Number|72|72.0||||||
3949146|NCT01350999|3770562|B1|<25.0 kg/m^2||Body Mass Index, Categorical||participants|Number|77|77.0||||||
3949147|NCT01350999|3770559|B4|||Weight||kg|Mean|70.70|70.7|Standard Deviation|12.568|12.568|||
3949148|NCT01350999|3770560|B3|||Weight||kg|Mean|71.61|71.61|Standard Deviation|13.311|13.311|||
3949149|NCT01350999|3770561|B2|||Weight||kg|Mean|70.46|70.46|Standard Deviation|12.097|12.097|||
3949150|NCT01350999|3770562|B1|||Weight||kg|Mean|70.02|70.02|Standard Deviation|12.291|12.291|||
3949151|NCT01350999|3770559|B4|≥80.0 kg||Weight, Categorical||participants|Number|101|101.0||||||
3949152|NCT01350999|3770560|B3|≥80.0 kg||Weight, Categorical||participants|Number|35|35.0||||||
3949153|NCT01350999|3770561|B2|≥80.0 kg||Weight, Categorical||participants|Number|34|34.0||||||
3949154|NCT01350999|3770562|B1|≥80.0 kg||Weight, Categorical||participants|Number|32|32.0||||||
3949155|NCT01350999|3770559|B4|≥70.0 - <80.0 kg||Weight, Categorical||participants|Number|151|151.0||||||
3949156|NCT01350999|3770560|B3|≥70.0 - <80.0 kg||Weight, Categorical||participants|Number|57|57.0||||||
3949157|NCT01350999|3770561|B2|≥70.0 - <80.0 kg||Weight, Categorical||participants|Number|50|50.0||||||
3949158|NCT01350999|3770562|B1|≥70.0 - <80.0 kg||Weight, Categorical||participants|Number|44|44.0||||||
3949159|NCT01350999|3770559|B4|≥60.0 - <70.0 kg||Weight, Categorical||participants|Number|153|153.0||||||
3949160|NCT01350999|3770560|B3|≥60.0 - <70.0 kg||Weight, Categorical||participants|Number|43|43.0||||||
3949161|NCT01350999|3770561|B2|≥60.0 - <70.0 kg||Weight, Categorical||participants|Number|53|53.0||||||
3949162|NCT01350999|3770562|B1|≥60.0 - <70.0 kg||Weight, Categorical||participants|Number|57|57.0||||||
3949163|NCT01350999|3770559|B4|<60 kg||Weight, Categorical||participants|Number|98|98.0||||||
3949164|NCT01350999|3770560|B3|<60 kg||Weight, Categorical||participants|Number|32|32.0||||||
3949165|NCT01350999|3770561|B2|<60 kg||Weight, Categorical||participants|Number|34|34.0||||||
3949166|NCT01350999|3770562|B1|<60 kg||Weight, Categorical||participants|Number|32|32.0||||||
3949167|NCT01350999|3770559|B4|||Height||cm|Mean|164.2|164.2|Standard Deviation|9.23|9.23|||
3949168|NCT01350999|3770560|B3|||Height||cm|Mean|164.4|164.4|Standard Deviation|9.65|9.65|||
3949169|NCT01350999|3770561|B2|||Height||cm|Mean|164.0|164.0|Standard Deviation|8.69|8.69|||
3949170|NCT01350999|3770562|B1|||Height||cm|Mean|164.2|164.2|Standard Deviation|9.40|9.4|||
3949171|NCT01350999|3770559|B4|≥170 cm||Height, Categorical||participants|Number|152|152.0||||||
3949172|NCT01350999|3770560|B3|≥170 cm||Height, Categorical||participants|Number|53|53.0||||||
3949173|NCT01350999|3770561|B2|≥170 cm||Height, Categorical||participants|Number|49|49.0||||||
3949174|NCT01350999|3770562|B1|≥170 cm||Height, Categorical||participants|Number|50|50.0||||||
3949175|NCT01350999|3770559|B4|≥160 - <170 cm||Height, Categorical||participants|Number|210|210.0||||||
3949176|NCT01350999|3770560|B3|≥160 - <170 cm||Height, Categorical||participants|Number|66|66.0||||||
3949177|NCT01350999|3770561|B2|≥160 - <170 cm||Height, Categorical||participants|Number|77|77.0||||||
3949178|NCT01350999|3770562|B1|≥160 - <170 cm||Height, Categorical||participants|Number|67|67.0||||||
3949179|NCT01350999|3770559|B4|<160 cm||Height, Categorical||participants|Number|141|141.0||||||
3949180|NCT01350999|3770560|B3|<160 cm||Height, Categorical||participants|Number|48|48.0||||||
3949181|NCT01350999|3770561|B2|<160 cm||Height, Categorical||participants|Number|45|45.0||||||
3949182|NCT01350999|3770562|B1|<160 cm||Height, Categorical||participants|Number|48|48.0||||||
3949183|NCT01350999|3770559|B4|Not Applicable||Menopause Status||participants|Number|358|358.0||||||
3949184|NCT01350999|3770560|B3|Not Applicable||Menopause Status||participants|Number|119|119.0||||||
3949185|NCT01350999|3770561|B2|Not Applicable||Menopause Status||participants|Number|121|121.0||||||
3949186|NCT01350999|3770562|B1|Not Applicable||Menopause Status||participants|Number|118|118.0||||||
3949187|NCT01350999|3770559|B4|Unknown||Menopause Status||participants|Number|9|9.0||||||
3949188|NCT01350999|3770560|B3|Unknown||Menopause Status||participants|Number|4|4.0||||||
3949189|NCT01350999|3770561|B2|Unknown||Menopause Status||participants|Number|1|1.0||||||
3949190|NCT01350999|3770562|B1|Unknown||Menopause Status||participants|Number|4|4.0||||||
3949191|NCT01350999|3770559|B4|No||Menopause Status||participants|Number|17|17.0||||||
3949192|NCT01350999|3770560|B3|No||Menopause Status||participants|Number|5|5.0||||||
3949193|NCT01350999|3770561|B2|No||Menopause Status||participants|Number|7|7.0||||||
3949194|NCT01350999|3770562|B1|No||Menopause Status||participants|Number|5|5.0||||||
3949195|NCT01350999|3770559|B4|Yes||Menopause Status||participants|Number|119|119.0||||||
3949196|NCT01350999|3770560|B3|Yes||Menopause Status||participants|Number|39|39.0||||||
3949197|NCT01350999|3770561|B2|Yes||Menopause Status||participants|Number|42|42.0||||||
3949198|NCT01350999|3770562|B1|Yes||Menopause Status||participants|Number|38|38.0||||||
3949199|NCT01350999|3770559|B4|Japan||Region of Enrollment||participants|Number|503|503.0||||||
3949200|NCT01350999|3770560|B3|Japan||Region of Enrollment||participants|Number|167|167.0||||||
3949201|NCT01350999|3770561|B2|Japan||Region of Enrollment||participants|Number|171|171.0||||||
3949202|NCT01350999|3770562|B1|Japan||Region of Enrollment||participants|Number|165|165.0||||||
3949203|NCT01350999|3770559|B4||Male|Sex: Female, Male||Participants|Count of Participants|358|358.0||||||
3949204|NCT01350999|3770560|B3||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3949205|NCT01350999|3770561|B2||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3949206|NCT01350999|3770562|B1||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3949207|NCT01350999|3770559|B4||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3949208|NCT01350999|3770560|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3949209|NCT01350999|3770561|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3949210|NCT01350999|3770562|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3949211|NCT01350999|3770559|B4|≥65 - ≤74 years||Age, Customized||participants|Number|114|114.0||||||
3949212|NCT01350999|3770560|B3|≥65 - ≤74 years||Age, Customized||participants|Number|31|31.0||||||
3949213|NCT01350999|3770561|B2|≥65 - ≤74 years||Age, Customized||participants|Number|37|37.0||||||
3949214|NCT01350999|3770562|B1|≥65 - ≤74 years||Age, Customized||participants|Number|46|46.0||||||
3949215|NCT01350999|3770559|B4|≥20 - <65 years||Age, Customized||participants|Number|389|389.0||||||
3949216|NCT01350999|3770560|B3|≥20 - <65 years||Age, Customized||participants|Number|136|136.0||||||
3949217|NCT01350999|3770561|B2|≥20 - <65 years||Age, Customized||participants|Number|134|134.0||||||
3949218|NCT01350999|3770562|B1|≥20 - <65 years||Age, Customized||participants|Number|119|119.0||||||
3949219|NCT01350999|3770559|B4|||Age||years|Mean|55.9|55.9|Standard Deviation|10.11|10.11|||
3949220|NCT01350999|3770560|B3|||Age||years|Mean|55.8|55.8|Standard Deviation|9.27|9.27|||
3949221|NCT01350999|3770561|B2|||Age||years|Mean|55.9|55.9|Standard Deviation|10.12|10.12|||
3949222|NCT01350999|3770562|B1|||Age||years|Mean|56.0|56.0|Standard Deviation|10.95|10.95|||
3949223|NCT01350973|3770599|B4|||Low Density Lipoprotein - Cholesterol (LDL-C)|The number of participants with available LDL-C data are 205, 210 and 195 in each treatment arm, respectively.|mg/dL|Mean|127.7|127.7|Standard Deviation|29.37|29.37|||
3949224|NCT01350973|3770600|B3|||Low Density Lipoprotein - Cholesterol (LDL-C)|The number of participants with available LDL-C data are 205, 210 and 195 in each treatment arm, respectively.|mg/dL|Mean|130.1|130.1|Standard Deviation|30.54|30.54|||
3949225|NCT01350973|3770601|B2|||Low Density Lipoprotein - Cholesterol (LDL-C)|The number of participants with available LDL-C data are 205, 210 and 195 in each treatment arm, respectively.|mg/dL|Mean|125.7|125.7|Standard Deviation|28.50|28.5|||
3949226|NCT01350973|3770602|B1|||Low Density Lipoprotein - Cholesterol (LDL-C)|The number of participants with available LDL-C data are 205, 210 and 195 in each treatment arm, respectively.|mg/dL|Mean|127.4|127.4|Standard Deviation|29.08|29.08|||
3949227|NCT01350973|3770599|B4|≥140 mg/dL||Low Density Lipoprotein - Cholesterol (LDL-C), Categorical|The number of participants with available LDL-C data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|197|197.0||||||
3949228|NCT01350973|3770600|B3|≥140 mg/dL||Low Density Lipoprotein - Cholesterol (LDL-C), Categorical|The number of participants with available LDL-C data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|71|71.0||||||
3949229|NCT01350973|3770601|B2|≥140 mg/dL||Low Density Lipoprotein - Cholesterol (LDL-C), Categorical|The number of participants with available LDL-C data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|61|61.0||||||
3949230|NCT01350973|3770602|B1|≥140 mg/dL||Low Density Lipoprotein - Cholesterol (LDL-C), Categorical|The number of participants with available LDL-C data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|65|65.0||||||
3949231|NCT01350973|3770599|B4|<140 mg/dL||Low Density Lipoprotein - Cholesterol (LDL-C), Categorical|The number of participants with available LDL-C data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|413|413.0||||||
3949232|NCT01350973|3770600|B3|<140 mg/dL||Low Density Lipoprotein - Cholesterol (LDL-C), Categorical|The number of participants with available LDL-C data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|124|124.0||||||
3949233|NCT01350973|3770601|B2|<140 mg/dL||Low Density Lipoprotein - Cholesterol (LDL-C), Categorical|The number of participants with available LDL-C data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|149|149.0||||||
3949234|NCT01350973|3770602|B1|<140 mg/dL||Low Density Lipoprotein - Cholesterol (LDL-C), Categorical|The number of participants with available LDL-C data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|140|140.0||||||
3949235|NCT01350973|3770599|B4|||Triglycerides|The number of participants with available triglyceride data are 205, 210 and 195 in each treatment arm, respectively.|mg/dL|Mean|272.8|272.8|Standard Deviation|89.12|89.12|||
3949275|NCT01350973|3770599|B4|Yes||Diabetes Mellitus (Including Impaired Glucose Tolerance)||participants|Number|199|199.0||||||
3949236|NCT01350973|3770600|B3|||Triglycerides|The number of participants with available triglyceride data are 205, 210 and 195 in each treatment arm, respectively.|mg/dL|Mean|271.8|271.8|Standard Deviation|91.53|91.53|||
3949237|NCT01350973|3770601|B2|||Triglycerides|The number of participants with available triglyceride data are 205, 210 and 195 in each treatment arm, respectively.|mg/dL|Mean|277.5|277.5|Standard Deviation|97.29|97.29|||
3949238|NCT01350973|3770602|B1|||Triglycerides|The number of participants with available triglyceride data are 205, 210 and 195 in each treatment arm, respectively.|mg/dL|Mean|269.0|269.0|Standard Deviation|77.52|77.52|||
3949239|NCT01350973|3770599|B4|≥500 mg/dL||Triglycerides, Categorical|The number of participants with available triglyceride data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|18|18.0||||||
3949240|NCT01350973|3770600|B3|≥500 mg/dL||Triglycerides, Categorical|The number of participants with available triglyceride data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|8|8.0||||||
3949241|NCT01350973|3770601|B2|≥500 mg/dL||Triglycerides, Categorical|The number of participants with available triglyceride data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|7|7.0||||||
3949242|NCT01350973|3770602|B1|≥500 mg/dL||Triglycerides, Categorical|The number of participants with available triglyceride data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|3|3.0||||||
3949243|NCT01350973|3770599|B4|≥300 - <500 mg/dL||Triglycerides, Categorical|The number of participants with available triglyceride data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|167|167.0||||||
3949244|NCT01350973|3770600|B3|≥300 - <500 mg/dL||Triglycerides, Categorical|The number of participants with available triglyceride data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|51|51.0||||||
3949245|NCT01350973|3770601|B2|≥300 - <500 mg/dL||Triglycerides, Categorical|The number of participants with available triglyceride data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|57|57.0||||||
3949246|NCT01350973|3770602|B1|≥300 - <500 mg/dL||Triglycerides, Categorical|The number of participants with available triglyceride data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|59|59.0||||||
3949247|NCT01350973|3770599|B4|≥150 - <300 mg/dL||Triglycerides, Categorical|The number of participants with available triglyceride data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|424|424.0||||||
3949248|NCT01350973|3770600|B3|≥150 - <300 mg/dL||Triglycerides, Categorical|The number of participants with available triglyceride data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|135|135.0||||||
3949249|NCT01350973|3770601|B2|≥150 - <300 mg/dL||Triglycerides, Categorical|The number of participants with available triglyceride data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|146|146.0||||||
3949250|NCT01350973|3770602|B1|≥150 - <300 mg/dL||Triglycerides, Categorical|The number of participants with available triglyceride data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|143|143.0||||||
3949251|NCT01350973|3770599|B4|<150 mg/dL||Triglycerides, Categorical|The number of participants with available triglyceride data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|1|1.0||||||
3949252|NCT01350973|3770600|B3|<150 mg/dL||Triglycerides, Categorical|The number of participants with available triglyceride data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|1|1.0||||||
3949253|NCT01350973|3770601|B2|<150 mg/dL||Triglycerides, Categorical|The number of participants with available triglyceride data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|0|0.0||||||
3949254|NCT01350973|3770602|B1|<150 mg/dL||Triglycerides, Categorical|The number of participants with available triglyceride data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|0|0.0||||||
3949255|NCT01350973|3770599|B4|No||Administration of 3-hydroxy 3-methylglutaryl coenzyme A (HMGCoA) Reductase Inhibitor||participants|Number|350|350.0||||||
3949256|NCT01350973|3770600|B3|No||Administration of 3-hydroxy 3-methylglutaryl coenzyme A (HMGCoA) Reductase Inhibitor||participants|Number|112|112.0||||||
3949257|NCT01350973|3770601|B2|No||Administration of 3-hydroxy 3-methylglutaryl coenzyme A (HMGCoA) Reductase Inhibitor||participants|Number|121|121.0||||||
3949258|NCT01350973|3770602|B1|No||Administration of 3-hydroxy 3-methylglutaryl coenzyme A (HMGCoA) Reductase Inhibitor||participants|Number|117|117.0||||||
3949259|NCT01350973|3770599|B4|Yes||Administration of 3-hydroxy 3-methylglutaryl coenzyme A (HMGCoA) Reductase Inhibitor||participants|Number|261|261.0||||||
3949260|NCT01350973|3770600|B3|Yes||Administration of 3-hydroxy 3-methylglutaryl coenzyme A (HMGCoA) Reductase Inhibitor||participants|Number|83|83.0||||||
3949261|NCT01350973|3770601|B2|Yes||Administration of 3-hydroxy 3-methylglutaryl coenzyme A (HMGCoA) Reductase Inhibitor||participants|Number|89|89.0||||||
3949262|NCT01350973|3770602|B1|Yes||Administration of 3-hydroxy 3-methylglutaryl coenzyme A (HMGCoA) Reductase Inhibitor||participants|Number|89|89.0||||||
3949263|NCT01350973|3770599|B4|No||Low High Density Lipoprotein - Cholesterol (HDL-C)||participants|Number|437|437.0||||||
3949264|NCT01350973|3770600|B3|No||Low High Density Lipoprotein - Cholesterol (HDL-C)||participants|Number|135|135.0||||||
3949265|NCT01350973|3770601|B2|No||Low High Density Lipoprotein - Cholesterol (HDL-C)||participants|Number|154|154.0||||||
3949266|NCT01350973|3770602|B1|No||Low High Density Lipoprotein - Cholesterol (HDL-C)||participants|Number|148|148.0||||||
3949267|NCT01350973|3770599|B4|Yes||Low High Density Lipoprotein - Cholesterol (HDL-C)||participants|Number|174|174.0||||||
3949268|NCT01350973|3770600|B3|Yes||Low High Density Lipoprotein - Cholesterol (HDL-C)||participants|Number|60|60.0||||||
3949269|NCT01350973|3770601|B2|Yes||Low High Density Lipoprotein - Cholesterol (HDL-C)||participants|Number|56|56.0||||||
3949270|NCT01350973|3770602|B1|Yes||Low High Density Lipoprotein - Cholesterol (HDL-C)||participants|Number|58|58.0||||||
3949271|NCT01350973|3770599|B4|No||Diabetes Mellitus (Including Impaired Glucose Tolerance)||participants|Number|412|412.0||||||
3949272|NCT01350973|3770600|B3|No||Diabetes Mellitus (Including Impaired Glucose Tolerance)||participants|Number|128|128.0||||||
3949273|NCT01350973|3770601|B2|No||Diabetes Mellitus (Including Impaired Glucose Tolerance)||participants|Number|140|140.0||||||
3949274|NCT01350973|3770602|B1|No||Diabetes Mellitus (Including Impaired Glucose Tolerance)||participants|Number|144|144.0||||||
3949276|NCT01350973|3770600|B3|Yes||Diabetes Mellitus (Including Impaired Glucose Tolerance)||participants|Number|67|67.0||||||
3949277|NCT01350973|3770601|B2|Yes||Diabetes Mellitus (Including Impaired Glucose Tolerance)||participants|Number|70|70.0||||||
3949278|NCT01350973|3770602|B1|Yes||Diabetes Mellitus (Including Impaired Glucose Tolerance)||participants|Number|62|62.0||||||
3949279|NCT01350973|3770599|B4|No||Hypertension||participants|Number|230|230.0||||||
3949280|NCT01350973|3770600|B3|No||Hypertension||participants|Number|64|64.0||||||
3949281|NCT01350973|3770601|B2|No||Hypertension||participants|Number|83|83.0||||||
3949282|NCT01350973|3770602|B1|No||Hypertension||participants|Number|83|83.0||||||
3949283|NCT01350973|3770599|B4|Yes||Hypertension||participants|Number|381|381.0||||||
3949284|NCT01350973|3770600|B3|Yes||Hypertension||participants|Number|131|131.0||||||
3949285|NCT01350973|3770601|B2|Yes||Hypertension||participants|Number|127|127.0||||||
3949286|NCT01350973|3770602|B1|Yes||Hypertension||participants|Number|123|123.0||||||
3949287|NCT01350973|3770599|B4|History of CAD||Coronary Artery Disease (CAD) Category|CAD Patient Categories define the degree of risk of CAD according to Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases. Categories are classified by the degree of risks in the patient [e.g, smoking, hypertension, excluding level of low density lipoprotein cholesterol (LDL-C)]. Category I=Low risk (best), Category II=Middle risk, Category III=High Risk and History of CAD.|participants|Number|6|6.0||||||
3949288|NCT01350973|3770600|B3|History of CAD||Coronary Artery Disease (CAD) Category|CAD Patient Categories define the degree of risk of CAD according to Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases. Categories are classified by the degree of risks in the patient [e.g, smoking, hypertension, excluding level of low density lipoprotein cholesterol (LDL-C)]. Category I=Low risk (best), Category II=Middle risk, Category III=High Risk and History of CAD.|participants|Number|2|2.0||||||
3949289|NCT01350973|3770601|B2|History of CAD||Coronary Artery Disease (CAD) Category|CAD Patient Categories define the degree of risk of CAD according to Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases. Categories are classified by the degree of risks in the patient [e.g, smoking, hypertension, excluding level of low density lipoprotein cholesterol (LDL-C)]. Category I=Low risk (best), Category II=Middle risk, Category III=High Risk and History of CAD.|participants|Number|1|1.0||||||
3949290|NCT01350973|3770602|B1|History of CAD||Coronary Artery Disease (CAD) Category|CAD Patient Categories define the degree of risk of CAD according to Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases. Categories are classified by the degree of risks in the patient [e.g, smoking, hypertension, excluding level of low density lipoprotein cholesterol (LDL-C)]. Category I=Low risk (best), Category II=Middle risk, Category III=High Risk and History of CAD.|participants|Number|3|3.0||||||
3949291|NCT01350973|3770599|B4|Category III||Coronary Artery Disease (CAD) Category|CAD Patient Categories define the degree of risk of CAD according to Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases. Categories are classified by the degree of risks in the patient [e.g, smoking, hypertension, excluding level of low density lipoprotein cholesterol (LDL-C)]. Category I=Low risk (best), Category II=Middle risk, Category III=High Risk and History of CAD.|participants|Number|336|336.0||||||
3949292|NCT01350973|3770600|B3|Category III||Coronary Artery Disease (CAD) Category|CAD Patient Categories define the degree of risk of CAD according to Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases. Categories are classified by the degree of risks in the patient [e.g, smoking, hypertension, excluding level of low density lipoprotein cholesterol (LDL-C)]. Category I=Low risk (best), Category II=Middle risk, Category III=High Risk and History of CAD.|participants|Number|110|110.0||||||
3949293|NCT01350973|3770601|B2|Category III||Coronary Artery Disease (CAD) Category|CAD Patient Categories define the degree of risk of CAD according to Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases. Categories are classified by the degree of risks in the patient [e.g, smoking, hypertension, excluding level of low density lipoprotein cholesterol (LDL-C)]. Category I=Low risk (best), Category II=Middle risk, Category III=High Risk and History of CAD.|participants|Number|124|124.0||||||
3949294|NCT01350973|3770602|B1|Category III||Coronary Artery Disease (CAD) Category|CAD Patient Categories define the degree of risk of CAD according to Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases. Categories are classified by the degree of risks in the patient [e.g, smoking, hypertension, excluding level of low density lipoprotein cholesterol (LDL-C)]. Category I=Low risk (best), Category II=Middle risk, Category III=High Risk and History of CAD.|participants|Number|102|102.0||||||
3949295|NCT01350973|3770599|B4|Category II||Coronary Artery Disease (CAD) Category|CAD Patient Categories define the degree of risk of CAD according to Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases. Categories are classified by the degree of risks in the patient [e.g, smoking, hypertension, excluding level of low density lipoprotein cholesterol (LDL-C)]. Category I=Low risk (best), Category II=Middle risk, Category III=High Risk and History of CAD.|participants|Number|244|244.0||||||
3949296|NCT01350973|3770600|B3|Category II||Coronary Artery Disease (CAD) Category|CAD Patient Categories define the degree of risk of CAD according to Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases. Categories are classified by the degree of risks in the patient [e.g, smoking, hypertension, excluding level of low density lipoprotein cholesterol (LDL-C)]. Category I=Low risk (best), Category II=Middle risk, Category III=High Risk and History of CAD.|participants|Number|79|79.0||||||
3949297|NCT01350973|3770601|B2|Category II||Coronary Artery Disease (CAD) Category|CAD Patient Categories define the degree of risk of CAD according to Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases. Categories are classified by the degree of risks in the patient [e.g, smoking, hypertension, excluding level of low density lipoprotein cholesterol (LDL-C)]. Category I=Low risk (best), Category II=Middle risk, Category III=High Risk and History of CAD.|participants|Number|70|70.0||||||
3949322|NCT01350973|3770602|B1|Male <85.0 cm||Waist Circumference, Categorical|"The number of participants with available waist circumference data are 205, 210 and 195 in each treatment arm, respectively.~Mean"|participants|Number|23|23.0||||||
3949323|NCT01350973|3770599|B4|Ex-Smoker||Smoking Classification||participants|Number|208|208.0||||||
3949298|NCT01350973|3770602|B1|Category II||Coronary Artery Disease (CAD) Category|CAD Patient Categories define the degree of risk of CAD according to Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases. Categories are classified by the degree of risks in the patient [e.g, smoking, hypertension, excluding level of low density lipoprotein cholesterol (LDL-C)]. Category I=Low risk (best), Category II=Middle risk, Category III=High Risk and History of CAD.|participants|Number|95|95.0||||||
3949299|NCT01350973|3770599|B4|Category I||Coronary Artery Disease (CAD) Category|CAD Patient Categories define the degree of risk of CAD according to Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases. Categories are classified by the degree of risks in the patient [e.g, smoking, hypertension, excluding level of low density lipoprotein cholesterol (LDL-C)]. Category I=Low risk (best), Category II=Middle risk, Category III=High Risk and History of CAD.|participants|Number|25|25.0||||||
3949300|NCT01350973|3770600|B3|Category I||Coronary Artery Disease (CAD) Category|CAD Patient Categories define the degree of risk of CAD according to Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases. Categories are classified by the degree of risks in the patient [e.g, smoking, hypertension, excluding level of low density lipoprotein cholesterol (LDL-C)]. Category I=Low risk (best), Category II=Middle risk, Category III=High Risk and History of CAD.|participants|Number|4|4.0||||||
3949301|NCT01350973|3770601|B2|Category I||Coronary Artery Disease (CAD) Category|CAD Patient Categories define the degree of risk of CAD according to Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases. Categories are classified by the degree of risks in the patient [e.g, smoking, hypertension, excluding level of low density lipoprotein cholesterol (LDL-C)]. Category I=Low risk (best), Category II=Middle risk, Category III=High Risk and History of CAD.|participants|Number|15|15.0||||||
3949302|NCT01350973|3770602|B1|Category I||Coronary Artery Disease (CAD) Category|CAD Patient Categories define the degree of risk of CAD according to Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases. Categories are classified by the degree of risks in the patient [e.g, smoking, hypertension, excluding level of low density lipoprotein cholesterol (LDL-C)]. Category I=Low risk (best), Category II=Middle risk, Category III=High Risk and History of CAD.|participants|Number|6|6.0||||||
3949303|NCT01350973|3770599|B4|||Waist Circumference|The number of participants with available waist circumference data are 205, 210 and 195 in each treatment arm, respectively.|cm|Mean|91.53|91.53|Standard Deviation|9.161|9.161|||
3949304|NCT01350973|3770600|B3|||Waist Circumference|The number of participants with available waist circumference data are 205, 210 and 195 in each treatment arm, respectively.|cm|Mean|91.51|91.51|Standard Deviation|9.232|9.232|||
3949305|NCT01350973|3770601|B2|||Waist Circumference|The number of participants with available waist circumference data are 205, 210 and 195 in each treatment arm, respectively.|cm|Mean|91.24|91.24|Standard Deviation|9.376|9.376|||
3949306|NCT01350973|3770602|B1|||Waist Circumference|The number of participants with available waist circumference data are 205, 210 and 195 in each treatment arm, respectively.|cm|Mean|91.85|91.85|Standard Deviation|8.901|8.901|||
3949307|NCT01350973|3770599|B4|Female ≥90.0 cm||Waist Circumference, Categorical|"The number of participants with available waist circumference data are 205, 210 and 195 in each treatment arm, respectively.~Mean"|participants|Number|57|57.0||||||
3949308|NCT01350973|3770600|B3|Female ≥90.0 cm||Waist Circumference, Categorical|"The number of participants with available waist circumference data are 205, 210 and 195 in each treatment arm, respectively.~Mean"|participants|Number|13|13.0||||||
3949309|NCT01350973|3770601|B2|Female ≥90.0 cm||Waist Circumference, Categorical|"The number of participants with available waist circumference data are 205, 210 and 195 in each treatment arm, respectively.~Mean"|participants|Number|23|23.0||||||
3949310|NCT01350973|3770602|B1|Female ≥90.0 cm||Waist Circumference, Categorical|"The number of participants with available waist circumference data are 205, 210 and 195 in each treatment arm, respectively.~Mean"|participants|Number|21|21.0||||||
3949311|NCT01350973|3770599|B4|Female <90.0 cm||Waist Circumference, Categorical|"The number of participants with available waist circumference data are 205, 210 and 195 in each treatment arm, respectively.~Mean"|participants|Number|80|80.0||||||
3949312|NCT01350973|3770600|B3|Female <90.0 cm||Waist Circumference, Categorical|"The number of participants with available waist circumference data are 205, 210 and 195 in each treatment arm, respectively.~Mean"|participants|Number|25|25.0||||||
3949313|NCT01350973|3770601|B2|Female <90.0 cm||Waist Circumference, Categorical|"The number of participants with available waist circumference data are 205, 210 and 195 in each treatment arm, respectively.~Mean"|participants|Number|30|30.0||||||
3949314|NCT01350973|3770602|B1|Female <90.0 cm||Waist Circumference, Categorical|"The number of participants with available waist circumference data are 205, 210 and 195 in each treatment arm, respectively.~Mean"|participants|Number|25|25.0||||||
3949315|NCT01350973|3770599|B4|Male ≥85.0 cm||Waist Circumference, Categorical|"The number of participants with available waist circumference data are 205, 210 and 195 in each treatment arm, respectively.~Mean"|participants|Number|392|392.0||||||
3949316|NCT01350973|3770600|B3|Male ≥85.0 cm||Waist Circumference, Categorical|"The number of participants with available waist circumference data are 205, 210 and 195 in each treatment arm, respectively.~Mean"|participants|Number|125|125.0||||||
3949317|NCT01350973|3770601|B2|Male ≥85.0 cm||Waist Circumference, Categorical|"The number of participants with available waist circumference data are 205, 210 and 195 in each treatment arm, respectively.~Mean"|participants|Number|131|131.0||||||
3949318|NCT01350973|3770602|B1|Male ≥85.0 cm||Waist Circumference, Categorical|"The number of participants with available waist circumference data are 205, 210 and 195 in each treatment arm, respectively.~Mean"|participants|Number|136|136.0||||||
3949319|NCT01350973|3770599|B4|Male <85.0 cm||Waist Circumference, Categorical|"The number of participants with available waist circumference data are 205, 210 and 195 in each treatment arm, respectively.~Mean"|participants|Number|81|81.0||||||
3949320|NCT01350973|3770600|B3|Male <85.0 cm||Waist Circumference, Categorical|"The number of participants with available waist circumference data are 205, 210 and 195 in each treatment arm, respectively.~Mean"|participants|Number|32|32.0||||||
3949321|NCT01350973|3770601|B2|Male <85.0 cm||Waist Circumference, Categorical|"The number of participants with available waist circumference data are 205, 210 and 195 in each treatment arm, respectively.~Mean"|participants|Number|26|26.0||||||
3949324|NCT01350973|3770600|B3|Ex-Smoker||Smoking Classification||participants|Number|72|72.0||||||
3949325|NCT01350973|3770601|B2|Ex-Smoker||Smoking Classification||participants|Number|68|68.0||||||
3949326|NCT01350973|3770602|B1|Ex-Smoker||Smoking Classification||participants|Number|68|68.0||||||
3949327|NCT01350973|3770599|B4|Current Smoker||Smoking Classification||participants|Number|223|223.0||||||
3949328|NCT01350973|3770600|B3|Current Smoker||Smoking Classification||participants|Number|69|69.0||||||
3949329|NCT01350973|3770601|B2|Current Smoker||Smoking Classification||participants|Number|76|76.0||||||
3949330|NCT01350973|3770602|B1|Current Smoker||Smoking Classification||participants|Number|78|78.0||||||
3949331|NCT01350973|3770599|B4|Never Smoked||Smoking Classification||participants|Number|180|180.0||||||
3949332|NCT01350973|3770600|B3|Never Smoked||Smoking Classification||participants|Number|54|54.0||||||
3949333|NCT01350973|3770601|B2|Never Smoked||Smoking Classification||participants|Number|66|66.0||||||
3949334|NCT01350973|3770602|B1|Never Smoked||Smoking Classification||participants|Number|60|60.0||||||
3949335|NCT01350973|3770599|B4|||Body Mass Index|The number of participants with available BMI data are 205, 210 and 195 in each treatment arm, respectively.|kg/m^2|Mean|26.38|26.38|Standard Deviation|3.710|3.71|||
3949336|NCT01350973|3770600|B3|||Body Mass Index|The number of participants with available BMI data are 205, 210 and 195 in each treatment arm, respectively.|kg/m^2|Mean|26.34|26.34|Standard Deviation|3.628|3.628|||
3949337|NCT01350973|3770601|B2|||Body Mass Index|The number of participants with available BMI data are 205, 210 and 195 in each treatment arm, respectively.|kg/m^2|Mean|26.26|26.26|Standard Deviation|3.846|3.846|||
3949338|NCT01350973|3770602|B1|||Body Mass Index|The number of participants with available BMI data are 205, 210 and 195 in each treatment arm, respectively.|kg/m^2|Mean|26.55|26.55|Standard Deviation|3.658|3.658|||
3949339|NCT01350973|3770599|B4|≥30.0 kg/m^2||Body Mass Index (BMI), Categorical|The number of participants with available BMI data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|91|91.0||||||
3949340|NCT01350973|3770600|B3|≥30.0 kg/m^2||Body Mass Index (BMI), Categorical|The number of participants with available BMI data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|27|27.0||||||
3949341|NCT01350973|3770601|B2|≥30.0 kg/m^2||Body Mass Index (BMI), Categorical|The number of participants with available BMI data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|28|28.0||||||
3949342|NCT01350973|3770602|B1|≥30.0 kg/m^2||Body Mass Index (BMI), Categorical|The number of participants with available BMI data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|36|36.0||||||
3949343|NCT01350973|3770599|B4|≥25.0 - <30.0 kg/m^2||Body Mass Index (BMI), Categorical|The number of participants with available BMI data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|286|286.0||||||
3949344|NCT01350973|3770600|B3|≥25.0 - <30.0 kg/m^2||Body Mass Index (BMI), Categorical|The number of participants with available BMI data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|99|99.0||||||
3949345|NCT01350973|3770601|B2|≥25.0 - <30.0 kg/m^2||Body Mass Index (BMI), Categorical|The number of participants with available BMI data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|93|93.0||||||
3949346|NCT01350973|3770602|B1|≥25.0 - <30.0 kg/m^2||Body Mass Index (BMI), Categorical|The number of participants with available BMI data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|94|94.0||||||
3949347|NCT01350973|3770599|B4|<25.0 kg/m^2||Body Mass Index (BMI), Categorical|The number of participants with available BMI data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|233|233.0||||||
3949348|NCT01350973|3770600|B3|<25.0 kg/m^2||Body Mass Index (BMI), Categorical|The number of participants with available BMI data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|69|69.0||||||
3949349|NCT01350973|3770601|B2|<25.0 kg/m^2||Body Mass Index (BMI), Categorical|The number of participants with available BMI data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|89|89.0||||||
3949350|NCT01350973|3770602|B1|<25.0 kg/m^2||Body Mass Index (BMI), Categorical|The number of participants with available BMI data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|75|75.0||||||
3949351|NCT01350973|3770599|B4|||Weight|The number of participants with available weight data are 205, 210 and 195 in each treatment arm, respectively.|kg|Mean|72.71|72.71|Standard Deviation|12.962|12.962|||
3949352|NCT01350973|3770600|B3|||Weight|The number of participants with available weight data are 205, 210 and 195 in each treatment arm, respectively.|kg|Mean|72.90|72.9|Standard Deviation|13.375|13.375|||
3949353|NCT01350973|3770601|B2|||Weight|The number of participants with available weight data are 205, 210 and 195 in each treatment arm, respectively.|kg|Mean|72.20|72.2|Standard Deviation|12.435|12.435|||
3949354|NCT01350973|3770602|B1|||Weight|The number of participants with available weight data are 205, 210 and 195 in each treatment arm, respectively.|kg|Mean|73.04|73.04|Standard Deviation|13.139|13.139|||
3949355|NCT01350973|3770599|B4|≥80.0 kg||Weight, Categorical|The number of participants with available weight data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|161|161.0||||||
3949356|NCT01350973|3770600|B3|≥80.0 kg||Weight, Categorical|The number of participants with available weight data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|55|55.0||||||
3949357|NCT01350973|3770601|B2|≥80.0 kg||Weight, Categorical|The number of participants with available weight data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|48|48.0||||||
3949358|NCT01350973|3770602|B1|≥80.0 kg||Weight, Categorical|The number of participants with available weight data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|58|58.0||||||
3949359|NCT01350973|3770599|B4|≥70.0 - <80.0 kg||Weight, Categorical|The number of participants with available weight data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|173|173.0||||||
3949360|NCT01350973|3770600|B3|≥70.0 - <80.0 kg||Weight, Categorical|The number of participants with available weight data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|49|49.0||||||
3949361|NCT01350973|3770601|B2|≥70.0 - <80.0 kg||Weight, Categorical|The number of participants with available weight data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|68|68.0||||||
3949362|NCT01350973|3770602|B1|≥70.0 - <80.0 kg||Weight, Categorical|The number of participants with available weight data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|56|56.0||||||
3949363|NCT01350973|3770599|B4|≥60.0 - <70.0 kg||Weight, Categorical|The number of participants with available weight data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|177|177.0||||||
3949364|NCT01350973|3770600|B3|≥60.0 - <70.0 kg||Weight, Categorical|The number of participants with available weight data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|58|58.0||||||
3949365|NCT01350973|3770601|B2|≥60.0 - <70.0 kg||Weight, Categorical|The number of participants with available weight data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|61|61.0||||||
3949366|NCT01350973|3770602|B1|≥60.0 - <70.0 kg||Weight, Categorical|The number of participants with available weight data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|58|58.0||||||
3949367|NCT01350973|3770599|B4|<60.0 kg||Weight, Categorical|The number of participants with available weight data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|99|99.0||||||
3949368|NCT01350973|3770600|B3|<60.0 kg||Weight, Categorical|The number of participants with available weight data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|33|33.0||||||
3949369|NCT01350973|3770601|B2|<60.0 kg||Weight, Categorical|The number of participants with available weight data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|33|33.0||||||
3949370|NCT01350973|3770602|B1|<60.0 kg||Weight, Categorical|The number of participants with available weight data are 205, 210 and 195 in each treatment arm, respectively.|participants|Number|33|33.0||||||
3949371|NCT01350973|3770599|B4|||Height||cm|Mean|165.7|165.7|Standard Deviation|8.69|8.69|||
3949372|NCT01350973|3770600|B3|||Height||cm|Mean|166.0|166.0|Standard Deviation|8.89|8.89|||
3949373|NCT01350973|3770601|B2|||Height||cm|Mean|165.7|165.7|Standard Deviation|8.64|8.64|||
3949374|NCT01350973|3770602|B1|||Height||cm|Mean|165.5|165.5|Standard Deviation|8.60|8.6|||
3949375|NCT01350973|3770599|B4|≥170 cm||Height, Categorical||participants|Number|217|217.0||||||
3949376|NCT01350973|3770600|B3|≥170 cm||Height, Categorical||participants|Number|76|76.0||||||
3949377|NCT01350973|3770601|B2|≥170 cm||Height, Categorical||participants|Number|75|75.0||||||
3949378|NCT01350973|3770602|B1|≥170 cm||Height, Categorical||participants|Number|66|66.0||||||
3949379|NCT01350973|3770599|B4|≥160 - <170 cm||Height, Categorical||participants|Number|255|255.0||||||
3949380|NCT01350973|3770600|B3|≥160 - <170 cm||Height, Categorical||participants|Number|78|78.0||||||
3949381|NCT01350973|3770601|B2|≥160 - <170 cm||Height, Categorical||participants|Number|86|86.0||||||
3949382|NCT01350973|3770602|B1|≥160 - <170 cm||Height, Categorical||participants|Number|91|91.0||||||
3949383|NCT01350973|3770599|B4|<160 cm||Height, Categorical||participants|Number|139|139.0||||||
3949384|NCT01350973|3770600|B3|<160 cm||Height, Categorical||participants|Number|41|41.0||||||
3949385|NCT01350973|3770601|B2|<160 cm||Height, Categorical||participants|Number|49|49.0||||||
3949386|NCT01350973|3770602|B1|<160 cm||Height, Categorical||participants|Number|49|49.0||||||
3949387|NCT01350973|3770599|B4|Not Applicable||Menopause Status||participants|Number|482|482.0||||||
3949388|NCT01350973|3770600|B3|Not Applicable||Menopause Status||participants|Number|158|158.0||||||
3949389|NCT01350973|3770601|B2|Not Applicable||Menopause Status||participants|Number|162|162.0||||||
3949390|NCT01350973|3770602|B1|Not Applicable||Menopause Status||participants|Number|162|162.0||||||
3949391|NCT01350973|3770599|B4|No||Menopause Status||participants|Number|20|20.0||||||
3949392|NCT01350973|3770600|B3|No||Menopause Status||participants|Number|6|6.0||||||
3949393|NCT01350973|3770601|B2|No||Menopause Status||participants|Number|6|6.0||||||
3949394|NCT01350973|3770602|B1|No||Menopause Status||participants|Number|8|8.0||||||
3949395|NCT01350973|3770599|B4|Yes||Menopause Status||participants|Number|109|109.0||||||
3949396|NCT01350973|3770600|B3|Yes||Menopause Status||participants|Number|31|31.0||||||
3949397|NCT01350973|3770601|B2|Yes||Menopause Status||participants|Number|42|42.0||||||
3949398|NCT01350973|3770602|B1|Yes||Menopause Status||participants|Number|36|36.0||||||
3949399|NCT01350973|3770599|B4|Japan||Region of Enrollment||participants|Number|611|611.0||||||
3949400|NCT01350973|3770600|B3|Japan||Region of Enrollment||participants|Number|195|195.0||||||
3949401|NCT01350973|3770601|B2|Japan||Region of Enrollment||participants|Number|210|210.0||||||
3949402|NCT01350973|3770602|B1|Japan||Region of Enrollment||participants|Number|206|206.0||||||
3949403|NCT01350973|3770599|B4||Male|Sex: Female, Male||Participants|Count of Participants|474|474.0||||||
3949404|NCT01350973|3770600|B3||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3949405|NCT01350973|3770601|B2||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3949406|NCT01350973|3770602|B1||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3949407|NCT01350973|3770599|B4||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3949408|NCT01350973|3770600|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3949409|NCT01350973|3770601|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3949410|NCT01350973|3770602|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3949411|NCT01350973|3770599|B4|≥65 - ≤74 years||Age, Customized||participants|Number|126|126.0||||||
3949412|NCT01350973|3770600|B3|≥65 - ≤74 years||Age, Customized||participants|Number|47|47.0||||||
3949413|NCT01350973|3770601|B2|≥65 - ≤74 years||Age, Customized||participants|Number|41|41.0||||||
3949414|NCT01350973|3770602|B1|≥65 - ≤74 years||Age, Customized||participants|Number|38|38.0||||||
3949415|NCT01350973|3770599|B4|≥20 - <65 years||Age, Customized||participants|Number|485|485.0||||||
3949416|NCT01350973|3770600|B3|≥20 - <65 years||Age, Customized||participants|Number|148|148.0||||||
3949417|NCT01350973|3770601|B2|≥20 - <65 years||Age, Customized||participants|Number|169|169.0||||||
3949418|NCT01350973|3770602|B1|≥20 - <65 years||Age, Customized||participants|Number|168|168.0||||||
3949419|NCT01350973|3770599|B4|||Age||years|Mean|54.8|54.8|Standard Deviation|10.60|10.6|||
3949420|NCT01350973|3770600|B3|||Age||years|Mean|55.6|55.6|Standard Deviation|10.52|10.52|||
3949421|NCT01350973|3770601|B2|||Age||years|Mean|55.0|55.0|Standard Deviation|10.50|10.5|||
3949422|NCT01350973|3770602|B1|||Age||years|Mean|53.9|53.9|Standard Deviation|10.76|10.76|||
3949423|NCT01350947|3770639|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3949424|NCT01350947|3770639|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3949425|NCT01350947|3770639|B1|||Age||years|Median|69|69.0|Full Range|||56.0|85.0|
3949426|NCT01350934|3770643|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3949427|NCT01350934|3770644|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3949428|NCT01350934|3770645|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3949429|NCT01350934|3770643|B3||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
3949430|NCT01350934|3770644|B2||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3949431|NCT01350934|3770645|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3949432|NCT01350934|3770643|B3|||Age||Years|Mean|65.2|65.2|Standard Deviation|7.69|7.69|||
3949433|NCT01350934|3770644|B2|||Age||Years|Mean|64.8|64.8|Standard Deviation|7.44|7.44|||
3949434|NCT01350934|3770645|B1|||Age||Years|Mean|65.6|65.6|Standard Deviation|7.97|7.97|||
3949435|NCT01350804|3770664|B5||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3949436|NCT01350804|3770665|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3949437|NCT01350804|3770666|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3949438|NCT01350804|3770667|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3949439|NCT01350804|3770668|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3949440|NCT01350804|3770664|B5||Female|Sex: Female, Male||Participants|Count of Participants|450|450.0||||||
3949441|NCT01350804|3770665|B4||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3949442|NCT01350804|3770666|B3||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3949443|NCT01350804|3770667|B2||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3949444|NCT01350804|3770668|B1||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3949445|NCT01350804|3770664|B5||>=65 years|Age||Participants|Count of Participants|116|116.0||||||
3949446|NCT01350804|3770665|B4||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3949447|NCT01350804|3770666|B3||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
3949448|NCT01350804|3770667|B2||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
3949449|NCT01350804|3770668|B1||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
3949450|NCT01350804|3770664|B5||Between 18 and 65 years|Age||Participants|Count of Participants|435|435.0||||||
3949451|NCT01350804|3770665|B4||Between 18 and 65 years|Age||Participants|Count of Participants|115|115.0||||||
3949452|NCT01350804|3770666|B3||Between 18 and 65 years|Age||Participants|Count of Participants|106|106.0||||||
3949453|NCT01350804|3770667|B2||Between 18 and 65 years|Age||Participants|Count of Participants|103|103.0||||||
3949454|NCT01350804|3770668|B1||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
3949455|NCT01350804|3770664|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3949456|NCT01350804|3770665|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3949457|NCT01350804|3770666|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3949458|NCT01350804|3770667|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3949459|NCT01350804|3770668|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3949460|NCT01350583|3770760|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3949461|NCT01350583|3770760|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3949462|NCT01350583|3770760|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3949463|NCT01350583|3770760|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3949464|NCT01350583|3770760|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3949465|NCT01350583|3770760|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3949466|NCT01350544|3770766|B3|Unknow||Ever Incarcerated||Participants|Count of Participants|1|1.0||||||
3949467|NCT01350544|3770767|B2|Unknow||Ever Incarcerated||Participants|Count of Participants|0|0.0||||||
3949468|NCT01350544|3770768|B1|Unknow||Ever Incarcerated||Participants|Count of Participants|1|1.0||||||
3949469|NCT01350544|3770766|B3|never incarcerated||Ever Incarcerated||Participants|Count of Participants|97|97.0||||||
3949470|NCT01350544|3770767|B2|never incarcerated||Ever Incarcerated||Participants|Count of Participants|48|48.0||||||
3949471|NCT01350544|3770768|B1|never incarcerated||Ever Incarcerated||Participants|Count of Participants|49|49.0||||||
3949472|NCT01350544|3770766|B3|ever incarcerated||Ever Incarcerated||Participants|Count of Participants|117|117.0||||||
3949473|NCT01350544|3770767|B2|ever incarcerated||Ever Incarcerated||Participants|Count of Participants|59|59.0||||||
3949474|NCT01350544|3770768|B1|ever incarcerated||Ever Incarcerated||Participants|Count of Participants|58|58.0||||||
3949475|NCT01350544|3770766|B3|Other||Sexual Orientation||Participants|Count of Participants|6|6.0||||||
3949476|NCT01350544|3770767|B2|Other||Sexual Orientation||Participants|Count of Participants|2|2.0||||||
3949477|NCT01350544|3770768|B1|Other||Sexual Orientation||Participants|Count of Participants|4|4.0||||||
3949478|NCT01350544|3770766|B3|Not Sure||Sexual Orientation||Participants|Count of Participants|3|3.0||||||
3949534|NCT01350544|3770768|B1|Homeless||Housing Status||Participants|Count of Participants|5|5.0||||||
3949479|NCT01350544|3770767|B2|Not Sure||Sexual Orientation||Participants|Count of Participants|2|2.0||||||
3949480|NCT01350544|3770768|B1|Not Sure||Sexual Orientation||Participants|Count of Participants|1|1.0||||||
3949481|NCT01350544|3770766|B3|Bisexual||Sexual Orientation||Participants|Count of Participants|32|32.0||||||
3949482|NCT01350544|3770767|B2|Bisexual||Sexual Orientation||Participants|Count of Participants|16|16.0||||||
3949483|NCT01350544|3770768|B1|Bisexual||Sexual Orientation||Participants|Count of Participants|16|16.0||||||
3949484|NCT01350544|3770766|B3|Gay woman||Sexual Orientation||Participants|Count of Participants|4|4.0||||||
3949485|NCT01350544|3770767|B2|Gay woman||Sexual Orientation||Participants|Count of Participants|3|3.0||||||
3949486|NCT01350544|3770768|B1|Gay woman||Sexual Orientation||Participants|Count of Participants|1|1.0||||||
3949487|NCT01350544|3770766|B3|Gay man||Sexual Orientation||Participants|Count of Participants|92|92.0||||||
3949488|NCT01350544|3770767|B2|Gay man||Sexual Orientation||Participants|Count of Participants|42|42.0||||||
3949489|NCT01350544|3770768|B1|Gay man||Sexual Orientation||Participants|Count of Participants|50|50.0||||||
3949490|NCT01350544|3770766|B3|Straight||Sexual Orientation||Participants|Count of Participants|79|79.0||||||
3949491|NCT01350544|3770767|B2|Straight||Sexual Orientation||Participants|Count of Participants|43|43.0||||||
3949492|NCT01350544|3770768|B1|Straight||Sexual Orientation||Participants|Count of Participants|36|36.0||||||
3949493|NCT01350544|3770766|B3|did not receive HIV care||Received HIV care in last 6 months||Participants|Count of Participants|10|10.0||||||
3949494|NCT01350544|3770767|B2|did not receive HIV care||Received HIV care in last 6 months||Participants|Count of Participants|5|5.0||||||
3949495|NCT01350544|3770768|B1|did not receive HIV care||Received HIV care in last 6 months||Participants|Count of Participants|5|5.0||||||
3949496|NCT01350544|3770766|B3|received HIV care||Received HIV care in last 6 months||Participants|Count of Participants|205|205.0||||||
3949497|NCT01350544|3770767|B2|received HIV care||Received HIV care in last 6 months||Participants|Count of Participants|102|102.0||||||
3949498|NCT01350544|3770768|B1|received HIV care||Received HIV care in last 6 months||Participants|Count of Participants|103|103.0||||||
3949499|NCT01350544|3770766|B3|||CD4 Cell Count||cells per microliter|Mean|593|593.0|Standard Deviation|334|334.0|||
3949500|NCT01350544|3770767|B2|||CD4 Cell Count||cells per microliter|Mean|650|650.0|Standard Deviation|343|343.0|||
3949501|NCT01350544|3770768|B1|||CD4 Cell Count||cells per microliter|Mean|534|534.0|Standard Deviation|316|316.0|||
3949502|NCT01350544|3770766|B3|Unknown||Viral Load|Medical record value closest to baseline|Participants|Count of Participants|49|49.0||||||
3949503|NCT01350544|3770767|B2|Unknown||Viral Load|Medical record value closest to baseline|Participants|Count of Participants|23|23.0||||||
3949504|NCT01350544|3770768|B1|Unknown||Viral Load|Medical record value closest to baseline|Participants|Count of Participants|26|26.0||||||
3949505|NCT01350544|3770766|B3|Undetectable (<200 copies)||Viral Load|Medical record value closest to baseline|Participants|Count of Participants|95|95.0||||||
3949506|NCT01350544|3770767|B2|Undetectable (<200 copies)||Viral Load|Medical record value closest to baseline|Participants|Count of Participants|54|54.0||||||
3949507|NCT01350544|3770768|B1|Undetectable (<200 copies)||Viral Load|Medical record value closest to baseline|Participants|Count of Participants|41|41.0||||||
3949508|NCT01350544|3770766|B3|Detectable||Viral Load|Medical record value closest to baseline|Participants|Count of Participants|71|71.0||||||
3949509|NCT01350544|3770767|B2|Detectable||Viral Load|Medical record value closest to baseline|Participants|Count of Participants|30|30.0||||||
3949510|NCT01350544|3770768|B1|Detectable||Viral Load|Medical record value closest to baseline|Participants|Count of Participants|41|41.0||||||
3949511|NCT01350544|3770766|B3|||Length of Time Diagnosed||years|Mean|15.5|15.5|Standard Deviation|8.3|8.3|||
3949512|NCT01350544|3770767|B2|||Length of Time Diagnosed||years|Mean|15.5|15.5|Standard Deviation|7.9|7.9|||
3949513|NCT01350544|3770768|B1|||Length of Time Diagnosed||years|Mean|15.3|15.3|Standard Deviation|8.8|8.8|||
3949514|NCT01350544|3770766|B3|Other||Employment Status||Participants|Count of Participants|35|35.0||||||
3949515|NCT01350544|3770767|B2|Other||Employment Status||Participants|Count of Participants|17|17.0||||||
3949516|NCT01350544|3770768|B1|Other||Employment Status||Participants|Count of Participants|18|18.0||||||
3949517|NCT01350544|3770766|B3|Retired||Employment Status||Participants|Count of Participants|33|33.0||||||
3949518|NCT01350544|3770767|B2|Retired||Employment Status||Participants|Count of Participants|14|14.0||||||
3949519|NCT01350544|3770768|B1|Retired||Employment Status||Participants|Count of Participants|19|19.0||||||
3949520|NCT01350544|3770766|B3|Unemployed||Employment Status||Participants|Count of Participants|134|134.0||||||
3949521|NCT01350544|3770767|B2|Unemployed||Employment Status||Participants|Count of Participants|71|71.0||||||
3949522|NCT01350544|3770768|B1|Unemployed||Employment Status||Participants|Count of Participants|63|63.0||||||
3949523|NCT01350544|3770766|B3|Part time||Employment Status||Participants|Count of Participants|9|9.0||||||
3949524|NCT01350544|3770767|B2|Part time||Employment Status||Participants|Count of Participants|5|5.0||||||
3949525|NCT01350544|3770768|B1|Part time||Employment Status||Participants|Count of Participants|4|4.0||||||
3949526|NCT01350544|3770766|B3|Full time||Employment Status||Participants|Count of Participants|5|5.0||||||
3949527|NCT01350544|3770767|B2|Full time||Employment Status||Participants|Count of Participants|1|1.0||||||
3949528|NCT01350544|3770768|B1|Full time||Employment Status||Participants|Count of Participants|4|4.0||||||
3949529|NCT01350544|3770766|B3|Other||Housing Status||Participants|Count of Participants|2|2.0||||||
3949530|NCT01350544|3770767|B2|Other||Housing Status||Participants|Count of Participants|1|1.0||||||
3949531|NCT01350544|3770768|B1|Other||Housing Status||Participants|Count of Participants|1|1.0||||||
3949532|NCT01350544|3770766|B3|Homeless||Housing Status||Participants|Count of Participants|11|11.0||||||
3949533|NCT01350544|3770767|B2|Homeless||Housing Status||Participants|Count of Participants|6|6.0||||||
3949535|NCT01350544|3770766|B3|Temporary or transitional||Housing Status||Participants|Count of Participants|22|22.0||||||
3949536|NCT01350544|3770767|B2|Temporary or transitional||Housing Status||Participants|Count of Participants|13|13.0||||||
3949537|NCT01350544|3770768|B1|Temporary or transitional||Housing Status||Participants|Count of Participants|9|9.0||||||
3949538|NCT01350544|3770766|B3|Friend / relative||Housing Status||Participants|Count of Participants|19|19.0||||||
3949539|NCT01350544|3770767|B2|Friend / relative||Housing Status||Participants|Count of Participants|8|8.0||||||
3949540|NCT01350544|3770768|B1|Friend / relative||Housing Status||Participants|Count of Participants|11|11.0||||||
3949541|NCT01350544|3770766|B3|Subsidized / Sect. 8||Housing Status||Participants|Count of Participants|16|16.0||||||
3949542|NCT01350544|3770767|B2|Subsidized / Sect. 8||Housing Status||Participants|Count of Participants|8|8.0||||||
3949543|NCT01350544|3770768|B1|Subsidized / Sect. 8||Housing Status||Participants|Count of Participants|8|8.0||||||
3949544|NCT01350544|3770766|B3|Treatment facility||Housing Status||Participants|Count of Participants|11|11.0||||||
3949545|NCT01350544|3770767|B2|Treatment facility||Housing Status||Participants|Count of Participants|2|2.0||||||
3949546|NCT01350544|3770768|B1|Treatment facility||Housing Status||Participants|Count of Participants|9|9.0||||||
3949547|NCT01350544|3770766|B3|Rent/Own||Housing Status||Participants|Count of Participants|134|134.0||||||
3949548|NCT01350544|3770767|B2|Rent/Own||Housing Status||Participants|Count of Participants|69|69.0||||||
3949549|NCT01350544|3770768|B1|Rent/Own||Housing Status||Participants|Count of Participants|65|65.0||||||
3949550|NCT01350544|3770766|B3|Graduate degree||Education||Participants|Count of Participants|4|4.0||||||
3949551|NCT01350544|3770767|B2|Graduate degree||Education||Participants|Count of Participants|0.0|0.0||||||
3949552|NCT01350544|3770768|B1|Graduate degree||Education||Participants|Count of Participants|4|4.0||||||
3949553|NCT01350544|3770766|B3|Some graduate school||Education||Participants|Count of Participants|7|7.0||||||
3949554|NCT01350544|3770767|B2|Some graduate school||Education||Participants|Count of Participants|4|4.0||||||
3949555|NCT01350544|3770768|B1|Some graduate school||Education||Participants|Count of Participants|3|3.0||||||
3949556|NCT01350544|3770766|B3|College degree||Education||Participants|Count of Participants|13|13.0||||||
3949557|NCT01350544|3770767|B2|College degree||Education||Participants|Count of Participants|7|7.0||||||
3949558|NCT01350544|3770768|B1|College degree||Education||Participants|Count of Participants|6|6.0||||||
3949559|NCT01350544|3770766|B3|Some college||Education||Participants|Count of Participants|81|81.0||||||
3949560|NCT01350544|3770767|B2|Some college||Education||Participants|Count of Participants|40|40.0||||||
3949561|NCT01350544|3770768|B1|Some college||Education||Participants|Count of Participants|41|41.0||||||
3949562|NCT01350544|3770766|B3|High School diploma or GED||Education||Participants|Count of Participants|70|70.0||||||
3949563|NCT01350544|3770767|B2|High School diploma or GED||Education||Participants|Count of Participants|33|33.0||||||
3949564|NCT01350544|3770768|B1|High School diploma or GED||Education||Participants|Count of Participants|37|37.0||||||
3949565|NCT01350544|3770766|B3|7th to 11th Grade||Education||Participants|Count of Participants|40|40.0||||||
3949566|NCT01350544|3770767|B2|7th to 11th Grade||Education||Participants|Count of Participants|23|23.0||||||
3949567|NCT01350544|3770768|B1|7th to 11th Grade||Education||Participants|Count of Participants|17|17.0||||||
3949568|NCT01350544|3770766|B3|Unknown||Income||Participants|Count of Participants|2|2.0||||||
3949569|NCT01350544|3770767|B2|Unknown||Income||Participants|Count of Participants|1|1.0||||||
3949570|NCT01350544|3770768|B1|Unknown||Income||Participants|Count of Participants|1|1.0||||||
3949571|NCT01350544|3770766|B3|>$30K - $40K||Income||Participants|Count of Participants|2|2.0||||||
3949572|NCT01350544|3770767|B2|>$30K - $40K||Income||Participants|Count of Participants|0.0|0.0||||||
3949573|NCT01350544|3770768|B1|>$30K - $40K||Income||Participants|Count of Participants|2|2.0||||||
3949574|NCT01350544|3770766|B3|>$20K – $30K||Income||Participants|Count of Participants|18|18.0||||||
3949575|NCT01350544|3770767|B2|>$20K – $30K||Income||Participants|Count of Participants|8|8.0||||||
3949576|NCT01350544|3770768|B1|>$20K – $30K||Income||Participants|Count of Participants|10|10.0||||||
3949577|NCT01350544|3770766|B3|$10K - $20K||Income||Participants|Count of Participants|53|53.0||||||
3949578|NCT01350544|3770767|B2|$10K - $20K||Income||Participants|Count of Participants|35|35.0||||||
3949579|NCT01350544|3770768|B1|$10K - $20K||Income||Participants|Count of Participants|18|18.0||||||
3949580|NCT01350544|3770766|B3|>$0 - <$10K||Income||Participants|Count of Participants|119|119.0||||||
3949581|NCT01350544|3770767|B2|>$0 - <$10K||Income||Participants|Count of Participants|53|53.0||||||
3949582|NCT01350544|3770768|B1|>$0 - <$10K||Income||Participants|Count of Participants|66|66.0||||||
3949583|NCT01350544|3770766|B3|None||Income||Participants|Count of Participants|21|21.0||||||
3949584|NCT01350544|3770767|B2|None||Income||Participants|Count of Participants|10|10.0||||||
3949585|NCT01350544|3770768|B1|None||Income||Participants|Count of Participants|11|11.0||||||
3949586|NCT01350544|3770766|B3|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3949587|NCT01350544|3770767|B2|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3949588|NCT01350544|3770768|B1|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3949589|NCT01350544|3770766|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|202|202.0||||||
3949590|NCT01350544|3770767|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|101|101.0||||||
3949591|NCT01350544|3770768|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|101|101.0||||||
3949592|NCT01350544|3770766|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3949593|NCT01350544|3770767|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3949594|NCT01350544|3770768|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3949595|NCT01350544|3770766|B3|Transgender||Sex/Gender, Customized||Participants|Count of Participants|7|7.0||||||
3949596|NCT01350544|3770767|B2|Transgender||Sex/Gender, Customized||Participants|Count of Participants|2|2.0||||||
3949597|NCT01350544|3770768|B1|Transgender||Sex/Gender, Customized||Participants|Count of Participants|5|5.0||||||
3949598|NCT01350544|3770766|B3|Female||Sex/Gender, Customized||Participants|Count of Participants|51|51.0||||||
3949599|NCT01350544|3770767|B2|Female||Sex/Gender, Customized||Participants|Count of Participants|27|27.0||||||
3949600|NCT01350544|3770768|B1|Female||Sex/Gender, Customized||Participants|Count of Participants|24|24.0||||||
3949601|NCT01350544|3770766|B3|Male||Sex/Gender, Customized||Participants|Count of Participants|157|157.0||||||
3949602|NCT01350544|3770767|B2|Male||Sex/Gender, Customized||Participants|Count of Participants|78|78.0||||||
3949603|NCT01350544|3770768|B1|Male||Sex/Gender, Customized||Participants|Count of Participants|79|79.0||||||
3949604|NCT01350544|3770766|B3|||Age||years|Mean|48.6|48.6|Standard Deviation|10.2|10.2|||
3949605|NCT01350544|3770767|B2|||Age||years|Mean|50.1|50.1|Standard Deviation|10.0|10.0|||
3949606|NCT01350544|3770768|B1|||Age||years|Mean|47.0|47.0|Standard Deviation|10.2|10.2|||
3949607|NCT01350479|3770775|B3|United States||Region of Enrollment||participants|Number|200|200.0||||||
3949608|NCT01350479|3770776|B2|United States||Region of Enrollment||participants|Number|106|106.0||||||
3949609|NCT01350479|3770777|B1|United States||Region of Enrollment||participants|Number|94|94.0||||||
3949610|NCT01350479|3770775|B3||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
3949611|NCT01350479|3770776|B2||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3949612|NCT01350479|3770777|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3949613|NCT01350479|3770775|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3949614|NCT01350479|3770776|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3949615|NCT01350479|3770777|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3949616|NCT01350479|3770775|B3|||Age||years|Mean|71|71.0|Standard Deviation|13|13.0|||
3949617|NCT01350479|3770776|B2|||Age||years|Mean|70|70.0|Standard Deviation|13|13.0|||
3949618|NCT01350479|3770777|B1|||Age||years|Mean|73|73.0|Standard Deviation|13|13.0|||
3949619|NCT01350414|3770784|B1|||amPEF (Peak Expiratory Flow)||L/min (liters per minute)|Mean|383.4|383.4|Standard Deviation|104.65|104.65|||
3949620|NCT01350414|3770784|B1|||Post-Bronchodilator FEV1 (Forced Expiratory Volume in 1 second)||% predicted|Mean|86|86.0|Standard Deviation|15.65|15.65|||
3949621|NCT01350414|3770784|B1|||Pre-Bronchodilator FEV1 (Forced Expiratory Volume in 1 second)||% predicted|Mean|77.8|77.8|Standard Deviation|15.67|15.67|||
3949622|NCT01350414|3770784|B1|||Asthma Quality of Life Questionnaire (AQLQ) Score|There are 32 questions in the AQLQ and they are in 4 domains (symptoms, activity limitation, emotional function and environmental stimuli). Patients are asked to think about how they have been during the previous two weeks and to respond to each of the 32 questions on a 7-point scale (7 = not impaired at all - 1 = severely impaired). The overall AQLQ score is the mean of all 32 responses and the individual domain scores are the means of the items in those domains.|Scores on a scale|Mean|4.32|4.32|Standard Deviation|1.15|1.15|||
3949623|NCT01350414|3770784|B1|||OCS Dose (Oral corticosteroids)|This measure includes only 7 participants using OCS at baseline.|mg/day|Mean|6.4|6.4|Standard Deviation|1.97|1.97|||
3949624|NCT01350414|3770784|B1|||LABA Dose (Long-acting Beta Agonists)||mcg/day|Mean|119.2|119.2|Standard Deviation|45.64|45.64|||
3949625|NCT01350414|3770784|B1|||ICS Dose (Inhaled Corticosteroid dose)||mcg/day (micrograms/day)|Mean|1943.9|1943.9|Standard Deviation|722.39|722.39|||
3949626|NCT01350414|3770784|B1|||Weight (kg)||kg|Mean|81.9|81.9|Standard Deviation|17.95|17.95|||
3949627|NCT01350414|3770784|B1|||Height (cm)||cm|Mean|166.8|166.8|Standard Deviation|8.94|8.94|||
3949628|NCT01350414|3770784|B1|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
3949629|NCT01350414|3770784|B1|United Kingdom||Region of Enrollment||participants|Number|27|27.0||||||
3949630|NCT01350414|3770784|B1|Australia||Region of Enrollment||participants|Number|7|7.0||||||
3949631|NCT01350414|3770784|B1|United States||Region of Enrollment||participants|Number|54|54.0||||||
3949632|NCT01350414|3770784|B1|Canada||Region of Enrollment||participants|Number|34|34.0||||||
3949633|NCT01350414|3770784|B1|Brazil||Region of Enrollment||participants|Number|54|54.0||||||
3949634|NCT01350414|3770784|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3949635|NCT01350414|3770784|B1||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3949636|NCT01350414|3770784|B1|||Age||years|Mean|40.8|40.8|Standard Deviation|11.81|11.81|||
3949637|NCT01350401|3770801|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949638|NCT01350401|3770801|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949639|NCT01350401|3770801|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3949640|NCT01350401|3770801|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949641|NCT01350401|3770801|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949642|NCT01350401|3770801|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949643|NCT01350401|3770801|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949644|NCT01350401|3770801|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949645|NCT01350401|3770801|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3949646|NCT01350401|3770801|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949647|NCT01350401|3770801|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3949648|NCT01350401|3770801|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3949649|NCT01350401|3770801|B1|||Age||Years|Median|49|49.0|Full Range|||41.0|61.0|
3949650|NCT01350401|3770801|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3949651|NCT01350401|3770801|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3949652|NCT01350401|3770801|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3949653|NCT01350388|3770811|B3|||Estimated Glomerular Filtration Rate (eGFR)||milliliters per minute|Mean|53.5|53.5|Standard Deviation|17.2|17.2|||
3949654|NCT01350388|3770812|B2|||Estimated Glomerular Filtration Rate (eGFR)||milliliters per minute|Mean|54.8|54.8|Standard Deviation|19.0|19.0|||
3949655|NCT01350388|3770813|B1|||Estimated Glomerular Filtration Rate (eGFR)||milliliters per minute|Mean|52.2|52.2|Standard Deviation|15.3|15.3|||
3949656|NCT01350388|3770811|B3|||Plasma Uric Acid Level||milligram per deciliter|Mean|7.2|7.2|Standard Deviation|1.4|1.4|||
3949657|NCT01350388|3770812|B2|||Plasma Uric Acid Level||milligram per deciliter|Mean|7.1|7.1|Standard Deviation|1.2|1.2|||
3949658|NCT01350388|3770813|B1|||Plasma Uric Acid Level||milligram per deciliter|Mean|7.2|7.2|Standard Deviation|1.5|1.5|||
3949659|NCT01350388|3770811|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3949660|NCT01350388|3770812|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3949661|NCT01350388|3770813|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3949662|NCT01350388|3770811|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3949663|NCT01350388|3770812|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3949664|NCT01350388|3770813|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3949665|NCT01350388|3770811|B3|||Age||years|Mean|68|68.0|Standard Deviation|10|10.0|||
3949666|NCT01350388|3770812|B2|||Age||years|Mean|68|68.0|Standard Deviation|11|11.0|||
3949667|NCT01350388|3770813|B1|||Age||years|Mean|67|67.0|Standard Deviation|10|10.0|||
3949668|NCT01350271|3770830|B4|Sri Lanka||Region of Enrollment||participants|Number|214|214.0||||||
3949669|NCT01350271|3770831|B3|Sri Lanka||Region of Enrollment||participants|Number|74|74.0||||||
3949670|NCT01350271|3770832|B2|Sri Lanka||Region of Enrollment||participants|Number|70|70.0||||||
3949671|NCT01350271|3770833|B1|Sri Lanka||Region of Enrollment||participants|Number|70|70.0||||||
3949672|NCT01350271|3770830|B4||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3949673|NCT01350271|3770831|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3949674|NCT01350271|3770832|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3949675|NCT01350271|3770833|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3949676|NCT01350271|3770830|B4||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3949677|NCT01350271|3770831|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3949678|NCT01350271|3770832|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3949679|NCT01350271|3770833|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3949680|NCT01350271|3770830|B4|||Age||years|Mean|34|34.0|Standard Deviation|18|18.0|||
3949681|NCT01350271|3770831|B3|||Age||years|Mean|32|32.0|Standard Deviation|18|18.0|||
3949682|NCT01350271|3770832|B2|||Age||years|Mean|36|36.0|Standard Deviation|19|19.0|||
3949683|NCT01350271|3770833|B1|||Age||years|Mean|34|34.0|Standard Deviation|18|18.0|||
3949684|NCT01350271|3770830|B4||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3949685|NCT01350271|3770831|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3949686|NCT01350271|3770832|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3949687|NCT01350271|3770833|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3949688|NCT01350271|3770830|B4||Between 18 and 65 years|Age||Participants|Count of Participants|144|144.0||||||
3949689|NCT01350271|3770831|B3||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3949690|NCT01350271|3770832|B2||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
3949691|NCT01350271|3770833|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3949692|NCT01350271|3770830|B4||<=18 years|Age||Participants|Count of Participants|58|58.0||||||
3949693|NCT01350271|3770831|B3||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
3949694|NCT01350271|3770832|B2||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
3949695|NCT01350271|3770833|B1||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
3949696|NCT01350258|3770849|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3949697|NCT01350258|3770849|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949698|NCT01350258|3770849|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3949699|NCT01350258|3770849|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949700|NCT01350258|3770849|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949701|NCT01350258|3770849|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949702|NCT01350258|3770849|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3949703|NCT01350258|3770849|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3949704|NCT01350258|3770849|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949705|NCT01350258|3770849|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949706|NCT01350258|3770849|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949707|NCT01350258|3770849|B1||Male|Gender||Participants|Count of Participants|7|7.0||||||
3949708|NCT01350258|3770849|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
3949709|NCT01350258|3770849|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3949710|NCT01350258|3770849|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3949711|NCT01350258|3770849|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3949712|NCT01350258|3770849|B1|||Age||years|Mean|60.43|60.43|Standard Deviation|7.86|7.86|||
3949713|NCT01350245|3770858|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
3949714|NCT01350245|3770858|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3949715|NCT01350245|3770858|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3949716|NCT01350245|3770858|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3949717|NCT01350245|3770858|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949718|NCT01350245|3770858|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949719|NCT01350245|3770858|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3949720|NCT01350245|3770858|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3949721|NCT01350245|3770858|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949722|NCT01350245|3770858|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3949723|NCT01350245|3770858|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949724|NCT01350245|3770858|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3949725|NCT01350245|3770858|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3949726|NCT01350245|3770858|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3949727|NCT01350245|3770858|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3949728|NCT01350245|3770858|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3949729|NCT01350245|3770858|B1|||Age||years|Mean|45.2|45.2|Standard Deviation|14.3|14.3|||
3949730|NCT01350232|3770863|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3949731|NCT01350232|3770863|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3949732|NCT01350232|3770863|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3949733|NCT01350232|3770863|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949734|NCT01350232|3770863|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949735|NCT01350232|3770863|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949736|NCT01350232|3770863|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3949737|NCT01350232|3770863|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3949738|NCT01350232|3770863|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949739|NCT01350232|3770863|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949740|NCT01350232|3770863|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949741|NCT01350232|3770863|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3949742|NCT01350232|3770863|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3949743|NCT01350232|3770863|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3949744|NCT01350232|3770863|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3949745|NCT01350232|3770863|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3949746|NCT01350232|3770863|B1|||Age||years|Mean|32.3|32.3|Standard Deviation|3.5|3.5|||
3949747|NCT01350141|3770874|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3949748|NCT01350141|3770875|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3949749|NCT01350141|3770876|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3949750|NCT01350141|3770877|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3949751|NCT01350141|3770874|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3949752|NCT01350141|3770875|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3949753|NCT01350141|3770876|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3949754|NCT01350141|3770877|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3949755|NCT01350141|3770874|B4|||Age||years|Mean|56|56.0|Standard Deviation|10.1|10.1|||
3949756|NCT01350141|3770875|B3|||Age||years|Mean|57.6|57.6|Standard Deviation|9.0|9.0|||
3949757|NCT01350141|3770876|B2|||Age||years|Mean|56.3|56.3|Standard Deviation|10.9|10.9|||
3949758|NCT01350141|3770877|B1|||Age||years|Mean|54.1|54.1|Standard Deviation|10.9|10.9|||
3949759|NCT01350128|3770913|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3949760|NCT01350128|3770913|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3949761|NCT01350128|3770913|B1|||Age||years|Mean|61.2|61.2|Standard Deviation|8.19|8.19|||
3949762|NCT01350115|3770975|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3949763|NCT01350115|3770976|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3949764|NCT01350115|3770977|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3949765|NCT01350115|3770975|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3949766|NCT01350115|3770976|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3949767|NCT01350115|3770977|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3949768|NCT01350115|3770975|B3|||Age||Years|Mean|53.6|53.6|Standard Deviation|10.95|10.95|37.0|68.0|
3949769|NCT01350115|3770976|B2|||Age||Years|Mean|66|66.0|Standard Deviation|2.00|2.0|64.0|68.0|
3949770|NCT01350115|3770977|B1|||Age||Years|Mean|50.5|50.5|Standard Deviation|9.90|9.9|37.0|68.0|
3949771|NCT01350102|3770990|B5|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3949772|NCT01350102|3770992|B3|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3949773|NCT01350102|3770993|B2|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3949774|NCT01350102|3770990|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3949775|NCT01350102|3770991|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3949776|NCT01350102|3770992|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3949777|NCT01350102|3770993|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3949778|NCT01350102|3770994|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3949779|NCT01350102|3770990|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3949780|NCT01350102|3770991|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3949781|NCT01350102|3770992|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3949782|NCT01350102|3770993|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3949783|NCT01350102|3770994|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3949784|NCT01350102|3770990|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3949785|NCT01350102|3770991|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3949786|NCT01350102|3770992|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3949787|NCT01350102|3770993|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3949788|NCT01350102|3770994|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3949789|NCT01350102|3770990|B5||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3949790|NCT01350102|3770991|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3949791|NCT01350102|3770992|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3949792|NCT01350102|3770993|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3949793|NCT01350102|3770994|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3949794|NCT01350102|3770990|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3949795|NCT01350102|3770991|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3949796|NCT01350102|3770992|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3949797|NCT01350102|3770993|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3949798|NCT01350102|3770994|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3949799|NCT01349972|3771015|B3||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3949800|NCT01349972|3771016|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3949801|NCT01349972|3771017|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3949802|NCT01349972|3771015|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3949803|NCT01349972|3771016|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3949804|NCT01349972|3771017|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3949805|NCT01349972|3771015|B3||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
3949806|NCT01349972|3771016|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3949807|NCT01349972|3771017|B1||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
3949808|NCT01349972|3771015|B3||Between 18 and 65 years|Age||Participants|Count of Participants|122|122.0||||||
3949809|NCT01349972|3771016|B2||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
3949810|NCT01349972|3771017|B1||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
3949811|NCT01349972|3771015|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3949812|NCT01349972|3771016|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3949813|NCT01349972|3771017|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3949814|NCT01349959|3771034|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3949815|NCT01349959|3771034|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949816|NCT01349959|3771034|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3949817|NCT01349959|3771034|B1||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3949818|NCT01349959|3771034|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3949819|NCT01349959|3771034|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949820|NCT01349959|3771034|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949821|NCT01349959|3771034|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949822|NCT01349959|3771034|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3949823|NCT01349959|3771034|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3949824|NCT01349959|3771034|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3949825|NCT01349959|3771034|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3949826|NCT01349959|3771034|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3949827|NCT01349959|3771034|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3949828|NCT01349959|3771034|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3949829|NCT01349959|3771034|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3949830|NCT01349933|3771040|B1|Hong Kong||Region of Enrollment||participants|Number|12|12.0||||||
3949831|NCT01349933|3771040|B1|Singapore||Region of Enrollment||participants|Number|9|9.0||||||
3949832|NCT01349933|3771040|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3949833|NCT01349933|3771040|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3949834|NCT01349933|3771040|B1|||Age||years|Median|47|47.0|Full Range|||32.0|67.0|
3949835|NCT01349920|3771050|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3949836|NCT01349920|3771050|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3949837|NCT01349920|3771050|B1|||Age||Years|Mean|25.0|25.0|Standard Deviation|9.6|9.6|||
3949838|NCT01349907|3771068|B3||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3949839|NCT01349907|3771069|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3949840|NCT01349907|3771070|B1||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3949841|NCT01349907|3771068|B3||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3949842|NCT01349907|3771069|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3949843|NCT01349907|3771070|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3949844|NCT01349907|3771068|B3|||Age||Years|Mean|13.8|13.8|Standard Deviation|2.0|2.0|||
3949845|NCT01349907|3771069|B2|||Age||Years|Mean|13.7|13.7|Standard Deviation|2.0|2.0|||
3949846|NCT01349907|3771070|B1|||Age||Years|Mean|13.8|13.8|Standard Deviation|2.0|2.0|||
3949847|NCT01349829|3771107|B3||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3949848|NCT01349829|3771108|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3949849|NCT01349829|3771109|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3949850|NCT01349829|3771107|B3||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3949851|NCT01349829|3771108|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3949852|NCT01349829|3771109|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3949853|NCT01349829|3771107|B3|||Age||months|Mean|27.8|27.8|Standard Deviation|8.33|8.33|||
3949854|NCT01349829|3771108|B2|||Age||months|Mean|27.9|27.9|Standard Deviation|8.23|8.23|||
3949855|NCT01349829|3771109|B1|||Age||months|Mean|27.6|27.6|Standard Deviation|8.45|8.45|||
3949856|NCT01349829|3771107|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3949857|NCT01349829|3771108|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3949858|NCT01349829|3771109|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3949859|NCT01349829|3771107|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3949860|NCT01349829|3771108|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3949861|NCT01349829|3771109|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3949862|NCT01349829|3771107|B3||<=18 years|Age||Participants|Count of Participants|251|251.0||||||
3949863|NCT01349829|3771108|B2||<=18 years|Age||Participants|Count of Participants|125|125.0||||||
3949864|NCT01349829|3771109|B1||<=18 years|Age||Participants|Count of Participants|126|126.0||||||
3949865|NCT01349816|3771128|B1||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3949866|NCT01349816|3771128|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3949867|NCT01349816|3771128|B1|||Age||Years|Mean|62.1|62.1|Standard Deviation|9.18|9.18|||
3949868|NCT01349803|3771190|B5||Male|Gender||Participants|Count of Participants|115|115.0||||||
3949869|NCT01349803|3771191|B4||Male|Gender||Participants|Count of Participants|28|28.0||||||
3949870|NCT01349803|3771192|B3||Male|Gender||Participants|Count of Participants|34|34.0||||||
3949871|NCT01349803|3771193|B2||Male|Gender||Participants|Count of Participants|26|26.0||||||
3949872|NCT01349803|3771194|B1||Male|Gender||Participants|Count of Participants|27|27.0||||||
3949873|NCT01349803|3771190|B5||Female|Gender||Participants|Count of Participants|122|122.0||||||
3949874|NCT01349803|3771191|B4||Female|Gender||Participants|Count of Participants|31|31.0||||||
3949875|NCT01349803|3771192|B3||Female|Gender||Participants|Count of Participants|26|26.0||||||
3949876|NCT01349803|3771193|B2||Female|Gender||Participants|Count of Participants|32|32.0||||||
3949877|NCT01349803|3771194|B1||Female|Gender||Participants|Count of Participants|33|33.0||||||
3949878|NCT01349803|3771190|B5|||Age||Years|Mean|64.0|64.0|Standard Deviation|7.80|7.8|||
3949879|NCT01349803|3771191|B4|||Age||Years|Mean|64.1|64.1|Standard Deviation|7.91|7.91|||
3949880|NCT01349803|3771192|B3|||Age||Years|Mean|64.3|64.3|Standard Deviation|7.38|7.38|||
3949881|NCT01349803|3771193|B2|||Age||Years|Mean|63.3|63.3|Standard Deviation|7.93|7.93|||
3949882|NCT01349803|3771194|B1|||Age||Years|Mean|64.1|64.1|Standard Deviation|8.13|8.13|||
3949883|NCT01349790|3771267|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3949884|NCT01349790|3771267|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3949885|NCT01349790|3771267|B1|||Age||years|Mean|36.7|36.7|Standard Deviation|15.34|15.34|||
3949886|NCT01349660|3771286|B4||Bevacizumab Naive|Prior Treatment with Bevacizumab||Participants|Count of Participants|57|57.0||||||
3949887|NCT01349660|3771287|B3||Bevacizumab Naive|Prior Treatment with Bevacizumab||Participants|Count of Participants|57|57.0||||||
3949888|NCT01349660|3771286|B4||Prior Bevacizumab Treatment|Prior Treatment with Bevacizumab||Participants|Count of Participants|19|19.0||||||
3949889|NCT01349660|3771287|B3||Prior Bevacizumab Treatment|Prior Treatment with Bevacizumab||Participants|Count of Participants|19|19.0||||||
3949890|NCT01349660|3771286|B4||Lung|Primary Tumor Type||Participants|Count of Participants|2|2.0||||||
3949891|NCT01349660|3771287|B3||Lung|Primary Tumor Type||Participants|Count of Participants|0|0.0||||||
3949892|NCT01349660|3771288|B2||Lung|Primary Tumor Type||Participants|Count of Participants|0|0.0||||||
3949893|NCT01349660|3771289|B1||Lung|Primary Tumor Type||Participants|Count of Participants|2|2.0||||||
3949894|NCT01349660|3771286|B4||Colorectal|Primary Tumor Type||Participants|Count of Participants|5|5.0||||||
3949895|NCT01349660|3771287|B3||Colorectal|Primary Tumor Type||Participants|Count of Participants|0|0.0||||||
3949896|NCT01349660|3771288|B2||Colorectal|Primary Tumor Type||Participants|Count of Participants|3|3.0||||||
3949897|NCT01349660|3771289|B1||Colorectal|Primary Tumor Type||Participants|Count of Participants|2|2.0||||||
3949898|NCT01349660|3771286|B4||Glioblastoma Multiforme|Primary Tumor Type||Participants|Count of Participants|81|81.0||||||
3949899|NCT01349660|3771287|B3||Glioblastoma Multiforme|Primary Tumor Type||Participants|Count of Participants|76|76.0||||||
3949900|NCT01349660|3771288|B2||Glioblastoma Multiforme|Primary Tumor Type||Participants|Count of Participants|3|3.0||||||
3949901|NCT01349660|3771289|B1||Glioblastoma Multiforme|Primary Tumor Type||Participants|Count of Participants|2|2.0||||||
3949902|NCT01349660|3771286|B4|United States||Region of Enrollment||participants|Number|88|88.0||||||
3949903|NCT01349660|3771287|B3|United States||Region of Enrollment||participants|Number|76|76.0||||||
3949904|NCT01349660|3771288|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3949905|NCT01349660|3771289|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3949906|NCT01349660|3771286|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3949907|NCT01349660|3771287|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3949908|NCT01349660|3771288|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949909|NCT01349660|3771289|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949910|NCT01349660|3771286|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949911|NCT01349660|3771287|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949912|NCT01349660|3771288|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949913|NCT01349660|3771289|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949914|NCT01349660|3771286|B4||White|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3949915|NCT01349660|3771287|B3||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3949916|NCT01349660|3771288|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3949917|NCT01349660|3771289|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3949918|NCT01349660|3771286|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3949919|NCT01349660|3771287|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3949920|NCT01349660|3771288|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949921|NCT01349660|3771289|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949922|NCT01349660|3771286|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949923|NCT01349660|3771287|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949924|NCT01349660|3771288|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949925|NCT01349660|3771289|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949926|NCT01349660|3771286|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949927|NCT01349660|3771287|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949928|NCT01349660|3771288|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949929|NCT01349660|3771289|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949930|NCT01349660|3771286|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949931|NCT01349660|3771287|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949932|NCT01349660|3771288|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949933|NCT01349660|3771289|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3949934|NCT01349660|3771286|B4||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3949935|NCT01349660|3771287|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3949936|NCT01349660|3771288|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3949937|NCT01349660|3771289|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3949938|NCT01349660|3771286|B4||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3949939|NCT01349660|3771287|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3949940|NCT01349660|3771288|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3949941|NCT01349660|3771289|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3949942|NCT01349660|3771286|B4|||Age||years|Median|57|57.0|Full Range|||19.0|82.0|
3949943|NCT01349660|3771287|B3|||Age||years|Median|57|57.0|Full Range|||19.0|77.0|
3949944|NCT01349660|3771288|B2|||Age||years|Median|64|64.0|Full Range|||43.0|82.0|
3949945|NCT01349660|3771289|B1|||Age||years|Median|61|61.0|Full Range|||44.0|82.0|
3949946|NCT01349595|3771307|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3949947|NCT01349595|3771308|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3949948|NCT01349595|3771309|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3949949|NCT01349595|3771307|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3949950|NCT01349595|3771308|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3949951|NCT01349595|3771309|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3949952|NCT01349595|3771307|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3949953|NCT01349595|3771308|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3949954|NCT01349595|3771309|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3949955|NCT01349595|3771307|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3949956|NCT01349595|3771308|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3949957|NCT01349595|3771309|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3949958|NCT01349595|3771307|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3949959|NCT01349595|3771308|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3949960|NCT01349595|3771309|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3949961|NCT01349595|3771307|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3949962|NCT01349595|3771308|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3949963|NCT01349595|3771309|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3949964|NCT01349491|3771316|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3949965|NCT01349491|3771317|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3949966|NCT01349491|3771318|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3949967|NCT01349491|3771316|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3949968|NCT01349491|3771317|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3949969|NCT01349491|3771318|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3949970|NCT01349491|3771316|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3949971|NCT01349491|3771317|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3949972|NCT01349491|3771318|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3949973|NCT01349491|3771316|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3949974|NCT01349491|3771317|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3949975|NCT01349491|3771318|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3949976|NCT01349491|3771316|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3949977|NCT01349491|3771317|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3949978|NCT01349491|3771318|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3949979|NCT01349491|3771316|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3949980|NCT01349491|3771317|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3949981|NCT01349491|3771318|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3949982|NCT01349465|3771325|B3||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3949983|NCT01349465|3771326|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3949984|NCT01349465|3771327|B1||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3949985|NCT01349465|3771325|B3||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3949986|NCT01349465|3771326|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3949987|NCT01349465|3771327|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3949988|NCT01349465|3771325|B3|||Age||years|Median|53|53.0|Full Range|||22.0|70.0|
3949989|NCT01349465|3771326|B2|||Age||years|Median|56|56.0|Full Range|||28.0|70.0|
3949990|NCT01349465|3771327|B1|||Age||years|Median|52|52.0|Full Range|||22.0|70.0|
3949991|NCT01349231|3771340|B1|||Yale-Brown Obsessive Compulsive Scale (Y-BOCS)|The Yale-Brown Obsessive Compulsive Scale (Y-BOCS) assesses obsessive and compulsive symptom severity. Obsessions are rated on a scale from 0-20 and compulsions are rated on a scale of 0-20 for a total scale of 0-40. Scores on the obsessions scale and scores on the compulsions scale are summed to obtain the total score. Lower values represent better outcomes.|units on a scale|Mean|32.9|32.9|Standard Deviation|1.9|1.9|||
3949992|NCT01349231|3771340|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3949993|NCT01349231|3771340|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3949994|NCT01349231|3771340|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3949995|NCT01349231|3771340|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3949996|NCT01349231|3771340|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3949997|NCT01349231|3771340|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3949998|NCT01349231|3771340|B1|||Age||years|Mean|41.7|41.7|Standard Deviation|13.5|13.5|||
3949999|NCT01349192|3771347|B3||>100%|FEV1 Percent of Predicted Category||Participants|Count of Participants|23|23.0||||||
3950000|NCT01349192|3771348|B2||>100%|FEV1 Percent of Predicted Category||Participants|Count of Participants|12|12.0||||||
3950001|NCT01349192|3771349|B1||>100%|FEV1 Percent of Predicted Category||Participants|Count of Participants|11|11.0||||||
3950002|NCT01349192|3771347|B3||>75% to <=100%|FEV1 Percent of Predicted Category||Participants|Count of Participants|12|12.0||||||
3950003|NCT01349192|3771348|B2||>75% to <=100%|FEV1 Percent of Predicted Category||Participants|Count of Participants|5|5.0||||||
3950004|NCT01349192|3771349|B1||>75% to <=100%|FEV1 Percent of Predicted Category||Participants|Count of Participants|7|7.0||||||
3950005|NCT01349192|3771347|B3||>50% to <=75%|FEV1 Percent of Predicted Category||Participants|Count of Participants|1|1.0||||||
3950006|NCT01349192|3771348|B2||>50% to <=75%|FEV1 Percent of Predicted Category||Participants|Count of Participants|0|0.0||||||
3950007|NCT01349192|3771349|B1||>50% to <=75%|FEV1 Percent of Predicted Category||Participants|Count of Participants|1|1.0||||||
3950008|NCT01349192|3771347|B3||>=30% to <=50%|FEV1 Percent of Predicted Category||Participants|Count of Participants|1|1.0||||||
3950009|NCT01349192|3771348|B2||>=30% to <=50%|FEV1 Percent of Predicted Category||Participants|Count of Participants|0|0.0||||||
3950010|NCT01349192|3771349|B1||>=30% to <=50%|FEV1 Percent of Predicted Category||Participants|Count of Participants|1|1.0||||||
3950011|NCT01349192|3771347|B3|||FEV1 Percent of Predicted|Percent of predicted forced expiratory volume in one second, based on Wang and Hankinson reference equations.|percent|Mean|99.8|99.8|Standard Deviation|17.6|17.6|||
3950012|NCT01349192|3771348|B2|||FEV1 Percent of Predicted|Percent of predicted forced expiratory volume in one second, based on Wang and Hankinson reference equations.|percent|Mean|101.2|101.2|Standard Deviation|11.8|11.8|||
3950013|NCT01349192|3771349|B1|||FEV1 Percent of Predicted|Percent of predicted forced expiratory volume in one second, based on Wang and Hankinson reference equations.|percent|Mean|98.5|98.5|Standard Deviation|21.6|21.6|||
3950014|NCT01349192|3771347|B3||Unidentified|CF Genotype||Participants|Count of Participants|0|0.0||||||
3950015|NCT01349192|3771348|B2||Unidentified|CF Genotype||Participants|Count of Participants|0|0.0||||||
3950016|NCT01349192|3771349|B1||Unidentified|CF Genotype||Participants|Count of Participants|0|0.0||||||
3950017|NCT01349192|3771347|B3||Other|CF Genotype||Participants|Count of Participants|6|6.0||||||
3950018|NCT01349192|3771348|B2||Other|CF Genotype||Participants|Count of Participants|2|2.0||||||
3950019|NCT01349192|3771349|B1||Other|CF Genotype||Participants|Count of Participants|4|4.0||||||
3950020|NCT01349192|3771347|B3||Delta F508 Heterozygous|CF Genotype||Participants|Count of Participants|21|21.0||||||
3950021|NCT01349192|3771348|B2||Delta F508 Heterozygous|CF Genotype||Participants|Count of Participants|7|7.0||||||
3950022|NCT01349192|3771349|B1||Delta F508 Heterozygous|CF Genotype||Participants|Count of Participants|14|14.0||||||
3950023|NCT01349192|3771347|B3||Delta F508 Homozygous|CF Genotype||Participants|Count of Participants|18|18.0||||||
3950024|NCT01349192|3771348|B2||Delta F508 Homozygous|CF Genotype||Participants|Count of Participants|12|12.0||||||
3950025|NCT01349192|3771349|B1||Delta F508 Homozygous|CF Genotype||Participants|Count of Participants|6|6.0||||||
3950026|NCT01349192|3771347|B3|Race/Ethnicity Combined|Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3950027|NCT01349192|3771348|B2|Race/Ethnicity Combined|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3950028|NCT01349192|3771349|B1|Race/Ethnicity Combined|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3950029|NCT01349192|3771347|B3|Race/Ethnicity Combined|African-American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3950030|NCT01349192|3771348|B2|Race/Ethnicity Combined|African-American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3950031|NCT01349192|3771349|B1|Race/Ethnicity Combined|African-American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3950032|NCT01349192|3771347|B3|Race/Ethnicity Combined|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3950033|NCT01349192|3771348|B2|Race/Ethnicity Combined|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3950034|NCT01349192|3771349|B1|Race/Ethnicity Combined|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3950035|NCT01349192|3771347|B3|Race/Ethnicity Combined|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3950036|NCT01349192|3771348|B2|Race/Ethnicity Combined|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3950037|NCT01349192|3771349|B1|Race/Ethnicity Combined|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3950038|NCT01349192|3771347|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3950039|NCT01349192|3771348|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3950040|NCT01349192|3771349|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3950041|NCT01349192|3771347|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3950042|NCT01349192|3771348|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3950043|NCT01349192|3771349|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3950044|NCT01349192|3771347|B3|Age Category|>18 years|Age, Customized||Participants|Count of Participants|6|6.0||||||
3950045|NCT01349192|3771348|B2|Age Category|>18 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
3950046|NCT01349192|3771349|B1|Age Category|>18 years|Age, Customized||Participants|Count of Participants|5|5.0||||||
3950047|NCT01349192|3771347|B3|Age Category|>=12 and <18 years|Age, Customized||Participants|Count of Participants|11|11.0||||||
3950048|NCT01349192|3771348|B2|Age Category|>=12 and <18 years|Age, Customized||Participants|Count of Participants|5|5.0||||||
3950049|NCT01349192|3771349|B1|Age Category|>=12 and <18 years|Age, Customized||Participants|Count of Participants|6|6.0||||||
3950050|NCT01349192|3771347|B3|Age Category|>=4 and <12 years|Age, Customized||Participants|Count of Participants|28|28.0||||||
3950051|NCT01349192|3771348|B2|Age Category|>=4 and <12 years|Age, Customized||Participants|Count of Participants|15|15.0||||||
3950052|NCT01349192|3771349|B1|Age Category|>=4 and <12 years|Age, Customized||Participants|Count of Participants|13|13.0||||||
3950053|NCT01349192|3771347|B3|||Age||years|Mean|11.5|11.5|Standard Deviation|6.1|6.1|||
3950054|NCT01349192|3771348|B2|||Age||years|Mean|10.5|10.5|Standard Deviation|5.5|5.5|||
3950055|NCT01349192|3771349|B1|||Age||years|Mean|12.3|12.3|Standard Deviation|6.6|6.6|||
3950056|NCT01349114|3771362|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
3950057|NCT01349114|3771363|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3950058|NCT01349114|3771364|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3950059|NCT01349114|3771362|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3950060|NCT01349114|3771363|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3950061|NCT01349114|3771364|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3950062|NCT01349114|3771362|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3950063|NCT01349114|3771363|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3950064|NCT01349114|3771364|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3950065|NCT01349114|3771362|B3|||Age||years|Mean|60.7|60.7|Standard Deviation|9.8|9.8|||
3950066|NCT01349114|3771363|B2|||Age||years|Mean|63.4|63.4|Standard Deviation|8.3|8.3|||
3950067|NCT01349114|3771364|B1|||Age||years|Mean|57.3|57.3|Standard Deviation|11|11.0|||
3950068|NCT01349114|3771362|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3950069|NCT01349114|3771363|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3950070|NCT01349114|3771364|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3950071|NCT01349114|3771362|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3950072|NCT01349114|3771363|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3950073|NCT01349114|3771364|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3950074|NCT01349114|3771362|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3950075|NCT01349114|3771363|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3950076|NCT01349114|3771364|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3950077|NCT01348854|3771373|B3|Germany||Region of Enrollment||paticipants|Number|20|20.0||||||
3950078|NCT01348854|3771374|B2|Germany||Region of Enrollment||paticipants|Number|3|3.0||||||
3950079|NCT01348854|3771375|B1|Germany||Region of Enrollment||paticipants|Number|17|17.0||||||
3950080|NCT01348854|3771373|B3|Austria||Region of Enrollment||paticipants|Number|19|19.0||||||
3950081|NCT01348854|3771374|B2|Austria||Region of Enrollment||paticipants|Number|2|2.0||||||
3950082|NCT01348854|3771375|B1|Austria||Region of Enrollment||paticipants|Number|17|17.0||||||
3950083|NCT01348854|3771373|B3|France||Region of Enrollment||paticipants|Number|1|1.0||||||
3950084|NCT01348854|3771374|B2|France||Region of Enrollment||paticipants|Number|1|1.0||||||
3950085|NCT01348854|3771375|B1|France||Region of Enrollment||paticipants|Number|0|0.0||||||
3950086|NCT01348854|3771373|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3950087|NCT01348854|3771374|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3950088|NCT01348854|3771375|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3950089|NCT01348854|3771373|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3950090|NCT01348854|3771374|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3950091|NCT01348854|3771375|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3950092|NCT01348854|3771373|B3|||Age||years|Mean|53.7|53.7|Standard Deviation|16.6|16.6|||
3950093|NCT01348854|3771374|B2|||Age||years|Mean|55.0|55.0|Standard Deviation|15.9|15.9|||
3950094|NCT01348854|3771375|B1|||Age||years|Mean|52.4|52.4|Standard Deviation|16.6|16.6|||
3950095|NCT01348789|3771384|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
3950096|NCT01348789|3771384|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3950097|NCT01348789|3771384|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3950098|NCT01348789|3771384|B1|||Age||years|Mean|32.5|32.5|Standard Deviation|8.1|8.1|||
3950099|NCT01348789|3771384|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3950100|NCT01348789|3771384|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3950101|NCT01348789|3771384|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3950102|NCT01348776|3771395|B1|United States||Region of Enrollment||participants|Number|87|87.0||||||
3950103|NCT01348776|3771395|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3950104|NCT01348776|3771395|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3950105|NCT01348776|3771395|B1|||Age||years|Mean|36.4|36.4|Standard Deviation|9|9.0|||
3950106|NCT01348776|3771395|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3950107|NCT01348776|3771395|B1||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
3950108|NCT01348776|3771395|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3950109|NCT01348698|3771408|B1|United States||Region of Enrollment||Participants|Count of Participants|74|74.0||||||
3950110|NCT01348698|3771408|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3950111|NCT01348698|3771408|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950112|NCT01348698|3771408|B1||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3950113|NCT01348698|3771408|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3950114|NCT01348698|3771408|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3950115|NCT01348698|3771408|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3950116|NCT01348698|3771408|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950117|NCT01348698|3771408|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3950118|NCT01348698|3771408|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3950119|NCT01348698|3771408|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3950120|NCT01348698|3771408|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3950121|NCT01348698|3771408|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3950122|NCT01348698|3771408|B1|||Age||years|Mean|54.33|54.33|Standard Deviation|12.58|12.58|||
3950123|NCT01348698|3771408|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3950124|NCT01348698|3771408|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3950125|NCT01348698|3771408|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3950126|NCT01348607|3771415|B4|United States||Region of Enrollment||participants|Number|1|1.0||||||
3950127|NCT01348607|3771418|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3950128|NCT01348607|3771415|B4|Male||Gender||participants|Number|1|1.0||||||
3950129|NCT01348607|3771418|B1|Male||Gender||participants|Number|1|1.0||||||
3950130|NCT01348607|3771415|B4|Female||Gender||participants|Number|0|0.0||||||
3950131|NCT01348607|3771418|B1|Female||Gender||participants|Number|0|0.0||||||
3950132|NCT01348607|3771415|B4|||Age||years|Mean|13.9|13.9|Standard Deviation|||||
3950133|NCT01348607|3771418|B1|||Age||years|Mean|13.9|13.9|Standard Deviation|||||
3950134|NCT01348607|3771415|B4|>=65 years||Age||participants|Number|0|0.0||||||
3950135|NCT01348607|3771418|B1|>=65 years||Age||participants|Number|0|0.0||||||
3950136|NCT01348607|3771415|B4|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
3950137|NCT01348607|3771418|B1|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
3950138|NCT01348607|3771415|B4|<=18 years||Age||participants|Number|1|1.0||||||
3950139|NCT01348607|3771418|B1|<=18 years||Age||participants|Number|1|1.0||||||
3950140|NCT01348425|3771431|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3950141|NCT01348425|3771432|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3950142|NCT01348425|3771433|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3950143|NCT01348425|3771431|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3950144|NCT01348425|3771432|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3950145|NCT01348425|3771433|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3950146|NCT01348425|3771431|B3|||Age||years|Mean|68.8|68.8|Standard Deviation|9|9.0|||
3950147|NCT01348425|3771432|B2|||Age||years|Mean|71.6|71.6|Standard Deviation|8.3|8.3|||
3950148|NCT01348425|3771433|B1|||Age||years|Mean|67.6|67.6|Standard Deviation|9.2|9.2|||
3950149|NCT01348347|3771439|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3950150|NCT01348347|3771440|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3950151|NCT01348347|3771441|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3950152|NCT01348347|3771442|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3950153|NCT01348347|3771439|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3950154|NCT01348347|3771440|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3950155|NCT01348347|3771441|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3950156|NCT01348347|3771442|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3950157|NCT01348347|3771439|B4|||Age||Years|Mean|61.7|61.7|Standard Deviation|9.8|9.8|||
3950158|NCT01348347|3771440|B3|||Age||Years|Mean|60.8|60.8|Standard Deviation|8.6|8.6|||
3950159|NCT01348347|3771441|B2|||Age||Years|Mean|58.8|58.8|Standard Deviation|11.4|11.4|||
3950160|NCT01348347|3771442|B1|||Age||Years|Mean|69.0|69.0|Standard Deviation|7.9|7.9|||
3950161|NCT01348165|3771468|B8|Drinks - possible interference||Alcohol Status|Level of interference was based on if a subject drank alcohol to an extent that would interfere with the objectives of the trial.|participants|Number|0|0.0||||||
3950162|NCT01348165|3771469|B7|Drinks - possible interference||Alcohol Status|Level of interference was based on if a subject drank alcohol to an extent that would interfere with the objectives of the trial.|participants|Number|0|0.0||||||
3950163|NCT01348165|3771470|B6|Drinks - possible interference||Alcohol Status|Level of interference was based on if a subject drank alcohol to an extent that would interfere with the objectives of the trial.|participants|Number|0|0.0||||||
3950164|NCT01348165|3771471|B5|Drinks - possible interference||Alcohol Status|Level of interference was based on if a subject drank alcohol to an extent that would interfere with the objectives of the trial.|participants|Number|0|0.0||||||
3950165|NCT01348165|3771472|B4|Drinks - possible interference||Alcohol Status|Level of interference was based on if a subject drank alcohol to an extent that would interfere with the objectives of the trial.|participants|Number|0|0.0||||||
3950166|NCT01348165|3771473|B3|Drinks - possible interference||Alcohol Status|Level of interference was based on if a subject drank alcohol to an extent that would interfere with the objectives of the trial.|participants|Number|0|0.0||||||
3950167|NCT01348165|3771474|B2|Drinks - possible interference||Alcohol Status|Level of interference was based on if a subject drank alcohol to an extent that would interfere with the objectives of the trial.|participants|Number|0|0.0||||||
3950168|NCT01348165|3771475|B1|Drinks - possible interference||Alcohol Status|Level of interference was based on if a subject drank alcohol to an extent that would interfere with the objectives of the trial.|participants|Number|0|0.0||||||
3950169|NCT01348165|3771468|B8|Drinks - no interference||Alcohol Status|Level of interference was based on if a subject drank alcohol to an extent that would interfere with the objectives of the trial.|participants|Number|38|38.0||||||
3950170|NCT01348165|3771469|B7|Drinks - no interference||Alcohol Status|Level of interference was based on if a subject drank alcohol to an extent that would interfere with the objectives of the trial.|participants|Number|5|5.0||||||
3950171|NCT01348165|3771470|B6|Drinks - no interference||Alcohol Status|Level of interference was based on if a subject drank alcohol to an extent that would interfere with the objectives of the trial.|participants|Number|1|1.0||||||
3950172|NCT01348165|3771471|B5|Drinks - no interference||Alcohol Status|Level of interference was based on if a subject drank alcohol to an extent that would interfere with the objectives of the trial.|participants|Number|6|6.0||||||
3950173|NCT01348165|3771472|B4|Drinks - no interference||Alcohol Status|Level of interference was based on if a subject drank alcohol to an extent that would interfere with the objectives of the trial.|participants|Number|6|6.0||||||
3950174|NCT01348165|3771473|B3|Drinks - no interference||Alcohol Status|Level of interference was based on if a subject drank alcohol to an extent that would interfere with the objectives of the trial.|participants|Number|6|6.0||||||
3950175|NCT01348165|3771474|B2|Drinks - no interference||Alcohol Status|Level of interference was based on if a subject drank alcohol to an extent that would interfere with the objectives of the trial.|participants|Number|5|5.0||||||
3950176|NCT01348165|3771475|B1|Drinks - no interference||Alcohol Status|Level of interference was based on if a subject drank alcohol to an extent that would interfere with the objectives of the trial.|participants|Number|9|9.0||||||
3950177|NCT01348165|3771468|B8|Never Drinker||Alcohol Status|Level of interference was based on if a subject drank alcohol to an extent that would interfere with the objectives of the trial.|participants|Number|2|2.0||||||
3950178|NCT01348165|3771469|B7|Never Drinker||Alcohol Status|Level of interference was based on if a subject drank alcohol to an extent that would interfere with the objectives of the trial.|participants|Number|1|1.0||||||
3950179|NCT01348165|3771470|B6|Never Drinker||Alcohol Status|Level of interference was based on if a subject drank alcohol to an extent that would interfere with the objectives of the trial.|participants|Number|0|0.0||||||
3950180|NCT01348165|3771471|B5|Never Drinker||Alcohol Status|Level of interference was based on if a subject drank alcohol to an extent that would interfere with the objectives of the trial.|participants|Number|0|0.0||||||
3950181|NCT01348165|3771472|B4|Never Drinker||Alcohol Status|Level of interference was based on if a subject drank alcohol to an extent that would interfere with the objectives of the trial.|participants|Number|0|0.0||||||
3950182|NCT01348165|3771473|B3|Never Drinker||Alcohol Status|Level of interference was based on if a subject drank alcohol to an extent that would interfere with the objectives of the trial.|participants|Number|0|0.0||||||
3950183|NCT01348165|3771474|B2|Never Drinker||Alcohol Status|Level of interference was based on if a subject drank alcohol to an extent that would interfere with the objectives of the trial.|participants|Number|0|0.0||||||
3950184|NCT01348165|3771475|B1|Never Drinker||Alcohol Status|Level of interference was based on if a subject drank alcohol to an extent that would interfere with the objectives of the trial.|participants|Number|1|1.0||||||
3950185|NCT01348165|3771468|B8|Currently Smokes||Smoking Status||participants|Number|10|10.0||||||
3950186|NCT01348165|3771469|B7|Currently Smokes||Smoking Status||participants|Number|2|2.0||||||
3950187|NCT01348165|3771470|B6|Currently Smokes||Smoking Status||participants|Number|0|0.0||||||
3950188|NCT01348165|3771471|B5|Currently Smokes||Smoking Status||participants|Number|1|1.0||||||
3950189|NCT01348165|3771472|B4|Currently Smokes||Smoking Status||participants|Number|1|1.0||||||
3950190|NCT01348165|3771473|B3|Currently Smokes||Smoking Status||participants|Number|0|0.0||||||
3950191|NCT01348165|3771474|B2|Currently Smokes||Smoking Status||participants|Number|1|1.0||||||
3950192|NCT01348165|3771475|B1|Currently Smokes||Smoking Status||participants|Number|5|5.0||||||
3950193|NCT01348165|3771468|B8|Ex-Smoker||Smoking Status||participants|Number|8|8.0||||||
3950194|NCT01348165|3771469|B7|Ex-Smoker||Smoking Status||participants|Number|0|0.0||||||
3950195|NCT01348165|3771470|B6|Ex-Smoker||Smoking Status||participants|Number|0|0.0||||||
3950196|NCT01348165|3771471|B5|Ex-Smoker||Smoking Status||participants|Number|2|2.0||||||
3950197|NCT01348165|3771472|B4|Ex-Smoker||Smoking Status||participants|Number|0|0.0||||||
3950198|NCT01348165|3771473|B3|Ex-Smoker||Smoking Status||participants|Number|1|1.0||||||
3950199|NCT01348165|3771474|B2|Ex-Smoker||Smoking Status||participants|Number|2|2.0||||||
3950200|NCT01348165|3771475|B1|Ex-Smoker||Smoking Status||participants|Number|3|3.0||||||
3950201|NCT01348165|3771468|B8|Never Smoked||Smoking Status||participants|Number|22|22.0||||||
3950202|NCT01348165|3771469|B7|Never Smoked||Smoking Status||participants|Number|4|4.0||||||
3950203|NCT01348165|3771470|B6|Never Smoked||Smoking Status||participants|Number|1|1.0||||||
3950204|NCT01348165|3771471|B5|Never Smoked||Smoking Status||participants|Number|3|3.0||||||
3950205|NCT01348165|3771472|B4|Never Smoked||Smoking Status||participants|Number|5|5.0||||||
3950206|NCT01348165|3771473|B3|Never Smoked||Smoking Status||participants|Number|5|5.0||||||
3950207|NCT01348165|3771474|B2|Never Smoked||Smoking Status||participants|Number|2|2.0||||||
3950208|NCT01348165|3771475|B1|Never Smoked||Smoking Status||participants|Number|2|2.0||||||
3950209|NCT01348165|3771468|B8||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3950210|NCT01348165|3771469|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3950211|NCT01348165|3771470|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3950212|NCT01348165|3771471|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3950213|NCT01348165|3771472|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3950214|NCT01348165|3771473|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3950215|NCT01348165|3771474|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3950216|NCT01348165|3771475|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3950217|NCT01348165|3771468|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3950218|NCT01348165|3771469|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3950219|NCT01348165|3771470|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3950220|NCT01348165|3771471|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3950221|NCT01348165|3771472|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3950222|NCT01348165|3771473|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3950223|NCT01348165|3771474|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3950224|NCT01348165|3771475|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3950225|NCT01348165|3771468|B8|||Age||Years|Mean|36.8|36.8|Standard Deviation|7.9|7.9|||
3950226|NCT01348165|3771469|B7|||Age||Years|Mean|35.5|35.5|Standard Deviation|8.5|8.5|||
3950227|NCT01348165|3771470|B6|||Age||Years|Mean|42.0|42.0|Standard Deviation|NA||||Measure of variation not applicable as only one patient in treatment group
3950228|NCT01348165|3771471|B5|||Age||Years|Mean|36.5|36.5|Standard Deviation|10.0|10.0|||
3950229|NCT01348165|3771472|B4|||Age||Years|Mean|37.2|37.2|Standard Deviation|7.1|7.1|||
3950230|NCT01348165|3771473|B3|||Age||Years|Mean|40.8|40.8|Standard Deviation|6.6|6.6|||
3950231|NCT01348165|3771474|B2|||Age||Years|Mean|34.8|34.8|Standard Deviation|10.3|10.3|||
3950232|NCT01348165|3771475|B1|||Age||Years|Mean|35.7|35.7|Standard Deviation|7.6|7.6|||
3950233|NCT01348139|3771610|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3950234|NCT01348139|3771610|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3950235|NCT01348139|3771610|B1|White||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
3950236|NCT01348139|3771610|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3950237|NCT01348139|3771610|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3950238|NCT01348139|3771610|B1|All||Age||Years|Mean|36.5|36.5|Standard Deviation|11.29|11.29|||
3950239|NCT01348100|3771689|B8||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3950240|NCT01348100|3771690|B7||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3950241|NCT01348100|3771691|B6||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3950242|NCT01348100|3771692|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3950243|NCT01348100|3771693|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3950244|NCT01348100|3771694|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3950245|NCT01348100|3771695|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3950246|NCT01348100|3771696|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3950247|NCT01348100|3771689|B8||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3950248|NCT01348100|3771690|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3950249|NCT01348100|3771691|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3950250|NCT01348100|3771692|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3950251|NCT01348100|3771693|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3950252|NCT01348100|3771694|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3950253|NCT01348100|3771695|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3950254|NCT01348100|3771696|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3950255|NCT01348100|3771689|B8|||Age||years|Mean|43.3|43.3|Standard Deviation|11.60|11.6|||
3950256|NCT01348100|3771690|B7|||Age||years|Mean|45.1|45.1|Standard Deviation|11.21|11.21|||
3950257|NCT01348100|3771691|B6|||Age||years|Mean|41.3|41.3|Standard Deviation|10.03|10.03|||
3950258|NCT01348100|3771692|B5|||Age||years|Mean|42.3|42.3|Standard Deviation|10.62|10.62|||
3950259|NCT01348100|3771693|B4|||Age||years|Mean|43.5|43.5|Standard Deviation|13.02|13.02|||
3950260|NCT01348100|3771694|B3|||Age||years|Mean|45.5|45.5|Standard Deviation|14.81|14.81|||
3950261|NCT01348100|3771695|B2|||Age||years|Mean|35.5|35.5|Standard Deviation|12.02|12.02|||
3950262|NCT01348100|3771696|B1|||Age||years|Mean|42.0|42.0|Standard Deviation|2.83|2.83|||
3950263|NCT01348087|3771747|B1||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3950264|NCT01348087|3771747|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3950265|NCT01348087|3771747|B1|||Age||Years|Mean|26.6|26.6|Standard Deviation|6.85|6.85|||
3950266|NCT01347931|3771761|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3950267|NCT01347931|3771761|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950268|NCT01347931|3771761|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950269|NCT01347931|3771761|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3950270|NCT01347931|3771761|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3950271|NCT01347931|3771761|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950272|NCT01347931|3771761|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950273|NCT01347931|3771761|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950274|NCT01347931|3771761|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3950275|NCT01347931|3771761|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3950276|NCT01347931|3771761|B1|||Age||years|Mean|72|72.0|Standard Deviation|6.3|6.3|||
3950277|NCT01347879|3771771|B3|Skin type VI||Skin type|"Fitzpatrick skin type. The Fitzpatrick Scale:~Type I (scores 0–7) Light, pale white. Always burns, never tans~Type II (scores 8–16) White; fair. Usually burns, tans with difficulty~Type III (scores 17–24) Medium, white to olive. Sometimes mild burn, gradually tans to olive.~Type IV (scores 25–30) Olive, moderate brown. Rarely burns, tans with ease to a moderate brown.~Type V (scores over 30) Brown, dark brown. Very rarely burns, tans very easily~Type VI Black, very dark brown to black. Never burns, tans very easily, deeply pigmented."|participants|Number|5|5.0||||||
3950331|NCT01347866|3771821|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3950332|NCT01347866|3771822|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3950333|NCT01347866|3771823|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3950334|NCT01347866|3771806|B18||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3950335|NCT01347866|3771807|B17||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3950278|NCT01347879|3771772|B2|Skin type VI||Skin type|"Fitzpatrick skin type. The Fitzpatrick Scale:~Type I (scores 0–7) Light, pale white. Always burns, never tans~Type II (scores 8–16) White; fair. Usually burns, tans with difficulty~Type III (scores 17–24) Medium, white to olive. Sometimes mild burn, gradually tans to olive.~Type IV (scores 25–30) Olive, moderate brown. Rarely burns, tans with ease to a moderate brown.~Type V (scores over 30) Brown, dark brown. Very rarely burns, tans very easily~Type VI Black, very dark brown to black. Never burns, tans very easily, deeply pigmented."|participants|Number|4|4.0||||||
3950279|NCT01347879|3771773|B1|Skin type VI||Skin type|"Fitzpatrick skin type. The Fitzpatrick Scale:~Type I (scores 0–7) Light, pale white. Always burns, never tans~Type II (scores 8–16) White; fair. Usually burns, tans with difficulty~Type III (scores 17–24) Medium, white to olive. Sometimes mild burn, gradually tans to olive.~Type IV (scores 25–30) Olive, moderate brown. Rarely burns, tans with ease to a moderate brown.~Type V (scores over 30) Brown, dark brown. Very rarely burns, tans very easily~Type VI Black, very dark brown to black. Never burns, tans very easily, deeply pigmented."|participants|Number|1|1.0||||||
3950280|NCT01347879|3771771|B3|Skin type V||Skin type|"Fitzpatrick skin type. The Fitzpatrick Scale:~Type I (scores 0–7) Light, pale white. Always burns, never tans~Type II (scores 8–16) White; fair. Usually burns, tans with difficulty~Type III (scores 17–24) Medium, white to olive. Sometimes mild burn, gradually tans to olive.~Type IV (scores 25–30) Olive, moderate brown. Rarely burns, tans with ease to a moderate brown.~Type V (scores over 30) Brown, dark brown. Very rarely burns, tans very easily~Type VI Black, very dark brown to black. Never burns, tans very easily, deeply pigmented."|participants|Number|14|14.0||||||
3950281|NCT01347879|3771772|B2|Skin type V||Skin type|"Fitzpatrick skin type. The Fitzpatrick Scale:~Type I (scores 0–7) Light, pale white. Always burns, never tans~Type II (scores 8–16) White; fair. Usually burns, tans with difficulty~Type III (scores 17–24) Medium, white to olive. Sometimes mild burn, gradually tans to olive.~Type IV (scores 25–30) Olive, moderate brown. Rarely burns, tans with ease to a moderate brown.~Type V (scores over 30) Brown, dark brown. Very rarely burns, tans very easily~Type VI Black, very dark brown to black. Never burns, tans very easily, deeply pigmented."|participants|Number|8|8.0||||||
3950282|NCT01347879|3771773|B1|Skin type V||Skin type|"Fitzpatrick skin type. The Fitzpatrick Scale:~Type I (scores 0–7) Light, pale white. Always burns, never tans~Type II (scores 8–16) White; fair. Usually burns, tans with difficulty~Type III (scores 17–24) Medium, white to olive. Sometimes mild burn, gradually tans to olive.~Type IV (scores 25–30) Olive, moderate brown. Rarely burns, tans with ease to a moderate brown.~Type V (scores over 30) Brown, dark brown. Very rarely burns, tans very easily~Type VI Black, very dark brown to black. Never burns, tans very easily, deeply pigmented."|participants|Number|6|6.0||||||
3950283|NCT01347879|3771771|B3|Skin type IV||Skin type|"Fitzpatrick skin type. The Fitzpatrick Scale:~Type I (scores 0–7) Light, pale white. Always burns, never tans~Type II (scores 8–16) White; fair. Usually burns, tans with difficulty~Type III (scores 17–24) Medium, white to olive. Sometimes mild burn, gradually tans to olive.~Type IV (scores 25–30) Olive, moderate brown. Rarely burns, tans with ease to a moderate brown.~Type V (scores over 30) Brown, dark brown. Very rarely burns, tans very easily~Type VI Black, very dark brown to black. Never burns, tans very easily, deeply pigmented."|participants|Number|22|22.0||||||
3950284|NCT01347879|3771772|B2|Skin type IV||Skin type|"Fitzpatrick skin type. The Fitzpatrick Scale:~Type I (scores 0–7) Light, pale white. Always burns, never tans~Type II (scores 8–16) White; fair. Usually burns, tans with difficulty~Type III (scores 17–24) Medium, white to olive. Sometimes mild burn, gradually tans to olive.~Type IV (scores 25–30) Olive, moderate brown. Rarely burns, tans with ease to a moderate brown.~Type V (scores over 30) Brown, dark brown. Very rarely burns, tans very easily~Type VI Black, very dark brown to black. Never burns, tans very easily, deeply pigmented."|participants|Number|15|15.0||||||
3950285|NCT01347879|3771773|B1|Skin type IV||Skin type|"Fitzpatrick skin type. The Fitzpatrick Scale:~Type I (scores 0–7) Light, pale white. Always burns, never tans~Type II (scores 8–16) White; fair. Usually burns, tans with difficulty~Type III (scores 17–24) Medium, white to olive. Sometimes mild burn, gradually tans to olive.~Type IV (scores 25–30) Olive, moderate brown. Rarely burns, tans with ease to a moderate brown.~Type V (scores over 30) Brown, dark brown. Very rarely burns, tans very easily~Type VI Black, very dark brown to black. Never burns, tans very easily, deeply pigmented."|participants|Number|7|7.0||||||
3950286|NCT01347879|3771771|B3|Skin type III||Skin type|"Fitzpatrick skin type. The Fitzpatrick Scale:~Type I (scores 0–7) Light, pale white. Always burns, never tans~Type II (scores 8–16) White; fair. Usually burns, tans with difficulty~Type III (scores 17–24) Medium, white to olive. Sometimes mild burn, gradually tans to olive.~Type IV (scores 25–30) Olive, moderate brown. Rarely burns, tans with ease to a moderate brown.~Type V (scores over 30) Brown, dark brown. Very rarely burns, tans very easily~Type VI Black, very dark brown to black. Never burns, tans very easily, deeply pigmented."|participants|Number|53|53.0||||||
3950287|NCT01347879|3771772|B2|Skin type III||Skin type|"Fitzpatrick skin type. The Fitzpatrick Scale:~Type I (scores 0–7) Light, pale white. Always burns, never tans~Type II (scores 8–16) White; fair. Usually burns, tans with difficulty~Type III (scores 17–24) Medium, white to olive. Sometimes mild burn, gradually tans to olive.~Type IV (scores 25–30) Olive, moderate brown. Rarely burns, tans with ease to a moderate brown.~Type V (scores over 30) Brown, dark brown. Very rarely burns, tans very easily~Type VI Black, very dark brown to black. Never burns, tans very easily, deeply pigmented."|participants|Number|38|38.0||||||
3950288|NCT01347879|3771773|B1|Skin type III||Skin type|"Fitzpatrick skin type. The Fitzpatrick Scale:~Type I (scores 0–7) Light, pale white. Always burns, never tans~Type II (scores 8–16) White; fair. Usually burns, tans with difficulty~Type III (scores 17–24) Medium, white to olive. Sometimes mild burn, gradually tans to olive.~Type IV (scores 25–30) Olive, moderate brown. Rarely burns, tans with ease to a moderate brown.~Type V (scores over 30) Brown, dark brown. Very rarely burns, tans very easily~Type VI Black, very dark brown to black. Never burns, tans very easily, deeply pigmented."|participants|Number|15|15.0||||||
3950289|NCT01347879|3771771|B3|Skin type II||Skin type|"Fitzpatrick skin type. The Fitzpatrick Scale:~Type I (scores 0–7) Light, pale white. Always burns, never tans~Type II (scores 8–16) White; fair. Usually burns, tans with difficulty~Type III (scores 17–24) Medium, white to olive. Sometimes mild burn, gradually tans to olive.~Type IV (scores 25–30) Olive, moderate brown. Rarely burns, tans with ease to a moderate brown.~Type V (scores over 30) Brown, dark brown. Very rarely burns, tans very easily~Type VI Black, very dark brown to black. Never burns, tans very easily, deeply pigmented."|participants|Number|58|58.0||||||
3950336|NCT01347866|3771808|B16||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3950290|NCT01347879|3771772|B2|Skin type II||Skin type|"Fitzpatrick skin type. The Fitzpatrick Scale:~Type I (scores 0–7) Light, pale white. Always burns, never tans~Type II (scores 8–16) White; fair. Usually burns, tans with difficulty~Type III (scores 17–24) Medium, white to olive. Sometimes mild burn, gradually tans to olive.~Type IV (scores 25–30) Olive, moderate brown. Rarely burns, tans with ease to a moderate brown.~Type V (scores over 30) Brown, dark brown. Very rarely burns, tans very easily~Type VI Black, very dark brown to black. Never burns, tans very easily, deeply pigmented."|participants|Number|34|34.0||||||
3950291|NCT01347879|3771773|B1|Skin type II||Skin type|"Fitzpatrick skin type. The Fitzpatrick Scale:~Type I (scores 0–7) Light, pale white. Always burns, never tans~Type II (scores 8–16) White; fair. Usually burns, tans with difficulty~Type III (scores 17–24) Medium, white to olive. Sometimes mild burn, gradually tans to olive.~Type IV (scores 25–30) Olive, moderate brown. Rarely burns, tans with ease to a moderate brown.~Type V (scores over 30) Brown, dark brown. Very rarely burns, tans very easily~Type VI Black, very dark brown to black. Never burns, tans very easily, deeply pigmented."|participants|Number|24|24.0||||||
3950292|NCT01347879|3771771|B3|Skin type I||Skin type|"Fitzpatrick skin type. The Fitzpatrick Scale:~Type I (scores 0–7) Light, pale white. Always burns, never tans~Type II (scores 8–16) White; fair. Usually burns, tans with difficulty~Type III (scores 17–24) Medium, white to olive. Sometimes mild burn, gradually tans to olive.~Type IV (scores 25–30) Olive, moderate brown. Rarely burns, tans with ease to a moderate brown.~Type V (scores over 30) Brown, dark brown. Very rarely burns, tans very easily~Type VI Black, very dark brown to black. Never burns, tans very easily, deeply pigmented."|participants|Number|1|1.0||||||
3950293|NCT01347879|3771772|B2|Skin type I||Skin type|"Fitzpatrick skin type. The Fitzpatrick Scale:~Type I (scores 0–7) Light, pale white. Always burns, never tans~Type II (scores 8–16) White; fair. Usually burns, tans with difficulty~Type III (scores 17–24) Medium, white to olive. Sometimes mild burn, gradually tans to olive.~Type IV (scores 25–30) Olive, moderate brown. Rarely burns, tans with ease to a moderate brown.~Type V (scores over 30) Brown, dark brown. Very rarely burns, tans very easily~Type VI Black, very dark brown to black. Never burns, tans very easily, deeply pigmented."|participants|Number|1|1.0||||||
3950294|NCT01347879|3771773|B1|Skin type I||Skin type|"Fitzpatrick skin type. The Fitzpatrick Scale:~Type I (scores 0–7) Light, pale white. Always burns, never tans~Type II (scores 8–16) White; fair. Usually burns, tans with difficulty~Type III (scores 17–24) Medium, white to olive. Sometimes mild burn, gradually tans to olive.~Type IV (scores 25–30) Olive, moderate brown. Rarely burns, tans with ease to a moderate brown.~Type V (scores over 30) Brown, dark brown. Very rarely burns, tans very easily~Type VI Black, very dark brown to black. Never burns, tans very easily, deeply pigmented."|participants|Number|0|0.0||||||
3950295|NCT01347879|3771771|B3|United States||Region of Enrollment||participants|Number|153|153.0||||||
3950296|NCT01347879|3771772|B2|United States||Region of Enrollment||participants|Number|100|100.0||||||
3950297|NCT01347879|3771773|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
3950298|NCT01347879|3771771|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3950299|NCT01347879|3771772|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3950300|NCT01347879|3771773|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3950301|NCT01347879|3771771|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3950302|NCT01347879|3771772|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3950303|NCT01347879|3771773|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3950304|NCT01347879|3771771|B3|||Age||years|Mean|18.6|18.6|Standard Deviation|5.6|5.6|||
3950305|NCT01347879|3771772|B2|||Age||years|Mean|18.6|18.6|Standard Deviation|5.5|5.5|||
3950306|NCT01347879|3771773|B1|||Age||years|Mean|18.6|18.6|Standard Deviation|5.8|5.8|||
3950307|NCT01347879|3771771|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3950308|NCT01347879|3771772|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3950309|NCT01347879|3771773|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3950310|NCT01347879|3771771|B3||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
3950311|NCT01347879|3771772|B2||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3950312|NCT01347879|3771773|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3950313|NCT01347879|3771771|B3||<=18 years|Age||Participants|Count of Participants|94|94.0||||||
3950314|NCT01347879|3771772|B2||<=18 years|Age||Participants|Count of Participants|59|59.0||||||
3950315|NCT01347879|3771773|B1||<=18 years|Age||Participants|Count of Participants|35|35.0||||||
3950316|NCT01347866|3771806|B18||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3950317|NCT01347866|3771807|B17||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3950318|NCT01347866|3771808|B16||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3950319|NCT01347866|3771809|B15||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3950320|NCT01347866|3771810|B14||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3950321|NCT01347866|3771811|B13||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3950322|NCT01347866|3771812|B12||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3950323|NCT01347866|3771813|B11||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3950324|NCT01347866|3771814|B10||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3950325|NCT01347866|3771815|B9||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3950326|NCT01347866|3771816|B8||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3950327|NCT01347866|3771817|B7||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3950328|NCT01347866|3771818|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3950329|NCT01347866|3771819|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3950330|NCT01347866|3771820|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3950337|NCT01347866|3771809|B15||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3950338|NCT01347866|3771810|B14||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3950339|NCT01347866|3771811|B13||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3950340|NCT01347866|3771812|B12||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3950341|NCT01347866|3771813|B11||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3950342|NCT01347866|3771814|B10||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3950343|NCT01347866|3771815|B9||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3950344|NCT01347866|3771816|B8||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3950345|NCT01347866|3771817|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3950346|NCT01347866|3771818|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3950347|NCT01347866|3771819|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3950348|NCT01347866|3771820|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3950349|NCT01347866|3771821|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3950350|NCT01347866|3771822|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3950351|NCT01347866|3771823|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3950352|NCT01347866|3771806|B18|||Age||years|Mean|58.5|58.5|Standard Deviation|11.8|11.8|||
3950353|NCT01347866|3771807|B17|||Age||years|Mean|54.5|54.5|Standard Deviation|9.2|9.2|||
3950354|NCT01347866|3771808|B16|||Age||years|Mean|60.0|60.0|Standard Deviation|11.8|11.8|||
3950355|NCT01347866|3771809|B15|||Age||years|Mean|61.3|61.3|Standard Deviation|14.2|14.2|||
3950356|NCT01347866|3771810|B14|||Age||years|Mean|57.9|57.9|Standard Deviation|12.9|12.9|||
3950357|NCT01347866|3771811|B13|||Age||years|Mean|55.7|55.7|Standard Deviation|10.0|10.0|||
3950358|NCT01347866|3771812|B12|||Age||years|Mean|64.0|64.0|Standard Deviation|8.9|8.9|||
3950359|NCT01347866|3771813|B11|||Age||years|Mean|43.3|43.3|Standard Deviation|9.1|9.1|||
3950360|NCT01347866|3771814|B10|||Age||years|Mean|63.3|63.3|Standard Deviation|5.9|5.9|||
3950361|NCT01347866|3771815|B9|||Age||years|Mean|56.7|56.7|Standard Deviation|12.4|12.4|||
3950362|NCT01347866|3771816|B8|||Age||years|Mean|63.3|63.3|Standard Deviation|14.5|14.5|||
3950363|NCT01347866|3771817|B7|||Age||years|Mean|60.8|60.8|Standard Deviation|7.2|7.2|||
3950364|NCT01347866|3771818|B6|||Age||years|Mean|67.0|67.0|Standard Deviation|3.6|3.6|||
3950365|NCT01347866|3771819|B5|||Age||years|Mean|59.1|59.1|Standard Deviation|12.9|12.9|||
3950366|NCT01347866|3771820|B4|||Age||years|Mean|53.6|53.6|Standard Deviation|14.1|14.1|||
3950367|NCT01347866|3771821|B3|||Age||years|Mean|49.0|49.0|Standard Deviation|0.0|0.0|||
3950368|NCT01347866|3771822|B2|||Age||years|Mean|54.0|54.0|Standard Deviation|0.0|0.0|||
3950369|NCT01347866|3771823|B1|||Age||years|Mean|58.8|58.8|Standard Deviation|8.7|8.7|||
3950370|NCT01347840|3772213|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3950371|NCT01347840|3772213|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3950372|NCT01347840|3772213|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3950373|NCT01347840|3772213|B1|||Age||years|Mean|51|51.0|Standard Deviation|0|0.0|||
3950374|NCT01347840|3772213|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3950375|NCT01347840|3772213|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3950376|NCT01347840|3772213|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3950377|NCT01347788|3772226|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
3950378|NCT01347788|3772226|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3950379|NCT01347788|3772226|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3950380|NCT01347788|3772226|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3950381|NCT01347788|3772226|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3950382|NCT01347788|3772226|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3950383|NCT01347788|3772226|B1|||Age||years|Median|66|66.0|Full Range|||48.0|83.0|
3950384|NCT01347762|3772236|B5|||Average Number of Inhales of Marijuana Per Day||Inhales per day|Mean|30.52|30.52|Standard Deviation|33.65|33.65|||
3950385|NCT01347762|3772237|B4|||Average Number of Inhales of Marijuana Per Day||Inhales per day|Mean|16.53|16.53|Standard Deviation|29.13|29.13|||
3950386|NCT01347762|3772238|B3|||Average Number of Inhales of Marijuana Per Day||Inhales per day|Mean|28.9|28.9|Standard Deviation|31.8|31.8|||
3950387|NCT01347762|3772239|B2|||Average Number of Inhales of Marijuana Per Day||Inhales per day|Mean|27.1|27.1|Standard Deviation|13.2|13.2|||
3950388|NCT01347762|3772240|B1|||Average Number of Inhales of Marijuana Per Day||Inhales per day|Mean|50.1|50.1|Standard Deviation|43.8|43.8|||
3950389|NCT01347762|3772236|B5|||Baseline Urine THC/Creatinine Ratio||Ratio|Mean|489.8|489.8|Standard Deviation|496.1|496.1|||
3950390|NCT01347762|3772237|B4|||Baseline Urine THC/Creatinine Ratio||Ratio|Mean|371.0|371.0|Standard Deviation|265.4|265.4|||
3950391|NCT01347762|3772238|B3|||Baseline Urine THC/Creatinine Ratio||Ratio|Mean|633.2|633.2|Standard Deviation|728.5|728.5|||
3950392|NCT01347762|3772239|B2|||Baseline Urine THC/Creatinine Ratio||Ratio|Mean|458.7|458.7|Standard Deviation|568.9|568.9|||
3950393|NCT01347762|3772240|B1|||Baseline Urine THC/Creatinine Ratio||Ratio|Mean|491.6|491.6|Standard Deviation|283.0|283.0|||
3950394|NCT01347762|3772236|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950395|NCT01347762|3772237|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950396|NCT01347762|3772238|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950397|NCT01347762|3772239|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950398|NCT01347762|3772240|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950399|NCT01347762|3772236|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3950400|NCT01347762|3772237|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950401|NCT01347762|3772238|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3950402|NCT01347762|3772239|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950403|NCT01347762|3772240|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3950404|NCT01347762|3772236|B5||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3950405|NCT01347762|3772237|B4||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3950406|NCT01347762|3772238|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3950407|NCT01347762|3772239|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3950408|NCT01347762|3772240|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3950409|NCT01347762|3772236|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3950410|NCT01347762|3772237|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3950411|NCT01347762|3772238|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3950412|NCT01347762|3772239|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3950413|NCT01347762|3772240|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3950414|NCT01347762|3772236|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950415|NCT01347762|3772237|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950416|NCT01347762|3772238|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950417|NCT01347762|3772239|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950418|NCT01347762|3772240|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950419|NCT01347762|3772236|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3950420|NCT01347762|3772237|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3950421|NCT01347762|3772238|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950422|NCT01347762|3772239|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950423|NCT01347762|3772240|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950424|NCT01347762|3772236|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950425|NCT01347762|3772237|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950426|NCT01347762|3772238|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950427|NCT01347762|3772239|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950428|NCT01347762|3772240|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950429|NCT01347762|3772236|B5||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3950430|NCT01347762|3772237|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3950431|NCT01347762|3772238|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3950432|NCT01347762|3772239|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3950433|NCT01347762|3772240|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3950434|NCT01347762|3772236|B5||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3950435|NCT01347762|3772237|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3950436|NCT01347762|3772238|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3950437|NCT01347762|3772239|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3950438|NCT01347762|3772240|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3950439|NCT01347762|3772236|B5|||Age||years|Mean|27.42|27.42|Standard Deviation|6.79|6.79|||
3950440|NCT01347762|3772237|B4|||Age||years|Mean|28.11|28.11|Standard Deviation|7.26|7.26|||
3950441|NCT01347762|3772238|B3|||Age||years|Mean|27.81|27.81|Standard Deviation|6.81|6.81|||
3950442|NCT01347762|3772239|B2|||Age||years|Mean|28.88|28.88|Standard Deviation|7.53|7.53|||
3950443|NCT01347762|3772240|B1|||Age||years|Mean|24.40|24.4|Standard Deviation|5.17|5.17|||
3950444|NCT01347710|3772269|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3950445|NCT01347710|3772269|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950446|NCT01347710|3772269|B1||White|Race (NIH/OMB)||Participants|Count of Participants|652|652.0||||||
3950447|NCT01347710|3772269|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
3950448|NCT01347710|3772269|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3950449|NCT01347710|3772269|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3950450|NCT01347710|3772269|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3950451|NCT01347710|3772269|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3950452|NCT01347710|3772269|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|708|708.0||||||
3950453|NCT01347710|3772269|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3950454|NCT01347710|3772269|B1||Male|Sex: Female, Male||Participants|Count of Participants|546|546.0||||||
3950455|NCT01347710|3772269|B1||Female|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
3950456|NCT01347710|3772269|B1||>=65 years|Age||Participants|Count of Participants|337|337.0||||||
3950457|NCT01347710|3772269|B1||Between 18 and 65 years|Age||Participants|Count of Participants|458|458.0||||||
3950458|NCT01347710|3772269|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3950459|NCT01347632|3772284|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3950460|NCT01347632|3772284|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3950461|NCT01347632|3772284|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3950462|NCT01347632|3772284|B1|||Age||years|Mean|33|33.0|Standard Deviation|2|2.0|||
3950463|NCT01347632|3772284|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3950464|NCT01347632|3772284|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3950465|NCT01347632|3772284|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3950466|NCT01347580|3772289|B3|||Time between the 2 loading doses||minutes|Median|31|31.0|Inter-Quartile Range|||22.0|44.0|
3950467|NCT01347580|3772290|B2|||Time between the 2 loading doses||minutes|Median|30|30.0|Inter-Quartile Range|||22.0|43.0|
3950468|NCT01347580|3772291|B1|||Time between the 2 loading doses||minutes|Median|32|32.0|Inter-Quartile Range|||22.0|45.0|
3950469|NCT01347580|3772289|B3|without stent||type of PCI|on patients with PCI|patients|Number|94|94.0||||||
3950470|NCT01347580|3772290|B2|without stent||type of PCI|on patients with PCI|patients|Number|54|54.0||||||
3950471|NCT01347580|3772291|B1|without stent||type of PCI|on patients with PCI|patients|Number|40|40.0||||||
3950472|NCT01347580|3772289|B3|with stent||type of PCI|on patients with PCI|patients|Number|1536|1536.0||||||
3950473|NCT01347580|3772290|B2|with stent||type of PCI|on patients with PCI|patients|Number|776|776.0||||||
3950474|NCT01347580|3772291|B1|with stent||type of PCI|on patients with PCI|patients|Number|760|760.0||||||
3950475|NCT01347580|3772289|B3|no||PCI|Percutaneous coronary intervention (PCI) is a non-surgery intervention performed to open blocked coronary arteries and to restore arterial blood flow to the heart tissue.|Patients|Number|232|232.0||||||
3950476|NCT01347580|3772290|B2|no||PCI|Percutaneous coronary intervention (PCI) is a non-surgery intervention performed to open blocked coronary arteries and to restore arterial blood flow to the heart tissue.|Patients|Number|123|123.0||||||
3950477|NCT01347580|3772291|B1|no||PCI|Percutaneous coronary intervention (PCI) is a non-surgery intervention performed to open blocked coronary arteries and to restore arterial blood flow to the heart tissue.|Patients|Number|109|109.0||||||
3950478|NCT01347580|3772289|B3|yes||PCI|Percutaneous coronary intervention (PCI) is a non-surgery intervention performed to open blocked coronary arteries and to restore arterial blood flow to the heart tissue.|Patients|Number|1630|1630.0||||||
3950479|NCT01347580|3772290|B2|yes||PCI|Percutaneous coronary intervention (PCI) is a non-surgery intervention performed to open blocked coronary arteries and to restore arterial blood flow to the heart tissue.|Patients|Number|830|830.0||||||
3950480|NCT01347580|3772291|B1|yes||PCI|Percutaneous coronary intervention (PCI) is a non-surgery intervention performed to open blocked coronary arteries and to restore arterial blood flow to the heart tissue.|Patients|Number|800|800.0||||||
3950481|NCT01347580|3772289|B3|in emergency department||First medical contact||patients|Number|450|450.0||||||
3950482|NCT01347580|3772290|B2|in emergency department||First medical contact||patients|Number|230|230.0||||||
3950483|NCT01347580|3772291|B1|in emergency department||First medical contact||patients|Number|220|220.0||||||
3950484|NCT01347580|3772289|B3|in ambulance||First medical contact||patients|Number|1412|1412.0||||||
3950485|NCT01347580|3772290|B2|in ambulance||First medical contact||patients|Number|723|723.0||||||
3950486|NCT01347580|3772291|B1|in ambulance||First medical contact||patients|Number|689|689.0||||||
3950487|NCT01347580|3772289|B3|unknown||Killip class|Killip class assesses the presence and severity of heart failure by physical examination. Class I :No rales, no 3rd heart sound. Class 2: Rales in <1⁄2 lung field or presence of a 3rd heart sound. Class 3: Rales in >1⁄2 lung field–pulmonary edema.Class 4 : Cardiogenic shock–determined clinically.|patients|Number|87|87.0||||||
3950488|NCT01347580|3772290|B2|unknown||Killip class|Killip class assesses the presence and severity of heart failure by physical examination. Class I :No rales, no 3rd heart sound. Class 2: Rales in <1⁄2 lung field or presence of a 3rd heart sound. Class 3: Rales in >1⁄2 lung field–pulmonary edema.Class 4 : Cardiogenic shock–determined clinically.|patients|Number|48|48.0||||||
3950489|NCT01347580|3772291|B1|unknown||Killip class|Killip class assesses the presence and severity of heart failure by physical examination. Class I :No rales, no 3rd heart sound. Class 2: Rales in <1⁄2 lung field or presence of a 3rd heart sound. Class 3: Rales in >1⁄2 lung field–pulmonary edema.Class 4 : Cardiogenic shock–determined clinically.|patients|Number|39|39.0||||||
3950490|NCT01347580|3772289|B3|II, III, IV||Killip class|Killip class assesses the presence and severity of heart failure by physical examination. Class I :No rales, no 3rd heart sound. Class 2: Rales in <1⁄2 lung field or presence of a 3rd heart sound. Class 3: Rales in >1⁄2 lung field–pulmonary edema.Class 4 : Cardiogenic shock–determined clinically.|patients|Number|94|94.0||||||
3950491|NCT01347580|3772290|B2|II, III, IV||Killip class|Killip class assesses the presence and severity of heart failure by physical examination. Class I :No rales, no 3rd heart sound. Class 2: Rales in <1⁄2 lung field or presence of a 3rd heart sound. Class 3: Rales in >1⁄2 lung field–pulmonary edema.Class 4 : Cardiogenic shock–determined clinically.|patients|Number|43|43.0||||||
3950492|NCT01347580|3772291|B1|II, III, IV||Killip class|Killip class assesses the presence and severity of heart failure by physical examination. Class I :No rales, no 3rd heart sound. Class 2: Rales in <1⁄2 lung field or presence of a 3rd heart sound. Class 3: Rales in >1⁄2 lung field–pulmonary edema.Class 4 : Cardiogenic shock–determined clinically.|patients|Number|51|51.0||||||
3950528|NCT01347554|3772322|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3950529|NCT01347554|3772320|B3|||Age||years|Mean|64.5|64.5|Standard Deviation|12.3|12.3|||
3950493|NCT01347580|3772289|B3|I||Killip class|Killip class assesses the presence and severity of heart failure by physical examination. Class I :No rales, no 3rd heart sound. Class 2: Rales in <1⁄2 lung field or presence of a 3rd heart sound. Class 3: Rales in >1⁄2 lung field–pulmonary edema.Class 4 : Cardiogenic shock–determined clinically.|patients|Number|1681|1681.0||||||
3950494|NCT01347580|3772290|B2|I||Killip class|Killip class assesses the presence and severity of heart failure by physical examination. Class I :No rales, no 3rd heart sound. Class 2: Rales in <1⁄2 lung field or presence of a 3rd heart sound. Class 3: Rales in >1⁄2 lung field–pulmonary edema.Class 4 : Cardiogenic shock–determined clinically.|patients|Number|862|862.0||||||
3950495|NCT01347580|3772291|B1|I||Killip class|Killip class assesses the presence and severity of heart failure by physical examination. Class I :No rales, no 3rd heart sound. Class 2: Rales in <1⁄2 lung field or presence of a 3rd heart sound. Class 3: Rales in >1⁄2 lung field–pulmonary edema.Class 4 : Cardiogenic shock–determined clinically.|patients|Number|819|819.0||||||
3950496|NCT01347580|3772289|B3|>6||TIMI risk score|Thrombolysis in Myocardial Infarction (TIMI) is a scoring system based on independant predictors of mortality such as age, diabetes mellitus, history of hypertension, history of angina, ST segment elevation. The death rate at 30 days for the following scores are: 0-2: 0.8%-2.2%, 3-6: 4.4% -16.1%, score>6: 23.4% to 35.9%.|patients|Number|35|35.0||||||
3950497|NCT01347580|3772290|B2|>6||TIMI risk score|Thrombolysis in Myocardial Infarction (TIMI) is a scoring system based on independant predictors of mortality such as age, diabetes mellitus, history of hypertension, history of angina, ST segment elevation. The death rate at 30 days for the following scores are: 0-2: 0.8%-2.2%, 3-6: 4.4% -16.1%, score>6: 23.4% to 35.9%.|patients|Number|15|15.0||||||
3950498|NCT01347580|3772291|B1|>6||TIMI risk score|Thrombolysis in Myocardial Infarction (TIMI) is a scoring system based on independant predictors of mortality such as age, diabetes mellitus, history of hypertension, history of angina, ST segment elevation. The death rate at 30 days for the following scores are: 0-2: 0.8%-2.2%, 3-6: 4.4% -16.1%, score>6: 23.4% to 35.9%.|patients|Number|20|20.0||||||
3950499|NCT01347580|3772289|B3|3-6||TIMI risk score|Thrombolysis in Myocardial Infarction (TIMI) is a scoring system based on independant predictors of mortality such as age, diabetes mellitus, history of hypertension, history of angina, ST segment elevation. The death rate at 30 days for the following scores are: 0-2: 0.8%-2.2%, 3-6: 4.4% -16.1%, score>6: 23.4% to 35.9%.|patients|Number|702|702.0||||||
3950500|NCT01347580|3772290|B2|3-6||TIMI risk score|Thrombolysis in Myocardial Infarction (TIMI) is a scoring system based on independant predictors of mortality such as age, diabetes mellitus, history of hypertension, history of angina, ST segment elevation. The death rate at 30 days for the following scores are: 0-2: 0.8%-2.2%, 3-6: 4.4% -16.1%, score>6: 23.4% to 35.9%.|patients|Number|365|365.0||||||
3950501|NCT01347580|3772291|B1|3-6||TIMI risk score|Thrombolysis in Myocardial Infarction (TIMI) is a scoring system based on independant predictors of mortality such as age, diabetes mellitus, history of hypertension, history of angina, ST segment elevation. The death rate at 30 days for the following scores are: 0-2: 0.8%-2.2%, 3-6: 4.4% -16.1%, score>6: 23.4% to 35.9%.|patients|Number|337|337.0||||||
3950502|NCT01347580|3772289|B3|0-2||TIMI risk score|Thrombolysis in Myocardial Infarction (TIMI) is a scoring system based on independant predictors of mortality such as age, diabetes mellitus, history of hypertension, history of angina, ST segment elevation. The death rate at 30 days for the following scores are: 0-2: 0.8%-2.2%, 3-6: 4.4% -16.1%, score>6: 23.4% to 35.9%.|patients|Number|1125|1125.0||||||
3950503|NCT01347580|3772290|B2|0-2||TIMI risk score|Thrombolysis in Myocardial Infarction (TIMI) is a scoring system based on independant predictors of mortality such as age, diabetes mellitus, history of hypertension, history of angina, ST segment elevation. The death rate at 30 days for the following scores are: 0-2: 0.8%-2.2%, 3-6: 4.4% -16.1%, score>6: 23.4% to 35.9%.|patients|Number|573|573.0||||||
3950504|NCT01347580|3772291|B1|0-2||TIMI risk score|Thrombolysis in Myocardial Infarction (TIMI) is a scoring system based on independant predictors of mortality such as age, diabetes mellitus, history of hypertension, history of angina, ST segment elevation. The death rate at 30 days for the following scores are: 0-2: 0.8%-2.2%, 3-6: 4.4% -16.1%, score>6: 23.4% to 35.9%.|patients|Number|552|552.0||||||
3950505|NCT01347580|3772289|B3|no/unknown||Diabetes mellitus||patients|Number|1609|1609.0||||||
3950506|NCT01347580|3772290|B2|no/unknown||Diabetes mellitus||patients|Number|815|815.0||||||
3950507|NCT01347580|3772291|B1|no/unknown||Diabetes mellitus||patients|Number|794|794.0||||||
3950508|NCT01347580|3772289|B3|yes||Diabetes mellitus||patients|Number|253|253.0||||||
3950509|NCT01347580|3772290|B2|yes||Diabetes mellitus||patients|Number|138|138.0||||||
3950510|NCT01347580|3772291|B1|yes||Diabetes mellitus||patients|Number|115|115.0||||||
3950511|NCT01347580|3772289|B3||Male|Sex: Female, Male||Participants|Count of Participants|1493|1493.0||||||
3950512|NCT01347580|3772290|B2||Male|Sex: Female, Male||Participants|Count of Participants|757|757.0||||||
3950513|NCT01347580|3772291|B1||Male|Sex: Female, Male||Participants|Count of Participants|736|736.0||||||
3950514|NCT01347580|3772289|B3||Female|Sex: Female, Male||Participants|Count of Participants|369|369.0||||||
3950515|NCT01347580|3772290|B2||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
3950516|NCT01347580|3772291|B1||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
3950517|NCT01347580|3772289|B3|Years||Age||Years|Mean|60.8|60.8|Standard Deviation|12.43|12.43|||
3950518|NCT01347580|3772290|B2|Years||Age||Years|Mean|61.0|61.0|Standard Deviation|12.49|12.49|||
3950519|NCT01347580|3772291|B1|Years||Age||Years|Mean|60.6|60.6|Standard Deviation|12.38|12.38|||
3950520|NCT01347554|3772320|B3|Korea, Republic of||Region of Enrollment||participants|Number|461|461.0||||||
3950521|NCT01347554|3772321|B2|Korea, Republic of||Region of Enrollment||participants|Number|231|231.0||||||
3950522|NCT01347554|3772322|B1|Korea, Republic of||Region of Enrollment||participants|Number|230|230.0||||||
3950523|NCT01347554|3772320|B3||Male|Sex: Female, Male||Participants|Count of Participants|336|336.0||||||
3950524|NCT01347554|3772321|B2||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3950525|NCT01347554|3772322|B1||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3950526|NCT01347554|3772320|B3||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3950527|NCT01347554|3772321|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3950530|NCT01347554|3772321|B2|||Age||years|Mean|64.5|64.5|Standard Deviation|11.8|11.8|||
3950531|NCT01347554|3772322|B1|||Age||years|Mean|64.5|64.5|Standard Deviation|12.8|12.8|||
3950532|NCT01347554|3772320|B3||>=65 years|Age||Participants|Count of Participants|249|249.0||||||
3950533|NCT01347554|3772321|B2||>=65 years|Age||Participants|Count of Participants|125|125.0||||||
3950534|NCT01347554|3772322|B1||>=65 years|Age||Participants|Count of Participants|124|124.0||||||
3950535|NCT01347554|3772320|B3||Between 18 and 65 years|Age||Participants|Count of Participants|212|212.0||||||
3950536|NCT01347554|3772321|B2||Between 18 and 65 years|Age||Participants|Count of Participants|106|106.0||||||
3950537|NCT01347554|3772322|B1||Between 18 and 65 years|Age||Participants|Count of Participants|106|106.0||||||
3950538|NCT01347554|3772320|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3950539|NCT01347554|3772321|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3950540|NCT01347554|3772322|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3950541|NCT01347255|3772335|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3950542|NCT01347255|3772335|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3950543|NCT01347255|3772335|B1|||Age||years|Mean|50.5|50.5|Standard Deviation|15.8|15.8|||
3950544|NCT01347112|3772358|B3|||tobacco use||cigarettes per day|Mean|20.4|20.4|Standard Deviation|7.4|7.4|||
3950545|NCT01347112|3772359|B2|||tobacco use||cigarettes per day|Mean|21.6|21.6|Standard Deviation|7.3|7.3|||
3950546|NCT01347112|3772360|B1|||tobacco use||cigarettes per day|Mean|19.1|19.1|Standard Deviation|7.5|7.5|||
3950547|NCT01347112|3772358|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950548|NCT01347112|3772359|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950549|NCT01347112|3772360|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950550|NCT01347112|3772358|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3950551|NCT01347112|3772359|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3950552|NCT01347112|3772360|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3950553|NCT01347112|3772358|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950554|NCT01347112|3772359|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950555|NCT01347112|3772360|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950556|NCT01347112|3772358|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950557|NCT01347112|3772359|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950558|NCT01347112|3772360|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950559|NCT01347112|3772358|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950560|NCT01347112|3772359|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950561|NCT01347112|3772360|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950562|NCT01347112|3772358|B3||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3950563|NCT01347112|3772359|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3950564|NCT01347112|3772360|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3950565|NCT01347112|3772358|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3950566|NCT01347112|3772359|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950567|NCT01347112|3772360|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3950568|NCT01347112|3772358|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950569|NCT01347112|3772359|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950570|NCT01347112|3772360|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950571|NCT01347112|3772358|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3950572|NCT01347112|3772359|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3950573|NCT01347112|3772360|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950574|NCT01347112|3772358|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950575|NCT01347112|3772359|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950576|NCT01347112|3772360|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950577|NCT01347112|3772358|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3950578|NCT01347112|3772359|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3950579|NCT01347112|3772360|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3950580|NCT01347112|3772358|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3950581|NCT01347112|3772359|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3950582|NCT01347112|3772360|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3950583|NCT01347112|3772358|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3950584|NCT01347112|3772359|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3950585|NCT01347112|3772360|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3950586|NCT01347112|3772358|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3950587|NCT01347112|3772359|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3950588|NCT01347112|3772360|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3950589|NCT01347112|3772358|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3950590|NCT01347112|3772359|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3950591|NCT01347112|3772360|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3950592|NCT01347112|3772358|B3|||Age||years|Mean|39.5|39.5|Standard Deviation|11.0|11.0|||
3950593|NCT01347112|3772359|B2|||Age||years|Mean|38.8|38.8|Standard Deviation|10.4|10.4|||
3950594|NCT01347112|3772360|B1|||Age||years|Mean|40.2|40.2|Standard Deviation|11.9|11.9|||
3950595|NCT01347086|3772371|B11||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3950596|NCT01347086|3772372|B10||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3950597|NCT01347086|3772373|B9||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3950598|NCT01347086|3772374|B8||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3950599|NCT01347086|3772375|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3950600|NCT01347086|3772376|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3950601|NCT01347086|3772377|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3950602|NCT01347086|3772378|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3950603|NCT01347086|3772379|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3950604|NCT01347086|3772380|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3950605|NCT01347086|3772381|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3950606|NCT01347086|3772371|B11||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3950607|NCT01347086|3772372|B10||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3950608|NCT01347086|3772373|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3950609|NCT01347086|3772374|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3950610|NCT01347086|3772375|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3950611|NCT01347086|3772376|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3950612|NCT01347086|3772377|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3950613|NCT01347086|3772378|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3950614|NCT01347086|3772379|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3950615|NCT01347086|3772380|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3950616|NCT01347086|3772381|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3950617|NCT01347086|3772371|B11|||Age||years|Mean|26.4|26.4|Standard Deviation|5.2|5.2|||
3950618|NCT01347086|3772372|B10|||Age||years|Mean|23.0|23.0|Standard Deviation|2.1|2.1|||
3950619|NCT01347086|3772373|B9|||Age||years|Mean|23.7|23.7|Standard Deviation|2.3|2.3|||
3950620|NCT01347086|3772374|B8|||Age||years|Mean|26.0|26.0|Standard Deviation|3.9|3.9|||
3950621|NCT01347086|3772375|B7|||Age||years|Mean|24.7|24.7|Standard Deviation|2.1|2.1|||
3950622|NCT01347086|3772376|B6|||Age||years|Mean|29.2|29.2|Standard Deviation|7.1|7.1|||
3950623|NCT01347086|3772377|B5|||Age||years|Mean|23.7|23.7|Standard Deviation|3.6|3.6|||
3950624|NCT01347086|3772378|B4|||Age||years|Mean|28.2|28.2|Standard Deviation|4.6|4.6|||
3950625|NCT01347086|3772379|B3|||Age||years|Mean|28.8|28.8|Standard Deviation|7.0|7.0|||
3950626|NCT01347086|3772380|B2|||Age||years|Mean|31.0|31.0|Standard Deviation|8.5|8.5|||
3950627|NCT01347086|3772381|B1|||Age||years|Mean|29.3|29.3|Standard Deviation|7.0|7.0|||
3950628|NCT01347073|3772489|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
3950629|NCT01347073|3772489|B1||Male|Gender||Participants|Count of Participants|11|11.0||||||
3950630|NCT01347073|3772489|B1||Female|Gender||Participants|Count of Participants|12|12.0||||||
3950631|NCT01347073|3772489|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3950632|NCT01347073|3772489|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3950633|NCT01347073|3772489|B1||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
3950634|NCT01347060|3772501|B3|||Number of participants with comorbid COPD at baseline|International Classification of Disease-9 (ICD-9) codes 491, 492, 496, 490-492.8, 493.00-493.91, 494, 495.0-505, 506.4|participants|Number|16380|16380.0||||||
3950635|NCT01347060|3772502|B2|||Number of participants with comorbid COPD at baseline|International Classification of Disease-9 (ICD-9) codes 491, 492, 496, 490-492.8, 493.00-493.91, 494, 495.0-505, 506.4|participants|Number|7153|7153.0||||||
3950636|NCT01347060|3772503|B1|||Number of participants with comorbid COPD at baseline|International Classification of Disease-9 (ICD-9) codes 491, 492, 496, 490-492.8, 493.00-493.91, 494, 495.0-505, 506.4|participants|Number|9227|9227.0||||||
3950637|NCT01347060|3772501|B3||Male|Sex: Female, Male||Participants|Count of Participants|6565|6565.0||||||
3950638|NCT01347060|3772502|B2||Male|Sex: Female, Male||Participants|Count of Participants|2780|2780.0||||||
3950639|NCT01347060|3772503|B1||Male|Sex: Female, Male||Participants|Count of Participants|3785|3785.0||||||
3950640|NCT01347060|3772501|B3||Female|Sex: Female, Male||Participants|Count of Participants|10883|10883.0||||||
3950641|NCT01347060|3772502|B2||Female|Sex: Female, Male||Participants|Count of Participants|4800|4800.0||||||
3950642|NCT01347060|3772503|B1||Female|Sex: Female, Male||Participants|Count of Participants|6083|6083.0||||||
3950643|NCT01347060|3772501|B3|75-79 years old||Age, Customized||Participants|Number|4868|4868.0||||||
3950644|NCT01347060|3772502|B2|75-79 years old||Age, Customized||Participants|Number|1847|1847.0||||||
3950645|NCT01347060|3772503|B1|75-79 years old||Age, Customized||Participants|Number|3021|3021.0||||||
3950646|NCT01347060|3772501|B3|70-74 years old||Age, Customized||Participants|Number|5363|5363.0||||||
3950647|NCT01347060|3772502|B2|70-74 years old||Age, Customized||Participants|Number|2669|2669.0||||||
3950648|NCT01347060|3772503|B1|70-74 years old||Age, Customized||Participants|Number|2694|2694.0||||||
3950649|NCT01347060|3772501|B3|65-69 years old||Age, Customized||Participants|Number|7217|7217.0||||||
3950650|NCT01347060|3772502|B2|65-69 years old||Age, Customized||Participants|Number|3064|3064.0||||||
3950651|NCT01347060|3772503|B1|65-69 years old||Age, Customized||Participants|Number|4153|4153.0||||||
3950652|NCT01347034|3772514|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3950653|NCT01347034|3772515|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3950654|NCT01347034|3772516|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3950655|NCT01347034|3772514|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3950656|NCT01347034|3772515|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3950657|NCT01347034|3772516|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3950658|NCT01347034|3772514|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3950659|NCT01347034|3772515|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3950660|NCT01347034|3772516|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3950661|NCT01347034|3772514|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3950662|NCT01347034|3772515|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3950663|NCT01347034|3772516|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3950664|NCT01347034|3772514|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3950665|NCT01347034|3772515|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3950666|NCT01347034|3772516|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3950667|NCT01347034|3772514|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3950668|NCT01347034|3772515|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3950669|NCT01347034|3772516|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3950670|NCT01347034|3772514|B3|||Age||years|Mean|57.35|57.35|Full Range|||42.0|77.0|
3950671|NCT01347034|3772515|B2|||Age||years|Mean|59.5|59.5|Full Range|||42.0|77.0|
3950672|NCT01347034|3772516|B1|||Age||years|Mean|53.8|53.8|Full Range|||45.0|74.0|
3950673|NCT01347008|3772525|B3|||Daily frequency of Raynuad's Phenomenon attacks|Daily frequency of RP attacks as self registered in a 1-week diary. Any episode of pallor or cyanosis of the hand/fingers was considered as a RP attack, and patients were supposed to register the daily amount of such episodes on a 1-week diary, previously to the medical visit.|number of attacks per day|Mean|2.1|2.1|Standard Deviation|2.3|2.3|||
3950674|NCT01347008|3772526|B2|||Daily frequency of Raynuad's Phenomenon attacks|Daily frequency of RP attacks as self registered in a 1-week diary. Any episode of pallor or cyanosis of the hand/fingers was considered as a RP attack, and patients were supposed to register the daily amount of such episodes on a 1-week diary, previously to the medical visit.|number of attacks per day|Mean|1.9|1.9|Standard Deviation|2.0|2.0|||
3950675|NCT01347008|3772527|B1|||Daily frequency of Raynuad's Phenomenon attacks|Daily frequency of RP attacks as self registered in a 1-week diary. Any episode of pallor or cyanosis of the hand/fingers was considered as a RP attack, and patients were supposed to register the daily amount of such episodes on a 1-week diary, previously to the medical visit.|number of attacks per day|Mean|2.3|2.3|Standard Deviation|2.5|2.5|||
3950676|NCT01347008|3772525|B3|||Digital skin microvascular blood flow measured by Laser Doppler Imaging (LDI) after cold stimulus.|Finger blood flow of the four medial fingers, measured by laser Doppler imaging and expressed in arbitrary perfusion units (p.u.). Measure taken after submersion of both hands in water at 15°C for 1 minute.|perfusion units|Mean|200.2|200.2|Standard Deviation|96.1|96.1|||
3950677|NCT01347008|3772526|B2|||Digital skin microvascular blood flow measured by Laser Doppler Imaging (LDI) after cold stimulus.|Finger blood flow of the four medial fingers, measured by laser Doppler imaging and expressed in arbitrary perfusion units (p.u.). Measure taken after submersion of both hands in water at 15°C for 1 minute.|perfusion units|Mean|218.6|218.6|Standard Deviation|98.9|98.9|||
3950678|NCT01347008|3772527|B1|||Digital skin microvascular blood flow measured by Laser Doppler Imaging (LDI) after cold stimulus.|Finger blood flow of the four medial fingers, measured by laser Doppler imaging and expressed in arbitrary perfusion units (p.u.). Measure taken after submersion of both hands in water at 15°C for 1 minute.|perfusion units|Mean|178.8|178.8|Standard Deviation|92.4|92.4|||
3950679|NCT01347008|3772525|B3|||Digital skin microvascular blood flow measured by Laser Doppler Imaging (LDI) before cold stimulus|Finger blood flow of the four medial fingers, measured by laser Doppler imaging and expressed in arbitrary perfusion units (p.u.).|perfusion units|Mean|234.6|234.6|Standard Deviation|105.8|105.8|||
3950680|NCT01347008|3772526|B2|||Digital skin microvascular blood flow measured by Laser Doppler Imaging (LDI) before cold stimulus|Finger blood flow of the four medial fingers, measured by laser Doppler imaging and expressed in arbitrary perfusion units (p.u.).|perfusion units|Mean|241.9|241.9|Standard Deviation|104.4|104.4|||
3950681|NCT01347008|3772527|B1|||Digital skin microvascular blood flow measured by Laser Doppler Imaging (LDI) before cold stimulus|Finger blood flow of the four medial fingers, measured by laser Doppler imaging and expressed in arbitrary perfusion units (p.u.).|perfusion units|Mean|213.1|213.1|Standard Deviation|87.9|87.9|||
3950682|NCT01347008|3772525|B3|Brazil||Region of Enrollment||participants|Number|41|41.0||||||
3950683|NCT01347008|3772526|B2|Brazil||Region of Enrollment||participants|Number|20|20.0||||||
3950684|NCT01347008|3772527|B1|Brazil||Region of Enrollment||participants|Number|21|21.0||||||
3950685|NCT01347008|3772525|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3950686|NCT01347008|3772526|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3950687|NCT01347008|3772527|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3950688|NCT01347008|3772525|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3950689|NCT01347008|3772526|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3950690|NCT01347008|3772527|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3950691|NCT01347008|3772525|B3|||Age||years|Mean|44.5|44.5|Standard Deviation|12.3|12.3|||
3950692|NCT01347008|3772526|B2|||Age||years|Mean|41.6|41.6|Standard Deviation|13.3|13.3|||
3950693|NCT01347008|3772527|B1|||Age||years|Mean|47.2|47.2|Standard Deviation|10.9|10.9|||
3950694|NCT01346852|3772538|B3||Male|Sex: Female, Male||Participants|Count of Participants|44887|44887.0||||||
3950695|NCT01346852|3772539|B2||Male|Sex: Female, Male||Participants|Count of Participants|21473|21473.0||||||
3950696|NCT01346852|3772540|B1||Male|Sex: Female, Male||Participants|Count of Participants|23414|23414.0||||||
3950697|NCT01346852|3772538|B3||Female|Sex: Female, Male||Participants|Count of Participants|56550|56550.0||||||
3950698|NCT01346852|3772539|B2||Female|Sex: Female, Male||Participants|Count of Participants|38211|38211.0||||||
3950699|NCT01346852|3772540|B1||Female|Sex: Female, Male||Participants|Count of Participants|18339|18339.0||||||
3950700|NCT01346852|3772538|B3|||Age||Years|Mean|29.8|29.8|Standard Deviation|19.5|19.5|||
3950701|NCT01346852|3772539|B2|||Age||Years|Mean|43.6|43.6|Standard Deviation|13.3|13.3|||
3950702|NCT01346852|3772540|B1|||Age||Years|Mean|10.1|10.1|Standard Deviation|4.0|4.0|||
3950703|NCT01346839|3772549|B3|||Number of Comorbidities||Comorbidities|Mean|2.2|2.2|Standard Deviation|1.4|1.4|||
3950704|NCT01346839|3772550|B2|||Number of Comorbidities||Comorbidities|Mean|2.1|2.1|Standard Deviation|1.4|1.4|||
3950705|NCT01346839|3772551|B1|||Number of Comorbidities||Comorbidities|Mean|2.2|2.2|Standard Deviation|1.3|1.3|||
3950706|NCT01346839|3772549|B3|United States||Region of Enrollment||participants|Number|733|733.0||||||
3950707|NCT01346839|3772550|B2|United States||Region of Enrollment||participants|Number|364|364.0||||||
3950708|NCT01346839|3772551|B1|United States||Region of Enrollment||participants|Number|369|369.0||||||
3950709|NCT01346839|3772549|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3950710|NCT01346839|3772550|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3950711|NCT01346839|3772551|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3950712|NCT01346839|3772549|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950713|NCT01346839|3772550|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950714|NCT01346839|3772551|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950715|NCT01346839|3772549|B3||White|Race (NIH/OMB)||Participants|Count of Participants|392|392.0||||||
3950716|NCT01346839|3772550|B2||White|Race (NIH/OMB)||Participants|Count of Participants|179|179.0||||||
3950717|NCT01346839|3772551|B1||White|Race (NIH/OMB)||Participants|Count of Participants|213|213.0||||||
3950718|NCT01346839|3772549|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|295|295.0||||||
3950719|NCT01346839|3772550|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|154|154.0||||||
3950720|NCT01346839|3772551|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|141|141.0||||||
3950721|NCT01346839|3772549|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950722|NCT01346839|3772550|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950723|NCT01346839|3772551|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950724|NCT01346839|3772549|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3950725|NCT01346839|3772550|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3950726|NCT01346839|3772551|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3950727|NCT01346839|3772549|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3950728|NCT01346839|3772550|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3950729|NCT01346839|3772551|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950730|NCT01346839|3772549|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950731|NCT01346839|3772550|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950732|NCT01346839|3772551|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950733|NCT01346839|3772549|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|665|665.0||||||
3950734|NCT01346839|3772550|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|331|331.0||||||
3950735|NCT01346839|3772551|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|334|334.0||||||
3950736|NCT01346839|3772549|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3950737|NCT01346839|3772550|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3950738|NCT01346839|3772551|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3950739|NCT01346839|3772549|B3||Male|Sex: Female, Male||Participants|Count of Participants|629|629.0||||||
3950740|NCT01346839|3772550|B2||Male|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
3950741|NCT01346839|3772551|B1||Male|Sex: Female, Male||Participants|Count of Participants|331|331.0||||||
3950742|NCT01346839|3772549|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3950743|NCT01346839|3772550|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3950744|NCT01346839|3772551|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3950745|NCT01346839|3772549|B3|||Age||years|Mean|60.3|60.3|Standard Deviation|7.9|7.9|||
3950746|NCT01346839|3772550|B2|||Age||years|Mean|60.3|60.3|Standard Deviation|8.5|8.5|||
3950747|NCT01346839|3772551|B1|||Age||years|Mean|60.4|60.4|Standard Deviation|7.4|7.4|||
3950748|NCT01346774|3772566|B3|Other||Type of Surgery|Categories are not mutually exclusive; participants may have required more than one type of surgery.|participants|Number|8|8.0||||||
3950749|NCT01346774|3772567|B2|Other||Type of Surgery|Categories are not mutually exclusive; participants may have required more than one type of surgery.|participants|Number|4|4.0||||||
3950750|NCT01346774|3772568|B1|Other||Type of Surgery|Categories are not mutually exclusive; participants may have required more than one type of surgery.|participants|Number|4|4.0||||||
3950751|NCT01346774|3772566|B3|Hysterectomy/other extirpative||Type of Surgery|Categories are not mutually exclusive; participants may have required more than one type of surgery.|participants|Number|77|77.0||||||
3950752|NCT01346774|3772567|B2|Hysterectomy/other extirpative||Type of Surgery|Categories are not mutually exclusive; participants may have required more than one type of surgery.|participants|Number|42|42.0||||||
3950753|NCT01346774|3772568|B1|Hysterectomy/other extirpative||Type of Surgery|Categories are not mutually exclusive; participants may have required more than one type of surgery.|participants|Number|35|35.0||||||
3950754|NCT01346774|3772566|B3|Prolapse/reconstructive||Type of Surgery|Categories are not mutually exclusive; participants may have required more than one type of surgery.|participants|Number|110|110.0||||||
3950755|NCT01346774|3772567|B2|Prolapse/reconstructive||Type of Surgery|Categories are not mutually exclusive; participants may have required more than one type of surgery.|participants|Number|58|58.0||||||
3950756|NCT01346774|3772568|B1|Prolapse/reconstructive||Type of Surgery|Categories are not mutually exclusive; participants may have required more than one type of surgery.|participants|Number|52|52.0||||||
3950757|NCT01346774|3772566|B3|Urinary incontinence operation||Type of Surgery|Categories are not mutually exclusive; participants may have required more than one type of surgery.|participants|Number|48|48.0||||||
3950758|NCT01346774|3772567|B2|Urinary incontinence operation||Type of Surgery|Categories are not mutually exclusive; participants may have required more than one type of surgery.|participants|Number|24|24.0||||||
3950759|NCT01346774|3772568|B1|Urinary incontinence operation||Type of Surgery|Categories are not mutually exclusive; participants may have required more than one type of surgery.|participants|Number|24|24.0||||||
3950760|NCT01346774|3772566|B3|Other||Reasons for surgery|Categories are not mutually exclusive. Participants may have had more than one reason for surgery.|participants|Number|27|27.0||||||
3950761|NCT01346774|3772567|B2|Other||Reasons for surgery|Categories are not mutually exclusive. Participants may have had more than one reason for surgery.|participants|Number|18|18.0||||||
3950762|NCT01346774|3772568|B1|Other||Reasons for surgery|Categories are not mutually exclusive. Participants may have had more than one reason for surgery.|participants|Number|9|9.0||||||
3950763|NCT01346774|3772566|B3|Adnexal mass||Reasons for surgery|Categories are not mutually exclusive. Participants may have had more than one reason for surgery.|participants|Number|8|8.0||||||
3950764|NCT01346774|3772567|B2|Adnexal mass||Reasons for surgery|Categories are not mutually exclusive. Participants may have had more than one reason for surgery.|participants|Number|4|4.0||||||
3950765|NCT01346774|3772568|B1|Adnexal mass||Reasons for surgery|Categories are not mutually exclusive. Participants may have had more than one reason for surgery.|participants|Number|4|4.0||||||
3950766|NCT01346774|3772566|B3|Abnormal uterine bleeding||Reasons for surgery|Categories are not mutually exclusive. Participants may have had more than one reason for surgery.|participants|Number|17|17.0||||||
3950767|NCT01346774|3772567|B2|Abnormal uterine bleeding||Reasons for surgery|Categories are not mutually exclusive. Participants may have had more than one reason for surgery.|participants|Number|6|6.0||||||
3950768|NCT01346774|3772568|B1|Abnormal uterine bleeding||Reasons for surgery|Categories are not mutually exclusive. Participants may have had more than one reason for surgery.|participants|Number|11|11.0||||||
3950769|NCT01346774|3772566|B3|Endometriosis||Reasons for surgery|Categories are not mutually exclusive. Participants may have had more than one reason for surgery.|participants|Number|2|2.0||||||
3950770|NCT01346774|3772567|B2|Endometriosis||Reasons for surgery|Categories are not mutually exclusive. Participants may have had more than one reason for surgery.|participants|Number|2|2.0||||||
3950771|NCT01346774|3772568|B1|Endometriosis||Reasons for surgery|Categories are not mutually exclusive. Participants may have had more than one reason for surgery.|participants|Number|0|0.0||||||
3950772|NCT01346774|3772566|B3|Chronic pelvic pain||Reasons for surgery|Categories are not mutually exclusive. Participants may have had more than one reason for surgery.|participants|Number|5|5.0||||||
3950773|NCT01346774|3772567|B2|Chronic pelvic pain||Reasons for surgery|Categories are not mutually exclusive. Participants may have had more than one reason for surgery.|participants|Number|3|3.0||||||
3950774|NCT01346774|3772568|B1|Chronic pelvic pain||Reasons for surgery|Categories are not mutually exclusive. Participants may have had more than one reason for surgery.|participants|Number|2|2.0||||||
3950775|NCT01346774|3772566|B3|Stress urinary incontinence||Reasons for surgery|Categories are not mutually exclusive. Participants may have had more than one reason for surgery.|participants|Number|44|44.0||||||
3950776|NCT01346774|3772567|B2|Stress urinary incontinence||Reasons for surgery|Categories are not mutually exclusive. Participants may have had more than one reason for surgery.|participants|Number|23|23.0||||||
3950777|NCT01346774|3772568|B1|Stress urinary incontinence||Reasons for surgery|Categories are not mutually exclusive. Participants may have had more than one reason for surgery.|participants|Number|21|21.0||||||
3950778|NCT01346774|3772566|B3|Pelvic organ prolapse||Reasons for surgery|Categories are not mutually exclusive. Participants may have had more than one reason for surgery.|participants|Number|107|107.0||||||
3950779|NCT01346774|3772567|B2|Pelvic organ prolapse||Reasons for surgery|Categories are not mutually exclusive. Participants may have had more than one reason for surgery.|participants|Number|56|56.0||||||
3950780|NCT01346774|3772568|B1|Pelvic organ prolapse||Reasons for surgery|Categories are not mutually exclusive. Participants may have had more than one reason for surgery.|participants|Number|51|51.0||||||
3950781|NCT01346774|3772566|B3|Fibroids||Reasons for surgery|Categories are not mutually exclusive. Participants may have had more than one reason for surgery.|participants|Number|20|20.0||||||
3950835|NCT01346592|3772575|B4||Male|Sex: Female, Male||Participants|Count of Participants|3079|3079.0||||||
3950782|NCT01346774|3772567|B2|Fibroids||Reasons for surgery|Categories are not mutually exclusive. Participants may have had more than one reason for surgery.|participants|Number|9|9.0||||||
3950783|NCT01346774|3772568|B1|Fibroids||Reasons for surgery|Categories are not mutually exclusive. Participants may have had more than one reason for surgery.|participants|Number|11|11.0||||||
3950784|NCT01346774|3772566|B3|||Ever experienced UTI in life|Participant has experienced UTI at least once in her lifetime prior to her gynecologic surgery.|participants|Number|99|99.0||||||
3950785|NCT01346774|3772567|B2|||Ever experienced UTI in life|Participant has experienced UTI at least once in her lifetime prior to her gynecologic surgery.|participants|Number|50|50.0||||||
3950786|NCT01346774|3772568|B1|||Ever experienced UTI in life|Participant has experienced UTI at least once in her lifetime prior to her gynecologic surgery.|participants|Number|49|49.0||||||
3950787|NCT01346774|3772566|B3|||Experienced a UTI in the past 12 mo|Participant has experienced UTI in the 12 months prior to her gynecologic surgery.|participants|Number|37|37.0||||||
3950788|NCT01346774|3772567|B2|||Experienced a UTI in the past 12 mo|Participant has experienced UTI in the 12 months prior to her gynecologic surgery.|participants|Number|19|19.0||||||
3950789|NCT01346774|3772568|B1|||Experienced a UTI in the past 12 mo|Participant has experienced UTI in the 12 months prior to her gynecologic surgery.|participants|Number|18|18.0||||||
3950790|NCT01346774|3772566|B3|United States||Region of Enrollment||participants|Number|160|160.0||||||
3950791|NCT01346774|3772567|B2|United States||Region of Enrollment||participants|Number|80|80.0||||||
3950792|NCT01346774|3772568|B1|United States||Region of Enrollment||participants|Number|80|80.0||||||
3950793|NCT01346774|3772566|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3950794|NCT01346774|3772567|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950795|NCT01346774|3772568|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3950796|NCT01346774|3772566|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3950797|NCT01346774|3772567|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3950798|NCT01346774|3772568|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3950799|NCT01346774|3772566|B3||White|Race (NIH/OMB)||Participants|Count of Participants|141|141.0||||||
3950800|NCT01346774|3772567|B2||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3950801|NCT01346774|3772568|B1||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3950802|NCT01346774|3772566|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3950803|NCT01346774|3772567|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3950804|NCT01346774|3772568|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3950805|NCT01346774|3772566|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950806|NCT01346774|3772567|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950807|NCT01346774|3772568|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950808|NCT01346774|3772566|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950809|NCT01346774|3772567|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950810|NCT01346774|3772568|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950811|NCT01346774|3772566|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950812|NCT01346774|3772567|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950813|NCT01346774|3772568|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950814|NCT01346774|3772566|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3950815|NCT01346774|3772567|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3950816|NCT01346774|3772568|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3950817|NCT01346774|3772566|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|152|152.0||||||
3950818|NCT01346774|3772567|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3950819|NCT01346774|3772568|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3950820|NCT01346774|3772566|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3950821|NCT01346774|3772567|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3950822|NCT01346774|3772568|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3950823|NCT01346774|3772566|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3950824|NCT01346774|3772567|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3950825|NCT01346774|3772568|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3950826|NCT01346774|3772566|B3||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3950827|NCT01346774|3772567|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3950828|NCT01346774|3772568|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3950829|NCT01346774|3772566|B3|> 60 years||Age, Customized||participants|Number|65|65.0||||||
3950830|NCT01346774|3772567|B2|> 60 years||Age, Customized||participants|Number|32|32.0||||||
3950831|NCT01346774|3772568|B1|> 60 years||Age, Customized||participants|Number|33|33.0||||||
3950832|NCT01346774|3772566|B3|18 - 60 years||Age, Customized||participants|Number|95|95.0||||||
3950833|NCT01346774|3772567|B2|18 - 60 years||Age, Customized||participants|Number|48|48.0||||||
3950834|NCT01346774|3772568|B1|18 - 60 years||Age, Customized||participants|Number|47|47.0||||||
3950836|NCT01346592|3772576|B3||Male|Sex: Female, Male||Participants|Count of Participants|755|755.0||||||
3950837|NCT01346592|3772577|B2||Male|Sex: Female, Male||Participants|Count of Participants|733|733.0||||||
3950838|NCT01346592|3772578|B1||Male|Sex: Female, Male||Participants|Count of Participants|1591|1591.0||||||
3950839|NCT01346592|3772575|B4||Female|Sex: Female, Male||Participants|Count of Participants|3021|3021.0||||||
3950840|NCT01346592|3772576|B3||Female|Sex: Female, Male||Participants|Count of Participants|731|731.0||||||
3950841|NCT01346592|3772577|B2||Female|Sex: Female, Male||Participants|Count of Participants|745|745.0||||||
3950842|NCT01346592|3772578|B1||Female|Sex: Female, Male||Participants|Count of Participants|1545|1545.0||||||
3950843|NCT01346592|3772575|B4|||Age||Months|Mean|33.7|33.7|Standard Deviation|18.1|18.1|||
3950844|NCT01346592|3772576|B3|||Age||Months|Mean|30.2|30.2|Standard Deviation|16.9|16.9|||
3950845|NCT01346592|3772577|B2|||Age||Months|Mean|30.0|30.0|Standard Deviation|16.9|16.9|||
3950846|NCT01346592|3772578|B1|||Age||Months|Mean|37.1|37.1|Standard Deviation|18.6|18.6|||
3950847|NCT01346540|3772670|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3950848|NCT01346540|3772671|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3950849|NCT01346540|3772672|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3950850|NCT01346540|3772670|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3950851|NCT01346540|3772671|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3950852|NCT01346540|3772672|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3950853|NCT01346540|3772670|B3|||Age||Years|Mean|65.4|65.4|Standard Deviation|6.5|6.5|||
3950854|NCT01346540|3772671|B2|||Age||Years|Mean|65.7|65.7|Standard Deviation|5.0|5.0|||
3950855|NCT01346540|3772672|B1|||Age||Years|Mean|64.5|64.5|Standard Deviation|10.9|10.9|||
3950856|NCT01346514|3772682|B3|Unknown||Episodes of Homelessness||participants|Number|1|1.0||||||
3950857|NCT01346514|3772683|B2|Unknown||Episodes of Homelessness||participants|Number|1|1.0||||||
3950858|NCT01346514|3772684|B1|Unknown||Episodes of Homelessness||participants|Number|0|0.0||||||
3950859|NCT01346514|3772682|B3|5 or more episodes||Episodes of Homelessness||participants|Number|11|11.0||||||
3950860|NCT01346514|3772683|B2|5 or more episodes||Episodes of Homelessness||participants|Number|3|3.0||||||
3950861|NCT01346514|3772684|B1|5 or more episodes||Episodes of Homelessness||participants|Number|8|8.0||||||
3950862|NCT01346514|3772682|B3|4 episodes||Episodes of Homelessness||participants|Number|8|8.0||||||
3950863|NCT01346514|3772683|B2|4 episodes||Episodes of Homelessness||participants|Number|4|4.0||||||
3950864|NCT01346514|3772684|B1|4 episodes||Episodes of Homelessness||participants|Number|4|4.0||||||
3950865|NCT01346514|3772682|B3|3 episodes||Episodes of Homelessness||participants|Number|14|14.0||||||
3950866|NCT01346514|3772683|B2|3 episodes||Episodes of Homelessness||participants|Number|10|10.0||||||
3950867|NCT01346514|3772684|B1|3 episodes||Episodes of Homelessness||participants|Number|4|4.0||||||
3950868|NCT01346514|3772682|B3|2 episodes||Episodes of Homelessness||participants|Number|41|41.0||||||
3950869|NCT01346514|3772683|B2|2 episodes||Episodes of Homelessness||participants|Number|17|17.0||||||
3950870|NCT01346514|3772684|B1|2 episodes||Episodes of Homelessness||participants|Number|24|24.0||||||
3950871|NCT01346514|3772682|B3|1 episode||Episodes of Homelessness||participants|Number|106|106.0||||||
3950872|NCT01346514|3772683|B2|1 episode||Episodes of Homelessness||participants|Number|55|55.0||||||
3950873|NCT01346514|3772684|B1|1 episode||Episodes of Homelessness||participants|Number|51|51.0||||||
3950874|NCT01346514|3772682|B3|Unknown||Time Homeless, Current Episode||participants|Number|1|1.0||||||
3950875|NCT01346514|3772683|B2|Unknown||Time Homeless, Current Episode||participants|Number|1|1.0||||||
3950876|NCT01346514|3772684|B1|Unknown||Time Homeless, Current Episode||participants|Number|0|0.0||||||
3950877|NCT01346514|3772682|B3|2 or more years||Time Homeless, Current Episode||participants|Number|42|42.0||||||
3950878|NCT01346514|3772683|B2|2 or more years||Time Homeless, Current Episode||participants|Number|27|27.0||||||
3950879|NCT01346514|3772684|B1|2 or more years||Time Homeless, Current Episode||participants|Number|15|15.0||||||
3950880|NCT01346514|3772682|B3|1-2 years||Time Homeless, Current Episode||participants|Number|19|19.0||||||
3950881|NCT01346514|3772683|B2|1-2 years||Time Homeless, Current Episode||participants|Number|10|10.0||||||
3950882|NCT01346514|3772684|B1|1-2 years||Time Homeless, Current Episode||participants|Number|9|9.0||||||
3950883|NCT01346514|3772682|B3|6-12 months||Time Homeless, Current Episode||participants|Number|36|36.0||||||
3950884|NCT01346514|3772683|B2|6-12 months||Time Homeless, Current Episode||participants|Number|15|15.0||||||
3950885|NCT01346514|3772684|B1|6-12 months||Time Homeless, Current Episode||participants|Number|21|21.0||||||
3950886|NCT01346514|3772682|B3|1-6 months||Time Homeless, Current Episode||participants|Number|58|58.0||||||
3950887|NCT01346514|3772683|B2|1-6 months||Time Homeless, Current Episode||participants|Number|27|27.0||||||
3950888|NCT01346514|3772684|B1|1-6 months||Time Homeless, Current Episode||participants|Number|31|31.0||||||
3950889|NCT01346514|3772682|B3|Less than 1 month||Time Homeless, Current Episode||participants|Number|25|25.0||||||
3950890|NCT01346514|3772683|B2|Less than 1 month||Time Homeless, Current Episode||participants|Number|10|10.0||||||
3950891|NCT01346514|3772684|B1|Less than 1 month||Time Homeless, Current Episode||participants|Number|15|15.0||||||
3950892|NCT01346514|3772682|B3|Other||Primary Substance of Use||participants|Number|18|18.0||||||
3950893|NCT01346514|3772683|B2|Other||Primary Substance of Use||participants|Number|8|8.0||||||
3950894|NCT01346514|3772684|B1|Other||Primary Substance of Use||participants|Number|10|10.0||||||
3950895|NCT01346514|3772682|B3|Opioids||Primary Substance of Use||participants|Number|17|17.0||||||
3950896|NCT01346514|3772683|B2|Opioids||Primary Substance of Use||participants|Number|8|8.0||||||
3950897|NCT01346514|3772684|B1|Opioids||Primary Substance of Use||participants|Number|9|9.0||||||
3950898|NCT01346514|3772682|B3|Cocaine||Primary Substance of Use||participants|Number|30|30.0||||||
3950899|NCT01346514|3772683|B2|Cocaine||Primary Substance of Use||participants|Number|15|15.0||||||
3950900|NCT01346514|3772684|B1|Cocaine||Primary Substance of Use||participants|Number|15|15.0||||||
3950901|NCT01346514|3772682|B3|Alcohol||Primary Substance of Use||participants|Number|116|116.0||||||
3950902|NCT01346514|3772683|B2|Alcohol||Primary Substance of Use||participants|Number|59|59.0||||||
3950903|NCT01346514|3772684|B1|Alcohol||Primary Substance of Use||participants|Number|57|57.0||||||
3950904|NCT01346514|3772682|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3950905|NCT01346514|3772683|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3950906|NCT01346514|3772684|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3950907|NCT01346514|3772682|B3|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3950908|NCT01346514|3772683|B2|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3950909|NCT01346514|3772684|B1|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3950910|NCT01346514|3772682|B3|Native American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3950911|NCT01346514|3772683|B2|Native American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3950912|NCT01346514|3772684|B1|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3950913|NCT01346514|3772682|B3|Black||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
3950914|NCT01346514|3772683|B2|Black||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3950915|NCT01346514|3772684|B1|Black||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3950916|NCT01346514|3772682|B3|White||Race/Ethnicity, Customized||participants|Number|108|108.0||||||
3950917|NCT01346514|3772683|B2|White||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
3950918|NCT01346514|3772684|B1|White||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
3950919|NCT01346514|3772682|B3||Male|Gender||Participants|Count of Participants|177|177.0||||||
3950920|NCT01346514|3772683|B2||Male|Gender||Participants|Count of Participants|88|88.0||||||
3950921|NCT01346514|3772684|B1||Male|Gender||Participants|Count of Participants|89|89.0||||||
3950922|NCT01346514|3772682|B3||Female|Gender||Participants|Count of Participants|4|4.0||||||
3950923|NCT01346514|3772683|B2||Female|Gender||Participants|Count of Participants|2|2.0||||||
3950924|NCT01346514|3772684|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
3950925|NCT01346514|3772682|B3|||Age||years|Mean|50.9|50.9|Standard Deviation|9.5|9.5|||
3950926|NCT01346514|3772683|B2|||Age||years|Mean|50.9|50.9|Standard Deviation|9.6|9.6|||
3950927|NCT01346514|3772684|B1|||Age||years|Mean|50.8|50.8|Standard Deviation|9.5|9.5|||
3950928|NCT01346501|3772703|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3950929|NCT01346501|3772704|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3950930|NCT01346501|3772705|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3950931|NCT01346501|3772703|B3||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3950932|NCT01346501|3772704|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3950933|NCT01346501|3772705|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3950934|NCT01346501|3772703|B3|||Age||Years|Mean|55.8|55.8|Standard Deviation|12.8|12.8|||
3950935|NCT01346501|3772704|B2|||Age||Years|Mean|55.2|55.2|Standard Deviation|12.1|12.1|||
3950936|NCT01346501|3772705|B1|||Age||Years|Mean|56.4|56.4|Standard Deviation|13.6|13.6|||
3950937|NCT01346488|3772719|B1||Male|Sex: Female, Male||Participants|Count of Participants|484|484.0||||||
3950938|NCT01346488|3772719|B1||Female|Sex: Female, Male||Participants|Count of Participants|1484|1484.0||||||
3950939|NCT01346488|3772719|B1|||Age||years|Mean|55.8|55.8|Standard Deviation|13.5|13.5|||
3950940|NCT01346475|3772737|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950941|NCT01346475|3772738|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950942|NCT01346475|3772739|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950943|NCT01346475|3772737|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950944|NCT01346475|3772738|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950945|NCT01346475|3772739|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950946|NCT01346475|3772737|B3||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3950947|NCT01346475|3772738|B2||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3950948|NCT01346475|3772739|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3950949|NCT01346475|3772737|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3950950|NCT01346475|3772738|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3950951|NCT01346475|3772739|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3950952|NCT01346475|3772737|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950953|NCT01346475|3772738|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950954|NCT01346475|3772739|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950955|NCT01346475|3772737|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950956|NCT01346475|3772738|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950957|NCT01346475|3772739|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950958|NCT01346475|3772737|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3950959|NCT01346475|3772738|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3950960|NCT01346475|3772739|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3950961|NCT01346475|3772737|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3950962|NCT01346475|3772738|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3950963|NCT01346475|3772739|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3950964|NCT01346475|3772737|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3950965|NCT01346475|3772738|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3950966|NCT01346475|3772739|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3950967|NCT01346475|3772737|B3|||Age||years|Mean|40.4|40.4|Standard Deviation|11.8|11.8|||
3950968|NCT01346475|3772738|B2|||Age||years|Mean|37.7|37.7|Standard Deviation|12.8|12.8|||
3950969|NCT01346475|3772739|B1|||Age||years|Mean|43.9|43.9|Standard Deviation|9.5|9.5|||
3950970|NCT01346410|3772752|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3950971|NCT01346410|3772752|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3950972|NCT01346410|3772752|B1|||Age||years|Mean|79|79.0|Full Range|||||
3950973|NCT01346397|3772756|B3|||Deceased donor kidney transplant recipients||participants|Number|49|49.0||||||
3950974|NCT01346397|3772757|B2|||Deceased donor kidney transplant recipients||participants|Number|21|21.0||||||
3950975|NCT01346397|3772758|B1|||Deceased donor kidney transplant recipients||participants|Number|28|28.0||||||
3950976|NCT01346397|3772756|B3|Male||Gender||participants|Number|92|92.0||||||
3950977|NCT01346397|3772757|B2|Male||Gender||participants|Number|40|40.0||||||
3950978|NCT01346397|3772758|B1|Male||Gender||participants|Number|52|52.0||||||
3950979|NCT01346397|3772756|B3|Female||Gender||participants|Number|68|68.0||||||
3950980|NCT01346397|3772757|B2|Female||Gender||participants|Number|35|35.0||||||
3950981|NCT01346397|3772758|B1|Female||Gender||participants|Number|33|33.0||||||
3950982|NCT01346397|3772756|B3|||Age||years|Mean|20|20.0|Standard Deviation|14|14.0|||
3950983|NCT01346397|3772757|B2|||Age||years|Mean|21|21.0|Standard Deviation|15|15.0|||
3950984|NCT01346397|3772758|B1|||Age||years|Mean|19|19.0|Standard Deviation|14|14.0|||
3950985|NCT01346293|3772767|B3|United States||Region of Enrollment||Participants|Number|3372|3372.0||||||
3950986|NCT01346293|3772768|B2|United States||Region of Enrollment||Participants|Number|629|629.0||||||
3950987|NCT01346293|3772769|B1|United States||Region of Enrollment||Participants|Number|2743|2743.0||||||
3950988|NCT01346293|3772767|B3||Male|Sex: Female, Male||Participants|Count of Participants|1736|1736.0||||||
3950989|NCT01346293|3772768|B2||Male|Sex: Female, Male||Participants|Count of Participants|323|323.0||||||
3950990|NCT01346293|3772769|B1||Male|Sex: Female, Male||Participants|Count of Participants|1413|1413.0||||||
3950991|NCT01346293|3772767|B3||Female|Sex: Female, Male||Participants|Count of Participants|1636|1636.0||||||
3950992|NCT01346293|3772768|B2||Female|Sex: Female, Male||Participants|Count of Participants|306|306.0||||||
3950993|NCT01346293|3772769|B1||Female|Sex: Female, Male||Participants|Count of Participants|1330|1330.0||||||
3950994|NCT01346293|3772767|B3|||Age||Years|Mean|4.4|4.4|Standard Deviation|0.5|0.5|||
3950995|NCT01346293|3772768|B2|||Age||Years|Mean|4.4|4.4|Standard Deviation|0.5|0.5|||
3950996|NCT01346293|3772769|B1|||Age||Years|Mean|4.4|4.4|Standard Deviation|0.5|0.5|||
3950997|NCT01346293|3772767|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3950998|NCT01346293|3772768|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3950999|NCT01346293|3772769|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3951000|NCT01346293|3772767|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3951001|NCT01346293|3772768|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3951002|NCT01346293|3772769|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3951003|NCT01346293|3772767|B3||<=18 years|Age||Participants|Count of Participants|3372|3372.0||||||
3951004|NCT01346293|3772768|B2||<=18 years|Age||Participants|Count of Participants|629|629.0||||||
3951005|NCT01346293|3772769|B1||<=18 years|Age||Participants|Count of Participants|2743|2743.0||||||
3951006|NCT01346189|3772796|B5|||Taking cholesterol-reducing medications at baseline||Participants|Count of Participants|712|712.0||||||
3951007|NCT01346189|3772797|B4|||Taking cholesterol-reducing medications at baseline||Participants|Count of Participants|166|166.0||||||
3951008|NCT01346189|3772798|B3|||Taking cholesterol-reducing medications at baseline||Participants|Count of Participants|200|200.0||||||
3951009|NCT01346189|3772799|B2|||Taking cholesterol-reducing medications at baseline||Participants|Count of Participants|180|180.0||||||
3951010|NCT01346189|3772800|B1|||Taking cholesterol-reducing medications at baseline||Participants|Count of Participants|166|166.0||||||
3951011|NCT01346189|3772796|B5|||Pre-existing coronary artery disease (CAD)||Participants|Count of Participants|516|516.0||||||
3951012|NCT01346189|3772797|B4|||Pre-existing coronary artery disease (CAD)||Participants|Count of Participants|148|148.0||||||
3951013|NCT01346189|3772798|B3|||Pre-existing coronary artery disease (CAD)||Participants|Count of Participants|115|115.0||||||
3951014|NCT01346189|3772799|B2|||Pre-existing coronary artery disease (CAD)||Participants|Count of Participants|110|110.0||||||
3951015|NCT01346189|3772800|B1|||Pre-existing coronary artery disease (CAD)||Participants|Count of Participants|143|143.0||||||
3951016|NCT01346189|3772796|B5|||Framingham Risk Score (FRS)|The Framingham Risk Score is a gender-specific algorithm used to estimate the 10-year cardiovascular risk of an individual. Individuals with low risk have 10% or less CHD risk at 10 years, with intermediate risk 10-20%, and with high risk 20% or more.|%|Mean|19.8|19.8|Standard Deviation|8.7|8.7|||
3951017|NCT01346189|3772797|B4|||Framingham Risk Score (FRS)|The Framingham Risk Score is a gender-specific algorithm used to estimate the 10-year cardiovascular risk of an individual. Individuals with low risk have 10% or less CHD risk at 10 years, with intermediate risk 10-20%, and with high risk 20% or more.|%|Mean|20.1|20.1|Standard Deviation|8.7|8.7|||
3951018|NCT01346189|3772798|B3|||Framingham Risk Score (FRS)|The Framingham Risk Score is a gender-specific algorithm used to estimate the 10-year cardiovascular risk of an individual. Individuals with low risk have 10% or less CHD risk at 10 years, with intermediate risk 10-20%, and with high risk 20% or more.|%|Mean|19.1|19.1|Standard Deviation|8.7|8.7|||
3951019|NCT01346189|3772799|B2|||Framingham Risk Score (FRS)|The Framingham Risk Score is a gender-specific algorithm used to estimate the 10-year cardiovascular risk of an individual. Individuals with low risk have 10% or less CHD risk at 10 years, with intermediate risk 10-20%, and with high risk 20% or more.|%|Mean|19.7|19.7|Standard Deviation|8.6|8.6|||
3951020|NCT01346189|3772800|B1|||Framingham Risk Score (FRS)|The Framingham Risk Score is a gender-specific algorithm used to estimate the 10-year cardiovascular risk of an individual. Individuals with low risk have 10% or less CHD risk at 10 years, with intermediate risk 10-20%, and with high risk 20% or more.|%|Mean|20.1|20.1|Standard Deviation|9.0|9.0|||
3951021|NCT01346189|3772796|B5|Other||Marital Status||Participants|Count of Participants|278|278.0||||||
3951022|NCT01346189|3772797|B4|Other||Marital Status||Participants|Count of Participants|75|75.0||||||
3951023|NCT01346189|3772798|B3|Other||Marital Status||Participants|Count of Participants|60|60.0||||||
3951024|NCT01346189|3772799|B2|Other||Marital Status||Participants|Count of Participants|62|62.0||||||
3951025|NCT01346189|3772800|B1|Other||Marital Status||Participants|Count of Participants|81|81.0||||||
3951026|NCT01346189|3772796|B5|Married||Marital Status||Participants|Count of Participants|992|992.0||||||
3951027|NCT01346189|3772797|B4|Married||Marital Status||Participants|Count of Participants|231|231.0||||||
3951028|NCT01346189|3772798|B3|Married||Marital Status||Participants|Count of Participants|239|239.0||||||
3951029|NCT01346189|3772799|B2|Married||Marital Status||Participants|Count of Participants|236|236.0||||||
3951030|NCT01346189|3772800|B1|Married||Marital Status||Participants|Count of Participants|286|286.0||||||
3951031|NCT01346189|3772796|B5|Single||Marital Status||Participants|Count of Participants|225|225.0||||||
3951032|NCT01346189|3772797|B4|Single||Marital Status||Participants|Count of Participants|59|59.0||||||
3951033|NCT01346189|3772798|B3|Single||Marital Status||Participants|Count of Participants|43|43.0||||||
3951034|NCT01346189|3772799|B2|Single||Marital Status||Participants|Count of Participants|59|59.0||||||
3951035|NCT01346189|3772800|B1|Single||Marital Status||Participants|Count of Participants|64|64.0||||||
3951036|NCT01346189|3772796|B5|College and postcollege graduate||Education||Participants|Count of Participants|577|577.0||||||
3951037|NCT01346189|3772797|B4|College and postcollege graduate||Education||Participants|Count of Participants|131|131.0||||||
3951038|NCT01346189|3772798|B3|College and postcollege graduate||Education||Participants|Count of Participants|133|133.0||||||
3951039|NCT01346189|3772799|B2|College and postcollege graduate||Education||Participants|Count of Participants|148|148.0||||||
3951040|NCT01346189|3772800|B1|College and postcollege graduate||Education||Participants|Count of Participants|165|165.0||||||
3951041|NCT01346189|3772796|B5|Some college||Education||Participants|Count of Participants|433|433.0||||||
3951042|NCT01346189|3772797|B4|Some college||Education||Participants|Count of Participants|105|105.0||||||
3951043|NCT01346189|3772798|B3|Some college||Education||Participants|Count of Participants|108|108.0||||||
3951044|NCT01346189|3772799|B2|Some college||Education||Participants|Count of Participants|102|102.0||||||
3951045|NCT01346189|3772800|B1|Some college||Education||Participants|Count of Participants|118|118.0||||||
3951046|NCT01346189|3772796|B5|<College||Education||Participants|Count of Participants|486|486.0||||||
3951047|NCT01346189|3772797|B4|<College||Education||Participants|Count of Participants|129|129.0||||||
3951048|NCT01346189|3772798|B3|<College||Education||Participants|Count of Participants|102|102.0||||||
3951049|NCT01346189|3772799|B2|<College||Education||Participants|Count of Participants|107|107.0||||||
3951050|NCT01346189|3772800|B1|<College||Education||Participants|Count of Participants|148|148.0||||||
3951051|NCT01346189|3772796|B5|>100,000||Annual Household Income, No., $||Participants|Count of Participants|297|297.0||||||
3951052|NCT01346189|3772797|B4|>100,000||Annual Household Income, No., $||Participants|Count of Participants|68|68.0||||||
3951053|NCT01346189|3772798|B3|>100,000||Annual Household Income, No., $||Participants|Count of Participants|68|68.0||||||
3951054|NCT01346189|3772799|B2|>100,000||Annual Household Income, No., $||Participants|Count of Participants|76|76.0||||||
3951055|NCT01346189|3772800|B1|>100,000||Annual Household Income, No., $||Participants|Count of Participants|85|85.0||||||
3951056|NCT01346189|3772796|B5|50,000 to 100,000||Annual Household Income, No., $||Participants|Count of Participants|523|523.0||||||
3951057|NCT01346189|3772797|B4|50,000 to 100,000||Annual Household Income, No., $||Participants|Count of Participants|124|124.0||||||
3951058|NCT01346189|3772798|B3|50,000 to 100,000||Annual Household Income, No., $||Participants|Count of Participants|126|126.0||||||
3951059|NCT01346189|3772799|B2|50,000 to 100,000||Annual Household Income, No., $||Participants|Count of Participants|129|129.0||||||
3951060|NCT01346189|3772800|B1|50,000 to 100,000||Annual Household Income, No., $||Participants|Count of Participants|144|144.0||||||
3951061|NCT01346189|3772796|B5|<50,000||Annual Household Income, No., $||Participants|Count of Participants|635|635.0||||||
3951062|NCT01346189|3772797|B4|<50,000||Annual Household Income, No., $||Participants|Count of Participants|163|163.0||||||
3951063|NCT01346189|3772798|B3|<50,000||Annual Household Income, No., $||Participants|Count of Participants|134|134.0||||||
3951064|NCT01346189|3772799|B2|<50,000||Annual Household Income, No., $||Participants|Count of Participants|145|145.0||||||
3951065|NCT01346189|3772800|B1|<50,000||Annual Household Income, No., $||Participants|Count of Participants|193|193.0||||||
3951066|NCT01346189|3772796|B5||Missing|Race/Ethnicity||Participants|Count of Participants|11|11.0||||||
3951067|NCT01346189|3772797|B4||Missing|Race/Ethnicity||Participants|Count of Participants|2|2.0||||||
3951068|NCT01346189|3772798|B3||Missing|Race/Ethnicity||Participants|Count of Participants|6|6.0||||||
3951069|NCT01346189|3772799|B2||Missing|Race/Ethnicity||Participants|Count of Participants|1|1.0||||||
3951070|NCT01346189|3772800|B1||Missing|Race/Ethnicity||Participants|Count of Participants|2|2.0||||||
3951071|NCT01346189|3772796|B5||Hispanic|Race/Ethnicity||Participants|Count of Participants|30|30.0||||||
3951072|NCT01346189|3772797|B4||Hispanic|Race/Ethnicity||Participants|Count of Participants|7|7.0||||||
3951073|NCT01346189|3772798|B3||Hispanic|Race/Ethnicity||Participants|Count of Participants|7|7.0||||||
3951074|NCT01346189|3772799|B2||Hispanic|Race/Ethnicity||Participants|Count of Participants|10|10.0||||||
3951075|NCT01346189|3772800|B1||Hispanic|Race/Ethnicity||Participants|Count of Participants|6|6.0||||||
3951076|NCT01346189|3772796|B5||Other non-Hispanic|Race/Ethnicity||Participants|Count of Participants|31|31.0||||||
3951077|NCT01346189|3772797|B4||Other non-Hispanic|Race/Ethnicity||Participants|Count of Participants|7|7.0||||||
3951078|NCT01346189|3772798|B3||Other non-Hispanic|Race/Ethnicity||Participants|Count of Participants|6|6.0||||||
3951079|NCT01346189|3772799|B2||Other non-Hispanic|Race/Ethnicity||Participants|Count of Participants|10|10.0||||||
3951080|NCT01346189|3772800|B1||Other non-Hispanic|Race/Ethnicity||Participants|Count of Participants|8|8.0||||||
3951081|NCT01346189|3772796|B5||African American, non-Hispanic|Race/Ethnicity||Participants|Count of Participants|232|232.0||||||
3951082|NCT01346189|3772797|B4||African American, non-Hispanic|Race/Ethnicity||Participants|Count of Participants|61|61.0||||||
3951083|NCT01346189|3772798|B3||African American, non-Hispanic|Race/Ethnicity||Participants|Count of Participants|42|42.0||||||
3951084|NCT01346189|3772799|B2||African American, non-Hispanic|Race/Ethnicity||Participants|Count of Participants|72|72.0||||||
3951085|NCT01346189|3772800|B1||African American, non-Hispanic|Race/Ethnicity||Participants|Count of Participants|57|57.0||||||
3951086|NCT01346189|3772796|B5||White, non-Hispanic|Race/Ethnicity||Participants|Count of Participants|1199|1199.0||||||
3951087|NCT01346189|3772797|B4||White, non-Hispanic|Race/Ethnicity||Participants|Count of Participants|289|289.0||||||
3951088|NCT01346189|3772798|B3||White, non-Hispanic|Race/Ethnicity||Participants|Count of Participants|285|285.0||||||
3951089|NCT01346189|3772799|B2||White, non-Hispanic|Race/Ethnicity||Participants|Count of Participants|265|265.0||||||
3951090|NCT01346189|3772800|B1||White, non-Hispanic|Race/Ethnicity||Participants|Count of Participants|360|360.0||||||
3951091|NCT01346189|3772796|B5||Male|Sex: Female, Male||Participants|Count of Participants|864|864.0||||||
3951092|NCT01346189|3772797|B4||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
3951093|NCT01346189|3772798|B3||Male|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
3951094|NCT01346189|3772799|B2||Male|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
3951095|NCT01346189|3772800|B1||Male|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
3951096|NCT01346189|3772796|B5||Female|Sex: Female, Male||Participants|Count of Participants|639|639.0||||||
3951097|NCT01346189|3772797|B4||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3951098|NCT01346189|3772798|B3||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3951099|NCT01346189|3772799|B2||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3951100|NCT01346189|3772800|B1||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
3951101|NCT01346189|3772796|B5|||Age||years|Mean|61.99|61.99|Standard Deviation|8.70|8.7|||
3951102|NCT01346189|3772797|B4|||Age||years|Mean|61.70|61.7|Standard Deviation|8.89|8.89|||
3951103|NCT01346189|3772798|B3|||Age||years|Mean|62.03|62.03|Standard Deviation|8.64|8.64|||
3951104|NCT01346189|3772799|B2|||Age||years|Mean|62.41|62.41|Standard Deviation|8.63|8.63|||
3951105|NCT01346189|3772800|B1|||Age||years|Mean|61.68|61.68|Standard Deviation|8.67|8.67|||
3951106|NCT01346176|3772817|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3951107|NCT01346176|3772818|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951108|NCT01346176|3772819|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3951109|NCT01346176|3772820|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3951110|NCT01346176|3772817|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951111|NCT01346176|3772818|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951112|NCT01346176|3772819|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951113|NCT01346176|3772820|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951114|NCT01346176|3772817|B4||White|Race (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3951115|NCT01346176|3772818|B3||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3951116|NCT01346176|3772819|B2||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3951117|NCT01346176|3772820|B1||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3951118|NCT01346176|3772817|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3951119|NCT01346176|3772818|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3951120|NCT01346176|3772819|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3951121|NCT01346176|3772820|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3951122|NCT01346176|3772817|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951123|NCT01346176|3772818|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951124|NCT01346176|3772819|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951125|NCT01346176|3772820|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951126|NCT01346176|3772817|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951127|NCT01346176|3772818|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951128|NCT01346176|3772819|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951129|NCT01346176|3772820|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951130|NCT01346176|3772817|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951131|NCT01346176|3772818|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951132|NCT01346176|3772819|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951133|NCT01346176|3772820|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951134|NCT01346176|3772817|B4||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3951135|NCT01346176|3772818|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3951136|NCT01346176|3772819|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3951137|NCT01346176|3772820|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3951138|NCT01346176|3772817|B4||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3951139|NCT01346176|3772818|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3951140|NCT01346176|3772819|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3951141|NCT01346176|3772820|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3951142|NCT01346176|3772817|B4|||Age||years|Mean|64.63|64.63|Standard Deviation|8.05|8.05|||
3951143|NCT01346176|3772818|B3|||Age||years|Mean|64.4|64.4|Standard Deviation|7.12|7.12|||
3951144|NCT01346176|3772819|B2|||Age||years|Mean|64.8|64.8|Standard Deviation|8.61|8.61|||
3951145|NCT01346176|3772820|B1|||Age||years|Mean|64.6|64.6|Standard Deviation|8.50|8.5|||
3951146|NCT01346085|3772833|B1|Switzerland||Region of Enrollment||participants|Number|2|2.0||||||
3951147|NCT01346085|3772833|B1|Italy||Region of Enrollment||participants|Number|8|8.0||||||
3951148|NCT01346085|3772833|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3951149|NCT01346085|3772833|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3951150|NCT01346085|3772833|B1|||Age||years|Mean|39.6|39.6|Standard Deviation|4.94|4.94|||
3951151|NCT01346072|3772838|B3|||Total Daily Dose of Loop Diuretic||mg|Mean|84|84.0|Standard Deviation|86|86.0|||
3951152|NCT01346072|3772839|B2|||Total Daily Dose of Loop Diuretic||mg|Mean|47|47.0|Standard Deviation|46|46.0|||
3951153|NCT01346072|3772840|B1|||Total Daily Dose of Loop Diuretic||mg|Mean|124|124.0|Standard Deviation|104|104.0|||
3951154|NCT01346072|3772838|B3|||Serum Sodium||mEq/L|Mean|141.0|141.0|Standard Deviation|2.86|2.86|||
3951155|NCT01346072|3772839|B2|||Serum Sodium||mEq/L|Mean|140.8|140.8|Standard Deviation|3.46|3.46|||
3951156|NCT01346072|3772840|B1|||Serum Sodium||mEq/L|Mean|141.1|141.1|Standard Deviation|2.28|2.28|||
3951157|NCT01346072|3772838|B3|||Serum Creatinine||mg/dL|Mean|1.10|1.1|Standard Deviation|0.30|0.3|||
3951158|NCT01346072|3772839|B2|||Serum Creatinine||mg/dL|Mean|1.03|1.03|Standard Deviation|0.35|0.35|||
3951159|NCT01346072|3772840|B1|||Serum Creatinine||mg/dL|Mean|1.18|1.18|Standard Deviation|0.23|0.23|||
3951160|NCT01346072|3772838|B3|||Baseline Copeptin||pmol/L|Mean|13.1|13.1|Standard Deviation|9.7|9.7|||
3951161|NCT01346072|3772839|B2|||Baseline Copeptin||pmol/L|Mean|5.7|5.7|Standard Deviation|1.9|1.9|||
3951162|NCT01346072|3772840|B1|||Baseline Copeptin||pmol/L|Mean|20.5|20.5|Standard Deviation|8.7|8.7|||
3951163|NCT01346072|3772838|B3|||LVEF||%|Mean|27|27.0|Standard Deviation|9.6|9.6|||
3951164|NCT01346072|3772839|B2|||LVEF||%|Mean|31|31.0|Standard Deviation|11|11.0|||
3951165|NCT01346072|3772840|B1|||LVEF||%|Mean|23|23.0|Standard Deviation|6.0|6.0|||
3951166|NCT01346072|3772838|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3951167|NCT01346072|3772839|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3951168|NCT01346072|3772840|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3951169|NCT01346072|3772838|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951170|NCT01346072|3772839|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951171|NCT01346072|3772840|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951172|NCT01346072|3772838|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951173|NCT01346072|3772839|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951174|NCT01346072|3772840|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951175|NCT01346072|3772838|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3951176|NCT01346072|3772839|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3951177|NCT01346072|3772840|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3951178|NCT01346072|3772838|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3951179|NCT01346072|3772839|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3951180|NCT01346072|3772840|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3951181|NCT01346072|3772838|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951182|NCT01346072|3772839|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951183|NCT01346072|3772840|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951184|NCT01346072|3772838|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3951185|NCT01346072|3772839|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3951186|NCT01346072|3772840|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951187|NCT01346072|3772838|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951188|NCT01346072|3772839|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951189|NCT01346072|3772840|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951190|NCT01346072|3772838|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3951191|NCT01346072|3772839|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3951192|NCT01346072|3772840|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3951193|NCT01346072|3772838|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3951194|NCT01346072|3772839|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3951195|NCT01346072|3772840|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3951196|NCT01346072|3772838|B3|||Age||years|Mean|60|60.0|Standard Deviation|12|12.0|||
3951197|NCT01346072|3772839|B2|||Age||years|Mean|59|59.0|Standard Deviation|13|13.0|||
3951198|NCT01346072|3772840|B1|||Age||years|Mean|60|60.0|Standard Deviation|11|11.0|||
3951199|NCT01346072|3772838|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3951200|NCT01346072|3772839|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3951201|NCT01346072|3772840|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3951202|NCT01346072|3772838|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3951203|NCT01346072|3772839|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3951204|NCT01346072|3772840|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3951205|NCT01346072|3772838|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3951206|NCT01346072|3772839|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3951207|NCT01346072|3772840|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3951208|NCT01346059|3772849|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3951209|NCT01346059|3772850|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3951210|NCT01346059|3772851|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3951211|NCT01346059|3772849|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3951212|NCT01346059|3772850|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3951213|NCT01346059|3772851|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3951214|NCT01346059|3772849|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3951215|NCT01346059|3772850|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3951216|NCT01346059|3772851|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3951217|NCT01346059|3772849|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3951218|NCT01346059|3772850|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3951219|NCT01346059|3772851|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3951220|NCT01346059|3772849|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3951221|NCT01346059|3772850|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3951222|NCT01346059|3772851|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3951223|NCT01346059|3772849|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3951224|NCT01346059|3772850|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3951225|NCT01346059|3772851|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3951226|NCT01345929|3772862|B3||Male|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
3951227|NCT01345929|3772863|B2||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3951228|NCT01345929|3772864|B1||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
3951229|NCT01345929|3772862|B3||Female|Sex: Female, Male||Participants|Count of Participants|754|754.0||||||
3951230|NCT01345929|3772863|B2||Female|Sex: Female, Male||Participants|Count of Participants|380|380.0||||||
3951231|NCT01345929|3772864|B1||Female|Sex: Female, Male||Participants|Count of Participants|374|374.0||||||
3951232|NCT01345929|3772862|B3|||Age||years|Mean|49.1|49.1|Standard Deviation|19.79|19.79|||
3951233|NCT01345929|3772863|B2|||Age||years|Mean|48.6|48.6|Standard Deviation|20.05|20.05|||
3951234|NCT01345929|3772864|B1|||Age||years|Mean|49.7|49.7|Standard Deviation|19.52|19.52|||
3951235|NCT01345786|3772873|B5||Male|Sex: Female, Male|Baseline characteristic is an overview of participants who received medication|Participants|Count of Participants|0|0.0||||||
3951236|NCT01345786|3772874|B4||Male|Sex: Female, Male|Baseline characteristic is an overview of participants who received medication|Participants|Count of Participants|0|0.0||||||
3951237|NCT01345786|3772875|B3||Male|Sex: Female, Male|Baseline characteristic is an overview of participants who received medication|Participants|Count of Participants|0|0.0||||||
3951238|NCT01345786|3772876|B2||Male|Sex: Female, Male|Baseline characteristic is an overview of participants who received medication|Participants|Count of Participants|0|0.0||||||
3951239|NCT01345786|3772877|B1||Male|Sex: Female, Male|Baseline characteristic is an overview of participants who received medication|Participants|Count of Participants|0|0.0||||||
3951240|NCT01345786|3772873|B5||Female|Sex: Female, Male|Baseline characteristic is an overview of participants who received medication|Participants|Count of Participants|156|156.0||||||
3951241|NCT01345786|3772874|B4||Female|Sex: Female, Male|Baseline characteristic is an overview of participants who received medication|Participants|Count of Participants|37|37.0||||||
3951242|NCT01345786|3772875|B3||Female|Sex: Female, Male|Baseline characteristic is an overview of participants who received medication|Participants|Count of Participants|37|37.0||||||
3951243|NCT01345786|3772876|B2||Female|Sex: Female, Male|Baseline characteristic is an overview of participants who received medication|Participants|Count of Participants|41|41.0||||||
3951244|NCT01345786|3772877|B1||Female|Sex: Female, Male|Baseline characteristic is an overview of participants who received medication|Participants|Count of Participants|41|41.0||||||
3951245|NCT01345786|3772873|B5|||Age|Baseline characteristic is an overview of participants who received medication|years|Mean|55.78|55.78|Full Range|||45.0|70.0|
3951246|NCT01345786|3772874|B4|||Age|Baseline characteristic is an overview of participants who received medication|years|Mean|56.5|56.5|Full Range|||46.0|70.0|
3951247|NCT01345786|3772875|B3|||Age|Baseline characteristic is an overview of participants who received medication|years|Mean|55.9|55.9|Full Range|||45.0|66.0|
3951248|NCT01345786|3772876|B2|||Age|Baseline characteristic is an overview of participants who received medication|years|Mean|55.5|55.5|Full Range|||45.0|70.0|
3951249|NCT01345786|3772877|B1|||Age|Baseline characteristic is an overview of participants who received medication|years|Mean|55.3|55.3|Full Range|||47.0|65.0|
3951250|NCT01345721|3772926|B4||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3951251|NCT01345721|3772927|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3951252|NCT01345721|3772928|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3951253|NCT01345721|3772929|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3951254|NCT01345721|3772926|B4||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3951255|NCT01345721|3772927|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3951256|NCT01345721|3772928|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3951257|NCT01345721|3772929|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3951258|NCT01345721|3772926|B4|||Age||months|Mean|37.3|37.3|Standard Deviation|5.4|5.4|||
3951259|NCT01345721|3772927|B3|||Age||months|Mean|37.9|37.9|Standard Deviation|5.3|5.3|||
3951260|NCT01345721|3772928|B2|||Age||months|Mean|37.4|37.4|Standard Deviation|5.6|5.6|||
3951261|NCT01345721|3772929|B1|||Age||months|Mean|36.7|36.7|Standard Deviation|5.3|5.3|||
3951262|NCT01345682|3772958|B3||Male|Sex: Female, Male||Participants|Count of Participants|412|412.0||||||
3951263|NCT01345682|3772959|B2||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3951264|NCT01345682|3772960|B1||Male|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
3951265|NCT01345682|3772958|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3951266|NCT01345682|3772959|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3951267|NCT01345682|3772960|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3951268|NCT01345682|3772958|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|9.1|9.1|||
3951269|NCT01345682|3772959|B2|||Age||years|Mean|59.3|59.3|Standard Deviation|9.7|9.7|||
3951270|NCT01345682|3772960|B1|||Age||years|Mean|60.0|60.0|Standard Deviation|8.8|8.8|||
3951271|NCT01345669|3772993|B3||Male|Sex: Female, Male||Participants|Count of Participants|528|528.0||||||
3951272|NCT01345669|3772994|B2||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
3951273|NCT01345669|3772995|B1||Male|Sex: Female, Male||Participants|Count of Participants|350|350.0||||||
3951274|NCT01345669|3772993|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3951275|NCT01345669|3772994|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3951276|NCT01345669|3772995|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3951277|NCT01345669|3772993|B3|||Age||Years|Mean|58.0|58.0|Standard Deviation|8.38|8.38|||
3951278|NCT01345669|3772994|B2|||Age||Years|Mean|57.3|57.3|Standard Deviation|8.64|8.64|||
3951279|NCT01345669|3772995|B1|||Age||Years|Mean|58.3|58.3|Standard Deviation|8.23|8.23|||
3951280|NCT01345630|3773012|B3||Male|Sex: Female, Male||Participants|Count of Participants|727|727.0||||||
3951281|NCT01345630|3773013|B2||Male|Sex: Female, Male||Participants|Count of Participants|367|367.0||||||
3951282|NCT01345630|3773014|B1||Male|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
3951283|NCT01345630|3773012|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3951284|NCT01345630|3773013|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3951285|NCT01345630|3773014|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3951286|NCT01345630|3773012|B3|||Age||Years|Mean|37.1|37.1|Standard Deviation|10.9|10.9|||
3951287|NCT01345630|3773013|B2|||Age||Years|Mean|36.2|36.2|Standard Deviation|10.9|10.9|||
3951288|NCT01345630|3773014|B1|||Age||Years|Mean|37.9|37.9|Standard Deviation|10.9|10.9|||
3951289|NCT01345591|3773071|B1|||tissue thickness||milliliters|Mean|0.352|0.352|Standard Deviation|0.180|0.18|||
3951290|NCT01345591|3773071|B1|||volume||milliliters|Mean|1.0|1.0|Standard Deviation|0.0001|0.0001|||
3951291|NCT01345591|3773071|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3951292|NCT01345591|3773071|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3951293|NCT01345591|3773071|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3951294|NCT01345591|3773071|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3951295|NCT01345591|3773071|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3951296|NCT01345318|3773080|B1||MALE|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3951297|NCT01345318|3773080|B1||FEMALE|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3951298|NCT01345318|3773080|B1|||Age||years|Mean|40.1|40.1|Standard Deviation|12.9|12.9|||
3951299|NCT01345292|3773085|B4|USA||Region of Enrollment||participants|Number|226|226.0||||||
3951300|NCT01345292|3773086|B3|USA||Region of Enrollment||participants|Number|75|75.0||||||
3951301|NCT01345292|3773087|B2|USA||Region of Enrollment||participants|Number|76|76.0||||||
3951302|NCT01345292|3773088|B1|USA||Region of Enrollment||participants|Number|75|75.0||||||
3951303|NCT01345292|3773085|B4||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3951304|NCT01345292|3773086|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3951305|NCT01345292|3773087|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3951306|NCT01345292|3773088|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3951307|NCT01345292|3773085|B4||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3951308|NCT01345292|3773086|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3951309|NCT01345292|3773087|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3951310|NCT01345292|3773088|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3951311|NCT01345292|3773085|B4|||Age||years|Mean|36.3|36.3|Standard Deviation|11.30|11.3|||
3951312|NCT01345292|3773086|B3|||Age||years|Mean|37.4|37.4|Standard Deviation|11.10|11.1|||
3951313|NCT01345292|3773087|B2|||Age||years|Mean|35.8|35.8|Standard Deviation|12.14|12.14|||
3951314|NCT01345292|3773088|B1|||Age||years|Mean|35.6|35.6|Standard Deviation|10.65|10.65|||
3951315|NCT01345253|3773119|B3|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3951316|NCT01345253|3773120|B2|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3951317|NCT01345253|3773121|B1|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3951318|NCT01345253|3773119|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3951319|NCT01345253|3773120|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3951320|NCT01345253|3773121|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3951321|NCT01345253|3773119|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|64|64.0||||||
3951322|NCT01345253|3773120|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
3951323|NCT01345253|3773121|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
3951324|NCT01345253|3773119|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|598|598.0||||||
3951325|NCT01345253|3773120|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|403|403.0||||||
3951326|NCT01345253|3773121|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|195|195.0||||||
3951327|NCT01345253|3773119|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3951328|NCT01345253|3773120|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3951329|NCT01345253|3773121|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3951330|NCT01345253|3773119|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3951331|NCT01345253|3773120|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3951332|NCT01345253|3773121|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3951333|NCT01345253|3773119|B3||Female|Sex: Female, Male||Participants|Count of Participants|629|629.0||||||
3951334|NCT01345253|3773120|B2||Female|Sex: Female, Male||Participants|Count of Participants|419|419.0||||||
3951335|NCT01345253|3773121|B1||Female|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
3951336|NCT01345253|3773119|B3|||Age||Years|Mean|32.1|32.1|Standard Deviation|9.50|9.5|||
3951337|NCT01345253|3773120|B2|||Age||Years|Mean|32.3|32.3|Standard Deviation|9.65|9.65|||
3951338|NCT01345253|3773121|B1|||Age||Years|Mean|31.7|31.7|Standard Deviation|9.18|9.18|||
3951339|NCT01345240|3773136|B6|African Heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|705|705.0||||||
3951340|NCT01345240|3773137|B5|African Heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|139|139.0||||||
3951341|NCT01345240|3773138|B4|African Heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|141|141.0||||||
3951342|NCT01345240|3773139|B3|African Heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|141|141.0||||||
3951343|NCT01345240|3773140|B2|African Heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|142|142.0||||||
3951344|NCT01345240|3773141|B1|African Heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|142|142.0||||||
3951345|NCT01345240|3773136|B6||Male|Sex: Female, Male||Participants|Count of Participants|366|366.0||||||
3951346|NCT01345240|3773137|B5||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3951347|NCT01345240|3773138|B4||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3951348|NCT01345240|3773139|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3951349|NCT01345240|3773140|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3951350|NCT01345240|3773141|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3951351|NCT01345240|3773136|B6||Female|Sex: Female, Male||Participants|Count of Participants|339|339.0||||||
3951352|NCT01345240|3773137|B5||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3951353|NCT01345240|3773138|B4||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3951354|NCT01345240|3773139|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3951355|NCT01345240|3773140|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3951356|NCT01345240|3773141|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3951357|NCT01345240|3773136|B6|||Age||Weeks|Mean|8.32|8.32|Standard Deviation|0.73|0.73|||
3951358|NCT01345240|3773137|B5|||Age||Weeks|Mean|8.3|8.3|Standard Deviation|0.74|0.74|||
3951359|NCT01345240|3773138|B4|||Age||Weeks|Mean|8.3|8.3|Standard Deviation|0.74|0.74|||
3951360|NCT01345240|3773139|B3|||Age||Weeks|Mean|8.3|8.3|Standard Deviation|0.69|0.69|||
3951361|NCT01345240|3773140|B2|||Age||Weeks|Mean|8.3|8.3|Standard Deviation|0.62|0.62|||
3951362|NCT01345240|3773141|B1|||Age||Weeks|Mean|8.4|8.4|Standard Deviation|0.83|0.83|||
3951363|NCT01345188|3773238|B1|||Prior myocardial infarction||participants|Number|23|23.0||||||
3951364|NCT01345188|3773238|B1|||Diabetes Mellitus||participants|Number|19|19.0||||||
3951365|NCT01345188|3773238|B1|||Ejection Fraction||Percentage|Mean|33.1|33.1|Standard Deviation|7.6|7.6|||
3951366|NCT01345188|3773238|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3951367|NCT01345188|3773238|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3951368|NCT01345188|3773238|B1|||Age||years|Mean|71.5|71.5|Standard Deviation|8.4|8.4|||
3951369|NCT01345162|3773248|B3||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3951370|NCT01345162|3773249|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3951371|NCT01345162|3773250|B1||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3951372|NCT01345162|3773248|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3951373|NCT01345162|3773249|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3951374|NCT01345162|3773250|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3951375|NCT01345162|3773248|B3|||Age||years|Mean|56.6|56.6|Standard Deviation|14.8|14.8|||
3951376|NCT01345162|3773249|B2|||Age||years|Mean|56.6|56.6|Standard Deviation|15|15.0|||
3951377|NCT01345162|3773250|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|14.6|14.6|||
3951378|NCT01345123|3773257|B4|United States||Region of Enrollment||participants|Number|9925|9925.0||||||
3951379|NCT01345123|3773258|B3|United States||Region of Enrollment||participants|Number|3291|3291.0||||||
3951380|NCT01345123|3773259|B2|United States||Region of Enrollment||participants|Number|3311|3311.0||||||
3951381|NCT01345123|3773260|B1|United States||Region of Enrollment||participants|Number|3323|3323.0||||||
3951382|NCT01345123|3773257|B4||Male|Sex: Female, Male||Participants|Count of Participants|4235|4235.0||||||
3951383|NCT01345123|3773258|B3||Male|Sex: Female, Male||Participants|Count of Participants|1385|1385.0||||||
3951384|NCT01345123|3773259|B2||Male|Sex: Female, Male||Participants|Count of Participants|1423|1423.0||||||
3951385|NCT01345123|3773260|B1||Male|Sex: Female, Male||Participants|Count of Participants|1427|1427.0||||||
3951386|NCT01345123|3773257|B4||Female|Sex: Female, Male||Participants|Count of Participants|5690|5690.0||||||
3951387|NCT01345123|3773258|B3||Female|Sex: Female, Male||Participants|Count of Participants|1906|1906.0||||||
3951388|NCT01345123|3773259|B2||Female|Sex: Female, Male||Participants|Count of Participants|1888|1888.0||||||
3951389|NCT01345123|3773260|B1||Female|Sex: Female, Male||Participants|Count of Participants|1896|1896.0||||||
3951390|NCT01345123|3773257|B4|||Age||years|Mean|56.04|56.04|Standard Deviation|10.08|10.08|||
3951391|NCT01345123|3773258|B3|||Age||years|Mean|56.06|56.06|Standard Deviation|10.14|10.14|||
3951392|NCT01345123|3773259|B2|||Age||years|Mean|56.12|56.12|Standard Deviation|9.73|9.73|||
3951393|NCT01345123|3773260|B1|||Age||years|Mean|55.94|55.94|Standard Deviation|10.37|10.37|||
3951394|NCT01345123|3773257|B4||>=65 years|Age||Participants|Count of Participants|1261|1261.0||||||
3951395|NCT01345123|3773258|B3||>=65 years|Age||Participants|Count of Participants|430|430.0||||||
3951396|NCT01345123|3773259|B2||>=65 years|Age||Participants|Count of Participants|388|388.0||||||
3951397|NCT01345123|3773260|B1||>=65 years|Age||Participants|Count of Participants|443|443.0||||||
3951398|NCT01345123|3773257|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8663|8663.0||||||
3951399|NCT01345123|3773258|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2861|2861.0||||||
3951400|NCT01345123|3773259|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2922|2922.0||||||
3951401|NCT01345123|3773260|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2880|2880.0||||||
3951402|NCT01345123|3773257|B4||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3951403|NCT01345123|3773258|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3951404|NCT01345123|3773259|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3951405|NCT01345123|3773260|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3951406|NCT01345058|3773282|B3|United States||Region of Enrollment||Participants|Count of Participants|56|56.0||||||
3951407|NCT01345058|3773283|B2|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3951408|NCT01345058|3773284|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3951409|NCT01345058|3773282|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3951410|NCT01345058|3773283|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3951411|NCT01345058|3773284|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3951412|NCT01345058|3773282|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3951413|NCT01345058|3773283|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3951414|NCT01345058|3773284|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3951415|NCT01345058|3773282|B3|||Age||years|Mean|43.4|43.4|Standard Deviation|18.8|18.8|||
3951416|NCT01345058|3773283|B2|||Age||years|Mean|43.7|43.7|Standard Deviation|19.8|19.8|||
3951417|NCT01345058|3773284|B1|||Age||years|Mean|42.9|42.9|Standard Deviation|17.5|17.5|||
3951515|NCT01345019|3773300|B2||≥ 65 years|Age, Customized||Participants|Count of Participants|387|387.0||||||
3951516|NCT01345019|3773301|B1||≥ 65 years|Age, Customized||Participants|Count of Participants|395|395.0||||||
3951418|NCT01345019|3773299|B3|Region: Non-Japan||Summary of Randomization Stratifications|"Randomization was stratified by~Intent to undergo autologous peripheral blood stem cell (PBSC) transplantation: yes or no~The anti-myeloma agent being utilized/planned to be utilized in first-line therapy: novel therapy (included bortezomib, lenalidomide, or thalidomide) based or non-novel therapy-based,~International Staging System (ISS) stage at diagnosis: I (serum β2 microglobulin < 3.5 mg/L; serum albumin ≥ 3.5 g/dL) or II (neither stage I or III) or III (serum β2 microglobulin ≥ 5.5 mg/L),~Previous skeletal-related event (SRE): yes or no,~Region (Japan, non-Japan)."|participants|Number|1676|1676.0||||||
3951419|NCT01345019|3773300|B2|Region: Non-Japan||Summary of Randomization Stratifications|"Randomization was stratified by~Intent to undergo autologous peripheral blood stem cell (PBSC) transplantation: yes or no~The anti-myeloma agent being utilized/planned to be utilized in first-line therapy: novel therapy (included bortezomib, lenalidomide, or thalidomide) based or non-novel therapy-based,~International Staging System (ISS) stage at diagnosis: I (serum β2 microglobulin < 3.5 mg/L; serum albumin ≥ 3.5 g/dL) or II (neither stage I or III) or III (serum β2 microglobulin ≥ 5.5 mg/L),~Previous skeletal-related event (SRE): yes or no,~Region (Japan, non-Japan)."|participants|Number|835|835.0||||||
3951420|NCT01345019|3773301|B1|Region: Non-Japan||Summary of Randomization Stratifications|"Randomization was stratified by~Intent to undergo autologous peripheral blood stem cell (PBSC) transplantation: yes or no~The anti-myeloma agent being utilized/planned to be utilized in first-line therapy: novel therapy (included bortezomib, lenalidomide, or thalidomide) based or non-novel therapy-based,~International Staging System (ISS) stage at diagnosis: I (serum β2 microglobulin < 3.5 mg/L; serum albumin ≥ 3.5 g/dL) or II (neither stage I or III) or III (serum β2 microglobulin ≥ 5.5 mg/L),~Previous skeletal-related event (SRE): yes or no,~Region (Japan, non-Japan)."|participants|Number|841|841.0||||||
3951421|NCT01345019|3773299|B3|Region: Japan||Summary of Randomization Stratifications|"Randomization was stratified by~Intent to undergo autologous peripheral blood stem cell (PBSC) transplantation: yes or no~The anti-myeloma agent being utilized/planned to be utilized in first-line therapy: novel therapy (included bortezomib, lenalidomide, or thalidomide) based or non-novel therapy-based,~International Staging System (ISS) stage at diagnosis: I (serum β2 microglobulin < 3.5 mg/L; serum albumin ≥ 3.5 g/dL) or II (neither stage I or III) or III (serum β2 microglobulin ≥ 5.5 mg/L),~Previous skeletal-related event (SRE): yes or no,~Region (Japan, non-Japan)."|participants|Number|42|42.0||||||
3951422|NCT01345019|3773300|B2|Region: Japan||Summary of Randomization Stratifications|"Randomization was stratified by~Intent to undergo autologous peripheral blood stem cell (PBSC) transplantation: yes or no~The anti-myeloma agent being utilized/planned to be utilized in first-line therapy: novel therapy (included bortezomib, lenalidomide, or thalidomide) based or non-novel therapy-based,~International Staging System (ISS) stage at diagnosis: I (serum β2 microglobulin < 3.5 mg/L; serum albumin ≥ 3.5 g/dL) or II (neither stage I or III) or III (serum β2 microglobulin ≥ 5.5 mg/L),~Previous skeletal-related event (SRE): yes or no,~Region (Japan, non-Japan)."|participants|Number|24|24.0||||||
3951423|NCT01345019|3773301|B1|Region: Japan||Summary of Randomization Stratifications|"Randomization was stratified by~Intent to undergo autologous peripheral blood stem cell (PBSC) transplantation: yes or no~The anti-myeloma agent being utilized/planned to be utilized in first-line therapy: novel therapy (included bortezomib, lenalidomide, or thalidomide) based or non-novel therapy-based,~International Staging System (ISS) stage at diagnosis: I (serum β2 microglobulin < 3.5 mg/L; serum albumin ≥ 3.5 g/dL) or II (neither stage I or III) or III (serum β2 microglobulin ≥ 5.5 mg/L),~Previous skeletal-related event (SRE): yes or no,~Region (Japan, non-Japan)."|participants|Number|18|18.0||||||
3951424|NCT01345019|3773299|B3|Previous SRE : No||Summary of Randomization Stratifications|"Randomization was stratified by~Intent to undergo autologous peripheral blood stem cell (PBSC) transplantation: yes or no~The anti-myeloma agent being utilized/planned to be utilized in first-line therapy: novel therapy (included bortezomib, lenalidomide, or thalidomide) based or non-novel therapy-based,~International Staging System (ISS) stage at diagnosis: I (serum β2 microglobulin < 3.5 mg/L; serum albumin ≥ 3.5 g/dL) or II (neither stage I or III) or III (serum β2 microglobulin ≥ 5.5 mg/L),~Previous skeletal-related event (SRE): yes or no,~Region (Japan, non-Japan)."|participants|Number|753|753.0||||||
3951425|NCT01345019|3773300|B2|Previous SRE : No||Summary of Randomization Stratifications|"Randomization was stratified by~Intent to undergo autologous peripheral blood stem cell (PBSC) transplantation: yes or no~The anti-myeloma agent being utilized/planned to be utilized in first-line therapy: novel therapy (included bortezomib, lenalidomide, or thalidomide) based or non-novel therapy-based,~International Staging System (ISS) stage at diagnosis: I (serum β2 microglobulin < 3.5 mg/L; serum albumin ≥ 3.5 g/dL) or II (neither stage I or III) or III (serum β2 microglobulin ≥ 5.5 mg/L),~Previous skeletal-related event (SRE): yes or no,~Region (Japan, non-Japan)."|participants|Number|378|378.0||||||
3951426|NCT01345019|3773301|B1|Previous SRE : No||Summary of Randomization Stratifications|"Randomization was stratified by~Intent to undergo autologous peripheral blood stem cell (PBSC) transplantation: yes or no~The anti-myeloma agent being utilized/planned to be utilized in first-line therapy: novel therapy (included bortezomib, lenalidomide, or thalidomide) based or non-novel therapy-based,~International Staging System (ISS) stage at diagnosis: I (serum β2 microglobulin < 3.5 mg/L; serum albumin ≥ 3.5 g/dL) or II (neither stage I or III) or III (serum β2 microglobulin ≥ 5.5 mg/L),~Previous skeletal-related event (SRE): yes or no,~Region (Japan, non-Japan)."|participants|Number|375|375.0||||||
3951427|NCT01345019|3773299|B3|Previous SRE : Yes||Summary of Randomization Stratifications|"Randomization was stratified by~Intent to undergo autologous peripheral blood stem cell (PBSC) transplantation: yes or no~The anti-myeloma agent being utilized/planned to be utilized in first-line therapy: novel therapy (included bortezomib, lenalidomide, or thalidomide) based or non-novel therapy-based,~International Staging System (ISS) stage at diagnosis: I (serum β2 microglobulin < 3.5 mg/L; serum albumin ≥ 3.5 g/dL) or II (neither stage I or III) or III (serum β2 microglobulin ≥ 5.5 mg/L),~Previous skeletal-related event (SRE): yes or no,~Region (Japan, non-Japan)."|participants|Number|965|965.0||||||
3951428|NCT01345019|3773300|B2|Previous SRE : Yes||Summary of Randomization Stratifications|"Randomization was stratified by~Intent to undergo autologous peripheral blood stem cell (PBSC) transplantation: yes or no~The anti-myeloma agent being utilized/planned to be utilized in first-line therapy: novel therapy (included bortezomib, lenalidomide, or thalidomide) based or non-novel therapy-based,~International Staging System (ISS) stage at diagnosis: I (serum β2 microglobulin < 3.5 mg/L; serum albumin ≥ 3.5 g/dL) or II (neither stage I or III) or III (serum β2 microglobulin ≥ 5.5 mg/L),~Previous skeletal-related event (SRE): yes or no,~Region (Japan, non-Japan)."|participants|Number|481|481.0||||||
3951429|NCT01345019|3773301|B1|Previous SRE : Yes||Summary of Randomization Stratifications|"Randomization was stratified by~Intent to undergo autologous peripheral blood stem cell (PBSC) transplantation: yes or no~The anti-myeloma agent being utilized/planned to be utilized in first-line therapy: novel therapy (included bortezomib, lenalidomide, or thalidomide) based or non-novel therapy-based,~International Staging System (ISS) stage at diagnosis: I (serum β2 microglobulin < 3.5 mg/L; serum albumin ≥ 3.5 g/dL) or II (neither stage I or III) or III (serum β2 microglobulin ≥ 5.5 mg/L),~Previous skeletal-related event (SRE): yes or no,~Region (Japan, non-Japan)."|participants|Number|484|484.0||||||
3951430|NCT01345019|3773299|B3|ISS stage at diagnosis: III||Summary of Randomization Stratifications|"Randomization was stratified by~Intent to undergo autologous peripheral blood stem cell (PBSC) transplantation: yes or no~The anti-myeloma agent being utilized/planned to be utilized in first-line therapy: novel therapy (included bortezomib, lenalidomide, or thalidomide) based or non-novel therapy-based,~International Staging System (ISS) stage at diagnosis: I (serum β2 microglobulin < 3.5 mg/L; serum albumin ≥ 3.5 g/dL) or II (neither stage I or III) or III (serum β2 microglobulin ≥ 5.5 mg/L),~Previous skeletal-related event (SRE): yes or no,~Region (Japan, non-Japan)."|participants|Number|555|555.0||||||
3951431|NCT01345019|3773300|B2|ISS stage at diagnosis: III||Summary of Randomization Stratifications|"Randomization was stratified by~Intent to undergo autologous peripheral blood stem cell (PBSC) transplantation: yes or no~The anti-myeloma agent being utilized/planned to be utilized in first-line therapy: novel therapy (included bortezomib, lenalidomide, or thalidomide) based or non-novel therapy-based,~International Staging System (ISS) stage at diagnosis: I (serum β2 microglobulin < 3.5 mg/L; serum albumin ≥ 3.5 g/dL) or II (neither stage I or III) or III (serum β2 microglobulin ≥ 5.5 mg/L),~Previous skeletal-related event (SRE): yes or no,~Region (Japan, non-Japan)."|participants|Number|277|277.0||||||
3951432|NCT01345019|3773301|B1|ISS stage at diagnosis: III||Summary of Randomization Stratifications|"Randomization was stratified by~Intent to undergo autologous peripheral blood stem cell (PBSC) transplantation: yes or no~The anti-myeloma agent being utilized/planned to be utilized in first-line therapy: novel therapy (included bortezomib, lenalidomide, or thalidomide) based or non-novel therapy-based,~International Staging System (ISS) stage at diagnosis: I (serum β2 microglobulin < 3.5 mg/L; serum albumin ≥ 3.5 g/dL) or II (neither stage I or III) or III (serum β2 microglobulin ≥ 5.5 mg/L),~Previous skeletal-related event (SRE): yes or no,~Region (Japan, non-Japan)."|participants|Number|278|278.0||||||
3951433|NCT01345019|3773299|B3|ISS stage at diagnosis: II||Summary of Randomization Stratifications|"Randomization was stratified by~Intent to undergo autologous peripheral blood stem cell (PBSC) transplantation: yes or no~The anti-myeloma agent being utilized/planned to be utilized in first-line therapy: novel therapy (included bortezomib, lenalidomide, or thalidomide) based or non-novel therapy-based,~International Staging System (ISS) stage at diagnosis: I (serum β2 microglobulin < 3.5 mg/L; serum albumin ≥ 3.5 g/dL) or II (neither stage I or III) or III (serum β2 microglobulin ≥ 5.5 mg/L),~Previous skeletal-related event (SRE): yes or no,~Region (Japan, non-Japan)."|participants|Number|632|632.0||||||
3951434|NCT01345019|3773300|B2|ISS stage at diagnosis: II||Summary of Randomization Stratifications|"Randomization was stratified by~Intent to undergo autologous peripheral blood stem cell (PBSC) transplantation: yes or no~The anti-myeloma agent being utilized/planned to be utilized in first-line therapy: novel therapy (included bortezomib, lenalidomide, or thalidomide) based or non-novel therapy-based,~International Staging System (ISS) stage at diagnosis: I (serum β2 microglobulin < 3.5 mg/L; serum albumin ≥ 3.5 g/dL) or II (neither stage I or III) or III (serum β2 microglobulin ≥ 5.5 mg/L),~Previous skeletal-related event (SRE): yes or no,~Region (Japan, non-Japan)."|participants|Number|319|319.0||||||
3951435|NCT01345019|3773301|B1|ISS stage at diagnosis: II||Summary of Randomization Stratifications|"Randomization was stratified by~Intent to undergo autologous peripheral blood stem cell (PBSC) transplantation: yes or no~The anti-myeloma agent being utilized/planned to be utilized in first-line therapy: novel therapy (included bortezomib, lenalidomide, or thalidomide) based or non-novel therapy-based,~International Staging System (ISS) stage at diagnosis: I (serum β2 microglobulin < 3.5 mg/L; serum albumin ≥ 3.5 g/dL) or II (neither stage I or III) or III (serum β2 microglobulin ≥ 5.5 mg/L),~Previous skeletal-related event (SRE): yes or no,~Region (Japan, non-Japan)."|participants|Number|313|313.0||||||
3951436|NCT01345019|3773299|B3|ISS stage at diagnosis: I||Summary of Randomization Stratifications|"Randomization was stratified by~Intent to undergo autologous peripheral blood stem cell (PBSC) transplantation: yes or no~The anti-myeloma agent being utilized/planned to be utilized in first-line therapy: novel therapy (included bortezomib, lenalidomide, or thalidomide) based or non-novel therapy-based,~International Staging System (ISS) stage at diagnosis: I (serum β2 microglobulin < 3.5 mg/L; serum albumin ≥ 3.5 g/dL) or II (neither stage I or III) or III (serum β2 microglobulin ≥ 5.5 mg/L),~Previous skeletal-related event (SRE): yes or no,~Region (Japan, non-Japan)."|participants|Number|531|531.0||||||
3951437|NCT01345019|3773300|B2|ISS stage at diagnosis: I||Summary of Randomization Stratifications|"Randomization was stratified by~Intent to undergo autologous peripheral blood stem cell (PBSC) transplantation: yes or no~The anti-myeloma agent being utilized/planned to be utilized in first-line therapy: novel therapy (included bortezomib, lenalidomide, or thalidomide) based or non-novel therapy-based,~International Staging System (ISS) stage at diagnosis: I (serum β2 microglobulin < 3.5 mg/L; serum albumin ≥ 3.5 g/dL) or II (neither stage I or III) or III (serum β2 microglobulin ≥ 5.5 mg/L),~Previous skeletal-related event (SRE): yes or no,~Region (Japan, non-Japan)."|participants|Number|263|263.0||||||
3951438|NCT01345019|3773301|B1|ISS stage at diagnosis: I||Summary of Randomization Stratifications|"Randomization was stratified by~Intent to undergo autologous peripheral blood stem cell (PBSC) transplantation: yes or no~The anti-myeloma agent being utilized/planned to be utilized in first-line therapy: novel therapy (included bortezomib, lenalidomide, or thalidomide) based or non-novel therapy-based,~International Staging System (ISS) stage at diagnosis: I (serum β2 microglobulin < 3.5 mg/L; serum albumin ≥ 3.5 g/dL) or II (neither stage I or III) or III (serum β2 microglobulin ≥ 5.5 mg/L),~Previous skeletal-related event (SRE): yes or no,~Region (Japan, non-Japan)."|participants|Number|268|268.0||||||
3951517|NCT01345019|3773299|B3||< 65 years|Age, Customized||Participants|Count of Participants|936|936.0||||||
3951518|NCT01345019|3773300|B2||< 65 years|Age, Customized||Participants|Count of Participants|472|472.0||||||
3951519|NCT01345019|3773301|B1||< 65 years|Age, Customized||Participants|Count of Participants|464|464.0||||||
3951520|NCT01345019|3773299|B3|||Age||years|Mean|63.4|63.4|Standard Deviation|10.6|10.6|||
3951521|NCT01345019|3773300|B2|||Age||years|Mean|63.5|63.5|Standard Deviation|10.6|10.6|||
3951439|NCT01345019|3773299|B3|Anti-myeloma agent utilized/planned: Non-novel||Summary of Randomization Stratifications|"Randomization was stratified by~Intent to undergo autologous peripheral blood stem cell (PBSC) transplantation: yes or no~The anti-myeloma agent being utilized/planned to be utilized in first-line therapy: novel therapy (included bortezomib, lenalidomide, or thalidomide) based or non-novel therapy-based,~International Staging System (ISS) stage at diagnosis: I (serum β2 microglobulin < 3.5 mg/L; serum albumin ≥ 3.5 g/dL) or II (neither stage I or III) or III (serum β2 microglobulin ≥ 5.5 mg/L),~Previous skeletal-related event (SRE): yes or no,~Region (Japan, non-Japan)."|participants|Number|78|78.0||||||
3951440|NCT01345019|3773300|B2|Anti-myeloma agent utilized/planned: Non-novel||Summary of Randomization Stratifications|"Randomization was stratified by~Intent to undergo autologous peripheral blood stem cell (PBSC) transplantation: yes or no~The anti-myeloma agent being utilized/planned to be utilized in first-line therapy: novel therapy (included bortezomib, lenalidomide, or thalidomide) based or non-novel therapy-based,~International Staging System (ISS) stage at diagnosis: I (serum β2 microglobulin < 3.5 mg/L; serum albumin ≥ 3.5 g/dL) or II (neither stage I or III) or III (serum β2 microglobulin ≥ 5.5 mg/L),~Previous skeletal-related event (SRE): yes or no,~Region (Japan, non-Japan)."|participants|Number|40|40.0||||||
3951441|NCT01345019|3773301|B1|Anti-myeloma agent utilized/planned: Non-novel||Summary of Randomization Stratifications|"Randomization was stratified by~Intent to undergo autologous peripheral blood stem cell (PBSC) transplantation: yes or no~The anti-myeloma agent being utilized/planned to be utilized in first-line therapy: novel therapy (included bortezomib, lenalidomide, or thalidomide) based or non-novel therapy-based,~International Staging System (ISS) stage at diagnosis: I (serum β2 microglobulin < 3.5 mg/L; serum albumin ≥ 3.5 g/dL) or II (neither stage I or III) or III (serum β2 microglobulin ≥ 5.5 mg/L),~Previous skeletal-related event (SRE): yes or no,~Region (Japan, non-Japan)."|participants|Number|38|38.0||||||
3951442|NCT01345019|3773299|B3|Anti-myeloma agent utilized/planned: Novel||Summary of Randomization Stratifications|"Randomization was stratified by~Intent to undergo autologous peripheral blood stem cell (PBSC) transplantation: yes or no~The anti-myeloma agent being utilized/planned to be utilized in first-line therapy: novel therapy (included bortezomib, lenalidomide, or thalidomide) based or non-novel therapy-based,~International Staging System (ISS) stage at diagnosis: I (serum β2 microglobulin < 3.5 mg/L; serum albumin ≥ 3.5 g/dL) or II (neither stage I or III) or III (serum β2 microglobulin ≥ 5.5 mg/L),~Previous skeletal-related event (SRE): yes or no,~Region (Japan, non-Japan)."|participants|Number|1640|1640.0||||||
3951443|NCT01345019|3773300|B2|Anti-myeloma agent utilized/planned: Novel||Summary of Randomization Stratifications|"Randomization was stratified by~Intent to undergo autologous peripheral blood stem cell (PBSC) transplantation: yes or no~The anti-myeloma agent being utilized/planned to be utilized in first-line therapy: novel therapy (included bortezomib, lenalidomide, or thalidomide) based or non-novel therapy-based,~International Staging System (ISS) stage at diagnosis: I (serum β2 microglobulin < 3.5 mg/L; serum albumin ≥ 3.5 g/dL) or II (neither stage I or III) or III (serum β2 microglobulin ≥ 5.5 mg/L),~Previous skeletal-related event (SRE): yes or no,~Region (Japan, non-Japan)."|participants|Number|819|819.0||||||
3951444|NCT01345019|3773301|B1|Anti-myeloma agent utilized/planned: Novel||Summary of Randomization Stratifications|"Randomization was stratified by~Intent to undergo autologous peripheral blood stem cell (PBSC) transplantation: yes or no~The anti-myeloma agent being utilized/planned to be utilized in first-line therapy: novel therapy (included bortezomib, lenalidomide, or thalidomide) based or non-novel therapy-based,~International Staging System (ISS) stage at diagnosis: I (serum β2 microglobulin < 3.5 mg/L; serum albumin ≥ 3.5 g/dL) or II (neither stage I or III) or III (serum β2 microglobulin ≥ 5.5 mg/L),~Previous skeletal-related event (SRE): yes or no,~Region (Japan, non-Japan)."|participants|Number|821|821.0||||||
3951445|NCT01345019|3773299|B3|Intent to undergo PBSC transplantation: No||Summary of Randomization Stratifications|"Randomization was stratified by~Intent to undergo autologous peripheral blood stem cell (PBSC) transplantation: yes or no~The anti-myeloma agent being utilized/planned to be utilized in first-line therapy: novel therapy (included bortezomib, lenalidomide, or thalidomide) based or non-novel therapy-based,~International Staging System (ISS) stage at diagnosis: I (serum β2 microglobulin < 3.5 mg/L; serum albumin ≥ 3.5 g/dL) or II (neither stage I or III) or III (serum β2 microglobulin ≥ 5.5 mg/L),~Previous skeletal-related event (SRE): yes or no,~Region (Japan, non-Japan)."|participants|Number|788|788.0||||||
3951446|NCT01345019|3773300|B2|Intent to undergo PBSC transplantation: No||Summary of Randomization Stratifications|"Randomization was stratified by~Intent to undergo autologous peripheral blood stem cell (PBSC) transplantation: yes or no~The anti-myeloma agent being utilized/planned to be utilized in first-line therapy: novel therapy (included bortezomib, lenalidomide, or thalidomide) based or non-novel therapy-based,~International Staging System (ISS) stage at diagnosis: I (serum β2 microglobulin < 3.5 mg/L; serum albumin ≥ 3.5 g/dL) or II (neither stage I or III) or III (serum β2 microglobulin ≥ 5.5 mg/L),~Previous skeletal-related event (SRE): yes or no,~Region (Japan, non-Japan)."|participants|Number|394|394.0||||||
3951447|NCT01345019|3773301|B1|Intent to undergo PBSC transplantation: No||Summary of Randomization Stratifications|"Randomization was stratified by~Intent to undergo autologous peripheral blood stem cell (PBSC) transplantation: yes or no~The anti-myeloma agent being utilized/planned to be utilized in first-line therapy: novel therapy (included bortezomib, lenalidomide, or thalidomide) based or non-novel therapy-based,~International Staging System (ISS) stage at diagnosis: I (serum β2 microglobulin < 3.5 mg/L; serum albumin ≥ 3.5 g/dL) or II (neither stage I or III) or III (serum β2 microglobulin ≥ 5.5 mg/L),~Previous skeletal-related event (SRE): yes or no,~Region (Japan, non-Japan)."|participants|Number|394|394.0||||||
3951448|NCT01345019|3773299|B3|Intent to undergo PBSC transplantation: Yes||Summary of Randomization Stratifications|"Randomization was stratified by~Intent to undergo autologous peripheral blood stem cell (PBSC) transplantation: yes or no~The anti-myeloma agent being utilized/planned to be utilized in first-line therapy: novel therapy (included bortezomib, lenalidomide, or thalidomide) based or non-novel therapy-based,~International Staging System (ISS) stage at diagnosis: I (serum β2 microglobulin < 3.5 mg/L; serum albumin ≥ 3.5 g/dL) or II (neither stage I or III) or III (serum β2 microglobulin ≥ 5.5 mg/L),~Previous skeletal-related event (SRE): yes or no,~Region (Japan, non-Japan)."|participants|Number|930|930.0||||||
3951522|NCT01345019|3773301|B1|||Age||years|Mean|63.3|63.3|Standard Deviation|10.5|10.5|||
3951523|NCT01344876|3773322|B1|Japan||Region of Enrollment||participants|Number|20|20.0||||||
3951524|NCT01344876|3773322|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3951525|NCT01344876|3773322|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3951449|NCT01345019|3773300|B2|Intent to undergo PBSC transplantation: Yes||Summary of Randomization Stratifications|"Randomization was stratified by~Intent to undergo autologous peripheral blood stem cell (PBSC) transplantation: yes or no~The anti-myeloma agent being utilized/planned to be utilized in first-line therapy: novel therapy (included bortezomib, lenalidomide, or thalidomide) based or non-novel therapy-based,~International Staging System (ISS) stage at diagnosis: I (serum β2 microglobulin < 3.5 mg/L; serum albumin ≥ 3.5 g/dL) or II (neither stage I or III) or III (serum β2 microglobulin ≥ 5.5 mg/L),~Previous skeletal-related event (SRE): yes or no,~Region (Japan, non-Japan)."|participants|Number|465|465.0||||||
3951450|NCT01345019|3773301|B1|Intent to undergo PBSC transplantation: Yes||Summary of Randomization Stratifications|"Randomization was stratified by~Intent to undergo autologous peripheral blood stem cell (PBSC) transplantation: yes or no~The anti-myeloma agent being utilized/planned to be utilized in first-line therapy: novel therapy (included bortezomib, lenalidomide, or thalidomide) based or non-novel therapy-based,~International Staging System (ISS) stage at diagnosis: I (serum β2 microglobulin < 3.5 mg/L; serum albumin ≥ 3.5 g/dL) or II (neither stage I or III) or III (serum β2 microglobulin ≥ 5.5 mg/L),~Previous skeletal-related event (SRE): yes or no,~Region (Japan, non-Japan)."|participants|Number|465|465.0||||||
3951451|NCT01345019|3773299|B3|Surgery to bone||Skeletal Related Event History||participants|Number|286|286.0||||||
3951452|NCT01345019|3773300|B2|Surgery to bone||Skeletal Related Event History||participants|Number|142|142.0||||||
3951453|NCT01345019|3773301|B1|Surgery to bone||Skeletal Related Event History||participants|Number|144|144.0||||||
3951454|NCT01345019|3773299|B3|Radiation therapy to bone||Skeletal Related Event History||participants|Number|257|257.0||||||
3951455|NCT01345019|3773300|B2|Radiation therapy to bone||Skeletal Related Event History||participants|Number|118|118.0||||||
3951456|NCT01345019|3773301|B1|Radiation therapy to bone||Skeletal Related Event History||participants|Number|139|139.0||||||
3951457|NCT01345019|3773299|B3|Spinal cord compression||Skeletal Related Event History||participants|Number|207|207.0||||||
3951458|NCT01345019|3773300|B2|Spinal cord compression||Skeletal Related Event History||participants|Number|92|92.0||||||
3951459|NCT01345019|3773301|B1|Spinal cord compression||Skeletal Related Event History||participants|Number|115|115.0||||||
3951460|NCT01345019|3773299|B3|Pathological fracture||Skeletal Related Event History||participants|Number|942|942.0||||||
3951461|NCT01345019|3773300|B2|Pathological fracture||Skeletal Related Event History||participants|Number|479|479.0||||||
3951462|NCT01345019|3773301|B1|Pathological fracture||Skeletal Related Event History||participants|Number|463|463.0||||||
3951463|NCT01345019|3773299|B3|Any Skeletal Related Event||Skeletal Related Event History||participants|Number|1144|1144.0||||||
3951464|NCT01345019|3773300|B2|Any Skeletal Related Event||Skeletal Related Event History||participants|Number|567|567.0||||||
3951465|NCT01345019|3773301|B1|Any Skeletal Related Event||Skeletal Related Event History||participants|Number|577|577.0||||||
3951466|NCT01345019|3773299|B3||2 (Ambulatory but unable to work)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|383|383.0||||||
3951467|NCT01345019|3773300|B2||2 (Ambulatory but unable to work)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|196|196.0||||||
3951468|NCT01345019|3773301|B1||2 (Ambulatory but unable to work)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|187|187.0||||||
3951469|NCT01345019|3773299|B3||1 (Restricted but ambulatory)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|813|813.0||||||
3951470|NCT01345019|3773300|B2||1 (Restricted but ambulatory)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|400|400.0||||||
3951471|NCT01345019|3773301|B1||1 (Restricted but ambulatory)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|413|413.0||||||
3951472|NCT01345019|3773299|B3||0 (Fully active)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|522|522.0||||||
3951473|NCT01345019|3773300|B2||0 (Fully active)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|263|263.0||||||
3951474|NCT01345019|3773301|B1||0 (Fully active)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|259|259.0||||||
3951475|NCT01345019|3773299|B3||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3951476|NCT01345019|3773300|B2||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3951477|NCT01345019|3773301|B1||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3951478|NCT01345019|3773299|B3||Multiracial|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3951479|NCT01345019|3773300|B2||Multiracial|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3951480|NCT01345019|3773301|B1||Multiracial|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3951481|NCT01345019|3773299|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3951482|NCT01345019|3773300|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3951483|NCT01345019|3773301|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3951484|NCT01345019|3773299|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3951485|NCT01345019|3773300|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3951486|NCT01345019|3773301|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3951487|NCT01345019|3773299|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3951488|NCT01345019|3773300|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3951489|NCT01345019|3773301|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3951490|NCT01345019|3773299|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|65|65.0||||||
3951491|NCT01345019|3773300|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
3951492|NCT01345019|3773301|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3951493|NCT01345019|3773299|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|208|208.0||||||
3951494|NCT01345019|3773300|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|107|107.0||||||
3951495|NCT01345019|3773301|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|101|101.0||||||
3951496|NCT01345019|3773299|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|1410|1410.0||||||
3951497|NCT01345019|3773300|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|711|711.0||||||
3951498|NCT01345019|3773301|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|699|699.0||||||
3951499|NCT01345019|3773299|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3951500|NCT01345019|3773300|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3951501|NCT01345019|3773301|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3951502|NCT01345019|3773299|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1642|1642.0||||||
3951503|NCT01345019|3773300|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|823|823.0||||||
3951504|NCT01345019|3773301|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|819|819.0||||||
3951505|NCT01345019|3773299|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3951506|NCT01345019|3773300|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3951507|NCT01345019|3773301|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3951508|NCT01345019|3773299|B3||Male|Sex: Female, Male||Participants|Count of Participants|935|935.0||||||
3951509|NCT01345019|3773300|B2||Male|Sex: Female, Male||Participants|Count of Participants|462|462.0||||||
3951510|NCT01345019|3773301|B1||Male|Sex: Female, Male||Participants|Count of Participants|473|473.0||||||
3951511|NCT01345019|3773299|B3||Female|Sex: Female, Male||Participants|Count of Participants|783|783.0||||||
3951512|NCT01345019|3773300|B2||Female|Sex: Female, Male||Participants|Count of Participants|397|397.0||||||
3951513|NCT01345019|3773301|B1||Female|Sex: Female, Male||Participants|Count of Participants|386|386.0||||||
3951514|NCT01345019|3773299|B3||≥ 65 years|Age, Customized||Participants|Count of Participants|782|782.0||||||
3951526|NCT01344876|3773322|B1|||Age||years|Mean|64.5|64.5|Standard Deviation|6.5|6.5|||
3951527|NCT01344876|3773322|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3951528|NCT01344876|3773322|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3951529|NCT01344876|3773322|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3951530|NCT01344824|3773340|B1||Unknown|Mutation status||Participants|Count of Participants|4|4.0||||||
3951531|NCT01344824|3773340|B1||None (tested and no driver found)|Mutation status||Participants|Count of Participants|22|22.0||||||
3951532|NCT01344824|3773340|B1||MET del14|Mutation status||Participants|Count of Participants|1|1.0||||||
3951533|NCT01344824|3773340|B1||EML4/ALK|Mutation status||Participants|Count of Participants|0|0.0||||||
3951534|NCT01344824|3773340|B1||KRAS|Mutation status||Participants|Count of Participants|5|5.0||||||
3951535|NCT01344824|3773340|B1||EGFR|Mutation status||Participants|Count of Participants|6|6.0||||||
3951536|NCT01344824|3773340|B1|||Previous erlotinib treatment||Participants|Count of Participants|10|10.0||||||
3951537|NCT01344824|3773340|B1||Neuroendocrine carcinoma|Histology||Participants|Count of Participants|1|1.0||||||
3951538|NCT01344824|3773340|B1||Adenocarcinoma|Histology||Participants|Count of Participants|37|37.0||||||
3951539|NCT01344824|3773340|B1||Former light smoker|Smoking Status||Participants|Count of Participants|14|14.0||||||
3951540|NCT01344824|3773340|B1||Never smoker|Smoking Status||Participants|Count of Participants|24|24.0||||||
3951541|NCT01344824|3773340|B1||not performed|Eastern Cooperative Oncology Group (ECOG) Performance Status|"A scale from 0-5 to describe a patient's level of functioning in terms of selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|Participants|Count of Participants|6|6.0||||||
3951542|NCT01344824|3773340|B1||grade 1|Eastern Cooperative Oncology Group (ECOG) Performance Status|"A scale from 0-5 to describe a patient's level of functioning in terms of selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|Participants|Count of Participants|14|14.0||||||
3951543|NCT01344824|3773340|B1||grade 0|Eastern Cooperative Oncology Group (ECOG) Performance Status|"A scale from 0-5 to describe a patient's level of functioning in terms of selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|Participants|Count of Participants|18|18.0||||||
3951544|NCT01344824|3773340|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
3951545|NCT01344824|3773340|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3951546|NCT01344824|3773340|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951547|NCT01344824|3773340|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3951548|NCT01344824|3773340|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3951549|NCT01344824|3773340|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951550|NCT01344824|3773340|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3951551|NCT01344824|3773340|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951552|NCT01344824|3773340|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3951553|NCT01344824|3773340|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3951554|NCT01344824|3773340|B1|||Age||years|Median|63.5|63.5|Full Range|||27.0|80.0|
3951555|NCT01344759|3773346|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
3951556|NCT01344759|3773347|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3951557|NCT01344759|3773348|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3951558|NCT01344759|3773346|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3951559|NCT01344759|3773347|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3951560|NCT01344759|3773348|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3951561|NCT01344759|3773346|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3951562|NCT01344759|3773347|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3951563|NCT01344759|3773348|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3951564|NCT01344759|3773346|B3|||Age||years|Mean|8.6|8.6|Inter-Quartile Range|||5.3|15.2|
3951565|NCT01344759|3773347|B2|||Age||years|Mean|8.3|8.3|Inter-Quartile Range|||4.7|16.1|
3951566|NCT01344759|3773348|B1|||Age||years|Mean|8.8|8.8|Inter-Quartile Range|||5.8|14.3|
3951567|NCT01344759|3773346|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3951568|NCT01344759|3773347|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3951569|NCT01344759|3773348|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3951570|NCT01344759|3773346|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3951571|NCT01344759|3773347|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3951572|NCT01344759|3773348|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3951573|NCT01344759|3773346|B3||<=18 years|Age||Participants|Count of Participants|60|60.0||||||
3951574|NCT01344759|3773347|B2||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
3951575|NCT01344759|3773348|B1||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
3951576|NCT01344629|3773379|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3951577|NCT01344629|3773380|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3951578|NCT01344629|3773381|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3951579|NCT01344629|3773379|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3951580|NCT01344629|3773380|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3951581|NCT01344629|3773381|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3951582|NCT01344629|3773379|B3|||Age||Year|Mean|24.3|24.3|Standard Deviation|3.5|3.5|||
3951583|NCT01344629|3773380|B2|||Age||Year|Mean|24.5|24.5|Standard Deviation|3.8|3.8|||
3951584|NCT01344629|3773381|B1|||Age||Year|Mean|24.1|24.1|Standard Deviation|3.3|3.3|||
3951585|NCT01344616|3773400|B3|United States||Region of Enrollment||participants|Number|482|482.0||||||
3951586|NCT01344616|3773401|B2|United States||Region of Enrollment||participants|Number|238|238.0||||||
3951587|NCT01344616|3773402|B1|United States||Region of Enrollment||participants|Number|244|244.0||||||
3951588|NCT01344616|3773400|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951589|NCT01344616|3773401|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951590|NCT01344616|3773402|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951591|NCT01344616|3773400|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951592|NCT01344616|3773401|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951593|NCT01344616|3773402|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951594|NCT01344616|3773400|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951595|NCT01344616|3773401|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951596|NCT01344616|3773402|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951597|NCT01344616|3773400|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|482|482.0||||||
3951598|NCT01344616|3773401|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|238|238.0||||||
3951599|NCT01344616|3773402|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|244|244.0||||||
3951600|NCT01344616|3773400|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951601|NCT01344616|3773401|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951602|NCT01344616|3773402|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951603|NCT01344616|3773400|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951604|NCT01344616|3773401|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951605|NCT01344616|3773402|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951606|NCT01344616|3773400|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951607|NCT01344616|3773401|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951608|NCT01344616|3773402|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951609|NCT01344616|3773400|B3|Female||Sex/Gender, Customized||participants|Number|482|482.0||||||
3951610|NCT01344616|3773401|B2|Female||Sex/Gender, Customized||participants|Number|238|238.0||||||
3951611|NCT01344616|3773402|B1|Female||Sex/Gender, Customized||participants|Number|244|244.0||||||
3951612|NCT01344616|3773400|B3|||Age||Years|Mean|24.4|24.4|Standard Deviation|5.21|5.21|||
3951613|NCT01344616|3773401|B2|||Age||Years|Mean|24.36|24.36|Standard Deviation|5.18|5.18|||
3951614|NCT01344616|3773402|B1|||Age||Years|Mean|24.41|24.41|Standard Deviation|5.26|5.26|||
3951615|NCT01344538|3773409|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
3951616|NCT01344538|3773410|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3951617|NCT01344538|3773411|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3951618|NCT01344538|3773409|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3951619|NCT01344538|3773410|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3951620|NCT01344538|3773411|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3951621|NCT01344538|3773409|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3951622|NCT01344538|3773410|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3951623|NCT01344538|3773411|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3951624|NCT01344538|3773409|B3|||Age||years|Mean|34.0|34.0|Standard Deviation|11.1|11.1|||
3951625|NCT01344538|3773410|B2|||Age||years|Mean|33.4|33.4|Standard Deviation|10.1|10.1|||
3951626|NCT01344538|3773411|B1|||Age||years|Mean|34.5|34.5|Standard Deviation|13.1|13.1|||
3951627|NCT01344460|3773418|B1|||Baseline Weight||kilogram(s)|Mean|77.5|77.5|Standard Deviation|16.9|16.9|||
3951628|NCT01344460|3773418|B1||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
3951629|NCT01344460|3773418|B1||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3951630|NCT01344460|3773418|B1|>= 65 years||Age, Customized||participants|Number|112|112.0||||||
3951631|NCT01344460|3773418|B1|45 - 64 years||Age, Customized||participants|Number|111|111.0||||||
3951632|NCT01344460|3773418|B1|< 45 years||Age, Customized||participants|Number|92|92.0||||||
3951633|NCT01344460|3773418|B1|||Age||years|Mean|54.9|54.9|Standard Deviation|16.9|16.9|||
3951634|NCT01344447|3773463|B1|||Baseline Weight||kilogram|Mean|76.0|76.0|Standard Deviation|14.5|14.5|||
3951635|NCT01344447|3773463|B1||Male|Sex: Female, Male||Participants|Count of Participants|312|312.0||||||
3951636|NCT01344447|3773463|B1||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3951637|NCT01344447|3773463|B1|>=65 years||Age, Customized||participants|Number|315|315.0||||||
3951638|NCT01344447|3773463|B1|45-64 years||Age, Customized||participants|Number|155|155.0||||||
3951639|NCT01344447|3773463|B1|<45 years||Age, Customized||participants|Number|9|9.0||||||
3951640|NCT01344447|3773463|B1|||Age||years|Mean|68.2|68.2|Standard Deviation|10|10.0|||
3951641|NCT01344369|3773505|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
3951642|NCT01344369|3773506|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
3951643|NCT01344369|3773507|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3951644|NCT01344369|3773505|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3951645|NCT01344369|3773506|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3951646|NCT01344369|3773507|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3951647|NCT01344369|3773505|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3951648|NCT01344369|3773506|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3951649|NCT01344369|3773507|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3951650|NCT01344369|3773505|B3|Black||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3951651|NCT01344369|3773506|B2|Black||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3951652|NCT01344369|3773507|B1|Black||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3951653|NCT01344369|3773505|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3951654|NCT01344369|3773506|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3951655|NCT01344369|3773507|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3951656|NCT01344369|3773505|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3951657|NCT01344369|3773506|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3951658|NCT01344369|3773507|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3951659|NCT01344369|3773505|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3951660|NCT01344369|3773506|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3951661|NCT01344369|3773507|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3951662|NCT01344369|3773505|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3951663|NCT01344369|3773506|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3951664|NCT01344369|3773507|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3951665|NCT01344369|3773505|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3951666|NCT01344369|3773506|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3951667|NCT01344369|3773507|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3951668|NCT01344226|3773524|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
3951669|NCT01344226|3773524|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3951670|NCT01344226|3773524|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3951671|NCT01344226|3773524|B1|||Age||years|Mean|68.93|68.93|Standard Deviation|9.61|9.61|||
3951672|NCT01344226|3773524|B1||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
3951673|NCT01344226|3773524|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3951674|NCT01344226|3773524|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3951675|NCT01344161|3773531|B3|Iran, Islamic Republic of||Region of Enrollment||participants|Number|77|77.0||||||
3951676|NCT01344161|3773532|B2|Iran, Islamic Republic of||Region of Enrollment||participants|Number|39|39.0||||||
3951677|NCT01344161|3773533|B1|Iran, Islamic Republic of||Region of Enrollment||participants|Number|38|38.0||||||
3951678|NCT01344161|3773531|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3951679|NCT01344161|3773532|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3951680|NCT01344161|3773533|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3951681|NCT01344161|3773531|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3951682|NCT01344161|3773532|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3951683|NCT01344161|3773533|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3951684|NCT01344161|3773531|B3|||Age||years|Mean|38|38.0|Standard Deviation|8|8.0|||
3951685|NCT01344161|3773532|B2|||Age||years|Mean|37|37.0|Standard Deviation|8|8.0|||
3951686|NCT01344161|3773533|B1|||Age||years|Mean|38.9|38.9|Standard Deviation|7|7.0|||
3951687|NCT01344161|3773531|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3951688|NCT01344161|3773532|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3951689|NCT01344161|3773533|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3951690|NCT01344161|3773531|B3||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
3951691|NCT01344161|3773532|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3951692|NCT01344161|3773533|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3951693|NCT01344161|3773531|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3951694|NCT01344161|3773532|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3951695|NCT01344161|3773533|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3951696|NCT01344057|3773546|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3951697|NCT01344057|3773546|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3951698|NCT01344057|3773546|B1|||Age||Years|Mean|73.2|73.2|Standard Deviation|5.2|5.2|||
3951699|NCT01343901|3773553|B1||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3951700|NCT01343901|3773553|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3951701|NCT01343901|3773553|B1|||Age||years|Mean|65.83|65.83|Standard Deviation|9.63|9.63|||
3951702|NCT01343888|3773574|B4||Male|Sex: Female, Male||Participants|Count of Participants|342|342.0||||||
3951703|NCT01343888|3773575|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3951704|NCT01343888|3773576|B2||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3951705|NCT01343888|3773577|B1||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3951706|NCT01343888|3773574|B4||Female|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
3951707|NCT01343888|3773575|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3951708|NCT01343888|3773576|B2||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3951709|NCT01343888|3773577|B1||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3951710|NCT01343888|3773574|B4|||Age||years|Mean|47.8|47.8|Standard Deviation|11.85|11.85|||
3951711|NCT01343888|3773575|B3|||Age||years|Mean|46.6|46.6|Standard Deviation|12.53|12.53|||
3951712|NCT01343888|3773576|B2|||Age||years|Mean|48.3|48.3|Standard Deviation|11.89|11.89|||
3951713|NCT01343888|3773577|B1|||Age||years|Mean|47.9|47.9|Standard Deviation|11.44|11.44|||
3951714|NCT01343823|3773617|B5|United States||Region of Enrollment||participants|Number|76|76.0||0|0.0|0.0|0.0|
3951715|NCT01343823|3773618|B4|United States||Region of Enrollment||participants|Number|18|18.0||||||
3951716|NCT01343823|3773619|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
3951717|NCT01343823|3773620|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3951718|NCT01343823|3773621|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3951719|NCT01343823|3773617|B5||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3951720|NCT01343823|3773618|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3951721|NCT01343823|3773619|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3951722|NCT01343823|3773620|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3951723|NCT01343823|3773621|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3951724|NCT01343823|3773617|B5||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3951725|NCT01343823|3773618|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3951726|NCT01343823|3773619|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3951727|NCT01343823|3773620|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3951728|NCT01343823|3773621|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3951729|NCT01343823|3773617|B5||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3951730|NCT01343823|3773618|B4||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3951731|NCT01343823|3773619|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3951732|NCT01343823|3773620|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3951733|NCT01343823|3773621|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3951734|NCT01343823|3773617|B5||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3951735|NCT01343823|3773618|B4||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3951736|NCT01343823|3773619|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3951737|NCT01343823|3773620|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3951738|NCT01343823|3773621|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3951739|NCT01343823|3773617|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3951740|NCT01343823|3773618|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3951741|NCT01343823|3773619|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3951742|NCT01343823|3773620|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3951743|NCT01343823|3773621|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3951744|NCT01343667|3773638|B3|Not Reported||Race/Ethnicity, Customized|"This measure is structured as a check all that apply field on the Case Report Form. Thus, the race categories are not mutually exclusive, except that Not Reported is mutually exclusive with the others. Because of this, the sum of the individual category counts is greater than the overall number of participants."|participants|Number|3|3.0||||||
3951745|NCT01343667|3773639|B2|Not Reported||Race/Ethnicity, Customized|"This measure is structured as a check all that apply field on the Case Report Form. Thus, the race categories are not mutually exclusive, except that Not Reported is mutually exclusive with the others. Because of this, the sum of the individual category counts is greater than the overall number of participants."|participants|Number|1|1.0||||||
3951746|NCT01343667|3773640|B1|Not Reported||Race/Ethnicity, Customized|"This measure is structured as a check all that apply field on the Case Report Form. Thus, the race categories are not mutually exclusive, except that Not Reported is mutually exclusive with the others. Because of this, the sum of the individual category counts is greater than the overall number of participants."|participants|Number|2|2.0||||||
3951747|NCT01343667|3773638|B3|White or Caucasian||Race/Ethnicity, Customized|"This measure is structured as a check all that apply field on the Case Report Form. Thus, the race categories are not mutually exclusive, except that Not Reported is mutually exclusive with the others. Because of this, the sum of the individual category counts is greater than the overall number of participants."|participants|Number|1282|1282.0||||||
3951748|NCT01343667|3773639|B2|White or Caucasian||Race/Ethnicity, Customized|"This measure is structured as a check all that apply field on the Case Report Form. Thus, the race categories are not mutually exclusive, except that Not Reported is mutually exclusive with the others. Because of this, the sum of the individual category counts is greater than the overall number of participants."|participants|Number|901|901.0||||||
3951749|NCT01343667|3773640|B1|White or Caucasian||Race/Ethnicity, Customized|"This measure is structured as a check all that apply field on the Case Report Form. Thus, the race categories are not mutually exclusive, except that Not Reported is mutually exclusive with the others. Because of this, the sum of the individual category counts is greater than the overall number of participants."|participants|Number|381|381.0||||||
3951750|NCT01343667|3773638|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|"This measure is structured as a check all that apply field on the Case Report Form. Thus, the race categories are not mutually exclusive, except that Not Reported is mutually exclusive with the others. Because of this, the sum of the individual category counts is greater than the overall number of participants."|participants|Number|3|3.0||||||
3951751|NCT01343667|3773639|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|"This measure is structured as a check all that apply field on the Case Report Form. Thus, the race categories are not mutually exclusive, except that Not Reported is mutually exclusive with the others. Because of this, the sum of the individual category counts is greater than the overall number of participants."|participants|Number|1|1.0||||||
3951752|NCT01343667|3773640|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|"This measure is structured as a check all that apply field on the Case Report Form. Thus, the race categories are not mutually exclusive, except that Not Reported is mutually exclusive with the others. Because of this, the sum of the individual category counts is greater than the overall number of participants."|participants|Number|2|2.0||||||
3951753|NCT01343667|3773638|B3|Black or African American||Race/Ethnicity, Customized|"This measure is structured as a check all that apply field on the Case Report Form. Thus, the race categories are not mutually exclusive, except that Not Reported is mutually exclusive with the others. Because of this, the sum of the individual category counts is greater than the overall number of participants."|participants|Number|82|82.0||||||
3951754|NCT01343667|3773639|B2|Black or African American||Race/Ethnicity, Customized|"This measure is structured as a check all that apply field on the Case Report Form. Thus, the race categories are not mutually exclusive, except that Not Reported is mutually exclusive with the others. Because of this, the sum of the individual category counts is greater than the overall number of participants."|participants|Number|56|56.0||||||
3951755|NCT01343667|3773640|B1|Black or African American||Race/Ethnicity, Customized|"This measure is structured as a check all that apply field on the Case Report Form. Thus, the race categories are not mutually exclusive, except that Not Reported is mutually exclusive with the others. Because of this, the sum of the individual category counts is greater than the overall number of participants."|participants|Number|26|26.0||||||
3951756|NCT01343667|3773638|B3|Asian||Race/Ethnicity, Customized|"This measure is structured as a check all that apply field on the Case Report Form. Thus, the race categories are not mutually exclusive, except that Not Reported is mutually exclusive with the others. Because of this, the sum of the individual category counts is greater than the overall number of participants."|participants|Number|15|15.0||||||
3951757|NCT01343667|3773639|B2|Asian||Race/Ethnicity, Customized|"This measure is structured as a check all that apply field on the Case Report Form. Thus, the race categories are not mutually exclusive, except that Not Reported is mutually exclusive with the others. Because of this, the sum of the individual category counts is greater than the overall number of participants."|participants|Number|8|8.0||||||
3951758|NCT01343667|3773640|B1|Asian||Race/Ethnicity, Customized|"This measure is structured as a check all that apply field on the Case Report Form. Thus, the race categories are not mutually exclusive, except that Not Reported is mutually exclusive with the others. Because of this, the sum of the individual category counts is greater than the overall number of participants."|participants|Number|7|7.0||||||
3951759|NCT01343667|3773638|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|"This measure is structured as a check all that apply field on the Case Report Form. Thus, the race categories are not mutually exclusive, except that Not Reported is mutually exclusive with the others. Because of this, the sum of the individual category counts is greater than the overall number of participants."|participants|Number|17|17.0||||||
3951760|NCT01343667|3773639|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|"This measure is structured as a check all that apply field on the Case Report Form. Thus, the race categories are not mutually exclusive, except that Not Reported is mutually exclusive with the others. Because of this, the sum of the individual category counts is greater than the overall number of participants."|participants|Number|9|9.0||||||
3951761|NCT01343667|3773640|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|"This measure is structured as a check all that apply field on the Case Report Form. Thus, the race categories are not mutually exclusive, except that Not Reported is mutually exclusive with the others. Because of this, the sum of the individual category counts is greater than the overall number of participants."|participants|Number|8|8.0||||||
3951762|NCT01343667|3773638|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3951763|NCT01343667|3773639|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3951764|NCT01343667|3773640|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3951765|NCT01343667|3773638|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1369|1369.0||||||
3951766|NCT01343667|3773639|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|955|955.0||||||
3951767|NCT01343667|3773640|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|414|414.0||||||
3951768|NCT01343667|3773638|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3951769|NCT01343667|3773639|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3951770|NCT01343667|3773640|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3951771|NCT01343667|3773638|B3||Male|Sex: Female, Male||Participants|Count of Participants|671|671.0||||||
3951772|NCT01343667|3773639|B2||Male|Sex: Female, Male||Participants|Count of Participants|385|385.0||||||
3951773|NCT01343667|3773640|B1||Male|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
3951774|NCT01343667|3773638|B3||Female|Sex: Female, Male||Participants|Count of Participants|726|726.0||||||
3951775|NCT01343667|3773639|B2||Female|Sex: Female, Male||Participants|Count of Participants|587|587.0||||||
3951776|NCT01343667|3773640|B1||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3951777|NCT01343667|3773638|B3|||Age||years|Mean|72.9|72.9|Standard Deviation|9.2|9.2|||
3951778|NCT01343667|3773639|B2|||Age||years|Mean|73.0|73.0|Standard Deviation|9.4|9.4|||
3951779|NCT01343667|3773640|B1|||Age||years|Mean|72.7|72.7|Standard Deviation|8.7|8.7|||
3951780|NCT01343485|3773647|B3|United States||Region of Enrollment||participants|Number|365|365.0||||||
3951781|NCT01343485|3773648|B2|United States||Region of Enrollment||participants|Number|180|180.0||||||
3951782|NCT01343485|3773649|B1|United States||Region of Enrollment||participants|Number|185|185.0||||||
3951783|NCT01343485|3773647|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3951784|NCT01343485|3773648|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3951785|NCT01343485|3773649|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3951786|NCT01343485|3773647|B3||Female|Sex: Female, Male||Participants|Count of Participants|365|365.0||||||
3951787|NCT01343485|3773648|B2||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3951788|NCT01343485|3773649|B1||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
3951789|NCT01343485|3773647|B3|||Age||years|Mean|23.41|23.41|Standard Deviation|2.18|2.18|||
3951790|NCT01343485|3773648|B2|||Age||years|Mean|23.17|23.17|Standard Deviation|2.18|2.18|||
3951791|NCT01343485|3773649|B1|||Age||years|Mean|23.64|23.64|Standard Deviation|2.15|2.15|||
3951792|NCT01343485|3773647|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3951793|NCT01343485|3773648|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3951794|NCT01343485|3773649|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3951795|NCT01343485|3773647|B3||Between 18 and 65 years|Age||Participants|Count of Participants|365|365.0||||||
3951796|NCT01343485|3773648|B2||Between 18 and 65 years|Age||Participants|Count of Participants|180|180.0||||||
3951797|NCT01343485|3773649|B1||Between 18 and 65 years|Age||Participants|Count of Participants|185|185.0||||||
3951798|NCT01343485|3773647|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3951799|NCT01343485|3773648|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3951800|NCT01343485|3773649|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3951801|NCT01343368|3773656|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3951802|NCT01343368|3773657|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3951803|NCT01343368|3773658|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3951804|NCT01343368|3773656|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3951805|NCT01343368|3773657|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3951806|NCT01343368|3773658|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3951807|NCT01343368|3773656|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3951808|NCT01343368|3773657|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3951809|NCT01343368|3773658|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3951810|NCT01343368|3773656|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3951811|NCT01343368|3773657|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3951812|NCT01343368|3773658|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3951813|NCT01343368|3773656|B3||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
3951814|NCT01343368|3773657|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3951815|NCT01343368|3773658|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3951816|NCT01343277|3773693|B3|USA||Region of Enrollment||participants|Number|539|539.0||||||
3951817|NCT01343277|3773694|B2|USA||Region of Enrollment||participants|Number|183|183.0||||||
3951818|NCT01343277|3773695|B1|USA||Region of Enrollment||participants|Number|356|356.0||||||
3951819|NCT01343277|3773693|B3|NZL||Region of Enrollment||participants|Number|3|3.0||||||
3951820|NCT01343277|3773694|B2|NZL||Region of Enrollment||participants|Number|0|0.0||||||
3951821|NCT01343277|3773695|B1|NZL||Region of Enrollment||participants|Number|3|3.0||||||
3951822|NCT01343277|3773693|B3|BRA||Region of Enrollment||participants|Number|12|12.0||||||
3951823|NCT01343277|3773694|B2|BRA||Region of Enrollment||participants|Number|2|2.0||||||
3951824|NCT01343277|3773695|B1|BRA||Region of Enrollment||participants|Number|10|10.0||||||
3951825|NCT01343277|3773693|B3|AUS||Region of Enrollment||participants|Number|23|23.0||||||
3951826|NCT01343277|3773694|B2|AUS||Region of Enrollment||participants|Number|8|8.0||||||
3951827|NCT01343277|3773695|B1|AUS||Region of Enrollment||participants|Number|15|15.0||||||
3951828|NCT01343277|3773693|B3||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
3951829|NCT01343277|3773694|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3951830|NCT01343277|3773695|B1||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3951831|NCT01343277|3773693|B3||Female|Sex: Female, Male||Participants|Count of Participants|402|402.0||||||
3951832|NCT01343277|3773694|B2||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3951833|NCT01343277|3773695|B1||Female|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
3951834|NCT01343277|3773693|B3|||Age||years|Mean|55.7|55.7|Standard Deviation|11.39|11.39|||
3951835|NCT01343277|3773694|B2|||Age||years|Mean|54.1|54.1|Standard Deviation|11.92|11.92|||
3951836|NCT01343277|3773695|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|11.04|11.04|||
3951837|NCT01343251|3773712|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
3951838|NCT01343251|3773713|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3951839|NCT01343251|3773714|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3951840|NCT01343251|3773712|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3951841|NCT01343251|3773713|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3951842|NCT01343251|3773714|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3951843|NCT01343251|3773712|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3951844|NCT01343251|3773713|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3951845|NCT01343251|3773714|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3951846|NCT01343251|3773712|B3|||Age||years|Mean|60.00|60.0|Standard Deviation|11.38|11.38|||
3951847|NCT01343251|3773713|B2|||Age||years|Mean|63.12|63.12|Standard Deviation|11.49|11.49|||
3951848|NCT01343251|3773714|B1|||Age||years|Mean|56.69|56.69|Standard Deviation|11.08|11.08|||
3951849|NCT01343095|3773729|B4|||Mean SAPS II|"Severe Acute Physiology Scale II. The SAPS II score is made of 12 physiological variables and 3 disease-related variables. The worst physiological variables were collected within the first 24 hours of ICU admission. The worst measurement was defined as the measure that correlated to the highest number of points. The study did not continually calculate SAPS II scores beyond the first 24 hours of ICU admission. The SAPS II score ranges from 0 to 163 points."|units on a scale|Mean|51|51.0|Full Range|||22.0|88.0|
3951850|NCT01343095|3773730|B3|||Mean SAPS II|"Severe Acute Physiology Scale II. The SAPS II score is made of 12 physiological variables and 3 disease-related variables. The worst physiological variables were collected within the first 24 hours of ICU admission. The worst measurement was defined as the measure that correlated to the highest number of points. The study did not continually calculate SAPS II scores beyond the first 24 hours of ICU admission. The SAPS II score ranges from 0 to 163 points."|units on a scale|Mean|57.6|57.6|Full Range|||43.0|74.0|
3951851|NCT01343095|3773731|B2|||Mean SAPS II|"Severe Acute Physiology Scale II. The SAPS II score is made of 12 physiological variables and 3 disease-related variables. The worst physiological variables were collected within the first 24 hours of ICU admission. The worst measurement was defined as the measure that correlated to the highest number of points. The study did not continually calculate SAPS II scores beyond the first 24 hours of ICU admission. The SAPS II score ranges from 0 to 163 points."|units on a scale|Mean|40|40.0|Full Range|||22.0|68.0|
3951852|NCT01343095|3773732|B1|||Mean SAPS II|"Severe Acute Physiology Scale II. The SAPS II score is made of 12 physiological variables and 3 disease-related variables. The worst physiological variables were collected within the first 24 hours of ICU admission. The worst measurement was defined as the measure that correlated to the highest number of points. The study did not continually calculate SAPS II scores beyond the first 24 hours of ICU admission. The SAPS II score ranges from 0 to 163 points."|units on a scale|Mean|57.5|57.5|Full Range|||27.0|88.0|
3951853|NCT01343095|3773729|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
3951854|NCT01343095|3773730|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3951855|NCT01343095|3773731|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3951856|NCT01343095|3773732|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3951857|NCT01343095|3773729|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3951858|NCT01343095|3773730|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3951859|NCT01343095|3773731|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3951860|NCT01343095|3773732|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3951861|NCT01343095|3773729|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3951862|NCT01343095|3773730|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3951863|NCT01343095|3773731|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3951864|NCT01343095|3773732|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3951865|NCT01343095|3773729|B4|||Age||years|Mean|63|63.0|Full Range|||40.0|77.0|
3951866|NCT01343095|3773730|B3|||Age||years|Mean|56|56.0|Full Range|||40.0|77.0|
3951867|NCT01343095|3773731|B2|||Age||years|Mean|66|66.0|Full Range|||53.0|71.0|
3951868|NCT01343095|3773732|B1|||Age||years|Mean|72|72.0|Full Range|||71.0|73.0|
3951869|NCT01343082|3773757|B1|Japan||Region of Enrollment||participants|Number|136|136.0||||||
3951870|NCT01343082|3773757|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3951871|NCT01343082|3773757|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3951872|NCT01343082|3773757|B1|||Age||years|Mean|64.0|64.0|Standard Deviation|12.0|12.0|||
3951873|NCT01343082|3773757|B1||>=65 years|Age||Participants|Count of Participants|74|74.0||||||
3951874|NCT01343082|3773757|B1||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
3951875|NCT01343082|3773757|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3951876|NCT01343056|3773763|B5|United States||Region of Enrollment||participants|Number|141|141.0||||||
3951877|NCT01343056|3773764|B4|United States||Region of Enrollment||participants|Number|38|38.0||||||
3951878|NCT01343056|3773765|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
3951879|NCT01343056|3773766|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
3951880|NCT01343056|3773767|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3951881|NCT01343056|3773763|B5||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3951882|NCT01343056|3773764|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3951883|NCT01343056|3773765|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3951884|NCT01343056|3773766|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3951885|NCT01343056|3773767|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3951886|NCT01343056|3773763|B5||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3951887|NCT01343056|3773764|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3951888|NCT01343056|3773765|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3951889|NCT01343056|3773766|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3951890|NCT01343056|3773767|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3951891|NCT01343056|3773763|B5|||Age||years|Mean|60|60.0|Standard Deviation|10|10.0|||
3951892|NCT01343056|3773764|B4|||Age||years|Mean|60|60.0|Standard Deviation|10|10.0|||
3951893|NCT01343056|3773765|B3|||Age||years|Mean|60|60.0|Standard Deviation|12|12.0|||
3951894|NCT01343056|3773766|B2|||Age||years|Mean|64|64.0|Standard Deviation|10|10.0|||
3951895|NCT01343056|3773767|B1|||Age||years|Mean|60|60.0|Standard Deviation|13.4|13.4|||
3951896|NCT01343056|3773763|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3951897|NCT01343056|3773764|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3951898|NCT01343056|3773765|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3951899|NCT01343056|3773766|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3951900|NCT01343056|3773767|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3951901|NCT01343056|3773763|B5||Between 18 and 65 years|Age||Participants|Count of Participants|141|141.0||||||
3951902|NCT01343056|3773764|B4||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3951903|NCT01343056|3773765|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3951904|NCT01343056|3773766|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3951905|NCT01343056|3773767|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3951906|NCT01343056|3773763|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3951907|NCT01343056|3773764|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3951908|NCT01343056|3773765|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3951909|NCT01343056|3773766|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3951910|NCT01343056|3773767|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3951911|NCT01343004|3773808|B4||Male|Gender||Participants|Count of Participants|0|0.0||||||
3951912|NCT01343004|3773809|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3951913|NCT01343004|3773810|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3951914|NCT01343004|3773811|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3951915|NCT01343004|3773808|B4||Female|Gender||Participants|Count of Participants|2463|2463.0||||||
3951916|NCT01343004|3773809|B3||Female|Gender||Participants|Count of Participants|818|818.0||||||
3951917|NCT01343004|3773810|B2||Female|Gender||Participants|Count of Participants|824|824.0||||||
3951918|NCT01343004|3773811|B1||Female|Gender||Participants|Count of Participants|821|821.0||||||
3951919|NCT01343004|3773808|B4|||Age||years|Mean|68.8|68.8|Standard Deviation|6.5|6.5|||
3951920|NCT01343004|3773809|B3|||Age||years|Mean|68.8|68.8|Standard Deviation|6.6|6.6|||
3951921|NCT01343004|3773810|B2|||Age||years|Mean|68.9|68.9|Standard Deviation|6.5|6.5|||
3951922|NCT01343004|3773811|B1|||Age||years|Mean|68.7|68.7|Standard Deviation|6.5|6.5|||
3951923|NCT01342965|3773836|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3951924|NCT01342965|3773837|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3951925|NCT01342965|3773838|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3951926|NCT01342965|3773836|B3||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3951927|NCT01342965|3773837|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3951928|NCT01342965|3773838|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3951929|NCT01342965|3773836|B3|||Age||years|Mean|56.3|56.3|Standard Deviation|10.37|10.37|||
3951930|NCT01342965|3773837|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|10.41|10.41|||
3951931|NCT01342965|3773838|B1|||Age||years|Mean|56.7|56.7|Standard Deviation|10.37|10.37|||
3951932|NCT01342926|3773853|B5|White||Race/Ethnicity, Customized||Participants|Number|190|190.0||||||
3951933|NCT01342926|3773854|B4|White||Race/Ethnicity, Customized||Participants|Number|51|51.0||||||
3951934|NCT01342926|3773855|B3|White||Race/Ethnicity, Customized||Participants|Number|48|48.0||||||
3951935|NCT01342926|3773856|B2|White||Race/Ethnicity, Customized||Participants|Number|46|46.0||||||
3951936|NCT01342926|3773857|B1|White||Race/Ethnicity, Customized||Participants|Number|45|45.0||||||
3951937|NCT01342926|3773853|B5|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3951938|NCT01342926|3773854|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3951939|NCT01342926|3773855|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3951940|NCT01342926|3773856|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3951941|NCT01342926|3773857|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3951942|NCT01342926|3773853|B5||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3951943|NCT01342926|3773854|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3951944|NCT01342926|3773855|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3951945|NCT01342926|3773856|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3951946|NCT01342926|3773857|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3951947|NCT01342926|3773853|B5||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3951948|NCT01342926|3773854|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3951949|NCT01342926|3773855|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3951950|NCT01342926|3773856|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3951951|NCT01342926|3773857|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3951952|NCT01342926|3773853|B5|||Age||Years|Mean|77.2|77.2|Standard Deviation|8.63|8.63|||
3951953|NCT01342926|3773854|B4|||Age||Years|Mean|78.6|78.6|Standard Deviation|7.22|7.22|||
3951954|NCT01342926|3773855|B3|||Age||Years|Mean|77.5|77.5|Standard Deviation|8.57|8.57|||
3951955|NCT01342926|3773856|B2|||Age||Years|Mean|77.2|77.2|Standard Deviation|9.09|9.09|||
3951956|NCT01342926|3773857|B1|||Age||Years|Mean|75.3|75.3|Standard Deviation|9.55|9.55|||
3951957|NCT01342913|3773938|B3|White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|423|423.0||||||
3951958|NCT01342913|3773939|B2|White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|217|217.0||||||
3951959|NCT01342913|3773940|B1|White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|206|206.0||||||
3951960|NCT01342913|3773938|B3|White-Arabic/North African Hertage||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3951961|NCT01342913|3773939|B2|White-Arabic/North African Hertage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3951962|NCT01342913|3773940|B1|White-Arabic/North African Hertage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3951963|NCT01342913|3773938|B3|Asian-South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|101|101.0||||||
3951964|NCT01342913|3773939|B2|Asian-South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
3951965|NCT01342913|3773940|B1|Asian-South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
3951966|NCT01342913|3773938|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3951967|NCT01342913|3773939|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3951968|NCT01342913|3773940|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3951969|NCT01342913|3773938|B3||Male|Sex: Female, Male||Participants|Count of Participants|433|433.0||||||
3951970|NCT01342913|3773939|B2||Male|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
3951971|NCT01342913|3773940|B1||Male|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
3951972|NCT01342913|3773938|B3||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3951973|NCT01342913|3773939|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3951974|NCT01342913|3773940|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3951975|NCT01342913|3773938|B3|||Age||Years|Mean|62.9|62.9|Standard Deviation|8.59|8.59|||
3951976|NCT01342913|3773939|B2|||Age||Years|Mean|63.0|63.0|Standard Deviation|8.10|8.1|||
3951977|NCT01342913|3773940|B1|||Age||Years|Mean|62.9|62.9|Standard Deviation|9.07|9.07|||
3951978|NCT01342887|3773952|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3951979|NCT01342887|3773952|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3951980|NCT01342887|3773952|B1|||Age||years|Mean|51|51.0|Full Range|||40.0|57.0|
3951981|NCT01342770|3773959|B1|Current||Smoking Status||participants|Number|2|2.0||||||
3951982|NCT01342770|3773959|B1|Former||Smoking Status||participants|Number|4|4.0||||||
3951983|NCT01342770|3773959|B1|1=Symptomatic and fully ambulatory||Baseline Eastern Cooperative Oncology Group (ECOG) performance status||participants|Number|1|1.0||||||
3951984|NCT01342770|3773959|B1|0=Asymptomatic and fully active||Baseline Eastern Cooperative Oncology Group (ECOG) performance status||participants|Number|5|5.0||||||
3951985|NCT01342770|3773959|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3951986|NCT01342770|3773959|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3951987|NCT01342770|3773959|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3951988|NCT01342770|3773959|B1|||Age||years|Median|64|64.0|Full Range|||54.0|72.0|
3951989|NCT01342757|3773977|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3951990|NCT01342757|3773977|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3951991|NCT01342757|3773977|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3951992|NCT01342757|3773977|B1|||Age||years|Mean|52|52.0|Standard Deviation|10|10.0|||
3951993|NCT01342757|3773977|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3951994|NCT01342757|3773977|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3951995|NCT01342757|3773977|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3951996|NCT01342666|3773984|B3|Mexico||Region of Enrollment||participants|Number|50|50.0||||||
3951997|NCT01342666|3773985|B2|Mexico||Region of Enrollment||participants|Number|24|24.0||||||
3951998|NCT01342666|3773986|B1|Mexico||Region of Enrollment||participants|Number|26|26.0||||||
3951999|NCT01342666|3773984|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3952000|NCT01342666|3773985|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3952001|NCT01342666|3773986|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3952002|NCT01342666|3773984|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3952003|NCT01342666|3773985|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3952004|NCT01342666|3773986|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3952005|NCT01342666|3773984|B3|||Age||years|Mean|41.8|41.8|Standard Deviation|15.7|15.7|||
3952006|NCT01342666|3773985|B2|||Age||years|Mean|40.3|40.3|Standard Deviation|16.0|16.0|||
3952007|NCT01342666|3773986|B1|||Age||years|Mean|43.4|43.4|Standard Deviation|15.5|15.5|||
3952008|NCT01342666|3773984|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3952009|NCT01342666|3773985|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3952010|NCT01342666|3773986|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3952011|NCT01342666|3773984|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3952012|NCT01342666|3773985|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3952013|NCT01342666|3773986|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3952014|NCT01342666|3773984|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952015|NCT01342666|3773985|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952016|NCT01342666|3773986|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952017|NCT01342640|3773993|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3952018|NCT01342640|3773993|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3952019|NCT01342640|3773993|B1|||Age||Years|Mean|45.80|45.8|Standard Deviation|16.68|16.68|||
3952020|NCT01342549|3773999|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
3952021|NCT01342549|3774000|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
3952022|NCT01342549|3774001|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
3952023|NCT01342549|3773999|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3952024|NCT01342549|3774000|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3952025|NCT01342549|3774001|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3952026|NCT01342549|3773999|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3952027|NCT01342549|3774000|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3952028|NCT01342549|3774001|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3952029|NCT01342549|3773999|B3|||Age|Age range of 18-60. We decided to exclude patients over 60 years in order to avoid significant confounders such as the neurodegenerative changes associated with aging as well as those related to the presence of cerebrovascular pathology, a frequent complication observed among older veterans. 2. Presence of a diagnosis of alcohol dependence according to DSM-IV criteria.|years|Mean|47.42|47.42|Standard Deviation|9.17|9.17|||
3952030|NCT01342549|3774000|B2|||Age|Age range of 18-60. We decided to exclude patients over 60 years in order to avoid significant confounders such as the neurodegenerative changes associated with aging as well as those related to the presence of cerebrovascular pathology, a frequent complication observed among older veterans. 2. Presence of a diagnosis of alcohol dependence according to DSM-IV criteria.|years|Mean|48.13|48.13|Standard Deviation|8.79|8.79|||
3952031|NCT01342549|3774001|B1|||Age|Age range of 18-60. We decided to exclude patients over 60 years in order to avoid significant confounders such as the neurodegenerative changes associated with aging as well as those related to the presence of cerebrovascular pathology, a frequent complication observed among older veterans. 2. Presence of a diagnosis of alcohol dependence according to DSM-IV criteria.|years|Mean|46.71|46.71|Standard Deviation|9.52|9.52|||
3952032|NCT01342549|3773999|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3952033|NCT01342549|3774000|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3952034|NCT01342549|3774001|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3952035|NCT01342549|3773999|B3||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
3952036|NCT01342549|3774000|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3952037|NCT01342549|3774001|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3952038|NCT01342549|3773999|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952039|NCT01342549|3774000|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952040|NCT01342549|3774001|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952041|NCT01342523|3774008|B33|United States||Region of Enrollment||participants|Number|1034|1034.0||||||
3952042|NCT01342523|3774009|B32|United States||Region of Enrollment||participants|Number|28|28.0||||||
3952043|NCT01342523|3774010|B31|United States||Region of Enrollment||participants|Number|31|31.0||||||
3952044|NCT01342523|3774011|B30|United States||Region of Enrollment||participants|Number|29|29.0||||||
3952045|NCT01342523|3774012|B29|United States||Region of Enrollment||participants|Number|35|35.0||||||
3952046|NCT01342523|3774013|B28|United States||Region of Enrollment||participants|Number|31|31.0||||||
3952047|NCT01342523|3774014|B27|United States||Region of Enrollment||participants|Number|34|34.0||||||
3952048|NCT01342523|3774015|B26|United States||Region of Enrollment||participants|Number|38|38.0||||||
3952049|NCT01342523|3774016|B25|United States||Region of Enrollment||participants|Number|37|37.0||||||
3952050|NCT01342523|3774017|B24|United States||Region of Enrollment||participants|Number|36|36.0||||||
3952051|NCT01342523|3774018|B23|United States||Region of Enrollment||participants|Number|36|36.0||||||
3952052|NCT01342523|3774019|B22|United States||Region of Enrollment||participants|Number|30|30.0||||||
3952053|NCT01342523|3774020|B21|United States||Region of Enrollment||participants|Number|29|29.0||||||
3952054|NCT01342523|3774021|B20|United States||Region of Enrollment||participants|Number|27|27.0||||||
3952055|NCT01342523|3774022|B19|United States||Region of Enrollment||participants|Number|21|21.0||||||
3952056|NCT01342523|3774023|B18|United States||Region of Enrollment||participants|Number|27|27.0||||||
3952057|NCT01342523|3774024|B17|United States||Region of Enrollment||participants|Number|29|29.0||||||
3952058|NCT01342523|3774025|B16|United States||Region of Enrollment||participants|Number|32|32.0||||||
3952059|NCT01342523|3774026|B15|United States||Region of Enrollment||participants|Number|38|38.0||||||
3952060|NCT01342523|3774027|B14|United States||Region of Enrollment||participants|Number|38|38.0||||||
3952061|NCT01342523|3774028|B13|United States||Region of Enrollment||participants|Number|39|39.0||||||
3952062|NCT01342523|3774029|B12|United States||Region of Enrollment||participants|Number|38|38.0||||||
3952063|NCT01342523|3774030|B11|United States||Region of Enrollment||participants|Number|38|38.0||||||
3952064|NCT01342523|3774031|B10|United States||Region of Enrollment||participants|Number|28|28.0||||||
3952065|NCT01342523|3774032|B9|United States||Region of Enrollment||participants|Number|28|28.0||||||
3952066|NCT01342523|3774033|B8|United States||Region of Enrollment||participants|Number|27|27.0||||||
3952067|NCT01342523|3774034|B7|United States||Region of Enrollment||participants|Number|22|22.0||||||
3952068|NCT01342523|3774035|B6|United States||Region of Enrollment||participants|Number|36|36.0||||||
3952069|NCT01342523|3774036|B5|United States||Region of Enrollment||participants|Number|36|36.0||||||
3952070|NCT01342523|3774037|B4|United States||Region of Enrollment||participants|Number|33|33.0||||||
3952071|NCT01342523|3774038|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
3952072|NCT01342523|3774039|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
3952073|NCT01342523|3774040|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3952074|NCT01342523|3774008|B33||Male|Sex: Female, Male||Participants|Count of Participants|331|331.0||||||
3952075|NCT01342523|3774009|B32||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3952076|NCT01342523|3774010|B31||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3952077|NCT01342523|3774011|B30||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3952078|NCT01342523|3774012|B29||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3952079|NCT01342523|3774013|B28||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3952080|NCT01342523|3774014|B27||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3952081|NCT01342523|3774015|B26||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3952082|NCT01342523|3774016|B25||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3952083|NCT01342523|3774017|B24||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3952084|NCT01342523|3774018|B23||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3952085|NCT01342523|3774019|B22||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3952086|NCT01342523|3774020|B21||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3952087|NCT01342523|3774021|B20||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3952088|NCT01342523|3774022|B19||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3952089|NCT01342523|3774023|B18||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3952090|NCT01342523|3774024|B17||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3952091|NCT01342523|3774025|B16||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3952092|NCT01342523|3774026|B15||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3952093|NCT01342523|3774027|B14||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3952094|NCT01342523|3774028|B13||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3952095|NCT01342523|3774029|B12||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3952096|NCT01342523|3774030|B11||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3952097|NCT01342523|3774031|B10||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3952098|NCT01342523|3774032|B9||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3952099|NCT01342523|3774033|B8||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3952100|NCT01342523|3774034|B7||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3952101|NCT01342523|3774035|B6||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3952102|NCT01342523|3774036|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3952103|NCT01342523|3774037|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3952104|NCT01342523|3774038|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3952105|NCT01342523|3774039|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3952106|NCT01342523|3774040|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3952107|NCT01342523|3774008|B33||Female|Sex: Female, Male||Participants|Count of Participants|703|703.0||||||
3952108|NCT01342523|3774009|B32||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3952109|NCT01342523|3774010|B31||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3952110|NCT01342523|3774011|B30||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3952111|NCT01342523|3774012|B29||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3952112|NCT01342523|3774013|B28||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3952113|NCT01342523|3774014|B27||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3952114|NCT01342523|3774015|B26||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3952115|NCT01342523|3774016|B25||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3952116|NCT01342523|3774017|B24||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3952117|NCT01342523|3774018|B23||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3952118|NCT01342523|3774019|B22||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3952119|NCT01342523|3774020|B21||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3952120|NCT01342523|3774021|B20||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3952121|NCT01342523|3774022|B19||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3952122|NCT01342523|3774023|B18||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3952123|NCT01342523|3774024|B17||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3952124|NCT01342523|3774025|B16||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3952125|NCT01342523|3774026|B15||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3952126|NCT01342523|3774027|B14||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3952127|NCT01342523|3774028|B13||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3952128|NCT01342523|3774029|B12||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3952129|NCT01342523|3774030|B11||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3952130|NCT01342523|3774031|B10||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3952131|NCT01342523|3774032|B9||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3952132|NCT01342523|3774033|B8||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3952133|NCT01342523|3774034|B7||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3952134|NCT01342523|3774035|B6||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3952135|NCT01342523|3774036|B5||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3952136|NCT01342523|3774037|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3952137|NCT01342523|3774038|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3952138|NCT01342523|3774039|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3952139|NCT01342523|3774040|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3952140|NCT01342523|3774008|B33|||Age||years|Mean|39.28|39.28|Standard Deviation|12.343|12.343|||
3952141|NCT01342523|3774009|B32|||Age||years|Mean|42.54|42.54|Standard Deviation|12.96|12.96|||
3952142|NCT01342523|3774010|B31|||Age||years|Mean|38.23|38.23|Standard Deviation|13.674|13.674|||
3952143|NCT01342523|3774011|B30|||Age||years|Mean|35.62|35.62|Standard Deviation|12.754|12.754|||
3952144|NCT01342523|3774012|B29|||Age||years|Mean|36.91|36.91|Standard Deviation|10.441|10.441|||
3952145|NCT01342523|3774013|B28|||Age||years|Mean|37.77|37.77|Standard Deviation|13.386|13.386|||
3952146|NCT01342523|3774014|B27|||Age||years|Mean|38.47|38.47|Standard Deviation|12.310|12.31|||
3952147|NCT01342523|3774015|B26|||Age||years|Mean|40.32|40.32|Standard Deviation|11.242|11.242|||
3952148|NCT01342523|3774016|B25|||Age||years|Mean|38.92|38.92|Standard Deviation|13.215|13.215|||
3952149|NCT01342523|3774017|B24|||Age||years|Mean|42.97|42.97|Standard Deviation|13.716|13.716|||
3952150|NCT01342523|3774018|B23|||Age||years|Mean|38.81|38.81|Standard Deviation|11.112|11.112|||
3952151|NCT01342523|3774019|B22|||Age||years|Mean|40.37|40.37|Standard Deviation|13.433|13.433|||
3952152|NCT01342523|3774020|B21|||Age||years|Mean|37.79|37.79|Standard Deviation|10.115|10.115|||
3952153|NCT01342523|3774021|B20|||Age||years|Mean|39.26|39.26|Standard Deviation|10.376|10.376|||
3952154|NCT01342523|3774022|B19|||Age||years|Mean|35.76|35.76|Standard Deviation|12.373|12.373|||
3952155|NCT01342523|3774023|B18|||Age||years|Mean|43.04|43.04|Standard Deviation|12.738|12.738|||
3952156|NCT01342523|3774024|B17|||Age||years|Mean|42.31|42.31|Standard Deviation|13.134|13.134|||
3952157|NCT01342523|3774025|B16|||Age||years|Mean|40.56|40.56|Standard Deviation|11.007|11.007|||
3952158|NCT01342523|3774026|B15|||Age||years|Mean|38.18|38.18|Standard Deviation|11.925|11.925|||
3952159|NCT01342523|3774027|B14|||Age||years|Mean|39.47|39.47|Standard Deviation|12.967|12.967|||
3952160|NCT01342523|3774028|B13|||Age||years|Mean|36.03|36.03|Standard Deviation|11.957|11.957|||
3952161|NCT01342523|3774029|B12|||Age||years|Mean|39.16|39.16|Standard Deviation|10.812|10.812|||
3952162|NCT01342523|3774030|B11|||Age||years|Mean|39|39.0|Standard Deviation|12.192|12.192|||
3952163|NCT01342523|3774031|B10|||Age||years|Mean|38.11|38.11|Standard Deviation|13.076|13.076|||
3952164|NCT01342523|3774032|B9|||Age||years|Mean|37.71|37.71|Standard Deviation|13.160|13.16|||
3952165|NCT01342523|3774033|B8|||Age||years|Mean|38.52|38.52|Standard Deviation|14.091|14.091|||
3952166|NCT01342523|3774034|B7|||Age||years|Mean|40.5|40.5|Standard Deviation|11.859|11.859|||
3952167|NCT01342523|3774035|B6|||Age||years|Mean|39.92|39.92|Standard Deviation|13|13.0|||
3952168|NCT01342523|3774036|B5|||Age||years|Mean|39.89|39.89|Standard Deviation|12.132|12.132|||
3952169|NCT01342523|3774037|B4|||Age||years|Mean|40.58|40.58|Standard Deviation|13.709|13.709|||
3952170|NCT01342523|3774038|B3|||Age||years|Mean|39.47|39.47|Standard Deviation|11.661|11.661|||
3952171|NCT01342523|3774039|B2|||Age||years|Mean|41.97|41.97|Standard Deviation|12.124|12.124|||
3952172|NCT01342523|3774040|B1|||Age||years|Mean|38.8|38.8|Standard Deviation|13.117|13.117|||
3952173|NCT01342523|3774008|B33||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3952174|NCT01342523|3774009|B32||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3952175|NCT01342523|3774010|B31||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3952176|NCT01342523|3774011|B30||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3952177|NCT01342523|3774012|B29||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3952178|NCT01342523|3774013|B28||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3952179|NCT01342523|3774014|B27||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3952180|NCT01342523|3774015|B26||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3952181|NCT01342523|3774016|B25||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3952182|NCT01342523|3774017|B24||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3952183|NCT01342523|3774018|B23||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3952184|NCT01342523|3774019|B22||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3952185|NCT01342523|3774020|B21||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3952186|NCT01342523|3774021|B20||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3952187|NCT01342523|3774022|B19||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3952188|NCT01342523|3774023|B18||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3952189|NCT01342523|3774024|B17||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3952190|NCT01342523|3774025|B16||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3952191|NCT01342523|3774026|B15||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3952192|NCT01342523|3774027|B14||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3952193|NCT01342523|3774028|B13||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3952194|NCT01342523|3774029|B12||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3952195|NCT01342523|3774030|B11||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3952196|NCT01342523|3774031|B10||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3952197|NCT01342523|3774032|B9||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3952198|NCT01342523|3774033|B8||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3952199|NCT01342523|3774034|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3952200|NCT01342523|3774035|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3952201|NCT01342523|3774036|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3952202|NCT01342523|3774037|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3952203|NCT01342523|3774038|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3952204|NCT01342523|3774039|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3952205|NCT01342523|3774040|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3952206|NCT01342523|3774008|B33||Between 18 and 65 years|Age||Participants|Count of Participants|1008|1008.0||||||
3952207|NCT01342523|3774009|B32||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3952208|NCT01342523|3774010|B31||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3952209|NCT01342523|3774011|B30||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3952210|NCT01342523|3774012|B29||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3952211|NCT01342523|3774013|B28||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3952212|NCT01342523|3774014|B27||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3952213|NCT01342523|3774015|B26||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3952214|NCT01342523|3774016|B25||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3952215|NCT01342523|3774017|B24||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3952216|NCT01342523|3774018|B23||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3952217|NCT01342523|3774019|B22||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3952218|NCT01342523|3774020|B21||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3952219|NCT01342523|3774021|B20||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3952220|NCT01342523|3774022|B19||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3952221|NCT01342523|3774023|B18||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3952222|NCT01342523|3774024|B17||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3952223|NCT01342523|3774025|B16||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3952224|NCT01342523|3774026|B15||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3952225|NCT01342523|3774027|B14||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3952226|NCT01342523|3774028|B13||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
3952227|NCT01342523|3774029|B12||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3952228|NCT01342523|3774030|B11||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3952229|NCT01342523|3774031|B10||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3952230|NCT01342523|3774032|B9||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3952231|NCT01342523|3774033|B8||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3952232|NCT01342523|3774034|B7||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3952233|NCT01342523|3774035|B6||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3952234|NCT01342523|3774036|B5||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3952235|NCT01342523|3774037|B4||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3952236|NCT01342523|3774038|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3952237|NCT01342523|3774039|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3952238|NCT01342523|3774040|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3952239|NCT01342523|3774008|B33||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3952240|NCT01342523|3774009|B32||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952241|NCT01342523|3774010|B31||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3952242|NCT01342523|3774011|B30||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3952243|NCT01342523|3774012|B29||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952244|NCT01342523|3774013|B28||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952245|NCT01342523|3774014|B27||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952246|NCT01342523|3774015|B26||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952247|NCT01342523|3774016|B25||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3952248|NCT01342523|3774017|B24||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952249|NCT01342523|3774018|B23||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952250|NCT01342523|3774019|B22||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3952251|NCT01342523|3774020|B21||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952252|NCT01342523|3774021|B20||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952253|NCT01342523|3774022|B19||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952254|NCT01342523|3774023|B18||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3952255|NCT01342523|3774024|B17||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952256|NCT01342523|3774025|B16||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952257|NCT01342523|3774026|B15||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952258|NCT01342523|3774027|B14||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952259|NCT01342523|3774028|B13||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952260|NCT01342523|3774029|B12||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952261|NCT01342523|3774030|B11||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952262|NCT01342523|3774031|B10||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952263|NCT01342523|3774032|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952264|NCT01342523|3774033|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952265|NCT01342523|3774034|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952266|NCT01342523|3774035|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952267|NCT01342523|3774036|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952268|NCT01342523|3774037|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952269|NCT01342523|3774038|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952270|NCT01342523|3774039|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952271|NCT01342523|3774040|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952272|NCT01342510|3774084|B5|United States||Region of Enrollment||participants|Number|158|158.0||||||
3952273|NCT01342510|3774085|B4|United States||Region of Enrollment||participants|Number|39|39.0||||||
3952274|NCT01342510|3774086|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
3952275|NCT01342510|3774087|B2|United States||Region of Enrollment||participants|Number|44|44.0||||||
3952276|NCT01342510|3774088|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
3952277|NCT01342510|3774084|B5||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3952278|NCT01342510|3774085|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3952279|NCT01342510|3774086|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3952280|NCT01342510|3774087|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3952281|NCT01342510|3774088|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3952282|NCT01342510|3774084|B5||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3952283|NCT01342510|3774085|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3952284|NCT01342510|3774086|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3952285|NCT01342510|3774087|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3952286|NCT01342510|3774088|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3952287|NCT01342510|3774084|B5|||Age||years|Mean|45.1|45.1|Standard Deviation|16.5|16.5|||
3952288|NCT01342510|3774085|B4|||Age||years|Mean|45.3|45.3|Standard Deviation|18.6|18.6|||
3952289|NCT01342510|3774086|B3|||Age||years|Mean|44.3|44.3|Standard Deviation|16.2|16.2|||
3952290|NCT01342510|3774087|B2|||Age||years|Mean|44.4|44.4|Standard Deviation|17.2|17.2|||
3952291|NCT01342510|3774088|B1|||Age||years|Mean|45.4|45.4|Standard Deviation|15.3|15.3|||
3952292|NCT01342510|3774084|B5||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3952293|NCT01342510|3774085|B4||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3952294|NCT01342510|3774086|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3952295|NCT01342510|3774087|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3952296|NCT01342510|3774088|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3952297|NCT01342510|3774084|B5||Between 18 and 65 years|Age||Participants|Count of Participants|140|140.0||||||
3952298|NCT01342510|3774085|B4||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3952299|NCT01342510|3774086|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3952300|NCT01342510|3774087|B2||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3952301|NCT01342510|3774088|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3952302|NCT01342510|3774084|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952303|NCT01342510|3774085|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952304|NCT01342510|3774086|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952305|NCT01342510|3774087|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952306|NCT01342510|3774088|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952307|NCT01342484|3774101|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3952308|NCT01342484|3774102|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3952309|NCT01342484|3774103|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3952310|NCT01342484|3774104|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3952311|NCT01342484|3774101|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3952312|NCT01342484|3774102|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3952313|NCT01342484|3774103|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3952314|NCT01342484|3774104|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3952315|NCT01342484|3774101|B4|||Age||Years|Mean|14.0|14.0|Standard Deviation|1.9|1.9|||
3952316|NCT01342484|3774102|B3|||Age||Years|Mean|14.3|14.3|Standard Deviation|2.1|2.1|||
3952317|NCT01342484|3774103|B2|||Age||Years|Mean|14.0|14.0|Standard Deviation|1.8|1.8|||
3952318|NCT01342484|3774104|B1|||Age||Years|Mean|13.7|13.7|Standard Deviation|2.0|2.0|||
3952319|NCT01342471|3774120|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
3952320|NCT01342471|3774121|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
3952321|NCT01342471|3774122|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3952322|NCT01342471|3774120|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3952323|NCT01342471|3774121|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3952324|NCT01342471|3774122|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3952325|NCT01342471|3774120|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3952326|NCT01342471|3774121|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3952327|NCT01342471|3774122|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3952328|NCT01342471|3774120|B3|||Age||years|Mean|52.0|52.0|Standard Deviation|8.6|8.6|||
3952329|NCT01342471|3774121|B2|||Age||years|Mean|53.8|53.8|Standard Deviation|6.8|6.8|||
3952330|NCT01342471|3774122|B1|||Age||years|Mean|50.2|50.2|Standard Deviation|9.8|9.8|||
3952331|NCT01342471|3774120|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3952332|NCT01342471|3774121|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3952333|NCT01342471|3774122|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3952334|NCT01342471|3774120|B3||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3952335|NCT01342471|3774121|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3952336|NCT01342471|3774122|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3952337|NCT01342471|3774120|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952338|NCT01342471|3774121|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952339|NCT01342471|3774122|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952340|NCT01342458|3774137|B3|Brazil||Region of Enrollment||participants|Number|56|56.0||||||
3952341|NCT01342458|3774138|B2|Brazil||Region of Enrollment||participants|Number|28|28.0||||||
3952342|NCT01342458|3774139|B1|Brazil||Region of Enrollment||participants|Number|28|28.0||||||
3952343|NCT01342458|3774137|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3952344|NCT01342458|3774138|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3952345|NCT01342458|3774139|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3952346|NCT01342458|3774137|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3952347|NCT01342458|3774138|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3952348|NCT01342458|3774139|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3952349|NCT01342458|3774137|B3|||Age||years|Mean|66|66.0|Standard Deviation|5|5.0|||
3952350|NCT01342458|3774138|B2|||Age||years|Mean|66|66.0|Standard Deviation|6|6.0|||
3952351|NCT01342458|3774139|B1|||Age||years|Mean|66|66.0|Standard Deviation|5|5.0|||
3952352|NCT01342458|3774137|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3952353|NCT01342458|3774138|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3952354|NCT01342458|3774139|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3952355|NCT01342458|3774137|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3952356|NCT01342458|3774138|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3952357|NCT01342458|3774139|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3952358|NCT01342458|3774137|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952359|NCT01342458|3774138|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952360|NCT01342458|3774139|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952361|NCT01342445|3774160|B3|Training program or certificate||Mother's level of education||participants|Number|2|2.0||||||
3952362|NCT01342445|3774161|B2|Training program or certificate||Mother's level of education||participants|Number|2|2.0||||||
3952363|NCT01342445|3774162|B1|Training program or certificate||Mother's level of education||participants|Number|0|0.0||||||
3952364|NCT01342445|3774160|B3|Graduate degree||Mother's level of education||participants|Number|15|15.0||||||
3952365|NCT01342445|3774161|B2|Graduate degree||Mother's level of education||participants|Number|9|9.0||||||
3952366|NCT01342445|3774162|B1|Graduate degree||Mother's level of education||participants|Number|6|6.0||||||
3952367|NCT01342445|3774160|B3|Bachelor's degree||Mother's level of education||participants|Number|17|17.0||||||
3952368|NCT01342445|3774161|B2|Bachelor's degree||Mother's level of education||participants|Number|8|8.0||||||
3952369|NCT01342445|3774162|B1|Bachelor's degree||Mother's level of education||participants|Number|9|9.0||||||
3952370|NCT01342445|3774160|B3|Some college||Mother's level of education||participants|Number|9|9.0||||||
3952371|NCT01342445|3774161|B2|Some college||Mother's level of education||participants|Number|4|4.0||||||
3952372|NCT01342445|3774162|B1|Some college||Mother's level of education||participants|Number|5|5.0||||||
3952373|NCT01342445|3774160|B3|HS diploma or equivalent||Mother's level of education||participants|Number|6|6.0||||||
3952374|NCT01342445|3774161|B2|HS diploma or equivalent||Mother's level of education||participants|Number|3|3.0||||||
3952375|NCT01342445|3774162|B1|HS diploma or equivalent||Mother's level of education||participants|Number|3|3.0||||||
3952376|NCT01342445|3774160|B3|Less than high school (HS)||Mother's level of education||participants|Number|1|1.0||||||
3952377|NCT01342445|3774161|B2|Less than high school (HS)||Mother's level of education||participants|Number|0|0.0||||||
3952378|NCT01342445|3774162|B1|Less than high school (HS)||Mother's level of education||participants|Number|1|1.0||||||
3952379|NCT01342445|3774160|B3|Training program or certificate||Father's level of education||participants|Number|1|1.0||||||
3952380|NCT01342445|3774161|B2|Training program or certificate||Father's level of education||participants|Number|1|1.0||||||
3952381|NCT01342445|3774162|B1|Training program or certificate||Father's level of education||participants|Number|0|0.0||||||
3952382|NCT01342445|3774160|B3|Graduate degree||Father's level of education||participants|Number|14|14.0||||||
3952383|NCT01342445|3774161|B2|Graduate degree||Father's level of education||participants|Number|9|9.0||||||
3952384|NCT01342445|3774162|B1|Graduate degree||Father's level of education||participants|Number|5|5.0||||||
3952385|NCT01342445|3774160|B3|Bachelor's degree||Father's level of education||participants|Number|18|18.0||||||
3952386|NCT01342445|3774161|B2|Bachelor's degree||Father's level of education||participants|Number|7|7.0||||||
3952387|NCT01342445|3774162|B1|Bachelor's degree||Father's level of education||participants|Number|11|11.0||||||
3952388|NCT01342445|3774160|B3|Some college||Father's level of education||participants|Number|5|5.0||||||
3952389|NCT01342445|3774161|B2|Some college||Father's level of education||participants|Number|3|3.0||||||
3952390|NCT01342445|3774162|B1|Some college||Father's level of education||participants|Number|2|2.0||||||
3952391|NCT01342445|3774160|B3|HS diploma or equivalent||Father's level of education||participants|Number|12|12.0||||||
3952392|NCT01342445|3774161|B2|HS diploma or equivalent||Father's level of education||participants|Number|6|6.0||||||
3952393|NCT01342445|3774162|B1|HS diploma or equivalent||Father's level of education||participants|Number|6|6.0||||||
3952394|NCT01342445|3774160|B3|Less than high school (HS)||Father's level of education||participants|Number|0|0.0||||||
3952395|NCT01342445|3774161|B2|Less than high school (HS)||Father's level of education||participants|Number|0|0.0||||||
3952396|NCT01342445|3774162|B1|Less than high school (HS)||Father's level of education||participants|Number|0|0.0||||||
3952397|NCT01342445|3774160|B3|Senior||Year in College||participants|Number|18|18.0||||||
3952398|NCT01342445|3774161|B2|Senior||Year in College||participants|Number|8|8.0||||||
3952399|NCT01342445|3774162|B1|Senior||Year in College||participants|Number|10|10.0||||||
3952400|NCT01342445|3774160|B3|Junior||Year in College||participants|Number|11|11.0||||||
3952401|NCT01342445|3774161|B2|Junior||Year in College||participants|Number|7|7.0||||||
3952402|NCT01342445|3774162|B1|Junior||Year in College||participants|Number|4|4.0||||||
3952403|NCT01342445|3774160|B3|Sophomore||Year in College||participants|Number|13|13.0||||||
3952404|NCT01342445|3774161|B2|Sophomore||Year in College||participants|Number|6|6.0||||||
3952405|NCT01342445|3774162|B1|Sophomore||Year in College||participants|Number|7|7.0||||||
3952406|NCT01342445|3774160|B3|Freshman||Year in College||participants|Number|8|8.0||||||
3952407|NCT01342445|3774161|B2|Freshman||Year in College||participants|Number|5|5.0||||||
3952408|NCT01342445|3774162|B1|Freshman||Year in College||participants|Number|3|3.0||||||
3952409|NCT01342445|3774160|B3|||BRIEF|The BRIEF was converted to a T score with a mean of 50 and a standard deviation of 10. Higher scores represent poorer levels of functioning.|T score|Mean|54.86|54.86|Standard Deviation|NA||||The standard deviation was not prespecified to be calculated for the total sample.
3952410|NCT01342445|3774161|B2|||BRIEF|The BRIEF was converted to a T score with a mean of 50 and a standard deviation of 10. Higher scores represent poorer levels of functioning.|T score|Mean|44.31|44.31|Standard Deviation|7.62|7.62|||
3952411|NCT01342445|3774162|B1|||BRIEF|The BRIEF was converted to a T score with a mean of 50 and a standard deviation of 10. Higher scores represent poorer levels of functioning.|T score|Mean|65.41|65.41|Standard Deviation|11.661|11.661|||
3952412|NCT01342445|3774160|B3|||Conners Adult Rating Scale|The Conners was converted to a T score with a mean of 50 and standard deviation of 10. Higher scores represent more severe ADHD symptoms.|T score|Mean|47.08|47.08|Standard Deviation|NA||||The standard deviation was not pre-specified to be calculated.
3952413|NCT01342445|3774161|B2|||Conners Adult Rating Scale|The Conners was converted to a T score with a mean of 50 and standard deviation of 10. Higher scores represent more severe ADHD symptoms.|T score|Mean|36.12|36.12|Standard Deviation|4.98|4.98|||
3952414|NCT01342445|3774162|B1|||Conners Adult Rating Scale|The Conners was converted to a T score with a mean of 50 and standard deviation of 10. Higher scores represent more severe ADHD symptoms.|T score|Mean|58.04|58.04|Standard Deviation|7.51|7.51|||
3952415|NCT01342445|3774160|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3952416|NCT01342445|3774161|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
3952417|NCT01342445|3774162|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3952418|NCT01342445|3774160|B3|Indian||Race/Ethnicity, Customized|Not all ethnicity categories are covered, and a participant may be counted in more than one ethnicity|participants|Number|1|1.0||||||
3952419|NCT01342445|3774161|B2|Indian||Race/Ethnicity, Customized|Not all ethnicity categories are covered, and a participant may be counted in more than one ethnicity|participants|Number|1|1.0||||||
3952420|NCT01342445|3774162|B1|Indian||Race/Ethnicity, Customized|Not all ethnicity categories are covered, and a participant may be counted in more than one ethnicity|participants|Number|0|0.0||||||
3952421|NCT01342445|3774160|B3|Asian/Pacific Islander||Race/Ethnicity, Customized|Not all ethnicity categories are covered, and a participant may be counted in more than one ethnicity|participants|Number|2|2.0||||||
3952422|NCT01342445|3774161|B2|Asian/Pacific Islander||Race/Ethnicity, Customized|Not all ethnicity categories are covered, and a participant may be counted in more than one ethnicity|participants|Number|1|1.0||||||
3952423|NCT01342445|3774162|B1|Asian/Pacific Islander||Race/Ethnicity, Customized|Not all ethnicity categories are covered, and a participant may be counted in more than one ethnicity|participants|Number|1|1.0||||||
3952424|NCT01342445|3774160|B3|Hispanic||Race/Ethnicity, Customized|Not all ethnicity categories are covered, and a participant may be counted in more than one ethnicity|participants|Number|3|3.0||||||
3952425|NCT01342445|3774161|B2|Hispanic||Race/Ethnicity, Customized|Not all ethnicity categories are covered, and a participant may be counted in more than one ethnicity|participants|Number|3|3.0||||||
3952426|NCT01342445|3774162|B1|Hispanic||Race/Ethnicity, Customized|Not all ethnicity categories are covered, and a participant may be counted in more than one ethnicity|participants|Number|0|0.0||||||
3952427|NCT01342445|3774160|B3|African American||Race/Ethnicity, Customized|Not all ethnicity categories are covered, and a participant may be counted in more than one ethnicity|participants|Number|1|1.0||||||
3952428|NCT01342445|3774161|B2|African American||Race/Ethnicity, Customized|Not all ethnicity categories are covered, and a participant may be counted in more than one ethnicity|participants|Number|0|0.0||||||
3952429|NCT01342445|3774162|B1|African American||Race/Ethnicity, Customized|Not all ethnicity categories are covered, and a participant may be counted in more than one ethnicity|participants|Number|1|1.0||||||
3952430|NCT01342445|3774160|B3|White non-Hispanic||Race/Ethnicity, Customized|Not all ethnicity categories are covered, and a participant may be counted in more than one ethnicity|participants|Number|43|43.0||||||
3952431|NCT01342445|3774161|B2|White non-Hispanic||Race/Ethnicity, Customized|Not all ethnicity categories are covered, and a participant may be counted in more than one ethnicity|participants|Number|21|21.0||||||
3952432|NCT01342445|3774162|B1|White non-Hispanic||Race/Ethnicity, Customized|Not all ethnicity categories are covered, and a participant may be counted in more than one ethnicity|participants|Number|22|22.0||||||
3952433|NCT01342445|3774160|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3952434|NCT01342445|3774161|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3952435|NCT01342445|3774162|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3952436|NCT01342445|3774160|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3952437|NCT01342445|3774161|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3952438|NCT01342445|3774162|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3952439|NCT01342445|3774160|B3|||Age||years|Mean|20.17|20.17|Standard Deviation|1.2|1.2|||
3952440|NCT01342445|3774161|B2|||Age||years|Mean|20|20.0|Standard Deviation|1.1|1.1|||
3952441|NCT01342445|3774162|B1|||Age||years|Mean|20.17|20.17|Standard Deviation|1.2|1.2|||
3952442|NCT01342445|3774160|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3952443|NCT01342445|3774161|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3952444|NCT01342445|3774162|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3952445|NCT01342445|3774160|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3952446|NCT01342445|3774161|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3952447|NCT01342445|3774162|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3952448|NCT01342445|3774160|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952449|NCT01342445|3774161|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952450|NCT01342445|3774162|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952451|NCT01342341|3774177|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3952452|NCT01342341|3774178|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3952453|NCT01342341|3774179|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3952454|NCT01342341|3774177|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3952455|NCT01342341|3774178|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3952456|NCT01342341|3774179|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3952457|NCT01342341|3774177|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3952458|NCT01342341|3774178|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3952459|NCT01342341|3774179|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3952460|NCT01342341|3774177|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3952461|NCT01342341|3774178|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3952462|NCT01342341|3774179|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3952463|NCT01342341|3774177|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952464|NCT01342341|3774178|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952465|NCT01342341|3774179|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952466|NCT01342211|3774186|B6||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3952467|NCT01342211|3774187|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3952468|NCT01342211|3774188|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3952469|NCT01342211|3774189|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3952470|NCT01342211|3774190|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3952471|NCT01342211|3774191|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3952472|NCT01342211|3774186|B6||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3952473|NCT01342211|3774187|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3952474|NCT01342211|3774188|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3952475|NCT01342211|3774189|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3952476|NCT01342211|3774190|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3952477|NCT01342211|3774191|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3952478|NCT01342211|3774186|B6|||Age||years|Mean|58.4|58.4|Standard Deviation|9.9|9.9|||
3952479|NCT01342211|3774187|B5|||Age||years|Mean|60.8|60.8|Standard Deviation|5.7|5.7|||
3952480|NCT01342211|3774188|B4|||Age||years|Mean|58.0|58.0|Standard Deviation|10.6|10.6|||
3952481|NCT01342211|3774189|B3|||Age||years|Mean|56.3|56.3|Standard Deviation|9.1|9.1|||
3952482|NCT01342211|3774190|B2|||Age||years|Mean|57.9|57.9|Standard Deviation|10.3|10.3|||
3952483|NCT01342211|3774191|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|12.4|12.4|||
3952484|NCT01342172|3774261|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3952485|NCT01342172|3774261|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3952486|NCT01342172|3774261|B1|||Age||years|Median|69|69.0|Full Range|||44.0|81.0|
3952487|NCT01342107|3774265|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3952488|NCT01342107|3774266|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3952489|NCT01342107|3774267|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3952490|NCT01342107|3774265|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3952491|NCT01342107|3774266|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3952492|NCT01342107|3774267|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3952493|NCT01342107|3774265|B3|||Age||years|Mean|36.9|36.9|Standard Deviation|11.47|11.47|||
3952494|NCT01342107|3774266|B2|||Age||years|Mean|37.3|37.3|Standard Deviation|12.34|12.34|||
3952495|NCT01342107|3774267|B1|||Age||years|Mean|36.6|36.6|Standard Deviation|10.76|10.76|||
3952496|NCT01342094|3774274|B3|Japan||Region of Enrollment||participants|Number|166|166.0||||||
3952497|NCT01342094|3774275|B2|Japan||Region of Enrollment||participants|Number|84|84.0||||||
3952498|NCT01342094|3774276|B1|Japan||Region of Enrollment||participants|Number|82|82.0||||||
3952499|NCT01342094|3774274|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3952500|NCT01342094|3774275|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3952501|NCT01342094|3774276|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3952502|NCT01342094|3774274|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3952503|NCT01342094|3774275|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3952504|NCT01342094|3774276|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3952505|NCT01342094|3774274|B3|||Age||years|Mean|62.4|62.4|Standard Deviation|11.9|11.9|||
3952506|NCT01342094|3774275|B2|||Age||years|Mean|63.1|63.1|Standard Deviation|12.4|12.4|||
3952507|NCT01342094|3774276|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|11.4|11.4|||
3952508|NCT01342094|3774274|B3||>=65 years|Age||Participants|Count of Participants|85|85.0||||||
3952509|NCT01342094|3774275|B2||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
3952510|NCT01342094|3774276|B1||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
3952511|NCT01342094|3774274|B3||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
3952512|NCT01342094|3774275|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3952513|NCT01342094|3774276|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
3952514|NCT01342094|3774274|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952515|NCT01342094|3774275|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952516|NCT01342094|3774276|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952517|NCT01342081|3774283|B4|Japan||Region of Enrollment||participants|Number|487|487.0||||||
3952518|NCT01342081|3774284|B3|Japan||Region of Enrollment||participants|Number|163|163.0||||||
3952519|NCT01342081|3774285|B2|Japan||Region of Enrollment||participants|Number|163|163.0||||||
3952520|NCT01342081|3774286|B1|Japan||Region of Enrollment||participants|Number|161|161.0||||||
3952521|NCT01342081|3774283|B4||Male|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
3952522|NCT01342081|3774284|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3952523|NCT01342081|3774285|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3952524|NCT01342081|3774286|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3952525|NCT01342081|3774283|B4||Female|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
3952526|NCT01342081|3774284|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3952527|NCT01342081|3774285|B2||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3952528|NCT01342081|3774286|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3952529|NCT01342081|3774283|B4|||Age||years|Mean|61.7|61.7|Standard Deviation|12.7|12.7|||
3952530|NCT01342081|3774284|B3|||Age||years|Mean|60.6|60.6|Standard Deviation|13.6|13.6|||
3952531|NCT01342081|3774285|B2|||Age||years|Mean|63.0|63.0|Standard Deviation|12.6|12.6|||
3952532|NCT01342081|3774286|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|11.6|11.6|||
3952533|NCT01342081|3774283|B4||>=65 years|Age||Participants|Count of Participants|227|227.0||||||
3952534|NCT01342081|3774284|B3||>=65 years|Age||Participants|Count of Participants|76|76.0||||||
3952535|NCT01342081|3774285|B2||>=65 years|Age||Participants|Count of Participants|82|82.0||||||
3952536|NCT01342081|3774286|B1||>=65 years|Age||Participants|Count of Participants|69|69.0||||||
3952537|NCT01342081|3774283|B4||Between 18 and 65 years|Age||Participants|Count of Participants|260|260.0||||||
3952538|NCT01342081|3774284|B3||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
3952539|NCT01342081|3774285|B2||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
3952540|NCT01342081|3774286|B1||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
3952541|NCT01342081|3774283|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952542|NCT01342081|3774284|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952543|NCT01342081|3774285|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952544|NCT01342081|3774286|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952545|NCT01342029|3774296|B1|United States||Region of Enrollment||Participants|Count of Participants|142|142.0||||||
3952546|NCT01342029|3774296|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3952547|NCT01342029|3774296|B1||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3952548|NCT01342029|3774296|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|9.8|9.8|||
3952549|NCT01342029|3774296|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3952550|NCT01342029|3774296|B1||Between 18 and 65 years|Age||Participants|Count of Participants|142|142.0||||||
3952551|NCT01342029|3774296|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952552|NCT01341990|3774305|B3|United States||Region of Enrollment||participants|Number|68|68.0||||||
3952553|NCT01341990|3774306|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
3952554|NCT01341990|3774307|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3952555|NCT01341990|3774305|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3952556|NCT01341990|3774306|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3952557|NCT01341990|3774307|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3952558|NCT01341990|3774305|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3952559|NCT01341990|3774306|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3952560|NCT01341990|3774307|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3952561|NCT01341990|3774305|B3|||Age||years|Mean|43.4|43.4|Standard Deviation|10.2|10.2|||
3952562|NCT01341990|3774306|B2|||Age||years|Mean|42.8|42.8|Standard Deviation|11.2|11.2|||
3952563|NCT01341990|3774307|B1|||Age||years|Mean|43.9|43.9|Standard Deviation|9.2|9.2|||
3952564|NCT01341977|3774316|B3|United States||Region of Enrollment||participants|Number|573|573.0||||||
3952565|NCT01341977|3774317|B2|United States||Region of Enrollment||participants|Number|285|285.0||||||
3952566|NCT01341977|3774318|B1|United States||Region of Enrollment||participants|Number|288|288.0||||||
3952567|NCT01341977|3774316|B3||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3952568|NCT01341977|3774317|B2||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3952569|NCT01341977|3774318|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3952570|NCT01341977|3774316|B3||Female|Sex: Female, Male||Participants|Count of Participants|411|411.0||||||
3952571|NCT01341977|3774317|B2||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
3952572|NCT01341977|3774318|B1||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
3952573|NCT01341977|3774316|B3|||Age||years|Mean|33.9|33.9|Standard Deviation|11.0|11.0|||
3952574|NCT01341977|3774317|B2|||Age||years|Mean|33.9|33.9|Standard Deviation|11.4|11.4|||
3952575|NCT01341977|3774318|B1|||Age||years|Mean|34|34.0|Standard Deviation|10.7|10.7|||
3952576|NCT01341977|3774316|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3952577|NCT01341977|3774317|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3952578|NCT01341977|3774318|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3952579|NCT01341977|3774316|B3||Between 18 and 65 years|Age||Participants|Count of Participants|536|536.0||||||
3952580|NCT01341977|3774317|B2||Between 18 and 65 years|Age||Participants|Count of Participants|257|257.0||||||
3952581|NCT01341977|3774318|B1||Between 18 and 65 years|Age||Participants|Count of Participants|279|279.0||||||
3952582|NCT01341977|3774316|B3||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
3952583|NCT01341977|3774317|B2||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
3952584|NCT01341977|3774318|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
3952585|NCT01341912|3774325|B1|Bulgaria||Region of Enrollment||participants|Number|3|3.0||||||
3952586|NCT01341912|3774325|B1|United States||Region of Enrollment||participants|Number|0|0.0||||||
3952587|NCT01341912|3774325|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3952588|NCT01341912|3774325|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3952589|NCT01341912|3774325|B1|||Age||years|Mean|52|52.0|Standard Deviation|12.29|12.29|||
3952590|NCT01341912|3774325|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3952591|NCT01341912|3774325|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3952592|NCT01341912|3774325|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952593|NCT01341782|3774330|B3|||Intact parathyroid hormone level||pg/mL|Mean|526.3|526.3|Standard Deviation|204.03|204.03|||
3952594|NCT01341782|3774331|B2|||Intact parathyroid hormone level||pg/mL|Mean|527.1|527.1|Standard Deviation|203.33|203.33|||
3952595|NCT01341782|3774332|B1|||Intact parathyroid hormone level||pg/mL|Mean|525.4|525.4|Standard Deviation|205.55|205.55|||
3952596|NCT01341782|3774330|B3|||Duration of hemodialysis||years|Mean|8.6|8.6|Standard Deviation|7.12|7.12|||
3952597|NCT01341782|3774331|B2|||Duration of hemodialysis||years|Mean|8.9|8.9|Standard Deviation|7.50|7.5|||
3952598|NCT01341782|3774332|B1|||Duration of hemodialysis||years|Mean|8.4|8.4|Standard Deviation|6.73|6.73|||
3952599|NCT01341782|3774330|B3|Japan||Region of Enrollment||participants|Number|255|255.0||||||
3952600|NCT01341782|3774331|B2|Japan||Region of Enrollment||participants|Number|128|128.0||||||
3952601|NCT01341782|3774332|B1|Japan||Region of Enrollment||participants|Number|127|127.0||||||
3952602|NCT01341782|3774330|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3952603|NCT01341782|3774331|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3952604|NCT01341782|3774332|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3952605|NCT01341782|3774330|B3|Asian||Race/Ethnicity, Customized||participants|Number|255|255.0||||||
3952606|NCT01341782|3774331|B2|Asian||Race/Ethnicity, Customized||participants|Number|128|128.0||||||
3952607|NCT01341782|3774332|B1|Asian||Race/Ethnicity, Customized||participants|Number|127|127.0||||||
3952608|NCT01341782|3774330|B3||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3952609|NCT01341782|3774331|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3952610|NCT01341782|3774332|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3952611|NCT01341782|3774330|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3952612|NCT01341782|3774331|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3952613|NCT01341782|3774332|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3952614|NCT01341782|3774330|B3|||Age||years|Mean|61.6|61.6|Standard Deviation|11.85|11.85|||
3952615|NCT01341782|3774331|B2|||Age||years|Mean|61.6|61.6|Standard Deviation|12.46|12.46|||
3952616|NCT01341782|3774332|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|11.24|11.24|||
3952617|NCT01341600|3774349|B4|United States||Region of Enrollment||participants|Number|18|18.0||||||
3952618|NCT01341600|3774350|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3952619|NCT01341600|3774351|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3952620|NCT01341600|3774352|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3952621|NCT01341600|3774349|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3952622|NCT01341600|3774350|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3952623|NCT01341600|3774351|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3952624|NCT01341600|3774352|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3952625|NCT01341600|3774349|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3952626|NCT01341600|3774350|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3952627|NCT01341600|3774351|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3952628|NCT01341600|3774352|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3952629|NCT01341600|3774349|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3952630|NCT01341600|3774350|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3952631|NCT01341600|3774351|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3952632|NCT01341600|3774352|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3952633|NCT01341600|3774349|B4||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3952634|NCT01341600|3774350|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3952635|NCT01341600|3774351|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3952636|NCT01341600|3774352|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3952637|NCT01341600|3774349|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952638|NCT01341600|3774350|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952639|NCT01341600|3774351|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952640|NCT01341600|3774352|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952641|NCT01341587|3774371|B3|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3952642|NCT01341587|3774372|B2|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3952643|NCT01341587|3774373|B1|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3952644|NCT01341587|3774371|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952645|NCT01341587|3774372|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952646|NCT01341587|3774373|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952647|NCT01341587|3774371|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952648|NCT01341587|3774372|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952649|NCT01341587|3774373|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952650|NCT01341587|3774371|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3952651|NCT01341587|3774372|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3952652|NCT01341587|3774373|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952653|NCT01341587|3774371|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3952654|NCT01341587|3774372|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3952655|NCT01341587|3774373|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3952656|NCT01341587|3774371|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952657|NCT01341587|3774372|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952658|NCT01341587|3774373|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952659|NCT01341587|3774371|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952660|NCT01341587|3774372|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952661|NCT01341587|3774373|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952662|NCT01341587|3774371|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952663|NCT01341587|3774372|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952664|NCT01341587|3774373|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952665|NCT01341587|3774371|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3952666|NCT01341587|3774372|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3952667|NCT01341587|3774373|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3952668|NCT01341587|3774371|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3952669|NCT01341587|3774372|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3952670|NCT01341587|3774373|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3952671|NCT01341587|3774371|B3|||Age||years|Mean|52.3|52.3|Standard Deviation|14.1|14.1|||
3952672|NCT01341587|3774372|B2|||Age||years|Mean|52.8|52.8|Standard Deviation|13.4|13.4|||
3952673|NCT01341587|3774373|B1|||Age||years|Mean|51.3|51.3|Standard Deviation|18|18.0|||
3952674|NCT01341444|3774380|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952675|NCT01341444|3774381|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952676|NCT01341444|3774382|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952677|NCT01341444|3774380|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952678|NCT01341444|3774381|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952679|NCT01341444|3774382|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952680|NCT01341444|3774380|B3||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3952681|NCT01341444|3774381|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3952682|NCT01341444|3774382|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3952683|NCT01341444|3774380|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3952684|NCT01341444|3774381|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3952685|NCT01341444|3774382|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3952686|NCT01341444|3774380|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952687|NCT01341444|3774381|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952688|NCT01341444|3774382|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952689|NCT01341444|3774380|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3952690|NCT01341444|3774381|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3952691|NCT01341444|3774382|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3952692|NCT01341444|3774380|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3952693|NCT01341444|3774381|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3952694|NCT01341444|3774382|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952695|NCT01341444|3774380|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952696|NCT01341444|3774381|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952697|NCT01341444|3774382|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952698|NCT01341444|3774380|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3952699|NCT01341444|3774381|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3952700|NCT01341444|3774382|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3952701|NCT01341444|3774380|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3952702|NCT01341444|3774381|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3952703|NCT01341444|3774382|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3952704|NCT01341444|3774380|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3952705|NCT01341444|3774381|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3952706|NCT01341444|3774382|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3952707|NCT01341444|3774380|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3952708|NCT01341444|3774381|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3952709|NCT01341444|3774382|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3952710|NCT01341444|3774380|B3|||Age||years|Mean|50.25|50.25|Standard Deviation|11.76|11.76|||
3952711|NCT01341444|3774381|B2|||Age||years|Mean|51.75|51.75|Standard Deviation|12.19|12.19|||
3952712|NCT01341444|3774382|B1|||Age||years|Mean|48.71|48.71|Standard Deviation|11.29|11.29|||
3952713|NCT01341301|3774389|B1|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3952714|NCT01341301|3774389|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3952715|NCT01341301|3774389|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952716|NCT01341301|3774389|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3952717|NCT01341301|3774389|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3952718|NCT01341301|3774389|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952719|NCT01341301|3774389|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3952720|NCT01341301|3774389|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952721|NCT01341301|3774389|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3952722|NCT01341301|3774389|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3952723|NCT01341301|3774389|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3952724|NCT01341301|3774389|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3952725|NCT01341301|3774389|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3952726|NCT01341301|3774389|B1|||Age||years|Mean|51.5|51.5|Standard Deviation|13.6|13.6|||
3952727|NCT01341301|3774389|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3952728|NCT01341301|3774389|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3952729|NCT01341301|3774389|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952730|NCT01341067|3774396|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3952731|NCT01341067|3774396|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3952732|NCT01341067|3774396|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3952733|NCT01341067|3774396|B1|||Age||years|Mean|58|58.0|Standard Deviation|12.4|12.4|||
3952734|NCT01341067|3774396|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3952735|NCT01341067|3774396|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3952736|NCT01341067|3774396|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952737|NCT01340976|3774403|B7|United States||Region of Enrollment||participants|Number|33|33.0||||||
3952738|NCT01340976|3774404|B6|United States||Region of Enrollment||participants|Number|7|7.0||||||
3952739|NCT01340976|3774405|B5|United States||Region of Enrollment||participants|Number|7|7.0||||||
3952740|NCT01340976|3774406|B4|United States||Region of Enrollment||participants|Number|5|5.0||||||
3952741|NCT01340976|3774407|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
3952742|NCT01340976|3774408|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3952743|NCT01340976|3774409|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3952744|NCT01340976|3774403|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952745|NCT01340976|3774404|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952746|NCT01340976|3774405|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952747|NCT01340976|3774406|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952748|NCT01340976|3774407|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952749|NCT01340976|3774408|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952750|NCT01340976|3774409|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952751|NCT01340976|3774403|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952752|NCT01340976|3774404|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952753|NCT01340976|3774405|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952754|NCT01340976|3774406|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952755|NCT01340976|3774407|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952756|NCT01340976|3774408|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952757|NCT01340976|3774409|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952758|NCT01340976|3774403|B7||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3952759|NCT01340976|3774404|B6||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3952760|NCT01340976|3774405|B5||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3952761|NCT01340976|3774406|B4||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3952762|NCT01340976|3774407|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3952763|NCT01340976|3774408|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3952764|NCT01340976|3774409|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3952765|NCT01340976|3774403|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3952766|NCT01340976|3774404|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3952767|NCT01340976|3774405|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3952768|NCT01340976|3774406|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3952769|NCT01340976|3774407|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3952770|NCT01340976|3774408|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952771|NCT01340976|3774409|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952772|NCT01340976|3774403|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952773|NCT01340976|3774404|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952774|NCT01340976|3774405|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952775|NCT01340976|3774406|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952776|NCT01340976|3774407|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952777|NCT01340976|3774408|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952778|NCT01340976|3774409|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952779|NCT01340976|3774403|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3952780|NCT01340976|3774404|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952781|NCT01340976|3774405|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952782|NCT01340976|3774406|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3952783|NCT01340976|3774407|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952784|NCT01340976|3774408|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952785|NCT01340976|3774409|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952786|NCT01340976|3774403|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952787|NCT01340976|3774404|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952788|NCT01340976|3774405|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952789|NCT01340976|3774406|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952790|NCT01340976|3774407|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952791|NCT01340976|3774408|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952792|NCT01340976|3774409|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952793|NCT01340976|3774403|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952794|NCT01340976|3774404|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952795|NCT01340976|3774405|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952796|NCT01340976|3774406|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952797|NCT01340976|3774407|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952798|NCT01340976|3774408|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952799|NCT01340976|3774409|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952800|NCT01340976|3774403|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3952801|NCT01340976|3774404|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3952802|NCT01340976|3774405|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3952803|NCT01340976|3774406|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3952804|NCT01340976|3774407|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3952805|NCT01340976|3774408|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3952806|NCT01340976|3774409|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3952807|NCT01340976|3774403|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3952808|NCT01340976|3774404|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952809|NCT01340976|3774405|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3952810|NCT01340976|3774406|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952811|NCT01340976|3774407|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952812|NCT01340976|3774408|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952813|NCT01340976|3774409|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3952814|NCT01340976|3774403|B7||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3952815|NCT01340976|3774404|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3952816|NCT01340976|3774405|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3952817|NCT01340976|3774406|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3952818|NCT01340976|3774407|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3952819|NCT01340976|3774408|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3952820|NCT01340976|3774409|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3952821|NCT01340976|3774403|B7||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3952822|NCT01340976|3774404|B6||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3952823|NCT01340976|3774405|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3952824|NCT01340976|3774406|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3952825|NCT01340976|3774407|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3952826|NCT01340976|3774408|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3952827|NCT01340976|3774409|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3952828|NCT01340976|3774403|B7|||Age||years|Mean|64.9|64.9|Standard Deviation|10.0|10.0|||
3952829|NCT01340976|3774404|B6|||Age||years|Mean|62.7|62.7|Standard Deviation|7.5|7.5|||
3952830|NCT01340976|3774405|B5|||Age||years|Mean|66.3|66.3|Standard Deviation|9.2|9.2|||
3952831|NCT01340976|3774406|B4|||Age||years|Mean|63.2|63.2|Standard Deviation|7.9|7.9|||
3952832|NCT01340976|3774407|B3|||Age||years|Mean|62.1|62.1|Standard Deviation|13.4|13.4|||
3952833|NCT01340976|3774408|B2|||Age||years|Mean|76.7|76.7|Standard Deviation|12.7|12.7|||
3952834|NCT01340976|3774409|B1|||Age||years|Mean|64.5|64.5|Standard Deviation|7.3|7.3|||
3952835|NCT01340937|3774448|B5||Male|Sex: Female, Male||Participants|Count of Participants|1470|1470.0||||||
3952836|NCT01340937|3774449|B4||Male|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
3952837|NCT01340937|3774450|B3||Male|Sex: Female, Male||Participants|Count of Participants|429|429.0||||||
3952838|NCT01340937|3774451|B2||Male|Sex: Female, Male||Participants|Count of Participants|431|431.0||||||
3952839|NCT01340937|3774452|B1||Male|Sex: Female, Male||Participants|Count of Participants|423|423.0||||||
3952840|NCT01340937|3774448|B5||Female|Sex: Female, Male||Participants|Count of Participants|1338|1338.0||||||
3952841|NCT01340937|3774449|B4||Female|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
3952842|NCT01340937|3774450|B3||Female|Sex: Female, Male||Participants|Count of Participants|380|380.0||||||
3952843|NCT01340937|3774451|B2||Female|Sex: Female, Male||Participants|Count of Participants|366|366.0||||||
3952844|NCT01340937|3774452|B1||Female|Sex: Female, Male||Participants|Count of Participants|377|377.0||||||
3952845|NCT01340937|3774448|B5|||Age||Days|Mean|64.5|64.5|Standard Deviation|6.5|6.5|||
3952846|NCT01340937|3774449|B4|||Age||Days|Mean|64.3|64.3|Standard Deviation|6.6|6.6|||
3952847|NCT01340937|3774450|B3|||Age||Days|Mean|64.7|64.7|Standard Deviation|6.6|6.6|||
3952848|NCT01340937|3774451|B2|||Age||Days|Mean|64.4|64.4|Standard Deviation|6.2|6.2|||
3952849|NCT01340937|3774452|B1|||Age||Days|Mean|64.6|64.6|Standard Deviation|6.7|6.7|||
3952850|NCT01340872|3774612|B3|||Simple Clinical Colitis Activity Index (SCCAI) score at baseline|"Simple Clinical Colitis Activity Index (SCCAI) score at baseline (randomisation) of the 12-week double-blind phase (in participants with UC).~The SCCAI is a diagnostic and research questionnaire used to assess the severity of symptoms in people who suffer from UC. The calculated score ranges from 0 to 19, where active disease is a score of 5 or higher.~The score is determined by asking the person with UC questions regarding:~bowel frequency at day/night~urgency of defecation~blood in stool~general health~extracolonic manifestations"|score on a scale|Mean|1.6|1.6|Full Range|||0.0|3.0|
3952851|NCT01340872|3774613|B2|||Simple Clinical Colitis Activity Index (SCCAI) score at baseline|"Simple Clinical Colitis Activity Index (SCCAI) score at baseline (randomisation) of the 12-week double-blind phase (in participants with UC).~The SCCAI is a diagnostic and research questionnaire used to assess the severity of symptoms in people who suffer from UC. The calculated score ranges from 0 to 19, where active disease is a score of 5 or higher.~The score is determined by asking the person with UC questions regarding:~bowel frequency at day/night~urgency of defecation~blood in stool~general health~extracolonic manifestations"|score on a scale|Mean|1.4|1.4|Full Range|||0.0|3.0|
3952852|NCT01340872|3774614|B1|||Simple Clinical Colitis Activity Index (SCCAI) score at baseline|"Simple Clinical Colitis Activity Index (SCCAI) score at baseline (randomisation) of the 12-week double-blind phase (in participants with UC).~The SCCAI is a diagnostic and research questionnaire used to assess the severity of symptoms in people who suffer from UC. The calculated score ranges from 0 to 19, where active disease is a score of 5 or higher.~The score is determined by asking the person with UC questions regarding:~bowel frequency at day/night~urgency of defecation~blood in stool~general health~extracolonic manifestations"|score on a scale|Mean|1.8|1.8|Full Range|||0.0|3.0|
3952853|NCT01340872|3774612|B3|||Irritable Bowel Disease Questionnaire (IBDQ) score at baseline|"Irritable Bowel Disease Questionnaire (IBDQ) score at baseline (randomisation) of the 12 week double-blind phase.~The IBDQ was developed as an activity index for determining the effect of Ulcerative Colitis symptoms on perceived quality of life. It is a 32-item questionnaire with four dimensions: bowel function, emotional status, systemic symptoms and social function. Total IBDQ score ranges from 32 to 224, with higher scores indicating better quality of life. The score of patients in remission usually is between 170 and 190."|score on a scale|Mean|173.02|173.02|Standard Deviation|32.23|32.23|||
3952854|NCT01340872|3774613|B2|||Irritable Bowel Disease Questionnaire (IBDQ) score at baseline|"Irritable Bowel Disease Questionnaire (IBDQ) score at baseline (randomisation) of the 12 week double-blind phase.~The IBDQ was developed as an activity index for determining the effect of Ulcerative Colitis symptoms on perceived quality of life. It is a 32-item questionnaire with four dimensions: bowel function, emotional status, systemic symptoms and social function. Total IBDQ score ranges from 32 to 224, with higher scores indicating better quality of life. The score of patients in remission usually is between 170 and 190."|score on a scale|Mean|171.0|171.0|Standard Deviation|33.56|33.56|||
3952855|NCT01340872|3774614|B1|||Irritable Bowel Disease Questionnaire (IBDQ) score at baseline|"Irritable Bowel Disease Questionnaire (IBDQ) score at baseline (randomisation) of the 12 week double-blind phase.~The IBDQ was developed as an activity index for determining the effect of Ulcerative Colitis symptoms on perceived quality of life. It is a 32-item questionnaire with four dimensions: bowel function, emotional status, systemic symptoms and social function. Total IBDQ score ranges from 32 to 224, with higher scores indicating better quality of life. The score of patients in remission usually is between 170 and 190."|score on a scale|Mean|175.0|175.0|Standard Deviation|30.92|30.92|||
3952856|NCT01340872|3774612|B3|||TSAT% at baseline|TSAT% (transferrin saturation %) at baseline of the 12 week double-blind phase|percentage|Mean|10.05|10.05|Standard Deviation|9.6|9.6|||
3952857|NCT01340872|3774613|B2|||TSAT% at baseline|TSAT% (transferrin saturation %) at baseline of the 12 week double-blind phase|percentage|Mean|9.5|9.5|Standard Deviation|7.5|7.5|||
3952858|NCT01340872|3774614|B1|||TSAT% at baseline|TSAT% (transferrin saturation %) at baseline of the 12 week double-blind phase|percentage|Mean|10.6|10.6|Standard Deviation|11.7|11.7|||
3952859|NCT01340872|3774612|B3|||Serum Ferritin concentration at baseline|Serum Ferritin concentration at baseline of the 12 week double-blind phase|μg/L|Mean|8.4|8.4|Standard Deviation|6.6|6.6|||
3952860|NCT01340872|3774613|B2|||Serum Ferritin concentration at baseline|Serum Ferritin concentration at baseline of the 12 week double-blind phase|μg/L|Mean|8.2|8.2|Standard Deviation|6.5|6.5|||
3952861|NCT01340872|3774614|B1|||Serum Ferritin concentration at baseline|Serum Ferritin concentration at baseline of the 12 week double-blind phase|μg/L|Mean|8.6|8.6|Standard Deviation|6.8|6.8|||
3952862|NCT01340872|3774612|B3|||Haemoglobin concentration at baseline|Haemoglobin concentration at baseline of the 12 week double-blind phase|g/dL|Mean|11.05|11.05|Standard Deviation|0.93|0.93|||
3952863|NCT01340872|3774613|B2|||Haemoglobin concentration at baseline|Haemoglobin concentration at baseline of the 12 week double-blind phase|g/dL|Mean|11.1|11.1|Standard Deviation|0.85|0.85|||
3952864|NCT01340872|3774614|B1|||Haemoglobin concentration at baseline|Haemoglobin concentration at baseline of the 12 week double-blind phase|g/dL|Mean|11|11.0|Standard Deviation|1.03|1.03|||
3952865|NCT01340872|3774612|B3|||Time since last OFP dose (months)|Time since last prior oral ferrous product (OFP) dose (months)|months|Mean|34.76|34.76|Standard Deviation|41.7|41.7|||
3952866|NCT01340872|3774613|B2|||Time since last OFP dose (months)|Time since last prior oral ferrous product (OFP) dose (months)|months|Mean|33.34|33.34|Standard Deviation|44.04|44.04|||
3952867|NCT01340872|3774614|B1|||Time since last OFP dose (months)|Time since last prior oral ferrous product (OFP) dose (months)|months|Mean|36.17|36.17|Standard Deviation|40.1|40.1|||
3952868|NCT01340872|3774612|B3|||Time since last IBD flare-up (months)|Time since last IBD flare-up (months) recorded at baseline|months|Mean|23.2|23.2|Standard Deviation|48.4|48.4|||
3952869|NCT01340872|3774613|B2|||Time since last IBD flare-up (months)|Time since last IBD flare-up (months) recorded at baseline|months|Mean|21.51|21.51|Standard Deviation|38.46|38.46|||
3952870|NCT01340872|3774614|B1|||Time since last IBD flare-up (months)|Time since last IBD flare-up (months) recorded at baseline|months|Mean|24.8|24.8|Standard Deviation|59.16|59.16|||
3952871|NCT01340872|3774612|B3|||Duration of ulcerative colitis (years)|Duration of ulcerative colitis (years); for participants with UC|years|Mean|9.99|9.99|Standard Deviation|9.8|9.8|||
3952872|NCT01340872|3774613|B2|||Duration of ulcerative colitis (years)|Duration of ulcerative colitis (years); for participants with UC|years|Mean|10.99|10.99|Standard Deviation|11.43|11.43|||
3952873|NCT01340872|3774614|B1|||Duration of ulcerative colitis (years)|Duration of ulcerative colitis (years); for participants with UC|years|Mean|9.0|9.0|Standard Deviation|8.28|8.28|||
3952874|NCT01340872|3774612|B3|Austria||Region of Enrollment||participants|Number|10|10.0||||||
3952875|NCT01340872|3774613|B2|Austria||Region of Enrollment||participants|Number|6|6.0||||||
3952876|NCT01340872|3774614|B1|Austria||Region of Enrollment||participants|Number|4|4.0||||||
3952877|NCT01340872|3774612|B3|Germany||Region of Enrollment||participants|Number|67|67.0||||||
3952878|NCT01340872|3774613|B2|Germany||Region of Enrollment||participants|Number|32|32.0||||||
3952879|NCT01340872|3774614|B1|Germany||Region of Enrollment||participants|Number|35|35.0||||||
3952880|NCT01340872|3774612|B3|Hungary||Region of Enrollment||participants|Number|26|26.0||||||
3952881|NCT01340872|3774613|B2|Hungary||Region of Enrollment||participants|Number|15|15.0||||||
3952882|NCT01340872|3774614|B1|Hungary||Region of Enrollment||participants|Number|11|11.0||||||
3952883|NCT01340872|3774612|B3|United Kingdom||Region of Enrollment||participants|Number|25|25.0||||||
3952884|NCT01340872|3774613|B2|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
3952885|NCT01340872|3774614|B1|United Kingdom||Region of Enrollment||participants|Number|15|15.0||||||
3952886|NCT01340872|3774612|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3952887|NCT01340872|3774613|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3952888|NCT01340872|3774614|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3952889|NCT01340872|3774612|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3952890|NCT01340872|3774613|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3952891|NCT01340872|3774614|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3952892|NCT01340872|3774612|B3|||Age||years|Mean|39.2|39.2|Standard Deviation|12.9|12.9|||
3952893|NCT01340872|3774613|B2|||Age||years|Mean|38.5|38.5|Standard Deviation|12.3|12.3|||
3952894|NCT01340872|3774614|B1|||Age||years|Mean|40.1|40.1|Standard Deviation|13.52|13.52|||
3952895|NCT01340872|3774612|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3952896|NCT01340872|3774613|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3952897|NCT01340872|3774614|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3952898|NCT01340872|3774612|B3||Between 18 and 65 years|Age||Participants|Count of Participants|125|125.0||||||
3952899|NCT01340872|3774613|B2||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
3952900|NCT01340872|3774614|B1||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
3952901|NCT01340872|3774612|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952902|NCT01340872|3774613|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952903|NCT01340872|3774614|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952904|NCT01340794|3774675|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3952905|NCT01340794|3774676|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3952906|NCT01340794|3774677|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3952907|NCT01340794|3774675|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3952908|NCT01340794|3774676|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3952909|NCT01340794|3774677|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3952910|NCT01340794|3774675|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3952911|NCT01340794|3774676|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3952912|NCT01340794|3774677|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3952913|NCT01340794|3774675|B3|||Age||years|Median|57|57.0|Full Range|||39.0|80.0|
3952914|NCT01340794|3774676|B2|||Age||years|Median|64.5|64.5|Full Range|||53.0|80.0|
3952915|NCT01340794|3774677|B1|||Age||years|Median|42|42.0|Full Range|||39.0|45.0|
3952916|NCT01340768|3774692|B3||Male|Sex: Female, Male||Participants|Count of Participants|402|402.0||||||
3952917|NCT01340768|3774693|B2||Male|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
3952918|NCT01340768|3774694|B1||Male|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
3952919|NCT01340768|3774692|B3||Female|Sex: Female, Male||Participants|Count of Participants|446|446.0||||||
3952920|NCT01340768|3774693|B2||Female|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
3952921|NCT01340768|3774694|B1||Female|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
3952922|NCT01340768|3774692|B3|||Age||years|Mean|51.0|51.0|Full Range|||23.0|80.0|
3952923|NCT01340768|3774693|B2|||Age||years|Mean|50.7|50.7|Full Range|||23.0|78.0|
3952924|NCT01340768|3774694|B1|||Age||years|Mean|51.4|51.4|Full Range|||26.0|80.0|
3952925|NCT01340664|3774703|B4|UNITED STATES||Region Enroll||participants|Number|73|73.0||||||
3952926|NCT01340664|3774704|B3|UNITED STATES||Region Enroll||participants|Number|25|25.0||||||
3952927|NCT01340664|3774705|B2|UNITED STATES||Region Enroll||participants|Number|25|25.0||||||
3952928|NCT01340664|3774706|B1|UNITED STATES||Region Enroll||participants|Number|23|23.0||||||
3952929|NCT01340664|3774703|B4|SLOVAKIA||Region Enroll||participants|Number|30|30.0||||||
3952930|NCT01340664|3774704|B3|SLOVAKIA||Region Enroll||participants|Number|11|11.0||||||
3952931|NCT01340664|3774705|B2|SLOVAKIA||Region Enroll||participants|Number|9|9.0||||||
3952932|NCT01340664|3774706|B1|SLOVAKIA||Region Enroll||participants|Number|10|10.0||||||
3952933|NCT01340664|3774703|B4|RUSSIAN FEDERATION||Region Enroll||participants|Number|55|55.0||||||
3952934|NCT01340664|3774704|B3|RUSSIAN FEDERATION||Region Enroll||participants|Number|20|20.0||||||
3952935|NCT01340664|3774705|B2|RUSSIAN FEDERATION||Region Enroll||participants|Number|17|17.0||||||
3952936|NCT01340664|3774706|B1|RUSSIAN FEDERATION||Region Enroll||participants|Number|18|18.0||||||
3952937|NCT01340664|3774703|B4|ROMANIA||Region Enroll||participants|Number|37|37.0||||||
3952938|NCT01340664|3774704|B3|ROMANIA||Region Enroll||participants|Number|9|9.0||||||
3952939|NCT01340664|3774705|B2|ROMANIA||Region Enroll||participants|Number|15|15.0||||||
3952940|NCT01340664|3774706|B1|ROMANIA||Region Enroll||participants|Number|13|13.0||||||
3952941|NCT01340664|3774703|B4|MEXICO||Region Enroll||participants|Number|32|32.0||||||
3952942|NCT01340664|3774704|B3|MEXICO||Region Enroll||participants|Number|10|10.0||||||
3952943|NCT01340664|3774705|B2|MEXICO||Region Enroll||participants|Number|12|12.0||||||
3952944|NCT01340664|3774706|B1|MEXICO||Region Enroll||participants|Number|10|10.0||||||
3952945|NCT01340664|3774703|B4|CZECH REPUBLIC||Region Enroll||participants|Number|12|12.0||||||
3952946|NCT01340664|3774704|B3|CZECH REPUBLIC||Region Enroll||participants|Number|6|6.0||||||
3952947|NCT01340664|3774705|B2|CZECH REPUBLIC||Region Enroll||participants|Number|4|4.0||||||
3952948|NCT01340664|3774706|B1|CZECH REPUBLIC||Region Enroll||participants|Number|2|2.0||||||
3952949|NCT01340664|3774703|B4|CANADA||Region Enroll||participants|Number|40|40.0||||||
3952950|NCT01340664|3774704|B3|CANADA||Region Enroll||participants|Number|12|12.0||||||
3952951|NCT01340664|3774705|B2|CANADA||Region Enroll||participants|Number|11|11.0||||||
3952952|NCT01340664|3774706|B1|CANADA||Region Enroll||participants|Number|17|17.0||||||
3952953|NCT01340664|3774703|B4||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3952954|NCT01340664|3774704|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3952955|NCT01340664|3774705|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3952956|NCT01340664|3774706|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3952957|NCT01340664|3774703|B4||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3952958|NCT01340664|3774704|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3952959|NCT01340664|3774705|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3952960|NCT01340664|3774706|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3952961|NCT01340664|3774703|B4|||Age||years|Mean|57.4|57.4|Standard Deviation|9.53|9.53|||
3952962|NCT01340664|3774704|B3|||Age||years|Mean|56.7|56.7|Standard Deviation|10.33|10.33|||
3952963|NCT01340664|3774705|B2|||Age||years|Mean|58.6|58.6|Standard Deviation|8.88|8.88|||
3952964|NCT01340664|3774706|B1|||Age||years|Mean|57|57.0|Standard Deviation|9.32|9.32|||
3952965|NCT01340664|3774703|B4||>=65 years|Age||Participants|Count of Participants|56|56.0||||||
3952966|NCT01340664|3774704|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3952967|NCT01340664|3774705|B2||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3952968|NCT01340664|3774706|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3952969|NCT01340664|3774703|B4||Between 18 and 65 years|Age||Participants|Count of Participants|223|223.0||||||
3952970|NCT01340664|3774704|B3||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
3952971|NCT01340664|3774705|B2||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
3952972|NCT01340664|3774706|B1||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
3952973|NCT01340664|3774703|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952974|NCT01340664|3774704|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952975|NCT01340664|3774705|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952976|NCT01340664|3774706|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3952977|NCT01340651|3774725|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3952978|NCT01340651|3774725|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3952979|NCT01340651|3774725|B1|||Age||years|Mean|67.2|67.2|Standard Deviation|7.94|7.94|||
3952980|NCT01340625|3774739|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
3952981|NCT01340625|3774740|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
3952982|NCT01340625|3774741|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3952983|NCT01340625|3774739|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3952984|NCT01340625|3774740|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3952985|NCT01340625|3774741|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3952986|NCT01340625|3774739|B3|American Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3952987|NCT01340625|3774740|B2|American Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3952988|NCT01340625|3774741|B1|American Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3952989|NCT01340625|3774739|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3952990|NCT01340625|3774740|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3952991|NCT01340625|3774741|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3952992|NCT01340625|3774739|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3952993|NCT01340625|3774740|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3952994|NCT01340625|3774741|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3952995|NCT01340625|3774739|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3952996|NCT01340625|3774740|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3952997|NCT01340625|3774741|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3952998|NCT01340625|3774739|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3952999|NCT01340625|3774740|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3953000|NCT01340625|3774741|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3953001|NCT01340625|3774739|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3953002|NCT01340625|3774740|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3953003|NCT01340625|3774741|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3953004|NCT01340586|3774758|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3953005|NCT01340586|3774759|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3953006|NCT01340586|3774760|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3953007|NCT01340586|3774758|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3953008|NCT01340586|3774759|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3953009|NCT01340586|3774760|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3953010|NCT01340586|3774758|B3|||Age||years|Mean|46.9|46.9|Standard Deviation|7.5|7.5|||
3953011|NCT01340586|3774759|B2|||Age||years|Mean|46.9|46.9|Standard Deviation|7.9|7.9|||
3953012|NCT01340586|3774760|B1|||Age||years|Mean|47.0|47.0|Standard Deviation|7.7|7.7|||
3953013|NCT01340573|3774826|B1|Indonesia||Region of Enrollment||participants|Number|3|3.0||||||
3953014|NCT01340573|3774826|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3953015|NCT01340573|3774826|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3953016|NCT01340573|3774826|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3953017|NCT01340573|3774826|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3953018|NCT01340573|3774826|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3953019|NCT01340495|3774847|B1|United States||Region of Enrollment||Participants|Count of Participants|70|70.0||||||
3953020|NCT01340495|3774847|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3953021|NCT01340495|3774847|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953022|NCT01340495|3774847|B1||White|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3953023|NCT01340495|3774847|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953024|NCT01340495|3774847|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953025|NCT01340495|3774847|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3953026|NCT01340495|3774847|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953027|NCT01340495|3774847|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3953028|NCT01340495|3774847|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3953029|NCT01340495|3774847|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953030|NCT01340495|3774847|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3953031|NCT01340495|3774847|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3953032|NCT01340495|3774847|B1|||Age||years|Median|45|45.0|Full Range|||25.0|70.0|
3953033|NCT01340300|3774854|B5||Unknown|Prior Radiation Therapy||Participants|Count of Participants|5|5.0||||||
3953034|NCT01340300|3774855|B4||Unknown|Prior Radiation Therapy||Participants|Count of Participants|1|1.0||||||
3953035|NCT01340300|3774856|B3||Unknown|Prior Radiation Therapy||Participants|Count of Participants|0|0.0||||||
3953036|NCT01340300|3774857|B2||Unknown|Prior Radiation Therapy||Participants|Count of Participants|4|4.0||||||
3953037|NCT01340300|3774858|B1||Unknown|Prior Radiation Therapy||Participants|Count of Participants|0|0.0||||||
3953038|NCT01340300|3774854|B5||No|Prior Radiation Therapy||Participants|Count of Participants|71|71.0||||||
3953039|NCT01340300|3774855|B4||No|Prior Radiation Therapy||Participants|Count of Participants|17|17.0||||||
3953040|NCT01340300|3774856|B3||No|Prior Radiation Therapy||Participants|Count of Participants|21|21.0||||||
3953041|NCT01340300|3774857|B2||No|Prior Radiation Therapy||Participants|Count of Participants|15|15.0||||||
3953042|NCT01340300|3774858|B1||No|Prior Radiation Therapy||Participants|Count of Participants|18|18.0||||||
3953043|NCT01340300|3774854|B5||Yes|Prior Radiation Therapy||Participants|Count of Participants|63|63.0||||||
3953044|NCT01340300|3774855|B4||Yes|Prior Radiation Therapy||Participants|Count of Participants|16|16.0||||||
3953045|NCT01340300|3774856|B3||Yes|Prior Radiation Therapy||Participants|Count of Participants|14|14.0||||||
3953046|NCT01340300|3774857|B2||Yes|Prior Radiation Therapy||Participants|Count of Participants|16|16.0||||||
3953047|NCT01340300|3774858|B1||Yes|Prior Radiation Therapy||Participants|Count of Participants|17|17.0||||||
3953048|NCT01340300|3774854|B5||Unknown|Prior Chemotherapy||Participants|Count of Participants|5|5.0||||||
3953049|NCT01340300|3774855|B4||Unknown|Prior Chemotherapy||Participants|Count of Participants|1|1.0||||||
3953050|NCT01340300|3774856|B3||Unknown|Prior Chemotherapy||Participants|Count of Participants|0|0.0||||||
3953051|NCT01340300|3774857|B2||Unknown|Prior Chemotherapy||Participants|Count of Participants|4|4.0||||||
3953052|NCT01340300|3774858|B1||Unknown|Prior Chemotherapy||Participants|Count of Participants|0|0.0||||||
3953053|NCT01340300|3774854|B5||No|Prior Chemotherapy||Participants|Count of Participants|42|42.0||||||
3953054|NCT01340300|3774855|B4||No|Prior Chemotherapy||Participants|Count of Participants|11|11.0||||||
3953055|NCT01340300|3774856|B3||No|Prior Chemotherapy||Participants|Count of Participants|12|12.0||||||
3953056|NCT01340300|3774857|B2||No|Prior Chemotherapy||Participants|Count of Participants|9|9.0||||||
3953057|NCT01340300|3774858|B1||No|Prior Chemotherapy||Participants|Count of Participants|10|10.0||||||
3953058|NCT01340300|3774854|B5||Yes|Prior Chemotherapy||Participants|Count of Participants|92|92.0||||||
3953059|NCT01340300|3774855|B4||Yes|Prior Chemotherapy||Participants|Count of Participants|22|22.0||||||
3953060|NCT01340300|3774856|B3||Yes|Prior Chemotherapy||Participants|Count of Participants|23|23.0||||||
3953061|NCT01340300|3774857|B2||Yes|Prior Chemotherapy||Participants|Count of Participants|22|22.0||||||
3953062|NCT01340300|3774858|B1||Yes|Prior Chemotherapy||Participants|Count of Participants|25|25.0||||||
3953063|NCT01340300|3774854|B5||Unknown stage|Cancer Stage|Cancer is present. The higher the number, the larger the cancer tumor and the more it has spread into nearby tissues.|Participants|Count of Participants|2|2.0||||||
3953064|NCT01340300|3774855|B4||Unknown stage|Cancer Stage|Cancer is present. The higher the number, the larger the cancer tumor and the more it has spread into nearby tissues.|Participants|Count of Participants|1|1.0||||||
3953065|NCT01340300|3774856|B3||Unknown stage|Cancer Stage|Cancer is present. The higher the number, the larger the cancer tumor and the more it has spread into nearby tissues.|Participants|Count of Participants|0|0.0||||||
3953066|NCT01340300|3774857|B2||Unknown stage|Cancer Stage|Cancer is present. The higher the number, the larger the cancer tumor and the more it has spread into nearby tissues.|Participants|Count of Participants|1|1.0||||||
3953067|NCT01340300|3774858|B1||Unknown stage|Cancer Stage|Cancer is present. The higher the number, the larger the cancer tumor and the more it has spread into nearby tissues.|Participants|Count of Participants|0|0.0||||||
3953068|NCT01340300|3774854|B5||stage III|Cancer Stage|Cancer is present. The higher the number, the larger the cancer tumor and the more it has spread into nearby tissues.|Participants|Count of Participants|46|46.0||||||
3953069|NCT01340300|3774855|B4||stage III|Cancer Stage|Cancer is present. The higher the number, the larger the cancer tumor and the more it has spread into nearby tissues.|Participants|Count of Participants|9|9.0||||||
3953070|NCT01340300|3774856|B3||stage III|Cancer Stage|Cancer is present. The higher the number, the larger the cancer tumor and the more it has spread into nearby tissues.|Participants|Count of Participants|12|12.0||||||
3953071|NCT01340300|3774857|B2||stage III|Cancer Stage|Cancer is present. The higher the number, the larger the cancer tumor and the more it has spread into nearby tissues.|Participants|Count of Participants|12|12.0||||||
3953072|NCT01340300|3774858|B1||stage III|Cancer Stage|Cancer is present. The higher the number, the larger the cancer tumor and the more it has spread into nearby tissues.|Participants|Count of Participants|13|13.0||||||
3953073|NCT01340300|3774854|B5||stage II|Cancer Stage|Cancer is present. The higher the number, the larger the cancer tumor and the more it has spread into nearby tissues.|Participants|Count of Participants|40|40.0||||||
3953074|NCT01340300|3774855|B4||stage II|Cancer Stage|Cancer is present. The higher the number, the larger the cancer tumor and the more it has spread into nearby tissues.|Participants|Count of Participants|12|12.0||||||
3953075|NCT01340300|3774856|B3||stage II|Cancer Stage|Cancer is present. The higher the number, the larger the cancer tumor and the more it has spread into nearby tissues.|Participants|Count of Participants|9|9.0||||||
3953076|NCT01340300|3774857|B2||stage II|Cancer Stage|Cancer is present. The higher the number, the larger the cancer tumor and the more it has spread into nearby tissues.|Participants|Count of Participants|11|11.0||||||
3953077|NCT01340300|3774858|B1||stage II|Cancer Stage|Cancer is present. The higher the number, the larger the cancer tumor and the more it has spread into nearby tissues.|Participants|Count of Participants|8|8.0||||||
3953078|NCT01340300|3774854|B5||stage I|Cancer Stage|Cancer is present. The higher the number, the larger the cancer tumor and the more it has spread into nearby tissues.|Participants|Count of Participants|51|51.0||||||
3953079|NCT01340300|3774855|B4||stage I|Cancer Stage|Cancer is present. The higher the number, the larger the cancer tumor and the more it has spread into nearby tissues.|Participants|Count of Participants|12|12.0||||||
3953080|NCT01340300|3774856|B3||stage I|Cancer Stage|Cancer is present. The higher the number, the larger the cancer tumor and the more it has spread into nearby tissues.|Participants|Count of Participants|14|14.0||||||
3953081|NCT01340300|3774857|B2||stage I|Cancer Stage|Cancer is present. The higher the number, the larger the cancer tumor and the more it has spread into nearby tissues.|Participants|Count of Participants|11|11.0||||||
3953082|NCT01340300|3774858|B1||stage I|Cancer Stage|Cancer is present. The higher the number, the larger the cancer tumor and the more it has spread into nearby tissues.|Participants|Count of Participants|14|14.0||||||
3953083|NCT01340300|3774854|B5||Colorectal Cancer|Tumor Location||Participants|Count of Participants|52|52.0||||||
3953084|NCT01340300|3774855|B4||Colorectal Cancer|Tumor Location||Participants|Count of Participants|12|12.0||||||
3953085|NCT01340300|3774856|B3||Colorectal Cancer|Tumor Location||Participants|Count of Participants|13|13.0||||||
3953086|NCT01340300|3774857|B2||Colorectal Cancer|Tumor Location||Participants|Count of Participants|14|14.0||||||
3953087|NCT01340300|3774858|B1||Colorectal Cancer|Tumor Location||Participants|Count of Participants|13|13.0||||||
3953088|NCT01340300|3774854|B5||Breast Cancer|Tumor Location||Participants|Count of Participants|87|87.0||||||
3953089|NCT01340300|3774855|B4||Breast Cancer|Tumor Location||Participants|Count of Participants|22|22.0||||||
3953090|NCT01340300|3774856|B3||Breast Cancer|Tumor Location||Participants|Count of Participants|22|22.0||||||
3953091|NCT01340300|3774857|B2||Breast Cancer|Tumor Location||Participants|Count of Participants|21|21.0||||||
3953092|NCT01340300|3774858|B1||Breast Cancer|Tumor Location||Participants|Count of Participants|22|22.0||||||
3953093|NCT01340300|3774854|B5|||BMI||kg/m^2|Median|28.5|28.5|Inter-Quartile Range|||25.6|33.2|
3953094|NCT01340300|3774855|B4|||BMI||kg/m^2|Median|28.4|28.4|Inter-Quartile Range|||25.5|31.9|
3953095|NCT01340300|3774856|B3|||BMI||kg/m^2|Median|28.8|28.8|Inter-Quartile Range|||25.3|33.9|
3953096|NCT01340300|3774857|B2|||BMI||kg/m^2|Median|28.5|28.5|Inter-Quartile Range|||26.4|32.8|
3953097|NCT01340300|3774858|B1|||BMI||kg/m^2|Median|27.7|27.7|Inter-Quartile Range|||25.5|34.2|
3953098|NCT01340300|3774854|B5||Yale|Study Site||Participants|Count of Participants|21|21.0||||||
3953099|NCT01340300|3774855|B4||Yale|Study Site||Participants|Count of Participants|3|3.0||||||
3953100|NCT01340300|3774856|B3||Yale|Study Site||Participants|Count of Participants|6|6.0||||||
3953101|NCT01340300|3774857|B2||Yale|Study Site||Participants|Count of Participants|9|9.0||||||
3953102|NCT01340300|3774858|B1||Yale|Study Site||Participants|Count of Participants|3|3.0||||||
3953103|NCT01340300|3774854|B5||Duke|Study Site||Participants|Count of Participants|19|19.0||||||
3953104|NCT01340300|3774855|B4||Duke|Study Site||Participants|Count of Participants|6|6.0||||||
3953105|NCT01340300|3774856|B3||Duke|Study Site||Participants|Count of Participants|5|5.0||||||
3953106|NCT01340300|3774857|B2||Duke|Study Site||Participants|Count of Participants|4|4.0||||||
3953107|NCT01340300|3774858|B1||Duke|Study Site||Participants|Count of Participants|4|4.0||||||
3953108|NCT01340300|3774854|B5||DFCI|Study Site||Participants|Count of Participants|99|99.0||||||
3953109|NCT01340300|3774855|B4||DFCI|Study Site||Participants|Count of Participants|25|25.0||||||
3953110|NCT01340300|3774856|B3||DFCI|Study Site||Participants|Count of Participants|24|24.0||||||
3953111|NCT01340300|3774857|B2||DFCI|Study Site||Participants|Count of Participants|22|22.0||||||
3953112|NCT01340300|3774858|B1||DFCI|Study Site||Participants|Count of Participants|28|28.0||||||
3953113|NCT01340300|3774854|B5|United States||Region of Enrollment||participants|Number|139|139.0||||||
3953114|NCT01340300|3774855|B4|United States||Region of Enrollment||participants|Number|34|34.0||||||
3953115|NCT01340300|3774856|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
3953116|NCT01340300|3774857|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
3953117|NCT01340300|3774858|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3953118|NCT01340300|3774854|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3953119|NCT01340300|3774855|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3953120|NCT01340300|3774856|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3953121|NCT01340300|3774857|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3953122|NCT01340300|3774858|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3953123|NCT01340300|3774854|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953124|NCT01340300|3774855|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953125|NCT01340300|3774856|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953126|NCT01340300|3774857|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953127|NCT01340300|3774858|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953128|NCT01340300|3774854|B5||White|Race (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
3953129|NCT01340300|3774855|B4||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3953130|NCT01340300|3774856|B3||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3953131|NCT01340300|3774857|B2||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3953132|NCT01340300|3774858|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3953133|NCT01340300|3774854|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3953134|NCT01340300|3774855|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3953135|NCT01340300|3774856|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3953136|NCT01340300|3774857|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3953137|NCT01340300|3774858|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3953138|NCT01340300|3774854|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953139|NCT01340300|3774855|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953140|NCT01340300|3774856|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953141|NCT01340300|3774857|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953142|NCT01340300|3774858|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953143|NCT01340300|3774854|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3953144|NCT01340300|3774855|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3953145|NCT01340300|3774856|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3953146|NCT01340300|3774857|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3953147|NCT01340300|3774858|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3953148|NCT01340300|3774854|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953149|NCT01340300|3774855|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953150|NCT01340300|3774856|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953151|NCT01340300|3774857|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953152|NCT01340300|3774858|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953153|NCT01340300|3774854|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3953154|NCT01340300|3774855|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3953155|NCT01340300|3774856|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953156|NCT01340300|3774857|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953157|NCT01340300|3774858|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3953158|NCT01340300|3774854|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|133|133.0||||||
3953159|NCT01340300|3774855|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3953160|NCT01340300|3774856|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3953161|NCT01340300|3774857|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3953162|NCT01340300|3774858|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3953163|NCT01340300|3774854|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3953164|NCT01340300|3774855|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953165|NCT01340300|3774856|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3953166|NCT01340300|3774857|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953167|NCT01340300|3774858|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953168|NCT01340300|3774854|B5||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3953169|NCT01340300|3774855|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3953170|NCT01340300|3774856|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3953171|NCT01340300|3774857|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3953172|NCT01340300|3774858|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3953173|NCT01340300|3774854|B5||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3953174|NCT01340300|3774855|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3953175|NCT01340300|3774856|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3953176|NCT01340300|3774857|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3953177|NCT01340300|3774858|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3953178|NCT01340300|3774854|B5|||Age||years|Median|55|55.0|Inter-Quartile Range|||48.0|64.0|
3953179|NCT01340300|3774855|B4|||Age||years|Median|56|56.0|Inter-Quartile Range|||48.0|66.0|
3953180|NCT01340300|3774856|B3|||Age||years|Median|55|55.0|Inter-Quartile Range|||49.0|61.0|
3953181|NCT01340300|3774857|B2|||Age||years|Median|58|58.0|Inter-Quartile Range|||49.0|65.0|
3953182|NCT01340300|3774858|B1|||Age||years|Median|53|53.0|Inter-Quartile Range|||48.0|58.0|
3953183|NCT01340209|3774891|B4||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3953184|NCT01340209|3774892|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3953185|NCT01340209|3774893|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3953186|NCT01340209|3774894|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3953187|NCT01340209|3774891|B4||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
3953188|NCT01340209|3774892|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3953189|NCT01340209|3774893|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3953190|NCT01340209|3774894|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3953191|NCT01340209|3774891|B4|||Age||years|Mean|44.5|44.5|Standard Deviation|12.7|12.7|||
3953192|NCT01340209|3774892|B3|||Age||years|Mean|42.6|42.6|Standard Deviation|12.8|12.8|||
3953193|NCT01340209|3774893|B2|||Age||years|Mean|44.7|44.7|Standard Deviation|12.1|12.1|||
3953194|NCT01340209|3774894|B1|||Age||years|Mean|47.8|47.8|Standard Deviation|13.0|13.0|||
3953195|NCT01340196|3774931|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3953196|NCT01340196|3774931|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3953197|NCT01340196|3774931|B1|||Age||years|Mean|37|37.0|Standard Deviation|8.6|8.6|||
3953198|NCT01340144|3774960|B3|United States||Region of Enrollment||participants|Number|1250|1250.0||||||
3953199|NCT01340144|3774961|B2|United States||Region of Enrollment||participants|Number|625|625.0||||||
3953200|NCT01340144|3774962|B1|United States||Region of Enrollment||participants|Number|625|625.0||||||
3953201|NCT01340144|3774960|B3||Male|Sex: Female, Male||Participants|Count of Participants|548|548.0||||||
3953202|NCT01340144|3774961|B2||Male|Sex: Female, Male||Participants|Count of Participants|273|273.0||||||
3953203|NCT01340144|3774962|B1||Male|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
3953204|NCT01340144|3774960|B3||Female|Sex: Female, Male||Participants|Count of Participants|702|702.0||||||
3953205|NCT01340144|3774961|B2||Female|Sex: Female, Male||Participants|Count of Participants|352|352.0||||||
3953206|NCT01340144|3774962|B1||Female|Sex: Female, Male||Participants|Count of Participants|350|350.0||||||
3953207|NCT01340144|3774960|B3|||Age||Years|Mean|65.6|65.6|Inter-Quartile Range|||46.9|84.3|
3953208|NCT01340144|3774961|B2|||Age||Years|Mean|65.6|65.6|Inter-Quartile Range|||47.3|83.9|
3953209|NCT01340144|3774962|B1|||Age||Years|Mean|65.6|65.6|Inter-Quartile Range|||46.9|84.3|
3953210|NCT01340066|3774969|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3953211|NCT01340066|3774970|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3953212|NCT01340066|3774971|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3953213|NCT01340066|3774969|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3953214|NCT01340066|3774970|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3953215|NCT01340066|3774971|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3953216|NCT01340066|3774969|B3|All subjects||Age||Year|Mean|54.4|54.4|Full Range|||22.0|92.0|
3953217|NCT01340066|3774970|B2|All subjects||Age||Year|Mean|52.6|52.6|Full Range|||22.0|88.0|
3953218|NCT01340066|3774971|B1|All subjects||Age||Year|Mean|56.2|56.2|Full Range|||36.0|92.0|
3953219|NCT01340027|3774980|B13|||Mean Number of Urgency Incontinence Episodes per 24 Hours|The average number of urgency incontinence episodes (involuntary urine leakage accompanied by or immediately preceded by urgency) a day recorded by the participant in a micturition diary for 3 days prior to the Baseline visit. Data are reported for participants who took at least 1 dose of double-blind study medication with available primary efficacy data who reported at least 1 incontinence episode in the Baseline diary (Full Analysis Set-Incontinence): 17, 13, 18, 15, 35, 15, 35, 33, 32, 24, 24, and 20 participants in each treatment arm respectively.|urgency incontinence episodes|Mean|1.20|1.2|Standard Deviation|1.072|1.072|||
3953220|NCT01340027|3774981|B12|||Mean Number of Urgency Incontinence Episodes per 24 Hours|The average number of urgency incontinence episodes (involuntary urine leakage accompanied by or immediately preceded by urgency) a day recorded by the participant in a micturition diary for 3 days prior to the Baseline visit. Data are reported for participants who took at least 1 dose of double-blind study medication with available primary efficacy data who reported at least 1 incontinence episode in the Baseline diary (Full Analysis Set-Incontinence): 17, 13, 18, 15, 35, 15, 35, 33, 32, 24, 24, and 20 participants in each treatment arm respectively.|urgency incontinence episodes|Mean|1.20|1.2|Standard Deviation|0.901|0.901|||
3953221|NCT01340027|3774982|B11|||Mean Number of Urgency Incontinence Episodes per 24 Hours|The average number of urgency incontinence episodes (involuntary urine leakage accompanied by or immediately preceded by urgency) a day recorded by the participant in a micturition diary for 3 days prior to the Baseline visit. Data are reported for participants who took at least 1 dose of double-blind study medication with available primary efficacy data who reported at least 1 incontinence episode in the Baseline diary (Full Analysis Set-Incontinence): 17, 13, 18, 15, 35, 15, 35, 33, 32, 24, 24, and 20 participants in each treatment arm respectively.|urgency incontinence episodes|Mean|1.51|1.51|Standard Deviation|1.247|1.247|||
3953222|NCT01340027|3774983|B10|||Mean Number of Urgency Incontinence Episodes per 24 Hours|The average number of urgency incontinence episodes (involuntary urine leakage accompanied by or immediately preceded by urgency) a day recorded by the participant in a micturition diary for 3 days prior to the Baseline visit. Data are reported for participants who took at least 1 dose of double-blind study medication with available primary efficacy data who reported at least 1 incontinence episode in the Baseline diary (Full Analysis Set-Incontinence): 17, 13, 18, 15, 35, 15, 35, 33, 32, 24, 24, and 20 participants in each treatment arm respectively.|urgency incontinence episodes|Mean|1.08|1.08|Standard Deviation|1.193|1.193|||
3953223|NCT01340027|3774984|B9|||Mean Number of Urgency Incontinence Episodes per 24 Hours|The average number of urgency incontinence episodes (involuntary urine leakage accompanied by or immediately preceded by urgency) a day recorded by the participant in a micturition diary for 3 days prior to the Baseline visit. Data are reported for participants who took at least 1 dose of double-blind study medication with available primary efficacy data who reported at least 1 incontinence episode in the Baseline diary (Full Analysis Set-Incontinence): 17, 13, 18, 15, 35, 15, 35, 33, 32, 24, 24, and 20 participants in each treatment arm respectively.|urgency incontinence episodes|Mean|1.23|1.23|Standard Deviation|1.118|1.118|||
3953224|NCT01340027|3774985|B8|||Mean Number of Urgency Incontinence Episodes per 24 Hours|The average number of urgency incontinence episodes (involuntary urine leakage accompanied by or immediately preceded by urgency) a day recorded by the participant in a micturition diary for 3 days prior to the Baseline visit. Data are reported for participants who took at least 1 dose of double-blind study medication with available primary efficacy data who reported at least 1 incontinence episode in the Baseline diary (Full Analysis Set-Incontinence): 17, 13, 18, 15, 35, 15, 35, 33, 32, 24, 24, and 20 participants in each treatment arm respectively.|urgency incontinence episodes|Mean|1.06|1.06|Standard Deviation|0.757|0.757|||
3953225|NCT01340027|3774986|B7|||Mean Number of Urgency Incontinence Episodes per 24 Hours|The average number of urgency incontinence episodes (involuntary urine leakage accompanied by or immediately preceded by urgency) a day recorded by the participant in a micturition diary for 3 days prior to the Baseline visit. Data are reported for participants who took at least 1 dose of double-blind study medication with available primary efficacy data who reported at least 1 incontinence episode in the Baseline diary (Full Analysis Set-Incontinence): 17, 13, 18, 15, 35, 15, 35, 33, 32, 24, 24, and 20 participants in each treatment arm respectively.|urgency incontinence episodes|Mean|0.96|0.96|Standard Deviation|0.903|0.903|||
3953250|NCT01340027|3774985|B8|||Mean Number of Nocturia Episodes per 24 Hours|The average number of times a participant woke at night to urinate (excluding incontinence only episodes) recorded for 3 days prior to the Baseline visit in the patient micturition diary. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|nocturia episodes|Mean|2.05|2.05|Standard Deviation|1.219|1.219|||
3953226|NCT01340027|3774987|B6|||Mean Number of Urgency Incontinence Episodes per 24 Hours|The average number of urgency incontinence episodes (involuntary urine leakage accompanied by or immediately preceded by urgency) a day recorded by the participant in a micturition diary for 3 days prior to the Baseline visit. Data are reported for participants who took at least 1 dose of double-blind study medication with available primary efficacy data who reported at least 1 incontinence episode in the Baseline diary (Full Analysis Set-Incontinence): 17, 13, 18, 15, 35, 15, 35, 33, 32, 24, 24, and 20 participants in each treatment arm respectively.|urgency incontinence episodes|Mean|1.18|1.18|Standard Deviation|1.308|1.308|||
3953227|NCT01340027|3774988|B5|||Mean Number of Urgency Incontinence Episodes per 24 Hours|The average number of urgency incontinence episodes (involuntary urine leakage accompanied by or immediately preceded by urgency) a day recorded by the participant in a micturition diary for 3 days prior to the Baseline visit. Data are reported for participants who took at least 1 dose of double-blind study medication with available primary efficacy data who reported at least 1 incontinence episode in the Baseline diary (Full Analysis Set-Incontinence): 17, 13, 18, 15, 35, 15, 35, 33, 32, 24, 24, and 20 participants in each treatment arm respectively.|urgency incontinence episodes|Mean|1.32|1.32|Standard Deviation|1.227|1.227|||
3953228|NCT01340027|3774989|B4|||Mean Number of Urgency Incontinence Episodes per 24 Hours|The average number of urgency incontinence episodes (involuntary urine leakage accompanied by or immediately preceded by urgency) a day recorded by the participant in a micturition diary for 3 days prior to the Baseline visit. Data are reported for participants who took at least 1 dose of double-blind study medication with available primary efficacy data who reported at least 1 incontinence episode in the Baseline diary (Full Analysis Set-Incontinence): 17, 13, 18, 15, 35, 15, 35, 33, 32, 24, 24, and 20 participants in each treatment arm respectively.|urgency incontinence episodes|Mean|1.56|1.56|Standard Deviation|1.052|1.052|||
3953229|NCT01340027|3774990|B3|||Mean Number of Urgency Incontinence Episodes per 24 Hours|The average number of urgency incontinence episodes (involuntary urine leakage accompanied by or immediately preceded by urgency) a day recorded by the participant in a micturition diary for 3 days prior to the Baseline visit. Data are reported for participants who took at least 1 dose of double-blind study medication with available primary efficacy data who reported at least 1 incontinence episode in the Baseline diary (Full Analysis Set-Incontinence): 17, 13, 18, 15, 35, 15, 35, 33, 32, 24, 24, and 20 participants in each treatment arm respectively.|urgency incontinence episodes|Mean|1.19|1.19|Standard Deviation|1.043|1.043|||
3953230|NCT01340027|3774991|B2|||Mean Number of Urgency Incontinence Episodes per 24 Hours|The average number of urgency incontinence episodes (involuntary urine leakage accompanied by or immediately preceded by urgency) a day recorded by the participant in a micturition diary for 3 days prior to the Baseline visit. Data are reported for participants who took at least 1 dose of double-blind study medication with available primary efficacy data who reported at least 1 incontinence episode in the Baseline diary (Full Analysis Set-Incontinence): 17, 13, 18, 15, 35, 15, 35, 33, 32, 24, 24, and 20 participants in each treatment arm respectively.|urgency incontinence episodes|Mean|1.54|1.54|Standard Deviation|1.337|1.337|||
3953231|NCT01340027|3774992|B1|||Mean Number of Urgency Incontinence Episodes per 24 Hours|The average number of urgency incontinence episodes (involuntary urine leakage accompanied by or immediately preceded by urgency) a day recorded by the participant in a micturition diary for 3 days prior to the Baseline visit. Data are reported for participants who took at least 1 dose of double-blind study medication with available primary efficacy data who reported at least 1 incontinence episode in the Baseline diary (Full Analysis Set-Incontinence): 17, 13, 18, 15, 35, 15, 35, 33, 32, 24, 24, and 20 participants in each treatment arm respectively.|urgency incontinence episodes|Mean|0.78|0.78|Standard Deviation|0.807|0.807|||
3953232|NCT01340027|3774980|B13|||Mean Number of Incontinence Episodes per 24 Hours|The average number of incontinence episodes (any involuntary leakage of urine) a day recorded by the participant in a micturition diary for 3 days prior to the Baseline visit. Data are reported for participants who took at least 1 dose of double-blind study medication with available primary efficacy data who reported at least 1 incontinence episode in the Baseline diary (Full Analysis Set-Incontinence): 17, 13, 18, 15, 35, 15, 35, 33, 32, 24, 24, 20 participants in each treatment arm respectively.|incontinence episodes|Mean|1.31|1.31|Standard Deviation|1.109|1.109|||
3953233|NCT01340027|3774981|B12|||Mean Number of Incontinence Episodes per 24 Hours|The average number of incontinence episodes (any involuntary leakage of urine) a day recorded by the participant in a micturition diary for 3 days prior to the Baseline visit. Data are reported for participants who took at least 1 dose of double-blind study medication with available primary efficacy data who reported at least 1 incontinence episode in the Baseline diary (Full Analysis Set-Incontinence): 17, 13, 18, 15, 35, 15, 35, 33, 32, 24, 24, 20 participants in each treatment arm respectively.|incontinence episodes|Mean|1.25|1.25|Standard Deviation|0.858|0.858|||
3953234|NCT01340027|3774982|B11|||Mean Number of Incontinence Episodes per 24 Hours|The average number of incontinence episodes (any involuntary leakage of urine) a day recorded by the participant in a micturition diary for 3 days prior to the Baseline visit. Data are reported for participants who took at least 1 dose of double-blind study medication with available primary efficacy data who reported at least 1 incontinence episode in the Baseline diary (Full Analysis Set-Incontinence): 17, 13, 18, 15, 35, 15, 35, 33, 32, 24, 24, 20 participants in each treatment arm respectively.|incontinence episodes|Mean|1.53|1.53|Standard Deviation|1.235|1.235|||
3953235|NCT01340027|3774983|B10|||Mean Number of Incontinence Episodes per 24 Hours|The average number of incontinence episodes (any involuntary leakage of urine) a day recorded by the participant in a micturition diary for 3 days prior to the Baseline visit. Data are reported for participants who took at least 1 dose of double-blind study medication with available primary efficacy data who reported at least 1 incontinence episode in the Baseline diary (Full Analysis Set-Incontinence): 17, 13, 18, 15, 35, 15, 35, 33, 32, 24, 24, 20 participants in each treatment arm respectively.|incontinence episodes|Mean|1.17|1.17|Standard Deviation|1.196|1.196|||
3953236|NCT01340027|3774984|B9|||Mean Number of Incontinence Episodes per 24 Hours|The average number of incontinence episodes (any involuntary leakage of urine) a day recorded by the participant in a micturition diary for 3 days prior to the Baseline visit. Data are reported for participants who took at least 1 dose of double-blind study medication with available primary efficacy data who reported at least 1 incontinence episode in the Baseline diary (Full Analysis Set-Incontinence): 17, 13, 18, 15, 35, 15, 35, 33, 32, 24, 24, 20 participants in each treatment arm respectively.|incontinence episodes|Mean|1.24|1.24|Standard Deviation|1.108|1.108|||
3953237|NCT01340027|3774985|B8|||Mean Number of Incontinence Episodes per 24 Hours|The average number of incontinence episodes (any involuntary leakage of urine) a day recorded by the participant in a micturition diary for 3 days prior to the Baseline visit. Data are reported for participants who took at least 1 dose of double-blind study medication with available primary efficacy data who reported at least 1 incontinence episode in the Baseline diary (Full Analysis Set-Incontinence): 17, 13, 18, 15, 35, 15, 35, 33, 32, 24, 24, 20 participants in each treatment arm respectively.|incontinence episodes|Mean|1.14|1.14|Standard Deviation|0.791|0.791|||
3953238|NCT01340027|3774986|B7|||Mean Number of Incontinence Episodes per 24 Hours|The average number of incontinence episodes (any involuntary leakage of urine) a day recorded by the participant in a micturition diary for 3 days prior to the Baseline visit. Data are reported for participants who took at least 1 dose of double-blind study medication with available primary efficacy data who reported at least 1 incontinence episode in the Baseline diary (Full Analysis Set-Incontinence): 17, 13, 18, 15, 35, 15, 35, 33, 32, 24, 24, 20 participants in each treatment arm respectively.|incontinence episodes|Mean|1.27|1.27|Standard Deviation|1.096|1.096|||
3953239|NCT01340027|3774987|B6|||Mean Number of Incontinence Episodes per 24 Hours|The average number of incontinence episodes (any involuntary leakage of urine) a day recorded by the participant in a micturition diary for 3 days prior to the Baseline visit. Data are reported for participants who took at least 1 dose of double-blind study medication with available primary efficacy data who reported at least 1 incontinence episode in the Baseline diary (Full Analysis Set-Incontinence): 17, 13, 18, 15, 35, 15, 35, 33, 32, 24, 24, 20 participants in each treatment arm respectively.|incontinence episodes|Mean|1.40|1.4|Standard Deviation|1.280|1.28|||
3953240|NCT01340027|3774988|B5|||Mean Number of Incontinence Episodes per 24 Hours|The average number of incontinence episodes (any involuntary leakage of urine) a day recorded by the participant in a micturition diary for 3 days prior to the Baseline visit. Data are reported for participants who took at least 1 dose of double-blind study medication with available primary efficacy data who reported at least 1 incontinence episode in the Baseline diary (Full Analysis Set-Incontinence): 17, 13, 18, 15, 35, 15, 35, 33, 32, 24, 24, 20 participants in each treatment arm respectively.|incontinence episodes|Mean|1.33|1.33|Standard Deviation|1.242|1.242|||
3953241|NCT01340027|3774989|B4|||Mean Number of Incontinence Episodes per 24 Hours|The average number of incontinence episodes (any involuntary leakage of urine) a day recorded by the participant in a micturition diary for 3 days prior to the Baseline visit. Data are reported for participants who took at least 1 dose of double-blind study medication with available primary efficacy data who reported at least 1 incontinence episode in the Baseline diary (Full Analysis Set-Incontinence): 17, 13, 18, 15, 35, 15, 35, 33, 32, 24, 24, 20 participants in each treatment arm respectively.|incontinence episodes|Mean|1.80|1.8|Standard Deviation|1.167|1.167|||
3953242|NCT01340027|3774990|B3|||Mean Number of Incontinence Episodes per 24 Hours|The average number of incontinence episodes (any involuntary leakage of urine) a day recorded by the participant in a micturition diary for 3 days prior to the Baseline visit. Data are reported for participants who took at least 1 dose of double-blind study medication with available primary efficacy data who reported at least 1 incontinence episode in the Baseline diary (Full Analysis Set-Incontinence): 17, 13, 18, 15, 35, 15, 35, 33, 32, 24, 24, 20 participants in each treatment arm respectively.|incontinence episodes|Mean|1.26|1.26|Standard Deviation|1.000|1.0|||
3953243|NCT01340027|3774991|B2|||Mean Number of Incontinence Episodes per 24 Hours|The average number of incontinence episodes (any involuntary leakage of urine) a day recorded by the participant in a micturition diary for 3 days prior to the Baseline visit. Data are reported for participants who took at least 1 dose of double-blind study medication with available primary efficacy data who reported at least 1 incontinence episode in the Baseline diary (Full Analysis Set-Incontinence): 17, 13, 18, 15, 35, 15, 35, 33, 32, 24, 24, 20 participants in each treatment arm respectively.|incontinence episodes|Mean|1.87|1.87|Standard Deviation|1.578|1.578|||
3953244|NCT01340027|3774992|B1|||Mean Number of Incontinence Episodes per 24 Hours|The average number of incontinence episodes (any involuntary leakage of urine) a day recorded by the participant in a micturition diary for 3 days prior to the Baseline visit. Data are reported for participants who took at least 1 dose of double-blind study medication with available primary efficacy data who reported at least 1 incontinence episode in the Baseline diary (Full Analysis Set-Incontinence): 17, 13, 18, 15, 35, 15, 35, 33, 32, 24, 24, 20 participants in each treatment arm respectively.|incontinence episodes|Mean|0.95|0.95|Standard Deviation|0.765|0.765|||
3953245|NCT01340027|3774980|B13|||Mean Number of Nocturia Episodes per 24 Hours|The average number of times a participant woke at night to urinate (excluding incontinence only episodes) recorded for 3 days prior to the Baseline visit in the patient micturition diary. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|nocturia episodes|Mean|2.33|2.33|Standard Deviation|1.701|1.701|||
3953246|NCT01340027|3774981|B12|||Mean Number of Nocturia Episodes per 24 Hours|The average number of times a participant woke at night to urinate (excluding incontinence only episodes) recorded for 3 days prior to the Baseline visit in the patient micturition diary. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|nocturia episodes|Mean|2.41|2.41|Standard Deviation|2.001|2.001|||
3953247|NCT01340027|3774982|B11|||Mean Number of Nocturia Episodes per 24 Hours|The average number of times a participant woke at night to urinate (excluding incontinence only episodes) recorded for 3 days prior to the Baseline visit in the patient micturition diary. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|nocturia episodes|Mean|2.65|2.65|Standard Deviation|2.525|2.525|||
3953248|NCT01340027|3774983|B10|||Mean Number of Nocturia Episodes per 24 Hours|The average number of times a participant woke at night to urinate (excluding incontinence only episodes) recorded for 3 days prior to the Baseline visit in the patient micturition diary. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|nocturia episodes|Mean|2.27|2.27|Standard Deviation|1.305|1.305|||
3953249|NCT01340027|3774984|B9|||Mean Number of Nocturia Episodes per 24 Hours|The average number of times a participant woke at night to urinate (excluding incontinence only episodes) recorded for 3 days prior to the Baseline visit in the patient micturition diary. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|nocturia episodes|Mean|2.28|2.28|Standard Deviation|1.449|1.449|||
3953311|NCT01340027|3774981|B12|||Duration of OAB Symptoms||months|Mean|57.4|57.4|Standard Deviation|80.12|80.12|||
3953251|NCT01340027|3774986|B7|||Mean Number of Nocturia Episodes per 24 Hours|The average number of times a participant woke at night to urinate (excluding incontinence only episodes) recorded for 3 days prior to the Baseline visit in the patient micturition diary. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|nocturia episodes|Mean|2.64|2.64|Standard Deviation|2.259|2.259|||
3953252|NCT01340027|3774987|B6|||Mean Number of Nocturia Episodes per 24 Hours|The average number of times a participant woke at night to urinate (excluding incontinence only episodes) recorded for 3 days prior to the Baseline visit in the patient micturition diary. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|nocturia episodes|Mean|2.50|2.5|Standard Deviation|1.859|1.859|||
3953253|NCT01340027|3774988|B5|||Mean Number of Nocturia Episodes per 24 Hours|The average number of times a participant woke at night to urinate (excluding incontinence only episodes) recorded for 3 days prior to the Baseline visit in the patient micturition diary. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|nocturia episodes|Mean|2.19|2.19|Standard Deviation|1.399|1.399|||
3953254|NCT01340027|3774989|B4|||Mean Number of Nocturia Episodes per 24 Hours|The average number of times a participant woke at night to urinate (excluding incontinence only episodes) recorded for 3 days prior to the Baseline visit in the patient micturition diary. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|nocturia episodes|Mean|2.46|2.46|Standard Deviation|1.852|1.852|||
3953255|NCT01340027|3774990|B3|||Mean Number of Nocturia Episodes per 24 Hours|The average number of times a participant woke at night to urinate (excluding incontinence only episodes) recorded for 3 days prior to the Baseline visit in the patient micturition diary. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|nocturia episodes|Mean|2.31|2.31|Standard Deviation|1.517|1.517|||
3953256|NCT01340027|3774991|B2|||Mean Number of Nocturia Episodes per 24 Hours|The average number of times a participant woke at night to urinate (excluding incontinence only episodes) recorded for 3 days prior to the Baseline visit in the patient micturition diary. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|nocturia episodes|Mean|2.18|2.18|Standard Deviation|1.392|1.392|||
3953257|NCT01340027|3774992|B1|||Mean Number of Nocturia Episodes per 24 Hours|The average number of times a participant woke at night to urinate (excluding incontinence only episodes) recorded for 3 days prior to the Baseline visit in the patient micturition diary. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|nocturia episodes|Mean|2.19|2.19|Standard Deviation|1.584|1.584|||
3953258|NCT01340027|3774980|B13|||Mean Level of Urgency|Average of participants’ ratings on the degree of associated urgency for each micturition and/or incontinence episode recorded in a 3-day micturition diary according to the following 5-point categorical scale (Patient Perception of Intensity of Urgency Scale): 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|units on a scale|Mean|2.52|2.52|Standard Deviation|0.479|0.479|||
3953259|NCT01340027|3774981|B12|||Mean Level of Urgency|Average of participants’ ratings on the degree of associated urgency for each micturition and/or incontinence episode recorded in a 3-day micturition diary according to the following 5-point categorical scale (Patient Perception of Intensity of Urgency Scale): 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|units on a scale|Mean|2.53|2.53|Standard Deviation|0.473|0.473|||
3953260|NCT01340027|3774982|B11|||Mean Level of Urgency|Average of participants’ ratings on the degree of associated urgency for each micturition and/or incontinence episode recorded in a 3-day micturition diary according to the following 5-point categorical scale (Patient Perception of Intensity of Urgency Scale): 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|units on a scale|Mean|2.57|2.57|Standard Deviation|0.493|0.493|||
3953261|NCT01340027|3774983|B10|||Mean Level of Urgency|Average of participants’ ratings on the degree of associated urgency for each micturition and/or incontinence episode recorded in a 3-day micturition diary according to the following 5-point categorical scale (Patient Perception of Intensity of Urgency Scale): 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|units on a scale|Mean|2.51|2.51|Standard Deviation|0.441|0.441|||
3953262|NCT01340027|3774984|B9|||Mean Level of Urgency|Average of participants’ ratings on the degree of associated urgency for each micturition and/or incontinence episode recorded in a 3-day micturition diary according to the following 5-point categorical scale (Patient Perception of Intensity of Urgency Scale): 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|units on a scale|Mean|2.50|2.5|Standard Deviation|0.491|0.491|||
3953263|NCT01340027|3774985|B8|||Mean Level of Urgency|Average of participants’ ratings on the degree of associated urgency for each micturition and/or incontinence episode recorded in a 3-day micturition diary according to the following 5-point categorical scale (Patient Perception of Intensity of Urgency Scale): 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|units on a scale|Mean|2.59|2.59|Standard Deviation|0.446|0.446|||
3953312|NCT01340027|3774982|B11|||Duration of OAB Symptoms||months|Mean|64.9|64.9|Standard Deviation|100.57|100.57|||
3953313|NCT01340027|3774983|B10|||Duration of OAB Symptoms||months|Mean|57.4|57.4|Standard Deviation|81.53|81.53|||
3953264|NCT01340027|3774986|B7|||Mean Level of Urgency|Average of participants’ ratings on the degree of associated urgency for each micturition and/or incontinence episode recorded in a 3-day micturition diary according to the following 5-point categorical scale (Patient Perception of Intensity of Urgency Scale): 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|units on a scale|Mean|2.49|2.49|Standard Deviation|0.445|0.445|||
3953265|NCT01340027|3774987|B6|||Mean Level of Urgency|Average of participants’ ratings on the degree of associated urgency for each micturition and/or incontinence episode recorded in a 3-day micturition diary according to the following 5-point categorical scale (Patient Perception of Intensity of Urgency Scale): 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|units on a scale|Mean|2.48|2.48|Standard Deviation|0.503|0.503|||
3953266|NCT01340027|3774988|B5|||Mean Level of Urgency|Average of participants’ ratings on the degree of associated urgency for each micturition and/or incontinence episode recorded in a 3-day micturition diary according to the following 5-point categorical scale (Patient Perception of Intensity of Urgency Scale): 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|units on a scale|Mean|2.49|2.49|Standard Deviation|0.508|0.508|||
3953267|NCT01340027|3774989|B4|||Mean Level of Urgency|Average of participants’ ratings on the degree of associated urgency for each micturition and/or incontinence episode recorded in a 3-day micturition diary according to the following 5-point categorical scale (Patient Perception of Intensity of Urgency Scale): 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|units on a scale|Mean|2.53|2.53|Standard Deviation|0.539|0.539|||
3953268|NCT01340027|3774990|B3|||Mean Level of Urgency|Average of participants’ ratings on the degree of associated urgency for each micturition and/or incontinence episode recorded in a 3-day micturition diary according to the following 5-point categorical scale (Patient Perception of Intensity of Urgency Scale): 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|units on a scale|Mean|2.55|2.55|Standard Deviation|0.508|0.508|||
3953269|NCT01340027|3774991|B2|||Mean Level of Urgency|Average of participants’ ratings on the degree of associated urgency for each micturition and/or incontinence episode recorded in a 3-day micturition diary according to the following 5-point categorical scale (Patient Perception of Intensity of Urgency Scale): 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|units on a scale|Mean|2.53|2.53|Standard Deviation|0.439|0.439|||
3953270|NCT01340027|3774992|B1|||Mean Level of Urgency|Average of participants’ ratings on the degree of associated urgency for each micturition and/or incontinence episode recorded in a 3-day micturition diary according to the following 5-point categorical scale (Patient Perception of Intensity of Urgency Scale): 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|units on a scale|Mean|2.45|2.45|Standard Deviation|0.503|0.503|||
3953271|NCT01340027|3774980|B13|||Mean Number of Urgency Episodes per 24 Hours|Urgency episodes were those classified by the participant in a 3-day micturition diary as 3 or 4 on the Patient Perception of Intensity of Urgency (PPIUS) scale: 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|urgency episodes|Mean|6.37|6.37|Standard Deviation|3.931|3.931|||
3953272|NCT01340027|3774981|B12|||Mean Number of Urgency Episodes per 24 Hours|Urgency episodes were those classified by the participant in a 3-day micturition diary as 3 or 4 on the Patient Perception of Intensity of Urgency (PPIUS) scale: 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|urgency episodes|Mean|6.81|6.81|Standard Deviation|4.312|4.312|||
3953273|NCT01340027|3774982|B11|||Mean Number of Urgency Episodes per 24 Hours|Urgency episodes were those classified by the participant in a 3-day micturition diary as 3 or 4 on the Patient Perception of Intensity of Urgency (PPIUS) scale: 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|urgency episodes|Mean|6.91|6.91|Standard Deviation|4.319|4.319|||
3953274|NCT01340027|3774983|B10|||Mean Number of Urgency Episodes per 24 Hours|Urgency episodes were those classified by the participant in a 3-day micturition diary as 3 or 4 on the Patient Perception of Intensity of Urgency (PPIUS) scale: 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|urgency episodes|Mean|6.49|6.49|Standard Deviation|4.238|4.238|||
3953290|NCT01340027|3774986|B7|||Mean Volume Voided per Micturition|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|mL|Mean|156.8|156.8|Standard Deviation|61.97|61.97|||
3953275|NCT01340027|3774984|B9|||Mean Number of Urgency Episodes per 24 Hours|Urgency episodes were those classified by the participant in a 3-day micturition diary as 3 or 4 on the Patient Perception of Intensity of Urgency (PPIUS) scale: 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|urgency episodes|Mean|6.26|6.26|Standard Deviation|3.928|3.928|||
3953276|NCT01340027|3774985|B8|||Mean Number of Urgency Episodes per 24 Hours|Urgency episodes were those classified by the participant in a 3-day micturition diary as 3 or 4 on the Patient Perception of Intensity of Urgency (PPIUS) scale: 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|urgency episodes|Mean|6.78|6.78|Standard Deviation|3.419|3.419|||
3953277|NCT01340027|3774986|B7|||Mean Number of Urgency Episodes per 24 Hours|Urgency episodes were those classified by the participant in a 3-day micturition diary as 3 or 4 on the Patient Perception of Intensity of Urgency (PPIUS) scale: 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|urgency episodes|Mean|6.05|6.05|Standard Deviation|3.749|3.749|||
3953278|NCT01340027|3774987|B6|||Mean Number of Urgency Episodes per 24 Hours|Urgency episodes were those classified by the participant in a 3-day micturition diary as 3 or 4 on the Patient Perception of Intensity of Urgency (PPIUS) scale: 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|urgency episodes|Mean|6.37|6.37|Standard Deviation|4.530|4.53|||
3953279|NCT01340027|3774988|B5|||Mean Number of Urgency Episodes per 24 Hours|Urgency episodes were those classified by the participant in a 3-day micturition diary as 3 or 4 on the Patient Perception of Intensity of Urgency (PPIUS) scale: 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|urgency episodes|Mean|6.41|6.41|Standard Deviation|4.154|4.154|||
3953280|NCT01340027|3774989|B4|||Mean Number of Urgency Episodes per 24 Hours|Urgency episodes were those classified by the participant in a 3-day micturition diary as 3 or 4 on the Patient Perception of Intensity of Urgency (PPIUS) scale: 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|urgency episodes|Mean|6.20|6.2|Standard Deviation|3.870|3.87|||
3953281|NCT01340027|3774990|B3|||Mean Number of Urgency Episodes per 24 Hours|Urgency episodes were those classified by the participant in a 3-day micturition diary as 3 or 4 on the Patient Perception of Intensity of Urgency (PPIUS) scale: 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|urgency episodes|Mean|6.58|6.58|Standard Deviation|3.981|3.981|||
3953282|NCT01340027|3774991|B2|||Mean Number of Urgency Episodes per 24 Hours|Urgency episodes were those classified by the participant in a 3-day micturition diary as 3 or 4 on the Patient Perception of Intensity of Urgency (PPIUS) scale: 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|urgency episodes|Mean|6.25|6.25|Standard Deviation|3.332|3.332|||
3953283|NCT01340027|3774992|B1|||Mean Number of Urgency Episodes per 24 Hours|Urgency episodes were those classified by the participant in a 3-day micturition diary as 3 or 4 on the Patient Perception of Intensity of Urgency (PPIUS) scale: 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|urgency episodes|Mean|5.26|5.26|Standard Deviation|3.079|3.079|||
3953284|NCT01340027|3774980|B13|||Mean Volume Voided per Micturition|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|mL|Mean|152.5|152.5|Standard Deviation|55.65|55.65|||
3953285|NCT01340027|3774981|B12|||Mean Volume Voided per Micturition|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|mL|Mean|155.3|155.3|Standard Deviation|62.13|62.13|||
3953286|NCT01340027|3774982|B11|||Mean Volume Voided per Micturition|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|mL|Mean|141.4|141.4|Standard Deviation|51.29|51.29|||
3953287|NCT01340027|3774983|B10|||Mean Volume Voided per Micturition|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|mL|Mean|153.1|153.1|Standard Deviation|51.88|51.88|||
3953288|NCT01340027|3774984|B9|||Mean Volume Voided per Micturition|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|mL|Mean|155.0|155.0|Standard Deviation|55.55|55.55|||
3953289|NCT01340027|3774985|B8|||Mean Volume Voided per Micturition|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|mL|Mean|149.8|149.8|Standard Deviation|50.05|50.05|||
3953291|NCT01340027|3774987|B6|||Mean Volume Voided per Micturition|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|mL|Mean|148.0|148.0|Standard Deviation|52.74|52.74|||
3953292|NCT01340027|3774988|B5|||Mean Volume Voided per Micturition|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|mL|Mean|145.5|145.5|Standard Deviation|59.34|59.34|||
3953293|NCT01340027|3774989|B4|||Mean Volume Voided per Micturition|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|mL|Mean|162.4|162.4|Standard Deviation|57.59|57.59|||
3953294|NCT01340027|3774990|B3|||Mean Volume Voided per Micturition|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|mL|Mean|156.8|156.8|Standard Deviation|52.33|52.33|||
3953295|NCT01340027|3774991|B2|||Mean Volume Voided per Micturition|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|mL|Mean|152.7|152.7|Standard Deviation|56.70|56.7|||
3953296|NCT01340027|3774992|B1|||Mean Volume Voided per Micturition|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|mL|Mean|156.4|156.4|Standard Deviation|52.80|52.8|||
3953297|NCT01340027|3774980|B13|||Mean Number of Micturitions per 24 Hours|The average number of micturitions (urinations) a day recorded by the participant in a micturition diary for 3 days prior to the Baseline visit. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|micturitions|Mean|11.10|11.1|Standard Deviation|2.794|2.794|||
3953298|NCT01340027|3774981|B12|||Mean Number of Micturitions per 24 Hours|The average number of micturitions (urinations) a day recorded by the participant in a micturition diary for 3 days prior to the Baseline visit. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|micturitions|Mean|11.24|11.24|Standard Deviation|2.453|2.453|||
3953299|NCT01340027|3774982|B11|||Mean Number of Micturitions per 24 Hours|The average number of micturitions (urinations) a day recorded by the participant in a micturition diary for 3 days prior to the Baseline visit. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|micturitions|Mean|11.14|11.14|Standard Deviation|2.268|2.268|||
3953300|NCT01340027|3774983|B10|||Mean Number of Micturitions per 24 Hours|The average number of micturitions (urinations) a day recorded by the participant in a micturition diary for 3 days prior to the Baseline visit. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|micturitions|Mean|11.25|11.25|Standard Deviation|3.171|3.171|||
3953301|NCT01340027|3774984|B9|||Mean Number of Micturitions per 24 Hours|The average number of micturitions (urinations) a day recorded by the participant in a micturition diary for 3 days prior to the Baseline visit. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|micturitions|Mean|10.92|10.92|Standard Deviation|2.386|2.386|||
3953302|NCT01340027|3774985|B8|||Mean Number of Micturitions per 24 Hours|The average number of micturitions (urinations) a day recorded by the participant in a micturition diary for 3 days prior to the Baseline visit. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|micturitions|Mean|11.00|11.0|Standard Deviation|2.260|2.26|||
3953303|NCT01340027|3774986|B7|||Mean Number of Micturitions per 24 Hours|The average number of micturitions (urinations) a day recorded by the participant in a micturition diary for 3 days prior to the Baseline visit. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|micturitions|Mean|11.25|11.25|Standard Deviation|3.643|3.643|||
3953304|NCT01340027|3774987|B6|||Mean Number of Micturitions per 24 Hours|The average number of micturitions (urinations) a day recorded by the participant in a micturition diary for 3 days prior to the Baseline visit. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|micturitions|Mean|11.29|11.29|Standard Deviation|2.896|2.896|||
3953305|NCT01340027|3774988|B5|||Mean Number of Micturitions per 24 Hours|The average number of micturitions (urinations) a day recorded by the participant in a micturition diary for 3 days prior to the Baseline visit. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|micturitions|Mean|11.34|11.34|Standard Deviation|3.158|3.158|||
3953306|NCT01340027|3774989|B4|||Mean Number of Micturitions per 24 Hours|The average number of micturitions (urinations) a day recorded by the participant in a micturition diary for 3 days prior to the Baseline visit. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|micturitions|Mean|11.10|11.1|Standard Deviation|3.056|3.056|||
3953307|NCT01340027|3774990|B3|||Mean Number of Micturitions per 24 Hours|The average number of micturitions (urinations) a day recorded by the participant in a micturition diary for 3 days prior to the Baseline visit. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|micturitions|Mean|10.78|10.78|Standard Deviation|2.254|2.254|||
3953308|NCT01340027|3774991|B2|||Mean Number of Micturitions per 24 Hours|The average number of micturitions (urinations) a day recorded by the participant in a micturition diary for 3 days prior to the Baseline visit. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|micturitions|Mean|11.29|11.29|Standard Deviation|2.581|2.581|||
3953309|NCT01340027|3774992|B1|||Mean Number of Micturitions per 24 Hours|The average number of micturitions (urinations) a day recorded by the participant in a micturition diary for 3 days prior to the Baseline visit. Data available for 81, 76, 78, 79, 155, 78, 149, 148, 144, 152, 81 and 81 participants in each treatment arm respectively.|micturitions|Mean|10.36|10.36|Standard Deviation|2.036|2.036|||
3953310|NCT01340027|3774980|B13|||Duration of OAB Symptoms||months|Mean|57.8|57.8|Standard Deviation|73.82|73.82|||
3953314|NCT01340027|3774984|B9|||Duration of OAB Symptoms||months|Mean|56.3|56.3|Standard Deviation|84.78|84.78|||
3953315|NCT01340027|3774985|B8|||Duration of OAB Symptoms||months|Mean|57.0|57.0|Standard Deviation|66.85|66.85|||
3953316|NCT01340027|3774986|B7|||Duration of OAB Symptoms||months|Mean|57.7|57.7|Standard Deviation|68.91|68.91|||
3953317|NCT01340027|3774987|B6|||Duration of OAB Symptoms||months|Mean|52.4|52.4|Standard Deviation|56.98|56.98|||
3953318|NCT01340027|3774988|B5|||Duration of OAB Symptoms||months|Mean|61.8|61.8|Standard Deviation|78.21|78.21|||
3953319|NCT01340027|3774989|B4|||Duration of OAB Symptoms||months|Mean|60.2|60.2|Standard Deviation|67.85|67.85|||
3953320|NCT01340027|3774990|B3|||Duration of OAB Symptoms||months|Mean|56.9|56.9|Standard Deviation|66.62|66.62|||
3953321|NCT01340027|3774991|B2|||Duration of OAB Symptoms||months|Mean|61.2|61.2|Standard Deviation|68.03|68.03|||
3953322|NCT01340027|3774992|B1|||Duration of OAB Symptoms||months|Mean|48.3|48.3|Standard Deviation|38.37|38.37|||
3953323|NCT01340027|3774980|B13|Missing||Type of Overactive Bladder (OAB)||participants|Number|9|9.0||||||
3953324|NCT01340027|3774981|B12|Missing||Type of Overactive Bladder (OAB)||participants|Number|1|1.0||||||
3953325|NCT01340027|3774982|B11|Missing||Type of Overactive Bladder (OAB)||participants|Number|0|0.0||||||
3953326|NCT01340027|3774983|B10|Missing||Type of Overactive Bladder (OAB)||participants|Number|0|0.0||||||
3953327|NCT01340027|3774984|B9|Missing||Type of Overactive Bladder (OAB)||participants|Number|0|0.0||||||
3953328|NCT01340027|3774985|B8|Missing||Type of Overactive Bladder (OAB)||participants|Number|1|1.0||||||
3953329|NCT01340027|3774986|B7|Missing||Type of Overactive Bladder (OAB)||participants|Number|1|1.0||||||
3953330|NCT01340027|3774987|B6|Missing||Type of Overactive Bladder (OAB)||participants|Number|0|0.0||||||
3953331|NCT01340027|3774988|B5|Missing||Type of Overactive Bladder (OAB)||participants|Number|1|1.0||||||
3953332|NCT01340027|3774989|B4|Missing||Type of Overactive Bladder (OAB)||participants|Number|1|1.0||||||
3953333|NCT01340027|3774990|B3|Missing||Type of Overactive Bladder (OAB)||participants|Number|1|1.0||||||
3953334|NCT01340027|3774991|B2|Missing||Type of Overactive Bladder (OAB)||participants|Number|1|1.0||||||
3953335|NCT01340027|3774992|B1|Missing||Type of Overactive Bladder (OAB)||participants|Number|2|2.0||||||
3953336|NCT01340027|3774980|B13|Frequency||Type of Overactive Bladder (OAB)||participants|Number|793|793.0||||||
3953337|NCT01340027|3774981|B12|Frequency||Type of Overactive Bladder (OAB)||participants|Number|50|50.0||||||
3953338|NCT01340027|3774982|B11|Frequency||Type of Overactive Bladder (OAB)||participants|Number|44|44.0||||||
3953339|NCT01340027|3774983|B10|Frequency||Type of Overactive Bladder (OAB)||participants|Number|100|100.0||||||
3953340|NCT01340027|3774984|B9|Frequency||Type of Overactive Bladder (OAB)||participants|Number|90|90.0||||||
3953341|NCT01340027|3774985|B8|Frequency||Type of Overactive Bladder (OAB)||participants|Number|95|95.0||||||
3953342|NCT01340027|3774986|B7|Frequency||Type of Overactive Bladder (OAB)||participants|Number|84|84.0||||||
3953343|NCT01340027|3774987|B6|Frequency||Type of Overactive Bladder (OAB)||participants|Number|48|48.0||||||
3953344|NCT01340027|3774988|B5|Frequency||Type of Overactive Bladder (OAB)||participants|Number|89|89.0||||||
3953345|NCT01340027|3774989|B4|Frequency||Type of Overactive Bladder (OAB)||participants|Number|50|50.0||||||
3953346|NCT01340027|3774990|B3|Frequency||Type of Overactive Bladder (OAB)||participants|Number|48|48.0||||||
3953347|NCT01340027|3774991|B2|Frequency||Type of Overactive Bladder (OAB)||participants|Number|39|39.0||||||
3953348|NCT01340027|3774992|B1|Frequency||Type of Overactive Bladder (OAB)||participants|Number|56|56.0||||||
3953349|NCT01340027|3774980|B13|Mixed||Type of Overactive Bladder (OAB)||participants|Number|180|180.0||||||
3953350|NCT01340027|3774981|B12|Mixed||Type of Overactive Bladder (OAB)||participants|Number|10|10.0||||||
3953351|NCT01340027|3774982|B11|Mixed||Type of Overactive Bladder (OAB)||participants|Number|14|14.0||||||
3953352|NCT01340027|3774983|B10|Mixed||Type of Overactive Bladder (OAB)||participants|Number|18|18.0||||||
3953353|NCT01340027|3774984|B9|Mixed||Type of Overactive Bladder (OAB)||participants|Number|19|19.0||||||
3953354|NCT01340027|3774985|B8|Mixed||Type of Overactive Bladder (OAB)||participants|Number|20|20.0||||||
3953355|NCT01340027|3774986|B7|Mixed||Type of Overactive Bladder (OAB)||participants|Number|22|22.0||||||
3953356|NCT01340027|3774987|B6|Mixed||Type of Overactive Bladder (OAB)||participants|Number|11|11.0||||||
3953357|NCT01340027|3774988|B5|Mixed||Type of Overactive Bladder (OAB)||participants|Number|27|27.0||||||
3953358|NCT01340027|3774989|B4|Mixed||Type of Overactive Bladder (OAB)||participants|Number|10|10.0||||||
3953359|NCT01340027|3774990|B3|Mixed||Type of Overactive Bladder (OAB)||participants|Number|10|10.0||||||
3953360|NCT01340027|3774991|B2|Mixed||Type of Overactive Bladder (OAB)||participants|Number|10|10.0||||||
3953361|NCT01340027|3774992|B1|Mixed||Type of Overactive Bladder (OAB)||participants|Number|9|9.0||||||
3953362|NCT01340027|3774980|B13|Urge Incontinence||Type of Overactive Bladder (OAB)||participants|Number|324|324.0||||||
3953363|NCT01340027|3774981|B12|Urge Incontinence||Type of Overactive Bladder (OAB)||participants|Number|20|20.0||||||
3953364|NCT01340027|3774982|B11|Urge Incontinence||Type of Overactive Bladder (OAB)||participants|Number|23|23.0||||||
3953365|NCT01340027|3774983|B10|Urge Incontinence||Type of Overactive Bladder (OAB)||participants|Number|35|35.0||||||
3953366|NCT01340027|3774984|B9|Urge Incontinence||Type of Overactive Bladder (OAB)||participants|Number|35|35.0||||||
3953367|NCT01340027|3774985|B8|Urge Incontinence||Type of Overactive Bladder (OAB)||participants|Number|33|33.0||||||
3953368|NCT01340027|3774986|B7|Urge Incontinence||Type of Overactive Bladder (OAB)||participants|Number|42|42.0||||||
3953369|NCT01340027|3774987|B6|Urge Incontinence||Type of Overactive Bladder (OAB)||participants|Number|19|19.0||||||
3953370|NCT01340027|3774988|B5|Urge Incontinence||Type of Overactive Bladder (OAB)||participants|Number|39|39.0||||||
3953371|NCT01340027|3774989|B4|Urge Incontinence||Type of Overactive Bladder (OAB)||participants|Number|18|18.0||||||
3953372|NCT01340027|3774990|B3|Urge Incontinence||Type of Overactive Bladder (OAB)||participants|Number|19|19.0||||||
3953373|NCT01340027|3774991|B2|Urge Incontinence||Type of Overactive Bladder (OAB)||participants|Number|27|27.0||||||
3953374|NCT01340027|3774992|B1|Urge Incontinence||Type of Overactive Bladder (OAB)||participants|Number|14|14.0||||||
3953375|NCT01340027|3774980|B13|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3953376|NCT01340027|3774981|B12|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3953377|NCT01340027|3774982|B11|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3953378|NCT01340027|3774983|B10|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3953379|NCT01340027|3774984|B9|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3953380|NCT01340027|3774985|B8|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3953381|NCT01340027|3774986|B7|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3953382|NCT01340027|3774987|B6|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3953383|NCT01340027|3774988|B5|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3953384|NCT01340027|3774989|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3953385|NCT01340027|3774990|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3953386|NCT01340027|3774991|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3953387|NCT01340027|3774992|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3953388|NCT01340027|3774980|B13|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3953389|NCT01340027|3774981|B12|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3953390|NCT01340027|3774982|B11|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3953391|NCT01340027|3774983|B10|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3953392|NCT01340027|3774984|B9|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3953393|NCT01340027|3774985|B8|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3953394|NCT01340027|3774986|B7|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3953395|NCT01340027|3774987|B6|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3953396|NCT01340027|3774988|B5|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3953397|NCT01340027|3774989|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3953398|NCT01340027|3774990|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3953399|NCT01340027|3774991|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3953400|NCT01340027|3774992|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3953401|NCT01340027|3774980|B13|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3953402|NCT01340027|3774981|B12|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3953403|NCT01340027|3774982|B11|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3953404|NCT01340027|3774983|B10|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3953405|NCT01340027|3774984|B9|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3953406|NCT01340027|3774985|B8|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3953407|NCT01340027|3774986|B7|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3953408|NCT01340027|3774987|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3953409|NCT01340027|3774988|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3953410|NCT01340027|3774989|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3953411|NCT01340027|3774990|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3953412|NCT01340027|3774991|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3953413|NCT01340027|3774992|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3953414|NCT01340027|3774980|B13|White||Race/Ethnicity, Customized||participants|Number|1302|1302.0||||||
3953415|NCT01340027|3774981|B12|White||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
3953416|NCT01340027|3774982|B11|White||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
3953417|NCT01340027|3774983|B10|White||Race/Ethnicity, Customized||participants|Number|153|153.0||||||
3953418|NCT01340027|3774984|B9|White||Race/Ethnicity, Customized||participants|Number|143|143.0||||||
3953419|NCT01340027|3774985|B8|White||Race/Ethnicity, Customized||participants|Number|148|148.0||||||
3953420|NCT01340027|3774986|B7|White||Race/Ethnicity, Customized||participants|Number|149|149.0||||||
3953421|NCT01340027|3774987|B6|White||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
3953422|NCT01340027|3774988|B5|White||Race/Ethnicity, Customized||participants|Number|156|156.0||||||
3953423|NCT01340027|3774989|B4|White||Race/Ethnicity, Customized||participants|Number|78|78.0||||||
3953424|NCT01340027|3774990|B3|White||Race/Ethnicity, Customized||participants|Number|78|78.0||||||
3953425|NCT01340027|3774991|B2|White||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
3953426|NCT01340027|3774992|B1|White||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
3953427|NCT01340027|3774980|B13||Male|Sex: Female, Male||Participants|Count of Participants|439|439.0||||||
3953428|NCT01340027|3774981|B12||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3953429|NCT01340027|3774982|B11||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3953430|NCT01340027|3774983|B10||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3953431|NCT01340027|3774984|B9||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3953432|NCT01340027|3774985|B8||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3953433|NCT01340027|3774986|B7||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3953434|NCT01340027|3774987|B6||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3953435|NCT01340027|3774988|B5||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3953436|NCT01340027|3774989|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3953437|NCT01340027|3774990|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3953438|NCT01340027|3774991|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3953439|NCT01340027|3774992|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3953440|NCT01340027|3774980|B13||Female|Sex: Female, Male||Participants|Count of Participants|867|867.0||||||
3953441|NCT01340027|3774981|B12||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3953442|NCT01340027|3774982|B11||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3953443|NCT01340027|3774983|B10||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3953444|NCT01340027|3774984|B9||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3953445|NCT01340027|3774985|B8||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3953446|NCT01340027|3774986|B7||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3953447|NCT01340027|3774987|B6||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3953448|NCT01340027|3774988|B5||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3953449|NCT01340027|3774989|B4||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3953450|NCT01340027|3774990|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3953451|NCT01340027|3774991|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3953452|NCT01340027|3774992|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3953453|NCT01340027|3774980|B13|||Age||years|Mean|54.8|54.8|Standard Deviation|13.97|13.97|||
3953454|NCT01340027|3774981|B12|||Age||years|Mean|55.5|55.5|Standard Deviation|13.82|13.82|||
3953455|NCT01340027|3774982|B11|||Age||years|Mean|56.5|56.5|Standard Deviation|12.34|12.34|||
3953456|NCT01340027|3774983|B10|||Age||years|Mean|54.1|54.1|Standard Deviation|14.09|14.09|||
3953457|NCT01340027|3774984|B9|||Age||years|Mean|55.0|55.0|Standard Deviation|14.57|14.57|||
3953458|NCT01340027|3774985|B8|||Age||years|Mean|53.7|53.7|Standard Deviation|14.55|14.55|||
3953459|NCT01340027|3774986|B7|||Age||years|Mean|55.8|55.8|Standard Deviation|13.82|13.82|||
3953460|NCT01340027|3774987|B6|||Age||years|Mean|55.0|55.0|Standard Deviation|12.82|12.82|||
3953461|NCT01340027|3774988|B5|||Age||years|Mean|54.2|54.2|Standard Deviation|15.53|15.53|||
3953462|NCT01340027|3774989|B4|||Age||years|Mean|56.1|56.1|Standard Deviation|11.71|11.71|||
3953463|NCT01340027|3774990|B3|||Age||years|Mean|53.4|53.4|Standard Deviation|13.98|13.98|||
3953464|NCT01340027|3774991|B2|||Age||years|Mean|55.2|55.2|Standard Deviation|14.45|14.45|||
3953465|NCT01340027|3774992|B1|||Age||years|Mean|54.6|54.6|Standard Deviation|13.37|13.37|||
3953466|NCT01340014|3775377|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3953467|NCT01340014|3775378|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3953468|NCT01340014|3775379|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3953469|NCT01340014|3775377|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3953470|NCT01340014|3775378|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3953471|NCT01340014|3775379|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3953472|NCT01340014|3775377|B3|||Age||years|Mean|66.3|66.3|Standard Deviation|11.40|11.4|||
3953473|NCT01340014|3775378|B2|||Age||years|Mean|65.0|65.0|Standard Deviation|11.92|11.92|||
3953474|NCT01340014|3775379|B1|||Age||years|Mean|67.7|67.7|Standard Deviation|10.1|10.1|||
3953475|NCT01339936|3775388|B1|United Kingdom||Region of Enrollment||participants|Number|35|35.0||||||
3953476|NCT01339936|3775388|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3953477|NCT01339936|3775388|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3953478|NCT01339936|3775388|B1|||Age||years|Mean|49|49.0|Standard Deviation|16|16.0|||
3953479|NCT01339936|3775388|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3953480|NCT01339936|3775388|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3953481|NCT01339936|3775388|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3953482|NCT01339923|3775394|B8||Male|Sex: Female, Male||Participants|Count of Participants|710|710.0||||||
3953483|NCT01339923|3775395|B7||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3953484|NCT01339923|3775396|B6||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3953485|NCT01339923|3775397|B5||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3953486|NCT01339923|3775398|B4||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3953487|NCT01339923|3775399|B3||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3953488|NCT01339923|3775400|B2||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3953489|NCT01339923|3775401|B1||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3953490|NCT01339923|3775394|B8||Female|Sex: Female, Male||Participants|Count of Participants|699|699.0||||||
3953491|NCT01339923|3775395|B7||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3953492|NCT01339923|3775396|B6||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3953493|NCT01339923|3775397|B5||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3953494|NCT01339923|3775398|B4||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3953495|NCT01339923|3775399|B3||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3953496|NCT01339923|3775400|B2||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3953497|NCT01339923|3775401|B1||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3953498|NCT01339923|3775394|B8|||Age||month|Mean|26.6|26.6|Standard Deviation|39.3|39.3|||
3953499|NCT01339923|3775395|B7|||Age||month|Mean|3.0|3.0|Standard Deviation|0.1|0.1|||
3953500|NCT01339923|3775396|B6|||Age||month|Mean|3.0|3.0|Standard Deviation|0.2|0.2|||
3953501|NCT01339923|3775397|B5|||Age||month|Mean|96.9|96.9|Standard Deviation|16.8|16.8|||
3953502|NCT01339923|3775398|B4|||Age||month|Mean|47.5|47.5|Standard Deviation|13.4|13.4|||
3953503|NCT01339923|3775399|B3|||Age||month|Mean|6.0|6.0|Standard Deviation|0.0|0.0|||
3953504|NCT01339923|3775400|B2|||Age||month|Mean|3.0|3.0|Standard Deviation|0.1|0.1|||
3953505|NCT01339923|3775401|B1|||Age||month|Mean|2.0|2.0|Standard Deviation|0.1|0.1|||
3953506|NCT01339910|3775476|B3||Bone Marrow|Donor Source||Participants|Count of Participants|22|22.0||||||
3953507|NCT01339910|3775477|B2||Bone Marrow|Donor Source||Participants|Count of Participants|14|14.0||||||
3953508|NCT01339910|3775478|B1||Bone Marrow|Donor Source||Participants|Count of Participants|8|8.0||||||
3953509|NCT01339910|3775476|B3||Peripheral Blood|Donor Source||Participants|Count of Participants|250|250.0||||||
3953510|NCT01339910|3775477|B2||Peripheral Blood|Donor Source||Participants|Count of Participants|123|123.0||||||
3953511|NCT01339910|3775478|B1||Peripheral Blood|Donor Source||Participants|Count of Participants|127|127.0||||||
3953512|NCT01339910|3775476|B3||Mismatched Unrelated|Donor Type||Participants|Count of Participants|26|26.0||||||
3953513|NCT01339910|3775477|B2||Mismatched Unrelated|Donor Type||Participants|Count of Participants|16|16.0||||||
3953514|NCT01339910|3775478|B1||Mismatched Unrelated|Donor Type||Participants|Count of Participants|10|10.0||||||
3953515|NCT01339910|3775476|B3||Matched Unrelated|Donor Type||Participants|Count of Participants|124|124.0||||||
3953516|NCT01339910|3775477|B2||Matched Unrelated|Donor Type||Participants|Count of Participants|58|58.0||||||
3953517|NCT01339910|3775478|B1||Matched Unrelated|Donor Type||Participants|Count of Participants|66|66.0||||||
3953518|NCT01339910|3775476|B3||Mismatched Related|Donor Type||Participants|Count of Participants|7|7.0||||||
3953519|NCT01339910|3775477|B2||Mismatched Related|Donor Type||Participants|Count of Participants|5|5.0||||||
3953520|NCT01339910|3775478|B1||Mismatched Related|Donor Type||Participants|Count of Participants|2|2.0||||||
3953521|NCT01339910|3775476|B3||Matched Related|Donor Type||Participants|Count of Participants|115|115.0||||||
3953522|NCT01339910|3775477|B2||Matched Related|Donor Type||Participants|Count of Participants|58|58.0||||||
3953523|NCT01339910|3775478|B1||Matched Related|Donor Type||Participants|Count of Participants|57|57.0||||||
3953524|NCT01339910|3775476|B3||No|ATG Use|Use of Anti-Thymocyte Globulin|Participants|Count of Participants|232|232.0||||||
3953525|NCT01339910|3775477|B2||No|ATG Use|Use of Anti-Thymocyte Globulin|Participants|Count of Participants|115|115.0||||||
3953526|NCT01339910|3775478|B1||No|ATG Use|Use of Anti-Thymocyte Globulin|Participants|Count of Participants|117|117.0||||||
3953527|NCT01339910|3775476|B3||Yes|ATG Use|Use of Anti-Thymocyte Globulin|Participants|Count of Participants|40|40.0||||||
3953528|NCT01339910|3775477|B2||Yes|ATG Use|Use of Anti-Thymocyte Globulin|Participants|Count of Participants|22|22.0||||||
3953529|NCT01339910|3775478|B1||Yes|ATG Use|Use of Anti-Thymocyte Globulin|Participants|Count of Participants|18|18.0||||||
3953530|NCT01339910|3775476|B3||Other|GVHD Prophylaxis|Prophylaxis for Graft Versus Host Disease|Participants|Count of Participants|8|8.0||||||
3953531|NCT01339910|3775477|B2||Other|GVHD Prophylaxis|Prophylaxis for Graft Versus Host Disease|Participants|Count of Participants|5|5.0||||||
3953532|NCT01339910|3775478|B1||Other|GVHD Prophylaxis|Prophylaxis for Graft Versus Host Disease|Participants|Count of Participants|3|3.0||||||
3953533|NCT01339910|3775476|B3||Sirolimus / Tacrolimus|GVHD Prophylaxis|Prophylaxis for Graft Versus Host Disease|Participants|Count of Participants|22|22.0||||||
3953534|NCT01339910|3775477|B2||Sirolimus / Tacrolimus|GVHD Prophylaxis|Prophylaxis for Graft Versus Host Disease|Participants|Count of Participants|12|12.0||||||
3953535|NCT01339910|3775478|B1||Sirolimus / Tacrolimus|GVHD Prophylaxis|Prophylaxis for Graft Versus Host Disease|Participants|Count of Participants|10|10.0||||||
3953536|NCT01339910|3775476|B3||Cyclosporine / Mycophenolate mofetil|GVHD Prophylaxis|Prophylaxis for Graft Versus Host Disease|Participants|Count of Participants|1|1.0||||||
3953537|NCT01339910|3775477|B2||Cyclosporine / Mycophenolate mofetil|GVHD Prophylaxis|Prophylaxis for Graft Versus Host Disease|Participants|Count of Participants|0|0.0||||||
3953538|NCT01339910|3775478|B1||Cyclosporine / Mycophenolate mofetil|GVHD Prophylaxis|Prophylaxis for Graft Versus Host Disease|Participants|Count of Participants|1|1.0||||||
3953539|NCT01339910|3775476|B3||TAC / Mycophenolate mofetil|GVHD Prophylaxis|Prophylaxis for Graft Versus Host Disease|Participants|Count of Participants|13|13.0||||||
3953540|NCT01339910|3775477|B2||TAC / Mycophenolate mofetil|GVHD Prophylaxis|Prophylaxis for Graft Versus Host Disease|Participants|Count of Participants|5|5.0||||||
3953541|NCT01339910|3775478|B1||TAC / Mycophenolate mofetil|GVHD Prophylaxis|Prophylaxis for Graft Versus Host Disease|Participants|Count of Participants|8|8.0||||||
3953542|NCT01339910|3775476|B3||Cyclosporine / Methotrexate|GVHD Prophylaxis|Prophylaxis for Graft Versus Host Disease|Participants|Count of Participants|6|6.0||||||
3953543|NCT01339910|3775477|B2||Cyclosporine / Methotrexate|GVHD Prophylaxis|Prophylaxis for Graft Versus Host Disease|Participants|Count of Participants|3|3.0||||||
3953544|NCT01339910|3775478|B1||Cyclosporine / Methotrexate|GVHD Prophylaxis|Prophylaxis for Graft Versus Host Disease|Participants|Count of Participants|3|3.0||||||
3953545|NCT01339910|3775476|B3||Tacrolimus / Methotrexate|GVHD Prophylaxis|Prophylaxis for Graft Versus Host Disease|Participants|Count of Participants|222|222.0||||||
3953546|NCT01339910|3775477|B2||Tacrolimus / Methotrexate|GVHD Prophylaxis|Prophylaxis for Graft Versus Host Disease|Participants|Count of Participants|112|112.0||||||
3953624|NCT01339897|3775514|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
3953547|NCT01339910|3775478|B1||Tacrolimus / Methotrexate|GVHD Prophylaxis|Prophylaxis for Graft Versus Host Disease|Participants|Count of Participants|110|110.0||||||
3953548|NCT01339910|3775476|B3||Flu/Bu2|Conditioning Regimen|"Flu/Bu4: busulfan (16 mg/kg oral or 12.8 mg/kg IV) and fludarabine (120-180 mg/m2); Bu/Cy: busulfan (16 mg/kg oral or 12.8 mg/kg IV) and cyclophosphamide (120 mg/kg) ; Cy/TBI: cyclophosphamide (120 mg/kg) and total body irradiation (1200-1420 cGy); Flu/Mel: fludarabine (120-180 mg/m2) and melphalan (≤ 150 mg/m2); Flu/Bu2: fludarabine (120-180 mg/m2) with busulfan (≤ 8 mg/kg oral or 6.4 mg/kg IV);~Flu/Bu4, Bu/Cy, and Cy/TBI are myeloablative conditioning regimens, while Flu/Mel and Flu/Bu2 are reduced intensity conditioning regimens."|Participants|Count of Participants|110|110.0||||||
3953549|NCT01339910|3775477|B2||Flu/Bu2|Conditioning Regimen|"Flu/Bu4: busulfan (16 mg/kg oral or 12.8 mg/kg IV) and fludarabine (120-180 mg/m2); Bu/Cy: busulfan (16 mg/kg oral or 12.8 mg/kg IV) and cyclophosphamide (120 mg/kg) ; Cy/TBI: cyclophosphamide (120 mg/kg) and total body irradiation (1200-1420 cGy); Flu/Mel: fludarabine (120-180 mg/m2) and melphalan (≤ 150 mg/m2); Flu/Bu2: fludarabine (120-180 mg/m2) with busulfan (≤ 8 mg/kg oral or 6.4 mg/kg IV);~Flu/Bu4, Bu/Cy, and Cy/TBI are myeloablative conditioning regimens, while Flu/Mel and Flu/Bu2 are reduced intensity conditioning regimens."|Participants|Count of Participants|110|110.0||||||
3953550|NCT01339910|3775478|B1||Flu/Bu2|Conditioning Regimen|"Flu/Bu4: busulfan (16 mg/kg oral or 12.8 mg/kg IV) and fludarabine (120-180 mg/m2); Bu/Cy: busulfan (16 mg/kg oral or 12.8 mg/kg IV) and cyclophosphamide (120 mg/kg) ; Cy/TBI: cyclophosphamide (120 mg/kg) and total body irradiation (1200-1420 cGy); Flu/Mel: fludarabine (120-180 mg/m2) and melphalan (≤ 150 mg/m2); Flu/Bu2: fludarabine (120-180 mg/m2) with busulfan (≤ 8 mg/kg oral or 6.4 mg/kg IV);~Flu/Bu4, Bu/Cy, and Cy/TBI are myeloablative conditioning regimens, while Flu/Mel and Flu/Bu2 are reduced intensity conditioning regimens."|Participants|Count of Participants|0|0.0||||||
3953551|NCT01339910|3775476|B3||Flu/Mel|Conditioning Regimen|"Flu/Bu4: busulfan (16 mg/kg oral or 12.8 mg/kg IV) and fludarabine (120-180 mg/m2); Bu/Cy: busulfan (16 mg/kg oral or 12.8 mg/kg IV) and cyclophosphamide (120 mg/kg) ; Cy/TBI: cyclophosphamide (120 mg/kg) and total body irradiation (1200-1420 cGy); Flu/Mel: fludarabine (120-180 mg/m2) and melphalan (≤ 150 mg/m2); Flu/Bu2: fludarabine (120-180 mg/m2) with busulfan (≤ 8 mg/kg oral or 6.4 mg/kg IV);~Flu/Bu4, Bu/Cy, and Cy/TBI are myeloablative conditioning regimens, while Flu/Mel and Flu/Bu2 are reduced intensity conditioning regimens."|Participants|Count of Participants|27|27.0||||||
3953552|NCT01339910|3775477|B2||Flu/Mel|Conditioning Regimen|"Flu/Bu4: busulfan (16 mg/kg oral or 12.8 mg/kg IV) and fludarabine (120-180 mg/m2); Bu/Cy: busulfan (16 mg/kg oral or 12.8 mg/kg IV) and cyclophosphamide (120 mg/kg) ; Cy/TBI: cyclophosphamide (120 mg/kg) and total body irradiation (1200-1420 cGy); Flu/Mel: fludarabine (120-180 mg/m2) and melphalan (≤ 150 mg/m2); Flu/Bu2: fludarabine (120-180 mg/m2) with busulfan (≤ 8 mg/kg oral or 6.4 mg/kg IV);~Flu/Bu4, Bu/Cy, and Cy/TBI are myeloablative conditioning regimens, while Flu/Mel and Flu/Bu2 are reduced intensity conditioning regimens."|Participants|Count of Participants|27|27.0||||||
3953553|NCT01339910|3775478|B1||Flu/Mel|Conditioning Regimen|"Flu/Bu4: busulfan (16 mg/kg oral or 12.8 mg/kg IV) and fludarabine (120-180 mg/m2); Bu/Cy: busulfan (16 mg/kg oral or 12.8 mg/kg IV) and cyclophosphamide (120 mg/kg) ; Cy/TBI: cyclophosphamide (120 mg/kg) and total body irradiation (1200-1420 cGy); Flu/Mel: fludarabine (120-180 mg/m2) and melphalan (≤ 150 mg/m2); Flu/Bu2: fludarabine (120-180 mg/m2) with busulfan (≤ 8 mg/kg oral or 6.4 mg/kg IV);~Flu/Bu4, Bu/Cy, and Cy/TBI are myeloablative conditioning regimens, while Flu/Mel and Flu/Bu2 are reduced intensity conditioning regimens."|Participants|Count of Participants|0|0.0||||||
3953554|NCT01339910|3775476|B3||Cy/TBI|Conditioning Regimen|"Flu/Bu4: busulfan (16 mg/kg oral or 12.8 mg/kg IV) and fludarabine (120-180 mg/m2); Bu/Cy: busulfan (16 mg/kg oral or 12.8 mg/kg IV) and cyclophosphamide (120 mg/kg) ; Cy/TBI: cyclophosphamide (120 mg/kg) and total body irradiation (1200-1420 cGy); Flu/Mel: fludarabine (120-180 mg/m2) and melphalan (≤ 150 mg/m2); Flu/Bu2: fludarabine (120-180 mg/m2) with busulfan (≤ 8 mg/kg oral or 6.4 mg/kg IV);~Flu/Bu4, Bu/Cy, and Cy/TBI are myeloablative conditioning regimens, while Flu/Mel and Flu/Bu2 are reduced intensity conditioning regimens."|Participants|Count of Participants|8|8.0||||||
3953555|NCT01339910|3775477|B2||Cy/TBI|Conditioning Regimen|"Flu/Bu4: busulfan (16 mg/kg oral or 12.8 mg/kg IV) and fludarabine (120-180 mg/m2); Bu/Cy: busulfan (16 mg/kg oral or 12.8 mg/kg IV) and cyclophosphamide (120 mg/kg) ; Cy/TBI: cyclophosphamide (120 mg/kg) and total body irradiation (1200-1420 cGy); Flu/Mel: fludarabine (120-180 mg/m2) and melphalan (≤ 150 mg/m2); Flu/Bu2: fludarabine (120-180 mg/m2) with busulfan (≤ 8 mg/kg oral or 6.4 mg/kg IV);~Flu/Bu4, Bu/Cy, and Cy/TBI are myeloablative conditioning regimens, while Flu/Mel and Flu/Bu2 are reduced intensity conditioning regimens."|Participants|Count of Participants|0|0.0||||||
3953556|NCT01339910|3775478|B1||Cy/TBI|Conditioning Regimen|"Flu/Bu4: busulfan (16 mg/kg oral or 12.8 mg/kg IV) and fludarabine (120-180 mg/m2); Bu/Cy: busulfan (16 mg/kg oral or 12.8 mg/kg IV) and cyclophosphamide (120 mg/kg) ; Cy/TBI: cyclophosphamide (120 mg/kg) and total body irradiation (1200-1420 cGy); Flu/Mel: fludarabine (120-180 mg/m2) and melphalan (≤ 150 mg/m2); Flu/Bu2: fludarabine (120-180 mg/m2) with busulfan (≤ 8 mg/kg oral or 6.4 mg/kg IV);~Flu/Bu4, Bu/Cy, and Cy/TBI are myeloablative conditioning regimens, while Flu/Mel and Flu/Bu2 are reduced intensity conditioning regimens."|Participants|Count of Participants|8|8.0||||||
3953557|NCT01339910|3775476|B3||Bu/Cy|Conditioning Regimen|"Flu/Bu4: busulfan (16 mg/kg oral or 12.8 mg/kg IV) and fludarabine (120-180 mg/m2); Bu/Cy: busulfan (16 mg/kg oral or 12.8 mg/kg IV) and cyclophosphamide (120 mg/kg) ; Cy/TBI: cyclophosphamide (120 mg/kg) and total body irradiation (1200-1420 cGy); Flu/Mel: fludarabine (120-180 mg/m2) and melphalan (≤ 150 mg/m2); Flu/Bu2: fludarabine (120-180 mg/m2) with busulfan (≤ 8 mg/kg oral or 6.4 mg/kg IV);~Flu/Bu4, Bu/Cy, and Cy/TBI are myeloablative conditioning regimens, while Flu/Mel and Flu/Bu2 are reduced intensity conditioning regimens."|Participants|Count of Participants|40|40.0||||||
3953558|NCT01339910|3775477|B2||Bu/Cy|Conditioning Regimen|"Flu/Bu4: busulfan (16 mg/kg oral or 12.8 mg/kg IV) and fludarabine (120-180 mg/m2); Bu/Cy: busulfan (16 mg/kg oral or 12.8 mg/kg IV) and cyclophosphamide (120 mg/kg) ; Cy/TBI: cyclophosphamide (120 mg/kg) and total body irradiation (1200-1420 cGy); Flu/Mel: fludarabine (120-180 mg/m2) and melphalan (≤ 150 mg/m2); Flu/Bu2: fludarabine (120-180 mg/m2) with busulfan (≤ 8 mg/kg oral or 6.4 mg/kg IV);~Flu/Bu4, Bu/Cy, and Cy/TBI are myeloablative conditioning regimens, while Flu/Mel and Flu/Bu2 are reduced intensity conditioning regimens."|Participants|Count of Participants|0|0.0||||||
3953625|NCT01339897|3775515|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3953626|NCT01339897|3775516|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3953627|NCT01339897|3775517|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3953559|NCT01339910|3775478|B1||Bu/Cy|Conditioning Regimen|"Flu/Bu4: busulfan (16 mg/kg oral or 12.8 mg/kg IV) and fludarabine (120-180 mg/m2); Bu/Cy: busulfan (16 mg/kg oral or 12.8 mg/kg IV) and cyclophosphamide (120 mg/kg) ; Cy/TBI: cyclophosphamide (120 mg/kg) and total body irradiation (1200-1420 cGy); Flu/Mel: fludarabine (120-180 mg/m2) and melphalan (≤ 150 mg/m2); Flu/Bu2: fludarabine (120-180 mg/m2) with busulfan (≤ 8 mg/kg oral or 6.4 mg/kg IV);~Flu/Bu4, Bu/Cy, and Cy/TBI are myeloablative conditioning regimens, while Flu/Mel and Flu/Bu2 are reduced intensity conditioning regimens."|Participants|Count of Participants|40|40.0||||||
3953560|NCT01339910|3775476|B3||Flu/Bu4|Conditioning Regimen|"Flu/Bu4: busulfan (16 mg/kg oral or 12.8 mg/kg IV) and fludarabine (120-180 mg/m2); Bu/Cy: busulfan (16 mg/kg oral or 12.8 mg/kg IV) and cyclophosphamide (120 mg/kg) ; Cy/TBI: cyclophosphamide (120 mg/kg) and total body irradiation (1200-1420 cGy); Flu/Mel: fludarabine (120-180 mg/m2) and melphalan (≤ 150 mg/m2); Flu/Bu2: fludarabine (120-180 mg/m2) with busulfan (≤ 8 mg/kg oral or 6.4 mg/kg IV);~Flu/Bu4, Bu/Cy, and Cy/TBI are myeloablative conditioning regimens, while Flu/Mel and Flu/Bu2 are reduced intensity conditioning regimens."|Participants|Count of Participants|87|87.0||||||
3953561|NCT01339910|3775477|B2||Flu/Bu4|Conditioning Regimen|"Flu/Bu4: busulfan (16 mg/kg oral or 12.8 mg/kg IV) and fludarabine (120-180 mg/m2); Bu/Cy: busulfan (16 mg/kg oral or 12.8 mg/kg IV) and cyclophosphamide (120 mg/kg) ; Cy/TBI: cyclophosphamide (120 mg/kg) and total body irradiation (1200-1420 cGy); Flu/Mel: fludarabine (120-180 mg/m2) and melphalan (≤ 150 mg/m2); Flu/Bu2: fludarabine (120-180 mg/m2) with busulfan (≤ 8 mg/kg oral or 6.4 mg/kg IV);~Flu/Bu4, Bu/Cy, and Cy/TBI are myeloablative conditioning regimens, while Flu/Mel and Flu/Bu2 are reduced intensity conditioning regimens."|Participants|Count of Participants|0|0.0||||||
3953562|NCT01339910|3775478|B1||Flu/Bu4|Conditioning Regimen|"Flu/Bu4: busulfan (16 mg/kg oral or 12.8 mg/kg IV) and fludarabine (120-180 mg/m2); Bu/Cy: busulfan (16 mg/kg oral or 12.8 mg/kg IV) and cyclophosphamide (120 mg/kg) ; Cy/TBI: cyclophosphamide (120 mg/kg) and total body irradiation (1200-1420 cGy); Flu/Mel: fludarabine (120-180 mg/m2) and melphalan (≤ 150 mg/m2); Flu/Bu2: fludarabine (120-180 mg/m2) with busulfan (≤ 8 mg/kg oral or 6.4 mg/kg IV);~Flu/Bu4, Bu/Cy, and Cy/TBI are myeloablative conditioning regimens, while Flu/Mel and Flu/Bu2 are reduced intensity conditioning regimens."|Participants|Count of Participants|87|87.0||||||
3953563|NCT01339910|3775476|B3||Unknown|HCT-CI|The Hematopoietic Cell Transplantation-specific Comorbidity Index (HCT-CI) (Sorror et al., 2005) summarizes relevant comorbidities present in participants prior to allogeneic transplant. Each comorbidity reported at the time of transplant is given a score of 0, 1, 2, or 3 and the overall HCT-CI score is the sum of the comorbidity scores, ranging from 0 - 26.|Participants|Count of Participants|3|3.0||||||
3953564|NCT01339910|3775477|B2||Unknown|HCT-CI|The Hematopoietic Cell Transplantation-specific Comorbidity Index (HCT-CI) (Sorror et al., 2005) summarizes relevant comorbidities present in participants prior to allogeneic transplant. Each comorbidity reported at the time of transplant is given a score of 0, 1, 2, or 3 and the overall HCT-CI score is the sum of the comorbidity scores, ranging from 0 - 26.|Participants|Count of Participants|1|1.0||||||
3953565|NCT01339910|3775478|B1||Unknown|HCT-CI|The Hematopoietic Cell Transplantation-specific Comorbidity Index (HCT-CI) (Sorror et al., 2005) summarizes relevant comorbidities present in participants prior to allogeneic transplant. Each comorbidity reported at the time of transplant is given a score of 0, 1, 2, or 3 and the overall HCT-CI score is the sum of the comorbidity scores, ranging from 0 - 26.|Participants|Count of Participants|2|2.0||||||
3953566|NCT01339910|3775476|B3||3 or more|HCT-CI|The Hematopoietic Cell Transplantation-specific Comorbidity Index (HCT-CI) (Sorror et al., 2005) summarizes relevant comorbidities present in participants prior to allogeneic transplant. Each comorbidity reported at the time of transplant is given a score of 0, 1, 2, or 3 and the overall HCT-CI score is the sum of the comorbidity scores, ranging from 0 - 26.|Participants|Count of Participants|86|86.0||||||
3953567|NCT01339910|3775477|B2||3 or more|HCT-CI|The Hematopoietic Cell Transplantation-specific Comorbidity Index (HCT-CI) (Sorror et al., 2005) summarizes relevant comorbidities present in participants prior to allogeneic transplant. Each comorbidity reported at the time of transplant is given a score of 0, 1, 2, or 3 and the overall HCT-CI score is the sum of the comorbidity scores, ranging from 0 - 26.|Participants|Count of Participants|44|44.0||||||
3953568|NCT01339910|3775478|B1||3 or more|HCT-CI|The Hematopoietic Cell Transplantation-specific Comorbidity Index (HCT-CI) (Sorror et al., 2005) summarizes relevant comorbidities present in participants prior to allogeneic transplant. Each comorbidity reported at the time of transplant is given a score of 0, 1, 2, or 3 and the overall HCT-CI score is the sum of the comorbidity scores, ranging from 0 - 26.|Participants|Count of Participants|42|42.0||||||
3953569|NCT01339910|3775476|B3||1-2|HCT-CI|The Hematopoietic Cell Transplantation-specific Comorbidity Index (HCT-CI) (Sorror et al., 2005) summarizes relevant comorbidities present in participants prior to allogeneic transplant. Each comorbidity reported at the time of transplant is given a score of 0, 1, 2, or 3 and the overall HCT-CI score is the sum of the comorbidity scores, ranging from 0 - 26.|Participants|Count of Participants|97|97.0||||||
3953570|NCT01339910|3775477|B2||1-2|HCT-CI|The Hematopoietic Cell Transplantation-specific Comorbidity Index (HCT-CI) (Sorror et al., 2005) summarizes relevant comorbidities present in participants prior to allogeneic transplant. Each comorbidity reported at the time of transplant is given a score of 0, 1, 2, or 3 and the overall HCT-CI score is the sum of the comorbidity scores, ranging from 0 - 26.|Participants|Count of Participants|52|52.0||||||
3953571|NCT01339910|3775478|B1||1-2|HCT-CI|The Hematopoietic Cell Transplantation-specific Comorbidity Index (HCT-CI) (Sorror et al., 2005) summarizes relevant comorbidities present in participants prior to allogeneic transplant. Each comorbidity reported at the time of transplant is given a score of 0, 1, 2, or 3 and the overall HCT-CI score is the sum of the comorbidity scores, ranging from 0 - 26.|Participants|Count of Participants|45|45.0||||||
3953572|NCT01339910|3775476|B3||0|HCT-CI|The Hematopoietic Cell Transplantation-specific Comorbidity Index (HCT-CI) (Sorror et al., 2005) summarizes relevant comorbidities present in participants prior to allogeneic transplant. Each comorbidity reported at the time of transplant is given a score of 0, 1, 2, or 3 and the overall HCT-CI score is the sum of the comorbidity scores, ranging from 0 - 26.|Participants|Count of Participants|86|86.0||||||
3953573|NCT01339910|3775477|B2||0|HCT-CI|The Hematopoietic Cell Transplantation-specific Comorbidity Index (HCT-CI) (Sorror et al., 2005) summarizes relevant comorbidities present in participants prior to allogeneic transplant. Each comorbidity reported at the time of transplant is given a score of 0, 1, 2, or 3 and the overall HCT-CI score is the sum of the comorbidity scores, ranging from 0 - 26.|Participants|Count of Participants|40|40.0||||||
3953574|NCT01339910|3775478|B1||0|HCT-CI|The Hematopoietic Cell Transplantation-specific Comorbidity Index (HCT-CI) (Sorror et al., 2005) summarizes relevant comorbidities present in participants prior to allogeneic transplant. Each comorbidity reported at the time of transplant is given a score of 0, 1, 2, or 3 and the overall HCT-CI score is the sum of the comorbidity scores, ranging from 0 - 26.|Participants|Count of Participants|46|46.0||||||
3953575|NCT01339910|3775476|B3||Unknown|Disease Risk Status|Disease risk status is defined according to cytogenetic and molecular abnormalities identified prior to transplantation and classified as standard or high risk. Among AML participants, high-risk disease is defined as the presence of cytogenetic abnormalities at 3q, 9q, 11q, 20q, 21q, or 17p; the presence of del(5q)/-5, -7/del(7q), t(6;9), or t(9;22); and/or FLT-3 internal tandem duplication mutation. Among MDS participants, high-risk disease is defined as the presence of > 10% blasts in bone marrow.|Participants|Count of Participants|12|12.0||||||
3953576|NCT01339910|3775477|B2||Unknown|Disease Risk Status|Disease risk status is defined according to cytogenetic and molecular abnormalities identified prior to transplantation and classified as standard or high risk. Among AML participants, high-risk disease is defined as the presence of cytogenetic abnormalities at 3q, 9q, 11q, 20q, 21q, or 17p; the presence of del(5q)/-5, -7/del(7q), t(6;9), or t(9;22); and/or FLT-3 internal tandem duplication mutation. Among MDS participants, high-risk disease is defined as the presence of > 10% blasts in bone marrow.|Participants|Count of Participants|5|5.0||||||
3953577|NCT01339910|3775478|B1||Unknown|Disease Risk Status|Disease risk status is defined according to cytogenetic and molecular abnormalities identified prior to transplantation and classified as standard or high risk. Among AML participants, high-risk disease is defined as the presence of cytogenetic abnormalities at 3q, 9q, 11q, 20q, 21q, or 17p; the presence of del(5q)/-5, -7/del(7q), t(6;9), or t(9;22); and/or FLT-3 internal tandem duplication mutation. Among MDS participants, high-risk disease is defined as the presence of > 10% blasts in bone marrow.|Participants|Count of Participants|7|7.0||||||
3953578|NCT01339910|3775476|B3||High|Disease Risk Status|Disease risk status is defined according to cytogenetic and molecular abnormalities identified prior to transplantation and classified as standard or high risk. Among AML participants, high-risk disease is defined as the presence of cytogenetic abnormalities at 3q, 9q, 11q, 20q, 21q, or 17p; the presence of del(5q)/-5, -7/del(7q), t(6;9), or t(9;22); and/or FLT-3 internal tandem duplication mutation. Among MDS participants, high-risk disease is defined as the presence of > 10% blasts in bone marrow.|Participants|Count of Participants|115|115.0||||||
3953579|NCT01339910|3775477|B2||High|Disease Risk Status|Disease risk status is defined according to cytogenetic and molecular abnormalities identified prior to transplantation and classified as standard or high risk. Among AML participants, high-risk disease is defined as the presence of cytogenetic abnormalities at 3q, 9q, 11q, 20q, 21q, or 17p; the presence of del(5q)/-5, -7/del(7q), t(6;9), or t(9;22); and/or FLT-3 internal tandem duplication mutation. Among MDS participants, high-risk disease is defined as the presence of > 10% blasts in bone marrow.|Participants|Count of Participants|61|61.0||||||
3953580|NCT01339910|3775478|B1||High|Disease Risk Status|Disease risk status is defined according to cytogenetic and molecular abnormalities identified prior to transplantation and classified as standard or high risk. Among AML participants, high-risk disease is defined as the presence of cytogenetic abnormalities at 3q, 9q, 11q, 20q, 21q, or 17p; the presence of del(5q)/-5, -7/del(7q), t(6;9), or t(9;22); and/or FLT-3 internal tandem duplication mutation. Among MDS participants, high-risk disease is defined as the presence of > 10% blasts in bone marrow.|Participants|Count of Participants|54|54.0||||||
3953581|NCT01339910|3775476|B3||Standard|Disease Risk Status|Disease risk status is defined according to cytogenetic and molecular abnormalities identified prior to transplantation and classified as standard or high risk. Among AML participants, high-risk disease is defined as the presence of cytogenetic abnormalities at 3q, 9q, 11q, 20q, 21q, or 17p; the presence of del(5q)/-5, -7/del(7q), t(6;9), or t(9;22); and/or FLT-3 internal tandem duplication mutation. Among MDS participants, high-risk disease is defined as the presence of > 10% blasts in bone marrow.|Participants|Count of Participants|145|145.0||||||
3953582|NCT01339910|3775477|B2||Standard|Disease Risk Status|Disease risk status is defined according to cytogenetic and molecular abnormalities identified prior to transplantation and classified as standard or high risk. Among AML participants, high-risk disease is defined as the presence of cytogenetic abnormalities at 3q, 9q, 11q, 20q, 21q, or 17p; the presence of del(5q)/-5, -7/del(7q), t(6;9), or t(9;22); and/or FLT-3 internal tandem duplication mutation. Among MDS participants, high-risk disease is defined as the presence of > 10% blasts in bone marrow.|Participants|Count of Participants|71|71.0||||||
3953583|NCT01339910|3775478|B1||Standard|Disease Risk Status|Disease risk status is defined according to cytogenetic and molecular abnormalities identified prior to transplantation and classified as standard or high risk. Among AML participants, high-risk disease is defined as the presence of cytogenetic abnormalities at 3q, 9q, 11q, 20q, 21q, or 17p; the presence of del(5q)/-5, -7/del(7q), t(6;9), or t(9;22); and/or FLT-3 internal tandem duplication mutation. Among MDS participants, high-risk disease is defined as the presence of > 10% blasts in bone marrow.|Participants|Count of Participants|74|74.0||||||
3953584|NCT01339910|3775476|B3|||Disease Duration||months|Median|6|6.0|Full Range|||2.0|130.0|
3953585|NCT01339910|3775477|B2|||Disease Duration||months|Median|6|6.0|Full Range|||2.0|130.0|
3953586|NCT01339910|3775478|B1|||Disease Duration||months|Median|6|6.0|Full Range|||2.0|86.0|
3953587|NCT01339910|3775476|B3||AML, not otherwise specified|AML WHO Classification|"Participants with AML are categorized per 2008 WHO classification (Vardiman et al. 2009). Major features of each class are given below:~AML with recurrent genetic abnormalities: Presence of specific genetic abnormalities known to be prognostic; AML with multilineage dysplasia: > 50% of cells in at least 2 myeloid lineages are dysplastic; AML and MDS, therapy related: development of myeloid neoplasms in response to therapy that is diagnosed as either AML or MDS; AML not otherwise specified: AML that does not satisfy criteria for other classes"|Participants|Count of Participants|161|161.0||||||
3953588|NCT01339910|3775477|B2||AML, not otherwise specified|AML WHO Classification|"Participants with AML are categorized per 2008 WHO classification (Vardiman et al. 2009). Major features of each class are given below:~AML with recurrent genetic abnormalities: Presence of specific genetic abnormalities known to be prognostic; AML with multilineage dysplasia: > 50% of cells in at least 2 myeloid lineages are dysplastic; AML and MDS, therapy related: development of myeloid neoplasms in response to therapy that is diagnosed as either AML or MDS; AML not otherwise specified: AML that does not satisfy criteria for other classes"|Participants|Count of Participants|75|75.0||||||
3953589|NCT01339910|3775478|B1||AML, not otherwise specified|AML WHO Classification|"Participants with AML are categorized per 2008 WHO classification (Vardiman et al. 2009). Major features of each class are given below:~AML with recurrent genetic abnormalities: Presence of specific genetic abnormalities known to be prognostic; AML with multilineage dysplasia: > 50% of cells in at least 2 myeloid lineages are dysplastic; AML and MDS, therapy related: development of myeloid neoplasms in response to therapy that is diagnosed as either AML or MDS; AML not otherwise specified: AML that does not satisfy criteria for other classes"|Participants|Count of Participants|86|86.0||||||
3953590|NCT01339910|3775476|B3||AML and MDS, therapy related|AML WHO Classification|"Participants with AML are categorized per 2008 WHO classification (Vardiman et al. 2009). Major features of each class are given below:~AML with recurrent genetic abnormalities: Presence of specific genetic abnormalities known to be prognostic; AML with multilineage dysplasia: > 50% of cells in at least 2 myeloid lineages are dysplastic; AML and MDS, therapy related: development of myeloid neoplasms in response to therapy that is diagnosed as either AML or MDS; AML not otherwise specified: AML that does not satisfy criteria for other classes"|Participants|Count of Participants|5|5.0||||||
3953591|NCT01339910|3775477|B2||AML and MDS, therapy related|AML WHO Classification|"Participants with AML are categorized per 2008 WHO classification (Vardiman et al. 2009). Major features of each class are given below:~AML with recurrent genetic abnormalities: Presence of specific genetic abnormalities known to be prognostic; AML with multilineage dysplasia: > 50% of cells in at least 2 myeloid lineages are dysplastic; AML and MDS, therapy related: development of myeloid neoplasms in response to therapy that is diagnosed as either AML or MDS; AML not otherwise specified: AML that does not satisfy criteria for other classes"|Participants|Count of Participants|3|3.0||||||
3953592|NCT01339910|3775478|B1||AML and MDS, therapy related|AML WHO Classification|"Participants with AML are categorized per 2008 WHO classification (Vardiman et al. 2009). Major features of each class are given below:~AML with recurrent genetic abnormalities: Presence of specific genetic abnormalities known to be prognostic; AML with multilineage dysplasia: > 50% of cells in at least 2 myeloid lineages are dysplastic; AML and MDS, therapy related: development of myeloid neoplasms in response to therapy that is diagnosed as either AML or MDS; AML not otherwise specified: AML that does not satisfy criteria for other classes"|Participants|Count of Participants|2|2.0||||||
3953593|NCT01339910|3775476|B3||AML with multilineage dysplasia|AML WHO Classification|"Participants with AML are categorized per 2008 WHO classification (Vardiman et al. 2009). Major features of each class are given below:~AML with recurrent genetic abnormalities: Presence of specific genetic abnormalities known to be prognostic; AML with multilineage dysplasia: > 50% of cells in at least 2 myeloid lineages are dysplastic; AML and MDS, therapy related: development of myeloid neoplasms in response to therapy that is diagnosed as either AML or MDS; AML not otherwise specified: AML that does not satisfy criteria for other classes"|Participants|Count of Participants|20|20.0||||||
3953594|NCT01339910|3775477|B2||AML with multilineage dysplasia|AML WHO Classification|"Participants with AML are categorized per 2008 WHO classification (Vardiman et al. 2009). Major features of each class are given below:~AML with recurrent genetic abnormalities: Presence of specific genetic abnormalities known to be prognostic; AML with multilineage dysplasia: > 50% of cells in at least 2 myeloid lineages are dysplastic; AML and MDS, therapy related: development of myeloid neoplasms in response to therapy that is diagnosed as either AML or MDS; AML not otherwise specified: AML that does not satisfy criteria for other classes"|Participants|Count of Participants|12|12.0||||||
3953595|NCT01339910|3775478|B1||AML with multilineage dysplasia|AML WHO Classification|"Participants with AML are categorized per 2008 WHO classification (Vardiman et al. 2009). Major features of each class are given below:~AML with recurrent genetic abnormalities: Presence of specific genetic abnormalities known to be prognostic; AML with multilineage dysplasia: > 50% of cells in at least 2 myeloid lineages are dysplastic; AML and MDS, therapy related: development of myeloid neoplasms in response to therapy that is diagnosed as either AML or MDS; AML not otherwise specified: AML that does not satisfy criteria for other classes"|Participants|Count of Participants|8|8.0||||||
3953596|NCT01339910|3775476|B3||AML with recurrent genetic abnormalities|AML WHO Classification|"Participants with AML are categorized per 2008 WHO classification (Vardiman et al. 2009). Major features of each class are given below:~AML with recurrent genetic abnormalities: Presence of specific genetic abnormalities known to be prognostic; AML with multilineage dysplasia: > 50% of cells in at least 2 myeloid lineages are dysplastic; AML and MDS, therapy related: development of myeloid neoplasms in response to therapy that is diagnosed as either AML or MDS; AML not otherwise specified: AML that does not satisfy criteria for other classes"|Participants|Count of Participants|32|32.0||||||
3953597|NCT01339910|3775477|B2||AML with recurrent genetic abnormalities|AML WHO Classification|"Participants with AML are categorized per 2008 WHO classification (Vardiman et al. 2009). Major features of each class are given below:~AML with recurrent genetic abnormalities: Presence of specific genetic abnormalities known to be prognostic; AML with multilineage dysplasia: > 50% of cells in at least 2 myeloid lineages are dysplastic; AML and MDS, therapy related: development of myeloid neoplasms in response to therapy that is diagnosed as either AML or MDS; AML not otherwise specified: AML that does not satisfy criteria for other classes"|Participants|Count of Participants|20|20.0||||||
3953598|NCT01339910|3775478|B1||AML with recurrent genetic abnormalities|AML WHO Classification|"Participants with AML are categorized per 2008 WHO classification (Vardiman et al. 2009). Major features of each class are given below:~AML with recurrent genetic abnormalities: Presence of specific genetic abnormalities known to be prognostic; AML with multilineage dysplasia: > 50% of cells in at least 2 myeloid lineages are dysplastic; AML and MDS, therapy related: development of myeloid neoplasms in response to therapy that is diagnosed as either AML or MDS; AML not otherwise specified: AML that does not satisfy criteria for other classes"|Participants|Count of Participants|12|12.0||||||
3953599|NCT01339910|3775476|B3||RAEB-2|MDS WHO Classification|"Participants with MDS are categorized per 2008 WHO classification (Vardiman et al. 2009). Major features of each class are given below:~Refractory Anemia (RA): Anemia without marrow blasts or sideroblasts; Refractory Anemia with Ringed Sideroblasts (RARS): > 15% marrow sideroblasts; Refractory Cytopenias with Multilineage Dysplasia (RCMD): Dysplasia in >10% marrow cells; Isolated del(5q) (Del-5q): Isolated del(5q) in marrow; Unclassified (MDS-U) Refractory Anemia with Excess Blasts-1 (RAEB-1): 5-9% marrow blasts; Refractory Anemia with Excess Blasts-2 (RAEB-2): 10-19% marrow blasts;"|Participants|Count of Participants|11|11.0||||||
3953628|NCT01339897|3775513|B5||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3953629|NCT01339897|3775514|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3953600|NCT01339910|3775477|B2||RAEB-2|MDS WHO Classification|"Participants with MDS are categorized per 2008 WHO classification (Vardiman et al. 2009). Major features of each class are given below:~Refractory Anemia (RA): Anemia without marrow blasts or sideroblasts; Refractory Anemia with Ringed Sideroblasts (RARS): > 15% marrow sideroblasts; Refractory Cytopenias with Multilineage Dysplasia (RCMD): Dysplasia in >10% marrow cells; Isolated del(5q) (Del-5q): Isolated del(5q) in marrow; Unclassified (MDS-U) Refractory Anemia with Excess Blasts-1 (RAEB-1): 5-9% marrow blasts; Refractory Anemia with Excess Blasts-2 (RAEB-2): 10-19% marrow blasts;"|Participants|Count of Participants|5|5.0||||||
3953601|NCT01339910|3775478|B1||RAEB-2|MDS WHO Classification|"Participants with MDS are categorized per 2008 WHO classification (Vardiman et al. 2009). Major features of each class are given below:~Refractory Anemia (RA): Anemia without marrow blasts or sideroblasts; Refractory Anemia with Ringed Sideroblasts (RARS): > 15% marrow sideroblasts; Refractory Cytopenias with Multilineage Dysplasia (RCMD): Dysplasia in >10% marrow cells; Isolated del(5q) (Del-5q): Isolated del(5q) in marrow; Unclassified (MDS-U) Refractory Anemia with Excess Blasts-1 (RAEB-1): 5-9% marrow blasts; Refractory Anemia with Excess Blasts-2 (RAEB-2): 10-19% marrow blasts;"|Participants|Count of Participants|6|6.0||||||
3953602|NCT01339910|3775476|B3||RAEB-1|MDS WHO Classification|"Participants with MDS are categorized per 2008 WHO classification (Vardiman et al. 2009). Major features of each class are given below:~Refractory Anemia (RA): Anemia without marrow blasts or sideroblasts; Refractory Anemia with Ringed Sideroblasts (RARS): > 15% marrow sideroblasts; Refractory Cytopenias with Multilineage Dysplasia (RCMD): Dysplasia in >10% marrow cells; Isolated del(5q) (Del-5q): Isolated del(5q) in marrow; Unclassified (MDS-U) Refractory Anemia with Excess Blasts-1 (RAEB-1): 5-9% marrow blasts; Refractory Anemia with Excess Blasts-2 (RAEB-2): 10-19% marrow blasts;"|Participants|Count of Participants|10|10.0||||||
3953603|NCT01339910|3775477|B2||RAEB-1|MDS WHO Classification|"Participants with MDS are categorized per 2008 WHO classification (Vardiman et al. 2009). Major features of each class are given below:~Refractory Anemia (RA): Anemia without marrow blasts or sideroblasts; Refractory Anemia with Ringed Sideroblasts (RARS): > 15% marrow sideroblasts; Refractory Cytopenias with Multilineage Dysplasia (RCMD): Dysplasia in >10% marrow cells; Isolated del(5q) (Del-5q): Isolated del(5q) in marrow; Unclassified (MDS-U) Refractory Anemia with Excess Blasts-1 (RAEB-1): 5-9% marrow blasts; Refractory Anemia with Excess Blasts-2 (RAEB-2): 10-19% marrow blasts;"|Participants|Count of Participants|5|5.0||||||
3953604|NCT01339910|3775478|B1||RAEB-1|MDS WHO Classification|"Participants with MDS are categorized per 2008 WHO classification (Vardiman et al. 2009). Major features of each class are given below:~Refractory Anemia (RA): Anemia without marrow blasts or sideroblasts; Refractory Anemia with Ringed Sideroblasts (RARS): > 15% marrow sideroblasts; Refractory Cytopenias with Multilineage Dysplasia (RCMD): Dysplasia in >10% marrow cells; Isolated del(5q) (Del-5q): Isolated del(5q) in marrow; Unclassified (MDS-U) Refractory Anemia with Excess Blasts-1 (RAEB-1): 5-9% marrow blasts; Refractory Anemia with Excess Blasts-2 (RAEB-2): 10-19% marrow blasts;"|Participants|Count of Participants|5|5.0||||||
3953605|NCT01339910|3775476|B3||RA/RARS/RCMD/RCMD-RS/Del-5q/MDS-U|MDS WHO Classification|"Participants with MDS are categorized per 2008 WHO classification (Vardiman et al. 2009). Major features of each class are given below:~Refractory Anemia (RA): Anemia without marrow blasts or sideroblasts; Refractory Anemia with Ringed Sideroblasts (RARS): > 15% marrow sideroblasts; Refractory Cytopenias with Multilineage Dysplasia (RCMD): Dysplasia in >10% marrow cells; Isolated del(5q) (Del-5q): Isolated del(5q) in marrow; Unclassified (MDS-U) Refractory Anemia with Excess Blasts-1 (RAEB-1): 5-9% marrow blasts; Refractory Anemia with Excess Blasts-2 (RAEB-2): 10-19% marrow blasts;"|Participants|Count of Participants|33|33.0||||||
3953606|NCT01339910|3775477|B2||RA/RARS/RCMD/RCMD-RS/Del-5q/MDS-U|MDS WHO Classification|"Participants with MDS are categorized per 2008 WHO classification (Vardiman et al. 2009). Major features of each class are given below:~Refractory Anemia (RA): Anemia without marrow blasts or sideroblasts; Refractory Anemia with Ringed Sideroblasts (RARS): > 15% marrow sideroblasts; Refractory Cytopenias with Multilineage Dysplasia (RCMD): Dysplasia in >10% marrow cells; Isolated del(5q) (Del-5q): Isolated del(5q) in marrow; Unclassified (MDS-U) Refractory Anemia with Excess Blasts-1 (RAEB-1): 5-9% marrow blasts; Refractory Anemia with Excess Blasts-2 (RAEB-2): 10-19% marrow blasts;"|Participants|Count of Participants|17|17.0||||||
3953607|NCT01339910|3775478|B1||RA/RARS/RCMD/RCMD-RS/Del-5q/MDS-U|MDS WHO Classification|"Participants with MDS are categorized per 2008 WHO classification (Vardiman et al. 2009). Major features of each class are given below:~Refractory Anemia (RA): Anemia without marrow blasts or sideroblasts; Refractory Anemia with Ringed Sideroblasts (RARS): > 15% marrow sideroblasts; Refractory Cytopenias with Multilineage Dysplasia (RCMD): Dysplasia in >10% marrow cells; Isolated del(5q) (Del-5q): Isolated del(5q) in marrow; Unclassified (MDS-U) Refractory Anemia with Excess Blasts-1 (RAEB-1): 5-9% marrow blasts; Refractory Anemia with Excess Blasts-2 (RAEB-2): 10-19% marrow blasts;"|Participants|Count of Participants|16|16.0||||||
3953608|NCT01339910|3775476|B3||Myelodysplastic Syndrome (MDS)|Primary Disease||Participants|Count of Participants|54|54.0||||||
3953609|NCT01339910|3775477|B2||Myelodysplastic Syndrome (MDS)|Primary Disease||Participants|Count of Participants|27|27.0||||||
3953610|NCT01339910|3775478|B1||Myelodysplastic Syndrome (MDS)|Primary Disease||Participants|Count of Participants|27|27.0||||||
3953611|NCT01339910|3775476|B3||Acute Myeloid Leukemia (AML)|Primary Disease||Participants|Count of Participants|218|218.0||||||
3953612|NCT01339910|3775477|B2||Acute Myeloid Leukemia (AML)|Primary Disease||Participants|Count of Participants|110|110.0||||||
3953613|NCT01339910|3775478|B1||Acute Myeloid Leukemia (AML)|Primary Disease||Participants|Count of Participants|108|108.0||||||
3953614|NCT01339910|3775476|B3||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3953615|NCT01339910|3775477|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3953616|NCT01339910|3775478|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3953617|NCT01339910|3775476|B3||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3953618|NCT01339910|3775477|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3953619|NCT01339910|3775478|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3953620|NCT01339910|3775476|B3|||Age||years|Median|54.8|54.8|Full Range|||21.9|66.0|
3953621|NCT01339910|3775477|B2|||Age||years|Median|54.8|54.8|Full Range|||21.9|65.9|
3953622|NCT01339910|3775478|B1|||Age||years|Median|54.8|54.8|Full Range|||21.9|66.0|
3953623|NCT01339897|3775513|B5|United States||Region of Enrollment||participants|Number|25|25.0||||||
3953630|NCT01339897|3775515|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3953631|NCT01339897|3775516|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3953632|NCT01339897|3775517|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3953633|NCT01339897|3775513|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3953634|NCT01339897|3775514|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3953635|NCT01339897|3775515|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3953636|NCT01339897|3775516|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3953637|NCT01339897|3775517|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3953638|NCT01339897|3775513|B5|||Age||years|Median|33|33.0|Full Range|||22.0|45.0|
3953639|NCT01339897|3775514|B4|||Age||years|Median|35|35.0|Full Range|||25.0|45.0|
3953640|NCT01339897|3775515|B3|||Age||years|Median|35|35.0|Full Range|||22.0|45.0|
3953641|NCT01339897|3775516|B2|||Age||years|Median|31|31.0|Full Range|||22.0|45.0|
3953642|NCT01339897|3775517|B1|||Age||years|Median|32|32.0|Full Range|||25.0|39.0|
3953643|NCT01339897|3775513|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3953644|NCT01339897|3775514|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3953645|NCT01339897|3775515|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3953646|NCT01339897|3775516|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3953647|NCT01339897|3775517|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3953648|NCT01339897|3775513|B5||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3953649|NCT01339897|3775514|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3953650|NCT01339897|3775515|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3953651|NCT01339897|3775516|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3953652|NCT01339897|3775517|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3953653|NCT01339897|3775513|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3953654|NCT01339897|3775514|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3953655|NCT01339897|3775515|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3953656|NCT01339897|3775516|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3953657|NCT01339897|3775517|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3953658|NCT01339832|3775546|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3953659|NCT01339832|3775546|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3953660|NCT01339832|3775546|B1|||Age||years|Mean|59.8|59.8|Standard Deviation|8.8|8.8|||
3953661|NCT01339429|3775557|B1|Rwanda||Region of Enrollment||participants|Number|41|41.0||||||
3953662|NCT01339429|3775557|B1|Unknown||Sex/Gender, Customized|Gender was not consistently recorded.|participants|Number|37|37.0||||||
3953663|NCT01339429|3775557|B1|Female||Sex/Gender, Customized|Gender was not consistently recorded.|participants|Number|2|2.0||||||
3953664|NCT01339429|3775557|B1|Male||Sex/Gender, Customized|Gender was not consistently recorded.|participants|Number|2|2.0||||||
3953665|NCT01339429|3775557|B1|14 to 90 Years||Age, Customized||participants|Number|41|41.0||||||
3953666|NCT01339416|3775562|B1||Male|Sex: Female, Male||Participants|Count of Participants|5854|5854.0||||||
3953667|NCT01339416|3775562|B1||Female|Sex: Female, Male||Participants|Count of Participants|2348|2348.0||||||
3953668|NCT01339416|3775562|B1|||Age||years|Median|39|39.0|Inter-Quartile Range|||32.0|46.0|
3953669|NCT01339403|3775572|B3||Male|Sex: Female, Male||Participants|Count of Participants|255928|255928.0||||||
3953670|NCT01339403|3775573|B2||Male|Sex: Female, Male||Participants|Count of Participants|233466|233466.0||||||
3953671|NCT01339403|3775574|B1||Male|Sex: Female, Male||Participants|Count of Participants|22462|22462.0||||||
3953672|NCT01339403|3775572|B3||Female|Sex: Female, Male||Participants|Count of Participants|26440|26440.0||||||
3953673|NCT01339403|3775573|B2||Female|Sex: Female, Male||Participants|Count of Participants|24134|24134.0||||||
3953674|NCT01339403|3775574|B1||Female|Sex: Female, Male||Participants|Count of Participants|2306|2306.0||||||
3953675|NCT01339403|3775572|B3|Greater than (>) 65 years||Age, Customized||participants|Number|4478|4478.0||||||
3953676|NCT01339403|3775573|B2|Greater than (>) 65 years||Age, Customized||participants|Number|4074|4074.0||||||
3953677|NCT01339403|3775574|B1|Greater than (>) 65 years||Age, Customized||participants|Number|404|404.0||||||
3953678|NCT01339403|3775572|B3|Between 60 and 64 years||Age, Customized||participants|Number|6767|6767.0||||||
3953679|NCT01339403|3775573|B2|Between 60 and 64 years||Age, Customized||participants|Number|6154|6154.0||||||
3953680|NCT01339403|3775574|B1|Between 60 and 64 years||Age, Customized||participants|Number|613|613.0||||||
3953681|NCT01339403|3775572|B3|Between 55 and 59 years||Age, Customized||participants|Number|13445|13445.0||||||
3953682|NCT01339403|3775573|B2|Between 55 and 59 years||Age, Customized||participants|Number|12199|12199.0||||||
3953683|NCT01339403|3775574|B1|Between 55 and 59 years||Age, Customized||participants|Number|1246|1246.0||||||
3953684|NCT01339403|3775572|B3|Between 50 and 54 years||Age, Customized||participants|Number|25244|25244.0||||||
3953685|NCT01339403|3775573|B2|Between 50 and 54 years||Age, Customized||participants|Number|22942|22942.0||||||
3953686|NCT01339403|3775574|B1|Between 50 and 54 years||Age, Customized||participants|Number|2302|2302.0||||||
3953687|NCT01339403|3775572|B3|Between 45 and 49 years||Age, Customized||participants|Number|40885|40885.0||||||
3953688|NCT01339403|3775573|B2|Between 45 and 49 years||Age, Customized||participants|Number|37184|37184.0||||||
3953689|NCT01339403|3775574|B1|Between 45 and 49 years||Age, Customized||participants|Number|3701|3701.0||||||
3953690|NCT01339403|3775572|B3|Between 40 and 44 years||Age, Customized||participants|Number|52264|52264.0||||||
3953691|NCT01339403|3775573|B2|Between 40 and 44 years||Age, Customized||participants|Number|47564|47564.0||||||
3953692|NCT01339403|3775574|B1|Between 40 and 44 years||Age, Customized||participants|Number|4700|4700.0||||||
3953693|NCT01339403|3775572|B3|Between 35 and 39 years||Age, Customized||participants|Number|55576|55576.0||||||
3953694|NCT01339403|3775573|B2|Between 35 and 39 years||Age, Customized||participants|Number|50657|50657.0||||||
3953695|NCT01339403|3775574|B1|Between 35 and 39 years||Age, Customized||participants|Number|4919|4919.0||||||
3953696|NCT01339403|3775572|B3|Less than (<) 35 years||Age, Customized||participants|Number|83709|83709.0||||||
3953697|NCT01339403|3775573|B2|Less than (<) 35 years||Age, Customized||participants|Number|76826|76826.0||||||
3953698|NCT01339403|3775574|B1|Less than (<) 35 years||Age, Customized||participants|Number|6883|6883.0||||||
3953699|NCT01339390|3775595|B3|||Weight||pounds|Mean|229.58|229.58|Standard Deviation|43.28|43.28|||
3953700|NCT01339390|3775596|B2|||Weight||pounds|Mean|229.01|229.01|Standard Deviation|42.74|42.74|||
3953701|NCT01339390|3775597|B1|||Weight||pounds|Mean|230.16|230.16|Standard Deviation|43.82|43.82|||
3953702|NCT01339390|3775595|B3|United States||Region of Enrollment||participants|Number|3169|3169.0||||||
3953703|NCT01339390|3775596|B2|United States||Region of Enrollment||participants|Number|1598|1598.0||||||
3953704|NCT01339390|3775597|B1|United States||Region of Enrollment||participants|Number|1571|1571.0||||||
3953705|NCT01339390|3775595|B3||Male|Sex: Female, Male||Participants|Count of Participants|3049|3049.0||||||
3953706|NCT01339390|3775596|B2||Male|Sex: Female, Male||Participants|Count of Participants|1544|1544.0||||||
3953707|NCT01339390|3775597|B1||Male|Sex: Female, Male||Participants|Count of Participants|1505|1505.0||||||
3953708|NCT01339390|3775595|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3953709|NCT01339390|3775596|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3953710|NCT01339390|3775597|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3953711|NCT01339390|3775595|B3|||Age||years|Mean|59.54|59.54|Standard Deviation|10.6|10.6|||
3953712|NCT01339390|3775596|B2|||Age||years|Mean|59.80|59.8|Standard Deviation|10.4|10.4|||
3953713|NCT01339390|3775597|B1|||Age||years|Mean|59.26|59.26|Standard Deviation|10.8|10.8|||
3953714|NCT01339390|3775595|B3||>=65 years|Age||Participants|Count of Participants|1120|1120.0||||||
3953715|NCT01339390|3775596|B2||>=65 years|Age||Participants|Count of Participants|570|570.0||||||
3953716|NCT01339390|3775597|B1||>=65 years|Age||Participants|Count of Participants|550|550.0||||||
3953717|NCT01339390|3775595|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2049|2049.0||||||
3953718|NCT01339390|3775596|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1028|1028.0||||||
3953719|NCT01339390|3775597|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1021|1021.0||||||
3953720|NCT01339390|3775595|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3953721|NCT01339390|3775596|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3953722|NCT01339390|3775597|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3953723|NCT01339299|3775604|B3|Denmark||Region of Enrollment||participants|Number|100|100.0||||||
3953724|NCT01339299|3775605|B2|Denmark||Region of Enrollment||participants|Number|50|50.0||||||
3953725|NCT01339299|3775606|B1|Denmark||Region of Enrollment||participants|Number|50|50.0||||||
3953726|NCT01339299|3775604|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3953727|NCT01339299|3775605|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3953728|NCT01339299|3775606|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3953729|NCT01339299|3775604|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3953730|NCT01339299|3775605|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3953731|NCT01339299|3775606|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3953732|NCT01339299|3775604|B3|||Age||years|Mean|29.9|29.9|Standard Deviation|3.1|3.1|||
3953733|NCT01339299|3775605|B2|||Age||years|Mean|30.1|30.1|Standard Deviation|3.2|3.2|||
3953734|NCT01339299|3775606|B1|||Age||years|Mean|29.7|29.7|Standard Deviation|3.1|3.1|||
3953735|NCT01339299|3775604|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3953736|NCT01339299|3775605|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3953737|NCT01339299|3775606|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3953738|NCT01339299|3775604|B3||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
3953739|NCT01339299|3775605|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3953740|NCT01339299|3775606|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3953741|NCT01339299|3775604|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3953742|NCT01339299|3775605|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3953743|NCT01339299|3775606|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3953744|NCT01339260|3775613|B3|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3953745|NCT01339260|3775614|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3953746|NCT01339260|3775615|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3953747|NCT01339260|3775613|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
3953748|NCT01339260|3775614|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3953749|NCT01339260|3775615|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
3953750|NCT01339260|3775613|B3|Asian||Race/Ethnicity, Customized||participants|Number|204|204.0||||||
3953751|NCT01339260|3775614|B2|Asian||Race/Ethnicity, Customized||participants|Number|103|103.0||||||
3953752|NCT01339260|3775615|B1|Asian||Race/Ethnicity, Customized||participants|Number|101|101.0||||||
3953753|NCT01339260|3775613|B3|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3953754|NCT01339260|3775614|B2|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3953755|NCT01339260|3775615|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3953756|NCT01339260|3775613|B3|White||Race/Ethnicity, Customized||participants|Number|1153|1153.0||||||
3953757|NCT01339260|3775614|B2|White||Race/Ethnicity, Customized||participants|Number|579|579.0||||||
3953758|NCT01339260|3775615|B1|White||Race/Ethnicity, Customized||participants|Number|574|574.0||||||
3953759|NCT01339260|3775613|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3953760|NCT01339260|3775614|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3953761|NCT01339260|3775615|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3953762|NCT01339260|3775613|B3||Female|Sex: Female, Male||Participants|Count of Participants|1422|1422.0||||||
3953763|NCT01339260|3775614|B2||Female|Sex: Female, Male||Participants|Count of Participants|711|711.0||||||
3953764|NCT01339260|3775615|B1||Female|Sex: Female, Male||Participants|Count of Participants|711|711.0||||||
3953765|NCT01339260|3775613|B3|||Age||years|Mean|53.9|53.9|Standard Deviation|10.65|10.65|||
3953766|NCT01339260|3775614|B2|||Age||years|Mean|54.1|54.1|Standard Deviation|10.65|10.65|||
3953767|NCT01339260|3775615|B1|||Age||years|Mean|53.7|53.7|Standard Deviation|10.66|10.66|||
3953768|NCT01339247|3775628|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3953769|NCT01339247|3775628|B1|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3953770|NCT01339247|3775628|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3953771|NCT01339247|3775628|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3953772|NCT01339247|3775628|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3953773|NCT01339247|3775628|B1|||Age||Years|Mean|27.73|27.73|Standard Deviation|4.65|4.65|||
3953774|NCT01339091|3775639|B3||Male|Sex: Female, Male||Participants|Count of Participants|343|343.0||||||
3953775|NCT01339091|3775640|B2||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
3953776|NCT01339091|3775641|B1||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
3953777|NCT01339091|3775639|B3||Female|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
3953778|NCT01339091|3775640|B2||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3953779|NCT01339091|3775641|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3953780|NCT01339091|3775639|B3|||Age||years|Mean|48.9|48.9|Standard Deviation|15.18|15.18|||
3953781|NCT01339091|3775640|B2|||Age||years|Mean|48.9|48.9|Standard Deviation|15.08|15.08|||
3953782|NCT01339091|3775641|B1|||Age||years|Mean|48.8|48.8|Standard Deviation|15.3|15.3|||
3953783|NCT01339052|3775654|B3|Unknown/Pending||Mutation Status at Registration||Participants|Count of Participants|61|61.0||||||
3953784|NCT01339052|3775655|B2|Unknown/Pending||Mutation Status at Registration||Participants|Count of Participants|47|47.0||||||
3953785|NCT01339052|3775656|B1|Unknown/Pending||Mutation Status at Registration||Participants|Count of Participants|14|14.0||||||
3953786|NCT01339052|3775654|B3|Negative||Mutation Status at Registration||Participants|Count of Participants|1|1.0||||||
3953787|NCT01339052|3775655|B2|Negative||Mutation Status at Registration||Participants|Count of Participants|1|1.0||||||
3953788|NCT01339052|3775656|B1|Negative||Mutation Status at Registration||Participants|Count of Participants|0|0.0||||||
3953789|NCT01339052|3775654|B3|PIK3CA mutation||Mutation Status at Registration||Participants|Count of Participants|3|3.0||||||
3953790|NCT01339052|3775655|B2|PIK3CA mutation||Mutation Status at Registration||Participants|Count of Participants|2|2.0||||||
3953791|NCT01339052|3775656|B1|PIK3CA mutation||Mutation Status at Registration||Participants|Count of Participants|1|1.0||||||
3953792|NCT01339052|3775654|B3|Unknown/Pending||pAKT StatusStatus at Registration via Central Path Review||Participants|Count of Participants|9|9.0||||||
3953793|NCT01339052|3775655|B2|Unknown/Pending||pAKT StatusStatus at Registration via Central Path Review||Participants|Count of Participants|9|9.0||||||
3953794|NCT01339052|3775656|B1|Unknown/Pending||pAKT StatusStatus at Registration via Central Path Review||Participants|Count of Participants|0|0.0||||||
3953795|NCT01339052|3775654|B3|pAKT Negative||pAKT StatusStatus at Registration via Central Path Review||Participants|Count of Participants|2|2.0||||||
3953796|NCT01339052|3775655|B2|pAKT Negative||pAKT StatusStatus at Registration via Central Path Review||Participants|Count of Participants|2|2.0||||||
3953797|NCT01339052|3775656|B1|pAKT Negative||pAKT StatusStatus at Registration via Central Path Review||Participants|Count of Participants|0|0.0||||||
3953798|NCT01339052|3775654|B3|pAKT Positive||pAKT StatusStatus at Registration via Central Path Review||Participants|Count of Participants|54|54.0||||||
3953799|NCT01339052|3775655|B2|pAKT Positive||pAKT StatusStatus at Registration via Central Path Review||Participants|Count of Participants|39|39.0||||||
3953800|NCT01339052|3775656|B1|pAKT Positive||pAKT StatusStatus at Registration via Central Path Review||Participants|Count of Participants|15|15.0||||||
3953801|NCT01339052|3775654|B3|Unknown/Pending||PTEN Status at Registration via Central Path Review||Participants|Count of Participants|2|2.0||||||
3953802|NCT01339052|3775655|B2|Unknown/Pending||PTEN Status at Registration via Central Path Review||Participants|Count of Participants|2|2.0||||||
3953803|NCT01339052|3775656|B1|Unknown/Pending||PTEN Status at Registration via Central Path Review||Participants|Count of Participants|0|0.0||||||
3953804|NCT01339052|3775654|B3|PTEN Mutant||PTEN Status at Registration via Central Path Review||Participants|Count of Participants|1|1.0||||||
3953805|NCT01339052|3775655|B2|PTEN Mutant||PTEN Status at Registration via Central Path Review||Participants|Count of Participants|1|1.0||||||
3953806|NCT01339052|3775656|B1|PTEN Mutant||PTEN Status at Registration via Central Path Review||Participants|Count of Participants|0|0.0||||||
3953807|NCT01339052|3775654|B3|PTEN loss by FISH||PTEN Status at Registration via Central Path Review||Participants|Count of Participants|1|1.0||||||
3953808|NCT01339052|3775655|B2|PTEN loss by FISH||PTEN Status at Registration via Central Path Review||Participants|Count of Participants|1|1.0||||||
3953809|NCT01339052|3775656|B1|PTEN loss by FISH||PTEN Status at Registration via Central Path Review||Participants|Count of Participants|0|0.0||||||
3953810|NCT01339052|3775654|B3|Not PTEN Negative||PTEN Status at Registration via Central Path Review||Participants|Count of Participants|20|20.0||||||
3953811|NCT01339052|3775655|B2|Not PTEN Negative||PTEN Status at Registration via Central Path Review||Participants|Count of Participants|12|12.0||||||
3953812|NCT01339052|3775656|B1|Not PTEN Negative||PTEN Status at Registration via Central Path Review||Participants|Count of Participants|8|8.0||||||
3953813|NCT01339052|3775654|B3|PTEN Negative||PTEN Status at Registration via Central Path Review||Participants|Count of Participants|41|41.0||||||
3953814|NCT01339052|3775655|B2|PTEN Negative||PTEN Status at Registration via Central Path Review||Participants|Count of Participants|34|34.0||||||
3953815|NCT01339052|3775656|B1|PTEN Negative||PTEN Status at Registration via Central Path Review||Participants|Count of Participants|7|7.0||||||
3953816|NCT01339052|3775654|B3|Oligodendroglioma||Initial Tumor Diagnosis||Participants|Count of Participants|1|1.0||||||
3953817|NCT01339052|3775655|B2|Oligodendroglioma||Initial Tumor Diagnosis||Participants|Count of Participants|1|1.0||||||
3953818|NCT01339052|3775656|B1|Oligodendroglioma||Initial Tumor Diagnosis||Participants|Count of Participants|0|0.0||||||
3953819|NCT01339052|3775654|B3|High grade astrocytoma/glioblastoma||Initial Tumor Diagnosis||Participants|Count of Participants|1|1.0||||||
3953820|NCT01339052|3775655|B2|High grade astrocytoma/glioblastoma||Initial Tumor Diagnosis||Participants|Count of Participants|1|1.0||||||
3953821|NCT01339052|3775656|B1|High grade astrocytoma/glioblastoma||Initial Tumor Diagnosis||Participants|Count of Participants|0|0.0||||||
3953822|NCT01339052|3775654|B3|Gliosarcoma||Initial Tumor Diagnosis||Participants|Count of Participants|1|1.0||||||
3953823|NCT01339052|3775655|B2|Gliosarcoma||Initial Tumor Diagnosis||Participants|Count of Participants|1|1.0||||||
3953824|NCT01339052|3775656|B1|Gliosarcoma||Initial Tumor Diagnosis||Participants|Count of Participants|0|0.0||||||
3953825|NCT01339052|3775654|B3|Glioma consistent w/ mixed Oligoastrocytoma||Initial Tumor Diagnosis||Participants|Count of Participants|1|1.0||||||
3953826|NCT01339052|3775655|B2|Glioma consistent w/ mixed Oligoastrocytoma||Initial Tumor Diagnosis||Participants|Count of Participants|1|1.0||||||
3953827|NCT01339052|3775656|B1|Glioma consistent w/ mixed Oligoastrocytoma||Initial Tumor Diagnosis||Participants|Count of Participants|0|0.0||||||
3953828|NCT01339052|3775654|B3|Gemistocytic Astrocyoma||Initial Tumor Diagnosis||Participants|Count of Participants|1|1.0||||||
3953829|NCT01339052|3775655|B2|Gemistocytic Astrocyoma||Initial Tumor Diagnosis||Participants|Count of Participants|1|1.0||||||
3953830|NCT01339052|3775656|B1|Gemistocytic Astrocyoma||Initial Tumor Diagnosis||Participants|Count of Participants|0|0.0||||||
3953831|NCT01339052|3775654|B3|Anaplastic Astrocytoma (AA)||Initial Tumor Diagnosis||Participants|Count of Participants|3|3.0||||||
3953832|NCT01339052|3775655|B2|Anaplastic Astrocytoma (AA)||Initial Tumor Diagnosis||Participants|Count of Participants|3|3.0||||||
3953833|NCT01339052|3775656|B1|Anaplastic Astrocytoma (AA)||Initial Tumor Diagnosis||Participants|Count of Participants|0|0.0||||||
3953834|NCT01339052|3775654|B3|Astrocytoma||Initial Tumor Diagnosis||Participants|Count of Participants|1|1.0||||||
3953835|NCT01339052|3775655|B2|Astrocytoma||Initial Tumor Diagnosis||Participants|Count of Participants|1|1.0||||||
3953836|NCT01339052|3775656|B1|Astrocytoma||Initial Tumor Diagnosis||Participants|Count of Participants|0|0.0||||||
3953837|NCT01339052|3775654|B3|Gr4 Right Parietal Glioma||Initial Tumor Diagnosis||Participants|Count of Participants|1|1.0||||||
3953838|NCT01339052|3775655|B2|Gr4 Right Parietal Glioma||Initial Tumor Diagnosis||Participants|Count of Participants|0|0.0||||||
3953839|NCT01339052|3775656|B1|Gr4 Right Parietal Glioma||Initial Tumor Diagnosis||Participants|Count of Participants|1|1.0||||||
3953840|NCT01339052|3775654|B3|Anaplastic Astrocytoma (AA) merging w Glioblastoma||Initial Tumor Diagnosis||Participants|Count of Participants|1|1.0||||||
3953841|NCT01339052|3775655|B2|Anaplastic Astrocytoma (AA) merging w Glioblastoma||Initial Tumor Diagnosis||Participants|Count of Participants|0|0.0||||||
3953842|NCT01339052|3775656|B1|Anaplastic Astrocytoma (AA) merging w Glioblastoma||Initial Tumor Diagnosis||Participants|Count of Participants|1|1.0||||||
3953843|NCT01339052|3775654|B3|Glioblastoma Multiforme (GBM)||Initial Tumor Diagnosis||Participants|Count of Participants|54|54.0||||||
3953844|NCT01339052|3775655|B2|Glioblastoma Multiforme (GBM)||Initial Tumor Diagnosis||Participants|Count of Participants|41|41.0||||||
3953845|NCT01339052|3775656|B1|Glioblastoma Multiforme (GBM)||Initial Tumor Diagnosis||Participants|Count of Participants|13|13.0||||||
3953846|NCT01339052|3775654|B3|Gliosarcoma||Current Tumor Diagnosis||Participants|Count of Participants|3|3.0||||||
3953847|NCT01339052|3775655|B2|Gliosarcoma||Current Tumor Diagnosis||Participants|Count of Participants|3|3.0||||||
3953848|NCT01339052|3775656|B1|Gliosarcoma||Current Tumor Diagnosis||Participants|Count of Participants|0|0.0||||||
3953849|NCT01339052|3775654|B3|Glioblstoma Multiforme (GBM)||Current Tumor Diagnosis||Participants|Count of Participants|62|62.0||||||
3953850|NCT01339052|3775655|B2|Glioblstoma Multiforme (GBM)||Current Tumor Diagnosis||Participants|Count of Participants|47|47.0||||||
3953851|NCT01339052|3775656|B1|Glioblstoma Multiforme (GBM)||Current Tumor Diagnosis||Participants|Count of Participants|15|15.0||||||
3953852|NCT01339052|3775654|B3||100|Karnofsky performance status (KPS)|'Karnofsky Performance Status' (KPS) scale: 100 = Normal; no complaints; no evidence of disease; 90 = Able to carry on normal activity; minor signs or symptoms of disease; 80 = Normal activity with effort; some sign or symptoms of disease; 70 = Cares for self; unable to carry on normal activity or do active work.|Participants|Count of Participants|11|11.0||||||
3953853|NCT01339052|3775655|B2||100|Karnofsky performance status (KPS)|'Karnofsky Performance Status' (KPS) scale: 100 = Normal; no complaints; no evidence of disease; 90 = Able to carry on normal activity; minor signs or symptoms of disease; 80 = Normal activity with effort; some sign or symptoms of disease; 70 = Cares for self; unable to carry on normal activity or do active work.|Participants|Count of Participants|9|9.0||||||
3953854|NCT01339052|3775656|B1||100|Karnofsky performance status (KPS)|'Karnofsky Performance Status' (KPS) scale: 100 = Normal; no complaints; no evidence of disease; 90 = Able to carry on normal activity; minor signs or symptoms of disease; 80 = Normal activity with effort; some sign or symptoms of disease; 70 = Cares for self; unable to carry on normal activity or do active work.|Participants|Count of Participants|2|2.0||||||
3953855|NCT01339052|3775654|B3||90|Karnofsky performance status (KPS)|'Karnofsky Performance Status' (KPS) scale: 100 = Normal; no complaints; no evidence of disease; 90 = Able to carry on normal activity; minor signs or symptoms of disease; 80 = Normal activity with effort; some sign or symptoms of disease; 70 = Cares for self; unable to carry on normal activity or do active work.|Participants|Count of Participants|33|33.0||||||
3953856|NCT01339052|3775655|B2||90|Karnofsky performance status (KPS)|'Karnofsky Performance Status' (KPS) scale: 100 = Normal; no complaints; no evidence of disease; 90 = Able to carry on normal activity; minor signs or symptoms of disease; 80 = Normal activity with effort; some sign or symptoms of disease; 70 = Cares for self; unable to carry on normal activity or do active work.|Participants|Count of Participants|23|23.0||||||
3953857|NCT01339052|3775656|B1||90|Karnofsky performance status (KPS)|'Karnofsky Performance Status' (KPS) scale: 100 = Normal; no complaints; no evidence of disease; 90 = Able to carry on normal activity; minor signs or symptoms of disease; 80 = Normal activity with effort; some sign or symptoms of disease; 70 = Cares for self; unable to carry on normal activity or do active work.|Participants|Count of Participants|10|10.0||||||
3953858|NCT01339052|3775654|B3||80|Karnofsky performance status (KPS)|'Karnofsky Performance Status' (KPS) scale: 100 = Normal; no complaints; no evidence of disease; 90 = Able to carry on normal activity; minor signs or symptoms of disease; 80 = Normal activity with effort; some sign or symptoms of disease; 70 = Cares for self; unable to carry on normal activity or do active work.|Participants|Count of Participants|17|17.0||||||
3953859|NCT01339052|3775655|B2||80|Karnofsky performance status (KPS)|'Karnofsky Performance Status' (KPS) scale: 100 = Normal; no complaints; no evidence of disease; 90 = Able to carry on normal activity; minor signs or symptoms of disease; 80 = Normal activity with effort; some sign or symptoms of disease; 70 = Cares for self; unable to carry on normal activity or do active work.|Participants|Count of Participants|15|15.0||||||
3953860|NCT01339052|3775656|B1||80|Karnofsky performance status (KPS)|'Karnofsky Performance Status' (KPS) scale: 100 = Normal; no complaints; no evidence of disease; 90 = Able to carry on normal activity; minor signs or symptoms of disease; 80 = Normal activity with effort; some sign or symptoms of disease; 70 = Cares for self; unable to carry on normal activity or do active work.|Participants|Count of Participants|2|2.0||||||
3953861|NCT01339052|3775654|B3||70|Karnofsky performance status (KPS)|'Karnofsky Performance Status' (KPS) scale: 100 = Normal; no complaints; no evidence of disease; 90 = Able to carry on normal activity; minor signs or symptoms of disease; 80 = Normal activity with effort; some sign or symptoms of disease; 70 = Cares for self; unable to carry on normal activity or do active work.|Participants|Count of Participants|4|4.0||||||
3953862|NCT01339052|3775655|B2||70|Karnofsky performance status (KPS)|'Karnofsky Performance Status' (KPS) scale: 100 = Normal; no complaints; no evidence of disease; 90 = Able to carry on normal activity; minor signs or symptoms of disease; 80 = Normal activity with effort; some sign or symptoms of disease; 70 = Cares for self; unable to carry on normal activity or do active work.|Participants|Count of Participants|3|3.0||||||
3953863|NCT01339052|3775656|B1||70|Karnofsky performance status (KPS)|'Karnofsky Performance Status' (KPS) scale: 100 = Normal; no complaints; no evidence of disease; 90 = Able to carry on normal activity; minor signs or symptoms of disease; 80 = Normal activity with effort; some sign or symptoms of disease; 70 = Cares for self; unable to carry on normal activity or do active work.|Participants|Count of Participants|1|1.0||||||
3953864|NCT01339052|3775654|B3|United States||Region of Enrollment||Participants|Count of Participants|65|65.0||||||
3953865|NCT01339052|3775655|B2|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3953866|NCT01339052|3775656|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3953867|NCT01339052|3775654|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3953868|NCT01339052|3775655|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3953869|NCT01339052|3775656|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3953870|NCT01339052|3775654|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953871|NCT01339052|3775655|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953872|NCT01339052|3775656|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953873|NCT01339052|3775654|B3||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3953874|NCT01339052|3775655|B2||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3953875|NCT01339052|3775656|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3953876|NCT01339052|3775654|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953877|NCT01339052|3775655|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953878|NCT01339052|3775656|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953879|NCT01339052|3775654|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953880|NCT01339052|3775655|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953881|NCT01339052|3775656|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953882|NCT01339052|3775654|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3953883|NCT01339052|3775655|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3953884|NCT01339052|3775656|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953885|NCT01339052|3775654|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953886|NCT01339052|3775655|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953949|NCT01339000|3775681|B3|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
3953887|NCT01339052|3775656|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953888|NCT01339052|3775654|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3953889|NCT01339052|3775655|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3953890|NCT01339052|3775656|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3953891|NCT01339052|3775654|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3953892|NCT01339052|3775655|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3953893|NCT01339052|3775656|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3953894|NCT01339052|3775654|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3953895|NCT01339052|3775655|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3953896|NCT01339052|3775656|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953897|NCT01339052|3775654|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3953898|NCT01339052|3775655|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3953899|NCT01339052|3775656|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3953900|NCT01339052|3775654|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3953901|NCT01339052|3775655|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3953902|NCT01339052|3775656|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3953903|NCT01339052|3775654|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3953904|NCT01339052|3775655|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3953905|NCT01339052|3775656|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3953906|NCT01339052|3775654|B3||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
3953907|NCT01339052|3775655|B2||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
3953908|NCT01339052|3775656|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3953909|NCT01339052|3775654|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3953910|NCT01339052|3775655|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3953911|NCT01339052|3775656|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3953912|NCT01339013|3775677|B1|Sweden||Region of Enrollment||participants|Number|6|6.0||||||
3953913|NCT01339013|3775677|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3953914|NCT01339013|3775677|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3953915|NCT01339013|3775677|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3953916|NCT01339013|3775677|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3953917|NCT01339013|3775677|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3953918|NCT01339013|3775677|B1|||Age||years|Median|63|63.0|Full Range|||58.0|75.0|
3953919|NCT01339000|3775681|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3953920|NCT01339000|3775683|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3953921|NCT01339000|3775681|B3|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
3953922|NCT01339000|3775683|B1|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
3953923|NCT01339000|3775681|B3|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
3953924|NCT01339000|3775683|B1|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
3953925|NCT01339000|3775681|B3|White||Race (NIH/OMB)||participants|Number|1|1.0||||||
3953926|NCT01339000|3775683|B1|White||Race (NIH/OMB)||participants|Number|1|1.0||||||
3953927|NCT01339000|3775681|B3|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
3953928|NCT01339000|3775683|B1|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
3953929|NCT01339000|3775681|B3|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
3953930|NCT01339000|3775683|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
3953931|NCT01339000|3775681|B3|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
3953932|NCT01339000|3775683|B1|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
3953933|NCT01339000|3775681|B3|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
3953934|NCT01339000|3775683|B1|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
3953935|NCT01339000|3775681|B3|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
3953936|NCT01339000|3775683|B1|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
3953937|NCT01339000|3775681|B3|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|1|1.0||||||
3953938|NCT01339000|3775683|B1|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|1|1.0||||||
3953939|NCT01339000|3775681|B3|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
3953940|NCT01339000|3775683|B1|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
3953941|NCT01339000|3775681|B3|Male||Gender||participants|Number|1|1.0||||||
3953942|NCT01339000|3775683|B1|Male||Gender||participants|Number|1|1.0||||||
3953943|NCT01339000|3775681|B3|Female||Gender||participants|Number|0|0.0||||||
3953944|NCT01339000|3775683|B1|Female||Gender||participants|Number|0|0.0||||||
3953945|NCT01339000|3775681|B3|||Age||years|Mean|61.3|61.3|Standard Deviation|0|0.0|||
3953946|NCT01339000|3775683|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|0|0.0|||
3953947|NCT01339000|3775681|B3|>=65 years||Age||participants|Number|0|0.0||||||
3953948|NCT01339000|3775683|B1|>=65 years||Age||participants|Number|0|0.0||||||
3953950|NCT01339000|3775683|B1|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
3953951|NCT01339000|3775681|B3|<=18 years||Age||participants|Number|0|0.0||||||
3953952|NCT01339000|3775683|B1|<=18 years||Age||participants|Number|0|0.0||||||
3953953|NCT01338870|3775698|B7||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3953954|NCT01338870|3775699|B6||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3953955|NCT01338870|3775700|B5||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3953956|NCT01338870|3775701|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3953957|NCT01338870|3775702|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3953958|NCT01338870|3775703|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3953959|NCT01338870|3775704|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3953960|NCT01338870|3775698|B7||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3953961|NCT01338870|3775699|B6||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3953962|NCT01338870|3775700|B5||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3953963|NCT01338870|3775701|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3953964|NCT01338870|3775702|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3953965|NCT01338870|3775703|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3953966|NCT01338870|3775704|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3953967|NCT01338870|3775698|B7|||Age||years|Mean|56.6|56.6|Standard Deviation|8.3|8.3|||
3953968|NCT01338870|3775699|B6|||Age||years|Mean|55.6|55.6|Standard Deviation|9.0|9.0|||
3953969|NCT01338870|3775700|B5|||Age||years|Mean|56.0|56.0|Standard Deviation|7.7|7.7|||
3953970|NCT01338870|3775701|B4|||Age||years|Mean|57.2|57.2|Standard Deviation|8.7|8.7|||
3953971|NCT01338870|3775702|B3|||Age||years|Mean|56.1|56.1|Standard Deviation|8.6|8.6|||
3953972|NCT01338870|3775703|B2|||Age||years|Mean|59.2|59.2|Standard Deviation|6.8|6.8|||
3953973|NCT01338870|3775704|B1|||Age||years|Mean|55.7|55.7|Standard Deviation|8.8|8.8|||
3953974|NCT01338857|3775759|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3953975|NCT01338857|3775759|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
3953976|NCT01338857|3775759|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
3953977|NCT01338857|3775759|B1|||Age||years|Mean|9.25|9.25|Standard Deviation|3|3.0|||
3953978|NCT01338818|3775764|B1||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3953979|NCT01338818|3775764|B1||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3953980|NCT01338818|3775764|B1|||Age||years|Mean|36.3|36.3|Standard Deviation|11.4|11.4|||
3953981|NCT01338792|3775770|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
3953982|NCT01338792|3775770|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3953983|NCT01338792|3775770|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953984|NCT01338792|3775770|B1||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3953985|NCT01338792|3775770|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3953986|NCT01338792|3775770|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953987|NCT01338792|3775770|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3953988|NCT01338792|3775770|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953989|NCT01338792|3775770|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3953990|NCT01338792|3775770|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3953991|NCT01338792|3775770|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3953992|NCT01338792|3775770|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3953993|NCT01338792|3775770|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3953994|NCT01338792|3775770|B1||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
3953995|NCT01338792|3775770|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3953996|NCT01338792|3775770|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3953997|NCT01338649|3775776|B3|United States||Region of Enrollment|number of participants|participants|Number|27|27.0||||||
3953998|NCT01338649|3775777|B2|United States||Region of Enrollment|number of participants|participants|Number|14|14.0||||||
3953999|NCT01338649|3775778|B1|United States||Region of Enrollment|number of participants|participants|Number|13|13.0||||||
3954000|NCT01338649|3775776|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3954001|NCT01338649|3775777|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3954002|NCT01338649|3775778|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3954003|NCT01338649|3775776|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3954004|NCT01338649|3775777|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3954005|NCT01338649|3775778|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3954006|NCT01338649|3775776|B3|||Age||years|Mean|63.6|63.6|Standard Deviation|9.9|9.9|||
3954007|NCT01338649|3775777|B2|||Age||years|Mean|59.3|59.3|Standard Deviation|11.3|11.3|||
3954008|NCT01338649|3775778|B1|||Age||years|Mean|67|67.0|Standard Deviation|6.9|6.9|||
3954009|NCT01338636|3775785|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3954010|NCT01338636|3775785|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3954011|NCT01338636|3775785|B1|||Age||years|Mean|60.12|60.12|Standard Deviation|9.17|9.17|||
3954012|NCT01338610|3775796|B4|United States||Region of Enrollment||participants|Number|124|124.0||||||
3954013|NCT01338610|3775797|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
3954014|NCT01338610|3775798|B2|United States||Region of Enrollment||participants|Number|56|56.0||||||
3954015|NCT01338610|3775799|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
3954016|NCT01338610|3775796|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3954017|NCT01338610|3775797|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3954018|NCT01338610|3775798|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3954019|NCT01338610|3775799|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3954020|NCT01338610|3775796|B4||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3954021|NCT01338610|3775797|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3954022|NCT01338610|3775798|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3954023|NCT01338610|3775799|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3954024|NCT01338610|3775796|B4|≥65||Age, Customized||participants|Number|47|47.0||||||
3954025|NCT01338610|3775797|B3|≥65||Age, Customized||participants|Number|8|8.0||||||
3954026|NCT01338610|3775798|B2|≥65||Age, Customized||participants|Number|24|24.0||||||
3954027|NCT01338610|3775799|B1|≥65||Age, Customized||participants|Number|15|15.0||||||
3954028|NCT01338610|3775796|B4|<65||Age, Customized||participants|Number|77|77.0||||||
3954029|NCT01338610|3775797|B3|<65||Age, Customized||participants|Number|21|21.0||||||
3954030|NCT01338610|3775798|B2|<65||Age, Customized||participants|Number|32|32.0||||||
3954031|NCT01338610|3775799|B1|<65||Age, Customized||participants|Number|24|24.0||||||
3954032|NCT01338493|3775808|B1|Germany||Region of Enrollment||participants|Number|50|50.0||||||
3954033|NCT01338493|3775808|B1|Canada||Region of Enrollment||participants|Number|5|5.0||||||
3954034|NCT01338493|3775808|B1|France||Region of Enrollment||participants|Number|79|79.0||||||
3954035|NCT01338493|3775808|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3954036|NCT01338493|3775808|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3954037|NCT01338493|3775808|B1|||Age||years|Mean|43|43.0|Standard Deviation|9.0|9.0|||
3954038|NCT01338415|3775813|B3||FC III|World Health Organization functional class (WHO FC)|The World Health Organization (WHO) defines 4 classes to classify the functional status of patients with pulmonary hypertension: Class I (FC I): No limitation of physical activity; Class II (FC II): Slight limitation of physical activity; Class III (FC III): Marked limitation of physical activity; Class IV (FC IV): Inability to carry out any physical activity without symptoms.|Participants|Count of Participants|18|18.0||||||
3954039|NCT01338415|3775814|B2||FC III|World Health Organization functional class (WHO FC)|The World Health Organization (WHO) defines 4 classes to classify the functional status of patients with pulmonary hypertension: Class I (FC I): No limitation of physical activity; Class II (FC II): Slight limitation of physical activity; Class III (FC III): Marked limitation of physical activity; Class IV (FC IV): Inability to carry out any physical activity without symptoms.|Participants|Count of Participants|6|6.0||||||
3954040|NCT01338415|3775815|B1||FC III|World Health Organization functional class (WHO FC)|The World Health Organization (WHO) defines 4 classes to classify the functional status of patients with pulmonary hypertension: Class I (FC I): No limitation of physical activity; Class II (FC II): Slight limitation of physical activity; Class III (FC III): Marked limitation of physical activity; Class IV (FC IV): Inability to carry out any physical activity without symptoms.|Participants|Count of Participants|12|12.0||||||
3954041|NCT01338415|3775813|B3||FC II|World Health Organization functional class (WHO FC)|The World Health Organization (WHO) defines 4 classes to classify the functional status of patients with pulmonary hypertension: Class I (FC I): No limitation of physical activity; Class II (FC II): Slight limitation of physical activity; Class III (FC III): Marked limitation of physical activity; Class IV (FC IV): Inability to carry out any physical activity without symptoms.|Participants|Count of Participants|27|27.0||||||
3954042|NCT01338415|3775814|B2||FC II|World Health Organization functional class (WHO FC)|The World Health Organization (WHO) defines 4 classes to classify the functional status of patients with pulmonary hypertension: Class I (FC I): No limitation of physical activity; Class II (FC II): Slight limitation of physical activity; Class III (FC III): Marked limitation of physical activity; Class IV (FC IV): Inability to carry out any physical activity without symptoms.|Participants|Count of Participants|15|15.0||||||
3954043|NCT01338415|3775815|B1||FC II|World Health Organization functional class (WHO FC)|The World Health Organization (WHO) defines 4 classes to classify the functional status of patients with pulmonary hypertension: Class I (FC I): No limitation of physical activity; Class II (FC II): Slight limitation of physical activity; Class III (FC III): Marked limitation of physical activity; Class IV (FC IV): Inability to carry out any physical activity without symptoms.|Participants|Count of Participants|12|12.0||||||
3954044|NCT01338415|3775813|B3||FC I|World Health Organization functional class (WHO FC)|The World Health Organization (WHO) defines 4 classes to classify the functional status of patients with pulmonary hypertension: Class I (FC I): No limitation of physical activity; Class II (FC II): Slight limitation of physical activity; Class III (FC III): Marked limitation of physical activity; Class IV (FC IV): Inability to carry out any physical activity without symptoms.|Participants|Count of Participants|19|19.0||||||
3954045|NCT01338415|3775814|B2||FC I|World Health Organization functional class (WHO FC)|The World Health Organization (WHO) defines 4 classes to classify the functional status of patients with pulmonary hypertension: Class I (FC I): No limitation of physical activity; Class II (FC II): Slight limitation of physical activity; Class III (FC III): Marked limitation of physical activity; Class IV (FC IV): Inability to carry out any physical activity without symptoms.|Participants|Count of Participants|10|10.0||||||
3954068|NCT01338415|3775813|B3|Race as per protocol|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3954069|NCT01338415|3775814|B2|Race as per protocol|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3954046|NCT01338415|3775815|B1||FC I|World Health Organization functional class (WHO FC)|The World Health Organization (WHO) defines 4 classes to classify the functional status of patients with pulmonary hypertension: Class I (FC I): No limitation of physical activity; Class II (FC II): Slight limitation of physical activity; Class III (FC III): Marked limitation of physical activity; Class IV (FC IV): Inability to carry out any physical activity without symptoms.|Participants|Count of Participants|9|9.0||||||
3954047|NCT01338415|3775813|B3||Missing|Pulmonary Arterial Hypertension (PAH) etiology|Children had a diagnosis of PAH belonging to one of the following categories: - Idiopathic PAH - Heritable PAH - Associated PAH persisting after complete repair of a congenital heart defect - PAH-congenital heart disease (PAH-CHD) associated with open shunts|Participants|Count of Participants|1|1.0||||||
3954048|NCT01338415|3775814|B2||Missing|Pulmonary Arterial Hypertension (PAH) etiology|Children had a diagnosis of PAH belonging to one of the following categories: - Idiopathic PAH - Heritable PAH - Associated PAH persisting after complete repair of a congenital heart defect - PAH-congenital heart disease (PAH-CHD) associated with open shunts|Participants|Count of Participants|1|1.0||||||
3954049|NCT01338415|3775815|B1||Missing|Pulmonary Arterial Hypertension (PAH) etiology|Children had a diagnosis of PAH belonging to one of the following categories: - Idiopathic PAH - Heritable PAH - Associated PAH persisting after complete repair of a congenital heart defect - PAH-congenital heart disease (PAH-CHD) associated with open shunts|Participants|Count of Participants|0|0.0||||||
3954050|NCT01338415|3775813|B3||Associated PAH (i.e.,PAH after surgery for CHD)|Pulmonary Arterial Hypertension (PAH) etiology|Children had a diagnosis of PAH belonging to one of the following categories: - Idiopathic PAH - Heritable PAH - Associated PAH persisting after complete repair of a congenital heart defect - PAH-congenital heart disease (PAH-CHD) associated with open shunts|Participants|Count of Participants|24|24.0||||||
3954051|NCT01338415|3775814|B2||Associated PAH (i.e.,PAH after surgery for CHD)|Pulmonary Arterial Hypertension (PAH) etiology|Children had a diagnosis of PAH belonging to one of the following categories: - Idiopathic PAH - Heritable PAH - Associated PAH persisting after complete repair of a congenital heart defect - PAH-congenital heart disease (PAH-CHD) associated with open shunts|Participants|Count of Participants|13|13.0||||||
3954052|NCT01338415|3775815|B1||Associated PAH (i.e.,PAH after surgery for CHD)|Pulmonary Arterial Hypertension (PAH) etiology|Children had a diagnosis of PAH belonging to one of the following categories: - Idiopathic PAH - Heritable PAH - Associated PAH persisting after complete repair of a congenital heart defect - PAH-congenital heart disease (PAH-CHD) associated with open shunts|Participants|Count of Participants|11|11.0||||||
3954053|NCT01338415|3775813|B3||Congenital heart disease|Pulmonary Arterial Hypertension (PAH) etiology|Children had a diagnosis of PAH belonging to one of the following categories: - Idiopathic PAH - Heritable PAH - Associated PAH persisting after complete repair of a congenital heart defect - PAH-congenital heart disease (PAH-CHD) associated with open shunts|Participants|Count of Participants|8|8.0||||||
3954054|NCT01338415|3775814|B2||Congenital heart disease|Pulmonary Arterial Hypertension (PAH) etiology|Children had a diagnosis of PAH belonging to one of the following categories: - Idiopathic PAH - Heritable PAH - Associated PAH persisting after complete repair of a congenital heart defect - PAH-congenital heart disease (PAH-CHD) associated with open shunts|Participants|Count of Participants|2|2.0||||||
3954055|NCT01338415|3775815|B1||Congenital heart disease|Pulmonary Arterial Hypertension (PAH) etiology|Children had a diagnosis of PAH belonging to one of the following categories: - Idiopathic PAH - Heritable PAH - Associated PAH persisting after complete repair of a congenital heart defect - PAH-congenital heart disease (PAH-CHD) associated with open shunts|Participants|Count of Participants|6|6.0||||||
3954056|NCT01338415|3775813|B3||Heritable|Pulmonary Arterial Hypertension (PAH) etiology|Children had a diagnosis of PAH belonging to one of the following categories: - Idiopathic PAH - Heritable PAH - Associated PAH persisting after complete repair of a congenital heart defect - PAH-congenital heart disease (PAH-CHD) associated with open shunts|Participants|Count of Participants|2|2.0||||||
3954057|NCT01338415|3775814|B2||Heritable|Pulmonary Arterial Hypertension (PAH) etiology|Children had a diagnosis of PAH belonging to one of the following categories: - Idiopathic PAH - Heritable PAH - Associated PAH persisting after complete repair of a congenital heart defect - PAH-congenital heart disease (PAH-CHD) associated with open shunts|Participants|Count of Participants|0|0.0||||||
3954058|NCT01338415|3775815|B1||Heritable|Pulmonary Arterial Hypertension (PAH) etiology|Children had a diagnosis of PAH belonging to one of the following categories: - Idiopathic PAH - Heritable PAH - Associated PAH persisting after complete repair of a congenital heart defect - PAH-congenital heart disease (PAH-CHD) associated with open shunts|Participants|Count of Participants|2|2.0||||||
3954059|NCT01338415|3775813|B3||Idiopathic|Pulmonary Arterial Hypertension (PAH) etiology|Children had a diagnosis of PAH belonging to one of the following categories: - Idiopathic PAH - Heritable PAH - Associated PAH persisting after complete repair of a congenital heart defect - PAH-congenital heart disease (PAH-CHD) associated with open shunts|Participants|Count of Participants|29|29.0||||||
3954060|NCT01338415|3775814|B2||Idiopathic|Pulmonary Arterial Hypertension (PAH) etiology|Children had a diagnosis of PAH belonging to one of the following categories: - Idiopathic PAH - Heritable PAH - Associated PAH persisting after complete repair of a congenital heart defect - PAH-congenital heart disease (PAH-CHD) associated with open shunts|Participants|Count of Participants|15|15.0||||||
3954061|NCT01338415|3775815|B1||Idiopathic|Pulmonary Arterial Hypertension (PAH) etiology|Children had a diagnosis of PAH belonging to one of the following categories: - Idiopathic PAH - Heritable PAH - Associated PAH persisting after complete repair of a congenital heart defect - PAH-congenital heart disease (PAH-CHD) associated with open shunts|Participants|Count of Participants|14|14.0||||||
3954062|NCT01338415|3775813|B3|Race as per protocol|Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3954063|NCT01338415|3775814|B2|Race as per protocol|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3954064|NCT01338415|3775815|B1|Race as per protocol|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3954065|NCT01338415|3775813|B3|Race as per protocol|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3954066|NCT01338415|3775814|B2|Race as per protocol|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3954067|NCT01338415|3775815|B1|Race as per protocol|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3954070|NCT01338415|3775815|B1|Race as per protocol|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3954071|NCT01338415|3775813|B3|Race as per protocol|Black|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3954072|NCT01338415|3775814|B2|Race as per protocol|Black|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3954073|NCT01338415|3775815|B1|Race as per protocol|Black|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3954074|NCT01338415|3775813|B3|Race as per protocol|Caucasian/White|Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
3954075|NCT01338415|3775814|B2|Race as per protocol|Caucasian/White|Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3954076|NCT01338415|3775815|B1|Race as per protocol|Caucasian/White|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3954077|NCT01338415|3775813|B3||Male|Sex: Female, Male|Number of males and females randomized in the FUTURE 3 core study (AC-052-373)|Participants|Count of Participants|36|36.0||||||
3954078|NCT01338415|3775814|B2||Male|Sex: Female, Male|Number of males and females randomized in the FUTURE 3 core study (AC-052-373)|Participants|Count of Participants|21|21.0||||||
3954079|NCT01338415|3775815|B1||Male|Sex: Female, Male|Number of males and females randomized in the FUTURE 3 core study (AC-052-373)|Participants|Count of Participants|15|15.0||||||
3954080|NCT01338415|3775813|B3||Female|Sex: Female, Male|Number of males and females randomized in the FUTURE 3 core study (AC-052-373)|Participants|Count of Participants|28|28.0||||||
3954081|NCT01338415|3775814|B2||Female|Sex: Female, Male|Number of males and females randomized in the FUTURE 3 core study (AC-052-373)|Participants|Count of Participants|10|10.0||||||
3954082|NCT01338415|3775815|B1||Female|Sex: Female, Male|Number of males and females randomized in the FUTURE 3 core study (AC-052-373)|Participants|Count of Participants|18|18.0||||||
3954083|NCT01338415|3775813|B3|Age Categories as per protocol|Children (2-11 years)|Age, Customized|Number of subjects in each age category at randomization in the FUTURE 3 core study (AC-052-373)|Participants|Count of Participants|43|43.0||||||
3954084|NCT01338415|3775814|B2|Age Categories as per protocol|Children (2-11 years)|Age, Customized|Number of subjects in each age category at randomization in the FUTURE 3 core study (AC-052-373)|Participants|Count of Participants|20|20.0||||||
3954085|NCT01338415|3775815|B1|Age Categories as per protocol|Children (2-11 years)|Age, Customized|Number of subjects in each age category at randomization in the FUTURE 3 core study (AC-052-373)|Participants|Count of Participants|23|23.0||||||
3954086|NCT01338415|3775813|B3|Age Categories as per protocol|Infants and toddlers (28 days-23 months)|Age, Customized|Number of subjects in each age category at randomization in the FUTURE 3 core study (AC-052-373)|Participants|Count of Participants|21|21.0||||||
3954087|NCT01338415|3775814|B2|Age Categories as per protocol|Infants and toddlers (28 days-23 months)|Age, Customized|Number of subjects in each age category at randomization in the FUTURE 3 core study (AC-052-373)|Participants|Count of Participants|11|11.0||||||
3954088|NCT01338415|3775815|B1|Age Categories as per protocol|Infants and toddlers (28 days-23 months)|Age, Customized|Number of subjects in each age category at randomization in the FUTURE 3 core study (AC-052-373)|Participants|Count of Participants|10|10.0||||||
3954089|NCT01338415|3775813|B3|||Age|Age at randomization in the FUTURE 3 core study (AC-052-373)|years|Mean|4.8|4.8|Standard Deviation|3.57|3.57|||
3954090|NCT01338415|3775814|B2|||Age|Age at randomization in the FUTURE 3 core study (AC-052-373)|years|Mean|5.2|5.2|Standard Deviation|3.81|3.81|||
3954091|NCT01338415|3775815|B1|||Age|Age at randomization in the FUTURE 3 core study (AC-052-373)|years|Mean|4.5|4.5|Standard Deviation|3.35|3.35|||
3954092|NCT01338298|3775836|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
3954093|NCT01338298|3775837|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
3954094|NCT01338298|3775838|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3954095|NCT01338298|3775836|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3954096|NCT01338298|3775837|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3954097|NCT01338298|3775838|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3954098|NCT01338298|3775836|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3954099|NCT01338298|3775837|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3954100|NCT01338298|3775838|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3954101|NCT01338298|3775836|B3|||Age||years|Mean|36.6|36.6|Standard Deviation|9.4|9.4|||
3954102|NCT01338298|3775837|B2|||Age||years|Mean|36.0|36.0|Standard Deviation|10.1|10.1|||
3954103|NCT01338298|3775838|B1|||Age||years|Mean|37.8|37.8|Standard Deviation|8.9|8.9|||
3954104|NCT01338298|3775836|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3954105|NCT01338298|3775837|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3954106|NCT01338298|3775838|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3954107|NCT01338298|3775836|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3954108|NCT01338298|3775837|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3954109|NCT01338298|3775838|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3954110|NCT01338298|3775836|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3954111|NCT01338298|3775837|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3954112|NCT01338298|3775838|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3954113|NCT01338025|3775847|B3|||HIV-1 RNA viral load||log10 copies/mL|Mean|3.9|3.9|Standard Deviation|0.9|0.9|||
3954114|NCT01338025|3775848|B2|||HIV-1 RNA viral load||log10 copies/mL|Mean|3.8|3.8|Standard Deviation|0.7|0.7|||
3954115|NCT01338025|3775849|B1|||HIV-1 RNA viral load||log10 copies/mL|Mean|4.0|4.0|Standard Deviation|1.0|1.0|||
3954116|NCT01338025|3775847|B3|||Screening CD4 count||cells/mm3|Mean|510|510.0|Standard Deviation|232|232.0|||
3954117|NCT01338025|3775848|B2|||Screening CD4 count||cells/mm3|Mean|511|511.0|Standard Deviation|277|277.0|||
3954118|NCT01338025|3775849|B1|||Screening CD4 count||cells/mm3|Mean|509|509.0|Standard Deviation|176|176.0|||
3954119|NCT01338025|3775847|B3|Thailand||Region of Enrollment||participants|Number|6|6.0||||||
3954120|NCT01338025|3775848|B2|Thailand||Region of Enrollment||participants|Number|3|3.0||||||
3954121|NCT01338025|3775849|B1|Thailand||Region of Enrollment||participants|Number|3|3.0||||||
3954122|NCT01338025|3775847|B3|Brazil||Region of Enrollment||participants|Number|5|5.0||||||
3954123|NCT01338025|3775848|B2|Brazil||Region of Enrollment||participants|Number|4|4.0||||||
3954124|NCT01338025|3775849|B1|Brazil||Region of Enrollment||participants|Number|1|1.0||||||
3954125|NCT01338025|3775847|B3|Argentina||Region of Enrollment||participants|Number|3|3.0||||||
3954126|NCT01338025|3775848|B2|Argentina||Region of Enrollment||participants|Number|1|1.0||||||
3954127|NCT01338025|3775849|B1|Argentina||Region of Enrollment||participants|Number|2|2.0||||||
3954128|NCT01338025|3775847|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
3954129|NCT01338025|3775848|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3954130|NCT01338025|3775849|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3954131|NCT01338025|3775847|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954132|NCT01338025|3775848|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954133|NCT01338025|3775849|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954134|NCT01338025|3775847|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954135|NCT01338025|3775848|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954136|NCT01338025|3775849|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954137|NCT01338025|3775847|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3954138|NCT01338025|3775848|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3954139|NCT01338025|3775849|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3954140|NCT01338025|3775847|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3954141|NCT01338025|3775848|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3954142|NCT01338025|3775849|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3954143|NCT01338025|3775847|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954144|NCT01338025|3775848|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954145|NCT01338025|3775849|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954146|NCT01338025|3775847|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3954147|NCT01338025|3775848|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3954148|NCT01338025|3775849|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3954149|NCT01338025|3775847|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954150|NCT01338025|3775848|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954151|NCT01338025|3775849|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954152|NCT01338025|3775847|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3954153|NCT01338025|3775848|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954154|NCT01338025|3775849|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3954155|NCT01338025|3775847|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3954156|NCT01338025|3775848|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3954157|NCT01338025|3775849|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3954158|NCT01338025|3775847|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3954159|NCT01338025|3775848|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3954160|NCT01338025|3775849|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3954161|NCT01338025|3775847|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3954162|NCT01338025|3775848|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3954163|NCT01338025|3775849|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3954164|NCT01338025|3775847|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3954165|NCT01338025|3775848|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3954166|NCT01338025|3775849|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3954167|NCT01338025|3775847|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3954168|NCT01338025|3775848|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3954169|NCT01338025|3775849|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3954170|NCT01338025|3775847|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3954171|NCT01338025|3775848|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3954172|NCT01338025|3775849|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3954173|NCT01338025|3775847|B3||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
3954174|NCT01338025|3775848|B2||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
3954175|NCT01338025|3775849|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
3954227|NCT01337739|3775892|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3954176|NCT01338012|3775862|B1|ECOG 1= Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|2|2.0||||||
3954177|NCT01338012|3775862|B1|ECOG 0=Fully Active; No restrictions||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|6|6.0||||||
3954178|NCT01338012|3775862|B1|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3954179|NCT01338012|3775862|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954180|NCT01338012|3775862|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954181|NCT01338012|3775862|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3954182|NCT01338012|3775862|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954183|NCT01338012|3775862|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954184|NCT01338012|3775862|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954185|NCT01338012|3775862|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954186|NCT01338012|3775862|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3954187|NCT01338012|3775862|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3954188|NCT01338012|3775862|B1|||Age||years|Mean|74.4|74.4|Full Range|||66.0|83.0|
3954189|NCT01338012|3775862|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3954190|NCT01338012|3775862|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3954191|NCT01338012|3775862|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3954192|NCT01337960|3775866|B4|United States||Region of Enrollment||participants|Number|34|34.0||||||
3954193|NCT01337960|3775867|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3954194|NCT01337960|3775868|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3954195|NCT01337960|3775869|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3954196|NCT01337960|3775866|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3954197|NCT01337960|3775867|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3954198|NCT01337960|3775868|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3954199|NCT01337960|3775869|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3954200|NCT01337960|3775866|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3954201|NCT01337960|3775867|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3954202|NCT01337960|3775868|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3954203|NCT01337960|3775869|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3954204|NCT01337960|3775866|B4|||Age||years|Mean|57.8|57.8|Standard Deviation|11.1|11.1|||
3954205|NCT01337960|3775867|B3|||Age||years|Mean|56.7|56.7|Standard Deviation|15.2|15.2|||
3954206|NCT01337960|3775868|B2|||Age||years|Mean|59.5|59.5|Standard Deviation|15.3|15.3|||
3954207|NCT01337960|3775869|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|13.2|13.2|||
3954208|NCT01337739|3775891|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3954209|NCT01337739|3775892|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3954210|NCT01337739|3775893|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3954211|NCT01337739|3775891|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3954212|NCT01337739|3775892|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3954213|NCT01337739|3775893|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3954214|NCT01337739|3775891|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3954215|NCT01337739|3775892|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3954216|NCT01337739|3775893|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3954217|NCT01337739|3775891|B3|||Age||years|Mean|42.8|42.8|Standard Deviation|8.13|8.13|||
3954218|NCT01337739|3775892|B2|||Age||years|Mean|41.5|41.5|Standard Deviation|7.43|7.43|||
3954219|NCT01337739|3775893|B1|||Age||years|Mean|43.6|43.6|Standard Deviation|8.4|8.4|||
3954220|NCT01337739|3775891|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3954221|NCT01337739|3775892|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3954222|NCT01337739|3775893|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3954223|NCT01337739|3775891|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3954224|NCT01337739|3775892|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3954225|NCT01337739|3775893|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3954226|NCT01337739|3775891|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3954228|NCT01337739|3775893|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3954229|NCT01337674|3775902|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3954230|NCT01337674|3775903|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3954231|NCT01337674|3775904|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3954232|NCT01337674|3775902|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3954233|NCT01337674|3775903|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3954234|NCT01337674|3775904|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3954235|NCT01337674|3775902|B3|||Age||Years|Mean|54.5|54.5|Full Range|||41.0|77.0|
3954236|NCT01337674|3775903|B2|||Age||Years|Mean|55.2|55.2|Full Range|||41.0|77.0|
3954237|NCT01337674|3775904|B1|||Age||Years|Mean|53.8|53.8|Full Range|||42.0|68.0|
3954238|NCT01337635|3775923|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
3954239|NCT01337635|3775924|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3954240|NCT01337635|3775925|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3954241|NCT01337635|3775923|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3954242|NCT01337635|3775924|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3954243|NCT01337635|3775925|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3954244|NCT01337635|3775923|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3954245|NCT01337635|3775924|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3954246|NCT01337635|3775925|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3954247|NCT01337635|3775923|B3|||Age||years|Mean|6.7|6.7|Full Range|||2.0|15.0|
3954248|NCT01337635|3775924|B2|||Age||years|Mean|5|5.0|Full Range|||2.0|10.0|
3954249|NCT01337635|3775925|B1|||Age||years|Mean|9|9.0|Full Range|||3.0|15.0|
3954250|NCT01337635|3775923|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3954251|NCT01337635|3775924|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3954252|NCT01337635|3775925|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3954253|NCT01337635|3775923|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3954254|NCT01337635|3775924|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3954255|NCT01337635|3775925|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3954256|NCT01337635|3775923|B3||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
3954257|NCT01337635|3775924|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3954258|NCT01337635|3775925|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3954259|NCT01337609|3775934|B4|United States||Region of Enrollment||participants|Number|5|5.0||||||
3954260|NCT01337609|3775935|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3954261|NCT01337609|3775936|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3954262|NCT01337609|3775937|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3954263|NCT01337609|3775934|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954264|NCT01337609|3775935|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954265|NCT01337609|3775936|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954266|NCT01337609|3775937|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954267|NCT01337609|3775934|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954268|NCT01337609|3775935|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954269|NCT01337609|3775936|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954270|NCT01337609|3775937|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954271|NCT01337609|3775934|B4||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3954272|NCT01337609|3775935|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3954273|NCT01337609|3775936|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3954274|NCT01337609|3775937|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3954275|NCT01337609|3775934|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954276|NCT01337609|3775935|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954277|NCT01337609|3775936|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954278|NCT01337609|3775937|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954279|NCT01337609|3775934|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954280|NCT01337609|3775935|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954281|NCT01337609|3775936|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954282|NCT01337609|3775937|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954283|NCT01337609|3775934|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954284|NCT01337609|3775935|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954285|NCT01337609|3775936|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954286|NCT01337609|3775937|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954287|NCT01337609|3775934|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954402|NCT01337050|3776081|B2|||Age||years|Mean|56.5|56.5|Standard Deviation|12.4|12.4|||
3954288|NCT01337609|3775935|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954289|NCT01337609|3775936|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954290|NCT01337609|3775937|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954291|NCT01337609|3775934|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954292|NCT01337609|3775935|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954293|NCT01337609|3775936|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954294|NCT01337609|3775937|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954295|NCT01337609|3775934|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3954296|NCT01337609|3775935|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3954297|NCT01337609|3775936|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3954298|NCT01337609|3775937|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3954299|NCT01337609|3775934|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954300|NCT01337609|3775935|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954301|NCT01337609|3775936|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954302|NCT01337609|3775937|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954303|NCT01337609|3775934|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3954304|NCT01337609|3775935|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3954305|NCT01337609|3775936|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3954306|NCT01337609|3775937|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3954307|NCT01337609|3775934|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3954308|NCT01337609|3775935|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3954309|NCT01337609|3775936|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3954310|NCT01337609|3775937|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3954311|NCT01337609|3775934|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3954312|NCT01337609|3775935|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3954313|NCT01337609|3775936|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3954314|NCT01337609|3775937|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3954315|NCT01337609|3775934|B4||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3954316|NCT01337609|3775935|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3954317|NCT01337609|3775936|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3954318|NCT01337609|3775937|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3954319|NCT01337609|3775934|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3954320|NCT01337609|3775935|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3954321|NCT01337609|3775936|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3954322|NCT01337609|3775937|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3954323|NCT01337336|3775959|B3||Male|Sex: Female, Male||Participants|Count of Participants|1349|1349.0||||||
3954324|NCT01337336|3775960|B2||Male|Sex: Female, Male||Participants|Count of Participants|1013|1013.0||||||
3954325|NCT01337336|3775961|B1||Male|Sex: Female, Male||Participants|Count of Participants|336|336.0||||||
3954326|NCT01337336|3775959|B3||Female|Sex: Female, Male||Participants|Count of Participants|2652|2652.0||||||
3954327|NCT01337336|3775960|B2||Female|Sex: Female, Male||Participants|Count of Participants|1910|1910.0||||||
3954328|NCT01337336|3775961|B1||Female|Sex: Female, Male||Participants|Count of Participants|742|742.0||||||
3954329|NCT01337336|3775959|B3|||Age||Years|Mean|59.6|59.6|Standard Deviation|10.2|10.2|||
3954330|NCT01337336|3775960|B2|||Age||Years|Mean|60.3|60.3|Standard Deviation|10.3|10.3|||
3954331|NCT01337336|3775961|B1|||Age||Years|Mean|57.8|57.8|Standard Deviation|9.8|9.8|||
3954332|NCT01337297|3775974|B3|Brazil||Region of Enrollment||participants|Number|20|20.0||||||
3954333|NCT01337297|3775975|B2|Brazil||Region of Enrollment||participants|Number|9|9.0||||||
3954334|NCT01337297|3775976|B1|Brazil||Region of Enrollment||participants|Number|11|11.0||||||
3954335|NCT01337297|3775974|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3954336|NCT01337297|3775975|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3954337|NCT01337297|3775976|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3954338|NCT01337297|3775974|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3954339|NCT01337297|3775975|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3954340|NCT01337297|3775976|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3954341|NCT01337297|3775974|B3|||Age||years|Mean|29.5|29.5|Standard Deviation|6.3|6.3|||
3954342|NCT01337297|3775975|B2|||Age||years|Mean|28.3|28.3|Standard Deviation|5.0|5.0|||
3954343|NCT01337297|3775976|B1|||Age||years|Mean|30.5|30.5|Standard Deviation|7.3|7.3|||
3954344|NCT01337297|3775974|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3954345|NCT01337297|3775975|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3954346|NCT01337297|3775976|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3954347|NCT01337297|3775974|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3954348|NCT01337297|3775975|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3954349|NCT01337297|3775976|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3954350|NCT01337297|3775974|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3954351|NCT01337297|3775975|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3954352|NCT01337297|3775976|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3954353|NCT01337167|3775983|B3||Male|Sex: Female, Male||Participants|Count of Participants|780|780.0||||||
3954354|NCT01337167|3775984|B2||Male|Sex: Female, Male||Participants|Count of Participants|273|273.0||||||
3954355|NCT01337167|3775985|B1||Male|Sex: Female, Male||Participants|Count of Participants|507|507.0||||||
3954356|NCT01337167|3775983|B3||Female|Sex: Female, Male||Participants|Count of Participants|693|693.0||||||
3954357|NCT01337167|3775984|B2||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
3954358|NCT01337167|3775985|B1||Female|Sex: Female, Male||Participants|Count of Participants|479|479.0||||||
3954359|NCT01337167|3775983|B3|||Age||Days|Mean|65.4|65.4|Standard Deviation|7.3|7.3|||
3954360|NCT01337167|3775984|B2|||Age||Days|Mean|65.0|65.0|Standard Deviation|6.9|6.9|||
3954361|NCT01337167|3775985|B1|||Age||Days|Mean|65.6|65.6|Standard Deviation|7.5|7.5|||
3954362|NCT01337115|3776052|B3|Portugal||Region of Enrollment||participants|Number|50|50.0||||||
3954363|NCT01337115|3776053|B2|Portugal||Region of Enrollment||participants|Number|25|25.0||||||
3954364|NCT01337115|3776054|B1|Portugal||Region of Enrollment||participants|Number|25|25.0||||||
3954365|NCT01337115|3776052|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3954366|NCT01337115|3776053|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3954367|NCT01337115|3776054|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3954368|NCT01337115|3776052|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3954369|NCT01337115|3776053|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3954370|NCT01337115|3776054|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3954371|NCT01337115|3776052|B3|||Age||years|Mean|66.8|66.8|Standard Deviation|9.4|9.4|||
3954372|NCT01337115|3776053|B2|||Age||years|Mean|65.44|65.44|Standard Deviation|8.93|8.93|||
3954373|NCT01337115|3776054|B1|||Age||years|Mean|68.16|68.16|Standard Deviation|9.83|9.83|||
3954374|NCT01337115|3776052|B3||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3954375|NCT01337115|3776053|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3954376|NCT01337115|3776054|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3954377|NCT01337115|3776052|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3954378|NCT01337115|3776053|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3954379|NCT01337115|3776054|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3954380|NCT01337115|3776052|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3954381|NCT01337115|3776053|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3954382|NCT01337115|3776054|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3954383|NCT01337089|3776067|B1||Male|Sex: Female, Male||Participants|Count of Participants|347|347.0||||||
3954384|NCT01337089|3776067|B1||Female|Sex: Female, Male||Participants|Count of Participants|313|313.0||||||
3954385|NCT01337089|3776067|B1|||Age||years|Mean|60.2|60.2|Standard Deviation|11.1|11.1|||
3954386|NCT01337076|3776075|B1|||Preoperative AzBio Sentence Noise score - Treated Ear|AzBio Sentence Test (Spahr & Dorman, 2005). The AzBio Test is a validated test that consists of 15 lists of 20 sentences each. Each list includes 5 sentences from each of 4 different male and female speakers. Each word in the sentence counts towards the overall score. Subjects will be tested using a configuration of speech and noise at 0º azimuth.|percent correct|Mean|9.9|9.9|Full Range|||0.0|34.8|
3954387|NCT01337076|3776075|B1|||Preoperative HINT Quiet score - Treated Ear|The Hearing in Noise Test (HINT) (Nilsson et al. 1994). The HINT sentences are recorded and consist of 25 equivalent lists. Each test list contains 10 sentences that vary from 3 to 7 words in length. Subjects will be tested in quiet using a configuration of speech at 0º azimuth in quiet.|percent correct|Mean|62.3|62.3|Full Range|||47.2|86.4|
3954388|NCT01337076|3776075|B1|||Preoperative CNC word score - Treated Ear|Consonant Nucleus Consonant (CNC) Monosyllabic Word Test (Peterson & Lehiste, 1962). CNC Word Test is a validated test of open-set word recognition. The test consists of 10 lists with 50 monosyllabic words in each list. Subject responses are scored for words correct in the correct sequence. Subjects will be tested using a configuration of speech at 0º azimuth in quiet.|percent correct|Mean|23.6|23.6|Full Range|||12.0|35.0|
3954389|NCT01337076|3776075|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3954390|NCT01337076|3776075|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3954391|NCT01337076|3776075|B1|||Age||years|Mean|77|77.0|Full Range|||32.0|88.0|
3954392|NCT01337050|3776079|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3954393|NCT01337050|3776080|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3954394|NCT01337050|3776081|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3954395|NCT01337050|3776082|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3954396|NCT01337050|3776079|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3954397|NCT01337050|3776080|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3954398|NCT01337050|3776081|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3954399|NCT01337050|3776082|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3954400|NCT01337050|3776079|B4|||Age||years|Mean|57.4|57.4|Standard Deviation|12.3|12.3|||
3954401|NCT01337050|3776080|B3|||Age||years|Mean|57.7|57.7|Standard Deviation|13.1|13.1|||
3954403|NCT01337050|3776082|B1|||Age||years|Mean|59.0|59.0|Standard Deviation|10.9|10.9|||
3954404|NCT01336972|3776142|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3954405|NCT01336972|3776143|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3954406|NCT01336972|3776144|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3954407|NCT01336972|3776145|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3954408|NCT01336972|3776142|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3954409|NCT01336972|3776143|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3954410|NCT01336972|3776144|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3954411|NCT01336972|3776145|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3954412|NCT01336972|3776142|B4|||Age||Years|Mean|46.0|46.0|Standard Deviation|10.7|10.7|||
3954413|NCT01336972|3776143|B3|||Age||Years|Mean|52.1|52.1|Standard Deviation|6.7|6.7|||
3954414|NCT01336972|3776144|B2|||Age||Years|Mean|47.8|47.8|Standard Deviation|12.9|12.9|||
3954415|NCT01336972|3776145|B1|||Age||Years|Mean|38.7|38.7|Standard Deviation|7.1|7.1|||
3954416|NCT01336959|3776182|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3954417|NCT01336959|3776183|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3954418|NCT01336959|3776184|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3954419|NCT01336959|3776185|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3954420|NCT01336959|3776182|B4|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3954421|NCT01336959|3776183|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3954422|NCT01336959|3776184|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3954423|NCT01336959|3776185|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3954424|NCT01336959|3776182|B4|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|89|89.0||||||
3954425|NCT01336959|3776183|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3954426|NCT01336959|3776184|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
3954427|NCT01336959|3776185|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3954428|NCT01336959|3776182|B4||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3954429|NCT01336959|3776183|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3954430|NCT01336959|3776184|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3954431|NCT01336959|3776185|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3954432|NCT01336959|3776182|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3954433|NCT01336959|3776183|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3954434|NCT01336959|3776184|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3954435|NCT01336959|3776185|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3954436|NCT01336959|3776182|B4||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
3954437|NCT01336959|3776183|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3954438|NCT01336959|3776184|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3954439|NCT01336959|3776185|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3954440|NCT01336959|3776182|B4||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
3954441|NCT01336959|3776183|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3954442|NCT01336959|3776184|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3954443|NCT01336959|3776185|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3954444|NCT01336959|3776182|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3954445|NCT01336959|3776183|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3954446|NCT01336959|3776184|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3954447|NCT01336959|3776185|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3954448|NCT01336933|3776198|B1|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3954449|NCT01336933|3776198|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3954450|NCT01336933|3776198|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3954451|NCT01336933|3776198|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954452|NCT01336933|3776198|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3954453|NCT01336933|3776198|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3954454|NCT01336933|3776198|B1|||Age||years|Median|62|62.0|Full Range|||27.0|83.0|
3954455|NCT01336894|3776207|B3|||Baseline Forced Expiratory Volume in 1 second (FEV1)||Percentage of predicted|Median|54|54.0|Full Range|||22.0|118.0|
3954456|NCT01336894|3776208|B2|||Baseline Forced Expiratory Volume in 1 second (FEV1)||Percentage of predicted|Median|92|92.0|Full Range|||44.0|118.0|
3954457|NCT01336894|3776209|B1|||Baseline Forced Expiratory Volume in 1 second (FEV1)||Percentage of predicted|Median|42|42.0|Full Range|||22.0|65.0|
3954458|NCT01336894|3776207|B3|||Baseline diffusing capacity of the lung for carbon monoxide (DLCO)||Percentage of predicted|Median|44|44.0|Full Range|||28.0|92.0|
3954459|NCT01336894|3776208|B2|||Baseline diffusing capacity of the lung for carbon monoxide (DLCO)||Percentage of predicted|Median|43|43.0|Full Range|||28.0|92.0|
3954460|NCT01336894|3776209|B1|||Baseline diffusing capacity of the lung for carbon monoxide (DLCO)||Percentage of predicted|Median|46|46.0|Full Range|||33.0|80.0|
3954461|NCT01336894|3776207|B3||No|Institutional intent to use brachytherapy||Participants|Count of Participants|8|8.0||||||
3954462|NCT01336894|3776208|B2||No|Institutional intent to use brachytherapy||Participants|Count of Participants|5|5.0||||||
3954463|NCT01336894|3776209|B1||No|Institutional intent to use brachytherapy||Participants|Count of Participants|3|3.0||||||
3954464|NCT01336894|3776207|B3||Yes|Institutional intent to use brachytherapy||Participants|Count of Participants|3|3.0||||||
3954465|NCT01336894|3776208|B2||Yes|Institutional intent to use brachytherapy||Participants|Count of Participants|2|2.0||||||
3954466|NCT01336894|3776209|B1||Yes|Institutional intent to use brachytherapy||Participants|Count of Participants|1|1.0||||||
3954467|NCT01336894|3776207|B3||1=Symptomatic and fully ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|6|6.0||||||
3954468|NCT01336894|3776208|B2||1=Symptomatic and fully ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|4|4.0||||||
3954469|NCT01336894|3776209|B1||1=Symptomatic and fully ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|2|2.0||||||
3954470|NCT01336894|3776207|B3||0=Asymptomatic and fully active|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|5|5.0||||||
3954471|NCT01336894|3776208|B2||0=Asymptomatic and fully active|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|3|3.0||||||
3954472|NCT01336894|3776209|B1||0=Asymptomatic and fully active|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|2|2.0||||||
3954473|NCT01336894|3776207|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
3954474|NCT01336894|3776208|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3954475|NCT01336894|3776209|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3954476|NCT01336894|3776207|B3|Canada||Region of Enrollment||participants|Number|2|2.0||||||
3954477|NCT01336894|3776208|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
3954478|NCT01336894|3776209|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
3954479|NCT01336894|3776207|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954480|NCT01336894|3776208|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954481|NCT01336894|3776209|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954482|NCT01336894|3776207|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954483|NCT01336894|3776208|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954484|NCT01336894|3776209|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954485|NCT01336894|3776207|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3954486|NCT01336894|3776208|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3954487|NCT01336894|3776209|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3954488|NCT01336894|3776207|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3954489|NCT01336894|3776208|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3954490|NCT01336894|3776209|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954491|NCT01336894|3776207|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954492|NCT01336894|3776208|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954493|NCT01336894|3776209|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954494|NCT01336894|3776207|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954495|NCT01336894|3776208|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954496|NCT01336894|3776209|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954497|NCT01336894|3776207|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954498|NCT01336894|3776208|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954499|NCT01336894|3776209|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954500|NCT01336894|3776207|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954501|NCT01336894|3776208|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954502|NCT01336894|3776209|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954503|NCT01336894|3776207|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3954504|NCT01336894|3776208|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3954505|NCT01336894|3776209|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3954506|NCT01336894|3776207|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954507|NCT01336894|3776208|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954508|NCT01336894|3776209|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954509|NCT01336894|3776207|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3954510|NCT01336894|3776208|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3954511|NCT01336894|3776209|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3954512|NCT01336894|3776207|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3954513|NCT01336894|3776208|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3954514|NCT01336894|3776209|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3954515|NCT01336894|3776207|B3|||Age||years|Median|68|68.0|Full Range|||50.0|81.0|
3954516|NCT01336894|3776208|B2|||Age||years|Median|68|68.0|Full Range|||53.0|81.0|
3954517|NCT01336894|3776209|B1|||Age||years|Median|65|65.0|Full Range|||50.0|72.0|
3954518|NCT01336764|3776228|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3954519|NCT01336764|3776229|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3954520|NCT01336764|3776230|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3954521|NCT01336764|3776228|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3954522|NCT01336764|3776229|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3954523|NCT01336764|3776230|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3954524|NCT01336764|3776228|B3|age>/=18 years||Age, Customized||Participants|Count of Participants|22|22.0||||||
3954525|NCT01336764|3776229|B2|age>/=18 years||Age, Customized||Participants|Count of Participants|10|10.0||||||
3954526|NCT01336764|3776230|B1|age>/=18 years||Age, Customized||Participants|Count of Participants|12|12.0||||||
3954527|NCT01336738|3776237|B6||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3954528|NCT01336738|3776238|B5||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3954529|NCT01336738|3776239|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3954530|NCT01336738|3776240|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3954531|NCT01336738|3776241|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3954532|NCT01336738|3776242|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3954533|NCT01336738|3776237|B6||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3954534|NCT01336738|3776238|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3954535|NCT01336738|3776239|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3954536|NCT01336738|3776240|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3954537|NCT01336738|3776241|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3954538|NCT01336738|3776242|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3954539|NCT01336738|3776237|B6|||Age||years|Mean|55.9|55.9|Standard Deviation|8.7|8.7|||
3954540|NCT01336738|3776238|B5|||Age||years|Mean|55.6|55.6|Standard Deviation|8.5|8.5|||
3954541|NCT01336738|3776239|B4|||Age||years|Mean|57.8|57.8|Standard Deviation|8.3|8.3|||
3954542|NCT01336738|3776240|B3|||Age||years|Mean|55.5|55.5|Standard Deviation|7.3|7.3|||
3954543|NCT01336738|3776241|B2|||Age||years|Mean|55.1|55.1|Standard Deviation|9.3|9.3|||
3954544|NCT01336738|3776242|B1|||Age||years|Mean|55.3|55.3|Standard Deviation|9.9|9.9|||
3954545|NCT01336712|3776288|B1|Black/African America||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3954546|NCT01336712|3776288|B1|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3954547|NCT01336712|3776288|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3954548|NCT01336712|3776288|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3954549|NCT01336712|3776288|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3954550|NCT01336712|3776288|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3954551|NCT01336712|3776288|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3954552|NCT01336647|3776298|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3954553|NCT01336647|3776299|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3954554|NCT01336647|3776300|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3954555|NCT01336647|3776301|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3954556|NCT01336647|3776298|B4||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3954557|NCT01336647|3776299|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3954558|NCT01336647|3776300|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3954559|NCT01336647|3776301|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3954560|NCT01336647|3776298|B4|||Age, Customized||years|Mean|15.4|15.4|Standard Deviation|11.7|11.7|||
3954561|NCT01336647|3776299|B3|||Age, Customized||years|Mean|17.3|17.3|Standard Deviation|13.3|13.3|||
3954562|NCT01336647|3776300|B2|||Age, Customized||years|Mean|15.3|15.3|Standard Deviation|11.3|11.3|||
3954563|NCT01336647|3776301|B1|||Age, Customized||years|Mean|13.7|13.7|Standard Deviation|10.5|10.5|||
3954564|NCT01336647|3776298|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3954565|NCT01336647|3776299|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3954566|NCT01336647|3776300|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3954567|NCT01336647|3776301|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3954568|NCT01336647|3776298|B4||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3954569|NCT01336647|3776299|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3954570|NCT01336647|3776300|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3954571|NCT01336647|3776301|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3954572|NCT01336647|3776298|B4||<=18 years|Age||Participants|Count of Participants|103|103.0||||||
3954573|NCT01336647|3776299|B3||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
3954574|NCT01336647|3776300|B2||<=18 years|Age||Participants|Count of Participants|35|35.0||||||
3954575|NCT01336647|3776301|B1||<=18 years|Age||Participants|Count of Participants|38|38.0||||||
3954576|NCT01336634|3776314|B4|Other-missing||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3954577|NCT01336634|3776315|B3|Other-missing||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3954578|NCT01336634|3776316|B2|Other-missing||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3954579|NCT01336634|3776317|B1|Other-missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3954580|NCT01336634|3776314|B4|Other-African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3954581|NCT01336634|3776315|B3|Other-African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3954582|NCT01336634|3776316|B2|Other-African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3954583|NCT01336634|3776317|B1|Other-African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3954584|NCT01336634|3776314|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|139|139.0||||||
3954585|NCT01336634|3776315|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
3954586|NCT01336634|3776316|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|47|47.0||||||
3954587|NCT01336634|3776317|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|62|62.0||||||
3954588|NCT01336634|3776314|B4|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3954589|NCT01336634|3776315|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3954590|NCT01336634|3776316|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3954591|NCT01336634|3776317|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3954592|NCT01336634|3776314|B4|Native Hawaiian Or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3954593|NCT01336634|3776315|B3|Native Hawaiian Or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3954594|NCT01336634|3776316|B2|Native Hawaiian Or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3954595|NCT01336634|3776317|B1|Native Hawaiian Or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3954596|NCT01336634|3776314|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3954597|NCT01336634|3776315|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3954598|NCT01336634|3776316|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3954599|NCT01336634|3776317|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3954600|NCT01336634|3776314|B4|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3954601|NCT01336634|3776315|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3954602|NCT01336634|3776316|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3954603|NCT01336634|3776317|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3954604|NCT01336634|3776314|B4|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3954605|NCT01336634|3776315|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3954606|NCT01336634|3776316|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3954607|NCT01336634|3776317|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3954608|NCT01336634|3776314|B4|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
3954609|NCT01336634|3776315|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3954610|NCT01336634|3776316|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3954611|NCT01336634|3776317|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3954612|NCT01336634|3776314|B4||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3954613|NCT01336634|3776315|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3954614|NCT01336634|3776316|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3954615|NCT01336634|3776317|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3954616|NCT01336634|3776314|B4||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3954617|NCT01336634|3776315|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3954618|NCT01336634|3776316|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3954619|NCT01336634|3776317|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3954620|NCT01336634|3776314|B4|||Age||Years|Mean|65.5|65.5|Standard Deviation|10.50|10.5|||
3954621|NCT01336634|3776315|B3|||Age||Years|Mean|67.8|67.8|Standard Deviation|11.00|11.0|||
3954622|NCT01336634|3776316|B2|||Age||Years|Mean|65.1|65.1|Standard Deviation|10.14|10.14|||
3954623|NCT01336634|3776317|B1|||Age||Years|Mean|64.8|64.8|Standard Deviation|10.51|10.51|||
3954624|NCT01336621|3776360|B1|Race customized|White- White/Caucasian/ European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|90|90.0||||||
3954625|NCT01336621|3776360|B1|Race customized|Asian: South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3954626|NCT01336621|3776360|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3954627|NCT01336621|3776360|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3954628|NCT01336621|3776360|B1|||Age||Years|Mean|39.2|39.2|Standard Deviation|13.19|13.19|||
3954629|NCT01336608|3776407|B4|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3954630|NCT01336608|3776408|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3954631|NCT01336608|3776409|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3954632|NCT01336608|3776410|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3954633|NCT01336608|3776407|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|203|203.0||||||
3954634|NCT01336608|3776408|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|64|64.0||||||
3954635|NCT01336608|3776409|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|75|75.0||||||
3954636|NCT01336608|3776410|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|64|64.0||||||
3954637|NCT01336608|3776407|B4|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3954638|NCT01336608|3776408|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3954639|NCT01336608|3776409|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3954640|NCT01336608|3776410|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3954641|NCT01336608|3776407|B4|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3954642|NCT01336608|3776408|B3|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3954643|NCT01336608|3776409|B2|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3954644|NCT01336608|3776410|B1|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3954645|NCT01336608|3776407|B4|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|143|143.0||||||
3954646|NCT01336608|3776408|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|47|47.0||||||
3954647|NCT01336608|3776409|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|51|51.0||||||
3954648|NCT01336608|3776410|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|45|45.0||||||
3954649|NCT01336608|3776407|B4|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|62|62.0||||||
3954650|NCT01336608|3776408|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
3954651|NCT01336608|3776409|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
3954652|NCT01336608|3776410|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
3954653|NCT01336608|3776407|B4|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3954654|NCT01336608|3776408|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3954655|NCT01336608|3776409|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3954656|NCT01336608|3776410|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3954657|NCT01336608|3776407|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
3954658|NCT01336608|3776408|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3954659|NCT01336608|3776409|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3954660|NCT01336608|3776410|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3954661|NCT01336608|3776407|B4||Male|Sex: Female, Male||Participants|Count of Participants|341|341.0||||||
3954662|NCT01336608|3776408|B3||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3954663|NCT01336608|3776409|B2||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3954664|NCT01336608|3776410|B1||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3954665|NCT01336608|3776407|B4||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3954666|NCT01336608|3776408|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3954667|NCT01336608|3776409|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3954668|NCT01336608|3776410|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3954669|NCT01336608|3776407|B4|||Age||Years|Mean|68.5|68.5|Standard Deviation|7.91|7.91|||
3954670|NCT01336608|3776408|B3|||Age||Years|Mean|68.5|68.5|Standard Deviation|8.01|8.01|||
3954671|NCT01336608|3776409|B2|||Age||Years|Mean|68.7|68.7|Standard Deviation|7.69|7.69|||
3954672|NCT01336608|3776410|B1|||Age||Years|Mean|68.2|68.2|Standard Deviation|8.10|8.1|||
3954673|NCT01336569|3776427|B1|Brazil||Region of Enrollment||participants|Number|49|49.0||||||
3954674|NCT01336569|3776427|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3954675|NCT01336569|3776427|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3954676|NCT01336569|3776427|B1|||Age||years|Mean|63.3|63.3|Standard Deviation|10.6|10.6|||
3954677|NCT01336413|3776431|B3|United States||Region of Enrollment||participants|Number|53|53.0||||||
3954678|NCT01336413|3776432|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
3954679|NCT01336413|3776433|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3954680|NCT01336413|3776431|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3954681|NCT01336413|3776432|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3954682|NCT01336413|3776433|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3954683|NCT01336413|3776431|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3954684|NCT01336413|3776432|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3954685|NCT01336413|3776433|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3954686|NCT01336413|3776431|B3||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3954687|NCT01336413|3776432|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3954688|NCT01336413|3776433|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3954689|NCT01336413|3776431|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3954690|NCT01336413|3776432|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3954691|NCT01336413|3776433|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3954692|NCT01336413|3776431|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954693|NCT01336413|3776432|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954694|NCT01336413|3776433|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954695|NCT01336413|3776431|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3954696|NCT01336413|3776432|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954697|NCT01336413|3776433|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3954698|NCT01336413|3776431|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954699|NCT01336413|3776432|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954700|NCT01336413|3776433|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954701|NCT01336413|3776431|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3954702|NCT01336413|3776432|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3954703|NCT01336413|3776433|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3954704|NCT01336413|3776431|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3954705|NCT01336413|3776432|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3954706|NCT01336413|3776433|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3954707|NCT01336413|3776431|B3|||Age||years|Mean|33.87|33.87|Standard Deviation|6.15|6.15|||
3954708|NCT01336413|3776432|B2|||Age||years|Mean|35.04|35.04|Standard Deviation|6.75|6.75|||
3954709|NCT01336413|3776433|B1|||Age||years|Mean|32.74|32.74|Standard Deviation|5.40|5.4|||
3954710|NCT01336296|3776450|B3|United States||Region of Enrollment||participants|Number|61|61.0||||||
3954711|NCT01336296|3776451|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
3954712|NCT01336296|3776452|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3954713|NCT01336296|3776450|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954714|NCT01336296|3776451|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954715|NCT01336296|3776452|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954716|NCT01336296|3776450|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954717|NCT01336296|3776451|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954718|NCT01336296|3776452|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954719|NCT01336296|3776450|B3||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3954720|NCT01336296|3776451|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3954721|NCT01336296|3776452|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3954722|NCT01336296|3776450|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3954723|NCT01336296|3776451|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3954724|NCT01336296|3776452|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3954725|NCT01336296|3776450|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954726|NCT01336296|3776451|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954727|NCT01336296|3776452|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954728|NCT01336296|3776450|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954729|NCT01336296|3776451|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954730|NCT01336296|3776452|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954731|NCT01336296|3776450|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954732|NCT01336296|3776451|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954733|NCT01336296|3776452|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3954734|NCT01336296|3776450|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3954735|NCT01336296|3776451|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3954736|NCT01336296|3776452|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3954737|NCT01336296|3776450|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3954738|NCT01336296|3776451|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3954739|NCT01336296|3776452|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3954740|NCT01336296|3776450|B3|||Age||years|Mean|55.4|55.4|Standard Deviation|14|14.0|||
3954741|NCT01336296|3776451|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|13.1|13.1|||
3954742|NCT01336296|3776452|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|15|15.0|||
3954743|NCT01336205|3776467|B3|Other||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3954744|NCT01336205|3776468|B2|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3954745|NCT01336205|3776469|B1|Other||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3954746|NCT01336205|3776467|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3954747|NCT01336205|3776468|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3954748|NCT01336205|3776469|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3954749|NCT01336205|3776467|B3|Asian||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3954750|NCT01336205|3776468|B2|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3954751|NCT01336205|3776469|B1|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3954752|NCT01336205|3776467|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|158|158.0||||||
3954753|NCT01336205|3776468|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|60|60.0||||||
3954754|NCT01336205|3776469|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|98|98.0||||||
3954755|NCT01336205|3776467|B3|White||Race/Ethnicity, Customized||Participants|Number|627|627.0||||||
3954756|NCT01336205|3776468|B2|White||Race/Ethnicity, Customized||Participants|Number|204|204.0||||||
3954757|NCT01336205|3776469|B1|White||Race/Ethnicity, Customized||Participants|Number|423|423.0||||||
3954758|NCT01336205|3776467|B3||Male|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
3954759|NCT01336205|3776468|B2||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3954760|NCT01336205|3776469|B1||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
3954761|NCT01336205|3776467|B3||Female|Sex: Female, Male||Participants|Count of Participants|532|532.0||||||
3954762|NCT01336205|3776468|B2||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
3954763|NCT01336205|3776469|B1||Female|Sex: Female, Male||Participants|Count of Participants|353|353.0||||||
3954764|NCT01336205|3776467|B3|||Age||Years|Mean|52.7|52.7|Standard Deviation|10.13|10.13|||
3954765|NCT01336205|3776468|B2|||Age||Years|Mean|52.7|52.7|Standard Deviation|10.24|10.24|||
3954766|NCT01336205|3776469|B1|||Age||Years|Mean|52.8|52.8|Standard Deviation|10.09|10.09|||
3954767|NCT01336140|3776480|B3|United States||Region of Enrollment||participants|Number|300|300.0||||||
3954768|NCT01336140|3776481|B2|United States||Region of Enrollment||participants|Number|150|150.0||||||
3954769|NCT01336140|3776482|B1|United States||Region of Enrollment||participants|Number|150|150.0||||||
3954770|NCT01336140|3776480|B3||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
3954771|NCT01336140|3776481|B2||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3954772|NCT01336140|3776482|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3954773|NCT01336140|3776480|B3||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3954774|NCT01336140|3776481|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3954775|NCT01336140|3776482|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3954776|NCT01336140|3776480|B3|||Age||years|Mean|55|55.0|Standard Deviation|13|13.0|||
3954777|NCT01336140|3776481|B2|||Age||years|Mean|56|56.0|Standard Deviation|13|13.0|||
3954778|NCT01336140|3776482|B1|||Age||years|Mean|54|54.0|Standard Deviation|13|13.0|||
3954779|NCT01336140|3776480|B3||>=65 years|Age||Participants|Count of Participants|64|64.0||||||
3954780|NCT01336140|3776481|B2||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
3954781|NCT01336140|3776482|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3954782|NCT01336140|3776480|B3||Between 18 and 65 years|Age||Participants|Count of Participants|236|236.0||||||
3954783|NCT01336140|3776481|B2||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
3954784|NCT01336140|3776482|B1||Between 18 and 65 years|Age||Participants|Count of Participants|125|125.0||||||
3954785|NCT01336140|3776480|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3954786|NCT01336140|3776481|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3954787|NCT01336140|3776482|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3954788|NCT01336023|3776495|B4|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.3|8.3|Standard Deviation|0.9|0.9|||
3954789|NCT01336023|3776496|B3|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.3|8.3|Standard Deviation|0.9|0.9|||
3954790|NCT01336023|3776497|B2|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.3|8.3|Standard Deviation|0.9|0.9|||
3954791|NCT01336023|3776498|B1|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.3|8.3|Standard Deviation|1.0|1.0|||
3954792|NCT01336023|3776495|B4|||Normalised Incremental Area under curve (AUC)|The area under the glucose concentration (AUC) curve during 0-4 hours after the start of a standardised meal. The incremental AUC was calculated using the trapezoidal method and the resulting area was divided length of the observation period to yield the (normalised) prandial increment in mmol/L. The data was derived from the subjects who underwent a standard meal test conducted at selected sites.|mmol/L|Mean|4.11|4.11|Standard Deviation|1.93|1.93|||
3954793|NCT01336023|3776496|B3|||Normalised Incremental Area under curve (AUC)|The area under the glucose concentration (AUC) curve during 0-4 hours after the start of a standardised meal. The incremental AUC was calculated using the trapezoidal method and the resulting area was divided length of the observation period to yield the (normalised) prandial increment in mmol/L. The data was derived from the subjects who underwent a standard meal test conducted at selected sites.|mmol/L|Mean|4.12|4.12|Standard Deviation|1.82|1.82|||
3954794|NCT01336023|3776497|B2|||Normalised Incremental Area under curve (AUC)|The area under the glucose concentration (AUC) curve during 0-4 hours after the start of a standardised meal. The incremental AUC was calculated using the trapezoidal method and the resulting area was divided length of the observation period to yield the (normalised) prandial increment in mmol/L. The data was derived from the subjects who underwent a standard meal test conducted at selected sites.|mmol/L|Mean|4.11|4.11|Standard Deviation|2.05|2.05|||
3954900|NCT01335971|3776535|B1|Smoke cigarettes now||Chronic obstructive pulmonary disease (COPD) characteristics||participants|Number|20|20.0||||||
3954963|NCT01335867|3776713|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3954795|NCT01336023|3776498|B1|||Normalised Incremental Area under curve (AUC)|The area under the glucose concentration (AUC) curve during 0-4 hours after the start of a standardised meal. The incremental AUC was calculated using the trapezoidal method and the resulting area was divided length of the observation period to yield the (normalised) prandial increment in mmol/L. The data was derived from the subjects who underwent a standard meal test conducted at selected sites.|mmol/L|Mean|4.12|4.12|Standard Deviation|1.80|1.8|||
3954796|NCT01336023|3776495|B4|||Body Weight||kg|Mean|87.3|87.3|Standard Deviation|18.8|18.8|||
3954797|NCT01336023|3776496|B3|||Body Weight||kg|Mean|87.4|87.4|Standard Deviation|18.0|18.0|||
3954798|NCT01336023|3776497|B2|||Body Weight||kg|Mean|87.2|87.2|Standard Deviation|19.0|19.0|||
3954799|NCT01336023|3776498|B1|||Body Weight||kg|Mean|87.4|87.4|Standard Deviation|19.2|19.2|||
3954800|NCT01336023|3776495|B4||Male|Sex: Female, Male||Participants|Count of Participants|843|843.0||||||
3954801|NCT01336023|3776496|B3||Male|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
3954802|NCT01336023|3776497|B2||Male|Sex: Female, Male||Participants|Count of Participants|435|435.0||||||
3954803|NCT01336023|3776498|B1||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
3954804|NCT01336023|3776495|B4||Female|Sex: Female, Male||Participants|Count of Participants|817|817.0||||||
3954805|NCT01336023|3776496|B3||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
3954806|NCT01336023|3776497|B2||Female|Sex: Female, Male||Participants|Count of Participants|398|398.0||||||
3954807|NCT01336023|3776498|B1||Female|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
3954808|NCT01336023|3776495|B4|||Age||years|Mean|55.0|55.0|Standard Deviation|9.9|9.9|||
3954809|NCT01336023|3776496|B3|||Age||years|Mean|55.0|55.0|Standard Deviation|10.2|10.2|||
3954810|NCT01336023|3776497|B2|||Age||years|Mean|55.1|55.1|Standard Deviation|9.9|9.9|||
3954811|NCT01336023|3776498|B1|||Age||years|Mean|54.9|54.9|Standard Deviation|9.7|9.7|||
3954812|NCT01335997|3776519|B3||Male|Sex: Female, Male||Participants|Count of Participants|462|462.0||||||
3954813|NCT01335997|3776520|B2||Male|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
3954814|NCT01335997|3776521|B1||Male|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
3954815|NCT01335997|3776519|B3||Female|Sex: Female, Male||Participants|Count of Participants|677|677.0||||||
3954816|NCT01335997|3776520|B2||Female|Sex: Female, Male||Participants|Count of Participants|332|332.0||||||
3954817|NCT01335997|3776521|B1||Female|Sex: Female, Male||Participants|Count of Participants|345|345.0||||||
3954818|NCT01335997|3776519|B3|||Age||Years|Mean|56.3|56.3|Standard Deviation|10.43|10.43|||
3954819|NCT01335997|3776520|B2|||Age||Years|Mean|56.4|56.4|Standard Deviation|10.44|10.44|||
3954820|NCT01335997|3776521|B1|||Age||Years|Mean|56.2|56.2|Standard Deviation|10.44|10.44|||
3954821|NCT01335971|3776532|B4|Impacts score||St Georges Respiratory Questionnaire|"Scales, ranges, and descriptors:~All scores are expressed as a percentage of overall impairment where 100 is the worst possible health status and 0 is the best possible health status.~Total score (all items) summarizes the impact of the disease on overall health status Symptoms score (Q1-8) looks at the effect of respiratory symptoms, their frequency and severity.~Activity score (Q11-17, 37-45) measures activities causing or limited by breathlessness Impacts score (Q18-36, 46-52) covers a range of aspects re: social functioning and psychological disturbances resulting from airways disease"|units on a scale|Median|28|28.0|Inter-Quartile Range|||15.0|44.0|
3954822|NCT01335971|3776533|B3|Impacts score||St Georges Respiratory Questionnaire|"Scales, ranges, and descriptors:~All scores are expressed as a percentage of overall impairment where 100 is the worst possible health status and 0 is the best possible health status.~Total score (all items) summarizes the impact of the disease on overall health status Symptoms score (Q1-8) looks at the effect of respiratory symptoms, their frequency and severity.~Activity score (Q11-17, 37-45) measures activities causing or limited by breathlessness Impacts score (Q18-36, 46-52) covers a range of aspects re: social functioning and psychological disturbances resulting from airways disease"|units on a scale|Median|26|26.0|Inter-Quartile Range|||13.0|42.0|
3954823|NCT01335971|3776534|B2|Impacts score||St Georges Respiratory Questionnaire|"Scales, ranges, and descriptors:~All scores are expressed as a percentage of overall impairment where 100 is the worst possible health status and 0 is the best possible health status.~Total score (all items) summarizes the impact of the disease on overall health status Symptoms score (Q1-8) looks at the effect of respiratory symptoms, their frequency and severity.~Activity score (Q11-17, 37-45) measures activities causing or limited by breathlessness Impacts score (Q18-36, 46-52) covers a range of aspects re: social functioning and psychological disturbances resulting from airways disease"|units on a scale|Median|34|34.0|Inter-Quartile Range|||15.0|46.0|
3954824|NCT01335971|3776535|B1|Impacts score||St Georges Respiratory Questionnaire|"Scales, ranges, and descriptors:~All scores are expressed as a percentage of overall impairment where 100 is the worst possible health status and 0 is the best possible health status.~Total score (all items) summarizes the impact of the disease on overall health status Symptoms score (Q1-8) looks at the effect of respiratory symptoms, their frequency and severity.~Activity score (Q11-17, 37-45) measures activities causing or limited by breathlessness Impacts score (Q18-36, 46-52) covers a range of aspects re: social functioning and psychological disturbances resulting from airways disease"|units on a scale|Median|27|27.0|Inter-Quartile Range|||17.0|44.0|
3954825|NCT01335971|3776532|B4|Activity score||St Georges Respiratory Questionnaire|"Scales, ranges, and descriptors:~All scores are expressed as a percentage of overall impairment where 100 is the worst possible health status and 0 is the best possible health status.~Total score (all items) summarizes the impact of the disease on overall health status Symptoms score (Q1-8) looks at the effect of respiratory symptoms, their frequency and severity.~Activity score (Q11-17, 37-45) measures activities causing or limited by breathlessness Impacts score (Q18-36, 46-52) covers a range of aspects re: social functioning and psychological disturbances resulting from airways disease"|units on a scale|Median|55|55.0|Inter-Quartile Range|||36.0|74.0|
3954866|NCT01335971|3776533|B3|Slow vital capacity||Pulmonary function measures|Values were determined using either helium dilution or plethysmography methods, depending on equipment available at study sites. Lung volumes were measured in accordance with local hospital procedures.|Liters|Median|3.7|3.7|Inter-Quartile Range|||3.1|4.4|
3954826|NCT01335971|3776533|B3|Activity score||St Georges Respiratory Questionnaire|"Scales, ranges, and descriptors:~All scores are expressed as a percentage of overall impairment where 100 is the worst possible health status and 0 is the best possible health status.~Total score (all items) summarizes the impact of the disease on overall health status Symptoms score (Q1-8) looks at the effect of respiratory symptoms, their frequency and severity.~Activity score (Q11-17, 37-45) measures activities causing or limited by breathlessness Impacts score (Q18-36, 46-52) covers a range of aspects re: social functioning and psychological disturbances resulting from airways disease"|units on a scale|Median|50|50.0|Inter-Quartile Range|||41.0|73.0|
3954827|NCT01335971|3776534|B2|Activity score||St Georges Respiratory Questionnaire|"Scales, ranges, and descriptors:~All scores are expressed as a percentage of overall impairment where 100 is the worst possible health status and 0 is the best possible health status.~Total score (all items) summarizes the impact of the disease on overall health status Symptoms score (Q1-8) looks at the effect of respiratory symptoms, their frequency and severity.~Activity score (Q11-17, 37-45) measures activities causing or limited by breathlessness Impacts score (Q18-36, 46-52) covers a range of aspects re: social functioning and psychological disturbances resulting from airways disease"|units on a scale|Median|60|60.0|Inter-Quartile Range|||47.0|74.0|
3954828|NCT01335971|3776535|B1|Activity score||St Georges Respiratory Questionnaire|"Scales, ranges, and descriptors:~All scores are expressed as a percentage of overall impairment where 100 is the worst possible health status and 0 is the best possible health status.~Total score (all items) summarizes the impact of the disease on overall health status Symptoms score (Q1-8) looks at the effect of respiratory symptoms, their frequency and severity.~Activity score (Q11-17, 37-45) measures activities causing or limited by breathlessness Impacts score (Q18-36, 46-52) covers a range of aspects re: social functioning and psychological disturbances resulting from airways disease"|units on a scale|Median|54|54.0|Inter-Quartile Range|||30.0|74.0|
3954829|NCT01335971|3776532|B4|Symptoms score||St Georges Respiratory Questionnaire|"Scales, ranges, and descriptors:~All scores are expressed as a percentage of overall impairment where 100 is the worst possible health status and 0 is the best possible health status.~Total score (all items) summarizes the impact of the disease on overall health status Symptoms score (Q1-8) looks at the effect of respiratory symptoms, their frequency and severity.~Activity score (Q11-17, 37-45) measures activities causing or limited by breathlessness Impacts score (Q18-36, 46-52) covers a range of aspects re: social functioning and psychological disturbances resulting from airways disease"|units on a scale|Median|52|52.0|Inter-Quartile Range|||36.0|68.0|
3954830|NCT01335971|3776533|B3|Symptoms score||St Georges Respiratory Questionnaire|"Scales, ranges, and descriptors:~All scores are expressed as a percentage of overall impairment where 100 is the worst possible health status and 0 is the best possible health status.~Total score (all items) summarizes the impact of the disease on overall health status Symptoms score (Q1-8) looks at the effect of respiratory symptoms, their frequency and severity.~Activity score (Q11-17, 37-45) measures activities causing or limited by breathlessness Impacts score (Q18-36, 46-52) covers a range of aspects re: social functioning and psychological disturbances resulting from airways disease"|units on a scale|Median|50|50.0|Inter-Quartile Range|||31.0|57.0|
3954831|NCT01335971|3776534|B2|Symptoms score||St Georges Respiratory Questionnaire|"Scales, ranges, and descriptors:~All scores are expressed as a percentage of overall impairment where 100 is the worst possible health status and 0 is the best possible health status.~Total score (all items) summarizes the impact of the disease on overall health status Symptoms score (Q1-8) looks at the effect of respiratory symptoms, their frequency and severity.~Activity score (Q11-17, 37-45) measures activities causing or limited by breathlessness Impacts score (Q18-36, 46-52) covers a range of aspects re: social functioning and psychological disturbances resulting from airways disease"|units on a scale|Median|55|55.0|Inter-Quartile Range|||43.0|68.0|
3954832|NCT01335971|3776535|B1|Symptoms score||St Georges Respiratory Questionnaire|"Scales, ranges, and descriptors:~All scores are expressed as a percentage of overall impairment where 100 is the worst possible health status and 0 is the best possible health status.~Total score (all items) summarizes the impact of the disease on overall health status Symptoms score (Q1-8) looks at the effect of respiratory symptoms, their frequency and severity.~Activity score (Q11-17, 37-45) measures activities causing or limited by breathlessness Impacts score (Q18-36, 46-52) covers a range of aspects re: social functioning and psychological disturbances resulting from airways disease"|units on a scale|Median|58|58.0|Inter-Quartile Range|||32.0|70.0|
3954833|NCT01335971|3776532|B4|Total score||St Georges Respiratory Questionnaire|"Scales, ranges, and descriptors:~All scores are expressed as a percentage of overall impairment where 100 is the worst possible health status and 0 is the best possible health status.~Total score (all items) summarizes the impact of the disease on overall health status Symptoms score (Q1-8) looks at the effect of respiratory symptoms, their frequency and severity.~Activity score (Q11-17, 37-45) measures activities causing or limited by breathlessness Impacts score (Q18-36, 46-52) covers a range of aspects re: social functioning and psychological disturbances resulting from airways disease"|units on a scale|Median|40|40.0|Inter-Quartile Range|||26.0|56.0|
3954834|NCT01335971|3776533|B3|Total score||St Georges Respiratory Questionnaire|"Scales, ranges, and descriptors:~All scores are expressed as a percentage of overall impairment where 100 is the worst possible health status and 0 is the best possible health status.~Total score (all items) summarizes the impact of the disease on overall health status Symptoms score (Q1-8) looks at the effect of respiratory symptoms, their frequency and severity.~Activity score (Q11-17, 37-45) measures activities causing or limited by breathlessness Impacts score (Q18-36, 46-52) covers a range of aspects re: social functioning and psychological disturbances resulting from airways disease"|units on a scale|Median|39|39.0|Inter-Quartile Range|||24.0|54.0|
3954835|NCT01335971|3776534|B2|Total score||St Georges Respiratory Questionnaire|"Scales, ranges, and descriptors:~All scores are expressed as a percentage of overall impairment where 100 is the worst possible health status and 0 is the best possible health status.~Total score (all items) summarizes the impact of the disease on overall health status Symptoms score (Q1-8) looks at the effect of respiratory symptoms, their frequency and severity.~Activity score (Q11-17, 37-45) measures activities causing or limited by breathlessness Impacts score (Q18-36, 46-52) covers a range of aspects re: social functioning and psychological disturbances resulting from airways disease"|units on a scale|Median|47|47.0|Inter-Quartile Range|||27.0|56.0|
3954898|NCT01335971|3776533|B3|Smoke cigarettes now||Chronic obstructive pulmonary disease (COPD) characteristics||participants|Number|18|18.0||||||
3954899|NCT01335971|3776534|B2|Smoke cigarettes now||Chronic obstructive pulmonary disease (COPD) characteristics||participants|Number|16|16.0||||||
3954836|NCT01335971|3776535|B1|Total score||St Georges Respiratory Questionnaire|"Scales, ranges, and descriptors:~All scores are expressed as a percentage of overall impairment where 100 is the worst possible health status and 0 is the best possible health status.~Total score (all items) summarizes the impact of the disease on overall health status Symptoms score (Q1-8) looks at the effect of respiratory symptoms, their frequency and severity.~Activity score (Q11-17, 37-45) measures activities causing or limited by breathlessness Impacts score (Q18-36, 46-52) covers a range of aspects re: social functioning and psychological disturbances resulting from airways disease"|units on a scale|Median|43|43.0|Inter-Quartile Range|||24.0|58.0|
3954837|NCT01335971|3776532|B4|||Medical Research Council Dyspnea Score|Minimum score 1, maximum score 5. Higher values represent a worse outcome.|units on a scale|Median|2|2.0|Inter-Quartile Range|||1.0|3.0|
3954838|NCT01335971|3776533|B3|||Medical Research Council Dyspnea Score|Minimum score 1, maximum score 5. Higher values represent a worse outcome.|units on a scale|Median|2|2.0|Inter-Quartile Range|||1.0|3.0|
3954839|NCT01335971|3776534|B2|||Medical Research Council Dyspnea Score|Minimum score 1, maximum score 5. Higher values represent a worse outcome.|units on a scale|Median|2|2.0|Inter-Quartile Range|||2.0|3.0|
3954840|NCT01335971|3776535|B1|||Medical Research Council Dyspnea Score|Minimum score 1, maximum score 5. Higher values represent a worse outcome.|units on a scale|Median|2|2.0|Inter-Quartile Range|||1.0|3.0|
3954841|NCT01335971|3776532|B4|Long-acting anticholinergic bronchodilator||Use of respiratory medications in prior 2 weeks||participants|Number|26|26.0||||||
3954842|NCT01335971|3776533|B3|Long-acting anticholinergic bronchodilator||Use of respiratory medications in prior 2 weeks||participants|Number|10|10.0||||||
3954843|NCT01335971|3776534|B2|Long-acting anticholinergic bronchodilator||Use of respiratory medications in prior 2 weeks||participants|Number|9|9.0||||||
3954844|NCT01335971|3776535|B1|Long-acting anticholinergic bronchodilator||Use of respiratory medications in prior 2 weeks||participants|Number|7|7.0||||||
3954845|NCT01335971|3776532|B4|Long-acting beta-agonist & inhaled corticosteroid||Use of respiratory medications in prior 2 weeks||participants|Number|40|40.0||||||
3954846|NCT01335971|3776533|B3|Long-acting beta-agonist & inhaled corticosteroid||Use of respiratory medications in prior 2 weeks||participants|Number|13|13.0||||||
3954847|NCT01335971|3776534|B2|Long-acting beta-agonist & inhaled corticosteroid||Use of respiratory medications in prior 2 weeks||participants|Number|13|13.0||||||
3954848|NCT01335971|3776535|B1|Long-acting beta-agonist & inhaled corticosteroid||Use of respiratory medications in prior 2 weeks||participants|Number|14|14.0||||||
3954849|NCT01335971|3776532|B4|Long-acting beta-agonist||Use of respiratory medications in prior 2 weeks||participants|Number|5|5.0||||||
3954850|NCT01335971|3776533|B3|Long-acting beta-agonist||Use of respiratory medications in prior 2 weeks||participants|Number|2|2.0||||||
3954851|NCT01335971|3776534|B2|Long-acting beta-agonist||Use of respiratory medications in prior 2 weeks||participants|Number|1|1.0||||||
3954852|NCT01335971|3776535|B1|Long-acting beta-agonist||Use of respiratory medications in prior 2 weeks||participants|Number|2|2.0||||||
3954853|NCT01335971|3776532|B4|Short-acting beta-agonist||Use of respiratory medications in prior 2 weeks||participants|Number|61|61.0||||||
3954854|NCT01335971|3776533|B3|Short-acting beta-agonist||Use of respiratory medications in prior 2 weeks||participants|Number|18|18.0||||||
3954855|NCT01335971|3776534|B2|Short-acting beta-agonist||Use of respiratory medications in prior 2 weeks||participants|Number|21|21.0||||||
3954856|NCT01335971|3776535|B1|Short-acting beta-agonist||Use of respiratory medications in prior 2 weeks||participants|Number|22|22.0||||||
3954857|NCT01335971|3776532|B4|Residual volume||Pulmonary function measures|Values were determined using either helium dilution or plethysmography methods, depending on equipment available at study sites. Lung volumes were measured in accordance with local hospital procedures.|Liters|Median|2.6|2.6|Inter-Quartile Range|||2.2|3.2|
3954858|NCT01335971|3776533|B3|Residual volume||Pulmonary function measures|Values were determined using either helium dilution or plethysmography methods, depending on equipment available at study sites. Lung volumes were measured in accordance with local hospital procedures.|Liters|Median|2.7|2.7|Inter-Quartile Range|||2.3|2.9|
3954859|NCT01335971|3776534|B2|Residual volume||Pulmonary function measures|Values were determined using either helium dilution or plethysmography methods, depending on equipment available at study sites. Lung volumes were measured in accordance with local hospital procedures.|Liters|Median|2.6|2.6|Inter-Quartile Range|||2.2|3.5|
3954860|NCT01335971|3776535|B1|Residual volume||Pulmonary function measures|Values were determined using either helium dilution or plethysmography methods, depending on equipment available at study sites. Lung volumes were measured in accordance with local hospital procedures.|Liters|Median|2.6|2.6|Inter-Quartile Range|||2.5|3.4|
3954861|NCT01335971|3776532|B4|Forced residual capacity||Pulmonary function measures|Values were determined using either helium dilution or plethysmography methods, depending on equipment available at study sites. Lung volumes were measured in accordance with local hospital procedures.|Liters|Median|3.5|3.5|Inter-Quartile Range|||3.0|4.2|
3954862|NCT01335971|3776533|B3|Forced residual capacity||Pulmonary function measures|Values were determined using either helium dilution or plethysmography methods, depending on equipment available at study sites. Lung volumes were measured in accordance with local hospital procedures.|Liters|Median|3.4|3.4|Inter-Quartile Range|||3.0|3.9|
3954863|NCT01335971|3776534|B2|Forced residual capacity||Pulmonary function measures|Values were determined using either helium dilution or plethysmography methods, depending on equipment available at study sites. Lung volumes were measured in accordance with local hospital procedures.|Liters|Median|3.6|3.6|Inter-Quartile Range|||3.0|4.1|
3954864|NCT01335971|3776535|B1|Forced residual capacity||Pulmonary function measures|Values were determined using either helium dilution or plethysmography methods, depending on equipment available at study sites. Lung volumes were measured in accordance with local hospital procedures.|Liters|Median|3.6|3.6|Inter-Quartile Range|||3.1|4.5|
3954865|NCT01335971|3776532|B4|Slow vital capacity||Pulmonary function measures|Values were determined using either helium dilution or plethysmography methods, depending on equipment available at study sites. Lung volumes were measured in accordance with local hospital procedures.|Liters|Median|3.3|3.3|Inter-Quartile Range|||2.7|4.1|
3954964|NCT01335867|3776714|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3954867|NCT01335971|3776534|B2|Slow vital capacity||Pulmonary function measures|Values were determined using either helium dilution or plethysmography methods, depending on equipment available at study sites. Lung volumes were measured in accordance with local hospital procedures.|Liters|Median|3.0|3.0|Inter-Quartile Range|||2.8|3.7|
3954868|NCT01335971|3776535|B1|Slow vital capacity||Pulmonary function measures|Values were determined using either helium dilution or plethysmography methods, depending on equipment available at study sites. Lung volumes were measured in accordance with local hospital procedures.|Liters|Median|3.1|3.1|Inter-Quartile Range|||2.4|4.1|
3954869|NCT01335971|3776532|B4|Total lung capacity||Pulmonary function measures|Values were determined using either helium dilution or plethysmography methods, depending on equipment available at study sites. Lung volumes were measured in accordance with local hospital procedures.|Liters|Median|6.0|6.0|Inter-Quartile Range|||5.0|7.2|
3954870|NCT01335971|3776533|B3|Total lung capacity||Pulmonary function measures|Values were determined using either helium dilution or plethysmography methods, depending on equipment available at study sites. Lung volumes were measured in accordance with local hospital procedures.|Liters|Median|6.3|6.3|Inter-Quartile Range|||5.7|7.0|
3954871|NCT01335971|3776534|B2|Total lung capacity||Pulmonary function measures|Values were determined using either helium dilution or plethysmography methods, depending on equipment available at study sites. Lung volumes were measured in accordance with local hospital procedures.|Liters|Median|5.5|5.5|Inter-Quartile Range|||4.9|6.8|
3954872|NCT01335971|3776535|B1|Total lung capacity||Pulmonary function measures|Values were determined using either helium dilution or plethysmography methods, depending on equipment available at study sites. Lung volumes were measured in accordance with local hospital procedures.|Liters|Median|6.0|6.0|Inter-Quartile Range|||4.7|7.3|
3954873|NCT01335971|3776532|B4|||Pulse oximetry (SpO2)||Percentage of oxyhemoglobin|Median|96|96.0|Inter-Quartile Range|||94.0|97.0|
3954874|NCT01335971|3776533|B3|||Pulse oximetry (SpO2)||Percentage of oxyhemoglobin|Median|96|96.0|Inter-Quartile Range|||94.0|97.0|
3954875|NCT01335971|3776534|B2|||Pulse oximetry (SpO2)||Percentage of oxyhemoglobin|Median|96|96.0|Inter-Quartile Range|||95.0|97.0|
3954876|NCT01335971|3776535|B1|||Pulse oximetry (SpO2)||Percentage of oxyhemoglobin|Median|95|95.0|Inter-Quartile Range|||94.0|97.0|
3954877|NCT01335971|3776532|B4|||Diffusing Capacity of the Lungs for Carbon Monoxide (DLCO)|DLCO: Diffusing capacity of the lungs for carbon monoxide measured by the single breath technique in accordance with American Thoracic Society standards|mL/mmHg/min|Median|15.7|15.7|Inter-Quartile Range|||12.1|20.9|
3954878|NCT01335971|3776533|B3|||Diffusing Capacity of the Lungs for Carbon Monoxide (DLCO)|DLCO: Diffusing capacity of the lungs for carbon monoxide measured by the single breath technique in accordance with American Thoracic Society standards|mL/mmHg/min|Median|16.3|16.3|Inter-Quartile Range|||12.3|21.4|
3954879|NCT01335971|3776534|B2|||Diffusing Capacity of the Lungs for Carbon Monoxide (DLCO)|DLCO: Diffusing capacity of the lungs for carbon monoxide measured by the single breath technique in accordance with American Thoracic Society standards|mL/mmHg/min|Median|15.7|15.7|Inter-Quartile Range|||12.1|19.3|
3954880|NCT01335971|3776535|B1|||Diffusing Capacity of the Lungs for Carbon Monoxide (DLCO)|DLCO: Diffusing capacity of the lungs for carbon monoxide measured by the single breath technique in accordance with American Thoracic Society standards|mL/mmHg/min|Median|14.8|14.8|Inter-Quartile Range|||11.8|19.5|
3954881|NCT01335971|3776532|B4|||Post bronchodilator FEV1/FVC ratio|Ratio of forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) after bronchodilation|ratio|Median|0.56|0.56|Inter-Quartile Range|||0.48|0.62|
3954882|NCT01335971|3776533|B3|||Post bronchodilator FEV1/FVC ratio|Ratio of forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) after bronchodilation|ratio|Median|0.57|0.57|Inter-Quartile Range|||0.5|0.63|
3954883|NCT01335971|3776534|B2|||Post bronchodilator FEV1/FVC ratio|Ratio of forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) after bronchodilation|ratio|Median|0.52|0.52|Inter-Quartile Range|||0.47|0.59|
3954884|NCT01335971|3776535|B1|||Post bronchodilator FEV1/FVC ratio|Ratio of forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) after bronchodilation|ratio|Median|0.56|0.56|Inter-Quartile Range|||0.51|0.63|
3954885|NCT01335971|3776532|B4|||Post bronchodilator FEV1|Forced expiratory volume in 1 second (FEV1) after administration of bronchodilator|percent predicted|Median|61|61.0|Inter-Quartile Range|||53.0|70.0|
3954886|NCT01335971|3776533|B3|||Post bronchodilator FEV1|Forced expiratory volume in 1 second (FEV1) after administration of bronchodilator|percent predicted|Median|65|65.0|Inter-Quartile Range|||55.0|72.0|
3954887|NCT01335971|3776534|B2|||Post bronchodilator FEV1|Forced expiratory volume in 1 second (FEV1) after administration of bronchodilator|percent predicted|Median|54|54.0|Inter-Quartile Range|||50.0|65.0|
3954888|NCT01335971|3776535|B1|||Post bronchodilator FEV1|Forced expiratory volume in 1 second (FEV1) after administration of bronchodilator|percent predicted|Median|61|61.0|Inter-Quartile Range|||54.0|70.0|
3954889|NCT01335971|3776532|B4|COPD exacerbation in last 12 months||Chronic obstructive pulmonary disease (COPD) characteristics||participants|Number|19|19.0||||||
3954890|NCT01335971|3776533|B3|COPD exacerbation in last 12 months||Chronic obstructive pulmonary disease (COPD) characteristics||participants|Number|7|7.0||||||
3954891|NCT01335971|3776534|B2|COPD exacerbation in last 12 months||Chronic obstructive pulmonary disease (COPD) characteristics||participants|Number|7|7.0||||||
3954892|NCT01335971|3776535|B1|COPD exacerbation in last 12 months||Chronic obstructive pulmonary disease (COPD) characteristics||participants|Number|5|5.0||||||
3954893|NCT01335971|3776532|B4|Smoke 10 or more cigarettes a day now||Chronic obstructive pulmonary disease (COPD) characteristics||participants|Number|29|29.0||||||
3954894|NCT01335971|3776533|B3|Smoke 10 or more cigarettes a day now||Chronic obstructive pulmonary disease (COPD) characteristics||participants|Number|10|10.0||||||
3954895|NCT01335971|3776534|B2|Smoke 10 or more cigarettes a day now||Chronic obstructive pulmonary disease (COPD) characteristics||participants|Number|9|9.0||||||
3954896|NCT01335971|3776535|B1|Smoke 10 or more cigarettes a day now||Chronic obstructive pulmonary disease (COPD) characteristics||participants|Number|10|10.0||||||
3954897|NCT01335971|3776532|B4|Smoke cigarettes now||Chronic obstructive pulmonary disease (COPD) characteristics||participants|Number|54|54.0||||||
3954962|NCT01335867|3776715|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3954901|NCT01335971|3776532|B4|10 or more pack years of smoking history||Chronic obstructive pulmonary disease (COPD) characteristics||participants|Number|88|88.0||||||
3954902|NCT01335971|3776533|B3|10 or more pack years of smoking history||Chronic obstructive pulmonary disease (COPD) characteristics||participants|Number|29|29.0||||||
3954903|NCT01335971|3776534|B2|10 or more pack years of smoking history||Chronic obstructive pulmonary disease (COPD) characteristics||participants|Number|29|29.0||||||
3954904|NCT01335971|3776535|B1|10 or more pack years of smoking history||Chronic obstructive pulmonary disease (COPD) characteristics||participants|Number|30|30.0||||||
3954905|NCT01335971|3776532|B4|United States||Region of Enrollment||participants|Number|89|89.0||||||
3954906|NCT01335971|3776533|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
3954907|NCT01335971|3776534|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
3954908|NCT01335971|3776535|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
3954909|NCT01335971|3776532|B4||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3954910|NCT01335971|3776533|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3954911|NCT01335971|3776534|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3954912|NCT01335971|3776535|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3954913|NCT01335971|3776532|B4||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3954914|NCT01335971|3776533|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3954915|NCT01335971|3776534|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3954916|NCT01335971|3776535|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3954917|NCT01335971|3776532|B4|||Age||years|Median|58|58.0|Inter-Quartile Range|||54.0|65.0|
3954918|NCT01335971|3776533|B3|||Age||years|Median|56|56.0|Inter-Quartile Range|||52.0|62.0|
3954919|NCT01335971|3776534|B2|||Age||years|Median|59|59.0|Inter-Quartile Range|||54.0|65.0|
3954920|NCT01335971|3776535|B1|||Age||years|Median|59|59.0|Inter-Quartile Range|||52.0|67.0|
3954921|NCT01335971|3776532|B4||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3954922|NCT01335971|3776533|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3954923|NCT01335971|3776534|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3954924|NCT01335971|3776535|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3954925|NCT01335971|3776532|B4||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
3954926|NCT01335971|3776533|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3954927|NCT01335971|3776534|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3954928|NCT01335971|3776535|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3954929|NCT01335971|3776532|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3954930|NCT01335971|3776533|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3954931|NCT01335971|3776534|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3954932|NCT01335971|3776535|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3954933|NCT01335932|3776572|B3|United States||Region of Enrollment||participants|Number|160|160.0||||||
3954934|NCT01335932|3776573|B2|United States||Region of Enrollment||participants|Number|76|76.0||||||
3954935|NCT01335932|3776574|B1|United States||Region of Enrollment||participants|Number|84|84.0||||||
3954936|NCT01335932|3776572|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3954937|NCT01335932|3776573|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3954938|NCT01335932|3776574|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3954939|NCT01335932|3776572|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3954940|NCT01335932|3776573|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3954941|NCT01335932|3776574|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3954942|NCT01335932|3776572|B3|||Age||years|Mean|56.6|56.6|Full Range|||18.0|95.0|
3954943|NCT01335932|3776573|B2|||Age||years|Mean|58.2|58.2|Full Range|||18.0|95.0|
3954944|NCT01335932|3776574|B1|||Age||years|Mean|55.2|55.2|Full Range|||18.0|95.0|
3954945|NCT01335867|3776713|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
3954946|NCT01335867|3776714|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3954947|NCT01335867|3776715|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3954948|NCT01335867|3776713|B3||Male|Gender||Participants|Count of Participants|22|22.0||||||
3954949|NCT01335867|3776714|B2||Male|Gender||Participants|Count of Participants|10|10.0||||||
3954950|NCT01335867|3776715|B1||Male|Gender||Participants|Count of Participants|12|12.0||||||
3954951|NCT01335867|3776713|B3||Female|Gender||Participants|Count of Participants|10|10.0||||||
3954952|NCT01335867|3776714|B2||Female|Gender||Participants|Count of Participants|6|6.0||||||
3954953|NCT01335867|3776715|B1||Female|Gender||Participants|Count of Participants|4|4.0||||||
3954954|NCT01335867|3776713|B3|||Age||years|Mean|47|47.0|Standard Deviation|7.35|7.35|||
3954955|NCT01335867|3776714|B2|||Age||years|Mean|48|48.0|Standard Deviation|6.81|6.81|||
3954956|NCT01335867|3776715|B1|||Age||years|Mean|46|46.0|Standard Deviation|7.97|7.97|||
3954957|NCT01335867|3776713|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3954958|NCT01335867|3776714|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3954959|NCT01335867|3776715|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3954960|NCT01335867|3776713|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3954961|NCT01335867|3776714|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3954965|NCT01335867|3776715|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3954966|NCT01335789|3776724|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
3954967|NCT01335789|3776725|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3954968|NCT01335789|3776726|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3954969|NCT01335789|3776724|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3954970|NCT01335789|3776725|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3954971|NCT01335789|3776726|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3954972|NCT01335789|3776724|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3954973|NCT01335789|3776725|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3954974|NCT01335789|3776726|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3954975|NCT01335789|3776724|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3954976|NCT01335789|3776725|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3954977|NCT01335789|3776726|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3954978|NCT01335789|3776724|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3954979|NCT01335789|3776725|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3954980|NCT01335789|3776726|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3954981|NCT01335789|3776724|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3954982|NCT01335789|3776725|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3954983|NCT01335789|3776726|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3954984|NCT01335789|3776724|B3|||Age||years|Mean|23.3|23.3|Standard Deviation|6.5|6.5|||
3954985|NCT01335789|3776725|B2|||Age||years|Mean|22.9|22.9|Standard Deviation|7.1|7.1|||
3954986|NCT01335789|3776726|B1|||Age||years|Mean|23.7|23.7|Standard Deviation|6.3|6.3|||
3954987|NCT01335750|3776737|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3954988|NCT01335750|3776737|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3954989|NCT01335750|3776737|B1|||Age||Years|Mean|32|32.0|Full Range|||23.0|62.0|
3954990|NCT01335724|3776756|B3|Germany||Region of Enrollment||participants|Number|72|72.0||||||
3954991|NCT01335724|3776757|B2|Germany||Region of Enrollment||participants|Number|36|36.0||||||
3954992|NCT01335724|3776758|B1|Germany||Region of Enrollment||participants|Number|36|36.0||||||
3954993|NCT01335724|3776756|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3954994|NCT01335724|3776757|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3954995|NCT01335724|3776758|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3954996|NCT01335724|3776756|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3954997|NCT01335724|3776757|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3954998|NCT01335724|3776758|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3954999|NCT01335724|3776756|B3|||Age||years|Mean|33.8|33.8|Standard Deviation|13.6|13.6|||
3955000|NCT01335724|3776757|B2|||Age||years|Mean|37.8|37.8|Standard Deviation|15.2|15.2|||
3955001|NCT01335724|3776758|B1|||Age||years|Mean|29.8|29.8|Standard Deviation|10.5|10.5|||
3955002|NCT01335724|3776756|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3955003|NCT01335724|3776757|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3955004|NCT01335724|3776758|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3955005|NCT01335724|3776756|B3||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
3955006|NCT01335724|3776757|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3955007|NCT01335724|3776758|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3955008|NCT01335724|3776756|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3955009|NCT01335724|3776757|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3955010|NCT01335724|3776758|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3955011|NCT01335698|3776769|B6||United States|Country||Participants|Count of Participants|3|3.0||||||
3955012|NCT01335698|3776770|B5||United States|Country||Participants|Count of Participants|0|0.0||||||
3955013|NCT01335698|3776771|B4||United States|Country||Participants|Count of Participants|0|0.0||||||
3955014|NCT01335698|3776772|B3||United States|Country||Participants|Count of Participants|2|2.0||||||
3955015|NCT01335698|3776773|B2||United States|Country||Participants|Count of Participants|0|0.0||||||
3955016|NCT01335698|3776774|B1||United States|Country||Participants|Count of Participants|1|1.0||||||
3955017|NCT01335698|3776769|B6||Spain|Country||Participants|Count of Participants|3|3.0||||||
3955018|NCT01335698|3776770|B5||Spain|Country||Participants|Count of Participants|0|0.0||||||
3955019|NCT01335698|3776771|B4||Spain|Country||Participants|Count of Participants|2|2.0||||||
3955020|NCT01335698|3776772|B3||Spain|Country||Participants|Count of Participants|1|1.0||||||
3955021|NCT01335698|3776773|B2||Spain|Country||Participants|Count of Participants|0|0.0||||||
3955022|NCT01335698|3776774|B1||Spain|Country||Participants|Count of Participants|0|0.0||||||
3955023|NCT01335698|3776769|B6||South Africa|Country||Participants|Count of Participants|64|64.0||||||
3955024|NCT01335698|3776770|B5||South Africa|Country||Participants|Count of Participants|5|5.0||||||
3955025|NCT01335698|3776771|B4||South Africa|Country||Participants|Count of Participants|21|21.0||||||
3955026|NCT01335698|3776772|B3||South Africa|Country||Participants|Count of Participants|8|8.0||||||
3955027|NCT01335698|3776773|B2||South Africa|Country||Participants|Count of Participants|10|10.0||||||
3955028|NCT01335698|3776774|B1||South Africa|Country||Participants|Count of Participants|20|20.0||||||
3955029|NCT01335698|3776769|B6||Russia|Country||Participants|Count of Participants|4|4.0||||||
3955030|NCT01335698|3776770|B5||Russia|Country||Participants|Count of Participants|0|0.0||||||
3955031|NCT01335698|3776771|B4||Russia|Country||Participants|Count of Participants|3|3.0||||||
3955032|NCT01335698|3776772|B3||Russia|Country||Participants|Count of Participants|1|1.0||||||
3955033|NCT01335698|3776773|B2||Russia|Country||Participants|Count of Participants|0|0.0||||||
3955034|NCT01335698|3776774|B1||Russia|Country||Participants|Count of Participants|0|0.0||||||
3955035|NCT01335698|3776769|B6||Romania|Country||Participants|Count of Participants|1|1.0||||||
3955036|NCT01335698|3776770|B5||Romania|Country||Participants|Count of Participants|0|0.0||||||
3955037|NCT01335698|3776771|B4||Romania|Country||Participants|Count of Participants|1|1.0||||||
3955038|NCT01335698|3776772|B3||Romania|Country||Participants|Count of Participants|0|0.0||||||
3955039|NCT01335698|3776773|B2||Romania|Country||Participants|Count of Participants|0|0.0||||||
3955040|NCT01335698|3776774|B1||Romania|Country||Participants|Count of Participants|0|0.0||||||
3955041|NCT01335698|3776769|B6||Poland|Country||Participants|Count of Participants|1|1.0||||||
3955042|NCT01335698|3776770|B5||Poland|Country||Participants|Count of Participants|0|0.0||||||
3955043|NCT01335698|3776771|B4||Poland|Country||Participants|Count of Participants|0|0.0||||||
3955044|NCT01335698|3776772|B3||Poland|Country||Participants|Count of Participants|1|1.0||||||
3955045|NCT01335698|3776773|B2||Poland|Country||Participants|Count of Participants|0|0.0||||||
3955046|NCT01335698|3776774|B1||Poland|Country||Participants|Count of Participants|0|0.0||||||
3955047|NCT01335698|3776769|B6||Mexico|Country||Participants|Count of Participants|15|15.0||||||
3955048|NCT01335698|3776770|B5||Mexico|Country||Participants|Count of Participants|2|2.0||||||
3955049|NCT01335698|3776771|B4||Mexico|Country||Participants|Count of Participants|4|4.0||||||
3955050|NCT01335698|3776772|B3||Mexico|Country||Participants|Count of Participants|7|7.0||||||
3955051|NCT01335698|3776773|B2||Mexico|Country||Participants|Count of Participants|1|1.0||||||
3955052|NCT01335698|3776774|B1||Mexico|Country||Participants|Count of Participants|1|1.0||||||
3955053|NCT01335698|3776769|B6||Chile|Country||Participants|Count of Participants|3|3.0||||||
3955054|NCT01335698|3776770|B5||Chile|Country||Participants|Count of Participants|1|1.0||||||
3955055|NCT01335698|3776771|B4||Chile|Country||Participants|Count of Participants|1|1.0||||||
3955056|NCT01335698|3776772|B3||Chile|Country||Participants|Count of Participants|0|0.0||||||
3955057|NCT01335698|3776773|B2||Chile|Country||Participants|Count of Participants|0|0.0||||||
3955058|NCT01335698|3776774|B1||Chile|Country||Participants|Count of Participants|1|1.0||||||
3955059|NCT01335698|3776769|B6||Brazil|Country||Participants|Count of Participants|1|1.0||||||
3955060|NCT01335698|3776770|B5||Brazil|Country||Participants|Count of Participants|0|0.0||||||
3955061|NCT01335698|3776771|B4||Brazil|Country||Participants|Count of Participants|1|1.0||||||
3955062|NCT01335698|3776772|B3||Brazil|Country||Participants|Count of Participants|0|0.0||||||
3955063|NCT01335698|3776773|B2||Brazil|Country||Participants|Count of Participants|0|0.0||||||
3955064|NCT01335698|3776774|B1||Brazil|Country||Participants|Count of Participants|0|0.0||||||
3955065|NCT01335698|3776769|B6||Argentina|Country||Participants|Count of Participants|4|4.0||||||
3955066|NCT01335698|3776770|B5||Argentina|Country||Participants|Count of Participants|0|0.0||||||
3955067|NCT01335698|3776771|B4||Argentina|Country||Participants|Count of Participants|2|2.0||||||
3955068|NCT01335698|3776772|B3||Argentina|Country||Participants|Count of Participants|1|1.0||||||
3955069|NCT01335698|3776773|B2||Argentina|Country||Participants|Count of Participants|1|1.0||||||
3955070|NCT01335698|3776774|B1||Argentina|Country||Participants|Count of Participants|0|0.0||||||
3955071|NCT01335698|3776769|B6|Europe||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3955072|NCT01335698|3776770|B5|Europe||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3955073|NCT01335698|3776771|B4|Europe||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3955074|NCT01335698|3776772|B3|Europe||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3955075|NCT01335698|3776773|B2|Europe||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3955076|NCT01335698|3776774|B1|Europe||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3955077|NCT01335698|3776769|B6|Africa||Region of Enrollment||Participants|Count of Participants|64|64.0||||||
3955078|NCT01335698|3776770|B5|Africa||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3955079|NCT01335698|3776771|B4|Africa||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3955080|NCT01335698|3776772|B3|Africa||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3955081|NCT01335698|3776773|B2|Africa||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3955082|NCT01335698|3776774|B1|Africa||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3955083|NCT01335698|3776769|B6|South America||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3955084|NCT01335698|3776770|B5|South America||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3955085|NCT01335698|3776771|B4|South America||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3955086|NCT01335698|3776772|B3|South America||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3955087|NCT01335698|3776773|B2|South America||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3955088|NCT01335698|3776774|B1|South America||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3955089|NCT01335698|3776769|B6|North America||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3955090|NCT01335698|3776770|B5|North America||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3955091|NCT01335698|3776771|B4|North America||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3955092|NCT01335698|3776772|B3|North America||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3955093|NCT01335698|3776773|B2|North America||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3955094|NCT01335698|3776774|B1|North America||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3955095|NCT01335698|3776769|B6||Other|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3955096|NCT01335698|3776770|B5||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3955097|NCT01335698|3776771|B4||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3955098|NCT01335698|3776772|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3955099|NCT01335698|3776773|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3955100|NCT01335698|3776774|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3955101|NCT01335698|3776769|B6||Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|57|57.0||||||
3955102|NCT01335698|3776770|B5||Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3955103|NCT01335698|3776771|B4||Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3955104|NCT01335698|3776772|B3||Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3955105|NCT01335698|3776773|B2||Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3955106|NCT01335698|3776774|B1||Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3955107|NCT01335698|3776769|B6||White|Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3955108|NCT01335698|3776770|B5||White|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3955109|NCT01335698|3776771|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3955110|NCT01335698|3776772|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3955111|NCT01335698|3776773|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3955112|NCT01335698|3776774|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3955113|NCT01335698|3776769|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3955114|NCT01335698|3776770|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3955115|NCT01335698|3776771|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3955116|NCT01335698|3776772|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3955117|NCT01335698|3776773|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3955118|NCT01335698|3776774|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3955119|NCT01335698|3776769|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3955120|NCT01335698|3776770|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955121|NCT01335698|3776771|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3955122|NCT01335698|3776772|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3955123|NCT01335698|3776773|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3955124|NCT01335698|3776774|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3955125|NCT01335698|3776769|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3955126|NCT01335698|3776770|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955127|NCT01335698|3776771|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3955128|NCT01335698|3776772|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3955129|NCT01335698|3776773|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3955130|NCT01335698|3776774|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955131|NCT01335698|3776769|B6||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3955132|NCT01335698|3776770|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3955133|NCT01335698|3776771|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3955134|NCT01335698|3776772|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3955135|NCT01335698|3776773|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3955136|NCT01335698|3776774|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3955137|NCT01335698|3776769|B6||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3955138|NCT01335698|3776770|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3955139|NCT01335698|3776771|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3955140|NCT01335698|3776772|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3955141|NCT01335698|3776773|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3955142|NCT01335698|3776774|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3955143|NCT01335698|3776769|B6|||Age||Months|Mean|42.5|42.5|Standard Deviation|31.58|31.58|||
3955144|NCT01335698|3776770|B5|||Age||Months|Mean|93.4|93.4|Standard Deviation|15.53|15.53|||
3955145|NCT01335698|3776771|B4|||Age||Months|Mean|67.2|67.2|Standard Deviation|16.70|16.7|||
3955146|NCT01335698|3776772|B3|||Age||Months|Mean|37.4|37.4|Standard Deviation|12.44|12.44|||
3955147|NCT01335698|3776773|B2|||Age||Months|Mean|10.5|10.5|Standard Deviation|9.21|9.21|||
3955148|NCT01335698|3776774|B1|||Age||Months|Mean|8.4|8.4|Standard Deviation|6.42|6.42|||
3955149|NCT01335685|3776839|B5|||Body Surface Area at Baseline|Body Surface Area (m^2) = square root [height (cm) x weight (kg) / 3600].|m^2|Mean|1.795|1.795|Standard Deviation|0.2638|0.2638|||
3955150|NCT01335685|3776840|B4|||Body Surface Area at Baseline|Body Surface Area (m^2) = square root [height (cm) x weight (kg) / 3600].|m^2|Mean|1.718|1.718|Standard Deviation|0.3650|0.365|||
3955151|NCT01335685|3776841|B3|||Body Surface Area at Baseline|Body Surface Area (m^2) = square root [height (cm) x weight (kg) / 3600].|m^2|Mean|1.799|1.799|Standard Deviation|0.3337|0.3337|||
3955152|NCT01335685|3776842|B2|||Body Surface Area at Baseline|Body Surface Area (m^2) = square root [height (cm) x weight (kg) / 3600].|m^2|Mean|1.813|1.813|Standard Deviation|0.2638|0.2638|||
3955153|NCT01335685|3776843|B1|||Body Surface Area at Baseline|Body Surface Area (m^2) = square root [height (cm) x weight (kg) / 3600].|m^2|Mean|1.782|1.782|Standard Deviation|0.1426|0.1426|||
3955154|NCT01335685|3776839|B5|||Weight at Baseline||kg|Mean|72.17|72.17|Standard Deviation|16.509|16.509|||
3955155|NCT01335685|3776840|B4|||Weight at Baseline||kg|Mean|66.97|66.97|Standard Deviation|21.404|21.404|||
3955156|NCT01335685|3776841|B3|||Weight at Baseline||kg|Mean|72.77|72.77|Standard Deviation|20.532|20.532|||
3955157|NCT01335685|3776842|B2|||Weight at Baseline||kg|Mean|73.43|73.43|Standard Deviation|16.642|16.642|||
3955158|NCT01335685|3776843|B1|||Weight at Baseline||kg|Mean|70.58|70.58|Standard Deviation|9.389|9.389|||
3955159|NCT01335685|3776839|B5|||Height||cm|Mean|162.65|162.65|Standard Deviation|11.615|11.615|||
3955160|NCT01335685|3776840|B4|||Height||cm|Mean|160.50|160.5|Standard Deviation|16.897|16.897|||
3955161|NCT01335685|3776841|B3|||Height||cm|Mean|164.50|164.5|Standard Deviation|11.413|11.413|||
3955162|NCT01335685|3776842|B2|||Height||cm|Mean|162.68|162.68|Standard Deviation|12.087|12.087|||
3955163|NCT01335685|3776843|B1|||Height||cm|Mean|162.24|162.24|Standard Deviation|7.872|7.872|||
3955164|NCT01335685|3776839|B5|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3955165|NCT01335685|3776840|B4|United States||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3955166|NCT01335685|3776841|B3|United States||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3955167|NCT01335685|3776842|B2|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3955168|NCT01335685|3776843|B1|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3955169|NCT01335685|3776839|B5|United Kingdom||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3955170|NCT01335685|3776840|B4|United Kingdom||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3955171|NCT01335685|3776841|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3955172|NCT01335685|3776842|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3955173|NCT01335685|3776843|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3955174|NCT01335685|3776839|B5|Spain||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3955175|NCT01335685|3776840|B4|Spain||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3955176|NCT01335685|3776841|B3|Spain||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3955177|NCT01335685|3776842|B2|Spain||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3955178|NCT01335685|3776843|B1|Spain||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3955179|NCT01335685|3776839|B5|Czech Republic||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3955180|NCT01335685|3776840|B4|Czech Republic||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3955181|NCT01335685|3776841|B3|Czech Republic||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3955182|NCT01335685|3776842|B2|Czech Republic||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3955183|NCT01335685|3776843|B1|Czech Republic||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3955184|NCT01335685|3776839|B5|Canada||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3955185|NCT01335685|3776840|B4|Canada||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3955186|NCT01335685|3776841|B3|Canada||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3955187|NCT01335685|3776842|B2|Canada||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3955188|NCT01335685|3776843|B1|Canada||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3955189|NCT01335685|3776839|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3955190|NCT01335685|3776840|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3955191|NCT01335685|3776841|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3955192|NCT01335685|3776842|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3955193|NCT01335685|3776843|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3955194|NCT01335685|3776839|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|57|57.0||||||
3955195|NCT01335685|3776840|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3955196|NCT01335685|3776841|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3955197|NCT01335685|3776842|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3955198|NCT01335685|3776843|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3955199|NCT01335685|3776839|B5|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3955200|NCT01335685|3776840|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3955201|NCT01335685|3776841|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3955202|NCT01335685|3776842|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3955203|NCT01335685|3776843|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3955204|NCT01335685|3776839|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3955205|NCT01335685|3776840|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3955206|NCT01335685|3776841|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3955207|NCT01335685|3776842|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3955208|NCT01335685|3776843|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3955209|NCT01335685|3776839|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|56|56.0||||||
3955210|NCT01335685|3776840|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3955211|NCT01335685|3776841|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3955212|NCT01335685|3776842|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3955213|NCT01335685|3776843|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3955214|NCT01335685|3776839|B5|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3955215|NCT01335685|3776840|B4|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3955216|NCT01335685|3776841|B3|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3955217|NCT01335685|3776842|B2|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3955218|NCT01335685|3776843|B1|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3955219|NCT01335685|3776839|B5||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3955220|NCT01335685|3776840|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3955221|NCT01335685|3776841|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3955222|NCT01335685|3776842|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3955223|NCT01335685|3776843|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3955224|NCT01335685|3776839|B5||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3955225|NCT01335685|3776840|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3955226|NCT01335685|3776841|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3955227|NCT01335685|3776842|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3955228|NCT01335685|3776843|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3955229|NCT01335685|3776839|B5|>=75||Age, Customized||Participants|Count of Participants|30|30.0||||||
3955230|NCT01335685|3776840|B4|>=75||Age, Customized||Participants|Count of Participants|2|2.0||||||
3955231|NCT01335685|3776841|B3|>=75||Age, Customized||Participants|Count of Participants|8|8.0||||||
3955232|NCT01335685|3776842|B2|>=75||Age, Customized||Participants|Count of Participants|15|15.0||||||
3955233|NCT01335685|3776843|B1|>=75||Age, Customized||Participants|Count of Participants|5|5.0||||||
3955234|NCT01335685|3776839|B5|<75||Age, Customized||Participants|Count of Participants|31|31.0||||||
3955235|NCT01335685|3776840|B4|<75||Age, Customized||Participants|Count of Participants|4|4.0||||||
3955236|NCT01335685|3776841|B3|<75||Age, Customized||Participants|Count of Participants|2|2.0||||||
3955237|NCT01335685|3776842|B2|<75||Age, Customized||Participants|Count of Participants|19|19.0||||||
3955238|NCT01335685|3776843|B1|<75||Age, Customized||Participants|Count of Participants|6|6.0||||||
3955239|NCT01335685|3776839|B5|||Age||years|Mean|74.5|74.5|Standard Deviation|5.60|5.6|||
3955240|NCT01335685|3776840|B4|||Age||years|Mean|73.2|73.2|Standard Deviation|9.66|9.66|||
3955241|NCT01335685|3776841|B3|||Age||years|Mean|76.3|76.3|Standard Deviation|4.27|4.27|||
3955242|NCT01335685|3776842|B2|||Age||years|Mean|74.3|74.3|Standard Deviation|4.79|4.79|||
3955243|NCT01335685|3776843|B1|||Age||years|Mean|74.2|74.2|Standard Deviation|6.68|6.68|||
3955244|NCT01335542|3776952|B3|Morbidly Obese||BMI||participants|Number|5|5.0||||||
3955245|NCT01335542|3776953|B2|Morbidly Obese||BMI||participants|Number|3|3.0||||||
3955246|NCT01335542|3776954|B1|Morbidly Obese||BMI||participants|Number|2|2.0||||||
3955247|NCT01335542|3776952|B3|Obese||BMI||participants|Number|41|41.0||||||
3955248|NCT01335542|3776953|B2|Obese||BMI||participants|Number|20|20.0||||||
3955249|NCT01335542|3776954|B1|Obese||BMI||participants|Number|21|21.0||||||
3955250|NCT01335542|3776952|B3|Overweight||BMI||participants|Number|39|39.0||||||
3955251|NCT01335542|3776953|B2|Overweight||BMI||participants|Number|20|20.0||||||
3955252|NCT01335542|3776954|B1|Overweight||BMI||participants|Number|19|19.0||||||
3955253|NCT01335542|3776952|B3|Normal||BMI||participants|Number|5|5.0||||||
3955254|NCT01335542|3776953|B2|Normal||BMI||participants|Number|2|2.0||||||
3955255|NCT01335542|3776954|B1|Normal||BMI||participants|Number|3|3.0||||||
3955256|NCT01335542|3776952|B3|United States||Region of Enrollment||participants|Number|90|90.0||||||
3955257|NCT01335542|3776953|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
3955258|NCT01335542|3776954|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
3955259|NCT01335542|3776952|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3955260|NCT01335542|3776953|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3955261|NCT01335542|3776954|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3955262|NCT01335542|3776952|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3955263|NCT01335542|3776953|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3955264|NCT01335542|3776954|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3955265|NCT01335542|3776952|B3|||Age||years|Mean|66|66.0|Inter-Quartile Range|||49.0|82.0|
3955266|NCT01335542|3776953|B2|||Age||years|Mean|65|65.0|Inter-Quartile Range|||49.0|81.0|
3955267|NCT01335542|3776954|B1|||Age||years|Mean|67|67.0|Inter-Quartile Range|||50.0|84.0|
3955268|NCT01335477|3776961|B3||Male|Sex: Female, Male||Participants|Count of Participants|427|427.0||||||
3955269|NCT01335477|3776962|B2||Male|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
3955270|NCT01335477|3776963|B1||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3955271|NCT01335477|3776961|B3||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3955272|NCT01335477|3776962|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3955273|NCT01335477|3776963|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3955274|NCT01335477|3776961|B3|||Age||years|Mean|66.6|66.6|Standard Deviation|7.8|7.8|||
3955275|NCT01335477|3776962|B2|||Age||years|Mean|66.4|66.4|Standard Deviation|7.9|7.9|||
3955276|NCT01335477|3776963|B1|||Age||years|Mean|67.1|67.1|Standard Deviation|7.5|7.5|||
3955277|NCT01335464|3777026|B3||Male|Sex: Female, Male||Participants|Count of Participants|414|414.0||||||
3955278|NCT01335464|3777027|B2||Male|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
3955279|NCT01335464|3777028|B1||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3955280|NCT01335464|3777026|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3955281|NCT01335464|3777027|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3955282|NCT01335464|3777028|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3955283|NCT01335464|3777026|B3|||Age||years|Mean|66.9|66.9|Standard Deviation|8.3|8.3|||
3955284|NCT01335464|3777027|B2|||Age||years|Mean|66.9|66.9|Standard Deviation|8.4|8.4|||
3955285|NCT01335464|3777028|B1|||Age||years|Mean|66.9|66.9|Standard Deviation|8.2|8.2|||
3955286|NCT01335308|3777091|B4|United States||Region of Enrollment||participants|Number|645|645.0||||||
3955287|NCT01335308|3777092|B3|United States||Region of Enrollment||participants|Number|235|235.0||||||
3955288|NCT01335308|3777093|B2|United States||Region of Enrollment||participants|Number|212|212.0||||||
3955289|NCT01335308|3777094|B1|United States||Region of Enrollment||participants|Number|198|198.0||||||
3955290|NCT01335308|3777091|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3955291|NCT01335308|3777092|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3955292|NCT01335308|3777093|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3955293|NCT01335308|3777094|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3955294|NCT01335308|3777091|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955295|NCT01335308|3777092|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955296|NCT01335308|3777093|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955297|NCT01335308|3777094|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955298|NCT01335308|3777091|B4||White|Race (NIH/OMB)||Participants|Count of Participants|526|526.0||||||
3955299|NCT01335308|3777092|B3||White|Race (NIH/OMB)||Participants|Count of Participants|188|188.0||||||
3955300|NCT01335308|3777093|B2||White|Race (NIH/OMB)||Participants|Count of Participants|178|178.0||||||
3955301|NCT01335308|3777094|B1||White|Race (NIH/OMB)||Participants|Count of Participants|160|160.0||||||
3955302|NCT01335308|3777091|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3955303|NCT01335308|3777092|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3955304|NCT01335308|3777093|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3955305|NCT01335308|3777094|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3955306|NCT01335308|3777091|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955307|NCT01335308|3777092|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955308|NCT01335308|3777093|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955309|NCT01335308|3777094|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955310|NCT01335308|3777091|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3955311|NCT01335308|3777092|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3955312|NCT01335308|3777093|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3955313|NCT01335308|3777094|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3955314|NCT01335308|3777091|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955315|NCT01335308|3777092|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955316|NCT01335308|3777093|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955317|NCT01335308|3777094|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955318|NCT01335308|3777091|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3955319|NCT01335308|3777092|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3955320|NCT01335308|3777093|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3955321|NCT01335308|3777094|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3955322|NCT01335308|3777091|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|471|471.0||||||
3955323|NCT01335308|3777092|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|180|180.0||||||
3955324|NCT01335308|3777093|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|139|139.0||||||
3955325|NCT01335308|3777094|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|152|152.0||||||
3955326|NCT01335308|3777091|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|139|139.0||||||
3955327|NCT01335308|3777092|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3955328|NCT01335308|3777093|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3955329|NCT01335308|3777094|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3955330|NCT01335308|3777091|B4||Male|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
3955331|NCT01335308|3777092|B3||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3955332|NCT01335308|3777093|B2||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3955333|NCT01335308|3777094|B1||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3955334|NCT01335308|3777091|B4||Female|Sex: Female, Male||Participants|Count of Participants|367|367.0||||||
3955335|NCT01335308|3777092|B3||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3955336|NCT01335308|3777093|B2||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3955337|NCT01335308|3777094|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3955338|NCT01335308|3777091|B4|||Age||YEARS|Mean|5.1|5.1|Standard Deviation|1.8|1.8|||
3955339|NCT01335308|3777092|B3|||Age||YEARS|Mean|5.3|5.3|Standard Deviation|1.8|1.8|||
3955340|NCT01335308|3777093|B2|||Age||YEARS|Mean|5.1|5.1|Standard Deviation|1.9|1.9|||
3955341|NCT01335308|3777094|B1|||Age||YEARS|Mean|4.7|4.7|Standard Deviation|1.7|1.7|||
3955342|NCT01335308|3777091|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3955343|NCT01335308|3777092|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3955344|NCT01335308|3777093|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3955345|NCT01335308|3777094|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3955346|NCT01335308|3777091|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3955347|NCT01335308|3777092|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3955348|NCT01335308|3777093|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3955349|NCT01335308|3777094|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3955350|NCT01335308|3777091|B4||<=18 years|Age||Participants|Count of Participants|645|645.0||||||
3955351|NCT01335308|3777092|B3||<=18 years|Age||Participants|Count of Participants|235|235.0||||||
3955352|NCT01335308|3777093|B2||<=18 years|Age||Participants|Count of Participants|212|212.0||||||
3955353|NCT01335308|3777094|B1||<=18 years|Age||Participants|Count of Participants|198|198.0||||||
3955354|NCT01335230|3777113|B5|United States||Region of Enrollment||participants|Number|40|40.0||||||
3955355|NCT01335230|3777114|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
3955356|NCT01335230|3777115|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3955357|NCT01335230|3777116|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3955358|NCT01335230|3777117|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3955359|NCT01335230|3777113|B5||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3955360|NCT01335230|3777114|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3955361|NCT01335230|3777115|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3955362|NCT01335230|3777116|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3955363|NCT01335230|3777117|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3955364|NCT01335230|3777113|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3955365|NCT01335230|3777114|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3955366|NCT01335230|3777115|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3955367|NCT01335230|3777116|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3955368|NCT01335230|3777117|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3955369|NCT01335230|3777113|B5|||Age||years|Mean|51.4|51.4|Standard Deviation|9.3|9.3|||
3955370|NCT01335230|3777114|B4|||Age||years|Mean|56|56.0|Standard Deviation|6.8|6.8|||
3955371|NCT01335230|3777115|B3|||Age||years|Mean|49.1|49.1|Standard Deviation|6.2|6.2|||
3955372|NCT01335230|3777116|B2|||Age||years|Mean|56.8|56.8|Standard Deviation|6.5|6.5|||
3955373|NCT01335230|3777117|B1|||Age||years|Mean|43.5|43.5|Standard Deviation|10.7|10.7|||
3955374|NCT01335230|3777113|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3955375|NCT01335230|3777114|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3955376|NCT01335230|3777115|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3955377|NCT01335230|3777116|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3955378|NCT01335230|3777117|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3955379|NCT01335230|3777113|B5||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3955380|NCT01335230|3777114|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3955381|NCT01335230|3777115|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3955382|NCT01335230|3777116|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3955383|NCT01335230|3777117|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3955384|NCT01335230|3777113|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3955385|NCT01335230|3777114|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3955386|NCT01335230|3777115|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3955387|NCT01335230|3777116|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3955388|NCT01335230|3777117|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3955389|NCT01335204|3777130|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955390|NCT01335204|3777130|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955391|NCT01335204|3777130|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3955392|NCT01335204|3777130|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955393|NCT01335204|3777130|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955394|NCT01335204|3777130|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955395|NCT01335204|3777130|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955396|NCT01335204|3777130|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3955397|NCT01335204|3777130|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3955398|NCT01335204|3777130|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3955399|NCT01335204|3777130|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3955400|NCT01335204|3777130|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3955401|NCT01335191|3777139|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
3955402|NCT01335191|3777140|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3955403|NCT01335191|3777141|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3955404|NCT01335191|3777139|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3955405|NCT01335191|3777140|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3955406|NCT01335191|3777141|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3955407|NCT01335191|3777139|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3955408|NCT01335191|3777140|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3955409|NCT01335191|3777141|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3955410|NCT01335191|3777139|B3|Between 18 and 65 years||Age, Customized||years|Mean|43|43.0|Full Range|||24.0|55.0|
3955411|NCT01335191|3777140|B2|Between 18 and 65 years||Age, Customized||years|Mean|43|43.0|Full Range|||24.0|54.0|
3955412|NCT01335191|3777141|B1|Between 18 and 65 years||Age, Customized||years|Mean|45|45.0|Full Range|||27.0|55.0|
3955413|NCT01335061|3777148|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3955414|NCT01335061|3777148|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3955415|NCT01335061|3777148|B1|||Age||Years|Mean|31.3|31.3|Standard Deviation|12.6|12.6|||
3955416|NCT01334957|3777163|B1|United States||Region of Enrollment||participants|Number|300|300.0||||||
3955417|NCT01334957|3777163|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3955418|NCT01334957|3777163|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955419|NCT01334957|3777163|B1||White|Race (NIH/OMB)||Participants|Count of Participants|229|229.0||||||
3955420|NCT01334957|3777163|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3955421|NCT01334957|3777163|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955422|NCT01334957|3777163|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3955423|NCT01334957|3777163|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3955424|NCT01334957|3777163|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955425|NCT01334957|3777163|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|271|271.0||||||
3955426|NCT01334957|3777163|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3955427|NCT01334957|3777163|B1||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3955428|NCT01334957|3777163|B1||Female|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
3955429|NCT01334957|3777163|B1|Greater than or equal to 18 years of age||Age, Customized|Greater than or equal to 18 years of age|years|Number|300|300.0||||||
3955430|NCT01334944|3777171|B1|United States||Region of Enrollment||participants|Number|150|150.0||||||
3955431|NCT01334944|3777171|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3955432|NCT01334944|3777171|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955433|NCT01334944|3777171|B1||White|Race (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
3955434|NCT01334944|3777171|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3955435|NCT01334944|3777171|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3955436|NCT01334944|3777171|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3955437|NCT01334944|3777171|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955438|NCT01334944|3777171|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3955439|NCT01334944|3777171|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3955440|NCT01334944|3777171|B1|Greater than or equal to 18 years of age||Age, Customized|Greater than or equal to 18 years of age|years|Number|150|150.0||||||
3955441|NCT01334918|3777196|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
3955442|NCT01334918|3777197|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3955443|NCT01334918|3777198|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3955444|NCT01334918|3777196|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|78|78.0||||||
3955445|NCT01334918|3777197|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
3955446|NCT01334918|3777198|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
3955447|NCT01334918|3777196|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3955448|NCT01334918|3777197|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3955449|NCT01334918|3777198|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3955450|NCT01334918|3777196|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3955451|NCT01334918|3777197|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3955452|NCT01334918|3777198|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3955453|NCT01334918|3777196|B3|White||Race/Ethnicity, Customized||participants|Number|106|106.0||||||
3955454|NCT01334918|3777197|B2|White||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
3955455|NCT01334918|3777198|B1|White||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
3955456|NCT01334918|3777196|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3955457|NCT01334918|3777197|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3955458|NCT01334918|3777198|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3955459|NCT01334918|3777196|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3955460|NCT01334918|3777197|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3955461|NCT01334918|3777198|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3955462|NCT01334918|3777196|B3|||Age||years|Mean|61.6|61.6|Standard Deviation|9.29|9.29|||
3955463|NCT01334918|3777197|B2|||Age||years|Mean|62.3|62.3|Standard Deviation|9.41|9.41|||
3955464|NCT01334918|3777198|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|9.19|9.19|||
3955465|NCT01334866|3777225|B1|Canada||Region of Enrollment||participants|Number|46|46.0||||||
3955466|NCT01334866|3777225|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
3955467|NCT01334866|3777225|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3955468|NCT01334866|3777225|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3955469|NCT01334866|3777225|B1|||Age||years|Mean|64.1|64.1|Standard Deviation|8.3|8.3|||
3955470|NCT01334723|3777233|B3||Male|Sex: Female, Male||Participants|Count of Participants|35032|35032.0||||||
3955471|NCT01334723|3777234|B2||Male|Sex: Female, Male||Participants|Count of Participants|17739|17739.0||||||
3955472|NCT01334723|3777235|B1||Male|Sex: Female, Male||Participants|Count of Participants|17293|17293.0||||||
3955473|NCT01334723|3777233|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3955474|NCT01334723|3777234|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3955475|NCT01334723|3777235|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3955476|NCT01334723|3777233|B3|Age < 50||Age, Customized||participants|Number|0|0.0||||||
3955477|NCT01334723|3777234|B2|Age < 50||Age, Customized||participants|Number|0|0.0||||||
3955478|NCT01334723|3777235|B1|Age < 50||Age, Customized||participants|Number|0|0.0||||||
3955479|NCT01334723|3777233|B3|Age >= 50||Age, Customized||participants|Number|35032|35032.0||||||
3955480|NCT01334723|3777234|B2|Age >= 50||Age, Customized||participants|Number|17739|17739.0||||||
3955481|NCT01334723|3777235|B1|Age >= 50||Age, Customized||participants|Number|17293|17293.0||||||
3955482|NCT01334710|3777262|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3955483|NCT01334710|3777262|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3955484|NCT01334710|3777262|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3955485|NCT01334710|3777262|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3955486|NCT01334710|3777262|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3955487|NCT01334710|3777262|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3955488|NCT01334606|3777267|B1|Canada||Region of Enrollment||participants|Number|5|5.0||||||
3955489|NCT01334606|3777267|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3955490|NCT01334606|3777267|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3955491|NCT01334606|3777267|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3955492|NCT01334606|3777267|B1|||Age||years|Mean|59.1|59.1|Standard Deviation|9.45|9.45|||
3955493|NCT01334554|3777273|B3|||insulin||uU/ml|Mean|14.6|14.6|Standard Deviation|8.7|8.7|||
3955494|NCT01334554|3777274|B2|||insulin||uU/ml|Mean|14|14.0|Standard Deviation|9.9|9.9|||
3955495|NCT01334554|3777275|B1|||insulin||uU/ml|Mean|15|15.0|Standard Deviation|7.7|7.7|||
3955496|NCT01334554|3777273|B3|||glucose||mg/dL|Mean|93.5|93.5|Standard Deviation|11.4|11.4|||
3955497|NCT01334554|3777274|B2|||glucose||mg/dL|Mean|97|97.0|Standard Deviation|11.4|11.4|||
3955498|NCT01334554|3777275|B1|||glucose||mg/dL|Mean|90|90.0|Standard Deviation|10.6|10.6|||
3955499|NCT01334554|3777273|B3|||triglycerides||mg/dL|Mean|89|89.0|Standard Deviation|50.5|50.5|||
3955500|NCT01334554|3777274|B2|||triglycerides||mg/dL|Mean|85|85.0|Standard Deviation|48.5|48.5|||
3955501|NCT01334554|3777275|B1|||triglycerides||mg/dL|Mean|94.0|94.0|Standard Deviation|52.9|52.9|||
3955502|NCT01334554|3777273|B3|||HDL||mg/dL|Mean|44|44.0|Standard Deviation|10.4|10.4|||
3955503|NCT01334554|3777274|B2|||HDL||mg/dL|Mean|45|45.0|Standard Deviation|11.1|11.1|||
3955504|NCT01334554|3777275|B1|||HDL||mg/dL|Mean|44.0|44.0|Standard Deviation|9.9|9.9|||
3955505|NCT01334554|3777273|B3|||Waist circumference||cm|Mean|110|110.0|Standard Deviation|11.0|11.0|||
3955506|NCT01334554|3777274|B2|||Waist circumference||cm|Mean|108|108.0|Standard Deviation|11.4|11.4|||
3955507|NCT01334554|3777275|B1|||Waist circumference||cm|Mean|112|112.0|Standard Deviation|10.1|10.1|||
3955508|NCT01334554|3777273|B3|||Body mass index||kg/m^2|Mean|39|39.0|Standard Deviation|5.4|5.4|||
3955509|NCT01334554|3777274|B2|||Body mass index||kg/m^2|Mean|39|39.0|Standard Deviation|5.7|5.7|||
3955510|NCT01334554|3777275|B1|||Body mass index||kg/m^2|Mean|39|39.0|Standard Deviation|5.3|5.3|||
3955511|NCT01334554|3777273|B3|||Weight||kG|Mean|103.3|103.3|Standard Deviation|16.4|16.4|||
3955512|NCT01334554|3777274|B2|||Weight||kG|Mean|102|102.0|Standard Deviation|16.4|16.4|||
3955513|NCT01334554|3777275|B1|||Weight||kG|Mean|104.5|104.5|Standard Deviation|16.7|16.7|||
3955514|NCT01334554|3777273|B3|||Height||cm|Mean|163|163.0|Standard Deviation|5.0|5.0|||
3955515|NCT01334554|3777274|B2|||Height||cm|Mean|162|162.0|Standard Deviation|4.8|4.8|||
3955516|NCT01334554|3777275|B1|||Height||cm|Mean|164|164.0|Standard Deviation|5.2|5.2|||
3955517|NCT01334554|3777273|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3955518|NCT01334554|3777274|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3955519|NCT01334554|3777275|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3955520|NCT01334554|3777273|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3955521|NCT01334554|3777274|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3955522|NCT01334554|3777275|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3955523|NCT01334554|3777273|B3|||Age||years|Mean|42.4|42.4|Standard Deviation|9.9|9.9|||
3955524|NCT01334554|3777274|B2|||Age||years|Mean|43|43.0|Standard Deviation|10.4|10.4|||
3955525|NCT01334554|3777275|B1|||Age||years|Mean|42|42.0|Standard Deviation|9.5|9.5|||
3955526|NCT01334554|3777273|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3955527|NCT01334554|3777274|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3955528|NCT01334554|3777275|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3955529|NCT01334554|3777273|B3||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
3955530|NCT01334554|3777274|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3955531|NCT01334554|3777275|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3955532|NCT01334554|3777273|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3955533|NCT01334554|3777274|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3955534|NCT01334554|3777275|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3955535|NCT01334515|3777284|B3|Canada||Region of Enrollment||participants|Number|5|5.0||||||
3955536|NCT01334515|3777285|B2|Canada||Region of Enrollment||participants|Number|3|3.0||||||
3955537|NCT01334515|3777286|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
3955538|NCT01334515|3777284|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
3955539|NCT01334515|3777285|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
3955540|NCT01334515|3777286|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3955541|NCT01334515|3777284|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3955542|NCT01334515|3777285|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3955543|NCT01334515|3777286|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955544|NCT01334515|3777284|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3955545|NCT01334515|3777285|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3955546|NCT01334515|3777286|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3955547|NCT01334515|3777284|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3955548|NCT01334515|3777285|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3955549|NCT01334515|3777286|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3955550|NCT01334515|3777284|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3955551|NCT01334515|3777285|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3955552|NCT01334515|3777286|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3955553|NCT01334515|3777284|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955554|NCT01334515|3777285|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955555|NCT01334515|3777286|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955556|NCT01334515|3777284|B3||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3955557|NCT01334515|3777285|B2||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3955558|NCT01334515|3777286|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3955559|NCT01334515|3777284|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3955560|NCT01334515|3777285|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3955561|NCT01334515|3777286|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3955562|NCT01334515|3777284|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955563|NCT01334515|3777285|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955685|NCT01333943|3777381|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
3955564|NCT01334515|3777286|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955565|NCT01334515|3777284|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3955566|NCT01334515|3777285|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3955567|NCT01334515|3777286|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955568|NCT01334515|3777284|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955569|NCT01334515|3777285|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955570|NCT01334515|3777286|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955571|NCT01334515|3777284|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3955572|NCT01334515|3777285|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3955573|NCT01334515|3777286|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3955574|NCT01334515|3777284|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3955575|NCT01334515|3777285|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3955576|NCT01334515|3777286|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3955577|NCT01334515|3777284|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3955578|NCT01334515|3777285|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3955579|NCT01334515|3777286|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3955580|NCT01334515|3777284|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3955581|NCT01334515|3777285|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3955582|NCT01334515|3777286|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3955583|NCT01334515|3777284|B3||<=18 years|Age||Participants|Count of Participants|47|47.0||||||
3955584|NCT01334515|3777285|B2||<=18 years|Age||Participants|Count of Participants|32|32.0||||||
3955585|NCT01334515|3777286|B1||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
3955586|NCT01334515|3777284|B3|||Age||years|Median|8.31|8.31|Inter-Quartile Range|||5.39|11.37|
3955587|NCT01334515|3777285|B2|||Age||years|Median|8.75|8.75|Inter-Quartile Range|||5.79|12.38|
3955588|NCT01334515|3777286|B1|||Age||years|Median|6.94|6.94|Inter-Quartile Range|||4.3|9.8|
3955589|NCT01334229|3777295|B3|Canada||Region of Enrollment||participants|Number|22|22.0||||||
3955590|NCT01334229|3777296|B2|Canada||Region of Enrollment||participants|Number|11|11.0||||||
3955591|NCT01334229|3777297|B1|Canada||Region of Enrollment||participants|Number|11|11.0||||||
3955592|NCT01334229|3777295|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3955593|NCT01334229|3777296|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3955594|NCT01334229|3777297|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3955595|NCT01334229|3777295|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3955596|NCT01334229|3777296|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3955597|NCT01334229|3777297|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3955598|NCT01334229|3777295|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3955599|NCT01334229|3777296|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3955600|NCT01334229|3777297|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3955601|NCT01334229|3777295|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3955602|NCT01334229|3777296|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3955603|NCT01334229|3777297|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3955604|NCT01334229|3777295|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3955605|NCT01334229|3777296|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3955606|NCT01334229|3777297|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3955607|NCT01334229|3777295|B3|||Age||years|Mean|58.2|58.2|Standard Deviation|3.8|3.8|||
3955608|NCT01334229|3777296|B2|||Age||years|Mean|59|59.0|Standard Deviation|2.9|2.9|||
3955609|NCT01334229|3777297|B1|||Age||years|Mean|57.5|57.5|Standard Deviation|4.6|4.6|||
3955610|NCT01334216|3777314|B3|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3955611|NCT01334216|3777315|B2|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3955612|NCT01334216|3777316|B1|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3955613|NCT01334216|3777314|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3955614|NCT01334216|3777315|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3955615|NCT01334216|3777316|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3955616|NCT01334216|3777314|B3|Asian/Pacific Isl.||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3955617|NCT01334216|3777315|B2|Asian/Pacific Isl.||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3955618|NCT01334216|3777316|B1|Asian/Pacific Isl.||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3955619|NCT01334216|3777314|B3|Amer. Indian/Eskimo||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3955620|NCT01334216|3777315|B2|Amer. Indian/Eskimo||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3955621|NCT01334216|3777316|B1|Amer. Indian/Eskimo||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3955622|NCT01334216|3777314|B3|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
3955623|NCT01334216|3777315|B2|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3955624|NCT01334216|3777316|B1|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3955625|NCT01334216|3777314|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|112|112.0||||||
3955626|NCT01334216|3777315|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|59|59.0||||||
3955627|NCT01334216|3777316|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|53|53.0||||||
3955628|NCT01334216|3777314|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|182|182.0||||||
3955629|NCT01334216|3777315|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|98|98.0||||||
3955630|NCT01334216|3777316|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|84|84.0||||||
3955631|NCT01334216|3777314|B3||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3955632|NCT01334216|3777315|B2||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3955633|NCT01334216|3777316|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3955634|NCT01334216|3777314|B3||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
3955635|NCT01334216|3777315|B2||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3955636|NCT01334216|3777316|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3955637|NCT01334216|3777314|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3955638|NCT01334216|3777315|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3955639|NCT01334216|3777316|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3955640|NCT01334216|3777314|B3||Between 18 and 65 years|Age||Participants|Count of Participants|362|362.0||||||
3955641|NCT01334216|3777315|B2||Between 18 and 65 years|Age||Participants|Count of Participants|194|194.0||||||
3955642|NCT01334216|3777316|B1||Between 18 and 65 years|Age||Participants|Count of Participants|168|168.0||||||
3955643|NCT01334216|3777314|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3955644|NCT01334216|3777315|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3955645|NCT01334216|3777316|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3955646|NCT01334125|3777323|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
3955647|NCT01334125|3777324|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3955648|NCT01334125|3777325|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3955649|NCT01334125|3777323|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3955650|NCT01334125|3777324|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3955651|NCT01334125|3777325|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3955652|NCT01334125|3777323|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3955653|NCT01334125|3777324|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3955654|NCT01334125|3777325|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3955655|NCT01334125|3777323|B3|||Age||years|Mean|14.7|14.7|Standard Deviation|2.7|2.7|||
3955656|NCT01334125|3777324|B2|||Age||years|Mean|14.5|14.5|Standard Deviation|3.1|3.1|||
3955657|NCT01334125|3777325|B1|||Age||years|Mean|15|15.0|Standard Deviation|2.5|2.5|||
3955658|NCT01333956|3777338|B5|||Body Mass Index (BMI)||kg/m ^ 2|Mean|31.5|31.5|Standard Deviation|2.45|2.45|||
3955659|NCT01333956|3777339|B4|||Body Mass Index (BMI)||kg/m ^ 2|Mean|30|30.0|Standard Deviation|7|7.0|||
3955660|NCT01333956|3777340|B3|||Body Mass Index (BMI)||kg/m ^ 2|Mean|32|32.0|Standard Deviation|6|6.0|||
3955661|NCT01333956|3777341|B2|||Body Mass Index (BMI)||kg/m ^ 2|Mean|32|32.0|Standard Deviation|6|6.0|||
3955662|NCT01333956|3777342|B1|||Body Mass Index (BMI)||kg/m ^ 2|Mean|32|32.0|Standard Deviation|5|5.0|||
3955663|NCT01333956|3777338|B5|United States||Region of Enrollment||participants|Number|120|120.0||||||
3955664|NCT01333956|3777339|B4|United States||Region of Enrollment||participants|Number|30|30.0||||||
3955665|NCT01333956|3777340|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3955666|NCT01333956|3777341|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3955667|NCT01333956|3777342|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3955668|NCT01333956|3777338|B5||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3955669|NCT01333956|3777339|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3955670|NCT01333956|3777340|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3955671|NCT01333956|3777341|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3955672|NCT01333956|3777342|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3955673|NCT01333956|3777338|B5||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3955674|NCT01333956|3777339|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3955675|NCT01333956|3777340|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3955676|NCT01333956|3777341|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3955677|NCT01333956|3777342|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3955678|NCT01333956|3777338|B5|||Age||years|Mean|66.3|66.3|Standard Deviation|7.9|7.9|||
3955679|NCT01333956|3777339|B4|||Age||years|Mean|67.7|67.7|Standard Deviation|8.1|8.1|||
3955680|NCT01333956|3777340|B3|||Age||years|Mean|65.1|65.1|Standard Deviation|7.1|7.1|||
3955681|NCT01333956|3777341|B2|||Age||years|Mean|66.8|66.8|Standard Deviation|6.3|6.3|||
3955682|NCT01333956|3777342|B1|||Age||years|Mean|65.5|65.5|Standard Deviation|9.8|9.8|||
3955683|NCT01333943|3777379|B3|United States||Region of Enrollment||participants|Number|93|93.0||||||
3955684|NCT01333943|3777380|B2|United States||Region of Enrollment||participants|Number|47|47.0||||||
3955686|NCT01333943|3777379|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3955687|NCT01333943|3777380|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3955688|NCT01333943|3777381|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3955689|NCT01333943|3777379|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3955690|NCT01333943|3777380|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3955691|NCT01333943|3777381|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3955692|NCT01333943|3777379|B3|||Age||years|Mean|67.8|67.8|Standard Deviation|10.4|10.4|||
3955693|NCT01333943|3777380|B2|||Age||years|Mean|67.6|67.6|Standard Deviation|11.3|11.3|||
3955694|NCT01333943|3777381|B1|||Age||years|Mean|68.0|68.0|Standard Deviation|9.4|9.4|||
3955695|NCT01333865|3777398|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3955696|NCT01333865|3777398|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955697|NCT01333865|3777398|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955698|NCT01333865|3777398|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3955699|NCT01333865|3777398|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955700|NCT01333865|3777398|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955701|NCT01333865|3777398|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955702|NCT01333865|3777398|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955703|NCT01333865|3777398|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955704|NCT01333865|3777398|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3955705|NCT01333865|3777398|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3955706|NCT01333865|3777398|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3955707|NCT01333865|3777398|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3955708|NCT01333865|3777398|B1|||Age||Years|Mean|28.0|28.0|Standard Deviation|9.6|9.6|||
3955709|NCT01333865|3777398|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3955710|NCT01333865|3777398|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3955711|NCT01333865|3777398|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3955712|NCT01333813|3777403|B1||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3955713|NCT01333813|3777403|B1||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3955714|NCT01333813|3777403|B1|||Age||Years|Mean|7.5|7.5|Standard Deviation|0.52|0.52|||
3955715|NCT01333722|3777416|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3955716|NCT01333722|3777417|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3955717|NCT01333722|3777418|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3955718|NCT01333722|3777416|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3955719|NCT01333722|3777417|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3955720|NCT01333722|3777418|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3955721|NCT01333722|3777416|B3|||Age||years|Mean|40.3|40.3|Standard Deviation|12.84|12.84|||
3955722|NCT01333722|3777417|B2|||Age||years|Mean|41.6|41.6|Standard Deviation|13.85|13.85|||
3955723|NCT01333722|3777418|B1|||Age||years|Mean|39.0|39.0|Standard Deviation|11.79|11.79|||
3955724|NCT01333592|3777431|B3|||HbA1c||%|Mean|7.49|7.49|Standard Deviation|0.60|0.6|||
3955725|NCT01333592|3777432|B2|||HbA1c||%|Mean|7.50|7.5|Standard Deviation|0.66|0.66|||
3955726|NCT01333592|3777433|B1|||HbA1c||%|Mean|7.47|7.47|Standard Deviation|0.54|0.54|||
3955727|NCT01333592|3777431|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3955728|NCT01333592|3777432|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3955729|NCT01333592|3777433|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3955730|NCT01333592|3777431|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3955731|NCT01333592|3777432|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3955732|NCT01333592|3777433|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3955733|NCT01333592|3777431|B3|||Age||years|Mean|58.6|58.6|Standard Deviation|11.1|11.1|||
3955734|NCT01333592|3777432|B2|||Age||years|Mean|56.9|56.9|Standard Deviation|11.5|11.5|||
3955735|NCT01333592|3777433|B1|||Age||years|Mean|60.3|60.3|Standard Deviation|10.6|10.6|||
3955736|NCT01333501|3777442|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3955737|NCT01333501|3777443|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3955738|NCT01333501|3777444|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3955739|NCT01333501|3777442|B3||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3955740|NCT01333501|3777443|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3955741|NCT01333501|3777444|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3955742|NCT01333501|3777442|B3|||Age||Years|Mean|38.91|38.91|Standard Deviation|9.29|9.29|||
3955743|NCT01333501|3777443|B2|||Age||Years|Mean|37.53|37.53|Standard Deviation|9.27|9.27|||
3955744|NCT01333501|3777444|B1|||Age||Years|Mean|39.53|39.53|Standard Deviation|9.28|9.28|||
3955745|NCT01333488|3777491|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
3955746|NCT01333488|3777492|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3955747|NCT01333488|3777493|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3955748|NCT01333488|3777494|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3955749|NCT01333488|3777491|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3955750|NCT01333488|3777492|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3955751|NCT01333488|3777493|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3955752|NCT01333488|3777494|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3955753|NCT01333488|3777491|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3955754|NCT01333488|3777492|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3955755|NCT01333488|3777493|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3955756|NCT01333488|3777494|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3955757|NCT01333488|3777491|B4|||Age||years|Mean|32|32.0|Full Range|||20.0|46.0|
3955758|NCT01333488|3777492|B3|||Age||years|Mean|25.6|25.6|Full Range|||20.0|34.0|
3955759|NCT01333488|3777493|B2|||Age||years|Mean|43|43.0|Full Range|||43.0|43.0|
3955760|NCT01333488|3777494|B1|||Age||years|Mean|35.5|35.5|Full Range|||25.0|46.0|
3955761|NCT01333488|3777491|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3955762|NCT01333488|3777492|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3955763|NCT01333488|3777493|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3955764|NCT01333488|3777494|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3955765|NCT01333488|3777491|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3955766|NCT01333488|3777492|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3955767|NCT01333488|3777493|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3955768|NCT01333488|3777494|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3955769|NCT01333488|3777491|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3955770|NCT01333488|3777492|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3955771|NCT01333488|3777493|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3955772|NCT01333488|3777494|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3955773|NCT01333475|3777510|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
3955774|NCT01333475|3777511|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3955775|NCT01333475|3777512|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3955776|NCT01333475|3777510|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955777|NCT01333475|3777511|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955778|NCT01333475|3777512|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955779|NCT01333475|3777510|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3955780|NCT01333475|3777511|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3955781|NCT01333475|3777512|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3955782|NCT01333475|3777510|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3955783|NCT01333475|3777511|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3955784|NCT01333475|3777512|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955785|NCT01333475|3777510|B3||Unknown or Not Reported|Race (NIH/OMB)|"One participant selected White and Asian for Race, thus the category More than one race was selected. Six participants versus seven is noted in the White category and no participants is noted in the Asian category."|Participants|Count of Participants|0|0.0||||||
3955786|NCT01333475|3777511|B2||Unknown or Not Reported|Race (NIH/OMB)|"One participant selected White and Asian for Race, thus the category More than one race was selected. Six participants versus seven is noted in the White category and no participants is noted in the Asian category."|Participants|Count of Participants|0|0.0||||||
3955787|NCT01333475|3777512|B1||Unknown or Not Reported|Race (NIH/OMB)|"One participant selected White and Asian for Race, thus the category More than one race was selected. Six participants versus seven is noted in the White category and no participants is noted in the Asian category."|Participants|Count of Participants|0|0.0||||||
3955788|NCT01333475|3777510|B3||More than one race|Race (NIH/OMB)|"One participant selected White and Asian for Race, thus the category More than one race was selected. Six participants versus seven is noted in the White category and no participants is noted in the Asian category."|Participants|Count of Participants|1|1.0||||||
3955789|NCT01333475|3777511|B2||More than one race|Race (NIH/OMB)|"One participant selected White and Asian for Race, thus the category More than one race was selected. Six participants versus seven is noted in the White category and no participants is noted in the Asian category."|Participants|Count of Participants|1|1.0||||||
3955790|NCT01333475|3777512|B1||More than one race|Race (NIH/OMB)|"One participant selected White and Asian for Race, thus the category More than one race was selected. Six participants versus seven is noted in the White category and no participants is noted in the Asian category."|Participants|Count of Participants|0|0.0||||||
3955791|NCT01333475|3777510|B3||White|Race (NIH/OMB)|"One participant selected White and Asian for Race, thus the category More than one race was selected. Six participants versus seven is noted in the White category and no participants is noted in the Asian category."|Participants|Count of Participants|16|16.0||||||
3955792|NCT01333475|3777511|B2||White|Race (NIH/OMB)|"One participant selected White and Asian for Race, thus the category More than one race was selected. Six participants versus seven is noted in the White category and no participants is noted in the Asian category."|Participants|Count of Participants|6|6.0||||||
3955831|NCT01333436|3777522|B2|||Age||years|Mean|46.0|46.0|Standard Deviation|13.6|13.6|||
3955793|NCT01333475|3777512|B1||White|Race (NIH/OMB)|"One participant selected White and Asian for Race, thus the category More than one race was selected. Six participants versus seven is noted in the White category and no participants is noted in the Asian category."|Participants|Count of Participants|10|10.0||||||
3955794|NCT01333475|3777510|B3||Black or African American|Race (NIH/OMB)|"One participant selected White and Asian for Race, thus the category More than one race was selected. Six participants versus seven is noted in the White category and no participants is noted in the Asian category."|Participants|Count of Participants|3|3.0||||||
3955795|NCT01333475|3777511|B2||Black or African American|Race (NIH/OMB)|"One participant selected White and Asian for Race, thus the category More than one race was selected. Six participants versus seven is noted in the White category and no participants is noted in the Asian category."|Participants|Count of Participants|2|2.0||||||
3955796|NCT01333475|3777512|B1||Black or African American|Race (NIH/OMB)|"One participant selected White and Asian for Race, thus the category More than one race was selected. Six participants versus seven is noted in the White category and no participants is noted in the Asian category."|Participants|Count of Participants|1|1.0||||||
3955797|NCT01333475|3777510|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|"One participant selected White and Asian for Race, thus the category More than one race was selected. Six participants versus seven is noted in the White category and no participants is noted in the Asian category."|Participants|Count of Participants|0|0.0||||||
3955798|NCT01333475|3777511|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|"One participant selected White and Asian for Race, thus the category More than one race was selected. Six participants versus seven is noted in the White category and no participants is noted in the Asian category."|Participants|Count of Participants|0|0.0||||||
3955799|NCT01333475|3777512|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|"One participant selected White and Asian for Race, thus the category More than one race was selected. Six participants versus seven is noted in the White category and no participants is noted in the Asian category."|Participants|Count of Participants|0|0.0||||||
3955800|NCT01333475|3777510|B3||Asian|Race (NIH/OMB)|"One participant selected White and Asian for Race, thus the category More than one race was selected. Six participants versus seven is noted in the White category and no participants is noted in the Asian category."|Participants|Count of Participants|1|1.0||||||
3955801|NCT01333475|3777511|B2||Asian|Race (NIH/OMB)|"One participant selected White and Asian for Race, thus the category More than one race was selected. Six participants versus seven is noted in the White category and no participants is noted in the Asian category."|Participants|Count of Participants|0|0.0||||||
3955802|NCT01333475|3777512|B1||Asian|Race (NIH/OMB)|"One participant selected White and Asian for Race, thus the category More than one race was selected. Six participants versus seven is noted in the White category and no participants is noted in the Asian category."|Participants|Count of Participants|1|1.0||||||
3955803|NCT01333475|3777510|B3||American Indian or Alaska Native|Race (NIH/OMB)|"One participant selected White and Asian for Race, thus the category More than one race was selected. Six participants versus seven is noted in the White category and no participants is noted in the Asian category."|Participants|Count of Participants|0|0.0||||||
3955804|NCT01333475|3777511|B2||American Indian or Alaska Native|Race (NIH/OMB)|"One participant selected White and Asian for Race, thus the category More than one race was selected. Six participants versus seven is noted in the White category and no participants is noted in the Asian category."|Participants|Count of Participants|0|0.0||||||
3955805|NCT01333475|3777512|B1||American Indian or Alaska Native|Race (NIH/OMB)|"One participant selected White and Asian for Race, thus the category More than one race was selected. Six participants versus seven is noted in the White category and no participants is noted in the Asian category."|Participants|Count of Participants|0|0.0||||||
3955806|NCT01333475|3777510|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3955807|NCT01333475|3777511|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3955808|NCT01333475|3777512|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3955809|NCT01333475|3777510|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3955810|NCT01333475|3777511|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3955811|NCT01333475|3777512|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3955812|NCT01333475|3777510|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3955813|NCT01333475|3777511|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3955814|NCT01333475|3777512|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3955815|NCT01333475|3777510|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3955816|NCT01333475|3777511|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3955817|NCT01333475|3777512|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3955818|NCT01333475|3777510|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3955819|NCT01333475|3777511|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3955820|NCT01333475|3777512|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3955821|NCT01333475|3777510|B3|||Age||years|Mean|54.0|54.0|Standard Deviation|13.7|13.7|||
3955822|NCT01333475|3777511|B2|||Age||years|Mean|53.8|53.8|Standard Deviation|9.3|9.3|||
3955823|NCT01333475|3777512|B1|||Age||years|Mean|54.1|54.1|Standard Deviation|16.4|16.4|||
3955824|NCT01333436|3777521|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3955825|NCT01333436|3777522|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3955826|NCT01333436|3777523|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3955827|NCT01333436|3777521|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3955828|NCT01333436|3777522|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3955829|NCT01333436|3777523|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3955830|NCT01333436|3777521|B3|||Age||years|Mean|49.7|49.7|Standard Deviation|13.2|13.2|||
3955832|NCT01333436|3777523|B1|||Age||years|Mean|54.0|54.0|Standard Deviation|11.5|11.5|||
3955833|NCT01333397|3777534|B6|White||Race/Ethnicity, Customized||participants|Number|176|176.0||||||
3955834|NCT01333397|3777535|B5|White||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3955835|NCT01333397|3777536|B4|White||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3955836|NCT01333397|3777537|B3|White||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3955837|NCT01333397|3777538|B2|White||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3955838|NCT01333397|3777539|B1|White||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3955839|NCT01333397|3777534|B6|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|171|171.0||||||
3955840|NCT01333397|3777535|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
3955841|NCT01333397|3777536|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
3955842|NCT01333397|3777537|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3955843|NCT01333397|3777538|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
3955844|NCT01333397|3777539|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3955845|NCT01333397|3777534|B6|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3955846|NCT01333397|3777535|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3955847|NCT01333397|3777536|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3955848|NCT01333397|3777537|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3955849|NCT01333397|3777538|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3955850|NCT01333397|3777539|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3955851|NCT01333397|3777534|B6|Female||Sex/Gender, Customized||participants|Number|176|176.0||||||
3955852|NCT01333397|3777535|B5|Female||Sex/Gender, Customized||participants|Number|35|35.0||||||
3955853|NCT01333397|3777536|B4|Female||Sex/Gender, Customized||participants|Number|35|35.0||||||
3955854|NCT01333397|3777537|B3|Female||Sex/Gender, Customized||participants|Number|35|35.0||||||
3955855|NCT01333397|3777538|B2|Female||Sex/Gender, Customized||participants|Number|36|36.0||||||
3955856|NCT01333397|3777539|B1|Female||Sex/Gender, Customized||participants|Number|35|35.0||||||
3955857|NCT01333397|3777534|B6|||Age||years|Mean|47.3|47.3|Standard Deviation|6.9|6.9|||
3955858|NCT01333397|3777535|B5|||Age||years|Mean|47.0|47.0|Standard Deviation|6.6|6.6|||
3955859|NCT01333397|3777536|B4|||Age||years|Mean|47.9|47.9|Standard Deviation|6.0|6.0|||
3955860|NCT01333397|3777537|B3|||Age||years|Mean|48.1|48.1|Standard Deviation|6.9|6.9|||
3955861|NCT01333397|3777538|B2|||Age||years|Mean|46.7|46.7|Standard Deviation|8.4|8.4|||
3955862|NCT01333397|3777539|B1|||Age||years|Mean|46.8|46.8|Standard Deviation|6.4|6.4|||
3955863|NCT01333189|3777615|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3955864|NCT01333189|3777616|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3955865|NCT01333189|3777617|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3955866|NCT01333189|3777615|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3955867|NCT01333189|3777616|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3955868|NCT01333189|3777617|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3955869|NCT01333189|3777615|B3|Age||Age||years|Mean|67.4|67.4|Standard Deviation|8.2|8.2|||
3955870|NCT01333189|3777616|B2|Age||Age||years|Mean|66.6|66.6|Standard Deviation|8.1|8.1|||
3955871|NCT01333189|3777617|B1|Age||Age||years|Mean|68.2|68.2|Standard Deviation|8.6|8.6|||
3955872|NCT01333111|3777646|B4||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3955873|NCT01333111|3777647|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3955874|NCT01333111|3777648|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3955875|NCT01333111|3777649|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3955876|NCT01333111|3777646|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3955877|NCT01333111|3777647|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3955878|NCT01333111|3777648|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3955879|NCT01333111|3777649|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3955880|NCT01333111|3777646|B4|>=65 years||Age, Customized||Participants|Number|1|1.0||||||
3955881|NCT01333111|3777647|B3|>=65 years||Age, Customized||Participants|Number|0|0.0||||||
3955882|NCT01333111|3777648|B2|>=65 years||Age, Customized||Participants|Number|1|1.0||||||
3955883|NCT01333111|3777649|B1|>=65 years||Age, Customized||Participants|Number|0|0.0||||||
3955884|NCT01333111|3777646|B4|18-64 years||Age, Customized||Participants|Number|55|55.0||||||
3955885|NCT01333111|3777647|B3|18-64 years||Age, Customized||Participants|Number|13|13.0||||||
3955886|NCT01333111|3777648|B2|18-64 years||Age, Customized||Participants|Number|19|19.0||||||
3955887|NCT01333111|3777649|B1|18-64 years||Age, Customized||Participants|Number|23|23.0||||||
3955888|NCT01333111|3777646|B4|<=17 years||Age, Customized||Participants|Number|18|18.0||||||
3955889|NCT01333111|3777647|B3|<=17 years||Age, Customized||Participants|Number|2|2.0||||||
3955890|NCT01333111|3777648|B2|<=17 years||Age, Customized||Participants|Number|9|9.0||||||
3955891|NCT01333111|3777649|B1|<=17 years||Age, Customized||Participants|Number|7|7.0||||||
3955892|NCT01333111|3777646|B4|||Age||years|Mean|31.4|31.4|Standard Deviation|14.2|14.2|||
3955893|NCT01333111|3777647|B3|||Age||years|Mean|32.4|32.4|Standard Deviation|12.0|12.0|||
3955894|NCT01333111|3777648|B2|||Age||years|Mean|30|30.0|Standard Deviation|15.8|15.8|||
3955895|NCT01333111|3777649|B1|||Age||years|Mean|32.4|32.4|Standard Deviation|13.9|13.9|||
3955896|NCT01333072|3777675|B3|United States||Region of Enrollment||participants|Number|61|61.0||||||
3955897|NCT01333072|3777676|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
3955898|NCT01333072|3777677|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3955899|NCT01333072|3777675|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3955900|NCT01333072|3777676|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3955901|NCT01333072|3777677|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3955902|NCT01333072|3777675|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3955903|NCT01333072|3777676|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3955904|NCT01333072|3777677|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3955905|NCT01333072|3777675|B3|||Age||years|Median|8.4|8.4|Full Range|||6.0|17.5|
3955906|NCT01333072|3777676|B2|||Age||years|Median|8.5|8.5|Full Range|||6.0|15.1|
3955907|NCT01333072|3777677|B1|||Age||years|Median|8.3|8.3|Full Range|||6.3|17.5|
3955908|NCT01333059|3777684|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
3955909|NCT01333059|3777685|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3955910|NCT01333059|3777686|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3955911|NCT01333059|3777684|B3|Race/Ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3955912|NCT01333059|3777685|B2|Race/Ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3955913|NCT01333059|3777686|B1|Race/Ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3955914|NCT01333059|3777684|B3|Race/Ethnicity|Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3955915|NCT01333059|3777685|B2|Race/Ethnicity|Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3955916|NCT01333059|3777686|B1|Race/Ethnicity|Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3955917|NCT01333059|3777684|B3|Race/Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3955918|NCT01333059|3777685|B2|Race/Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3955919|NCT01333059|3777686|B1|Race/Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3955920|NCT01333059|3777684|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3955921|NCT01333059|3777685|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3955922|NCT01333059|3777686|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3955923|NCT01333059|3777684|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3955924|NCT01333059|3777685|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3955925|NCT01333059|3777686|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3955926|NCT01333059|3777684|B3|||Age||years|Median|0.22|0.22|Full Range|||0.04|17.31|
3955927|NCT01333059|3777685|B2|||Age||years|Median|.20|0.2|Full Range|||0.04|17.31|
3955928|NCT01333059|3777686|B1|||Age||years|Median|0.24|0.24|Full Range|||0.05|3.03|
3955929|NCT01333059|3777684|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3955930|NCT01333059|3777685|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3955931|NCT01333059|3777686|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3955932|NCT01333059|3777684|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3955933|NCT01333059|3777685|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3955934|NCT01333059|3777686|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3955935|NCT01333059|3777684|B3||<=18 years|Age||Participants|Count of Participants|25|25.0||||||
3955936|NCT01333059|3777685|B2||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
3955937|NCT01333059|3777686|B1||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
3955938|NCT01332994|3777697|B1||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3955939|NCT01332994|3777697|B1||Female|Sex: Female, Male||Participants|Count of Participants|352|352.0||||||
3955940|NCT01332994|3777697|B1|||Age||years|Mean|55.7|55.7|Standard Deviation|11.9|11.9|||
3955941|NCT01332981|3777753|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3955942|NCT01332981|3777753|B1||Female|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
3955943|NCT01332981|3777753|B1|||Age||Years|Mean|55.3|55.3|Standard Deviation|12.3|12.3|||
3955944|NCT01332968|3777764|B3|Male||Gender in Follicular Lymphoma Sub-Population|Gender of participants with follicular lymphoma, who encompassed the population for the primary outcome measure. The FL ITT included participants in the ITT population with follicular histology (n=601 for each arm).|participants|Number|563|563.0||||||
3955945|NCT01332968|3777765|B2|Male||Gender in Follicular Lymphoma Sub-Population|Gender of participants with follicular lymphoma, who encompassed the population for the primary outcome measure. The FL ITT included participants in the ITT population with follicular histology (n=601 for each arm).|participants|Number|283|283.0||||||
3955946|NCT01332968|3777766|B1|Male||Gender in Follicular Lymphoma Sub-Population|Gender of participants with follicular lymphoma, who encompassed the population for the primary outcome measure. The FL ITT included participants in the ITT population with follicular histology (n=601 for each arm).|participants|Number|280|280.0||||||
3955947|NCT01332968|3777764|B3|Female||Gender in Follicular Lymphoma Sub-Population|Gender of participants with follicular lymphoma, who encompassed the population for the primary outcome measure. The FL ITT included participants in the ITT population with follicular histology (n=601 for each arm).|participants|Number|639|639.0||||||
3955948|NCT01332968|3777765|B2|Female||Gender in Follicular Lymphoma Sub-Population|Gender of participants with follicular lymphoma, who encompassed the population for the primary outcome measure. The FL ITT included participants in the ITT population with follicular histology (n=601 for each arm).|participants|Number|318|318.0||||||
3955949|NCT01332968|3777766|B1|Female||Gender in Follicular Lymphoma Sub-Population|Gender of participants with follicular lymphoma, who encompassed the population for the primary outcome measure. The FL ITT included participants in the ITT population with follicular histology (n=601 for each arm).|participants|Number|321|321.0||||||
3955950|NCT01332968|3777764|B3|||Age Continuous in Follicular Lymphoma Sub-Population|Age continuous for participants with follicular lymphoma (FL) in each arm, who encompassed the population for the primary outcome measure. The FL ITT included participants in the ITT population with follicular histology (n=601 in each arm).|years|Mean|57.9|57.9|Standard Deviation|11.9|11.9|||
3955951|NCT01332968|3777765|B2|||Age Continuous in Follicular Lymphoma Sub-Population|Age continuous for participants with follicular lymphoma (FL) in each arm, who encompassed the population for the primary outcome measure. The FL ITT included participants in the ITT population with follicular histology (n=601 in each arm).|years|Mean|58.2|58.2|Standard Deviation|11.5|11.5|||
3955952|NCT01332968|3777766|B1|||Age Continuous in Follicular Lymphoma Sub-Population|Age continuous for participants with follicular lymphoma (FL) in each arm, who encompassed the population for the primary outcome measure. The FL ITT included participants in the ITT population with follicular histology (n=601 in each arm).|years|Mean|57.7|57.7|Standard Deviation|12.2|12.2|||
3955953|NCT01332968|3777764|B3||Male|Sex: Female, Male||Participants|Count of Participants|662|662.0||||||
3955954|NCT01332968|3777765|B2||Male|Sex: Female, Male||Participants|Count of Participants|337|337.0||||||
3955955|NCT01332968|3777766|B1||Male|Sex: Female, Male||Participants|Count of Participants|325|325.0||||||
3955956|NCT01332968|3777764|B3||Female|Sex: Female, Male||Participants|Count of Participants|739|739.0||||||
3955957|NCT01332968|3777765|B2||Female|Sex: Female, Male||Participants|Count of Participants|365|365.0||||||
3955958|NCT01332968|3777766|B1||Female|Sex: Female, Male||Participants|Count of Participants|374|374.0||||||
3955959|NCT01332968|3777764|B3|||Age||years|Mean|58.5|58.5|Standard Deviation|11.9|11.9|||
3955960|NCT01332968|3777765|B2|||Age||years|Mean|58.9|58.9|Standard Deviation|11.6|11.6|||
3955961|NCT01332968|3777766|B1|||Age||years|Mean|58.1|58.1|Standard Deviation|12.3|12.3|||
3955962|NCT01332851|3777837|B3|United States||Region of Enrollment|All 247 parents were recruited from Snohomish, southern Skagit, and northern King Counties, Washington, USA|participants|Number|247|247.0||||||
3955963|NCT01332851|3777838|B2|United States||Region of Enrollment|All 247 parents were recruited from Snohomish, southern Skagit, and northern King Counties, Washington, USA|participants|Number|123|123.0||||||
3955964|NCT01332851|3777839|B1|United States||Region of Enrollment|All 247 parents were recruited from Snohomish, southern Skagit, and northern King Counties, Washington, USA|participants|Number|124|124.0||||||
3955965|NCT01332851|3777837|B3|Parent gender|Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3955966|NCT01332851|3777838|B2|Parent gender|Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3955967|NCT01332851|3777839|B1|Parent gender|Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3955968|NCT01332851|3777837|B3|Parent gender|Female|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
3955969|NCT01332851|3777838|B2|Parent gender|Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3955970|NCT01332851|3777839|B1|Parent gender|Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3955971|NCT01332851|3777837|B3|parent age in years||Age||years|Mean|26.72|26.72|Standard Deviation|5.74|5.74|||
3955972|NCT01332851|3777838|B2|parent age in years||Age||years|Mean|27.04|27.04|Standard Deviation|6.25|6.25|||
3955973|NCT01332851|3777839|B1|parent age in years||Age||years|Mean|26.41|26.41|Standard Deviation|5.19|5.19|||
3955974|NCT01332721|3777872|B1|No prior VEGF inhibitor treatment||Prior VEGF inhibitor treatment||participants|Number|8|8.0||||||
3955975|NCT01332721|3777872|B1|Prior VEGF inhibitor treatment||Prior VEGF inhibitor treatment||participants|Number|30|30.0||||||
3955976|NCT01332721|3777872|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3955977|NCT01332721|3777872|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3955978|NCT01332721|3777872|B1|||Age||Years|Median|63|63.0|Full Range|||42.0|82.0|
3955979|NCT01332630|3777878|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3955980|NCT01332630|3777878|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955981|NCT01332630|3777878|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955982|NCT01332630|3777878|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3955983|NCT01332630|3777878|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3955984|NCT01332630|3777878|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955985|NCT01332630|3777878|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3955986|NCT01332630|3777878|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3955987|NCT01332630|3777878|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3955988|NCT01332630|3777878|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3955989|NCT01332630|3777878|B1|||Age||years|Median|45|45.0|Full Range|||28.0|68.0|
3955990|NCT01332630|3777878|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3955991|NCT01332630|3777878|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3955992|NCT01332630|3777878|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3955993|NCT01332578|3777882|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3955994|NCT01332578|3777882|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3955995|NCT01332578|3777882|B1|||Age||Years|Mean|30.5|30.5|Standard Deviation|11.23|11.23|||
3955996|NCT01332500|3777902|B5||Male|Sex: Female, Male||Participants|Count of Participants|9655|9655.0||||||
3955997|NCT01332500|3777903|B4||Male|Sex: Female, Male||Participants|Count of Participants|728|728.0||||||
3955998|NCT01332500|3777904|B3||Male|Sex: Female, Male||Participants|Count of Participants|378|378.0||||||
3955999|NCT01332500|3777905|B2||Male|Sex: Female, Male||Participants|Count of Participants|6400|6400.0||||||
3956000|NCT01332500|3777906|B1||Male|Sex: Female, Male||Participants|Count of Participants|2149|2149.0||||||
3956001|NCT01332500|3777902|B5||Female|Sex: Female, Male||Participants|Count of Participants|52082|52082.0||||||
3956002|NCT01332500|3777903|B4||Female|Sex: Female, Male||Participants|Count of Participants|5078|5078.0||||||
3956003|NCT01332500|3777904|B3||Female|Sex: Female, Male||Participants|Count of Participants|2525|2525.0||||||
3956004|NCT01332500|3777905|B2||Female|Sex: Female, Male||Participants|Count of Participants|33371|33371.0||||||
3956005|NCT01332500|3777906|B1||Female|Sex: Female, Male||Participants|Count of Participants|11108|11108.0||||||
3956006|NCT01332500|3777902|B5|>70 years old||Age, Customized||Participants|Number|755|755.0||||||
3956007|NCT01332500|3777903|B4|>70 years old||Age, Customized||Participants|Number|75|75.0||||||
3956008|NCT01332500|3777904|B3|>70 years old||Age, Customized||Participants|Number|26|26.0||||||
3956009|NCT01332500|3777905|B2|>70 years old||Age, Customized||Participants|Number|484|484.0||||||
3956010|NCT01332500|3777906|B1|>70 years old||Age, Customized||Participants|Number|170|170.0||||||
3956011|NCT01332500|3777902|B5|61-70 years old||Age, Customized||Participants|Number|3745|3745.0||||||
3956012|NCT01332500|3777903|B4|61-70 years old||Age, Customized||Participants|Number|428|428.0||||||
3956013|NCT01332500|3777904|B3|61-70 years old||Age, Customized||Participants|Number|191|191.0||||||
3956014|NCT01332500|3777905|B2|61-70 years old||Age, Customized||Participants|Number|2368|2368.0||||||
3956015|NCT01332500|3777906|B1|61-70 years old||Age, Customized||Participants|Number|758|758.0||||||
3956016|NCT01332500|3777902|B5|51-60 years old||Age, Customized||Participants|Number|11181|11181.0||||||
3956017|NCT01332500|3777903|B4|51-60 years old||Age, Customized||Participants|Number|1263|1263.0||||||
3956018|NCT01332500|3777904|B3|51-60 years old||Age, Customized||Participants|Number|610|610.0||||||
3956019|NCT01332500|3777905|B2|51-60 years old||Age, Customized||Participants|Number|6993|6993.0||||||
3956020|NCT01332500|3777906|B1|51-60 years old||Age, Customized||Participants|Number|2315|2315.0||||||
3956021|NCT01332500|3777902|B5|41-50 years old||Age, Customized||Participants|Number|17293|17293.0||||||
3956022|NCT01332500|3777903|B4|41-50 years old||Age, Customized||Participants|Number|1763|1763.0||||||
3956023|NCT01332500|3777904|B3|41-50 years old||Age, Customized||Participants|Number|943|943.0||||||
3956024|NCT01332500|3777905|B2|41-50 years old||Age, Customized||Participants|Number|10887|10887.0||||||
3956025|NCT01332500|3777906|B1|41-50 years old||Age, Customized||Participants|Number|3700|3700.0||||||
3956026|NCT01332500|3777902|B5|31-40 years old||Age, Customized||Participants|Number|15517|15517.0||||||
3956027|NCT01332500|3777903|B4|31-40 years old||Age, Customized||Participants|Number|1251|1251.0||||||
3956028|NCT01332500|3777904|B3|31-40 years old||Age, Customized||Participants|Number|669|669.0||||||
3956029|NCT01332500|3777905|B2|31-40 years old||Age, Customized||Participants|Number|10172|10172.0||||||
3956030|NCT01332500|3777906|B1|31-40 years old||Age, Customized||Participants|Number|3425|3425.0||||||
3956031|NCT01332500|3777902|B5|18-30 years old||Age, Customized||Participants|Number|13246|13246.0||||||
3956032|NCT01332500|3777903|B4|18-30 years old||Age, Customized||Participants|Number|1026|1026.0||||||
3956033|NCT01332500|3777904|B3|18-30 years old||Age, Customized||Participants|Number|464|464.0||||||
3956034|NCT01332500|3777905|B2|18-30 years old||Age, Customized||Participants|Number|8867|8867.0||||||
3956035|NCT01332500|3777906|B1|18-30 years old||Age, Customized||Participants|Number|2889|2889.0||||||
3956036|NCT01332487|3777927|B3|||Mean Benign Prostatic Hyperplasia (BPH) Disease Stage Scores|Disease staging for BPH was based on the International Classification of Diseases, 9th Revision (ICD-9), Clinical Modification codes. Scores: 0, BPH only; 1, BPH with urinary tract infection; 2, BPH with bladder outlet obstruction; 3, BPH with hydronephrosis; 4, BPH with renal failure; 5, BPH with sepsis; and 6, BPH with shock.|scores on a scale|Mean|0.86|0.86|Standard Deviation|1.07|1.07|||
3956037|NCT01332487|3777928|B2|||Mean Benign Prostatic Hyperplasia (BPH) Disease Stage Scores|Disease staging for BPH was based on the International Classification of Diseases, 9th Revision (ICD-9), Clinical Modification codes. Scores: 0, BPH only; 1, BPH with urinary tract infection; 2, BPH with bladder outlet obstruction; 3, BPH with hydronephrosis; 4, BPH with renal failure; 5, BPH with sepsis; and 6, BPH with shock.|scores on a scale|Mean|0.79|0.79|Standard Deviation|0.98|0.98|||
3956038|NCT01332487|3777929|B1|||Mean Benign Prostatic Hyperplasia (BPH) Disease Stage Scores|Disease staging for BPH was based on the International Classification of Diseases, 9th Revision (ICD-9), Clinical Modification codes. Scores: 0, BPH only; 1, BPH with urinary tract infection; 2, BPH with bladder outlet obstruction; 3, BPH with hydronephrosis; 4, BPH with renal failure; 5, BPH with sepsis; and 6, BPH with shock.|scores on a scale|Mean|0.90|0.9|Standard Deviation|1.11|1.11|||
3956039|NCT01332487|3777927|B3|||Mean Charlson Comorbidity Index Scores|The Charlson Comorbidity Index estimates 10-year mortality risk. Scores range from 0 - 37, with a lower score indicating a higher chance of survival.|scores on a scale|Mean|0.97|0.97|Standard Deviation|1.56|1.56|||
3956040|NCT01332487|3777928|B2|||Mean Charlson Comorbidity Index Scores|The Charlson Comorbidity Index estimates 10-year mortality risk. Scores range from 0 - 37, with a lower score indicating a higher chance of survival.|scores on a scale|Mean|0.86|0.86|Standard Deviation|1.41|1.41|||
3956041|NCT01332487|3777929|B1|||Mean Charlson Comorbidity Index Scores|The Charlson Comorbidity Index estimates 10-year mortality risk. Scores range from 0 - 37, with a lower score indicating a higher chance of survival.|scores on a scale|Mean|1.03|1.03|Standard Deviation|1.63|1.63|||
3956042|NCT01332487|3777927|B3||Male|Sex: Female, Male||Participants|Count of Participants|8617|8617.0||||||
3956043|NCT01332487|3777928|B2||Male|Sex: Female, Male||Participants|Count of Participants|3063|3063.0||||||
3956044|NCT01332487|3777929|B1||Male|Sex: Female, Male||Participants|Count of Participants|5554|5554.0||||||
3956045|NCT01332487|3777927|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3956046|NCT01332487|3777928|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3956047|NCT01332487|3777929|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3956048|NCT01332487|3777927|B3|||Age||Years|Mean|68.4|68.4|Standard Deviation|10.2|10.2|||
3956049|NCT01332487|3777928|B2|||Age||Years|Mean|67.8|67.8|Standard Deviation|10.1|10.1|||
3956050|NCT01332487|3777929|B1|||Age||Years|Mean|68.7|68.7|Standard Deviation|10.2|10.2|||
3956051|NCT01332461|3777938|B3||Male|Sex: Female, Male||Participants|Count of Participants|2796|2796.0||||||
3956052|NCT01332461|3777939|B2||Male|Sex: Female, Male||Participants|Count of Participants|2203|2203.0||||||
3956053|NCT01332461|3777940|B1||Male|Sex: Female, Male||Participants|Count of Participants|593|593.0||||||
3956054|NCT01332461|3777938|B3||Female|Sex: Female, Male||Participants|Count of Participants|2881|2881.0||||||
3956055|NCT01332461|3777939|B2||Female|Sex: Female, Male||Participants|Count of Participants|2183|2183.0||||||
3956056|NCT01332461|3777940|B1||Female|Sex: Female, Male||Participants|Count of Participants|698|698.0||||||
3956057|NCT01332461|3777938|B3|||Age||Years|Mean|68.2|68.2|Standard Deviation|12.1|12.1|||
3956058|NCT01332461|3777939|B2|||Age||Years|Mean|68.5|68.5|Standard Deviation|12.1|12.1|||
3956059|NCT01332461|3777940|B1|||Age||Years|Mean|67.1|67.1|Standard Deviation|12.1|12.1|||
3956060|NCT01332435|3777951|B5||Male|Sex: Female, Male||Participants|Count of Participants|6896|6896.0||||||
3956061|NCT01332435|3777952|B4||Male|Sex: Female, Male||Participants|Count of Participants|1656|1656.0||||||
3956062|NCT01332435|3777953|B3||Male|Sex: Female, Male||Participants|Count of Participants|2604|2604.0||||||
3956063|NCT01332435|3777954|B2||Male|Sex: Female, Male||Participants|Count of Participants|1064|1064.0||||||
3956064|NCT01332435|3777955|B1||Male|Sex: Female, Male||Participants|Count of Participants|1572|1572.0||||||
3956065|NCT01332435|3777951|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3956066|NCT01332435|3777952|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3956067|NCT01332435|3777953|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3956068|NCT01332435|3777954|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3956069|NCT01332435|3777955|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3956070|NCT01332435|3777951|B5|<50 years old||Age, Customized||Participants|Number|0|0.0||||||
3956071|NCT01332435|3777952|B4|<50 years old||Age, Customized||Participants|Number|0|0.0||||||
3956072|NCT01332435|3777953|B3|<50 years old||Age, Customized||Participants|Number|0|0.0||||||
3956073|NCT01332435|3777954|B2|<50 years old||Age, Customized||Participants|Number|0|0.0||||||
3956074|NCT01332435|3777955|B1|<50 years old||Age, Customized||Participants|Number|0|0.0||||||
3956075|NCT01332435|3777951|B5|>=50 years old||Age, Customized||Participants|Number|6896|6896.0||||||
3956076|NCT01332435|3777952|B4|>=50 years old||Age, Customized||Participants|Number|1656|1656.0||||||
3956077|NCT01332435|3777953|B3|>=50 years old||Age, Customized||Participants|Number|2604|2604.0||||||
3956078|NCT01332435|3777954|B2|>=50 years old||Age, Customized||Participants|Number|1064|1064.0||||||
3956079|NCT01332435|3777955|B1|>=50 years old||Age, Customized||Participants|Number|1572|1572.0||||||
3956080|NCT01332357|3777988|B1|||Charlson Comorbidity Index Scores|The Charlson Comorbidity Index estimates 10-year mortality risk. Scores range from 0 - 37, with a lower score indicating a higher chance of survival.|scores on a scale|Mean|1.14|1.14|Standard Deviation|0.57|0.57|||
3956081|NCT01332357|3777988|B1|Emergency Department Visit||Type of Index Event|The number of inpatient visits and emergency department visits that defined the index event are reported.|visits|Number|4808|4808.0||||||
3956082|NCT01332357|3777988|B1|Inpatient hospitalizations||Type of Index Event|The number of inpatient visits and emergency department visits that defined the index event are reported.|visits|Number|1331|1331.0||||||
3956083|NCT01332357|3777988|B1||Male|Sex: Female, Male||Participants|Count of Participants|2747|2747.0||||||
3956084|NCT01332357|3777988|B1||Female|Sex: Female, Male||Participants|Count of Participants|3392|3392.0||||||
3956085|NCT01332357|3777988|B1|||Age||Years|Mean|22.36|22.36|Standard Deviation|17.30|17.3|||
3956086|NCT01332318|3777992|B5|Other, Unknown||Race/Ethnicity, Customized|The Safety Population (all participants who received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics. There was one randomized participant (in the GEn 1200 mg and DPH Placebo group) who did not meet the criteria for inclusion in the Safety Population.|participants|Number|1|1.0||||||
3956087|NCT01332318|3777993|B4|Other, Unknown||Race/Ethnicity, Customized|The Safety Population (all participants who received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics. There was one randomized participant (in the GEn 1200 mg and DPH Placebo group) who did not meet the criteria for inclusion in the Safety Population.|participants|Number|0|0.0||||||
3956088|NCT01332318|3777994|B3|Other, Unknown||Race/Ethnicity, Customized|The Safety Population (all participants who received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics. There was one randomized participant (in the GEn 1200 mg and DPH Placebo group) who did not meet the criteria for inclusion in the Safety Population.|participants|Number|1|1.0||||||
3956089|NCT01332318|3777995|B2|Other, Unknown||Race/Ethnicity, Customized|The Safety Population (all participants who received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics. There was one randomized participant (in the GEn 1200 mg and DPH Placebo group) who did not meet the criteria for inclusion in the Safety Population.|participants|Number|0|0.0||||||
3956090|NCT01332318|3777996|B1|Other, Unknown||Race/Ethnicity, Customized|The Safety Population (all participants who received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics. There was one randomized participant (in the GEn 1200 mg and DPH Placebo group) who did not meet the criteria for inclusion in the Safety Population.|participants|Number|0|0.0||||||
3956091|NCT01332318|3777992|B5|White or Caucasian||Race/Ethnicity, Customized|The Safety Population (all participants who received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics. There was one randomized participant (in the GEn 1200 mg and DPH Placebo group) who did not meet the criteria for inclusion in the Safety Population.|participants|Number|128|128.0||||||
3956092|NCT01332318|3777993|B4|White or Caucasian||Race/Ethnicity, Customized|The Safety Population (all participants who received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics. There was one randomized participant (in the GEn 1200 mg and DPH Placebo group) who did not meet the criteria for inclusion in the Safety Population.|participants|Number|30|30.0||||||
3956093|NCT01332318|3777994|B3|White or Caucasian||Race/Ethnicity, Customized|The Safety Population (all participants who received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics. There was one randomized participant (in the GEn 1200 mg and DPH Placebo group) who did not meet the criteria for inclusion in the Safety Population.|participants|Number|33|33.0||||||
3956094|NCT01332318|3777995|B2|White or Caucasian||Race/Ethnicity, Customized|The Safety Population (all participants who received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics. There was one randomized participant (in the GEn 1200 mg and DPH Placebo group) who did not meet the criteria for inclusion in the Safety Population.|participants|Number|31|31.0||||||
3956095|NCT01332318|3777996|B1|White or Caucasian||Race/Ethnicity, Customized|The Safety Population (all participants who received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics. There was one randomized participant (in the GEn 1200 mg and DPH Placebo group) who did not meet the criteria for inclusion in the Safety Population.|participants|Number|34|34.0||||||
3956096|NCT01332318|3777992|B5||Male|Sex: Female, Male|The Safety Population (all participants who received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics. There was one randomized participant (in the GEn 1200 mg and DPH Placebo group) who did not meet the criteria for inclusion in the Safety Population.|Participants|Count of Participants|52|52.0||||||
3956097|NCT01332318|3777993|B4||Male|Sex: Female, Male|The Safety Population (all participants who received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics. There was one randomized participant (in the GEn 1200 mg and DPH Placebo group) who did not meet the criteria for inclusion in the Safety Population.|Participants|Count of Participants|11|11.0||||||
3956098|NCT01332318|3777994|B3||Male|Sex: Female, Male|The Safety Population (all participants who received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics. There was one randomized participant (in the GEn 1200 mg and DPH Placebo group) who did not meet the criteria for inclusion in the Safety Population.|Participants|Count of Participants|17|17.0||||||
3956099|NCT01332318|3777995|B2||Male|Sex: Female, Male|The Safety Population (all participants who received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics. There was one randomized participant (in the GEn 1200 mg and DPH Placebo group) who did not meet the criteria for inclusion in the Safety Population.|Participants|Count of Participants|10|10.0||||||
3956100|NCT01332318|3777996|B1||Male|Sex: Female, Male|The Safety Population (all participants who received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics. There was one randomized participant (in the GEn 1200 mg and DPH Placebo group) who did not meet the criteria for inclusion in the Safety Population.|Participants|Count of Participants|14|14.0||||||
3956101|NCT01332318|3777992|B5||Female|Sex: Female, Male|The Safety Population (all participants who received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics. There was one randomized participant (in the GEn 1200 mg and DPH Placebo group) who did not meet the criteria for inclusion in the Safety Population.|Participants|Count of Participants|77|77.0||||||
3956102|NCT01332318|3777993|B4||Female|Sex: Female, Male|The Safety Population (all participants who received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics. There was one randomized participant (in the GEn 1200 mg and DPH Placebo group) who did not meet the criteria for inclusion in the Safety Population.|Participants|Count of Participants|19|19.0||||||
3956103|NCT01332318|3777994|B3||Female|Sex: Female, Male|The Safety Population (all participants who received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics. There was one randomized participant (in the GEn 1200 mg and DPH Placebo group) who did not meet the criteria for inclusion in the Safety Population.|Participants|Count of Participants|17|17.0||||||
3956104|NCT01332318|3777995|B2||Female|Sex: Female, Male|The Safety Population (all participants who received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics. There was one randomized participant (in the GEn 1200 mg and DPH Placebo group) who did not meet the criteria for inclusion in the Safety Population.|Participants|Count of Participants|21|21.0||||||
3956105|NCT01332318|3777996|B1||Female|Sex: Female, Male|The Safety Population (all participants who received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics. There was one randomized participant (in the GEn 1200 mg and DPH Placebo group) who did not meet the criteria for inclusion in the Safety Population.|Participants|Count of Participants|20|20.0||||||
3956106|NCT01332318|3777992|B5|||Age|The Safety Population (all participants who received at least one dose [or a portion of a dose] of study drug) was used for all baseline characteristics. There was one randomized participant (in the GEn 1200 mg and DPH Placebo group) who did not meet the criteria for inclusion in the Safety Population.|Years|Mean|46.8|46.8|Standard Deviation|11.62|11.62|||
3956107|NCT01332318|3777993|B4|||Age|The Safety Population (all participants who received at least one dose [or a portion of a dose] of study drug) was used for all baseline characteristics. There was one randomized participant (in the GEn 1200 mg and DPH Placebo group) who did not meet the criteria for inclusion in the Safety Population.|Years|Mean|40.6|40.6|Standard Deviation|11.80|11.8|||
3956108|NCT01332318|3777994|B3|||Age|The Safety Population (all participants who received at least one dose [or a portion of a dose] of study drug) was used for all baseline characteristics. There was one randomized participant (in the GEn 1200 mg and DPH Placebo group) who did not meet the criteria for inclusion in the Safety Population.|Years|Mean|49.3|49.3|Standard Deviation|10.27|10.27|||
3956148|NCT01332305|3778106|B5|||Age||Years|Mean|45.9|45.9|Standard Deviation|13.93|13.93|||
3956109|NCT01332318|3777995|B2|||Age|The Safety Population (all participants who received at least one dose [or a portion of a dose] of study drug) was used for all baseline characteristics. There was one randomized participant (in the GEn 1200 mg and DPH Placebo group) who did not meet the criteria for inclusion in the Safety Population.|Years|Mean|46.8|46.8|Standard Deviation|11.31|11.31|||
3956110|NCT01332318|3777996|B1|||Age|The Safety Population (all participants who received at least one dose [or a portion of a dose] of study drug) was used for all baseline characteristics. There was one randomized participant (in the GEn 1200 mg and DPH Placebo group) who did not meet the criteria for inclusion in the Safety Population.|Years|Mean|49.6|49.6|Standard Deviation|11.40|11.4|||
3956111|NCT01332305|3778105|B6|Asian||Race/Ethnicity, Customized|There was one participant in the GEn 2400 mg arm who was categorized in more than one race.|participants|Number|2|2.0||||||
3956112|NCT01332305|3778106|B5|Asian||Race/Ethnicity, Customized|There was one participant in the GEn 2400 mg arm who was categorized in more than one race.|participants|Number|1|1.0||||||
3956113|NCT01332305|3778107|B4|Asian||Race/Ethnicity, Customized|There was one participant in the GEn 2400 mg arm who was categorized in more than one race.|participants|Number|1|1.0||||||
3956114|NCT01332305|3778108|B3|Asian||Race/Ethnicity, Customized|There was one participant in the GEn 2400 mg arm who was categorized in more than one race.|participants|Number|0|0.0||||||
3956115|NCT01332305|3778109|B2|Asian||Race/Ethnicity, Customized|There was one participant in the GEn 2400 mg arm who was categorized in more than one race.|participants|Number|0|0.0||||||
3956116|NCT01332305|3778110|B1|Asian||Race/Ethnicity, Customized|There was one participant in the GEn 2400 mg arm who was categorized in more than one race.|participants|Number|0|0.0||||||
3956117|NCT01332305|3778105|B6|American Indian or Alaska Native||Race/Ethnicity, Customized|There was one participant in the GEn 2400 mg arm who was categorized in more than one race.|participants|Number|2|2.0||||||
3956118|NCT01332305|3778106|B5|American Indian or Alaska Native||Race/Ethnicity, Customized|There was one participant in the GEn 2400 mg arm who was categorized in more than one race.|participants|Number|1|1.0||||||
3956119|NCT01332305|3778107|B4|American Indian or Alaska Native||Race/Ethnicity, Customized|There was one participant in the GEn 2400 mg arm who was categorized in more than one race.|participants|Number|0|0.0||||||
3956120|NCT01332305|3778108|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|There was one participant in the GEn 2400 mg arm who was categorized in more than one race.|participants|Number|0|0.0||||||
3956121|NCT01332305|3778109|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|There was one participant in the GEn 2400 mg arm who was categorized in more than one race.|participants|Number|0|0.0||||||
3956122|NCT01332305|3778110|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|There was one participant in the GEn 2400 mg arm who was categorized in more than one race.|participants|Number|1|1.0||||||
3956123|NCT01332305|3778105|B6|Black or African American||Race/Ethnicity, Customized|There was one participant in the GEn 2400 mg arm who was categorized in more than one race.|participants|Number|6|6.0||||||
3956124|NCT01332305|3778106|B5|Black or African American||Race/Ethnicity, Customized|There was one participant in the GEn 2400 mg arm who was categorized in more than one race.|participants|Number|2|2.0||||||
3956125|NCT01332305|3778107|B4|Black or African American||Race/Ethnicity, Customized|There was one participant in the GEn 2400 mg arm who was categorized in more than one race.|participants|Number|2|2.0||||||
3956126|NCT01332305|3778108|B3|Black or African American||Race/Ethnicity, Customized|There was one participant in the GEn 2400 mg arm who was categorized in more than one race.|participants|Number|1|1.0||||||
3956127|NCT01332305|3778109|B2|Black or African American||Race/Ethnicity, Customized|There was one participant in the GEn 2400 mg arm who was categorized in more than one race.|participants|Number|0|0.0||||||
3956128|NCT01332305|3778110|B1|Black or African American||Race/Ethnicity, Customized|There was one participant in the GEn 2400 mg arm who was categorized in more than one race.|participants|Number|1|1.0||||||
3956129|NCT01332305|3778105|B6|White or Caucasian||Race/Ethnicity, Customized|There was one participant in the GEn 2400 mg arm who was categorized in more than one race.|participants|Number|208|208.0||||||
3956130|NCT01332305|3778106|B5|White or Caucasian||Race/Ethnicity, Customized|There was one participant in the GEn 2400 mg arm who was categorized in more than one race.|participants|Number|42|42.0||||||
3956131|NCT01332305|3778107|B4|White or Caucasian||Race/Ethnicity, Customized|There was one participant in the GEn 2400 mg arm who was categorized in more than one race.|participants|Number|35|35.0||||||
3956132|NCT01332305|3778108|B3|White or Caucasian||Race/Ethnicity, Customized|There was one participant in the GEn 2400 mg arm who was categorized in more than one race.|participants|Number|44|44.0||||||
3956133|NCT01332305|3778109|B2|White or Caucasian||Race/Ethnicity, Customized|There was one participant in the GEn 2400 mg arm who was categorized in more than one race.|participants|Number|48|48.0||||||
3956134|NCT01332305|3778110|B1|White or Caucasian||Race/Ethnicity, Customized|There was one participant in the GEn 2400 mg arm who was categorized in more than one race.|participants|Number|39|39.0||||||
3956135|NCT01332305|3778105|B6||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3956136|NCT01332305|3778106|B5||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3956137|NCT01332305|3778107|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3956138|NCT01332305|3778108|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3956139|NCT01332305|3778109|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3956140|NCT01332305|3778110|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3956141|NCT01332305|3778105|B6||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3956142|NCT01332305|3778106|B5||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3956143|NCT01332305|3778107|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3956144|NCT01332305|3778108|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3956145|NCT01332305|3778109|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3956146|NCT01332305|3778110|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3956147|NCT01332305|3778105|B6|||Age||Years|Mean|48.0|48.0|Standard Deviation|12.67|12.67|||
3956149|NCT01332305|3778107|B4|||Age||Years|Mean|50.2|50.2|Standard Deviation|13.79|13.79|||
3956150|NCT01332305|3778108|B3|||Age||Years|Mean|49.8|49.8|Standard Deviation|11.51|11.51|||
3956151|NCT01332305|3778109|B2|||Age||Years|Mean|47.3|47.3|Standard Deviation|12.78|12.78|||
3956152|NCT01332305|3778110|B1|||Age||Years|Mean|47.1|47.1|Standard Deviation|11.16|11.16|||
3956153|NCT01332292|3778136|B1|Unknown; Child Was Adopted||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3956154|NCT01332292|3778136|B1|African American/African Heritage & White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3956155|NCT01332292|3778136|B1|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3956156|NCT01332292|3778136|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3956157|NCT01332292|3778136|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3956158|NCT01332292|3778136|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3956159|NCT01332292|3778136|B1|||Age||Years|Mean|8.2|8.2|Standard Deviation|2.08|2.08|||
3956160|NCT01332253|3778197|B3|United States||Region of Enrollment||participants|Number|161|161.0||||||
3956161|NCT01332253|3778198|B2|United States||Region of Enrollment||participants|Number|79|79.0||||||
3956162|NCT01332253|3778199|B1|United States||Region of Enrollment||participants|Number|82|82.0||||||
3956163|NCT01332253|3778197|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3956164|NCT01332253|3778198|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3956165|NCT01332253|3778199|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3956166|NCT01332253|3778197|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956167|NCT01332253|3778198|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956168|NCT01332253|3778199|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956169|NCT01332253|3778197|B3||White|Race (NIH/OMB)||Participants|Count of Participants|137|137.0||||||
3956170|NCT01332253|3778198|B2||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3956171|NCT01332253|3778199|B1||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3956172|NCT01332253|3778197|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3956173|NCT01332253|3778198|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3956174|NCT01332253|3778199|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3956175|NCT01332253|3778197|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956176|NCT01332253|3778198|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956177|NCT01332253|3778199|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956178|NCT01332253|3778197|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3956179|NCT01332253|3778198|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956180|NCT01332253|3778199|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3956181|NCT01332253|3778197|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956182|NCT01332253|3778198|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956183|NCT01332253|3778199|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956184|NCT01332253|3778197|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956185|NCT01332253|3778198|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956186|NCT01332253|3778199|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956187|NCT01332253|3778197|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
3956188|NCT01332253|3778198|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3956189|NCT01332253|3778199|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3956190|NCT01332253|3778197|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3956191|NCT01332253|3778198|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3956192|NCT01332253|3778199|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3956193|NCT01332253|3778197|B3||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3956194|NCT01332253|3778198|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3956195|NCT01332253|3778199|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3956196|NCT01332253|3778197|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3956197|NCT01332253|3778198|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3956198|NCT01332253|3778199|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3956199|NCT01332253|3778197|B3|||Age||years|Mean|9|9.0|Standard Deviation|3.2|3.2|||
3956200|NCT01332253|3778198|B2|||Age||years|Mean|9|9.0|Standard Deviation|3.0|3.0|||
3956201|NCT01332253|3778199|B1|||Age||years|Mean|10|10.0|Standard Deviation|3.4|3.4|||
3956202|NCT01332227|3778226|B3|Family history of premature coronary heart disease||Cardiovascular disease risk factors|Hypertension=systolic blood pressure/diastolic blood pressure >140/90 mm Hg or patient was taking antihypertensive medication; family history of coronary heart disease=father, mother, or sibling (male <55 years of age, and mother <65 years of age).|Participants|Number|4|4.0||||||
3956235|NCT01332227|3778226|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3956236|NCT01332227|3778227|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3956203|NCT01332227|3778227|B2|Family history of premature coronary heart disease||Cardiovascular disease risk factors|Hypertension=systolic blood pressure/diastolic blood pressure >140/90 mm Hg or patient was taking antihypertensive medication; family history of coronary heart disease=father, mother, or sibling (male <55 years of age, and mother <65 years of age).|Participants|Number|0|0.0||||||
3956204|NCT01332227|3778228|B1|Family history of premature coronary heart disease||Cardiovascular disease risk factors|Hypertension=systolic blood pressure/diastolic blood pressure >140/90 mm Hg or patient was taking antihypertensive medication; family history of coronary heart disease=father, mother, or sibling (male <55 years of age, and mother <65 years of age).|Participants|Number|4|4.0||||||
3956205|NCT01332227|3778226|B3|Previous smoker||Cardiovascular disease risk factors|Hypertension=systolic blood pressure/diastolic blood pressure >140/90 mm Hg or patient was taking antihypertensive medication; family history of coronary heart disease=father, mother, or sibling (male <55 years of age, and mother <65 years of age).|Participants|Number|15|15.0||||||
3956206|NCT01332227|3778227|B2|Previous smoker||Cardiovascular disease risk factors|Hypertension=systolic blood pressure/diastolic blood pressure >140/90 mm Hg or patient was taking antihypertensive medication; family history of coronary heart disease=father, mother, or sibling (male <55 years of age, and mother <65 years of age).|Participants|Number|8|8.0||||||
3956207|NCT01332227|3778228|B1|Previous smoker||Cardiovascular disease risk factors|Hypertension=systolic blood pressure/diastolic blood pressure >140/90 mm Hg or patient was taking antihypertensive medication; family history of coronary heart disease=father, mother, or sibling (male <55 years of age, and mother <65 years of age).|Participants|Number|7|7.0||||||
3956208|NCT01332227|3778226|B3|Current smoker||Cardiovascular disease risk factors|Hypertension=systolic blood pressure/diastolic blood pressure >140/90 mm Hg or patient was taking antihypertensive medication; family history of coronary heart disease=father, mother, or sibling (male <55 years of age, and mother <65 years of age).|Participants|Number|38|38.0||||||
3956209|NCT01332227|3778227|B2|Current smoker||Cardiovascular disease risk factors|Hypertension=systolic blood pressure/diastolic blood pressure >140/90 mm Hg or patient was taking antihypertensive medication; family history of coronary heart disease=father, mother, or sibling (male <55 years of age, and mother <65 years of age).|Participants|Number|11|11.0||||||
3956210|NCT01332227|3778228|B1|Current smoker||Cardiovascular disease risk factors|Hypertension=systolic blood pressure/diastolic blood pressure >140/90 mm Hg or patient was taking antihypertensive medication; family history of coronary heart disease=father, mother, or sibling (male <55 years of age, and mother <65 years of age).|Participants|Number|27|27.0||||||
3956211|NCT01332227|3778226|B3|Diabetes mellitus||Cardiovascular disease risk factors|Hypertension=systolic blood pressure/diastolic blood pressure >140/90 mm Hg or patient was taking antihypertensive medication; family history of coronary heart disease=father, mother, or sibling (male <55 years of age, and mother <65 years of age).|Participants|Number|4|4.0||||||
3956212|NCT01332227|3778227|B2|Diabetes mellitus||Cardiovascular disease risk factors|Hypertension=systolic blood pressure/diastolic blood pressure >140/90 mm Hg or patient was taking antihypertensive medication; family history of coronary heart disease=father, mother, or sibling (male <55 years of age, and mother <65 years of age).|Participants|Number|1|1.0||||||
3956213|NCT01332227|3778228|B1|Diabetes mellitus||Cardiovascular disease risk factors|Hypertension=systolic blood pressure/diastolic blood pressure >140/90 mm Hg or patient was taking antihypertensive medication; family history of coronary heart disease=father, mother, or sibling (male <55 years of age, and mother <65 years of age).|Participants|Number|3|3.0||||||
3956214|NCT01332227|3778226|B3|Hypertension||Cardiovascular disease risk factors|Hypertension=systolic blood pressure/diastolic blood pressure >140/90 mm Hg or patient was taking antihypertensive medication; family history of coronary heart disease=father, mother, or sibling (male <55 years of age, and mother <65 years of age).|Participants|Number|11|11.0||||||
3956215|NCT01332227|3778227|B2|Hypertension||Cardiovascular disease risk factors|Hypertension=systolic blood pressure/diastolic blood pressure >140/90 mm Hg or patient was taking antihypertensive medication; family history of coronary heart disease=father, mother, or sibling (male <55 years of age, and mother <65 years of age).|Participants|Number|6|6.0||||||
3956216|NCT01332227|3778228|B1|Hypertension||Cardiovascular disease risk factors|Hypertension=systolic blood pressure/diastolic blood pressure >140/90 mm Hg or patient was taking antihypertensive medication; family history of coronary heart disease=father, mother, or sibling (male <55 years of age, and mother <65 years of age).|Participants|Number|5|5.0||||||
3956217|NCT01332227|3778226|B3|||Median CD4 count||Cells/mm^3|Median|593.0|593.0|Full Range|||10.0|1511.0|
3956218|NCT01332227|3778227|B2|||Median CD4 count||Cells/mm^3|Median|639.5|639.5|Full Range|||159.0|1395.0|
3956219|NCT01332227|3778228|B1|||Median CD4 count||Cells/mm^3|Median|588.5|588.5|Full Range|||10.0|1511.0|
3956220|NCT01332227|3778226|B3|||Mean CD4 count||Cells/mm^3|Mean|601.5|601.5|Standard Deviation|257.48|257.48|||
3956221|NCT01332227|3778227|B2|||Mean CD4 count||Cells/mm^3|Mean|630.9|630.9|Standard Deviation|270.02|270.02|||
3956222|NCT01332227|3778228|B1|||Mean CD4 count||Cells/mm^3|Mean|587.7|587.7|Standard Deviation|252.09|252.09|||
3956223|NCT01332227|3778226|B3|Unknown||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
3956224|NCT01332227|3778227|B2|Unknown||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3956225|NCT01332227|3778228|B1|Unknown||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3956226|NCT01332227|3778226|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3956227|NCT01332227|3778227|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3956228|NCT01332227|3778228|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3956229|NCT01332227|3778226|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3956230|NCT01332227|3778227|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3956231|NCT01332227|3778228|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3956232|NCT01332227|3778226|B3|White||Race/Ethnicity, Customized||Participants|Number|78|78.0||||||
3956233|NCT01332227|3778227|B2|White||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
3956234|NCT01332227|3778228|B1|White||Race/Ethnicity, Customized||Participants|Number|54|54.0||||||
3956237|NCT01332227|3778228|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3956238|NCT01332227|3778226|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3956239|NCT01332227|3778227|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3956240|NCT01332227|3778228|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3956241|NCT01332227|3778226|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3956242|NCT01332227|3778227|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3956243|NCT01332227|3778228|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3956244|NCT01332227|3778226|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3956245|NCT01332227|3778227|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3956246|NCT01332227|3778228|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3956247|NCT01332227|3778226|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3956248|NCT01332227|3778227|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3956249|NCT01332227|3778228|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3956250|NCT01332227|3778226|B3|65-85 years||Age, Customized||Participants|Number|4|4.0||||||
3956251|NCT01332227|3778227|B2|65-85 years||Age, Customized||Participants|Number|1|1.0||||||
3956252|NCT01332227|3778228|B1|65-85 years||Age, Customized||Participants|Number|3|3.0||||||
3956253|NCT01332227|3778226|B3|< 65 years||Age, Customized||Participants|Number|105|105.0||||||
3956254|NCT01332227|3778227|B2|< 65 years||Age, Customized||Participants|Number|36|36.0||||||
3956255|NCT01332227|3778228|B1|< 65 years||Age, Customized||Participants|Number|69|69.0||||||
3956256|NCT01332227|3778226|B3|||Age|Median age|Years|Median|44.0|44.0|Full Range|||25.0|69.0|
3956257|NCT01332227|3778227|B2|||Age|Median age|Years|Median|44.0|44.0|Full Range|||25.0|69.0|
3956258|NCT01332227|3778228|B1|||Age|Median age|Years|Median|44.0|44.0|Full Range|||25.0|67.0|
3956259|NCT01332227|3778226|B3|||Age|Mean age|Years|Mean|43.4|43.4|Standard Deviation|9.62|9.62|||
3956260|NCT01332227|3778227|B2|||Age|Mean age|Years|Mean|44.0|44.0|Standard Deviation|10.38|10.38|||
3956261|NCT01332227|3778228|B1|||Age|Mean age|Years|Mean|43.1|43.1|Standard Deviation|9.26|9.26|||
3956262|NCT01332188|3778247|B5|United States||Region of Enrollment||participants|Number|101|101.0||||||
3956263|NCT01332188|3778248|B4|United States||Region of Enrollment||participants|Number|25|25.0||||||
3956264|NCT01332188|3778249|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
3956265|NCT01332188|3778250|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
3956266|NCT01332188|3778251|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3956267|NCT01332188|3778247|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956268|NCT01332188|3778248|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956269|NCT01332188|3778249|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956270|NCT01332188|3778250|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956271|NCT01332188|3778251|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956272|NCT01332188|3778247|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956273|NCT01332188|3778248|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956274|NCT01332188|3778249|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956275|NCT01332188|3778250|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956276|NCT01332188|3778251|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956277|NCT01332188|3778247|B5||White|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
3956278|NCT01332188|3778248|B4||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3956279|NCT01332188|3778249|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3956280|NCT01332188|3778250|B2||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3956281|NCT01332188|3778251|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3956282|NCT01332188|3778247|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3956283|NCT01332188|3778248|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3956284|NCT01332188|3778249|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3956285|NCT01332188|3778250|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3956286|NCT01332188|3778251|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3956287|NCT01332188|3778247|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956288|NCT01332188|3778248|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956289|NCT01332188|3778249|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956290|NCT01332188|3778250|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956291|NCT01332188|3778251|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956292|NCT01332188|3778247|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3956293|NCT01332188|3778248|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3956294|NCT01332188|3778249|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956295|NCT01332188|3778250|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956296|NCT01332188|3778251|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956297|NCT01332188|3778247|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956298|NCT01332188|3778248|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956299|NCT01332188|3778249|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956300|NCT01332188|3778250|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956301|NCT01332188|3778251|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956302|NCT01332188|3778247|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956303|NCT01332188|3778248|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956304|NCT01332188|3778249|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956305|NCT01332188|3778250|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956306|NCT01332188|3778251|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956307|NCT01332188|3778247|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3956308|NCT01332188|3778248|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3956309|NCT01332188|3778249|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3956310|NCT01332188|3778250|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3956311|NCT01332188|3778251|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3956312|NCT01332188|3778247|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3956313|NCT01332188|3778248|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3956314|NCT01332188|3778249|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3956315|NCT01332188|3778250|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3956316|NCT01332188|3778251|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3956317|NCT01332188|3778247|B5||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3956318|NCT01332188|3778248|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3956319|NCT01332188|3778249|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3956320|NCT01332188|3778250|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3956321|NCT01332188|3778251|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3956322|NCT01332188|3778247|B5||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3956323|NCT01332188|3778248|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3956324|NCT01332188|3778249|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3956325|NCT01332188|3778250|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3956326|NCT01332188|3778251|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3956327|NCT01332188|3778247|B5|||Age||years|Mean|41.4|41.4|Standard Deviation|13.59|13.59|||
3956328|NCT01332188|3778248|B4|||Age||years|Mean|38.1|38.1|Standard Deviation|14.12|14.12|||
3956329|NCT01332188|3778249|B3|||Age||years|Mean|38.9|38.9|Standard Deviation|12.53|12.53|||
3956330|NCT01332188|3778250|B2|||Age||years|Mean|43.1|43.1|Standard Deviation|13.5|13.5|||
3956331|NCT01332188|3778251|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|13.58|13.58|||
3956332|NCT01332149|3778408|B3||Male|Sex: Female, Male||Participants|Count of Participants|293|293.0||||||
3956333|NCT01332149|3778409|B2||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3956334|NCT01332149|3778410|B1||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3956335|NCT01332149|3778408|B3||Female|Sex: Female, Male||Participants|Count of Participants|327|327.0||||||
3956336|NCT01332149|3778409|B2||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3956337|NCT01332149|3778410|B1||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
3956338|NCT01332149|3778408|B3|More than or equal to (>=) 65 years||Age, Customized||participants|Number|230|230.0||||||
3956339|NCT01332149|3778409|B2|More than or equal to (>=) 65 years||Age, Customized||participants|Number|114|114.0||||||
3956340|NCT01332149|3778410|B1|More than or equal to (>=) 65 years||Age, Customized||participants|Number|116|116.0||||||
3956341|NCT01332149|3778408|B3|45-64 years||Age, Customized||participants|Number|350|350.0||||||
3956342|NCT01332149|3778409|B2|45-64 years||Age, Customized||participants|Number|178|178.0||||||
3956343|NCT01332149|3778410|B1|45-64 years||Age, Customized||participants|Number|172|172.0||||||
3956344|NCT01332149|3778408|B3|18-44 years||Age, Customized||participants|Number|40|40.0||||||
3956345|NCT01332149|3778409|B2|18-44 years||Age, Customized||participants|Number|15|15.0||9.5|9.5|||
3956346|NCT01332149|3778410|B1|18-44 years||Age, Customized||participants|Number|25|25.0||10.3|10.3|||
3956347|NCT01332123|3778465|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3956348|NCT01332123|3778465|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3956349|NCT01332123|3778465|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3956350|NCT01332123|3778465|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3956351|NCT01332123|3778465|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3956352|NCT01332123|3778465|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3956353|NCT01332123|3778465|B1|||Age||years|Mean|50.4|50.4|Standard Deviation|13.2|13.2|||
3956354|NCT01332071|3778470|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3956355|NCT01332071|3778470|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3956356|NCT01332071|3778470|B1|||Age||Years|Mean|29.77|29.77|Standard Deviation|6.80|6.8|||
3956357|NCT01332019|3778487|B3||Male|Gender||Participants|Count of Participants|301|301.0||||||
3956358|NCT01332019|3778488|B2||Male|Gender||Participants|Count of Participants|150|150.0||||||
3956359|NCT01332019|3778489|B1||Male|Gender||Participants|Count of Participants|151|151.0||||||
3956360|NCT01332019|3778487|B3||Female|Gender||Participants|Count of Participants|775|775.0||||||
3956361|NCT01332019|3778488|B2||Female|Gender||Participants|Count of Participants|397|397.0||||||
3956362|NCT01332019|3778489|B1||Female|Gender||Participants|Count of Participants|378|378.0||||||
3956363|NCT01332019|3778487|B3|60-65 years||Age, Customized||participants|Number|8|8.0||||||
3956364|NCT01332019|3778488|B2|60-65 years||Age, Customized||participants|Number|5|5.0||||||
3956365|NCT01332019|3778489|B1|60-65 years||Age, Customized||participants|Number|3|3.0||||||
3956366|NCT01332019|3778487|B3|50-59 years||Age, Customized||participants|Number|163|163.0||||||
3956367|NCT01332019|3778488|B2|50-59 years||Age, Customized||participants|Number|83|83.0||||||
3956368|NCT01332019|3778489|B1|50-59 years||Age, Customized||participants|Number|80|80.0||||||
3956369|NCT01332019|3778487|B3|40-49 years||Age, Customized||participants|Number|322|322.0||||||
3956370|NCT01332019|3778488|B2|40-49 years||Age, Customized||participants|Number|172|172.0||||||
3956371|NCT01332019|3778489|B1|40-49 years||Age, Customized||participants|Number|150|150.0||||||
3956372|NCT01332019|3778487|B3|30-39 years||Age, Customized||participants|Number|345|345.0||||||
3956373|NCT01332019|3778488|B2|30-39 years||Age, Customized||participants|Number|180|180.0||||||
3956374|NCT01332019|3778489|B1|30-39 years||Age, Customized||participants|Number|165|165.0||||||
3956375|NCT01332019|3778487|B3|20-29 years||Age, Customized||participants|Number|238|238.0||||||
3956376|NCT01332019|3778488|B2|20-29 years||Age, Customized||participants|Number|107|107.0||||||
3956377|NCT01332019|3778489|B1|20-29 years||Age, Customized||participants|Number|131|131.0||||||
3956378|NCT01332019|3778487|B3|||Age||years|Mean|38.4|38.4|Standard Deviation|9.77|9.77|||
3956379|NCT01332019|3778488|B2|||Age||years|Mean|38.7|38.7|Standard Deviation|9.59|9.59|||
3956380|NCT01332019|3778489|B1|||Age||years|Mean|38.1|38.1|Standard Deviation|9.95|9.95|||
3956381|NCT01331837|3778572|B3||Male|Sex: Female, Male||Participants|Count of Participants|685|685.0||||||
3956382|NCT01331837|3778573|B2||Male|Sex: Female, Male||Participants|Count of Participants|340|340.0||||||
3956383|NCT01331837|3778574|B1||Male|Sex: Female, Male||Participants|Count of Participants|345|345.0||||||
3956384|NCT01331837|3778572|B3||Female|Sex: Female, Male||Participants|Count of Participants|2395|2395.0||||||
3956385|NCT01331837|3778573|B2||Female|Sex: Female, Male||Participants|Count of Participants|1202|1202.0||||||
3956386|NCT01331837|3778574|B1||Female|Sex: Female, Male||Participants|Count of Participants|1193|1193.0||||||
3956387|NCT01331837|3778572|B3|||Age||Years|Mean|60.7|60.7|Standard Deviation|7.5|7.5|||
3956388|NCT01331837|3778573|B2|||Age||Years|Mean|60.7|60.7|Standard Deviation|7.6|7.6|||
3956389|NCT01331837|3778574|B1|||Age||Years|Mean|60.7|60.7|Standard Deviation|7.4|7.4|||
3956390|NCT01331824|3778615|B1|||Median time from prior chemotherapy||months|Median|6.8|6.8|Full Range|||1.4|34.2|
3956391|NCT01331824|3778615|B1|3 poor prognostic factors||Bellmunt prognostic factors|The significant prognostic factors were as follows: hemoglobin level more than 10 g/dL, ECOG PS less than 1, absence of liver metastases, metastasis restricted to one organ, and AST and AP levels in the normal range.|participants|Number|3|3.0||||||
3956392|NCT01331824|3778615|B1|2 poor prognostic factors||Bellmunt prognostic factors|The significant prognostic factors were as follows: hemoglobin level more than 10 g/dL, ECOG PS less than 1, absence of liver metastases, metastasis restricted to one organ, and AST and AP levels in the normal range.|participants|Number|6|6.0||||||
3956393|NCT01331824|3778615|B1|1 poor prognostic factors||Bellmunt prognostic factors|The significant prognostic factors were as follows: hemoglobin level more than 10 g/dL, ECOG PS less than 1, absence of liver metastases, metastasis restricted to one organ, and AST and AP levels in the normal range.|participants|Number|10|10.0||||||
3956394|NCT01331824|3778615|B1|0 poor prognostic factors||Bellmunt prognostic factors|The significant prognostic factors were as follows: hemoglobin level more than 10 g/dL, ECOG PS less than 1, absence of liver metastases, metastasis restricted to one organ, and AST and AP levels in the normal range.|participants|Number|3|3.0||||||
3956395|NCT01331824|3778615|B1|Gemcitabine + doxorubicin + paclitaxel||First-line chemotherapy regimen||participants|Number|1|1.0||||||
3956396|NCT01331824|3778615|B1|Gemcitabine + cisplatin + ipilimumab||First-line chemotherapy regimen||participants|Number|1|1.0||||||
3956397|NCT01331824|3778615|B1|Gemcitabine + cisplatin + dovitinib||First-line chemotherapy regimen||participants|Number|1|1.0||||||
3956398|NCT01331824|3778615|B1|Gemcitabine + cisplatin||First-line chemotherapy regimen||participants|Number|12|12.0||||||
3956399|NCT01331824|3778615|B1|Gemcitabine + carboplatin||First-line chemotherapy regimen||participants|Number|7|7.0||||||
3956400|NCT01331824|3778615|B1|Metastatic||"Prior first-line treatment"||participants|Number|14|14.0||||||
3956401|NCT01331824|3778615|B1|Adjuvant||"Prior first-line treatment"||participants|Number|4|4.0||||||
3956402|NCT01331824|3778615|B1|Neoadjuvant||"Prior first-line treatment"||participants|Number|4|4.0||||||
3956403|NCT01331824|3778615|B1|Urethra||Primary Site||participants|Number|3|3.0||||||
3956404|NCT01331824|3778615|B1|Renal Pelvis||Primary Site||participants|Number|3|3.0||||||
3956405|NCT01331824|3778615|B1|Bladder||Primary Site||participants|Number|16|16.0||||||
3956406|NCT01331824|3778615|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3956407|NCT01331824|3778615|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3956408|NCT01331824|3778615|B1|||Age||years|Median|65|65.0|Full Range|||58.0|79.0|
3956409|NCT01331694|3778622|B7||Male|Sex: Female, Male|Gender reported in claims records|Participants|Count of Participants|37530|37530.0||||||
3956410|NCT01331694|3778623|B6||Male|Sex: Female, Male|Gender reported in claims records|Participants|Count of Participants|4870|4870.0||||||
3956411|NCT01331694|3778624|B5||Male|Sex: Female, Male|Gender reported in claims records|Participants|Count of Participants|5319|5319.0||||||
3956412|NCT01331694|3778625|B4||Male|Sex: Female, Male|Gender reported in claims records|Participants|Count of Participants|5681|5681.0||||||
3956413|NCT01331694|3778626|B3||Male|Sex: Female, Male|Gender reported in claims records|Participants|Count of Participants|6797|6797.0||||||
3956414|NCT01331694|3778627|B2||Male|Sex: Female, Male|Gender reported in claims records|Participants|Count of Participants|7306|7306.0||||||
3956415|NCT01331694|3778628|B1||Male|Sex: Female, Male|Gender reported in claims records|Participants|Count of Participants|7557|7557.0||||||
3956416|NCT01331694|3778622|B7||Female|Sex: Female, Male|Gender reported in claims records|Participants|Count of Participants|38600|38600.0||||||
3956417|NCT01331694|3778623|B6||Female|Sex: Female, Male|Gender reported in claims records|Participants|Count of Participants|4256|4256.0||||||
3956418|NCT01331694|3778624|B5||Female|Sex: Female, Male|Gender reported in claims records|Participants|Count of Participants|5298|5298.0||||||
3956419|NCT01331694|3778625|B4||Female|Sex: Female, Male|Gender reported in claims records|Participants|Count of Participants|6914|6914.0||||||
3956420|NCT01331694|3778626|B3||Female|Sex: Female, Male|Gender reported in claims records|Participants|Count of Participants|5862|5862.0||||||
3956421|NCT01331694|3778627|B2||Female|Sex: Female, Male|Gender reported in claims records|Participants|Count of Participants|7143|7143.0||||||
3956422|NCT01331694|3778628|B1||Female|Sex: Female, Male|Gender reported in claims records|Participants|Count of Participants|9127|9127.0||||||
3956423|NCT01331694|3778622|B7|||Age|Age at initial treatment arm prescription|Years|Mean|64.0|64.0|Standard Deviation|12.06|12.06|||
3956424|NCT01331694|3778623|B6|||Age|Age at initial treatment arm prescription|Years|Mean|64.5|64.5|Standard Deviation|11.34|11.34|||
3956425|NCT01331694|3778624|B5|||Age|Age at initial treatment arm prescription|Years|Mean|65.0|65.0|Standard Deviation|12.42|12.42|||
3956426|NCT01331694|3778625|B4|||Age|Age at initial treatment arm prescription|Years|Mean|62.8|62.8|Standard Deviation|11.92|11.92|||
3956427|NCT01331694|3778626|B3|||Age|Age at initial treatment arm prescription|Years|Mean|64.5|64.5|Standard Deviation|11.33|11.33|||
3956428|NCT01331694|3778627|B2|||Age|Age at initial treatment arm prescription|Years|Mean|65.2|65.2|Standard Deviation|12.59|12.59|||
3956429|NCT01331694|3778628|B1|||Age|Age at initial treatment arm prescription|Years|Mean|62.8|62.8|Standard Deviation|12.00|12.0|||
3956430|NCT01331681|3778647|B4||Male|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
3956431|NCT01331681|3778648|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3956432|NCT01331681|3778649|B2||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3956433|NCT01331681|3778650|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3956434|NCT01331681|3778647|B4||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3956435|NCT01331681|3778648|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3956436|NCT01331681|3778649|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3956437|NCT01331681|3778650|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3956438|NCT01331681|3778647|B4|||Age||Years|Mean|63.6|63.6|Standard Deviation|8.3|8.3|||
3956439|NCT01331681|3778648|B3|||Age||Years|Mean|63.9|63.9|Standard Deviation|8.6|8.6|||
3956440|NCT01331681|3778649|B2|||Age||Years|Mean|64.2|64.2|Standard Deviation|7.8|7.8|||
3956441|NCT01331681|3778650|B1|||Age||Years|Mean|62.6|62.6|Standard Deviation|8.6|8.6|||
3956442|NCT01331304|3778678|B3|United States||Region of Enrollment||participants|Number|482|482.0||||||
3956443|NCT01331304|3778679|B2|United States||Region of Enrollment||participants|Number|242|242.0||||||
3956444|NCT01331304|3778680|B1|United States||Region of Enrollment||participants|Number|240|240.0||||||
3956445|NCT01331304|3778678|B3||Male|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
3956446|NCT01331304|3778679|B2||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3956447|NCT01331304|3778680|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3956448|NCT01331304|3778678|B3||Female|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
3956449|NCT01331304|3778679|B2||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3956450|NCT01331304|3778680|B1||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3956451|NCT01331304|3778678|B3|||Age||Years|Mean|38.9|38.9|Standard Deviation|12.1|12.1|||
3956452|NCT01331304|3778679|B2|||Age||Years|Mean|39.1|39.1|Standard Deviation|12.2|12.2|||
3956453|NCT01331304|3778680|B1|||Age||Years|Mean|38.6|38.6|Standard Deviation|12.1|12.1|||
3956454|NCT01331291|3778693|B3|||Prior chemoradiation|Number of patients who previously received standard, initial therapy with temozolomide and radiation at diagnosis|participants|Number|11|11.0||||||
3956455|NCT01331291|3778694|B2|||Prior chemoradiation|Number of patients who previously received standard, initial therapy with temozolomide and radiation at diagnosis|participants|Number|9|9.0||||||
3956456|NCT01331291|3778695|B1|||Prior chemoradiation|Number of patients who previously received standard, initial therapy with temozolomide and radiation at diagnosis|participants|Number|2|2.0||||||
3956457|NCT01331291|3778693|B3|||Karnofsky Performance Status (KPS)|A standard way of measuring the ability of cancer patients to perform ordinary tasks. The Karnofsky Performance Status scores range from 0 to 100. A higher score means the patient is better able to carry out daily activities. (0 being 'Dead' and 100 being 'Normal, no complaints; no evidence of disease'.)|units on a scale|Median|90|90.0|Full Range|||70.0|90.0|
3956513|NCT01331161|3778730|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3956514|NCT01331161|3778728|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3956515|NCT01331161|3778729|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3956458|NCT01331291|3778694|B2|||Karnofsky Performance Status (KPS)|A standard way of measuring the ability of cancer patients to perform ordinary tasks. The Karnofsky Performance Status scores range from 0 to 100. A higher score means the patient is better able to carry out daily activities. (0 being 'Dead' and 100 being 'Normal, no complaints; no evidence of disease'.)|units on a scale|Median|90|90.0|Full Range|||70.0|90.0|
3956459|NCT01331291|3778695|B1|||Karnofsky Performance Status (KPS)|A standard way of measuring the ability of cancer patients to perform ordinary tasks. The Karnofsky Performance Status scores range from 0 to 100. A higher score means the patient is better able to carry out daily activities. (0 being 'Dead' and 100 being 'Normal, no complaints; no evidence of disease'.)|units on a scale|Median|80|80.0|Full Range|||70.0|90.0|
3956460|NCT01331291|3778693|B3|No prior surgery||Prior Surgery|Surgery done at time of diagnosis with glioblastoma|participants|Number|1|1.0||||||
3956461|NCT01331291|3778694|B2|No prior surgery||Prior Surgery|Surgery done at time of diagnosis with glioblastoma|participants|Number|0|0.0||||||
3956462|NCT01331291|3778695|B1|No prior surgery||Prior Surgery|Surgery done at time of diagnosis with glioblastoma|participants|Number|1|1.0||||||
3956463|NCT01331291|3778693|B3|Sub total Resection||Prior Surgery|Surgery done at time of diagnosis with glioblastoma|participants|Number|3|3.0||||||
3956464|NCT01331291|3778694|B2|Sub total Resection||Prior Surgery|Surgery done at time of diagnosis with glioblastoma|participants|Number|3|3.0||||||
3956465|NCT01331291|3778695|B1|Sub total Resection||Prior Surgery|Surgery done at time of diagnosis with glioblastoma|participants|Number|0|0.0||||||
3956466|NCT01331291|3778693|B3|Gross Total Resection||Prior Surgery|Surgery done at time of diagnosis with glioblastoma|participants|Number|7|7.0||||||
3956467|NCT01331291|3778694|B2|Gross Total Resection||Prior Surgery|Surgery done at time of diagnosis with glioblastoma|participants|Number|6|6.0||||||
3956468|NCT01331291|3778695|B1|Gross Total Resection||Prior Surgery|Surgery done at time of diagnosis with glioblastoma|participants|Number|1|1.0||||||
3956469|NCT01331291|3778693|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3956470|NCT01331291|3778694|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3956471|NCT01331291|3778695|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3956472|NCT01331291|3778693|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3956473|NCT01331291|3778694|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3956474|NCT01331291|3778695|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3956475|NCT01331291|3778693|B3|||Age||years|Median|52|52.0|Full Range|||36.0|62.0|
3956476|NCT01331291|3778694|B2|||Age||years|Median|44|44.0|Full Range|||36.0|62.0|
3956477|NCT01331291|3778695|B1|||Age||years|Median|60|60.0|Full Range|||58.0|62.0|
3956478|NCT01331213|3778707|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
3956479|NCT01331213|3778708|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3956480|NCT01331213|3778709|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3956481|NCT01331213|3778707|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3956482|NCT01331213|3778708|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3956483|NCT01331213|3778709|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3956484|NCT01331213|3778707|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3956485|NCT01331213|3778708|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3956486|NCT01331213|3778709|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3956487|NCT01331213|3778707|B3|||Age||years|Mean|44.06|44.06|Standard Deviation|9.19|9.19|||
3956488|NCT01331213|3778708|B2|||Age||years|Mean|44.1|44.1|Standard Deviation|11.51|11.51|||
3956489|NCT01331213|3778709|B1|||Age||years|Mean|44|44.0|Standard Deviation|5.88|5.88|||
3956490|NCT01331161|3778728|B3|Non hispanic||Ethnicity||Participants|Number|71|71.0||||||
3956491|NCT01331161|3778729|B2|Non hispanic||Ethnicity||Participants|Number|30|30.0||||||
3956492|NCT01331161|3778730|B1|Non hispanic||Ethnicity||Participants|Number|41|41.0||||||
3956493|NCT01331161|3778728|B3|Hispanic||Ethnicity||Participants|Number|6|6.0||||||
3956494|NCT01331161|3778729|B2|Hispanic||Ethnicity||Participants|Number|3|3.0||||||
3956495|NCT01331161|3778730|B1|Hispanic||Ethnicity||Participants|Number|3|3.0||||||
3956496|NCT01331161|3778728|B3|United States||Region of Enrollment||participants|Number|77|77.0||||||
3956497|NCT01331161|3778729|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
3956498|NCT01331161|3778730|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
3956499|NCT01331161|3778728|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3956500|NCT01331161|3778729|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3956501|NCT01331161|3778730|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3956502|NCT01331161|3778728|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3956503|NCT01331161|3778729|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3956504|NCT01331161|3778730|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3956505|NCT01331161|3778728|B3|||Age||years|Median|61|61.0|Full Range|||25.0|77.0|
3956506|NCT01331161|3778729|B2|||Age||years|Median|33|33.0|Full Range|||25.0|40.0|
3956507|NCT01331161|3778730|B1|||Age||years|Median|68|68.0|Full Range|||60.0|77.0|
3956508|NCT01331161|3778728|B3||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3956509|NCT01331161|3778729|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3956510|NCT01331161|3778730|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3956511|NCT01331161|3778728|B3||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
3956512|NCT01331161|3778729|B2||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3956516|NCT01331161|3778730|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3956517|NCT01331109|3778739|B1|100mg||Maximum Tolerated Dose of Milnacipran|Maximum tolerated daily dose of milnacipran.|participants|Number|46|46.0||||||
3956518|NCT01331109|3778739|B1|75 mg||Maximum Tolerated Dose of Milnacipran|Maximum tolerated daily dose of milnacipran.|participants|Number|8|8.0||||||
3956519|NCT01331109|3778739|B1|50 mg||Maximum Tolerated Dose of Milnacipran|Maximum tolerated daily dose of milnacipran.|participants|Number|3|3.0||||||
3956520|NCT01331109|3778739|B1|Less than 50mg||Maximum Tolerated Dose of Milnacipran|Maximum tolerated daily dose of milnacipran.|participants|Number|0|0.0||||||
3956521|NCT01331109|3778739|B1|United States||Region of Enrollment||participants|Number|57|57.0||||||
3956522|NCT01331109|3778739|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3956523|NCT01331109|3778739|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3956524|NCT01331109|3778739|B1|17 years old||Age, Customized||participants|Number|17|17.0||||||
3956525|NCT01331109|3778739|B1|16 years old||Age, Customized||participants|Number|12|12.0||||||
3956526|NCT01331109|3778739|B1|15 years old||Age, Customized||participants|Number|11|11.0||||||
3956527|NCT01331109|3778739|B1|14 years old||Age, Customized||participants|Number|12|12.0||||||
3956528|NCT01331109|3778739|B1|13 years old||Age, Customized||participants|Number|5|5.0||||||
3956529|NCT01331109|3778739|B1|||Age||years|Mean|15.4|15.4|Standard Deviation|1.35|1.35|||
3956530|NCT01331005|3778749|B3|||Optical Coherence Tomography Retinal Volume||mm^3|Mean|7.8|7.8|Standard Deviation|0.5|0.5|||
3956531|NCT01331005|3778750|B2|||Optical Coherence Tomography Retinal Volume||mm^3|Mean|7.9|7.9|Standard Deviation|0.6|0.6|||
3956532|NCT01331005|3778751|B1|||Optical Coherence Tomography Retinal Volume||mm^3|Mean|7.7|7.7|Standard Deviation|0.4|0.4|||
3956533|NCT01331005|3778749|B3|||Optical Coherence Tomography Central Subfield Thickness||Microns|Mean|223|223.0|Standard Deviation|27|27.0|||
3956534|NCT01331005|3778750|B2|||Optical Coherence Tomography Central Subfield Thickness||Microns|Mean|227|227.0|Standard Deviation|29|29.0|||
3956535|NCT01331005|3778751|B1|||Optical Coherence Tomography Central Subfield Thickness||Microns|Mean|218|218.0|Standard Deviation|25|25.0|||
3956536|NCT01331005|3778749|B3|Heidelberg Spectralis||Optical Coherence Tomography Machine||participants|Number|47|47.0||||||
3956537|NCT01331005|3778750|B2|Heidelberg Spectralis||Optical Coherence Tomography Machine||participants|Number|24|24.0||||||
3956538|NCT01331005|3778751|B1|Heidelberg Spectralis||Optical Coherence Tomography Machine||participants|Number|23|23.0||||||
3956539|NCT01331005|3778749|B3|Zeiss Cirrus||Optical Coherence Tomography Machine||participants|Number|78|78.0||||||
3956540|NCT01331005|3778750|B2|Zeiss Cirrus||Optical Coherence Tomography Machine||participants|Number|37|37.0||||||
3956541|NCT01331005|3778751|B1|Zeiss Cirrus||Optical Coherence Tomography Machine||participants|Number|41|41.0||||||
3956542|NCT01331005|3778749|B3|no||History of Panretinal Photocoagulation||participants|Number|101|101.0||||||
3956543|NCT01331005|3778750|B2|no||History of Panretinal Photocoagulation||participants|Number|48|48.0||||||
3956544|NCT01331005|3778751|B1|no||History of Panretinal Photocoagulation||participants|Number|53|53.0||||||
3956545|NCT01331005|3778749|B3|yes||History of Panretinal Photocoagulation||participants|Number|24|24.0||||||
3956546|NCT01331005|3778750|B2|yes||History of Panretinal Photocoagulation||participants|Number|13|13.0||||||
3956547|NCT01331005|3778751|B1|yes||History of Panretinal Photocoagulation||participants|Number|11|11.0||||||
3956548|NCT01331005|3778749|B3|no||History of Diabetic Macular Edema Treatment||participants|Number|67|67.0||||||
3956549|NCT01331005|3778750|B2|no||History of Diabetic Macular Edema Treatment||participants|Number|31|31.0||||||
3956550|NCT01331005|3778751|B1|no||History of Diabetic Macular Edema Treatment||participants|Number|36|36.0||||||
3956551|NCT01331005|3778749|B3|yes||History of Diabetic Macular Edema Treatment||participants|Number|58|58.0||||||
3956552|NCT01331005|3778750|B2|yes||History of Diabetic Macular Edema Treatment||participants|Number|30|30.0||||||
3956553|NCT01331005|3778751|B1|yes||History of Diabetic Macular Edema Treatment||participants|Number|28|28.0||||||
3956554|NCT01331005|3778749|B3|||Electronic-Early Treatment Diabetic Retinopathy Study Visual Acuity Letter Score|Visual acuity was measured with the E-ETDRS method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|units on a scale|Mean|83|83.0|Standard Deviation|7|7.0|||
3956555|NCT01331005|3778750|B2|||Electronic-Early Treatment Diabetic Retinopathy Study Visual Acuity Letter Score|Visual acuity was measured with the E-ETDRS method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|units on a scale|Mean|82|82.0|Standard Deviation|6|6.0|||
3956556|NCT01331005|3778751|B1|||Electronic-Early Treatment Diabetic Retinopathy Study Visual Acuity Letter Score|Visual acuity was measured with the E-ETDRS method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|units on a scale|Mean|83|83.0|Standard Deviation|7|7.0|||
3956557|NCT01331005|3778749|B3|||Hemoglobin A1c||Percent HbA1c|Median|7.9|7.9|Inter-Quartile Range|||7.1|9.0|
3956558|NCT01331005|3778750|B2|||Hemoglobin A1c||Percent HbA1c|Median|8.1|8.1|Inter-Quartile Range|||7.1|8.7|
3956559|NCT01331005|3778751|B1|||Hemoglobin A1c||Percent HbA1c|Median|7.9|7.9|Inter-Quartile Range|||7.2|10.0|
3956560|NCT01331005|3778749|B3|||Duration of Diabetes||years|Mean|18|18.0|Standard Deviation|11|11.0|||
3956561|NCT01331005|3778750|B2|||Duration of Diabetes||years|Mean|19|19.0|Standard Deviation|11|11.0|||
3956562|NCT01331005|3778751|B1|||Duration of Diabetes||years|Mean|17|17.0|Standard Deviation|11|11.0|||
3956563|NCT01331005|3778749|B3|Uncertain||Type of Diabetes||participants|Number|6|6.0||||||
3956564|NCT01331005|3778750|B2|Uncertain||Type of Diabetes||participants|Number|3|3.0||||||
3956565|NCT01331005|3778751|B1|Uncertain||Type of Diabetes||participants|Number|3|3.0||||||
3956566|NCT01331005|3778749|B3|Type 2||Type of Diabetes||participants|Number|109|109.0||||||
3956567|NCT01331005|3778750|B2|Type 2||Type of Diabetes||participants|Number|53|53.0||||||
3956568|NCT01331005|3778751|B1|Type 2||Type of Diabetes||participants|Number|56|56.0||||||
3956569|NCT01331005|3778749|B3|Type 1||Type of Diabetes||participants|Number|10|10.0||||||
3956570|NCT01331005|3778750|B2|Type 1||Type of Diabetes||participants|Number|5|5.0||||||
3956571|NCT01331005|3778751|B1|Type 1||Type of Diabetes||participants|Number|5|5.0||||||
3956572|NCT01331005|3778749|B3|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3956573|NCT01331005|3778750|B2|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3956574|NCT01331005|3778751|B1|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3956575|NCT01331005|3778749|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3956576|NCT01331005|3778750|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3956577|NCT01331005|3778751|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3956578|NCT01331005|3778749|B3|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3956579|NCT01331005|3778750|B2|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3956580|NCT01331005|3778751|B1|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3956581|NCT01331005|3778749|B3|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3956582|NCT01331005|3778750|B2|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3956583|NCT01331005|3778751|B1|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3956584|NCT01331005|3778749|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3956585|NCT01331005|3778750|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3956586|NCT01331005|3778751|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3956587|NCT01331005|3778749|B3|African American||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3956588|NCT01331005|3778750|B2|African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3956589|NCT01331005|3778751|B1|African American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3956590|NCT01331005|3778749|B3|White||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
3956591|NCT01331005|3778750|B2|White||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
3956592|NCT01331005|3778751|B1|White||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
3956593|NCT01331005|3778749|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3956594|NCT01331005|3778750|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3956595|NCT01331005|3778751|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3956596|NCT01331005|3778749|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3956597|NCT01331005|3778750|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3956598|NCT01331005|3778751|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3956599|NCT01331005|3778749|B3|||Age, Customized||years|Median|60|60.0|Inter-Quartile Range|||51.0|67.0|
3956600|NCT01331005|3778750|B2|||Age, Customized||years|Median|60|60.0|Inter-Quartile Range|||52.0|68.0|
3956601|NCT01331005|3778751|B1|||Age, Customized||years|Median|59|59.0|Inter-Quartile Range|||51.0|66.0|
3956602|NCT01330953|3778762|B6|Singapore||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3956603|NCT01330953|3778763|B5|Singapore||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3956604|NCT01330953|3778764|B4|Singapore||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3956605|NCT01330953|3778765|B3|Singapore||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3956606|NCT01330953|3778766|B2|Singapore||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3956607|NCT01330953|3778767|B1|Singapore||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3956608|NCT01330953|3778762|B6|Asian||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3956609|NCT01330953|3778763|B5|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3956610|NCT01330953|3778764|B4|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3956611|NCT01330953|3778765|B3|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3956612|NCT01330953|3778766|B2|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3956613|NCT01330953|3778767|B1|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3956614|NCT01330953|3778762|B6||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3956615|NCT01330953|3778763|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3956616|NCT01330953|3778764|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3956617|NCT01330953|3778765|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3956618|NCT01330953|3778766|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3956619|NCT01330953|3778767|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3956620|NCT01330953|3778762|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3956621|NCT01330953|3778763|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3956622|NCT01330953|3778764|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3956623|NCT01330953|3778765|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3956624|NCT01330953|3778766|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3956625|NCT01330953|3778767|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3956626|NCT01330953|3778762|B6|||Age||years|Mean|33.7|33.7|Standard Deviation|11.5|11.5|||
3956627|NCT01330953|3778763|B5|||Age||years|Mean|27.0|27.0|Standard Deviation|6.1|6.1|||
3956628|NCT01330953|3778764|B4|||Age||years|Mean|40.2|40.2|Standard Deviation|11.7|11.7|||
3956629|NCT01330953|3778765|B3|||Age||years|Mean|31.0|31.0|Standard Deviation|6.3|6.3|||
3956630|NCT01330953|3778766|B2|||Age||years|Mean|33.5|33.5|Standard Deviation|14.8|14.8|||
3956631|NCT01330953|3778767|B1|||Age||years|Mean|36.0|36.0|Standard Deviation|13.8|13.8|||
3956632|NCT01330914|3778817|B1|||Spine volumetric bone mineral density (QCT)||g/cm3|Mean|0.159|0.159|Standard Deviation|0.036|0.036|||
3956633|NCT01330914|3778817|B1|||Femoral neck areal bone mineral density (DXA)||g/cm2|Mean|0.949|0.949|Standard Deviation|0.133|0.133|||
3956634|NCT01330914|3778817|B1|Not diabetic||Diabetes status||participants|Number|33|33.0||||||
3956635|NCT01330914|3778817|B1|Diabetic||Diabetes status||participants|Number|22|22.0||||||
3956636|NCT01330914|3778817|B1|||Percentage body fat||percentage of body fat|Mean|46.7|46.7|Standard Deviation|5.9|5.9|||
3956637|NCT01330914|3778817|B1|||Body mass index||kg/m2|Mean|44.2|44.2|Standard Deviation|7.0|7.0|||
3956638|NCT01330914|3778817|B1|||Weight||kg|Mean|122.7|122.7|Standard Deviation|19.3|19.3|||
3956639|NCT01330914|3778817|B1|N/A (Men)||Menopausal status||participants|Number|11|11.0||||||
3956640|NCT01330914|3778817|B1|Postmenopausal||Menopausal status||participants|Number|14|14.0||||||
3956641|NCT01330914|3778817|B1|Premenopausal||Menopausal status||participants|Number|30|30.0||||||
3956642|NCT01330914|3778817|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
3956643|NCT01330914|3778817|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956644|NCT01330914|3778817|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956645|NCT01330914|3778817|B1||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3956646|NCT01330914|3778817|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3956647|NCT01330914|3778817|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3956648|NCT01330914|3778817|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3956649|NCT01330914|3778817|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3956650|NCT01330914|3778817|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956651|NCT01330914|3778817|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3956652|NCT01330914|3778817|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3956653|NCT01330914|3778817|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3956654|NCT01330914|3778817|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3956655|NCT01330914|3778817|B1|||Age||years|Mean|45.8|45.8|Standard Deviation|11.2|11.2|||
3956656|NCT01330628|3778821|B3|United States||Region of Enrollment||participants|Number|252|252.0||||||
3956657|NCT01330628|3778822|B2|United States||Region of Enrollment||participants|Number|82|82.0||||||
3956658|NCT01330628|3778823|B1|United States||Region of Enrollment||participants|Number|170|170.0||||||
3956659|NCT01330628|3778821|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956660|NCT01330628|3778822|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956661|NCT01330628|3778823|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956662|NCT01330628|3778821|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3956663|NCT01330628|3778822|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956664|NCT01330628|3778823|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3956665|NCT01330628|3778821|B3||White|Race (NIH/OMB)||Participants|Count of Participants|218|218.0||||||
3956666|NCT01330628|3778822|B2||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3956667|NCT01330628|3778823|B1||White|Race (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
3956668|NCT01330628|3778821|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3956669|NCT01330628|3778822|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3956670|NCT01330628|3778823|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3956671|NCT01330628|3778821|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3956672|NCT01330628|3778822|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956673|NCT01330628|3778823|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3956674|NCT01330628|3778821|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3956675|NCT01330628|3778822|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956676|NCT01330628|3778823|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3956677|NCT01330628|3778821|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956678|NCT01330628|3778822|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956679|NCT01330628|3778823|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956680|NCT01330628|3778821|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956681|NCT01330628|3778822|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956682|NCT01330628|3778823|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956683|NCT01330628|3778821|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|219|219.0||||||
3956684|NCT01330628|3778822|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3956685|NCT01330628|3778823|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|149|149.0||||||
3956686|NCT01330628|3778821|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3956687|NCT01330628|3778822|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3956688|NCT01330628|3778823|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3956689|NCT01330628|3778821|B3||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3956690|NCT01330628|3778822|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3956691|NCT01330628|3778823|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3956692|NCT01330628|3778821|B3||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3956693|NCT01330628|3778822|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3956694|NCT01330628|3778823|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3956695|NCT01330628|3778821|B3|||Age||years|Mean|68.4|68.4|Standard Deviation|9.9|9.9|||
3956696|NCT01330628|3778822|B2|||Age||years|Mean|67.9|67.9|Standard Deviation|10.3|10.3|||
3956697|NCT01330628|3778823|B1|||Age||years|Mean|68.6|68.6|Standard Deviation|9.8|9.8|||
3956698|NCT01330433|3778832|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
3956699|NCT01330433|3778833|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3956700|NCT01330433|3778834|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3956701|NCT01330433|3778832|B3||Male|Gender||Participants|Count of Participants|26|26.0||||||
3956702|NCT01330433|3778833|B2||Male|Gender||Participants|Count of Participants|12|12.0||||||
3956703|NCT01330433|3778834|B1||Male|Gender||Participants|Count of Participants|14|14.0||||||
3956704|NCT01330433|3778832|B3||Female|Gender||Participants|Count of Participants|9|9.0||||||
3956705|NCT01330433|3778833|B2||Female|Gender||Participants|Count of Participants|7|7.0||||||
3956706|NCT01330433|3778834|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
3956707|NCT01330433|3778832|B3|||Age||years|Mean|1|1.0|Full Range|||0.0|2.0|
3956708|NCT01330433|3778833|B2|||Age||years|Mean|1|1.0|Full Range|||0.0|2.0|
3956709|NCT01330433|3778834|B1|||Age||years|Mean|1|1.0|Full Range|||0.0|2.0|
3956710|NCT01330433|3778832|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3956711|NCT01330433|3778833|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3956712|NCT01330433|3778834|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3956713|NCT01330433|3778832|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3956714|NCT01330433|3778833|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3956715|NCT01330433|3778834|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3956716|NCT01330433|3778832|B3||<=18 years|Age||Participants|Count of Participants|35|35.0||||||
3956717|NCT01330433|3778833|B2||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
3956718|NCT01330433|3778834|B1||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
3956719|NCT01330420|3778855|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
3956720|NCT01330420|3778855|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3956721|NCT01330420|3778855|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3956722|NCT01330420|3778855|B1|||Age||years|Mean|50.2|50.2|Standard Deviation|13.0|13.0|||
3956723|NCT01330420|3778855|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3956724|NCT01330420|3778855|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3956725|NCT01330420|3778855|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3956726|NCT01330394|3778863|B3|Brazil||Region of Enrollment||participants|Number|33|33.0||||||
3956727|NCT01330394|3778864|B2|Brazil||Region of Enrollment||participants|Number|16|16.0||||||
3956728|NCT01330394|3778865|B1|Brazil||Region of Enrollment||participants|Number|17|17.0||||||
3956729|NCT01330394|3778863|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3956730|NCT01330394|3778864|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3956731|NCT01330394|3778865|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3956732|NCT01330394|3778863|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3956733|NCT01330394|3778864|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3956734|NCT01330394|3778865|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3956735|NCT01330394|3778863|B3|||Age||years|Mean|44.1|44.1|Standard Deviation|8.6|8.6|||
3956736|NCT01330394|3778864|B2|||Age||years|Mean|44.0|44.0|Standard Deviation|7.8|7.8|||
3956737|NCT01330394|3778865|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|8.9|8.9|||
3956738|NCT01330394|3778863|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3956739|NCT01330394|3778864|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3956740|NCT01330394|3778865|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3956741|NCT01330394|3778863|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3956742|NCT01330394|3778864|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3956743|NCT01330394|3778865|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3956744|NCT01330394|3778863|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3956745|NCT01330394|3778864|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3956746|NCT01330394|3778865|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3956747|NCT01330381|3778872|B3|Italy||Region of Enrollment||participants|Number|3|3.0||||||
3956748|NCT01330381|3778873|B2|Italy||Region of Enrollment||participants|Number|1|1.0||||||
3956749|NCT01330381|3778874|B1|Italy||Region of Enrollment||participants|Number|2|2.0||||||
3956750|NCT01330381|3778872|B3|France||Region of Enrollment||participants|Number|4|4.0||||||
3956751|NCT01330381|3778873|B2|France||Region of Enrollment||participants|Number|2|2.0||||||
3956752|NCT01330381|3778874|B1|France||Region of Enrollment||participants|Number|2|2.0||||||
3956753|NCT01330381|3778872|B3|Germany||Region of Enrollment||participants|Number|7|7.0||||||
3956754|NCT01330381|3778873|B2|Germany||Region of Enrollment||participants|Number|6|6.0||||||
3956755|NCT01330381|3778874|B1|Germany||Region of Enrollment||participants|Number|1|1.0||||||
3956756|NCT01330381|3778872|B3|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
3956757|NCT01330381|3778873|B2|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
3956758|NCT01330381|3778874|B1|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
3956759|NCT01330381|3778872|B3|United Kingdom||Region of Enrollment||participants|Number|20|20.0||||||
3956760|NCT01330381|3778873|B2|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
3956761|NCT01330381|3778874|B1|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
3956762|NCT01330381|3778872|B3|Poland||Region of Enrollment||participants|Number|46|46.0||||||
3956763|NCT01330381|3778873|B2|Poland||Region of Enrollment||participants|Number|23|23.0||||||
3956764|NCT01330381|3778874|B1|Poland||Region of Enrollment||participants|Number|23|23.0||||||
3956765|NCT01330381|3778872|B3|Netherlands||Region of Enrollment||participants|Number|51|51.0||||||
3956766|NCT01330381|3778873|B2|Netherlands||Region of Enrollment||participants|Number|26|26.0||||||
3956767|NCT01330381|3778874|B1|Netherlands||Region of Enrollment||participants|Number|25|25.0||||||
3956768|NCT01330381|3778872|B3|Hungary||Region of Enrollment||participants|Number|74|74.0||||||
3956769|NCT01330381|3778873|B2|Hungary||Region of Enrollment||participants|Number|35|35.0||||||
3956770|NCT01330381|3778874|B1|Hungary||Region of Enrollment||participants|Number|39|39.0||||||
3956771|NCT01330381|3778872|B3||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3956772|NCT01330381|3778873|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3956773|NCT01330381|3778874|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3956774|NCT01330381|3778872|B3||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3956775|NCT01330381|3778873|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3956776|NCT01330381|3778874|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3956777|NCT01330381|3778872|B3|||Age||years|Mean|8.3|8.3|Standard Deviation|4.61|4.61|||
3956778|NCT01330381|3778873|B2|||Age||years|Mean|8.2|8.2|Standard Deviation|4.69|4.69|||
3956779|NCT01330381|3778874|B1|||Age||years|Mean|8.3|8.3|Standard Deviation|4.54|4.54|||
3956780|NCT01330381|3778872|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3956781|NCT01330381|3778873|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3956782|NCT01330381|3778874|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3956783|NCT01330381|3778872|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3956784|NCT01330381|3778873|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3956785|NCT01330381|3778874|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3956786|NCT01330381|3778872|B3||<=18 years|Age||Participants|Count of Participants|213|213.0||||||
3956787|NCT01330381|3778873|B2||<=18 years|Age||Participants|Count of Participants|107|107.0||||||
3956788|NCT01330381|3778874|B1||<=18 years|Age||Participants|Count of Participants|106|106.0||||||
3956789|NCT01330355|3778920|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3956790|NCT01330355|3778921|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3956791|NCT01330355|3778922|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3956792|NCT01330355|3778920|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956793|NCT01330355|3778921|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956794|NCT01330355|3778922|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956795|NCT01330355|3778920|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3956796|NCT01330355|3778921|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3956797|NCT01330355|3778922|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3956798|NCT01330355|3778920|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3956799|NCT01330355|3778921|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3956800|NCT01330355|3778922|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956801|NCT01330355|3778920|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956802|NCT01330355|3778921|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956803|NCT01330355|3778922|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956804|NCT01330355|3778920|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3956805|NCT01330355|3778921|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3956806|NCT01330355|3778922|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3956807|NCT01330355|3778920|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956808|NCT01330355|3778921|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956809|NCT01330355|3778922|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956810|NCT01330355|3778920|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3956811|NCT01330355|3778921|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3956812|NCT01330355|3778922|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3956813|NCT01330355|3778920|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3956814|NCT01330355|3778921|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3956815|NCT01330355|3778922|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3956816|NCT01330355|3778920|B3|||Age||days|Median|14|14.0|Full Range|||5.0|26.0|
3956817|NCT01330355|3778921|B2|||Age||days|Median|14|14.0|Full Range|||5.0|25.0|
3956818|NCT01330355|3778922|B1|||Age||days|Median|17|17.0|Full Range|||6.0|26.0|
3956819|NCT01330316|3778935|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3956820|NCT01330316|3778936|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3956821|NCT01330316|3778937|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3956822|NCT01330316|3778935|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3956823|NCT01330316|3778936|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3956824|NCT01330316|3778937|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3956825|NCT01330316|3778935|B3|||Age||years|Mean|54.1|54.1|Standard Deviation|8.78|8.78|||
3956826|NCT01330316|3778936|B2|||Age||years|Mean|53.4|53.4|Standard Deviation|9.46|9.46|||
3956827|NCT01330316|3778937|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|7.38|7.38|||
3956828|NCT01330303|3778974|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3956829|NCT01330303|3778974|B1|Mulatto||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3956830|NCT01330303|3778974|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3956831|NCT01330303|3778974|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3956832|NCT01330303|3778974|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3956833|NCT01330303|3778974|B1|||Age||Years|Mean|30.20|30.2|Standard Deviation|7.36|7.36|||
3956834|NCT01330290|3778985|B1|Missing||Type of care-giving: Patient lives at nursing home||participants|Number|24|24.0||||||
3956835|NCT01330290|3778985|B1|Yes||Type of care-giving: Patient lives at nursing home||participants|Number|16|16.0||||||
3956836|NCT01330290|3778985|B1|No||Type of care-giving: Patient lives at nursing home||participants|Number|108|108.0||||||
3956837|NCT01330290|3778985|B1|||Height||centimeters|Mean|168.39|168.39|Standard Deviation|10.28|10.28|||
3956838|NCT01330290|3778985|B1|||Weight||kilogram|Mean|73.43|73.43|Standard Deviation|14.71|14.71|||
3956839|NCT01330290|3778985|B1|Germany||Region of Enrollment||participants|Number|148|148.0||||||
3956840|NCT01330290|3778985|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3956841|NCT01330290|3778985|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3956842|NCT01330290|3778985|B1|||Age||years|Mean|74.61|74.61|Standard Deviation|8.26|8.26|||
3956843|NCT01330290|3778985|B1||>=65 years|Age||Participants|Count of Participants|131|131.0||||||
3956844|NCT01330290|3778985|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3956845|NCT01330290|3778985|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3956846|NCT01330134|3779009|B3|other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3956847|NCT01330134|3779010|B2|other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3956848|NCT01330134|3779011|B1|other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3956849|NCT01330134|3779009|B3|asian||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3956850|NCT01330134|3779010|B2|asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3956851|NCT01330134|3779011|B1|asian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3956852|NCT01330134|3779009|B3|african american||Race/Ethnicity, Customized||Participants|Count of Participants|184|184.0||||||
3956853|NCT01330134|3779010|B2|african american||Race/Ethnicity, Customized||Participants|Count of Participants|94|94.0||||||
3956854|NCT01330134|3779011|B1|african american||Race/Ethnicity, Customized||Participants|Count of Participants|90|90.0||||||
3956855|NCT01330134|3779009|B3|white, hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3956856|NCT01330134|3779010|B2|white, hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3956857|NCT01330134|3779011|B1|white, hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3956858|NCT01330134|3779009|B3|white, nonhispanic||Race/Ethnicity, Customized||Participants|Count of Participants|259|259.0||||||
3956859|NCT01330134|3779010|B2|white, nonhispanic||Race/Ethnicity, Customized||Participants|Count of Participants|123|123.0||||||
3956860|NCT01330134|3779011|B1|white, nonhispanic||Race/Ethnicity, Customized||Participants|Count of Participants|136|136.0||||||
3956861|NCT01330134|3779009|B3||Male|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
3956862|NCT01330134|3779010|B2||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3956863|NCT01330134|3779011|B1||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3956864|NCT01330134|3779009|B3||Female|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
3956865|NCT01330134|3779010|B2||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3956866|NCT01330134|3779011|B1||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3956867|NCT01330134|3779009|B3|||Age||years|Mean|57.4|57.4|Inter-Quartile Range|||45.2|67.4|
3956868|NCT01330134|3779010|B2|||Age||years|Mean|56.8|56.8|Inter-Quartile Range|||44.8|65.4|
3956869|NCT01330134|3779011|B1|||Age||years|Mean|58.5|58.5|Inter-Quartile Range|||46.4|68.6|
3956870|NCT01330108|3779022|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
3956871|NCT01330108|3779022|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956872|NCT01330108|3779022|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956873|NCT01330108|3779022|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3956874|NCT01330108|3779022|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3956875|NCT01330108|3779022|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956876|NCT01330108|3779022|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956877|NCT01330108|3779022|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3956878|NCT01330108|3779022|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3956879|NCT01330108|3779022|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3956880|NCT01330108|3779022|B1|||Age||years|Mean|52.6|52.6|Standard Deviation|12.9|12.9|||
3956881|NCT01330043|3779027|B3|United States||Region of Enrollment||participants|Number|223|223.0||||||
3956882|NCT01330043|3779028|B2|United States||Region of Enrollment||participants|Number|112|112.0||||||
3956883|NCT01330043|3779029|B1|United States||Region of Enrollment||participants|Number|111|111.0||||||
3956884|NCT01330043|3779027|B3||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3956885|NCT01330043|3779028|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3956886|NCT01330043|3779029|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3956887|NCT01330043|3779027|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3956888|NCT01330043|3779028|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3956889|NCT01330043|3779029|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3956890|NCT01330043|3779027|B3|||Age||years|Mean|43|43.0|Standard Deviation|12|12.0|||
3956891|NCT01330043|3779028|B2|||Age||years|Mean|43|43.0|Standard Deviation|12|12.0|||
3956892|NCT01330043|3779029|B1|||Age||years|Mean|42|42.0|Standard Deviation|12|12.0|||
3956893|NCT01330030|3779038|B3|United States||Region of Enrollment||participants|Number|243|243.0||||||
3956894|NCT01330030|3779039|B2|United States||Region of Enrollment||participants|Number|122|122.0||||||
3956895|NCT01330030|3779040|B1|United States||Region of Enrollment||participants|Number|121|121.0||||||
3956896|NCT01330030|3779038|B3||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3956897|NCT01330030|3779039|B2||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3956898|NCT01330030|3779040|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3956899|NCT01330030|3779038|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3956900|NCT01330030|3779039|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3956901|NCT01330030|3779040|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3956902|NCT01330030|3779038|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3956903|NCT01330030|3779039|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3956904|NCT01330030|3779040|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3956905|NCT01330030|3779038|B3||Between 18 and 65 years|Age||Participants|Count of Participants|243|243.0||||||
3956906|NCT01330030|3779039|B2||Between 18 and 65 years|Age||Participants|Count of Participants|122|122.0||||||
3956907|NCT01330030|3779040|B1||Between 18 and 65 years|Age||Participants|Count of Participants|121|121.0||||||
3956908|NCT01330030|3779038|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3956909|NCT01330030|3779039|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3956910|NCT01330030|3779040|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3956911|NCT01330017|3779047|B6||Male|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
3956912|NCT01330017|3779048|B5||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3956913|NCT01330017|3779049|B4||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3956914|NCT01330017|3779050|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3956915|NCT01330017|3779051|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3956916|NCT01330017|3779052|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3956917|NCT01330017|3779047|B6||Female|Sex: Female, Male||Participants|Count of Participants|325|325.0||||||
3956918|NCT01330017|3779048|B5||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3956919|NCT01330017|3779049|B4||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3956920|NCT01330017|3779050|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3956921|NCT01330017|3779051|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3956922|NCT01330017|3779052|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3956923|NCT01330017|3779047|B6|||Age||years|Mean|38.7|38.7|Standard Deviation|12.04|12.04|||
3956924|NCT01330017|3779048|B5|||Age||years|Mean|38.9|38.9|Standard Deviation|11.96|11.96|||
3956925|NCT01330017|3779049|B4|||Age||years|Mean|39.6|39.6|Standard Deviation|13.10|13.1|||
3956926|NCT01330017|3779050|B3|||Age||years|Mean|38.9|38.9|Standard Deviation|12.65|12.65|||
3956927|NCT01330017|3779051|B2|||Age||years|Mean|36.8|36.8|Standard Deviation|11.08|11.08|||
3956928|NCT01330017|3779052|B1|||Age||years|Mean|39.3|39.3|Standard Deviation|11.25|11.25|||
3956929|NCT01329978|3779102|B4|TT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|60|60.0||||||
3956930|NCT01329978|3779103|B3|TT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|28|28.0||||||
3956931|NCT01329978|3779104|B2|TT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|26|26.0||||||
3956932|NCT01329978|3779105|B1|TT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|6|6.0||||||
3956933|NCT01329978|3779102|B4|CT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|184|184.0||||||
3956934|NCT01329978|3779103|B3|CT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|88|88.0||||||
3956935|NCT01329978|3779104|B2|CT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|63|63.0||||||
3956936|NCT01329978|3779105|B1|CT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|33|33.0||||||
3956937|NCT01329978|3779102|B4|CC||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|88|88.0||||||
3956938|NCT01329978|3779103|B3|CC||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|39|39.0||||||
3956939|NCT01329978|3779104|B2|CC||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|36|36.0||||||
3956940|NCT01329978|3779105|B1|CC||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|13|13.0||||||
3956941|NCT01329978|3779102|B4|> 1.5 × ULN||ALT Category|The ULN for ALT was 60 IU/mL before March 26, 2012, then 56 IU/mL (males) and 45 IU/mL (females).|participants|Number|93|93.0||||||
3956942|NCT01329978|3779103|B3|> 1.5 × ULN||ALT Category|The ULN for ALT was 60 IU/mL before March 26, 2012, then 56 IU/mL (males) and 45 IU/mL (females).|participants|Number|40|40.0||||||
3956943|NCT01329978|3779104|B2|> 1.5 × ULN||ALT Category|The ULN for ALT was 60 IU/mL before March 26, 2012, then 56 IU/mL (males) and 45 IU/mL (females).|participants|Number|38|38.0||||||
3956944|NCT01329978|3779105|B1|> 1.5 × ULN||ALT Category|The ULN for ALT was 60 IU/mL before March 26, 2012, then 56 IU/mL (males) and 45 IU/mL (females).|participants|Number|15|15.0||||||
3956945|NCT01329978|3779102|B4|≤ 1.5 × the upper limit of the normal range (ULN)||ALT Category|The ULN for ALT was 60 IU/mL before March 26, 2012, then 56 IU/mL (males) and 45 IU/mL (females).|participants|Number|239|239.0||||||
3956946|NCT01329978|3779103|B3|≤ 1.5 × the upper limit of the normal range (ULN)||ALT Category|The ULN for ALT was 60 IU/mL before March 26, 2012, then 56 IU/mL (males) and 45 IU/mL (females).|participants|Number|115|115.0||||||
3956947|NCT01329978|3779104|B2|≤ 1.5 × the upper limit of the normal range (ULN)||ALT Category|The ULN for ALT was 60 IU/mL before March 26, 2012, then 56 IU/mL (males) and 45 IU/mL (females).|participants|Number|87|87.0||||||
3956948|NCT01329978|3779105|B1|≤ 1.5 × the upper limit of the normal range (ULN)||ALT Category|The ULN for ALT was 60 IU/mL before March 26, 2012, then 56 IU/mL (males) and 45 IU/mL (females).|participants|Number|37|37.0||||||
3956949|NCT01329978|3779102|B4|||Alanine Aminotransferase (ALT)||U/L|Mean|79.8|79.8|Standard Deviation|66.98|66.98|||
3956950|NCT01329978|3779103|B3|||Alanine Aminotransferase (ALT)||U/L|Mean|76.4|76.4|Standard Deviation|55.91|55.91|||
3956951|NCT01329978|3779104|B2|||Alanine Aminotransferase (ALT)||U/L|Mean|83.7|83.7|Standard Deviation|77.18|77.18|||
3956952|NCT01329978|3779105|B1|||Alanine Aminotransferase (ALT)||U/L|Mean|80.5|80.5|Standard Deviation|71.61|71.61|||
3956953|NCT01329978|3779102|B4|Portal Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|228|228.0||||||
3956954|NCT01329978|3779103|B3|Portal Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|99|99.0||||||
3956955|NCT01329978|3779104|B2|Portal Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|93|93.0||||||
3956956|NCT01329978|3779105|B1|Portal Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|36|36.0||||||
3956957|NCT01329978|3779102|B4|None or Minimal Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|43|43.0||||||
3956958|NCT01329978|3779103|B3|None or Minimal Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|20|20.0||||||
3956959|NCT01329978|3779104|B2|None or Minimal Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|14|14.0||||||
3956960|NCT01329978|3779105|B1|None or Minimal Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|9|9.0||||||
3956961|NCT01329978|3779102|B4|Bridging Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|47|47.0||||||
3956962|NCT01329978|3779103|B3|Bridging Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|23|23.0||||||
3956963|NCT01329978|3779104|B2|Bridging Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|17|17.0||||||
3956964|NCT01329978|3779105|B1|Bridging Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|7|7.0||||||
3956965|NCT01329978|3779102|B4|Missing||Liver Biopsy Fibrosis Score||participants|Number|14|14.0||||||
3956966|NCT01329978|3779103|B3|Missing||Liver Biopsy Fibrosis Score||participants|Number|13|13.0||||||
3956967|NCT01329978|3779104|B2|Missing||Liver Biopsy Fibrosis Score||participants|Number|1|1.0||||||
3956968|NCT01329978|3779105|B1|Missing||Liver Biopsy Fibrosis Score||participants|Number|0|0.0||||||
3956969|NCT01329978|3779102|B4|> 800,000 IU/mL||HCV RNA Category||participants|Number|264|264.0||||||
3956970|NCT01329978|3779103|B3|> 800,000 IU/mL||HCV RNA Category||participants|Number|127|127.0||||||
3956971|NCT01329978|3779104|B2|> 800,000 IU/mL||HCV RNA Category||participants|Number|92|92.0||||||
3956972|NCT01329978|3779105|B1|> 800,000 IU/mL||HCV RNA Category||participants|Number|45|45.0||||||
3956973|NCT01329978|3779102|B4|< 800,000 IU/mL||HCV RNA Category||participants|Number|68|68.0||||||
3956974|NCT01329978|3779103|B3|< 800,000 IU/mL||HCV RNA Category||participants|Number|28|28.0||||||
3956975|NCT01329978|3779104|B2|< 800,000 IU/mL||HCV RNA Category||participants|Number|33|33.0||||||
3956976|NCT01329978|3779105|B1|< 800,000 IU/mL||HCV RNA Category||participants|Number|7|7.0||||||
3956977|NCT01329978|3779102|B4|||HCV RNA||log10 copies/mL|Mean|6.4|6.4|Standard Deviation|0.75|0.75|||
3956978|NCT01329978|3779103|B3|||HCV RNA||log10 copies/mL|Mean|6.4|6.4|Standard Deviation|0.79|0.79|||
3956979|NCT01329978|3779104|B2|||HCV RNA||log10 copies/mL|Mean|6.3|6.3|Standard Deviation|0.73|0.73|||
3956980|NCT01329978|3779105|B1|||HCV RNA||log10 copies/mL|Mean|6.5|6.5|Standard Deviation|0.66|0.66|||
3957009|NCT01329978|3779102|B4|Black||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3956981|NCT01329978|3779102|B4|Genotype 6o||Hepatitis C Virus (HCV) genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes 1 (a or b), 2, 3, 4, 5, or 6 (e or o).|participants|Number|1|1.0||||||
3956982|NCT01329978|3779103|B3|Genotype 6o||Hepatitis C Virus (HCV) genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes 1 (a or b), 2, 3, 4, 5, or 6 (e or o).|participants|Number|0|0.0||||||
3956983|NCT01329978|3779104|B2|Genotype 6o||Hepatitis C Virus (HCV) genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes 1 (a or b), 2, 3, 4, 5, or 6 (e or o).|participants|Number|1|1.0||||||
3956984|NCT01329978|3779105|B1|Genotype 6o||Hepatitis C Virus (HCV) genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes 1 (a or b), 2, 3, 4, 5, or 6 (e or o).|participants|Number|0|0.0||||||
3956985|NCT01329978|3779102|B4|Genotype 6e||Hepatitis C Virus (HCV) genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes 1 (a or b), 2, 3, 4, 5, or 6 (e or o).|participants|Number|2|2.0||||||
3956986|NCT01329978|3779103|B3|Genotype 6e||Hepatitis C Virus (HCV) genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes 1 (a or b), 2, 3, 4, 5, or 6 (e or o).|participants|Number|0|0.0||||||
3956987|NCT01329978|3779104|B2|Genotype 6e||Hepatitis C Virus (HCV) genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes 1 (a or b), 2, 3, 4, 5, or 6 (e or o).|participants|Number|2|2.0||||||
3956988|NCT01329978|3779105|B1|Genotype 6e||Hepatitis C Virus (HCV) genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes 1 (a or b), 2, 3, 4, 5, or 6 (e or o).|participants|Number|0|0.0||||||
3956989|NCT01329978|3779102|B4|Genotype 6||Hepatitis C Virus (HCV) genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes 1 (a or b), 2, 3, 4, 5, or 6 (e or o).|participants|Number|2|2.0||||||
3956990|NCT01329978|3779103|B3|Genotype 6||Hepatitis C Virus (HCV) genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes 1 (a or b), 2, 3, 4, 5, or 6 (e or o).|participants|Number|0|0.0||||||
3956991|NCT01329978|3779104|B2|Genotype 6||Hepatitis C Virus (HCV) genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes 1 (a or b), 2, 3, 4, 5, or 6 (e or o).|participants|Number|2|2.0||||||
3956992|NCT01329978|3779105|B1|Genotype 6||Hepatitis C Virus (HCV) genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes 1 (a or b), 2, 3, 4, 5, or 6 (e or o).|participants|Number|0|0.0||||||
3956993|NCT01329978|3779102|B4|Genotype 4||Hepatitis C Virus (HCV) genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes 1 (a or b), 2, 3, 4, 5, or 6 (e or o).|participants|Number|11|11.0||||||
3956994|NCT01329978|3779103|B3|Genotype 4||Hepatitis C Virus (HCV) genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes 1 (a or b), 2, 3, 4, 5, or 6 (e or o).|participants|Number|0|0.0||||||
3956995|NCT01329978|3779104|B2|Genotype 4||Hepatitis C Virus (HCV) genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes 1 (a or b), 2, 3, 4, 5, or 6 (e or o).|participants|Number|11|11.0||||||
3956996|NCT01329978|3779105|B1|Genotype 4||Hepatitis C Virus (HCV) genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes 1 (a or b), 2, 3, 4, 5, or 6 (e or o).|participants|Number|0|0.0||||||
3956997|NCT01329978|3779102|B4|Genotype 1b||Hepatitis C Virus (HCV) genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes 1 (a or b), 2, 3, 4, 5, or 6 (e or o).|participants|Number|75|75.0||||||
3956998|NCT01329978|3779103|B3|Genotype 1b||Hepatitis C Virus (HCV) genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes 1 (a or b), 2, 3, 4, 5, or 6 (e or o).|participants|Number|39|39.0||||||
3956999|NCT01329978|3779104|B2|Genotype 1b||Hepatitis C Virus (HCV) genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes 1 (a or b), 2, 3, 4, 5, or 6 (e or o).|participants|Number|24|24.0||||||
3957000|NCT01329978|3779105|B1|Genotype 1b||Hepatitis C Virus (HCV) genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes 1 (a or b), 2, 3, 4, 5, or 6 (e or o).|participants|Number|12|12.0||||||
3957001|NCT01329978|3779102|B4|Genotype 1a||Hepatitis C Virus (HCV) genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes 1 (a or b), 2, 3, 4, 5, or 6 (e or o).|participants|Number|241|241.0||||||
3957002|NCT01329978|3779103|B3|Genotype 1a||Hepatitis C Virus (HCV) genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes 1 (a or b), 2, 3, 4, 5, or 6 (e or o).|participants|Number|116|116.0||||||
3957003|NCT01329978|3779104|B2|Genotype 1a||Hepatitis C Virus (HCV) genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes 1 (a or b), 2, 3, 4, 5, or 6 (e or o).|participants|Number|85|85.0||||||
3957004|NCT01329978|3779105|B1|Genotype 1a||Hepatitis C Virus (HCV) genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes 1 (a or b), 2, 3, 4, 5, or 6 (e or o).|participants|Number|40|40.0||||||
3957005|NCT01329978|3779102|B4|Not Black||Race/Ethnicity, Customized||participants|Number|297|297.0||||||
3957006|NCT01329978|3779103|B3|Not Black||Race/Ethnicity, Customized||participants|Number|139|139.0||||||
3957007|NCT01329978|3779104|B2|Not Black||Race/Ethnicity, Customized||participants|Number|108|108.0||||||
3957008|NCT01329978|3779105|B1|Not Black||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
3957010|NCT01329978|3779103|B3|Black||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3957011|NCT01329978|3779104|B2|Black||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3957012|NCT01329978|3779105|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3957013|NCT01329978|3779102|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3957014|NCT01329978|3779103|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3957015|NCT01329978|3779104|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3957016|NCT01329978|3779105|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3957017|NCT01329978|3779102|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|265|265.0||||||
3957018|NCT01329978|3779103|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
3957019|NCT01329978|3779104|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3957020|NCT01329978|3779105|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3957021|NCT01329978|3779102|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3957022|NCT01329978|3779103|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3957023|NCT01329978|3779104|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3957024|NCT01329978|3779105|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3957025|NCT01329978|3779102|B4||Male|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
3957026|NCT01329978|3779103|B3||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3957027|NCT01329978|3779104|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3957028|NCT01329978|3779105|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3957029|NCT01329978|3779102|B4||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3957030|NCT01329978|3779103|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3957031|NCT01329978|3779104|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3957032|NCT01329978|3779105|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3957033|NCT01329978|3779102|B4|||Age||years|Mean|50|50.0|Standard Deviation|10.7|10.7|||
3957034|NCT01329978|3779103|B3|||Age||years|Mean|50|50.0|Standard Deviation|10.8|10.8|||
3957035|NCT01329978|3779104|B2|||Age||years|Mean|50|50.0|Standard Deviation|11.0|11.0|||
3957036|NCT01329978|3779105|B1|||Age||years|Mean|51|51.0|Standard Deviation|9.8|9.8|||
3957037|NCT01329939|3779179|B5|||BMI||kg/m^2|Median|22.09|22.09|Inter-Quartile Range|||18.72|27.13|
3957038|NCT01329939|3779180|B4|||BMI||kg/m^2|Median|24.20|24.2|Inter-Quartile Range|||22.19|27.13|
3957039|NCT01329939|3779181|B3|||BMI||kg/m^2|Median|18.28|18.28|Inter-Quartile Range|||18.09|19.2|
3957040|NCT01329939|3779182|B2|||BMI||kg/m^2|Median|17.83|17.83|Inter-Quartile Range|||17.15|18.72|
3957041|NCT01329939|3779183|B1|||BMI||kg/m^2|Median|30.76|30.76|Inter-Quartile Range|||22.83|34.19|
3957042|NCT01329939|3779179|B5|||Weight (kg)||kg|Median|48.50|48.5|Inter-Quartile Range|||36.8|73.7|
3957043|NCT01329939|3779180|B4|||Weight (kg)||kg|Median|52.00|52.0|Inter-Quartile Range|||44.2|78.0|
3957044|NCT01329939|3779181|B3|||Weight (kg)||kg|Median|37.00|37.0|Inter-Quartile Range|||33.7|54.5|
3957045|NCT01329939|3779182|B2|||Weight (kg)||kg|Median|32.66|32.66|Inter-Quartile Range|||27.7|34.6|
3957046|NCT01329939|3779183|B1|||Weight (kg)||kg|Median|72.3|72.3|Inter-Quartile Range|||49.3|98.88|
3957047|NCT01329939|3779179|B5|||Height (cm)||cm|Median|143.95|143.95|Inter-Quartile Range|||134.4|167.64|
3957048|NCT01329939|3779180|B4|||Height (cm)||cm|Median|144.90|144.9|Inter-Quartile Range|||139.7|168.0|
3957049|NCT01329939|3779181|B3|||Height (cm)||cm|Median|143.00|143.0|Inter-Quartile Range|||132.5|170.6|
3957050|NCT01329939|3779182|B2|||Height (cm)||cm|Median|134.4|134.4|Inter-Quartile Range|||132.08|139.3|
3957051|NCT01329939|3779183|B1|||Height (cm)||cm|Median|153.30|153.3|Inter-Quartile Range|||140.4|167.64|
3957052|NCT01329939|3779179|B5|United States||Region of Enrollment||participants|Number|26|26.0||||||
3957053|NCT01329939|3779180|B4|United States||Region of Enrollment||participants|Number|9|9.0||||||
3957054|NCT01329939|3779181|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3957055|NCT01329939|3779182|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3957056|NCT01329939|3779183|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3957057|NCT01329939|3779179|B5|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3957058|NCT01329939|3779180|B4|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3957059|NCT01329939|3779181|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3957060|NCT01329939|3779182|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3957061|NCT01329939|3779183|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3957062|NCT01329939|3779179|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3957063|NCT01329939|3779180|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3957064|NCT01329939|3779181|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3957065|NCT01329939|3779182|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3957066|NCT01329939|3779183|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3957067|NCT01329939|3779179|B5|African-American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3957068|NCT01329939|3779180|B4|African-American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3957069|NCT01329939|3779181|B3|African-American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3957070|NCT01329939|3779182|B2|African-American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3957071|NCT01329939|3779183|B1|African-American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3957072|NCT01329939|3779179|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3957073|NCT01329939|3779180|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3957074|NCT01329939|3779181|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3957075|NCT01329939|3779182|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3957076|NCT01329939|3779183|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3957077|NCT01329939|3779179|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3957078|NCT01329939|3779180|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3957079|NCT01329939|3779181|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3957080|NCT01329939|3779182|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3957081|NCT01329939|3779183|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3957082|NCT01329939|3779179|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3957083|NCT01329939|3779180|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3957084|NCT01329939|3779181|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3957085|NCT01329939|3779182|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3957086|NCT01329939|3779183|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3957087|NCT01329939|3779179|B5|||Age||years|Median|10|10.0|Inter-Quartile Range|||9.0|15.0|
3957088|NCT01329939|3779180|B4|||Age||years|Median|9|9.0|Inter-Quartile Range|||8.0|16.0|
3957089|NCT01329939|3779181|B3|||Age||years|Median|10|10.0|Inter-Quartile Range|||9.0|14.0|
3957090|NCT01329939|3779182|B2|||Age||years|Median|9|9.0|Inter-Quartile Range|||8.0|12.0|
3957091|NCT01329939|3779183|B1|||Age||years|Median|10|10.0|Inter-Quartile Range|||10.0|15.0|
3957092|NCT01329848|3779224|B1|||Conlon Symptom Score|Measures visual discomfort symptoms while doing near work. 23 item survey using a 4-point rating scale (never, occasionally, often, almost always). Total raw score reported on a range from 0 to 69 with higher scores indicating more frequent symptoms.|units on a scale|Mean|24.4|24.4|Standard Deviation|9.4|9.4|||
3957093|NCT01329848|3779224|B1|United States||Region of Enrollment||participants|Number|83|83.0||||||
3957094|NCT01329848|3779224|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3957095|NCT01329848|3779224|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3957096|NCT01329848|3779224|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3957097|NCT01329848|3779224|B1||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
3957098|NCT01329848|3779224|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3957099|NCT01329679|3779229|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
3957100|NCT01329679|3779229|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3957101|NCT01329679|3779229|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3957102|NCT01329679|3779229|B1|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3957103|NCT01329679|3779229|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3957104|NCT01329679|3779229|B1||Male|Gender||Participants|Count of Participants|20|20.0||||||
3957105|NCT01329679|3779229|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
3957106|NCT01329679|3779229|B1|Age||Age||years|Mean|28.3|28.3|Standard Deviation|5.77|5.77|||
3957107|NCT01329679|3779229|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3957108|NCT01329679|3779229|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3957109|NCT01329679|3779229|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3957110|NCT01329562|3779248|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
3957111|NCT01329562|3779249|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
3957112|NCT01329562|3779250|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3957113|NCT01329562|3779248|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3957114|NCT01329562|3779249|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3957115|NCT01329562|3779250|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3957116|NCT01329562|3779248|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3957117|NCT01329562|3779249|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3957118|NCT01329562|3779250|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3957119|NCT01329562|3779248|B3|||Age||years|Mean|35.56|35.56|Standard Deviation|7.40|7.4|||
3957120|NCT01329562|3779249|B2|||Age||years|Mean|36.71|36.71|Standard Deviation|6.50|6.5|||
3957121|NCT01329562|3779250|B1|||Age||years|Mean|34.35|34.35|Standard Deviation|8.22|8.22|||
3957122|NCT01329562|3779248|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3957123|NCT01329562|3779249|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3957124|NCT01329562|3779250|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3957125|NCT01329562|3779248|B3||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3957126|NCT01329562|3779249|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3957127|NCT01329562|3779250|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3957128|NCT01329562|3779248|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3957129|NCT01329562|3779249|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3957130|NCT01329562|3779250|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3957131|NCT01329549|3779300|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3957132|NCT01329549|3779300|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3957133|NCT01329549|3779300|B1|||Age||years|Mean|63|63.0|Standard Deviation|1.4|1.4|||
3957134|NCT01329419|3779311|B1|Not Korean||Race/Ethnicity, Customized|Baseline characteristics were collected in members of the ITT Population, comprised of all participants who had been administered the investigational drug at least once and had undergone all safety assessments.|participants|Number|0|0.0||||||
3957135|NCT01329419|3779311|B1|Korean||Race/Ethnicity, Customized|Baseline characteristics were collected in members of the ITT Population, comprised of all participants who had been administered the investigational drug at least once and had undergone all safety assessments.|participants|Number|4158|4158.0||||||
3957136|NCT01329419|3779311|B1|Missing||Sex/Gender, Customized|Baseline characteristics were collected in members of the ITT Population, comprised of all participants who had been administered the investigational drug at least once and had undergone all safety assessments.|Participants|Number|4|4.0||||||
3957137|NCT01329419|3779311|B1|Male||Sex/Gender, Customized|Baseline characteristics were collected in members of the ITT Population, comprised of all participants who had been administered the investigational drug at least once and had undergone all safety assessments.|Participants|Number|3280|3280.0||||||
3957138|NCT01329419|3779311|B1|Female||Sex/Gender, Customized|Baseline characteristics were collected in members of the ITT Population, comprised of all participants who had been administered the investigational drug at least once and had undergone all safety assessments.|Participants|Number|874|874.0||||||
3957139|NCT01329419|3779311|B1|||Age|Baseline characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who had been administered the investigational drug at least once and had undergone all safety assessments.|Years|Mean|43.9|43.9|Standard Deviation|11|11.0|||
3957140|NCT01329263|3779317|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
3957141|NCT01329263|3779318|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3957142|NCT01329263|3779319|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
3957143|NCT01329263|3779317|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3957144|NCT01329263|3779318|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3957145|NCT01329263|3779319|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3957146|NCT01329263|3779317|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3957147|NCT01329263|3779318|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3957148|NCT01329263|3779319|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3957149|NCT01329263|3779317|B3|||Age||years|Mean|37.4|37.4|Standard Deviation|11.7|11.7|||
3957150|NCT01329263|3779318|B2|||Age||years|Mean|37.93|37.93|Standard Deviation|12.1|12.1|||
3957151|NCT01329263|3779319|B1|||Age||years|Mean|37.13|37.13|Standard Deviation|10.9|10.9|||
3957152|NCT01329263|3779317|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3957153|NCT01329263|3779318|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3957154|NCT01329263|3779319|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3957155|NCT01329263|3779317|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3957156|NCT01329263|3779318|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3957157|NCT01329263|3779319|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3957158|NCT01329263|3779317|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3957159|NCT01329263|3779318|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3957160|NCT01329263|3779319|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3957161|NCT01329198|3779332|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3957162|NCT01329198|3779333|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3957163|NCT01329198|3779334|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3957164|NCT01329198|3779332|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3957165|NCT01329198|3779333|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3957166|NCT01329198|3779334|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3957167|NCT01329198|3779332|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3957168|NCT01329198|3779333|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3957169|NCT01329198|3779334|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3957170|NCT01329198|3779332|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3957171|NCT01329198|3779333|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3957172|NCT01329198|3779334|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3957173|NCT01329198|3779332|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3957174|NCT01329198|3779333|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3957175|NCT01329198|3779334|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3957176|NCT01329198|3779332|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3957177|NCT01329198|3779333|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3957178|NCT01329198|3779334|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3957179|NCT01329198|3779332|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3957180|NCT01329198|3779333|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3957181|NCT01329198|3779334|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3957182|NCT01329198|3779332|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3957183|NCT01329198|3779333|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3957184|NCT01329198|3779334|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3957185|NCT01329198|3779332|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3957186|NCT01329198|3779333|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3957187|NCT01329198|3779334|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3957188|NCT01329185|3779346|B3|United States||Region of Enrollment|Donors were recruited from the University of Minnesota Medical Center|participants|Number|17|17.0||||||
3957189|NCT01329185|3779347|B2|United States||Region of Enrollment|Donors were recruited from the University of Minnesota Medical Center|participants|Number|7|7.0||||||
3957190|NCT01329185|3779348|B1|United States||Region of Enrollment|Donors were recruited from the University of Minnesota Medical Center|participants|Number|10|10.0||||||
3957191|NCT01329185|3779346|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3957192|NCT01329185|3779347|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3957193|NCT01329185|3779348|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3957194|NCT01329185|3779346|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3957195|NCT01329185|3779347|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3957196|NCT01329185|3779348|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3957197|NCT01329185|3779346|B3|||Age|Donor Age at Transplant|years|Mean|44.8|44.8|Full Range|||29.7|66.6|
3957198|NCT01329185|3779347|B2|||Age|Donor Age at Transplant|years|Mean|47|47.0|Full Range|||29.7|66.6|
3957199|NCT01329185|3779348|B1|||Age|Donor Age at Transplant|years|Mean|43.4|43.4|Full Range|||30.7|54.5|
3957200|NCT01329029|3779355|B3|||Post-bronchodilator FEV1/Forced Vital Capacity (FVC)|Calculated as FEV1/FVC * 100|FEV1/FVC percent|Mean|40.1|40.1|Standard Deviation|10.54|10.54|||
3957201|NCT01329029|3779356|B2|||Post-bronchodilator FEV1/Forced Vital Capacity (FVC)|Calculated as FEV1/FVC * 100|FEV1/FVC percent|Mean|40.1|40.1|Standard Deviation|10.26|10.26|||
3957202|NCT01329029|3779357|B1|||Post-bronchodilator FEV1/Forced Vital Capacity (FVC)|Calculated as FEV1/FVC * 100|FEV1/FVC percent|Mean|40.2|40.2|Standard Deviation|10.81|10.81|||
3957203|NCT01329029|3779355|B3|||FEV1 Reversibility Increase|Number of participants for whom FEV1 reversibility increase data was available was 912 and 915 in each treatment arm, respectively.|mL|Mean|65.3|65.3|Standard Deviation|115.29|115.29|||
3957204|NCT01329029|3779356|B2|||FEV1 Reversibility Increase|Number of participants for whom FEV1 reversibility increase data was available was 912 and 915 in each treatment arm, respectively.|mL|Mean|65.4|65.4|Standard Deviation|121.55|121.55|||
3957205|NCT01329029|3779357|B1|||FEV1 Reversibility Increase|Number of participants for whom FEV1 reversibility increase data was available was 912 and 915 in each treatment arm, respectively.|mL|Mean|65.2|65.2|Standard Deviation|108.72|108.72|||
3957206|NCT01329029|3779355|B3|||FEV1 Reversibility % Increase|FEV reversibility (%) = (post-bronchodilator FEV minus pre-bronchodilator FEV) / pre-bronchodilator FEV * 100. Number of participants for whom FEV1 reversibility % increase data was available was 912 and 915 in each treatment arm, respectively.|percent reversibility|Mean|7.424|7.424|Standard Deviation|11.6703|11.6703|||
3957207|NCT01329029|3779356|B2|||FEV1 Reversibility % Increase|FEV reversibility (%) = (post-bronchodilator FEV minus pre-bronchodilator FEV) / pre-bronchodilator FEV * 100. Number of participants for whom FEV1 reversibility % increase data was available was 912 and 915 in each treatment arm, respectively.|percent reversibility|Mean|7.383|7.383|Standard Deviation|12.0752|12.0752|||
3957208|NCT01329029|3779357|B1|||FEV1 Reversibility % Increase|FEV reversibility (%) = (post-bronchodilator FEV minus pre-bronchodilator FEV) / pre-bronchodilator FEV * 100. Number of participants for whom FEV1 reversibility % increase data was available was 912 and 915 in each treatment arm, respectively.|percent reversibility|Mean|7.465|7.465|Standard Deviation|11.2559|11.2559|||
3957209|NCT01329029|3779355|B3|||Post-bronchodilator FEV1 Predicted||percent predicted|Mean|35.462|35.462|Standard Deviation|9.0045|9.0045|||
3957210|NCT01329029|3779356|B2|||Post-bronchodilator FEV1 Predicted||percent predicted|Mean|35.532|35.532|Standard Deviation|8.7573|8.7573|||
3957211|NCT01329029|3779357|B1|||Post-bronchodilator FEV1 Predicted||percent predicted|Mean|35.392|35.392|Standard Deviation|9.2484|9.2484|||
3957212|NCT01329029|3779355|B3|||Pre-bronchodilator FEV1 Predicted|Number of participants for whom pre-bronchodilator FEV1 data was available was 938 and 933 in each treatment arm, respectively.|percent of predicted|Mean|33.411|33.411|Standard Deviation|9.0402|9.0402|||
3957213|NCT01329029|3779356|B2|||Pre-bronchodilator FEV1 Predicted|Number of participants for whom pre-bronchodilator FEV1 data was available was 938 and 933 in each treatment arm, respectively.|percent of predicted|Mean|33.562|33.562|Standard Deviation|9.0043|9.0043|||
3957214|NCT01329029|3779357|B1|||Pre-bronchodilator FEV1 Predicted|Number of participants for whom pre-bronchodilator FEV1 data was available was 938 and 933 in each treatment arm, respectively.|percent of predicted|Mean|33.259|33.259|Standard Deviation|9.0781|9.0781|||
3957215|NCT01329029|3779355|B3|||Post-bronchodilator FEV1||Liters|Mean|1.072|1.072|Standard Deviation|0.3280|0.328|||
3957216|NCT01329029|3779356|B2|||Post-bronchodilator FEV1||Liters|Mean|1.078|1.078|Standard Deviation|0.3244|0.3244|||
3957217|NCT01329029|3779357|B1|||Post-bronchodilator FEV1||Liters|Mean|1.066|1.066|Standard Deviation|0.3317|0.3317|||
3957218|NCT01329029|3779355|B3|||Pre-bronchodilator Forced Expiratory Volume in the First Second (FEV1)|Number of participants for whom pre-bronchodilator FEV1 data was available was 938 and 937 in each treatment arm, respectively.|Liters|Mean|1.008|1.008|Standard Deviation|0.3180|0.318|||
3957219|NCT01329029|3779356|B2|||Pre-bronchodilator Forced Expiratory Volume in the First Second (FEV1)|Number of participants for whom pre-bronchodilator FEV1 data was available was 938 and 937 in each treatment arm, respectively.|Liters|Mean|1.016|1.016|Standard Deviation|0.3209|0.3209|||
3957290|NCT01329029|3779355|B3|South Africa||Region of Enrollment||participants|Number|53|53.0||||||
3957220|NCT01329029|3779357|B1|||Pre-bronchodilator Forced Expiratory Volume in the First Second (FEV1)|Number of participants for whom pre-bronchodilator FEV1 data was available was 938 and 937 in each treatment arm, respectively.|Liters|Mean|0.999|0.999|Standard Deviation|0.3149|0.3149|||
3957221|NCT01329029|3779355|B3|||Cigarette Pack Years|Pack Years = (packs smoked per day) * (years as a smoker)|pack years|Mean|47.6|47.6|Standard Deviation|24.6|24.6|||
3957222|NCT01329029|3779356|B2|||Cigarette Pack Years|Pack Years = (packs smoked per day) * (years as a smoker)|pack years|Mean|47.6|47.6|Standard Deviation|23.56|23.56|||
3957223|NCT01329029|3779357|B1|||Cigarette Pack Years|Pack Years = (packs smoked per day) * (years as a smoker)|pack years|Mean|47.6|47.6|Standard Deviation|24.55|24.55|||
3957224|NCT01329029|3779355|B3|Nonsmoker||Smoking Status||participants|Number|0|0.0||||||
3957225|NCT01329029|3779356|B2|Nonsmoker||Smoking Status||participants|Number|0|0.0||||||
3957226|NCT01329029|3779357|B1|Nonsmoker||Smoking Status||participants|Number|0|0.0||||||
3957227|NCT01329029|3779355|B3|Former smoker||Smoking Status||participants|Number|1092|1092.0||||||
3957228|NCT01329029|3779356|B2|Former smoker||Smoking Status||participants|Number|534|534.0||||||
3957229|NCT01329029|3779357|B1|Former smoker||Smoking Status||participants|Number|558|558.0||||||
3957230|NCT01329029|3779355|B3|Current smoker||Smoking Status||participants|Number|843|843.0||||||
3957231|NCT01329029|3779356|B2|Current smoker||Smoking Status||participants|Number|432|432.0||||||
3957232|NCT01329029|3779357|B1|Current smoker||Smoking Status||participants|Number|411|411.0||||||
3957233|NCT01329029|3779355|B3|Missing||Global Initiative for Chronic Obstructive Lung Disease (GOLD) Patient Group||participants|Number|4|4.0||||||
3957234|NCT01329029|3779356|B2|Missing||Global Initiative for Chronic Obstructive Lung Disease (GOLD) Patient Group||participants|Number|2|2.0||||||
3957235|NCT01329029|3779357|B1|Missing||Global Initiative for Chronic Obstructive Lung Disease (GOLD) Patient Group||participants|Number|2|2.0||||||
3957236|NCT01329029|3779355|B3|D: high risk, more symptoms||Global Initiative for Chronic Obstructive Lung Disease (GOLD) Patient Group||participants|Number|1812|1812.0||||||
3957237|NCT01329029|3779356|B2|D: high risk, more symptoms||Global Initiative for Chronic Obstructive Lung Disease (GOLD) Patient Group||participants|Number|907|907.0||||||
3957238|NCT01329029|3779357|B1|D: high risk, more symptoms||Global Initiative for Chronic Obstructive Lung Disease (GOLD) Patient Group||participants|Number|905|905.0||||||
3957239|NCT01329029|3779355|B3|C: high risk, less symptoms||Global Initiative for Chronic Obstructive Lung Disease (GOLD) Patient Group||participants|Number|119|119.0||||||
3957240|NCT01329029|3779356|B2|C: high risk, less symptoms||Global Initiative for Chronic Obstructive Lung Disease (GOLD) Patient Group||participants|Number|57|57.0||||||
3957241|NCT01329029|3779357|B1|C: high risk, less symptoms||Global Initiative for Chronic Obstructive Lung Disease (GOLD) Patient Group||participants|Number|62|62.0||||||
3957242|NCT01329029|3779355|B3|B: low risk, more symptoms||Global Initiative for Chronic Obstructive Lung Disease (GOLD) Patient Group||participants|Number|0|0.0||||||
3957243|NCT01329029|3779356|B2|B: low risk, more symptoms||Global Initiative for Chronic Obstructive Lung Disease (GOLD) Patient Group||participants|Number|0|0.0||||||
3957244|NCT01329029|3779357|B1|B: low risk, more symptoms||Global Initiative for Chronic Obstructive Lung Disease (GOLD) Patient Group||participants|Number|0|0.0||||||
3957245|NCT01329029|3779355|B3|A : low risk, less symptoms||Global Initiative for Chronic Obstructive Lung Disease (GOLD) Patient Group||participants|Number|0|0.0||||||
3957246|NCT01329029|3779356|B2|A : low risk, less symptoms||Global Initiative for Chronic Obstructive Lung Disease (GOLD) Patient Group||participants|Number|0|0.0||||||
3957247|NCT01329029|3779357|B1|A : low risk, less symptoms||Global Initiative for Chronic Obstructive Lung Disease (GOLD) Patient Group||participants|Number|0|0.0||||||
3957248|NCT01329029|3779355|B3|Missing||COPD Disease Characteristics||participants|Number|1|1.0||||||
3957249|NCT01329029|3779356|B2|Missing||COPD Disease Characteristics||participants|Number|0|0.0||||||
3957250|NCT01329029|3779357|B1|Missing||COPD Disease Characteristics||participants|Number|1|1.0||||||
3957251|NCT01329029|3779355|B3|Combined emphysema and chronic bronchitis||COPD Disease Characteristics||participants|Number|1260|1260.0||||||
3957252|NCT01329029|3779356|B2|Combined emphysema and chronic bronchitis||COPD Disease Characteristics||participants|Number|634|634.0||||||
3957253|NCT01329029|3779357|B1|Combined emphysema and chronic bronchitis||COPD Disease Characteristics||participants|Number|626|626.0||||||
3957254|NCT01329029|3779355|B3|Predominantly chronic bronchitis||COPD Disease Characteristics||participants|Number|668|668.0||||||
3957255|NCT01329029|3779356|B2|Predominantly chronic bronchitis||COPD Disease Characteristics||participants|Number|330|330.0||||||
3957256|NCT01329029|3779357|B1|Predominantly chronic bronchitis||COPD Disease Characteristics||participants|Number|338|338.0||||||
3957257|NCT01329029|3779355|B3|Pure emphysema||COPD Disease Characteristics||participants|Number|6|6.0||||||
3957258|NCT01329029|3779356|B2|Pure emphysema||COPD Disease Characteristics||participants|Number|2|2.0||||||
3957259|NCT01329029|3779357|B1|Pure emphysema||COPD Disease Characteristics||participants|Number|4|4.0||||||
3957260|NCT01329029|3779355|B3|Very Severe||Chronic Obstructive Pulmonary Disease (COPD) Severity|COPD severity was classified according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guideline (2009) as: - Very severe COPD: baseline post-bronchodilator FEV1 %predicted < 30% - Severe COPD: baseline post-bronchodilator FEV1 %predicted ≥ 30% to < 50% - Moderate COPD: baseline post-bronchodilator FEV1 %predicted ≥ 50% to < 80% - Mild COPD: baseline post-bronchodilator FEV1 %predicted ≥ 80%.|participants|Number|564|564.0||||||
3957261|NCT01329029|3779356|B2|Very Severe||Chronic Obstructive Pulmonary Disease (COPD) Severity|COPD severity was classified according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guideline (2009) as: - Very severe COPD: baseline post-bronchodilator FEV1 %predicted < 30% - Severe COPD: baseline post-bronchodilator FEV1 %predicted ≥ 30% to < 50% - Moderate COPD: baseline post-bronchodilator FEV1 %predicted ≥ 50% to < 80% - Mild COPD: baseline post-bronchodilator FEV1 %predicted ≥ 80%.|participants|Number|273|273.0||||||
3957291|NCT01329029|3779356|B2|South Africa||Region of Enrollment||participants|Number|30|30.0||||||
3957292|NCT01329029|3779357|B1|South Africa||Region of Enrollment||participants|Number|23|23.0||||||
3957262|NCT01329029|3779357|B1|Very Severe||Chronic Obstructive Pulmonary Disease (COPD) Severity|COPD severity was classified according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guideline (2009) as: - Very severe COPD: baseline post-bronchodilator FEV1 %predicted < 30% - Severe COPD: baseline post-bronchodilator FEV1 %predicted ≥ 30% to < 50% - Moderate COPD: baseline post-bronchodilator FEV1 %predicted ≥ 50% to < 80% - Mild COPD: baseline post-bronchodilator FEV1 %predicted ≥ 80%.|participants|Number|291|291.0||||||
3957263|NCT01329029|3779355|B3|Severe||Chronic Obstructive Pulmonary Disease (COPD) Severity|COPD severity was classified according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guideline (2009) as: - Very severe COPD: baseline post-bronchodilator FEV1 %predicted < 30% - Severe COPD: baseline post-bronchodilator FEV1 %predicted ≥ 30% to < 50% - Moderate COPD: baseline post-bronchodilator FEV1 %predicted ≥ 50% to < 80% - Mild COPD: baseline post-bronchodilator FEV1 %predicted ≥ 80%.|participants|Number|1335|1335.0||||||
3957264|NCT01329029|3779356|B2|Severe||Chronic Obstructive Pulmonary Disease (COPD) Severity|COPD severity was classified according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guideline (2009) as: - Very severe COPD: baseline post-bronchodilator FEV1 %predicted < 30% - Severe COPD: baseline post-bronchodilator FEV1 %predicted ≥ 30% to < 50% - Moderate COPD: baseline post-bronchodilator FEV1 %predicted ≥ 50% to < 80% - Mild COPD: baseline post-bronchodilator FEV1 %predicted ≥ 80%.|participants|Number|677|677.0||||||
3957265|NCT01329029|3779357|B1|Severe||Chronic Obstructive Pulmonary Disease (COPD) Severity|COPD severity was classified according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guideline (2009) as: - Very severe COPD: baseline post-bronchodilator FEV1 %predicted < 30% - Severe COPD: baseline post-bronchodilator FEV1 %predicted ≥ 30% to < 50% - Moderate COPD: baseline post-bronchodilator FEV1 %predicted ≥ 50% to < 80% - Mild COPD: baseline post-bronchodilator FEV1 %predicted ≥ 80%.|participants|Number|658|658.0||||||
3957266|NCT01329029|3779355|B3|Moderate||Chronic Obstructive Pulmonary Disease (COPD) Severity|COPD severity was classified according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guideline (2009) as: - Very severe COPD: baseline post-bronchodilator FEV1 %predicted < 30% - Severe COPD: baseline post-bronchodilator FEV1 %predicted ≥ 30% to < 50% - Moderate COPD: baseline post-bronchodilator FEV1 %predicted ≥ 50% to < 80% - Mild COPD: baseline post-bronchodilator FEV1 %predicted ≥ 80%.|participants|Number|34|34.0||||||
3957267|NCT01329029|3779356|B2|Moderate||Chronic Obstructive Pulmonary Disease (COPD) Severity|COPD severity was classified according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guideline (2009) as: - Very severe COPD: baseline post-bronchodilator FEV1 %predicted < 30% - Severe COPD: baseline post-bronchodilator FEV1 %predicted ≥ 30% to < 50% - Moderate COPD: baseline post-bronchodilator FEV1 %predicted ≥ 50% to < 80% - Mild COPD: baseline post-bronchodilator FEV1 %predicted ≥ 80%.|participants|Number|16|16.0||||||
3957268|NCT01329029|3779357|B1|Moderate||Chronic Obstructive Pulmonary Disease (COPD) Severity|COPD severity was classified according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guideline (2009) as: - Very severe COPD: baseline post-bronchodilator FEV1 %predicted < 30% - Severe COPD: baseline post-bronchodilator FEV1 %predicted ≥ 30% to < 50% - Moderate COPD: baseline post-bronchodilator FEV1 %predicted ≥ 50% to < 80% - Mild COPD: baseline post-bronchodilator FEV1 %predicted ≥ 80%.|participants|Number|18|18.0||||||
3957269|NCT01329029|3779355|B3|Mild||Chronic Obstructive Pulmonary Disease (COPD) Severity|COPD severity was classified according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guideline (2009) as: - Very severe COPD: baseline post-bronchodilator FEV1 %predicted < 30% - Severe COPD: baseline post-bronchodilator FEV1 %predicted ≥ 30% to < 50% - Moderate COPD: baseline post-bronchodilator FEV1 %predicted ≥ 50% to < 80% - Mild COPD: baseline post-bronchodilator FEV1 %predicted ≥ 80%.|participants|Number|2|2.0||||||
3957270|NCT01329029|3779356|B2|Mild||Chronic Obstructive Pulmonary Disease (COPD) Severity|COPD severity was classified according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guideline (2009) as: - Very severe COPD: baseline post-bronchodilator FEV1 %predicted < 30% - Severe COPD: baseline post-bronchodilator FEV1 %predicted ≥ 30% to < 50% - Moderate COPD: baseline post-bronchodilator FEV1 %predicted ≥ 50% to < 80% - Mild COPD: baseline post-bronchodilator FEV1 %predicted ≥ 80%.|participants|Number|0|0.0||||||
3957271|NCT01329029|3779357|B1|Mild||Chronic Obstructive Pulmonary Disease (COPD) Severity|COPD severity was classified according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guideline (2009) as: - Very severe COPD: baseline post-bronchodilator FEV1 %predicted < 30% - Severe COPD: baseline post-bronchodilator FEV1 %predicted ≥ 30% to < 50% - Moderate COPD: baseline post-bronchodilator FEV1 %predicted ≥ 50% to < 80% - Mild COPD: baseline post-bronchodilator FEV1 %predicted ≥ 80%.|participants|Number|2|2.0||||||
3957272|NCT01329029|3779355|B3|||Body Mass Index (BMI)||kg/m^2|Mean|26.52|26.52|Standard Deviation|5.416|5.416|||
3957273|NCT01329029|3779356|B2|||Body Mass Index (BMI)||kg/m^2|Mean|26.58|26.58|Standard Deviation|5.359|5.359|||
3957274|NCT01329029|3779357|B1|||Body Mass Index (BMI)||kg/m^2|Mean|26.45|26.45|Standard Deviation|5.474|5.474|||
3957275|NCT01329029|3779355|B3|||Weight||kg|Mean|75.33|75.33|Standard Deviation|17.254|17.254|||
3957276|NCT01329029|3779356|B2|||Weight||kg|Mean|75.60|75.6|Standard Deviation|17.238|17.238|||
3957277|NCT01329029|3779357|B1|||Weight||kg|Mean|75.07|75.07|Standard Deviation|17.275|17.275|||
3957278|NCT01329029|3779355|B3|||Height||cm|Mean|168.26|168.26|Standard Deviation|8.427|8.427|||
3957279|NCT01329029|3779356|B2|||Height||cm|Mean|168.33|168.33|Standard Deviation|8.198|8.198|||
3957280|NCT01329029|3779357|B1|||Height||cm|Mean|168.20|168.2|Standard Deviation|8.652|8.652|||
3957281|NCT01329029|3779355|B3|United Kingdom||Region of Enrollment||participants|Number|50|50.0||||||
3957282|NCT01329029|3779356|B2|United Kingdom||Region of Enrollment||participants|Number|28|28.0||||||
3957283|NCT01329029|3779357|B1|United Kingdom||Region of Enrollment||participants|Number|22|22.0||||||
3957284|NCT01329029|3779355|B3|Turkey||Region of Enrollment||participants|Number|96|96.0||||||
3957285|NCT01329029|3779356|B2|Turkey||Region of Enrollment||participants|Number|44|44.0||||||
3957286|NCT01329029|3779357|B1|Turkey||Region of Enrollment||participants|Number|52|52.0||||||
3957287|NCT01329029|3779355|B3|Spain||Region of Enrollment||participants|Number|70|70.0||||||
3957288|NCT01329029|3779356|B2|Spain||Region of Enrollment||participants|Number|33|33.0||||||
3957289|NCT01329029|3779357|B1|Spain||Region of Enrollment||participants|Number|37|37.0||||||
3957293|NCT01329029|3779355|B3|Slovakia||Region of Enrollment||participants|Number|58|58.0||||||
3957294|NCT01329029|3779356|B2|Slovakia||Region of Enrollment||participants|Number|33|33.0||||||
3957295|NCT01329029|3779357|B1|Slovakia||Region of Enrollment||participants|Number|25|25.0||||||
3957296|NCT01329029|3779355|B3|Russian Federation||Region of Enrollment||participants|Number|358|358.0||||||
3957297|NCT01329029|3779356|B2|Russian Federation||Region of Enrollment||participants|Number|181|181.0||||||
3957298|NCT01329029|3779357|B1|Russian Federation||Region of Enrollment||participants|Number|177|177.0||||||
3957299|NCT01329029|3779355|B3|Poland||Region of Enrollment||participants|Number|176|176.0||||||
3957300|NCT01329029|3779356|B2|Poland||Region of Enrollment||participants|Number|88|88.0||||||
3957301|NCT01329029|3779357|B1|Poland||Region of Enrollment||participants|Number|88|88.0||||||
3957302|NCT01329029|3779355|B3|Netherlands||Region of Enrollment||participants|Number|19|19.0||||||
3957303|NCT01329029|3779356|B2|Netherlands||Region of Enrollment||participants|Number|8|8.0||||||
3957304|NCT01329029|3779357|B1|Netherlands||Region of Enrollment||participants|Number|11|11.0||||||
3957305|NCT01329029|3779355|B3|Korea, Republic Of||Region of Enrollment||participants|Number|18|18.0||||||
3957306|NCT01329029|3779356|B2|Korea, Republic Of||Region of Enrollment||participants|Number|7|7.0||||||
3957307|NCT01329029|3779357|B1|Korea, Republic Of||Region of Enrollment||participants|Number|11|11.0||||||
3957308|NCT01329029|3779355|B3|Italy||Region of Enrollment||participants|Number|115|115.0||||||
3957309|NCT01329029|3779356|B2|Italy||Region of Enrollment||participants|Number|51|51.0||||||
3957310|NCT01329029|3779357|B1|Italy||Region of Enrollment||participants|Number|64|64.0||||||
3957311|NCT01329029|3779355|B3|Israel||Region of Enrollment||participants|Number|240|240.0||||||
3957312|NCT01329029|3779356|B2|Israel||Region of Enrollment||participants|Number|126|126.0||||||
3957313|NCT01329029|3779357|B1|Israel||Region of Enrollment||participants|Number|114|114.0||||||
3957314|NCT01329029|3779355|B3|Hungary||Region of Enrollment||participants|Number|236|236.0||||||
3957315|NCT01329029|3779356|B2|Hungary||Region of Enrollment||participants|Number|125|125.0||||||
3957316|NCT01329029|3779357|B1|Hungary||Region of Enrollment||participants|Number|111|111.0||||||
3957317|NCT01329029|3779355|B3|Greece||Region of Enrollment||participants|Number|68|68.0||||||
3957318|NCT01329029|3779356|B2|Greece||Region of Enrollment||participants|Number|30|30.0||||||
3957319|NCT01329029|3779357|B1|Greece||Region of Enrollment||participants|Number|38|38.0||||||
3957320|NCT01329029|3779355|B3|Germany||Region of Enrollment||participants|Number|133|133.0||||||
3957321|NCT01329029|3779356|B2|Germany||Region of Enrollment||participants|Number|63|63.0||||||
3957322|NCT01329029|3779357|B1|Germany||Region of Enrollment||participants|Number|70|70.0||||||
3957323|NCT01329029|3779355|B3|France||Region of Enrollment||participants|Number|29|29.0||||||
3957324|NCT01329029|3779356|B2|France||Region of Enrollment||participants|Number|13|13.0||||||
3957325|NCT01329029|3779357|B1|France||Region of Enrollment||participants|Number|16|16.0||||||
3957326|NCT01329029|3779355|B3|Denmark||Region of Enrollment||participants|Number|34|34.0||||||
3957327|NCT01329029|3779356|B2|Denmark||Region of Enrollment||participants|Number|19|19.0||||||
3957328|NCT01329029|3779357|B1|Denmark||Region of Enrollment||participants|Number|15|15.0||||||
3957329|NCT01329029|3779355|B3|Canada||Region of Enrollment||participants|Number|26|26.0||||||
3957330|NCT01329029|3779356|B2|Canada||Region of Enrollment||participants|Number|12|12.0||||||
3957331|NCT01329029|3779357|B1|Canada||Region of Enrollment||participants|Number|14|14.0||||||
3957332|NCT01329029|3779355|B3|Brazil||Region of Enrollment||participants|Number|80|80.0||||||
3957333|NCT01329029|3779356|B2|Brazil||Region of Enrollment||participants|Number|38|38.0||||||
3957334|NCT01329029|3779357|B1|Brazil||Region of Enrollment||participants|Number|42|42.0||||||
3957335|NCT01329029|3779355|B3|Belgium||Region of Enrollment||participants|Number|37|37.0||||||
3957336|NCT01329029|3779356|B2|Belgium||Region of Enrollment||participants|Number|18|18.0||||||
3957337|NCT01329029|3779357|B1|Belgium||Region of Enrollment||participants|Number|19|19.0||||||
3957338|NCT01329029|3779355|B3|Austria||Region of Enrollment||participants|Number|14|14.0||||||
3957339|NCT01329029|3779356|B2|Austria||Region of Enrollment||participants|Number|3|3.0||||||
3957340|NCT01329029|3779357|B1|Austria||Region of Enrollment||participants|Number|11|11.0||||||
3957341|NCT01329029|3779355|B3|Australia||Region of Enrollment||participants|Number|25|25.0||||||
3957342|NCT01329029|3779356|B2|Australia||Region of Enrollment||participants|Number|16|16.0||||||
3957343|NCT01329029|3779357|B1|Australia||Region of Enrollment||participants|Number|9|9.0||||||
3957344|NCT01329029|3779355|B3|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3957345|NCT01329029|3779356|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3957346|NCT01329029|3779357|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3957347|NCT01329029|3779355|B3|White||Race/Ethnicity, Customized||participants|Number|1883|1883.0||||||
3957348|NCT01329029|3779356|B2|White||Race/Ethnicity, Customized||participants|Number|943|943.0||||||
3957349|NCT01329029|3779357|B1|White||Race/Ethnicity, Customized||participants|Number|940|940.0||||||
3957350|NCT01329029|3779355|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3957351|NCT01329029|3779356|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3957352|NCT01329029|3779357|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3957353|NCT01329029|3779355|B3|Asian||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3957354|NCT01329029|3779356|B2|Asian||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3957355|NCT01329029|3779357|B1|Asian||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3957356|NCT01329029|3779355|B3||Male|Gender||Participants|Count of Participants|1443|1443.0||||||
3957357|NCT01329029|3779356|B2||Male|Gender||Participants|Count of Participants|725|725.0||||||
3957358|NCT01329029|3779357|B1||Male|Gender||Participants|Count of Participants|718|718.0||||||
3957359|NCT01329029|3779355|B3||Female|Gender||Participants|Count of Participants|492|492.0||||||
3957360|NCT01329029|3779356|B2||Female|Gender||Participants|Count of Participants|241|241.0||||||
3957361|NCT01329029|3779357|B1||Female|Gender||Participants|Count of Participants|251|251.0||||||
3957362|NCT01329029|3779355|B3|> 65 years||Age, Customized||participants|Number|866|866.0||||||
3957363|NCT01329029|3779356|B2|> 65 years||Age, Customized||participants|Number|424|424.0||||||
3957364|NCT01329029|3779357|B1|> 65 years||Age, Customized||participants|Number|442|442.0||||||
3957365|NCT01329029|3779355|B3|≤ 65 years||Age, Customized||participants|Number|1069|1069.0||||||
3957366|NCT01329029|3779356|B2|≤ 65 years||Age, Customized||participants|Number|542|542.0||||||
3957367|NCT01329029|3779357|B1|≤ 65 years||Age, Customized||participants|Number|527|527.0||||||
3957368|NCT01329029|3779355|B3|||Age||years|Mean|64.7|64.7|Standard Deviation|8.37|8.37|||
3957369|NCT01329029|3779356|B2|||Age||years|Mean|64.7|64.7|Standard Deviation|8.37|8.37|||
3957370|NCT01329029|3779357|B1|||Age||years|Mean|64.7|64.7|Standard Deviation|8.38|8.38|||
3957371|NCT01328964|3779428|B4||Male|Sex: Female, Male||Participants|Count of Participants|5945|5945.0||||||
3957372|NCT01328964|3779429|B3||Male|Sex: Female, Male||Participants|Count of Participants|2627|2627.0||||||
3957373|NCT01328964|3779430|B2||Male|Sex: Female, Male||Participants|Count of Participants|2003|2003.0||||||
3957374|NCT01328964|3779431|B1||Male|Sex: Female, Male||Participants|Count of Participants|1315|1315.0||||||
3957375|NCT01328964|3779428|B4||Female|Sex: Female, Male||Participants|Count of Participants|3961|3961.0||||||
3957376|NCT01328964|3779429|B3||Female|Sex: Female, Male||Participants|Count of Participants|1797|1797.0||||||
3957377|NCT01328964|3779430|B2||Female|Sex: Female, Male||Participants|Count of Participants|1267|1267.0||||||
3957378|NCT01328964|3779431|B1||Female|Sex: Female, Male||Participants|Count of Participants|897|897.0||||||
3957379|NCT01328964|3779428|B4|||Age||Years|Mean|7.23|7.23|Standard Deviation|2.23|2.23|||
3957380|NCT01328964|3779429|B3|||Age||Years|Mean|7.21|7.21|Standard Deviation|2.23|2.23|||
3957381|NCT01328964|3779430|B2|||Age||Years|Mean|7.30|7.3|Standard Deviation|2.27|2.27|||
3957382|NCT01328964|3779431|B1|||Age||Years|Mean|7.18|7.18|Standard Deviation|2.20|2.2|||
3957383|NCT01328951|3779446|B3||Male|Sex: Female, Male||Participants|Count of Participants|482|482.0||||||
3957384|NCT01328951|3779447|B2||Male|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
3957385|NCT01328951|3779448|B1||Male|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
3957386|NCT01328951|3779446|B3||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3957387|NCT01328951|3779447|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3957388|NCT01328951|3779448|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3957389|NCT01328951|3779446|B3|||Age||years|Mean|60.7|60.7|Standard Deviation|8.9|8.9|||
3957390|NCT01328951|3779447|B2|||Age||years|Mean|60.8|60.8|Standard Deviation|8.8|8.8|||
3957391|NCT01328951|3779448|B1|||Age||years|Mean|60.6|60.6|Standard Deviation|9.1|9.1|||
3957392|NCT01328873|3779473|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
3957393|NCT01328873|3779473|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3957394|NCT01328873|3779473|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3957395|NCT01328873|3779473|B1||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3957396|NCT01328873|3779473|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3957397|NCT01328873|3779473|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3957398|NCT01328873|3779473|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3957399|NCT01328873|3779473|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3957400|NCT01328873|3779473|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3957401|NCT01328873|3779473|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3957402|NCT01328873|3779473|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3957403|NCT01328873|3779473|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3957404|NCT01328873|3779473|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3957405|NCT01328873|3779473|B1||>=65 years|Age|Patients were treated in an adult center. All patients were over the age of 18.|Participants|Count of Participants|13|13.0||||||
3957406|NCT01328873|3779473|B1||Between 18 and 65 years|Age|Patients were treated in an adult center. All patients were over the age of 18.|Participants|Count of Participants|36|36.0||||||
3957407|NCT01328873|3779473|B1||<=18 years|Age|Patients were treated in an adult center. All patients were over the age of 18.|Participants|Count of Participants|0|0.0||||||
3957408|NCT01328782|3779482|B4|United States||Region of Enrollment||participants|Number|124|124.0||||||
3957409|NCT01328782|3779483|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
3957410|NCT01328782|3779484|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
3957411|NCT01328782|3779485|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
3957412|NCT01328782|3779482|B4||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3957413|NCT01328782|3779483|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3957414|NCT01328782|3779484|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3957415|NCT01328782|3779485|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3957416|NCT01328782|3779482|B4||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3957417|NCT01328782|3779483|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3957418|NCT01328782|3779484|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3957419|NCT01328782|3779485|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3957420|NCT01328782|3779482|B4|||Age||years|Mean|6.85|6.85|Standard Deviation|1.97|1.97|||
3957421|NCT01328782|3779483|B3|||Age||years|Mean|6.73|6.73|Standard Deviation|2.21|2.21|||
3957422|NCT01328782|3779484|B2|||Age||years|Mean|6.86|6.86|Standard Deviation|1.74|1.74|||
3957423|NCT01328782|3779485|B1|||Age||years|Mean|6.92|6.92|Standard Deviation|1.99|1.99|||
3957424|NCT01328782|3779482|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3957425|NCT01328782|3779483|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3957426|NCT01328782|3779484|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3957427|NCT01328782|3779485|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3957428|NCT01328782|3779482|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3957429|NCT01328782|3779483|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3957430|NCT01328782|3779484|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3957431|NCT01328782|3779485|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3957432|NCT01328782|3779482|B4||<=18 years|Age||Participants|Count of Participants|124|124.0||||||
3957433|NCT01328782|3779483|B3||<=18 years|Age||Participants|Count of Participants|39|39.0||||||
3957434|NCT01328782|3779484|B2||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
3957435|NCT01328782|3779485|B1||<=18 years|Age||Participants|Count of Participants|43|43.0||||||
3957436|NCT01328769|3779507|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3957437|NCT01328769|3779508|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3957438|NCT01328769|3779509|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3957439|NCT01328769|3779507|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3957440|NCT01328769|3779508|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3957441|NCT01328769|3779509|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3957442|NCT01328769|3779507|B3|||Age||years|Mean|49.6|49.6|Standard Deviation|8.1|8.1|||
3957443|NCT01328769|3779508|B2|||Age||years|Mean|48.6|48.6|Standard Deviation|8.0|8.0|||
3957444|NCT01328769|3779509|B1|||Age||years|Mean|50.6|50.6|Standard Deviation|8.1|8.1|||
3957445|NCT01328756|3779518|B1|||ADHD-RS-IV: Hyperactivity/Impulsivity Subscore|ADHD-RS-IV consisted of 18 items designed to reflect current symptomatology of ADHD based on DSM-IV-TR criteria, completed by the Investigator. Each item was scored from a range of 0 (reflecting no symptoms) to 3 (reflecting severe symptoms) with total scores ranging from 0-54. The 18 items were grouped into 2 sub-scales: hyperactivity/impulsivity and inattention. Hyperactivity/impulsivity subscale score consisted of even number items 2-18 with scores ranging from 0 to 27. Higher score indicated worse symptom.|scores on a scale|Mean|19|19.0|Standard Deviation|5.86|5.86|||
3957446|NCT01328756|3779518|B1|||ADHD-RS-IV: Inattention Subscale Score|ADHD-RS-IV consisted of 18 items designed to reflect current symptomatology of ADHD based on DSM-IV-TR criteria, completed by the Investigator. Each item was scored from a range of 0 (reflecting no symptoms) to 3 (reflecting severe symptoms) with total scores ranging from 0-54. The 18 items were grouped into 2 sub-scales: hyperactivity/impulsivity and inattention. Inattention subscale score consisted of odd number items 1-17 with scores ranging from 0 to 27. Higher score indicated worse symptom.|scores on a scale|Mean|22.1|22.1|Standard Deviation|3.52|3.52|||
3957447|NCT01328756|3779518|B1|||Attention-Deficit/Hyperactivity Disorder Rating Scale-IV (ADHD-RS-IV): Total Score|ADHD-RS-IV consisted of 18 items designed to reflect current symptomatology of ADHD based on Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition – Text Revision (DSM-IV-TR) criteria, completed by the Investigator. Each item was scored from a range of 0 (reflecting no symptoms) to 3 (reflecting severe symptoms) with total scores ranging from 0-54. The 18 items were grouped into 2 sub-scales: hyperactivity/impulsivity (even number items 2-18 with score range of 0 to 27) and inattention (odd number items 1-17 with score range of 0 to 27). Higher scores depicted worse symptoms.|scores on a scale|Mean|41.1|41.1|Standard Deviation|7.03|7.03|||
3957448|NCT01328756|3779518|B1|||Body Mass Index (BMI)|BMI was calculated as (weight [kilogram] per height [square meter]) at screening.|kilogram per square meter|Mean|19.22|19.22|Standard Deviation|3.389|3.389|||
3957449|NCT01328756|3779518|B1|||Height||centimeters|Mean|152.29|152.29|Standard Deviation|16.633|16.633|||
3957450|NCT01328756|3779518|B1|||Body Weight||kilogram(s)|Mean|46.13|46.13|Standard Deviation|16.434|16.434|||
3957451|NCT01328756|3779518|B1|Among the most extremely ill participants||Clinical Global Impressions – Severity of Illness (CGI-S) Rating|The Clinical Global Impressions (CGI) Scale permits a global evaluation of the participant’s severity and improvement over time. This assessment will help guide the clinician on dosing adjustments. The CGI has been used extensively in clinical studies of ADHD. CGI-S was a 7-point scale ranging from 1 (normal, not at all ill) to 7 (among the most extremely ill participants), evaluated by the Investigator.|participants|Number|11|11.0||||||
3957452|NCT01328756|3779518|B1|Severely ill||Clinical Global Impressions – Severity of Illness (CGI-S) Rating|The Clinical Global Impressions (CGI) Scale permits a global evaluation of the participant’s severity and improvement over time. This assessment will help guide the clinician on dosing adjustments. The CGI has been used extensively in clinical studies of ADHD. CGI-S was a 7-point scale ranging from 1 (normal, not at all ill) to 7 (among the most extremely ill participants), evaluated by the Investigator.|participants|Number|81|81.0||||||
3957453|NCT01328756|3779518|B1|Markedly ill||Clinical Global Impressions – Severity of Illness (CGI-S) Rating|The Clinical Global Impressions (CGI) Scale permits a global evaluation of the participant’s severity and improvement over time. This assessment will help guide the clinician on dosing adjustments. The CGI has been used extensively in clinical studies of ADHD. CGI-S was a 7-point scale ranging from 1 (normal, not at all ill) to 7 (among the most extremely ill participants), evaluated by the Investigator.|participants|Number|152|152.0||||||
3957454|NCT01328756|3779518|B1|Moderately ill||Clinical Global Impressions – Severity of Illness (CGI-S) Rating|The Clinical Global Impressions (CGI) Scale permits a global evaluation of the participant’s severity and improvement over time. This assessment will help guide the clinician on dosing adjustments. The CGI has been used extensively in clinical studies of ADHD. CGI-S was a 7-point scale ranging from 1 (normal, not at all ill) to 7 (among the most extremely ill participants), evaluated by the Investigator.|participants|Number|69|69.0||||||
3957455|NCT01328756|3779518|B1|Mildly ill||Clinical Global Impressions – Severity of Illness (CGI-S) Rating|The Clinical Global Impressions (CGI) Scale permits a global evaluation of the participant’s severity and improvement over time. This assessment will help guide the clinician on dosing adjustments. The CGI has been used extensively in clinical studies of ADHD. CGI-S was a 7-point scale ranging from 1 (normal, not at all ill) to 7 (among the most extremely ill participants), evaluated by the Investigator.|participants|Number|1|1.0||||||
3957456|NCT01328756|3779518|B1|Borderline mentally ill||Clinical Global Impressions – Severity of Illness (CGI-S) Rating|The Clinical Global Impressions (CGI) Scale permits a global evaluation of the participant’s severity and improvement over time. This assessment will help guide the clinician on dosing adjustments. The CGI has been used extensively in clinical studies of ADHD. CGI-S was a 7-point scale ranging from 1 (normal, not at all ill) to 7 (among the most extremely ill participants), evaluated by the Investigator.|participants|Number|0|0.0||||||
3957457|NCT01328756|3779518|B1|Normal, not all ill||Clinical Global Impressions – Severity of Illness (CGI-S) Rating|The Clinical Global Impressions (CGI) Scale permits a global evaluation of the participant’s severity and improvement over time. This assessment will help guide the clinician on dosing adjustments. The CGI has been used extensively in clinical studies of ADHD. CGI-S was a 7-point scale ranging from 1 (normal, not at all ill) to 7 (among the most extremely ill participants), evaluated by the Investigator.|participants|Number|0|0.0||||||
3957458|NCT01328756|3779518|B1||Male|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
3957459|NCT01328756|3779518|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3957460|NCT01328756|3779518|B1|||Age||years|Mean|11.4|11.4|Standard Deviation|2.88|2.88|||
3957461|NCT01328717|3779535|B1|United States||Region of Enrollment||participants|Number|77|77.0||||||
3957462|NCT01328717|3779535|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3957463|NCT01328717|3779535|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3957464|NCT01328717|3779535|B1|||Age, Customized||years|Mean|55|55.0|Full Range|||20.0|85.0|
3957465|NCT01328574|3779540|B1|5||Number of Previous Therapies for Metastatic Disease||participants|Number|1|1.0||||||
3957466|NCT01328574|3779540|B1|4||Number of Previous Therapies for Metastatic Disease||participants|Number|2|2.0||||||
3957467|NCT01328574|3779540|B1|3||Number of Previous Therapies for Metastatic Disease||participants|Number|3|3.0||||||
3957468|NCT01328574|3779540|B1|2||Number of Previous Therapies for Metastatic Disease||participants|Number|4|4.0||||||
3957469|NCT01328574|3779540|B1|1||Number of Previous Therapies for Metastatic Disease||participants|Number|3|3.0||||||
3957470|NCT01328574|3779540|B1|Lymph node only||Metastatic Sites of Disease||participants|Number|3|3.0||||||
3957471|NCT01328574|3779540|B1|Any visceral metastases||Metastatic Sites of Disease||participants|Number|10|10.0||||||
3957472|NCT01328574|3779540|B1|Bone||Metastatic Sites of Disease||participants|Number|4|4.0||||||
3957473|NCT01328574|3779540|B1|Liver||Metastatic Sites of Disease||participants|Number|2|2.0||||||
3957474|NCT01328574|3779540|B1|Lung||Metastatic Sites of Disease||participants|Number|7|7.0||||||
3957475|NCT01328574|3779540|B1|Upper urinary tract||Primary Tumor Site||participants|Number|2|2.0||||||
3957476|NCT01328574|3779540|B1|Bladder||Primary Tumor Site||participants|Number|11|11.0||||||
3957477|NCT01328574|3779540|B1|90||Karnofsky Performance Status|Karnofsky Performance Scale: 60 - requires occasional assistance, but is able to care for most of his/her needs; 70 - cares for self, unable to carry on normal activity or to do active work; 80 - normal activity with effort; some signs or symptoms of disease; 90 - able to carry on normal activity; minor signs or symptoms of disease.|participants|Number|10|10.0||||||
3957478|NCT01328574|3779540|B1|80||Karnofsky Performance Status|Karnofsky Performance Scale: 60 - requires occasional assistance, but is able to care for most of his/her needs; 70 - cares for self, unable to carry on normal activity or to do active work; 80 - normal activity with effort; some signs or symptoms of disease; 90 - able to carry on normal activity; minor signs or symptoms of disease.|participants|Number|2|2.0||||||
3957479|NCT01328574|3779540|B1|70||Karnofsky Performance Status|Karnofsky Performance Scale: 60 - requires occasional assistance, but is able to care for most of his/her needs; 70 - cares for self, unable to carry on normal activity or to do active work; 80 - normal activity with effort; some signs or symptoms of disease; 90 - able to carry on normal activity; minor signs or symptoms of disease.|participants|Number|0|0.0||||||
3957480|NCT01328574|3779540|B1|60||Karnofsky Performance Status|Karnofsky Performance Scale: 60 - requires occasional assistance, but is able to care for most of his/her needs; 70 - cares for self, unable to carry on normal activity or to do active work; 80 - normal activity with effort; some signs or symptoms of disease; 90 - able to carry on normal activity; minor signs or symptoms of disease.|participants|Number|1|1.0||||||
3957481|NCT01328574|3779540|B1|||Median Age (Range)||years|Median|67|67.0|Full Range|||51.0|73.0|
3957482|NCT01328574|3779540|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3957483|NCT01328574|3779540|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3957484|NCT01328574|3779540|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3957485|NCT01328574|3779540|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3957486|NCT01328574|3779540|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3957487|NCT01328574|3779540|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3957488|NCT01328574|3779540|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3957489|NCT01328574|3779540|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3957490|NCT01328574|3779540|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3957491|NCT01328574|3779540|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3957492|NCT01328574|3779540|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3957493|NCT01328574|3779540|B1||Male|Gender||Participants|Count of Participants|8|8.0||||||
3957494|NCT01328574|3779540|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
3957495|NCT01328574|3779540|B1|||Age||years|Mean|63.28|63.28|Standard Deviation|6.64|6.64|||
3957496|NCT01328574|3779540|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3957497|NCT01328574|3779540|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3957498|NCT01328574|3779540|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3957499|NCT01328548|3779552|B3|Canada||Region of Enrollment||Participants|Number|241|241.0||||||
3957500|NCT01328548|3779553|B2|Canada||Region of Enrollment||Participants|Number|50|50.0||||||
3957501|NCT01328548|3779554|B1|Canada||Region of Enrollment||Participants|Number|191|191.0||||||
3957502|NCT01328548|3779552|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3957503|NCT01328548|3779553|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3957504|NCT01328548|3779554|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3957505|NCT01328548|3779552|B3||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
3957506|NCT01328548|3779553|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3957507|NCT01328548|3779554|B1||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3957508|NCT01328548|3779552|B3|||Age||Years|Mean|84.5|84.5|Standard Deviation|9.9|9.9|||
3957509|NCT01328548|3779553|B2|||Age||Years|Mean|67.3|67.3|Standard Deviation|4.34|4.34|||
3957510|NCT01328548|3779554|B1|||Age||Years|Mean|89.0|89.0|Standard Deviation|4.69|4.69|||
3957511|NCT01328548|3779552|B3||>=65 years|Age||Participants|Count of Participants|226|226.0||||||
3957512|NCT01328548|3779553|B2||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
3957513|NCT01328548|3779554|B1||>=65 years|Age||Participants|Count of Participants|191|191.0||||||
3957514|NCT01328548|3779552|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3957515|NCT01328548|3779553|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3957516|NCT01328548|3779554|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3957517|NCT01328548|3779552|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3957518|NCT01328548|3779553|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3957519|NCT01328548|3779554|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3957520|NCT01328535|3779573|B1|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3957521|NCT01328535|3779573|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3957522|NCT01328535|3779573|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3957523|NCT01328535|3779573|B1|||Age||years|Median|69.5|69.5|Full Range|||36.0|84.0|
3957524|NCT01328496|3779582|B3||Declined to respond|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3957525|NCT01328496|3779583|B2||Declined to respond|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3957526|NCT01328496|3779584|B1||Declined to respond|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3957527|NCT01328496|3779582|B3||Puerto Rican|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3957528|NCT01328496|3779583|B2||Puerto Rican|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3957529|NCT01328496|3779584|B1||Puerto Rican|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3957530|NCT01328496|3779582|B3||Non Spanish speaking, Non Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3957531|NCT01328496|3779583|B2||Non Spanish speaking, Non Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3957532|NCT01328496|3779584|B1||Non Spanish speaking, Non Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3957533|NCT01328496|3779582|B3||NOS Spanish, Hispanic, latino|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3957534|NCT01328496|3779583|B2||NOS Spanish, Hispanic, latino|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3957535|NCT01328496|3779584|B1||NOS Spanish, Hispanic, latino|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3957536|NCT01328496|3779582|B3||Mexican/Chicano|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3957537|NCT01328496|3779583|B2||Mexican/Chicano|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3957538|NCT01328496|3779584|B1||Mexican/Chicano|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3957539|NCT01328496|3779582|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3957540|NCT01328496|3779583|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3957541|NCT01328496|3779584|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3957542|NCT01328496|3779582|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3957543|NCT01328496|3779583|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3957544|NCT01328496|3779584|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3957545|NCT01328496|3779582|B3|||Age||years|Mean|6.76|6.76|Standard Deviation|5.83|5.83|||
3957546|NCT01328496|3779583|B2|||Age||years|Mean|14.3|14.3|Standard Deviation|2.98|2.98|||
3957547|NCT01328496|3779584|B1|||Age||years|Mean|3.40|3.4|Standard Deviation|2.54|2.54|||
3957548|NCT01328444|3779603|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3957549|NCT01328444|3779603|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|336|336.0||||||
3957550|NCT01328444|3779603|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3957551|NCT01328444|3779603|B1||Male|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
3957552|NCT01328444|3779603|B1||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3957553|NCT01328444|3779603|B1|||Age||Years|Mean|61.6|61.6|Standard Deviation|8.25|8.25|||
3957554|NCT01328431|3779652|B3||Male|Sex: Female, Male||Participants|Count of Participants|371|371.0||||||
3957555|NCT01328431|3779653|B2||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
3957556|NCT01328431|3779654|B1||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3957557|NCT01328431|3779652|B3||Female|Sex: Female, Male||Participants|Count of Participants|407|407.0||||||
3957558|NCT01328431|3779653|B2||Female|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
3957559|NCT01328431|3779654|B1||Female|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
3957560|NCT01328431|3779652|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3957561|NCT01328431|3779653|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3957562|NCT01328431|3779654|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3957563|NCT01328431|3779652|B3||Between 18 and 65 years|Age||Participants|Count of Participants|760|760.0||||||
3957564|NCT01328431|3779653|B2||Between 18 and 65 years|Age||Participants|Count of Participants|376|376.0||||||
3957565|NCT01328431|3779654|B1||Between 18 and 65 years|Age||Participants|Count of Participants|384|384.0||||||
3957566|NCT01328431|3779652|B3||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3957567|NCT01328431|3779653|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3957568|NCT01328431|3779654|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3957569|NCT01328405|3779663|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
3957570|NCT01328405|3779664|B2|United States||Region of Enrollment||participants|Number|48|48.0||||||
3957571|NCT01328405|3779665|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
3957572|NCT01328405|3779663|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3957573|NCT01328405|3779664|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3957574|NCT01328405|3779665|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3957575|NCT01328405|3779663|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3957576|NCT01328405|3779664|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3957577|NCT01328405|3779665|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3957578|NCT01328405|3779663|B3|||Age||years|Mean|39|39.0|Standard Deviation|13|13.0|||
3957579|NCT01328405|3779664|B2|||Age||years|Mean|39|39.0|Standard Deviation|14|14.0|||
3957580|NCT01328405|3779665|B1|||Age||years|Mean|39|39.0|Standard Deviation|12|12.0|||
3957581|NCT01328405|3779663|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3957582|NCT01328405|3779664|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3957583|NCT01328405|3779665|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3957584|NCT01328405|3779663|B3||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
3957585|NCT01328405|3779664|B2||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3957586|NCT01328405|3779665|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3957587|NCT01328405|3779663|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3957588|NCT01328405|3779664|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3957589|NCT01328405|3779665|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3957590|NCT01328379|3779680|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3957591|NCT01328379|3779681|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3957592|NCT01328379|3779682|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3957593|NCT01328379|3779683|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3957594|NCT01328379|3779680|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|409|409.0||||||
3957595|NCT01328379|3779681|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
3957596|NCT01328379|3779682|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|137|137.0||||||
3957597|NCT01328379|3779683|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
3957598|NCT01328379|3779680|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3957599|NCT01328379|3779681|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3957600|NCT01328379|3779682|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3957601|NCT01328379|3779683|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3957602|NCT01328379|3779680|B4||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3957603|NCT01328379|3779681|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3957604|NCT01328379|3779682|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3957605|NCT01328379|3779683|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3957606|NCT01328379|3779680|B4||Female|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
3957607|NCT01328379|3779681|B3||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3957608|NCT01328379|3779682|B2||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3957609|NCT01328379|3779683|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3957610|NCT01328379|3779680|B4|||Age||years|Mean|52.6|52.6|Standard Deviation|0.46|0.46|||
3957611|NCT01328379|3779681|B3|||Age||years|Mean|53.4|53.4|Standard Deviation|0.79|0.79|||
3957612|NCT01328379|3779682|B2|||Age||years|Mean|52.2|52.2|Standard Deviation|0.77|0.77|||
3957613|NCT01328379|3779683|B1|||Age||years|Mean|52.2|52.2|Standard Deviation|0.83|0.83|||
3957614|NCT01328366|3779711|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3957615|NCT01328366|3779711|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3957616|NCT01328366|3779711|B1|||Age||years|Mean|24.0|24.0|Standard Deviation|12.68|12.68|||
3957617|NCT01328249|3779729|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3957618|NCT01328249|3779730|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3957619|NCT01328249|3779731|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3957620|NCT01328249|3779729|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3957621|NCT01328249|3779730|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3957622|NCT01328249|3779731|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3957623|NCT01328249|3779729|B3|||Age||Years|Mean|49.6|49.6|Standard Deviation|9.12|9.12|||
3957624|NCT01328249|3779730|B2|||Age||Years|Mean|50.1|50.1|Standard Deviation|9.33|9.33|||
3957625|NCT01328249|3779731|B1|||Age||Years|Mean|49.4|49.4|Standard Deviation|9.09|9.09|||
3957626|NCT01328184|3779740|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3957627|NCT01328184|3779740|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3957628|NCT01328184|3779740|B1|||Age||years|Mean|27.2|27.2|Standard Deviation|4.1|4.1|||
3957629|NCT01328158|3779780|B1|Present||Presence/Absence of Previous Treatment of HIV-Infection||participants|Number|210|210.0||||||
3957630|NCT01328158|3779780|B1|Absent||Presence/Absence of Previous Treatment of HIV-Infection||participants|Number|10|10.0||||||
3957631|NCT01328158|3779780|B1||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
3957632|NCT01328158|3779780|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3957633|NCT01328158|3779780|B1|||Age||years|Mean|43.6|43.6|Standard Deviation|10.1|10.1|||
3957634|NCT01328080|3779818|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3957635|NCT01328080|3779818|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3957636|NCT01328080|3779818|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3957637|NCT01328080|3779818|B1|||Age||years|Mean|36.6|36.6|Standard Deviation|6.6|6.6|||
3957638|NCT01328080|3779818|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3957639|NCT01328080|3779818|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3957640|NCT01328080|3779818|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3957641|NCT01328054|3779822|B1|missing||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3957642|NCT01328054|3779822|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|51|51.0||||||
3957643|NCT01328054|3779822|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3957644|NCT01328054|3779822|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3957645|NCT01328054|3779822|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3957646|NCT01328054|3779822|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3957647|NCT01328054|3779822|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3957648|NCT01328054|3779822|B1|||Age||Years|Mean|55.1|55.1|Standard Deviation|12.30|12.3|||
3957649|NCT01328041|3779848|B1|White and African American/African Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3957650|NCT01328041|3779848|B1|White||Race/Ethnicity, Customized||participants|Number|130|130.0||||||
3957651|NCT01328041|3779848|B1|Asian-Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3957652|NCT01328041|3779848|B1|American Indian or Alaska Native and White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3957653|NCT01328041|3779848|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
3957654|NCT01328041|3779848|B1||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3957655|NCT01328041|3779848|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3957656|NCT01328041|3779848|B1|||Age||Years|Median|48|48.0|Full Range|||19.0|67.0|
3957657|NCT01327989|3779870|B1|||Modified Rankin Scale (mRS)|The mRS measures degree of disability. (0 No symptoms at all, 1 No significant disability despite symptoms; able to carry out all usual duties and activities, 2 Slight disability; unable to carry out all previous activities, but able to look after own affairs without assistance, 3 Moderate disability; requiring some help, but able to walk without assistance, 4 Moderately severe disability; unable to walk without assistance and unable to attend to own bodily needs without assistance, 5 Severe disability; bedridden, incontinent and requiring constant nursing care and attention, 6 Dead)|Scores on a scale|Median|0.0|0.0|Inter-Quartile Range|||0.0|3.0|
3957658|NCT01327989|3779870|B1||Male|Gender||Participants|Count of Participants|80|80.0||||||
3957659|NCT01327989|3779870|B1||Female|Gender||Participants|Count of Participants|122|122.0||||||
3957660|NCT01327989|3779870|B1|||Age||years|Mean|68.4|68.4|Standard Deviation|12.5|12.5|||
3957661|NCT01327976|3779882|B3|Australia||Region of Enrollment||participants|Number|57|57.0||||||
3957662|NCT01327976|3779883|B2|Australia||Region of Enrollment||participants|Number|17|17.0||||||
3957663|NCT01327976|3779884|B1|Australia||Region of Enrollment||participants|Number|40|40.0||||||
3957664|NCT01327976|3779882|B3|United States||Region of Enrollment||participants|Number|182|182.0||||||
3957665|NCT01327976|3779883|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
3957666|NCT01327976|3779884|B1|United States||Region of Enrollment||participants|Number|122|122.0||||||
3957667|NCT01327976|3779882|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3957668|NCT01327976|3779883|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3957669|NCT01327976|3779884|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3957670|NCT01327976|3779882|B3||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
3957671|NCT01327976|3779883|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3957672|NCT01327976|3779884|B1||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3957673|NCT01327976|3779882|B3|||Age||years|Mean|47|47.0|Standard Deviation|10|10.0|||
3957674|NCT01327976|3779883|B2|||Age||years|Mean|47|47.0|Standard Deviation|9|9.0|||
3957675|NCT01327976|3779884|B1|||Age||years|Mean|47|47.0|Standard Deviation|10|10.0|||
3957676|NCT01327976|3779882|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3957677|NCT01327976|3779883|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3957678|NCT01327976|3779884|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3957679|NCT01327976|3779882|B3||Between 18 and 65 years|Age||Participants|Count of Participants|239|239.0||||||
3957680|NCT01327976|3779883|B2||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
3957681|NCT01327976|3779884|B1||Between 18 and 65 years|Age||Participants|Count of Participants|162|162.0||||||
3957682|NCT01327976|3779882|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3957683|NCT01327976|3779883|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3957684|NCT01327976|3779884|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3957685|NCT01327885|3779895|B3||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3957686|NCT01327885|3779896|B2||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3957687|NCT01327885|3779897|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3957688|NCT01327885|3779895|B3||Female|Sex: Female, Male||Participants|Count of Participants|303|303.0||||||
3957689|NCT01327885|3779896|B2||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3957690|NCT01327885|3779897|B1||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3957691|NCT01327885|3779895|B3|||Age||Years|Geometric Mean|55.7|55.7|Standard Deviation|10.68|10.68|||
3957692|NCT01327885|3779896|B2|||Age||Years|Geometric Mean|55.7|55.7|Standard Deviation|10.35|10.35|||
3957693|NCT01327885|3779897|B1|||Age||Years|Geometric Mean|55.6|55.6|Standard Deviation|11.01|11.01|||
3957694|NCT01327703|3779910|B1|||Nutritional status as assessed by Vitamin D level|Nutritional status was assessed by determining Vitamin D level. Number of participants who were evaluable for Vitamin D level was 86.|nanomole/L (nmol/L)|Mean|55.4|55.4|Standard Deviation|33.24|33.24|||
3957695|NCT01327703|3779910|B1|Vitamin E (Beta-Gamma-Tocopherol) (n=83)||Nutritional status as assessed by Vitamin A and E level|Nutritional status was assessed by determining Vitamin A and E (Alpha-Tocopherol and Beta-Gamma-Tocopherol) level. Here, 'n' signifies number of participants who were evaluable for the specific categories of this baseline characteristic.|micromole/liter (mcmol/L)|Mean|1.231|1.231|Standard Deviation|2.0781|2.0781|||
3957696|NCT01327703|3779910|B1|Vitamin E (Alpha-Tocopherol) (n=87)||Nutritional status as assessed by Vitamin A and E level|Nutritional status was assessed by determining Vitamin A and E (Alpha-Tocopherol and Beta-Gamma-Tocopherol) level. Here, 'n' signifies number of participants who were evaluable for the specific categories of this baseline characteristic.|micromole/liter (mcmol/L)|Mean|18.554|18.554|Standard Deviation|8.9713|8.9713|||
3957697|NCT01327703|3779910|B1|Vitamin A (n=87)||Nutritional status as assessed by Vitamin A and E level|Nutritional status was assessed by determining Vitamin A and E (Alpha-Tocopherol and Beta-Gamma-Tocopherol) level. Here, 'n' signifies number of participants who were evaluable for the specific categories of this baseline characteristic.|micromole/liter (mcmol/L)|Mean|1.403|1.403|Standard Deviation|0.5329|0.5329|||
3957698|NCT01327703|3779910|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3957699|NCT01327703|3779910|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3957700|NCT01327703|3779910|B1|||Age||years|Mean|13.6|13.6|Standard Deviation|6.14|6.14|||
3957701|NCT01327677|3779943|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3957702|NCT01327677|3779944|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3957703|NCT01327677|3779945|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3957704|NCT01327677|3779943|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3957705|NCT01327677|3779944|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3957706|NCT01327677|3779945|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3957707|NCT01327677|3779943|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|86|86.0||||||
3957708|NCT01327677|3779944|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
3957709|NCT01327677|3779945|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3957710|NCT01327677|3779943|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3957711|NCT01327677|3779944|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3957712|NCT01327677|3779945|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3957713|NCT01327677|3779943|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3957714|NCT01327677|3779944|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3957715|NCT01327677|3779945|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3957716|NCT01327677|3779943|B3|||Age||years|Mean|49.8|49.8|Standard Deviation|13.8|13.8|||
3957717|NCT01327677|3779944|B2|||Age||years|Mean|50.4|50.4|Standard Deviation|13.7|13.7|||
3957718|NCT01327677|3779945|B1|||Age||years|Mean|49.1|49.1|Standard Deviation|14.0|14.0|||
3957719|NCT01327651|3779958|B10|||Number of anal intercourse without a condom||anal intercourse|Median|1|1.0|Inter-Quartile Range|||0.0|5.0|
3957720|NCT01327651|3779959|B9|||Number of anal intercourse without a condom||anal intercourse|Median|5|5.0|Inter-Quartile Range|||1.0|9.0|
3957721|NCT01327651|3779960|B8|||Number of anal intercourse without a condom||anal intercourse|Median|3|3.0|Inter-Quartile Range|||1.0|10.0|
3957722|NCT01327651|3779961|B7|||Number of anal intercourse without a condom||anal intercourse|Median|3|3.0|Inter-Quartile Range|||0.0|5.0|
3957723|NCT01327651|3779962|B6|||Number of anal intercourse without a condom||anal intercourse|Median|0|0.0|Inter-Quartile Range|||0.0|0.0|
3957724|NCT01327651|3779963|B5|||Number of anal intercourse without a condom||anal intercourse|Median|0|0.0|Inter-Quartile Range|||0.0|3.0|
3957725|NCT01327651|3779964|B4|||Number of anal intercourse without a condom||anal intercourse|Median|0|0.0|Inter-Quartile Range|||0.0|5.0|
3957726|NCT01327651|3779965|B3|||Number of anal intercourse without a condom||anal intercourse|Median|1|1.0|Inter-Quartile Range|||0.0|4.0|
3957727|NCT01327651|3779966|B2|||Number of anal intercourse without a condom||anal intercourse|Median|2|2.0|Inter-Quartile Range|||0.0|5.0|
3957728|NCT01327651|3779967|B1|||Number of anal intercourse without a condom||anal intercourse|Median|2|2.0|Inter-Quartile Range|||0.0|7.0|
3957729|NCT01327651|3779958|B10|||Number of sex partners in the past 3 months|Median number of sex partners in the past 3 months, measured at baseline|sex partners|Median|2|2.0|Inter-Quartile Range|||1.0|5.0|
3957730|NCT01327651|3779959|B9|||Number of sex partners in the past 3 months|Median number of sex partners in the past 3 months, measured at baseline|sex partners|Median|4|4.0|Inter-Quartile Range|||2.0|7.0|
3957731|NCT01327651|3779960|B8|||Number of sex partners in the past 3 months|Median number of sex partners in the past 3 months, measured at baseline|sex partners|Median|3|3.0|Inter-Quartile Range|||2.0|6.0|
3957732|NCT01327651|3779961|B7|||Number of sex partners in the past 3 months|Median number of sex partners in the past 3 months, measured at baseline|sex partners|Median|3|3.0|Inter-Quartile Range|||2.0|5.0|
3957733|NCT01327651|3779962|B6|||Number of sex partners in the past 3 months|Median number of sex partners in the past 3 months, measured at baseline|sex partners|Median|3|3.0|Inter-Quartile Range|||2.0|5.0|
3957734|NCT01327651|3779963|B5|||Number of sex partners in the past 3 months|Median number of sex partners in the past 3 months, measured at baseline|sex partners|Median|3|3.0|Inter-Quartile Range|||1.0|10.0|
3957735|NCT01327651|3779964|B4|||Number of sex partners in the past 3 months|Median number of sex partners in the past 3 months, measured at baseline|sex partners|Median|3|3.0|Inter-Quartile Range|||2.0|10.0|
3957736|NCT01327651|3779965|B3|||Number of sex partners in the past 3 months|Median number of sex partners in the past 3 months, measured at baseline|sex partners|Median|1|1.0|Inter-Quartile Range|||1.0|1.0|
3957737|NCT01327651|3779966|B2|||Number of sex partners in the past 3 months|Median number of sex partners in the past 3 months, measured at baseline|sex partners|Median|1|1.0|Inter-Quartile Range|||1.0|1.0|
3957738|NCT01327651|3779967|B1|||Number of sex partners in the past 3 months|Median number of sex partners in the past 3 months, measured at baseline|sex partners|Median|1|1.0|Inter-Quartile Range|||1.0|1.0|
3957739|NCT01327651|3779958|B10||Secondary and above|Education||Participants|Count of Participants|376|376.0||||||
3957740|NCT01327651|3779959|B9||Secondary and above|Education||Participants|Count of Participants|53|53.0||||||
3957741|NCT01327651|3779960|B8||Secondary and above|Education||Participants|Count of Participants|42|42.0||||||
3957742|NCT01327651|3779961|B7||Secondary and above|Education||Participants|Count of Participants|43|43.0||||||
3957743|NCT01327651|3779962|B6||Secondary and above|Education||Participants|Count of Participants|58|58.0||||||
3957744|NCT01327651|3779963|B5||Secondary and above|Education||Participants|Count of Participants|58|58.0||||||
3957745|NCT01327651|3779964|B4||Secondary and above|Education||Participants|Count of Participants|60|60.0||||||
3957746|NCT01327651|3779965|B3||Secondary and above|Education||Participants|Count of Participants|21|21.0||||||
3957747|NCT01327651|3779966|B2||Secondary and above|Education||Participants|Count of Participants|20|20.0||||||
3957748|NCT01327651|3779967|B1||Secondary and above|Education||Participants|Count of Participants|21|21.0||||||
3957749|NCT01327651|3779958|B10||Less than secondary|Education||Participants|Count of Participants|159|159.0||||||
3957750|NCT01327651|3779959|B9||Less than secondary|Education||Participants|Count of Participants|7|7.0||||||
3957751|NCT01327651|3779960|B8||Less than secondary|Education||Participants|Count of Participants|18|18.0||||||
3957752|NCT01327651|3779961|B7||Less than secondary|Education||Participants|Count of Participants|16|16.0||||||
3957753|NCT01327651|3779962|B6||Less than secondary|Education||Participants|Count of Participants|1|1.0||||||
3957754|NCT01327651|3779963|B5||Less than secondary|Education||Participants|Count of Participants|1|1.0||||||
3957755|NCT01327651|3779964|B4||Less than secondary|Education||Participants|Count of Participants|0|0.0||||||
3957756|NCT01327651|3779965|B3||Less than secondary|Education||Participants|Count of Participants|39|39.0||||||
3957757|NCT01327651|3779966|B2||Less than secondary|Education||Participants|Count of Participants|39|39.0||||||
3957758|NCT01327651|3779967|B1||Less than secondary|Education||Participants|Count of Participants|38|38.0||||||
3957759|NCT01327651|3779958|B10|Gender queer||Sex/Gender, Customized||Participants|Count of Participants|2|2.0||||||
3957760|NCT01327651|3779959|B9|Gender queer||Sex/Gender, Customized||Participants|Count of Participants|1|1.0||||||
3957761|NCT01327651|3779960|B8|Gender queer||Sex/Gender, Customized||Participants|Count of Participants|1|1.0||||||
3957762|NCT01327651|3779961|B7|Gender queer||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3957763|NCT01327651|3779962|B6|Gender queer||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3957764|NCT01327651|3779963|B5|Gender queer||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3957765|NCT01327651|3779964|B4|Gender queer||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3957766|NCT01327651|3779965|B3|Gender queer||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3957767|NCT01327651|3779966|B2|Gender queer||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3957768|NCT01327651|3779967|B1|Gender queer||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3957769|NCT01327651|3779958|B10|Transgender woman||Sex/Gender, Customized||Participants|Count of Participants|5|5.0||||||
3957770|NCT01327651|3779959|B9|Transgender woman||Sex/Gender, Customized||Participants|Count of Participants|1|1.0||||||
3957771|NCT01327651|3779960|B8|Transgender woman||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3957772|NCT01327651|3779961|B7|Transgender woman||Sex/Gender, Customized||Participants|Count of Participants|2|2.0||||||
3957773|NCT01327651|3779962|B6|Transgender woman||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3957774|NCT01327651|3779963|B5|Transgender woman||Sex/Gender, Customized||Participants|Count of Participants|1|1.0||||||
3957775|NCT01327651|3779964|B4|Transgender woman||Sex/Gender, Customized||Participants|Count of Participants|1|1.0||||||
3957776|NCT01327651|3779965|B3|Transgender woman||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3957777|NCT01327651|3779966|B2|Transgender woman||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3957778|NCT01327651|3779967|B1|Transgender woman||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3957779|NCT01327651|3779958|B10|Male||Sex/Gender, Customized||Participants|Count of Participants|350|350.0||||||
3957780|NCT01327651|3779959|B9|Male||Sex/Gender, Customized||Participants|Count of Participants|58|58.0||||||
3957781|NCT01327651|3779960|B8|Male||Sex/Gender, Customized||Participants|Count of Participants|59|59.0||||||
3957782|NCT01327651|3779961|B7|Male||Sex/Gender, Customized||Participants|Count of Participants|57|57.0||||||
3957783|NCT01327651|3779962|B6|Male||Sex/Gender, Customized||Participants|Count of Participants|59|59.0||||||
3957784|NCT01327651|3779963|B5|Male||Sex/Gender, Customized||Participants|Count of Participants|58|58.0||||||
3957785|NCT01327651|3779964|B4|Male||Sex/Gender, Customized||Participants|Count of Participants|59|59.0||||||
3957786|NCT01327651|3779965|B3|Male||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3957787|NCT01327651|3779966|B2|Male||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3957788|NCT01327651|3779967|B1|Male||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3957789|NCT01327651|3779958|B10|Female||Sex/Gender, Customized||Participants|Count of Participants|178|178.0||||||
3957790|NCT01327651|3779959|B9|Female||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3957791|NCT01327651|3779960|B8|Female||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3957792|NCT01327651|3779961|B7|Female||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3957793|NCT01327651|3779962|B6|Female||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3957794|NCT01327651|3779963|B5|Female||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3957795|NCT01327651|3779964|B4|Female||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3957796|NCT01327651|3779965|B3|Female||Sex/Gender, Customized||Participants|Count of Participants|60|60.0||||||
3957797|NCT01327651|3779966|B2|Female||Sex/Gender, Customized||Participants|Count of Participants|59|59.0||||||
3957798|NCT01327651|3779967|B1|Female||Sex/Gender, Customized||Participants|Count of Participants|59|59.0||||||
3957799|NCT01327651|3779958|B10|40+ years||Age, Customized||Participants|Count of Participants|100|100.0||||||
3957800|NCT01327651|3779959|B9|40+ years||Age, Customized||Participants|Count of Participants|21|21.0||||||
3957801|NCT01327651|3779960|B8|40+ years||Age, Customized||Participants|Count of Participants|20|20.0||||||
3957802|NCT01327651|3779961|B7|40+ years||Age, Customized||Participants|Count of Participants|16|16.0||||||
3957803|NCT01327651|3779962|B6|40+ years||Age, Customized||Participants|Count of Participants|7|7.0||||||
3957804|NCT01327651|3779963|B5|40+ years||Age, Customized||Participants|Count of Participants|5|5.0||||||
3957805|NCT01327651|3779964|B4|40+ years||Age, Customized||Participants|Count of Participants|3|3.0||||||
3957806|NCT01327651|3779965|B3|40+ years||Age, Customized||Participants|Count of Participants|10|10.0||||||
3957807|NCT01327651|3779966|B2|40+ years||Age, Customized||Participants|Count of Participants|9|9.0||||||
3957808|NCT01327651|3779967|B1|40+ years||Age, Customized||Participants|Count of Participants|9|9.0||||||
3957809|NCT01327651|3779958|B10|30-39 years||Age, Customized||Participants|Count of Participants|161|161.0||||||
3957810|NCT01327651|3779959|B9|30-39 years||Age, Customized||Participants|Count of Participants|14|14.0||||||
3957811|NCT01327651|3779960|B8|30-39 years||Age, Customized||Participants|Count of Participants|12|12.0||||||
3957812|NCT01327651|3779961|B7|30-39 years||Age, Customized||Participants|Count of Participants|11|11.0||||||
3957813|NCT01327651|3779962|B6|30-39 years||Age, Customized||Participants|Count of Participants|28|28.0||||||
3957814|NCT01327651|3779963|B5|30-39 years||Age, Customized||Participants|Count of Participants|23|23.0||||||
3957815|NCT01327651|3779964|B4|30-39 years||Age, Customized||Participants|Count of Participants|36|36.0||||||
3957816|NCT01327651|3779965|B3|30-39 years||Age, Customized||Participants|Count of Participants|16|16.0||||||
3957817|NCT01327651|3779966|B2|30-39 years||Age, Customized||Participants|Count of Participants|11|11.0||||||
3957818|NCT01327651|3779967|B1|30-39 years||Age, Customized||Participants|Count of Participants|10|10.0||||||
3957819|NCT01327651|3779958|B10|25-29 years||Age, Customized||Participants|Count of Participants|117|117.0||||||
3957820|NCT01327651|3779959|B9|25-29 years||Age, Customized||Participants|Count of Participants|8|8.0||||||
3957821|NCT01327651|3779960|B8|25-29 years||Age, Customized||Participants|Count of Participants|11|11.0||||||
3957822|NCT01327651|3779961|B7|25-29 years||Age, Customized||Participants|Count of Participants|13|13.0||||||
3957823|NCT01327651|3779962|B6|25-29 years||Age, Customized||Participants|Count of Participants|16|16.0||||||
3957824|NCT01327651|3779963|B5|25-29 years||Age, Customized||Participants|Count of Participants|19|19.0||||||
3957825|NCT01327651|3779964|B4|25-29 years||Age, Customized||Participants|Count of Participants|13|13.0||||||
3957826|NCT01327651|3779965|B3|25-29 years||Age, Customized||Participants|Count of Participants|8|8.0||||||
3957827|NCT01327651|3779966|B2|25-29 years||Age, Customized||Participants|Count of Participants|15|15.0||||||
3957828|NCT01327651|3779967|B1|25-29 years||Age, Customized||Participants|Count of Participants|14|14.0||||||
3957829|NCT01327651|3779958|B10|18-24 years||Age, Customized||Participants|Count of Participants|157|157.0||||||
3957830|NCT01327651|3779959|B9|18-24 years||Age, Customized||Participants|Count of Participants|17|17.0||||||
3957831|NCT01327651|3779960|B8|18-24 years||Age, Customized||Participants|Count of Participants|17|17.0||||||
3957832|NCT01327651|3779961|B7|18-24 years||Age, Customized||Participants|Count of Participants|19|19.0||||||
3957833|NCT01327651|3779962|B6|18-24 years||Age, Customized||Participants|Count of Participants|8|8.0||||||
3957834|NCT01327651|3779963|B5|18-24 years||Age, Customized||Participants|Count of Participants|12|12.0||||||
3957835|NCT01327651|3779964|B4|18-24 years||Age, Customized||Participants|Count of Participants|8|8.0||||||
3957836|NCT01327651|3779965|B3|18-24 years||Age, Customized||Participants|Count of Participants|26|26.0||||||
3957837|NCT01327651|3779966|B2|18-24 years||Age, Customized||Participants|Count of Participants|24|24.0||||||
3957838|NCT01327651|3779967|B1|18-24 years||Age, Customized||Participants|Count of Participants|26|26.0||||||
3957839|NCT01327651|3779958|B10|||Age||years|Median|29|29.0|Inter-Quartile Range|||24.0|37.0|
3957840|NCT01327651|3779959|B9|||Age||years|Median|32|32.0|Inter-Quartile Range|||24.0|46.0|
3957841|NCT01327651|3779960|B8|||Age||years|Median|31|31.0|Inter-Quartile Range|||24.0|41.0|
3957842|NCT01327651|3779961|B7|||Age||years|Median|28|28.0|Inter-Quartile Range|||23.0|43.0|
3957843|NCT01327651|3779962|B6|||Age||years|Median|31|31.0|Inter-Quartile Range|||27.0|34.0|
3957844|NCT01327651|3779963|B5|||Age||years|Median|28|28.0|Inter-Quartile Range|||25.0|35.0|
3957845|NCT01327651|3779964|B4|||Age||years|Median|31|31.0|Inter-Quartile Range|||28.0|34.0|
3957846|NCT01327651|3779965|B3|||Age||years|Median|25|25.0|Inter-Quartile Range|||21.0|37.0|
3957847|NCT01327651|3779966|B2|||Age||years|Median|26|26.0|Inter-Quartile Range|||21.0|33.0|
3957848|NCT01327651|3779967|B1|||Age||years|Median|25|25.0|Inter-Quartile Range|||21.0|37.0|
3957849|NCT01327599|3780094|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3957850|NCT01327599|3780094|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3957851|NCT01327599|3780094|B1|||Age||years|Mean|73.2|73.2|Standard Deviation|9.8|9.8|||
3957852|NCT01327547|3780102|B3||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3957853|NCT01327547|3780103|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3957854|NCT01327547|3780104|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3957855|NCT01327547|3780102|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3957856|NCT01327547|3780103|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3957857|NCT01327547|3780104|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3957858|NCT01327547|3780102|B3|≥65 years||Age, Customized||Participants|Number|2|2.0||||||
3957859|NCT01327547|3780103|B2|≥65 years||Age, Customized||Participants|Number|0|0.0||||||
3957860|NCT01327547|3780104|B1|≥65 years||Age, Customized||Participants|Number|2|2.0||||||
3957861|NCT01327547|3780102|B3|45-64 years||Age, Customized||Participants|Number|89|89.0||||||
3957862|NCT01327547|3780103|B2|45-64 years||Age, Customized||Participants|Number|47|47.0||||||
3957863|NCT01327547|3780104|B1|45-64 years||Age, Customized||Participants|Number|42|42.0||||||
3957864|NCT01327547|3780102|B3|18-44 years||Age, Customized||Participants|Number|46|46.0||||||
3957865|NCT01327547|3780103|B2|18-44 years||Age, Customized||Participants|Number|20|20.0||||||
3957866|NCT01327547|3780104|B1|18-44 years||Age, Customized||Participants|Number|26|26.0||||||
3957867|NCT01327547|3780102|B3|<18 years||Age, Customized||Participants|Number|0|0.0||||||
3957868|NCT01327547|3780103|B2|<18 years||Age, Customized||Participants|Number|0|0.0||||||
3957869|NCT01327547|3780104|B1|<18 years||Age, Customized||Participants|Number|0|0.0||||||
3957870|NCT01327508|3780156|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3957871|NCT01327508|3780157|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3957872|NCT01327508|3780158|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3957873|NCT01327508|3780156|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3957874|NCT01327508|3780157|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3957875|NCT01327508|3780158|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3957876|NCT01327508|3780156|B3|||Age||Years|Mean|36.5|36.5|Standard Deviation|19.1|19.1|||
3957877|NCT01327508|3780157|B2|||Age||Years|Mean|35.3|35.3|Standard Deviation|19.5|19.5|||
3957878|NCT01327508|3780158|B1|||Age||Years|Mean|37.7|37.7|Standard Deviation|19.0|19.0|||
3957879|NCT01327495|3780167|B7|||International Prostate Symptom Score (IPSS)|0-7 mildly symptomatic, 8-19 moderately symptomatic, 20-35 severely symptomatic|units on a scale|Median|2|2.0|Inter-Quartile Range|||0.0|3.0|
3957880|NCT01327495|3780168|B6|||International Prostate Symptom Score (IPSS)|0-7 mildly symptomatic, 8-19 moderately symptomatic, 20-35 severely symptomatic|units on a scale|Median|2|2.0|Inter-Quartile Range|||1.0|3.0|
3957881|NCT01327495|3780169|B5|||International Prostate Symptom Score (IPSS)|0-7 mildly symptomatic, 8-19 moderately symptomatic, 20-35 severely symptomatic|units on a scale|Median|1.5|1.5|Inter-Quartile Range|||0.0|3.0|
3957990|NCT01327274|3780427|B1|||Age||years|Mean|12|12.0|Full Range|||8.0|14.0|
3957882|NCT01327495|3780170|B4|||International Prostate Symptom Score (IPSS)|0-7 mildly symptomatic, 8-19 moderately symptomatic, 20-35 severely symptomatic|units on a scale|Median|0|0.0|Inter-Quartile Range|||0.0|1.0|
3957883|NCT01327495|3780171|B3|||International Prostate Symptom Score (IPSS)|0-7 mildly symptomatic, 8-19 moderately symptomatic, 20-35 severely symptomatic|units on a scale|Median|2|2.0|Inter-Quartile Range|||0.0|4.25|
3957884|NCT01327495|3780172|B2|||International Prostate Symptom Score (IPSS)|0-7 mildly symptomatic, 8-19 moderately symptomatic, 20-35 severely symptomatic|units on a scale|Median|1|1.0|Inter-Quartile Range|||1.0|3.0|
3957885|NCT01327495|3780173|B1|||International Prostate Symptom Score (IPSS)|0-7 mildly symptomatic, 8-19 moderately symptomatic, 20-35 severely symptomatic|units on a scale|Median|2.5|2.5|Inter-Quartile Range|||1.5|3.0|
3957886|NCT01327495|3780167|B7|||Prostate volume||cm^3|Median|18|18.0|Inter-Quartile Range|||14.0|21.0|
3957887|NCT01327495|3780168|B6|||Prostate volume||cm^3|Median|19|19.0|Inter-Quartile Range|||15.0|19.0|
3957888|NCT01327495|3780169|B5|||Prostate volume||cm^3|Median|17|17.0|Inter-Quartile Range|||14.0|20.0|
3957889|NCT01327495|3780170|B4|||Prostate volume||cm^3|Median|17|17.0|Inter-Quartile Range|||14.0|18.0|
3957890|NCT01327495|3780171|B3|||Prostate volume||cm^3|Median|17|17.0|Inter-Quartile Range|||17.0|21.0|
3957891|NCT01327495|3780172|B2|||Prostate volume||cm^3|Median|19|19.0|Inter-Quartile Range|||13.0|23.0|
3957892|NCT01327495|3780173|B1|||Prostate volume||cm^3|Median|20|20.0|Inter-Quartile Range|||16.0|22.0|
3957893|NCT01327495|3780167|B7|||Prostate Specific Antigen (PSA)||ng/dL|Median|0.75|0.75|Inter-Quartile Range|||0.42|0.96|
3957894|NCT01327495|3780168|B6|||Prostate Specific Antigen (PSA)||ng/dL|Median|0.69|0.69|Inter-Quartile Range|||0.35|0.91|
3957895|NCT01327495|3780169|B5|||Prostate Specific Antigen (PSA)||ng/dL|Median|0.67|0.67|Inter-Quartile Range|||0.41|0.91|
3957896|NCT01327495|3780170|B4|||Prostate Specific Antigen (PSA)||ng/dL|Median|0.74|0.74|Inter-Quartile Range|||0.34|0.86|
3957897|NCT01327495|3780171|B3|||Prostate Specific Antigen (PSA)||ng/dL|Median|1.09|1.09|Inter-Quartile Range|||0.75|1.25|
3957898|NCT01327495|3780172|B2|||Prostate Specific Antigen (PSA)||ng/dL|Median|0.71|0.71|Inter-Quartile Range|||0.66|0.88|
3957899|NCT01327495|3780173|B1|||Prostate Specific Antigen (PSA)||ng/dL|Median|0.80|0.8|Inter-Quartile Range|||0.61|0.91|
3957900|NCT01327495|3780167|B7|||Hematocrit||%|Median|43|43.0|Inter-Quartile Range|||41.0|45.0|
3957901|NCT01327495|3780168|B6|||Hematocrit||%|Median|43|43.0|Inter-Quartile Range|||41.0|44.0|
3957902|NCT01327495|3780169|B5|||Hematocrit||%|Median|45|45.0|Inter-Quartile Range|||42.0|45.0|
3957903|NCT01327495|3780170|B4|||Hematocrit||%|Median|44|44.0|Inter-Quartile Range|||41.0|46.0|
3957904|NCT01327495|3780171|B3|||Hematocrit||%|Median|43|43.0|Inter-Quartile Range|||42.0|44.0|
3957905|NCT01327495|3780172|B2|||Hematocrit||%|Median|43|43.0|Inter-Quartile Range|||41.0|44.0|
3957906|NCT01327495|3780173|B1|||Hematocrit||%|Median|43|43.0|Inter-Quartile Range|||42.0|45.0|
3957907|NCT01327495|3780167|B7|||FSH||mIU/mL|Median|5|5.0|Inter-Quartile Range|||4.0|7.0|
3957908|NCT01327495|3780168|B6|||FSH||mIU/mL|Median|7|7.0|Inter-Quartile Range|||4.0|8.0|
3957909|NCT01327495|3780169|B5|||FSH||mIU/mL|Median|5.5|5.5|Inter-Quartile Range|||5.0|7.0|
3957910|NCT01327495|3780170|B4|||FSH||mIU/mL|Median|5|5.0|Inter-Quartile Range|||3.0|6.0|
3957911|NCT01327495|3780171|B3|||FSH||mIU/mL|Median|5|5.0|Inter-Quartile Range|||3.0|6.0|
3957912|NCT01327495|3780172|B2|||FSH||mIU/mL|Median|4|4.0|Inter-Quartile Range|||3.0|6.0|
3957913|NCT01327495|3780173|B1|||FSH||mIU/mL|Median|5.5|5.5|Inter-Quartile Range|||4.0|8.5|
3957914|NCT01327495|3780167|B7|||Lutenizing Hormone||mIU/mL|Median|4|4.0|Inter-Quartile Range|||3.0|5.0|
3957915|NCT01327495|3780168|B6|||Lutenizing Hormone||mIU/mL|Median|3|3.0|Inter-Quartile Range|||3.0|5.0|
3957916|NCT01327495|3780169|B5|||Lutenizing Hormone||mIU/mL|Median|4|4.0|Inter-Quartile Range|||4.0|5.0|
3957917|NCT01327495|3780170|B4|||Lutenizing Hormone||mIU/mL|Median|3|3.0|Inter-Quartile Range|||3.0|4.0|
3957918|NCT01327495|3780171|B3|||Lutenizing Hormone||mIU/mL|Median|4|4.0|Inter-Quartile Range|||2.0|5.5|
3957919|NCT01327495|3780172|B2|||Lutenizing Hormone||mIU/mL|Median|5|5.0|Inter-Quartile Range|||4.0|6.0|
3957920|NCT01327495|3780173|B1|||Lutenizing Hormone||mIU/mL|Median|3.5|3.5|Inter-Quartile Range|||3.0|4.5|
3957921|NCT01327495|3780167|B7|||DHT Level||ng/dL|Median|40|40.0|Inter-Quartile Range|||28.0|52.0|
3957922|NCT01327495|3780168|B6|||DHT Level||ng/dL|Median|36|36.0|Inter-Quartile Range|||28.0|53.0|
3957923|NCT01327495|3780169|B5|||DHT Level||ng/dL|Median|49|49.0|Inter-Quartile Range|||44.0|55.0|
3957924|NCT01327495|3780170|B4|||DHT Level||ng/dL|Median|39|39.0|Inter-Quartile Range|||18.0|49.0|
3957925|NCT01327495|3780171|B3|||DHT Level||ng/dL|Median|43|43.0|Inter-Quartile Range|||39.0|59.0|
3957926|NCT01327495|3780172|B2|||DHT Level||ng/dL|Median|37|37.0|Inter-Quartile Range|||24.0|44.0|
3957927|NCT01327495|3780173|B1|||DHT Level||ng/dL|Median|36|36.0|Inter-Quartile Range|||27.0|47.0|
3957928|NCT01327495|3780167|B7|||Testosterone Level||ng/dL|Median|459|459.0|Inter-Quartile Range|||390.0|530.0|
3957929|NCT01327495|3780168|B6|||Testosterone Level||ng/dL|Median|452|452.0|Inter-Quartile Range|||396.0|536.0|
3957930|NCT01327495|3780169|B5|||Testosterone Level||ng/dL|Median|482|482.0|Inter-Quartile Range|||429.0|591.0|
3957931|NCT01327495|3780170|B4|||Testosterone Level||ng/dL|Median|419|419.0|Inter-Quartile Range|||387.0|505.0|
3957932|NCT01327495|3780171|B3|||Testosterone Level||ng/dL|Median|554|554.0|Inter-Quartile Range|||462.0|730.0|
3957933|NCT01327495|3780172|B2|||Testosterone Level||ng/dL|Median|448|448.0|Inter-Quartile Range|||345.0|509.0|
3957934|NCT01327495|3780173|B1|||Testosterone Level||ng/dL|Median|450|450.0|Inter-Quartile Range|||315.0|516.0|
3957935|NCT01327495|3780167|B7|||Body Mass Index (BMI)||kg^m2|Median|26|26.0|Inter-Quartile Range|||25.0|29.0|
3957936|NCT01327495|3780168|B6|||Body Mass Index (BMI)||kg^m2|Median|26|26.0|Inter-Quartile Range|||25.0|28.0|
3957937|NCT01327495|3780169|B5|||Body Mass Index (BMI)||kg^m2|Median|25|25.0|Inter-Quartile Range|||22.0|28.0|
3957938|NCT01327495|3780170|B4|||Body Mass Index (BMI)||kg^m2|Median|25|25.0|Inter-Quartile Range|||25.0|27.0|
3957939|NCT01327495|3780171|B3|||Body Mass Index (BMI)||kg^m2|Median|26|26.0|Inter-Quartile Range|||24.0|28.0|
3957940|NCT01327495|3780172|B2|||Body Mass Index (BMI)||kg^m2|Median|28|28.0|Inter-Quartile Range|||25.0|33.0|
3957941|NCT01327495|3780173|B1|||Body Mass Index (BMI)||kg^m2|Median|28|28.0|Inter-Quartile Range|||26.0|33.0|
3957942|NCT01327495|3780167|B7|Male||Sex/Gender, Customized||Participants|Count of Participants|51|51.0||||||
3957943|NCT01327495|3780168|B6|Male||Sex/Gender, Customized||Participants|Count of Participants|9|9.0||||||
3957944|NCT01327495|3780169|B5|Male||Sex/Gender, Customized||Participants|Count of Participants|8|8.0||||||
3957945|NCT01327495|3780170|B4|Male||Sex/Gender, Customized||Participants|Count of Participants|9|9.0||||||
3957946|NCT01327495|3780171|B3|Male||Sex/Gender, Customized||Participants|Count of Participants|8|8.0||||||
3957947|NCT01327495|3780172|B2|Male||Sex/Gender, Customized||Participants|Count of Participants|9|9.0||||||
3957948|NCT01327495|3780173|B1|Male||Sex/Gender, Customized||Participants|Count of Participants|8|8.0||||||
3957949|NCT01327495|3780167|B7|||Age||years|Mean|44|44.0|Inter-Quartile Range|||35.0|50.0|
3957950|NCT01327495|3780168|B6|||Age||years|Mean|51|51.0|Inter-Quartile Range|||50.0|54.0|
3957951|NCT01327495|3780169|B5|||Age||years|Mean|42|42.0|Inter-Quartile Range|||33.0|47.0|
3957952|NCT01327495|3780170|B4|||Age||years|Mean|34|34.0|Inter-Quartile Range|||30.0|44.0|
3957953|NCT01327495|3780171|B3|||Age||years|Mean|46|46.0|Inter-Quartile Range|||39.0|51.0|
3957954|NCT01327495|3780172|B2|||Age||years|Mean|45|45.0|Inter-Quartile Range|||41.0|46.0|
3957955|NCT01327495|3780173|B1|||Age||years|Mean|45|45.0|Inter-Quartile Range|||34.0|48.0|
3957956|NCT01327482|3780270|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3957957|NCT01327482|3780270|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3957958|NCT01327482|3780270|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3957959|NCT01327482|3780270|B1|||Age||years|Mean|30|30.0|Standard Deviation|8|8.0|||
3957960|NCT01327339|3780275|B1|Not Korean||Race/Ethnicity, Customized|Baseline characteristics were collected in members of the ITT Population, comprised of all participants who had been administered the investigational drug at least once and had completed safety assessments.|participants|Number|0|0.0||||||
3957961|NCT01327339|3780275|B1|Korean||Race/Ethnicity, Customized|Baseline characteristics were collected in members of the ITT Population, comprised of all participants who had been administered the investigational drug at least once and had completed safety assessments.|participants|Number|747|747.0||||||
3957962|NCT01327339|3780275|B1||Male|Sex: Female, Male|Baseline characteristics were collected in members of the ITT Population, comprised of all participants who had been administered the investigational drug at least once and had completed safety assessments.|Participants|Count of Participants|307|307.0||||||
3957963|NCT01327339|3780275|B1||Female|Sex: Female, Male|Baseline characteristics were collected in members of the ITT Population, comprised of all participants who had been administered the investigational drug at least once and had completed safety assessments.|Participants|Count of Participants|440|440.0||||||
3957964|NCT01327339|3780275|B1|||Age|Baseline characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who had been administered the investigational drug at least once and had completed safety assessments.|Years|Mean|60.9|60.9|Standard Deviation|13.4|13.4|||
3957965|NCT01327313|3780281|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3957966|NCT01327313|3780282|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3957967|NCT01327313|3780283|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3957968|NCT01327313|3780284|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3957969|NCT01327313|3780285|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3957970|NCT01327313|3780281|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3957971|NCT01327313|3780282|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3957972|NCT01327313|3780283|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3957973|NCT01327313|3780284|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3957974|NCT01327313|3780285|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3957975|NCT01327313|3780281|B5|||Age||years|Mean|56.3|56.3|Standard Deviation|10.69|10.69|||
3957976|NCT01327313|3780282|B4|||Age||years|Mean|57.3|57.3|Standard Deviation|10.81|10.81|||
3957977|NCT01327313|3780283|B3|||Age||years|Mean|54.7|54.7|Standard Deviation|14.32|14.32|||
3957978|NCT01327313|3780284|B2|||Age||years|Mean|60.5|60.5|Standard Deviation|4.42|4.42|||
3957979|NCT01327313|3780285|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|11.64|11.64|||
3957980|NCT01327300|3780410|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3957981|NCT01327300|3780410|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3957982|NCT01327300|3780410|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3957983|NCT01327300|3780410|B1|||Age||years|Mean|32|32.0|Standard Deviation|11.3|11.3|||
3957984|NCT01327300|3780410|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3957985|NCT01327300|3780410|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3957986|NCT01327300|3780410|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3957987|NCT01327274|3780427|B1|||Pectus Severity Index (Haller Index)|the Haller Index is calculated as a ratio by measuring across the chest internally from one rib on one side to the rib on the opposite side, then dividing the shortest distance between the spine and sternum.|Ratio|Mean|4.7|4.7|Full Range|||3.6|7.4|
3957988|NCT01327274|3780427|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3957989|NCT01327274|3780427|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3957991|NCT01327157|3780434|B3|Idiopatic||Cause of facial paralysis||participants|Number|7|7.0||||||
3957992|NCT01327157|3780435|B2|Idiopatic||Cause of facial paralysis||participants|Number|4|4.0||||||
3957993|NCT01327157|3780436|B1|Idiopatic||Cause of facial paralysis||participants|Number|3|3.0||||||
3957994|NCT01327157|3780434|B3|Traumatic||Cause of facial paralysis||participants|Number|7|7.0||||||
3957995|NCT01327157|3780435|B2|Traumatic||Cause of facial paralysis||participants|Number|3|3.0||||||
3957996|NCT01327157|3780436|B1|Traumatic||Cause of facial paralysis||participants|Number|4|4.0||||||
3957997|NCT01327157|3780434|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3957998|NCT01327157|3780435|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3957999|NCT01327157|3780436|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3958000|NCT01327157|3780434|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3958001|NCT01327157|3780435|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3958002|NCT01327157|3780436|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3958003|NCT01327157|3780434|B3|||Age|The patient's age affects the prognosis, the sample should be as uniform as possible.|years|Mean|36.42|36.42|Standard Deviation|9.13|9.13|||
3958004|NCT01327157|3780435|B2|||Age|The patient's age affects the prognosis, the sample should be as uniform as possible.|years|Mean|36.4|36.4|Standard Deviation|9.2|9.2|||
3958005|NCT01327157|3780436|B1|||Age|The patient's age affects the prognosis, the sample should be as uniform as possible.|years|Mean|36.6|36.6|Standard Deviation|9.8|9.8|||
3958006|NCT01327053|3780449|B3||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3958007|NCT01327053|3780450|B2||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3958008|NCT01327053|3780451|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3958009|NCT01327053|3780449|B3||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3958010|NCT01327053|3780450|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3958011|NCT01327053|3780451|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3958012|NCT01327053|3780449|B3|>=65 years||Age, Customized||Participants|Number|125|125.0||||||
3958013|NCT01327053|3780450|B2|>=65 years||Age, Customized||Participants|Number|78|78.0||||||
3958014|NCT01327053|3780451|B1|>=65 years||Age, Customized||Participants|Number|47|47.0||||||
3958015|NCT01327053|3780449|B3|<65 years||Age, Customized||Participants|Number|105|105.0||||||
3958016|NCT01327053|3780450|B2|<65 years||Age, Customized||Participants|Number|73|73.0||||||
3958017|NCT01327053|3780451|B1|<65 years||Age, Customized||Participants|Number|32|32.0||||||
3958018|NCT01327053|3780449|B3|||Age||Years|Mean|64.3|64.3|Standard Deviation|14.96|14.96|||
3958019|NCT01327053|3780450|B2|||Age||Years|Mean|63.6|63.6|Standard Deviation|14.59|14.59|||
3958020|NCT01327053|3780451|B1|||Age||Years|Mean|65.5|65.5|Standard Deviation|15.67|15.67|||
3958021|NCT01326962|3780480|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3958022|NCT01326962|3780480|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3958023|NCT01326962|3780480|B1|||Age||years|Mean|45.1|45.1|Standard Deviation|12.40|12.4|||
3958024|NCT01326910|3780496|B3|United States||Region of Enrollment||participants|Number|90|90.0||||||
3958025|NCT01326910|3780497|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
3958026|NCT01326910|3780498|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
3958027|NCT01326910|3780496|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3958028|NCT01326910|3780497|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3958029|NCT01326910|3780498|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3958030|NCT01326910|3780496|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3958031|NCT01326910|3780497|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3958032|NCT01326910|3780498|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3958033|NCT01326910|3780496|B3|||Age||years|Mean|8.1|8.1|Standard Deviation|3.96|3.96|||
3958034|NCT01326910|3780497|B2|||Age||years|Mean|9.3|9.3|Standard Deviation|4.26|4.26|||
3958035|NCT01326910|3780498|B1|||Age||years|Mean|6.9|6.9|Standard Deviation|3.26|3.26|||
3958036|NCT01326845|3780511|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3958037|NCT01326845|3780512|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3958038|NCT01326845|3780513|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3958039|NCT01326845|3780511|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3958040|NCT01326845|3780512|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3958041|NCT01326845|3780513|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3958042|NCT01326845|3780511|B3|||Age||Years|Mean|70.5|70.5|Standard Deviation|7.67|7.67|||
3958043|NCT01326845|3780512|B2|||Age||Years|Mean|71.6|71.6|Standard Deviation|8.65|8.65|||
3958044|NCT01326845|3780513|B1|||Age||Years|Mean|69.7|69.7|Standard Deviation|7.5|7.5|||
3958045|NCT01326780|3780536|B5|United States||Region of Enrollment||participants|Number|431|431.0||||||
3958046|NCT01326780|3780537|B4|United States||Region of Enrollment||participants|Number|107|107.0||||||
3958047|NCT01326780|3780538|B3|United States||Region of Enrollment||participants|Number|109|109.0||||||
3958048|NCT01326780|3780539|B2|United States||Region of Enrollment||participants|Number|109|109.0||||||
3958049|NCT01326780|3780540|B1|United States||Region of Enrollment||participants|Number|106|106.0||||||
3958050|NCT01326780|3780536|B5||Male|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
3958051|NCT01326780|3780537|B4||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3958052|NCT01326780|3780538|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3958053|NCT01326780|3780539|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3958054|NCT01326780|3780540|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3958055|NCT01326780|3780536|B5||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
3958056|NCT01326780|3780537|B4||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3958057|NCT01326780|3780538|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3958058|NCT01326780|3780539|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3958059|NCT01326780|3780540|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3958060|NCT01326780|3780536|B5|||Age||years|Mean|18.7|18.7|Standard Deviation|6.2|6.2|||
3958061|NCT01326780|3780537|B4|||Age||years|Mean|17.9|17.9|Standard Deviation|5.5|5.5|||
3958062|NCT01326780|3780538|B3|||Age||years|Mean|19.7|19.7|Standard Deviation|7|7.0|||
3958063|NCT01326780|3780539|B2|||Age||years|Mean|17.3|17.3|Standard Deviation|4|4.0|||
3958064|NCT01326780|3780540|B1|||Age||years|Mean|19.9|19.9|Standard Deviation|7.6|7.6|||
3958065|NCT01326728|3780573|B3|||Count of Participants with Disease Present Prior to Stem Cell Transplant Conditioning|Patients were receiving transplants to treat present disease of multiple varieties, so all patients would have had disease present at time of transplant. Because this was a natural history study, this data may have come from a transplant that occurred before they were on study.|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3958066|NCT01326728|3780574|B2|||Count of Participants with Disease Present Prior to Stem Cell Transplant Conditioning|Patients were receiving transplants to treat present disease of multiple varieties, so all patients would have had disease present at time of transplant. Because this was a natural history study, this data may have come from a transplant that occurred before they were on study.|Participants|Count of Participants|NA|||||||Healthy related donors underwent apheresis and provided white blood cells for study and/or for use in potential treatment options.
3958067|NCT01326728|3780575|B1|||Count of Participants with Disease Present Prior to Stem Cell Transplant Conditioning|Patients were receiving transplants to treat present disease of multiple varieties, so all patients would have had disease present at time of transplant. Because this was a natural history study, this data may have come from a transplant that occurred before they were on study.|Participants|Count of Participants|47|47.0||||||
3958068|NCT01326728|3780573|B3|Absence of GVHD||Count of Participants with Presence or Absence of GVHD Prior to Study|Recipients only (study specific baseline measure not applicable to donors) were assessed for graft versus host disease (GVHD) prior to study. GVHD is a medical complication following stem cell transplant that can affect the skin, gut, and various other parts of the body. Since the baseline would be pre-transplant, no patient would have GVHD and would have captured as a general patient assessment. Because this was a natural history study, this data may have come from a transplant that occurred before they were on study.|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3958069|NCT01326728|3780574|B2|Absence of GVHD||Count of Participants with Presence or Absence of GVHD Prior to Study|Recipients only (study specific baseline measure not applicable to donors) were assessed for graft versus host disease (GVHD) prior to study. GVHD is a medical complication following stem cell transplant that can affect the skin, gut, and various other parts of the body. Since the baseline would be pre-transplant, no patient would have GVHD and would have captured as a general patient assessment. Because this was a natural history study, this data may have come from a transplant that occurred before they were on study.|Participants|Count of Participants|NA|||||||Healthy related donors underwent apheresis and provided white blood cells for study and/or for use in potential treatment options.
3958070|NCT01326728|3780575|B1|Absence of GVHD||Count of Participants with Presence or Absence of GVHD Prior to Study|Recipients only (study specific baseline measure not applicable to donors) were assessed for graft versus host disease (GVHD) prior to study. GVHD is a medical complication following stem cell transplant that can affect the skin, gut, and various other parts of the body. Since the baseline would be pre-transplant, no patient would have GVHD and would have captured as a general patient assessment. Because this was a natural history study, this data may have come from a transplant that occurred before they were on study.|Participants|Count of Participants|47|47.0||||||
3958071|NCT01326728|3780573|B3|Presence of GVHD||Count of Participants with Presence or Absence of GVHD Prior to Study|Recipients only (study specific baseline measure not applicable to donors) were assessed for graft versus host disease (GVHD) prior to study. GVHD is a medical complication following stem cell transplant that can affect the skin, gut, and various other parts of the body. Since the baseline would be pre-transplant, no patient would have GVHD and would have captured as a general patient assessment. Because this was a natural history study, this data may have come from a transplant that occurred before they were on study.|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3958072|NCT01326728|3780574|B2|Presence of GVHD||Count of Participants with Presence or Absence of GVHD Prior to Study|Recipients only (study specific baseline measure not applicable to donors) were assessed for graft versus host disease (GVHD) prior to study. GVHD is a medical complication following stem cell transplant that can affect the skin, gut, and various other parts of the body. Since the baseline would be pre-transplant, no patient would have GVHD and would have captured as a general patient assessment. Because this was a natural history study, this data may have come from a transplant that occurred before they were on study.|Participants|Count of Participants|NA|||||||Healthy related donors underwent apheresis and provided white blood cells for study and/or for use in potential treatment options.
3958073|NCT01326728|3780575|B1|Presence of GVHD||Count of Participants with Presence or Absence of GVHD Prior to Study|Recipients only (study specific baseline measure not applicable to donors) were assessed for graft versus host disease (GVHD) prior to study. GVHD is a medical complication following stem cell transplant that can affect the skin, gut, and various other parts of the body. Since the baseline would be pre-transplant, no patient would have GVHD and would have captured as a general patient assessment. Because this was a natural history study, this data may have come from a transplant that occurred before they were on study.|Participants|Count of Participants|0|0.0||||||
3958074|NCT01326728|3780573|B3|United States||Region of Enrollment||participants|Number|56|56.0||||||
3958075|NCT01326728|3780574|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3958076|NCT01326728|3780575|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
3958077|NCT01326728|3780573|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3958078|NCT01326728|3780574|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3958079|NCT01326728|3780575|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3958080|NCT01326728|3780573|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958081|NCT01326728|3780574|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958082|NCT01326728|3780575|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958083|NCT01326728|3780573|B3||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3958084|NCT01326728|3780574|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3958085|NCT01326728|3780575|B1||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3958086|NCT01326728|3780573|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3958087|NCT01326728|3780574|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3958088|NCT01326728|3780575|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3958089|NCT01326728|3780573|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958090|NCT01326728|3780574|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958091|NCT01326728|3780575|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958092|NCT01326728|3780573|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3958093|NCT01326728|3780574|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3958094|NCT01326728|3780575|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3958095|NCT01326728|3780573|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3958096|NCT01326728|3780574|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958097|NCT01326728|3780575|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3958098|NCT01326728|3780573|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3958099|NCT01326728|3780574|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958100|NCT01326728|3780575|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3958101|NCT01326728|3780573|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3958102|NCT01326728|3780574|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3958103|NCT01326728|3780575|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3958104|NCT01326728|3780573|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3958105|NCT01326728|3780574|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3958106|NCT01326728|3780575|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3958107|NCT01326728|3780573|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3958108|NCT01326728|3780574|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3958109|NCT01326728|3780575|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3958110|NCT01326728|3780573|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3958111|NCT01326728|3780574|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3958112|NCT01326728|3780575|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3958113|NCT01326728|3780573|B3|||Age||years|Mean|49.83|49.83|Standard Deviation|15.0|15.0|||
3958114|NCT01326728|3780574|B2|||Age||years|Mean|50.33|50.33|Standard Deviation|14.54|14.54|||
3958115|NCT01326728|3780575|B1|||Age||years|Mean|49.34|49.34|Standard Deviation|15.46|15.46|||
3958116|NCT01326728|3780573|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3958117|NCT01326728|3780574|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3958118|NCT01326728|3780575|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3958119|NCT01326728|3780573|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
3958120|NCT01326728|3780574|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3958121|NCT01326728|3780575|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3958122|NCT01326728|3780573|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3958123|NCT01326728|3780574|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3958124|NCT01326728|3780575|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3958125|NCT01326533|3780593|B3|||Beta cell function (disposition index)||arbitrary units|Mean|1483|1483.0|Standard Deviation|1540|1540.0|||
3958126|NCT01326533|3780594|B2|||Beta cell function (disposition index)||arbitrary units|Mean|1214|1214.0|Standard Deviation|691|691.0|||
3958127|NCT01326533|3780595|B1|||Beta cell function (disposition index)||arbitrary units|Mean|1721|1721.0|Standard Deviation|2014|2014.0|||
3958128|NCT01326533|3780593|B3|||Insulin sensitivity (Si)||10^-4 / pmol*l / min|Mean|0.55|0.55|Standard Deviation|0.34|0.34|||
3958129|NCT01326533|3780594|B2|||Insulin sensitivity (Si)||10^-4 / pmol*l / min|Mean|0.58|0.58|Standard Deviation|0.42|0.42|||
3958130|NCT01326533|3780595|B1|||Insulin sensitivity (Si)||10^-4 / pmol*l / min|Mean|0.52|0.52|Standard Deviation|0.27|0.27|||
3958131|NCT01326533|3780593|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3958132|NCT01326533|3780594|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3958133|NCT01326533|3780595|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3958134|NCT01326533|3780593|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3958135|NCT01326533|3780594|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3958136|NCT01326533|3780595|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3958137|NCT01326533|3780593|B3|||Age||years|Mean|47.6|47.6|Standard Deviation|15.7|15.7|||
3958138|NCT01326533|3780594|B2|||Age||years|Mean|44.9|44.9|Standard Deviation|16.8|16.8|||
3958139|NCT01326533|3780595|B1|||Age||years|Mean|50.1|50.1|Standard Deviation|14.5|14.5|||
3958140|NCT01326026|3780604|B3|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.4|9.4|Standard Deviation|2.7|2.7|||
3958141|NCT01326026|3780605|B2|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.4|9.4|Standard Deviation|2.8|2.8|||
3958142|NCT01326026|3780606|B1|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.3|9.3|Standard Deviation|2.6|2.6|||
3958143|NCT01326026|3780604|B3|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.1|8.1|Standard Deviation|0.9|0.9|||
3958144|NCT01326026|3780605|B2|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.2|8.2|Standard Deviation|0.9|0.9|||
3958145|NCT01326026|3780606|B1|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.1|8.1|Standard Deviation|0.9|0.9|||
3958146|NCT01326026|3780604|B3||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3958147|NCT01326026|3780605|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3958148|NCT01326026|3780606|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3958149|NCT01326026|3780604|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3958150|NCT01326026|3780605|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3958151|NCT01326026|3780606|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3958152|NCT01326026|3780604|B3|||Age||years|Mean|58.9|58.9|Standard Deviation|10.3|10.3|||
3958153|NCT01326026|3780605|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|11.1|11.1|||
3958154|NCT01326026|3780606|B1|||Age||years|Mean|59.4|59.4|Standard Deviation|9.5|9.5|||
3958155|NCT01325870|3780621|B4|United States||Region of Enrollment||participants|Number|48|48.0||||||
3958156|NCT01325870|3780622|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
3958157|NCT01325870|3780623|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3958158|NCT01325870|3780624|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3958159|NCT01325870|3780621|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3958160|NCT01325870|3780622|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3958161|NCT01325870|3780623|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3958162|NCT01325870|3780624|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3958163|NCT01325870|3780621|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3958164|NCT01325870|3780622|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3958165|NCT01325870|3780623|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3958166|NCT01325870|3780624|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3958167|NCT01325870|3780621|B4||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
3958168|NCT01325870|3780622|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3958169|NCT01325870|3780623|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3958170|NCT01325870|3780624|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3958171|NCT01325870|3780621|B4||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3958172|NCT01325870|3780622|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3958173|NCT01325870|3780623|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3958174|NCT01325870|3780624|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3958175|NCT01325870|3780621|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3958176|NCT01325870|3780622|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3958177|NCT01325870|3780623|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3958178|NCT01325870|3780624|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3958179|NCT01325870|3780621|B4|||Age||years|Mean|64.8|64.8|Standard Deviation|15.8|15.8|||
3958180|NCT01325870|3780622|B3|||Age||years|Mean|64.7|64.7|Standard Deviation|14.0|14.0|||
3958181|NCT01325870|3780623|B2|||Age||years|Mean|66.8|66.8|Standard Deviation|18.9|18.9|||
3958182|NCT01325870|3780624|B1|||Age||years|Mean|63.1|63.1|Standard Deviation|14.6|14.6|||
3958183|NCT01325792|3780640|B1|||BMI (Body Mass Index)||kg/m^2|Mean|27.6|27.6|Standard Deviation|6.1|6.1|||
3958184|NCT01325792|3780640|B1|Contaminated||Wound Classification|Intraoperatively assessed, based on the level of contamination present, or due to concomitant surgical procedures, the surgical field was managed to reduce or appropriately eliminate microbial contaminants. After devitalized tissue was removed and the appropriate bioburden reduction techniques completed, the resulting surgical field/wound was characterized and documented as applicable based on the surgical wound classification scheme as suggested by the Centers for Disease Control, US Department of Human Services, with modifications for inclusion of stomas.|participants|Number|80|80.0||||||
3958242|NCT01325714|3780647|B1|No||Patient use of psychotropic medications (categorical)||participants|Number|96|96.0||||||
3958243|NCT01325714|3780645|B3|Yes||Patient use of psychotropic medications (categorical)||participants|Number|13|13.0||||||
3958185|NCT01325792|3780640|B1|Clean-contaminated||Wound Classification|Intraoperatively assessed, based on the level of contamination present, or due to concomitant surgical procedures, the surgical field was managed to reduce or appropriately eliminate microbial contaminants. After devitalized tissue was removed and the appropriate bioburden reduction techniques completed, the resulting surgical field/wound was characterized and documented as applicable based on the surgical wound classification scheme as suggested by the Centers for Disease Control, US Department of Human Services, with modifications for inclusion of stomas.|participants|Number|24|24.0||||||
3958186|NCT01325792|3780640|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3958187|NCT01325792|3780640|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3958188|NCT01325792|3780640|B1|||Age||years|Mean|57.7|57.7|Standard Deviation|13.4|13.4|||
3958189|NCT01325714|3780645|B3|||Patient-reported Overall Pain|One item on a 0-5 scale, where 0 = no pain, 1 = little pain, 2= moderate pain, 3 = quite bad pain, 4 = very bad pain, 5 = the pain is almost unbearable. Higher scores = greater pain severity.|units on a scale|Mean|2.04|2.04|Standard Deviation|1.18|1.18|||
3958190|NCT01325714|3780646|B2|||Patient-reported Overall Pain|One item on a 0-5 scale, where 0 = no pain, 1 = little pain, 2= moderate pain, 3 = quite bad pain, 4 = very bad pain, 5 = the pain is almost unbearable. Higher scores = greater pain severity.|units on a scale|Mean|1.96|1.96|Standard Deviation|1.24|1.24|||
3958191|NCT01325714|3780647|B1|||Patient-reported Overall Pain|One item on a 0-5 scale, where 0 = no pain, 1 = little pain, 2= moderate pain, 3 = quite bad pain, 4 = very bad pain, 5 = the pain is almost unbearable. Higher scores = greater pain severity.|units on a scale|Mean|2.13|2.13|Standard Deviation|1.11|1.11|||
3958192|NCT01325714|3780645|B3|||Patient-reported Worst pain (continuous)|One item on a 0-5 scale, where 0 = no pain, 1 = little pain, 2= moderate pain, 3 = quite bad pain, 4 = very bad pain, 5 = the pain is almost unbearable. Higher scores = greater pain severity.|units on a scale|Mean|2.93|2.93|Standard Deviation|1.41|1.41|||
3958193|NCT01325714|3780646|B2|||Patient-reported Worst pain (continuous)|One item on a 0-5 scale, where 0 = no pain, 1 = little pain, 2= moderate pain, 3 = quite bad pain, 4 = very bad pain, 5 = the pain is almost unbearable. Higher scores = greater pain severity.|units on a scale|Mean|2.84|2.84|Standard Deviation|1.51|1.51|||
3958194|NCT01325714|3780647|B1|||Patient-reported Worst pain (continuous)|One item on a 0-5 scale, where 0 = no pain, 1 = little pain, 2= moderate pain, 3 = quite bad pain, 4 = very bad pain, 5 = the pain is almost unbearable. Higher scores = greater pain severity.|units on a scale|Mean|3.01|3.01|Standard Deviation|1.30|1.3|||
3958195|NCT01325714|3780645|B3|||Caregiver-reported Overall pain (continuous)|One item on a 0-5 scale, where 0 = no pain, 1 = little pain, 2= moderate pain, 3 = quite bad pain, 4 = very bad pain, 5 = the pain is almost unbearable. Higher scores = greater pain severity.|units on a scale|Mean|2.24|2.24|Standard Deviation|1.05|1.05|||
3958196|NCT01325714|3780646|B2|||Caregiver-reported Overall pain (continuous)|One item on a 0-5 scale, where 0 = no pain, 1 = little pain, 2= moderate pain, 3 = quite bad pain, 4 = very bad pain, 5 = the pain is almost unbearable. Higher scores = greater pain severity.|units on a scale|Mean|2.06|2.06|Standard Deviation|0.94|0.94|||
3958197|NCT01325714|3780647|B1|||Caregiver-reported Overall pain (continuous)|One item on a 0-5 scale, where 0 = no pain, 1 = little pain, 2= moderate pain, 3 = quite bad pain, 4 = very bad pain, 5 = the pain is almost unbearable. Higher scores = greater pain severity.|units on a scale|Mean|2.43|2.43|Standard Deviation|1.13|1.13|||
3958198|NCT01325714|3780645|B3|||Caregiver-reported Worst Pain (continuous)|One item with scores from 0 to 5, where 0 = no pain, 1 = little pain, 2 = moderate pain, 3 = quite bad pain, 4 = very bad pain, 5 = the pain is almost unbearable. Higher scores = greater pain severity.|units on a scale|Mean|3.15|3.15|Standard Deviation|1.34|1.34|||
3958199|NCT01325714|3780646|B2|||Caregiver-reported Worst Pain (continuous)|One item with scores from 0 to 5, where 0 = no pain, 1 = little pain, 2 = moderate pain, 3 = quite bad pain, 4 = very bad pain, 5 = the pain is almost unbearable. Higher scores = greater pain severity.|units on a scale|Mean|3.03|3.03|Standard Deviation|1.29|1.29|||
3958200|NCT01325714|3780647|B1|||Caregiver-reported Worst Pain (continuous)|One item with scores from 0 to 5, where 0 = no pain, 1 = little pain, 2 = moderate pain, 3 = quite bad pain, 4 = very bad pain, 5 = the pain is almost unbearable. Higher scores = greater pain severity.|units on a scale|Mean|3.28|3.28|Standard Deviation|1.37|1.37|||
3958201|NCT01325714|3780645|B3|||Total Mutuality (continuous)|Fifteen items about the caregivers' relationship with the patient with dementia were responded to on a 0-4 scale, where 0 = not at all, 1 = a little, 2 = some, 3 = quite a bit, and 4 = a great deal. responses to all 15 items were averaged, so total scores range from 0-4, with higher values indicating greater mutuality.|units on a scale|Mean|2.96|2.96|Standard Deviation|0.66|0.66|||
3958202|NCT01325714|3780646|B2|||Total Mutuality (continuous)|Fifteen items about the caregivers' relationship with the patient with dementia were responded to on a 0-4 scale, where 0 = not at all, 1 = a little, 2 = some, 3 = quite a bit, and 4 = a great deal. responses to all 15 items were averaged, so total scores range from 0-4, with higher values indicating greater mutuality.|units on a scale|Mean|2.99|2.99|Standard Deviation|0.66|0.66|||
3958203|NCT01325714|3780647|B1|||Total Mutuality (continuous)|Fifteen items about the caregivers' relationship with the patient with dementia were responded to on a 0-4 scale, where 0 = not at all, 1 = a little, 2 = some, 3 = quite a bit, and 4 = a great deal. responses to all 15 items were averaged, so total scores range from 0-4, with higher values indicating greater mutuality.|units on a scale|Mean|2.93|2.93|Standard Deviation|0.66|0.66|||
3958204|NCT01325714|3780645|B3|||Burden Severity (continuous)|22 items are responded to on a 0-4 scale where 0 = never, 1 = rarely, 2 = sometimes, 3 = quite frequently, and 4 = nearly always. Scores are then summed so that the total range is from 0 - 88. Higher scores indicate greater caregiver burden.|units on a scale|Mean|28.78|28.78|Standard Deviation|15.19|15.19|||
3958205|NCT01325714|3780646|B2|||Burden Severity (continuous)|22 items are responded to on a 0-4 scale where 0 = never, 1 = rarely, 2 = sometimes, 3 = quite frequently, and 4 = nearly always. Scores are then summed so that the total range is from 0 - 88. Higher scores indicate greater caregiver burden.|units on a scale|Mean|28.63|28.63|Standard Deviation|15.18|15.18|||
3958244|NCT01325714|3780646|B2|Yes||Patient use of psychotropic medications (categorical)||participants|Number|8|8.0||||||
3958245|NCT01325714|3780647|B1|Yes||Patient use of psychotropic medications (categorical)||participants|Number|5|5.0||||||
3958206|NCT01325714|3780647|B1|||Burden Severity (continuous)|22 items are responded to on a 0-4 scale where 0 = never, 1 = rarely, 2 = sometimes, 3 = quite frequently, and 4 = nearly always. Scores are then summed so that the total range is from 0 - 88. Higher scores indicate greater caregiver burden.|units on a scale|Mean|28.94|28.94|Standard Deviation|15.27|15.27|||
3958207|NCT01325714|3780645|B3|||Enjoyment of Pleasant Events (continuous)|For each of 20 events, participants answered the frequency (0 = not at all, 1 = 1-6 times, 2 = 7+ times) they engaged in the event and whether they enjoyed the event (1 = yes, 0 = no). Scores for each of the 20 items were added together. The possible range of scores on the PES frequency of engagement in pleasant events is from 0 - 40, with higher scores indicating more frequent engagement in pleasant events.|units on a scale|Mean|23.87|23.87|Standard Deviation|6.67|6.67|||
3958208|NCT01325714|3780646|B2|||Enjoyment of Pleasant Events (continuous)|For each of 20 events, participants answered the frequency (0 = not at all, 1 = 1-6 times, 2 = 7+ times) they engaged in the event and whether they enjoyed the event (1 = yes, 0 = no). Scores for each of the 20 items were added together. The possible range of scores on the PES frequency of engagement in pleasant events is from 0 - 40, with higher scores indicating more frequent engagement in pleasant events.|units on a scale|Mean|24.65|24.65|Standard Deviation|7.39|7.39|||
3958209|NCT01325714|3780647|B1|||Enjoyment of Pleasant Events (continuous)|For each of 20 events, participants answered the frequency (0 = not at all, 1 = 1-6 times, 2 = 7+ times) they engaged in the event and whether they enjoyed the event (1 = yes, 0 = no). Scores for each of the 20 items were added together. The possible range of scores on the PES frequency of engagement in pleasant events is from 0 - 40, with higher scores indicating more frequent engagement in pleasant events.|units on a scale|Mean|23.09|23.09|Standard Deviation|5.78|5.78|||
3958210|NCT01325714|3780645|B3|||Geriatric Depression Scale (continuous)|30 item scale with response options of yes = 1 and no = 0 to each item. Total GDS scores range from 0 to 30, with greater scores indicating greater depression.|units on a scale|Mean|14.15|14.15|Standard Deviation|6.21|6.21|||
3958211|NCT01325714|3780646|B2|||Geriatric Depression Scale (continuous)|30 item scale with response options of yes = 1 and no = 0 to each item. Total GDS scores range from 0 to 30, with greater scores indicating greater depression.|units on a scale|Mean|13.97|13.97|Standard Deviation|6.22|6.22|||
3958212|NCT01325714|3780647|B1|||Geriatric Depression Scale (continuous)|30 item scale with response options of yes = 1 and no = 0 to each item. Total GDS scores range from 0 to 30, with greater scores indicating greater depression.|units on a scale|Mean|14.33|14.33|Standard Deviation|6.22|6.22|||
3958213|NCT01325714|3780645|B3|Missing||FAST stage (categorical)|The fast is a measure that ascertains which of the 7 stages of dementia one has: higher scores indicate more severe dementia. Stage 1 is normal adult with no functional decline, Stage 2 is normal older adult with some functional decline, Stage 3 is mild cognitive impairment, Stage 4 is mild dementia, Stage 5 is moderate dementia, Stage 6 is moderately severe dementia, and Stage 7 is severe dementia. Those with FAST scores between 2-6 were eligible for participation. We combined stages 2 and 3 (possible/mild cognitive impairment) and stages 5 and 6 (moderate/moderately severe dementia).|participants|Number|2|2.0||||||
3958214|NCT01325714|3780646|B2|Missing||FAST stage (categorical)|The fast is a measure that ascertains which of the 7 stages of dementia one has: higher scores indicate more severe dementia. Stage 1 is normal adult with no functional decline, Stage 2 is normal older adult with some functional decline, Stage 3 is mild cognitive impairment, Stage 4 is mild dementia, Stage 5 is moderate dementia, Stage 6 is moderately severe dementia, and Stage 7 is severe dementia. Those with FAST scores between 2-6 were eligible for participation. We combined stages 2 and 3 (possible/mild cognitive impairment) and stages 5 and 6 (moderate/moderately severe dementia).|participants|Number|1|1.0||||||
3958215|NCT01325714|3780647|B1|Missing||FAST stage (categorical)|The fast is a measure that ascertains which of the 7 stages of dementia one has: higher scores indicate more severe dementia. Stage 1 is normal adult with no functional decline, Stage 2 is normal older adult with some functional decline, Stage 3 is mild cognitive impairment, Stage 4 is mild dementia, Stage 5 is moderate dementia, Stage 6 is moderately severe dementia, and Stage 7 is severe dementia. Those with FAST scores between 2-6 were eligible for participation. We combined stages 2 and 3 (possible/mild cognitive impairment) and stages 5 and 6 (moderate/moderately severe dementia).|participants|Number|1|1.0||||||
3958216|NCT01325714|3780645|B3|Moderate/moderately severe dementia (stages 5-6)||FAST stage (categorical)|The fast is a measure that ascertains which of the 7 stages of dementia one has: higher scores indicate more severe dementia. Stage 1 is normal adult with no functional decline, Stage 2 is normal older adult with some functional decline, Stage 3 is mild cognitive impairment, Stage 4 is mild dementia, Stage 5 is moderate dementia, Stage 6 is moderately severe dementia, and Stage 7 is severe dementia. Those with FAST scores between 2-6 were eligible for participation. We combined stages 2 and 3 (possible/mild cognitive impairment) and stages 5 and 6 (moderate/moderately severe dementia).|participants|Number|147|147.0||||||
3958217|NCT01325714|3780646|B2|Moderate/moderately severe dementia (stages 5-6)||FAST stage (categorical)|The fast is a measure that ascertains which of the 7 stages of dementia one has: higher scores indicate more severe dementia. Stage 1 is normal adult with no functional decline, Stage 2 is normal older adult with some functional decline, Stage 3 is mild cognitive impairment, Stage 4 is mild dementia, Stage 5 is moderate dementia, Stage 6 is moderately severe dementia, and Stage 7 is severe dementia. Those with FAST scores between 2-6 were eligible for participation. We combined stages 2 and 3 (possible/mild cognitive impairment) and stages 5 and 6 (moderate/moderately severe dementia).|participants|Number|73|73.0||||||
3958218|NCT01325714|3780647|B1|Moderate/moderately severe dementia (stages 5-6)||FAST stage (categorical)|The fast is a measure that ascertains which of the 7 stages of dementia one has: higher scores indicate more severe dementia. Stage 1 is normal adult with no functional decline, Stage 2 is normal older adult with some functional decline, Stage 3 is mild cognitive impairment, Stage 4 is mild dementia, Stage 5 is moderate dementia, Stage 6 is moderately severe dementia, and Stage 7 is severe dementia. Those with FAST scores between 2-6 were eligible for participation. We combined stages 2 and 3 (possible/mild cognitive impairment) and stages 5 and 6 (moderate/moderately severe dementia).|participants|Number|74|74.0||||||
3958246|NCT01325714|3780645|B3|Missing||Patient income (categorical)||participants|Number|14|14.0||||||
3958247|NCT01325714|3780646|B2|Missing||Patient income (categorical)||participants|Number|6|6.0||||||
3958248|NCT01325714|3780647|B1|Missing||Patient income (categorical)||participants|Number|8|8.0||||||
3958219|NCT01325714|3780645|B3|Mild dementia (stage 4)||FAST stage (categorical)|The fast is a measure that ascertains which of the 7 stages of dementia one has: higher scores indicate more severe dementia. Stage 1 is normal adult with no functional decline, Stage 2 is normal older adult with some functional decline, Stage 3 is mild cognitive impairment, Stage 4 is mild dementia, Stage 5 is moderate dementia, Stage 6 is moderately severe dementia, and Stage 7 is severe dementia. Those with FAST scores between 2-6 were eligible for participation. We combined stages 2 and 3 (possible/mild cognitive impairment) and stages 5 and 6 (moderate/moderately severe dementia).|participants|Number|47|47.0||||||
3958220|NCT01325714|3780646|B2|Mild dementia (stage 4)||FAST stage (categorical)|The fast is a measure that ascertains which of the 7 stages of dementia one has: higher scores indicate more severe dementia. Stage 1 is normal adult with no functional decline, Stage 2 is normal older adult with some functional decline, Stage 3 is mild cognitive impairment, Stage 4 is mild dementia, Stage 5 is moderate dementia, Stage 6 is moderately severe dementia, and Stage 7 is severe dementia. Those with FAST scores between 2-6 were eligible for participation. We combined stages 2 and 3 (possible/mild cognitive impairment) and stages 5 and 6 (moderate/moderately severe dementia).|participants|Number|24|24.0||||||
3958221|NCT01325714|3780647|B1|Mild dementia (stage 4)||FAST stage (categorical)|The fast is a measure that ascertains which of the 7 stages of dementia one has: higher scores indicate more severe dementia. Stage 1 is normal adult with no functional decline, Stage 2 is normal older adult with some functional decline, Stage 3 is mild cognitive impairment, Stage 4 is mild dementia, Stage 5 is moderate dementia, Stage 6 is moderately severe dementia, and Stage 7 is severe dementia. Those with FAST scores between 2-6 were eligible for participation. We combined stages 2 and 3 (possible/mild cognitive impairment) and stages 5 and 6 (moderate/moderately severe dementia).|participants|Number|23|23.0||||||
3958222|NCT01325714|3780645|B3|Possible/mild cognitive impairment (stages 2-3)||FAST stage (categorical)|The fast is a measure that ascertains which of the 7 stages of dementia one has: higher scores indicate more severe dementia. Stage 1 is normal adult with no functional decline, Stage 2 is normal older adult with some functional decline, Stage 3 is mild cognitive impairment, Stage 4 is mild dementia, Stage 5 is moderate dementia, Stage 6 is moderately severe dementia, and Stage 7 is severe dementia. Those with FAST scores between 2-6 were eligible for participation. We combined stages 2 and 3 (possible/mild cognitive impairment) and stages 5 and 6 (moderate/moderately severe dementia).|participants|Number|7|7.0||||||
3958223|NCT01325714|3780646|B2|Possible/mild cognitive impairment (stages 2-3)||FAST stage (categorical)|The fast is a measure that ascertains which of the 7 stages of dementia one has: higher scores indicate more severe dementia. Stage 1 is normal adult with no functional decline, Stage 2 is normal older adult with some functional decline, Stage 3 is mild cognitive impairment, Stage 4 is mild dementia, Stage 5 is moderate dementia, Stage 6 is moderately severe dementia, and Stage 7 is severe dementia. Those with FAST scores between 2-6 were eligible for participation. We combined stages 2 and 3 (possible/mild cognitive impairment) and stages 5 and 6 (moderate/moderately severe dementia).|participants|Number|4|4.0||||||
3958224|NCT01325714|3780647|B1|Possible/mild cognitive impairment (stages 2-3)||FAST stage (categorical)|The fast is a measure that ascertains which of the 7 stages of dementia one has: higher scores indicate more severe dementia. Stage 1 is normal adult with no functional decline, Stage 2 is normal older adult with some functional decline, Stage 3 is mild cognitive impairment, Stage 4 is mild dementia, Stage 5 is moderate dementia, Stage 6 is moderately severe dementia, and Stage 7 is severe dementia. Those with FAST scores between 2-6 were eligible for participation. We combined stages 2 and 3 (possible/mild cognitive impairment) and stages 5 and 6 (moderate/moderately severe dementia).|participants|Number|3|3.0||||||
3958225|NCT01325714|3780645|B3|||Mini-blessed (continuous)|The mini-blessed measures cognitive impairment and responses to items are summed, resulting in a range of scores from 0 - 28, where higher scores indicate more cognitive impairment. Scores of 0-8 indicate no or minimal impairment, scores 9-19 indicate moderate impairment, and scores between 20-28 indicate severe impairment.|units on a scale|Mean|14.95|14.95|Standard Deviation|7.36|7.36|||
3958226|NCT01325714|3780646|B2|||Mini-blessed (continuous)|The mini-blessed measures cognitive impairment and responses to items are summed, resulting in a range of scores from 0 - 28, where higher scores indicate more cognitive impairment. Scores of 0-8 indicate no or minimal impairment, scores 9-19 indicate moderate impairment, and scores between 20-28 indicate severe impairment.|units on a scale|Mean|14.70|14.7|Standard Deviation|7.39|7.39|||
3958227|NCT01325714|3780647|B1|||Mini-blessed (continuous)|The mini-blessed measures cognitive impairment and responses to items are summed, resulting in a range of scores from 0 - 28, where higher scores indicate more cognitive impairment. Scores of 0-8 indicate no or minimal impairment, scores 9-19 indicate moderate impairment, and scores between 20-28 indicate severe impairment.|units on a scale|Mean|15.21|15.21|Standard Deviation|7.36|7.36|||
3958228|NCT01325714|3780645|B3|Nonfamily||Relationship of patient to his or her caregiver||participants|Number|4|4.0||||||
3958229|NCT01325714|3780646|B2|Nonfamily||Relationship of patient to his or her caregiver||participants|Number|2|2.0||||||
3958230|NCT01325714|3780647|B1|Nonfamily||Relationship of patient to his or her caregiver||participants|Number|2|2.0||||||
3958231|NCT01325714|3780645|B3|Other family||Relationship of patient to his or her caregiver||participants|Number|66|66.0||||||
3958232|NCT01325714|3780646|B2|Other family||Relationship of patient to his or her caregiver||participants|Number|36|36.0||||||
3958233|NCT01325714|3780647|B1|Other family||Relationship of patient to his or her caregiver||participants|Number|30|30.0||||||
3958234|NCT01325714|3780645|B3|Spouse||Relationship of patient to his or her caregiver||participants|Number|133|133.0||||||
3958235|NCT01325714|3780646|B2|Spouse||Relationship of patient to his or her caregiver||participants|Number|64|64.0||||||
3958236|NCT01325714|3780647|B1|Spouse||Relationship of patient to his or her caregiver||participants|Number|69|69.0||||||
3958237|NCT01325714|3780645|B3|Missing||Patient use of psychotropic medications (categorical)||participants|Number|1|1.0||||||
3958238|NCT01325714|3780646|B2|Missing||Patient use of psychotropic medications (categorical)||participants|Number|1|1.0||||||
3958239|NCT01325714|3780647|B1|Missing||Patient use of psychotropic medications (categorical)||participants|Number|0|0.0||||||
3958240|NCT01325714|3780645|B3|No||Patient use of psychotropic medications (categorical)||participants|Number|189|189.0||||||
3958241|NCT01325714|3780646|B2|No||Patient use of psychotropic medications (categorical)||participants|Number|93|93.0||||||
3958249|NCT01325714|3780645|B3|$>=50,000||Patient income (categorical)||participants|Number|13|13.0||||||
3958250|NCT01325714|3780646|B2|$>=50,000||Patient income (categorical)||participants|Number|6|6.0||||||
3958251|NCT01325714|3780647|B1|$>=50,000||Patient income (categorical)||participants|Number|7|7.0||||||
3958252|NCT01325714|3780645|B3|$20,000-49,999||Patient income (categorical)||participants|Number|93|93.0||||||
3958253|NCT01325714|3780646|B2|$20,000-49,999||Patient income (categorical)||participants|Number|44|44.0||||||
3958254|NCT01325714|3780647|B1|$20,000-49,999||Patient income (categorical)||participants|Number|49|49.0||||||
3958255|NCT01325714|3780645|B3|$<20,000||Patient income (categorical)||participants|Number|83|83.0||||||
3958256|NCT01325714|3780646|B2|$<20,000||Patient income (categorical)||participants|Number|46|46.0||||||
3958257|NCT01325714|3780647|B1|$<20,000||Patient income (categorical)||participants|Number|37|37.0||||||
3958258|NCT01325714|3780645|B3|Missing||Caregiver income (categorical)||participants|Number|10|10.0||||||
3958259|NCT01325714|3780646|B2|Missing||Caregiver income (categorical)||participants|Number|4|4.0||||||
3958260|NCT01325714|3780647|B1|Missing||Caregiver income (categorical)||participants|Number|6|6.0||||||
3958261|NCT01325714|3780645|B3|$>=50,000||Caregiver income (categorical)||participants|Number|16|16.0||||||
3958262|NCT01325714|3780646|B2|$>=50,000||Caregiver income (categorical)||participants|Number|8|8.0||||||
3958263|NCT01325714|3780647|B1|$>=50,000||Caregiver income (categorical)||participants|Number|8|8.0||||||
3958264|NCT01325714|3780645|B3|$20,000-49,999||Caregiver income (categorical)||participants|Number|47|47.0||||||
3958265|NCT01325714|3780646|B2|$20,000-49,999||Caregiver income (categorical)||participants|Number|24|24.0||||||
3958266|NCT01325714|3780647|B1|$20,000-49,999||Caregiver income (categorical)||participants|Number|23|23.0||||||
3958267|NCT01325714|3780645|B3|$<20,000||Caregiver income (categorical)||participants|Number|130|130.0||||||
3958268|NCT01325714|3780646|B2|$<20,000||Caregiver income (categorical)||participants|Number|66|66.0||||||
3958269|NCT01325714|3780647|B1|$<20,000||Caregiver income (categorical)||participants|Number|64|64.0||||||
3958270|NCT01325714|3780645|B3|Other||Caregiver race/ethnicity (categorical)||participants|Number|9|9.0||||||
3958271|NCT01325714|3780646|B2|Other||Caregiver race/ethnicity (categorical)||participants|Number|4|4.0||||||
3958272|NCT01325714|3780647|B1|Other||Caregiver race/ethnicity (categorical)||participants|Number|5|5.0||||||
3958273|NCT01325714|3780645|B3|Hispanic or Latino||Caregiver race/ethnicity (categorical)||participants|Number|34|34.0||||||
3958274|NCT01325714|3780646|B2|Hispanic or Latino||Caregiver race/ethnicity (categorical)||participants|Number|17|17.0||||||
3958275|NCT01325714|3780647|B1|Hispanic or Latino||Caregiver race/ethnicity (categorical)||participants|Number|17|17.0||||||
3958276|NCT01325714|3780645|B3|Black||Caregiver race/ethnicity (categorical)||participants|Number|71|71.0||||||
3958277|NCT01325714|3780646|B2|Black||Caregiver race/ethnicity (categorical)||participants|Number|35|35.0||||||
3958278|NCT01325714|3780647|B1|Black||Caregiver race/ethnicity (categorical)||participants|Number|36|36.0||||||
3958279|NCT01325714|3780645|B3|Non-Hispanic White||Caregiver race/ethnicity (categorical)||participants|Number|89|89.0||||||
3958280|NCT01325714|3780646|B2|Non-Hispanic White||Caregiver race/ethnicity (categorical)||participants|Number|46|46.0||||||
3958281|NCT01325714|3780647|B1|Non-Hispanic White||Caregiver race/ethnicity (categorical)||participants|Number|43|43.0||||||
3958282|NCT01325714|3780645|B3|Females||Caregiver gender (categorical)||participants|Number|187|187.0||||||
3958283|NCT01325714|3780646|B2|Females||Caregiver gender (categorical)||participants|Number|92|92.0||||||
3958284|NCT01325714|3780647|B1|Females||Caregiver gender (categorical)||participants|Number|95|95.0||||||
3958285|NCT01325714|3780645|B3|Males||Caregiver gender (categorical)||participants|Number|16|16.0||||||
3958286|NCT01325714|3780646|B2|Males||Caregiver gender (categorical)||participants|Number|10|10.0||||||
3958287|NCT01325714|3780647|B1|Males||Caregiver gender (categorical)||participants|Number|6|6.0||||||
3958288|NCT01325714|3780645|B3|||Caregiver age (continuous)||years|Mean|66.06|66.06|Standard Deviation|12.61|12.61|||
3958289|NCT01325714|3780646|B2|||Caregiver age (continuous)||years|Mean|65.69|65.69|Standard Deviation|12.72|12.72|||
3958290|NCT01325714|3780647|B1|||Caregiver age (continuous)||years|Mean|66.43|66.43|Standard Deviation|12.54|12.54|||
3958291|NCT01325714|3780645|B3|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3958292|NCT01325714|3780646|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3958293|NCT01325714|3780647|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3958294|NCT01325714|3780645|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3958295|NCT01325714|3780646|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3958296|NCT01325714|3780647|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3958297|NCT01325714|3780645|B3|Black||Race/Ethnicity, Customized||participants|Number|73|73.0||||||
3958298|NCT01325714|3780646|B2|Black||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
3958299|NCT01325714|3780647|B1|Black||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3958300|NCT01325714|3780645|B3|Non-Hispanic White||Race/Ethnicity, Customized||participants|Number|94|94.0||||||
3958301|NCT01325714|3780646|B2|Non-Hispanic White||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
3958302|NCT01325714|3780647|B1|Non-Hispanic White||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
3958303|NCT01325714|3780645|B3||Male|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
3958304|NCT01325714|3780646|B2||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3958305|NCT01325714|3780647|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3958306|NCT01325714|3780645|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3958307|NCT01325714|3780646|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3958308|NCT01325714|3780647|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3958309|NCT01325714|3780645|B3|||Age||years|Mean|79.24|79.24|Standard Deviation|8.27|8.27|||
3958310|NCT01325714|3780646|B2|||Age||years|Mean|80.26|80.26|Standard Deviation|8.00|8.0|||
3958311|NCT01325714|3780647|B1|||Age||years|Mean|78.21|78.21|Standard Deviation|8.46|8.46|||
3958312|NCT01325701|3780670|B3|United States||Region of Enrollment||participants|Number|78|78.0||||||
3958313|NCT01325701|3780671|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3958314|NCT01325701|3780672|B1|United States||Region of Enrollment||participants|Number|70|70.0||||||
3958315|NCT01325701|3780670|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3958316|NCT01325701|3780671|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3958317|NCT01325701|3780672|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3958318|NCT01325701|3780670|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3958319|NCT01325701|3780671|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3958320|NCT01325701|3780672|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3958321|NCT01325701|3780670|B3|||Age||Years|Mean|62.7|62.7|Standard Deviation|13.38|13.38|||
3958322|NCT01325701|3780671|B2|||Age||Years|Mean|64.4|64.4|Standard Deviation|13.96|13.96|||
3958323|NCT01325701|3780672|B1|||Age||Years|Mean|62.5|62.5|Standard Deviation|13.40|13.4|||
3958324|NCT01325701|3780670|B3||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
3958325|NCT01325701|3780671|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3958326|NCT01325701|3780672|B1||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
3958327|NCT01325701|3780670|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3958328|NCT01325701|3780671|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3958329|NCT01325701|3780672|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3958330|NCT01325701|3780670|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3958331|NCT01325701|3780671|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3958332|NCT01325701|3780672|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3958333|NCT01325623|3780683|B1|Yes||Seizures with Auras in the Past 2 Months||participants|Number|16|16.0||||||
3958334|NCT01325623|3780683|B1|No||Seizures with Auras in the Past 2 Months||participants|Number|15|15.0||||||
3958335|NCT01325623|3780683|B1|Yes||Family History of Seizures||participants|Number|7|7.0||||||
3958336|NCT01325623|3780683|B1|No||Family History of Seizures||participants|Number|24|24.0||||||
3958337|NCT01325623|3780683|B1|Cryptogenic||Etiology||participants|Number|12|12.0||||||
3958338|NCT01325623|3780683|B1|Symptomatic||Etiology||participants|Number|16|16.0||||||
3958339|NCT01325623|3780683|B1|Idiopathic||Etiology||participants|Number|3|3.0||||||
3958340|NCT01325623|3780683|B1|Yes||Previous Brain or Epilepsy Surgery||participants|Number|9|9.0||||||
3958341|NCT01325623|3780683|B1|No||Previous Brain or Epilepsy Surgery||participants|Number|22|22.0||||||
3958342|NCT01325623|3780683|B1|||Age at Epilepsy Onset||years|Mean|15.9|15.9|Standard Deviation|10.9|10.9|||
3958343|NCT01325623|3780683|B1|||Age at Epilepsy Onset||years|Median|14|14.0|Full Range|||2.0|43.0|
3958344|NCT01325623|3780683|B1|Severe Impairment||Cognitive Status||participants|Number|0|0.0||||||
3958345|NCT01325623|3780683|B1|Moderate Impairment||Cognitive Status||participants|Number|3|3.0||||||
3958346|NCT01325623|3780683|B1|Minimal Impairment||Cognitive Status||participants|Number|8|8.0||||||
3958347|NCT01325623|3780683|B1|Normal||Cognitive Status||participants|Number|20|20.0||||||
3958348|NCT01325623|3780683|B1|Germany||Region of Enrollment||participants|Number|10|10.0||||||
3958349|NCT01325623|3780683|B1|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
3958350|NCT01325623|3780683|B1|Norway||Region of Enrollment||participants|Number|1|1.0||||||
3958351|NCT01325623|3780683|B1|Belgium||Region of Enrollment||participants|Number|10|10.0||||||
3958352|NCT01325623|3780683|B1|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
3958353|NCT01325623|3780683|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3958354|NCT01325623|3780683|B1|White||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3958355|NCT01325623|3780683|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3958356|NCT01325623|3780683|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3958357|NCT01325623|3780683|B1|60 years or older||Age, Customized||participants|Number|3|3.0||||||
3958358|NCT01325623|3780683|B1|50-59 years||Age, Customized||participants|Number|5|5.0||||||
3958359|NCT01325623|3780683|B1|40-49 years||Age, Customized||participants|Number|5|5.0||||||
3958360|NCT01325623|3780683|B1|30-39 years||Age, Customized||participants|Number|8|8.0||||||
3958361|NCT01325623|3780683|B1|18-29 years||Age, Customized||participants|Number|10|10.0||||||
3958362|NCT01325623|3780683|B1|||Age, Customized||years|Median|38|38.0|Full Range|||19.0|66.0|
3958363|NCT01325623|3780683|B1|||Age||years|Mean|39.6|39.6|Standard Deviation|13.4|13.4|||
3958364|NCT01325584|3780725|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3958365|NCT01325584|3780725|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3958366|NCT01325584|3780725|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3958367|NCT01325584|3780725|B1|||Age||Years|Mean|58|58.0|Standard Deviation|10.2|10.2|||
3958368|NCT01325584|3780725|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3958369|NCT01325584|3780725|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3958370|NCT01325584|3780725|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3958371|NCT01325532|3780733|B3|||Hamilton Depression Rating Scale|The Hamilton Depression Rating Scale used here is a 17-item scale that measures severity of depression. Items are individually scored from 0-4 or from 0-2 depending on the item, and the individual scores for each item are added to comprise one score. Higher scores indicate greater severity of depression. Possible scores on the scale range from a minimum of zero (0) to a maximum of 52.|units on a scale|Mean|18.3|18.3|Standard Deviation|2.8|2.8|||
3958372|NCT01325532|3780734|B2|||Hamilton Depression Rating Scale|The Hamilton Depression Rating Scale used here is a 17-item scale that measures severity of depression. Items are individually scored from 0-4 or from 0-2 depending on the item, and the individual scores for each item are added to comprise one score. Higher scores indicate greater severity of depression. Possible scores on the scale range from a minimum of zero (0) to a maximum of 52.|units on a scale|Mean|18.7|18.7|Standard Deviation|3.9|3.9|||
3958373|NCT01325532|3780735|B1|||Hamilton Depression Rating Scale|The Hamilton Depression Rating Scale used here is a 17-item scale that measures severity of depression. Items are individually scored from 0-4 or from 0-2 depending on the item, and the individual scores for each item are added to comprise one score. Higher scores indicate greater severity of depression. Possible scores on the scale range from a minimum of zero (0) to a maximum of 52.|units on a scale|Mean|18.1|18.1|Standard Deviation|1.5|1.5|||
3958374|NCT01325532|3780733|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3958375|NCT01325532|3780734|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3958376|NCT01325532|3780735|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3958377|NCT01325532|3780733|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3958378|NCT01325532|3780734|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3958379|NCT01325532|3780735|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3958380|NCT01325532|3780733|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3958381|NCT01325532|3780734|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3958382|NCT01325532|3780735|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3958383|NCT01325532|3780733|B3|||Age||years|Mean|48.1|48.1|Standard Deviation|12.3|12.3|||
3958384|NCT01325532|3780734|B2|||Age||years|Mean|51.4|51.4|Standard Deviation|11.9|11.9|||
3958385|NCT01325532|3780735|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|12.3|12.3|||
3958386|NCT01325532|3780733|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3958387|NCT01325532|3780734|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3958388|NCT01325532|3780735|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3958389|NCT01325532|3780733|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3958390|NCT01325532|3780734|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3958391|NCT01325532|3780735|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3958392|NCT01325532|3780733|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3958393|NCT01325532|3780734|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3958394|NCT01325532|3780735|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3958395|NCT01325493|3780746|B3|ASA 3||American Society of Anesthesiology classification|ASA classifications: ASA Physical Status 1 - A normal healthy patient ASA Physical Status 2 - A patient with mild systemic disease ASA Physical Status 3 - A patient with severe systemic disease|participants|Number|1|1.0||||||
3958396|NCT01325493|3780747|B2|ASA 3||American Society of Anesthesiology classification|ASA classifications: ASA Physical Status 1 - A normal healthy patient ASA Physical Status 2 - A patient with mild systemic disease ASA Physical Status 3 - A patient with severe systemic disease|participants|Number|0|0.0||||||
3958397|NCT01325493|3780748|B1|ASA 3||American Society of Anesthesiology classification|ASA classifications: ASA Physical Status 1 - A normal healthy patient ASA Physical Status 2 - A patient with mild systemic disease ASA Physical Status 3 - A patient with severe systemic disease|participants|Number|1|1.0||||||
3958398|NCT01325493|3780746|B3|ASA 2||American Society of Anesthesiology classification|ASA classifications: ASA Physical Status 1 - A normal healthy patient ASA Physical Status 2 - A patient with mild systemic disease ASA Physical Status 3 - A patient with severe systemic disease|participants|Number|22|22.0||||||
3958399|NCT01325493|3780747|B2|ASA 2||American Society of Anesthesiology classification|ASA classifications: ASA Physical Status 1 - A normal healthy patient ASA Physical Status 2 - A patient with mild systemic disease ASA Physical Status 3 - A patient with severe systemic disease|participants|Number|7|7.0||||||
3958400|NCT01325493|3780748|B1|ASA 2||American Society of Anesthesiology classification|ASA classifications: ASA Physical Status 1 - A normal healthy patient ASA Physical Status 2 - A patient with mild systemic disease ASA Physical Status 3 - A patient with severe systemic disease|participants|Number|15|15.0||||||
3958401|NCT01325493|3780746|B3|ASA 1||American Society of Anesthesiology classification|ASA classifications: ASA Physical Status 1 - A normal healthy patient ASA Physical Status 2 - A patient with mild systemic disease ASA Physical Status 3 - A patient with severe systemic disease|participants|Number|27|27.0||||||
3958402|NCT01325493|3780747|B2|ASA 1||American Society of Anesthesiology classification|ASA classifications: ASA Physical Status 1 - A normal healthy patient ASA Physical Status 2 - A patient with mild systemic disease ASA Physical Status 3 - A patient with severe systemic disease|participants|Number|14|14.0||||||
3958403|NCT01325493|3780748|B1|ASA 1||American Society of Anesthesiology classification|ASA classifications: ASA Physical Status 1 - A normal healthy patient ASA Physical Status 2 - A patient with mild systemic disease ASA Physical Status 3 - A patient with severe systemic disease|participants|Number|13|13.0||||||
3958404|NCT01325493|3780746|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3958405|NCT01325493|3780747|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
3958406|NCT01325493|3780748|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3958407|NCT01325493|3780746|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3958408|NCT01325493|3780747|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3958409|NCT01325493|3780748|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3958410|NCT01325493|3780746|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3958411|NCT01325493|3780747|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3958412|NCT01325493|3780748|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3958413|NCT01325493|3780746|B3|||Age||years|Median|14|14.0|Full Range|||11.0|18.0|
3958414|NCT01325493|3780747|B2|||Age||years|Median|14|14.0|Full Range|||12.0|18.0|
3958415|NCT01325493|3780748|B1|||Age||years|Median|14|14.0|Full Range|||11.0|18.0|
3958416|NCT01325428|3780761|B1|Male (Part B)||Sex/Gender, Customized||Participants|Number|0|0.0||||||
3958417|NCT01325428|3780761|B1|Male (Part A)||Sex/Gender, Customized||Participants|Number|0|0.0||||||
3958418|NCT01325428|3780761|B1|Female (Part B)||Sex/Gender, Customized||Participants|Number|10|10.0||||||
3958419|NCT01325428|3780761|B1|Female (Part A)||Sex/Gender, Customized||Participants|Number|26|26.0||||||
3958420|NCT01325428|3780761|B1|Part B||Age, Customized||Years|Mean|51.5|51.5|Standard Deviation|12.5|12.5|||
3958421|NCT01325428|3780761|B1|Part A||Age, Customized||Years|Mean|51.5|51.5|Standard Deviation|8.8|8.8|||
3958422|NCT01325350|3780776|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3958423|NCT01325350|3780777|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3958424|NCT01325350|3780778|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3958425|NCT01325350|3780779|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3958426|NCT01325350|3780780|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3958427|NCT01325350|3780781|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3958428|NCT01325350|3780776|B6||Female|Sex: Female, Male||Participants|Count of Participants|306|306.0||||||
3958429|NCT01325350|3780777|B5||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3958430|NCT01325350|3780778|B4||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3958431|NCT01325350|3780779|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3958432|NCT01325350|3780780|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3958433|NCT01325350|3780781|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3958434|NCT01325350|3780776|B6|35 to 59 years||Age, Customized||Participants|Number|244|244.0||||||
3958435|NCT01325350|3780777|B5|35 to 59 years||Age, Customized||Participants|Number|50|50.0||||||
3958436|NCT01325350|3780778|B4|35 to 59 years||Age, Customized||Participants|Number|48|48.0||||||
3958437|NCT01325350|3780779|B3|35 to 59 years||Age, Customized||Participants|Number|49|49.0||||||
3958438|NCT01325350|3780780|B2|35 to 59 years||Age, Customized||Participants|Number|48|48.0||||||
3958439|NCT01325350|3780781|B1|35 to 59 years||Age, Customized||Participants|Number|49|49.0||||||
3958440|NCT01325350|3780776|B6|18 to 34 years||Age, Customized||Participants|Number|62|62.0||||||
3958441|NCT01325350|3780777|B5|18 to 34 years||Age, Customized||Participants|Number|12|12.0||||||
3958442|NCT01325350|3780778|B4|18 to 34 years||Age, Customized||Participants|Number|13|13.0||||||
3958443|NCT01325350|3780779|B3|18 to 34 years||Age, Customized||Participants|Number|12|12.0||||||
3958444|NCT01325350|3780780|B2|18 to 34 years||Age, Customized||Participants|Number|13|13.0||||||
3958445|NCT01325350|3780781|B1|18 to 34 years||Age, Customized||Participants|Number|12|12.0||||||
3958446|NCT01325337|3780822|B6||Male|Sex: Female, Male||Participants|Count of Participants|307|307.0||||||
3958447|NCT01325337|3780823|B5||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3958448|NCT01325337|3780824|B4||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3958449|NCT01325337|3780825|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3958450|NCT01325337|3780826|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3958451|NCT01325337|3780827|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3958452|NCT01325337|3780822|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3958453|NCT01325337|3780823|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3958454|NCT01325337|3780824|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3958455|NCT01325337|3780825|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3958456|NCT01325337|3780826|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3958457|NCT01325337|3780827|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3958458|NCT01325337|3780822|B6|35 to 50 years||Age, Customized||Participants|Number|214|214.0||||||
3958459|NCT01325337|3780823|B5|35 to 50 years||Age, Customized||Participants|Number|43|43.0||||||
3958460|NCT01325337|3780824|B4|35 to 50 years||Age, Customized||Participants|Number|44|44.0||||||
3958461|NCT01325337|3780825|B3|35 to 50 years||Age, Customized||Participants|Number|42|42.0||||||
3958462|NCT01325337|3780826|B2|35 to 50 years||Age, Customized||Participants|Number|43|43.0||||||
3958463|NCT01325337|3780827|B1|35 to 50 years||Age, Customized||Participants|Number|42|42.0||||||
3958464|NCT01325337|3780822|B6|18 to 34 years||Age, Customized||Participants|Number|93|93.0||||||
3958465|NCT01325337|3780823|B5|18 to 34 years||Age, Customized||Participants|Number|18|18.0||||||
3958466|NCT01325337|3780824|B4|18 to 34 years||Age, Customized||Participants|Number|18|18.0||||||
3958467|NCT01325337|3780825|B3|18 to 34 years||Age, Customized||Participants|Number|20|20.0||||||
3958468|NCT01325337|3780826|B2|18 to 34 years||Age, Customized||Participants|Number|18|18.0||||||
3958469|NCT01325337|3780827|B1|18 to 34 years||Age, Customized||Participants|Number|19|19.0||||||
3958470|NCT01325311|3780868|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
3958471|NCT01325311|3780869|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3958472|NCT01325311|3780870|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3958473|NCT01325311|3780868|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958474|NCT01325311|3780869|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958475|NCT01325311|3780870|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958476|NCT01325311|3780868|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958477|NCT01325311|3780869|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958478|NCT01325311|3780870|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958479|NCT01325311|3780868|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3958480|NCT01325311|3780869|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3958481|NCT01325311|3780870|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3958482|NCT01325311|3780868|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958483|NCT01325311|3780869|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958484|NCT01325311|3780870|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958485|NCT01325311|3780868|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958486|NCT01325311|3780869|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958487|NCT01325311|3780870|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958488|NCT01325311|3780868|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958489|NCT01325311|3780869|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958490|NCT01325311|3780870|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958491|NCT01325311|3780868|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958492|NCT01325311|3780869|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958493|NCT01325311|3780870|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958494|NCT01325311|3780868|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958495|NCT01325311|3780869|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958496|NCT01325311|3780870|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958497|NCT01325311|3780868|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3958498|NCT01325311|3780869|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3958499|NCT01325311|3780870|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3958500|NCT01325311|3780868|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3958501|NCT01325311|3780869|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958502|NCT01325311|3780870|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3958503|NCT01325311|3780868|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3958504|NCT01325311|3780869|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3958505|NCT01325311|3780870|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3958506|NCT01325311|3780868|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3958507|NCT01325311|3780869|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3958508|NCT01325311|3780870|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3958509|NCT01325311|3780868|B3|||Age||years|Mean|61.40|61.4|Standard Deviation|4.29|4.29|||
3958510|NCT01325311|3780869|B2|||Age||years|Mean|62.14|62.14|Standard Deviation|4.26|4.26|||
3958511|NCT01325311|3780870|B1|||Age||years|Mean|60.75|60.75|Standard Deviation|4.50|4.5|||
3958512|NCT01325311|3780868|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3958513|NCT01325311|3780869|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3958514|NCT01325311|3780870|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3958515|NCT01325311|3780868|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3958516|NCT01325311|3780869|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3958517|NCT01325311|3780870|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3958518|NCT01325311|3780868|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3958519|NCT01325311|3780869|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3958520|NCT01325311|3780870|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3958521|NCT01325181|3780905|B3|Korea, Republic of||Region of Enrollment||participants|Number|34|34.0||||||
3958522|NCT01325181|3780906|B2|Korea, Republic of||Region of Enrollment||participants|Number|16|16.0||||||
3958523|NCT01325181|3780907|B1|Korea, Republic of||Region of Enrollment||participants|Number|18|18.0||||||
3958524|NCT01325181|3780905|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3958525|NCT01325181|3780906|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3958526|NCT01325181|3780907|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3958527|NCT01325181|3780905|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3958528|NCT01325181|3780906|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3958529|NCT01325181|3780907|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3958530|NCT01325181|3780905|B3|||Age||years|Mean|50.8|50.8|Standard Deviation|7.7|7.7|||
3958531|NCT01325181|3780906|B2|||Age||years|Mean|48.9|48.9|Standard Deviation|7.5|7.5|||
3958532|NCT01325181|3780907|B1|||Age||years|Mean|51.4|51.4|Standard Deviation|8.2|8.2|||
3958533|NCT01325181|3780905|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3958534|NCT01325181|3780906|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3958535|NCT01325181|3780907|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3958536|NCT01325181|3780905|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3958537|NCT01325181|3780906|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3958538|NCT01325181|3780907|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3958539|NCT01325181|3780905|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3958540|NCT01325181|3780906|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3958541|NCT01325181|3780907|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3958542|NCT01324999|3780914|B1|||Pulmonary Vascular Resistance||Wood Units|Mean|6.2|6.2|Standard Deviation|3.6|3.6|||
3958543|NCT01324999|3780914|B1|||Cardiac Index||L/min/m²|Mean|2.4|2.4|Standard Deviation|0.6|0.6|||
3958544|NCT01324999|3780914|B1|||Pulmonary Artery Wedge Pressure||mm Hg|Mean|10.3|10.3|Standard Deviation|3.6|3.6|||
3958545|NCT01324999|3780914|B1|||Mean Pulmonary Artery Pressure||mm Hg|Mean|34.8|34.8|Standard Deviation|7.1|7.1|||
3958546|NCT01324999|3780914|B1|||Right Atrial Pressure||mm Hg|Mean|6.2|6.2|Standard Deviation|4.0|4.0|||
3958547|NCT01324999|3780914|B1|||DLCO||percent predicted|Mean|60.3|60.3|Standard Deviation|25.0|25.0|||
3958548|NCT01324999|3780914|B1|||FVC||percent predicted|Mean|65.9|65.9|Standard Deviation|13.4|13.4|||
3958549|NCT01324999|3780914|B1|||FEV1||percent predicted|Mean|58.0|58.0|Standard Deviation|14.7|14.7|||
3958550|NCT01324999|3780914|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3958551|NCT01324999|3780914|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3958552|NCT01324999|3780914|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3958553|NCT01324999|3780914|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3958554|NCT01324999|3780914|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3958555|NCT01324999|3780914|B1|||Age||years|Mean|54.5|54.5|Standard Deviation|9.48|9.48|||
3958556|NCT01324947|3780925|B1|||Time From First Pathologic Diagnosis||years|Mean|7.6|7.6|Standard Deviation|3.72|3.72|||
3958557|NCT01324947|3780925|B1|Missing||Durie-Salmon Multiple Myeloma Stage before Study Entry|"Stages are:~Stage I: Hemoglobulin > 10 g/dL; serum calcium normal on roentgenogram; normal bone structure or solitary bone plasmacytoma only; Low M-component production rates (IgG value < 5 g/dL, IgA value < 3 g/dL; Bence Jones protein < 4 g/24h)~Stage II: Overall data as minimally abnormal for stage I, and no single value as abnormal as defined for stage III~Stage III: 1 or more of below:~Hemoglobin < 8.5 g/dL; serum calcium > 12 mg/dL; Advanced lytic bone lesions (scale 3); High-M-component production rates (IgG value > 7 g/dL, IgA value > 5 g/dL; Bence Jones protein > 12 g/24h)"|participants|Number|1|1.0||||||
3958558|NCT01324947|3780925|B1|Stage III||Durie-Salmon Multiple Myeloma Stage before Study Entry|"Stages are:~Stage I: Hemoglobulin > 10 g/dL; serum calcium normal on roentgenogram; normal bone structure or solitary bone plasmacytoma only; Low M-component production rates (IgG value < 5 g/dL, IgA value < 3 g/dL; Bence Jones protein < 4 g/24h)~Stage II: Overall data as minimally abnormal for stage I, and no single value as abnormal as defined for stage III~Stage III: 1 or more of below:~Hemoglobin < 8.5 g/dL; serum calcium > 12 mg/dL; Advanced lytic bone lesions (scale 3); High-M-component production rates (IgG value > 7 g/dL, IgA value > 5 g/dL; Bence Jones protein > 12 g/24h)"|participants|Number|50|50.0||||||
3958559|NCT01324947|3780925|B1|Stage II||Durie-Salmon Multiple Myeloma Stage before Study Entry|"Stages are:~Stage I: Hemoglobulin > 10 g/dL; serum calcium normal on roentgenogram; normal bone structure or solitary bone plasmacytoma only; Low M-component production rates (IgG value < 5 g/dL, IgA value < 3 g/dL; Bence Jones protein < 4 g/24h)~Stage II: Overall data as minimally abnormal for stage I, and no single value as abnormal as defined for stage III~Stage III: 1 or more of below:~Hemoglobin < 8.5 g/dL; serum calcium > 12 mg/dL; Advanced lytic bone lesions (scale 3); High-M-component production rates (IgG value > 7 g/dL, IgA value > 5 g/dL; Bence Jones protein > 12 g/24h)"|participants|Number|15|15.0||||||
3958560|NCT01324947|3780925|B1|Stage I||Durie-Salmon Multiple Myeloma Stage before Study Entry|"Stages are:~Stage I: Hemoglobulin > 10 g/dL; serum calcium normal on roentgenogram; normal bone structure or solitary bone plasmacytoma only; Low M-component production rates (IgG value < 5 g/dL, IgA value < 3 g/dL; Bence Jones protein < 4 g/24h)~Stage II: Overall data as minimally abnormal for stage I, and no single value as abnormal as defined for stage III~Stage III: 1 or more of below:~Hemoglobin < 8.5 g/dL; serum calcium > 12 mg/dL; Advanced lytic bone lesions (scale 3); High-M-component production rates (IgG value > 7 g/dL, IgA value > 5 g/dL; Bence Jones protein > 12 g/24h)"|participants|Number|8|8.0||||||
3958561|NCT01324947|3780925|B1|||Participants with Prior Anti-Myeloma (MM) Therapies||participants|Number|74|74.0||||||
3958562|NCT01324947|3780925|B1|Not Collected||Ethnicity||participants|Number|19|19.0||||||
3958563|NCT01324947|3780925|B1|Not Hispanic or Latino||Ethnicity||participants|Number|49|49.0||||||
3958564|NCT01324947|3780925|B1|Hispanic or Latino||Ethnicity||participants|Number|6|6.0||||||
3958565|NCT01324947|3780925|B1|Not Collected||Race||participants|Number|19|19.0||||||
3958566|NCT01324947|3780925|B1|Other||Race||participants|Number|2|2.0||||||
3958567|NCT01324947|3780925|B1|White||Race||participants|Number|52|52.0||||||
3958568|NCT01324947|3780925|B1|Native Hawaiian or Other Pacific Islanders||Race||participants|Number|0|0.0||||||
3958569|NCT01324947|3780925|B1|Black or African American||Race||participants|Number|1|1.0||||||
3958570|NCT01324947|3780925|B1|Asian||Race||participants|Number|0|0.0||||||
3958571|NCT01324947|3780925|B1|American Indian or Alaska Native||Race||participants|Number|0|0.0||||||
3958572|NCT01324947|3780925|B1||Male|Gender||Participants|Count of Participants|42|42.0||||||
3958573|NCT01324947|3780925|B1||Female|Gender||Participants|Count of Participants|32|32.0||||||
3958574|NCT01324947|3780925|B1|||Age||years|Mean|64.9|64.9|Standard Deviation|9.25|9.25|||
3958575|NCT01324882|3780936|B3|United States||Region of Enrollment||participants|Number|57|57.0||||||
3958576|NCT01324882|3780937|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3958577|NCT01324882|3780938|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3958578|NCT01324882|3780936|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3958579|NCT01324882|3780937|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3958580|NCT01324882|3780938|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3958581|NCT01324882|3780936|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3958582|NCT01324882|3780937|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3958583|NCT01324882|3780938|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3958584|NCT01324882|3780936|B3|||Age||years|Mean|55.85|55.85|Standard Deviation|7.5|7.5|||
3958585|NCT01324882|3780937|B2|||Age||years|Mean|56|56.0|Standard Deviation|8.3|8.3|||
3958586|NCT01324882|3780938|B1|||Age||years|Mean|55.7|55.7|Standard Deviation|6.8|6.8|||
3958587|NCT01324882|3780936|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3958588|NCT01324882|3780937|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3958589|NCT01324882|3780938|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3958590|NCT01324882|3780936|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3958591|NCT01324882|3780937|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3958592|NCT01324882|3780938|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3958593|NCT01324882|3780936|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3958594|NCT01324882|3780937|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3958595|NCT01324882|3780938|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3958596|NCT01324830|3780947|B20||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3958597|NCT01324830|3780948|B19||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3958598|NCT01324830|3780949|B18||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3958599|NCT01324830|3780950|B17||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3958600|NCT01324830|3780951|B16||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3958601|NCT01324830|3780952|B15||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3958602|NCT01324830|3780953|B14||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3958603|NCT01324830|3780954|B13||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3958604|NCT01324830|3780955|B12||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3958605|NCT01324830|3780956|B11||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3958606|NCT01324830|3780957|B10||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3958607|NCT01324830|3780958|B9||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3958608|NCT01324830|3780959|B8||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3958609|NCT01324830|3780960|B7||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3958610|NCT01324830|3780961|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3958611|NCT01324830|3780962|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3958612|NCT01324830|3780963|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3958613|NCT01324830|3780964|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3958614|NCT01324830|3780965|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3958615|NCT01324830|3780966|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3958616|NCT01324830|3780947|B20||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3958617|NCT01324830|3780948|B19||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3958618|NCT01324830|3780949|B18||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3958619|NCT01324830|3780950|B17||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3958620|NCT01324830|3780951|B16||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3958621|NCT01324830|3780952|B15||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3958622|NCT01324830|3780953|B14||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3958623|NCT01324830|3780954|B13||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3958624|NCT01324830|3780955|B12||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3958625|NCT01324830|3780956|B11||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3958626|NCT01324830|3780957|B10||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3958627|NCT01324830|3780958|B9||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3958628|NCT01324830|3780959|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3958629|NCT01324830|3780960|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3958630|NCT01324830|3780961|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3958631|NCT01324830|3780962|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3958632|NCT01324830|3780963|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3958633|NCT01324830|3780964|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3958634|NCT01324830|3780965|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3958635|NCT01324830|3780966|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3958636|NCT01324830|3780947|B20|||Age||Years|Mean|56.8|56.8|Standard Deviation|10.6|10.6|||
3958637|NCT01324830|3780948|B19|||Age||Years|Mean|51.7|51.7|Standard Deviation|13.4|13.4|||
3958638|NCT01324830|3780949|B18|||Age||Years|Mean|62.2|62.2|Standard Deviation|13.5|13.5|||
3958639|NCT01324830|3780950|B17|||Age||Years|Mean|42.7|42.7|Standard Deviation|3.5|3.5|||
3958640|NCT01324830|3780951|B16|||Age||Years|Mean|49.3|49.3|Standard Deviation|15.3|15.3|||
3958641|NCT01324830|3780952|B15|||Age||Years|Mean|62|62.0|Standard Deviation|0|0.0|||
3958642|NCT01324830|3780953|B14|||Age||Years|Mean|44|44.0|Standard Deviation|0|0.0|||
3958643|NCT01324830|3780954|B13|||Age||Years|Mean|49|49.0|Standard Deviation|0|0.0|||
3958644|NCT01324830|3780955|B12|||Age||Years|Mean|60|60.0|Standard Deviation|0|0.0|||
3958645|NCT01324830|3780956|B11|||Age||Years|Mean|55|55.0|Standard Deviation|7.4|7.4|||
3958646|NCT01324830|3780957|B10|||Age||Years|Mean|59.3|59.3|Standard Deviation|8.2|8.2|||
3958647|NCT01324830|3780958|B9|||Age||Years|Mean|58.6|58.6|Standard Deviation|9.9|9.9|||
3958648|NCT01324830|3780959|B8|||Age||Years|Mean|55.3|55.3|Standard Deviation|5.1|5.1|||
3958649|NCT01324830|3780960|B7|||Age||Years|Mean|66|66.0|Standard Deviation|10.4|10.4|||
3958650|NCT01324830|3780961|B6|||Age||Years|Mean|55.3|55.3|Standard Deviation|14.1|14.1|||
3958651|NCT01324830|3780962|B5|||Age||Years|Mean|58.9|58.9|Standard Deviation|9.8|9.8|||
3958652|NCT01324830|3780963|B4|||Age||Years|Mean|57.7|57.7|Standard Deviation|12.2|12.2|||
3958653|NCT01324830|3780964|B3|||Age||Years|Mean|58.7|58.7|Standard Deviation|4.2|4.2|||
3958654|NCT01324830|3780965|B2|||Age||Years|Mean|62.7|62.7|Standard Deviation|3.5|3.5|||
3958655|NCT01324830|3780966|B1|||Age||Years|Mean|58.7|58.7|Standard Deviation|8.1|8.1|||
3958656|NCT01324700|3781096|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3958657|NCT01324700|3781097|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958658|NCT01324700|3781098|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958659|NCT01324700|3781099|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958660|NCT01324700|3781100|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3958661|NCT01324700|3781096|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958662|NCT01324700|3781097|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958663|NCT01324700|3781098|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958664|NCT01324700|3781099|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958665|NCT01324700|3781100|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958666|NCT01324700|3781096|B5||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3958667|NCT01324700|3781097|B4||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3958668|NCT01324700|3781098|B3||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3958669|NCT01324700|3781099|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3958670|NCT01324700|3781100|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3958671|NCT01324700|3781096|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3958672|NCT01324700|3781097|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3958673|NCT01324700|3781098|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3958674|NCT01324700|3781099|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3958675|NCT01324700|3781100|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3958676|NCT01324700|3781096|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958677|NCT01324700|3781097|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958678|NCT01324700|3781098|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958679|NCT01324700|3781099|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958680|NCT01324700|3781100|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958681|NCT01324700|3781096|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3958682|NCT01324700|3781097|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3958683|NCT01324700|3781098|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3958684|NCT01324700|3781099|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958685|NCT01324700|3781100|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958686|NCT01324700|3781096|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958687|NCT01324700|3781097|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958688|NCT01324700|3781098|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958689|NCT01324700|3781099|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958690|NCT01324700|3781100|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958691|NCT01324700|3781096|B5||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3958692|NCT01324700|3781097|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3958693|NCT01324700|3781098|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3958694|NCT01324700|3781099|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3958695|NCT01324700|3781100|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3958696|NCT01324700|3781096|B5||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3958697|NCT01324700|3781097|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3958698|NCT01324700|3781098|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3958699|NCT01324700|3781099|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3958700|NCT01324700|3781100|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3958701|NCT01324700|3781096|B5|||Age||years|Mean|44.18|44.18|Standard Deviation|11.74|11.74|||
3958702|NCT01324700|3781097|B4|||Age||years|Mean|43.92|43.92|Standard Deviation|11.60|11.6|||
3958703|NCT01324700|3781098|B3|||Age||years|Mean|44.51|44.51|Standard Deviation|12.08|12.08|||
3958704|NCT01324700|3781099|B2|||Age||years|Mean|45.85|45.85|Standard Deviation|11.17|11.17|||
3958705|NCT01324700|3781100|B1|||Age||years|Mean|42.50|42.5|Standard Deviation|12.34|12.34|||
3958706|NCT01324687|3781117|B3|United States||Region of Enrollment||participants|Number|1537|1537.0||||||
3958707|NCT01324687|3781118|B2|United States||Region of Enrollment||participants|Number|479|479.0||||||
3958708|NCT01324687|3781119|B1|United States||Region of Enrollment||participants|Number|1058|1058.0||||||
3958709|NCT01324687|3781117|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958710|NCT01324687|3781118|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958711|NCT01324687|3781119|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958712|NCT01324687|3781117|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958713|NCT01324687|3781118|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958714|NCT01324687|3781119|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958715|NCT01324687|3781117|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1474|1474.0||||||
3958716|NCT01324687|3781118|B2||White|Race (NIH/OMB)||Participants|Count of Participants|452|452.0||||||
3958717|NCT01324687|3781119|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1022|1022.0||||||
3958718|NCT01324687|3781117|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3958719|NCT01324687|3781118|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3958720|NCT01324687|3781119|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3958721|NCT01324687|3781117|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958722|NCT01324687|3781118|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958723|NCT01324687|3781119|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958724|NCT01324687|3781117|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958725|NCT01324687|3781118|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958726|NCT01324687|3781119|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958727|NCT01324687|3781117|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958728|NCT01324687|3781118|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958729|NCT01324687|3781119|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958730|NCT01324687|3781117|B3||Male|Sex: Female, Male||Participants|Count of Participants|444|444.0||||||
3958731|NCT01324687|3781118|B2||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3958732|NCT01324687|3781119|B1||Male|Sex: Female, Male||Participants|Count of Participants|312|312.0||||||
3958733|NCT01324687|3781117|B3||Female|Sex: Female, Male||Participants|Count of Participants|1093|1093.0||||||
3958734|NCT01324687|3781118|B2||Female|Sex: Female, Male||Participants|Count of Participants|347|347.0||||||
3958735|NCT01324687|3781119|B1||Female|Sex: Female, Male||Participants|Count of Participants|746|746.0||||||
3958736|NCT01324687|3781117|B3|||Age||years|Median|85|85.0|Inter-Quartile Range|||79.0|90.0|
3958737|NCT01324687|3781118|B2|||Age||years|Median|85|85.0|Inter-Quartile Range|||19.0|89.0|
3958738|NCT01324687|3781119|B1|||Age||years|Median|85|85.0|Inter-Quartile Range|||79.0|90.0|
3958739|NCT01324622|3781128|B3|||BMI||kg/m2|Mean|30|30.0|Standard Deviation|6|6.0|||
3958740|NCT01324622|3781129|B2|||BMI||kg/m2|Mean|30|30.0|Standard Deviation|4|4.0|||
3958741|NCT01324622|3781130|B1|||BMI||kg/m2|Mean|29|29.0|Standard Deviation|7|7.0|||
3958742|NCT01324622|3781128|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
3958743|NCT01324622|3781129|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3958744|NCT01324622|3781130|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3958745|NCT01324622|3781128|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3958746|NCT01324622|3781129|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3958747|NCT01324622|3781130|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3958748|NCT01324622|3781128|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3958749|NCT01324622|3781129|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3958750|NCT01324622|3781130|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3958751|NCT01324622|3781128|B3|||Age||years|Mean|58|58.0|Standard Deviation|11|11.0|||
3958752|NCT01324622|3781129|B2|||Age||years|Mean|59|59.0|Standard Deviation|12|12.0|||
3958753|NCT01324622|3781130|B1|||Age||years|Mean|57|57.0|Standard Deviation|10|10.0|||
3958872|NCT01324440|3781198|B2|50 to 59||Age, Customized||participants|Number|10|10.0||||||
3958754|NCT01324570|3781159|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3958755|NCT01324570|3781160|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3958756|NCT01324570|3781161|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3958757|NCT01324570|3781159|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3958758|NCT01324570|3781160|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3958759|NCT01324570|3781161|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3958760|NCT01324570|3781159|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3958761|NCT01324570|3781160|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3958762|NCT01324570|3781161|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3958763|NCT01324570|3781159|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3958764|NCT01324570|3781160|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3958765|NCT01324570|3781161|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3958766|NCT01324570|3781159|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3958767|NCT01324570|3781160|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3958768|NCT01324570|3781161|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3958769|NCT01324570|3781159|B3|||Age||years|Mean|14.0|14.0|Standard Deviation|1.99|1.99|||
3958770|NCT01324570|3781160|B2|||Age||years|Mean|14.6|14.6|Standard Deviation|1.31|1.31|||
3958771|NCT01324570|3781161|B1|||Age||years|Mean|10.3|10.3|Standard Deviation|1.21|1.21|||
3958772|NCT01324453|3781174|B3|||Ischemic Duration||Minutes|Median|146|146.0|Inter-Quartile Range|||112.0|211.0|
3958773|NCT01324453|3781175|B2|||Ischemic Duration||Minutes|Median|158|158.0|Inter-Quartile Range|||115.0|214.0|
3958774|NCT01324453|3781176|B1|||Ischemic Duration||Minutes|Median|144|144.0|Inter-Quartile Range|||112.0|207.0|
3958775|NCT01324453|3781174|B3|||Ejection Fraction||Percent of blood ejected|Mean|50.2|50.2|Standard Deviation|10.0|10.0|||
3958776|NCT01324453|3781175|B2|||Ejection Fraction||Percent of blood ejected|Mean|50.1|50.1|Standard Deviation|10.1|10.1|||
3958777|NCT01324453|3781176|B1|||Ejection Fraction||Percent of blood ejected|Mean|50.3|50.3|Standard Deviation|10.0|10.0|||
3958778|NCT01324453|3781174|B3||Multiple Arteries|Infarct related artery||Participants|Count of Participants|4|4.0||||||
3958779|NCT01324453|3781175|B2||Multiple Arteries|Infarct related artery||Participants|Count of Participants|1|1.0||||||
3958780|NCT01324453|3781176|B1||Multiple Arteries|Infarct related artery||Participants|Count of Participants|3|3.0||||||
3958781|NCT01324453|3781174|B3||RCA|Infarct related artery||Participants|Count of Participants|53|53.0||||||
3958782|NCT01324453|3781175|B2||RCA|Infarct related artery||Participants|Count of Participants|28|28.0||||||
3958783|NCT01324453|3781176|B1||RCA|Infarct related artery||Participants|Count of Participants|25|25.0||||||
3958784|NCT01324453|3781174|B3||LAD|Infarct related artery||Participants|Count of Participants|39|39.0||||||
3958785|NCT01324453|3781175|B2||LAD|Infarct related artery||Participants|Count of Participants|17|17.0||||||
3958786|NCT01324453|3781176|B1||LAD|Infarct related artery||Participants|Count of Participants|22|22.0||||||
3958787|NCT01324453|3781174|B3||LCx|Infarct related artery||Participants|Count of Participants|7|7.0||||||
3958788|NCT01324453|3781175|B2||LCx|Infarct related artery||Participants|Count of Participants|3|3.0||||||
3958789|NCT01324453|3781176|B1||LCx|Infarct related artery||Participants|Count of Participants|4|4.0||||||
3958790|NCT01324453|3781174|B3||No|Family History of Myocardial Infarction||Participants|Count of Participants|62|62.0||||||
3958791|NCT01324453|3781175|B2||No|Family History of Myocardial Infarction||Participants|Count of Participants|26|26.0||||||
3958792|NCT01324453|3781176|B1||No|Family History of Myocardial Infarction||Participants|Count of Participants|36|36.0||||||
3958793|NCT01324453|3781174|B3||Yes|Family History of Myocardial Infarction||Participants|Count of Participants|41|41.0||||||
3958794|NCT01324453|3781175|B2||Yes|Family History of Myocardial Infarction||Participants|Count of Participants|23|23.0||||||
3958795|NCT01324453|3781176|B1||Yes|Family History of Myocardial Infarction||Participants|Count of Participants|18|18.0||||||
3958796|NCT01324453|3781174|B3||No|History of Stroke||Participants|Count of Participants|102|102.0||||||
3958797|NCT01324453|3781175|B2||No|History of Stroke||Participants|Count of Participants|49|49.0||||||
3958798|NCT01324453|3781176|B1||No|History of Stroke||Participants|Count of Participants|53|53.0||||||
3958799|NCT01324453|3781174|B3||Yes|History of Stroke||Participants|Count of Participants|1|1.0||||||
3958800|NCT01324453|3781175|B2||Yes|History of Stroke||Participants|Count of Participants|0|0.0||||||
3958801|NCT01324453|3781176|B1||Yes|History of Stroke||Participants|Count of Participants|1|1.0||||||
3958802|NCT01324453|3781174|B3||Unknown|Current Smoker||Participants|Count of Participants|1|1.0||||||
3958803|NCT01324453|3781175|B2||Unknown|Current Smoker||Participants|Count of Participants|1|1.0||||||
3958804|NCT01324453|3781176|B1||Unknown|Current Smoker||Participants|Count of Participants|0|0.0||||||
3958805|NCT01324453|3781174|B3||No|Current Smoker||Participants|Count of Participants|44|44.0||||||
3958806|NCT01324453|3781175|B2||No|Current Smoker||Participants|Count of Participants|18|18.0||||||
3958807|NCT01324453|3781176|B1||No|Current Smoker||Participants|Count of Participants|26|26.0||||||
3958808|NCT01324453|3781174|B3||Yes|Current Smoker||Participants|Count of Participants|58|58.0||||||
3958809|NCT01324453|3781175|B2||Yes|Current Smoker||Participants|Count of Participants|30|30.0||||||
3958810|NCT01324453|3781176|B1||Yes|Current Smoker||Participants|Count of Participants|28|28.0||||||
3958811|NCT01324453|3781174|B3||No Dylsipidemia|Hyperlipidemia||Participants|Count of Participants|44|44.0||||||
3958812|NCT01324453|3781175|B2||No Dylsipidemia|Hyperlipidemia||Participants|Count of Participants|23|23.0||||||
3958813|NCT01324453|3781176|B1||No Dylsipidemia|Hyperlipidemia||Participants|Count of Participants|21|21.0||||||
3958814|NCT01324453|3781174|B3||Dyslipidemia|Hyperlipidemia||Participants|Count of Participants|59|59.0||||||
3958815|NCT01324453|3781175|B2||Dyslipidemia|Hyperlipidemia||Participants|Count of Participants|26|26.0||||||
3958816|NCT01324453|3781176|B1||Dyslipidemia|Hyperlipidemia||Participants|Count of Participants|33|33.0||||||
3958817|NCT01324453|3781174|B3||No Hypertension|Hypertension||Participants|Count of Participants|52|52.0||||||
3958818|NCT01324453|3781175|B2||No Hypertension|Hypertension||Participants|Count of Participants|27|27.0||||||
3958819|NCT01324453|3781176|B1||No Hypertension|Hypertension||Participants|Count of Participants|25|25.0||||||
3958820|NCT01324453|3781174|B3||Hypertension|Hypertension||Participants|Count of Participants|51|51.0||||||
3958821|NCT01324453|3781175|B2||Hypertension|Hypertension||Participants|Count of Participants|22|22.0||||||
3958822|NCT01324453|3781176|B1||Hypertension|Hypertension||Participants|Count of Participants|29|29.0||||||
3958823|NCT01324453|3781174|B3||No Diabetes|Diabetes||Participants|Count of Participants|84|84.0||||||
3958824|NCT01324453|3781175|B2||No Diabetes|Diabetes||Participants|Count of Participants|40|40.0||||||
3958825|NCT01324453|3781176|B1||No Diabetes|Diabetes||Participants|Count of Participants|44|44.0||||||
3958826|NCT01324453|3781174|B3||Diabetes|Diabetes||Participants|Count of Participants|19|19.0||||||
3958827|NCT01324453|3781175|B2||Diabetes|Diabetes||Participants|Count of Participants|9|9.0||||||
3958828|NCT01324453|3781176|B1||Diabetes|Diabetes||Participants|Count of Participants|10|10.0||||||
3958829|NCT01324453|3781174|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3958830|NCT01324453|3781175|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3958831|NCT01324453|3781176|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3958832|NCT01324453|3781174|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958833|NCT01324453|3781175|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958834|NCT01324453|3781176|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958835|NCT01324453|3781174|B3||White|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3958836|NCT01324453|3781175|B2||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3958837|NCT01324453|3781176|B1||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3958838|NCT01324453|3781174|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3958839|NCT01324453|3781175|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3958840|NCT01324453|3781176|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3958841|NCT01324453|3781174|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958842|NCT01324453|3781175|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958843|NCT01324453|3781176|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958844|NCT01324453|3781174|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3958845|NCT01324453|3781175|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958846|NCT01324453|3781176|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3958847|NCT01324453|3781174|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3958848|NCT01324453|3781175|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3958849|NCT01324453|3781176|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958850|NCT01324453|3781174|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3958851|NCT01324453|3781175|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3958852|NCT01324453|3781176|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3958853|NCT01324453|3781174|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3958854|NCT01324453|3781175|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3958855|NCT01324453|3781176|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3958856|NCT01324453|3781174|B3|||Age||Years|Mean|59.9|59.9|Standard Deviation|9.8|9.8|||
3958857|NCT01324453|3781175|B2|||Age||Years|Mean|60.0|60.0|Standard Deviation|9.7|9.7|||
3958858|NCT01324453|3781176|B1|||Age||Years|Mean|59.8|59.8|Standard Deviation|10.0|10.0|||
3958859|NCT01324440|3781197|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3958860|NCT01324440|3781198|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3958861|NCT01324440|3781199|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3958862|NCT01324440|3781197|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3958863|NCT01324440|3781198|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3958864|NCT01324440|3781199|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3958865|NCT01324440|3781197|B3|Over 69||Age, Customized||participants|Number|0|0.0||||||
3958866|NCT01324440|3781198|B2|Over 69||Age, Customized||participants|Number|0|0.0||||||
3958867|NCT01324440|3781199|B1|Over 69||Age, Customized||participants|Number|0|0.0||||||
3958868|NCT01324440|3781197|B3|60 to 69||Age, Customized||participants|Number|10|10.0||||||
3958869|NCT01324440|3781198|B2|60 to 69||Age, Customized||participants|Number|6|6.0||||||
3958870|NCT01324440|3781199|B1|60 to 69||Age, Customized||participants|Number|4|4.0||||||
3958871|NCT01324440|3781197|B3|50 to 59||Age, Customized||participants|Number|22|22.0||||||
3958873|NCT01324440|3781199|B1|50 to 59||Age, Customized||participants|Number|12|12.0||||||
3958874|NCT01324440|3781197|B3|40 to 49||Age, Customized||participants|Number|16|16.0||||||
3958875|NCT01324440|3781198|B2|40 to 49||Age, Customized||participants|Number|7|7.0||||||
3958876|NCT01324440|3781199|B1|40 to 49||Age, Customized||participants|Number|9|9.0||||||
3958877|NCT01324440|3781197|B3|30 to 39||Age, Customized||participants|Number|5|5.0||||||
3958878|NCT01324440|3781198|B2|30 to 39||Age, Customized||participants|Number|4|4.0||||||
3958879|NCT01324440|3781199|B1|30 to 39||Age, Customized||participants|Number|1|1.0||||||
3958880|NCT01324440|3781197|B3|18 to 29||Age, Customized||participants|Number|11|11.0||||||
3958881|NCT01324440|3781198|B2|18 to 29||Age, Customized||participants|Number|5|5.0||||||
3958882|NCT01324440|3781199|B1|18 to 29||Age, Customized||participants|Number|6|6.0||||||
3958883|NCT01324440|3781197|B3|17 and under||Age, Customized||participants|Number|0|0.0||||||
3958884|NCT01324440|3781198|B2|17 and under||Age, Customized||participants|Number|0|0.0||||||
3958885|NCT01324440|3781199|B1|17 and under||Age, Customized||participants|Number|0|0.0||||||
3958886|NCT01324401|3781212|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3958887|NCT01324401|3781213|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
3958888|NCT01324401|3781214|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3958889|NCT01324401|3781212|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958890|NCT01324401|3781213|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958891|NCT01324401|3781214|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958892|NCT01324401|3781212|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3958893|NCT01324401|3781213|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3958894|NCT01324401|3781214|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3958895|NCT01324401|3781212|B3||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3958896|NCT01324401|3781213|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3958897|NCT01324401|3781214|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3958898|NCT01324401|3781212|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958899|NCT01324401|3781213|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958900|NCT01324401|3781214|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958901|NCT01324401|3781212|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958902|NCT01324401|3781213|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958903|NCT01324401|3781214|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958904|NCT01324401|3781212|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3958905|NCT01324401|3781213|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3958906|NCT01324401|3781214|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958907|NCT01324401|3781212|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958908|NCT01324401|3781213|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958909|NCT01324401|3781214|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958910|NCT01324401|3781212|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3958911|NCT01324401|3781213|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3958912|NCT01324401|3781214|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3958913|NCT01324401|3781212|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3958914|NCT01324401|3781213|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3958915|NCT01324401|3781214|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3958916|NCT01324401|3781212|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3958917|NCT01324401|3781213|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3958918|NCT01324401|3781214|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3958919|NCT01324401|3781212|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3958920|NCT01324401|3781213|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3958921|NCT01324401|3781214|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3958922|NCT01324401|3781212|B3||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
3958923|NCT01324401|3781213|B2||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
3958924|NCT01324401|3781214|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3958925|NCT01324388|3781223|B4|United States||Region of Enrollment||participants|Number|51|51.0||||||
3958926|NCT01324388|3781224|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3958927|NCT01324388|3781225|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3958928|NCT01324388|3781226|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
3958929|NCT01324388|3781223|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958930|NCT01324388|3781224|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958931|NCT01324388|3781225|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958932|NCT01324388|3781226|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958991|NCT01324349|3781249|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3958933|NCT01324388|3781223|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3958934|NCT01324388|3781224|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3958935|NCT01324388|3781225|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3958936|NCT01324388|3781226|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3958937|NCT01324388|3781223|B4||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3958938|NCT01324388|3781224|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3958939|NCT01324388|3781225|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3958940|NCT01324388|3781226|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3958941|NCT01324388|3781223|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3958942|NCT01324388|3781224|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3958943|NCT01324388|3781225|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3958944|NCT01324388|3781226|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3958945|NCT01324388|3781223|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958946|NCT01324388|3781224|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958947|NCT01324388|3781225|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958948|NCT01324388|3781226|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958949|NCT01324388|3781223|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3958950|NCT01324388|3781224|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3958951|NCT01324388|3781225|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958952|NCT01324388|3781226|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3958953|NCT01324388|3781223|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958954|NCT01324388|3781224|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958955|NCT01324388|3781225|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958956|NCT01324388|3781226|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958957|NCT01324388|3781223|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958958|NCT01324388|3781224|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958959|NCT01324388|3781225|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958960|NCT01324388|3781226|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958961|NCT01324388|3781223|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3958962|NCT01324388|3781224|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3958963|NCT01324388|3781225|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3958964|NCT01324388|3781226|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3958965|NCT01324388|3781223|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3958966|NCT01324388|3781224|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3958967|NCT01324388|3781225|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3958968|NCT01324388|3781226|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3958969|NCT01324388|3781223|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3958970|NCT01324388|3781224|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3958971|NCT01324388|3781225|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3958972|NCT01324388|3781226|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3958973|NCT01324388|3781223|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3958974|NCT01324388|3781224|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3958975|NCT01324388|3781225|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3958976|NCT01324388|3781226|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3958977|NCT01324388|3781223|B4|||Age||years|Mean|51.8|51.8|Standard Deviation|14.6|14.6|||
3958978|NCT01324388|3781224|B3|||Age||years|Mean|44.6|44.6|Standard Deviation|16.7|16.7|||
3958979|NCT01324388|3781225|B2|||Age||years|Mean|54.0|54.0|Standard Deviation|13.0|13.0|||
3958980|NCT01324388|3781226|B1|||Age||years|Mean|57.2|57.2|Standard Deviation|10.4|10.4|||
3958981|NCT01324349|3781248|B3|Germany||Region of Enrollment||participants|Number|24|24.0||||||
3958982|NCT01324349|3781249|B2|Germany||Region of Enrollment||participants|Number|9|9.0||||||
3958983|NCT01324349|3781250|B1|Germany||Region of Enrollment||participants|Number|15|15.0||||||
3958984|NCT01324349|3781248|B3|Austria||Region of Enrollment||participants|Number|10|10.0||||||
3958985|NCT01324349|3781249|B2|Austria||Region of Enrollment||participants|Number|4|4.0||||||
3958986|NCT01324349|3781250|B1|Austria||Region of Enrollment||participants|Number|6|6.0||||||
3958987|NCT01324349|3781248|B3|Belgium||Region of Enrollment||participants|Number|16|16.0||||||
3958988|NCT01324349|3781249|B2|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
3958989|NCT01324349|3781250|B1|Belgium||Region of Enrollment||participants|Number|11|11.0||||||
3958990|NCT01324349|3781248|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3958992|NCT01324349|3781250|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3958993|NCT01324349|3781248|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3958994|NCT01324349|3781249|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3958995|NCT01324349|3781250|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3958996|NCT01324349|3781248|B3|||Age||years|Mean|62.1|62.1|Standard Deviation|13.4|13.4|||
3958997|NCT01324349|3781249|B2|||Age||years|Mean|62|62.0|Standard Deviation|10.6|10.6|||
3958998|NCT01324349|3781250|B1|||Age||years|Mean|62.2|62.2|Standard Deviation|14.9|14.9|||
3958999|NCT01324349|3781248|B3||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3959000|NCT01324349|3781249|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3959001|NCT01324349|3781250|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3959002|NCT01324349|3781248|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3959003|NCT01324349|3781249|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3959004|NCT01324349|3781250|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3959005|NCT01324349|3781248|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3959006|NCT01324349|3781249|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3959007|NCT01324349|3781250|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3959008|NCT01324323|3781261|B1|4 = Completely Disabled||Eastern Cooperative Oncology Group Performance Status (ECOG)|"Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)"|Participants|Number|0|0.0||||||
3959009|NCT01324323|3781261|B1|3 = Limited Self-Care||Eastern Cooperative Oncology Group Performance Status (ECOG)|"Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)"|Participants|Number|0|0.0||||||
3959010|NCT01324323|3781261|B1|2 = Ambulaotry but unable to work||Eastern Cooperative Oncology Group Performance Status (ECOG)|"Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)"|Participants|Number|0|0.0||||||
3959011|NCT01324323|3781261|B1|1 = Restricted in physical strenuous activity||Eastern Cooperative Oncology Group Performance Status (ECOG)|"Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)"|Participants|Number|7|7.0||||||
3959012|NCT01324323|3781261|B1|0 = Fully active||Eastern Cooperative Oncology Group Performance Status (ECOG)|"Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)"|Participants|Number|7|7.0||||||
3959013|NCT01324323|3781261|B1|||Body Surface Area (BSA)||Metered Squares m^2|Mean|1.9|1.9|Standard Deviation|0.22|0.22|||
3959014|NCT01324323|3781261|B1|||Weight||kilograms|Mean|78.2|78.2|Standard Deviation|18.85|18.85|||
3959015|NCT01324323|3781261|B1|||Height||Centimeters|Mean|167.6|167.6|Standard Deviation|9.54|9.54|||
3959016|NCT01324323|3781261|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3959017|NCT01324323|3781261|B1|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
3959018|NCT01324323|3781261|B1|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3959019|NCT01324323|3781261|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3959020|NCT01324323|3781261|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3959021|NCT01324323|3781261|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3959022|NCT01324323|3781261|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3959023|NCT01324323|3781261|B1|White||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
3959024|NCT01324323|3781261|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3959025|NCT01324323|3781261|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3959026|NCT01324323|3781261|B1|||Age||years|Mean|63.6|63.6|Standard Deviation|12.57|12.57|||
3959027|NCT01324310|3781281|B1|4 = Completely Disabled||Eastern Cooperative Oncology Group Performance Status (ECOG)|"Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care"|Participants|Number|0|0.0||||||
3959028|NCT01324310|3781281|B1|3 = Limited Self Care||Eastern Cooperative Oncology Group Performance Status (ECOG)|"Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care"|Participants|Number|0|0.0||||||
3959029|NCT01324310|3781281|B1|2 = Ambulatory but unable to work||Eastern Cooperative Oncology Group Performance Status (ECOG)|"Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care"|Participants|Number|0|0.0||||||
3959030|NCT01324310|3781281|B1|1 = Restricted in physical strenuous activity||Eastern Cooperative Oncology Group Performance Status (ECOG)|"Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care"|Participants|Number|8|8.0||||||
3959031|NCT01324310|3781281|B1|0 = Fully Active||Eastern Cooperative Oncology Group Performance Status (ECOG)|"Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care"|Participants|Number|7|7.0||||||
3959032|NCT01324310|3781281|B1|||Body Surface Area (BSA)||m^2|Mean|1.9|1.9|Standard Deviation|0.24|0.24|||
3959033|NCT01324310|3781281|B1|||Weight||kilograms|Mean|78.4|78.4|Standard Deviation|18.77|18.77|||
3959034|NCT01324310|3781281|B1|||Height||Centimeters|Mean|174.9|174.9|Standard Deviation|9.59|9.59|||
3959035|NCT01324310|3781281|B1|United States||Region of Enrollment||Participants|Number|9|9.0||||||
3959036|NCT01324310|3781281|B1|United Kingdom||Region of Enrollment||Participants|Number|6|6.0||||||
3959037|NCT01324310|3781281|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3959038|NCT01324310|3781281|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3959039|NCT01324310|3781281|B1|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3959040|NCT01324310|3781281|B1|White||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3959041|NCT01324310|3781281|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959042|NCT01324310|3781281|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3959043|NCT01324310|3781281|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959044|NCT01324310|3781281|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3959045|NCT01324310|3781281|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3959046|NCT01324310|3781281|B1|||Age||years|Mean|61.8|61.8|Standard Deviation|11.50|11.5|||
3959047|NCT01324271|3781301|B1|United States||Region of Enrollment||participants|Number|85|85.0||||||
3959048|NCT01324271|3781301|B1|Other races (self-reported)||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3959049|NCT01324271|3781301|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3959050|NCT01324271|3781301|B1|White||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
3959051|NCT01324271|3781301|B1|African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3959052|NCT01324271|3781301|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3959053|NCT01324271|3781301|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3959054|NCT01324271|3781301|B1|||Age||years|Mean|17.01|17.01|Standard Deviation|24.19|24.19|||
3959055|NCT01324128|3781308|B3|South Africa||Region of Enrollment||participants|Number|7|7.0||||||
3959056|NCT01324128|3781309|B2|South Africa||Region of Enrollment||participants|Number|2|2.0||||||
3959057|NCT01324128|3781310|B1|South Africa||Region of Enrollment||participants|Number|5|5.0||||||
3959058|NCT01324128|3781308|B3|Croatia||Region of Enrollment||participants|Number|27|27.0||||||
3959059|NCT01324128|3781309|B2|Croatia||Region of Enrollment||participants|Number|8|8.0||||||
3959060|NCT01324128|3781310|B1|Croatia||Region of Enrollment||participants|Number|19|19.0||||||
3959061|NCT01324128|3781308|B3|Serbia||Region of Enrollment||participants|Number|71|71.0||||||
3959062|NCT01324128|3781309|B2|Serbia||Region of Enrollment||participants|Number|24|24.0||||||
3959063|NCT01324128|3781310|B1|Serbia||Region of Enrollment||participants|Number|47|47.0||||||
3959064|NCT01324128|3781308|B3|Ukraine||Region of Enrollment||participants|Number|51|51.0||||||
3959065|NCT01324128|3781309|B2|Ukraine||Region of Enrollment||participants|Number|17|17.0||||||
3959066|NCT01324128|3781310|B1|Ukraine||Region of Enrollment||participants|Number|34|34.0||||||
3959067|NCT01324128|3781308|B3|Russian Federation||Region of Enrollment||participants|Number|151|151.0||||||
3959068|NCT01324128|3781309|B2|Russian Federation||Region of Enrollment||participants|Number|50|50.0||||||
3959069|NCT01324128|3781310|B1|Russian Federation||Region of Enrollment||participants|Number|101|101.0||||||
3959070|NCT01324128|3781308|B3|Europe||Region of Enrollment||participants|Number|236|236.0||||||
3959071|NCT01324128|3781309|B2|Europe||Region of Enrollment||participants|Number|77|77.0||||||
3959072|NCT01324128|3781310|B1|Europe||Region of Enrollment||participants|Number|159|159.0||||||
3959073|NCT01324128|3781308|B3|United States||Region of Enrollment||participants|Number|516|516.0||||||
3959074|NCT01324128|3781309|B2|United States||Region of Enrollment||participants|Number|171|171.0||||||
3959075|NCT01324128|3781310|B1|United States||Region of Enrollment||participants|Number|345|345.0||||||
3959076|NCT01324128|3781308|B3||Male|Sex: Female, Male||Participants|Count of Participants|616|616.0||||||
3959077|NCT01324128|3781309|B2||Male|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
3959078|NCT01324128|3781310|B1||Male|Sex: Female, Male||Participants|Count of Participants|396|396.0||||||
3959079|NCT01324128|3781308|B3||Female|Sex: Female, Male||Participants|Count of Participants|443|443.0||||||
3959080|NCT01324128|3781309|B2||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3959081|NCT01324128|3781310|B1||Female|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
3959082|NCT01324128|3781308|B3|||Age||years|Mean|56.2|56.2|Standard Deviation|13.77|13.77|||
3959083|NCT01324128|3781309|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|14.59|14.59|||
3959084|NCT01324128|3781310|B1|||Age||years|Mean|56.3|56.3|Standard Deviation|13.35|13.35|||
3959085|NCT01324128|3781308|B3||>=65 years|Age||Participants|Count of Participants|305|305.0||||||
3959086|NCT01324128|3781309|B2||>=65 years|Age||Participants|Count of Participants|107|107.0||||||
3959087|NCT01324128|3781310|B1||>=65 years|Age||Participants|Count of Participants|198|198.0||||||
3959088|NCT01324128|3781308|B3||Between 18 and 65 years|Age||Participants|Count of Participants|754|754.0||||||
3959089|NCT01324128|3781309|B2||Between 18 and 65 years|Age||Participants|Count of Participants|242|242.0||||||
3959090|NCT01324128|3781310|B1||Between 18 and 65 years|Age||Participants|Count of Participants|512|512.0||||||
3959091|NCT01324128|3781308|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3959092|NCT01324128|3781309|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3959093|NCT01324128|3781310|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3959094|NCT01324102|3781323|B3|All other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3959095|NCT01324102|3781324|B2|All other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3959096|NCT01324102|3781325|B1|All other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3959097|NCT01324102|3781323|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3959098|NCT01324102|3781324|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3959099|NCT01324102|3781325|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3959100|NCT01324102|3781323|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3959101|NCT01324102|3781324|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3959102|NCT01324102|3781325|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3959103|NCT01324102|3781323|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3959104|NCT01324102|3781324|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3959105|NCT01324102|3781325|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3959106|NCT01324102|3781323|B3|Mean||Age, Customized|Adult individuals of any age were permitted, but since most of those diagnosed with cancer are older, the sample is predominantly older.|Years|Mean|69.42|69.42|Full Range|||55.0|84.0|
3959107|NCT01324102|3781324|B2|Mean||Age, Customized|Adult individuals of any age were permitted, but since most of those diagnosed with cancer are older, the sample is predominantly older.|Years|Mean|69.42|69.42|Full Range|||55.0|84.0|
3959108|NCT01324102|3781325|B1|Mean||Age, Customized|Adult individuals of any age were permitted, but since most of those diagnosed with cancer are older, the sample is predominantly older.|Years|Mean|69.42|69.42|Full Range|||55.0|84.0|
3959109|NCT01324024|3781333|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
3959110|NCT01324024|3781333|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959111|NCT01324024|3781333|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3959112|NCT01324024|3781333|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3959113|NCT01324024|3781333|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3959114|NCT01324024|3781333|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959115|NCT01324024|3781333|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959116|NCT01324024|3781333|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3959117|NCT01324024|3781333|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959118|NCT01324024|3781333|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3959119|NCT01324024|3781333|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3959120|NCT01324024|3781333|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3959121|NCT01324024|3781333|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3959122|NCT01324024|3781333|B1|||Age||years|Mean|53.1|53.1|Standard Deviation|2.8|2.8|||
3959123|NCT01324024|3781333|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3959124|NCT01324024|3781333|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3959125|NCT01324024|3781333|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3959126|NCT01323998|3781347|B6||Male|Sex: Female, Male||Participants|Count of Participants|248393|248393.0||||||
3959127|NCT01323998|3781348|B5||Male|Sex: Female, Male||Participants|Count of Participants|6735|6735.0||||||
3959128|NCT01323998|3781349|B4||Male|Sex: Female, Male||Participants|Count of Participants|12052|12052.0||||||
3959129|NCT01323998|3781350|B3||Male|Sex: Female, Male||Participants|Count of Participants|10294|10294.0||||||
3959130|NCT01323998|3781351|B2||Male|Sex: Female, Male||Participants|Count of Participants|18681|18681.0||||||
3959131|NCT01323998|3781352|B1||Male|Sex: Female, Male||Participants|Count of Participants|200631|200631.0||||||
3959132|NCT01323998|3781347|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3959133|NCT01323998|3781348|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3959134|NCT01323998|3781349|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3959135|NCT01323998|3781350|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3959136|NCT01323998|3781351|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3959137|NCT01323998|3781352|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3959138|NCT01323998|3781347|B6|||Age||Years|Mean|67.4|67.4|Standard Deviation|10.4|10.4|||
3959139|NCT01323998|3781348|B5|||Age||Years|Mean|68.9|68.9|Standard Deviation|10.1|10.1|||
3959140|NCT01323998|3781349|B4|||Age||Years|Mean|68.0|68.0|Standard Deviation|10.1|10.1|||
3959141|NCT01323998|3781350|B3|||Age||Years|Mean|68.8|68.8|Standard Deviation|10.3|10.3|||
3959142|NCT01323998|3781351|B2|||Age||Years|Mean|67.6|67.6|Standard Deviation|10.4|10.4|||
3959143|NCT01323998|3781352|B1|||Age||Years|Mean|67.2|67.2|Standard Deviation|10.4|10.4|||
3959144|NCT01323972|3781368|B5|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|320|320.0||||||
3959145|NCT01323972|3781369|B4|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|80|80.0||||||
3959146|NCT01323972|3781370|B3|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|80|80.0||||||
3959147|NCT01323972|3781371|B2|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|79|79.0||||||
3959148|NCT01323972|3781372|B1|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|81|81.0||||||
3959149|NCT01323972|3781368|B5||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
3959150|NCT01323972|3781369|B4||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3959151|NCT01323972|3781370|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3959152|NCT01323972|3781371|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3959153|NCT01323972|3781372|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3959154|NCT01323972|3781368|B5||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3959155|NCT01323972|3781369|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3959156|NCT01323972|3781370|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3959157|NCT01323972|3781371|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3959158|NCT01323972|3781372|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3959159|NCT01323972|3781368|B5|||Age||Months|Mean|10.07|10.07|Standard Deviation|3.28|3.28|||
3959160|NCT01323972|3781369|B4|||Age||Months|Mean|10.2|10.2|Standard Deviation|3.01|3.01|||
3959161|NCT01323972|3781370|B3|||Age||Months|Mean|10.1|10.1|Standard Deviation|3.24|3.24|||
3959162|NCT01323972|3781371|B2|||Age||Months|Mean|10.2|10.2|Standard Deviation|3.56|3.56|||
3959163|NCT01323972|3781372|B1|||Age||Months|Mean|9.8|9.8|Standard Deviation|3.35|3.35|||
3959164|NCT01323959|3781407|B4||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3959165|NCT01323959|3781408|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3959166|NCT01323959|3781409|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3959167|NCT01323959|3781410|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3959168|NCT01323959|3781407|B4||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3959169|NCT01323959|3781408|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3959170|NCT01323959|3781409|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3959171|NCT01323959|3781410|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3959172|NCT01323959|3781407|B4|||Age||Years|Mean|50.33|50.33|Standard Deviation|12.78|12.78|||
3959173|NCT01323959|3781408|B3|||Age||Years|Mean|51.4|51.4|Standard Deviation|13.06|13.06|||
3959174|NCT01323959|3781409|B2|||Age||Years|Mean|49.2|49.2|Standard Deviation|12.53|12.53|||
3959175|NCT01323959|3781410|B1|||Age||Years|Mean|50.4|50.4|Standard Deviation|12.82|12.82|||
3959176|NCT01323920|3781468|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
3959177|NCT01323920|3781468|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3959178|NCT01323920|3781468|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3959179|NCT01323920|3781468|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3959180|NCT01323920|3781468|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3959181|NCT01323920|3781468|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3959182|NCT01323855|3781475|B6||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3959183|NCT01323855|3781476|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3959184|NCT01323855|3781477|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3959185|NCT01323855|3781478|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3959186|NCT01323855|3781479|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3959187|NCT01323855|3781480|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3959188|NCT01323855|3781475|B6||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3959189|NCT01323855|3781476|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3959190|NCT01323855|3781477|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3959191|NCT01323855|3781478|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3959192|NCT01323855|3781479|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3959193|NCT01323855|3781480|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3959194|NCT01323855|3781475|B6|||Age||Years|Mean|63.5|63.5|Standard Deviation|9.3|9.3|||
3959195|NCT01323855|3781476|B5|||Age||Years|Mean|67.4|67.4|Standard Deviation|4.0|4.0|||
3959196|NCT01323855|3781477|B4|||Age||Years|Mean|59.3|59.3|Standard Deviation|11.3|11.3|||
3959197|NCT01323855|3781478|B3|||Age||Years|Mean|63.3|63.3|Standard Deviation|7.6|7.6|||
3959198|NCT01323855|3781479|B2|||Age||Years|Mean|66.9|66.9|Standard Deviation|7.8|7.8|||
3959199|NCT01323855|3781480|B1|||Age||Years|Mean|59.6|59.6|Standard Deviation|12.4|12.4|||
3959200|NCT01323790|3781506|B4|Laxative Unknown Response (LUR)||Baseline laxative response status|Laxative response status was determined at the screening visit (Visit 1) based on the Baseline Laxative Response Status Questionnaire. Patients were classified as: Laxative Inadequate Responder (LIR: patients who reported moderate, severe, or very severe symptoms in at least 1 of the 4 stool symptom domains); Laxative Adequate Responder (LAR: patients who reported no symptoms or only mild symptoms); and Laxative Unknown Responder (LUR: patients who had not taken laxatives over the previous 2 weeks or who had taken 1 or more laxative classes on <4 days over the previous 2 weeks).|Participants|Number|312|312.0||||||
3959201|NCT01323790|3781507|B3|Laxative Unknown Response (LUR)||Baseline laxative response status|Laxative response status was determined at the screening visit (Visit 1) based on the Baseline Laxative Response Status Questionnaire. Patients were classified as: Laxative Inadequate Responder (LIR: patients who reported moderate, severe, or very severe symptoms in at least 1 of the 4 stool symptom domains); Laxative Adequate Responder (LAR: patients who reported no symptoms or only mild symptoms); and Laxative Unknown Responder (LUR: patients who had not taken laxatives over the previous 2 weeks or who had taken 1 or more laxative classes on <4 days over the previous 2 weeks).|Participants|Number|107|107.0||||||
3959202|NCT01323790|3781508|B2|Laxative Unknown Response (LUR)||Baseline laxative response status|Laxative response status was determined at the screening visit (Visit 1) based on the Baseline Laxative Response Status Questionnaire. Patients were classified as: Laxative Inadequate Responder (LIR: patients who reported moderate, severe, or very severe symptoms in at least 1 of the 4 stool symptom domains); Laxative Adequate Responder (LAR: patients who reported no symptoms or only mild symptoms); and Laxative Unknown Responder (LUR: patients who had not taken laxatives over the previous 2 weeks or who had taken 1 or more laxative classes on <4 days over the previous 2 weeks).|Participants|Number|103|103.0||||||
3959203|NCT01323790|3781509|B1|Laxative Unknown Response (LUR)||Baseline laxative response status|Laxative response status was determined at the screening visit (Visit 1) based on the Baseline Laxative Response Status Questionnaire. Patients were classified as: Laxative Inadequate Responder (LIR: patients who reported moderate, severe, or very severe symptoms in at least 1 of the 4 stool symptom domains); Laxative Adequate Responder (LAR: patients who reported no symptoms or only mild symptoms); and Laxative Unknown Responder (LUR: patients who had not taken laxatives over the previous 2 weeks or who had taken 1 or more laxative classes on <4 days over the previous 2 weeks).|Participants|Number|102|102.0||||||
3959204|NCT01323790|3781506|B4|Laxative Adequate Response (LAR)||Baseline laxative response status|Laxative response status was determined at the screening visit (Visit 1) based on the Baseline Laxative Response Status Questionnaire. Patients were classified as: Laxative Inadequate Responder (LIR: patients who reported moderate, severe, or very severe symptoms in at least 1 of the 4 stool symptom domains); Laxative Adequate Responder (LAR: patients who reported no symptoms or only mild symptoms); and Laxative Unknown Responder (LUR: patients who had not taken laxatives over the previous 2 weeks or who had taken 1 or more laxative classes on <4 days over the previous 2 weeks).|Participants|Number|14|14.0||||||
3959205|NCT01323790|3781507|B3|Laxative Adequate Response (LAR)||Baseline laxative response status|Laxative response status was determined at the screening visit (Visit 1) based on the Baseline Laxative Response Status Questionnaire. Patients were classified as: Laxative Inadequate Responder (LIR: patients who reported moderate, severe, or very severe symptoms in at least 1 of the 4 stool symptom domains); Laxative Adequate Responder (LAR: patients who reported no symptoms or only mild symptoms); and Laxative Unknown Responder (LUR: patients who had not taken laxatives over the previous 2 weeks or who had taken 1 or more laxative classes on <4 days over the previous 2 weeks).|Participants|Number|4|4.0||||||
3959206|NCT01323790|3781508|B2|Laxative Adequate Response (LAR)||Baseline laxative response status|Laxative response status was determined at the screening visit (Visit 1) based on the Baseline Laxative Response Status Questionnaire. Patients were classified as: Laxative Inadequate Responder (LIR: patients who reported moderate, severe, or very severe symptoms in at least 1 of the 4 stool symptom domains); Laxative Adequate Responder (LAR: patients who reported no symptoms or only mild symptoms); and Laxative Unknown Responder (LUR: patients who had not taken laxatives over the previous 2 weeks or who had taken 1 or more laxative classes on <4 days over the previous 2 weeks).|Participants|Number|5|5.0||||||
3959207|NCT01323790|3781509|B1|Laxative Adequate Response (LAR)||Baseline laxative response status|Laxative response status was determined at the screening visit (Visit 1) based on the Baseline Laxative Response Status Questionnaire. Patients were classified as: Laxative Inadequate Responder (LIR: patients who reported moderate, severe, or very severe symptoms in at least 1 of the 4 stool symptom domains); Laxative Adequate Responder (LAR: patients who reported no symptoms or only mild symptoms); and Laxative Unknown Responder (LUR: patients who had not taken laxatives over the previous 2 weeks or who had taken 1 or more laxative classes on <4 days over the previous 2 weeks).|Participants|Number|5|5.0||||||
3959208|NCT01323790|3781506|B4|Laxative Inadequate Response (LIR)||Baseline laxative response status|Laxative response status was determined at the screening visit (Visit 1) based on the Baseline Laxative Response Status Questionnaire. Patients were classified as: Laxative Inadequate Responder (LIR: patients who reported moderate, severe, or very severe symptoms in at least 1 of the 4 stool symptom domains); Laxative Adequate Responder (LAR: patients who reported no symptoms or only mild symptoms); and Laxative Unknown Responder (LUR: patients who had not taken laxatives over the previous 2 weeks or who had taken 1 or more laxative classes on <4 days over the previous 2 weeks).|Participants|Number|370|370.0||||||
3959255|NCT01323777|3781549|B1|||Age||years|Mean|66.4|66.4|Standard Deviation|9.9|9.9|||
3959256|NCT01323673|3781560|B3|White||Race/Ethnicity, Customized||participants|Number|99|99.0||||||
3959257|NCT01323673|3781561|B2|White||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
3959209|NCT01323790|3781507|B3|Laxative Inadequate Response (LIR)||Baseline laxative response status|Laxative response status was determined at the screening visit (Visit 1) based on the Baseline Laxative Response Status Questionnaire. Patients were classified as: Laxative Inadequate Responder (LIR: patients who reported moderate, severe, or very severe symptoms in at least 1 of the 4 stool symptom domains); Laxative Adequate Responder (LAR: patients who reported no symptoms or only mild symptoms); and Laxative Unknown Responder (LUR: patients who had not taken laxatives over the previous 2 weeks or who had taken 1 or more laxative classes on <4 days over the previous 2 weeks).|Participants|Number|121|121.0||||||
3959210|NCT01323790|3781508|B2|Laxative Inadequate Response (LIR)||Baseline laxative response status|Laxative response status was determined at the screening visit (Visit 1) based on the Baseline Laxative Response Status Questionnaire. Patients were classified as: Laxative Inadequate Responder (LIR: patients who reported moderate, severe, or very severe symptoms in at least 1 of the 4 stool symptom domains); Laxative Adequate Responder (LAR: patients who reported no symptoms or only mild symptoms); and Laxative Unknown Responder (LUR: patients who had not taken laxatives over the previous 2 weeks or who had taken 1 or more laxative classes on <4 days over the previous 2 weeks).|Participants|Number|124|124.0||||||
3959211|NCT01323790|3781509|B1|Laxative Inadequate Response (LIR)||Baseline laxative response status|Laxative response status was determined at the screening visit (Visit 1) based on the Baseline Laxative Response Status Questionnaire. Patients were classified as: Laxative Inadequate Responder (LIR: patients who reported moderate, severe, or very severe symptoms in at least 1 of the 4 stool symptom domains); Laxative Adequate Responder (LAR: patients who reported no symptoms or only mild symptoms); and Laxative Unknown Responder (LUR: patients who had not taken laxatives over the previous 2 weeks or who had taken 1 or more laxative classes on <4 days over the previous 2 weeks).|Participants|Number|125|125.0||||||
3959212|NCT01323790|3781506|B4|Other||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3959213|NCT01323790|3781507|B3|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3959214|NCT01323790|3781508|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3959215|NCT01323790|3781509|B1|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3959216|NCT01323790|3781506|B4|White||Race/Ethnicity, Customized||Participants|Number|559|559.0||||||
3959217|NCT01323790|3781507|B3|White||Race/Ethnicity, Customized||Participants|Number|183|183.0||||||
3959218|NCT01323790|3781508|B2|White||Race/Ethnicity, Customized||Participants|Number|189|189.0||||||
3959219|NCT01323790|3781509|B1|White||Race/Ethnicity, Customized||Participants|Number|187|187.0||||||
3959220|NCT01323790|3781506|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|125|125.0||||||
3959221|NCT01323790|3781507|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|44|44.0||||||
3959222|NCT01323790|3781508|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
3959223|NCT01323790|3781509|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|41|41.0||||||
3959224|NCT01323790|3781506|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3959225|NCT01323790|3781507|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3959226|NCT01323790|3781508|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3959227|NCT01323790|3781509|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3959228|NCT01323790|3781506|B4|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3959229|NCT01323790|3781507|B3|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3959230|NCT01323790|3781508|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3959231|NCT01323790|3781509|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3959232|NCT01323790|3781506|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3959233|NCT01323790|3781507|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3959234|NCT01323790|3781508|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3959235|NCT01323790|3781509|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3959236|NCT01323790|3781506|B4||Male|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
3959237|NCT01323790|3781507|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3959238|NCT01323790|3781508|B2||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3959239|NCT01323790|3781509|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3959240|NCT01323790|3781506|B4||Female|Sex: Female, Male||Participants|Count of Participants|441|441.0||||||
3959241|NCT01323790|3781507|B3||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3959242|NCT01323790|3781508|B2||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3959243|NCT01323790|3781509|B1||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3959244|NCT01323790|3781506|B4|||Age||Years|Mean|52.1|52.1|Standard Deviation|11.58|11.58|||
3959245|NCT01323790|3781507|B3|||Age||Years|Mean|52.3|52.3|Standard Deviation|11.62|11.62|||
3959246|NCT01323790|3781508|B2|||Age||Years|Mean|51.9|51.9|Standard Deviation|12.11|12.11|||
3959247|NCT01323790|3781509|B1|||Age||Years|Mean|52.0|52.0|Standard Deviation|11.02|11.02|||
3959248|NCT01323777|3781549|B1|Japan||Region of Enrollment||participants|Number|65|65.0||||||
3959249|NCT01323777|3781549|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3959250|NCT01323777|3781549|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3959251|NCT01323777|3781549|B1|≥ 80 years||Age, Customized||participants|Number|4|4.0||||||
3959252|NCT01323777|3781549|B1|70-79 years||Age, Customized||participants|Number|25|25.0||||||
3959253|NCT01323777|3781549|B1|60-69 years||Age, Customized||participants|Number|24|24.0||||||
3959254|NCT01323777|3781549|B1|<60 years||Age, Customized||participants|Number|12|12.0||||||
3959258|NCT01323673|3781562|B1|White||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
3959259|NCT01323673|3781560|B3|Multiracial||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3959260|NCT01323673|3781561|B2|Multiracial||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3959261|NCT01323673|3781562|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3959262|NCT01323673|3781560|B3|Black||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3959263|NCT01323673|3781561|B2|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3959264|NCT01323673|3781562|B1|Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3959265|NCT01323673|3781560|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3959266|NCT01323673|3781561|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3959267|NCT01323673|3781562|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3959268|NCT01323673|3781560|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3959269|NCT01323673|3781561|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3959270|NCT01323673|3781562|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3959271|NCT01323673|3781560|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3959272|NCT01323673|3781561|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3959273|NCT01323673|3781562|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3959274|NCT01323673|3781560|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3959275|NCT01323673|3781561|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3959276|NCT01323673|3781562|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3959277|NCT01323673|3781560|B3|||Age||Years|Mean|49.4|49.4|Standard Deviation|15.5|15.5|||
3959278|NCT01323673|3781561|B2|||Age||Years|Mean|47.3|47.3|Standard Deviation|14.3|14.3|||
3959279|NCT01323673|3781562|B1|||Age||Years|Mean|51.5|51.5|Standard Deviation|16.4|16.4|||
3959280|NCT01323660|3781583|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3959281|NCT01323660|3781583|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|298|298.0||||||
3959282|NCT01323660|3781583|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3959283|NCT01323660|3781583|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3959284|NCT01323660|3781583|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3959285|NCT01323660|3781583|B1||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3959286|NCT01323660|3781583|B1||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3959287|NCT01323660|3781583|B1|||Age||Years|Mean|62.6|62.6|Standard Deviation|7.88|7.88|||
3959288|NCT01323647|3781632|B3||Male|Sex: Female, Male||Participants|Count of Participants|496|496.0||||||
3959289|NCT01323647|3781633|B2||Male|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
3959290|NCT01323647|3781634|B1||Male|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
3959291|NCT01323647|3781632|B3||Female|Sex: Female, Male||Participants|Count of Participants|461|461.0||||||
3959292|NCT01323647|3781633|B2||Female|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
3959293|NCT01323647|3781634|B1||Female|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
3959294|NCT01323647|3781632|B3|||Age||Months|Mean|18.75|18.75|Standard Deviation|0.97|0.97|||
3959295|NCT01323647|3781633|B2|||Age||Months|Mean|18.8|18.8|Standard Deviation|1.01|1.01|||
3959296|NCT01323647|3781634|B1|||Age||Months|Mean|18.7|18.7|Standard Deviation|0.93|0.93|||
3959297|NCT01323634|3781650|B3|White/Caucasian/European Heritage||Race/Ethnicity, Customized|Baseline characteristic data are reported for members of the Intent-to-Treat Population, comprised of all randomized participants who received at least one dose of study medication during the treatment period.|participants|Number|504|504.0||||||
3959298|NCT01323634|3781651|B2|White/Caucasian/European Heritage||Race/Ethnicity, Customized|Baseline characteristic data are reported for members of the Intent-to-Treat Population, comprised of all randomized participants who received at least one dose of study medication during the treatment period.|participants|Number|254|254.0||||||
3959299|NCT01323634|3781652|B1|White/Caucasian/European Heritage||Race/Ethnicity, Customized|Baseline characteristic data are reported for members of the Intent-to-Treat Population, comprised of all randomized participants who received at least one dose of study medication during the treatment period.|participants|Number|250|250.0||||||
3959300|NCT01323634|3781650|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|Baseline characteristic data are reported for members of the Intent-to-Treat Population, comprised of all randomized participants who received at least one dose of study medication during the treatment period.|participants|Number|1|1.0||||||
3959301|NCT01323634|3781651|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|Baseline characteristic data are reported for members of the Intent-to-Treat Population, comprised of all randomized participants who received at least one dose of study medication during the treatment period.|participants|Number|1|1.0||||||
3959302|NCT01323634|3781652|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Baseline characteristic data are reported for members of the Intent-to-Treat Population, comprised of all randomized participants who received at least one dose of study medication during the treatment period.|participants|Number|0|0.0||||||
3959303|NCT01323634|3781650|B3|African American/ African Heritage||Race/Ethnicity, Customized|Baseline characteristic data are reported for members of the Intent-to-Treat Population, comprised of all randomized participants who received at least one dose of study medication during the treatment period.|participants|Number|14|14.0||||||
3959304|NCT01323634|3781651|B2|African American/ African Heritage||Race/Ethnicity, Customized|Baseline characteristic data are reported for members of the Intent-to-Treat Population, comprised of all randomized participants who received at least one dose of study medication during the treatment period.|participants|Number|5|5.0||||||
3959305|NCT01323634|3781652|B1|African American/ African Heritage||Race/Ethnicity, Customized|Baseline characteristic data are reported for members of the Intent-to-Treat Population, comprised of all randomized participants who received at least one dose of study medication during the treatment period.|participants|Number|9|9.0||||||
3959306|NCT01323634|3781650|B3||Male|Sex: Female, Male|Baseline characteristic data are reported for members of the Intent-to-Treat Population, comprised of all randomized participants who received at least one dose of study medication during the treatment period.|Participants|Count of Participants|333|333.0||||||
3959307|NCT01323634|3781651|B2||Male|Sex: Female, Male|Baseline characteristic data are reported for members of the Intent-to-Treat Population, comprised of all randomized participants who received at least one dose of study medication during the treatment period.|Participants|Count of Participants|164|164.0||||||
3959308|NCT01323634|3781652|B1||Male|Sex: Female, Male|Baseline characteristic data are reported for members of the Intent-to-Treat Population, comprised of all randomized participants who received at least one dose of study medication during the treatment period.|Participants|Count of Participants|169|169.0||||||
3959309|NCT01323634|3781650|B3||Female|Sex: Female, Male|Baseline characteristic data are reported for members of the Intent-to-Treat Population, comprised of all randomized participants who received at least one dose of study medication during the treatment period.|Participants|Count of Participants|186|186.0||||||
3959310|NCT01323634|3781651|B2||Female|Sex: Female, Male|Baseline characteristic data are reported for members of the Intent-to-Treat Population, comprised of all randomized participants who received at least one dose of study medication during the treatment period.|Participants|Count of Participants|96|96.0||||||
3959311|NCT01323634|3781652|B1||Female|Sex: Female, Male|Baseline characteristic data are reported for members of the Intent-to-Treat Population, comprised of all randomized participants who received at least one dose of study medication during the treatment period.|Participants|Count of Participants|90|90.0||||||
3959312|NCT01323634|3781650|B3|||Age|Baseline characteristic data are reported for members of the Intent-to-Treat Population, comprised of all randomized participants who received at least one dose of study medication during the treatment period.|Years|Mean|61.2|61.2|Standard Deviation|8.11|8.11|||
3959313|NCT01323634|3781651|B2|||Age|Baseline characteristic data are reported for members of the Intent-to-Treat Population, comprised of all randomized participants who received at least one dose of study medication during the treatment period.|Years|Mean|61.1|61.1|Standard Deviation|7.92|7.92|||
3959314|NCT01323634|3781652|B1|||Age|Baseline characteristic data are reported for members of the Intent-to-Treat Population, comprised of all randomized participants who received at least one dose of study medication during the treatment period.|Years|Mean|61.2|61.2|Standard Deviation|8.32|8.32|||
3959315|NCT01323621|3781662|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3959316|NCT01323621|3781663|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3959317|NCT01323621|3781664|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3959318|NCT01323621|3781662|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3959319|NCT01323621|3781663|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3959320|NCT01323621|3781664|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3959321|NCT01323621|3781662|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|479|479.0||||||
3959322|NCT01323621|3781663|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|241|241.0||||||
3959323|NCT01323621|3781664|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|238|238.0||||||
3959324|NCT01323621|3781662|B3||Male|Sex: Female, Male||Participants|Count of Participants|348|348.0||||||
3959325|NCT01323621|3781663|B2||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
3959326|NCT01323621|3781664|B1||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3959327|NCT01323621|3781662|B3||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3959328|NCT01323621|3781663|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3959329|NCT01323621|3781664|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3959330|NCT01323621|3781662|B3|||Age||Years|Mean|61.6|61.6|Standard Deviation|9.32|9.32|||
3959331|NCT01323621|3781663|B2|||Age||Years|Mean|61.6|61.6|Standard Deviation|9.59|9.59|||
3959332|NCT01323621|3781664|B1|||Age||Years|Mean|61.7|61.7|Standard Deviation|9.05|9.05|||
3959333|NCT01323595|3781674|B3|United States||Region of Enrollment||participants|Number|78|78.0||||||
3959334|NCT01323595|3781675|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
3959335|NCT01323595|3781676|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
3959336|NCT01323595|3781674|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3959337|NCT01323595|3781675|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3959338|NCT01323595|3781676|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3959339|NCT01323595|3781674|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3959340|NCT01323595|3781675|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3959341|NCT01323595|3781676|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3959342|NCT01323595|3781674|B3|||Age||years|Mean|37|37.0|Standard Deviation|5|5.0|||
3959343|NCT01323595|3781675|B2|||Age||years|Mean|35|35.0|Standard Deviation|5|5.0|||
3959344|NCT01323595|3781676|B1|||Age||years|Mean|39|39.0|Standard Deviation|5|5.0|||
3959345|NCT01323595|3781674|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3959346|NCT01323595|3781675|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3959347|NCT01323595|3781676|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3959348|NCT01323595|3781674|B3||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
3959349|NCT01323595|3781675|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3959350|NCT01323595|3781676|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3959351|NCT01323595|3781674|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3959352|NCT01323595|3781675|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3959353|NCT01323595|3781676|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3959354|NCT01323582|3781685|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
3959355|NCT01323582|3781686|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3959356|NCT01323582|3781687|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3959357|NCT01323582|3781685|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3959358|NCT01323582|3781686|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3959359|NCT01323582|3781687|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3959360|NCT01323582|3781685|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3959361|NCT01323582|3781686|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3959362|NCT01323582|3781687|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3959363|NCT01323582|3781685|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3959364|NCT01323582|3781686|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3959365|NCT01323582|3781687|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3959366|NCT01323582|3781685|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3959367|NCT01323582|3781686|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3959368|NCT01323582|3781687|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3959369|NCT01323582|3781685|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3959370|NCT01323582|3781686|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3959371|NCT01323582|3781687|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3959372|NCT01323582|3781685|B3|||Age||years|Mean|47.4|47.4|Standard Deviation|12.0|12.0|||
3959373|NCT01323582|3781686|B2|||Age||years|Mean|48.5|48.5|Standard Deviation|11.7|11.7|||
3959374|NCT01323582|3781687|B1|||Age||years|Mean|46.1|46.1|Standard Deviation|12.7|12.7|||
3959375|NCT01323517|3781704|B1|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3959376|NCT01323517|3781704|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3959377|NCT01323517|3781704|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959378|NCT01323517|3781704|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3959379|NCT01323517|3781704|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3959380|NCT01323517|3781704|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959381|NCT01323517|3781704|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959382|NCT01323517|3781704|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959383|NCT01323517|3781704|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959384|NCT01323517|3781704|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3959385|NCT01323517|3781704|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959386|NCT01323517|3781704|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3959387|NCT01323517|3781704|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3959388|NCT01323517|3781704|B1|||Age||years|Median|64|64.0|Full Range|||37.0|80.0|
3959389|NCT01323478|3781711|B1|||MADRS: Baseline from lead-in study 13267A (NCT01140906)||units on a scale|Mean|31.1|31.1|Standard Deviation|3.3|3.3|||
3959390|NCT01323478|3781711|B1|||HAM-A: Baseline present study, 13267B|The Hamilton Anxiety Rating Scale (HAM-A) consists of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behaviour at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic, and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total score from 0 to 56. The higher the score, the more severe.|units on a scale|Mean|11.9|11.9|Standard Deviation|6.6|6.6|||
3959391|NCT01323478|3781711|B1|||CGI-S: Baseline present study, 13267B|The Clinical Global Impression - Severity of Illness (CGI-S) is a 7-point scale rated from 1 (normal, not at all ill) to 7 (among the most extremely ill patients). The investigator should use his/her total clinical experience with this patient population to judge how mentally ill the patient is at the time of rating.|units on a scale|Mean|3.0|3.0|Standard Deviation|1.3|1.3|||
3959392|NCT01323478|3781711|B1|||MADRS: Baseline present study, 13267B|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 (no symptom) to 6 (severe symptom). The 10 items represent the core symptoms of depressive illness. The rating should be based on a clinical interview with the patient, moving from broadly phrased questions about symptoms to more detailed ones, which allow a precise rating of severity, covering the last 7 days. Total score from 0 to 60. The higher the score, the more severe.|units on a scale|Mean|16.2|16.2|Standard Deviation|10.0|10.0|||
3959393|NCT01323478|3781711|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3959394|NCT01323478|3781711|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3959395|NCT01323478|3781711|B1|||Age||years|Mean|44.1|44.1|Standard Deviation|12.7|12.7|||
3959396|NCT01323387|3781724|B1|United States||Region of Enrollment||participants|Number|150|150.0||||||
3959397|NCT01323387|3781724|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3959398|NCT01323387|3781724|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3959399|NCT01323387|3781724|B1|||Age||years|Mean|43.6|43.6|Standard Deviation|9.29|9.29|||
3959400|NCT01323387|3781724|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3959401|NCT01323387|3781724|B1||Between 18 and 65 years|Age||Participants|Count of Participants|150|150.0||||||
3959402|NCT01323387|3781724|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3959403|NCT01323270|3781735|B3||Male|Sex: Female, Male||Participants|Count of Participants|382|382.0||||||
3959404|NCT01323270|3781736|B2||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
3959405|NCT01323270|3781737|B1||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
3959406|NCT01323270|3781735|B3||Female|Sex: Female, Male||Participants|Count of Participants|367|367.0||||||
3959407|NCT01323270|3781736|B2||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3959408|NCT01323270|3781737|B1||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3959409|NCT01323270|3781735|B3|>=14 years-<19 years||Age, Customized||participants|Number|317|317.0||||||
3959410|NCT01323270|3781736|B2|>=14 years-<19 years||Age, Customized||participants|Number|161|161.0||||||
3959411|NCT01323270|3781737|B1|>=14 years-<19 years||Age, Customized||participants|Number|156|156.0||||||
3959412|NCT01323270|3781735|B3|Greater than or equal (>=)11-less than (<)14years||Age, Customized||participants|Number|432|432.0||||||
3959413|NCT01323270|3781736|B2|Greater than or equal (>=)11-less than (<)14years||Age, Customized||participants|Number|215|215.0||||||
3959414|NCT01323270|3781737|B1|Greater than or equal (>=)11-less than (<)14years||Age, Customized||participants|Number|217|217.0||||||
3959415|NCT01323192|3781758|B3|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3959416|NCT01323192|3781759|B2|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3959417|NCT01323192|3781760|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3959418|NCT01323192|3781758|B3|Asian||Race/Ethnicity, Customized||Participants|Number|282|282.0||||||
3959419|NCT01323192|3781759|B2|Asian||Race/Ethnicity, Customized||Participants|Number|139|139.0||||||
3959420|NCT01323192|3781760|B1|Asian||Race/Ethnicity, Customized||Participants|Number|143|143.0||||||
3959421|NCT01323192|3781758|B3||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3959422|NCT01323192|3781759|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3959423|NCT01323192|3781760|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3959424|NCT01323192|3781758|B3||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3959425|NCT01323192|3781759|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3959426|NCT01323192|3781760|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3959427|NCT01323192|3781758|B3|50-64 years of age||Age, Customized||Participants|Number|10|10.0||||||
3959428|NCT01323192|3781759|B2|50-64 years of age||Age, Customized||Participants|Number|6|6.0||||||
3959429|NCT01323192|3781760|B1|50-64 years of age||Age, Customized||Participants|Number|4|4.0||||||
3959430|NCT01323192|3781758|B3|36-49 years of age||Age, Customized||Participants|Number|106|106.0||||||
3959431|NCT01323192|3781759|B2|36-49 years of age||Age, Customized||Participants|Number|51|51.0||||||
3959432|NCT01323192|3781760|B1|36-49 years of age||Age, Customized||Participants|Number|55|55.0||||||
3959433|NCT01323192|3781758|B3|25-35 years of age||Age, Customized||Participants|Number|125|125.0||||||
3959434|NCT01323192|3781759|B2|25-35 years of age||Age, Customized||Participants|Number|65|65.0||||||
3959435|NCT01323192|3781760|B1|25-35 years of age||Age, Customized||Participants|Number|60|60.0||||||
3959436|NCT01323192|3781758|B3|18-24 years of age||Age, Customized||Participants|Number|43|43.0||||||
3959437|NCT01323192|3781759|B2|18-24 years of age||Age, Customized||Participants|Number|19|19.0||||||
3959438|NCT01323192|3781760|B1|18-24 years of age||Age, Customized||Participants|Number|24|24.0||||||
3959439|NCT01323153|3781777|B3|United Kingdom||Region of Enrollment||participants|Number|26|26.0||||||
3959440|NCT01323153|3781778|B2|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
3959441|NCT01323153|3781779|B1|United Kingdom||Region of Enrollment||participants|Number|14|14.0||||||
3959442|NCT01323153|3781777|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
3959443|NCT01323153|3781778|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3959444|NCT01323153|3781779|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3959445|NCT01323153|3781777|B3|Czechia||Region of Enrollment||participants|Number|149|149.0||||||
3959446|NCT01323153|3781778|B2|Czechia||Region of Enrollment||participants|Number|75|75.0||||||
3959447|NCT01323153|3781779|B1|Czechia||Region of Enrollment||participants|Number|74|74.0||||||
3959448|NCT01323153|3781777|B3|Netherlands||Region of Enrollment||participants|Number|102|102.0||||||
3959449|NCT01323153|3781778|B2|Netherlands||Region of Enrollment||participants|Number|52|52.0||||||
3959450|NCT01323153|3781779|B1|Netherlands||Region of Enrollment||participants|Number|50|50.0||||||
3959451|NCT01323153|3781777|B3||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3959452|NCT01323153|3781778|B2||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3959453|NCT01323153|3781779|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3959454|NCT01323153|3781777|B3||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3959455|NCT01323153|3781778|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3959456|NCT01323153|3781779|B1||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3959457|NCT01323153|3781777|B3|||Age||years|Mean|60.9|60.9|Standard Deviation|9.92|9.92|||
3959458|NCT01323153|3781778|B2|||Age||years|Mean|60.7|60.7|Standard Deviation|10.09|10.09|||
3959459|NCT01323153|3781779|B1|||Age||years|Mean|61|61.0|Standard Deviation|9.77|9.77|||
3959460|NCT01323140|3781786|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3959461|NCT01323140|3781786|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3959462|NCT01323140|3781786|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3959463|NCT01323140|3781786|B1|||Age||years|Mean|49.1|49.1|Standard Deviation|7.6|7.6|||
3959464|NCT01323140|3781786|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3959465|NCT01323140|3781786|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3959466|NCT01323140|3781786|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3959467|NCT01323010|3781790|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3959468|NCT01323010|3781791|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3959469|NCT01323010|3781792|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3959470|NCT01323010|3781790|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3959471|NCT01323010|3781791|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3959472|NCT01323010|3781792|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3959473|NCT01323010|3781790|B3||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3959474|NCT01323010|3781791|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3959475|NCT01323010|3781792|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3959476|NCT01323010|3781790|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3959477|NCT01323010|3781791|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3959478|NCT01323010|3781792|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3959479|NCT01323010|3781790|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959480|NCT01323010|3781791|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959481|NCT01323010|3781792|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959482|NCT01323010|3781790|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959483|NCT01323010|3781791|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959484|NCT01323010|3781792|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959485|NCT01323010|3781790|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959486|NCT01323010|3781791|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959487|NCT01323010|3781792|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959488|NCT01323010|3781790|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3959489|NCT01323010|3781791|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3959490|NCT01323010|3781792|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3959491|NCT01323010|3781790|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3959492|NCT01323010|3781791|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3959493|NCT01323010|3781792|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3959494|NCT01323010|3781790|B3|||Age||years|Mean|6.55|6.55|Standard Deviation|3.52|3.52|||
3959495|NCT01323010|3781791|B2|||Age||years|Mean|6.42|6.42|Standard Deviation|3.74|3.74|||
3959496|NCT01323010|3781792|B1|||Age||years|Mean|6.68|6.68|Standard Deviation|3.38|3.38|||
3959497|NCT01322971|3781842|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3959498|NCT01322971|3781843|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3959499|NCT01322971|3781844|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3959500|NCT01322971|3781842|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3959501|NCT01322971|3781843|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3959502|NCT01322971|3781844|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3959503|NCT01322971|3781842|B3||Female|Gender||Participants|Count of Participants|2|2.0||||||
3959504|NCT01322971|3781843|B2||Female|Gender||Participants|Count of Participants|1|1.0||||||
3959505|NCT01322971|3781844|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
3959506|NCT01322971|3781842|B3|||Age||years|Median|37|37.0|Standard Deviation|0|0.0|||
3959507|NCT01322971|3781843|B2|||Age||years|Median|37|37.0|Standard Deviation|0|0.0|||
3959508|NCT01322971|3781844|B1|||Age||years|Median|37|37.0|Standard Deviation|0|0.0|||
3959509|NCT01322971|3781842|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3959510|NCT01322971|3781843|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3959511|NCT01322971|3781844|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3959512|NCT01322971|3781842|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3959513|NCT01322971|3781843|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3959514|NCT01322971|3781844|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3959515|NCT01322971|3781842|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3959516|NCT01322971|3781843|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3959517|NCT01322971|3781844|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3959518|NCT01322945|3781857|B3|United States||Region of Enrollment||participants|Number|94|94.0||||||
3959519|NCT01322945|3781858|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
3959520|NCT01322945|3781859|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
3959521|NCT01322945|3781857|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3959522|NCT01322945|3781858|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3959523|NCT01322945|3781859|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3959524|NCT01322945|3781857|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3959525|NCT01322945|3781858|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3959526|NCT01322945|3781859|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3959527|NCT01322945|3781857|B3|||Age||years|Mean|50.27|50.27|Standard Deviation|15.26|15.26|||
3959528|NCT01322945|3781858|B2|||Age||years|Mean|54.17|54.17|Standard Deviation|14.83|14.83|||
3959529|NCT01322945|3781859|B1|||Age||years|Mean|50|50.0|Standard Deviation|15.49|15.49|||
3959530|NCT01322945|3781857|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3959531|NCT01322945|3781858|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3959532|NCT01322945|3781859|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3959533|NCT01322945|3781857|B3||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
3959534|NCT01322945|3781858|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3959535|NCT01322945|3781859|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3959536|NCT01322945|3781857|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3959537|NCT01322945|3781858|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3959538|NCT01322945|3781859|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3959539|NCT01322841|3781868|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3959540|NCT01322841|3781869|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3959541|NCT01322841|3781870|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3959542|NCT01322841|3781868|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959543|NCT01322841|3781869|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959544|NCT01322841|3781870|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959545|NCT01322841|3781868|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1341|1341.0||||||
3959546|NCT01322841|3781869|B2||White|Race (NIH/OMB)||Participants|Count of Participants|662|662.0||||||
3959547|NCT01322841|3781870|B1||White|Race (NIH/OMB)||Participants|Count of Participants|679|679.0||||||
3959548|NCT01322841|3781868|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|791|791.0||||||
3959549|NCT01322841|3781869|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|397|397.0||||||
3959550|NCT01322841|3781870|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|394|394.0||||||
3959551|NCT01322841|3781868|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3959552|NCT01322841|3781869|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3959553|NCT01322841|3781870|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3959554|NCT01322841|3781868|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959555|NCT01322841|3781869|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959556|NCT01322841|3781870|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959557|NCT01322841|3781868|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3959558|NCT01322841|3781869|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959559|NCT01322841|3781870|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3959560|NCT01322841|3781868|B3||Male|Sex: Female, Male||Participants|Count of Participants|1159|1159.0||||||
3959561|NCT01322841|3781869|B2||Male|Sex: Female, Male||Participants|Count of Participants|581|581.0||||||
3959562|NCT01322841|3781870|B1||Male|Sex: Female, Male||Participants|Count of Participants|578|578.0||||||
3959563|NCT01322841|3781868|B3||Female|Sex: Female, Male||Participants|Count of Participants|1080|1080.0||||||
3959564|NCT01322841|3781869|B2||Female|Sex: Female, Male||Participants|Count of Participants|542|542.0||||||
3959565|NCT01322841|3781870|B1||Female|Sex: Female, Male||Participants|Count of Participants|538|538.0||||||
3959566|NCT01322841|3781868|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3959567|NCT01322841|3781869|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3959568|NCT01322841|3781870|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3959569|NCT01322841|3781868|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3959570|NCT01322841|3781869|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3959571|NCT01322841|3781870|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3959572|NCT01322841|3781868|B3||<=18 years|Age||Participants|Count of Participants|2239|2239.0||||||
3959573|NCT01322841|3781869|B2||<=18 years|Age||Participants|Count of Participants|1123|1123.0||||||
3959574|NCT01322841|3781870|B1||<=18 years|Age||Participants|Count of Participants|1116|1116.0||||||
3959575|NCT01322815|3781879|B3|No prior therapy||Prior treatment status||participants|Number|7|7.0||||||
3959576|NCT01322815|3781880|B2|No prior therapy||Prior treatment status||participants|Number|0|0.0||||||
3959577|NCT01322815|3781881|B1|No prior therapy||Prior treatment status||participants|Number|7|7.0||||||
3959578|NCT01322815|3781879|B3|Prior 1st-line therapy||Prior treatment status||participants|Number|4|4.0||||||
3959579|NCT01322815|3781880|B2|Prior 1st-line therapy||Prior treatment status||participants|Number|4|4.0||||||
3959580|NCT01322815|3781881|B1|Prior 1st-line therapy||Prior treatment status||participants|Number|0|0.0||||||
3959581|NCT01322815|3781879|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3959582|NCT01322815|3781880|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3959583|NCT01322815|3781881|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3959584|NCT01322815|3781879|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3959585|NCT01322815|3781880|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3959586|NCT01322815|3781881|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3959587|NCT01322815|3781879|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3959588|NCT01322815|3781880|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3959589|NCT01322815|3781881|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3959590|NCT01322815|3781879|B3|||Age||years|Median|45|45.0|Full Range|||35.0|71.0|
3959591|NCT01322815|3781880|B2|||Age||years|Median|45|45.0|Full Range|||42.0|51.0|
3959592|NCT01322815|3781881|B1|||Age||years|Median|48|48.0|Full Range|||35.0|71.0|
3959593|NCT01322815|3781879|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3959594|NCT01322815|3781880|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3959595|NCT01322815|3781881|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3959596|NCT01322815|3781879|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3959597|NCT01322815|3781880|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3959598|NCT01322815|3781881|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3959599|NCT01322815|3781879|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3959600|NCT01322815|3781880|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3959601|NCT01322815|3781881|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3959602|NCT01322633|3781888|B3||Male|Sex: Female, Male||Participants|Count of Participants|27220|27220.0||||||
3959603|NCT01322633|3781889|B2||Male|Sex: Female, Male||Participants|Count of Participants|12075|12075.0||||||
3959604|NCT01322633|3781890|B1||Male|Sex: Female, Male||Participants|Count of Participants|15145|15145.0||||||
3959605|NCT01322633|3781888|B3||Female|Sex: Female, Male||Participants|Count of Participants|34644|34644.0||||||
3959606|NCT01322633|3781889|B2||Female|Sex: Female, Male||Participants|Count of Participants|15611|15611.0||||||
3959607|NCT01322633|3781890|B1||Female|Sex: Female, Male||Participants|Count of Participants|19033|19033.0||||||
3959608|NCT01322633|3781888|B3|||Age||years|Median|60|60.0|Inter-Quartile Range|||49.0|71.0|
3959609|NCT01322633|3781889|B2|||Age||years|Median|60|60.0|Inter-Quartile Range|||50.0|71.0|
3959610|NCT01322633|3781890|B1|||Age||years|Median|59|59.0|Inter-Quartile Range|||49.0|71.0|
3959611|NCT01322607|3781901|B3|||Height||cm|Mean|171.33|171.33|Standard Deviation|11.13|11.13|||
3959612|NCT01322607|3781902|B2|||Height||cm|Mean|169.54|169.54|Standard Deviation|11.87|11.87|||
3959613|NCT01322607|3781903|B1|||Height||cm|Mean|172.79|172.79|Standard Deviation|10.83|10.83|||
3959614|NCT01322607|3781901|B3|||Weight||kg|Mean|87.86|87.86|Standard Deviation|20.59|20.59|||
3959615|NCT01322607|3781902|B2|||Weight||kg|Mean|86.56|86.56|Standard Deviation|19.57|19.57|||
3959616|NCT01322607|3781903|B1|||Weight||kg|Mean|88.92|88.92|Standard Deviation|22.27|22.27|||
3959617|NCT01322607|3781901|B3|||BMI||kg/m2|Mean|29.92|29.92|Standard Deviation|6.43|6.43|||
3959618|NCT01322607|3781902|B2|||BMI||kg/m2|Mean|30.34|30.34|Standard Deviation|7.53|7.53|||
3959619|NCT01322607|3781903|B1|||BMI||kg/m2|Mean|29.57|29.57|Standard Deviation|5.73|5.73|||
3959620|NCT01322607|3781901|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3959621|NCT01322607|3781902|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3959622|NCT01322607|3781903|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3959623|NCT01322607|3781901|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959624|NCT01322607|3781902|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959625|NCT01322607|3781903|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959626|NCT01322607|3781901|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959627|NCT01322607|3781902|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959628|NCT01322607|3781903|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959629|NCT01322607|3781901|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3959630|NCT01322607|3781902|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3959631|NCT01322607|3781903|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3959632|NCT01322607|3781901|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3959633|NCT01322607|3781902|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3959634|NCT01322607|3781903|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3959635|NCT01322607|3781901|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3959636|NCT01322607|3781902|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959637|NCT01322607|3781903|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3959638|NCT01322607|3781901|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959639|NCT01322607|3781902|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959640|NCT01322607|3781903|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959641|NCT01322607|3781901|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959642|NCT01322607|3781902|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959643|NCT01322607|3781903|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959644|NCT01322607|3781901|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3959645|NCT01322607|3781902|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3959646|NCT01322607|3781903|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3959647|NCT01322607|3781901|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3959648|NCT01322607|3781902|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3959649|NCT01322607|3781903|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3959650|NCT01322607|3781901|B3|||Age||years|Mean|60.5|60.5|Standard Deviation|8.67|8.67|||
3959651|NCT01322607|3781902|B2|||Age||years|Mean|61.89|61.89|Standard Deviation|9.03|9.03|||
3959652|NCT01322607|3781903|B1|||Age||years|Mean|59.36|59.36|Standard Deviation|8.63|8.63|||
3959653|NCT01322607|3781901|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3959654|NCT01322607|3781902|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3959655|NCT01322607|3781903|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3959656|NCT01322607|3781901|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3959657|NCT01322607|3781902|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3959658|NCT01322607|3781903|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3959659|NCT01322607|3781901|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3959660|NCT01322607|3781902|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3959661|NCT01322607|3781903|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3959662|NCT01322594|3781916|B7||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3959663|NCT01322594|3781917|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3959664|NCT01322594|3781918|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3959665|NCT01322594|3781919|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3959666|NCT01322594|3781920|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3959667|NCT01322594|3781921|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3959668|NCT01322594|3781922|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3959669|NCT01322594|3781916|B7||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3959670|NCT01322594|3781917|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3959671|NCT01322594|3781918|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3959672|NCT01322594|3781919|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3959673|NCT01322594|3781920|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3959674|NCT01322594|3781921|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3959675|NCT01322594|3781922|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3959676|NCT01322594|3781916|B7|||Age||Years|Mean|59.1|59.1|Standard Deviation|6.8|6.8|||
3959677|NCT01322594|3781917|B6|||Age||Years|Mean|60.8|60.8|Standard Deviation|6.0|6.0|||
3959678|NCT01322594|3781918|B5|||Age||Years|Mean|55.1|55.1|Standard Deviation|5.3|5.3|||
3959679|NCT01322594|3781919|B4|||Age||Years|Mean|60.3|60.3|Standard Deviation|7.1|7.1|||
3959680|NCT01322594|3781920|B3|||Age||Years|Mean|59.7|59.7|Standard Deviation|11.0|11.0|||
3959681|NCT01322594|3781921|B2|||Age||Years|Mean|57.0|57.0|Standard Deviation|4.0|4.0|||
3959682|NCT01322594|3781922|B1|||Age||Years|Mean|61.3|61.3|Standard Deviation|8.0|8.0|||
3959683|NCT01322386|3782007|B3|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3959684|NCT01322386|3782008|B2|African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3959685|NCT01322386|3782009|B1|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3959686|NCT01322386|3782007|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3959687|NCT01322386|3782008|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3959688|NCT01322386|3782009|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3959689|NCT01322386|3782007|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3959690|NCT01322386|3782008|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3959691|NCT01322386|3782009|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3959692|NCT01322386|3782007|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3959693|NCT01322386|3782008|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3959694|NCT01322386|3782009|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3959695|NCT01322386|3782007|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3959696|NCT01322386|3782008|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3959697|NCT01322386|3782009|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3959698|NCT01322386|3782007|B3|12-16 years||Age, Customized||participants|Number|6|6.0||||||
3959699|NCT01322386|3782008|B2|12-16 years||Age, Customized||participants|Number|6|6.0||||||
3959700|NCT01322386|3782009|B1|12-16 years||Age, Customized||participants|Number|0|0.0||||||
3959701|NCT01322386|3782007|B3|9-11 years||Age, Customized||participants|Number|2|2.0||||||
3959702|NCT01322386|3782008|B2|9-11 years||Age, Customized||participants|Number|2|2.0||||||
3959703|NCT01322386|3782009|B1|9-11 years||Age, Customized||participants|Number|0|0.0||||||
3959704|NCT01322386|3782007|B3|2-4 years||Age, Customized||participants|Number|3|3.0||||||
3959705|NCT01322386|3782008|B2|2-4 years||Age, Customized||participants|Number|3|3.0||||||
3959706|NCT01322386|3782009|B1|2-4 years||Age, Customized||participants|Number|0|0.0||||||
3959707|NCT01322386|3782007|B3|1-3 months||Age, Customized||participants|Number|10|10.0||||||
3959708|NCT01322386|3782008|B2|1-3 months||Age, Customized||participants|Number|0|0.0||||||
3959709|NCT01322386|3782009|B1|1-3 months||Age, Customized||participants|Number|10|10.0||||||
3959710|NCT01322360|3782018|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3959711|NCT01322360|3782018|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3959712|NCT01322360|3782018|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3959713|NCT01322360|3782018|B1|||Age||years|Mean|9.3|9.3|Standard Deviation|5.03|5.03|||
3959714|NCT01322360|3782018|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3959715|NCT01322360|3782018|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3959716|NCT01322360|3782018|B1||<=18 years|Age||Participants|Count of Participants|50|50.0||||||
3959717|NCT01322347|3782023|B3|||Post-dialysis weight||kilograms|Mean|85.86|85.86|Standard Deviation|22.857|22.857|||
3959718|NCT01322347|3782024|B2|||Post-dialysis weight||kilograms|Mean|85.09|85.09|Standard Deviation|23.474|23.474|||
3959719|NCT01322347|3782025|B1|||Post-dialysis weight||kilograms|Mean|86.64|86.64|Standard Deviation|22.270|22.27|||
3959720|NCT01322347|3782023|B3|||Height||centimeters|Mean|169.40|169.4|Standard Deviation|10.093|10.093|||
3959721|NCT01322347|3782024|B2|||Height||centimeters|Mean|170.01|170.01|Standard Deviation|9.944|9.944|||
3959722|NCT01322347|3782025|B1|||Height||centimeters|Mean|168.80|168.8|Standard Deviation|10.238|10.238|||
3959723|NCT01322347|3782023|B3|Canada||Region of Enrollment||participants|Number|43|43.0||||||
3959724|NCT01322347|3782024|B2|Canada||Region of Enrollment||participants|Number|24|24.0||||||
3959725|NCT01322347|3782025|B1|Canada||Region of Enrollment||participants|Number|19|19.0||||||
3959726|NCT01322347|3782023|B3|United States||Region of Enrollment||participants|Number|251|251.0||||||
3959727|NCT01322347|3782024|B2|United States||Region of Enrollment||participants|Number|123|123.0||||||
3959728|NCT01322347|3782025|B1|United States||Region of Enrollment||participants|Number|128|128.0||||||
3959729|NCT01322347|3782023|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3959730|NCT01322347|3782024|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3959731|NCT01322347|3782025|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3959732|NCT01322347|3782023|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959733|NCT01322347|3782024|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959734|NCT01322347|3782025|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959735|NCT01322347|3782023|B3||White|Race (NIH/OMB)||Participants|Count of Participants|156|156.0||||||
3959736|NCT01322347|3782024|B2||White|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
3959737|NCT01322347|3782025|B1||White|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3959738|NCT01322347|3782023|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|118|118.0||||||
3959739|NCT01322347|3782024|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3959740|NCT01322347|3782025|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3959741|NCT01322347|3782023|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3959742|NCT01322347|3782024|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3959743|NCT01322347|3782025|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959744|NCT01322347|3782023|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3959745|NCT01322347|3782024|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3959746|NCT01322347|3782025|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3959747|NCT01322347|3782023|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3959748|NCT01322347|3782024|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3959749|NCT01322347|3782025|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959750|NCT01322347|3782023|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959751|NCT01322347|3782024|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959752|NCT01322347|3782025|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959753|NCT01322347|3782023|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|225|225.0||||||
3959754|NCT01322347|3782024|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
3959755|NCT01322347|3782025|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|114|114.0||||||
3959756|NCT01322347|3782023|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3959757|NCT01322347|3782024|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3959758|NCT01322347|3782025|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3959759|NCT01322347|3782023|B3||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
3959760|NCT01322347|3782024|B2||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3959761|NCT01322347|3782025|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3959762|NCT01322347|3782023|B3||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3959763|NCT01322347|3782024|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3959764|NCT01322347|3782025|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3959765|NCT01322347|3782023|B3|||Age||years|Mean|58.5|58.5|Standard Deviation|13.54|13.54|||
3959766|NCT01322347|3782024|B2|||Age||years|Mean|59.0|59.0|Standard Deviation|14.38|14.38|||
3959767|NCT01322347|3782025|B1|||Age||years|Mean|58.1|58.1|Standard Deviation|12.68|12.68|||
3959768|NCT01322048|3782061|B3|United States||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
3959769|NCT01322048|3782062|B2|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3959770|NCT01322048|3782063|B1|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3959771|NCT01322048|3782061|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959772|NCT01322048|3782062|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959773|NCT01322048|3782063|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959774|NCT01322048|3782061|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959775|NCT01322048|3782062|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959776|NCT01322048|3782063|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959777|NCT01322048|3782061|B3||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3959778|NCT01322048|3782062|B2||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3959779|NCT01322048|3782063|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3959780|NCT01322048|3782061|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3959781|NCT01322048|3782062|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3959782|NCT01322048|3782063|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3959783|NCT01322048|3782061|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959784|NCT01322048|3782062|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959785|NCT01322048|3782063|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959786|NCT01322048|3782061|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959787|NCT01322048|3782062|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959788|NCT01322048|3782063|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959789|NCT01322048|3782061|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959790|NCT01322048|3782062|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959791|NCT01322048|3782063|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959792|NCT01322048|3782061|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959793|NCT01322048|3782062|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959794|NCT01322048|3782063|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959795|NCT01322048|3782061|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3959796|NCT01322048|3782062|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3959797|NCT01322048|3782063|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3959798|NCT01322048|3782061|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959799|NCT01322048|3782062|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959800|NCT01322048|3782063|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3959801|NCT01322048|3782061|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3959802|NCT01322048|3782062|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3959803|NCT01322048|3782063|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3959804|NCT01322048|3782061|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3959805|NCT01322048|3782062|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3959806|NCT01322048|3782063|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3959807|NCT01322048|3782061|B3|||Age||years|Median|25|25.0|Inter-Quartile Range|||19.0|34.0|
3959808|NCT01322048|3782062|B2|||Age||years|Median|27.5|27.5|Inter-Quartile Range|||18.5|36.0|
3959809|NCT01322048|3782063|B1|||Age||years|Median|24|24.0|Inter-Quartile Range|||21.0|34.0|
3959810|NCT01322022|3782072|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
3959811|NCT01322022|3782073|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
3959812|NCT01322022|3782074|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3959813|NCT01322022|3782072|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3959814|NCT01322022|3782073|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3959815|NCT01322022|3782074|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3959816|NCT01322022|3782072|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3959817|NCT01322022|3782073|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3959818|NCT01322022|3782074|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3959819|NCT01322022|3782072|B3|||Age||years|Mean|3.56|3.56|Full Range|||2.0|6.0|
3959820|NCT01322022|3782073|B2|||Age||years|Mean|3.6|3.6|Full Range|||2.0|6.0|
3959821|NCT01322022|3782074|B1|||Age||years|Mean|3.51|3.51|Full Range|||2.0|6.0|
3959822|NCT01322022|3782072|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3959823|NCT01322022|3782073|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3959824|NCT01322022|3782074|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3959825|NCT01322022|3782072|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3959826|NCT01322022|3782073|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3959827|NCT01322022|3782074|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3959828|NCT01322022|3782072|B3||<=18 years|Age||Participants|Count of Participants|33|33.0||||||
3959829|NCT01322022|3782073|B2||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
3959830|NCT01322022|3782074|B1||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
3959831|NCT01322009|3782087|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
3959832|NCT01322009|3782088|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3959833|NCT01322009|3782089|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3959834|NCT01322009|3782087|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3959835|NCT01322009|3782088|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3959836|NCT01322009|3782089|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3959837|NCT01322009|3782087|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3959838|NCT01322009|3782088|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3959839|NCT01322009|3782089|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3959840|NCT01322009|3782087|B3|||Age||years|Mean|9.1|9.1|Standard Deviation|5.1|5.1|||
3959841|NCT01322009|3782088|B2|||Age||years|Mean|9.7|9.7|Standard Deviation|5.7|5.7|||
3959842|NCT01322009|3782089|B1|||Age||years|Mean|8.6|8.6|Standard Deviation|4.9|4.9|||
3959843|NCT01322009|3782087|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3959844|NCT01322009|3782088|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3959845|NCT01322009|3782089|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3959846|NCT01322009|3782087|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3959847|NCT01322009|3782088|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3959848|NCT01322009|3782089|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3959849|NCT01322009|3782087|B3||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
3959850|NCT01322009|3782088|B2||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
3959851|NCT01322009|3782089|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
3959852|NCT01321749|3782098|B3|China||Region of Enrollment||participants|Number|103|103.0||||||
3959853|NCT01321749|3782099|B2|China||Region of Enrollment||participants|Number|52|52.0||||||
3959854|NCT01321749|3782100|B1|China||Region of Enrollment||participants|Number|51|51.0||||||
3959855|NCT01321749|3782098|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3959856|NCT01321749|3782099|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3959857|NCT01321749|3782100|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3959858|NCT01321749|3782098|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3959859|NCT01321749|3782099|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3959860|NCT01321749|3782100|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3959861|NCT01321749|3782098|B3|||Age||years|Mean|60.5|60.5|Standard Deviation|9.7|9.7|||
3959862|NCT01321749|3782099|B2|||Age||years|Mean|60|60.0|Standard Deviation|9.4|9.4|||
3959863|NCT01321749|3782100|B1|||Age||years|Mean|61|61.0|Standard Deviation|10.1|10.1|||
3959864|NCT01321749|3782098|B3||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
3959865|NCT01321749|3782099|B2||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3959866|NCT01321749|3782100|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3959867|NCT01321749|3782098|B3||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
3959868|NCT01321749|3782099|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3959869|NCT01321749|3782100|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3959870|NCT01321749|3782098|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3959871|NCT01321749|3782099|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3959872|NCT01321749|3782100|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3959873|NCT01321723|3782107|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3959874|NCT01321723|3782108|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3959875|NCT01321723|3782109|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3959876|NCT01321723|3782110|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3959877|NCT01321723|3782107|B4||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3959878|NCT01321723|3782108|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3959879|NCT01321723|3782109|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3959880|NCT01321723|3782110|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3959881|NCT01321723|3782107|B4|||Age||years|Mean|66.7|66.7|Standard Deviation|5.77|5.77|||
3959882|NCT01321723|3782108|B3|||Age||years|Mean|66.1|66.1|Standard Deviation|6.09|6.09|||
3959883|NCT01321723|3782109|B2|||Age||years|Mean|67.4|67.4|Standard Deviation|3.95|3.95|||
3959884|NCT01321723|3782110|B1|||Age||years|Mean|66.5|66.5|Standard Deviation|6.99|6.99|||
3959885|NCT01321710|3782131|B4|United States||Region of Enrollment||participants|Number|152|152.0||||||
3959886|NCT01321710|3782132|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
3959887|NCT01321710|3782133|B2|United States||Region of Enrollment||participants|Number|58|58.0||||||
3959888|NCT01321710|3782134|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3959889|NCT01321710|3782131|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3959890|NCT01321710|3782132|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3959891|NCT01321710|3782133|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3959892|NCT01321710|3782134|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3959893|NCT01321710|3782131|B4||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3959894|NCT01321710|3782132|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3959895|NCT01321710|3782133|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3959896|NCT01321710|3782134|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3959897|NCT01321710|3782131|B4|||Age||years|Mean|26.6|26.6|Standard Deviation|6.6|6.6|||
3959898|NCT01321710|3782132|B3|||Age||years|Mean|26.5|26.5|Standard Deviation|7.1|7.1|||
3959899|NCT01321710|3782133|B2|||Age||years|Mean|26.4|26.4|Standard Deviation|6.4|6.4|||
3959900|NCT01321710|3782134|B1|||Age||years|Mean|26.8|26.8|Standard Deviation|6.5|6.5|||
3959901|NCT01321710|3782131|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3959902|NCT01321710|3782132|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3959903|NCT01321710|3782133|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3959904|NCT01321710|3782134|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3959905|NCT01321710|3782131|B4||Between 18 and 65 years|Age||Participants|Count of Participants|152|152.0||||||
3959906|NCT01321710|3782132|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3959907|NCT01321710|3782133|B2||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3959908|NCT01321710|3782134|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3959909|NCT01321710|3782131|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3959910|NCT01321710|3782132|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3959911|NCT01321710|3782133|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3959912|NCT01321710|3782134|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3959913|NCT01321697|3782151|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3959914|NCT01321697|3782151|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3959915|NCT01321697|3782151|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3959916|NCT01321697|3782151|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3959917|NCT01321697|3782151|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3959918|NCT01321697|3782151|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3959919|NCT01321606|3782155|B3||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3959920|NCT01321606|3782156|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3959921|NCT01321606|3782157|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3959922|NCT01321606|3782155|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3959923|NCT01321606|3782156|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3959924|NCT01321606|3782157|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3959925|NCT01321606|3782155|B3|||Age||years|Mean|63.6|63.6|Standard Deviation|13.6|13.6|||
3959926|NCT01321606|3782156|B2|||Age||years|Mean|62.9|62.9|Standard Deviation|12.6|12.6|||
3959927|NCT01321606|3782157|B1|||Age||years|Mean|64.4|64.4|Standard Deviation|14.7|14.7|||
3959928|NCT01321554|3782178|B3||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
3959929|NCT01321554|3782179|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3959930|NCT01321554|3782180|B1||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3959931|NCT01321554|3782178|B3||Female|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
3959932|NCT01321554|3782179|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3959933|NCT01321554|3782180|B1||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3959934|NCT01321554|3782178|B3|||Age||years|Geometric Mean|61.9|61.9|Standard Deviation|10.40|10.4|||
3959935|NCT01321554|3782179|B2|||Age||years|Geometric Mean|61.5|61.5|Standard Deviation|10.09|10.09|||
3959936|NCT01321554|3782180|B1|||Age||years|Geometric Mean|62.1|62.1|Standard Deviation|10.57|10.57|||
3959937|NCT01321073|3782196|B1|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3959938|NCT01321073|3782196|B1||White or Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
3959939|NCT01321073|3782196|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3959940|NCT01321073|3782196|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3959941|NCT01321073|3782196|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3959942|NCT01321073|3782196|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3959943|NCT01321073|3782196|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3959944|NCT01321073|3782196|B1|||Age||years|Mean|50.1|50.1|Standard Deviation|13.5|13.5|||
3959945|NCT01321008|3782200|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3959946|NCT01321008|3782200|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3959947|NCT01321008|3782200|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3959948|NCT01321008|3782200|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3959949|NCT01321008|3782200|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3959950|NCT01321008|3782200|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3959951|NCT01320943|3782204|B3|||Hepatitis B Virus Surface Antigen||log10 IU/mL|Mean|4.5|4.5|Standard Deviation|0.56|0.56|||
3959952|NCT01320943|3782205|B2|||Hepatitis B Virus Surface Antigen||log10 IU/mL|Mean|4.5|4.5|Standard Deviation|0.35|0.35|||
3959953|NCT01320943|3782206|B1|||Hepatitis B Virus Surface Antigen||log10 IU/mL|Mean|4.4|4.4|Standard Deviation|0.71|0.71|||
3959954|NCT01320943|3782204|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3959955|NCT01320943|3782205|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3959956|NCT01320943|3782206|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3959957|NCT01320943|3782204|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
3959958|NCT01320943|3782205|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3959959|NCT01320943|3782206|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3959960|NCT01320943|3782204|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3959961|NCT01320943|3782205|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3959962|NCT01320943|3782206|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3959963|NCT01320943|3782204|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3959964|NCT01320943|3782205|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3959965|NCT01320943|3782206|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3959966|NCT01320943|3782204|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3959967|NCT01320943|3782205|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3959968|NCT01320943|3782206|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3959969|NCT01320943|3782204|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3959970|NCT01320943|3782205|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3959971|NCT01320943|3782206|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3959972|NCT01320943|3782204|B3|||Age||years|Mean|44.8|44.8|Standard Deviation|8.85|8.85|||
3959973|NCT01320943|3782205|B2|||Age||years|Mean|45.0|45.0|Standard Deviation|7.06|7.06|||
3959974|NCT01320943|3782206|B1|||Age||years|Mean|44.6|44.6|Standard Deviation|10.51|10.51|||
3959975|NCT01320826|3782226|B1|Canada||Region of Enrollment||participants|Number|577|577.0||||||
3959976|NCT01320826|3782226|B1||Male|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
3959977|NCT01320826|3782226|B1||Female|Sex: Female, Male||Participants|Count of Participants|295|295.0||||||
3959978|NCT01320826|3782226|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|13.3|13.3|||
3959979|NCT01320826|3782226|B1||>=65 years|Age||Participants|Count of Participants|162|162.0||||||
3959980|NCT01320826|3782226|B1||Between 18 and 65 years|Age||Participants|Count of Participants|415|415.0||||||
3959981|NCT01320826|3782226|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3959982|NCT01320735|3782241|B1||Male|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
3959983|NCT01320735|3782241|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3959984|NCT01320735|3782241|B1|||Age||Years|Mean|65.4|65.4|Standard Deviation|6.3|6.3|||
3959985|NCT01320722|3782258|B6|||Angiotensin II Concentration (ATII) [Uric Acid]||pg/mL|Mean|19.1|19.1|Standard Deviation|4.6|4.6|||
3959986|NCT01320722|3782259|B5|||Angiotensin II Concentration (ATII) [Uric Acid]||pg/mL|Mean|18.8|18.8|Standard Deviation|4.8|4.8|||
3959987|NCT01320722|3782260|B4|||Angiotensin II Concentration (ATII) [Uric Acid]||pg/mL|Mean|18.9|18.9|Standard Deviation|4.0|4.0|||
3959988|NCT01320722|3782261|B3|||Angiotensin II Concentration (ATII) [Uric Acid]||pg/mL|Mean|19.6|19.6|Standard Deviation|5.0|5.0|||
3959989|NCT01320722|3782258|B6|||Angiotensin II Concentration (ATII) [Vitamin D]||picogram(pg)/mL|Mean|19.9|19.9|Standard Deviation|5.0|5.0|||
3959990|NCT01320722|3782262|B2|||Angiotensin II Concentration (ATII) [Vitamin D]||picogram(pg)/mL|Mean|19.9|19.9|Standard Deviation|4.5|4.5|||
3959991|NCT01320722|3782263|B1|||Angiotensin II Concentration (ATII) [Vitamin D]||picogram(pg)/mL|Mean|19.9|19.9|Standard Deviation|5.9|5.9|||
3959992|NCT01320722|3782258|B6|||Plasma Renin Activity (PRA) [Uric Acid]||ng/mL|Mean|0.27|0.27|Standard Deviation|0.40|0.4|||
3959993|NCT01320722|3782259|B5|||Plasma Renin Activity (PRA) [Uric Acid]||ng/mL|Mean|0.2|0.2|Standard Deviation|0.33|0.33|||
3959994|NCT01320722|3782260|B4|||Plasma Renin Activity (PRA) [Uric Acid]||ng/mL|Mean|0.3|0.3|Standard Deviation|0.33|0.33|||
3959995|NCT01320722|3782261|B3|||Plasma Renin Activity (PRA) [Uric Acid]||ng/mL|Mean|0.3|0.3|Standard Deviation|0.52|0.52|||
3959996|NCT01320722|3782258|B6|||Plasma Renin Activity (PRA) [Vitamin D]||nanograms (ng)/mL per hour|Mean|0.38|0.38|Standard Deviation|0.40|0.4|||
3959997|NCT01320722|3782262|B2|||Plasma Renin Activity (PRA) [Vitamin D]||nanograms (ng)/mL per hour|Mean|0.42|0.42|Standard Deviation|0.44|0.44|||
3959998|NCT01320722|3782263|B1|||Plasma Renin Activity (PRA) [Vitamin D]||nanograms (ng)/mL per hour|Mean|0.34|0.34|Standard Deviation|0.37|0.37|||
3960032|NCT01320553|3782312|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3960033|NCT01320553|3782313|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3959999|NCT01320722|3782258|B6|||Change in RPF in Response to Captopril [Uric Acid]|An 8 milligrams (mg)/kilogram(kg) loading dose of para-aminohippuric acid (PAH) was given, immediately followed by a continuous PAH infusion at 12 mg/minute. After 60 minutes a single dose of 25 mg of captopril was administered. Three pre-captopril measurements and three post-captopril measurements of RPF were made. RPF was normalized to body surface area of 1.73 meters squared (m^2). The change in RPF was calculated as post-captopril RPF- pre-captopril RPF.|mL/min per 1.73 m^2|Mean|36.3|36.3|Standard Deviation|38.7|38.7|||
3960000|NCT01320722|3782259|B5|||Change in RPF in Response to Captopril [Uric Acid]|An 8 milligrams (mg)/kilogram(kg) loading dose of para-aminohippuric acid (PAH) was given, immediately followed by a continuous PAH infusion at 12 mg/minute. After 60 minutes a single dose of 25 mg of captopril was administered. Three pre-captopril measurements and three post-captopril measurements of RPF were made. RPF was normalized to body surface area of 1.73 meters squared (m^2). The change in RPF was calculated as post-captopril RPF- pre-captopril RPF.|mL/min per 1.73 m^2|Mean|30|30.0|Standard Deviation|35.5|35.5|||
3960001|NCT01320722|3782260|B4|||Change in RPF in Response to Captopril [Uric Acid]|An 8 milligrams (mg)/kilogram(kg) loading dose of para-aminohippuric acid (PAH) was given, immediately followed by a continuous PAH infusion at 12 mg/minute. After 60 minutes a single dose of 25 mg of captopril was administered. Three pre-captopril measurements and three post-captopril measurements of RPF were made. RPF was normalized to body surface area of 1.73 meters squared (m^2). The change in RPF was calculated as post-captopril RPF- pre-captopril RPF.|mL/min per 1.73 m^2|Mean|41|41.0|Standard Deviation|32.2|32.2|||
3960002|NCT01320722|3782261|B3|||Change in RPF in Response to Captopril [Uric Acid]|An 8 milligrams (mg)/kilogram(kg) loading dose of para-aminohippuric acid (PAH) was given, immediately followed by a continuous PAH infusion at 12 mg/minute. After 60 minutes a single dose of 25 mg of captopril was administered. Three pre-captopril measurements and three post-captopril measurements of RPF were made. RPF was normalized to body surface area of 1.73 meters squared (m^2). The change in RPF was calculated as post-captopril RPF- pre-captopril RPF.|mL/min per 1.73 m^2|Mean|38|38.0|Standard Deviation|46.0|46.0|||
3960003|NCT01320722|3782258|B6|||Change in Renal Plasma Flow (RPF) in Response to Captopril [Vitamin D]|An 8 milligrams (mg)/kilogram(kg) loading dose of para-aminohippuric acid (PAH) was given, immediately followed by a continuous PAH infusion at 12 mg/minute. After 60 minutes a single dose of 25 mg of captopril was administered. Three pre-captopril measurements and three post-captopril measurements of RPF were made. RPF was normalized to body surface area of 1.73 meters squared (m^2). The change in RPF was calculated as post-captopril RPF- pre-captopril RPF.|milliliters(mL)/minute(min) per 1.73 m^2|Mean|35.6|35.6|Standard Deviation|50.0|50.0|||
3960004|NCT01320722|3782262|B2|||Change in Renal Plasma Flow (RPF) in Response to Captopril [Vitamin D]|An 8 milligrams (mg)/kilogram(kg) loading dose of para-aminohippuric acid (PAH) was given, immediately followed by a continuous PAH infusion at 12 mg/minute. After 60 minutes a single dose of 25 mg of captopril was administered. Three pre-captopril measurements and three post-captopril measurements of RPF were made. RPF was normalized to body surface area of 1.73 meters squared (m^2). The change in RPF was calculated as post-captopril RPF- pre-captopril RPF.|milliliters(mL)/minute(min) per 1.73 m^2|Mean|37.3|37.3|Standard Deviation|46.9|46.9|||
3960005|NCT01320722|3782263|B1|||Change in Renal Plasma Flow (RPF) in Response to Captopril [Vitamin D]|An 8 milligrams (mg)/kilogram(kg) loading dose of para-aminohippuric acid (PAH) was given, immediately followed by a continuous PAH infusion at 12 mg/minute. After 60 minutes a single dose of 25 mg of captopril was administered. Three pre-captopril measurements and three post-captopril measurements of RPF were made. RPF was normalized to body surface area of 1.73 meters squared (m^2). The change in RPF was calculated as post-captopril RPF- pre-captopril RPF.|milliliters(mL)/minute(min) per 1.73 m^2|Mean|33.9|33.9|Standard Deviation|56.1|56.1|||
3960006|NCT01320722|3782258|B6||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3960007|NCT01320722|3782259|B5||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3960008|NCT01320722|3782260|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3960009|NCT01320722|3782261|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3960010|NCT01320722|3782262|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3960011|NCT01320722|3782263|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3960012|NCT01320722|3782258|B6||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3960013|NCT01320722|3782259|B5||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3960014|NCT01320722|3782260|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3960015|NCT01320722|3782261|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3960016|NCT01320722|3782262|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3960017|NCT01320722|3782263|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3960018|NCT01320722|3782258|B6|||Age|All randomized participants.|years|Mean|41|41.0|Standard Deviation|14|14.0|||
3960019|NCT01320722|3782259|B5|||Age|All randomized participants.|years|Mean|41|41.0|Standard Deviation|14|14.0|||
3960020|NCT01320722|3782260|B4|||Age|All randomized participants.|years|Mean|43|43.0|Standard Deviation|12.5|12.5|||
3960021|NCT01320722|3782261|B3|||Age|All randomized participants.|years|Mean|37|37.0|Standard Deviation|14|14.0|||
3960022|NCT01320722|3782258|B6|||Age||years|Mean|37|37.0|Standard Deviation|12.3|12.3|||
3960023|NCT01320722|3782262|B2|||Age||years|Mean|35|35.0|Standard Deviation|11|11.0|||
3960024|NCT01320722|3782263|B1|||Age||years|Mean|39|39.0|Standard Deviation|13|13.0|||
3960025|NCT01320683|3782304|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3960026|NCT01320683|3782304|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3960027|NCT01320683|3782304|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3960028|NCT01320683|3782304|B1|||Age||years|Median|66|66.0|Full Range|||66.0|66.0|
3960029|NCT01320553|3782309|B5||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3960030|NCT01320553|3782310|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3960031|NCT01320553|3782311|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3960034|NCT01320553|3782309|B5||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3960035|NCT01320553|3782310|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3960036|NCT01320553|3782311|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3960037|NCT01320553|3782312|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3960038|NCT01320553|3782313|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3960039|NCT01320553|3782309|B5|||Age||years|Mean|35.6|35.6|Standard Deviation|14.35|14.35|||
3960040|NCT01320553|3782310|B4|||Age||years|Mean|40.6|40.6|Standard Deviation|13.57|13.57|||
3960041|NCT01320553|3782311|B3|||Age||years|Mean|33.7|33.7|Standard Deviation|15.94|15.94|||
3960042|NCT01320553|3782312|B2|||Age||years|Mean|34.8|34.8|Standard Deviation|15.42|15.42|||
3960043|NCT01320553|3782313|B1|||Age||years|Mean|33.4|33.4|Standard Deviation|11.58|11.58|||
3960044|NCT01320293|3782330|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3960045|NCT01320293|3782330|B1||Male|Gender||Participants|Count of Participants|12|12.0||||||
3960046|NCT01320293|3782330|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
3960047|NCT01320293|3782330|B1|||Age||years|Median|39|39.0|Full Range|||19.0|52.0|
3960048|NCT01320293|3782330|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3960049|NCT01320293|3782330|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3960050|NCT01320293|3782330|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3960051|NCT01320202|3782336|B3|||height||centimeters|Mean|168.82|168.82|Standard Deviation|9.771|9.771|||
3960052|NCT01320202|3782337|B2|||height||centimeters|Mean|169.17|169.17|Standard Deviation|9.350|9.35|||
3960053|NCT01320202|3782338|B1|||height||centimeters|Mean|168.48|168.48|Standard Deviation|10.197|10.197|||
3960054|NCT01320202|3782336|B3|||post-dialysis body weight||kilograms|Mean|83.61|83.61|Standard Deviation|22.685|22.685|||
3960055|NCT01320202|3782337|B2|||post-dialysis body weight||kilograms|Mean|83.15|83.15|Standard Deviation|22.166|22.166|||
3960056|NCT01320202|3782338|B1|||post-dialysis body weight||kilograms|Mean|84.08|84.08|Standard Deviation|23.264|23.264|||
3960057|NCT01320202|3782336|B3|Puerto Rico||Region of Enrollment||participants|Number|17|17.0||||||
3960058|NCT01320202|3782337|B2|Puerto Rico||Region of Enrollment||participants|Number|10|10.0||||||
3960059|NCT01320202|3782338|B1|Puerto Rico||Region of Enrollment||participants|Number|7|7.0||||||
3960060|NCT01320202|3782336|B3|United States||Region of Enrollment||participants|Number|288|288.0||||||
3960061|NCT01320202|3782337|B2|United States||Region of Enrollment||participants|Number|143|143.0||||||
3960062|NCT01320202|3782338|B1|United States||Region of Enrollment||participants|Number|145|145.0||||||
3960063|NCT01320202|3782336|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3960064|NCT01320202|3782337|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3960065|NCT01320202|3782338|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3960066|NCT01320202|3782336|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960067|NCT01320202|3782337|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960068|NCT01320202|3782338|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960069|NCT01320202|3782336|B3||White|Race (NIH/OMB)||Participants|Count of Participants|168|168.0||||||
3960070|NCT01320202|3782337|B2||White|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3960071|NCT01320202|3782338|B1||White|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3960072|NCT01320202|3782336|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3960073|NCT01320202|3782337|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3960074|NCT01320202|3782338|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3960075|NCT01320202|3782336|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3960076|NCT01320202|3782337|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960077|NCT01320202|3782338|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3960078|NCT01320202|3782336|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3960079|NCT01320202|3782337|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3960080|NCT01320202|3782338|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3960081|NCT01320202|3782336|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3960082|NCT01320202|3782337|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3960083|NCT01320202|3782338|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3960084|NCT01320202|3782336|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960085|NCT01320202|3782337|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960086|NCT01320202|3782338|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960087|NCT01320202|3782336|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|166|166.0||||||
3960088|NCT01320202|3782337|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3960089|NCT01320202|3782338|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3960090|NCT01320202|3782336|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|139|139.0||||||
3960091|NCT01320202|3782337|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3960092|NCT01320202|3782338|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3960093|NCT01320202|3782336|B3||Male|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
3960094|NCT01320202|3782337|B2||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3960095|NCT01320202|3782338|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3960096|NCT01320202|3782336|B3||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3960097|NCT01320202|3782337|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3960098|NCT01320202|3782338|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3960099|NCT01320202|3782336|B3|||Age||years|Mean|58.3|58.3|Standard Deviation|12.87|12.87|||
3960100|NCT01320202|3782337|B2|||Age||years|Mean|59.9|59.9|Standard Deviation|13.01|13.01|||
3960101|NCT01320202|3782338|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|12.56|12.56|||
3960102|NCT01320137|3782374|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3960103|NCT01320137|3782375|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3960104|NCT01320137|3782376|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3960105|NCT01320137|3782374|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3960106|NCT01320137|3782375|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3960107|NCT01320137|3782376|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3960108|NCT01320137|3782374|B3|||Age||Years|Mean|29.35|29.35|Standard Deviation|7.18|7.18|||
3960109|NCT01320137|3782375|B2|||Age||Years|Mean|28.6|28.6|Standard Deviation|6.92|6.92|||
3960110|NCT01320137|3782376|B1|||Age||Years|Mean|30.1|30.1|Standard Deviation|7.44|7.44|||
3960111|NCT01320072|3782389|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
3960112|NCT01320072|3782390|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3960113|NCT01320072|3782391|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3960114|NCT01320072|3782389|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960115|NCT01320072|3782390|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960116|NCT01320072|3782391|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960117|NCT01320072|3782389|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960118|NCT01320072|3782390|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960119|NCT01320072|3782391|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960120|NCT01320072|3782389|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3960121|NCT01320072|3782390|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3960122|NCT01320072|3782391|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3960123|NCT01320072|3782389|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3960124|NCT01320072|3782390|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3960125|NCT01320072|3782391|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3960126|NCT01320072|3782389|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960127|NCT01320072|3782390|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960128|NCT01320072|3782391|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960129|NCT01320072|3782389|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3960130|NCT01320072|3782390|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3960131|NCT01320072|3782391|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960132|NCT01320072|3782389|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960133|NCT01320072|3782390|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960134|NCT01320072|3782391|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960135|NCT01320072|3782389|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3960136|NCT01320072|3782390|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3960137|NCT01320072|3782391|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3960138|NCT01320072|3782389|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3960139|NCT01320072|3782390|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3960140|NCT01320072|3782391|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3960141|NCT01320072|3782389|B3|||Age||years|Mean|40.3|40.3|Standard Deviation|2.9|2.9|||
3960142|NCT01320072|3782390|B2|||Age||years|Mean|42.6|42.6|Standard Deviation|2.4|2.4|||
3960143|NCT01320072|3782391|B1|||Age||years|Mean|37.8|37.8|Standard Deviation|3.2|3.2|||
3960144|NCT01320072|3782389|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3960145|NCT01320072|3782390|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3960146|NCT01320072|3782391|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3960147|NCT01320072|3782389|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3960148|NCT01320072|3782390|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3960149|NCT01320072|3782391|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3960150|NCT01320072|3782389|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3960151|NCT01320072|3782390|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3960152|NCT01320072|3782391|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3960153|NCT01319877|3782401|B3|China||Region of Enrollment||participants|Number|606|606.0||||||
3960154|NCT01319877|3782402|B2|China||Region of Enrollment||participants|Number|153|153.0||||||
3960155|NCT01319877|3782403|B1|China||Region of Enrollment||participants|Number|453|453.0||||||
3960156|NCT01319877|3782401|B3||Male|Sex: Female, Male||Participants|Count of Participants|370|370.0||||||
3960157|NCT01319877|3782402|B2||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3960158|NCT01319877|3782403|B1||Male|Sex: Female, Male||Participants|Count of Participants|270|270.0||||||
3960159|NCT01319877|3782401|B3||Female|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
3960160|NCT01319877|3782402|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3960161|NCT01319877|3782403|B1||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3960162|NCT01319877|3782401|B3|||Age||years|Mean|55.4|55.4|Standard Deviation|11.9|11.9|||
3960163|NCT01319877|3782402|B2|||Age||years|Mean|54.5|54.5|Standard Deviation|11.9|11.9|||
3960164|NCT01319877|3782403|B1|||Age||years|Mean|55.7|55.7|Standard Deviation|11.9|11.9|||
3960165|NCT01319851|3782439|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3960166|NCT01319851|3782439|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3960167|NCT01319851|3782439|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3960168|NCT01319851|3782439|B1|||Age||years|Mean|7|7.0|Standard Deviation|3.54|3.54|||
3960169|NCT01319851|3782439|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3960170|NCT01319851|3782439|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3960171|NCT01319851|3782439|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3960172|NCT01319812|3782449|B3|Type D||Trans-Atlantic Inter-Society Consensus (TASC II) Type|TASC II grading is from the Trans-Atlantic Inter-Society Consensus. Type A lesions include a single stenosis <10 cm long or a single occlusion <5cm long; type B lesions include multiple lesions <5 cm, a single lesion <15cm, or a single popliteal stenosis; type C lesions include multiple stenosis or occlusions >15 cm with or without calcification, or a chronic total occlusion >20cm involving the popliteal; type D lesions include chronic total occlusions of the popliteal artery and proximal vessels. Generally, Type D lesions are mores severe than Type A lesions.|Participants|Number|NA|||||||Study arms are independent with no overlap or comparison. A total would not present meaningful information and would be conflated by four subjects who were enrolled in both arms of the study.
3960173|NCT01319812|3782450|B2|Type D||Trans-Atlantic Inter-Society Consensus (TASC II) Type|TASC II grading is from the Trans-Atlantic Inter-Society Consensus. Type A lesions include a single stenosis <10 cm long or a single occlusion <5cm long; type B lesions include multiple lesions <5 cm, a single lesion <15cm, or a single popliteal stenosis; type C lesions include multiple stenosis or occlusions >15 cm with or without calcification, or a chronic total occlusion >20cm involving the popliteal; type D lesions include chronic total occlusions of the popliteal artery and proximal vessels. Generally, Type D lesions are mores severe than Type A lesions.|Participants|Number|3|3.0||||||
3960174|NCT01319812|3782451|B1|Type D||Trans-Atlantic Inter-Society Consensus (TASC II) Type|TASC II grading is from the Trans-Atlantic Inter-Society Consensus. Type A lesions include a single stenosis <10 cm long or a single occlusion <5cm long; type B lesions include multiple lesions <5 cm, a single lesion <15cm, or a single popliteal stenosis; type C lesions include multiple stenosis or occlusions >15 cm with or without calcification, or a chronic total occlusion >20cm involving the popliteal; type D lesions include chronic total occlusions of the popliteal artery and proximal vessels. Generally, Type D lesions are mores severe than Type A lesions.|Participants|Number|0|0.0||||||
3960175|NCT01319812|3782449|B3|Type C||Trans-Atlantic Inter-Society Consensus (TASC II) Type|TASC II grading is from the Trans-Atlantic Inter-Society Consensus. Type A lesions include a single stenosis <10 cm long or a single occlusion <5cm long; type B lesions include multiple lesions <5 cm, a single lesion <15cm, or a single popliteal stenosis; type C lesions include multiple stenosis or occlusions >15 cm with or without calcification, or a chronic total occlusion >20cm involving the popliteal; type D lesions include chronic total occlusions of the popliteal artery and proximal vessels. Generally, Type D lesions are mores severe than Type A lesions.|Participants|Number|NA|||||||Study arms are independent with no overlap or comparison. A total would not present meaningful information and would be conflated by four subjects who were enrolled in both arms of the study.
3960176|NCT01319812|3782450|B2|Type C||Trans-Atlantic Inter-Society Consensus (TASC II) Type|TASC II grading is from the Trans-Atlantic Inter-Society Consensus. Type A lesions include a single stenosis <10 cm long or a single occlusion <5cm long; type B lesions include multiple lesions <5 cm, a single lesion <15cm, or a single popliteal stenosis; type C lesions include multiple stenosis or occlusions >15 cm with or without calcification, or a chronic total occlusion >20cm involving the popliteal; type D lesions include chronic total occlusions of the popliteal artery and proximal vessels. Generally, Type D lesions are mores severe than Type A lesions.|Participants|Number|26|26.0||||||
3960177|NCT01319812|3782451|B1|Type C||Trans-Atlantic Inter-Society Consensus (TASC II) Type|TASC II grading is from the Trans-Atlantic Inter-Society Consensus. Type A lesions include a single stenosis <10 cm long or a single occlusion <5cm long; type B lesions include multiple lesions <5 cm, a single lesion <15cm, or a single popliteal stenosis; type C lesions include multiple stenosis or occlusions >15 cm with or without calcification, or a chronic total occlusion >20cm involving the popliteal; type D lesions include chronic total occlusions of the popliteal artery and proximal vessels. Generally, Type D lesions are mores severe than Type A lesions.|Participants|Number|6|6.0||||||
3960201|NCT01319812|3782451|B1|Reference vessel diameter||Vessel Diameter||mm|Mean|7.6|7.6|Standard Deviation|1.5|1.5|||
3960202|NCT01319812|3782449|B3|Post-deployment Minimum Lumen Diameter (MLD)||Vessel Diameter||mm|Mean|NA||Standard Deviation|NA||||Study arms are independent with no overlap or comparison. A total would not present meaningful information and would be conflated by four subjects who were enrolled in both arms of the study.
3960203|NCT01319812|3782450|B2|Post-deployment Minimum Lumen Diameter (MLD)||Vessel Diameter||mm|Mean|4.1|4.1|Standard Deviation|0.7|0.7|||
3960204|NCT01319812|3782451|B1|Post-deployment Minimum Lumen Diameter (MLD)||Vessel Diameter||mm|Mean|6.0|6.0|Standard Deviation|1.2|1.2|||
3960178|NCT01319812|3782449|B3|Type B||Trans-Atlantic Inter-Society Consensus (TASC II) Type|TASC II grading is from the Trans-Atlantic Inter-Society Consensus. Type A lesions include a single stenosis <10 cm long or a single occlusion <5cm long; type B lesions include multiple lesions <5 cm, a single lesion <15cm, or a single popliteal stenosis; type C lesions include multiple stenosis or occlusions >15 cm with or without calcification, or a chronic total occlusion >20cm involving the popliteal; type D lesions include chronic total occlusions of the popliteal artery and proximal vessels. Generally, Type D lesions are mores severe than Type A lesions.|Participants|Number|NA|||||||Study arms are independent with no overlap or comparison. A total would not present meaningful information and would be conflated by four subjects who were enrolled in both arms of the study.
3960179|NCT01319812|3782450|B2|Type B||Trans-Atlantic Inter-Society Consensus (TASC II) Type|TASC II grading is from the Trans-Atlantic Inter-Society Consensus. Type A lesions include a single stenosis <10 cm long or a single occlusion <5cm long; type B lesions include multiple lesions <5 cm, a single lesion <15cm, or a single popliteal stenosis; type C lesions include multiple stenosis or occlusions >15 cm with or without calcification, or a chronic total occlusion >20cm involving the popliteal; type D lesions include chronic total occlusions of the popliteal artery and proximal vessels. Generally, Type D lesions are mores severe than Type A lesions.|Participants|Number|106|106.0||||||
3960180|NCT01319812|3782451|B1|Type B||Trans-Atlantic Inter-Society Consensus (TASC II) Type|TASC II grading is from the Trans-Atlantic Inter-Society Consensus. Type A lesions include a single stenosis <10 cm long or a single occlusion <5cm long; type B lesions include multiple lesions <5 cm, a single lesion <15cm, or a single popliteal stenosis; type C lesions include multiple stenosis or occlusions >15 cm with or without calcification, or a chronic total occlusion >20cm involving the popliteal; type D lesions include chronic total occlusions of the popliteal artery and proximal vessels. Generally, Type D lesions are mores severe than Type A lesions.|Participants|Number|56|56.0||||||
3960181|NCT01319812|3782449|B3|Type A||Trans-Atlantic Inter-Society Consensus (TASC II) Type|TASC II grading is from the Trans-Atlantic Inter-Society Consensus. Type A lesions include a single stenosis <10 cm long or a single occlusion <5cm long; type B lesions include multiple lesions <5 cm, a single lesion <15cm, or a single popliteal stenosis; type C lesions include multiple stenosis or occlusions >15 cm with or without calcification, or a chronic total occlusion >20cm involving the popliteal; type D lesions include chronic total occlusions of the popliteal artery and proximal vessels. Generally, Type D lesions are mores severe than Type A lesions.|Participants|Number|NA|||||||Study arms are independent with no overlap or comparison. A total would not present meaningful information and would be conflated by four subjects who were enrolled in both arms of the study.
3960182|NCT01319812|3782450|B2|Type A||Trans-Atlantic Inter-Society Consensus (TASC II) Type|TASC II grading is from the Trans-Atlantic Inter-Society Consensus. Type A lesions include a single stenosis <10 cm long or a single occlusion <5cm long; type B lesions include multiple lesions <5 cm, a single lesion <15cm, or a single popliteal stenosis; type C lesions include multiple stenosis or occlusions >15 cm with or without calcification, or a chronic total occlusion >20cm involving the popliteal; type D lesions include chronic total occlusions of the popliteal artery and proximal vessels. Generally, Type D lesions are mores severe than Type A lesions.|Participants|Number|166|166.0||||||
3960183|NCT01319812|3782451|B1|Type A||Trans-Atlantic Inter-Society Consensus (TASC II) Type|TASC II grading is from the Trans-Atlantic Inter-Society Consensus. Type A lesions include a single stenosis <10 cm long or a single occlusion <5cm long; type B lesions include multiple lesions <5 cm, a single lesion <15cm, or a single popliteal stenosis; type C lesions include multiple stenosis or occlusions >15 cm with or without calcification, or a chronic total occlusion >20cm involving the popliteal; type D lesions include chronic total occlusions of the popliteal artery and proximal vessels. Generally, Type D lesions are mores severe than Type A lesions.|Participants|Number|99|99.0||||||
3960184|NCT01319812|3782449|B3|3 Vessel||Distal Vessel Runoff||Participants|Number|NA|||||||Study arms are independent with no overlap or comparison. A total would not present meaningful information and would be conflated by four subjects who were enrolled in both arms of the study.
3960185|NCT01319812|3782450|B2|3 Vessel||Distal Vessel Runoff||Participants|Number|84|84.0||||||
3960186|NCT01319812|3782451|B1|3 Vessel||Distal Vessel Runoff||Participants|Number|37|37.0||||||
3960187|NCT01319812|3782449|B3|2 Vessel||Distal Vessel Runoff||Participants|Number|NA|||||||Study arms are independent with no overlap or comparison. A total would not present meaningful information and would be conflated by four subjects who were enrolled in both arms of the study.
3960188|NCT01319812|3782450|B2|2 Vessel||Distal Vessel Runoff||Participants|Number|93|93.0||||||
3960189|NCT01319812|3782451|B1|2 Vessel||Distal Vessel Runoff||Participants|Number|48|48.0||||||
3960190|NCT01319812|3782449|B3|1 Vessel||Distal Vessel Runoff||Participants|Number|NA|||||||Study arms are independent with no overlap or comparison. A total would not present meaningful information and would be conflated by four subjects who were enrolled in both arms of the study.
3960191|NCT01319812|3782450|B2|1 Vessel||Distal Vessel Runoff||Participants|Number|74|74.0||||||
3960192|NCT01319812|3782451|B1|1 Vessel||Distal Vessel Runoff||Participants|Number|32|32.0||||||
3960193|NCT01319812|3782449|B3|0 Vessel||Distal Vessel Runoff||Participants|Number|NA|||||||Study arms are independent with no overlap or comparison. A total would not present meaningful information and would be conflated by four subjects who were enrolled in both arms of the study.
3960194|NCT01319812|3782450|B2|0 Vessel||Distal Vessel Runoff||Participants|Number|19|19.0||||||
3960195|NCT01319812|3782451|B1|0 Vessel||Distal Vessel Runoff||Participants|Number|9|9.0||||||
3960196|NCT01319812|3782449|B3|Not Available||Distal Vessel Runoff||Participants|Number|NA|||||||Study arms are independent with no overlap or comparison. A total would not present meaningful information and would be conflated by four subjects who were enrolled in both arms of the study.
3960197|NCT01319812|3782450|B2|Not Available||Distal Vessel Runoff||Participants|Number|32|32.0||||||
3960198|NCT01319812|3782451|B1|Not Available||Distal Vessel Runoff||Participants|Number|35|35.0||||||
3960199|NCT01319812|3782449|B3|Reference vessel diameter||Vessel Diameter||mm|Mean|NA||Standard Deviation|NA||||Study arms are independent with no overlap or comparison. A total would not present meaningful information and would be conflated by four subjects who were enrolled in both arms of the study.
3960200|NCT01319812|3782450|B2|Reference vessel diameter||Vessel Diameter||mm|Mean|5.0|5.0|Standard Deviation|0.9|0.9|||
3960205|NCT01319812|3782449|B3|Pre-deployment Minimum Lumen Diameter (MLD)||Vessel Diameter||mm|Mean|NA||Standard Deviation|NA||||Study arms are independent with no overlap or comparison. A total would not present meaningful information and would be conflated by four subjects who were enrolled in both arms of the study.
3960206|NCT01319812|3782450|B2|Pre-deployment Minimum Lumen Diameter (MLD)||Vessel Diameter||mm|Mean|1.0|1.0|Standard Deviation|0.9|0.9|||
3960207|NCT01319812|3782451|B1|Pre-deployment Minimum Lumen Diameter (MLD)||Vessel Diameter||mm|Mean|2.1|2.1|Standard Deviation|1.3|1.3|||
3960208|NCT01319812|3782449|B3|||Lesion Length||mm|Mean|NA||Standard Deviation|NA||||Study arms are independent with no overlap or comparison. A total would not present meaningful information and would be conflated by four subjects who were enrolled in both arms of the study.
3960209|NCT01319812|3782450|B2|||Lesion Length||mm|Mean|82.0|82.0|Standard Deviation|46.9|46.9|||
3960210|NCT01319812|3782451|B1|||Lesion Length||mm|Mean|35.9|35.9|Standard Deviation|21.3|21.3|||
3960211|NCT01319812|3782449|B3|Severe||Lesion Calcification||Participants|Number|NA|||||||Study arms are independent with no overlap or comparison. A total would not present meaningful information and would be conflated by four subjects who were enrolled in both arms of the study.
3960212|NCT01319812|3782450|B2|Severe||Lesion Calcification||Participants|Number|129|129.0||||||
3960213|NCT01319812|3782451|B1|Severe||Lesion Calcification||Participants|Number|46|46.0||||||
3960214|NCT01319812|3782449|B3|Moderate||Lesion Calcification||Participants|Number|NA|||||||Study arms are independent with no overlap or comparison. A total would not present meaningful information and would be conflated by four subjects who were enrolled in both arms of the study.
3960215|NCT01319812|3782450|B2|Moderate||Lesion Calcification||Participants|Number|91|91.0||||||
3960216|NCT01319812|3782451|B1|Moderate||Lesion Calcification||Participants|Number|68|68.0||||||
3960217|NCT01319812|3782449|B3|None||Lesion Calcification||Participants|Number|NA|||||||Study arms are independent with no overlap or comparison. A total would not present meaningful information and would be conflated by four subjects who were enrolled in both arms of the study.
3960218|NCT01319812|3782450|B2|None||Lesion Calcification||Participants|Number|82|82.0||||||
3960219|NCT01319812|3782451|B1|None||Lesion Calcification||Participants|Number|47|47.0||||||
3960220|NCT01319812|3782449|B3|Proximal popliteal||Lesion Location||Participants|Number|7|7.0||||||
3960221|NCT01319812|3782450|B2|Proximal popliteal||Lesion Location||Participants|Number|7|7.0||||||
3960222|NCT01319812|3782451|B1|Proximal popliteal||Lesion Location||Participants|Number|0|0.0||||||
3960223|NCT01319812|3782449|B3|Distal SFA||Lesion Location||Participants|Number|99|99.0||||||
3960224|NCT01319812|3782450|B2|Distal SFA||Lesion Location||Participants|Number|99|99.0||||||
3960225|NCT01319812|3782451|B1|Distal SFA||Lesion Location||Participants|Number|0|0.0||||||
3960226|NCT01319812|3782449|B3|Mid SFA||Lesion Location||Participants|Number|156|156.0||||||
3960227|NCT01319812|3782450|B2|Mid SFA||Lesion Location||Participants|Number|156|156.0||||||
3960228|NCT01319812|3782451|B1|Mid SFA||Lesion Location||Participants|Number|0|0.0||||||
3960229|NCT01319812|3782449|B3|Proximal SFA||Lesion Location||Participants|Number|38|38.0||||||
3960230|NCT01319812|3782450|B2|Proximal SFA||Lesion Location||Participants|Number|38|38.0||||||
3960231|NCT01319812|3782451|B1|Proximal SFA||Lesion Location||Participants|Number|0|0.0||||||
3960232|NCT01319812|3782449|B3|Ostial SFA||Lesion Location||Participants|Number|2|2.0||||||
3960233|NCT01319812|3782450|B2|Ostial SFA||Lesion Location||Participants|Number|2|2.0||||||
3960234|NCT01319812|3782451|B1|Ostial SFA||Lesion Location||Participants|Number|0|0.0||||||
3960235|NCT01319812|3782449|B3|External iliac||Lesion Location||Participants|Number|54|54.0||||||
3960236|NCT01319812|3782450|B2|External iliac||Lesion Location||Participants|Number|0|0.0||||||
3960237|NCT01319812|3782451|B1|External iliac||Lesion Location||Participants|Number|54|54.0||||||
3960238|NCT01319812|3782449|B3|Common iliac||Lesion Location||Participants|Number|107|107.0||||||
3960239|NCT01319812|3782450|B2|Common iliac||Lesion Location||Participants|Number|0|0.0||||||
3960240|NCT01319812|3782451|B1|Common iliac||Lesion Location||Participants|Number|107|107.0||||||
3960241|NCT01319812|3782449|B3|Renal insufficiency||Medical History||Participants|Number|NA|||||||Study arms are independent with no overlap or comparison. A total would not present meaningful information and would be conflated by four subjects who were enrolled in both arms of the study.
3960242|NCT01319812|3782450|B2|Renal insufficiency||Medical History||Participants|Number|17|17.0||||||
3960243|NCT01319812|3782451|B1|Renal insufficiency||Medical History||Participants|Number|11|11.0||||||
3960244|NCT01319812|3782449|B3|History of coronary revasularization||Medical History||Participants|Number|NA|||||||Study arms are independent with no overlap or comparison. A total would not present meaningful information and would be conflated by four subjects who were enrolled in both arms of the study.
3960245|NCT01319812|3782450|B2|History of coronary revasularization||Medical History||Participants|Number|110|110.0||||||
3960246|NCT01319812|3782451|B1|History of coronary revasularization||Medical History||Participants|Number|54|54.0||||||
3960247|NCT01319812|3782449|B3|History of ischemic heart disease||Medical History||Participants|Number|NA|||||||Study arms are independent with no overlap or comparison. A total would not present meaningful information and would be conflated by four subjects who were enrolled in both arms of the study.
3960248|NCT01319812|3782450|B2|History of ischemic heart disease||Medical History||Participants|Number|124|124.0||||||
3960249|NCT01319812|3782451|B1|History of ischemic heart disease||Medical History||Participants|Number|69|69.0||||||
3960250|NCT01319812|3782449|B3|History of congestive heart failure||Medical History||Participants|Number|NA|||||||Study arms are independent with no overlap or comparison. A total would not present meaningful information and would be conflated by four subjects who were enrolled in both arms of the study.
3960251|NCT01319812|3782450|B2|History of congestive heart failure||Medical History||Participants|Number|27|27.0||||||
3960252|NCT01319812|3782451|B1|History of congestive heart failure||Medical History||Participants|Number|11|11.0||||||
3960354|NCT01319773|3782533|B2|> 40 years||Age, Customized||participants|Number|0|0.0||||||
3960253|NCT01319812|3782449|B3|Cerebrovascular disease||Medical History||Participants|Number|NA|||||||Study arms are independent with no overlap or comparison. A total would not present meaningful information and would be conflated by four subjects who were enrolled in both arms of the study.
3960254|NCT01319812|3782450|B2|Cerebrovascular disease||Medical History||Participants|Number|48|48.0||||||
3960255|NCT01319812|3782451|B1|Cerebrovascular disease||Medical History||Participants|Number|22|22.0||||||
3960256|NCT01319812|3782449|B3|Never smoked or not within last 5 years||Medical History||Participants|Number|NA|||||||Study arms are independent with no overlap or comparison. A total would not present meaningful information and would be conflated by four subjects who were enrolled in both arms of the study.
3960257|NCT01319812|3782450|B2|Never smoked or not within last 5 years||Medical History||Participants|Number|134|134.0||||||
3960258|NCT01319812|3782451|B1|Never smoked or not within last 5 years||Medical History||Participants|Number|47|47.0||||||
3960259|NCT01319812|3782449|B3|Smoked within last 5 years||Medical History||Participants|Number|NA|||||||Study arms are independent with no overlap or comparison. A total would not present meaningful information and would be conflated by four subjects who were enrolled in both arms of the study.
3960260|NCT01319812|3782450|B2|Smoked within last 5 years||Medical History||Participants|Number|46|46.0||||||
3960261|NCT01319812|3782451|B1|Smoked within last 5 years||Medical History||Participants|Number|36|36.0||||||
3960262|NCT01319812|3782449|B3|Current smoker||Medical History||Participants|Number|NA|||||||Study arms are independent with no overlap or comparison. A total would not present meaningful information and would be conflated by four subjects who were enrolled in both arms of the study.
3960263|NCT01319812|3782450|B2|Current smoker||Medical History||Participants|Number|122|122.0||||||
3960264|NCT01319812|3782451|B1|Current smoker||Medical History||Participants|Number|78|78.0||||||
3960265|NCT01319812|3782449|B3|Hyperlipidemia||Medical History||Participants|Number|NA|||||||Study arms are independent with no overlap or comparison. A total would not present meaningful information and would be conflated by four subjects who were enrolled in both arms of the study.
3960266|NCT01319812|3782450|B2|Hyperlipidemia||Medical History||Participants|Number|245|245.0||||||
3960267|NCT01319812|3782451|B1|Hyperlipidemia||Medical History||Participants|Number|125|125.0||||||
3960268|NCT01319812|3782449|B3|Hypertension||Medical History||Participants|Number|NA|||||||Study arms are independent with no overlap or comparison. A total would not present meaningful information and would be conflated by four subjects who were enrolled in both arms of the study.
3960269|NCT01319812|3782450|B2|Hypertension||Medical History||Participants|Number|255|255.0||||||
3960270|NCT01319812|3782451|B1|Hypertension||Medical History||Participants|Number|117|117.0||||||
3960271|NCT01319812|3782449|B3|Diabetes||Medical History||Participants|Number|NA|||||||Study arms are independent with no overlap or comparison. A total would not present meaningful information and would be conflated by four subjects who were enrolled in both arms of the study.
3960272|NCT01319812|3782450|B2|Diabetes||Medical History||Participants|Number|123|123.0||||||
3960273|NCT01319812|3782451|B1|Diabetes||Medical History||Participants|Number|32|32.0||||||
3960274|NCT01319812|3782449|B3|Germany||Region of Enrollment||Participants|Number|NA|||||||Study arms are independent with no overlap or comparison. A total would not present meaningful information and would be conflated by four subjects who were enrolled in both arms of the study.
3960275|NCT01319812|3782450|B2|Germany||Region of Enrollment||Participants|Number|14|14.0||||||
3960276|NCT01319812|3782451|B1|Germany||Region of Enrollment||Participants|Number|0|0.0||||||
3960277|NCT01319812|3782449|B3|Switzerland||Region of Enrollment||Participants|Number|NA|||||||Study arms are independent with no overlap or comparison. A total would not present meaningful information and would be conflated by four subjects who were enrolled in both arms of the study.
3960278|NCT01319812|3782450|B2|Switzerland||Region of Enrollment||Participants|Number|6|6.0||||||
3960279|NCT01319812|3782451|B1|Switzerland||Region of Enrollment||Participants|Number|0|0.0||||||
3960280|NCT01319812|3782449|B3|Belgium||Region of Enrollment||Participants|Number|NA|||||||Study arms are independent with no overlap or comparison. A total would not present meaningful information and would be conflated by four subjects who were enrolled in both arms of the study.
3960281|NCT01319812|3782450|B2|Belgium||Region of Enrollment||Participants|Number|32|32.0||||||
3960282|NCT01319812|3782451|B1|Belgium||Region of Enrollment||Participants|Number|0|0.0||||||
3960283|NCT01319812|3782449|B3|Austria||Region of Enrollment||Participants|Number|NA|||||||Study arms are independent with no overlap or comparison. A total would not present meaningful information and would be conflated by four subjects who were enrolled in both arms of the study.
3960284|NCT01319812|3782450|B2|Austria||Region of Enrollment||Participants|Number|34|34.0||||||
3960285|NCT01319812|3782451|B1|Austria||Region of Enrollment||Participants|Number|32|32.0||||||
3960286|NCT01319812|3782449|B3|Canada||Region of Enrollment||Participants|Number|NA|||||||Study arms are independent with no overlap or comparison. A total would not present meaningful information and would be conflated by four subjects who were enrolled in both arms of the study.
3960287|NCT01319812|3782450|B2|Canada||Region of Enrollment||Participants|Number|29|29.0||||||
3960288|NCT01319812|3782451|B1|Canada||Region of Enrollment||Participants|Number|38|38.0||||||
3960289|NCT01319812|3782449|B3|United States||Region of Enrollment||Participants|Number|NA|||||||Study arms are independent with no overlap or comparison. A total would not present meaningful information and would be conflated by four subjects who were enrolled in both arms of the study.
3960290|NCT01319812|3782450|B2|United States||Region of Enrollment||Participants|Number|187|187.0||||||
3960291|NCT01319812|3782451|B1|United States||Region of Enrollment||Participants|Number|91|91.0||||||
3960292|NCT01319812|3782449|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960293|NCT01319812|3782450|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960294|NCT01319812|3782451|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960295|NCT01319812|3782449|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960296|NCT01319812|3782450|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960297|NCT01319812|3782451|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960298|NCT01319812|3782449|B3||White|Race (NIH/OMB)||Participants|Count of Participants|425|425.0||||||
3960299|NCT01319812|3782450|B2||White|Race (NIH/OMB)||Participants|Count of Participants|273|273.0||||||
3960300|NCT01319812|3782451|B1||White|Race (NIH/OMB)||Participants|Count of Participants|152|152.0||||||
3960301|NCT01319812|3782449|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3960302|NCT01319812|3782450|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3960303|NCT01319812|3782451|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3960304|NCT01319812|3782449|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960305|NCT01319812|3782450|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960306|NCT01319812|3782451|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960307|NCT01319812|3782449|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3960308|NCT01319812|3782450|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3960309|NCT01319812|3782451|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3960310|NCT01319812|3782449|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3960311|NCT01319812|3782450|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960312|NCT01319812|3782451|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3960313|NCT01319812|3782449|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960314|NCT01319812|3782450|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960315|NCT01319812|3782451|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960316|NCT01319812|3782449|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|424|424.0||||||
3960317|NCT01319812|3782450|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|281|281.0||||||
3960318|NCT01319812|3782451|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|143|143.0||||||
3960319|NCT01319812|3782449|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3960320|NCT01319812|3782450|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3960321|NCT01319812|3782451|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3960322|NCT01319812|3782449|B3||Male|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
3960323|NCT01319812|3782450|B2||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
3960324|NCT01319812|3782451|B1||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3960325|NCT01319812|3782449|B3||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3960326|NCT01319812|3782450|B2||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3960327|NCT01319812|3782451|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3960328|NCT01319812|3782449|B3|||Age||Years|Mean|NA||Standard Deviation|NA||||Study arms are independent with no overlap or comparison. A total would not present meaningful information and would be conflated by four subjects who were enrolled in both arms of the study.
3960329|NCT01319812|3782450|B2|||Age||Years|Mean|67.3|67.3|Standard Deviation|10.3|10.3|||
3960330|NCT01319812|3782451|B1|||Age||Years|Mean|63.6|63.6|Standard Deviation|10.1|10.1|||
3960331|NCT01319799|3782524|B1|Sweden||Region of Enrollment||participants|Number|10|10.0||||||
3960332|NCT01319799|3782524|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3960333|NCT01319799|3782524|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3960334|NCT01319799|3782524|B1|||Age||years|Mean|75|75.0|Standard Deviation|5|5.0|||
3960335|NCT01319799|3782524|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3960336|NCT01319799|3782524|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3960337|NCT01319799|3782524|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3960338|NCT01319773|3782529|B6||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3960339|NCT01319773|3782530|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3960340|NCT01319773|3782531|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3960341|NCT01319773|3782532|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3960342|NCT01319773|3782533|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3960343|NCT01319773|3782534|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3960344|NCT01319773|3782529|B6||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3960345|NCT01319773|3782530|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3960346|NCT01319773|3782531|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3960347|NCT01319773|3782532|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3960348|NCT01319773|3782533|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3960349|NCT01319773|3782534|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3960350|NCT01319773|3782529|B6|> 40 years||Age, Customized||participants|Number|20|20.0||||||
3960351|NCT01319773|3782530|B5|> 40 years||Age, Customized||participants|Number|7|7.0||||||
3960352|NCT01319773|3782531|B4|> 40 years||Age, Customized||participants|Number|6|6.0||||||
3960353|NCT01319773|3782532|B3|> 40 years||Age, Customized||participants|Number|7|7.0||||||
3960355|NCT01319773|3782534|B1|> 40 years||Age, Customized||participants|Number|0|0.0||||||
3960356|NCT01319773|3782529|B6|> 30 to 40 years||Age, Customized||participants|Number|5|5.0||||||
3960357|NCT01319773|3782530|B5|> 30 to 40 years||Age, Customized||participants|Number|0|0.0||||||
3960358|NCT01319773|3782531|B4|> 30 to 40 years||Age, Customized||participants|Number|1|1.0||||||
3960359|NCT01319773|3782532|B3|> 30 to 40 years||Age, Customized||participants|Number|0|0.0||||||
3960360|NCT01319773|3782533|B2|> 30 to 40 years||Age, Customized||participants|Number|2|2.0||||||
3960361|NCT01319773|3782534|B1|> 30 to 40 years||Age, Customized||participants|Number|2|2.0||||||
3960362|NCT01319773|3782529|B6|18 to 30 years||Age, Customized||participants|Number|19|19.0||||||
3960363|NCT01319773|3782530|B5|18 to 30 years||Age, Customized||participants|Number|1|1.0||||||
3960364|NCT01319773|3782531|B4|18 to 30 years||Age, Customized||participants|Number|1|1.0||||||
3960365|NCT01319773|3782532|B3|18 to 30 years||Age, Customized||participants|Number|1|1.0||||||
3960366|NCT01319773|3782533|B2|18 to 30 years||Age, Customized||participants|Number|8|8.0||||||
3960367|NCT01319773|3782534|B1|18 to 30 years||Age, Customized||participants|Number|8|8.0||||||
3960368|NCT01319721|3782552|B3|China||Region of Enrollment||eyes|Number|89|89.0||||||
3960369|NCT01319721|3782553|B2|China||Region of Enrollment||eyes|Number|42|42.0||||||
3960370|NCT01319721|3782554|B1|China||Region of Enrollment||eyes|Number|47|47.0||||||
3960371|NCT01319721|3782552|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3960372|NCT01319721|3782553|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3960373|NCT01319721|3782554|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3960374|NCT01319721|3782552|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3960375|NCT01319721|3782553|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3960376|NCT01319721|3782554|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3960377|NCT01319721|3782552|B3|||Age||years|Mean|54.1|54.1|Standard Deviation|11.8|11.8|||
3960378|NCT01319721|3782553|B2|||Age||years|Mean|55.3|55.3|Standard Deviation|11.5|11.5|||
3960379|NCT01319721|3782554|B1|||Age||years|Mean|53.1|53.1|Standard Deviation|12.2|12.2|||
3960380|NCT01319617|3782569|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
3960381|NCT01319617|3782569|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3960382|NCT01319617|3782569|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3960383|NCT01319617|3782569|B1|||Age||years|Mean|54.6|54.6|Standard Deviation|16.5|16.5|||
3960384|NCT01319617|3782569|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3960385|NCT01319617|3782569|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3960386|NCT01319617|3782569|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3960387|NCT01319552|3782573|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3960388|NCT01319552|3782573|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960389|NCT01319552|3782573|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960390|NCT01319552|3782573|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3960391|NCT01319552|3782573|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3960392|NCT01319552|3782573|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960393|NCT01319552|3782573|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3960394|NCT01319552|3782573|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960395|NCT01319552|3782573|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960396|NCT01319552|3782573|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3960397|NCT01319552|3782573|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3960398|NCT01319552|3782573|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3960399|NCT01319552|3782573|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3960400|NCT01319552|3782573|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3960401|NCT01319552|3782573|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3960402|NCT01319552|3782573|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3960403|NCT01319539|3782578|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3960404|NCT01319539|3782578|B1|Non-Hispanic Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3960405|NCT01319539|3782578|B1|Non-Hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3960406|NCT01319539|3782578|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3960407|NCT01319539|3782578|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3960408|NCT01319539|3782578|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3960409|NCT01319539|3782578|B1|||Age||years|Mean|53.2|53.2|Standard Deviation|11.2|11.2|||
3960410|NCT01319500|3782586|B3|Croatia||Region of Enrollment||participants|Number|3776|3776.0||||||
3960411|NCT01319500|3782587|B2|Croatia||Region of Enrollment||participants|Number|2589|2589.0||||||
3960412|NCT01319500|3782588|B1|Croatia||Region of Enrollment||participants|Number|1187|1187.0||||||
3960413|NCT01319500|3782586|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3960414|NCT01319500|3782587|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3960415|NCT01319500|3782588|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3960473|NCT01319422|3782606|B3|||lines of prior therapy||lines|Median|4|4.0|Full Range|||2.0|9.0|
3960416|NCT01319500|3782586|B3||Female|Sex: Female, Male||Participants|Count of Participants|3776|3776.0||||||
3960417|NCT01319500|3782587|B2||Female|Sex: Female, Male||Participants|Count of Participants|2589|2589.0||||||
3960418|NCT01319500|3782588|B1||Female|Sex: Female, Male||Participants|Count of Participants|1187|1187.0||||||
3960419|NCT01319500|3782586|B3|Missing||Age, Customized||participants|Number|62|62.0||||||
3960420|NCT01319500|3782587|B2|Missing||Age, Customized||participants|Number|50|50.0||||||
3960421|NCT01319500|3782588|B1|Missing||Age, Customized||participants|Number|12|12.0||||||
3960422|NCT01319500|3782586|B3|>=40 years||Age, Customized||participants|Number|90|90.0||||||
3960423|NCT01319500|3782587|B2|>=40 years||Age, Customized||participants|Number|79|79.0||||||
3960424|NCT01319500|3782588|B1|>=40 years||Age, Customized||participants|Number|11|11.0||||||
3960425|NCT01319500|3782586|B3|>=18 and <40 years||Age, Customized||participants|Number|3495|3495.0||||||
3960426|NCT01319500|3782587|B2|>=18 and <40 years||Age, Customized||participants|Number|2398|2398.0||||||
3960427|NCT01319500|3782588|B1|>=18 and <40 years||Age, Customized||participants|Number|1097|1097.0||||||
3960428|NCT01319500|3782586|B3|<18 years||Age, Customized||participants|Number|129|129.0||||||
3960429|NCT01319500|3782587|B2|<18 years||Age, Customized||participants|Number|62|62.0||||||
3960430|NCT01319500|3782588|B1|<18 years||Age, Customized||participants|Number|67|67.0||||||
3960431|NCT01319500|3782586|B3|||Age||years|Mean|25.7|25.7|Standard Deviation|6.0|6.0|||
3960432|NCT01319500|3782587|B2|||Age||years|Mean|26.5|26.5|Standard Deviation|6.3|6.3|||
3960433|NCT01319500|3782588|B1|||Age||years|Mean|23.8|23.8|Standard Deviation|5.0|5.0|||
3960434|NCT01319422|3782606|B3|no||Resistance to prior therapy-Len+bortezomib refractory||participants|Number|8|8.0||||||
3960435|NCT01319422|3782607|B2|no||Resistance to prior therapy-Len+bortezomib refractory||participants|Number|4|4.0||||||
3960436|NCT01319422|3782608|B1|no||Resistance to prior therapy-Len+bortezomib refractory||participants|Number|4|4.0||||||
3960437|NCT01319422|3782606|B3|yes||Resistance to prior therapy-Len+bortezomib refractory||participants|Number|31|31.0||||||
3960438|NCT01319422|3782607|B2|yes||Resistance to prior therapy-Len+bortezomib refractory||participants|Number|16|16.0||||||
3960439|NCT01319422|3782608|B1|yes||Resistance to prior therapy-Len+bortezomib refractory||participants|Number|15|15.0||||||
3960440|NCT01319422|3782606|B3|no||Resistance to prior therapy-Len refractory||participants|Number|0|0.0||||||
3960441|NCT01319422|3782607|B2|no||Resistance to prior therapy-Len refractory||participants|Number|0|0.0||||||
3960442|NCT01319422|3782608|B1|no||Resistance to prior therapy-Len refractory||participants|Number|0|0.0||||||
3960443|NCT01319422|3782606|B3|yes||Resistance to prior therapy-Len refractory||participants|Number|39|39.0||||||
3960444|NCT01319422|3782607|B2|yes||Resistance to prior therapy-Len refractory||participants|Number|20|20.0||||||
3960445|NCT01319422|3782608|B1|yes||Resistance to prior therapy-Len refractory||participants|Number|19|19.0||||||
3960446|NCT01319422|3782606|B3|no||Lenalidomide (Len) as most recent therapy||participants|Number|24|24.0||||||
3960447|NCT01319422|3782607|B2|no||Lenalidomide (Len) as most recent therapy||participants|Number|11|11.0||||||
3960448|NCT01319422|3782608|B1|no||Lenalidomide (Len) as most recent therapy||participants|Number|13|13.0||||||
3960449|NCT01319422|3782606|B3|yes||Lenalidomide (Len) as most recent therapy||participants|Number|15|15.0||||||
3960450|NCT01319422|3782607|B2|yes||Lenalidomide (Len) as most recent therapy||participants|Number|9|9.0||||||
3960451|NCT01319422|3782608|B1|yes||Lenalidomide (Len) as most recent therapy||participants|Number|6|6.0||||||
3960452|NCT01319422|3782606|B3|no||Deletion chromosome 13|Monosomy 13 on molecular cytogenics or deletion of 13q on fluorescence in situ hybridization (FISH) cytogenics|participants|Number|26|26.0||||||
3960453|NCT01319422|3782607|B2|no||Deletion chromosome 13|Monosomy 13 on molecular cytogenics or deletion of 13q on fluorescence in situ hybridization (FISH) cytogenics|participants|Number|12|12.0||||||
3960454|NCT01319422|3782608|B1|no||Deletion chromosome 13|Monosomy 13 on molecular cytogenics or deletion of 13q on fluorescence in situ hybridization (FISH) cytogenics|participants|Number|14|14.0||||||
3960455|NCT01319422|3782606|B3|yes||Deletion chromosome 13|Monosomy 13 on molecular cytogenics or deletion of 13q on fluorescence in situ hybridization (FISH) cytogenics|participants|Number|13|13.0||||||
3960456|NCT01319422|3782607|B2|yes||Deletion chromosome 13|Monosomy 13 on molecular cytogenics or deletion of 13q on fluorescence in situ hybridization (FISH) cytogenics|participants|Number|8|8.0||||||
3960457|NCT01319422|3782608|B1|yes||Deletion chromosome 13|Monosomy 13 on molecular cytogenics or deletion of 13q on fluorescence in situ hybridization (FISH) cytogenics|participants|Number|5|5.0||||||
3960458|NCT01319422|3782606|B3|no||Chromosome 1q abnormalities||participants|Number|21|21.0||||||
3960459|NCT01319422|3782607|B2|no||Chromosome 1q abnormalities||participants|Number|12|12.0||||||
3960460|NCT01319422|3782608|B1|no||Chromosome 1q abnormalities||participants|Number|9|9.0||||||
3960461|NCT01319422|3782606|B3|yes||Chromosome 1q abnormalities||participants|Number|18|18.0||||||
3960462|NCT01319422|3782607|B2|yes||Chromosome 1q abnormalities||participants|Number|8|8.0||||||
3960463|NCT01319422|3782608|B1|yes||Chromosome 1q abnormalities||participants|Number|10|10.0||||||
3960464|NCT01319422|3782606|B3|missing||Deletion of chromosome 17p||participants|Number|13|13.0||||||
3960465|NCT01319422|3782607|B2|missing||Deletion of chromosome 17p||participants|Number|8|8.0||||||
3960466|NCT01319422|3782608|B1|missing||Deletion of chromosome 17p||participants|Number|5|5.0||||||
3960467|NCT01319422|3782606|B3|no||Deletion of chromosome 17p||participants|Number|19|19.0||||||
3960468|NCT01319422|3782607|B2|no||Deletion of chromosome 17p||participants|Number|9|9.0||||||
3960469|NCT01319422|3782608|B1|no||Deletion of chromosome 17p||participants|Number|10|10.0||||||
3960470|NCT01319422|3782606|B3|yes||Deletion of chromosome 17p||participants|Number|7|7.0||||||
3960471|NCT01319422|3782607|B2|yes||Deletion of chromosome 17p||participants|Number|3|3.0||||||
3960472|NCT01319422|3782608|B1|yes||Deletion of chromosome 17p||participants|Number|4|4.0||||||
3960474|NCT01319422|3782607|B2|||lines of prior therapy||lines|Median|4|4.0|Full Range|||2.0|9.0|
3960475|NCT01319422|3782608|B1|||lines of prior therapy||lines|Median|4|4.0|Full Range|||2.0|7.0|
3960476|NCT01319422|3782606|B3|||serum albumin||g/dL|Mean|3.9|3.9|Full Range|||3.2|5.0|
3960477|NCT01319422|3782607|B2|||serum albumin||g/dL|Mean|3.9|3.9|Full Range|||3.2|4.8|
3960478|NCT01319422|3782608|B1|||serum albumin||g/dL|Mean|3.9|3.9|Full Range|||3.2|5.0|
3960479|NCT01319422|3782606|B3|||serum beta 2 microglobulin||mg/L|Mean|3.2|3.2|Full Range|||1.55|8.36|
3960480|NCT01319422|3782607|B2|||serum beta 2 microglobulin||mg/L|Mean|3.4|3.4|Full Range|||2.09|8.36|
3960481|NCT01319422|3782608|B1|||serum beta 2 microglobulin||mg/L|Mean|3.0|3.0|Full Range|||1.55|5.12|
3960482|NCT01319422|3782606|B3|lambda||Immunoglobulin Light chain (IgL) type||participants|Number|11|11.0||||||
3960483|NCT01319422|3782607|B2|lambda||Immunoglobulin Light chain (IgL) type||participants|Number|5|5.0||||||
3960484|NCT01319422|3782608|B1|lambda||Immunoglobulin Light chain (IgL) type||participants|Number|6|6.0||||||
3960485|NCT01319422|3782606|B3|kappa||Immunoglobulin Light chain (IgL) type||participants|Number|28|28.0||||||
3960486|NCT01319422|3782607|B2|kappa||Immunoglobulin Light chain (IgL) type||participants|Number|15|15.0||||||
3960487|NCT01319422|3782608|B1|kappa||Immunoglobulin Light chain (IgL) type||participants|Number|13|13.0||||||
3960488|NCT01319422|3782606|B3|Light chain only||Immunoglobulin Heavy chain (IgH) type||participants|Number|14|14.0||||||
3960489|NCT01319422|3782607|B2|Light chain only||Immunoglobulin Heavy chain (IgH) type||participants|Number|7|7.0||||||
3960490|NCT01319422|3782608|B1|Light chain only||Immunoglobulin Heavy chain (IgH) type||participants|Number|7|7.0||||||
3960491|NCT01319422|3782606|B3|Immunoglobulin A (IgA)||Immunoglobulin Heavy chain (IgH) type||participants|Number|5|5.0||||||
3960492|NCT01319422|3782607|B2|Immunoglobulin A (IgA)||Immunoglobulin Heavy chain (IgH) type||participants|Number|1|1.0||||||
3960493|NCT01319422|3782608|B1|Immunoglobulin A (IgA)||Immunoglobulin Heavy chain (IgH) type||participants|Number|4|4.0||||||
3960494|NCT01319422|3782606|B3|Immunoglobulin G (IgG)||Immunoglobulin Heavy chain (IgH) type||participants|Number|20|20.0||||||
3960495|NCT01319422|3782607|B2|Immunoglobulin G (IgG)||Immunoglobulin Heavy chain (IgH) type||participants|Number|12|12.0||||||
3960496|NCT01319422|3782608|B1|Immunoglobulin G (IgG)||Immunoglobulin Heavy chain (IgH) type||participants|Number|8|8.0||||||
3960497|NCT01319422|3782606|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3960498|NCT01319422|3782607|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3960499|NCT01319422|3782608|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3960500|NCT01319422|3782606|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3960501|NCT01319422|3782607|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3960502|NCT01319422|3782608|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3960503|NCT01319422|3782606|B3|||Age||years|Median|61|61.0|Full Range|||44.0|87.0|
3960504|NCT01319422|3782607|B2|||Age||years|Median|61|61.0|Full Range|||47.0|80.0|
3960505|NCT01319422|3782608|B1|||Age||years|Median|63|63.0|Full Range|||44.0|87.0|
3960506|NCT01319396|3782623|B1|Ireland||Region of Enrollment||participants|Number|15|15.0||||||
3960507|NCT01319396|3782623|B1|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
3960508|NCT01319396|3782623|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3960509|NCT01319396|3782623|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3960510|NCT01319396|3782623|B1|||Age||years|Mean|40.6|40.6|Standard Deviation|14.1|14.1|||
3960511|NCT01319396|3782623|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3960512|NCT01319396|3782623|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3960513|NCT01319396|3782623|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3960514|NCT01319383|3782627|B1|||CD4 Cell Count||cells/µL|Median|718|718.0|Full Range|||402.0|1302.0|
3960515|NCT01319383|3782627|B1|||CD4 Nadir||cells/µL|Median|403|403.0|Full Range|||49.0|879.0|
3960516|NCT01319383|3782627|B1|>= 50 copies/mL||HIV-1 RNA Categories||Participants|Count of Participants|0|0.0||||||
3960517|NCT01319383|3782627|B1|< 50 copies/mL||HIV-1 RNA Categories||Participants|Count of Participants|25|25.0||||||
3960518|NCT01319383|3782627|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3960519|NCT01319383|3782627|B1|Caucasian or White||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
3960520|NCT01319383|3782627|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3960521|NCT01319383|3782627|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3960522|NCT01319383|3782627|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3960523|NCT01319383|3782627|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3960524|NCT01319383|3782627|B1|||Age||years|Median|49|49.0|Full Range|||23.0|65.0|
3960525|NCT01319383|3782627|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3960526|NCT01319383|3782627|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3960527|NCT01319383|3782627|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3960528|NCT01319318|3782645|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3960529|NCT01319318|3782645|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3960530|NCT01319318|3782645|B1|||Age||Years|Mean|69.6|69.6|Standard Deviation|10.06|10.06|47.0|90.0|
3960531|NCT01319110|3782649|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3960532|NCT01319110|3782650|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3960533|NCT01319110|3782651|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3960534|NCT01319110|3782649|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3960535|NCT01319110|3782650|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3960536|NCT01319110|3782651|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3960537|NCT01319110|3782649|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3960538|NCT01319110|3782650|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3960539|NCT01319110|3782651|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3960540|NCT01319110|3782649|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3960541|NCT01319110|3782650|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3960542|NCT01319110|3782651|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3960543|NCT01319110|3782649|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3960544|NCT01319110|3782650|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3960545|NCT01319110|3782651|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3960546|NCT01319045|3782660|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3960547|NCT01319045|3782660|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3960548|NCT01319045|3782660|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3960549|NCT01319045|3782660|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3960550|NCT01319045|3782660|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3960551|NCT01318993|3782667|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960552|NCT01318993|3782667|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3960553|NCT01318993|3782667|B1||White|Race (NIH/OMB)||Participants|Count of Participants|351|351.0||||||
3960554|NCT01318993|3782667|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3960555|NCT01318993|3782667|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960556|NCT01318993|3782667|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3960557|NCT01318993|3782667|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3960558|NCT01318993|3782667|B1||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
3960559|NCT01318993|3782667|B1||Female|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
3960560|NCT01318993|3782667|B1|||Age||Years|Mean|36.5|36.5|Standard Deviation|11.99|11.99|||
3960561|NCT01318967|3782683|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3960562|NCT01318967|3782683|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3960563|NCT01318967|3782683|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3960564|NCT01318967|3782683|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3960565|NCT01318967|3782683|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3960566|NCT01318967|3782683|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3960567|NCT01318915|3782688|B1|||Glucose|The glucose collected on the day of transplant. If there is no value recorded on the day of transplant, the value from the screening visit is used. Glucose, a sugar, is an energy source that the body relies on to properly function. If levels are too high for a long period of time, diabetes can develop. Diabetes can result in many long-term complications such as eye, kidney, and nerve damage, stroke, and cardiovascular complications. Fasting levels for glucose should be around 70-99 mg/dL and less than 140 mg/dL within 2 hours after a meal.|mg/dL|Mean|102.0|102.0|Standard Deviation|22.57|22.57|||
3960568|NCT01318915|3782688|B1|||Total Cholesterol|The total cholesterol collected on the day of transplant. If there is no value recorded on the day of transplant, the value from the screening visit is used. Total cholesterol measures the amount of cholesterol found in the blood. Cholesterol is a waxy substance your body needs to build cells, but too much can be a problem since it can build-up in arteries. Narrowed arteries can result in heart attack or stroke. A value less than 200 mg/dL is considered good.|mg/dL|Mean|181.6|181.6|Standard Deviation|67.10|67.1|||
3960569|NCT01318915|3782688|B1|||Diastolic Blood Pressure|The diastolic blood pressure collected on the day of transplant. If there is no value recorded on the day of transplant, the value from the screening visit is used. Diastolic blood pressure measures the pressure in the arteries when the heart is at rest and is thus filled with blood. A normal diastolic blood pressure is lower than 80 mmHg. High blood pressure, as known as hypertension, is a risk factor for coronary artery disease, stroke, heart failure, and other complications if left unmanaged.|mmHg|Mean|82.5|82.5|Standard Deviation|15.01|15.01|||
3960570|NCT01318915|3782688|B1|||Systolic Blood Pressure|The systolic blood pressure collected on the day of transplant. If there is no value recorded on the day of transplant, the value from the screening visit is used. Systolic blood pressure measures the pressure on the blood vessels when the heart is beats and thus is pushing blood to the rest of the body. A normal systolic blood pressure is lower than 120 mmHg. High blood pressure, also known as hypertension, is a risk factor for coronary artery disease, stroke, heart failure, and other complications if left unmanaged.|mmHg|Mean|142.3|142.3|Standard Deviation|21.27|21.27|||
3960571|NCT01318915|3782688|B1|||eGFR|Glomerular filtration rate (GFR) is a measure of kidney function and helps determine the stage of kidney disease. The equation developed by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) is used to estimate GFR (e.g., eGFR) from serum creatinine. Baseline serum creatinine was used in the equation, which is the average of the lowest three creatinine values during 2 to 4 weeks post-transplant, excluding days on dialysis.|mg/dL|Mean|55.1|55.1|Standard Deviation|20.79|20.79|||
3960620|NCT01318538|3782785|B1|Employment||Addiction Severity Index (ASI) composite scores|The Addiction Severity Index (ASI) is a multidimensional assessment of substance-related problems which yields composite scores for alcohol use, drug use, psychiatric status, medical status, legal status, family/social relationships, and employment status. Composite scores range from 0 to 1, with higher scores indicating more significant problems.|units on a scale from 0-1|Mean|0.42|0.42|Standard Deviation|0.24|0.24|||
3960572|NCT01318915|3782688|B1|||Serum Creatinine|Serum creatinine provides an estimate of how well the kidneys filter (glomerular filtration rate). Higher results= poorer kidney function. The baseline creatinine interval per protocol is defined as the 2 to 4 week interval post-kidney transplant and is calculated using the lowest N=3 serum creatinine values during this pre-defined interval, the interval prior to immunosuppressive maintenance withdrawal (IMW) initiation. Normal values: Adult males, 0.7 to 1.3 mg/dL; adult females, 0.6 to 1.1 mg/dL.|mg/dL|Mean|1.7|1.7|Standard Deviation|0.73|0.73|||
3960573|NCT01318915|3782688|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3960574|NCT01318915|3782688|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960575|NCT01318915|3782688|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960576|NCT01318915|3782688|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3960577|NCT01318915|3782688|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3960578|NCT01318915|3782688|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3960579|NCT01318915|3782688|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960580|NCT01318915|3782688|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960581|NCT01318915|3782688|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960582|NCT01318915|3782688|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3960583|NCT01318915|3782688|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960584|NCT01318915|3782688|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3960585|NCT01318915|3782688|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3960586|NCT01318915|3782688|B1|||Age||years|Mean|36.6|36.6|Standard Deviation|13.7|13.7|||
3960587|NCT01318915|3782688|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3960588|NCT01318915|3782688|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3960589|NCT01318915|3782688|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3960590|NCT01318876|3782713|B1||Male|Sex: Female, Male||Participants|Count of Participants|1630|1630.0||||||
3960591|NCT01318876|3782713|B1||Female|Sex: Female, Male||Participants|Count of Participants|4639|4639.0||||||
3960592|NCT01318876|3782713|B1|||Age||years|Mean|41.77|41.77|Standard Deviation|11.87|11.87|||
3960593|NCT01318876|3782713|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3960594|NCT01318876|3782713|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6269|6269.0||||||
3960595|NCT01318876|3782713|B1||<=18 years|Age||Participants|Count of Participants|NA|||||||participants under 18 years old were not recruted.
3960596|NCT01318733|3782718|B1|United States||Region of Enrollment||participants|Number|449|449.0||||||
3960597|NCT01318733|3782718|B1||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3960598|NCT01318733|3782718|B1||Female|Sex: Female, Male||Participants|Count of Participants|336|336.0||||||
3960599|NCT01318733|3782718|B1|||Age||years|Mean|50.9|50.9|Standard Deviation|12.08|12.08|||
3960600|NCT01318733|3782718|B1||>=65 years|Age||Participants|Count of Participants|54|54.0||||||
3960601|NCT01318733|3782718|B1||Between 18 and 65 years|Age||Participants|Count of Participants|395|395.0||||||
3960602|NCT01318733|3782718|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3960603|NCT01318694|3782722|B5||Male|Sex: Female, Male||Participants|Count of Participants|610|610.0||||||
3960604|NCT01318694|3782723|B4||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3960605|NCT01318694|3782724|B3||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3960606|NCT01318694|3782725|B2||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3960607|NCT01318694|3782726|B1||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3960608|NCT01318694|3782722|B5||Female|Sex: Female, Male||Participants|Count of Participants|467|467.0||||||
3960609|NCT01318694|3782723|B4||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3960610|NCT01318694|3782724|B3||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3960611|NCT01318694|3782725|B2||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3960612|NCT01318694|3782726|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3960613|NCT01318694|3782722|B5|||Age||years|Mean|45.9|45.9|Standard Deviation|11.67|11.67|||
3960614|NCT01318694|3782723|B4|||Age||years|Mean|46.3|46.3|Standard Deviation|11.53|11.53|||
3960615|NCT01318694|3782724|B3|||Age||years|Mean|45.5|45.5|Standard Deviation|12.15|12.15|||
3960616|NCT01318694|3782725|B2|||Age||years|Mean|45.8|45.8|Standard Deviation|11.95|11.95|||
3960617|NCT01318694|3782726|B1|||Age||years|Mean|45.9|45.9|Standard Deviation|11.08|11.08|||
3960618|NCT01318538|3782783|B3|Employment||Addiction Severity Index (ASI) composite scores|The Addiction Severity Index (ASI) is a multidimensional assessment of substance-related problems which yields composite scores for alcohol use, drug use, psychiatric status, medical status, legal status, family/social relationships, and employment status. Composite scores range from 0 to 1, with higher scores indicating more significant problems.|units on a scale from 0-1|Mean|0.43|0.43|Standard Deviation|0.27|0.27|||
3960619|NCT01318538|3782784|B2|Employment||Addiction Severity Index (ASI) composite scores|The Addiction Severity Index (ASI) is a multidimensional assessment of substance-related problems which yields composite scores for alcohol use, drug use, psychiatric status, medical status, legal status, family/social relationships, and employment status. Composite scores range from 0 to 1, with higher scores indicating more significant problems.|units on a scale from 0-1|Mean|0.43|0.43|Standard Deviation|0.29|0.29|||
3960680|NCT01318538|3782785|B1|Cocaine lifetime||Substance use diagnoses||participants|Number|17|17.0||||||
3960681|NCT01318538|3782783|B3|Cocaine current||Substance use diagnoses||participants|Number|28|28.0||||||
3960621|NCT01318538|3782783|B3|Family||Addiction Severity Index (ASI) composite scores|The Addiction Severity Index (ASI) is a multidimensional assessment of substance-related problems which yields composite scores for alcohol use, drug use, psychiatric status, medical status, legal status, family/social relationships, and employment status. Composite scores range from 0 to 1, with higher scores indicating more significant problems.|units on a scale from 0-1|Mean|0.26|0.26|Standard Deviation|0.39|0.39|||
3960622|NCT01318538|3782784|B2|Family||Addiction Severity Index (ASI) composite scores|The Addiction Severity Index (ASI) is a multidimensional assessment of substance-related problems which yields composite scores for alcohol use, drug use, psychiatric status, medical status, legal status, family/social relationships, and employment status. Composite scores range from 0 to 1, with higher scores indicating more significant problems.|units on a scale from 0-1|Mean|0.24|0.24|Standard Deviation|0.28|0.28|||
3960623|NCT01318538|3782785|B1|Family||Addiction Severity Index (ASI) composite scores|The Addiction Severity Index (ASI) is a multidimensional assessment of substance-related problems which yields composite scores for alcohol use, drug use, psychiatric status, medical status, legal status, family/social relationships, and employment status. Composite scores range from 0 to 1, with higher scores indicating more significant problems.|units on a scale from 0-1|Mean|0.29|0.29|Standard Deviation|0.55|0.55|||
3960624|NCT01318538|3782783|B3|Legal||Addiction Severity Index (ASI) composite scores|The Addiction Severity Index (ASI) is a multidimensional assessment of substance-related problems which yields composite scores for alcohol use, drug use, psychiatric status, medical status, legal status, family/social relationships, and employment status. Composite scores range from 0 to 1, with higher scores indicating more significant problems.|units on a scale from 0-1|Mean|0.07|0.07|Standard Deviation|0.56|0.56|||
3960625|NCT01318538|3782784|B2|Legal||Addiction Severity Index (ASI) composite scores|The Addiction Severity Index (ASI) is a multidimensional assessment of substance-related problems which yields composite scores for alcohol use, drug use, psychiatric status, medical status, legal status, family/social relationships, and employment status. Composite scores range from 0 to 1, with higher scores indicating more significant problems.|units on a scale from 0-1|Mean|0.09|0.09|Standard Deviation|0.68|0.68|||
3960626|NCT01318538|3782785|B1|Legal||Addiction Severity Index (ASI) composite scores|The Addiction Severity Index (ASI) is a multidimensional assessment of substance-related problems which yields composite scores for alcohol use, drug use, psychiatric status, medical status, legal status, family/social relationships, and employment status. Composite scores range from 0 to 1, with higher scores indicating more significant problems.|units on a scale from 0-1|Mean|0.04|0.04|Standard Deviation|0.11|0.11|||
3960627|NCT01318538|3782783|B3|Psychiatric||Addiction Severity Index (ASI) composite scores|The Addiction Severity Index (ASI) is a multidimensional assessment of substance-related problems which yields composite scores for alcohol use, drug use, psychiatric status, medical status, legal status, family/social relationships, and employment status. Composite scores range from 0 to 1, with higher scores indicating more significant problems.|units on a scale from 0-1|Mean|0.21|0.21|Standard Deviation|0.19|0.19|||
3960628|NCT01318538|3782784|B2|Psychiatric||Addiction Severity Index (ASI) composite scores|The Addiction Severity Index (ASI) is a multidimensional assessment of substance-related problems which yields composite scores for alcohol use, drug use, psychiatric status, medical status, legal status, family/social relationships, and employment status. Composite scores range from 0 to 1, with higher scores indicating more significant problems.|units on a scale from 0-1|Mean|0.19|0.19|Standard Deviation|0.19|0.19|||
3960629|NCT01318538|3782785|B1|Psychiatric||Addiction Severity Index (ASI) composite scores|The Addiction Severity Index (ASI) is a multidimensional assessment of substance-related problems which yields composite scores for alcohol use, drug use, psychiatric status, medical status, legal status, family/social relationships, and employment status. Composite scores range from 0 to 1, with higher scores indicating more significant problems.|units on a scale from 0-1|Mean|0.25|0.25|Standard Deviation|0.20|0.2|||
3960630|NCT01318538|3782783|B3|Medical||Addiction Severity Index (ASI) composite scores|The Addiction Severity Index (ASI) is a multidimensional assessment of substance-related problems which yields composite scores for alcohol use, drug use, psychiatric status, medical status, legal status, family/social relationships, and employment status. Composite scores range from 0 to 1, with higher scores indicating more significant problems.|units on a scale from 0-1|Mean|0.18|0.18|Standard Deviation|0.26|0.26|||
3960631|NCT01318538|3782784|B2|Medical||Addiction Severity Index (ASI) composite scores|The Addiction Severity Index (ASI) is a multidimensional assessment of substance-related problems which yields composite scores for alcohol use, drug use, psychiatric status, medical status, legal status, family/social relationships, and employment status. Composite scores range from 0 to 1, with higher scores indicating more significant problems.|units on a scale from 0-1|Mean|0.18|0.18|Standard Deviation|0.27|0.27|||
3960632|NCT01318538|3782785|B1|Medical||Addiction Severity Index (ASI) composite scores|The Addiction Severity Index (ASI) is a multidimensional assessment of substance-related problems which yields composite scores for alcohol use, drug use, psychiatric status, medical status, legal status, family/social relationships, and employment status. Composite scores range from 0 to 1, with higher scores indicating more significant problems.|units on a scale from 0-1|Mean|0.18|0.18|Standard Deviation|0.24|0.24|||
3960633|NCT01318538|3782783|B3|Drug||Addiction Severity Index (ASI) composite scores|The Addiction Severity Index (ASI) is a multidimensional assessment of substance-related problems which yields composite scores for alcohol use, drug use, psychiatric status, medical status, legal status, family/social relationships, and employment status. Composite scores range from 0 to 1, with higher scores indicating more significant problems.|units on a scale from 0-1|Mean|0.08|0.08|Standard Deviation|0.13|0.13|||
3960634|NCT01318538|3782784|B2|Drug||Addiction Severity Index (ASI) composite scores|The Addiction Severity Index (ASI) is a multidimensional assessment of substance-related problems which yields composite scores for alcohol use, drug use, psychiatric status, medical status, legal status, family/social relationships, and employment status. Composite scores range from 0 to 1, with higher scores indicating more significant problems.|units on a scale from 0-1|Mean|0.08|0.08|Standard Deviation|0.15|0.15|||
3960635|NCT01318538|3782785|B1|Drug||Addiction Severity Index (ASI) composite scores|The Addiction Severity Index (ASI) is a multidimensional assessment of substance-related problems which yields composite scores for alcohol use, drug use, psychiatric status, medical status, legal status, family/social relationships, and employment status. Composite scores range from 0 to 1, with higher scores indicating more significant problems.|units on a scale from 0-1|Mean|0.07|0.07|Standard Deviation|0.11|0.11|||
3960636|NCT01318538|3782783|B3|Alcohol||Addiction Severity Index (ASI) composite scores|The Addiction Severity Index (ASI) is a multidimensional assessment of substance-related problems which yields composite scores for alcohol use, drug use, psychiatric status, medical status, legal status, family/social relationships, and employment status. Composite scores range from 0 to 1, with higher scores indicating more significant problems.|units on a scale from 0-1|Mean|0.52|0.52|Standard Deviation|0.30|0.3|||
3960637|NCT01318538|3782784|B2|Alcohol||Addiction Severity Index (ASI) composite scores|The Addiction Severity Index (ASI) is a multidimensional assessment of substance-related problems which yields composite scores for alcohol use, drug use, psychiatric status, medical status, legal status, family/social relationships, and employment status. Composite scores range from 0 to 1, with higher scores indicating more significant problems.|units on a scale from 0-1|Mean|0.55|0.55|Standard Deviation|0.29|0.29|||
3960638|NCT01318538|3782785|B1|Alcohol||Addiction Severity Index (ASI) composite scores|The Addiction Severity Index (ASI) is a multidimensional assessment of substance-related problems which yields composite scores for alcohol use, drug use, psychiatric status, medical status, legal status, family/social relationships, and employment status. Composite scores range from 0 to 1, with higher scores indicating more significant problems.|units on a scale from 0-1|Mean|0.47|0.47|Standard Deviation|0.33|0.33|||
3960639|NCT01318538|3782783|B3|Controlled environment days||Substance use days (past 30 days)||Days|Mean|.30|0.3|Standard Deviation|1.4|1.4|||
3960640|NCT01318538|3782784|B2|Controlled environment days||Substance use days (past 30 days)||Days|Mean|0.26|0.26|Standard Deviation|1.3|1.3|||
3960641|NCT01318538|3782785|B1|Controlled environment days||Substance use days (past 30 days)||Days|Mean|0.38|0.38|Standard Deviation|1.6|1.6|||
3960642|NCT01318538|3782783|B3|Drinks per drinking day||Substance use days (past 30 days)||Days|Mean|10.0|10.0|Standard Deviation|6.8|6.8|||
3960643|NCT01318538|3782784|B2|Drinks per drinking day||Substance use days (past 30 days)||Days|Mean|11.3|11.3|Standard Deviation|7.1|7.1|||
3960644|NCT01318538|3782785|B1|Drinks per drinking day||Substance use days (past 30 days)||Days|Mean|7.0|7.0|Standard Deviation|5.0|5.0|||
3960645|NCT01318538|3782783|B3|Heavy drinking days||Substance use days (past 30 days)||Days|Mean|12.3|12.3|Standard Deviation|10.6|10.6|||
3960646|NCT01318538|3782784|B2|Heavy drinking days||Substance use days (past 30 days)||Days|Mean|13.5|13.5|Standard Deviation|10.6|10.6|||
3960647|NCT01318538|3782785|B1|Heavy drinking days||Substance use days (past 30 days)||Days|Mean|9.8|9.8|Standard Deviation|9.7|9.7|||
3960648|NCT01318538|3782783|B3|Primary substance use days||Substance use days (past 30 days)||Days|Mean|14.9|14.9|Standard Deviation|10.3|10.3|||
3960649|NCT01318538|3782784|B2|Primary substance use days||Substance use days (past 30 days)||Days|Mean|15.7|15.7|Standard Deviation|10.4|10.4|||
3960650|NCT01318538|3782785|B1|Primary substance use days||Substance use days (past 30 days)||Days|Mean|13.4|13.4|Standard Deviation|9.9|9.9|||
3960651|NCT01318538|3782783|B3|Drug use days (excluding alcohol)||Substance use days (past 30 days)||Days|Mean|4.8|4.8|Standard Deviation|9.0|9.0|||
3960652|NCT01318538|3782784|B2|Drug use days (excluding alcohol)||Substance use days (past 30 days)||Days|Mean|4.8|4.8|Standard Deviation|9.0|9.0|||
3960653|NCT01318538|3782785|B1|Drug use days (excluding alcohol)||Substance use days (past 30 days)||Days|Mean|4.8|4.8|Standard Deviation|9.2|9.2|||
3960654|NCT01318538|3782783|B3|Days of any substance use (including alcohol)||Substance use days (past 30 days)||Days|Mean|17.3|17.3|Standard Deviation|9.6|9.6|||
3960655|NCT01318538|3782784|B2|Days of any substance use (including alcohol)||Substance use days (past 30 days)||Days|Mean|17.8|17.8|Standard Deviation|9.8|9.8|||
3960656|NCT01318538|3782785|B1|Days of any substance use (including alcohol)||Substance use days (past 30 days)||Days|Mean|16.5|16.5|Standard Deviation|9.3|9.3|||
3960657|NCT01318538|3782783|B3|Alcohol use days||Substance use days (past 30 days)||Days|Mean|14.6|14.6|Standard Deviation|10.3|10.3|||
3960658|NCT01318538|3782784|B2|Alcohol use days||Substance use days (past 30 days)||Days|Mean|15.4|15.4|Standard Deviation|10.5|10.5|||
3960659|NCT01318538|3782785|B1|Alcohol use days||Substance use days (past 30 days)||Days|Mean|12.7|12.7|Standard Deviation|9.9|9.9|||
3960660|NCT01318538|3782783|B3|Sedatives lifetime||Substance use diagnoses||participants|Number|22|22.0||||||
3960661|NCT01318538|3782784|B2|Sedatives lifetime||Substance use diagnoses||participants|Number|17|17.0||||||
3960662|NCT01318538|3782785|B1|Sedatives lifetime||Substance use diagnoses||participants|Number|5|5.0||||||
3960663|NCT01318538|3782783|B3|Sedatives current||Substance use diagnoses||participants|Number|16|16.0||||||
3960664|NCT01318538|3782784|B2|Sedatives current||Substance use diagnoses||participants|Number|11|11.0||||||
3960665|NCT01318538|3782785|B1|Sedatives current||Substance use diagnoses||participants|Number|5|5.0||||||
3960666|NCT01318538|3782783|B3|Opioids lifetime||Substance use diagnoses||participants|Number|40|40.0||||||
3960667|NCT01318538|3782784|B2|Opioids lifetime||Substance use diagnoses||participants|Number|27|27.0||||||
3960668|NCT01318538|3782785|B1|Opioids lifetime||Substance use diagnoses||participants|Number|13|13.0||||||
3960669|NCT01318538|3782783|B3|Opioids current||Substance use diagnoses||participants|Number|26|26.0||||||
3960670|NCT01318538|3782784|B2|Opioids current||Substance use diagnoses||participants|Number|19|19.0||||||
3960671|NCT01318538|3782785|B1|Opioids current||Substance use diagnoses||participants|Number|7|7.0||||||
3960672|NCT01318538|3782783|B3|Cannabis lifetime||Substance use diagnoses||participants|Number|34|34.0||||||
3960673|NCT01318538|3782784|B2|Cannabis lifetime||Substance use diagnoses||participants|Number|27|27.0||||||
3960674|NCT01318538|3782785|B1|Cannabis lifetime||Substance use diagnoses||participants|Number|7|7.0||||||
3960675|NCT01318538|3782783|B3|Cannabis current||Substance use diagnoses||participants|Number|19|19.0||||||
3960676|NCT01318538|3782784|B2|Cannabis current||Substance use diagnoses||participants|Number|16|16.0||||||
3960677|NCT01318538|3782785|B1|Cannabis current||Substance use diagnoses||participants|Number|3|3.0||||||
3960678|NCT01318538|3782783|B3|Cocaine lifetime||Substance use diagnoses||participants|Number|57|57.0||||||
3960679|NCT01318538|3782784|B2|Cocaine lifetime||Substance use diagnoses||participants|Number|40|40.0||||||
3960682|NCT01318538|3782784|B2|Cocaine current||Substance use diagnoses||participants|Number|20|20.0||||||
3960683|NCT01318538|3782785|B1|Cocaine current||Substance use diagnoses||participants|Number|8|8.0||||||
3960684|NCT01318538|3782783|B3|Alcohol lifetime||Substance use diagnoses||participants|Number|146|146.0||||||
3960685|NCT01318538|3782784|B2|Alcohol lifetime||Substance use diagnoses||participants|Number|101|101.0||||||
3960686|NCT01318538|3782785|B1|Alcohol lifetime||Substance use diagnoses||participants|Number|45|45.0||||||
3960687|NCT01318538|3782783|B3|Alcohol current||Substance use diagnoses||participants|Number|140|140.0||||||
3960688|NCT01318538|3782784|B2|Alcohol current||Substance use diagnoses||participants|Number|97|97.0||||||
3960689|NCT01318538|3782785|B1|Alcohol current||Substance use diagnoses||participants|Number|43|43.0||||||
3960690|NCT01318538|3782783|B3|Any Axis II||Current psychiatric diagnoses||participants|Number|24|24.0||||||
3960691|NCT01318538|3782784|B2|Any Axis II||Current psychiatric diagnoses||participants|Number|15|15.0||||||
3960692|NCT01318538|3782785|B1|Any Axis II||Current psychiatric diagnoses||participants|Number|9|9.0||||||
3960693|NCT01318538|3782783|B3|Any Axis I||Current psychiatric diagnoses||participants|Number|116|116.0||||||
3960694|NCT01318538|3782784|B2|Any Axis I||Current psychiatric diagnoses||participants|Number|79|79.0||||||
3960695|NCT01318538|3782785|B1|Any Axis I||Current psychiatric diagnoses||participants|Number|37|37.0||||||
3960696|NCT01318538|3782783|B3|Post-traumatic stress disorder||Current psychiatric diagnoses||participants|Number|29|29.0||||||
3960697|NCT01318538|3782784|B2|Post-traumatic stress disorder||Current psychiatric diagnoses||participants|Number|20|20.0||||||
3960698|NCT01318538|3782785|B1|Post-traumatic stress disorder||Current psychiatric diagnoses||participants|Number|9|9.0||||||
3960699|NCT01318538|3782783|B3|Generalized anxiety disorder||Current psychiatric diagnoses||participants|Number|31|31.0||||||
3960700|NCT01318538|3782784|B2|Generalized anxiety disorder||Current psychiatric diagnoses||participants|Number|20|20.0||||||
3960701|NCT01318538|3782785|B1|Generalized anxiety disorder||Current psychiatric diagnoses||participants|Number|11|11.0||||||
3960702|NCT01318538|3782783|B3|Major depressive disorder||Current psychiatric diagnoses||participants|Number|88|88.0||||||
3960703|NCT01318538|3782784|B2|Major depressive disorder||Current psychiatric diagnoses||participants|Number|58|58.0||||||
3960704|NCT01318538|3782785|B1|Major depressive disorder||Current psychiatric diagnoses||participants|Number|30|30.0||||||
3960705|NCT01318538|3782783|B3|More than $100,000||Household Income||participants|Number|36|36.0||||||
3960706|NCT01318538|3782784|B2|More than $100,000||Household Income||participants|Number|21|21.0||||||
3960707|NCT01318538|3782785|B1|More than $100,000||Household Income||participants|Number|15|15.0||||||
3960708|NCT01318538|3782783|B3|$50,001-$100,000||Household Income||participants|Number|39|39.0||||||
3960709|NCT01318538|3782784|B2|$50,001-$100,000||Household Income||participants|Number|28|28.0||||||
3960710|NCT01318538|3782785|B1|$50,001-$100,000||Household Income||participants|Number|11|11.0||||||
3960711|NCT01318538|3782783|B3|$20,001-$50,000||Household Income||participants|Number|40|40.0||||||
3960712|NCT01318538|3782784|B2|$20,001-$50,000||Household Income||participants|Number|31|31.0||||||
3960713|NCT01318538|3782785|B1|$20,001-$50,000||Household Income||participants|Number|9|9.0||||||
3960714|NCT01318538|3782783|B3|$0-$20,000||Household Income||participants|Number|43|43.0||||||
3960715|NCT01318538|3782784|B2|$0-$20,000||Household Income||participants|Number|26|26.0||||||
3960716|NCT01318538|3782785|B1|$0-$20,000||Household Income||participants|Number|17|17.0||||||
3960717|NCT01318538|3782783|B3|Postgraduate||Education||participants|Number|33|33.0||||||
3960718|NCT01318538|3782784|B2|Postgraduate||Education||participants|Number|21|21.0||||||
3960719|NCT01318538|3782785|B1|Postgraduate||Education||participants|Number|12|12.0||||||
3960720|NCT01318538|3782783|B3|Graduated from college||Education||participants|Number|52|52.0||||||
3960721|NCT01318538|3782784|B2|Graduated from college||Education||participants|Number|34|34.0||||||
3960722|NCT01318538|3782785|B1|Graduated from college||Education||participants|Number|18|18.0||||||
3960723|NCT01318538|3782783|B3|Some college||Education||participants|Number|33|33.0||||||
3960724|NCT01318538|3782784|B2|Some college||Education||participants|Number|22|22.0||||||
3960725|NCT01318538|3782785|B1|Some college||Education||participants|Number|11|11.0||||||
3960726|NCT01318538|3782783|B3|Graduated high school||Education||participants|Number|29|29.0||||||
3960727|NCT01318538|3782784|B2|Graduated high school||Education||participants|Number|22|22.0||||||
3960728|NCT01318538|3782785|B1|Graduated high school||Education||participants|Number|7|7.0||||||
3960729|NCT01318538|3782783|B3|Did not graduate high school||Education||participants|Number|11|11.0||||||
3960730|NCT01318538|3782784|B2|Did not graduate high school||Education||participants|Number|7|7.0||||||
3960731|NCT01318538|3782785|B1|Did not graduate high school||Education||participants|Number|4|4.0||||||
3960732|NCT01318538|3782783|B3|Widowed||Marital Status||participants|Number|3|3.0||||||
3960733|NCT01318538|3782784|B2|Widowed||Marital Status||participants|Number|3|3.0||||||
3960734|NCT01318538|3782785|B1|Widowed||Marital Status||participants|Number|0|0.0||||||
3960735|NCT01318538|3782783|B3|Unmarried and living with partner||Marital Status||participants|Number|9|9.0||||||
3960736|NCT01318538|3782784|B2|Unmarried and living with partner||Marital Status||participants|Number|5|5.0||||||
3960737|NCT01318538|3782785|B1|Unmarried and living with partner||Marital Status||participants|Number|4|4.0||||||
3960738|NCT01318538|3782783|B3|Never married||Marital Status||participants|Number|42|42.0||||||
3960739|NCT01318538|3782784|B2|Never married||Marital Status||participants|Number|30|30.0||||||
3960740|NCT01318538|3782785|B1|Never married||Marital Status||participants|Number|12|12.0||||||
3960741|NCT01318538|3782783|B3|Divorced/Separated||Marital Status||participants|Number|44|44.0||||||
3960742|NCT01318538|3782784|B2|Divorced/Separated||Marital Status||participants|Number|27|27.0||||||
3960743|NCT01318538|3782785|B1|Divorced/Separated||Marital Status||participants|Number|17|17.0||||||
3960744|NCT01318538|3782783|B3|Married||Marital Status||participants|Number|60|60.0||||||
3960745|NCT01318538|3782784|B2|Married||Marital Status||participants|Number|41|41.0||||||
3960746|NCT01318538|3782785|B1|Married||Marital Status||participants|Number|19|19.0||||||
3960747|NCT01318538|3782783|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960748|NCT01318538|3782784|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960749|NCT01318538|3782785|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960750|NCT01318538|3782783|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960751|NCT01318538|3782784|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960752|NCT01318538|3782785|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960753|NCT01318538|3782783|B3||White|Race (NIH/OMB)||Participants|Count of Participants|149|149.0||||||
3960754|NCT01318538|3782784|B2||White|Race (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
3960755|NCT01318538|3782785|B1||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3960756|NCT01318538|3782783|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3960757|NCT01318538|3782784|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3960758|NCT01318538|3782785|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3960759|NCT01318538|3782783|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960760|NCT01318538|3782784|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960761|NCT01318538|3782785|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960762|NCT01318538|3782783|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3960763|NCT01318538|3782784|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960764|NCT01318538|3782785|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3960765|NCT01318538|3782783|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960766|NCT01318538|3782784|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960767|NCT01318538|3782785|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960768|NCT01318538|3782783|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960769|NCT01318538|3782784|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960770|NCT01318538|3782785|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960771|NCT01318538|3782783|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|157|157.0||||||
3960772|NCT01318538|3782784|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
3960773|NCT01318538|3782785|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3960774|NCT01318538|3782783|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3960775|NCT01318538|3782784|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3960776|NCT01318538|3782785|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960777|NCT01318538|3782783|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3960778|NCT01318538|3782784|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3960779|NCT01318538|3782785|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3960780|NCT01318538|3782783|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3960781|NCT01318538|3782784|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3960782|NCT01318538|3782785|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3960783|NCT01318538|3782783|B3|||Age||Years|Mean|47|47.0|Standard Deviation|12.2|12.2|||
3960784|NCT01318538|3782784|B2|||Age||Years|Mean|47.6|47.6|Standard Deviation|12.0|12.0|||
3960785|NCT01318538|3782785|B1|||Age||Years|Mean|45.7|45.7|Standard Deviation|12.6|12.6|||
3960786|NCT01318512|3782811|B1||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
3960787|NCT01318512|3782811|B1||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3960788|NCT01318512|3782811|B1|||Age||years|Mean|62.4|62.4|Standard Deviation|14.6|14.6|||
3960789|NCT01318499|3782827|B4|United States||Region of Enrollment||participants|Number|1257|1257.0||||||
3960790|NCT01318499|3782828|B3|United States||Region of Enrollment||participants|Number|252|252.0||||||
3960791|NCT01318499|3782829|B2|United States||Region of Enrollment||participants|Number|493|493.0||||||
3960792|NCT01318499|3782830|B1|United States||Region of Enrollment||participants|Number|512|512.0||||||
3960793|NCT01318499|3782827|B4||Male|Sex: Female, Male||Participants|Count of Participants|532|532.0||||||
3960794|NCT01318499|3782828|B3||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3960795|NCT01318499|3782829|B2||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
3960796|NCT01318499|3782830|B1||Male|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
3960797|NCT01318499|3782827|B4||Female|Sex: Female, Male||Participants|Count of Participants|725|725.0||||||
3960798|NCT01318499|3782828|B3||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3960799|NCT01318499|3782829|B2||Female|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
3960800|NCT01318499|3782830|B1||Female|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
3960801|NCT01318499|3782827|B4|||Age||years|Mean|69.3|69.3|Standard Deviation|9.28|9.28|||
3960802|NCT01318499|3782828|B3|||Age||years|Mean|69.3|69.3|Standard Deviation|9.6|9.6|||
3960803|NCT01318499|3782829|B2|||Age||years|Mean|69.4|69.4|Standard Deviation|9.15|9.15|||
3960804|NCT01318499|3782830|B1|||Age||years|Mean|69.3|69.3|Standard Deviation|9.26|9.26|||
3960805|NCT01318408|3782850|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3960806|NCT01318408|3782850|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3960807|NCT01318408|3782850|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3960808|NCT01318408|3782850|B1|||Age||years|Mean|69.9|69.9|Full Range|||50.0|84.0|
3960809|NCT01318382|3782855|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3960810|NCT01318382|3782855|B1||Female|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
3960811|NCT01318382|3782855|B1|||Age||years|Mean|47.1|47.1|Standard Deviation|13.46|13.46|||
3960812|NCT01318278|3782862|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3960813|NCT01318278|3782863|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3960814|NCT01318278|3782864|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3960815|NCT01318278|3782865|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3960816|NCT01318278|3782862|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3960817|NCT01318278|3782863|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3960818|NCT01318278|3782864|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3960819|NCT01318278|3782865|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3960820|NCT01318278|3782862|B4|||Age|Gestational age of subjects in weeks|weeks|Mean|25.6|25.6|Standard Deviation|1.4|1.4|||
3960821|NCT01318278|3782863|B3|||Age|Gestational age of subjects in weeks|weeks|Mean|25.6|25.6|Standard Deviation|1|1.0|||
3960822|NCT01318278|3782864|B2|||Age|Gestational age of subjects in weeks|weeks|Mean|25.7|25.7|Standard Deviation|2|2.0|||
3960823|NCT01318278|3782865|B1|||Age|Gestational age of subjects in weeks|weeks|Mean|25.1|25.1|Standard Deviation|1|1.0|||
3960824|NCT01318135|3782909|B5||Male|Sex: Female, Male||Participants|Count of Participants|394|394.0||||||
3960825|NCT01318135|3782910|B4||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3960826|NCT01318135|3782911|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3960827|NCT01318135|3782912|B2||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3960828|NCT01318135|3782913|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3960829|NCT01318135|3782909|B5||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
3960830|NCT01318135|3782910|B4||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3960831|NCT01318135|3782911|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3960832|NCT01318135|3782912|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3960833|NCT01318135|3782913|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3960834|NCT01318135|3782909|B5|≥ 65 years||Age, Customized|Participants randomized in core phase 2/3 glimepiride add-on study, excluding those randomized to the “glimepiride monotherapy group” was 304. Participants randomized in core phase 2/3 metformin add-on study, excluding those randomized to the “metformin monotherapy group” was 287. The following are included in baseline: Column 1: 7 patients participated in CCT-005 but not entered OCT-005; Column 2: 1 participated in CCT-005 but not entered OCT-005; Column 3: 2 participated in CCT-006 but not entered OCT-005; Column 4: 9 participated in CCT-006 but not entered OCT-005.|participants|Number|104|104.0||||||
3960835|NCT01318135|3782910|B4|≥ 65 years||Age, Customized|Participants randomized in core phase 2/3 glimepiride add-on study, excluding those randomized to the “glimepiride monotherapy group” was 304. Participants randomized in core phase 2/3 metformin add-on study, excluding those randomized to the “metformin monotherapy group” was 287. The following are included in baseline: Column 1: 7 patients participated in CCT-005 but not entered OCT-005; Column 2: 1 participated in CCT-005 but not entered OCT-005; Column 3: 2 participated in CCT-006 but not entered OCT-005; Column 4: 9 participated in CCT-006 but not entered OCT-005.|participants|Number|0|0.0||||||
3960836|NCT01318135|3782911|B3|≥ 65 years||Age, Customized|Participants randomized in core phase 2/3 glimepiride add-on study, excluding those randomized to the “glimepiride monotherapy group” was 304. Participants randomized in core phase 2/3 metformin add-on study, excluding those randomized to the “metformin monotherapy group” was 287. The following are included in baseline: Column 1: 7 patients participated in CCT-005 but not entered OCT-005; Column 2: 1 participated in CCT-005 but not entered OCT-005; Column 3: 2 participated in CCT-006 but not entered OCT-005; Column 4: 9 participated in CCT-006 but not entered OCT-005.|participants|Number|0|0.0||||||
3960837|NCT01318135|3782912|B2|≥ 65 years||Age, Customized|Participants randomized in core phase 2/3 glimepiride add-on study, excluding those randomized to the “glimepiride monotherapy group” was 304. Participants randomized in core phase 2/3 metformin add-on study, excluding those randomized to the “metformin monotherapy group” was 287. The following are included in baseline: Column 1: 7 patients participated in CCT-005 but not entered OCT-005; Column 2: 1 participated in CCT-005 but not entered OCT-005; Column 3: 2 participated in CCT-006 but not entered OCT-005; Column 4: 9 participated in CCT-006 but not entered OCT-005.|participants|Number|47|47.0||||||
3960838|NCT01318135|3782913|B1|≥ 65 years||Age, Customized|Participants randomized in core phase 2/3 glimepiride add-on study, excluding those randomized to the “glimepiride monotherapy group” was 304. Participants randomized in core phase 2/3 metformin add-on study, excluding those randomized to the “metformin monotherapy group” was 287. The following are included in baseline: Column 1: 7 patients participated in CCT-005 but not entered OCT-005; Column 2: 1 participated in CCT-005 but not entered OCT-005; Column 3: 2 participated in CCT-006 but not entered OCT-005; Column 4: 9 participated in CCT-006 but not entered OCT-005.|participants|Number|57|57.0||||||
3960879|NCT01318083|3783161|B1|≥ 65 years||Age, Customized||participants|Number|39|39.0||||||
3960880|NCT01318083|3783158|B4|≤ 64 years||Age, Customized||participants|Number|203|203.0||||||
3960839|NCT01318135|3782909|B5|≤ 64 years||Age, Customized|Participants randomized in core phase 2/3 glimepiride add-on study, excluding those randomized to the “glimepiride monotherapy group” was 304. Participants randomized in core phase 2/3 metformin add-on study, excluding those randomized to the “metformin monotherapy group” was 287. The following are included in baseline: Column 1: 7 patients participated in CCT-005 but not entered OCT-005; Column 2: 1 participated in CCT-005 but not entered OCT-005; Column 3: 2 participated in CCT-006 but not entered OCT-005; Column 4: 9 participated in CCT-006 but not entered OCT-005.|participants|Number|485|485.0||||||
3960840|NCT01318135|3782910|B4|≤ 64 years||Age, Customized|Participants randomized in core phase 2/3 glimepiride add-on study, excluding those randomized to the “glimepiride monotherapy group” was 304. Participants randomized in core phase 2/3 metformin add-on study, excluding those randomized to the “metformin monotherapy group” was 287. The following are included in baseline: Column 1: 7 patients participated in CCT-005 but not entered OCT-005; Column 2: 1 participated in CCT-005 but not entered OCT-005; Column 3: 2 participated in CCT-006 but not entered OCT-005; Column 4: 9 participated in CCT-006 but not entered OCT-005.|participants|Number|145|145.0||8.41|8.41|||
3960841|NCT01318135|3782911|B3|≤ 64 years||Age, Customized|Participants randomized in core phase 2/3 glimepiride add-on study, excluding those randomized to the “glimepiride monotherapy group” was 304. Participants randomized in core phase 2/3 metformin add-on study, excluding those randomized to the “metformin monotherapy group” was 287. The following are included in baseline: Column 1: 7 patients participated in CCT-005 but not entered OCT-005; Column 2: 1 participated in CCT-005 but not entered OCT-005; Column 3: 2 participated in CCT-006 but not entered OCT-005; Column 4: 9 participated in CCT-006 but not entered OCT-005.|participants|Number|142|142.0||8.12|8.12|||
3960842|NCT01318135|3782912|B2|≤ 64 years||Age, Customized|Participants randomized in core phase 2/3 glimepiride add-on study, excluding those randomized to the “glimepiride monotherapy group” was 304. Participants randomized in core phase 2/3 metformin add-on study, excluding those randomized to the “metformin monotherapy group” was 287. The following are included in baseline: Column 1: 7 patients participated in CCT-005 but not entered OCT-005; Column 2: 1 participated in CCT-005 but not entered OCT-005; Column 3: 2 participated in CCT-006 but not entered OCT-005; Column 4: 9 participated in CCT-006 but not entered OCT-005.|participants|Number|105|105.0||8.92|8.92|||
3960843|NCT01318135|3782913|B1|≤ 64 years||Age, Customized|Participants randomized in core phase 2/3 glimepiride add-on study, excluding those randomized to the “glimepiride monotherapy group” was 304. Participants randomized in core phase 2/3 metformin add-on study, excluding those randomized to the “metformin monotherapy group” was 287. The following are included in baseline: Column 1: 7 patients participated in CCT-005 but not entered OCT-005; Column 2: 1 participated in CCT-005 but not entered OCT-005; Column 3: 2 participated in CCT-006 but not entered OCT-005; Column 4: 9 participated in CCT-006 but not entered OCT-005.|participants|Number|93|93.0||9.50|9.5|||
3960844|NCT01318122|3783050|B3||Male|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
3960845|NCT01318122|3783051|B2||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3960846|NCT01318122|3783052|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3960847|NCT01318122|3783050|B3||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3960848|NCT01318122|3783051|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3960849|NCT01318122|3783052|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3960850|NCT01318122|3783050|B3|≥ 65 years||Age, Customized||participants|Number|112|112.0||||||
3960851|NCT01318122|3783051|B2|≥ 65 years||Age, Customized||participants|Number|62|62.0||||||
3960852|NCT01318122|3783052|B1|≥ 65 years||Age, Customized||participants|Number|50|50.0||||||
3960853|NCT01318122|3783050|B3|≤ 64 years||Age, Customized||participants|Number|219|219.0||||||
3960854|NCT01318122|3783051|B2|≤ 64 years||Age, Customized||participants|Number|103|103.0||||||
3960855|NCT01318122|3783052|B1|≤ 64 years||Age, Customized||participants|Number|116|116.0||||||
3960856|NCT01318109|3783121|B4||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
3960857|NCT01318109|3783122|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3960858|NCT01318109|3783123|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3960859|NCT01318109|3783124|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3960860|NCT01318109|3783121|B4||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3960861|NCT01318109|3783122|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3960862|NCT01318109|3783123|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3960863|NCT01318109|3783124|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3960864|NCT01318109|3783121|B4|||Age||years|Mean|52.6|52.6|Standard Deviation|8.28|8.28|||
3960865|NCT01318109|3783122|B3|||Age||years|Mean|52.1|52.1|Standard Deviation|8.05|8.05|||
3960866|NCT01318109|3783123|B2|||Age||years|Mean|52.3|52.3|Standard Deviation|8.02|8.02|||
3960867|NCT01318109|3783124|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|8.80|8.8|||
3960868|NCT01318083|3783158|B4||Male|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
3960869|NCT01318083|3783159|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3960870|NCT01318083|3783160|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3960871|NCT01318083|3783161|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3960872|NCT01318083|3783158|B4||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3960873|NCT01318083|3783159|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3960874|NCT01318083|3783160|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3960875|NCT01318083|3783161|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3960876|NCT01318083|3783158|B4|≥ 65 years||Age, Customized||participants|Number|109|109.0||||||
3960877|NCT01318083|3783159|B3|≥ 65 years||Age, Customized||participants|Number|39|39.0||||||
3960878|NCT01318083|3783160|B2|≥ 65 years||Age, Customized||participants|Number|31|31.0||||||
3960881|NCT01318083|3783159|B3|≤ 64 years||Age, Customized||participants|Number|64|64.0||||||
3960882|NCT01318083|3783160|B2|≤ 64 years||Age, Customized||participants|Number|73|73.0||||||
3960883|NCT01318083|3783161|B1|≤ 64 years||Age, Customized||participants|Number|66|66.0||||||
3960884|NCT01318070|3783195|B4||Male|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
3960885|NCT01318070|3783196|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3960886|NCT01318070|3783197|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3960887|NCT01318070|3783198|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3960888|NCT01318070|3783195|B4||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3960889|NCT01318070|3783196|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3960890|NCT01318070|3783197|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3960891|NCT01318070|3783198|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3960892|NCT01318070|3783195|B4|≥ 65 years||Age, Customized||participants|Number|115|115.0||||||
3960893|NCT01318070|3783196|B3|≥ 65 years||Age, Customized||participants|Number|38|38.0||||||
3960894|NCT01318070|3783197|B2|≥ 65 years||Age, Customized||participants|Number|43|43.0||||||
3960895|NCT01318070|3783198|B1|≥ 65 years||Age, Customized||participants|Number|34|34.0||||||
3960896|NCT01318070|3783195|B4|≤ 64 years||Age, Customized||participants|Number|224|224.0||||||
3960897|NCT01318070|3783196|B3|≤ 64 years||Age, Customized||participants|Number|77|77.0||||||
3960898|NCT01318070|3783197|B2|≤ 64 years||Age, Customized||participants|Number|70|70.0||||||
3960899|NCT01318070|3783198|B1|≤ 64 years||Age, Customized||participants|Number|77|77.0||||||
3960900|NCT01318018|3783232|B3|Germany||Region of Enrollment||participants|Number|20|20.0||||||
3960901|NCT01318018|3783233|B2|Germany||Region of Enrollment||participants|Number|10|10.0||||||
3960902|NCT01318018|3783234|B1|Germany||Region of Enrollment||participants|Number|10|10.0||||||
3960903|NCT01318018|3783232|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3960904|NCT01318018|3783233|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3960905|NCT01318018|3783234|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3960906|NCT01318018|3783232|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3960907|NCT01318018|3783233|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3960908|NCT01318018|3783234|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3960909|NCT01318018|3783232|B3|||Age||years|Mean|50|50.0|Standard Deviation|14|14.0|||
3960910|NCT01318018|3783233|B2|||Age||years|Mean|55|55.0|Standard Deviation|12|12.0|||
3960911|NCT01318018|3783234|B1|||Age||years|Mean|45|45.0|Standard Deviation|14|14.0|||
3960912|NCT01317901|3783241|B3|Highrisk (3-5 points)||FLIPI|Follicular Lymphoma International Prognostic Index|participants|Number|2|2.0||||||
3960913|NCT01317901|3783242|B2|Highrisk (3-5 points)||FLIPI|Follicular Lymphoma International Prognostic Index|participants|Number|2|2.0||||||
3960914|NCT01317901|3783243|B1|Highrisk (3-5 points)||FLIPI|Follicular Lymphoma International Prognostic Index|participants|Number|0|0.0||||||
3960915|NCT01317901|3783241|B3|Intermediate risk (2 points)||FLIPI|Follicular Lymphoma International Prognostic Index|participants|Number|4|4.0||||||
3960916|NCT01317901|3783242|B2|Intermediate risk (2 points)||FLIPI|Follicular Lymphoma International Prognostic Index|participants|Number|1|1.0||||||
3960917|NCT01317901|3783243|B1|Intermediate risk (2 points)||FLIPI|Follicular Lymphoma International Prognostic Index|participants|Number|3|3.0||||||
3960918|NCT01317901|3783241|B3|Low risk (0-1 points)||FLIPI|Follicular Lymphoma International Prognostic Index|participants|Number|6|6.0||||||
3960919|NCT01317901|3783242|B2|Low risk (0-1 points)||FLIPI|Follicular Lymphoma International Prognostic Index|participants|Number|3|3.0||||||
3960920|NCT01317901|3783243|B1|Low risk (0-1 points)||FLIPI|Follicular Lymphoma International Prognostic Index|participants|Number|3|3.0||||||
3960921|NCT01317901|3783241|B3|Not done||Staging at diagnosis||participants|Number|1|1.0||||||
3960922|NCT01317901|3783242|B2|Not done||Staging at diagnosis||participants|Number|0|0.0||||||
3960923|NCT01317901|3783243|B1|Not done||Staging at diagnosis||participants|Number|1|1.0||||||
3960924|NCT01317901|3783241|B3|Stage 4||Staging at diagnosis||participants|Number|5|5.0||||||
3960925|NCT01317901|3783242|B2|Stage 4||Staging at diagnosis||participants|Number|3|3.0||||||
3960926|NCT01317901|3783243|B1|Stage 4||Staging at diagnosis||participants|Number|2|2.0||||||
3960927|NCT01317901|3783241|B3|Stage 3||Staging at diagnosis||participants|Number|3|3.0||||||
3960928|NCT01317901|3783242|B2|Stage 3||Staging at diagnosis||participants|Number|2|2.0||||||
3960929|NCT01317901|3783243|B1|Stage 3||Staging at diagnosis||participants|Number|1|1.0||||||
3960930|NCT01317901|3783241|B3|Stage 2||Staging at diagnosis||participants|Number|2|2.0||||||
3960931|NCT01317901|3783242|B2|Stage 2||Staging at diagnosis||participants|Number|1|1.0||||||
3960932|NCT01317901|3783243|B1|Stage 2||Staging at diagnosis||participants|Number|1|1.0||||||
3960933|NCT01317901|3783241|B3|Stage 1||Staging at diagnosis||participants|Number|1|1.0||||||
3960934|NCT01317901|3783242|B2|Stage 1||Staging at diagnosis||participants|Number|0|0.0||||||
3960935|NCT01317901|3783243|B1|Stage 1||Staging at diagnosis||participants|Number|1|1.0||||||
3960936|NCT01317901|3783241|B3|unknown||Direct Anti-globulin Test||participants|Number|1|1.0||||||
3960937|NCT01317901|3783242|B2|unknown||Direct Anti-globulin Test||participants|Number|1|1.0||||||
3960938|NCT01317901|3783243|B1|unknown||Direct Anti-globulin Test||participants|Number|0|0.0||||||
3960939|NCT01317901|3783241|B3|Negative||Direct Anti-globulin Test||participants|Number|11|11.0||||||
3960940|NCT01317901|3783242|B2|Negative||Direct Anti-globulin Test||participants|Number|5|5.0||||||
3960941|NCT01317901|3783243|B1|Negative||Direct Anti-globulin Test||participants|Number|6|6.0||||||
3960942|NCT01317901|3783241|B3|Positive||Direct Anti-globulin Test||participants|Number|0|0.0||||||
3960943|NCT01317901|3783242|B2|Positive||Direct Anti-globulin Test||participants|Number|0|0.0||||||
3960944|NCT01317901|3783243|B1|Positive||Direct Anti-globulin Test||participants|Number|0|0.0||||||
3960945|NCT01317901|3783241|B3|||Time since first diagnosis of primary cancer||years|Mean|4.6|4.6|Standard Deviation|4.0|4.0|||
3960946|NCT01317901|3783242|B2|||Time since first diagnosis of primary cancer||years|Mean|6.0|6.0|Standard Deviation|4.7|4.7|||
3960947|NCT01317901|3783243|B1|||Time since first diagnosis of primary cancer||years|Mean|3.2|3.2|Standard Deviation|2.8|2.8|||
3960948|NCT01317901|3783241|B3|||Sum of product diameters||cm2|Mean|37.9|37.9|Standard Deviation|28.5|28.5|||
3960949|NCT01317901|3783242|B2|||Sum of product diameters||cm2|Mean|35.0|35.0|Standard Deviation|32.6|32.6|||
3960950|NCT01317901|3783243|B1|||Sum of product diameters||cm2|Mean|40.9|40.9|Standard Deviation|26.5|26.5|||
3960951|NCT01317901|3783241|B3|||β2-microglobulin||MG/l|Mean|2.6|2.6|Standard Deviation|1.5|1.5|||
3960952|NCT01317901|3783242|B2|||β2-microglobulin||MG/l|Mean|2.9|2.9|Standard Deviation|1.9|1.9|||
3960953|NCT01317901|3783243|B1|||β2-microglobulin||MG/l|Mean|2.4|2.4|Standard Deviation|1.3|1.3|||
3960954|NCT01317901|3783241|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960955|NCT01317901|3783242|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960956|NCT01317901|3783243|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960957|NCT01317901|3783241|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960958|NCT01317901|3783242|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960959|NCT01317901|3783243|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960960|NCT01317901|3783241|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3960961|NCT01317901|3783242|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3960962|NCT01317901|3783243|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3960963|NCT01317901|3783241|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3960964|NCT01317901|3783242|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960965|NCT01317901|3783243|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3960966|NCT01317901|3783241|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960967|NCT01317901|3783242|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960968|NCT01317901|3783243|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960969|NCT01317901|3783241|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960970|NCT01317901|3783242|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960971|NCT01317901|3783243|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960972|NCT01317901|3783241|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960973|NCT01317901|3783242|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960974|NCT01317901|3783243|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960975|NCT01317901|3783241|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960976|NCT01317901|3783242|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960977|NCT01317901|3783243|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960978|NCT01317901|3783241|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3960979|NCT01317901|3783242|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3960980|NCT01317901|3783243|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3960981|NCT01317901|3783241|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3960982|NCT01317901|3783242|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3960983|NCT01317901|3783243|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3960984|NCT01317901|3783241|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3960985|NCT01317901|3783242|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3960986|NCT01317901|3783243|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3960987|NCT01317901|3783241|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3960988|NCT01317901|3783242|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3960989|NCT01317901|3783243|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3960990|NCT01317901|3783241|B3|||Age||years|Mean|60.8|60.8|Standard Deviation|8.65|8.65|||
3960991|NCT01317901|3783242|B2|||Age||years|Mean|64.3|64.3|Standard Deviation|10.61|10.61|||
3960992|NCT01317901|3783243|B1|||Age||years|Mean|57.3|57.3|Standard Deviation|4.76|4.76|||
3960993|NCT01317797|3783250|B4|||Disease Activity Score 28-Erythrocyte Sedimentation Rate (DAS28-ESR) Score|The DAS28-ESR is expressed on a unit on a scale with the minimum score=0 (best) to maximum score=10 (worst).|score on a scale|Mean|4.65|4.65|Standard Deviation|0.510|0.51|||
3960994|NCT01317797|3783251|B3|||Disease Activity Score 28-Erythrocyte Sedimentation Rate (DAS28-ESR) Score|The DAS28-ESR is expressed on a unit on a scale with the minimum score=0 (best) to maximum score=10 (worst).|score on a scale|Mean|4.60|4.6|Standard Deviation|0.512|0.512|||
3960995|NCT01317797|3783252|B2|||Disease Activity Score 28-Erythrocyte Sedimentation Rate (DAS28-ESR) Score|The DAS28-ESR is expressed on a unit on a scale with the minimum score=0 (best) to maximum score=10 (worst).|score on a scale|Mean|4.66|4.66|Standard Deviation|0.544|0.544|||
3960996|NCT01317797|3783253|B1|||Disease Activity Score 28-Erythrocyte Sedimentation Rate (DAS28-ESR) Score|The DAS28-ESR is expressed on a unit on a scale with the minimum score=0 (best) to maximum score=10 (worst).|score on a scale|Mean|4.70|4.7|Standard Deviation|0.542|0.542|||
3960997|NCT01317797|3783250|B4|||Body Mass Index (BMI)||kg/m^2|Mean|26.75|26.75|Standard Deviation|2.607|2.607|||
3960998|NCT01317797|3783251|B3|||Body Mass Index (BMI)||kg/m^2|Mean|27.37|27.37|Standard Deviation|2.246|2.246|||
3960999|NCT01317797|3783252|B2|||Body Mass Index (BMI)||kg/m^2|Mean|28.30|28.3|Standard Deviation|1.778|1.778|||
3961000|NCT01317797|3783253|B1|||Body Mass Index (BMI)||kg/m^2|Mean|24.69|24.69|Standard Deviation|2.471|2.471|||
3961001|NCT01317797|3783250|B4|||Weight||kg|Mean|75.35|75.35|Standard Deviation|9.147|9.147|||
3961002|NCT01317797|3783251|B3|||Weight||kg|Mean|77.80|77.8|Standard Deviation|8.617|8.617|||
3961003|NCT01317797|3783252|B2|||Weight||kg|Mean|80.44|80.44|Standard Deviation|7.305|7.305|||
3961004|NCT01317797|3783253|B1|||Weight||kg|Mean|68.13|68.13|Standard Deviation|7.140|7.14|||
3961005|NCT01317797|3783250|B4|||Height||cm|Mean|167.74|167.74|Standard Deviation|6.581|6.581|||
3961006|NCT01317797|3783251|B3|||Height||cm|Mean|168.44|168.44|Standard Deviation|5.126|5.126|||
3961007|NCT01317797|3783252|B2|||Height||cm|Mean|168.57|168.57|Standard Deviation|6.321|6.321|||
3961008|NCT01317797|3783253|B1|||Height||cm|Mean|166.21|166.21|Standard Deviation|8.605|8.605|||
3961009|NCT01317797|3783250|B4|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3961010|NCT01317797|3783251|B3|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3961011|NCT01317797|3783252|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3961012|NCT01317797|3783253|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3961013|NCT01317797|3783250|B4|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3961014|NCT01317797|3783251|B3|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3961015|NCT01317797|3783252|B2|White||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3961016|NCT01317797|3783253|B1|White||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3961017|NCT01317797|3783250|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3961018|NCT01317797|3783251|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3961019|NCT01317797|3783252|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3961020|NCT01317797|3783253|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3961021|NCT01317797|3783250|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3961022|NCT01317797|3783251|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3961023|NCT01317797|3783252|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3961024|NCT01317797|3783253|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3961025|NCT01317797|3783250|B4|||Age||years|Mean|55.9|55.9|Standard Deviation|11.05|11.05|||
3961026|NCT01317797|3783251|B3|||Age||years|Mean|53.4|53.4|Standard Deviation|11.05|11.05|||
3961027|NCT01317797|3783252|B2|||Age||years|Mean|56.6|56.6|Standard Deviation|15.28|15.28|||
3961028|NCT01317797|3783253|B1|||Age||years|Mean|58.0|58.0|Standard Deviation|6.95|6.95|||
3961029|NCT01317667|3783307|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961030|NCT01317667|3783308|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961031|NCT01317667|3783309|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961032|NCT01317667|3783310|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961033|NCT01317667|3783307|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961034|NCT01317667|3783308|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961035|NCT01317667|3783309|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961036|NCT01317667|3783310|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961037|NCT01317667|3783307|B4||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3961038|NCT01317667|3783308|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3961039|NCT01317667|3783309|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3961040|NCT01317667|3783310|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3961041|NCT01317667|3783307|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3961042|NCT01317667|3783308|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3961043|NCT01317667|3783309|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961044|NCT01317667|3783310|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961045|NCT01317667|3783307|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961046|NCT01317667|3783308|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961047|NCT01317667|3783309|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961048|NCT01317667|3783310|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961049|NCT01317667|3783307|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961050|NCT01317667|3783308|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961051|NCT01317667|3783309|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961052|NCT01317667|3783310|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961053|NCT01317667|3783307|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961218|NCT01317199|3783455|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961054|NCT01317667|3783308|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961055|NCT01317667|3783309|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961056|NCT01317667|3783310|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961057|NCT01317667|3783307|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961058|NCT01317667|3783308|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961059|NCT01317667|3783309|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961060|NCT01317667|3783310|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961061|NCT01317667|3783307|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3961062|NCT01317667|3783308|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3961063|NCT01317667|3783309|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3961064|NCT01317667|3783310|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3961065|NCT01317667|3783307|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3961066|NCT01317667|3783308|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961067|NCT01317667|3783309|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3961068|NCT01317667|3783310|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3961069|NCT01317667|3783307|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3961070|NCT01317667|3783308|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3961071|NCT01317667|3783309|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3961072|NCT01317667|3783310|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3961073|NCT01317667|3783307|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3961074|NCT01317667|3783308|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3961075|NCT01317667|3783309|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3961076|NCT01317667|3783310|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3961077|NCT01317667|3783307|B4|||Age||years|Mean|34.3|34.3|Standard Deviation|7.85|7.85|||
3961078|NCT01317667|3783308|B3|||Age||years|Mean|32.2|32.2|Standard Deviation|8.13|8.13|||
3961079|NCT01317667|3783309|B2|||Age||years|Mean|35.0|35.0|Standard Deviation|7.62|7.62|||
3961080|NCT01317667|3783310|B1|||Age||years|Mean|35.6|35.6|Standard Deviation|8.19|8.19|||
3961081|NCT01317641|3783323|B10||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3961082|NCT01317641|3783324|B9||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3961083|NCT01317641|3783325|B8||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3961084|NCT01317641|3783326|B7||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3961085|NCT01317641|3783327|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3961086|NCT01317641|3783328|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3961087|NCT01317641|3783329|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3961088|NCT01317641|3783330|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3961089|NCT01317641|3783331|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3961090|NCT01317641|3783332|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3961091|NCT01317641|3783323|B10||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3961092|NCT01317641|3783324|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3961093|NCT01317641|3783325|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3961094|NCT01317641|3783326|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3961095|NCT01317641|3783327|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3961096|NCT01317641|3783328|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3961097|NCT01317641|3783329|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3961098|NCT01317641|3783330|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3961099|NCT01317641|3783331|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3961100|NCT01317641|3783332|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3961101|NCT01317641|3783323|B10|||Age||years|Mean|69.4|69.4|Standard Deviation|7.4|7.4|||
3961102|NCT01317641|3783324|B9|||Age||years|Mean|71.3|71.3|Standard Deviation|8.0|8.0|||
3961103|NCT01317641|3783325|B8|||Age||years|Mean|69.1|69.1|Standard Deviation|7.4|7.4|||
3961104|NCT01317641|3783326|B7|||Age||years|Mean|68.3|68.3|Standard Deviation|7.0|7.0|||
3961105|NCT01317641|3783327|B6|||Age||years|Mean|67.7|67.7|Standard Deviation|3.2|3.2|||
3961106|NCT01317641|3783328|B5|||Age||years|Mean|67.7|67.7|Standard Deviation|5.5|5.5|||
3961107|NCT01317641|3783329|B4|||Age||years|Mean|65.8|65.8|Standard Deviation|11.2|11.2|||
3961108|NCT01317641|3783330|B3|||Age||years|Mean|65.3|65.3|Standard Deviation|3.5|3.5|||
3961109|NCT01317641|3783331|B2|||Age||years|Mean|71.9|71.9|Standard Deviation|8.5|8.5|||
3961110|NCT01317641|3783332|B1|||Age||years|Mean|73|73.0|Standard Deviation|1.4|1.4|||
3961111|NCT01317615|3783442|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3961112|NCT01317615|3783442|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3961113|NCT01317615|3783442|B1|||Age||Years|Mean|62|62.0|Standard Deviation|8.9|8.9|||
3961114|NCT01317199|3783451|B5|Valine/Valine (Val/Val)||Superoxide dismutase 2 (SOD2) genotype||Participants|Count of Participants|21|21.0||||||
3961115|NCT01317199|3783452|B4|Valine/Valine (Val/Val)||Superoxide dismutase 2 (SOD2) genotype||Participants|Count of Participants|5|5.0||||||
3961116|NCT01317199|3783453|B3|Valine/Valine (Val/Val)||Superoxide dismutase 2 (SOD2) genotype||Participants|Count of Participants|11|11.0||||||
3961117|NCT01317199|3783454|B2|Valine/Valine (Val/Val)||Superoxide dismutase 2 (SOD2) genotype||Participants|Count of Participants|5|5.0||||||
3961118|NCT01317199|3783451|B5|Alanine/Valine (Ala/Val)||Superoxide dismutase 2 (SOD2) genotype||Participants|Count of Participants|54|54.0||||||
3961119|NCT01317199|3783452|B4|Alanine/Valine (Ala/Val)||Superoxide dismutase 2 (SOD2) genotype||Participants|Count of Participants|22|22.0||||||
3961120|NCT01317199|3783453|B3|Alanine/Valine (Ala/Val)||Superoxide dismutase 2 (SOD2) genotype||Participants|Count of Participants|21|21.0||||||
3961121|NCT01317199|3783454|B2|Alanine/Valine (Ala/Val)||Superoxide dismutase 2 (SOD2) genotype||Participants|Count of Participants|11|11.0||||||
3961122|NCT01317199|3783451|B5|Alanine/Alanine (Ala/Ala)||Superoxide dismutase 2 (SOD2) genotype||Participants|Count of Participants|27|27.0||||||
3961123|NCT01317199|3783452|B4|Alanine/Alanine (Ala/Ala)||Superoxide dismutase 2 (SOD2) genotype||Participants|Count of Participants|10|10.0||||||
3961124|NCT01317199|3783453|B3|Alanine/Alanine (Ala/Ala)||Superoxide dismutase 2 (SOD2) genotype||Participants|Count of Participants|12|12.0||||||
3961125|NCT01317199|3783454|B2|Alanine/Alanine (Ala/Ala)||Superoxide dismutase 2 (SOD2) genotype||Participants|Count of Participants|5|5.0||||||
3961126|NCT01317199|3783451|B5|Androgen Deprivation Therapy (ADT)||Prior therapy||Participants|Count of Participants|46|46.0||||||
3961127|NCT01317199|3783452|B4|Androgen Deprivation Therapy (ADT)||Prior therapy||Participants|Count of Participants|19|19.0||||||
3961128|NCT01317199|3783453|B3|Androgen Deprivation Therapy (ADT)||Prior therapy||Participants|Count of Participants|25|25.0||||||
3961129|NCT01317199|3783454|B2|Androgen Deprivation Therapy (ADT)||Prior therapy||Participants|Count of Participants|2|2.0||||||
3961130|NCT01317199|3783451|B5|Brachytherapy||Prior therapy||Participants|Count of Participants|11|11.0||||||
3961131|NCT01317199|3783452|B4|Brachytherapy||Prior therapy||Participants|Count of Participants|3|3.0||||||
3961132|NCT01317199|3783453|B3|Brachytherapy||Prior therapy||Participants|Count of Participants|5|5.0||||||
3961133|NCT01317199|3783454|B2|Brachytherapy||Prior therapy||Participants|Count of Participants|3|3.0||||||
3961134|NCT01317199|3783451|B5|Cryotherapy||Prior therapy||Participants|Count of Participants|50|50.0||||||
3961135|NCT01317199|3783452|B4|Cryotherapy||Prior therapy||Participants|Count of Participants|1|1.0||||||
3961136|NCT01317199|3783453|B3|Cryotherapy||Prior therapy||Participants|Count of Participants|49|49.0||||||
3961137|NCT01317199|3783454|B2|Cryotherapy||Prior therapy||Participants|Count of Participants|0|0.0||||||
3961138|NCT01317199|3783451|B5|Radiation & Surgery||Prior therapy||Participants|Count of Participants|9|9.0||||||
3961139|NCT01317199|3783455|B1|Radiation & Surgery||Prior therapy||Participants|Count of Participants|9|9.0||||||
3961140|NCT01317199|3783451|B5|Surgery||Prior therapy||Participants|Count of Participants|89|89.0||||||
3961141|NCT01317199|3783452|B4|Surgery||Prior therapy||Participants|Count of Participants|32|32.0||||||
3961142|NCT01317199|3783453|B3|Surgery||Prior therapy||Participants|Count of Participants|40|40.0||||||
3961143|NCT01317199|3783454|B2|Surgery||Prior therapy||Participants|Count of Participants|16|16.0||||||
3961144|NCT01317199|3783455|B1|Surgery||Prior therapy||Participants|Count of Participants|1|1.0||||||
3961145|NCT01317199|3783451|B5|Radiation||Prior therapy||Participants|Count of Participants|116|116.0||||||
3961146|NCT01317199|3783452|B4|Radiation||Prior therapy||Participants|Count of Participants|42|42.0||||||
3961147|NCT01317199|3783453|B3|Radiation||Prior therapy||Participants|Count of Participants|49|49.0||||||
3961148|NCT01317199|3783454|B2|Radiation||Prior therapy||Participants|Count of Participants|21|21.0||||||
3961149|NCT01317199|3783455|B1|Radiation||Prior therapy||Participants|Count of Participants|4|4.0||||||
3961150|NCT01317199|3783451|B5||>9 months|Baseline PSADT||Participants|Count of Participants|54|54.0||||||
3961151|NCT01317199|3783452|B4||>9 months|Baseline PSADT||Participants|Count of Participants|21|21.0||||||
3961152|NCT01317199|3783453|B3||>9 months|Baseline PSADT||Participants|Count of Participants|23|23.0||||||
3961153|NCT01317199|3783454|B2||>9 months|Baseline PSADT||Participants|Count of Participants|10|10.0||||||
3961154|NCT01317199|3783451|B5||≤9 months|Baseline PSADT||Participants|Count of Participants|72|72.0||||||
3961155|NCT01317199|3783452|B4||≤9 months|Baseline PSADT||Participants|Count of Participants|27|27.0||||||
3961156|NCT01317199|3783453|B3||≤9 months|Baseline PSADT||Participants|Count of Participants|32|32.0||||||
3961157|NCT01317199|3783454|B2||≤9 months|Baseline PSADT||Participants|Count of Participants|13|13.0||||||
3961158|NCT01317199|3783451|B5|||Baseline PSA doubling time (PSADT)||months|Mean|13|13.0|Standard Deviation|10.1|10.1|||
3961159|NCT01317199|3783455|B1|||Baseline PSA doubling time (PSADT)||months|Mean|13|13.0|Standard Deviation|10.1|10.1|||
3961160|NCT01317199|3783451|B5|9||Gleason score|The gleason score is an indication of prognosis based on prostate pathology. The score ranges from 2 to 10 with a higher score reflecting less-differentiated tumors with worse prognosis. The total score is a sum of two numbers which are based on the microscopic appearance of cells. The first number is the score based on the dominant, cell morphology (scored 1-5) and the second number is based on the highest grade of the non-dominant cell pattern (scored 1-5).|Participants|Count of Participants|3|3.0||||||
3961161|NCT01317199|3783455|B1|9||Gleason score|The gleason score is an indication of prognosis based on prostate pathology. The score ranges from 2 to 10 with a higher score reflecting less-differentiated tumors with worse prognosis. The total score is a sum of two numbers which are based on the microscopic appearance of cells. The first number is the score based on the dominant, cell morphology (scored 1-5) and the second number is based on the highest grade of the non-dominant cell pattern (scored 1-5).|Participants|Count of Participants|3|3.0||||||
3961219|NCT01317199|3783451|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961162|NCT01317199|3783451|B5|8||Gleason score|The gleason score is an indication of prognosis based on prostate pathology. The score ranges from 2 to 10 with a higher score reflecting less-differentiated tumors with worse prognosis. The total score is a sum of two numbers which are based on the microscopic appearance of cells. The first number is the score based on the dominant, cell morphology (scored 1-5) and the second number is based on the highest grade of the non-dominant cell pattern (scored 1-5).|Participants|Count of Participants|1|1.0||||||
3961163|NCT01317199|3783455|B1|8||Gleason score|The gleason score is an indication of prognosis based on prostate pathology. The score ranges from 2 to 10 with a higher score reflecting less-differentiated tumors with worse prognosis. The total score is a sum of two numbers which are based on the microscopic appearance of cells. The first number is the score based on the dominant, cell morphology (scored 1-5) and the second number is based on the highest grade of the non-dominant cell pattern (scored 1-5).|Participants|Count of Participants|1|1.0||||||
3961164|NCT01317199|3783451|B5|7||Gleason score|The gleason score is an indication of prognosis based on prostate pathology. The score ranges from 2 to 10 with a higher score reflecting less-differentiated tumors with worse prognosis. The total score is a sum of two numbers which are based on the microscopic appearance of cells. The first number is the score based on the dominant, cell morphology (scored 1-5) and the second number is based on the highest grade of the non-dominant cell pattern (scored 1-5).|Participants|Count of Participants|7|7.0||||||
3961165|NCT01317199|3783455|B1|7||Gleason score|The gleason score is an indication of prognosis based on prostate pathology. The score ranges from 2 to 10 with a higher score reflecting less-differentiated tumors with worse prognosis. The total score is a sum of two numbers which are based on the microscopic appearance of cells. The first number is the score based on the dominant, cell morphology (scored 1-5) and the second number is based on the highest grade of the non-dominant cell pattern (scored 1-5).|Participants|Count of Participants|7|7.0||||||
3961166|NCT01317199|3783451|B5|6||Gleason score|The gleason score is an indication of prognosis based on prostate pathology. The score ranges from 2 to 10 with a higher score reflecting less-differentiated tumors with worse prognosis. The total score is a sum of two numbers which are based on the microscopic appearance of cells. The first number is the score based on the dominant, cell morphology (scored 1-5) and the second number is based on the highest grade of the non-dominant cell pattern (scored 1-5).|Participants|Count of Participants|3|3.0||||||
3961167|NCT01317199|3783455|B1|6||Gleason score|The gleason score is an indication of prognosis based on prostate pathology. The score ranges from 2 to 10 with a higher score reflecting less-differentiated tumors with worse prognosis. The total score is a sum of two numbers which are based on the microscopic appearance of cells. The first number is the score based on the dominant, cell morphology (scored 1-5) and the second number is based on the highest grade of the non-dominant cell pattern (scored 1-5).|Participants|Count of Participants|3|3.0||||||
3961168|NCT01317199|3783451|B5|≥8, 4+3||Gleason score|The gleason score is an indication of prognosis based on prostate pathology. The score ranges from 2 to 10 with a higher score reflecting less-differentiated tumors with worse prognosis. The total score is a sum of two numbers which are based on the microscopic appearance of cells. The first number is the score based on the dominant, cell morphology (scored 1-5) and the second number is based on the highest grade of the non-dominant cell pattern (scored 1-5).|Participants|Count of Participants|70|70.0||||||
3961169|NCT01317199|3783452|B4|≥8, 4+3||Gleason score|The gleason score is an indication of prognosis based on prostate pathology. The score ranges from 2 to 10 with a higher score reflecting less-differentiated tumors with worse prognosis. The total score is a sum of two numbers which are based on the microscopic appearance of cells. The first number is the score based on the dominant, cell morphology (scored 1-5) and the second number is based on the highest grade of the non-dominant cell pattern (scored 1-5).|Participants|Count of Participants|26|26.0||||||
3961170|NCT01317199|3783453|B3|≥8, 4+3||Gleason score|The gleason score is an indication of prognosis based on prostate pathology. The score ranges from 2 to 10 with a higher score reflecting less-differentiated tumors with worse prognosis. The total score is a sum of two numbers which are based on the microscopic appearance of cells. The first number is the score based on the dominant, cell morphology (scored 1-5) and the second number is based on the highest grade of the non-dominant cell pattern (scored 1-5).|Participants|Count of Participants|31|31.0||||||
3961171|NCT01317199|3783454|B2|≥8, 4+3||Gleason score|The gleason score is an indication of prognosis based on prostate pathology. The score ranges from 2 to 10 with a higher score reflecting less-differentiated tumors with worse prognosis. The total score is a sum of two numbers which are based on the microscopic appearance of cells. The first number is the score based on the dominant, cell morphology (scored 1-5) and the second number is based on the highest grade of the non-dominant cell pattern (scored 1-5).|Participants|Count of Participants|13|13.0||||||
3961172|NCT01317199|3783451|B5|≤6, 3+4||Gleason score|The gleason score is an indication of prognosis based on prostate pathology. The score ranges from 2 to 10 with a higher score reflecting less-differentiated tumors with worse prognosis. The total score is a sum of two numbers which are based on the microscopic appearance of cells. The first number is the score based on the dominant, cell morphology (scored 1-5) and the second number is based on the highest grade of the non-dominant cell pattern (scored 1-5).|Participants|Count of Participants|59|59.0||||||
3961173|NCT01317199|3783452|B4|≤6, 3+4||Gleason score|The gleason score is an indication of prognosis based on prostate pathology. The score ranges from 2 to 10 with a higher score reflecting less-differentiated tumors with worse prognosis. The total score is a sum of two numbers which are based on the microscopic appearance of cells. The first number is the score based on the dominant, cell morphology (scored 1-5) and the second number is based on the highest grade of the non-dominant cell pattern (scored 1-5).|Participants|Count of Participants|23|23.0||||||
3961174|NCT01317199|3783453|B3|≤6, 3+4||Gleason score|The gleason score is an indication of prognosis based on prostate pathology. The score ranges from 2 to 10 with a higher score reflecting less-differentiated tumors with worse prognosis. The total score is a sum of two numbers which are based on the microscopic appearance of cells. The first number is the score based on the dominant, cell morphology (scored 1-5) and the second number is based on the highest grade of the non-dominant cell pattern (scored 1-5).|Participants|Count of Participants|25|25.0||||||
3961220|NCT01317199|3783452|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961221|NCT01317199|3783453|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961222|NCT01317199|3783454|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961175|NCT01317199|3783454|B2|≤6, 3+4||Gleason score|The gleason score is an indication of prognosis based on prostate pathology. The score ranges from 2 to 10 with a higher score reflecting less-differentiated tumors with worse prognosis. The total score is a sum of two numbers which are based on the microscopic appearance of cells. The first number is the score based on the dominant, cell morphology (scored 1-5) and the second number is based on the highest grade of the non-dominant cell pattern (scored 1-5).|Participants|Count of Participants|11|11.0||||||
3961176|NCT01317199|3783451|B5||1|Eastern Cooperative Oncology Group (ECOG)|The Eastern Cooperative Oncology Group (ECOG) scale is a measure of performance status with 0 (fully active) as the best score and 1 being restricted to physically strenuous activity.|Participants|Count of Participants|15|15.0||||||
3961177|NCT01317199|3783452|B4||1|Eastern Cooperative Oncology Group (ECOG)|The Eastern Cooperative Oncology Group (ECOG) scale is a measure of performance status with 0 (fully active) as the best score and 1 being restricted to physically strenuous activity.|Participants|Count of Participants|8|8.0||||||
3961178|NCT01317199|3783453|B3||1|Eastern Cooperative Oncology Group (ECOG)|The Eastern Cooperative Oncology Group (ECOG) scale is a measure of performance status with 0 (fully active) as the best score and 1 being restricted to physically strenuous activity.|Participants|Count of Participants|2|2.0||||||
3961179|NCT01317199|3783454|B2||1|Eastern Cooperative Oncology Group (ECOG)|The Eastern Cooperative Oncology Group (ECOG) scale is a measure of performance status with 0 (fully active) as the best score and 1 being restricted to physically strenuous activity.|Participants|Count of Participants|5|5.0||||||
3961180|NCT01317199|3783451|B5||0|Eastern Cooperative Oncology Group (ECOG)|The Eastern Cooperative Oncology Group (ECOG) scale is a measure of performance status with 0 (fully active) as the best score and 1 being restricted to physically strenuous activity.|Participants|Count of Participants|109|109.0||||||
3961181|NCT01317199|3783452|B4||0|Eastern Cooperative Oncology Group (ECOG)|The Eastern Cooperative Oncology Group (ECOG) scale is a measure of performance status with 0 (fully active) as the best score and 1 being restricted to physically strenuous activity.|Participants|Count of Participants|39|39.0||||||
3961182|NCT01317199|3783453|B3||0|Eastern Cooperative Oncology Group (ECOG)|The Eastern Cooperative Oncology Group (ECOG) scale is a measure of performance status with 0 (fully active) as the best score and 1 being restricted to physically strenuous activity.|Participants|Count of Participants|52|52.0||||||
3961183|NCT01317199|3783454|B2||0|Eastern Cooperative Oncology Group (ECOG)|The Eastern Cooperative Oncology Group (ECOG) scale is a measure of performance status with 0 (fully active) as the best score and 1 being restricted to physically strenuous activity.|Participants|Count of Participants|18|18.0||||||
3961184|NCT01317199|3783451|B5|United States||Region of Enrollment||participants|Number|143|143.0||||||
3961185|NCT01317199|3783452|B4|United States||Region of Enrollment||participants|Number|49|49.0||||||
3961186|NCT01317199|3783453|B3|United States||Region of Enrollment||participants|Number|56|56.0||||||
3961187|NCT01317199|3783454|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
3961188|NCT01317199|3783455|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3961189|NCT01317199|3783451|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3961190|NCT01317199|3783452|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3961191|NCT01317199|3783453|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3961192|NCT01317199|3783454|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961193|NCT01317199|3783455|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961194|NCT01317199|3783451|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961195|NCT01317199|3783452|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961196|NCT01317199|3783453|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961197|NCT01317199|3783454|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961198|NCT01317199|3783455|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961199|NCT01317199|3783451|B5||White|Race (NIH/OMB)||Participants|Count of Participants|109|109.0||||||
3961200|NCT01317199|3783452|B4||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3961201|NCT01317199|3783453|B3||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3961202|NCT01317199|3783454|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3961203|NCT01317199|3783455|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3961204|NCT01317199|3783451|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3961205|NCT01317199|3783452|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3961206|NCT01317199|3783453|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3961207|NCT01317199|3783454|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3961208|NCT01317199|3783455|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3961209|NCT01317199|3783451|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961210|NCT01317199|3783452|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961211|NCT01317199|3783453|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961212|NCT01317199|3783454|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961213|NCT01317199|3783455|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961214|NCT01317199|3783451|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961215|NCT01317199|3783452|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961216|NCT01317199|3783453|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961217|NCT01317199|3783454|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961223|NCT01317199|3783455|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961224|NCT01317199|3783451|B5||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3961225|NCT01317199|3783452|B4||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3961226|NCT01317199|3783453|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3961227|NCT01317199|3783454|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3961228|NCT01317199|3783455|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3961229|NCT01317199|3783451|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3961230|NCT01317199|3783452|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3961231|NCT01317199|3783453|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3961232|NCT01317199|3783454|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3961233|NCT01317199|3783455|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3961234|NCT01317199|3783451|B5|||Age||years|Mean|67.2|67.2|Standard Deviation|7.1|7.1|||
3961235|NCT01317199|3783452|B4|||Age||years|Mean|68|68.0|Standard Deviation|6.9|6.9|||
3961236|NCT01317199|3783453|B3|||Age||years|Mean|67|67.0|Standard Deviation|7.2|7.2|||
3961237|NCT01317199|3783454|B2|||Age||years|Mean|69|69.0|Standard Deviation|7.1|7.1|||
3961238|NCT01317199|3783455|B1|||Age||years|Mean|62.6|62.6|Standard Deviation|7.5|7.5|||
3961239|NCT01317160|3783485|B3|||Body mass index||Kg/m/m|Mean|26.9|26.9|Full Range|||20.2|41.2|
3961240|NCT01317160|3783486|B2|||Body mass index||Kg/m/m|Mean|27.1|27.1|Full Range|||21.0|41.2|
3961241|NCT01317160|3783487|B1|||Body mass index||Kg/m/m|Mean|26.7|26.7|Full Range|||20.2|35.7|
3961242|NCT01317160|3783485|B3|Tobacco user: No||Tobacco user||participants|Number|127|127.0||||||
3961243|NCT01317160|3783486|B2|Tobacco user: No||Tobacco user||participants|Number|64|64.0||||||
3961244|NCT01317160|3783487|B1|Tobacco user: No||Tobacco user||participants|Number|63|63.0||||||
3961245|NCT01317160|3783485|B3|Tobacco user: Yes||Tobacco user||participants|Number|13|13.0||||||
3961246|NCT01317160|3783486|B2|Tobacco user: Yes||Tobacco user||participants|Number|5|5.0||||||
3961247|NCT01317160|3783487|B1|Tobacco user: Yes||Tobacco user||participants|Number|8|8.0||||||
3961248|NCT01317160|3783485|B3|Sweden||Region of Enrollment||participants|Number|140|140.0||||||
3961249|NCT01317160|3783486|B2|Sweden||Region of Enrollment||participants|Number|69|69.0||||||
3961250|NCT01317160|3783487|B1|Sweden||Region of Enrollment||participants|Number|71|71.0||||||
3961251|NCT01317160|3783485|B3||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3961252|NCT01317160|3783486|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3961253|NCT01317160|3783487|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3961254|NCT01317160|3783485|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3961255|NCT01317160|3783486|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3961256|NCT01317160|3783487|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3961257|NCT01317160|3783485|B3|||Age||years|Mean|40.4|40.4|Full Range|||18.0|71.0|
3961258|NCT01317160|3783486|B2|||Age||years|Mean|40.9|40.9|Full Range|||26.0|62.0|
3961259|NCT01317160|3783487|B1|||Age||years|Mean|39.9|39.9|Full Range|||18.0|71.0|
3961260|NCT01317160|3783485|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3961261|NCT01317160|3783486|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3961262|NCT01317160|3783487|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3961263|NCT01317160|3783485|B3||Between 18 and 65 years|Age||Participants|Count of Participants|139|139.0||||||
3961264|NCT01317160|3783486|B2||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
3961265|NCT01317160|3783487|B1||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
3961266|NCT01317160|3783485|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3961267|NCT01317160|3783486|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3961268|NCT01317160|3783487|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3961269|NCT01317095|3783496|B3|United States||Region of Enrollment||Participants|Count of Participants|80|80.0||||||
3961270|NCT01317095|3783497|B2|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3961271|NCT01317095|3783498|B1|United States||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3961272|NCT01317095|3783496|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3961273|NCT01317095|3783497|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3961274|NCT01317095|3783498|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3961275|NCT01317095|3783496|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3961276|NCT01317095|3783497|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3961277|NCT01317095|3783498|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3961278|NCT01317095|3783496|B3|||Age||years|Mean|65|65.0|Standard Deviation|9|9.0|||
3961279|NCT01317095|3783497|B2|||Age||years|Mean|65|65.0|Standard Deviation|8|8.0|||
3961280|NCT01317095|3783498|B1|||Age||years|Mean|66|66.0|Standard Deviation|9|9.0|||
3961281|NCT01317095|3783496|B3||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
3961282|NCT01317095|3783497|B2||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3961283|NCT01317095|3783498|B1||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
3961284|NCT01317095|3783496|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3961285|NCT01317095|3783497|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3961286|NCT01317095|3783498|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3961287|NCT01317095|3783496|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3961288|NCT01317095|3783497|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3961289|NCT01317095|3783498|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3961290|NCT01317004|3783511|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3961291|NCT01317004|3783512|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3961292|NCT01317004|3783513|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3961293|NCT01317004|3783511|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3961294|NCT01317004|3783512|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3961295|NCT01317004|3783513|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3961296|NCT01317004|3783511|B3|||Age||Years|Mean|37.57|37.57|Standard Deviation|8.43|8.43|||
3961297|NCT01317004|3783512|B2|||Age||Years|Mean|35.82|35.82|Standard Deviation|7.22|7.22|||
3961298|NCT01317004|3783513|B1|||Age||Years|Mean|37.96|37.96|Standard Deviation|8.69|8.69|||
3961299|NCT01316939|3783532|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3961300|NCT01316939|3783533|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961301|NCT01316939|3783534|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3961302|NCT01316939|3783535|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961303|NCT01316939|3783532|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961304|NCT01316939|3783533|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961305|NCT01316939|3783534|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961306|NCT01316939|3783535|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961307|NCT01316939|3783532|B4||White|Race (NIH/OMB)||Participants|Count of Participants|206|206.0||||||
3961308|NCT01316939|3783533|B3||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3961309|NCT01316939|3783534|B2||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3961310|NCT01316939|3783535|B1||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3961311|NCT01316939|3783532|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3961312|NCT01316939|3783533|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961313|NCT01316939|3783534|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3961314|NCT01316939|3783535|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3961315|NCT01316939|3783532|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961316|NCT01316939|3783533|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961317|NCT01316939|3783534|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961318|NCT01316939|3783535|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961319|NCT01316939|3783532|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3961320|NCT01316939|3783533|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3961321|NCT01316939|3783534|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3961322|NCT01316939|3783535|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3961323|NCT01316939|3783532|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3961324|NCT01316939|3783533|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3961325|NCT01316939|3783534|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961326|NCT01316939|3783535|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961327|NCT01316939|3783532|B4||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3961328|NCT01316939|3783533|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3961329|NCT01316939|3783534|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3961330|NCT01316939|3783535|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3961331|NCT01316939|3783532|B4||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3961332|NCT01316939|3783533|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3961333|NCT01316939|3783534|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3961334|NCT01316939|3783535|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3961335|NCT01316939|3783532|B4|||Age||Years|Mean|37.9|37.9|Standard Deviation|12.96|12.96|||
3961336|NCT01316939|3783533|B3|||Age||Years|Mean|38.8|38.8|Standard Deviation|12.75|12.75|||
3961337|NCT01316939|3783534|B2|||Age||Years|Mean|36.7|36.7|Standard Deviation|13.00|13.0|||
3961338|NCT01316939|3783535|B1|||Age||Years|Mean|38.2|38.2|Standard Deviation|13.20|13.2|||
3961339|NCT01316926|3783617|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
3961340|NCT01316926|3783617|B1|Black||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3961341|NCT01316926|3783617|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
3961342|NCT01316926|3783617|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3961343|NCT01316926|3783617|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3961344|NCT01316926|3783617|B1|||Age||Years|Mean|28.85|28.85|Standard Deviation|4.91|4.91|||
3961345|NCT01316913|3783628|B5|Mixed Race||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3961346|NCT01316913|3783629|B4|Mixed Race||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3961347|NCT01316913|3783630|B3|Mixed Race||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3961348|NCT01316913|3783631|B2|Mixed Race||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3961349|NCT01316913|3783632|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3961350|NCT01316913|3783628|B5|White - Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3961351|NCT01316913|3783629|B4|White - Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3961352|NCT01316913|3783630|B3|White - Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3961353|NCT01316913|3783631|B2|White - Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3961354|NCT01316913|3783632|B1|White - Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3961355|NCT01316913|3783628|B5|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|655|655.0||||||
3961356|NCT01316913|3783629|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|163|163.0||||||
3961357|NCT01316913|3783630|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|160|160.0||||||
3961358|NCT01316913|3783631|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|163|163.0||||||
3961359|NCT01316913|3783632|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|169|169.0||||||
3961360|NCT01316913|3783628|B5|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3961361|NCT01316913|3783629|B4|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3961362|NCT01316913|3783630|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3961363|NCT01316913|3783631|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3961364|NCT01316913|3783632|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3961365|NCT01316913|3783628|B5|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3961366|NCT01316913|3783629|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3961367|NCT01316913|3783630|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3961368|NCT01316913|3783631|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3961369|NCT01316913|3783632|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3961370|NCT01316913|3783628|B5|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3961371|NCT01316913|3783629|B4|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3961372|NCT01316913|3783630|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3961373|NCT01316913|3783631|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3961374|NCT01316913|3783632|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3961375|NCT01316913|3783628|B5|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|139|139.0||||||
3961376|NCT01316913|3783629|B4|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
3961377|NCT01316913|3783630|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3961378|NCT01316913|3783631|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
3961379|NCT01316913|3783632|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3961380|NCT01316913|3783628|B5|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3961381|NCT01316913|3783629|B4|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3961382|NCT01316913|3783630|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3961383|NCT01316913|3783631|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3961384|NCT01316913|3783632|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3961385|NCT01316913|3783628|B5||Male|Sex: Female, Male||Participants|Count of Participants|589|589.0||||||
3961386|NCT01316913|3783629|B4||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3961387|NCT01316913|3783630|B3||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3961388|NCT01316913|3783631|B2||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3961389|NCT01316913|3783632|B1||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3961390|NCT01316913|3783628|B5||Female|Sex: Female, Male||Participants|Count of Participants|280|280.0||||||
3961391|NCT01316913|3783629|B4||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3961392|NCT01316913|3783630|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3961393|NCT01316913|3783631|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3961394|NCT01316913|3783632|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3961395|NCT01316913|3783628|B5|||Age||Years|Mean|64.6|64.6|Standard Deviation|8.44|8.44|||
3961396|NCT01316913|3783629|B4|||Age||Years|Mean|65.2|65.2|Standard Deviation|8.30|8.3|||
3961397|NCT01316913|3783630|B3|||Age||Years|Mean|63.8|63.8|Standard Deviation|8.51|8.51|||
3961398|NCT01316913|3783631|B2|||Age||Years|Mean|65.0|65.0|Standard Deviation|8.62|8.62|||
3961399|NCT01316913|3783632|B1|||Age||Years|Mean|64.5|64.5|Standard Deviation|8.33|8.33|||
3961400|NCT01316900|3783653|B5|Mixed Race||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3961401|NCT01316900|3783654|B4|Mixed Race||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3961402|NCT01316900|3783655|B3|Mixed Race||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3961403|NCT01316900|3783656|B2|Mixed Race||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3961404|NCT01316900|3783657|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3961405|NCT01316900|3783653|B5|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|723|723.0||||||
3961406|NCT01316900|3783654|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|177|177.0||||||
3961407|NCT01316900|3783655|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|180|180.0||||||
3961408|NCT01316900|3783656|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|182|182.0||||||
3961409|NCT01316900|3783657|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|184|184.0||||||
3961410|NCT01316900|3783653|B5|Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3961411|NCT01316900|3783654|B4|Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3961412|NCT01316900|3783655|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3961413|NCT01316900|3783656|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3961414|NCT01316900|3783657|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3961415|NCT01316900|3783653|B5|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3961416|NCT01316900|3783654|B4|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3961417|NCT01316900|3783655|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3961418|NCT01316900|3783656|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3961419|NCT01316900|3783657|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3961420|NCT01316900|3783653|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
3961421|NCT01316900|3783654|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3961422|NCT01316900|3783655|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3961423|NCT01316900|3783656|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3961424|NCT01316900|3783657|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3961425|NCT01316900|3783653|B5|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3961426|NCT01316900|3783654|B4|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3961427|NCT01316900|3783655|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3961428|NCT01316900|3783656|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3961429|NCT01316900|3783657|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3961430|NCT01316900|3783653|B5||Male|Sex: Female, Male||Participants|Count of Participants|582|582.0||||||
3961431|NCT01316900|3783654|B4||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3961432|NCT01316900|3783655|B3||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3961433|NCT01316900|3783656|B2||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3961434|NCT01316900|3783657|B1||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3961435|NCT01316900|3783653|B5||Female|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
3961436|NCT01316900|3783654|B4||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3961437|NCT01316900|3783655|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3961438|NCT01316900|3783656|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3961439|NCT01316900|3783657|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3961440|NCT01316900|3783653|B5|||Age||Years|Mean|62.9|62.9|Standard Deviation|9.00|9.0|||
3961441|NCT01316900|3783654|B4|||Age||Years|Mean|62.6|62.6|Standard Deviation|9.39|9.39|||
3961442|NCT01316900|3783655|B3|||Age||Years|Mean|62.9|62.9|Standard Deviation|8.87|8.87|||
3961443|NCT01316900|3783656|B2|||Age||Years|Mean|63.0|63.0|Standard Deviation|8.67|8.67|||
3961444|NCT01316900|3783657|B1|||Age||Years|Mean|63.2|63.2|Standard Deviation|9.10|9.1|||
3961445|NCT01316887|3783678|B4||Male|Sex: Female, Male||Participants|Count of Participants|374|374.0||||||
3961446|NCT01316887|3783679|B3||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3961447|NCT01316887|3783680|B2||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3961448|NCT01316887|3783681|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3961449|NCT01316887|3783678|B4||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3961450|NCT01316887|3783679|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3961451|NCT01316887|3783680|B2||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3961452|NCT01316887|3783681|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3961453|NCT01316887|3783678|B4|White||Sex/Gender, Customized||Participants|Number|529|529.0||||||
3961454|NCT01316887|3783679|B3|White||Sex/Gender, Customized||Participants|Number|211|211.0||||||
3961455|NCT01316887|3783680|B2|White||Sex/Gender, Customized||Participants|Number|214|214.0||||||
3961456|NCT01316887|3783681|B1|White||Sex/Gender, Customized||Participants|Number|104|104.0||||||
3961457|NCT01316887|3783678|B4|Japanese/East Asian HER/South East Asian HER||Sex/Gender, Customized||Participants|Number|3|3.0||||||
3961458|NCT01316887|3783679|B3|Japanese/East Asian HER/South East Asian HER||Sex/Gender, Customized||Participants|Number|1|1.0||||||
3961459|NCT01316887|3783680|B2|Japanese/East Asian HER/South East Asian HER||Sex/Gender, Customized||Participants|Number|0|0.0||||||
3961460|NCT01316887|3783681|B1|Japanese/East Asian HER/South East Asian HER||Sex/Gender, Customized||Participants|Number|2|2.0||||||
3961461|NCT01316887|3783678|B4|African American/African Heritage (HER)||Sex/Gender, Customized||Participants|Number|30|30.0||||||
3961462|NCT01316887|3783679|B3|African American/African Heritage (HER)||Sex/Gender, Customized||Participants|Number|14|14.0||||||
3961463|NCT01316887|3783680|B2|African American/African Heritage (HER)||Sex/Gender, Customized||Participants|Number|13|13.0||||||
3961464|NCT01316887|3783681|B1|African American/African Heritage (HER)||Sex/Gender, Customized||Participants|Number|3|3.0||||||
3961465|NCT01316887|3783678|B4|||Age||Years|Mean|61.3|61.3|Standard Deviation|8.92|8.92|||
3961466|NCT01316887|3783679|B3|||Age||Years|Mean|61.4|61.4|Standard Deviation|9.01|9.01|||
3961467|NCT01316887|3783680|B2|||Age||Years|Mean|61.7|61.7|Standard Deviation|9.10|9.1|||
3961468|NCT01316887|3783681|B1|||Age||Years|Mean|60.1|60.1|Standard Deviation|8.28|8.28|||
3961469|NCT01316770|3783745|B1|Not randomized, left-side parotid|Not done|Technetium Release with Stimulation|Baseline table counts are the count of parotid glands (2 per participant).|parotid glands|Count of Units|1|1.0||||||
3961470|NCT01316770|3783745|B1|Not randomized, left-side parotid|No|Technetium Release with Stimulation|Baseline table counts are the count of parotid glands (2 per participant).|parotid glands|Count of Units|0|0.0||||||
3961471|NCT01316770|3783745|B1|Not randomized, left-side parotid|Yes|Technetium Release with Stimulation|Baseline table counts are the count of parotid glands (2 per participant).|parotid glands|Count of Units|1|1.0||||||
3961472|NCT01316770|3783745|B1|Not randomized, right-side parotid|Not done|Technetium Release with Stimulation|Baseline table counts are the count of parotid glands (2 per participant).|parotid glands|Count of Units|1|1.0||||||
3961473|NCT01316770|3783745|B1|Not randomized, right-side parotid|No|Technetium Release with Stimulation|Baseline table counts are the count of parotid glands (2 per participant).|parotid glands|Count of Units|0|0.0||||||
3961474|NCT01316770|3783745|B1|Not randomized, right-side parotid|Yes|Technetium Release with Stimulation|Baseline table counts are the count of parotid glands (2 per participant).|parotid glands|Count of Units|1|1.0||||||
3961475|NCT01316770|3783745|B1|Parotid randomized to placebo irrigation|Not done|Technetium Release with Stimulation|Baseline table counts are the count of parotid glands (2 per participant).|parotid glands|Count of Units|0|0.0||||||
3961476|NCT01316770|3783745|B1|Parotid randomized to placebo irrigation|No|Technetium Release with Stimulation|Baseline table counts are the count of parotid glands (2 per participant).|parotid glands|Count of Units|2|2.0||||||
3961477|NCT01316770|3783745|B1|Parotid randomized to placebo irrigation|Yes|Technetium Release with Stimulation|Baseline table counts are the count of parotid glands (2 per participant).|parotid glands|Count of Units|7|7.0||||||
3961478|NCT01316770|3783745|B1|Parotid randomized to dexamethasone irrigation|Not done|Technetium Release with Stimulation|Baseline table counts are the count of parotid glands (2 per participant).|parotid glands|Count of Units|0|0.0||||||
3961479|NCT01316770|3783745|B1|Parotid randomized to dexamethasone irrigation|No|Technetium Release with Stimulation|Baseline table counts are the count of parotid glands (2 per participant).|parotid glands|Count of Units|1|1.0||||||
3961480|NCT01316770|3783745|B1|Parotid randomized to dexamethasone irrigation|Yes|Technetium Release with Stimulation|Baseline table counts are the count of parotid glands (2 per participant).|parotid glands|Count of Units|8|8.0||||||
3961481|NCT01316770|3783745|B1|Not randomized, left-side parotid|Not done|Technetium Isotope Uptake|Baseline table counts are the count of parotid glands (2 per participant).|parotid glands|Count of Units|1|1.0||||||
3961482|NCT01316770|3783745|B1|Not randomized, left-side parotid|No|Technetium Isotope Uptake|Baseline table counts are the count of parotid glands (2 per participant).|parotid glands|Count of Units|0|0.0||||||
3961483|NCT01316770|3783745|B1|Not randomized, left-side parotid|Yes|Technetium Isotope Uptake|Baseline table counts are the count of parotid glands (2 per participant).|parotid glands|Count of Units|1|1.0||||||
3961484|NCT01316770|3783745|B1|Not randomized, right-side parotid|Not done|Technetium Isotope Uptake|Baseline table counts are the count of parotid glands (2 per participant).|parotid glands|Count of Units|1|1.0||||||
3961485|NCT01316770|3783745|B1|Not randomized, right-side parotid|No|Technetium Isotope Uptake|Baseline table counts are the count of parotid glands (2 per participant).|parotid glands|Count of Units|0|0.0||||||
3961486|NCT01316770|3783745|B1|Not randomized, right-side parotid|Yes|Technetium Isotope Uptake|Baseline table counts are the count of parotid glands (2 per participant).|parotid glands|Count of Units|1|1.0||||||
3961487|NCT01316770|3783745|B1|Parotid randomized to placebo irrigation|Not done|Technetium Isotope Uptake|Baseline table counts are the count of parotid glands (2 per participant).|parotid glands|Count of Units|0|0.0||||||
3961488|NCT01316770|3783745|B1|Parotid randomized to placebo irrigation|No|Technetium Isotope Uptake|Baseline table counts are the count of parotid glands (2 per participant).|parotid glands|Count of Units|0|0.0||||||
3961489|NCT01316770|3783745|B1|Parotid randomized to placebo irrigation|Yes|Technetium Isotope Uptake|Baseline table counts are the count of parotid glands (2 per participant).|parotid glands|Count of Units|9|9.0||||||
3961490|NCT01316770|3783745|B1|Parotid randomized to dexamethasone irrigation|Not done|Technetium Isotope Uptake|Baseline table counts are the count of parotid glands (2 per participant).|parotid glands|Count of Units|0|0.0||||||
3961491|NCT01316770|3783745|B1|Parotid randomized to dexamethasone irrigation|No|Technetium Isotope Uptake|Baseline table counts are the count of parotid glands (2 per participant).|parotid glands|Count of Units|0|0.0||||||
3961492|NCT01316770|3783745|B1|Parotid randomized to dexamethasone irrigation|Yes|Technetium Isotope Uptake|Baseline table counts are the count of parotid glands (2 per participant).|parotid glands|Count of Units|9|9.0||||||
3961493|NCT01316770|3783745|B1|Not randomized, left-side parotid|Not done|Technetium Scan Evaluation|Baseline table counts are the count of parotid glands (2 per participant)|parotid glands|Count of Units|1|1.0||||||
3961494|NCT01316770|3783745|B1|Not randomized, left-side parotid|Abnormal|Technetium Scan Evaluation|Baseline table counts are the count of parotid glands (2 per participant)|parotid glands|Count of Units|1|1.0||||||
3961495|NCT01316770|3783745|B1|Not randomized, left-side parotid|Normal|Technetium Scan Evaluation|Baseline table counts are the count of parotid glands (2 per participant)|parotid glands|Count of Units|0|0.0||||||
3961496|NCT01316770|3783745|B1|Not randomized, right-side parotid|Not done|Technetium Scan Evaluation|Baseline table counts are the count of parotid glands (2 per participant)|parotid glands|Count of Units|1|1.0||||||
3961497|NCT01316770|3783745|B1|Not randomized, right-side parotid|Abnormal|Technetium Scan Evaluation|Baseline table counts are the count of parotid glands (2 per participant)|parotid glands|Count of Units|1|1.0||||||
3961498|NCT01316770|3783745|B1|Not randomized, right-side parotid|Normal|Technetium Scan Evaluation|Baseline table counts are the count of parotid glands (2 per participant)|parotid glands|Count of Units|0|0.0||||||
3961499|NCT01316770|3783745|B1|Placebo randomized parotid: Normal|Not done|Technetium Scan Evaluation|Baseline table counts are the count of parotid glands (2 per participant)|parotid glands|Count of Units|0|0.0||||||
3961500|NCT01316770|3783745|B1|Placebo randomized parotid: Normal|Abnormal|Technetium Scan Evaluation|Baseline table counts are the count of parotid glands (2 per participant)|parotid glands|Count of Units|5|5.0||||||
3961501|NCT01316770|3783745|B1|Placebo randomized parotid: Normal|Normal|Technetium Scan Evaluation|Baseline table counts are the count of parotid glands (2 per participant)|parotid glands|Count of Units|4|4.0||||||
3961502|NCT01316770|3783745|B1|Parotid randomized to dexamethasone irrigation|Not done|Technetium Scan Evaluation|Baseline table counts are the count of parotid glands (2 per participant)|parotid glands|Count of Units|0|0.0||||||
3961503|NCT01316770|3783745|B1|Parotid randomized to dexamethasone irrigation|Abnormal|Technetium Scan Evaluation|Baseline table counts are the count of parotid glands (2 per participant)|parotid glands|Count of Units|5|5.0||||||
3961504|NCT01316770|3783745|B1|Parotid randomized to dexamethasone irrigation|Normal|Technetium Scan Evaluation|Baseline table counts are the count of parotid glands (2 per participant)|parotid glands|Count of Units|4|4.0||||||
3961505|NCT01316770|3783745|B1|Not randomized, left-side parotid|Not done|MRI Scan Evaluation|"Baseline table counts are the count of parotid glands (2 per participant). In the table: Abnormal, not clinically significant is abbreviated as Abnormal ncs; Abnormal, clinically significant is abbreviated as Abnormal cs."|parotid glands|Count of Units|2|2.0||||||
3961506|NCT01316770|3783745|B1|Not randomized, left-side parotid|Abnormal cs|MRI Scan Evaluation|"Baseline table counts are the count of parotid glands (2 per participant). In the table: Abnormal, not clinically significant is abbreviated as Abnormal ncs; Abnormal, clinically significant is abbreviated as Abnormal cs."|parotid glands|Count of Units|0|0.0||||||
3961507|NCT01316770|3783745|B1|Not randomized, left-side parotid|Abnormal ncs|MRI Scan Evaluation|"Baseline table counts are the count of parotid glands (2 per participant). In the table: Abnormal, not clinically significant is abbreviated as Abnormal ncs; Abnormal, clinically significant is abbreviated as Abnormal cs."|parotid glands|Count of Units|0|0.0||||||
3961508|NCT01316770|3783745|B1|Not randomized, left-side parotid|Normal|MRI Scan Evaluation|"Baseline table counts are the count of parotid glands (2 per participant). In the table: Abnormal, not clinically significant is abbreviated as Abnormal ncs; Abnormal, clinically significant is abbreviated as Abnormal cs."|parotid glands|Count of Units|0|0.0||||||
3961509|NCT01316770|3783745|B1|Not randomized, right-side parotid|Not done|MRI Scan Evaluation|"Baseline table counts are the count of parotid glands (2 per participant). In the table: Abnormal, not clinically significant is abbreviated as Abnormal ncs; Abnormal, clinically significant is abbreviated as Abnormal cs."|parotid glands|Count of Units|2|2.0||||||
3961510|NCT01316770|3783745|B1|Not randomized, right-side parotid|Abnormal cs|MRI Scan Evaluation|"Baseline table counts are the count of parotid glands (2 per participant). In the table: Abnormal, not clinically significant is abbreviated as Abnormal ncs; Abnormal, clinically significant is abbreviated as Abnormal cs."|parotid glands|Count of Units|0|0.0||||||
3961511|NCT01316770|3783745|B1|Not randomized, right-side parotid|Abnormal ncs|MRI Scan Evaluation|"Baseline table counts are the count of parotid glands (2 per participant). In the table: Abnormal, not clinically significant is abbreviated as Abnormal ncs; Abnormal, clinically significant is abbreviated as Abnormal cs."|parotid glands|Count of Units|0|0.0||||||
3961512|NCT01316770|3783745|B1|Not randomized, right-side parotid|Normal|MRI Scan Evaluation|"Baseline table counts are the count of parotid glands (2 per participant). In the table: Abnormal, not clinically significant is abbreviated as Abnormal ncs; Abnormal, clinically significant is abbreviated as Abnormal cs."|parotid glands|Count of Units|0|0.0||||||
3961513|NCT01316770|3783745|B1|Parotid randomized to placebo irrigation|Not done|MRI Scan Evaluation|"Baseline table counts are the count of parotid glands (2 per participant). In the table: Abnormal, not clinically significant is abbreviated as Abnormal ncs; Abnormal, clinically significant is abbreviated as Abnormal cs."|parotid glands|Count of Units|0|0.0||||||
3961514|NCT01316770|3783745|B1|Parotid randomized to placebo irrigation|Abnormal cs|MRI Scan Evaluation|"Baseline table counts are the count of parotid glands (2 per participant). In the table: Abnormal, not clinically significant is abbreviated as Abnormal ncs; Abnormal, clinically significant is abbreviated as Abnormal cs."|parotid glands|Count of Units|0|0.0||||||
3961515|NCT01316770|3783745|B1|Parotid randomized to placebo irrigation|Abnormal ncs|MRI Scan Evaluation|"Baseline table counts are the count of parotid glands (2 per participant). In the table: Abnormal, not clinically significant is abbreviated as Abnormal ncs; Abnormal, clinically significant is abbreviated as Abnormal cs."|parotid glands|Count of Units|4|4.0||||||
3961516|NCT01316770|3783745|B1|Parotid randomized to placebo irrigation|Normal|MRI Scan Evaluation|"Baseline table counts are the count of parotid glands (2 per participant). In the table: Abnormal, not clinically significant is abbreviated as Abnormal ncs; Abnormal, clinically significant is abbreviated as Abnormal cs."|parotid glands|Count of Units|5|5.0||||||
3961517|NCT01316770|3783745|B1|Parotid randomized to dexamethasone irrigation|Not done|MRI Scan Evaluation|"Baseline table counts are the count of parotid glands (2 per participant). In the table: Abnormal, not clinically significant is abbreviated as Abnormal ncs; Abnormal, clinically significant is abbreviated as Abnormal cs."|parotid glands|Count of Units|0|0.0||||||
3961518|NCT01316770|3783745|B1|Parotid randomized to dexamethasone irrigation|Abnormal cs|MRI Scan Evaluation|"Baseline table counts are the count of parotid glands (2 per participant). In the table: Abnormal, not clinically significant is abbreviated as Abnormal ncs; Abnormal, clinically significant is abbreviated as Abnormal cs."|parotid glands|Count of Units|0|0.0||||||
3961519|NCT01316770|3783745|B1|Parotid randomized to dexamethasone irrigation|Abnormal ncs|MRI Scan Evaluation|"Baseline table counts are the count of parotid glands (2 per participant). In the table: Abnormal, not clinically significant is abbreviated as Abnormal ncs; Abnormal, clinically significant is abbreviated as Abnormal cs."|parotid glands|Count of Units|4|4.0||||||
3961520|NCT01316770|3783745|B1|Parotid randomized to dexamethasone irrigation|Normal|MRI Scan Evaluation|"Baseline table counts are the count of parotid glands (2 per participant). In the table: Abnormal, not clinically significant is abbreviated as Abnormal ncs; Abnormal, clinically significant is abbreviated as Abnormal cs."|parotid glands|Count of Units|5|5.0||||||
3961521|NCT01316770|3783745|B1|Parotid randomized to placebo irrigation||Focus Score|Focus score is the number of mononuclear cell infiltrates containing at least 50 inflammatory cells in a 4 mm² glandular section. Focus scores ≥1 are key criteria used in the diagnosis of inflammation in the oral component of Sjögren's Syndrome. Higher numbers are associated with more inflammation. (Range 0-12).|score on a scale|Median|1.5|1.5|Full Range|||0.0|2.0|
3961522|NCT01316770|3783745|B1|Parotid randomized to dexamethasone irrigation||Focus Score|Focus score is the number of mononuclear cell infiltrates containing at least 50 inflammatory cells in a 4 mm² glandular section. Focus scores ≥1 are key criteria used in the diagnosis of inflammation in the oral component of Sjögren's Syndrome. Higher numbers are associated with more inflammation. (Range 0-12).|score on a scale|Median|2.5|2.5|Full Range|||1.0|12.0|
3961523|NCT01316770|3783745|B1|Parotid randomized to placebo irrigation||Saliva Flow||mL/min|Mean|0.19096|0.19096|Standard Deviation|0.136399|0.136399|||
3961524|NCT01316770|3783745|B1|Parotid randomized to dexamethasone irrigation||Saliva Flow||mL/min|Mean|0.21250|0.2125|Standard Deviation|0.158850|0.15885|||
3961525|NCT01316770|3783745|B1|Not randomized, left-side parotid||Parotid Fill Volume|Fill volumes were determined by injecting saline using a syringe into the parotid. Injection was terminated when the parotid volume was full or a maximum of 1 mL was injected.|mL/min|Median|0.875|0.875|Full Range|||0.75|1.0|
3961526|NCT01316770|3783745|B1|Not randomized, right-side parotid||Parotid Fill Volume|Fill volumes were determined by injecting saline using a syringe into the parotid. Injection was terminated when the parotid volume was full or a maximum of 1 mL was injected.|mL/min|Median|0.875|0.875|Full Range|||0.75|1.0|
3961527|NCT01316770|3783745|B1|Parotid randomized to placebo irrigation||Parotid Fill Volume|Fill volumes were determined by injecting saline using a syringe into the parotid. Injection was terminated when the parotid volume was full or a maximum of 1 mL was injected.|mL/min|Median|1.0|1.0|Full Range|||0.7|1.0|
3961528|NCT01316770|3783745|B1|Parotid randomized to dexamethasone irrigation||Parotid Fill Volume|Fill volumes were determined by injecting saline using a syringe into the parotid. Injection was terminated when the parotid volume was full or a maximum of 1 mL was injected.|mL/min|Median|1.0|1.0|Full Range|||0.6|1.0|
3961529|NCT01316770|3783745|B1|||Height||cm|Mean|158.68|158.68|Full Range|||132.0|170.5|
3961530|NCT01316770|3783745|B1|||Weight||kg|Mean|68.95|68.95|Full Range|||57.1|78.1|
3961531|NCT01316770|3783745|B1|||Waist Circumference||cm|Mean|98.0|98.0|Full Range|||95.0|101.0|
3961532|NCT01316770|3783745|B1|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3961533|NCT01316770|3783745|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3961534|NCT01316770|3783745|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961535|NCT01316770|3783745|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3961536|NCT01316770|3783745|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3961537|NCT01316770|3783745|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961538|NCT01316770|3783745|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3961539|NCT01316770|3783745|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961540|NCT01316770|3783745|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961541|NCT01316770|3783745|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3961542|NCT01316770|3783745|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3961543|NCT01316770|3783745|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3961544|NCT01316770|3783745|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3961545|NCT01316770|3783745|B1|Age Category|Missing|Age, Customized||Participants|Count of Participants|1|1.0||||||
3961546|NCT01316770|3783745|B1|Age Category|66-70 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3961547|NCT01316770|3783745|B1|Age Category|61-65 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
3961548|NCT01316770|3783745|B1|Age Category|51-60 years|Age, Customized||Participants|Count of Participants|6|6.0||||||
3961549|NCT01316770|3783745|B1|Age Category|41-50 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
3961550|NCT01316770|3783745|B1|Age Category|31-40 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
3961551|NCT01316770|3783745|B1|Age Category|18-30 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3961552|NCT01316692|3783808|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3961553|NCT01316692|3783808|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961554|NCT01316692|3783808|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961555|NCT01316692|3783808|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3961556|NCT01316692|3783808|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3961557|NCT01316692|3783808|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961558|NCT01316692|3783808|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961559|NCT01316692|3783808|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961560|NCT01316692|3783808|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961561|NCT01316692|3783808|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3961562|NCT01316692|3783808|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961563|NCT01316692|3783808|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3961564|NCT01316692|3783808|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3961565|NCT01316692|3783808|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3961566|NCT01316692|3783808|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3961567|NCT01316692|3783808|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3961568|NCT01316614|3783817|B1|25-gauge||Needle gauge used||participants|Number|23|23.0||||||
3961569|NCT01316614|3783817|B1|22-gauge||Needle gauge used||participants|Number|77|77.0||||||
3961570|NCT01316614|3783817|B1|Mixed echogenicity||Tissue echogenecity||participants|Number|14|14.0||||||
3961571|NCT01316614|3783817|B1|Hypoechoic||Tissue echogenecity||participants|Number|86|86.0||||||
3961572|NCT01316614|3783817|B1|All other lesions||Size of lesions||centimeters (cm)|Mean|3.35|3.35|Standard Deviation|4.0|4.0|||
3961573|NCT01316614|3783817|B1|Lymph node||Size of lesions||centimeters (cm)|Mean|2.08|2.08|Standard Deviation|1.3|1.3|||
3961574|NCT01316614|3783817|B1|Pancreas||Size of lesions||centimeters (cm)|Mean|3.18|3.18|Standard Deviation|1.53|1.53|||
3961575|NCT01316614|3783817|B1|All lesions||Size of lesions||centimeters (cm)|Mean|2.95|2.95|Standard Deviation|21.8|21.8|||
3961576|NCT01316614|3783817|B1|Mediastinal mass||Lesions that underwent EUS-FNA||participants|Number|2|2.0||||||
3961577|NCT01316614|3783817|B1|Left adrenal gland||Lesions that underwent EUS-FNA||participants|Number|1|1.0||||||
3961578|NCT01316614|3783817|B1|Ampulla||Lesions that underwent EUS-FNA||participants|Number|1|1.0||||||
3961579|NCT01316614|3783817|B1|Liver||Lesions that underwent EUS-FNA||participants|Number|1|1.0||||||
3961580|NCT01316614|3783817|B1|Hilar mass||Lesions that underwent EUS-FNA||participants|Number|1|1.0||||||
3961581|NCT01316614|3783817|B1|Biliary stricture||Lesions that underwent EUS-FNA||participants|Number|3|3.0||||||
3961582|NCT01316614|3783817|B1|Esophageal subepithelial lesion||Lesions that underwent EUS-FNA||participants|Number|2|2.0||||||
3961583|NCT01316614|3783817|B1|Gastric subepithelial lesion||Lesions that underwent EUS-FNA||participants|Number|6|6.0||||||
3961584|NCT01316614|3783817|B1|Lymph nodes||Lesions that underwent EUS-FNA||participants|Number|25|25.0||||||
3961585|NCT01316614|3783817|B1|Pancreatic masses||Lesions that underwent EUS-FNA||participants|Number|58|58.0||||||
3961586|NCT01316614|3783817|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
3961587|NCT01316614|3783817|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961588|NCT01316614|3783817|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961589|NCT01316614|3783817|B1||White|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3961590|NCT01316614|3783817|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3961591|NCT01316614|3783817|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961592|NCT01316614|3783817|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961593|NCT01316614|3783817|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961594|NCT01316614|3783817|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3961595|NCT01316614|3783817|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3961596|NCT01316614|3783817|B1|||Age||years|Mean|65.5|65.5|Standard Deviation|10.9|10.9|||
3961597|NCT01316575|3783832|B3|Canada||Region of Enrollment||participants|Number|40|40.0||||||
3961598|NCT01316575|3783833|B2|Canada||Region of Enrollment||participants|Number|20|20.0||||||
3961599|NCT01316575|3783834|B1|Canada||Region of Enrollment||participants|Number|20|20.0||||||
3961600|NCT01316575|3783832|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3961601|NCT01316575|3783833|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3961602|NCT01316575|3783834|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3961603|NCT01316575|3783832|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3961604|NCT01316575|3783833|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3961605|NCT01316575|3783834|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3961606|NCT01316575|3783832|B3|||Age||years|Mean|62|62.0|Standard Deviation|11.6|11.6|||
3961607|NCT01316575|3783833|B2|||Age||years|Mean|61|61.0|Standard Deviation|11.4|11.4|||
3961608|NCT01316575|3783834|B1|||Age||years|Mean|63|63.0|Standard Deviation|12|12.0|||
3961609|NCT01316510|3783847|B3|||Birth weight||Grams|Mean|2541|2541.0|Standard Deviation|380|380.0|||
3961610|NCT01316510|3783848|B2|||Birth weight||Grams|Mean|2550|2550.0|Standard Deviation|342|342.0|||
3961611|NCT01316510|3783849|B1|||Birth weight||Grams|Mean|2533|2533.0|Standard Deviation|431|431.0|||
3961612|NCT01316510|3783847|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
3961613|NCT01316510|3783848|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3961614|NCT01316510|3783849|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3961615|NCT01316510|3783847|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3961616|NCT01316510|3783848|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3961617|NCT01316510|3783849|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3961618|NCT01316510|3783847|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3961619|NCT01316510|3783848|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3961620|NCT01316510|3783849|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3961621|NCT01316510|3783847|B3|Gestational Age||Age, Customized||Weeks|Median|37|37.0|Inter-Quartile Range|||36.0|37.0|
3961622|NCT01316510|3783848|B2|Gestational Age||Age, Customized||Weeks|Median|37|37.0|Inter-Quartile Range|||36.0|37.0|
3961623|NCT01316510|3783849|B1|Gestational Age||Age, Customized||Weeks|Median|36.5|36.5|Inter-Quartile Range|||35.75|37.0|
3961624|NCT01316419|3783858|B1||Male|Sex: Female, Male||Participants|Count of Participants|1046|1046.0||||||
3961625|NCT01316419|3783858|B1||Female|Sex: Female, Male||Participants|Count of Participants|778|778.0||||||
3961626|NCT01316419|3783858|B1|||Age||years|Mean|57.65|57.65|Standard Deviation|13.38|13.38|||
3961627|NCT01316380|3783881|B4||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3961628|NCT01316380|3783882|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3961629|NCT01316380|3783883|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3961630|NCT01316380|3783884|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3961631|NCT01316380|3783881|B4||Female|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
3961632|NCT01316380|3783882|B3||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3961633|NCT01316380|3783883|B2||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3961634|NCT01316380|3783884|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3961635|NCT01316380|3783881|B4|||Age||Years|Mean|42.9|42.9|Standard Deviation|13|13.0|||
3961636|NCT01316380|3783882|B3|||Age||Years|Mean|41.9|41.9|Standard Deviation|13.0|13.0|||
3961637|NCT01316380|3783883|B2|||Age||Years|Mean|43.8|43.8|Standard Deviation|14.0|14.0|||
3961638|NCT01316380|3783884|B1|||Age||Years|Mean|42.8|42.8|Standard Deviation|12.1|12.1|||
3961639|NCT01316341|3783924|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3961640|NCT01316341|3783925|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3961641|NCT01316341|3783926|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3961642|NCT01316341|3783927|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3961643|NCT01316341|3783924|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3961644|NCT01316341|3783925|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3961645|NCT01316341|3783926|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3961646|NCT01316341|3783927|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3961647|NCT01316341|3783924|B4|||Age||years|Mean|53.4|53.4|Standard Deviation|8.7|8.7|||
3961648|NCT01316341|3783925|B3|||Age||years|Mean|52.7|52.7|Standard Deviation|9.9|9.9|||
3961649|NCT01316341|3783926|B2|||Age||years|Mean|54.1|54.1|Standard Deviation|7.9|7.9|||
3961650|NCT01316341|3783927|B1|||Age||years|Mean|53.5|53.5|Standard Deviation|9.6|9.6|||
3961651|NCT01316315|3783995|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
3961652|NCT01316315|3783996|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3961653|NCT01316315|3783997|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3961654|NCT01316315|3783995|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961655|NCT01316315|3783996|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961656|NCT01316315|3783997|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961657|NCT01316315|3783995|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3961658|NCT01316315|3783996|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3961659|NCT01316315|3783997|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3961660|NCT01316315|3783995|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3961661|NCT01316315|3783996|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3961662|NCT01316315|3783997|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961663|NCT01316315|3783995|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3961664|NCT01316315|3783996|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961665|NCT01316315|3783997|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3961666|NCT01316315|3783995|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961667|NCT01316315|3783996|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961668|NCT01316315|3783997|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961669|NCT01316315|3783995|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3961670|NCT01316315|3783996|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3961671|NCT01316315|3783997|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3961672|NCT01316315|3783995|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3961673|NCT01316315|3783996|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961674|NCT01316315|3783997|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3961675|NCT01316315|3783995|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961676|NCT01316315|3783996|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961677|NCT01316315|3783997|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961678|NCT01316315|3783995|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961679|NCT01316315|3783996|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961680|NCT01316315|3783997|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961681|NCT01316315|3783995|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961682|NCT01316315|3783996|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961683|NCT01316315|3783997|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961684|NCT01316315|3783995|B3||Male|Sex: Female, Male|Any patient that received a dose of N6022 or placebo|Participants|Count of Participants|12|12.0||||||
3961685|NCT01316315|3783996|B2||Male|Sex: Female, Male|Any patient that received a dose of N6022 or placebo|Participants|Count of Participants|6|6.0||||||
3961686|NCT01316315|3783997|B1||Male|Sex: Female, Male|Any patient that received a dose of N6022 or placebo|Participants|Count of Participants|6|6.0||||||
3961687|NCT01316315|3783995|B3||Female|Sex: Female, Male|Any patient that received a dose of N6022 or placebo|Participants|Count of Participants|2|2.0||||||
3961688|NCT01316315|3783996|B2||Female|Sex: Female, Male|Any patient that received a dose of N6022 or placebo|Participants|Count of Participants|1|1.0||||||
3961689|NCT01316315|3783997|B1||Female|Sex: Female, Male|Any patient that received a dose of N6022 or placebo|Participants|Count of Participants|1|1.0||||||
3961690|NCT01316315|3783995|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3961691|NCT01316315|3783996|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3961692|NCT01316315|3783997|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3961693|NCT01316315|3783995|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3961694|NCT01316315|3783996|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3961695|NCT01316315|3783997|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3961696|NCT01316315|3783995|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3961697|NCT01316315|3783996|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3961698|NCT01316315|3783997|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3961699|NCT01316302|3784010|B3|United States||Region of Enrollment||participants|Number|63|63.0||||||
3961700|NCT01316302|3784011|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
3961701|NCT01316302|3784012|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3961702|NCT01316302|3784010|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3961703|NCT01316302|3784011|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3961704|NCT01316302|3784012|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3961705|NCT01316302|3784010|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3961706|NCT01316302|3784011|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3961707|NCT01316302|3784012|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3961708|NCT01316302|3784010|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3961709|NCT01316302|3784011|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3961710|NCT01316302|3784012|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3961711|NCT01316302|3784010|B3||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
3961712|NCT01316302|3784011|B2||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3961713|NCT01316302|3784012|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3961714|NCT01316302|3784010|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3961715|NCT01316302|3784011|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3961716|NCT01316302|3784012|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3961717|NCT01316302|3784010|B3|||Age||years|Mean|40.0|40.0|Standard Deviation|19.9|19.9|||
3961718|NCT01316302|3784011|B2|||Age||years|Mean|41.9|41.9|Standard Deviation|13.7|13.7|||
3961719|NCT01316302|3784012|B1|||Age||years|Mean|39.9|39.9|Standard Deviation|14.6|14.6|||
3961720|NCT01316263|3784023|B3|Missing||Current M Classification Staging|Staging: presence or absence of distance metastasis, including lymph nodes that were not regional. M0=no distant metastasis; M1=distant metastasis; MX=distance metastasis could not be assessed.|participants|Number|2|2.0||||||
3961721|NCT01316263|3784024|B2|Missing||Current M Classification Staging|Staging: presence or absence of distance metastasis, including lymph nodes that were not regional. M0=no distant metastasis; M1=distant metastasis; MX=distance metastasis could not be assessed.|participants|Number|1|1.0||||||
3961722|NCT01316263|3784025|B1|Missing||Current M Classification Staging|Staging: presence or absence of distance metastasis, including lymph nodes that were not regional. M0=no distant metastasis; M1=distant metastasis; MX=distance metastasis could not be assessed.|participants|Number|1|1.0||||||
3961723|NCT01316263|3784023|B3|M1||Current M Classification Staging|Staging: presence or absence of distance metastasis, including lymph nodes that were not regional. M0=no distant metastasis; M1=distant metastasis; MX=distance metastasis could not be assessed.|participants|Number|19|19.0||||||
3961724|NCT01316263|3784024|B2|M1||Current M Classification Staging|Staging: presence or absence of distance metastasis, including lymph nodes that were not regional. M0=no distant metastasis; M1=distant metastasis; MX=distance metastasis could not be assessed.|participants|Number|13|13.0||||||
3961725|NCT01316263|3784025|B1|M1||Current M Classification Staging|Staging: presence or absence of distance metastasis, including lymph nodes that were not regional. M0=no distant metastasis; M1=distant metastasis; MX=distance metastasis could not be assessed.|participants|Number|6|6.0||||||
3961726|NCT01316263|3784023|B3|Missing||Current N Classification Staging|Staging: N0=no regional lymph nodes metastasis; N1 to N3=Regional lymph node metastasis, higher number indicated greater involvement.|participants|Number|4|4.0||||||
3961727|NCT01316263|3784024|B2|Missing||Current N Classification Staging|Staging: N0=no regional lymph nodes metastasis; N1 to N3=Regional lymph node metastasis, higher number indicated greater involvement.|participants|Number|3|3.0||||||
3961728|NCT01316263|3784025|B1|Missing||Current N Classification Staging|Staging: N0=no regional lymph nodes metastasis; N1 to N3=Regional lymph node metastasis, higher number indicated greater involvement.|participants|Number|1|1.0||||||
3961729|NCT01316263|3784023|B3|N2||Current N Classification Staging|Staging: N0=no regional lymph nodes metastasis; N1 to N3=Regional lymph node metastasis, higher number indicated greater involvement.|participants|Number|1|1.0||||||
3961730|NCT01316263|3784024|B2|N2||Current N Classification Staging|Staging: N0=no regional lymph nodes metastasis; N1 to N3=Regional lymph node metastasis, higher number indicated greater involvement.|participants|Number|0|0.0||||||
3961731|NCT01316263|3784025|B1|N2||Current N Classification Staging|Staging: N0=no regional lymph nodes metastasis; N1 to N3=Regional lymph node metastasis, higher number indicated greater involvement.|participants|Number|1|1.0||||||
3961732|NCT01316263|3784023|B3|N1||Current N Classification Staging|Staging: N0=no regional lymph nodes metastasis; N1 to N3=Regional lymph node metastasis, higher number indicated greater involvement.|participants|Number|3|3.0||||||
3961733|NCT01316263|3784024|B2|N1||Current N Classification Staging|Staging: N0=no regional lymph nodes metastasis; N1 to N3=Regional lymph node metastasis, higher number indicated greater involvement.|participants|Number|3|3.0||||||
3961734|NCT01316263|3784025|B1|N1||Current N Classification Staging|Staging: N0=no regional lymph nodes metastasis; N1 to N3=Regional lymph node metastasis, higher number indicated greater involvement.|participants|Number|0|0.0||||||
3961735|NCT01316263|3784023|B3|N0||Current N Classification Staging|Staging: N0=no regional lymph nodes metastasis; N1 to N3=Regional lymph node metastasis, higher number indicated greater involvement.|participants|Number|13|13.0||||||
3961736|NCT01316263|3784024|B2|N0||Current N Classification Staging|Staging: N0=no regional lymph nodes metastasis; N1 to N3=Regional lymph node metastasis, higher number indicated greater involvement.|participants|Number|8|8.0||||||
3961737|NCT01316263|3784025|B1|N0||Current N Classification Staging|Staging: N0=no regional lymph nodes metastasis; N1 to N3=Regional lymph node metastasis, higher number indicated greater involvement.|participants|Number|5|5.0||||||
3961738|NCT01316263|3784023|B3|Missing||Current T Classification Staging|Staging: T0=no evidence of primary tumor; Tis=Carcinoma in situ; T1 to 4=presence of tumors, higher numbers indicate increased size, extent or degree of penetration; TX=primary tumor could not be assessed.|participants|Number|2|2.0||||||
3961739|NCT01316263|3784024|B2|Missing||Current T Classification Staging|Staging: T0=no evidence of primary tumor; Tis=Carcinoma in situ; T1 to 4=presence of tumors, higher numbers indicate increased size, extent or degree of penetration; TX=primary tumor could not be assessed.|participants|Number|1|1.0||||||
3961740|NCT01316263|3784025|B1|Missing||Current T Classification Staging|Staging: T0=no evidence of primary tumor; Tis=Carcinoma in situ; T1 to 4=presence of tumors, higher numbers indicate increased size, extent or degree of penetration; TX=primary tumor could not be assessed.|participants|Number|1|1.0||||||
3961741|NCT01316263|3784023|B3|Unknown||Current T Classification Staging|Staging: T0=no evidence of primary tumor; Tis=Carcinoma in situ; T1 to 4=presence of tumors, higher numbers indicate increased size, extent or degree of penetration; TX=primary tumor could not be assessed.|participants|Number|1|1.0||||||
3961742|NCT01316263|3784024|B2|Unknown||Current T Classification Staging|Staging: T0=no evidence of primary tumor; Tis=Carcinoma in situ; T1 to 4=presence of tumors, higher numbers indicate increased size, extent or degree of penetration; TX=primary tumor could not be assessed.|participants|Number|1|1.0||||||
3961743|NCT01316263|3784025|B1|Unknown||Current T Classification Staging|Staging: T0=no evidence of primary tumor; Tis=Carcinoma in situ; T1 to 4=presence of tumors, higher numbers indicate increased size, extent or degree of penetration; TX=primary tumor could not be assessed.|participants|Number|0|0.0||||||
3961744|NCT01316263|3784023|B3|TX||Current T Classification Staging|Staging: T0=no evidence of primary tumor; Tis=Carcinoma in situ; T1 to 4=presence of tumors, higher numbers indicate increased size, extent or degree of penetration; TX=primary tumor could not be assessed.|participants|Number|6|6.0||||||
3961745|NCT01316263|3784024|B2|TX||Current T Classification Staging|Staging: T0=no evidence of primary tumor; Tis=Carcinoma in situ; T1 to 4=presence of tumors, higher numbers indicate increased size, extent or degree of penetration; TX=primary tumor could not be assessed.|participants|Number|4|4.0||||||
3961746|NCT01316263|3784025|B1|TX||Current T Classification Staging|Staging: T0=no evidence of primary tumor; Tis=Carcinoma in situ; T1 to 4=presence of tumors, higher numbers indicate increased size, extent or degree of penetration; TX=primary tumor could not be assessed.|participants|Number|2|2.0||||||
3961747|NCT01316263|3784023|B3|T4||Current T Classification Staging|Staging: T0=no evidence of primary tumor; Tis=Carcinoma in situ; T1 to 4=presence of tumors, higher numbers indicate increased size, extent or degree of penetration; TX=primary tumor could not be assessed.|participants|Number|4|4.0||||||
3961748|NCT01316263|3784024|B2|T4||Current T Classification Staging|Staging: T0=no evidence of primary tumor; Tis=Carcinoma in situ; T1 to 4=presence of tumors, higher numbers indicate increased size, extent or degree of penetration; TX=primary tumor could not be assessed.|participants|Number|2|2.0||||||
3961749|NCT01316263|3784025|B1|T4||Current T Classification Staging|Staging: T0=no evidence of primary tumor; Tis=Carcinoma in situ; T1 to 4=presence of tumors, higher numbers indicate increased size, extent or degree of penetration; TX=primary tumor could not be assessed.|participants|Number|2|2.0||||||
3961750|NCT01316263|3784023|B3|T3||Current T Classification Staging|Staging: T0=no evidence of primary tumor; Tis=Carcinoma in situ; T1 to 4=presence of tumors, higher numbers indicate increased size, extent or degree of penetration; TX=primary tumor could not be assessed.|participants|Number|4|4.0||||||
3961751|NCT01316263|3784024|B2|T3||Current T Classification Staging|Staging: T0=no evidence of primary tumor; Tis=Carcinoma in situ; T1 to 4=presence of tumors, higher numbers indicate increased size, extent or degree of penetration; TX=primary tumor could not be assessed.|participants|Number|4|4.0||||||
3961752|NCT01316263|3784025|B1|T3||Current T Classification Staging|Staging: T0=no evidence of primary tumor; Tis=Carcinoma in situ; T1 to 4=presence of tumors, higher numbers indicate increased size, extent or degree of penetration; TX=primary tumor could not be assessed.|participants|Number|0|0.0||||||
3961753|NCT01316263|3784023|B3|T0||Current T Classification Staging|Staging: T0=no evidence of primary tumor; Tis=Carcinoma in situ; T1 to 4=presence of tumors, higher numbers indicate increased size, extent or degree of penetration; TX=primary tumor could not be assessed.|participants|Number|4|4.0||||||
3961754|NCT01316263|3784024|B2|T0||Current T Classification Staging|Staging: T0=no evidence of primary tumor; Tis=Carcinoma in situ; T1 to 4=presence of tumors, higher numbers indicate increased size, extent or degree of penetration; TX=primary tumor could not be assessed.|participants|Number|2|2.0||||||
3961755|NCT01316263|3784025|B1|T0||Current T Classification Staging|Staging: T0=no evidence of primary tumor; Tis=Carcinoma in situ; T1 to 4=presence of tumors, higher numbers indicate increased size, extent or degree of penetration; TX=primary tumor could not be assessed.|participants|Number|2|2.0||||||
3961756|NCT01316263|3784023|B3|Missing||Initial M Stage at Diagnosis|Staging: presence or absence of distance metastasis, including lymph nodes that were not regional. M0=no distant metastasis; M1=distant metastasis; MX=distance metastasis could not be assessed.|participants|Number|3|3.0||||||
3961757|NCT01316263|3784024|B2|Missing||Initial M Stage at Diagnosis|Staging: presence or absence of distance metastasis, including lymph nodes that were not regional. M0=no distant metastasis; M1=distant metastasis; MX=distance metastasis could not be assessed.|participants|Number|1|1.0||||||
3961758|NCT01316263|3784025|B1|Missing||Initial M Stage at Diagnosis|Staging: presence or absence of distance metastasis, including lymph nodes that were not regional. M0=no distant metastasis; M1=distant metastasis; MX=distance metastasis could not be assessed.|participants|Number|2|2.0||||||
3961759|NCT01316263|3784023|B3|MX||Initial M Stage at Diagnosis|Staging: presence or absence of distance metastasis, including lymph nodes that were not regional. M0=no distant metastasis; M1=distant metastasis; MX=distance metastasis could not be assessed.|participants|Number|1|1.0||||||
3961760|NCT01316263|3784024|B2|MX||Initial M Stage at Diagnosis|Staging: presence or absence of distance metastasis, including lymph nodes that were not regional. M0=no distant metastasis; M1=distant metastasis; MX=distance metastasis could not be assessed.|participants|Number|1|1.0||||||
3961761|NCT01316263|3784025|B1|MX||Initial M Stage at Diagnosis|Staging: presence or absence of distance metastasis, including lymph nodes that were not regional. M0=no distant metastasis; M1=distant metastasis; MX=distance metastasis could not be assessed.|participants|Number|0|0.0||||||
3961762|NCT01316263|3784023|B3|M1||Initial M Stage at Diagnosis|Staging: presence or absence of distance metastasis, including lymph nodes that were not regional. M0=no distant metastasis; M1=distant metastasis; MX=distance metastasis could not be assessed.|participants|Number|6|6.0||||||
3961763|NCT01316263|3784024|B2|M1||Initial M Stage at Diagnosis|Staging: presence or absence of distance metastasis, including lymph nodes that were not regional. M0=no distant metastasis; M1=distant metastasis; MX=distance metastasis could not be assessed.|participants|Number|5|5.0||||||
3961764|NCT01316263|3784025|B1|M1||Initial M Stage at Diagnosis|Staging: presence or absence of distance metastasis, including lymph nodes that were not regional. M0=no distant metastasis; M1=distant metastasis; MX=distance metastasis could not be assessed.|participants|Number|1|1.0||||||
3961765|NCT01316263|3784023|B3|M0||Initial M Stage at Diagnosis|Staging: presence or absence of distance metastasis, including lymph nodes that were not regional. M0=no distant metastasis; M1=distant metastasis; MX=distance metastasis could not be assessed.|participants|Number|11|11.0||||||
3961766|NCT01316263|3784024|B2|M0||Initial M Stage at Diagnosis|Staging: presence or absence of distance metastasis, including lymph nodes that were not regional. M0=no distant metastasis; M1=distant metastasis; MX=distance metastasis could not be assessed.|participants|Number|7|7.0||||||
3961767|NCT01316263|3784025|B1|M0||Initial M Stage at Diagnosis|Staging: presence or absence of distance metastasis, including lymph nodes that were not regional. M0=no distant metastasis; M1=distant metastasis; MX=distance metastasis could not be assessed.|participants|Number|4|4.0||||||
3961768|NCT01316263|3784023|B3|Missing||Initial N Classification Staging at Diagnosis|Staging: N0=no regional lymph nodes metastasis; N1 to N3=Regional lymph node metastasis, higher number indicated greater involvement.|participants|Number|4|4.0||||||
3961769|NCT01316263|3784024|B2|Missing||Initial N Classification Staging at Diagnosis|Staging: N0=no regional lymph nodes metastasis; N1 to N3=Regional lymph node metastasis, higher number indicated greater involvement.|participants|Number|2|2.0||||||
3961770|NCT01316263|3784025|B1|Missing||Initial N Classification Staging at Diagnosis|Staging: N0=no regional lymph nodes metastasis; N1 to N3=Regional lymph node metastasis, higher number indicated greater involvement.|participants|Number|2|2.0||||||
3961771|NCT01316263|3784023|B3|N1||Initial N Classification Staging at Diagnosis|Staging: N0=no regional lymph nodes metastasis; N1 to N3=Regional lymph node metastasis, higher number indicated greater involvement.|participants|Number|1|1.0||||||
3961772|NCT01316263|3784024|B2|N1||Initial N Classification Staging at Diagnosis|Staging: N0=no regional lymph nodes metastasis; N1 to N3=Regional lymph node metastasis, higher number indicated greater involvement.|participants|Number|1|1.0||||||
3961773|NCT01316263|3784025|B1|N1||Initial N Classification Staging at Diagnosis|Staging: N0=no regional lymph nodes metastasis; N1 to N3=Regional lymph node metastasis, higher number indicated greater involvement.|participants|Number|0|0.0||||||
3961774|NCT01316263|3784023|B3|N0||Initial N Classification Staging at Diagnosis|Staging: N0=no regional lymph nodes metastasis; N1 to N3=Regional lymph node metastasis, higher number indicated greater involvement.|participants|Number|16|16.0||||||
3961775|NCT01316263|3784024|B2|N0||Initial N Classification Staging at Diagnosis|Staging: N0=no regional lymph nodes metastasis; N1 to N3=Regional lymph node metastasis, higher number indicated greater involvement.|participants|Number|11|11.0||||||
3961776|NCT01316263|3784025|B1|N0||Initial N Classification Staging at Diagnosis|Staging: N0=no regional lymph nodes metastasis; N1 to N3=Regional lymph node metastasis, higher number indicated greater involvement.|participants|Number|5|5.0||||||
3961777|NCT01316263|3784023|B3|Missing||Initial T Classification Staging at Diagnosis|Staging: T0=no evidence of primary tumor; Tis=Carcinoma in situ; T1 to 4=presence of tumors, higher numbers indicate increased size, extent or degree of penetration; TX=primary tumor could not be assessed.|participants|Number|3|3.0||||||
3961778|NCT01316263|3784024|B2|Missing||Initial T Classification Staging at Diagnosis|Staging: T0=no evidence of primary tumor; Tis=Carcinoma in situ; T1 to 4=presence of tumors, higher numbers indicate increased size, extent or degree of penetration; TX=primary tumor could not be assessed.|participants|Number|1|1.0||||||
3961839|NCT01316263|3784025|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961840|NCT01316263|3784023|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961779|NCT01316263|3784025|B1|Missing||Initial T Classification Staging at Diagnosis|Staging: T0=no evidence of primary tumor; Tis=Carcinoma in situ; T1 to 4=presence of tumors, higher numbers indicate increased size, extent or degree of penetration; TX=primary tumor could not be assessed.|participants|Number|2|2.0||||||
3961780|NCT01316263|3784023|B3|TX||Initial T Classification Staging at Diagnosis|Staging: T0=no evidence of primary tumor; Tis=Carcinoma in situ; T1 to 4=presence of tumors, higher numbers indicate increased size, extent or degree of penetration; TX=primary tumor could not be assessed.|participants|Number|5|5.0||||||
3961781|NCT01316263|3784024|B2|TX||Initial T Classification Staging at Diagnosis|Staging: T0=no evidence of primary tumor; Tis=Carcinoma in situ; T1 to 4=presence of tumors, higher numbers indicate increased size, extent or degree of penetration; TX=primary tumor could not be assessed.|participants|Number|4|4.0||||||
3961782|NCT01316263|3784025|B1|TX||Initial T Classification Staging at Diagnosis|Staging: T0=no evidence of primary tumor; Tis=Carcinoma in situ; T1 to 4=presence of tumors, higher numbers indicate increased size, extent or degree of penetration; TX=primary tumor could not be assessed.|participants|Number|1|1.0||||||
3961783|NCT01316263|3784023|B3|T4||Initial T Classification Staging at Diagnosis|Staging: T0=no evidence of primary tumor; Tis=Carcinoma in situ; T1 to 4=presence of tumors, higher numbers indicate increased size, extent or degree of penetration; TX=primary tumor could not be assessed.|participants|Number|4|4.0||||||
3961784|NCT01316263|3784024|B2|T4||Initial T Classification Staging at Diagnosis|Staging: T0=no evidence of primary tumor; Tis=Carcinoma in situ; T1 to 4=presence of tumors, higher numbers indicate increased size, extent or degree of penetration; TX=primary tumor could not be assessed.|participants|Number|1|1.0||||||
3961785|NCT01316263|3784025|B1|T4||Initial T Classification Staging at Diagnosis|Staging: T0=no evidence of primary tumor; Tis=Carcinoma in situ; T1 to 4=presence of tumors, higher numbers indicate increased size, extent or degree of penetration; TX=primary tumor could not be assessed.|participants|Number|3|3.0||||||
3961786|NCT01316263|3784023|B3|T3||Initial T Classification Staging at Diagnosis|Staging: T0=no evidence of primary tumor; Tis=Carcinoma in situ; T1 to 4=presence of tumors, higher numbers indicate increased size, extent or degree of penetration; TX=primary tumor could not be assessed.|participants|Number|4|4.0||||||
3961787|NCT01316263|3784024|B2|T3||Initial T Classification Staging at Diagnosis|Staging: T0=no evidence of primary tumor; Tis=Carcinoma in situ; T1 to 4=presence of tumors, higher numbers indicate increased size, extent or degree of penetration; TX=primary tumor could not be assessed.|participants|Number|4|4.0||||||
3961788|NCT01316263|3784025|B1|T3||Initial T Classification Staging at Diagnosis|Staging: T0=no evidence of primary tumor; Tis=Carcinoma in situ; T1 to 4=presence of tumors, higher numbers indicate increased size, extent or degree of penetration; TX=primary tumor could not be assessed.|participants|Number|0|0.0||||||
3961789|NCT01316263|3784023|B3|T2||Initial T Classification Staging at Diagnosis|Staging: T0=no evidence of primary tumor; Tis=Carcinoma in situ; T1 to 4=presence of tumors, higher numbers indicate increased size, extent or degree of penetration; TX=primary tumor could not be assessed.|participants|Number|4|4.0||||||
3961790|NCT01316263|3784024|B2|T2||Initial T Classification Staging at Diagnosis|Staging: T0=no evidence of primary tumor; Tis=Carcinoma in situ; T1 to 4=presence of tumors, higher numbers indicate increased size, extent or degree of penetration; TX=primary tumor could not be assessed.|participants|Number|3|3.0||||||
3961791|NCT01316263|3784025|B1|T2||Initial T Classification Staging at Diagnosis|Staging: T0=no evidence of primary tumor; Tis=Carcinoma in situ; T1 to 4=presence of tumors, higher numbers indicate increased size, extent or degree of penetration; TX=primary tumor could not be assessed.|participants|Number|1|1.0||||||
3961792|NCT01316263|3784023|B3|Tis||Initial T Classification Staging at Diagnosis|Staging: T0=no evidence of primary tumor; Tis=Carcinoma in situ; T1 to 4=presence of tumors, higher numbers indicate increased size, extent or degree of penetration; TX=primary tumor could not be assessed.|participants|Number|1|1.0||||||
3961793|NCT01316263|3784024|B2|Tis||Initial T Classification Staging at Diagnosis|Staging: T0=no evidence of primary tumor; Tis=Carcinoma in situ; T1 to 4=presence of tumors, higher numbers indicate increased size, extent or degree of penetration; TX=primary tumor could not be assessed.|participants|Number|1|1.0||||||
3961794|NCT01316263|3784025|B1|Tis||Initial T Classification Staging at Diagnosis|Staging: T0=no evidence of primary tumor; Tis=Carcinoma in situ; T1 to 4=presence of tumors, higher numbers indicate increased size, extent or degree of penetration; TX=primary tumor could not be assessed.|participants|Number|0|0.0||||||
3961795|NCT01316263|3784023|B3|Other-unspecified||Histology-Cell Type||participants|Number|2|2.0||||||
3961796|NCT01316263|3784024|B2|Other-unspecified||Histology-Cell Type||participants|Number|1|1.0||||||
3961797|NCT01316263|3784025|B1|Other-unspecified||Histology-Cell Type||participants|Number|1|1.0||||||
3961798|NCT01316263|3784023|B3|Mixed/Combined||Histology-Cell Type||participants|Number|4|4.0||||||
3961799|NCT01316263|3784024|B2|Mixed/Combined||Histology-Cell Type||participants|Number|4|4.0||||||
3961800|NCT01316263|3784025|B1|Mixed/Combined||Histology-Cell Type||participants|Number|0|0.0||||||
3961801|NCT01316263|3784023|B3|Spindle Cell||Histology-Cell Type||participants|Number|9|9.0||||||
3961802|NCT01316263|3784024|B2|Spindle Cell||Histology-Cell Type||participants|Number|9|9.0||||||
3961803|NCT01316263|3784025|B1|Spindle Cell||Histology-Cell Type||participants|Number|0|0.0||||||
3961804|NCT01316263|3784023|B3|Epitheloid Cell||Histology-Cell Type||participants|Number|6|6.0||||||
3961805|NCT01316263|3784024|B2|Epitheloid Cell||Histology-Cell Type||participants|Number|0|0.0||||||
3961806|NCT01316263|3784025|B1|Epitheloid Cell||Histology-Cell Type||participants|Number|6|6.0||||||
3961807|NCT01316263|3784023|B3|||Type of Cancer-Gastrointestinal Stromal Tumor||participants|Number|21|21.0||||||
3961808|NCT01316263|3784024|B2|||Type of Cancer-Gastrointestinal Stromal Tumor||participants|Number|14|14.0||||||
3961809|NCT01316263|3784025|B1|||Type of Cancer-Gastrointestinal Stromal Tumor||participants|Number|7|7.0||||||
3961841|NCT01316263|3784024|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961842|NCT01316263|3784025|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961843|NCT01316263|3784023|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3961810|NCT01316263|3784023|B3|ECOG PS ≥2||Eastern Cooperative Oncology Group Performance Status(ECOG PS)|"ECOG classifies participants according to their functional impairment. Scores range from 0 (fully active) to 5 (death).~0=Fully active, able to carry on all pre-disease performance without restriction; 1=Ambulatory, restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory, no work activities; 3=Partially confined to bed, limited self-care; 4=Completely disabled."|participants|Number|1|1.0||||||
3961811|NCT01316263|3784024|B2|ECOG PS ≥2||Eastern Cooperative Oncology Group Performance Status(ECOG PS)|"ECOG classifies participants according to their functional impairment. Scores range from 0 (fully active) to 5 (death).~0=Fully active, able to carry on all pre-disease performance without restriction; 1=Ambulatory, restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory, no work activities; 3=Partially confined to bed, limited self-care; 4=Completely disabled."|participants|Number|0|0.0||||||
3961812|NCT01316263|3784025|B1|ECOG PS ≥2||Eastern Cooperative Oncology Group Performance Status(ECOG PS)|"ECOG classifies participants according to their functional impairment. Scores range from 0 (fully active) to 5 (death).~0=Fully active, able to carry on all pre-disease performance without restriction; 1=Ambulatory, restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory, no work activities; 3=Partially confined to bed, limited self-care; 4=Completely disabled."|participants|Number|1|1.0||||||
3961813|NCT01316263|3784023|B3|ECOG PS =1||Eastern Cooperative Oncology Group Performance Status(ECOG PS)|"ECOG classifies participants according to their functional impairment. Scores range from 0 (fully active) to 5 (death).~0=Fully active, able to carry on all pre-disease performance without restriction; 1=Ambulatory, restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory, no work activities; 3=Partially confined to bed, limited self-care; 4=Completely disabled."|participants|Number|13|13.0||||||
3961814|NCT01316263|3784024|B2|ECOG PS =1||Eastern Cooperative Oncology Group Performance Status(ECOG PS)|"ECOG classifies participants according to their functional impairment. Scores range from 0 (fully active) to 5 (death).~0=Fully active, able to carry on all pre-disease performance without restriction; 1=Ambulatory, restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory, no work activities; 3=Partially confined to bed, limited self-care; 4=Completely disabled."|participants|Number|9|9.0||||||
3961815|NCT01316263|3784025|B1|ECOG PS =1||Eastern Cooperative Oncology Group Performance Status(ECOG PS)|"ECOG classifies participants according to their functional impairment. Scores range from 0 (fully active) to 5 (death).~0=Fully active, able to carry on all pre-disease performance without restriction; 1=Ambulatory, restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory, no work activities; 3=Partially confined to bed, limited self-care; 4=Completely disabled."|participants|Number|4|4.0||||||
3961816|NCT01316263|3784023|B3|ECOG PS =0||Eastern Cooperative Oncology Group Performance Status(ECOG PS)|"ECOG classifies participants according to their functional impairment. Scores range from 0 (fully active) to 5 (death).~0=Fully active, able to carry on all pre-disease performance without restriction; 1=Ambulatory, restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory, no work activities; 3=Partially confined to bed, limited self-care; 4=Completely disabled."|participants|Number|7|7.0||||||
3961817|NCT01316263|3784024|B2|ECOG PS =0||Eastern Cooperative Oncology Group Performance Status(ECOG PS)|"ECOG classifies participants according to their functional impairment. Scores range from 0 (fully active) to 5 (death).~0=Fully active, able to carry on all pre-disease performance without restriction; 1=Ambulatory, restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory, no work activities; 3=Partially confined to bed, limited self-care; 4=Completely disabled."|participants|Number|5|5.0||||||
3961818|NCT01316263|3784025|B1|ECOG PS =0||Eastern Cooperative Oncology Group Performance Status(ECOG PS)|"ECOG classifies participants according to their functional impairment. Scores range from 0 (fully active) to 5 (death).~0=Fully active, able to carry on all pre-disease performance without restriction; 1=Ambulatory, restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory, no work activities; 3=Partially confined to bed, limited self-care; 4=Completely disabled."|participants|Number|2|2.0||||||
3961819|NCT01316263|3784023|B3|Germany||Region of Enrollment||participants|Number|4|4.0||||||
3961820|NCT01316263|3784024|B2|Germany||Region of Enrollment||participants|Number|2|2.0||||||
3961821|NCT01316263|3784025|B1|Germany||Region of Enrollment||participants|Number|2|2.0||||||
3961822|NCT01316263|3784023|B3|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
3961823|NCT01316263|3784024|B2|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
3961824|NCT01316263|3784025|B1|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
3961825|NCT01316263|3784023|B3|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
3961826|NCT01316263|3784024|B2|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
3961827|NCT01316263|3784025|B1|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
3961828|NCT01316263|3784023|B3|Poland||Region of Enrollment||participants|Number|6|6.0||||||
3961829|NCT01316263|3784024|B2|Poland||Region of Enrollment||participants|Number|4|4.0||||||
3961830|NCT01316263|3784025|B1|Poland||Region of Enrollment||participants|Number|2|2.0||||||
3961831|NCT01316263|3784023|B3|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3961832|NCT01316263|3784024|B2|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3961833|NCT01316263|3784025|B1|Spain||Region of Enrollment||participants|Number|0|0.0||||||
3961834|NCT01316263|3784023|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3961835|NCT01316263|3784024|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3961836|NCT01316263|3784025|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3961837|NCT01316263|3784023|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961838|NCT01316263|3784024|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961844|NCT01316263|3784024|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3961845|NCT01316263|3784025|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3961846|NCT01316263|3784023|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961847|NCT01316263|3784024|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961848|NCT01316263|3784025|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961849|NCT01316263|3784023|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961850|NCT01316263|3784024|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961851|NCT01316263|3784025|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961852|NCT01316263|3784023|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961853|NCT01316263|3784024|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961854|NCT01316263|3784025|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961855|NCT01316263|3784023|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961856|NCT01316263|3784024|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961857|NCT01316263|3784025|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961858|NCT01316263|3784023|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961859|NCT01316263|3784024|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961860|NCT01316263|3784025|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961861|NCT01316263|3784023|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3961862|NCT01316263|3784024|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3961863|NCT01316263|3784025|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3961864|NCT01316263|3784023|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961865|NCT01316263|3784024|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961866|NCT01316263|3784025|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961867|NCT01316263|3784023|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3961868|NCT01316263|3784024|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3961869|NCT01316263|3784025|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3961870|NCT01316263|3784023|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3961871|NCT01316263|3784024|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3961872|NCT01316263|3784025|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3961873|NCT01316263|3784023|B3|||Age||years|Mean|54.2|54.2|Standard Deviation|11.48|11.48|||
3961874|NCT01316263|3784024|B2|||Age||years|Mean|48.9|48.9|Standard Deviation|9.11|9.11|||
3961875|NCT01316263|3784025|B1|||Age||years|Mean|64.9|64.9|Standard Deviation|7.90|7.9|||
3961876|NCT01316224|3784052|B1|Prior Biologic Therapy||Study Specific Characteristic|Participants with family history of PsA is based on available information from participants who completed the visits to the rheumatologist.|Participants|Number|14|14.0||||||
3961877|NCT01316224|3784052|B1|Current Methotrexate Use||Study Specific Characteristic|Participants with family history of PsA is based on available information from participants who completed the visits to the rheumatologist.|Participants|Number|11|11.0||||||
3961878|NCT01316224|3784052|B1|Prior Methotrexate Use||Study Specific Characteristic|Participants with family history of PsA is based on available information from participants who completed the visits to the rheumatologist.|Participants|Number|36|36.0||||||
3961879|NCT01316224|3784052|B1|Presence of Family History of PsA (N=49)||Study Specific Characteristic|Participants with family history of PsA is based on available information from participants who completed the visits to the rheumatologist.|Participants|Number|11|11.0||||||
3961880|NCT01316224|3784052|B1|Presence of Hypertension||Study Specific Characteristic|Participants with family history of PsA is based on available information from participants who completed the visits to the rheumatologist.|Participants|Number|15|15.0||||||
3961881|NCT01316224|3784052|B1|Presence of Metabolic Syndrome||Study Specific Characteristic|Participants with family history of PsA is based on available information from participants who completed the visits to the rheumatologist.|Participants|Number|8|8.0||||||
3961882|NCT01316224|3784052|B1|Positive History of Comorbidities||Study Specific Characteristic|Participants with family history of PsA is based on available information from participants who completed the visits to the rheumatologist.|Participants|Number|28|28.0||||||
3961883|NCT01316224|3784052|B1|Participants Who Smoke||Study Specific Characteristic|Participants with family history of PsA is based on available information from participants who completed the visits to the rheumatologist.|Participants|Number|21|21.0||||||
3961884|NCT01316224|3784052|B1|||C-Reactive Protein (CRP) (N=10)|Data is based on available information.|mg/dl|Mean|1.39|1.39|Standard Deviation|1.63|1.63|||
3961885|NCT01316224|3784052|B1|||Body Mass Index (BMI)||kg/m^2|Mean|28.83|28.83|Standard Deviation|5.06|5.06|||
3961886|NCT01316224|3784052|B1|||Weight||kg|Mean|78.70|78.7|Standard Deviation|14.70|14.7|||
3961887|NCT01316224|3784052|B1|Colombia||Region of Enrollment||Participants|Number|52|52.0||||||
3961888|NCT01316224|3784052|B1||Unknown or Not Reported|Race (NIH/OMB)|"Participants who indicated more than one race are referred to as Metis"|Participants|Count of Participants|0|0.0||||||
3961889|NCT01316224|3784052|B1||More than one race|Race (NIH/OMB)|"Participants who indicated more than one race are referred to as Metis"|Participants|Count of Participants|34|34.0||||||
3961890|NCT01316224|3784052|B1||White|Race (NIH/OMB)|"Participants who indicated more than one race are referred to as Metis"|Participants|Count of Participants|18|18.0||||||
3961891|NCT01316224|3784052|B1||Black or African American|Race (NIH/OMB)|"Participants who indicated more than one race are referred to as Metis"|Participants|Count of Participants|0|0.0||||||
3961892|NCT01316224|3784052|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|"Participants who indicated more than one race are referred to as Metis"|Participants|Count of Participants|0|0.0||||||
3961893|NCT01316224|3784052|B1||Asian|Race (NIH/OMB)|"Participants who indicated more than one race are referred to as Metis"|Participants|Count of Participants|0|0.0||||||
3961894|NCT01316224|3784052|B1||American Indian or Alaska Native|Race (NIH/OMB)|"Participants who indicated more than one race are referred to as Metis"|Participants|Count of Participants|0|0.0||||||
3961895|NCT01316224|3784052|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3961896|NCT01316224|3784052|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3961897|NCT01316224|3784052|B1|||Age||Years|Mean|48.85|48.85|Standard Deviation|14.66|14.66|||
3961898|NCT01316055|3784066|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3961899|NCT01316055|3784067|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3961900|NCT01316055|3784068|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3961901|NCT01316055|3784069|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3961902|NCT01316055|3784066|B4|White||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3961903|NCT01316055|3784067|B3|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3961904|NCT01316055|3784068|B2|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3961905|NCT01316055|3784069|B1|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3961906|NCT01316055|3784066|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3961907|NCT01316055|3784067|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3961908|NCT01316055|3784068|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3961909|NCT01316055|3784069|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3961910|NCT01316055|3784066|B4|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3961911|NCT01316055|3784067|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3961912|NCT01316055|3784068|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3961913|NCT01316055|3784069|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3961914|NCT01316055|3784066|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3961915|NCT01316055|3784067|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3961916|NCT01316055|3784068|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3961917|NCT01316055|3784069|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3961918|NCT01316055|3784066|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3961919|NCT01316055|3784067|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3961920|NCT01316055|3784068|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3961921|NCT01316055|3784069|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3961922|NCT01316055|3784066|B4|||Age||years|Mean|57.7|57.7|Standard Deviation|14.71|14.71|||
3961923|NCT01316055|3784067|B3|||Age||years|Mean|67.1|67.1|Standard Deviation|7.65|7.65|||
3961924|NCT01316055|3784068|B2|||Age||years|Mean|63.2|63.2|Standard Deviation|7.22|7.22|||
3961925|NCT01316055|3784069|B1|||Age||years|Mean|41.9|41.9|Standard Deviation|14.65|14.65|||
3961926|NCT01316055|3784066|B4||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3961927|NCT01316055|3784067|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3961928|NCT01316055|3784068|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3961929|NCT01316055|3784069|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3961930|NCT01316055|3784066|B4||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3961931|NCT01316055|3784067|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3961932|NCT01316055|3784068|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3961933|NCT01316055|3784069|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3961934|NCT01316055|3784066|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3961935|NCT01316055|3784067|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3961936|NCT01316055|3784068|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3961937|NCT01316055|3784069|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3961938|NCT01316042|3784085|B3|||DHEAS||ug/dL|Mean|122.3|122.3|Full Range|||51.0|295.0|
3961939|NCT01316042|3784086|B2|||DHEAS||ug/dL|Mean|67.6|67.6|Full Range|||51.0|84.2|
3961940|NCT01316042|3784087|B1|||DHEAS||ug/dL|Mean|177.0|177.0|Full Range|||59.0|295.0|
3961941|NCT01316042|3784085|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3961942|NCT01316042|3784086|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3961943|NCT01316042|3784087|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3961944|NCT01316042|3784085|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3961945|NCT01316042|3784086|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3961946|NCT01316042|3784087|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3961947|NCT01316042|3784085|B3|||Age||years|Mean|6.75|6.75|Full Range|||6.0|9.0|
3961948|NCT01316042|3784086|B2|||Age||years|Mean|6|6.0|Full Range|||6.0|6.0|
3961949|NCT01316042|3784087|B1|||Age||years|Mean|7.5|7.5|Full Range|||6.0|9.0|
3961950|NCT01315873|3784094|B1|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3961951|NCT01315873|3784094|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3961952|NCT01315873|3784094|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3961953|NCT01315873|3784094|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3961954|NCT01315873|3784094|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3961955|NCT01315873|3784094|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3961956|NCT01315847|3784100|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3961957|NCT01315847|3784101|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3961958|NCT01315847|3784102|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3961959|NCT01315847|3784100|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3961960|NCT01315847|3784101|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3961961|NCT01315847|3784102|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3961962|NCT01315847|3784100|B3|||Age||years|Mean|34.60|34.6|Standard Deviation|11.33|11.33|||
3961963|NCT01315847|3784101|B2|||Age||years|Mean|37.75|37.75|Standard Deviation|13.20|13.2|||
3961964|NCT01315847|3784102|B1|||Age||years|Mean|32.50|32.5|Standard Deviation|10.63|10.63|||
3961965|NCT01315665|3784115|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
3961966|NCT01315665|3784116|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3961967|NCT01315665|3784117|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3961968|NCT01315665|3784115|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961969|NCT01315665|3784116|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961970|NCT01315665|3784117|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961971|NCT01315665|3784115|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961972|NCT01315665|3784116|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961973|NCT01315665|3784117|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961974|NCT01315665|3784115|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3961975|NCT01315665|3784116|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3961976|NCT01315665|3784117|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3961977|NCT01315665|3784115|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961978|NCT01315665|3784116|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961979|NCT01315665|3784117|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961980|NCT01315665|3784115|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961981|NCT01315665|3784116|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961982|NCT01315665|3784117|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961983|NCT01315665|3784115|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961984|NCT01315665|3784116|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961985|NCT01315665|3784117|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961986|NCT01315665|3784115|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961987|NCT01315665|3784116|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961988|NCT01315665|3784117|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3961989|NCT01315665|3784115|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3961990|NCT01315665|3784116|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3961991|NCT01315665|3784117|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3961992|NCT01315665|3784115|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3961993|NCT01315665|3784116|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3961994|NCT01315665|3784117|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3961995|NCT01315665|3784115|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3961996|NCT01315665|3784116|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3961997|NCT01315665|3784117|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3961998|NCT01315665|3784115|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3961999|NCT01315665|3784116|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3962000|NCT01315665|3784117|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3962001|NCT01315665|3784115|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3962002|NCT01315665|3784116|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3962003|NCT01315665|3784117|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3962004|NCT01315574|3784132|B3|||Tear Break-Up Time (TBUT)||seconds|Mean|8.1|8.1|Standard Deviation|2.9|2.9|||
3962005|NCT01315574|3784133|B2|||Tear Break-Up Time (TBUT)||seconds|Mean|8.4|8.4|Standard Deviation|3.7|3.7|||
3962006|NCT01315574|3784134|B1|||Tear Break-Up Time (TBUT)||seconds|Mean|7.9|7.9|Standard Deviation|2.0|2.0|||
3962007|NCT01315574|3784132|B3|||Corneal Fluorescein Staining Score|Corneal fluorescein staining scores range from 0 to 4 points: 0=non-staining to 4 =regional whole staining of the cornea. Higher scores indicate worse eye condition.|units on a scale|Mean|0.9|0.9|Standard Deviation|1.6|1.6|||
3962101|NCT01315353|3784146|B3||Hispanic (Regardless of Race)|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3962008|NCT01315574|3784133|B2|||Corneal Fluorescein Staining Score|Corneal fluorescein staining scores range from 0 to 4 points: 0=non-staining to 4 =regional whole staining of the cornea. Higher scores indicate worse eye condition.|units on a scale|Mean|1.3|1.3|Standard Deviation|2.0|2.0|||
3962009|NCT01315574|3784134|B1|||Corneal Fluorescein Staining Score|Corneal fluorescein staining scores range from 0 to 4 points: 0=non-staining to 4 =regional whole staining of the cornea. Higher scores indicate worse eye condition.|units on a scale|Mean|0.6|0.6|Standard Deviation|1.1|1.1|||
3962010|NCT01315574|3784132|B3|||Intraocular Pressure||mmHg|Mean|21.5|21.5|Standard Deviation|4.8|4.8|||
3962011|NCT01315574|3784133|B2|||Intraocular Pressure||mmHg|Mean|22|22.0|Standard Deviation|4|4.0|||
3962012|NCT01315574|3784134|B1|||Intraocular Pressure||mmHg|Mean|21|21.0|Standard Deviation|6|6.0|||
3962013|NCT01315574|3784132|B3|||Central Corneal Dendritic Cell Density||cells/mm^2|Mean|109|109.0|Standard Deviation|75|75.0|||
3962014|NCT01315574|3784133|B2|||Central Corneal Dendritic Cell Density||cells/mm^2|Mean|91|91.0|Standard Deviation|60|60.0|||
3962015|NCT01315574|3784134|B1|||Central Corneal Dendritic Cell Density||cells/mm^2|Mean|126|126.0|Standard Deviation|88|88.0|||
3962016|NCT01315574|3784132|B3|United States||Region of Enrollment|Participant population: newly diagnosed glaucoma patients.|participants|Number|14|14.0||||||
3962017|NCT01315574|3784133|B2|United States||Region of Enrollment|Participant population: newly diagnosed glaucoma patients.|participants|Number|7|7.0||||||
3962018|NCT01315574|3784134|B1|United States||Region of Enrollment|Participant population: newly diagnosed glaucoma patients.|participants|Number|7|7.0||||||
3962019|NCT01315574|3784132|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3962020|NCT01315574|3784133|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3962021|NCT01315574|3784134|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3962022|NCT01315574|3784132|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3962023|NCT01315574|3784133|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3962024|NCT01315574|3784134|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3962025|NCT01315574|3784132|B3|||Age||years|Mean|66.8|66.8|Standard Deviation|8.8|8.8|||
3962026|NCT01315574|3784133|B2|||Age||years|Mean|68.3|68.3|Standard Deviation|10.0|10.0|||
3962027|NCT01315574|3784134|B1|||Age||years|Mean|65.3|65.3|Standard Deviation|7.9|7.9|||
3962028|NCT01315353|3784145|B4||Taking any ART|Antiretroviral Therapy (ART) Use|Participants status of ART use at screening.|Participants|Count of Participants|383|383.0||||||
3962029|NCT01315353|3784146|B3||Taking any ART|Antiretroviral Therapy (ART) Use|Participants status of ART use at screening.|Participants|Count of Participants|142|142.0||||||
3962030|NCT01315353|3784147|B2||Taking any ART|Antiretroviral Therapy (ART) Use|Participants status of ART use at screening.|Participants|Count of Participants|121|121.0||||||
3962031|NCT01315353|3784148|B1||Taking any ART|Antiretroviral Therapy (ART) Use|Participants status of ART use at screening.|Participants|Count of Participants|120|120.0||||||
3962032|NCT01315353|3784145|B4||Not taking any ART|Antiretroviral Therapy (ART) Use|Participants status of ART use at screening.|Participants|Count of Participants|82|82.0||||||
3962033|NCT01315353|3784146|B3||Not taking any ART|Antiretroviral Therapy (ART) Use|Participants status of ART use at screening.|Participants|Count of Participants|35|35.0||||||
3962034|NCT01315353|3784147|B2||Not taking any ART|Antiretroviral Therapy (ART) Use|Participants status of ART use at screening.|Participants|Count of Participants|22|22.0||||||
3962035|NCT01315353|3784148|B1||Not taking any ART|Antiretroviral Therapy (ART) Use|Participants status of ART use at screening.|Participants|Count of Participants|25|25.0||||||
3962036|NCT01315353|3784145|B4||>=LLQ|HIV-1 RNA|Entry HIV-1 RNA value categorized as below the assay's corresponding lower limit of quantification (<LLQ) or otherwise (>=LLQ).|Participants|Count of Participants|171|171.0||||||
3962037|NCT01315353|3784146|B3||>=LLQ|HIV-1 RNA|Entry HIV-1 RNA value categorized as below the assay's corresponding lower limit of quantification (<LLQ) or otherwise (>=LLQ).|Participants|Count of Participants|61|61.0||||||
3962038|NCT01315353|3784147|B2||>=LLQ|HIV-1 RNA|Entry HIV-1 RNA value categorized as below the assay's corresponding lower limit of quantification (<LLQ) or otherwise (>=LLQ).|Participants|Count of Participants|58|58.0||||||
3962039|NCT01315353|3784148|B1||>=LLQ|HIV-1 RNA|Entry HIV-1 RNA value categorized as below the assay's corresponding lower limit of quantification (<LLQ) or otherwise (>=LLQ).|Participants|Count of Participants|52|52.0||||||
3962040|NCT01315353|3784145|B4||<LLQ|HIV-1 RNA|Entry HIV-1 RNA value categorized as below the assay's corresponding lower limit of quantification (<LLQ) or otherwise (>=LLQ).|Participants|Count of Participants|294|294.0||||||
3962041|NCT01315353|3784146|B3||<LLQ|HIV-1 RNA|Entry HIV-1 RNA value categorized as below the assay's corresponding lower limit of quantification (<LLQ) or otherwise (>=LLQ).|Participants|Count of Participants|116|116.0||||||
3962042|NCT01315353|3784147|B2||<LLQ|HIV-1 RNA|Entry HIV-1 RNA value categorized as below the assay's corresponding lower limit of quantification (<LLQ) or otherwise (>=LLQ).|Participants|Count of Participants|85|85.0||||||
3962043|NCT01315353|3784148|B1||<LLQ|HIV-1 RNA|Entry HIV-1 RNA value categorized as below the assay's corresponding lower limit of quantification (<LLQ) or otherwise (>=LLQ).|Participants|Count of Participants|93|93.0||||||
3962044|NCT01315353|3784145|B4||>500 cells/mm^3|Nadir CD4+ T-Cell Count|Nadir CD4+ T-cell count at screening.|Participants|Count of Participants|55|55.0||||||
3962045|NCT01315353|3784146|B3||>500 cells/mm^3|Nadir CD4+ T-Cell Count|Nadir CD4+ T-cell count at screening.|Participants|Count of Participants|33|33.0||||||
3962046|NCT01315353|3784147|B2||>500 cells/mm^3|Nadir CD4+ T-Cell Count|Nadir CD4+ T-cell count at screening.|Participants|Count of Participants|10|10.0||||||
3962047|NCT01315353|3784148|B1||>500 cells/mm^3|Nadir CD4+ T-Cell Count|Nadir CD4+ T-cell count at screening.|Participants|Count of Participants|12|12.0||||||
3962048|NCT01315353|3784145|B4||201-500 cells/mm^3|Nadir CD4+ T-Cell Count|Nadir CD4+ T-cell count at screening.|Participants|Count of Participants|188|188.0||||||
3962049|NCT01315353|3784146|B3||201-500 cells/mm^3|Nadir CD4+ T-Cell Count|Nadir CD4+ T-cell count at screening.|Participants|Count of Participants|70|70.0||||||
3962050|NCT01315353|3784147|B2||201-500 cells/mm^3|Nadir CD4+ T-Cell Count|Nadir CD4+ T-cell count at screening.|Participants|Count of Participants|57|57.0||||||
3962051|NCT01315353|3784148|B1||201-500 cells/mm^3|Nadir CD4+ T-Cell Count|Nadir CD4+ T-cell count at screening.|Participants|Count of Participants|61|61.0||||||
3962052|NCT01315353|3784145|B4||101-200 cells/mm^3|Nadir CD4+ T-Cell Count|Nadir CD4+ T-cell count at screening.|Participants|Count of Participants|101|101.0||||||
3962053|NCT01315353|3784146|B3||101-200 cells/mm^3|Nadir CD4+ T-Cell Count|Nadir CD4+ T-cell count at screening.|Participants|Count of Participants|34|34.0||||||
3962054|NCT01315353|3784147|B2||101-200 cells/mm^3|Nadir CD4+ T-Cell Count|Nadir CD4+ T-cell count at screening.|Participants|Count of Participants|34|34.0||||||
3962055|NCT01315353|3784148|B1||101-200 cells/mm^3|Nadir CD4+ T-Cell Count|Nadir CD4+ T-cell count at screening.|Participants|Count of Participants|33|33.0||||||
3962056|NCT01315353|3784145|B4||51-100 cells/mm^3|Nadir CD4+ T-Cell Count|Nadir CD4+ T-cell count at screening.|Participants|Count of Participants|48|48.0||||||
3962057|NCT01315353|3784146|B3||51-100 cells/mm^3|Nadir CD4+ T-Cell Count|Nadir CD4+ T-cell count at screening.|Participants|Count of Participants|17|17.0||||||
3962058|NCT01315353|3784147|B2||51-100 cells/mm^3|Nadir CD4+ T-Cell Count|Nadir CD4+ T-cell count at screening.|Participants|Count of Participants|19|19.0||||||
3962059|NCT01315353|3784148|B1||51-100 cells/mm^3|Nadir CD4+ T-Cell Count|Nadir CD4+ T-cell count at screening.|Participants|Count of Participants|12|12.0||||||
3962060|NCT01315353|3784145|B4||<=50 cells/mm^3|Nadir CD4+ T-Cell Count|Nadir CD4+ T-cell count at screening.|Participants|Count of Participants|44|44.0||||||
3962061|NCT01315353|3784146|B3||<=50 cells/mm^3|Nadir CD4+ T-Cell Count|Nadir CD4+ T-cell count at screening.|Participants|Count of Participants|13|13.0||||||
3962062|NCT01315353|3784147|B2||<=50 cells/mm^3|Nadir CD4+ T-Cell Count|Nadir CD4+ T-cell count at screening.|Participants|Count of Participants|15|15.0||||||
3962063|NCT01315353|3784148|B1||<=50 cells/mm^3|Nadir CD4+ T-Cell Count|Nadir CD4+ T-cell count at screening.|Participants|Count of Participants|16|16.0||||||
3962064|NCT01315353|3784145|B4|||CD4+ T-cell Count|CD4+ T-cell count at entry.|cells/mm^3|Median|521|521.0|Inter-Quartile Range|||381.0|699.0|
3962065|NCT01315353|3784146|B3|||CD4+ T-cell Count|CD4+ T-cell count at entry.|cells/mm^3|Median|568|568.0|Inter-Quartile Range|||391.0|728.0|
3962066|NCT01315353|3784147|B2|||CD4+ T-cell Count|CD4+ T-cell count at entry.|cells/mm^3|Median|479|479.0|Inter-Quartile Range|||330.0|649.0|
3962067|NCT01315353|3784148|B1|||CD4+ T-cell Count|CD4+ T-cell count at entry.|cells/mm^3|Median|529|529.0|Inter-Quartile Range|||386.0|687.0|
3962068|NCT01315353|3784145|B4|India||Region of Enrollment||Participants|Count of Participants|70|70.0||||||
3962069|NCT01315353|3784146|B3|India||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3962070|NCT01315353|3784147|B2|India||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3962071|NCT01315353|3784148|B1|India||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3962072|NCT01315353|3784145|B4|Peru||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3962073|NCT01315353|3784146|B3|Peru||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3962074|NCT01315353|3784147|B2|Peru||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3962075|NCT01315353|3784148|B1|Peru||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3962076|NCT01315353|3784145|B4|Zimbabwe||Region of Enrollment||Participants|Count of Participants|56|56.0||||||
3962077|NCT01315353|3784146|B3|Zimbabwe||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3962078|NCT01315353|3784147|B2|Zimbabwe||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3962079|NCT01315353|3784148|B1|Zimbabwe||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3962080|NCT01315353|3784145|B4|South Africa||Region of Enrollment||Participants|Count of Participants|136|136.0||||||
3962081|NCT01315353|3784146|B3|South Africa||Region of Enrollment||Participants|Count of Participants|55|55.0||||||
3962082|NCT01315353|3784147|B2|South Africa||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3962083|NCT01315353|3784148|B1|South Africa||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
3962084|NCT01315353|3784145|B4|Botswana||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3962085|NCT01315353|3784146|B3|Botswana||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3962086|NCT01315353|3784147|B2|Botswana||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3962087|NCT01315353|3784148|B1|Botswana||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3962088|NCT01315353|3784145|B4|Malawi||Region of Enrollment||Participants|Count of Participants|95|95.0||||||
3962089|NCT01315353|3784146|B3|Malawi||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3962090|NCT01315353|3784147|B2|Malawi||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3962091|NCT01315353|3784148|B1|Malawi||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3962092|NCT01315353|3784145|B4|Haiti||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3962093|NCT01315353|3784146|B3|Haiti||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3962094|NCT01315353|3784147|B2|Haiti||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3962095|NCT01315353|3784148|B1|Haiti||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3962096|NCT01315353|3784145|B4||Asian, Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|70|70.0||||||
3962097|NCT01315353|3784146|B3||Asian, Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3962098|NCT01315353|3784147|B2||Asian, Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3962099|NCT01315353|3784148|B1||Asian, Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3962100|NCT01315353|3784145|B4||Hispanic (Regardless of Race)|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3962163|NCT01315145|3784230|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3962102|NCT01315353|3784147|B2||Hispanic (Regardless of Race)|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3962103|NCT01315353|3784148|B1||Hispanic (Regardless of Race)|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3962104|NCT01315353|3784145|B4||Black Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|369|369.0||||||
3962105|NCT01315353|3784146|B3||Black Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|156|156.0||||||
3962106|NCT01315353|3784147|B2||Black Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|107|107.0||||||
3962107|NCT01315353|3784148|B1||Black Non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|106|106.0||||||
3962108|NCT01315353|3784145|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3962109|NCT01315353|3784146|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3962110|NCT01315353|3784147|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3962111|NCT01315353|3784148|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3962112|NCT01315353|3784145|B4||Female|Sex: Female, Male||Participants|Count of Participants|465|465.0||||||
3962113|NCT01315353|3784146|B3||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
3962114|NCT01315353|3784147|B2||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3962115|NCT01315353|3784148|B1||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3962116|NCT01315353|3784145|B4|||Age||years|Median|36|36.0|Inter-Quartile Range|||31.0|41.0|
3962117|NCT01315353|3784146|B3|||Age||years|Median|36|36.0|Inter-Quartile Range|||32.0|42.0|
3962118|NCT01315353|3784147|B2|||Age||years|Median|34|34.0|Inter-Quartile Range|||29.0|39.0|
3962119|NCT01315353|3784148|B1|||Age||years|Median|38|38.0|Inter-Quartile Range|||32.0|42.0|
3962120|NCT01315353|3784145|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3962121|NCT01315353|3784146|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3962122|NCT01315353|3784147|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3962123|NCT01315353|3784148|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3962124|NCT01315353|3784145|B4||Between 18 and 65 years|Age||Participants|Count of Participants|463|463.0||||||
3962125|NCT01315353|3784146|B3||Between 18 and 65 years|Age||Participants|Count of Participants|175|175.0||||||
3962126|NCT01315353|3784147|B2||Between 18 and 65 years|Age||Participants|Count of Participants|143|143.0||||||
3962127|NCT01315353|3784148|B1||Between 18 and 65 years|Age||Participants|Count of Participants|145|145.0||||||
3962128|NCT01315353|3784145|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3962129|NCT01315353|3784146|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3962130|NCT01315353|3784147|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3962131|NCT01315353|3784148|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3962132|NCT01315249|3784175|B3||Male|Sex: Female, Male||Participants|Count of Participants|370|370.0||||||
3962133|NCT01315249|3784176|B2||Male|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
3962134|NCT01315249|3784177|B1||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
3962135|NCT01315249|3784175|B3||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3962136|NCT01315249|3784176|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3962137|NCT01315249|3784177|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3962138|NCT01315249|3784175|B3|||Age||years|Mean|63.3|63.3|Standard Deviation|7.93|7.93|||
3962139|NCT01315249|3784176|B2|||Age||years|Mean|63.4|63.4|Standard Deviation|7.71|7.71|||
3962140|NCT01315249|3784177|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|8.16|8.16|||
3962141|NCT01315158|3784204|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
3962142|NCT01315158|3784205|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3962143|NCT01315158|3784206|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3962144|NCT01315158|3784204|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3962145|NCT01315158|3784205|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3962146|NCT01315158|3784206|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3962147|NCT01315158|3784204|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3962148|NCT01315158|3784205|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3962149|NCT01315158|3784206|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3962150|NCT01315158|3784204|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3962151|NCT01315158|3784205|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3962152|NCT01315158|3784206|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3962153|NCT01315158|3784204|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3962154|NCT01315158|3784205|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3962155|NCT01315158|3784206|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3962156|NCT01315158|3784204|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3962157|NCT01315158|3784205|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3962158|NCT01315158|3784206|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3962159|NCT01315145|3784229|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3962160|NCT01315145|3784230|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3962161|NCT01315145|3784231|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3962162|NCT01315145|3784229|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3962164|NCT01315145|3784231|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3962165|NCT01315145|3784229|B3|||Age||Years|Mean|72.56|72.56|Standard Deviation|9.91|9.91|||
3962166|NCT01315145|3784230|B2|||Age||Years|Mean|69.94|69.94|Standard Deviation|9.73|9.73|||
3962167|NCT01315145|3784231|B1|||Age||Years|Mean|72.9|72.9|Standard Deviation|9.73|9.73|||
3962168|NCT01315028|3784238|B3|United Kingdom||Region of Enrollment||participants|Number|20|20.0||||||
3962169|NCT01315028|3784239|B2|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
3962170|NCT01315028|3784240|B1|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
3962171|NCT01315028|3784238|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3962172|NCT01315028|3784239|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3962173|NCT01315028|3784240|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3962174|NCT01315028|3784238|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3962175|NCT01315028|3784239|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3962176|NCT01315028|3784240|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3962177|NCT01315028|3784238|B3|||Age||years|Mean|37.5|37.5|Standard Deviation|12.02|12.02|||
3962178|NCT01315028|3784239|B2|||Age||years|Mean|41.60|41.6|Standard Deviation|45.50|45.5|||
3962179|NCT01315028|3784240|B1|||Age||years|Mean|33.40|33.4|Standard Deviation|6.90|6.9|||
3962180|NCT01315028|3784238|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3962181|NCT01315028|3784239|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3962182|NCT01315028|3784240|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3962183|NCT01315028|3784238|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3962184|NCT01315028|3784239|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3962185|NCT01315028|3784240|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3962186|NCT01315028|3784238|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3962187|NCT01315028|3784239|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3962188|NCT01315028|3784240|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3962189|NCT01315002|3784253|B1|Germany||Region of Enrollment||participants|Number|121|121.0||||||
3962190|NCT01315002|3784253|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3962191|NCT01315002|3784253|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3962192|NCT01315002|3784253|B1|||Age||years|Mean|30.23|30.23|Standard Deviation|9.26|9.26|||
3962193|NCT01315002|3784253|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3962194|NCT01315002|3784253|B1||Between 18 and 65 years|Age||Participants|Count of Participants|121|121.0||||||
3962195|NCT01315002|3784253|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3962196|NCT01314963|3784260|B1|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3962197|NCT01314963|3784260|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3962198|NCT01314963|3784260|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962199|NCT01314963|3784260|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962200|NCT01314963|3784260|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962201|NCT01314963|3784260|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962202|NCT01314963|3784260|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962203|NCT01314963|3784260|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962204|NCT01314963|3784260|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3962205|NCT01314963|3784260|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962206|NCT01314963|3784260|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962207|NCT01314963|3784260|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3962208|NCT01314963|3784260|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3962209|NCT01314963|3784260|B1|18 years old or greater||Age, Customized|All available information on age is provided. Some data are missing, specifically whether or not certain participants were older or younger than age 65. Therefore the number of participants 18 to 65 vs the number of participants older than 65 is not available.|Participants|Count of Participants|50|50.0||||||
3962210|NCT01314872|3784266|B12||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3962211|NCT01314872|3784267|B11||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3962212|NCT01314872|3784268|B10||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3962213|NCT01314872|3784269|B9||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3962214|NCT01314872|3784270|B8||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3962215|NCT01314872|3784271|B7||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3962216|NCT01314872|3784272|B6||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3962217|NCT01314872|3784273|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3962218|NCT01314872|3784274|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3962219|NCT01314872|3784275|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3962220|NCT01314872|3784276|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3962221|NCT01314872|3784277|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3962222|NCT01314872|3784266|B12||Female|Sex: Female, Male||Participants|Count of Participants|1251|1251.0||||||
3962223|NCT01314872|3784267|B11||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3962224|NCT01314872|3784268|B10||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3962225|NCT01314872|3784269|B9||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3962226|NCT01314872|3784270|B8||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3962227|NCT01314872|3784271|B7||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3962228|NCT01314872|3784272|B6||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3962229|NCT01314872|3784273|B5||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3962230|NCT01314872|3784274|B4||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3962231|NCT01314872|3784275|B3||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3962232|NCT01314872|3784276|B2||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3962233|NCT01314872|3784277|B1||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3962234|NCT01314872|3784266|B12|||Age||Years|Mean|58.6|58.6|Standard Deviation|9.3|9.3|||
3962235|NCT01314872|3784267|B11|||Age||Years|Mean|55.5|55.5|Standard Deviation|11.7|11.7|||
3962236|NCT01314872|3784268|B10|||Age||Years|Mean|57.9|57.9|Standard Deviation|10.9|10.9|||
3962237|NCT01314872|3784269|B9|||Age||Years|Mean|57.2|57.2|Standard Deviation|10.1|10.1|||
3962238|NCT01314872|3784270|B8|||Age||Years|Mean|56.3|56.3|Standard Deviation|10.6|10.6|||
3962239|NCT01314872|3784271|B7|||Age||Years|Mean|59.4|59.4|Standard Deviation|8.5|8.5|||
3962240|NCT01314872|3784272|B6|||Age||Years|Mean|59.1|59.1|Standard Deviation|8.1|8.1|||
3962241|NCT01314872|3784273|B5|||Age||Years|Mean|60.3|60.3|Standard Deviation|8.3|8.3|||
3962242|NCT01314872|3784274|B4|||Age||Years|Mean|60.3|60.3|Standard Deviation|8.7|8.7|||
3962243|NCT01314872|3784275|B3|||Age||Years|Mean|58.6|58.6|Standard Deviation|8.1|8.1|||
3962244|NCT01314872|3784276|B2|||Age||Years|Mean|59.4|59.4|Standard Deviation|8.7|8.7|||
3962245|NCT01314872|3784277|B1|||Age||Years|Mean|58.6|58.6|Standard Deviation|9.0|9.0|||
3962246|NCT01314742|3784382|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
3962247|NCT01314742|3784383|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
3962248|NCT01314742|3784384|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3962249|NCT01314742|3784382|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3962250|NCT01314742|3784383|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3962251|NCT01314742|3784384|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3962252|NCT01314742|3784382|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3962253|NCT01314742|3784383|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3962254|NCT01314742|3784384|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3962255|NCT01314742|3784382|B3|||Age||gestational age (weeks)|Median|24|24.0|Inter-Quartile Range|0|0.0|24.0|25.0|
3962256|NCT01314742|3784383|B2|||Age||gestational age (weeks)|Median|25|25.0|Inter-Quartile Range|0|0.0|24.0|25.0|
3962257|NCT01314742|3784384|B1|||Age||gestational age (weeks)|Median|24|24.0|Inter-Quartile Range|0|0.0|24.0|25.0|
3962258|NCT01314742|3784382|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3962259|NCT01314742|3784383|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3962260|NCT01314742|3784384|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3962261|NCT01314742|3784382|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3962262|NCT01314742|3784383|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3962263|NCT01314742|3784384|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3962264|NCT01314742|3784382|B3||<=18 years|Age||Participants|Count of Participants|41|41.0||||||
3962265|NCT01314742|3784383|B2||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
3962266|NCT01314742|3784384|B1||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
3962267|NCT01314716|3784393|B3|||QOL-B Respiratory Symptom Score|The Quality of Life Questionnaire-Bronchiectasis (QOL-B) overall score was scaled from 0-100 with higher scores representing better quality of life.|units on a scale|Mean|56.8|56.8|Standard Deviation|18.00|18.0|||
3962268|NCT01314716|3784394|B2|||QOL-B Respiratory Symptom Score|The Quality of Life Questionnaire-Bronchiectasis (QOL-B) overall score was scaled from 0-100 with higher scores representing better quality of life.|units on a scale|Mean|57.4|57.4|Standard Deviation|18.07|18.07|||
3962269|NCT01314716|3784395|B1|||QOL-B Respiratory Symptom Score|The Quality of Life Questionnaire-Bronchiectasis (QOL-B) overall score was scaled from 0-100 with higher scores representing better quality of life.|units on a scale|Mean|56.2|56.2|Standard Deviation|17.98|17.98|||
3962270|NCT01314716|3784393|B3|Italy||Region of Enrollment||participants|Number|17|17.0||||||
3962271|NCT01314716|3784394|B2|Italy||Region of Enrollment||participants|Number|12|12.0||||||
3962272|NCT01314716|3784395|B1|Italy||Region of Enrollment||participants|Number|5|5.0||||||
3962273|NCT01314716|3784393|B3|United Kingdom||Region of Enrollment||participants|Number|22|22.0||||||
3962274|NCT01314716|3784394|B2|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
3962275|NCT01314716|3784395|B1|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
3962276|NCT01314716|3784393|B3|Germany||Region of Enrollment||participants|Number|37|37.0||||||
3962277|NCT01314716|3784394|B2|Germany||Region of Enrollment||participants|Number|21|21.0||||||
3962278|NCT01314716|3784395|B1|Germany||Region of Enrollment||participants|Number|16|16.0||||||
3962279|NCT01314716|3784393|B3|Netherlands||Region of Enrollment||participants|Number|17|17.0||||||
3962280|NCT01314716|3784394|B2|Netherlands||Region of Enrollment||participants|Number|12|12.0||||||
3962281|NCT01314716|3784395|B1|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
3962282|NCT01314716|3784393|B3|Australia||Region of Enrollment||participants|Number|5|5.0||||||
3962283|NCT01314716|3784394|B2|Australia||Region of Enrollment||participants|Number|2|2.0||||||
3962284|NCT01314716|3784395|B1|Australia||Region of Enrollment||participants|Number|3|3.0||||||
3962285|NCT01314716|3784393|B3|Belgium||Region of Enrollment||participants|Number|11|11.0||||||
3962286|NCT01314716|3784394|B2|Belgium||Region of Enrollment||participants|Number|6|6.0||||||
3962287|NCT01314716|3784395|B1|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
3962288|NCT01314716|3784393|B3|Spain||Region of Enrollment||participants|Number|39|39.0||||||
3962289|NCT01314716|3784394|B2|Spain||Region of Enrollment||participants|Number|17|17.0||||||
3962290|NCT01314716|3784395|B1|Spain||Region of Enrollment||participants|Number|22|22.0||||||
3962291|NCT01314716|3784393|B3|Canada||Region of Enrollment||participants|Number|2|2.0||||||
3962292|NCT01314716|3784394|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
3962293|NCT01314716|3784395|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
3962294|NCT01314716|3784393|B3|United States||Region of Enrollment||participants|Number|110|110.0||||||
3962295|NCT01314716|3784394|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
3962296|NCT01314716|3784395|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
3962297|NCT01314716|3784393|B3|France||Region of Enrollment||participants|Number|14|14.0||||||
3962298|NCT01314716|3784394|B2|France||Region of Enrollment||participants|Number|3|3.0||||||
3962299|NCT01314716|3784395|B1|France||Region of Enrollment||participants|Number|11|11.0||||||
3962300|NCT01314716|3784393|B3|Not permitted||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3962301|NCT01314716|3784394|B2|Not permitted||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3962302|NCT01314716|3784395|B1|Not permitted||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3962303|NCT01314716|3784393|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3962304|NCT01314716|3784394|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3962305|NCT01314716|3784395|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3962306|NCT01314716|3784393|B3|Black or African Heritage||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3962307|NCT01314716|3784394|B2|Black or African Heritage||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3962308|NCT01314716|3784395|B1|Black or African Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3962309|NCT01314716|3784393|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3962310|NCT01314716|3784394|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3962311|NCT01314716|3784395|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3962312|NCT01314716|3784393|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3962313|NCT01314716|3784394|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3962314|NCT01314716|3784395|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3962315|NCT01314716|3784393|B3|White||Race/Ethnicity, Customized||participants|Number|247|247.0||||||
3962316|NCT01314716|3784394|B2|White||Race/Ethnicity, Customized||participants|Number|128|128.0||||||
3962317|NCT01314716|3784395|B1|White||Race/Ethnicity, Customized||participants|Number|119|119.0||||||
3962318|NCT01314716|3784393|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3962319|NCT01314716|3784394|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3962320|NCT01314716|3784395|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3962321|NCT01314716|3784393|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|234|234.0||||||
3962322|NCT01314716|3784394|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|112|112.0||||||
3962323|NCT01314716|3784395|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
3962324|NCT01314716|3784393|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3962325|NCT01314716|3784394|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3962326|NCT01314716|3784395|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3962327|NCT01314716|3784393|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3962328|NCT01314716|3784394|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3962329|NCT01314716|3784395|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3962330|NCT01314716|3784393|B3||Female|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
3962331|NCT01314716|3784394|B2||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3962332|NCT01314716|3784395|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3962333|NCT01314716|3784393|B3||>=65 years|Age||Participants|Count of Participants|155|155.0||||||
3962334|NCT01314716|3784394|B2||>=65 years|Age||Participants|Count of Participants|72|72.0||||||
3962335|NCT01314716|3784395|B1||>=65 years|Age||Participants|Count of Participants|83|83.0||||||
3962336|NCT01314716|3784393|B3||Between 18 and 65 years|Age||Participants|Count of Participants|119|119.0||||||
3962337|NCT01314716|3784394|B2||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
3962338|NCT01314716|3784395|B1||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
3962339|NCT01314716|3784393|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3962340|NCT01314716|3784394|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3962341|NCT01314716|3784395|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3962342|NCT01314716|3784393|B3|||Age||years|Mean|63.0|63.0|Standard Deviation|13.75|13.75|||
3962343|NCT01314716|3784394|B2|||Age||years|Mean|62.7|62.7|Standard Deviation|13.33|13.33|||
3962344|NCT01314716|3784395|B1|||Age||years|Mean|63.3|63.3|Standard Deviation|14.22|14.22|||
3962345|NCT01314703|3784408|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3962346|NCT01314703|3784408|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3962347|NCT01314703|3784408|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3962348|NCT01314703|3784408|B1|||Age||years|Mean|35|35.0|Standard Deviation|12.7|12.7|||
3962349|NCT01314703|3784408|B1|||Age||years|Mean|35|35.0|Standard Deviation|12.7|12.7|19.0|62.0|
3962350|NCT01314443|3784413|B5|United States||Region of Enrollment||participants|Number|56|56.0||||||
3962351|NCT01314443|3784414|B4|United States||Region of Enrollment||participants|Number|13|13.0||||||
3962352|NCT01314443|3784415|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
3962353|NCT01314443|3784416|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3962354|NCT01314443|3784417|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3962355|NCT01314443|3784413|B5||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3962356|NCT01314443|3784414|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3962357|NCT01314443|3784415|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3962358|NCT01314443|3784416|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3962359|NCT01314443|3784417|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3962360|NCT01314443|3784413|B5||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3962361|NCT01314443|3784414|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3962362|NCT01314443|3784415|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3962363|NCT01314443|3784416|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3962364|NCT01314443|3784417|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3962365|NCT01314443|3784413|B5|||Age||years|Mean|24|24.0|Standard Deviation|6|6.0|||
3962366|NCT01314443|3784414|B4|||Age||years|Mean|25|25.0|Standard Deviation|8|8.0|||
3962367|NCT01314443|3784415|B3|||Age||years|Mean|26|26.0|Standard Deviation|8|8.0|||
3962368|NCT01314443|3784416|B2|||Age||years|Mean|22|22.0|Standard Deviation|4|4.0|||
3962369|NCT01314443|3784417|B1|||Age||years|Mean|22|22.0|Standard Deviation|4|4.0|||
3962370|NCT01314443|3784413|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3962371|NCT01314443|3784414|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3962372|NCT01314443|3784415|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3962373|NCT01314443|3784416|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3962374|NCT01314443|3784417|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3962375|NCT01314443|3784413|B5||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
3962376|NCT01314443|3784414|B4||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3962377|NCT01314443|3784415|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3962378|NCT01314443|3784416|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3962379|NCT01314443|3784417|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3962380|NCT01314443|3784413|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3962381|NCT01314443|3784414|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3962382|NCT01314443|3784415|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3962383|NCT01314443|3784416|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3962384|NCT01314443|3784417|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3962385|NCT01314417|3784438|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3962386|NCT01314417|3784438|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3962387|NCT01314417|3784438|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3962388|NCT01314417|3784438|B1|||Age||years|Mean|55.0|55.0|Standard Deviation|11.3|11.3|||
3962389|NCT01314417|3784438|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3962390|NCT01314417|3784438|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3962391|NCT01314417|3784438|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3962392|NCT01314313|3784467|B3|NYHA III/VI||NYHA Classification|New York Heart Association (NYHA), functional classification of heart failure based on how much a patient is limited during physical activity. The rating ranges from I - IV, with the lowest as no limitations and the highest unable to carry on any physical activity without discomfort.|participants|Number|1558|1558.0||||||
3962393|NCT01314313|3784468|B2|NYHA III/VI||NYHA Classification|New York Heart Association (NYHA), functional classification of heart failure based on how much a patient is limited during physical activity. The rating ranges from I - IV, with the lowest as no limitations and the highest unable to carry on any physical activity without discomfort.|participants|Number|776|776.0||||||
3962394|NCT01314313|3784469|B1|NYHA III/VI||NYHA Classification|New York Heart Association (NYHA), functional classification of heart failure based on how much a patient is limited during physical activity. The rating ranges from I - IV, with the lowest as no limitations and the highest unable to carry on any physical activity without discomfort.|participants|Number|782|782.0||||||
3962395|NCT01314313|3784467|B3|NYHA I/II||NYHA Classification|New York Heart Association (NYHA), functional classification of heart failure based on how much a patient is limited during physical activity. The rating ranges from I - IV, with the lowest as no limitations and the highest unable to carry on any physical activity without discomfort.|participants|Number|473|473.0||||||
3962448|NCT01314014|3784596|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962396|NCT01314313|3784468|B2|NYHA I/II||NYHA Classification|New York Heart Association (NYHA), functional classification of heart failure based on how much a patient is limited during physical activity. The rating ranges from I - IV, with the lowest as no limitations and the highest unable to carry on any physical activity without discomfort.|participants|Number|244|244.0||||||
3962397|NCT01314313|3784469|B1|NYHA I/II||NYHA Classification|New York Heart Association (NYHA), functional classification of heart failure based on how much a patient is limited during physical activity. The rating ranges from I - IV, with the lowest as no limitations and the highest unable to carry on any physical activity without discomfort.|participants|Number|229|229.0||||||
3962398|NCT01314313|3784467|B3|||STS Score|The Society of Thoracic Surgeons (STS) score measures patient risk at the time of cardiovascular surgery on a scale that ranges from 0% to 100%, with higher numbers indicating greater risk.|% risk of mortality or morbidity|Mean|5.8|5.8|Standard Deviation|1.98|1.98|||
3962399|NCT01314313|3784468|B2|||STS Score|The Society of Thoracic Surgeons (STS) score measures patient risk at the time of cardiovascular surgery on a scale that ranges from 0% to 100%, with higher numbers indicating greater risk.|% risk of mortality or morbidity|Mean|5.8|5.8|Standard Deviation|1.87|1.87|||
3962400|NCT01314313|3784469|B1|||STS Score|The Society of Thoracic Surgeons (STS) score measures patient risk at the time of cardiovascular surgery on a scale that ranges from 0% to 100%, with higher numbers indicating greater risk.|% risk of mortality or morbidity|Mean|5.8|5.8|Standard Deviation|2.08|2.08|||
3962401|NCT01314313|3784467|B3||Male|Sex: Female, Male||Participants|Count of Participants|1108|1108.0||||||
3962402|NCT01314313|3784468|B2||Male|Sex: Female, Male||Participants|Count of Participants|560|560.0||||||
3962403|NCT01314313|3784469|B1||Male|Sex: Female, Male||Participants|Count of Participants|548|548.0||||||
3962404|NCT01314313|3784467|B3||Female|Sex: Female, Male||Participants|Count of Participants|924|924.0||||||
3962405|NCT01314313|3784468|B2||Female|Sex: Female, Male||Participants|Count of Participants|461|461.0||||||
3962406|NCT01314313|3784469|B1||Female|Sex: Female, Male||Participants|Count of Participants|463|463.0||||||
3962407|NCT01314313|3784467|B3|||Age||years|Mean|81.6|81.6|Standard Deviation|6.70|6.7|||
3962408|NCT01314313|3784468|B2|||Age||years|Mean|81.7|81.7|Standard Deviation|6.71|6.71|||
3962409|NCT01314313|3784469|B1|||Age||years|Mean|81.5|81.5|Standard Deviation|6.70|6.7|||
3962410|NCT01314261|3784486|B5||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3962411|NCT01314261|3784487|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3962412|NCT01314261|3784488|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3962413|NCT01314261|3784489|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3962414|NCT01314261|3784490|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3962415|NCT01314261|3784486|B5||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3962416|NCT01314261|3784487|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3962417|NCT01314261|3784488|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3962418|NCT01314261|3784489|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3962419|NCT01314261|3784490|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3962420|NCT01314261|3784486|B5|||Age||years|Mean|48.3|48.3|Standard Deviation|10.55|10.55|||
3962421|NCT01314261|3784487|B4|||Age||years|Mean|48.1|48.1|Standard Deviation|12.32|12.32|||
3962422|NCT01314261|3784488|B3|||Age||years|Mean|46.0|46.0|Standard Deviation|10.26|10.26|||
3962423|NCT01314261|3784489|B2|||Age||years|Mean|49.2|49.2|Standard Deviation|9.55|9.55|||
3962424|NCT01314261|3784490|B1|||Age||years|Mean|50.1|50.1|Standard Deviation|11.32|11.32|||
3962425|NCT01314118|3784544|B1|USA||Region of Enrollment||participants|Number|131|131.0||||||
3962426|NCT01314118|3784544|B1||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3962427|NCT01314118|3784544|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3962428|NCT01314118|3784544|B1|||Age||years|Mean|71.2|71.2|Standard Deviation|8.82|8.82|||
3962429|NCT01314105|3784551|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3962430|NCT01314105|3784552|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3962431|NCT01314105|3784553|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3962432|NCT01314105|3784551|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3962433|NCT01314105|3784552|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3962434|NCT01314105|3784553|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3962435|NCT01314105|3784551|B3|||Age||years|Mean|54.9|54.9|Standard Deviation|9.2|9.2|36.0|71.0|
3962436|NCT01314105|3784552|B2|||Age||years|Mean|53.1|53.1|Standard Deviation|6.4|6.4|40.0|63.0|
3962437|NCT01314105|3784553|B1|||Age||years|Mean|58.0|58.0|Standard Deviation|12.7|12.7|36.0|71.0|
3962438|NCT01314014|3784596|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3962439|NCT01314014|3784596|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962440|NCT01314014|3784596|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3962441|NCT01314014|3784596|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3962442|NCT01314014|3784596|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962443|NCT01314014|3784596|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962444|NCT01314014|3784596|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3962445|NCT01314014|3784596|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962446|NCT01314014|3784596|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962447|NCT01314014|3784596|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962449|NCT01314014|3784596|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3962450|NCT01314014|3784596|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3962451|NCT01314014|3784596|B1|||Age||years|Median|64|64.0|Full Range|||43.0|92.0|
3962452|NCT01314001|3784601|B7|||Cigarettes per day|Self-report measure of the number of cigarettes smoked in a typical day.|cigarettes per day|Mean|18.0|18.0|Standard Deviation|7.0|7.0|||
3962453|NCT01314001|3784602|B6|||Cigarettes per day|Self-report measure of the number of cigarettes smoked in a typical day.|cigarettes per day|Mean|18.4|18.4|Standard Deviation|6.3|6.3|||
3962454|NCT01314001|3784603|B5|||Cigarettes per day|Self-report measure of the number of cigarettes smoked in a typical day.|cigarettes per day|Mean|16.7|16.7|Standard Deviation|5.4|5.4|||
3962455|NCT01314001|3784604|B4|||Cigarettes per day|Self-report measure of the number of cigarettes smoked in a typical day.|cigarettes per day|Mean|18.5|18.5|Standard Deviation|7.0|7.0|||
3962456|NCT01314001|3784605|B3|||Cigarettes per day|Self-report measure of the number of cigarettes smoked in a typical day.|cigarettes per day|Mean|17.6|17.6|Standard Deviation|7.0|7.0|||
3962457|NCT01314001|3784606|B2|||Cigarettes per day|Self-report measure of the number of cigarettes smoked in a typical day.|cigarettes per day|Mean|19.6|19.6|Standard Deviation|8.7|8.7|||
3962458|NCT01314001|3784607|B1|||Cigarettes per day|Self-report measure of the number of cigarettes smoked in a typical day.|cigarettes per day|Mean|17.6|17.6|Standard Deviation|7.0|7.0|||
3962459|NCT01314001|3784601|B7|||FTND Score|The Fagerstrom Test for Nicotine Dependence (FTND) is a six-item self-report scale that measures the level of nicotine dependence. Summary scores are calculated, ranging from 0 to 10, with higher scores indicating a greater difficulty quitting smoking.|units on a scale|Mean|5.2|5.2|Standard Deviation|1.97|1.97|||
3962460|NCT01314001|3784602|B6|||FTND Score|The Fagerstrom Test for Nicotine Dependence (FTND) is a six-item self-report scale that measures the level of nicotine dependence. Summary scores are calculated, ranging from 0 to 10, with higher scores indicating a greater difficulty quitting smoking.|units on a scale|Mean|2.1|2.1|Standard Deviation|2.02|2.02|||
3962461|NCT01314001|3784603|B5|||FTND Score|The Fagerstrom Test for Nicotine Dependence (FTND) is a six-item self-report scale that measures the level of nicotine dependence. Summary scores are calculated, ranging from 0 to 10, with higher scores indicating a greater difficulty quitting smoking.|units on a scale|Mean|5.1|5.1|Standard Deviation|2.00|2.0|||
3962462|NCT01314001|3784604|B4|||FTND Score|The Fagerstrom Test for Nicotine Dependence (FTND) is a six-item self-report scale that measures the level of nicotine dependence. Summary scores are calculated, ranging from 0 to 10, with higher scores indicating a greater difficulty quitting smoking.|units on a scale|Mean|5.3|5.3|Standard Deviation|1.89|1.89|||
3962463|NCT01314001|3784605|B3|||FTND Score|The Fagerstrom Test for Nicotine Dependence (FTND) is a six-item self-report scale that measures the level of nicotine dependence. Summary scores are calculated, ranging from 0 to 10, with higher scores indicating a greater difficulty quitting smoking.|units on a scale|Mean|5.2|5.2|Standard Deviation|2.00|2.0|||
3962464|NCT01314001|3784606|B2|||FTND Score|The Fagerstrom Test for Nicotine Dependence (FTND) is a six-item self-report scale that measures the level of nicotine dependence. Summary scores are calculated, ranging from 0 to 10, with higher scores indicating a greater difficulty quitting smoking.|units on a scale|Mean|5.4|5.4|Standard Deviation|2.00|2.0|||
3962465|NCT01314001|3784607|B1|||FTND Score|The Fagerstrom Test for Nicotine Dependence (FTND) is a six-item self-report scale that measures the level of nicotine dependence. Summary scores are calculated, ranging from 0 to 10, with higher scores indicating a greater difficulty quitting smoking.|units on a scale|Mean|5.3|5.3|Standard Deviation|1.92|1.92|||
3962466|NCT01314001|3784601|B7|Employed||Employment Status|"Question on Demographics measure (self-report) completed at the Intake session (Are you currently employed full-time or part-time for salary or wages?)."|participants|Number|780|780.0||||||
3962467|NCT01314001|3784602|B6|Employed||Employment Status|"Question on Demographics measure (self-report) completed at the Intake session (Are you currently employed full-time or part-time for salary or wages?)."|participants|Number|125|125.0||||||
3962468|NCT01314001|3784603|B5|Employed||Employment Status|"Question on Demographics measure (self-report) completed at the Intake session (Are you currently employed full-time or part-time for salary or wages?)."|participants|Number|132|132.0||||||
3962469|NCT01314001|3784604|B4|Employed||Employment Status|"Question on Demographics measure (self-report) completed at the Intake session (Are you currently employed full-time or part-time for salary or wages?)."|participants|Number|120|120.0||||||
3962470|NCT01314001|3784605|B3|Employed||Employment Status|"Question on Demographics measure (self-report) completed at the Intake session (Are you currently employed full-time or part-time for salary or wages?)."|participants|Number|158|158.0||||||
3962471|NCT01314001|3784606|B2|Employed||Employment Status|"Question on Demographics measure (self-report) completed at the Intake session (Are you currently employed full-time or part-time for salary or wages?)."|participants|Number|109|109.0||||||
3962472|NCT01314001|3784607|B1|Employed||Employment Status|"Question on Demographics measure (self-report) completed at the Intake session (Are you currently employed full-time or part-time for salary or wages?)."|participants|Number|136|136.0||||||
3962473|NCT01314001|3784601|B7|Not employed||Employment Status|"Question on Demographics measure (self-report) completed at the Intake session (Are you currently employed full-time or part-time for salary or wages?)."|participants|Number|466|466.0||||||
3962474|NCT01314001|3784602|B6|Not employed||Employment Status|"Question on Demographics measure (self-report) completed at the Intake session (Are you currently employed full-time or part-time for salary or wages?)."|participants|Number|75|75.0||||||
3962475|NCT01314001|3784603|B5|Not employed||Employment Status|"Question on Demographics measure (self-report) completed at the Intake session (Are you currently employed full-time or part-time for salary or wages?)."|participants|Number|88|88.0||||||
3962476|NCT01314001|3784604|B4|Not employed||Employment Status|"Question on Demographics measure (self-report) completed at the Intake session (Are you currently employed full-time or part-time for salary or wages?)."|participants|Number|71|71.0||||||
3962477|NCT01314001|3784605|B3|Not employed||Employment Status|"Question on Demographics measure (self-report) completed at the Intake session (Are you currently employed full-time or part-time for salary or wages?)."|participants|Number|69|69.0||||||
3962478|NCT01314001|3784606|B2|Not employed||Employment Status|"Question on Demographics measure (self-report) completed at the Intake session (Are you currently employed full-time or part-time for salary or wages?)."|participants|Number|84|84.0||||||
3962479|NCT01314001|3784607|B1|Not employed||Employment Status|"Question on Demographics measure (self-report) completed at the Intake session (Are you currently employed full-time or part-time for salary or wages?)."|participants|Number|79|79.0||||||
3962480|NCT01314001|3784601|B7|Less than US$50,000||Annual Income (US dollars)|"Question on Demographics measure (self-report) completed at the Intake session (What was your household income before taxes last year?)."|participants|Number|800|800.0||||||
3962481|NCT01314001|3784602|B6|Less than US$50,000||Annual Income (US dollars)|"Question on Demographics measure (self-report) completed at the Intake session (What was your household income before taxes last year?)."|participants|Number|129|129.0||||||
3962482|NCT01314001|3784603|B5|Less than US$50,000||Annual Income (US dollars)|"Question on Demographics measure (self-report) completed at the Intake session (What was your household income before taxes last year?)."|participants|Number|146|146.0||||||
3962483|NCT01314001|3784604|B4|Less than US$50,000||Annual Income (US dollars)|"Question on Demographics measure (self-report) completed at the Intake session (What was your household income before taxes last year?)."|participants|Number|116|116.0||||||
3962484|NCT01314001|3784605|B3|Less than US$50,000||Annual Income (US dollars)|"Question on Demographics measure (self-report) completed at the Intake session (What was your household income before taxes last year?)."|participants|Number|145|145.0||||||
3962485|NCT01314001|3784606|B2|Less than US$50,000||Annual Income (US dollars)|"Question on Demographics measure (self-report) completed at the Intake session (What was your household income before taxes last year?)."|participants|Number|114|114.0||||||
3962486|NCT01314001|3784607|B1|Less than US$50,000||Annual Income (US dollars)|"Question on Demographics measure (self-report) completed at the Intake session (What was your household income before taxes last year?)."|participants|Number|150|150.0||||||
3962487|NCT01314001|3784601|B7|Greater than or equal to US$50,000||Annual Income (US dollars)|"Question on Demographics measure (self-report) completed at the Intake session (What was your household income before taxes last year?)."|participants|Number|446|446.0||||||
3962488|NCT01314001|3784602|B6|Greater than or equal to US$50,000||Annual Income (US dollars)|"Question on Demographics measure (self-report) completed at the Intake session (What was your household income before taxes last year?)."|participants|Number|71|71.0||||||
3962489|NCT01314001|3784603|B5|Greater than or equal to US$50,000||Annual Income (US dollars)|"Question on Demographics measure (self-report) completed at the Intake session (What was your household income before taxes last year?)."|participants|Number|74|74.0||||||
3962490|NCT01314001|3784604|B4|Greater than or equal to US$50,000||Annual Income (US dollars)|"Question on Demographics measure (self-report) completed at the Intake session (What was your household income before taxes last year?)."|participants|Number|75|75.0||||||
3962491|NCT01314001|3784605|B3|Greater than or equal to US$50,000||Annual Income (US dollars)|"Question on Demographics measure (self-report) completed at the Intake session (What was your household income before taxes last year?)."|participants|Number|82|82.0||||||
3962492|NCT01314001|3784606|B2|Greater than or equal to US$50,000||Annual Income (US dollars)|"Question on Demographics measure (self-report) completed at the Intake session (What was your household income before taxes last year?)."|participants|Number|79|79.0||||||
3962493|NCT01314001|3784607|B1|Greater than or equal to US$50,000||Annual Income (US dollars)|"Question on Demographics measure (self-report) completed at the Intake session (What was your household income before taxes last year?)."|participants|Number|65|65.0||||||
3962494|NCT01314001|3784601|B7|Post-high school education||Education level|"Question on Demographics measure (self-report) completed at the Intake session (What is the highest level of education you completed?)."|participants|Number|859|859.0||||||
3962495|NCT01314001|3784602|B6|Post-high school education||Education level|"Question on Demographics measure (self-report) completed at the Intake session (What is the highest level of education you completed?)."|participants|Number|139|139.0||||||
3962496|NCT01314001|3784603|B5|Post-high school education||Education level|"Question on Demographics measure (self-report) completed at the Intake session (What is the highest level of education you completed?)."|participants|Number|146|146.0||||||
3962497|NCT01314001|3784604|B4|Post-high school education||Education level|"Question on Demographics measure (self-report) completed at the Intake session (What is the highest level of education you completed?)."|participants|Number|142|142.0||||||
3962498|NCT01314001|3784605|B3|Post-high school education||Education level|"Question on Demographics measure (self-report) completed at the Intake session (What is the highest level of education you completed?)."|participants|Number|149|149.0||||||
3962499|NCT01314001|3784606|B2|Post-high school education||Education level|"Question on Demographics measure (self-report) completed at the Intake session (What is the highest level of education you completed?)."|participants|Number|136|136.0||||||
3962500|NCT01314001|3784607|B1|Post-high school education||Education level|"Question on Demographics measure (self-report) completed at the Intake session (What is the highest level of education you completed?)."|participants|Number|147|147.0||||||
3962501|NCT01314001|3784601|B7|High school education or lower||Education level|"Question on Demographics measure (self-report) completed at the Intake session (What is the highest level of education you completed?)."|participants|Number|387|387.0||||||
3962502|NCT01314001|3784602|B6|High school education or lower||Education level|"Question on Demographics measure (self-report) completed at the Intake session (What is the highest level of education you completed?)."|participants|Number|61|61.0||||||
3962503|NCT01314001|3784603|B5|High school education or lower||Education level|"Question on Demographics measure (self-report) completed at the Intake session (What is the highest level of education you completed?)."|participants|Number|74|74.0||||||
3962504|NCT01314001|3784604|B4|High school education or lower||Education level|"Question on Demographics measure (self-report) completed at the Intake session (What is the highest level of education you completed?)."|participants|Number|49|49.0||||||
3962505|NCT01314001|3784605|B3|High school education or lower||Education level|"Question on Demographics measure (self-report) completed at the Intake session (What is the highest level of education you completed?)."|participants|Number|78|78.0||||||
3962567|NCT01313936|3784656|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3962506|NCT01314001|3784606|B2|High school education or lower||Education level|"Question on Demographics measure (self-report) completed at the Intake session (What is the highest level of education you completed?)."|participants|Number|57|57.0||||||
3962507|NCT01314001|3784607|B1|High school education or lower||Education level|"Question on Demographics measure (self-report) completed at the Intake session (What is the highest level of education you completed?)."|participants|Number|68|68.0||||||
3962508|NCT01314001|3784601|B7|United States||Region of Enrollment||participants|Number|970|970.0||||||
3962509|NCT01314001|3784602|B6|United States||Region of Enrollment||participants|Number|156|156.0||||||
3962510|NCT01314001|3784603|B5|United States||Region of Enrollment||participants|Number|172|172.0||||||
3962511|NCT01314001|3784604|B4|United States||Region of Enrollment||participants|Number|149|149.0||||||
3962512|NCT01314001|3784605|B3|United States||Region of Enrollment||participants|Number|175|175.0||||||
3962513|NCT01314001|3784606|B2|United States||Region of Enrollment||participants|Number|150|150.0||||||
3962514|NCT01314001|3784607|B1|United States||Region of Enrollment||participants|Number|168|168.0||||||
3962515|NCT01314001|3784601|B7|Canada||Region of Enrollment||participants|Number|276|276.0||||||
3962516|NCT01314001|3784602|B6|Canada||Region of Enrollment||participants|Number|44|44.0||||||
3962517|NCT01314001|3784603|B5|Canada||Region of Enrollment||participants|Number|48|48.0||||||
3962518|NCT01314001|3784604|B4|Canada||Region of Enrollment||participants|Number|42|42.0||||||
3962519|NCT01314001|3784605|B3|Canada||Region of Enrollment||participants|Number|52|52.0||||||
3962520|NCT01314001|3784606|B2|Canada||Region of Enrollment||participants|Number|43|43.0||||||
3962521|NCT01314001|3784607|B1|Canada||Region of Enrollment||participants|Number|47|47.0||||||
3962522|NCT01314001|3784601|B7|Other||Race/Ethnicity, Customized||participants|Number|91|91.0||||||
3962523|NCT01314001|3784602|B6|Other||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3962524|NCT01314001|3784603|B5|Other||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3962525|NCT01314001|3784604|B4|Other||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3962526|NCT01314001|3784605|B3|Other||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3962527|NCT01314001|3784606|B2|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3962528|NCT01314001|3784607|B1|Other||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3962529|NCT01314001|3784601|B7|Black||Race/Ethnicity, Customized||participants|Number|462|462.0||||||
3962530|NCT01314001|3784602|B6|Black||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
3962531|NCT01314001|3784603|B5|Black||Race/Ethnicity, Customized||participants|Number|107|107.0||||||
3962532|NCT01314001|3784604|B4|Black||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
3962533|NCT01314001|3784605|B3|Black||Race/Ethnicity, Customized||participants|Number|94|94.0||||||
3962534|NCT01314001|3784606|B2|Black||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
3962535|NCT01314001|3784607|B1|Black||Race/Ethnicity, Customized||participants|Number|95|95.0||||||
3962536|NCT01314001|3784601|B7|White||Race/Ethnicity, Customized||participants|Number|693|693.0||||||
3962537|NCT01314001|3784602|B6|White||Race/Ethnicity, Customized||participants|Number|133|133.0||||||
3962538|NCT01314001|3784603|B5|White||Race/Ethnicity, Customized||participants|Number|99|99.0||||||
3962539|NCT01314001|3784604|B4|White||Race/Ethnicity, Customized||participants|Number|119|119.0||||||
3962540|NCT01314001|3784605|B3|White||Race/Ethnicity, Customized||participants|Number|117|117.0||||||
3962541|NCT01314001|3784606|B2|White||Race/Ethnicity, Customized||participants|Number|128|128.0||||||
3962542|NCT01314001|3784607|B1|White||Race/Ethnicity, Customized||participants|Number|97|97.0||||||
3962543|NCT01314001|3784601|B7||Male|Sex: Female, Male||Participants|Count of Participants|703|703.0||||||
3962544|NCT01314001|3784602|B6||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3962545|NCT01314001|3784603|B5||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3962546|NCT01314001|3784604|B4||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3962547|NCT01314001|3784605|B3||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3962548|NCT01314001|3784606|B2||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3962549|NCT01314001|3784607|B1||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3962550|NCT01314001|3784601|B7||Female|Sex: Female, Male||Participants|Count of Participants|543|543.0||||||
3962551|NCT01314001|3784602|B6||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3962552|NCT01314001|3784603|B5||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3962553|NCT01314001|3784604|B4||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3962554|NCT01314001|3784605|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3962555|NCT01314001|3784606|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3962556|NCT01314001|3784607|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3962557|NCT01314001|3784601|B7|||Age||years|Mean|45|45.0|Standard Deviation|11|11.0|||
3962558|NCT01314001|3784602|B6|||Age||years|Mean|46|46.0|Standard Deviation|12|12.0|||
3962559|NCT01314001|3784603|B5|||Age||years|Mean|44|44.0|Standard Deviation|12|12.0|||
3962560|NCT01314001|3784604|B4|||Age||years|Mean|46|46.0|Standard Deviation|11|11.0|||
3962561|NCT01314001|3784605|B3|||Age||years|Mean|46|46.0|Standard Deviation|11|11.0|||
3962562|NCT01314001|3784606|B2|||Age||years|Mean|47|47.0|Standard Deviation|11|11.0|||
3962563|NCT01314001|3784607|B1|||Age||years|Mean|44|44.0|Standard Deviation|11|11.0|||
3962564|NCT01313936|3784656|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
3962565|NCT01313936|3784657|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
3962566|NCT01313936|3784658|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3962568|NCT01313936|3784657|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3962569|NCT01313936|3784658|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3962570|NCT01313936|3784656|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3962571|NCT01313936|3784657|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3962572|NCT01313936|3784658|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3962573|NCT01313936|3784656|B3|Age||Age, Customized||years|Median|6|6.0|Full Range|||2.0|30.0|
3962574|NCT01313936|3784657|B2|Age||Age, Customized||years|Median|6|6.0|Full Range|||2.0|30.0|
3962575|NCT01313936|3784658|B1|Age||Age, Customized||years|Median|12.5|12.5|Full Range|||4.0|23.0|
3962576|NCT01313923|3784667|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3962577|NCT01313923|3784667|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3962578|NCT01313923|3784667|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3962579|NCT01313923|3784667|B1|||Age||years|Mean|59|59.0|Full Range|||57.0|60.0|
3962580|NCT01313923|3784667|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3962581|NCT01313923|3784667|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3962582|NCT01313923|3784667|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3962583|NCT01313910|3784671|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3962584|NCT01313910|3784671|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3962585|NCT01313910|3784671|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3962586|NCT01313910|3784671|B1|||Age||years|Mean|44.5|44.5|Standard Deviation|4.5|4.5|||
3962587|NCT01313910|3784671|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3962588|NCT01313910|3784671|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3962589|NCT01313910|3784671|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3962590|NCT01313897|3784679|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3962591|NCT01313897|3784679|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3962592|NCT01313897|3784679|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3962593|NCT01313897|3784679|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3962594|NCT01313897|3784679|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3962595|NCT01313884|3784683|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3962596|NCT01313884|3784683|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3962597|NCT01313884|3784683|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962598|NCT01313884|3784683|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3962599|NCT01313884|3784683|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962600|NCT01313884|3784683|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962601|NCT01313884|3784683|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3962602|NCT01313884|3784683|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962603|NCT01313884|3784683|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962604|NCT01313884|3784683|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3962605|NCT01313884|3784683|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3962606|NCT01313884|3784683|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3962607|NCT01313884|3784683|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3962608|NCT01313884|3784683|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3962609|NCT01313884|3784683|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3962610|NCT01313884|3784683|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3962611|NCT01313858|3784688|B4||Male|Sex: Female, Male|The mITT population consists of all participants who were treated with Simponi® and have a baseline assessment and at least one additional visit, regardless of any protocol violations during the study.|Participants|Count of Participants|680|680.0||||||
3962612|NCT01313858|3784689|B3||Male|Sex: Female, Male|The mITT population consists of all participants who were treated with Simponi® and have a baseline assessment and at least one additional visit, regardless of any protocol violations during the study.|Participants|Count of Participants|321|321.0||||||
3962613|NCT01313858|3784690|B2||Male|Sex: Female, Male|The mITT population consists of all participants who were treated with Simponi® and have a baseline assessment and at least one additional visit, regardless of any protocol violations during the study.|Participants|Count of Participants|230|230.0||||||
3962614|NCT01313858|3784691|B1||Male|Sex: Female, Male|The mITT population consists of all participants who were treated with Simponi® and have a baseline assessment and at least one additional visit, regardless of any protocol violations during the study.|Participants|Count of Participants|129|129.0||||||
3962615|NCT01313858|3784688|B4||Female|Sex: Female, Male|The mITT population consists of all participants who were treated with Simponi® and have a baseline assessment and at least one additional visit, regardless of any protocol violations during the study.|Participants|Count of Participants|778|778.0||||||
3962616|NCT01313858|3784689|B3||Female|Sex: Female, Male|The mITT population consists of all participants who were treated with Simponi® and have a baseline assessment and at least one additional visit, regardless of any protocol violations during the study.|Participants|Count of Participants|162|162.0||||||
3962617|NCT01313858|3784690|B2||Female|Sex: Female, Male|The mITT population consists of all participants who were treated with Simponi® and have a baseline assessment and at least one additional visit, regardless of any protocol violations during the study.|Participants|Count of Participants|271|271.0||||||
3962618|NCT01313858|3784691|B1||Female|Sex: Female, Male|The mITT population consists of all participants who were treated with Simponi® and have a baseline assessment and at least one additional visit, regardless of any protocol violations during the study.|Participants|Count of Participants|345|345.0||||||
3962619|NCT01313858|3784688|B4|||Age|The mITT population consists of all participants who were treated with Simponi® and have a baseline assessment and at least one additional visit, regardless of any protocol violations during the study.|Years|Mean|49.6|49.6|Standard Deviation|13.39|13.39|||
3962620|NCT01313858|3784689|B3|||Age|The mITT population consists of all participants who were treated with Simponi® and have a baseline assessment and at least one additional visit, regardless of any protocol violations during the study.|Years|Mean|43.6|43.6|Standard Deviation|12.29|12.29|||
3962621|NCT01313858|3784690|B2|||Age|The mITT population consists of all participants who were treated with Simponi® and have a baseline assessment and at least one additional visit, regardless of any protocol violations during the study.|Years|Mean|50.3|50.3|Standard Deviation|12.07|12.07|||
3962622|NCT01313858|3784691|B1|||Age|The mITT population consists of all participants who were treated with Simponi® and have a baseline assessment and at least one additional visit, regardless of any protocol violations during the study.|Years|Mean|54.9|54.9|Standard Deviation|13.38|13.38|||
3962623|NCT01313780|3784714|B3|Korea, Republic of||Region of Enrollment||participants|Number|117|117.0||||||
3962624|NCT01313780|3784715|B2|Korea, Republic of||Region of Enrollment||participants|Number|59|59.0||||||
3962625|NCT01313780|3784716|B1|Korea, Republic of||Region of Enrollment||participants|Number|58|58.0||||||
3962626|NCT01313780|3784714|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3962627|NCT01313780|3784715|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3962628|NCT01313780|3784716|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3962629|NCT01313780|3784714|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3962630|NCT01313780|3784715|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3962631|NCT01313780|3784716|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3962632|NCT01313780|3784714|B3|70~79 years||Age, Customized||participants|Number|28|28.0||||||
3962633|NCT01313780|3784715|B2|70~79 years||Age, Customized||participants|Number|11|11.0||||||
3962634|NCT01313780|3784716|B1|70~79 years||Age, Customized||participants|Number|17|17.0||||||
3962635|NCT01313780|3784714|B3|60~69 years||Age, Customized||participants|Number|37|37.0||||||
3962636|NCT01313780|3784715|B2|60~69 years||Age, Customized||participants|Number|23|23.0||||||
3962637|NCT01313780|3784716|B1|60~69 years||Age, Customized||participants|Number|14|14.0||||||
3962638|NCT01313780|3784714|B3|50~59years||Age, Customized||participants|Number|36|36.0||||||
3962639|NCT01313780|3784715|B2|50~59years||Age, Customized||participants|Number|17|17.0||||||
3962640|NCT01313780|3784716|B1|50~59years||Age, Customized||participants|Number|19|19.0||||||
3962641|NCT01313780|3784714|B3|40~49years||Age, Customized||participants|Number|12|12.0||||||
3962642|NCT01313780|3784715|B2|40~49years||Age, Customized||participants|Number|5|5.0||||||
3962643|NCT01313780|3784716|B1|40~49years||Age, Customized||participants|Number|7|7.0||||||
3962644|NCT01313780|3784714|B3|<39years||Age, Customized||participants|Number|4|4.0||||||
3962645|NCT01313780|3784715|B2|<39years||Age, Customized||participants|Number|3|3.0||||||
3962646|NCT01313780|3784716|B1|<39years||Age, Customized||participants|Number|1|1.0||||||
3962647|NCT01313728|3784725|B1|Type III||Fitzpatrick Score|Skin type is categorized according to the Fitzpatrick skin type scale, which ranges from very fair (skin type I) to very dark (skin type VI). Only Skin Types I-III were included in this study.|Participants|Number|14|14.0||||||
3962648|NCT01313728|3784725|B1|Type II||Fitzpatrick Score|Skin type is categorized according to the Fitzpatrick skin type scale, which ranges from very fair (skin type I) to very dark (skin type VI). Only Skin Types I-III were included in this study.|Participants|Number|10|10.0||||||
3962649|NCT01313728|3784725|B1|Type I||Fitzpatrick Score|Skin type is categorized according to the Fitzpatrick skin type scale, which ranges from very fair (skin type I) to very dark (skin type VI). Only Skin Types I-III were included in this study.|Participants|Number|1|1.0||||||
3962650|NCT01313728|3784725|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3962651|NCT01313728|3784725|B1|||Sex/Gender, Customized|Gender was not a relevant measure for the trial, and was not recorded. Number reported reflects Participants in the overall study who were either Male or Female.|Participants|Number|25|25.0||||||
3962652|NCT01313728|3784725|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3962653|NCT01313728|3784725|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3962654|NCT01313728|3784725|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3962655|NCT01313689|3784740|B6|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|199|199.0||||||
3962656|NCT01313689|3784741|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|41|41.0||||||
3962657|NCT01313689|3784742|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
3962658|NCT01313689|3784743|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
3962659|NCT01313689|3784744|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|43|43.0||||||
3962660|NCT01313689|3784745|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|78|78.0||||||
3962661|NCT01313689|3784740|B6|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3962662|NCT01313689|3784741|B5|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3962663|NCT01313689|3784742|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3962664|NCT01313689|3784743|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3962665|NCT01313689|3784744|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3962779|NCT01313650|3784890|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3962666|NCT01313689|3784745|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3962667|NCT01313689|3784740|B6||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3962668|NCT01313689|3784741|B5||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3962669|NCT01313689|3784742|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3962670|NCT01313689|3784743|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3962671|NCT01313689|3784744|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3962672|NCT01313689|3784745|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3962673|NCT01313689|3784740|B6||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3962674|NCT01313689|3784741|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3962675|NCT01313689|3784742|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3962676|NCT01313689|3784743|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3962677|NCT01313689|3784744|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3962678|NCT01313689|3784745|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3962679|NCT01313689|3784740|B6|||Age||Years|Mean|62.8|62.8|Standard Deviation|9.28|9.28|||
3962680|NCT01313689|3784741|B5|||Age||Years|Mean|63.2|63.2|Standard Deviation|9.52|9.52|||
3962681|NCT01313689|3784742|B4|||Age||Years|Mean|66.7|66.7|Standard Deviation|5.99|5.99|||
3962682|NCT01313689|3784743|B3|||Age||Years|Mean|61.7|61.7|Standard Deviation|9.09|9.09|||
3962683|NCT01313689|3784744|B2|||Age||Years|Mean|61.8|61.8|Standard Deviation|9.87|9.87|||
3962684|NCT01313689|3784745|B1|||Age||Years|Mean|63.3|63.3|Standard Deviation|8.95|8.95|||
3962685|NCT01313676|3784824|B5|Mixed Race||Race/Ethnicity, Customized||Participants|Number|115|115.0||||||
3962686|NCT01313676|3784825|B4|Mixed Race||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
3962687|NCT01313676|3784826|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|28|28.0||||||
3962688|NCT01313676|3784827|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
3962689|NCT01313676|3784828|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
3962690|NCT01313676|3784824|B5|White - White/Caucasian /European Heritage||Race/Ethnicity, Customized||Participants|Number|13391|13391.0||||||
3962691|NCT01313676|3784825|B4|White - White/Caucasian /European Heritage||Race/Ethnicity, Customized||Participants|Number|3337|3337.0||||||
3962692|NCT01313676|3784826|B3|White - White/Caucasian /European Heritage||Race/Ethnicity, Customized||Participants|Number|3353|3353.0||||||
3962693|NCT01313676|3784827|B2|White - White/Caucasian /European Heritage||Race/Ethnicity, Customized||Participants|Number|3367|3367.0||||||
3962694|NCT01313676|3784828|B1|White - White/Caucasian /European Heritage||Race/Ethnicity, Customized||Participants|Number|3334|3334.0||||||
3962695|NCT01313676|3784824|B5|White - Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3962696|NCT01313676|3784825|B4|White - Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3962697|NCT01313676|3784826|B3|White - Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3962698|NCT01313676|3784827|B2|White - Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3962699|NCT01313676|3784828|B1|White - Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3962700|NCT01313676|3784824|B5|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|46|46.0||||||
3962701|NCT01313676|3784825|B4|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3962702|NCT01313676|3784826|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3962703|NCT01313676|3784827|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
3962704|NCT01313676|3784828|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3962705|NCT01313676|3784824|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3962706|NCT01313676|3784825|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3962707|NCT01313676|3784826|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3962708|NCT01313676|3784827|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3962709|NCT01313676|3784828|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3962710|NCT01313676|3784824|B5|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1568|1568.0||||||
3962711|NCT01313676|3784825|B4|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|394|394.0||||||
3962712|NCT01313676|3784826|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|386|386.0||||||
3962713|NCT01313676|3784827|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|399|399.0||||||
3962714|NCT01313676|3784828|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|389|389.0||||||
3962715|NCT01313676|3784824|B5|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3962716|NCT01313676|3784825|B4|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3962717|NCT01313676|3784826|B3|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3962718|NCT01313676|3784827|B2|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3962719|NCT01313676|3784828|B1|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3962720|NCT01313676|3784824|B5|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|144|144.0||||||
3962721|NCT01313676|3784825|B4|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
3962834|NCT01313650|3784890|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3962722|NCT01313676|3784826|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
3962723|NCT01313676|3784827|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|36|36.0||||||
3962724|NCT01313676|3784828|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|34|34.0||||||
3962725|NCT01313676|3784824|B5|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|772|772.0||||||
3962726|NCT01313676|3784825|B4|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|192|192.0||||||
3962727|NCT01313676|3784826|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|195|195.0||||||
3962728|NCT01313676|3784827|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|193|193.0||||||
3962729|NCT01313676|3784828|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|192|192.0||||||
3962730|NCT01313676|3784824|B5|Asian - Central /South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|238|238.0||||||
3962731|NCT01313676|3784825|B4|Asian - Central /South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|57|57.0||||||
3962732|NCT01313676|3784826|B3|Asian - Central /South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|62|62.0||||||
3962733|NCT01313676|3784827|B2|Asian - Central /South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|55|55.0||||||
3962734|NCT01313676|3784828|B1|Asian - Central /South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|64|64.0||||||
3962735|NCT01313676|3784824|B5|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
3962736|NCT01313676|3784825|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3962737|NCT01313676|3784826|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3962738|NCT01313676|3784827|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3962739|NCT01313676|3784828|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3962740|NCT01313676|3784824|B5|African American /African Heritage||Race/Ethnicity, Customized||Participants|Number|260|260.0||||||
3962741|NCT01313676|3784825|B4|African American /African Heritage||Race/Ethnicity, Customized||Participants|Number|69|69.0||||||
3962742|NCT01313676|3784826|B3|African American /African Heritage||Race/Ethnicity, Customized||Participants|Number|68|68.0||||||
3962743|NCT01313676|3784827|B2|African American /African Heritage||Race/Ethnicity, Customized||Participants|Number|62|62.0||||||
3962744|NCT01313676|3784828|B1|African American /African Heritage||Race/Ethnicity, Customized||Participants|Number|61|61.0||||||
3962745|NCT01313676|3784824|B5||Male|Sex: Female, Male||Participants|Count of Participants|12330|12330.0||||||
3962746|NCT01313676|3784825|B4||Male|Sex: Female, Male||Participants|Count of Participants|3121|3121.0||||||
3962747|NCT01313676|3784826|B3||Male|Sex: Female, Male||Participants|Count of Participants|3069|3069.0||||||
3962748|NCT01313676|3784827|B2||Male|Sex: Female, Male||Participants|Count of Participants|3059|3059.0||||||
3962749|NCT01313676|3784828|B1||Male|Sex: Female, Male||Participants|Count of Participants|3081|3081.0||||||
3962750|NCT01313676|3784824|B5||Female|Sex: Female, Male||Participants|Count of Participants|4238|4238.0||||||
3962751|NCT01313676|3784825|B4||Female|Sex: Female, Male||Participants|Count of Participants|1019|1019.0||||||
3962752|NCT01313676|3784826|B3||Female|Sex: Female, Male||Participants|Count of Participants|1071|1071.0||||||
3962753|NCT01313676|3784827|B2||Female|Sex: Female, Male||Participants|Count of Participants|1098|1098.0||||||
3962754|NCT01313676|3784828|B1||Female|Sex: Female, Male||Participants|Count of Participants|1050|1050.0||||||
3962755|NCT01313676|3784824|B5|||Age||Years|Mean|65.2|65.2|Standard Deviation|7.89|7.89|||
3962756|NCT01313676|3784825|B4|||Age||Years|Mean|65.3|65.3|Standard Deviation|7.97|7.97|||
3962757|NCT01313676|3784826|B3|||Age||Years|Mean|65.2|65.2|Standard Deviation|7.68|7.68|||
3962758|NCT01313676|3784827|B2|||Age||Years|Mean|65.0|65.0|Standard Deviation|8.02|8.02|||
3962759|NCT01313676|3784828|B1|||Age||Years|Mean|65.2|65.2|Standard Deviation|7.90|7.9|||
3962760|NCT01313663|3784849|B3|Missing||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3962761|NCT01313663|3784850|B2|Missing||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3962762|NCT01313663|3784851|B1|Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3962763|NCT01313663|3784849|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
3962764|NCT01313663|3784850|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
3962765|NCT01313663|3784851|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3962766|NCT01313663|3784849|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3962767|NCT01313663|3784850|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3962768|NCT01313663|3784851|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3962769|NCT01313663|3784849|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3962770|NCT01313663|3784850|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3962771|NCT01313663|3784851|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3962772|NCT01313663|3784849|B3|||Age||Years|Mean|72.0|72.0|Standard Deviation|11.64|11.64|||
3962773|NCT01313663|3784850|B2|||Age||Years|Mean|72.6|72.6|Standard Deviation|11.81|11.81|||
3962774|NCT01313663|3784851|B1|||Age||Years|Mean|71.1|71.1|Standard Deviation|12.09|12.09|||
3962775|NCT01313650|3784886|B5|Mixed Race||Race/Ethnicity, Customized||Participants|Number|46|46.0||||||
3962776|NCT01313650|3784887|B4|Mixed Race||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3962777|NCT01313650|3784888|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3962778|NCT01313650|3784889|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3962780|NCT01313650|3784886|B5|White - Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3962781|NCT01313650|3784887|B4|White - Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3962782|NCT01313650|3784888|B3|White - Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3962783|NCT01313650|3784889|B2|White - Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3962784|NCT01313650|3784890|B1|White - Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3962785|NCT01313650|3784886|B5|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|1302|1302.0||||||
3962786|NCT01313650|3784887|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|348|348.0||||||
3962787|NCT01313650|3784888|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|363|363.0||||||
3962788|NCT01313650|3784889|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|354|354.0||||||
3962789|NCT01313650|3784890|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|237|237.0||||||
3962790|NCT01313650|3784886|B5|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3962791|NCT01313650|3784887|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3962792|NCT01313650|3784888|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3962793|NCT01313650|3784889|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3962794|NCT01313650|3784890|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3962795|NCT01313650|3784886|B5|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|50|50.0||||||
3962796|NCT01313650|3784887|B4|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
3962797|NCT01313650|3784888|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
3962798|NCT01313650|3784889|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
3962799|NCT01313650|3784890|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3962800|NCT01313650|3784886|B5|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|68|68.0||||||
3962801|NCT01313650|3784887|B4|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
3962802|NCT01313650|3784888|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
3962803|NCT01313650|3784889|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
3962804|NCT01313650|3784890|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3962805|NCT01313650|3784886|B5|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3962806|NCT01313650|3784887|B4|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3962807|NCT01313650|3784888|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3962808|NCT01313650|3784889|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3962809|NCT01313650|3784890|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3962810|NCT01313650|3784886|B5|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3962811|NCT01313650|3784887|B4|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3962812|NCT01313650|3784888|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3962813|NCT01313650|3784889|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3962814|NCT01313650|3784890|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3962815|NCT01313650|3784886|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3962816|NCT01313650|3784887|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3962817|NCT01313650|3784888|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3962818|NCT01313650|3784889|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3962819|NCT01313650|3784890|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3962820|NCT01313650|3784886|B5|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|47|47.0||||||
3962821|NCT01313650|3784887|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
3962822|NCT01313650|3784888|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3962823|NCT01313650|3784889|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3962824|NCT01313650|3784890|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3962825|NCT01313650|3784886|B5||Male|Sex: Female, Male||Participants|Count of Participants|1083|1083.0||||||
3962826|NCT01313650|3784887|B4||Male|Sex: Female, Male||Participants|Count of Participants|305|305.0||||||
3962827|NCT01313650|3784888|B3||Male|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
3962828|NCT01313650|3784889|B2||Male|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
3962829|NCT01313650|3784890|B1||Male|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
3962830|NCT01313650|3784886|B5||Female|Sex: Female, Male||Participants|Count of Participants|449|449.0||||||
3962831|NCT01313650|3784887|B4||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3962832|NCT01313650|3784888|B3||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3962833|NCT01313650|3784889|B2||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3962835|NCT01313650|3784886|B5|||Age||Years|Mean|63.1|63.1|Standard Deviation|8.86|8.86|||
3962836|NCT01313650|3784887|B4|||Age||Years|Mean|63.1|63.1|Standard Deviation|8.71|8.71|||
3962837|NCT01313650|3784888|B3|||Age||Years|Mean|62.7|62.7|Standard Deviation|8.52|8.52|||
3962838|NCT01313650|3784889|B2|||Age||Years|Mean|64.0|64.0|Standard Deviation|9.16|9.16|||
3962839|NCT01313650|3784890|B1|||Age||Years|Mean|62.2|62.2|Standard Deviation|9.04|9.04|||
3962840|NCT01313637|3784915|B5|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3962841|NCT01313637|3784916|B4|Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3962842|NCT01313637|3784917|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3962843|NCT01313637|3784918|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3962844|NCT01313637|3784919|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3962845|NCT01313637|3784915|B5|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|1310|1310.0||||||
3962846|NCT01313637|3784916|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|359|359.0||||||
3962847|NCT01313637|3784917|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|353|353.0||||||
3962848|NCT01313637|3784918|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|361|361.0||||||
3962849|NCT01313637|3784919|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|237|237.0||||||
3962850|NCT01313637|3784915|B5|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3962851|NCT01313637|3784916|B4|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3962852|NCT01313637|3784917|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3962853|NCT01313637|3784918|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3962854|NCT01313637|3784919|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3962855|NCT01313637|3784915|B5|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|73|73.0||||||
3962856|NCT01313637|3784916|B4|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
3962857|NCT01313637|3784917|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
3962858|NCT01313637|3784918|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
3962859|NCT01313637|3784919|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
3962860|NCT01313637|3784915|B5|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|74|74.0||||||
3962861|NCT01313637|3784916|B4|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
3962862|NCT01313637|3784917|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
3962863|NCT01313637|3784918|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
3962864|NCT01313637|3784919|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
3962865|NCT01313637|3784915|B5|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3962866|NCT01313637|3784916|B4|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3962867|NCT01313637|3784917|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3962868|NCT01313637|3784918|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3962869|NCT01313637|3784919|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3962870|NCT01313637|3784915|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3962871|NCT01313637|3784916|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3962872|NCT01313637|3784917|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3962873|NCT01313637|3784918|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3962874|NCT01313637|3784919|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3962875|NCT01313637|3784915|B5|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
3962876|NCT01313637|3784916|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3962877|NCT01313637|3784917|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3962878|NCT01313637|3784918|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3962879|NCT01313637|3784919|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3962880|NCT01313637|3784915|B5||Male|Sex: Female, Male||Participants|Count of Participants|974|974.0||||||
3962881|NCT01313637|3784916|B4||Male|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
3962882|NCT01313637|3784917|B3||Male|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
3962883|NCT01313637|3784918|B2||Male|Sex: Female, Male||Participants|Count of Participants|270|270.0||||||
3962884|NCT01313637|3784919|B1||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
3962885|NCT01313637|3784915|B5||Female|Sex: Female, Male||Participants|Count of Participants|515|515.0||||||
3962886|NCT01313637|3784916|B4||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3962887|NCT01313637|3784917|B3||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3962888|NCT01313637|3784918|B2||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3962889|NCT01313637|3784919|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3962890|NCT01313637|3784915|B5|||Age||Years|Mean|62.9|62.9|Standard Deviation|8.47|8.47|||
3962891|NCT01313637|3784916|B4|||Age||Years|Mean|63.4|63.4|Standard Deviation|8.08|8.08|||
3962892|NCT01313637|3784917|B3|||Age||Years|Mean|62.8|62.8|Standard Deviation|8.80|8.8|||
3962893|NCT01313637|3784918|B2|||Age||Years|Mean|63.1|63.1|Standard Deviation|8.48|8.48|||
3962894|NCT01313637|3784919|B1|||Age||Years|Mean|62.2|62.2|Standard Deviation|8.53|8.53|||
3962895|NCT01313624|3784944|B3|||QOL-B Respiratory Symptom Score|The Quality of Life Questionnaire-Bronchiectasis (QOL-B) overall score was scaled from 0-100 with higher scores representing better quality of life.|units on a scale|Mean|55.2|55.2|Standard Deviation|19.26|19.26|||
3962896|NCT01313624|3784945|B2|||QOL-B Respiratory Symptom Score|The Quality of Life Questionnaire-Bronchiectasis (QOL-B) overall score was scaled from 0-100 with higher scores representing better quality of life.|units on a scale|Mean|55.5|55.5|Standard Deviation|19.26|19.26|||
3962897|NCT01313624|3784946|B1|||QOL-B Respiratory Symptom Score|The Quality of Life Questionnaire-Bronchiectasis (QOL-B) overall score was scaled from 0-100 with higher scores representing better quality of life.|units on a scale|Mean|55.0|55.0|Standard Deviation|19.32|19.32|||
3962898|NCT01313624|3784944|B3|Australia||Region of Enrollment||participants|Number|73|73.0||||||
3962899|NCT01313624|3784945|B2|Australia||Region of Enrollment||participants|Number|42|42.0||||||
3962900|NCT01313624|3784946|B1|Australia||Region of Enrollment||participants|Number|31|31.0||||||
3962901|NCT01313624|3784944|B3|Canada||Region of Enrollment||participants|Number|28|28.0||||||
3962902|NCT01313624|3784945|B2|Canada||Region of Enrollment||participants|Number|11|11.0||||||
3962903|NCT01313624|3784946|B1|Canada||Region of Enrollment||participants|Number|17|17.0||||||
3962904|NCT01313624|3784944|B3|United States||Region of Enrollment||participants|Number|165|165.0||||||
3962905|NCT01313624|3784945|B2|United States||Region of Enrollment||participants|Number|79|79.0||||||
3962906|NCT01313624|3784946|B1|United States||Region of Enrollment||participants|Number|86|86.0||||||
3962907|NCT01313624|3784944|B3|Not Permitted||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3962908|NCT01313624|3784945|B2|Not Permitted||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3962909|NCT01313624|3784946|B1|Not Permitted||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3962910|NCT01313624|3784944|B3|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3962911|NCT01313624|3784945|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3962912|NCT01313624|3784946|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3962913|NCT01313624|3784944|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3962914|NCT01313624|3784945|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3962915|NCT01313624|3784946|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3962916|NCT01313624|3784944|B3|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3962917|NCT01313624|3784945|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3962918|NCT01313624|3784946|B1|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3962919|NCT01313624|3784944|B3|African-American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3962920|NCT01313624|3784945|B2|African-American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3962921|NCT01313624|3784946|B1|African-American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3962922|NCT01313624|3784944|B3|White||Race/Ethnicity, Customized||participants|Number|240|240.0||||||
3962923|NCT01313624|3784945|B2|White||Race/Ethnicity, Customized||participants|Number|119|119.0||||||
3962924|NCT01313624|3784946|B1|White||Race/Ethnicity, Customized||participants|Number|121|121.0||||||
3962925|NCT01313624|3784944|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3962926|NCT01313624|3784945|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962927|NCT01313624|3784946|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3962928|NCT01313624|3784944|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|242|242.0||||||
3962929|NCT01313624|3784945|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|121|121.0||||||
3962930|NCT01313624|3784946|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|121|121.0||||||
3962931|NCT01313624|3784944|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3962932|NCT01313624|3784945|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3962933|NCT01313624|3784946|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3962934|NCT01313624|3784944|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3962935|NCT01313624|3784945|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3962936|NCT01313624|3784946|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3962937|NCT01313624|3784944|B3||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
3962938|NCT01313624|3784945|B2||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3962939|NCT01313624|3784946|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3962940|NCT01313624|3784944|B3||>=65 years|Age||Participants|Count of Participants|159|159.0||||||
3962941|NCT01313624|3784945|B2||>=65 years|Age||Participants|Count of Participants|78|78.0||||||
3962942|NCT01313624|3784946|B1||>=65 years|Age||Participants|Count of Participants|81|81.0||||||
3962943|NCT01313624|3784944|B3||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
3962944|NCT01313624|3784945|B2||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3962945|NCT01313624|3784946|B1||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
3962946|NCT01313624|3784944|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3962947|NCT01313624|3784945|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3962948|NCT01313624|3784946|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3962949|NCT01313624|3784944|B3|||Age||years|Mean|64.6|64.6|Standard Deviation|12.51|12.51|||
3962950|NCT01313624|3784945|B2|||Age||years|Mean|64.9|64.9|Standard Deviation|12.11|12.11|||
3962951|NCT01313624|3784946|B1|||Age||years|Mean|64.2|64.2|Standard Deviation|12.92|12.92|||
3962952|NCT01313559|3784959|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3962953|NCT01313559|3784960|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3962954|NCT01313559|3784961|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3962955|NCT01313559|3784959|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962956|NCT01313559|3784960|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962957|NCT01313559|3784961|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962958|NCT01313559|3784959|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962959|NCT01313559|3784960|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962960|NCT01313559|3784961|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962961|NCT01313559|3784959|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3962962|NCT01313559|3784960|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3962963|NCT01313559|3784961|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3962964|NCT01313559|3784959|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3962965|NCT01313559|3784960|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962966|NCT01313559|3784961|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3962967|NCT01313559|3784959|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962968|NCT01313559|3784960|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962969|NCT01313559|3784961|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962970|NCT01313559|3784959|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3962971|NCT01313559|3784960|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962972|NCT01313559|3784961|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3962973|NCT01313559|3784959|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962974|NCT01313559|3784960|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962975|NCT01313559|3784961|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962976|NCT01313559|3784959|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962977|NCT01313559|3784960|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962978|NCT01313559|3784961|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962979|NCT01313559|3784959|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3962980|NCT01313559|3784960|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3962981|NCT01313559|3784961|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3962982|NCT01313559|3784959|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962983|NCT01313559|3784960|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962984|NCT01313559|3784961|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3962985|NCT01313559|3784959|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3962986|NCT01313559|3784960|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3962987|NCT01313559|3784961|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3962988|NCT01313559|3784959|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3962989|NCT01313559|3784960|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3962990|NCT01313559|3784961|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3962991|NCT01313559|3784959|B3|||Age||years|Mean|75.2|75.2|Standard Deviation|6.8|6.8|||
3962992|NCT01313559|3784960|B2|||Age||years|Mean|69.4|69.4|Standard Deviation|8.4|8.4|||
3962993|NCT01313559|3784961|B1|||Age||years|Mean|78.0|78.0|Standard Deviation|4.6|4.6|||
3962994|NCT01313559|3784959|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3962995|NCT01313559|3784960|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3962996|NCT01313559|3784961|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3962997|NCT01313559|3784959|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3962998|NCT01313559|3784960|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3962999|NCT01313559|3784961|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3963000|NCT01313559|3784959|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3963001|NCT01313559|3784960|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3963002|NCT01313559|3784961|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3963003|NCT01313520|3784974|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3963004|NCT01313520|3784975|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3963005|NCT01313520|3784976|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3963006|NCT01313520|3784974|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3963007|NCT01313520|3784975|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3963008|NCT01313520|3784976|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3963009|NCT01313520|3784974|B3|||Age||years|Mean|50.2|50.2|Standard Deviation|10.04|10.04|||
3963010|NCT01313520|3784975|B2|||Age||years|Mean|50.1|50.1|Standard Deviation|10.7|10.7|||
3963011|NCT01313520|3784976|B1|||Age||years|Mean|50.3|50.3|Standard Deviation|9.5|9.5|||
3963012|NCT01313507|3784997|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3963013|NCT01313507|3784997|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3963014|NCT01313507|3784997|B1|||Age||Years|Mean|23.8|23.8|Standard Deviation|19.78|19.78|||
3963015|NCT01313494|3785003|B3|||Post-bronchodilator FEV1/forced vital capacity (FVC)|Calculated as FEV1/FVC * 100|FEV1/FVC percent|Mean|35.5|35.5|Standard Deviation|9.31|9.31|||
3963016|NCT01313494|3785004|B2|||Post-bronchodilator FEV1/forced vital capacity (FVC)|Calculated as FEV1/FVC * 100|FEV1/FVC percent|Mean|35.3|35.3|Standard Deviation|8.92|8.92|||
3963017|NCT01313494|3785005|B1|||Post-bronchodilator FEV1/forced vital capacity (FVC)|Calculated as FEV1/FVC * 100|FEV1/FVC percent|Mean|35.8|35.8|Standard Deviation|9.69|9.69|||
3963018|NCT01313494|3785003|B3|||FEV1 reversibility % increase|FEV reversibility (%) = (post-bronchodilator FEV minus pre-bronchodilator FEV) / pre-bronchodilator FEV * 100.|Percent reversibility|Mean|12.7|12.7|Standard Deviation|14.27|14.27|||
3963019|NCT01313494|3785004|B2|||FEV1 reversibility % increase|FEV reversibility (%) = (post-bronchodilator FEV minus pre-bronchodilator FEV) / pre-bronchodilator FEV * 100.|Percent reversibility|Mean|11.8|11.8|Standard Deviation|13.15|13.15|||
3963020|NCT01313494|3785005|B1|||FEV1 reversibility % increase|FEV reversibility (%) = (post-bronchodilator FEV minus pre-bronchodilator FEV) / pre-bronchodilator FEV * 100.|Percent reversibility|Mean|13.6|13.6|Standard Deviation|15.29|15.29|||
3963021|NCT01313494|3785003|B3|||FEV1 reversibility increase||mL|Mean|101.6|101.6|Standard Deviation|107.94|107.94|||
3963022|NCT01313494|3785004|B2|||FEV1 reversibility increase||mL|Mean|94.8|94.8|Standard Deviation|104.71|104.71|||
3963023|NCT01313494|3785005|B1|||FEV1 reversibility increase||mL|Mean|108.4|108.4|Standard Deviation|110.83|110.83|||
3963024|NCT01313494|3785003|B3|||Post-bronchodilator FEV1 predicted||Percent of predicted|Mean|36.6|36.6|Standard Deviation|10.79|10.79|||
3963025|NCT01313494|3785004|B2|||Post-bronchodilator FEV1 predicted||Percent of predicted|Mean|36.4|36.4|Standard Deviation|10.13|10.13|||
3963026|NCT01313494|3785005|B1|||Post-bronchodilator FEV1 predicted||Percent of predicted|Mean|36.8|36.8|Standard Deviation|11.42|11.42|||
3963027|NCT01313494|3785003|B3|||Pre-bronchodilator FEV1 predicted||Percent of predicted|Mean|32.7|32.7|Standard Deviation|9.63|9.63|||
3963028|NCT01313494|3785004|B2|||Pre-bronchodilator FEV1 predicted||Percent of predicted|Mean|32.7|32.7|Standard Deviation|9.00|9.0|||
3963029|NCT01313494|3785005|B1|||Pre-bronchodilator FEV1 predicted||Percent of predicted|Mean|32.7|32.7|Standard Deviation|10.23|10.23|||
3963030|NCT01313494|3785003|B3|||Post-bronchodilator FEV1||Liters|Mean|0.9|0.9|Standard Deviation|0.31|0.31|||
3963031|NCT01313494|3785004|B2|||Post-bronchodilator FEV1||Liters|Mean|0.9|0.9|Standard Deviation|0.27|0.27|||
3963032|NCT01313494|3785005|B1|||Post-bronchodilator FEV1||Liters|Mean|1.0|1.0|Standard Deviation|0.35|0.35|||
3963033|NCT01313494|3785003|B3|||Pre-bronchodilator forced expiratory volume in the first second (FEV1)||Liters|Mean|0.8|0.8|Standard Deviation|0.28|0.28|||
3963034|NCT01313494|3785004|B2|||Pre-bronchodilator forced expiratory volume in the first second (FEV1)||Liters|Mean|0.8|0.8|Standard Deviation|0.24|0.24|||
3963035|NCT01313494|3785005|B1|||Pre-bronchodilator forced expiratory volume in the first second (FEV1)||Liters|Mean|0.8|0.8|Standard Deviation|0.31|0.31|||
3963036|NCT01313494|3785003|B3|||Cigarette pack years||pack years|Mean|37.4|37.4|Standard Deviation|22.09|22.09|||
3963037|NCT01313494|3785004|B2|||Cigarette pack years||pack years|Mean|37.5|37.5|Standard Deviation|23.00|23.0|||
3963038|NCT01313494|3785005|B1|||Cigarette pack years||pack years|Mean|37.2|37.2|Standard Deviation|21.18|21.18|||
3963039|NCT01313494|3785003|B3|Current smoker||Smoking status||Participants|Number|167|167.0||||||
3963040|NCT01313494|3785004|B2|Current smoker||Smoking status||Participants|Number|92|92.0||||||
3963041|NCT01313494|3785005|B1|Current smoker||Smoking status||Participants|Number|75|75.0||||||
3963042|NCT01313494|3785003|B3|Former smoker||Smoking status||Participants|Number|459|459.0||||||
3963043|NCT01313494|3785004|B2|Former smoker||Smoking status||Participants|Number|221|221.0||||||
3963044|NCT01313494|3785005|B1|Former smoker||Smoking status||Participants|Number|238|238.0||||||
3963045|NCT01313494|3785003|B3|Predominantly emphysema||COPD disease characteristics||Participants|Number|76|76.0||||||
3963046|NCT01313494|3785004|B2|Predominantly emphysema||COPD disease characteristics||Participants|Number|36|36.0||||||
3963047|NCT01313494|3785005|B1|Predominantly emphysema||COPD disease characteristics||Participants|Number|40|40.0||||||
3963048|NCT01313494|3785003|B3|Combined emphysema and chronic bronchitis||COPD disease characteristics||Participants|Number|433|433.0||||||
3963049|NCT01313494|3785004|B2|Combined emphysema and chronic bronchitis||COPD disease characteristics||Participants|Number|216|216.0||||||
3963050|NCT01313494|3785005|B1|Combined emphysema and chronic bronchitis||COPD disease characteristics||Participants|Number|217|217.0||||||
3963051|NCT01313494|3785003|B3|Predominantly chronic bronchitis||COPD disease characteristics||Participants|Number|117|117.0||||||
3963052|NCT01313494|3785004|B2|Predominantly chronic bronchitis||COPD disease characteristics||Participants|Number|61|61.0||||||
3963053|NCT01313494|3785005|B1|Predominantly chronic bronchitis||COPD disease characteristics||Participants|Number|56|56.0||||||
3963074|NCT01313494|3785005|B1|||Height||cm|Mean|166.2|166.2|Standard Deviation|7.27|7.27|||
3963075|NCT01313494|3785003|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963076|NCT01313494|3785004|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963054|NCT01313494|3785003|B3|Very severe||Chronic obstructive pulmonary disease (COPD) severity|COPD severity was classified according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guideline (2009) as: - Very severe COPD: baseline post-bronchodilator FEV1 %predicted < 30% - Severe COPD: baseline post-bronchodilator FEV1 %predicted ≥ 30% to < 50% - Moderate COPD: baseline post-bronchodilator FEV1 %predicted ≥ 50% to < 80% - Mild COPD: baseline post-bronchodilator FEV1 %predicted ≥ 80%.|Participants|Number|180|180.0||||||
3963055|NCT01313494|3785004|B2|Very severe||Chronic obstructive pulmonary disease (COPD) severity|COPD severity was classified according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guideline (2009) as: - Very severe COPD: baseline post-bronchodilator FEV1 %predicted < 30% - Severe COPD: baseline post-bronchodilator FEV1 %predicted ≥ 30% to < 50% - Moderate COPD: baseline post-bronchodilator FEV1 %predicted ≥ 50% to < 80% - Mild COPD: baseline post-bronchodilator FEV1 %predicted ≥ 80%.|Participants|Number|92|92.0||||||
3963056|NCT01313494|3785005|B1|Very severe||Chronic obstructive pulmonary disease (COPD) severity|COPD severity was classified according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guideline (2009) as: - Very severe COPD: baseline post-bronchodilator FEV1 %predicted < 30% - Severe COPD: baseline post-bronchodilator FEV1 %predicted ≥ 30% to < 50% - Moderate COPD: baseline post-bronchodilator FEV1 %predicted ≥ 50% to < 80% - Mild COPD: baseline post-bronchodilator FEV1 %predicted ≥ 80%.|Participants|Number|88|88.0||||||
3963057|NCT01313494|3785003|B3|Severe||Chronic obstructive pulmonary disease (COPD) severity|COPD severity was classified according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guideline (2009) as: - Very severe COPD: baseline post-bronchodilator FEV1 %predicted < 30% - Severe COPD: baseline post-bronchodilator FEV1 %predicted ≥ 30% to < 50% - Moderate COPD: baseline post-bronchodilator FEV1 %predicted ≥ 50% to < 80% - Mild COPD: baseline post-bronchodilator FEV1 %predicted ≥ 80%.|Participants|Number|400|400.0||||||
3963058|NCT01313494|3785004|B2|Severe||Chronic obstructive pulmonary disease (COPD) severity|COPD severity was classified according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guideline (2009) as: - Very severe COPD: baseline post-bronchodilator FEV1 %predicted < 30% - Severe COPD: baseline post-bronchodilator FEV1 %predicted ≥ 30% to < 50% - Moderate COPD: baseline post-bronchodilator FEV1 %predicted ≥ 50% to < 80% - Mild COPD: baseline post-bronchodilator FEV1 %predicted ≥ 80%.|Participants|Number|204|204.0||||||
3963059|NCT01313494|3785005|B1|Severe||Chronic obstructive pulmonary disease (COPD) severity|COPD severity was classified according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guideline (2009) as: - Very severe COPD: baseline post-bronchodilator FEV1 %predicted < 30% - Severe COPD: baseline post-bronchodilator FEV1 %predicted ≥ 30% to < 50% - Moderate COPD: baseline post-bronchodilator FEV1 %predicted ≥ 50% to < 80% - Mild COPD: baseline post-bronchodilator FEV1 %predicted ≥ 80%.|Participants|Number|196|196.0||||||
3963060|NCT01313494|3785003|B3|Moderate||Chronic obstructive pulmonary disease (COPD) severity|COPD severity was classified according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guideline (2009) as: - Very severe COPD: baseline post-bronchodilator FEV1 %predicted < 30% - Severe COPD: baseline post-bronchodilator FEV1 %predicted ≥ 30% to < 50% - Moderate COPD: baseline post-bronchodilator FEV1 %predicted ≥ 50% to < 80% - Mild COPD: baseline post-bronchodilator FEV1 %predicted ≥ 80%.|Participants|Number|44|44.0||||||
3963061|NCT01313494|3785004|B2|Moderate||Chronic obstructive pulmonary disease (COPD) severity|COPD severity was classified according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guideline (2009) as: - Very severe COPD: baseline post-bronchodilator FEV1 %predicted < 30% - Severe COPD: baseline post-bronchodilator FEV1 %predicted ≥ 30% to < 50% - Moderate COPD: baseline post-bronchodilator FEV1 %predicted ≥ 50% to < 80% - Mild COPD: baseline post-bronchodilator FEV1 %predicted ≥ 80%.|Participants|Number|16|16.0||||||
3963062|NCT01313494|3785005|B1|Moderate||Chronic obstructive pulmonary disease (COPD) severity|COPD severity was classified according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guideline (2009) as: - Very severe COPD: baseline post-bronchodilator FEV1 %predicted < 30% - Severe COPD: baseline post-bronchodilator FEV1 %predicted ≥ 30% to < 50% - Moderate COPD: baseline post-bronchodilator FEV1 %predicted ≥ 50% to < 80% - Mild COPD: baseline post-bronchodilator FEV1 %predicted ≥ 80%.|Participants|Number|28|28.0||||||
3963063|NCT01313494|3785003|B3|Mild||Chronic obstructive pulmonary disease (COPD) severity|COPD severity was classified according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guideline (2009) as: - Very severe COPD: baseline post-bronchodilator FEV1 %predicted < 30% - Severe COPD: baseline post-bronchodilator FEV1 %predicted ≥ 30% to < 50% - Moderate COPD: baseline post-bronchodilator FEV1 %predicted ≥ 50% to < 80% - Mild COPD: baseline post-bronchodilator FEV1 %predicted ≥ 80%.|Participants|Number|2|2.0||||||
3963064|NCT01313494|3785004|B2|Mild||Chronic obstructive pulmonary disease (COPD) severity|COPD severity was classified according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guideline (2009) as: - Very severe COPD: baseline post-bronchodilator FEV1 %predicted < 30% - Severe COPD: baseline post-bronchodilator FEV1 %predicted ≥ 30% to < 50% - Moderate COPD: baseline post-bronchodilator FEV1 %predicted ≥ 50% to < 80% - Mild COPD: baseline post-bronchodilator FEV1 %predicted ≥ 80%.|Participants|Number|1|1.0||||||
3963065|NCT01313494|3785005|B1|Mild||Chronic obstructive pulmonary disease (COPD) severity|COPD severity was classified according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guideline (2009) as: - Very severe COPD: baseline post-bronchodilator FEV1 %predicted < 30% - Severe COPD: baseline post-bronchodilator FEV1 %predicted ≥ 30% to < 50% - Moderate COPD: baseline post-bronchodilator FEV1 %predicted ≥ 50% to < 80% - Mild COPD: baseline post-bronchodilator FEV1 %predicted ≥ 80%.|Participants|Number|1|1.0||||||
3963066|NCT01313494|3785003|B3|||Body Mass Index (BMI)||kg/m^2|Mean|22.1|22.1|Standard Deviation|3.44|3.44|||
3963067|NCT01313494|3785004|B2|||Body Mass Index (BMI)||kg/m^2|Mean|22.4|22.4|Standard Deviation|3.43|3.43|||
3963068|NCT01313494|3785005|B1|||Body Mass Index (BMI)||kg/m^2|Mean|21.8|21.8|Standard Deviation|3.42|3.42|||
3963069|NCT01313494|3785003|B3|||Weight||kg|Mean|61.1|61.1|Standard Deviation|10.78|10.78|||
3963070|NCT01313494|3785004|B2|||Weight||kg|Mean|61.8|61.8|Standard Deviation|10.54|10.54|||
3963071|NCT01313494|3785005|B1|||Weight||kg|Mean|60.4|60.4|Standard Deviation|11.00|11.0|||
3963072|NCT01313494|3785003|B3|||Height||cm|Mean|166.1|166.1|Standard Deviation|7.20|7.2|||
3963073|NCT01313494|3785004|B2|||Height||cm|Mean|165.9|165.9|Standard Deviation|7.12|7.12|||
3963077|NCT01313494|3785005|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963078|NCT01313494|3785003|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963079|NCT01313494|3785004|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963080|NCT01313494|3785005|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963081|NCT01313494|3785003|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963082|NCT01313494|3785004|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963083|NCT01313494|3785005|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963084|NCT01313494|3785003|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963085|NCT01313494|3785004|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963086|NCT01313494|3785005|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963087|NCT01313494|3785003|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963088|NCT01313494|3785004|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963089|NCT01313494|3785005|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963090|NCT01313494|3785003|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|626|626.0||||||
3963091|NCT01313494|3785004|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|313|313.0||||||
3963092|NCT01313494|3785005|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|313|313.0||||||
3963093|NCT01313494|3785003|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963094|NCT01313494|3785004|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963095|NCT01313494|3785005|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963096|NCT01313494|3785003|B3||Male|Gender||Participants|Count of Participants|569|569.0||||||
3963097|NCT01313494|3785004|B2||Male|Gender||Participants|Count of Participants|286|286.0||||||
3963098|NCT01313494|3785005|B1||Male|Gender||Participants|Count of Participants|283|283.0||||||
3963099|NCT01313494|3785003|B3||Female|Gender||Participants|Count of Participants|57|57.0||||||
3963100|NCT01313494|3785004|B2||Female|Gender||Participants|Count of Participants|27|27.0||||||
3963101|NCT01313494|3785005|B1||Female|Gender||Participants|Count of Participants|30|30.0||||||
3963102|NCT01313494|3785003|B3|||Age||Years|Mean|64.1|64.1|Standard Deviation|8.51|8.51|||
3963103|NCT01313494|3785004|B2|||Age||Years|Mean|64.0|64.0|Standard Deviation|8.27|8.27|||
3963104|NCT01313494|3785005|B1|||Age||Years|Mean|64.2|64.2|Standard Deviation|8.76|8.76|||
3963105|NCT01313312|3785058|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963106|NCT01313312|3785058|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3963107|NCT01313312|3785058|B1||White|Race (NIH/OMB)||Participants|Count of Participants|218|218.0||||||
3963108|NCT01313312|3785058|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3963109|NCT01313312|3785058|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963110|NCT01313312|3785058|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3963111|NCT01313312|3785058|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963112|NCT01313312|3785058|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963113|NCT01313312|3785058|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|238|238.0||||||
3963114|NCT01313312|3785058|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3963115|NCT01313312|3785058|B1||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3963116|NCT01313312|3785058|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3963117|NCT01313312|3785058|B1|||Age||years|Mean|52.4|52.4|Standard Deviation|14|14.0|||
3963118|NCT01313312|3785058|B1||>=65 years|Age||Participants|Count of Participants|53|53.0||||||
3963119|NCT01313312|3785058|B1||Between 18 and 65 years|Age||Participants|Count of Participants|201|201.0||||||
3963120|NCT01313312|3785058|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3963121|NCT01313299|3785102|B4|||Disability Assessment Scale (DAS)|"DAS is a 4-point scale used to determine the extent of functional impairment in 4 functional domains (dressing, hygiene, limb position and pain). DAS scale rating: 0=No disability, 1=Mild disability (noticeable but does not interfere significantly with normal activities), 2=Moderate disability (normal activities require increased effort and/or assistance) and 3=Severe disability (normal activities limited). If the subject chose Hygiene as PTT the score collected will be between 0 and 3.~Placebo: N=79, Dysport 500 U: N=80 and Dysport 1000 U: N=79."|units on a scale|Mean|2.6|2.6|Standard Deviation|0.5|0.5|||
3963122|NCT01313299|3785103|B3|||Disability Assessment Scale (DAS)|"DAS is a 4-point scale used to determine the extent of functional impairment in 4 functional domains (dressing, hygiene, limb position and pain). DAS scale rating: 0=No disability, 1=Mild disability (noticeable but does not interfere significantly with normal activities), 2=Moderate disability (normal activities require increased effort and/or assistance) and 3=Severe disability (normal activities limited). If the subject chose Hygiene as PTT the score collected will be between 0 and 3.~Placebo: N=79, Dysport 500 U: N=80 and Dysport 1000 U: N=79."|units on a scale|Mean|2.5|2.5|Standard Deviation|0.5|0.5|||
3963156|NCT01313299|3785105|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3963157|NCT01313299|3785102|B4||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3963158|NCT01313299|3785103|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3963159|NCT01313299|3785104|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3963123|NCT01313299|3785104|B2|||Disability Assessment Scale (DAS)|"DAS is a 4-point scale used to determine the extent of functional impairment in 4 functional domains (dressing, hygiene, limb position and pain). DAS scale rating: 0=No disability, 1=Mild disability (noticeable but does not interfere significantly with normal activities), 2=Moderate disability (normal activities require increased effort and/or assistance) and 3=Severe disability (normal activities limited). If the subject chose Hygiene as PTT the score collected will be between 0 and 3.~Placebo: N=79, Dysport 500 U: N=80 and Dysport 1000 U: N=79."|units on a scale|Mean|2.6|2.6|Standard Deviation|0.5|0.5|||
3963124|NCT01313299|3785105|B1|||Disability Assessment Scale (DAS)|"DAS is a 4-point scale used to determine the extent of functional impairment in 4 functional domains (dressing, hygiene, limb position and pain). DAS scale rating: 0=No disability, 1=Mild disability (noticeable but does not interfere significantly with normal activities), 2=Moderate disability (normal activities require increased effort and/or assistance) and 3=Severe disability (normal activities limited). If the subject chose Hygiene as PTT the score collected will be between 0 and 3.~Placebo: N=79, Dysport 500 U: N=80 and Dysport 1000 U: N=79."|units on a scale|Mean|2.6|2.6|Standard Deviation|0.5|0.5|||
3963125|NCT01313299|3785102|B4|||Modified Ashworth Scale (MAS)|"MAS scale is used to assess muscle tone (MT) using a 6-point scale where:0=No increase in MT, 1=Slight increase in MT,1±=Slight increase in MT manifested by a catch followed by minimal resistance throughout remainder of ROM,2=Marked increase in MT through most of ROM but affected part easily moved,3=Considerable increase in MT passive movement difficult or 4=Affected part(s) rigid in flexion or extension. The MAS has been derived for analyses as follows: 0=0 ; 1=1; 1+=2; 2=3; 3=4 and 4=5.~Placebo:N=79, Dysport 500U:N=80 & Dysport 1000U:N=79."|units on a scale|Mean|3.9|3.9|Standard Deviation|0.4|0.4|||
3963126|NCT01313299|3785103|B3|||Modified Ashworth Scale (MAS)|"MAS scale is used to assess muscle tone (MT) using a 6-point scale where:0=No increase in MT, 1=Slight increase in MT,1±=Slight increase in MT manifested by a catch followed by minimal resistance throughout remainder of ROM,2=Marked increase in MT through most of ROM but affected part easily moved,3=Considerable increase in MT passive movement difficult or 4=Affected part(s) rigid in flexion or extension. The MAS has been derived for analyses as follows: 0=0 ; 1=1; 1+=2; 2=3; 3=4 and 4=5.~Placebo:N=79, Dysport 500U:N=80 & Dysport 1000U:N=79."|units on a scale|Mean|3.9|3.9|Standard Deviation|0.4|0.4|||
3963127|NCT01313299|3785104|B2|||Modified Ashworth Scale (MAS)|"MAS scale is used to assess muscle tone (MT) using a 6-point scale where:0=No increase in MT, 1=Slight increase in MT,1±=Slight increase in MT manifested by a catch followed by minimal resistance throughout remainder of ROM,2=Marked increase in MT through most of ROM but affected part easily moved,3=Considerable increase in MT passive movement difficult or 4=Affected part(s) rigid in flexion or extension. The MAS has been derived for analyses as follows: 0=0 ; 1=1; 1+=2; 2=3; 3=4 and 4=5.~Placebo:N=79, Dysport 500U:N=80 & Dysport 1000U:N=79."|units on a scale|Mean|3.9|3.9|Standard Deviation|0.5|0.5|||
3963128|NCT01313299|3785105|B1|||Modified Ashworth Scale (MAS)|"MAS scale is used to assess muscle tone (MT) using a 6-point scale where:0=No increase in MT, 1=Slight increase in MT,1±=Slight increase in MT manifested by a catch followed by minimal resistance throughout remainder of ROM,2=Marked increase in MT through most of ROM but affected part easily moved,3=Considerable increase in MT passive movement difficult or 4=Affected part(s) rigid in flexion or extension. The MAS has been derived for analyses as follows: 0=0 ; 1=1; 1+=2; 2=3; 3=4 and 4=5.~Placebo:N=79, Dysport 500U:N=80 & Dysport 1000U:N=79."|units on a scale|Mean|3.9|3.9|Standard Deviation|0.4|0.4|||
3963129|NCT01313299|3785102|B4|||Body Mass Index (BMI)|Placebo: N=78, Dysport 500 U: N=80, and Dysport 1000 U: N=80.|kg/m2|Mean|27.33|27.33|Standard Deviation|5.17|5.17|||
3963130|NCT01313299|3785103|B3|||Body Mass Index (BMI)|Placebo: N=78, Dysport 500 U: N=80, and Dysport 1000 U: N=80.|kg/m2|Mean|27.58|27.58|Standard Deviation|5.51|5.51|||
3963131|NCT01313299|3785104|B2|||Body Mass Index (BMI)|Placebo: N=78, Dysport 500 U: N=80, and Dysport 1000 U: N=80.|kg/m2|Mean|27.63|27.63|Standard Deviation|4.61|4.61|||
3963132|NCT01313299|3785105|B1|||Body Mass Index (BMI)|Placebo: N=78, Dysport 500 U: N=80, and Dysport 1000 U: N=80.|kg/m2|Mean|26.78|26.78|Standard Deviation|5.38|5.38|||
3963133|NCT01313299|3785102|B4|Not Hispanic/Latino||Ethnicity||participants|Number|225|225.0||||||
3963134|NCT01313299|3785103|B3|Not Hispanic/Latino||Ethnicity||participants|Number|71|71.0||||||
3963135|NCT01313299|3785104|B2|Not Hispanic/Latino||Ethnicity||participants|Number|78|78.0||||||
3963136|NCT01313299|3785105|B1|Not Hispanic/Latino||Ethnicity||participants|Number|76|76.0||||||
3963137|NCT01313299|3785102|B4|Hispanic/Latino||Ethnicity||participants|Number|18|18.0||||||
3963138|NCT01313299|3785103|B3|Hispanic/Latino||Ethnicity||participants|Number|10|10.0||||||
3963139|NCT01313299|3785104|B2|Hispanic/Latino||Ethnicity||participants|Number|3|3.0||||||
3963140|NCT01313299|3785105|B1|Hispanic/Latino||Ethnicity||participants|Number|5|5.0||||||
3963141|NCT01313299|3785102|B4|Multiple||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3963142|NCT01313299|3785103|B3|Multiple||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3963143|NCT01313299|3785104|B2|Multiple||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3963144|NCT01313299|3785105|B1|Multiple||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3963145|NCT01313299|3785102|B4|Caucasian/White||Race/Ethnicity, Customized||participants|Number|208|208.0||||||
3963146|NCT01313299|3785103|B3|Caucasian/White||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
3963147|NCT01313299|3785104|B2|Caucasian/White||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
3963148|NCT01313299|3785105|B1|Caucasian/White||Race/Ethnicity, Customized||participants|Number|71|71.0||||||
3963149|NCT01313299|3785102|B4|Black/African American||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
3963150|NCT01313299|3785103|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3963151|NCT01313299|3785104|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3963152|NCT01313299|3785105|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3963153|NCT01313299|3785102|B4|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3963154|NCT01313299|3785103|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3963155|NCT01313299|3785104|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3963160|NCT01313299|3785105|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3963161|NCT01313299|3785102|B4||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3963162|NCT01313299|3785103|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3963163|NCT01313299|3785104|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3963164|NCT01313299|3785105|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3963165|NCT01313299|3785102|B4|||Age||years|Mean|52.9|52.9|Standard Deviation|13.4|13.4|||
3963166|NCT01313299|3785103|B3|||Age||years|Mean|53.2|53.2|Standard Deviation|13.8|13.8|||
3963167|NCT01313299|3785104|B2|||Age||years|Mean|52.8|52.8|Standard Deviation|12.8|12.8|||
3963168|NCT01313299|3785105|B1|||Age||years|Mean|52.9|52.9|Standard Deviation|13.8|13.8|||
3963169|NCT01313286|3785121|B1|Singapore||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3963170|NCT01313286|3785121|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3963171|NCT01313286|3785121|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3963172|NCT01313286|3785121|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3963173|NCT01313286|3785121|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3963174|NCT01313286|3785121|B1|||Age||years|Mean|34.3|34.3|Standard Deviation|10.1|10.1|||
3963175|NCT01313273|3785130|B3|Italy||Region of Enrollment||participants|Number|3|3.0||||||
3963176|NCT01313273|3785131|B2|Italy||Region of Enrollment||participants|Number|1|1.0||||||
3963177|NCT01313273|3785132|B1|Italy||Region of Enrollment||participants|Number|2|2.0||||||
3963178|NCT01313273|3785130|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3963179|NCT01313273|3785131|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3963180|NCT01313273|3785132|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3963181|NCT01313273|3785130|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3963182|NCT01313273|3785131|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3963183|NCT01313273|3785132|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3963184|NCT01313273|3785130|B3|Between 18 and 65 years||Age, Customized||Participants|Number|2|2.0||||||
3963185|NCT01313273|3785131|B2|Between 18 and 65 years||Age, Customized||Participants|Number|1|1.0||||||
3963186|NCT01313273|3785132|B1|Between 18 and 65 years||Age, Customized||Participants|Number|1|1.0||||||
3963187|NCT01313273|3785130|B3|>=65 years||Age, Customized||Participants|Number|1|1.0||||||
3963188|NCT01313273|3785131|B2|>=65 years||Age, Customized||Participants|Number|0|0.0||||||
3963189|NCT01313273|3785132|B1|>=65 years||Age, Customized||Participants|Number|1|1.0||||||
3963190|NCT01313273|3785130|B3|||Age||years|Median|61.00|61.0|Full Range|||57.0|84.0|
3963191|NCT01313273|3785131|B2|||Age||years|Median|57.00|57.0|Full Range|||57.0|57.0|
3963192|NCT01313273|3785132|B1|||Age||years|Median|72.50|72.5|Full Range|||61.0|84.0|
3963193|NCT01313221|3785145|B4|Naive||Prior anti-Tumor Necrosis Factor (TNF) Treatment|Based on participants in the Efficacy Evaluable set, all randomized participants, who had taken at least 1 dose of study drug and had at least 1 postrandomization efficacy evaluation (140 and 142 particiapants in each randomized treatment group respectively).|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3963194|NCT01313221|3785146|B3|Naive||Prior anti-Tumor Necrosis Factor (TNF) Treatment|Based on participants in the Efficacy Evaluable set, all randomized participants, who had taken at least 1 dose of study drug and had at least 1 postrandomization efficacy evaluation (140 and 142 particiapants in each randomized treatment group respectively).|participants|Number|NA|||||||Not reported for non-randomized participants
3963195|NCT01313221|3785147|B2|Naive||Prior anti-Tumor Necrosis Factor (TNF) Treatment|Based on participants in the Efficacy Evaluable set, all randomized participants, who had taken at least 1 dose of study drug and had at least 1 postrandomization efficacy evaluation (140 and 142 particiapants in each randomized treatment group respectively).|participants|Number|120|120.0||||||
3963196|NCT01313221|3785148|B1|Naive||Prior anti-Tumor Necrosis Factor (TNF) Treatment|Based on participants in the Efficacy Evaluable set, all randomized participants, who had taken at least 1 dose of study drug and had at least 1 postrandomization efficacy evaluation (140 and 142 particiapants in each randomized treatment group respectively).|participants|Number|116|116.0||||||
3963197|NCT01313221|3785145|B4|Prior exposure||Prior anti-Tumor Necrosis Factor (TNF) Treatment|Based on participants in the Efficacy Evaluable set, all randomized participants, who had taken at least 1 dose of study drug and had at least 1 postrandomization efficacy evaluation (140 and 142 particiapants in each randomized treatment group respectively).|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3963198|NCT01313221|3785146|B3|Prior exposure||Prior anti-Tumor Necrosis Factor (TNF) Treatment|Based on participants in the Efficacy Evaluable set, all randomized participants, who had taken at least 1 dose of study drug and had at least 1 postrandomization efficacy evaluation (140 and 142 particiapants in each randomized treatment group respectively).|participants|Number|NA|||||||Not reported for non-randomized participants
3963199|NCT01313221|3785147|B2|Prior exposure||Prior anti-Tumor Necrosis Factor (TNF) Treatment|Based on participants in the Efficacy Evaluable set, all randomized participants, who had taken at least 1 dose of study drug and had at least 1 postrandomization efficacy evaluation (140 and 142 particiapants in each randomized treatment group respectively).|participants|Number|22|22.0||||||
3963200|NCT01313221|3785148|B1|Prior exposure||Prior anti-Tumor Necrosis Factor (TNF) Treatment|Based on participants in the Efficacy Evaluable set, all randomized participants, who had taken at least 1 dose of study drug and had at least 1 postrandomization efficacy evaluation (140 and 142 particiapants in each randomized treatment group respectively).|participants|Number|24|24.0||||||
3963201|NCT01313221|3785145|B4|> 30||Body Mass Index (BMI)||participants|Number|136|136.0||||||
3963202|NCT01313221|3785146|B3|> 30||Body Mass Index (BMI)||participants|Number|10|10.0||||||
3963203|NCT01313221|3785147|B2|> 30||Body Mass Index (BMI)||participants|Number|63|63.0||||||
3963204|NCT01313221|3785148|B1|> 30||Body Mass Index (BMI)||participants|Number|63|63.0||||||
3963205|NCT01313221|3785145|B4|≤ 30||Body Mass Index (BMI)||participants|Number|174|174.0||||||
3963206|NCT01313221|3785146|B3|≤ 30||Body Mass Index (BMI)||participants|Number|13|13.0||||||
3963207|NCT01313221|3785147|B2|≤ 30||Body Mass Index (BMI)||participants|Number|80|80.0||||||
3963208|NCT01313221|3785148|B1|≤ 30||Body Mass Index (BMI)||participants|Number|81|81.0||||||
3963209|NCT01313221|3785145|B4|Other||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3963210|NCT01313221|3785146|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3963211|NCT01313221|3785147|B2|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3963212|NCT01313221|3785148|B1|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3963213|NCT01313221|3785145|B4|White||Race/Ethnicity, Customized||participants|Number|272|272.0||||||
3963214|NCT01313221|3785146|B3|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3963215|NCT01313221|3785147|B2|White||Race/Ethnicity, Customized||participants|Number|130|130.0||||||
3963216|NCT01313221|3785148|B1|White||Race/Ethnicity, Customized||participants|Number|120|120.0||||||
3963217|NCT01313221|3785145|B4|Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3963218|NCT01313221|3785146|B3|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3963219|NCT01313221|3785147|B2|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3963220|NCT01313221|3785148|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3963221|NCT01313221|3785145|B4|Asian||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3963222|NCT01313221|3785146|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3963223|NCT01313221|3785147|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3963224|NCT01313221|3785148|B1|Asian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3963225|NCT01313221|3785145|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3963226|NCT01313221|3785146|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3963227|NCT01313221|3785147|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3963228|NCT01313221|3785148|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3963229|NCT01313221|3785145|B4||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3963230|NCT01313221|3785146|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3963231|NCT01313221|3785147|B2||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3963232|NCT01313221|3785148|B1||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3963233|NCT01313221|3785145|B4||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3963234|NCT01313221|3785146|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3963235|NCT01313221|3785147|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3963236|NCT01313221|3785148|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3963237|NCT01313221|3785145|B4|||Age||years|Mean|45.3|45.3|Standard Deviation|13.9|13.9|||
3963238|NCT01313221|3785146|B3|||Age||years|Mean|36.6|36.6|Standard Deviation|11.2|11.2|||
3963239|NCT01313221|3785147|B2|||Age||years|Mean|46.3|46.3|Standard Deviation|14.6|14.6|||
3963240|NCT01313221|3785148|B1|||Age||years|Mean|45.7|45.7|Standard Deviation|13.1|13.1|||
3963241|NCT01313208|3785200|B3|No||Baseline methotrexate use||participants|Number|23|23.0||||||
3963242|NCT01313208|3785201|B2|No||Baseline methotrexate use||participants|Number|12|12.0||||||
3963243|NCT01313208|3785202|B1|No||Baseline methotrexate use||participants|Number|11|11.0||||||
3963244|NCT01313208|3785200|B3|Yes||Baseline methotrexate use||participants|Number|187|187.0||||||
3963245|NCT01313208|3785201|B2|Yes||Baseline methotrexate use||participants|Number|94|94.0||||||
3963246|NCT01313208|3785202|B1|Yes||Baseline methotrexate use||participants|Number|93|93.0||||||
3963247|NCT01313208|3785200|B3|||Duration of Rheumatoid Arthritis||years|Mean|7.84|7.84|Standard Deviation|9.76|9.76|||
3963248|NCT01313208|3785201|B2|||Duration of Rheumatoid Arthritis||years|Mean|8.26|8.26|Standard Deviation|11.16|11.16|||
3963249|NCT01313208|3785202|B1|||Duration of Rheumatoid Arthritis||years|Mean|7.41|7.41|Standard Deviation|8.11|8.11|||
3963250|NCT01313208|3785200|B3|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3963251|NCT01313208|3785201|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3963252|NCT01313208|3785202|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3963253|NCT01313208|3785200|B3|White||Race/Ethnicity, Customized||participants|Number|181|181.0||||||
3963254|NCT01313208|3785201|B2|White||Race/Ethnicity, Customized||participants|Number|91|91.0||||||
3963255|NCT01313208|3785202|B1|White||Race/Ethnicity, Customized||participants|Number|90|90.0||||||
3963256|NCT01313208|3785200|B3|Mixed race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3963257|NCT01313208|3785201|B2|Mixed race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3963258|NCT01313208|3785202|B1|Mixed race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3963259|NCT01313208|3785200|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3963260|NCT01313208|3785201|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3963261|NCT01313208|3785202|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3963262|NCT01313208|3785200|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3963263|NCT01313208|3785201|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3963264|NCT01313208|3785202|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3963265|NCT01313208|3785200|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3963266|NCT01313208|3785201|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3963267|NCT01313208|3785202|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3963268|NCT01313208|3785200|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3963269|NCT01313208|3785201|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3963270|NCT01313208|3785202|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3963271|NCT01313208|3785200|B3||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3963272|NCT01313208|3785201|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3963273|NCT01313208|3785202|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3963274|NCT01313208|3785200|B3|||Age||years|Mean|56.0|56.0|Standard Deviation|12.4|12.4|||
3963275|NCT01313208|3785201|B2|||Age||years|Mean|56.5|56.5|Standard Deviation|12.1|12.1|||
3963276|NCT01313208|3785202|B1|||Age||years|Mean|55.5|55.5|Standard Deviation|12.8|12.8|||
3963277|NCT01313182|3785291|B3|United States||Region of Enrollment||participants|Number|1697|1697.0||||||
3963278|NCT01313182|3785292|B2|United States||Region of Enrollment||participants|Number|855|855.0||||||
3963279|NCT01313182|3785293|B1|United States||Region of Enrollment||participants|Number|842|842.0||||||
3963280|NCT01313182|3785291|B3||Male|Sex: Female, Male||Participants|Count of Participants|675|675.0||||||
3963281|NCT01313182|3785292|B2||Male|Sex: Female, Male||Participants|Count of Participants|332|332.0||||||
3963282|NCT01313182|3785293|B1||Male|Sex: Female, Male||Participants|Count of Participants|343|343.0||||||
3963283|NCT01313182|3785291|B3||Female|Sex: Female, Male||Participants|Count of Participants|1022|1022.0||||||
3963284|NCT01313182|3785292|B2||Female|Sex: Female, Male||Participants|Count of Participants|523|523.0||||||
3963285|NCT01313182|3785293|B1||Female|Sex: Female, Male||Participants|Count of Participants|499|499.0||||||
3963286|NCT01313182|3785291|B3|||Age||years|Mean|62.1|62.1|Full Range|||19.1|93.2|
3963287|NCT01313182|3785292|B2|||Age||years|Mean|62.4|62.4|Full Range|||19.2|93.2|
3963288|NCT01313182|3785293|B1|||Age||years|Mean|61.8|61.8|Full Range|||19.1|92.4|
3963289|NCT01313117|3785300|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3963290|NCT01313117|3785300|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3963291|NCT01313117|3785300|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3963292|NCT01313117|3785300|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3963293|NCT01313117|3785300|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3963294|NCT01313117|3785300|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3963295|NCT01313117|3785300|B1|||Age||years|Mean|56.7|56.7|Full Range|||47.0|67.0|
3963296|NCT01313078|3785307|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3963297|NCT01313078|3785307|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963298|NCT01313078|3785307|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963299|NCT01313078|3785307|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3963300|NCT01313078|3785307|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963301|NCT01313078|3785307|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963302|NCT01313078|3785307|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963303|NCT01313078|3785307|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963304|NCT01313078|3785307|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963305|NCT01313078|3785307|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3963306|NCT01313078|3785307|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963307|NCT01313078|3785307|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3963308|NCT01313078|3785307|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3963309|NCT01313078|3785307|B1|||Age||years|Mean|52.1|52.1|Standard Deviation|12.8|12.8|||
3963310|NCT01313078|3785307|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3963311|NCT01313078|3785307|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3963312|NCT01313078|3785307|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3963313|NCT01313039|3785312|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3963314|NCT01313039|3785312|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3963315|NCT01313039|3785312|B1||Female|Gender||Participants|Count of Participants|4|4.0||||||
3963316|NCT01313039|3785312|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3963317|NCT01313039|3785312|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3963318|NCT01313039|3785312|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3963319|NCT01313039|3785312|B1|||Age||years|Mean|59.75|59.75|Full Range|||56.0|70.0|
3963320|NCT01312961|3785316|B3|||Number of Inhalations of Albuterol or Levalbuterol in a 24-hour Period|Number of Albuterol or Levalbuterol inhalations were recorded daily by the participants in their electronic diary.|number of inhalations|Mean|2.10|2.1|Standard Deviation|2.10|2.1|||
3963321|NCT01312961|3785317|B2|||Number of Inhalations of Albuterol or Levalbuterol in a 24-hour Period|Number of Albuterol or Levalbuterol inhalations were recorded daily by the participants in their electronic diary.|number of inhalations|Mean|2.16|2.16|Standard Deviation|2.40|2.4|||
3963322|NCT01312961|3785318|B1|||Number of Inhalations of Albuterol or Levalbuterol in a 24-hour Period|Number of Albuterol or Levalbuterol inhalations were recorded daily by the participants in their electronic diary.|number of inhalations|Mean|2.04|2.04|Standard Deviation|1.78|1.78|||
3963323|NCT01312961|3785316|B3|||Morning Peak Expiratory Flow (PEF)|PEF is a participant's maximum speed of expiration, as measured with a peak flow meter. Testing for PEF was performed at home while sitting or standing prior to using any medication for asthma.|L/min|Mean|400.02|400.02|Standard Deviation|105.80|105.8|||
3963324|NCT01312961|3785317|B2|||Morning Peak Expiratory Flow (PEF)|PEF is a participant's maximum speed of expiration, as measured with a peak flow meter. Testing for PEF was performed at home while sitting or standing prior to using any medication for asthma.|L/min|Mean|393.04|393.04|Standard Deviation|101.13|101.13|||
3963325|NCT01312961|3785318|B1|||Morning Peak Expiratory Flow (PEF)|PEF is a participant's maximum speed of expiration, as measured with a peak flow meter. Testing for PEF was performed at home while sitting or standing prior to using any medication for asthma.|L/min|Mean|406.87|406.87|Standard Deviation|110.74|110.74|||
3963326|NCT01312961|3785316|B3||Medium Dose|Prior ICS/LABA Combination Therapy Dose|High-Dose combination therapy was defined as Fluticasone (≥500 µg) and Salmeterol (50 µg) twice daily or the equivalent. Medium-dose combination therapy was defined as Fluticasone (250-499 µg) and Salmeterol (50 µg) twice daily or the equivalent.|Participants|Count of Participants|21|21.0||||||
3963327|NCT01312961|3785317|B2||Medium Dose|Prior ICS/LABA Combination Therapy Dose|High-Dose combination therapy was defined as Fluticasone (≥500 µg) and Salmeterol (50 µg) twice daily or the equivalent. Medium-dose combination therapy was defined as Fluticasone (250-499 µg) and Salmeterol (50 µg) twice daily or the equivalent.|Participants|Count of Participants|10|10.0||||||
3963328|NCT01312961|3785318|B1||Medium Dose|Prior ICS/LABA Combination Therapy Dose|High-Dose combination therapy was defined as Fluticasone (≥500 µg) and Salmeterol (50 µg) twice daily or the equivalent. Medium-dose combination therapy was defined as Fluticasone (250-499 µg) and Salmeterol (50 µg) twice daily or the equivalent.|Participants|Count of Participants|11|11.0||||||
3963329|NCT01312961|3785316|B3||High Dose|Prior ICS/LABA Combination Therapy Dose|High-Dose combination therapy was defined as Fluticasone (≥500 µg) and Salmeterol (50 µg) twice daily or the equivalent. Medium-dose combination therapy was defined as Fluticasone (250-499 µg) and Salmeterol (50 µg) twice daily or the equivalent.|Participants|Count of Participants|83|83.0||||||
3963330|NCT01312961|3785317|B2||High Dose|Prior ICS/LABA Combination Therapy Dose|High-Dose combination therapy was defined as Fluticasone (≥500 µg) and Salmeterol (50 µg) twice daily or the equivalent. Medium-dose combination therapy was defined as Fluticasone (250-499 µg) and Salmeterol (50 µg) twice daily or the equivalent.|Participants|Count of Participants|42|42.0||||||
3963331|NCT01312961|3785318|B1||High Dose|Prior ICS/LABA Combination Therapy Dose|High-Dose combination therapy was defined as Fluticasone (≥500 µg) and Salmeterol (50 µg) twice daily or the equivalent. Medium-dose combination therapy was defined as Fluticasone (250-499 µg) and Salmeterol (50 µg) twice daily or the equivalent.|Participants|Count of Participants|41|41.0||||||
3963332|NCT01312961|3785316|B3||Other than specified above|Race||Participants|Count of Participants|3|3.0||||||
3963333|NCT01312961|3785317|B2||Other than specified above|Race||Participants|Count of Participants|1|1.0||||||
3963334|NCT01312961|3785318|B1||Other than specified above|Race||Participants|Count of Participants|2|2.0||||||
3963335|NCT01312961|3785316|B3||Asian/Oriental|Race||Participants|Count of Participants|4|4.0||||||
3963336|NCT01312961|3785317|B2||Asian/Oriental|Race||Participants|Count of Participants|1|1.0||||||
3963337|NCT01312961|3785318|B1||Asian/Oriental|Race||Participants|Count of Participants|3|3.0||||||
3963338|NCT01312961|3785316|B3||Black|Race||Participants|Count of Participants|14|14.0||||||
3963339|NCT01312961|3785317|B2||Black|Race||Participants|Count of Participants|5|5.0||||||
3963340|NCT01312961|3785318|B1||Black|Race||Participants|Count of Participants|9|9.0||||||
3963341|NCT01312961|3785316|B3||Caucasian/White|Race||Participants|Count of Participants|83|83.0||||||
3963342|NCT01312961|3785317|B2||Caucasian/White|Race||Participants|Count of Participants|45|45.0||||||
3963343|NCT01312961|3785318|B1||Caucasian/White|Race||Participants|Count of Participants|38|38.0||||||
3963344|NCT01312961|3785316|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963345|NCT01312961|3785317|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963346|NCT01312961|3785318|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963347|NCT01312961|3785316|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3963348|NCT01312961|3785317|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3963349|NCT01312961|3785318|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3963350|NCT01312961|3785316|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3963351|NCT01312961|3785317|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3963352|NCT01312961|3785318|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3963353|NCT01312961|3785316|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3963354|NCT01312961|3785317|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3963355|NCT01312961|3785318|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3963356|NCT01312961|3785316|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3963357|NCT01312961|3785317|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3963358|NCT01312961|3785318|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3963359|NCT01312961|3785316|B3|||Age||years|Mean|39.7|39.7|Standard Deviation|13.2|13.2|||
3963360|NCT01312961|3785317|B2|||Age||years|Mean|37.8|37.8|Standard Deviation|13.2|13.2|||
3963361|NCT01312961|3785318|B1|||Age||years|Mean|41.6|41.6|Standard Deviation|13.1|13.1|||
3963362|NCT01312948|3785345|B1|Australia||Region of Enrollment||participants|Number|6|6.0||||||
3963363|NCT01312948|3785345|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3963364|NCT01312948|3785345|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3963365|NCT01312948|3785345|B1|||Age||years|Mean|4.6|4.6|Standard Deviation|1.8|1.8|||
3963366|NCT01312948|3785345|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3963367|NCT01312948|3785345|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3963368|NCT01312948|3785345|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3963369|NCT01312909|3785352|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3963370|NCT01312909|3785353|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3963371|NCT01312909|3785354|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3963372|NCT01312909|3785355|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3963373|NCT01312909|3785352|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|53|53.0||||||
3963374|NCT01312909|3785353|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3963375|NCT01312909|3785354|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3963376|NCT01312909|3785355|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3963377|NCT01312909|3785352|B4|Black||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3963378|NCT01312909|3785353|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3963379|NCT01312909|3785354|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3963380|NCT01312909|3785355|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3963381|NCT01312909|3785352|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|228|228.0||||||
3963382|NCT01312909|3785353|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|74|74.0||||||
3963383|NCT01312909|3785354|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|73|73.0||||||
3963384|NCT01312909|3785355|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|81|81.0||||||
3963385|NCT01312909|3785352|B4||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
3963386|NCT01312909|3785353|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3963387|NCT01312909|3785354|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3963388|NCT01312909|3785355|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3963389|NCT01312909|3785352|B4||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3963390|NCT01312909|3785353|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3963391|NCT01312909|3785354|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3963392|NCT01312909|3785355|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3963393|NCT01312909|3785352|B4|||Age||years|Mean|15.9|15.9|Standard Deviation|1.8|1.8|||
3963394|NCT01312909|3785353|B3|||Age||years|Mean|15.8|15.8|Standard Deviation|1.8|1.8|||
3963395|NCT01312909|3785354|B2|||Age||years|Mean|16.0|16.0|Standard Deviation|1.7|1.7|||
3963396|NCT01312909|3785355|B1|||Age||years|Mean|16.0|16.0|Standard Deviation|2.0|2.0|||
3963397|NCT01312844|3785404|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
3963398|NCT01312844|3785405|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3963399|NCT01312844|3785406|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3963400|NCT01312844|3785404|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3963401|NCT01312844|3785405|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3963402|NCT01312844|3785406|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3963403|NCT01312844|3785404|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3963404|NCT01312844|3785405|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3963405|NCT01312844|3785406|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3963406|NCT01312844|3785404|B3|||Age||years|Mean|51.86|51.86|Standard Deviation|14.68|14.68|||
3963407|NCT01312844|3785405|B2|||Age||years|Mean|56.67|56.67|Standard Deviation|21.78|21.78|||
3963408|NCT01312844|3785406|B1|||Age||years|Mean|48.25|48.25|Standard Deviation|8.62|8.62|||
3963409|NCT01312844|3785404|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3963410|NCT01312844|3785405|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3963411|NCT01312844|3785406|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3963412|NCT01312844|3785404|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3963413|NCT01312844|3785405|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3963414|NCT01312844|3785406|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3963415|NCT01312844|3785404|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3963416|NCT01312844|3785405|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3963417|NCT01312844|3785406|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3963418|NCT01312818|3785429|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3963419|NCT01312818|3785429|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3963420|NCT01312818|3785429|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3963421|NCT01312818|3785429|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3963422|NCT01312818|3785429|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3963423|NCT01312818|3785429|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3963424|NCT01312805|3785435|B3||Male|Sex: Female, Male||Participants|Count of Participants|1053|1053.0||||||
3963425|NCT01312805|3785436|B2||Male|Sex: Female, Male||Participants|Count of Participants|552|552.0||||||
3963426|NCT01312805|3785437|B1||Male|Sex: Female, Male||Participants|Count of Participants|501|501.0||||||
3963427|NCT01312805|3785435|B3||Female|Sex: Female, Male||Participants|Count of Participants|1045|1045.0||||||
3963428|NCT01312805|3785436|B2||Female|Sex: Female, Male||Participants|Count of Participants|530|530.0||||||
3963429|NCT01312805|3785437|B1||Female|Sex: Female, Male||Participants|Count of Participants|515|515.0||||||
3963430|NCT01312805|3785435|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3963431|NCT01312805|3785436|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3963432|NCT01312805|3785437|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3963433|NCT01312805|3785435|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3963434|NCT01312805|3785436|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3963435|NCT01312805|3785437|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3963436|NCT01312805|3785435|B3||<=18 years|Age||Participants|Count of Participants|2098|2098.0||||||
3963437|NCT01312805|3785436|B2||<=18 years|Age||Participants|Count of Participants|1082|1082.0||||||
3963438|NCT01312805|3785437|B1||<=18 years|Age||Participants|Count of Participants|1016|1016.0||||||
3963439|NCT01312766|3785444|B3|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3963440|NCT01312766|3785445|B2|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3963441|NCT01312766|3785446|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3963442|NCT01312766|3785444|B3|Asian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3963443|NCT01312766|3785445|B2|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3963444|NCT01312766|3785446|B1|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3963445|NCT01312766|3785444|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|252|252.0||||||
3963446|NCT01312766|3785445|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|126|126.0||||||
3963447|NCT01312766|3785446|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|126|126.0||||||
3963448|NCT01312766|3785444|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3963449|NCT01312766|3785445|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3963450|NCT01312766|3785446|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3963451|NCT01312766|3785444|B3||Female|Sex: Female, Male||Participants|Count of Participants|270|270.0||||||
3963452|NCT01312766|3785445|B2||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3963453|NCT01312766|3785446|B1||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3963454|NCT01312766|3785444|B3|||Age||years|Mean|33.1|33.1|Standard Deviation|4.1|4.1|||
3963455|NCT01312766|3785445|B2|||Age||years|Mean|33.0|33.0|Standard Deviation|4.1|4.1|||
3963456|NCT01312766|3785446|B1|||Age||years|Mean|33.3|33.3|Standard Deviation|4.0|4.0|||
3963457|NCT01312675|3785477|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963458|NCT01312675|3785478|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963459|NCT01312675|3785479|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963460|NCT01312675|3785477|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963461|NCT01312675|3785478|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963462|NCT01312675|3785479|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963463|NCT01312675|3785477|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3963464|NCT01312675|3785478|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3963465|NCT01312675|3785479|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3963466|NCT01312675|3785477|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3963467|NCT01312675|3785478|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3963468|NCT01312675|3785479|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3963469|NCT01312675|3785477|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963470|NCT01312675|3785478|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963471|NCT01312675|3785479|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963472|NCT01312675|3785477|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963473|NCT01312675|3785478|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963474|NCT01312675|3785479|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963475|NCT01312675|3785477|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963476|NCT01312675|3785478|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963477|NCT01312675|3785479|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963478|NCT01312675|3785477|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3963479|NCT01312675|3785478|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3963480|NCT01312675|3785479|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963481|NCT01312675|3785477|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3963482|NCT01312675|3785478|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3963483|NCT01312675|3785479|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3963484|NCT01312675|3785477|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963485|NCT01312675|3785478|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963486|NCT01312675|3785479|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963487|NCT01312675|3785477|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3963488|NCT01312675|3785478|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3963489|NCT01312675|3785479|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3963490|NCT01312675|3785477|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3963491|NCT01312675|3785478|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3963492|NCT01312675|3785479|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3963493|NCT01312675|3785477|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3963494|NCT01312675|3785478|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3963495|NCT01312675|3785479|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3963496|NCT01312675|3785477|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3963497|NCT01312675|3785478|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3963498|NCT01312675|3785479|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3963499|NCT01312675|3785477|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3963500|NCT01312675|3785478|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3963501|NCT01312675|3785479|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3963502|NCT01312519|3785486|B3|Spain||Region of Enrollment||participants|Number|20|20.0||||||
3963503|NCT01312519|3785487|B2|Spain||Region of Enrollment||participants|Number|6|6.0||||||
3963504|NCT01312519|3785488|B1|Spain||Region of Enrollment||participants|Number|14|14.0||||||
3963505|NCT01312519|3785486|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3963506|NCT01312519|3785487|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
3963507|NCT01312519|3785488|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3963508|NCT01312519|3785486|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3963509|NCT01312519|3785487|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3963510|NCT01312519|3785488|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3963511|NCT01312519|3785486|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3963512|NCT01312519|3785487|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3963513|NCT01312519|3785488|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3963514|NCT01312519|3785486|B3|||Age||years|Mean|56.0|56.0|Standard Deviation|18.0|18.0|||
3963515|NCT01312519|3785487|B2|||Age||years|Mean|53|53.0|Standard Deviation|19.0|19.0|||
3963516|NCT01312519|3785488|B1|||Age||years|Mean|59|59.0|Standard Deviation|17|17.0|||
3963517|NCT01312519|3785486|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3963518|NCT01312519|3785487|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3963519|NCT01312519|3785488|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3963520|NCT01312519|3785486|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3963521|NCT01312519|3785487|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3963522|NCT01312519|3785488|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3963523|NCT01312519|3785486|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3963524|NCT01312519|3785487|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3963525|NCT01312519|3785488|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3963526|NCT01312467|3785497|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
3963527|NCT01312467|3785497|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
3963528|NCT01312467|3785497|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3963529|NCT01312467|3785497|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3963530|NCT01312467|3785497|B1|||Age||years|Mean|59.6|59.6|Standard Deviation|6.83|6.83|||
3963531|NCT01312428|3785504|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3963532|NCT01312428|3785505|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3963533|NCT01312428|3785506|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3963534|NCT01312428|3785504|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3963535|NCT01312428|3785505|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3963536|NCT01312428|3785506|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3963537|NCT01312428|3785504|B3|||Age||years|Mean|65.5|65.5|Standard Deviation|8.0|8.0|||
3963538|NCT01312428|3785505|B2|||Age||years|Mean|65.9|65.9|Standard Deviation|4.1|4.1|||
3963539|NCT01312428|3785506|B1|||Age||years|Mean|65|65.0|Standard Deviation|12.9|12.9|||
3963540|NCT01312272|3785515|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
3963541|NCT01312272|3785516|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3963542|NCT01312272|3785517|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3963543|NCT01312272|3785515|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963544|NCT01312272|3785516|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963545|NCT01312272|3785517|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963546|NCT01312272|3785515|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3963547|NCT01312272|3785516|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3963548|NCT01312272|3785517|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3963549|NCT01312272|3785515|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3963550|NCT01312272|3785516|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3963551|NCT01312272|3785517|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3963552|NCT01312272|3785515|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3963553|NCT01312272|3785516|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3963554|NCT01312272|3785517|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3963555|NCT01312272|3785515|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963556|NCT01312272|3785516|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963557|NCT01312272|3785517|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963558|NCT01312272|3785515|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3963559|NCT01312272|3785516|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963560|NCT01312272|3785517|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3963561|NCT01312272|3785515|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963562|NCT01312272|3785516|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963563|NCT01312272|3785517|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963564|NCT01312272|3785515|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3963565|NCT01312272|3785516|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3963566|NCT01312272|3785517|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3963567|NCT01312272|3785515|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3963568|NCT01312272|3785516|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3963569|NCT01312272|3785517|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3963570|NCT01312272|3785515|B3|||Age||years|Mean|48.6|48.6|Standard Deviation|7.9|7.9|||
3963571|NCT01312272|3785516|B2|||Age||years|Mean|48.6|48.6|Standard Deviation|6.6|6.6|||
3963572|NCT01312272|3785517|B1|||Age||years|Mean|48.6|48.6|Standard Deviation|9.1|9.1|||
3963573|NCT01312181|3785534|B4|United States||Region of Enrollment||participants|Number|240|240.0||||||
3963574|NCT01312181|3785535|B3|United States||Region of Enrollment||participants|Number|83|83.0||||||
3963575|NCT01312181|3785536|B2|United States||Region of Enrollment||participants|Number|77|77.0||||||
3963576|NCT01312181|3785537|B1|United States||Region of Enrollment||participants|Number|80|80.0||||||
3963577|NCT01312181|3785534|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963578|NCT01312181|3785535|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963579|NCT01312181|3785536|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963580|NCT01312181|3785537|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963581|NCT01312181|3785534|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963582|NCT01312181|3785535|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963583|NCT01312181|3785536|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963584|NCT01312181|3785537|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963585|NCT01312181|3785534|B4||White|Race (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
3963586|NCT01312181|3785535|B3||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3963587|NCT01312181|3785536|B2||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3963588|NCT01312181|3785537|B1||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3963589|NCT01312181|3785534|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
3963590|NCT01312181|3785535|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3963591|NCT01312181|3785536|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3963592|NCT01312181|3785537|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3963593|NCT01312181|3785534|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963594|NCT01312181|3785535|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963595|NCT01312181|3785536|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963596|NCT01312181|3785537|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963597|NCT01312181|3785534|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963598|NCT01312181|3785535|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963599|NCT01312181|3785536|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963600|NCT01312181|3785537|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963601|NCT01312181|3785534|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963602|NCT01312181|3785535|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963603|NCT01312181|3785536|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963604|NCT01312181|3785537|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963605|NCT01312181|3785534|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963606|NCT01312181|3785535|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963607|NCT01312181|3785536|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963608|NCT01312181|3785537|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963609|NCT01312181|3785534|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|178|178.0||||||
3963610|NCT01312181|3785535|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3963611|NCT01312181|3785536|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3963612|NCT01312181|3785537|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3963613|NCT01312181|3785534|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3963614|NCT01312181|3785535|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3963615|NCT01312181|3785536|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3963616|NCT01312181|3785537|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3963617|NCT01312181|3785534|B4||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3963618|NCT01312181|3785535|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3963619|NCT01312181|3785536|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3963620|NCT01312181|3785537|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3963621|NCT01312181|3785534|B4||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3963622|NCT01312181|3785535|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3963623|NCT01312181|3785536|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3963624|NCT01312181|3785537|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3963625|NCT01312181|3785534|B4|||Age||years|Mean|46.54|46.54|Standard Deviation|9.34|9.34|||
3963626|NCT01312181|3785535|B3|||Age||years|Mean|46.72|46.72|Standard Deviation|10.32|10.32|||
3963627|NCT01312181|3785536|B2|||Age||years|Mean|47.38|47.38|Standard Deviation|8.31|8.31|||
3963628|NCT01312181|3785537|B1|||Age||years|Mean|45.53|45.53|Standard Deviation|9.23|9.23|||
3963629|NCT01312129|3785550|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
3963630|NCT01312129|3785551|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3963631|NCT01312129|3785552|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3963632|NCT01312129|3785550|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3963633|NCT01312129|3785551|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3963634|NCT01312129|3785552|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3963635|NCT01312129|3785550|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3963636|NCT01312129|3785551|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3963637|NCT01312129|3785552|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3963638|NCT01312129|3785550|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3963639|NCT01312129|3785551|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3963640|NCT01312129|3785552|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3963641|NCT01312129|3785550|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3963642|NCT01312129|3785551|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3963643|NCT01312129|3785552|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3963644|NCT01312129|3785550|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3963645|NCT01312129|3785551|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3963646|NCT01312129|3785552|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3963647|NCT01312038|3785559|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
3963648|NCT01312038|3785560|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3963649|NCT01312038|3785561|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3963650|NCT01312038|3785559|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963651|NCT01312038|3785560|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963652|NCT01312038|3785561|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963653|NCT01312038|3785559|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963654|NCT01312038|3785560|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963655|NCT01312038|3785561|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963656|NCT01312038|3785559|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3963657|NCT01312038|3785560|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3963658|NCT01312038|3785561|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3963659|NCT01312038|3785559|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3963660|NCT01312038|3785560|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3963661|NCT01312038|3785561|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3963662|NCT01312038|3785559|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963663|NCT01312038|3785560|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963664|NCT01312038|3785561|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963665|NCT01312038|3785559|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963666|NCT01312038|3785560|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963667|NCT01312038|3785561|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963668|NCT01312038|3785559|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963669|NCT01312038|3785560|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963670|NCT01312038|3785561|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963671|NCT01312038|3785559|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3963672|NCT01312038|3785560|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3963673|NCT01312038|3785561|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3963674|NCT01312038|3785559|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3963675|NCT01312038|3785560|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3963676|NCT01312038|3785561|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3963677|NCT01312038|3785559|B3|||Age||years|Mean|29.8|29.8|Standard Deviation|10.6|10.6|||
3963678|NCT01312038|3785560|B2|||Age||years|Mean|32.8|32.8|Standard Deviation|11.7|11.7|||
3963679|NCT01312038|3785561|B1|||Age||years|Mean|27.1|27.1|Standard Deviation|9.1|9.1|||
3963680|NCT01311895|3785568|B3|No||Nauseated or vomited before receiving opioids in the Emergency Department (ED)||Participants|Count of Participants|121|121.0||||||
3963681|NCT01311895|3785569|B2|No||Nauseated or vomited before receiving opioids in the Emergency Department (ED)||Participants|Count of Participants|63|63.0||||||
3963682|NCT01311895|3785570|B1|No||Nauseated or vomited before receiving opioids in the Emergency Department (ED)||Participants|Count of Participants|58|58.0||||||
3963683|NCT01311895|3785568|B3|Yes||Nauseated or vomited before receiving opioids in the Emergency Department (ED)||Participants|Count of Participants|213|213.0||||||
3963684|NCT01311895|3785569|B2|Yes||Nauseated or vomited before receiving opioids in the Emergency Department (ED)||Participants|Count of Participants|105|105.0||||||
3963685|NCT01311895|3785570|B1|Yes||Nauseated or vomited before receiving opioids in the Emergency Department (ED)||Participants|Count of Participants|108|108.0||||||
3963686|NCT01311895|3785568|B3|10||Pain intensity|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable)."|Participants|Count of Participants|190|190.0||||||
3963687|NCT01311895|3785569|B2|10||Pain intensity|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable)."|Participants|Count of Participants|92|92.0||||||
3963688|NCT01311895|3785570|B1|10||Pain intensity|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable)."|Participants|Count of Participants|98|98.0||||||
3963689|NCT01311895|3785568|B3|9||Pain intensity|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable)."|Participants|Count of Participants|38|38.0||||||
3963690|NCT01311895|3785569|B2|9||Pain intensity|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable)."|Participants|Count of Participants|22|22.0||||||
3963691|NCT01311895|3785570|B1|9||Pain intensity|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable)."|Participants|Count of Participants|16|16.0||||||
3963692|NCT01311895|3785568|B3|8||Pain intensity|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable)."|Participants|Count of Participants|52|52.0||||||
3963693|NCT01311895|3785569|B2|8||Pain intensity|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable)."|Participants|Count of Participants|28|28.0||||||
3963694|NCT01311895|3785570|B1|8||Pain intensity|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable)."|Participants|Count of Participants|24|24.0||||||
3963695|NCT01311895|3785568|B3|3-7||Pain intensity|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable)."|Participants|Count of Participants|54|54.0||||||
3963696|NCT01311895|3785569|B2|3-7||Pain intensity|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable)."|Participants|Count of Participants|26|26.0||||||
3963697|NCT01311895|3785570|B1|3-7||Pain intensity|"Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable)."|Participants|Count of Participants|28|28.0||||||
3963698|NCT01311895|3785568|B3|Other||Location of pain||Participants|Count of Participants|106|106.0||||||
3963699|NCT01311895|3785569|B2|Other||Location of pain||Participants|Count of Participants|56|56.0||||||
3963700|NCT01311895|3785570|B1|Other||Location of pain||Participants|Count of Participants|50|50.0||||||
3963701|NCT01311895|3785568|B3|Abdomen||Location of pain||Participants|Count of Participants|228|228.0||||||
3963702|NCT01311895|3785569|B2|Abdomen||Location of pain||Participants|Count of Participants|112|112.0||||||
3963703|NCT01311895|3785570|B1|Abdomen||Location of pain||Participants|Count of Participants|116|116.0||||||
3963704|NCT01311895|3785568|B3|||Weight||lbs|Median|184|184.0|Inter-Quartile Range|||165.0|219.0|
3963705|NCT01311895|3785569|B2|||Weight||lbs|Median|186|186.0|Inter-Quartile Range|||170.0|219.0|
3963706|NCT01311895|3785570|B1|||Weight||lbs|Median|180|180.0|Inter-Quartile Range|||165.0|210.0|
3963707|NCT01311895|3785568|B3|United States||Region of Enrollment||Participants|Count of Participants|334|334.0||||||
3963708|NCT01311895|3785569|B2|United States||Region of Enrollment||Participants|Count of Participants|168|168.0||||||
3963709|NCT01311895|3785570|B1|United States||Region of Enrollment||Participants|Count of Participants|166|166.0||||||
3963710|NCT01311895|3785568|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3963711|NCT01311895|3785569|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3963712|NCT01311895|3785570|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3963713|NCT01311895|3785568|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3963714|NCT01311895|3785569|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3963715|NCT01311895|3785570|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3963716|NCT01311895|3785568|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|92|92.0||||||
3963717|NCT01311895|3785569|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
3963718|NCT01311895|3785570|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
3963719|NCT01311895|3785568|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|225|225.0||||||
3963720|NCT01311895|3785569|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|116|116.0||||||
3963721|NCT01311895|3785570|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|109|109.0||||||
3963722|NCT01311895|3785568|B3||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3963723|NCT01311895|3785569|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3963724|NCT01311895|3785570|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3963725|NCT01311895|3785568|B3||Female|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
3963726|NCT01311895|3785569|B2||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3963727|NCT01311895|3785570|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3963728|NCT01311895|3785568|B3|||Age||years|Median|43|43.0|Inter-Quartile Range|||33.0|51.0|
3963729|NCT01311895|3785569|B2|||Age||years|Median|42|42.0|Inter-Quartile Range|||33.0|50.0|
3963730|NCT01311895|3785570|B1|||Age||years|Median|44|44.0|Inter-Quartile Range|||33.0|52.0|
3963731|NCT01311687|3785581|B3||Missing|Multiple Myeloma Stage before Study Entry|The International Staging System divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels. Stage I: Serum beta-2 microglobulin is less than 3.5 (mg/L) and the albumin level is above 3.5 (g/L); Stage II: Neither stage I or III, meaning that either: ◾ The beta-2 microglobulin level is between 3.5 and 5.5 (with any albumin level), OR ◾ The albumin is below 3.5 while the beta-2 microglobulin is less than 3.5 Stage III: Serum beta-2 microglobulin is greater than 5.5.|Participants|Count of Participants|22|22.0||||||
3963732|NCT01311687|3785582|B2||Missing|Multiple Myeloma Stage before Study Entry|The International Staging System divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels. Stage I: Serum beta-2 microglobulin is less than 3.5 (mg/L) and the albumin level is above 3.5 (g/L); Stage II: Neither stage I or III, meaning that either: ◾ The beta-2 microglobulin level is between 3.5 and 5.5 (with any albumin level), OR ◾ The albumin is below 3.5 while the beta-2 microglobulin is less than 3.5 Stage III: Serum beta-2 microglobulin is greater than 5.5.|Participants|Count of Participants|8|8.0||||||
3963733|NCT01311687|3785583|B1||Missing|Multiple Myeloma Stage before Study Entry|The International Staging System divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels. Stage I: Serum beta-2 microglobulin is less than 3.5 (mg/L) and the albumin level is above 3.5 (g/L); Stage II: Neither stage I or III, meaning that either: ◾ The beta-2 microglobulin level is between 3.5 and 5.5 (with any albumin level), OR ◾ The albumin is below 3.5 while the beta-2 microglobulin is less than 3.5 Stage III: Serum beta-2 microglobulin is greater than 5.5.|Participants|Count of Participants|14|14.0||||||
3963734|NCT01311687|3785581|B3||Stage III|Multiple Myeloma Stage before Study Entry|The International Staging System divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels. Stage I: Serum beta-2 microglobulin is less than 3.5 (mg/L) and the albumin level is above 3.5 (g/L); Stage II: Neither stage I or III, meaning that either: ◾ The beta-2 microglobulin level is between 3.5 and 5.5 (with any albumin level), OR ◾ The albumin is below 3.5 while the beta-2 microglobulin is less than 3.5 Stage III: Serum beta-2 microglobulin is greater than 5.5.|Participants|Count of Participants|145|145.0||||||
3963735|NCT01311687|3785582|B2||Stage III|Multiple Myeloma Stage before Study Entry|The International Staging System divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels. Stage I: Serum beta-2 microglobulin is less than 3.5 (mg/L) and the albumin level is above 3.5 (g/L); Stage II: Neither stage I or III, meaning that either: ◾ The beta-2 microglobulin level is between 3.5 and 5.5 (with any albumin level), OR ◾ The albumin is below 3.5 while the beta-2 microglobulin is less than 3.5 Stage III: Serum beta-2 microglobulin is greater than 5.5.|Participants|Count of Participants|53|53.0||||||
3963736|NCT01311687|3785583|B1||Stage III|Multiple Myeloma Stage before Study Entry|The International Staging System divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels. Stage I: Serum beta-2 microglobulin is less than 3.5 (mg/L) and the albumin level is above 3.5 (g/L); Stage II: Neither stage I or III, meaning that either: ◾ The beta-2 microglobulin level is between 3.5 and 5.5 (with any albumin level), OR ◾ The albumin is below 3.5 while the beta-2 microglobulin is less than 3.5 Stage III: Serum beta-2 microglobulin is greater than 5.5.|Participants|Count of Participants|92|92.0||||||
3963737|NCT01311687|3785581|B3||Stage II|Multiple Myeloma Stage before Study Entry|The International Staging System divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels. Stage I: Serum beta-2 microglobulin is less than 3.5 (mg/L) and the albumin level is above 3.5 (g/L); Stage II: Neither stage I or III, meaning that either: ◾ The beta-2 microglobulin level is between 3.5 and 5.5 (with any albumin level), OR ◾ The albumin is below 3.5 while the beta-2 microglobulin is less than 3.5 Stage III: Serum beta-2 microglobulin is greater than 5.5.|Participants|Count of Participants|171|171.0||||||
3963738|NCT01311687|3785582|B2||Stage II|Multiple Myeloma Stage before Study Entry|The International Staging System divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels. Stage I: Serum beta-2 microglobulin is less than 3.5 (mg/L) and the albumin level is above 3.5 (g/L); Stage II: Neither stage I or III, meaning that either: ◾ The beta-2 microglobulin level is between 3.5 and 5.5 (with any albumin level), OR ◾ The albumin is below 3.5 while the beta-2 microglobulin is less than 3.5 Stage III: Serum beta-2 microglobulin is greater than 5.5.|Participants|Count of Participants|56|56.0||||||
3963739|NCT01311687|3785583|B1||Stage II|Multiple Myeloma Stage before Study Entry|The International Staging System divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels. Stage I: Serum beta-2 microglobulin is less than 3.5 (mg/L) and the albumin level is above 3.5 (g/L); Stage II: Neither stage I or III, meaning that either: ◾ The beta-2 microglobulin level is between 3.5 and 5.5 (with any albumin level), OR ◾ The albumin is below 3.5 while the beta-2 microglobulin is less than 3.5 Stage III: Serum beta-2 microglobulin is greater than 5.5.|Participants|Count of Participants|115|115.0||||||
3963740|NCT01311687|3785581|B3||Stage I|Multiple Myeloma Stage before Study Entry|The International Staging System divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels. Stage I: Serum beta-2 microglobulin is less than 3.5 (mg/L) and the albumin level is above 3.5 (g/L); Stage II: Neither stage I or III, meaning that either: ◾ The beta-2 microglobulin level is between 3.5 and 5.5 (with any albumin level), OR ◾ The albumin is below 3.5 while the beta-2 microglobulin is less than 3.5 Stage III: Serum beta-2 microglobulin is greater than 5.5.|Participants|Count of Participants|117|117.0||||||
3963741|NCT01311687|3785582|B2||Stage I|Multiple Myeloma Stage before Study Entry|The International Staging System divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels. Stage I: Serum beta-2 microglobulin is less than 3.5 (mg/L) and the albumin level is above 3.5 (g/L); Stage II: Neither stage I or III, meaning that either: ◾ The beta-2 microglobulin level is between 3.5 and 5.5 (with any albumin level), OR ◾ The albumin is below 3.5 while the beta-2 microglobulin is less than 3.5 Stage III: Serum beta-2 microglobulin is greater than 5.5.|Participants|Count of Participants|36|36.0||||||
3963742|NCT01311687|3785583|B1||Stage I|Multiple Myeloma Stage before Study Entry|The International Staging System divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels. Stage I: Serum beta-2 microglobulin is less than 3.5 (mg/L) and the albumin level is above 3.5 (g/L); Stage II: Neither stage I or III, meaning that either: ◾ The beta-2 microglobulin level is between 3.5 and 5.5 (with any albumin level), OR ◾ The albumin is below 3.5 while the beta-2 microglobulin is less than 3.5 Stage III: Serum beta-2 microglobulin is greater than 5.5.|Participants|Count of Participants|81|81.0||||||
3963743|NCT01311687|3785581|B3||> 2 Prior Anti-MM Therapies|Stratification Factor 3: Number of Prior Anti-MM Therapies||Participants|Count of Participants|430|430.0||||||
3963744|NCT01311687|3785582|B2||> 2 Prior Anti-MM Therapies|Stratification Factor 3: Number of Prior Anti-MM Therapies||Participants|Count of Participants|145|145.0||||||
3963745|NCT01311687|3785583|B1||> 2 Prior Anti-MM Therapies|Stratification Factor 3: Number of Prior Anti-MM Therapies||Participants|Count of Participants|285|285.0||||||
3963746|NCT01311687|3785581|B3||2 Prior Anti-MM Therapies|Stratification Factor 3: Number of Prior Anti-MM Therapies||Participants|Count of Participants|25|25.0||||||
3963747|NCT01311687|3785582|B2||2 Prior Anti-MM Therapies|Stratification Factor 3: Number of Prior Anti-MM Therapies||Participants|Count of Participants|8|8.0||||||
3963748|NCT01311687|3785583|B1||2 Prior Anti-MM Therapies|Stratification Factor 3: Number of Prior Anti-MM Therapies||Participants|Count of Participants|17|17.0||||||
3963749|NCT01311687|3785581|B3||Disease Population Group 3|Stratification Factor 2: Disease Population|Disease Population Group 1 is defined as refractory patients who have progressed on or within 60 days of both lenalidomide and bortezomib based treatments. Disease Population Group 2 is defined as relapsed and refractory patients who achieved at least a partial response (PR) and progressed within 6 months after stopping treatment with lenalidomide and/or bortezomib. Disease Population Group 3 is defined as refractory/intolerant patients who developed intolerance/toxicity after a minimum of 2 cycles of bortezomib.|Participants|Count of Participants|68|68.0||||||
3963750|NCT01311687|3785582|B2||Disease Population Group 3|Stratification Factor 2: Disease Population|Disease Population Group 1 is defined as refractory patients who have progressed on or within 60 days of both lenalidomide and bortezomib based treatments. Disease Population Group 2 is defined as relapsed and refractory patients who achieved at least a partial response (PR) and progressed within 6 months after stopping treatment with lenalidomide and/or bortezomib. Disease Population Group 3 is defined as refractory/intolerant patients who developed intolerance/toxicity after a minimum of 2 cycles of bortezomib.|Participants|Count of Participants|23|23.0||||||
3963751|NCT01311687|3785583|B1||Disease Population Group 3|Stratification Factor 2: Disease Population|Disease Population Group 1 is defined as refractory patients who have progressed on or within 60 days of both lenalidomide and bortezomib based treatments. Disease Population Group 2 is defined as relapsed and refractory patients who achieved at least a partial response (PR) and progressed within 6 months after stopping treatment with lenalidomide and/or bortezomib. Disease Population Group 3 is defined as refractory/intolerant patients who developed intolerance/toxicity after a minimum of 2 cycles of bortezomib.|Participants|Count of Participants|45|45.0||||||
3963752|NCT01311687|3785581|B3||Disease Population Group 2|Stratification Factor 2: Disease Population|Disease Population Group 1 is defined as refractory patients who have progressed on or within 60 days of both lenalidomide and bortezomib based treatments. Disease Population Group 2 is defined as relapsed and refractory patients who achieved at least a partial response (PR) and progressed within 6 months after stopping treatment with lenalidomide and/or bortezomib. Disease Population Group 3 is defined as refractory/intolerant patients who developed intolerance/toxicity after a minimum of 2 cycles of bortezomib.|Participants|Count of Participants|13|13.0||||||
3963753|NCT01311687|3785582|B2||Disease Population Group 2|Stratification Factor 2: Disease Population|Disease Population Group 1 is defined as refractory patients who have progressed on or within 60 days of both lenalidomide and bortezomib based treatments. Disease Population Group 2 is defined as relapsed and refractory patients who achieved at least a partial response (PR) and progressed within 6 months after stopping treatment with lenalidomide and/or bortezomib. Disease Population Group 3 is defined as refractory/intolerant patients who developed intolerance/toxicity after a minimum of 2 cycles of bortezomib.|Participants|Count of Participants|5|5.0||||||
3963754|NCT01311687|3785583|B1||Disease Population Group 2|Stratification Factor 2: Disease Population|Disease Population Group 1 is defined as refractory patients who have progressed on or within 60 days of both lenalidomide and bortezomib based treatments. Disease Population Group 2 is defined as relapsed and refractory patients who achieved at least a partial response (PR) and progressed within 6 months after stopping treatment with lenalidomide and/or bortezomib. Disease Population Group 3 is defined as refractory/intolerant patients who developed intolerance/toxicity after a minimum of 2 cycles of bortezomib.|Participants|Count of Participants|8|8.0||||||
3963755|NCT01311687|3785581|B3||Disease Population Group 1|Stratification Factor 2: Disease Population|Disease Population Group 1 is defined as refractory patients who have progressed on or within 60 days of both lenalidomide and bortezomib based treatments. Disease Population Group 2 is defined as relapsed and refractory patients who achieved at least a partial response (PR) and progressed within 6 months after stopping treatment with lenalidomide and/or bortezomib. Disease Population Group 3 is defined as refractory/intolerant patients who developed intolerance/toxicity after a minimum of 2 cycles of bortezomib.|Participants|Count of Participants|374|374.0||||||
3963756|NCT01311687|3785582|B2||Disease Population Group 1|Stratification Factor 2: Disease Population|Disease Population Group 1 is defined as refractory patients who have progressed on or within 60 days of both lenalidomide and bortezomib based treatments. Disease Population Group 2 is defined as relapsed and refractory patients who achieved at least a partial response (PR) and progressed within 6 months after stopping treatment with lenalidomide and/or bortezomib. Disease Population Group 3 is defined as refractory/intolerant patients who developed intolerance/toxicity after a minimum of 2 cycles of bortezomib.|Participants|Count of Participants|125|125.0||||||
3963757|NCT01311687|3785583|B1||Disease Population Group 1|Stratification Factor 2: Disease Population|Disease Population Group 1 is defined as refractory patients who have progressed on or within 60 days of both lenalidomide and bortezomib based treatments. Disease Population Group 2 is defined as relapsed and refractory patients who achieved at least a partial response (PR) and progressed within 6 months after stopping treatment with lenalidomide and/or bortezomib. Disease Population Group 3 is defined as refractory/intolerant patients who developed intolerance/toxicity after a minimum of 2 cycles of bortezomib.|Participants|Count of Participants|249|249.0||||||
3963758|NCT01311687|3785581|B3|||Time from First Pathologic Diagnosis||years|Mean|6.3|6.3|Standard Deviation|3.89|3.89|||
3963759|NCT01311687|3785582|B2|||Time from First Pathologic Diagnosis||years|Mean|6.5|6.5|Standard Deviation|3.63|3.63|||
3963760|NCT01311687|3785583|B1|||Time from First Pathologic Diagnosis||years|Mean|6.2|6.2|Standard Deviation|4.02|4.02|||
3963761|NCT01311687|3785581|B3|||Participants with Prior Anti-Myeloma (MM) Therapies||Participants|Count of Participants|455|455.0||||||
3963762|NCT01311687|3785582|B2|||Participants with Prior Anti-Myeloma (MM) Therapies||Participants|Count of Participants|153|153.0||||||
3963763|NCT01311687|3785583|B1|||Participants with Prior Anti-Myeloma (MM) Therapies||Participants|Count of Participants|302|302.0||||||
3963764|NCT01311687|3785581|B3||Not collected|Race/Ethnicity, Customized||Participants|Count of Participants|83|83.0||||||
3963765|NCT01311687|3785582|B2||Not collected|Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
3963766|NCT01311687|3785583|B1||Not collected|Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
3963767|NCT01311687|3785581|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3963768|NCT01311687|3785582|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3963769|NCT01311687|3785583|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3963770|NCT01311687|3785581|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|357|357.0||||||
3963771|NCT01311687|3785582|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|113|113.0||||||
3963772|NCT01311687|3785583|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|244|244.0||||||
3963773|NCT01311687|3785581|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3963774|NCT01311687|3785582|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3963775|NCT01311687|3785583|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3963776|NCT01311687|3785581|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3963777|NCT01311687|3785582|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3963778|NCT01311687|3785583|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3963779|NCT01311687|3785581|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3963780|NCT01311687|3785582|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3963781|NCT01311687|3785583|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3963782|NCT01311687|3785581|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|332|332.0||||||
3963783|NCT01311687|3785582|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
3963784|NCT01311687|3785583|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|228|228.0||||||
3963785|NCT01311687|3785581|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3963786|NCT01311687|3785582|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3963787|NCT01311687|3785583|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3963788|NCT01311687|3785581|B3||Male|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
3963789|NCT01311687|3785582|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3963790|NCT01311687|3785583|B1||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
3963791|NCT01311687|3785581|B3||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
3963792|NCT01311687|3785582|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3963793|NCT01311687|3785583|B1||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3963794|NCT01311687|3785581|B3||> 75 Years Old|Age, Customized|Stratification Factor 1|Participants|Count of Participants|36|36.0||||||
3963795|NCT01311687|3785582|B2||> 75 Years Old|Age, Customized|Stratification Factor 1|Participants|Count of Participants|12|12.0||||||
3963796|NCT01311687|3785583|B1||> 75 Years Old|Age, Customized|Stratification Factor 1|Participants|Count of Participants|24|24.0||||||
3963797|NCT01311687|3785581|B3||≤ 75 Years Old|Age, Customized|Stratification Factor 1|Participants|Count of Participants|419|419.0||||||
3963798|NCT01311687|3785582|B2||≤ 75 Years Old|Age, Customized|Stratification Factor 1|Participants|Count of Participants|141|141.0||||||
3963799|NCT01311687|3785583|B1||≤ 75 Years Old|Age, Customized|Stratification Factor 1|Participants|Count of Participants|278|278.0||||||
3963800|NCT01311687|3785581|B3|||Age||years|Mean|63.6|63.6|Standard Deviation|9.40|9.4|||
3963801|NCT01311687|3785582|B2|||Age||years|Mean|63.7|63.7|Standard Deviation|9.56|9.56|||
3963802|NCT01311687|3785583|B1|||Age||years|Mean|63.6|63.6|Standard Deviation|9.33|9.33|||
3963803|NCT01311661|3785638|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3963804|NCT01311661|3785638|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3963805|NCT01311661|3785638|B1|||Age||years|Mean|43.7|43.7|Standard Deviation|12.2|12.2|||
3963806|NCT01311557|3785780|B3|United States||Region of Enrollment||Participants|Number|1302|1302.0||||||
3963807|NCT01311557|3785781|B2|United States||Region of Enrollment||Participants|Number|651|651.0||||||
3963808|NCT01311557|3785782|B1|United States||Region of Enrollment||Participants|Number|651|651.0||||||
3963809|NCT01311557|3785780|B3||Male|Sex: Female, Male||Participants|Count of Participants|682|682.0||||||
3963810|NCT01311557|3785781|B2||Male|Sex: Female, Male||Participants|Count of Participants|336|336.0||||||
3963811|NCT01311557|3785782|B1||Male|Sex: Female, Male||Participants|Count of Participants|346|346.0||||||
3963812|NCT01311557|3785780|B3||Female|Sex: Female, Male||Participants|Count of Participants|620|620.0||||||
3963813|NCT01311557|3785781|B2||Female|Sex: Female, Male||Participants|Count of Participants|315|315.0||||||
3963814|NCT01311557|3785782|B1||Female|Sex: Female, Male||Participants|Count of Participants|305|305.0||||||
3963815|NCT01311557|3785780|B3|||Age||Years|Mean|10.5|10.5|Standard Deviation|0.3|0.3|||
3963816|NCT01311557|3785781|B2|||Age||Years|Mean|11.4|11.4|Standard Deviation|0.3|0.3|||
3963817|NCT01311557|3785782|B1|||Age||Years|Mean|10.5|10.5|Standard Deviation|0.3|0.3|||
3963818|NCT01311557|3785780|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3963819|NCT01311557|3785781|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3963820|NCT01311557|3785782|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3963821|NCT01311557|3785780|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3963822|NCT01311557|3785781|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3963823|NCT01311557|3785782|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3963824|NCT01311557|3785780|B3||<=18 years|Age||Participants|Count of Participants|1302|1302.0||||||
3963825|NCT01311557|3785781|B2||<=18 years|Age||Participants|Count of Participants|651|651.0||||||
3963826|NCT01311557|3785782|B1||<=18 years|Age||Participants|Count of Participants|651|651.0||||||
3963827|NCT01311505|3785799|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3963828|NCT01311505|3785799|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3963829|NCT01311505|3785799|B1|33 to 37 years||Age, Customized||participants|Number|2|2.0||||||
3963830|NCT01311505|3785799|B1|28 to 32 years||Age, Customized||participants|Number|2|2.0||||||
3963831|NCT01311505|3785799|B1|23 to 27 years||Age, Customized||participants|Number|4|4.0||||||
3963832|NCT01311505|3785799|B1|18 to 22 years||Age, Customized||participants|Number|12|12.0||||||
3963833|NCT01311362|3785828|B1|Germany||Region of Enrollment||participants|Number|20|20.0||||||
3963834|NCT01311362|3785828|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3963835|NCT01311362|3785828|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3963836|NCT01311362|3785828|B1|||Age||years|Mean|31.3|31.3|Standard Deviation|7.7|7.7|||
3963837|NCT01311102|3785839|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3963838|NCT01311102|3785840|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3963839|NCT01311102|3785841|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3963840|NCT01311102|3785839|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3963841|NCT01311102|3785840|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3963842|NCT01311102|3785841|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3963843|NCT01311102|3785839|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3963844|NCT01311102|3785840|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3963845|NCT01311102|3785841|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3963846|NCT01311102|3785839|B3|Age Range||Age||years|Mean|32.055|32.055|Full Range|Not reported|0.0|19.0|46.0|
3963847|NCT01311102|3785840|B2|Age Range||Age||years|Mean|32.06|32.06|Full Range|Not reported|0.0|19.0|46.0|
3963848|NCT01311102|3785841|B1|Age Range||Age||years|Mean|32.05|32.05|Full Range|Not reported|0.0|20.0|43.0|
3963849|NCT01311102|3785839|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3963850|NCT01311102|3785840|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3963851|NCT01311102|3785841|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3963852|NCT01311102|3785839|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3963853|NCT01311102|3785840|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3963854|NCT01311102|3785841|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3963855|NCT01311102|3785839|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3963856|NCT01311102|3785840|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3963857|NCT01311102|3785841|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3963858|NCT01311024|3785854|B3||Male|Sex: Female, Male||Participants|Count of Participants|720|720.0||||||
3963859|NCT01311024|3785855|B2||Male|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
3963860|NCT01311024|3785856|B1||Male|Sex: Female, Male||Participants|Count of Participants|459|459.0||||||
3963861|NCT01311024|3785854|B3||Female|Sex: Female, Male||Participants|Count of Participants|725|725.0||||||
3963862|NCT01311024|3785855|B2||Female|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
3963863|NCT01311024|3785856|B1||Female|Sex: Female, Male||Participants|Count of Participants|468|468.0||||||
3963864|NCT01311024|3785854|B3|||Age||years|Median|4|4.0|Full Range|||3.0|7.0|
3963865|NCT01311024|3785855|B2|||Age||years|Median|4|4.0|Full Range|||3.0|7.0|
3963866|NCT01311024|3785856|B1|||Age||years|Median|4|4.0|Full Range|||3.0|7.0|
3963867|NCT01310868|3785863|B1|United Kingdom||Region of Enrollment||participants|Number|72|72.0||||||
3963868|NCT01310868|3785863|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3963869|NCT01310868|3785863|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3963870|NCT01310868|3785863|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3963871|NCT01310868|3785863|B1||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3963872|NCT01310868|3785863|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3963873|NCT01310855|3785869|B3|United Kingdom||Region of Enrollment||participants|Number|38|38.0||||||
3963874|NCT01310855|3785870|B2|United Kingdom||Region of Enrollment||participants|Number|19|19.0||||||
3963875|NCT01310855|3785871|B1|United Kingdom||Region of Enrollment||participants|Number|19|19.0||||||
3963876|NCT01310855|3785869|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3963877|NCT01310855|3785870|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3963878|NCT01310855|3785871|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3963879|NCT01310855|3785869|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3963880|NCT01310855|3785870|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3963881|NCT01310855|3785871|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3963882|NCT01310855|3785869|B3|||Age||years|Mean|55.7|55.7|Full Range|||30.0|71.0|
3963883|NCT01310855|3785870|B2|||Age||years|Mean|56.9|56.9|Full Range|||40.0|69.0|
3963884|NCT01310855|3785871|B1|||Age||years|Mean|54.4|54.4|Full Range|||30.0|71.0|
3963885|NCT01310855|3785869|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3963886|NCT01310855|3785870|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3963887|NCT01310855|3785871|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3963888|NCT01310855|3785869|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3963889|NCT01310855|3785870|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3963890|NCT01310855|3785871|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3963891|NCT01310855|3785869|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3963892|NCT01310855|3785870|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3963893|NCT01310855|3785871|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3963894|NCT01310803|3785878|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963895|NCT01310803|3785880|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963896|NCT01310803|3785878|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963897|NCT01310803|3785880|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963898|NCT01310803|3785878|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3963899|NCT01310803|3785880|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3963900|NCT01310803|3785878|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963901|NCT01310803|3785880|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963902|NCT01310803|3785878|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963903|NCT01310803|3785880|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963904|NCT01310803|3785878|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963905|NCT01310803|3785880|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963906|NCT01310803|3785878|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963907|NCT01310803|3785880|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963908|NCT01310803|3785878|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963909|NCT01310803|3785880|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963910|NCT01310803|3785878|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3963911|NCT01310803|3785880|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3963912|NCT01310803|3785878|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963913|NCT01310803|3785880|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3963914|NCT01310803|3785878|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3963915|NCT01310803|3785880|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3963916|NCT01310803|3785878|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3963917|NCT01310803|3785880|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3963918|NCT01310803|3785878|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3963919|NCT01310803|3785880|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3963920|NCT01310803|3785878|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3963921|NCT01310803|3785880|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3963922|NCT01310803|3785878|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3963923|NCT01310803|3785880|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3963924|NCT01310777|3785889|B4||Male|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
3963925|NCT01310777|3785890|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3963926|NCT01310777|3785891|B2||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3963927|NCT01310777|3785892|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3963928|NCT01310777|3785889|B4||Female|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
3963929|NCT01310777|3785890|B3||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3963930|NCT01310777|3785891|B2||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3963931|NCT01310777|3785892|B1||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3963932|NCT01310777|3785889|B4|≥65 years||Age, Customized||participants|Number|303|303.0||||||
3963933|NCT01310777|3785890|B3|≥65 years||Age, Customized||participants|Number|96|96.0||||||
3963934|NCT01310777|3785891|B2|≥65 years||Age, Customized||participants|Number|105|105.0||||||
3963935|NCT01310777|3785892|B1|≥65 years||Age, Customized||participants|Number|102|102.0||||||
3963936|NCT01310777|3785889|B4|<65 years||Age, Customized||participants|Number|257|257.0||||||
3963937|NCT01310777|3785890|B3|<65 years||Age, Customized||participants|Number|79|79.0||||||
3963938|NCT01310777|3785891|B2|<65 years||Age, Customized||participants|Number|87|87.0||||||
3963939|NCT01310777|3785892|B1|<65 years||Age, Customized||participants|Number|91|91.0||||||
3963940|NCT01310699|3785902|B3||Male|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
3963941|NCT01310699|3785903|B2||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3963942|NCT01310699|3785904|B1||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3963943|NCT01310699|3785902|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3963944|NCT01310699|3785903|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3963945|NCT01310699|3785904|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3963946|NCT01310699|3785902|B3|||Age||years|Mean|63|63.0|Standard Deviation|9.01|9.01|||
3963947|NCT01310699|3785903|B2|||Age||years|Mean|62.3|62.3|Standard Deviation|8.6|8.6|||
3963948|NCT01310699|3785904|B1|||Age||years|Mean|63.7|63.7|Standard Deviation|9.4|9.4|||
3963949|NCT01310582|3785915|B3|United States||Region of Enrollment||participants|Number|57|57.0||||||
3963950|NCT01310582|3785916|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
3963951|NCT01310582|3785917|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
3963952|NCT01310582|3785915|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3963953|NCT01310582|3785916|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3963954|NCT01310582|3785917|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3963955|NCT01310582|3785915|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3963956|NCT01310582|3785916|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3963957|NCT01310582|3785917|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3963958|NCT01310582|3785915|B3|||Age||years|Mean|67.6|67.6|Standard Deviation|6.24|6.24|||
3963959|NCT01310582|3785916|B2|||Age||years|Mean|67.1|67.1|Standard Deviation|6.11|6.11|||
3963960|NCT01310582|3785917|B1|||Age||years|Mean|68.2|68.2|Standard Deviation|6.43|6.43|||
3963961|NCT01310582|3785915|B3||>=65 years|Age||Participants|Count of Participants|57|57.0||||||
3963962|NCT01310582|3785916|B2||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
3963963|NCT01310582|3785917|B1||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
3963964|NCT01310582|3785915|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3963965|NCT01310582|3785916|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3963966|NCT01310582|3785917|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3963967|NCT01310582|3785915|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3963968|NCT01310582|3785916|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3963969|NCT01310582|3785917|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3963970|NCT01310413|3785926|B7||Male|Sex: Female, Male||Participants|Count of Participants|437|437.0||||||
3963971|NCT01310413|3785927|B6||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3963972|NCT01310413|3785928|B5||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3963973|NCT01310413|3785929|B4||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3963974|NCT01310413|3785930|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3963975|NCT01310413|3785931|B2||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3963976|NCT01310413|3785932|B1||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3963977|NCT01310413|3785926|B7||Female|Sex: Female, Male||Participants|Count of Participants|401|401.0||||||
3963978|NCT01310413|3785927|B6||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3963979|NCT01310413|3785928|B5||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3963980|NCT01310413|3785929|B4||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3963981|NCT01310413|3785930|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3963982|NCT01310413|3785931|B2||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3963983|NCT01310413|3785932|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3963984|NCT01310413|3785926|B7|||Age||Months|Mean|84.9|84.9|Standard Deviation|61.40|61.4|||
3963985|NCT01310413|3785927|B6|||Age||Months|Mean|156.0|156.0|Standard Deviation|31.29|31.29|||
3963986|NCT01310413|3785928|B5|||Age||Months|Mean|65.2|65.2|Standard Deviation|20.2|20.2|||
3963987|NCT01310413|3785929|B4|||Age||Months|Mean|22.6|22.6|Standard Deviation|8.17|8.17|||
3963988|NCT01310413|3785930|B3|||Age||Months|Mean|160.8|160.8|Standard Deviation|28.21|28.21|||
3963989|NCT01310413|3785931|B2|||Age||Months|Mean|70.5|70.5|Standard Deviation|21.71|21.71|||
3963990|NCT01310413|3785932|B1|||Age||Months|Mean|21.7|21.7|Standard Deviation|8.17|8.17|||
3963991|NCT01310400|3786091|B4|China||Region of Enrollment||participants|Number|1354|1354.0||||||
3963992|NCT01310400|3786092|B3|China||Region of Enrollment||participants|Number|451|451.0||||||
3963993|NCT01310400|3786093|B2|China||Region of Enrollment||participants|Number|451|451.0||||||
3963994|NCT01310400|3786094|B1|China||Region of Enrollment||participants|Number|452|452.0||||||
3963995|NCT01310400|3786091|B4||Male|Sex: Female, Male||Participants|Count of Participants|706|706.0||||||
3963996|NCT01310400|3786092|B3||Male|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
3963997|NCT01310400|3786093|B2||Male|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
3963998|NCT01310400|3786094|B1||Male|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
3963999|NCT01310400|3786091|B4||Female|Sex: Female, Male||Participants|Count of Participants|648|648.0||||||
3964000|NCT01310400|3786092|B3||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
3964001|NCT01310400|3786093|B2||Female|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
3964002|NCT01310400|3786094|B1||Female|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
3964003|NCT01310400|3786091|B4|||Age||years|Mean|1.8|1.8|Standard Deviation|0.7|0.7|||
3964004|NCT01310400|3786092|B3|||Age||years|Mean|1.8|1.8|Standard Deviation|0.7|0.7|||
3964005|NCT01310400|3786093|B2|||Age||years|Mean|1.8|1.8|Standard Deviation|0.7|0.7|||
3964006|NCT01310400|3786094|B1|||Age||years|Mean|1.8|1.8|Standard Deviation|0.7|0.7|||
3964007|NCT01310400|3786091|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3964008|NCT01310400|3786092|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3964009|NCT01310400|3786093|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3964010|NCT01310400|3786094|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3964011|NCT01310400|3786091|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3964012|NCT01310400|3786092|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3964013|NCT01310400|3786093|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3964014|NCT01310400|3786094|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3964015|NCT01310400|3786091|B4||<=18 years|Age||Participants|Count of Participants|1354|1354.0||||||
3964016|NCT01310400|3786092|B3||<=18 years|Age||Participants|Count of Participants|451|451.0||||||
3964017|NCT01310400|3786093|B2||<=18 years|Age||Participants|Count of Participants|451|451.0||||||
3964018|NCT01310400|3786094|B1||<=18 years|Age||Participants|Count of Participants|452|452.0||||||
3964019|NCT01310179|3786113|B1|Not Present||Non-Target Lesions|presence or absence of additional cancerous lesions that were not treated with the study drug|participants|Number|5|5.0||||||
3964020|NCT01310179|3786113|B1|Present||Non-Target Lesions|presence or absence of additional cancerous lesions that were not treated with the study drug|participants|Number|7|7.0||||||
3964021|NCT01310179|3786113|B1|Distant||Recurrence||participants|Number|1|1.0||||||
3964022|NCT01310179|3786113|B1|Regional||Recurrence||participants|Number|4|4.0||||||
3964023|NCT01310179|3786113|B1|Local||Recurrence||participants|Number|7|7.0||||||
3964024|NCT01310179|3786113|B1|melanoma||Tumor Histology||participants|Number|2|2.0||||||
3964025|NCT01310179|3786113|B1|adenoid cycstic carcinoma||Tumor Histology||participants|Number|2|2.0||||||
3964026|NCT01310179|3786113|B1|squamous cell carcinoma||Tumor Histology||participants|Number|8|8.0||||||
3964027|NCT01310179|3786113|B1|Lower Extremities||Tumor Site|location of primary tumor|participants|Number|1|1.0||||||
3964028|NCT01310179|3786113|B1|Scalp||Tumor Site|location of primary tumor|participants|Number|1|1.0||||||
3964029|NCT01310179|3786113|B1|Lower Lip||Tumor Site|location of primary tumor|participants|Number|1|1.0||||||
3964030|NCT01310179|3786113|B1|Tonsil||Tumor Site|location of primary tumor|participants|Number|1|1.0||||||
3964031|NCT01310179|3786113|B1|Hard Palate||Tumor Site|location of primary tumor|participants|Number|1|1.0||||||
3964032|NCT01310179|3786113|B1|Cheek||Tumor Site|location of primary tumor|participants|Number|1|1.0||||||
3964033|NCT01310179|3786113|B1|Neck||Tumor Site|location of primary tumor|participants|Number|6|6.0||||||
3964034|NCT01310179|3786113|B1|70%||Karnofsky Performance Status Score|"The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a patient's ability to survive chemotherapy for cancer.~100 - Normal; no complaints; no evidence of disease.~90 - Able to carry on normal activity; minor signs or symptoms of disease.~80 - Normal activity with effort; some signs or symptoms of disease.~70 - Cares for self; unable to carry on normal activity or to do active work."|participants|Number|4|4.0||||||
3964035|NCT01310179|3786113|B1|80%||Karnofsky Performance Status Score|"The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a patient's ability to survive chemotherapy for cancer.~100 - Normal; no complaints; no evidence of disease.~90 - Able to carry on normal activity; minor signs or symptoms of disease.~80 - Normal activity with effort; some signs or symptoms of disease.~70 - Cares for self; unable to carry on normal activity or to do active work."|participants|Number|3|3.0||||||
3964089|NCT01309997|3786144|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964090|NCT01309997|3786145|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964036|NCT01310179|3786113|B1|90%||Karnofsky Performance Status Score|"The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a patient's ability to survive chemotherapy for cancer.~100 - Normal; no complaints; no evidence of disease.~90 - Able to carry on normal activity; minor signs or symptoms of disease.~80 - Normal activity with effort; some signs or symptoms of disease.~70 - Cares for self; unable to carry on normal activity or to do active work."|participants|Number|3|3.0||||||
3964037|NCT01310179|3786113|B1|100%||Karnofsky Performance Status Score|"The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a patient's ability to survive chemotherapy for cancer.~100 - Normal; no complaints; no evidence of disease.~90 - Able to carry on normal activity; minor signs or symptoms of disease.~80 - Normal activity with effort; some signs or symptoms of disease.~70 - Cares for self; unable to carry on normal activity or to do active work."|participants|Number|2|2.0||||||
3964038|NCT01310179|3786113|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964039|NCT01310179|3786113|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964040|NCT01310179|3786113|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3964041|NCT01310179|3786113|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3964042|NCT01310179|3786113|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964043|NCT01310179|3786113|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964044|NCT01310179|3786113|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964045|NCT01310179|3786113|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964046|NCT01310179|3786113|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3964047|NCT01310179|3786113|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964048|NCT01310179|3786113|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3964049|NCT01310179|3786113|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3964050|NCT01310179|3786113|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3964051|NCT01310179|3786113|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3964052|NCT01310179|3786113|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964053|NCT01310127|3786118|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
3964054|NCT01310127|3786119|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3964055|NCT01310127|3786120|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3964056|NCT01310127|3786118|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3964057|NCT01310127|3786119|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3964058|NCT01310127|3786120|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3964059|NCT01310127|3786118|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3964060|NCT01310127|3786119|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3964061|NCT01310127|3786120|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3964062|NCT01310127|3786118|B3|||Age||years|Mean|69.9|69.9|Standard Deviation|9.5|9.5|||
3964063|NCT01310127|3786119|B2|||Age||years|Mean|69.7|69.7|Standard Deviation|9.0|9.0|||
3964064|NCT01310127|3786120|B1|||Age||years|Mean|70.1|70.1|Standard Deviation|10.5|10.5|||
3964065|NCT01310127|3786118|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3964066|NCT01310127|3786119|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3964067|NCT01310127|3786120|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3964068|NCT01310127|3786118|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3964069|NCT01310127|3786119|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3964070|NCT01310127|3786120|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3964071|NCT01310127|3786118|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964072|NCT01310127|3786119|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964073|NCT01310127|3786120|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964074|NCT01310036|3786133|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3964075|NCT01310036|3786133|B1||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3964076|NCT01310036|3786133|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|11.56|11.56|||
3964077|NCT01309997|3786144|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3964078|NCT01309997|3786145|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3964079|NCT01309997|3786146|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3964080|NCT01309997|3786144|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3964081|NCT01309997|3786145|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3964082|NCT01309997|3786146|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3964083|NCT01309997|3786144|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3964084|NCT01309997|3786145|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3964085|NCT01309997|3786146|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3964086|NCT01309997|3786144|B3||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
3964087|NCT01309997|3786145|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3964088|NCT01309997|3786146|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3964091|NCT01309997|3786146|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964092|NCT01309919|3786169|B3|||Body Mass Index||kg/m^2|Mean|32|32.0|Standard Deviation|7|7.0|||
3964093|NCT01309919|3786170|B2|||Body Mass Index||kg/m^2|Mean|31.6|31.6|Standard Deviation|7|7.0|||
3964094|NCT01309919|3786171|B1|||Body Mass Index||kg/m^2|Mean|32.4|32.4|Standard Deviation|7|7.0|||
3964095|NCT01309919|3786169|B3|Other||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3964096|NCT01309919|3786170|B2|Other||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3964097|NCT01309919|3786171|B1|Other||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3964098|NCT01309919|3786169|B3|Black||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3964099|NCT01309919|3786170|B2|Black||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3964100|NCT01309919|3786171|B1|Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3964101|NCT01309919|3786169|B3|White||Race/Ethnicity, Customized||participants|Number|102|102.0||||||
3964102|NCT01309919|3786170|B2|White||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
3964103|NCT01309919|3786171|B1|White||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
3964104|NCT01309919|3786169|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3964105|NCT01309919|3786170|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964106|NCT01309919|3786171|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3964107|NCT01309919|3786169|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3964108|NCT01309919|3786170|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3964109|NCT01309919|3786171|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3964110|NCT01309919|3786169|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3964111|NCT01309919|3786170|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3964112|NCT01309919|3786171|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3964113|NCT01309919|3786169|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3964114|NCT01309919|3786170|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3964115|NCT01309919|3786171|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3964116|NCT01309919|3786169|B3||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3964117|NCT01309919|3786170|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3964118|NCT01309919|3786171|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3964119|NCT01309919|3786169|B3|||Age||years|Mean|24.5|24.5|Standard Deviation|5|5.0|||
3964120|NCT01309919|3786170|B2|||Age||years|Mean|24|24.0|Standard Deviation|5|5.0|||
3964121|NCT01309919|3786171|B1|||Age||years|Mean|25|25.0|Standard Deviation|5|5.0|||
3964122|NCT01309893|3786184|B1|United States||Region of Enrollment||participants|Number|66|66.0||||||
3964123|NCT01309893|3786184|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3964124|NCT01309893|3786184|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3964125|NCT01309893|3786184|B1|||Age||years|Mean|29.6|29.6|Standard Deviation|9.4|9.4|||
3964126|NCT01309880|3786195|B1|United States||Region of Enrollment||participants|Number|66|66.0||||||
3964127|NCT01309880|3786195|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3964128|NCT01309880|3786195|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3964129|NCT01309880|3786195|B1|||Age||years|Mean|36.2|36.2|Standard Deviation|9.6|9.6|||
3964130|NCT01309841|3786206|B4|Laxative Unknown Response (LUR)||Baseline laxative response status|Laxative response status was determined at the screening visit (Visit 1) based on the Baseline Laxative Response Status Questionnaire. Patients were classified as: Laxative Inadequate Responder (LIR: patients who reported moderate, severe, or very severe symptoms in at least 1 of the 4 stool symptom domains); Laxative Adequate Responder (LAR: patients who reported no symptoms or only mild symptoms); and Laxative Unknown Responder (LUR: patients who had not taken laxatives over the previous 2 weeks or who had taken 1 or more laxative classes on <4 days over the previous 2 weeks).|Participants|Number|284|284.0||||||
3964131|NCT01309841|3786207|B3|Laxative Unknown Response (LUR)||Baseline laxative response status|Laxative response status was determined at the screening visit (Visit 1) based on the Baseline Laxative Response Status Questionnaire. Patients were classified as: Laxative Inadequate Responder (LIR: patients who reported moderate, severe, or very severe symptoms in at least 1 of the 4 stool symptom domains); Laxative Adequate Responder (LAR: patients who reported no symptoms or only mild symptoms); and Laxative Unknown Responder (LUR: patients who had not taken laxatives over the previous 2 weeks or who had taken 1 or more laxative classes on <4 days over the previous 2 weeks).|Participants|Number|94|94.0||||||
3964132|NCT01309841|3786208|B2|Laxative Unknown Response (LUR)||Baseline laxative response status|Laxative response status was determined at the screening visit (Visit 1) based on the Baseline Laxative Response Status Questionnaire. Patients were classified as: Laxative Inadequate Responder (LIR: patients who reported moderate, severe, or very severe symptoms in at least 1 of the 4 stool symptom domains); Laxative Adequate Responder (LAR: patients who reported no symptoms or only mild symptoms); and Laxative Unknown Responder (LUR: patients who had not taken laxatives over the previous 2 weeks or who had taken 1 or more laxative classes on <4 days over the previous 2 weeks).|Participants|Number|95|95.0||||||
3964152|NCT01309841|3786208|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|38|38.0||||||
3964153|NCT01309841|3786209|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|42|42.0||||||
3964154|NCT01309841|3786206|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3964155|NCT01309841|3786207|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3964133|NCT01309841|3786209|B1|Laxative Unknown Response (LUR)||Baseline laxative response status|Laxative response status was determined at the screening visit (Visit 1) based on the Baseline Laxative Response Status Questionnaire. Patients were classified as: Laxative Inadequate Responder (LIR: patients who reported moderate, severe, or very severe symptoms in at least 1 of the 4 stool symptom domains); Laxative Adequate Responder (LAR: patients who reported no symptoms or only mild symptoms); and Laxative Unknown Responder (LUR: patients who had not taken laxatives over the previous 2 weeks or who had taken 1 or more laxative classes on <4 days over the previous 2 weeks).|Participants|Number|95|95.0||||||
3964134|NCT01309841|3786206|B4|Laxative Adequate Response (LAR)||Baseline laxative response status|Laxative response status was determined at the screening visit (Visit 1) based on the Baseline Laxative Response Status Questionnaire. Patients were classified as: Laxative Inadequate Responder (LIR: patients who reported moderate, severe, or very severe symptoms in at least 1 of the 4 stool symptom domains); Laxative Adequate Responder (LAR: patients who reported no symptoms or only mild symptoms); and Laxative Unknown Responder (LUR: patients who had not taken laxatives over the previous 2 weeks or who had taken 1 or more laxative classes on <4 days over the previous 2 weeks).|Participants|Number|7|7.0||||||
3964135|NCT01309841|3786207|B3|Laxative Adequate Response (LAR)||Baseline laxative response status|Laxative response status was determined at the screening visit (Visit 1) based on the Baseline Laxative Response Status Questionnaire. Patients were classified as: Laxative Inadequate Responder (LIR: patients who reported moderate, severe, or very severe symptoms in at least 1 of the 4 stool symptom domains); Laxative Adequate Responder (LAR: patients who reported no symptoms or only mild symptoms); and Laxative Unknown Responder (LUR: patients who had not taken laxatives over the previous 2 weeks or who had taken 1 or more laxative classes on <4 days over the previous 2 weeks).|Participants|Number|2|2.0||||||
3964136|NCT01309841|3786208|B2|Laxative Adequate Response (LAR)||Baseline laxative response status|Laxative response status was determined at the screening visit (Visit 1) based on the Baseline Laxative Response Status Questionnaire. Patients were classified as: Laxative Inadequate Responder (LIR: patients who reported moderate, severe, or very severe symptoms in at least 1 of the 4 stool symptom domains); Laxative Adequate Responder (LAR: patients who reported no symptoms or only mild symptoms); and Laxative Unknown Responder (LUR: patients who had not taken laxatives over the previous 2 weeks or who had taken 1 or more laxative classes on <4 days over the previous 2 weeks).|Participants|Number|2|2.0||||||
3964137|NCT01309841|3786209|B1|Laxative Adequate Response (LAR)||Baseline laxative response status|Laxative response status was determined at the screening visit (Visit 1) based on the Baseline Laxative Response Status Questionnaire. Patients were classified as: Laxative Inadequate Responder (LIR: patients who reported moderate, severe, or very severe symptoms in at least 1 of the 4 stool symptom domains); Laxative Adequate Responder (LAR: patients who reported no symptoms or only mild symptoms); and Laxative Unknown Responder (LUR: patients who had not taken laxatives over the previous 2 weeks or who had taken 1 or more laxative classes on <4 days over the previous 2 weeks).|Participants|Number|3|3.0||||||
3964138|NCT01309841|3786206|B4|Laxative Inadequate Response (LIR)||Baseline laxative response status|Laxative response status was determined at the screening visit (Visit 1) based on the Baseline Laxative Response Status Questionnaire. Patients were classified as: Laxative Inadequate Responder (LIR: patients who reported moderate, severe, or very severe symptoms in at least 1 of the 4 stool symptom domains); Laxative Adequate Responder (LAR: patients who reported no symptoms or only mild symptoms); and Laxative Unknown Responder (LUR: patients who had not taken laxatives over the previous 2 weeks or who had taken 1 or more laxative classes on <4 days over the previous 2 weeks).|Participants|Number|350|350.0||||||
3964139|NCT01309841|3786207|B3|Laxative Inadequate Response (LIR)||Baseline laxative response status|Laxative response status was determined at the screening visit (Visit 1) based on the Baseline Laxative Response Status Questionnaire. Patients were classified as: Laxative Inadequate Responder (LIR: patients who reported moderate, severe, or very severe symptoms in at least 1 of the 4 stool symptom domains); Laxative Adequate Responder (LAR: patients who reported no symptoms or only mild symptoms); and Laxative Unknown Responder (LUR: patients who had not taken laxatives over the previous 2 weeks or who had taken 1 or more laxative classes on <4 days over the previous 2 weeks).|Participants|Number|118|118.0||||||
3964140|NCT01309841|3786208|B2|Laxative Inadequate Response (LIR)||Baseline laxative response status|Laxative response status was determined at the screening visit (Visit 1) based on the Baseline Laxative Response Status Questionnaire. Patients were classified as: Laxative Inadequate Responder (LIR: patients who reported moderate, severe, or very severe symptoms in at least 1 of the 4 stool symptom domains); Laxative Adequate Responder (LAR: patients who reported no symptoms or only mild symptoms); and Laxative Unknown Responder (LUR: patients who had not taken laxatives over the previous 2 weeks or who had taken 1 or more laxative classes on <4 days over the previous 2 weeks).|Participants|Number|117|117.0||||||
3964141|NCT01309841|3786209|B1|Laxative Inadequate Response (LIR)||Baseline laxative response status|Laxative response status was determined at the screening visit (Visit 1) based on the Baseline Laxative Response Status Questionnaire. Patients were classified as: Laxative Inadequate Responder (LIR: patients who reported moderate, severe, or very severe symptoms in at least 1 of the 4 stool symptom domains); Laxative Adequate Responder (LAR: patients who reported no symptoms or only mild symptoms); and Laxative Unknown Responder (LUR: patients who had not taken laxatives over the previous 2 weeks or who had taken 1 or more laxative classes on <4 days over the previous 2 weeks).|Participants|Number|115|115.0||||||
3964142|NCT01309841|3786206|B4|Other||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3964143|NCT01309841|3786207|B3|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3964144|NCT01309841|3786208|B2|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3964145|NCT01309841|3786209|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3964146|NCT01309841|3786206|B4|White||Race/Ethnicity, Customized||Participants|Number|497|497.0||||||
3964147|NCT01309841|3786207|B3|White||Race/Ethnicity, Customized||Participants|Number|160|160.0||||||
3964148|NCT01309841|3786208|B2|White||Race/Ethnicity, Customized||Participants|Number|173|173.0||||||
3964149|NCT01309841|3786209|B1|White||Race/Ethnicity, Customized||Participants|Number|164|164.0||||||
3964150|NCT01309841|3786206|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|124|124.0||||||
3964151|NCT01309841|3786207|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|44|44.0||||||
3964156|NCT01309841|3786208|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3964157|NCT01309841|3786209|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3964158|NCT01309841|3786206|B4|Asian||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
3964159|NCT01309841|3786207|B3|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3964160|NCT01309841|3786208|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3964161|NCT01309841|3786209|B1|Asian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3964162|NCT01309841|3786206|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3964163|NCT01309841|3786207|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3964164|NCT01309841|3786208|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3964165|NCT01309841|3786209|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3964166|NCT01309841|3786206|B4||Male|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
3964167|NCT01309841|3786207|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3964168|NCT01309841|3786208|B2||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3964169|NCT01309841|3786209|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3964170|NCT01309841|3786206|B4||Female|Sex: Female, Male||Participants|Count of Participants|393|393.0||||||
3964171|NCT01309841|3786207|B3||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3964172|NCT01309841|3786208|B2||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3964173|NCT01309841|3786209|B1||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3964174|NCT01309841|3786206|B4|||Age||Years|Mean|52.3|52.3|Standard Deviation|10.23|10.23|||
3964175|NCT01309841|3786207|B3|||Age||Years|Mean|52.9|52.9|Standard Deviation|9.99|9.99|||
3964176|NCT01309841|3786208|B2|||Age||Years|Mean|52.2|52.2|Standard Deviation|10.29|10.29|||
3964177|NCT01309841|3786209|B1|||Age||Years|Mean|51.9|51.9|Standard Deviation|10.43|10.43|||
3964178|NCT01309828|3786249|B3|≥90 mm Hg||Diastolic blood pressure categories||participants|Number|51|51.0||||||
3964179|NCT01309828|3786250|B2|≥90 mm Hg||Diastolic blood pressure categories||participants|Number|26|26.0||||||
3964180|NCT01309828|3786251|B1|≥90 mm Hg||Diastolic blood pressure categories||participants|Number|25|25.0||||||
3964181|NCT01309828|3786249|B3|<90 mm Hg||Diastolic blood pressure categories||participants|Number|102|102.0||||||
3964182|NCT01309828|3786250|B2|<90 mm Hg||Diastolic blood pressure categories||participants|Number|50|50.0||||||
3964183|NCT01309828|3786251|B1|<90 mm Hg||Diastolic blood pressure categories||participants|Number|52|52.0||||||
3964184|NCT01309828|3786249|B3|≥180 mm Hg||Systolic blood pressure categories||participants|Number|1|1.0||||||
3964185|NCT01309828|3786250|B2|≥180 mm Hg||Systolic blood pressure categories||participants|Number|0|0.0||||||
3964186|NCT01309828|3786251|B1|≥180 mm Hg||Systolic blood pressure categories||participants|Number|1|1.0||||||
3964187|NCT01309828|3786249|B3|≥160 to <180 mm Hg||Systolic blood pressure categories||participants|Number|7|7.0||||||
3964188|NCT01309828|3786250|B2|≥160 to <180 mm Hg||Systolic blood pressure categories||participants|Number|2|2.0||||||
3964189|NCT01309828|3786251|B1|≥160 to <180 mm Hg||Systolic blood pressure categories||participants|Number|5|5.0||||||
3964190|NCT01309828|3786249|B3|≥140 to <160 mm Hg||Systolic blood pressure categories||participants|Number|124|124.0||||||
3964191|NCT01309828|3786250|B2|≥140 to <160 mm Hg||Systolic blood pressure categories||participants|Number|64|64.0||||||
3964192|NCT01309828|3786251|B1|≥140 to <160 mm Hg||Systolic blood pressure categories||participants|Number|60|60.0||||||
3964193|NCT01309828|3786249|B3|<140 mm Hg||Systolic blood pressure categories||participants|Number|21|21.0||||||
3964194|NCT01309828|3786250|B2|<140 mm Hg||Systolic blood pressure categories||participants|Number|10|10.0||||||
3964195|NCT01309828|3786251|B1|<140 mm Hg||Systolic blood pressure categories||participants|Number|11|11.0||||||
3964196|NCT01309828|3786249|B3|||Diastolic blood pressure||mm Hg|Mean|84.7|84.7|Standard Deviation|9.97|9.97|||
3964197|NCT01309828|3786250|B2|||Diastolic blood pressure||mm Hg|Mean|84.7|84.7|Standard Deviation|9.68|9.68|||
3964198|NCT01309828|3786251|B1|||Diastolic blood pressure||mm Hg|Mean|84.8|84.8|Standard Deviation|10.31|10.31|||
3964199|NCT01309828|3786249|B3|||Systolic blood pressure||mm Hg|Mean|150.1|150.1|Standard Deviation|9.18|9.18|||
3964200|NCT01309828|3786250|B2|||Systolic blood pressure||mm Hg|Mean|149.0|149.0|Standard Deviation|7.80|7.8|||
3964201|NCT01309828|3786251|B1|||Systolic blood pressure||mm Hg|Mean|151.1|151.1|Standard Deviation|10.30|10.3|||
3964202|NCT01309828|3786249|B3|≥60 mL/min/1.73 m^2||Baseline estimated glomerular filtration rate (eGFR) category||participants|Number|10|10.0||||||
3964203|NCT01309828|3786250|B2|≥60 mL/min/1.73 m^2||Baseline estimated glomerular filtration rate (eGFR) category||participants|Number|4|4.0||||||
3964204|NCT01309828|3786251|B1|≥60 mL/min/1.73 m^2||Baseline estimated glomerular filtration rate (eGFR) category||participants|Number|6|6.0||||||
3964205|NCT01309828|3786249|B3|≥30 and <45 mL/min/1.73 m^2||Baseline estimated glomerular filtration rate (eGFR) category||participants|Number|64|64.0||||||
3964206|NCT01309828|3786250|B2|≥30 and <45 mL/min/1.73 m^2||Baseline estimated glomerular filtration rate (eGFR) category||participants|Number|33|33.0||||||
3964207|NCT01309828|3786251|B1|≥30 and <45 mL/min/1.73 m^2||Baseline estimated glomerular filtration rate (eGFR) category||participants|Number|31|31.0||||||
3964208|NCT01309828|3786249|B3|≥45 and <60 mL/min/1.73 m^2||Baseline estimated glomerular filtration rate (eGFR) category||participants|Number|79|79.0||||||
3964209|NCT01309828|3786250|B2|≥45 and <60 mL/min/1.73 m^2||Baseline estimated glomerular filtration rate (eGFR) category||participants|Number|39|39.0||||||
3964210|NCT01309828|3786251|B1|≥45 and <60 mL/min/1.73 m^2||Baseline estimated glomerular filtration rate (eGFR) category||participants|Number|40|40.0||||||
3964211|NCT01309828|3786249|B3|||Estimated glomerular filtration rate (eGFR)||mL/min/1.73 m^2|Mean|47.99|47.99|Standard Deviation|9.487|9.487|||
3964212|NCT01309828|3786250|B2|||Estimated glomerular filtration rate (eGFR)||mL/min/1.73 m^2|Mean|47.73|47.73|Standard Deviation|8.761|8.761|||
3964213|NCT01309828|3786251|B1|||Estimated glomerular filtration rate (eGFR)||mL/min/1.73 m^2|Mean|48.25|48.25|Standard Deviation|10.205|10.205|||
3964214|NCT01309828|3786249|B3|No||Diabetes Status||participants|Number|88|88.0||||||
3964215|NCT01309828|3786250|B2|No||Diabetes Status||participants|Number|44|44.0||||||
3964216|NCT01309828|3786251|B1|No||Diabetes Status||participants|Number|44|44.0||||||
3964217|NCT01309828|3786249|B3|Yes||Diabetes Status||participants|Number|65|65.0||||||
3964218|NCT01309828|3786250|B2|Yes||Diabetes Status||participants|Number|32|32.0||||||
3964219|NCT01309828|3786251|B1|Yes||Diabetes Status||participants|Number|33|33.0||||||
3964220|NCT01309828|3786249|B3|Ex-smoker||Smoking Classification||participants|Number|45|45.0||||||
3964221|NCT01309828|3786250|B2|Ex-smoker||Smoking Classification||participants|Number|25|25.0||||||
3964222|NCT01309828|3786251|B1|Ex-smoker||Smoking Classification||participants|Number|20|20.0||||||
3964223|NCT01309828|3786249|B3|Current Smoker||Smoking Classification||participants|Number|22|22.0||||||
3964224|NCT01309828|3786250|B2|Current Smoker||Smoking Classification||participants|Number|11|11.0||||||
3964225|NCT01309828|3786251|B1|Current Smoker||Smoking Classification||participants|Number|11|11.0||||||
3964226|NCT01309828|3786249|B3|Never Smoked||Smoking Classification||participants|Number|86|86.0||||||
3964227|NCT01309828|3786250|B2|Never Smoked||Smoking Classification||participants|Number|40|40.0||||||
3964228|NCT01309828|3786251|B1|Never Smoked||Smoking Classification||participants|Number|46|46.0||||||
3964229|NCT01309828|3786249|B3|||Body Mass Index (BMI)||kg/m^2|Mean|31.00|31.0|Standard Deviation|6.380|6.38|||
3964230|NCT01309828|3786250|B2|||Body Mass Index (BMI)||kg/m^2|Mean|31.57|31.57|Standard Deviation|6.524|6.524|||
3964231|NCT01309828|3786251|B1|||Body Mass Index (BMI)||kg/m^2|Mean|30.44|30.44|Standard Deviation|6.226|6.226|||
3964232|NCT01309828|3786249|B3|||Height||cm|Mean|167.2|167.2|Standard Deviation|9.65|9.65|||
3964233|NCT01309828|3786250|B2|||Height||cm|Mean|168.7|168.7|Standard Deviation|9.48|9.48|||
3964234|NCT01309828|3786251|B1|||Height||cm|Mean|165.7|165.7|Standard Deviation|9.65|9.65|||
3964235|NCT01309828|3786249|B3|||Weight||kg|Mean|86.82|86.82|Standard Deviation|20.025|20.025|||
3964236|NCT01309828|3786250|B2|||Weight||kg|Mean|90.14|90.14|Standard Deviation|21.587|21.587|||
3964237|NCT01309828|3786251|B1|||Weight||kg|Mean|83.54|83.54|Standard Deviation|17.894|17.894|||
3964238|NCT01309828|3786249|B3|United States||Region of Enrollment||participants|Number|76|76.0||||||
3964239|NCT01309828|3786250|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
3964240|NCT01309828|3786251|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
3964241|NCT01309828|3786249|B3|Ukraine||Region of Enrollment||participants|Number|17|17.0||||||
3964242|NCT01309828|3786250|B2|Ukraine||Region of Enrollment||participants|Number|11|11.0||||||
3964243|NCT01309828|3786251|B1|Ukraine||Region of Enrollment||participants|Number|6|6.0||||||
3964244|NCT01309828|3786249|B3|Slovakia||Region of Enrollment||participants|Number|12|12.0||||||
3964245|NCT01309828|3786250|B2|Slovakia||Region of Enrollment||participants|Number|6|6.0||||||
3964246|NCT01309828|3786251|B1|Slovakia||Region of Enrollment||participants|Number|6|6.0||||||
3964247|NCT01309828|3786249|B3|Poland||Region of Enrollment||participants|Number|13|13.0||||||
3964248|NCT01309828|3786250|B2|Poland||Region of Enrollment||participants|Number|6|6.0||||||
3964249|NCT01309828|3786251|B1|Poland||Region of Enrollment||participants|Number|7|7.0||||||
3964250|NCT01309828|3786249|B3|Lithuania||Region of Enrollment||participants|Number|7|7.0||||||
3964251|NCT01309828|3786250|B2|Lithuania||Region of Enrollment||participants|Number|2|2.0||||||
3964252|NCT01309828|3786251|B1|Lithuania||Region of Enrollment||participants|Number|5|5.0||||||
3964253|NCT01309828|3786249|B3|Latvia||Region of Enrollment||participants|Number|9|9.0||||||
3964254|NCT01309828|3786250|B2|Latvia||Region of Enrollment||participants|Number|5|5.0||||||
3964255|NCT01309828|3786251|B1|Latvia||Region of Enrollment||participants|Number|4|4.0||||||
3964256|NCT01309828|3786249|B3|Germany||Region of Enrollment||participants|Number|19|19.0||||||
3964257|NCT01309828|3786250|B2|Germany||Region of Enrollment||participants|Number|9|9.0||||||
3964258|NCT01309828|3786251|B1|Germany||Region of Enrollment||participants|Number|10|10.0||||||
3964259|NCT01309828|3786249|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3964260|NCT01309828|3786250|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3964261|NCT01309828|3786251|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3964262|NCT01309828|3786249|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3964263|NCT01309828|3786250|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3964264|NCT01309828|3786251|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3964265|NCT01309828|3786249|B3|White||Race/Ethnicity, Customized||participants|Number|119|119.0||||||
3964266|NCT01309828|3786250|B2|White||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
3964267|NCT01309828|3786251|B1|White||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
3964268|NCT01309828|3786249|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3964269|NCT01309828|3786250|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3964270|NCT01309828|3786251|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3964271|NCT01309828|3786249|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3964272|NCT01309828|3786250|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3964273|NCT01309828|3786251|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3964274|NCT01309828|3786249|B3|≥75 years||Age, Customized||participants|Number|36|36.0||||||
3964275|NCT01309828|3786250|B2|≥75 years||Age, Customized||participants|Number|18|18.0||||||
3964276|NCT01309828|3786251|B1|≥75 years||Age, Customized||participants|Number|18|18.0||||||
3964277|NCT01309828|3786249|B3|≥65 to <75 years||Age, Customized||participants|Number|77|77.0||||||
3964278|NCT01309828|3786250|B2|≥65 to <75 years||Age, Customized||participants|Number|39|39.0||||||
3964279|NCT01309828|3786251|B1|≥65 to <75 years||Age, Customized||participants|Number|38|38.0||||||
3964280|NCT01309828|3786249|B3|≥45 to <65 years||Age, Customized||participants|Number|39|39.0||||||
3964281|NCT01309828|3786250|B2|≥45 to <65 years||Age, Customized||participants|Number|18|18.0||||||
3964282|NCT01309828|3786251|B1|≥45 to <65 years||Age, Customized||participants|Number|21|21.0||||||
3964283|NCT01309828|3786249|B3|<45 years||Age, Customized||participants|Number|1|1.0||||||
3964284|NCT01309828|3786250|B2|<45 years||Age, Customized||participants|Number|1|1.0||||||
3964285|NCT01309828|3786251|B1|<45 years||Age, Customized||participants|Number|0|0.0||||||
3964286|NCT01309828|3786249|B3|||Age||years|Mean|68.4|68.4|Standard Deviation|8.66|8.66|||
3964287|NCT01309828|3786250|B2|||Age||years|Mean|68.9|68.9|Standard Deviation|9.10|9.1|||
3964288|NCT01309828|3786251|B1|||Age||years|Mean|67.9|67.9|Standard Deviation|8.24|8.24|||
3964289|NCT01309802|3786264|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
3964290|NCT01309802|3786265|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
3964291|NCT01309802|3786266|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3964292|NCT01309802|3786264|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3964293|NCT01309802|3786265|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3964294|NCT01309802|3786266|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3964295|NCT01309802|3786264|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3964296|NCT01309802|3786265|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3964297|NCT01309802|3786266|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3964298|NCT01309802|3786264|B3|||Age||years|Mean|51.3|51.3|Full Range|||24.0|73.0|
3964299|NCT01309802|3786265|B2|||Age||years|Mean|49.2|49.2|Full Range|||26.0|70.0|
3964300|NCT01309802|3786266|B1|||Age||years|Mean|53.3|53.3|Full Range|||24.0|73.0|
3964301|NCT01309802|3786264|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3964302|NCT01309802|3786265|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3964303|NCT01309802|3786266|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3964304|NCT01309802|3786264|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3964305|NCT01309802|3786265|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3964306|NCT01309802|3786266|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3964307|NCT01309802|3786264|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964308|NCT01309802|3786265|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964309|NCT01309802|3786266|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964310|NCT01309737|3786283|B4||Male|Sex: Female, Male||Participants|Count of Participants|648|648.0||||||
3964311|NCT01309737|3786284|B3||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3964312|NCT01309737|3786285|B2||Male|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
3964313|NCT01309737|3786286|B1||Male|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
3964314|NCT01309737|3786283|B4||Female|Sex: Female, Male||Participants|Count of Participants|311|311.0||||||
3964315|NCT01309737|3786284|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3964316|NCT01309737|3786285|B2||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3964317|NCT01309737|3786286|B1||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3964318|NCT01309737|3786283|B4|||Age||years|Mean|45.0|45.0|Standard Deviation|12.9|12.9|||
3964319|NCT01309737|3786284|B3|||Age||years|Mean|44.8|44.8|Standard Deviation|12.6|12.6|||
3964320|NCT01309737|3786285|B2|||Age||years|Mean|44.3|44.3|Standard Deviation|13.0|13.0|||
3964321|NCT01309737|3786286|B1|||Age||years|Mean|45.9|45.9|Standard Deviation|12.9|12.9|||
3964322|NCT01309672|3786485|B1|Stable/falling level||PSA status at registration||Participants|Count of Participants|6|6.0||||||
3964323|NCT01309672|3786485|B1|Rising level||PSA status at registration||Participants|Count of Participants|34|34.0||||||
3964324|NCT01309672|3786485|B1|No||Antiandrogen use||Participants|Count of Participants|5|5.0||||||
3964325|NCT01309672|3786485|B1|Yes||Antiandrogen use||Participants|Count of Participants|35|35.0||||||
3964326|NCT01309672|3786485|B1|No||Prostatectomy||Participants|Count of Participants|35|35.0||||||
3964327|NCT01309672|3786485|B1|Yes||Prostatectomy||Participants|Count of Participants|5|5.0||||||
3964328|NCT01309672|3786485|B1|No||Prostate RT||Participants|Count of Participants|35|35.0||||||
3964329|NCT01309672|3786485|B1|Yes||Prostate RT||Participants|Count of Participants|5|5.0||||||
3964330|NCT01309672|3786485|B1|Visceral||Metastasis||Participants|Count of Participants|6|6.0||||||
3964331|NCT01309672|3786485|B1|Lymph node||Metastasis||Participants|Count of Participants|8|8.0||||||
3964332|NCT01309672|3786485|B1|Bone||Metastasis||Participants|Count of Participants|37|37.0||||||
3964370|NCT01309659|3786493|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964371|NCT01309659|3786494|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964372|NCT01309659|3786495|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964333|NCT01309672|3786485|B1|8-10||Gleason Score|"Pathologists grade prostate cancers using numbers from 1 to 5 based on how much the cells in the cancerous tissue look like normal tissue. This is called the Gleason system.~If the cancerous tissue looks like normal tissue, a grade of 1 is assigned. If the cancer cells look very abnormal, a grade of 5 is assigned. Grades 2-4 have features in between these extremes.~Since prostate cancers often have areas with different grades, a grade is assigned to the 2 areas that make up most of the cancer. These 2 grades are added to yield the Gleason score. The highest a Gleason score can be is 10."|Participants|Count of Participants|30|30.0||||||
3964334|NCT01309672|3786485|B1|7||Gleason Score|"Pathologists grade prostate cancers using numbers from 1 to 5 based on how much the cells in the cancerous tissue look like normal tissue. This is called the Gleason system.~If the cancerous tissue looks like normal tissue, a grade of 1 is assigned. If the cancer cells look very abnormal, a grade of 5 is assigned. Grades 2-4 have features in between these extremes.~Since prostate cancers often have areas with different grades, a grade is assigned to the 2 areas that make up most of the cancer. These 2 grades are added to yield the Gleason score. The highest a Gleason score can be is 10."|Participants|Count of Participants|7|7.0||||||
3964335|NCT01309672|3786485|B1|2-6||Gleason Score|"Pathologists grade prostate cancers using numbers from 1 to 5 based on how much the cells in the cancerous tissue look like normal tissue. This is called the Gleason system.~If the cancerous tissue looks like normal tissue, a grade of 1 is assigned. If the cancer cells look very abnormal, a grade of 5 is assigned. Grades 2-4 have features in between these extremes.~Since prostate cancers often have areas with different grades, a grade is assigned to the 2 areas that make up most of the cancer. These 2 grades are added to yield the Gleason score. The highest a Gleason score can be is 10."|Participants|Count of Participants|3|3.0||||||
3964336|NCT01309672|3786485|B1|2||Performance Status|"Zubrod Performance Status Scale:~0= Fully active, able to carry on all pre-disease performance without restriction.~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours.~Capable of limited self-care, confined to bed or chair more than 50% of waking hours.~Completely disabled; cannot carry on any self-care; totally confined to bed or chair."|Participants|Count of Participants|1|1.0||||||
3964337|NCT01309672|3786485|B1|0-1||Performance Status|"Zubrod Performance Status Scale:~0= Fully active, able to carry on all pre-disease performance without restriction.~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours.~Capable of limited self-care, confined to bed or chair more than 50% of waking hours.~Completely disabled; cannot carry on any self-care; totally confined to bed or chair."|Participants|Count of Participants|39|39.0||||||
3964338|NCT01309672|3786485|B1|||PSA at entry||ng/mL|Median|23.6|23.6|Inter-Quartile Range|||11.7|64.4|
3964339|NCT01309672|3786485|B1|||Testosterone||ng/dL|Median|12.8|12.8|Full Range|||3.0|50.0|
3964340|NCT01309672|3786485|B1|Ethnicity|Not Hispanic/unknown|Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3964341|NCT01309672|3786485|B1|Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3964342|NCT01309672|3786485|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964343|NCT01309672|3786485|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964344|NCT01309672|3786485|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3964345|NCT01309672|3786485|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3964346|NCT01309672|3786485|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964347|NCT01309672|3786485|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3964348|NCT01309672|3786485|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3964349|NCT01309672|3786485|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3964350|NCT01309672|3786485|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3964351|NCT01309672|3786485|B1|||Age||years|Median|66|66.0|Full Range|||39.0|85.0|
3964352|NCT01309659|3786493|B3|||hemoglobin||g/dl|Mean|11.25|11.25|Standard Deviation|.71|0.71|||
3964353|NCT01309659|3786494|B2|||hemoglobin||g/dl|Mean|11.3|11.3|Standard Deviation|.80|0.8|||
3964354|NCT01309659|3786495|B1|||hemoglobin||g/dl|Mean|11.19|11.19|Standard Deviation|0.64|0.64|||
3964355|NCT01309659|3786493|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
3964356|NCT01309659|3786494|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3964357|NCT01309659|3786495|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3964358|NCT01309659|3786493|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964359|NCT01309659|3786494|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964360|NCT01309659|3786495|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964361|NCT01309659|3786493|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3964362|NCT01309659|3786494|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3964363|NCT01309659|3786495|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3964364|NCT01309659|3786493|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3964365|NCT01309659|3786494|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3964366|NCT01309659|3786495|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964367|NCT01309659|3786493|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964368|NCT01309659|3786494|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964369|NCT01309659|3786495|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964373|NCT01309659|3786493|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3964374|NCT01309659|3786494|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3964375|NCT01309659|3786495|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3964376|NCT01309659|3786493|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3964377|NCT01309659|3786494|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3964378|NCT01309659|3786495|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3964379|NCT01309659|3786493|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964380|NCT01309659|3786494|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964381|NCT01309659|3786495|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964382|NCT01309659|3786493|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3964383|NCT01309659|3786494|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3964384|NCT01309659|3786495|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964385|NCT01309659|3786493|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964386|NCT01309659|3786494|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964387|NCT01309659|3786495|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964388|NCT01309659|3786493|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3964389|NCT01309659|3786494|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3964390|NCT01309659|3786495|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3964391|NCT01309659|3786493|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3964392|NCT01309659|3786494|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3964393|NCT01309659|3786495|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3964394|NCT01309659|3786493|B3||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3964395|NCT01309659|3786494|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3964396|NCT01309659|3786495|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3964397|NCT01309659|3786493|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3964398|NCT01309659|3786494|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3964399|NCT01309659|3786495|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3964400|NCT01309659|3786493|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964401|NCT01309659|3786494|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964402|NCT01309659|3786495|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964403|NCT01309646|3786536|B3|Not specified||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3964404|NCT01309646|3786537|B2|Not specified||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3964405|NCT01309646|3786538|B1|Not specified||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3964406|NCT01309646|3786536|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|450|450.0||||||
3964407|NCT01309646|3786537|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|226|226.0||||||
3964408|NCT01309646|3786538|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|224|224.0||||||
3964409|NCT01309646|3786536|B3||Male|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
3964410|NCT01309646|3786537|B2||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3964411|NCT01309646|3786538|B1||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3964412|NCT01309646|3786536|B3||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
3964413|NCT01309646|3786537|B2||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3964414|NCT01309646|3786538|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3964415|NCT01309646|3786536|B3|||Age||weeks|Mean|8.8|8.8|Standard Deviation|1.09|1.09|||
3964416|NCT01309646|3786537|B2|||Age||weeks|Mean|8.8|8.8|Standard Deviation|1.09|1.09|||
3964417|NCT01309646|3786538|B1|||Age||weeks|Mean|8.8|8.8|Standard Deviation|1.10|1.1|||
3964418|NCT01309581|3786577|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3964419|NCT01309581|3786578|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3964420|NCT01309581|3786579|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3964421|NCT01309581|3786577|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3964422|NCT01309581|3786578|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3964423|NCT01309581|3786579|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3964424|NCT01309581|3786577|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3964425|NCT01309581|3786578|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3964426|NCT01309581|3786579|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3964427|NCT01309581|3786577|B3|||Age||years|Mean|50|50.0|Standard Deviation|4.3|4.3|||
3964428|NCT01309581|3786578|B2|||Age||years|Mean|50|50.0|Standard Deviation|0|0.0|||
3964429|NCT01309581|3786579|B1|||Age||years|Mean|53|53.0|Standard Deviation|5.6|5.6|||
3964430|NCT01309451|3786588|B3|United States||Region of Enrollment|The sample size was 40 eyes (30 subjects, 10 subjects had both eyes in study)|eyes|Number|40|40.0||||||
3964431|NCT01309451|3786589|B2|United States||Region of Enrollment|The sample size was 40 eyes (30 subjects, 10 subjects had both eyes in study)|eyes|Number|21|21.0||||||
3964432|NCT01309451|3786590|B1|United States||Region of Enrollment|The sample size was 40 eyes (30 subjects, 10 subjects had both eyes in study)|eyes|Number|19|19.0||||||
3964433|NCT01309451|3786588|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3964434|NCT01309451|3786589|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3964435|NCT01309451|3786590|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3964436|NCT01309451|3786588|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3964437|NCT01309451|3786589|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3964438|NCT01309451|3786590|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3964439|NCT01309451|3786588|B3|||Age||years|Mean|60.5|60.5|Standard Deviation|10|10.0|||
3964440|NCT01309451|3786589|B2|||Age||years|Mean|59|59.0|Standard Deviation|12|12.0|||
3964441|NCT01309451|3786590|B1|||Age||years|Mean|62|62.0|Standard Deviation|9|9.0|||
3964442|NCT01309451|3786588|B3||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
3964443|NCT01309451|3786589|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3964444|NCT01309451|3786590|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3964445|NCT01309451|3786588|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3964446|NCT01309451|3786589|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3964447|NCT01309451|3786590|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3964448|NCT01309451|3786588|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964449|NCT01309451|3786589|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964450|NCT01309451|3786590|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964451|NCT01309386|3786599|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3964452|NCT01309386|3786600|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3964453|NCT01309386|3786601|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3964454|NCT01309386|3786599|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3964455|NCT01309386|3786600|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3964456|NCT01309386|3786601|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3964457|NCT01309386|3786599|B3|More than or equal to 65 years||Age, Customized||Participants|Number|52|52.0||||||
3964458|NCT01309386|3786600|B2|More than or equal to 65 years||Age, Customized||Participants|Number|25|25.0||||||
3964459|NCT01309386|3786601|B1|More than or equal to 65 years||Age, Customized||Participants|Number|27|27.0||||||
3964460|NCT01309386|3786599|B3|Less than 65 years||Age, Customized||Participants|Number|48|48.0||||||
3964461|NCT01309386|3786600|B2|Less than 65 years||Age, Customized||Participants|Number|25|25.0||9.97|9.97|||
3964462|NCT01309386|3786601|B1|Less than 65 years||Age, Customized||Participants|Number|23|23.0||8.5|8.5|||
3964463|NCT01309360|3786620|B4|||percentage of methemoglobin|Baseline levels of Met-Hb (percentage of methemoglobin) were measured using spectrophotometry prior to the anesthesia.|percentage of methemoglobin|Mean|0.87|0.87|Standard Deviation|0.16|0.16|||
3964464|NCT01309360|3786621|B3|||percentage of methemoglobin|Baseline levels of Met-Hb (percentage of methemoglobin) were measured using spectrophotometry prior to the anesthesia.|percentage of methemoglobin|Mean|0.86|0.86|Standard Deviation|0.17|0.17|||
3964465|NCT01309360|3786622|B2|||percentage of methemoglobin|Baseline levels of Met-Hb (percentage of methemoglobin) were measured using spectrophotometry prior to the anesthesia.|percentage of methemoglobin|Mean|0.9|0.9|Standard Deviation|0.16|0.16|||
3964466|NCT01309360|3786623|B1|||percentage of methemoglobin|Baseline levels of Met-Hb (percentage of methemoglobin) were measured using spectrophotometry prior to the anesthesia.|percentage of methemoglobin|Mean|0.84|0.84|Standard Deviation|0.15|0.15|||
3964467|NCT01309360|3786620|B4||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3964468|NCT01309360|3786621|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3964469|NCT01309360|3786622|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3964470|NCT01309360|3786623|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3964471|NCT01309360|3786620|B4||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3964472|NCT01309360|3786621|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3964473|NCT01309360|3786622|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3964474|NCT01309360|3786623|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3964475|NCT01309360|3786620|B4|||Age||years|Mean|47|47.0|Standard Deviation|15|15.0|||
3964476|NCT01309360|3786621|B3|||Age||years|Mean|45|45.0|Standard Deviation|16|16.0|||
3964477|NCT01309360|3786622|B2|||Age||years|Mean|47|47.0|Standard Deviation|16|16.0|||
3964478|NCT01309360|3786623|B1|||Age||years|Mean|50|50.0|Standard Deviation|14|14.0|||
3964479|NCT01309308|3786648|B3|Turkey||Region of Enrollment||participants|Number|150|150.0||||||
3964480|NCT01309308|3786649|B2|Turkey||Region of Enrollment||participants|Number|75|75.0||||||
3964481|NCT01309308|3786650|B1|Turkey||Region of Enrollment||participants|Number|75|75.0||||||
3964482|NCT01309308|3786648|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3964483|NCT01309308|3786649|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3964484|NCT01309308|3786650|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3964485|NCT01309308|3786648|B3||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3964486|NCT01309308|3786649|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3964487|NCT01309308|3786650|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3964488|NCT01309308|3786648|B3|||Age||years|Mean|27.69|27.69|Standard Deviation|4.92|4.92|||
3964489|NCT01309308|3786649|B2|||Age||years|Mean|28.11|28.11|Standard Deviation|4.78|4.78|||
3964490|NCT01309308|3786650|B1|||Age||years|Mean|27.25|27.25|Standard Deviation|5.06|5.06|||
3964491|NCT01309308|3786648|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3964492|NCT01309308|3786649|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3964493|NCT01309308|3786650|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3964494|NCT01309308|3786648|B3||Between 18 and 65 years|Age||Participants|Count of Participants|150|150.0||||||
3964495|NCT01309308|3786649|B2||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
3964496|NCT01309308|3786650|B1||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
3964497|NCT01309308|3786648|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964498|NCT01309308|3786649|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964499|NCT01309308|3786650|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964500|NCT01309282|3786659|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3964501|NCT01309282|3786659|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3964502|NCT01309282|3786659|B1|||Age||years|Mean|57.78|57.78|Standard Deviation|14.10|14.1|||
3964503|NCT01309269|3786676|B1||Male|Gender||Participants|Count of Participants|550|550.0||||||
3964504|NCT01309269|3786676|B1||Female|Gender||Participants|Count of Participants|428|428.0||||||
3964505|NCT01309269|3786676|B1|||Age||years|Mean|67.0|67.0|Standard Deviation|13.9|13.9|||
3964506|NCT01309243|3786682|B3|No||Use of lipid-lowering agent||participants|Number|781|781.0||||||
3964507|NCT01309243|3786683|B2|No||Use of lipid-lowering agent||participants|Number|391|391.0||||||
3964508|NCT01309243|3786684|B1|No||Use of lipid-lowering agent||participants|Number|390|390.0||||||
3964509|NCT01309243|3786682|B3|Yes||Use of lipid-lowering agent||participants|Number|5|5.0||||||
3964510|NCT01309243|3786683|B2|Yes||Use of lipid-lowering agent||participants|Number|1|1.0||||||
3964511|NCT01309243|3786684|B1|Yes||Use of lipid-lowering agent||participants|Number|4|4.0||||||
3964512|NCT01309243|3786682|B3|||Cluster of differentiation 4 (CD4) Cell Count||cells/μL|Mean|390.5|390.5|Standard Deviation|183.21|183.21|||
3964513|NCT01309243|3786683|B2|||Cluster of differentiation 4 (CD4) Cell Count||cells/μL|Mean|385.2|385.2|Standard Deviation|186.82|186.82|||
3964514|NCT01309243|3786684|B1|||Cluster of differentiation 4 (CD4) Cell Count||cells/μL|Mean|395.7|395.7|Standard Deviation|179.64|179.64|||
3964515|NCT01309243|3786682|B3|> 100,000 copies/mL||HIV-1 RNA Category||participants|Number|276|276.0||||||
3964516|NCT01309243|3786683|B2|> 100,000 copies/mL||HIV-1 RNA Category||participants|Number|142|142.0||||||
3964517|NCT01309243|3786684|B1|> 100,000 copies/mL||HIV-1 RNA Category||participants|Number|134|134.0||||||
3964518|NCT01309243|3786682|B3|≤ 100,000 copies/mL||HIV-1 RNA Category||participants|Number|510|510.0||||||
3964519|NCT01309243|3786683|B2|≤ 100,000 copies/mL||HIV-1 RNA Category||participants|Number|250|250.0||||||
3964520|NCT01309243|3786684|B1|≤ 100,000 copies/mL||HIV-1 RNA Category||participants|Number|260|260.0||||||
3964521|NCT01309243|3786682|B3|||HIV-1 RNA||log10 copies/mL|Mean|4.8|4.8|Standard Deviation|0.63|0.63|||
3964522|NCT01309243|3786683|B2|||HIV-1 RNA||log10 copies/mL|Mean|4.8|4.8|Standard Deviation|0.61|0.61|||
3964523|NCT01309243|3786684|B1|||HIV-1 RNA||log10 copies/mL|Mean|4.8|4.8|Standard Deviation|0.65|0.65|||
3964524|NCT01309243|3786682|B3|Austria||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment|participants|Number|13|13.0||||||
3964525|NCT01309243|3786683|B2|Austria||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment|participants|Number|6|6.0||||||
3964526|NCT01309243|3786684|B1|Austria||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment|participants|Number|7|7.0||||||
3964527|NCT01309243|3786682|B3|Switzerland||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment|participants|Number|5|5.0||||||
3964528|NCT01309243|3786683|B2|Switzerland||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment|participants|Number|3|3.0||||||
3964529|NCT01309243|3786684|B1|Switzerland||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment|participants|Number|2|2.0||||||
3964530|NCT01309243|3786682|B3|Portugal||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment|participants|Number|7|7.0||||||
3964531|NCT01309243|3786683|B2|Portugal||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment|participants|Number|5|5.0||||||
3964532|NCT01309243|3786684|B1|Portugal||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment|participants|Number|2|2.0||||||
3964533|NCT01309243|3786682|B3|Belgium||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment|participants|Number|9|9.0||||||
3964534|NCT01309243|3786683|B2|Belgium||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment|participants|Number|5|5.0||||||
3964535|NCT01309243|3786684|B1|Belgium||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment|participants|Number|4|4.0||||||
3964536|NCT01309243|3786682|B3|Italy||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment|participants|Number|13|13.0||||||
3964537|NCT01309243|3786683|B2|Italy||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment|participants|Number|3|3.0||||||
3964538|NCT01309243|3786684|B1|Italy||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment|participants|Number|10|10.0||||||
3964539|NCT01309243|3786682|B3|Spain||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment|participants|Number|15|15.0||||||
3964540|NCT01309243|3786683|B2|Spain||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment|participants|Number|6|6.0||||||
3964541|NCT01309243|3786684|B1|Spain||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment|participants|Number|9|9.0||||||
3964542|NCT01309243|3786682|B3|Puerto Rico||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment|participants|Number|18|18.0||||||
3964543|NCT01309243|3786683|B2|Puerto Rico||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment|participants|Number|10|10.0||||||
3964544|NCT01309243|3786684|B1|Puerto Rico||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment|participants|Number|8|8.0||||||
3964545|NCT01309243|3786682|B3|United Kingdom||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment|participants|Number|20|20.0||||||
3964546|NCT01309243|3786683|B2|United Kingdom||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment|participants|Number|8|8.0||||||
3964547|NCT01309243|3786684|B1|United Kingdom||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment|participants|Number|12|12.0||||||
3964548|NCT01309243|3786682|B3|France||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment|participants|Number|23|23.0||||||
3964549|NCT01309243|3786683|B2|France||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment|participants|Number|7|7.0||||||
3964550|NCT01309243|3786684|B1|France||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment|participants|Number|16|16.0||||||
3964551|NCT01309243|3786682|B3|Germany||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment|participants|Number|47|47.0||||||
3964552|NCT01309243|3786683|B2|Germany||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment|participants|Number|22|22.0||||||
3964553|NCT01309243|3786684|B1|Germany||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment|participants|Number|25|25.0||||||
3964554|NCT01309243|3786682|B3|Canada||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment|participants|Number|48|48.0||||||
3964555|NCT01309243|3786683|B2|Canada||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment|participants|Number|20|20.0||||||
3964556|NCT01309243|3786684|B1|Canada||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment|participants|Number|28|28.0||||||
3964557|NCT01309243|3786682|B3|Australia||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment|participants|Number|40|40.0||||||
3964558|NCT01309243|3786683|B2|Australia||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment|participants|Number|25|25.0||||||
3964559|NCT01309243|3786684|B1|Australia||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment|participants|Number|15|15.0||||||
3964560|NCT01309243|3786682|B3|United States||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment|participants|Number|541|541.0||||||
3964561|NCT01309243|3786683|B2|United States||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment|participants|Number|279|279.0||||||
3964562|NCT01309243|3786684|B1|United States||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment|participants|Number|262|262.0||||||
3964563|NCT01309243|3786682|B3|Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3964564|NCT01309243|3786683|B2|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3964565|NCT01309243|3786684|B1|Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3964566|NCT01309243|3786682|B3|Not Permitted||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3964567|NCT01309243|3786683|B2|Not Permitted||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3964568|NCT01309243|3786684|B1|Not Permitted||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3964569|NCT01309243|3786682|B3|Non-Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|646|646.0||||||
3964570|NCT01309243|3786683|B2|Non-Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|315|315.0||||||
3964571|NCT01309243|3786684|B1|Non-Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|331|331.0||||||
3964572|NCT01309243|3786682|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|134|134.0||||||
3964573|NCT01309243|3786683|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|75|75.0||||||
3964574|NCT01309243|3786684|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
3964575|NCT01309243|3786682|B3|Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3964576|NCT01309243|3786683|B2|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3964577|NCT01309243|3786684|B1|Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3964578|NCT01309243|3786682|B3|Not Permitted||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3964579|NCT01309243|3786683|B2|Not Permitted||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3964580|NCT01309243|3786684|B1|Not Permitted||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3964581|NCT01309243|3786682|B3|Other||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3964582|NCT01309243|3786683|B2|Other||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3964583|NCT01309243|3786684|B1|Other||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3964584|NCT01309243|3786682|B3|White||Race/Ethnicity, Customized||participants|Number|528|528.0||||||
3964585|NCT01309243|3786683|B2|White||Race/Ethnicity, Customized||participants|Number|262|262.0||||||
3964586|NCT01309243|3786684|B1|White||Race/Ethnicity, Customized||participants|Number|266|266.0||||||
3964587|NCT01309243|3786682|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3964588|NCT01309243|3786683|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3964589|NCT01309243|3786684|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3964590|NCT01309243|3786682|B3|Black or African Heritage||Race/Ethnicity, Customized||participants|Number|192|192.0||||||
3964591|NCT01309243|3786683|B2|Black or African Heritage||Race/Ethnicity, Customized||participants|Number|94|94.0||||||
3964592|NCT01309243|3786684|B1|Black or African Heritage||Race/Ethnicity, Customized||participants|Number|98|98.0||||||
3964593|NCT01309243|3786682|B3|Asian||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3964594|NCT01309243|3786683|B2|Asian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3964595|NCT01309243|3786684|B1|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3964596|NCT01309243|3786682|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3964597|NCT01309243|3786683|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3964598|NCT01309243|3786684|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3964599|NCT01309243|3786682|B3||Male|Sex: Female, Male||Participants|Count of Participants|730|730.0||||||
3964600|NCT01309243|3786683|B2||Male|Sex: Female, Male||Participants|Count of Participants|364|364.0||||||
3964601|NCT01309243|3786684|B1||Male|Sex: Female, Male||Participants|Count of Participants|366|366.0||||||
3964602|NCT01309243|3786682|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3964603|NCT01309243|3786683|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3964604|NCT01309243|3786684|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3964605|NCT01309243|3786682|B3|||Age||years|Mean|37|37.0|Standard Deviation|10.7|10.7|||
3964606|NCT01309243|3786683|B2|||Age||years|Mean|37|37.0|Standard Deviation|11.0|11.0|||
3964607|NCT01309243|3786684|B1|||Age||years|Mean|37|37.0|Standard Deviation|10.4|10.4|||
3964608|NCT01309204|3786709|B3||Male|Sex: Female, Male||Participants|Count of Participants|390|390.0||||||
3964609|NCT01309204|3786710|B2||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
3964610|NCT01309204|3786711|B1||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
3964611|NCT01309204|3786709|B3||Female|Sex: Female, Male||Participants|Count of Participants|498|498.0||||||
3964612|NCT01309204|3786710|B2||Female|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
3964613|NCT01309204|3786711|B1||Female|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
3964614|NCT01309204|3786709|B3|≥ 65 years||Age, Customized||participants|Number|450|450.0||||||
3964615|NCT01309204|3786710|B2|≥ 65 years||Age, Customized||participants|Number|225|225.0||||||
3964616|NCT01309204|3786711|B1|≥ 65 years||Age, Customized||participants|Number|225|225.0||||||
3964617|NCT01309204|3786709|B3|<65 years||Age, Customized||participants|Number|438|438.0||||||
3964618|NCT01309204|3786710|B2|<65 years||Age, Customized||participants|Number|211|211.0||||||
3964619|NCT01309204|3786711|B1|<65 years||Age, Customized||participants|Number|227|227.0||||||
3964620|NCT01309100|3786718|B1|United States||Region of Enrollment||participants|Number|144|144.0||||||
3964621|NCT01309100|3786718|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3964622|NCT01309100|3786718|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3964623|NCT01309100|3786718|B1|||Age||years|Mean|30.6|30.6|Standard Deviation|8.7|8.7|||
3964624|NCT01308918|3786729|B1|||Weight||kg|Mean|74.3|74.3|Standard Deviation|14.5|14.5|||
3964625|NCT01308918|3786729|B1|||Body mass index||kg/m2|Mean|26.8|26.8|Standard Deviation|4.8|4.8|||
3964626|NCT01308918|3786729|B1|Canada||Region of Enrollment||participants|Number|50|50.0||||||
3964627|NCT01308918|3786729|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3964628|NCT01308918|3786729|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3964629|NCT01308918|3786729|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|14.3|14.3|||
3964630|NCT01308918|3786729|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3964631|NCT01308918|3786729|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3964632|NCT01308918|3786729|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964633|NCT01308840|3786736|B1|pelvic soft tissue||metastases||participants|Number|1|1.0||||||
3964634|NCT01308840|3786736|B1|adrenal||metastases||participants|Number|3|3.0||||||
3964635|NCT01308840|3786736|B1|omentum/peritoneal||metastases||participants|Number|4|4.0||||||
3964636|NCT01308840|3786736|B1|bone||metastases||participants|Number|4|4.0||||||
3964637|NCT01308840|3786736|B1|lung||metastases||participants|Number|8|8.0||||||
3964638|NCT01308840|3786736|B1|lymph nodes||metastases||participants|Number|24|24.0||||||
3964639|NCT01308840|3786736|B1|extrahepatic cholantiocarcinoma||primary tumor site||participants|Number|3|3.0||||||
3964640|NCT01308840|3786736|B1|gallbladder||primary tumor site||participants|Number|3|3.0||||||
3964641|NCT01308840|3786736|B1|intrahepatic cholangiocarcinoma||primary tumor site||participants|Number|25|25.0||||||
3964642|NCT01308840|3786736|B1|metastatic||Extent of disease||participants|Number|29|29.0||||||
3964643|NCT01308840|3786736|B1|locally advanced||Extent of disease||participants|Number|2|2.0||||||
3964644|NCT01308840|3786736|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance status|ECOG describes a patient’s level of functioning in terms of their ability to care for themself, daily activity, and physical ability. It ranges from 0-5 with higher numbers indicating reduced ability to care for themself.|participants|Number|21|21.0||||||
3964645|NCT01308840|3786736|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance status|ECOG describes a patient’s level of functioning in terms of their ability to care for themself, daily activity, and physical ability. It ranges from 0-5 with higher numbers indicating reduced ability to care for themself.|participants|Number|10|10.0||||||
3964646|NCT01308840|3786736|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
3964647|NCT01308840|3786736|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3964648|NCT01308840|3786736|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3964649|NCT01308840|3786736|B1|||Age||years|Median|61|61.0|Full Range|||36.0|74.0|
3964650|NCT01308814|3786743|B3|United States||Region of Enrollment||participants|Number|172|172.0||||||
3964651|NCT01308814|3786744|B2|United States||Region of Enrollment||participants|Number|86|86.0||||||
3964652|NCT01308814|3786745|B1|United States||Region of Enrollment||participants|Number|86|86.0||||||
3964653|NCT01308814|3786743|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3964654|NCT01308814|3786744|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3964655|NCT01308814|3786745|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3964656|NCT01308814|3786743|B3||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3964657|NCT01308814|3786744|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3964658|NCT01308814|3786745|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3964659|NCT01308814|3786743|B3|||Age||years|Mean|50.5|50.5|Standard Deviation|3.0|3.0|||
3964660|NCT01308814|3786744|B2|||Age||years|Mean|50.5|50.5|Standard Deviation|3.0|3.0|||
3964661|NCT01308814|3786745|B1|||Age||years|Mean|50.5|50.5|Standard Deviation|3.0|3.0|||
3964662|NCT01308814|3786743|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3964663|NCT01308814|3786744|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3964664|NCT01308814|3786745|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3964665|NCT01308814|3786743|B3||Between 18 and 65 years|Age||Participants|Count of Participants|172|172.0||||||
3964666|NCT01308814|3786744|B2||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
3964667|NCT01308814|3786745|B1||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
3964668|NCT01308814|3786743|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964669|NCT01308814|3786744|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964670|NCT01308814|3786745|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964671|NCT01308788|3786764|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
3964672|NCT01308788|3786765|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3964673|NCT01308788|3786766|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3964674|NCT01308788|3786764|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3964675|NCT01308788|3786765|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3964676|NCT01308788|3786766|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3964677|NCT01308788|3786764|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3964678|NCT01308788|3786765|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3964679|NCT01308788|3786766|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3964680|NCT01308788|3786764|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3964681|NCT01308788|3786765|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3964682|NCT01308788|3786766|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3964683|NCT01308788|3786764|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3964684|NCT01308788|3786765|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3964685|NCT01308788|3786766|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3964686|NCT01308788|3786764|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964687|NCT01308788|3786765|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964688|NCT01308788|3786766|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964689|NCT01308762|3786799|B4|United Kingdom||Region of Enrollment||participants|Number|19|19.0||||||
3964690|NCT01308762|3786800|B3|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3964691|NCT01308762|3786801|B2|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
3964692|NCT01308762|3786802|B1|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3964693|NCT01308762|3786799|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3964694|NCT01308762|3786800|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3964695|NCT01308762|3786801|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3964696|NCT01308762|3786802|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3964697|NCT01308762|3786799|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3964698|NCT01308762|3786800|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3964699|NCT01308762|3786801|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3964700|NCT01308762|3786802|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3964701|NCT01308762|3786799|B4|||Age||years|Mean|53.4|53.4|Standard Deviation|18.3|18.3|||
3964702|NCT01308762|3786800|B3|||Age||years|Mean|56.3|56.3|Standard Deviation|18.8|18.8|||
3964703|NCT01308762|3786801|B2|||Age||years|Mean|56.1|56.1|Standard Deviation|20.2|20.2|||
3964704|NCT01308762|3786802|B1|||Age||years|Mean|47.3|47.3|Standard Deviation|17.3|17.3|||
3964705|NCT01308762|3786799|B4||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3964706|NCT01308762|3786800|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3964707|NCT01308762|3786801|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3964708|NCT01308762|3786802|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3964709|NCT01308762|3786799|B4||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3964710|NCT01308762|3786800|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3964711|NCT01308762|3786801|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3964712|NCT01308762|3786802|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3964713|NCT01308762|3786799|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964714|NCT01308762|3786800|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964715|NCT01308762|3786801|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964716|NCT01308762|3786802|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964717|NCT01308749|3786815|B3|||Intelligence Quotient (IQ) <70||Participants|Count of Participants|14|14.0||||||
3964718|NCT01308749|3786816|B2|||Intelligence Quotient (IQ) <70||Participants|Count of Participants|4|4.0||||||
3964719|NCT01308749|3786817|B1|||Intelligence Quotient (IQ) <70||Participants|Count of Participants|10|10.0||||||
3964720|NCT01308749|3786815|B3|||Non-verbal||Participants|Count of Participants|11|11.0||||||
3964721|NCT01308749|3786816|B2|||Non-verbal||Participants|Count of Participants|4|4.0||||||
3964722|NCT01308749|3786817|B1|||Non-verbal||Participants|Count of Participants|7|7.0||||||
3964723|NCT01308749|3786815|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964724|NCT01308749|3786816|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964725|NCT01308749|3786817|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964726|NCT01308749|3786815|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964727|NCT01308749|3786816|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964728|NCT01308749|3786817|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964729|NCT01308749|3786815|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3964730|NCT01308749|3786816|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3964731|NCT01308749|3786817|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3964732|NCT01308749|3786815|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3964733|NCT01308749|3786816|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3964734|NCT01308749|3786817|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3964735|NCT01308749|3786815|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964736|NCT01308749|3786816|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964737|NCT01308749|3786817|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964738|NCT01308749|3786815|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3964739|NCT01308749|3786816|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964740|NCT01308749|3786817|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3964741|NCT01308749|3786815|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964742|NCT01308749|3786816|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964743|NCT01308749|3786817|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964744|NCT01308749|3786815|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964745|NCT01308749|3786816|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964746|NCT01308749|3786817|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964747|NCT01308749|3786815|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3964748|NCT01308749|3786816|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3964749|NCT01308749|3786817|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3964750|NCT01308749|3786815|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964751|NCT01308749|3786816|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964752|NCT01308749|3786817|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964753|NCT01308749|3786815|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3964754|NCT01308749|3786816|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3964755|NCT01308749|3786817|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3964756|NCT01308749|3786815|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3964757|NCT01308749|3786816|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3964758|NCT01308749|3786817|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3964759|NCT01308749|3786815|B3|||Age||years|Mean|10.3|10.3|Standard Deviation|4.4|4.4|||
3964760|NCT01308749|3786816|B2|||Age||years|Mean|10.6|10.6|Standard Deviation|4.4|4.4|||
3964761|NCT01308749|3786817|B1|||Age||years|Mean|10.0|10.0|Standard Deviation|4.4|4.4|||
3964762|NCT01308749|3786815|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3964763|NCT01308749|3786816|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3964764|NCT01308749|3786817|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3964765|NCT01308749|3786815|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3964766|NCT01308749|3786816|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3964767|NCT01308749|3786817|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3964768|NCT01308749|3786815|B3||<=18 years|Age||Participants|Count of Participants|25|25.0||||||
3964769|NCT01308749|3786816|B2||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
3964770|NCT01308749|3786817|B1||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
3964771|NCT01308736|3786846|B3|United States||Region of Enrollment||participants|Number|63|63.0||||||
3964772|NCT01308736|3786847|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
3964773|NCT01308736|3786848|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
3964774|NCT01308736|3786846|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3964775|NCT01308736|3786847|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3964776|NCT01308736|3786848|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3964777|NCT01308736|3786846|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3964778|NCT01308736|3786847|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3964779|NCT01308736|3786848|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3964780|NCT01308736|3786846|B3|||Age||years|Mean|44.43|44.43|Standard Deviation|11.29|11.29|||
3964781|NCT01308736|3786847|B2|||Age||years|Mean|44.81|44.81|Standard Deviation|12.14|12.14|||
3964782|NCT01308736|3786848|B1|||Age||years|Mean|44.03|44.03|Standard Deviation|10.54|10.54|||
3964783|NCT01308619|3786855|B3|United States||Region of Enrollment||participants|Number|170|170.0||||||
3964784|NCT01308619|3786856|B2|United States||Region of Enrollment||participants|Number|86|86.0||||||
3964785|NCT01308619|3786857|B1|United States||Region of Enrollment||participants|Number|84|84.0||||||
3964786|NCT01308619|3786855|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3964787|NCT01308619|3786856|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3964788|NCT01308619|3786857|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3964789|NCT01308619|3786855|B3||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3964790|NCT01308619|3786856|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3964791|NCT01308619|3786857|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3964792|NCT01308619|3786855|B3|||Age||years|Mean|49.1|49.1|Standard Deviation|11.1|11.1|||
3964793|NCT01308619|3786856|B2|||Age||years|Mean|48.7|48.7|Standard Deviation|10.8|10.8|||
3964794|NCT01308619|3786857|B1|||Age||years|Mean|49.6|49.6|Standard Deviation|11.4|11.4|||
3964795|NCT01308580|3786870|B3||Male|Sex: Female, Male||Participants|Count of Participants|1200|1200.0||||||
3964796|NCT01308580|3786871|B2||Male|Sex: Female, Male||Participants|Count of Participants|602|602.0||||||
3964797|NCT01308580|3786872|B1||Male|Sex: Female, Male||Participants|Count of Participants|598|598.0||||||
3964798|NCT01308580|3786870|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3964799|NCT01308580|3786871|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3964800|NCT01308580|3786872|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3964801|NCT01308580|3786870|B3|≥75 years||Age, Customized||participants|Number|247|247.0||||||
3964802|NCT01308580|3786871|B2|≥75 years||Age, Customized||participants|Number|127|127.0||||||
3964803|NCT01308580|3786872|B1|≥75 years||Age, Customized||participants|Number|120|120.0||||||
3964804|NCT01308580|3786870|B3|65 to 74 years||Age, Customized||participants|Number|591|591.0||||||
3964805|NCT01308580|3786871|B2|65 to 74 years||Age, Customized||participants|Number|295|295.0||||||
3964806|NCT01308580|3786872|B1|65 to 74 years||Age, Customized||participants|Number|296|296.0||||||
3964807|NCT01308580|3786870|B3|<65 years||Age, Customized||participants|Number|362|362.0||||||
3964808|NCT01308580|3786871|B2|<65 years||Age, Customized||participants|Number|180|180.0||||||
3964809|NCT01308580|3786872|B1|<65 years||Age, Customized||participants|Number|182|182.0||||||
3964810|NCT01308567|3786913|B4||Male|Sex: Female, Male||Participants|Count of Participants|1168|1168.0||||||
3964811|NCT01308567|3786914|B3||Male|Sex: Female, Male||Participants|Count of Participants|388|388.0||||||
3964812|NCT01308567|3786915|B2||Male|Sex: Female, Male||Participants|Count of Participants|389|389.0||||||
3964813|NCT01308567|3786916|B1||Male|Sex: Female, Male||Participants|Count of Participants|391|391.0||||||
3964814|NCT01308567|3786913|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3964815|NCT01308567|3786914|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3964816|NCT01308567|3786915|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3964817|NCT01308567|3786916|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3964818|NCT01308567|3786913|B4|≥75 years||Age, Customized||participants|Number|242|242.0||||||
3964819|NCT01308567|3786914|B3|≥75 years||Age, Customized||participants|Number|81|81.0||||||
3964820|NCT01308567|3786915|B2|≥75 years||Age, Customized||participants|Number|74|74.0||||||
3964821|NCT01308567|3786916|B1|≥75 years||Age, Customized||participants|Number|87|87.0||||||
3964822|NCT01308567|3786913|B4|65-74 years||Age, Customized||participants|Number|550|550.0||||||
3964823|NCT01308567|3786914|B3|65-74 years||Age, Customized||participants|Number|182|182.0||||||
3964824|NCT01308567|3786915|B2|65-74 years||Age, Customized||participants|Number|187|187.0||||||
3964825|NCT01308567|3786916|B1|65-74 years||Age, Customized||participants|Number|181|181.0||||||
3964826|NCT01308567|3786913|B4|<65 years||Age, Customized||participants|Number|376|376.0||||||
3964827|NCT01308567|3786914|B3|<65 years||Age, Customized||participants|Number|125|125.0||||||
3964828|NCT01308567|3786915|B2|<65 years||Age, Customized||participants|Number|128|128.0||||||
3964829|NCT01308567|3786916|B1|<65 years||Age, Customized||participants|Number|123|123.0||||||
3964830|NCT01308476|3786956|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3964831|NCT01308476|3786957|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3964832|NCT01308476|3786958|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3964833|NCT01308476|3786956|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3964834|NCT01308476|3786957|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3964835|NCT01308476|3786958|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3964836|NCT01308476|3786956|B3|||Age||Years|Mean|62.9|62.9|Standard Deviation|7.7|7.7|||
3964837|NCT01308476|3786957|B2|||Age||Years|Mean|63.2|63.2|Standard Deviation|8.1|8.1|||
3964838|NCT01308476|3786958|B1|||Age||Years|Mean|62.6|62.6|Standard Deviation|7.3|7.3|||
3964839|NCT01308463|3786979|B1|Unknown||Primary Diagnosis||Participants|Count of Participants|1|1.0||||||
3964840|NCT01308463|3786979|B1|Traumatic Arthritis||Primary Diagnosis||Participants|Count of Participants|7|7.0||||||
3964841|NCT01308463|3786979|B1|Rheumatoid Arthritis||Primary Diagnosis||Participants|Count of Participants|11|11.0||||||
3964842|NCT01308463|3786979|B1|Other||Primary Diagnosis||Participants|Count of Participants|4|4.0||||||
3964843|NCT01308463|3786979|B1|Osteoarthritis||Primary Diagnosis||Participants|Count of Participants|2|2.0||||||
3964844|NCT01308463|3786979|B1|Humeral Fracture||Primary Diagnosis||Participants|Count of Participants|3|3.0||||||
3964845|NCT01308463|3786979|B1|Functional Deformity||Primary Diagnosis||Participants|Count of Participants|1|1.0||||||
3964846|NCT01308463|3786979|B1|Unknown||Hand Dominance||Participants|Count of Participants|1|1.0||||||
3964847|NCT01308463|3786979|B1|Right||Hand Dominance||Participants|Count of Participants|25|25.0||||||
3964848|NCT01308463|3786979|B1|Left||Hand Dominance||Participants|Count of Participants|2|2.0||||||
3964849|NCT01308463|3786979|B1|Ambidextrous||Hand Dominance||Participants|Count of Participants|1|1.0||||||
3964850|NCT01308463|3786979|B1|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3964851|NCT01308463|3786979|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3964852|NCT01308463|3786979|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3964853|NCT01308463|3786979|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3964854|NCT01308463|3786979|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3964855|NCT01308463|3786979|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964856|NCT01308450|3786986|B1|United States||Region of Enrollment||participants|Number|302|302.0||||||
3964857|NCT01308450|3786986|B1||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3964858|NCT01308450|3786986|B1||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3964859|NCT01308450|3786986|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3964860|NCT01308450|3786986|B1||Between 18 and 65 years|Age||Participants|Count of Participants|280|280.0||||||
3964861|NCT01308450|3786986|B1||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
3964862|NCT01308424|3786990|B3|United States||Region of Enrollment||participants|Number|171|171.0||||||
3964863|NCT01308424|3786991|B2|United States||Region of Enrollment||participants|Number|84|84.0||||||
3964864|NCT01308424|3786992|B1|United States||Region of Enrollment||participants|Number|87|87.0||||||
3964865|NCT01308424|3786990|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3964866|NCT01308424|3786991|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3964867|NCT01308424|3786992|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3964868|NCT01308424|3786990|B3||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3964869|NCT01308424|3786991|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3964870|NCT01308424|3786992|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3964871|NCT01308424|3786990|B3|||Age||years|Mean|43.3|43.3|Full Range|||19.2|76.9|
3964872|NCT01308424|3786991|B2|||Age||years|Mean|45.2|45.2|Full Range|||20.0|76.9|
3964873|NCT01308424|3786992|B1|||Age||years|Mean|41.6|41.6|Full Range|||19.2|70.7|
3964874|NCT01308008|3787001|B3|||Comfortable gait speed|Gait velocity over 6 meters|meters per second|Mean|1.1|1.1|Standard Deviation|0.2|0.2|||
3964875|NCT01308008|3787002|B2|||Comfortable gait speed|Gait velocity over 6 meters|meters per second|Mean|1.1|1.1|Standard Deviation|0.2|0.2|||
3964876|NCT01308008|3787003|B1|||Comfortable gait speed|Gait velocity over 6 meters|meters per second|Mean|1.1|1.1|Standard Deviation|0.2|0.2|||
3964877|NCT01308008|3787001|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3964878|NCT01308008|3787002|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3964879|NCT01308008|3787003|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3964880|NCT01308008|3787001|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964881|NCT01308008|3787002|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964882|NCT01308008|3787003|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964883|NCT01308008|3787001|B3||White|Race (NIH/OMB)||Participants|Count of Participants|112|112.0||||||
3964884|NCT01308008|3787002|B2||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3964885|NCT01308008|3787003|B1||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3964886|NCT01308008|3787001|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3964887|NCT01308008|3787002|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3964888|NCT01308008|3787003|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3964889|NCT01308008|3787001|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964890|NCT01308008|3787002|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964891|NCT01308008|3787003|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964892|NCT01308008|3787001|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3964893|NCT01308008|3787002|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3964894|NCT01308008|3787003|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3964895|NCT01308008|3787001|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964896|NCT01308008|3787002|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964897|NCT01308008|3787003|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964898|NCT01308008|3787001|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3964899|NCT01308008|3787002|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3964900|NCT01308008|3787003|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3964901|NCT01308008|3787001|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3964902|NCT01308008|3787002|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3964903|NCT01308008|3787003|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3964904|NCT01308008|3787001|B3|||Age||Years|Mean|70|70.0|Standard Deviation|6|6.0|||
3964905|NCT01308008|3787002|B2|||Age||Years|Mean|70|70.0|Standard Deviation|6|6.0|||
3964906|NCT01308008|3787003|B1|||Age||Years|Mean|69|69.0|Standard Deviation|6|6.0|||
3964907|NCT01308008|3787001|B3||>=65 years|Age||Participants|Count of Participants|144|144.0||||||
3964908|NCT01308008|3787002|B2||>=65 years|Age||Participants|Count of Participants|73|73.0||||||
3964909|NCT01308008|3787003|B1||>=65 years|Age||Participants|Count of Participants|71|71.0||||||
3964910|NCT01308008|3787001|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3964911|NCT01308008|3787002|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3964912|NCT01308008|3787003|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3964913|NCT01308008|3787001|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964914|NCT01308008|3787002|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964915|NCT01308008|3787003|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964916|NCT01307956|3787014|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3964917|NCT01307956|3787014|B1|Asian/Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3964918|NCT01307956|3787014|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3964919|NCT01307956|3787014|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3964920|NCT01307956|3787014|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3964921|NCT01307956|3787014|B1|Participants >= 19 years of age||Age, Customized||Participants|Count of Participants|11|11.0||||||
3964922|NCT01307891|3787018|B3|United States||Region of Enrollment||participants|Number|64|64.0||||||
3964923|NCT01307891|3787019|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
3964924|NCT01307891|3787020|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
3964925|NCT01307891|3787018|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3964926|NCT01307891|3787019|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964927|NCT01307891|3787020|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3964928|NCT01307891|3787018|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964929|NCT01307891|3787019|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964930|NCT01307891|3787020|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964931|NCT01307891|3787018|B3||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3964932|NCT01307891|3787019|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3964933|NCT01307891|3787020|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3964934|NCT01307891|3787018|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3964935|NCT01307891|3787019|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3964936|NCT01307891|3787020|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3964937|NCT01307891|3787018|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964938|NCT01307891|3787019|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964939|NCT01307891|3787020|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964940|NCT01307891|3787018|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964941|NCT01307891|3787019|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964942|NCT01307891|3787020|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964943|NCT01307891|3787018|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3964944|NCT01307891|3787019|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964945|NCT01307891|3787020|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3964946|NCT01307891|3787018|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3964947|NCT01307891|3787019|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3964948|NCT01307891|3787020|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3964949|NCT01307891|3787018|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3964950|NCT01307891|3787019|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3964951|NCT01307891|3787020|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3964952|NCT01307891|3787018|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3964953|NCT01307891|3787019|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3964954|NCT01307891|3787020|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3964955|NCT01307891|3787018|B3||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
3964956|NCT01307891|3787019|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3964957|NCT01307891|3787020|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3964958|NCT01307891|3787018|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964959|NCT01307891|3787019|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964960|NCT01307891|3787020|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964961|NCT01307787|3787031|B3|Netherlands||Region of Enrollment||participants|Number|34|34.0||||||
3964962|NCT01307787|3787032|B2|Netherlands||Region of Enrollment||participants|Number|15|15.0||||||
3964963|NCT01307787|3787033|B1|Netherlands||Region of Enrollment||participants|Number|19|19.0||||||
3964964|NCT01307787|3787031|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3964965|NCT01307787|3787032|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3964966|NCT01307787|3787033|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3964967|NCT01307787|3787031|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3964968|NCT01307787|3787032|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3964969|NCT01307787|3787033|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3964970|NCT01307787|3787031|B3|||Age||years|Mean|48|48.0|Standard Deviation|11.3|11.3|||
3964971|NCT01307787|3787032|B2|||Age||years|Mean|51.8|51.8|Standard Deviation|9.4|9.4|||
3964972|NCT01307787|3787033|B1|||Age||years|Mean|45|45.0|Standard Deviation|11.9|11.9|||
3964973|NCT01307787|3787031|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3964974|NCT01307787|3787032|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3964975|NCT01307787|3787033|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3964976|NCT01307787|3787031|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3964977|NCT01307787|3787032|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3964978|NCT01307787|3787033|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3964979|NCT01307787|3787031|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964980|NCT01307787|3787032|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964981|NCT01307787|3787033|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964982|NCT01307631|3787054|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
3964983|NCT01307631|3787054|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3964984|NCT01307631|3787054|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3964985|NCT01307631|3787054|B1|||Age||years|Median|56|56.0|Full Range|||39.0|73.0|
3964986|NCT01307631|3787054|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3964987|NCT01307631|3787054|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3964988|NCT01307631|3787054|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3964989|NCT01307618|3787063|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3964990|NCT01307618|3787064|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3964991|NCT01307618|3787065|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3964992|NCT01307618|3787063|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3964993|NCT01307618|3787064|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3964994|NCT01307618|3787065|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3964995|NCT01307618|3787063|B3|||Age||years|Mean|62.01|62.01|Standard Deviation|13.81|13.81|||
3964996|NCT01307618|3787064|B2|||Age||years|Mean|66.16|66.16|Standard Deviation|15.11|15.11|||
3964997|NCT01307618|3787065|B1|||Age||years|Mean|57.86|57.86|Standard Deviation|12.55|12.55|||
3964998|NCT01307462|3787082|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3964999|NCT01307462|3787082|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965000|NCT01307462|3787082|B1||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3965001|NCT01307462|3787082|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3965002|NCT01307462|3787082|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965003|NCT01307462|3787082|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965004|NCT01307462|3787082|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965005|NCT01307462|3787082|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965006|NCT01307462|3787082|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3965007|NCT01307462|3787082|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3965008|NCT01307462|3787082|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3965009|NCT01307462|3787082|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3965010|NCT01307462|3787082|B1|||Age||years|Median|57|57.0|Full Range|||24.0|72.0|
3965011|NCT01307449|3787095|B5|United States||Region of Enrollment||participants|Number|88|88.0||||||
3965012|NCT01307449|3787096|B4|United States||Region of Enrollment||participants|Number|11|11.0||||||
3965013|NCT01307449|3787097|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3965014|NCT01307449|3787098|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
3965015|NCT01307449|3787099|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
3965016|NCT01307449|3787095|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3965017|NCT01307449|3787096|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965018|NCT01307449|3787097|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965019|NCT01307449|3787098|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965020|NCT01307449|3787099|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3965021|NCT01307449|3787095|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3965022|NCT01307449|3787096|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965023|NCT01307449|3787097|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965024|NCT01307449|3787098|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3965025|NCT01307449|3787099|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3965026|NCT01307449|3787095|B5||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3965027|NCT01307449|3787096|B4||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3965028|NCT01307449|3787097|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3965029|NCT01307449|3787098|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3965030|NCT01307449|3787099|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3965031|NCT01307449|3787095|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3965032|NCT01307449|3787096|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3965033|NCT01307449|3787097|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3965034|NCT01307449|3787098|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3965035|NCT01307449|3787099|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3965036|NCT01307449|3787095|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965037|NCT01307449|3787096|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965038|NCT01307449|3787097|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965039|NCT01307449|3787098|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965040|NCT01307449|3787099|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965041|NCT01307449|3787095|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3965042|NCT01307449|3787096|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965043|NCT01307449|3787097|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3965044|NCT01307449|3787098|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3965045|NCT01307449|3787099|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965046|NCT01307449|3787095|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965047|NCT01307449|3787096|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965048|NCT01307449|3787097|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965049|NCT01307449|3787098|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965050|NCT01307449|3787099|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965051|NCT01307449|3787095|B5||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3965052|NCT01307449|3787096|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3965053|NCT01307449|3787097|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3965054|NCT01307449|3787098|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3965055|NCT01307449|3787099|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3965056|NCT01307449|3787095|B5||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3965057|NCT01307449|3787096|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3965058|NCT01307449|3787097|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3965059|NCT01307449|3787098|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3965060|NCT01307449|3787099|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3965061|NCT01307449|3787095|B5||>=65 years|Age||Participants|Count of Participants|52|52.0||||||
3965062|NCT01307449|3787096|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3965063|NCT01307449|3787097|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3965064|NCT01307449|3787098|B2||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3965065|NCT01307449|3787099|B1||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
3965066|NCT01307449|3787095|B5||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3965067|NCT01307449|3787096|B4||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3965068|NCT01307449|3787097|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3965069|NCT01307449|3787098|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3965070|NCT01307449|3787099|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3965071|NCT01307449|3787095|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3965072|NCT01307449|3787096|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3965073|NCT01307449|3787097|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3965074|NCT01307449|3787098|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3965075|NCT01307449|3787099|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3965076|NCT01307423|3787132|B4|||Duration of Psoriatic Arthritis|Psoriatic arthritis (PsA) is a chronic and progressive inflammatory arthritis that, depending on the method of ascertainment, occurs in 6% to 39% of patients with psoriasis. Disease onset typically occurs between the ages of 30 and 55 years and affects both sexes equally. In the majority of patients, psoriasis precedes PsA by several years. The diagnosis of PsA is made on clinical grounds in patients with psoriasis having skin, scalp or nail changes.|years|Mean|3.41|3.41|Standard Deviation|4.947|4.947|||
3965077|NCT01307423|3787133|B3|||Duration of Psoriatic Arthritis|Psoriatic arthritis (PsA) is a chronic and progressive inflammatory arthritis that, depending on the method of ascertainment, occurs in 6% to 39% of patients with psoriasis. Disease onset typically occurs between the ages of 30 and 55 years and affects both sexes equally. In the majority of patients, psoriasis precedes PsA by several years. The diagnosis of PsA is made on clinical grounds in patients with psoriasis having skin, scalp or nail changes.|years|Mean|3.62|3.62|Standard Deviation|5.041|5.041|||
3965078|NCT01307423|3787134|B2|||Duration of Psoriatic Arthritis|Psoriatic arthritis (PsA) is a chronic and progressive inflammatory arthritis that, depending on the method of ascertainment, occurs in 6% to 39% of patients with psoriasis. Disease onset typically occurs between the ages of 30 and 55 years and affects both sexes equally. In the majority of patients, psoriasis precedes PsA by several years. The diagnosis of PsA is made on clinical grounds in patients with psoriasis having skin, scalp or nail changes.|years|Mean|3.19|3.19|Standard Deviation|4.706|4.706|||
3965079|NCT01307423|3787135|B1|||Duration of Psoriatic Arthritis|Psoriatic arthritis (PsA) is a chronic and progressive inflammatory arthritis that, depending on the method of ascertainment, occurs in 6% to 39% of patients with psoriasis. Disease onset typically occurs between the ages of 30 and 55 years and affects both sexes equally. In the majority of patients, psoriasis precedes PsA by several years. The diagnosis of PsA is made on clinical grounds in patients with psoriasis having skin, scalp or nail changes.|years|Mean|3.42|3.42|Standard Deviation|5.103|5.103|||
3965080|NCT01307423|3787132|B4||Male|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
3965081|NCT01307423|3787133|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3965082|NCT01307423|3787134|B2||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3965083|NCT01307423|3787135|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3965084|NCT01307423|3787132|B4||Female|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
3965085|NCT01307423|3787133|B3||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3965086|NCT01307423|3787134|B2||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3965087|NCT01307423|3787135|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3965088|NCT01307423|3787132|B4|||Age||years|Mean|49.4|49.4|Standard Deviation|12.05|12.05|||
3965089|NCT01307423|3787133|B3|||Age||years|Mean|48.4|48.4|Standard Deviation|12.52|12.52|||
3965090|NCT01307423|3787134|B2|||Age||years|Mean|49.2|49.2|Standard Deviation|12.00|12.0|||
3965091|NCT01307423|3787135|B1|||Age||years|Mean|50.5|50.5|Standard Deviation|11.58|11.58|||
3965092|NCT01307397|3787327|B1||Male|Sex: Female, Male||Participants|Count of Participants|1822|1822.0||||||
3965093|NCT01307397|3787327|B1||Female|Sex: Female, Male||Participants|Count of Participants|1397|1397.0||||||
3965094|NCT01307397|3787327|B1|||Age||years|Mean|54.5|54.5|Standard Deviation|14.06|14.06|||
3965095|NCT01307319|3787346|B4|||Body Mass Index||kg/m^2|Mean|19.1|19.1|Standard Deviation|4.46|4.46|||
3965096|NCT01307319|3787347|B3|||Body Mass Index||kg/m^2|Mean|19.1|19.1|Standard Deviation|4.72|4.72|||
3965097|NCT01307319|3787348|B2|||Body Mass Index||kg/m^2|Mean|19.4|19.4|Standard Deviation|4.52|4.52|||
3965098|NCT01307319|3787349|B1|||Body Mass Index||kg/m^2|Mean|19.0|19.0|Standard Deviation|4.15|4.15|||
3965099|NCT01307319|3787346|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|576|576.0||||||
3965100|NCT01307319|3787347|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|189|189.0||||||
3965101|NCT01307319|3787348|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|188|188.0||||||
3965102|NCT01307319|3787349|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|199|199.0||||||
3965103|NCT01307319|3787346|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|138|138.0||||||
3965104|NCT01307319|3787347|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
3965105|NCT01307319|3787348|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
3965106|NCT01307319|3787349|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
3965107|NCT01307319|3787346|B4|Other||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
3965108|NCT01307319|3787347|B3|Other||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3965109|NCT01307319|3787348|B2|Other||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3965110|NCT01307319|3787349|B1|Other||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3965111|NCT01307319|3787346|B4|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3965112|NCT01307319|3787347|B3|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3965113|NCT01307319|3787348|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3965114|NCT01307319|3787349|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3965115|NCT01307319|3787346|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|163|163.0||||||
3965116|NCT01307319|3787347|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
3965117|NCT01307319|3787348|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
3965118|NCT01307319|3787349|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
3965119|NCT01307319|3787346|B4|White||Race/Ethnicity, Customized||participants|Number|505|505.0||||||
3965120|NCT01307319|3787347|B3|White||Race/Ethnicity, Customized||participants|Number|164|164.0||||||
3965121|NCT01307319|3787348|B2|White||Race/Ethnicity, Customized||participants|Number|172|172.0||||||
3965122|NCT01307319|3787349|B1|White||Race/Ethnicity, Customized||participants|Number|169|169.0||||||
3965123|NCT01307319|3787346|B4||Male|Sex: Female, Male||Participants|Count of Participants|382|382.0||||||
3965124|NCT01307319|3787347|B3||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3965125|NCT01307319|3787348|B2||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3965126|NCT01307319|3787349|B1||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3965127|NCT01307319|3787346|B4||Female|Sex: Female, Male||Participants|Count of Participants|332|332.0||||||
3965128|NCT01307319|3787347|B3||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3965129|NCT01307319|3787348|B2||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3965130|NCT01307319|3787349|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3965131|NCT01307319|3787346|B4|||Age||years|Mean|9.0|9.0|Standard Deviation|1.67|1.67|||
3965132|NCT01307319|3787347|B3|||Age||years|Mean|9.1|9.1|Standard Deviation|1.65|1.65|||
3965133|NCT01307319|3787348|B2|||Age||years|Mean|9.1|9.1|Standard Deviation|1.62|1.62|||
3965134|NCT01307319|3787349|B1|||Age||years|Mean|8.9|8.9|Standard Deviation|1.73|1.73|||
3965135|NCT01307111|3787362|B4|United States||Region of Enrollment||participants|Number|85|85.0||||||
3965136|NCT01307111|3787363|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3965137|NCT01307111|3787364|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
3965138|NCT01307111|3787365|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
3965139|NCT01307111|3787362|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3965140|NCT01307111|3787363|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3965141|NCT01307111|3787364|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3965142|NCT01307111|3787365|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3965143|NCT01307111|3787362|B4||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3965144|NCT01307111|3787363|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3965145|NCT01307111|3787364|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3965146|NCT01307111|3787365|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3965147|NCT01307111|3787362|B4|||Age||years|Mean|24.1|24.1|Standard Deviation|4.4|4.4|||
3965148|NCT01307111|3787363|B3|||Age||years|Mean|NA||Standard Deviation|NA||||Patient data not collected, deemed ineligible after recruitment.
3965149|NCT01307111|3787364|B2|||Age||years|Mean|24.1|24.1|Standard Deviation|4.6|4.6|||
3965150|NCT01307111|3787365|B1|||Age||years|Mean|24.1|24.1|Standard Deviation|4.3|4.3|||
3965151|NCT01307098|3787374|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965152|NCT01307098|3787375|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965153|NCT01307098|3787376|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965154|NCT01307098|3787377|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965155|NCT01307098|3787374|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965156|NCT01307098|3787375|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965157|NCT01307098|3787376|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965158|NCT01307098|3787377|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965159|NCT01307098|3787374|B4||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3965160|NCT01307098|3787375|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3965161|NCT01307098|3787376|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3965162|NCT01307098|3787377|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3965163|NCT01307098|3787374|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965164|NCT01307098|3787375|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965165|NCT01307098|3787376|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965166|NCT01307098|3787377|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965167|NCT01307098|3787374|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965168|NCT01307098|3787375|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965169|NCT01307098|3787376|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965170|NCT01307098|3787377|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965171|NCT01307098|3787374|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965172|NCT01307098|3787375|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965173|NCT01307098|3787376|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965174|NCT01307098|3787377|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965175|NCT01307098|3787374|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965176|NCT01307098|3787375|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965177|NCT01307098|3787376|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965178|NCT01307098|3787377|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965179|NCT01307098|3787374|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965180|NCT01307098|3787375|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965181|NCT01307098|3787376|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965182|NCT01307098|3787377|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965183|NCT01307098|3787374|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3965184|NCT01307098|3787375|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3965185|NCT01307098|3787376|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3965186|NCT01307098|3787377|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3965187|NCT01307098|3787374|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965188|NCT01307098|3787375|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965189|NCT01307098|3787376|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965190|NCT01307098|3787377|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965191|NCT01307098|3787374|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3965192|NCT01307098|3787375|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3965193|NCT01307098|3787376|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3965194|NCT01307098|3787377|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3965195|NCT01307098|3787374|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3965196|NCT01307098|3787375|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3965197|NCT01307098|3787376|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3965198|NCT01307098|3787377|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3965199|NCT01307098|3787374|B4|||Age||years|Mean|31.6|31.6|Standard Deviation|10.74|10.74|||
3965200|NCT01307098|3787375|B3|||Age||years|Mean|27.0|27.0|Standard Deviation|12.17|12.17|||
3965201|NCT01307098|3787376|B2|||Age||years|Mean|35.3|35.3|Standard Deviation|14.22|14.22|||
3965202|NCT01307098|3787377|B1|||Age||years|Mean|32.3|32.3|Standard Deviation|7.57|7.57|||
3965203|NCT01307098|3787374|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3965204|NCT01307098|3787375|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3965205|NCT01307098|3787376|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3965206|NCT01307098|3787377|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3965207|NCT01307098|3787374|B4||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3965208|NCT01307098|3787375|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3965209|NCT01307098|3787376|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3965210|NCT01307098|3787377|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3965211|NCT01307098|3787374|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3965212|NCT01307098|3787375|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3965213|NCT01307098|3787376|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3965214|NCT01307098|3787377|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3965215|NCT01307046|3787387|B3||Male|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
3965216|NCT01307046|3787388|B2||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3965217|NCT01307046|3787389|B1||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3965218|NCT01307046|3787387|B3||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3965219|NCT01307046|3787388|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3965220|NCT01307046|3787389|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3965221|NCT01307046|3787387|B3|||Age||years|Mean|55.3|55.3|Standard Deviation|9.4|9.4|||
3965222|NCT01307046|3787388|B2|||Age||years|Mean|54.9|54.9|Standard Deviation|9.5|9.5|||
3965223|NCT01307046|3787389|B1|||Age||years|Mean|55.7|55.7|Standard Deviation|9.2|9.2|||
3965224|NCT01307033|3787400|B3||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
3965225|NCT01307033|3787401|B2||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3965226|NCT01307033|3787402|B1||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3965227|NCT01307033|3787400|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3965228|NCT01307033|3787401|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3965229|NCT01307033|3787402|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3965230|NCT01307033|3787400|B3|||Age||Years|Mean|57.3|57.3|Standard Deviation|10.7|10.7|||
3965231|NCT01307033|3787401|B2|||Age||Years|Mean|57.8|57.8|Standard Deviation|10.8|10.8|||
3965232|NCT01307033|3787402|B1|||Age||Years|Mean|56.9|56.9|Standard Deviation|10.7|10.7|||
3965233|NCT01307020|3787417|B11|||BMI|Body Mass Index (measured in kg/m^2)|kg/m^2|Mean|23.3|23.3|Standard Deviation|3.21|3.21|||
3965234|NCT01307020|3787418|B10|||BMI|Body Mass Index (measured in kg/m^2)|kg/m^2|Mean|22.7|22.7|Standard Deviation|2.80|2.8|||
3965235|NCT01307020|3787419|B9|||BMI|Body Mass Index (measured in kg/m^2)|kg/m^2|Mean|22.4|22.4|Standard Deviation|3.04|3.04|||
3965236|NCT01307020|3787420|B8|||BMI|Body Mass Index (measured in kg/m^2)|kg/m^2|Mean|24.2|24.2|Standard Deviation|3.08|3.08|||
3965346|NCT01306877|3787516|B3|Non-Smoker||Smoking History||participants|Number|87|87.0||||||
3965237|NCT01307020|3787421|B7|||BMI|Body Mass Index (measured in kg/m^2)|kg/m^2|Mean|23.0|23.0|Standard Deviation|3.19|3.19|||
3965238|NCT01307020|3787422|B6|||BMI|Body Mass Index (measured in kg/m^2)|kg/m^2|Mean|23.5|23.5|Standard Deviation|3.30|3.3|||
3965239|NCT01307020|3787423|B5|||BMI|Body Mass Index (measured in kg/m^2)|kg/m^2|Mean|23.6|23.6|Standard Deviation|3.20|3.2|||
3965240|NCT01307020|3787424|B4|||BMI|Body Mass Index (measured in kg/m^2)|kg/m^2|Mean|23.2|23.2|Standard Deviation|3.19|3.19|||
3965241|NCT01307020|3787425|B3|||BMI|Body Mass Index (measured in kg/m^2)|kg/m^2|Mean|23.0|23.0|Standard Deviation|2.87|2.87|||
3965242|NCT01307020|3787426|B2|||BMI|Body Mass Index (measured in kg/m^2)|kg/m^2|Mean|24.1|24.1|Standard Deviation|3.69|3.69|||
3965243|NCT01307020|3787427|B1|||BMI|Body Mass Index (measured in kg/m^2)|kg/m^2|Mean|23.7|23.7|Standard Deviation|3.39|3.39|||
3965244|NCT01307020|3787417|B11||Male|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
3965245|NCT01307020|3787418|B10||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3965246|NCT01307020|3787419|B9||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3965247|NCT01307020|3787420|B8||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3965248|NCT01307020|3787421|B7||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3965249|NCT01307020|3787422|B6||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3965250|NCT01307020|3787423|B5||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3965251|NCT01307020|3787424|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3965252|NCT01307020|3787425|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3965253|NCT01307020|3787426|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3965254|NCT01307020|3787427|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3965255|NCT01307020|3787417|B11||Female|Sex: Female, Male||Participants|Count of Participants|364|364.0||||||
3965256|NCT01307020|3787418|B10||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3965257|NCT01307020|3787419|B9||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3965258|NCT01307020|3787420|B8||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3965259|NCT01307020|3787421|B7||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3965260|NCT01307020|3787422|B6||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3965261|NCT01307020|3787423|B5||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3965262|NCT01307020|3787424|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3965263|NCT01307020|3787425|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3965264|NCT01307020|3787426|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3965265|NCT01307020|3787427|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3965266|NCT01307020|3787417|B11|||Age||years|Mean|26.9|26.9|Standard Deviation|7.56|7.56|||
3965267|NCT01307020|3787418|B10|||Age||years|Mean|26.1|26.1|Standard Deviation|6.64|6.64|||
3965268|NCT01307020|3787419|B9|||Age||years|Mean|26.6|26.6|Standard Deviation|6.48|6.48|||
3965269|NCT01307020|3787420|B8|||Age||years|Mean|27.8|27.8|Standard Deviation|7.99|7.99|||
3965270|NCT01307020|3787421|B7|||Age||years|Mean|25.5|25.5|Standard Deviation|7.15|7.15|||
3965271|NCT01307020|3787422|B6|||Age||years|Mean|26.9|26.9|Standard Deviation|6.94|6.94|||
3965272|NCT01307020|3787423|B5|||Age||years|Mean|27.0|27.0|Standard Deviation|9.85|9.85|||
3965273|NCT01307020|3787424|B4|||Age||years|Mean|27.3|27.3|Standard Deviation|7.55|7.55|||
3965274|NCT01307020|3787425|B3|||Age||years|Mean|26.3|26.3|Standard Deviation|7.33|7.33|||
3965275|NCT01307020|3787426|B2|||Age||years|Mean|26.9|26.9|Standard Deviation|7.62|7.62|||
3965276|NCT01307020|3787427|B1|||Age||years|Mean|28.6|28.6|Standard Deviation|7.64|7.64|||
3965277|NCT01307007|3787478|B3|United States||Region of Enrollment||participants|Number|55|55.0||||||
3965278|NCT01307007|3787479|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3965279|NCT01307007|3787480|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3965280|NCT01307007|3787478|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3965281|NCT01307007|3787479|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3965282|NCT01307007|3787480|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3965283|NCT01307007|3787478|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3965284|NCT01307007|3787479|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3965285|NCT01307007|3787480|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3965286|NCT01307007|3787478|B3|||Age||years|Mean|35.1|35.1|Standard Deviation|10.54|10.54|||
3965287|NCT01307007|3787479|B2|||Age||years|Mean|33.7|33.7|Standard Deviation|10.72|10.72|||
3965288|NCT01307007|3787480|B1|||Age||years|Mean|36.8|36.8|Standard Deviation|10.26|10.26|||
3965289|NCT01307007|3787478|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3965290|NCT01307007|3787479|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3965291|NCT01307007|3787480|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3965292|NCT01307007|3787478|B3||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
3965293|NCT01307007|3787479|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3965294|NCT01307007|3787480|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3965295|NCT01307007|3787478|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3965296|NCT01307007|3787479|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3965297|NCT01307007|3787480|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3965298|NCT01306968|3787487|B5|RPQ Total||Post-concussion Symptom Scores|The Rivermead Post-Concussion Symptom Questionnaire (RPQ) was created to measure the severity of post-concussion symptoms following traumatic brain injury (TBI). RPQ-3 are the first 3 symptoms of the RPQ Total including headaches, dizziness, and nausea/vomiting. RPQ-13 are the remaining 13 TBI symptoms. Using values of 0 (not experienced at all), 1 (no more of a problem than before the injury), 2 (mild problem), 3 (moderate problem), or 4 (severe problem). The range is 0 to 64. The score is a summation of symptoms rated as >2 representing new symptom onset or exacerbation of symptom(s).|units on a scale|Mean|31.1|31.1|Standard Deviation|14.55|14.55|||
3965299|NCT01306968|3787488|B4|RPQ Total||Post-concussion Symptom Scores|The Rivermead Post-Concussion Symptom Questionnaire (RPQ) was created to measure the severity of post-concussion symptoms following traumatic brain injury (TBI). RPQ-3 are the first 3 symptoms of the RPQ Total including headaches, dizziness, and nausea/vomiting. RPQ-13 are the remaining 13 TBI symptoms. Using values of 0 (not experienced at all), 1 (no more of a problem than before the injury), 2 (mild problem), 3 (moderate problem), or 4 (severe problem). The range is 0 to 64. The score is a summation of symptoms rated as >2 representing new symptom onset or exacerbation of symptom(s).|units on a scale|Mean|30.2|30.2|Standard Deviation|14.17|14.17|||
3965300|NCT01306968|3787489|B3|RPQ Total||Post-concussion Symptom Scores|The Rivermead Post-Concussion Symptom Questionnaire (RPQ) was created to measure the severity of post-concussion symptoms following traumatic brain injury (TBI). RPQ-3 are the first 3 symptoms of the RPQ Total including headaches, dizziness, and nausea/vomiting. RPQ-13 are the remaining 13 TBI symptoms. Using values of 0 (not experienced at all), 1 (no more of a problem than before the injury), 2 (mild problem), 3 (moderate problem), or 4 (severe problem). The range is 0 to 64. The score is a summation of symptoms rated as >2 representing new symptom onset or exacerbation of symptom(s).|units on a scale|Mean|33.0|33.0|Standard Deviation|15.82|15.82|||
3965301|NCT01306968|3787490|B2|RPQ Total||Post-concussion Symptom Scores|The Rivermead Post-Concussion Symptom Questionnaire (RPQ) was created to measure the severity of post-concussion symptoms following traumatic brain injury (TBI). RPQ-3 are the first 3 symptoms of the RPQ Total including headaches, dizziness, and nausea/vomiting. RPQ-13 are the remaining 13 TBI symptoms. Using values of 0 (not experienced at all), 1 (no more of a problem than before the injury), 2 (mild problem), 3 (moderate problem), or 4 (severe problem). The range is 0 to 64. The score is a summation of symptoms rated as >2 representing new symptom onset or exacerbation of symptom(s).|units on a scale|Mean|32.5|32.5|Standard Deviation|14.39|14.39|||
3965302|NCT01306968|3787491|B1|RPQ Total||Post-concussion Symptom Scores|The Rivermead Post-Concussion Symptom Questionnaire (RPQ) was created to measure the severity of post-concussion symptoms following traumatic brain injury (TBI). RPQ-3 are the first 3 symptoms of the RPQ Total including headaches, dizziness, and nausea/vomiting. RPQ-13 are the remaining 13 TBI symptoms. Using values of 0 (not experienced at all), 1 (no more of a problem than before the injury), 2 (mild problem), 3 (moderate problem), or 4 (severe problem). The range is 0 to 64. The score is a summation of symptoms rated as >2 representing new symptom onset or exacerbation of symptom(s).|units on a scale|Mean|23.6|23.6|Standard Deviation|10.11|10.11|||
3965303|NCT01306968|3787487|B5|RPQ-13||Post-concussion Symptom Scores|The Rivermead Post-Concussion Symptom Questionnaire (RPQ) was created to measure the severity of post-concussion symptoms following traumatic brain injury (TBI). RPQ-3 are the first 3 symptoms of the RPQ Total including headaches, dizziness, and nausea/vomiting. RPQ-13 are the remaining 13 TBI symptoms. Using values of 0 (not experienced at all), 1 (no more of a problem than before the injury), 2 (mild problem), 3 (moderate problem), or 4 (severe problem). The range is 0 to 64. The score is a summation of symptoms rated as >2 representing new symptom onset or exacerbation of symptom(s).|units on a scale|Mean|26.2|26.2|Standard Deviation|12.02|12.02|||
3965304|NCT01306968|3787488|B4|RPQ-13||Post-concussion Symptom Scores|The Rivermead Post-Concussion Symptom Questionnaire (RPQ) was created to measure the severity of post-concussion symptoms following traumatic brain injury (TBI). RPQ-3 are the first 3 symptoms of the RPQ Total including headaches, dizziness, and nausea/vomiting. RPQ-13 are the remaining 13 TBI symptoms. Using values of 0 (not experienced at all), 1 (no more of a problem than before the injury), 2 (mild problem), 3 (moderate problem), or 4 (severe problem). The range is 0 to 64. The score is a summation of symptoms rated as >2 representing new symptom onset or exacerbation of symptom(s).|units on a scale|Mean|25.5|25.5|Standard Deviation|11.61|11.61|||
3965305|NCT01306968|3787489|B3|RPQ-13||Post-concussion Symptom Scores|The Rivermead Post-Concussion Symptom Questionnaire (RPQ) was created to measure the severity of post-concussion symptoms following traumatic brain injury (TBI). RPQ-3 are the first 3 symptoms of the RPQ Total including headaches, dizziness, and nausea/vomiting. RPQ-13 are the remaining 13 TBI symptoms. Using values of 0 (not experienced at all), 1 (no more of a problem than before the injury), 2 (mild problem), 3 (moderate problem), or 4 (severe problem). The range is 0 to 64. The score is a summation of symptoms rated as >2 representing new symptom onset or exacerbation of symptom(s).|units on a scale|Mean|27.5|27.5|Standard Deviation|13.15|13.15|||
3965306|NCT01306968|3787490|B2|RPQ-13||Post-concussion Symptom Scores|The Rivermead Post-Concussion Symptom Questionnaire (RPQ) was created to measure the severity of post-concussion symptoms following traumatic brain injury (TBI). RPQ-3 are the first 3 symptoms of the RPQ Total including headaches, dizziness, and nausea/vomiting. RPQ-13 are the remaining 13 TBI symptoms. Using values of 0 (not experienced at all), 1 (no more of a problem than before the injury), 2 (mild problem), 3 (moderate problem), or 4 (severe problem). The range is 0 to 64. The score is a summation of symptoms rated as >2 representing new symptom onset or exacerbation of symptom(s).|units on a scale|Mean|27.1|27.1|Standard Deviation|12.20|12.2|||
3965307|NCT01306968|3787491|B1|RPQ-13||Post-concussion Symptom Scores|The Rivermead Post-Concussion Symptom Questionnaire (RPQ) was created to measure the severity of post-concussion symptoms following traumatic brain injury (TBI). RPQ-3 are the first 3 symptoms of the RPQ Total including headaches, dizziness, and nausea/vomiting. RPQ-13 are the remaining 13 TBI symptoms. Using values of 0 (not experienced at all), 1 (no more of a problem than before the injury), 2 (mild problem), 3 (moderate problem), or 4 (severe problem). The range is 0 to 64. The score is a summation of symptoms rated as >2 representing new symptom onset or exacerbation of symptom(s).|units on a scale|Mean|20.9|20.9|Standard Deviation|9.19|9.19|||
3965347|NCT01306877|3787517|B2|Non-Smoker||Smoking History||participants|Number|38|38.0||||||
3965348|NCT01306877|3787518|B1|Non-Smoker||Smoking History||participants|Number|49|49.0||||||
3965419|NCT01306617|3787547|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3965308|NCT01306968|3787487|B5|RPQ-3||Post-concussion Symptom Scores|The Rivermead Post-Concussion Symptom Questionnaire (RPQ) was created to measure the severity of post-concussion symptoms following traumatic brain injury (TBI). RPQ-3 are the first 3 symptoms of the RPQ Total including headaches, dizziness, and nausea/vomiting. RPQ-13 are the remaining 13 TBI symptoms. Using values of 0 (not experienced at all), 1 (no more of a problem than before the injury), 2 (mild problem), 3 (moderate problem), or 4 (severe problem). The range is 0 to 64. The score is a summation of symptoms rated as >2 representing new symptom onset or exacerbation of symptom(s).|units on a scale|Mean|5.0|5.0|Standard Deviation|3.01|3.01|||
3965309|NCT01306968|3787488|B4|RPQ-3||Post-concussion Symptom Scores|The Rivermead Post-Concussion Symptom Questionnaire (RPQ) was created to measure the severity of post-concussion symptoms following traumatic brain injury (TBI). RPQ-3 are the first 3 symptoms of the RPQ Total including headaches, dizziness, and nausea/vomiting. RPQ-13 are the remaining 13 TBI symptoms. Using values of 0 (not experienced at all), 1 (no more of a problem than before the injury), 2 (mild problem), 3 (moderate problem), or 4 (severe problem). The range is 0 to 64. The score is a summation of symptoms rated as >2 representing new symptom onset or exacerbation of symptom(s).|units on a scale|Mean|4.7|4.7|Standard Deviation|3.09|3.09|||
3965310|NCT01306968|3787489|B3|RPQ-3||Post-concussion Symptom Scores|The Rivermead Post-Concussion Symptom Questionnaire (RPQ) was created to measure the severity of post-concussion symptoms following traumatic brain injury (TBI). RPQ-3 are the first 3 symptoms of the RPQ Total including headaches, dizziness, and nausea/vomiting. RPQ-13 are the remaining 13 TBI symptoms. Using values of 0 (not experienced at all), 1 (no more of a problem than before the injury), 2 (mild problem), 3 (moderate problem), or 4 (severe problem). The range is 0 to 64. The score is a summation of symptoms rated as >2 representing new symptom onset or exacerbation of symptom(s).|units on a scale|Mean|5.5|5.5|Standard Deviation|3.27|3.27|||
3965311|NCT01306968|3787490|B2|RPQ-3||Post-concussion Symptom Scores|The Rivermead Post-Concussion Symptom Questionnaire (RPQ) was created to measure the severity of post-concussion symptoms following traumatic brain injury (TBI). RPQ-3 are the first 3 symptoms of the RPQ Total including headaches, dizziness, and nausea/vomiting. RPQ-13 are the remaining 13 TBI symptoms. Using values of 0 (not experienced at all), 1 (no more of a problem than before the injury), 2 (mild problem), 3 (moderate problem), or 4 (severe problem). The range is 0 to 64. The score is a summation of symptoms rated as >2 representing new symptom onset or exacerbation of symptom(s).|units on a scale|Mean|5.4|5.4|Standard Deviation|2.74|2.74|||
3965312|NCT01306968|3787491|B1|RPQ-3||Post-concussion Symptom Scores|The Rivermead Post-Concussion Symptom Questionnaire (RPQ) was created to measure the severity of post-concussion symptoms following traumatic brain injury (TBI). RPQ-3 are the first 3 symptoms of the RPQ Total including headaches, dizziness, and nausea/vomiting. RPQ-13 are the remaining 13 TBI symptoms. Using values of 0 (not experienced at all), 1 (no more of a problem than before the injury), 2 (mild problem), 3 (moderate problem), or 4 (severe problem). The range is 0 to 64. The score is a summation of symptoms rated as >2 representing new symptom onset or exacerbation of symptom(s).|units on a scale|Mean|2.7|2.7|Standard Deviation|1.89|1.89|||
3965313|NCT01306968|3787487|B5||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3965314|NCT01306968|3787488|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3965315|NCT01306968|3787489|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3965316|NCT01306968|3787490|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3965317|NCT01306968|3787491|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3965318|NCT01306968|3787487|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3965319|NCT01306968|3787488|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3965320|NCT01306968|3787489|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3965321|NCT01306968|3787490|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3965322|NCT01306968|3787491|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3965323|NCT01306968|3787487|B5|||Age||years|Mean|31.6|31.6|Standard Deviation|7.6|7.6|||
3965324|NCT01306968|3787488|B4|||Age||years|Mean|31.4|31.4|Standard Deviation|7.6|7.6|||
3965325|NCT01306968|3787489|B3|||Age||years|Mean|32.5|32.5|Standard Deviation|7.9|7.9|||
3965326|NCT01306968|3787490|B2|||Age||years|Mean|30.3|30.3|Standard Deviation|7.2|7.2|||
3965327|NCT01306968|3787491|B1|||Age||years|Mean|33.0|33.0|Standard Deviation|9.0|9.0|||
3965328|NCT01306877|3787516|B3|||Weight||Kg|Mean|81.50|81.5|Standard Deviation|18.05|18.05|||
3965329|NCT01306877|3787517|B2|||Weight||Kg|Mean|81.29|81.29|Standard Deviation|18.65|18.65|||
3965330|NCT01306877|3787518|B1|||Weight||Kg|Mean|81.69|81.69|Standard Deviation|17.61|17.61|||
3965331|NCT01306877|3787516|B3|||BMI||kg/m2|Mean|27.54|27.54|Standard Deviation|4.97|4.97|||
3965332|NCT01306877|3787517|B2|||BMI||kg/m2|Mean|27.11|27.11|Standard Deviation|4.85|4.85|||
3965333|NCT01306877|3787518|B1|||BMI||kg/m2|Mean|27.94|27.94|Standard Deviation|17.61|17.61|||
3965334|NCT01306877|3787516|B3|No Treatment||Prior Hemorrhoid Treatment||participants|Number|84|84.0||||||
3965335|NCT01306877|3787517|B2|No Treatment||Prior Hemorrhoid Treatment||participants|Number|35|35.0||||||
3965336|NCT01306877|3787518|B1|No Treatment||Prior Hemorrhoid Treatment||participants|Number|49|49.0||||||
3965337|NCT01306877|3787516|B3|At least 1 Treatment||Prior Hemorrhoid Treatment||participants|Number|65|65.0||||||
3965338|NCT01306877|3787517|B2|At least 1 Treatment||Prior Hemorrhoid Treatment||participants|Number|36|36.0||||||
3965339|NCT01306877|3787518|B1|At least 1 Treatment||Prior Hemorrhoid Treatment||participants|Number|29|29.0||||||
3965340|NCT01306877|3787516|B3|Current Smoker||Smoking History||participants|Number|26|26.0||||||
3965341|NCT01306877|3787517|B2|Current Smoker||Smoking History||participants|Number|9|9.0||||||
3965342|NCT01306877|3787518|B1|Current Smoker||Smoking History||participants|Number|17|17.0||||||
3965343|NCT01306877|3787516|B3|Past Smoker||Smoking History||participants|Number|36|36.0||||||
3965344|NCT01306877|3787517|B2|Past Smoker||Smoking History||participants|Number|24|24.0||||||
3965345|NCT01306877|3787518|B1|Past Smoker||Smoking History||participants|Number|12|12.0||||||
3965349|NCT01306877|3787516|B3|Grade 4||Hemorrhoid Grade|"Hemorrhoid grading is based on the scale from The American Society of Colon and Rectal Surgeons classification where grade IV represents the worst onset of hemorrhoids and grade I is the best case. Surgeons use the following classification to grade subjects in the study. Grades increase in severity with Grade I being better than Grade IV Grade Physical Findings I Prominent hemorrhoidal vessels, no prolapse~II Prolapse with Valsalva and spontaneous reduction~III Prolapse with Valsalva requires manual reduction~IV Chronically prolapsed manual reduction ineffective"|participants|Number|0|0.0||||||
3965350|NCT01306877|3787517|B2|Grade 4||Hemorrhoid Grade|"Hemorrhoid grading is based on the scale from The American Society of Colon and Rectal Surgeons classification where grade IV represents the worst onset of hemorrhoids and grade I is the best case. Surgeons use the following classification to grade subjects in the study. Grades increase in severity with Grade I being better than Grade IV Grade Physical Findings I Prominent hemorrhoidal vessels, no prolapse~II Prolapse with Valsalva and spontaneous reduction~III Prolapse with Valsalva requires manual reduction~IV Chronically prolapsed manual reduction ineffective"|participants|Number|0|0.0||||||
3965351|NCT01306877|3787518|B1|Grade 4||Hemorrhoid Grade|"Hemorrhoid grading is based on the scale from The American Society of Colon and Rectal Surgeons classification where grade IV represents the worst onset of hemorrhoids and grade I is the best case. Surgeons use the following classification to grade subjects in the study. Grades increase in severity with Grade I being better than Grade IV Grade Physical Findings I Prominent hemorrhoidal vessels, no prolapse~II Prolapse with Valsalva and spontaneous reduction~III Prolapse with Valsalva requires manual reduction~IV Chronically prolapsed manual reduction ineffective"|participants|Number|0|0.0||||||
3965352|NCT01306877|3787516|B3|Grade 3||Hemorrhoid Grade|"Hemorrhoid grading is based on the scale from The American Society of Colon and Rectal Surgeons classification where grade IV represents the worst onset of hemorrhoids and grade I is the best case. Surgeons use the following classification to grade subjects in the study. Grades increase in severity with Grade I being better than Grade IV Grade Physical Findings I Prominent hemorrhoidal vessels, no prolapse~II Prolapse with Valsalva and spontaneous reduction~III Prolapse with Valsalva requires manual reduction~IV Chronically prolapsed manual reduction ineffective"|participants|Number|101|101.0||||||
3965353|NCT01306877|3787517|B2|Grade 3||Hemorrhoid Grade|"Hemorrhoid grading is based on the scale from The American Society of Colon and Rectal Surgeons classification where grade IV represents the worst onset of hemorrhoids and grade I is the best case. Surgeons use the following classification to grade subjects in the study. Grades increase in severity with Grade I being better than Grade IV Grade Physical Findings I Prominent hemorrhoidal vessels, no prolapse~II Prolapse with Valsalva and spontaneous reduction~III Prolapse with Valsalva requires manual reduction~IV Chronically prolapsed manual reduction ineffective"|participants|Number|51|51.0||||||
3965354|NCT01306877|3787518|B1|Grade 3||Hemorrhoid Grade|"Hemorrhoid grading is based on the scale from The American Society of Colon and Rectal Surgeons classification where grade IV represents the worst onset of hemorrhoids and grade I is the best case. Surgeons use the following classification to grade subjects in the study. Grades increase in severity with Grade I being better than Grade IV Grade Physical Findings I Prominent hemorrhoidal vessels, no prolapse~II Prolapse with Valsalva and spontaneous reduction~III Prolapse with Valsalva requires manual reduction~IV Chronically prolapsed manual reduction ineffective"|participants|Number|50|50.0||||||
3965355|NCT01306877|3787516|B3|Grade 2||Hemorrhoid Grade|"Hemorrhoid grading is based on the scale from The American Society of Colon and Rectal Surgeons classification where grade IV represents the worst onset of hemorrhoids and grade I is the best case. Surgeons use the following classification to grade subjects in the study. Grades increase in severity with Grade I being better than Grade IV Grade Physical Findings I Prominent hemorrhoidal vessels, no prolapse~II Prolapse with Valsalva and spontaneous reduction~III Prolapse with Valsalva requires manual reduction~IV Chronically prolapsed manual reduction ineffective"|participants|Number|48|48.0||||||
3965356|NCT01306877|3787517|B2|Grade 2||Hemorrhoid Grade|"Hemorrhoid grading is based on the scale from The American Society of Colon and Rectal Surgeons classification where grade IV represents the worst onset of hemorrhoids and grade I is the best case. Surgeons use the following classification to grade subjects in the study. Grades increase in severity with Grade I being better than Grade IV Grade Physical Findings I Prominent hemorrhoidal vessels, no prolapse~II Prolapse with Valsalva and spontaneous reduction~III Prolapse with Valsalva requires manual reduction~IV Chronically prolapsed manual reduction ineffective"|participants|Number|20|20.0||||||
3965357|NCT01306877|3787518|B1|Grade 2||Hemorrhoid Grade|"Hemorrhoid grading is based on the scale from The American Society of Colon and Rectal Surgeons classification where grade IV represents the worst onset of hemorrhoids and grade I is the best case. Surgeons use the following classification to grade subjects in the study. Grades increase in severity with Grade I being better than Grade IV Grade Physical Findings I Prominent hemorrhoidal vessels, no prolapse~II Prolapse with Valsalva and spontaneous reduction~III Prolapse with Valsalva requires manual reduction~IV Chronically prolapsed manual reduction ineffective"|participants|Number|28|28.0||||||
3965358|NCT01306877|3787516|B3|Grade 1||Hemorrhoid Grade|"Hemorrhoid grading is based on the scale from The American Society of Colon and Rectal Surgeons classification where grade IV represents the worst onset of hemorrhoids and grade I is the best case. Surgeons use the following classification to grade subjects in the study. Grades increase in severity with Grade I being better than Grade IV Grade Physical Findings I Prominent hemorrhoidal vessels, no prolapse~II Prolapse with Valsalva and spontaneous reduction~III Prolapse with Valsalva requires manual reduction~IV Chronically prolapsed manual reduction ineffective"|participants|Number|0|0.0||||||
3965359|NCT01306877|3787517|B2|Grade 1||Hemorrhoid Grade|"Hemorrhoid grading is based on the scale from The American Society of Colon and Rectal Surgeons classification where grade IV represents the worst onset of hemorrhoids and grade I is the best case. Surgeons use the following classification to grade subjects in the study. Grades increase in severity with Grade I being better than Grade IV Grade Physical Findings I Prominent hemorrhoidal vessels, no prolapse~II Prolapse with Valsalva and spontaneous reduction~III Prolapse with Valsalva requires manual reduction~IV Chronically prolapsed manual reduction ineffective"|participants|Number|0|0.0||||||
3965415|NCT01306617|3787547|B3|1A||Hepatitis C Virus (HCV) Genotype/ Subtype||participants|Number|16|16.0||||||
3965416|NCT01306617|3787548|B2|1A||Hepatitis C Virus (HCV) Genotype/ Subtype||participants|Number|11|11.0||||||
3965417|NCT01306617|3787549|B1|1A||Hepatitis C Virus (HCV) Genotype/ Subtype||participants|Number|17|17.0||||||
3965418|NCT01306617|3787546|B4||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3965360|NCT01306877|3787518|B1|Grade 1||Hemorrhoid Grade|"Hemorrhoid grading is based on the scale from The American Society of Colon and Rectal Surgeons classification where grade IV represents the worst onset of hemorrhoids and grade I is the best case. Surgeons use the following classification to grade subjects in the study. Grades increase in severity with Grade I being better than Grade IV Grade Physical Findings I Prominent hemorrhoidal vessels, no prolapse~II Prolapse with Valsalva and spontaneous reduction~III Prolapse with Valsalva requires manual reduction~IV Chronically prolapsed manual reduction ineffective"|participants|Number|0|0.0||||||
3965361|NCT01306877|3787516|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3965362|NCT01306877|3787517|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3965363|NCT01306877|3787518|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3965364|NCT01306877|3787516|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965365|NCT01306877|3787517|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965366|NCT01306877|3787518|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965367|NCT01306877|3787516|B3||White|Race (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
3965368|NCT01306877|3787517|B2||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3965369|NCT01306877|3787518|B1||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3965370|NCT01306877|3787516|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3965371|NCT01306877|3787517|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3965372|NCT01306877|3787518|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3965373|NCT01306877|3787516|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3965374|NCT01306877|3787517|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965375|NCT01306877|3787518|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3965376|NCT01306877|3787516|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3965377|NCT01306877|3787517|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3965378|NCT01306877|3787518|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3965379|NCT01306877|3787516|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965380|NCT01306877|3787517|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965381|NCT01306877|3787518|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965382|NCT01306877|3787516|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3965383|NCT01306877|3787517|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3965384|NCT01306877|3787518|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3965385|NCT01306877|3787516|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3965386|NCT01306877|3787517|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3965387|NCT01306877|3787518|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3965388|NCT01306877|3787516|B3|||Age||years|Mean|53.8|53.8|Standard Deviation|13.7|13.7|||
3965389|NCT01306877|3787517|B2|||Age||years|Mean|52.1|52.1|Standard Deviation|13.4|13.4|||
3965390|NCT01306877|3787518|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|13.8|13.8|||
3965391|NCT01306643|3787537|B1|Missing||Diagnosis||participants|Number|1|1.0||||||
3965392|NCT01306643|3787537|B1|Small lymphocytic lymphoma||Diagnosis||participants|Number|4|4.0||||||
3965393|NCT01306643|3787537|B1|Marginal zone lymphoma||Diagnosis||participants|Number|3|3.0||||||
3965394|NCT01306643|3787537|B1|Follicular lymphoma||Diagnosis||participants|Number|10|10.0||||||
3965395|NCT01306643|3787537|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3965396|NCT01306643|3787537|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3965397|NCT01306643|3787537|B1|||Age||years|Mean|58|58.0|Standard Deviation|12.6|12.6|||
3965398|NCT01306617|3787546|B4|TT||Interleukin 28B (IL28B) Genotype||participants|Number|9|9.0||||||
3965399|NCT01306617|3787547|B3|TT||Interleukin 28B (IL28B) Genotype||participants|Number|5|5.0||||||
3965400|NCT01306617|3787548|B2|TT||Interleukin 28B (IL28B) Genotype||participants|Number|2|2.0||||||
3965401|NCT01306617|3787549|B1|TT||Interleukin 28B (IL28B) Genotype||participants|Number|2|2.0||||||
3965402|NCT01306617|3787546|B4|CT||Interleukin 28B (IL28B) Genotype||participants|Number|26|26.0||||||
3965403|NCT01306617|3787547|B3|CT||Interleukin 28B (IL28B) Genotype||participants|Number|12|12.0||||||
3965404|NCT01306617|3787548|B2|CT||Interleukin 28B (IL28B) Genotype||participants|Number|7|7.0||||||
3965405|NCT01306617|3787549|B1|CT||Interleukin 28B (IL28B) Genotype||participants|Number|7|7.0||||||
3965406|NCT01306617|3787546|B4|CC||Interleukin 28B (IL28B) Genotype||participants|Number|15|15.0||||||
3965407|NCT01306617|3787547|B3|CC||Interleukin 28B (IL28B) Genotype||participants|Number|0|0.0||||||
3965408|NCT01306617|3787548|B2|CC||Interleukin 28B (IL28B) Genotype||participants|Number|5|5.0||||||
3965409|NCT01306617|3787549|B1|CC||Interleukin 28B (IL28B) Genotype||participants|Number|10|10.0||||||
3965410|NCT01306617|3787546|B4|1B||Hepatitis C Virus (HCV) Genotype/ Subtype||participants|Number|6|6.0||||||
3965411|NCT01306617|3787547|B3|1B||Hepatitis C Virus (HCV) Genotype/ Subtype||participants|Number|1|1.0||||||
3965412|NCT01306617|3787548|B2|1B||Hepatitis C Virus (HCV) Genotype/ Subtype||participants|Number|3|3.0||||||
3965413|NCT01306617|3787549|B1|1B||Hepatitis C Virus (HCV) Genotype/ Subtype||participants|Number|2|2.0||||||
3965414|NCT01306617|3787546|B4|1A||Hepatitis C Virus (HCV) Genotype/ Subtype||participants|Number|44|44.0||||||
3965420|NCT01306617|3787548|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3965421|NCT01306617|3787549|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3965422|NCT01306617|3787546|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3965423|NCT01306617|3787547|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3965424|NCT01306617|3787548|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3965425|NCT01306617|3787549|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3965426|NCT01306617|3787546|B4|||Age||years|Mean|52.4|52.4|Standard Deviation|9.59|9.59|||
3965427|NCT01306617|3787547|B3|||Age||years|Mean|52.3|52.3|Standard Deviation|9.03|9.03|||
3965428|NCT01306617|3787548|B2|||Age||years|Mean|50.9|50.9|Standard Deviation|10.45|10.45|||
3965429|NCT01306617|3787549|B1|||Age||years|Mean|53.6|53.6|Standard Deviation|9.78|9.78|||
3965430|NCT01306305|3787592|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3965431|NCT01306305|3787593|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3965432|NCT01306305|3787594|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3965433|NCT01306305|3787592|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3965434|NCT01306305|3787593|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3965435|NCT01306305|3787594|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3965436|NCT01306305|3787592|B3|||Age||years|Mean|56.4|56.4|Standard Deviation|16.4|16.4|||
3965437|NCT01306305|3787593|B2|||Age||years|Mean|69.8|69.8|Standard Deviation|5.7|5.7|||
3965438|NCT01306305|3787594|B1|||Age||years|Mean|43.0|43.0|Standard Deviation|11.9|11.9|||
3965439|NCT01306292|3787609|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
3965440|NCT01306292|3787610|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
3965441|NCT01306292|3787611|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3965442|NCT01306292|3787609|B3||Male|Gender||Participants|Count of Participants|25|25.0||||||
3965443|NCT01306292|3787610|B2||Male|Gender||Participants|Count of Participants|12|12.0||||||
3965444|NCT01306292|3787611|B1||Male|Gender||Participants|Count of Participants|13|13.0||||||
3965445|NCT01306292|3787609|B3||Female|Gender||Participants|Count of Participants|11|11.0||||||
3965446|NCT01306292|3787610|B2||Female|Gender||Participants|Count of Participants|6|6.0||||||
3965447|NCT01306292|3787611|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
3965448|NCT01306292|3787609|B3|||Age||years|Mean|57.6|57.6|Standard Deviation|11.72|11.72|||
3965449|NCT01306292|3787610|B2|||Age||years|Mean|57.2|57.2|Standard Deviation|10.70|10.7|||
3965450|NCT01306292|3787611|B1|||Age||years|Mean|58.0|58.0|Standard Deviation|12.96|12.96|||
3965451|NCT01306292|3787609|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3965452|NCT01306292|3787610|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3965453|NCT01306292|3787611|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3965454|NCT01306292|3787609|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3965455|NCT01306292|3787610|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3965456|NCT01306292|3787611|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3965457|NCT01306292|3787609|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3965458|NCT01306292|3787610|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3965459|NCT01306292|3787611|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3965460|NCT01306253|3787630|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3965461|NCT01306253|3787631|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3965462|NCT01306253|3787632|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3965463|NCT01306253|3787630|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3965464|NCT01306253|3787631|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3965465|NCT01306253|3787632|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3965466|NCT01306253|3787630|B3|||Age||years|Mean|55.4|55.4|Standard Deviation|16.3|16.3|||
3965467|NCT01306253|3787631|B2|||Age||years|Mean|68.5|68.5|Standard Deviation|5.8|5.8|||
3965468|NCT01306253|3787632|B1|||Age||years|Mean|42.3|42.3|Standard Deviation|12.3|12.3|||
3965469|NCT01306214|3787647|B4||Male|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
3965470|NCT01306214|3787648|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3965471|NCT01306214|3787649|B2||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3965472|NCT01306214|3787650|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3965473|NCT01306214|3787647|B4||Female|Sex: Female, Male||Participants|Count of Participants|307|307.0||||||
3965474|NCT01306214|3787648|B3||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3965475|NCT01306214|3787649|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3965476|NCT01306214|3787650|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3965477|NCT01306214|3787647|B4|||Age||years|Mean|56.7|56.7|Standard Deviation|9.5|9.5|||
3965478|NCT01306214|3787648|B3|||Age||years|Mean|58.0|58.0|Standard Deviation|9.4|9.4|||
3965479|NCT01306214|3787649|B2|||Age||years|Mean|56.7|56.7|Standard Deviation|8.7|8.7|||
3965480|NCT01306214|3787650|B1|||Age||years|Mean|55.3|55.3|Standard Deviation|10.1|10.1|||
3965481|NCT01306201|3787669|B1|United States||Region of Enrollment||participants|Number|63|63.0||||||
3965482|NCT01306201|3787669|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3965483|NCT01306201|3787669|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3965484|NCT01306201|3787669|B1|||Age||years|Mean|47|47.0|Standard Deviation|15|15.0|||
3965485|NCT01306201|3787669|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3965486|NCT01306201|3787669|B1||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
3965487|NCT01306201|3787669|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3965488|NCT01306175|3787677|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3965489|NCT01306175|3787677|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3965490|NCT01306175|3787677|B1|||Age||years|Mean|34.3|34.3|Standard Deviation|8.1|8.1|||
3965491|NCT01306162|3787687|B5||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3965492|NCT01306162|3787688|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3965493|NCT01306162|3787689|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3965494|NCT01306162|3787690|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3965495|NCT01306162|3787691|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3965496|NCT01306162|3787687|B5||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3965497|NCT01306162|3787688|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3965498|NCT01306162|3787689|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3965499|NCT01306162|3787690|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3965500|NCT01306162|3787691|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3965501|NCT01306162|3787687|B5|||Age||Years|Mean|35.4|35.4|Standard Deviation|9.6|9.6|||
3965502|NCT01306162|3787688|B4|||Age||Years|Mean|33.3|33.3|Standard Deviation|7.9|7.9|||
3965503|NCT01306162|3787689|B3|||Age||Years|Mean|38.1|38.1|Standard Deviation|9.7|9.7|||
3965504|NCT01306162|3787690|B2|||Age||Years|Mean|37.8|37.8|Standard Deviation|10.4|10.4|||
3965505|NCT01306162|3787691|B1|||Age||Years|Mean|32.2|32.2|Standard Deviation|10.7|10.7|||
3965506|NCT01306058|3787722|B1|Fibrolamellar||Participants with Hepatocellular Cancer & Fibrolamellar|HCC is liver cancer usually found in patients with cirrhosis or liver disease. Fibolamellar is a rare form of HCC. The tumor cells are mixed with fibrous layers.|Participants|Count of Participants|1|1.0||||||
3965507|NCT01306058|3787722|B1|Hepatocellular Cancer (HCC)||Participants with Hepatocellular Cancer & Fibrolamellar|HCC is liver cancer usually found in patients with cirrhosis or liver disease. Fibolamellar is a rare form of HCC. The tumor cells are mixed with fibrous layers.|Participants|Count of Participants|24|24.0||||||
3965508|NCT01306058|3787722|B1|Grade 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Grade 0 is normal activity. Fully active, able to carry on all-pre-disease performance without restriction. Grade 1 is symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature. Grade 2 is in bed <50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Grade 3 is in bed >50% of the time. Capable of only limited self-care, confined to bed or chair more than 50% of waking hours. Grade 4 is 100% bedridden. Completely disabled. Grade 5 is dead.|Participants|Count of Participants|17|17.0||||||
3965509|NCT01306058|3787722|B1|Grade 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Grade 0 is normal activity. Fully active, able to carry on all-pre-disease performance without restriction. Grade 1 is symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature. Grade 2 is in bed <50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Grade 3 is in bed >50% of the time. Capable of only limited self-care, confined to bed or chair more than 50% of waking hours. Grade 4 is 100% bedridden. Completely disabled. Grade 5 is dead.|Participants|Count of Participants|8|8.0||||||
3965510|NCT01306058|3787722|B1|No||Number of Participants with Liver Cirrhosis|Cirrhosis is scar tissue on the liver.|Participants|Count of Participants|10|10.0||||||
3965511|NCT01306058|3787722|B1|Yes||Number of Participants with Liver Cirrhosis|Cirrhosis is scar tissue on the liver.|Participants|Count of Participants|15|15.0||||||
3965512|NCT01306058|3787722|B1|Transplant||Prior Therapies|Of note, some patients received more than one prior therapeutic intervention. Transcatheter arterial chemoembolization (TACE) is performed to restrict blood flow. Ablation is a procedure to destroy cardiac tissue. Radioembolization is a combination of embolization and radiation therapy to treat liver cancer. Locoregional is a recurrence of cancer at the same original site of disease. Transplant refers to a liver transplant.|Participants|Count of Participants|2|2.0||||||
3965513|NCT01306058|3787722|B1|Radioembolization||Prior Therapies|Of note, some patients received more than one prior therapeutic intervention. Transcatheter arterial chemoembolization (TACE) is performed to restrict blood flow. Ablation is a procedure to destroy cardiac tissue. Radioembolization is a combination of embolization and radiation therapy to treat liver cancer. Locoregional is a recurrence of cancer at the same original site of disease. Transplant refers to a liver transplant.|Participants|Count of Participants|2|2.0||||||
3965514|NCT01306058|3787722|B1|Ablation||Prior Therapies|Of note, some patients received more than one prior therapeutic intervention. Transcatheter arterial chemoembolization (TACE) is performed to restrict blood flow. Ablation is a procedure to destroy cardiac tissue. Radioembolization is a combination of embolization and radiation therapy to treat liver cancer. Locoregional is a recurrence of cancer at the same original site of disease. Transplant refers to a liver transplant.|Participants|Count of Participants|2|2.0||||||
3965515|NCT01306058|3787722|B1|Surgery||Prior Therapies|Of note, some patients received more than one prior therapeutic intervention. Transcatheter arterial chemoembolization (TACE) is performed to restrict blood flow. Ablation is a procedure to destroy cardiac tissue. Radioembolization is a combination of embolization and radiation therapy to treat liver cancer. Locoregional is a recurrence of cancer at the same original site of disease. Transplant refers to a liver transplant.|Participants|Count of Participants|5|5.0||||||
3965540|NCT01306058|3787722|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3965541|NCT01306058|3787722|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3965516|NCT01306058|3787722|B1|Previous TACE||Prior Therapies|Of note, some patients received more than one prior therapeutic intervention. Transcatheter arterial chemoembolization (TACE) is performed to restrict blood flow. Ablation is a procedure to destroy cardiac tissue. Radioembolization is a combination of embolization and radiation therapy to treat liver cancer. Locoregional is a recurrence of cancer at the same original site of disease. Transplant refers to a liver transplant.|Participants|Count of Participants|8|8.0||||||
3965517|NCT01306058|3787722|B1|≥2 locoregional procedures||Prior Therapies|Of note, some patients received more than one prior therapeutic intervention. Transcatheter arterial chemoembolization (TACE) is performed to restrict blood flow. Ablation is a procedure to destroy cardiac tissue. Radioembolization is a combination of embolization and radiation therapy to treat liver cancer. Locoregional is a recurrence of cancer at the same original site of disease. Transplant refers to a liver transplant.|Participants|Count of Participants|7|7.0||||||
3965518|NCT01306058|3787722|B1|No prior intervention||Prior Therapies|Of note, some patients received more than one prior therapeutic intervention. Transcatheter arterial chemoembolization (TACE) is performed to restrict blood flow. Ablation is a procedure to destroy cardiac tissue. Radioembolization is a combination of embolization and radiation therapy to treat liver cancer. Locoregional is a recurrence of cancer at the same original site of disease. Transplant refers to a liver transplant.|Participants|Count of Participants|9|9.0||||||
3965519|NCT01306058|3787722|B1|No||Number of Participants with Extrahepatic disease|Extrahepatic is defined as disease outside of the liver.|Participants|Count of Participants|8|8.0||||||
3965520|NCT01306058|3787722|B1|Yes||Number of Participants with Extrahepatic disease|Extrahepatic is defined as disease outside of the liver.|Participants|Count of Participants|17|17.0||||||
3965521|NCT01306058|3787722|B1|NA||Baseline Child Pugh Score|The Modified Child-Pugh classifies the severity of liver disease according to the degree of ascites, plasma concentrations of bilirubin and albumin, the prothrombin time and degree of encephalopathy. A total score of 5-6 is considered grade A (well-compensated disease); 7-9 grade B (significant functional compromise) and 10-15 is grade C (decompensated disease). NA = not all patients had cirrhosis. You only do a Pugh Score if cirrhosis is present.|Participants|Count of Participants|10|10.0||||||
3965522|NCT01306058|3787722|B1|Child Pugh Score - 7||Baseline Child Pugh Score|The Modified Child-Pugh classifies the severity of liver disease according to the degree of ascites, plasma concentrations of bilirubin and albumin, the prothrombin time and degree of encephalopathy. A total score of 5-6 is considered grade A (well-compensated disease); 7-9 grade B (significant functional compromise) and 10-15 is grade C (decompensated disease). NA = not all patients had cirrhosis. You only do a Pugh Score if cirrhosis is present.|Participants|Count of Participants|1|1.0||||||
3965523|NCT01306058|3787722|B1|Child Pugh Score - 6||Baseline Child Pugh Score|The Modified Child-Pugh classifies the severity of liver disease according to the degree of ascites, plasma concentrations of bilirubin and albumin, the prothrombin time and degree of encephalopathy. A total score of 5-6 is considered grade A (well-compensated disease); 7-9 grade B (significant functional compromise) and 10-15 is grade C (decompensated disease). NA = not all patients had cirrhosis. You only do a Pugh Score if cirrhosis is present.|Participants|Count of Participants|4|4.0||||||
3965524|NCT01306058|3787722|B1|Child Pugh Score - 5||Baseline Child Pugh Score|The Modified Child-Pugh classifies the severity of liver disease according to the degree of ascites, plasma concentrations of bilirubin and albumin, the prothrombin time and degree of encephalopathy. A total score of 5-6 is considered grade A (well-compensated disease); 7-9 grade B (significant functional compromise) and 10-15 is grade C (decompensated disease). NA = not all patients had cirrhosis. You only do a Pugh Score if cirrhosis is present.|Participants|Count of Participants|10|10.0||||||
3965525|NCT01306058|3787722|B1|Hematochromatosis||Participant Etiology of Hepatocellular Cancer (HCC)|Hepatitis B virus is a viral infection that affects the liver. Hepatitis C virus is a virus spread by infected blood (e.g. share needles). Crytogenic means the cause of the disease is unknown. Hematochromatosis is an iron disorder in which the body has an excess of iron in the blood.|Participants|Count of Participants|1|1.0||||||
3965526|NCT01306058|3787722|B1|Cryptogenic||Participant Etiology of Hepatocellular Cancer (HCC)|Hepatitis B virus is a viral infection that affects the liver. Hepatitis C virus is a virus spread by infected blood (e.g. share needles). Crytogenic means the cause of the disease is unknown. Hematochromatosis is an iron disorder in which the body has an excess of iron in the blood.|Participants|Count of Participants|6|6.0||||||
3965527|NCT01306058|3787722|B1|Hepatitis C Virus (HCV)||Participant Etiology of Hepatocellular Cancer (HCC)|Hepatitis B virus is a viral infection that affects the liver. Hepatitis C virus is a virus spread by infected blood (e.g. share needles). Crytogenic means the cause of the disease is unknown. Hematochromatosis is an iron disorder in which the body has an excess of iron in the blood.|Participants|Count of Participants|15|15.0||||||
3965528|NCT01306058|3787722|B1|Hepatitis B Virus (HBV)||Participant Etiology of Hepatocellular Cancer (HCC)|Hepatitis B virus is a viral infection that affects the liver. Hepatitis C virus is a virus spread by infected blood (e.g. share needles). Crytogenic means the cause of the disease is unknown. Hematochromatosis is an iron disorder in which the body has an excess of iron in the blood.|Participants|Count of Participants|3|3.0||||||
3965529|NCT01306058|3787722|B1|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3965530|NCT01306058|3787722|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3965531|NCT01306058|3787722|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965532|NCT01306058|3787722|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3965533|NCT01306058|3787722|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3965534|NCT01306058|3787722|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965535|NCT01306058|3787722|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3965536|NCT01306058|3787722|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3965537|NCT01306058|3787722|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965538|NCT01306058|3787722|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3965539|NCT01306058|3787722|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3965542|NCT01306058|3787722|B1|||Age||years|Mean|55.3|55.3|Standard Deviation|13|13.0|||
3965543|NCT01306058|3787722|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3965544|NCT01306058|3787722|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3965545|NCT01306058|3787722|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3965546|NCT01306032|3787743|B7|Canada||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3965547|NCT01306032|3787744|B6|Canada||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3965548|NCT01306032|3787745|B5|Canada||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3965549|NCT01306032|3787746|B4|Canada||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3965550|NCT01306032|3787747|B3|Canada||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3965551|NCT01306032|3787748|B2|Canada||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3965552|NCT01306032|3787749|B1|Canada||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3965553|NCT01306032|3787743|B7|United States||Region of Enrollment||Participants|Count of Participants|89|89.0||||||
3965554|NCT01306032|3787744|B6|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3965555|NCT01306032|3787745|B5|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3965556|NCT01306032|3787746|B4|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3965557|NCT01306032|3787747|B3|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3965558|NCT01306032|3787748|B2|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3965559|NCT01306032|3787749|B1|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3965560|NCT01306032|3787743|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965561|NCT01306032|3787744|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965562|NCT01306032|3787745|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965563|NCT01306032|3787746|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965564|NCT01306032|3787747|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965565|NCT01306032|3787748|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965566|NCT01306032|3787749|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965567|NCT01306032|3787743|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965568|NCT01306032|3787744|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965569|NCT01306032|3787745|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965570|NCT01306032|3787746|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965571|NCT01306032|3787747|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965572|NCT01306032|3787748|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965573|NCT01306032|3787749|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965574|NCT01306032|3787743|B7||White|Race (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
3965575|NCT01306032|3787744|B6||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3965576|NCT01306032|3787745|B5||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3965577|NCT01306032|3787746|B4||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3965578|NCT01306032|3787747|B3||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3965579|NCT01306032|3787748|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3965580|NCT01306032|3787749|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3965581|NCT01306032|3787743|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3965582|NCT01306032|3787744|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965583|NCT01306032|3787745|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965584|NCT01306032|3787746|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965585|NCT01306032|3787747|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965586|NCT01306032|3787748|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3965587|NCT01306032|3787749|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3965588|NCT01306032|3787743|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965589|NCT01306032|3787744|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965590|NCT01306032|3787745|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965591|NCT01306032|3787746|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965592|NCT01306032|3787747|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965593|NCT01306032|3787748|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965594|NCT01306032|3787749|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965595|NCT01306032|3787743|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3965596|NCT01306032|3787744|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965597|NCT01306032|3787745|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965598|NCT01306032|3787746|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3965599|NCT01306032|3787747|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3965600|NCT01306032|3787748|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3965601|NCT01306032|3787749|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3965602|NCT01306032|3787743|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965603|NCT01306032|3787744|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965604|NCT01306032|3787745|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965605|NCT01306032|3787746|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965606|NCT01306032|3787747|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965607|NCT01306032|3787748|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965608|NCT01306032|3787749|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965609|NCT01306032|3787743|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3965610|NCT01306032|3787744|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965611|NCT01306032|3787745|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3965612|NCT01306032|3787746|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3965613|NCT01306032|3787747|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965614|NCT01306032|3787748|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3965615|NCT01306032|3787749|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3965616|NCT01306032|3787743|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
3965617|NCT01306032|3787744|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3965618|NCT01306032|3787745|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3965619|NCT01306032|3787746|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3965620|NCT01306032|3787747|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3965621|NCT01306032|3787748|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3965622|NCT01306032|3787749|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3965623|NCT01306032|3787743|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3965624|NCT01306032|3787744|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965625|NCT01306032|3787745|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965626|NCT01306032|3787746|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3965627|NCT01306032|3787747|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3965628|NCT01306032|3787748|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3965629|NCT01306032|3787749|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3965630|NCT01306032|3787743|B7||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3965631|NCT01306032|3787744|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3965632|NCT01306032|3787745|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3965633|NCT01306032|3787746|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3965634|NCT01306032|3787747|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3965635|NCT01306032|3787748|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3965636|NCT01306032|3787749|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3965637|NCT01306032|3787743|B7||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3965638|NCT01306032|3787744|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3965639|NCT01306032|3787745|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3965640|NCT01306032|3787746|B4||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3965641|NCT01306032|3787747|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3965642|NCT01306032|3787748|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3965643|NCT01306032|3787749|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3965644|NCT01306032|3787743|B7|||Age||years|Mean|57|57.0|Standard Deviation|11|11.0|||
3965645|NCT01306032|3787744|B6|||Age||years|Mean|56|56.0|Standard Deviation|6|6.0|||
3965646|NCT01306032|3787745|B5|||Age||years|Mean|70|70.0|Standard Deviation|24|24.0|||
3965647|NCT01306032|3787746|B4|||Age||years|Mean|58|58.0|Standard Deviation|10|10.0|||
3965648|NCT01306032|3787747|B3|||Age||years|Mean|57|57.0|Standard Deviation|10|10.0|||
3965649|NCT01306032|3787748|B2|||Age||years|Mean|53|53.0|Standard Deviation|13|13.0|||
3965650|NCT01306032|3787749|B1|||Age||years|Mean|55|55.0|Standard Deviation|10|10.0|||
3965651|NCT01306032|3787743|B7||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
3965652|NCT01306032|3787744|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3965653|NCT01306032|3787745|B5||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3965654|NCT01306032|3787746|B4||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3965655|NCT01306032|3787747|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3965656|NCT01306032|3787748|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3965657|NCT01306032|3787749|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3965658|NCT01306032|3787743|B7||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
3965659|NCT01306032|3787744|B6||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3965660|NCT01306032|3787745|B5||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3965661|NCT01306032|3787746|B4||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3965662|NCT01306032|3787747|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3965663|NCT01306032|3787748|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3965664|NCT01306032|3787749|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3965665|NCT01306032|3787743|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3965666|NCT01306032|3787744|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3965667|NCT01306032|3787745|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3965668|NCT01306032|3787746|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3965669|NCT01306032|3787747|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3965670|NCT01306032|3787748|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3965671|NCT01306032|3787749|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3965672|NCT01305941|3787806|B1|||Extracranial disease at enrollment|Outside of the cranium (bones that surround the brain).|Participants|Count of Participants|20|20.0||||||
3965673|NCT01305941|3787806|B1|||Steroid use at baseline|Treatment with corticosteroid drugs to reduce swelling, pain, and other symptoms of inflammation.|Participants|Count of Participants|10|10.0||||||
3965674|NCT01305941|3787806|B1||Class 3|Recursive Partitioning Analysis (RPA) Score|"Recursive partitioning creates a decision tree that classifies members of a population by splitting it into sub-populations based on several dichotomous independent variables. The process is termed recursive because each sub-population may in turn be split an indefinite number of times.~This includes three classes: Class 1 (patients <65 years, ECOG Performance Status of 0-1, controlled primary tumor, and no extracranial metastases), Class 3 (ECOG Performance Status of 2 or greater), and Class 2 (all others);"|Participants|Count of Participants|1|1.0||||||
3965675|NCT01305941|3787806|B1||Class 2|Recursive Partitioning Analysis (RPA) Score|"Recursive partitioning creates a decision tree that classifies members of a population by splitting it into sub-populations based on several dichotomous independent variables. The process is termed recursive because each sub-population may in turn be split an indefinite number of times.~This includes three classes: Class 1 (patients <65 years, ECOG Performance Status of 0-1, controlled primary tumor, and no extracranial metastases), Class 3 (ECOG Performance Status of 2 or greater), and Class 2 (all others);"|Participants|Count of Participants|21|21.0||||||
3965676|NCT01305941|3787806|B1||Class 1|Recursive Partitioning Analysis (RPA) Score|"Recursive partitioning creates a decision tree that classifies members of a population by splitting it into sub-populations based on several dichotomous independent variables. The process is termed recursive because each sub-population may in turn be split an indefinite number of times.~This includes three classes: Class 1 (patients <65 years, ECOG Performance Status of 0-1, controlled primary tumor, and no extracranial metastases), Class 3 (ECOG Performance Status of 2 or greater), and Class 2 (all others);"|Participants|Count of Participants|10|10.0||||||
3965677|NCT01305941|3787806|B1|Stereotactic Radiosurgery (SRS)||Prior Central Nervous System Local Therapy||Participants|Count of Participants|17|17.0||||||
3965678|NCT01305941|3787806|B1|Whole brain radiation therapy||Prior Central Nervous System Local Therapy||Participants|Count of Participants|22|22.0||||||
3965679|NCT01305941|3787806|B1|Surgery||Prior Central Nervous System Local Therapy||Participants|Count of Participants|10|10.0||||||
3965680|NCT01305941|3787806|B1|Trastuzumab Emtansine (TDM-1)||Prior anti-Her2 (metastatic) Agents||Participants|Count of Participants|8|8.0||||||
3965681|NCT01305941|3787806|B1|Pertuzumab||Prior anti-Her2 (metastatic) Agents||Participants|Count of Participants|12|12.0||||||
3965682|NCT01305941|3787806|B1|Lapatinib||Prior anti-Her2 (metastatic) Agents||Participants|Count of Participants|22|22.0||||||
3965683|NCT01305941|3787806|B1|Trastuzumab||Prior anti-Her2 (metastatic) Agents||Participants|Count of Participants|29|29.0||||||
3965684|NCT01305941|3787806|B1|||Prior metastatic chemotherapy lines, # (range)||Metastatic Lines|Median|2|2.0|Full Range|||0.0|7.0|
3965685|NCT01305941|3787806|B1|||Prior Systemic Chemotherapy (metastatic)|Number of participants who received prior systemic chemotherapy.|Participants|Count of Participants|30|30.0||||||
3965686|NCT01305941|3787806|B1|||Median time since first brain metastases (years)||years|Median|1.12|1.12|Full Range|||0.4|6.5|
3965687|NCT01305941|3787806|B1||IV|Stage at breast cancer diagnosis|"Anatomic stage for NSCLC is the American Joint Committee on Cancer (AJCC) tumor, node, and metastases (TNM) system, which is based on:~Size of primary tumor (T) and whether it has grown into nearby areas. Spread to regional lymph nodes (N). Spread (metastasis; M) to other organs of the body. Once the T, N, and M categories have been determined, this information is combined into a prognostic group. Higher numbers mean the cancer is more advanced."|Participants|Count of Participants|13|13.0||||||
3965688|NCT01305941|3787806|B1||0-III|Stage at breast cancer diagnosis|"Anatomic stage for NSCLC is the American Joint Committee on Cancer (AJCC) tumor, node, and metastases (TNM) system, which is based on:~Size of primary tumor (T) and whether it has grown into nearby areas. Spread to regional lymph nodes (N). Spread (metastasis; M) to other organs of the body. Once the T, N, and M categories have been determined, this information is combined into a prognostic group. Higher numbers mean the cancer is more advanced."|Participants|Count of Participants|19|19.0||||||
3965689|NCT01305941|3787806|B1|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3965690|NCT01305941|3787806|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3965691|NCT01305941|3787806|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965692|NCT01305941|3787806|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3965693|NCT01305941|3787806|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3965694|NCT01305941|3787806|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965695|NCT01305941|3787806|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3965696|NCT01305941|3787806|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965697|NCT01305941|3787806|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3965698|NCT01305941|3787806|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3965699|NCT01305941|3787806|B1|||Age||years|Median|53|53.0|Full Range|||28.0|70.0|
3965700|NCT01305811|3787818|B3|United States||Region of Enrollment||participants|Number|104|104.0||||||
3965701|NCT01305811|3787819|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
3965702|NCT01305811|3787820|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
3965703|NCT01305811|3787818|B3||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3965704|NCT01305811|3787819|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3965705|NCT01305811|3787820|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3965706|NCT01305811|3787818|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3965707|NCT01305811|3787819|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3965708|NCT01305811|3787820|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3965709|NCT01305811|3787818|B3|||Age||years|Mean|48.2|48.2|Standard Deviation|6.7|6.7|||
3965710|NCT01305811|3787819|B2|||Age||years|Mean|48.2|48.2|Standard Deviation|3.5|3.5|||
3965711|NCT01305811|3787820|B1|||Age||years|Mean|48.2|48.2|Standard Deviation|9.9|9.9|||
3965712|NCT01305811|3787818|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3965713|NCT01305811|3787819|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3965714|NCT01305811|3787820|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3965715|NCT01305811|3787818|B3||Between 18 and 65 years|Age||Participants|Count of Participants|104|104.0||||||
3965716|NCT01305811|3787819|B2||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3965717|NCT01305811|3787820|B1||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3965718|NCT01305811|3787818|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3965719|NCT01305811|3787819|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3965720|NCT01305811|3787820|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3965721|NCT01305772|3787829|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3965722|NCT01305772|3787830|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3965723|NCT01305772|3787831|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3965724|NCT01305772|3787829|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3965725|NCT01305772|3787830|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3965726|NCT01305772|3787831|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3965727|NCT01305772|3787829|B3|||Age||years|Mean|65.33|65.33|Standard Deviation|6.22|6.22|||
3965728|NCT01305772|3787830|B2|||Age||years|Mean|69|69.0|Standard Deviation|NA||||Cannot measure uncertainty about one (1) subject.
3965729|NCT01305772|3787831|B1|||Age||years|Mean|64.60|64.6|Standard Deviation|6.66|6.66|||
3965730|NCT01305655|3787839|B1|Lithuania||Region of Enrollment||participants|Number|3|3.0||||||
3965731|NCT01305655|3787839|B1|Iceland||Region of Enrollment||participants|Number|2|2.0||||||
3965732|NCT01305655|3787839|B1|Denmark||Region of Enrollment||participants|Number|11|11.0||||||
3965733|NCT01305655|3787839|B1|Finland||Region of Enrollment||participants|Number|1|1.0||||||
3965734|NCT01305655|3787839|B1|Norway||Region of Enrollment||participants|Number|16|16.0||||||
3965735|NCT01305655|3787839|B1|Sweden||Region of Enrollment||participants|Number|14|14.0||||||
3965736|NCT01305655|3787839|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3965737|NCT01305655|3787839|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3965738|NCT01305655|3787839|B1|||Age|Children 1-18 years|years|Median|7.5|7.5|Standard Deviation|4.89|4.89|||
3965739|NCT01305655|3787839|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3965740|NCT01305655|3787839|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3965741|NCT01305655|3787839|B1||<=18 years|Age||Participants|Count of Participants|47|47.0||||||
3965742|NCT01305577|3787843|B4|IV-VI||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|47|47.0||||||
3965743|NCT01305577|3787844|B3|IV-VI||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|23|23.0||||||
3965781|NCT01305577|3787846|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3965782|NCT01305577|3787843|B4||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3965783|NCT01305577|3787844|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3965784|NCT01305577|3787845|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3965744|NCT01305577|3787845|B2|IV-VI||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|12|12.0||||||
3965745|NCT01305577|3787846|B1|IV-VI||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|12|12.0||||||
3965746|NCT01305577|3787843|B4|I-III||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|316|316.0||||||
3965747|NCT01305577|3787844|B3|I-III||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|99|99.0||||||
3965748|NCT01305577|3787845|B2|I-III||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|109|109.0||||||
3965749|NCT01305577|3787846|B1|I-III||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|108|108.0||||||
3965750|NCT01305577|3787843|B4|||Body Mass Index (BMI)||kg/m²|Mean|25.71|25.71|Standard Deviation|2.850|2.85|||
3965751|NCT01305577|3787844|B3|||Body Mass Index (BMI)||kg/m²|Mean|25.54|25.54|Standard Deviation|2.758|2.758|||
3965752|NCT01305577|3787845|B2|||Body Mass Index (BMI)||kg/m²|Mean|25.66|25.66|Standard Deviation|3.063|3.063|||
3965753|NCT01305577|3787846|B1|||Body Mass Index (BMI)||kg/m²|Mean|25.94|25.94|Standard Deviation|2.724|2.724|||
3965754|NCT01305577|3787843|B4|||Weight||kg|Mean|73.62|73.62|Standard Deviation|11.994|11.994|||
3965755|NCT01305577|3787844|B3|||Weight||kg|Mean|73.50|73.5|Standard Deviation|12.126|12.126|||
3965756|NCT01305577|3787845|B2|||Weight||kg|Mean|73.53|73.53|Standard Deviation|12.413|12.413|||
3965757|NCT01305577|3787846|B1|||Weight||kg|Mean|73.83|73.83|Standard Deviation|11.518|11.518|||
3965758|NCT01305577|3787843|B4|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3965759|NCT01305577|3787844|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3965760|NCT01305577|3787845|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3965761|NCT01305577|3787846|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3965762|NCT01305577|3787843|B4|White||Race/Ethnicity, Customized||participants|Number|344|344.0||||||
3965763|NCT01305577|3787844|B3|White||Race/Ethnicity, Customized||participants|Number|117|117.0||||||
3965764|NCT01305577|3787845|B2|White||Race/Ethnicity, Customized||participants|Number|116|116.0||||||
3965765|NCT01305577|3787846|B1|White||Race/Ethnicity, Customized||participants|Number|111|111.0||||||
3965766|NCT01305577|3787843|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3965767|NCT01305577|3787844|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3965768|NCT01305577|3787845|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3965769|NCT01305577|3787846|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3965770|NCT01305577|3787843|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3965771|NCT01305577|3787844|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3965772|NCT01305577|3787845|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3965773|NCT01305577|3787846|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3965774|NCT01305577|3787843|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3965775|NCT01305577|3787844|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3965776|NCT01305577|3787845|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3965777|NCT01305577|3787846|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3965778|NCT01305577|3787843|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3965779|NCT01305577|3787844|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3965780|NCT01305577|3787845|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3965785|NCT01305577|3787846|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3965786|NCT01305577|3787843|B4||Female|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
3965787|NCT01305577|3787844|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3965788|NCT01305577|3787845|B2||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3965789|NCT01305577|3787846|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3965790|NCT01305577|3787843|B4|51 - 65 years||Age, Customized||participants|Number|135|135.0||||||
3965791|NCT01305577|3787844|B3|51 - 65 years||Age, Customized||participants|Number|50|50.0||||||
3965792|NCT01305577|3787845|B2|51 - 65 years||Age, Customized||participants|Number|42|42.0||||||
3965793|NCT01305577|3787846|B1|51 - 65 years||Age, Customized||participants|Number|43|43.0||||||
3965794|NCT01305577|3787843|B4|18 - 50 years||Age, Customized||participants|Number|228|228.0||||||
3965795|NCT01305577|3787844|B3|18 - 50 years||Age, Customized||participants|Number|72|72.0||||||
3965796|NCT01305577|3787845|B2|18 - 50 years||Age, Customized||participants|Number|79|79.0||||||
3965797|NCT01305577|3787846|B1|18 - 50 years||Age, Customized||participants|Number|77|77.0||||||
3965798|NCT01305577|3787843|B4|||Age||years|Mean|46.4|46.4|Standard Deviation|10.28|10.28|||
3965799|NCT01305577|3787844|B3|||Age||years|Mean|46.6|46.6|Standard Deviation|10.17|10.17|||
3965800|NCT01305577|3787845|B2|||Age||years|Mean|46.7|46.7|Standard Deviation|9.78|9.78|||
3965801|NCT01305577|3787846|B1|||Age||years|Mean|45.8|45.8|Standard Deviation|10.94|10.94|||
3965802|NCT01305564|3787877|B1|United States||Region of Enrollment||participants|Number|200|200.0||||||
3965803|NCT01305564|3787877|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3965804|NCT01305564|3787877|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965805|NCT01305564|3787877|B1||White|Race (NIH/OMB)||Participants|Count of Participants|164|164.0||||||
3965806|NCT01305564|3787877|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3965807|NCT01305564|3787877|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965808|NCT01305564|3787877|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965809|NCT01305564|3787877|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3965810|NCT01305564|3787877|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965811|NCT01305564|3787877|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|189|189.0||||||
3965812|NCT01305564|3787877|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3965813|NCT01305564|3787877|B1||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3965814|NCT01305564|3787877|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3965815|NCT01305564|3787877|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|15.63|15.63|||
3965816|NCT01305473|3787892|B1|Umbilical and Incisional||Hernia Classification|Type of hernia subject had repaired during the index procedure: umbilical, incisional, or umbilical and incisional.|participants|Number|5|5.0||||||
3965817|NCT01305473|3787892|B1|Incisional||Hernia Classification|Type of hernia subject had repaired during the index procedure: umbilical, incisional, or umbilical and incisional.|participants|Number|42|42.0||||||
3965818|NCT01305473|3787892|B1|Umbilical||Hernia Classification|Type of hernia subject had repaired during the index procedure: umbilical, incisional, or umbilical and incisional.|participants|Number|43|43.0||||||
3965819|NCT01305473|3787892|B1|||Body Mass Index||kilograms per square meter|Mean|33.9|33.9|Standard Deviation|7.36|7.36|||
3965820|NCT01305473|3787892|B1|||Height||centimeters|Mean|170.3|170.3|Standard Deviation|10.16|10.16|||
3965821|NCT01305473|3787892|B1|||Weight||kilograms|Mean|98.5|98.5|Standard Deviation|23.92|23.92|||
3965822|NCT01305473|3787892|B1|United States||Region of Enrollment||participants|Number|90|90.0||||||
3965823|NCT01305473|3787892|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3965824|NCT01305473|3787892|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965825|NCT01305473|3787892|B1||White|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3965826|NCT01305473|3787892|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3965827|NCT01305473|3787892|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965828|NCT01305473|3787892|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3965829|NCT01305473|3787892|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965830|NCT01305473|3787892|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965831|NCT01305473|3787892|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
3965832|NCT01305473|3787892|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965833|NCT01305473|3787892|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3965834|NCT01305473|3787892|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3965835|NCT01305473|3787892|B1|||Age||years|Mean|56.0|56.0|Standard Deviation|12.23|12.23|||
3965836|NCT01305408|3787902|B3|||Time Since First Diagnosis for Bipolar||years|Mean|10.3|10.3|Standard Deviation|8.63|8.63|||
3965837|NCT01305408|3787903|B2|||Time Since First Diagnosis for Bipolar||years|Mean|10.7|10.7|Standard Deviation|8.55|8.55|||
3965838|NCT01305408|3787904|B1|||Time Since First Diagnosis for Bipolar||years|Mean|9.9|9.9|Standard Deviation|8.72|8.72|||
3965839|NCT01305408|3787902|B3|||Time Since Start of Current Depressive Episode||weeks|Mean|12.2|12.2|Standard Deviation|9.49|9.49|||
3965840|NCT01305408|3787903|B2|||Time Since Start of Current Depressive Episode||weeks|Mean|12.3|12.3|Standard Deviation|9.89|9.89|||
3965841|NCT01305408|3787904|B1|||Time Since Start of Current Depressive Episode||weeks|Mean|12.1|12.1|Standard Deviation|9.10|9.1|||
3965842|NCT01305408|3787902|B3|||Body Mass Index||kg/m^2|Mean|28.4|28.4|Standard Deviation|5.73|5.73|||
3965843|NCT01305408|3787903|B2|||Body Mass Index||kg/m^2|Mean|28.2|28.2|Standard Deviation|5.52|5.52|||
3965844|NCT01305408|3787904|B1|||Body Mass Index||kg/m^2|Mean|28.7|28.7|Standard Deviation|5.95|5.95|||
3965845|NCT01305408|3787902|B3|||Height||cm|Mean|168.6|168.6|Standard Deviation|9.27|9.27|||
3965846|NCT01305408|3787903|B2|||Height||cm|Mean|168.9|168.9|Standard Deviation|9.23|9.23|||
3965847|NCT01305408|3787904|B1|||Height||cm|Mean|168.4|168.4|Standard Deviation|9.32|9.32|||
3965848|NCT01305408|3787902|B3|||Weight||kg|Mean|80.9|80.9|Standard Deviation|17.48|17.48|||
3965849|NCT01305408|3787903|B2|||Weight||kg|Mean|80.7|80.7|Standard Deviation|17.54|17.54|||
3965850|NCT01305408|3787904|B1|||Weight||kg|Mean|81.2|81.2|Standard Deviation|17.46|17.46|||
3965851|NCT01305408|3787902|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3965852|NCT01305408|3787903|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965853|NCT01305408|3787904|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3965854|NCT01305408|3787902|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965855|NCT01305408|3787903|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965856|NCT01305408|3787904|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965857|NCT01305408|3787902|B3||White|Race (NIH/OMB)||Participants|Count of Participants|358|358.0||||||
3965858|NCT01305408|3787903|B2||White|Race (NIH/OMB)||Participants|Count of Participants|182|182.0||||||
3965859|NCT01305408|3787904|B1||White|Race (NIH/OMB)||Participants|Count of Participants|176|176.0||||||
3965860|NCT01305408|3787902|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3965861|NCT01305408|3787903|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3965862|NCT01305408|3787904|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3965863|NCT01305408|3787902|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965864|NCT01305408|3787903|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965865|NCT01305408|3787904|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965866|NCT01305408|3787902|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3965867|NCT01305408|3787903|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3965868|NCT01305408|3787904|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3965869|NCT01305408|3787902|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3965870|NCT01305408|3787903|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3965871|NCT01305408|3787904|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3965872|NCT01305408|3787902|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3965873|NCT01305408|3787903|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3965874|NCT01305408|3787904|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3965875|NCT01305408|3787902|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|359|359.0||||||
3965876|NCT01305408|3787903|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|176|176.0||||||
3965877|NCT01305408|3787904|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|183|183.0||||||
3965878|NCT01305408|3787902|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3965879|NCT01305408|3787903|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3965880|NCT01305408|3787904|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3965881|NCT01305408|3787902|B3||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3965882|NCT01305408|3787903|B2||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3965883|NCT01305408|3787904|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3965884|NCT01305408|3787902|B3||Female|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
3965885|NCT01305408|3787903|B2||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3965886|NCT01305408|3787904|B1||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3965887|NCT01305408|3787902|B3|||Age||years|Mean|44.5|44.5|Standard Deviation|11.45|11.45|||
3965888|NCT01305408|3787903|B2|||Age||years|Mean|45.3|45.3|Standard Deviation|11.26|11.26|||
3965889|NCT01305408|3787904|B1|||Age||years|Mean|43.7|43.7|Standard Deviation|11.62|11.62|||
3965890|NCT01305356|3787955|B3||Yes|Ever smoked||Participants|Count of Participants|155|155.0||||||
3965891|NCT01305356|3787956|B2||Yes|Ever smoked||Participants|Count of Participants|84|84.0||||||
3965892|NCT01305356|3787957|B1||Yes|Ever smoked||Participants|Count of Participants|71|71.0||||||
3965893|NCT01305356|3787955|B3||No|Ever smoked||Participants|Count of Participants|144|144.0||||||
3965894|NCT01305356|3787956|B2||No|Ever smoked||Participants|Count of Participants|83|83.0||||||
3965895|NCT01305356|3787957|B1||No|Ever smoked||Participants|Count of Participants|61|61.0||||||
3965896|NCT01305356|3787955|B3||Triple arthordesis|Affected Foot/Ankle||Participants|Count of Participants|55|55.0||||||
3965897|NCT01305356|3787956|B2||Triple arthordesis|Affected Foot/Ankle||Participants|Count of Participants|36|36.0||||||
3965898|NCT01305356|3787957|B1||Triple arthordesis|Affected Foot/Ankle||Participants|Count of Participants|19|19.0||||||
3965899|NCT01305356|3787955|B3||Double fusion|Affected Foot/Ankle||Participants|Count of Participants|38|38.0||||||
3965900|NCT01305356|3787956|B2||Double fusion|Affected Foot/Ankle||Participants|Count of Participants|17|17.0||||||
3965901|NCT01305356|3787957|B1||Double fusion|Affected Foot/Ankle||Participants|Count of Participants|21|21.0||||||
3965902|NCT01305356|3787955|B3||Talonavicular fusion|Affected Foot/Ankle||Participants|Count of Participants|15|15.0||||||
3965903|NCT01305356|3787956|B2||Talonavicular fusion|Affected Foot/Ankle||Participants|Count of Participants|9|9.0||||||
3965904|NCT01305356|3787957|B1||Talonavicular fusion|Affected Foot/Ankle||Participants|Count of Participants|6|6.0||||||
3965905|NCT01305356|3787955|B3||Calcaneocuboid fusion|Affected Foot/Ankle||Participants|Count of Participants|3|3.0||||||
3965906|NCT01305356|3787956|B2||Calcaneocuboid fusion|Affected Foot/Ankle||Participants|Count of Participants|0|0.0||||||
3965907|NCT01305356|3787957|B1||Calcaneocuboid fusion|Affected Foot/Ankle||Participants|Count of Participants|3|3.0||||||
3965908|NCT01305356|3787955|B3||Subtalar fusion|Affected Foot/Ankle||Participants|Count of Participants|111|111.0||||||
3965909|NCT01305356|3787956|B2||Subtalar fusion|Affected Foot/Ankle||Participants|Count of Participants|59|59.0||||||
3965910|NCT01305356|3787957|B1||Subtalar fusion|Affected Foot/Ankle||Participants|Count of Participants|52|52.0||||||
3965911|NCT01305356|3787955|B3||Ankle fusion|Affected Foot/Ankle||Participants|Count of Participants|77|77.0||||||
3965912|NCT01305356|3787956|B2||Ankle fusion|Affected Foot/Ankle||Participants|Count of Participants|46|46.0||||||
3965913|NCT01305356|3787957|B1||Ankle fusion|Affected Foot/Ankle||Participants|Count of Participants|31|31.0||||||
3965914|NCT01305356|3787955|B3||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3965915|NCT01305356|3787956|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3965916|NCT01305356|3787957|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3965917|NCT01305356|3787955|B3||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3965918|NCT01305356|3787956|B2||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3965919|NCT01305356|3787957|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3965920|NCT01305356|3787955|B3||>=65 years|Age||Participants|Count of Participants|93|93.0||||||
3965921|NCT01305356|3787956|B2||>=65 years|Age||Participants|Count of Participants|58|58.0||||||
3965922|NCT01305356|3787957|B1||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
3965923|NCT01305356|3787955|B3||Between 18 and 65 years|Age||Participants|Count of Participants|206|206.0||||||
3965924|NCT01305356|3787956|B2||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
3965925|NCT01305356|3787957|B1||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
3965926|NCT01305356|3787955|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3965927|NCT01305356|3787956|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3965928|NCT01305356|3787957|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3965929|NCT01305265|3787972|B3|United States||Region of Enrollment||participants|Number|133|133.0||||||
3965930|NCT01305265|3787973|B2|United States||Region of Enrollment||participants|Number|64|64.0||||||
3965931|NCT01305265|3787974|B1|United States||Region of Enrollment||participants|Number|69|69.0||||||
3965932|NCT01305265|3787972|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3965933|NCT01305265|3787973|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3965934|NCT01305265|3787974|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3965935|NCT01305265|3787972|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3965936|NCT01305265|3787973|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3965937|NCT01305265|3787974|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3965938|NCT01305265|3787972|B3|||Age||years|Mean|51.4|51.4|Standard Deviation|14.9|14.9|||
3965939|NCT01305265|3787973|B2|||Age||years|Mean|50.3|50.3|Standard Deviation|13.8|13.8|||
3965940|NCT01305265|3787974|B1|||Age||years|Mean|52.4|52.4|Standard Deviation|15.8|15.8|||
3965941|NCT01305252|3787981|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3965942|NCT01305252|3787982|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3965943|NCT01305252|3787983|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3965944|NCT01305252|3787981|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3965945|NCT01305252|3787982|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3965946|NCT01305252|3787983|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3965947|NCT01305252|3787981|B3|||Age||years|Mean|51.9|51.9|Standard Deviation|10.3|10.3|||
3965948|NCT01305252|3787982|B2|||Age||years|Mean|52.1|52.1|Standard Deviation|9.7|9.7|||
3965949|NCT01305252|3787983|B1|||Age||years|Mean|51.6|51.6|Standard Deviation|11.4|11.4|||
3965950|NCT01305252|3787981|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3965951|NCT01305252|3787982|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3965952|NCT01305252|3787983|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3965953|NCT01305252|3787981|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3965954|NCT01305252|3787982|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3965955|NCT01305252|3787983|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3965956|NCT01305252|3787981|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3965957|NCT01305252|3787982|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3965958|NCT01305252|3787983|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3965959|NCT01305239|3787998|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3965960|NCT01305239|3787998|B1||Female|Sex: Female, Male||Participants|Count of Participants|397|397.0||||||
3965961|NCT01305239|3787998|B1|||Age|N = 392, number of participants with baseline age data.|years|Mean|63.1|63.1|Standard Deviation|10.3|10.3|||
3965962|NCT01305213|3788006|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3965963|NCT01305213|3788007|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3965964|NCT01305213|3788008|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3965965|NCT01305213|3788006|B3||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3965966|NCT01305213|3788007|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3965967|NCT01305213|3788008|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3965968|NCT01305213|3788006|B3|> = 80 years||Age, Customized||Participants|Count of Participants|7|7.0||||||
3965969|NCT01305213|3788007|B2|> = 80 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
3965970|NCT01305213|3788008|B1|> = 80 years||Age, Customized||Participants|Count of Participants|4|4.0||||||
3965971|NCT01305213|3788006|B3|70 - 79 years||Age, Customized||Participants|Count of Participants|32|32.0||||||
3965972|NCT01305213|3788007|B2|70 - 79 years||Age, Customized||Participants|Count of Participants|19|19.0||||||
3965973|NCT01305213|3788008|B1|70 - 79 years||Age, Customized||Participants|Count of Participants|13|13.0||||||
3965974|NCT01305213|3788006|B3|60 - 69 years||Age, Customized||Participants|Count of Participants|34|34.0||||||
3965975|NCT01305213|3788007|B2|60 - 69 years||Age, Customized||Participants|Count of Participants|15|15.0||||||
3965976|NCT01305213|3788008|B1|60 - 69 years||Age, Customized||Participants|Count of Participants|19|19.0||||||
3965977|NCT01305213|3788006|B3|50 - 59 years||Age, Customized||Participants|Count of Participants|24|24.0||||||
3965978|NCT01305213|3788007|B2|50 - 59 years||Age, Customized||Participants|Count of Participants|12|12.0||||||
3965979|NCT01305213|3788008|B1|50 - 59 years||Age, Customized||Participants|Count of Participants|12|12.0||||||
3965980|NCT01305213|3788006|B3|40 - 49 years||Age, Customized||Participants|Count of Participants|8|8.0||||||
3965981|NCT01305213|3788007|B2|40 - 49 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
3965982|NCT01305213|3788008|B1|40 - 49 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
3965983|NCT01305213|3788006|B3|30 - 39 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
3965984|NCT01305213|3788007|B2|30 - 39 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3965985|NCT01305213|3788008|B1|30 - 39 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
3965986|NCT01305213|3788006|B3|||Age||years|Mean|64.6|64.6|Standard Deviation|11.15|11.15|||
3965987|NCT01305213|3788007|B2|||Age||years|Mean|64.9|64.9|Standard Deviation|10.3|10.3|||
3965988|NCT01305213|3788008|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|12|12.0|||
3965989|NCT01305200|3788025|B4|Puerto Rico||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3965990|NCT01305200|3788026|B3|Puerto Rico||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3965991|NCT01305200|3788027|B2|Puerto Rico||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3965992|NCT01305200|3788028|B1|Puerto Rico||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3965993|NCT01305200|3788025|B4|Australia||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3965994|NCT01305200|3788026|B3|Australia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3965995|NCT01305200|3788027|B2|Australia||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3965996|NCT01305200|3788028|B1|Australia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3965997|NCT01305200|3788025|B4|United States||Region of Enrollment||Participants|Count of Participants|210|210.0||||||
3965998|NCT01305200|3788026|B3|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3965999|NCT01305200|3788027|B2|United States||Region of Enrollment||Participants|Count of Participants|102|102.0||||||
3966000|NCT01305200|3788028|B1|United States||Region of Enrollment||Participants|Count of Participants|105|105.0||||||
3966001|NCT01305200|3788025|B4|Canada||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3966002|NCT01305200|3788026|B3|Canada||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3966003|NCT01305200|3788027|B2|Canada||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3966004|NCT01305200|3788028|B1|Canada||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3966005|NCT01305200|3788025|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3966006|NCT01305200|3788026|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966007|NCT01305200|3788027|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3966008|NCT01305200|3788028|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3966009|NCT01305200|3788025|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966010|NCT01305200|3788026|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966011|NCT01305200|3788027|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966012|NCT01305200|3788028|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966013|NCT01305200|3788025|B4||White|Race (NIH/OMB)||Participants|Count of Participants|172|172.0||||||
3966014|NCT01305200|3788026|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3966015|NCT01305200|3788027|B2||White|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3966016|NCT01305200|3788028|B1||White|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3966017|NCT01305200|3788025|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3966018|NCT01305200|3788026|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966019|NCT01305200|3788027|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3966020|NCT01305200|3788028|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3966021|NCT01305200|3788025|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966022|NCT01305200|3788026|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966023|NCT01305200|3788027|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966024|NCT01305200|3788028|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966025|NCT01305200|3788025|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3966026|NCT01305200|3788026|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966027|NCT01305200|3788027|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3966028|NCT01305200|3788028|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3966029|NCT01305200|3788025|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3966030|NCT01305200|3788026|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966031|NCT01305200|3788027|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3966032|NCT01305200|3788028|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966033|NCT01305200|3788025|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3966034|NCT01305200|3788026|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966035|NCT01305200|3788027|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3966036|NCT01305200|3788028|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3966037|NCT01305200|3788025|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|163|163.0||||||
3966038|NCT01305200|3788026|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3966039|NCT01305200|3788027|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3966040|NCT01305200|3788028|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3966041|NCT01305200|3788025|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3966042|NCT01305200|3788026|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3966043|NCT01305200|3788027|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3966044|NCT01305200|3788028|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3966045|NCT01305200|3788025|B4||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3966046|NCT01305200|3788026|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3966047|NCT01305200|3788027|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3966048|NCT01305200|3788028|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3966049|NCT01305200|3788025|B4||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3966050|NCT01305200|3788026|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3966051|NCT01305200|3788027|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3966052|NCT01305200|3788028|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3966053|NCT01305200|3788025|B4|||Age||years|Mean|12.88|12.88|Standard Deviation|4.79|4.79|||
3966054|NCT01305200|3788026|B3|||Age||years|Mean|12.00|12.0|Standard Deviation|1.73|1.73|||
3966055|NCT01305200|3788027|B2|||Age||years|Mean|13.02|13.02|Standard Deviation|4.54|4.54|||
3966056|NCT01305200|3788028|B1|||Age||years|Mean|12.75|12.75|Standard Deviation|5.05|5.05|||
3966057|NCT01305044|3788058|B3|United States||Region of Enrollment||participants|Number|63|63.0||||||
3966058|NCT01305044|3788059|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
3966059|NCT01305044|3788060|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
3966060|NCT01305044|3788058|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3966061|NCT01305044|3788059|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3966062|NCT01305044|3788060|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3966063|NCT01305044|3788058|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3966064|NCT01305044|3788059|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3966065|NCT01305044|3788060|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3966066|NCT01305044|3788058|B3||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
3966067|NCT01305044|3788059|B2||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3966068|NCT01305044|3788060|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3966069|NCT01305044|3788058|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3966070|NCT01305044|3788059|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3966071|NCT01305044|3788060|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3966072|NCT01305044|3788058|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3966073|NCT01305044|3788059|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3966074|NCT01305044|3788060|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3966075|NCT01304966|3788085|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966076|NCT01304966|3788085|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966077|NCT01304966|3788085|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966078|NCT01304966|3788085|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966079|NCT01304966|3788085|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966080|NCT01304966|3788085|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3966081|NCT01304966|3788085|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966082|NCT01304966|3788085|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3966083|NCT01304966|3788085|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3966084|NCT01304966|3788085|B1|||Age||years|Mean|2.67|2.67|Standard Deviation|0.049|0.049|||
3966085|NCT01304706|3788091|B1|United States||Region of Enrollment||participants|Number|120|120.0||||||
3966086|NCT01304706|3788091|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3966087|NCT01304706|3788091|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3966088|NCT01304706|3788091|B1|>=85||Age, Customized||participants|Number|1|1.0||||||
3966089|NCT01304706|3788091|B1|75-84||Age, Customized||participants|Number|17|17.0||||||
3966090|NCT01304706|3788091|B1|65-74||Age, Customized||participants|Number|43|43.0||||||
3966091|NCT01304706|3788091|B1|55-64||Age, Customized||participants|Number|42|42.0||||||
3966092|NCT01304706|3788091|B1|45-54||Age, Customized||participants|Number|14|14.0||||||
3966093|NCT01304706|3788091|B1|35-44||Age, Customized||participants|Number|3|3.0||||||
3966094|NCT01304706|3788091|B1|<35||Age, Customized||participants|Number|0|0.0||||||
3966095|NCT01304706|3788091|B1|||Age||years|Mean|65.2|65.2|Standard Deviation|9.29|9.29|||
3966096|NCT01304693|3788095|B6||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3966097|NCT01304693|3788096|B5||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3966098|NCT01304693|3788097|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3966099|NCT01304693|3788098|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3966100|NCT01304693|3788099|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3966101|NCT01304693|3788100|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3966102|NCT01304693|3788095|B6||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3966103|NCT01304693|3788096|B5||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3966104|NCT01304693|3788097|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3966105|NCT01304693|3788098|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3966106|NCT01304693|3788099|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3966107|NCT01304693|3788100|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3966108|NCT01304693|3788095|B6|||Age|This analysis population includes all patients who were randomized, received study drug, and completed at least 1 scheduled on-therapy study visit (Intent-to-Treat).|years|Mean|76.5|76.5|Standard Deviation|8.4|8.4|||
3966109|NCT01304693|3788096|B5|||Age|This analysis population includes all patients who were randomized, received study drug, and completed at least 1 scheduled on-therapy study visit (Intent-to-Treat).|years|Mean|77.8|77.8|Standard Deviation|8.1|8.1|||
3966110|NCT01304693|3788097|B4|||Age|This analysis population includes all patients who were randomized, received study drug, and completed at least 1 scheduled on-therapy study visit (Intent-to-Treat).|years|Mean|74.5|74.5|Standard Deviation|9.8|9.8|||
3966111|NCT01304693|3788098|B3|||Age|This analysis population includes all patients who were randomized, received study drug, and completed at least 1 scheduled on-therapy study visit (Intent-to-Treat).|years|Mean|75.2|75.2|Standard Deviation|7.7|7.7|||
3966112|NCT01304693|3788099|B2|||Age|This analysis population includes all patients who were randomized, received study drug, and completed at least 1 scheduled on-therapy study visit (Intent-to-Treat).|years|Mean|78.5|78.5|Standard Deviation|8.3|8.3|||
3966113|NCT01304693|3788100|B1|||Age|This analysis population includes all patients who were randomized, received study drug, and completed at least 1 scheduled on-therapy study visit (Intent-to-Treat).|years|Mean|75.9|75.9|Standard Deviation|6.9|6.9|||
3966114|NCT01304641|3788121|B3||Male|Sex: Female, Male||Participants|Count of Participants|12610|12610.0||||||
3966115|NCT01304641|3788122|B2||Male|Sex: Female, Male||Participants|Count of Participants|8062|8062.0||||||
3966116|NCT01304641|3788123|B1||Male|Sex: Female, Male||Participants|Count of Participants|4548|4548.0||||||
3966117|NCT01304641|3788121|B3||Female|Sex: Female, Male||Participants|Count of Participants|18992|18992.0||||||
3966118|NCT01304641|3788122|B2||Female|Sex: Female, Male||Participants|Count of Participants|12070|12070.0||||||
3966119|NCT01304641|3788123|B1||Female|Sex: Female, Male||Participants|Count of Participants|6922|6922.0||||||
3966120|NCT01304641|3788121|B3|Greater than and equal to (>=) 85 years||Age, Customized||Participants|Number|1498|1498.0||||||
3966121|NCT01304641|3788122|B2|Greater than and equal to (>=) 85 years||Age, Customized||Participants|Number|973|973.0||||||
3966122|NCT01304641|3788123|B1|Greater than and equal to (>=) 85 years||Age, Customized||Participants|Number|525|525.0||||||
3966123|NCT01304641|3788121|B3|75 to 84 years||Age, Customized||Participants|Number|8727|8727.0||||||
3966124|NCT01304641|3788122|B2|75 to 84 years||Age, Customized||Participants|Number|5790|5790.0||||||
3966125|NCT01304641|3788123|B1|75 to 84 years||Age, Customized||Participants|Number|2937|2937.0||||||
3966126|NCT01304641|3788121|B3|65 to 74 years||Age, Customized||Participants|Number|21377|21377.0||||||
3966127|NCT01304641|3788122|B2|65 to 74 years||Age, Customized||Participants|Number|13369|13369.0||||||
3966128|NCT01304641|3788123|B1|65 to 74 years||Age, Customized||Participants|Number|8008|8008.0||||||
3966366|NCT01304238|3788220|B11|Male||Sex/Gender, Customized|Gender information is missing in one participant in the lepirudin arm.|Participants|Number|110|110.0||||||
3966129|NCT01304589|3788142|B1|||24-hour vulvar pain|"0 equals no vulvar pain within the last 24 hours to 10 equals worse imaginable vulvar pain within the last 24 hours."|units on a scale|Mean|2.09|2.09|Standard Deviation|2.03|2.03|||
3966130|NCT01304589|3788142|B1|||coital pain|"0 equals no pain with intercourse to 10 equals worse imaginable pain with intercourse."|units on a scale|Mean|6.94|6.94|Standard Deviation|2.51|2.51|||
3966131|NCT01304589|3788142|B1|||Tampon test|"0 equals no pain with tampon insertion to 10 equals worse pain imaginable with tampon insertion."|units on a scale|Mean|5.14|5.14|Standard Deviation|3.01|3.01|||
3966132|NCT01304589|3788142|B1|||Pain Rating Index|"The Pain Rating Index is a component of the McGill Pain Questionnaire which measures sensory and affective components of pain. 0 equals no pain to 45 equals severe pain."|units on a scale|Mean|20.0|20.0|Standard Deviation|8.9|8.9|||
3966133|NCT01304589|3788142|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
3966134|NCT01304589|3788142|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3966135|NCT01304589|3788142|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3966136|NCT01304589|3788142|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3966137|NCT01304589|3788142|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3966138|NCT01304589|3788142|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3966139|NCT01304498|3788149|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3966140|NCT01304498|3788150|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3966141|NCT01304498|3788151|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3966142|NCT01304498|3788149|B3||Female|Sex: Female, Male||Participants|Count of Participants|600|600.0||||||
3966143|NCT01304498|3788150|B2||Female|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
3966144|NCT01304498|3788151|B1||Female|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
3966145|NCT01304498|3788149|B3|13 to 15 years old||Age, Customized||Participants|Number|300|300.0||||||
3966146|NCT01304498|3788150|B2|13 to 15 years old||Age, Customized||Participants|Number|150|150.0||||||
3966147|NCT01304498|3788151|B1|13 to 15 years old||Age, Customized||Participants|Number|150|150.0||||||
3966148|NCT01304498|3788149|B3|9 to 12 years old||Age, Customized||Participants|Number|300|300.0||||||
3966149|NCT01304498|3788150|B2|9 to 12 years old||Age, Customized||Participants|Number|150|150.0||||||
3966150|NCT01304498|3788151|B1|9 to 12 years old||Age, Customized||Participants|Number|150|150.0||||||
3966151|NCT01304498|3788149|B3|||Age||Years|Mean|12.6|12.6|Standard Deviation|1.9|1.9|||
3966152|NCT01304498|3788150|B2|||Age||Years|Mean|12.6|12.6|Standard Deviation|1.9|1.9|||
3966153|NCT01304498|3788151|B1|||Age||Years|Mean|12.6|12.6|Standard Deviation|1.9|1.9|||
3966154|NCT01304329|3788172|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3966155|NCT01304329|3788172|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3966156|NCT01304329|3788172|B1|||Age||years|Mean|35.9|35.9|Standard Deviation|8.8|8.8|||
3966157|NCT01304316|3788194|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966158|NCT01304316|3788194|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966159|NCT01304316|3788194|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3966160|NCT01304316|3788194|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3966161|NCT01304316|3788194|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966162|NCT01304316|3788194|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3966163|NCT01304316|3788194|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966164|NCT01304316|3788194|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966165|NCT01304316|3788194|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3966166|NCT01304316|3788194|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3966167|NCT01304316|3788194|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3966168|NCT01304316|3788194|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3966169|NCT01304316|3788194|B1|||Age||years|Mean|30.2|30.2|Standard Deviation|7.45|7.45|||
3966170|NCT01304277|3788208|B1|||Study Specific Characteristic [Plasma Gb3]|Baseline is the average of Gb3 (globotriaosylceramide) levels on RB Replagal at screening, Week 0, and Week 2 prior to AF Replagal dosing.|nmol/mL|Mean|5.276|5.276|Standard Deviation|1.562|1.562|||
3966171|NCT01304277|3788208|B1|||Study Specific Characteristic [Urine Gb3]|Baseline is the average of Gb3 (globotriaosylceramide) levels on RB Replagal at screening, Week 0, and Week 2 prior to AF Replagal dosing.|nmol/g creatinine|Mean|919.27|919.27|Standard Deviation|990.144|990.144|||
3966172|NCT01304277|3788208|B1|CANADA||Region of Enrollment||Participants|Number|17|17.0||||||
3966173|NCT01304277|3788208|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3966174|NCT01304277|3788208|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3966175|NCT01304277|3788208|B1|||Age||Years|Mean|39.8|39.8|Standard Deviation|13.589|13.589|||
3966176|NCT01304277|3788208|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3966177|NCT01304277|3788208|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3966178|NCT01304277|3788208|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3966179|NCT01304238|3788220|B11|Other||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|14|14.0||||||
3966180|NCT01304238|3788221|B10|Other||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|0|0.0||||||
3966420|NCT01304147|3788311|B1|yes||Chronic||participants|Number|9|9.0||||||
3966181|NCT01304238|3788222|B9|Other||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|1|1.0||||||
3966182|NCT01304238|3788223|B8|Other||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|0|0.0||||||
3966183|NCT01304238|3788224|B7|Other||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|0|0.0||||||
3966184|NCT01304238|3788225|B6|Other||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|4|4.0||||||
3966185|NCT01304238|3788226|B5|Other||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|2|2.0||||||
3966186|NCT01304238|3788227|B4|Other||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|0|0.0||||||
3966187|NCT01304238|3788228|B3|Other||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|3|3.0||||||
3966188|NCT01304238|3788229|B2|Other||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|1|1.0||||||
3966189|NCT01304238|3788230|B1|Other||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|3|3.0||||||
3966190|NCT01304238|3788220|B11|Alternative anticoagulation in cardiac valve||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|4|4.0||||||
3966191|NCT01304238|3788221|B10|Alternative anticoagulation in cardiac valve||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|0|0.0||||||
3966192|NCT01304238|3788222|B9|Alternative anticoagulation in cardiac valve||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|0|0.0||||||
3966193|NCT01304238|3788223|B8|Alternative anticoagulation in cardiac valve||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|0|0.0||||||
3966194|NCT01304238|3788224|B7|Alternative anticoagulation in cardiac valve||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|0|0.0||||||
3966195|NCT01304238|3788225|B6|Alternative anticoagulation in cardiac valve||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|0|0.0||||||
3966196|NCT01304238|3788226|B5|Alternative anticoagulation in cardiac valve||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|0|0.0||||||
3966197|NCT01304238|3788227|B4|Alternative anticoagulation in cardiac valve||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|3|3.0||||||
3966198|NCT01304238|3788228|B3|Alternative anticoagulation in cardiac valve||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|0|0.0||||||
3966199|NCT01304238|3788229|B2|Alternative anticoagulation in cardiac valve||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|0|0.0||||||
3966200|NCT01304238|3788230|B1|Alternative anticoagulation in cardiac valve||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|1|1.0||||||
3966201|NCT01304238|3788220|B11|Alternative anticoagulation in atrial fibrillation||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|31|31.0||||||
3966202|NCT01304238|3788221|B10|Alternative anticoagulation in atrial fibrillation||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|2|2.0||||||
3966203|NCT01304238|3788222|B9|Alternative anticoagulation in atrial fibrillation||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|0|0.0||||||
3966204|NCT01304238|3788223|B8|Alternative anticoagulation in atrial fibrillation||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|0|0.0||||||
3966205|NCT01304238|3788224|B7|Alternative anticoagulation in atrial fibrillation||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|2|2.0||||||
3966206|NCT01304238|3788225|B6|Alternative anticoagulation in atrial fibrillation||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|0|0.0||||||
3966207|NCT01304238|3788226|B5|Alternative anticoagulation in atrial fibrillation||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|1|1.0||||||
3966208|NCT01304238|3788227|B4|Alternative anticoagulation in atrial fibrillation||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|13|13.0||||||
3966209|NCT01304238|3788228|B3|Alternative anticoagulation in atrial fibrillation||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|9|9.0||||||
3966210|NCT01304238|3788229|B2|Alternative anticoagulation in atrial fibrillation||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|0|0.0||||||
3966211|NCT01304238|3788230|B1|Alternative anticoagulation in atrial fibrillation||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|4|4.0||||||
3966212|NCT01304238|3788220|B11|Acute coronary syndrome||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|12|12.0||||||
3966213|NCT01304238|3788221|B10|Acute coronary syndrome||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|0|0.0||||||
3966214|NCT01304238|3788222|B9|Acute coronary syndrome||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|0|0.0||||||
3966593|NCT01303861|3788367|B6||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
3966215|NCT01304238|3788223|B8|Acute coronary syndrome||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|1|1.0||||||
3966216|NCT01304238|3788224|B7|Acute coronary syndrome||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|0|0.0||||||
3966217|NCT01304238|3788225|B6|Acute coronary syndrome||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|2|2.0||||||
3966218|NCT01304238|3788226|B5|Acute coronary syndrome||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|0|0.0||||||
3966219|NCT01304238|3788227|B4|Acute coronary syndrome||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|4|4.0||||||
3966220|NCT01304238|3788228|B3|Acute coronary syndrome||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|3|3.0||||||
3966221|NCT01304238|3788229|B2|Acute coronary syndrome||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|1|1.0||||||
3966222|NCT01304238|3788230|B1|Acute coronary syndrome||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|1|1.0||||||
3966223|NCT01304238|3788220|B11|Peripheral artery occlusive disease||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|3|3.0||||||
3966224|NCT01304238|3788221|B10|Peripheral artery occlusive disease||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|0|0.0||||||
3966225|NCT01304238|3788222|B9|Peripheral artery occlusive disease||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|0|0.0||||||
3966226|NCT01304238|3788223|B8|Peripheral artery occlusive disease||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|0|0.0||||||
3966227|NCT01304238|3788224|B7|Peripheral artery occlusive disease||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|1|1.0||||||
3966228|NCT01304238|3788225|B6|Peripheral artery occlusive disease||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|0|0.0||||||
3966229|NCT01304238|3788226|B5|Peripheral artery occlusive disease||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|0|0.0||||||
3966230|NCT01304238|3788227|B4|Peripheral artery occlusive disease||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|1|1.0||||||
3966231|NCT01304238|3788228|B3|Peripheral artery occlusive disease||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|1|1.0||||||
3966232|NCT01304238|3788229|B2|Peripheral artery occlusive disease||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|0|0.0||||||
3966233|NCT01304238|3788230|B1|Peripheral artery occlusive disease||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|0|0.0||||||
3966234|NCT01304238|3788220|B11|Pulmonary embolism||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|12|12.0||||||
3966235|NCT01304238|3788221|B10|Pulmonary embolism||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|1|1.0||||||
3966236|NCT01304238|3788222|B9|Pulmonary embolism||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|0|0.0||||||
3966237|NCT01304238|3788223|B8|Pulmonary embolism||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|1|1.0||||||
3966238|NCT01304238|3788224|B7|Pulmonary embolism||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|0|0.0||||||
3966239|NCT01304238|3788225|B6|Pulmonary embolism||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|1|1.0||||||
3966240|NCT01304238|3788226|B5|Pulmonary embolism||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|3|3.0||||||
3966241|NCT01304238|3788227|B4|Pulmonary embolism||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|1|1.0||||||
3966242|NCT01304238|3788228|B3|Pulmonary embolism||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|1|1.0||||||
3966243|NCT01304238|3788229|B2|Pulmonary embolism||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|0|0.0||||||
3966244|NCT01304238|3788230|B1|Pulmonary embolism||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|4|4.0||||||
3966245|NCT01304238|3788220|B11|Deep vein thrombosis||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|14|14.0||||||
3966246|NCT01304238|3788221|B10|Deep vein thrombosis||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|1|1.0||||||
3966247|NCT01304238|3788222|B9|Deep vein thrombosis||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|0|0.0||||||
3966248|NCT01304238|3788223|B8|Deep vein thrombosis||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|0|0.0||||||
3966249|NCT01304238|3788224|B7|Deep vein thrombosis||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|0|0.0||||||
3966367|NCT01304238|3788221|B10|Male||Sex/Gender, Customized|Gender information is missing in one participant in the lepirudin arm.|Participants|Number|1|1.0||||||
3966250|NCT01304238|3788225|B6|Deep vein thrombosis||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|2|2.0||||||
3966251|NCT01304238|3788226|B5|Deep vein thrombosis||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|2|2.0||||||
3966252|NCT01304238|3788227|B4|Deep vein thrombosis||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|2|2.0||||||
3966253|NCT01304238|3788228|B3|Deep vein thrombosis||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|2|2.0||||||
3966254|NCT01304238|3788229|B2|Deep vein thrombosis||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|0|0.0||||||
3966255|NCT01304238|3788230|B1|Deep vein thrombosis||Number of participants with the indicated thromboembolic therapy (specified)|Multiple responses are possible.|participants|Number|5|5.0||||||
3966256|NCT01304238|3788220|B11|Indication for thromboembolic therapy||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|76|76.0||||||
3966257|NCT01304238|3788221|B10|Indication for thromboembolic therapy||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|3|3.0||||||
3966258|NCT01304238|3788222|B9|Indication for thromboembolic therapy||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|1|1.0||||||
3966259|NCT01304238|3788223|B8|Indication for thromboembolic therapy||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|2|2.0||||||
3966260|NCT01304238|3788224|B7|Indication for thromboembolic therapy||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|3|3.0||||||
3966261|NCT01304238|3788225|B6|Indication for thromboembolic therapy||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|6|6.0||||||
3966262|NCT01304238|3788226|B5|Indication for thromboembolic therapy||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|6|6.0||||||
3966263|NCT01304238|3788227|B4|Indication for thromboembolic therapy||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|21|21.0||||||
3966264|NCT01304238|3788228|B3|Indication for thromboembolic therapy||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|18|18.0||||||
3966265|NCT01304238|3788229|B2|Indication for thromboembolic therapy||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|2|2.0||||||
3966266|NCT01304238|3788230|B1|Indication for thromboembolic therapy||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|14|14.0||||||
3966267|NCT01304238|3788220|B11|Prophylaxis: Neurology/Neurosurgery||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|14|14.0||||||
3966268|NCT01304238|3788221|B10|Prophylaxis: Neurology/Neurosurgery||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|0|0.0||||||
3966269|NCT01304238|3788222|B9|Prophylaxis: Neurology/Neurosurgery||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|0|0.0||||||
3966270|NCT01304238|3788223|B8|Prophylaxis: Neurology/Neurosurgery||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|0|0.0||||||
3966271|NCT01304238|3788224|B7|Prophylaxis: Neurology/Neurosurgery||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|1|1.0||||||
3966272|NCT01304238|3788225|B6|Prophylaxis: Neurology/Neurosurgery||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|0|0.0||||||
3966273|NCT01304238|3788226|B5|Prophylaxis: Neurology/Neurosurgery||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|1|1.0||||||
3966274|NCT01304238|3788227|B4|Prophylaxis: Neurology/Neurosurgery||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|0|0.0||||||
3966275|NCT01304238|3788228|B3|Prophylaxis: Neurology/Neurosurgery||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|10|10.0||||||
3966276|NCT01304238|3788229|B2|Prophylaxis: Neurology/Neurosurgery||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|0|0.0||||||
3966277|NCT01304238|3788230|B1|Prophylaxis: Neurology/Neurosurgery||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|2|2.0||||||
3966278|NCT01304238|3788220|B11|Prophylaxis: Internal Medicine||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|55|55.0||||||
3966419|NCT01304147|3788311|B1|no||Chronic||participants|Number|11|11.0||||||
3966279|NCT01304238|3788221|B10|Prophylaxis: Internal Medicine||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|2|2.0||||||
3966280|NCT01304238|3788222|B9|Prophylaxis: Internal Medicine||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|0|0.0||||||
3966281|NCT01304238|3788223|B8|Prophylaxis: Internal Medicine||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|1|1.0||||||
3966282|NCT01304238|3788224|B7|Prophylaxis: Internal Medicine||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|1|1.0||||||
3966283|NCT01304238|3788225|B6|Prophylaxis: Internal Medicine||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|5|5.0||||||
3966284|NCT01304238|3788226|B5|Prophylaxis: Internal Medicine||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|2|2.0||||||
3966285|NCT01304238|3788227|B4|Prophylaxis: Internal Medicine||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|4|4.0||||||
3966286|NCT01304238|3788228|B3|Prophylaxis: Internal Medicine||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|27|27.0||||||
3966287|NCT01304238|3788229|B2|Prophylaxis: Internal Medicine||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|0|0.0||||||
3966288|NCT01304238|3788230|B1|Prophylaxis: Internal Medicine||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|13|13.0||||||
3966289|NCT01304238|3788220|B11|Prophylaxis: Surgery||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|102|102.0||||||
3966290|NCT01304238|3788221|B10|Prophylaxis: Surgery||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|0|0.0||||||
3966291|NCT01304238|3788222|B9|Prophylaxis: Surgery||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|0|0.0||||||
3966292|NCT01304238|3788223|B8|Prophylaxis: Surgery||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|3|3.0||||||
3966293|NCT01304238|3788224|B7|Prophylaxis: Surgery||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|1|1.0||||||
3966294|NCT01304238|3788225|B6|Prophylaxis: Surgery||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|5|5.0||||||
3966295|NCT01304238|3788226|B5|Prophylaxis: Surgery||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|6|6.0||||||
3966296|NCT01304238|3788227|B4|Prophylaxis: Surgery||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|62|62.0||||||
3966297|NCT01304238|3788228|B3|Prophylaxis: Surgery||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|11|11.0||||||
3966298|NCT01304238|3788229|B2|Prophylaxis: Surgery||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|2|2.0||||||
3966299|NCT01304238|3788230|B1|Prophylaxis: Surgery||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|12|12.0||||||
3966300|NCT01304238|3788220|B11|Prophylaxis (no further specification)||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|5|5.0||||||
3966301|NCT01304238|3788221|B10|Prophylaxis (no further specification)||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|0|0.0||||||
3966302|NCT01304238|3788222|B9|Prophylaxis (no further specification)||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|0|0.0||||||
3966303|NCT01304238|3788223|B8|Prophylaxis (no further specification)||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|0|0.0||||||
3966304|NCT01304238|3788224|B7|Prophylaxis (no further specification)||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|0|0.0||||||
3966305|NCT01304238|3788225|B6|Prophylaxis (no further specification)||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|1|1.0||||||
3966306|NCT01304238|3788226|B5|Prophylaxis (no further specification)||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|1|1.0||||||
3966365|NCT01304238|3788230|B1|Only unfractionated heparin (UFH)||Number of participants receiving the indicated heparin treatment prior to HIT II||participants|Number|19|19.0||||||
3966307|NCT01304238|3788227|B4|Prophylaxis (no further specification)||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|1|1.0||||||
3966308|NCT01304238|3788228|B3|Prophylaxis (no further specification)||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|0|0.0||||||
3966309|NCT01304238|3788229|B2|Prophylaxis (no further specification)||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|0|0.0||||||
3966310|NCT01304238|3788230|B1|Prophylaxis (no further specification)||Number of participants receving the indicated AT before HIT II (specified) with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment.|participants|Number|2|2.0||||||
3966311|NCT01304238|3788220|B11|Therapeutic||Number of participants receiving the indicated AT before HIT II with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment. “Rationale” refers to the initial reason for giving antithrombotics, e.g., for prophylaxis or for therapy of thrombosis.|participants|Number|76|76.0||||||
3966312|NCT01304238|3788221|B10|Therapeutic||Number of participants receiving the indicated AT before HIT II with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment. “Rationale” refers to the initial reason for giving antithrombotics, e.g., for prophylaxis or for therapy of thrombosis.|participants|Number|3|3.0||||||
3966313|NCT01304238|3788222|B9|Therapeutic||Number of participants receiving the indicated AT before HIT II with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment. “Rationale” refers to the initial reason for giving antithrombotics, e.g., for prophylaxis or for therapy of thrombosis.|participants|Number|1|1.0||||||
3966314|NCT01304238|3788223|B8|Therapeutic||Number of participants receiving the indicated AT before HIT II with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment. “Rationale” refers to the initial reason for giving antithrombotics, e.g., for prophylaxis or for therapy of thrombosis.|participants|Number|2|2.0||||||
3966315|NCT01304238|3788224|B7|Therapeutic||Number of participants receiving the indicated AT before HIT II with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment. “Rationale” refers to the initial reason for giving antithrombotics, e.g., for prophylaxis or for therapy of thrombosis.|participants|Number|3|3.0||||||
3966316|NCT01304238|3788225|B6|Therapeutic||Number of participants receiving the indicated AT before HIT II with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment. “Rationale” refers to the initial reason for giving antithrombotics, e.g., for prophylaxis or for therapy of thrombosis.|participants|Number|6|6.0||||||
3966317|NCT01304238|3788226|B5|Therapeutic||Number of participants receiving the indicated AT before HIT II with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment. “Rationale” refers to the initial reason for giving antithrombotics, e.g., for prophylaxis or for therapy of thrombosis.|participants|Number|6|6.0||||||
3966318|NCT01304238|3788227|B4|Therapeutic||Number of participants receiving the indicated AT before HIT II with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment. “Rationale” refers to the initial reason for giving antithrombotics, e.g., for prophylaxis or for therapy of thrombosis.|participants|Number|21|21.0||||||
3966319|NCT01304238|3788228|B3|Therapeutic||Number of participants receiving the indicated AT before HIT II with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment. “Rationale” refers to the initial reason for giving antithrombotics, e.g., for prophylaxis or for therapy of thrombosis.|participants|Number|18|18.0||||||
3966320|NCT01304238|3788229|B2|Therapeutic||Number of participants receiving the indicated AT before HIT II with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment. “Rationale” refers to the initial reason for giving antithrombotics, e.g., for prophylaxis or for therapy of thrombosis.|participants|Number|2|2.0||||||
3966321|NCT01304238|3788230|B1|Therapeutic||Number of participants receiving the indicated AT before HIT II with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment. “Rationale” refers to the initial reason for giving antithrombotics, e.g., for prophylaxis or for therapy of thrombosis.|participants|Number|14|14.0||||||
3966322|NCT01304238|3788220|B11|Prophylactic||Number of participants receiving the indicated AT before HIT II with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment. “Rationale” refers to the initial reason for giving antithrombotics, e.g., for prophylaxis or for therapy of thrombosis.|participants|Number|155|155.0||||||
3966323|NCT01304238|3788221|B10|Prophylactic||Number of participants receiving the indicated AT before HIT II with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment. “Rationale” refers to the initial reason for giving antithrombotics, e.g., for prophylaxis or for therapy of thrombosis.|participants|Number|2|2.0||||||
3966324|NCT01304238|3788222|B9|Prophylactic||Number of participants receiving the indicated AT before HIT II with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment. “Rationale” refers to the initial reason for giving antithrombotics, e.g., for prophylaxis or for therapy of thrombosis.|participants|Number|0|0.0||||||
3966325|NCT01304238|3788223|B8|Prophylactic||Number of participants receiving the indicated AT before HIT II with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment. “Rationale” refers to the initial reason for giving antithrombotics, e.g., for prophylaxis or for therapy of thrombosis.|participants|Number|3|3.0||||||
3966326|NCT01304238|3788224|B7|Prophylactic||Number of participants receiving the indicated AT before HIT II with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment. “Rationale” refers to the initial reason for giving antithrombotics, e.g., for prophylaxis or for therapy of thrombosis.|participants|Number|2|2.0||||||
3966327|NCT01304238|3788225|B6|Prophylactic||Number of participants receiving the indicated AT before HIT II with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment. “Rationale” refers to the initial reason for giving antithrombotics, e.g., for prophylaxis or for therapy of thrombosis.|participants|Number|8|8.0||||||
3966328|NCT01304238|3788226|B5|Prophylactic||Number of participants receiving the indicated AT before HIT II with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment. “Rationale” refers to the initial reason for giving antithrombotics, e.g., for prophylaxis or for therapy of thrombosis.|participants|Number|9|9.0||||||
3966329|NCT01304238|3788227|B4|Prophylactic||Number of participants receiving the indicated AT before HIT II with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment. “Rationale” refers to the initial reason for giving antithrombotics, e.g., for prophylaxis or for therapy of thrombosis.|participants|Number|66|66.0||||||
3966330|NCT01304238|3788228|B3|Prophylactic||Number of participants receiving the indicated AT before HIT II with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment. “Rationale” refers to the initial reason for giving antithrombotics, e.g., for prophylaxis or for therapy of thrombosis.|participants|Number|39|39.0||||||
3966331|NCT01304238|3788229|B2|Prophylactic||Number of participants receiving the indicated AT before HIT II with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment. “Rationale” refers to the initial reason for giving antithrombotics, e.g., for prophylaxis or for therapy of thrombosis.|participants|Number|2|2.0||||||
3966332|NCT01304238|3788230|B1|Prophylactic||Number of participants receiving the indicated AT before HIT II with regard to rationale|Multiple responses are possible. AT, anticoagulant treatment. “Rationale” refers to the initial reason for giving antithrombotics, e.g., for prophylaxis or for therapy of thrombosis.|participants|Number|24|24.0||||||
3966333|NCT01304238|3788220|B11|UFH and LMWH||Number of participants receiving the indicated heparin treatment prior to HIT II||participants|Number|62|62.0||||||
3966334|NCT01304238|3788221|B10|UFH and LMWH||Number of participants receiving the indicated heparin treatment prior to HIT II||participants|Number|1|1.0||||||
3966335|NCT01304238|3788222|B9|UFH and LMWH||Number of participants receiving the indicated heparin treatment prior to HIT II||participants|Number|0|0.0||||||
3966336|NCT01304238|3788223|B8|UFH and LMWH||Number of participants receiving the indicated heparin treatment prior to HIT II||participants|Number|2|2.0||||||
3966337|NCT01304238|3788224|B7|UFH and LMWH||Number of participants receiving the indicated heparin treatment prior to HIT II||participants|Number|1|1.0||||||
3966338|NCT01304238|3788225|B6|UFH and LMWH||Number of participants receiving the indicated heparin treatment prior to HIT II||participants|Number|4|4.0||||||
3966339|NCT01304238|3788226|B5|UFH and LMWH||Number of participants receiving the indicated heparin treatment prior to HIT II||participants|Number|7|7.0||||||
3966340|NCT01304238|3788227|B4|UFH and LMWH||Number of participants receiving the indicated heparin treatment prior to HIT II||participants|Number|22|22.0||||||
3966341|NCT01304238|3788228|B3|UFH and LMWH||Number of participants receiving the indicated heparin treatment prior to HIT II||participants|Number|12|12.0||||||
3966342|NCT01304238|3788229|B2|UFH and LMWH||Number of participants receiving the indicated heparin treatment prior to HIT II||participants|Number|2|2.0||||||
3966343|NCT01304238|3788230|B1|UFH and LMWH||Number of participants receiving the indicated heparin treatment prior to HIT II||participants|Number|11|11.0||||||
3966344|NCT01304238|3788220|B11|Only low molecular weight heparin (LMWH)||Number of participants receiving the indicated heparin treatment prior to HIT II||participants|Number|24|24.0||||||
3966345|NCT01304238|3788221|B10|Only low molecular weight heparin (LMWH)||Number of participants receiving the indicated heparin treatment prior to HIT II||participants|Number|1|1.0||||||
3966346|NCT01304238|3788222|B9|Only low molecular weight heparin (LMWH)||Number of participants receiving the indicated heparin treatment prior to HIT II||participants|Number|1|1.0||||||
3966347|NCT01304238|3788223|B8|Only low molecular weight heparin (LMWH)||Number of participants receiving the indicated heparin treatment prior to HIT II||participants|Number|2|2.0||||||
3966348|NCT01304238|3788224|B7|Only low molecular weight heparin (LMWH)||Number of participants receiving the indicated heparin treatment prior to HIT II||participants|Number|3|3.0||||||
3966349|NCT01304238|3788225|B6|Only low molecular weight heparin (LMWH)||Number of participants receiving the indicated heparin treatment prior to HIT II||participants|Number|0|0.0||||||
3966350|NCT01304238|3788226|B5|Only low molecular weight heparin (LMWH)||Number of participants receiving the indicated heparin treatment prior to HIT II||participants|Number|1|1.0||||||
3966351|NCT01304238|3788227|B4|Only low molecular weight heparin (LMWH)||Number of participants receiving the indicated heparin treatment prior to HIT II||participants|Number|3|3.0||||||
3966352|NCT01304238|3788228|B3|Only low molecular weight heparin (LMWH)||Number of participants receiving the indicated heparin treatment prior to HIT II||participants|Number|10|10.0||||||
3966353|NCT01304238|3788229|B2|Only low molecular weight heparin (LMWH)||Number of participants receiving the indicated heparin treatment prior to HIT II||participants|Number|1|1.0||||||
3966354|NCT01304238|3788230|B1|Only low molecular weight heparin (LMWH)||Number of participants receiving the indicated heparin treatment prior to HIT II||participants|Number|2|2.0||||||
3966355|NCT01304238|3788220|B11|Only unfractionated heparin (UFH)||Number of participants receiving the indicated heparin treatment prior to HIT II||participants|Number|109|109.0||||||
3966356|NCT01304238|3788221|B10|Only unfractionated heparin (UFH)||Number of participants receiving the indicated heparin treatment prior to HIT II||participants|Number|1|1.0||||||
3966357|NCT01304238|3788222|B9|Only unfractionated heparin (UFH)||Number of participants receiving the indicated heparin treatment prior to HIT II||participants|Number|0|0.0||||||
3966358|NCT01304238|3788223|B8|Only unfractionated heparin (UFH)||Number of participants receiving the indicated heparin treatment prior to HIT II||participants|Number|0|0.0||||||
3966359|NCT01304238|3788224|B7|Only unfractionated heparin (UFH)||Number of participants receiving the indicated heparin treatment prior to HIT II||participants|Number|1|1.0||||||
3966360|NCT01304238|3788225|B6|Only unfractionated heparin (UFH)||Number of participants receiving the indicated heparin treatment prior to HIT II||participants|Number|7|7.0||||||
3966361|NCT01304238|3788226|B5|Only unfractionated heparin (UFH)||Number of participants receiving the indicated heparin treatment prior to HIT II||participants|Number|3|3.0||||||
3966362|NCT01304238|3788227|B4|Only unfractionated heparin (UFH)||Number of participants receiving the indicated heparin treatment prior to HIT II||participants|Number|53|53.0||||||
3966363|NCT01304238|3788228|B3|Only unfractionated heparin (UFH)||Number of participants receiving the indicated heparin treatment prior to HIT II||participants|Number|24|24.0||||||
3966364|NCT01304238|3788229|B2|Only unfractionated heparin (UFH)||Number of participants receiving the indicated heparin treatment prior to HIT II||participants|Number|1|1.0||||||
3966368|NCT01304238|3788222|B9|Male||Sex/Gender, Customized|Gender information is missing in one participant in the lepirudin arm.|Participants|Number|0|0.0||||||
3966369|NCT01304238|3788223|B8|Male||Sex/Gender, Customized|Gender information is missing in one participant in the lepirudin arm.|Participants|Number|2|2.0||||||
3966370|NCT01304238|3788224|B7|Male||Sex/Gender, Customized|Gender information is missing in one participant in the lepirudin arm.|Participants|Number|3|3.0||||||
3966371|NCT01304238|3788225|B6|Male||Sex/Gender, Customized|Gender information is missing in one participant in the lepirudin arm.|Participants|Number|6|6.0||||||
3966372|NCT01304238|3788226|B5|Male||Sex/Gender, Customized|Gender information is missing in one participant in the lepirudin arm.|Participants|Number|6|6.0||||||
3966373|NCT01304238|3788227|B4|Male||Sex/Gender, Customized|Gender information is missing in one participant in the lepirudin arm.|Participants|Number|43|43.0||||||
3966374|NCT01304238|3788228|B3|Male||Sex/Gender, Customized|Gender information is missing in one participant in the lepirudin arm.|Participants|Number|25|25.0||||||
3966375|NCT01304238|3788229|B2|Male||Sex/Gender, Customized|Gender information is missing in one participant in the lepirudin arm.|Participants|Number|2|2.0||||||
3966376|NCT01304238|3788230|B1|Male||Sex/Gender, Customized|Gender information is missing in one participant in the lepirudin arm.|Participants|Number|22|22.0||||||
3966377|NCT01304238|3788220|B11|Female||Sex/Gender, Customized|Gender information is missing in one participant in the lepirudin arm.|Participants|Number|84|84.0||||||
3966378|NCT01304238|3788221|B10|Female||Sex/Gender, Customized|Gender information is missing in one participant in the lepirudin arm.|Participants|Number|2|2.0||||||
3966379|NCT01304238|3788222|B9|Female||Sex/Gender, Customized|Gender information is missing in one participant in the lepirudin arm.|Participants|Number|1|1.0||||||
3966380|NCT01304238|3788223|B8|Female||Sex/Gender, Customized|Gender information is missing in one participant in the lepirudin arm.|Participants|Number|2|2.0||||||
3966381|NCT01304238|3788224|B7|Female||Sex/Gender, Customized|Gender information is missing in one participant in the lepirudin arm.|Participants|Number|2|2.0||||||
3966382|NCT01304238|3788225|B6|Female||Sex/Gender, Customized|Gender information is missing in one participant in the lepirudin arm.|Participants|Number|5|5.0||||||
3966383|NCT01304238|3788226|B5|Female||Sex/Gender, Customized|Gender information is missing in one participant in the lepirudin arm.|Participants|Number|5|5.0||||||
3966384|NCT01304238|3788227|B4|Female||Sex/Gender, Customized|Gender information is missing in one participant in the lepirudin arm.|Participants|Number|35|35.0||||||
3966385|NCT01304238|3788228|B3|Female||Sex/Gender, Customized|Gender information is missing in one participant in the lepirudin arm.|Participants|Number|21|21.0||||||
3966386|NCT01304238|3788229|B2|Female||Sex/Gender, Customized|Gender information is missing in one participant in the lepirudin arm.|Participants|Number|1|1.0||||||
3966387|NCT01304238|3788230|B1|Female||Sex/Gender, Customized|Gender information is missing in one participant in the lepirudin arm.|Participants|Number|10|10.0||||||
3966388|NCT01304238|3788220|B11|||Age||Years|Mean|68.5|68.5|Standard Deviation|12.5|12.5|||
3966389|NCT01304238|3788221|B10|||Age||Years|Mean|63.7|63.7|Standard Deviation|7.5|7.5|||
3966390|NCT01304238|3788222|B9|||Age||Years|Mean|56.0|56.0|Standard Deviation|0.0|0.0|||
3966391|NCT01304238|3788223|B8|||Age||Years|Mean|55.3|55.3|Standard Deviation|16.0|16.0|||
3966392|NCT01304238|3788224|B7|||Age||Years|Mean|71.0|71.0|Standard Deviation|8.6|8.6|||
3966393|NCT01304238|3788225|B6|||Age||Years|Mean|60.0|60.0|Standard Deviation|14.0|14.0|||
3966394|NCT01304238|3788226|B5|||Age||Years|Mean|71.5|71.5|Standard Deviation|12.1|12.1|||
3966395|NCT01304238|3788227|B4|||Age||Years|Mean|71.7|71.7|Standard Deviation|11.4|11.4|||
3966396|NCT01304238|3788228|B3|||Age||Years|Mean|67.8|67.8|Standard Deviation|13.0|13.0|||
3966397|NCT01304238|3788229|B2|||Age||Years|Mean|61.8|61.8|Standard Deviation|13.7|13.7|||
3966398|NCT01304238|3788230|B1|||Age||Years|Mean|66.4|66.4|Standard Deviation|12.3|12.3|||
3966399|NCT01304147|3788311|B1|||Baseline Inventory of Depressive Symptoms- Clinician Rated (Screen)|Inventory of Depressive Symptoms - Clinician Rated (IDS-C) has 30 items. Each item is rated 0-3, total score rage from 0 to 90, from mild to severe.|units on a scale|Mean|42.7|42.7|Standard Deviation|8.5|8.5|||
3966400|NCT01304147|3788311|B1|no||Atypical||participants|Number|18|18.0||||||
3966401|NCT01304147|3788311|B1|yes||Atypical||participants|Number|2|2.0||||||
3966402|NCT01304147|3788311|B1|no||Melancholic||participants|Number|11|11.0||||||
3966403|NCT01304147|3788311|B1|yes||Melancholic||participants|Number|9|9.0||||||
3966404|NCT01304147|3788311|B1|no||Current Anxiety Disorder||participants|Number|16|16.0||||||
3966405|NCT01304147|3788311|B1|yes||Current Anxiety Disorder||participants|Number|4|4.0||||||
3966406|NCT01304147|3788311|B1|no||Past Substance Use Disorder||participants|Number|17|17.0||||||
3966407|NCT01304147|3788311|B1|yes||Past Substance Use Disorder||participants|Number|3|3.0||||||
3966408|NCT01304147|3788311|B1|no||History of Suicide Attempts||participants|Number|18|18.0||||||
3966409|NCT01304147|3788311|B1|yes||History of Suicide Attempts||participants|Number|2|2.0||||||
3966410|NCT01304147|3788311|B1|missing information||History of Psychotherapy|n=19 missing information for one participant|participants|Number|1|1.0||||||
3966411|NCT01304147|3788311|B1|no||History of Psychotherapy|n=19 missing information for one participant|participants|Number|2|2.0||||||
3966412|NCT01304147|3788311|B1|yes||History of Psychotherapy|n=19 missing information for one participant|participants|Number|17|17.0||||||
3966413|NCT01304147|3788311|B1|no||History of Electroconvulsive Therapy||participants|Number|16|16.0||||||
3966414|NCT01304147|3788311|B1|yes||History of Electroconvulsive Therapy||participants|Number|4|4.0||||||
3966415|NCT01304147|3788311|B1|||Failed Antidepressants Medications|n=19 missing information for one participant|number of medications|Mean|4.1|4.1|Standard Deviation|3.9|3.9|||
3966416|NCT01304147|3788311|B1|||Length of Current Episode in Years||years|Mean|15.2|15.2|Standard Deviation|17.4|17.4|||
3966417|NCT01304147|3788311|B1|no||Recurrent||participants|Number|3|3.0||||||
3966418|NCT01304147|3788311|B1|yes||Recurrent||participants|Number|17|17.0||||||
3966421|NCT01304147|3788311|B1|||Illness Duration in Years||years|Mean|27.4|27.4|Standard Deviation|13.7|13.7|||
3966422|NCT01304147|3788311|B1|||Age of Onset||years|Mean|21.4|21.4|Standard Deviation|12.0|12.0|||
3966423|NCT01304147|3788311|B1|no||Employed||participants|Number|10|10.0||||||
3966424|NCT01304147|3788311|B1|yes||Employed||participants|Number|10|10.0||||||
3966425|NCT01304147|3788311|B1|no||Married||participants|Number|14|14.0||||||
3966426|NCT01304147|3788311|B1|yes||Married||participants|Number|6|6.0||||||
3966427|NCT01304147|3788311|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3966428|NCT01304147|3788311|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966429|NCT01304147|3788311|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3966430|NCT01304147|3788311|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966431|NCT01304147|3788311|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966432|NCT01304147|3788311|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3966433|NCT01304147|3788311|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966434|NCT01304147|3788311|B1||Male|Gender||Participants|Count of Participants|10|10.0||||||
3966435|NCT01304147|3788311|B1||Female|Gender||Participants|Count of Participants|10|10.0||||||
3966436|NCT01304147|3788311|B1|||Age|Age at enrollment|years|Mean|48.0|48.0|Standard Deviation|12.8|12.8|||
3966437|NCT01304082|3788320|B1|||Baseline Pain Score|This pain score is a validated 11-point numeric rating scale in which patients rate pain between 0 (no pain) and 10 (worst pain imaginable).|units on a scale|Median|6|6.0|Inter-Quartile Range|||4.0|7.0|
3966438|NCT01304082|3788320|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3966439|NCT01304082|3788320|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966440|NCT01304082|3788320|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966441|NCT01304082|3788320|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3966442|NCT01304082|3788320|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966443|NCT01304082|3788320|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966444|NCT01304082|3788320|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966445|NCT01304082|3788320|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966446|NCT01304082|3788320|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3966447|NCT01304082|3788320|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3966448|NCT01304082|3788320|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3966449|NCT01304082|3788320|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3966450|NCT01304082|3788320|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3966451|NCT01304082|3788320|B1|||Age||years|Median|54.5|54.5|Inter-Quartile Range|||44.5|62.5|
3966452|NCT01303965|3788341|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966453|NCT01303965|3788342|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966454|NCT01303965|3788343|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966455|NCT01303965|3788341|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966456|NCT01303965|3788342|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966457|NCT01303965|3788343|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966458|NCT01303965|3788341|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3966459|NCT01303965|3788342|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3966460|NCT01303965|3788343|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3966461|NCT01303965|3788341|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966462|NCT01303965|3788342|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966463|NCT01303965|3788343|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966464|NCT01303965|3788341|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966465|NCT01303965|3788342|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966466|NCT01303965|3788343|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966467|NCT01303965|3788341|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3966468|NCT01303965|3788342|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3966469|NCT01303965|3788343|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966470|NCT01303965|3788341|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966471|NCT01303965|3788342|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966472|NCT01303965|3788343|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966473|NCT01303965|3788341|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966474|NCT01303965|3788342|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966475|NCT01303965|3788343|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966476|NCT01303965|3788341|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3966477|NCT01303965|3788342|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3966478|NCT01303965|3788343|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3966479|NCT01303965|3788341|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966480|NCT01303965|3788342|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966481|NCT01303965|3788343|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966482|NCT01303965|3788341|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3966483|NCT01303965|3788342|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3966484|NCT01303965|3788343|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3966485|NCT01303965|3788341|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3966486|NCT01303965|3788342|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3966487|NCT01303965|3788343|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3966488|NCT01303965|3788341|B3|||Age||years|Mean|53.7|53.7|Standard Deviation|7.9|7.9|||
3966489|NCT01303965|3788342|B2|||Age||years|Mean|52.8|52.8|Standard Deviation|8.70|8.7|||
3966490|NCT01303965|3788343|B1|||Age||years|Mean|57.1|57.1|Standard Deviation|2.44|2.44|||
3966491|NCT01303965|3788341|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3966492|NCT01303965|3788342|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3966493|NCT01303965|3788343|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3966494|NCT01303965|3788341|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3966495|NCT01303965|3788342|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3966496|NCT01303965|3788343|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3966497|NCT01303965|3788341|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3966498|NCT01303965|3788342|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3966499|NCT01303965|3788343|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3966500|NCT01303939|3788356|B3|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3966501|NCT01303939|3788357|B2|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3966502|NCT01303939|3788358|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3966503|NCT01303939|3788356|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3966504|NCT01303939|3788357|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3966505|NCT01303939|3788358|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3966506|NCT01303939|3788356|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3966507|NCT01303939|3788357|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3966508|NCT01303939|3788358|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3966509|NCT01303939|3788356|B3|||Age||years|Mean|65.85|65.85|Standard Deviation|11.25|11.25|||
3966510|NCT01303939|3788357|B2|||Age||years|Mean|65.6|65.6|Standard Deviation|11.3|11.3|||
3966511|NCT01303939|3788358|B1|||Age||years|Mean|66.1|66.1|Standard Deviation|11.2|11.2|||
3966512|NCT01303939|3788356|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3966513|NCT01303939|3788357|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3966514|NCT01303939|3788358|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3966515|NCT01303939|3788356|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3966516|NCT01303939|3788357|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3966517|NCT01303939|3788358|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3966518|NCT01303939|3788356|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3966519|NCT01303939|3788357|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3966520|NCT01303939|3788358|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3966521|NCT01303861|3788367|B6|United States||Region of Enrollment||participants|Number|349|349.0||||||
3966522|NCT01303861|3788368|B5|United States||Region of Enrollment||participants|Number|22|22.0||||||
3966523|NCT01303861|3788369|B4|United States||Region of Enrollment||participants|Number|113|113.0||||||
3966524|NCT01303861|3788370|B3|United States||Region of Enrollment||participants|Number|55|55.0||||||
3966525|NCT01303861|3788371|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
3966526|NCT01303861|3788372|B1|United States||Region of Enrollment||participants|Number|109|109.0||||||
3966527|NCT01303861|3788367|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3966528|NCT01303861|3788368|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966529|NCT01303861|3788369|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3966530|NCT01303861|3788370|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966531|NCT01303861|3788371|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966532|NCT01303861|3788372|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3966533|NCT01303861|3788367|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3966534|NCT01303861|3788368|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3966535|NCT01303861|3788369|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3966536|NCT01303861|3788370|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3966537|NCT01303861|3788371|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3966538|NCT01303861|3788372|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3966539|NCT01303861|3788367|B6||White|Race (NIH/OMB)||Participants|Count of Participants|210|210.0||||||
3966540|NCT01303861|3788368|B5||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3966541|NCT01303861|3788369|B4||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3966542|NCT01303861|3788370|B3||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3966543|NCT01303861|3788371|B2||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3966544|NCT01303861|3788372|B1||White|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3966545|NCT01303861|3788367|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|121|121.0||||||
3966546|NCT01303861|3788368|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3966547|NCT01303861|3788369|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3966548|NCT01303861|3788370|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3966549|NCT01303861|3788371|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3966550|NCT01303861|3788372|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3966551|NCT01303861|3788367|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3966552|NCT01303861|3788368|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966553|NCT01303861|3788369|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966554|NCT01303861|3788370|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3966555|NCT01303861|3788371|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966556|NCT01303861|3788372|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966557|NCT01303861|3788367|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3966558|NCT01303861|3788368|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966559|NCT01303861|3788369|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966560|NCT01303861|3788370|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966561|NCT01303861|3788371|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966562|NCT01303861|3788372|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3966563|NCT01303861|3788367|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3966564|NCT01303861|3788368|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966565|NCT01303861|3788369|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966566|NCT01303861|3788370|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3966567|NCT01303861|3788371|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966568|NCT01303861|3788372|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966569|NCT01303861|3788367|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966570|NCT01303861|3788368|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966571|NCT01303861|3788369|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966572|NCT01303861|3788370|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966573|NCT01303861|3788371|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966574|NCT01303861|3788372|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966575|NCT01303861|3788367|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|340|340.0||||||
3966576|NCT01303861|3788368|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3966577|NCT01303861|3788369|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
3966578|NCT01303861|3788370|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3966579|NCT01303861|3788371|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3966580|NCT01303861|3788372|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
3966581|NCT01303861|3788367|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3966582|NCT01303861|3788368|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3966583|NCT01303861|3788369|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3966584|NCT01303861|3788370|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3966585|NCT01303861|3788371|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3966586|NCT01303861|3788372|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3966587|NCT01303861|3788367|B6||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3966588|NCT01303861|3788368|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3966589|NCT01303861|3788369|B4||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3966590|NCT01303861|3788370|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3966591|NCT01303861|3788371|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3966592|NCT01303861|3788372|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3966594|NCT01303861|3788368|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3966595|NCT01303861|3788369|B4||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3966596|NCT01303861|3788370|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3966597|NCT01303861|3788371|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3966598|NCT01303861|3788372|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3966599|NCT01303861|3788367|B6|||Age||years|Mean|44.42|44.42|Standard Deviation|11.20|11.2|||
3966600|NCT01303861|3788368|B5|||Age||years|Mean|44.77|44.77|Standard Deviation|11.28|11.28|||
3966601|NCT01303861|3788369|B4|||Age||years|Mean|44.22|44.22|Standard Deviation|10.47|10.47|||
3966602|NCT01303861|3788370|B3|||Age||years|Mean|42.09|42.09|Standard Deviation|12.22|12.22|||
3966603|NCT01303861|3788371|B2|||Age||years|Mean|45.20|45.2|Standard Deviation|10.56|10.56|||
3966604|NCT01303861|3788372|B1|||Age||years|Mean|45.58|45.58|Standard Deviation|11.39|11.39|||
3966605|NCT01303861|3788367|B6||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3966606|NCT01303861|3788368|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3966607|NCT01303861|3788369|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3966608|NCT01303861|3788370|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3966609|NCT01303861|3788371|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3966610|NCT01303861|3788372|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3966611|NCT01303861|3788367|B6||Between 18 and 65 years|Age||Participants|Count of Participants|347|347.0||||||
3966612|NCT01303861|3788368|B5||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3966613|NCT01303861|3788369|B4||Between 18 and 65 years|Age||Participants|Count of Participants|113|113.0||||||
3966614|NCT01303861|3788370|B3||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3966615|NCT01303861|3788371|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3966616|NCT01303861|3788372|B1||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
3966617|NCT01303861|3788367|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3966618|NCT01303861|3788368|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3966619|NCT01303861|3788369|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3966620|NCT01303861|3788370|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3966621|NCT01303861|3788371|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3966622|NCT01303861|3788372|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3966623|NCT01303835|3788394|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3966624|NCT01303835|3788395|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3966625|NCT01303835|3788396|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3966626|NCT01303835|3788394|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3966627|NCT01303835|3788395|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3966628|NCT01303835|3788396|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3966629|NCT01303835|3788394|B3|||Age||years|Mean|56.2|56.2|Standard Deviation|11.1|11.1|||
3966630|NCT01303835|3788395|B2|||Age||years|Mean|56.7|56.7|Standard Deviation|11.3|11.3|||
3966631|NCT01303835|3788396|B1|||Age||years|Mean|55.6|55.6|Standard Deviation|11.0|11.0|||
3966632|NCT01303744|3788407|B5|Italy||Region of Enrollment||participants|Number|5|5.0||||||
3966633|NCT01303744|3788408|B4|Italy||Region of Enrollment||participants|Number|0|0.0||||||
3966634|NCT01303744|3788409|B3|Italy||Region of Enrollment||participants|Number|5|5.0||||||
3966635|NCT01303744|3788410|B2|Italy||Region of Enrollment||participants|Number|0|0.0||||||
3966636|NCT01303744|3788411|B1|Italy||Region of Enrollment||participants|Number|0|0.0||||||
3966637|NCT01303744|3788407|B5|United States||Region of Enrollment||participants|Number|91|91.0||||||
3966638|NCT01303744|3788408|B4|United States||Region of Enrollment||participants|Number|24|24.0||||||
3966639|NCT01303744|3788409|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
3966640|NCT01303744|3788410|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
3966641|NCT01303744|3788411|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3966642|NCT01303744|3788407|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966643|NCT01303744|3788408|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966644|NCT01303744|3788409|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966645|NCT01303744|3788410|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966646|NCT01303744|3788411|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966647|NCT01303744|3788407|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966648|NCT01303744|3788408|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966649|NCT01303744|3788409|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966650|NCT01303744|3788410|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966651|NCT01303744|3788411|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966652|NCT01303744|3788407|B5||White|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
3966653|NCT01303744|3788408|B4||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3966654|NCT01303744|3788409|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3966655|NCT01303744|3788410|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3966656|NCT01303744|3788411|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3966657|NCT01303744|3788407|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3966658|NCT01303744|3788408|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966659|NCT01303744|3788409|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966660|NCT01303744|3788410|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3966661|NCT01303744|3788411|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3966662|NCT01303744|3788407|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966663|NCT01303744|3788408|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966664|NCT01303744|3788409|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966665|NCT01303744|3788410|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966666|NCT01303744|3788411|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966667|NCT01303744|3788407|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3966668|NCT01303744|3788408|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3966669|NCT01303744|3788409|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966670|NCT01303744|3788410|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3966671|NCT01303744|3788411|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966672|NCT01303744|3788407|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966673|NCT01303744|3788408|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966674|NCT01303744|3788409|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966675|NCT01303744|3788410|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966676|NCT01303744|3788411|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966677|NCT01303744|3788407|B5||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3966678|NCT01303744|3788408|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3966679|NCT01303744|3788409|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3966680|NCT01303744|3788410|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3966681|NCT01303744|3788411|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3966682|NCT01303744|3788407|B5||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3966683|NCT01303744|3788408|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3966684|NCT01303744|3788409|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3966685|NCT01303744|3788410|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3966686|NCT01303744|3788411|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3966687|NCT01303744|3788407|B5|||Age||years|Mean|68.4|68.4|Standard Deviation|8.3|8.3|||
3966688|NCT01303744|3788408|B4|||Age||years|Mean|68.1|68.1|Standard Deviation|8.0|8.0|||
3966689|NCT01303744|3788409|B3|||Age||years|Mean|69.0|69.0|Standard Deviation|9.2|9.2|||
3966690|NCT01303744|3788410|B2|||Age||years|Mean|68.9|68.9|Standard Deviation|8.5|8.5|||
3966691|NCT01303744|3788411|B1|||Age||years|Mean|67.7|67.7|Standard Deviation|8.1|8.1|||
3966692|NCT01303627|3788432|B3|Turkey||Region of Enrollment||participants|Number|41|41.0||||||
3966693|NCT01303627|3788433|B2|Turkey||Region of Enrollment||participants|Number|20|20.0||||||
3966694|NCT01303627|3788434|B1|Turkey||Region of Enrollment||participants|Number|21|21.0||||||
3966695|NCT01303627|3788432|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3966696|NCT01303627|3788433|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3966697|NCT01303627|3788434|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3966698|NCT01303627|3788432|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3966699|NCT01303627|3788433|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3966700|NCT01303627|3788434|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3966701|NCT01303627|3788432|B3|||Age||years|Mean|39|39.0|Standard Deviation|12|12.0|||
3966702|NCT01303627|3788433|B2|||Age||years|Mean|38|38.0|Standard Deviation|12|12.0|||
3966703|NCT01303627|3788434|B1|||Age||years|Mean|41|41.0|Standard Deviation|13|13.0|||
3966704|NCT01303627|3788432|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3966705|NCT01303627|3788433|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3966706|NCT01303627|3788434|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3966707|NCT01303627|3788432|B3||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3966708|NCT01303627|3788433|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3966709|NCT01303627|3788434|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3966710|NCT01303627|3788432|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3966711|NCT01303627|3788433|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3966712|NCT01303627|3788434|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3966713|NCT01303510|3788441|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3966714|NCT01303510|3788442|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3966715|NCT01303510|3788443|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3966716|NCT01303510|3788441|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3966717|NCT01303510|3788442|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3966718|NCT01303510|3788443|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3966719|NCT01303510|3788441|B3|||Age||years|Mean|54.4|54.4|Standard Deviation|18.0|18.0|||
3966720|NCT01303510|3788442|B2|||Age||years|Mean|69.3|69.3|Standard Deviation|5.2|5.2|||
3966721|NCT01303510|3788443|B1|||Age||years|Mean|39.2|39.2|Standard Deviation|13.0|13.0|||
3966722|NCT01303445|3788458|B1|||Body Mass Index (BMI)||kilograms per square meter|Mean|26.81|26.81|Full Range|||20.45|31.94|
3966723|NCT01303445|3788458|B1|||Weight||kilograms|Mean|75.69|75.69|Full Range|||55.2|101.7|
3966724|NCT01303445|3788458|B1|Black / African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3966725|NCT01303445|3788458|B1|White||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
3966726|NCT01303445|3788458|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966727|NCT01303445|3788458|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3966728|NCT01303445|3788458|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3966729|NCT01303445|3788458|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3966730|NCT01303445|3788458|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3966731|NCT01303445|3788458|B1|||Age||years|Mean|35.3|35.3|Full Range|||20.0|50.0|
3966732|NCT01303406|3788489|B3|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
3966733|NCT01303406|3788490|B2|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
3966734|NCT01303406|3788491|B1|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
3966735|NCT01303406|3788489|B3|Austria||Region of Enrollment||participants|Number|4|4.0||||||
3966736|NCT01303406|3788490|B2|Austria||Region of Enrollment||participants|Number|2|2.0||||||
3966737|NCT01303406|3788491|B1|Austria||Region of Enrollment||participants|Number|2|2.0||||||
3966738|NCT01303406|3788489|B3|United Kingdom||Region of Enrollment||participants|Number|14|14.0||||||
3966739|NCT01303406|3788490|B2|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
3966740|NCT01303406|3788491|B1|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
3966741|NCT01303406|3788489|B3|Germany||Region of Enrollment||participants|Number|8|8.0||||||
3966742|NCT01303406|3788490|B2|Germany||Region of Enrollment||participants|Number|5|5.0||||||
3966743|NCT01303406|3788491|B1|Germany||Region of Enrollment||participants|Number|3|3.0||||||
3966744|NCT01303406|3788489|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3966745|NCT01303406|3788490|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3966746|NCT01303406|3788491|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3966747|NCT01303406|3788489|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3966748|NCT01303406|3788490|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3966749|NCT01303406|3788491|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3966750|NCT01303406|3788489|B3|||Age||years|Mean|37.1|37.1|Standard Deviation|16.5|16.5|||
3966751|NCT01303406|3788490|B2|||Age||years|Mean|35.8|35.8|Standard Deviation|16.9|16.9|||
3966752|NCT01303406|3788491|B1|||Age||years|Mean|38.7|38.7|Standard Deviation|16.5|16.5|||
3966753|NCT01303380|3788500|B1|Spain||Region of Enrollment||participants|Number|9|9.0||||||
3966754|NCT01303380|3788500|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3966755|NCT01303380|3788500|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3966756|NCT01303380|3788500|B1|Adults (18-­64 years)||Age, Customized||participants|Number|3|3.0||||||
3966757|NCT01303380|3788500|B1|Adolescents (12­-17 years)||Age, Customized||participants|Number|3|3.0||||||
3966758|NCT01303380|3788500|B1|Children (2­-11 years)||Age, Customized||participants|Number|3|3.0||||||
3966759|NCT01303380|3788500|B1|||Age||years|Median|17.3|17.3|Full Range|||5.0|29.0|
3966760|NCT01303224|3788526|B5|||European Quality of Life Questionnaire 5D (EQ-5D) QoL VAS|"European quality of life visual analogue scale ranging from 0= worst imaginable health state to 100= best imaginable health state"|Scores on a scale|Mean|55.8|55.8|Standard Deviation|22.5|22.5|||
3966761|NCT01303224|3788527|B4|||European Quality of Life Questionnaire 5D (EQ-5D) QoL VAS|"European quality of life visual analogue scale ranging from 0= worst imaginable health state to 100= best imaginable health state"|Scores on a scale|Mean|55.3|55.3|Standard Deviation|22.3|22.3|||
3966762|NCT01303224|3788528|B3|||European Quality of Life Questionnaire 5D (EQ-5D) QoL VAS|"European quality of life visual analogue scale ranging from 0= worst imaginable health state to 100= best imaginable health state"|Scores on a scale|Mean|58.1|58.1|Standard Deviation|22.9|22.9|||
3966763|NCT01303224|3788529|B2|||European Quality of Life Questionnaire 5D (EQ-5D) QoL VAS|"European quality of life visual analogue scale ranging from 0= worst imaginable health state to 100= best imaginable health state"|Scores on a scale|Mean|55.5|55.5|Standard Deviation|21.9|21.9|||
3966764|NCT01303224|3788530|B1|||European Quality of Life Questionnaire 5D (EQ-5D) QoL VAS|"European quality of life visual analogue scale ranging from 0= worst imaginable health state to 100= best imaginable health state"|Scores on a scale|Mean|54.5|54.5|Standard Deviation|22.9|22.9|||
3966765|NCT01303224|3788526|B5|||IBS-Symptom Severity Scale score|"IBS symptom severity score, ranging from 0= no symptoms to 500= very severe symptoms"|Scores on a scale|Mean|336.3|336.3|Standard Deviation|72.7|72.7|||
3966766|NCT01303224|3788527|B4|||IBS-Symptom Severity Scale score|"IBS symptom severity score, ranging from 0= no symptoms to 500= very severe symptoms"|Scores on a scale|Mean|335.7|335.7|Standard Deviation|69.4|69.4|||
3966767|NCT01303224|3788528|B3|||IBS-Symptom Severity Scale score|"IBS symptom severity score, ranging from 0= no symptoms to 500= very severe symptoms"|Scores on a scale|Mean|332.6|332.6|Standard Deviation|74.3|74.3|||
3966768|NCT01303224|3788529|B2|||IBS-Symptom Severity Scale score|"IBS symptom severity score, ranging from 0= no symptoms to 500= very severe symptoms"|Scores on a scale|Mean|333.3|333.3|Standard Deviation|78.3|78.3|||
3966769|NCT01303224|3788530|B1|||IBS-Symptom Severity Scale score|"IBS symptom severity score, ranging from 0= no symptoms to 500= very severe symptoms"|Scores on a scale|Mean|343.4|343.4|Standard Deviation|68.8|68.8|||
3966770|NCT01303224|3788526|B5|||Stool consistency|"7-point Bristol stool scale ranging from 1= hard lumpy stool to 7= watery, liquid stool"|Scores on a scale|Mean|5.7|5.7|Standard Deviation|0.6|0.6|||
3966771|NCT01303224|3788527|B4|||Stool consistency|"7-point Bristol stool scale ranging from 1= hard lumpy stool to 7= watery, liquid stool"|Scores on a scale|Mean|5.7|5.7|Standard Deviation|0.6|0.6|||
3966772|NCT01303224|3788528|B3|||Stool consistency|"7-point Bristol stool scale ranging from 1= hard lumpy stool to 7= watery, liquid stool"|Scores on a scale|Mean|5.7|5.7|Standard Deviation|0.6|0.6|||
3966773|NCT01303224|3788529|B2|||Stool consistency|"7-point Bristol stool scale ranging from 1= hard lumpy stool to 7= watery, liquid stool"|Scores on a scale|Mean|5.7|5.7|Standard Deviation|0.5|0.5|||
3966774|NCT01303224|3788530|B1|||Stool consistency|"7-point Bristol stool scale ranging from 1= hard lumpy stool to 7= watery, liquid stool"|Scores on a scale|Mean|5.7|5.7|Standard Deviation|0.6|0.6|||
3966775|NCT01303224|3788526|B5|||Stool frequency/day|Overall stool frequency per day|bowel movements/day|Mean|4.5|4.5|Standard Deviation|1.4|1.4|||
3966776|NCT01303224|3788527|B4|||Stool frequency/day|Overall stool frequency per day|bowel movements/day|Mean|4.4|4.4|Standard Deviation|1.2|1.2|||
3966777|NCT01303224|3788528|B3|||Stool frequency/day|Overall stool frequency per day|bowel movements/day|Mean|4.4|4.4|Standard Deviation|1.5|1.5|||
3966778|NCT01303224|3788529|B2|||Stool frequency/day|Overall stool frequency per day|bowel movements/day|Mean|4.4|4.4|Standard Deviation|1.3|1.3|||
3966779|NCT01303224|3788530|B1|||Stool frequency/day|Overall stool frequency per day|bowel movements/day|Mean|4.6|4.6|Standard Deviation|1.5|1.5|||
3966780|NCT01303224|3788526|B5|IBS symptom severity rate||IBS symptoms at baseline/ randomisation)|"5 point scale ranging from 0= no symptoms to 4= very severe"|Scores on a scale|Mean|2.7|2.7|Standard Deviation|0.6|0.6|||
3966781|NCT01303224|3788527|B4|IBS symptom severity rate||IBS symptoms at baseline/ randomisation)|"5 point scale ranging from 0= no symptoms to 4= very severe"|Scores on a scale|Mean|2.6|2.6|Standard Deviation|0.6|0.6|||
3966782|NCT01303224|3788528|B3|IBS symptom severity rate||IBS symptoms at baseline/ randomisation)|"5 point scale ranging from 0= no symptoms to 4= very severe"|Scores on a scale|Mean|2.6|2.6|Standard Deviation|0.6|0.6|||
3966783|NCT01303224|3788529|B2|IBS symptom severity rate||IBS symptoms at baseline/ randomisation)|"5 point scale ranging from 0= no symptoms to 4= very severe"|Scores on a scale|Mean|2.6|2.6|Standard Deviation|0.6|0.6|||
3966784|NCT01303224|3788530|B1|IBS symptom severity rate||IBS symptoms at baseline/ randomisation)|"5 point scale ranging from 0= no symptoms to 4= very severe"|Scores on a scale|Mean|2.7|2.7|Standard Deviation|0.7|0.7|||
3966785|NCT01303224|3788526|B5|Urgency score||IBS symptoms at baseline/ randomisation)|"5 point scale ranging from 0= no symptoms to 4= very severe"|Scores on a scale|Mean|2.4|2.4|Standard Deviation|0.7|0.7|||
3966786|NCT01303224|3788527|B4|Urgency score||IBS symptoms at baseline/ randomisation)|"5 point scale ranging from 0= no symptoms to 4= very severe"|Scores on a scale|Mean|2.4|2.4|Standard Deviation|0.6|0.6|||
3966787|NCT01303224|3788528|B3|Urgency score||IBS symptoms at baseline/ randomisation)|"5 point scale ranging from 0= no symptoms to 4= very severe"|Scores on a scale|Mean|2.4|2.4|Standard Deviation|0.6|0.6|||
3966788|NCT01303224|3788529|B2|Urgency score||IBS symptoms at baseline/ randomisation)|"5 point scale ranging from 0= no symptoms to 4= very severe"|Scores on a scale|Mean|2.5|2.5|Standard Deviation|0.6|0.6|||
3966789|NCT01303224|3788530|B1|Urgency score||IBS symptoms at baseline/ randomisation)|"5 point scale ranging from 0= no symptoms to 4= very severe"|Scores on a scale|Mean|2.5|2.5|Standard Deviation|0.7|0.7|||
3966790|NCT01303224|3788526|B5|Bloating score||IBS symptoms at baseline/ randomisation)|"5 point scale ranging from 0= no symptoms to 4= very severe"|Scores on a scale|Mean|2.3|2.3|Standard Deviation|0.7|0.7|||
3966791|NCT01303224|3788527|B4|Bloating score||IBS symptoms at baseline/ randomisation)|"5 point scale ranging from 0= no symptoms to 4= very severe"|Scores on a scale|Mean|2.2|2.2|Standard Deviation|0.6|0.6|||
3966792|NCT01303224|3788528|B3|Bloating score||IBS symptoms at baseline/ randomisation)|"5 point scale ranging from 0= no symptoms to 4= very severe"|Scores on a scale|Mean|2.2|2.2|Standard Deviation|0.7|0.7|||
3966793|NCT01303224|3788529|B2|Bloating score||IBS symptoms at baseline/ randomisation)|"5 point scale ranging from 0= no symptoms to 4= very severe"|Scores on a scale|Mean|2.2|2.2|Standard Deviation|0.7|0.7|||
3966794|NCT01303224|3788530|B1|Bloating score||IBS symptoms at baseline/ randomisation)|"5 point scale ranging from 0= no symptoms to 4= very severe"|Scores on a scale|Mean|2.4|2.4|Standard Deviation|0.8|0.8|||
3966795|NCT01303224|3788526|B5|Abdominal pain score||IBS symptoms at baseline/ randomisation)|"5 point scale ranging from 0= no symptoms to 4= very severe"|Scores on a scale|Mean|2.3|2.3|Standard Deviation|0.5|0.5|||
3966796|NCT01303224|3788527|B4|Abdominal pain score||IBS symptoms at baseline/ randomisation)|"5 point scale ranging from 0= no symptoms to 4= very severe"|Scores on a scale|Mean|2.3|2.3|Standard Deviation|0.6|0.6|||
3966797|NCT01303224|3788528|B3|Abdominal pain score||IBS symptoms at baseline/ randomisation)|"5 point scale ranging from 0= no symptoms to 4= very severe"|Scores on a scale|Mean|2.3|2.3|Standard Deviation|0.5|0.5|||
3966798|NCT01303224|3788529|B2|Abdominal pain score||IBS symptoms at baseline/ randomisation)|"5 point scale ranging from 0= no symptoms to 4= very severe"|Scores on a scale|Mean|2.3|2.3|Standard Deviation|0.5|0.5|||
3966799|NCT01303224|3788530|B1|Abdominal pain score||IBS symptoms at baseline/ randomisation)|"5 point scale ranging from 0= no symptoms to 4= very severe"|Scores on a scale|Mean|2.5|2.5|Standard Deviation|0.6|0.6|||
3966800|NCT01303224|3788526|B5|||Time since onset of IBS symptoms||years|Mean|5.8|5.8|Standard Deviation|7.0|7.0|||
3966801|NCT01303224|3788527|B4|||Time since onset of IBS symptoms||years|Mean|4.6|4.6|Standard Deviation|6.2|6.2|||
3966802|NCT01303224|3788528|B3|||Time since onset of IBS symptoms||years|Mean|6.3|6.3|Standard Deviation|6.9|6.9|||
3966861|NCT01302964|3788576|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3966803|NCT01303224|3788529|B2|||Time since onset of IBS symptoms||years|Mean|6.3|6.3|Standard Deviation|7.5|7.5|||
3966804|NCT01303224|3788530|B1|||Time since onset of IBS symptoms||years|Mean|6.2|6.2|Standard Deviation|7.3|7.3|||
3966805|NCT01303224|3788526|B5||Male|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
3966806|NCT01303224|3788527|B4||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3966807|NCT01303224|3788528|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3966808|NCT01303224|3788529|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3966809|NCT01303224|3788530|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3966810|NCT01303224|3788526|B5||Female|Sex: Female, Male||Participants|Count of Participants|333|333.0||||||
3966811|NCT01303224|3788527|B4||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3966812|NCT01303224|3788528|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3966813|NCT01303224|3788529|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3966814|NCT01303224|3788530|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3966815|NCT01303224|3788526|B5|||Age||years|Mean|46.0|46.0|Standard Deviation|13.5|13.5|||
3966816|NCT01303224|3788527|B4|||Age||years|Mean|44.1|44.1|Standard Deviation|14.0|14.0|||
3966817|NCT01303224|3788528|B3|||Age||years|Mean|47.0|47.0|Standard Deviation|12.8|12.8|||
3966818|NCT01303224|3788529|B2|||Age||years|Mean|47.1|47.1|Standard Deviation|13.4|13.4|||
3966819|NCT01303224|3788530|B1|||Age||years|Mean|45.9|45.9|Standard Deviation|13.7|13.7|||
3966820|NCT01303159|3788559|B1|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3966821|NCT01303159|3788559|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3966822|NCT01303159|3788559|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3966823|NCT01303159|3788559|B1|||Age||years|Mean|69|69.0|Standard Deviation|12.9|12.9|||
3966824|NCT01302964|3788575|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3966825|NCT01302964|3788576|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3966826|NCT01302964|3788577|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3966827|NCT01302964|3788575|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3966828|NCT01302964|3788576|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966829|NCT01302964|3788577|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3966830|NCT01302964|3788575|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966831|NCT01302964|3788576|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966832|NCT01302964|3788577|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966833|NCT01302964|3788575|B3||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3966834|NCT01302964|3788576|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3966835|NCT01302964|3788577|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3966836|NCT01302964|3788575|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3966837|NCT01302964|3788576|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3966838|NCT01302964|3788577|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3966839|NCT01302964|3788575|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966840|NCT01302964|3788576|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966841|NCT01302964|3788577|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966842|NCT01302964|3788575|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3966843|NCT01302964|3788576|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966844|NCT01302964|3788577|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3966845|NCT01302964|3788575|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966846|NCT01302964|3788576|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966847|NCT01302964|3788577|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966848|NCT01302964|3788575|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3966849|NCT01302964|3788576|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3966850|NCT01302964|3788577|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3966851|NCT01302964|3788575|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3966852|NCT01302964|3788576|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3966853|NCT01302964|3788577|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3966854|NCT01302964|3788575|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3966855|NCT01302964|3788576|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3966856|NCT01302964|3788577|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3966857|NCT01302964|3788575|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3966858|NCT01302964|3788576|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3966859|NCT01302964|3788577|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3966860|NCT01302964|3788575|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3966862|NCT01302964|3788577|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3966863|NCT01302964|3788575|B3|||Age||years|Mean|11.0|11.0|Standard Deviation|3.7|3.7|||
3966864|NCT01302964|3788576|B2|||Age||years|Mean|11.3|11.3|Standard Deviation|4.1|4.1|||
3966865|NCT01302964|3788577|B1|||Age||years|Mean|10.9|10.9|Standard Deviation|3.6|3.6|||
3966866|NCT01302938|3788586|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3966867|NCT01302938|3788587|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3966868|NCT01302938|3788588|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3966869|NCT01302938|3788586|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3966870|NCT01302938|3788587|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3966871|NCT01302938|3788588|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3966872|NCT01302938|3788586|B3|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|1|1.0||||||
3966873|NCT01302938|3788587|B2|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|0|0.0||||||
3966874|NCT01302938|3788588|B1|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|1|1.0||||||
3966875|NCT01302938|3788586|B3|45 to 64 years||Age, Customized||participants|Number|10|10.0||||||
3966876|NCT01302938|3788587|B2|45 to 64 years||Age, Customized||participants|Number|3|3.0||||||
3966877|NCT01302938|3788588|B1|45 to 64 years||Age, Customized||participants|Number|7|7.0||||||
3966878|NCT01302938|3788586|B3|18 to 44 years||Age, Customized||participants|Number|7|7.0||||||
3966879|NCT01302938|3788587|B2|18 to 44 years||Age, Customized||participants|Number|3|3.0||||||
3966880|NCT01302938|3788588|B1|18 to 44 years||Age, Customized||participants|Number|4|4.0||||||
3966881|NCT01302899|3788632|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3966882|NCT01302899|3788633|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3966883|NCT01302899|3788634|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3966884|NCT01302899|3788632|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3966885|NCT01302899|3788633|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3966886|NCT01302899|3788634|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3966887|NCT01302899|3788632|B3|||Age||years|Mean|54.5|54.5|Standard Deviation|8.38|8.38|||
3966888|NCT01302899|3788633|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|8.70|8.7|||
3966889|NCT01302899|3788634|B1|||Age||years|Mean|50.5|50.5|Standard Deviation|6.76|6.76|||
3966890|NCT01302860|3788685|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3966891|NCT01302860|3788685|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3966892|NCT01302860|3788685|B1|Children (2-5 years)||Age, Customized||participants|Number|11|11.0||||||
3966893|NCT01302860|3788685|B1|Infants and toddlers (28 days-23 months)||Age, Customized||participants|Number|6|6.0||||||
3966894|NCT01302860|3788685|B1|||Age||years|Mean|1.9|1.9|Standard Deviation|1.39|1.39|||
3966895|NCT01302743|3788697|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3966896|NCT01302743|3788698|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3966897|NCT01302743|3788699|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3966898|NCT01302743|3788700|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3966899|NCT01302743|3788697|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3966900|NCT01302743|3788698|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3966901|NCT01302743|3788699|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3966902|NCT01302743|3788700|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3966903|NCT01302743|3788697|B4||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3966904|NCT01302743|3788698|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3966905|NCT01302743|3788699|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3966906|NCT01302743|3788700|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3966907|NCT01302743|3788697|B4||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3966908|NCT01302743|3788698|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3966909|NCT01302743|3788699|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3966910|NCT01302743|3788700|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3966911|NCT01302743|3788697|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3966912|NCT01302743|3788698|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3966913|NCT01302743|3788699|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3966914|NCT01302743|3788700|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3966915|NCT01302691|3788713|B3||Male|Gender||Participants|Count of Participants|253|253.0||||||
3966916|NCT01302691|3788714|B2||Male|Gender||Participants|Count of Participants|122|122.0||||||
3966917|NCT01302691|3788715|B1||Male|Gender||Participants|Count of Participants|131|131.0||||||
3966918|NCT01302691|3788713|B3||Female|Gender||Participants|Count of Participants|74|74.0||||||
3966919|NCT01302691|3788714|B2||Female|Gender||Participants|Count of Participants|41|41.0||||||
3966920|NCT01302691|3788715|B1||Female|Gender||Participants|Count of Participants|33|33.0||||||
3966921|NCT01302691|3788713|B3|||Age||years|Mean|55.2|55.2|Standard Deviation|9.7|9.7|||
3966922|NCT01302691|3788714|B2|||Age||years|Mean|55.4|55.4|Standard Deviation|10.1|10.1|||
3966923|NCT01302691|3788715|B1|||Age||years|Mean|54.9|54.9|Standard Deviation|9.4|9.4|||
3966924|NCT01302548|3788734|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
3966925|NCT01302548|3788735|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3966926|NCT01302548|3788736|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3966927|NCT01302548|3788734|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3966928|NCT01302548|3788735|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3966929|NCT01302548|3788736|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3966930|NCT01302548|3788734|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3966931|NCT01302548|3788735|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3966932|NCT01302548|3788736|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3966933|NCT01302548|3788734|B3|||Age||years|Mean|27.87|27.87|Standard Deviation|10.08|10.08|||
3966934|NCT01302548|3788735|B2|||Age||years|Mean|24.83|24.83|Standard Deviation|9.81|9.81|||
3966935|NCT01302548|3788736|B1|||Age||years|Mean|32.42|32.42|Standard Deviation|9.04|9.04|||
3966936|NCT01302548|3788734|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3966937|NCT01302548|3788735|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3966938|NCT01302548|3788736|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3966939|NCT01302548|3788734|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3966940|NCT01302548|3788735|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3966941|NCT01302548|3788736|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3966942|NCT01302548|3788734|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3966943|NCT01302548|3788735|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3966944|NCT01302548|3788736|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3966945|NCT01302483|3788747|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
3966946|NCT01302483|3788748|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3966947|NCT01302483|3788749|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3966948|NCT01302483|3788747|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3966949|NCT01302483|3788748|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3966950|NCT01302483|3788749|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3966951|NCT01302483|3788747|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3966952|NCT01302483|3788748|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3966953|NCT01302483|3788749|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3966954|NCT01302483|3788747|B3|||Age||years|Mean|39.3|39.3|Standard Deviation|13.6|13.6|||
3966955|NCT01302483|3788748|B2|||Age||years|Mean|40.8|40.8|Standard Deviation|15.3|15.3|||
3966956|NCT01302483|3788749|B1|||Age||years|Mean|38.6|38.6|Standard Deviation|12.8|12.8|||
3966957|NCT01302483|3788747|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3966958|NCT01302483|3788748|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3966959|NCT01302483|3788749|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3966960|NCT01302483|3788747|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3966961|NCT01302483|3788748|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3966962|NCT01302483|3788749|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3966963|NCT01302483|3788747|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3966964|NCT01302483|3788748|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3966965|NCT01302483|3788749|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3966966|NCT01302444|3788764|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3966967|NCT01302444|3788766|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3966968|NCT01302444|3788764|B3|Male||Gender||participants|Number|0|0.0||||||
3966969|NCT01302444|3788766|B1|Male||Gender||participants|Number|0|0.0||||||
3966970|NCT01302444|3788764|B3|Female||Gender||participants|Number|1|1.0||||||
3966971|NCT01302444|3788766|B1|Female||Gender||participants|Number|1|1.0||||||
3966972|NCT01302444|3788764|B3|>=65 years||Age||participants|Number|0|0.0||||||
3966973|NCT01302444|3788766|B1|>=65 years||Age||participants|Number|0|0.0||||||
3966974|NCT01302444|3788764|B3|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
3966975|NCT01302444|3788766|B1|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
3966976|NCT01302444|3788764|B3|<=18 years||Age||participants|Number|0|0.0||||||
3966977|NCT01302444|3788766|B1|<=18 years||Age||participants|Number|0|0.0||||||
3966978|NCT01302418|3788787|B1|United States||Region of Enrollment||participants|Number|272|272.0||||||
3966979|NCT01302418|3788787|B1||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3966980|NCT01302418|3788787|B1||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3966981|NCT01302418|3788787|B1|||Age||years|Mean|14|14.0|Standard Deviation|16.1|16.1|||
3966982|NCT01302418|3788787|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3966983|NCT01302418|3788787|B1||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
3966984|NCT01302418|3788787|B1||<=18 years|Age||Participants|Count of Participants|202|202.0||||||
3966985|NCT01302392|3788791|B3|≥5||Number of Prior Regimens to Treat Multiple Myeloma||participants|Number|210|210.0||||||
3966986|NCT01302392|3788792|B2|≥5||Number of Prior Regimens to Treat Multiple Myeloma||participants|Number|106|106.0||||||
3966987|NCT01302392|3788793|B1|≥5||Number of Prior Regimens to Treat Multiple Myeloma||participants|Number|104|104.0||||||
3966988|NCT01302392|3788791|B3|4||Number of Prior Regimens to Treat Multiple Myeloma||participants|Number|69|69.0||||||
3966989|NCT01302392|3788792|B2|4||Number of Prior Regimens to Treat Multiple Myeloma||participants|Number|34|34.0||||||
3966990|NCT01302392|3788793|B1|4||Number of Prior Regimens to Treat Multiple Myeloma||participants|Number|35|35.0||||||
3966991|NCT01302392|3788791|B3|3||Number of Prior Regimens to Treat Multiple Myeloma||participants|Number|36|36.0||||||
3966992|NCT01302392|3788792|B2|3||Number of Prior Regimens to Treat Multiple Myeloma||participants|Number|17|17.0||||||
3966993|NCT01302392|3788793|B1|3||Number of Prior Regimens to Treat Multiple Myeloma||participants|Number|19|19.0||||||
3966994|NCT01302392|3788791|B3|Non-Europe||Region||participants|Number|37|37.0||||||
3966995|NCT01302392|3788792|B2|Non-Europe||Region||participants|Number|17|17.0||||||
3966996|NCT01302392|3788793|B1|Non-Europe||Region||participants|Number|20|20.0||||||
3966997|NCT01302392|3788791|B3|Europe||Region||participants|Number|278|278.0||||||
3966998|NCT01302392|3788792|B2|Europe||Region||participants|Number|140|140.0||||||
3966999|NCT01302392|3788793|B1|Europe||Region||participants|Number|138|138.0||||||
3967000|NCT01302392|3788791|B3|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3967001|NCT01302392|3788792|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3967002|NCT01302392|3788793|B1|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3967003|NCT01302392|3788791|B3|White||Race/Ethnicity, Customized||participants|Number|299|299.0||||||
3967004|NCT01302392|3788792|B2|White||Race/Ethnicity, Customized||participants|Number|151|151.0||||||
3967005|NCT01302392|3788793|B1|White||Race/Ethnicity, Customized||participants|Number|148|148.0||||||
3967006|NCT01302392|3788791|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3967007|NCT01302392|3788792|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3967008|NCT01302392|3788793|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3967009|NCT01302392|3788791|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3967010|NCT01302392|3788792|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3967011|NCT01302392|3788793|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3967012|NCT01302392|3788791|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3967013|NCT01302392|3788792|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3967014|NCT01302392|3788793|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3967015|NCT01302392|3788791|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3967016|NCT01302392|3788792|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3967017|NCT01302392|3788793|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3967018|NCT01302392|3788791|B3||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
3967019|NCT01302392|3788792|B2||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3967020|NCT01302392|3788793|B1||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3967021|NCT01302392|3788791|B3||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3967022|NCT01302392|3788792|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3967023|NCT01302392|3788793|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3967024|NCT01302392|3788791|B3|||Age||years|Mean|64.4|64.4|Standard Deviation|9.50|9.5|||
3967025|NCT01302392|3788792|B2|||Age||years|Mean|63.3|63.3|Standard Deviation|10.71|10.71|||
3967026|NCT01302392|3788793|B1|||Age||years|Mean|65.5|65.5|Standard Deviation|8.02|8.02|||
3967027|NCT01302366|3788814|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3967028|NCT01302366|3788814|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3967029|NCT01302366|3788814|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967030|NCT01302366|3788814|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3967031|NCT01302366|3788814|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3967032|NCT01302366|3788814|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967033|NCT01302366|3788814|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967034|NCT01302366|3788814|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967035|NCT01302366|3788814|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3967036|NCT01302366|3788814|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3967037|NCT01302366|3788814|B1|74-83 years||Age, Customized||participants|Number|3|3.0||||||
3967038|NCT01302366|3788814|B1|64-73 years||Age, Customized||participants|Number|5|5.0||||||
3967039|NCT01302366|3788814|B1|54-63 years||Age, Customized||participants|Number|9|9.0||||||
3967040|NCT01302366|3788814|B1|45-53 years||Age, Customized||participants|Number|2|2.0||||||
3967041|NCT01302366|3788814|B1|35-44 years||Age, Customized||participants|Number|1|1.0||||||
3967042|NCT01302119|3788820|B3|Canada||Region of Enrollment||participants|Number|121|121.0||||||
3967043|NCT01302119|3788821|B2|Canada||Region of Enrollment||participants|Number|40|40.0||||||
3967044|NCT01302119|3788822|B1|Canada||Region of Enrollment||participants|Number|81|81.0||||||
3967045|NCT01302119|3788820|B3|United States||Region of Enrollment||participants|Number|480|480.0||||||
3967046|NCT01302119|3788821|B2|United States||Region of Enrollment||participants|Number|165|165.0||||||
3967047|NCT01302119|3788822|B1|United States||Region of Enrollment||participants|Number|315|315.0||||||
3967048|NCT01302119|3788820|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3967049|NCT01302119|3788821|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3967050|NCT01302119|3788822|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3967051|NCT01302119|3788820|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967052|NCT01302119|3788821|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967053|NCT01302119|3788822|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967054|NCT01302119|3788820|B3||White|Race (NIH/OMB)||Participants|Count of Participants|538|538.0||||||
3967055|NCT01302119|3788821|B2||White|Race (NIH/OMB)||Participants|Count of Participants|183|183.0||||||
3967056|NCT01302119|3788822|B1||White|Race (NIH/OMB)||Participants|Count of Participants|355|355.0||||||
3967057|NCT01302119|3788820|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3967058|NCT01302119|3788821|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3967059|NCT01302119|3788822|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3967060|NCT01302119|3788820|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3967061|NCT01302119|3788821|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3967062|NCT01302119|3788822|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3967063|NCT01302119|3788820|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3967064|NCT01302119|3788821|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3967065|NCT01302119|3788822|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3967066|NCT01302119|3788820|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3967067|NCT01302119|3788821|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3967068|NCT01302119|3788822|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3967069|NCT01302119|3788820|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967070|NCT01302119|3788821|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967071|NCT01302119|3788822|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967072|NCT01302119|3788820|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|514|514.0||||||
3967073|NCT01302119|3788821|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|175|175.0||||||
3967074|NCT01302119|3788822|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|339|339.0||||||
3967075|NCT01302119|3788820|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3967076|NCT01302119|3788821|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3967077|NCT01302119|3788822|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3967078|NCT01302119|3788820|B3||Male|Sex: Female, Male||Participants|Count of Participants|497|497.0||||||
3967079|NCT01302119|3788821|B2||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3967080|NCT01302119|3788822|B1||Male|Sex: Female, Male||Participants|Count of Participants|323|323.0||||||
3967081|NCT01302119|3788820|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3967082|NCT01302119|3788821|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3967083|NCT01302119|3788822|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3967084|NCT01302119|3788820|B3|||Age||years|Mean|55.5|55.5|Standard Deviation|11.3|11.3|||
3967085|NCT01302119|3788821|B2|||Age||years|Mean|55.4|55.4|Standard Deviation|11.0|11.0|||
3967086|NCT01302119|3788822|B1|||Age||years|Mean|55.5|55.5|Standard Deviation|11.5|11.5|||
3967087|NCT01302067|3788835|B4||Male|Sex: Female, Male||Participants|Count of Participants|365|365.0||||||
3967088|NCT01302067|3788836|B3||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3967089|NCT01302067|3788837|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3967090|NCT01302067|3788838|B1||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3967091|NCT01302067|3788835|B4||Female|Sex: Female, Male||Participants|Count of Participants|1590|1590.0||||||
3967092|NCT01302067|3788836|B3||Female|Sex: Female, Male||Participants|Count of Participants|627|627.0||||||
3967093|NCT01302067|3788837|B2||Female|Sex: Female, Male||Participants|Count of Participants|316|316.0||||||
3967094|NCT01302067|3788838|B1||Female|Sex: Female, Male||Participants|Count of Participants|647|647.0||||||
3967095|NCT01302067|3788835|B4|>= 65||Age, Customized||Years|Number|743|743.0||||||
3967096|NCT01302067|3788836|B3|>= 65||Age, Customized||Years|Number|303|303.0||||||
3967097|NCT01302067|3788837|B2|>= 65||Age, Customized||Years|Number|144|144.0||||||
3967098|NCT01302067|3788838|B1|>= 65||Age, Customized||Years|Number|296|296.0||||||
3967099|NCT01302067|3788835|B4|45 to 64||Age, Customized||Years|Number|950|950.0||||||
3967100|NCT01302067|3788836|B3|45 to 64||Age, Customized||Years|Number|377|377.0||||||
3967101|NCT01302067|3788837|B2|45 to 64||Age, Customized||Years|Number|193|193.0||||||
3967102|NCT01302067|3788838|B1|45 to 64||Age, Customized||Years|Number|380|380.0||||||
3967103|NCT01302067|3788835|B4|18 to 44||Age, Customized||Years|Number|262|262.0||||||
3967104|NCT01302067|3788836|B3|18 to 44||Age, Customized||Years|Number|99|99.0||||||
3967105|NCT01302067|3788837|B2|18 to 44||Age, Customized||Years|Number|49|49.0||||||
3967106|NCT01302067|3788838|B1|18 to 44||Age, Customized||Years|Number|114|114.0||||||
3967107|NCT01302067|3788835|B4|<18||Age, Customized||Years|Number|0|0.0||||||
3967108|NCT01302067|3788836|B3|<18||Age, Customized||Years|Number|0|0.0||||||
3967109|NCT01302067|3788837|B2|<18||Age, Customized||Years|Number|0|0.0||||||
3967110|NCT01302067|3788838|B1|<18||Age, Customized||Years|Number|0|0.0||||||
3967111|NCT01302054|3788911|B1||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3967112|NCT01302054|3788911|B1||Female|Sex: Female, Male||Participants|Count of Participants|810|810.0||||||
3967113|NCT01302054|3788911|B1|||Age||years|Mean|57.1|57.1|Standard Deviation|13.7|13.7|||
3967114|NCT01302041|3788940|B1|Other Surgeries/Procedures||Previous Interventions|Participants may have received more than one intervention|Participants|Count of Participants|4|4.0||||||
3967115|NCT01302041|3788940|B1|Watchful Waiting||Previous Interventions|Participants may have received more than one intervention|Participants|Count of Participants|14|14.0||||||
3967116|NCT01302041|3788940|B1|Pelvic Lymph Node Dissection||Previous Interventions|Participants may have received more than one intervention|Participants|Count of Participants|6|6.0||||||
3967117|NCT01302041|3788940|B1|Transurethral Resection of the Prostate||Previous Interventions|Participants may have received more than one intervention|Participants|Count of Participants|4|4.0||||||
3967118|NCT01302041|3788940|B1|Prostatectomy||Previous Interventions|Participants may have received more than one intervention|Participants|Count of Participants|24|24.0||||||
3967119|NCT01302041|3788940|B1|Radiotherapy||Previous Interventions|Participants may have received more than one intervention|Participants|Count of Participants|16|16.0||||||
3967120|NCT01302041|3788940|B1|||Number of Metastatic Lesions by Bone Scan||Lesions|Median|1|1.0|Full Range|||1.0|8.0|
3967121|NCT01302041|3788940|B1|||Participants With Metastases at Study Entry||Participants|Count of Participants|26|26.0||||||
3967122|NCT01302041|3788940|B1|Unknown||Distant Metastasis (M) at Initial Diagnosis||Participants|Count of Participants|11|11.0||||||
3967123|NCT01302041|3788940|B1|M1: Distant metastasis||Distant Metastasis (M) at Initial Diagnosis||Participants|Count of Participants|10|10.0||||||
3967124|NCT01302041|3788940|B1|M0: No distant metastasis||Distant Metastasis (M) at Initial Diagnosis||Participants|Count of Participants|35|35.0||||||
3967125|NCT01302041|3788940|B1|MX: Distant metastasis could not be assessed||Distant Metastasis (M) at Initial Diagnosis||Participants|Count of Participants|11|11.0||||||
3967126|NCT01302041|3788940|B1|Unknown||Clinical Lymph Node Stage (N) at Initial Diagnosis||Participants|Count of Participants|15|15.0||||||
3967127|NCT01302041|3788940|B1|N1: Metastasis in regional lymph node(s)||Clinical Lymph Node Stage (N) at Initial Diagnosis||Participants|Count of Participants|6|6.0||||||
3967128|NCT01302041|3788940|B1|N0: No regional lymph node metastasis||Clinical Lymph Node Stage (N) at Initial Diagnosis||Participants|Count of Participants|22|22.0||||||
3967129|NCT01302041|3788940|B1|NX: Regional lymph nodes were not assessed||Clinical Lymph Node Stage (N) at Initial Diagnosis||Participants|Count of Participants|24|24.0||||||
3967130|NCT01302041|3788940|B1|Unknown||Clinical Tumor Stage (T) at Initial Diagnosis||Participants|Count of Participants|6|6.0||||||
3967131|NCT01302041|3788940|B1|T4: Tumor is fixed or invades adjacent structures||Clinical Tumor Stage (T) at Initial Diagnosis||Participants|Count of Participants|1|1.0||||||
3967132|NCT01302041|3788940|B1|T3: Tumor extends through the prostatic capsule||Clinical Tumor Stage (T) at Initial Diagnosis||Participants|Count of Participants|18|18.0||||||
3967133|NCT01302041|3788940|B1|T2: Tumor confined within the prostate||Clinical Tumor Stage (T) at Initial Diagnosis||Participants|Count of Participants|31|31.0||||||
3967134|NCT01302041|3788940|B1|T1: Tumor neither palpable or visible by imaging||Clinical Tumor Stage (T) at Initial Diagnosis||Participants|Count of Participants|9|9.0||||||
3967135|NCT01302041|3788940|B1|T0: No evidence of primary tumor||Clinical Tumor Stage (T) at Initial Diagnosis||Participants|Count of Participants|1|1.0||||||
3967136|NCT01302041|3788940|B1|TX: Primary tumor cannot be assessed||Clinical Tumor Stage (T) at Initial Diagnosis||Participants|Count of Participants|1|1.0||||||
3967137|NCT01302041|3788940|B1|Unknown||Total Gleason Score at Initial Diagnosis|A system of grading prostate cancer tissue based on how it looks under a microscope. Gleason scores range from 2 to 10 and indicate how likely it is that a tumor will spread. A low Gleason score means the cancer tissue is similar to normal prostate tissue and the tumor is less likely to spread; a high Gleason score means the cancer tissue is very different from normal and the tumor is more likely to spread.|Participants|Count of Participants|1|1.0||||||
3967138|NCT01302041|3788940|B1|10||Total Gleason Score at Initial Diagnosis|A system of grading prostate cancer tissue based on how it looks under a microscope. Gleason scores range from 2 to 10 and indicate how likely it is that a tumor will spread. A low Gleason score means the cancer tissue is similar to normal prostate tissue and the tumor is less likely to spread; a high Gleason score means the cancer tissue is very different from normal and the tumor is more likely to spread.|Participants|Count of Participants|3|3.0||||||
3967139|NCT01302041|3788940|B1|9||Total Gleason Score at Initial Diagnosis|A system of grading prostate cancer tissue based on how it looks under a microscope. Gleason scores range from 2 to 10 and indicate how likely it is that a tumor will spread. A low Gleason score means the cancer tissue is similar to normal prostate tissue and the tumor is less likely to spread; a high Gleason score means the cancer tissue is very different from normal and the tumor is more likely to spread.|Participants|Count of Participants|6|6.0||||||
3967140|NCT01302041|3788940|B1|8||Total Gleason Score at Initial Diagnosis|A system of grading prostate cancer tissue based on how it looks under a microscope. Gleason scores range from 2 to 10 and indicate how likely it is that a tumor will spread. A low Gleason score means the cancer tissue is similar to normal prostate tissue and the tumor is less likely to spread; a high Gleason score means the cancer tissue is very different from normal and the tumor is more likely to spread.|Participants|Count of Participants|7|7.0||||||
3967141|NCT01302041|3788940|B1|7||Total Gleason Score at Initial Diagnosis|A system of grading prostate cancer tissue based on how it looks under a microscope. Gleason scores range from 2 to 10 and indicate how likely it is that a tumor will spread. A low Gleason score means the cancer tissue is similar to normal prostate tissue and the tumor is less likely to spread; a high Gleason score means the cancer tissue is very different from normal and the tumor is more likely to spread.|Participants|Count of Participants|34|34.0||||||
3967190|NCT01301963|3788969|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3967142|NCT01302041|3788940|B1|6||Total Gleason Score at Initial Diagnosis|A system of grading prostate cancer tissue based on how it looks under a microscope. Gleason scores range from 2 to 10 and indicate how likely it is that a tumor will spread. A low Gleason score means the cancer tissue is similar to normal prostate tissue and the tumor is less likely to spread; a high Gleason score means the cancer tissue is very different from normal and the tumor is more likely to spread.|Participants|Count of Participants|10|10.0||||||
3967143|NCT01302041|3788940|B1|5||Total Gleason Score at Initial Diagnosis|A system of grading prostate cancer tissue based on how it looks under a microscope. Gleason scores range from 2 to 10 and indicate how likely it is that a tumor will spread. A low Gleason score means the cancer tissue is similar to normal prostate tissue and the tumor is less likely to spread; a high Gleason score means the cancer tissue is very different from normal and the tumor is more likely to spread.|Participants|Count of Participants|5|5.0||||||
3967144|NCT01302041|3788940|B1|4||Total Gleason Score at Initial Diagnosis|A system of grading prostate cancer tissue based on how it looks under a microscope. Gleason scores range from 2 to 10 and indicate how likely it is that a tumor will spread. A low Gleason score means the cancer tissue is similar to normal prostate tissue and the tumor is less likely to spread; a high Gleason score means the cancer tissue is very different from normal and the tumor is more likely to spread.|Participants|Count of Participants|1|1.0||||||
3967145|NCT01302041|3788940|B1|||Duration of Prostate Cancer||years|Median|1.0|1.0|Full Range|||0.0|16.0|
3967146|NCT01302041|3788940|B1|||Prostate Specific Antigen (PSA)||ng/mL|Median|18.2|18.2|Inter-Quartile Range|102.990|102.99|6.4|45.0|
3967147|NCT01302041|3788940|B1|||Body Mass Index (BMI)||kg/m²|Median|26.17|26.17|Full Range|||20.8|39.7|
3967148|NCT01302041|3788940|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3967149|NCT01302041|3788940|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3967150|NCT01302041|3788940|B1|||Age||Years|Median|73.0|73.0|Full Range|||48.0|86.0|
3967151|NCT01301963|3788969|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
3967152|NCT01301963|3788970|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3967153|NCT01301963|3788971|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3967154|NCT01301963|3788969|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967155|NCT01301963|3788970|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967156|NCT01301963|3788971|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967157|NCT01301963|3788969|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3967158|NCT01301963|3788970|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3967159|NCT01301963|3788971|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3967160|NCT01301963|3788969|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967161|NCT01301963|3788970|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967162|NCT01301963|3788971|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967163|NCT01301963|3788969|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967164|NCT01301963|3788970|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967165|NCT01301963|3788971|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967166|NCT01301963|3788969|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967167|NCT01301963|3788970|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967168|NCT01301963|3788971|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967169|NCT01301963|3788969|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3967170|NCT01301963|3788970|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3967171|NCT01301963|3788971|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3967172|NCT01301963|3788969|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3967173|NCT01301963|3788970|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967174|NCT01301963|3788971|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3967175|NCT01301963|3788969|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967176|NCT01301963|3788970|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967177|NCT01301963|3788971|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967178|NCT01301963|3788969|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967179|NCT01301963|3788970|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967180|NCT01301963|3788971|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967181|NCT01301963|3788969|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967182|NCT01301963|3788970|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967183|NCT01301963|3788971|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967184|NCT01301963|3788969|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3967185|NCT01301963|3788970|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3967186|NCT01301963|3788971|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3967187|NCT01301963|3788969|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3967188|NCT01301963|3788970|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3967189|NCT01301963|3788971|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3967191|NCT01301963|3788970|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3967192|NCT01301963|3788971|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3967193|NCT01301963|3788969|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3967194|NCT01301963|3788970|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3967195|NCT01301963|3788971|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3967196|NCT01301963|3788969|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3967197|NCT01301963|3788970|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3967198|NCT01301963|3788971|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3967199|NCT01301963|3788969|B3|||Age||years|Mean|53.00|53.0|Standard Deviation|6.15|6.15|||
3967200|NCT01301963|3788970|B2|||Age||years|Mean|56.25|56.25|Standard Deviation|8.18|8.18|||
3967201|NCT01301963|3788971|B1|||Age||years|Mean|52.40|52.4|Standard Deviation|4.16|4.16|||
3967202|NCT01301950|3788980|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3967203|NCT01301950|3788981|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3967204|NCT01301950|3788982|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3967205|NCT01301950|3788980|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3967206|NCT01301950|3788981|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3967207|NCT01301950|3788982|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3967208|NCT01301950|3788980|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3967209|NCT01301950|3788981|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3967210|NCT01301950|3788982|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3967211|NCT01301950|3788980|B3|||Age||years|Mean|62.8|62.8|Standard Deviation|10.9|10.9|||
3967212|NCT01301950|3788981|B2|||Age||years|Mean|62.7|62.7|Standard Deviation|9.1|9.1|||
3967213|NCT01301950|3788982|B1|||Age||years|Mean|62.9|62.9|Standard Deviation|12.9|12.9|||
3967214|NCT01301833|3788997|B5||Male|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
3967215|NCT01301833|3788998|B4||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3967216|NCT01301833|3788999|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3967217|NCT01301833|3789000|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3967218|NCT01301833|3789001|B1||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3967219|NCT01301833|3788997|B5||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3967220|NCT01301833|3788998|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3967221|NCT01301833|3788999|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3967222|NCT01301833|3789000|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3967223|NCT01301833|3789001|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3967224|NCT01301833|3788997|B5|>=65 years||Age, Customized||participants|Number|171|171.0||||||
3967225|NCT01301833|3788998|B4|>=65 years||Age, Customized||participants|Number|36|36.0||||||
3967226|NCT01301833|3788999|B3|>=65 years||Age, Customized||participants|Number|29|29.0||||||
3967227|NCT01301833|3789000|B2|>=65 years||Age, Customized||participants|Number|35|35.0||||||
3967228|NCT01301833|3789001|B1|>=65 years||Age, Customized||participants|Number|71|71.0||||||
3967229|NCT01301833|3788997|B5|<65 years||Age, Customized||participants|Number|291|291.0||||||
3967230|NCT01301833|3788998|B4|<65 years||Age, Customized||participants|Number|39|39.0||||||
3967231|NCT01301833|3788999|B3|<65 years||Age, Customized||participants|Number|66|66.0||||||
3967232|NCT01301833|3789000|B2|<65 years||Age, Customized||participants|Number|45|45.0||||||
3967233|NCT01301833|3789001|B1|<65 years||Age, Customized||participants|Number|141|141.0||||||
3967234|NCT01301742|3789030|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3967235|NCT01301742|3789030|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3967236|NCT01301742|3789030|B1|||Age||years|Mean|35.1|35.1|Standard Deviation|10.2|10.2|||
3967237|NCT01301729|3789042|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3967238|NCT01301729|3789042|B1||Female|Gender||Participants|Count of Participants|32|32.0||||||
3967239|NCT01301729|3789042|B1|||Age||years|Mean|48.5|48.5|Standard Deviation|11.61|11.61|||
3967240|NCT01301625|3789053|B1|Australia||Region of Enrollment|Total patient population was enrolled from Australia. No patients were enrolled from New Zealand. The study recruitment rate was lower than anticipated.|participants|Number|78|78.0||||||
3967241|NCT01301625|3789053|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3967242|NCT01301625|3789053|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3967243|NCT01301625|3789053|B1|||Age||years|Mean|77.1|77.1|Standard Deviation|10.8|10.8|||
3967244|NCT01301508|3789123|B3||Male|Gender||Participants|Count of Participants|25|25.0||||||
3967245|NCT01301508|3789124|B2||Male|Gender||Participants|Count of Participants|15|15.0||||||
3967246|NCT01301508|3789125|B1||Male|Gender||Participants|Count of Participants|10|10.0||||||
3967247|NCT01301508|3789123|B3||Female|Gender||Participants|Count of Participants|21|21.0||||||
3967248|NCT01301508|3789124|B2||Female|Gender||Participants|Count of Participants|10|10.0||||||
3967249|NCT01301508|3789125|B1||Female|Gender||Participants|Count of Participants|11|11.0||||||
3967250|NCT01301508|3789123|B3|Greater Than 65 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
3967251|NCT01301508|3789124|B2|Greater Than 65 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
3967252|NCT01301508|3789125|B1|Greater Than 65 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3967253|NCT01301508|3789123|B3|18 to 65 years||Age, Customized||Participants|Count of Participants|43|43.0||||||
3967254|NCT01301508|3789124|B2|18 to 65 years||Age, Customized||Participants|Count of Participants|22|22.0||||||
3967255|NCT01301508|3789125|B1|18 to 65 years||Age, Customized||Participants|Count of Participants|21|21.0||||||
3967256|NCT01301456|3789144|B13||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3967257|NCT01301456|3789145|B12||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3967258|NCT01301456|3789146|B11||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3967259|NCT01301456|3789147|B10||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3967260|NCT01301456|3789148|B9||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3967261|NCT01301456|3789149|B8||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3967262|NCT01301456|3789150|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3967263|NCT01301456|3789151|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3967264|NCT01301456|3789152|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3967265|NCT01301456|3789153|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3967266|NCT01301456|3789154|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3967267|NCT01301456|3789155|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3967268|NCT01301456|3789156|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3967269|NCT01301456|3789144|B13||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3967270|NCT01301456|3789145|B12||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3967271|NCT01301456|3789146|B11||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3967272|NCT01301456|3789147|B10||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3967273|NCT01301456|3789148|B9||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3967274|NCT01301456|3789149|B8||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3967275|NCT01301456|3789150|B7||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3967276|NCT01301456|3789151|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3967277|NCT01301456|3789152|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3967278|NCT01301456|3789153|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3967279|NCT01301456|3789154|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3967280|NCT01301456|3789155|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3967281|NCT01301456|3789156|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3967282|NCT01301456|3789144|B13|>=65 years||Age, Customized||participants|Number|13|13.0||||||
3967283|NCT01301456|3789145|B12|>=65 years||Age, Customized||participants|Number|0|0.0||||||
3967284|NCT01301456|3789146|B11|>=65 years||Age, Customized||participants|Number|0|0.0||||||
3967285|NCT01301456|3789147|B10|>=65 years||Age, Customized||participants|Number|3|3.0||||||
3967286|NCT01301456|3789148|B9|>=65 years||Age, Customized||participants|Number|0|0.0||||||
3967287|NCT01301456|3789149|B8|>=65 years||Age, Customized||participants|Number|1|1.0||||||
3967288|NCT01301456|3789150|B7|>=65 years||Age, Customized||participants|Number|2|2.0||||||
3967289|NCT01301456|3789151|B6|>=65 years||Age, Customized||participants|Number|1|1.0||||||
3967290|NCT01301456|3789152|B5|>=65 years||Age, Customized||participants|Number|1|1.0||||||
3967291|NCT01301456|3789153|B4|>=65 years||Age, Customized||participants|Number|2|2.0||||||
3967292|NCT01301456|3789154|B3|>=65 years||Age, Customized||participants|Number|1|1.0||||||
3967293|NCT01301456|3789155|B2|>=65 years||Age, Customized||participants|Number|2|2.0||||||
3967294|NCT01301456|3789156|B1|>=65 years||Age, Customized||participants|Number|0|0.0||||||
3967295|NCT01301456|3789144|B13|Between 18 and 64 years||Age, Customized||participants|Number|71|71.0||||||
3967296|NCT01301456|3789145|B12|Between 18 and 64 years||Age, Customized||participants|Number|6|6.0||||||
3967297|NCT01301456|3789146|B11|Between 18 and 64 years||Age, Customized||participants|Number|7|7.0||||||
3967298|NCT01301456|3789147|B10|Between 18 and 64 years||Age, Customized||participants|Number|4|4.0||||||
3967299|NCT01301456|3789148|B9|Between 18 and 64 years||Age, Customized||participants|Number|5|5.0||||||
3967300|NCT01301456|3789149|B8|Between 18 and 64 years||Age, Customized||participants|Number|6|6.0||||||
3967301|NCT01301456|3789150|B7|Between 18 and 64 years||Age, Customized||participants|Number|6|6.0||||||
3967302|NCT01301456|3789151|B6|Between 18 and 64 years||Age, Customized||participants|Number|4|4.0||||||
3967303|NCT01301456|3789152|B5|Between 18 and 64 years||Age, Customized||participants|Number|6|6.0||||||
3967304|NCT01301456|3789153|B4|Between 18 and 64 years||Age, Customized||participants|Number|4|4.0||||||
3967305|NCT01301456|3789154|B3|Between 18 and 64 years||Age, Customized||participants|Number|5|5.0||||||
3967306|NCT01301456|3789155|B2|Between 18 and 64 years||Age, Customized||participants|Number|3|3.0||||||
3967307|NCT01301456|3789156|B1|Between 18 and 64 years||Age, Customized||participants|Number|15|15.0||||||
3967308|NCT01301456|3789144|B13|<18 years||Age, Customized||participants|Number|0|0.0||||||
3967309|NCT01301456|3789145|B12|<18 years||Age, Customized||participants|Number|0|0.0||||||
3967310|NCT01301456|3789146|B11|<18 years||Age, Customized||participants|Number|0|0.0||||||
3967311|NCT01301456|3789147|B10|<18 years||Age, Customized||participants|Number|0|0.0||||||
3967312|NCT01301456|3789148|B9|<18 years||Age, Customized||participants|Number|0|0.0||||||
3967313|NCT01301456|3789149|B8|<18 years||Age, Customized||participants|Number|0|0.0||||||
3967314|NCT01301456|3789150|B7|<18 years||Age, Customized||participants|Number|0|0.0||||||
3967315|NCT01301456|3789151|B6|<18 years||Age, Customized||participants|Number|0|0.0||||||
3967316|NCT01301456|3789152|B5|<18 years||Age, Customized||participants|Number|0|0.0||||||
3967317|NCT01301456|3789153|B4|<18 years||Age, Customized||participants|Number|0|0.0||||||
3967318|NCT01301456|3789154|B3|<18 years||Age, Customized||participants|Number|0|0.0||||||
3967319|NCT01301456|3789155|B2|<18 years||Age, Customized||participants|Number|0|0.0||||||
3967320|NCT01301456|3789156|B1|<18 years||Age, Customized||participants|Number|0|0.0||||||
3967321|NCT01301391|3789393|B1||Not available|Masaoka clinical staging at study entry|Staging used to evaluate invasiveness of the tumor.|Participants|Count of Participants|7|7.0||||||
3967322|NCT01301391|3789393|B1||Not assessed|Masaoka clinical staging at study entry|Staging used to evaluate invasiveness of the tumor.|Participants|Count of Participants|6|6.0||||||
3967323|NCT01301391|3789393|B1||Stage IVB: Hematogenous or lymphatic dissemination|Masaoka clinical staging at study entry|Staging used to evaluate invasiveness of the tumor.|Participants|Count of Participants|10|10.0||||||
3967324|NCT01301391|3789393|B1||Stage IVA: Pleural or pericardial dissemination|Masaoka clinical staging at study entry|Staging used to evaluate invasiveness of the tumor.|Participants|Count of Participants|7|7.0||||||
3967325|NCT01301391|3789393|B1||Stage III: Macroscopic invasion neighboring organs|Masaoka clinical staging at study entry|Staging used to evaluate invasiveness of the tumor.|Participants|Count of Participants|0|0.0||||||
3967326|NCT01301391|3789393|B1||Stage II: Thymoma invades beyond the capsule|Masaoka clinical staging at study entry|Staging used to evaluate invasiveness of the tumor.|Participants|Count of Participants|0|0.0||||||
3967327|NCT01301391|3789393|B1||Stage I: Grossly and microscopically encapsulate|Masaoka clinical staging at study entry|Staging used to evaluate invasiveness of the tumor.|Participants|Count of Participants|0|0.0||||||
3967328|NCT01301391|3789393|B1||In situ|Tumor extent at study entry||Participants|Count of Participants|0|0.0||||||
3967329|NCT01301391|3789393|B1||Metastatic|Tumor extent at study entry||Participants|Count of Participants|30|30.0||||||
3967330|NCT01301391|3789393|B1|C - Thymic Carcinoma||World Health Organization classification (International Classification of Diseases)||Participants|Count of Participants|13|13.0||||||
3967331|NCT01301391|3789393|B1|B3 - Well Differentiated Thymic Carcinoma||World Health Organization classification (International Classification of Diseases)||Participants|Count of Participants|17|17.0||||||
3967332|NCT01301391|3789393|B1|Italy||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3967333|NCT01301391|3789393|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3967334|NCT01301391|3789393|B1|Not Listed||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3967335|NCT01301391|3789393|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3967336|NCT01301391|3789393|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3967337|NCT01301391|3789393|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3967338|NCT01301391|3789393|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3967339|NCT01301391|3789393|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3967340|NCT01301391|3789393|B1|||Age||years|Mean|54.2|54.2|Standard Deviation|11.3|11.3|||
3967341|NCT01301391|3789393|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3967342|NCT01301391|3789393|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3967343|NCT01301391|3789393|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3967344|NCT01301274|3789403|B3|Argentina||Region of Enrollment||participants|Number|66|66.0||||||
3967345|NCT01301274|3789404|B2|Argentina||Region of Enrollment||participants|Number|32|32.0||||||
3967346|NCT01301274|3789405|B1|Argentina||Region of Enrollment||participants|Number|34|34.0||||||
3967347|NCT01301274|3789403|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3967348|NCT01301274|3789404|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3967349|NCT01301274|3789405|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3967350|NCT01301274|3789403|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3967351|NCT01301274|3789404|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3967352|NCT01301274|3789405|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3967353|NCT01301274|3789403|B3|||Age||years|Mean|2.2|2.2|Standard Deviation|4.1|4.1|||
3967354|NCT01301274|3789404|B2|||Age||years|Mean|1.2|1.2|Standard Deviation|3.2|3.2|||
3967355|NCT01301274|3789405|B1|||Age||years|Mean|3|3.0|Standard Deviation|4.7|4.7|||
3967356|NCT01301274|3789403|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3967357|NCT01301274|3789404|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3967358|NCT01301274|3789405|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3967359|NCT01301274|3789403|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3967360|NCT01301274|3789404|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3967361|NCT01301274|3789405|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3967362|NCT01301274|3789403|B3||<=18 years|Age||Participants|Count of Participants|66|66.0||||||
3967363|NCT01301274|3789404|B2||<=18 years|Age||Participants|Count of Participants|32|32.0||||||
3967364|NCT01301274|3789405|B1||<=18 years|Age||Participants|Count of Participants|34|34.0||||||
3967365|NCT01301092|3789418|B4|United States||Region of Enrollment||participants|Number|30|30.0||||||
3967366|NCT01301092|3789419|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3967367|NCT01301092|3789420|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3967368|NCT01301092|3789421|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3967369|NCT01301092|3789418|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967370|NCT01301092|3789419|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967371|NCT01301092|3789420|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967372|NCT01301092|3789421|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967373|NCT01301092|3789418|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967374|NCT01301092|3789419|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967375|NCT01301092|3789420|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967376|NCT01301092|3789421|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967377|NCT01301092|3789418|B4||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3967378|NCT01301092|3789419|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3967379|NCT01301092|3789420|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3967380|NCT01301092|3789421|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3967381|NCT01301092|3789418|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3967382|NCT01301092|3789419|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3967383|NCT01301092|3789420|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3967384|NCT01301092|3789421|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967385|NCT01301092|3789418|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967386|NCT01301092|3789419|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967387|NCT01301092|3789420|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967388|NCT01301092|3789421|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967389|NCT01301092|3789418|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967390|NCT01301092|3789419|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967391|NCT01301092|3789420|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967392|NCT01301092|3789421|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967393|NCT01301092|3789418|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967394|NCT01301092|3789419|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967395|NCT01301092|3789420|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967396|NCT01301092|3789421|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967397|NCT01301092|3789418|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967398|NCT01301092|3789419|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967399|NCT01301092|3789420|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967400|NCT01301092|3789421|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967401|NCT01301092|3789418|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3967402|NCT01301092|3789419|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3967403|NCT01301092|3789420|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3967404|NCT01301092|3789421|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3967405|NCT01301092|3789418|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3967406|NCT01301092|3789419|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967407|NCT01301092|3789420|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967408|NCT01301092|3789421|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3967409|NCT01301092|3789418|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3967410|NCT01301092|3789419|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3967411|NCT01301092|3789420|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3967412|NCT01301092|3789421|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3967413|NCT01301092|3789418|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3967414|NCT01301092|3789419|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3967415|NCT01301092|3789420|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3967416|NCT01301092|3789421|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3967417|NCT01301092|3789418|B4|||Age||years|Mean|44.10|44.1|Standard Deviation|14.71|14.71|||
3967418|NCT01301092|3789419|B3|||Age||years|Mean|45.6|45.6|Standard Deviation|16.6|16.6|||
3967419|NCT01301092|3789420|B2|||Age||years|Mean|42.3|42.3|Standard Deviation|15.0|15.0|||
3967420|NCT01301092|3789421|B1|||Age||years|Mean|47.0|47.0|Standard Deviation|13.1|13.1|||
3967421|NCT01301079|3789438|B3|Brazil||Region of Enrollment||participants|Number|60|60.0||||||
3967422|NCT01301079|3789439|B2|Brazil||Region of Enrollment||participants|Number|30|30.0||||||
3967423|NCT01301079|3789440|B1|Brazil||Region of Enrollment||participants|Number|30|30.0||||||
3967424|NCT01301079|3789438|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3967425|NCT01301079|3789439|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3967426|NCT01301079|3789440|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3967427|NCT01301079|3789438|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3967428|NCT01301079|3789439|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3967429|NCT01301079|3789440|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3967430|NCT01301079|3789438|B3|||Age||years|Mean|44.60|44.6|Standard Deviation|14.50|14.5|||
3967431|NCT01301079|3789439|B2|||Age||years|Mean|43.40|43.4|Standard Deviation|15.90|15.9|||
3967432|NCT01301079|3789440|B1|||Age||years|Mean|45.80|45.8|Standard Deviation|13.10|13.1|||
3967433|NCT01301079|3789438|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3967434|NCT01301079|3789439|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3967435|NCT01301079|3789440|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3967436|NCT01301079|3789438|B3||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
3967437|NCT01301079|3789439|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3967438|NCT01301079|3789440|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3967439|NCT01301079|3789438|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3967440|NCT01301079|3789439|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3967441|NCT01301079|3789440|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3967442|NCT01301066|3789517|B3|United States||Region of Enrollment||participants|Number|252|252.0||||||
3967443|NCT01301066|3789518|B2|United States||Region of Enrollment||participants|Number|126|126.0||||||
3967444|NCT01301066|3789519|B1|United States||Region of Enrollment||participants|Number|126|126.0||||||
3967445|NCT01301066|3789517|B3||Male|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
3967446|NCT01301066|3789518|B2||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3967447|NCT01301066|3789519|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3967448|NCT01301066|3789517|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3967449|NCT01301066|3789518|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3967450|NCT01301066|3789519|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3967451|NCT01301066|3789517|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3967452|NCT01301066|3789518|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3967453|NCT01301066|3789519|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3967454|NCT01301066|3789517|B3||Between 18 and 65 years|Age||Participants|Count of Participants|252|252.0||||||
3967455|NCT01301066|3789518|B2||Between 18 and 65 years|Age||Participants|Count of Participants|126|126.0||||||
3967456|NCT01301066|3789519|B1||Between 18 and 65 years|Age||Participants|Count of Participants|126|126.0||||||
3967457|NCT01301066|3789517|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3967458|NCT01301066|3789518|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3967459|NCT01301066|3789519|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3967460|NCT01301027|3789526|B3|||Body Mass Index||kilograms per meter squared|Mean|32.6|32.6|Standard Deviation|7.0|7.0|||
3967461|NCT01301027|3789527|B2|||Body Mass Index||kilograms per meter squared|Mean|32.9|32.9|Standard Deviation|7.5|7.5|||
3967462|NCT01301027|3789528|B1|||Body Mass Index||kilograms per meter squared|Mean|32.3|32.3|Standard Deviation|6.6|6.6|||
3967463|NCT01301027|3789526|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3967464|NCT01301027|3789527|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3967465|NCT01301027|3789528|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3967466|NCT01301027|3789526|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3967467|NCT01301027|3789527|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3967468|NCT01301027|3789528|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3967469|NCT01301027|3789526|B3|||Age||years|Mean|58.32|58.32|Standard Deviation|13.05|13.05|||
3967470|NCT01301027|3789527|B2|||Age||years|Mean|57.45|57.45|Standard Deviation|14.12|14.12|||
3967471|NCT01301027|3789528|B1|||Age||years|Mean|59.17|59.17|Standard Deviation|12.01|12.01|||
3967472|NCT01301001|3789541|B1|United States||Region of Enrollment||participants|Number|89|89.0||||||
3967473|NCT01301001|3789541|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967474|NCT01301001|3789541|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3967475|NCT01301001|3789541|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3967476|NCT01301001|3789541|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3967477|NCT01301001|3789541|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967478|NCT01301001|3789541|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967479|NCT01301001|3789541|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967480|NCT01301001|3789541|B1|Male||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3967481|NCT01301001|3789541|B1|Female||Sex/Gender, Customized||Participants|Count of Participants|89|89.0||||||
3967482|NCT01301001|3789541|B1|||Age||years|Mean|36.54|36.54|Standard Deviation|2.30|2.3|||
3967483|NCT01300949|3789552|B4|United States||Region of Enrollment||participants|Number|314|314.0||||||
3967484|NCT01300949|3789553|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
3967485|NCT01300949|3789554|B2|United States||Region of Enrollment||participants|Number|125|125.0||||||
3967486|NCT01300949|3789555|B1|United States||Region of Enrollment||participants|Number|154|154.0||||||
3967487|NCT01300949|3789552|B4||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3967488|NCT01300949|3789553|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3967489|NCT01300949|3789554|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3967490|NCT01300949|3789555|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3967491|NCT01300949|3789552|B4||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3967492|NCT01300949|3789553|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3967493|NCT01300949|3789554|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3967494|NCT01300949|3789555|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3967495|NCT01300949|3789552|B4|||Age||years|Mean|62|62.0|Full Range|||19.0|98.0|
3967496|NCT01300949|3789553|B3|||Age||years|Mean|81|81.0|Full Range|||74.0|88.0|
3967497|NCT01300949|3789554|B2|||Age||years|Mean|49|49.0|Full Range|||20.0|83.0|
3967498|NCT01300949|3789555|B1|||Age||years|Mean|68|68.0|Full Range|||19.0|98.0|
3967499|NCT01300923|3789565|B1|||Brain-derived neurotropic factor|Brain-derived neurotrophic factor (BDNF) is a protein that supports the survival of existing neurons and growth and differentiation of new neurons and synapses.|pg/mL|Mean|790.4|790.4|Standard Deviation|1.3050|1.305|||
3967500|NCT01300923|3789565|B1|Expressive Communication Domain||Vineland Adaptive Behavior Scales-II (VABS-II) Communication Domain|The VABS-II is a semi-structured interview designed to assess adaptive functioning in communication, daily living, socialization and motor skills. Recognizing that language is a major area of impairment in the study population, the Communication Domain (99 Items from 0-198), in particular the Expressive Subdomain (54 Items from 0-108) are of interest to this study. Items arranged in a developmental sequence are rated on a 3-point scale. Each item is rated from 0 (never performs the behavior) to 2 (usually performs behavior independently). Higher scores indicate higher adaptive functioning.|units on a scale|Mean|69.8|69.8|Standard Deviation|23.0|23.0|||
3967501|NCT01300923|3789565|B1|Communication Domain||Vineland Adaptive Behavior Scales-II (VABS-II) Communication Domain|The VABS-II is a semi-structured interview designed to assess adaptive functioning in communication, daily living, socialization and motor skills. Recognizing that language is a major area of impairment in the study population, the Communication Domain (99 Items from 0-198), in particular the Expressive Subdomain (54 Items from 0-108) are of interest to this study. Items arranged in a developmental sequence are rated on a 3-point scale. Each item is rated from 0 (never performs the behavior) to 2 (usually performs behavior independently). Higher scores indicate higher adaptive functioning.|units on a scale|Mean|63.4|63.4|Standard Deviation|10.0|10.0|||
3967502|NCT01300923|3789565|B1|||Peabody Picture Vocabulary Test|The Peabody Picture Vocabulary Test is one of the most commonly used assessment tests that measure verbal ability in standard American English vocabulary. This test has been nationally standardized using examinees from various age groups, from children to adults. Thus, the raw scores are equated to mental age, using the norms obtained from standardization. The total standard scores range from 40 (worse receptive vocabulary) to 160 (better receptive vocabulary). The scores can also be converted to percentile rank.|units on a scale|Mean|85.2|85.2|Standard Deviation|32.0|32.0|||
3967503|NCT01300923|3789565|B1|||ADHD Rating Scale 4th Edition|The ADHD Rating Scale is an 18-item scale directly derived from DSM-IV criteria for Attention Deficit Hyperactivity Disorder. The ADHD Rating Scale-IV is completed by the parent and scored by a clinician. The scale consists of 2 subscales: inattention (9 items) and hyperactivity-impulsivity (9 items). If 3 or more items are skipped, the clinician should use extreme caution in interpreting the scale. The total score can range from 0 to 54, with a higher score indicating greater severity.|units on a scale|Mean|23.6|23.6|Standard Deviation|10.6|10.6|||
3967504|NCT01300923|3789565|B1|||Social Responsiveness Scale|The 65-item SRS is a standardized measure of the core symptoms of autism. Each item is scored on a 4-point Likert scale. The score of each individual item is summed to create a total raw score. A total scores results are as follows: 0-62: Within normal limits 63-79: Mild range of impairment 80-108: Moderate range of impairment 109-149: Severe range of impairment|units on a scale|Mean|91.3|91.3|Standard Deviation|27.4|27.4|||
3967505|NCT01300923|3789565|B1|||Children's Yale-Brown Obsessive Compulsive Scale Modified for PDD|The Children's Yale-Brown Obsessive Compulsive Scales-Modified (CY-BOCS) is a 5-item, semi-structured clinician rating scale modified designed to rate the current severity of repetitive behavior in children and adolescents with PDD. Once the current repetitive behaviors are identified, they are separately rated on 5 items: Time Spent, Interference, Distress, Resistance, and Control. Each of these items is scored on a 5-point scale form 0 (least symptomatic) to 4 (most symptomatic). The CY-BOCS yields a Total Score from 0 to 20 and is sensitive to change.|units on a scale|Mean|11.1|11.1|Standard Deviation|2.6|2.6|||
3967506|NCT01300923|3789565|B1|||Clinical Global Impression -Severity|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale that requires the clinician to rate the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis. Considering total clinical experience, a patient is assessed on severity of mental illness at the time of rating 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|units on a scale|Mean|4.25|4.25|Standard Deviation|0.45|0.45|||
3967507|NCT01300923|3789565|B1|ABC Social Avoidance||Aberrant Behavior Checklist|Aberrant Behavior Checklist (ABC) is a 58-item rating scale assessing maladaptive behaviors across 5 original subscales: Irritability(15 items from 0-45), Social Withdrawal(16 items from 0-48), Stereotypy(7 items from 0-21), Hyperactivity(16 items from 0-48), Inappropriate Speech(4 items from 0-12). Also reported is Social Avoidance, a newly developed 4-item subscale (from 0-12) that captures core social avoidance aspects of Fragile X Syndrome. Items on the ABC are rated from 0 (not at all a problem) to 3 (the problem is severe in degree). Higher scores indicate greater maladaptive behaviors.|units on a scale|Mean|3.3|3.3|Standard Deviation|2.6|2.6|||
3967508|NCT01300923|3789565|B1|ABC Inappropriate Speech||Aberrant Behavior Checklist|Aberrant Behavior Checklist (ABC) is a 58-item rating scale assessing maladaptive behaviors across 5 original subscales: Irritability(15 items from 0-45), Social Withdrawal(16 items from 0-48), Stereotypy(7 items from 0-21), Hyperactivity(16 items from 0-48), Inappropriate Speech(4 items from 0-12). Also reported is Social Avoidance, a newly developed 4-item subscale (from 0-12) that captures core social avoidance aspects of Fragile X Syndrome. Items on the ABC are rated from 0 (not at all a problem) to 3 (the problem is severe in degree). Higher scores indicate greater maladaptive behaviors.|units on a scale|Mean|5.2|5.2|Standard Deviation|3.5|3.5|||
3967552|NCT01300819|3789579|B1|Spain||Region of Enrollment||participants|Number|12|12.0||||||
3967509|NCT01300923|3789565|B1|ABC Hyperactivity||Aberrant Behavior Checklist|Aberrant Behavior Checklist (ABC) is a 58-item rating scale assessing maladaptive behaviors across 5 original subscales: Irritability(15 items from 0-45), Social Withdrawal(16 items from 0-48), Stereotypy(7 items from 0-21), Hyperactivity(16 items from 0-48), Inappropriate Speech(4 items from 0-12). Also reported is Social Avoidance, a newly developed 4-item subscale (from 0-12) that captures core social avoidance aspects of Fragile X Syndrome. Items on the ABC are rated from 0 (not at all a problem) to 3 (the problem is severe in degree). Higher scores indicate greater maladaptive behaviors.|units on a scale|Mean|16.8|16.8|Standard Deviation|9.1|9.1|||
3967510|NCT01300923|3789565|B1|ABC Stereotypy||Aberrant Behavior Checklist|Aberrant Behavior Checklist (ABC) is a 58-item rating scale assessing maladaptive behaviors across 5 original subscales: Irritability(15 items from 0-45), Social Withdrawal(16 items from 0-48), Stereotypy(7 items from 0-21), Hyperactivity(16 items from 0-48), Inappropriate Speech(4 items from 0-12). Also reported is Social Avoidance, a newly developed 4-item subscale (from 0-12) that captures core social avoidance aspects of Fragile X Syndrome. Items on the ABC are rated from 0 (not at all a problem) to 3 (the problem is severe in degree). Higher scores indicate greater maladaptive behaviors.|units on a scale|Mean|6.8|6.8|Standard Deviation|6.8|6.8|||
3967511|NCT01300923|3789565|B1|ABC Social Withdrawal||Aberrant Behavior Checklist|Aberrant Behavior Checklist (ABC) is a 58-item rating scale assessing maladaptive behaviors across 5 original subscales: Irritability(15 items from 0-45), Social Withdrawal(16 items from 0-48), Stereotypy(7 items from 0-21), Hyperactivity(16 items from 0-48), Inappropriate Speech(4 items from 0-12). Also reported is Social Avoidance, a newly developed 4-item subscale (from 0-12) that captures core social avoidance aspects of Fragile X Syndrome. Items on the ABC are rated from 0 (not at all a problem) to 3 (the problem is severe in degree). Higher scores indicate greater maladaptive behaviors.|units on a scale|Mean|8.8|8.8|Standard Deviation|5.8|5.8|||
3967512|NCT01300923|3789565|B1|ABC Irritability||Aberrant Behavior Checklist|Aberrant Behavior Checklist (ABC) is a 58-item rating scale assessing maladaptive behaviors across 5 original subscales: Irritability(15 items from 0-45), Social Withdrawal(16 items from 0-48), Stereotypy(7 items from 0-21), Hyperactivity(16 items from 0-48), Inappropriate Speech(4 items from 0-12). Also reported is Social Avoidance, a newly developed 4-item subscale (from 0-12) that captures core social avoidance aspects of Fragile X Syndrome. Items on the ABC are rated from 0 (not at all a problem) to 3 (the problem is severe in degree). Higher scores indicate greater maladaptive behaviors.|units on a scale|Mean|9.9|9.9|Standard Deviation|7.8|7.8|||
3967513|NCT01300923|3789565|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3967514|NCT01300923|3789565|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3967515|NCT01300923|3789565|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3967516|NCT01300923|3789565|B1|||Age||years|Mean|11.9|11.9|Full Range|||6.0|15.0|
3967517|NCT01300923|3789565|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3967518|NCT01300923|3789565|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3967519|NCT01300923|3789565|B1||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
3967520|NCT01300819|3789577|B3|||Body Mass Index (BMI)||kilogram per square meter|Mean|27.243|27.243|Standard Deviation|4.406|4.406|||
3967521|NCT01300819|3789578|B2|||Body Mass Index (BMI)||kilogram per square meter|Mean|27.047|27.047|Standard Deviation|4.348|4.348|||
3967522|NCT01300819|3789579|B1|||Body Mass Index (BMI)||kilogram per square meter|Mean|27.593|27.593|Standard Deviation|4.505|4.505|||
3967523|NCT01300819|3789577|B3|||Height||centimeter|Mean|168.14|168.14|Standard Deviation|9.17|9.17|||
3967524|NCT01300819|3789578|B2|||Height||centimeter|Mean|168.54|168.54|Standard Deviation|8.56|8.56|||
3967525|NCT01300819|3789579|B1|||Height||centimeter|Mean|167.42|167.42|Standard Deviation|10.17|10.17|||
3967526|NCT01300819|3789577|B3|||Weight||kilogram|Mean|77.16|77.16|Standard Deviation|14.10|14.1|||
3967527|NCT01300819|3789578|B2|||Weight||kilogram|Mean|76.97|76.97|Standard Deviation|13.66|13.66|||
3967528|NCT01300819|3789579|B1|||Weight||kilogram|Mean|77.52|77.52|Standard Deviation|14.90|14.9|||
3967529|NCT01300819|3789577|B3|Italy||Region of Enrollment||participants|Number|28|28.0||||||
3967530|NCT01300819|3789578|B2|Italy||Region of Enrollment||participants|Number|19|19.0||||||
3967531|NCT01300819|3789579|B1|Italy||Region of Enrollment||participants|Number|9|9.0||||||
3967532|NCT01300819|3789577|B3|Switzerland||Region of Enrollment||participants|Number|4|4.0||||||
3967533|NCT01300819|3789578|B2|Switzerland||Region of Enrollment||participants|Number|3|3.0||||||
3967534|NCT01300819|3789579|B1|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
3967535|NCT01300819|3789577|B3|Germany||Region of Enrollment||participants|Number|39|39.0||||||
3967536|NCT01300819|3789578|B2|Germany||Region of Enrollment||participants|Number|24|24.0||||||
3967537|NCT01300819|3789579|B1|Germany||Region of Enrollment||participants|Number|15|15.0||||||
3967538|NCT01300819|3789577|B3|Bulgaria||Region of Enrollment||participants|Number|81|81.0||||||
3967539|NCT01300819|3789578|B2|Bulgaria||Region of Enrollment||participants|Number|51|51.0||||||
3967540|NCT01300819|3789579|B1|Bulgaria||Region of Enrollment||participants|Number|30|30.0||||||
3967541|NCT01300819|3789577|B3|Austria||Region of Enrollment||participants|Number|3|3.0||||||
3967542|NCT01300819|3789578|B2|Austria||Region of Enrollment||participants|Number|1|1.0||||||
3967543|NCT01300819|3789579|B1|Austria||Region of Enrollment||participants|Number|2|2.0||||||
3967544|NCT01300819|3789577|B3|Romania||Region of Enrollment||participants|Number|54|54.0||||||
3967545|NCT01300819|3789578|B2|Romania||Region of Enrollment||participants|Number|36|36.0||||||
3967546|NCT01300819|3789579|B1|Romania||Region of Enrollment||participants|Number|18|18.0||||||
3967547|NCT01300819|3789577|B3|Belgium||Region of Enrollment||participants|Number|13|13.0||||||
3967548|NCT01300819|3789578|B2|Belgium||Region of Enrollment||participants|Number|9|9.0||||||
3967549|NCT01300819|3789579|B1|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
3967550|NCT01300819|3789577|B3|Spain||Region of Enrollment||participants|Number|35|35.0||||||
3967551|NCT01300819|3789578|B2|Spain||Region of Enrollment||participants|Number|23|23.0||||||
3967553|NCT01300819|3789577|B3|Slovakia||Region of Enrollment||participants|Number|43|43.0||||||
3967554|NCT01300819|3789578|B2|Slovakia||Region of Enrollment||participants|Number|28|28.0||||||
3967555|NCT01300819|3789579|B1|Slovakia||Region of Enrollment||participants|Number|15|15.0||||||
3967556|NCT01300819|3789577|B3|Czech Republic||Region of Enrollment||participants|Number|21|21.0||||||
3967557|NCT01300819|3789578|B2|Czech Republic||Region of Enrollment||participants|Number|13|13.0||||||
3967558|NCT01300819|3789579|B1|Czech Republic||Region of Enrollment||participants|Number|8|8.0||||||
3967559|NCT01300819|3789577|B3|Hungary||Region of Enrollment||participants|Number|19|19.0||||||
3967560|NCT01300819|3789578|B2|Hungary||Region of Enrollment||participants|Number|11|11.0||||||
3967561|NCT01300819|3789579|B1|Hungary||Region of Enrollment||participants|Number|8|8.0||||||
3967562|NCT01300819|3789577|B3|France||Region of Enrollment||participants|Number|9|9.0||||||
3967563|NCT01300819|3789578|B2|France||Region of Enrollment||participants|Number|6|6.0||||||
3967564|NCT01300819|3789579|B1|France||Region of Enrollment||participants|Number|3|3.0||||||
3967565|NCT01300819|3789577|B3||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
3967566|NCT01300819|3789578|B2||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3967567|NCT01300819|3789579|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3967568|NCT01300819|3789577|B3||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3967569|NCT01300819|3789578|B2||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3967570|NCT01300819|3789579|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3967571|NCT01300819|3789577|B3|>= 65 years||Age, Customized||participants|Number|224|224.0||||||
3967572|NCT01300819|3789578|B2|>= 65 years||Age, Customized||participants|Number|150|150.0||||||
3967573|NCT01300819|3789579|B1|>= 65 years||Age, Customized||participants|Number|74|74.0||||||
3967574|NCT01300819|3789577|B3|< 65 years||Age, Customized||participants|Number|125|125.0||||||
3967575|NCT01300819|3789578|B2|< 65 years||Age, Customized||participants|Number|74|74.0||||||
3967576|NCT01300819|3789579|B1|< 65 years||Age, Customized||participants|Number|51|51.0||||||
3967577|NCT01300819|3789577|B3|||Age||years|Mean|67.5|67.5|Standard Deviation|9.6|9.6|||
3967578|NCT01300819|3789578|B2|||Age||years|Mean|68.0|68.0|Standard Deviation|9.4|9.4|||
3967579|NCT01300819|3789579|B1|||Age||years|Mean|66.6|66.6|Standard Deviation|9.8|9.8|||
3967580|NCT01300767|3789608|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3967581|NCT01300767|3789608|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3967582|NCT01300767|3789608|B1|||Age||years|Mean|32.8|32.8|Standard Deviation|10.1|10.1|||
3967583|NCT01300741|3789636|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3967584|NCT01300741|3789636|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3967585|NCT01300741|3789636|B1|||Age||years|Mean|30.9|30.9|Standard Deviation|9.2|9.2|||
3967586|NCT01300728|3789664|B3|CDR_SB||Mean Cognitive Performance|"12 month cognitive performance in treatment (IVIG/placebo) is measured by:~Alzheimer Disease Assessment Scale-cognitive subscale (ADAS-cog)~Scale from 0 to 85 (0 is best cognitive performance)~Score is the sum of 12 sub-scales.~Mini Mental State Exam (MMSE)~Scale from 0 to 30 (30 is best cognitive performance)~Score is the sum of 11 sub-scales.~Clinical Dementia Rating - Sum of Boxes (CDR-SB)~Scale is 0 to 18 (0 is best cognitive performance)~Score is the sum of 6 sub-scales"|units on a scale|Mean|1.78|1.78|Standard Deviation|0.94|0.94|||
3967587|NCT01300728|3789665|B2|CDR_SB||Mean Cognitive Performance|"12 month cognitive performance in treatment (IVIG/placebo) is measured by:~Alzheimer Disease Assessment Scale-cognitive subscale (ADAS-cog)~Scale from 0 to 85 (0 is best cognitive performance)~Score is the sum of 12 sub-scales.~Mini Mental State Exam (MMSE)~Scale from 0 to 30 (30 is best cognitive performance)~Score is the sum of 11 sub-scales.~Clinical Dementia Rating - Sum of Boxes (CDR-SB)~Scale is 0 to 18 (0 is best cognitive performance)~Score is the sum of 6 sub-scales"|units on a scale|Mean|1.58|1.58|Standard Deviation|0.90|0.9|||
3967588|NCT01300728|3789666|B1|CDR_SB||Mean Cognitive Performance|"12 month cognitive performance in treatment (IVIG/placebo) is measured by:~Alzheimer Disease Assessment Scale-cognitive subscale (ADAS-cog)~Scale from 0 to 85 (0 is best cognitive performance)~Score is the sum of 12 sub-scales.~Mini Mental State Exam (MMSE)~Scale from 0 to 30 (30 is best cognitive performance)~Score is the sum of 11 sub-scales.~Clinical Dementia Rating - Sum of Boxes (CDR-SB)~Scale is 0 to 18 (0 is best cognitive performance)~Score is the sum of 6 sub-scales"|units on a scale|Mean|1.96|1.96|Standard Deviation|0.95|0.95|||
3967589|NCT01300728|3789664|B3|ADAS-cog||Mean Cognitive Performance|"12 month cognitive performance in treatment (IVIG/placebo) is measured by:~Alzheimer Disease Assessment Scale-cognitive subscale (ADAS-cog)~Scale from 0 to 85 (0 is best cognitive performance)~Score is the sum of 12 sub-scales.~Mini Mental State Exam (MMSE)~Scale from 0 to 30 (30 is best cognitive performance)~Score is the sum of 11 sub-scales.~Clinical Dementia Rating - Sum of Boxes (CDR-SB)~Scale is 0 to 18 (0 is best cognitive performance)~Score is the sum of 6 sub-scales"|units on a scale|Mean|10.46|10.46|Standard Deviation|4.97|4.97|||
3967590|NCT01300728|3789665|B2|ADAS-cog||Mean Cognitive Performance|"12 month cognitive performance in treatment (IVIG/placebo) is measured by:~Alzheimer Disease Assessment Scale-cognitive subscale (ADAS-cog)~Scale from 0 to 85 (0 is best cognitive performance)~Score is the sum of 12 sub-scales.~Mini Mental State Exam (MMSE)~Scale from 0 to 30 (30 is best cognitive performance)~Score is the sum of 11 sub-scales.~Clinical Dementia Rating - Sum of Boxes (CDR-SB)~Scale is 0 to 18 (0 is best cognitive performance)~Score is the sum of 6 sub-scales"|units on a scale|Mean|10.29|10.29|Standard Deviation|5.68|5.68|||
3967591|NCT01300728|3789666|B1|ADAS-cog||Mean Cognitive Performance|"12 month cognitive performance in treatment (IVIG/placebo) is measured by:~Alzheimer Disease Assessment Scale-cognitive subscale (ADAS-cog)~Scale from 0 to 85 (0 is best cognitive performance)~Score is the sum of 12 sub-scales.~Mini Mental State Exam (MMSE)~Scale from 0 to 30 (30 is best cognitive performance)~Score is the sum of 11 sub-scales.~Clinical Dementia Rating - Sum of Boxes (CDR-SB)~Scale is 0 to 18 (0 is best cognitive performance)~Score is the sum of 6 sub-scales"|units on a scale|Mean|10.63|10.63|Standard Deviation|4.23|4.23|||
3967592|NCT01300728|3789664|B3|MMSE||Mean Cognitive Performance|"12 month cognitive performance in treatment (IVIG/placebo) is measured by:~Alzheimer Disease Assessment Scale-cognitive subscale (ADAS-cog)~Scale from 0 to 85 (0 is best cognitive performance)~Score is the sum of 12 sub-scales.~Mini Mental State Exam (MMSE)~Scale from 0 to 30 (30 is best cognitive performance)~Score is the sum of 11 sub-scales.~Clinical Dementia Rating - Sum of Boxes (CDR-SB)~Scale is 0 to 18 (0 is best cognitive performance)~Score is the sum of 6 sub-scales"|units on a scale|Mean|26.59|26.59|Standard Deviation|2.37|2.37|||
3967593|NCT01300728|3789665|B2|MMSE||Mean Cognitive Performance|"12 month cognitive performance in treatment (IVIG/placebo) is measured by:~Alzheimer Disease Assessment Scale-cognitive subscale (ADAS-cog)~Scale from 0 to 85 (0 is best cognitive performance)~Score is the sum of 12 sub-scales.~Mini Mental State Exam (MMSE)~Scale from 0 to 30 (30 is best cognitive performance)~Score is the sum of 11 sub-scales.~Clinical Dementia Rating - Sum of Boxes (CDR-SB)~Scale is 0 to 18 (0 is best cognitive performance)~Score is the sum of 6 sub-scales"|units on a scale|Mean|26.44|26.44|Standard Deviation|2.6|2.6|||
3967594|NCT01300728|3789666|B1|MMSE||Mean Cognitive Performance|"12 month cognitive performance in treatment (IVIG/placebo) is measured by:~Alzheimer Disease Assessment Scale-cognitive subscale (ADAS-cog)~Scale from 0 to 85 (0 is best cognitive performance)~Score is the sum of 12 sub-scales.~Mini Mental State Exam (MMSE)~Scale from 0 to 30 (30 is best cognitive performance)~Score is the sum of 11 sub-scales.~Clinical Dementia Rating - Sum of Boxes (CDR-SB)~Scale is 0 to 18 (0 is best cognitive performance)~Score is the sum of 6 sub-scales"|units on a scale|Mean|26.75|26.75|Standard Deviation|2.15|2.15|||
3967595|NCT01300728|3789664|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3967596|NCT01300728|3789665|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3967597|NCT01300728|3789666|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3967598|NCT01300728|3789664|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3967599|NCT01300728|3789665|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3967600|NCT01300728|3789666|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3967601|NCT01300728|3789664|B3|||Age||years|Mean|72.32|72.32|Standard Deviation|7.56|7.56|||
3967602|NCT01300728|3789665|B2|||Age||years|Mean|72.40|72.4|Standard Deviation|7.36|7.36|||
3967603|NCT01300728|3789666|B1|||Age||years|Mean|72.26|72.26|Standard Deviation|7.91|7.91|||
3967604|NCT01300650|3789681|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3967605|NCT01300650|3789681|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3967606|NCT01300650|3789681|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3967607|NCT01300650|3789681|B1|||Age||years|Mean|55|55.0|Standard Deviation|11|11.0|||
3967608|NCT01300650|3789681|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3967609|NCT01300650|3789681|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3967610|NCT01300650|3789681|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3967611|NCT01300624|3789687|B1|||Communicative Effectiveness Ratings|"This questionnaire (Lomas et al, 1989) was provided to persons who communicated with the treatment participant regularly (e.g., a spouse). They rated how well the participant was able to perform on 16 common communication tasks (e.g., participating in a conversation over coffee). They rated each scenario along a line that spanned between the two extremes of ability, from not at all able to as able as before the stroke. The line was 100 mm. To score responses, the place where they bisected the line was measured. An average of their responses across the 16 questions was calculated."|units on a scale|Mean|32.6|32.6|Standard Deviation|65.3|65.3|||
3967612|NCT01300624|3789687|B1|||Western Aphasia Battery|The Western Aphasia Battery-Revised is a standardized aphasia battery which evaluates the severity and type of aphasia. It is a criterion measure that results in an Aphasia Quotient (AQ) (range: 0-100, where lower scores indicate more severe aphasia). An AQ of 0-25 is very severe; an AQ of 26-50 is severe; an AQ of 51-75 is moderate; and AQ of 76 and above is mild. This aphasia quotient considers language production, comprehension and repetition. The score provided here is the mean AQ across participants.|units on a scale|Mean|75.9|75.9|Standard Deviation|10.4|10.4|||
3967613|NCT01300624|3789687|B1|||Complete Utterances in discourse|"We elicited 10 discourse responses that included personal information (What you do on Sundays), picture descriptions and procedural information (how to wash dishes) (Nicholas & Brookshire 1993). Each utterance was evaluated against the criteria for complete utterances (containing a subject, verb and object (if required) while ALSO being relevant). E.g., The woman is something lacks a main verb and is not fully informative, whereas The woman is pouring a drink is complete and relevant to the picture. Percentage of complete utterances relative to total number of utterances was calculated."|Percentage of complete utterances|Mean|39.7|39.7|Standard Deviation|1.9|1.9|||
3967614|NCT01300624|3789687|B1|||Untrained sentence probe|"This task required the production of a sentence to a given picture (N=10). Each picture contained a person or animal doing something with/to something. E.g., A farmer is weighing apples. To be correct (1 point), the sentence had to contain the correct subject (farmer), verb (weigh) and object (apples). These words could not be substituted by pronouns (he) or general words (man). Articles and verb inflections (the, is, ing) were not required.~This is called the Untrained Sentence Probes, because the verb in the picture (weigh) was semantically related to a trained verb (measure)."|Percentage correct sentence production|Mean|19.8|19.8|Standard Deviation|11.0|11.0|||
3967615|NCT01300624|3789687|B1|||Trained sentence probes|"This task required the production of a sentence to a given picture (N=10). Each picture contained a person or animal doing something with/to something. E.g.,, A carpenter is measures the lumber. For a sentence to be considered correct (1 point), it had to contain the correct subject (carpenter), verb (measure) and object (lumber). These words could not be substituted by pronouns (he) or general words (man). Articles and verb inflections (i.e., the, is, ing) were not required.~This task is called the Trained Sentence Probes, because the verb was trained in treatment."|Percentage correct sentence production|Mean|20.4|20.4|Standard Deviation|13.3|13.3|||
3967616|NCT01300624|3789687|B1|||Verb naming|Participants were asked to name the 100 action pictures (e.g., climbing, sitting) from An Object and Action Naming Battery. There was no time limit, and their final response was scored. An average of their correct responses was then calculated.|Percentage of correct naming|Mean|64.6|64.6|Standard Deviation|18.2|18.2|||
3967617|NCT01300624|3789687|B1|||Noun naming|Participants were asked to name the 162 object pictures (e.g., basket, arm) from An Object and Action Naming Battery. There was no time limit, and their final response was scored. An average of their correct responses was then calculated.|Percentage of correct naming|Mean|79.9|79.9|Standard Deviation|12.3|12.3|||
3967618|NCT01300624|3789687|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3967619|NCT01300624|3789687|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3967620|NCT01300624|3789687|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3967621|NCT01300624|3789687|B1|||Age||years|Mean|63.9|63.9|Standard Deviation|12.4|12.4|||
3967622|NCT01300559|3789697|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
3967623|NCT01300559|3789698|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3967624|NCT01300559|3789699|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3967625|NCT01300559|3789697|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3967626|NCT01300559|3789698|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3967627|NCT01300559|3789699|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3967628|NCT01300559|3789697|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3967629|NCT01300559|3789698|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3967630|NCT01300559|3789699|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3967631|NCT01300559|3789697|B3|||Age||years|Mean|62.2|62.2|Standard Deviation|10.7|10.7|||
3967632|NCT01300559|3789698|B2|||Age||years|Mean|61.8|61.8|Standard Deviation|10|10.0|||
3967633|NCT01300559|3789699|B1|||Age||years|Mean|62.6|62.6|Standard Deviation|11.3|11.3|||
3967634|NCT01300559|3789697|B3||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3967635|NCT01300559|3789698|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3967636|NCT01300559|3789699|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3967637|NCT01300559|3789697|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3967638|NCT01300559|3789698|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3967639|NCT01300559|3789699|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3967640|NCT01300559|3789697|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3967641|NCT01300559|3789698|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3967642|NCT01300559|3789699|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3967643|NCT01300546|3789706|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
3967644|NCT01300546|3789707|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3967645|NCT01300546|3789708|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3967646|NCT01300546|3789706|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3967647|NCT01300546|3789707|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3967648|NCT01300546|3789708|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3967649|NCT01300546|3789706|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3967650|NCT01300546|3789707|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3967651|NCT01300546|3789708|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3967652|NCT01300546|3789706|B3|||Age||years|Mean|39.5|39.5|Standard Deviation|10.1|10.1|||
3967653|NCT01300546|3789707|B2|||Age||years|Mean|43.1|43.1|Standard Deviation|9.3|9.3|||
3967654|NCT01300546|3789708|B1|||Age||years|Mean|35.7|35.7|Standard Deviation|9.6|9.6|||
3967655|NCT01300546|3789706|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3967656|NCT01300546|3789707|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3967657|NCT01300546|3789708|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3967658|NCT01300546|3789706|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3967659|NCT01300546|3789707|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3967660|NCT01300546|3789708|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3967661|NCT01300546|3789706|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3967662|NCT01300546|3789707|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3967663|NCT01300546|3789708|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3967664|NCT01300455|3789737|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3967665|NCT01300455|3789738|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3967666|NCT01300455|3789739|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3967667|NCT01300455|3789737|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3967668|NCT01300455|3789738|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3967669|NCT01300455|3789739|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3967670|NCT01300455|3789737|B3|||Age||years|Mean|49|49.0|Full Range|||30.0|64.0|
3967671|NCT01300455|3789738|B2|||Age||years|Mean|50|50.0|Full Range|||30.0|64.0|
3967672|NCT01300455|3789739|B1|||Age||years|Mean|48|48.0|Full Range|||34.0|63.0|
3967673|NCT01300351|3789758|B3|Metastatic disease||Extent of disease at baseline||participants|Number|219|219.0||||||
3967674|NCT01300351|3789759|B2|Metastatic disease||Extent of disease at baseline||participants|Number|109|109.0||||||
3967675|NCT01300351|3789760|B1|Metastatic disease||Extent of disease at baseline||participants|Number|110|110.0||||||
3967676|NCT01300351|3789758|B3|Locally advanced breast cancer only||Extent of disease at baseline||participants|Number|2|2.0||||||
3967677|NCT01300351|3789759|B2|Locally advanced breast cancer only||Extent of disease at baseline||participants|Number|1|1.0||||||
3967678|NCT01300351|3789760|B1|Locally advanced breast cancer only||Extent of disease at baseline||participants|Number|1|1.0||||||
3967679|NCT01300351|3789758|B3|(2) In bed ≤50% of the time||WHO Performance Status||participants|Number|6|6.0||||||
3967680|NCT01300351|3789759|B2|(2) In bed ≤50% of the time||WHO Performance Status||participants|Number|3|3.0||||||
3967681|NCT01300351|3789760|B1|(2) In bed ≤50% of the time||WHO Performance Status||participants|Number|3|3.0||||||
3967682|NCT01300351|3789758|B3|(1) Restricted activity||WHO Performance Status||participants|Number|58|58.0||||||
3967683|NCT01300351|3789759|B2|(1) Restricted activity||WHO Performance Status||participants|Number|30|30.0||||||
3967684|NCT01300351|3789760|B1|(1) Restricted activity||WHO Performance Status||participants|Number|28|28.0||||||
3967685|NCT01300351|3789758|B3|(0) Normal activity||WHO Performance Status||participants|Number|157|157.0||||||
3967686|NCT01300351|3789759|B2|(0) Normal activity||WHO Performance Status||participants|Number|77|77.0||||||
3967687|NCT01300351|3789760|B1|(0) Normal activity||WHO Performance Status||participants|Number|80|80.0||||||
3967688|NCT01300351|3789758|B3|||Weight||kg|Mean|60.7|60.7|Full Range|||35.0|88.0|
3967689|NCT01300351|3789759|B2|||Weight||kg|Mean|60.5|60.5|Full Range|||42.0|88.0|
3967690|NCT01300351|3789760|B1|||Weight||kg|Mean|61.0|61.0|Full Range|||35.0|85.0|
3967691|NCT01300351|3789758|B3|Asian||Race/Ethnicity, Customized|A PHASE III STUDY OF FULVESTRANT 500 MG VERSUS 250 MG IN POSTMENOPAUSAL CHINESE WOMEN WITH ADVANCED BREAST CANCER AND DISEASE PROGRESSION FOLLOWING FAILURE ON PRIOR ANTIESTROGEN OR AROMATASE INHIBITOR THERAPY|Participants|Number|221|221.0||||||
3967692|NCT01300351|3789759|B2|Asian||Race/Ethnicity, Customized|A PHASE III STUDY OF FULVESTRANT 500 MG VERSUS 250 MG IN POSTMENOPAUSAL CHINESE WOMEN WITH ADVANCED BREAST CANCER AND DISEASE PROGRESSION FOLLOWING FAILURE ON PRIOR ANTIESTROGEN OR AROMATASE INHIBITOR THERAPY|Participants|Number|110|110.0||||||
3967693|NCT01300351|3789760|B1|Asian||Race/Ethnicity, Customized|A PHASE III STUDY OF FULVESTRANT 500 MG VERSUS 250 MG IN POSTMENOPAUSAL CHINESE WOMEN WITH ADVANCED BREAST CANCER AND DISEASE PROGRESSION FOLLOWING FAILURE ON PRIOR ANTIESTROGEN OR AROMATASE INHIBITOR THERAPY|Participants|Number|111|111.0||||||
3967694|NCT01300351|3789758|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3967695|NCT01300351|3789759|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3967696|NCT01300351|3789760|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3967697|NCT01300351|3789758|B3||Female|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
3967698|NCT01300351|3789759|B2||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3967699|NCT01300351|3789760|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3967700|NCT01300351|3789758|B3|≥65 Years||Age, Customized||participants|Number|27|27.0||||||
3967701|NCT01300351|3789759|B2|≥65 Years||Age, Customized||participants|Number|14|14.0||||||
3967702|NCT01300351|3789760|B1|≥65 Years||Age, Customized||participants|Number|13|13.0||||||
3967703|NCT01300351|3789758|B3|≥50 to <65 Years||Age, Customized||participants|Number|117|117.0||||||
3967704|NCT01300351|3789759|B2|≥50 to <65 Years||Age, Customized||participants|Number|56|56.0||||||
3967705|NCT01300351|3789760|B1|≥50 to <65 Years||Age, Customized||participants|Number|61|61.0||||||
3967706|NCT01300351|3789758|B3|<50 Years||Age, Customized||participants|Number|77|77.0||||||
3967707|NCT01300351|3789759|B2|<50 Years||Age, Customized||participants|Number|40|40.0||||||
3967708|NCT01300351|3789760|B1|<50 Years||Age, Customized||participants|Number|37|37.0||||||
3967709|NCT01300351|3789758|B3|||Age||years|Mean|53.3|53.3|Standard Deviation|10.15|10.15|||
3967710|NCT01300351|3789759|B2|||Age||years|Mean|53.1|53.1|Standard Deviation|10.22|10.22|||
3967711|NCT01300351|3789760|B1|||Age||years|Mean|53.6|53.6|Standard Deviation|10.12|10.12|||
3967712|NCT01300338|3789775|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3967713|NCT01300338|3789776|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3967714|NCT01300338|3789777|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3967715|NCT01300338|3789775|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3967716|NCT01300338|3789776|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3967717|NCT01300338|3789777|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3967718|NCT01300338|3789775|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3967719|NCT01300338|3789776|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3967720|NCT01300338|3789777|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3967721|NCT01300338|3789775|B3|||Age|Age is indicated in years|years|Mean|62.8|62.8|Standard Deviation|8.17|8.17|||
3967722|NCT01300338|3789776|B2|||Age|Age is indicated in years|years|Mean|62.36|62.36|Standard Deviation|8.55|8.55|||
3967723|NCT01300338|3789777|B1|||Age|Age is indicated in years|years|Mean|63.24|63.24|Standard Deviation|7.93|7.93|||
3967724|NCT01300286|3789786|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
3967725|NCT01300286|3789786|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3967726|NCT01300286|3789786|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3967727|NCT01300286|3789786|B1|||Age||years|Mean|52|52.0|Standard Deviation|13|13.0|||
3967728|NCT01300260|3789794|B3|Germany||Region of Enrollment||participants|Number|32|32.0||||||
3967729|NCT01300260|3789795|B2|Germany||Region of Enrollment||participants|Number|22|22.0||||||
3967730|NCT01300260|3789796|B1|Germany||Region of Enrollment||participants|Number|10|10.0||||||
3967731|NCT01300260|3789794|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967732|NCT01300260|3789795|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967733|NCT01300260|3789796|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967734|NCT01300260|3789794|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967735|NCT01300260|3789795|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967736|NCT01300260|3789796|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967737|NCT01300260|3789794|B3||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3967738|NCT01300260|3789795|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3967739|NCT01300260|3789796|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3967740|NCT01300260|3789794|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967741|NCT01300260|3789795|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967742|NCT01300260|3789796|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967743|NCT01300260|3789794|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967744|NCT01300260|3789795|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967745|NCT01300260|3789796|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967746|NCT01300260|3789794|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967747|NCT01300260|3789795|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967748|NCT01300260|3789796|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967749|NCT01300260|3789794|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967750|NCT01300260|3789795|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967751|NCT01300260|3789796|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967752|NCT01300260|3789794|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967753|NCT01300260|3789795|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967754|NCT01300260|3789796|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967755|NCT01300260|3789794|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3967756|NCT01300260|3789795|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3967757|NCT01300260|3789796|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3967758|NCT01300260|3789794|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967759|NCT01300260|3789795|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967760|NCT01300260|3789796|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967761|NCT01300260|3789794|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3967762|NCT01300260|3789795|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3967763|NCT01300260|3789796|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3967764|NCT01300260|3789794|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3967765|NCT01300260|3789795|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3967766|NCT01300260|3789796|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3967767|NCT01300260|3789794|B3|||Age||years|Mean|54.9|54.9|Standard Deviation|6.1|6.1|||
3967768|NCT01300260|3789795|B2|||Age||years|Mean|56.3|56.3|Standard Deviation|6.1|6.1|||
3967769|NCT01300260|3789796|B1|||Age||years|Mean|51.9|51.9|Standard Deviation|5.0|5.0|||
3967770|NCT01300247|3789827|B3||Male|Gender||Participants|Count of Participants|32|32.0||||||
3967771|NCT01300247|3789828|B2||Male|Gender||Participants|Count of Participants|15|15.0||||||
3967772|NCT01300247|3789829|B1||Male|Gender||Participants|Count of Participants|17|17.0||||||
3967773|NCT01300247|3789827|B3||Female|Gender||Participants|Count of Participants|9|9.0||||||
3967774|NCT01300247|3789828|B2||Female|Gender||Participants|Count of Participants|5|5.0||||||
3967775|NCT01300247|3789829|B1||Female|Gender||Participants|Count of Participants|4|4.0||||||
3967776|NCT01300247|3789827|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|10.2|10.2|||
3967777|NCT01300247|3789828|B2|||Age||years|Mean|62.0|62.0|Standard Deviation|9.0|9.0|||
3967778|NCT01300247|3789829|B1|||Age||years|Mean|57.8|57.8|Standard Deviation|11.1|11.1|||
3967779|NCT01300234|3789860|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized|Baseline data were collected in members of the Intent-to-Treat Population, comprised of all randomized participants who received at least one dose of study medication.|participants|Number|509|509.0||||||
3967780|NCT01300234|3789861|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized|Baseline data were collected in members of the Intent-to-Treat Population, comprised of all randomized participants who received at least one dose of study medication.|participants|Number|252|252.0||||||
3967781|NCT01300234|3789862|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized|Baseline data were collected in members of the Intent-to-Treat Population, comprised of all randomized participants who received at least one dose of study medication.|participants|Number|257|257.0||||||
3967782|NCT01300234|3789860|B3||Male|Sex: Female, Male|Baseline data were collected in members of the Intent-to-Treat Population, comprised of all randomized participants who received at least one dose of study medication.|Participants|Count of Participants|424|424.0||||||
3967783|NCT01300234|3789861|B2||Male|Sex: Female, Male|Baseline data were collected in members of the Intent-to-Treat Population, comprised of all randomized participants who received at least one dose of study medication.|Participants|Count of Participants|210|210.0||||||
3967836|NCT01299909|3789926|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3967784|NCT01300234|3789862|B1||Male|Sex: Female, Male|Baseline data were collected in members of the Intent-to-Treat Population, comprised of all randomized participants who received at least one dose of study medication.|Participants|Count of Participants|214|214.0||||||
3967785|NCT01300234|3789860|B3||Female|Sex: Female, Male|Baseline data were collected in members of the Intent-to-Treat Population, comprised of all randomized participants who received at least one dose of study medication.|Participants|Count of Participants|85|85.0||||||
3967786|NCT01300234|3789861|B2||Female|Sex: Female, Male|Baseline data were collected in members of the Intent-to-Treat Population, comprised of all randomized participants who received at least one dose of study medication.|Participants|Count of Participants|42|42.0||||||
3967787|NCT01300234|3789862|B1||Female|Sex: Female, Male|Baseline data were collected in members of the Intent-to-Treat Population, comprised of all randomized participants who received at least one dose of study medication.|Participants|Count of Participants|43|43.0||||||
3967788|NCT01300234|3789860|B3|||Age|Baseline data were collected in members of the Intent-to-Treat Population, comprised of all randomized participants who received at least one dose of study medication.|Years|Mean|36.3|36.3|Standard Deviation|10.44|10.44|||
3967789|NCT01300234|3789861|B2|||Age|Baseline data were collected in members of the Intent-to-Treat Population, comprised of all randomized participants who received at least one dose of study medication.|Years|Mean|36.4|36.4|Standard Deviation|10.43|10.43|||
3967790|NCT01300234|3789862|B1|||Age|Baseline data were collected in members of the Intent-to-Treat Population, comprised of all randomized participants who received at least one dose of study medication.|Years|Mean|36.1|36.1|Standard Deviation|10.48|10.48|||
3967791|NCT01300052|3789897|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3967792|NCT01300052|3789898|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3967793|NCT01300052|3789899|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3967794|NCT01300052|3789897|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3967795|NCT01300052|3789898|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3967796|NCT01300052|3789899|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3967797|NCT01300052|3789897|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3967798|NCT01300052|3789898|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3967799|NCT01300052|3789899|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3967800|NCT01300052|3789897|B3||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
3967801|NCT01300052|3789898|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3967802|NCT01300052|3789899|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3967803|NCT01300052|3789897|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3967804|NCT01300052|3789898|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3967805|NCT01300052|3789899|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3967806|NCT01299961|3789918|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3967807|NCT01299961|3789918|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3967808|NCT01299961|3789918|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3967809|NCT01299961|3789918|B1|||Age|This is a the average age of the cohort that started the mediation, Abatacept 125mg sq qwk.|years|Mean|52.6|52.6|Standard Deviation|13.4|13.4|||
3967810|NCT01299909|3789924|B4|United States||Region of Enrollment||participants|Number|135|135.0||||||
3967811|NCT01299909|3789925|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3967812|NCT01299909|3789926|B2|United States||Region of Enrollment||participants|Number|67|67.0||||||
3967813|NCT01299909|3789927|B1|United States||Region of Enrollment||participants|Number|68|68.0||||||
3967814|NCT01299909|3789924|B4||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3967815|NCT01299909|3789925|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3967816|NCT01299909|3789926|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3967817|NCT01299909|3789927|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3967818|NCT01299909|3789924|B4||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3967819|NCT01299909|3789925|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3967820|NCT01299909|3789926|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3967821|NCT01299909|3789927|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3967822|NCT01299909|3789924|B4|||Age||years|Mean|44.69|44.69|Standard Deviation|12.51|12.51|||
3967823|NCT01299909|3789925|B3|||Age||years|Mean|45.33|45.33|Standard Deviation|11.89|11.89|||
3967824|NCT01299909|3789926|B2|||Age||years|Mean|45.78|45.78|Standard Deviation|13.35|13.35|||
3967825|NCT01299909|3789927|B1|||Age||years|Mean|43.24|43.24|Standard Deviation|12.05|12.05|||
3967826|NCT01299909|3789924|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3967827|NCT01299909|3789925|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3967828|NCT01299909|3789926|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3967829|NCT01299909|3789927|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3967830|NCT01299909|3789924|B4||Between 18 and 65 years|Age||Participants|Count of Participants|175|175.0||||||
3967831|NCT01299909|3789925|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3967832|NCT01299909|3789926|B2||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
3967833|NCT01299909|3789927|B1||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
3967834|NCT01299909|3789924|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3967835|NCT01299909|3789925|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3967837|NCT01299909|3789927|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3967838|NCT01299896|3789942|B3|United States||Region of Enrollment||participants|Number|633|633.0||||||
3967839|NCT01299896|3789943|B2|United States||Region of Enrollment||participants|Number|314|314.0||||||
3967840|NCT01299896|3789944|B1|United States||Region of Enrollment||participants|Number|319|319.0||||||
3967841|NCT01299896|3789942|B3||Male|Sex: Female, Male||Participants|Count of Participants|567|567.0||||||
3967842|NCT01299896|3789943|B2||Male|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
3967843|NCT01299896|3789944|B1||Male|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
3967844|NCT01299896|3789942|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3967845|NCT01299896|3789943|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3967846|NCT01299896|3789944|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3967847|NCT01299896|3789942|B3|||Age||years|Mean|55.2|55.2|Standard Deviation|10.2|10.2|||
3967848|NCT01299896|3789943|B2|||Age||years|Mean|55.7|55.7|Standard Deviation|8.7|8.7|||
3967849|NCT01299896|3789944|B1|||Age||years|Mean|54.7|54.7|Standard Deviation|11.5|11.5|||
3967850|NCT01299805|3789951|B3|Consumes >5 cups daily||Caffeine consumption||participants|Number|0|0.0||||||
3967851|NCT01299805|3789952|B2|Consumes >5 cups daily||Caffeine consumption||participants|Number|0|0.0||||||
3967852|NCT01299805|3789953|B1|Consumes >5 cups daily||Caffeine consumption||participants|Number|0|0.0||||||
3967853|NCT01299805|3789951|B3|Consumes 0-5 cups daily||Caffeine consumption||participants|Number|17|17.0||||||
3967854|NCT01299805|3789952|B2|Consumes 0-5 cups daily||Caffeine consumption||participants|Number|5|5.0||||||
3967855|NCT01299805|3789953|B1|Consumes 0-5 cups daily||Caffeine consumption||participants|Number|12|12.0||||||
3967856|NCT01299805|3789951|B3|Drinks >14/week||Drinking habits||participants|Number|0|0.0||||||
3967857|NCT01299805|3789952|B2|Drinks >14/week||Drinking habits||participants|Number|0|0.0||||||
3967858|NCT01299805|3789953|B1|Drinks >14/week||Drinking habits||participants|Number|0|0.0||||||
3967859|NCT01299805|3789951|B3|Drinks 0-14/week||Drinking habits||participants|Number|17|17.0||||||
3967860|NCT01299805|3789952|B2|Drinks 0-14/week||Drinking habits||participants|Number|5|5.0||||||
3967861|NCT01299805|3789953|B1|Drinks 0-14/week||Drinking habits||participants|Number|12|12.0||||||
3967862|NCT01299805|3789951|B3|No||Former nicotine user||participants|Number|15|15.0||||||
3967863|NCT01299805|3789952|B2|No||Former nicotine user||participants|Number|4|4.0||||||
3967864|NCT01299805|3789953|B1|No||Former nicotine user||participants|Number|11|11.0||||||
3967865|NCT01299805|3789951|B3|Yes||Former nicotine user||participants|Number|2|2.0||||||
3967866|NCT01299805|3789952|B2|Yes||Former nicotine user||participants|Number|1|1.0||||||
3967867|NCT01299805|3789953|B1|Yes||Former nicotine user||participants|Number|1|1.0||||||
3967868|NCT01299805|3789951|B3|No||Current nicotine user||participants|Number|17|17.0||||||
3967869|NCT01299805|3789952|B2|No||Current nicotine user||participants|Number|5|5.0||||||
3967870|NCT01299805|3789953|B1|No||Current nicotine user||participants|Number|12|12.0||||||
3967871|NCT01299805|3789951|B3|Yes||Current nicotine user||participants|Number|0|0.0||||||
3967872|NCT01299805|3789952|B2|Yes||Current nicotine user||participants|Number|0|0.0||||||
3967873|NCT01299805|3789953|B1|Yes||Current nicotine user||participants|Number|0|0.0||||||
3967874|NCT01299805|3789951|B3|||Body Mass Index (BMI)||kg/m^2|Mean|26.1|26.1|Standard Deviation|2.56|2.56|||
3967875|NCT01299805|3789952|B2|||Body Mass Index (BMI)||kg/m^2|Mean|25.8|25.8|Standard Deviation|1.92|1.92|||
3967876|NCT01299805|3789953|B1|||Body Mass Index (BMI)||kg/m^2|Mean|26.2|26.2|Standard Deviation|2.85|2.85|||
3967877|NCT01299805|3789951|B3|||Weight||kg|Mean|81.3|81.3|Standard Deviation|8.29|8.29|||
3967878|NCT01299805|3789952|B2|||Weight||kg|Mean|79.9|79.9|Standard Deviation|7.52|7.52|||
3967879|NCT01299805|3789953|B1|||Weight||kg|Mean|81.8|81.8|Standard Deviation|8.84|8.84|||
3967880|NCT01299805|3789951|B3|||Height||cm|Mean|176.6|176.6|Standard Deviation|6.37|6.37|||
3967881|NCT01299805|3789952|B2|||Height||cm|Mean|175.9|175.9|Standard Deviation|8.15|8.15|||
3967882|NCT01299805|3789953|B1|||Height||cm|Mean|176.8|176.8|Standard Deviation|5.88|5.88|||
3967883|NCT01299805|3789951|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
3967884|NCT01299805|3789952|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3967885|NCT01299805|3789953|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3967886|NCT01299805|3789951|B3|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3967887|NCT01299805|3789952|B2|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3967888|NCT01299805|3789953|B1|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3967889|NCT01299805|3789951|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3967890|NCT01299805|3789952|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3967891|NCT01299805|3789953|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3967892|NCT01299805|3789951|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3967893|NCT01299805|3789952|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3967894|NCT01299805|3789953|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3967895|NCT01299805|3789951|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3967896|NCT01299805|3789952|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3967897|NCT01299805|3789953|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3967898|NCT01299805|3789951|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3967899|NCT01299805|3789952|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3967900|NCT01299805|3789953|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3967901|NCT01299805|3789951|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3967902|NCT01299805|3789952|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3967903|NCT01299805|3789953|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3967904|NCT01299805|3789951|B3|||Age||years|Mean|34.4|34.4|Standard Deviation|10.71|10.71|||
3967905|NCT01299805|3789952|B2|||Age||years|Mean|34.8|34.8|Standard Deviation|10.71|10.71|||
3967906|NCT01299805|3789953|B1|||Age||years|Mean|34.3|34.3|Standard Deviation|11.19|11.19|||
3967907|NCT01299766|3789982|B3|United States||Region of Enrollment||participants|Number|221|221.0||||||
3967908|NCT01299766|3789983|B2|United States||Region of Enrollment||participants|Number|110|110.0||||||
3967909|NCT01299766|3789984|B1|United States||Region of Enrollment||participants|Number|111|111.0||||||
3967910|NCT01299766|3789982|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967911|NCT01299766|3789983|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967912|NCT01299766|3789984|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967913|NCT01299766|3789982|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967914|NCT01299766|3789983|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967915|NCT01299766|3789984|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967916|NCT01299766|3789982|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967917|NCT01299766|3789983|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967918|NCT01299766|3789984|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967919|NCT01299766|3789982|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|221|221.0||||||
3967920|NCT01299766|3789983|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
3967921|NCT01299766|3789984|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
3967922|NCT01299766|3789982|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967923|NCT01299766|3789983|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967924|NCT01299766|3789984|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967925|NCT01299766|3789982|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967926|NCT01299766|3789983|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967927|NCT01299766|3789984|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967928|NCT01299766|3789982|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967929|NCT01299766|3789983|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967930|NCT01299766|3789984|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967931|NCT01299766|3789982|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967932|NCT01299766|3789983|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967933|NCT01299766|3789984|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967934|NCT01299766|3789982|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|220|220.0||||||
3967935|NCT01299766|3789983|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
3967936|NCT01299766|3789984|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
3967937|NCT01299766|3789982|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3967938|NCT01299766|3789983|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967939|NCT01299766|3789984|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3967940|NCT01299766|3789982|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3967941|NCT01299766|3789983|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3967942|NCT01299766|3789984|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3967943|NCT01299766|3789982|B3||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
3967944|NCT01299766|3789983|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3967945|NCT01299766|3789984|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3967946|NCT01299766|3789982|B3|||Age||years|Mean|75.8|75.8|Standard Deviation|7.0|7.0|||
3967947|NCT01299766|3789983|B2|||Age||years|Mean|76.2|76.2|Standard Deviation|6.9|6.9|||
3967948|NCT01299766|3789984|B1|||Age||years|Mean|75.5|75.5|Standard Deviation|7.1|7.1|||
3967949|NCT01299610|3789993|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967950|NCT01299610|3789994|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967951|NCT01299610|3789995|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967952|NCT01299610|3789996|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967953|NCT01299610|3789993|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967954|NCT01299610|3789994|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967955|NCT01299610|3789995|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967956|NCT01299610|3789996|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967957|NCT01299610|3789993|B4||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3967958|NCT01299610|3789994|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3967959|NCT01299610|3789995|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3967960|NCT01299610|3789996|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3967961|NCT01299610|3789993|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967962|NCT01299610|3789994|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967963|NCT01299610|3789995|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967964|NCT01299610|3789996|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967965|NCT01299610|3789993|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967966|NCT01299610|3789994|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967967|NCT01299610|3789995|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967968|NCT01299610|3789996|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967969|NCT01299610|3789993|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967970|NCT01299610|3789994|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967971|NCT01299610|3789995|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967972|NCT01299610|3789996|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967973|NCT01299610|3789993|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967974|NCT01299610|3789994|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967975|NCT01299610|3789995|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967976|NCT01299610|3789996|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3967977|NCT01299610|3789993|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3967978|NCT01299610|3789994|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3967979|NCT01299610|3789995|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3967980|NCT01299610|3789996|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3967981|NCT01299610|3789993|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3967982|NCT01299610|3789994|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3967983|NCT01299610|3789995|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3967984|NCT01299610|3789996|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3967985|NCT01299610|3789993|B4|||Age||Years|Mean|36.2|36.2|Standard Deviation|16.68|16.68|||
3967986|NCT01299610|3789994|B3|||Age||Years|Mean|28.3|28.3|Standard Deviation|10.15|10.15|||
3967987|NCT01299610|3789995|B2|||Age||Years|Mean|40.8|40.8|Standard Deviation|19.43|19.43|||
3967988|NCT01299610|3789996|B1|||Age||Years|Mean|41.9|41.9|Standard Deviation|18.81|18.81|||
3967989|NCT01299584|3790043|B1|Not Korean||Race/Ethnicity, Customized|Baseline characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who had been administered the investigational drug at least once and had undergone all safety assessments.|participants|Number|0|0.0||||||
3967990|NCT01299584|3790043|B1|Korean||Race/Ethnicity, Customized|Baseline characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who had been administered the investigational drug at least once and had undergone all safety assessments.|participants|Number|766|766.0||||||
3967991|NCT01299584|3790043|B1|Male||Sex/Gender, Customized|Baseline characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who had been administered the investigational drug at least once and had undergone all safety assessments. Gender data are missing for one participant.|Participants|Number|343|343.0||||||
3967992|NCT01299584|3790043|B1|Female||Sex/Gender, Customized|Baseline characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who had been administered the investigational drug at least once and had undergone all safety assessments. Gender data are missing for one participant.|Participants|Number|422|422.0||||||
3967993|NCT01299584|3790043|B1|||Age|Baseline characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who had been administered the investigational drug at least once and had undergone all safety assessments.|Years|Mean|45.3|45.3|Standard Deviation|16.5|16.5|||
3967994|NCT01299571|3790050|B1|Not Korean||Race/Ethnicity, Customized|Baseline characteristics were collected in members of the ITT Population, comprised of all participants who had been administered the investigational drug at least once and had completed safety assessments.|participants|Number|0|0.0||||||
3967995|NCT01299571|3790050|B1|Korean||Race/Ethnicity, Customized|Baseline characteristics were collected in members of the ITT Population, comprised of all participants who had been administered the investigational drug at least once and had completed safety assessments.|participants|Number|3870|3870.0||||||
3967996|NCT01299571|3790050|B1||Male|Sex: Female, Male|Baseline characteristics were collected in members of the ITT Population, comprised of all participants who had been administered the investigational drug at least once and had completed safety assessments.|Participants|Count of Participants|3870|3870.0||||||
3967997|NCT01299571|3790050|B1||Female|Sex: Female, Male|Baseline characteristics were collected in members of the ITT Population, comprised of all participants who had been administered the investigational drug at least once and had completed safety assessments.|Participants|Count of Participants|0|0.0||||||
3967998|NCT01299571|3790050|B1|||Age|Baseline characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who had been administered the investigational drug at least once and had completed safety assessments.|Years|Mean|67.3|67.3|Standard Deviation|9.1|9.1|||
3967999|NCT01299480|3790056|B6||Male|Sex: Female, Male||Participants|Count of Participants|842|842.0||||||
3968000|NCT01299480|3790057|B5||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3968001|NCT01299480|3790058|B4||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3968002|NCT01299480|3790059|B3||Male|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
3968003|NCT01299480|3790060|B2||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
3968004|NCT01299480|3790061|B1||Male|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
3968005|NCT01299480|3790056|B6||Female|Sex: Female, Male||Participants|Count of Participants|871|871.0||||||
3968006|NCT01299480|3790057|B5||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3968007|NCT01299480|3790058|B4||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3968008|NCT01299480|3790059|B3||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
3968009|NCT01299480|3790060|B2||Female|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
3968010|NCT01299480|3790061|B1||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
3968011|NCT01299480|3790056|B6|14 - <19 years||Age, Customized||participants|Number|1084|1084.0||||||
3968012|NCT01299480|3790057|B5|14 - <19 years||Age, Customized||participants|Number|90|90.0||||||
3968013|NCT01299480|3790058|B4|14 - <19 years||Age, Customized||participants|Number|180|180.0||||||
3968014|NCT01299480|3790059|B3|14 - <19 years||Age, Customized||participants|Number|271|271.0||||||
3968015|NCT01299480|3790060|B2|14 - <19 years||Age, Customized||participants|Number|272|272.0||||||
3968016|NCT01299480|3790061|B1|14 - <19 years||Age, Customized||participants|Number|271|271.0||||||
3968017|NCT01299480|3790056|B6|11- less than (<) 14 years||Age, Customized||participants|Number|629|629.0||||||
3968018|NCT01299480|3790057|B5|11- less than (<) 14 years||Age, Customized||participants|Number|53|53.0||||||
3968019|NCT01299480|3790058|B4|11- less than (<) 14 years||Age, Customized||participants|Number|106|106.0||||||
3968020|NCT01299480|3790059|B3|11- less than (<) 14 years||Age, Customized||participants|Number|156|156.0||||||
3968021|NCT01299480|3790060|B2|11- less than (<) 14 years||Age, Customized||participants|Number|158|158.0||||||
3968022|NCT01299480|3790061|B1|11- less than (<) 14 years||Age, Customized||participants|Number|156|156.0||||||
3968023|NCT01299454|3790100|B5||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3968024|NCT01299454|3790101|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3968025|NCT01299454|3790102|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3968026|NCT01299454|3790103|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3968027|NCT01299454|3790104|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3968028|NCT01299454|3790100|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3968029|NCT01299454|3790101|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3968030|NCT01299454|3790102|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3968031|NCT01299454|3790103|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3968032|NCT01299454|3790104|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3968033|NCT01299454|3790100|B5|||Age||Years|Mean|56.4|56.4|Standard Deviation|5.7|5.7|||
3968034|NCT01299454|3790101|B4|||Age||Years|Mean|56.2|56.2|Standard Deviation|5.2|5.2|||
3968035|NCT01299454|3790102|B3|||Age||Years|Mean|51.2|51.2|Standard Deviation|4.4|4.4|||
3968036|NCT01299454|3790103|B2|||Age||Years|Mean|57.8|57.8|Standard Deviation|3.8|3.8|||
3968037|NCT01299454|3790104|B1|||Age||Years|Mean|59.5|59.5|Standard Deviation|7.3|7.3|||
3968038|NCT01299389|3790265|B3||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3968039|NCT01299389|3790266|B2||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3968040|NCT01299389|3790267|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3968041|NCT01299389|3790265|B3||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3968042|NCT01299389|3790266|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3968043|NCT01299389|3790267|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3968044|NCT01299389|3790265|B3|||Age||years|Mean|44.8|44.8|Standard Deviation|12.99|12.99|||
3968045|NCT01299389|3790266|B2|||Age||years|Mean|45.7|45.7|Standard Deviation|13.55|13.55|||
3968046|NCT01299389|3790267|B1|||Age||years|Mean|44.0|44.0|Standard Deviation|12.41|12.41|||
3968047|NCT01299376|3790290|B3||Male|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
3968048|NCT01299376|3790291|B2||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3968049|NCT01299376|3790292|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3968050|NCT01299376|3790290|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3968051|NCT01299376|3790291|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3968052|NCT01299376|3790292|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3968053|NCT01299376|3790290|B3|||Age||Years|Mean|55.1|55.1|Standard Deviation|9.5|9.5|||
3968054|NCT01299376|3790291|B2|||Age||Years|Mean|56.3|56.3|Standard Deviation|9.7|9.7|||
3968055|NCT01299376|3790292|B1|||Age||Years|Mean|53.9|53.9|Standard Deviation|9.1|9.1|||
3968056|NCT01299285|3790323|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3968057|NCT01299285|3790323|B1|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3968058|NCT01299285|3790323|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3968059|NCT01299285|3790323|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3968060|NCT01299285|3790323|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3968061|NCT01299285|3790323|B1|||Age||years|Mean|36.7|36.7|Standard Deviation|11.3|11.3|||
3968062|NCT01299272|3790336|B1|South Korea||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3968063|NCT01299272|3790336|B1|Germany||Region of Enrollment||Participants|Count of Participants|73|73.0||||||
3968064|NCT01299272|3790336|B1|Romania||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3968065|NCT01299272|3790336|B1|Croatia||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3968066|NCT01299272|3790336|B1|Belgium||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3968067|NCT01299272|3790336|B1|Argentina||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
3968068|NCT01299272|3790336|B1|Puerto Rico||Region of Enrollment||Participants|Count of Participants|77|77.0||||||
3968069|NCT01299272|3790336|B1|Mexico||Region of Enrollment||Participants|Count of Participants|63|63.0||||||
3968070|NCT01299272|3790336|B1|France||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
3968071|NCT01299272|3790336|B1|Italy||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3968072|NCT01299272|3790336|B1|Russia||Region of Enrollment||Participants|Count of Participants|96|96.0||||||
3968073|NCT01299272|3790336|B1|Turkey||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3968074|NCT01299272|3790336|B1|Spain||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
3968075|NCT01299272|3790336|B1|Greece||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
3968076|NCT01299272|3790336|B1|Slovakia||Region of Enrollment||Participants|Count of Participants|65|65.0||||||
3968077|NCT01299272|3790336|B1|United States||Region of Enrollment||Participants|Count of Participants|535|535.0||||||
3968078|NCT01299272|3790336|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|373|373.0||||||
3968079|NCT01299272|3790336|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|622|622.0||||||
3968080|NCT01299272|3790336|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|254|254.0||||||
3968081|NCT01299272|3790336|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968082|NCT01299272|3790336|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3968083|NCT01299272|3790336|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1066|1066.0||||||
3968084|NCT01299272|3790336|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3968085|NCT01299272|3790336|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968086|NCT01299272|3790336|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3968087|NCT01299272|3790336|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3968088|NCT01299272|3790336|B1||Male|Sex: Female, Male||Participants|Count of Participants|332|332.0||||||
3968089|NCT01299272|3790336|B1||Female|Sex: Female, Male||Participants|Count of Participants|917|917.0||||||
3968090|NCT01299272|3790336|B1|||Age||years|Mean|47.4|47.4|Standard Deviation|12.54|12.54|||
3968091|NCT01299116|3790391|B4|All other single and multiple race||Race/Ethnicity, Customized|Three participants did not provide race/ethnicity information|Participants|Count of Participants|92|92.0||||||
3968092|NCT01299116|3790392|B3|All other single and multiple race||Race/Ethnicity, Customized|Three participants did not provide race/ethnicity information|Participants|Count of Participants|16|16.0||||||
3968093|NCT01299116|3790393|B2|All other single and multiple race||Race/Ethnicity, Customized|Three participants did not provide race/ethnicity information|Participants|Count of Participants|18|18.0||||||
3968094|NCT01299116|3790394|B1|All other single and multiple race||Race/Ethnicity, Customized|Three participants did not provide race/ethnicity information|Participants|Count of Participants|58|58.0||||||
3968095|NCT01299116|3790391|B4|Non-Hispanic, black||Race/Ethnicity, Customized|Three participants did not provide race/ethnicity information|Participants|Count of Participants|202|202.0||||||
3968096|NCT01299116|3790392|B3|Non-Hispanic, black||Race/Ethnicity, Customized|Three participants did not provide race/ethnicity information|Participants|Count of Participants|44|44.0||||||
3968097|NCT01299116|3790393|B2|Non-Hispanic, black||Race/Ethnicity, Customized|Three participants did not provide race/ethnicity information|Participants|Count of Participants|34|34.0||||||
3968098|NCT01299116|3790394|B1|Non-Hispanic, black||Race/Ethnicity, Customized|Three participants did not provide race/ethnicity information|Participants|Count of Participants|124|124.0||||||
3968099|NCT01299116|3790391|B4|Non-Hispanic, white||Race/Ethnicity, Customized|Three participants did not provide race/ethnicity information|Participants|Count of Participants|485|485.0||||||
3968100|NCT01299116|3790392|B3|Non-Hispanic, white||Race/Ethnicity, Customized|Three participants did not provide race/ethnicity information|Participants|Count of Participants|105|105.0||||||
3968101|NCT01299116|3790393|B2|Non-Hispanic, white||Race/Ethnicity, Customized|Three participants did not provide race/ethnicity information|Participants|Count of Participants|111|111.0||||||
3968102|NCT01299116|3790394|B1|Non-Hispanic, white||Race/Ethnicity, Customized|Three participants did not provide race/ethnicity information|Participants|Count of Participants|269|269.0||||||
3968103|NCT01299116|3790391|B4|Hispanic||Race/Ethnicity, Customized|Three participants did not provide race/ethnicity information|Participants|Count of Participants|112|112.0||||||
3968104|NCT01299116|3790392|B3|Hispanic||Race/Ethnicity, Customized|Three participants did not provide race/ethnicity information|Participants|Count of Participants|30|30.0||||||
3968105|NCT01299116|3790393|B2|Hispanic||Race/Ethnicity, Customized|Three participants did not provide race/ethnicity information|Participants|Count of Participants|14|14.0||||||
3968106|NCT01299116|3790394|B1|Hispanic||Race/Ethnicity, Customized|Three participants did not provide race/ethnicity information|Participants|Count of Participants|68|68.0||||||
3968107|NCT01299116|3790391|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3968108|NCT01299116|3790392|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3968109|NCT01299116|3790393|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3968110|NCT01299116|3790394|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3968111|NCT01299116|3790391|B4||Female|Sex: Female, Male||Participants|Count of Participants|894|894.0||||||
3968112|NCT01299116|3790392|B3||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
3968113|NCT01299116|3790393|B2||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
3968114|NCT01299116|3790394|B1||Female|Sex: Female, Male||Participants|Count of Participants|522|522.0||||||
3968115|NCT01299116|3790391|B4|||Age||years|Mean|23|23.0|Inter-Quartile Range|||21.0|26.0|
3968116|NCT01299116|3790392|B3|||Age||years|Mean|23|23.0|Inter-Quartile Range|||21.0|26.0|
3968117|NCT01299116|3790393|B2|||Age||years|Mean|23|23.0|Inter-Quartile Range|||21.0|26.0|
3968118|NCT01299116|3790394|B1|||Age||years|Mean|23|23.0|Inter-Quartile Range|||21.0|26.0|
3968119|NCT01299103|3790410|B4|United States||Region of Enrollment||participants|Number|40|40.0||||||
3968120|NCT01299103|3790411|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3968121|NCT01299103|3790412|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3968122|NCT01299103|3790413|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3968123|NCT01299103|3790410|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3968124|NCT01299103|3790411|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3968125|NCT01299103|3790412|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3968126|NCT01299103|3790413|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3968127|NCT01299103|3790410|B4||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3968128|NCT01299103|3790411|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3968129|NCT01299103|3790412|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3968130|NCT01299103|3790413|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3968131|NCT01299103|3790410|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3968132|NCT01299103|3790411|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3968133|NCT01299103|3790412|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3968134|NCT01299103|3790413|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3968135|NCT01299103|3790410|B4||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3968136|NCT01299103|3790411|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3968137|NCT01299103|3790412|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3968138|NCT01299103|3790413|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3968139|NCT01299103|3790410|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3968140|NCT01299103|3790411|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3968141|NCT01299103|3790412|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3968142|NCT01299103|3790413|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3968143|NCT01299103|3790410|B4|||Age||years|Mean|52|52.0|Standard Deviation|6.3|6.3|||
3968144|NCT01299103|3790411|B3|||Age||years|Mean|53|53.0|Standard Deviation|5.2|5.2|||
3968145|NCT01299103|3790412|B2|||Age||years|Mean|52|52.0|Standard Deviation|6.5|6.5|||
3968146|NCT01299103|3790413|B1|||Age||years|Mean|52|52.0|Standard Deviation|7.2|7.2|||
3968147|NCT01299090|3790426|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
3968148|NCT01299090|3790426|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3968149|NCT01299090|3790426|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3968150|NCT01299090|3790426|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3968151|NCT01299090|3790426|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3968152|NCT01299090|3790426|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3968153|NCT01299090|3790426|B1|||Age||years|Mean|61|61.0|Standard Deviation|8.1|8.1|||
3968154|NCT01299077|3790431|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968155|NCT01299077|3790431|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968156|NCT01299077|3790431|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968157|NCT01299077|3790431|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968158|NCT01299077|3790431|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968159|NCT01299077|3790431|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|478|478.0||||||
3968160|NCT01299077|3790431|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968161|NCT01299077|3790431|B1||Male|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
3968162|NCT01299077|3790431|B1||Female|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
3968163|NCT01299077|3790431|B1|||Age||years|Mean|50.34|50.34|Standard Deviation|12.63|12.63|||
3968164|NCT01299025|3790439|B3|Sweden||Region of Enrollment||participants|Number|84|84.0||||||
3968165|NCT01299025|3790440|B2|Sweden||Region of Enrollment||participants|Number|42|42.0||||||
3968166|NCT01299025|3790441|B1|Sweden||Region of Enrollment||participants|Number|42|42.0||||||
3968167|NCT01299025|3790439|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3968168|NCT01299025|3790440|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3968169|NCT01299025|3790441|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3968170|NCT01299025|3790439|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3968171|NCT01299025|3790440|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3968172|NCT01299025|3790441|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3968173|NCT01299025|3790439|B3|||Age||years|Mean|49.8|49.8|Standard Deviation|11.2|11.2|||
3968174|NCT01299025|3790440|B2|||Age||years|Mean|50.0|50.0|Standard Deviation|11.5|11.5|||
3968175|NCT01299025|3790441|B1|||Age||years|Mean|49.4|49.4|Standard Deviation|11.1|11.1|||
3968176|NCT01298778|3790454|B3|||ASA class|American Society Anesthesiology classification of 1 (healthy), 2, 3, or 4 (most severely ill)|units on a scale|Median|2|2.0|Full Range|||1.0|4.0|
3968177|NCT01298778|3790455|B2|||ASA class|American Society Anesthesiology classification of 1 (healthy), 2, 3, or 4 (most severely ill)|units on a scale|Median|2|2.0|Full Range|||1.0|4.0|
3968178|NCT01298778|3790456|B1|||ASA class|American Society Anesthesiology classification of 1 (healthy), 2, 3, or 4 (most severely ill)|units on a scale|Median|2|2.0|Full Range|||1.0|4.0|
3968179|NCT01298778|3790454|B3|||Previous Cesarean Section|Number of subjects out of the total subjects per group that had experienced a previous CS Delivery|Participants|Count of Participants|51|51.0||||||
3968180|NCT01298778|3790455|B2|||Previous Cesarean Section|Number of subjects out of the total subjects per group that had experienced a previous CS Delivery|Participants|Count of Participants|24|24.0||||||
3968181|NCT01298778|3790456|B1|||Previous Cesarean Section|Number of subjects out of the total subjects per group that had experienced a previous CS Delivery|Participants|Count of Participants|27|27.0||||||
3968182|NCT01298778|3790454|B3|||Parity||number previous deliveries|Mean|1|1.0|Full Range|||1.0|2.0|
3968183|NCT01298778|3790455|B2|||Parity||number previous deliveries|Mean|1|1.0|Full Range|||1.0|2.0|
3968184|NCT01298778|3790456|B1|||Parity||number previous deliveries|Mean|1|1.0|Full Range|||1.0|2.0|
3968185|NCT01298778|3790454|B3|||Gestational Age-weeks||weeks gestation|Mean|39|39.0|Standard Deviation|0.5|0.5|||
3968186|NCT01298778|3790455|B2|||Gestational Age-weeks||weeks gestation|Mean|39|39.0|Standard Deviation|0.7|0.7|||
3968187|NCT01298778|3790456|B1|||Gestational Age-weeks||weeks gestation|Mean|39|39.0|Standard Deviation|0.3|0.3|||
3968188|NCT01298778|3790454|B3|||Weight-kg||kg|Mean|89.7|89.7|Standard Deviation|17.7|17.7|||
3968189|NCT01298778|3790455|B2|||Weight-kg||kg|Mean|92|92.0|Standard Deviation|19|19.0|||
3968190|NCT01298778|3790456|B1|||Weight-kg||kg|Mean|88|88.0|Standard Deviation|17|17.0|||
3968191|NCT01298778|3790454|B3|||Height-cm||cm|Mean|163.3|163.3|Standard Deviation|6|6.0|||
3968192|NCT01298778|3790455|B2|||Height-cm||cm|Mean|164|164.0|Standard Deviation|6|6.0|||
3968193|NCT01298778|3790456|B1|||Height-cm||cm|Mean|163|163.0|Standard Deviation|6|6.0|||
3968194|NCT01298778|3790454|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
3968195|NCT01298778|3790455|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3968196|NCT01298778|3790456|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3968197|NCT01298778|3790454|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3968198|NCT01298778|3790455|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3968199|NCT01298778|3790456|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3968200|NCT01298778|3790454|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3968201|NCT01298778|3790455|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3968202|NCT01298778|3790456|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3968203|NCT01298778|3790454|B3||>=65 years|Age|years of age at time of consent|Participants|Count of Participants|0|0.0||||||
3968204|NCT01298778|3790455|B2||>=65 years|Age|years of age at time of consent|Participants|Count of Participants|0|0.0||||||
3968205|NCT01298778|3790456|B1||>=65 years|Age|years of age at time of consent|Participants|Count of Participants|0|0.0||||||
3968206|NCT01298778|3790454|B3||Between 18 and 65 years|Age|years of age at time of consent|Participants|Count of Participants|60|60.0||||||
3968207|NCT01298778|3790455|B2||Between 18 and 65 years|Age|years of age at time of consent|Participants|Count of Participants|30|30.0||||||
3968208|NCT01298778|3790456|B1||Between 18 and 65 years|Age|years of age at time of consent|Participants|Count of Participants|30|30.0||||||
3968209|NCT01298778|3790454|B3||<=18 years|Age|years of age at time of consent|Participants|Count of Participants|0|0.0||||||
3968210|NCT01298778|3790455|B2||<=18 years|Age|years of age at time of consent|Participants|Count of Participants|0|0.0||||||
3968211|NCT01298778|3790456|B1||<=18 years|Age|years of age at time of consent|Participants|Count of Participants|0|0.0||||||
3968212|NCT01298765|3790477|B1|||NRS Pain Score|Measure Description: The NRS Pain intensity score is a segmented version of a visual analog scale used to measure pain. The scale is from 0 (no pain) to 10. Scores between greater than 0 and 3 are considered mild pain, scores from greater than 3 to 6 are moderate and greater than 6 to 10 are severe. The daily average is calculated and used as baseline.|units on a scale|Mean|3.3|3.3|Standard Deviation|1.94|1.94|||
3968213|NCT01298765|3790477|B1|||BMI (kg/m^2)||kg/m^2|Mean|32.226|32.226|Standard Deviation|6.8542|6.8542|||
3968214|NCT01298765|3790477|B1|||Height (cm)||centimeters|Mean|169.14|169.14|Standard Deviation|10.540|10.54|||
3968215|NCT01298765|3790477|B1|||Weight (kg)||kilograms|Mean|92.86|92.86|Standard Deviation|22.250|22.25|||
3968216|NCT01298765|3790477|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3968217|NCT01298765|3790477|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968218|NCT01298765|3790477|B1||White|Race (NIH/OMB)||Participants|Count of Participants|237|237.0||||||
3968219|NCT01298765|3790477|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3968220|NCT01298765|3790477|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968221|NCT01298765|3790477|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3968222|NCT01298765|3790477|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3968223|NCT01298765|3790477|B1||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3968224|NCT01298765|3790477|B1||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3968225|NCT01298765|3790477|B1|||Age||Years|Mean|55.5|55.5|Standard Deviation|12.45|12.45|||
3968226|NCT01298765|3790477|B1||>=65 years|Age||Participants|Count of Participants|67|67.0||||||
3968227|NCT01298765|3790477|B1||Between 18 and 65 years|Age||Participants|Count of Participants|235|235.0||||||
3968228|NCT01298765|3790477|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3968229|NCT01298700|3790485|B3||Male|Sex: Female, Male||Participants|Count of Participants|414|414.0||||||
3968230|NCT01298700|3790486|B2||Male|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
3968231|NCT01298700|3790487|B1||Male|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
3968232|NCT01298700|3790485|B3||Female|Sex: Female, Male||Participants|Count of Participants|384|384.0||||||
3968233|NCT01298700|3790486|B2||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
3968234|NCT01298700|3790487|B1||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
3968235|NCT01298700|3790485|B3|> 65 years||Age, Customized||participants|Number|323|323.0||||||
3968236|NCT01298700|3790486|B2|> 65 years||Age, Customized||participants|Number|161|161.0||||||
3968237|NCT01298700|3790487|B1|> 65 years||Age, Customized||participants|Number|162|162.0||||||
3968238|NCT01298700|3790485|B3|≥ 45 years to ≤ 65 years||Age, Customized||participants|Number|427|427.0||||||
3968239|NCT01298700|3790486|B2|≥ 45 years to ≤ 65 years||Age, Customized||participants|Number|211|211.0||||||
3968240|NCT01298700|3790487|B1|≥ 45 years to ≤ 65 years||Age, Customized||participants|Number|216|216.0||||||
3968241|NCT01298700|3790485|B3|< 45 years||Age, Customized||participants|Number|48|48.0||||||
3968242|NCT01298700|3790486|B2|< 45 years||Age, Customized||participants|Number|26|26.0||||||
3968243|NCT01298700|3790487|B1|< 45 years||Age, Customized||participants|Number|22|22.0||||||
3968244|NCT01298700|3790485|B3|||Age||years|Mean|62.4|62.4|Standard Deviation|11.3|11.3|||
3968245|NCT01298700|3790486|B2|||Age||years|Mean|62.2|62.2|Standard Deviation|11.5|11.5|||
3968246|NCT01298700|3790487|B1|||Age||years|Mean|62.7|62.7|Standard Deviation|11.0|11.0|||
3968247|NCT01298661|3790496|B4|Brazil||Region of Enrollment||participants|Number|87|87.0||||||
3968248|NCT01298661|3790497|B3|Brazil||Region of Enrollment||participants|Number|32|32.0||||||
3968249|NCT01298661|3790498|B2|Brazil||Region of Enrollment||participants|Number|24|24.0||||||
3968250|NCT01298661|3790499|B1|Brazil||Region of Enrollment||participants|Number|31|31.0||||||
3968251|NCT01298661|3790496|B4||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3968252|NCT01298661|3790497|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3968253|NCT01298661|3790498|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3968254|NCT01298661|3790499|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3968255|NCT01298661|3790496|B4||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3968256|NCT01298661|3790497|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3968257|NCT01298661|3790498|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3968258|NCT01298661|3790499|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3968259|NCT01298661|3790496|B4|||Age||years|Mean|52.3|52.3|Standard Deviation|23.3|23.3|||
3968260|NCT01298661|3790497|B3|||Age||years|Mean|68.6|68.6|Standard Deviation|10.3|10.3|||
3968261|NCT01298661|3790498|B2|||Age||years|Mean|68.9|68.9|Standard Deviation|6.75|6.75|||
3968262|NCT01298661|3790499|B1|||Age||years|Mean|22.7|22.7|Standard Deviation|2.52|2.52|||
3968263|NCT01298661|3790496|B4||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
3968264|NCT01298661|3790497|B3||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3968265|NCT01298661|3790498|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3968266|NCT01298661|3790499|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3968267|NCT01298661|3790496|B4||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
3968268|NCT01298661|3790497|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3968269|NCT01298661|3790498|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3968270|NCT01298661|3790499|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3968271|NCT01298661|3790496|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3968272|NCT01298661|3790497|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3968273|NCT01298661|3790498|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3968274|NCT01298661|3790499|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3968275|NCT01298648|3790579|B1||Male|Sex: Female, Male||Participants|Count of Participants|1109|1109.0||||||
3968276|NCT01298648|3790579|B1||Female|Sex: Female, Male||Participants|Count of Participants|584|584.0||||||
3968277|NCT01298648|3790579|B1|||Age||years|Mean|35.5|35.5|Standard Deviation|11.7|11.7|||
3968278|NCT01298570|3790588|B3||Unknown|Locally Reported BRAF|Many mutations of the BRAF gene are associated with cancer. Some drugs are designed to work with mutated forms of the gene.|Participants|Count of Participants|135|135.0||||||
3968279|NCT01298570|3790589|B2||Unknown|Locally Reported BRAF|Many mutations of the BRAF gene are associated with cancer. Some drugs are designed to work with mutated forms of the gene.|Participants|Count of Participants|47|47.0||||||
3968280|NCT01298570|3790590|B1||Unknown|Locally Reported BRAF|Many mutations of the BRAF gene are associated with cancer. Some drugs are designed to work with mutated forms of the gene.|Participants|Count of Participants|88|88.0||||||
3968281|NCT01298570|3790588|B3||Mutated|Locally Reported BRAF|Many mutations of the BRAF gene are associated with cancer. Some drugs are designed to work with mutated forms of the gene.|Participants|Count of Participants|12|12.0||||||
3968282|NCT01298570|3790589|B2||Mutated|Locally Reported BRAF|Many mutations of the BRAF gene are associated with cancer. Some drugs are designed to work with mutated forms of the gene.|Participants|Count of Participants|2|2.0||||||
3968283|NCT01298570|3790590|B1||Mutated|Locally Reported BRAF|Many mutations of the BRAF gene are associated with cancer. Some drugs are designed to work with mutated forms of the gene.|Participants|Count of Participants|10|10.0||||||
3968284|NCT01298570|3790588|B3||Wildtype|Locally Reported BRAF|Many mutations of the BRAF gene are associated with cancer. Some drugs are designed to work with mutated forms of the gene.|Participants|Count of Participants|34|34.0||||||
3968285|NCT01298570|3790589|B2||Wildtype|Locally Reported BRAF|Many mutations of the BRAF gene are associated with cancer. Some drugs are designed to work with mutated forms of the gene.|Participants|Count of Participants|12|12.0||||||
3968286|NCT01298570|3790590|B1||Wildtype|Locally Reported BRAF|Many mutations of the BRAF gene are associated with cancer. Some drugs are designed to work with mutated forms of the gene.|Participants|Count of Participants|22|22.0||||||
3968287|NCT01298570|3790588|B3||Unknown|Locally Reported RAS|The 3 Ras genes in humans (HRas, KRas, and NRas) are the most common oncogenes in human cancer; some therapies are more effective with nonmutated wildtype genes.|Participants|Count of Participants|23|23.0||||||
3968288|NCT01298570|3790589|B2||Unknown|Locally Reported RAS|The 3 Ras genes in humans (HRas, KRas, and NRas) are the most common oncogenes in human cancer; some therapies are more effective with nonmutated wildtype genes.|Participants|Count of Participants|6|6.0||||||
3968289|NCT01298570|3790590|B1||Unknown|Locally Reported RAS|The 3 Ras genes in humans (HRas, KRas, and NRas) are the most common oncogenes in human cancer; some therapies are more effective with nonmutated wildtype genes.|Participants|Count of Participants|17|17.0||||||
3968290|NCT01298570|3790588|B3||Mutated|Locally Reported RAS|The 3 Ras genes in humans (HRas, KRas, and NRas) are the most common oncogenes in human cancer; some therapies are more effective with nonmutated wildtype genes.|Participants|Count of Participants|91|91.0||||||
3968291|NCT01298570|3790589|B2||Mutated|Locally Reported RAS|The 3 Ras genes in humans (HRas, KRas, and NRas) are the most common oncogenes in human cancer; some therapies are more effective with nonmutated wildtype genes.|Participants|Count of Participants|37|37.0||||||
3968292|NCT01298570|3790590|B1||Mutated|Locally Reported RAS|The 3 Ras genes in humans (HRas, KRas, and NRas) are the most common oncogenes in human cancer; some therapies are more effective with nonmutated wildtype genes.|Participants|Count of Participants|54|54.0||||||
3968293|NCT01298570|3790588|B3||Wildtype|Locally Reported RAS|The 3 Ras genes in humans (HRas, KRas, and NRas) are the most common oncogenes in human cancer; some therapies are more effective with nonmutated wildtype genes.|Participants|Count of Participants|67|67.0||||||
3968294|NCT01298570|3790589|B2||Wildtype|Locally Reported RAS|The 3 Ras genes in humans (HRas, KRas, and NRas) are the most common oncogenes in human cancer; some therapies are more effective with nonmutated wildtype genes.|Participants|Count of Participants|18|18.0||||||
3968295|NCT01298570|3790590|B1||Wildtype|Locally Reported RAS|The 3 Ras genes in humans (HRas, KRas, and NRas) are the most common oncogenes in human cancer; some therapies are more effective with nonmutated wildtype genes.|Participants|Count of Participants|49|49.0||||||
3968296|NCT01298570|3790588|B3||EGFR inhibitor|Prior Biologic Agent||Participants|Count of Participants|15|15.0||||||
3968297|NCT01298570|3790589|B2||EGFR inhibitor|Prior Biologic Agent||Participants|Count of Participants|4|4.0||||||
3968298|NCT01298570|3790590|B1||EGFR inhibitor|Prior Biologic Agent||Participants|Count of Participants|11|11.0||||||
3968299|NCT01298570|3790588|B3||Bevacizumab|Prior Biologic Agent||Participants|Count of Participants|117|117.0||||||
3968300|NCT01298570|3790589|B2||Bevacizumab|Prior Biologic Agent||Participants|Count of Participants|41|41.0||||||
3968301|NCT01298570|3790590|B1||Bevacizumab|Prior Biologic Agent||Participants|Count of Participants|76|76.0||||||
3968302|NCT01298570|3790588|B3||None|Prior Biologic Agent||Participants|Count of Participants|49|49.0||||||
3968303|NCT01298570|3790589|B2||None|Prior Biologic Agent||Participants|Count of Participants|16|16.0||||||
3968304|NCT01298570|3790590|B1||None|Prior Biologic Agent||Participants|Count of Participants|33|33.0||||||
3968305|NCT01298570|3790588|B3||Unknown|Stage at diagnosis|Stages I, II, III indicate that cancer is present, and the higher the number the larger the cancer tumor and the more it has spread into nearby tissues. Stage IV indicates that cancer has spread to distant parts of the body.|Participants|Count of Participants|3|3.0||||||
3968306|NCT01298570|3790589|B2||Unknown|Stage at diagnosis|Stages I, II, III indicate that cancer is present, and the higher the number the larger the cancer tumor and the more it has spread into nearby tissues. Stage IV indicates that cancer has spread to distant parts of the body.|Participants|Count of Participants|0|0.0||||||
3968307|NCT01298570|3790590|B1||Unknown|Stage at diagnosis|Stages I, II, III indicate that cancer is present, and the higher the number the larger the cancer tumor and the more it has spread into nearby tissues. Stage IV indicates that cancer has spread to distant parts of the body.|Participants|Count of Participants|3|3.0||||||
3968308|NCT01298570|3790588|B3||IV|Stage at diagnosis|Stages I, II, III indicate that cancer is present, and the higher the number the larger the cancer tumor and the more it has spread into nearby tissues. Stage IV indicates that cancer has spread to distant parts of the body.|Participants|Count of Participants|132|132.0||||||
3968309|NCT01298570|3790589|B2||IV|Stage at diagnosis|Stages I, II, III indicate that cancer is present, and the higher the number the larger the cancer tumor and the more it has spread into nearby tissues. Stage IV indicates that cancer has spread to distant parts of the body.|Participants|Count of Participants|46|46.0||||||
3968310|NCT01298570|3790590|B1||IV|Stage at diagnosis|Stages I, II, III indicate that cancer is present, and the higher the number the larger the cancer tumor and the more it has spread into nearby tissues. Stage IV indicates that cancer has spread to distant parts of the body.|Participants|Count of Participants|86|86.0||||||
3968311|NCT01298570|3790588|B3||III|Stage at diagnosis|Stages I, II, III indicate that cancer is present, and the higher the number the larger the cancer tumor and the more it has spread into nearby tissues. Stage IV indicates that cancer has spread to distant parts of the body.|Participants|Count of Participants|35|35.0||||||
3968312|NCT01298570|3790589|B2||III|Stage at diagnosis|Stages I, II, III indicate that cancer is present, and the higher the number the larger the cancer tumor and the more it has spread into nearby tissues. Stage IV indicates that cancer has spread to distant parts of the body.|Participants|Count of Participants|11|11.0||||||
3968336|NCT01298570|3790589|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968313|NCT01298570|3790590|B1||III|Stage at diagnosis|Stages I, II, III indicate that cancer is present, and the higher the number the larger the cancer tumor and the more it has spread into nearby tissues. Stage IV indicates that cancer has spread to distant parts of the body.|Participants|Count of Participants|24|24.0||||||
3968314|NCT01298570|3790588|B3||II|Stage at diagnosis|Stages I, II, III indicate that cancer is present, and the higher the number the larger the cancer tumor and the more it has spread into nearby tissues. Stage IV indicates that cancer has spread to distant parts of the body.|Participants|Count of Participants|8|8.0||||||
3968315|NCT01298570|3790589|B2||II|Stage at diagnosis|Stages I, II, III indicate that cancer is present, and the higher the number the larger the cancer tumor and the more it has spread into nearby tissues. Stage IV indicates that cancer has spread to distant parts of the body.|Participants|Count of Participants|4|4.0||||||
3968316|NCT01298570|3790590|B1||II|Stage at diagnosis|Stages I, II, III indicate that cancer is present, and the higher the number the larger the cancer tumor and the more it has spread into nearby tissues. Stage IV indicates that cancer has spread to distant parts of the body.|Participants|Count of Participants|4|4.0||||||
3968317|NCT01298570|3790588|B3||I|Stage at diagnosis|Stages I, II, III indicate that cancer is present, and the higher the number the larger the cancer tumor and the more it has spread into nearby tissues. Stage IV indicates that cancer has spread to distant parts of the body.|Participants|Count of Participants|3|3.0||||||
3968318|NCT01298570|3790589|B2||I|Stage at diagnosis|Stages I, II, III indicate that cancer is present, and the higher the number the larger the cancer tumor and the more it has spread into nearby tissues. Stage IV indicates that cancer has spread to distant parts of the body.|Participants|Count of Participants|0|0.0||||||
3968319|NCT01298570|3790590|B1||I|Stage at diagnosis|Stages I, II, III indicate that cancer is present, and the higher the number the larger the cancer tumor and the more it has spread into nearby tissues. Stage IV indicates that cancer has spread to distant parts of the body.|Participants|Count of Participants|3|3.0||||||
3968320|NCT01298570|3790588|B3||1|ECOG Performance Status|"A scale by the Eastern Cooperative Oncology Group (ECOG) from 0-5 to describe patient's selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|Participants|Count of Participants|106|106.0||||||
3968321|NCT01298570|3790589|B2||1|ECOG Performance Status|"A scale by the Eastern Cooperative Oncology Group (ECOG) from 0-5 to describe patient's selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|Participants|Count of Participants|38|38.0||||||
3968322|NCT01298570|3790590|B1||1|ECOG Performance Status|"A scale by the Eastern Cooperative Oncology Group (ECOG) from 0-5 to describe patient's selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|Participants|Count of Participants|68|68.0||||||
3968323|NCT01298570|3790588|B3||0|ECOG Performance Status|"A scale by the Eastern Cooperative Oncology Group (ECOG) from 0-5 to describe patient's selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|Participants|Count of Participants|75|75.0||||||
3968324|NCT01298570|3790589|B2||0|ECOG Performance Status|"A scale by the Eastern Cooperative Oncology Group (ECOG) from 0-5 to describe patient's selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|Participants|Count of Participants|23|23.0||||||
3968325|NCT01298570|3790590|B1||0|ECOG Performance Status|"A scale by the Eastern Cooperative Oncology Group (ECOG) from 0-5 to describe patient's selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|Participants|Count of Participants|52|52.0||||||
3968326|NCT01298570|3790588|B3|Ireland||Region of Enrollment||count of participants|Number|54|54.0||||||
3968327|NCT01298570|3790589|B2|Ireland||Region of Enrollment||count of participants|Number|18|18.0||||||
3968328|NCT01298570|3790590|B1|Ireland||Region of Enrollment||count of participants|Number|36|36.0||||||
3968329|NCT01298570|3790588|B3|United States||Region of Enrollment||count of participants|Number|127|127.0||||||
3968330|NCT01298570|3790589|B2|United States||Region of Enrollment||count of participants|Number|43|43.0||||||
3968331|NCT01298570|3790590|B1|United States||Region of Enrollment||count of participants|Number|84|84.0||||||
3968332|NCT01298570|3790588|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3968333|NCT01298570|3790589|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3968334|NCT01298570|3790590|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3968335|NCT01298570|3790588|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968337|NCT01298570|3790590|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968338|NCT01298570|3790588|B3||White|Race (NIH/OMB)||Participants|Count of Participants|147|147.0||||||
3968339|NCT01298570|3790589|B2||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3968340|NCT01298570|3790590|B1||White|Race (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3968341|NCT01298570|3790588|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3968342|NCT01298570|3790589|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3968343|NCT01298570|3790590|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3968344|NCT01298570|3790588|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968345|NCT01298570|3790589|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968346|NCT01298570|3790590|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968347|NCT01298570|3790588|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968348|NCT01298570|3790589|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968349|NCT01298570|3790590|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968350|NCT01298570|3790588|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968351|NCT01298570|3790589|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968352|NCT01298570|3790590|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968353|NCT01298570|3790588|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3968354|NCT01298570|3790589|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3968355|NCT01298570|3790590|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3968356|NCT01298570|3790588|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3968357|NCT01298570|3790589|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3968358|NCT01298570|3790590|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3968359|NCT01298570|3790588|B3|||Age||years|Median|62|62.0|Full Range|||30.0|94.0|
3968360|NCT01298570|3790589|B2|||Age||years|Median|62|62.0|Full Range|||30.0|82.0|
3968361|NCT01298570|3790590|B1|||Age||years|Median|62|62.0|Full Range|||30.0|94.0|
3968362|NCT01298544|3790607|B1||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
3968363|NCT01298544|3790607|B1||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3968364|NCT01298544|3790607|B1|||Age||years|Mean|5.04|5.04|Standard Deviation|0.150|0.15|||
3968365|NCT01298531|3790616|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3968366|NCT01298531|3790617|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3968367|NCT01298531|3790618|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3968368|NCT01298531|3790616|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3968369|NCT01298531|3790617|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3968370|NCT01298531|3790618|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3968371|NCT01298531|3790616|B3|≥ 65 Years||Age, Customized||Participants|Number|3|3.0||||||
3968372|NCT01298531|3790617|B2|≥ 65 Years||Age, Customized||Participants|Number|1|1.0||||||
3968373|NCT01298531|3790618|B1|≥ 65 Years||Age, Customized||Participants|Number|2|2.0||||||
3968374|NCT01298531|3790616|B3|45 - 64 Years||Age, Customized||Participants|Number|24|24.0||||||
3968375|NCT01298531|3790617|B2|45 - 64 Years||Age, Customized||Participants|Number|15|15.0||||||
3968376|NCT01298531|3790618|B1|45 - 64 Years||Age, Customized||Participants|Number|9|9.0||||||
3968377|NCT01298531|3790616|B3|18 - 44 Years||Age, Customized||Participants|Number|63|63.0||||||
3968378|NCT01298531|3790617|B2|18 - 44 Years||Age, Customized||Participants|Number|32|32.0||||||
3968379|NCT01298531|3790618|B1|18 - 44 Years||Age, Customized||Participants|Number|31|31.0||||||
3968380|NCT01298518|3790745|B4|||Body Mass Index||kg/m^2|Mean|31.6|31.6|Standard Deviation|3.7|3.7|||
3968381|NCT01298518|3790746|B3|||Body Mass Index||kg/m^2|Mean|32.6|32.6|Standard Deviation|3.7|3.7|||
3968382|NCT01298518|3790747|B2|||Body Mass Index||kg/m^2|Mean|30.3|30.3|Standard Deviation|3.3|3.3|||
3968383|NCT01298518|3790748|B1|||Body Mass Index||kg/m^2|Mean|31.9|31.9|Standard Deviation|3.8|3.8|||
3968384|NCT01298518|3790745|B4||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3968385|NCT01298518|3790746|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3968386|NCT01298518|3790747|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3968387|NCT01298518|3790748|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3968388|NCT01298518|3790745|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3968389|NCT01298518|3790746|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3968390|NCT01298518|3790747|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3968391|NCT01298518|3790748|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3968392|NCT01298518|3790745|B4|||Age||years|Mean|52.4|52.4|Standard Deviation|5.5|5.5|||
3968393|NCT01298518|3790746|B3|||Age||years|Mean|52.6|52.6|Standard Deviation|6.3|6.3|||
3968394|NCT01298518|3790747|B2|||Age||years|Mean|53.4|53.4|Standard Deviation|4.2|4.2|||
3968395|NCT01298518|3790748|B1|||Age||years|Mean|51.1|51.1|Standard Deviation|5.8|5.8|||
3968396|NCT01298492|3790802|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3968397|NCT01298492|3790802|B1||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3968398|NCT01298492|3790802|B1|||Age||year|Mean|36.5|36.5|Standard Deviation|11.7|11.7|||
3968399|NCT01298362|3790808|B3|No||Orthopedic Surgery||participants|Number|195|195.0||||||
3968400|NCT01298362|3790809|B2|No||Orthopedic Surgery||participants|Number|114|114.0||||||
3968401|NCT01298362|3790810|B1|No||Orthopedic Surgery||participants|Number|81|81.0||||||
3968402|NCT01298362|3790808|B3|Yes||Orthopedic Surgery||participants|Number|14|14.0||||||
3968403|NCT01298362|3790809|B2|Yes||Orthopedic Surgery||participants|Number|9|9.0||||||
3968404|NCT01298362|3790810|B1|Yes||Orthopedic Surgery||participants|Number|5|5.0||||||
3968405|NCT01298362|3790808|B3|No||Fracture History||participants|Number|186|186.0||||||
3968406|NCT01298362|3790809|B2|No||Fracture History||participants|Number|110|110.0||||||
3968407|NCT01298362|3790810|B1|No||Fracture History||participants|Number|76|76.0||||||
3968408|NCT01298362|3790808|B3|Yes||Fracture History||participants|Number|23|23.0||||||
3968409|NCT01298362|3790809|B2|Yes||Fracture History||participants|Number|13|13.0||||||
3968410|NCT01298362|3790810|B1|Yes||Fracture History||participants|Number|10|10.0||||||
3968411|NCT01298362|3790808|B3|||Number of fractures in the past||fractures|Mean|1.2|1.2|Standard Deviation|0.4|0.4|||
3968412|NCT01298362|3790809|B2|||Number of fractures in the past||fractures|Mean|1.2|1.2|Standard Deviation|0.4|0.4|||
3968413|NCT01298362|3790810|B1|||Number of fractures in the past||fractures|Mean|1.2|1.2|Standard Deviation|0.4|0.4|||
3968414|NCT01298362|3790808|B3|No||1st degree relative with osteoporosis||participants|Number|187|187.0||||||
3968415|NCT01298362|3790809|B2|No||1st degree relative with osteoporosis||participants|Number|108|108.0||||||
3968416|NCT01298362|3790810|B1|No||1st degree relative with osteoporosis||participants|Number|79|79.0||||||
3968417|NCT01298362|3790808|B3|Yes||1st degree relative with osteoporosis||participants|Number|22|22.0||||||
3968418|NCT01298362|3790809|B2|Yes||1st degree relative with osteoporosis||participants|Number|15|15.0||||||
3968419|NCT01298362|3790810|B1|Yes||1st degree relative with osteoporosis||participants|Number|7|7.0||||||
3968420|NCT01298362|3790808|B3|Absent||Osteopenia/osteoporosis before AI start||participants|Number|159|159.0||||||
3968421|NCT01298362|3790809|B2|Absent||Osteopenia/osteoporosis before AI start||participants|Number|89|89.0||||||
3968422|NCT01298362|3790810|B1|Absent||Osteopenia/osteoporosis before AI start||participants|Number|70|70.0||||||
3968423|NCT01298362|3790808|B3|Present||Osteopenia/osteoporosis before AI start||participants|Number|50|50.0||||||
3968424|NCT01298362|3790809|B2|Present||Osteopenia/osteoporosis before AI start||participants|Number|34|34.0||||||
3968425|NCT01298362|3790810|B1|Present||Osteopenia/osteoporosis before AI start||participants|Number|16|16.0||||||
3968426|NCT01298362|3790808|B3|No||Physical Exercise||participants|Number|175|175.0||||||
3968427|NCT01298362|3790809|B2|No||Physical Exercise||participants|Number|101|101.0||||||
3968428|NCT01298362|3790810|B1|No||Physical Exercise||participants|Number|74|74.0||||||
3968429|NCT01298362|3790808|B3|Yes||Physical Exercise||participants|Number|34|34.0||||||
3968430|NCT01298362|3790809|B2|Yes||Physical Exercise||participants|Number|22|22.0||||||
3968431|NCT01298362|3790810|B1|Yes||Physical Exercise||participants|Number|12|12.0||||||
3968432|NCT01298362|3790808|B3|Non smoker||Smoker||participants|Number|145|145.0||||||
3968433|NCT01298362|3790809|B2|Non smoker||Smoker||participants|Number|93|93.0||||||
3968434|NCT01298362|3790810|B1|Non smoker||Smoker||participants|Number|52|52.0||||||
3968435|NCT01298362|3790808|B3|Ex smoker||Smoker||participants|Number|23|23.0||||||
3968436|NCT01298362|3790809|B2|Ex smoker||Smoker||participants|Number|9|9.0||||||
3968437|NCT01298362|3790810|B1|Ex smoker||Smoker||participants|Number|14|14.0||||||
3968438|NCT01298362|3790808|B3|Current smoker||Smoker||participants|Number|41|41.0||||||
3968439|NCT01298362|3790809|B2|Current smoker||Smoker||participants|Number|21|21.0||||||
3968440|NCT01298362|3790810|B1|Current smoker||Smoker||participants|Number|20|20.0||||||
3968441|NCT01298362|3790808|B3|||BMI||kg/m^2|Mean|29.4|29.4|Standard Deviation|5.3|5.3|||
3968442|NCT01298362|3790809|B2|||BMI||kg/m^2|Mean|29.3|29.3|Standard Deviation|5.3|5.3|||
3968443|NCT01298362|3790810|B1|||BMI||kg/m^2|Mean|29.6|29.6|Standard Deviation|5.4|5.4|||
3968444|NCT01298362|3790808|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3968445|NCT01298362|3790809|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3968446|NCT01298362|3790810|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3968447|NCT01298362|3790808|B3||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
3968448|NCT01298362|3790809|B2||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3968449|NCT01298362|3790810|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3968450|NCT01298362|3790808|B3|||Age||years|Mean|63.9|63.9|Standard Deviation|9.1|9.1|||
3968451|NCT01298362|3790809|B2|||Age||years|Mean|65.8|65.8|Standard Deviation|9.2|9.2|||
3968452|NCT01298362|3790810|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|8.9|8.9|||
3968453|NCT01298362|3790808|B3||>=65 years|Age||Participants|Count of Participants|85|85.0||||||
3968454|NCT01298362|3790809|B2||>=65 years|Age||Participants|Count of Participants|60|60.0||||||
3968455|NCT01298362|3790810|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3968456|NCT01298362|3790808|B3||Between 18 and 65 years|Age||Participants|Count of Participants|124|124.0||||||
3968457|NCT01298362|3790809|B2||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
3968458|NCT01298362|3790810|B1||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
3968459|NCT01298362|3790808|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3968460|NCT01298362|3790809|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3968461|NCT01298362|3790810|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3968462|NCT01298323|3790829|B3|White||Race/Ethnicity, Customized||Participants|Number|171|171.0||||||
3968463|NCT01298323|3790830|B2|White||Race/Ethnicity, Customized||Participants|Number|84|84.0||||||
3968464|NCT01298323|3790831|B1|White||Race/Ethnicity, Customized||Participants|Number|87|87.0||||||
3968465|NCT01298323|3790829|B3|Asian||Race/Ethnicity, Customized||Participants|Number|34|34.0||||||
3968466|NCT01298323|3790830|B2|Asian||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
3968467|NCT01298323|3790831|B1|Asian||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
3968468|NCT01298323|3790829|B3||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3968469|NCT01298323|3790830|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3968470|NCT01298323|3790831|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3968471|NCT01298323|3790829|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3968472|NCT01298323|3790830|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3968473|NCT01298323|3790831|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3968474|NCT01298323|3790829|B3|>=75 Years||Age, Customized||Participants|Number|7|7.0||||||
3968475|NCT01298323|3790830|B2|>=75 Years||Age, Customized||Participants|Number|6|6.0||||||
3968476|NCT01298323|3790831|B1|>=75 Years||Age, Customized||Participants|Number|1|1.0||||||
3968477|NCT01298323|3790829|B3|>=65 - <75 Years||Age, Customized||Participants|Number|37|37.0||||||
3968478|NCT01298323|3790830|B2|>=65 - <75 Years||Age, Customized||Participants|Number|22|22.0||||||
3968479|NCT01298323|3790831|B1|>=65 - <75 Years||Age, Customized||Participants|Number|15|15.0||||||
3968480|NCT01298323|3790829|B3|>=40 - <65 Years||Age, Customized||Participants|Number|117|117.0||||||
3968481|NCT01298323|3790830|B2|>=40 - <65 Years||Age, Customized||Participants|Number|52|52.0||||||
3968482|NCT01298323|3790831|B1|>=40 - <65 Years||Age, Customized||Participants|Number|65|65.0||||||
3968483|NCT01298323|3790829|B3|>=18 - <40 Years||Age, Customized||Participants|Number|44|44.0||||||
3968484|NCT01298323|3790830|B2|>=18 - <40 Years||Age, Customized||Participants|Number|23|23.0||||||
3968485|NCT01298323|3790831|B1|>=18 - <40 Years||Age, Customized||Participants|Number|21|21.0||||||
3968486|NCT01298323|3790829|B3|||Age||Years|Mean|51.9|51.9|Standard Deviation|13.93|13.93|20.0|77.0|
3968487|NCT01298323|3790830|B2|||Age||Years|Mean|53.0|53.0|Standard Deviation|14.34|14.34|23.0|77.0|
3968488|NCT01298323|3790831|B1|||Age||Years|Mean|50.8|50.8|Standard Deviation|13.47|13.47|20.0|77.0|
3968489|NCT01298167|3790838|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3968490|NCT01298167|3790839|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3968491|NCT01298167|3790840|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3968492|NCT01298167|3790838|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3968493|NCT01298167|3790839|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3968494|NCT01298167|3790840|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3968495|NCT01298167|3790838|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3968496|NCT01298167|3790839|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3968497|NCT01298167|3790840|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3968498|NCT01298167|3790838|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3968499|NCT01298167|3790839|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3968500|NCT01298167|3790840|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3968501|NCT01298167|3790838|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3968502|NCT01298167|3790839|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3968503|NCT01298167|3790840|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3968504|NCT01298128|3790847|B3|Canada||Region of Enrollment||participants|Number|70|70.0||||||
3968505|NCT01298128|3790848|B2|Canada||Region of Enrollment||participants|Number|35|35.0||||||
3968506|NCT01298128|3790849|B1|Canada||Region of Enrollment||participants|Number|35|35.0||||||
3968507|NCT01298128|3790847|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3968508|NCT01298128|3790848|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3968509|NCT01298128|3790849|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3968510|NCT01298128|3790847|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3968511|NCT01298128|3790848|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3968512|NCT01298128|3790849|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3968513|NCT01298128|3790847|B3|||Age||years|Mean|33|33.0|Standard Deviation|2|2.0|||
3968514|NCT01298128|3790848|B2|||Age||years|Mean|32.8|32.8|Standard Deviation|2|2.0|||
3968515|NCT01298128|3790849|B1|||Age||years|Mean|33.6|33.6|Standard Deviation|2|2.0|||
3968516|NCT01298128|3790847|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3968517|NCT01298128|3790848|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3968518|NCT01298128|3790849|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3968519|NCT01298128|3790847|B3||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
3968520|NCT01298128|3790848|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3968521|NCT01298128|3790849|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3968522|NCT01298128|3790847|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3968523|NCT01298128|3790848|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3968524|NCT01298128|3790849|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3968525|NCT01298063|3790856|B6||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3968526|NCT01298063|3790857|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3968527|NCT01298063|3790858|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3968528|NCT01298063|3790859|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3968529|NCT01298063|3790860|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3968530|NCT01298063|3790861|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3968531|NCT01298063|3790856|B6||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3968532|NCT01298063|3790857|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3968533|NCT01298063|3790858|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3968534|NCT01298063|3790859|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3968535|NCT01298063|3790860|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3968536|NCT01298063|3790861|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3968537|NCT01298063|3790856|B6|||Age||years|Mean|55.3|55.3|Standard Deviation|9.5|9.5|||
3968538|NCT01298063|3790857|B5|||Age||years|Mean|53.1|53.1|Standard Deviation|7.9|7.9|||
3968539|NCT01298063|3790858|B4|||Age||years|Mean|55.9|55.9|Standard Deviation|12.6|12.6|||
3968540|NCT01298063|3790859|B3|||Age||years|Mean|54.8|54.8|Standard Deviation|9.0|9.0|||
3968541|NCT01298063|3790860|B2|||Age||years|Mean|64.3|64.3|Standard Deviation|6.1|6.1|||
3968542|NCT01298063|3790861|B1|||Age||years|Mean|53.9|53.9|Standard Deviation|9.0|9.0|||
3968543|NCT01297920|3790892|B4|United States||Region of Enrollment||participants|Number|690|690.0||||||
3968544|NCT01297920|3790893|B3|United States||Region of Enrollment||participants|Number|235|235.0||||||
3968545|NCT01297920|3790894|B2|United States||Region of Enrollment||participants|Number|234|234.0||||||
3968546|NCT01297920|3790895|B1|United States||Region of Enrollment||participants|Number|221|221.0||||||
3968547|NCT01297920|3790892|B4||Male|Sex: Female, Male||Participants|Count of Participants|303|303.0||||||
3968548|NCT01297920|3790893|B3||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3968549|NCT01297920|3790894|B2||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3968550|NCT01297920|3790895|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3968551|NCT01297920|3790892|B4||Female|Sex: Female, Male||Participants|Count of Participants|387|387.0||||||
3968552|NCT01297920|3790893|B3||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3968553|NCT01297920|3790894|B2||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3968554|NCT01297920|3790895|B1||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3968555|NCT01297920|3790892|B4|≥65 years||Age, Customized||participants|Number|363|363.0||||||
3968556|NCT01297920|3790893|B3|≥65 years||Age, Customized||participants|Number|120|120.0||||||
3968557|NCT01297920|3790894|B2|≥65 years||Age, Customized||participants|Number|121|121.0||||||
3968558|NCT01297920|3790895|B1|≥65 years||Age, Customized||participants|Number|122|122.0||||||
3968559|NCT01297920|3790892|B4|18 to 64 years||Age, Customized||participants|Number|327|327.0||||||
3968560|NCT01297920|3790893|B3|18 to 64 years||Age, Customized||participants|Number|115|115.0||||||
3968561|NCT01297920|3790894|B2|18 to 64 years||Age, Customized||participants|Number|113|113.0||||||
3968562|NCT01297920|3790895|B1|18 to 64 years||Age, Customized||participants|Number|99|99.0||||||
3968563|NCT01297595|3790905|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3968564|NCT01297595|3790905|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3968565|NCT01297595|3790905|B1|||Age||years|Mean|38.0|38.0|Standard Deviation|11.9|11.9|||
3968566|NCT01297517|3790938|B4||Male|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
3968567|NCT01297517|3790939|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3968568|NCT01297517|3790940|B2||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3968569|NCT01297517|3790941|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3968570|NCT01297517|3790938|B4||Female|Sex: Female, Male||Participants|Count of Participants|403|403.0||||||
3968571|NCT01297517|3790939|B3||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3968572|NCT01297517|3790940|B2||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3968573|NCT01297517|3790941|B1||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3968574|NCT01297517|3790938|B4|≥65 years||Age, Customized||participants|Number|335|335.0||||||
3968575|NCT01297517|3790939|B3|≥65 years||Age, Customized||participants|Number|103|103.0||||||
3968576|NCT01297517|3790940|B2|≥65 years||Age, Customized||participants|Number|125|125.0||||||
3968577|NCT01297517|3790941|B1|≥65 years||Age, Customized||participants|Number|107|107.0||||||
3968578|NCT01297517|3790938|B4|18 to 64 years||Age, Customized||participants|Number|325|325.0||||||
3968579|NCT01297517|3790939|B3|18 to 64 years||Age, Customized||participants|Number|117|117.0||||||
3968580|NCT01297517|3790940|B2|18 to 64 years||Age, Customized||participants|Number|101|101.0||||||
3968581|NCT01297517|3790941|B1|18 to 64 years||Age, Customized||participants|Number|107|107.0||||||
3968582|NCT01297504|3790951|B1|||Birth Weight||g|Mean|1344.6|1344.6|Standard Deviation|460.5|460.5|||
3968583|NCT01297504|3790951|B1|Colombia||Region of Enrollment||participants|Number|147|147.0||||||
3968584|NCT01297504|3790951|B1|Chile||Region of Enrollment||participants|Number|32|32.0||||||
3968585|NCT01297504|3790951|B1|Peru||Region of Enrollment||participants|Number|13|13.0||||||
3968586|NCT01297504|3790951|B1|Uruguay||Region of Enrollment||participants|Number|10|10.0||||||
3968587|NCT01297504|3790951|B1|Argentina||Region of Enrollment||participants|Number|149|149.0||||||
3968588|NCT01297504|3790951|B1|Ecuador||Region of Enrollment||participants|Number|7|7.0||||||
3968589|NCT01297504|3790951|B1|Mexico||Region of Enrollment||participants|Number|100|100.0||||||
3968590|NCT01297504|3790951|B1||Male|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
3968591|NCT01297504|3790951|B1||Female|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
3968592|NCT01297504|3790951|B1|||Age||days|Median|55|55.0|Inter-Quartile Range|||31.0|99.0|
3968593|NCT01297491|3790963|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3968594|NCT01297491|3790964|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3968595|NCT01297491|3790965|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3968596|NCT01297491|3790963|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3968597|NCT01297491|3790964|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3968598|NCT01297491|3790965|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3968599|NCT01297491|3790963|B3|>= 65 years||Age, Customized||Participants|Number|32|32.0||||||
3968600|NCT01297491|3790964|B2|>= 65 years||Age, Customized||Participants|Number|14|14.0||||||
3968601|NCT01297491|3790965|B1|>= 65 years||Age, Customized||Participants|Number|18|18.0||||||
3968602|NCT01297491|3790963|B3|< 65 years||Age, Customized||Participants|Number|31|31.0||||||
3968603|NCT01297491|3790964|B2|< 65 years||Age, Customized||Participants|Number|19|19.0||||||
3968604|NCT01297491|3790965|B1|< 65 years||Age, Customized||Participants|Number|12|12.0||||||
3968605|NCT01297465|3790982|B3|||Weight||kilogram|Mean|65.33|65.33|Standard Deviation|9.645|9.645|||
3968606|NCT01297465|3790983|B2|||Weight||kilogram|Mean|65.82|65.82|Standard Deviation|8.923|8.923|||
3968607|NCT01297465|3790984|B1|||Weight||kilogram|Mean|64.81|64.81|Standard Deviation|10.364|10.364|||
3968608|NCT01297465|3790982|B3|||Height||centimeter|Mean|166.2|166.2|Standard Deviation|6.46|6.46|||
3968609|NCT01297465|3790983|B2|||Height||centimeter|Mean|166.3|166.3|Standard Deviation|6.47|6.47|||
3968610|NCT01297465|3790984|B1|||Height||centimeter|Mean|166.1|166.1|Standard Deviation|6.49|6.49|||
3968611|NCT01297465|3790982|B3|White||Race||participants|Number|181|181.0||||||
3968612|NCT01297465|3790983|B2|White||Race||participants|Number|92|92.0||||||
3968613|NCT01297465|3790984|B1|White||Race||participants|Number|89|89.0||||||
3968614|NCT01297465|3790982|B3|Other||Race||participants|Number|4|4.0||||||
3968615|NCT01297465|3790983|B2|Other||Race||participants|Number|2|2.0||||||
3968616|NCT01297465|3790984|B1|Other||Race||participants|Number|2|2.0||||||
3968617|NCT01297465|3790982|B3|Asian||Race||participants|Number|10|10.0||||||
3968618|NCT01297465|3790983|B2|Asian||Race||participants|Number|6|6.0||||||
3968619|NCT01297465|3790984|B1|Asian||Race||participants|Number|4|4.0||||||
3968620|NCT01297465|3790982|B3|Black||Race||participants|Number|7|7.0||||||
3968621|NCT01297465|3790983|B2|Black||Race||participants|Number|3|3.0||||||
3968622|NCT01297465|3790984|B1|Black||Race||participants|Number|4|4.0||||||
3968623|NCT01297465|3790982|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3968624|NCT01297465|3790983|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3968625|NCT01297465|3790984|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3968626|NCT01297465|3790982|B3||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3968627|NCT01297465|3790983|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3968628|NCT01297465|3790984|B1||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3968629|NCT01297465|3790982|B3|||Age||years|Mean|37.5|37.5|Standard Deviation|1.15|1.15|||
3968630|NCT01297465|3790983|B2|||Age||years|Mean|37.4|37.4|Standard Deviation|1.14|1.14|||
3968631|NCT01297465|3790984|B1|||Age||years|Mean|37.6|37.6|Standard Deviation|1.16|1.16|||
3968632|NCT01297348|3791017|B3|Greater than or equal to 5 years||Percentage of Participants With Length of Stay in Health Plan|Length of stay in health plan was categorized into: less than 1, 1 to 2, 3 to 4 and greater than or equal to 5 years. Health plan was referred to the managed care plans which included information on paid claims for pharmaceuticals, medical diagnoses, procedures and demographic information on the participants.|percentage of participants|Number|77.2|77.2||||||
3968633|NCT01297348|3791018|B2|Greater than or equal to 5 years||Percentage of Participants With Length of Stay in Health Plan|Length of stay in health plan was categorized into: less than 1, 1 to 2, 3 to 4 and greater than or equal to 5 years. Health plan was referred to the managed care plans which included information on paid claims for pharmaceuticals, medical diagnoses, procedures and demographic information on the participants.|percentage of participants|Number|37.2|37.2||||||
3968634|NCT01297348|3791019|B1|Greater than or equal to 5 years||Percentage of Participants With Length of Stay in Health Plan|Length of stay in health plan was categorized into: less than 1, 1 to 2, 3 to 4 and greater than or equal to 5 years. Health plan was referred to the managed care plans which included information on paid claims for pharmaceuticals, medical diagnoses, procedures and demographic information on the participants.|percentage of participants|Number|40.0|40.0||||||
3968635|NCT01297348|3791017|B3|3 to 4 years||Percentage of Participants With Length of Stay in Health Plan|Length of stay in health plan was categorized into: less than 1, 1 to 2, 3 to 4 and greater than or equal to 5 years. Health plan was referred to the managed care plans which included information on paid claims for pharmaceuticals, medical diagnoses, procedures and demographic information on the participants.|percentage of participants|Number|83.3|83.3||||||
3968636|NCT01297348|3791018|B2|3 to 4 years||Percentage of Participants With Length of Stay in Health Plan|Length of stay in health plan was categorized into: less than 1, 1 to 2, 3 to 4 and greater than or equal to 5 years. Health plan was referred to the managed care plans which included information on paid claims for pharmaceuticals, medical diagnoses, procedures and demographic information on the participants.|percentage of participants|Number|41.6|41.6||||||
3968744|NCT01297322|3791037|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3968637|NCT01297348|3791019|B1|3 to 4 years||Percentage of Participants With Length of Stay in Health Plan|Length of stay in health plan was categorized into: less than 1, 1 to 2, 3 to 4 and greater than or equal to 5 years. Health plan was referred to the managed care plans which included information on paid claims for pharmaceuticals, medical diagnoses, procedures and demographic information on the participants.|percentage of participants|Number|41.8|41.8||||||
3968638|NCT01297348|3791017|B3|1 to 2 years||Percentage of Participants With Length of Stay in Health Plan|Length of stay in health plan was categorized into: less than 1, 1 to 2, 3 to 4 and greater than or equal to 5 years. Health plan was referred to the managed care plans which included information on paid claims for pharmaceuticals, medical diagnoses, procedures and demographic information on the participants.|percentage of participants|Number|31.4|31.4||||||
3968639|NCT01297348|3791018|B2|1 to 2 years||Percentage of Participants With Length of Stay in Health Plan|Length of stay in health plan was categorized into: less than 1, 1 to 2, 3 to 4 and greater than or equal to 5 years. Health plan was referred to the managed care plans which included information on paid claims for pharmaceuticals, medical diagnoses, procedures and demographic information on the participants.|percentage of participants|Number|16.8|16.8||||||
3968640|NCT01297348|3791019|B1|1 to 2 years||Percentage of Participants With Length of Stay in Health Plan|Length of stay in health plan was categorized into: less than 1, 1 to 2, 3 to 4 and greater than or equal to 5 years. Health plan was referred to the managed care plans which included information on paid claims for pharmaceuticals, medical diagnoses, procedures and demographic information on the participants.|percentage of participants|Number|14.6|14.6||||||
3968641|NCT01297348|3791017|B3|Less than 1 year||Percentage of Participants With Length of Stay in Health Plan|Length of stay in health plan was categorized into: less than 1, 1 to 2, 3 to 4 and greater than or equal to 5 years. Health plan was referred to the managed care plans which included information on paid claims for pharmaceuticals, medical diagnoses, procedures and demographic information on the participants.|percentage of participants|Number|8.1|8.1||||||
3968642|NCT01297348|3791018|B2|Less than 1 year||Percentage of Participants With Length of Stay in Health Plan|Length of stay in health plan was categorized into: less than 1, 1 to 2, 3 to 4 and greater than or equal to 5 years. Health plan was referred to the managed care plans which included information on paid claims for pharmaceuticals, medical diagnoses, procedures and demographic information on the participants.|percentage of participants|Number|4.4|4.4||||||
3968643|NCT01297348|3791019|B1|Less than 1 year||Percentage of Participants With Length of Stay in Health Plan|Length of stay in health plan was categorized into: less than 1, 1 to 2, 3 to 4 and greater than or equal to 5 years. Health plan was referred to the managed care plans which included information on paid claims for pharmaceuticals, medical diagnoses, procedures and demographic information on the participants.|percentage of participants|Number|3.7|3.7||||||
3968644|NCT01297348|3791017|B3|||Percentage of Participants With Thyroid Disease||percentage of participants|Number|1.6|1.6||||||
3968645|NCT01297348|3791018|B2|||Percentage of Participants With Thyroid Disease||percentage of participants|Number|0.8|0.8||||||
3968646|NCT01297348|3791019|B1|||Percentage of Participants With Thyroid Disease||percentage of participants|Number|0.8|0.8||||||
3968647|NCT01297348|3791017|B3|||Percentage of Participants With Asthma||percentage of participants|Number|13.7|13.7||||||
3968648|NCT01297348|3791018|B2|||Percentage of Participants With Asthma||percentage of participants|Number|6.8|6.8||||||
3968649|NCT01297348|3791019|B1|||Percentage of Participants With Asthma||percentage of participants|Number|6.9|6.9||||||
3968650|NCT01297348|3791017|B3|||Percentage of Participants With Diabetes||percentage of participants|Number|3.9|3.9||||||
3968651|NCT01297348|3791018|B2|||Percentage of Participants With Diabetes||percentage of participants|Number|1.7|1.7||||||
3968652|NCT01297348|3791019|B1|||Percentage of Participants With Diabetes||percentage of participants|Number|2.2|2.2||||||
3968653|NCT01297348|3791017|B3|||Percentage of Participants With Hyperlipidemia||percentage of participants|Number|14.4|14.4||||||
3968654|NCT01297348|3791018|B2|||Percentage of Participants With Hyperlipidemia||percentage of participants|Number|5.5|5.5||||||
3968655|NCT01297348|3791019|B1|||Percentage of Participants With Hyperlipidemia||percentage of participants|Number|8.9|8.9||||||
3968656|NCT01297348|3791017|B3|||Percentage of Participants With Hypertension||percentage of participants|Number|10.0|10.0||||||
3968657|NCT01297348|3791018|B2|||Percentage of Participants With Hypertension||percentage of participants|Number|3.7|3.7||||||
3968658|NCT01297348|3791019|B1|||Percentage of Participants With Hypertension||percentage of participants|Number|6.3|6.3||||||
3968659|NCT01297348|3791017|B3|||Percentage of Participants With Cardiovascular Disease||percentage of participants|Number|6.1|6.1||||||
3968660|NCT01297348|3791018|B2|||Percentage of Participants With Cardiovascular Disease||percentage of participants|Number|2.8|2.8||||||
3968661|NCT01297348|3791019|B1|||Percentage of Participants With Cardiovascular Disease||percentage of participants|Number|3.3|3.3||||||
3968662|NCT01297348|3791017|B3|||Percentage of Participants With Back Pain||percentage of participants|Number|19.5|19.5||||||
3968663|NCT01297348|3791018|B2|||Percentage of Participants With Back Pain||percentage of participants|Number|8.5|8.5||||||
3968664|NCT01297348|3791019|B1|||Percentage of Participants With Back Pain||percentage of participants|Number|11.0|11.0||||||
3968665|NCT01297348|3791017|B3|Uterine leiomyoma||Percentage of Participants With Gynecological Disorders|Percentage of participants were reported for following gynecological disorders: endometriosis, menstrual disorder and uterine leiomyoma.|percentage of participants|Number|0.1|0.1||||||
3968666|NCT01297348|3791018|B2|Uterine leiomyoma||Percentage of Participants With Gynecological Disorders|Percentage of participants were reported for following gynecological disorders: endometriosis, menstrual disorder and uterine leiomyoma.|percentage of participants|Number|0.0|0.0||||||
3968667|NCT01297348|3791019|B1|Uterine leiomyoma||Percentage of Participants With Gynecological Disorders|Percentage of participants were reported for following gynecological disorders: endometriosis, menstrual disorder and uterine leiomyoma.|percentage of participants|Number|0.1|0.1||||||
3968668|NCT01297348|3791017|B3|Menstrual disorder||Percentage of Participants With Gynecological Disorders|Percentage of participants were reported for following gynecological disorders: endometriosis, menstrual disorder and uterine leiomyoma.|percentage of participants|Number|51.6|51.6||||||
3968669|NCT01297348|3791018|B2|Menstrual disorder||Percentage of Participants With Gynecological Disorders|Percentage of participants were reported for following gynecological disorders: endometriosis, menstrual disorder and uterine leiomyoma.|percentage of participants|Number|24.8|24.8||||||
3968670|NCT01297348|3791019|B1|Menstrual disorder||Percentage of Participants With Gynecological Disorders|Percentage of participants were reported for following gynecological disorders: endometriosis, menstrual disorder and uterine leiomyoma.|percentage of participants|Number|26.8|26.8||||||
3968671|NCT01297348|3791017|B3|Endometriosis||Percentage of Participants With Gynecological Disorders|Percentage of participants were reported for following gynecological disorders: endometriosis, menstrual disorder and uterine leiomyoma.|percentage of participants|Number|7.4|7.4||||||
3968672|NCT01297348|3791018|B2|Endometriosis||Percentage of Participants With Gynecological Disorders|Percentage of participants were reported for following gynecological disorders: endometriosis, menstrual disorder and uterine leiomyoma.|percentage of participants|Number|1.1|1.1||||||
3968673|NCT01297348|3791019|B1|Endometriosis||Percentage of Participants With Gynecological Disorders|Percentage of participants were reported for following gynecological disorders: endometriosis, menstrual disorder and uterine leiomyoma.|percentage of participants|Number|6.3|6.3||||||
3968674|NCT01297348|3791017|B3|||Percentage of Obese Participants||percentage of participants|Number|6.7|6.7||||||
3968675|NCT01297348|3791018|B2|||Percentage of Obese Participants||percentage of participants|Number|3.0|3.0||||||
3968676|NCT01297348|3791019|B1|||Percentage of Obese Participants||percentage of participants|Number|3.7|3.7||||||
3968677|NCT01297348|3791017|B3|More than 60 months||Percentage of Participants With Duration in Health Plan Before First Study OC Prescription|Duration in health plan was categorized into 4 categories: 6 to 12, 12 to 24, 24 to 60 and more than 60 months. Health plan was referred to the managed care plans which included information on paid claims for pharmaceuticals, medical diagnoses, procedures and demographic information on the participants.|percentage of participants|Number|12.9|12.9||||||
3968678|NCT01297348|3791018|B2|More than 60 months||Percentage of Participants With Duration in Health Plan Before First Study OC Prescription|Duration in health plan was categorized into 4 categories: 6 to 12, 12 to 24, 24 to 60 and more than 60 months. Health plan was referred to the managed care plans which included information on paid claims for pharmaceuticals, medical diagnoses, procedures and demographic information on the participants.|percentage of participants|Number|7.1|7.1||||||
3968679|NCT01297348|3791019|B1|More than 60 months||Percentage of Participants With Duration in Health Plan Before First Study OC Prescription|Duration in health plan was categorized into 4 categories: 6 to 12, 12 to 24, 24 to 60 and more than 60 months. Health plan was referred to the managed care plans which included information on paid claims for pharmaceuticals, medical diagnoses, procedures and demographic information on the participants.|percentage of participants|Number|5.8|5.8||||||
3968680|NCT01297348|3791017|B3|24 to 60 months||Percentage of Participants With Duration in Health Plan Before First Study OC Prescription|Duration in health plan was categorized into 4 categories: 6 to 12, 12 to 24, 24 to 60 and more than 60 months. Health plan was referred to the managed care plans which included information on paid claims for pharmaceuticals, medical diagnoses, procedures and demographic information on the participants.|percentage of participants|Number|64.5|64.5||||||
3968681|NCT01297348|3791018|B2|24 to 60 months||Percentage of Participants With Duration in Health Plan Before First Study OC Prescription|Duration in health plan was categorized into 4 categories: 6 to 12, 12 to 24, 24 to 60 and more than 60 months. Health plan was referred to the managed care plans which included information on paid claims for pharmaceuticals, medical diagnoses, procedures and demographic information on the participants.|percentage of participants|Number|37.0|37.0||||||
3968682|NCT01297348|3791019|B1|24 to 60 months||Percentage of Participants With Duration in Health Plan Before First Study OC Prescription|Duration in health plan was categorized into 4 categories: 6 to 12, 12 to 24, 24 to 60 and more than 60 months. Health plan was referred to the managed care plans which included information on paid claims for pharmaceuticals, medical diagnoses, procedures and demographic information on the participants.|percentage of participants|Number|27.5|27.5||||||
3968683|NCT01297348|3791017|B3|12 to 24 months||Percentage of Participants With Duration in Health Plan Before First Study OC Prescription|Duration in health plan was categorized into 4 categories: 6 to 12, 12 to 24, 24 to 60 and more than 60 months. Health plan was referred to the managed care plans which included information on paid claims for pharmaceuticals, medical diagnoses, procedures and demographic information on the participants.|percentage of participants|Number|71.0|71.0||||||
3968684|NCT01297348|3791018|B2|12 to 24 months||Percentage of Participants With Duration in Health Plan Before First Study OC Prescription|Duration in health plan was categorized into 4 categories: 6 to 12, 12 to 24, 24 to 60 and more than 60 months. Health plan was referred to the managed care plans which included information on paid claims for pharmaceuticals, medical diagnoses, procedures and demographic information on the participants.|percentage of participants|Number|31.9|31.9||||||
3968685|NCT01297348|3791019|B1|12 to 24 months||Percentage of Participants With Duration in Health Plan Before First Study OC Prescription|Duration in health plan was categorized into 4 categories: 6 to 12, 12 to 24, 24 to 60 and more than 60 months. Health plan was referred to the managed care plans which included information on paid claims for pharmaceuticals, medical diagnoses, procedures and demographic information on the participants.|percentage of participants|Number|39.1|39.1||||||
3968686|NCT01297348|3791017|B3|6 to 12 months||Percentage of Participants With Duration in Health Plan Before First Study OC Prescription|Duration in health plan was categorized into 4 categories: 6 to 12, 12 to 24, 24 to 60 and more than 60 months. Health plan was referred to the managed care plans which included information on paid claims for pharmaceuticals, medical diagnoses, procedures and demographic information on the participants.|percentage of participants|Number|51.6|51.6||||||
3968687|NCT01297348|3791018|B2|6 to 12 months||Percentage of Participants With Duration in Health Plan Before First Study OC Prescription|Duration in health plan was categorized into 4 categories: 6 to 12, 12 to 24, 24 to 60 and more than 60 months. Health plan was referred to the managed care plans which included information on paid claims for pharmaceuticals, medical diagnoses, procedures and demographic information on the participants.|percentage of participants|Number|24.0|24.0||||||
3968745|NCT01297322|3791038|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968746|NCT01297322|3791036|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3968688|NCT01297348|3791019|B1|6 to 12 months||Percentage of Participants With Duration in Health Plan Before First Study OC Prescription|Duration in health plan was categorized into 4 categories: 6 to 12, 12 to 24, 24 to 60 and more than 60 months. Health plan was referred to the managed care plans which included information on paid claims for pharmaceuticals, medical diagnoses, procedures and demographic information on the participants.|percentage of participants|Number|27.6|27.6||||||
3968689|NCT01297348|3791017|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3968690|NCT01297348|3791018|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3968691|NCT01297348|3791019|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3968692|NCT01297348|3791017|B3||Female|Sex: Female, Male||Participants|Count of Participants|598682|598682.0||||||
3968693|NCT01297348|3791018|B2||Female|Sex: Female, Male||Participants|Count of Participants|586401|586401.0||||||
3968694|NCT01297348|3791019|B1||Female|Sex: Female, Male||Participants|Count of Participants|12281|12281.0||||||
3968695|NCT01297348|3791017|B3|45 to 49 years||Age, Customized||participants|Number|30465|30465.0||||||
3968696|NCT01297348|3791018|B2|45 to 49 years||Age, Customized||participants|Number|29264|29264.0||||||
3968697|NCT01297348|3791019|B1|45 to 49 years||Age, Customized||participants|Number|1201|1201.0||||||
3968698|NCT01297348|3791017|B3|40 to 44 years||Age, Customized||participants|Number|42967|42967.0||||||
3968699|NCT01297348|3791018|B2|40 to 44 years||Age, Customized||participants|Number|41299|41299.0||||||
3968700|NCT01297348|3791019|B1|40 to 44 years||Age, Customized||participants|Number|1668|1668.0||||||
3968701|NCT01297348|3791017|B3|35 to 39 years||Age, Customized||participants|Number|58748|58748.0||||||
3968702|NCT01297348|3791018|B2|35 to 39 years||Age, Customized||participants|Number|56674|56674.0||||||
3968703|NCT01297348|3791019|B1|35 to 39 years||Age, Customized||participants|Number|2074|2074.0||||||
3968704|NCT01297348|3791017|B3|30 to 34 years||Age, Customized||participants|Number|81263|81263.0||||||
3968705|NCT01297348|3791018|B2|30 to 34 years||Age, Customized||participants|Number|79184|79184.0||||||
3968706|NCT01297348|3791019|B1|30 to 34 years||Age, Customized||participants|Number|2079|2079.0||||||
3968707|NCT01297348|3791017|B3|25 to 29 years||Age, Customized||participants|Number|101557|101557.0||||||
3968708|NCT01297348|3791018|B2|25 to 29 years||Age, Customized||participants|Number|99632|99632.0||||||
3968709|NCT01297348|3791019|B1|25 to 29 years||Age, Customized||participants|Number|1925|1925.0||||||
3968710|NCT01297348|3791017|B3|20 to 24 years||Age, Customized||participants|Number|130542|130542.0||||||
3968711|NCT01297348|3791018|B2|20 to 24 years||Age, Customized||participants|Number|128757|128757.0||||||
3968712|NCT01297348|3791019|B1|20 to 24 years||Age, Customized||participants|Number|1785|1785.0||||||
3968713|NCT01297348|3791017|B3|15 to 19 years||Age, Customized||participants|Number|153140|153140.0||||||
3968714|NCT01297348|3791018|B2|15 to 19 years||Age, Customized||participants|Number|151591|151591.0||||||
3968715|NCT01297348|3791019|B1|15 to 19 years||Age, Customized||participants|Number|1549|1549.0||||||
3968716|NCT01297335|3791030|B1|3 active antihypertensive medications||Number of active antihypertensive medications||participants|Number|2|2.0||||||
3968717|NCT01297335|3791030|B1|4 active antihypertensive medications||Number of active antihypertensive medications||participants|Number|8|8.0||||||
3968718|NCT01297335|3791030|B1|||Duration of Hypertension Diagnosis||years|Mean|17|17.0|Full Range|||6.0|25.0|
3968719|NCT01297335|3791030|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3968720|NCT01297335|3791030|B1|White, Non-hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3968721|NCT01297335|3791030|B1|African American, Non-hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3968722|NCT01297335|3791030|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3968723|NCT01297335|3791030|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3968724|NCT01297335|3791030|B1|||Age||years|Mean|57|57.0|Standard Deviation|5|5.0|||
3968725|NCT01297335|3791030|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3968726|NCT01297335|3791030|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3968727|NCT01297335|3791030|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3968728|NCT01297322|3791036|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3968729|NCT01297322|3791037|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3968730|NCT01297322|3791038|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968731|NCT01297322|3791036|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968732|NCT01297322|3791037|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968733|NCT01297322|3791038|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968734|NCT01297322|3791036|B3||White|Race (NIH/OMB)||Participants|Count of Participants|379|379.0||||||
3968735|NCT01297322|3791037|B2||White|Race (NIH/OMB)||Participants|Count of Participants|249|249.0||||||
3968736|NCT01297322|3791038|B1||White|Race (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
3968737|NCT01297322|3791036|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3968738|NCT01297322|3791037|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3968739|NCT01297322|3791038|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3968740|NCT01297322|3791036|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3968741|NCT01297322|3791037|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3968742|NCT01297322|3791038|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3968743|NCT01297322|3791036|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3968747|NCT01297322|3791037|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3968748|NCT01297322|3791038|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3968749|NCT01297322|3791036|B3||Male|Sex: Female, Male||Participants|Count of Participants|297|297.0||||||
3968750|NCT01297322|3791037|B2||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
3968751|NCT01297322|3791038|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3968752|NCT01297322|3791036|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3968753|NCT01297322|3791037|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3968754|NCT01297322|3791038|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3968755|NCT01297322|3791036|B3|||Age||years|Mean|62|62.0|Standard Deviation|10.8|10.8|||
3968756|NCT01297322|3791037|B2|||Age||years|Mean|61.8|61.8|Standard Deviation|11.2|11.2|||
3968757|NCT01297322|3791038|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|10.4|10.4|||
3968758|NCT01297283|3791059|B1|Other AV junctional arrhythmias and blocks||AV Junctional Arrhythmia History||participants|Number|5|5.0||||||
3968759|NCT01297283|3791059|B1|Right bundle branch block||AV Junctional Arrhythmia History||participants|Number|15|15.0||||||
3968760|NCT01297283|3791059|B1|Left bundle branch block||AV Junctional Arrhythmia History||participants|Number|96|96.0||||||
3968761|NCT01297283|3791059|B1|Intermediate bundle branch block||AV Junctional Arrhythmia History||participants|Number|4|4.0||||||
3968762|NCT01297283|3791059|B1|3rd degree AV block||AV Junctional Arrhythmia History||participants|Number|43|43.0||||||
3968763|NCT01297283|3791059|B1|2nd degree AV block||AV Junctional Arrhythmia History||participants|Number|10|10.0||||||
3968764|NCT01297283|3791059|B1|1st degree AV block||AV Junctional Arrhythmia History||participants|Number|31|31.0||||||
3968765|NCT01297283|3791059|B1|NONE||AV Junctional Arrhythmia History||participants|Number|44|44.0||||||
3968766|NCT01297283|3791059|B1|Other ventricular arrhythmias||Ventricular Arrhythmia History||participants|Number|3|3.0||||||
3968767|NCT01297283|3791059|B1|Ventricular tachycardia, sustained, unknown morpho||Ventricular Arrhythmia History||participants|Number|2|2.0||||||
3968768|NCT01297283|3791059|B1|Ventricular tachycardia, sustained monomorphic||Ventricular Arrhythmia History||participants|Number|1|1.0||||||
3968769|NCT01297283|3791059|B1|Ventricular tachycardia, non-sustained||Ventricular Arrhythmia History||participants|Number|6|6.0||||||
3968770|NCT01297283|3791059|B1|Ventricular flutter||Ventricular Arrhythmia History||participants|Number|1|1.0||||||
3968771|NCT01297283|3791059|B1|Ventricular asystole||Ventricular Arrhythmia History||participants|Number|1|1.0||||||
3968772|NCT01297283|3791059|B1|Torsades de pointes||Ventricular Arrhythmia History||participants|Number|1|1.0||||||
3968773|NCT01297283|3791059|B1|Premature ventricular complexes||Ventricular Arrhythmia History||participants|Number|7|7.0||||||
3968774|NCT01297283|3791059|B1|NONE||Ventricular Arrhythmia History||participants|Number|174|174.0||||||
3968775|NCT01297283|3791059|B1|Other atrial arrhythmias||Atrial Arrhythmia History||participants|Number|3|3.0||||||
3968776|NCT01297283|3791059|B1|Supraventricular tachycardia||Atrial Arrhythmia History||participants|Number|1|1.0||||||
3968777|NCT01297283|3791059|B1|Sinus node dysfunction||Atrial Arrhythmia History||participants|Number|6|6.0||||||
3968778|NCT01297283|3791059|B1|Premature atrial complexes||Atrial Arrhythmia History||participants|Number|1|1.0||||||
3968779|NCT01297283|3791059|B1|Atrial tachycardia||Atrial Arrhythmia History||participants|Number|1|1.0||||||
3968780|NCT01297283|3791059|B1|Atrial flutter||Atrial Arrhythmia History||participants|Number|12|12.0||||||
3968781|NCT01297283|3791059|B1|Atrial fibrillation||Atrial Arrhythmia History||participants|Number|99|99.0||||||
3968782|NCT01297283|3791059|B1|NONE||Atrial Arrhythmia History||participants|Number|86|86.0||||||
3968783|NCT01297283|3791059|B1|other||Previous Device||participants|Number|5|5.0||||||
3968784|NCT01297283|3791059|B1|IPG implant||Previous Device||participants|Number|37|37.0||||||
3968785|NCT01297283|3791059|B1|ICD implant||Previous Device||participants|Number|1|1.0||||||
3968786|NCT01297283|3791059|B1|CRT-P implant||Previous Device||participants|Number|39|39.0||||||
3968787|NCT01297283|3791059|B1|CRT-D implant||Previous Device||participants|Number|6|6.0||||||
3968788|NCT01297283|3791059|B1|Other cardiovascular surgery||Cardiovascular Surgical History||participants|Number|5|5.0||||||
3968789|NCT01297283|3791059|B1|Valve surgery||Cardiovascular Surgical History||participants|Number|20|20.0||||||
3968790|NCT01297283|3791059|B1|Coronary artery intervention||Cardiovascular Surgical History||participants|Number|43|43.0||||||
3968791|NCT01297283|3791059|B1|Coronary artery bypass graft (CABG)||Cardiovascular Surgical History||participants|Number|11|11.0||||||
3968792|NCT01297283|3791059|B1|Ablation||Cardiovascular Surgical History||participants|Number|16|16.0||||||
3968793|NCT01297283|3791059|B1|NONE||Cardiovascular Surgical History||participants|Number|65|65.0||||||
3968794|NCT01297283|3791059|B1|Other cardiovascular history||General cardiovascular history||participants|Number|17|17.0||||||
3968795|NCT01297283|3791059|B1|Valve dysfunction||General cardiovascular history||participants|Number|26|26.0||||||
3968796|NCT01297283|3791059|B1|Pulmonary hypertension (PH)||General cardiovascular history||participants|Number|2|2.0||||||
3968797|NCT01297283|3791059|B1|Myocardial infarction||General cardiovascular history||participants|Number|25|25.0||||||
3968798|NCT01297283|3791059|B1|Hypertension||General cardiovascular history||participants|Number|66|66.0||||||
3968799|NCT01297283|3791059|B1|Coronary artery disease||General cardiovascular history||participants|Number|24|24.0||||||
3968800|NCT01297283|3791059|B1|Congestive Heart Failure||General cardiovascular history||participants|Number|29|29.0||||||
3968801|NCT01297283|3791059|B1|Congenital Heart Disease||General cardiovascular history||participants|Number|2|2.0||||||
3968802|NCT01297283|3791059|B1|Cardiomyopathy||General cardiovascular history||participants|Number|187|187.0||||||
3968803|NCT01297283|3791059|B1|||LVEF||%|Median|31|31.0|Inter-Quartile Range|||25.0|35.0|
3968804|NCT01297283|3791059|B1|||LVEF||%|Mean|31.67|31.67|Standard Deviation|8.18|8.18|||
3968805|NCT01297283|3791059|B1|Not available||NYHA Class||participants|Number|31|31.0||||||
3968806|NCT01297283|3791059|B1|Class IV||NYHA Class||participants|Number|12|12.0||||||
3968807|NCT01297283|3791059|B1|Class III||NYHA Class||participants|Number|105|105.0||||||
3968808|NCT01297283|3791059|B1|Class II||NYHA Class||participants|Number|41|41.0||||||
3968809|NCT01297283|3791059|B1|Class I||NYHA Class||participants|Number|6|6.0||||||
3968810|NCT01297283|3791059|B1|||BMC Index||kg/m²|Median|24.75|24.75|Inter-Quartile Range|||22.64|27.76|
3968811|NCT01297283|3791059|B1|||Height||meters|Median|1.69|1.69|Inter-Quartile Range|||1.62|1.75|
3968812|NCT01297283|3791059|B1|||Height||meters|Mean|1.68|1.68|Standard Deviation|0.09|0.09|||
3968813|NCT01297283|3791059|B1|||Weight||Kilogramms|Median|71|71.0|Inter-Quartile Range|||63.0|81.0|
3968814|NCT01297283|3791059|B1|||Weight||Kilogramms|Mean|72.9|72.9|Standard Deviation|14.37|14.37|||
3968815|NCT01297283|3791059|B1|||BMC Index||kg/m²|Mean|25.64|25.64|Standard Deviation|4.38|4.38|||
3968816|NCT01297283|3791059|B1||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3968817|NCT01297283|3791059|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3968818|NCT01297283|3791059|B1|||Age||years|Median|80|80.0|Inter-Quartile Range|||74.0|84.0|
3968819|NCT01297283|3791059|B1|||Age||years|Mean|77.6|77.6|Standard Deviation|9.83|9.83|||
3968820|NCT01297270|3791064|B4||Male|Sex: Female, Male||Participants|Count of Participants|389|389.0||||||
3968821|NCT01297270|3791065|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3968822|NCT01297270|3791066|B2||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3968823|NCT01297270|3791067|B1||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3968824|NCT01297270|3791064|B4||Female|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
3968825|NCT01297270|3791065|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3968826|NCT01297270|3791066|B2||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3968827|NCT01297270|3791067|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3968828|NCT01297270|3791064|B4|||Age||years|Mean|50.3|50.3|Standard Deviation|9.53|9.53|||
3968829|NCT01297270|3791065|B3|||Age||years|Mean|50.2|50.2|Standard Deviation|8.78|8.78|||
3968830|NCT01297270|3791066|B2|||Age||years|Mean|50.4|50.4|Standard Deviation|9.40|9.4|||
3968831|NCT01297270|3791067|B1|||Age||years|Mean|50.2|50.2|Standard Deviation|10.05|10.05|||
3968832|NCT01297257|3791107|B1|Male||Gender|Gender of 20 (0.26%) patients not reported by investigators|participants|Number|5862|5862.0||||||
3968833|NCT01297257|3791107|B1|Female||Gender|Gender of 20 (0.26%) patients not reported by investigators|participants|Number|1858|1858.0||||||
3968834|NCT01297257|3791107|B1|||Age|Age of 20 (0.26%) patients not reported by investigators|years|Mean|63.5|63.5|Standard Deviation|11.2|11.2|||
3968835|NCT01297257|3791107|B1|>=65 years||Age|Age of 20 (0.26%) patients not reported by investigators.|participants|Number|3662|3662.0||||||
3968836|NCT01297257|3791107|B1|Between 18 and 65 years||Age|Age of 20 (0.26%) patients not reported by investigators.|participants|Number|4058|4058.0||||||
3968837|NCT01297257|3791107|B1|<=18 years||Age|Age of 20 (0.26%) patients not reported by investigators.|participants|Number|0|0.0||||||
3968838|NCT01297062|3791112|B7|||Weight||kilogram|Mean|88.94|88.94|Standard Deviation|10.899|10.899|||
3968839|NCT01297062|3791113|B6|||Weight||kilogram|Mean|90.71|90.71|Standard Deviation|11.251|11.251|||
3968840|NCT01297062|3791114|B5|||Weight||kilogram|Mean|89.71|89.71|Standard Deviation|7.726|7.726|||
3968841|NCT01297062|3791115|B4|||Weight||kilogram|Mean|93.66|93.66|Standard Deviation|11.704|11.704|||
3968842|NCT01297062|3791116|B3|||Weight||kilogram|Mean|90.77|90.77|Standard Deviation|12.375|12.375|||
3968843|NCT01297062|3791117|B2|||Weight||kilogram|Mean|81.16|81.16|Standard Deviation|11.235|11.235|||
3968844|NCT01297062|3791118|B1|||Weight||kilogram|Mean|87.66|87.66|Standard Deviation|8.107|8.107|||
3968845|NCT01297062|3791112|B7||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3968846|NCT01297062|3791113|B6||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3968847|NCT01297062|3791114|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3968848|NCT01297062|3791115|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3968849|NCT01297062|3791116|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3968850|NCT01297062|3791117|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3968851|NCT01297062|3791118|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3968852|NCT01297062|3791112|B7||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3968853|NCT01297062|3791113|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3968854|NCT01297062|3791114|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3968855|NCT01297062|3791115|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3968856|NCT01297062|3791116|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3968857|NCT01297062|3791117|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3968858|NCT01297062|3791118|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3968859|NCT01297062|3791112|B7|||Age||years|Mean|42.1|42.1|Standard Deviation|11.16|11.16|||
3968860|NCT01297062|3791113|B6|||Age||years|Mean|41.0|41.0|Standard Deviation|10.50|10.5|||
3968861|NCT01297062|3791114|B5|||Age||years|Mean|43.3|43.3|Standard Deviation|13.74|13.74|||
3968862|NCT01297062|3791115|B4|||Age||years|Mean|37.8|37.8|Standard Deviation|10.66|10.66|||
3968863|NCT01297062|3791116|B3|||Age||years|Mean|43.7|43.7|Standard Deviation|11.56|11.56|||
3968864|NCT01297062|3791117|B2|||Age||years|Mean|45.1|45.1|Standard Deviation|11.43|11.43|||
3968865|NCT01297062|3791118|B1|||Age||years|Mean|41.5|41.5|Standard Deviation|8.98|8.98|||
3968866|NCT01296841|3791146|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
3968867|NCT01296841|3791147|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3968868|NCT01296841|3791148|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3968869|NCT01296841|3791146|B3||Male|Gender||Participants|Count of Participants|26|26.0||||||
3968870|NCT01296841|3791147|B2||Male|Gender||Participants|Count of Participants|13|13.0||||||
3968871|NCT01296841|3791148|B1||Male|Gender||Participants|Count of Participants|13|13.0||||||
3968872|NCT01296841|3791146|B3||Female|Gender||Participants|Count of Participants|8|8.0||||||
3968873|NCT01296841|3791147|B2||Female|Gender||Participants|Count of Participants|2|2.0||||||
3968874|NCT01296841|3791148|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
3968875|NCT01296841|3791146|B3|||Age||years|Mean|60.4|60.4|Standard Deviation|10.5|10.5|||
3968876|NCT01296841|3791147|B2|||Age||years|Mean|62.8|62.8|Standard Deviation|11.5|11.5|||
3968877|NCT01296841|3791148|B1|||Age||years|Mean|58.5|58.5|Standard Deviation|9.6|9.6|||
3968878|NCT01296841|3791146|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3968879|NCT01296841|3791147|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3968880|NCT01296841|3791148|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3968881|NCT01296841|3791146|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3968882|NCT01296841|3791147|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3968883|NCT01296841|3791148|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3968884|NCT01296841|3791146|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3968885|NCT01296841|3791147|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3968886|NCT01296841|3791148|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3968887|NCT01296815|3791159|B3|Mexico||Region of Enrollment||participants|Number|14|14.0||||||
3968888|NCT01296815|3791160|B2|Mexico||Region of Enrollment||participants|Number|7|7.0||||||
3968889|NCT01296815|3791161|B1|Mexico||Region of Enrollment||participants|Number|7|7.0||||||
3968890|NCT01296815|3791159|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3968891|NCT01296815|3791160|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3968892|NCT01296815|3791161|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3968893|NCT01296815|3791159|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3968894|NCT01296815|3791160|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3968895|NCT01296815|3791161|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3968896|NCT01296815|3791159|B3|||Age||years|Median|30.5|30.5|Inter-Quartile Range|||24.7|38.2|
3968897|NCT01296815|3791160|B2|||Age||years|Median|35|35.0|Inter-Quartile Range|||29.0|39.0|
3968898|NCT01296815|3791161|B1|||Age||years|Median|27|27.0|Inter-Quartile Range|||24.0|32.0|
3968899|NCT01296815|3791159|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3968900|NCT01296815|3791160|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3968901|NCT01296815|3791161|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3968902|NCT01296815|3791159|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3968903|NCT01296815|3791160|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3968904|NCT01296815|3791161|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3968905|NCT01296815|3791159|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3968906|NCT01296815|3791160|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3968907|NCT01296815|3791161|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3968908|NCT01296763|3791168|B4|United States||Region of Enrollment||participants|Number|18|18.0||||||
3968909|NCT01296763|3791169|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3968910|NCT01296763|3791170|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3968911|NCT01296763|3791171|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3968912|NCT01296763|3791168|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968913|NCT01296763|3791169|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968914|NCT01296763|3791170|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968915|NCT01296763|3791171|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968916|NCT01296763|3791168|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968917|NCT01296763|3791169|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968918|NCT01296763|3791170|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968919|NCT01296763|3791171|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968920|NCT01296763|3791168|B4||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3968921|NCT01296763|3791169|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3968922|NCT01296763|3791170|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3968923|NCT01296763|3791171|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3968924|NCT01296763|3791168|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3968925|NCT01296763|3791169|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3968926|NCT01296763|3791170|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968927|NCT01296763|3791171|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968928|NCT01296763|3791168|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968929|NCT01296763|3791169|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968930|NCT01296763|3791170|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968931|NCT01296763|3791171|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968932|NCT01296763|3791168|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968933|NCT01296763|3791169|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968934|NCT01296763|3791170|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968935|NCT01296763|3791171|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968936|NCT01296763|3791168|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968937|NCT01296763|3791169|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968938|NCT01296763|3791170|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968939|NCT01296763|3791171|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968940|NCT01296763|3791168|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968941|NCT01296763|3791169|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968942|NCT01296763|3791170|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968943|NCT01296763|3791171|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968944|NCT01296763|3791168|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3968945|NCT01296763|3791169|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3968946|NCT01296763|3791170|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3968947|NCT01296763|3791171|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3968948|NCT01296763|3791168|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3968949|NCT01296763|3791169|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3968950|NCT01296763|3791170|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968951|NCT01296763|3791171|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3968952|NCT01296763|3791168|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3968953|NCT01296763|3791169|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3968954|NCT01296763|3791170|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3968955|NCT01296763|3791171|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3968956|NCT01296763|3791168|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3968957|NCT01296763|3791169|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3968958|NCT01296763|3791170|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3968959|NCT01296763|3791171|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3968960|NCT01296763|3791168|B4|||Age||years|Mean|56.79|56.79|Full Range|||33.09|76.48|
3968961|NCT01296763|3791169|B3|||Age||years|Mean|51.98|51.98|Full Range|||38.73|76.48|
3968962|NCT01296763|3791170|B2|||Age||years|Mean|59.08|59.08|Full Range|||33.09|72.9|
3968963|NCT01296763|3791171|B1|||Age||years|Mean|59.28|59.28|Full Range|||47.31|65.81|
3968964|NCT01296763|3791168|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3968965|NCT01296763|3791169|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3968966|NCT01296763|3791170|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3968967|NCT01296763|3791171|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3968968|NCT01296763|3791168|B4||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3968969|NCT01296763|3791169|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3968970|NCT01296763|3791170|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3968971|NCT01296763|3791171|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3968972|NCT01296763|3791168|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3968973|NCT01296763|3791169|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3968974|NCT01296763|3791170|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3968975|NCT01296763|3791171|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3968976|NCT01296698|3791184|B3|United States||Region of Enrollment||participants|Number|257|257.0||||||
3968977|NCT01296698|3791185|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3968978|NCT01296698|3791186|B1|United States||Region of Enrollment||participants|Number|244|244.0||||||
3968979|NCT01296698|3791184|B3||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3968980|NCT01296698|3791185|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3968981|NCT01296698|3791186|B1||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3968982|NCT01296698|3791184|B3||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3968983|NCT01296698|3791185|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3968984|NCT01296698|3791186|B1||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3968985|NCT01296698|3791184|B3|||Age||years|Mean|47.2|47.2|Standard Deviation|13.9|13.9|||
3968986|NCT01296698|3791185|B2|||Age||years|Mean|49.9|49.9|Standard Deviation|11.4|11.4|||
3968987|NCT01296698|3791186|B1|||Age||years|Mean|47.1|47.1|Standard Deviation|14.0|14.0|||
3968988|NCT01296672|3791239|B3|||Prostate Specific Antigen||ng/ml|Median|5.2|5.2|Inter-Quartile Range|||4.3|6.6|
3968989|NCT01296672|3791240|B2|||Prostate Specific Antigen||ng/ml|Median|5.3|5.3|Inter-Quartile Range|||4.5|6.7|
3968990|NCT01296672|3791241|B1|||Prostate Specific Antigen||ng/ml|Median|5.2|5.2|Inter-Quartile Range|||4.3|6.6|
3968991|NCT01296672|3791239|B3|United States||Region of Enrollment||participants|Number|383|383.0||||||
3968992|NCT01296672|3791240|B2|United States||Region of Enrollment||participants|Number|77|77.0||||||
3968993|NCT01296672|3791241|B1|United States||Region of Enrollment||participants|Number|306|306.0||||||
3968994|NCT01296672|3791239|B3|Race|Other race|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3968995|NCT01296672|3791240|B2|Race|Other race|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3968996|NCT01296672|3791241|B1|Race|Other race|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3968997|NCT01296672|3791239|B3|Race|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|168|168.0||||||
3968998|NCT01296672|3791240|B2|Race|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3968999|NCT01296672|3791241|B1|Race|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|134|134.0||||||
3969000|NCT01296672|3791239|B3|Race|Non-Hispanic black|Race/Ethnicity, Customized||Participants|Count of Participants|54|54.0||||||
3969001|NCT01296672|3791240|B2|Race|Non-Hispanic black|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3969002|NCT01296672|3791241|B1|Race|Non-Hispanic black|Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3969003|NCT01296672|3791239|B3|Race|Non-Hispanic white|Race/Ethnicity, Customized||Participants|Count of Participants|156|156.0||||||
3969004|NCT01296672|3791240|B2|Race|Non-Hispanic white|Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3969005|NCT01296672|3791241|B1|Race|Non-Hispanic white|Race/Ethnicity, Customized||Participants|Count of Participants|125|125.0||||||
3969006|NCT01296672|3791239|B3||Male|Sex: Female, Male||Participants|Count of Participants|383|383.0||||||
3969007|NCT01296672|3791240|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3969008|NCT01296672|3791241|B1||Male|Sex: Female, Male||Participants|Count of Participants|306|306.0||||||
3969009|NCT01296672|3791239|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3969010|NCT01296672|3791240|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3969011|NCT01296672|3791241|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3969012|NCT01296672|3791239|B3|||Age||years|Median|65|65.0|Inter-Quartile Range|||61.0|68.0|
3969013|NCT01296672|3791240|B2|||Age||years|Median|66|66.0|Inter-Quartile Range|||61.0|68.0|
3969014|NCT01296672|3791241|B1|||Age||years|Median|65|65.0|Inter-Quartile Range|||61.0|68.0|
3969015|NCT01296646|3791252|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
3969016|NCT01296646|3791253|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
3969017|NCT01296646|3791254|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3969018|NCT01296646|3791252|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3969019|NCT01296646|3791253|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3969020|NCT01296646|3791254|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3969021|NCT01296646|3791252|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3969022|NCT01296646|3791253|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3969023|NCT01296646|3791254|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3969024|NCT01296646|3791252|B3|||Age||years|Mean|47.0|47.0|Standard Deviation|8.5|8.5|||
3969025|NCT01296646|3791253|B2|||Age||years|Mean|45.8|45.8|Standard Deviation|8.6|8.6|||
3969026|NCT01296646|3791254|B1|||Age||years|Mean|48.3|48.3|Standard Deviation|8.4|8.4|||
3969027|NCT01296568|3791263|B1|Switzerland||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3969028|NCT01296568|3791263|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3969029|NCT01296568|3791263|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3969030|NCT01296568|3791263|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3969031|NCT01296568|3791263|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3969032|NCT01296568|3791263|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3969033|NCT01296568|3791263|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3969034|NCT01296412|3791277|B3|||Fasting Plasma Glucose|FPG baseline values are presented for participants with data: Sitagliptin + metformin, n=325; liraglutide + metformin, n= 325; total population, n=650|mg/dL|Mean|173.5|173.5|Standard Deviation|42.3|42.3|||
3969035|NCT01296412|3791278|B2|||Fasting Plasma Glucose|FPG baseline values are presented for participants with data: Sitagliptin + metformin, n=325; liraglutide + metformin, n= 325; total population, n=650|mg/dL|Mean|172.9|172.9|Standard Deviation|40.8|40.8|||
3969036|NCT01296412|3791279|B1|||Fasting Plasma Glucose|FPG baseline values are presented for participants with data: Sitagliptin + metformin, n=325; liraglutide + metformin, n= 325; total population, n=650|mg/dL|Mean|174.1|174.1|Standard Deviation|43.7|43.7|||
3969037|NCT01296412|3791277|B3|||Hemoglobin A1c (A1C)|A1C baseline values are presented for participants with data: Sitagliptin + metformin, n=325; liraglutide + metformin, n= 325; total population, n=650|Percent|Mean|8.2|8.2|Standard Deviation|1.0|1.0|||
3969038|NCT01296412|3791278|B2|||Hemoglobin A1c (A1C)|A1C baseline values are presented for participants with data: Sitagliptin + metformin, n=325; liraglutide + metformin, n= 325; total population, n=650|Percent|Mean|8.1|8.1|Standard Deviation|0.9|0.9|||
3969039|NCT01296412|3791279|B1|||Hemoglobin A1c (A1C)|A1C baseline values are presented for participants with data: Sitagliptin + metformin, n=325; liraglutide + metformin, n= 325; total population, n=650|Percent|Mean|8.2|8.2|Standard Deviation|1.1|1.1|||
3969040|NCT01296412|3791277|B3||Male|Sex: Female, Male||Participants|Count of Participants|358|358.0||||||
3969041|NCT01296412|3791278|B2||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3969042|NCT01296412|3791279|B1||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
3969043|NCT01296412|3791277|B3||Female|Sex: Female, Male||Participants|Count of Participants|295|295.0||||||
3969044|NCT01296412|3791278|B2||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3969045|NCT01296412|3791279|B1||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3969046|NCT01296412|3791277|B3|||Age||years|Mean|57.3|57.3|Standard Deviation|10.4|10.4|||
3969047|NCT01296412|3791278|B2|||Age||years|Mean|57.6|57.6|Standard Deviation|10.8|10.8|||
3969048|NCT01296412|3791279|B1|||Age||years|Mean|56.9|56.9|Standard Deviation|10.0|10.0|||
3969049|NCT01296360|3791292|B3||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3969050|NCT01296360|3791293|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3969051|NCT01296360|3791294|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3969052|NCT01296360|3791292|B3||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3969053|NCT01296360|3791293|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3969054|NCT01296360|3791294|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3969055|NCT01296360|3791292|B3|||Age||years|Mean|5.30|5.3|Standard Deviation|5.101|5.101|||
3969056|NCT01296360|3791293|B2|||Age||years|Mean|5.36|5.36|Standard Deviation|5.135|5.135|||
3969057|NCT01296360|3791294|B1|||Age||years|Mean|5.23|5.23|Standard Deviation|5.084|5.084|||
3969058|NCT01296347|3791301|B3|United Kingdom||Region of Enrollment||participants|Number|104|104.0||||||
3969059|NCT01296347|3791302|B2|United Kingdom||Region of Enrollment||participants|Number|52|52.0||||||
3969060|NCT01296347|3791303|B1|United Kingdom||Region of Enrollment||participants|Number|52|52.0||||||
3969061|NCT01296347|3791301|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3969062|NCT01296347|3791302|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3969063|NCT01296347|3791303|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3969064|NCT01296347|3791301|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3969065|NCT01296347|3791302|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3969066|NCT01296347|3791303|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3969067|NCT01296347|3791301|B3|||Age||years|Mean|57.84|57.84|Full Range|||18.0|87.0|
3969068|NCT01296347|3791302|B2|||Age||years|Mean|56.025|56.025|Full Range|||18.0|81.0|
3969069|NCT01296347|3791303|B1|||Age||years|Mean|59.645|59.645|Full Range|||22.0|87.0|
3969070|NCT01296152|3791310|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3969071|NCT01296152|3791310|B1|American Indian, Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3969072|NCT01296152|3791310|B1|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3969073|NCT01296152|3791310|B1|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3969074|NCT01296152|3791310|B1|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3969075|NCT01296152|3791310|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3969076|NCT01296152|3791310|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3969077|NCT01296152|3791310|B1|||Age||years|Median|31|31.0|Full Range|||15.0|47.0|
3969078|NCT01296152|3791310|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3969079|NCT01296152|3791310|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3969080|NCT01296152|3791310|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3969081|NCT01296035|3791337|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3969082|NCT01296035|3791337|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3969083|NCT01296035|3791337|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3969084|NCT01296035|3791337|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3969085|NCT01296035|3791337|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3969086|NCT01296035|3791337|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3969087|NCT01295905|3791342|B3|United States||Region of Enrollment||participants|Number|90|90.0||||||
3969088|NCT01295905|3791343|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3969089|NCT01295905|3791344|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
3969090|NCT01295905|3791342|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3969091|NCT01295905|3791343|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3969092|NCT01295905|3791344|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3969093|NCT01295905|3791342|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3969094|NCT01295905|3791343|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3969095|NCT01295905|3791344|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3969096|NCT01295905|3791342|B3|||Age||years|Mean|29.80|29.8|Standard Deviation|9.29|9.29|||
3969097|NCT01295905|3791343|B2|||Age||years|Mean|31.39|31.39|Standard Deviation|10.05|10.05|||
3969098|NCT01295905|3791344|B1|||Age||years|Mean|29.01|29.01|Standard Deviation|8.86|8.86|||
3969099|NCT01295879|3791357|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3969100|NCT01295879|3791357|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3969101|NCT01295879|3791357|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3969102|NCT01295879|3791357|B1|||Age||years|Mean|48|48.0|Standard Deviation|12|12.0|||
3969103|NCT01295879|3791357|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3969104|NCT01295879|3791357|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3969105|NCT01295879|3791357|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3969106|NCT01295840|3791363|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3969107|NCT01295840|3791363|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3969108|NCT01295840|3791363|B1|||Age||years|Mean|65.4|65.4|Standard Deviation|9.3|9.3|||
3969109|NCT01295814|3791377|B3|United States||Region of Enrollment||participants|Number|43|43.0||||||
3969110|NCT01295814|3791378|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
3969111|NCT01295814|3791379|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3969112|NCT01295814|3791377|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3969113|NCT01295814|3791378|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3969114|NCT01295814|3791379|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3969115|NCT01295814|3791377|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3969116|NCT01295814|3791378|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3969117|NCT01295814|3791379|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3969118|NCT01295814|3791377|B3|||Age||years|Mean|45.9|45.9|Standard Deviation|13.7|13.7|||
3969119|NCT01295814|3791378|B2|||Age||years|Mean|45.2|45.2|Standard Deviation|14|14.0|||
3969120|NCT01295814|3791379|B1|||Age||years|Mean|46.5|46.5|Standard Deviation|13.4|13.4|||
3969121|NCT01295814|3791377|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3969122|NCT01295814|3791378|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3969123|NCT01295814|3791379|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3969124|NCT01295814|3791377|B3||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
3969125|NCT01295814|3791378|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3969126|NCT01295814|3791379|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3969127|NCT01295814|3791377|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3969128|NCT01295814|3791378|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3969129|NCT01295814|3791379|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3969130|NCT01295671|3791394|B4|||Preference for sweet taste|We evaluated preference for sweet taste using ten solutions ranging in sucrose concentration (%m/v) from 0% (sample 1) to 18% (sample 10). After tasting each solution, participant reported the sample number corresponding to his or her overall favorite.|Sample number|Median|6|6.0|Inter-Quartile Range|||5.0|8.0|
3969131|NCT01295671|3791395|B3|||Preference for sweet taste|We evaluated preference for sweet taste using ten solutions ranging in sucrose concentration (%m/v) from 0% (sample 1) to 18% (sample 10). After tasting each solution, participant reported the sample number corresponding to his or her overall favorite.|Sample number|Median|7|7.0|Inter-Quartile Range|||5.0|7.0|
3969132|NCT01295671|3791396|B2|||Preference for sweet taste|We evaluated preference for sweet taste using ten solutions ranging in sucrose concentration (%m/v) from 0% (sample 1) to 18% (sample 10). After tasting each solution, participant reported the sample number corresponding to his or her overall favorite.|Sample number|Median|6|6.0|Inter-Quartile Range|||5.0|8.0|
3969133|NCT01295671|3791397|B1|||Preference for sweet taste|We evaluated preference for sweet taste using ten solutions ranging in sucrose concentration (%m/v) from 0% (sample 1) to 18% (sample 10). After tasting each solution, participant reported the sample number corresponding to his or her overall favorite.|Sample number|Median|6|6.0|Inter-Quartile Range|||5.0|7.0|
3969134|NCT01295671|3791394|B4|||Diet Quality: Sugar-Sweetened Beverage Consumption||Servings per day|Mean|1.6|1.6|Standard Deviation|1.3|1.3|||
3969135|NCT01295671|3791395|B3|||Diet Quality: Sugar-Sweetened Beverage Consumption||Servings per day|Mean|1.8|1.8|Standard Deviation|1.3|1.3|||
3969136|NCT01295671|3791396|B2|||Diet Quality: Sugar-Sweetened Beverage Consumption||Servings per day|Mean|1.5|1.5|Standard Deviation|1.4|1.4|||
3969137|NCT01295671|3791397|B1|||Diet Quality: Sugar-Sweetened Beverage Consumption||Servings per day|Mean|1.4|1.4|Standard Deviation|1.1|1.1|||
3969138|NCT01295671|3791394|B4|||Body Weight||kg|Mean|76.6|76.6|Standard Deviation|16.1|16.1|||
3969139|NCT01295671|3791395|B3|||Body Weight||kg|Mean|77.5|77.5|Standard Deviation|16.1|16.1|||
3969140|NCT01295671|3791396|B2|||Body Weight||kg|Mean|76.8|76.8|Standard Deviation|16.7|16.7|||
3969141|NCT01295671|3791397|B1|||Body Weight||kg|Mean|75.5|75.5|Standard Deviation|15.6|15.6|||
3969142|NCT01295671|3791394|B4|||Diastolic Blood Pressure||mmHg|Mean|67|67.0|Standard Deviation|8|8.0|||
3969143|NCT01295671|3791395|B3|||Diastolic Blood Pressure||mmHg|Mean|68|68.0|Standard Deviation|7|7.0|||
3969144|NCT01295671|3791396|B2|||Diastolic Blood Pressure||mmHg|Mean|67|67.0|Standard Deviation|8|8.0|||
3969145|NCT01295671|3791397|B1|||Diastolic Blood Pressure||mmHg|Mean|67|67.0|Standard Deviation|8|8.0|||
3969146|NCT01295671|3791394|B4|||Systolic Blood Pressure||mmHg|Mean|108|108.0|Standard Deviation|11|11.0|||
3969147|NCT01295671|3791395|B3|||Systolic Blood Pressure||mmHg|Mean|106|106.0|Standard Deviation|10|10.0|||
3969148|NCT01295671|3791396|B2|||Systolic Blood Pressure||mmHg|Mean|109|109.0|Standard Deviation|13|13.0|||
3969149|NCT01295671|3791397|B1|||Systolic Blood Pressure||mmHg|Mean|108|108.0|Standard Deviation|9|9.0|||
3969150|NCT01295671|3791394|B4|||ALT||U/L|Median|16|16.0|Inter-Quartile Range|||13.0|22.0|
3969151|NCT01295671|3791395|B3|||ALT||U/L|Median|16|16.0|Inter-Quartile Range|||13.0|22.0|
3969152|NCT01295671|3791396|B2|||ALT||U/L|Median|18|18.0|Inter-Quartile Range|||13.0|27.0|
3969153|NCT01295671|3791397|B1|||ALT||U/L|Median|14|14.0|Inter-Quartile Range|||12.0|21.0|
3969154|NCT01295671|3791394|B4|||Uric Acid||mg/dL|Mean|5.3|5.3|Standard Deviation|1.4|1.4|||
3969155|NCT01295671|3791395|B3|||Uric Acid||mg/dL|Mean|5.3|5.3|Standard Deviation|1.5|1.5|||
3969156|NCT01295671|3791396|B2|||Uric Acid||mg/dL|Mean|5.2|5.2|Standard Deviation|1.4|1.4|||
3969157|NCT01295671|3791397|B1|||Uric Acid||mg/dL|Mean|5.3|5.3|Standard Deviation|1.3|1.3|||
3969158|NCT01295671|3791394|B4|||Fibrinogen||mg/dL|Mean|244|244.0|Standard Deviation|70|70.0|||
3969159|NCT01295671|3791395|B3|||Fibrinogen||mg/dL|Mean|250|250.0|Standard Deviation|71|71.0|||
3969160|NCT01295671|3791396|B2|||Fibrinogen||mg/dL|Mean|241|241.0|Standard Deviation|74|74.0|||
3969161|NCT01295671|3791397|B1|||Fibrinogen||mg/dL|Mean|241|241.0|Standard Deviation|64|64.0|||
3969162|NCT01295671|3791394|B4|||hsCRP||mg/L|Median|0.69|0.69|Inter-Quartile Range|||0.34|2.08|
3969163|NCT01295671|3791395|B3|||hsCRP||mg/L|Median|0.73|0.73|Inter-Quartile Range|||0.43|1.38|
3969164|NCT01295671|3791396|B2|||hsCRP||mg/L|Median|0.77|0.77|Inter-Quartile Range|||0.34|2.3|
3969165|NCT01295671|3791397|B1|||hsCRP||mg/L|Median|0.62|0.62|Inter-Quartile Range|||0.32|1.84|
3969166|NCT01295671|3791394|B4|||LDL-C||mg/dL|Mean|104|104.0|Standard Deviation|30|30.0|||
3969167|NCT01295671|3791395|B3|||LDL-C||mg/dL|Mean|110|110.0|Standard Deviation|33|33.0|||
3969168|NCT01295671|3791396|B2|||LDL-C||mg/dL|Mean|102|102.0|Standard Deviation|28|28.0|||
3969169|NCT01295671|3791397|B1|||LDL-C||mg/dL|Mean|100|100.0|Standard Deviation|27|27.0|||
3969170|NCT01295671|3791394|B4|||Ratio of Serum Triglyceride to HDL-cholesterol Concentration (TG:HDLC)||ratio of Triglycerides-to-HDL|Mean|1.37|1.37|Inter-Quartile Range|||0.9|2.17|
3969171|NCT01295671|3791395|B3|||Ratio of Serum Triglyceride to HDL-cholesterol Concentration (TG:HDLC)||ratio of Triglycerides-to-HDL|Mean|1.51|1.51|Inter-Quartile Range|||1.08|2.51|
3969172|NCT01295671|3791396|B2|||Ratio of Serum Triglyceride to HDL-cholesterol Concentration (TG:HDLC)||ratio of Triglycerides-to-HDL|Mean|1.30|1.3|Inter-Quartile Range|||0.78|1.98|
3969173|NCT01295671|3791397|B1|||Ratio of Serum Triglyceride to HDL-cholesterol Concentration (TG:HDLC)||ratio of Triglycerides-to-HDL|Mean|1.37|1.37|Inter-Quartile Range|||0.87|2.16|
3969174|NCT01295671|3791394|B4|United States||Region of Enrollment||Participants|Count of Participants|203|203.0||||||
3969175|NCT01295671|3791395|B3|United States||Region of Enrollment||Participants|Count of Participants|69|69.0||||||
3969176|NCT01295671|3791396|B2|United States||Region of Enrollment||Participants|Count of Participants|67|67.0||||||
3969177|NCT01295671|3791397|B1|United States||Region of Enrollment||Participants|Count of Participants|67|67.0||||||
3969178|NCT01295671|3791394|B4||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3969179|NCT01295671|3791395|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3969180|NCT01295671|3791396|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3969181|NCT01295671|3791397|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3969182|NCT01295671|3791394|B4||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3969183|NCT01295671|3791395|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3969184|NCT01295671|3791396|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3969185|NCT01295671|3791397|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3969186|NCT01295671|3791394|B4|||Age||years|Mean|26.9|26.9|Standard Deviation|5.7|5.7|||
3969187|NCT01295671|3791395|B3|||Age||years|Mean|28.0|28.0|Standard Deviation|6.0|6.0|||
3969188|NCT01295671|3791396|B2|||Age||years|Mean|26.7|26.7|Standard Deviation|5.7|5.7|||
3969189|NCT01295671|3791397|B1|||Age||years|Mean|25.9|25.9|Standard Deviation|5.1|5.1|||
3969190|NCT01295671|3791394|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3969191|NCT01295671|3791395|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3969192|NCT01295671|3791396|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3969193|NCT01295671|3791397|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3969194|NCT01295671|3791394|B4||Between 18 and 65 years|Age||Participants|Count of Participants|203|203.0||||||
3969195|NCT01295671|3791395|B3||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
3969196|NCT01295671|3791396|B2||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
3969197|NCT01295671|3791397|B1||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
3969198|NCT01295671|3791394|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3969199|NCT01295671|3791395|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3969200|NCT01295671|3791396|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3969201|NCT01295671|3791397|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3969202|NCT01295320|3791437|B1|African Heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3969203|NCT01295320|3791437|B1|White - Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|128|128.0||||||
3969204|NCT01295320|3791437|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3969205|NCT01295320|3791437|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3969206|NCT01295320|3791437|B1|||Age||Years|Mean|72.8|72.8|Standard Deviation|4.96|4.96|||
3969207|NCT01295281|3791452|B3|Sweden||Region of Enrollment||participants|Number|105|105.0||||||
3969208|NCT01295281|3791453|B2|Sweden||Region of Enrollment||participants|Number|52|52.0||||||
3969209|NCT01295281|3791454|B1|Sweden||Region of Enrollment||participants|Number|53|53.0||||||
3969210|NCT01295281|3791452|B3||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3969211|NCT01295281|3791453|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3969212|NCT01295281|3791454|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3969213|NCT01295281|3791452|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3969214|NCT01295281|3791453|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3969215|NCT01295281|3791454|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3969216|NCT01295281|3791452|B3|||Age||years|Mean|72|72.0|Standard Deviation|10|10.0|||
3969217|NCT01295281|3791453|B2|||Age||years|Mean|72|72.0|Standard Deviation|10|10.0|||
3969218|NCT01295281|3791454|B1|||Age||years|Mean|71|71.0|Standard Deviation|10|10.0|||
3969219|NCT01295216|3791461|B3|Peru||Region of Enrollment||participants|Number|212|212.0||||||
3969220|NCT01295216|3791462|B2|Peru||Region of Enrollment||participants|Number|105|105.0||||||
3969221|NCT01295216|3791463|B1|Peru||Region of Enrollment||participants|Number|107|107.0||||||
3969222|NCT01295216|3791461|B3|Guatemala||Region of Enrollment||participants|Number|213|213.0||||||
3969223|NCT01295216|3791462|B2|Guatemala||Region of Enrollment||participants|Number|108|108.0||||||
3969224|NCT01295216|3791463|B1|Guatemala||Region of Enrollment||participants|Number|105|105.0||||||
3969225|NCT01295216|3791461|B3|Argentina||Region of Enrollment||participants|Number|212|212.0||||||
3969226|NCT01295216|3791462|B2|Argentina||Region of Enrollment||participants|Number|108|108.0||||||
3969227|NCT01295216|3791463|B1|Argentina||Region of Enrollment||participants|Number|104|104.0||||||
3969228|NCT01295216|3791461|B3||Male|Sex: Female, Male||Participants|Count of Participants|295|295.0||||||
3969229|NCT01295216|3791462|B2||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3969230|NCT01295216|3791463|B1||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3969231|NCT01295216|3791461|B3||Female|Sex: Female, Male||Participants|Count of Participants|342|342.0||||||
3969232|NCT01295216|3791462|B2||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
3969233|NCT01295216|3791463|B1||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3969234|NCT01295216|3791461|B3|||Age||Years|Mean|43.4|43.4|Standard Deviation|8.4|8.4|||
3969235|NCT01295216|3791462|B2|||Age||Years|Mean|43.2|43.2|Standard Deviation|8.4|8.4|||
3969236|NCT01295216|3791463|B1|||Age||Years|Mean|43.6|43.6|Standard Deviation|8.4|8.4|||
3969237|NCT01295112|3791480|B3|||Baseline Central Foveal Thickness in Fellow Eye||microns|Mean|211.2|211.2|Standard Deviation|36.9|36.9|||
3969238|NCT01295112|3791481|B2|||Baseline Central Foveal Thickness in Fellow Eye||microns|Mean|213.1|213.1|Standard Deviation|35.6|35.6|||
3969239|NCT01295112|3791482|B1|||Baseline Central Foveal Thickness in Fellow Eye||microns|Mean|209.3|209.3|Standard Deviation|39.1|39.1|||
3969240|NCT01295112|3791480|B3|||Baseline Central Foveal Thickness in Study Eye||microns|Mean|263.3|263.3|Standard Deviation|68.8|68.8|||
3969241|NCT01295112|3791481|B2|||Baseline Central Foveal Thickness in Study Eye||microns|Mean|262.1|262.1|Standard Deviation|70.0|70.0|||
3969242|NCT01295112|3791482|B1|||Baseline Central Foveal Thickness in Study Eye||microns|Mean|264.5|264.5|Standard Deviation|68.9|68.9|||
3969243|NCT01295112|3791480|B3|||Baselinen best corrected visual acuity (BCVA) in Fellow Eye|Best corrected visual acuity (BCVA): best possible vision a person can achieve with corrective lenses, measured using the method from the early treatment for diabetic retinopathy study (ETDRS) protocol. BCVA ranges from 0 to 100.|letters|Mean|82.1|82.1|Standard Deviation|11.2|11.2|||
3969244|NCT01295112|3791481|B2|||Baselinen best corrected visual acuity (BCVA) in Fellow Eye|Best corrected visual acuity (BCVA): best possible vision a person can achieve with corrective lenses, measured using the method from the early treatment for diabetic retinopathy study (ETDRS) protocol. BCVA ranges from 0 to 100.|letters|Mean|82.2|82.2|Standard Deviation|9.6|9.6|||
3969245|NCT01295112|3791482|B1|||Baselinen best corrected visual acuity (BCVA) in Fellow Eye|Best corrected visual acuity (BCVA): best possible vision a person can achieve with corrective lenses, measured using the method from the early treatment for diabetic retinopathy study (ETDRS) protocol. BCVA ranges from 0 to 100.|letters|Mean|82.0|82.0|Standard Deviation|12.6|12.6|||
3969246|NCT01295112|3791480|B3|||Baseline best corrected visual acuity (BCVA) in Study Eye|Best corrected visual acuity (BCVA): best possible vision a person can achieve with corrective lenses, measured using the method from the early treatment for diabetic retinopathy study (ETDRS) protocol. BCVA ranges from 0 to 100.|letters|Mean|52.5|52.5|Standard Deviation|17.8|17.8|||
3969247|NCT01295112|3791481|B2|||Baseline best corrected visual acuity (BCVA) in Study Eye|Best corrected visual acuity (BCVA): best possible vision a person can achieve with corrective lenses, measured using the method from the early treatment for diabetic retinopathy study (ETDRS) protocol. BCVA ranges from 0 to 100.|letters|Mean|55.7|55.7|Standard Deviation|17.2|17.2|||
3969248|NCT01295112|3791482|B1|||Baseline best corrected visual acuity (BCVA) in Study Eye|Best corrected visual acuity (BCVA): best possible vision a person can achieve with corrective lenses, measured using the method from the early treatment for diabetic retinopathy study (ETDRS) protocol. BCVA ranges from 0 to 100.|letters|Mean|49.6|49.6|Standard Deviation|18.2|18.2|||
3969249|NCT01295112|3791480|B3||OS|Study Eye||Participants|Count of Participants|35|35.0||||||
3969250|NCT01295112|3791481|B2||OS|Study Eye||Participants|Count of Participants|18|18.0||||||
3969251|NCT01295112|3791482|B1||OS|Study Eye||Participants|Count of Participants|17|17.0||||||
3969252|NCT01295112|3791480|B3||OD|Study Eye||Participants|Count of Participants|33|33.0||||||
3969253|NCT01295112|3791481|B2||OD|Study Eye||Participants|Count of Participants|15|15.0||||||
3969254|NCT01295112|3791482|B1||OD|Study Eye||Participants|Count of Participants|18|18.0||||||
3969255|NCT01295112|3791480|B3||Bevacizumab and Aflibercept|Previous Injections||Participants|Count of Participants|3|3.0||||||
3969256|NCT01295112|3791481|B2||Bevacizumab and Aflibercept|Previous Injections||Participants|Count of Participants|0|0.0||||||
3969257|NCT01295112|3791482|B1||Bevacizumab and Aflibercept|Previous Injections||Participants|Count of Participants|3|3.0||||||
3969258|NCT01295112|3791480|B3||Bevacizumab and Ranibizumab|Previous Injections||Participants|Count of Participants|2|2.0||||||
3969259|NCT01295112|3791481|B2||Bevacizumab and Ranibizumab|Previous Injections||Participants|Count of Participants|1|1.0||||||
3969260|NCT01295112|3791482|B1||Bevacizumab and Ranibizumab|Previous Injections||Participants|Count of Participants|1|1.0||||||
3969261|NCT01295112|3791480|B3||Ranibizumab|Previous Injections||Participants|Count of Participants|7|7.0||||||
3969262|NCT01295112|3791481|B2||Ranibizumab|Previous Injections||Participants|Count of Participants|3|3.0||||||
3969263|NCT01295112|3791482|B1||Ranibizumab|Previous Injections||Participants|Count of Participants|4|4.0||||||
3969264|NCT01295112|3791480|B3||No Injection|Previous Injections||Participants|Count of Participants|43|43.0||||||
3969265|NCT01295112|3791481|B2||No Injection|Previous Injections||Participants|Count of Participants|21|21.0||||||
3969266|NCT01295112|3791482|B1||No Injection|Previous Injections||Participants|Count of Participants|22|22.0||||||
3969267|NCT01295112|3791480|B3||Bevacizumab|Previous Injections||Participants|Count of Participants|13|13.0||||||
3969268|NCT01295112|3791481|B2||Bevacizumab|Previous Injections||Participants|Count of Participants|8|8.0||||||
3969269|NCT01295112|3791482|B1||Bevacizumab|Previous Injections||Participants|Count of Participants|5|5.0||||||
3969270|NCT01295112|3791480|B3||Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3969271|NCT01295112|3791481|B2||Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3969272|NCT01295112|3791482|B1||Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3969273|NCT01295112|3791480|B3||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3969274|NCT01295112|3791481|B2||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3969275|NCT01295112|3791482|B1||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3969276|NCT01295112|3791480|B3||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|49|49.0||||||
3969277|NCT01295112|3791481|B2||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3969278|NCT01295112|3791482|B1||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3969279|NCT01295112|3791480|B3||Black|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3969280|NCT01295112|3791481|B2||Black|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3969281|NCT01295112|3791482|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3969282|NCT01295112|3791480|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3969283|NCT01295112|3791481|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3969284|NCT01295112|3791482|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3969285|NCT01295112|3791480|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3969286|NCT01295112|3791481|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3969287|NCT01295112|3791482|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3969288|NCT01295112|3791480|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3969289|NCT01295112|3791481|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3969290|NCT01295112|3791482|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3969291|NCT01295112|3791480|B3|||Age||years|Mean|68.5|68.5|Standard Deviation|14.0|14.0|||
3969292|NCT01295112|3791481|B2|||Age||years|Mean|70.7|70.7|Standard Deviation|12.6|12.6|||
3969293|NCT01295112|3791482|B1|||Age||years|Mean|66.4|66.4|Standard Deviation|15.0|15.0|||
3969294|NCT01295034|3791491|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
3969295|NCT01295034|3791492|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3969296|NCT01295034|3791493|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
3969297|NCT01295034|3791491|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3969298|NCT01295034|3791492|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3969299|NCT01295034|3791493|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3969300|NCT01295034|3791491|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3969301|NCT01295034|3791492|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3969302|NCT01295034|3791493|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3969303|NCT01295034|3791491|B3|||Age||years|Median|48|48.0|Inter-Quartile Range|||41.0|51.0|
3969304|NCT01295034|3791492|B2|||Age||years|Median|48|48.0|Inter-Quartile Range|||42.0|52.0|
3969305|NCT01295034|3791493|B1|||Age||years|Median|47|47.0|Inter-Quartile Range|||39.0|51.0|
3969306|NCT01295034|3791491|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3969307|NCT01295034|3791492|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3969308|NCT01295034|3791493|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3969309|NCT01295034|3791491|B3||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
3969310|NCT01295034|3791492|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3969311|NCT01295034|3791493|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3969312|NCT01295034|3791491|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3969313|NCT01295034|3791492|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3969314|NCT01295034|3791493|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3969315|NCT01294917|3791502|B1|Canada||Region of Enrollment||participants|Number|42|42.0||||||
3969316|NCT01294917|3791502|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3969317|NCT01294917|3791502|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3969318|NCT01294917|3791502|B1|||Age||years|Mean|28.1|28.1|Standard Deviation|10.9|10.9|||
3969319|NCT01294917|3791502|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3969320|NCT01294917|3791502|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3969321|NCT01294917|3791502|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3969322|NCT01294800|3791508|B5||Male|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
3969323|NCT01294800|3791509|B4||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3969324|NCT01294800|3791510|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3969325|NCT01294800|3791511|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3969326|NCT01294800|3791512|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3969327|NCT01294800|3791508|B5||Female|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
3969328|NCT01294800|3791509|B4||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3969329|NCT01294800|3791510|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3969330|NCT01294800|3791511|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3969331|NCT01294800|3791512|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3969332|NCT01294800|3791508|B5|||Age||Years|Mean|67.3|67.3|Standard Deviation|8.3|8.3|||
3969333|NCT01294800|3791509|B4|||Age||Years|Mean|65.8|65.8|Standard Deviation|9.1|9.1|||
3969334|NCT01294800|3791510|B3|||Age||Years|Mean|67.8|67.8|Standard Deviation|7.6|7.6|||
3969335|NCT01294800|3791511|B2|||Age||Years|Mean|67.6|67.6|Standard Deviation|8.3|8.3|||
3969336|NCT01294800|3791512|B1|||Age||Years|Mean|68.0|68.0|Standard Deviation|7.9|7.9|||
3969337|NCT01294787|3791541|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3969338|NCT01294787|3791541|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3969339|NCT01294787|3791541|B1|All participants||Age||years|Mean|62.1|62.1|Standard Deviation|8.11|8.11|||
3969340|NCT01294748|3791588|B3|Sweden||Region of Enrollment||participants|Number|6|6.0||||||
3969341|NCT01294748|3791589|B2|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
3969342|NCT01294748|3791590|B1|Sweden||Region of Enrollment||participants|Number|5|5.0||||||
3969343|NCT01294748|3791588|B3|New Zealand||Region of Enrollment||participants|Number|7|7.0||||||
3969344|NCT01294748|3791589|B2|New Zealand||Region of Enrollment||participants|Number|3|3.0||||||
3969345|NCT01294748|3791590|B1|New Zealand||Region of Enrollment||participants|Number|4|4.0||||||
3969346|NCT01294748|3791588|B3|United Kingdom||Region of Enrollment||participants|Number|15|15.0||||||
3969347|NCT01294748|3791589|B2|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
3969348|NCT01294748|3791590|B1|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
3969349|NCT01294748|3791588|B3|Netherlands||Region of Enrollment||participants|Number|22|22.0||||||
3969350|NCT01294748|3791589|B2|Netherlands||Region of Enrollment||participants|Number|7|7.0||||||
3969351|NCT01294748|3791590|B1|Netherlands||Region of Enrollment||participants|Number|15|15.0||||||
3969352|NCT01294748|3791588|B3|Belgium||Region of Enrollment||participants|Number|124|124.0||||||
3969353|NCT01294748|3791589|B2|Belgium||Region of Enrollment||participants|Number|42|42.0||||||
3969354|NCT01294748|3791590|B1|Belgium||Region of Enrollment||participants|Number|82|82.0||||||
3969355|NCT01294748|3791588|B3|France||Region of Enrollment||participants|Number|10|10.0||||||
3969356|NCT01294748|3791589|B2|France||Region of Enrollment||participants|Number|3|3.0||||||
3969357|NCT01294748|3791590|B1|France||Region of Enrollment||participants|Number|7|7.0||||||
3969358|NCT01294748|3791588|B3||Male|Gender||Participants|Count of Participants|130|130.0||||||
3969359|NCT01294748|3791589|B2||Male|Gender||Participants|Count of Participants|45|45.0||||||
3969360|NCT01294748|3791590|B1||Male|Gender||Participants|Count of Participants|85|85.0||||||
3969361|NCT01294748|3791588|B3||Female|Gender||Participants|Count of Participants|54|54.0||||||
3969362|NCT01294748|3791589|B2||Female|Gender||Participants|Count of Participants|16|16.0||||||
3969363|NCT01294748|3791590|B1||Female|Gender||Participants|Count of Participants|38|38.0||||||
3969364|NCT01294748|3791588|B3||>=65 years|Age||Participants|Count of Participants|90|90.0||||||
3969365|NCT01294748|3791589|B2||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
3969366|NCT01294748|3791590|B1||>=65 years|Age||Participants|Count of Participants|62|62.0||||||
3969367|NCT01294748|3791588|B3||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
3969368|NCT01294748|3791589|B2||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3969369|NCT01294748|3791590|B1||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
3969370|NCT01294748|3791588|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3969371|NCT01294748|3791589|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3969372|NCT01294748|3791590|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3969373|NCT01294748|3791588|B3|||Age||years|Mean|65.02|65.02|Standard Deviation|10.42|10.42|||
3969374|NCT01294748|3791589|B2|||Age||years|Mean|65.13|65.13|Standard Deviation|10.47|10.47|||
3969375|NCT01294748|3791590|B1|||Age||years|Mean|64.96|64.96|Standard Deviation|10.43|10.43|||
3969376|NCT01294709|3791617|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3969377|NCT01294709|3791617|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3969378|NCT01294709|3791617|B1|||Age||years|Mean|63.5|63.5|Full Range|10.38|10.38|38.0|85.0|
3969379|NCT01294696|3791635|B3||Male|Sex: Female, Male||Participants|Count of Participants|379|379.0||||||
3969380|NCT01294696|3791636|B2||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3969381|NCT01294696|3791637|B1||Male|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
3969382|NCT01294696|3791635|B3||Female|Sex: Female, Male||Participants|Count of Participants|808|808.0||||||
3969383|NCT01294696|3791636|B2||Female|Sex: Female, Male||Participants|Count of Participants|479|479.0||||||
3969384|NCT01294696|3791637|B1||Female|Sex: Female, Male||Participants|Count of Participants|329|329.0||||||
3969385|NCT01294696|3791635|B3|||Age||Years|Mean|67.8|67.8|Standard Deviation|9.43|9.43|||
3969386|NCT01294696|3791636|B2|||Age||Years|Mean|68.0|68.0|Standard Deviation|9.76|9.76|||
3969387|NCT01294696|3791637|B1|||Age||Years|Mean|67.6|67.6|Standard Deviation|9.03|9.03|||
3969388|NCT01294683|3791649|B3||Male|Sex: Female, Male||Participants|Count of Participants|489|489.0||||||
3969389|NCT01294683|3791650|B2||Male|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
3969390|NCT01294683|3791651|B1||Male|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
3969391|NCT01294683|3791649|B3||Female|Sex: Female, Male||Participants|Count of Participants|488|488.0||||||
3969392|NCT01294683|3791650|B2||Female|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
3969393|NCT01294683|3791651|B1||Female|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
3969394|NCT01294683|3791649|B3|||Age||years|Mean|56.9|56.9|Standard Deviation|10.3|10.3|||
3969395|NCT01294683|3791650|B2|||Age||years|Mean|57.9|57.9|Standard Deviation|10.2|10.2|||
3969396|NCT01294683|3791651|B1|||Age||years|Mean|55.9|55.9|Standard Deviation|10.2|10.2|||
3969397|NCT01294644|3791702|B4|IV-VI||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|67|67.0||||||
3969398|NCT01294644|3791703|B3|IV-VI||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|23|23.0||||||
3969399|NCT01294644|3791704|B2|IV-VI||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|25|25.0||||||
3969400|NCT01294644|3791705|B1|IV-VI||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|19|19.0||||||
3969401|NCT01294644|3791702|B4|I-III||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|287|287.0||||||
3969402|NCT01294644|3791703|B3|I-III||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|91|91.0||||||
3969403|NCT01294644|3791704|B2|I-III||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|97|97.0||||||
3969404|NCT01294644|3791705|B1|I-III||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|99|99.0||||||
3969405|NCT01294644|3791702|B4|||Body Mass Index (BMI)||kg/m²|Mean|26.29|26.29|Standard Deviation|2.646|2.646|||
3969406|NCT01294644|3791703|B3|||Body Mass Index (BMI)||kg/m²|Mean|26.06|26.06|Standard Deviation|2.550|2.55|||
3969407|NCT01294644|3791704|B2|||Body Mass Index (BMI)||kg/m²|Mean|26.53|26.53|Standard Deviation|2.673|2.673|||
3969408|NCT01294644|3791705|B1|||Body Mass Index (BMI)||kg/m²|Mean|26.26|26.26|Standard Deviation|2.709|2.709|||
3969409|NCT01294644|3791702|B4|||Weight||kg|Mean|75.32|75.32|Standard Deviation|11.205|11.205|||
3969410|NCT01294644|3791703|B3|||Weight||kg|Mean|74.62|74.62|Standard Deviation|11.879|11.879|||
3969411|NCT01294644|3791704|B2|||Weight||kg|Mean|75.60|75.6|Standard Deviation|10.913|10.913|||
3969412|NCT01294644|3791705|B1|||Weight||kg|Mean|75.69|75.69|Standard Deviation|10.892|10.892|||
3969413|NCT01294644|3791702|B4|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3969414|NCT01294644|3791703|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3969415|NCT01294644|3791704|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3969416|NCT01294644|3791705|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3969417|NCT01294644|3791702|B4|White||Race/Ethnicity, Customized||participants|Number|329|329.0||||||
3969418|NCT01294644|3791703|B3|White||Race/Ethnicity, Customized||participants|Number|104|104.0||||||
3969419|NCT01294644|3791704|B2|White||Race/Ethnicity, Customized||participants|Number|114|114.0||||||
3969420|NCT01294644|3791705|B1|White||Race/Ethnicity, Customized||participants|Number|111|111.0||||||
3969421|NCT01294644|3791702|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3969422|NCT01294644|3791703|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3969423|NCT01294644|3791704|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3969424|NCT01294644|3791705|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3969425|NCT01294644|3791702|B4|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3969426|NCT01294644|3791703|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3969427|NCT01294644|3791704|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3969428|NCT01294644|3791705|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3969429|NCT01294644|3791702|B4||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3969430|NCT01294644|3791703|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3969431|NCT01294644|3791704|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3969432|NCT01294644|3791705|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3969433|NCT01294644|3791702|B4||Female|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
3969434|NCT01294644|3791703|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3969435|NCT01294644|3791704|B2||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3969436|NCT01294644|3791705|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3969437|NCT01294644|3791702|B4|51 - 65 years||Age, Customized||participants|Number|125|125.0||||||
3969438|NCT01294644|3791703|B3|51 - 65 years||Age, Customized||participants|Number|39|39.0||||||
3969439|NCT01294644|3791704|B2|51 - 65 years||Age, Customized||participants|Number|42|42.0||||||
3969440|NCT01294644|3791705|B1|51 - 65 years||Age, Customized||participants|Number|44|44.0||||||
3969441|NCT01294644|3791702|B4|18 - 50 years||Age, Customized||participants|Number|229|229.0||||||
3969442|NCT01294644|3791703|B3|18 - 50 years||Age, Customized||participants|Number|75|75.0||||||
3969443|NCT01294644|3791704|B2|18 - 50 years||Age, Customized||participants|Number|80|80.0||||||
3969444|NCT01294644|3791705|B1|18 - 50 years||Age, Customized||participants|Number|74|74.0||||||
3969445|NCT01294644|3791702|B4|||Age||years|Mean|46.0|46.0|Standard Deviation|9.87|9.87|||
3969446|NCT01294644|3791703|B3|||Age||years|Mean|46.1|46.1|Standard Deviation|9.50|9.5|||
3969447|NCT01294644|3791704|B2|||Age||years|Mean|45.9|45.9|Standard Deviation|9.95|9.95|||
3969448|NCT01294644|3791705|B1|||Age||years|Mean|45.9|45.9|Standard Deviation|10.21|10.21|||
3969449|NCT01294592|3791736|B3|Missing||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
3969450|NCT01294592|3791737|B2|Missing||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3969451|NCT01294592|3791738|B1|Missing||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3969452|NCT01294592|3791736|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3969453|NCT01294592|3791737|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3969454|NCT01294592|3791738|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3969455|NCT01294592|3791736|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3969456|NCT01294592|3791737|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3969457|NCT01294592|3791738|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3969458|NCT01294592|3791736|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3969459|NCT01294592|3791737|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3969460|NCT01294592|3791738|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3969461|NCT01294592|3791736|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|720|720.0||||||
3969462|NCT01294592|3791737|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|363|363.0||||||
3969463|NCT01294592|3791738|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|357|357.0||||||
3969464|NCT01294592|3791736|B3||Male|Sex: Female, Male||Participants|Count of Participants|742|742.0||||||
3969465|NCT01294592|3791737|B2||Male|Sex: Female, Male||Participants|Count of Participants|373|373.0||||||
3969466|NCT01294592|3791738|B1||Male|Sex: Female, Male||Participants|Count of Participants|369|369.0||||||
3969467|NCT01294592|3791736|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3969468|NCT01294592|3791737|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3969469|NCT01294592|3791738|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3969470|NCT01294592|3791736|B3|||Age||Years|Mean|66.2|66.2|Standard Deviation|7.56|7.56|||
3969471|NCT01294592|3791737|B2|||Age||Years|Mean|66.2|66.2|Standard Deviation|7.34|7.34|||
3969472|NCT01294592|3791738|B1|||Age||Years|Mean|66.3|66.3|Standard Deviation|7.78|7.78|||
3969473|NCT01294579|3791767|B1|Mixed race||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3969574|NCT01294436|3791817|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3969474|NCT01294579|3791767|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|45|45.0||||||
3969475|NCT01294579|3791767|B1|African American/African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3969476|NCT01294579|3791767|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3969477|NCT01294579|3791767|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3969478|NCT01294579|3791767|B1|||Age||years|Mean|66.3|66.3|Standard Deviation|11.61|11.61|||
3969479|NCT01294553|3791777|B1|Not Korean||Race/Ethnicity, Customized|Baseline characteristics were collected in members of the ITT Population, comprised of all participants who had been administered the investigational drug at least once and had undergone all safety assessments.|participants|Number|0|0.0||||||
3969480|NCT01294553|3791777|B1|Korean||Race/Ethnicity, Customized|Baseline characteristics were collected in members of the ITT Population, comprised of all participants who had been administered the investigational drug at least once and had undergone all safety assessments.|participants|Number|713|713.0||||||
3969481|NCT01294553|3791777|B1||Male|Sex: Female, Male|Baseline characteristics were collected in members of the ITT population, comprised of all participants who had been administered the investigational drug at least once and had undergone all safety assessments.|Participants|Count of Participants|344|344.0||||||
3969482|NCT01294553|3791777|B1||Female|Sex: Female, Male|Baseline characteristics were collected in members of the ITT population, comprised of all participants who had been administered the investigational drug at least once and had undergone all safety assessments.|Participants|Count of Participants|369|369.0||||||
3969483|NCT01294553|3791777|B1|||Age|Baseline characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who had been administered the investigational drug at least once and had undergone all safety assessments.|Years|Mean|56.4|56.4|Standard Deviation|11.5|11.5|||
3969484|NCT01294514|3791783|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3969485|NCT01294514|3791783|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3969486|NCT01294514|3791783|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3969487|NCT01294514|3791783|B1|||Age||years|Mean|35|35.0|Standard Deviation|10|10.0|||
3969488|NCT01294514|3791783|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3969489|NCT01294514|3791783|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3969490|NCT01294514|3791783|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3969491|NCT01294462|3791791|B3|Korean||Race/Ethnicity, Customized||Participants|Number|44|44.0||||||
3969492|NCT01294462|3791792|B2|Korean||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
3969493|NCT01294462|3791793|B1|Korean||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
3969494|NCT01294462|3791791|B3|Japanese||Race/Ethnicity, Customized||Participants|Number|721|721.0||||||
3969495|NCT01294462|3791792|B2|Japanese||Race/Ethnicity, Customized||Participants|Number|360|360.0||||||
3969496|NCT01294462|3791793|B1|Japanese||Race/Ethnicity, Customized||Participants|Number|361|361.0||||||
3969497|NCT01294462|3791791|B3|Chinese||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
3969498|NCT01294462|3791792|B2|Chinese||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
3969499|NCT01294462|3791793|B1|Chinese||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
3969500|NCT01294462|3791791|B3||Male|Sex: Female, Male||Participants|Count of Participants|612|612.0||||||
3969501|NCT01294462|3791792|B2||Male|Sex: Female, Male||Participants|Count of Participants|307|307.0||||||
3969502|NCT01294462|3791793|B1||Male|Sex: Female, Male||Participants|Count of Participants|305|305.0||||||
3969503|NCT01294462|3791791|B3||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3969504|NCT01294462|3791792|B2||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3969505|NCT01294462|3791793|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3969506|NCT01294462|3791791|B3|||Age||Years|Mean|67|67.0|Standard Deviation|11|11.0|||
3969507|NCT01294462|3791792|B2|||Age||Years|Mean|66|66.0|Standard Deviation|11|11.0|||
3969508|NCT01294462|3791793|B1|||Age||Years|Mean|67|67.0|Standard Deviation|12|12.0|||
3969509|NCT01294449|3791806|B3|Nonspecific Intraventricular Conduction||Conduction disorder||participants|Number|64|64.0||||||
3969510|NCT01294449|3791807|B2|Nonspecific Intraventricular Conduction||Conduction disorder||participants|Number|40|40.0||||||
3969511|NCT01294449|3791808|B1|Nonspecific Intraventricular Conduction||Conduction disorder||participants|Number|24|24.0||||||
3969512|NCT01294449|3791806|B3|Right Bundle Brach Block||Conduction disorder||participants|Number|53|53.0||||||
3969513|NCT01294449|3791807|B2|Right Bundle Brach Block||Conduction disorder||participants|Number|31|31.0||||||
3969514|NCT01294449|3791808|B1|Right Bundle Brach Block||Conduction disorder||participants|Number|22|22.0||||||
3969515|NCT01294449|3791806|B3|Left Bundle Branch Block||Conduction disorder||participants|Number|291|291.0||||||
3969516|NCT01294449|3791807|B2|Left Bundle Branch Block||Conduction disorder||participants|Number|181|181.0||||||
3969517|NCT01294449|3791808|B1|Left Bundle Branch Block||Conduction disorder||participants|Number|110|110.0||||||
3969518|NCT01294449|3791806|B3|||QRS duration||milliseconds|Mean|159|159.0|Standard Deviation|19|19.0|||
3969519|NCT01294449|3791807|B2|||QRS duration||milliseconds|Mean|159|159.0|Standard Deviation|18|18.0|||
3969520|NCT01294449|3791808|B1|||QRS duration||milliseconds|Mean|158|158.0|Standard Deviation|21|21.0|||
3969521|NCT01294449|3791806|B3|||Left Ventricular Ejection Fraction||percentage|Mean|24|24.0|Standard Deviation|6|6.0|||
3969522|NCT01294449|3791807|B2|||Left Ventricular Ejection Fraction||percentage|Mean|24|24.0|Standard Deviation|6|6.0|||
3969523|NCT01294449|3791808|B1|||Left Ventricular Ejection Fraction||percentage|Mean|24|24.0|Standard Deviation|5|5.0|||
3969524|NCT01294449|3791806|B3|NYHA Class II - Non Ischemic||New York Heart Association (NYHA) Class|"Definitions of New York Heart Association Classification:~NYHA Class I: Asymptomatic HF: no symptoms; NYHA Class II: Mild HF: symptomatic with moderate exertion"|participants|Number|210|210.0||||||
3969525|NCT01294449|3791807|B2|NYHA Class II - Non Ischemic||New York Heart Association (NYHA) Class|"Definitions of New York Heart Association Classification:~NYHA Class I: Asymptomatic HF: no symptoms; NYHA Class II: Mild HF: symptomatic with moderate exertion"|participants|Number|129|129.0||||||
3969526|NCT01294449|3791808|B1|NYHA Class II - Non Ischemic||New York Heart Association (NYHA) Class|"Definitions of New York Heart Association Classification:~NYHA Class I: Asymptomatic HF: no symptoms; NYHA Class II: Mild HF: symptomatic with moderate exertion"|participants|Number|81|81.0||||||
3969527|NCT01294449|3791806|B3|NYHA Class II - Ischemic||New York Heart Association (NYHA) Class|"Definitions of New York Heart Association Classification:~NYHA Class I: Asymptomatic HF: no symptoms; NYHA Class II: Mild HF: symptomatic with moderate exertion"|participants|Number|141|141.0||||||
3969528|NCT01294449|3791807|B2|NYHA Class II - Ischemic||New York Heart Association (NYHA) Class|"Definitions of New York Heart Association Classification:~NYHA Class I: Asymptomatic HF: no symptoms; NYHA Class II: Mild HF: symptomatic with moderate exertion"|participants|Number|87|87.0||||||
3969529|NCT01294449|3791808|B1|NYHA Class II - Ischemic||New York Heart Association (NYHA) Class|"Definitions of New York Heart Association Classification:~NYHA Class I: Asymptomatic HF: no symptoms; NYHA Class II: Mild HF: symptomatic with moderate exertion"|participants|Number|54|54.0||||||
3969530|NCT01294449|3791806|B3|NYHA Class I - Ischemic||New York Heart Association (NYHA) Class|"Definitions of New York Heart Association Classification:~NYHA Class I: Asymptomatic HF: no symptoms; NYHA Class II: Mild HF: symptomatic with moderate exertion"|participants|Number|57|57.0||||||
3969531|NCT01294449|3791807|B2|NYHA Class I - Ischemic||New York Heart Association (NYHA) Class|"Definitions of New York Heart Association Classification:~NYHA Class I: Asymptomatic HF: no symptoms; NYHA Class II: Mild HF: symptomatic with moderate exertion"|participants|Number|36|36.0||||||
3969532|NCT01294449|3791808|B1|NYHA Class I - Ischemic||New York Heart Association (NYHA) Class|"Definitions of New York Heart Association Classification:~NYHA Class I: Asymptomatic HF: no symptoms; NYHA Class II: Mild HF: symptomatic with moderate exertion"|participants|Number|21|21.0||||||
3969533|NCT01294449|3791806|B3|United States||Region of Enrollment||participants|Number|408|408.0||||||
3969534|NCT01294449|3791807|B2|United States||Region of Enrollment||participants|Number|252|252.0||||||
3969535|NCT01294449|3791808|B1|United States||Region of Enrollment||participants|Number|156|156.0||||||
3969536|NCT01294449|3791806|B3||Male|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
3969537|NCT01294449|3791807|B2||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3969538|NCT01294449|3791808|B1||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3969539|NCT01294449|3791806|B3||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3969540|NCT01294449|3791807|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3969541|NCT01294449|3791808|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3969542|NCT01294449|3791806|B3||>=65 years|Age||Participants|Count of Participants|205|205.0||||||
3969543|NCT01294449|3791807|B2||>=65 years|Age||Participants|Count of Participants|126|126.0||||||
3969544|NCT01294449|3791808|B1||>=65 years|Age||Participants|Count of Participants|79|79.0||||||
3969545|NCT01294449|3791806|B3||Between 18 and 65 years|Age||Participants|Count of Participants|203|203.0||||||
3969546|NCT01294449|3791807|B2||Between 18 and 65 years|Age||Participants|Count of Participants|126|126.0||||||
3969547|NCT01294449|3791808|B1||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
3969548|NCT01294449|3791806|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3969549|NCT01294449|3791807|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3969550|NCT01294449|3791808|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3969551|NCT01294436|3791815|B3|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|144.93|144.93|Standard Deviation|28.057|28.057|||
3969552|NCT01294436|3791816|B2|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|147.35|147.35|Standard Deviation|29.097|29.097|||
3969553|NCT01294436|3791817|B1|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|140.29|140.29|Standard Deviation|25.355|25.355|||
3969554|NCT01294436|3791815|B3|||HbA1c||Percent|Mean|7.72|7.72|Standard Deviation|0.842|0.842|||
3969555|NCT01294436|3791816|B2|||HbA1c||Percent|Mean|7.82|7.82|Standard Deviation|0.865|0.865|||
3969556|NCT01294436|3791817|B1|||HbA1c||Percent|Mean|7.53|7.53|Standard Deviation|0.761|0.761|||
3969557|NCT01294436|3791815|B3|||Seated Systolic Blood Pressure||mmHg|Mean|126.4|126.4|Standard Deviation|14.01|14.01|||
3969558|NCT01294436|3791816|B2|||Seated Systolic Blood Pressure||mmHg|Mean|125.8|125.8|Standard Deviation|14.13|14.13|||
3969559|NCT01294436|3791817|B1|||Seated Systolic Blood Pressure||mmHg|Mean|127.5|127.5|Standard Deviation|13.73|13.73|||
3969560|NCT01294436|3791815|B3|||Body Mass Index||kg/m^2|Mean|25.64|25.64|Standard Deviation|4.355|4.355|||
3969561|NCT01294436|3791816|B2|||Body Mass Index||kg/m^2|Mean|25.61|25.61|Standard Deviation|4.440|4.44|||
3969562|NCT01294436|3791817|B1|||Body Mass Index||kg/m^2|Mean|25.72|25.72|Standard Deviation|4.196|4.196|||
3969563|NCT01294436|3791815|B3|||Body Weight||kg|Mean|67.52|67.52|Standard Deviation|14.157|14.157|||
3969564|NCT01294436|3791816|B2|||Body Weight||kg|Mean|67.40|67.4|Standard Deviation|14.529|14.529|||
3969565|NCT01294436|3791817|B1|||Body Weight||kg|Mean|67.77|67.77|Standard Deviation|13.437|13.437|||
3969566|NCT01294436|3791815|B3|Japan||Region of Enrollment||participants|Number|728|728.0||||||
3969567|NCT01294436|3791816|B2|Japan||Region of Enrollment||participants|Number|479|479.0||||||
3969568|NCT01294436|3791817|B1|Japan||Region of Enrollment||participants|Number|249|249.0||||||
3969569|NCT01294436|3791815|B3||Male|Sex: Female, Male||Participants|Count of Participants|414|414.0||||||
3969570|NCT01294436|3791816|B2||Male|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
3969571|NCT01294436|3791817|B1||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3969572|NCT01294436|3791815|B3||Female|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
3969573|NCT01294436|3791816|B2||Female|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
3969575|NCT01294436|3791815|B3|>= 75 years||Age, Customized||participants|Number|24|24.0||||||
3969576|NCT01294436|3791816|B2|>= 75 years||Age, Customized||participants|Number|12|12.0||||||
3969577|NCT01294436|3791817|B1|>= 75 years||Age, Customized||participants|Number|12|12.0||||||
3969578|NCT01294436|3791815|B3|65 - <75 years||Age, Customized||participants|Number|157|157.0||||||
3969579|NCT01294436|3791816|B2|65 - <75 years||Age, Customized||participants|Number|102|102.0||||||
3969580|NCT01294436|3791817|B1|65 - <75 years||Age, Customized||participants|Number|55|55.0||||||
3969581|NCT01294436|3791815|B3|< 65 years||Age, Customized||participants|Number|547|547.0||||||
3969582|NCT01294436|3791816|B2|< 65 years||Age, Customized||participants|Number|365|365.0||||||
3969583|NCT01294436|3791817|B1|< 65 years||Age, Customized||participants|Number|182|182.0||||||
3969584|NCT01294436|3791815|B3|||Age||years|Mean|57.5|57.5|Standard Deviation|10.18|10.18|||
3969585|NCT01294436|3791816|B2|||Age||years|Mean|57.2|57.2|Standard Deviation|10.06|10.06|||
3969586|NCT01294436|3791817|B1|||Age||years|Mean|58.1|58.1|Standard Deviation|10.40|10.4|||
3969587|NCT01294423|3791850|B4|||FPG||mg/dL|Mean|138.6|138.6|Standard Deviation|22.68|22.68|||
3969588|NCT01294423|3791851|B3|||FPG||mg/dL|Mean|139.6|139.6|Standard Deviation|21.63|21.63|||
3969589|NCT01294423|3791852|B2|||FPG||mg/dL|Mean|138.8|138.8|Standard Deviation|22.14|22.14|||
3969590|NCT01294423|3791853|B1|||FPG||mg/dL|Mean|137.5|137.5|Standard Deviation|24.41|24.41|||
3969591|NCT01294423|3791850|B4|||HbA1c||Percent|Mean|7.49|7.49|Standard Deviation|0.649|0.649|||
3969592|NCT01294423|3791851|B3|||HbA1c||Percent|Mean|7.50|7.5|Standard Deviation|0.625|0.625|||
3969593|NCT01294423|3791852|B2|||HbA1c||Percent|Mean|7.46|7.46|Standard Deviation|0.608|0.608|||
3969594|NCT01294423|3791853|B1|||HbA1c||Percent|Mean|7.50|7.5|Standard Deviation|0.718|0.718|||
3969595|NCT01294423|3791850|B4|||Seated Systolic Blood Pressure||mmHg|Mean|124.9|124.9|Standard Deviation|13.41|13.41|||
3969596|NCT01294423|3791851|B3|||Seated Systolic Blood Pressure||mmHg|Mean|126.5|126.5|Standard Deviation|14.36|14.36|||
3969597|NCT01294423|3791852|B2|||Seated Systolic Blood Pressure||mmHg|Mean|126.2|126.2|Standard Deviation|12.46|12.46|||
3969598|NCT01294423|3791853|B1|||Seated Systolic Blood Pressure||mmHg|Mean|122.0|122.0|Standard Deviation|13.01|13.01|||
3969599|NCT01294423|3791850|B4|||Body Mass Index||kg/m^2|Mean|25.39|25.39|Standard Deviation|4.296|4.296|||
3969600|NCT01294423|3791851|B3|||Body Mass Index||kg/m^2|Mean|25.22|25.22|Standard Deviation|4.394|4.394|||
3969601|NCT01294423|3791852|B2|||Body Mass Index||kg/m^2|Mean|26.06|26.06|Standard Deviation|4.519|4.519|||
3969602|NCT01294423|3791853|B1|||Body Mass Index||kg/m^2|Mean|24.88|24.88|Standard Deviation|3.907|3.907|||
3969603|NCT01294423|3791850|B4|||Body Weight||kg|Mean|67.17|67.17|Standard Deviation|13.777|13.777|||
3969604|NCT01294423|3791851|B3|||Body Weight||kg|Mean|65.96|65.96|Standard Deviation|12.908|12.908|||
3969605|NCT01294423|3791852|B2|||Body Weight||kg|Mean|69.70|69.7|Standard Deviation|13.821|13.821|||
3969606|NCT01294423|3791853|B1|||Body Weight||kg|Mean|65.81|65.81|Standard Deviation|14.371|14.371|||
3969607|NCT01294423|3791850|B4|Japan||Region of Enrollment||participants|Number|261|261.0||||||
3969608|NCT01294423|3791851|B3|Japan||Region of Enrollment||participants|Number|87|87.0||||||
3969609|NCT01294423|3791852|B2|Japan||Region of Enrollment||participants|Number|88|88.0||||||
3969610|NCT01294423|3791853|B1|Japan||Region of Enrollment||participants|Number|86|86.0||||||
3969611|NCT01294423|3791850|B4||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3969612|NCT01294423|3791851|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3969613|NCT01294423|3791852|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3969614|NCT01294423|3791853|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3969615|NCT01294423|3791850|B4||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3969616|NCT01294423|3791851|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3969617|NCT01294423|3791852|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3969618|NCT01294423|3791853|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3969619|NCT01294423|3791850|B4|>= 75 years||Age, Customized||participants|Number|8|8.0||||||
3969620|NCT01294423|3791851|B3|>= 75 years||Age, Customized||participants|Number|3|3.0||||||
3969621|NCT01294423|3791852|B2|>= 75 years||Age, Customized||participants|Number|1|1.0||||||
3969622|NCT01294423|3791853|B1|>= 75 years||Age, Customized||participants|Number|4|4.0||||||
3969623|NCT01294423|3791850|B4|65 - <75 years||Age, Customized||participants|Number|72|72.0||||||
3969624|NCT01294423|3791851|B3|65 - <75 years||Age, Customized||participants|Number|29|29.0||||||
3969625|NCT01294423|3791852|B2|65 - <75 years||Age, Customized||participants|Number|20|20.0||||||
3969626|NCT01294423|3791853|B1|65 - <75 years||Age, Customized||participants|Number|23|23.0||||||
3969627|NCT01294423|3791850|B4|< 65 years||Age, Customized||participants|Number|181|181.0||||||
3969628|NCT01294423|3791851|B3|< 65 years||Age, Customized||participants|Number|55|55.0||||||
3969629|NCT01294423|3791852|B2|< 65 years||Age, Customized||participants|Number|67|67.0||||||
3969630|NCT01294423|3791853|B1|< 65 years||Age, Customized||participants|Number|59|59.0||||||
3969631|NCT01294423|3791850|B4|||Age||years|Mean|58.9|58.9|Standard Deviation|9.83|9.83|||
3969632|NCT01294423|3791851|B3|||Age||years|Mean|60.4|60.4|Standard Deviation|9.65|9.65|||
3969633|NCT01294423|3791852|B2|||Age||years|Mean|57.5|57.5|Standard Deviation|9.29|9.29|||
3969634|NCT01294423|3791853|B1|||Age||years|Mean|58.6|58.6|Standard Deviation|10.41|10.41|||
3969635|NCT01294397|3791869|B1|White||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3969636|NCT01294397|3791869|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3969637|NCT01294397|3791869|B1|Mixed race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3969638|NCT01294397|3791869|B1|Black (or African American)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3969639|NCT01294397|3791869|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3969640|NCT01294397|3791869|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3969641|NCT01294397|3791869|B1|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3969642|NCT01294397|3791869|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3969643|NCT01294397|3791869|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3969644|NCT01294397|3791869|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3969645|NCT01294397|3791869|B1|||Age||years|Mean|63.1|63.1|Standard Deviation|6.6|6.6|||
3969646|NCT01294384|3791879|B4||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3969647|NCT01294384|3791880|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3969648|NCT01294384|3791881|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3969649|NCT01294384|3791882|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3969650|NCT01294384|3791879|B4||Female|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
3969651|NCT01294384|3791880|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3969652|NCT01294384|3791881|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3969653|NCT01294384|3791882|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3969654|NCT01294384|3791879|B4|> 60 years||Age, Customized||Participants|Number|158|158.0||||||
3969655|NCT01294384|3791880|B3|> 60 years||Age, Customized||Participants|Number|54|54.0||||||
3969656|NCT01294384|3791881|B2|> 60 years||Age, Customized||Participants|Number|54|54.0||||||
3969657|NCT01294384|3791882|B1|> 60 years||Age, Customized||Participants|Number|50|50.0||||||
3969658|NCT01294384|3791879|B4|40 to 60 years||Age, Customized||Participants|Number|118|118.0||||||
3969659|NCT01294384|3791880|B3|40 to 60 years||Age, Customized||Participants|Number|43|43.0||||||
3969660|NCT01294384|3791881|B2|40 to 60 years||Age, Customized||Participants|Number|33|33.0||||||
3969661|NCT01294384|3791882|B1|40 to 60 years||Age, Customized||Participants|Number|42|42.0||||||
3969662|NCT01294384|3791879|B4|< 40 years||Age, Customized||Participants|Number|29|29.0||||||
3969663|NCT01294384|3791880|B3|< 40 years||Age, Customized||Participants|Number|7|7.0||||||
3969664|NCT01294384|3791881|B2|< 40 years||Age, Customized||Participants|Number|13|13.0||||||
3969665|NCT01294384|3791882|B1|< 40 years||Age, Customized||Participants|Number|9|9.0||||||
3969666|NCT01294371|3791913|B1|Severe||Severity of Endometriosis|"Surgically, endometriosis can be staged I–IV (Revised Classification of the American Society of Reproductive Medicine) per the following:~Stage I (Minimal): Findings restricted to only superficial lesions and possibly a few filmy adhesions;~Stage II (Mild): In addition, some deep lesions are present in the cul-de-sac;~Stage III (Moderate): As above, plus presence of endometriomas on the ovary and more adhesions;~Stage IV (Severe): As above, plus large endometriomas, extensive adhesions."|participants|Number|115|115.0||||||
3969667|NCT01294371|3791913|B1|Moderate||Severity of Endometriosis|"Surgically, endometriosis can be staged I–IV (Revised Classification of the American Society of Reproductive Medicine) per the following:~Stage I (Minimal): Findings restricted to only superficial lesions and possibly a few filmy adhesions;~Stage II (Mild): In addition, some deep lesions are present in the cul-de-sac;~Stage III (Moderate): As above, plus presence of endometriomas on the ovary and more adhesions;~Stage IV (Severe): As above, plus large endometriomas, extensive adhesions."|participants|Number|180|180.0||||||
3969668|NCT01294371|3791913|B1|Mild||Severity of Endometriosis|"Surgically, endometriosis can be staged I–IV (Revised Classification of the American Society of Reproductive Medicine) per the following:~Stage I (Minimal): Findings restricted to only superficial lesions and possibly a few filmy adhesions;~Stage II (Mild): In addition, some deep lesions are present in the cul-de-sac;~Stage III (Moderate): As above, plus presence of endometriomas on the ovary and more adhesions;~Stage IV (Severe): As above, plus large endometriomas, extensive adhesions."|participants|Number|74|74.0||||||
3969669|NCT01294371|3791913|B1|Minimal||Severity of Endometriosis|"Surgically, endometriosis can be staged I–IV (Revised Classification of the American Society of Reproductive Medicine) per the following:~Stage I (Minimal): Findings restricted to only superficial lesions and possibly a few filmy adhesions;~Stage II (Mild): In addition, some deep lesions are present in the cul-de-sac;~Stage III (Moderate): As above, plus presence of endometriomas on the ovary and more adhesions;~Stage IV (Severe): As above, plus large endometriomas, extensive adhesions."|participants|Number|22|22.0||||||
3969670|NCT01294371|3791913|B1|||Time from endometriosis diagnosis||months|Mean|3.8|3.8|Standard Deviation|16.7|16.7|||
3969671|NCT01294371|3791913|B1|Combined type||Endometriosis location|Endometriosis is divided into genital and extra-genital by location. Genital endometriosis is internal endometriosis - adenomyosis (endometriosis of the uterus). Extra-genital endometriosis is external endometriosis (endometriosis of the uterine cervix, vagina, retro cervix area, ovaries, fallopian tubes, peritoneum, rectouterine space).|participants|Number|104|104.0||||||
3969672|NCT01294371|3791913|B1|Internal endometriosis||Endometriosis location|Endometriosis is divided into genital and extra-genital by location. Genital endometriosis is internal endometriosis - adenomyosis (endometriosis of the uterus). Extra-genital endometriosis is external endometriosis (endometriosis of the uterine cervix, vagina, retro cervix area, ovaries, fallopian tubes, peritoneum, rectouterine space).|participants|Number|108|108.0||||||
3969673|NCT01294371|3791913|B1|External endometriosis||Endometriosis location|Endometriosis is divided into genital and extra-genital by location. Genital endometriosis is internal endometriosis - adenomyosis (endometriosis of the uterus). Extra-genital endometriosis is external endometriosis (endometriosis of the uterine cervix, vagina, retro cervix area, ovaries, fallopian tubes, peritoneum, rectouterine space).|participants|Number|179|179.0||||||
3969674|NCT01294371|3791913|B1|Russian Federation||Region of Enrollment||participants|Number|391|391.0||||||
3969675|NCT01294371|3791913|B1|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3969676|NCT01294371|3791913|B1|White||Race/Ethnicity, Customized||participants|Number|386|386.0||||||
3969677|NCT01294371|3791913|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3969678|NCT01294371|3791913|B1||Female|Sex: Female, Male||Participants|Count of Participants|391|391.0||||||
3969679|NCT01294371|3791913|B1|||Age||years|Mean|33.8|33.8|Standard Deviation|7.3|7.3|||
3969680|NCT01294358|3791921|B1|||Serum CA 19-9 Level at the Time of Enrollment|The reference range of CA 19-9 is <37 units/mL.|Units/ml|Median|133|133.0|Full Range|||1.0|521.0|
3969681|NCT01294358|3791921|B1|||Time from Diagnosis to Trial Enrollment||Months|Median|8.5|8.5|Full Range|||5.0|16.0|
3969682|NCT01294358|3791921|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3969683|NCT01294358|3791921|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3969684|NCT01294358|3791921|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3969685|NCT01294358|3791921|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3969686|NCT01294358|3791921|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3969687|NCT01294358|3791921|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3969688|NCT01294358|3791921|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3969689|NCT01294358|3791921|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3969690|NCT01294358|3791921|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3969691|NCT01294358|3791921|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3969692|NCT01294358|3791921|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3969693|NCT01294358|3791921|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3969694|NCT01294358|3791921|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3969695|NCT01294358|3791921|B1|||Age||years|Mean|67.57|67.57|Standard Deviation|6.2|6.2|||
3969696|NCT01294358|3791921|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3969697|NCT01294358|3791921|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3969698|NCT01294358|3791921|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3969699|NCT01294319|3791979|B9|||Fat mass||kg|Mean|16.61|16.61|Standard Deviation|5.45|5.45|||
3969700|NCT01294319|3791980|B8|||Fat mass||kg|Mean|13.69|13.69|Standard Deviation|4.56|4.56|||
3969701|NCT01294319|3791981|B7|||Fat mass||kg|Mean|17.64|17.64|Standard Deviation|4.31|4.31|||
3969702|NCT01294319|3791982|B6|||Fat mass||kg|Mean|15.13|15.13|Standard Deviation|3.79|3.79|||
3969703|NCT01294319|3791983|B5|||Fat mass||kg|Mean|19.21|19.21|Standard Deviation|8.69|8.69|||
3969704|NCT01294319|3791984|B4|||Fat mass||kg|Mean|14.70|14.7|Standard Deviation|3.19|3.19|||
3969705|NCT01294319|3791985|B3|||Fat mass||kg|Mean|19.13|19.13|Standard Deviation|4.80|4.8|||
3969706|NCT01294319|3791986|B2|||Fat mass||kg|Mean|16.73|16.73|Standard Deviation|5.60|5.6|||
3969707|NCT01294319|3791987|B1|||Fat mass||kg|Mean|16.28|16.28|Standard Deviation|8.05|8.05|||
3969708|NCT01294319|3791979|B9|||Total Fat Percent||percent|Mean|21.33|21.33|Standard Deviation|5.28|5.28|||
3969709|NCT01294319|3791980|B8|||Total Fat Percent||percent|Mean|16.8|16.8|Standard Deviation|4.04|4.04|||
3969710|NCT01294319|3791981|B7|||Total Fat Percent||percent|Mean|24.4|24.4|Standard Deviation|5.16|5.16|||
3969711|NCT01294319|3791982|B6|||Total Fat Percent||percent|Mean|19.7|19.7|Standard Deviation|5.15|5.15|||
3969712|NCT01294319|3791983|B5|||Total Fat Percent||percent|Mean|23.2|23.2|Standard Deviation|5.82|5.82|||
3969713|NCT01294319|3791984|B4|||Total Fat Percent||percent|Mean|19.5|19.5|Standard Deviation|1.99|1.99|||
3969714|NCT01294319|3791985|B3|||Total Fat Percent||percent|Mean|25.2|25.2|Standard Deviation|5.11|5.11|||
3969715|NCT01294319|3791986|B2|||Total Fat Percent||percent|Mean|20.2|20.2|Standard Deviation|5.16|5.16|||
3969716|NCT01294319|3791987|B1|||Total Fat Percent||percent|Mean|21.1|21.1|Standard Deviation|6.90|6.9|||
3969717|NCT01294319|3791979|B9|Unknown||Race||Participants|Count of Participants|11|11.0||||||
3969718|NCT01294319|3791980|B8|Unknown||Race||Participants|Count of Participants|4|4.0||||||
3969719|NCT01294319|3791981|B7|Unknown||Race||Participants|Count of Participants|1|1.0||||||
3969720|NCT01294319|3791982|B6|Unknown||Race||Participants|Count of Participants|0|0.0||||||
3969721|NCT01294319|3791983|B5|Unknown||Race||Participants|Count of Participants|1|1.0||||||
3969722|NCT01294319|3791984|B4|Unknown||Race||Participants|Count of Participants|0|0.0||||||
3969723|NCT01294319|3791985|B3|Unknown||Race||Participants|Count of Participants|1|1.0||||||
3969724|NCT01294319|3791986|B2|Unknown||Race||Participants|Count of Participants|2|2.0||||||
3969725|NCT01294319|3791987|B1|Unknown||Race||Participants|Count of Participants|2|2.0||||||
3969726|NCT01294319|3791979|B9|White||Race||Participants|Count of Participants|17|17.0||||||
3969727|NCT01294319|3791980|B8|White||Race||Participants|Count of Participants|1|1.0||||||
3969728|NCT01294319|3791981|B7|White||Race||Participants|Count of Participants|2|2.0||||||
3969729|NCT01294319|3791982|B6|White||Race||Participants|Count of Participants|2|2.0||||||
3969730|NCT01294319|3791983|B5|White||Race||Participants|Count of Participants|2|2.0||||||
3969731|NCT01294319|3791984|B4|White||Race||Participants|Count of Participants|4|4.0||||||
3969732|NCT01294319|3791985|B3|White||Race||Participants|Count of Participants|2|2.0||||||
3969733|NCT01294319|3791986|B2|White||Race||Participants|Count of Participants|3|3.0||||||
3969734|NCT01294319|3791987|B1|White||Race||Participants|Count of Participants|1|1.0||||||
3969735|NCT01294319|3791979|B9|Black||Race||Participants|Count of Participants|4|4.0||||||
3969736|NCT01294319|3791980|B8|Black||Race||Participants|Count of Participants|0|0.0||||||
3969737|NCT01294319|3791981|B7|Black||Race||Participants|Count of Participants|1|1.0||||||
3969738|NCT01294319|3791982|B6|Black||Race||Participants|Count of Participants|1|1.0||||||
3969739|NCT01294319|3791983|B5|Black||Race||Participants|Count of Participants|2|2.0||||||
3969740|NCT01294319|3791984|B4|Black||Race||Participants|Count of Participants|0|0.0||||||
3969741|NCT01294319|3791985|B3|Black||Race||Participants|Count of Participants|0|0.0||||||
3969742|NCT01294319|3791986|B2|Black||Race||Participants|Count of Participants|0|0.0||||||
3969743|NCT01294319|3791987|B1|Black||Race||Participants|Count of Participants|0|0.0||||||
3969744|NCT01294319|3791979|B9|Asian||Race||Participants|Count of Participants|7|7.0||||||
3969745|NCT01294319|3791980|B8|Asian||Race||Participants|Count of Participants|0|0.0||||||
3969746|NCT01294319|3791981|B7|Asian||Race||Participants|Count of Participants|1|1.0||||||
3969747|NCT01294319|3791982|B6|Asian||Race||Participants|Count of Participants|1|1.0||||||
3969748|NCT01294319|3791983|B5|Asian||Race||Participants|Count of Participants|0|0.0||||||
3969749|NCT01294319|3791984|B4|Asian||Race||Participants|Count of Participants|1|1.0||||||
3969750|NCT01294319|3791985|B3|Asian||Race||Participants|Count of Participants|2|2.0||||||
3969751|NCT01294319|3791986|B2|Asian||Race||Participants|Count of Participants|1|1.0||||||
3969752|NCT01294319|3791987|B1|Asian||Race||Participants|Count of Participants|1|1.0||||||
3969753|NCT01294319|3791979|B9|||Body Mass Index||Kg/m^2|Mean|23.53|23.53|Standard Deviation|2.63|2.63|||
3969754|NCT01294319|3791980|B8|||Body Mass Index||Kg/m^2|Mean|22.8|22.8|Standard Deviation|2.00|2.0|||
3969755|NCT01294319|3791981|B7|||Body Mass Index||Kg/m^2|Mean|23.4|23.4|Standard Deviation|2.98|2.98|||
3969756|NCT01294319|3791982|B6|||Body Mass Index||Kg/m^2|Mean|24.1|24.1|Standard Deviation|1.10|1.1|||
3969757|NCT01294319|3791983|B5|||Body Mass Index||Kg/m^2|Mean|24.2|24.2|Standard Deviation|2.75|2.75|||
3969758|NCT01294319|3791984|B4|||Body Mass Index||Kg/m^2|Mean|22.3|22.3|Standard Deviation|1.89|1.89|||
3969759|NCT01294319|3791985|B3|||Body Mass Index||Kg/m^2|Mean|23.7|23.7|Standard Deviation|3.04|3.04|||
3969760|NCT01294319|3791986|B2|||Body Mass Index||Kg/m^2|Mean|24.0|24.0|Standard Deviation|3.27|3.27|||
3969761|NCT01294319|3791987|B1|||Body Mass Index||Kg/m^2|Mean|23.6|23.6|Standard Deviation|4.33|4.33|||
3969762|NCT01294319|3791979|B9|Unknown||Sex/Gender, Customized||Participants|Count of Participants|2|2.0||||||
3969763|NCT01294319|3791980|B8|Unknown||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3969764|NCT01294319|3791981|B7|Unknown||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3969765|NCT01294319|3791982|B6|Unknown||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3969766|NCT01294319|3791983|B5|Unknown||Sex/Gender, Customized||Participants|Count of Participants|1|1.0||||||
3969767|NCT01294319|3791984|B4|Unknown||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3969768|NCT01294319|3791985|B3|Unknown||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3969769|NCT01294319|3791986|B2|Unknown||Sex/Gender, Customized||Participants|Count of Participants|1|1.0||||||
3969770|NCT01294319|3791987|B1|Unknown||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3969771|NCT01294319|3791979|B9|Male||Sex/Gender, Customized||Participants|Count of Participants|37|37.0||||||
3969772|NCT01294319|3791980|B8|Male||Sex/Gender, Customized||Participants|Count of Participants|5|5.0||||||
3969773|NCT01294319|3791981|B7|Male||Sex/Gender, Customized||Participants|Count of Participants|5|5.0||||||
3969774|NCT01294319|3791982|B6|Male||Sex/Gender, Customized||Participants|Count of Participants|4|4.0||||||
3969775|NCT01294319|3791983|B5|Male||Sex/Gender, Customized||Participants|Count of Participants|4|4.0||||||
3969776|NCT01294319|3791984|B4|Male||Sex/Gender, Customized||Participants|Count of Participants|5|5.0||||||
3969777|NCT01294319|3791985|B3|Male||Sex/Gender, Customized||Participants|Count of Participants|5|5.0||||||
3969778|NCT01294319|3791986|B2|Male||Sex/Gender, Customized||Participants|Count of Participants|5|5.0||||||
3969779|NCT01294319|3791987|B1|Male||Sex/Gender, Customized||Participants|Count of Participants|4|4.0||||||
3969780|NCT01294319|3791979|B9|||Age||years|Mean|24.73|24.73|Standard Deviation|2.87|2.87|||
3969781|NCT01294319|3791980|B8|||Age||years|Mean|23.6|23.6|Standard Deviation|4.01|4.01|||
3969782|NCT01294319|3791981|B7|||Age||years|Mean|27.8|27.8|Standard Deviation|3.06|3.06|||
3969783|NCT01294319|3791982|B6|||Age||years|Mean|24.5|24.5|Standard Deviation|4.22|4.22|||
3969784|NCT01294319|3791983|B5|||Age||years|Mean|23.3|23.3|Standard Deviation|2.97|2.97|||
3969785|NCT01294319|3791984|B4|||Age||years|Mean|25.2|25.2|Standard Deviation|1.79|1.79|||
3969786|NCT01294319|3791985|B3|||Age||years|Mean|24.2|24.2|Standard Deviation|2.33|2.33|||
3969787|NCT01294319|3791986|B2|||Age||years|Mean|25.01|25.01|Standard Deviation|1.58|1.58|||
3969788|NCT01294319|3791987|B1|||Age||years|Mean|23.57|23.57|Standard Deviation|0.99|0.99|||
3969789|NCT01294306|3792002|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
3969790|NCT01294306|3792003|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
3969791|NCT01294306|3792004|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
3969792|NCT01294306|3792002|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3969793|NCT01294306|3792003|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3969794|NCT01294306|3792004|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3969795|NCT01294306|3792002|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3969796|NCT01294306|3792003|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3969797|NCT01294306|3792004|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3969798|NCT01294306|3792002|B3||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3969799|NCT01294306|3792003|B2||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3969800|NCT01294306|3792004|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3969801|NCT01294306|3792002|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3969802|NCT01294306|3792003|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3969803|NCT01294306|3792004|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3969804|NCT01294306|3792002|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3969805|NCT01294306|3792003|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3969806|NCT01294306|3792004|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3969807|NCT01294306|3792002|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3969808|NCT01294306|3792003|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3969809|NCT01294306|3792004|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3969810|NCT01294306|3792002|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3969811|NCT01294306|3792003|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3969812|NCT01294306|3792004|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3969813|NCT01294306|3792002|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3969814|NCT01294306|3792003|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3969815|NCT01294306|3792004|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3969816|NCT01294306|3792002|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3969817|NCT01294306|3792003|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3969818|NCT01294306|3792004|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3969819|NCT01294306|3792002|B3|||Age||years|Median|64|64.0|Full Range|||40.0|86.0|
3969820|NCT01294306|3792003|B2|||Age||years|Median|63|63.0|Full Range|||40.0|83.0|
3969821|NCT01294306|3792004|B1|||Age||years|Median|64|64.0|Full Range|||44.0|86.0|
3969822|NCT01294267|3792019|B1|||Diabetes Mellitus||Participants|Count of Participants|6|6.0||||||
3969823|NCT01294267|3792019|B1|||Chronic Kidney Disease||Participants|Count of Participants|6|6.0||||||
3969824|NCT01294267|3792019|B1|||Hypertension||Participants|Count of Participants|14|14.0||||||
3969825|NCT01294267|3792019|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3969826|NCT01294267|3792019|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3969827|NCT01294267|3792019|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3969828|NCT01294267|3792019|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3969829|NCT01294267|3792019|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3969830|NCT01294267|3792019|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3969831|NCT01294267|3792019|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3969832|NCT01294267|3792019|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3969833|NCT01294267|3792019|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3969834|NCT01294267|3792019|B1|||Age||years|Mean|58.5|58.5|Standard Deviation|11.6|11.6|||
3969835|NCT01294241|3792025|B1|Germany||Region of Enrollment||participants|Number|10|10.0||||||
3969836|NCT01294241|3792025|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3969837|NCT01294241|3792025|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3969838|NCT01294241|3792025|B1|||Age||years|Median|20|20.0|Full Range|||6.0|48.0|
3969839|NCT01294241|3792025|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3969840|NCT01294241|3792025|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3969841|NCT01294241|3792025|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3969842|NCT01294228|3792033|B1|United States||Region of Enrollment||participants|Number|790|790.0||||||
3969843|NCT01294228|3792033|B1|Canada||Region of Enrollment||participants|Number|81|81.0||||||
3969844|NCT01294228|3792033|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3969845|NCT01294228|3792033|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3969846|NCT01294228|3792033|B1||White|Race (NIH/OMB)||Participants|Count of Participants|625|625.0||||||
3969847|NCT01294228|3792033|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|187|187.0||||||
3969848|NCT01294228|3792033|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3969849|NCT01294228|3792033|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3969850|NCT01294228|3792033|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3969851|NCT01294228|3792033|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3969852|NCT01294228|3792033|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|809|809.0||||||
3969853|NCT01294228|3792033|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3969854|NCT01294228|3792033|B1||Male|Gender||Participants|Count of Participants|496|496.0||||||
3969855|NCT01294228|3792033|B1||Female|Gender||Participants|Count of Participants|375|375.0||||||
3969856|NCT01294228|3792033|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|15.7|15.7|||
3969857|NCT01294163|3792037|B4|||BMI||kg/m²|Mean|27.55|27.55|Standard Deviation|3.78|3.78|||
3969858|NCT01294163|3792038|B3|||BMI||kg/m²|Mean|27.78|27.78|Standard Deviation|4.00|4.0|||
3969859|NCT01294163|3792039|B2|||BMI||kg/m²|Mean|27.21|27.21|Standard Deviation|3.68|3.68|||
3969860|NCT01294163|3792040|B1|||BMI||kg/m²|Mean|27.65|27.65|Standard Deviation|3.64|3.64|||
3969861|NCT01294163|3792037|B4|Germany||Region of Enrollment||participants|Number|172|172.0||||||
3969862|NCT01294163|3792038|B3|Germany||Region of Enrollment||participants|Number|58|58.0||||||
3969863|NCT01294163|3792039|B2|Germany||Region of Enrollment||participants|Number|57|57.0||||||
3969864|NCT01294163|3792040|B1|Germany||Region of Enrollment||participants|Number|57|57.0||||||
3969865|NCT01294163|3792037|B4|France||Region of Enrollment||participants|Number|275|275.0||||||
3969866|NCT01294163|3792038|B3|France||Region of Enrollment||participants|Number|93|93.0||||||
3969867|NCT01294163|3792039|B2|France||Region of Enrollment||participants|Number|93|93.0||||||
3969868|NCT01294163|3792040|B1|France||Region of Enrollment||participants|Number|89|89.0||||||
3969869|NCT01294163|3792037|B4|Italy||Region of Enrollment||participants|Number|11|11.0||||||
3969870|NCT01294163|3792038|B3|Italy||Region of Enrollment||participants|Number|4|4.0||||||
3969871|NCT01294163|3792039|B2|Italy||Region of Enrollment||participants|Number|4|4.0||||||
3969872|NCT01294163|3792040|B1|Italy||Region of Enrollment||participants|Number|3|3.0||||||
3969873|NCT01294163|3792037|B4|Netherlands||Region of Enrollment||participants|Number|34|34.0||||||
3969874|NCT01294163|3792038|B3|Netherlands||Region of Enrollment||participants|Number|11|11.0||||||
3969875|NCT01294163|3792039|B2|Netherlands||Region of Enrollment||participants|Number|11|11.0||||||
3969876|NCT01294163|3792040|B1|Netherlands||Region of Enrollment||participants|Number|12|12.0||||||
3969877|NCT01294163|3792037|B4||Male|Sex: Female, Male||Participants|Count of Participants|428|428.0||||||
3969878|NCT01294163|3792038|B3||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3969879|NCT01294163|3792039|B2||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3969880|NCT01294163|3792040|B1||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3969881|NCT01294163|3792037|B4||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3969882|NCT01294163|3792038|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3969883|NCT01294163|3792039|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3969884|NCT01294163|3792040|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3969885|NCT01294163|3792037|B4|||Age||years|Mean|64.14|64.14|Standard Deviation|9.06|9.06|||
3969886|NCT01294163|3792038|B3|||Age||years|Mean|63.89|63.89|Standard Deviation|9.40|9.4|||
3969887|NCT01294163|3792039|B2|||Age||years|Mean|63.86|63.86|Standard Deviation|8.66|8.66|||
3969888|NCT01294163|3792040|B1|||Age||years|Mean|64.66|64.66|Standard Deviation|9.12|9.12|||
3969889|NCT01294150|3792051|B3|Australia||Region of Enrollment||participants|Number|37|37.0||||||
3969890|NCT01294150|3792052|B2|Australia||Region of Enrollment||participants|Number|11|11.0||||||
3969891|NCT01294150|3792053|B1|Australia||Region of Enrollment||participants|Number|26|26.0||||||
3969892|NCT01294150|3792051|B3|Canada||Region of Enrollment||participants|Number|30|30.0||||||
3969893|NCT01294150|3792052|B2|Canada||Region of Enrollment||participants|Number|10|10.0||||||
3969894|NCT01294150|3792053|B1|Canada||Region of Enrollment||participants|Number|20|20.0||||||
3969895|NCT01294150|3792051|B3|United States||Region of Enrollment||participants|Number|139|139.0||||||
3969896|NCT01294150|3792052|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
3969897|NCT01294150|3792053|B1|United States||Region of Enrollment||participants|Number|94|94.0||||||
3969898|NCT01294150|3792051|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3969899|NCT01294150|3792052|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3969900|NCT01294150|3792053|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3969901|NCT01294150|3792051|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3969902|NCT01294150|3792052|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3969903|NCT01294150|3792053|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3969904|NCT01294150|3792051|B3||White|Race (NIH/OMB)||Participants|Count of Participants|193|193.0||||||
3969905|NCT01294150|3792052|B2||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3969906|NCT01294150|3792053|B1||White|Race (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
3969907|NCT01294150|3792051|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3969908|NCT01294150|3792052|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3969909|NCT01294150|3792053|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3969910|NCT01294150|3792051|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3969911|NCT01294150|3792052|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3969912|NCT01294150|3792053|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3969913|NCT01294150|3792051|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3969914|NCT01294150|3792052|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3969915|NCT01294150|3792053|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3969916|NCT01294150|3792051|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3969917|NCT01294150|3792052|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3969918|NCT01294150|3792053|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3969919|NCT01294150|3792051|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3969920|NCT01294150|3792052|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3969921|NCT01294150|3792053|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3969922|NCT01294150|3792051|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|199|199.0||||||
3969923|NCT01294150|3792052|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3969924|NCT01294150|3792053|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|136|136.0||||||
3969925|NCT01294150|3792051|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3969926|NCT01294150|3792052|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3969927|NCT01294150|3792053|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3969928|NCT01294150|3792051|B3||Male|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
3969929|NCT01294150|3792052|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3969930|NCT01294150|3792053|B1||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3969931|NCT01294150|3792051|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3969932|NCT01294150|3792052|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3969933|NCT01294150|3792053|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3969934|NCT01294150|3792051|B3|||Age||years|Mean|66|66.0|Standard Deviation|8.6|8.6|||
3969935|NCT01294150|3792052|B2|||Age||years|Mean|65|65.0|Standard Deviation|8.0|8.0|||
3969936|NCT01294150|3792053|B1|||Age||years|Mean|67|67.0|Standard Deviation|8.6|8.6|||
3969937|NCT01294098|3792064|B4|United States||Region of Enrollment||participants|Number|2|2.0||||||
3969938|NCT01294098|3792065|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3969939|NCT01294098|3792066|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3969940|NCT01294098|3792064|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3969941|NCT01294098|3792065|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3969942|NCT01294098|3792066|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3969943|NCT01294098|3792064|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3969944|NCT01294098|3792065|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3969945|NCT01294098|3792066|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3969946|NCT01294098|3792064|B4|||Age||years|Mean|10.5|10.5|Full Range|||8.0|13.0|
3969947|NCT01294098|3792065|B3|||Age||years|Mean|8|8.0|Full Range|||8.0|8.0|
3969948|NCT01294098|3792066|B2|||Age||years|Mean|13|13.0|Full Range|||13.0|13.0|
3969949|NCT01294098|3792064|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3969950|NCT01294098|3792065|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3969951|NCT01294098|3792066|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3969952|NCT01294098|3792064|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3969953|NCT01294098|3792065|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3969954|NCT01294098|3792066|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3969955|NCT01294098|3792064|B4||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3969956|NCT01294098|3792065|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3969957|NCT01294098|3792066|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3969958|NCT01294046|3792083|B1||>=65 years|Age||||0|0.0||||||
3969959|NCT01294046|3792083|B1||Between 18 and 65 years|Age||||0|0.0||||||
3969960|NCT01294046|3792083|B1||<=18 years|Age||||0|0.0||||||
3969961|NCT01293968|3792096|B3|Iran, Islamic Republic of||Region of Enrollment||participants|Number|31|31.0||||||
3969962|NCT01293968|3792097|B2|Iran, Islamic Republic of||Region of Enrollment||participants|Number|14|14.0||||||
3969963|NCT01293968|3792098|B1|Iran, Islamic Republic of||Region of Enrollment||participants|Number|17|17.0||||||
3969964|NCT01293968|3792096|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3969965|NCT01293968|3792097|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3969966|NCT01293968|3792098|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3969967|NCT01293968|3792096|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3969968|NCT01293968|3792097|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3969969|NCT01293968|3792098|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3969970|NCT01293968|3792096|B3|||Age||years|Mean|32.2|32.2|Standard Deviation|10.02|10.02|||
3969971|NCT01293968|3792097|B2|||Age||years|Mean|32.0|32.0|Standard Deviation|10.0|10.0|||
3969972|NCT01293968|3792098|B1|||Age||years|Mean|32.4|32.4|Standard Deviation|10.04|10.04|||
3969973|NCT01293968|3792096|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3969974|NCT01293968|3792097|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3969975|NCT01293968|3792098|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3969976|NCT01293968|3792096|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3969977|NCT01293968|3792097|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3969978|NCT01293968|3792098|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3969979|NCT01293968|3792096|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3969980|NCT01293968|3792097|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3969981|NCT01293968|3792098|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3969982|NCT01293825|3792105|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3969983|NCT01293825|3792105|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3969984|NCT01293825|3792105|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3969985|NCT01293825|3792105|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3969986|NCT01293825|3792105|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3969987|NCT01293825|3792105|B1|||Age||years|Mean|44.2|44.2|Standard Deviation|10.2|10.2|||
3969988|NCT01293695|3792117|B3|||Pittsburg Sleep Quality Index (PSQI)|The Pittsburg Sleep Quality Index (PSQI) is a self-report inventory designed to measure sleep quality. The participants self rated their sleep quality over seven areas of sleep.The questions about sleep quality are answered on a 0-3 scale with higher scores indicating greater sleep pathology. The global score was determined by summing the raw scores of the seven sleep components. The global score can range from 0 - 21 and total scores above 5 are normally considered indicative of poor sleep quality.|units on a scale|Mean|11.79|11.79|Standard Deviation|.52|0.52|||
3969989|NCT01293695|3792118|B2|||Pittsburg Sleep Quality Index (PSQI)|The Pittsburg Sleep Quality Index (PSQI) is a self-report inventory designed to measure sleep quality. The participants self rated their sleep quality over seven areas of sleep.The questions about sleep quality are answered on a 0-3 scale with higher scores indicating greater sleep pathology. The global score was determined by summing the raw scores of the seven sleep components. The global score can range from 0 - 21 and total scores above 5 are normally considered indicative of poor sleep quality.|units on a scale|Mean|11.89|11.89|Standard Deviation|.48|0.48|||
3969990|NCT01293695|3792119|B1|||Pittsburg Sleep Quality Index (PSQI)|The Pittsburg Sleep Quality Index (PSQI) is a self-report inventory designed to measure sleep quality. The participants self rated their sleep quality over seven areas of sleep.The questions about sleep quality are answered on a 0-3 scale with higher scores indicating greater sleep pathology. The global score was determined by summing the raw scores of the seven sleep components. The global score can range from 0 - 21 and total scores above 5 are normally considered indicative of poor sleep quality.|units on a scale|Mean|11.69|11.69|Standard Deviation|.56|0.56|||
3969991|NCT01293695|3792117|B3|||Hot Flash Related Daily Interference Scale (HFRDIS)|This questionnaire was used to measure the effects of hot flashes on women as they go about their daily activities. Answers on the scale can range 0 (Do Not Interfere) to 10 (Completely Interfere). The total score was computed by averaging the subjective ratings over the 10 items. A lower score indicates better outcome.|units on a scale|Mean|5.81|5.81|Standard Deviation|24|24.0|||
3969992|NCT01293695|3792118|B2|||Hot Flash Related Daily Interference Scale (HFRDIS)|This questionnaire was used to measure the effects of hot flashes on women as they go about their daily activities. Answers on the scale can range 0 (Do Not Interfere) to 10 (Completely Interfere). The total score was computed by averaging the subjective ratings over the 10 items. A lower score indicates better outcome.|units on a scale|Mean|5.75|5.75|Standard Deviation|.24|0.24|||
3969993|NCT01293695|3792119|B1|||Hot Flash Related Daily Interference Scale (HFRDIS)|This questionnaire was used to measure the effects of hot flashes on women as they go about their daily activities. Answers on the scale can range 0 (Do Not Interfere) to 10 (Completely Interfere). The total score was computed by averaging the subjective ratings over the 10 items. A lower score indicates better outcome.|units on a scale|Mean|5.87|5.87|Standard Deviation|.23|0.23|||
3969994|NCT01293695|3792117|B3|||Biolog Hot Flash Monitor (physiological measure)|As a secondary outcome, hot flashes were measured using a Biolog ambulatory recorder. Skin conductance was expressed in micro Siemens (0 to infinity) and the final value was obtained by averaging the recorded skin conductance for a period of 24 hours. Lower skin conductance measure indicates less sweating.|micro Siemens|Mean|9.63|9.63|Standard Deviation|.88|0.88|||
3969995|NCT01293695|3792118|B2|||Biolog Hot Flash Monitor (physiological measure)|As a secondary outcome, hot flashes were measured using a Biolog ambulatory recorder. Skin conductance was expressed in micro Siemens (0 to infinity) and the final value was obtained by averaging the recorded skin conductance for a period of 24 hours. Lower skin conductance measure indicates less sweating.|micro Siemens|Mean|8.85|8.85|Standard Deviation|.75|0.75|||
3969996|NCT01293695|3792119|B1|||Biolog Hot Flash Monitor (physiological measure)|As a secondary outcome, hot flashes were measured using a Biolog ambulatory recorder. Skin conductance was expressed in micro Siemens (0 to infinity) and the final value was obtained by averaging the recorded skin conductance for a period of 24 hours. Lower skin conductance measure indicates less sweating.|micro Siemens|Mean|10.41|10.41|Standard Deviation|1|1.0|||
3969997|NCT01293695|3792117|B3|||Hot Flash Score|"Hot Flash Score is a product of frequency of hot flashes × severity of hot flashes, which could range from 0 (best possible outcome) to infinity (worst possible outcome).~Hot flash frequency and hot flash severity were obtained using the Hot Flash Symptoms Diary. Participants recorded their daily hot flashes marking each hot flash (frequency) and rating the severity of each as mild (1), moderate (2), severe (3), and very severe (4).~The values presented represent the average of daily hot flash scores."|units on a scale|Mean|23.69|23.69|Standard Deviation|1.13|1.13|||
3969998|NCT01293695|3792118|B2|||Hot Flash Score|"Hot Flash Score is a product of frequency of hot flashes × severity of hot flashes, which could range from 0 (best possible outcome) to infinity (worst possible outcome).~Hot flash frequency and hot flash severity were obtained using the Hot Flash Symptoms Diary. Participants recorded their daily hot flashes marking each hot flash (frequency) and rating the severity of each as mild (1), moderate (2), severe (3), and very severe (4).~The values presented represent the average of daily hot flash scores."|units on a scale|Mean|22.94|22.94|Standard Deviation|1.23|1.23|||
3969999|NCT01293695|3792119|B1|||Hot Flash Score|"Hot Flash Score is a product of frequency of hot flashes × severity of hot flashes, which could range from 0 (best possible outcome) to infinity (worst possible outcome).~Hot flash frequency and hot flash severity were obtained using the Hot Flash Symptoms Diary. Participants recorded their daily hot flashes marking each hot flash (frequency) and rating the severity of each as mild (1), moderate (2), severe (3), and very severe (4).~The values presented represent the average of daily hot flash scores."|units on a scale|Mean|24.43|24.43|Standard Deviation|1.02|1.02|||
3970000|NCT01293695|3792117|B3|||Hot Flash Frequency|Hot flash frequency and hot flash severity were obtained using the Hot Flash Symptoms Diary. Participants recorded their hot flashes over seven days marking each hot flash (frequency) and rating the severity of each as mild (1), moderate (2), severe (3), and very severe (4).|hot flashes per week|Mean|75.24|75.24|Standard Deviation|2.97|2.97|||
3970061|NCT01293695|3792118|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3970001|NCT01293695|3792118|B2|||Hot Flash Frequency|Hot flash frequency and hot flash severity were obtained using the Hot Flash Symptoms Diary. Participants recorded their hot flashes over seven days marking each hot flash (frequency) and rating the severity of each as mild (1), moderate (2), severe (3), and very severe (4).|hot flashes per week|Mean|75.21|75.21|Standard Deviation|3.11|3.11|||
3970002|NCT01293695|3792119|B1|||Hot Flash Frequency|Hot flash frequency and hot flash severity were obtained using the Hot Flash Symptoms Diary. Participants recorded their hot flashes over seven days marking each hot flash (frequency) and rating the severity of each as mild (1), moderate (2), severe (3), and very severe (4).|hot flashes per week|Mean|75.26|75.26|Standard Deviation|2.82|2.82|||
3970003|NCT01293695|3792117|B3|Graduate Degree||Education||participants|Number|19|19.0||||||
3970004|NCT01293695|3792118|B2|Graduate Degree||Education||participants|Number|8|8.0||||||
3970005|NCT01293695|3792119|B1|Graduate Degree||Education||participants|Number|11|11.0||||||
3970006|NCT01293695|3792117|B3|Bachelor's Degree||Education||participants|Number|36|36.0||||||
3970007|NCT01293695|3792118|B2|Bachelor's Degree||Education||participants|Number|22|22.0||||||
3970008|NCT01293695|3792119|B1|Bachelor's Degree||Education||participants|Number|14|14.0||||||
3970009|NCT01293695|3792117|B3|Associate Degree||Education||participants|Number|24|24.0||||||
3970010|NCT01293695|3792118|B2|Associate Degree||Education||participants|Number|12|12.0||||||
3970011|NCT01293695|3792119|B1|Associate Degree||Education||participants|Number|12|12.0||||||
3970012|NCT01293695|3792117|B3|College, non degree||Education||participants|Number|40|40.0||||||
3970013|NCT01293695|3792118|B2|College, non degree||Education||participants|Number|20|20.0||||||
3970014|NCT01293695|3792119|B1|College, non degree||Education||participants|Number|20|20.0||||||
3970015|NCT01293695|3792117|B3|High School Diploma||Education||participants|Number|52|52.0||||||
3970016|NCT01293695|3792118|B2|High School Diploma||Education||participants|Number|26|26.0||||||
3970017|NCT01293695|3792119|B1|High School Diploma||Education||participants|Number|26|26.0||||||
3970018|NCT01293695|3792117|B3|Less than High School||Education||participants|Number|16|16.0||||||
3970019|NCT01293695|3792118|B2|Less than High School||Education||participants|Number|6|6.0||||||
3970020|NCT01293695|3792119|B1|Less than High School||Education||participants|Number|10|10.0||||||
3970021|NCT01293695|3792117|B3|Widowed||Marital Status||participants|Number|6|6.0||||||
3970022|NCT01293695|3792118|B2|Widowed||Marital Status||participants|Number|2|2.0||||||
3970023|NCT01293695|3792119|B1|Widowed||Marital Status||participants|Number|4|4.0||||||
3970024|NCT01293695|3792117|B3|Single||Marital Status||participants|Number|31|31.0||||||
3970025|NCT01293695|3792118|B2|Single||Marital Status||participants|Number|12|12.0||||||
3970026|NCT01293695|3792119|B1|Single||Marital Status||participants|Number|19|19.0||||||
3970027|NCT01293695|3792117|B3|Separated||Marital Status||participants|Number|10|10.0||||||
3970028|NCT01293695|3792118|B2|Separated||Marital Status||participants|Number|5|5.0||||||
3970029|NCT01293695|3792119|B1|Separated||Marital Status||participants|Number|5|5.0||||||
3970030|NCT01293695|3792117|B3|Divorced||Marital Status||participants|Number|18|18.0||||||
3970031|NCT01293695|3792118|B2|Divorced||Marital Status||participants|Number|10|10.0||||||
3970032|NCT01293695|3792119|B1|Divorced||Marital Status||participants|Number|8|8.0||||||
3970033|NCT01293695|3792117|B3|Married||Marital Status||participants|Number|122|122.0||||||
3970034|NCT01293695|3792118|B2|Married||Marital Status||participants|Number|65|65.0||||||
3970035|NCT01293695|3792119|B1|Married||Marital Status||participants|Number|57|57.0||||||
3970036|NCT01293695|3792117|B3|United States||Region of Enrollment||participants|Number|187|187.0||||||
3970037|NCT01293695|3792118|B2|United States||Region of Enrollment||participants|Number|94|94.0||||||
3970038|NCT01293695|3792119|B1|United States||Region of Enrollment||participants|Number|93|93.0||||||
3970039|NCT01293695|3792117|B3|White||Race/Ethnicity, Customized||participants|Number|138|138.0||||||
3970040|NCT01293695|3792118|B2|White||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
3970041|NCT01293695|3792119|B1|White||Race/Ethnicity, Customized||participants|Number|64|64.0||||||
3970042|NCT01293695|3792117|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3970043|NCT01293695|3792118|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3970044|NCT01293695|3792119|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3970045|NCT01293695|3792117|B3|African American||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3970046|NCT01293695|3792118|B2|African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3970047|NCT01293695|3792119|B1|African American||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3970048|NCT01293695|3792117|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3970049|NCT01293695|3792118|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3970050|NCT01293695|3792119|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3970051|NCT01293695|3792117|B3|American Indian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3970052|NCT01293695|3792118|B2|American Indian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3970053|NCT01293695|3792119|B1|American Indian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3970054|NCT01293695|3792117|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3970055|NCT01293695|3792118|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3970056|NCT01293695|3792119|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3970057|NCT01293695|3792117|B3||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
3970058|NCT01293695|3792118|B2||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3970059|NCT01293695|3792119|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3970060|NCT01293695|3792117|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3970062|NCT01293695|3792119|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3970063|NCT01293695|3792117|B3||Between 18 and 65 years|Age||Participants|Count of Participants|171|171.0||||||
3970064|NCT01293695|3792118|B2||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
3970065|NCT01293695|3792119|B1||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
3970066|NCT01293695|3792117|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970067|NCT01293695|3792118|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970068|NCT01293695|3792119|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970069|NCT01293539|3792134|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3970070|NCT01293539|3792134|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3970071|NCT01293539|3792134|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970072|NCT01293539|3792134|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3970073|NCT01293539|3792134|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3970074|NCT01293539|3792134|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970075|NCT01293539|3792134|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970076|NCT01293539|3792134|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970077|NCT01293539|3792134|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970078|NCT01293539|3792134|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3970079|NCT01293539|3792134|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3970080|NCT01293539|3792134|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3970081|NCT01293539|3792134|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3970082|NCT01293539|3792134|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3970083|NCT01293539|3792134|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3970084|NCT01293539|3792134|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
3970085|NCT01293240|3792138|B1|Male||Gender|This reporting group includes 115 enrolled and dispensed participants - i.e., 117 total minus 2 missing responses.|participants|Number|36|36.0||||||
3970086|NCT01293240|3792138|B1|Female||Gender|This reporting group includes 115 enrolled and dispensed participants - i.e., 117 total minus 2 missing responses.|participants|Number|79|79.0||||||
3970087|NCT01293240|3792138|B1|||Age|This reporting group includes 114 enrolled and dispensed participants - i.e., 117 total minus 3 missing responses.|years|Mean|45.8|45.8|Standard Deviation|12.6|12.6|||
3970088|NCT01293084|3792153|B1|Other||Genotype||participants|Number|1|1.0||||||
3970089|NCT01293084|3792153|B1|F508heterozygous||Genotype||participants|Number|2|2.0||||||
3970090|NCT01293084|3792153|B1|F508del homozygous||Genotype||participants|Number|9|9.0||||||
3970091|NCT01293084|3792153|B1|||FEV1 (% predicted)||percent predicted|Median|108|108.0|Inter-Quartile Range|||102.5|117.5|
3970092|NCT01293084|3792153|B1|||FVC (% predicted)||percent predicted|Median|107|107.0|Inter-Quartile Range|||101.5|116.0|
3970093|NCT01293084|3792153|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3970094|NCT01293084|3792153|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3970095|NCT01293084|3792153|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3970096|NCT01293084|3792153|B1|||Age||years|Median|10.5|10.5|Inter-Quartile Range|||8.9|12.4|
3970097|NCT01293032|3792161|B5|United States||Region of Enrollment||participants|Number|48|48.0||||||
3970098|NCT01293032|3792162|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
3970099|NCT01293032|3792163|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
3970100|NCT01293032|3792164|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3970101|NCT01293032|3792165|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3970102|NCT01293032|3792161|B5|Canada||Region of Enrollment||participants|Number|11|11.0||||||
3970103|NCT01293032|3792162|B4|Canada||Region of Enrollment||participants|Number|4|4.0||||||
3970104|NCT01293032|3792163|B3|Canada||Region of Enrollment||participants|Number|2|2.0||||||
3970105|NCT01293032|3792164|B2|Canada||Region of Enrollment||participants|Number|4|4.0||||||
3970106|NCT01293032|3792165|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
3970107|NCT01293032|3792161|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970108|NCT01293032|3792162|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970109|NCT01293032|3792163|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970110|NCT01293032|3792164|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970111|NCT01293032|3792165|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970112|NCT01293032|3792161|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970113|NCT01293032|3792162|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970114|NCT01293032|3792163|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970115|NCT01293032|3792164|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970116|NCT01293032|3792165|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970117|NCT01293032|3792161|B5||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3970118|NCT01293032|3792162|B4||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3970119|NCT01293032|3792163|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3970120|NCT01293032|3792164|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3970121|NCT01293032|3792165|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3970122|NCT01293032|3792161|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3970123|NCT01293032|3792162|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3970124|NCT01293032|3792163|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3970125|NCT01293032|3792164|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970126|NCT01293032|3792165|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3970127|NCT01293032|3792161|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970128|NCT01293032|3792162|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970129|NCT01293032|3792163|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970130|NCT01293032|3792164|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970131|NCT01293032|3792165|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970132|NCT01293032|3792161|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970133|NCT01293032|3792162|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970134|NCT01293032|3792163|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970135|NCT01293032|3792164|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970136|NCT01293032|3792165|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970137|NCT01293032|3792161|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970138|NCT01293032|3792162|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970139|NCT01293032|3792163|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970140|NCT01293032|3792164|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970141|NCT01293032|3792165|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970142|NCT01293032|3792161|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3970143|NCT01293032|3792162|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970144|NCT01293032|3792163|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970145|NCT01293032|3792164|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3970146|NCT01293032|3792165|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970147|NCT01293032|3792161|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3970148|NCT01293032|3792162|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3970149|NCT01293032|3792163|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3970150|NCT01293032|3792164|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3970151|NCT01293032|3792165|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3970152|NCT01293032|3792161|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3970153|NCT01293032|3792162|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970154|NCT01293032|3792163|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3970155|NCT01293032|3792164|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970156|NCT01293032|3792165|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3970157|NCT01293032|3792161|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3970158|NCT01293032|3792162|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3970159|NCT01293032|3792163|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3970160|NCT01293032|3792164|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3970161|NCT01293032|3792165|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3970162|NCT01293032|3792161|B5||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3970163|NCT01293032|3792162|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3970164|NCT01293032|3792163|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3970165|NCT01293032|3792164|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3970166|NCT01293032|3792165|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3970167|NCT01293032|3792161|B5|||Age||years|Mean|61.25423729|61.25423729|Standard Deviation|10.52188724|10.52188724|||
3970168|NCT01293032|3792162|B4|||Age||years|Mean|60.64286|60.64286|Standard Deviation|7.312867|7.312867|||
3970169|NCT01293032|3792163|B3|||Age||years|Mean|55.3125|55.3125|Standard Deviation|12.2556|12.2556|||
3970170|NCT01293032|3792164|B2|||Age||years|Mean|63.64706|63.64706|Standard Deviation|11.5539|11.5539|||
3970171|NCT01293032|3792165|B1|||Age||years|Mean|55.3125|55.3125|Standard Deviation|5.931426|5.931426|||
3970172|NCT01293032|3792161|B5||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3970173|NCT01293032|3792162|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3970174|NCT01293032|3792163|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3970175|NCT01293032|3792164|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3970176|NCT01293032|3792165|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3970177|NCT01293032|3792161|B5||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3970178|NCT01293032|3792162|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3970179|NCT01293032|3792163|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3970180|NCT01293032|3792164|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3970181|NCT01293032|3792165|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3970182|NCT01293032|3792161|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970183|NCT01293032|3792162|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970184|NCT01293032|3792163|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970185|NCT01293032|3792164|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970186|NCT01293032|3792165|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970187|NCT01293006|3792175|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3970188|NCT01293006|3792176|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3970189|NCT01293006|3792177|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3970190|NCT01293006|3792178|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3970191|NCT01293006|3792179|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3970192|NCT01293006|3792175|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3970193|NCT01293006|3792176|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3970194|NCT01293006|3792177|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3970195|NCT01293006|3792178|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3970196|NCT01293006|3792179|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3970197|NCT01293006|3792175|B5|||Age||years|Mean|58.2|58.2|Full Range|||39.0|72.0|
3970198|NCT01293006|3792176|B4|||Age||years|Mean|70.3|70.3|Full Range|||69.0|72.0|
3970199|NCT01293006|3792177|B3|||Age||years|Mean|56.7|56.7|Full Range|||47.0|64.0|
3970200|NCT01293006|3792178|B2|||Age||years|Mean|67.0|67.0|Full Range|||67.0|67.0|
3970201|NCT01293006|3792179|B1|||Age||years|Mean|54.9|54.9|Full Range|||39.0|64.0|
3970202|NCT01292928|3792203|B1|Not Available||Baseline Lesion Characteristics: Presence of Calcification||lesions|Number|2|2.0||||||
3970203|NCT01292928|3792203|B1|Severe||Baseline Lesion Characteristics: Presence of Calcification||lesions|Number|106|106.0||||||
3970204|NCT01292928|3792203|B1|Moderate||Baseline Lesion Characteristics: Presence of Calcification||lesions|Number|103|103.0||||||
3970205|NCT01292928|3792203|B1|None/Mild||Baseline Lesion Characteristics: Presence of Calcification||lesions|Number|88|88.0||||||
3970206|NCT01292928|3792203|B1|||Baseline Lesion Characteristics: Target Lesion Length||millimeters|Mean|90.8|90.8|Standard Deviation|44.4|44.4|||
3970207|NCT01292928|3792203|B1|||Baseline Lesion Characteristics: Diameter Stenosis||percentage occluded|Mean|91.7|91.7|Standard Deviation|9.2|9.2|||
3970208|NCT01292928|3792203|B1|||Baseline Lesion Characteristics: Reference Vessel Diameter||millimeters|Mean|5.6|5.6|Standard Deviation|0.7|0.7|||
3970209|NCT01292928|3792203|B1|Left leg||Baseline Lesion Characteristics: Treated Limb||lesions|Number|161|161.0||||||
3970210|NCT01292928|3792203|B1|Right leg||Baseline Lesion Characteristics: Treated Limb||lesions|Number|138|138.0||||||
3970211|NCT01292928|3792203|B1|History of Claudication||Peripheral Vascular History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|281|281.0||||||
3970212|NCT01292928|3792203|B1|History of Other Peripheral Interventions||Peripheral Vascular History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|125|125.0||||||
3970213|NCT01292928|3792203|B1|History of Peripheral Vascular Surgery||Peripheral Vascular History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|27|27.0||||||
3970214|NCT01292928|3792203|B1|History of Renal Percutaneous Intervention||Neurological/Renal History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|4|4.0||||||
3970215|NCT01292928|3792203|B1|History of Renal Insufficiency||Neurological/Renal History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|31|31.0||||||
3970216|NCT01292928|3792203|B1|History of Cerebrovascular Accident||Neurological/Renal History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|24|24.0||||||
3970217|NCT01292928|3792203|B1|History of Transient Ischemic Attacks||Neurological/Renal History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|21|21.0||||||
3970218|NCT01292928|3792203|B1|No Angina||Cardiac History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|245|245.0||||||
3970254|NCT01292837|3792226|B1|Japan||Region of Enrollment||participants|Number|13|13.0||||||
3970255|NCT01292837|3792226|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3970219|NCT01292928|3792203|B1|Unstable Angina||Cardiac History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|1|1.0||||||
3970220|NCT01292928|3792203|B1|Stable Angina||Cardiac History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|44|44.0||||||
3970221|NCT01292928|3792203|B1|History of Coronary Artery Bypass Graft Surgery||Cardiac History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|54|54.0||||||
3970222|NCT01292928|3792203|B1|History of Percutaneous Coronary Intervention||Cardiac History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|85|85.0||||||
3970223|NCT01292928|3792203|B1|History of Congestive Heart Failure||Cardiac History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|25|25.0||||||
3970224|NCT01292928|3792203|B1|History of Myocardial Infarction (MI)||Cardiac History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|74|74.0||||||
3970225|NCT01292928|3792203|B1|History of Coronary Artery Disease||Cardiac History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|130|130.0||||||
3970226|NCT01292928|3792203|B1|History of Chronic Obstructive Pulmonary Disease||General Medical History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|25|25.0||||||
3970227|NCT01292928|3792203|B1|History of Hypertension requiring medication||General Medical History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|239|239.0||||||
3970228|NCT01292928|3792203|B1|History of Hyperlipidemia requiring medication||General Medical History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|224|224.0||||||
3970229|NCT01292928|3792203|B1|Medically-Treated Diabetes||General Medical History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|105|105.0||||||
3970230|NCT01292928|3792203|B1|Current Diabetes Mellitus||General Medical History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|121|121.0||||||
3970231|NCT01292928|3792203|B1|History of Smoking||General Medical History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|251|251.0||||||
3970232|NCT01292928|3792203|B1|Germany||Region of Enrollment||participants|Number|44|44.0||||||
3970233|NCT01292928|3792203|B1|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
3970234|NCT01292928|3792203|B1|Japan||Region of Enrollment||participants|Number|42|42.0||||||
3970235|NCT01292928|3792203|B1|United States||Region of Enrollment||participants|Number|117|117.0||||||
3970236|NCT01292928|3792203|B1|Belgium||Region of Enrollment||participants|Number|52|52.0||||||
3970237|NCT01292928|3792203|B1|Austria||Region of Enrollment||participants|Number|6|6.0||||||
3970238|NCT01292928|3792203|B1|Canada||Region of Enrollment||participants|Number|31|31.0||||||
3970239|NCT01292928|3792203|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3970240|NCT01292928|3792203|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3970241|NCT01292928|3792203|B1|Black, or African heritage||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3970242|NCT01292928|3792203|B1|Asian (Japanese)||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
3970243|NCT01292928|3792203|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|238|238.0||||||
3970244|NCT01292928|3792203|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3970245|NCT01292928|3792203|B1||Male|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
3970246|NCT01292928|3792203|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3970247|NCT01292928|3792203|B1|||Age||Years|Mean|67.4|67.4|Standard Deviation|9.7|9.7|||
3970248|NCT01292876|3792220|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3970249|NCT01292876|3792220|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3970250|NCT01292876|3792220|B1|||Age||years|Mean|35|35.0|Standard Deviation|10.5|10.5|||
3970251|NCT01292837|3792226|B1|||Body Mass Index||kilogram per squaremeter (kg/m^2)|Mean|17.89|17.89|Standard Deviation|3.75|3.75|||
3970252|NCT01292837|3792226|B1|||Height||centimeter|Mean|129.36|129.36|Standard Deviation|26.32|26.32|||
3970253|NCT01292837|3792226|B1|||Weight||kilogram|Mean|32.22|32.22|Standard Deviation|16.56|16.56|||
3970256|NCT01292837|3792226|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3970257|NCT01292837|3792226|B1|≥12 to <16 years||Age, Customized||participants|Number|7|7.0||||||
3970258|NCT01292837|3792226|B1|≥8 to <12 years||Age, Customized||participants|Number|2|2.0||||||
3970259|NCT01292837|3792226|B1|≥4 to <8 years||Age, Customized||participants|Number|4|4.0||||||
3970260|NCT01292837|3792226|B1|||Age||years|Mean|9.7|9.7|Standard Deviation|4.1|4.1|||
3970261|NCT01292798|3792235|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
3970262|NCT01292798|3792235|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3970263|NCT01292798|3792235|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3970264|NCT01292798|3792235|B1|||Age||years|Mean|64.0|64.0|Standard Deviation|10.1|10.1|||
3970265|NCT01292746|3792241|B1|||Non-Vellus Terminal Hair Count|Non-vellus terminal hair count per centimeter squared (cm2) was calculated by independent evaluator analysis employing digital photograph images and macroimage analysis software|hairs/cm2|Mean|171.57|171.57|Standard Deviation|60.78|60.78|||
3970266|NCT01292746|3792241|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3970267|NCT01292746|3792241|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970268|NCT01292746|3792241|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970269|NCT01292746|3792241|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3970270|NCT01292746|3792241|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970271|NCT01292746|3792241|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970272|NCT01292746|3792241|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970273|NCT01292746|3792241|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970274|NCT01292746|3792241|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3970275|NCT01292746|3792241|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3970276|NCT01292746|3792241|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3970277|NCT01292746|3792241|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3970278|NCT01292746|3792241|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970279|NCT01292642|3792245|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3970280|NCT01292642|3792245|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3970281|NCT01292642|3792245|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3970282|NCT01292642|3792245|B1|||Age||years|Mean|28.2|28.2|Standard Deviation|11.0|11.0|||
3970283|NCT01292642|3792245|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3970284|NCT01292642|3792245|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3970285|NCT01292642|3792245|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970286|NCT01292629|3792253|B1|Male||Sex/Gender, Customized||participants|Number|48|48.0||||||
3970287|NCT01292629|3792253|B1|Female||Sex/Gender, Customized||participants|Number|77|77.0||||||
3970288|NCT01292629|3792253|B1|≥ 80 years of age||Age, Customized|A total of 125 subjects were implanted with the iSert® IOL. Data analysis for baseline characteristics was completed on these 125 subjects.|participants|Number|15|15.0||||||
3970289|NCT01292629|3792253|B1|70 – 79 years of age||Age, Customized|A total of 125 subjects were implanted with the iSert® IOL. Data analysis for baseline characteristics was completed on these 125 subjects.|participants|Number|53|53.0||||||
3970290|NCT01292629|3792253|B1|61 – 69 years of age||Age, Customized|A total of 125 subjects were implanted with the iSert® IOL. Data analysis for baseline characteristics was completed on these 125 subjects.|participants|Number|50|50.0||||||
3970291|NCT01292629|3792253|B1|< 60 years of age||Age, Customized|A total of 125 subjects were implanted with the iSert® IOL. Data analysis for baseline characteristics was completed on these 125 subjects.|participants|Number|7|7.0||||||
3970292|NCT01292603|3792258|B6||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3970293|NCT01292603|3792259|B5||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3970294|NCT01292603|3792260|B4||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3970295|NCT01292603|3792261|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3970296|NCT01292603|3792262|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3970297|NCT01292603|3792263|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3970298|NCT01292603|3792258|B6||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3970299|NCT01292603|3792259|B5||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3970300|NCT01292603|3792260|B4||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3970301|NCT01292603|3792261|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3970302|NCT01292603|3792262|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3970303|NCT01292603|3792263|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3970304|NCT01292603|3792258|B6|||Age||years|Mean|58.8|58.8|Standard Deviation|8.8|8.8|||
3970305|NCT01292603|3792259|B5|||Age||years|Mean|59.1|59.1|Standard Deviation|8.87|8.87|||
3970306|NCT01292603|3792260|B4|||Age||years|Mean|58.7|58.7|Standard Deviation|9.03|9.03|||
3970307|NCT01292603|3792261|B3|||Age||years|Mean|56.9|56.9|Standard Deviation|6.79|6.79|||
3970308|NCT01292603|3792262|B2|||Age||years|Mean|60.4|60.4|Standard Deviation|8.18|8.18|||
3970309|NCT01292603|3792263|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|10.13|10.13|||
3970310|NCT01292538|3792312|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3970373|NCT01292226|3792419|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3970311|NCT01292538|3792313|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970312|NCT01292538|3792314|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3970313|NCT01292538|3792312|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3970314|NCT01292538|3792313|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3970315|NCT01292538|3792314|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3970316|NCT01292538|3792312|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970317|NCT01292538|3792313|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970318|NCT01292538|3792314|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970319|NCT01292538|3792312|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3970320|NCT01292538|3792313|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3970321|NCT01292538|3792314|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3970322|NCT01292538|3792312|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3970323|NCT01292538|3792313|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3970324|NCT01292538|3792314|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3970325|NCT01292538|3792312|B3|||Age||years|Mean|38.04|38.04|Standard Deviation|10.08|10.08|||
3970326|NCT01292538|3792313|B2|||Age||years|Mean|39.03|39.03|Standard Deviation|10.16|10.16|||
3970327|NCT01292538|3792314|B1|||Age||years|Mean|36.60|36.6|Standard Deviation|10.05|10.05|||
3970328|NCT01292486|3792321|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
3970329|NCT01292486|3792321|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3970330|NCT01292486|3792321|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3970331|NCT01292486|3792321|B1|||Age||years|Median|63|63.0|Full Range|||39.0|74.0|
3970332|NCT01292486|3792321|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3970333|NCT01292486|3792321|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3970334|NCT01292486|3792321|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970335|NCT01292473|3792331|B5||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3970336|NCT01292473|3792332|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3970337|NCT01292473|3792333|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3970338|NCT01292473|3792334|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3970339|NCT01292473|3792335|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3970340|NCT01292473|3792331|B5||Female|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
3970341|NCT01292473|3792332|B4||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3970342|NCT01292473|3792333|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3970343|NCT01292473|3792334|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3970344|NCT01292473|3792335|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3970345|NCT01292473|3792331|B5|||Age||Years|Mean|42.5|42.5|Standard Deviation|13.7|13.7|||
3970346|NCT01292473|3792332|B4|||Age||Years|Mean|44.3|44.3|Standard Deviation|13.7|13.7|||
3970347|NCT01292473|3792333|B3|||Age||Years|Mean|43.0|43.0|Standard Deviation|13.2|13.2|||
3970348|NCT01292473|3792334|B2|||Age||Years|Mean|39.7|39.7|Standard Deviation|15.0|15.0|||
3970349|NCT01292473|3792335|B1|||Age||Years|Mean|43.1|43.1|Standard Deviation|12.5|12.5|||
3970350|NCT01292304|3792380|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3970351|NCT01292304|3792380|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3970352|NCT01292304|3792380|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3970353|NCT01292304|3792380|B1|||Age||years|Median|62.5|62.5|Full Range|||54.0|82.0|
3970354|NCT01292304|3792380|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3970355|NCT01292304|3792380|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3970356|NCT01292304|3792380|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970357|NCT01292265|3792388|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3970358|NCT01292265|3792388|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3970359|NCT01292265|3792388|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3970360|NCT01292265|3792388|B1|||Age||years|Mean|44|44.0|Standard Deviation|4|4.0|||
3970361|NCT01292265|3792388|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3970362|NCT01292265|3792388|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3970363|NCT01292265|3792388|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970364|NCT01292239|3792395|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3970365|NCT01292239|3792396|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3970366|NCT01292239|3792397|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3970367|NCT01292239|3792395|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3970368|NCT01292239|3792396|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3970369|NCT01292239|3792397|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3970370|NCT01292239|3792395|B3|||Age||years|Median|55|55.0|Full Range|||23.0|69.0|
3970371|NCT01292239|3792396|B2|||Age||years|Median|54.5|54.5|Full Range|||30.0|69.0|
3970372|NCT01292239|3792397|B1|||Age||years|Median|56|56.0|Full Range|||23.0|69.0|
3970374|NCT01292226|3792419|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3970375|NCT01292226|3792419|B1|||Age||years|Mean|46.60|46.6|Standard Deviation|9.92|9.92|||
3970376|NCT01292187|3792450|B3|||CTx-1|C-terminal telopeptide-1|ng/L|Mean|421.74|421.74|Standard Deviation|193.638|193.638|||
3970377|NCT01292187|3792451|B2|||CTx-1|C-terminal telopeptide-1|ng/L|Mean|417|417.0|Standard Deviation|119.882|119.882|||
3970378|NCT01292187|3792452|B1|||CTx-1|C-terminal telopeptide-1|ng/L|Mean|423.95|423.95|Standard Deviation|219.419|219.419|||
3970379|NCT01292187|3792450|B3|||Body Mass Index||kg/m^2|Mean|26.13|26.13|Standard Deviation|25.48|25.48|||
3970380|NCT01292187|3792451|B2|||Body Mass Index||kg/m^2|Mean|26.77|26.77|Standard Deviation|5.983|5.983|||
3970381|NCT01292187|3792452|B1|||Body Mass Index||kg/m^2|Mean|25.81|25.81|Standard Deviation|3.765|3.765|||
3970382|NCT01292187|3792450|B3|||LS BMD|LS BMD was determined at baseline with Dual Energy X-ray Absorptionometry (DEXA) scans and expressed as grams/square centimeter. This was used to calculate T-scores and used as the baseline to assess changes.|grams per square centimeter|Mean|0.936|0.936|Standard Deviation|0.102|0.102|||
3970383|NCT01292187|3792451|B2|||LS BMD|LS BMD was determined at baseline with Dual Energy X-ray Absorptionometry (DEXA) scans and expressed as grams/square centimeter. This was used to calculate T-scores and used as the baseline to assess changes.|grams per square centimeter|Mean|0.929|0.929|Standard Deviation|0.907|0.907|||
3970384|NCT01292187|3792452|B1|||LS BMD|LS BMD was determined at baseline with Dual Energy X-ray Absorptionometry (DEXA) scans and expressed as grams/square centimeter. This was used to calculate T-scores and used as the baseline to assess changes.|grams per square centimeter|Mean|0.940|0.94|Standard Deviation|0.106|0.106|||
3970385|NCT01292187|3792450|B3|||FRAX Score|FRAX® is a computer based algorithm (http://www.shef.ac.uk/FRAX) that provides models for the assessment of fracture probability in men and women. The approach uses easily obtained clinical risk factors to estimate 10 year fracture probability for a major fracture due to osteoporosis. Major fracture means a clinically apparent fracture of the hip, spine, humerus (upper arm) or wrist.|percent probability|Mean|11.77|11.77|Standard Deviation|4.827|4.827|||
3970386|NCT01292187|3792451|B2|||FRAX Score|FRAX® is a computer based algorithm (http://www.shef.ac.uk/FRAX) that provides models for the assessment of fracture probability in men and women. The approach uses easily obtained clinical risk factors to estimate 10 year fracture probability for a major fracture due to osteoporosis. Major fracture means a clinically apparent fracture of the hip, spine, humerus (upper arm) or wrist.|percent probability|Mean|11.57|11.57|Standard Deviation|4.468|4.468|||
3970387|NCT01292187|3792452|B1|||FRAX Score|FRAX® is a computer based algorithm (http://www.shef.ac.uk/FRAX) that provides models for the assessment of fracture probability in men and women. The approach uses easily obtained clinical risk factors to estimate 10 year fracture probability for a major fracture due to osteoporosis. Major fracture means a clinically apparent fracture of the hip, spine, humerus (upper arm) or wrist.|percent probability|Mean|11.87|11.87|Standard Deviation|5.019|5.019|||
3970388|NCT01292187|3792450|B3|||T-score|The National Osteoporosis Foundation suggested that women with osteopenia (T-score between -1.0 and -2.5 Standard Deviations from the BMD mean value of healthy 30-year old women) and additional risk factors should be treated. For entry into this study, the recommendations of the US Preventative Services Task Force (USPSTF) have been adapted, such that subjects with osteopenia (BMD and a 10-year fracture risk at least that of an average risk 65-year-old woman) were included (World Health Organization’s Fracture Risk Assessment Tool (FRAX®) [USPSTF, 2010].|T-score|Mean|-1.14|-1.14|Standard Deviation|0.872|0.872|||
3970389|NCT01292187|3792451|B2|||T-score|The National Osteoporosis Foundation suggested that women with osteopenia (T-score between -1.0 and -2.5 Standard Deviations from the BMD mean value of healthy 30-year old women) and additional risk factors should be treated. For entry into this study, the recommendations of the US Preventative Services Task Force (USPSTF) have been adapted, such that subjects with osteopenia (BMD and a 10-year fracture risk at least that of an average risk 65-year-old woman) were included (World Health Organization’s Fracture Risk Assessment Tool (FRAX®) [USPSTF, 2010].|T-score|Mean|-1.12|-1.12|Standard Deviation|0.864|0.864|||
3970390|NCT01292187|3792452|B1|||T-score|The National Osteoporosis Foundation suggested that women with osteopenia (T-score between -1.0 and -2.5 Standard Deviations from the BMD mean value of healthy 30-year old women) and additional risk factors should be treated. For entry into this study, the recommendations of the US Preventative Services Task Force (USPSTF) have been adapted, such that subjects with osteopenia (BMD and a 10-year fracture risk at least that of an average risk 65-year-old woman) were included (World Health Organization’s Fracture Risk Assessment Tool (FRAX®) [USPSTF, 2010].|T-score|Mean|-1.15|-1.15|Standard Deviation|0.881|0.881|||
3970391|NCT01292187|3792450|B3|United States||Region of Enrollment||participants|Number|129|129.0||||||
3970392|NCT01292187|3792451|B2|United States||Region of Enrollment||participants|Number|43|43.0||||||
3970393|NCT01292187|3792452|B1|United States||Region of Enrollment||participants|Number|86|86.0||||||
3970394|NCT01292187|3792450|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3970395|NCT01292187|3792451|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970396|NCT01292187|3792452|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3970397|NCT01292187|3792450|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970398|NCT01292187|3792451|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970399|NCT01292187|3792452|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970400|NCT01292187|3792450|B3||White|Race (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
3970401|NCT01292187|3792451|B2||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3970402|NCT01292187|3792452|B1||White|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
3970403|NCT01292187|3792450|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3970404|NCT01292187|3792451|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3970405|NCT01292187|3792452|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3970467|NCT01292057|3792486|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3970406|NCT01292187|3792450|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970407|NCT01292187|3792451|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970408|NCT01292187|3792452|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970409|NCT01292187|3792450|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3970410|NCT01292187|3792451|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970411|NCT01292187|3792452|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3970412|NCT01292187|3792450|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970413|NCT01292187|3792451|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970414|NCT01292187|3792452|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970415|NCT01292187|3792450|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3970416|NCT01292187|3792451|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3970417|NCT01292187|3792452|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3970418|NCT01292187|3792450|B3||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3970419|NCT01292187|3792451|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3970420|NCT01292187|3792452|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3970421|NCT01292187|3792450|B3|||Age||years|Mean|67.2|67.2|Standard Deviation|6.37|6.37|||
3970422|NCT01292187|3792451|B2|||Age||years|Mean|66.6|66.6|Standard Deviation|5.16|5.16|||
3970423|NCT01292187|3792452|B1|||Age||years|Mean|67.5|67.5|Standard Deviation|6.90|6.9|||
3970424|NCT01292187|3792450|B3||>=65 years|Age||Participants|Count of Participants|87|87.0||||||
3970425|NCT01292187|3792451|B2||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
3970426|NCT01292187|3792452|B1||>=65 years|Age||Participants|Count of Participants|58|58.0||||||
3970427|NCT01292187|3792450|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3970428|NCT01292187|3792451|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3970429|NCT01292187|3792452|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3970430|NCT01292187|3792450|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970431|NCT01292187|3792451|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970432|NCT01292187|3792452|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970433|NCT01292135|3792461|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
3970434|NCT01292135|3792462|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3970435|NCT01292135|3792463|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3970436|NCT01292135|3792461|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3970437|NCT01292135|3792462|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3970438|NCT01292135|3792463|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3970439|NCT01292135|3792461|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3970440|NCT01292135|3792462|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3970441|NCT01292135|3792463|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3970442|NCT01292135|3792461|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3970443|NCT01292135|3792462|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3970444|NCT01292135|3792463|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3970445|NCT01292135|3792461|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3970446|NCT01292135|3792462|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3970447|NCT01292135|3792463|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3970448|NCT01292135|3792461|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970449|NCT01292135|3792462|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970450|NCT01292135|3792463|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970451|NCT01292135|3792461|B3|||Age||Years|Mean|60.8|60.8|Standard Deviation|9.24|9.24|||
3970452|NCT01292135|3792462|B2|||Age||Years|Mean|61.3|61.3|Standard Deviation|9.58|9.58|||
3970453|NCT01292135|3792463|B1|||Age||Years|Mean|56.3|56.3|Standard Deviation|1.53|1.53|||
3970454|NCT01292070|3792482|B1|Australia||Region of Enrollment||participants|Number|4|4.0||||||
3970455|NCT01292070|3792482|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3970456|NCT01292070|3792482|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3970457|NCT01292070|3792482|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3970458|NCT01292070|3792482|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3970459|NCT01292070|3792482|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970460|NCT01292070|3792482|B1|||Age||years|Mean|25.3|25.3|Standard Deviation|2.4|2.4|||
3970461|NCT01292057|3792486|B3|United States||Region of Enrollment||Participants|Count of Participants|95|95.0||||||
3970462|NCT01292057|3792487|B2|United States||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
3970463|NCT01292057|3792488|B1|United States||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
3970464|NCT01292057|3792486|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3970465|NCT01292057|3792487|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3970466|NCT01292057|3792488|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3970468|NCT01292057|3792487|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3970469|NCT01292057|3792488|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3970470|NCT01292057|3792486|B3|||Age||years|Mean|26.8|26.8|Standard Deviation|5.4|5.4|||
3970471|NCT01292057|3792487|B2|||Age||years|Mean|27.0|27.0|Standard Deviation|5.3|5.3|||
3970472|NCT01292057|3792488|B1|||Age||years|Mean|26.5|26.5|Standard Deviation|5.6|5.6|||
3970473|NCT01292005|3792497|B3|||Body Mass Index||kg/m^2|Median|30.3|30.3|Full Range|||16.7|50.1|
3970474|NCT01292005|3792498|B2|||Body Mass Index||kg/m^2|Median|32.5|32.5|Full Range|||16.7|50.1|
3970475|NCT01292005|3792499|B1|||Body Mass Index||kg/m^2|Median|30.2|30.2|Full Range|||20.6|42.9|
3970476|NCT01292005|3792497|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
3970477|NCT01292005|3792498|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3970478|NCT01292005|3792499|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3970479|NCT01292005|3792497|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3970480|NCT01292005|3792498|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3970481|NCT01292005|3792499|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3970482|NCT01292005|3792497|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3970483|NCT01292005|3792498|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3970484|NCT01292005|3792499|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3970485|NCT01292005|3792497|B3|||Age||years|Median|64|64.0|Full Range|||24.0|87.0|
3970486|NCT01292005|3792498|B2|||Age||years|Median|58|58.0|Full Range|||24.0|82.0|
3970487|NCT01292005|3792499|B1|||Age||years|Median|69|69.0|Full Range|||34.0|87.0|
3970488|NCT01291836|3792524|B1|Spain||Region of Enrollment||participants|Number|15|15.0||||||
3970489|NCT01291836|3792524|B1|Germany||Region of Enrollment||participants|Number|1|1.0||||||
3970490|NCT01291836|3792524|B1|Switzerland||Region of Enrollment||participants|Number|52|52.0||||||
3970491|NCT01291836|3792524|B1|Italy||Region of Enrollment||participants|Number|110|110.0||||||
3970492|NCT01291836|3792524|B1|Ireland||Region of Enrollment||participants|Number|41|41.0||||||
3970493|NCT01291836|3792524|B1|United States||Region of Enrollment||participants|Number|587|587.0||||||
3970494|NCT01291836|3792524|B1|Netherlands||Region of Enrollment||participants|Number|97|97.0||||||
3970495|NCT01291836|3792524|B1|Greece||Region of Enrollment||participants|Number|27|27.0||||||
3970496|NCT01291836|3792524|B1||Male|Sex: Female, Male||Participants|Count of Participants|576|576.0||||||
3970497|NCT01291836|3792524|B1||Female|Sex: Female, Male||Participants|Count of Participants|354|354.0||||||
3970498|NCT01291836|3792524|B1||>=65 years|Age||Participants|Count of Participants|586|586.0||||||
3970499|NCT01291836|3792524|B1||Between 18 and 65 years|Age||Participants|Count of Participants|344|344.0||||||
3970500|NCT01291836|3792524|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970501|NCT01291784|3792531|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3970502|NCT01291784|3792531|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3970503|NCT01291784|3792531|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3970504|NCT01291784|3792531|B1|||Age|Actual age|years|Mean|68.67|68.67|Standard Deviation|10.07|10.07|70.0|70.0|
3970505|NCT01291498|3792553|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3970506|NCT01291498|3792553|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3970507|NCT01291498|3792553|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3970508|NCT01291498|3792553|B1|||Age||years|Mean|61|61.0|Standard Deviation|NA||||Only one subject entered the study
3970509|NCT01291498|3792553|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3970510|NCT01291498|3792553|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3970511|NCT01291498|3792553|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970512|NCT01291277|3792559|B3||Male|Gender||Participants|Count of Participants|69|69.0||||||
3970513|NCT01291277|3792560|B2||Male|Gender||Participants|Count of Participants|38|38.0||||||
3970514|NCT01291277|3792561|B1||Male|Gender||Participants|Count of Participants|31|31.0||||||
3970515|NCT01291277|3792559|B3||Female|Gender||Participants|Count of Participants|21|21.0||||||
3970516|NCT01291277|3792560|B2||Female|Gender||Participants|Count of Participants|7|7.0||||||
3970517|NCT01291277|3792561|B1||Female|Gender||Participants|Count of Participants|14|14.0||||||
3970518|NCT01291277|3792559|B3|||Age||years|Median|54|54.0|Full Range|||27.0|78.0|
3970519|NCT01291277|3792560|B2|||Age||years|Median|54|54.0|Full Range|||30.0|78.0|
3970520|NCT01291277|3792561|B1|||Age||years|Median|53|53.0|Full Range|||27.0|66.0|
3970521|NCT01291264|3792568|B1||Male|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
3970522|NCT01291264|3792568|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3970523|NCT01291264|3792568|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3970524|NCT01291264|3792568|B1||Between 18 and 65 years|Age||Participants|Count of Participants|260|260.0||||||
3970525|NCT01291264|3792568|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970526|NCT01291225|3792572|B3|United States||Region of Enrollment||participants|Number|311|311.0||||||
3970527|NCT01291225|3792573|B2|United States||Region of Enrollment||participants|Number|160|160.0||||||
3970528|NCT01291225|3792574|B1|United States||Region of Enrollment||participants|Number|151|151.0||||||
3970529|NCT01291225|3792572|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3970530|NCT01291225|3792573|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3970531|NCT01291225|3792574|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3970532|NCT01291225|3792572|B3||Female|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
3970533|NCT01291225|3792573|B2||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3970534|NCT01291225|3792574|B1||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3970535|NCT01291225|3792572|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3970536|NCT01291225|3792573|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3970537|NCT01291225|3792574|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3970538|NCT01291225|3792572|B3||Between 18 and 65 years|Age||Participants|Count of Participants|311|311.0||||||
3970539|NCT01291225|3792573|B2||Between 18 and 65 years|Age||Participants|Count of Participants|160|160.0||||||
3970540|NCT01291225|3792574|B1||Between 18 and 65 years|Age||Participants|Count of Participants|151|151.0||||||
3970541|NCT01291225|3792572|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970542|NCT01291225|3792573|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970543|NCT01291225|3792574|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970544|NCT01291225|3792572|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3970545|NCT01291225|3792573|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3970546|NCT01291225|3792574|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3970547|NCT01291225|3792572|B3||Between 18 and 65 years|Age||Participants|Count of Participants|311|311.0||||||
3970548|NCT01291225|3792573|B2||Between 18 and 65 years|Age||Participants|Count of Participants|160|160.0||||||
3970549|NCT01291225|3792574|B1||Between 18 and 65 years|Age||Participants|Count of Participants|151|151.0||||||
3970550|NCT01291225|3792572|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970551|NCT01291225|3792573|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970552|NCT01291225|3792574|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970553|NCT01291173|3792585|B5|United States||Region of Enrollment||participants|Number|259|259.0||||||
3970554|NCT01291173|3792586|B4|United States||Region of Enrollment||participants|Number|65|65.0||||||
3970555|NCT01291173|3792587|B3|United States||Region of Enrollment||participants|Number|65|65.0||||||
3970556|NCT01291173|3792588|B2|United States||Region of Enrollment||participants|Number|66|66.0||||||
3970557|NCT01291173|3792589|B1|United States||Region of Enrollment||participants|Number|63|63.0||||||
3970558|NCT01291173|3792585|B5||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3970559|NCT01291173|3792586|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3970560|NCT01291173|3792587|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3970561|NCT01291173|3792588|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3970562|NCT01291173|3792589|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3970563|NCT01291173|3792585|B5||Female|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
3970564|NCT01291173|3792586|B4||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3970565|NCT01291173|3792587|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3970566|NCT01291173|3792588|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3970567|NCT01291173|3792589|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3970568|NCT01291173|3792585|B5|40-55 years||Age, Customized||participants|Number|125|125.0||||||
3970569|NCT01291173|3792586|B4|40-55 years||Age, Customized||participants|Number|31|31.0||||||
3970570|NCT01291173|3792587|B3|40-55 years||Age, Customized||participants|Number|35|35.0||||||
3970571|NCT01291173|3792588|B2|40-55 years||Age, Customized||participants|Number|31|31.0||||||
3970572|NCT01291173|3792589|B1|40-55 years||Age, Customized||participants|Number|28|28.0||||||
3970573|NCT01291173|3792585|B5|18-39 years||Age, Customized||participants|Number|134|134.0||||||
3970574|NCT01291173|3792586|B4|18-39 years||Age, Customized||participants|Number|34|34.0||||||
3970575|NCT01291173|3792587|B3|18-39 years||Age, Customized||participants|Number|30|30.0||||||
3970576|NCT01291173|3792588|B2|18-39 years||Age, Customized||participants|Number|35|35.0||||||
3970577|NCT01291173|3792589|B1|18-39 years||Age, Customized||participants|Number|35|35.0||||||
3970578|NCT01291173|3792585|B5|||Age||years|Mean|38.7|38.7|Standard Deviation|10.17|10.17|||
3970579|NCT01291173|3792586|B4|||Age||years|Mean|38.6|38.6|Standard Deviation|10.01|10.01|||
3970580|NCT01291173|3792587|B3|||Age||years|Mean|39.6|39.6|Standard Deviation|9.32|9.32|||
3970581|NCT01291173|3792588|B2|||Age||years|Mean|38.4|38.4|Standard Deviation|11.14|11.14|||
3970582|NCT01291173|3792589|B1|||Age||years|Mean|38.0|38.0|Standard Deviation|10.30|10.3|||
3970583|NCT01291160|3792654|B3||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3970584|NCT01291160|3792655|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3970585|NCT01291160|3792656|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3970586|NCT01291160|3792654|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3970587|NCT01291160|3792655|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3970588|NCT01291160|3792656|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3970589|NCT01291160|3792654|B3||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
3970590|NCT01291160|3792655|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3970591|NCT01291160|3792656|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3970592|NCT01291160|3792654|B3||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
3970593|NCT01291160|3792655|B2||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3970594|NCT01291160|3792656|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3970595|NCT01291160|3792654|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970596|NCT01291160|3792655|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970597|NCT01291160|3792656|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970598|NCT01291160|3792654|B3|||Age||years|Mean|59.25|59.25|Standard Deviation|13.06|13.06|||
3970599|NCT01291160|3792655|B2|||Age||years|Mean|58.46|58.46|Standard Deviation|9.53|9.53|||
3970600|NCT01291160|3792656|B1|||Age||years|Mean|59.25|59.25|Standard Deviation|13.06|13.06|||
3970601|NCT01291108|3792663|B5||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3970602|NCT01291108|3792664|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3970603|NCT01291108|3792665|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3970604|NCT01291108|3792666|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3970605|NCT01291108|3792667|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3970606|NCT01291108|3792663|B5||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3970607|NCT01291108|3792664|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3970608|NCT01291108|3792665|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3970609|NCT01291108|3792666|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3970610|NCT01291108|3792667|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3970611|NCT01291108|3792663|B5|>65 years||Age, Customized||Participants|Number|68|68.0||||||
3970612|NCT01291108|3792664|B4|>65 years||Age, Customized||Participants|Number|13|13.0||||||
3970613|NCT01291108|3792665|B3|>65 years||Age, Customized||Participants|Number|19|19.0||||||
3970614|NCT01291108|3792666|B2|>65 years||Age, Customized||Participants|Number|10|10.0||||||
3970615|NCT01291108|3792667|B1|>65 years||Age, Customized||Participants|Number|26|26.0||||||
3970616|NCT01291108|3792663|B5|45 to 65 years||Age, Customized||Participants|Number|54|54.0||||||
3970617|NCT01291108|3792664|B4|45 to 65 years||Age, Customized||Participants|Number|7|7.0||||||
3970618|NCT01291108|3792665|B3|45 to 65 years||Age, Customized||Participants|Number|20|20.0||||||
3970619|NCT01291108|3792666|B2|45 to 65 years||Age, Customized||Participants|Number|10|10.0||||||
3970620|NCT01291108|3792667|B1|45 to 65 years||Age, Customized||Participants|Number|17|17.0||||||
3970621|NCT01291108|3792663|B5|<45 years||Age, Customized||Participants|Number|3|3.0||||||
3970622|NCT01291108|3792664|B4|<45 years||Age, Customized||Participants|Number|0|0.0||||||
3970623|NCT01291108|3792665|B3|<45 years||Age, Customized||Participants|Number|1|1.0||||||
3970624|NCT01291108|3792666|B2|<45 years||Age, Customized||Participants|Number|1|1.0||||||
3970625|NCT01291108|3792667|B1|<45 years||Age, Customized||Participants|Number|1|1.0||||||
3970626|NCT01291056|3792686|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3970627|NCT01291056|3792687|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3970628|NCT01291056|3792688|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3970629|NCT01291056|3792686|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3970630|NCT01291056|3792687|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3970631|NCT01291056|3792688|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3970632|NCT01291056|3792686|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3970633|NCT01291056|3792687|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3970634|NCT01291056|3792688|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3970635|NCT01291056|3792686|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3970636|NCT01291056|3792687|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3970637|NCT01291056|3792688|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3970638|NCT01291056|3792686|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970639|NCT01291056|3792687|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970640|NCT01291056|3792688|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970641|NCT01291017|3792701|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3970642|NCT01291017|3792701|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3970643|NCT01291017|3792701|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3970644|NCT01291017|3792701|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3970645|NCT01291017|3792701|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3970646|NCT01291017|3792701|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970647|NCT01290978|3792709|B1||Male|Sex: Female, Male|Eleven males and 11 females were enrolled into the study|Participants|Count of Participants|11|11.0||||||
3970648|NCT01290978|3792709|B1||Female|Sex: Female, Male|Eleven males and 11 females were enrolled into the study|Participants|Count of Participants|11|11.0||||||
3970649|NCT01290978|3792709|B1|||Age||participants|Mean|40.4|40.4|Standard Deviation|13|13.0|||
3970650|NCT01290952|3792716|B3|||Euroscore > 6 (high risk for early mortality for cardiac surgery)||participants|Number|411|411.0||||||
3970651|NCT01290952|3792717|B2|||Euroscore > 6 (high risk for early mortality for cardiac surgery)||participants|Number|207|207.0||||||
3970652|NCT01290952|3792718|B1|||Euroscore > 6 (high risk for early mortality for cardiac surgery)||participants|Number|204|204.0||||||
3970653|NCT01290952|3792716|B3|Switzerland||Region of Enrollment||participants|Number|26|26.0||||||
3970654|NCT01290952|3792717|B2|Switzerland||Region of Enrollment||participants|Number|11|11.0||||||
3970655|NCT01290952|3792718|B1|Switzerland||Region of Enrollment||participants|Number|15|15.0||||||
3970656|NCT01290952|3792716|B3|Italy||Region of Enrollment||participants|Number|385|385.0||||||
3970657|NCT01290952|3792717|B2|Italy||Region of Enrollment||participants|Number|196|196.0||||||
3970658|NCT01290952|3792718|B1|Italy||Region of Enrollment||participants|Number|189|189.0||||||
3970659|NCT01290952|3792716|B3||Male|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
3970660|NCT01290952|3792717|B2||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3970661|NCT01290952|3792718|B1||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3970662|NCT01290952|3792716|B3||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3970663|NCT01290952|3792717|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3970664|NCT01290952|3792718|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3970665|NCT01290952|3792716|B3||>=65 years|Age||Participants|Count of Participants|411|411.0||||||
3970666|NCT01290952|3792717|B2||>=65 years|Age||Participants|Count of Participants|207|207.0||||||
3970667|NCT01290952|3792718|B1||>=65 years|Age||Participants|Count of Participants|204|204.0||||||
3970668|NCT01290952|3792716|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3970669|NCT01290952|3792717|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3970670|NCT01290952|3792718|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3970671|NCT01290952|3792716|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970672|NCT01290952|3792717|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970673|NCT01290952|3792718|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970674|NCT01290913|3792727|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3970675|NCT01290913|3792727|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3970676|NCT01290913|3792727|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3970677|NCT01290913|3792727|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3970678|NCT01290913|3792727|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3970679|NCT01290913|3792727|B1||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
3970680|NCT01290887|3792732|B3|||Daily average number of puffs in past 3 days|n= 475, 554, 1029|puffs/day|Mean|1.827|1.827|Standard Deviation|2.4604|2.4604|||
3970681|NCT01290887|3792733|B2|||Daily average number of puffs in past 3 days|n= 475, 554, 1029|puffs/day|Mean|1.568|1.568|Standard Deviation|2.3982|2.3982|||
3970682|NCT01290887|3792734|B1|||Daily average number of puffs in past 3 days|n= 475, 554, 1029|puffs/day|Mean|2.130|2.13|Standard Deviation|2.4996|2.4996|||
3970683|NCT01290887|3792732|B3|No||Used Beta Agonist in Past 3 Days|"Usage of inhaled corticosteroids/long-acting beta-agonists and usage of oral corticosteroids.~n= 480, 571, 1051"|participants|Number|454|454.0||||||
3970684|NCT01290887|3792733|B2|No||Used Beta Agonist in Past 3 Days|"Usage of inhaled corticosteroids/long-acting beta-agonists and usage of oral corticosteroids.~n= 480, 571, 1051"|participants|Number|274|274.0||||||
3970685|NCT01290887|3792734|B1|No||Used Beta Agonist in Past 3 Days|"Usage of inhaled corticosteroids/long-acting beta-agonists and usage of oral corticosteroids.~n= 480, 571, 1051"|participants|Number|180|180.0||||||
3970686|NCT01290887|3792732|B3|Yes||Used Beta Agonist in Past 3 Days|"Usage of inhaled corticosteroids/long-acting beta-agonists and usage of oral corticosteroids.~n= 480, 571, 1051"|participants|Number|597|597.0||||||
3970687|NCT01290887|3792733|B2|Yes||Used Beta Agonist in Past 3 Days|"Usage of inhaled corticosteroids/long-acting beta-agonists and usage of oral corticosteroids.~n= 480, 571, 1051"|participants|Number|297|297.0||||||
3970688|NCT01290887|3792734|B1|Yes||Used Beta Agonist in Past 3 Days|"Usage of inhaled corticosteroids/long-acting beta-agonists and usage of oral corticosteroids.~n= 480, 571, 1051"|participants|Number|300|300.0||||||
3970689|NCT01290887|3792732|B3|||Blood Eosinophil Count||10^9 blood eosinophil/L|Mean|0.284|0.284|Standard Deviation|0.3577|0.3577|||
3970690|NCT01290887|3792733|B2|||Blood Eosinophil Count||10^9 blood eosinophil/L|Mean|0.078|0.078|Standard Deviation|0.1480|0.148|||
3970691|NCT01290887|3792734|B1|||Blood Eosinophil Count||10^9 blood eosinophil/L|Mean|0.528|0.528|Standard Deviation|0.3792|0.3792|||
3970692|NCT01290887|3792732|B3|||Asthma Symptom Utility Index (ASUI)|"The ASUI is an 11-item instrument designed to assess the frequency and severity of asthma symptoms and side effects, weighted by patient preferences (Revicki et al 1998). ASUI is a utility score that ranges from 0 to 1, with higher values indicating better asthma control.~n= 186, 191, 377"|units on a scale|Mean|0.832|0.832|Standard Deviation|0.1728|0.1728|||
3970693|NCT01290887|3792733|B2|||Asthma Symptom Utility Index (ASUI)|"The ASUI is an 11-item instrument designed to assess the frequency and severity of asthma symptoms and side effects, weighted by patient preferences (Revicki et al 1998). ASUI is a utility score that ranges from 0 to 1, with higher values indicating better asthma control.~n= 186, 191, 377"|units on a scale|Mean|0.861|0.861|Standard Deviation|0.1479|0.1479|||
3970694|NCT01290887|3792734|B1|||Asthma Symptom Utility Index (ASUI)|"The ASUI is an 11-item instrument designed to assess the frequency and severity of asthma symptoms and side effects, weighted by patient preferences (Revicki et al 1998). ASUI is a utility score that ranges from 0 to 1, with higher values indicating better asthma control.~n= 186, 191, 377"|units on a scale|Mean|0.803|0.803|Standard Deviation|0.1910|0.191|||
3970695|NCT01290887|3792732|B3|||Asthma Quality of Life Questionnaire (AQLQ)|"The AQLQ is a 32-item instrument administered as a self-assessment (Juniper et al 1992). The questionnaire is divided into 4 domains: activity limitation, symptoms, emotional function, and environmental stimuli. Patients were asked to recall their experiences during the last 2 weeks and to respond to each question on a 7-point scale (1=severe impairment, 7=no impairment). The overall AQLQ score is the mean of all 32 responses.~n= 476, 569, 1045"|units on a scale|Mean|5.347|5.347|Standard Deviation|1.1875|1.1875|||
3970733|NCT01290887|3792734|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
3970734|NCT01290887|3792732|B3|Other||Race/Ethnicity, Customized||participants|Number|101|101.0||||||
3970735|NCT01290887|3792733|B2|Other||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
3970736|NCT01290887|3792734|B1|Other||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
3970696|NCT01290887|3792733|B2|||Asthma Quality of Life Questionnaire (AQLQ)|"The AQLQ is a 32-item instrument administered as a self-assessment (Juniper et al 1992). The questionnaire is divided into 4 domains: activity limitation, symptoms, emotional function, and environmental stimuli. Patients were asked to recall their experiences during the last 2 weeks and to respond to each question on a 7-point scale (1=severe impairment, 7=no impairment). The overall AQLQ score is the mean of all 32 responses.~n= 476, 569, 1045"|units on a scale|Mean|5.496|5.496|Standard Deviation|1.1431|1.1431|||
3970697|NCT01290887|3792734|B1|||Asthma Quality of Life Questionnaire (AQLQ)|"The AQLQ is a 32-item instrument administered as a self-assessment (Juniper et al 1992). The questionnaire is divided into 4 domains: activity limitation, symptoms, emotional function, and environmental stimuli. Patients were asked to recall their experiences during the last 2 weeks and to respond to each question on a 7-point scale (1=severe impairment, 7=no impairment). The overall AQLQ score is the mean of all 32 responses.~n= 476, 569, 1045"|units on a scale|Mean|5.170|5.17|Standard Deviation|1.2160|1.216|||
3970698|NCT01290887|3792732|B3|||Asthma Control Questionnaire (ACQ)|"The ACQ is a 7-item instrument that measures asthma control (Juniper et al 1999). Six questions are self-assessments; the seventh item, completed by a member of the study staff, is the result of the patient's FEV1 measurement. Each item has 7 possible answers on a scale of 0 to 6, and the total score is the mean of all responses (the total scale is therefore 0-6). A higher score is an indication of poorer asthma control.~n= 480, 571, 1051"|units on a scale|Mean|1.624|1.624|Standard Deviation|1.0527|1.0527|||
3970699|NCT01290887|3792733|B2|||Asthma Control Questionnaire (ACQ)|"The ACQ is a 7-item instrument that measures asthma control (Juniper et al 1999). Six questions are self-assessments; the seventh item, completed by a member of the study staff, is the result of the patient's FEV1 measurement. Each item has 7 possible answers on a scale of 0 to 6, and the total score is the mean of all responses (the total scale is therefore 0-6). A higher score is an indication of poorer asthma control.~n= 480, 571, 1051"|units on a scale|Mean|1.450|1.45|Standard Deviation|0.9870|0.987|||
3970700|NCT01290887|3792734|B1|||Asthma Control Questionnaire (ACQ)|"The ACQ is a 7-item instrument that measures asthma control (Juniper et al 1999). Six questions are self-assessments; the seventh item, completed by a member of the study staff, is the result of the patient's FEV1 measurement. Each item has 7 possible answers on a scale of 0 to 6, and the total score is the mean of all responses (the total scale is therefore 0-6). A higher score is an indication of poorer asthma control.~n= 480, 571, 1051"|units on a scale|Mean|1.832|1.832|Standard Deviation|1.0912|1.0912|||
3970701|NCT01290887|3792732|B3|||Forced Expiratory Flow at 25% to 75% Forced Vital Capacity (FEF 25%-75%)|n= 478, 568, 1046|liters/second|Mean|1.558|1.558|Standard Deviation|0.9009|0.9009|||
3970702|NCT01290887|3792733|B2|||Forced Expiratory Flow at 25% to 75% Forced Vital Capacity (FEF 25%-75%)|n= 478, 568, 1046|liters/second|Mean|1.634|1.634|Standard Deviation|0.9045|0.9045|||
3970703|NCT01290887|3792734|B1|||Forced Expiratory Flow at 25% to 75% Forced Vital Capacity (FEF 25%-75%)|n= 478, 568, 1046|liters/second|Mean|1.467|1.467|Standard Deviation|0.8890|0.889|||
3970704|NCT01290887|3792732|B3|||Forced Vital Capacity (FVC)||liters|Mean|3.273|3.273|Standard Deviation|1.0632|1.0632|||
3970705|NCT01290887|3792733|B2|||Forced Vital Capacity (FVC)||liters|Mean|3.366|3.366|Standard Deviation|1.0779|1.0779|||
3970706|NCT01290887|3792734|B1|||Forced Vital Capacity (FVC)||liters|Mean|3.163|3.163|Standard Deviation|1.0357|1.0357|||
3970707|NCT01290887|3792732|B3|||% Predicted Expiratory Volume In 1 Second||percentage of predicted FEV1|Mean|73.115|73.115|Standard Deviation|19.9664|19.9664|||
3970708|NCT01290887|3792733|B2|||% Predicted Expiratory Volume In 1 Second||percentage of predicted FEV1|Mean|75.116|75.116|Standard Deviation|19.9404|19.9404|||
3970709|NCT01290887|3792734|B1|||% Predicted Expiratory Volume In 1 Second||percentage of predicted FEV1|Mean|70.739|70.739|Standard Deviation|19.7560|19.756|||
3970710|NCT01290887|3792732|B3|||Forced Expiratory Volume in 1 Second (FEV1)||liters|Mean|2.199|2.199|Standard Deviation|0.8108|0.8108|||
3970711|NCT01290887|3792733|B2|||Forced Expiratory Volume in 1 Second (FEV1)||liters|Mean|2.285|2.285|Standard Deviation|0.8222|0.8222|||
3970712|NCT01290887|3792734|B1|||Forced Expiratory Volume in 1 Second (FEV1)||liters|Mean|2.096|2.096|Standard Deviation|0.7856|0.7856|||
3970713|NCT01290887|3792732|B3|||Body Mass Index|n=463, 555, 1018|kg/m^2|Mean|27.7|27.7|Standard Deviation|5.77|5.77|||
3970714|NCT01290887|3792733|B2|||Body Mass Index|n=463, 555, 1018|kg/m^2|Mean|27.7|27.7|Standard Deviation|6.04|6.04|||
3970715|NCT01290887|3792734|B1|||Body Mass Index|n=463, 555, 1018|kg/m^2|Mean|27.6|27.6|Standard Deviation|5.42|5.42|||
3970716|NCT01290887|3792732|B3|||Height|n=463, 555, 1018|cm|Mean|165.7|165.7|Standard Deviation|9.99|9.99|||
3970717|NCT01290887|3792733|B2|||Height|n=463, 555, 1018|cm|Mean|166.0|166.0|Standard Deviation|9.96|9.96|||
3970718|NCT01290887|3792734|B1|||Height|n=463, 555, 1018|cm|Mean|165.3|165.3|Standard Deviation|10.03|10.03|||
3970719|NCT01290887|3792732|B3|||Weight|n=466, 555,1021|kg|Mean|76.0|76.0|Standard Deviation|17.32|17.32|||
3970720|NCT01290887|3792733|B2|||Weight|n=466, 555,1021|kg|Mean|76.5|76.5|Standard Deviation|17.85|17.85|||
3970721|NCT01290887|3792734|B1|||Weight|n=466, 555,1021|kg|Mean|75.4|75.4|Standard Deviation|16.67|16.67|||
3970722|NCT01290887|3792732|B3|Unknown||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3970723|NCT01290887|3792733|B2|Unknown||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3970724|NCT01290887|3792734|B1|Unknown||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3970725|NCT01290887|3792732|B3|Non-Hispanic and non-Latino||Race/Ethnicity, Customized||participants|Number|480|480.0||||||
3970726|NCT01290887|3792733|B2|Non-Hispanic and non-Latino||Race/Ethnicity, Customized||participants|Number|272|272.0||||||
3970727|NCT01290887|3792734|B1|Non-Hispanic and non-Latino||Race/Ethnicity, Customized||participants|Number|208|208.0||||||
3970728|NCT01290887|3792732|B3|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|365|365.0||||||
3970729|NCT01290887|3792733|B2|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|178|178.0||||||
3970730|NCT01290887|3792734|B1|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|187|187.0||||||
3970731|NCT01290887|3792732|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|201|201.0||||||
3970732|NCT01290887|3792733|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|118|118.0||||||
3970737|NCT01290887|3792732|B3|Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3970738|NCT01290887|3792733|B2|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3970739|NCT01290887|3792734|B1|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3970740|NCT01290887|3792732|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3970741|NCT01290887|3792733|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3970742|NCT01290887|3792734|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3970743|NCT01290887|3792732|B3|Asian||Race/Ethnicity, Customized||participants|Number|87|87.0||||||
3970744|NCT01290887|3792733|B2|Asian||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
3970745|NCT01290887|3792734|B1|Asian||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
3970746|NCT01290887|3792732|B3|Black||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
3970747|NCT01290887|3792733|B2|Black||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3970748|NCT01290887|3792734|B1|Black||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3970749|NCT01290887|3792732|B3|White||Race/Ethnicity, Customized||participants|Number|808|808.0||||||
3970750|NCT01290887|3792733|B2|White||Race/Ethnicity, Customized||participants|Number|437|437.0||||||
3970751|NCT01290887|3792734|B1|White||Race/Ethnicity, Customized||participants|Number|371|371.0||||||
3970752|NCT01290887|3792732|B3||Male|Sex: Female, Male||Participants|Count of Participants|406|406.0||||||
3970753|NCT01290887|3792733|B2||Male|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
3970754|NCT01290887|3792734|B1||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3970755|NCT01290887|3792732|B3||Female|Sex: Female, Male||Participants|Count of Participants|646|646.0||||||
3970756|NCT01290887|3792733|B2||Female|Sex: Female, Male||Participants|Count of Participants|332|332.0||||||
3970757|NCT01290887|3792734|B1||Female|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
3970758|NCT01290887|3792732|B3|||Age||years|Mean|47.2|47.2|Standard Deviation|14.02|14.02|||
3970759|NCT01290887|3792733|B2|||Age||years|Mean|47.1|47.1|Standard Deviation|13.58|13.58|||
3970760|NCT01290887|3792734|B1|||Age||years|Mean|47.4|47.4|Standard Deviation|14.53|14.53|||
3970761|NCT01290874|3792773|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970762|NCT01290874|3792774|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970763|NCT01290874|3792775|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970764|NCT01290874|3792773|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970765|NCT01290874|3792774|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970766|NCT01290874|3792775|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970767|NCT01290874|3792773|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970768|NCT01290874|3792774|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970769|NCT01290874|3792775|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970770|NCT01290874|3792773|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1070|1070.0||||||
3970771|NCT01290874|3792774|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|538|538.0||||||
3970772|NCT01290874|3792775|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|532|532.0||||||
3970773|NCT01290874|3792773|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970774|NCT01290874|3792774|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970775|NCT01290874|3792775|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970776|NCT01290874|3792773|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970777|NCT01290874|3792774|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970778|NCT01290874|3792775|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970779|NCT01290874|3792773|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970780|NCT01290874|3792774|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970781|NCT01290874|3792775|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970782|NCT01290874|3792773|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970783|NCT01290874|3792774|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970784|NCT01290874|3792775|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970785|NCT01290874|3792773|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1003|1003.0||||||
3970786|NCT01290874|3792774|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|502|502.0||||||
3970787|NCT01290874|3792775|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|501|501.0||||||
3970788|NCT01290874|3792773|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3970789|NCT01290874|3792774|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3970790|NCT01290874|3792775|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3970791|NCT01290874|3792773|B3||Male|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
3970792|NCT01290874|3792774|B2||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3970793|NCT01290874|3792775|B1||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3970794|NCT01290874|3792773|B3||Female|Sex: Female, Male||Participants|Count of Participants|813|813.0||||||
3970795|NCT01290874|3792774|B2||Female|Sex: Female, Male||Participants|Count of Participants|408|408.0||||||
3970796|NCT01290874|3792775|B1||Female|Sex: Female, Male||Participants|Count of Participants|405|405.0||||||
3970797|NCT01290874|3792773|B3|||Age||years|Mean|45.15|45.15|Standard Deviation|12.6|12.6|||
3970798|NCT01290874|3792774|B2|||Age||years|Mean|45.1|45.1|Standard Deviation|12.6|12.6|||
3970799|NCT01290874|3792775|B1|||Age||years|Mean|45.2|45.2|Standard Deviation|12.6|12.6|||
3970800|NCT01290822|3792796|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970801|NCT01290822|3792796|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3970802|NCT01290822|3792796|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3970803|NCT01290822|3792796|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3970804|NCT01290822|3792796|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970805|NCT01290822|3792796|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970806|NCT01290822|3792796|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970807|NCT01290822|3792796|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3970808|NCT01290822|3792796|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3970809|NCT01290822|3792796|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3970810|NCT01290822|3792796|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3970811|NCT01290822|3792796|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970812|NCT01290796|3792805|B1|United States||Region of Enrollment||participants|Number|153|153.0||||||
3970813|NCT01290796|3792805|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970814|NCT01290796|3792805|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|149|149.0||||||
3970815|NCT01290796|3792805|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3970816|NCT01290796|3792805|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970817|NCT01290796|3792805|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970818|NCT01290796|3792805|B1||White|Race (NIH/OMB)||Participants|Count of Participants|143|143.0||||||
3970819|NCT01290796|3792805|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3970820|NCT01290796|3792805|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3970821|NCT01290796|3792805|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3970822|NCT01290796|3792805|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3970823|NCT01290796|3792805|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3970824|NCT01290796|3792805|B1||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3970825|NCT01290796|3792805|B1|>=65 years||Age, Customized||participants|Number|24|24.0||||||
3970826|NCT01290796|3792805|B1|<65 years||Age, Customized||participants|Number|129|129.0||||||
3970827|NCT01290796|3792805|B1|||Age||years|Mean|51.4|51.4|Standard Deviation|10.3|10.3|||
3970828|NCT01290757|3792819|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3970829|NCT01290757|3792820|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3970830|NCT01290757|3792821|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3970831|NCT01290757|3792819|B3||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3970832|NCT01290757|3792820|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3970833|NCT01290757|3792821|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3970834|NCT01290757|3792819|B3|||Age||Years|Mean|39.6|39.6|Standard Deviation|9.6|9.6|||
3970835|NCT01290757|3792820|B2|||Age||Years|Mean|39.4|39.4|Standard Deviation|9.1|9.1|||
3970836|NCT01290757|3792821|B1|||Age||Years|Mean|39.8|39.8|Standard Deviation|10.1|10.1|||
3970837|NCT01290731|3792838|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3970838|NCT01290731|3792838|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3970839|NCT01290731|3792838|B1|||Age||years|Median|61|61.0|Full Range|||22.0|70.0|
3970840|NCT01290718|3792850|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3970841|NCT01290718|3792850|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3970842|NCT01290718|3792850|B1|||Age||years|Mean|53.75|53.75|Standard Deviation|9.03|9.03|||
3970843|NCT01290679|3792857|B3||Male|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
3970844|NCT01290679|3792858|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3970845|NCT01290679|3792859|B1||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3970846|NCT01290679|3792857|B3||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3970847|NCT01290679|3792858|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3970848|NCT01290679|3792859|B1||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3970849|NCT01290679|3792857|B3|||Age||years|Median|47|47.0|Full Range|||18.0|73.0|
3970850|NCT01290679|3792858|B2|||Age||years|Median|47|47.0|Full Range|||18.0|73.0|
3970851|NCT01290679|3792859|B1|||Age||years|Median|46|46.0|Full Range|||18.0|73.0|
3970852|NCT01290666|3792929|B1|United States||Region of Enrollment||participants|Number|93|93.0||||||
3970853|NCT01290666|3792929|B1||Male|Gender||Participants|Count of Participants|71|71.0||||||
3970854|NCT01290666|3792929|B1||Female|Gender||Participants|Count of Participants|22|22.0||||||
3970855|NCT01290666|3792929|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3970856|NCT01290666|3792929|B1||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
3970857|NCT01290666|3792929|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970858|NCT01290640|3792933|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
3970859|NCT01290640|3792934|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3970860|NCT01290640|3792935|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3970861|NCT01290640|3792933|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3970862|NCT01290640|3792934|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3970863|NCT01290640|3792935|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3970864|NCT01290640|3792933|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3970865|NCT01290640|3792934|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3970866|NCT01290640|3792935|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3970867|NCT01290640|3792933|B3|||Age||years|Mean|72.5|72.5|Standard Deviation|10.10|10.1|||
3970868|NCT01290640|3792934|B2|||Age||years|Mean|74.06|74.06|Standard Deviation|10.1|10.1|||
3970869|NCT01290640|3792935|B1|||Age||years|Mean|70.7|70.7|Standard Deviation|9.8|9.8|||
3970870|NCT01290640|3792933|B3||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3970871|NCT01290640|3792934|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3970872|NCT01290640|3792935|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3970873|NCT01290640|3792933|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3970874|NCT01290640|3792934|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3970875|NCT01290640|3792935|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3970876|NCT01290640|3792933|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970877|NCT01290640|3792934|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970878|NCT01290640|3792935|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970879|NCT01290627|3792944|B4|United States||Region of Enrollment||participants|Number|30|30.0||||||
3970880|NCT01290627|3792945|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3970881|NCT01290627|3792946|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3970882|NCT01290627|3792947|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3970883|NCT01290627|3792944|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3970884|NCT01290627|3792945|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3970885|NCT01290627|3792946|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3970886|NCT01290627|3792947|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3970887|NCT01290627|3792944|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3970888|NCT01290627|3792945|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3970889|NCT01290627|3792946|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3970890|NCT01290627|3792947|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3970891|NCT01290627|3792944|B4|||Age||years|Mean|53.67|53.67|Standard Deviation|16.18|16.18|||
3970892|NCT01290627|3792945|B3|||Age||years|Mean|34.2|34.2|Standard Deviation|8.9|8.9|||
3970893|NCT01290627|3792946|B2|||Age||years|Mean|64.3|64.3|Standard Deviation|8.7|8.7|||
3970894|NCT01290627|3792947|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|7.8|7.8|||
3970895|NCT01290627|3792944|B4||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3970896|NCT01290627|3792945|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3970897|NCT01290627|3792946|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3970898|NCT01290627|3792947|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3970899|NCT01290627|3792944|B4||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3970900|NCT01290627|3792945|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3970901|NCT01290627|3792946|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3970902|NCT01290627|3792947|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3970903|NCT01290627|3792944|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970904|NCT01290627|3792945|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970905|NCT01290627|3792946|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970906|NCT01290627|3792947|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3970907|NCT01290614|3792969|B3|United States||Region of Enrollment||participants|Number|2199|2199.0||||||
3970908|NCT01290614|3792970|B2|United States||Region of Enrollment||participants|Number|1129|1129.0||||||
3970909|NCT01290614|3792971|B1|United States||Region of Enrollment||participants|Number|1070|1070.0||||||
3970910|NCT01290614|3792969|B3|Not Black||Race/Ethnicity, Customized||participants|Number|2081|2081.0||||||
3970911|NCT01290614|3792970|B2|Not Black||Race/Ethnicity, Customized||participants|Number|1073|1073.0||||||
3970912|NCT01290614|3792971|B1|Not Black||Race/Ethnicity, Customized||participants|Number|1008|1008.0||||||
3970913|NCT01290614|3792969|B3|Black||Race/Ethnicity, Customized||participants|Number|118|118.0||||||
3970914|NCT01290614|3792970|B2|Black||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
3970915|NCT01290614|3792971|B1|Black||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
3970916|NCT01290614|3792969|B3||Male|Sex: Female, Male||Participants|Count of Participants|2160|2160.0||||||
3970917|NCT01290614|3792970|B2||Male|Sex: Female, Male||Participants|Count of Participants|1106|1106.0||||||
3970918|NCT01290614|3792971|B1||Male|Sex: Female, Male||Participants|Count of Participants|1054|1054.0||||||
3970919|NCT01290614|3792969|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3970920|NCT01290614|3792970|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3970921|NCT01290614|3792971|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3970922|NCT01290614|3792969|B3|||Age||years|Mean|75.6|75.6|Standard Deviation|8.2|8.2|||
3970923|NCT01290614|3792970|B2|||Age||years|Mean|75.7|75.7|Standard Deviation|8.2|8.2|||
3970924|NCT01290614|3792971|B1|||Age||years|Mean|75.6|75.6|Standard Deviation|8.2|8.2|||
3970925|NCT01290601|3792980|B3|Thailand||Region of Enrollment||participants|Number|70|70.0||||||
3970926|NCT01290601|3792981|B2|Thailand||Region of Enrollment||participants|Number|24|24.0||||||
3970927|NCT01290601|3792982|B1|Thailand||Region of Enrollment||participants|Number|46|46.0||||||
3970928|NCT01290601|3792980|B3|Oriental||Race/Ethnicity, Customized||Participants|Count of Participants|70|70.0||||||
3970929|NCT01290601|3792981|B2|Oriental||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3970930|NCT01290601|3792982|B1|Oriental||Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
3970931|NCT01290601|3792980|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3970932|NCT01290601|3792981|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3970933|NCT01290601|3792982|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3970934|NCT01290601|3792980|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3970935|NCT01290601|3792981|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3970936|NCT01290601|3792982|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3970937|NCT01290601|3792980|B3|||Age||years|Mean|29.7|29.7|Standard Deviation|8.57|8.57|||
3970938|NCT01290601|3792981|B2|||Age||years|Mean|29.7|29.7|Standard Deviation|8.57|8.57|||
3970939|NCT01290601|3792982|B1|||Age||years|Mean|25.5|25.5|Standard Deviation|6.37|6.37|||
3970940|NCT01290536|3792999|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
3970941|NCT01290536|3792999|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3970942|NCT01290536|3792999|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3970943|NCT01290536|3792999|B1|||Age||years|Median|61|61.0|Full Range|||35.0|85.0|
3970944|NCT01290523|3793006|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3970945|NCT01290523|3793006|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3970946|NCT01290523|3793006|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3970947|NCT01290523|3793006|B1|||Age||years|Median|63|63.0|Full Range|||54.0|90.0|
3970948|NCT01290484|3793011|B1|||Weight||Kilograms|Mean|17.0|17.0|Full Range|||9.7|24.2|
3970949|NCT01290484|3793011|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3970950|NCT01290484|3793011|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3970951|NCT01290484|3793011|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3970952|NCT01290484|3793011|B1|||Age||months|Mean|51.3|51.3|Full Range|||13.0|85.0|
3970953|NCT01290341|3793015|B3|United States||Region of Enrollment||participants|Number|859|859.0||||||
3970954|NCT01290341|3793016|B2|United States||Region of Enrollment||participants|Number|287|287.0||||||
3970955|NCT01290341|3793017|B1|United States||Region of Enrollment||participants|Number|572|572.0||||||
3970956|NCT01290341|3793015|B3||Male|Sex: Female, Male||Participants|Count of Participants|668|668.0||||||
3970957|NCT01290341|3793016|B2||Male|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
3970958|NCT01290341|3793017|B1||Male|Sex: Female, Male||Participants|Count of Participants|454|454.0||||||
3970959|NCT01290341|3793015|B3||Female|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
3970960|NCT01290341|3793016|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3970961|NCT01290341|3793017|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3970962|NCT01290341|3793015|B3|||Age||years|Mean|45.2|45.2|Standard Deviation|14.9|14.9|||
3970963|NCT01290341|3793016|B2|||Age||years|Mean|45.2|45.2|Standard Deviation|14.7|14.7|||
3970964|NCT01290341|3793017|B1|||Age||years|Mean|45.2|45.2|Standard Deviation|14.9|14.9|||
3970965|NCT01290341|3793015|B3||>=65 years|Age||Participants|Count of Participants|88|88.0||||||
3970966|NCT01290341|3793016|B2||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
3970967|NCT01290341|3793017|B1||>=65 years|Age||Participants|Count of Participants|57|57.0||||||
3970968|NCT01290341|3793015|B3||Between 18 and 65 years|Age||Participants|Count of Participants|752|752.0||||||
3970969|NCT01290341|3793016|B2||Between 18 and 65 years|Age||Participants|Count of Participants|252|252.0||||||
3970970|NCT01290341|3793017|B1||Between 18 and 65 years|Age||Participants|Count of Participants|500|500.0||||||
3970971|NCT01290341|3793015|B3||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
3970972|NCT01290341|3793016|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3970973|NCT01290341|3793017|B1||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
3970974|NCT01290315|3793026|B5|United States||Region of Enrollment||participants|Number|49|49.0||||||
3970975|NCT01290315|3793027|B4|United States||Region of Enrollment||participants|Number|13|13.0||||||
3970976|NCT01290315|3793028|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3970977|NCT01290315|3793029|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3970978|NCT01290315|3793030|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3970979|NCT01290315|3793026|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3970980|NCT01290315|3793027|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3970981|NCT01290315|3793028|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3970982|NCT01290315|3793029|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3970983|NCT01290315|3793030|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3970984|NCT01290315|3793026|B5||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3970985|NCT01290315|3793027|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3970986|NCT01290315|3793028|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3970987|NCT01290315|3793029|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3970988|NCT01290315|3793030|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3970989|NCT01290315|3793026|B5|||Age||years|Mean|34.8|34.8|Standard Deviation|9.48|9.48|||
3970990|NCT01290315|3793027|B4|||Age||years|Mean|39.2|39.2|Standard Deviation|9.21|9.21|||
3970991|NCT01290315|3793028|B3|||Age||years|Mean|39.2|39.2|Standard Deviation|7.97|7.97|||
3970992|NCT01290315|3793029|B2|||Age||years|Mean|29.6|29.6|Standard Deviation|9.93|9.93|||
3970993|NCT01290315|3793030|B1|||Age||years|Mean|32.1|32.1|Standard Deviation|7.66|7.66|||
3970994|NCT01290315|3793026|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3970995|NCT01290315|3793027|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3970996|NCT01290315|3793028|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3970997|NCT01290315|3793029|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3970998|NCT01290315|3793030|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3970999|NCT01290315|3793026|B5||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3971000|NCT01290315|3793027|B4||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3971001|NCT01290315|3793028|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3971002|NCT01290315|3793029|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3971003|NCT01290315|3793030|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3971004|NCT01290315|3793026|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3971005|NCT01290315|3793027|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3971006|NCT01290315|3793028|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3971007|NCT01290315|3793029|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3971008|NCT01290315|3793030|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3971009|NCT01290263|3793053|B3|3||Number of Prior Relapses||participants|Number|1|1.0||||||
3971010|NCT01290263|3793054|B2|3||Number of Prior Relapses||participants|Number|1|1.0||||||
3971011|NCT01290263|3793055|B1|3||Number of Prior Relapses||participants|Number|0|0.0||||||
3971012|NCT01290263|3793053|B3|2||Number of Prior Relapses||participants|Number|16|16.0||||||
3971013|NCT01290263|3793054|B2|2||Number of Prior Relapses||participants|Number|2|2.0||||||
3971014|NCT01290263|3793055|B1|2||Number of Prior Relapses||participants|Number|14|14.0||||||
3971015|NCT01290263|3793053|B3|1||Number of Prior Relapses||participants|Number|31|31.0||||||
3971016|NCT01290263|3793054|B2|1||Number of Prior Relapses||participants|Number|8|8.0||||||
3971017|NCT01290263|3793055|B1|1||Number of Prior Relapses||participants|Number|23|23.0||||||
3971018|NCT01290263|3793053|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3971019|NCT01290263|3793054|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971020|NCT01290263|3793055|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3971021|NCT01290263|3793053|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3971022|NCT01290263|3793054|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3971023|NCT01290263|3793055|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3971024|NCT01290263|3793053|B3||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3971025|NCT01290263|3793054|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3971026|NCT01290263|3793055|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3971027|NCT01290263|3793053|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971028|NCT01290263|3793054|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971029|NCT01290263|3793055|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971030|NCT01290263|3793053|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971031|NCT01290263|3793054|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971032|NCT01290263|3793055|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971033|NCT01290263|3793053|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971034|NCT01290263|3793054|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971035|NCT01290263|3793055|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971036|NCT01290263|3793053|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971037|NCT01290263|3793054|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971038|NCT01290263|3793055|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971039|NCT01290263|3793053|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3971040|NCT01290263|3793054|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971041|NCT01290263|3793055|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3971042|NCT01290263|3793053|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3971043|NCT01290263|3793054|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3971044|NCT01290263|3793055|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3971045|NCT01290263|3793053|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3971046|NCT01290263|3793054|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3971047|NCT01290263|3793055|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971048|NCT01290263|3793053|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3971049|NCT01290263|3793054|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3971050|NCT01290263|3793055|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3971051|NCT01290263|3793053|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3971052|NCT01290263|3793054|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3971053|NCT01290263|3793055|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3971054|NCT01290263|3793053|B3|||Age||years|Median|62|62.0|Full Range|||29.0|86.0|
3971055|NCT01290263|3793054|B2|||Age||years|Median|62|62.0|Full Range|||29.0|78.0|
3971056|NCT01290263|3793055|B1|||Age||years|Median|63|63.0|Full Range|||37.0|86.0|
3971057|NCT01290237|3793075|B3|United States||Region of Enrollment||participants|Number|59|59.0||||||
3971058|NCT01290237|3793076|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
3971059|NCT01290237|3793077|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3971060|NCT01290237|3793075|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3971061|NCT01290237|3793076|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3971062|NCT01290237|3793077|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3971063|NCT01290237|3793075|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3971064|NCT01290237|3793076|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3971065|NCT01290237|3793077|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3971066|NCT01290237|3793075|B3|||Age||years|Mean|8.70|8.7|Standard Deviation|4.22|4.22|||
3971067|NCT01290237|3793076|B2|||Age||years|Mean|8.76|8.76|Standard Deviation|4.04|4.04|||
3971068|NCT01290237|3793077|B1|||Age||years|Mean|8.63|8.63|Standard Deviation|4.4|4.4|||
3971069|NCT01290224|3793086|B1|>6 months||Duration of pain symptoms at baseline||participants|Number|0|0.0||||||
3971070|NCT01290224|3793086|B1|<=6 months||Duration of pain symptoms at baseline||participants|Number|10|10.0||||||
3971071|NCT01290224|3793086|B1|Multiple Agents||Number of neurotoxic agents exposed to||participants|Number|3|3.0||||||
3971072|NCT01290224|3793086|B1|Single Agent||Number of neurotoxic agents exposed to||participants|Number|7|7.0||||||
3971073|NCT01290224|3793086|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3971074|NCT01290224|3793086|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971075|NCT01290224|3793086|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3971076|NCT01290224|3793086|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971077|NCT01290224|3793086|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3971078|NCT01290224|3793086|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3971079|NCT01290224|3793086|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|9.8|9.8|||
3971080|NCT01290094|3793097|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3971081|NCT01290094|3793097|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3971082|NCT01290094|3793097|B1|||Age||years|Mean|60.60|60.6|Standard Deviation|5.812|5.812|||
3971083|NCT01290068|3793108|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3971084|NCT01290068|3793109|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3971085|NCT01290068|3793110|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3971086|NCT01290068|3793108|B3||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3971087|NCT01290068|3793109|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3971088|NCT01290068|3793110|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3971089|NCT01290068|3793108|B3|≥80 years||Age, Customized||participants|Number|25|25.0||||||
3971090|NCT01290068|3793109|B2|≥80 years||Age, Customized||participants|Number|10|10.0||||||
3971091|NCT01290068|3793110|B1|≥80 years||Age, Customized||participants|Number|15|15.0||||||
3971092|NCT01290068|3793108|B3|70 to 79 years||Age, Customized||participants|Number|85|85.0||||||
3971093|NCT01290068|3793109|B2|70 to 79 years||Age, Customized||participants|Number|45|45.0||||||
3971094|NCT01290068|3793110|B1|70 to 79 years||Age, Customized||participants|Number|40|40.0||||||
3971095|NCT01290068|3793108|B3|60 to 69 years||Age, Customized||participants|Number|76|76.0||||||
3971096|NCT01290068|3793109|B2|60 to 69 years||Age, Customized||participants|Number|36|36.0||||||
3971097|NCT01290068|3793110|B1|60 to 69 years||Age, Customized||participants|Number|40|40.0||||||
3971098|NCT01290068|3793108|B3|21 to 59 years||Age, Customized||participants|Number|20|20.0||||||
3971099|NCT01290068|3793109|B2|21 to 59 years||Age, Customized||participants|Number|7|7.0||||||
3971100|NCT01290068|3793110|B1|21 to 59 years||Age, Customized||participants|Number|13|13.0||||||
3971101|NCT01290029|3793123|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3971102|NCT01290029|3793123|B1|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3971103|NCT01290029|3793123|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3971104|NCT01290029|3793123|B1|Black (or African American)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3971105|NCT01290029|3793123|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3971106|NCT01290029|3793123|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3971107|NCT01290029|3793123|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3971108|NCT01290029|3793123|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3971109|NCT01290029|3793123|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3971110|NCT01290029|3793123|B1||Male|Gender||Participants|Count of Participants|7|7.0||||||
3971111|NCT01290029|3793123|B1||Female|Gender||Participants|Count of Participants|7|7.0||||||
3971112|NCT01290029|3793123|B1|||Age||months|Mean|39.5|39.5|Standard Deviation|17.1|17.1|||
3971113|NCT01289990|3793136|B14||Male|Sex: Female, Male||Participants|Count of Participants|1492|1492.0||||||
3971114|NCT01289990|3793137|B13||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3971115|NCT01289990|3793138|B12||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3971116|NCT01289990|3793139|B11||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3971117|NCT01289990|3793140|B10||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3971118|NCT01289990|3793141|B9||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3971119|NCT01289990|3793142|B8||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3971120|NCT01289990|3793143|B7||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3971121|NCT01289990|3793144|B6||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3971122|NCT01289990|3793145|B5||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3971123|NCT01289990|3793146|B4||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3971124|NCT01289990|3793147|B3||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3971125|NCT01289990|3793148|B2||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3971126|NCT01289990|3793149|B1||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3971127|NCT01289990|3793136|B14||Female|Sex: Female, Male||Participants|Count of Participants|1208|1208.0||||||
3971128|NCT01289990|3793137|B13||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3971129|NCT01289990|3793138|B12||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3971130|NCT01289990|3793139|B11||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3971131|NCT01289990|3793140|B10||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3971132|NCT01289990|3793141|B9||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3971133|NCT01289990|3793142|B8||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3971134|NCT01289990|3793143|B7||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3971135|NCT01289990|3793144|B6||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3971136|NCT01289990|3793145|B5||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3971137|NCT01289990|3793146|B4||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3971138|NCT01289990|3793147|B3||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3971139|NCT01289990|3793148|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3971140|NCT01289990|3793149|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3971141|NCT01289990|3793136|B14|||Age||years|Mean|55.6|55.6|Standard Deviation|10.2|10.2|||
3971142|NCT01289990|3793137|B13|||Age||years|Mean|56.9|56.9|Standard Deviation|9.2|9.2|||
3971143|NCT01289990|3793138|B12|||Age||years|Mean|57.4|57.4|Standard Deviation|9.3|9.3|||
3971144|NCT01289990|3793139|B11|||Age||years|Mean|57.0|57.0|Standard Deviation|9.2|9.2|||
3971145|NCT01289990|3793140|B10|||Age||years|Mean|56.0|56.0|Standard Deviation|9.7|9.7|||
3971146|NCT01289990|3793141|B9|||Age||years|Mean|55.6|55.6|Standard Deviation|10.2|10.2|||
3971147|NCT01289990|3793142|B8|||Age||years|Mean|55.5|55.5|Standard Deviation|9.9|9.9|||
3971148|NCT01289990|3793143|B7|||Age||years|Mean|54.6|54.6|Standard Deviation|10.5|10.5|||
3971149|NCT01289990|3793144|B6|||Age||years|Mean|54.2|54.2|Standard Deviation|8.9|8.9|||
3971150|NCT01289990|3793145|B5|||Age||years|Mean|54.7|54.7|Standard Deviation|9.9|9.9|||
3971151|NCT01289990|3793146|B4|||Age||years|Mean|55.1|55.1|Standard Deviation|9.9|9.9|||
3971152|NCT01289990|3793147|B3|||Age||years|Mean|54.9|54.9|Standard Deviation|10.9|10.9|||
3971153|NCT01289990|3793148|B2|||Age||years|Mean|53.8|53.8|Standard Deviation|11.6|11.6|||
3971154|NCT01289990|3793149|B1|||Age||years|Mean|56.2|56.2|Standard Deviation|11.6|11.6|||
3971155|NCT01289912|3793345|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3971156|NCT01289912|3793346|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3971157|NCT01289912|3793347|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3971158|NCT01289912|3793345|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3971159|NCT01289912|3793346|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3971160|NCT01289912|3793347|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3971161|NCT01289912|3793345|B3|||Age||years|Mean|12.68|12.68|Standard Deviation|5.15|5.15|||
3971162|NCT01289912|3793346|B2|||Age||years|Mean|11.47|11.47|Standard Deviation|5.30|5.3|||
3971163|NCT01289912|3793347|B1|||Age||years|Mean|13.25|13.25|Standard Deviation|5.06|5.06|||
3971164|NCT01289847|3793378|B1|Chile||Region of Enrollment||participants|Number|1|1.0||||||
3971165|NCT01289847|3793378|B1|Israel||Region of Enrollment||participants|Number|2|2.0||||||
3971166|NCT01289847|3793378|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3971167|NCT01289847|3793378|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3971168|NCT01289847|3793378|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3971169|NCT01289847|3793378|B1|12 to 16 year age group||Age, Customized||participants|Number|10|10.0||||||
3971170|NCT01289847|3793378|B1|6 to 11 year age group||Age, Customized||participants|Number|12|12.0||||||
3971171|NCT01289847|3793378|B1|2 to 5 year age group||Age, Customized||participants|Number|3|3.0||||||
3971172|NCT01289821|3793387|B1|IV||Stage at initial diagnosis|The TNM Classification of Malignant Tumors (TNM) is a cancer staging system that describes the extent of a person's cancer. T describes the size of the original (primary) tumor and whether it has invaded nearby tissue, N describes nearby (regional) lymph nodes that are involved, M describes distant metastasis. For colon carcinoma, this is translated into stages I-IV. Stages II-IV can be further subdivided in subgroups (eg, A,B, or C).|Participants|Number|41|41.0||||||
3971173|NCT01289821|3793387|B1|IIIC||Stage at initial diagnosis|The TNM Classification of Malignant Tumors (TNM) is a cancer staging system that describes the extent of a person's cancer. T describes the size of the original (primary) tumor and whether it has invaded nearby tissue, N describes nearby (regional) lymph nodes that are involved, M describes distant metastasis. For colon carcinoma, this is translated into stages I-IV. Stages II-IV can be further subdivided in subgroups (eg, A,B, or C).|Participants|Number|4|4.0||||||
3971174|NCT01289821|3793387|B1|IIIB||Stage at initial diagnosis|The TNM Classification of Malignant Tumors (TNM) is a cancer staging system that describes the extent of a person's cancer. T describes the size of the original (primary) tumor and whether it has invaded nearby tissue, N describes nearby (regional) lymph nodes that are involved, M describes distant metastasis. For colon carcinoma, this is translated into stages I-IV. Stages II-IV can be further subdivided in subgroups (eg, A,B, or C).|Participants|Number|3|3.0||||||
3971175|NCT01289821|3793387|B1|IIA||Stage at initial diagnosis|The TNM Classification of Malignant Tumors (TNM) is a cancer staging system that describes the extent of a person's cancer. T describes the size of the original (primary) tumor and whether it has invaded nearby tissue, N describes nearby (regional) lymph nodes that are involved, M describes distant metastasis. For colon carcinoma, this is translated into stages I-IV. Stages II-IV can be further subdivided in subgroups (eg, A,B, or C).|Participants|Number|5|5.0||||||
3971176|NCT01289821|3793387|B1|I||Stage at initial diagnosis|The TNM Classification of Malignant Tumors (TNM) is a cancer staging system that describes the extent of a person's cancer. T describes the size of the original (primary) tumor and whether it has invaded nearby tissue, N describes nearby (regional) lymph nodes that are involved, M describes distant metastasis. For colon carcinoma, this is translated into stages I-IV. Stages II-IV can be further subdivided in subgroups (eg, A,B, or C).|Participants|Number|1|1.0||||||
3971177|NCT01289821|3793387|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) at study entry|The ECOG PS required for the study was 0 (fully active) or 1 (restricted in physically strenous activity but ambulatory and able to carry out work of a light or sedentary nature)|Participants|Number|19|19.0||||||
3971178|NCT01289821|3793387|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) at study entry|The ECOG PS required for the study was 0 (fully active) or 1 (restricted in physically strenous activity but ambulatory and able to carry out work of a light or sedentary nature)|Participants|Number|35|35.0||||||
3971179|NCT01289821|3793387|B1|||Caucasian||Participants|Number|54|54.0||||||
3971180|NCT01289821|3793387|B1|Male||Sex/Gender, Customized||Paricipants|Number|28|28.0||||||
3971181|NCT01289821|3793387|B1|Female||Sex/Gender, Customized||Paricipants|Number|26|26.0||||||
3971182|NCT01289821|3793387|B1|> 75 years||Age, Customized||Participants|Number|3|3.0||||||
3971183|NCT01289821|3793387|B1|65 - 75 years||Age, Customized||Participants|Number|18|18.0||||||
3971184|NCT01289821|3793387|B1|< 65 years||Age, Customized||Participants|Number|33|33.0||||||
3971185|NCT01289782|3793396|B3||Male|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
3971186|NCT01289782|3793397|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3971187|NCT01289782|3793398|B1||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3971188|NCT01289782|3793396|B3||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3971189|NCT01289782|3793397|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3971190|NCT01289782|3793398|B1||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3971191|NCT01289782|3793396|B3|||Age||years|Median|48|48.0|Full Range|||19.0|68.0|
3971192|NCT01289782|3793397|B2|||Age||years|Median|48|48.0|Full Range|||20.0|66.0|
3971193|NCT01289782|3793398|B1|||Age||years|Median|48|48.0|Full Range|||19.0|68.0|
3971194|NCT01289639|3793468|B4|United States||Region of Enrollment||participants|Number|11|11.0||||||
3971195|NCT01289639|3793470|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3971196|NCT01289639|3793471|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3971197|NCT01289639|3793468|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3971198|NCT01289639|3793470|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3971199|NCT01289639|3793471|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3971200|NCT01289639|3793468|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3971201|NCT01289639|3793470|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3971202|NCT01289639|3793471|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3971203|NCT01289639|3793468|B4|||Age||years|Mean|51.91|51.91|Standard Deviation|6.41|6.41|||
3971204|NCT01289639|3793470|B2|||Age||years|Mean|54.17|54.17|Standard Deviation|5.08|5.08|||
3971205|NCT01289639|3793471|B1|||Age||years|Mean|49.2|49.2|Standard Deviation|7.3|7.3|||
3971206|NCT01289574|3793496|B4|Taiwan||Region of Enrollment||participants|Number|139|139.0||||||
3971207|NCT01289574|3793497|B3|Taiwan||Region of Enrollment||participants|Number|48|48.0||||||
3971208|NCT01289574|3793498|B2|Taiwan||Region of Enrollment||participants|Number|47|47.0||||||
3971209|NCT01289574|3793499|B1|Taiwan||Region of Enrollment||participants|Number|44|44.0||||||
3971210|NCT01289574|3793496|B4|United States||Region of Enrollment||participants|Number|42|42.0||||||
3971211|NCT01289574|3793497|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
3971212|NCT01289574|3793498|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3971213|NCT01289574|3793499|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3971214|NCT01289574|3793496|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971215|NCT01289574|3793497|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971216|NCT01289574|3793498|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971217|NCT01289574|3793499|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971218|NCT01289574|3793496|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|176|176.0||||||
3971219|NCT01289574|3793497|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3971220|NCT01289574|3793498|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3971221|NCT01289574|3793499|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3971222|NCT01289574|3793496|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3971223|NCT01289574|3793497|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3971224|NCT01289574|3793498|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3971225|NCT01289574|3793499|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3971226|NCT01289574|3793496|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3971227|NCT01289574|3793497|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971228|NCT01289574|3793498|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3971229|NCT01289574|3793499|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971230|NCT01289574|3793496|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971231|NCT01289574|3793497|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971232|NCT01289574|3793498|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971233|NCT01289574|3793499|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971234|NCT01289574|3793496|B4||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3971235|NCT01289574|3793497|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3971236|NCT01289574|3793498|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3971237|NCT01289574|3793499|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3971238|NCT01289574|3793496|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3971239|NCT01289574|3793497|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3971240|NCT01289574|3793498|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3971241|NCT01289574|3793499|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971242|NCT01289574|3793496|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971243|NCT01289574|3793497|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971244|NCT01289574|3793498|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971245|NCT01289574|3793499|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971246|NCT01289574|3793496|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|141|141.0||||||
3971247|NCT01289574|3793497|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3971248|NCT01289574|3793498|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3971249|NCT01289574|3793499|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3971250|NCT01289574|3793496|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971251|NCT01289574|3793497|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971252|NCT01289574|3793498|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971253|NCT01289574|3793499|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971254|NCT01289574|3793496|B4||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3971255|NCT01289574|3793497|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3971256|NCT01289574|3793498|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3971257|NCT01289574|3793499|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3971258|NCT01289574|3793496|B4||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3971259|NCT01289574|3793497|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3971260|NCT01289574|3793498|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3971261|NCT01289574|3793499|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3971262|NCT01289574|3793496|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3971263|NCT01289574|3793497|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3971264|NCT01289574|3793498|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3971265|NCT01289574|3793499|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3971266|NCT01289574|3793496|B4||Between 18 and 65 years|Age||Participants|Count of Participants|123|123.0||||||
3971267|NCT01289574|3793497|B3||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3971268|NCT01289574|3793498|B2||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3971269|NCT01289574|3793499|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3971270|NCT01289574|3793496|B4||<=18 years|Age||Participants|Count of Participants|58|58.0||||||
3971271|NCT01289574|3793497|B3||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
3971272|NCT01289574|3793498|B2||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
3971273|NCT01289574|3793499|B1||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
3971274|NCT01289574|3793496|B4|||Age||Years|Mean|21.3|21.3|Standard Deviation|5.6|5.6|||
3971275|NCT01289574|3793497|B3|||Age||Years|Mean|22.0|22.0|Standard Deviation|6.3|6.3|||
3971276|NCT01289574|3793498|B2|||Age||Years|Mean|20.7|20.7|Standard Deviation|4.8|4.8|||
3971277|NCT01289574|3793499|B1|||Age||Years|Mean|21.1|21.1|Standard Deviation|5.7|5.7|||
3971278|NCT01289548|3793515|B4|spouses||Relationship|The donor's relationship with the recipient|donors/recipients pairs|Number|5|5.0||||||
3971279|NCT01289548|3793516|B3|spouses||Relationship|The donor's relationship with the recipient|donors/recipients pairs|Number|1|1.0||||||
3971280|NCT01289548|3793517|B2|spouses||Relationship|The donor's relationship with the recipient|donors/recipients pairs|Number|2|2.0||||||
3971281|NCT01289548|3793518|B1|spouses||Relationship|The donor's relationship with the recipient|donors/recipients pairs|Number|2|2.0||||||
3971282|NCT01289548|3793515|B4|siblings||Relationship|The donor's relationship with the recipient|donors/recipients pairs|Number|13|13.0||||||
3971283|NCT01289548|3793516|B3|siblings||Relationship|The donor's relationship with the recipient|donors/recipients pairs|Number|5|5.0||||||
3971284|NCT01289548|3793517|B2|siblings||Relationship|The donor's relationship with the recipient|donors/recipients pairs|Number|2|2.0||||||
3971285|NCT01289548|3793518|B1|siblings||Relationship|The donor's relationship with the recipient|donors/recipients pairs|Number|6|6.0||||||
3971286|NCT01289548|3793515|B4|parents||Relationship|The donor's relationship with the recipient|donors/recipients pairs|Number|42|42.0||||||
3971287|NCT01289548|3793516|B3|parents||Relationship|The donor's relationship with the recipient|donors/recipients pairs|Number|14|14.0||||||
3971288|NCT01289548|3793517|B2|parents||Relationship|The donor's relationship with the recipient|donors/recipients pairs|Number|16|16.0||||||
3971289|NCT01289548|3793518|B1|parents||Relationship|The donor's relationship with the recipient|donors/recipients pairs|Number|12|12.0||||||
3971290|NCT01289548|3793515|B4|||Body mass index (BMI)|BMI of the donor. BMI=weight(kg)/〖height(m)〗^2|kg/m^2|Mean|22.61|22.61|Standard Deviation|2.90|2.9|||
3971291|NCT01289548|3793516|B3|||Body mass index (BMI)|BMI of the donor. BMI=weight(kg)/〖height(m)〗^2|kg/m^2|Mean|23.45|23.45|Standard Deviation|2.61|2.61|||
3971292|NCT01289548|3793517|B2|||Body mass index (BMI)|BMI of the donor. BMI=weight(kg)/〖height(m)〗^2|kg/m^2|Mean|22.19|22.19|Standard Deviation|2.43|2.43|||
3971293|NCT01289548|3793518|B1|||Body mass index (BMI)|BMI of the donor. BMI=weight(kg)/〖height(m)〗^2|kg/m^2|Mean|22.19|22.19|Standard Deviation|3.51|3.51|||
3971294|NCT01289548|3793515|B4|||Cold ischemic time|Time from fully perfusion of the donor kidney to complement of the artery unclamping in the transplantation surgery|minutes|Mean|173.05|173.05|Standard Deviation|28.52|28.52|||
3971295|NCT01289548|3793516|B3|||Cold ischemic time|Time from fully perfusion of the donor kidney to complement of the artery unclamping in the transplantation surgery|minutes|Mean|177.25|177.25|Standard Deviation|27.59|27.59|||
3971296|NCT01289548|3793517|B2|||Cold ischemic time|Time from fully perfusion of the donor kidney to complement of the artery unclamping in the transplantation surgery|minutes|Mean|166.25|166.25|Standard Deviation|19.22|19.22|||
3971297|NCT01289548|3793518|B1|||Cold ischemic time|Time from fully perfusion of the donor kidney to complement of the artery unclamping in the transplantation surgery|minutes|Mean|175.65|175.65|Standard Deviation|36.35|36.35|||
3971298|NCT01289548|3793515|B4|||Body mass index (BMI)|BMI of the recipient. BMI=weight(kg)/〖height(m)〗^2|kg/m^2|Mean|20.13|20.13|Standard Deviation|2.65|2.65|||
3971299|NCT01289548|3793516|B3|||Body mass index (BMI)|BMI of the recipient. BMI=weight(kg)/〖height(m)〗^2|kg/m^2|Mean|20.38|20.38|Standard Deviation|3.20|3.2|||
3971300|NCT01289548|3793517|B2|||Body mass index (BMI)|BMI of the recipient. BMI=weight(kg)/〖height(m)〗^2|kg/m^2|Mean|19.94|19.94|Standard Deviation|1.99|1.99|||
3971301|NCT01289548|3793518|B1|||Body mass index (BMI)|BMI of the recipient. BMI=weight(kg)/〖height(m)〗^2|kg/m^2|Mean|20.08|20.08|Standard Deviation|2.75|2.75|||
3971302|NCT01289548|3793515|B4|China||Region of Enrollment||donors/recipients pairs|Number|60|60.0||||||
3971303|NCT01289548|3793516|B3|China||Region of Enrollment||donors/recipients pairs|Number|20|20.0||||||
3971304|NCT01289548|3793517|B2|China||Region of Enrollment||donors/recipients pairs|Number|20|20.0||||||
3971305|NCT01289548|3793518|B1|China||Region of Enrollment||donors/recipients pairs|Number|20|20.0||||||
3971306|NCT01289548|3793515|B4||Male|Sex: Female, Male|Gender of the donor|Participants|Count of Participants|24|24.0||||||
3971307|NCT01289548|3793516|B3||Male|Sex: Female, Male|Gender of the donor|Participants|Count of Participants|10|10.0||||||
3971308|NCT01289548|3793517|B2||Male|Sex: Female, Male|Gender of the donor|Participants|Count of Participants|6|6.0||||||
3971309|NCT01289548|3793518|B1||Male|Sex: Female, Male|Gender of the donor|Participants|Count of Participants|8|8.0||||||
3971310|NCT01289548|3793515|B4||Female|Sex: Female, Male|Gender of the donor|Participants|Count of Participants|36|36.0||||||
3971311|NCT01289548|3793516|B3||Female|Sex: Female, Male|Gender of the donor|Participants|Count of Participants|10|10.0||||||
3971312|NCT01289548|3793517|B2||Female|Sex: Female, Male|Gender of the donor|Participants|Count of Participants|14|14.0||||||
3971313|NCT01289548|3793518|B1||Female|Sex: Female, Male|Gender of the donor|Participants|Count of Participants|12|12.0||||||
3971314|NCT01289548|3793515|B4||Male|Sex: Female, Male|Gender of the recipient|Participants|Count of Participants|46|46.0||||||
3971315|NCT01289548|3793516|B3||Male|Sex: Female, Male|Gender of the recipient|Participants|Count of Participants|14|14.0||||||
3971316|NCT01289548|3793517|B2||Male|Sex: Female, Male|Gender of the recipient|Participants|Count of Participants|16|16.0||||||
3971317|NCT01289548|3793518|B1||Male|Sex: Female, Male|Gender of the recipient|Participants|Count of Participants|16|16.0||||||
3971318|NCT01289548|3793515|B4||Female|Sex: Female, Male|Gender of the recipient|Participants|Count of Participants|14|14.0||||||
3971319|NCT01289548|3793516|B3||Female|Sex: Female, Male|Gender of the recipient|Participants|Count of Participants|6|6.0||||||
3971320|NCT01289548|3793517|B2||Female|Sex: Female, Male|Gender of the recipient|Participants|Count of Participants|4|4.0||||||
3971321|NCT01289548|3793518|B1||Female|Sex: Female, Male|Gender of the recipient|Participants|Count of Participants|4|4.0||||||
3971322|NCT01289548|3793515|B4|||Age|Age of the donor|years|Mean|47.6|47.6|Standard Deviation|7.4|7.4|||
3971323|NCT01289548|3793516|B3|||Age|Age of the donor|years|Mean|48.7|48.7|Standard Deviation|5.2|5.2|||
3971324|NCT01289548|3793517|B2|||Age|Age of the donor|years|Mean|47.4|47.4|Standard Deviation|10.0|10.0|||
3971325|NCT01289548|3793518|B1|||Age|Age of the donor|years|Mean|46.9|46.9|Standard Deviation|6.4|6.4|||
3971326|NCT01289548|3793515|B4|||Age|Age of the recipient|years|Mean|30.4|30.4|Standard Deviation|8.2|8.2|||
3971327|NCT01289548|3793516|B3|||Age|Age of the recipient|years|Mean|30.6|30.6|Standard Deviation|7.0|7.0|||
3971328|NCT01289548|3793517|B2|||Age|Age of the recipient|years|Mean|28.1|28.1|Standard Deviation|6.5|6.5|||
3971329|NCT01289548|3793518|B1|||Age|Age of the recipient|years|Mean|32.5|32.5|Standard Deviation|10.3|10.3|||
3971330|NCT01289522|3793564|B1|France||Region of Enrollment||participants|Number|46|46.0||||||
3971331|NCT01289522|3793564|B1|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
3971332|NCT01289522|3793564|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3971333|NCT01289522|3793564|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3971334|NCT01289522|3793564|B1|||Age||years|Median|57.8|57.8|Full Range|||28.9|69.2|
3971335|NCT01289522|3793564|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3971336|NCT01289522|3793564|B1||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3971337|NCT01289522|3793564|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3971338|NCT01289418|3793570|B4|Canada||Region of Enrollment||participants|Number|6525|6525.0||||||
3971339|NCT01289418|3793571|B3|Canada||Region of Enrollment||participants|Number|823|823.0||||||
3971340|NCT01289418|3793572|B2|Canada||Region of Enrollment||participants|Number|519|519.0||||||
3971341|NCT01289418|3793573|B1|Canada||Region of Enrollment||participants|Number|5183|5183.0||||||
3971342|NCT01289418|3793570|B4|Male||Gender|Demographic data was collected in only one site (n=3159). Some participants did not complete all the questions. That's why we don't have the age and the gender for all the participants.|participants|Number|841|841.0||||||
3971343|NCT01289418|3793571|B3|Male||Gender|Demographic data was collected in only one site (n=3159). Some participants did not complete all the questions. That's why we don't have the age and the gender for all the participants.|participants|Number|NA|||||||demographic data were available only for Quebec
3971344|NCT01289418|3793572|B2|Male||Gender|Demographic data was collected in only one site (n=3159). Some participants did not complete all the questions. That's why we don't have the age and the gender for all the participants.|participants|Number|NA|||||||demographic data were available only for Quebec
3971345|NCT01289418|3793573|B1|Male||Gender|Demographic data was collected in only one site (n=3159). Some participants did not complete all the questions. That's why we don't have the age and the gender for all the participants.|participants|Number|841|841.0||||||
3971346|NCT01289418|3793570|B4|Female||Gender|Demographic data was collected in only one site (n=3159). Some participants did not complete all the questions. That's why we don't have the age and the gender for all the participants.|participants|Number|2310|2310.0||||||
3971347|NCT01289418|3793571|B3|Female||Gender|Demographic data was collected in only one site (n=3159). Some participants did not complete all the questions. That's why we don't have the age and the gender for all the participants.|participants|Number|NA|||||||demographic data were available only for Quebec
3971348|NCT01289418|3793572|B2|Female||Gender|Demographic data was collected in only one site (n=3159). Some participants did not complete all the questions. That's why we don't have the age and the gender for all the participants.|participants|Number|NA|||||||demographic data were available only for Quebec
3971349|NCT01289418|3793573|B1|Female||Gender|Demographic data was collected in only one site (n=3159). Some participants did not complete all the questions. That's why we don't have the age and the gender for all the participants.|participants|Number|2310|2310.0||||||
3971350|NCT01289418|3793570|B4|||Age||years|Mean|37.5|37.5|Standard Deviation|11.7|11.7|||
3971351|NCT01289418|3793571|B3|||Age||years|Mean|NA||Standard Deviation|NA||||demographic data were available only for Quebec
3971352|NCT01289418|3793572|B2|||Age||years|Mean|NA||Standard Deviation|NA||||demographic data were available only for Quebec
3971353|NCT01289418|3793573|B1|||Age||years|Mean|37.5|37.5|Standard Deviation|11.7|11.7|||
3971354|NCT01289418|3793570|B4|>=65 years||Age|Demographic data was collected in only one site (n=3159). Some participants did not complete all the questions. That's why we don't have the age and the gender for all the participants.|participants|Number|1|1.0||||||
3971355|NCT01289418|3793571|B3|>=65 years||Age|Demographic data was collected in only one site (n=3159). Some participants did not complete all the questions. That's why we don't have the age and the gender for all the participants.|participants|Number|NA|||||||demographic data were available only for Quebec
3971356|NCT01289418|3793572|B2|>=65 years||Age|Demographic data was collected in only one site (n=3159). Some participants did not complete all the questions. That's why we don't have the age and the gender for all the participants.|participants|Number|NA|||||||demographic data were available only for Quebec
3971357|NCT01289418|3793573|B1|>=65 years||Age|Demographic data was collected in only one site (n=3159). Some participants did not complete all the questions. That's why we don't have the age and the gender for all the participants.|participants|Number|1|1.0||||||
3971358|NCT01289418|3793570|B4|Between 18 and 65 years||Age|Demographic data was collected in only one site (n=3159). Some participants did not complete all the questions. That's why we don't have the age and the gender for all the participants.|participants|Number|3152|3152.0||||||
3971359|NCT01289418|3793571|B3|Between 18 and 65 years||Age|Demographic data was collected in only one site (n=3159). Some participants did not complete all the questions. That's why we don't have the age and the gender for all the participants.|participants|Number|NA|||||||demographic data were available only for Quebec
3971360|NCT01289418|3793572|B2|Between 18 and 65 years||Age|Demographic data was collected in only one site (n=3159). Some participants did not complete all the questions. That's why we don't have the age and the gender for all the participants.|participants|Number|NA|||||||demographic data were available only for Quebec
3971361|NCT01289418|3793573|B1|Between 18 and 65 years||Age|Demographic data was collected in only one site (n=3159). Some participants did not complete all the questions. That's why we don't have the age and the gender for all the participants.|participants|Number|3152|3152.0||||||
3971362|NCT01289418|3793570|B4|<=18 years||Age|Demographic data was collected in only one site (n=3159). Some participants did not complete all the questions. That's why we don't have the age and the gender for all the participants.|participants|Number|0|0.0||||||
3971363|NCT01289418|3793571|B3|<=18 years||Age|Demographic data was collected in only one site (n=3159). Some participants did not complete all the questions. That's why we don't have the age and the gender for all the participants.|participants|Number|NA|||||||demographic data were available only for Quebec
3971364|NCT01289418|3793572|B2|<=18 years||Age|Demographic data was collected in only one site (n=3159). Some participants did not complete all the questions. That's why we don't have the age and the gender for all the participants.|participants|Number|NA|||||||demographic data were available only for Quebec
3971365|NCT01289418|3793573|B1|<=18 years||Age|Demographic data was collected in only one site (n=3159). Some participants did not complete all the questions. That's why we don't have the age and the gender for all the participants.|participants|Number|0|0.0||||||
3971366|NCT01289392|3793579|B4|Brazil||Region of Enrollment||participants|Number|25|25.0||||||
3971367|NCT01289392|3793580|B3|Brazil||Region of Enrollment||participants|Number|7|7.0||||||
3971368|NCT01289392|3793581|B2|Brazil||Region of Enrollment||participants|Number|9|9.0||||||
3971369|NCT01289392|3793582|B1|Brazil||Region of Enrollment||participants|Number|9|9.0||||||
3971370|NCT01289392|3793579|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3971371|NCT01289392|3793580|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3971372|NCT01289392|3793581|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3971373|NCT01289392|3793582|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3971374|NCT01289392|3793579|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3971375|NCT01289392|3793580|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3971376|NCT01289392|3793581|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3971377|NCT01289392|3793582|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3971378|NCT01289392|3793579|B4|||Age||years|Mean|41.10|41.1|Standard Deviation|7.27|7.27|||
3971379|NCT01289392|3793580|B3|||Age||years|Mean|42.28|42.28|Standard Deviation|8.28|8.28|||
3971380|NCT01289392|3793581|B2|||Age||years|Mean|42.33|42.33|Standard Deviation|6.20|6.2|||
3971381|NCT01289392|3793582|B1|||Age||years|Mean|38.62|38.62|Standard Deviation|8.15|8.15|||
3971382|NCT01289392|3793579|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3971383|NCT01289392|3793580|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3971384|NCT01289392|3793581|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3971385|NCT01289392|3793582|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3971386|NCT01289392|3793579|B4||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3971387|NCT01289392|3793580|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3971388|NCT01289392|3793581|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3971389|NCT01289392|3793582|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3971390|NCT01289392|3793579|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3971391|NCT01289392|3793580|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3971392|NCT01289392|3793581|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3971393|NCT01289392|3793582|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3971394|NCT01289275|3793592|B5|United States||Region of Enrollment||participants|Number|1270|1270.0||||||
3971395|NCT01289275|3793593|B4|United States||Region of Enrollment||participants|Number|316|316.0||||||
3971396|NCT01289275|3793594|B3|United States||Region of Enrollment||participants|Number|317|317.0||||||
3971397|NCT01289275|3793595|B2|United States||Region of Enrollment||participants|Number|320|320.0||||||
3971398|NCT01289275|3793596|B1|United States||Region of Enrollment||participants|Number|317|317.0||||||
3971399|NCT01289275|3793592|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|298|298.0||||||
3971400|NCT01289275|3793593|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3971401|NCT01289275|3793594|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
3971402|NCT01289275|3793595|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3971403|NCT01289275|3793596|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3971404|NCT01289275|3793592|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3971405|NCT01289275|3793593|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3971406|NCT01289275|3793594|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3971407|NCT01289275|3793595|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3971408|NCT01289275|3793596|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3971409|NCT01289275|3793592|B5||White|Race (NIH/OMB)||Participants|Count of Participants|646|646.0||||||
3971410|NCT01289275|3793593|B4||White|Race (NIH/OMB)||Participants|Count of Participants|158|158.0||||||
3971411|NCT01289275|3793594|B3||White|Race (NIH/OMB)||Participants|Count of Participants|160|160.0||||||
3971412|NCT01289275|3793595|B2||White|Race (NIH/OMB)||Participants|Count of Participants|163|163.0||||||
3971413|NCT01289275|3793596|B1||White|Race (NIH/OMB)||Participants|Count of Participants|165|165.0||||||
3971414|NCT01289275|3793592|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|236|236.0||||||
3971415|NCT01289275|3793593|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3971416|NCT01289275|3793594|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3971417|NCT01289275|3793595|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3971418|NCT01289275|3793596|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3971419|NCT01289275|3793592|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971420|NCT01289275|3793593|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971421|NCT01289275|3793594|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971422|NCT01289275|3793595|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971423|NCT01289275|3793596|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971424|NCT01289275|3793592|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3971425|NCT01289275|3793593|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3971426|NCT01289275|3793594|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3971427|NCT01289275|3793595|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3971428|NCT01289275|3793596|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3971429|NCT01289275|3793592|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3971430|NCT01289275|3793593|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3971431|NCT01289275|3793594|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3971432|NCT01289275|3793595|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3971433|NCT01289275|3793596|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3971434|NCT01289275|3793592|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971435|NCT01289275|3793593|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971436|NCT01289275|3793594|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971437|NCT01289275|3793595|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971438|NCT01289275|3793596|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3971439|NCT01289275|3793592|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|976|976.0||||||
3971440|NCT01289275|3793593|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|241|241.0||||||
3971441|NCT01289275|3793594|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|244|244.0||||||
3971442|NCT01289275|3793595|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|248|248.0||||||
3971443|NCT01289275|3793596|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|243|243.0||||||
3971444|NCT01289275|3793592|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|294|294.0||||||
3971445|NCT01289275|3793593|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3971446|NCT01289275|3793594|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3971447|NCT01289275|3793595|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3971448|NCT01289275|3793596|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3971449|NCT01289275|3793592|B5||Male|Sex: Female, Male||Participants|Count of Participants|720|720.0||||||
3971450|NCT01289275|3793593|B4||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3971451|NCT01289275|3793594|B3||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
3971452|NCT01289275|3793595|B2||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
3971453|NCT01289275|3793596|B1||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
3971454|NCT01289275|3793592|B5||Female|Sex: Female, Male||Participants|Count of Participants|550|550.0||||||
3971455|NCT01289275|3793593|B4||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3971456|NCT01289275|3793594|B3||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3971457|NCT01289275|3793595|B2||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3971458|NCT01289275|3793596|B1||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3971459|NCT01289275|3793592|B5|||Age|years old at enrollment|years|Mean|49.9|49.9|Standard Deviation|13.2|13.2|||
3971460|NCT01289275|3793593|B4|||Age|years old at enrollment|years|Mean|49.6|49.6|Standard Deviation|13.0|13.0|||
3971461|NCT01289275|3793594|B3|||Age|years old at enrollment|years|Mean|49.1|49.1|Standard Deviation|13.0|13.0|||
3971462|NCT01289275|3793595|B2|||Age|years old at enrollment|years|Mean|51.1|51.1|Standard Deviation|13.5|13.5|||
3971463|NCT01289275|3793596|B1|||Age|years old at enrollment|years|Mean|48.2|48.2|Standard Deviation|13.2|13.2|||
3971464|NCT01289210|3793609|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3971465|NCT01289210|3793609|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3971466|NCT01289210|3793609|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3971467|NCT01289210|3793609|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3971468|NCT01289210|3793609|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3971469|NCT01289119|3793613|B7|||Stable Daily Dose of Pioglitazone|Participant population for this measure for each treatment arm: 0, 0, 0, 0, 63, 61; Total population: 124|mg|Mean|21.0|21.0|Standard Deviation|9.55|9.55|||
3971470|NCT01289119|3793614|B6|||Stable Daily Dose of Pioglitazone|Participant population for this measure for each treatment arm: 0, 0, 0, 0, 63, 61; Total population: 124|mg|Mean|20.2|20.2|Standard Deviation|7.19|7.19|||
3971471|NCT01289119|3793615|B5|||Stable Daily Dose of Pioglitazone|Participant population for this measure for each treatment arm: 0, 0, 0, 0, 63, 61; Total population: 124|mg|Mean|21.9|21.9|Standard Deviation|11.37|11.37|||
3971472|NCT01289119|3793616|B4|||Stable Daily Dose of Pioglitazone|Participant population for this measure for each treatment arm: 0, 0, 0, 0, 63, 61; Total population: 124|mg|Mean|NA||Standard Deviation|NA||||Participants in this arm were not taking Pioglitazone
3971473|NCT01289119|3793617|B3|||Stable Daily Dose of Pioglitazone|Participant population for this measure for each treatment arm: 0, 0, 0, 0, 63, 61; Total population: 124|mg|Mean|NA||Standard Deviation|NA||||Participants in this arm were not taking Pioglitazone
3971474|NCT01289119|3793618|B2|||Stable Daily Dose of Pioglitazone|Participant population for this measure for each treatment arm: 0, 0, 0, 0, 63, 61; Total population: 124|mg|Mean|NA||Standard Deviation|NA||||Participants in this arm were not taking Pioglitazone
3971475|NCT01289119|3793619|B1|||Stable Daily Dose of Pioglitazone|Participant population for this measure for each treatment arm: 0, 0, 0, 0, 63, 61; Total population: 124|mg|Mean|NA||Standard Deviation|NA||||Participants in this arm were not taking Pioglitazone
3971476|NCT01289119|3793613|B7|||Stable Daily Dose of Metformin|Participant population for this measure for each treatment arm: 0, 0, 98, 99, 50, 50; Total population: 297|mg|Mean|1426.6|1426.6|Standard Deviation|450.90|450.9|||
3971477|NCT01289119|3793614|B6|||Stable Daily Dose of Metformin|Participant population for this measure for each treatment arm: 0, 0, 98, 99, 50, 50; Total population: 297|mg|Mean|1295.0|1295.0|Standard Deviation|506.82|506.82|||
3971478|NCT01289119|3793615|B5|||Stable Daily Dose of Metformin|Participant population for this measure for each treatment arm: 0, 0, 98, 99, 50, 50; Total population: 297|mg|Mean|1355.0|1355.0|Standard Deviation|431.80|431.8|||
3971479|NCT01289119|3793616|B4|||Stable Daily Dose of Metformin|Participant population for this measure for each treatment arm: 0, 0, 98, 99, 50, 50; Total population: 297|mg|Mean|1472.2|1472.2|Standard Deviation|417.31|417.31|||
3971480|NCT01289119|3793617|B3|||Stable Daily Dose of Metformin|Participant population for this measure for each treatment arm: 0, 0, 98, 99, 50, 50; Total population: 297|mg|Mean|1484.2|1484.2|Standard Deviation|451.09|451.09|||
3971481|NCT01289119|3793618|B2|||Stable Daily Dose of Metformin|Participant population for this measure for each treatment arm: 0, 0, 98, 99, 50, 50; Total population: 297|mg|Mean|NA||Standard Deviation|NA||||Participants in this arm were not taking Metformin
3971482|NCT01289119|3793619|B1|||Stable Daily Dose of Metformin|Participant population for this measure for each treatment arm: 0, 0, 98, 99, 50, 50; Total population: 297|mg|Mean|NA||Standard Deviation|NA||||Participants in this arm were not taking Metformin
3971483|NCT01289119|3793613|B7|≥8.0%||HbA1c||participants|Number|236|236.0||||||
3971484|NCT01289119|3793614|B6|≥8.0%||HbA1c||participants|Number|29|29.0||||||
3971485|NCT01289119|3793615|B5|≥8.0%||HbA1c||participants|Number|29|29.0||||||
3971486|NCT01289119|3793616|B4|≥8.0%||HbA1c||participants|Number|44|44.0||||||
3971487|NCT01289119|3793617|B3|≥8.0%||HbA1c||participants|Number|44|44.0||||||
3971488|NCT01289119|3793618|B2|≥8.0%||HbA1c||participants|Number|44|44.0||||||
3971489|NCT01289119|3793619|B1|≥8.0%||HbA1c||participants|Number|46|46.0||||||
3971490|NCT01289119|3793613|B7|<8.0%||HbA1c||participants|Number|270|270.0||||||
3971491|NCT01289119|3793614|B6|<8.0%||HbA1c||participants|Number|32|32.0||||||
3971492|NCT01289119|3793615|B5|<8.0%||HbA1c||participants|Number|34|34.0||||||
3971493|NCT01289119|3793616|B4|<8.0%||HbA1c||participants|Number|55|55.0||||||
3971494|NCT01289119|3793617|B3|<8.0%||HbA1c||participants|Number|54|54.0||||||
3971495|NCT01289119|3793618|B2|<8.0%||HbA1c||participants|Number|48|48.0||||||
3971496|NCT01289119|3793619|B1|<8.0%||HbA1c||participants|Number|47|47.0||||||
3971497|NCT01289119|3793613|B7|||Diabetes duration||years|Mean|4.11|4.11|Standard Deviation|4.215|4.215|||
3971498|NCT01289119|3793614|B6|||Diabetes duration||years|Mean|5.80|5.8|Standard Deviation|5.300|5.3|||
3971499|NCT01289119|3793615|B5|||Diabetes duration||years|Mean|4.85|4.85|Standard Deviation|4.724|4.724|||
3971500|NCT01289119|3793616|B4|||Diabetes duration||years|Mean|5.38|5.38|Standard Deviation|4.335|4.335|||
3971501|NCT01289119|3793617|B3|||Diabetes duration||years|Mean|5.33|5.33|Standard Deviation|3.873|3.873|||
3971502|NCT01289119|3793618|B2|||Diabetes duration||years|Mean|1.86|1.86|Standard Deviation|2.369|2.369|||
3971503|NCT01289119|3793619|B1|||Diabetes duration||years|Mean|2.12|2.12|Standard Deviation|2.845|2.845|||
3971504|NCT01289119|3793613|B7|||Body Mass Index (BMI)||kg/m^2|Mean|25.73|25.73|Standard Deviation|3.042|3.042|||
3971505|NCT01289119|3793614|B6|||Body Mass Index (BMI)||kg/m^2|Mean|25.32|25.32|Standard Deviation|3.223|3.223|||
3971506|NCT01289119|3793615|B5|||Body Mass Index (BMI)||kg/m^2|Mean|26.13|26.13|Standard Deviation|3.031|3.031|||
3971507|NCT01289119|3793616|B4|||Body Mass Index (BMI)||kg/m^2|Mean|25.75|25.75|Standard Deviation|3.122|3.122|||
3971508|NCT01289119|3793617|B3|||Body Mass Index (BMI)||kg/m^2|Mean|25.54|25.54|Standard Deviation|2.876|2.876|||
3971509|NCT01289119|3793618|B2|||Body Mass Index (BMI)||kg/m^2|Mean|25.79|25.79|Standard Deviation|3.086|3.086|||
3971510|NCT01289119|3793619|B1|||Body Mass Index (BMI)||kg/m^2|Mean|25.86|25.86|Standard Deviation|3.002|3.002|||
3971511|NCT01289119|3793613|B7|||Weight||kg|Mean|70.55|70.55|Standard Deviation|11.856|11.856|||
3971512|NCT01289119|3793614|B6|||Weight||kg|Mean|67.59|67.59|Standard Deviation|11.989|11.989|||
3971513|NCT01289119|3793615|B5|||Weight||kg|Mean|72.44|72.44|Standard Deviation|11.989|11.989|||
3971514|NCT01289119|3793616|B4|||Weight||kg|Mean|71.20|71.2|Standard Deviation|13.473|13.473|||
3971515|NCT01289119|3793617|B3|||Weight||kg|Mean|69.67|69.67|Standard Deviation|11.792|11.792|||
3971516|NCT01289119|3793618|B2|||Weight||kg|Mean|71.16|71.16|Standard Deviation|11.065|11.065|||
3971517|NCT01289119|3793619|B1|||Weight||kg|Mean|70.86|70.86|Standard Deviation|10.464|10.464|||
3971518|NCT01289119|3793613|B7|||Height||cm|Mean|165.2|165.2|Standard Deviation|8.31|8.31|||
3971519|NCT01289119|3793614|B6|||Height||cm|Mean|163.0|163.0|Standard Deviation|7.06|7.06|||
3971520|NCT01289119|3793615|B5|||Height||cm|Mean|166.2|166.2|Standard Deviation|8.87|8.87|||
3971521|NCT01289119|3793616|B4|||Height||cm|Mean|165.7|165.7|Standard Deviation|9.06|9.06|||
3971522|NCT01289119|3793617|B3|||Height||cm|Mean|164.8|164.8|Standard Deviation|8.47|8.47|||
3971523|NCT01289119|3793618|B2|||Height||cm|Mean|165.9|165.9|Standard Deviation|8.61|8.61|||
3971524|NCT01289119|3793619|B1|||Height||cm|Mean|165.4|165.4|Standard Deviation|7.19|7.19|||
3971525|NCT01289119|3793613|B7|China||Region of Enrollment||participants|Number|491|491.0||||||
3971526|NCT01289119|3793614|B6|China||Region of Enrollment||participants|Number|61|61.0||||||
3971527|NCT01289119|3793615|B5|China||Region of Enrollment||participants|Number|63|63.0||||||
3971528|NCT01289119|3793616|B4|China||Region of Enrollment||participants|Number|92|92.0||||||
3971529|NCT01289119|3793617|B3|China||Region of Enrollment||participants|Number|94|94.0||||||
3971530|NCT01289119|3793618|B2|China||Region of Enrollment||participants|Number|90|90.0||||||
3971531|NCT01289119|3793619|B1|China||Region of Enrollment||participants|Number|91|91.0||||||
3971532|NCT01289119|3793613|B7|Hong Kong||Region of Enrollment||participants|Number|9|9.0||||||
3971533|NCT01289119|3793614|B6|Hong Kong||Region of Enrollment||participants|Number|0|0.0||||||
3971534|NCT01289119|3793615|B5|Hong Kong||Region of Enrollment||participants|Number|0|0.0||||||
3971535|NCT01289119|3793616|B4|Hong Kong||Region of Enrollment||participants|Number|4|4.0||||||
3971536|NCT01289119|3793617|B3|Hong Kong||Region of Enrollment||participants|Number|2|2.0||||||
3971537|NCT01289119|3793618|B2|Hong Kong||Region of Enrollment||participants|Number|2|2.0||||||
3971538|NCT01289119|3793619|B1|Hong Kong||Region of Enrollment||participants|Number|1|1.0||||||
3971539|NCT01289119|3793613|B7|Taiwan||Region of Enrollment||participants|Number|6|6.0||||||
3971540|NCT01289119|3793614|B6|Taiwan||Region of Enrollment||participants|Number|0|0.0||||||
3971541|NCT01289119|3793615|B5|Taiwan||Region of Enrollment||participants|Number|0|0.0||||||
3971542|NCT01289119|3793616|B4|Taiwan||Region of Enrollment||participants|Number|3|3.0||||||
3971543|NCT01289119|3793617|B3|Taiwan||Region of Enrollment||participants|Number|2|2.0||||||
3971544|NCT01289119|3793618|B2|Taiwan||Region of Enrollment||participants|Number|0|0.0||||||
3971545|NCT01289119|3793619|B1|Taiwan||Region of Enrollment||participants|Number|1|1.0||||||
3971546|NCT01289119|3793613|B7|||Race/Ethnicity, Customized||participants|Number|506|506.0||||||
3971547|NCT01289119|3793614|B6|||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
3971548|NCT01289119|3793615|B5|||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
3971549|NCT01289119|3793616|B4|||Race/Ethnicity, Customized||participants|Number|99|99.0||||||
3971550|NCT01289119|3793617|B3|||Race/Ethnicity, Customized||participants|Number|98|98.0||||||
3971551|NCT01289119|3793618|B2|||Race/Ethnicity, Customized||participants|Number|92|92.0||||||
3971552|NCT01289119|3793619|B1|||Race/Ethnicity, Customized||participants|Number|93|93.0||||||
3971553|NCT01289119|3793613|B7||Male|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
3971554|NCT01289119|3793614|B6||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3971555|NCT01289119|3793615|B5||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3971556|NCT01289119|3793616|B4||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3971557|NCT01289119|3793617|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3971558|NCT01289119|3793618|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3971559|NCT01289119|3793619|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3971560|NCT01289119|3793613|B7||Female|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
3971561|NCT01289119|3793614|B6||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3971562|NCT01289119|3793615|B5||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3971563|NCT01289119|3793616|B4||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3971564|NCT01289119|3793617|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3971565|NCT01289119|3793618|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3971566|NCT01289119|3793619|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3971567|NCT01289119|3793613|B7|≥65 years||Age, Customized||participants|Number|66|66.0||||||
3971568|NCT01289119|3793614|B6|≥65 years||Age, Customized||participants|Number|9|9.0||||||
3971569|NCT01289119|3793615|B5|≥65 years||Age, Customized||participants|Number|7|7.0||||||
3971570|NCT01289119|3793616|B4|≥65 years||Age, Customized||participants|Number|14|14.0||||||
3971571|NCT01289119|3793617|B3|≥65 years||Age, Customized||participants|Number|12|12.0||||||
3971572|NCT01289119|3793618|B2|≥65 years||Age, Customized||participants|Number|12|12.0||||||
3971573|NCT01289119|3793619|B1|≥65 years||Age, Customized||participants|Number|12|12.0||||||
3971574|NCT01289119|3793613|B7|<65 Years||Age, Customized||participants|Number|440|440.0||||||
3971575|NCT01289119|3793614|B6|<65 Years||Age, Customized||participants|Number|52|52.0||||||
3971576|NCT01289119|3793615|B5|<65 Years||Age, Customized||participants|Number|56|56.0||||||
3971577|NCT01289119|3793616|B4|<65 Years||Age, Customized||participants|Number|85|85.0||||||
3971578|NCT01289119|3793617|B3|<65 Years||Age, Customized||participants|Number|86|86.0||||||
3971579|NCT01289119|3793618|B2|<65 Years||Age, Customized||participants|Number|80|80.0||||||
3971580|NCT01289119|3793619|B1|<65 Years||Age, Customized||participants|Number|81|81.0||||||
3971581|NCT01289119|3793613|B7|||Age||years|Mean|52.6|52.6|Standard Deviation|9.71|9.71|||
3971582|NCT01289119|3793614|B6|||Age||years|Mean|52.6|52.6|Standard Deviation|9.44|9.44|||
3971583|NCT01289119|3793615|B5|||Age||years|Mean|51.8|51.8|Standard Deviation|10.37|10.37|||
3971584|NCT01289119|3793616|B4|||Age||years|Mean|53.0|53.0|Standard Deviation|9.88|9.88|||
3971585|NCT01289119|3793617|B3|||Age||years|Mean|53.2|53.2|Standard Deviation|9.46|9.46|||
3971586|NCT01289119|3793618|B2|||Age||years|Mean|51.6|51.6|Standard Deviation|10.41|10.41|||
3971587|NCT01289119|3793619|B1|||Age||years|Mean|53.1|53.1|Standard Deviation|8.88|8.88|||
3971588|NCT01289080|3793704|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3971589|NCT01289080|3793705|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3971590|NCT01289080|3793706|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3971591|NCT01289080|3793704|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3971592|NCT01289080|3793705|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3971593|NCT01289080|3793706|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3971594|NCT01289080|3793704|B3|||Age||Years|Mean|60.9|60.9|Standard Deviation|11.1|11.1|||
3971595|NCT01289080|3793705|B2|||Age||Years|Mean|62.9|62.9|Standard Deviation|12.2|12.2|||
3971596|NCT01289080|3793706|B1|||Age||Years|Mean|58.8|58.8|Standard Deviation|10.1|10.1|||
3971597|NCT01289067|3793738|B1|||PSA|pre-treatment PSA|ng/ml|Median|71.67|71.67|Full Range|||0.04|3057.0|
3971598|NCT01289067|3793738|B1|Gleason 9||Gleason Score|Gleason scores range from 2 to 10, with 2 representing the most well-differentiated tumors and 10 the least-differentiated tumors. Least-differentiated tumors typically have a worse prognosis.|participants|Number|4|4.0||||||
3971599|NCT01289067|3793738|B1|Gleason 8||Gleason Score|Gleason scores range from 2 to 10, with 2 representing the most well-differentiated tumors and 10 the least-differentiated tumors. Least-differentiated tumors typically have a worse prognosis.|participants|Number|5|5.0||||||
3971600|NCT01289067|3793738|B1|Gleason 7||Gleason Score|Gleason scores range from 2 to 10, with 2 representing the most well-differentiated tumors and 10 the least-differentiated tumors. Least-differentiated tumors typically have a worse prognosis.|participants|Number|4|4.0||||||
3971601|NCT01289067|3793738|B1|Bone, Lymph Node, and Visceral||Metastasis site||participants|Number|2|2.0||||||
3971602|NCT01289067|3793738|B1|Lymph Node and Visceral||Metastasis site||participants|Number|1|1.0||||||
3971603|NCT01289067|3793738|B1|Bone and Visceral||Metastasis site||participants|Number|3|3.0||||||
3971604|NCT01289067|3793738|B1|Bone and Lymph Node||Metastasis site||participants|Number|1|1.0||||||
3971605|NCT01289067|3793738|B1|Visceral only||Metastasis site||participants|Number|0|0.0||||||
3971606|NCT01289067|3793738|B1|Lymph Node only||Metastasis site||participants|Number|4|4.0||||||
3971607|NCT01289067|3793738|B1|Bone only||Metastasis site||participants|Number|6|6.0||||||
3971608|NCT01289067|3793738|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3971609|NCT01289067|3793738|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3971610|NCT01289067|3793738|B1|||Age||years|Median|69|69.0|Full Range|||54.0|77.0|
3971611|NCT01289041|3793745|B1|Male||Sex/Gender, Customized||participants|Number|0|0.0||||||
3971612|NCT01289041|3793745|B1|Female||Sex/Gender, Customized||participants|Number|70|70.0||||||
3971613|NCT01289041|3793745|B1|||Age||years|Mean|63|63.0|Standard Deviation|9.04|9.04|||
3971614|NCT01289028|3793757|B1||Male|Gender||Participants|Count of Participants|79|79.0||||||
3971615|NCT01289028|3793757|B1||Female|Gender||Participants|Count of Participants|46|46.0||||||
3971616|NCT01289028|3793757|B1|||Age||years|Mean|60|60.0|Standard Deviation|12.1|12.1|||
3971617|NCT01289015|3793769|B3|Puerto Rico||Region of Enrollment||participants|Number|39|39.0||||||
3971618|NCT01289015|3793770|B2|Puerto Rico||Region of Enrollment||participants|Number|13|13.0||||||
3971619|NCT01289015|3793771|B1|Puerto Rico||Region of Enrollment||participants|Number|26|26.0||||||
3971620|NCT01289015|3793769|B3|United States||Region of Enrollment||participants|Number|816|816.0||||||
3971621|NCT01289015|3793770|B2|United States||Region of Enrollment||participants|Number|271|271.0||||||
3971622|NCT01289015|3793771|B1|United States||Region of Enrollment||participants|Number|545|545.0||||||
3971623|NCT01289015|3793769|B3||Male|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
3971624|NCT01289015|3793770|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3971625|NCT01289015|3793771|B1||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3971626|NCT01289015|3793769|B3||Female|Sex: Female, Male||Participants|Count of Participants|637|637.0||||||
3971627|NCT01289015|3793770|B2||Female|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
3971628|NCT01289015|3793771|B1||Female|Sex: Female, Male||Participants|Count of Participants|416|416.0||||||
3971629|NCT01289015|3793769|B3|||Age||years|Mean|45.7|45.7|Standard Deviation|13.6|13.6|||
3971630|NCT01289015|3793770|B2|||Age||years|Mean|46.4|46.4|Standard Deviation|14.3|14.3|||
3971631|NCT01289015|3793771|B1|||Age||years|Mean|45.3|45.3|Standard Deviation|13.3|13.3|||
3971632|NCT01289015|3793769|B3||>=65 years|Age||Participants|Count of Participants|69|69.0||||||
3971633|NCT01289015|3793770|B2||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
3971634|NCT01289015|3793771|B1||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
3971635|NCT01289015|3793769|B3||Between 18 and 65 years|Age||Participants|Count of Participants|779|779.0||||||
3971636|NCT01289015|3793770|B2||Between 18 and 65 years|Age||Participants|Count of Participants|255|255.0||||||
3971637|NCT01289015|3793771|B1||Between 18 and 65 years|Age||Participants|Count of Participants|524|524.0||||||
3971638|NCT01289015|3793769|B3||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
3971639|NCT01289015|3793770|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3971640|NCT01289015|3793771|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3971641|NCT01288976|3793780|B4|Europe||Region of Enrollment||participants|Number|721|721.0||||||
3971642|NCT01288976|3793781|B3|Europe||Region of Enrollment||participants|Number|105|105.0||||||
3971643|NCT01288976|3793782|B2|Europe||Region of Enrollment||participants|Number|49|49.0||||||
3971644|NCT01288976|3793783|B1|Europe||Region of Enrollment||participants|Number|567|567.0||||||
3971645|NCT01288976|3793780|B4||Male|Sex: Female, Male||Participants|Count of Participants|447|447.0||||||
3971646|NCT01288976|3793781|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3971647|NCT01288976|3793782|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3971648|NCT01288976|3793783|B1||Male|Sex: Female, Male||Participants|Count of Participants|362|362.0||||||
3971649|NCT01288976|3793780|B4||Female|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
3971650|NCT01288976|3793781|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3971651|NCT01288976|3793782|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3971652|NCT01288976|3793783|B1||Female|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
3971653|NCT01288976|3793780|B4|||Age||years|Mean|68.1|68.1|Standard Deviation|12.4|12.4|||
3971654|NCT01288976|3793781|B3|||Age||years|Mean|60.0|60.0|Standard Deviation|15.2|15.2|||
3971655|NCT01288976|3793782|B2|||Age||years|Mean|70.7|70.7|Standard Deviation|12.6|12.6|||
3971656|NCT01288976|3793783|B1|||Age||years|Mean|73.7|73.7|Standard Deviation|9.6|9.6|||
3971657|NCT01288911|3793812|B3||After diagnosis of metastasis|LHRH agonist/antagonist initiation or bilateral orchiectomy relative to diagnosis of metastasis||Participants|Count of Participants|212|212.0||||||
3971658|NCT01288911|3793813|B2||After diagnosis of metastasis|LHRH agonist/antagonist initiation or bilateral orchiectomy relative to diagnosis of metastasis||Participants|Count of Participants|115|115.0||||||
3971659|NCT01288911|3793814|B1||After diagnosis of metastasis|LHRH agonist/antagonist initiation or bilateral orchiectomy relative to diagnosis of metastasis||Participants|Count of Participants|97|97.0||||||
3971660|NCT01288911|3793812|B3||Before diagnosis of metastasis|LHRH agonist/antagonist initiation or bilateral orchiectomy relative to diagnosis of metastasis||Participants|Count of Participants|163|163.0||||||
3971661|NCT01288911|3793813|B2||Before diagnosis of metastasis|LHRH agonist/antagonist initiation or bilateral orchiectomy relative to diagnosis of metastasis||Participants|Count of Participants|76|76.0||||||
3971662|NCT01288911|3793814|B1||Before diagnosis of metastasis|LHRH agonist/antagonist initiation or bilateral orchiectomy relative to diagnosis of metastasis||Participants|Count of Participants|87|87.0||||||
3971663|NCT01288911|3793812|B3||Hispanic or Latino|Ethnicity||Participants|Count of Participants|4|4.0||||||
3971664|NCT01288911|3793813|B2||Hispanic or Latino|Ethnicity||Participants|Count of Participants|4|4.0||||||
3971665|NCT01288911|3793814|B1||Hispanic or Latino|Ethnicity||Participants|Count of Participants|0|0.0||||||
3971666|NCT01288911|3793812|B3||Not Hispanic or Latino|Ethnicity||Participants|Count of Participants|371|371.0||||||
3971667|NCT01288911|3793813|B2||Not Hispanic or Latino|Ethnicity||Participants|Count of Participants|187|187.0||||||
3971668|NCT01288911|3793814|B1||Not Hispanic or Latino|Ethnicity||Participants|Count of Participants|184|184.0||||||
3971669|NCT01288911|3793812|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3971670|NCT01288911|3793813|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3971671|NCT01288911|3793814|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3971672|NCT01288911|3793812|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3971673|NCT01288911|3793813|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3971674|NCT01288911|3793814|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3971675|NCT01288911|3793812|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3971676|NCT01288911|3793813|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3971677|NCT01288911|3793814|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3971678|NCT01288911|3793812|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3971679|NCT01288911|3793813|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3971680|NCT01288911|3793814|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3971681|NCT01288911|3793812|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|348|348.0||||||
3971682|NCT01288911|3793813|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|176|176.0||||||
3971683|NCT01288911|3793814|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|172|172.0||||||
3971684|NCT01288911|3793812|B3||Male|Sex: Female, Male||Participants|Count of Participants|375|375.0||||||
3971685|NCT01288911|3793813|B2||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
3971686|NCT01288911|3793814|B1||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3971687|NCT01288911|3793812|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3971688|NCT01288911|3793813|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3971689|NCT01288911|3793814|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3971690|NCT01288911|3793812|B3|> 75 years||Age, Customized||participants|Number|118|118.0||||||
3971691|NCT01288911|3793813|B2|> 75 years||Age, Customized||participants|Number|64|64.0||||||
3971692|NCT01288911|3793814|B1|> 75 years||Age, Customized||participants|Number|54|54.0||||||
3971693|NCT01288911|3793812|B3|65-75 years||Age, Customized||participants|Number|165|165.0||||||
3971694|NCT01288911|3793813|B2|65-75 years||Age, Customized||participants|Number|80|80.0||||||
3971695|NCT01288911|3793814|B1|65-75 years||Age, Customized||participants|Number|85|85.0||||||
3971696|NCT01288911|3793812|B3|< 65 years||Age, Customized||participants|Number|92|92.0||||||
3971697|NCT01288911|3793813|B2|< 65 years||Age, Customized||participants|Number|47|47.0||||||
3971698|NCT01288911|3793814|B1|< 65 years||Age, Customized||participants|Number|45|45.0||||||
3971699|NCT01288911|3793812|B3|||Age||years|Mean|70.7|70.7|Standard Deviation|9.05|9.05|||
3971700|NCT01288911|3793813|B2|||Age||years|Mean|71.1|71.1|Standard Deviation|8.89|8.89|||
3971701|NCT01288911|3793814|B1|||Age||years|Mean|70.3|70.3|Standard Deviation|9.22|9.22|||
3971702|NCT01288859|3793846|B1|Italy||Region of Enrollment||participants|Number|10|10.0||||||
3971703|NCT01288859|3793846|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3971704|NCT01288859|3793846|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3971705|NCT01288859|3793846|B1|||Age||years|Mean|31|31.0|Standard Deviation|2|2.0|||
3971706|NCT01288859|3793846|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3971707|NCT01288859|3793846|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3971708|NCT01288859|3793846|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3971709|NCT01288833|3793877|B3||Symptoms|Indication||Participants|Count of Participants|104|104.0||||||
3971710|NCT01288833|3793878|B2||Symptoms|Indication||Participants|Count of Participants|52|52.0||||||
3971711|NCT01288833|3793879|B1||Symptoms|Indication||Participants|Count of Participants|52|52.0||||||
3971712|NCT01288833|3793877|B3||Surveillance|Indication||Participants|Count of Participants|244|244.0||||||
3971713|NCT01288833|3793878|B2||Surveillance|Indication||Participants|Count of Participants|123|123.0||||||
3971714|NCT01288833|3793879|B1||Surveillance|Indication||Participants|Count of Participants|121|121.0||||||
3971715|NCT01288833|3793877|B3||Screening|Indication||Participants|Count of Participants|210|210.0||||||
3971716|NCT01288833|3793878|B2||Screening|Indication||Participants|Count of Participants|106|106.0||||||
3971717|NCT01288833|3793879|B1||Screening|Indication||Participants|Count of Participants|104|104.0||||||
3971718|NCT01288833|3793877|B3||Male|Sex: Female, Male||Participants|Count of Participants|530|530.0||||||
3971719|NCT01288833|3793878|B2||Male|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
3971720|NCT01288833|3793879|B1||Male|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
3971721|NCT01288833|3793877|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3971722|NCT01288833|3793878|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3971723|NCT01288833|3793879|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3971724|NCT01288833|3793877|B3|||Age||years|Mean|62.7|62.7|Standard Deviation|8.2|8.2|||
3971725|NCT01288833|3793878|B2|||Age||years|Mean|62.4|62.4|Standard Deviation|8.7|8.7|||
3971726|NCT01288833|3793879|B1|||Age||years|Mean|63|63.0|Standard Deviation|7.7|7.7|||
3971727|NCT01288781|3793894|B3|United Kingdom||Region of Enrollment||participants|Number|23|23.0||||||
3971728|NCT01288781|3793895|B2|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
3971729|NCT01288781|3793896|B1|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
3971730|NCT01288781|3793894|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3971731|NCT01288781|3793895|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3971732|NCT01288781|3793896|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3971733|NCT01288781|3793894|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3971734|NCT01288781|3793895|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3971735|NCT01288781|3793896|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3971736|NCT01288781|3793894|B3|||Age||years|Mean|21|21.0|Standard Deviation|3|3.0|||
3971737|NCT01288781|3793895|B2|||Age||years|Mean|20|20.0|Standard Deviation|1|1.0|||
3971738|NCT01288781|3793896|B1|||Age||years|Mean|24|24.0|Standard Deviation|6|6.0|||
3971739|NCT01288781|3793894|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3971740|NCT01288781|3793895|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3971741|NCT01288781|3793896|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3971742|NCT01288781|3793894|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3971743|NCT01288781|3793895|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3971744|NCT01288781|3793896|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3971745|NCT01288781|3793894|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3971746|NCT01288781|3793895|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3971747|NCT01288781|3793896|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3971748|NCT01288729|3793915|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3971749|NCT01288729|3793916|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3971750|NCT01288729|3793917|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3971751|NCT01288729|3793915|B3||Male|Gender||Participants|Count of Participants|12|12.0||||||
3971752|NCT01288729|3793916|B2||Male|Gender||Participants|Count of Participants|6|6.0||||||
3971753|NCT01288729|3793917|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
3971754|NCT01288729|3793915|B3||Female|Gender||Participants|Count of Participants|8|8.0||||||
3971755|NCT01288729|3793916|B2||Female|Gender||Participants|Count of Participants|4|4.0||||||
3971756|NCT01288729|3793917|B1||Female|Gender||Participants|Count of Participants|4|4.0||||||
3971757|NCT01288729|3793915|B3|||Age||years|Mean|22.3|22.3|Standard Deviation|8.8|8.8|||
3971758|NCT01288729|3793916|B2|||Age||years|Mean|22.3|22.3|Standard Deviation|8.8|8.8|||
3971759|NCT01288729|3793917|B1|||Age||years|Mean|22.3|22.3|Standard Deviation|8.8|8.8|||
3971760|NCT01288612|3793924|B4|No||Use of Proton Pump Inhibitor (PPI)||participants|Number|383|383.0||||||
3971761|NCT01288612|3793925|B3|No||Use of Proton Pump Inhibitor (PPI)||participants|Number|130|130.0||||||
3971762|NCT01288612|3793926|B2|No||Use of Proton Pump Inhibitor (PPI)||participants|Number|128|128.0||||||
3971763|NCT01288612|3793927|B1|No||Use of Proton Pump Inhibitor (PPI)||participants|Number|125|125.0||||||
3971764|NCT01288612|3793924|B4|Yes||Use of Proton Pump Inhibitor (PPI)||participants|Number|76|76.0||||||
3971765|NCT01288612|3793925|B3|Yes||Use of Proton Pump Inhibitor (PPI)||participants|Number|28|28.0||||||
3971766|NCT01288612|3793926|B2|Yes||Use of Proton Pump Inhibitor (PPI)||participants|Number|23|23.0||||||
3971767|NCT01288612|3793927|B1|Yes||Use of Proton Pump Inhibitor (PPI)||participants|Number|25|25.0||||||
3971768|NCT01288612|3793924|B4|Unknown/not answered||Marital Status||participants|Number|2|2.0||||||
3971769|NCT01288612|3793925|B3|Unknown/not answered||Marital Status||participants|Number|1|1.0||||||
3971770|NCT01288612|3793926|B2|Unknown/not answered||Marital Status||participants|Number|0|0.0||||||
3971771|NCT01288612|3793927|B1|Unknown/not answered||Marital Status||participants|Number|1|1.0||||||
3971772|NCT01288612|3793924|B4|Not married (single/widowed/divorced/separated)||Marital Status||participants|Number|108|108.0||||||
3971773|NCT01288612|3793925|B3|Not married (single/widowed/divorced/separated)||Marital Status||participants|Number|41|41.0||||||
3971774|NCT01288612|3793926|B2|Not married (single/widowed/divorced/separated)||Marital Status||participants|Number|33|33.0||||||
3971775|NCT01288612|3793927|B1|Not married (single/widowed/divorced/separated)||Marital Status||participants|Number|34|34.0||||||
3971776|NCT01288612|3793924|B4|Married||Marital Status||participants|Number|349|349.0||||||
3971777|NCT01288612|3793925|B3|Married||Marital Status||participants|Number|116|116.0||||||
3971778|NCT01288612|3793926|B2|Married||Marital Status||participants|Number|118|118.0||||||
3971779|NCT01288612|3793927|B1|Married||Marital Status||participants|Number|115|115.0||||||
3971780|NCT01288612|3793924|B4|Unknown/not answered||Employment||participants|Number|17|17.0||||||
3971781|NCT01288612|3793925|B3|Unknown/not answered||Employment||participants|Number|5|5.0||||||
3971782|NCT01288612|3793926|B2|Unknown/not answered||Employment||participants|Number|5|5.0||||||
3971783|NCT01288612|3793927|B1|Unknown/not answered||Employment||participants|Number|7|7.0||||||
3971784|NCT01288612|3793924|B4|Retired||Employment||participants|Number|248|248.0||||||
3971785|NCT01288612|3793925|B3|Retired||Employment||participants|Number|86|86.0||||||
3971786|NCT01288612|3793926|B2|Retired||Employment||participants|Number|75|75.0||||||
3971787|NCT01288612|3793927|B1|Retired||Employment||participants|Number|87|87.0||||||
3971788|NCT01288612|3793924|B4|Unemployed/homemaker||Employment||participants|Number|27|27.0||||||
3971789|NCT01288612|3793925|B3|Unemployed/homemaker||Employment||participants|Number|11|11.0||||||
3971790|NCT01288612|3793926|B2|Unemployed/homemaker||Employment||participants|Number|8|8.0||||||
3971791|NCT01288612|3793927|B1|Unemployed/homemaker||Employment||participants|Number|8|8.0||||||
3971792|NCT01288612|3793924|B4|Employed||Employment||participants|Number|167|167.0||||||
3971793|NCT01288612|3793925|B3|Employed||Employment||participants|Number|56|56.0||||||
3971794|NCT01288612|3793926|B2|Employed||Employment||participants|Number|63|63.0||||||
3971795|NCT01288612|3793927|B1|Employed||Employment||participants|Number|48|48.0||||||
3971796|NCT01288612|3793924|B4|Unknown/not answered||Education||participants|Number|17|17.0||||||
3971797|NCT01288612|3793925|B3|Unknown/not answered||Education||participants|Number|5|5.0||||||
3971798|NCT01288612|3793926|B2|Unknown/not answered||Education||participants|Number|5|5.0||||||
3971799|NCT01288612|3793927|B1|Unknown/not answered||Education||participants|Number|7|7.0||||||
3971800|NCT01288612|3793924|B4|College/professional training||Education||participants|Number|205|205.0||||||
3971801|NCT01288612|3793925|B3|College/professional training||Education||participants|Number|74|74.0||||||
3971802|NCT01288612|3793926|B2|College/professional training||Education||participants|Number|67|67.0||||||
3971803|NCT01288612|3793927|B1|College/professional training||Education||participants|Number|64|64.0||||||
3971804|NCT01288612|3793924|B4|High school or some college||Education||participants|Number|225|225.0||||||
3971805|NCT01288612|3793925|B3|High school or some college||Education||participants|Number|72|72.0||||||
3971806|NCT01288612|3793926|B2|High school or some college||Education||participants|Number|76|76.0||||||
3971807|NCT01288612|3793927|B1|High school or some college||Education||participants|Number|77|77.0||||||
3971808|NCT01288612|3793924|B4|Less than high school||Education||participants|Number|12|12.0||||||
3971809|NCT01288612|3793925|B3|Less than high school||Education||participants|Number|7|7.0||||||
3971810|NCT01288612|3793926|B2|Less than high school||Education||participants|Number|3|3.0||||||
3971811|NCT01288612|3793927|B1|Less than high school||Education||participants|Number|2|2.0||||||
3971812|NCT01288612|3793924|B4|No heartburn or acid regurgitation||Reflux Symptoms||participants|Number|219|219.0||||||
3971813|NCT01288612|3793925|B3|No heartburn or acid regurgitation||Reflux Symptoms||participants|Number|75|75.0||||||
3971814|NCT01288612|3793926|B2|No heartburn or acid regurgitation||Reflux Symptoms||participants|Number|68|68.0||||||
3971815|NCT01288612|3793927|B1|No heartburn or acid regurgitation||Reflux Symptoms||participants|Number|76|76.0||||||
3971816|NCT01288612|3793924|B4|Heartburn or acid regurgitation < 1/week||Reflux Symptoms||participants|Number|197|197.0||||||
3971817|NCT01288612|3793925|B3|Heartburn or acid regurgitation < 1/week||Reflux Symptoms||participants|Number|68|68.0||||||
3971818|NCT01288612|3793926|B2|Heartburn or acid regurgitation < 1/week||Reflux Symptoms||participants|Number|67|67.0||||||
3971819|NCT01288612|3793927|B1|Heartburn or acid regurgitation < 1/week||Reflux Symptoms||participants|Number|62|62.0||||||
3971820|NCT01288612|3793924|B4|Heartburn or acid regurgitation > 1/week||Reflux Symptoms||participants|Number|43|43.0||||||
3971821|NCT01288612|3793925|B3|Heartburn or acid regurgitation > 1/week||Reflux Symptoms||participants|Number|15|15.0||||||
3971822|NCT01288612|3793926|B2|Heartburn or acid regurgitation > 1/week||Reflux Symptoms||participants|Number|16|16.0||||||
3971823|NCT01288612|3793927|B1|Heartburn or acid regurgitation > 1/week||Reflux Symptoms||participants|Number|12|12.0||||||
3971824|NCT01288612|3793924|B4|United States||Region of Enrollment||participants|Number|459|459.0||||||
3971825|NCT01288612|3793925|B3|United States||Region of Enrollment||participants|Number|158|158.0||||||
3971826|NCT01288612|3793926|B2|United States||Region of Enrollment||participants|Number|151|151.0||||||
3971827|NCT01288612|3793927|B1|United States||Region of Enrollment||participants|Number|150|150.0||||||
3971828|NCT01288612|3793924|B4||Male|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
3971829|NCT01288612|3793925|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3971830|NCT01288612|3793926|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3971831|NCT01288612|3793927|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3971832|NCT01288612|3793924|B4||Female|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
3971833|NCT01288612|3793925|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3971834|NCT01288612|3793926|B2||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3971835|NCT01288612|3793927|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3971836|NCT01288612|3793924|B4|||Age||years|Mean|65|65.0|Standard Deviation|9|9.0|||
3971837|NCT01288612|3793925|B3|||Age||years|Mean|64|64.0|Standard Deviation|10|10.0|||
3971838|NCT01288612|3793926|B2|||Age||years|Mean|64|64.0|Standard Deviation|10|10.0|||
3971839|NCT01288612|3793927|B1|||Age||years|Mean|65|65.0|Standard Deviation|9|9.0|||
3971840|NCT01288534|3793958|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3971841|NCT01288534|3793958|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3971842|NCT01288534|3793958|B1|||Age||years|Median|63|63.0|Full Range|||46.0|80.0|
3971843|NCT01288521|3793966|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3971844|NCT01288521|3793967|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3971845|NCT01288521|3793968|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3971846|NCT01288521|3793966|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3971847|NCT01288521|3793967|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3971848|NCT01288521|3793968|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3971849|NCT01288521|3793966|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3971850|NCT01288521|3793967|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3971851|NCT01288521|3793968|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3971852|NCT01288521|3793966|B3|||Age||years|Mean|55.6|55.6|Standard Deviation|8.2|8.2|||
3971853|NCT01288521|3793967|B2|||Age||years|Mean|57|57.0|Standard Deviation|5.5|5.5|||
3971854|NCT01288521|3793968|B1|||Age||years|Mean|53|53.0|Standard Deviation|12.5|12.5|||
3971855|NCT01288521|3793966|B3||>=65 years|Age|Information gathered through self-report and medical records review|Participants|Count of Participants|1|1.0||||||
3971856|NCT01288521|3793967|B2||>=65 years|Age|Information gathered through self-report and medical records review|Participants|Count of Participants|0|0.0||||||
3971857|NCT01288521|3793968|B1||>=65 years|Age|Information gathered through self-report and medical records review|Participants|Count of Participants|1|1.0||||||
3971858|NCT01288521|3793966|B3||Between 18 and 65 years|Age|Information gathered through self-report and medical records review|Participants|Count of Participants|7|7.0||||||
3971859|NCT01288521|3793967|B2||Between 18 and 65 years|Age|Information gathered through self-report and medical records review|Participants|Count of Participants|5|5.0||||||
3971860|NCT01288521|3793968|B1||Between 18 and 65 years|Age|Information gathered through self-report and medical records review|Participants|Count of Participants|2|2.0||||||
3971861|NCT01288521|3793966|B3||<=18 years|Age|Information gathered through self-report and medical records review|Participants|Count of Participants|0|0.0||||||
3971862|NCT01288521|3793967|B2||<=18 years|Age|Information gathered through self-report and medical records review|Participants|Count of Participants|0|0.0||||||
3971863|NCT01288521|3793968|B1||<=18 years|Age|Information gathered through self-report and medical records review|Participants|Count of Participants|0|0.0||||||
3971864|NCT01288469|3793975|B4|||LDL-C in mg/dL||mg/dL|Mean|122.6|122.6|Standard Deviation|18.7|18.7|||
3971865|NCT01288469|3793976|B3|||LDL-C in mg/dL||mg/dL|Mean|126.9|126.9|Standard Deviation|21.8|21.8|||
3971866|NCT01288469|3793977|B2|||LDL-C in mg/dL||mg/dL|Mean|119.7|119.7|Standard Deviation|15.5|15.5|||
3971867|NCT01288469|3793978|B1|||LDL-C in mg/dL||mg/dL|Mean|121.2|121.2|Standard Deviation|18.1|18.1|||
3971868|NCT01288469|3793975|B4|||Low-Density Lipoprotein Cholesterol (LDL-C) in mmol/L||mmol/L|Mean|3.174|3.174|Standard Deviation|0.484|0.484|||
3971869|NCT01288469|3793976|B3|||Low-Density Lipoprotein Cholesterol (LDL-C) in mmol/L||mmol/L|Mean|3.288|3.288|Standard Deviation|0.564|0.564|||
3971870|NCT01288469|3793977|B2|||Low-Density Lipoprotein Cholesterol (LDL-C) in mmol/L||mmol/L|Mean|3.101|3.101|Standard Deviation|0.402|0.402|||
3971871|NCT01288469|3793978|B1|||Low-Density Lipoprotein Cholesterol (LDL-C) in mmol/L||mmol/L|Mean|3.138|3.138|Standard Deviation|0.469|0.469|||
3971872|NCT01288469|3793975|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3971873|NCT01288469|3793976|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3971874|NCT01288469|3793977|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3971875|NCT01288469|3793978|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3971876|NCT01288469|3793975|B4||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3971877|NCT01288469|3793976|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3971878|NCT01288469|3793977|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3971879|NCT01288469|3793978|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3971880|NCT01288469|3793975|B4|||Age||years|Mean|56.9|56.9|Standard Deviation|9.8|9.8|||
3971881|NCT01288469|3793976|B3|||Age||years|Mean|57.6|57.6|Standard Deviation|9.3|9.3|||
3971882|NCT01288469|3793977|B2|||Age||years|Mean|57.9|57.9|Standard Deviation|10.0|10.0|||
3971883|NCT01288469|3793978|B1|||Age||years|Mean|55.3|55.3|Standard Deviation|10.3|10.3|||
3971884|NCT01288443|3794006|B7|||LDL-C in mg/dL|Number of participants analysed = 31, 30, 31, 31, 29, 30 and 182, respectively.|mg/dL|Mean|127.3|127.3|Standard Deviation|26.2|26.2|||
3971885|NCT01288443|3794007|B6|||LDL-C in mg/dL|Number of participants analysed = 31, 30, 31, 31, 29, 30 and 182, respectively.|mg/dL|Mean|131.6|131.6|Standard Deviation|24.8|24.8|||
3971886|NCT01288443|3794008|B5|||LDL-C in mg/dL|Number of participants analysed = 31, 30, 31, 31, 29, 30 and 182, respectively.|mg/dL|Mean|127.2|127.2|Standard Deviation|19.6|19.6|||
3971887|NCT01288443|3794009|B4|||LDL-C in mg/dL|Number of participants analysed = 31, 30, 31, 31, 29, 30 and 182, respectively.|mg/dL|Mean|124.7|124.7|Standard Deviation|26.9|26.9|||
3971888|NCT01288443|3794010|B3|||LDL-C in mg/dL|Number of participants analysed = 31, 30, 31, 31, 29, 30 and 182, respectively.|mg/dL|Mean|127.0|127.0|Standard Deviation|30.4|30.4|||
3971889|NCT01288443|3794011|B2|||LDL-C in mg/dL|Number of participants analysed = 31, 30, 31, 31, 29, 30 and 182, respectively.|mg/dL|Mean|123.2|123.2|Standard Deviation|27.9|27.9|||
3971890|NCT01288443|3794012|B1|||LDL-C in mg/dL|Number of participants analysed = 31, 30, 31, 31, 29, 30 and 182, respectively.|mg/dL|Mean|130.2|130.2|Standard Deviation|27.3|27.3|||
3971891|NCT01288443|3794006|B7|||Low-Density Lipoprotein Cholesterol (LDL-C) in mmol/L|Number of participants analysed = 31, 30, 31, 31, 29, 30 and 182, respectively.|mmol/L|Mean|3.3|3.3|Standard Deviation|0.7|0.7|||
3971892|NCT01288443|3794007|B6|||Low-Density Lipoprotein Cholesterol (LDL-C) in mmol/L|Number of participants analysed = 31, 30, 31, 31, 29, 30 and 182, respectively.|mmol/L|Mean|3.4|3.4|Standard Deviation|0.6|0.6|||
3971893|NCT01288443|3794008|B5|||Low-Density Lipoprotein Cholesterol (LDL-C) in mmol/L|Number of participants analysed = 31, 30, 31, 31, 29, 30 and 182, respectively.|mmol/L|Mean|3.3|3.3|Standard Deviation|0.5|0.5|||
3971894|NCT01288443|3794009|B4|||Low-Density Lipoprotein Cholesterol (LDL-C) in mmol/L|Number of participants analysed = 31, 30, 31, 31, 29, 30 and 182, respectively.|mmol/L|Mean|3.2|3.2|Standard Deviation|0.7|0.7|||
3971895|NCT01288443|3794010|B3|||Low-Density Lipoprotein Cholesterol (LDL-C) in mmol/L|Number of participants analysed = 31, 30, 31, 31, 29, 30 and 182, respectively.|mmol/L|Mean|3.3|3.3|Standard Deviation|0.8|0.8|||
3971896|NCT01288443|3794011|B2|||Low-Density Lipoprotein Cholesterol (LDL-C) in mmol/L|Number of participants analysed = 31, 30, 31, 31, 29, 30 and 182, respectively.|mmol/L|Mean|3.2|3.2|Standard Deviation|0.7|0.7|||
3971897|NCT01288443|3794012|B1|||Low-Density Lipoprotein Cholesterol (LDL-C) in mmol/L|Number of participants analysed = 31, 30, 31, 31, 29, 30 and 182, respectively.|mmol/L|Mean|3.4|3.4|Standard Deviation|0.7|0.7|||
3971898|NCT01288443|3794006|B7||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3971899|NCT01288443|3794007|B6||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3971900|NCT01288443|3794008|B5||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3971901|NCT01288443|3794009|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3971902|NCT01288443|3794010|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3971903|NCT01288443|3794011|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3971904|NCT01288443|3794012|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3971905|NCT01288443|3794006|B7||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3971906|NCT01288443|3794007|B6||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3971907|NCT01288443|3794008|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3971908|NCT01288443|3794009|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3971909|NCT01288443|3794010|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3971910|NCT01288443|3794011|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3971911|NCT01288443|3794012|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3971912|NCT01288443|3794006|B7|||Age||years|Mean|56.7|56.7|Standard Deviation|10.0|10.0|||
3971913|NCT01288443|3794007|B6|||Age||years|Mean|55.5|55.5|Standard Deviation|10.1|10.1|||
3971914|NCT01288443|3794008|B5|||Age||years|Mean|54.9|54.9|Standard Deviation|10.8|10.8|||
3971915|NCT01288443|3794009|B4|||Age||years|Mean|59.9|59.9|Standard Deviation|11.1|11.1|||
3971916|NCT01288443|3794010|B3|||Age||years|Mean|58.1|58.1|Standard Deviation|9.2|9.2|||
3971917|NCT01288443|3794011|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|9.1|9.1|||
3971918|NCT01288443|3794012|B1|||Age||years|Mean|53.3|53.3|Standard Deviation|8.5|8.5|||
3971919|NCT01288287|3794067|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3971920|NCT01288287|3794067|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3971921|NCT01288287|3794067|B1|>= 65 years||Age, Customized||participants|Number|36|36.0||||||
3971922|NCT01288287|3794067|B1|< 65 years||Age, Customized||participants|Number|111|111.0||||||
3971923|NCT01288287|3794067|B1|||Age||years|Mean|55.6|55.6|Standard Deviation|11.85|11.85|||
3971924|NCT01288209|3794080|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3971925|NCT01288209|3794081|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3971926|NCT01288209|3794082|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3971927|NCT01288209|3794080|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3971928|NCT01288209|3794081|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3971929|NCT01288209|3794082|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3971930|NCT01288209|3794080|B3|||Age||years|Median|60|60.0|Full Range|||24.0|70.0|
3971931|NCT01288209|3794081|B2|||Age||years|Median|60|60.0|Full Range|||24.0|70.0|
3971932|NCT01288209|3794082|B1|||Age||years|Median|60|60.0|Full Range|||30.0|70.0|
3971933|NCT01288079|3794109|B5|||Montgomery-Asberg Depression Rating Scale (MADRS) total score at randomization|A 10-item scale for the evaluation of depressive symptoms. Each Montgomery-Asberg Depression Rating Scale (MADRS) item is rated on a 0 to 6 scale. The MADRS total score is calculated as the sum of the 10 individual item scores; the total score can range from 0 to 60. Higher MADRS scores indicate higher levels of depressive symptoms.|Scores on a scale|Mean|27.577|27.577|Standard Deviation|5.734|5.734|||
3971934|NCT01288079|3794110|B4|||Montgomery-Asberg Depression Rating Scale (MADRS) total score at randomization|A 10-item scale for the evaluation of depressive symptoms. Each Montgomery-Asberg Depression Rating Scale (MADRS) item is rated on a 0 to 6 scale. The MADRS total score is calculated as the sum of the 10 individual item scores; the total score can range from 0 to 60. Higher MADRS scores indicate higher levels of depressive symptoms.|Scores on a scale|Mean|27.625|27.625|Standard Deviation|5.320|5.32|||
3971935|NCT01288079|3794111|B3|||Montgomery-Asberg Depression Rating Scale (MADRS) total score at randomization|A 10-item scale for the evaluation of depressive symptoms. Each Montgomery-Asberg Depression Rating Scale (MADRS) item is rated on a 0 to 6 scale. The MADRS total score is calculated as the sum of the 10 individual item scores; the total score can range from 0 to 60. Higher MADRS scores indicate higher levels of depressive symptoms.|Scores on a scale|Mean|28.600|28.6|Standard Deviation|6.796|6.796|||
3971936|NCT01288079|3794112|B2|||Montgomery-Asberg Depression Rating Scale (MADRS) total score at randomization|A 10-item scale for the evaluation of depressive symptoms. Each Montgomery-Asberg Depression Rating Scale (MADRS) item is rated on a 0 to 6 scale. The MADRS total score is calculated as the sum of the 10 individual item scores; the total score can range from 0 to 60. Higher MADRS scores indicate higher levels of depressive symptoms.|Scores on a scale|Mean|26.857|26.857|Standard Deviation|5.542|5.542|||
3971937|NCT01288079|3794113|B1|||Montgomery-Asberg Depression Rating Scale (MADRS) total score at randomization|A 10-item scale for the evaluation of depressive symptoms. Each Montgomery-Asberg Depression Rating Scale (MADRS) item is rated on a 0 to 6 scale. The MADRS total score is calculated as the sum of the 10 individual item scores; the total score can range from 0 to 60. Higher MADRS scores indicate higher levels of depressive symptoms.|Scores on a scale|Mean|27.228|27.228|Standard Deviation|5.202|5.202|||
3971938|NCT01288079|3794109|B5|||Hamilton Rating Scale for Depression-17 items (HAMD-17) total score at randomization|A 17-item, clinician-rated scale that assesses depressive symptoms. The Hamilton Rating Scale for Depression-17 items (HAMD-17) consists of 17 symptoms, each of which is rated from 0 to 2 or 0 to 4, where 0 is none/absent. Higher HAMD-17 scores indicate more severe depression.|Scores on a scale|Mean|21.372|21.372|Standard Deviation|3.632|3.632|||
3971939|NCT01288079|3794110|B4|||Hamilton Rating Scale for Depression-17 items (HAMD-17) total score at randomization|A 17-item, clinician-rated scale that assesses depressive symptoms. The Hamilton Rating Scale for Depression-17 items (HAMD-17) consists of 17 symptoms, each of which is rated from 0 to 2 or 0 to 4, where 0 is none/absent. Higher HAMD-17 scores indicate more severe depression.|Scores on a scale|Mean|21.344|21.344|Standard Deviation|4.100|4.1|||
3971940|NCT01288079|3794111|B3|||Hamilton Rating Scale for Depression-17 items (HAMD-17) total score at randomization|A 17-item, clinician-rated scale that assesses depressive symptoms. The Hamilton Rating Scale for Depression-17 items (HAMD-17) consists of 17 symptoms, each of which is rated from 0 to 2 or 0 to 4, where 0 is none/absent. Higher HAMD-17 scores indicate more severe depression.|Scores on a scale|Mean|21.857|21.857|Standard Deviation|3.499|3.499|||
3971941|NCT01288079|3794112|B2|||Hamilton Rating Scale for Depression-17 items (HAMD-17) total score at randomization|A 17-item, clinician-rated scale that assesses depressive symptoms. The Hamilton Rating Scale for Depression-17 items (HAMD-17) consists of 17 symptoms, each of which is rated from 0 to 2 or 0 to 4, where 0 is none/absent. Higher HAMD-17 scores indicate more severe depression.|Scores on a scale|Mean|21.371|21.371|Standard Deviation|3.606|3.606|||
3971942|NCT01288079|3794113|B1|||Hamilton Rating Scale for Depression-17 items (HAMD-17) total score at randomization|A 17-item, clinician-rated scale that assesses depressive symptoms. The Hamilton Rating Scale for Depression-17 items (HAMD-17) consists of 17 symptoms, each of which is rated from 0 to 2 or 0 to 4, where 0 is none/absent. Higher HAMD-17 scores indicate more severe depression.|Scores on a scale|Mean|20.914|20.914|Standard Deviation|3.425|3.425|||
3971943|NCT01288079|3794109|B5|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3971944|NCT01288079|3794110|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3971945|NCT01288079|3794111|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3971946|NCT01288079|3794112|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3971947|NCT01288079|3794113|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3971948|NCT01288079|3794109|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3971949|NCT01288079|3794110|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3971950|NCT01288079|3794111|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3971951|NCT01288079|3794112|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3971952|NCT01288079|3794113|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3971953|NCT01288079|3794109|B5|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3971954|NCT01288079|3794110|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3971955|NCT01288079|3794111|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3971956|NCT01288079|3794112|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3971957|NCT01288079|3794113|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3971958|NCT01288079|3794109|B5|Asian||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
3971959|NCT01288079|3794110|B4|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3971960|NCT01288079|3794111|B3|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3971961|NCT01288079|3794112|B2|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3971962|NCT01288079|3794113|B1|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3971963|NCT01288079|3794109|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3971964|NCT01288079|3794110|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3971965|NCT01288079|3794111|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3971966|NCT01288079|3794112|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3971967|NCT01288079|3794113|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3971968|NCT01288079|3794109|B5|White||Race/Ethnicity, Customized||participants|Number|86|86.0||||||
3971969|NCT01288079|3794110|B4|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3971970|NCT01288079|3794111|B3|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3971971|NCT01288079|3794112|B2|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3971972|NCT01288079|3794113|B1|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3971973|NCT01288079|3794109|B5||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3971974|NCT01288079|3794110|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3971975|NCT01288079|3794111|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3971976|NCT01288079|3794112|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3971977|NCT01288079|3794113|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3971978|NCT01288079|3794109|B5||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3971979|NCT01288079|3794110|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3971980|NCT01288079|3794111|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3971981|NCT01288079|3794112|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3971982|NCT01288079|3794113|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3971983|NCT01288079|3794109|B5|||Age||years|Mean|41.7|41.7|Standard Deviation|12.24|12.24|||
3971984|NCT01288079|3794110|B4|||Age||years|Mean|40.1|40.1|Standard Deviation|10.49|10.49|||
3971985|NCT01288079|3794111|B3|||Age||years|Mean|41.8|41.8|Standard Deviation|12.70|12.7|||
3971986|NCT01288079|3794112|B2|||Age||years|Mean|40.3|40.3|Standard Deviation|12.50|12.5|||
3971987|NCT01288079|3794113|B1|||Age||years|Mean|44.5|44.5|Standard Deviation|13.03|13.03|||
3971988|NCT01288053|3794126|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3971989|NCT01288053|3794126|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3971990|NCT01288053|3794126|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3971991|NCT01288053|3794126|B1|||Age||years|Mean|26.11|26.11|Standard Deviation|7.13|7.13|||
3971992|NCT01288053|3794126|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3971993|NCT01288053|3794126|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3971994|NCT01288053|3794126|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3971995|NCT01288027|3794130|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3971996|NCT01288027|3794130|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3971997|NCT01288027|3794130|B1|||Age||years|Mean|51.6|51.6|Standard Deviation|13.69|13.69|||
3971998|NCT01287897|3794140|B5||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3971999|NCT01287897|3794141|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3972000|NCT01287897|3794142|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3972001|NCT01287897|3794143|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3972002|NCT01287897|3794144|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3972003|NCT01287897|3794140|B5||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3972004|NCT01287897|3794141|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3972005|NCT01287897|3794142|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3972006|NCT01287897|3794143|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3972007|NCT01287897|3794144|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3972008|NCT01287897|3794140|B5|||Age||Years|Mean|39.3|39.3|Standard Deviation|13.2|13.2|||
3972009|NCT01287897|3794141|B4|||Age||Years|Mean|42.2|42.2|Standard Deviation|13.2|13.2|||
3972010|NCT01287897|3794142|B3|||Age||Years|Mean|38.9|38.9|Standard Deviation|13.1|13.1|||
3972011|NCT01287897|3794143|B2|||Age||Years|Mean|38.9|38.9|Standard Deviation|12.9|12.9|||
3972012|NCT01287897|3794144|B1|||Age||Years|Mean|38.4|38.4|Standard Deviation|13.6|13.6|||
3972013|NCT01287832|3794196|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3972014|NCT01287832|3794197|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3972015|NCT01287832|3794198|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3972016|NCT01287832|3794196|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3972017|NCT01287832|3794197|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3972018|NCT01287832|3794198|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3972019|NCT01287832|3794196|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3972020|NCT01287832|3794197|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3972021|NCT01287832|3794198|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3972022|NCT01287832|3794196|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3972023|NCT01287832|3794197|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3972024|NCT01287832|3794198|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3972025|NCT01287832|3794196|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3972026|NCT01287832|3794197|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3972027|NCT01287832|3794198|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3972028|NCT01287832|3794196|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3972029|NCT01287832|3794197|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3972030|NCT01287832|3794198|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3972031|NCT01287832|3794196|B3|||Age||years|Mean|64.7|64.7|Standard Deviation|17.5|17.5|||
3972032|NCT01287832|3794197|B2|||Age||years|Mean|68.2|68.2|Standard Deviation|10.2|10.2|||
3972033|NCT01287832|3794198|B1|||Age||years|Mean|61.8|61.8|Standard Deviation|22.6|22.6|||
3972034|NCT01287754|3794205|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3972035|NCT01287754|3794206|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3972036|NCT01287754|3794207|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3972037|NCT01287754|3794205|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3972038|NCT01287754|3794206|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3972039|NCT01287754|3794207|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3972040|NCT01287754|3794205|B3|||Age||years|Mean|68|68.0|Standard Deviation|8.5|8.5|||
3972041|NCT01287754|3794206|B2|||Age||years|Mean|67|67.0|Standard Deviation|8.4|8.4|||
3972042|NCT01287754|3794207|B1|||Age||years|Mean|75|75.0|Standard Deviation|7.6|7.6|||
3972043|NCT01287741|3794218|B3||Male|Sex: Female, Male||Participants|Count of Participants|752|752.0||||||
3972044|NCT01287741|3794219|B2||Male|Sex: Female, Male||Participants|Count of Participants|369|369.0||||||
3972045|NCT01287741|3794220|B1||Male|Sex: Female, Male||Participants|Count of Participants|383|383.0||||||
3972046|NCT01287741|3794218|B3||Female|Sex: Female, Male||Participants|Count of Participants|666|666.0||||||
3972047|NCT01287741|3794219|B2||Female|Sex: Female, Male||Participants|Count of Participants|337|337.0||||||
3972048|NCT01287741|3794220|B1||Female|Sex: Female, Male||Participants|Count of Participants|329|329.0||||||
3972049|NCT01287741|3794218|B3|||Age||years|Mean|59.2|59.2|Standard Deviation|13.5|13.5|||
3972050|NCT01287741|3794219|B2|||Age||years|Mean|59.4|59.4|Standard Deviation|13.3|13.3|||
3972051|NCT01287741|3794220|B1|||Age||years|Mean|59.1|59.1|Standard Deviation|13.6|13.6|||
3972052|NCT01287611|3794255|B3|Turkey||Region of Enrollment||participants|Number|116|116.0||||||
3972053|NCT01287611|3794256|B2|Turkey||Region of Enrollment||participants|Number|65|65.0||||||
3972054|NCT01287611|3794257|B1|Turkey||Region of Enrollment||participants|Number|51|51.0||||||
3972055|NCT01287611|3794255|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3972056|NCT01287611|3794256|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3972057|NCT01287611|3794257|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3972058|NCT01287611|3794255|B3||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3972059|NCT01287611|3794256|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3972060|NCT01287611|3794257|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3972061|NCT01287611|3794255|B3|||Age||years|Mean|29.05|29.05|Standard Deviation|5.15|5.15|||
3972062|NCT01287611|3794256|B2|||Age||years|Mean|28.5|28.5|Standard Deviation|5.3|5.3|||
3972063|NCT01287611|3794257|B1|||Age||years|Mean|29.6|29.6|Standard Deviation|5.0|5.0|||
3972064|NCT01287416|3794266|B3|Did not know someone who died by suicide||When most recent suicide death|measured only among those who had reported knowing someone who died by suicide|participants|Number|6|6.0||||||
3972065|NCT01287416|3794267|B2|Did not know someone who died by suicide||When most recent suicide death|measured only among those who had reported knowing someone who died by suicide|participants|Number|3|3.0||||||
3972066|NCT01287416|3794268|B1|Did not know someone who died by suicide||When most recent suicide death|measured only among those who had reported knowing someone who died by suicide|participants|Number|3|3.0||||||
3972067|NCT01287416|3794266|B3|Missing||When most recent suicide death|measured only among those who had reported knowing someone who died by suicide|participants|Number|2|2.0||||||
3972068|NCT01287416|3794267|B2|Missing||When most recent suicide death|measured only among those who had reported knowing someone who died by suicide|participants|Number|0|0.0||||||
3972069|NCT01287416|3794268|B1|Missing||When most recent suicide death|measured only among those who had reported knowing someone who died by suicide|participants|Number|2|2.0||||||
3972070|NCT01287416|3794266|B3|Within the last 1 month||When most recent suicide death|measured only among those who had reported knowing someone who died by suicide|participants|Number|0|0.0||||||
3972122|NCT01287416|3794267|B2|Never married||Marital status||participants|Number|14|14.0||||||
3972071|NCT01287416|3794267|B2|Within the last 1 month||When most recent suicide death|measured only among those who had reported knowing someone who died by suicide|participants|Number|0|0.0||||||
3972072|NCT01287416|3794268|B1|Within the last 1 month||When most recent suicide death|measured only among those who had reported knowing someone who died by suicide|participants|Number|0|0.0||||||
3972073|NCT01287416|3794266|B3|Within the last 6 months||When most recent suicide death|measured only among those who had reported knowing someone who died by suicide|participants|Number|8|8.0||||||
3972074|NCT01287416|3794267|B2|Within the last 6 months||When most recent suicide death|measured only among those who had reported knowing someone who died by suicide|participants|Number|3|3.0||||||
3972075|NCT01287416|3794268|B1|Within the last 6 months||When most recent suicide death|measured only among those who had reported knowing someone who died by suicide|participants|Number|5|5.0||||||
3972076|NCT01287416|3794266|B3|Within the last year||When most recent suicide death|measured only among those who had reported knowing someone who died by suicide|participants|Number|11|11.0||||||
3972077|NCT01287416|3794267|B2|Within the last year||When most recent suicide death|measured only among those who had reported knowing someone who died by suicide|participants|Number|8|8.0||||||
3972078|NCT01287416|3794268|B1|Within the last year||When most recent suicide death|measured only among those who had reported knowing someone who died by suicide|participants|Number|3|3.0||||||
3972079|NCT01287416|3794266|B3|More than 1 year ago||When most recent suicide death|measured only among those who had reported knowing someone who died by suicide|participants|Number|28|28.0||||||
3972080|NCT01287416|3794267|B2|More than 1 year ago||When most recent suicide death|measured only among those who had reported knowing someone who died by suicide|participants|Number|10|10.0||||||
3972081|NCT01287416|3794268|B1|More than 1 year ago||When most recent suicide death|measured only among those who had reported knowing someone who died by suicide|participants|Number|18|18.0||||||
3972082|NCT01287416|3794266|B3|No||Know someone who died by suicide||participants|Number|6|6.0||||||
3972083|NCT01287416|3794267|B2|No||Know someone who died by suicide||participants|Number|3|3.0||||||
3972084|NCT01287416|3794268|B1|No||Know someone who died by suicide||participants|Number|3|3.0||||||
3972085|NCT01287416|3794266|B3|Yes||Know someone who died by suicide||participants|Number|49|49.0||||||
3972086|NCT01287416|3794267|B2|Yes||Know someone who died by suicide||participants|Number|21|21.0||||||
3972087|NCT01287416|3794268|B1|Yes||Know someone who died by suicide||participants|Number|28|28.0||||||
3972088|NCT01287416|3794266|B3|Retired/at home full-time/student||Current work status||participants|Number|16|16.0||||||
3972089|NCT01287416|3794267|B2|Retired/at home full-time/student||Current work status||participants|Number|5|5.0||||||
3972090|NCT01287416|3794268|B1|Retired/at home full-time/student||Current work status||participants|Number|11|11.0||||||
3972091|NCT01287416|3794266|B3|Unemployed/social assistance||Current work status||participants|Number|25|25.0||||||
3972092|NCT01287416|3794267|B2|Unemployed/social assistance||Current work status||participants|Number|11|11.0||||||
3972093|NCT01287416|3794268|B1|Unemployed/social assistance||Current work status||participants|Number|14|14.0||||||
3972094|NCT01287416|3794266|B3|Working full- or part-time||Current work status||participants|Number|14|14.0||||||
3972095|NCT01287416|3794267|B2|Working full- or part-time||Current work status||participants|Number|8|8.0||||||
3972096|NCT01287416|3794268|B1|Working full- or part-time||Current work status||participants|Number|6|6.0||||||
3972097|NCT01287416|3794266|B3|Missing||Language spoken most often||participants|Number|2|2.0||||||
3972098|NCT01287416|3794267|B2|Missing||Language spoken most often||participants|Number|0|0.0||||||
3972099|NCT01287416|3794268|B1|Missing||Language spoken most often||participants|Number|2|2.0||||||
3972100|NCT01287416|3794266|B3|Cree||Language spoken most often||participants|Number|13|13.0||||||
3972101|NCT01287416|3794267|B2|Cree||Language spoken most often||participants|Number|4|4.0||||||
3972102|NCT01287416|3794268|B1|Cree||Language spoken most often||participants|Number|9|9.0||||||
3972103|NCT01287416|3794266|B3|English||Language spoken most often||participants|Number|40|40.0||||||
3972104|NCT01287416|3794267|B2|English||Language spoken most often||participants|Number|20|20.0||||||
3972105|NCT01287416|3794268|B1|English||Language spoken most often||participants|Number|20|20.0||||||
3972106|NCT01287416|3794266|B3|Grade 10 or higher||Educational attainment|Level of educational attainment of the participant|participants|Number|33|33.0||||||
3972107|NCT01287416|3794267|B2|Grade 10 or higher||Educational attainment|Level of educational attainment of the participant|participants|Number|21|21.0||||||
3972108|NCT01287416|3794268|B1|Grade 10 or higher||Educational attainment|Level of educational attainment of the participant|participants|Number|12|12.0||||||
3972109|NCT01287416|3794266|B3|Grade 9 or lower||Educational attainment|Level of educational attainment of the participant|participants|Number|22|22.0||||||
3972110|NCT01287416|3794267|B2|Grade 9 or lower||Educational attainment|Level of educational attainment of the participant|participants|Number|3|3.0||||||
3972111|NCT01287416|3794268|B1|Grade 9 or lower||Educational attainment|Level of educational attainment of the participant|participants|Number|19|19.0||||||
3972112|NCT01287416|3794266|B3|Missing||Marital status||participants|Number|4|4.0||||||
3972113|NCT01287416|3794267|B2|Missing||Marital status||participants|Number|0|0.0||||||
3972114|NCT01287416|3794268|B1|Missing||Marital status||participants|Number|4|4.0||||||
3972115|NCT01287416|3794266|B3|Married/common-law||Marital status||participants|Number|18|18.0||||||
3972116|NCT01287416|3794267|B2|Married/common-law||Marital status||participants|Number|7|7.0||||||
3972117|NCT01287416|3794268|B1|Married/common-law||Marital status||participants|Number|11|11.0||||||
3972118|NCT01287416|3794266|B3|Widowed/separated/divorced||Marital status||participants|Number|7|7.0||||||
3972119|NCT01287416|3794267|B2|Widowed/separated/divorced||Marital status||participants|Number|3|3.0||||||
3972120|NCT01287416|3794268|B1|Widowed/separated/divorced||Marital status||participants|Number|4|4.0||||||
3972121|NCT01287416|3794266|B3|Never married||Marital status||participants|Number|26|26.0||||||
3972123|NCT01287416|3794268|B1|Never married||Marital status||participants|Number|12|12.0||||||
3972124|NCT01287416|3794266|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3972125|NCT01287416|3794267|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3972126|NCT01287416|3794268|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3972127|NCT01287416|3794266|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3972128|NCT01287416|3794267|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3972129|NCT01287416|3794268|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3972130|NCT01287416|3794266|B3|Missing||Age, Customized||participants|Number|1|1.0||||||
3972131|NCT01287416|3794267|B2|Missing||Age, Customized||participants|Number|1|1.0||||||
3972132|NCT01287416|3794268|B1|Missing||Age, Customized||participants|Number|0|0.0||||||
3972133|NCT01287416|3794266|B3|45+||Age, Customized||participants|Number|12|12.0||||||
3972134|NCT01287416|3794267|B2|45+||Age, Customized||participants|Number|4|4.0||||||
3972135|NCT01287416|3794268|B1|45+||Age, Customized||participants|Number|8|8.0||||||
3972136|NCT01287416|3794266|B3|22-44||Age, Customized||participants|Number|18|18.0||||||
3972137|NCT01287416|3794267|B2|22-44||Age, Customized||participants|Number|10|10.0||||||
3972138|NCT01287416|3794268|B1|22-44||Age, Customized||participants|Number|8|8.0||||||
3972139|NCT01287416|3794266|B3|16-21||Age, Customized||participants|Number|24|24.0||||||
3972140|NCT01287416|3794267|B2|16-21||Age, Customized||participants|Number|9|9.0||||||
3972141|NCT01287416|3794268|B1|16-21||Age, Customized||participants|Number|15|15.0||||||
3972142|NCT01287403|3794305|B1|Switzerland||Region of Enrollment||participants|Number|14|14.0||||||
3972143|NCT01287403|3794305|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3972144|NCT01287403|3794305|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3972145|NCT01287403|3794305|B1|> 55 years||Age, Customized||participants|Number|0|0.0||||||
3972146|NCT01287403|3794305|B1|between 18 and 55 years||Age, Customized||participants|Number|14|14.0||||||
3972147|NCT01287403|3794305|B1|< 18 years||Age, Customized||participants|Number|0|0.0||||||
3972148|NCT01287364|3794319|B3|Multiple||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3972149|NCT01287364|3794320|B2|Multiple||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3972150|NCT01287364|3794321|B1|Multiple||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3972151|NCT01287364|3794319|B3|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3972152|NCT01287364|3794320|B2|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3972153|NCT01287364|3794321|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3972154|NCT01287364|3794319|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3972155|NCT01287364|3794320|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3972156|NCT01287364|3794321|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3972157|NCT01287364|3794319|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3972158|NCT01287364|3794320|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3972159|NCT01287364|3794321|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3972160|NCT01287364|3794319|B3|Asian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3972161|NCT01287364|3794320|B2|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3972162|NCT01287364|3794321|B1|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3972163|NCT01287364|3794319|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
3972164|NCT01287364|3794320|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3972165|NCT01287364|3794321|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
3972166|NCT01287364|3794319|B3|White/Caucasian||Race/Ethnicity, Customized||Participants|Number|157|157.0||||||
3972167|NCT01287364|3794320|B2|White/Caucasian||Race/Ethnicity, Customized||Participants|Number|77|77.0||||||
3972168|NCT01287364|3794321|B1|White/Caucasian||Race/Ethnicity, Customized||Participants|Number|80|80.0||||||
3972169|NCT01287364|3794319|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3972170|NCT01287364|3794320|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3972171|NCT01287364|3794321|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3972172|NCT01287364|3794319|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|145|145.0||||||
3972173|NCT01287364|3794320|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3972174|NCT01287364|3794321|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
3972175|NCT01287364|3794319|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3972176|NCT01287364|3794320|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3972177|NCT01287364|3794321|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3972178|NCT01287364|3794319|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3972179|NCT01287364|3794320|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3972180|NCT01287364|3794321|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3972181|NCT01287364|3794319|B3||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3972182|NCT01287364|3794320|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3972183|NCT01287364|3794321|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3972184|NCT01287364|3794319|B3|||Age||years|Mean|38.3|38.3|Standard Deviation|14.8|14.8|||
3972185|NCT01287364|3794320|B2|||Age||years|Mean|37.5|37.5|Standard Deviation|14.6|14.6|||
3972186|NCT01287364|3794321|B1|||Age||years|Mean|39.1|39.1|Standard Deviation|15.1|15.1|||
3972187|NCT01287364|3794319|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3972188|NCT01287364|3794320|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3972189|NCT01287364|3794321|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3972190|NCT01287364|3794319|B3||Between 18 and 65 years|Age||Participants|Count of Participants|159|159.0||||||
3972191|NCT01287364|3794320|B2||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
3972192|NCT01287364|3794321|B1||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
3972193|NCT01287364|3794319|B3||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
3972194|NCT01287364|3794320|B2||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
3972195|NCT01287364|3794321|B1||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
3972196|NCT01287221|3794342|B3|Possible||Certainty of Multiple System Atrophy (MSA) Diagnosis|"Criteria for probable MSA:1)Autonomic failure involving urinary incontinence or an orthostatic decrease of blood pressure within 3 min of standing by at least 30 mm Hg systolic or 15 mm Hg diastolic and 2)Poorly levodopa-responsive parkinsonism, or 3) cerebellar syndrome (gait ataxia with cerebellar dysarthria, limb ataxia, or cerebellar oculomotor dysfunction).~Criteria for possible MSA:1)Parkinsonism or 2)cerebellar syndrome and 3)at least one feature suggesting autonomic dysfunction (unexplained urinary urgency, frequent bladder emptying, erectile dysfunction, orthostatic hypotension.)"|participants|Number|35|35.0||||||
3972197|NCT01287221|3794343|B2|Possible||Certainty of Multiple System Atrophy (MSA) Diagnosis|"Criteria for probable MSA:1)Autonomic failure involving urinary incontinence or an orthostatic decrease of blood pressure within 3 min of standing by at least 30 mm Hg systolic or 15 mm Hg diastolic and 2)Poorly levodopa-responsive parkinsonism, or 3) cerebellar syndrome (gait ataxia with cerebellar dysarthria, limb ataxia, or cerebellar oculomotor dysfunction).~Criteria for possible MSA:1)Parkinsonism or 2)cerebellar syndrome and 3)at least one feature suggesting autonomic dysfunction (unexplained urinary urgency, frequent bladder emptying, erectile dysfunction, orthostatic hypotension.)"|participants|Number|16|16.0||||||
3972198|NCT01287221|3794344|B1|Possible||Certainty of Multiple System Atrophy (MSA) Diagnosis|"Criteria for probable MSA:1)Autonomic failure involving urinary incontinence or an orthostatic decrease of blood pressure within 3 min of standing by at least 30 mm Hg systolic or 15 mm Hg diastolic and 2)Poorly levodopa-responsive parkinsonism, or 3) cerebellar syndrome (gait ataxia with cerebellar dysarthria, limb ataxia, or cerebellar oculomotor dysfunction).~Criteria for possible MSA:1)Parkinsonism or 2)cerebellar syndrome and 3)at least one feature suggesting autonomic dysfunction (unexplained urinary urgency, frequent bladder emptying, erectile dysfunction, orthostatic hypotension.)"|participants|Number|19|19.0||||||
3972199|NCT01287221|3794342|B3|Probable||Certainty of Multiple System Atrophy (MSA) Diagnosis|"Criteria for probable MSA:1)Autonomic failure involving urinary incontinence or an orthostatic decrease of blood pressure within 3 min of standing by at least 30 mm Hg systolic or 15 mm Hg diastolic and 2)Poorly levodopa-responsive parkinsonism, or 3) cerebellar syndrome (gait ataxia with cerebellar dysarthria, limb ataxia, or cerebellar oculomotor dysfunction).~Criteria for possible MSA:1)Parkinsonism or 2)cerebellar syndrome and 3)at least one feature suggesting autonomic dysfunction (unexplained urinary urgency, frequent bladder emptying, erectile dysfunction, orthostatic hypotension.)"|participants|Number|65|65.0||||||
3972200|NCT01287221|3794343|B2|Probable||Certainty of Multiple System Atrophy (MSA) Diagnosis|"Criteria for probable MSA:1)Autonomic failure involving urinary incontinence or an orthostatic decrease of blood pressure within 3 min of standing by at least 30 mm Hg systolic or 15 mm Hg diastolic and 2)Poorly levodopa-responsive parkinsonism, or 3) cerebellar syndrome (gait ataxia with cerebellar dysarthria, limb ataxia, or cerebellar oculomotor dysfunction).~Criteria for possible MSA:1)Parkinsonism or 2)cerebellar syndrome and 3)at least one feature suggesting autonomic dysfunction (unexplained urinary urgency, frequent bladder emptying, erectile dysfunction, orthostatic hypotension.)"|participants|Number|34|34.0||||||
3972201|NCT01287221|3794344|B1|Probable||Certainty of Multiple System Atrophy (MSA) Diagnosis|"Criteria for probable MSA:1)Autonomic failure involving urinary incontinence or an orthostatic decrease of blood pressure within 3 min of standing by at least 30 mm Hg systolic or 15 mm Hg diastolic and 2)Poorly levodopa-responsive parkinsonism, or 3) cerebellar syndrome (gait ataxia with cerebellar dysarthria, limb ataxia, or cerebellar oculomotor dysfunction).~Criteria for possible MSA:1)Parkinsonism or 2)cerebellar syndrome and 3)at least one feature suggesting autonomic dysfunction (unexplained urinary urgency, frequent bladder emptying, erectile dysfunction, orthostatic hypotension.)"|participants|Number|31|31.0||||||
3972202|NCT01287221|3794342|B3|Cerebellar (MSA-C)||Multiple System Atrophy (MSA) Type||participants|Number|59|59.0||||||
3972203|NCT01287221|3794343|B2|Cerebellar (MSA-C)||Multiple System Atrophy (MSA) Type||participants|Number|28|28.0||||||
3972204|NCT01287221|3794344|B1|Cerebellar (MSA-C)||Multiple System Atrophy (MSA) Type||participants|Number|31|31.0||||||
3972205|NCT01287221|3794342|B3|Parkinsonian (MSA-P)||Multiple System Atrophy (MSA) Type||participants|Number|41|41.0||||||
3972206|NCT01287221|3794343|B2|Parkinsonian (MSA-P)||Multiple System Atrophy (MSA) Type||participants|Number|22|22.0||||||
3972207|NCT01287221|3794344|B1|Parkinsonian (MSA-P)||Multiple System Atrophy (MSA) Type||participants|Number|19|19.0||||||
3972208|NCT01287221|3794342|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
3972209|NCT01287221|3794343|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
3972210|NCT01287221|3794344|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3972211|NCT01287221|3794342|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3972212|NCT01287221|3794343|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3972213|NCT01287221|3794344|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3972214|NCT01287221|3794342|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3972215|NCT01287221|3794343|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3972216|NCT01287221|3794344|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3972217|NCT01287221|3794342|B3|||Age||years|Mean|61.0|61.0|Standard Deviation|8.5|8.5|||
3972218|NCT01287221|3794343|B2|||Age||years|Mean|61.1|61.1|Standard Deviation|9.2|9.2|||
3972219|NCT01287221|3794344|B1|||Age||years|Mean|60.9|60.9|Standard Deviation|7.8|7.8|||
3972220|NCT01287208|3794363|B3|United States||Region of Enrollment||participants|Number|104|104.0||||||
3972221|NCT01287208|3794364|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
3972222|NCT01287208|3794365|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
3972223|NCT01287208|3794363|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3972224|NCT01287208|3794364|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3972225|NCT01287208|3794365|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3972226|NCT01287208|3794363|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3972227|NCT01287208|3794364|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3972228|NCT01287208|3794365|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3972229|NCT01287208|3794363|B3|||Age||years|Mean|29|29.0|Standard Deviation|0.2|0.2|||
3972230|NCT01287208|3794364|B2|||Age||years|Mean|29|29.0|Standard Deviation|0.4|0.4|||
3972231|NCT01287208|3794365|B1|||Age||years|Mean|29|29.0|Standard Deviation|0.3|0.3|||
3972232|NCT01287208|3794363|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3972233|NCT01287208|3794364|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3972234|NCT01287208|3794365|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3972235|NCT01287208|3794363|B3||Between 18 and 65 years|Age||Participants|Count of Participants|104|104.0||||||
3972236|NCT01287208|3794364|B2||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3972237|NCT01287208|3794365|B1||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3972238|NCT01287208|3794363|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3972239|NCT01287208|3794364|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3972240|NCT01287208|3794365|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3972241|NCT01287195|3794380|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3972242|NCT01287195|3794380|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3972243|NCT01287195|3794380|B1|||Age||years|Mean|39.5|39.5|Standard Deviation|13.5|13.5|||
3972244|NCT01287117|3794391|B5||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3972245|NCT01287117|3794392|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3972246|NCT01287117|3794393|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3972247|NCT01287117|3794394|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3972248|NCT01287117|3794395|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3972249|NCT01287117|3794391|B5||Female|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
3972250|NCT01287117|3794392|B4||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3972251|NCT01287117|3794393|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3972252|NCT01287117|3794394|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3972253|NCT01287117|3794395|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3972254|NCT01287117|3794391|B5|||Age||years|Mean|41.2|41.2|Standard Deviation|14.5|14.5|||
3972255|NCT01287117|3794392|B4|||Age||years|Mean|42.4|42.4|Standard Deviation|13.2|13.2|||
3972256|NCT01287117|3794393|B3|||Age||years|Mean|41.1|41.1|Standard Deviation|14.0|14.0|||
3972257|NCT01287117|3794394|B2|||Age||years|Mean|40.7|40.7|Standard Deviation|15.2|15.2|||
3972258|NCT01287117|3794395|B1|||Age||years|Mean|40.4|40.4|Standard Deviation|15.6|15.6|||
3972259|NCT01287065|3794444|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3972260|NCT01287065|3794444|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
3972261|NCT01287065|3794444|B1||Male|Gender||Participants|Count of Participants|18|18.0||||||
3972262|NCT01287065|3794444|B1||Female|Gender||Participants|Count of Participants|8|8.0||||||
3972263|NCT01287065|3794444|B1|||Age||Years|Mean|38.1|38.1|Standard Deviation|11.30|11.3|||
3972264|NCT01287039|3794466|B3|||Number of Short-Acting Beta-Agonist Puffs (SABA) Daily|Based on patient-reported total number of SABA puffs over the past 3 days.|puffs/day|Mean|2.6|2.6|Standard Deviation|3.01|3.01|||
3972265|NCT01287039|3794467|B2|||Number of Short-Acting Beta-Agonist Puffs (SABA) Daily|Based on patient-reported total number of SABA puffs over the past 3 days.|puffs/day|Mean|2.4|2.4|Standard Deviation|2.82|2.82|||
3972266|NCT01287039|3794468|B1|||Number of Short-Acting Beta-Agonist Puffs (SABA) Daily|Based on patient-reported total number of SABA puffs over the past 3 days.|puffs/day|Mean|2.7|2.7|Standard Deviation|3.18|3.18|||
3972267|NCT01287039|3794466|B3|||Asthma Symptom Utility Index (ASUI)|The ASUI is an 11-item instrument designed to assess the frequency and severity of asthma symptoms and side effects, weighted by patient preferences (Revicki et al 1998). ASUI is a utility score that ranges from 0 to 1, with higher values indicating better asthma control.|units on a scale|Mean|0.623|0.623|Standard Deviation|0.1984|0.1984|||
3972268|NCT01287039|3794467|B2|||Asthma Symptom Utility Index (ASUI)|The ASUI is an 11-item instrument designed to assess the frequency and severity of asthma symptoms and side effects, weighted by patient preferences (Revicki et al 1998). ASUI is a utility score that ranges from 0 to 1, with higher values indicating better asthma control.|units on a scale|Mean|0.633|0.633|Standard Deviation|0.1938|0.1938|||
3972345|NCT01287013|3794499|B4||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3972346|NCT01287013|3794500|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3972347|NCT01287013|3794501|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3972269|NCT01287039|3794468|B1|||Asthma Symptom Utility Index (ASUI)|The ASUI is an 11-item instrument designed to assess the frequency and severity of asthma symptoms and side effects, weighted by patient preferences (Revicki et al 1998). ASUI is a utility score that ranges from 0 to 1, with higher values indicating better asthma control.|units on a scale|Mean|0.613|0.613|Standard Deviation|0.2029|0.2029|||
3972270|NCT01287039|3794466|B3|||Asthma Quality of Life Questionnaire (AQLQ)|The AQLQ is a 32-item instrument administered as a self-assessment (Juniper et al 1992). The questionnaire is divided into 4 domains: activity limitation, symptoms, emotional function, and environmental stimuli. Patients were asked to recall their experiences during the last 2 weeks and to respond to each question on a 7-point scale (1=severe impairment, 7=no impairment). The overall AQLQ score is the mean of all 32 responses.|units on a scale|Mean|4.231|4.231|Standard Deviation|1.1059|1.1059|||
3972271|NCT01287039|3794467|B2|||Asthma Quality of Life Questionnaire (AQLQ)|The AQLQ is a 32-item instrument administered as a self-assessment (Juniper et al 1992). The questionnaire is divided into 4 domains: activity limitation, symptoms, emotional function, and environmental stimuli. Patients were asked to recall their experiences during the last 2 weeks and to respond to each question on a 7-point scale (1=severe impairment, 7=no impairment). The overall AQLQ score is the mean of all 32 responses.|units on a scale|Mean|4.303|4.303|Standard Deviation|1.1208|1.1208|||
3972272|NCT01287039|3794468|B1|||Asthma Quality of Life Questionnaire (AQLQ)|The AQLQ is a 32-item instrument administered as a self-assessment (Juniper et al 1992). The questionnaire is divided into 4 domains: activity limitation, symptoms, emotional function, and environmental stimuli. Patients were asked to recall their experiences during the last 2 weeks and to respond to each question on a 7-point scale (1=severe impairment, 7=no impairment). The overall AQLQ score is the mean of all 32 responses.|units on a scale|Mean|4.159|4.159|Standard Deviation|1.0883|1.0883|||
3972273|NCT01287039|3794466|B3|||Asthma Control Questionnaire (ACQ) Overall Score|The ACQ is a 7-item instrument that measures asthma control (Juniper et al 1999). Six questions are self-assessments; the seventh item, completed by a member of the study staff, is the result of the patient’s FEV1 measurement. Each item has 7 possible answers on a scale of 0 to 6, and the overall score is the mean of all responses. A higher score is an indication of poorer asthma control.|units on a scale|Mean|2.710|2.71|Standard Deviation|0.867|0.867|||
3972274|NCT01287039|3794467|B2|||Asthma Control Questionnaire (ACQ) Overall Score|The ACQ is a 7-item instrument that measures asthma control (Juniper et al 1999). Six questions are self-assessments; the seventh item, completed by a member of the study staff, is the result of the patient’s FEV1 measurement. Each item has 7 possible answers on a scale of 0 to 6, and the overall score is the mean of all responses. A higher score is an indication of poorer asthma control.|units on a scale|Mean|2.657|2.657|Standard Deviation|0.8541|0.8541|||
3972275|NCT01287039|3794468|B1|||Asthma Control Questionnaire (ACQ) Overall Score|The ACQ is a 7-item instrument that measures asthma control (Juniper et al 1999). Six questions are self-assessments; the seventh item, completed by a member of the study staff, is the result of the patient’s FEV1 measurement. Each item has 7 possible answers on a scale of 0 to 6, and the overall score is the mean of all responses. A higher score is an indication of poorer asthma control.|units on a scale|Mean|2.763|2.763|Standard Deviation|0.8782|0.8782|||
3972276|NCT01287039|3794466|B3|||Forced Expiratory Volume in 1 Second||liters|Mean|1.911|1.911|Standard Deviation|0.7583|0.7583|||
3972277|NCT01287039|3794467|B2|||Forced Expiratory Volume in 1 Second||liters|Mean|1.894|1.894|Standard Deviation|0.7258|0.7258|||
3972278|NCT01287039|3794468|B1|||Forced Expiratory Volume in 1 Second||liters|Mean|1.928|1.928|Standard Deviation|0.7908|0.7908|||
3972279|NCT01287039|3794466|B3|||Asthma Exacerbations In Previous 12 Months||exacerbations|Mean|2.0|2.0|Standard Deviation|2.00|2.0|||
3972280|NCT01287039|3794467|B2|||Asthma Exacerbations In Previous 12 Months||exacerbations|Mean|1.9|1.9|Standard Deviation|1.63|1.63|||
3972281|NCT01287039|3794468|B1|||Asthma Exacerbations In Previous 12 Months||exacerbations|Mean|2.1|2.1|Standard Deviation|2.31|2.31|||
3972282|NCT01287039|3794466|B3|OCS - No||Oral Glucocorticosteroid (OCS) Use at Baseline|Oral glucocorticosteroid (OCS) use at baseline was a stratification factor. Values input by the investigator into the interactive response technology (IRT) were used during randomization. However, 6 patients in the placebo group and 22 patients in the reslizumab group were misclassified in IRT as having used oral glucocorticosteroids at baseline according to the case report form.|participants|Number|397|397.0||||||
3972283|NCT01287039|3794467|B2|OCS - No||Oral Glucocorticosteroid (OCS) Use at Baseline|Oral glucocorticosteroid (OCS) use at baseline was a stratification factor. Values input by the investigator into the interactive response technology (IRT) were used during randomization. However, 6 patients in the placebo group and 22 patients in the reslizumab group were misclassified in IRT as having used oral glucocorticosteroids at baseline according to the case report form.|participants|Number|199|199.0||||||
3972284|NCT01287039|3794468|B1|OCS - No||Oral Glucocorticosteroid (OCS) Use at Baseline|Oral glucocorticosteroid (OCS) use at baseline was a stratification factor. Values input by the investigator into the interactive response technology (IRT) were used during randomization. However, 6 patients in the placebo group and 22 patients in the reslizumab group were misclassified in IRT as having used oral glucocorticosteroids at baseline according to the case report form.|participants|Number|198|198.0||||||
3972285|NCT01287039|3794466|B3|OCS - Yes||Oral Glucocorticosteroid (OCS) Use at Baseline|Oral glucocorticosteroid (OCS) use at baseline was a stratification factor. Values input by the investigator into the interactive response technology (IRT) were used during randomization. However, 6 patients in the placebo group and 22 patients in the reslizumab group were misclassified in IRT as having used oral glucocorticosteroids at baseline according to the case report form.|participants|Number|92|92.0||||||
3972286|NCT01287039|3794467|B2|OCS - Yes||Oral Glucocorticosteroid (OCS) Use at Baseline|Oral glucocorticosteroid (OCS) use at baseline was a stratification factor. Values input by the investigator into the interactive response technology (IRT) were used during randomization. However, 6 patients in the placebo group and 22 patients in the reslizumab group were misclassified in IRT as having used oral glucocorticosteroids at baseline according to the case report form.|participants|Number|46|46.0||||||
3972348|NCT01287013|3794502|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3972349|NCT01287013|3794499|B4||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3972350|NCT01287013|3794500|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3972287|NCT01287039|3794468|B1|OCS - Yes||Oral Glucocorticosteroid (OCS) Use at Baseline|Oral glucocorticosteroid (OCS) use at baseline was a stratification factor. Values input by the investigator into the interactive response technology (IRT) were used during randomization. However, 6 patients in the placebo group and 22 patients in the reslizumab group were misclassified in IRT as having used oral glucocorticosteroids at baseline according to the case report form.|participants|Number|46|46.0||||||
3972288|NCT01287039|3794466|B3|||Body Mass Index||kg/m^2|Mean|27.9|27.9|Standard Deviation|6.20|6.2|||
3972289|NCT01287039|3794467|B2|||Body Mass Index||kg/m^2|Mean|27.7|27.7|Standard Deviation|6.26|6.26|||
3972290|NCT01287039|3794468|B1|||Body Mass Index||kg/m^2|Mean|28.0|28.0|Standard Deviation|6.16|6.16|||
3972291|NCT01287039|3794466|B3|||Height||cm|Mean|164.9|164.9|Standard Deviation|10.07|10.07|||
3972292|NCT01287039|3794467|B2|||Height||cm|Mean|164.9|164.9|Standard Deviation|10.42|10.42|||
3972293|NCT01287039|3794468|B1|||Height||cm|Mean|165.0|165.0|Standard Deviation|9.74|9.74|||
3972294|NCT01287039|3794466|B3|||Weight||kg|Mean|76.0|76.0|Standard Deviation|18.87|18.87|||
3972295|NCT01287039|3794467|B2|||Weight||kg|Mean|75.6|75.6|Standard Deviation|19.05|19.05|||
3972296|NCT01287039|3794468|B1|||Weight||kg|Mean|76.5|76.5|Standard Deviation|18.71|18.71|||
3972297|NCT01287039|3794466|B3|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3972298|NCT01287039|3794467|B2|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3972299|NCT01287039|3794468|B1|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3972300|NCT01287039|3794466|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
3972301|NCT01287039|3794467|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3972302|NCT01287039|3794468|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3972303|NCT01287039|3794466|B3|Non-Hispanic and non-Latino||Race/Ethnicity, Customized||participants|Number|439|439.0||||||
3972304|NCT01287039|3794467|B2|Non-Hispanic and non-Latino||Race/Ethnicity, Customized||participants|Number|216|216.0||||||
3972305|NCT01287039|3794468|B1|Non-Hispanic and non-Latino||Race/Ethnicity, Customized||participants|Number|223|223.0||||||
3972306|NCT01287039|3794466|B3|Other||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3972307|NCT01287039|3794467|B2|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3972308|NCT01287039|3794468|B1|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3972309|NCT01287039|3794466|B3|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3972310|NCT01287039|3794467|B2|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3972311|NCT01287039|3794468|B1|Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3972312|NCT01287039|3794466|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3972313|NCT01287039|3794467|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3972314|NCT01287039|3794468|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3972315|NCT01287039|3794466|B3|Asian||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
3972316|NCT01287039|3794467|B2|Asian||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
3972317|NCT01287039|3794468|B1|Asian||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
3972318|NCT01287039|3794466|B3|Black||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
3972319|NCT01287039|3794467|B2|Black||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3972320|NCT01287039|3794468|B1|Black||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3972321|NCT01287039|3794466|B3|White||Race/Ethnicity, Customized||participants|Number|355|355.0||||||
3972322|NCT01287039|3794467|B2|White||Race/Ethnicity, Customized||participants|Number|173|173.0||||||
3972323|NCT01287039|3794468|B1|White||Race/Ethnicity, Customized||participants|Number|182|182.0||||||
3972324|NCT01287039|3794466|B3||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
3972325|NCT01287039|3794467|B2||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3972326|NCT01287039|3794468|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3972327|NCT01287039|3794466|B3||Female|Sex: Female, Male||Participants|Count of Participants|303|303.0||||||
3972328|NCT01287039|3794467|B2||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3972329|NCT01287039|3794468|B1||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
3972330|NCT01287039|3794466|B3|||Age||years|Mean|46.6|46.6|Standard Deviation|14.32|14.32|||
3972331|NCT01287039|3794467|B2|||Age||years|Mean|46.6|46.6|Standard Deviation|13.82|13.82|||
3972332|NCT01287039|3794468|B1|||Age||years|Mean|46.7|46.7|Standard Deviation|14.83|14.83|||
3972333|NCT01287013|3794499|B4||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3972334|NCT01287013|3794500|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3972335|NCT01287013|3794501|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3972336|NCT01287013|3794502|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3972337|NCT01287013|3794499|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3972338|NCT01287013|3794500|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3972339|NCT01287013|3794501|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3972340|NCT01287013|3794502|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3972341|NCT01287013|3794499|B4||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
3972342|NCT01287013|3794500|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3972343|NCT01287013|3794501|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3972344|NCT01287013|3794502|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3972351|NCT01287013|3794501|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3972352|NCT01287013|3794502|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3972353|NCT01286818|3794519|B1|1 - Ambulatory, restricted strenuous activity||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG performance status classified participants according to their functional impairment. Scores ranged from 0 (fully active) to 5 (death).|participants|Number|3|3.0||||||
3972354|NCT01286818|3794519|B1|0 - Fully active||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG performance status classified participants according to their functional impairment. Scores ranged from 0 (fully active) to 5 (death).|participants|Number|3|3.0||||||
3972355|NCT01286818|3794519|B1|Japan||Region of Enrollment||participants|Number|6|6.0||||||
3972356|NCT01286818|3794519|B1|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3972357|NCT01286818|3794519|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3972358|NCT01286818|3794519|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3972359|NCT01286818|3794519|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3972360|NCT01286818|3794519|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3972361|NCT01286818|3794519|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3972362|NCT01286805|3794531|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3972363|NCT01286805|3794532|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3972364|NCT01286805|3794533|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3972365|NCT01286805|3794531|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3972366|NCT01286805|3794532|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3972367|NCT01286805|3794533|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3972368|NCT01286805|3794531|B3|||Age||years|Mean|35|35.0|Standard Deviation|11|11.0|||
3972369|NCT01286805|3794532|B2|||Age||years|Mean|37|37.0|Standard Deviation|11|11.0|||
3972370|NCT01286805|3794533|B1|||Age||years|Mean|33|33.0|Standard Deviation|11|11.0|||
3972371|NCT01286779|3794554|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3972372|NCT01286779|3794554|B1|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3972373|NCT01286779|3794554|B1|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3972374|NCT01286779|3794554|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|99|99.0||||||
3972375|NCT01286779|3794554|B1||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3972376|NCT01286779|3794554|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3972377|NCT01286779|3794554|B1|||Age||years|Mean|29.6|29.6|Standard Deviation|16.39|16.39|||
3972378|NCT01286753|3794604|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3972379|NCT01286753|3794605|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3972380|NCT01286753|3794606|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3972381|NCT01286753|3794604|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3972382|NCT01286753|3794605|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3972383|NCT01286753|3794606|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3972384|NCT01286753|3794604|B3|||Age||years|Mean|64.0|64.0|Standard Deviation|11.5|11.5|||
3972385|NCT01286753|3794605|B2|||Age||years|Mean|65.2|65.2|Standard Deviation|9.1|9.1|||
3972386|NCT01286753|3794606|B1|||Age||years|Mean|62.9|62.9|Standard Deviation|13.5|13.5|||
3972387|NCT01286740|3794625|B1|||EFV plasma concentration||ng/mL|Mean|2204.9|2204.9|Standard Deviation|1059.42|1059.42|||
3972388|NCT01286740|3794625|B1|50 to < 400 Copies/mL||Baseline HIV-1 RNA Category||participants|Number|2|2.0||||||
3972389|NCT01286740|3794625|B1|< 50 Copies/mL||Baseline HIV-1 RNA Category||participants|Number|47|47.0||||||
3972390|NCT01286740|3794625|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3972391|NCT01286740|3794625|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3972392|NCT01286740|3794625|B1|White||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
3972393|NCT01286740|3794625|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3972394|NCT01286740|3794625|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3972395|NCT01286740|3794625|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3972396|NCT01286740|3794625|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3972397|NCT01286740|3794625|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3972398|NCT01286740|3794625|B1|||Age||years|Mean|38|38.0|Standard Deviation|8.3|8.3|||
3972399|NCT01286558|3794641|B3||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
3972400|NCT01286558|3794642|B2||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3972401|NCT01286558|3794643|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3972402|NCT01286558|3794641|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3972403|NCT01286558|3794642|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3972404|NCT01286558|3794643|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3972405|NCT01286558|3794641|B3|||Age||year|Mean|53.7|53.7|Standard Deviation|8.9|8.9|||
3972406|NCT01286558|3794642|B2|||Age||year|Mean|52.8|52.8|Standard Deviation|9.4|9.4|||
3972407|NCT01286558|3794643|B1|||Age||year|Mean|54.6|54.6|Standard Deviation|8.4|8.4|||
3972408|NCT01286493|3794674|B1|||CD4+ T lymphocyte counts||cell/mm^3|Median|489|489.0|Full Range|||94.0|1120.0|
3972409|NCT01286493|3794674|B1|Thailand||Region of Enrollment||participants|Number|33|33.0||||||
3972410|NCT01286493|3794674|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3972411|NCT01286493|3794674|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3972412|NCT01286493|3794674|B1|||Age||years|Median|43|43.0|Standard Deviation|7.8|7.8|||
3972413|NCT01286480|3794678|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3972414|NCT01286480|3794679|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3972415|NCT01286480|3794680|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3972416|NCT01286480|3794678|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3972417|NCT01286480|3794679|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3972418|NCT01286480|3794680|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3972419|NCT01286480|3794678|B3|||Age||years|Mean|16.5|16.5|Standard Deviation|1.0|1.0|||
3972420|NCT01286480|3794679|B2|||Age||years|Mean|16.4|16.4|Standard Deviation|1.0|1.0|||
3972421|NCT01286480|3794680|B1|||Age||years|Mean|16.6|16.6|Standard Deviation|1.0|1.0|||
3972422|NCT01286454|3794689|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3972423|NCT01286454|3794689|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3972424|NCT01286454|3794689|B1|||Age||years|Mean|39.5|39.5|Standard Deviation|10.8|10.8|||
3972425|NCT01286402|3794737|B3|||Carbon monoxide reading||parts per million|Mean|12.0|12.0|Standard Deviation|12.4|12.4|||
3972426|NCT01286402|3794738|B2|||Carbon monoxide reading||parts per million|Mean|15.2|15.2|Standard Deviation|17.5|17.5|||
3972427|NCT01286402|3794739|B1|||Carbon monoxide reading||parts per million|Mean|8.8|8.8|Standard Deviation|3.7|3.7|||
3972428|NCT01286402|3794737|B3|||Age started smoking||years|Mean|17.5|17.5|Standard Deviation|4.3|4.3|||
3972429|NCT01286402|3794738|B2|||Age started smoking||years|Mean|17.3|17.3|Standard Deviation|9.0|9.0|||
3972430|NCT01286402|3794739|B1|||Age started smoking||years|Mean|17.8|17.8|Standard Deviation|3.0|3.0|||
3972431|NCT01286402|3794737|B3|||# cigs smoked in past 30 days||cigarettes|Mean|10.7|10.7|Standard Deviation|8.0|8.0|||
3972432|NCT01286402|3794738|B2|||# cigs smoked in past 30 days||cigarettes|Mean|10.7|10.7|Standard Deviation|5.4|5.4|||
3972433|NCT01286402|3794739|B1|||# cigs smoked in past 30 days||cigarettes|Mean|10.8|10.8|Standard Deviation|11.1|11.1|||
3972434|NCT01286402|3794737|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3972435|NCT01286402|3794738|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3972436|NCT01286402|3794739|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3972437|NCT01286402|3794737|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3972438|NCT01286402|3794738|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3972439|NCT01286402|3794739|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3972440|NCT01286402|3794737|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3972441|NCT01286402|3794738|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3972442|NCT01286402|3794739|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3972443|NCT01286402|3794737|B3|||Age||years|Mean|26.9|26.9|Standard Deviation|5.5|5.5|||
3972444|NCT01286402|3794738|B2|||Age||years|Mean|26.7|26.7|Standard Deviation|5.9|5.9|||
3972445|NCT01286402|3794739|B1|||Age||years|Mean|27.2|27.2|Standard Deviation|5.6|5.6|||
3972446|NCT01286324|3794746|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
3972447|NCT01286324|3794747|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3972448|NCT01286324|3794748|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3972449|NCT01286324|3794746|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3972450|NCT01286324|3794747|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3972451|NCT01286324|3794748|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3972452|NCT01286324|3794746|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3972453|NCT01286324|3794747|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3972454|NCT01286324|3794748|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3972455|NCT01286324|3794746|B3|||Age||years|Mean|41.4|41.4|Standard Deviation|14.2|14.2|||
3972456|NCT01286324|3794747|B2|||Age||years|Mean|42.2|42.2|Standard Deviation|13.5|13.5|||
3972457|NCT01286324|3794748|B1|||Age||years|Mean|40.8|40.8|Standard Deviation|15.3|15.3|||
3972458|NCT01286324|3794746|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3972459|NCT01286324|3794747|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3972460|NCT01286324|3794748|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3972461|NCT01286324|3794746|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3972462|NCT01286324|3794747|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3972463|NCT01286324|3794748|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3972464|NCT01286324|3794746|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3972465|NCT01286324|3794747|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3972466|NCT01286324|3794748|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3972467|NCT01286311|3794765|B3|United States||Region of Enrollment||participants|Number|464|464.0||||||
3972468|NCT01286311|3794766|B2|United States||Region of Enrollment||participants|Number|232|232.0||||||
3972469|NCT01286311|3794767|B1|United States||Region of Enrollment||participants|Number|232|232.0||||||
3972470|NCT01286311|3794765|B3|Male||Gender|Physicians were not enrolled according to gender criteria, and are therefore not included above.|participants|Number|336|336.0||||||
3972471|NCT01286311|3794766|B2|Male||Gender|Physicians were not enrolled according to gender criteria, and are therefore not included above.|participants|Number|167|167.0||||||
3972472|NCT01286311|3794767|B1|Male||Gender|Physicians were not enrolled according to gender criteria, and are therefore not included above.|participants|Number|169|169.0||||||
3972473|NCT01286311|3794765|B3|Female||Gender|Physicians were not enrolled according to gender criteria, and are therefore not included above.|participants|Number|99|99.0||||||
3972474|NCT01286311|3794766|B2|Female||Gender|Physicians were not enrolled according to gender criteria, and are therefore not included above.|participants|Number|50|50.0||||||
3972475|NCT01286311|3794767|B1|Female||Gender|Physicians were not enrolled according to gender criteria, and are therefore not included above.|participants|Number|49|49.0||||||
3972476|NCT01286311|3794765|B3|||Age||years|Mean|60.7|60.7|Standard Deviation|9.4|9.4|||
3972477|NCT01286311|3794766|B2|||Age||years|Mean|60.1|60.1|Standard Deviation|9.2|9.2|||
3972478|NCT01286311|3794767|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|9.4|9.4|||
3972479|NCT01286311|3794765|B3|>=65 years||Age|Physicians were not enrolled according to age criteria, and are therefore not included above.|patient participants|Number|151|151.0||||||
3972480|NCT01286311|3794766|B2|>=65 years||Age|Physicians were not enrolled according to age criteria, and are therefore not included above.|patient participants|Number|70|70.0||||||
3972481|NCT01286311|3794767|B1|>=65 years||Age|Physicians were not enrolled according to age criteria, and are therefore not included above.|patient participants|Number|81|81.0||||||
3972482|NCT01286311|3794765|B3|Between 18 and 65 years||Age|Physicians were not enrolled according to age criteria, and are therefore not included above.|patient participants|Number|284|284.0||||||
3972483|NCT01286311|3794766|B2|Between 18 and 65 years||Age|Physicians were not enrolled according to age criteria, and are therefore not included above.|patient participants|Number|147|147.0||||||
3972484|NCT01286311|3794767|B1|Between 18 and 65 years||Age|Physicians were not enrolled according to age criteria, and are therefore not included above.|patient participants|Number|137|137.0||||||
3972485|NCT01286311|3794765|B3|<=18 years||Age|Physicians were not enrolled according to age criteria, and are therefore not included above.|patient participants|Number|0|0.0||||||
3972486|NCT01286311|3794766|B2|<=18 years||Age|Physicians were not enrolled according to age criteria, and are therefore not included above.|patient participants|Number|0|0.0||||||
3972487|NCT01286311|3794767|B1|<=18 years||Age|Physicians were not enrolled according to age criteria, and are therefore not included above.|patient participants|Number|0|0.0||||||
3972488|NCT01286207|3794782|B4||Male|Sex: Female, Male||Participants|Count of Participants|289|289.0||||||
3972489|NCT01286207|3794783|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3972490|NCT01286207|3794784|B2||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3972491|NCT01286207|3794785|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3972492|NCT01286207|3794782|B4||Female|Sex: Female, Male||Participants|Count of Participants|1670|1670.0||||||
3972493|NCT01286207|3794783|B3||Female|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
3972494|NCT01286207|3794784|B2||Female|Sex: Female, Male||Participants|Count of Participants|727|727.0||||||
3972495|NCT01286207|3794785|B1||Female|Sex: Female, Male||Participants|Count of Participants|643|643.0||||||
3972496|NCT01286207|3794782|B4|||Age||years|Mean|41.2|41.2|Full Range|||18.0|66.0|
3972497|NCT01286207|3794783|B3|||Age||years|Mean|40.7|40.7|Full Range|||18.0|64.0|
3972498|NCT01286207|3794784|B2|||Age||years|Mean|41.1|41.1|Full Range|||18.0|65.0|
3972499|NCT01286207|3794785|B1|||Age||years|Mean|41.6|41.6|Full Range|||18.0|66.0|
3972500|NCT01286168|3794807|B1|No||Adjuvant Radiation Therapy (Control Side)|Adjuvant radiation therapy within one year, but prior to tissue expander exchange.|participants|Number|96|96.0||||||
3972501|NCT01286168|3794807|B1|Yes||Adjuvant Radiation Therapy (Control Side)|Adjuvant radiation therapy within one year, but prior to tissue expander exchange.|participants|Number|8|8.0||||||
3972502|NCT01286168|3794807|B1|No||Adjuvant Radiation Therapy (Antisepsis Side)|Adjuvant radiation therapy within one year, but prior to tissue expander exchange.|participants|Number|97|97.0||||||
3972503|NCT01286168|3794807|B1|Yes||Adjuvant Radiation Therapy (Antisepsis Side)|Adjuvant radiation therapy within one year, but prior to tissue expander exchange.|participants|Number|7|7.0||||||
3972504|NCT01286168|3794807|B1|||Maximum Drain Duration (Control Side)|Maximum duration across all drains on a given side.|days|Median|13|13.0|Full Range|||6.0|34.0|
3972505|NCT01286168|3794807|B1|||Maximum Drain Duration (Antisepsis Side)|Maximum duration across all drains on a given side.|days|Median|13|13.0|Full Range|||6.0|50.0|
3972506|NCT01286168|3794807|B1|||Number of Lymph Nodes Removed (Control Side)|Among sides with either SLNB or ALND, n=43 control.|lymph nodes|Median|4|4.0|Full Range|||1.0|36.0|
3972507|NCT01286168|3794807|B1|||Number of Lymph Nodes Removed (Antisepsis Side)|Among sides with either sentinel lymph node biopsy (SLNB) or axillary lymph node dissection (ALND), n=46 antisepsis side.|lymph nodes|Median|3|3.0|Full Range|||1.0|33.0|
3972508|NCT01286168|3794807|B1|||Intraoperative Fill Volume (Control Side)|Interoperative fill volume available in n=101 participants, and missing in n=3 participants.|mL|Median|150|150.0|Full Range|||0.0|800.0|
3972509|NCT01286168|3794807|B1|||Intraoperative Fill Volume (Antisepsis Side)|Interoperative fill volume available in n=101 participants, and missing in n=3 participants.|mL|Median|150|150.0|Full Range|||0.0|800.0|
3972510|NCT01286168|3794807|B1|No||Acellular dermal matrix used (Control Side)||participants|Number|28|28.0||||||
3972511|NCT01286168|3794807|B1|Yes||Acellular dermal matrix used (Control Side)||participants|Number|76|76.0||||||
3972512|NCT01286168|3794807|B1|No||Acellular dermal matrix used (Antisepsis Side)||participants|Number|29|29.0||||||
3972513|NCT01286168|3794807|B1|Yes||Acellular dermal matrix used (Antisepsis Side)||participants|Number|75|75.0||||||
3972514|NCT01286168|3794807|B1|Direct-to-implant||Type of Reconstruction (Control Side)||participants|Number|9|9.0||||||
3972515|NCT01286168|3794807|B1|Tissue expander||Type of Reconstruction (Control Side)||participants|Number|95|95.0||||||
3972516|NCT01286168|3794807|B1|Direct-to-implant||Type of Reconstruction (Antisepsis Side)||participants|Number|9|9.0||||||
3972517|NCT01286168|3794807|B1|Tissue expander||Type of Reconstruction (Antisepsis Side)||participants|Number|95|95.0||||||
3972518|NCT01286168|3794807|B1|3||Number of Drains (Control Side)||participants|Number|8|8.0||||||
3972519|NCT01286168|3794807|B1|2||Number of Drains (Control Side)||participants|Number|42|42.0||||||
3972520|NCT01286168|3794807|B1|1||Number of Drains (Control Side)||participants|Number|54|54.0||||||
3972521|NCT01286168|3794807|B1|3||Number of Drains (Antisepsis Side)||participants|Number|5|5.0||||||
3972522|NCT01286168|3794807|B1|2||Number of Drains (Antisepsis Side)||participants|Number|47|47.0||||||
3972523|NCT01286168|3794807|B1|1||Number of Drains (Antisepsis Side)||participants|Number|52|52.0||||||
3972524|NCT01286168|3794807|B1|Risk-reducing||Indication for Mastectomy (Control Side)||participants|Number|62|62.0||||||
3972525|NCT01286168|3794807|B1|Cancer||Indication for Mastectomy (Control Side)||participants|Number|42|42.0||||||
3972526|NCT01286168|3794807|B1|Risk-reducing||Indication for Mastectomy (Antisepsis Side)||participants|Number|58|58.0||||||
3972527|NCT01286168|3794807|B1|Cancer||Indication for Mastectomy (Antisepsis Side)||participants|Number|46|46.0||||||
3972528|NCT01286168|3794807|B1|Nipple-sparing||Type of Mastectomy (Control Side)||participants|Number|68|68.0||||||
3972529|NCT01286168|3794807|B1|Skin-sparing||Type of Mastectomy (Control Side)||participants|Number|36|36.0||||||
3972530|NCT01286168|3794807|B1|Nipple-sparing||Type of Mastectomy (Antisepsis Side)||participants|Number|67|67.0||||||
3972531|NCT01286168|3794807|B1|Skin-sparing||Type of Mastectomy (Antisepsis Side)||participants|Number|37|37.0||||||
3972532|NCT01286168|3794807|B1|Mastectomy + axillary lymph node dissection (ALND)||Type of Operation (Control Side)||participants|Number|11|11.0||||||
3972533|NCT01286168|3794807|B1|Mastectomy + sentinel lymph node biopsy (SLNB)||Type of Operation (Control Side)||participants|Number|32|32.0||||||
3972534|NCT01286168|3794807|B1|Mastectomy only||Type of Operation (Control Side)||participants|Number|61|61.0||||||
3972535|NCT01286168|3794807|B1|Mastectomy + axillary lymph node dissection (ALND)||Type of Operation (Antisepsis side)||participants|Number|11|11.0||||||
3972536|NCT01286168|3794807|B1|Mastectomy + sentinel lymph node biopsy (SLNB)||Type of Operation (Antisepsis side)||participants|Number|35|35.0||||||
3972537|NCT01286168|3794807|B1|Mastectomy only||Type of Operation (Antisepsis side)||participants|Number|58|58.0||||||
3972538|NCT01286168|3794807|B1|Vancomycin||Type of Preoperative Antibiotic||participants|Number|3|3.0||||||
3972539|NCT01286168|3794807|B1|Levofloxacin||Type of Preoperative Antibiotic||participants|Number|3|3.0||||||
3972540|NCT01286168|3794807|B1|Clindamycin||Type of Preoperative Antibiotic||participants|Number|6|6.0||||||
3972541|NCT01286168|3794807|B1|Cefazolin||Type of Preoperative Antibiotic||participants|Number|92|92.0||||||
3972542|NCT01286168|3794807|B1|Bilateral cancer||Indication for surgery|Contralateral prophylactic mastectomy (CPM)|participants|Number|8|8.0||||||
3972543|NCT01286168|3794807|B1|Bilateral prophylactic mastectomy||Indication for surgery|Contralateral prophylactic mastectomy (CPM)|participants|Number|24|24.0||||||
3972544|NCT01286168|3794807|B1|Unilateral cancer with CPM||Indication for surgery|Contralateral prophylactic mastectomy (CPM)|participants|Number|72|72.0||||||
3972545|NCT01286168|3794807|B1|No||Neoadjuvant chemotherapy||participants|Number|72|72.0||||||
3972546|NCT01286168|3794807|B1|Yes||Neoadjuvant chemotherapy||participants|Number|32|32.0||||||
3972547|NCT01286168|3794807|B1|No||Diagnosis of diabetes||participants|Number|101|101.0||||||
3972548|NCT01286168|3794807|B1|Yes||Diagnosis of diabetes||participants|Number|3|3.0||||||
3972549|NCT01286168|3794807|B1|Unknown||Smoking within 4 weeks preoperation||participants|Number|1|1.0||||||
3972550|NCT01286168|3794807|B1|No||Smoking within 4 weeks preoperation||participants|Number|99|99.0||||||
3972551|NCT01286168|3794807|B1|Yes||Smoking within 4 weeks preoperation||participants|Number|4|4.0||||||
3972552|NCT01286168|3794807|B1|||Operative Time||hours|Median|5.1|5.1|Full Range|||2.9|9.3|
3972553|NCT01286168|3794807|B1|Class III||American Society of Anesthesiologists (ASA) Class|The ASA physical status classification system is a system for assessing the fitness of cases before surgery. Class 1: Healthy person. Class 2: Mild systemic disease. Class 3: Severe systemic disease. Class 4: Severe systemic disease that is a constant threat to life. Class 5: A moribund person who is not expected to survive without the operation. Class 6: A declared brain-dead person whose organs are being removed for donor purposes.|participants|Number|8|8.0||||||
3972554|NCT01286168|3794807|B1|Class II||American Society of Anesthesiologists (ASA) Class|The ASA physical status classification system is a system for assessing the fitness of cases before surgery. Class 1: Healthy person. Class 2: Mild systemic disease. Class 3: Severe systemic disease. Class 4: Severe systemic disease that is a constant threat to life. Class 5: A moribund person who is not expected to survive without the operation. Class 6: A declared brain-dead person whose organs are being removed for donor purposes.|participants|Number|77|77.0||||||
3972555|NCT01286168|3794807|B1|Class I||American Society of Anesthesiologists (ASA) Class|The ASA physical status classification system is a system for assessing the fitness of cases before surgery. Class 1: Healthy person. Class 2: Mild systemic disease. Class 3: Severe systemic disease. Class 4: Severe systemic disease that is a constant threat to life. Class 5: A moribund person who is not expected to survive without the operation. Class 6: A declared brain-dead person whose organs are being removed for donor purposes.|participants|Number|19|19.0||||||
3972556|NCT01286168|3794807|B1|||Body Mass Index|Body Mass Index (BMI) is a health index for comparing weight to height. BMI is a person's weight in kilograms (kg) divided by his or her height in meters squared. The body mass index is an indication if a person is at a suitable weight for his height on an approximation of body fat. A body mass index of under 20 is considered to be underweight, while a body mass index between 20 to 25 is considered healthy. A body mass index in the range of 25 to 30 is regarded as overweight. A body mass index over 30 is regarded as obese.|kg/m^2|Median|23.8|23.8|Full Range|||17.0|45.1|
3972557|NCT01286168|3794807|B1|United States||Region of Enrollment||participants|Number|104|104.0||||||
3972558|NCT01286168|3794807|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3972559|NCT01286168|3794807|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3972560|NCT01286168|3794807|B1|||Age||years|Median|46|46.0|Full Range|||25.0|67.0|
3972561|NCT01286129|3794819|B3|Canada||Region of Enrollment||participants|Number|45|45.0||||||
3972562|NCT01286129|3794820|B2|Canada||Region of Enrollment||participants|Number|18|18.0||||||
3972563|NCT01286129|3794821|B1|Canada||Region of Enrollment||participants|Number|27|27.0||||||
3972564|NCT01286129|3794819|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3972565|NCT01286129|3794820|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3972566|NCT01286129|3794821|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3972567|NCT01286129|3794819|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3972568|NCT01286129|3794820|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3972569|NCT01286129|3794821|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3972570|NCT01286129|3794819|B3|||Age||years|Mean|24|24.0|Standard Deviation|5|5.0|||
3972571|NCT01286129|3794820|B2|||Age||years|Mean|24|24.0|Standard Deviation|7|7.0|||
3972572|NCT01286129|3794821|B1|||Age||years|Mean|24|24.0|Standard Deviation|4|4.0|||
3972573|NCT01286129|3794819|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3972574|NCT01286129|3794820|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3972575|NCT01286129|3794821|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3972576|NCT01286129|3794819|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
3972577|NCT01286129|3794820|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3972578|NCT01286129|3794821|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3972579|NCT01286129|3794819|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3972580|NCT01286129|3794820|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3972581|NCT01286129|3794821|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3972582|NCT01286077|3794830|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3972583|NCT01286077|3794831|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3972584|NCT01286077|3794832|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3972585|NCT01286077|3794830|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3972586|NCT01286077|3794831|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3972587|NCT01286077|3794832|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3972588|NCT01286077|3794830|B3|||Age||years|Mean|55.7|55.7|Full Range|||27.0|75.0|
3972589|NCT01286077|3794831|B2|||Age||years|Mean|54.7|54.7|Full Range|||35.0|73.0|
3972590|NCT01286077|3794832|B1|||Age||years|Mean|56.7|56.7|Full Range|||27.0|75.0|
3972591|NCT01286012|3794867|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3972592|NCT01286012|3794868|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3972593|NCT01286012|3794869|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3972594|NCT01286012|3794867|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3972595|NCT01286012|3794868|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3972596|NCT01286012|3794869|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3972597|NCT01286012|3794867|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3972598|NCT01286012|3794868|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3972599|NCT01286012|3794869|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3972600|NCT01286012|3794867|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3972601|NCT01286012|3794868|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3972602|NCT01286012|3794869|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3972603|NCT01286012|3794867|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3972604|NCT01286012|3794868|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3972605|NCT01286012|3794869|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3972606|NCT01286012|3794867|B3||White|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3972607|NCT01286012|3794868|B2||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3972608|NCT01286012|3794869|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3972609|NCT01286012|3794867|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3972610|NCT01286012|3794868|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3972611|NCT01286012|3794869|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3972612|NCT01286012|3794867|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3972613|NCT01286012|3794868|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3972614|NCT01286012|3794869|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3972615|NCT01286012|3794867|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3972616|NCT01286012|3794868|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3972617|NCT01286012|3794869|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3972618|NCT01286012|3794867|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3972619|NCT01286012|3794868|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3972620|NCT01286012|3794869|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3972621|NCT01286012|3794867|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3972622|NCT01286012|3794868|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3972623|NCT01286012|3794869|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3972624|NCT01286012|3794867|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3972625|NCT01286012|3794868|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3972626|NCT01286012|3794869|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3972627|NCT01286012|3794867|B3|||Age||years|Mean|59|59.0|Standard Deviation|13.07|13.07|||
3972628|NCT01286012|3794868|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|13.89|13.89|||
3972629|NCT01286012|3794869|B1|||Age||years|Mean|59.4|59.4|Standard Deviation|12.40|12.4|||
3972630|NCT01285947|3794884|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3972631|NCT01285947|3794885|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3972632|NCT01285947|3794886|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3972633|NCT01285947|3794884|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3972634|NCT01285947|3794885|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3972635|NCT01285947|3794886|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3972636|NCT01285947|3794884|B3||Female|Gender||Participants|Count of Participants|20|20.0||||||
3972637|NCT01285947|3794885|B2||Female|Gender||Participants|Count of Participants|10|10.0||||||
3972638|NCT01285947|3794886|B1||Female|Gender||Participants|Count of Participants|10|10.0||||||
3972639|NCT01285947|3794884|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3972640|NCT01285947|3794885|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3972641|NCT01285947|3794886|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3972642|NCT01285947|3794884|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3972643|NCT01285947|3794885|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3972644|NCT01285947|3794886|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3972645|NCT01285947|3794884|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3972646|NCT01285947|3794885|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3972647|NCT01285947|3794886|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3972648|NCT01285908|3794893|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3972649|NCT01285908|3794893|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3972650|NCT01285908|3794893|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3972651|NCT01285908|3794893|B1|||Age||years|Mean|65|65.0|Standard Deviation|4|4.0|||
3972652|NCT01285908|3794893|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3972653|NCT01285908|3794893|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3972654|NCT01285908|3794893|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3972655|NCT01285843|3794927|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3972656|NCT01285843|3794928|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3972657|NCT01285843|3794929|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3972658|NCT01285843|3794927|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3972659|NCT01285843|3794928|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3972660|NCT01285843|3794929|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3972661|NCT01285843|3794927|B3|||Age||years|Mean|66|66.0|Standard Deviation|9.4|9.4|||
3972662|NCT01285843|3794928|B2|||Age||years|Mean|64|64.0|Standard Deviation|9.6|9.6|||
3972663|NCT01285843|3794929|B1|||Age||years|Mean|69|69.0|Standard Deviation|9|9.0|||
3972664|NCT01285791|3794942|B4|Israel||Region of Enrollment||participants|Number|39|39.0||||||
3972665|NCT01285791|3794943|B3|Israel||Region of Enrollment||participants|Number|13|13.0||||||
3972666|NCT01285791|3794944|B2|Israel||Region of Enrollment||participants|Number|15|15.0||||||
3972667|NCT01285791|3794945|B1|Israel||Region of Enrollment||participants|Number|11|11.0||||||
3972668|NCT01285791|3794942|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3972669|NCT01285791|3794943|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3972670|NCT01285791|3794944|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3972671|NCT01285791|3794945|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3972672|NCT01285791|3794942|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3972673|NCT01285791|3794943|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3972674|NCT01285791|3794944|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3972675|NCT01285791|3794945|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3972676|NCT01285791|3794942|B4|||Age||years|Mean|37.9|37.9|Standard Deviation|1.6|1.6|||
3972677|NCT01285791|3794943|B3|||Age||years|Mean|38.7|38.7|Standard Deviation|3|3.0|||
3972678|NCT01285791|3794944|B2|||Age||years|Mean|36.5|36.5|Standard Deviation|3.1|3.1|||
3972679|NCT01285791|3794945|B1|||Age||years|Mean|38.9|38.9|Standard Deviation|1.6|1.6|||
3972680|NCT01285713|3794955|B3|United States||Region of Enrollment||participants|Number|83|83.0||||||
3972681|NCT01285713|3794956|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
3972682|NCT01285713|3794957|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
3972683|NCT01285713|3794955|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3972684|NCT01285713|3794956|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3972685|NCT01285713|3794957|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3972686|NCT01285713|3794955|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3972687|NCT01285713|3794956|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3972688|NCT01285713|3794957|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3972689|NCT01285713|3794955|B3|||Age||years|Mean|3.5|3.5|Standard Deviation|3.1|3.1|||
3972690|NCT01285713|3794956|B2|||Age||years|Mean|3.4|3.4|Standard Deviation|3.0|3.0|||
3972691|NCT01285713|3794957|B1|||Age||years|Mean|3.6|3.6|Standard Deviation|3.3|3.3|||
3972692|NCT01285713|3794955|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3972693|NCT01285713|3794956|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3972694|NCT01285713|3794957|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3972695|NCT01285713|3794955|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3972696|NCT01285713|3794956|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3972697|NCT01285713|3794957|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3972698|NCT01285713|3794955|B3||<=18 years|Age||Participants|Count of Participants|83|83.0||||||
3972699|NCT01285713|3794956|B2||<=18 years|Age||Participants|Count of Participants|41|41.0||||||
3972700|NCT01285713|3794957|B1||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
3972701|NCT01285635|3794964|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3972702|NCT01285635|3794965|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3972703|NCT01285635|3794966|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3972704|NCT01285635|3794967|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3972705|NCT01285635|3794964|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3972706|NCT01285635|3794965|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3972707|NCT01285635|3794966|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3972708|NCT01285635|3794967|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3972709|NCT01285635|3794964|B4|||Age||years|Mean|56|56.0|Full Range|||33.0|75.0|
3972710|NCT01285635|3794965|B3|||Age||years|Mean|59|59.0|Full Range|||41.0|74.0|
3972711|NCT01285635|3794966|B2|||Age||years|Mean|56|56.0|Full Range|||38.0|67.0|
3972712|NCT01285635|3794967|B1|||Age||years|Mean|56|56.0|Full Range|||35.0|75.0|
3972713|NCT01285609|3794987|B3||Recurrent|Disease Stage at Study Entry|Non-Small Cell Lung Cancer is categorized in 4 Stages (I-IV). I: Cancer located only in lungs and has not spread to any lymph nodes. II: Cancer in the lung and nearby lymph nodes. III: Cancer in the lung and lymph nodes in the middle of the chest. Stage III has two subtypes, IIIA (cancer has spread only to lymph nodes on the same side of the chest where the cancer started) and IIIB (cancer has spread to the lymph nodes on the opposite side of the chest, or above the collar bone). IV: Cancer has spread to both lungs, to fluid in the area around the lungs, or to another part of the body.|Participants|Count of Participants|49|49.0||||||
3972714|NCT01285609|3794988|B2||Recurrent|Disease Stage at Study Entry|Non-Small Cell Lung Cancer is categorized in 4 Stages (I-IV). I: Cancer located only in lungs and has not spread to any lymph nodes. II: Cancer in the lung and nearby lymph nodes. III: Cancer in the lung and lymph nodes in the middle of the chest. Stage III has two subtypes, IIIA (cancer has spread only to lymph nodes on the same side of the chest where the cancer started) and IIIB (cancer has spread to the lymph nodes on the opposite side of the chest, or above the collar bone). IV: Cancer has spread to both lungs, to fluid in the area around the lungs, or to another part of the body.|Participants|Count of Participants|28|28.0||||||
3972715|NCT01285609|3794989|B1||Recurrent|Disease Stage at Study Entry|Non-Small Cell Lung Cancer is categorized in 4 Stages (I-IV). I: Cancer located only in lungs and has not spread to any lymph nodes. II: Cancer in the lung and nearby lymph nodes. III: Cancer in the lung and lymph nodes in the middle of the chest. Stage III has two subtypes, IIIA (cancer has spread only to lymph nodes on the same side of the chest where the cancer started) and IIIB (cancer has spread to the lymph nodes on the opposite side of the chest, or above the collar bone). IV: Cancer has spread to both lungs, to fluid in the area around the lungs, or to another part of the body.|Participants|Count of Participants|21|21.0||||||
3972716|NCT01285609|3794987|B3||Stage IV|Disease Stage at Study Entry|Non-Small Cell Lung Cancer is categorized in 4 Stages (I-IV). I: Cancer located only in lungs and has not spread to any lymph nodes. II: Cancer in the lung and nearby lymph nodes. III: Cancer in the lung and lymph nodes in the middle of the chest. Stage III has two subtypes, IIIA (cancer has spread only to lymph nodes on the same side of the chest where the cancer started) and IIIB (cancer has spread to the lymph nodes on the opposite side of the chest, or above the collar bone). IV: Cancer has spread to both lungs, to fluid in the area around the lungs, or to another part of the body.|Participants|Count of Participants|700|700.0||||||
3972717|NCT01285609|3794988|B2||Stage IV|Disease Stage at Study Entry|Non-Small Cell Lung Cancer is categorized in 4 Stages (I-IV). I: Cancer located only in lungs and has not spread to any lymph nodes. II: Cancer in the lung and nearby lymph nodes. III: Cancer in the lung and lymph nodes in the middle of the chest. Stage III has two subtypes, IIIA (cancer has spread only to lymph nodes on the same side of the chest where the cancer started) and IIIB (cancer has spread to the lymph nodes on the opposite side of the chest, or above the collar bone). IV: Cancer has spread to both lungs, to fluid in the area around the lungs, or to another part of the body.|Participants|Count of Participants|333|333.0||||||
3972741|NCT01285609|3794988|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3972742|NCT01285609|3794989|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3972718|NCT01285609|3794989|B1||Stage IV|Disease Stage at Study Entry|Non-Small Cell Lung Cancer is categorized in 4 Stages (I-IV). I: Cancer located only in lungs and has not spread to any lymph nodes. II: Cancer in the lung and nearby lymph nodes. III: Cancer in the lung and lymph nodes in the middle of the chest. Stage III has two subtypes, IIIA (cancer has spread only to lymph nodes on the same side of the chest where the cancer started) and IIIB (cancer has spread to the lymph nodes on the opposite side of the chest, or above the collar bone). IV: Cancer has spread to both lungs, to fluid in the area around the lungs, or to another part of the body.|Participants|Count of Participants|367|367.0||||||
3972719|NCT01285609|3794987|B3||3|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all pre-disease performance without restriction and (worst score) 5=death.|Participants|Count of Participants|1|1.0||||||
3972720|NCT01285609|3794988|B2||3|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all pre-disease performance without restriction and (worst score) 5=death.|Participants|Count of Participants|0|0.0||||||
3972721|NCT01285609|3794989|B1||3|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all pre-disease performance without restriction and (worst score) 5=death.|Participants|Count of Participants|1|1.0||||||
3972722|NCT01285609|3794987|B3||2|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all pre-disease performance without restriction and (worst score) 5=death.|Participants|Count of Participants|4|4.0||||||
3972723|NCT01285609|3794988|B2||2|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all pre-disease performance without restriction and (worst score) 5=death.|Participants|Count of Participants|3|3.0||||||
3972724|NCT01285609|3794989|B1||2|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all pre-disease performance without restriction and (worst score) 5=death.|Participants|Count of Participants|1|1.0||||||
3972725|NCT01285609|3794987|B3||1|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all pre-disease performance without restriction and (worst score) 5=death.|Participants|Count of Participants|485|485.0||||||
3972726|NCT01285609|3794988|B2||1|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all pre-disease performance without restriction and (worst score) 5=death.|Participants|Count of Participants|234|234.0||||||
3972727|NCT01285609|3794989|B1||1|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all pre-disease performance without restriction and (worst score) 5=death.|Participants|Count of Participants|251|251.0||||||
3972728|NCT01285609|3794987|B3||0|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all pre-disease performance without restriction and (worst score) 5=death.|Participants|Count of Participants|259|259.0||||||
3972729|NCT01285609|3794988|B2||0|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all pre-disease performance without restriction and (worst score) 5=death.|Participants|Count of Participants|124|124.0||||||
3972730|NCT01285609|3794989|B1||0|Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a 6-item scale used to assess disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all pre-disease performance without restriction and (worst score) 5=death.|Participants|Count of Participants|135|135.0||||||
3972731|NCT01285609|3794987|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3972732|NCT01285609|3794988|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3972733|NCT01285609|3794989|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3972734|NCT01285609|3794987|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3972735|NCT01285609|3794988|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3972736|NCT01285609|3794989|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3972737|NCT01285609|3794987|B3||White|Race (NIH/OMB)||Participants|Count of Participants|519|519.0||||||
3972738|NCT01285609|3794988|B2||White|Race (NIH/OMB)||Participants|Count of Participants|243|243.0||||||
3972739|NCT01285609|3794989|B1||White|Race (NIH/OMB)||Participants|Count of Participants|276|276.0||||||
3972740|NCT01285609|3794987|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3972743|NCT01285609|3794987|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3972744|NCT01285609|3794988|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3972745|NCT01285609|3794989|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3972746|NCT01285609|3794987|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|214|214.0||||||
3972747|NCT01285609|3794988|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
3972748|NCT01285609|3794989|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
3972749|NCT01285609|3794987|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3972750|NCT01285609|3794988|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3972751|NCT01285609|3794989|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3972752|NCT01285609|3794987|B3||Male|Sex: Female, Male||Participants|Count of Participants|635|635.0||||||
3972753|NCT01285609|3794988|B2||Male|Sex: Female, Male||Participants|Count of Participants|309|309.0||||||
3972754|NCT01285609|3794989|B1||Male|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
3972755|NCT01285609|3794987|B3||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3972756|NCT01285609|3794988|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3972757|NCT01285609|3794989|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3972758|NCT01285609|3794987|B3|||Age||years|Mean|63.7|63.7|Standard Deviation|8.47|8.47|||
3972759|NCT01285609|3794988|B2|||Age||years|Mean|63.7|63.7|Standard Deviation|8.70|8.7|||
3972760|NCT01285609|3794989|B1|||Age||years|Mean|63.7|63.7|Standard Deviation|8.27|8.27|||
3972761|NCT01285518|3795000|B9||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3972762|NCT01285518|3795001|B8||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3972763|NCT01285518|3795002|B7||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3972764|NCT01285518|3795003|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3972765|NCT01285518|3795004|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3972766|NCT01285518|3795005|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3972767|NCT01285518|3795006|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3972768|NCT01285518|3795007|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3972769|NCT01285518|3795008|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3972770|NCT01285518|3795000|B9||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3972771|NCT01285518|3795001|B8||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3972772|NCT01285518|3795002|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3972773|NCT01285518|3795003|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3972774|NCT01285518|3795004|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3972775|NCT01285518|3795005|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3972776|NCT01285518|3795006|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3972777|NCT01285518|3795007|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3972778|NCT01285518|3795008|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3972779|NCT01285518|3795000|B9|||Age||years|Mean|55.5|55.5|Standard Deviation|6.8|6.8|||
3972780|NCT01285518|3795001|B8|||Age||years|Mean|52.9|52.9|Standard Deviation|6.8|6.8|||
3972781|NCT01285518|3795002|B7|||Age||years|Mean|57.2|57.2|Standard Deviation|5.7|5.7|||
3972782|NCT01285518|3795003|B6|||Age||years|Mean|55.2|55.2|Standard Deviation|7.3|7.3|||
3972783|NCT01285518|3795004|B5|||Age||years|Mean|54.5|54.5|Standard Deviation|8.6|8.6|||
3972784|NCT01285518|3795005|B4|||Age||years|Mean|53.3|53.3|Standard Deviation|8.2|8.2|||
3972785|NCT01285518|3795006|B3|||Age||years|Mean|53.8|53.8|Standard Deviation|7.2|7.2|||
3972786|NCT01285518|3795007|B2|||Age||years|Mean|58.4|58.4|Standard Deviation|3.9|3.9|||
3972787|NCT01285518|3795008|B1|||Age||years|Mean|59.4|59.4|Standard Deviation|4.1|4.1|||
3972788|NCT01285492|3795273|B3|||Baseline Body Mass Index||kg/m^2|Mean|22.49|22.49|Standard Deviation|3.037|3.037|||
3972789|NCT01285492|3795274|B2|||Baseline Body Mass Index||kg/m^2|Mean|23.02|23.02|Standard Deviation|2.919|2.919|||
3972790|NCT01285492|3795275|B1|||Baseline Body Mass Index||kg/m^2|Mean|22.31|22.31|Standard Deviation|3.067|3.067|||
3972791|NCT01285492|3795273|B3|||Baseline Height||cm|Mean|164.1|164.1|Standard Deviation|6.91|6.91|||
3972792|NCT01285492|3795274|B2|||Baseline Height||cm|Mean|163.3|163.3|Standard Deviation|6.38|6.38|||
3972793|NCT01285492|3795275|B1|||Baseline Height||cm|Mean|164.4|164.4|Standard Deviation|7.08|7.08|||
3972794|NCT01285492|3795273|B3|||Baseline Weight||kg|Mean|60.64|60.64|Standard Deviation|9.400|9.4|||
3972795|NCT01285492|3795274|B2|||Baseline Weight||kg|Mean|61.44|61.44|Standard Deviation|8.788|8.788|||
3972796|NCT01285492|3795275|B1|||Baseline Weight||kg|Mean|60.38|60.38|Standard Deviation|9.613|9.613|||
3972797|NCT01285492|3795273|B3||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3972798|NCT01285492|3795274|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3972799|NCT01285492|3795275|B1||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3972800|NCT01285492|3795273|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3972801|NCT01285492|3795274|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3972802|NCT01285492|3795275|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3972803|NCT01285492|3795273|B3|||Age||years|Mean|69.3|69.3|Standard Deviation|6.80|6.8|||
3972804|NCT01285492|3795274|B2|||Age||years|Mean|69.4|69.4|Standard Deviation|6.90|6.9|||
3972805|NCT01285492|3795275|B1|||Age||years|Mean|69.3|69.3|Standard Deviation|6.79|6.79|||
3972806|NCT01285427|3795294|B1|||de-identified whole blood samples||participants|Number|300|300.0||||||
3972807|NCT01285427|3795294|B1||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Not Applicable, De-identified leftover blood samples
3972808|NCT01285427|3795294|B1||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Not Applicable, De-identified leftover blood samples
3972809|NCT01285427|3795294|B1|||Age||years|Mean|NA||Standard Deviation|NA||||Not Applicable, de-identified leftover blood samples
3972810|NCT01285427|3795294|B1||>=65 years|Age||Participants|Count of Participants|NA|||||||Not Applicable, De-identified whole blood samples
3972811|NCT01285427|3795294|B1||Between 18 and 65 years|Age||Participants|Count of Participants|NA|||||||Not Applicable, De-identified whole blood samples
3972812|NCT01285427|3795294|B1||<=18 years|Age||Participants|Count of Participants|NA|||||||Not Applicable, De-identified leftover blood samples
3972813|NCT01285401|3795306|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3972814|NCT01285401|3795307|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3972815|NCT01285401|3795308|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3972816|NCT01285401|3795306|B3||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3972817|NCT01285401|3795307|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3972818|NCT01285401|3795308|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3972819|NCT01285401|3795306|B3|||Age||years|Mean|33.9|33.9|Standard Deviation|8.8|8.8|||
3972820|NCT01285401|3795307|B2|||Age||years|Mean|33.6|33.6|Standard Deviation|9.3|9.3|||
3972821|NCT01285401|3795308|B1|||Age||years|Mean|34.2|34.2|Standard Deviation|8.1|8.1|||
3972822|NCT01285323|3795347|B3|||Number of Short-Acting Beta-Agonist Puffs (SABA) Daily|Based on patient-reported total number of SABA puffs over the past 3 days. N=201, 204, 405|puffs/day|Mean|2.8|2.8|Standard Deviation|2.62|2.62|||
3972823|NCT01285323|3795348|B2|||Number of Short-Acting Beta-Agonist Puffs (SABA) Daily|Based on patient-reported total number of SABA puffs over the past 3 days. N=201, 204, 405|puffs/day|Mean|2.9|2.9|Standard Deviation|2.82|2.82|||
3972824|NCT01285323|3795349|B1|||Number of Short-Acting Beta-Agonist Puffs (SABA) Daily|Based on patient-reported total number of SABA puffs over the past 3 days. N=201, 204, 405|puffs/day|Mean|2.7|2.7|Standard Deviation|2.41|2.41|||
3972825|NCT01285323|3795347|B3|||Blood Eosinophil Count||10^9 blood eosinophil/L|Mean|0.649|0.649|Standard Deviation|0.5642|0.5642|||
3972826|NCT01285323|3795348|B2|||Blood Eosinophil Count||10^9 blood eosinophil/L|Mean|0.610|0.61|Standard Deviation|0.4115|0.4115|||
3972827|NCT01285323|3795349|B1|||Blood Eosinophil Count||10^9 blood eosinophil/L|Mean|0.688|0.688|Standard Deviation|0.6824|0.6824|||
3972828|NCT01285323|3795347|B3|||Asthma Symptom Utility Index (ASUI)|The ASUI is an 11-item instrument designed to assess the frequency and severity of asthma symptoms and side effects, weighted by patient preferences (Revicki et al 1998). ASUI is a utility score that ranges from 0 to 1, with higher values indicating better asthma control.|units on a scale|Mean|0.656|0.656|Standard Deviation|0.1961|0.1961|||
3972829|NCT01285323|3795348|B2|||Asthma Symptom Utility Index (ASUI)|The ASUI is an 11-item instrument designed to assess the frequency and severity of asthma symptoms and side effects, weighted by patient preferences (Revicki et al 1998). ASUI is a utility score that ranges from 0 to 1, with higher values indicating better asthma control.|units on a scale|Mean|0.664|0.664|Standard Deviation|0.2005|0.2005|||
3972830|NCT01285323|3795349|B1|||Asthma Symptom Utility Index (ASUI)|The ASUI is an 11-item instrument designed to assess the frequency and severity of asthma symptoms and side effects, weighted by patient preferences (Revicki et al 1998). ASUI is a utility score that ranges from 0 to 1, with higher values indicating better asthma control.|units on a scale|Mean|0.649|0.649|Standard Deviation|0.1919|0.1919|||
3972831|NCT01285323|3795347|B3|||Asthma Quality of Life Questionnaire (AQLQ)|The AQLQ is a 32-item instrument administered as a self-assessment (Juniper et al 1992). The questionnaire is divided into 4 domains: activity limitation, symptoms, emotional function, and environmental stimuli. Patients were asked to recall their experiences during the last 2 weeks and to respond to each question on a 7-point scale (1=severe impairment, 7=no impairment). The overall AQLQ score is the mean of all 32 responses.|units on a scale|Mean|4.287|4.287|Standard Deviation|1.0521|1.0521|||
3972832|NCT01285323|3795348|B2|||Asthma Quality of Life Questionnaire (AQLQ)|The AQLQ is a 32-item instrument administered as a self-assessment (Juniper et al 1992). The questionnaire is divided into 4 domains: activity limitation, symptoms, emotional function, and environmental stimuli. Patients were asked to recall their experiences during the last 2 weeks and to respond to each question on a 7-point scale (1=severe impairment, 7=no impairment). The overall AQLQ score is the mean of all 32 responses.|units on a scale|Mean|4.352|4.352|Standard Deviation|1.0220|1.022|||
3972833|NCT01285323|3795349|B1|||Asthma Quality of Life Questionnaire (AQLQ)|The AQLQ is a 32-item instrument administered as a self-assessment (Juniper et al 1992). The questionnaire is divided into 4 domains: activity limitation, symptoms, emotional function, and environmental stimuli. Patients were asked to recall their experiences during the last 2 weeks and to respond to each question on a 7-point scale (1=severe impairment, 7=no impairment). The overall AQLQ score is the mean of all 32 responses.|units on a scale|Mean|4.223|4.223|Standard Deviation|1.0794|1.0794|||
3972834|NCT01285323|3795347|B3|||Asthma Control Questionnaire (ACQ)|The ACQ is a 7-item instrument that measures asthma control (Juniper et al 1999). Six questions are self-assessments; the seventh item, completed by a member of the study staff, is the result of the patient's FEV1 measurement. Each item has 7 possible answers on a scale of 0 to 6, and the overall score is the mean of all responses. A higher score is an indication of poorer asthma control.|units on a scale|Mean|2.587|2.587|Standard Deviation|0.84|0.84|||
3972835|NCT01285323|3795348|B2|||Asthma Control Questionnaire (ACQ)|The ACQ is a 7-item instrument that measures asthma control (Juniper et al 1999). Six questions are self-assessments; the seventh item, completed by a member of the study staff, is the result of the patient's FEV1 measurement. Each item has 7 possible answers on a scale of 0 to 6, and the overall score is the mean of all responses. A higher score is an indication of poorer asthma control.|units on a scale|Mean|2.570|2.57|Standard Deviation|0.89|0.89|||
3972836|NCT01285323|3795349|B1|||Asthma Control Questionnaire (ACQ)|The ACQ is a 7-item instrument that measures asthma control (Juniper et al 1999). Six questions are self-assessments; the seventh item, completed by a member of the study staff, is the result of the patient's FEV1 measurement. Each item has 7 possible answers on a scale of 0 to 6, and the overall score is the mean of all responses. A higher score is an indication of poorer asthma control.|units on a scale|Mean|2.605|2.605|Standard Deviation|0.79|0.79|||
3972837|NCT01285323|3795347|B3|||Forced Expiratory Volume in 1 Second (FEV1)||liters|Mean|2.066|2.066|Standard Deviation|0.7307|0.7307|||
3972838|NCT01285323|3795348|B2|||Forced Expiratory Volume in 1 Second (FEV1)||liters|Mean|2.129|2.129|Standard Deviation|0.7848|0.7848|||
3972839|NCT01285323|3795349|B1|||Forced Expiratory Volume in 1 Second (FEV1)||liters|Mean|2.004|2.004|Standard Deviation|0.6682|0.6682|||
3972840|NCT01285323|3795347|B3|||Asthma exacerbations in the previous 12 months|One Reslizumab participant reported no asthma exacerbations in the past 12 months.|exacerbations|Mean|1.9|1.9|Standard Deviation|1.68|1.68|||
3972841|NCT01285323|3795348|B2|||Asthma exacerbations in the previous 12 months|One Reslizumab participant reported no asthma exacerbations in the past 12 months.|exacerbations|Mean|1.9|1.9|Standard Deviation|1.58|1.58|||
3972842|NCT01285323|3795349|B1|||Asthma exacerbations in the previous 12 months|One Reslizumab participant reported no asthma exacerbations in the past 12 months.|exacerbations|Mean|2.0|2.0|Standard Deviation|1.78|1.78|||
3972843|NCT01285323|3795347|B3|No||Participants in the United States|This was a stratification factor as reported by the interactive response technology (IRT).|participants|Number|433|433.0||||||
3972844|NCT01285323|3795348|B2|No||Participants in the United States|This was a stratification factor as reported by the interactive response technology (IRT).|participants|Number|216|216.0||||||
3972845|NCT01285323|3795349|B1|No||Participants in the United States|This was a stratification factor as reported by the interactive response technology (IRT).|participants|Number|217|217.0||||||
3972846|NCT01285323|3795347|B3|Yes||Participants in the United States|This was a stratification factor as reported by the interactive response technology (IRT).|participants|Number|31|31.0||||||
3972847|NCT01285323|3795348|B2|Yes||Participants in the United States|This was a stratification factor as reported by the interactive response technology (IRT).|participants|Number|16|16.0||||||
3972848|NCT01285323|3795349|B1|Yes||Participants in the United States|This was a stratification factor as reported by the interactive response technology (IRT).|participants|Number|15|15.0||||||
3972849|NCT01285323|3795347|B3|No||Oral Corticosteroid Use at Baseline|Participants who were taking oral corticosteroids at baseline as recorded by interactive response technology. This was a stratification factor.|participants|Number|410|410.0||||||
3972850|NCT01285323|3795348|B2|No||Oral Corticosteroid Use at Baseline|Participants who were taking oral corticosteroids at baseline as recorded by interactive response technology. This was a stratification factor.|participants|Number|205|205.0||||||
3972851|NCT01285323|3795349|B1|No||Oral Corticosteroid Use at Baseline|Participants who were taking oral corticosteroids at baseline as recorded by interactive response technology. This was a stratification factor.|participants|Number|205|205.0||||||
3972852|NCT01285323|3795347|B3|Yes||Oral Corticosteroid Use at Baseline|Participants who were taking oral corticosteroids at baseline as recorded by interactive response technology. This was a stratification factor.|participants|Number|54|54.0||||||
3972853|NCT01285323|3795348|B2|Yes||Oral Corticosteroid Use at Baseline|Participants who were taking oral corticosteroids at baseline as recorded by interactive response technology. This was a stratification factor.|participants|Number|27|27.0||||||
3972854|NCT01285323|3795349|B1|Yes||Oral Corticosteroid Use at Baseline|Participants who were taking oral corticosteroids at baseline as recorded by interactive response technology. This was a stratification factor.|participants|Number|27|27.0||||||
3972855|NCT01285323|3795347|B3|||Body Mass Index||kg/m^2|Mean|27|27.0|Standard Deviation|5.15|5.15|||
3972856|NCT01285323|3795348|B2|||Body Mass Index||kg/m^2|Mean|27|27.0|Standard Deviation|5.26|5.26|||
3972857|NCT01285323|3795349|B1|||Body Mass Index||kg/m^2|Mean|27|27.0|Standard Deviation|5.05|5.05|||
3972858|NCT01285323|3795347|B3|||Height||cm|Mean|165.8|165.8|Standard Deviation|9.69|9.69|||
3972859|NCT01285323|3795348|B2|||Height||cm|Mean|166.4|166.4|Standard Deviation|9.56|9.56|||
3972860|NCT01285323|3795349|B1|||Height||cm|Mean|165.2|165.2|Standard Deviation|9.81|9.81|||
3972861|NCT01285323|3795347|B3|||Weight||kg|Mean|74.3|74.3|Standard Deviation|15.81|15.81|||
3972862|NCT01285323|3795348|B2|||Weight||kg|Mean|74.7|74.7|Standard Deviation|15.72|15.72|||
3972863|NCT01285323|3795349|B1|||Weight||kg|Mean|73.9|73.9|Standard Deviation|15.93|15.93|||
3972864|NCT01285323|3795347|B3|Other||Race||participants|Number|68|68.0||||||
3972865|NCT01285323|3795348|B2|Other||Race||participants|Number|35|35.0||||||
3972866|NCT01285323|3795349|B1|Other||Race||participants|Number|33|33.0||||||
3972867|NCT01285323|3795347|B3|Pacific Islander||Race||participants|Number|1|1.0||||||
3972868|NCT01285323|3795348|B2|Pacific Islander||Race||participants|Number|0|0.0||||||
3972869|NCT01285323|3795349|B1|Pacific Islander||Race||participants|Number|1|1.0||||||
3972870|NCT01285323|3795347|B3|American Indian or Alaskan Native||Race||participants|Number|11|11.0||||||
3972871|NCT01285323|3795348|B2|American Indian or Alaskan Native||Race||participants|Number|7|7.0||||||
3972872|NCT01285323|3795349|B1|American Indian or Alaskan Native||Race||participants|Number|4|4.0||||||
3972873|NCT01285323|3795347|B3|Asian||Race||participants|Number|37|37.0||||||
3972874|NCT01285323|3795348|B2|Asian||Race||participants|Number|16|16.0||||||
3972875|NCT01285323|3795349|B1|Asian||Race||participants|Number|21|21.0||||||
3972876|NCT01285323|3795347|B3|Black||Race||participants|Number|10|10.0||||||
3972877|NCT01285323|3795348|B2|Black||Race||participants|Number|6|6.0||||||
3972878|NCT01285323|3795349|B1|Black||Race||participants|Number|4|4.0||||||
3972879|NCT01285323|3795347|B3|White||Race||participants|Number|337|337.0||||||
3972880|NCT01285323|3795348|B2|White||Race||participants|Number|168|168.0||||||
3972881|NCT01285323|3795349|B1|White||Race||participants|Number|169|169.0||||||
3972882|NCT01285323|3795347|B3||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
3972883|NCT01285323|3795348|B2||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3972884|NCT01285323|3795349|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3972885|NCT01285323|3795347|B3||Female|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
3972886|NCT01285323|3795348|B2||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3972887|NCT01285323|3795349|B1||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3972888|NCT01285323|3795347|B3|||Age||years|Mean|47.0|47.0|Standard Deviation|13.76|13.76|||
3972889|NCT01285323|3795348|B2|||Age||years|Mean|46.4|46.4|Standard Deviation|13.79|13.79|||
3972890|NCT01285323|3795349|B1|||Age||years|Mean|47.5|47.5|Standard Deviation|13.75|13.75|||
3972891|NCT01285310|3795382|B4|||Duration of Rheumatoid Arthritis Diagnosis||years|Mean|9.41|9.41|Standard Deviation|9.351|9.351|||
3972892|NCT01285310|3795383|B3|||Duration of Rheumatoid Arthritis Diagnosis||years|Mean|7.76|7.76|Standard Deviation|7.833|7.833|||
3972893|NCT01285310|3795384|B2|||Duration of Rheumatoid Arthritis Diagnosis||years|Mean|8.46|8.46|Standard Deviation|6.856|6.856|||
3972894|NCT01285310|3795385|B1|||Duration of Rheumatoid Arthritis Diagnosis||years|Mean|11.98|11.98|Standard Deviation|12.104|12.104|||
3972895|NCT01285310|3795382|B4||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3972896|NCT01285310|3795383|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3972897|NCT01285310|3795384|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3972898|NCT01285310|3795385|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3972899|NCT01285310|3795382|B4||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3972900|NCT01285310|3795383|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3972901|NCT01285310|3795384|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3972902|NCT01285310|3795385|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3972903|NCT01285310|3795382|B4|||Age||years|Mean|56.0|56.0|Standard Deviation|12.26|12.26|||
3972904|NCT01285310|3795383|B3|||Age||years|Mean|52.6|52.6|Standard Deviation|11.87|11.87|||
3972905|NCT01285310|3795384|B2|||Age||years|Mean|58.6|58.6|Standard Deviation|11.84|11.84|||
3972906|NCT01285310|3795385|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|12.45|12.45|||
3972907|NCT01285076|3795622|B1||Male|Sex: Female, Male||Participants|Count of Participants|472|472.0||||||
3972908|NCT01285076|3795622|B1||Female|Sex: Female, Male||Participants|Count of Participants|362|362.0||||||
3972909|NCT01285076|3795622|B1|||Age||years|Mean|65.1|65.1|Standard Deviation|12.0|12.0|||
3972910|NCT01285050|3795635|B1|||HCV infected||participants|Number|20|20.0||||||
3972911|NCT01285050|3795635|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3972912|NCT01285050|3795635|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3972913|NCT01285050|3795635|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3972914|NCT01285050|3795635|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3972915|NCT01285050|3795635|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3972916|NCT01285024|3795640|B3|||BMI||kg/m^2|Mean|31.5|31.5|Standard Deviation|7.0|7.0|||
3972917|NCT01285024|3795641|B2|||BMI||kg/m^2|Mean|32.6|32.6|Standard Deviation|7.0|7.0|||
3972918|NCT01285024|3795642|B1|||BMI||kg/m^2|Mean|30.1|30.1|Standard Deviation|6.7|6.7|||
3972919|NCT01285024|3795640|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3972920|NCT01285024|3795641|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3972921|NCT01285024|3795642|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3972922|NCT01285024|3795640|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3972923|NCT01285024|3795641|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3972924|NCT01285024|3795642|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3972925|NCT01285024|3795640|B3|||Age||years|Mean|58.0|58.0|Standard Deviation|10.7|10.7|||
3972926|NCT01285024|3795641|B2|||Age||years|Mean|58.2|58.2|Standard Deviation|11.8|11.8|||
3972927|NCT01285024|3795642|B1|||Age||years|Mean|57.9|57.9|Standard Deviation|9.4|9.4|||
3972928|NCT01284959|3795651|B4|Korea, Republic of||Region of Enrollment||participants|Number|34|34.0||||||
3972929|NCT01284959|3795652|B3|Korea, Republic of||Region of Enrollment||participants|Number|11|11.0||||||
3972930|NCT01284959|3795653|B2|Korea, Republic of||Region of Enrollment||participants|Number|12|12.0||||||
3972931|NCT01284959|3795654|B1|Korea, Republic of||Region of Enrollment||participants|Number|11|11.0||||||
3972932|NCT01284959|3795651|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3972933|NCT01284959|3795652|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3972934|NCT01284959|3795653|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3972935|NCT01284959|3795654|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3972936|NCT01284959|3795651|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3972937|NCT01284959|3795652|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3972938|NCT01284959|3795653|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3972939|NCT01284959|3795654|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3972940|NCT01284959|3795651|B4|||Age||years|Mean|28.97|28.97|Standard Deviation|2.85|2.85|||
3972941|NCT01284959|3795652|B3|||Age||years|Mean|30.60|30.6|Standard Deviation|3.27|3.27|||
3972942|NCT01284959|3795653|B2|||Age||years|Mean|28.08|28.08|Standard Deviation|2.23|2.23|||
3972943|NCT01284959|3795654|B1|||Age||years|Mean|28.40|28.4|Standard Deviation|2.59|2.59|||
3972944|NCT01284959|3795651|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3972945|NCT01284959|3795652|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3972946|NCT01284959|3795653|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3972947|NCT01284959|3795654|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3972948|NCT01284959|3795651|B4||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3972949|NCT01284959|3795652|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3972950|NCT01284959|3795653|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3972951|NCT01284959|3795654|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3972952|NCT01284959|3795651|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3972953|NCT01284959|3795652|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3972954|NCT01284959|3795653|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3972955|NCT01284959|3795654|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3972956|NCT01284634|3795682|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3972957|NCT01284634|3795683|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3972958|NCT01284634|3795684|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3972959|NCT01284634|3795685|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3972960|NCT01284634|3795686|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3972961|NCT01284634|3795682|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3972962|NCT01284634|3795683|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3972963|NCT01284634|3795684|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3972964|NCT01284634|3795685|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3972965|NCT01284634|3795686|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3972966|NCT01284634|3795682|B5|||Age||years|Mean|46.39|46.39|Standard Deviation|13.29|13.29|||
3972967|NCT01284634|3795683|B4|||Age||years|Mean|50.41|50.41|Standard Deviation|18.41|18.41|||
3972968|NCT01284634|3795684|B3|||Age||years|Mean|46.90|46.9|Standard Deviation|12.57|12.57|||
3972969|NCT01284634|3795685|B2|||Age||years|Mean|49.08|49.08|Standard Deviation|7.72|7.72|||
3972970|NCT01284634|3795686|B1|||Age||years|Mean|40.69|40.69|Standard Deviation|14.62|14.62|||
3972971|NCT01284621|3795719|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3972972|NCT01284621|3795719|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3972973|NCT01284621|3795719|B1|||Age||years|Mean|38.0|38.0|Standard Deviation|11.3|11.3|||
3972974|NCT01284517|3795766|B3|India||Region of Enrollment||participants|Number|42|42.0||||||
3972975|NCT01284517|3795767|B2|India||Region of Enrollment||participants|Number|22|22.0||||||
3972976|NCT01284517|3795768|B1|India||Region of Enrollment||participants|Number|20|20.0||||||
3972977|NCT01284517|3795766|B3|Japan||Region of Enrollment||participants|Number|9|9.0||||||
3972978|NCT01284517|3795767|B2|Japan||Region of Enrollment||participants|Number|4|4.0||||||
3972979|NCT01284517|3795768|B1|Japan||Region of Enrollment||participants|Number|5|5.0||||||
3972980|NCT01284517|3795766|B3|Colombia||Region of Enrollment||participants|Number|22|22.0||||||
3972981|NCT01284517|3795767|B2|Colombia||Region of Enrollment||participants|Number|10|10.0||||||
3972982|NCT01284517|3795768|B1|Colombia||Region of Enrollment||participants|Number|12|12.0||||||
3972983|NCT01284517|3795766|B3|Peru||Region of Enrollment||participants|Number|13|13.0||||||
3972984|NCT01284517|3795767|B2|Peru||Region of Enrollment||participants|Number|7|7.0||||||
3972985|NCT01284517|3795768|B1|Peru||Region of Enrollment||participants|Number|6|6.0||||||
3972986|NCT01284517|3795766|B3|Lithuania||Region of Enrollment||participants|Number|19|19.0||||||
3972987|NCT01284517|3795767|B2|Lithuania||Region of Enrollment||participants|Number|9|9.0||||||
3972988|NCT01284517|3795768|B1|Lithuania||Region of Enrollment||participants|Number|10|10.0||||||
3972989|NCT01284517|3795766|B3|Ukraine||Region of Enrollment||participants|Number|31|31.0||||||
3972990|NCT01284517|3795767|B2|Ukraine||Region of Enrollment||participants|Number|14|14.0||||||
3972991|NCT01284517|3795768|B1|Ukraine||Region of Enrollment||participants|Number|17|17.0||||||
3972992|NCT01284517|3795766|B3|Canada||Region of Enrollment||participants|Number|17|17.0||||||
3972993|NCT01284517|3795767|B2|Canada||Region of Enrollment||participants|Number|8|8.0||||||
3972994|NCT01284517|3795768|B1|Canada||Region of Enrollment||participants|Number|9|9.0||||||
3972995|NCT01284517|3795766|B3|Slovakia||Region of Enrollment||participants|Number|38|38.0||||||
3972996|NCT01284517|3795767|B2|Slovakia||Region of Enrollment||participants|Number|21|21.0||||||
3972997|NCT01284517|3795768|B1|Slovakia||Region of Enrollment||participants|Number|17|17.0||||||
3972998|NCT01284517|3795766|B3|Czech Republic||Region of Enrollment||participants|Number|17|17.0||||||
3972999|NCT01284517|3795767|B2|Czech Republic||Region of Enrollment||participants|Number|8|8.0||||||
3973000|NCT01284517|3795768|B1|Czech Republic||Region of Enrollment||participants|Number|9|9.0||||||
3973001|NCT01284517|3795766|B3|United States||Region of Enrollment||participants|Number|134|134.0||||||
3973002|NCT01284517|3795767|B2|United States||Region of Enrollment||participants|Number|63|63.0||||||
3973003|NCT01284517|3795768|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
3973004|NCT01284517|3795766|B3||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3973005|NCT01284517|3795767|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3973006|NCT01284517|3795768|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3973007|NCT01284517|3795766|B3||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3973008|NCT01284517|3795767|B2||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3973009|NCT01284517|3795768|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3973010|NCT01284517|3795766|B3|||Age||years|Mean|43.6|43.6|Standard Deviation|11.94|11.94|||
3973011|NCT01284517|3795767|B2|||Age||years|Mean|44.1|44.1|Standard Deviation|11.99|11.99|||
3973012|NCT01284517|3795768|B1|||Age||years|Mean|43.1|43.1|Standard Deviation|11.90|11.9|||
3973013|NCT01284517|3795766|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3973014|NCT01284517|3795767|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3973015|NCT01284517|3795768|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3973016|NCT01284517|3795766|B3||Between 18 and 65 years|Age||Participants|Count of Participants|327|327.0||||||
3973017|NCT01284517|3795767|B2||Between 18 and 65 years|Age||Participants|Count of Participants|161|161.0||||||
3973018|NCT01284517|3795768|B1||Between 18 and 65 years|Age||Participants|Count of Participants|166|166.0||||||
3973019|NCT01284517|3795766|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3973020|NCT01284517|3795767|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3973021|NCT01284517|3795768|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3973022|NCT01284504|3795779|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3973023|NCT01284504|3795781|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3973024|NCT01284504|3795779|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3973025|NCT01284504|3795781|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3973026|NCT01284504|3795779|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3973027|NCT01284504|3795781|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3973028|NCT01284504|3795779|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3973029|NCT01284504|3795781|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3973030|NCT01284504|3795779|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3973031|NCT01284504|3795781|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3973032|NCT01284504|3795779|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3973033|NCT01284504|3795781|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3973034|NCT01284504|3795779|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3973035|NCT01284504|3795781|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3973036|NCT01284504|3795779|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3973037|NCT01284504|3795781|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3973038|NCT01284504|3795779|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3973039|NCT01284504|3795781|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3973040|NCT01284504|3795779|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3973041|NCT01284504|3795781|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3973042|NCT01284504|3795779|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3973043|NCT01284504|3795781|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3973044|NCT01284504|3795779|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3973045|NCT01284504|3795781|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3973046|NCT01284504|3795779|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3973047|NCT01284504|3795781|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3973048|NCT01284491|3795792|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3973049|NCT01284491|3795792|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3973050|NCT01284491|3795792|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3973051|NCT01284491|3795792|B1|18 to 70 years||Age, Customized|An integrity audit found that the data for this study could not be analyzed owing to unverifiable source documentation. The protocol-specified age range is used for this baseline measure.|participants|Number|13|13.0||||||
3973052|NCT01284426|3795798|B1|Thailand||Region of Enrollment||participants|Number|92|92.0||||||
3973053|NCT01284426|3795798|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3973054|NCT01284426|3795798|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3973055|NCT01284426|3795798|B1|||Age|Children 4-15 years of age|Years|Median|8.4|8.4|Full Range|||4.0|15.5|
3973056|NCT01284361|3795802|B1|United States||Region of Enrollment||participants|Number|82|82.0||||||
3973057|NCT01284361|3795802|B1||Male|Gender||Participants|Count of Participants|82|82.0||||||
3973058|NCT01284361|3795802|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
3973059|NCT01284361|3795802|B1|||Age||years|Mean|38.3|38.3|Standard Deviation|11.7|11.7|||
3973060|NCT01284361|3795802|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3973061|NCT01284361|3795802|B1||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
3973062|NCT01284361|3795802|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3973063|NCT01284335|3795809|B14|United States||Region of Enrollment||Participants|Count of Participants|234|234.0||||||
3973064|NCT01284335|3795810|B13|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3973065|NCT01284335|3795811|B12|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3973066|NCT01284335|3795812|B11|United States||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
3973067|NCT01284335|3795813|B10|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3973068|NCT01284335|3795814|B9|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3973069|NCT01284335|3795815|B8|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3973070|NCT01284335|3795816|B7|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3973071|NCT01284335|3795817|B6|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3973072|NCT01284335|3795818|B5|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3973073|NCT01284335|3795819|B4|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3973074|NCT01284335|3795820|B3|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3973075|NCT01284335|3795821|B2|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3973076|NCT01284335|3795822|B1|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3973077|NCT01284335|3795809|B14|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3973078|NCT01284335|3795810|B13|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3973079|NCT01284335|3795811|B12|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3973080|NCT01284335|3795812|B11|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3973081|NCT01284335|3795813|B10|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3973082|NCT01284335|3795814|B9|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3973083|NCT01284335|3795815|B8|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3973084|NCT01284335|3795816|B7|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3973085|NCT01284335|3795817|B6|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3973086|NCT01284335|3795818|B5|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3973087|NCT01284335|3795819|B4|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3973088|NCT01284335|3795820|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3973089|NCT01284335|3795821|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3973090|NCT01284335|3795822|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3973091|NCT01284335|3795809|B14|West Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3973092|NCT01284335|3795810|B13|West Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3973093|NCT01284335|3795811|B12|West Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3973094|NCT01284335|3795812|B11|West Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3973095|NCT01284335|3795813|B10|West Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3973096|NCT01284335|3795814|B9|West Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3973097|NCT01284335|3795815|B8|West Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3973098|NCT01284335|3795816|B7|West Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3973099|NCT01284335|3795817|B6|West Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3973100|NCT01284335|3795818|B5|West Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3973101|NCT01284335|3795819|B4|West Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3973102|NCT01284335|3795820|B3|West Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3973103|NCT01284335|3795821|B2|West Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3973104|NCT01284335|3795822|B1|West Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3973105|NCT01284335|3795809|B14|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3973106|NCT01284335|3795810|B13|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3973107|NCT01284335|3795811|B12|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3973108|NCT01284335|3795812|B11|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3973109|NCT01284335|3795813|B10|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3973110|NCT01284335|3795814|B9|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3973111|NCT01284335|3795815|B8|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3973112|NCT01284335|3795816|B7|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3973113|NCT01284335|3795817|B6|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3973114|NCT01284335|3795818|B5|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3973115|NCT01284335|3795819|B4|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3973116|NCT01284335|3795820|B3|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3973117|NCT01284335|3795821|B2|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3973118|NCT01284335|3795822|B1|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3973119|NCT01284335|3795809|B14|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|197|197.0||||||
3973120|NCT01284335|3795810|B13|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3973121|NCT01284335|3795811|B12|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3973122|NCT01284335|3795812|B11|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3973123|NCT01284335|3795813|B10|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3973124|NCT01284335|3795814|B9|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3973125|NCT01284335|3795815|B8|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3973126|NCT01284335|3795816|B7|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3973127|NCT01284335|3795817|B6|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3973128|NCT01284335|3795818|B5|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3973129|NCT01284335|3795819|B4|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3973130|NCT01284335|3795820|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3973131|NCT01284335|3795821|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3973132|NCT01284335|3795822|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3973133|NCT01284335|3795809|B14|African||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3973134|NCT01284335|3795810|B13|African||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3973135|NCT01284335|3795811|B12|African||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3973136|NCT01284335|3795812|B11|African||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3973137|NCT01284335|3795813|B10|African||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3973138|NCT01284335|3795814|B9|African||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3973139|NCT01284335|3795815|B8|African||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3973140|NCT01284335|3795816|B7|African||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3973141|NCT01284335|3795817|B6|African||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3973142|NCT01284335|3795818|B5|African||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3973143|NCT01284335|3795819|B4|African||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3973144|NCT01284335|3795820|B3|African||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3973145|NCT01284335|3795821|B2|African||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3973146|NCT01284335|3795822|B1|African||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3973147|NCT01284335|3795809|B14||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3973148|NCT01284335|3795810|B13||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3973149|NCT01284335|3795811|B12||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3973150|NCT01284335|3795812|B11||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3973151|NCT01284335|3795813|B10||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3973152|NCT01284335|3795814|B9||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3973153|NCT01284335|3795815|B8||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3973154|NCT01284335|3795816|B7||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3973155|NCT01284335|3795817|B6||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3973156|NCT01284335|3795818|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3973157|NCT01284335|3795819|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3973158|NCT01284335|3795820|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3973159|NCT01284335|3795821|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3973160|NCT01284335|3795822|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3973161|NCT01284335|3795809|B14||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3973162|NCT01284335|3795810|B13||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3973163|NCT01284335|3795811|B12||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3973164|NCT01284335|3795812|B11||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3973165|NCT01284335|3795813|B10||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3973166|NCT01284335|3795814|B9||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3973167|NCT01284335|3795815|B8||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3973168|NCT01284335|3795816|B7||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3973169|NCT01284335|3795817|B6||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3973170|NCT01284335|3795818|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3973171|NCT01284335|3795819|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3973172|NCT01284335|3795820|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3973173|NCT01284335|3795821|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3973174|NCT01284335|3795822|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3973175|NCT01284335|3795809|B14|||Age||years|Median|63.6|63.6|Full Range|||21.4|89.5|
3973176|NCT01284335|3795810|B13|||Age||years|Median|61.63|61.63|Full Range|||52.07|78.16|
3973177|NCT01284335|3795811|B12|||Age||years|Median|57.84|57.84|Full Range|||32.42|81.28|
3973178|NCT01284335|3795812|B11|||Age||years|Median|67.36|67.36|Full Range|||30.53|89.5|
3973179|NCT01284335|3795813|B10|||Age||years|Median|54.88|54.88|Full Range|||31.45|75.6|
3973180|NCT01284335|3795814|B9|||Age||years|Median|48.46|48.46|Full Range|||39.22|67.27|
3973181|NCT01284335|3795815|B8|||Age||years|Median|65.7|65.7|Full Range|||50.4|84.4|
3973182|NCT01284335|3795816|B7|||Age||years|Median|63.3|63.3|Full Range|||31.0|78.3|
3973183|NCT01284335|3795817|B6|||Age||years|Median|62.7|62.7|Full Range|||30.0|83.0|
3973184|NCT01284335|3795818|B5|||Age||years|Median|64.2|64.2|Full Range|||37.1|83.2|
3973185|NCT01284335|3795819|B4|||Age||years|Median|78.8|78.8|Full Range|||73.0|82.1|
3973186|NCT01284335|3795820|B3|||Age||years|Median|66.3|66.3|Full Range|||54.2|77.3|
3973187|NCT01284335|3795821|B2|||Age||years|Median|65.5|65.5|Full Range|||21.4|83.0|
3973188|NCT01284335|3795822|B1|||Age||years|Median|63.2|63.2|Full Range|||56.6|81.5|
3973189|NCT01284296|3795882|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3973190|NCT01284296|3795882|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3973191|NCT01284296|3795882|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3973192|NCT01284296|3795882|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3973193|NCT01284296|3795882|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3973194|NCT01284244|3795887|B3|Canada||Region of Enrollment||participants|Number|36|36.0||||||
3973195|NCT01284244|3795888|B2|Canada||Region of Enrollment||participants|Number|18|18.0||||||
3973196|NCT01284244|3795889|B1|Canada||Region of Enrollment||participants|Number|18|18.0||||||
3973197|NCT01284244|3795887|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3973198|NCT01284244|3795888|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3973199|NCT01284244|3795889|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3973200|NCT01284244|3795887|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3973201|NCT01284244|3795888|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3973202|NCT01284244|3795889|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3973203|NCT01284244|3795887|B3|||Age||years|Mean|51|51.0|Standard Deviation|9|9.0|||
3973204|NCT01284244|3795888|B2|||Age||years|Mean|50|50.0|Standard Deviation|7|7.0|||
3973205|NCT01284244|3795889|B1|||Age||years|Mean|52|52.0|Standard Deviation|11|11.0|||
3973206|NCT01284140|3795896|B3|||Dexmedetomidine during study period||Participants|Count of Participants|1|1.0||||||
3973207|NCT01284140|3795897|B2|||Dexmedetomidine during study period||Participants|Count of Participants|1|1.0||||||
3973208|NCT01284140|3795898|B1|||Dexmedetomidine during study period||Participants|Count of Participants|0|0.0||||||
3973209|NCT01284140|3795896|B3|||Benzodiazepines during study period||Participants|Count of Participants|3|3.0||||||
3973210|NCT01284140|3795897|B2|||Benzodiazepines during study period||Participants|Count of Participants|3|3.0||||||
3973211|NCT01284140|3795898|B1|||Benzodiazepines during study period||Participants|Count of Participants|0|0.0||||||
3973212|NCT01284140|3795896|B3|||Opioids during study period||Participants|Count of Participants|11|11.0||||||
3973213|NCT01284140|3795897|B2|||Opioids during study period||Participants|Count of Participants|5|5.0||||||
3973214|NCT01284140|3795898|B1|||Opioids during study period||Participants|Count of Participants|6|6.0||||||
3973215|NCT01284140|3795896|B3|||Propofol during study period||Participants|Count of Participants|11|11.0||||||
3973216|NCT01284140|3795897|B2|||Propofol during study period||Participants|Count of Participants|5|5.0||||||
3973217|NCT01284140|3795898|B1|||Propofol during study period||Participants|Count of Participants|6|6.0||||||
3973218|NCT01284140|3795896|B3|||Average peak creatinine during study period||mg per deciliter|Mean|1.9|1.9|Standard Deviation|1.3|1.3|||
3973219|NCT01284140|3795897|B2|||Average peak creatinine during study period||mg per deciliter|Mean|1.8|1.8|Standard Deviation|0.5|0.5|||
3973220|NCT01284140|3795898|B1|||Average peak creatinine during study period||mg per deciliter|Mean|2.0|2.0|Standard Deviation|0.6|0.6|||
3973221|NCT01284140|3795896|B3|||Body mass index||kg per meters squared|Median|26.4|26.4|Inter-Quartile Range|||24.0|35.5|
3973222|NCT01284140|3795897|B2|||Body mass index||kg per meters squared|Median|27.4|27.4|Inter-Quartile Range|||26.0|37.9|
3973223|NCT01284140|3795898|B1|||Body mass index||kg per meters squared|Median|25.0|25.0|Inter-Quartile Range|||21.8|33.2|
3973224|NCT01284140|3795896|B3|||Total urinary 6-sulfatoxymelatonin excretion on day 1 (micrograms)||micrograms|Mean|17.2|17.2|Standard Deviation|14.5|14.5|||
3973225|NCT01284140|3795897|B2|||Total urinary 6-sulfatoxymelatonin excretion on day 1 (micrograms)||micrograms|Mean|20.4|20.4|Standard Deviation|8.1|8.1|||
3973226|NCT01284140|3795898|B1|||Total urinary 6-sulfatoxymelatonin excretion on day 1 (micrograms)||micrograms|Mean|14.5|14.5|Standard Deviation|4.7|4.7|||
3973227|NCT01284140|3795896|B3|||Mechanically ventilated during study period||Participants|Count of Participants|11|11.0||||||
3973228|NCT01284140|3795897|B2|||Mechanically ventilated during study period||Participants|Count of Participants|5|5.0||||||
3973229|NCT01284140|3795898|B1|||Mechanically ventilated during study period||Participants|Count of Participants|6|6.0||||||
3973230|NCT01284140|3795896|B3|||Acute Physiology and Chronic Health Evaluation II score|The Acute Physiology and Chronic Health Evaluation (APACHE) II score is a severity of illness score that estimates ICU mortality. An integer score from 0 to 71 is computed based on several measurements, with higher scores corresponding to higher predicted mortality.|units on a scale|Mean|25|25.0|Standard Deviation|5.3|5.3|||
3973231|NCT01284140|3795897|B2|||Acute Physiology and Chronic Health Evaluation II score|The Acute Physiology and Chronic Health Evaluation (APACHE) II score is a severity of illness score that estimates ICU mortality. An integer score from 0 to 71 is computed based on several measurements, with higher scores corresponding to higher predicted mortality.|units on a scale|Mean|24.4|24.4|Standard Deviation|2.0|2.0|||
3973232|NCT01284140|3795898|B1|||Acute Physiology and Chronic Health Evaluation II score|The Acute Physiology and Chronic Health Evaluation (APACHE) II score is a severity of illness score that estimates ICU mortality. An integer score from 0 to 71 is computed based on several measurements, with higher scores corresponding to higher predicted mortality.|units on a scale|Mean|25.5|25.5|Standard Deviation|2.5|2.5|||
3973233|NCT01284140|3795896|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3973234|NCT01284140|3795897|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3973235|NCT01284140|3795898|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3973236|NCT01284140|3795896|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3973237|NCT01284140|3795897|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3973238|NCT01284140|3795898|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3973239|NCT01284140|3795896|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3973240|NCT01284140|3795897|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3973241|NCT01284140|3795898|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3973242|NCT01284140|3795896|B3|||Age||years|Mean|63.7|63.7|Standard Deviation|9.7|9.7|||
3973243|NCT01284140|3795897|B2|||Age||years|Mean|59.6|59.6|Standard Deviation|7.7|7.7|||
3973244|NCT01284140|3795898|B1|||Age||years|Mean|67.2|67.2|Standard Deviation|10.4|10.4|||
3973245|NCT01284114|3795913|B1|Japan||Region of Enrollment||participants|Number|23|23.0||||||
3973246|NCT01284114|3795913|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3973247|NCT01284114|3795913|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3973248|NCT01284114|3795913|B1|||Age||years|Mean|75.2|75.2|Standard Deviation|7.2|7.2|||
3973249|NCT01284114|3795913|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3973250|NCT01284114|3795913|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3973251|NCT01284114|3795913|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3973252|NCT01284062|3795921|B5||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3973253|NCT01284062|3795922|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3973254|NCT01284062|3795923|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3973255|NCT01284062|3795924|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3973256|NCT01284062|3795925|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3973257|NCT01284062|3795921|B5||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3973258|NCT01284062|3795922|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3973259|NCT01284062|3795923|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3973260|NCT01284062|3795924|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3973261|NCT01284062|3795925|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3973262|NCT01284062|3795921|B5|||Age||years|Mean|39.4|39.4|Standard Deviation|12.8|12.8|||
3973263|NCT01284062|3795922|B4|||Age||years|Mean|37.0|37.0|Standard Deviation|11.5|11.5|||
3973264|NCT01284062|3795923|B3|||Age||years|Mean|46.3|46.3|Standard Deviation|12.9|12.9|||
3973265|NCT01284062|3795924|B2|||Age||years|Mean|37.5|37.5|Standard Deviation|10.4|10.4|||
3973266|NCT01284062|3795925|B1|||Age||years|Mean|36.6|36.6|Standard Deviation|14.5|14.5|||
3973267|NCT01283971|3796000|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3973268|NCT01283971|3796001|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3973269|NCT01283971|3796002|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3973270|NCT01283971|3796000|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3973271|NCT01283971|3796001|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3973272|NCT01283971|3796002|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3973273|NCT01283971|3796000|B3|>75 years||Age, Customized||Participants|Number|1|1.0||||||
3973274|NCT01283971|3796001|B2|>75 years||Age, Customized||Participants|Number|0|0.0||||||
3973275|NCT01283971|3796002|B1|>75 years||Age, Customized||Participants|Number|1|1.0||||||
3973276|NCT01283971|3796000|B3|≥65 to 75 years||Age, Customized||Participants|Number|19|19.0||||||
3973277|NCT01283971|3796001|B2|≥65 to 75 years||Age, Customized||Participants|Number|10|10.0||||||
3973278|NCT01283971|3796002|B1|≥65 to 75 years||Age, Customized||Participants|Number|9|9.0||||||
3973279|NCT01283971|3796000|B3|50 to 64 years||Age, Customized||Participants|Number|40|40.0||||||
3973280|NCT01283971|3796001|B2|50 to 64 years||Age, Customized||Participants|Number|18|18.0||||||
3973281|NCT01283971|3796002|B1|50 to 64 years||Age, Customized||Participants|Number|22|22.0||||||
3973282|NCT01283971|3796000|B3|<50 years||Age, Customized||Participants|Number|36|36.0||||||
3973283|NCT01283971|3796001|B2|<50 years||Age, Customized||Participants|Number|20|20.0||||||
3973284|NCT01283971|3796002|B1|<50 years||Age, Customized||Participants|Number|16|16.0||||||
3973285|NCT01283971|3796000|B3|||Age||years|Mean|52.8|52.8|Standard Deviation|12.2|12.2|||
3973286|NCT01283971|3796001|B2|||Age||years|Mean|51.3|51.3|Standard Deviation|12.51|12.51|||
3973287|NCT01283971|3796002|B1|||Age||years|Mean|54.3|54.3|Standard Deviation|11.89|11.89|||
3973288|NCT01283581|3796047|B4|Subjects with at least 1 MSSA||Pathogens isolated at baseline||Participants|Number|53|53.0||||||
3973289|NCT01283581|3796048|B3|Subjects with at least 1 MSSA||Pathogens isolated at baseline||Participants|Number|26|26.0||||||
3973290|NCT01283581|3796049|B2|Subjects with at least 1 MSSA||Pathogens isolated at baseline||Participants|Number|16|16.0||||||
3973291|NCT01283581|3796050|B1|Subjects with at least 1 MSSA||Pathogens isolated at baseline||Participants|Number|11|11.0||||||
3973292|NCT01283581|3796047|B4|Subjects with at least 1 MRSA||Pathogens isolated at baseline||Participants|Number|106|106.0||||||
3973293|NCT01283581|3796048|B3|Subjects with at least 1 MRSA||Pathogens isolated at baseline||Participants|Number|35|35.0||||||
3973294|NCT01283581|3796049|B2|Subjects with at least 1 MRSA||Pathogens isolated at baseline||Participants|Number|37|37.0||||||
3973295|NCT01283581|3796050|B1|Subjects with at least 1 MRSA||Pathogens isolated at baseline||Participants|Number|34|34.0||||||
3973296|NCT01283581|3796047|B4|Subjects with at least 1 Staphylococcus aureus||Pathogens isolated at baseline||Participants|Number|159|159.0||||||
3973297|NCT01283581|3796048|B3|Subjects with at least 1 Staphylococcus aureus||Pathogens isolated at baseline||Participants|Number|61|61.0||||||
3973298|NCT01283581|3796049|B2|Subjects with at least 1 Staphylococcus aureus||Pathogens isolated at baseline||Participants|Number|53|53.0||||||
3973299|NCT01283581|3796050|B1|Subjects with at least 1 Staphylococcus aureus||Pathogens isolated at baseline||Participants|Number|45|45.0||||||
3973300|NCT01283581|3796047|B4|Subjects without pathogens||Pathogens isolated at baseline||Participants|Number|81|81.0||||||
3973301|NCT01283581|3796048|B3|Subjects without pathogens||Pathogens isolated at baseline||Participants|Number|31|31.0||||||
3973302|NCT01283581|3796049|B2|Subjects without pathogens||Pathogens isolated at baseline||Participants|Number|20|20.0||||||
3973303|NCT01283581|3796050|B1|Subjects without pathogens||Pathogens isolated at baseline||Participants|Number|30|30.0||||||
3973304|NCT01283581|3796047|B4|Subjects with positive blood cultures||Pathogens isolated at baseline||Participants|Number|7|7.0||||||
3973305|NCT01283581|3796048|B3|Subjects with positive blood cultures||Pathogens isolated at baseline||Participants|Number|1|1.0||||||
3973306|NCT01283581|3796049|B2|Subjects with positive blood cultures||Pathogens isolated at baseline||Participants|Number|6|6.0||||||
3973307|NCT01283581|3796050|B1|Subjects with positive blood cultures||Pathogens isolated at baseline||Participants|Number|0|0.0||||||
3973308|NCT01283581|3796047|B4|Subjects with multiple pathogens||Pathogens isolated at baseline||Participants|Number|29|29.0||||||
3973309|NCT01283581|3796048|B3|Subjects with multiple pathogens||Pathogens isolated at baseline||Participants|Number|8|8.0||||||
3973310|NCT01283581|3796049|B2|Subjects with multiple pathogens||Pathogens isolated at baseline||Participants|Number|15|15.0||||||
3973311|NCT01283581|3796050|B1|Subjects with multiple pathogens||Pathogens isolated at baseline||Participants|Number|6|6.0||||||
3973312|NCT01283581|3796047|B4|Subjects with at least 1 pathogen||Pathogens isolated at baseline||Participants|Number|175|175.0||||||
3973313|NCT01283581|3796048|B3|Subjects with at least 1 pathogen||Pathogens isolated at baseline||Participants|Number|67|67.0||||||
3973314|NCT01283581|3796049|B2|Subjects with at least 1 pathogen||Pathogens isolated at baseline||Participants|Number|57|57.0||||||
3973315|NCT01283581|3796050|B1|Subjects with at least 1 pathogen||Pathogens isolated at baseline||Participants|Number|51|51.0||||||
3973316|NCT01283581|3796047|B4|Not assessed||Baseline Infection Category|Categories of infection included major cutaneous abscess, cellulitis/erysipelas, wound infection, or burn infection|Participants|Number|1|1.0||||||
3973317|NCT01283581|3796048|B3|Not assessed||Baseline Infection Category|Categories of infection included major cutaneous abscess, cellulitis/erysipelas, wound infection, or burn infection|Participants|Number|1|1.0||||||
3973318|NCT01283581|3796049|B2|Not assessed||Baseline Infection Category|Categories of infection included major cutaneous abscess, cellulitis/erysipelas, wound infection, or burn infection|Participants|Number|0|0.0||||||
3973319|NCT01283581|3796050|B1|Not assessed||Baseline Infection Category|Categories of infection included major cutaneous abscess, cellulitis/erysipelas, wound infection, or burn infection|Participants|Number|0|0.0||||||
3973320|NCT01283581|3796047|B4|Burn infection||Baseline Infection Category|Categories of infection included major cutaneous abscess, cellulitis/erysipelas, wound infection, or burn infection|Participants|Number|5|5.0||||||
3973321|NCT01283581|3796048|B3|Burn infection||Baseline Infection Category|Categories of infection included major cutaneous abscess, cellulitis/erysipelas, wound infection, or burn infection|Participants|Number|1|1.0||||||
3973322|NCT01283581|3796049|B2|Burn infection||Baseline Infection Category|Categories of infection included major cutaneous abscess, cellulitis/erysipelas, wound infection, or burn infection|Participants|Number|2|2.0||||||
3973323|NCT01283581|3796050|B1|Burn infection||Baseline Infection Category|Categories of infection included major cutaneous abscess, cellulitis/erysipelas, wound infection, or burn infection|Participants|Number|2|2.0||||||
3973324|NCT01283581|3796047|B4|Wound infection||Baseline Infection Category|Categories of infection included major cutaneous abscess, cellulitis/erysipelas, wound infection, or burn infection|Participants|Number|62|62.0||||||
3973325|NCT01283581|3796048|B3|Wound infection||Baseline Infection Category|Categories of infection included major cutaneous abscess, cellulitis/erysipelas, wound infection, or burn infection|Participants|Number|23|23.0||||||
3973326|NCT01283581|3796049|B2|Wound infection||Baseline Infection Category|Categories of infection included major cutaneous abscess, cellulitis/erysipelas, wound infection, or burn infection|Participants|Number|20|20.0||||||
3973327|NCT01283581|3796050|B1|Wound infection||Baseline Infection Category|Categories of infection included major cutaneous abscess, cellulitis/erysipelas, wound infection, or burn infection|Participants|Number|19|19.0||||||
3973328|NCT01283581|3796047|B4|Cellulitis/erysipelas||Baseline Infection Category|Categories of infection included major cutaneous abscess, cellulitis/erysipelas, wound infection, or burn infection|Participants|Number|113|113.0||||||
3973329|NCT01283581|3796048|B3|Cellulitis/erysipelas||Baseline Infection Category|Categories of infection included major cutaneous abscess, cellulitis/erysipelas, wound infection, or burn infection|Participants|Number|44|44.0||||||
3973330|NCT01283581|3796049|B2|Cellulitis/erysipelas||Baseline Infection Category|Categories of infection included major cutaneous abscess, cellulitis/erysipelas, wound infection, or burn infection|Participants|Number|31|31.0||||||
3973331|NCT01283581|3796050|B1|Cellulitis/erysipelas||Baseline Infection Category|Categories of infection included major cutaneous abscess, cellulitis/erysipelas, wound infection, or burn infection|Participants|Number|38|38.0||||||
3973332|NCT01283581|3796047|B4|Major cutaneous abscess||Baseline Infection Category|Categories of infection included major cutaneous abscess, cellulitis/erysipelas, wound infection, or burn infection|Participants|Number|75|75.0||||||
3973333|NCT01283581|3796048|B3|Major cutaneous abscess||Baseline Infection Category|Categories of infection included major cutaneous abscess, cellulitis/erysipelas, wound infection, or burn infection|Participants|Number|29|29.0||||||
3973334|NCT01283581|3796049|B2|Major cutaneous abscess||Baseline Infection Category|Categories of infection included major cutaneous abscess, cellulitis/erysipelas, wound infection, or burn infection|Participants|Number|24|24.0||||||
3973335|NCT01283581|3796050|B1|Major cutaneous abscess||Baseline Infection Category|Categories of infection included major cutaneous abscess, cellulitis/erysipelas, wound infection, or burn infection|Participants|Number|22|22.0||||||
3973336|NCT01283581|3796047|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3973337|NCT01283581|3796048|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3973338|NCT01283581|3796049|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3973339|NCT01283581|3796050|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3973340|NCT01283581|3796047|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3973341|NCT01283581|3796048|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3973342|NCT01283581|3796049|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3973343|NCT01283581|3796050|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3973344|NCT01283581|3796047|B4||White|Race (NIH/OMB)||Participants|Count of Participants|195|195.0||||||
3973345|NCT01283581|3796048|B3||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3973346|NCT01283581|3796049|B2||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3973347|NCT01283581|3796050|B1||White|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
3973348|NCT01283581|3796047|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3973349|NCT01283581|3796048|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3973350|NCT01283581|3796049|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3973351|NCT01283581|3796050|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3973352|NCT01283581|3796047|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3973353|NCT01283581|3796048|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3973354|NCT01283581|3796049|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3973355|NCT01283581|3796050|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3973356|NCT01283581|3796047|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3973357|NCT01283581|3796048|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3973358|NCT01283581|3796049|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3973359|NCT01283581|3796050|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3973360|NCT01283581|3796047|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3973361|NCT01283581|3796048|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3973362|NCT01283581|3796049|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3973363|NCT01283581|3796050|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3973364|NCT01283581|3796047|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3973365|NCT01283581|3796048|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3973366|NCT01283581|3796049|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3973367|NCT01283581|3796050|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3973368|NCT01283581|3796047|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|199|199.0||||||
3973369|NCT01283581|3796048|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3973370|NCT01283581|3796049|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3973371|NCT01283581|3796050|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3973372|NCT01283581|3796047|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3973373|NCT01283581|3796048|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3973374|NCT01283581|3796049|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3973375|NCT01283581|3796050|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3973376|NCT01283581|3796047|B4||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3973377|NCT01283581|3796048|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3973378|NCT01283581|3796049|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3973379|NCT01283581|3796050|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3973380|NCT01283581|3796047|B4||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3973381|NCT01283581|3796048|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3973382|NCT01283581|3796049|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3973383|NCT01283581|3796050|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3973384|NCT01283581|3796047|B4|||Age||years|Mean|43.2|43.2|Standard Deviation|15.08|15.08|||
3973385|NCT01283581|3796048|B3|||Age||years|Mean|44.8|44.8|Standard Deviation|15.54|15.54|||
3973386|NCT01283581|3796049|B2|||Age||years|Mean|44.8|44.8|Standard Deviation|14.91|14.91|||
3973387|NCT01283581|3796050|B1|||Age||years|Mean|39.7|39.7|Standard Deviation|14.26|14.26|||
3973388|NCT01283555|3796063|B1|Dominican Republic||Region of Enrollment||participants|Number|25|25.0||||||
3973389|NCT01283555|3796063|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3973390|NCT01283555|3796063|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3973391|NCT01283555|3796063|B1|||Age||years|Mean|33|33.0|Standard Deviation|6|6.0|||
3973392|NCT01283555|3796063|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3973393|NCT01283555|3796063|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3973394|NCT01283555|3796063|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3973395|NCT01283516|3796107|B10|Current Smoker||Smoking History||Participants|Number|8|8.0||||||
3973396|NCT01283516|3796108|B9|Current Smoker||Smoking History||Participants|Number|8|8.0||||||
3973397|NCT01283516|3796109|B8|Current Smoker||Smoking History||Participants|Number|0|0.0||||||
3973398|NCT01283516|3796110|B7|Current Smoker||Smoking History||Participants|Number|0|0.0||||||
3973399|NCT01283516|3796111|B6|Current Smoker||Smoking History||Participants|Number|0|0.0||||||
3973400|NCT01283516|3796112|B5|Current Smoker||Smoking History||Participants|Number|0|0.0||||||
3973401|NCT01283516|3796113|B4|Current Smoker||Smoking History||Participants|Number|0|0.0||||||
3973402|NCT01283516|3796114|B3|Current Smoker||Smoking History||Participants|Number|0|0.0||||||
3973403|NCT01283516|3796115|B2|Current Smoker||Smoking History||Participants|Number|0|0.0||||||
3973404|NCT01283516|3796116|B1|Current Smoker||Smoking History||Participants|Number|0|0.0||||||
3973405|NCT01283516|3796107|B10|Ex-Smoker||Smoking History||Participants|Number|104|104.0||||||
3973406|NCT01283516|3796108|B9|Ex-Smoker||Smoking History||Participants|Number|88|88.0||||||
3973407|NCT01283516|3796109|B8|Ex-Smoker||Smoking History||Participants|Number|2|2.0||||||
3973408|NCT01283516|3796110|B7|Ex-Smoker||Smoking History||Participants|Number|2|2.0||||||
3973409|NCT01283516|3796111|B6|Ex-Smoker||Smoking History||Participants|Number|3|3.0||||||
3973410|NCT01283516|3796112|B5|Ex-Smoker||Smoking History||Participants|Number|5|5.0||||||
3973411|NCT01283516|3796113|B4|Ex-Smoker||Smoking History||Participants|Number|1|1.0||||||
3973412|NCT01283516|3796114|B3|Ex-Smoker||Smoking History||Participants|Number|2|2.0||||||
3973413|NCT01283516|3796115|B2|Ex-Smoker||Smoking History||Participants|Number|1|1.0||||||
3973414|NCT01283516|3796116|B1|Ex-Smoker||Smoking History||Participants|Number|0|0.0||||||
3973415|NCT01283516|3796107|B10|Never Smoked||Smoking History||Participants|Number|192|192.0||||||
3973416|NCT01283516|3796108|B9|Never Smoked||Smoking History||Participants|Number|159|159.0||||||
3973417|NCT01283516|3796109|B8|Never Smoked||Smoking History||Participants|Number|3|3.0||||||
3973418|NCT01283516|3796110|B7|Never Smoked||Smoking History||Participants|Number|8|8.0||||||
3973419|NCT01283516|3796111|B6|Never Smoked||Smoking History||Participants|Number|7|7.0||||||
3973420|NCT01283516|3796112|B5|Never Smoked||Smoking History||Participants|Number|9|9.0||||||
3973421|NCT01283516|3796113|B4|Never Smoked||Smoking History||Participants|Number|2|2.0||||||
3973422|NCT01283516|3796114|B3|Never Smoked||Smoking History||Participants|Number|1|1.0||||||
3973423|NCT01283516|3796115|B2|Never Smoked||Smoking History||Participants|Number|1|1.0||||||
3973424|NCT01283516|3796116|B1|Never Smoked||Smoking History||Participants|Number|2|2.0||||||
3973425|NCT01283516|3796107|B10|3: Limited self-care, confined to bed/chair >50%||WHO/ECOG Performance status|The ECOG performance status is a scale used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|1|1.0||||||
3973426|NCT01283516|3796108|B9|3: Limited self-care, confined to bed/chair >50%||WHO/ECOG Performance status|The ECOG performance status is a scale used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|1|1.0||||||
3973427|NCT01283516|3796109|B8|3: Limited self-care, confined to bed/chair >50%||WHO/ECOG Performance status|The ECOG performance status is a scale used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|0|0.0||||||
3973428|NCT01283516|3796110|B7|3: Limited self-care, confined to bed/chair >50%||WHO/ECOG Performance status|The ECOG performance status is a scale used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|0|0.0||||||
3973429|NCT01283516|3796111|B6|3: Limited self-care, confined to bed/chair >50%||WHO/ECOG Performance status|The ECOG performance status is a scale used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|0|0.0||||||
3973430|NCT01283516|3796112|B5|3: Limited self-care, confined to bed/chair >50%||WHO/ECOG Performance status|The ECOG performance status is a scale used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|0|0.0||||||
3973431|NCT01283516|3796113|B4|3: Limited self-care, confined to bed/chair >50%||WHO/ECOG Performance status|The ECOG performance status is a scale used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|0|0.0||||||
3973432|NCT01283516|3796114|B3|3: Limited self-care, confined to bed/chair >50%||WHO/ECOG Performance status|The ECOG performance status is a scale used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|0|0.0||||||
3973433|NCT01283516|3796115|B2|3: Limited self-care, confined to bed/chair >50%||WHO/ECOG Performance status|The ECOG performance status is a scale used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|0|0.0||||||
3973434|NCT01283516|3796116|B1|3: Limited self-care, confined to bed/chair >50%||WHO/ECOG Performance status|The ECOG performance status is a scale used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|0|0.0||||||
3973435|NCT01283516|3796107|B10|2:Capable of self-care up & about >50% of the time||WHO/ECOG Performance status|The ECOG performance status is a scale used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|34|34.0||||||
3973436|NCT01283516|3796108|B9|2:Capable of self-care up & about >50% of the time||WHO/ECOG Performance status|The ECOG performance status is a scale used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|28|28.0||||||
3973437|NCT01283516|3796109|B8|2:Capable of self-care up & about >50% of the time||WHO/ECOG Performance status|The ECOG performance status is a scale used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|1|1.0||||||
3973438|NCT01283516|3796110|B7|2:Capable of self-care up & about >50% of the time||WHO/ECOG Performance status|The ECOG performance status is a scale used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|1|1.0||||||
3973439|NCT01283516|3796111|B6|2:Capable of self-care up & about >50% of the time||WHO/ECOG Performance status|The ECOG performance status is a scale used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|1|1.0||||||
3973440|NCT01283516|3796112|B5|2:Capable of self-care up & about >50% of the time||WHO/ECOG Performance status|The ECOG performance status is a scale used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|3|3.0||||||
3973441|NCT01283516|3796113|B4|2:Capable of self-care up & about >50% of the time||WHO/ECOG Performance status|The ECOG performance status is a scale used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|0|0.0||||||
3973442|NCT01283516|3796114|B3|2:Capable of self-care up & about >50% of the time||WHO/ECOG Performance status|The ECOG performance status is a scale used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|0|0.0||||||
3973443|NCT01283516|3796115|B2|2:Capable of self-care up & about >50% of the time||WHO/ECOG Performance status|The ECOG performance status is a scale used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|0|0.0||||||
3973444|NCT01283516|3796116|B1|2:Capable of self-care up & about >50% of the time||WHO/ECOG Performance status|The ECOG performance status is a scale used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|0|0.0||||||
3973445|NCT01283516|3796107|B10|1: Able to carry out light work||WHO/ECOG Performance status|The ECOG performance status is a scale used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|193|193.0||||||
3973446|NCT01283516|3796108|B9|1: Able to carry out light work||WHO/ECOG Performance status|The ECOG performance status is a scale used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|161|161.0||||||
3973447|NCT01283516|3796109|B8|1: Able to carry out light work||WHO/ECOG Performance status|The ECOG performance status is a scale used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|3|3.0||||||
3973448|NCT01283516|3796110|B7|1: Able to carry out light work||WHO/ECOG Performance status|The ECOG performance status is a scale used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|7|7.0||||||
3973449|NCT01283516|3796111|B6|1: Able to carry out light work||WHO/ECOG Performance status|The ECOG performance status is a scale used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|7|7.0||||||
3973450|NCT01283516|3796112|B5|1: Able to carry out light work||WHO/ECOG Performance status|The ECOG performance status is a scale used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|8|8.0||||||
3973451|NCT01283516|3796113|B4|1: Able to carry out light work||WHO/ECOG Performance status|The ECOG performance status is a scale used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|3|3.0||||||
3973452|NCT01283516|3796114|B3|1: Able to carry out light work||WHO/ECOG Performance status|The ECOG performance status is a scale used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|2|2.0||||||
3973453|NCT01283516|3796115|B2|1: Able to carry out light work||WHO/ECOG Performance status|The ECOG performance status is a scale used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|1|1.0||||||
3973454|NCT01283516|3796116|B1|1: Able to carry out light work||WHO/ECOG Performance status|The ECOG performance status is a scale used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|1|1.0||||||
3973455|NCT01283516|3796107|B10|0:Fully active,in line with pre-disease activities||WHO/ECOG Performance status|The ECOG performance status is a scale used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|76|76.0||||||
3973456|NCT01283516|3796108|B9|0:Fully active,in line with pre-disease activities||WHO/ECOG Performance status|The ECOG performance status is a scale used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|65|65.0||||||
3973457|NCT01283516|3796109|B8|0:Fully active,in line with pre-disease activities||WHO/ECOG Performance status|The ECOG performance status is a scale used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|1|1.0||||||
3973458|NCT01283516|3796110|B7|0:Fully active,in line with pre-disease activities||WHO/ECOG Performance status|The ECOG performance status is a scale used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|2|2.0||||||
3973459|NCT01283516|3796111|B6|0:Fully active,in line with pre-disease activities||WHO/ECOG Performance status|The ECOG performance status is a scale used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|2|2.0||||||
3973460|NCT01283516|3796112|B5|0:Fully active,in line with pre-disease activities||WHO/ECOG Performance status|The ECOG performance status is a scale used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|3|3.0||||||
3973461|NCT01283516|3796113|B4|0:Fully active,in line with pre-disease activities||WHO/ECOG Performance status|The ECOG performance status is a scale used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|0|0.0||||||
3973462|NCT01283516|3796114|B3|0:Fully active,in line with pre-disease activities||WHO/ECOG Performance status|The ECOG performance status is a scale used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|1|1.0||||||
3973463|NCT01283516|3796115|B2|0:Fully active,in line with pre-disease activities||WHO/ECOG Performance status|The ECOG performance status is a scale used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|1|1.0||||||
3973464|NCT01283516|3796116|B1|0:Fully active,in line with pre-disease activities||WHO/ECOG Performance status|The ECOG performance status is a scale used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|1|1.0||||||
3973465|NCT01283516|3796107|B10|||Body Mass Index||kg/m^2|Mean|24.4|24.4|Standard Deviation|4.48|4.48|||
3973466|NCT01283516|3796108|B9|||Body Mass Index||kg/m^2|Mean|24.5|24.5|Standard Deviation|4.40|4.4|||
3973467|NCT01283516|3796109|B8|||Body Mass Index||kg/m^2|Mean|24.3|24.3|Standard Deviation|6.06|6.06|||
3973468|NCT01283516|3796110|B7|||Body Mass Index||kg/m^2|Mean|23.1|23.1|Standard Deviation|2.78|2.78|||
3973469|NCT01283516|3796111|B6|||Body Mass Index||kg/m^2|Mean|25.9|25.9|Standard Deviation|5.41|5.41|||
3973470|NCT01283516|3796112|B5|||Body Mass Index||kg/m^2|Mean|24.0|24.0|Standard Deviation|5.38|5.38|||
3973471|NCT01283516|3796113|B4|||Body Mass Index||kg/m^2|Mean|20.2|20.2|Standard Deviation|5.08|5.08|||
3973472|NCT01283516|3796114|B3|||Body Mass Index||kg/m^2|Mean|26.5|26.5|Standard Deviation|5.69|5.69|||
3973473|NCT01283516|3796115|B2|||Body Mass Index||kg/m^2|Mean|21.8|21.8|Standard Deviation|5.30|5.3|||
3973474|NCT01283516|3796116|B1|||Body Mass Index||kg/m^2|Mean|21.1|21.1|Standard Deviation|5.16|5.16|||
3973475|NCT01283516|3796107|B10|||Height||centimenters (cm)|Mean|167.5|167.5|Standard Deviation|9.78|9.78|||
3973476|NCT01283516|3796108|B9|||Height||centimenters (cm)|Mean|167.5|167.5|Standard Deviation|9.87|9.87|||
3973477|NCT01283516|3796109|B8|||Height||centimenters (cm)|Mean|163.6|163.6|Standard Deviation|5.05|5.05|||
3973478|NCT01283516|3796110|B7|||Height||centimenters (cm)|Mean|165.1|165.1|Standard Deviation|8.67|8.67|||
3973479|NCT01283516|3796111|B6|||Height||centimenters (cm)|Mean|166.4|166.4|Standard Deviation|12.24|12.24|||
3973480|NCT01283516|3796112|B5|||Height||centimenters (cm)|Mean|169.9|169.9|Standard Deviation|9.35|9.35|||
3973481|NCT01283516|3796113|B4|||Height||centimenters (cm)|Mean|164.6|164.6|Standard Deviation|5.82|5.82|||
3973482|NCT01283516|3796114|B3|||Height||centimenters (cm)|Mean|161.3|161.3|Standard Deviation|3.04|3.04|||
3973483|NCT01283516|3796115|B2|||Height||centimenters (cm)|Mean|178.0|178.0|Standard Deviation|14.14|14.14|||
3973484|NCT01283516|3796116|B1|||Height||centimenters (cm)|Mean|169.0|169.0|Standard Deviation|7.07|7.07|||
3973485|NCT01283516|3796107|B10|||Weight||Kilograms (kg)|Mean|68.8|68.8|Standard Deviation|15.61|15.61|||
3973486|NCT01283516|3796108|B9|||Weight||Kilograms (kg)|Mean|69.2|69.2|Standard Deviation|15.64|15.64|||
3973487|NCT01283516|3796109|B8|||Weight||Kilograms (kg)|Mean|61.6|61.6|Standard Deviation|16.05|16.05|||
3973488|NCT01283516|3796110|B7|||Weight||Kilograms (kg)|Mean|63.8|63.8|Standard Deviation|13.23|13.23|||
3973489|NCT01283516|3796111|B6|||Weight||Kilograms (kg)|Mean|72.2|72.2|Standard Deviation|18.74|18.74|||
3973490|NCT01283516|3796112|B5|||Weight||Kilograms (kg)|Mean|69.2|69.2|Standard Deviation|15.91|15.91|||
3973491|NCT01283516|3796113|B4|||Weight||Kilograms (kg)|Mean|54.1|54.1|Standard Deviation|9.70|9.7|||
3973492|NCT01283516|3796114|B3|||Weight||Kilograms (kg)|Mean|69.2|69.2|Standard Deviation|17.20|17.2|||
3973493|NCT01283516|3796115|B2|||Weight||Kilograms (kg)|Mean|67.8|67.8|Standard Deviation|5.94|5.94|||
3973494|NCT01283516|3796116|B1|||Weight||Kilograms (kg)|Mean|60.8|60.8|Standard Deviation|19.80|19.8|||
3973495|NCT01283516|3796107|B10|Other||Predominant Race||Participants|Number|4|4.0||||||
3973496|NCT01283516|3796108|B9|Other||Predominant Race||Participants|Number|3|3.0||||||
3973497|NCT01283516|3796109|B8|Other||Predominant Race||Participants|Number|1|1.0||||||
3973498|NCT01283516|3796110|B7|Other||Predominant Race||Participants|Number|0|0.0||||||
3973499|NCT01283516|3796111|B6|Other||Predominant Race||Participants|Number|0|0.0||||||
3973500|NCT01283516|3796112|B5|Other||Predominant Race||Participants|Number|0|0.0||||||
3973501|NCT01283516|3796113|B4|Other||Predominant Race||Participants|Number|0|0.0||||||
3973502|NCT01283516|3796114|B3|Other||Predominant Race||Participants|Number|0|0.0||||||
3973503|NCT01283516|3796115|B2|Other||Predominant Race||Participants|Number|0|0.0||||||
3973504|NCT01283516|3796116|B1|Other||Predominant Race||Participants|Number|0|0.0||||||
3973505|NCT01283516|3796107|B10|Pacific Islander||Predominant Race||Participants|Number|1|1.0||||||
3973506|NCT01283516|3796108|B9|Pacific Islander||Predominant Race||Participants|Number|0|0.0||||||
3973507|NCT01283516|3796109|B8|Pacific Islander||Predominant Race||Participants|Number|0|0.0||||||
3973508|NCT01283516|3796110|B7|Pacific Islander||Predominant Race||Participants|Number|0|0.0||||||
3973509|NCT01283516|3796111|B6|Pacific Islander||Predominant Race||Participants|Number|0|0.0||||||
3973510|NCT01283516|3796112|B5|Pacific Islander||Predominant Race||Participants|Number|0|0.0||||||
3973511|NCT01283516|3796113|B4|Pacific Islander||Predominant Race||Participants|Number|0|0.0||||||
3973512|NCT01283516|3796114|B3|Pacific Islander||Predominant Race||Participants|Number|1|1.0||||||
3973513|NCT01283516|3796115|B2|Pacific Islander||Predominant Race||Participants|Number|0|0.0||||||
3973514|NCT01283516|3796116|B1|Pacific Islander||Predominant Race||Participants|Number|0|0.0||||||
3973515|NCT01283516|3796107|B10|Native American||Predominant Race||Participants|Number|1|1.0||||||
3973516|NCT01283516|3796108|B9|Native American||Predominant Race||Participants|Number|1|1.0||||||
3973517|NCT01283516|3796109|B8|Native American||Predominant Race||Participants|Number|0|0.0||||||
3973518|NCT01283516|3796110|B7|Native American||Predominant Race||Participants|Number|0|0.0||||||
3973519|NCT01283516|3796111|B6|Native American||Predominant Race||Participants|Number|0|0.0||||||
3973520|NCT01283516|3796112|B5|Native American||Predominant Race||Participants|Number|0|0.0||||||
3973521|NCT01283516|3796113|B4|Native American||Predominant Race||Participants|Number|0|0.0||||||
3973522|NCT01283516|3796114|B3|Native American||Predominant Race||Participants|Number|0|0.0||||||
3973523|NCT01283516|3796115|B2|Native American||Predominant Race||Participants|Number|0|0.0||||||
3973524|NCT01283516|3796116|B1|Native American||Predominant Race||Participants|Number|0|0.0||||||
3973525|NCT01283516|3796107|B10|Asian||Predominant Race||Participants|Number|95|95.0||||||
3973526|NCT01283516|3796108|B9|Asian||Predominant Race||Participants|Number|87|87.0||||||
3973527|NCT01283516|3796109|B8|Asian||Predominant Race||Participants|Number|1|1.0||||||
3973528|NCT01283516|3796110|B7|Asian||Predominant Race||Participants|Number|2|2.0||||||
3973529|NCT01283516|3796111|B6|Asian||Predominant Race||Participants|Number|2|2.0||||||
3973530|NCT01283516|3796112|B5|Asian||Predominant Race||Participants|Number|2|2.0||||||
3973531|NCT01283516|3796113|B4|Asian||Predominant Race||Participants|Number|1|1.0||||||
3973532|NCT01283516|3796114|B3|Asian||Predominant Race||Participants|Number|0|0.0||||||
3973533|NCT01283516|3796115|B2|Asian||Predominant Race||Participants|Number|0|0.0||||||
3973534|NCT01283516|3796116|B1|Asian||Predominant Race||Participants|Number|0|0.0||||||
3973535|NCT01283516|3796107|B10|Black||Predominant Race||Participants|Number|4|4.0||||||
3973536|NCT01283516|3796108|B9|Black||Predominant Race||Participants|Number|4|4.0||||||
3973537|NCT01283516|3796109|B8|Black||Predominant Race||Participants|Number|0|0.0||||||
3973538|NCT01283516|3796110|B7|Black||Predominant Race||Participants|Number|0|0.0||||||
3973539|NCT01283516|3796111|B6|Black||Predominant Race||Participants|Number|0|0.0||||||
3973540|NCT01283516|3796112|B5|Black||Predominant Race||Participants|Number|0|0.0||||||
3973541|NCT01283516|3796113|B4|Black||Predominant Race||Participants|Number|0|0.0||||||
3973542|NCT01283516|3796114|B3|Black||Predominant Race||Participants|Number|0|0.0||||||
3973543|NCT01283516|3796115|B2|Black||Predominant Race||Participants|Number|0|0.0||||||
3973544|NCT01283516|3796116|B1|Black||Predominant Race||Participants|Number|0|0.0||||||
3973545|NCT01283516|3796107|B10|Caucasian||Predominant Race||Participants|Number|199|199.0||||||
3973546|NCT01283516|3796108|B9|Caucasian||Predominant Race||Participants|Number|160|160.0||||||
3973547|NCT01283516|3796109|B8|Caucasian||Predominant Race||Participants|Number|3|3.0||||||
3973548|NCT01283516|3796110|B7|Caucasian||Predominant Race||Participants|Number|8|8.0||||||
3973549|NCT01283516|3796111|B6|Caucasian||Predominant Race||Participants|Number|8|8.0||||||
3973550|NCT01283516|3796112|B5|Caucasian||Predominant Race||Participants|Number|12|12.0||||||
3973551|NCT01283516|3796113|B4|Caucasian||Predominant Race||Participants|Number|2|2.0||||||
3973552|NCT01283516|3796114|B3|Caucasian||Predominant Race||Participants|Number|2|2.0||||||
3973553|NCT01283516|3796115|B2|Caucasian||Predominant Race||Participants|Number|2|2.0||||||
3973554|NCT01283516|3796116|B1|Caucasian||Predominant Race||Participants|Number|2|2.0||||||
3973555|NCT01283516|3796107|B10|Other||Race/Ethnicity, Customized||Participants|Number|244|244.0||||||
3973556|NCT01283516|3796108|B9|Other||Race/Ethnicity, Customized||Participants|Number|205|205.0||||||
3973557|NCT01283516|3796109|B8|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3973558|NCT01283516|3796110|B7|Other||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3973559|NCT01283516|3796111|B6|Other||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3973560|NCT01283516|3796112|B5|Other||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3973561|NCT01283516|3796113|B4|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3973562|NCT01283516|3796114|B3|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3973563|NCT01283516|3796115|B2|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3973564|NCT01283516|3796116|B1|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3973565|NCT01283516|3796107|B10|Mixed Ethnicity||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3973566|NCT01283516|3796108|B9|Mixed Ethnicity||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3973567|NCT01283516|3796109|B8|Mixed Ethnicity||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3973568|NCT01283516|3796110|B7|Mixed Ethnicity||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3973569|NCT01283516|3796111|B6|Mixed Ethnicity||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3973570|NCT01283516|3796112|B5|Mixed Ethnicity||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3973571|NCT01283516|3796113|B4|Mixed Ethnicity||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3973572|NCT01283516|3796114|B3|Mixed Ethnicity||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3973573|NCT01283516|3796115|B2|Mixed Ethnicity||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3973574|NCT01283516|3796116|B1|Mixed Ethnicity||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3973575|NCT01283516|3796107|B10|Indian (Indian subcontinent)||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3973576|NCT01283516|3796108|B9|Indian (Indian subcontinent)||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3973577|NCT01283516|3796109|B8|Indian (Indian subcontinent)||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3973578|NCT01283516|3796110|B7|Indian (Indian subcontinent)||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3973579|NCT01283516|3796111|B6|Indian (Indian subcontinent)||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3973580|NCT01283516|3796112|B5|Indian (Indian subcontinent)||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3973581|NCT01283516|3796113|B4|Indian (Indian subcontinent)||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3973582|NCT01283516|3796114|B3|Indian (Indian subcontinent)||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3973583|NCT01283516|3796115|B2|Indian (Indian subcontinent)||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3973584|NCT01283516|3796116|B1|Indian (Indian subcontinent)||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3973585|NCT01283516|3796107|B10|Chinese||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
3973586|NCT01283516|3796108|B9|Chinese||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
3973587|NCT01283516|3796109|B8|Chinese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3973588|NCT01283516|3796110|B7|Chinese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3973589|NCT01283516|3796111|B6|Chinese||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3973590|NCT01283516|3796112|B5|Chinese||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3973591|NCT01283516|3796113|B4|Chinese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3973592|NCT01283516|3796114|B3|Chinese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3973593|NCT01283516|3796115|B2|Chinese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3973594|NCT01283516|3796116|B1|Chinese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3973595|NCT01283516|3796107|B10|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
3973596|NCT01283516|3796108|B9|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|26|26.0||||||
3973597|NCT01283516|3796109|B8|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3973598|NCT01283516|3796110|B7|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3973599|NCT01283516|3796111|B6|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3973600|NCT01283516|3796112|B5|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3973601|NCT01283516|3796113|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3973602|NCT01283516|3796114|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3973603|NCT01283516|3796115|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3973604|NCT01283516|3796116|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3973605|NCT01283516|3796107|B10||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3973606|NCT01283516|3796108|B9||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3973607|NCT01283516|3796109|B8||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3973608|NCT01283516|3796110|B7||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3973609|NCT01283516|3796111|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3973610|NCT01283516|3796112|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3973611|NCT01283516|3796113|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3973612|NCT01283516|3796114|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3973613|NCT01283516|3796115|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3973614|NCT01283516|3796116|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3973615|NCT01283516|3796107|B10||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
3973616|NCT01283516|3796108|B9||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3973617|NCT01283516|3796109|B8||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3973618|NCT01283516|3796110|B7||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3973619|NCT01283516|3796111|B6||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3973620|NCT01283516|3796112|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3973621|NCT01283516|3796113|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3973622|NCT01283516|3796114|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3973623|NCT01283516|3796115|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3973624|NCT01283516|3796116|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3973625|NCT01283516|3796107|B10|>=65 years||Age, Customized||Participants|Number|49|49.0||||||
3973626|NCT01283516|3796108|B9|>=65 years||Age, Customized||Participants|Number|40|40.0||||||
3973627|NCT01283516|3796109|B8|>=65 years||Age, Customized||Participants|Number|0|0.0||||||
3973628|NCT01283516|3796110|B7|>=65 years||Age, Customized||Participants|Number|3|3.0||||||
3973629|NCT01283516|3796111|B6|>=65 years||Age, Customized||Participants|Number|3|3.0||||||
3973630|NCT01283516|3796112|B5|>=65 years||Age, Customized||Participants|Number|2|2.0||||||
3973631|NCT01283516|3796113|B4|>=65 years||Age, Customized||Participants|Number|0|0.0||||||
3973632|NCT01283516|3796114|B3|>=65 years||Age, Customized||Participants|Number|1|1.0||||||
3973633|NCT01283516|3796115|B2|>=65 years||Age, Customized||Participants|Number|0|0.0||||||
3973634|NCT01283516|3796116|B1|>=65 years||Age, Customized||Participants|Number|0|0.0||||||
3973635|NCT01283516|3796107|B10|<65 years||Age, Customized||Participants|Number|255|255.0||||||
3973636|NCT01283516|3796108|B9|<65 years||Age, Customized||Participants|Number|215|215.0||||||
3973637|NCT01283516|3796109|B8|<65 years||Age, Customized||Participants|Number|5|5.0||||||
3973638|NCT01283516|3796110|B7|<65 years||Age, Customized||Participants|Number|7|7.0||||||
3973639|NCT01283516|3796111|B6|<65 years||Age, Customized||Participants|Number|7|7.0||||||
3973640|NCT01283516|3796112|B5|<65 years||Age, Customized||Participants|Number|12|12.0||||||
3973641|NCT01283516|3796113|B4|<65 years||Age, Customized||Participants|Number|3|3.0||||||
3973642|NCT01283516|3796114|B3|<65 years||Age, Customized||Participants|Number|2|2.0||||||
3973643|NCT01283516|3796115|B2|<65 years||Age, Customized||Participants|Number|2|2.0||||||
3973644|NCT01283516|3796116|B1|<65 years||Age, Customized||Participants|Number|2|2.0||||||
3973645|NCT01283516|3796107|B10|||Age||Years|Mean|52.0|52.0|Standard Deviation|12.41|12.41|||
3973646|NCT01283516|3796108|B9|||Age||Years|Mean|51.9|51.9|Standard Deviation|12.08|12.08|||
3973647|NCT01283516|3796109|B8|||Age||Years|Mean|56.4|56.4|Standard Deviation|4.67|4.67|||
3973648|NCT01283516|3796110|B7|||Age||Years|Mean|54.6|54.6|Standard Deviation|13.22|13.22|||
3973649|NCT01283516|3796111|B6|||Age||Years|Mean|55.0|55.0|Standard Deviation|15.99|15.99|||
3973650|NCT01283516|3796112|B5|||Age||Years|Mean|48.7|48.7|Standard Deviation|15.62|15.62|||
3973651|NCT01283516|3796113|B4|||Age||Years|Mean|58.7|58.7|Standard Deviation|5.03|5.03|||
3973652|NCT01283516|3796114|B3|||Age||Years|Mean|53.7|53.7|Standard Deviation|10.69|10.69|||
3973653|NCT01283516|3796115|B2|||Age||Years|Mean|30.5|30.5|Standard Deviation|12.02|12.02|||
3973654|NCT01283516|3796116|B1|||Age||Years|Mean|46.5|46.5|Standard Deviation|23.33|23.33|||
3973655|NCT01283464|3796146|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
3973656|NCT01283464|3796147|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3973657|NCT01283464|3796148|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3973658|NCT01283464|3796146|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3973659|NCT01283464|3796147|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3973660|NCT01283464|3796148|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3973661|NCT01283464|3796146|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3973662|NCT01283464|3796147|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3973663|NCT01283464|3796148|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3973664|NCT01283464|3796146|B3|||Age||years|Mean|61.8|61.8|Standard Deviation|9.5|9.5|||
3973665|NCT01283464|3796147|B2|||Age||years|Mean|62.7|62.7|Standard Deviation|7.6|7.6|||
3973666|NCT01283464|3796148|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|11.3|11.3|||
3973667|NCT01283464|3796146|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3973668|NCT01283464|3796147|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3973669|NCT01283464|3796148|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3973670|NCT01283464|3796146|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3973671|NCT01283464|3796147|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3973672|NCT01283464|3796148|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3973673|NCT01283464|3796146|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3973674|NCT01283464|3796147|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3973675|NCT01283464|3796148|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3973676|NCT01283334|3796155|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3973677|NCT01283334|3796155|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3973678|NCT01283334|3796155|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3973679|NCT01283334|3796155|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3973680|NCT01283334|3796155|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3973681|NCT01283334|3796155|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3973682|NCT01283334|3796155|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3973683|NCT01283334|3796155|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3973684|NCT01283334|3796155|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3973685|NCT01283334|3796155|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3973686|NCT01283334|3796155|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3973687|NCT01283334|3796155|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3973688|NCT01283334|3796155|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3973689|NCT01283321|3796161|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3973690|NCT01283321|3796162|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3973691|NCT01283321|3796163|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3973692|NCT01283321|3796161|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3973693|NCT01283321|3796162|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3973694|NCT01283321|3796163|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3973695|NCT01283321|3796161|B3|||Age||years|Mean|68.7|68.7|Standard Deviation|7.6|7.6|||
3973696|NCT01283321|3796162|B2|||Age||years|Mean|66.1|66.1|Standard Deviation|8.9|8.9|||
3973697|NCT01283321|3796163|B1|||Age||years|Mean|71.3|71.3|Standard Deviation|5.3|5.3|||
3973698|NCT01283321|3796161|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3973699|NCT01283321|3796162|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3973700|NCT01283321|3796163|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3973701|NCT01283321|3796161|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3973702|NCT01283321|3796162|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3973703|NCT01283321|3796163|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3973704|NCT01283321|3796161|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3973705|NCT01283321|3796162|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3973706|NCT01283321|3796163|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3973707|NCT01283282|3796178|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3973708|NCT01283282|3796178|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3973709|NCT01283282|3796178|B1|||Age||years|Mean|63|63.0|Standard Deviation|1.5|1.5|||
3973710|NCT01283152|3796197|B3|CTP score||MELD and CTP Scores|Model of End-stage Liver Disease (MELD) score assesses the severity of chronic liver disease. MELD has a range from less than 9 to more than 40 with higher numbers indicating greater severity; Child-Turcotte-Pugh (CTP) score assesses the prognosis of chronic liver disease. CTP has a range from 5 to 15 with higher numbers indicating a worse prognosis.|units on a scale|Mean|10|10.0|Standard Deviation|2|2.0|||
3973711|NCT01283152|3796198|B2|CTP score||MELD and CTP Scores|Model of End-stage Liver Disease (MELD) score assesses the severity of chronic liver disease. MELD has a range from less than 9 to more than 40 with higher numbers indicating greater severity; Child-Turcotte-Pugh (CTP) score assesses the prognosis of chronic liver disease. CTP has a range from 5 to 15 with higher numbers indicating a worse prognosis.|units on a scale|Mean|10|10.0|Standard Deviation|1|1.0|||
3973712|NCT01283152|3796199|B1|CTP score||MELD and CTP Scores|Model of End-stage Liver Disease (MELD) score assesses the severity of chronic liver disease. MELD has a range from less than 9 to more than 40 with higher numbers indicating greater severity; Child-Turcotte-Pugh (CTP) score assesses the prognosis of chronic liver disease. CTP has a range from 5 to 15 with higher numbers indicating a worse prognosis.|units on a scale|Mean|10|10.0|Standard Deviation|2|2.0|||
3973713|NCT01283152|3796197|B3|MELD score||MELD and CTP Scores|Model of End-stage Liver Disease (MELD) score assesses the severity of chronic liver disease. MELD has a range from less than 9 to more than 40 with higher numbers indicating greater severity; Child-Turcotte-Pugh (CTP) score assesses the prognosis of chronic liver disease. CTP has a range from 5 to 15 with higher numbers indicating a worse prognosis.|units on a scale|Mean|17|17.0|Standard Deviation|5|5.0|||
3973714|NCT01283152|3796198|B2|MELD score||MELD and CTP Scores|Model of End-stage Liver Disease (MELD) score assesses the severity of chronic liver disease. MELD has a range from less than 9 to more than 40 with higher numbers indicating greater severity; Child-Turcotte-Pugh (CTP) score assesses the prognosis of chronic liver disease. CTP has a range from 5 to 15 with higher numbers indicating a worse prognosis.|units on a scale|Mean|17|17.0|Standard Deviation|5|5.0|||
3973715|NCT01283152|3796199|B1|MELD score||MELD and CTP Scores|Model of End-stage Liver Disease (MELD) score assesses the severity of chronic liver disease. MELD has a range from less than 9 to more than 40 with higher numbers indicating greater severity; Child-Turcotte-Pugh (CTP) score assesses the prognosis of chronic liver disease. CTP has a range from 5 to 15 with higher numbers indicating a worse prognosis.|units on a scale|Mean|17|17.0|Standard Deviation|6|6.0|||
3973716|NCT01283152|3796197|B3|||Albumin||g/dL|Mean|2.7|2.7|Standard Deviation|0.6|0.6|||
3973717|NCT01283152|3796198|B2|||Albumin||g/dL|Mean|2.8|2.8|Standard Deviation|0.5|0.5|||
3973718|NCT01283152|3796199|B1|||Albumin||g/dL|Mean|2.7|2.7|Standard Deviation|0.6|0.6|||
3973719|NCT01283152|3796197|B3|||International Normalized Ratio (INR)|INR is based on the ratio of the patient's prothrombin time and the normal mean prothrombin time.|unitless (ratio)|Mean|1.5|1.5|Standard Deviation|0.4|0.4|||
3973720|NCT01283152|3796198|B2|||International Normalized Ratio (INR)|INR is based on the ratio of the patient's prothrombin time and the normal mean prothrombin time.|unitless (ratio)|Mean|1.4|1.4|Standard Deviation|0.3|0.3|||
3973721|NCT01283152|3796199|B1|||International Normalized Ratio (INR)|INR is based on the ratio of the patient's prothrombin time and the normal mean prothrombin time.|unitless (ratio)|Mean|1.5|1.5|Standard Deviation|0.4|0.4|||
3973722|NCT01283152|3796197|B3|Total Bilirubin||Blood Lab Values||mg/dL|Mean|3.3|3.3|Standard Deviation|2.3|2.3|||
3973723|NCT01283152|3796198|B2|Total Bilirubin||Blood Lab Values||mg/dL|Mean|2.9|2.9|Standard Deviation|1.4|1.4|||
3973724|NCT01283152|3796199|B1|Total Bilirubin||Blood Lab Values||mg/dL|Mean|3.6|3.6|Standard Deviation|3|3.0|||
3973725|NCT01283152|3796197|B3|Creatinine||Blood Lab Values||mg/dL|Mean|1.41|1.41|Standard Deviation|1.02|1.02|||
3973726|NCT01283152|3796198|B2|Creatinine||Blood Lab Values||mg/dL|Mean|1.12|1.12|Standard Deviation|0.52|0.52|||
3973727|NCT01283152|3796199|B1|Creatinine||Blood Lab Values||mg/dL|Mean|1.7|1.7|Standard Deviation|1.29|1.29|||
3973728|NCT01283152|3796197|B3|Blood Urea Nitrogen||Blood Lab Values||mg/dL|Mean|26|26.0|Standard Deviation|15|15.0|||
3973729|NCT01283152|3796198|B2|Blood Urea Nitrogen||Blood Lab Values||mg/dL|Mean|21|21.0|Standard Deviation|11|11.0|||
3973730|NCT01283152|3796199|B1|Blood Urea Nitrogen||Blood Lab Values||mg/dL|Mean|30|30.0|Standard Deviation|17|17.0|||
3973731|NCT01283152|3796197|B3|||White Blood Cell count||cells*10^9/L|Mean|6.2|6.2|Standard Deviation|2.6|2.6|||
3973732|NCT01283152|3796198|B2|||White Blood Cell count||cells*10^9/L|Mean|6.2|6.2|Standard Deviation|2.6|2.6|||
3973733|NCT01283152|3796199|B1|||White Blood Cell count||cells*10^9/L|Mean|6.3|6.3|Standard Deviation|2.6|2.6|||
3973734|NCT01283152|3796197|B3|Hepatitis B||Cirrhosis cause||participants|Number|2|2.0||||||
3973735|NCT01283152|3796198|B2|Hepatitis B||Cirrhosis cause||participants|Number|1|1.0||||||
3973736|NCT01283152|3796199|B1|Hepatitis B||Cirrhosis cause||participants|Number|1|1.0||||||
3973737|NCT01283152|3796197|B3|Hepatitis C||Cirrhosis cause||participants|Number|17|17.0||||||
3973738|NCT01283152|3796198|B2|Hepatitis C||Cirrhosis cause||participants|Number|9|9.0||||||
3973739|NCT01283152|3796199|B1|Hepatitis C||Cirrhosis cause||participants|Number|8|8.0||||||
3973740|NCT01283152|3796197|B3|Cryptogenic||Cirrhosis cause||participants|Number|12|12.0||||||
3973741|NCT01283152|3796198|B2|Cryptogenic||Cirrhosis cause||participants|Number|6|6.0||||||
3973742|NCT01283152|3796199|B1|Cryptogenic||Cirrhosis cause||participants|Number|6|6.0||||||
3973743|NCT01283152|3796197|B3|Alcoholic Liver Disease||Cirrhosis cause||participants|Number|19|19.0||||||
3973744|NCT01283152|3796198|B2|Alcoholic Liver Disease||Cirrhosis cause||participants|Number|9|9.0||||||
3973745|NCT01283152|3796199|B1|Alcoholic Liver Disease||Cirrhosis cause||participants|Number|10|10.0||||||
3973746|NCT01283152|3796197|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3973747|NCT01283152|3796198|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3973748|NCT01283152|3796199|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3973749|NCT01283152|3796197|B3|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3973750|NCT01283152|3796198|B2|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3973751|NCT01283152|3796199|B1|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3973752|NCT01283152|3796197|B3|White, Hispanic||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3973753|NCT01283152|3796198|B2|White, Hispanic||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3973754|NCT01283152|3796199|B1|White, Hispanic||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3973755|NCT01283152|3796197|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3973756|NCT01283152|3796198|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3973757|NCT01283152|3796199|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3973758|NCT01283152|3796197|B3|African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3973759|NCT01283152|3796198|B2|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3973760|NCT01283152|3796199|B1|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3973761|NCT01283152|3796197|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3973762|NCT01283152|3796198|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3973763|NCT01283152|3796199|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3973764|NCT01283152|3796197|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3973765|NCT01283152|3796198|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3973766|NCT01283152|3796199|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3973767|NCT01283152|3796197|B3|||Age||years|Mean|56|56.0|Standard Deviation|9|9.0|||
3973768|NCT01283152|3796198|B2|||Age||years|Mean|56|56.0|Standard Deviation|11|11.0|||
3973769|NCT01283152|3796199|B1|||Age||years|Mean|56|56.0|Standard Deviation|7|7.0|||
3973770|NCT01283139|3796210|B5||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3973771|NCT01283139|3796211|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3973772|NCT01283139|3796212|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3973773|NCT01283139|3796213|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3973774|NCT01283139|3796214|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3973775|NCT01283139|3796210|B5||Female|Sex: Female, Male||Participants|Count of Participants|399|399.0||||||
3973776|NCT01283139|3796211|B4||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3973777|NCT01283139|3796212|B3||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3973778|NCT01283139|3796213|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3973779|NCT01283139|3796214|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3973780|NCT01283139|3796210|B5|||Age||years|Mean|39.4|39.4|Standard Deviation|11.7|11.7|||
3973781|NCT01283139|3796211|B4|||Age||years|Mean|39.4|39.4|Standard Deviation|12.1|12.1|||
3973782|NCT01283139|3796212|B3|||Age||years|Mean|40.1|40.1|Standard Deviation|11.3|11.3|||
3973783|NCT01283139|3796213|B2|||Age||years|Mean|39.9|39.9|Standard Deviation|11.4|11.4|||
3973784|NCT01283139|3796214|B1|||Age||years|Mean|38.4|38.4|Standard Deviation|12.3|12.3|||
3973785|NCT01283035|3796259|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3973786|NCT01283035|3796259|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3973787|NCT01283035|3796259|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3973788|NCT01283035|3796259|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3973789|NCT01283035|3796259|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3973790|NCT01283035|3796259|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3973791|NCT01283022|3796268|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3973792|NCT01283022|3796268|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3973793|NCT01283022|3796268|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3973794|NCT01283022|3796268|B1|||Age||years|Mean|28.0|28.0|Standard Deviation|6.33|6.33|||
3973795|NCT01283022|3796268|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3973796|NCT01283022|3796268|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3973797|NCT01283022|3796268|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3973798|NCT01282866|3796274|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3973799|NCT01282866|3796274|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3973800|NCT01282866|3796274|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3973801|NCT01282866|3796274|B1|||Age||years|Mean|30.9|30.9|Standard Deviation|10|10.0|||
3973802|NCT01282814|3796280|B3|Canada||Region of Enrollment||participants|Number|24|24.0||||||
3973803|NCT01282814|3796281|B2|Canada||Region of Enrollment||participants|Number|12|12.0||||||
3973804|NCT01282814|3796282|B1|Canada||Region of Enrollment||participants|Number|12|12.0||||||
3973805|NCT01282814|3796280|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3973806|NCT01282814|3796281|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3973807|NCT01282814|3796282|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3973808|NCT01282814|3796280|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3973809|NCT01282814|3796281|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3973810|NCT01282814|3796282|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3973811|NCT01282814|3796280|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3973812|NCT01282814|3796281|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3973813|NCT01282814|3796282|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3973814|NCT01282814|3796280|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3973815|NCT01282814|3796281|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3973816|NCT01282814|3796282|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3973817|NCT01282814|3796280|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3973818|NCT01282814|3796281|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3973819|NCT01282814|3796282|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3973820|NCT01282814|3796280|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3973821|NCT01282814|3796281|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3973822|NCT01282814|3796282|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3973823|NCT01282814|3796280|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3973824|NCT01282814|3796281|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3973825|NCT01282814|3796282|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3973826|NCT01282801|3796293|B3|Canada||Region of Enrollment||participants|Number|18|18.0||||||
3973827|NCT01282801|3796294|B2|Canada||Region of Enrollment||participants|Number|9|9.0||||||
3973828|NCT01282801|3796295|B1|Canada||Region of Enrollment||participants|Number|9|9.0||||||
3973829|NCT01282801|3796293|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3973830|NCT01282801|3796294|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3973831|NCT01282801|3796295|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3973832|NCT01282801|3796293|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3973833|NCT01282801|3796294|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3973834|NCT01282801|3796295|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3973835|NCT01282801|3796293|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3973836|NCT01282801|3796294|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3973837|NCT01282801|3796295|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3973838|NCT01282801|3796293|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3973839|NCT01282801|3796294|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3973840|NCT01282801|3796295|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3973841|NCT01282801|3796293|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3973842|NCT01282801|3796294|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3973843|NCT01282801|3796295|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3973844|NCT01282801|3796293|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3973845|NCT01282801|3796294|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3973846|NCT01282801|3796295|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3973847|NCT01282723|3796312|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3973848|NCT01282723|3796312|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3973849|NCT01282723|3796312|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3973850|NCT01282723|3796312|B1|||Age||years|Mean|24.85|24.85|Standard Deviation|4.38|4.38|||
3973851|NCT01282723|3796312|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3973852|NCT01282723|3796312|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3973853|NCT01282723|3796312|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3973854|NCT01282710|3796316|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3973855|NCT01282710|3796316|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3973856|NCT01282710|3796316|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3973857|NCT01282710|3796316|B1|||Age||years|Mean|24.85|24.85|Standard Deviation|4.38|4.38|||
3973858|NCT01282710|3796316|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3973859|NCT01282710|3796316|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3973860|NCT01282710|3796316|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3973861|NCT01282476|3796320|B1||3|Number of prior radiation treatments||Participants|Count of Participants|1|1.0||||||
3973862|NCT01282476|3796320|B1||2|Number of prior radiation treatments||Participants|Count of Participants|2|2.0||||||
3973863|NCT01282476|3796320|B1||1|Number of prior radiation treatments||Participants|Count of Participants|3|3.0||||||
3973864|NCT01282476|3796320|B1||0|Number of prior radiation treatments||Participants|Count of Participants|12|12.0||||||
3973865|NCT01282476|3796320|B1||4|Number of prior surgeries||Participants|Count of Participants|1|1.0||||||
3973866|NCT01282476|3796320|B1||3|Number of prior surgeries||Participants|Count of Participants|1|1.0||||||
3973867|NCT01282476|3796320|B1||2|Number of prior surgeries||Participants|Count of Participants|2|2.0||||||
3973868|NCT01282476|3796320|B1||1|Number of prior surgeries||Participants|Count of Participants|2|2.0||||||
3973869|NCT01282476|3796320|B1||0|Number of prior surgeries||Participants|Count of Participants|12|12.0||||||
3973870|NCT01282476|3796320|B1||6-8|Number of prior non-surgical therapies||Participants|Count of Participants|5|5.0||||||
3973871|NCT01282476|3796320|B1||3-5|Number of prior non-surgical therapies||Participants|Count of Participants|7|7.0||||||
3973872|NCT01282476|3796320|B1||0-2|Number of prior non-surgical therapies||Participants|Count of Participants|6|6.0||||||
3973873|NCT01282476|3796320|B1||9+|Number of prior therapies||Participants|Count of Participants|2|2.0||||||
3973874|NCT01282476|3796320|B1||5-8|Number of prior therapies||Participants|Count of Participants|9|9.0||||||
3973875|NCT01282476|3796320|B1||1-4|Number of prior therapies||Participants|Count of Participants|7|7.0||||||
3973876|NCT01282476|3796320|B1|||Time from last prior therapy||days|Median|117|117.0|Full Range|||10.0|776.0|
3973877|NCT01282476|3796320|B1||6+|Number of non-target lesions||Participants|Count of Participants|2|2.0||||||
3973878|NCT01282476|3796320|B1||3-5|Number of non-target lesions||Participants|Count of Participants|4|4.0||||||
3973879|NCT01282476|3796320|B1||0-2|Number of non-target lesions||Participants|Count of Participants|12|12.0||||||
3973880|NCT01282476|3796320|B1||6+|Number of target lesions||Participants|Count of Participants|8|8.0||||||
3973881|NCT01282476|3796320|B1||3-5|Number of target lesions||Participants|Count of Participants|6|6.0||||||
3973882|NCT01282476|3796320|B1||0-2|Number of target lesions||Participants|Count of Participants|4|4.0||||||
3973883|NCT01282476|3796320|B1||6|Number of extranodal sites||Participants|Count of Participants|2|2.0||||||
3973884|NCT01282476|3796320|B1||3|Number of extranodal sites||Participants|Count of Participants|9|9.0||||||
3973885|NCT01282476|3796320|B1||2|Number of extranodal sites||Participants|Count of Participants|3|3.0||||||
3973886|NCT01282476|3796320|B1||1|Number of extranodal sites||Participants|Count of Participants|3|3.0||||||
3973887|NCT01282476|3796320|B1||0|Number of extranodal sites||Participants|Count of Participants|1|1.0||||||
3973888|NCT01282476|3796320|B1||Relapsed|Disease status||Participants|Count of Participants|8|8.0||||||
3973889|NCT01282476|3796320|B1||Refractory|Disease status||Participants|Count of Participants|10|10.0||||||
3973890|NCT01282476|3796320|B1||02-Ambulatory and Capable of Self Care|ECOG PS (Eastern Cooperative Oncology Group Performance Status)||Participants|Count of Participants|3|3.0||||||
3973891|NCT01282476|3796320|B1||01-Restricted|ECOG PS (Eastern Cooperative Oncology Group Performance Status)||Participants|Count of Participants|8|8.0||||||
3973892|NCT01282476|3796320|B1||00-Fully Active|ECOG PS (Eastern Cooperative Oncology Group Performance Status)||Participants|Count of Participants|7|7.0||||||
3973893|NCT01282476|3796320|B1||Missing|elevated LDH (Lactate dehydrogenase)||Participants|Count of Participants|6|6.0||||||
3973894|NCT01282476|3796320|B1||No|elevated LDH (Lactate dehydrogenase)||Participants|Count of Participants|3|3.0||||||
3973895|NCT01282476|3796320|B1||Yes|elevated LDH (Lactate dehydrogenase)||Participants|Count of Participants|9|9.0||||||
3973896|NCT01282476|3796320|B1||Normal|EKG (electrocardiogram)||Participants|Count of Participants|15|15.0||||||
3973897|NCT01282476|3796320|B1||Abnormal|EKG (electrocardiogram)||Participants|Count of Participants|3|3.0||||||
3973898|NCT01282476|3796320|B1||Gray zone lymphoma|Histology||Participants|Count of Participants|1|1.0||||||
3973899|NCT01282476|3796320|B1||DLBCL of follicular center derivation|Histology||Participants|Count of Participants|1|1.0||||||
3973900|NCT01282476|3796320|B1||DLBCL not otherwise specified|Histology||Participants|Count of Participants|14|14.0||||||
3973901|NCT01282476|3796320|B1||DLBCL follicular cell derivation w/high grade BCL|Histology||Participants|Count of Participants|1|1.0||||||
3973902|NCT01282476|3796320|B1||Centroblastic DLBCL(Diffuse large B cell lymphoma)|Histology||Participants|Count of Participants|1|1.0||||||
3973903|NCT01282476|3796320|B1|United States||Region of Enrollment|8 from DFCI, 10 from MGH|participants|Number|18|18.0||||||
3973904|NCT01282476|3796320|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3973905|NCT01282476|3796320|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3973906|NCT01282476|3796320|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3973907|NCT01282476|3796320|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3973908|NCT01282476|3796320|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3973909|NCT01282476|3796320|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3973910|NCT01282476|3796320|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3973911|NCT01282476|3796320|B1|||Age||years|Median|68|68.0|Full Range|||37.0|83.0|
3973912|NCT01282424|3796326|B1|Marginal zone lymphoma||Baseline Disease History|LPL/WM: Lymphoplasmacytic lymphoma/Waldenström macroglobulinemia|participants|Number|15|15.0||||||
3973913|NCT01282424|3796326|B1|LPL/WM||Baseline Disease History|LPL/WM: Lymphoplasmacytic lymphoma/Waldenström macroglobulinemia|participants|Number|10|10.0||||||
3973914|NCT01282424|3796326|B1|Small lymphocytic lymphoma||Baseline Disease History|LPL/WM: Lymphoplasmacytic lymphoma/Waldenström macroglobulinemia|participants|Number|28|28.0||||||
3973915|NCT01282424|3796326|B1|Folicular lymphoma||Baseline Disease History|LPL/WM: Lymphoplasmacytic lymphoma/Waldenström macroglobulinemia|participants|Number|72|72.0||||||
3973916|NCT01282424|3796326|B1|100||Karnofsky Performance Status|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|46|46.0||||||
3973917|NCT01282424|3796326|B1|90||Karnofsky Performance Status|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|44|44.0||||||
3973918|NCT01282424|3796326|B1|80||Karnofsky Performance Status|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|27|27.0||||||
3973919|NCT01282424|3796326|B1|70||Karnofsky Performance Status|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|6|6.0||||||
3973920|NCT01282424|3796326|B1|60||Karnofsky Performance Status|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|2|2.0||||||
3973921|NCT01282424|3796326|B1|Italy||Region of Enrollment||participants|Number|6|6.0||||||
3973922|NCT01282424|3796326|B1|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3973923|NCT01282424|3796326|B1|Germany||Region of Enrollment||participants|Number|10|10.0||||||
3973924|NCT01282424|3796326|B1|Poland||Region of Enrollment||participants|Number|8|8.0||||||
3973925|NCT01282424|3796326|B1|United States||Region of Enrollment||participants|Number|83|83.0||||||
3973926|NCT01282424|3796326|B1|France||Region of Enrollment||participants|Number|10|10.0||||||
3973927|NCT01282424|3796326|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3973928|NCT01282424|3796326|B1|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3973929|NCT01282424|3796326|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3973930|NCT01282424|3796326|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3973931|NCT01282424|3796326|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3973932|NCT01282424|3796326|B1|White/Caucasian||Race/Ethnicity, Customized||participants|Number|110|110.0||||||
3973933|NCT01282424|3796326|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3973934|NCT01282424|3796326|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|117|117.0||||||
3973935|NCT01282424|3796326|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3973936|NCT01282424|3796326|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3973937|NCT01282424|3796326|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3973938|NCT01282424|3796326|B1|||Age||years|Mean|62|62.0|Standard Deviation|11.4|11.4|||
3973939|NCT01282372|3796343|B1|Student||Employment Status||Participants|Number|9|9.0||||||
3973940|NCT01282372|3796343|B1|Unemployed||Employment Status||Participants|Number|35|35.0||||||
3973941|NCT01282372|3796343|B1|Self-employed||Employment Status||Participants|Number|95|95.0||||||
3973942|NCT01282372|3796343|B1|Employee||Employment Status||Participants|Number|116|116.0||||||
3973943|NCT01282372|3796343|B1|Retired||Employment Status||Participants|Number|118|118.0||||||
3973944|NCT01282372|3796343|B1|Housewife||Employment Status||Participants|Number|127|127.0||||||
3973945|NCT01282372|3796343|B1||Male|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
3973946|NCT01282372|3796343|B1||Female|Sex: Female, Male||Participants|Count of Participants|289|289.0||||||
3973947|NCT01282372|3796343|B1|||Age||Years|Mean|52.5|52.5|Standard Deviation|14.8|14.8|||
3973948|NCT01282294|3796371|B1|None||Use of systemic antibiotics prophylaxis|More than one option possible.|participants|Number|0|0.0||||||
3973949|NCT01282294|3796371|B1|Post-Operative||Use of systemic antibiotics prophylaxis|More than one option possible.|participants|Number|32|32.0||||||
3973950|NCT01282294|3796371|B1|Peri-Operative||Use of systemic antibiotics prophylaxis|More than one option possible.|participants|Number|76|76.0||||||
3973951|NCT01282294|3796371|B1|Pre-Operative||Use of systemic antibiotics prophylaxis|More than one option possible.|participants|Number|28|28.0||||||
3973952|NCT01282294|3796371|B1|||Time from injury to surgery for revision patients|The time-to-surgery was recorded for 21 revision-patients.|months|Mean|17.1|17.1|Standard Deviation|16.5|16.5|||
3973953|NCT01282294|3796371|B1|||Time from injury to surgery for traumatic/pathologic patients|The time-to-surgery was recorded for 67 traumatic/pathologic patients.|days|Mean|8.7|8.7|Standard Deviation|28.5|28.5|||
3973954|NCT01282294|3796371|B1|Unknown||Fracture type (open or closed)||participants|Number|3|3.0||||||
3973955|NCT01282294|3796371|B1|None||Fracture type (open or closed)||participants|Number|1|1.0||||||
3973956|NCT01282294|3796371|B1|Closed||Fracture type (open or closed)||participants|Number|50|50.0||||||
3973957|NCT01282294|3796371|B1|Open||Fracture type (open or closed)||participants|Number|45|45.0||||||
3973958|NCT01282294|3796371|B1|revision purposes||Fracture type|Patients were divided into two groups of fracture types: (1) traumatic/pathologic fractures and (2) other: patients receiving the ETN PROtect due to revision purposes.|participants|Number|31|31.0||||||
3974011|NCT01282242|3796390|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3973959|NCT01282294|3796371|B1|traumatic/pathologic||Fracture type|Patients were divided into two groups of fracture types: (1) traumatic/pathologic fractures and (2) other: patients receiving the ETN PROtect due to revision purposes.|participants|Number|68|68.0||||||
3973960|NCT01282294|3796371|B1|Ex-drug abuser||Drugs||participants|Number|15|15.0||||||
3973961|NCT01282294|3796371|B1|Drug abuser||Drugs||participants|Number|0|0.0||||||
3973962|NCT01282294|3796371|B1|Never used drugs||Drugs||participants|Number|84|84.0||||||
3973963|NCT01282294|3796371|B1|Ex-drinker||Drinking||participants|Number|1|1.0||||||
3973964|NCT01282294|3796371|B1|Drinker||Drinking||participants|Number|0|0.0||||||
3973965|NCT01282294|3796371|B1|Drinks small amounts (<3 units/day)||Drinking||participants|Number|76|76.0||||||
3973966|NCT01282294|3796371|B1|Never drank||Drinking||participants|Number|22|22.0||||||
3973967|NCT01282294|3796371|B1|No, never smoked||Smoking||participants|Number|45|45.0||||||
3973968|NCT01282294|3796371|B1|No, quit > 6 Months ago||Smoking||participants|Number|19|19.0||||||
3973969|NCT01282294|3796371|B1|No, quit <= 6 Months ago||Smoking||participants|Number|4|4.0||||||
3973970|NCT01282294|3796371|B1|Yes||Smoking||participants|Number|31|31.0||||||
3973971|NCT01282294|3796371|B1|Other||Allergies||participants|Number|23|23.0||||||
3973972|NCT01282294|3796371|B1|Gentamicin||Allergies||participants|Number|0|0.0||||||
3973973|NCT01282294|3796371|B1|Metal||Allergies||participants|Number|2|2.0||||||
3973974|NCT01282294|3796371|B1|No or unknown||Allergies||participants|Number|74|74.0||||||
3973975|NCT01282294|3796371|B1|||Weight||kg|Mean|82.8|82.8|Standard Deviation|18.7|18.7|||
3973976|NCT01282294|3796371|B1|||Height||cm|Mean|177.6|177.6|Standard Deviation|8.6|8.6|||
3973977|NCT01282294|3796371|B1|||Body Mass Index (BMI)||kg/m^2|Mean|26.2|26.2|Standard Deviation|5.2|5.2|||
3973978|NCT01282294|3796371|B1|Germany||Region of Enrollment||participants|Number|99|99.0||||||
3973979|NCT01282294|3796371|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3973980|NCT01282294|3796371|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3973981|NCT01282294|3796371|B1|Negroid||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3973982|NCT01282294|3796371|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|97|97.0||||||
3973983|NCT01282294|3796371|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3973984|NCT01282294|3796371|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3973985|NCT01282294|3796371|B1|||Age||years|Mean|46.6|46.6|Standard Deviation|15.6|15.6|||
3973986|NCT01282242|3796389|B3|||Modified Rankin Scale|Modified Rankin Scale (mRS) measures a subjects degree of disability on a scale of 0 to 6, where 0 is no disability and 6 is death.|units on a scale|Mean|1.18|1.18|Standard Deviation|1.72|1.72|||
3973987|NCT01282242|3796390|B2|||Modified Rankin Scale|Modified Rankin Scale (mRS) measures a subjects degree of disability on a scale of 0 to 6, where 0 is no disability and 6 is death.|units on a scale|Mean|1.38|1.38|Standard Deviation|2.26|2.26|||
3973988|NCT01282242|3796391|B1|||Modified Rankin Scale|Modified Rankin Scale (mRS) measures a subjects degree of disability on a scale of 0 to 6, where 0 is no disability and 6 is death.|units on a scale|Mean|0.48|0.48|Standard Deviation|1.09|1.09|||
3973989|NCT01282242|3796389|B3|||NIH Stroke Scale (NIHSS)|NIH Stroke Scale measured the severity of the stroke. The scores ranged between 4 to 42, with higher score indicating worsening of the Outcome. NIHSS score above 20 is indicative of severe stroke.|units on a scale|Mean|9.35|9.35|Standard Deviation|5.91|5.91|||
3973990|NCT01282242|3796390|B2|||NIH Stroke Scale (NIHSS)|NIH Stroke Scale measured the severity of the stroke. The scores ranged between 4 to 42, with higher score indicating worsening of the Outcome. NIHSS score above 20 is indicative of severe stroke.|units on a scale|Mean|10.13|10.13|Standard Deviation|4.64|4.64|||
3973991|NCT01282242|3796391|B1|||NIH Stroke Scale (NIHSS)|NIH Stroke Scale measured the severity of the stroke. The scores ranged between 4 to 42, with higher score indicating worsening of the Outcome. NIHSS score above 20 is indicative of severe stroke.|units on a scale|Mean|9.31|9.31|Standard Deviation|5.87|5.87|||
3973992|NCT01282242|3796389|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3973993|NCT01282242|3796390|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3973994|NCT01282242|3796391|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3973995|NCT01282242|3796389|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3973996|NCT01282242|3796390|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3973997|NCT01282242|3796391|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3973998|NCT01282242|3796389|B3||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3973999|NCT01282242|3796390|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3974000|NCT01282242|3796391|B1||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3974001|NCT01282242|3796389|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3974002|NCT01282242|3796390|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3974003|NCT01282242|3796391|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3974004|NCT01282242|3796389|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974005|NCT01282242|3796390|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974006|NCT01282242|3796391|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974007|NCT01282242|3796389|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3974008|NCT01282242|3796390|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3974009|NCT01282242|3796391|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3974010|NCT01282242|3796389|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3974012|NCT01282242|3796391|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3974013|NCT01282242|3796389|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3974014|NCT01282242|3796390|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974015|NCT01282242|3796391|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3974016|NCT01282242|3796389|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
3974017|NCT01282242|3796390|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3974018|NCT01282242|3796391|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3974019|NCT01282242|3796389|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3974020|NCT01282242|3796390|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974021|NCT01282242|3796391|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3974022|NCT01282242|3796389|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3974023|NCT01282242|3796390|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3974024|NCT01282242|3796391|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3974025|NCT01282242|3796389|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3974026|NCT01282242|3796390|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3974027|NCT01282242|3796391|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3974028|NCT01282242|3796389|B3|||Age||years|Mean|67.43|67.43|Standard Deviation|13.26|13.26|||
3974029|NCT01282242|3796390|B2|||Age||years|Mean|67.13|67.13|Standard Deviation|11.63|11.63|||
3974030|NCT01282242|3796391|B1|||Age||years|Mean|67.46|67.46|Standard Deviation|13.5|13.5|||
3974031|NCT01282229|3796400|B1|Coronal Debridement||Gingival Index (GI)|Modified Gingival Index of Lobene et al (1986). Inflammation rated 0 (none) to 4 (severe).|units on a scale|Mean|2.43|2.43|Standard Deviation|0.95|0.95|||
3974032|NCT01282229|3796400|B1|Scaling and Root Planing||Gingival Index (GI)|Modified Gingival Index of Lobene et al (1986). Inflammation rated 0 (none) to 4 (severe).|units on a scale|Mean|2.44|2.44|Standard Deviation|0.96|0.96|||
3974033|NCT01282229|3796400|B1|Modified Widman Flap||Gingival Index (GI)|Modified Gingival Index of Lobene et al (1986). Inflammation rated 0 (none) to 4 (severe).|units on a scale|Mean|2.42|2.42|Standard Deviation|0.95|0.95|||
3974034|NCT01282229|3796400|B1|LANAP Quadrant||Gingival Index (GI)|Modified Gingival Index of Lobene et al (1986). Inflammation rated 0 (none) to 4 (severe).|units on a scale|Mean|2.48|2.48|Standard Deviation|0.95|0.95|||
3974035|NCT01282229|3796400|B1|Coronal Debridement||Bleeding on Probing (BOP)|Percent of pockets within a quadrant that bled on probing by time and treatment|percentage of pockets|Mean|47.5|47.5|Standard Deviation|31.2|31.2|||
3974036|NCT01282229|3796400|B1|Scaling and Root Planing||Bleeding on Probing (BOP)|Percent of pockets within a quadrant that bled on probing by time and treatment|percentage of pockets|Mean|48.2|48.2|Standard Deviation|30.6|30.6|||
3974037|NCT01282229|3796400|B1|Modified Widman Flap||Bleeding on Probing (BOP)|Percent of pockets within a quadrant that bled on probing by time and treatment|percentage of pockets|Mean|46.5|46.5|Standard Deviation|31.2|31.2|||
3974038|NCT01282229|3796400|B1|LANAP Quadrant||Bleeding on Probing (BOP)|Percent of pockets within a quadrant that bled on probing by time and treatment|percentage of pockets|Mean|49.4|49.4|Standard Deviation|31.4|31.4|||
3974039|NCT01282229|3796400|B1|PD >= 7mm (Coronal Debridement)||Average Clinical Attachment Level (CAL)||mm|Mean|7.681|7.681|Standard Deviation|1.659|1.659|||
3974040|NCT01282229|3796400|B1|PD >= 7mm (Scaling and Root Planing)||Average Clinical Attachment Level (CAL)||mm|Mean|7.528|7.528|Standard Deviation|1.751|1.751|||
3974041|NCT01282229|3796400|B1|PD >= 7mm (Modified Widman Flap)||Average Clinical Attachment Level (CAL)||mm|Mean|7.737|7.737|Standard Deviation|1.586|1.586|||
3974042|NCT01282229|3796400|B1|PD >= 7mm (LANAP Quadrant)||Average Clinical Attachment Level (CAL)||mm|Mean|7.453|7.453|Standard Deviation|1.594|1.594|||
3974043|NCT01282229|3796400|B1|PD = 5-6mm (Coronal Debridement)||Average Clinical Attachment Level (CAL)||mm|Mean|5.468|5.468|Standard Deviation|1.486|1.486|||
3974044|NCT01282229|3796400|B1|PD = 5-6mm (Scaling and Root Planing)||Average Clinical Attachment Level (CAL)||mm|Mean|5.364|5.364|Standard Deviation|1.244|1.244|||
3974045|NCT01282229|3796400|B1|PD = 5-6mm ( Modified Widman Flap)||Average Clinical Attachment Level (CAL)||mm|Mean|5.440|5.44|Standard Deviation|1.349|1.349|||
3974046|NCT01282229|3796400|B1|PD = 5-6mm (LANAP Quadrant)||Average Clinical Attachment Level (CAL)||mm|Mean|5.431|5.431|Standard Deviation|1.301|1.301|||
3974047|NCT01282229|3796400|B1|PD >= 7mm (Coronal Debridement)||Average Probing Depth (PD)||mm|Mean|7.672|7.672|Standard Deviation|1.069|1.069|||
3974048|NCT01282229|3796400|B1|PD >= 7mm (Scaling and Root Planing)||Average Probing Depth (PD)||mm|Mean|7.657|7.657|Standard Deviation|.967|0.967|||
3974049|NCT01282229|3796400|B1|PD >= 7mm (Modified Widman Flap)||Average Probing Depth (PD)||mm|Mean|7.562|7.562|Standard Deviation|.901|0.901|||
3974050|NCT01282229|3796400|B1|PD >= 7mm (LANAP Quadrant)||Average Probing Depth (PD)||mm|Mean|7.606|7.606|Standard Deviation|.867|0.867|||
3974051|NCT01282229|3796400|B1|PD = 5-6mm (Coronal Debridement)||Average Probing Depth (PD)||mm|Mean|5.382|5.382|Standard Deviation|.554|0.554|||
3974052|NCT01282229|3796400|B1|PD = 5-6mm (Scaling and Root Planing)||Average Probing Depth (PD)||mm|Mean|5.358|5.358|Standard Deviation|.570|0.57|||
3974053|NCT01282229|3796400|B1|PD = 5-6mm ( Modified Widman Flap)||Average Probing Depth (PD)||mm|Mean|5.358|5.358|Standard Deviation|.569|0.569|||
3974054|NCT01282229|3796400|B1|PD = 5-6mm (LANAP Quadrant)||Average Probing Depth (PD)||mm|Mean|5.364|5.364|Standard Deviation|.553|0.553|||
3974055|NCT01282229|3796400|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3974056|NCT01282229|3796400|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3974057|NCT01282229|3796400|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3974058|NCT01282229|3796400|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3974059|NCT01282229|3796400|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3974060|NCT01282203|3796430|B1||Male|Sex: Female, Male||Participants|Count of Participants|503|503.0||||||
3974061|NCT01282203|3796430|B1||Female|Sex: Female, Male||Participants|Count of Participants|619|619.0||||||
3974062|NCT01282203|3796430|B1|||Age||years|Mean|45.1|45.1|Standard Deviation|9.0|9.0|||
3974063|NCT01282164|3796450|B3|United States||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
3974064|NCT01282164|3796451|B2|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3974065|NCT01282164|3796452|B1|United States||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3974066|NCT01282164|3796450|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3974067|NCT01282164|3796451|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3974068|NCT01282164|3796452|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3974069|NCT01282164|3796450|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3974070|NCT01282164|3796451|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3974071|NCT01282164|3796452|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3974072|NCT01282164|3796450|B3|||Age||years|Mean|50.3|50.3|Standard Deviation|11.9|11.9|||
3974073|NCT01282164|3796451|B2|||Age||years|Mean|49.0|49.0|Standard Deviation|12.2|12.2|||
3974074|NCT01282164|3796452|B1|||Age||years|Mean|51.0|51.0|Standard Deviation|11.9|11.9|||
3974075|NCT01282164|3796450|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3974076|NCT01282164|3796451|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3974077|NCT01282164|3796452|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3974078|NCT01282164|3796450|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3974079|NCT01282164|3796451|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3974080|NCT01282164|3796452|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3974081|NCT01282164|3796450|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3974082|NCT01282164|3796451|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3974083|NCT01282164|3796452|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3974084|NCT01282138|3796476|B3|Canada||Region of Enrollment||participants|Number|13|13.0||||||
3974085|NCT01282138|3796477|B2|Canada||Region of Enrollment||participants|Number|7|7.0||||||
3974086|NCT01282138|3796478|B1|Canada||Region of Enrollment||participants|Number|6|6.0||||||
3974087|NCT01282138|3796476|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3974088|NCT01282138|3796477|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3974089|NCT01282138|3796478|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3974090|NCT01282138|3796476|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3974091|NCT01282138|3796477|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3974092|NCT01282138|3796478|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3974093|NCT01282138|3796476|B3|||Age||years|Mean|38.1|38.1|Standard Deviation|10.6|10.6|||
3974094|NCT01282138|3796477|B2|||Age||years|Mean|39.9|39.9|Standard Deviation|11.2|11.2|||
3974095|NCT01282138|3796478|B1|||Age||years|Mean|36.0|36.0|Standard Deviation|10.4|10.4|||
3974096|NCT01282086|3796487|B1||Male|Sex: Female, Male||Participants|Count of Participants|471|471.0||||||
3974097|NCT01282086|3796487|B1||Female|Sex: Female, Male||Participants|Count of Participants|894|894.0||||||
3974098|NCT01282086|3796487|B1|||Age||years|Mean|44.6|44.6|Standard Deviation|3.0|3.0|||
3974099|NCT01281956|3796504|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3974100|NCT01281956|3796504|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3974101|NCT01281956|3796504|B1|||Age||years|Mean|40|40.0|Standard Deviation|12.16|12.16|||
3974102|NCT01281956|3796504|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3974103|NCT01281956|3796504|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3974104|NCT01281956|3796504|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3974105|NCT01281917|3796536|B1||2|ECOG Performance Status|"ECOG scales and criteria are used by doctors and researchers to assess how a patient's disease is progressing. Grade 0 is no affect to the daily living abilities of the patient, and Grade 5 is dead. This study was limited to participants with ECOG grades 0-2. Grade 0 is Fully active, able to carry on all pre-disease performance without restriction, and Grade 2 is Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours."|Participants|Count of Participants|6|6.0||||||
3974106|NCT01281917|3796536|B1||1|ECOG Performance Status|"ECOG scales and criteria are used by doctors and researchers to assess how a patient's disease is progressing. Grade 0 is no affect to the daily living abilities of the patient, and Grade 5 is dead. This study was limited to participants with ECOG grades 0-2. Grade 0 is Fully active, able to carry on all pre-disease performance without restriction, and Grade 2 is Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours."|Participants|Count of Participants|16|16.0||||||
3974107|NCT01281917|3796536|B1||0|ECOG Performance Status|"ECOG scales and criteria are used by doctors and researchers to assess how a patient's disease is progressing. Grade 0 is no affect to the daily living abilities of the patient, and Grade 5 is dead. This study was limited to participants with ECOG grades 0-2. Grade 0 is Fully active, able to carry on all pre-disease performance without restriction, and Grade 2 is Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours."|Participants|Count of Participants|17|17.0||||||
3974156|NCT01281501|3796627|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3974108|NCT01281917|3796536|B1||Marginal zone lymphoma|Histology||Participants|Count of Participants|2|2.0||||||
3974109|NCT01281917|3796536|B1||Small lymphocytic lymphoma|Histology||Participants|Count of Participants|3|3.0||||||
3974110|NCT01281917|3796536|B1||Mantle cell lymphoma|Histology||Participants|Count of Participants|7|7.0||||||
3974111|NCT01281917|3796536|B1||Follicular lymphoma|Histology||Participants|Count of Participants|9|9.0||||||
3974112|NCT01281917|3796536|B1||DLBCL|Histology||Participants|Count of Participants|18|18.0||||||
3974113|NCT01281917|3796536|B1|||Number of prior treatments||Prior treatments|Median|4|4.0|Full Range|||1.0|11.0|
3974114|NCT01281917|3796536|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
3974115|NCT01281917|3796536|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3974116|NCT01281917|3796536|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3974117|NCT01281917|3796536|B1|||Age||years|Median|68|68.0|Full Range|||38.0|89.0|
3974118|NCT01281865|3796546|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
3974119|NCT01281865|3796547|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3974120|NCT01281865|3796548|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3974121|NCT01281865|3796546|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3974122|NCT01281865|3796547|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3974123|NCT01281865|3796548|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3974124|NCT01281865|3796546|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3974125|NCT01281865|3796547|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3974126|NCT01281865|3796548|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3974127|NCT01281865|3796546|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3974128|NCT01281865|3796547|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3974129|NCT01281865|3796548|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3974130|NCT01281865|3796546|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3974131|NCT01281865|3796547|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3974132|NCT01281865|3796548|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3974133|NCT01281865|3796546|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3974134|NCT01281865|3796547|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3974135|NCT01281865|3796548|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3974136|NCT01281839|3796555|B3||Male|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
3974137|NCT01281839|3796556|B2||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3974138|NCT01281839|3796557|B1||Male|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
3974139|NCT01281839|3796555|B3||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3974140|NCT01281839|3796556|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3974141|NCT01281839|3796557|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3974142|NCT01281839|3796555|B3|||Age||years|Median|52|52.0|Full Range|||20.0|71.0|
3974143|NCT01281839|3796556|B2|||Age||years|Median|52|52.0|Full Range|||21.0|71.0|
3974144|NCT01281839|3796557|B1|||Age||years|Median|52|52.0|Full Range|||20.0|70.0|
3974145|NCT01281644|3796619|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3974146|NCT01281644|3796619|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3974147|NCT01281644|3796619|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3974148|NCT01281644|3796619|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3974149|NCT01281644|3796619|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3974150|NCT01281501|3796627|B3|||Pretreatment 100-millimeter visual analog scale (VAS) scores|Self-marked pain scores on the 100-millimeter VAS lines were assessed by the patients before treatment. The minimal and maximal scores were between 0-100 millimeters. Good responders (good outcome) defined those had ≥ 50% decreases in post-treatment VAS compared with the pre-treatment evaluation and post-treatment scores ≤ 40 millimeters at the end of the study. Non-responders (worse outcome) defined those who had <50% decreases in post-treatment VAS compared with the pre-treatment evaluation or post-treatment scores > 40 millimeters at the end of the study.|millimeters|Mean|64|64.0|Standard Deviation|14|14.0|||
3974151|NCT01281501|3796628|B2|||Pretreatment 100-millimeter visual analog scale (VAS) scores|Self-marked pain scores on the 100-millimeter VAS lines were assessed by the patients before treatment. The minimal and maximal scores were between 0-100 millimeters. Good responders (good outcome) defined those had ≥ 50% decreases in post-treatment VAS compared with the pre-treatment evaluation and post-treatment scores ≤ 40 millimeters at the end of the study. Non-responders (worse outcome) defined those who had <50% decreases in post-treatment VAS compared with the pre-treatment evaluation or post-treatment scores > 40 millimeters at the end of the study.|millimeters|Mean|64|64.0|Standard Deviation|16|16.0|||
3974152|NCT01281501|3796629|B1|||Pretreatment 100-millimeter visual analog scale (VAS) scores|Self-marked pain scores on the 100-millimeter VAS lines were assessed by the patients before treatment. The minimal and maximal scores were between 0-100 millimeters. Good responders (good outcome) defined those had ≥ 50% decreases in post-treatment VAS compared with the pre-treatment evaluation and post-treatment scores ≤ 40 millimeters at the end of the study. Non-responders (worse outcome) defined those who had <50% decreases in post-treatment VAS compared with the pre-treatment evaluation or post-treatment scores > 40 millimeters at the end of the study.|millimeters|Mean|64|64.0|Standard Deviation|13|13.0|||
3974153|NCT01281501|3796627|B3|Thailand||Region of Enrollment||participants|Number|87|87.0||||||
3974154|NCT01281501|3796628|B2|Thailand||Region of Enrollment||participants|Number|43|43.0||||||
3974155|NCT01281501|3796629|B1|Thailand||Region of Enrollment||participants|Number|44|44.0||||||
3974157|NCT01281501|3796628|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3974158|NCT01281501|3796629|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3974159|NCT01281501|3796627|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3974160|NCT01281501|3796628|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3974161|NCT01281501|3796629|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3974162|NCT01281501|3796627|B3|||Age||years|Mean|29.6|29.6|Standard Deviation|8.6|8.6|||
3974163|NCT01281501|3796628|B2|||Age||years|Mean|29.4|29.4|Standard Deviation|9.2|9.2|||
3974164|NCT01281501|3796629|B1|||Age||years|Mean|29.8|29.8|Standard Deviation|8.1|8.1|||
3974165|NCT01281501|3796627|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3974166|NCT01281501|3796628|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3974167|NCT01281501|3796629|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3974168|NCT01281501|3796627|B3||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
3974169|NCT01281501|3796628|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3974170|NCT01281501|3796629|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
3974171|NCT01281501|3796627|B3||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3974172|NCT01281501|3796628|B2||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3974173|NCT01281501|3796629|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3974174|NCT01281475|3796642|B3|||Tremors|Presence of tremors at baseline|Participants|Count of Participants|31|31.0||||||
3974175|NCT01281475|3796643|B2|||Tremors|Presence of tremors at baseline|Participants|Count of Participants|15|15.0||||||
3974176|NCT01281475|3796644|B1|||Tremors|Presence of tremors at baseline|Participants|Count of Participants|16|16.0||||||
3974177|NCT01281475|3796642|B3|||Developmental age - Bayley Cognitive||months|Mean|19|19.0|Standard Deviation|7|7.0|||
3974178|NCT01281475|3796643|B2|||Developmental age - Bayley Cognitive||months|Mean|18|18.0|Standard Deviation|6|6.0|||
3974179|NCT01281475|3796644|B1|||Developmental age - Bayley Cognitive||months|Mean|19|19.0|Standard Deviation|8|8.0|||
3974180|NCT01281475|3796642|B3|Male||Sex/Gender, Customized||participants|Number|30|30.0||||||
3974181|NCT01281475|3796643|B2|Male||Sex/Gender, Customized||participants|Number|14|14.0||||||
3974182|NCT01281475|3796644|B1|Male||Sex/Gender, Customized||participants|Number|16|16.0||||||
3974183|NCT01281475|3796642|B3|Female||Sex/Gender, Customized||participants|Number|25|25.0||||||
3974184|NCT01281475|3796643|B2|Female||Sex/Gender, Customized||participants|Number|12|12.0||||||
3974185|NCT01281475|3796644|B1|Female||Sex/Gender, Customized||participants|Number|13|13.0||||||
3974186|NCT01281475|3796642|B3||>=65 years|Age|In the Levodopa group, 4 participants failed to complete the study; in the Placebo group, 8 participants failed to complete the study. None of these 12 participants could be analyzed further, so we do not have the breakdown of their gender and other measures.|Participants|Count of Participants|0|0.0||||||
3974187|NCT01281475|3796643|B2||>=65 years|Age|In the Levodopa group, 4 participants failed to complete the study; in the Placebo group, 8 participants failed to complete the study. None of these 12 participants could be analyzed further, so we do not have the breakdown of their gender and other measures.|Participants|Count of Participants|0|0.0||||||
3974188|NCT01281475|3796644|B1||>=65 years|Age|In the Levodopa group, 4 participants failed to complete the study; in the Placebo group, 8 participants failed to complete the study. None of these 12 participants could be analyzed further, so we do not have the breakdown of their gender and other measures.|Participants|Count of Participants|0|0.0||||||
3974189|NCT01281475|3796642|B3||Between 18 and 65 years|Age|In the Levodopa group, 4 participants failed to complete the study; in the Placebo group, 8 participants failed to complete the study. None of these 12 participants could be analyzed further, so we do not have the breakdown of their gender and other measures.|Participants|Count of Participants|0|0.0||||||
3974190|NCT01281475|3796643|B2||Between 18 and 65 years|Age|In the Levodopa group, 4 participants failed to complete the study; in the Placebo group, 8 participants failed to complete the study. None of these 12 participants could be analyzed further, so we do not have the breakdown of their gender and other measures.|Participants|Count of Participants|0|0.0||||||
3974191|NCT01281475|3796644|B1||Between 18 and 65 years|Age|In the Levodopa group, 4 participants failed to complete the study; in the Placebo group, 8 participants failed to complete the study. None of these 12 participants could be analyzed further, so we do not have the breakdown of their gender and other measures.|Participants|Count of Participants|0|0.0||||||
3974192|NCT01281475|3796642|B3||<=18 years|Age|In the Levodopa group, 4 participants failed to complete the study; in the Placebo group, 8 participants failed to complete the study. None of these 12 participants could be analyzed further, so we do not have the breakdown of their gender and other measures.|Participants|Count of Participants|55|55.0||||||
3974193|NCT01281475|3796643|B2||<=18 years|Age|In the Levodopa group, 4 participants failed to complete the study; in the Placebo group, 8 participants failed to complete the study. None of these 12 participants could be analyzed further, so we do not have the breakdown of their gender and other measures.|Participants|Count of Participants|26|26.0||||||
3974194|NCT01281475|3796644|B1||<=18 years|Age|In the Levodopa group, 4 participants failed to complete the study; in the Placebo group, 8 participants failed to complete the study. None of these 12 participants could be analyzed further, so we do not have the breakdown of their gender and other measures.|Participants|Count of Participants|29|29.0||||||
3974195|NCT01281306|3796653|B8||Male|Sex: Female, Male||Participants|Count of Participants|495|495.0||||||
3974196|NCT01281306|3796654|B7||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3974197|NCT01281306|3796655|B6||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3974198|NCT01281306|3796656|B5||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3974199|NCT01281306|3796657|B4||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3974200|NCT01281306|3796658|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3974201|NCT01281306|3796659|B2||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3974202|NCT01281306|3796660|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3974203|NCT01281306|3796653|B8||Female|Sex: Female, Male||Participants|Count of Participants|412|412.0||||||
3974204|NCT01281306|3796654|B7||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3974205|NCT01281306|3796655|B6||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3974206|NCT01281306|3796656|B5||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3974207|NCT01281306|3796657|B4||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3974208|NCT01281306|3796658|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3974209|NCT01281306|3796659|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3974210|NCT01281306|3796660|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3974211|NCT01281306|3796653|B8|||Age||Years|Mean|61.5|61.5|Standard Deviation|11.13|11.13|||
3974212|NCT01281306|3796654|B7|||Age||Years|Mean|60.8|60.8|Standard Deviation|11.81|11.81|||
3974213|NCT01281306|3796655|B6|||Age||Years|Mean|61.2|61.2|Standard Deviation|10.60|10.6|||
3974214|NCT01281306|3796656|B5|||Age||Years|Mean|62.0|62.0|Standard Deviation|11.45|11.45|||
3974215|NCT01281306|3796657|B4|||Age||Years|Mean|62.0|62.0|Standard Deviation|10.73|10.73|||
3974216|NCT01281306|3796658|B3|||Age||Years|Mean|61.0|61.0|Standard Deviation|11.03|11.03|||
3974217|NCT01281306|3796659|B2|||Age||Years|Mean|61.7|61.7|Standard Deviation|11.44|11.44|||
3974218|NCT01281306|3796660|B1|||Age||Years|Mean|61.7|61.7|Standard Deviation|11.36|11.36|||
3974219|NCT01281202|3796780|B3|United States||Region of Enrollment||participants|Number|207|207.0||||||
3974220|NCT01281202|3796781|B2|United States||Region of Enrollment||participants|Number|104|104.0||||||
3974221|NCT01281202|3796782|B1|United States||Region of Enrollment||participants|Number|103|103.0||||||
3974222|NCT01281202|3796780|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3974223|NCT01281202|3796781|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3974224|NCT01281202|3796782|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3974225|NCT01281202|3796780|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3974226|NCT01281202|3796781|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3974227|NCT01281202|3796782|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3974228|NCT01281202|3796780|B3||White|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3974229|NCT01281202|3796781|B2||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3974230|NCT01281202|3796782|B1||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3974231|NCT01281202|3796780|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
3974232|NCT01281202|3796781|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3974233|NCT01281202|3796782|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3974234|NCT01281202|3796780|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974235|NCT01281202|3796781|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974236|NCT01281202|3796782|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974237|NCT01281202|3796780|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3974238|NCT01281202|3796781|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974239|NCT01281202|3796782|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3974240|NCT01281202|3796780|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3974241|NCT01281202|3796781|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3974242|NCT01281202|3796782|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974243|NCT01281202|3796780|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3974244|NCT01281202|3796781|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3974245|NCT01281202|3796782|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3974246|NCT01281202|3796780|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|169|169.0||||||
3974247|NCT01281202|3796781|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3974248|NCT01281202|3796782|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3974249|NCT01281202|3796780|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3974250|NCT01281202|3796781|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3974251|NCT01281202|3796782|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3974252|NCT01281202|3796780|B3||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3974253|NCT01281202|3796781|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3974254|NCT01281202|3796782|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3974255|NCT01281202|3796780|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3974256|NCT01281202|3796781|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3974257|NCT01281202|3796782|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3974258|NCT01281202|3796780|B3|||Age||years|Mean|46.6|46.6|Standard Deviation|7.5|7.5|||
3974259|NCT01281202|3796781|B2|||Age||years|Mean|47.2|47.2|Standard Deviation|7.4|7.4|||
3974260|NCT01281202|3796782|B1|||Age||years|Mean|46.1|46.1|Standard Deviation|7.5|7.5|||
3974261|NCT01281124|3796791|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3974262|NCT01281124|3796791|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3974263|NCT01281124|3796791|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3974264|NCT01281124|3796791|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3974265|NCT01281124|3796791|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3974266|NCT01281124|3796791|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3974267|NCT01281007|3796797|B3|Brazil||Region of Enrollment||participants|Number|150|150.0||||||
3974268|NCT01281007|3796798|B2|Brazil||Region of Enrollment||participants|Number|75|75.0||||||
3974269|NCT01281007|3796799|B1|Brazil||Region of Enrollment||participants|Number|75|75.0||||||
3974270|NCT01281007|3796797|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3974271|NCT01281007|3796798|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3974272|NCT01281007|3796799|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3974273|NCT01281007|3796797|B3||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3974274|NCT01281007|3796798|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3974275|NCT01281007|3796799|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3974276|NCT01281007|3796797|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3974277|NCT01281007|3796798|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3974278|NCT01281007|3796799|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3974279|NCT01281007|3796797|B3||Between 18 and 65 years|Age||Participants|Count of Participants|143|143.0||||||
3974280|NCT01281007|3796798|B2||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
3974281|NCT01281007|3796799|B1||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
3974282|NCT01281007|3796797|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3974283|NCT01281007|3796798|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3974284|NCT01281007|3796799|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3974285|NCT01280981|3796806|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3974286|NCT01280981|3796806|B1||Female|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
3974287|NCT01280981|3796806|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3974288|NCT01280981|3796806|B1||Between 18 and 65 years|Age||Participants|Count of Participants|288|288.0||||||
3974289|NCT01280981|3796806|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3974290|NCT01280968|3796815|B3|||Pack-Years|pack-years that each participant has smoked, calculated by multiplying the number of packs of cigarettes participant smokes each day by number of years participant has smoked|pack-years|Mean|22|22.0|Full Range|||4.0|45.0|
3974291|NCT01280968|3796816|B2|||Pack-Years|pack-years that each participant has smoked, calculated by multiplying the number of packs of cigarettes participant smokes each day by number of years participant has smoked|pack-years|Mean|25|25.0|Full Range|||18.0|32.0|
3974292|NCT01280968|3796817|B1|||Pack-Years|pack-years that each participant has smoked, calculated by multiplying the number of packs of cigarettes participant smokes each day by number of years participant has smoked|pack-years|Mean|22|22.0|Full Range|||4.0|45.0|
3974293|NCT01280968|3796815|B3|||Cigarettes Per Day|average number of cigarettes participant smokes each day|cigarettes per day|Mean|19|19.0|Full Range|||10.0|30.0|
3974294|NCT01280968|3796816|B2|||Cigarettes Per Day|average number of cigarettes participant smokes each day|cigarettes per day|Mean|21|21.0|Full Range|||16.0|30.0|
3974295|NCT01280968|3796817|B1|||Cigarettes Per Day|average number of cigarettes participant smokes each day|cigarettes per day|Mean|19|19.0|Full Range|||10.0|30.0|
3974296|NCT01280968|3796815|B3|United States||Region of Enrollment||participants|Number|52|52.0||||||
3974297|NCT01280968|3796816|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3974298|NCT01280968|3796817|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
3974299|NCT01280968|3796815|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3974300|NCT01280968|3796816|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3974301|NCT01280968|3796817|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3974302|NCT01280968|3796815|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3974303|NCT01280968|3796816|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3974304|NCT01280968|3796817|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3974305|NCT01280968|3796815|B3|||Age, Customized|One participant reported that she was 54 at the screening, but after she was consented, it was discovered that she was actually 56. However, the subject was discontinued after the first study visit because she could not use the smoking delivery device; therefore, she received no vaccinations. Safety Event #14 was submitted to Duke IRB to account for this Protocol Deviation in which the subject was out of the age range.|years|Mean|43|43.0|Full Range|||23.0|56.0|
3974306|NCT01280968|3796816|B2|||Age, Customized|One participant reported that she was 54 at the screening, but after she was consented, it was discovered that she was actually 56. However, the subject was discontinued after the first study visit because she could not use the smoking delivery device; therefore, she received no vaccinations. Safety Event #14 was submitted to Duke IRB to account for this Protocol Deviation in which the subject was out of the age range.|years|Mean|44|44.0|Full Range|||35.0|55.0|
3974355|NCT01280903|3796878|B1|||Self-efficacy: Arthritis Other Symptoms|The subscale score range is 10-100; higher scores are better|units on a scale|Mean|76.8|76.8|Standard Deviation|17.4|17.4|||
3974526|NCT01280903|3796878|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3974307|NCT01280968|3796817|B1|||Age, Customized|One participant reported that she was 54 at the screening, but after she was consented, it was discovered that she was actually 56. However, the subject was discontinued after the first study visit because she could not use the smoking delivery device; therefore, she received no vaccinations. Safety Event #14 was submitted to Duke IRB to account for this Protocol Deviation in which the subject was out of the age range.|years|Mean|43|43.0|Full Range|||23.0|56.0|
3974308|NCT01280955|3796834|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3974309|NCT01280955|3796834|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3974310|NCT01280955|3796834|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3974311|NCT01280955|3796834|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3974312|NCT01280955|3796834|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3974313|NCT01280955|3796834|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3974314|NCT01280942|3796865|B3|United States||Region of Enrollment||participants|Number|20031|20031.0||||||
3974315|NCT01280942|3796866|B2|United States||Region of Enrollment||participants|Number|9911|9911.0||||||
3974316|NCT01280942|3796867|B1|United States||Region of Enrollment||participants|Number|10120|10120.0||||||
3974317|NCT01280942|3796865|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|381|381.0||||||
3974318|NCT01280942|3796866|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|187|187.0||||||
3974319|NCT01280942|3796867|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|194|194.0||||||
3974320|NCT01280942|3796865|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974321|NCT01280942|3796866|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974322|NCT01280942|3796867|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974323|NCT01280942|3796865|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9996|9996.0||||||
3974324|NCT01280942|3796866|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4934|4934.0||||||
3974325|NCT01280942|3796867|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5062|5062.0||||||
3974326|NCT01280942|3796865|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9654|9654.0||||||
3974327|NCT01280942|3796866|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4790|4790.0||||||
3974328|NCT01280942|3796867|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4864|4864.0||||||
3974329|NCT01280942|3796865|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974330|NCT01280942|3796866|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974331|NCT01280942|3796867|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974332|NCT01280942|3796865|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974333|NCT01280942|3796866|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974334|NCT01280942|3796867|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974335|NCT01280942|3796865|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974336|NCT01280942|3796866|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974337|NCT01280942|3796867|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974338|NCT01280942|3796865|B3||Male|Sex: Female, Male||Participants|Count of Participants|9368|9368.0||||||
3974339|NCT01280942|3796866|B2||Male|Sex: Female, Male||Participants|Count of Participants|4603|4603.0||||||
3974340|NCT01280942|3796867|B1||Male|Sex: Female, Male||Participants|Count of Participants|4765|4765.0||||||
3974341|NCT01280942|3796865|B3||Female|Sex: Female, Male||Participants|Count of Participants|10663|10663.0||||||
3974342|NCT01280942|3796866|B2||Female|Sex: Female, Male||Participants|Count of Participants|5308|5308.0||||||
3974343|NCT01280942|3796867|B1||Female|Sex: Female, Male||Participants|Count of Participants|5355|5355.0||||||
3974344|NCT01280942|3796865|B3|||Age||years|Median|57|57.0|Inter-Quartile Range|||44.0|70.0|
3974345|NCT01280942|3796866|B2|||Age||years|Median|57|57.0|Inter-Quartile Range|||44.0|70.0|
3974346|NCT01280942|3796867|B1|||Age||years|Median|57|57.0|Inter-Quartile Range|||44.0|69.0|
3974347|NCT01280903|3796876|B3|||Perceived Therapeutic Efficacy - Exercise & Hypertension|The PTE Exercise & Hypertension scale score range is 0-100; higher scores are better|units on a scale|Mean|74.5|74.5|Standard Deviation|22.3|22.3|||
3974348|NCT01280903|3796877|B2|||Perceived Therapeutic Efficacy - Exercise & Hypertension|The PTE Exercise & Hypertension scale score range is 0-100; higher scores are better|units on a scale|Mean|74.7|74.7|Standard Deviation|23.4|23.4|||
3974349|NCT01280903|3796878|B1|||Perceived Therapeutic Efficacy - Exercise & Hypertension|The PTE Exercise & Hypertension scale score range is 0-100; higher scores are better|units on a scale|Mean|74.2|74.2|Standard Deviation|21.2|21.2|||
3974350|NCT01280903|3796876|B3|||Perceived Therapeutic Efficacy - Exercise & Arthritis|The PTE Exercise & Arthritis scale score range is 0-100; higher scores are better|units on a scale|Mean|70.0|70.0|Standard Deviation|23.1|23.1|||
3974351|NCT01280903|3796877|B2|||Perceived Therapeutic Efficacy - Exercise & Arthritis|The PTE Exercise & Arthritis scale score range is 0-100; higher scores are better|units on a scale|Mean|72.1|72.1|Standard Deviation|21.7|21.7|||
3974352|NCT01280903|3796878|B1|||Perceived Therapeutic Efficacy - Exercise & Arthritis|The PTE Exercise & Arthritis scale score range is 0-100; higher scores are better|units on a scale|Mean|67.8|67.8|Standard Deviation|24.5|24.5|||
3974353|NCT01280903|3796876|B3|||Self-efficacy: Arthritis Other Symptoms|The subscale score range is 10-100; higher scores are better|units on a scale|Mean|77.3|77.3|Standard Deviation|17.2|17.2|||
3974354|NCT01280903|3796877|B2|||Self-efficacy: Arthritis Other Symptoms|The subscale score range is 10-100; higher scores are better|units on a scale|Mean|77.8|77.8|Standard Deviation|17.2|17.2|||
3974356|NCT01280903|3796876|B3|||Self-efficacy: Arthritis Function|The subscale score range is 10-100; higher scores are better|units on a scale|Mean|84.2|84.2|Standard Deviation|15.6|15.6|||
3974357|NCT01280903|3796877|B2|||Self-efficacy: Arthritis Function|The subscale score range is 10-100; higher scores are better|units on a scale|Mean|85.2|85.2|Standard Deviation|15.6|15.6|||
3974358|NCT01280903|3796878|B1|||Self-efficacy: Arthritis Function|The subscale score range is 10-100; higher scores are better|units on a scale|Mean|83.1|83.1|Standard Deviation|15.5|15.5|||
3974359|NCT01280903|3796876|B3|||Self-efficacy: Arthritis Pain|The subscale score range is 10-100; higher scores are better|units on a scale|Mean|74.1|74.1|Standard Deviation|17.6|17.6|||
3974360|NCT01280903|3796877|B2|||Self-efficacy: Arthritis Pain|The subscale score range is 10-100; higher scores are better|units on a scale|Mean|74.4|74.4|Standard Deviation|18.2|18.2|||
3974361|NCT01280903|3796878|B1|||Self-efficacy: Arthritis Pain|The subscale score range is 10-100; higher scores are better|units on a scale|Mean|73.7|73.7|Standard Deviation|17.0|17.0|||
3974362|NCT01280903|3796876|B3|||Self-efficacy: Exercise Barriers|The subscale score range is 0-100; higher scores are better|units on a scale|Mean|64.3|64.3|Standard Deviation|23.9|23.9|||
3974363|NCT01280903|3796877|B2|||Self-efficacy: Exercise Barriers|The subscale score range is 0-100; higher scores are better|units on a scale|Mean|68.3|68.3|Standard Deviation|21.4|21.4|||
3974364|NCT01280903|3796878|B1|||Self-efficacy: Exercise Barriers|The subscale score range is 0-100; higher scores are better|units on a scale|Mean|60.3|60.3|Standard Deviation|25.6|25.6|||
3974365|NCT01280903|3796876|B3|||Self-efficacy: Exercise|The subscale score range is 0-100; higher scores are better|units on a scale|Mean|73.6|73.6|Standard Deviation|27.5|27.5|||
3974366|NCT01280903|3796877|B2|||Self-efficacy: Exercise|The subscale score range is 0-100; higher scores are better|units on a scale|Mean|74.4|74.4|Standard Deviation|27.2|27.2|||
3974367|NCT01280903|3796878|B1|||Self-efficacy: Exercise|The subscale score range is 0-100; higher scores are better|units on a scale|Mean|72.8|72.8|Standard Deviation|28.0|28.0|||
3974368|NCT01280903|3796876|B3|||Brief Fatigue Inventory|The scale score range is 0-10; lower scores are better|units on a scale|Mean|2.8|2.8|Standard Deviation|2.4|2.4|||
3974369|NCT01280903|3796877|B2|||Brief Fatigue Inventory|The scale score range is 0-10; lower scores are better|units on a scale|Mean|2.7|2.7|Standard Deviation|2.2|2.2|||
3974370|NCT01280903|3796878|B1|||Brief Fatigue Inventory|The scale score range is 0-10; lower scores are better|units on a scale|Mean|2.8|2.8|Standard Deviation|2.6|2.6|||
3974371|NCT01280903|3796876|B3|||Short Form-36v2 Health Survey: Mental Component Score|This summary scale is composed of eight subscale scores primarily derived from the mental health, role functioning-emotional, and social functioning scores; the scale score range is 0-100; higher scores are better|units on a scale|Mean|53.7|53.7|Standard Deviation|9.6|9.6|||
3974372|NCT01280903|3796877|B2|||Short Form-36v2 Health Survey: Mental Component Score|This summary scale is composed of eight subscale scores primarily derived from the mental health, role functioning-emotional, and social functioning scores; the scale score range is 0-100; higher scores are better|units on a scale|Mean|54.0|54.0|Standard Deviation|9.4|9.4|||
3974373|NCT01280903|3796878|B1|||Short Form-36v2 Health Survey: Mental Component Score|This summary scale is composed of eight subscale scores primarily derived from the mental health, role functioning-emotional, and social functioning scores; the scale score range is 0-100; higher scores are better|units on a scale|Mean|53.4|53.4|Standard Deviation|9.8|9.8|||
3974374|NCT01280903|3796876|B3|||Short Form-36v2 Health Survey: Physical Component Score|This summary scale is composed of eight subscale scores primarily derived from the physical functioning, role functioning-physical, and bodily pain scores; the scale score range is 0-100; higher scores are better|units on a scale|Mean|42.4|42.4|Standard Deviation|8.7|8.7|||
3974375|NCT01280903|3796877|B2|||Short Form-36v2 Health Survey: Physical Component Score|This summary scale is composed of eight subscale scores primarily derived from the physical functioning, role functioning-physical, and bodily pain scores; the scale score range is 0-100; higher scores are better|units on a scale|Mean|42.8|42.8|Standard Deviation|8.6|8.6|||
3974376|NCT01280903|3796878|B1|||Short Form-36v2 Health Survey: Physical Component Score|This summary scale is composed of eight subscale scores primarily derived from the physical functioning, role functioning-physical, and bodily pain scores; the scale score range is 0-100; higher scores are better|units on a scale|Mean|42.0|42.0|Standard Deviation|8.8|8.8|||
3974377|NCT01280903|3796876|B3|||Short Form-36v2 Health Survey: Physical Functioning|The subscale score range is 0-100; higher scores are better|units on a scale|Mean|63.6|63.6|Standard Deviation|21.6|21.6|||
3974378|NCT01280903|3796877|B2|||Short Form-36v2 Health Survey: Physical Functioning|The subscale score range is 0-100; higher scores are better|units on a scale|Mean|65.2|65.2|Standard Deviation|19.7|19.7|||
3974379|NCT01280903|3796878|B1|||Short Form-36v2 Health Survey: Physical Functioning|The subscale score range is 0-100; higher scores are better|units on a scale|Mean|62.0|62.0|Standard Deviation|23.4|23.4|||
3974380|NCT01280903|3796876|B3|||Short Form-36v2 Health Survey: Bodily Pain|The subscale score range is 0-100; higher scores are better|units on a scale|Mean|56.2|56.2|Standard Deviation|19.5|19.5|||
3974381|NCT01280903|3796877|B2|||Short Form-36v2 Health Survey: Bodily Pain|The subscale score range is 0-100; higher scores are better|units on a scale|Mean|56.8|56.8|Standard Deviation|18.7|18.7|||
3974382|NCT01280903|3796878|B1|||Short Form-36v2 Health Survey: Bodily Pain|The subscale score range is 0-100; higher scores are better|units on a scale|Mean|55.7|55.7|Standard Deviation|20.3|20.3|||
3974383|NCT01280903|3796876|B3|||Western Ontario and McMaster Universities Osteoarthritis Index: Stiffness|The WOMAC Osteoarthritis Index Stiffness subscale score range is 0-8; lower scores are better|units on a scale|Mean|2.9|2.9|Standard Deviation|1.8|1.8|||
3974384|NCT01280903|3796877|B2|||Western Ontario and McMaster Universities Osteoarthritis Index: Stiffness|The WOMAC Osteoarthritis Index Stiffness subscale score range is 0-8; lower scores are better|units on a scale|Mean|2.7|2.7|Standard Deviation|1.8|1.8|||
3974385|NCT01280903|3796878|B1|||Western Ontario and McMaster Universities Osteoarthritis Index: Stiffness|The WOMAC Osteoarthritis Index Stiffness subscale score range is 0-8; lower scores are better|units on a scale|Mean|3.1|3.1|Standard Deviation|1.8|1.8|||
3974524|NCT01280903|3796876|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3974386|NCT01280903|3796876|B3|||Western Ontario and McMaster Universities Osteoarthritis Index: Function|The WOMAC Osteoarthritis Index Function subscale score range is 0-68; lower scores are better|units on a scale|Mean|20.9|20.9|Standard Deviation|12.8|12.8|||
3974387|NCT01280903|3796877|B2|||Western Ontario and McMaster Universities Osteoarthritis Index: Function|The WOMAC Osteoarthritis Index Function subscale score range is 0-68; lower scores are better|units on a scale|Mean|19.3|19.3|Standard Deviation|11.9|11.9|||
3974388|NCT01280903|3796878|B1|||Western Ontario and McMaster Universities Osteoarthritis Index: Function|The WOMAC Osteoarthritis Index Function subscale score range is 0-68; lower scores are better|units on a scale|Mean|22.5|22.5|Standard Deviation|13.4|13.4|||
3974389|NCT01280903|3796876|B3|||Western Ontario and McMaster Universities Osteoarthritis Index: Pain|The WOMAC Osteoarthritis Index Pain subscale score range is 0-20; lower scores are better|units on a scale|Mean|5.3|5.3|Standard Deviation|3.5|3.5|||
3974390|NCT01280903|3796877|B2|||Western Ontario and McMaster Universities Osteoarthritis Index: Pain|The WOMAC Osteoarthritis Index Pain subscale score range is 0-20; lower scores are better|units on a scale|Mean|4.8|4.8|Standard Deviation|3.0|3.0|||
3974391|NCT01280903|3796878|B1|||Western Ontario and McMaster Universities Osteoarthritis Index: Pain|The WOMAC Osteoarthritis Index Pain subscale score range is 0-20; lower scores are better|units on a scale|Mean|5.8|5.8|Standard Deviation|3.9|3.9|||
3974392|NCT01280903|3796876|B3|||Quadriceps strength (mean maximum for right and left quadriceps)||pounds|Mean|42.4|42.4|Standard Deviation|14.8|14.8|||
3974393|NCT01280903|3796877|B2|||Quadriceps strength (mean maximum for right and left quadriceps)||pounds|Mean|43.0|43.0|Standard Deviation|16.1|16.1|||
3974394|NCT01280903|3796878|B1|||Quadriceps strength (mean maximum for right and left quadriceps)||pounds|Mean|41.8|41.8|Standard Deviation|13.5|13.5|||
3974395|NCT01280903|3796876|B3|||8-foot up-and-go||seconds|Mean|6.6|6.6|Standard Deviation|1.6|1.6|||
3974396|NCT01280903|3796877|B2|||8-foot up-and-go||seconds|Mean|6.6|6.6|Standard Deviation|1.3|1.3|||
3974397|NCT01280903|3796878|B1|||8-foot up-and-go||seconds|Mean|6.5|6.5|Standard Deviation|1.8|1.8|||
3974398|NCT01280903|3796876|B3|||Chair sit-and-reach||inches|Mean|-1.1|-1.1|Standard Deviation|5.6|5.6|||
3974399|NCT01280903|3796877|B2|||Chair sit-and-reach||inches|Mean|-0.8|-0.8|Standard Deviation|5.6|5.6|||
3974400|NCT01280903|3796878|B1|||Chair sit-and-reach||inches|Mean|-1.4|-1.4|Standard Deviation|5.7|5.7|||
3974401|NCT01280903|3796876|B3|||Short Physical Performance Battery: standing balance|The standing balance subscale score range is 0-5; higher scores are better|units on a scale|Mean|4.1|4.1|Standard Deviation|0.8|0.8|||
3974402|NCT01280903|3796877|B2|||Short Physical Performance Battery: standing balance|The standing balance subscale score range is 0-5; higher scores are better|units on a scale|Mean|4.0|4.0|Standard Deviation|0.9|0.9|||
3974403|NCT01280903|3796878|B1|||Short Physical Performance Battery: standing balance|The standing balance subscale score range is 0-5; higher scores are better|units on a scale|Mean|4.2|4.2|Standard Deviation|0.8|0.8|||
3974404|NCT01280903|3796876|B3|||Short Physical Performance Battery: 4-meter usual walk|The 4-meter usual walk subscale score range is 0-4; higher scores are better|units on a scale|Mean|4.0|4.0|Standard Deviation|0.2|0.2|||
3974405|NCT01280903|3796877|B2|||Short Physical Performance Battery: 4-meter usual walk|The 4-meter usual walk subscale score range is 0-4; higher scores are better|units on a scale|Mean|4.0|4.0|Standard Deviation|0.0|0.0|||
3974406|NCT01280903|3796878|B1|||Short Physical Performance Battery: 4-meter usual walk|The 4-meter usual walk subscale score range is 0-4; higher scores are better|units on a scale|Mean|4.0|4.0|Standard Deviation|0.2|0.2|||
3974407|NCT01280903|3796876|B3|||Short Physical Performance Battery: repeated chair stands|The repeated chair stands subscale score range is 0-4; higher scores are better|units on a scale|Mean|2.8|2.8|Standard Deviation|1.1|1.1|||
3974408|NCT01280903|3796877|B2|||Short Physical Performance Battery: repeated chair stands|The repeated chair stands subscale score range is 0-4; higher scores are better|units on a scale|Mean|2.7|2.7|Standard Deviation|1.1|1.1|||
3974409|NCT01280903|3796878|B1|||Short Physical Performance Battery: repeated chair stands|The repeated chair stands subscale score range is 0-4; higher scores are better|units on a scale|Mean|2.9|2.9|Standard Deviation|1.2|1.2|||
3974410|NCT01280903|3796876|B3|||Short Physical Performance Battery: total|Subscale scores are summed for a total scale score; the total scale score range is 0-13; higher scores are better|units on a scale|Mean|10.8|10.8|Standard Deviation|1.6|1.6|||
3974411|NCT01280903|3796877|B2|||Short Physical Performance Battery: total|Subscale scores are summed for a total scale score; the total scale score range is 0-13; higher scores are better|units on a scale|Mean|10.6|10.6|Standard Deviation|1.6|1.6|||
3974412|NCT01280903|3796878|B1|||Short Physical Performance Battery: total|Subscale scores are summed for a total scale score; the total scale score range is 0-13; higher scores are better|units on a scale|Mean|11.0|11.0|Standard Deviation|1.7|1.7|||
3974413|NCT01280903|3796876|B3|||6-minute walk||yards|Mean|485.5|485.5|Standard Deviation|97.1|97.1|||
3974414|NCT01280903|3796877|B2|||6-minute walk||yards|Mean|484.7|484.7|Standard Deviation|88.1|88.1|||
3974415|NCT01280903|3796878|B1|||6-minute walk||yards|Mean|486.2|486.2|Standard Deviation|105.9|105.9|||
3974416|NCT01280903|3796876|B3|||Diastolic blood pressure||mm Hg|Mean|73.01|73.01|Standard Deviation|10.33|10.33|||
3974417|NCT01280903|3796877|B2|||Diastolic blood pressure||mm Hg|Mean|73.15|73.15|Standard Deviation|9.47|9.47|||
3974418|NCT01280903|3796878|B1|||Diastolic blood pressure||mm Hg|Mean|72.86|72.86|Standard Deviation|11.18|11.18|||
3974419|NCT01280903|3796876|B3|||Systolic blood pressure||mm Hg|Mean|121.96|121.96|Standard Deviation|14.37|14.37|||
3974420|NCT01280903|3796877|B2|||Systolic blood pressure||mm Hg|Mean|121.82|121.82|Standard Deviation|13.78|13.78|||
3974421|NCT01280903|3796878|B1|||Systolic blood pressure||mm Hg|Mean|122.09|122.09|Standard Deviation|15.01|15.01|||
3974422|NCT01280903|3796876|B3|||Mean number of daily bouts (ActiGraph): bouts of moderate-to-vigorous activity||bouts|Mean|0.3|0.3|Standard Deviation|0.7|0.7|||
3974423|NCT01280903|3796877|B2|||Mean number of daily bouts (ActiGraph): bouts of moderate-to-vigorous activity||bouts|Mean|0.4|0.4|Standard Deviation|0.9|0.9|||
3974525|NCT01280903|3796877|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3974424|NCT01280903|3796878|B1|||Mean number of daily bouts (ActiGraph): bouts of moderate-to-vigorous activity||bouts|Mean|0.2|0.2|Standard Deviation|0.4|0.4|||
3974425|NCT01280903|3796876|B3|||Mean number of daily activity minutes (ActiGraph): moderate-to-vigorous (counts of >2,020/min)||minutes|Mean|44.7|44.7|Standard Deviation|31.6|31.6|||
3974426|NCT01280903|3796877|B2|||Mean number of daily activity minutes (ActiGraph): moderate-to-vigorous (counts of >2,020/min)||minutes|Mean|51.2|51.2|Standard Deviation|38.7|38.7|||
3974427|NCT01280903|3796878|B1|||Mean number of daily activity minutes (ActiGraph): moderate-to-vigorous (counts of >2,020/min)||minutes|Mean|38.3|38.3|Standard Deviation|20.7|20.7|||
3974428|NCT01280903|3796876|B3|||Mean number of daily activity minutes (ActiGraph): light (counts of 100-2,019/min)||minutes|Mean|333.4|333.4|Standard Deviation|81.7|81.7|||
3974429|NCT01280903|3796877|B2|||Mean number of daily activity minutes (ActiGraph): light (counts of 100-2,019/min)||minutes|Mean|339.3|339.3|Standard Deviation|86.4|86.4|||
3974430|NCT01280903|3796878|B1|||Mean number of daily activity minutes (ActiGraph): light (counts of 100-2,019/min)||minutes|Mean|327.5|327.5|Standard Deviation|76.8|76.8|||
3974431|NCT01280903|3796876|B3|||Mean number of daily activity minutes (ActiGraph): no to very low (counts of 0-99/min)||minutes|Mean|425.2|425.2|Standard Deviation|104.9|104.9|||
3974432|NCT01280903|3796877|B2|||Mean number of daily activity minutes (ActiGraph): no to very low (counts of 0-99/min)||minutes|Mean|410.26|410.26|Standard Deviation|111.1|111.1|||
3974433|NCT01280903|3796878|B1|||Mean number of daily activity minutes (ActiGraph): no to very low (counts of 0-99/min)||minutes|Mean|440.14|440.14|Standard Deviation|96.5|96.5|||
3974434|NCT01280903|3796876|B3|||Mean duration of bouts over 7 days (ActiGraph): bouts of moderate-to-vigorous activity n=96||minutes|Mean|18.6|18.6|Standard Deviation|8.2|8.2|||
3974435|NCT01280903|3796877|B2|||Mean duration of bouts over 7 days (ActiGraph): bouts of moderate-to-vigorous activity n=96||minutes|Mean|19.9|19.9|Standard Deviation|8.7|8.7|||
3974436|NCT01280903|3796878|B1|||Mean duration of bouts over 7 days (ActiGraph): bouts of moderate-to-vigorous activity n=96||minutes|Mean|17.2|17.2|Standard Deviation|7.5|7.5|||
3974437|NCT01280903|3796876|B3|||Number of bouts over 7 days (ActiGraph): bouts of moderate-to-vigorous activity||bouts|Mean|2.2|2.2|Standard Deviation|5.0|5.0|||
3974438|NCT01280903|3796877|B2|||Number of bouts over 7 days (ActiGraph): bouts of moderate-to-vigorous activity||bouts|Mean|2.7|2.7|Standard Deviation|6.5|6.5|||
3974439|NCT01280903|3796878|B1|||Number of bouts over 7 days (ActiGraph): bouts of moderate-to-vigorous activity||bouts|Mean|1.7|1.7|Standard Deviation|2.6|2.6|||
3974440|NCT01280903|3796876|B3|||Activity minutes over 7 days (ActiGraph): moderate-to-vigorous (counts of > 2,020/min)||minutes|Mean|320.6|320.6|Standard Deviation|234.9|234.9|||
3974441|NCT01280903|3796877|B2|||Activity minutes over 7 days (ActiGraph): moderate-to-vigorous (counts of > 2,020/min)||minutes|Mean|365.5|365.5|Standard Deviation|288.4|288.4|||
3974442|NCT01280903|3796878|B1|||Activity minutes over 7 days (ActiGraph): moderate-to-vigorous (counts of > 2,020/min)||minutes|Mean|275.8|275.8|Standard Deviation|154.0|154.0|||
3974443|NCT01280903|3796876|B3|||Activity minutes over 7 days (ActiGraph): light (counts of 100-2,019/min)||minutes|Mean|2383.8|2383.8|Standard Deviation|602.2|602.2|||
3974444|NCT01280903|3796877|B2|||Activity minutes over 7 days (ActiGraph): light (counts of 100-2,019/min)||minutes|Mean|2418.8|2418.8|Standard Deviation|632.1|632.1|||
3974445|NCT01280903|3796878|B1|||Activity minutes over 7 days (ActiGraph): light (counts of 100-2,019/min)||minutes|Mean|2348.7|2348.7|Standard Deviation|572.0|572.0|||
3974446|NCT01280903|3796876|B3|||Activity minutes over 7 days (ActiGraph): no to very low (counts of 0-99/min)||minutes|Mean|3045.2|3045.2|Standard Deviation|786.7|786.7|||
3974447|NCT01280903|3796877|B2|||Activity minutes over 7 days (ActiGraph): no to very low (counts of 0-99/min)||minutes|Mean|2934.8|2934.8|Standard Deviation|842.3|842.3|||
3974448|NCT01280903|3796878|B1|||Activity minutes over 7 days (ActiGraph): no to very low (counts of 0-99/min)||minutes|Mean|3155.5|3155.5|Standard Deviation|714.6|714.6|||
3974449|NCT01280903|3796876|B3|||Fitness walking (e-diary): average minutes/day||average minutes/day|Mean|2.42|2.42|Standard Deviation|6.12|6.12|||
3974450|NCT01280903|3796877|B2|||Fitness walking (e-diary): average minutes/day||average minutes/day|Mean|2.19|2.19|Standard Deviation|5.40|5.4|||
3974451|NCT01280903|3796878|B1|||Fitness walking (e-diary): average minutes/day||average minutes/day|Mean|2.65|2.65|Standard Deviation|6.78|6.78|||
3974452|NCT01280903|3796876|B3|||Fitness walking (e-diary): minutes/week||minutes/week|Mean|16.93|16.93|Standard Deviation|42.82|42.82|||
3974453|NCT01280903|3796877|B2|||Fitness walking (e-diary): minutes/week||minutes/week|Mean|15.33|15.33|Standard Deviation|37.83|37.83|||
3974454|NCT01280903|3796878|B1|||Fitness walking (e-diary): minutes/week||minutes/week|Mean|18.54|18.54|Standard Deviation|47.45|47.45|||
3974455|NCT01280903|3796876|B3|||Fitness walking (e-dairy): days/week||days/week|Mean|0.61|0.61|Standard Deviation|1.36|1.36|||
3974456|NCT01280903|3796877|B2|||Fitness walking (e-dairy): days/week||days/week|Mean|0.57|0.57|Standard Deviation|1.31|1.31|||
3974457|NCT01280903|3796878|B1|||Fitness walking (e-dairy): days/week||days/week|Mean|0.65|0.65|Standard Deviation|1.41|1.41|||
3974458|NCT01280903|3796876|B3|||Lower extremity exercise (e-diary): volume [repetitions x sets over 7-day period]/week||repetitions x sets/week|Mean|43.67|43.67|Standard Deviation|199.79|199.79|||
3974459|NCT01280903|3796877|B2|||Lower extremity exercise (e-diary): volume [repetitions x sets over 7-day period]/week||repetitions x sets/week|Mean|30.41|30.41|Standard Deviation|121.21|121.21|||
3974460|NCT01280903|3796878|B1|||Lower extremity exercise (e-diary): volume [repetitions x sets over 7-day period]/week||repetitions x sets/week|Mean|56.93|56.93|Standard Deviation|255.39|255.39|||
3974461|NCT01280903|3796876|B3|||Lower extremity exercise (e-diary): average minutes/day||average minutes/day|Mean|1.07|1.07|Standard Deviation|3.50|3.5|||
3974462|NCT01280903|3796877|B2|||Lower extremity exercise (e-diary): average minutes/day||average minutes/day|Mean|1.06|1.06|Standard Deviation|3.47|3.47|||
3974463|NCT01280903|3796878|B1|||Lower extremity exercise (e-diary): average minutes/day||average minutes/day|Mean|1.09|1.09|Standard Deviation|3.55|3.55|||
3974464|NCT01280903|3796876|B3|||Lower extremity exercise (e-diary): minutes/week||minutes/week|Mean|7.52|7.52|Standard Deviation|24.52|24.52|||
3974465|NCT01280903|3796877|B2|||Lower extremity exercise (e-diary): minutes/week||minutes/week|Mean|7.43|7.43|Standard Deviation|24.51|24.51|||
3974466|NCT01280903|3796878|B1|||Lower extremity exercise (e-diary): minutes/week||minutes/week|Mean|7.60|7.6|Standard Deviation|24.87|24.87|||
3974467|NCT01280903|3796876|B3|||Lower extremity exercise (e-diary): days/week||days/week|Mean|0.38|0.38|Standard Deviation|1.01|1.01|||
3974468|NCT01280903|3796877|B2|||Lower extremity exercise (e-diary): days/week||days/week|Mean|0.36|0.36|Standard Deviation|1.02|1.02|||
3974469|NCT01280903|3796878|B1|||Lower extremity exercise (e-diary): days/week||days/week|Mean|0.41|0.41|Standard Deviation|1.01|1.01|||
3974470|NCT01280903|3796876|B3|Missing||Household income||participants|Number|30|30.0||||||
3974471|NCT01280903|3796877|B2|Missing||Household income||participants|Number|15|15.0||||||
3974472|NCT01280903|3796878|B1|Missing||Household income||participants|Number|15|15.0||||||
3974473|NCT01280903|3796876|B3|$50,000 or more/year||Household income||participants|Number|77|77.0||||||
3974474|NCT01280903|3796877|B2|$50,000 or more/year||Household income||participants|Number|38|38.0||||||
3974475|NCT01280903|3796878|B1|$50,000 or more/year||Household income||participants|Number|39|39.0||||||
3974476|NCT01280903|3796876|B3|< $50,000/year||Household income||participants|Number|75|75.0||||||
3974477|NCT01280903|3796877|B2|< $50,000/year||Household income||participants|Number|38|38.0||||||
3974478|NCT01280903|3796878|B1|< $50,000/year||Household income||participants|Number|37|37.0||||||
3974479|NCT01280903|3796876|B3|Not employed||Employment status||participants|Number|94|94.0||||||
3974480|NCT01280903|3796877|B2|Not employed||Employment status||participants|Number|48|48.0||||||
3974481|NCT01280903|3796878|B1|Not employed||Employment status||participants|Number|46|46.0||||||
3974482|NCT01280903|3796876|B3|Employed||Employment status||participants|Number|88|88.0||||||
3974483|NCT01280903|3796877|B2|Employed||Employment status||participants|Number|43|43.0||||||
3974484|NCT01280903|3796878|B1|Employed||Employment status||participants|Number|45|45.0||||||
3974485|NCT01280903|3796876|B3|Missing||Educational status||participants|Number|0|0.0||||||
3974486|NCT01280903|3796877|B2|Missing||Educational status||participants|Number|1|1.0||||||
3974487|NCT01280903|3796878|B1|Missing||Educational status||participants|Number|0|0.0||||||
3974488|NCT01280903|3796876|B3|High school or less||Educational status||participants|Number|39|39.0||||||
3974489|NCT01280903|3796877|B2|High school or less||Educational status||participants|Number|19|19.0||||||
3974490|NCT01280903|3796878|B1|High school or less||Educational status||participants|Number|19|19.0||||||
3974491|NCT01280903|3796876|B3|> High school||Educational status||participants|Number|143|143.0||||||
3974492|NCT01280903|3796877|B2|> High school||Educational status||participants|Number|71|71.0||||||
3974493|NCT01280903|3796878|B1|> High school||Educational status||participants|Number|72|72.0||||||
3974494|NCT01280903|3796876|B3|Not married||Marital status||participants|Number|98|98.0||||||
3974495|NCT01280903|3796877|B2|Not married||Marital status||participants|Number|45|45.0||||||
3974496|NCT01280903|3796878|B1|Not married||Marital status||participants|Number|53|53.0||||||
3974497|NCT01280903|3796876|B3|Married||Marital status||participants|Number|84|84.0||||||
3974498|NCT01280903|3796877|B2|Married||Marital status||participants|Number|46|46.0||||||
3974499|NCT01280903|3796878|B1|Married||Marital status||participants|Number|38|38.0||||||
3974500|NCT01280903|3796876|B3|||Number of comorbidities||comorbidities|Mean|6.6|6.6|Standard Deviation|2.8|2.8|||
3974501|NCT01280903|3796877|B2|||Number of comorbidities||comorbidities|Mean|6.5|6.5|Standard Deviation|2.7|2.7|||
3974502|NCT01280903|3796878|B1|||Number of comorbidities||comorbidities|Mean|6.8|6.8|Standard Deviation|2.9|2.9|||
3974503|NCT01280903|3796876|B3|||Body mass index||kg/m²|Mean|34.07|34.07|Standard Deviation|6.97|6.97|||
3974504|NCT01280903|3796877|B2|||Body mass index||kg/m²|Mean|33.64|33.64|Standard Deviation|6.43|6.43|||
3974505|NCT01280903|3796878|B1|||Body mass index||kg/m²|Mean|34.50|34.5|Standard Deviation|7.48|7.48|||
3974506|NCT01280903|3796876|B3|United States||Region of Enrollment||participants|Number|182|182.0||||||
3974507|NCT01280903|3796877|B2|United States||Region of Enrollment||participants|Number|91|91.0||||||
3974508|NCT01280903|3796878|B1|United States||Region of Enrollment||participants|Number|91|91.0||||||
3974509|NCT01280903|3796876|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974510|NCT01280903|3796877|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974511|NCT01280903|3796878|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974512|NCT01280903|3796876|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3974513|NCT01280903|3796877|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3974514|NCT01280903|3796878|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3974515|NCT01280903|3796876|B3||White|Race (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
3974516|NCT01280903|3796877|B2||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3974517|NCT01280903|3796878|B1||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
3974518|NCT01280903|3796876|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3974519|NCT01280903|3796877|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3974520|NCT01280903|3796878|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3974521|NCT01280903|3796876|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974522|NCT01280903|3796877|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974523|NCT01280903|3796878|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974527|NCT01280903|3796876|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3974528|NCT01280903|3796877|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974529|NCT01280903|3796878|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3974530|NCT01280903|3796876|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974531|NCT01280903|3796877|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974532|NCT01280903|3796878|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974533|NCT01280903|3796876|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|176|176.0||||||
3974534|NCT01280903|3796877|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3974535|NCT01280903|3796878|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3974536|NCT01280903|3796876|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3974537|NCT01280903|3796877|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3974538|NCT01280903|3796878|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3974539|NCT01280903|3796876|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3974540|NCT01280903|3796877|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3974541|NCT01280903|3796878|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3974542|NCT01280903|3796876|B3||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3974543|NCT01280903|3796877|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3974544|NCT01280903|3796878|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3974545|NCT01280903|3796876|B3|||Age||years|Mean|64.71|64.71|Standard Deviation|8.10|8.1|||
3974546|NCT01280903|3796877|B2|||Age||years|Mean|64.96|64.96|Standard Deviation|7.76|7.76|||
3974547|NCT01280903|3796878|B1|||Age||years|Mean|64.47|64.47|Standard Deviation|8.46|8.46|||
3974548|NCT01280695|3796943|B6|United States||Region of Enrollment||participants|Number|129|129.0||||||
3974549|NCT01280695|3796944|B5|United States||Region of Enrollment||participants|Number|26|26.0||||||
3974550|NCT01280695|3796945|B4|United States||Region of Enrollment||participants|Number|26|26.0||||||
3974551|NCT01280695|3796946|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
3974552|NCT01280695|3796947|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3974553|NCT01280695|3796948|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
3974554|NCT01280695|3796943|B6||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3974555|NCT01280695|3796944|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3974556|NCT01280695|3796945|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3974557|NCT01280695|3796946|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3974558|NCT01280695|3796947|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3974559|NCT01280695|3796948|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3974560|NCT01280695|3796943|B6||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3974561|NCT01280695|3796944|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3974562|NCT01280695|3796945|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3974563|NCT01280695|3796946|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3974564|NCT01280695|3796947|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3974565|NCT01280695|3796948|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3974566|NCT01280695|3796943|B6|||Age||years|Mean|56.7|56.7|Standard Deviation|8.12|8.12|||
3974567|NCT01280695|3796944|B5|||Age||years|Mean|55.7|55.7|Standard Deviation|8.01|8.01|||
3974568|NCT01280695|3796945|B4|||Age||years|Mean|55.5|55.5|Standard Deviation|8.59|8.59|||
3974569|NCT01280695|3796946|B3|||Age||years|Mean|57.7|57.7|Standard Deviation|7.35|7.35|||
3974570|NCT01280695|3796947|B2|||Age||years|Mean|57.6|57.6|Standard Deviation|8.07|8.07|||
3974571|NCT01280695|3796948|B1|||Age||years|Mean|57.2|57.2|Standard Deviation|8.87|8.87|||
3974572|NCT01280656|3796989|B4||Male|Sex: Female, Male||Participants|Count of Participants|303|303.0||||||
3974573|NCT01280656|3796990|B3||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3974574|NCT01280656|3796991|B2||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3974575|NCT01280656|3796992|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3974576|NCT01280656|3796989|B4||Female|Sex: Female, Male||Participants|Count of Participants|357|357.0||||||
3974577|NCT01280656|3796990|B3||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3974578|NCT01280656|3796991|B2||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3974579|NCT01280656|3796992|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3974580|NCT01280656|3796989|B4|||Age||years|Mean|49.5|49.5|Standard Deviation|10.0|10.0|||
3974581|NCT01280656|3796990|B3|||Age||years|Mean|49.5|49.5|Standard Deviation|9.5|9.5|||
3974582|NCT01280656|3796991|B2|||Age||years|Mean|49.2|49.2|Standard Deviation|10.7|10.7|||
3974583|NCT01280656|3796992|B1|||Age||years|Mean|50.4|50.4|Standard Deviation|8.6|8.6|||
3974584|NCT01280604|3797038|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
3974585|NCT01280604|3797039|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
3974586|NCT01280604|3797040|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3974587|NCT01280604|3797038|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3974588|NCT01280604|3797039|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3974589|NCT01280604|3797040|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3974590|NCT01280604|3797038|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974591|NCT01280604|3797039|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974592|NCT01280604|3797040|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974593|NCT01280604|3797038|B3||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3974594|NCT01280604|3797039|B2||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3974595|NCT01280604|3797040|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3974596|NCT01280604|3797038|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3974597|NCT01280604|3797039|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3974598|NCT01280604|3797040|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3974599|NCT01280604|3797038|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974600|NCT01280604|3797039|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974601|NCT01280604|3797040|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974602|NCT01280604|3797038|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974603|NCT01280604|3797039|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974604|NCT01280604|3797040|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974605|NCT01280604|3797038|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974606|NCT01280604|3797039|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974607|NCT01280604|3797040|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974608|NCT01280604|3797038|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3974609|NCT01280604|3797039|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3974610|NCT01280604|3797040|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3974611|NCT01280604|3797038|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3974612|NCT01280604|3797039|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3974613|NCT01280604|3797040|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3974614|NCT01280604|3797038|B3|||Age||years|Mean|57.41|57.41|Standard Deviation|8.36|8.36|||
3974615|NCT01280604|3797039|B2|||Age||years|Mean|57.55|57.55|Standard Deviation|9.26|9.26|||
3974616|NCT01280604|3797040|B1|||Age||years|Mean|57.2|57.2|Standard Deviation|8.67|8.67|||
3974617|NCT01280591|3797057|B5|Severe pain||Baseline Categorical Pain Rating Scale||Participants|Number|218|218.0||||||
3974618|NCT01280591|3797058|B4|Severe pain||Baseline Categorical Pain Rating Scale||Participants|Number|28|28.0||||||
3974619|NCT01280591|3797059|B3|Severe pain||Baseline Categorical Pain Rating Scale||Participants|Number|63|63.0||||||
3974620|NCT01280591|3797060|B2|Severe pain||Baseline Categorical Pain Rating Scale||Participants|Number|70|70.0||||||
3974621|NCT01280591|3797061|B1|Severe pain||Baseline Categorical Pain Rating Scale||Participants|Number|57|57.0||||||
3974622|NCT01280591|3797057|B5|Moderate pain||Baseline Categorical Pain Rating Scale||Participants|Number|494|494.0||||||
3974623|NCT01280591|3797058|B4|Moderate pain||Baseline Categorical Pain Rating Scale||Participants|Number|74|74.0||||||
3974624|NCT01280591|3797059|B3|Moderate pain||Baseline Categorical Pain Rating Scale||Participants|Number|140|140.0||||||
3974625|NCT01280591|3797060|B2|Moderate pain||Baseline Categorical Pain Rating Scale||Participants|Number|134|134.0||||||
3974626|NCT01280591|3797061|B1|Moderate pain||Baseline Categorical Pain Rating Scale||Participants|Number|146|146.0||||||
3974627|NCT01280591|3797057|B5|Mild pain||Baseline Categorical Pain Rating Scale||Participants|Number|0|0.0||||||
3974628|NCT01280591|3797058|B4|Mild pain||Baseline Categorical Pain Rating Scale||Participants|Number|0|0.0||||||
3974629|NCT01280591|3797059|B3|Mild pain||Baseline Categorical Pain Rating Scale||Participants|Number|0|0.0||||||
3974630|NCT01280591|3797060|B2|Mild pain||Baseline Categorical Pain Rating Scale||Participants|Number|0|0.0||||||
3974631|NCT01280591|3797061|B1|Mild pain||Baseline Categorical Pain Rating Scale||Participants|Number|0|0.0||||||
3974632|NCT01280591|3797057|B5|No pain||Baseline Categorical Pain Rating Scale||Participants|Number|0|0.0||||||
3974633|NCT01280591|3797058|B4|No pain||Baseline Categorical Pain Rating Scale||Participants|Number|0|0.0||||||
3974634|NCT01280591|3797059|B3|No pain||Baseline Categorical Pain Rating Scale||Participants|Number|0|0.0||||||
3974635|NCT01280591|3797060|B2|No pain||Baseline Categorical Pain Rating Scale||Participants|Number|0|0.0||||||
3974636|NCT01280591|3797061|B1|No pain||Baseline Categorical Pain Rating Scale||Participants|Number|0|0.0||||||
3974637|NCT01280591|3797057|B5||Male|Sex: Female, Male||Participants|Count of Participants|309|309.0||||||
3974638|NCT01280591|3797058|B4||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3974639|NCT01280591|3797059|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3974640|NCT01280591|3797060|B2||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3974641|NCT01280591|3797061|B1||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3974642|NCT01280591|3797057|B5||Female|Sex: Female, Male||Participants|Count of Participants|403|403.0||||||
3974643|NCT01280591|3797058|B4||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3974644|NCT01280591|3797059|B3||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3974645|NCT01280591|3797060|B2||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3974646|NCT01280591|3797061|B1||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3974647|NCT01280591|3797057|B5|||Age||Years|Mean|21.2|21.2|Standard Deviation|4.70|4.7|||
3974648|NCT01280591|3797058|B4|||Age||Years|Mean|21.5|21.5|Standard Deviation|5.59|5.59|||
3974649|NCT01280591|3797059|B3|||Age||Years|Mean|21.0|21.0|Standard Deviation|4.50|4.5|||
3974650|NCT01280591|3797060|B2|||Age||Years|Mean|21.0|21.0|Standard Deviation|4.25|4.25|||
3974651|NCT01280591|3797061|B1|||Age||Years|Mean|21.4|21.4|Standard Deviation|4.87|4.87|||
3974652|NCT01280552|3797154|B3|United States||Region of Enrollment||participants|Number|124|124.0||||||
3974653|NCT01280552|3797155|B2|United States||Region of Enrollment||participants|Number|43|43.0||||||
3974654|NCT01280552|3797156|B1|United States||Region of Enrollment||participants|Number|81|81.0||||||
3974655|NCT01280552|3797154|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3974656|NCT01280552|3797155|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3974657|NCT01280552|3797156|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3974658|NCT01280552|3797154|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3974659|NCT01280552|3797155|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3974660|NCT01280552|3797156|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3974661|NCT01280552|3797154|B3||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
3974662|NCT01280552|3797155|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3974663|NCT01280552|3797156|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3974664|NCT01280552|3797154|B3||Between 18 and 65 years|Age||Participants|Count of Participants|88|88.0||||||
3974665|NCT01280552|3797155|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3974666|NCT01280552|3797156|B1||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
3974667|NCT01280552|3797154|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3974668|NCT01280552|3797155|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3974669|NCT01280552|3797156|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3974670|NCT01280409|3797169|B3|United States||Region of Enrollment||Participants|Count of Participants|79|79.0||||||
3974671|NCT01280409|3797170|B2|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3974672|NCT01280409|3797171|B1|United States||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
3974673|NCT01280409|3797169|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3974674|NCT01280409|3797170|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3974675|NCT01280409|3797171|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3974676|NCT01280409|3797169|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3974677|NCT01280409|3797170|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3974678|NCT01280409|3797171|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3974679|NCT01280409|3797169|B3|||Age||years|Mean|30.2|30.2|Standard Deviation|5.8|5.8|||
3974680|NCT01280409|3797170|B2|||Age||years|Mean|31.6|31.6|Standard Deviation|5.3|5.3|||
3974681|NCT01280409|3797171|B1|||Age||years|Mean|28.8|28.8|Standard Deviation|6.4|6.4|||
3974682|NCT01280409|3797169|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3974683|NCT01280409|3797170|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3974684|NCT01280409|3797171|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3974685|NCT01280409|3797169|B3||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
3974686|NCT01280409|3797170|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3974687|NCT01280409|3797171|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
3974688|NCT01280409|3797169|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3974689|NCT01280409|3797170|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3974690|NCT01280409|3797171|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3974691|NCT01280357|3797202|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
3974692|NCT01280357|3797202|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3974693|NCT01280357|3797202|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3974694|NCT01280357|3797202|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3974695|NCT01280357|3797202|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3974696|NCT01280357|3797202|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3974697|NCT01280266|3797209|B3|No prior use||Prior use of vasodilator||Participant|Number|17|17.0||||||
3974698|NCT01280266|3797210|B2|No prior use||Prior use of vasodilator||Participant|Number|7|7.0||||||
3974699|NCT01280266|3797211|B1|No prior use||Prior use of vasodilator||Participant|Number|10|10.0||||||
3974700|NCT01280266|3797209|B3|Pentyxifylline||Prior use of vasodilator||Participant|Number|2|2.0||||||
3974701|NCT01280266|3797210|B2|Pentyxifylline||Prior use of vasodilator||Participant|Number|1|1.0||||||
3974702|NCT01280266|3797211|B1|Pentyxifylline||Prior use of vasodilator||Participant|Number|1|1.0||||||
3974703|NCT01280266|3797209|B3|angiotensin receptor blocker||Prior use of vasodilator||Participant|Number|2|2.0||||||
3974704|NCT01280266|3797210|B2|angiotensin receptor blocker||Prior use of vasodilator||Participant|Number|0|0.0||||||
3974705|NCT01280266|3797211|B1|angiotensin receptor blocker||Prior use of vasodilator||Participant|Number|2|2.0||||||
3974706|NCT01280266|3797209|B3|calcium channel blocker||Prior use of vasodilator||Participant|Number|5|5.0||||||
3974707|NCT01280266|3797210|B2|calcium channel blocker||Prior use of vasodilator||Participant|Number|4|4.0||||||
3974708|NCT01280266|3797211|B1|calcium channel blocker||Prior use of vasodilator||Participant|Number|1|1.0||||||
3974709|NCT01280266|3797209|B3|||RP duration||years|Mean|7.3|7.3|Standard Deviation|6.6|6.6|||
3974710|NCT01280266|3797210|B2|||RP duration||years|Mean|5.6|5.6|Standard Deviation|2.3|2.3|||
3974711|NCT01280266|3797211|B1|||RP duration||years|Mean|8.8|8.8|Standard Deviation|8.7|8.7|||
3974712|NCT01280266|3797209|B3|Sjogren's disease||Disease subtype|Underlying rheumatic disease|participant|Number|3|3.0||||||
3974713|NCT01280266|3797210|B2|Sjogren's disease||Disease subtype|Underlying rheumatic disease|participant|Number|1|1.0||||||
3974714|NCT01280266|3797211|B1|Sjogren's disease||Disease subtype|Underlying rheumatic disease|participant|Number|2|2.0||||||
3974715|NCT01280266|3797209|B3|Mixed connective tissue disease||Disease subtype|Underlying rheumatic disease|participant|Number|3|3.0||||||
3974716|NCT01280266|3797210|B2|Mixed connective tissue disease||Disease subtype|Underlying rheumatic disease|participant|Number|2|2.0||||||
3974717|NCT01280266|3797211|B1|Mixed connective tissue disease||Disease subtype|Underlying rheumatic disease|participant|Number|1|1.0||||||
3974718|NCT01280266|3797209|B3|diffuse SSc||Disease subtype|Underlying rheumatic disease|participant|Number|17|17.0||||||
3974719|NCT01280266|3797210|B2|diffuse SSc||Disease subtype|Underlying rheumatic disease|participant|Number|7|7.0||||||
3974720|NCT01280266|3797211|B1|diffuse SSc||Disease subtype|Underlying rheumatic disease|participant|Number|10|10.0||||||
3974721|NCT01280266|3797209|B3|Localized systemic sclerosis (SSc)||Disease subtype|Underlying rheumatic disease|participant|Number|3|3.0||||||
3974722|NCT01280266|3797210|B2|Localized systemic sclerosis (SSc)||Disease subtype|Underlying rheumatic disease|participant|Number|2|2.0||||||
3974723|NCT01280266|3797211|B1|Localized systemic sclerosis (SSc)||Disease subtype|Underlying rheumatic disease|participant|Number|1|1.0||||||
3974724|NCT01280266|3797209|B3|Korea, Republic of||Region of Enrollment||participants|Number|26|26.0||||||
3974725|NCT01280266|3797210|B2|Korea, Republic of||Region of Enrollment||participants|Number|12|12.0||||||
3974726|NCT01280266|3797211|B1|Korea, Republic of||Region of Enrollment||participants|Number|14|14.0||||||
3974727|NCT01280266|3797209|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3974728|NCT01280266|3797210|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3974729|NCT01280266|3797211|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3974730|NCT01280266|3797209|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3974731|NCT01280266|3797210|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3974732|NCT01280266|3797211|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3974733|NCT01280266|3797209|B3|||Age||years|Mean|50.9|50.9|Standard Deviation|12.3|12.3|||
3974734|NCT01280266|3797210|B2|||Age||years|Mean|52.3|52.3|Standard Deviation|10.3|10.3|||
3974735|NCT01280266|3797211|B1|||Age||years|Mean|49.6|49.6|Standard Deviation|14.0|14.0|||
3974736|NCT01280266|3797209|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3974737|NCT01280266|3797210|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3974738|NCT01280266|3797211|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3974739|NCT01280266|3797209|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3974740|NCT01280266|3797210|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3974741|NCT01280266|3797211|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3974742|NCT01280266|3797209|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3974743|NCT01280266|3797210|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3974744|NCT01280266|3797211|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3974745|NCT01280123|3797234|B4|selegiline use||rasagiline/selegiline use|Proportion of patients on stable regimen of either 1 mg/day rasagiline or 10 mg/day selegiline at baseline.|participants|Number|33|33.0||||||
3974746|NCT01280123|3797235|B3|selegiline use||rasagiline/selegiline use|Proportion of patients on stable regimen of either 1 mg/day rasagiline or 10 mg/day selegiline at baseline.|participants|Number|11|11.0||||||
3974747|NCT01280123|3797236|B2|selegiline use||rasagiline/selegiline use|Proportion of patients on stable regimen of either 1 mg/day rasagiline or 10 mg/day selegiline at baseline.|participants|Number|10|10.0||||||
3974748|NCT01280123|3797237|B1|selegiline use||rasagiline/selegiline use|Proportion of patients on stable regimen of either 1 mg/day rasagiline or 10 mg/day selegiline at baseline.|participants|Number|12|12.0||||||
3974749|NCT01280123|3797234|B4|rasagiline use||rasagiline/selegiline use|Proportion of patients on stable regimen of either 1 mg/day rasagiline or 10 mg/day selegiline at baseline.|participants|Number|177|177.0||||||
3974750|NCT01280123|3797235|B3|rasagiline use||rasagiline/selegiline use|Proportion of patients on stable regimen of either 1 mg/day rasagiline or 10 mg/day selegiline at baseline.|participants|Number|60|60.0||||||
3974751|NCT01280123|3797236|B2|rasagiline use||rasagiline/selegiline use|Proportion of patients on stable regimen of either 1 mg/day rasagiline or 10 mg/day selegiline at baseline.|participants|Number|57|57.0||||||
3974752|NCT01280123|3797237|B1|rasagiline use||rasagiline/selegiline use|Proportion of patients on stable regimen of either 1 mg/day rasagiline or 10 mg/day selegiline at baseline.|participants|Number|60|60.0||||||
3974753|NCT01280123|3797234|B4|||Mattis-Dementia Rating scale|Mattis Dementia Rating scale (DRS-2) raw score is the sum of 5 raw sub-scores (attention has possible 37 points, initiation/perseveration has possible 37 points, construction has possible 6 points, conceptualization has possible 39 points, memory has possible 25 points). Total range is 0-144. Higher scores are better.|units on a scale|Mean|138.4|138.4|Standard Deviation|9.9|9.9|||
3974776|NCT01280123|3797237|B1|||UPDRS ADL|The UPDRS ADL score is the sum of the questions in part II (activities of daily living). The possible range of the UPDRS ADL is from 0-52. Higher values indicate worse outcomes.|units on a scale|Mean|5.9|5.9|Standard Deviation|3.2|3.2|||
3974754|NCT01280123|3797235|B3|||Mattis-Dementia Rating scale|Mattis Dementia Rating scale (DRS-2) raw score is the sum of 5 raw sub-scores (attention has possible 37 points, initiation/perseveration has possible 37 points, construction has possible 6 points, conceptualization has possible 39 points, memory has possible 25 points). Total range is 0-144. Higher scores are better.|units on a scale|Mean|138|138.0|Standard Deviation|11.4|11.4|||
3974755|NCT01280123|3797236|B2|||Mattis-Dementia Rating scale|Mattis Dementia Rating scale (DRS-2) raw score is the sum of 5 raw sub-scores (attention has possible 37 points, initiation/perseveration has possible 37 points, construction has possible 6 points, conceptualization has possible 39 points, memory has possible 25 points). Total range is 0-144. Higher scores are better.|units on a scale|Mean|138.8|138.8|Standard Deviation|10.2|10.2|||
3974756|NCT01280123|3797237|B1|||Mattis-Dementia Rating scale|Mattis Dementia Rating scale (DRS-2) raw score is the sum of 5 raw sub-scores (attention has possible 37 points, initiation/perseveration has possible 37 points, construction has possible 6 points, conceptualization has possible 39 points, memory has possible 25 points). Total range is 0-144. Higher scores are better.|units on a scale|Mean|138.6|138.6|Standard Deviation|8.2|8.2|||
3974757|NCT01280123|3797234|B4|||Geriatric Depression Scale (GDS)|Short version. 15 questions. A score of 0 to 5 is normal. A score greater than 5 suggests depression.|units on a scale|Mean|1.4|1.4|Standard Deviation|1.6|1.6|||
3974758|NCT01280123|3797235|B3|||Geriatric Depression Scale (GDS)|Short version. 15 questions. A score of 0 to 5 is normal. A score greater than 5 suggests depression.|units on a scale|Mean|1.8|1.8|Standard Deviation|1.9|1.9|||
3974759|NCT01280123|3797236|B2|||Geriatric Depression Scale (GDS)|Short version. 15 questions. A score of 0 to 5 is normal. A score greater than 5 suggests depression.|units on a scale|Mean|1.1|1.1|Standard Deviation|1.3|1.3|||
3974760|NCT01280123|3797237|B1|||Geriatric Depression Scale (GDS)|Short version. 15 questions. A score of 0 to 5 is normal. A score greater than 5 suggests depression.|units on a scale|Mean|1.4|1.4|Standard Deviation|1.4|1.4|||
3974761|NCT01280123|3797234|B4|||Parkinson's Disease Questionnaire 39 (PDQ-39) Summary Index|The PDQ-39 is a 39-item self-report questionnaire, which assesses Parkinson’s disease-specific health related quality. The total score ranges from 0 (never have difficulty) to 100 (always have difficulty). Lower scores reflect better quality of life.|units on a scale|Mean|9.1|9.1|Standard Deviation|7.4|7.4|||
3974762|NCT01280123|3797235|B3|||Parkinson's Disease Questionnaire 39 (PDQ-39) Summary Index|The PDQ-39 is a 39-item self-report questionnaire, which assesses Parkinson’s disease-specific health related quality. The total score ranges from 0 (never have difficulty) to 100 (always have difficulty). Lower scores reflect better quality of life.|units on a scale|Mean|10.6|10.6|Standard Deviation|7.9|7.9|||
3974763|NCT01280123|3797236|B2|||Parkinson's Disease Questionnaire 39 (PDQ-39) Summary Index|The PDQ-39 is a 39-item self-report questionnaire, which assesses Parkinson’s disease-specific health related quality. The total score ranges from 0 (never have difficulty) to 100 (always have difficulty). Lower scores reflect better quality of life.|units on a scale|Mean|8.1|8.1|Standard Deviation|5.9|5.9|||
3974764|NCT01280123|3797237|B1|||Parkinson's Disease Questionnaire 39 (PDQ-39) Summary Index|The PDQ-39 is a 39-item self-report questionnaire, which assesses Parkinson’s disease-specific health related quality. The total score ranges from 0 (never have difficulty) to 100 (always have difficulty). Lower scores reflect better quality of life.|units on a scale|Mean|8.5|8.5|Standard Deviation|8.1|8.1|||
3974765|NCT01280123|3797234|B4|||Schwab and England Activities of Daily Living scale (SEADL)|The modified Schwab and England Activities of Daily Living is a single question ranging from 0-100% with anchors for each 10% interval. Higher scores are better (100% completely independent- 0% vegetative).|units on a scale|Mean|93.9|93.9|Standard Deviation|4.9|4.9|||
3974766|NCT01280123|3797235|B3|||Schwab and England Activities of Daily Living scale (SEADL)|The modified Schwab and England Activities of Daily Living is a single question ranging from 0-100% with anchors for each 10% interval. Higher scores are better (100% completely independent- 0% vegetative).|units on a scale|Mean|93.9|93.9|Standard Deviation|5.0|5.0|||
3974767|NCT01280123|3797236|B2|||Schwab and England Activities of Daily Living scale (SEADL)|The modified Schwab and England Activities of Daily Living is a single question ranging from 0-100% with anchors for each 10% interval. Higher scores are better (100% completely independent- 0% vegetative).|units on a scale|Mean|94.1|94.1|Standard Deviation|5.0|5.0|||
3974768|NCT01280123|3797237|B1|||Schwab and England Activities of Daily Living scale (SEADL)|The modified Schwab and England Activities of Daily Living is a single question ranging from 0-100% with anchors for each 10% interval. Higher scores are better (100% completely independent- 0% vegetative).|units on a scale|Mean|93.8|93.8|Standard Deviation|4.9|4.9|||
3974769|NCT01280123|3797234|B4|||Ambulatory capacity|Ambulatory Capacity is calculated as the sum of items 13-15, 29, 30 of the Unified Parkinson's Disease Rating Scale (UPDRS). It ranges from 0-20. Higher scores are worse.|units on a scale|Mean|1.0|1.0|Standard Deviation|0.9|0.9|||
3974770|NCT01280123|3797235|B3|||Ambulatory capacity|Ambulatory Capacity is calculated as the sum of items 13-15, 29, 30 of the Unified Parkinson's Disease Rating Scale (UPDRS). It ranges from 0-20. Higher scores are worse.|units on a scale|Mean|1.1|1.1|Standard Deviation|0.9|0.9|||
3974771|NCT01280123|3797236|B2|||Ambulatory capacity|Ambulatory Capacity is calculated as the sum of items 13-15, 29, 30 of the Unified Parkinson's Disease Rating Scale (UPDRS). It ranges from 0-20. Higher scores are worse.|units on a scale|Mean|0.8|0.8|Standard Deviation|0.8|0.8|||
3974772|NCT01280123|3797237|B1|||Ambulatory capacity|Ambulatory Capacity is calculated as the sum of items 13-15, 29, 30 of the Unified Parkinson's Disease Rating Scale (UPDRS). It ranges from 0-20. Higher scores are worse.|units on a scale|Mean|1.1|1.1|Standard Deviation|0.9|0.9|||
3974773|NCT01280123|3797234|B4|||UPDRS ADL|The UPDRS ADL score is the sum of the questions in part II (activities of daily living). The possible range of the UPDRS ADL is from 0-52. Higher values indicate worse outcomes.|units on a scale|Mean|5.6|5.6|Standard Deviation|3.0|3.0|||
3974774|NCT01280123|3797235|B3|||UPDRS ADL|The UPDRS ADL score is the sum of the questions in part II (activities of daily living). The possible range of the UPDRS ADL is from 0-52. Higher values indicate worse outcomes.|units on a scale|Mean|5.5|5.5|Standard Deviation|3.0|3.0|||
3974775|NCT01280123|3797236|B2|||UPDRS ADL|The UPDRS ADL score is the sum of the questions in part II (activities of daily living). The possible range of the UPDRS ADL is from 0-52. Higher values indicate worse outcomes.|units on a scale|Mean|5.5|5.5|Standard Deviation|2.9|2.9|||
3974777|NCT01280123|3797234|B4|||UPDRS motor|The UPDRS motor score is the sum of the questions in part III. The possible range of the UPDRS motor is from 0-108. Higher values indicate worse outcomes.|units on a scale|Mean|15.8|15.8|Standard Deviation|7.1|7.1|||
3974778|NCT01280123|3797235|B3|||UPDRS motor|The UPDRS motor score is the sum of the questions in part III. The possible range of the UPDRS motor is from 0-108. Higher values indicate worse outcomes.|units on a scale|Mean|15.3|15.3|Standard Deviation|6.5|6.5|||
3974779|NCT01280123|3797236|B2|||UPDRS motor|The UPDRS motor score is the sum of the questions in part III. The possible range of the UPDRS motor is from 0-108. Higher values indicate worse outcomes.|units on a scale|Mean|15.0|15.0|Standard Deviation|7.1|7.1|||
3974780|NCT01280123|3797237|B1|||UPDRS motor|The UPDRS motor score is the sum of the questions in part III. The possible range of the UPDRS motor is from 0-108. Higher values indicate worse outcomes.|units on a scale|Mean|17.7|17.7|Standard Deviation|7.7|7.7|||
3974781|NCT01280123|3797234|B4|||UPDRS mental|The UPDRS mental score is the sum of the questions in part I. The possible range of the UPDRS mental is from 0-16. Higher values indicate worse outcomes.|units on a scale|Mean|0.8|0.8|Standard Deviation|1.0|1.0|||
3974782|NCT01280123|3797235|B3|||UPDRS mental|The UPDRS mental score is the sum of the questions in part I. The possible range of the UPDRS mental is from 0-16. Higher values indicate worse outcomes.|units on a scale|Mean|0.9|0.9|Standard Deviation|1.1|1.1|||
3974783|NCT01280123|3797236|B2|||UPDRS mental|The UPDRS mental score is the sum of the questions in part I. The possible range of the UPDRS mental is from 0-16. Higher values indicate worse outcomes.|units on a scale|Mean|0.8|0.8|Standard Deviation|0.9|0.9|||
3974784|NCT01280123|3797237|B1|||UPDRS mental|The UPDRS mental score is the sum of the questions in part I. The possible range of the UPDRS mental is from 0-16. Higher values indicate worse outcomes.|units on a scale|Mean|0.8|0.8|Standard Deviation|0.9|0.9|||
3974785|NCT01280123|3797234|B4|||Total Unified Parkinson's Disease Rating Scale (UPDRS)|The Total UPDRS is the sum of parts I, II, and III. The possible range of the total UPDRS is from 0-176. Higher values indicate worse outcomes.|units on a scale|Mean|22.2|22.2|Standard Deviation|9.2|9.2|||
3974786|NCT01280123|3797235|B3|||Total Unified Parkinson's Disease Rating Scale (UPDRS)|The Total UPDRS is the sum of parts I, II, and III. The possible range of the total UPDRS is from 0-176. Higher values indicate worse outcomes.|units on a scale|Mean|21.7|21.7|Standard Deviation|8.7|8.7|||
3974787|NCT01280123|3797236|B2|||Total Unified Parkinson's Disease Rating Scale (UPDRS)|The Total UPDRS is the sum of parts I, II, and III. The possible range of the total UPDRS is from 0-176. Higher values indicate worse outcomes.|units on a scale|Mean|21.2|21.2|Standard Deviation|8.8|8.8|||
3974788|NCT01280123|3797237|B1|||Total Unified Parkinson's Disease Rating Scale (UPDRS)|The Total UPDRS is the sum of parts I, II, and III. The possible range of the total UPDRS is from 0-176. Higher values indicate worse outcomes.|units on a scale|Mean|23.8|23.8|Standard Deviation|9.9|9.9|||
3974789|NCT01280123|3797234|B4|||Time since PD diagnosis (years)||years|Mean|0.7|0.7|Standard Deviation|0.7|0.7|||
3974790|NCT01280123|3797235|B3|||Time since PD diagnosis (years)||years|Mean|0.8|0.8|Standard Deviation|0.7|0.7|||
3974791|NCT01280123|3797236|B2|||Time since PD diagnosis (years)||years|Mean|0.7|0.7|Standard Deviation|0.7|0.7|||
3974792|NCT01280123|3797237|B1|||Time since PD diagnosis (years)||years|Mean|0.8|0.8|Standard Deviation|0.7|0.7|||
3974793|NCT01280123|3797234|B4|||Duration of PD symptoms (years)||years|Mean|2.2|2.2|Standard Deviation|1.9|1.9|||
3974794|NCT01280123|3797235|B3|||Duration of PD symptoms (years)||years|Mean|2.3|2.3|Standard Deviation|2.3|2.3|||
3974795|NCT01280123|3797236|B2|||Duration of PD symptoms (years)||years|Mean|2.0|2.0|Standard Deviation|1.2|1.2|||
3974796|NCT01280123|3797237|B1|||Duration of PD symptoms (years)||years|Mean|2.3|2.3|Standard Deviation|1.9|1.9|||
3974797|NCT01280123|3797234|B4|No||Right-handed||participants|Number|24|24.0||||||
3974798|NCT01280123|3797235|B3|No||Right-handed||participants|Number|9|9.0||||||
3974799|NCT01280123|3797236|B2|No||Right-handed||participants|Number|5|5.0||||||
3974800|NCT01280123|3797237|B1|No||Right-handed||participants|Number|10|10.0||||||
3974801|NCT01280123|3797234|B4|Yes||Right-handed||participants|Number|186|186.0||||||
3974802|NCT01280123|3797235|B3|Yes||Right-handed||participants|Number|62|62.0||||||
3974803|NCT01280123|3797236|B2|Yes||Right-handed||participants|Number|62|62.0||||||
3974804|NCT01280123|3797237|B1|Yes||Right-handed||participants|Number|62|62.0||||||
3974805|NCT01280123|3797234|B4|||Years of education||years|Mean|16.7|16.7|Standard Deviation|3.1|3.1|||
3974806|NCT01280123|3797235|B3|||Years of education||years|Mean|16.8|16.8|Standard Deviation|3.0|3.0|||
3974807|NCT01280123|3797236|B2|||Years of education||years|Mean|16.2|16.2|Standard Deviation|3.3|3.3|||
3974808|NCT01280123|3797237|B1|||Years of education||years|Mean|17.1|17.1|Standard Deviation|3.1|3.1|||
3974809|NCT01280123|3797234|B4|Racial/Ethnic Minority||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3974810|NCT01280123|3797235|B3|Racial/Ethnic Minority||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3974811|NCT01280123|3797236|B2|Racial/Ethnic Minority||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3974812|NCT01280123|3797237|B1|Racial/Ethnic Minority||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3974813|NCT01280123|3797234|B4|Non-Latino whites||Race/Ethnicity, Customized||participants|Number|184|184.0||||||
3974814|NCT01280123|3797235|B3|Non-Latino whites||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
3974815|NCT01280123|3797236|B2|Non-Latino whites||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
3974816|NCT01280123|3797237|B1|Non-Latino whites||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
3974817|NCT01280123|3797234|B4|Females||Sex/Gender, Customized||participants|Number|62|62.0||||||
3974818|NCT01280123|3797235|B3|Females||Sex/Gender, Customized||participants|Number|23|23.0||||||
3974819|NCT01280123|3797236|B2|Females||Sex/Gender, Customized||participants|Number|20|20.0||||||
3974820|NCT01280123|3797237|B1|Females||Sex/Gender, Customized||participants|Number|19|19.0||||||
3974821|NCT01280123|3797234|B4|Males||Sex/Gender, Customized||participants|Number|148|148.0||||||
3974822|NCT01280123|3797235|B3|Males||Sex/Gender, Customized||participants|Number|48|48.0||||||
3974823|NCT01280123|3797236|B2|Males||Sex/Gender, Customized||participants|Number|47|47.0||||||
3974824|NCT01280123|3797237|B1|Males||Sex/Gender, Customized||participants|Number|53|53.0||||||
3974825|NCT01280123|3797234|B4|||Age||years|Mean|59.7|59.7|Standard Deviation|9.9|9.9|||
3974826|NCT01280123|3797235|B3|||Age||years|Mean|59.0|59.0|Standard Deviation|9.9|9.9|||
3974827|NCT01280123|3797236|B2|||Age||years|Mean|58.8|58.8|Standard Deviation|9.2|9.2|||
3974828|NCT01280123|3797237|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|10.6|10.6|||
3974829|NCT01280110|3797262|B3|Brazil||Region of Enrollment||participants|Number|44|44.0||||||
3974830|NCT01280110|3797263|B2|Brazil||Region of Enrollment||participants|Number|22|22.0||||||
3974831|NCT01280110|3797264|B1|Brazil||Region of Enrollment||participants|Number|22|22.0||||||
3974832|NCT01280110|3797262|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3974833|NCT01280110|3797263|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3974834|NCT01280110|3797264|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3974835|NCT01280110|3797262|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3974836|NCT01280110|3797263|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3974837|NCT01280110|3797264|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3974838|NCT01280110|3797262|B3|||Age||years|Mean|67.1|67.1|Standard Deviation|11.5|11.5|||
3974839|NCT01280110|3797263|B2|||Age||years|Mean|65.2|65.2|Standard Deviation|12.2|12.2|||
3974840|NCT01280110|3797264|B1|||Age||years|Mean|69|69.0|Standard Deviation|10.7|10.7|||
3974841|NCT01280110|3797262|B3||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
3974842|NCT01280110|3797263|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3974843|NCT01280110|3797264|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3974844|NCT01280110|3797262|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3974845|NCT01280110|3797263|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3974846|NCT01280110|3797264|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3974847|NCT01280110|3797262|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3974848|NCT01280110|3797263|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3974849|NCT01280110|3797264|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3974850|NCT01280058|3797273|B3|United States||Region of Enrollment||Participants|Count of Participants|73|73.0||||||
3974851|NCT01280058|3797274|B2|United States||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
3974852|NCT01280058|3797275|B1|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3974853|NCT01280058|3797273|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3974854|NCT01280058|3797274|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3974855|NCT01280058|3797275|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3974856|NCT01280058|3797273|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3974857|NCT01280058|3797274|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3974858|NCT01280058|3797275|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974859|NCT01280058|3797273|B3||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3974860|NCT01280058|3797274|B2||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3974861|NCT01280058|3797275|B1||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3974862|NCT01280058|3797273|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3974863|NCT01280058|3797274|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974864|NCT01280058|3797275|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3974865|NCT01280058|3797273|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974866|NCT01280058|3797274|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974867|NCT01280058|3797275|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974868|NCT01280058|3797273|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974869|NCT01280058|3797274|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974870|NCT01280058|3797275|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974871|NCT01280058|3797273|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3974872|NCT01280058|3797274|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974873|NCT01280058|3797275|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3974874|NCT01280058|3797273|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3974875|NCT01280058|3797274|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3974876|NCT01280058|3797275|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3974877|NCT01280058|3797273|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3974878|NCT01280058|3797274|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3974879|NCT01280058|3797275|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3974880|NCT01280058|3797273|B3|||Age||years|Median|64|64.0|Full Range|||39.0|84.0|
3974881|NCT01280058|3797274|B2|||Age||years|Median|66|66.0|Full Range|||45.0|81.0|
3974882|NCT01280058|3797275|B1|||Age||years|Median|61.5|61.5|Full Range|||39.0|84.0|
3974883|NCT01279681|3797292|B3||Capecitabine|Physician determined 5-FU choice prior to randomization||Participants|Count of Participants|12|12.0||||||
3974884|NCT01279681|3797293|B2||Capecitabine|Physician determined 5-FU choice prior to randomization||Participants|Count of Participants|4|4.0||||||
3974885|NCT01279681|3797294|B1||Capecitabine|Physician determined 5-FU choice prior to randomization||Participants|Count of Participants|8|8.0||||||
3974886|NCT01279681|3797292|B3||Infusional|Physician determined 5-FU choice prior to randomization||Participants|Count of Participants|20|20.0||||||
3974887|NCT01279681|3797293|B2||Infusional|Physician determined 5-FU choice prior to randomization||Participants|Count of Participants|13|13.0||||||
3974888|NCT01279681|3797294|B1||Infusional|Physician determined 5-FU choice prior to randomization||Participants|Count of Participants|7|7.0||||||
3974889|NCT01279681|3797292|B3|>1||Number of Metastatic Sites||Participants|Count of Participants|22|22.0||||||
3974890|NCT01279681|3797293|B2|>1||Number of Metastatic Sites||Participants|Count of Participants|12|12.0||||||
3974891|NCT01279681|3797294|B1|>1||Number of Metastatic Sites||Participants|Count of Participants|10|10.0||||||
3974892|NCT01279681|3797292|B3|1||Number of Metastatic Sites||Participants|Count of Participants|10|10.0||||||
3974893|NCT01279681|3797293|B2|1||Number of Metastatic Sites||Participants|Count of Participants|5|5.0||||||
3974894|NCT01279681|3797294|B1|1||Number of Metastatic Sites||Participants|Count of Participants|5|5.0||||||
3974895|NCT01279681|3797292|B3||2|Eastern Cooperative Oncology Group (ECOG) Performance Status|Performance Status was defined as 0=Asymptomatic and fully active, 1=Symptomatic and fully ambulatory, 2=Symptomatic and ambulatory.|Participants|Count of Participants|3|3.0||||||
3974896|NCT01279681|3797293|B2||2|Eastern Cooperative Oncology Group (ECOG) Performance Status|Performance Status was defined as 0=Asymptomatic and fully active, 1=Symptomatic and fully ambulatory, 2=Symptomatic and ambulatory.|Participants|Count of Participants|2|2.0||||||
3974897|NCT01279681|3797294|B1||2|Eastern Cooperative Oncology Group (ECOG) Performance Status|Performance Status was defined as 0=Asymptomatic and fully active, 1=Symptomatic and fully ambulatory, 2=Symptomatic and ambulatory.|Participants|Count of Participants|1|1.0||||||
3974898|NCT01279681|3797292|B3||0-1|Eastern Cooperative Oncology Group (ECOG) Performance Status|Performance Status was defined as 0=Asymptomatic and fully active, 1=Symptomatic and fully ambulatory, 2=Symptomatic and ambulatory.|Participants|Count of Participants|29|29.0||||||
3974899|NCT01279681|3797293|B2||0-1|Eastern Cooperative Oncology Group (ECOG) Performance Status|Performance Status was defined as 0=Asymptomatic and fully active, 1=Symptomatic and fully ambulatory, 2=Symptomatic and ambulatory.|Participants|Count of Participants|15|15.0||||||
3974900|NCT01279681|3797294|B1||0-1|Eastern Cooperative Oncology Group (ECOG) Performance Status|Performance Status was defined as 0=Asymptomatic and fully active, 1=Symptomatic and fully ambulatory, 2=Symptomatic and ambulatory.|Participants|Count of Participants|14|14.0||||||
3974901|NCT01279681|3797292|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3974902|NCT01279681|3797293|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3974903|NCT01279681|3797294|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3974904|NCT01279681|3797292|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3974905|NCT01279681|3797293|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3974906|NCT01279681|3797294|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3974907|NCT01279681|3797292|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3974908|NCT01279681|3797293|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3974909|NCT01279681|3797294|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3974910|NCT01279681|3797292|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3974911|NCT01279681|3797293|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3974912|NCT01279681|3797294|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3974913|NCT01279681|3797292|B3||85+ years|Age, Customized||Participants|Count of Participants|1|1.0||||||
3974914|NCT01279681|3797293|B2||85+ years|Age, Customized||Participants|Count of Participants|1|1.0||||||
3974915|NCT01279681|3797294|B1||85+ years|Age, Customized||Participants|Count of Participants|0|0.0||||||
3974916|NCT01279681|3797292|B3||80-84 years|Age, Customized||Participants|Count of Participants|3|3.0||||||
3974917|NCT01279681|3797293|B2||80-84 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
3974918|NCT01279681|3797294|B1||80-84 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
3974919|NCT01279681|3797292|B3||75-79 years|Age, Customized||Participants|Count of Participants|14|14.0||||||
3974920|NCT01279681|3797293|B2||75-79 years|Age, Customized||Participants|Count of Participants|7|7.0||||||
3974921|NCT01279681|3797294|B1||75-79 years|Age, Customized||Participants|Count of Participants|7|7.0||||||
3974922|NCT01279681|3797292|B3||70-74 years|Age, Customized||Participants|Count of Participants|14|14.0||||||
3974923|NCT01279681|3797293|B2||70-74 years|Age, Customized||Participants|Count of Participants|7|7.0||||||
3974924|NCT01279681|3797294|B1||70-74 years|Age, Customized||Participants|Count of Participants|7|7.0||||||
3974925|NCT01279681|3797292|B3|||Age||years|Median|75.5|75.5|Full Range|||71.0|86.0|
3974926|NCT01279681|3797293|B2|||Age||years|Median|77|77.0|Full Range|||71.0|86.0|
3974927|NCT01279681|3797294|B1|||Age||years|Median|75|75.0|Full Range|||71.0|81.0|
3974928|NCT01279564|3797307|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3974929|NCT01279564|3797308|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3974930|NCT01279564|3797309|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3974931|NCT01279564|3797307|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3974932|NCT01279564|3797308|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3974933|NCT01279564|3797309|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3974934|NCT01279564|3797307|B3|||Age||years|Mean|42.8|42.8|Standard Deviation|4.1|4.1|||
3974935|NCT01279564|3797308|B2|||Age||years|Mean|42.5|42.5|Standard Deviation|3.2|3.2|||
3974936|NCT01279564|3797309|B1|||Age||years|Mean|43.1|43.1|Standard Deviation|4.9|4.9|||
3974937|NCT01279486|3797316|B1||Unclear (ticked more than one category)|Occupation||Participants|Count of Participants|2|2.0||||||
3974938|NCT01279486|3797316|B1||Other|Occupation||Participants|Count of Participants|28|28.0||||||
3974939|NCT01279486|3797316|B1||Homemaker|Occupation||Participants|Count of Participants|14|14.0||||||
3974940|NCT01279486|3797316|B1||Student|Occupation||Participants|Count of Participants|29|29.0||||||
3974941|NCT01279486|3797316|B1||Support Personnel|Occupation||Participants|Count of Participants|0|0.0||||||
3974942|NCT01279486|3797316|B1||Manufacturing / Driver|Occupation||Participants|Count of Participants|1|1.0||||||
3974943|NCT01279486|3797316|B1||Sales / Customer Services|Occupation||Participants|Count of Participants|21|21.0||||||
3974944|NCT01279486|3797316|B1||Personal Services|Occupation||Participants|Count of Participants|1|1.0||||||
3974945|NCT01279486|3797316|B1||Skilled Trade|Occupation||Participants|Count of Participants|0|0.0||||||
3974946|NCT01279486|3797316|B1||Administrative / Secretarial|Occupation||Participants|Count of Participants|7|7.0||||||
3974947|NCT01279486|3797316|B1||Associate Professional / Technical|Occupation||Participants|Count of Participants|0|0.0||||||
3974948|NCT01279486|3797316|B1||Professional|Occupation||Participants|Count of Participants|10|10.0||||||
3974949|NCT01279486|3797316|B1||Managerial|Occupation||Participants|Count of Participants|7|7.0||||||
3974950|NCT01279486|3797316|B1||Unclear|Educational Status||Participants|Count of Participants|2|2.0||||||
3974951|NCT01279486|3797316|B1||No qualifications|Educational Status||Participants|Count of Participants|10|10.0||||||
3974952|NCT01279486|3797316|B1||Other qualifications|Educational Status||Participants|Count of Participants|5|5.0||||||
3974953|NCT01279486|3797316|B1||Qualifications at level 1 or below|Educational Status||Participants|Count of Participants|2|2.0||||||
3974954|NCT01279486|3797316|B1||GCSE (grade A*-C), vocational level 2 and equivale|Educational Status||Participants|Count of Participants|45|45.0||||||
3974955|NCT01279486|3797316|B1||A levels, vocational level 3 and equivalents|Educational Status||Participants|Count of Participants|31|31.0||||||
3974956|NCT01279486|3797316|B1||Other higher education below degree level|Educational Status||Participants|Count of Participants|13|13.0||||||
3974957|NCT01279486|3797316|B1||Degree, or equivalent, and above|Educational Status||Participants|Count of Participants|12|12.0||||||
3974958|NCT01279486|3797316|B1|Race/Ethnicity|Mixed|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3974959|NCT01279486|3797316|B1|Race/Ethnicity|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3974960|NCT01279486|3797316|B1|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|94|94.0||||||
3974961|NCT01279486|3797316|B1|Race/Ethnicity|Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3974962|NCT01279486|3797316|B1|Race/Ethnicity|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3974963|NCT01279486|3797316|B1|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3974964|NCT01279486|3797316|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3974965|NCT01279486|3797316|B1||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3974966|NCT01279486|3797316|B1|Age|41-45|Age, Customized||Participants|Count of Participants|3|3.0||||||
3974967|NCT01279486|3797316|B1|Age|36-40|Age, Customized||Participants|Count of Participants|5|5.0||||||
3974968|NCT01279486|3797316|B1|Age|31-35|Age, Customized||Participants|Count of Participants|5|5.0||||||
3974969|NCT01279486|3797316|B1|Age|26-30|Age, Customized||Participants|Count of Participants|11|11.0||||||
3974970|NCT01279486|3797316|B1|Age|18-25|Age, Customized||Participants|Count of Participants|96|96.0||||||
3974971|NCT01279447|3797320|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3974972|NCT01279447|3797321|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3974973|NCT01279447|3797322|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3974974|NCT01279447|3797320|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3974975|NCT01279447|3797321|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3974976|NCT01279447|3797322|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3974977|NCT01279447|3797320|B3|||Age||years|Mean|50.6|50.6|Standard Deviation|13|13.0|||
3974978|NCT01279447|3797321|B2|||Age||years|Mean|51.7|51.7|Standard Deviation|12.1|12.1|||
3974979|NCT01279447|3797322|B1|||Age||years|Mean|49.6|49.6|Standard Deviation|14.1|14.1|||
3974980|NCT01279317|3797329|B1|Netherlands||Region of Enrollment||participants|Number|12|12.0||||||
3974981|NCT01279317|3797329|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3974982|NCT01279317|3797329|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3974983|NCT01279317|3797329|B1|||Age||years|Mean|65|65.0|Standard Deviation|4|4.0|||
3974984|NCT01279317|3797329|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3974985|NCT01279317|3797329|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3974986|NCT01279317|3797329|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3974987|NCT01279265|3797335|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3974988|NCT01279265|3797336|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3974989|NCT01279265|3797337|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3974990|NCT01279265|3797335|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974991|NCT01279265|3797336|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974992|NCT01279265|3797337|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974993|NCT01279265|3797335|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974994|NCT01279265|3797336|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974995|NCT01279265|3797337|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3974996|NCT01279265|3797335|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3974997|NCT01279265|3797336|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3974998|NCT01279265|3797337|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3974999|NCT01279265|3797335|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3975000|NCT01279265|3797336|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3975001|NCT01279265|3797337|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3975002|NCT01279265|3797335|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975003|NCT01279265|3797336|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975004|NCT01279265|3797337|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975005|NCT01279265|3797335|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975006|NCT01279265|3797336|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975007|NCT01279265|3797337|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975008|NCT01279265|3797335|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975009|NCT01279265|3797336|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975010|NCT01279265|3797337|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975011|NCT01279265|3797335|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3975012|NCT01279265|3797336|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3975013|NCT01279265|3797337|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3975014|NCT01279265|3797335|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3975015|NCT01279265|3797336|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3975016|NCT01279265|3797337|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3975017|NCT01279265|3797335|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3975018|NCT01279265|3797336|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3975019|NCT01279265|3797337|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3975020|NCT01279265|3797335|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3975021|NCT01279265|3797336|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3975022|NCT01279265|3797337|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3975023|NCT01279265|3797335|B3||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
3975024|NCT01279265|3797336|B2||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
3975025|NCT01279265|3797337|B1||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
3975026|NCT01279200|3797348|B3|no prior diagnosis of ovulatory dysfunction||Diagnosis of ovulatory dysfunction||participants|Number|14|14.0||||||
3975027|NCT01279200|3797349|B2|no prior diagnosis of ovulatory dysfunction||Diagnosis of ovulatory dysfunction||participants|Number|8|8.0||||||
3975028|NCT01279200|3797350|B1|no prior diagnosis of ovulatory dysfunction||Diagnosis of ovulatory dysfunction||participants|Number|6|6.0||||||
3975029|NCT01279200|3797348|B3|prior diagnosis of ovulatory dysfunction||Diagnosis of ovulatory dysfunction||participants|Number|7|7.0||||||
3975030|NCT01279200|3797349|B2|prior diagnosis of ovulatory dysfunction||Diagnosis of ovulatory dysfunction||participants|Number|3|3.0||||||
3975031|NCT01279200|3797350|B1|prior diagnosis of ovulatory dysfunction||Diagnosis of ovulatory dysfunction||participants|Number|4|4.0||||||
3975032|NCT01279200|3797348|B3|||Gravidity: number of previous pregnancies||pregnancies|Mean|.9|0.9|Full Range|||0.0|4.0|
3975033|NCT01279200|3797349|B2|||Gravidity: number of previous pregnancies||pregnancies|Mean|1.1|1.1|Full Range|||0.0|4.0|
3975034|NCT01279200|3797350|B1|||Gravidity: number of previous pregnancies||pregnancies|Mean|.7|0.7|Full Range|||0.0|2.0|
3975035|NCT01279200|3797348|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975036|NCT01279200|3797349|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975037|NCT01279200|3797350|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975038|NCT01279200|3797348|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975039|NCT01279200|3797349|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975040|NCT01279200|3797350|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975041|NCT01279200|3797348|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3975042|NCT01279200|3797349|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3975043|NCT01279200|3797350|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3975044|NCT01279200|3797348|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975045|NCT01279200|3797349|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975166|NCT01279044|3797407|B3|Mixed||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3975046|NCT01279200|3797350|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975047|NCT01279200|3797348|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975048|NCT01279200|3797349|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975049|NCT01279200|3797350|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975050|NCT01279200|3797348|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3975051|NCT01279200|3797349|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3975052|NCT01279200|3797350|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3975053|NCT01279200|3797348|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975054|NCT01279200|3797349|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975055|NCT01279200|3797350|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975056|NCT01279200|3797348|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3975057|NCT01279200|3797349|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3975058|NCT01279200|3797350|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3975059|NCT01279200|3797348|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3975060|NCT01279200|3797349|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3975061|NCT01279200|3797350|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3975062|NCT01279200|3797348|B3|||Age||years|Mean|29.3|29.3|Full Range|||21.0|39.0|
3975063|NCT01279200|3797349|B2|||Age||years|Mean|29.8|29.8|Full Range|||21.0|39.0|
3975064|NCT01279200|3797350|B1|||Age||years|Mean|28.7|28.7|Full Range|||21.0|39.0|
3975065|NCT01279187|3797359|B3|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3975066|NCT01279187|3797360|B2|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3975067|NCT01279187|3797361|B1|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3975068|NCT01279187|3797359|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3975069|NCT01279187|3797360|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3975070|NCT01279187|3797361|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3975071|NCT01279187|3797359|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3975072|NCT01279187|3797360|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3975073|NCT01279187|3797361|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3975074|NCT01279187|3797359|B3|||Age||years|Mean|53.95|53.95|Full Range|||33.0|71.0|
3975075|NCT01279187|3797360|B2|||Age||years|Mean|53.5|53.5|Full Range|||33.0|71.0|
3975076|NCT01279187|3797361|B1|||Age||years|Mean|54|54.0|Full Range|||33.0|71.0|
3975077|NCT01279109|3797376|B3|Obese||Baseline Body Mass Index Category||participants|Number|36|36.0||||||
3975078|NCT01279109|3797377|B2|Obese||Baseline Body Mass Index Category||participants|Number|17|17.0||||||
3975079|NCT01279109|3797378|B1|Obese||Baseline Body Mass Index Category||participants|Number|19|19.0||||||
3975080|NCT01279109|3797376|B3|Overweight||Baseline Body Mass Index Category||participants|Number|46|46.0||||||
3975081|NCT01279109|3797377|B2|Overweight||Baseline Body Mass Index Category||participants|Number|23|23.0||||||
3975082|NCT01279109|3797378|B1|Overweight||Baseline Body Mass Index Category||participants|Number|23|23.0||||||
3975083|NCT01279109|3797376|B3|Normal weight||Baseline Body Mass Index Category||participants|Number|53|53.0||||||
3975084|NCT01279109|3797377|B2|Normal weight||Baseline Body Mass Index Category||participants|Number|27|27.0||||||
3975085|NCT01279109|3797378|B1|Normal weight||Baseline Body Mass Index Category||participants|Number|26|26.0||||||
3975086|NCT01279109|3797376|B3|Underweight||Baseline Body Mass Index Category||participants|Number|0|0.0||||||
3975087|NCT01279109|3797377|B2|Underweight||Baseline Body Mass Index Category||participants|Number|0|0.0||||||
3975088|NCT01279109|3797378|B1|Underweight||Baseline Body Mass Index Category||participants|Number|0|0.0||||||
3975089|NCT01279109|3797376|B3|English AND Spanish||Language preference||Participants|Count of Participants|9|9.0||||||
3975090|NCT01279109|3797377|B2|English AND Spanish||Language preference||Participants|Count of Participants|2|2.0||||||
3975091|NCT01279109|3797378|B1|English AND Spanish||Language preference||Participants|Count of Participants|7|7.0||||||
3975092|NCT01279109|3797376|B3|Spanish||Language preference||Participants|Count of Participants|89|89.0||||||
3975093|NCT01279109|3797377|B2|Spanish||Language preference||Participants|Count of Participants|48|48.0||||||
3975094|NCT01279109|3797378|B1|Spanish||Language preference||Participants|Count of Participants|41|41.0||||||
3975095|NCT01279109|3797376|B3|English||Language preference||Participants|Count of Participants|37|37.0||||||
3975096|NCT01279109|3797377|B2|English||Language preference||Participants|Count of Participants|17|17.0||||||
3975097|NCT01279109|3797378|B1|English||Language preference||Participants|Count of Participants|20|20.0||||||
3975098|NCT01279109|3797376|B3|United States||Region of Enrollment||participants|Number|135|135.0||||||
3975099|NCT01279109|3797377|B2|United States||Region of Enrollment||participants|Number|67|67.0||||||
3975100|NCT01279109|3797378|B1|United States||Region of Enrollment||participants|Number|68|68.0||||||
3975101|NCT01279109|3797376|B3|Not self-identified||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3975102|NCT01279109|3797377|B2|Not self-identified||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3975103|NCT01279109|3797378|B1|Not self-identified||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3975104|NCT01279109|3797376|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3975105|NCT01279109|3797377|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3975106|NCT01279109|3797378|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3975107|NCT01279109|3797376|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3975108|NCT01279109|3797377|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3975109|NCT01279109|3797378|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3975110|NCT01279109|3797376|B3|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3975111|NCT01279109|3797377|B2|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3975112|NCT01279109|3797378|B1|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3975113|NCT01279109|3797376|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3975114|NCT01279109|3797377|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3975115|NCT01279109|3797378|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3975116|NCT01279109|3797376|B3|Latina||Race/Ethnicity, Customized||Participants|Count of Participants|98|98.0||||||
3975117|NCT01279109|3797377|B2|Latina||Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
3975118|NCT01279109|3797378|B1|Latina||Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
3975119|NCT01279109|3797376|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3975120|NCT01279109|3797377|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3975121|NCT01279109|3797378|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3975122|NCT01279109|3797376|B3||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3975123|NCT01279109|3797377|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3975124|NCT01279109|3797378|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3975125|NCT01279109|3797376|B3|||Age||years|Mean|26.2|26.2|Standard Deviation|5.9|5.9|||
3975126|NCT01279109|3797377|B2|||Age||years|Mean|26.3|26.3|Standard Deviation|5.9|5.9|||
3975127|NCT01279109|3797378|B1|||Age||years|Mean|26.1|26.1|Standard Deviation|5.9|5.9|||
3975128|NCT01279070|3797387|B3|Spain||Region of Enrollment||participants|Number|62|62.0||||||
3975129|NCT01279070|3797388|B2|Spain||Region of Enrollment||participants|Number|34|34.0||||||
3975130|NCT01279070|3797389|B1|Spain||Region of Enrollment||participants|Number|28|28.0||||||
3975131|NCT01279070|3797387|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3975132|NCT01279070|3797388|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3975133|NCT01279070|3797389|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3975134|NCT01279070|3797387|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3975135|NCT01279070|3797388|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3975136|NCT01279070|3797389|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3975137|NCT01279070|3797387|B3|||Age||years|Mean|40.6|40.6|Standard Deviation|7.6|7.6|||
3975138|NCT01279070|3797388|B2|||Age||years|Mean|39.6|39.6|Standard Deviation|8.2|8.2|||
3975139|NCT01279070|3797389|B1|||Age||years|Mean|41.9|41.9|Standard Deviation|6.7|6.7|||
3975140|NCT01279070|3797387|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3975141|NCT01279070|3797388|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3975142|NCT01279070|3797389|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3975143|NCT01279070|3797387|B3||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
3975144|NCT01279070|3797388|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3975145|NCT01279070|3797389|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3975146|NCT01279070|3797387|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3975147|NCT01279070|3797388|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3975148|NCT01279070|3797389|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3975149|NCT01279044|3797406|B4|United States||Region of Enrollment||participants|Number|385|385.0||||||
3975150|NCT01279044|3797407|B3|United States||Region of Enrollment||participants|Number|164|164.0||||||
3975151|NCT01279044|3797408|B2|United States||Region of Enrollment||participants|Number|162|162.0||||||
3975152|NCT01279044|3797409|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
3975153|NCT01279044|3797406|B4|White||Race/Ethnicity, Customized||participants|Number|204|204.0||||||
3975154|NCT01279044|3797407|B3|White||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
3975155|NCT01279044|3797408|B2|White||Race/Ethnicity, Customized||participants|Number|84|84.0||||||
3975156|NCT01279044|3797409|B1|White||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
3975157|NCT01279044|3797406|B4|Other||Race/Ethnicity, Customized||participants|Number|73|73.0||||||
3975158|NCT01279044|3797407|B3|Other||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
3975159|NCT01279044|3797408|B2|Other||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
3975160|NCT01279044|3797409|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3975161|NCT01279044|3797406|B4|Native American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3975162|NCT01279044|3797407|B3|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3975163|NCT01279044|3797408|B2|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3975164|NCT01279044|3797409|B1|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3975165|NCT01279044|3797406|B4|Mixed||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
3975167|NCT01279044|3797408|B2|Mixed||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3975168|NCT01279044|3797409|B1|Mixed||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3975169|NCT01279044|3797406|B4|Asian Pacific Islander||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
3975170|NCT01279044|3797407|B3|Asian Pacific Islander||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3975171|NCT01279044|3797408|B2|Asian Pacific Islander||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3975172|NCT01279044|3797409|B1|Asian Pacific Islander||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3975173|NCT01279044|3797406|B4|Black/African American||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3975174|NCT01279044|3797407|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3975175|NCT01279044|3797408|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3975176|NCT01279044|3797409|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3975177|NCT01279044|3797406|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975178|NCT01279044|3797407|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975179|NCT01279044|3797408|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975180|NCT01279044|3797409|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975181|NCT01279044|3797406|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|288|288.0||||||
3975182|NCT01279044|3797407|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
3975183|NCT01279044|3797408|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
3975184|NCT01279044|3797409|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3975185|NCT01279044|3797406|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
3975186|NCT01279044|3797407|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3975187|NCT01279044|3797408|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3975188|NCT01279044|3797409|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3975189|NCT01279044|3797406|B4||Male|Sex: Female, Male||Participants|Count of Participants|385|385.0||||||
3975190|NCT01279044|3797407|B3||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
3975191|NCT01279044|3797408|B2||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3975192|NCT01279044|3797409|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3975193|NCT01279044|3797406|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3975194|NCT01279044|3797407|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3975195|NCT01279044|3797408|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3975196|NCT01279044|3797409|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3975197|NCT01279044|3797406|B4|||Age||years|Mean|33.6|33.6|Full Range|||18.0|63.0|
3975198|NCT01279044|3797407|B3|||Age||years|Mean|33.1|33.1|Full Range|||19.0|63.0|
3975199|NCT01279044|3797408|B2|||Age||years|Mean|34|34.0|Full Range|||18.0|61.0|
3975200|NCT01279044|3797409|B1|||Age||years|Mean|33|33.0|Full Range|||18.0|50.0|
3975201|NCT01278953|3797429|B3|Europe||Region of Enrollment||participants|Number|117|117.0||||||
3975202|NCT01278953|3797430|B2|Europe||Region of Enrollment||participants|Number|58|58.0||||||
3975203|NCT01278953|3797431|B1|Europe||Region of Enrollment||participants|Number|59|59.0||||||
3975204|NCT01278953|3797429|B3|United States||Region of Enrollment||participants|Number|183|183.0||||||
3975205|NCT01278953|3797430|B2|United States||Region of Enrollment||participants|Number|87|87.0||||||
3975206|NCT01278953|3797431|B1|United States||Region of Enrollment||participants|Number|96|96.0||||||
3975207|NCT01278953|3797429|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3975208|NCT01278953|3797430|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3975209|NCT01278953|3797431|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3975210|NCT01278953|3797429|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3975211|NCT01278953|3797430|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3975212|NCT01278953|3797431|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3975213|NCT01278953|3797429|B3||White|Race (NIH/OMB)||Participants|Count of Participants|289|289.0||||||
3975214|NCT01278953|3797430|B2||White|Race (NIH/OMB)||Participants|Count of Participants|141|141.0||||||
3975215|NCT01278953|3797431|B1||White|Race (NIH/OMB)||Participants|Count of Participants|148|148.0||||||
3975216|NCT01278953|3797429|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3975217|NCT01278953|3797430|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975218|NCT01278953|3797431|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3975219|NCT01278953|3797429|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975220|NCT01278953|3797430|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975221|NCT01278953|3797431|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975222|NCT01278953|3797429|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3975223|NCT01278953|3797430|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975224|NCT01278953|3797431|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3975225|NCT01278953|3797429|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975226|NCT01278953|3797430|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975227|NCT01278953|3797431|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975228|NCT01278953|3797429|B3||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
3975229|NCT01278953|3797430|B2||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3975230|NCT01278953|3797431|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3975231|NCT01278953|3797429|B3||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3975232|NCT01278953|3797430|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3975233|NCT01278953|3797431|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3975234|NCT01278953|3797429|B3|||Age||years|Mean|60.3|60.3|Standard Deviation|10.09|10.09|||
3975235|NCT01278953|3797430|B2|||Age||years|Mean|61|61.0|Standard Deviation|10.84|10.84|||
3975236|NCT01278953|3797431|B1|||Age||years|Mean|59.6|59.6|Standard Deviation|9.32|9.32|||
3975237|NCT01278927|3797440|B5|Missing||Disease||participants|Number|5|5.0||||||
3975238|NCT01278927|3797441|B4|Missing||Disease||participants|Number|1|1.0||||||
3975239|NCT01278927|3797442|B3|Missing||Disease||participants|Number|3|3.0||||||
3975240|NCT01278927|3797443|B2|Missing||Disease||participants|Number|0|0.0||||||
3975241|NCT01278927|3797444|B1|Missing||Disease||participants|Number|1|1.0||||||
3975242|NCT01278927|3797440|B5|Other Disease||Disease||participants|Number|1|1.0||||||
3975243|NCT01278927|3797441|B4|Other Disease||Disease||participants|Number|0|0.0||||||
3975244|NCT01278927|3797442|B3|Other Disease||Disease||participants|Number|0|0.0||||||
3975245|NCT01278927|3797443|B2|Other Disease||Disease||participants|Number|0|0.0||||||
3975246|NCT01278927|3797444|B1|Other Disease||Disease||participants|Number|1|1.0||||||
3975247|NCT01278927|3797440|B5|SAA||Disease||participants|Number|9|9.0||||||
3975248|NCT01278927|3797441|B4|SAA||Disease||participants|Number|2|2.0||||||
3975249|NCT01278927|3797442|B3|SAA||Disease||participants|Number|2|2.0||||||
3975250|NCT01278927|3797443|B2|SAA||Disease||participants|Number|2|2.0||||||
3975251|NCT01278927|3797444|B1|SAA||Disease||participants|Number|3|3.0||||||
3975252|NCT01278927|3797440|B5|Solid Tumors||Disease||participants|Number|2|2.0||||||
3975253|NCT01278927|3797441|B4|Solid Tumors||Disease||participants|Number|1|1.0||||||
3975254|NCT01278927|3797442|B3|Solid Tumors||Disease||participants|Number|0|0.0||||||
3975255|NCT01278927|3797443|B2|Solid Tumors||Disease||participants|Number|1|1.0||||||
3975256|NCT01278927|3797444|B1|Solid Tumors||Disease||participants|Number|0|0.0||||||
3975257|NCT01278927|3797440|B5|CLL/SLL||Disease||participants|Number|20|20.0||||||
3975258|NCT01278927|3797441|B4|CLL/SLL||Disease||participants|Number|7|7.0||||||
3975259|NCT01278927|3797442|B3|CLL/SLL||Disease||participants|Number|5|5.0||||||
3975260|NCT01278927|3797443|B2|CLL/SLL||Disease||participants|Number|3|3.0||||||
3975261|NCT01278927|3797444|B1|CLL/SLL||Disease||participants|Number|5|5.0||||||
3975262|NCT01278927|3797440|B5|Lymphoma||Disease||participants|Number|230|230.0||||||
3975263|NCT01278927|3797441|B4|Lymphoma||Disease||participants|Number|50|50.0||||||
3975264|NCT01278927|3797442|B3|Lymphoma||Disease||participants|Number|66|66.0||||||
3975265|NCT01278927|3797443|B2|Lymphoma||Disease||participants|Number|60|60.0||||||
3975266|NCT01278927|3797444|B1|Lymphoma||Disease||participants|Number|54|54.0||||||
3975267|NCT01278927|3797440|B5|MM/PCD||Disease||participants|Number|196|196.0||||||
3975268|NCT01278927|3797441|B4|MM/PCD||Disease||participants|Number|57|57.0||||||
3975269|NCT01278927|3797442|B3|MM/PCD||Disease||participants|Number|45|45.0||||||
3975270|NCT01278927|3797443|B2|MM/PCD||Disease||participants|Number|44|44.0||||||
3975271|NCT01278927|3797444|B1|MM/PCD||Disease||participants|Number|50|50.0||||||
3975272|NCT01278927|3797440|B5|MDS/MPS||Disease||participants|Number|63|63.0||||||
3975273|NCT01278927|3797441|B4|MDS/MPS||Disease||participants|Number|13|13.0||||||
3975274|NCT01278927|3797442|B3|MDS/MPS||Disease||participants|Number|15|15.0||||||
3975275|NCT01278927|3797443|B2|MDS/MPS||Disease||participants|Number|16|16.0||||||
3975276|NCT01278927|3797444|B1|MDS/MPS||Disease||participants|Number|19|19.0||||||
3975277|NCT01278927|3797440|B5|CML||Disease||participants|Number|14|14.0||||||
3975278|NCT01278927|3797441|B4|CML||Disease||participants|Number|2|2.0||||||
3975279|NCT01278927|3797442|B3|CML||Disease||participants|Number|2|2.0||||||
3975280|NCT01278927|3797443|B2|CML||Disease||participants|Number|5|5.0||||||
3975281|NCT01278927|3797444|B1|CML||Disease||participants|Number|5|5.0||||||
3975282|NCT01278927|3797440|B5|AML/ANLL/ALL||Disease||participants|Number|171|171.0||||||
3975283|NCT01278927|3797441|B4|AML/ANLL/ALL||Disease||participants|Number|42|42.0||||||
3975284|NCT01278927|3797442|B3|AML/ANLL/ALL||Disease||participants|Number|40|40.0||||||
3975285|NCT01278927|3797443|B2|AML/ANLL/ALL||Disease||participants|Number|47|47.0||||||
3975286|NCT01278927|3797444|B1|AML/ANLL/ALL||Disease||participants|Number|42|42.0||||||
3975287|NCT01278927|3797440|B5|Missing/Not done||Karnofsky Performance-status Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|9|9.0||||||
3975288|NCT01278927|3797441|B4|Missing/Not done||Karnofsky Performance-status Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|1|1.0||||||
3975289|NCT01278927|3797442|B3|Missing/Not done||Karnofsky Performance-status Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|5|5.0||||||
3975290|NCT01278927|3797443|B2|Missing/Not done||Karnofsky Performance-status Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|2|2.0||||||
3975291|NCT01278927|3797444|B1|Missing/Not done||Karnofsky Performance-status Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|1|1.0||||||
3975292|NCT01278927|3797440|B5|50%-60%||Karnofsky Performance-status Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|10|10.0||||||
3975293|NCT01278927|3797441|B4|50%-60%||Karnofsky Performance-status Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|4|4.0||||||
3975294|NCT01278927|3797442|B3|50%-60%||Karnofsky Performance-status Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|3|3.0||||||
3975295|NCT01278927|3797443|B2|50%-60%||Karnofsky Performance-status Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|1|1.0||||||
3975296|NCT01278927|3797444|B1|50%-60%||Karnofsky Performance-status Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|2|2.0||||||
3975297|NCT01278927|3797440|B5|70%-80%||Karnofsky Performance-status Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|273|273.0||||||
3975298|NCT01278927|3797441|B4|70%-80%||Karnofsky Performance-status Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|68|68.0||||||
3975299|NCT01278927|3797442|B3|70%-80%||Karnofsky Performance-status Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|76|76.0||||||
3975300|NCT01278927|3797443|B2|70%-80%||Karnofsky Performance-status Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|64|64.0||||||
3975301|NCT01278927|3797444|B1|70%-80%||Karnofsky Performance-status Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|65|65.0||||||
3975302|NCT01278927|3797440|B5|>=90%||Karnofsky Performance-status Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|419|419.0||||||
3975303|NCT01278927|3797441|B4|>=90%||Karnofsky Performance-status Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|102|102.0||||||
3975304|NCT01278927|3797442|B3|>=90%||Karnofsky Performance-status Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|94|94.0||||||
3975305|NCT01278927|3797443|B2|>=90%||Karnofsky Performance-status Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|111|111.0||||||
3975306|NCT01278927|3797444|B1|>=90%||Karnofsky Performance-status Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|112|112.0||||||
3975307|NCT01278927|3797440|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3975308|NCT01278927|3797441|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3975309|NCT01278927|3797442|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975310|NCT01278927|3797443|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3975311|NCT01278927|3797444|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975312|NCT01278927|3797440|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3975313|NCT01278927|3797441|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3975314|NCT01278927|3797442|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3975315|NCT01278927|3797443|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3975316|NCT01278927|3797444|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975317|NCT01278927|3797440|B5||White|Race (NIH/OMB)||Participants|Count of Participants|626|626.0||||||
3975318|NCT01278927|3797441|B4||White|Race (NIH/OMB)||Participants|Count of Participants|152|152.0||||||
3975319|NCT01278927|3797442|B3||White|Race (NIH/OMB)||Participants|Count of Participants|160|160.0||||||
3975320|NCT01278927|3797443|B2||White|Race (NIH/OMB)||Participants|Count of Participants|152|152.0||||||
3975321|NCT01278927|3797444|B1||White|Race (NIH/OMB)||Participants|Count of Participants|162|162.0||||||
3975322|NCT01278927|3797440|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3975323|NCT01278927|3797441|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3975324|NCT01278927|3797442|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3975325|NCT01278927|3797443|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3975326|NCT01278927|3797444|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3975327|NCT01278927|3797440|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3975386|NCT01278862|3797485|B3||Female|Sex: Female, Male||Crowns|Count of Units|71|71.0||||||
3975328|NCT01278927|3797441|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3975329|NCT01278927|3797442|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3975330|NCT01278927|3797443|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975331|NCT01278927|3797444|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3975332|NCT01278927|3797440|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3975333|NCT01278927|3797441|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3975334|NCT01278927|3797442|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3975335|NCT01278927|3797443|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3975336|NCT01278927|3797444|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3975337|NCT01278927|3797440|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3975338|NCT01278927|3797441|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975339|NCT01278927|3797442|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975340|NCT01278927|3797443|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3975341|NCT01278927|3797444|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975342|NCT01278927|3797440|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3975343|NCT01278927|3797441|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3975344|NCT01278927|3797442|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975345|NCT01278927|3797443|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975346|NCT01278927|3797444|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3975347|NCT01278927|3797440|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|673|673.0||||||
3975348|NCT01278927|3797441|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
3975349|NCT01278927|3797442|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
3975350|NCT01278927|3797443|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
3975351|NCT01278927|3797444|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|172|172.0||||||
3975352|NCT01278927|3797440|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3975353|NCT01278927|3797441|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3975354|NCT01278927|3797442|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3975355|NCT01278927|3797443|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3975356|NCT01278927|3797444|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3975357|NCT01278927|3797440|B5||Male|Sex: Female, Male||Participants|Count of Participants|405|405.0||||||
3975358|NCT01278927|3797441|B4||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3975359|NCT01278927|3797442|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3975360|NCT01278927|3797443|B2||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3975361|NCT01278927|3797444|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3975362|NCT01278927|3797440|B5||Female|Sex: Female, Male||Participants|Count of Participants|306|306.0||||||
3975363|NCT01278927|3797441|B4||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3975364|NCT01278927|3797442|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3975365|NCT01278927|3797443|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3975366|NCT01278927|3797444|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3975367|NCT01278927|3797440|B5|>=65 years||Age, Customized||participants|Number|154|154.0||||||
3975368|NCT01278927|3797441|B4|>=65 years||Age, Customized||participants|Number|37|37.0||||||
3975369|NCT01278927|3797442|B3|>=65 years||Age, Customized||participants|Number|34|34.0||||||
3975370|NCT01278927|3797443|B2|>=65 years||Age, Customized||participants|Number|34|34.0||||||
3975371|NCT01278927|3797444|B1|>=65 years||Age, Customized||participants|Number|49|49.0||||||
3975372|NCT01278927|3797440|B5|41-<65 years||Age, Customized||participants|Number|457|457.0||||||
3975373|NCT01278927|3797441|B4|41-<65 years||Age, Customized||participants|Number|111|111.0||||||
3975374|NCT01278927|3797442|B3|41-<65 years||Age, Customized||participants|Number|118|118.0||||||
3975375|NCT01278927|3797443|B2|41-<65 years||Age, Customized||participants|Number|123|123.0||||||
3975376|NCT01278927|3797444|B1|41-<65 years||Age, Customized||participants|Number|105|105.0||||||
3975377|NCT01278927|3797440|B5|<=40 years||Age, Customized||participants|Number|100|100.0||||||
3975378|NCT01278927|3797441|B4|<=40 years||Age, Customized||participants|Number|27|27.0||||||
3975379|NCT01278927|3797442|B3|<=40 years||Age, Customized||participants|Number|26|26.0||||||
3975380|NCT01278927|3797443|B2|<=40 years||Age, Customized||participants|Number|21|21.0||||||
3975381|NCT01278927|3797444|B1|<=40 years||Age, Customized||participants|Number|26|26.0||||||
3975382|NCT01278862|3797485|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3975383|NCT01278862|3797485|B3||Male|Sex: Female, Male||Crowns|Count of Units|29|29.0||||||
3975384|NCT01278862|3797486|B2||Male|Sex: Female, Male||Crowns|Count of Units|17|17.0||||||
3975385|NCT01278862|3797487|B1||Male|Sex: Female, Male||Crowns|Count of Units|12|12.0||||||
3975387|NCT01278862|3797486|B2||Female|Sex: Female, Male||Crowns|Count of Units|33|33.0||||||
3975388|NCT01278862|3797487|B1||Female|Sex: Female, Male||Crowns|Count of Units|38|38.0||||||
3975389|NCT01278862|3797485|B3||>=65 years|Age||Crowns|Count of Units|10|10.0||||||
3975390|NCT01278862|3797486|B2||>=65 years|Age||Crowns|Count of Units|4|4.0||||||
3975391|NCT01278862|3797487|B1||>=65 years|Age||Crowns|Count of Units|6|6.0||||||
3975392|NCT01278862|3797485|B3||Between 18 and 65 years|Age||Crowns|Count of Units|90|90.0||||||
3975393|NCT01278862|3797486|B2||Between 18 and 65 years|Age||Crowns|Count of Units|46|46.0||||||
3975394|NCT01278862|3797487|B1||Between 18 and 65 years|Age||Crowns|Count of Units|44|44.0||||||
3975395|NCT01278862|3797485|B3||<=18 years|Age||Crowns|Count of Units|0|0.0||||||
3975396|NCT01278862|3797486|B2||<=18 years|Age||Crowns|Count of Units|0|0.0||||||
3975397|NCT01278862|3797487|B1||<=18 years|Age||Crowns|Count of Units|0|0.0||||||
3975398|NCT01278797|3797496|B1|||Body Mass Index||kilogram / square meter|Mean|26.7|26.7|Standard Deviation|2.5|2.5|||
3975399|NCT01278797|3797496|B1|||Weight||kilogram|Mean|80.3|80.3|Standard Deviation|9.9|9.9|||
3975400|NCT01278797|3797496|B1|||Height||centimeter|Mean|173.1|173.1|Standard Deviation|7.1|7.1|||
3975401|NCT01278797|3797496|B1|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3975402|NCT01278797|3797496|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3975403|NCT01278797|3797496|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3975404|NCT01278797|3797496|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3975405|NCT01278797|3797496|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3975406|NCT01278797|3797496|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3975407|NCT01278797|3797496|B1|||Age||years|Mean|39|39.0|Standard Deviation|9|9.0|||
3975408|NCT01278745|3797507|B3|United States||Region of Enrollment||Participants|Count of Participants|163|163.0||||||
3975409|NCT01278745|3797508|B2|United States||Region of Enrollment||Participants|Count of Participants|74|74.0||||||
3975410|NCT01278745|3797509|B1|United States||Region of Enrollment||Participants|Count of Participants|89|89.0||||||
3975411|NCT01278745|3797507|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3975412|NCT01278745|3797508|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3975413|NCT01278745|3797509|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3975414|NCT01278745|3797507|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975415|NCT01278745|3797508|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975416|NCT01278745|3797509|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975417|NCT01278745|3797507|B3||White|Race (NIH/OMB)||Participants|Count of Participants|127|127.0||||||
3975418|NCT01278745|3797508|B2||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3975419|NCT01278745|3797509|B1||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3975420|NCT01278745|3797507|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3975421|NCT01278745|3797508|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3975422|NCT01278745|3797509|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3975423|NCT01278745|3797507|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975424|NCT01278745|3797508|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975425|NCT01278745|3797509|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975426|NCT01278745|3797507|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3975427|NCT01278745|3797508|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3975428|NCT01278745|3797509|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3975429|NCT01278745|3797507|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3975430|NCT01278745|3797508|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3975431|NCT01278745|3797509|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975432|NCT01278745|3797507|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3975433|NCT01278745|3797508|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3975434|NCT01278745|3797509|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3975435|NCT01278745|3797507|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
3975436|NCT01278745|3797508|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3975437|NCT01278745|3797509|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3975438|NCT01278745|3797507|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3975439|NCT01278745|3797508|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3975440|NCT01278745|3797509|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3975441|NCT01278745|3797507|B3||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3975442|NCT01278745|3797508|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3975443|NCT01278745|3797509|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3975444|NCT01278745|3797507|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3975445|NCT01278745|3797508|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3975446|NCT01278745|3797509|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3975447|NCT01278745|3797507|B3|||Age||years|Mean|54.7|54.7|Standard Deviation|11.75|11.75|||
3975448|NCT01278745|3797508|B2|||Age||years|Mean|54.8|54.8|Standard Deviation|11.76|11.76|||
3975449|NCT01278745|3797509|B1|||Age||years|Mean|54.6|54.6|Standard Deviation|11.80|11.8|||
3975450|NCT01278615|3797544|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3975451|NCT01278615|3797544|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3975452|NCT01278615|3797544|B1|||Age||years|Median|70|70.0|Full Range|||28.7|86.0|
3975453|NCT01278485|3797554|B1||Male|Sex: Female, Male||Participants|Count of Participants|400|400.0||||||
3975454|NCT01278485|3797554|B1||Female|Sex: Female, Male||Participants|Count of Participants|319|319.0||||||
3975455|NCT01278485|3797554|B1|||Age||years|Mean|65.91|65.91|Standard Deviation|9.98|9.98|||
3975456|NCT01278407|3797567|B4|||Mini-Mental State Examination (MMSE) Score|The score ranged from 0 to 30, with a higher score indicating better function.|Unit on a scale|Mean|20.4|20.4|Standard Deviation|4.3|4.3|||
3975457|NCT01278407|3797568|B3|||Mini-Mental State Examination (MMSE) Score|The score ranged from 0 to 30, with a higher score indicating better function.|Unit on a scale|Mean|20.3|20.3|Standard Deviation|4.8|4.8|||
3975458|NCT01278407|3797569|B2|||Mini-Mental State Examination (MMSE) Score|The score ranged from 0 to 30, with a higher score indicating better function.|Unit on a scale|Mean|20.6|20.6|Standard Deviation|4.1|4.1|||
3975459|NCT01278407|3797570|B1|||Mini-Mental State Examination (MMSE) Score|The score ranged from 0 to 30, with a higher score indicating better function.|Unit on a scale|Mean|20.3|20.3|Standard Deviation|4.2|4.2|||
3975460|NCT01278407|3797567|B4||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3975461|NCT01278407|3797568|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3975462|NCT01278407|3797569|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3975463|NCT01278407|3797570|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3975464|NCT01278407|3797567|B4||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3975465|NCT01278407|3797568|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3975466|NCT01278407|3797569|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3975467|NCT01278407|3797570|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3975468|NCT01278407|3797567|B4|||Age||Years|Mean|77.9|77.9|Standard Deviation|6.1|6.1|||
3975469|NCT01278407|3797568|B3|||Age||Years|Mean|77.7|77.7|Standard Deviation|6.8|6.8|||
3975470|NCT01278407|3797569|B2|||Age||Years|Mean|78.8|78.8|Standard Deviation|5.1|5.1|||
3975471|NCT01278407|3797570|B1|||Age||Years|Mean|77.2|77.2|Standard Deviation|6.1|6.1|||
3975472|NCT01278394|3797587|B1|||Age||years|Mean|46.9|46.9|Standard Deviation|10.15|10.15|||
3975473|NCT01278394|3797587|B1|Mexico||Region of Enrollment||participants|Number|29|29.0||||||
3975474|NCT01278394|3797587|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975475|NCT01278394|3797587|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975476|NCT01278394|3797587|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3975477|NCT01278394|3797587|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3975478|NCT01278394|3797587|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3975479|NCT01278394|3797587|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3975480|NCT01278394|3797587|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3975481|NCT01278394|3797587|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3975482|NCT01278342|3797597|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3975483|NCT01278342|3797598|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3975484|NCT01278342|3797599|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3975485|NCT01278342|3797600|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3975486|NCT01278342|3797597|B4||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3975487|NCT01278342|3797598|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3975488|NCT01278342|3797599|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3975489|NCT01278342|3797600|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3975490|NCT01278342|3797597|B4|||Age||years|Mean|48.1|48.1|Standard Deviation|10.90|10.9|||
3975491|NCT01278342|3797598|B3|||Age||years|Mean|49.3|49.3|Standard Deviation|10.50|10.5|||
3975492|NCT01278342|3797599|B2|||Age||years|Mean|44.6|44.6|Standard Deviation|10.54|10.54|||
3975493|NCT01278342|3797600|B1|||Age||years|Mean|57.9|57.9|Standard Deviation|7.71|7.71|||
3975494|NCT01278303|3797616|B1|United States||Region of Enrollment||participants|Number|82|82.0||||||
3975495|NCT01278303|3797616|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3975496|NCT01278303|3797616|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3975497|NCT01278303|3797616|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3975498|NCT01278303|3797616|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3975499|NCT01278303|3797616|B1||<=18 years|Age||Participants|Count of Participants|41|41.0||||||
3975500|NCT01278303|3797616|B1|||Age||years|Median|18|18.0|Full Range|||6.0|67.0|
3975501|NCT01278173|3797622|B1|United States||Region of Enrollment||participants|Number|65|65.0||||||
3975502|NCT01278173|3797622|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975503|NCT01278173|3797622|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975504|NCT01278173|3797622|B1||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3975505|NCT01278173|3797622|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3975506|NCT01278173|3797622|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975507|NCT01278173|3797622|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3975508|NCT01278173|3797622|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975509|NCT01278173|3797622|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3975510|NCT01278173|3797622|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3975511|NCT01278173|3797622|B1|||Age||years|Mean|39.8|39.8|Standard Deviation|12.3|12.3|||
3975512|NCT01278160|3797627|B3|Missing data||Diabetic complications||participants|Number|5|5.0||||||
3975513|NCT01278160|3797628|B2|Missing data||Diabetic complications||participants|Number|1|1.0||||||
3975514|NCT01278160|3797629|B1|Missing data||Diabetic complications||participants|Number|4|4.0||||||
3975515|NCT01278160|3797627|B3|No||Diabetic complications||participants|Number|136|136.0||||||
3975516|NCT01278160|3797628|B2|No||Diabetic complications||participants|Number|67|67.0||||||
3975517|NCT01278160|3797629|B1|No||Diabetic complications||participants|Number|69|69.0||||||
3975518|NCT01278160|3797627|B3|Yes||Diabetic complications||participants|Number|38|38.0||||||
3975519|NCT01278160|3797628|B2|Yes||Diabetic complications||participants|Number|22|22.0||||||
3975520|NCT01278160|3797629|B1|Yes||Diabetic complications||participants|Number|16|16.0||||||
3975521|NCT01278160|3797627|B3|||Duration of diabetes|Number of years since diagnosis|years|Mean|9.65|9.65|Standard Deviation|5.98|5.98|||
3975522|NCT01278160|3797628|B2|||Duration of diabetes|Number of years since diagnosis|years|Mean|10.23|10.23|Standard Deviation|5.89|5.89|||
3975523|NCT01278160|3797629|B1|||Duration of diabetes|Number of years since diagnosis|years|Mean|9.08|9.08|Standard Deviation|6.05|6.05|||
3975524|NCT01278160|3797627|B3|||Glycosylated haemoglobin (HbA1c) at screening||percentage of glycosylated haemoglobin|Mean|7.80|7.8|Standard Deviation|0.69|0.69|||
3975525|NCT01278160|3797628|B2|||Glycosylated haemoglobin (HbA1c) at screening||percentage of glycosylated haemoglobin|Mean|7.80|7.8|Standard Deviation|0.73|0.73|||
3975526|NCT01278160|3797629|B1|||Glycosylated haemoglobin (HbA1c) at screening||percentage of glycosylated haemoglobin|Mean|7.80|7.8|Standard Deviation|0.65|0.65|||
3975527|NCT01278160|3797627|B3|||Body mass index (BMI)||kg/m^2|Mean|26.38|26.38|Standard Deviation|3.35|3.35|||
3975528|NCT01278160|3797628|B2|||Body mass index (BMI)||kg/m^2|Mean|26.36|26.36|Standard Deviation|3.28|3.28|||
3975529|NCT01278160|3797629|B1|||Body mass index (BMI)||kg/m^2|Mean|26.40|26.4|Standard Deviation|3.44|3.44|||
3975530|NCT01278160|3797627|B3|||Weight||kg|Mean|72.2|72.2|Standard Deviation|11.3|11.3|||
3975531|NCT01278160|3797628|B2|||Weight||kg|Mean|72.3|72.3|Standard Deviation|11.6|11.6|||
3975532|NCT01278160|3797629|B1|||Weight||kg|Mean|72.2|72.2|Standard Deviation|11.1|11.1|||
3975533|NCT01278160|3797627|B3|||Height||cm|Mean|165.3|165.3|Standard Deviation|7.9|7.9|||
3975534|NCT01278160|3797628|B2|||Height||cm|Mean|165.3|165.3|Standard Deviation|8.4|8.4|||
3975535|NCT01278160|3797629|B1|||Height||cm|Mean|165.2|165.2|Standard Deviation|7.4|7.4|||
3975536|NCT01278160|3797627|B3|China||Region of Enrollment||participants|Number|179|179.0||||||
3975537|NCT01278160|3797628|B2|China||Region of Enrollment||participants|Number|90|90.0||||||
3975538|NCT01278160|3797629|B1|China||Region of Enrollment||participants|Number|89|89.0||||||
3975539|NCT01278160|3797627|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975540|NCT01278160|3797628|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975541|NCT01278160|3797629|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975542|NCT01278160|3797627|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975543|NCT01278160|3797628|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975544|NCT01278160|3797629|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975545|NCT01278160|3797627|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975546|NCT01278160|3797628|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975547|NCT01278160|3797629|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975548|NCT01278160|3797627|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975549|NCT01278160|3797628|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975550|NCT01278160|3797629|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975551|NCT01278160|3797627|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975552|NCT01278160|3797628|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975553|NCT01278160|3797629|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975554|NCT01278160|3797627|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|179|179.0||||||
3975555|NCT01278160|3797628|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
3975556|NCT01278160|3797629|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
3975557|NCT01278160|3797627|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975558|NCT01278160|3797628|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975559|NCT01278160|3797629|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975560|NCT01278160|3797627|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3975561|NCT01278160|3797628|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3975562|NCT01278160|3797629|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3975563|NCT01278160|3797627|B3||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3975564|NCT01278160|3797628|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3975565|NCT01278160|3797629|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3975566|NCT01278160|3797627|B3|||Age||years|Mean|56.1|56.1|Standard Deviation|9.7|9.7|||
3975567|NCT01278160|3797628|B2|||Age||years|Mean|57.1|57.1|Standard Deviation|9.4|9.4|||
3975568|NCT01278160|3797629|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|9.9|9.9|||
3975569|NCT01278030|3797644|B3|United States||Region of Enrollment||participants|Number|78|78.0||||||
3975570|NCT01278030|3797645|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
3975571|NCT01278030|3797646|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
3975572|NCT01278030|3797644|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3975573|NCT01278030|3797645|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3975574|NCT01278030|3797646|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3975575|NCT01278030|3797644|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3975576|NCT01278030|3797645|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3975577|NCT01278030|3797646|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3975578|NCT01278030|3797644|B3|||Age||years|Mean|67|67.0|Standard Deviation|12|12.0|||
3975579|NCT01278030|3797645|B2|||Age||years|Mean|67|67.0|Standard Deviation|11|11.0|||
3975580|NCT01278030|3797646|B1|||Age||years|Mean|67|67.0|Standard Deviation|13|13.0|||
3975581|NCT01278030|3797644|B3||>=65 years|Age||Participants|Count of Participants|47|47.0||||||
3975582|NCT01278030|3797645|B2||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3975583|NCT01278030|3797646|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3975584|NCT01278030|3797644|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3975585|NCT01278030|3797645|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3975586|NCT01278030|3797646|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3975587|NCT01278030|3797644|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3975588|NCT01278030|3797645|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3975589|NCT01278030|3797646|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3975590|NCT01277887|3797653|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
3975591|NCT01277887|3797654|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3975592|NCT01277887|3797655|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3975593|NCT01277887|3797653|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3975594|NCT01277887|3797654|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3975595|NCT01277887|3797655|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3975596|NCT01277887|3797653|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3975597|NCT01277887|3797654|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3975598|NCT01277887|3797655|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3975599|NCT01277887|3797653|B3|||Age||years|Mean|51.47|51.47|Standard Deviation|12.25|12.25|||
3975600|NCT01277887|3797654|B2|||Age||years|Mean|51.20|51.2|Standard Deviation|10.73|10.73|||
3975601|NCT01277887|3797655|B1|||Age||years|Mean|51.86|51.86|Standard Deviation|15.07|15.07|||
3975602|NCT01277887|3797653|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3975603|NCT01277887|3797654|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3975604|NCT01277887|3797655|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3975605|NCT01277887|3797653|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3975606|NCT01277887|3797654|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3975607|NCT01277887|3797655|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3975608|NCT01277887|3797653|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3975609|NCT01277887|3797654|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3975610|NCT01277887|3797655|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3975611|NCT01277861|3797666|B3|||Body Mass Index|Body mass index is calculated from height and weight of the patient.|kg/m2|Mean|26.8|26.8|Standard Deviation|4.5|4.5|||
3975612|NCT01277861|3797667|B2|||Body Mass Index|Body mass index is calculated from height and weight of the patient.|kg/m2|Mean|26.8|26.8|Standard Deviation|4.7|4.7|||
3975613|NCT01277861|3797668|B1|||Body Mass Index|Body mass index is calculated from height and weight of the patient.|kg/m2|Mean|26.8|26.8|Standard Deviation|4.3|4.3|||
3975614|NCT01277861|3797666|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3975615|NCT01277861|3797667|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3975616|NCT01277861|3797668|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3975617|NCT01277861|3797666|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3975618|NCT01277861|3797667|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3975619|NCT01277861|3797668|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3975620|NCT01277861|3797666|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3975621|NCT01277861|3797667|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3975622|NCT01277861|3797668|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3975623|NCT01277861|3797666|B3||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
3975624|NCT01277861|3797667|B2||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3975625|NCT01277861|3797668|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3975626|NCT01277861|3797666|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3975627|NCT01277861|3797667|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3975628|NCT01277861|3797668|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3975629|NCT01277822|3797679|B3||Male|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
3975630|NCT01277822|3797680|B2||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3975631|NCT01277822|3797681|B1||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3975632|NCT01277822|3797679|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3975633|NCT01277822|3797680|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3975634|NCT01277822|3797681|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3975635|NCT01277822|3797679|B3|||Age||years|Mean|52.9|52.9|Standard Deviation|10.6|10.6|||
3975636|NCT01277822|3797680|B2|||Age||years|Mean|51.8|51.8|Standard Deviation|10.6|10.6|||
3975637|NCT01277822|3797681|B1|||Age||years|Mean|54|54.0|Standard Deviation|10.5|10.5|||
3975638|NCT01277757|3797702|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3975639|NCT01277757|3797702|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3975640|NCT01277757|3797702|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3975641|NCT01277757|3797702|B1|||Age||years|Median|52.5|52.5|Full Range|||31.0|74.0|
3975642|NCT01277718|3797709|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3975643|NCT01277718|3797709|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3975644|NCT01277718|3797709|B1|||Age||years|Mean|31|31.0|Full Range|||22.0|53.0|
3975645|NCT01277666|3797721|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3975646|NCT01277666|3797722|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3975647|NCT01277666|3797723|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975648|NCT01277666|3797724|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975649|NCT01277666|3797721|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3975650|NCT01277666|3797722|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3975651|NCT01277666|3797723|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975652|NCT01277666|3797724|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975653|NCT01277666|3797721|B4||White|Race (NIH/OMB)||Participants|Count of Participants|533|533.0||||||
3975654|NCT01277666|3797722|B3||White|Race (NIH/OMB)||Participants|Count of Participants|179|179.0||||||
3975655|NCT01277666|3797723|B2||White|Race (NIH/OMB)||Participants|Count of Participants|177|177.0||||||
3975656|NCT01277666|3797724|B1||White|Race (NIH/OMB)||Participants|Count of Participants|177|177.0||||||
3975657|NCT01277666|3797721|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3975658|NCT01277666|3797722|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3975659|NCT01277666|3797723|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3975660|NCT01277666|3797724|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3975661|NCT01277666|3797721|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975662|NCT01277666|3797722|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975663|NCT01277666|3797723|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975664|NCT01277666|3797724|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975665|NCT01277666|3797721|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3975666|NCT01277666|3797722|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3975667|NCT01277666|3797723|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3975668|NCT01277666|3797724|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3975669|NCT01277666|3797721|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3975670|NCT01277666|3797722|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3975671|NCT01277666|3797723|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3975672|NCT01277666|3797724|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3975673|NCT01277666|3797721|B4||Male|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
3975674|NCT01277666|3797722|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3975675|NCT01277666|3797723|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3975676|NCT01277666|3797724|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3975677|NCT01277666|3797721|B4||Female|Sex: Female, Male||Participants|Count of Participants|339|339.0||||||
3975678|NCT01277666|3797722|B3||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3975679|NCT01277666|3797723|B2||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3975680|NCT01277666|3797724|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3975681|NCT01277666|3797721|B4|||Age||Years|Mean|36.3|36.3|Standard Deviation|12.56|12.56|||
3975682|NCT01277666|3797722|B3|||Age||Years|Mean|35.9|35.9|Standard Deviation|12.51|12.51|||
3975683|NCT01277666|3797723|B2|||Age||Years|Mean|37.0|37.0|Standard Deviation|12.60|12.6|||
3975684|NCT01277666|3797724|B1|||Age||Years|Mean|36.1|36.1|Standard Deviation|12.62|12.62|||
3975685|NCT01277601|3797755|B5|||Alanine Aminotransferase (ALT)||U/L|Mean|110.3|110.3|Standard Deviation|116.94|116.94|||
3975686|NCT01277601|3797756|B4|||Alanine Aminotransferase (ALT)||U/L|Mean|106.6|106.6|Standard Deviation|91.51|91.51|||
3975687|NCT01277601|3797757|B3|||Alanine Aminotransferase (ALT)||U/L|Mean|100.9|100.9|Standard Deviation|67.65|67.65|||
3975688|NCT01277601|3797758|B2|||Alanine Aminotransferase (ALT)||U/L|Mean|112.2|112.2|Standard Deviation|94.44|94.44|||
3975689|NCT01277601|3797759|B1|||Alanine Aminotransferase (ALT)||U/L|Mean|121.2|121.2|Standard Deviation|180.82|180.82|||
3975690|NCT01277601|3797755|B5|Genotype E-H||HBV Genotype||participants|Number|8|8.0||||||
3975691|NCT01277601|3797756|B4|Genotype E-H||HBV Genotype||participants|Number|1|1.0||||||
3975692|NCT01277601|3797757|B3|Genotype E-H||HBV Genotype||participants|Number|3|3.0||||||
3975693|NCT01277601|3797758|B2|Genotype E-H||HBV Genotype||participants|Number|2|2.0||||||
3975694|NCT01277601|3797759|B1|Genotype E-H||HBV Genotype||participants|Number|2|2.0||||||
3975695|NCT01277601|3797755|B5|Genotype D||HBV Genotype||participants|Number|154|154.0||||||
3975696|NCT01277601|3797756|B4|Genotype D||HBV Genotype||participants|Number|38|38.0||||||
3975697|NCT01277601|3797757|B3|Genotype D||HBV Genotype||participants|Number|41|41.0||||||
3975698|NCT01277601|3797758|B2|Genotype D||HBV Genotype||participants|Number|36|36.0||||||
3975699|NCT01277601|3797759|B1|Genotype D||HBV Genotype||participants|Number|39|39.0||||||
3975700|NCT01277601|3797755|B5|Genotype C||HBV Genotype||participants|Number|314|314.0||||||
3975701|NCT01277601|3797756|B4|Genotype C||HBV Genotype||participants|Number|79|79.0||||||
3975702|NCT01277601|3797757|B3|Genotype C||HBV Genotype||participants|Number|78|78.0||||||
3975703|NCT01277601|3797758|B2|Genotype C||HBV Genotype||participants|Number|79|79.0||||||
3975704|NCT01277601|3797759|B1|Genotype C||HBV Genotype||participants|Number|78|78.0||||||
3975705|NCT01277601|3797755|B5|Genotype B||HBV Genotype||participants|Number|203|203.0||||||
3975706|NCT01277601|3797756|B4|Genotype B||HBV Genotype||participants|Number|53|53.0||||||
3975707|NCT01277601|3797757|B3|Genotype B||HBV Genotype||participants|Number|49|49.0||||||
3975708|NCT01277601|3797758|B2|Genotype B||HBV Genotype||participants|Number|51|51.0||||||
3975709|NCT01277601|3797759|B1|Genotype B||HBV Genotype||participants|Number|50|50.0||||||
3975710|NCT01277601|3797755|B5|Genotype A||HBV Genotype||participants|Number|61|61.0||||||
3975711|NCT01277601|3797756|B4|Genotype A||HBV Genotype||participants|Number|14|14.0||||||
3975712|NCT01277601|3797757|B3|Genotype A||HBV Genotype||participants|Number|14|14.0||||||
3975713|NCT01277601|3797758|B2|Genotype A||HBV Genotype||participants|Number|16|16.0||||||
3975714|NCT01277601|3797759|B1|Genotype A||HBV Genotype||participants|Number|17|17.0||||||
3975715|NCT01277601|3797755|B5|||Hepatitis B Virus (HBV) DNA||log 10 IU/mL|Mean|7.04|7.04|Standard Deviation|1.553|1.553|||
3975716|NCT01277601|3797756|B4|||Hepatitis B Virus (HBV) DNA||log 10 IU/mL|Mean|6.94|6.94|Standard Deviation|1.619|1.619|||
3975717|NCT01277601|3797757|B3|||Hepatitis B Virus (HBV) DNA||log 10 IU/mL|Mean|7.02|7.02|Standard Deviation|1.550|1.55|||
3975718|NCT01277601|3797758|B2|||Hepatitis B Virus (HBV) DNA||log 10 IU/mL|Mean|7.13|7.13|Standard Deviation|1.505|1.505|||
3975719|NCT01277601|3797759|B1|||Hepatitis B Virus (HBV) DNA||log 10 IU/mL|Mean|7.06|7.06|Standard Deviation|1.542|1.542|||
3975720|NCT01277601|3797755|B5|Nonreactive||Hepatitis B e Antigen (HBeAg) Status||participants|Number|312|312.0||||||
3975721|NCT01277601|3797756|B4|Nonreactive||Hepatitis B e Antigen (HBeAg) Status||participants|Number|79|79.0||||||
3975722|NCT01277601|3797757|B3|Nonreactive||Hepatitis B e Antigen (HBeAg) Status||participants|Number|76|76.0||||||
3975723|NCT01277601|3797758|B2|Nonreactive||Hepatitis B e Antigen (HBeAg) Status||participants|Number|79|79.0||||||
3975724|NCT01277601|3797759|B1|Nonreactive||Hepatitis B e Antigen (HBeAg) Status||participants|Number|78|78.0||||||
3975725|NCT01277601|3797755|B5|Reactive||Hepatitis B e Antigen (HBeAg) Status||participants|Number|428|428.0||||||
3975726|NCT01277601|3797756|B4|Reactive||Hepatitis B e Antigen (HBeAg) Status||participants|Number|106|106.0||||||
3975727|NCT01277601|3797757|B3|Reactive||Hepatitis B e Antigen (HBeAg) Status||participants|Number|109|109.0||||||
3975728|NCT01277601|3797758|B2|Reactive||Hepatitis B e Antigen (HBeAg) Status||participants|Number|105|105.0||||||
3975729|NCT01277601|3797759|B1|Reactive||Hepatitis B e Antigen (HBeAg) Status||participants|Number|108|108.0||||||
3975730|NCT01277601|3797755|B5|||Hepatitis B Surface Antigen (HBsAg)||log 10 IU/mL|Mean|3.84|3.84|Standard Deviation|0.836|0.836|||
3975731|NCT01277601|3797756|B4|||Hepatitis B Surface Antigen (HBsAg)||log 10 IU/mL|Mean|3.76|3.76|Standard Deviation|0.844|0.844|||
3975732|NCT01277601|3797757|B3|||Hepatitis B Surface Antigen (HBsAg)||log 10 IU/mL|Mean|3.89|3.89|Standard Deviation|0.812|0.812|||
3975733|NCT01277601|3797758|B2|||Hepatitis B Surface Antigen (HBsAg)||log 10 IU/mL|Mean|3.84|3.84|Standard Deviation|0.849|0.849|||
3975734|NCT01277601|3797759|B1|||Hepatitis B Surface Antigen (HBsAg)||log 10 IU/mL|Mean|3.88|3.88|Standard Deviation|0.840|0.84|||
3975735|NCT01277601|3797755|B5|Germany||Region of Enrollment||participants|Number|20|20.0||||||
3975736|NCT01277601|3797756|B4|Germany||Region of Enrollment||participants|Number|3|3.0||||||
3975737|NCT01277601|3797757|B3|Germany||Region of Enrollment||participants|Number|4|4.0||||||
3975738|NCT01277601|3797758|B2|Germany||Region of Enrollment||participants|Number|7|7.0||||||
3975739|NCT01277601|3797759|B1|Germany||Region of Enrollment||participants|Number|6|6.0||||||
3975740|NCT01277601|3797755|B5|France||Region of Enrollment||participants|Number|13|13.0||||||
3975741|NCT01277601|3797756|B4|France||Region of Enrollment||participants|Number|3|3.0||||||
3975742|NCT01277601|3797757|B3|France||Region of Enrollment||participants|Number|1|1.0||||||
3975743|NCT01277601|3797758|B2|France||Region of Enrollment||participants|Number|3|3.0||||||
3975744|NCT01277601|3797759|B1|France||Region of Enrollment||participants|Number|6|6.0||||||
3975745|NCT01277601|3797755|B5|Australia||Region of Enrollment||participants|Number|53|53.0||||||
3975746|NCT01277601|3797756|B4|Australia||Region of Enrollment||participants|Number|14|14.0||||||
3975747|NCT01277601|3797757|B3|Australia||Region of Enrollment||participants|Number|15|15.0||||||
3975748|NCT01277601|3797758|B2|Australia||Region of Enrollment||participants|Number|14|14.0||||||
3975749|NCT01277601|3797759|B1|Australia||Region of Enrollment||participants|Number|10|10.0||||||
3975750|NCT01277601|3797755|B5|Italy||Region of Enrollment||participants|Number|11|11.0||||||
3975751|NCT01277601|3797756|B4|Italy||Region of Enrollment||participants|Number|4|4.0||||||
3975752|NCT01277601|3797757|B3|Italy||Region of Enrollment||participants|Number|4|4.0||||||
3975753|NCT01277601|3797758|B2|Italy||Region of Enrollment||participants|Number|1|1.0||||||
3975754|NCT01277601|3797759|B1|Italy||Region of Enrollment||participants|Number|2|2.0||||||
3975755|NCT01277601|3797755|B5|Poland||Region of Enrollment||participants|Number|22|22.0||||||
3975756|NCT01277601|3797756|B4|Poland||Region of Enrollment||participants|Number|5|5.0||||||
3975757|NCT01277601|3797757|B3|Poland||Region of Enrollment||participants|Number|6|6.0||||||
3975758|NCT01277601|3797758|B2|Poland||Region of Enrollment||participants|Number|7|7.0||||||
3975759|NCT01277601|3797759|B1|Poland||Region of Enrollment||participants|Number|4|4.0||||||
3975760|NCT01277601|3797755|B5|Korea, Republic of||Region of Enrollment||participants|Number|145|145.0||||||
3975761|NCT01277601|3797756|B4|Korea, Republic of||Region of Enrollment||participants|Number|35|35.0||||||
3975762|NCT01277601|3797757|B3|Korea, Republic of||Region of Enrollment||participants|Number|38|38.0||||||
3975763|NCT01277601|3797758|B2|Korea, Republic of||Region of Enrollment||participants|Number|38|38.0||||||
3975764|NCT01277601|3797759|B1|Korea, Republic of||Region of Enrollment||participants|Number|34|34.0||||||
3975765|NCT01277601|3797755|B5|Taiwan||Region of Enrollment||participants|Number|66|66.0||||||
3975766|NCT01277601|3797756|B4|Taiwan||Region of Enrollment||participants|Number|19|19.0||||||
3975767|NCT01277601|3797757|B3|Taiwan||Region of Enrollment||participants|Number|12|12.0||||||
3975768|NCT01277601|3797758|B2|Taiwan||Region of Enrollment||participants|Number|15|15.0||||||
3975769|NCT01277601|3797759|B1|Taiwan||Region of Enrollment||participants|Number|20|20.0||||||
3975770|NCT01277601|3797755|B5|Turkey||Region of Enrollment||participants|Number|24|24.0||||||
3975771|NCT01277601|3797756|B4|Turkey||Region of Enrollment||participants|Number|7|7.0||||||
3975772|NCT01277601|3797757|B3|Turkey||Region of Enrollment||participants|Number|6|6.0||||||
3975773|NCT01277601|3797758|B2|Turkey||Region of Enrollment||participants|Number|6|6.0||||||
3975774|NCT01277601|3797759|B1|Turkey||Region of Enrollment||participants|Number|5|5.0||||||
3975775|NCT01277601|3797755|B5|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
3975776|NCT01277601|3797756|B4|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
3975777|NCT01277601|3797757|B3|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
3975778|NCT01277601|3797758|B2|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
3975779|NCT01277601|3797759|B1|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
3975780|NCT01277601|3797755|B5|Canada||Region of Enrollment||participants|Number|58|58.0||||||
3975781|NCT01277601|3797756|B4|Canada||Region of Enrollment||participants|Number|11|11.0||||||
3975782|NCT01277601|3797757|B3|Canada||Region of Enrollment||participants|Number|14|14.0||||||
3975783|NCT01277601|3797758|B2|Canada||Region of Enrollment||participants|Number|14|14.0||||||
3975784|NCT01277601|3797759|B1|Canada||Region of Enrollment||participants|Number|19|19.0||||||
3975785|NCT01277601|3797755|B5|Greece||Region of Enrollment||participants|Number|9|9.0||||||
3975786|NCT01277601|3797756|B4|Greece||Region of Enrollment||participants|Number|4|4.0||||||
3975787|NCT01277601|3797757|B3|Greece||Region of Enrollment||participants|Number|2|2.0||||||
3975788|NCT01277601|3797758|B2|Greece||Region of Enrollment||participants|Number|3|3.0||||||
3975789|NCT01277601|3797759|B1|Greece||Region of Enrollment||participants|Number|0|0.0||||||
3975790|NCT01277601|3797755|B5|Spain||Region of Enrollment||participants|Number|14|14.0||||||
3975791|NCT01277601|3797756|B4|Spain||Region of Enrollment||participants|Number|5|5.0||||||
3975792|NCT01277601|3797757|B3|Spain||Region of Enrollment||participants|Number|3|3.0||||||
3975793|NCT01277601|3797758|B2|Spain||Region of Enrollment||participants|Number|3|3.0||||||
3975794|NCT01277601|3797759|B1|Spain||Region of Enrollment||participants|Number|3|3.0||||||
3975795|NCT01277601|3797755|B5|India||Region of Enrollment||participants|Number|30|30.0||||||
3975796|NCT01277601|3797756|B4|India||Region of Enrollment||participants|Number|6|6.0||||||
3975797|NCT01277601|3797757|B3|India||Region of Enrollment||participants|Number|9|9.0||||||
3975798|NCT01277601|3797758|B2|India||Region of Enrollment||participants|Number|5|5.0||||||
3975799|NCT01277601|3797759|B1|India||Region of Enrollment||participants|Number|10|10.0||||||
3975800|NCT01277601|3797755|B5|Portugal||Region of Enrollment||participants|Number|3|3.0||||||
3975801|NCT01277601|3797756|B4|Portugal||Region of Enrollment||participants|Number|0|0.0||||||
3975802|NCT01277601|3797757|B3|Portugal||Region of Enrollment||participants|Number|0|0.0||||||
3975803|NCT01277601|3797758|B2|Portugal||Region of Enrollment||participants|Number|3|3.0||||||
3975804|NCT01277601|3797759|B1|Portugal||Region of Enrollment||participants|Number|0|0.0||||||
3975805|NCT01277601|3797755|B5|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
3975806|NCT01277601|3797756|B4|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3975807|NCT01277601|3797757|B3|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
3975808|NCT01277601|3797758|B2|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3975809|NCT01277601|3797759|B1|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
3975810|NCT01277601|3797755|B5|United States||Region of Enrollment||participants|Number|85|85.0||||||
3975811|NCT01277601|3797756|B4|United States||Region of Enrollment||participants|Number|26|26.0||||||
3975812|NCT01277601|3797757|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
3975813|NCT01277601|3797758|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3975814|NCT01277601|3797759|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3975815|NCT01277601|3797755|B5|Hong Kong||Region of Enrollment||participants|Number|97|97.0||||||
3975816|NCT01277601|3797756|B4|Hong Kong||Region of Enrollment||participants|Number|21|21.0||||||
3975817|NCT01277601|3797757|B3|Hong Kong||Region of Enrollment||participants|Number|27|27.0||||||
3975818|NCT01277601|3797758|B2|Hong Kong||Region of Enrollment||participants|Number|24|24.0||||||
3975819|NCT01277601|3797759|B1|Hong Kong||Region of Enrollment||participants|Number|25|25.0||||||
3975820|NCT01277601|3797755|B5|Singapore||Region of Enrollment||participants|Number|27|27.0||||||
3975821|NCT01277601|3797756|B4|Singapore||Region of Enrollment||participants|Number|8|8.0||||||
3975822|NCT01277601|3797757|B3|Singapore||Region of Enrollment||participants|Number|7|7.0||||||
3975823|NCT01277601|3797758|B2|Singapore||Region of Enrollment||participants|Number|5|5.0||||||
3975824|NCT01277601|3797759|B1|Singapore||Region of Enrollment||participants|Number|7|7.0||||||
3975825|NCT01277601|3797755|B5|Romania||Region of Enrollment||participants|Number|49|49.0||||||
3975826|NCT01277601|3797756|B4|Romania||Region of Enrollment||participants|Number|9|9.0||||||
3975827|NCT01277601|3797757|B3|Romania||Region of Enrollment||participants|Number|13|13.0||||||
3975828|NCT01277601|3797758|B2|Romania||Region of Enrollment||participants|Number|15|15.0||||||
3975829|NCT01277601|3797759|B1|Romania||Region of Enrollment||participants|Number|12|12.0||||||
3975830|NCT01277601|3797755|B5|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3975831|NCT01277601|3797756|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3975832|NCT01277601|3797757|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3975833|NCT01277601|3797758|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3975834|NCT01277601|3797759|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3975835|NCT01277601|3797755|B5|White||Race/Ethnicity, Customized||participants|Number|161|161.0||||||
3975836|NCT01277601|3797756|B4|White||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
3975837|NCT01277601|3797757|B3|White||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
3975838|NCT01277601|3797758|B2|White||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
3975839|NCT01277601|3797759|B1|White||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3975840|NCT01277601|3797755|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3975841|NCT01277601|3797756|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3975842|NCT01277601|3797757|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3975843|NCT01277601|3797758|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3975844|NCT01277601|3797759|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3975845|NCT01277601|3797755|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3975846|NCT01277601|3797756|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3975847|NCT01277601|3797757|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3975848|NCT01277601|3797758|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3975849|NCT01277601|3797759|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3975850|NCT01277601|3797755|B5|Asian||Race/Ethnicity, Customized||participants|Number|554|554.0||||||
3975851|NCT01277601|3797756|B4|Asian||Race/Ethnicity, Customized||participants|Number|137|137.0||||||
3975852|NCT01277601|3797757|B3|Asian||Race/Ethnicity, Customized||participants|Number|141|141.0||||||
3975853|NCT01277601|3797758|B2|Asian||Race/Ethnicity, Customized||participants|Number|134|134.0||||||
3975854|NCT01277601|3797759|B1|Asian||Race/Ethnicity, Customized||participants|Number|142|142.0||||||
3975855|NCT01277601|3797755|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3975856|NCT01277601|3797756|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3975857|NCT01277601|3797757|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3975858|NCT01277601|3797758|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3975859|NCT01277601|3797759|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3975860|NCT01277601|3797755|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|719|719.0||||||
3975861|NCT01277601|3797756|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|177|177.0||||||
3975862|NCT01277601|3797757|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|181|181.0||||||
3975863|NCT01277601|3797758|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|179|179.0||||||
3975864|NCT01277601|3797759|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|182|182.0||||||
3975865|NCT01277601|3797755|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3975866|NCT01277601|3797756|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3975867|NCT01277601|3797757|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3975868|NCT01277601|3797758|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3975869|NCT01277601|3797759|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3975870|NCT01277601|3797755|B5||Male|Sex: Female, Male||Participants|Count of Participants|486|486.0||||||
3975871|NCT01277601|3797756|B4||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3975872|NCT01277601|3797757|B3||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3975873|NCT01277601|3797758|B2||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3975874|NCT01277601|3797759|B1||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3975875|NCT01277601|3797755|B5||Female|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
3975876|NCT01277601|3797756|B4||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3975877|NCT01277601|3797757|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3975878|NCT01277601|3797758|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3975879|NCT01277601|3797759|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3975880|NCT01277601|3797755|B5|||Age||years|Mean|37|37.0|Standard Deviation|10.5|10.5|||
3975881|NCT01277601|3797756|B4|||Age||years|Mean|38|38.0|Standard Deviation|10.5|10.5|||
3975882|NCT01277601|3797757|B3|||Age||years|Mean|36|36.0|Standard Deviation|10.8|10.8|||
3975883|NCT01277601|3797758|B2|||Age||years|Mean|37|37.0|Standard Deviation|9.9|9.9|||
3975884|NCT01277601|3797759|B1|||Age||years|Mean|38|38.0|Standard Deviation|10.7|10.7|||
3975885|NCT01277549|3797851|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3975886|NCT01277549|3797852|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3975887|NCT01277549|3797853|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3975888|NCT01277549|3797851|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3975889|NCT01277549|3797852|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3975890|NCT01277549|3797853|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3975891|NCT01277549|3797851|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3975892|NCT01277549|3797852|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3975893|NCT01277549|3797853|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3975894|NCT01277549|3797851|B3|||Age|Median and range reported are for donors who completed the study.|Years of Age|Median|31|31.0|Full Range|||19.0|47.0|
3975895|NCT01277549|3797852|B2|||Age|Median and range reported are for donors who completed the study.|Years of Age|Median|33|33.0|Full Range|||29.0|47.0|
3975896|NCT01277549|3797853|B1|||Age|Median and range reported are for donors who completed the study.|Years of Age|Median|25|25.0|Full Range|||19.0|45.0|
3975897|NCT01277523|3797868|B4||Male|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
3975898|NCT01277523|3797869|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3975899|NCT01277523|3797870|B2||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3975900|NCT01277523|3797871|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3975901|NCT01277523|3797868|B4||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3975902|NCT01277523|3797869|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3975903|NCT01277523|3797870|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3975904|NCT01277523|3797871|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3975905|NCT01277523|3797868|B4|||Age||years|Mean|14.2|14.2|Standard Deviation|1.7|1.7|||
3975906|NCT01277523|3797869|B3|||Age||years|Mean|14.3|14.3|Standard Deviation|1.6|1.6|||
3975907|NCT01277523|3797870|B2|||Age||years|Mean|14.4|14.4|Standard Deviation|1.8|1.8|||
3975908|NCT01277523|3797871|B1|||Age||years|Mean|14.1|14.1|Standard Deviation|1.7|1.7|||
3975909|NCT01277510|3797923|B3|||Serum Phosphorous||mg/dL|Mean|6.53|6.53|Standard Deviation|1.63|1.63|||
3975910|NCT01277510|3797924|B2|||Serum Phosphorous||mg/dL|Mean|6.68|6.68|Standard Deviation|1.78|1.78|||
3975911|NCT01277510|3797925|B1|||Serum Phosphorous||mg/dL|Mean|6.37|6.37|Standard Deviation|1.48|1.48|||
3975912|NCT01277510|3797923|B3|||Corrected Total Serum Calcium|"Serum calcium was reported as a corrected value by the central laboratory based on calcium and albumin concentrations:~Corrected total calcium (mg/dL) = measured total serum calcium (mg/dL) + 0.8 (4.0 – Serum albumin (g/dL))."|mg/dL|Mean|9.90|9.9|Standard Deviation|0.58|0.58|||
3975913|NCT01277510|3797924|B2|||Corrected Total Serum Calcium|"Serum calcium was reported as a corrected value by the central laboratory based on calcium and albumin concentrations:~Corrected total calcium (mg/dL) = measured total serum calcium (mg/dL) + 0.8 (4.0 – Serum albumin (g/dL))."|mg/dL|Mean|9.91|9.91|Standard Deviation|0.54|0.54|||
3975914|NCT01277510|3797925|B1|||Corrected Total Serum Calcium|"Serum calcium was reported as a corrected value by the central laboratory based on calcium and albumin concentrations:~Corrected total calcium (mg/dL) = measured total serum calcium (mg/dL) + 0.8 (4.0 – Serum albumin (g/dL))."|mg/dL|Mean|9.88|9.88|Standard Deviation|0.62|0.62|||
3975915|NCT01277510|3797923|B3|||Intact Parathyroid Hormone (iPTH)||pg/mL|Mean|776.0|776.0|Standard Deviation|484.8|484.8|||
3975916|NCT01277510|3797924|B2|||Intact Parathyroid Hormone (iPTH)||pg/mL|Mean|757.1|757.1|Standard Deviation|440.1|440.1|||
3975917|NCT01277510|3797925|B1|||Intact Parathyroid Hormone (iPTH)||pg/mL|Mean|795.8|795.8|Standard Deviation|537.9|537.9|||
3975918|NCT01277510|3797923|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3975919|NCT01277510|3797924|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3975920|NCT01277510|3797925|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3975921|NCT01277510|3797923|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3975922|NCT01277510|3797924|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3975923|NCT01277510|3797925|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3975924|NCT01277510|3797923|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3975925|NCT01277510|3797924|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3975926|NCT01277510|3797925|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3975927|NCT01277510|3797923|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3975928|NCT01277510|3797924|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3975929|NCT01277510|3797925|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3975930|NCT01277510|3797923|B3|White||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3975931|NCT01277510|3797924|B2|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3975932|NCT01277510|3797925|B1|White||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3975933|NCT01277510|3797923|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3975934|NCT01277510|3797924|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3975935|NCT01277510|3797925|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3975936|NCT01277510|3797923|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3975937|NCT01277510|3797924|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3975938|NCT01277510|3797925|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3975939|NCT01277510|3797923|B3|12 to < 18 years||Age, Customized||participants|Number|32|32.0||||||
3975940|NCT01277510|3797924|B2|12 to < 18 years||Age, Customized||participants|Number|16|16.0||||||
3975941|NCT01277510|3797925|B1|12 to < 18 years||Age, Customized||participants|Number|16|16.0||||||
3975942|NCT01277510|3797923|B3|6 to < 12 years||Age, Customized||participants|Number|11|11.0||||||
3975943|NCT01277510|3797924|B2|6 to < 12 years||Age, Customized||participants|Number|6|6.0||||||
3975944|NCT01277510|3797925|B1|6 to < 12 years||Age, Customized||participants|Number|5|5.0||||||
3975945|NCT01277510|3797923|B3|||Age||years|Mean|13.2|13.2|Standard Deviation|3.3|3.3|||
3975946|NCT01277510|3797924|B2|||Age||years|Mean|13.3|13.3|Standard Deviation|3.6|3.6|||
3975947|NCT01277510|3797925|B1|||Age||years|Mean|13.2|13.2|Standard Deviation|2.9|2.9|||
3975948|NCT01277354|3797948|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3975949|NCT01277354|3797949|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3975950|NCT01277354|3797950|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3975951|NCT01277354|3797948|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3975952|NCT01277354|3797949|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3975953|NCT01277354|3797950|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3975954|NCT01277354|3797948|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3975955|NCT01277354|3797949|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3975956|NCT01277354|3797950|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3975957|NCT01277354|3797948|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3975958|NCT01277354|3797949|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3975959|NCT01277354|3797950|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3975960|NCT01277354|3797948|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3975961|NCT01277354|3797949|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3975962|NCT01277354|3797950|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3975963|NCT01277354|3797948|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3975964|NCT01277354|3797949|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3975965|NCT01277354|3797950|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3975966|NCT01277302|3797957|B4||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3975967|NCT01277302|3797958|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3975968|NCT01277302|3797959|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3975969|NCT01277302|3797960|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3975970|NCT01277302|3797957|B4||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3975971|NCT01277302|3797958|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3975972|NCT01277302|3797959|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3975973|NCT01277302|3797960|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3975974|NCT01277302|3797957|B4|||Age||years|Mean|66.3|66.3|Standard Deviation|12.4|12.4|||
3975975|NCT01277302|3797958|B3|||Age||years|Mean|66.3|66.3|Standard Deviation|12.3|12.3|||
3975976|NCT01277302|3797959|B2|||Age||years|Mean|65.2|65.2|Standard Deviation|12.8|12.8|||
3975977|NCT01277302|3797960|B1|||Age||years|Mean|67.3|67.3|Standard Deviation|12.1|12.1|||
3975978|NCT01277211|3797992|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3975979|NCT01277211|3797993|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3975980|NCT01277211|3797994|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3975981|NCT01277211|3797992|B3||Female|Sex: Female, Male||Participants|Count of Participants|946|946.0||||||
3975982|NCT01277211|3797993|B2||Female|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
3975983|NCT01277211|3797994|B1||Female|Sex: Female, Male||Participants|Count of Participants|714|714.0||||||
3975984|NCT01277211|3797992|B3|||Age||Years|Mean|31.7|31.7|Standard Deviation|4.0|4.0|||
3975985|NCT01277211|3797993|B2|||Age||Years|Mean|31.2|31.2|Standard Deviation|3.9|3.9|||
3975986|NCT01277211|3797994|B1|||Age||Years|Mean|31.8|31.8|Standard Deviation|4.0|4.0|||
3975987|NCT01277159|3798005|B6|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3975988|NCT01277159|3798005|B6||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3975989|NCT01277159|3798006|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3975990|NCT01277159|3798007|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3975991|NCT01277159|3798008|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3975992|NCT01277159|3798009|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3975993|NCT01277159|3798010|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3975994|NCT01277159|3798005|B6||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3975995|NCT01277159|3798006|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3975996|NCT01277159|3798007|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3975997|NCT01277159|3798008|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3975998|NCT01277159|3798009|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3975999|NCT01277159|3798010|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3976000|NCT01277159|3798005|B6|||Age||years|Mean|49.1|49.1|Standard Deviation|8.6|8.6|||
3976001|NCT01277159|3798006|B5|||Age||years|Mean|52.19|52.19|Standard Deviation|7.2|7.2|||
3976002|NCT01277159|3798007|B4|||Age||years|Mean|47.95|47.95|Standard Deviation|8.6|8.6|||
3976003|NCT01277159|3798008|B3|||Age||years|Mean|46.26|46.26|Standard Deviation|7.5|7.5|||
3976004|NCT01277159|3798009|B2|||Age||years|Mean|47.81|47.81|Standard Deviation|9.5|9.5|||
3976005|NCT01277159|3798010|B1|||Age||years|Mean|51.29|51.29|Standard Deviation|6.8|6.8|||
3976006|NCT01277081|3798026|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3976007|NCT01277081|3798027|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3976008|NCT01277081|3798028|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3976009|NCT01277081|3798026|B3||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3976010|NCT01277081|3798027|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3976011|NCT01277081|3798028|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3976012|NCT01277081|3798026|B3|||Age||Years|Mean|20.0|20.0|Standard Deviation|1.92|1.92|||
3976013|NCT01277081|3798027|B2|||Age||Years|Mean|20.0|20.0|Standard Deviation|1.98|1.98|||
3976014|NCT01277081|3798028|B1|||Age||Years|Mean|20.0|20.0|Standard Deviation|1.85|1.85|||
3976015|NCT01277042|3798045|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3976016|NCT01277042|3798046|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3976017|NCT01277042|3798047|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3976018|NCT01277042|3798045|B3||Female|Sex: Female, Male||Participants|Count of Participants|1212|1212.0||||||
3976019|NCT01277042|3798046|B2||Female|Sex: Female, Male||Participants|Count of Participants|606|606.0||||||
3976020|NCT01277042|3798047|B1||Female|Sex: Female, Male||Participants|Count of Participants|606|606.0||||||
3976021|NCT01277042|3798045|B3|||Age||Years|Mean|35.7|35.7|Standard Deviation|4.99|4.99|||
3976022|NCT01277042|3798046|B2|||Age||Years|Mean|35.6|35.6|Standard Deviation|5.06|5.06|||
3976023|NCT01277042|3798047|B1|||Age||Years|Mean|35.8|35.8|Standard Deviation|4.92|4.92|||
3976024|NCT01276847|3798070|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3976025|NCT01276847|3798071|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3976026|NCT01276847|3798072|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3976027|NCT01276847|3798073|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3976028|NCT01276847|3798070|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3976029|NCT01276847|3798071|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3976030|NCT01276847|3798072|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3976031|NCT01276847|3798073|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3976032|NCT01276847|3798070|B4|||Age||years|Mean|46.1|46.1|Standard Deviation|13.1|13.1|||
3976033|NCT01276847|3798071|B3|||Age||years|Mean|45.7|45.7|Standard Deviation|12.1|12.1|||
3976034|NCT01276847|3798072|B2|||Age||years|Mean|53.4|53.4|Standard Deviation|13.0|13.0|||
3976035|NCT01276847|3798073|B1|||Age||years|Mean|39.5|39.5|Standard Deviation|12.5|12.5|||
3976036|NCT01276821|3798083|B3|No||History suggestive of Atopy||participants|Number|90|90.0||||||
3976037|NCT01276821|3798084|B2|No||History suggestive of Atopy||participants|Number|43|43.0||||||
3976038|NCT01276821|3798085|B1|No||History suggestive of Atopy||participants|Number|47|47.0||||||
3976039|NCT01276821|3798083|B3|Yes||History suggestive of Atopy||participants|Number|10|10.0||||||
3976040|NCT01276821|3798084|B2|Yes||History suggestive of Atopy||participants|Number|7|7.0||||||
3976041|NCT01276821|3798085|B1|Yes||History suggestive of Atopy||participants|Number|3|3.0||||||
3976042|NCT01276821|3798083|B3|No||Prematurity||participants|Number|95|95.0||||||
3976043|NCT01276821|3798084|B2|No||Prematurity||participants|Number|47|47.0||||||
3976044|NCT01276821|3798085|B1|No||Prematurity||participants|Number|48|48.0||||||
3976045|NCT01276821|3798083|B3|Yes||Prematurity||participants|Number|5|5.0||||||
3976046|NCT01276821|3798084|B2|Yes||Prematurity||participants|Number|3|3.0||||||
3976047|NCT01276821|3798085|B1|Yes||Prematurity||participants|Number|2|2.0||||||
3976048|NCT01276821|3798083|B3|No||Breastfeeding Status||participants|Number|4|4.0||||||
3976049|NCT01276821|3798084|B2|No||Breastfeeding Status||participants|Number|2|2.0||||||
3976050|NCT01276821|3798085|B1|No||Breastfeeding Status||participants|Number|2|2.0||||||
3976051|NCT01276821|3798083|B3|Yes||Breastfeeding Status||participants|Number|96|96.0||||||
3976052|NCT01276821|3798084|B2|Yes||Breastfeeding Status||participants|Number|48|48.0||||||
3976053|NCT01276821|3798085|B1|Yes||Breastfeeding Status||participants|Number|48|48.0||||||
3976054|NCT01276821|3798083|B3|No||Exposure to Biofuels||participants|Number|78|78.0||||||
3976055|NCT01276821|3798084|B2|No||Exposure to Biofuels||participants|Number|36|36.0||||||
3976056|NCT01276821|3798085|B1|No||Exposure to Biofuels||participants|Number|42|42.0||||||
3976057|NCT01276821|3798083|B3|Yes||Exposure to Biofuels||participants|Number|22|22.0||||||
3976058|NCT01276821|3798084|B2|Yes||Exposure to Biofuels||participants|Number|14|14.0||||||
3976059|NCT01276821|3798085|B1|Yes||Exposure to Biofuels||participants|Number|8|8.0||||||
3976060|NCT01276821|3798083|B3|Enrollment from Out-Patient Department||Enrollment from Emergency Department||participants|Number|96|96.0||||||
3976061|NCT01276821|3798084|B2|Enrollment from Out-Patient Department||Enrollment from Emergency Department||participants|Number|48|48.0||||||
3976062|NCT01276821|3798085|B1|Enrollment from Out-Patient Department||Enrollment from Emergency Department||participants|Number|48|48.0||||||
3976063|NCT01276821|3798083|B3|Enrollment from Emergency Room||Enrollment from Emergency Department||participants|Number|4|4.0||||||
3976064|NCT01276821|3798084|B2|Enrollment from Emergency Room||Enrollment from Emergency Department||participants|Number|2|2.0||||||
3976065|NCT01276821|3798085|B1|Enrollment from Emergency Room||Enrollment from Emergency Department||participants|Number|2|2.0||||||
3976066|NCT01276821|3798083|B3|No||Parental Smoking|History of parental Smoking (Secondhand passive smoke exposure status) of children|participants|Number|49|49.0||||||
3976067|NCT01276821|3798084|B2|No||Parental Smoking|History of parental Smoking (Secondhand passive smoke exposure status) of children|participants|Number|20|20.0||||||
3976068|NCT01276821|3798085|B1|No||Parental Smoking|History of parental Smoking (Secondhand passive smoke exposure status) of children|participants|Number|29|29.0||||||
3976069|NCT01276821|3798083|B3|Yes||Parental Smoking|History of parental Smoking (Secondhand passive smoke exposure status) of children|participants|Number|51|51.0||||||
3976070|NCT01276821|3798084|B2|Yes||Parental Smoking|History of parental Smoking (Secondhand passive smoke exposure status) of children|participants|Number|30|30.0||||||
3976071|NCT01276821|3798085|B1|Yes||Parental Smoking|History of parental Smoking (Secondhand passive smoke exposure status) of children|participants|Number|21|21.0||||||
3976072|NCT01276821|3798083|B3|Negative||Family History of Asthma,||participants|Number|91|91.0||||||
3976073|NCT01276821|3798084|B2|Negative||Family History of Asthma,||participants|Number|46|46.0||||||
3976074|NCT01276821|3798085|B1|Negative||Family History of Asthma,||participants|Number|45|45.0||||||
3976075|NCT01276821|3798083|B3|Positive||Family History of Asthma,||participants|Number|9|9.0||||||
3976076|NCT01276821|3798084|B2|Positive||Family History of Asthma,||participants|Number|4|4.0||||||
3976077|NCT01276821|3798085|B1|Positive||Family History of Asthma,||participants|Number|5|5.0||||||
3976078|NCT01276821|3798083|B3|||Temperature||Degrees Fahreinheit|Mean|99.15|99.15|Standard Deviation|0.6|0.6|||
3976079|NCT01276821|3798084|B2|||Temperature||Degrees Fahreinheit|Mean|99.1|99.1|Standard Deviation|0.6|0.6|||
3976080|NCT01276821|3798085|B1|||Temperature||Degrees Fahreinheit|Mean|99.2|99.2|Standard Deviation|0.6|0.6|||
3976081|NCT01276821|3798083|B3|||Heart rate||Beats per minute|Mean|149.2|149.2|Standard Deviation|7.3|7.3|||
3976082|NCT01276821|3798084|B2|||Heart rate||Beats per minute|Mean|148.7|148.7|Standard Deviation|7.5|7.5|||
3976083|NCT01276821|3798085|B1|||Heart rate||Beats per minute|Mean|149.7|149.7|Standard Deviation|7.1|7.1|||
3976084|NCT01276821|3798083|B3|||Spo2 (Oxygen Saturation)||Percentage of Oxygen Saturation|Mean|93.45|93.45|Standard Deviation|0.75|0.75|||
3976085|NCT01276821|3798084|B2|||Spo2 (Oxygen Saturation)||Percentage of Oxygen Saturation|Mean|93.4|93.4|Standard Deviation|0.8|0.8|||
3976086|NCT01276821|3798085|B1|||Spo2 (Oxygen Saturation)||Percentage of Oxygen Saturation|Mean|93.5|93.5|Standard Deviation|0.7|0.7|||
3976087|NCT01276821|3798083|B3|||Respiratory Rate||Breaths per minute|Mean|49.05|49.05|Standard Deviation|2.25|2.25|||
3976088|NCT01276821|3798084|B2|||Respiratory Rate||Breaths per minute|Mean|49.1|49.1|Standard Deviation|2.5|2.5|||
3976089|NCT01276821|3798085|B1|||Respiratory Rate||Breaths per minute|Mean|49|49.0|Standard Deviation|2|2.0|||
3976090|NCT01276821|3798083|B3|||Clinical Severity Score Units|"The Clinical Severity scoring system initially described by Wang, assesses respiratory rate, wheezing, retraction, and general condition,to assess the degree of respiratory distress in young children. It provides a score ranging from 0 to 12, with increased severity receiving a higher score.~These scoring systems have previously been validated in a number of well designed randomized controlled trials (Anil 2010, Kuzik 2007, Sarrell 2002, and Mandelberg 2003). A 1 point improvement in the clinical severity score implies approximately 7% betterment of symptoms on the scale."|Clinical Severity Score Units|Mean|5.25|5.25|Standard Deviation|1.35|1.35|||
3976091|NCT01276821|3798084|B2|||Clinical Severity Score Units|"The Clinical Severity scoring system initially described by Wang, assesses respiratory rate, wheezing, retraction, and general condition,to assess the degree of respiratory distress in young children. It provides a score ranging from 0 to 12, with increased severity receiving a higher score.~These scoring systems have previously been validated in a number of well designed randomized controlled trials (Anil 2010, Kuzik 2007, Sarrell 2002, and Mandelberg 2003). A 1 point improvement in the clinical severity score implies approximately 7% betterment of symptoms on the scale."|Clinical Severity Score Units|Mean|5.3|5.3|Standard Deviation|1.6|1.6|||
3976246|NCT01276314|3798469|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3976247|NCT01276314|3798470|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3976248|NCT01276314|3798471|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3976092|NCT01276821|3798085|B1|||Clinical Severity Score Units|"The Clinical Severity scoring system initially described by Wang, assesses respiratory rate, wheezing, retraction, and general condition,to assess the degree of respiratory distress in young children. It provides a score ranging from 0 to 12, with increased severity receiving a higher score.~These scoring systems have previously been validated in a number of well designed randomized controlled trials (Anil 2010, Kuzik 2007, Sarrell 2002, and Mandelberg 2003). A 1 point improvement in the clinical severity score implies approximately 7% betterment of symptoms on the scale."|Clinical Severity Score Units|Mean|5.2|5.2|Standard Deviation|1.1|1.1|||
3976093|NCT01276821|3798083|B3|||Duration of illness (days)||Days|Mean|3.38|3.38|Standard Deviation|0.99|0.99|||
3976094|NCT01276821|3798084|B2|||Duration of illness (days)||Days|Mean|3.43|3.43|Standard Deviation|1.02|1.02|||
3976095|NCT01276821|3798085|B1|||Duration of illness (days)||Days|Mean|3.33|3.33|Standard Deviation|0.96|0.96|||
3976096|NCT01276821|3798083|B3|Nepal||Region of Enrollment||participants|Number|100|100.0||||||
3976097|NCT01276821|3798084|B2|Nepal||Region of Enrollment||participants|Number|50|50.0||||||
3976098|NCT01276821|3798085|B1|Nepal||Region of Enrollment||participants|Number|50|50.0||||||
3976099|NCT01276821|3798083|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3976100|NCT01276821|3798084|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3976101|NCT01276821|3798085|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3976102|NCT01276821|3798083|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3976103|NCT01276821|3798084|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3976104|NCT01276821|3798085|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3976105|NCT01276821|3798083|B3|||Age||months|Mean|9.66|9.66|Standard Deviation|4.67|4.67|||
3976106|NCT01276821|3798084|B2|||Age||months|Mean|9.51|9.51|Standard Deviation|4.28|4.28|||
3976107|NCT01276821|3798085|B1|||Age||months|Mean|9.82|9.82|Standard Deviation|5.06|5.06|||
3976108|NCT01276821|3798083|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3976109|NCT01276821|3798084|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3976110|NCT01276821|3798085|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3976111|NCT01276821|3798083|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3976112|NCT01276821|3798084|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3976113|NCT01276821|3798085|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3976114|NCT01276821|3798083|B3||<=18 years|Age||Participants|Count of Participants|100|100.0||||||
3976115|NCT01276821|3798084|B2||<=18 years|Age||Participants|Count of Participants|50|50.0||||||
3976116|NCT01276821|3798085|B1||<=18 years|Age||Participants|Count of Participants|50|50.0||||||
3976117|NCT01276756|3798104|B3|Egypt||Region of Enrollment||participants|Number|100|100.0||||||
3976118|NCT01276756|3798105|B2|Egypt||Region of Enrollment||participants|Number|50|50.0||||||
3976119|NCT01276756|3798106|B1|Egypt||Region of Enrollment||participants|Number|50|50.0||||||
3976120|NCT01276756|3798104|B3||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3976121|NCT01276756|3798105|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3976122|NCT01276756|3798106|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3976123|NCT01276756|3798104|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3976124|NCT01276756|3798105|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3976125|NCT01276756|3798106|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3976126|NCT01276756|3798104|B3|||Age||years|Mean|45.44|45.44|Standard Deviation|7.61|7.61|||
3976127|NCT01276756|3798105|B2|||Age||years|Mean|45.42|45.42|Standard Deviation|8.36|8.36|||
3976128|NCT01276756|3798106|B1|||Age||years|Mean|45.46|45.46|Standard Deviation|6.88|6.88|||
3976129|NCT01276756|3798104|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3976130|NCT01276756|3798105|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3976131|NCT01276756|3798106|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3976132|NCT01276756|3798104|B3||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
3976133|NCT01276756|3798105|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3976134|NCT01276756|3798106|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3976135|NCT01276756|3798104|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3976136|NCT01276756|3798105|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3976137|NCT01276756|3798106|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3976138|NCT01276652|3798121|B4|||APACHE II score|The Acute Physiology and Chronic Health Evaluation II score is designed to measure the severity of illness of patients admitted to intensive care units, with higher scores indicating patients who are more likely to die during the admission. The score is an integer score that ranges from 0 to 71 and is calculated within 24 hours of admission from the patient's age, routinely collected physiologic data, and information regarding the patient's chronic health status.|units on a scale|Mean|20.9|20.9|Standard Deviation|7.3|7.3|||
3976139|NCT01276652|3798122|B3|||APACHE II score|The Acute Physiology and Chronic Health Evaluation II score is designed to measure the severity of illness of patients admitted to intensive care units, with higher scores indicating patients who are more likely to die during the admission. The score is an integer score that ranges from 0 to 71 and is calculated within 24 hours of admission from the patient's age, routinely collected physiologic data, and information regarding the patient's chronic health status.|units on a scale|Mean|19.2|19.2|Standard Deviation|6.5|6.5|||
3976249|NCT01276314|3798472|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3976250|NCT01276301|3798485|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3976140|NCT01276652|3798123|B2|||APACHE II score|The Acute Physiology and Chronic Health Evaluation II score is designed to measure the severity of illness of patients admitted to intensive care units, with higher scores indicating patients who are more likely to die during the admission. The score is an integer score that ranges from 0 to 71 and is calculated within 24 hours of admission from the patient's age, routinely collected physiologic data, and information regarding the patient's chronic health status.|units on a scale|Mean|21.0|21.0|Standard Deviation|8.0|8.0|||
3976141|NCT01276652|3798124|B1|||APACHE II score|The Acute Physiology and Chronic Health Evaluation II score is designed to measure the severity of illness of patients admitted to intensive care units, with higher scores indicating patients who are more likely to die during the admission. The score is an integer score that ranges from 0 to 71 and is calculated within 24 hours of admission from the patient's age, routinely collected physiologic data, and information regarding the patient's chronic health status.|units on a scale|Mean|22.7|22.7|Standard Deviation|6.6|6.6|||
3976142|NCT01276652|3798121|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3976143|NCT01276652|3798122|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3976144|NCT01276652|3798123|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3976145|NCT01276652|3798124|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3976146|NCT01276652|3798121|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3976147|NCT01276652|3798122|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3976148|NCT01276652|3798123|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3976149|NCT01276652|3798124|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3976150|NCT01276652|3798121|B4|||Age||years|Mean|62.2|62.2|Standard Deviation|17.4|17.4|||
3976151|NCT01276652|3798122|B3|||Age||years|Mean|65.8|65.8|Standard Deviation|6.0|6.0|||
3976152|NCT01276652|3798123|B2|||Age||years|Mean|59.4|59.4|Standard Deviation|16.8|16.8|||
3976153|NCT01276652|3798124|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|22.7|22.7|||
3976154|NCT01276639|3798149|B4||Male|Sex: Female, Male||Participants|Count of Participants|643|643.0||||||
3976155|NCT01276639|3798150|B3||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3976156|NCT01276639|3798151|B2||Male|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
3976157|NCT01276639|3798152|B1||Male|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
3976158|NCT01276639|3798149|B4||Female|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
3976159|NCT01276639|3798150|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3976160|NCT01276639|3798151|B2||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3976161|NCT01276639|3798152|B1||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3976162|NCT01276639|3798149|B4|||Age||years|Mean|45.3|45.3|Standard Deviation|13.0|13.0|||
3976163|NCT01276639|3798150|B3|||Age||years|Mean|45.0|45.0|Standard Deviation|12.6|12.6|||
3976164|NCT01276639|3798151|B2|||Age||years|Mean|45.2|45.2|Standard Deviation|12.8|12.8|||
3976165|NCT01276639|3798152|B1|||Age||years|Mean|45.6|45.6|Standard Deviation|13.4|13.4|||
3976166|NCT01276535|3798351|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3976167|NCT01276535|3798351|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3976168|NCT01276535|3798351|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3976169|NCT01276535|3798351|B1|||Age||years|Mean|29.5|29.5|Standard Deviation|5.98|5.98|||
3976170|NCT01276509|3798357|B5||MALE|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3976171|NCT01276509|3798358|B4||MALE|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3976172|NCT01276509|3798359|B3||MALE|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3976173|NCT01276509|3798360|B2||MALE|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3976174|NCT01276509|3798361|B1||MALE|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3976175|NCT01276509|3798357|B5||FEMALE|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3976176|NCT01276509|3798358|B4||FEMALE|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3976177|NCT01276509|3798359|B3||FEMALE|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3976178|NCT01276509|3798360|B2||FEMALE|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3976179|NCT01276509|3798361|B1||FEMALE|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3976180|NCT01276509|3798357|B5|||Age||years|Mean|35.5|35.5|Standard Deviation|11.5|11.5|||
3976181|NCT01276509|3798358|B4|||Age||years|Mean|34.4|34.4|Standard Deviation|11.1|11.1|||
3976182|NCT01276509|3798359|B3|||Age||years|Mean|35.9|35.9|Standard Deviation|11.0|11.0|||
3976183|NCT01276509|3798360|B2|||Age||years|Mean|34.4|34.4|Standard Deviation|10.7|10.7|||
3976184|NCT01276509|3798361|B1|||Age||years|Mean|37.3|37.3|Standard Deviation|13.0|13.0|||
3976185|NCT01276457|3798415|B3||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3976186|NCT01276457|3798416|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3976187|NCT01276457|3798417|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3976188|NCT01276457|3798415|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3976189|NCT01276457|3798416|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3976190|NCT01276457|3798417|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3976191|NCT01276457|3798415|B3|||Age||Years|Mean|45.5|45.5|Standard Deviation|11.2|11.2|||
3976192|NCT01276457|3798416|B2|||Age||Years|Mean|45.7|45.7|Standard Deviation|10.2|10.2|||
3976193|NCT01276457|3798417|B1|||Age||Years|Mean|45.3|45.3|Standard Deviation|12.2|12.2|||
3976251|NCT01276301|3798485|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3976194|NCT01276353|3798430|B3|||Hachinski Score|The Hachinski Ischaemic Score (HIS) is an attempt to differentiate Alzheimer's type dementia and multi-infarct dementia. It uses a system of 13 features of with a score of 1 or 2, adding the scores together for a final score. A cut-off score less than or equal to 4 for Dementia of Alzheimer’s Type (DAT) and greater than or equal to 7 for Vascular Dememntia (VaD) has a sensitivity of 89% and a specificity of 89%.|Scores on a Scale|Mean|0.9|0.9|Standard Deviation|1.2|1.2|||
3976195|NCT01276353|3798431|B2|||Hachinski Score|The Hachinski Ischaemic Score (HIS) is an attempt to differentiate Alzheimer's type dementia and multi-infarct dementia. It uses a system of 13 features of with a score of 1 or 2, adding the scores together for a final score. A cut-off score less than or equal to 4 for Dementia of Alzheimer’s Type (DAT) and greater than or equal to 7 for Vascular Dememntia (VaD) has a sensitivity of 89% and a specificity of 89%.|Scores on a Scale|Mean|0.7|0.7|Standard Deviation|1.1|1.1|||
3976196|NCT01276353|3798432|B1|||Hachinski Score|The Hachinski Ischaemic Score (HIS) is an attempt to differentiate Alzheimer's type dementia and multi-infarct dementia. It uses a system of 13 features of with a score of 1 or 2, adding the scores together for a final score. A cut-off score less than or equal to 4 for Dementia of Alzheimer’s Type (DAT) and greater than or equal to 7 for Vascular Dememntia (VaD) has a sensitivity of 89% and a specificity of 89%.|Scores on a Scale|Mean|1.1|1.1|Standard Deviation|1.3|1.3|||
3976197|NCT01276353|3798430|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3976198|NCT01276353|3798431|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3976199|NCT01276353|3798432|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3976200|NCT01276353|3798430|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3976201|NCT01276353|3798431|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3976202|NCT01276353|3798432|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3976203|NCT01276353|3798430|B3|||Age||Years|Mean|76.4|76.4|Standard Deviation|10.6|10.6|||
3976204|NCT01276353|3798431|B2|||Age||Years|Mean|73.6|73.6|Standard Deviation|10.8|10.8|||
3976205|NCT01276353|3798432|B1|||Age||Years|Mean|79.3|79.3|Standard Deviation|9.8|9.8|||
3976206|NCT01276327|3798443|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3976207|NCT01276327|3798444|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3976208|NCT01276327|3798445|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3976209|NCT01276327|3798443|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3976210|NCT01276327|3798444|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3976211|NCT01276327|3798445|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3976212|NCT01276327|3798443|B3|||Age||years|Mean|37.9|37.9|Standard Deviation|9.0|9.0|||
3976213|NCT01276327|3798444|B2|||Age||years|Mean|38.0|38.0|Standard Deviation|9.3|9.3|||
3976214|NCT01276327|3798445|B1|||Age||years|Mean|37.8|37.8|Standard Deviation|8.8|8.8|||
3976215|NCT01276314|3798468|B5|Taiwan||Region of Enrollment||Participants|Count of Participants|135|135.0||||||
3976216|NCT01276314|3798469|B4|Taiwan||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3976217|NCT01276314|3798470|B3|Taiwan||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3976218|NCT01276314|3798471|B2|Taiwan||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
3976219|NCT01276314|3798472|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
3976220|NCT01276314|3798468|B5||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3976221|NCT01276314|3798469|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3976222|NCT01276314|3798470|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3976223|NCT01276314|3798471|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3976224|NCT01276314|3798472|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3976225|NCT01276314|3798468|B5||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3976226|NCT01276314|3798469|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3976227|NCT01276314|3798470|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3976228|NCT01276314|3798471|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3976229|NCT01276314|3798472|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3976230|NCT01276314|3798468|B5|||Age||years|Mean|56.53|56.53|Standard Deviation|20.20|20.2|||
3976231|NCT01276314|3798469|B4|||Age||years|Mean|60.95|60.95|Standard Deviation|20.39|20.39|||
3976232|NCT01276314|3798470|B3|||Age||years|Mean|53.95|53.95|Standard Deviation|17.41|17.41|||
3976233|NCT01276314|3798471|B2|||Age||years|Mean|59.84|59.84|Standard Deviation|24.20|24.2|||
3976234|NCT01276314|3798472|B1|||Age||years|Mean|52.73|52.73|Standard Deviation|16.78|16.78|||
3976235|NCT01276314|3798468|B5||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
3976236|NCT01276314|3798469|B4||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3976237|NCT01276314|3798470|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3976238|NCT01276314|3798471|B2||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3976239|NCT01276314|3798472|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3976240|NCT01276314|3798468|B5||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
3976241|NCT01276314|3798469|B4||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3976242|NCT01276314|3798470|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3976243|NCT01276314|3798471|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3976244|NCT01276314|3798472|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3976245|NCT01276314|3798468|B5||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3976252|NCT01276301|3798485|B1|||Age||years|Mean|34.3|34.3|Standard Deviation|10.3|10.3|||
3976253|NCT01276288|3798513|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3976254|NCT01276288|3798513|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3976255|NCT01276288|3798513|B1|||Age||years|Mean|54.0|54.0|Standard Deviation|8.1|8.1|||
3976256|NCT01276223|3798640|B4|United States||Region of Enrollment||participants|Number|289|289.0||||||
3976257|NCT01276223|3798641|B3|United States||Region of Enrollment||participants|Number|104|104.0||||||
3976258|NCT01276223|3798642|B2|United States||Region of Enrollment||participants|Number|107|107.0||||||
3976259|NCT01276223|3798643|B1|United States||Region of Enrollment||participants|Number|78|78.0||||||
3976260|NCT01276223|3798640|B4||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3976261|NCT01276223|3798641|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3976262|NCT01276223|3798642|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3976263|NCT01276223|3798643|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3976264|NCT01276223|3798640|B4||Female|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
3976265|NCT01276223|3798641|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3976266|NCT01276223|3798642|B2||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3976267|NCT01276223|3798643|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3976268|NCT01276223|3798640|B4|||Age||years|Mean|58.5|58.5|Standard Deviation|14.2|14.2|||
3976269|NCT01276223|3798641|B3|||Age||years|Mean|60.1|60.1|Standard Deviation|13.8|13.8|||
3976270|NCT01276223|3798642|B2|||Age||years|Mean|54.4|54.4|Standard Deviation|14.8|14.8|||
3976271|NCT01276223|3798643|B1|||Age||years|Mean|61.9|61.9|Standard Deviation|12.7|12.7|||
3976272|NCT01276197|3798652|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976273|NCT01276197|3798653|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976274|NCT01276197|3798654|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976275|NCT01276197|3798652|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976276|NCT01276197|3798653|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976277|NCT01276197|3798654|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976278|NCT01276197|3798652|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976279|NCT01276197|3798653|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976280|NCT01276197|3798654|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976281|NCT01276197|3798652|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|618|618.0||||||
3976282|NCT01276197|3798653|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|310|310.0||||||
3976283|NCT01276197|3798654|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|308|308.0||||||
3976284|NCT01276197|3798652|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976285|NCT01276197|3798653|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976286|NCT01276197|3798654|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976287|NCT01276197|3798652|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976288|NCT01276197|3798653|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976289|NCT01276197|3798654|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976290|NCT01276197|3798652|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976291|NCT01276197|3798653|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976292|NCT01276197|3798654|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976293|NCT01276197|3798652|B3||Male|Sex: Female, Male||Participants|Count of Participants|567|567.0||||||
3976294|NCT01276197|3798653|B2||Male|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
3976295|NCT01276197|3798654|B1||Male|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
3976296|NCT01276197|3798652|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3976297|NCT01276197|3798653|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3976298|NCT01276197|3798654|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3976299|NCT01276197|3798652|B3||>=65 years|Age||Participants|Count of Participants|242|242.0||||||
3976300|NCT01276197|3798653|B2||>=65 years|Age||Participants|Count of Participants|124|124.0||||||
3976301|NCT01276197|3798654|B1||>=65 years|Age||Participants|Count of Participants|118|118.0||||||
3976302|NCT01276197|3798652|B3||Between 18 and 65 years|Age||Participants|Count of Participants|376|376.0||||||
3976303|NCT01276197|3798653|B2||Between 18 and 65 years|Age||Participants|Count of Participants|186|186.0||||||
3976304|NCT01276197|3798654|B1||Between 18 and 65 years|Age||Participants|Count of Participants|190|190.0||||||
3976305|NCT01276197|3798652|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3976306|NCT01276197|3798653|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3976307|NCT01276197|3798654|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3976308|NCT01276171|3798663|B4|United States||Region of Enrollment||participants|Number|749|749.0||||||
3976309|NCT01276171|3798664|B3|United States||Region of Enrollment||participants|Number|256|256.0||||||
3976310|NCT01276171|3798665|B2|United States||Region of Enrollment||participants|Number|244|244.0||||||
3976311|NCT01276171|3798666|B1|United States||Region of Enrollment||participants|Number|249|249.0||||||
3976312|NCT01276171|3798663|B4||Male|Sex: Female, Male||Participants|Count of Participants|430|430.0||||||
3976313|NCT01276171|3798664|B3||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3976314|NCT01276171|3798665|B2||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3976315|NCT01276171|3798666|B1||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3976316|NCT01276171|3798663|B4||Female|Sex: Female, Male||Participants|Count of Participants|319|319.0||||||
3976317|NCT01276171|3798664|B3||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3976318|NCT01276171|3798665|B2||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3976319|NCT01276171|3798666|B1||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3976320|NCT01276171|3798663|B4|||Age||years|Median|60|60.0|Inter-Quartile Range|||50.0|70.0|
3976321|NCT01276171|3798664|B3|||Age||years|Median|59|59.0|Inter-Quartile Range|||50.0|70.0|
3976322|NCT01276171|3798665|B2|||Age||years|Median|61|61.0|Inter-Quartile Range|||51.0|72.0|
3976323|NCT01276171|3798666|B1|||Age||years|Median|60|60.0|Inter-Quartile Range|||48.0|71.0|
3976324|NCT01276171|3798663|B4||>=65 years|Age||Participants|Count of Participants|300|300.0||||||
3976325|NCT01276171|3798664|B3||>=65 years|Age||Participants|Count of Participants|99|99.0||||||
3976326|NCT01276171|3798665|B2||>=65 years|Age||Participants|Count of Participants|100|100.0||||||
3976327|NCT01276171|3798666|B1||>=65 years|Age||Participants|Count of Participants|101|101.0||||||
3976328|NCT01276171|3798663|B4||Between 18 and 65 years|Age||Participants|Count of Participants|449|449.0||||||
3976329|NCT01276171|3798664|B3||Between 18 and 65 years|Age||Participants|Count of Participants|157|157.0||||||
3976330|NCT01276171|3798665|B2||Between 18 and 65 years|Age||Participants|Count of Participants|144|144.0||||||
3976331|NCT01276171|3798666|B1||Between 18 and 65 years|Age||Participants|Count of Participants|148|148.0||||||
3976332|NCT01276171|3798663|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3976333|NCT01276171|3798664|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3976334|NCT01276171|3798665|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3976335|NCT01276171|3798666|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3976336|NCT01276106|3798682|B5|||HbA1c||%|Mean|8.4|8.4|Standard Deviation|0.7|0.7|||
3976337|NCT01276106|3798683|B4|||HbA1c||%|Mean|8.4|8.4|Standard Deviation|0.7|0.7|||
3976338|NCT01276106|3798684|B3|||HbA1c||%|Mean|8.5|8.5|Standard Deviation|0.7|0.7|||
3976339|NCT01276106|3798685|B2|||HbA1c||%|Mean|8.3|8.3|Standard Deviation|0.7|0.7|||
3976340|NCT01276106|3798686|B1|||HbA1c||%|Mean|8.4|8.4|Standard Deviation|0.6|0.6|||
3976341|NCT01276106|3798682|B5|Taiwan||Region of Enrollment||participants|Number|109|109.0||||||
3976342|NCT01276106|3798683|B4|Taiwan||Region of Enrollment||participants|Number|28|28.0||||||
3976343|NCT01276106|3798684|B3|Taiwan||Region of Enrollment||participants|Number|27|27.0||||||
3976344|NCT01276106|3798685|B2|Taiwan||Region of Enrollment||participants|Number|27|27.0||||||
3976345|NCT01276106|3798686|B1|Taiwan||Region of Enrollment||participants|Number|27|27.0||||||
3976346|NCT01276106|3798682|B5|United States||Region of Enrollment||participants|Number|150|150.0||||||
3976347|NCT01276106|3798683|B4|United States||Region of Enrollment||participants|Number|37|37.0||||||
3976348|NCT01276106|3798684|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
3976349|NCT01276106|3798685|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
3976350|NCT01276106|3798686|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
3976351|NCT01276106|3798682|B5||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3976352|NCT01276106|3798683|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3976353|NCT01276106|3798684|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3976354|NCT01276106|3798685|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3976355|NCT01276106|3798686|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3976356|NCT01276106|3798682|B5||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3976357|NCT01276106|3798683|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3976358|NCT01276106|3798684|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3976359|NCT01276106|3798685|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3976360|NCT01276106|3798686|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3976361|NCT01276106|3798682|B5|||Age||years|Mean|56|56.0|Standard Deviation|9|9.0|||
3976362|NCT01276106|3798683|B4|||Age||years|Mean|55|55.0|Standard Deviation|8|8.0|||
3976363|NCT01276106|3798684|B3|||Age||years|Mean|57|57.0|Standard Deviation|9|9.0|||
3976364|NCT01276106|3798685|B2|||Age||years|Mean|55|55.0|Standard Deviation|9|9.0|||
3976365|NCT01276106|3798686|B1|||Age||years|Mean|56|56.0|Standard Deviation|9|9.0|||
3976366|NCT01276054|3798699|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3976367|NCT01276054|3798700|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3976368|NCT01276054|3798701|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3976369|NCT01276054|3798699|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976370|NCT01276054|3798700|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976371|NCT01276054|3798701|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976372|NCT01276054|3798699|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3976373|NCT01276054|3798700|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3976374|NCT01276054|3798701|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3976375|NCT01276054|3798699|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3976376|NCT01276054|3798700|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976377|NCT01276054|3798701|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3976378|NCT01276054|3798699|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3976379|NCT01276054|3798700|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976380|NCT01276054|3798701|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3976381|NCT01276054|3798699|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976382|NCT01276054|3798700|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976383|NCT01276054|3798701|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976384|NCT01276054|3798699|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976385|NCT01276054|3798700|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976386|NCT01276054|3798701|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976387|NCT01276054|3798699|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3976388|NCT01276054|3798700|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3976389|NCT01276054|3798701|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976390|NCT01276054|3798699|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976391|NCT01276054|3798700|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976392|NCT01276054|3798701|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976393|NCT01276054|3798699|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3976394|NCT01276054|3798700|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3976395|NCT01276054|3798701|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3976396|NCT01276054|3798699|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976397|NCT01276054|3798700|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976398|NCT01276054|3798701|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976399|NCT01276054|3798699|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3976400|NCT01276054|3798700|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3976401|NCT01276054|3798701|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3976402|NCT01276054|3798699|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3976403|NCT01276054|3798700|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3976404|NCT01276054|3798701|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3976405|NCT01276054|3798699|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3976406|NCT01276054|3798700|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3976407|NCT01276054|3798701|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3976408|NCT01276054|3798699|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3976409|NCT01276054|3798700|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3976410|NCT01276054|3798701|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3976411|NCT01276054|3798699|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3976412|NCT01276054|3798700|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3976413|NCT01276054|3798701|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3976414|NCT01275833|3798708|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3976415|NCT01275833|3798709|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3976416|NCT01275833|3798710|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3976417|NCT01275833|3798708|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3976418|NCT01275833|3798709|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3976419|NCT01275833|3798710|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3976420|NCT01275833|3798708|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3976421|NCT01275833|3798709|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3976422|NCT01275833|3798710|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3976423|NCT01275833|3798708|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3976424|NCT01275833|3798709|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3976425|NCT01275833|3798710|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3976426|NCT01275833|3798708|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3976427|NCT01275833|3798709|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3976428|NCT01275833|3798710|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3976429|NCT01275833|3798708|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3976430|NCT01275833|3798709|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3976431|NCT01275833|3798710|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3976432|NCT01275755|3798717|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3976433|NCT01275755|3798718|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3976434|NCT01275755|3798719|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3976435|NCT01275755|3798717|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3976436|NCT01275755|3798718|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3976437|NCT01275755|3798719|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3976438|NCT01275755|3798717|B3||GTE65|Age||Participants|Count of Participants|9|9.0||||||
3976439|NCT01275755|3798718|B2||GTE65|Age||Participants|Count of Participants|5|5.0||||||
3976440|NCT01275755|3798719|B1||GTE65|Age||Participants|Count of Participants|4|4.0||||||
3976441|NCT01275755|3798717|B3||BTWN|Age||Participants|Count of Participants|72|72.0||||||
3976442|NCT01275755|3798718|B2||BTWN|Age||Participants|Count of Participants|35|35.0||||||
3976443|NCT01275755|3798719|B1||BTWN|Age||Participants|Count of Participants|37|37.0||||||
3976444|NCT01275755|3798717|B3||LTE18|Age||Participants|Count of Participants|0|0.0||||||
3976445|NCT01275755|3798718|B2||LTE18|Age||Participants|Count of Participants|0|0.0||||||
3976446|NCT01275755|3798719|B1||LTE18|Age||Participants|Count of Participants|0|0.0||||||
3976447|NCT01275664|3798726|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3976448|NCT01275664|3798726|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3976449|NCT01275664|3798726|B1|70-79 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3976450|NCT01275664|3798726|B1|60-69 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
3976451|NCT01275664|3798726|B1|50-59 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3976452|NCT01275664|3798726|B1|40-49 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
3976453|NCT01275625|3798734|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3976454|NCT01275625|3798734|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3976455|NCT01275625|3798734|B1|||Age||Years|Mean|35.2|35.2|Standard Deviation|8.3|8.3|||
3976456|NCT01275586|3798748|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3976457|NCT01275586|3798748|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976458|NCT01275586|3798748|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976459|NCT01275586|3798748|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3976460|NCT01275586|3798748|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976461|NCT01275586|3798748|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976462|NCT01275586|3798748|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976463|NCT01275586|3798748|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976464|NCT01275586|3798748|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976465|NCT01275586|3798748|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3976466|NCT01275586|3798748|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976467|NCT01275586|3798748|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3976468|NCT01275586|3798748|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3976469|NCT01275586|3798748|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3976470|NCT01275586|3798748|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3976471|NCT01275586|3798748|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3976472|NCT01275430|3798752|B1|Right||Access Side||participants|Number|12|12.0||||||
3976473|NCT01275430|3798752|B1|Left||Access Side||participants|Number|6|6.0||||||
3976474|NCT01275430|3798752|B1|Basilic||Access Vein||participants|Number|9|9.0||||||
3976475|NCT01275430|3798752|B1|Brachial||Access Vein||participants|Number|9|9.0||||||
3976476|NCT01275430|3798752|B1|Total Parenteral Nutrition (TPN)||Reason For PICC Placement||participants|Number|1|1.0||||||
3976477|NCT01275430|3798752|B1|Antibiotics||Reason For PICC Placement||participants|Number|17|17.0||||||
3976478|NCT01275430|3798752|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3976479|NCT01275430|3798752|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3976480|NCT01275430|3798752|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3976481|NCT01275430|3798752|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3976482|NCT01275430|3798752|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976483|NCT01275430|3798752|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3976484|NCT01275430|3798752|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976485|NCT01275430|3798752|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976486|NCT01275430|3798752|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976487|NCT01275430|3798752|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976488|NCT01275430|3798752|B1||Male|Gender||Participants|Count of Participants|12|12.0||||||
3976489|NCT01275430|3798752|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
3976490|NCT01275430|3798752|B1|||Age||years|Mean|52.7|52.7|Standard Deviation|13.2|13.2|||
3976491|NCT01275365|3798760|B5|||Diabetes||Participants|Count of Participants|14|14.0||||||
3976492|NCT01275365|3798761|B4|||Diabetes||Participants|Count of Participants|3|3.0||||||
3976493|NCT01275365|3798762|B3|||Diabetes||Participants|Count of Participants|3|3.0||||||
3976494|NCT01275365|3798763|B2|||Diabetes||Participants|Count of Participants|4|4.0||||||
3976495|NCT01275365|3798764|B1|||Diabetes||Participants|Count of Participants|4|4.0||||||
3976496|NCT01275365|3798760|B5|||Body Mass Index (BMI)||kg/m2|Mean|30.3|30.3|Standard Deviation|4.9|4.9|||
3976497|NCT01275365|3798761|B4|||Body Mass Index (BMI)||kg/m2|Mean|29.0|29.0|Standard Deviation|5.0|5.0|||
3976498|NCT01275365|3798762|B3|||Body Mass Index (BMI)||kg/m2|Mean|31.4|31.4|Standard Deviation|5.5|5.5|||
3976499|NCT01275365|3798763|B2|||Body Mass Index (BMI)||kg/m2|Mean|29.6|29.6|Standard Deviation|4.6|4.6|||
3976500|NCT01275365|3798764|B1|||Body Mass Index (BMI)||kg/m2|Mean|31.1|31.1|Standard Deviation|4.2|4.2|||
3976501|NCT01275365|3798760|B5|||Body weight||kg|Mean|91.8|91.8|Standard Deviation|16.2|16.2|||
3976502|NCT01275365|3798761|B4|||Body weight||kg|Mean|87.2|87.2|Standard Deviation|18.3|18.3|||
3976503|NCT01275365|3798762|B3|||Body weight||kg|Mean|94.4|94.4|Standard Deviation|17.6|17.6|||
3976504|NCT01275365|3798763|B2|||Body weight||kg|Mean|90.2|90.2|Standard Deviation|15.8|15.8|||
3976505|NCT01275365|3798764|B1|||Body weight||kg|Mean|95.3|95.3|Standard Deviation|12.5|12.5|||
3976506|NCT01275365|3798760|B5|United States||Region of Enrollment||participants|Number|92|92.0||||||
3976507|NCT01275365|3798761|B4|United States||Region of Enrollment||participants|Number|22|22.0||||||
3976508|NCT01275365|3798762|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
3976509|NCT01275365|3798763|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
3976510|NCT01275365|3798764|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3976511|NCT01275365|3798760|B5|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3976512|NCT01275365|3798760|B5||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3976513|NCT01275365|3798761|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3976514|NCT01275365|3798762|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3976515|NCT01275365|3798763|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3976516|NCT01275365|3798764|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3976517|NCT01275365|3798760|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3976518|NCT01275365|3798761|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3976519|NCT01275365|3798762|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3976520|NCT01275365|3798763|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3976521|NCT01275365|3798764|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3976522|NCT01275365|3798760|B5|||Age||years|Mean|73.0|73.0|Standard Deviation|5.8|5.8|||
3976523|NCT01275365|3798761|B4|||Age||years|Mean|76.0|76.0|Standard Deviation|7.9|7.9|||
3976524|NCT01275365|3798762|B3|||Age||years|Mean|71.0|71.0|Standard Deviation|3.6|3.6|||
3976525|NCT01275365|3798763|B2|||Age||years|Mean|73.5|73.5|Standard Deviation|5.7|5.7|||
3976526|NCT01275365|3798764|B1|||Age||years|Mean|71.3|71.3|Standard Deviation|4.2|4.2|||
3976527|NCT01275313|3798813|B3||Unknown|Pelvic Obliquity||Participants|Count of Participants|16|16.0||||||
3976528|NCT01275313|3798814|B2||Unknown|Pelvic Obliquity||Participants|Count of Participants|12|12.0||||||
3976529|NCT01275313|3798815|B1||Unknown|Pelvic Obliquity||Participants|Count of Participants|4|4.0||||||
3976530|NCT01275313|3798813|B3||fixed deformity|Pelvic Obliquity||Participants|Count of Participants|8|8.0||||||
3976531|NCT01275313|3798814|B2||fixed deformity|Pelvic Obliquity||Participants|Count of Participants|5|5.0||||||
3976532|NCT01275313|3798815|B1||fixed deformity|Pelvic Obliquity||Participants|Count of Participants|3|3.0||||||
3976533|NCT01275313|3798813|B3||Flex deformity|Pelvic Obliquity||Participants|Count of Participants|39|39.0||||||
3976534|NCT01275313|3798814|B2||Flex deformity|Pelvic Obliquity||Participants|Count of Participants|21|21.0||||||
3976535|NCT01275313|3798815|B1||Flex deformity|Pelvic Obliquity||Participants|Count of Participants|18|18.0||||||
3976536|NCT01275313|3798813|B3||Neutral|Pelvic Obliquity||Participants|Count of Participants|195|195.0||||||
3976537|NCT01275313|3798814|B2||Neutral|Pelvic Obliquity||Participants|Count of Participants|93|93.0||||||
3976538|NCT01275313|3798815|B1||Neutral|Pelvic Obliquity||Participants|Count of Participants|102|102.0||||||
3976539|NCT01275313|3798813|B3||Unknown|Pelvic Rotation||Participants|Count of Participants|16|16.0||||||
3976540|NCT01275313|3798814|B2||Unknown|Pelvic Rotation||Participants|Count of Participants|12|12.0||||||
3976541|NCT01275313|3798815|B1||Unknown|Pelvic Rotation||Participants|Count of Participants|4|4.0||||||
3976542|NCT01275313|3798813|B3||Fixed deformity|Pelvic Rotation||Participants|Count of Participants|6|6.0||||||
3976543|NCT01275313|3798814|B2||Fixed deformity|Pelvic Rotation||Participants|Count of Participants|4|4.0||||||
3976544|NCT01275313|3798815|B1||Fixed deformity|Pelvic Rotation||Participants|Count of Participants|2|2.0||||||
3976545|NCT01275313|3798813|B3||Flex deformity|Pelvic Rotation||Participants|Count of Participants|52|52.0||||||
3976546|NCT01275313|3798814|B2||Flex deformity|Pelvic Rotation||Participants|Count of Participants|28|28.0||||||
3976547|NCT01275313|3798815|B1||Flex deformity|Pelvic Rotation||Participants|Count of Participants|24|24.0||||||
3976548|NCT01275313|3798813|B3||Neutral|Pelvic Rotation||Participants|Count of Participants|184|184.0||||||
3976549|NCT01275313|3798814|B2||Neutral|Pelvic Rotation||Participants|Count of Participants|87|87.0||||||
3976550|NCT01275313|3798815|B1||Neutral|Pelvic Rotation||Participants|Count of Participants|97|97.0||||||
3976551|NCT01275313|3798813|B3||Unknown|Pelvic tilt||Participants|Count of Participants|16|16.0||||||
3976552|NCT01275313|3798814|B2||Unknown|Pelvic tilt||Participants|Count of Participants|12|12.0||||||
3976553|NCT01275313|3798815|B1||Unknown|Pelvic tilt||Participants|Count of Participants|4|4.0||||||
3976554|NCT01275313|3798813|B3||Fixed deformity|Pelvic tilt||Participants|Count of Participants|49|49.0||||||
3976555|NCT01275313|3798814|B2||Fixed deformity|Pelvic tilt||Participants|Count of Participants|22|22.0||||||
3976556|NCT01275313|3798815|B1||Fixed deformity|Pelvic tilt||Participants|Count of Participants|27|27.0||||||
3976557|NCT01275313|3798813|B3||Flex deformity|Pelvic tilt||Participants|Count of Participants|126|126.0||||||
3976558|NCT01275313|3798814|B2||Flex deformity|Pelvic tilt||Participants|Count of Participants|62|62.0||||||
3976559|NCT01275313|3798815|B1||Flex deformity|Pelvic tilt||Participants|Count of Participants|64|64.0||||||
3976560|NCT01275313|3798813|B3||Neutral|Pelvic tilt||Participants|Count of Participants|67|67.0||||||
3976561|NCT01275313|3798814|B2||Neutral|Pelvic tilt||Participants|Count of Participants|35|35.0||||||
3976562|NCT01275313|3798815|B1||Neutral|Pelvic tilt||Participants|Count of Participants|32|32.0||||||
3976563|NCT01275313|3798813|B3||Unknown|Lordosis||Participants|Count of Participants|16|16.0||||||
3976564|NCT01275313|3798814|B2||Unknown|Lordosis||Participants|Count of Participants|12|12.0||||||
3976565|NCT01275313|3798815|B1||Unknown|Lordosis||Participants|Count of Participants|4|4.0||||||
3976566|NCT01275313|3798813|B3||Neutral|Lordosis||Participants|Count of Participants|242|242.0||||||
3976567|NCT01275313|3798814|B2||Neutral|Lordosis||Participants|Count of Participants|119|119.0||||||
3976568|NCT01275313|3798815|B1||Neutral|Lordosis||Participants|Count of Participants|123|123.0||||||
3976569|NCT01275313|3798813|B3||Unknown|Kyphosis||Participants|Count of Participants|16|16.0||||||
3976570|NCT01275313|3798814|B2||Unknown|Kyphosis||Participants|Count of Participants|12|12.0||||||
3976571|NCT01275313|3798815|B1||Unknown|Kyphosis||Participants|Count of Participants|4|4.0||||||
3976572|NCT01275313|3798813|B3||Fixed deformity|Kyphosis||Participants|Count of Participants|61|61.0||||||
3976573|NCT01275313|3798814|B2||Fixed deformity|Kyphosis||Participants|Count of Participants|29|29.0||||||
3976574|NCT01275313|3798815|B1||Fixed deformity|Kyphosis||Participants|Count of Participants|32|32.0||||||
3976575|NCT01275313|3798813|B3||Flex deformity|Kyphosis||Participants|Count of Participants|129|129.0||||||
3976576|NCT01275313|3798814|B2||Flex deformity|Kyphosis||Participants|Count of Participants|64|64.0||||||
3976577|NCT01275313|3798815|B1||Flex deformity|Kyphosis||Participants|Count of Participants|65|65.0||||||
3976578|NCT01275313|3798813|B3||Neutral|Kyphosis||Participants|Count of Participants|52|52.0||||||
3976579|NCT01275313|3798814|B2||Neutral|Kyphosis||Participants|Count of Participants|26|26.0||||||
3976580|NCT01275313|3798815|B1||Neutral|Kyphosis||Participants|Count of Participants|26|26.0||||||
3976581|NCT01275313|3798813|B3||Unknown|Scoliosis||Participants|Count of Participants|16|16.0||||||
3976582|NCT01275313|3798814|B2||Unknown|Scoliosis||Participants|Count of Participants|12|12.0||||||
3976583|NCT01275313|3798815|B1||Unknown|Scoliosis||Participants|Count of Participants|4|4.0||||||
3976584|NCT01275313|3798813|B3||Fixed deformity|Scoliosis||Participants|Count of Participants|24|24.0||||||
3976585|NCT01275313|3798814|B2||Fixed deformity|Scoliosis||Participants|Count of Participants|13|13.0||||||
3976586|NCT01275313|3798815|B1||Fixed deformity|Scoliosis||Participants|Count of Participants|11|11.0||||||
3976587|NCT01275313|3798813|B3||Flex deformity|Scoliosis||Participants|Count of Participants|46|46.0||||||
3976588|NCT01275313|3798814|B2||Flex deformity|Scoliosis||Participants|Count of Participants|23|23.0||||||
3976589|NCT01275313|3798815|B1||Flex deformity|Scoliosis||Participants|Count of Participants|23|23.0||||||
3976590|NCT01275313|3798813|B3||Neutral|Scoliosis||Participants|Count of Participants|172|172.0||||||
3976591|NCT01275313|3798814|B2||Neutral|Scoliosis||Participants|Count of Participants|83|83.0||||||
3976592|NCT01275313|3798815|B1||Neutral|Scoliosis||Participants|Count of Participants|89|89.0||||||
3976593|NCT01275313|3798813|B3||Unknown|Sensation||Participants|Count of Participants|16|16.0||||||
3976594|NCT01275313|3798814|B2||Unknown|Sensation||Participants|Count of Participants|12|12.0||||||
3976595|NCT01275313|3798815|B1||Unknown|Sensation||Participants|Count of Participants|4|4.0||||||
3976596|NCT01275313|3798813|B3||Absent|Sensation||Participants|Count of Participants|1|1.0||||||
3976597|NCT01275313|3798814|B2||Absent|Sensation||Participants|Count of Participants|0|0.0||||||
3976598|NCT01275313|3798815|B1||Absent|Sensation||Participants|Count of Participants|1|1.0||||||
3976599|NCT01275313|3798813|B3||Diminished/Questionable|Sensation||Participants|Count of Participants|57|57.0||||||
3976600|NCT01275313|3798814|B2||Diminished/Questionable|Sensation||Participants|Count of Participants|31|31.0||||||
3976601|NCT01275313|3798815|B1||Diminished/Questionable|Sensation||Participants|Count of Participants|26|26.0||||||
3976602|NCT01275313|3798813|B3||Normal|Sensation||Participants|Count of Participants|184|184.0||||||
3976603|NCT01275313|3798814|B2||Normal|Sensation||Participants|Count of Participants|88|88.0||||||
3976604|NCT01275313|3798815|B1||Normal|Sensation||Participants|Count of Participants|96|96.0||||||
3976605|NCT01275313|3798813|B3||Unknown|Ambulation Distance||Participants|Count of Participants|1|1.0||||||
3976606|NCT01275313|3798814|B2||Unknown|Ambulation Distance||Participants|Count of Participants|1|1.0||||||
3976607|NCT01275313|3798815|B1||Unknown|Ambulation Distance||Participants|Count of Participants|0|0.0||||||
3976608|NCT01275313|3798813|B3||>10 ft|Ambulation Distance||Participants|Count of Participants|67|67.0||||||
3976609|NCT01275313|3798814|B2||>10 ft|Ambulation Distance||Participants|Count of Participants|31|31.0||||||
3976610|NCT01275313|3798815|B1||>10 ft|Ambulation Distance||Participants|Count of Participants|36|36.0||||||
3976611|NCT01275313|3798813|B3||<= 10 ft|Ambulation Distance||Participants|Count of Participants|50|50.0||||||
3976612|NCT01275313|3798814|B2||<= 10 ft|Ambulation Distance||Participants|Count of Participants|22|22.0||||||
3976613|NCT01275313|3798815|B1||<= 10 ft|Ambulation Distance||Participants|Count of Participants|28|28.0||||||
3976614|NCT01275313|3798813|B3||0 ft|Ambulation Distance||Participants|Count of Participants|140|140.0||||||
3976615|NCT01275313|3798814|B2||0 ft|Ambulation Distance||Participants|Count of Participants|77|77.0||||||
3976616|NCT01275313|3798815|B1||0 ft|Ambulation Distance||Participants|Count of Participants|63|63.0||||||
3976617|NCT01275313|3798813|B3|||Patient alert and oriented||Participants|Count of Participants|230|230.0||||||
3976618|NCT01275313|3798814|B2|||Patient alert and oriented||Participants|Count of Participants|116|116.0||||||
3976619|NCT01275313|3798815|B1|||Patient alert and oriented||Participants|Count of Participants|114|114.0||||||
3976620|NCT01275313|3798813|B3|||Previous history of pressure injury||Participants|Count of Participants|44|44.0||||||
3976621|NCT01275313|3798814|B2|||Previous history of pressure injury||Participants|Count of Participants|17|17.0||||||
3976622|NCT01275313|3798815|B1|||Previous history of pressure injury||Participants|Count of Participants|27|27.0||||||
3976623|NCT01275313|3798813|B3|||Incontinent||Participants|Count of Participants|197|197.0||||||
3976624|NCT01275313|3798814|B2|||Incontinent||Participants|Count of Participants|95|95.0||||||
3976625|NCT01275313|3798815|B1|||Incontinent||Participants|Count of Participants|102|102.0||||||
3976626|NCT01275313|3798813|B3|||Body Mass Index (BMI)||kg/m^2|Mean|26.5|26.5|Standard Deviation|5.5|5.5|||
3976627|NCT01275313|3798814|B2|||Body Mass Index (BMI)||kg/m^2|Mean|26.9|26.9|Standard Deviation|5.8|5.8|||
3976628|NCT01275313|3798815|B1|||Body Mass Index (BMI)||kg/m^2|Mean|26.0|26.0|Standard Deviation|5.2|5.2|||
3976629|NCT01275313|3798813|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3976630|NCT01275313|3798814|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3976631|NCT01275313|3798815|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3976632|NCT01275313|3798813|B3||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3976633|NCT01275313|3798814|B2||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3976634|NCT01275313|3798815|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3976635|NCT01275313|3798813|B3|||Age||years|Mean|89.0|89.0|Standard Deviation|8.9|8.9|||
3976636|NCT01275313|3798814|B2|||Age||years|Mean|89.1|89.1|Standard Deviation|9.2|9.2|||
3976637|NCT01275313|3798815|B1|||Age||years|Mean|89.0|89.0|Standard Deviation|8.7|8.7|||
3976638|NCT01275196|3798822|B3||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3976639|NCT01275196|3798823|B2||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3976640|NCT01275196|3798824|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3976641|NCT01275196|3798822|B3||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3976642|NCT01275196|3798823|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3976643|NCT01275196|3798824|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3976644|NCT01275196|3798822|B3|||Age||Years|Mean|40.6|40.6|Standard Deviation|12.82|12.82|||
3976645|NCT01275196|3798823|B2|||Age||Years|Mean|41.5|41.5|Standard Deviation|12.76|12.76|||
3976646|NCT01275196|3798824|B1|||Age||Years|Mean|39.7|39.7|Standard Deviation|12.86|12.86|||
3976647|NCT01275131|3798864|B5|United States||Region of Enrollment||Participants|Number|45|45.0||||||
3976648|NCT01275131|3798865|B4|United States||Region of Enrollment||Participants|Number|12|12.0||||||
3976649|NCT01275131|3798866|B3|United States||Region of Enrollment||Participants|Number|13|13.0||||||
3976650|NCT01275131|3798867|B2|United States||Region of Enrollment||Participants|Number|9|9.0||||||
3976651|NCT01275131|3798868|B1|United States||Region of Enrollment||Participants|Number|11|11.0||||||
3976652|NCT01275131|3798864|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976653|NCT01275131|3798865|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976654|NCT01275131|3798866|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976655|NCT01275131|3798867|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976656|NCT01275131|3798868|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976657|NCT01275131|3798864|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3976658|NCT01275131|3798865|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3976659|NCT01275131|3798866|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3976660|NCT01275131|3798867|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3976661|NCT01275131|3798868|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3976662|NCT01275131|3798864|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3976663|NCT01275131|3798865|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976664|NCT01275131|3798866|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976665|NCT01275131|3798867|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3976666|NCT01275131|3798868|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3976667|NCT01275131|3798864|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3976668|NCT01275131|3798865|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976669|NCT01275131|3798866|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3976670|NCT01275131|3798867|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976671|NCT01275131|3798868|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976672|NCT01275131|3798864|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976673|NCT01275131|3798865|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976674|NCT01275131|3798866|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976675|NCT01275131|3798867|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976676|NCT01275131|3798868|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976677|NCT01275131|3798864|B5||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3976678|NCT01275131|3798865|B4||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3976679|NCT01275131|3798866|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3976680|NCT01275131|3798867|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3976681|NCT01275131|3798868|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3976682|NCT01275131|3798864|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3976683|NCT01275131|3798865|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3976684|NCT01275131|3798866|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3976685|NCT01275131|3798867|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976686|NCT01275131|3798868|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976687|NCT01275131|3798864|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976688|NCT01275131|3798865|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976689|NCT01275131|3798866|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976690|NCT01275131|3798867|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976691|NCT01275131|3798868|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976692|NCT01275131|3798864|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976693|NCT01275131|3798865|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976694|NCT01275131|3798866|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976695|NCT01275131|3798867|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976696|NCT01275131|3798868|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976697|NCT01275131|3798864|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976698|NCT01275131|3798865|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976699|NCT01275131|3798866|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976700|NCT01275131|3798867|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976701|NCT01275131|3798868|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976702|NCT01275131|3798864|B5||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3976703|NCT01275131|3798865|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3976704|NCT01275131|3798866|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3976705|NCT01275131|3798867|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3976706|NCT01275131|3798868|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3976707|NCT01275131|3798864|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3976708|NCT01275131|3798865|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3976709|NCT01275131|3798866|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3976710|NCT01275131|3798867|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3976711|NCT01275131|3798868|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3976712|NCT01275131|3798864|B5|||Age||Years|Mean|35.44|35.44|Standard Deviation|9.95|9.95|||
3976713|NCT01275131|3798865|B4|||Age||Years|Mean|32.3|32.3|Standard Deviation|10.29|10.29|||
3976714|NCT01275131|3798866|B3|||Age||Years|Mean|35.5|35.5|Standard Deviation|9.50|9.5|||
3976715|NCT01275131|3798867|B2|||Age||Years|Mean|44.6|44.6|Standard Deviation|9.00|9.0|||
3976716|NCT01275131|3798868|B1|||Age||Years|Mean|31.3|31.3|Standard Deviation|6.39|6.39|||
3976717|NCT01275092|3798905|B1|Colombia||Region of Enrollment||participants|Number|20|20.0||||||
3976718|NCT01275092|3798905|B1|United States||Region of Enrollment||participants|Number|144|144.0||||||
3976719|NCT01275092|3798905|B1||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3976720|NCT01275092|3798905|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3976721|NCT01275092|3798905|B1|||Age||years|Mean|64.1|64.1|Standard Deviation|10.0|10.0|||
3976722|NCT01275092|3798905|B1||>=65 years|Age||Participants|Count of Participants|77|77.0||||||
3976723|NCT01275092|3798905|B1||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
3976724|NCT01275092|3798905|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3976725|NCT01275066|3798911|B4|United States||Region of Enrollment||participants|Number|33|33.0||||||
3976726|NCT01275066|3798912|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
3976727|NCT01275066|3798913|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3976728|NCT01275066|3798914|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3976729|NCT01275066|3798911|B4|United Kingdom||Region of Enrollment||participants|Number|23|23.0||||||
3976730|NCT01275066|3798912|B3|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
3976731|NCT01275066|3798913|B2|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3976732|NCT01275066|3798914|B1|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
3976733|NCT01275066|3798911|B4|Taiwan||Region of Enrollment||participants|Number|5|5.0||||||
3976734|NCT01275066|3798912|B3|Taiwan||Region of Enrollment||participants|Number|1|1.0||||||
3976735|NCT01275066|3798913|B2|Taiwan||Region of Enrollment||participants|Number|3|3.0||||||
3976736|NCT01275066|3798914|B1|Taiwan||Region of Enrollment||participants|Number|1|1.0||||||
3976737|NCT01275066|3798911|B4|Saudi Arabia||Region of Enrollment||participants|Number|7|7.0||||||
3976738|NCT01275066|3798912|B3|Saudi Arabia||Region of Enrollment||participants|Number|4|4.0||||||
3976739|NCT01275066|3798913|B2|Saudi Arabia||Region of Enrollment||participants|Number|1|1.0||||||
3976740|NCT01275066|3798914|B1|Saudi Arabia||Region of Enrollment||participants|Number|2|2.0||||||
3976741|NCT01275066|3798911|B4|Qatar||Region of Enrollment||participants|Number|2|2.0||||||
3976742|NCT01275066|3798912|B3|Qatar||Region of Enrollment||participants|Number|1|1.0||||||
3976743|NCT01275066|3798913|B2|Qatar||Region of Enrollment||participants|Number|0|0.0||||||
3976744|NCT01275066|3798914|B1|Qatar||Region of Enrollment||participants|Number|1|1.0||||||
3976745|NCT01275066|3798911|B4|Portugal||Region of Enrollment||participants|Number|3|3.0||||||
3976746|NCT01275066|3798912|B3|Portugal||Region of Enrollment||participants|Number|0|0.0||||||
3976747|NCT01275066|3798913|B2|Portugal||Region of Enrollment||participants|Number|1|1.0||||||
3976748|NCT01275066|3798914|B1|Portugal||Region of Enrollment||participants|Number|2|2.0||||||
3976749|NCT01275066|3798911|B4|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
3976750|NCT01275066|3798912|B3|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
3976751|NCT01275066|3798913|B2|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
3976752|NCT01275066|3798914|B1|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
3976753|NCT01275066|3798911|B4|Korea, South||Region of Enrollment||participants|Number|7|7.0||||||
3976754|NCT01275066|3798912|B3|Korea, South||Region of Enrollment||participants|Number|3|3.0||||||
3976755|NCT01275066|3798913|B2|Korea, South||Region of Enrollment||participants|Number|1|1.0||||||
3976756|NCT01275066|3798914|B1|Korea, South||Region of Enrollment||participants|Number|3|3.0||||||
3976757|NCT01275066|3798911|B4|Japan||Region of Enrollment||participants|Number|6|6.0||||||
3976758|NCT01275066|3798912|B3|Japan||Region of Enrollment||participants|Number|2|2.0||||||
3976759|NCT01275066|3798913|B2|Japan||Region of Enrollment||participants|Number|4|4.0||||||
3976760|NCT01275066|3798914|B1|Japan||Region of Enrollment||participants|Number|0|0.0||||||
3976761|NCT01275066|3798911|B4|Italy||Region of Enrollment||participants|Number|10|10.0||||||
3976762|NCT01275066|3798912|B3|Italy||Region of Enrollment||participants|Number|2|2.0||||||
3976763|NCT01275066|3798913|B2|Italy||Region of Enrollment||participants|Number|4|4.0||||||
3976764|NCT01275066|3798914|B1|Italy||Region of Enrollment||participants|Number|4|4.0||||||
3976765|NCT01275066|3798911|B4|Germany||Region of Enrollment||participants|Number|10|10.0||||||
3976766|NCT01275066|3798912|B3|Germany||Region of Enrollment||participants|Number|1|1.0||||||
3976767|NCT01275066|3798913|B2|Germany||Region of Enrollment||participants|Number|5|5.0||||||
3976768|NCT01275066|3798914|B1|Germany||Region of Enrollment||participants|Number|4|4.0||||||
3976769|NCT01275066|3798911|B4|France||Region of Enrollment||participants|Number|20|20.0||||||
3976770|NCT01275066|3798912|B3|France||Region of Enrollment||participants|Number|8|8.0||||||
3976771|NCT01275066|3798913|B2|France||Region of Enrollment||participants|Number|5|5.0||||||
3976772|NCT01275066|3798914|B1|France||Region of Enrollment||participants|Number|7|7.0||||||
3976773|NCT01275066|3798911|B4|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
3976774|NCT01275066|3798912|B3|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
3976775|NCT01275066|3798913|B2|Denmark||Region of Enrollment||participants|Number|0|0.0||||||
3976776|NCT01275066|3798914|B1|Denmark||Region of Enrollment||participants|Number|0|0.0||||||
3976777|NCT01275066|3798911|B4|Colombia||Region of Enrollment||participants|Number|6|6.0||||||
3976778|NCT01275066|3798912|B3|Colombia||Region of Enrollment||participants|Number|2|2.0||||||
3976779|NCT01275066|3798913|B2|Colombia||Region of Enrollment||participants|Number|2|2.0||||||
3976780|NCT01275066|3798914|B1|Colombia||Region of Enrollment||participants|Number|2|2.0||||||
3976781|NCT01275066|3798911|B4|Canada||Region of Enrollment||participants|Number|14|14.0||||||
3976782|NCT01275066|3798912|B3|Canada||Region of Enrollment||participants|Number|5|5.0||||||
3976783|NCT01275066|3798913|B2|Canada||Region of Enrollment||participants|Number|5|5.0||||||
3976784|NCT01275066|3798914|B1|Canada||Region of Enrollment||participants|Number|4|4.0||||||
3976785|NCT01275066|3798911|B4|Brazil||Region of Enrollment||participants|Number|21|21.0||||||
3976786|NCT01275066|3798912|B3|Brazil||Region of Enrollment||participants|Number|5|5.0||||||
3976787|NCT01275066|3798913|B2|Brazil||Region of Enrollment||participants|Number|10|10.0||||||
3976788|NCT01275066|3798914|B1|Brazil||Region of Enrollment||participants|Number|6|6.0||||||
3976789|NCT01275066|3798911|B4|Argentina||Region of Enrollment||participants|Number|2|2.0||||||
3976790|NCT01275066|3798912|B3|Argentina||Region of Enrollment||participants|Number|0|0.0||||||
3976791|NCT01275066|3798913|B2|Argentina||Region of Enrollment||participants|Number|1|1.0||||||
3976792|NCT01275066|3798914|B1|Argentina||Region of Enrollment||participants|Number|1|1.0||||||
3976793|NCT01275066|3798911|B4|Other||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3976794|NCT01275066|3798912|B3|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3976795|NCT01275066|3798913|B2|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3976796|NCT01275066|3798914|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3976797|NCT01275066|3798911|B4|White||Race/Ethnicity, Customized||participants|Number|115|115.0||||||
3976798|NCT01275066|3798912|B3|White||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3976799|NCT01275066|3798913|B2|White||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
3976800|NCT01275066|3798914|B1|White||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
3976801|NCT01275066|3798911|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3976802|NCT01275066|3798912|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3976803|NCT01275066|3798913|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3976804|NCT01275066|3798914|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3976805|NCT01275066|3798911|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3976806|NCT01275066|3798912|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3976807|NCT01275066|3798913|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3976808|NCT01275066|3798914|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3976809|NCT01275066|3798911|B4|Asian||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
3976810|NCT01275066|3798912|B3|Asian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3976811|NCT01275066|3798913|B2|Asian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3976812|NCT01275066|3798914|B1|Asian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3976813|NCT01275066|3798911|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3976814|NCT01275066|3798912|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3976815|NCT01275066|3798913|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3976816|NCT01275066|3798914|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3976817|NCT01275066|3798911|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976818|NCT01275066|3798912|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976819|NCT01275066|3798913|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976820|NCT01275066|3798914|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976821|NCT01275066|3798911|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
3976822|NCT01275066|3798912|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3976823|NCT01275066|3798913|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3976824|NCT01275066|3798914|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3976825|NCT01275066|3798911|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3976826|NCT01275066|3798912|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3976827|NCT01275066|3798913|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3976828|NCT01275066|3798914|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3976829|NCT01275066|3798911|B4||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3976830|NCT01275066|3798912|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3976831|NCT01275066|3798913|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3976832|NCT01275066|3798914|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3976833|NCT01275066|3798911|B4||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3976834|NCT01275066|3798912|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3976835|NCT01275066|3798913|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3976836|NCT01275066|3798914|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3976837|NCT01275066|3798911|B4|>= 19 years||Age, Customized||participants|Number|36|36.0||||||
3976838|NCT01275066|3798912|B3|>= 19 years||Age, Customized||participants|Number|10|10.0||||||
3976839|NCT01275066|3798913|B2|>= 19 years||Age, Customized||participants|Number|12|12.0||||||
3976840|NCT01275066|3798914|B1|>= 19 years||Age, Customized||participants|Number|14|14.0||||||
3976841|NCT01275066|3798911|B4|12 - 18 years||Age, Customized||participants|Number|47|47.0||||||
3976842|NCT01275066|3798912|B3|12 - 18 years||Age, Customized||participants|Number|16|16.0||||||
3976843|NCT01275066|3798913|B2|12 - 18 years||Age, Customized||participants|Number|16|16.0||||||
3976844|NCT01275066|3798914|B1|12 - 18 years||Age, Customized||participants|Number|15|15.0||||||
3976845|NCT01275066|3798911|B4|5 - 11 years||Age, Customized||participants|Number|93|93.0||||||
3976846|NCT01275066|3798912|B3|5 - 11 years||Age, Customized||participants|Number|32|32.0||||||
3976847|NCT01275066|3798913|B2|5 - 11 years||Age, Customized||participants|Number|31|31.0||||||
3976848|NCT01275066|3798914|B1|5 - 11 years||Age, Customized||participants|Number|30|30.0||||||
3976849|NCT01275066|3798911|B4|||Age||years|Mean|14.5|14.5|Standard Deviation|10.16|10.16|||
3976850|NCT01275066|3798912|B3|||Age||years|Mean|13.1|13.1|Standard Deviation|8.10|8.1|||
3976851|NCT01275066|3798913|B2|||Age||years|Mean|15.3|15.3|Standard Deviation|10.79|10.79|||
3976852|NCT01275066|3798914|B1|||Age||years|Mean|15.0|15.0|Standard Deviation|11.30|11.3|||
3976853|NCT01275053|3798930|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3976854|NCT01275053|3798930|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3976855|NCT01275053|3798930|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3976856|NCT01275053|3798930|B1|All participants||Age||years|Mean|43.3|43.3|Standard Deviation|10.78|10.78|||
3976857|NCT01275053|3798930|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3976858|NCT01275053|3798930|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3976859|NCT01275053|3798930|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3976860|NCT01274897|3798934|B3||Male|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
3976861|NCT01274897|3798935|B2||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3976862|NCT01274897|3798936|B1||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3976863|NCT01274897|3798934|B3||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
3976864|NCT01274897|3798935|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3976865|NCT01274897|3798936|B1||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3976866|NCT01274897|3798934|B3|Age, Years||Age||years|Mean|19.5|19.5|Standard Deviation|9.1|9.1|||
3976867|NCT01274897|3798935|B2|Age, Years||Age||years|Mean|19.3|19.3|Standard Deviation|8.9|8.9|||
3976868|NCT01274897|3798936|B1|Age, Years||Age||years|Mean|19.6|19.6|Standard Deviation|9.2|9.2|||
3976869|NCT01274715|3798949|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3976870|NCT01274715|3798949|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3976871|NCT01274715|3798949|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3976872|NCT01274715|3798949|B1|||Age||years|Mean|61.4|61.4|Standard Deviation|5.71|5.71|||
3976873|NCT01274715|3798949|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3976874|NCT01274715|3798949|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3976875|NCT01274715|3798949|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3976876|NCT01274637|3798954|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
3976877|NCT01274637|3798955|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3976878|NCT01274637|3798956|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3976879|NCT01274637|3798954|B3|Canada||Region of Enrollment||participants|Number|55|55.0||||||
3976880|NCT01274637|3798955|B2|Canada||Region of Enrollment||participants|Number|28|28.0||||||
3976881|NCT01274637|3798956|B1|Canada||Region of Enrollment||participants|Number|27|27.0||||||
3976882|NCT01274637|3798954|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976883|NCT01274637|3798955|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976884|NCT01274637|3798956|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976885|NCT01274637|3798954|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3976886|NCT01274637|3798955|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976887|NCT01274637|3798956|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3976888|NCT01274637|3798954|B3||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3976889|NCT01274637|3798955|B2||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3976890|NCT01274637|3798956|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3976891|NCT01274637|3798954|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3976892|NCT01274637|3798955|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3976893|NCT01274637|3798956|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3976894|NCT01274637|3798954|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976895|NCT01274637|3798955|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976896|NCT01274637|3798956|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976897|NCT01274637|3798954|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3976898|NCT01274637|3798955|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3976899|NCT01274637|3798956|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3976900|NCT01274637|3798954|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976901|NCT01274637|3798955|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976902|NCT01274637|3798956|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976903|NCT01274637|3798954|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976904|NCT01274637|3798955|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976905|NCT01274637|3798956|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3976906|NCT01274637|3798954|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3976907|NCT01274637|3798955|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3976908|NCT01274637|3798956|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3976909|NCT01274637|3798954|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3976910|NCT01274637|3798955|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3976911|NCT01274637|3798956|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3976912|NCT01274637|3798954|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3976913|NCT01274637|3798955|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3976914|NCT01274637|3798956|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3976915|NCT01274637|3798954|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3976916|NCT01274637|3798955|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3976917|NCT01274637|3798956|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3976918|NCT01274637|3798954|B3|||Age||years|Mean|30.8|30.8|Full Range|||18.0|43.0|
3976919|NCT01274637|3798955|B2|||Age||years|Mean|31.6|31.6|Full Range|||18.0|38.0|
3976920|NCT01274637|3798956|B1|||Age||years|Mean|30.0|30.0|Full Range|||20.0|43.0|
3976921|NCT01274611|3798973|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3976922|NCT01274611|3798973|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3976923|NCT01274611|3798973|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3976924|NCT01274611|3798973|B1|||Age||years|Mean|30.9|30.9|Standard Deviation|8.67|8.67|||
3976925|NCT01274611|3798973|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3976926|NCT01274611|3798973|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3976927|NCT01274611|3798973|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3976928|NCT01274585|3798981|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3976929|NCT01274585|3798982|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3976930|NCT01274585|3798983|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3976931|NCT01274585|3798981|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3976932|NCT01274585|3798982|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3976933|NCT01274585|3798983|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3976934|NCT01274585|3798981|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3976935|NCT01274585|3798982|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3976936|NCT01274585|3798983|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3976937|NCT01274585|3798981|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3976938|NCT01274585|3798982|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3976939|NCT01274585|3798983|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3976940|NCT01274585|3798981|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3976941|NCT01274585|3798982|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3976942|NCT01274585|3798983|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3976943|NCT01274585|3798981|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3976944|NCT01274585|3798982|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3976945|NCT01274585|3798983|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3976946|NCT01274585|3798981|B3|||Age||years|Mean|61|61.0|Full Range|||33.0|74.0|
3976947|NCT01274585|3798982|B2|||Age||years|Mean|69|69.0|Full Range|||63.0|74.0|
3976948|NCT01274585|3798983|B1|||Age||years|Mean|50|50.0|Full Range|||33.0|66.0|
3976949|NCT01274559|3798994|B3||Male|Sex: Female, Male||Participants|Count of Participants|691|691.0||||||
3976950|NCT01274559|3798995|B2||Male|Sex: Female, Male||Participants|Count of Participants|343|343.0||||||
3976951|NCT01274559|3798996|B1||Male|Sex: Female, Male||Participants|Count of Participants|348|348.0||||||
3976952|NCT01274559|3798994|B3||Female|Sex: Female, Male||Participants|Count of Participants|482|482.0||||||
3976953|NCT01274559|3798995|B2||Female|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
3976954|NCT01274559|3798996|B1||Female|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
3976955|NCT01274559|3798994|B3|>80 years||Age, Customized||Participants|Number|27|27.0||||||
3976956|NCT01274559|3798995|B2|>80 years||Age, Customized||Participants|Number|12|12.0||||||
3976957|NCT01274559|3798996|B1|>80 years||Age, Customized||Participants|Number|15|15.0||||||
3976958|NCT01274559|3798994|B3|71 to 80 years||Age, Customized||Participants|Number|206|206.0||||||
3976959|NCT01274559|3798995|B2|71 to 80 years||Age, Customized||Participants|Number|98|98.0||||||
3976960|NCT01274559|3798996|B1|71 to 80 years||Age, Customized||Participants|Number|108|108.0||||||
3976961|NCT01274559|3798994|B3|61 to 70 years||Age, Customized||Participants|Number|441|441.0||||||
3976962|NCT01274559|3798995|B2|61 to 70 years||Age, Customized||Participants|Number|232|232.0||||||
3976963|NCT01274559|3798996|B1|61 to 70 years||Age, Customized||Participants|Number|209|209.0||||||
3976964|NCT01274559|3798994|B3|51 to 60 years||Age, Customized||Participants|Number|350|350.0||||||
3976965|NCT01274559|3798995|B2|51 to 60 years||Age, Customized||Participants|Number|168|168.0||||||
3976966|NCT01274559|3798996|B1|51 to 60 years||Age, Customized||Participants|Number|182|182.0||||||
3976967|NCT01274559|3798994|B3|41 to 50 years||Age, Customized||Participants|Number|125|125.0||||||
3976968|NCT01274559|3798995|B2|41 to 50 years||Age, Customized||Participants|Number|62|62.0||||||
3976969|NCT01274559|3798996|B1|41 to 50 years||Age, Customized||Participants|Number|63|63.0||||||
3976970|NCT01274559|3798994|B3|31 to 40 years||Age, Customized||Participants|Number|21|21.0||||||
3976971|NCT01274559|3798995|B2|31 to 40 years||Age, Customized||Participants|Number|12|12.0||||||
3976972|NCT01274559|3798996|B1|31 to 40 years||Age, Customized||Participants|Number|9|9.0||||||
3976973|NCT01274559|3798994|B3|21 to 30 years||Age, Customized||Participants|Number|3|3.0||||||
3976974|NCT01274559|3798995|B2|21 to 30 years||Age, Customized||Participants|Number|2|2.0||||||
3976975|NCT01274559|3798996|B1|21 to 30 years||Age, Customized||Participants|Number|1|1.0||||||
3976976|NCT01274533|3799047|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3976977|NCT01274533|3799047|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3976978|NCT01274533|3799047|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3976979|NCT01274533|3799047|B1|18 years and older||Age, Customized||participants|Number|4|4.0||||||
3976980|NCT01274429|3799052|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
3976981|NCT01274429|3799052|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3976982|NCT01274429|3799052|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3976983|NCT01274429|3799052|B1|||Age||years|Mean|19.5|19.5|Full Range|||18.8|21.5|
3976984|NCT01274429|3799052|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3976985|NCT01274429|3799052|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3976986|NCT01274429|3799052|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3976987|NCT01274182|3799057|B4||Missing|Anti-drug antibodies (ADA)||Participants|Count of Participants|3|3.0||||||
3976988|NCT01274182|3799058|B3||Missing|Anti-drug antibodies (ADA)||Participants|Count of Participants|2|2.0||||||
3976989|NCT01274182|3799059|B2||Missing|Anti-drug antibodies (ADA)||Participants|Count of Participants|0|0.0||||||
3976990|NCT01274182|3799060|B1||Missing|Anti-drug antibodies (ADA)||Participants|Count of Participants|1|1.0||||||
3976991|NCT01274182|3799057|B4||Positive|Anti-drug antibodies (ADA)||Participants|Count of Participants|5|5.0||||||
3976992|NCT01274182|3799058|B3||Positive|Anti-drug antibodies (ADA)||Participants|Count of Participants|3|3.0||||||
3976993|NCT01274182|3799059|B2||Positive|Anti-drug antibodies (ADA)||Participants|Count of Participants|2|2.0||||||
3976994|NCT01274182|3799060|B1||Positive|Anti-drug antibodies (ADA)||Participants|Count of Participants|0|0.0||||||
3976995|NCT01274182|3799057|B4||Negative|Anti-drug antibodies (ADA)||Participants|Count of Participants|304|304.0||||||
3976996|NCT01274182|3799058|B3||Negative|Anti-drug antibodies (ADA)||Participants|Count of Participants|87|87.0||||||
3976997|NCT01274182|3799059|B2||Negative|Anti-drug antibodies (ADA)||Participants|Count of Participants|85|85.0||||||
3976998|NCT01274182|3799060|B1||Negative|Anti-drug antibodies (ADA)||Participants|Count of Participants|132|132.0||||||
3976999|NCT01274182|3799057|B4|||Dose of methotrexate at baseline||mg/week|Mean|15.03|15.03|Standard Deviation|4.939|4.939|||
3977000|NCT01274182|3799058|B3|||Dose of methotrexate at baseline||mg/week|Mean|15.29|15.29|Standard Deviation|4.888|4.888|||
3977001|NCT01274182|3799059|B2|||Dose of methotrexate at baseline||mg/week|Mean|14.65|14.65|Standard Deviation|5.154|5.154|||
3977002|NCT01274182|3799060|B1|||Dose of methotrexate at baseline||mg/week|Mean|15.09|15.09|Standard Deviation|4.856|4.856|||
3977003|NCT01274182|3799057|B4|||Disease Activity Score 28 joint count - C-reactive proteine (DAS28-CRP)|"In order to calculate the DAS28(CRP) the number of tender joints and swollen joints were assessed using 28-joint count (tender28 and swollen28).The patient’s global assessment of disease activity (GH) measured on a Visual Analogue Scale (VAS from 0mm - best to 100mm - worst) was obtained.~DAS28(CRP) = 0.56 * sqrt(tender28) + 0.28* sqrt(swollen28) + 0.36 * ln(CRP+1) + 0.014 * GH + 0.96 The DAS28(CRP) provides a number on a scale from 0 to 10 indicating the current activity of the RA, while lower values correspond with less disease activity. A decrease in DAS28 signifies a clinical improvement"|units on a scale|Mean|5.86|5.86|Standard Deviation|0.935|0.935|||
3977004|NCT01274182|3799058|B3|||Disease Activity Score 28 joint count - C-reactive proteine (DAS28-CRP)|"In order to calculate the DAS28(CRP) the number of tender joints and swollen joints were assessed using 28-joint count (tender28 and swollen28).The patient’s global assessment of disease activity (GH) measured on a Visual Analogue Scale (VAS from 0mm - best to 100mm - worst) was obtained.~DAS28(CRP) = 0.56 * sqrt(tender28) + 0.28* sqrt(swollen28) + 0.36 * ln(CRP+1) + 0.014 * GH + 0.96 The DAS28(CRP) provides a number on a scale from 0 to 10 indicating the current activity of the RA, while lower values correspond with less disease activity. A decrease in DAS28 signifies a clinical improvement"|units on a scale|Mean|5.91|5.91|Standard Deviation|1.009|1.009|||
3977005|NCT01274182|3799059|B2|||Disease Activity Score 28 joint count - C-reactive proteine (DAS28-CRP)|"In order to calculate the DAS28(CRP) the number of tender joints and swollen joints were assessed using 28-joint count (tender28 and swollen28).The patient’s global assessment of disease activity (GH) measured on a Visual Analogue Scale (VAS from 0mm - best to 100mm - worst) was obtained.~DAS28(CRP) = 0.56 * sqrt(tender28) + 0.28* sqrt(swollen28) + 0.36 * ln(CRP+1) + 0.014 * GH + 0.96 The DAS28(CRP) provides a number on a scale from 0 to 10 indicating the current activity of the RA, while lower values correspond with less disease activity. A decrease in DAS28 signifies a clinical improvement"|units on a scale|Mean|5.85|5.85|Standard Deviation|0.880|0.88|||
3977006|NCT01274182|3799060|B1|||Disease Activity Score 28 joint count - C-reactive proteine (DAS28-CRP)|"In order to calculate the DAS28(CRP) the number of tender joints and swollen joints were assessed using 28-joint count (tender28 and swollen28).The patient’s global assessment of disease activity (GH) measured on a Visual Analogue Scale (VAS from 0mm - best to 100mm - worst) was obtained.~DAS28(CRP) = 0.56 * sqrt(tender28) + 0.28* sqrt(swollen28) + 0.36 * ln(CRP+1) + 0.014 * GH + 0.96 The DAS28(CRP) provides a number on a scale from 0 to 10 indicating the current activity of the RA, while lower values correspond with less disease activity. A decrease in DAS28 signifies a clinical improvement"|units on a scale|Mean|5.83|5.83|Standard Deviation|0.922|0.922|||
3977007|NCT01274182|3799057|B4||>2|Number of patients having received 1, 2 or >2 TNF inhibitor therapies.||Participants|Count of Participants|13|13.0||||||
3977008|NCT01274182|3799058|B3||>2|Number of patients having received 1, 2 or >2 TNF inhibitor therapies.||Participants|Count of Participants|6|6.0||||||
3977009|NCT01274182|3799059|B2||>2|Number of patients having received 1, 2 or >2 TNF inhibitor therapies.||Participants|Count of Participants|1|1.0||||||
3977010|NCT01274182|3799060|B1||>2|Number of patients having received 1, 2 or >2 TNF inhibitor therapies.||Participants|Count of Participants|6|6.0||||||
3977011|NCT01274182|3799057|B4||2|Number of patients having received 1, 2 or >2 TNF inhibitor therapies.||Participants|Count of Participants|47|47.0||||||
3977012|NCT01274182|3799058|B3||2|Number of patients having received 1, 2 or >2 TNF inhibitor therapies.||Participants|Count of Participants|13|13.0||||||
3977013|NCT01274182|3799059|B2||2|Number of patients having received 1, 2 or >2 TNF inhibitor therapies.||Participants|Count of Participants|16|16.0||||||
3977014|NCT01274182|3799060|B1||2|Number of patients having received 1, 2 or >2 TNF inhibitor therapies.||Participants|Count of Participants|18|18.0||||||
3977015|NCT01274182|3799057|B4||1|Number of patients having received 1, 2 or >2 TNF inhibitor therapies.||Participants|Count of Participants|252|252.0||||||
3977016|NCT01274182|3799058|B3||1|Number of patients having received 1, 2 or >2 TNF inhibitor therapies.||Participants|Count of Participants|73|73.0||||||
3977017|NCT01274182|3799059|B2||1|Number of patients having received 1, 2 or >2 TNF inhibitor therapies.||Participants|Count of Participants|70|70.0||||||
3977018|NCT01274182|3799060|B1||1|Number of patients having received 1, 2 or >2 TNF inhibitor therapies.||Participants|Count of Participants|109|109.0||||||
3977019|NCT01274182|3799057|B4|||Duration of Rheumatoid Arthritis(RA)|Time in years since initial diagnosis of RA|years|Mean|10.78|10.78|Standard Deviation|7.874|7.874|||
3977020|NCT01274182|3799058|B3|||Duration of Rheumatoid Arthritis(RA)|Time in years since initial diagnosis of RA|years|Mean|11.10|11.1|Standard Deviation|8.299|8.299|||
3977021|NCT01274182|3799059|B2|||Duration of Rheumatoid Arthritis(RA)|Time in years since initial diagnosis of RA|years|Mean|10.81|10.81|Standard Deviation|7.137|7.137|||
3977022|NCT01274182|3799060|B1|||Duration of Rheumatoid Arthritis(RA)|Time in years since initial diagnosis of RA|years|Mean|10.53|10.53|Standard Deviation|8.074|8.074|||
3977023|NCT01274182|3799057|B4|||Body Mass Index (BMI)||kg/m2|Mean|28.02|28.02|Standard Deviation|6.353|6.353|||
3977024|NCT01274182|3799058|B3|||Body Mass Index (BMI)||kg/m2|Mean|29.66|29.66|Standard Deviation|6.606|6.606|||
3977025|NCT01274182|3799059|B2|||Body Mass Index (BMI)||kg/m2|Mean|27.25|27.25|Standard Deviation|6.000|6.0|||
3977026|NCT01274182|3799060|B1|||Body Mass Index (BMI)||kg/m2|Mean|27.37|27.37|Standard Deviation|6.230|6.23|||
3977027|NCT01274182|3799057|B4|Estonia||Region of Enrollment||participants|Number|2|2.0||||||
3977028|NCT01274182|3799058|B3|Estonia||Region of Enrollment||participants|Number|1|1.0||||||
3977029|NCT01274182|3799059|B2|Estonia||Region of Enrollment||participants|Number|0|0.0||||||
3977030|NCT01274182|3799060|B1|Estonia||Region of Enrollment||participants|Number|1|1.0||||||
3977031|NCT01274182|3799057|B4|Hungary||Region of Enrollment||participants|Number|4|4.0||||||
3977032|NCT01274182|3799058|B3|Hungary||Region of Enrollment||participants|Number|1|1.0||||||
3977033|NCT01274182|3799059|B2|Hungary||Region of Enrollment||participants|Number|0|0.0||||||
3977034|NCT01274182|3799060|B1|Hungary||Region of Enrollment||participants|Number|3|3.0||||||
3977035|NCT01274182|3799057|B4|Russia||Region of Enrollment||participants|Number|17|17.0||||||
3977036|NCT01274182|3799058|B3|Russia||Region of Enrollment||participants|Number|11|11.0||||||
3977037|NCT01274182|3799059|B2|Russia||Region of Enrollment||participants|Number|0|0.0||||||
3977038|NCT01274182|3799060|B1|Russia||Region of Enrollment||participants|Number|6|6.0||||||
3977039|NCT01274182|3799057|B4|Spain||Region of Enrollment||participants|Number|33|33.0||||||
3977040|NCT01274182|3799058|B3|Spain||Region of Enrollment||participants|Number|4|4.0||||||
3977041|NCT01274182|3799059|B2|Spain||Region of Enrollment||participants|Number|16|16.0||||||
3977042|NCT01274182|3799060|B1|Spain||Region of Enrollment||participants|Number|13|13.0||||||
3977043|NCT01274182|3799057|B4|India||Region of Enrollment||participants|Number|24|24.0||||||
3977044|NCT01274182|3799058|B3|India||Region of Enrollment||participants|Number|0|0.0||||||
3977045|NCT01274182|3799059|B2|India||Region of Enrollment||participants|Number|12|12.0||||||
3977046|NCT01274182|3799060|B1|India||Region of Enrollment||participants|Number|12|12.0||||||
3977047|NCT01274182|3799057|B4|Germany||Region of Enrollment||participants|Number|62|62.0||||||
3977048|NCT01274182|3799058|B3|Germany||Region of Enrollment||participants|Number|14|14.0||||||
3977049|NCT01274182|3799059|B2|Germany||Region of Enrollment||participants|Number|17|17.0||||||
3977050|NCT01274182|3799060|B1|Germany||Region of Enrollment||participants|Number|31|31.0||||||
3977051|NCT01274182|3799057|B4|France||Region of Enrollment||participants|Number|5|5.0||||||
3977052|NCT01274182|3799058|B3|France||Region of Enrollment||participants|Number|0|0.0||||||
3977053|NCT01274182|3799059|B2|France||Region of Enrollment||participants|Number|1|1.0||||||
3977054|NCT01274182|3799060|B1|France||Region of Enrollment||participants|Number|4|4.0||||||
3977055|NCT01274182|3799057|B4|Italy||Region of Enrollment||participants|Number|11|11.0||||||
3977056|NCT01274182|3799058|B3|Italy||Region of Enrollment||participants|Number|3|3.0||||||
3977057|NCT01274182|3799059|B2|Italy||Region of Enrollment||participants|Number|3|3.0||||||
3977058|NCT01274182|3799060|B1|Italy||Region of Enrollment||participants|Number|5|5.0||||||
3977059|NCT01274182|3799057|B4|Brazil||Region of Enrollment||participants|Number|50|50.0||||||
3977060|NCT01274182|3799058|B3|Brazil||Region of Enrollment||participants|Number|19|19.0||||||
3977061|NCT01274182|3799059|B2|Brazil||Region of Enrollment||participants|Number|12|12.0||||||
3977062|NCT01274182|3799060|B1|Brazil||Region of Enrollment||participants|Number|19|19.0||||||
3977063|NCT01274182|3799057|B4|United States||Region of Enrollment||participants|Number|29|29.0||||||
3977064|NCT01274182|3799058|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
3977065|NCT01274182|3799059|B2|United States||Region of Enrollment||participants|Number|0|0.0||||||
3977066|NCT01274182|3799060|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3977067|NCT01274182|3799057|B4|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
3977068|NCT01274182|3799058|B3|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
3977069|NCT01274182|3799059|B2|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
3977070|NCT01274182|3799060|B1|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
3977071|NCT01274182|3799057|B4|Romania||Region of Enrollment||participants|Number|23|23.0||||||
3977072|NCT01274182|3799058|B3|Romania||Region of Enrollment||participants|Number|6|6.0||||||
3977073|NCT01274182|3799059|B2|Romania||Region of Enrollment||participants|Number|8|8.0||||||
3977074|NCT01274182|3799060|B1|Romania||Region of Enrollment||participants|Number|9|9.0||||||
3977075|NCT01274182|3799057|B4|Turkey||Region of Enrollment||participants|Number|7|7.0||||||
3977076|NCT01274182|3799058|B3|Turkey||Region of Enrollment||participants|Number|2|2.0||||||
3977077|NCT01274182|3799059|B2|Turkey||Region of Enrollment||participants|Number|1|1.0||||||
3977078|NCT01274182|3799060|B1|Turkey||Region of Enrollment||participants|Number|4|4.0||||||
3977079|NCT01274182|3799057|B4|Austria||Region of Enrollment||participants|Number|20|20.0||||||
3977080|NCT01274182|3799058|B3|Austria||Region of Enrollment||participants|Number|3|3.0||||||
3977081|NCT01274182|3799059|B2|Austria||Region of Enrollment||participants|Number|10|10.0||||||
3977082|NCT01274182|3799060|B1|Austria||Region of Enrollment||participants|Number|7|7.0||||||
3977083|NCT01274182|3799057|B4|Argentina||Region of Enrollment||participants|Number|20|20.0||||||
3977084|NCT01274182|3799058|B3|Argentina||Region of Enrollment||participants|Number|9|9.0||||||
3977085|NCT01274182|3799059|B2|Argentina||Region of Enrollment||participants|Number|3|3.0||||||
3977086|NCT01274182|3799060|B1|Argentina||Region of Enrollment||participants|Number|8|8.0||||||
3977087|NCT01274182|3799057|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3977088|NCT01274182|3799058|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3977089|NCT01274182|3799059|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977090|NCT01274182|3799060|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3977091|NCT01274182|3799057|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977092|NCT01274182|3799058|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977093|NCT01274182|3799059|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977094|NCT01274182|3799060|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977095|NCT01274182|3799057|B4||White|Race (NIH/OMB)||Participants|Count of Participants|260|260.0||||||
3977096|NCT01274182|3799058|B3||White|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3977097|NCT01274182|3799059|B2||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3977098|NCT01274182|3799060|B1||White|Race (NIH/OMB)||Participants|Count of Participants|117|117.0||||||
3977099|NCT01274182|3799057|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3977100|NCT01274182|3799058|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3977101|NCT01274182|3799059|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3977102|NCT01274182|3799060|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3977103|NCT01274182|3799057|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3977104|NCT01274182|3799058|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977105|NCT01274182|3799059|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977106|NCT01274182|3799060|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3977107|NCT01274182|3799057|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3977108|NCT01274182|3799058|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977109|NCT01274182|3799059|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3977110|NCT01274182|3799060|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3977111|NCT01274182|3799057|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3977112|NCT01274182|3799058|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977113|NCT01274182|3799059|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3977114|NCT01274182|3799060|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977115|NCT01274182|3799057|B4||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3977116|NCT01274182|3799058|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3977117|NCT01274182|3799059|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3977118|NCT01274182|3799060|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3977119|NCT01274182|3799057|B4||Female|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
3977120|NCT01274182|3799058|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3977121|NCT01274182|3799059|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3977122|NCT01274182|3799060|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3977123|NCT01274182|3799057|B4|||Age||years|Mean|54.10|54.1|Standard Deviation|11.701|11.701|||
3977124|NCT01274182|3799058|B3|||Age||years|Mean|54.95|54.95|Standard Deviation|10.750|10.75|||
3977125|NCT01274182|3799059|B2|||Age||years|Mean|52.17|52.17|Standard Deviation|12.531|12.531|||
3977126|NCT01274182|3799060|B1|||Age||years|Mean|54.42|54.42|Standard Deviation|11.779|11.779|||
3977127|NCT01273896|3799099|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3977128|NCT01273896|3799099|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3977129|NCT01273896|3799099|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3977130|NCT01273896|3799099|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3977131|NCT01273896|3799099|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3977132|NCT01273883|3799103|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
3977133|NCT01273883|3799103|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3977134|NCT01273883|3799103|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3977135|NCT01273883|3799103|B1|||Age||years|Mean|61.45|61.45|Standard Deviation|11.58|11.58|||
3977136|NCT01273857|3799116|B3|Japan||Region of Enrollment||participants|Number|14|14.0||||||
3977137|NCT01273857|3799117|B2|Japan||Region of Enrollment||participants|Number|7|7.0||||||
3977138|NCT01273857|3799118|B1|Japan||Region of Enrollment||participants|Number|7|7.0||||||
3977139|NCT01273857|3799116|B3|Japanese||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3977140|NCT01273857|3799117|B2|Japanese||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3977141|NCT01273857|3799118|B1|Japanese||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3977142|NCT01273857|3799116|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3977143|NCT01273857|3799117|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3977144|NCT01273857|3799118|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3977145|NCT01273857|3799116|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3977146|NCT01273857|3799117|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3977147|NCT01273857|3799118|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3977148|NCT01273857|3799116|B3|||Age||years|Mean|1.7|1.7|Standard Deviation|1.5|1.5|||
3977149|NCT01273857|3799117|B2|||Age||years|Mean|2.1|2.1|Standard Deviation|1.2|1.2|||
3977150|NCT01273857|3799118|B1|||Age||years|Mean|1.5|1.5|Standard Deviation|1.7|1.7|||
3977151|NCT01273818|3799127|B4|Turkey||Region of Enrollment||participants|Number|276|276.0||||||
3977152|NCT01273818|3799128|B3|Turkey||Region of Enrollment||participants|Number|91|91.0||||||
3977153|NCT01273818|3799129|B2|Turkey||Region of Enrollment||participants|Number|98|98.0||||||
3977154|NCT01273818|3799130|B1|Turkey||Region of Enrollment||participants|Number|87|87.0||||||
3977155|NCT01273818|3799127|B4||Male|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
3977156|NCT01273818|3799128|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3977157|NCT01273818|3799129|B2||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3977158|NCT01273818|3799130|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3977159|NCT01273818|3799127|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3977160|NCT01273818|3799128|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3977161|NCT01273818|3799129|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3977162|NCT01273818|3799130|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3977163|NCT01273818|3799127|B4|||Age||years|Mean|50.10|50.1|Standard Deviation|14.85|14.85|||
3977164|NCT01273818|3799128|B3|||Age||years|Mean|50.36|50.36|Standard Deviation|15.49|15.49|||
3977165|NCT01273818|3799129|B2|||Age||years|Mean|49.60|49.6|Standard Deviation|13.85|13.85|||
3977166|NCT01273818|3799130|B1|||Age||years|Mean|50.39|50.39|Standard Deviation|15.39|15.39|||
3977167|NCT01273818|3799127|B4||>=65 years|Age||Participants|Count of Participants|80|80.0||||||
3977168|NCT01273818|3799128|B3||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3977169|NCT01273818|3799129|B2||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
3977170|NCT01273818|3799130|B1||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
3977171|NCT01273818|3799127|B4||Between 18 and 65 years|Age||Participants|Count of Participants|196|196.0||||||
3977172|NCT01273818|3799128|B3||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
3977173|NCT01273818|3799129|B2||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
3977174|NCT01273818|3799130|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3977175|NCT01273818|3799127|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3977176|NCT01273818|3799128|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3977177|NCT01273818|3799129|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3977178|NCT01273818|3799130|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3977179|NCT01273805|3799140|B3|Other||Location of Metastasis||participants|Number|4|4.0||||||
3977180|NCT01273805|3799141|B2|Other||Location of Metastasis||participants|Number|2|2.0||||||
3977181|NCT01273805|3799142|B1|Other||Location of Metastasis||participants|Number|2|2.0||||||
3977182|NCT01273805|3799140|B3|Peritoneum||Location of Metastasis||participants|Number|9|9.0||||||
3977183|NCT01273805|3799141|B2|Peritoneum||Location of Metastasis||participants|Number|5|5.0||||||
3977184|NCT01273805|3799142|B1|Peritoneum||Location of Metastasis||participants|Number|4|4.0||||||
3977185|NCT01273805|3799140|B3|Lung||Location of Metastasis||participants|Number|7|7.0||||||
3977186|NCT01273805|3799141|B2|Lung||Location of Metastasis||participants|Number|3|3.0||||||
3977187|NCT01273805|3799142|B1|Lung||Location of Metastasis||participants|Number|4|4.0||||||
3977188|NCT01273805|3799140|B3|Liver||Location of Metastasis||participants|Number|15|15.0||||||
3977189|NCT01273805|3799141|B2|Liver||Location of Metastasis||participants|Number|7|7.0||||||
3977190|NCT01273805|3799142|B1|Liver||Location of Metastasis||participants|Number|8|8.0||||||
3977191|NCT01273805|3799140|B3|Body or Tail||Site of Primary Tumor||participants|Number|7|7.0||||||
3977192|NCT01273805|3799141|B2|Body or Tail||Site of Primary Tumor||participants|Number|3|3.0||||||
3977193|NCT01273805|3799142|B1|Body or Tail||Site of Primary Tumor||participants|Number|4|4.0||||||
3977194|NCT01273805|3799140|B3|Head or Head and Body||Site of Primary Tumor||participants|Number|13|13.0||||||
3977195|NCT01273805|3799141|B2|Head or Head and Body||Site of Primary Tumor||participants|Number|7|7.0||||||
3977196|NCT01273805|3799142|B1|Head or Head and Body||Site of Primary Tumor||participants|Number|6|6.0||||||
3977197|NCT01273805|3799140|B3|PS2||ECOG Performance Status (PS)|ECOG PS0: Fully active, able to carry on all pre-disease performance without restriction ECOG PS1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature ECOG PS2: Ambulatory and capable of all self-care but unable to carry out any work activities; Up and about more than 50% of waking hours|participants|Number|5|5.0||||||
3977239|NCT01273766|3799160|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3977240|NCT01273766|3799161|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3977198|NCT01273805|3799141|B2|PS2||ECOG Performance Status (PS)|ECOG PS0: Fully active, able to carry on all pre-disease performance without restriction ECOG PS1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature ECOG PS2: Ambulatory and capable of all self-care but unable to carry out any work activities; Up and about more than 50% of waking hours|participants|Number|1|1.0||||||
3977199|NCT01273805|3799142|B1|PS2||ECOG Performance Status (PS)|ECOG PS0: Fully active, able to carry on all pre-disease performance without restriction ECOG PS1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature ECOG PS2: Ambulatory and capable of all self-care but unable to carry out any work activities; Up and about more than 50% of waking hours|participants|Number|4|4.0||||||
3977200|NCT01273805|3799140|B3|PS1||ECOG Performance Status (PS)|ECOG PS0: Fully active, able to carry on all pre-disease performance without restriction ECOG PS1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature ECOG PS2: Ambulatory and capable of all self-care but unable to carry out any work activities; Up and about more than 50% of waking hours|participants|Number|13|13.0||||||
3977201|NCT01273805|3799141|B2|PS1||ECOG Performance Status (PS)|ECOG PS0: Fully active, able to carry on all pre-disease performance without restriction ECOG PS1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature ECOG PS2: Ambulatory and capable of all self-care but unable to carry out any work activities; Up and about more than 50% of waking hours|participants|Number|8|8.0||||||
3977202|NCT01273805|3799142|B1|PS1||ECOG Performance Status (PS)|ECOG PS0: Fully active, able to carry on all pre-disease performance without restriction ECOG PS1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature ECOG PS2: Ambulatory and capable of all self-care but unable to carry out any work activities; Up and about more than 50% of waking hours|participants|Number|5|5.0||||||
3977203|NCT01273805|3799140|B3|PS0||ECOG Performance Status (PS)|ECOG PS0: Fully active, able to carry on all pre-disease performance without restriction ECOG PS1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature ECOG PS2: Ambulatory and capable of all self-care but unable to carry out any work activities; Up and about more than 50% of waking hours|participants|Number|2|2.0||||||
3977204|NCT01273805|3799141|B2|PS0||ECOG Performance Status (PS)|ECOG PS0: Fully active, able to carry on all pre-disease performance without restriction ECOG PS1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature ECOG PS2: Ambulatory and capable of all self-care but unable to carry out any work activities; Up and about more than 50% of waking hours|participants|Number|1|1.0||||||
3977205|NCT01273805|3799142|B1|PS0||ECOG Performance Status (PS)|ECOG PS0: Fully active, able to carry on all pre-disease performance without restriction ECOG PS1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature ECOG PS2: Ambulatory and capable of all self-care but unable to carry out any work activities; Up and about more than 50% of waking hours|participants|Number|1|1.0||||||
3977206|NCT01273805|3799140|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3977207|NCT01273805|3799141|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3977208|NCT01273805|3799142|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3977209|NCT01273805|3799140|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3977210|NCT01273805|3799141|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3977211|NCT01273805|3799142|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3977212|NCT01273805|3799140|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3977213|NCT01273805|3799141|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3977214|NCT01273805|3799142|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3977215|NCT01273805|3799140|B3|||Age||years|Median|67|67.0|Full Range|||56.0|83.0|
3977216|NCT01273805|3799141|B2|||Age||years|Median|66|66.0|Full Range|||58.0|76.0|
3977217|NCT01273805|3799142|B1|||Age||years|Median|67.5|67.5|Full Range|||56.0|83.0|
3977218|NCT01273766|3799159|B4|United States||Region of Enrollment||participants|Number|16|16.0||||||
3977219|NCT01273766|3799160|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3977220|NCT01273766|3799161|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3977221|NCT01273766|3799162|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3977222|NCT01273766|3799159|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3977223|NCT01273766|3799160|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3977224|NCT01273766|3799161|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3977225|NCT01273766|3799162|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3977226|NCT01273766|3799159|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3977227|NCT01273766|3799160|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3977228|NCT01273766|3799161|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3977229|NCT01273766|3799162|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3977230|NCT01273766|3799159|B4|||Age||years|Mean|48.0|48.0|Standard Deviation|14.5|14.5|||
3977231|NCT01273766|3799160|B3|||Age||years|Mean|55.0|55.0|Standard Deviation|17.6|17.6|||
3977232|NCT01273766|3799161|B2|||Age||years|Mean|40.1|40.1|Standard Deviation|7.0|7.0|||
3977233|NCT01273766|3799162|B1|||Age||years|Mean|53.1|53.1|Standard Deviation|12.9|12.9|||
3977234|NCT01273766|3799159|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3977235|NCT01273766|3799160|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3977236|NCT01273766|3799161|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3977237|NCT01273766|3799162|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3977238|NCT01273766|3799159|B4||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3977241|NCT01273766|3799162|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3977242|NCT01273766|3799159|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3977243|NCT01273766|3799160|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3977244|NCT01273766|3799161|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3977245|NCT01273766|3799162|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3977246|NCT01273623|3799174|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3977247|NCT01273623|3799174|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3977248|NCT01273623|3799174|B1|||Age||years|Mean|73|73.0|Standard Deviation|11|11.0|||
3977249|NCT01273597|3799181|B1|Hungary||Region of Enrollment||participants|Number|60|60.0||||||
3977250|NCT01273597|3799181|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3977251|NCT01273597|3799181|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3977252|NCT01273597|3799181|B1|||Age||years|Mean|57.7|57.7|Full Range|||31.0|86.0|
3977253|NCT01273519|3799193|B4||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3977254|NCT01273519|3799194|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3977255|NCT01273519|3799195|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3977256|NCT01273519|3799196|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3977257|NCT01273519|3799193|B4||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3977258|NCT01273519|3799194|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3977259|NCT01273519|3799195|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3977260|NCT01273519|3799196|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3977261|NCT01273519|3799193|B4|||Age||years|Mean|49.6|49.6|Standard Deviation|13.56|13.56|||
3977262|NCT01273519|3799194|B3|||Age||years|Mean|42.02|42.02|Standard Deviation|10.97|10.97|||
3977263|NCT01273519|3799195|B2|||Age||years|Mean|48.07|48.07|Standard Deviation|12.71|12.71|||
3977264|NCT01273519|3799196|B1|||Age||years|Mean|54.76|54.76|Standard Deviation|13.11|13.11|||
3977265|NCT01273181|3799231|B5|United States||Region of Enrollment||participants|Number|9|9.0||||||
3977266|NCT01273181|3799232|B4|United States||Region of Enrollment||participants|Number|1|1.0||||||
3977267|NCT01273181|3799233|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3977268|NCT01273181|3799234|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3977269|NCT01273181|3799235|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3977270|NCT01273181|3799231|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977271|NCT01273181|3799232|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977272|NCT01273181|3799233|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977273|NCT01273181|3799234|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977274|NCT01273181|3799235|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977275|NCT01273181|3799231|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977276|NCT01273181|3799232|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977277|NCT01273181|3799233|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977278|NCT01273181|3799234|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977279|NCT01273181|3799235|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977280|NCT01273181|3799231|B5||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3977281|NCT01273181|3799232|B4||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3977282|NCT01273181|3799233|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3977283|NCT01273181|3799234|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3977284|NCT01273181|3799235|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3977285|NCT01273181|3799231|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977286|NCT01273181|3799232|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977287|NCT01273181|3799233|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977288|NCT01273181|3799234|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|00|0.0||||||
3977289|NCT01273181|3799235|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977290|NCT01273181|3799231|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977291|NCT01273181|3799232|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977292|NCT01273181|3799233|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977293|NCT01273181|3799234|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977294|NCT01273181|3799235|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977295|NCT01273181|3799231|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977296|NCT01273181|3799232|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977297|NCT01273181|3799233|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977298|NCT01273181|3799234|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977299|NCT01273181|3799235|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977300|NCT01273181|3799231|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977301|NCT01273181|3799232|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977302|NCT01273181|3799233|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977303|NCT01273181|3799234|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977304|NCT01273181|3799235|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977305|NCT01273181|3799231|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977306|NCT01273181|3799232|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977307|NCT01273181|3799233|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977308|NCT01273181|3799234|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977309|NCT01273181|3799235|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977310|NCT01273181|3799231|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3977311|NCT01273181|3799232|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3977312|NCT01273181|3799233|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3977313|NCT01273181|3799234|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3977314|NCT01273181|3799235|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3977315|NCT01273181|3799231|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977316|NCT01273181|3799232|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977317|NCT01273181|3799233|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977318|NCT01273181|3799234|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977319|NCT01273181|3799235|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977320|NCT01273181|3799231|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3977321|NCT01273181|3799232|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3977322|NCT01273181|3799233|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3977323|NCT01273181|3799234|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3977324|NCT01273181|3799235|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3977325|NCT01273181|3799231|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3977326|NCT01273181|3799232|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3977327|NCT01273181|3799233|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3977328|NCT01273181|3799234|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3977329|NCT01273181|3799235|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3977330|NCT01273181|3799231|B5|||Age||years|Mean|51.9|51.9|Standard Deviation|15.2|15.2|||
3977331|NCT01273181|3799232|B4|||Age||years|Mean|71.0|71.0|Standard Deviation|||||
3977332|NCT01273181|3799233|B3|||Age||years|Mean|62.0|62.0|Standard Deviation|0.0|0.0|||
3977333|NCT01273181|3799234|B2|||Age||years|Mean|39.7|39.7|Standard Deviation|16.9|16.9|||
3977334|NCT01273181|3799235|B1|||Age||years|Mean|51.0|51.0|Standard Deviation|11.4|11.4|||
3977335|NCT01273181|3799231|B5||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3977336|NCT01273181|3799232|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3977337|NCT01273181|3799233|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3977338|NCT01273181|3799234|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3977339|NCT01273181|3799235|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3977340|NCT01273181|3799231|B5||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3977341|NCT01273181|3799232|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3977342|NCT01273181|3799233|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3977343|NCT01273181|3799234|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3977344|NCT01273181|3799235|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3977345|NCT01273181|3799231|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3977346|NCT01273181|3799232|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3977347|NCT01273181|3799233|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3977348|NCT01273181|3799234|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3977349|NCT01273181|3799235|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3977350|NCT01273064|3799252|B6|United States||Region of Enrollment||participants|Number|114|114.0||||||
3977351|NCT01273064|3799253|B5|United States||Region of Enrollment||participants|Number|10|10.0||||||
3977352|NCT01273064|3799254|B4|United States||Region of Enrollment||participants|Number|20|20.0||||||
3977353|NCT01273064|3799255|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
3977354|NCT01273064|3799256|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3977355|NCT01273064|3799257|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
3977356|NCT01273064|3799252|B6||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3977357|NCT01273064|3799253|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3977358|NCT01273064|3799254|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3977359|NCT01273064|3799255|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3977360|NCT01273064|3799256|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3977361|NCT01273064|3799257|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3977362|NCT01273064|3799252|B6||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3977363|NCT01273064|3799253|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3977364|NCT01273064|3799254|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3977365|NCT01273064|3799255|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3977366|NCT01273064|3799256|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3977367|NCT01273064|3799257|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3977368|NCT01273064|3799252|B6|||Age||years|Mean|53.2|53.2|Standard Deviation|8.3|8.3|||
3977369|NCT01273064|3799253|B5|||Age||years|Mean|57.7|57.7|Standard Deviation|5.9|5.9|||
3977370|NCT01273064|3799254|B4|||Age||years|Mean|52.8|52.8|Standard Deviation|7.1|7.1|||
3977371|NCT01273064|3799255|B3|||Age||years|Mean|50.5|50.5|Standard Deviation|11.3|11.3|||
3977372|NCT01273064|3799256|B2|||Age||years|Mean|55.1|55.1|Standard Deviation|6.0|6.0|||
3977373|NCT01273064|3799257|B1|||Age||years|Mean|53.1|53.1|Standard Deviation|7.0|7.0|||
3977374|NCT01273064|3799252|B6||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3977375|NCT01273064|3799253|B5||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3977376|NCT01273064|3799254|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3977377|NCT01273064|3799255|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3977378|NCT01273064|3799256|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3977379|NCT01273064|3799257|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3977380|NCT01273064|3799252|B6||Between 18 and 65 years|Age||Participants|Count of Participants|108|108.0||||||
3977381|NCT01273064|3799253|B5||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3977382|NCT01273064|3799254|B4||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3977383|NCT01273064|3799255|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3977384|NCT01273064|3799256|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3977385|NCT01273064|3799257|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3977386|NCT01273064|3799252|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3977387|NCT01273064|3799253|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3977388|NCT01273064|3799254|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3977389|NCT01273064|3799255|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3977390|NCT01273064|3799256|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3977391|NCT01273064|3799257|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3977392|NCT01273038|3799278|B3|Gender information not available||Sex/Gender, Customized||participants|Number|1|1.0||||||
3977393|NCT01273038|3799279|B2|Gender information not available||Sex/Gender, Customized||participants|Number|0|0.0||||||
3977394|NCT01273038|3799280|B1|Gender information not available||Sex/Gender, Customized||participants|Number|1|1.0||||||
3977395|NCT01273038|3799278|B3|Male||Sex/Gender, Customized||participants|Number|11|11.0||||||
3977396|NCT01273038|3799279|B2|Male||Sex/Gender, Customized||participants|Number|5|5.0||||||
3977397|NCT01273038|3799280|B1|Male||Sex/Gender, Customized||participants|Number|6|6.0||||||
3977398|NCT01273038|3799278|B3|Female||Sex/Gender, Customized||participants|Number|8|8.0||||||
3977399|NCT01273038|3799279|B2|Female||Sex/Gender, Customized||participants|Number|5|5.0||||||
3977400|NCT01273038|3799280|B1|Female||Sex/Gender, Customized||participants|Number|3|3.0||||||
3977401|NCT01273038|3799278|B3|||Age||years|Mean|66|66.0|Standard Deviation|6|6.0|||
3977402|NCT01273038|3799279|B2|||Age||years|Mean|66|66.0|Standard Deviation|7|7.0|||
3977403|NCT01273038|3799280|B1|||Age||years|Mean|65|65.0|Standard Deviation|7|7.0|||
3977404|NCT01272960|3799287|B3|||Number of pregnancies at viable gestational age||Pregnancies|Number|9|9.0||||||
3977405|NCT01272960|3799288|B2|||Number of pregnancies at viable gestational age||Pregnancies|Number|6|6.0||||||
3977406|NCT01272960|3799289|B1|||Number of pregnancies at viable gestational age||Pregnancies|Number|3|3.0||||||
3977407|NCT01272960|3799287|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
3977408|NCT01272960|3799288|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3977409|NCT01272960|3799289|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3977410|NCT01272960|3799287|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3977411|NCT01272960|3799288|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3977412|NCT01272960|3799289|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3977413|NCT01272960|3799287|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3977414|NCT01272960|3799288|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3977415|NCT01272960|3799289|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3977416|NCT01272960|3799287|B3|||Age||years|Mean|26.6|26.6|Standard Deviation|5.6|5.6|||
3977417|NCT01272960|3799288|B2|||Age||years|Mean|26.9|26.9|Standard Deviation|4.2|4.2|||
3977418|NCT01272960|3799289|B1|||Age||years|Mean|26.1|26.1|Standard Deviation|4.6|4.6|||
3977419|NCT01272960|3799287|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3977420|NCT01272960|3799288|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3977421|NCT01272960|3799289|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3977422|NCT01272960|3799287|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3977423|NCT01272960|3799288|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3977424|NCT01272960|3799289|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3977425|NCT01272960|3799287|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3977426|NCT01272960|3799288|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3977427|NCT01272960|3799289|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3977428|NCT01272947|3799302|B3|Germany||Region of Enrollment||participants|Number|204|204.0||||||
3977429|NCT01272947|3799303|B2|Germany||Region of Enrollment||participants|Number|100|100.0||||||
3977430|NCT01272947|3799304|B1|Germany||Region of Enrollment||participants|Number|104|104.0||||||
3977431|NCT01272947|3799302|B3||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3977432|NCT01272947|3799303|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3977433|NCT01272947|3799304|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3977434|NCT01272947|3799302|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3977435|NCT01272947|3799303|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3977436|NCT01272947|3799304|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3977437|NCT01272947|3799302|B3|Unit : years||Age||years|Mean|30.4|30.4|Standard Deviation|10.9|10.9|||
3977438|NCT01272947|3799303|B2|Unit : years||Age||years|Mean|31.4|31.4|Standard Deviation|12.1|12.1|||
3977439|NCT01272947|3799304|B1|Unit : years||Age||years|Mean|29.4|29.4|Standard Deviation|9.6|9.6|||
3977440|NCT01272934|3799313|B3|Germany||Region of Enrollment||participants|Number|205|205.0||||||
3977441|NCT01272934|3799314|B2|Germany||Region of Enrollment||participants|Number|103|103.0||||||
3977442|NCT01272934|3799315|B1|Germany||Region of Enrollment||participants|Number|102|102.0||||||
3977443|NCT01272934|3799313|B3||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3977444|NCT01272934|3799314|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3977445|NCT01272934|3799315|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3977446|NCT01272934|3799313|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3977447|NCT01272934|3799314|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3977448|NCT01272934|3799315|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3977449|NCT01272934|3799313|B3|||Age|Age : 18 years and over|years|Mean|31.5|31.5|Standard Deviation|11.4|11.4|||
3977450|NCT01272934|3799314|B2|||Age|Age : 18 years and over|years|Mean|30.5|30.5|Standard Deviation|10.8|10.8|||
3977451|NCT01272934|3799315|B1|||Age|Age : 18 years and over|years|Mean|32.5|32.5|Standard Deviation|12.0|12.0|||
3977452|NCT01272921|3799324|B3|United States||Region of Enrollment||participants|Number|139|139.0||||||
3977453|NCT01272921|3799325|B2|United States||Region of Enrollment||participants|Number|70|70.0||||||
3977454|NCT01272921|3799326|B1|United States||Region of Enrollment||participants|Number|69|69.0||||||
3977455|NCT01272921|3799324|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3977456|NCT01272921|3799325|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3977457|NCT01272921|3799326|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3977458|NCT01272921|3799324|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3977459|NCT01272921|3799325|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3977460|NCT01272921|3799326|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3977461|NCT01272921|3799324|B3|||Age||years|Mean|65.81|65.81|Standard Deviation|9.27|9.27|||
3977462|NCT01272921|3799325|B2|||Age||years|Mean|64.70|64.7|Standard Deviation|9.26|9.26|||
3977463|NCT01272921|3799326|B1|||Age||years|Mean|66.93|66.93|Standard Deviation|9.21|9.21|||
3977464|NCT01272921|3799324|B3||>=65 years|Age||Participants|Count of Participants|73|73.0||||||
3977465|NCT01272921|3799325|B2||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
3977466|NCT01272921|3799326|B1||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
3977467|NCT01272921|3799324|B3||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
3977468|NCT01272921|3799325|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3977469|NCT01272921|3799326|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3977470|NCT01272921|3799324|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3977471|NCT01272921|3799325|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3977472|NCT01272921|3799326|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3977473|NCT01272908|3799335|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3977474|NCT01272908|3799335|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3977475|NCT01272908|3799335|B1|||Age||years|Mean|55.6|55.6|Standard Deviation|10.20|10.2|||
3977476|NCT01272882|3799369|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3977477|NCT01272882|3799369|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3977478|NCT01272882|3799369|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3977479|NCT01272882|3799369|B1|||Age||years|Mean|55|55.0|Standard Deviation|22|22.0|||
3977480|NCT01272882|3799369|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3977481|NCT01272882|3799369|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3977482|NCT01272882|3799369|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3977483|NCT01272869|3799373|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3977484|NCT01272869|3799374|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3977485|NCT01272869|3799375|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3977486|NCT01272869|3799373|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3977487|NCT01272869|3799374|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3977488|NCT01272869|3799375|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3977489|NCT01272869|3799373|B3|||Age||years|Mean|60|60.0|Standard Deviation|11|11.0|||
3977490|NCT01272869|3799374|B2|||Age||years|Mean|61|61.0|Standard Deviation|10|10.0|||
3977491|NCT01272869|3799375|B1|||Age||years|Mean|59|59.0|Standard Deviation|13|13.0|||
3977492|NCT01272830|3799382|B3|||Initial Pain Visual Analog Scale (VAS)|"VAS Scale range (0-100 )~Higher VAS score indicate worst knee pain."|units on a scale|Mean|51.4|51.4|Standard Deviation|25.1|25.1|||
3977493|NCT01272830|3799383|B2|||Initial Pain Visual Analog Scale (VAS)|"VAS Scale range (0-100 )~Higher VAS score indicate worst knee pain."|units on a scale|Mean|46.8|46.8|Standard Deviation|24.9|24.9|||
3977494|NCT01272830|3799384|B1|||Initial Pain Visual Analog Scale (VAS)|"VAS Scale range (0-100 )~Higher VAS score indicate worst knee pain."|units on a scale|Mean|57|57.0|Standard Deviation|24.1|24.1|||
3977495|NCT01272830|3799382|B3|||Time elapsed since TKA|TKA - Total Knee Arthroplasty|years|Mean|3.3|3.3|Standard Deviation|2.9|2.9|||
3977496|NCT01272830|3799383|B2|||Time elapsed since TKA|TKA - Total Knee Arthroplasty|years|Mean|4.0|4.0|Standard Deviation|3.3|3.3|||
3977497|NCT01272830|3799384|B1|||Time elapsed since TKA|TKA - Total Knee Arthroplasty|years|Mean|2.5|2.5|Standard Deviation|1.9|1.9|||
3977498|NCT01272830|3799382|B3|||Height||centimeters|Mean|170.6|170.6|Standard Deviation|9.2|9.2|||
3977499|NCT01272830|3799383|B2|||Height||centimeters|Mean|169.8|169.8|Standard Deviation|8.6|8.6|||
3977500|NCT01272830|3799384|B1|||Height||centimeters|Mean|171.7|171.7|Standard Deviation|9.9|9.9|||
3977501|NCT01272830|3799382|B3|||Weight||kilograms|Mean|99|99.0|Standard Deviation|18.5|18.5|||
3977502|NCT01272830|3799383|B2|||Weight||kilograms|Mean|100|100.0|Standard Deviation|16.8|16.8|||
3977503|NCT01272830|3799384|B1|||Weight||kilograms|Mean|96.7|96.7|Standard Deviation|20.4|20.4|||
3977504|NCT01272830|3799382|B3|United States||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
3977505|NCT01272830|3799383|B2|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3977506|NCT01272830|3799384|B1|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3977507|NCT01272830|3799382|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3977508|NCT01272830|3799383|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3977509|NCT01272830|3799384|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3977510|NCT01272830|3799382|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3977511|NCT01272830|3799383|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3977512|NCT01272830|3799384|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3977513|NCT01272830|3799382|B3|||Age||years|Mean|63.9|63.9|Standard Deviation|9.7|9.7|||
3977514|NCT01272830|3799383|B2|||Age||years|Mean|65.4|65.4|Standard Deviation|9.6|9.6|||
3977515|NCT01272830|3799384|B1|||Age||years|Mean|62.1|62.1|Standard Deviation|9.5|9.5|||
3977516|NCT01272804|3799397|B7||Male|Gender||Participants|Count of Participants|43|43.0||||||
3977517|NCT01272804|3799398|B6||Male|Gender||Participants|Count of Participants|10|10.0||||||
3977518|NCT01272804|3799399|B5||Male|Gender||Participants|Count of Participants|6|6.0||||||
3977519|NCT01272804|3799400|B4||Male|Gender||Participants|Count of Participants|6|6.0||||||
3977520|NCT01272804|3799401|B3||Male|Gender||Participants|Count of Participants|7|7.0||||||
3977521|NCT01272804|3799402|B2||Male|Gender||Participants|Count of Participants|9|9.0||||||
3977522|NCT01272804|3799403|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
3977523|NCT01272804|3799397|B7||Female|Gender||Participants|Count of Participants|18|18.0||||||
3977524|NCT01272804|3799398|B6||Female|Gender||Participants|Count of Participants|6|6.0||||||
3977525|NCT01272804|3799399|B5||Female|Gender||Participants|Count of Participants|3|3.0||||||
3977526|NCT01272804|3799400|B4||Female|Gender||Participants|Count of Participants|3|3.0||||||
3977527|NCT01272804|3799401|B3||Female|Gender||Participants|Count of Participants|2|2.0||||||
3977528|NCT01272804|3799402|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
3977529|NCT01272804|3799403|B1||Female|Gender||Participants|Count of Participants|4|4.0||||||
3977530|NCT01272804|3799397|B7|||Age||years|Mean|54.4|54.4|Standard Deviation|7.7|7.7|||
3977531|NCT01272804|3799398|B6|||Age||years|Mean|57.3|57.3|Standard Deviation|5.8|5.8|||
3977532|NCT01272804|3799399|B5|||Age||years|Mean|56.4|56.4|Standard Deviation|5.8|5.8|||
3977533|NCT01272804|3799400|B4|||Age||years|Mean|51.4|51.4|Standard Deviation|10.6|10.6|||
3977534|NCT01272804|3799401|B3|||Age||years|Mean|54.2|54.2|Standard Deviation|5.4|5.4|||
3977535|NCT01272804|3799402|B2|||Age||years|Mean|49.4|49.4|Standard Deviation|7.8|7.8|||
3977536|NCT01272804|3799403|B1|||Age||years|Mean|55.6|55.6|Standard Deviation|9.2|9.2|||
3977537|NCT01272661|3799563|B4|United States||Region of Enrollment||participants|Number|1296|1296.0||||||
3977538|NCT01272661|3799564|B3|United States||Region of Enrollment||participants|Number|386|386.0||||||
3977539|NCT01272661|3799565|B2|United States||Region of Enrollment||participants|Number|497|497.0||||||
3977540|NCT01272661|3799566|B1|United States||Region of Enrollment||participants|Number|413|413.0||||||
3977541|NCT01272661|3799563|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3977542|NCT01272661|3799564|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3977543|NCT01272661|3799565|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3977544|NCT01272661|3799566|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3977545|NCT01272661|3799563|B4||Female|Sex: Female, Male||Participants|Count of Participants|1296|1296.0||||||
3977546|NCT01272661|3799564|B3||Female|Sex: Female, Male||Participants|Count of Participants|386|386.0||||||
3977547|NCT01272661|3799565|B2||Female|Sex: Female, Male||Participants|Count of Participants|497|497.0||||||
3977548|NCT01272661|3799566|B1||Female|Sex: Female, Male||Participants|Count of Participants|413|413.0||||||
3977549|NCT01272661|3799563|B4|||Age||years|Mean|22.2|22.2|Standard Deviation|4.9|4.9|||
3977550|NCT01272661|3799564|B3|||Age||years|Mean|23.1|23.1|Standard Deviation|4.9|4.9|||
3977551|NCT01272661|3799565|B2|||Age||years|Mean|22.2|22.2|Standard Deviation|4.4|4.4|||
3977552|NCT01272661|3799566|B1|||Age||years|Mean|21.2|21.2|Standard Deviation|4.8|4.8|||
3977553|NCT01272635|3799591|B3|||Hospitalizations for respiratory symptoms in prior year||Hospitalizations|Median|1|1.0|Inter-Quartile Range|||0.0|4.0|
3977554|NCT01272635|3799592|B2|||Hospitalizations for respiratory symptoms in prior year||Hospitalizations|Median|1|1.0|Inter-Quartile Range|||0.0|4.0|
3977555|NCT01272635|3799593|B1|||Hospitalizations for respiratory symptoms in prior year||Hospitalizations|Median|1|1.0|Inter-Quartile Range|||0.0|4.0|
3977556|NCT01272635|3799591|B3|||Wheezing episodes in prior year||episodes|Mean|4.5|4.5|Standard Deviation|3.2|3.2|||
3977557|NCT01272635|3799592|B2|||Wheezing episodes in prior year||episodes|Mean|4.4|4.4|Standard Deviation|2.9|2.9|||
3977558|NCT01272635|3799593|B1|||Wheezing episodes in prior year||episodes|Mean|4.5|4.5|Standard Deviation|3.4|3.4|||
3977559|NCT01272635|3799591|B3|||Urgent care or ED visits in prior year||visits|Mean|2.5|2.5|Standard Deviation|1.6|1.6|||
3977560|NCT01272635|3799592|B2|||Urgent care or ED visits in prior year||visits|Mean|2.5|2.5|Standard Deviation|1.6|1.6|||
3977561|NCT01272635|3799593|B1|||Urgent care or ED visits in prior year||visits|Mean|2.5|2.5|Standard Deviation|1.7|1.7|||
3977562|NCT01272635|3799591|B3|United States||Region of Enrollment||participants|Number|607|607.0||||||
3977563|NCT01272635|3799592|B2|United States||Region of Enrollment||participants|Number|300|300.0||||||
3977564|NCT01272635|3799593|B1|United States||Region of Enrollment||participants|Number|307|307.0||||||
3977565|NCT01272635|3799591|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977566|NCT01272635|3799592|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977567|NCT01272635|3799593|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977568|NCT01272635|3799591|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3977569|NCT01272635|3799592|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3977570|NCT01272635|3799593|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3977571|NCT01272635|3799591|B3||White|Race (NIH/OMB)||Participants|Count of Participants|362|362.0||||||
3977572|NCT01272635|3799592|B2||White|Race (NIH/OMB)||Participants|Count of Participants|185|185.0||||||
3977573|NCT01272635|3799593|B1||White|Race (NIH/OMB)||Participants|Count of Participants|177|177.0||||||
3977574|NCT01272635|3799591|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|157|157.0||||||
3977575|NCT01272635|3799592|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3977576|NCT01272635|3799593|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3977577|NCT01272635|3799591|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977578|NCT01272635|3799592|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977579|NCT01272635|3799593|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977580|NCT01272635|3799591|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3977581|NCT01272635|3799592|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3977582|NCT01272635|3799593|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3977583|NCT01272635|3799591|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3977584|NCT01272635|3799592|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3977585|NCT01272635|3799593|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3977586|NCT01272635|3799591|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977587|NCT01272635|3799592|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977588|NCT01272635|3799593|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977589|NCT01272635|3799591|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|424|424.0||||||
3977590|NCT01272635|3799592|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|208|208.0||||||
3977591|NCT01272635|3799593|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|216|216.0||||||
3977592|NCT01272635|3799591|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|183|183.0||||||
3977593|NCT01272635|3799592|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
3977594|NCT01272635|3799593|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3977595|NCT01272635|3799591|B3||Male|Gender||Participants|Count of Participants|365|365.0||||||
3977596|NCT01272635|3799592|B2||Male|Gender||Participants|Count of Participants|182|182.0||||||
3977597|NCT01272635|3799593|B1||Male|Gender||Participants|Count of Participants|183|183.0||||||
3977598|NCT01272635|3799591|B3||Female|Gender||Participants|Count of Participants|242|242.0||||||
3977599|NCT01272635|3799592|B2||Female|Gender||Participants|Count of Participants|118|118.0||||||
3977600|NCT01272635|3799593|B1||Female|Gender||Participants|Count of Participants|124|124.0||||||
3977601|NCT01272635|3799591|B3|||Age||months|Mean|41.5|41.5|Standard Deviation|16.5|16.5|||
3977602|NCT01272635|3799592|B2|||Age||months|Mean|41.1|41.1|Standard Deviation|16.4|16.4|||
3977603|NCT01272635|3799593|B1|||Age||months|Mean|41.9|41.9|Standard Deviation|16.5|16.5|||
3977604|NCT01272583|3799612|B3|Netherlands||Region of Enrollment||participants|Number|16|16.0||||||
3977605|NCT01272583|3799613|B2|Netherlands||Region of Enrollment||participants|Number|8|8.0||||||
3977606|NCT01272583|3799614|B1|Netherlands||Region of Enrollment||participants|Number|8|8.0||||||
3977607|NCT01272583|3799612|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3977608|NCT01272583|3799613|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3977609|NCT01272583|3799614|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3977610|NCT01272583|3799612|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3977611|NCT01272583|3799613|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3977612|NCT01272583|3799614|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3977613|NCT01272583|3799612|B3|||Age||years|Median|31.5|31.5|Inter-Quartile Range|27.0-40.0|27.0|27.0|40.0|
3977614|NCT01272583|3799613|B2|||Age||years|Median|33.5|33.5|Inter-Quartile Range|27.8-40.8|27.8|27.8|40.8|
3977615|NCT01272583|3799614|B1|||Age||years|Median|30.5|30.5|Inter-Quartile Range|26.3-39|26.3|26.3|39.0|
3977616|NCT01272388|3799644|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3977617|NCT01272388|3799646|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3977618|NCT01272388|3799644|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3977619|NCT01272388|3799646|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3977620|NCT01272388|3799644|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3977621|NCT01272388|3799646|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3977622|NCT01272388|3799644|B3|||Age||years|Mean|69|69.0|Full Range|||||
3977623|NCT01272388|3799646|B1|||Age||years|Mean|69|69.0|Full Range|||||
3977624|NCT01272284|3799655|B1|Canada||Region of Enrollment||participants|Number|20|20.0||||||
3977625|NCT01272284|3799655|B1|United States||Region of Enrollment||participants|Number|93|93.0||||||
3977626|NCT01272284|3799655|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3977627|NCT01272284|3799655|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3977628|NCT01272284|3799655|B1|||Age||years|Mean|54.5|54.5|Standard Deviation|14.0|14.0|||
3977629|NCT01272284|3799655|B1||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
3977630|NCT01272284|3799655|B1||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
3977631|NCT01272284|3799655|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3977632|NCT01272245|3799669|B1|United States||Region of Enrollment||Count of Participants|Number|36|36.0||||||
3977633|NCT01272245|3799669|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3977634|NCT01272245|3799669|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3977635|NCT01272245|3799669|B1|||Age||years|Median|71|71.0|Full Range|||60.0|85.0|
3977636|NCT01272232|3799677|B4|||Duration of diabetes||years|Mean|7.30|7.3|Standard Deviation|5.39|5.39|||
3977637|NCT01272232|3799678|B3|||Duration of diabetes||years|Mean|6.71|6.71|Standard Deviation|5.07|5.07|||
3977638|NCT01272232|3799679|B2|||Duration of diabetes||years|Mean|7.43|7.43|Standard Deviation|5.16|5.16|||
3977639|NCT01272232|3799680|B1|||Duration of diabetes||years|Mean|7.54|7.54|Standard Deviation|5.65|5.65|||
3977640|NCT01272232|3799677|B4|Absent||Co-morbid dyslipidaemia|Presence or absence of untreated or treated dyslipidaemia|participants|Number|282|282.0||||||
3977641|NCT01272232|3799678|B3|Absent||Co-morbid dyslipidaemia|Presence or absence of untreated or treated dyslipidaemia|participants|Number|86|86.0||||||
3977642|NCT01272232|3799679|B2|Absent||Co-morbid dyslipidaemia|Presence or absence of untreated or treated dyslipidaemia|participants|Number|68|68.0||||||
3977643|NCT01272232|3799680|B1|Absent||Co-morbid dyslipidaemia|Presence or absence of untreated or treated dyslipidaemia|participants|Number|128|128.0||||||
3977644|NCT01272232|3799677|B4|Present||Co-morbid dyslipidaemia|Presence or absence of untreated or treated dyslipidaemia|participants|Number|564|564.0||||||
3977645|NCT01272232|3799678|B3|Present||Co-morbid dyslipidaemia|Presence or absence of untreated or treated dyslipidaemia|participants|Number|126|126.0||||||
3977646|NCT01272232|3799679|B2|Present||Co-morbid dyslipidaemia|Presence or absence of untreated or treated dyslipidaemia|participants|Number|143|143.0||||||
3977647|NCT01272232|3799680|B1|Present||Co-morbid dyslipidaemia|Presence or absence of untreated or treated dyslipidaemia|participants|Number|295|295.0||||||
3977648|NCT01272232|3799677|B4|Absent||Co-morbid hypertension|Presence or absence of untreated or treated hypertension|participants|Number|260|260.0||||||
3977649|NCT01272232|3799678|B3|Absent||Co-morbid hypertension|Presence or absence of untreated or treated hypertension|participants|Number|67|67.0||||||
3977650|NCT01272232|3799679|B2|Absent||Co-morbid hypertension|Presence or absence of untreated or treated hypertension|participants|Number|63|63.0||||||
3977651|NCT01272232|3799680|B1|Absent||Co-morbid hypertension|Presence or absence of untreated or treated hypertension|participants|Number|130|130.0||||||
3977652|NCT01272232|3799677|B4|Present||Co-morbid hypertension|Presence or absence of untreated or treated hypertension|participants|Number|586|586.0||||||
3977653|NCT01272232|3799678|B3|Present||Co-morbid hypertension|Presence or absence of untreated or treated hypertension|participants|Number|145|145.0||||||
3977654|NCT01272232|3799679|B2|Present||Co-morbid hypertension|Presence or absence of untreated or treated hypertension|participants|Number|148|148.0||||||
3977655|NCT01272232|3799680|B1|Present||Co-morbid hypertension|Presence or absence of untreated or treated hypertension|participants|Number|293|293.0||||||
3977656|NCT01272232|3799677|B4|||Fasting plasma glucose||mmol/L|Mean|8.8|8.8|Standard Deviation|1.9|1.9|||
3977657|NCT01272232|3799678|B3|||Fasting plasma glucose||mmol/L|Mean|8.6|8.6|Standard Deviation|1.8|1.8|||
3977658|NCT01272232|3799679|B2|||Fasting plasma glucose||mmol/L|Mean|8.9|8.9|Standard Deviation|2.0|2.0|||
3977659|NCT01272232|3799680|B1|||Fasting plasma glucose||mmol/L|Mean|8.8|8.8|Standard Deviation|1.9|1.9|||
3977660|NCT01272232|3799677|B4|||HbA1c (glycosylated haemoglobin)||Percent (%) glycosylated haemoglobin|Mean|7.9|7.9|Standard Deviation|0.8|0.8|||
3977661|NCT01272232|3799678|B3|||HbA1c (glycosylated haemoglobin)||Percent (%) glycosylated haemoglobin|Mean|7.9|7.9|Standard Deviation|0.8|0.8|||
3977662|NCT01272232|3799679|B2|||HbA1c (glycosylated haemoglobin)||Percent (%) glycosylated haemoglobin|Mean|8.0|8.0|Standard Deviation|0.8|0.8|||
3977663|NCT01272232|3799680|B1|||HbA1c (glycosylated haemoglobin)||Percent (%) glycosylated haemoglobin|Mean|7.9|7.9|Standard Deviation|0.8|0.8|||
3977664|NCT01272232|3799677|B4|>40.0 kg/m^2 - obese class III||Body Mass Index (BMI) group||participants|Number|252|252.0||||||
3977665|NCT01272232|3799678|B3|>40.0 kg/m^2 - obese class III||Body Mass Index (BMI) group||participants|Number|63|63.0||||||
3977666|NCT01272232|3799679|B2|>40.0 kg/m^2 - obese class III||Body Mass Index (BMI) group||participants|Number|65|65.0||||||
3977667|NCT01272232|3799680|B1|>40.0 kg/m^2 - obese class III||Body Mass Index (BMI) group||participants|Number|124|124.0||||||
3977668|NCT01272232|3799677|B4|35.0-39.9 kg/m^2 - obese class II||Body Mass Index (BMI) group||participants|Number|218|218.0||||||
3977669|NCT01272232|3799678|B3|35.0-39.9 kg/m^2 - obese class II||Body Mass Index (BMI) group||participants|Number|60|60.0||||||
3977670|NCT01272232|3799679|B2|35.0-39.9 kg/m^2 - obese class II||Body Mass Index (BMI) group||participants|Number|50|50.0||||||
3977671|NCT01272232|3799680|B1|35.0-39.9 kg/m^2 - obese class II||Body Mass Index (BMI) group||participants|Number|108|108.0||||||
3977672|NCT01272232|3799677|B4|30.0-34.9 kg/m^2 - obese class I||Body Mass Index (BMI) group||participants|Number|260|260.0||||||
3977673|NCT01272232|3799678|B3|30.0-34.9 kg/m^2 - obese class I||Body Mass Index (BMI) group||participants|Number|59|59.0||||||
3977674|NCT01272232|3799679|B2|30.0-34.9 kg/m^2 - obese class I||Body Mass Index (BMI) group||participants|Number|62|62.0||||||
3977675|NCT01272232|3799680|B1|30.0-34.9 kg/m^2 - obese class I||Body Mass Index (BMI) group||participants|Number|139|139.0||||||
3977676|NCT01272232|3799677|B4|25.0-29.9 kg/m^2 - pre-obese||Body Mass Index (BMI) group||participants|Number|116|116.0||||||
3977677|NCT01272232|3799678|B3|25.0-29.9 kg/m^2 - pre-obese||Body Mass Index (BMI) group||participants|Number|30|30.0||||||
3977678|NCT01272232|3799679|B2|25.0-29.9 kg/m^2 - pre-obese||Body Mass Index (BMI) group||participants|Number|34|34.0||||||
3977679|NCT01272232|3799680|B1|25.0-29.9 kg/m^2 - pre-obese||Body Mass Index (BMI) group||participants|Number|52|52.0||||||
3977680|NCT01272232|3799677|B4|||Body Mass Index (BMI)||kg/m^2|Mean|37.1|37.1|Standard Deviation|6.8|6.8|||
3977681|NCT01272232|3799678|B3|||Body Mass Index (BMI)||kg/m^2|Mean|37.4|37.4|Standard Deviation|7.1|7.1|||
3977682|NCT01272232|3799679|B2|||Body Mass Index (BMI)||kg/m^2|Mean|37.0|37.0|Standard Deviation|6.9|6.9|||
3977683|NCT01272232|3799680|B1|||Body Mass Index (BMI)||kg/m^2|Mean|37.1|37.1|Standard Deviation|6.5|6.5|||
3977684|NCT01272232|3799677|B4|||Height|Height was recorded without shoes.|m|Mean|1.69|1.69|Standard Deviation|0.10|0.1|||
3977685|NCT01272232|3799678|B3|||Height|Height was recorded without shoes.|m|Mean|1.69|1.69|Standard Deviation|0.10|0.1|||
3977686|NCT01272232|3799679|B2|||Height|Height was recorded without shoes.|m|Mean|1.69|1.69|Standard Deviation|0.10|0.1|||
3977687|NCT01272232|3799680|B1|||Height|Height was recorded without shoes.|m|Mean|1.69|1.69|Standard Deviation|0.11|0.11|||
3977688|NCT01272232|3799677|B4|||Fasting body weight|Weight was recorded to the nearest 0.1 kg for a subject in the fasting state with an empty bladder, without shoes and only wearing light clothing. The same calibrated scale was used throughout the trial.|kg|Mean|105.9|105.9|Standard Deviation|21.5|21.5|||
3977689|NCT01272232|3799678|B3|||Fasting body weight|Weight was recorded to the nearest 0.1 kg for a subject in the fasting state with an empty bladder, without shoes and only wearing light clothing. The same calibrated scale was used throughout the trial.|kg|Mean|106.5|106.5|Standard Deviation|21.3|21.3|||
3977690|NCT01272232|3799679|B2|||Fasting body weight|Weight was recorded to the nearest 0.1 kg for a subject in the fasting state with an empty bladder, without shoes and only wearing light clothing. The same calibrated scale was used throughout the trial.|kg|Mean|105.8|105.8|Standard Deviation|21.0|21.0|||
3977691|NCT01272232|3799680|B1|||Fasting body weight|Weight was recorded to the nearest 0.1 kg for a subject in the fasting state with an empty bladder, without shoes and only wearing light clothing. The same calibrated scale was used throughout the trial.|kg|Mean|105.7|105.7|Standard Deviation|21.9|21.9|||
3977692|NCT01272232|3799677|B4|>= 75 years||Age group||participants|Number|15|15.0||||||
3977693|NCT01272232|3799678|B3|>= 75 years||Age group||participants|Number|2|2.0||||||
3977694|NCT01272232|3799679|B2|>= 75 years||Age group||participants|Number|2|2.0||||||
3977695|NCT01272232|3799680|B1|>= 75 years||Age group||participants|Number|11|11.0||||||
3977696|NCT01272232|3799677|B4|65- < 75 years||Age group||participants|Number|142|142.0||||||
3977697|NCT01272232|3799678|B3|65- < 75 years||Age group||participants|Number|36|36.0||||||
3977698|NCT01272232|3799679|B2|65- < 75 years||Age group||participants|Number|32|32.0||||||
3977699|NCT01272232|3799680|B1|65- < 75 years||Age group||participants|Number|74|74.0||||||
3977700|NCT01272232|3799677|B4|40- < 65 years||Age group||participants|Number|623|623.0||||||
3977701|NCT01272232|3799678|B3|40- < 65 years||Age group||participants|Number|161|161.0||||||
3977702|NCT01272232|3799679|B2|40- < 65 years||Age group||participants|Number|162|162.0||||||
3977703|NCT01272232|3799680|B1|40- < 65 years||Age group||participants|Number|300|300.0||||||
3977704|NCT01272232|3799677|B4|18- < 40 years||Age group||participants|Number|66|66.0||||||
3977705|NCT01272232|3799678|B3|18- < 40 years||Age group||participants|Number|13|13.0||||||
3977706|NCT01272232|3799679|B2|18- < 40 years||Age group||participants|Number|15|15.0||||||
3977707|NCT01272232|3799680|B1|18- < 40 years||Age group||participants|Number|38|38.0||||||
3977708|NCT01272232|3799677|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3977709|NCT01272232|3799678|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3977710|NCT01272232|3799679|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3977711|NCT01272232|3799680|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3977712|NCT01272232|3799677|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977713|NCT01272232|3799678|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977714|NCT01272232|3799679|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977715|NCT01272232|3799680|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977716|NCT01272232|3799677|B4||White|Race (NIH/OMB)||Participants|Count of Participants|705|705.0||||||
3977717|NCT01272232|3799678|B3||White|Race (NIH/OMB)||Participants|Count of Participants|175|175.0||||||
3977718|NCT01272232|3799679|B2||White|Race (NIH/OMB)||Participants|Count of Participants|177|177.0||||||
3977719|NCT01272232|3799680|B1||White|Race (NIH/OMB)||Participants|Count of Participants|353|353.0||||||
3977720|NCT01272232|3799677|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3977721|NCT01272232|3799678|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3977722|NCT01272232|3799679|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3977723|NCT01272232|3799680|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3977724|NCT01272232|3799677|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977725|NCT01272232|3799678|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977726|NCT01272232|3799679|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977727|NCT01272232|3799680|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977728|NCT01272232|3799677|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3977729|NCT01272232|3799678|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3977730|NCT01272232|3799679|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3977731|NCT01272232|3799680|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3977732|NCT01272232|3799677|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3977733|NCT01272232|3799678|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977734|NCT01272232|3799679|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977735|NCT01272232|3799680|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3977736|NCT01272232|3799677|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3977737|NCT01272232|3799678|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3977738|NCT01272232|3799679|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977739|NCT01272232|3799680|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3977740|NCT01272232|3799677|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|756|756.0||||||
3977741|NCT01272232|3799678|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|187|187.0||||||
3977742|NCT01272232|3799679|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|194|194.0||||||
3977743|NCT01272232|3799680|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|375|375.0||||||
3977744|NCT01272232|3799677|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3977745|NCT01272232|3799678|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3977746|NCT01272232|3799679|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3977747|NCT01272232|3799680|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3977748|NCT01272232|3799677|B4||Male|Sex: Female, Male||Participants|Count of Participants|425|425.0||||||
3977749|NCT01272232|3799678|B3||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3977750|NCT01272232|3799679|B2||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3977751|NCT01272232|3799680|B1||Male|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
3977752|NCT01272232|3799677|B4||Female|Sex: Female, Male||Participants|Count of Participants|421|421.0||||||
3977753|NCT01272232|3799678|B3||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3977754|NCT01272232|3799679|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3977755|NCT01272232|3799680|B1||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
3977756|NCT01272232|3799677|B4|||Age||years|Mean|54.9|54.9|Standard Deviation|10.5|10.5|||
3977757|NCT01272232|3799678|B3|||Age||years|Mean|54.7|54.7|Standard Deviation|9.8|9.8|||
3977758|NCT01272232|3799679|B2|||Age||years|Mean|54.9|54.9|Standard Deviation|10.7|10.7|||
3977759|NCT01272232|3799680|B1|||Age||years|Mean|55.0|55.0|Standard Deviation|10.8|10.8|||
3977760|NCT01272219|3799723|B5|||Fasting Plasma Glucose (FPG)||mmol/L|Mean|5.3|5.3|Standard Deviation|0.6|0.6|||
3977761|NCT01272219|3799724|B4|||Fasting Plasma Glucose (FPG)||mmol/L|Mean|5.5|5.5|Standard Deviation|0.5|0.5|||
3977762|NCT01272219|3799725|B3|||Fasting Plasma Glucose (FPG)||mmol/L|Mean|5.5|5.5|Standard Deviation|0.6|0.6|||
3977763|NCT01272219|3799726|B2|||Fasting Plasma Glucose (FPG)||mmol/L|Mean|5.1|5.1|Standard Deviation|0.5|0.5|||
3977764|NCT01272219|3799727|B1|||Fasting Plasma Glucose (FPG)||mmol/L|Mean|5.0|5.0|Standard Deviation|0.4|0.4|||
3977765|NCT01272219|3799723|B5|||Glycosylated Haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|5.6|5.6|Standard Deviation|0.4|0.4|||
3977766|NCT01272219|3799724|B4|||Glycosylated Haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|5.7|5.7|Standard Deviation|0.3|0.3|||
3977767|NCT01272219|3799725|B3|||Glycosylated Haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|5.8|5.8|Standard Deviation|0.3|0.3|||
3977768|NCT01272219|3799726|B2|||Glycosylated Haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|5.3|5.3|Standard Deviation|0.3|0.3|||
3977769|NCT01272219|3799727|B1|||Glycosylated Haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|5.3|5.3|Standard Deviation|0.3|0.3|||
3977770|NCT01272219|3799723|B5|||Body Mass Index (BMI)||kg/m^2|Mean|38.3|38.3|Standard Deviation|6.4|6.4|||
3977771|NCT01272219|3799724|B4|||Body Mass Index (BMI)||kg/m^2|Mean|39.0|39.0|Standard Deviation|6.3|6.3|||
3977772|NCT01272219|3799725|B3|||Body Mass Index (BMI)||kg/m^2|Mean|38.8|38.8|Standard Deviation|6.4|6.4|||
3977773|NCT01272219|3799726|B2|||Body Mass Index (BMI)||kg/m^2|Mean|37.4|37.4|Standard Deviation|6.2|6.2|||
3977774|NCT01272219|3799727|B1|||Body Mass Index (BMI)||kg/m^2|Mean|37.5|37.5|Standard Deviation|6.2|6.2|||
3977775|NCT01272219|3799723|B5|||Fasting Body Weight||kg|Mean|106.2|106.2|Standard Deviation|21.4|21.4|||
3977776|NCT01272219|3799724|B4|||Fasting Body Weight||kg|Mean|107.9|107.9|Standard Deviation|21.8|21.8|||
3977777|NCT01272219|3799725|B3|||Fasting Body Weight||kg|Mean|107.6|107.6|Standard Deviation|21.8|21.8|||
3977778|NCT01272219|3799726|B2|||Fasting Body Weight||kg|Mean|103.6|103.6|Standard Deviation|21.2|21.2|||
3977779|NCT01272219|3799727|B1|||Fasting Body Weight||kg|Mean|104.0|104.0|Standard Deviation|20.1|20.1|||
3977780|NCT01272219|3799723|B5||Male|Sex: Female, Male||Participants|Count of Participants|803|803.0||||||
3977781|NCT01272219|3799724|B4||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
3977782|NCT01272219|3799725|B3||Male|Sex: Female, Male||Participants|Count of Participants|372|372.0||||||
3977783|NCT01272219|3799726|B2||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3977784|NCT01272219|3799727|B1||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3977785|NCT01272219|3799723|B5||Female|Sex: Female, Male||Participants|Count of Participants|2928|2928.0||||||
3977786|NCT01272219|3799724|B4||Female|Sex: Female, Male||Participants|Count of Participants|581|581.0||||||
3977787|NCT01272219|3799725|B3||Female|Sex: Female, Male||Participants|Count of Participants|1156|1156.0||||||
3977788|NCT01272219|3799726|B2||Female|Sex: Female, Male||Participants|Count of Participants|390|390.0||||||
3977789|NCT01272219|3799727|B1||Female|Sex: Female, Male||Participants|Count of Participants|801|801.0||||||
3977790|NCT01272219|3799723|B5|||Age||years|Mean|45.1|45.1|Standard Deviation|12.0|12.0|||
3977791|NCT01272219|3799724|B4|||Age||years|Mean|47.2|47.2|Standard Deviation|11.8|11.8|||
3977792|NCT01272219|3799725|B3|||Age||years|Mean|47.4|47.4|Standard Deviation|11.8|11.8|||
3977793|NCT01272219|3799726|B2|||Age||years|Mean|41.5|41.5|Standard Deviation|11.5|11.5|||
3977794|NCT01272219|3799727|B1|||Age||years|Mean|41.6|41.6|Standard Deviation|11.7|11.7|||
3977795|NCT01272193|3799764|B3|||Body weight||kg|Mean|66.3|66.3|Standard Deviation|13.4|13.4|||
3977796|NCT01272193|3799765|B2|||Body weight||kg|Mean|66.4|66.4|Standard Deviation|13.3|13.3|||
3977797|NCT01272193|3799766|B1|||Body weight||kg|Mean|66.2|66.2|Standard Deviation|13.4|13.4|||
3977798|NCT01272193|3799764|B3|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.0|9.0|Standard Deviation|1.7|1.7|||
3977799|NCT01272193|3799765|B2|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.1|9.1|Standard Deviation|1.9|1.9|||
3977800|NCT01272193|3799766|B1|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.0|9.0|Standard Deviation|1.6|1.6|||
3977801|NCT01272193|3799764|B3|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.4|8.4|Standard Deviation|0.8|0.8|||
3977802|NCT01272193|3799765|B2|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.5|8.5|Standard Deviation|0.8|0.8|||
3977803|NCT01272193|3799766|B1|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.3|8.3|Standard Deviation|0.8|0.8|||
3977804|NCT01272193|3799764|B3||Male|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
3977805|NCT01272193|3799765|B2||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3977806|NCT01272193|3799766|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3977807|NCT01272193|3799764|B3||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3977808|NCT01272193|3799765|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3977809|NCT01272193|3799766|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3977810|NCT01272193|3799764|B3|||Age||years|Mean|60.5|60.5|Standard Deviation|9.8|9.8|||
3977811|NCT01272193|3799765|B2|||Age||years|Mean|61.0|61.0|Standard Deviation|9.6|9.6|||
3977812|NCT01272193|3799766|B1|||Age||years|Mean|60.0|60.0|Standard Deviation|10.0|10.0|||
3977813|NCT01272180|3799783|B5||Male|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
3977814|NCT01272180|3799784|B4||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3977815|NCT01272180|3799785|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3977816|NCT01272180|3799786|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3977817|NCT01272180|3799787|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3977818|NCT01272180|3799783|B5||Female|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
3977819|NCT01272180|3799784|B4||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3977820|NCT01272180|3799785|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3977821|NCT01272180|3799786|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3977822|NCT01272180|3799787|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3977823|NCT01272180|3799783|B5|||Age||years|Mean|15.0|15.0|Standard Deviation|4.9|4.9|||
3977824|NCT01272180|3799784|B4|||Age||years|Mean|15.0|15.0|Standard Deviation|5.1|5.1|||
3977825|NCT01272180|3799785|B3|||Age||years|Mean|15.3|15.3|Standard Deviation|4.9|4.9|||
3977826|NCT01272180|3799786|B2|||Age||years|Mean|15.1|15.1|Standard Deviation|4.9|4.9|||
3977827|NCT01272180|3799787|B1|||Age||years|Mean|14.7|14.7|Standard Deviation|4.7|4.7|||
3977828|NCT01272141|3799827|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3977829|NCT01272141|3799827|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3977830|NCT01272141|3799827|B1|51-55 years||Age, Customized||participants|Number|1|1.0||||||
3977831|NCT01272141|3799827|B1|46-50 years||Age, Customized||participants|Number|2|2.0||||||
3977832|NCT01272141|3799827|B1|41-45 years||Age, Customized||participants|Number|2|2.0||||||
3977833|NCT01272076|3799832|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
3977834|NCT01272076|3799832|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3977835|NCT01272076|3799832|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3977836|NCT01272076|3799832|B1|||Age||years|Mean|83.6|83.6|Standard Deviation|6.2|6.2|||
3977837|NCT01272076|3799832|B1||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
3977838|NCT01272076|3799832|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3977839|NCT01272076|3799832|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3977840|NCT01272011|3799836|B4|United States||Region of Enrollment||participants|Number|14|14.0||||||
3977841|NCT01272011|3799837|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3977842|NCT01272011|3799838|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3977843|NCT01272011|3799839|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3977844|NCT01272011|3799836|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3977845|NCT01272011|3799837|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3977846|NCT01272011|3799838|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3977847|NCT01272011|3799839|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3977848|NCT01272011|3799836|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977849|NCT01272011|3799837|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977850|NCT01272011|3799838|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977851|NCT01272011|3799839|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977852|NCT01272011|3799836|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977853|NCT01272011|3799837|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977854|NCT01272011|3799838|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977855|NCT01272011|3799839|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977856|NCT01272011|3799836|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3977857|NCT01272011|3799837|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3977858|NCT01272011|3799838|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3977859|NCT01272011|3799839|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3977860|NCT01272011|3799836|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3977861|NCT01272011|3799837|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3977862|NCT01272011|3799838|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3977863|NCT01272011|3799839|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3977864|NCT01272011|3799836|B4|||Age||years|Mean|51.86|51.86|Full Range|||26.0|72.0|
3977865|NCT01272011|3799837|B3|||Age||years|Mean|48.33|48.33|Full Range|||26.0|67.0|
3977866|NCT01272011|3799838|B2|||Age||years|Mean|53.13|53.13|Full Range|||32.0|72.0|
3977867|NCT01272011|3799839|B1|||Age||years|Mean|52|52.0|Full Range|||52.0|52.0|
3977868|NCT01272011|3799836|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3977869|NCT01272011|3799837|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3977870|NCT01272011|3799838|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3977871|NCT01272011|3799839|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3977872|NCT01272011|3799836|B4||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3977873|NCT01272011|3799837|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3977874|NCT01272011|3799838|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3977875|NCT01272011|3799839|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3977876|NCT01272011|3799836|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3977877|NCT01272011|3799837|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3977878|NCT01272011|3799838|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3977879|NCT01272011|3799839|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3977880|NCT01271946|3799852|B3|United States||Region of Enrollment||participants|Number|351|351.0||||||
3977881|NCT01271946|3799853|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3977882|NCT01271946|3799854|B1|United States||Region of Enrollment||participants|Number|346|346.0||||||
3977883|NCT01271946|3799852|B3||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
3977884|NCT01271946|3799853|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3977885|NCT01271946|3799854|B1||Male|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
3977886|NCT01271946|3799852|B3||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3977887|NCT01271946|3799853|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3977888|NCT01271946|3799854|B1||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3977889|NCT01271946|3799852|B3|||Age||years|Mean|64.3|64.3|Standard Deviation|10.8|10.8|||
3977890|NCT01271946|3799853|B2|||Age||years|Mean|63.2|63.2|Standard Deviation|11.7|11.7|||
3977891|NCT01271946|3799854|B1|||Age||years|Mean|64.4|64.4|Standard Deviation|10.8|10.8|||
3977892|NCT01271946|3799852|B3||>=65 years|Age||Participants|Count of Participants|186|186.0||||||
3977893|NCT01271946|3799853|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3977894|NCT01271946|3799854|B1||>=65 years|Age||Participants|Count of Participants|185|185.0||||||
3977895|NCT01271946|3799852|B3||Between 18 and 65 years|Age||Participants|Count of Participants|165|165.0||||||
3977896|NCT01271946|3799853|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3977897|NCT01271946|3799854|B1||Between 18 and 65 years|Age||Participants|Count of Participants|161|161.0||||||
3977898|NCT01271946|3799852|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3977899|NCT01271946|3799853|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3977900|NCT01271946|3799854|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3977901|NCT01271933|3799877|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3977902|NCT01271933|3799877|B1||Female|Sex: Female, Male||Participants|Count of Participants|392|392.0||||||
3977903|NCT01271933|3799877|B1|≥ 65 years||Age, Customized||Participants|Number|36|36.0||||||
3977904|NCT01271933|3799877|B1|45 – 64 years||Age, Customized||Participants|Number|227|227.0||||||
3977905|NCT01271933|3799877|B1|18 – 44 years||Age, Customized||Participants|Number|178|178.0||||||
3977906|NCT01271933|3799877|B1|<18 years||Age, Customized||Participants|Number|0|0.0||||||
3977907|NCT01271907|3799976|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
3977908|NCT01271907|3799979|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3977909|NCT01271907|3799976|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977910|NCT01271907|3799979|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977911|NCT01271907|3799976|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977912|NCT01271907|3799979|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977913|NCT01271907|3799976|B4||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3977914|NCT01271907|3799979|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3977915|NCT01271907|3799976|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977916|NCT01271907|3799979|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977917|NCT01271907|3799976|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977918|NCT01271907|3799979|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977919|NCT01271907|3799976|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977920|NCT01271907|3799979|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977921|NCT01271907|3799976|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977922|NCT01271907|3799979|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977923|NCT01271907|3799976|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977924|NCT01271907|3799979|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977925|NCT01271907|3799976|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3977926|NCT01271907|3799979|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3977927|NCT01271907|3799976|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977928|NCT01271907|3799979|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3977929|NCT01271907|3799976|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3977930|NCT01271907|3799979|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3977931|NCT01271907|3799976|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3977932|NCT01271907|3799979|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3977933|NCT01271907|3799976|B4|||Age||years|Mean|53.0|53.0|Standard Deviation|7.2|7.2|||
3977934|NCT01271907|3799979|B1|||Age||years|Mean|53.0|53.0|Standard Deviation|7.2|7.2|||
3977935|NCT01271907|3799976|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3977936|NCT01271907|3799979|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3977937|NCT01271907|3799976|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3977938|NCT01271907|3799979|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3977939|NCT01271907|3799976|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3977940|NCT01271907|3799979|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3977941|NCT01271855|3799995|B3|||Visual Analogue Scale Pain Score|Patients' baseline Visual Analog Scale (VAS) pain score was recorded at 0 hours after delivery. This scale ranges from 0 to 10 (0=no pain and 10=worst pain).|units on a scale|Median|0|0.0|Inter-Quartile Range|||0.0|4.0|
3977994|NCT01271855|3799997|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3977942|NCT01271855|3799996|B2|||Visual Analogue Scale Pain Score|Patients' baseline Visual Analog Scale (VAS) pain score was recorded at 0 hours after delivery. This scale ranges from 0 to 10 (0=no pain and 10=worst pain).|units on a scale|Median|0|0.0|Inter-Quartile Range|||0.0|4.0|
3977943|NCT01271855|3799997|B1|||Visual Analogue Scale Pain Score|Patients' baseline Visual Analog Scale (VAS) pain score was recorded at 0 hours after delivery. This scale ranges from 0 to 10 (0=no pain and 10=worst pain).|units on a scale|Median|0|0.0|Inter-Quartile Range|||0.0|2.0|
3977944|NCT01271855|3799995|B3||Breastfeeding is unknown or not reported|Breastfeeding||Participants|Count of Participants|5|5.0||||||
3977945|NCT01271855|3799996|B2||Breastfeeding is unknown or not reported|Breastfeeding||Participants|Count of Participants|2|2.0||||||
3977946|NCT01271855|3799997|B1||Breastfeeding is unknown or not reported|Breastfeeding||Participants|Count of Participants|3|3.0||||||
3977947|NCT01271855|3799995|B3||Not Breastfeeding|Breastfeeding||Participants|Count of Participants|17|17.0||||||
3977948|NCT01271855|3799996|B2||Not Breastfeeding|Breastfeeding||Participants|Count of Participants|9|9.0||||||
3977949|NCT01271855|3799997|B1||Not Breastfeeding|Breastfeeding||Participants|Count of Participants|8|8.0||||||
3977950|NCT01271855|3799995|B3||Breastfeeding|Breastfeeding||Participants|Count of Participants|78|78.0||||||
3977951|NCT01271855|3799996|B2||Breastfeeding|Breastfeeding||Participants|Count of Participants|41|41.0||||||
3977952|NCT01271855|3799997|B1||Breastfeeding|Breastfeeding||Participants|Count of Participants|37|37.0||||||
3977953|NCT01271855|3799995|B3||Cesarean|Route of Delivery||Participants|Count of Participants|27|27.0||||||
3977954|NCT01271855|3799996|B2||Cesarean|Route of Delivery||Participants|Count of Participants|10|10.0||||||
3977955|NCT01271855|3799997|B1||Cesarean|Route of Delivery||Participants|Count of Participants|17|17.0||||||
3977956|NCT01271855|3799995|B3||Normal spontaneous vaginal delivery (NSVD)|Route of Delivery||Participants|Count of Participants|73|73.0||||||
3977957|NCT01271855|3799996|B2||Normal spontaneous vaginal delivery (NSVD)|Route of Delivery||Participants|Count of Participants|42|42.0||||||
3977958|NCT01271855|3799997|B1||Normal spontaneous vaginal delivery (NSVD)|Route of Delivery||Participants|Count of Participants|31|31.0||||||
3977959|NCT01271855|3799995|B3|||Gestational Age||Weeks|Mean|38.89|38.89|Standard Deviation|1.16|1.16|||
3977960|NCT01271855|3799996|B2|||Gestational Age||Weeks|Mean|39.09|39.09|Standard Deviation|1.05|1.05|||
3977961|NCT01271855|3799997|B1|||Gestational Age||Weeks|Mean|38.68|38.68|Standard Deviation|1.24|1.24|||
3977962|NCT01271855|3799995|B3|||Parity||Pregnancies to a viable gestational age|Median|1|1.0|Inter-Quartile Range|||0.0|2.0|
3977963|NCT01271855|3799996|B2|||Parity||Pregnancies to a viable gestational age|Median|1|1.0|Inter-Quartile Range|||0.0|2.0|
3977964|NCT01271855|3799997|B1|||Parity||Pregnancies to a viable gestational age|Median|1|1.0|Inter-Quartile Range|||1.0|2.0|
3977965|NCT01271855|3799995|B3|||Gravidity||Count of pregnancies|Median|2|2.0|Inter-Quartile Range|||2.0|3.0|
3977966|NCT01271855|3799996|B2|||Gravidity||Count of pregnancies|Median|2|2.0|Inter-Quartile Range|||1.0|3.0|
3977967|NCT01271855|3799997|B1|||Gravidity||Count of pregnancies|Median|2.5|2.5|Inter-Quartile Range|||2.0|3.0|
3977968|NCT01271855|3799995|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
3977969|NCT01271855|3799996|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
3977970|NCT01271855|3799997|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
3977971|NCT01271855|3799995|B3|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3977972|NCT01271855|3799996|B2|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3977973|NCT01271855|3799997|B1|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3977974|NCT01271855|3799995|B3|Other Race||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3977975|NCT01271855|3799996|B2|Other Race||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3977976|NCT01271855|3799997|B1|Other Race||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3977977|NCT01271855|3799995|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|49|49.0||||||
3977978|NCT01271855|3799996|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3977979|NCT01271855|3799997|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3977980|NCT01271855|3799995|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3977981|NCT01271855|3799996|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3977982|NCT01271855|3799997|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3977983|NCT01271855|3799995|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3977984|NCT01271855|3799996|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3977985|NCT01271855|3799997|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3977986|NCT01271855|3799995|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3977987|NCT01271855|3799996|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3977988|NCT01271855|3799997|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3977989|NCT01271855|3799995|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3977990|NCT01271855|3799996|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3977991|NCT01271855|3799997|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3977992|NCT01271855|3799995|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3977993|NCT01271855|3799996|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3977995|NCT01271855|3799995|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3977996|NCT01271855|3799996|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3977997|NCT01271855|3799997|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3977998|NCT01271855|3799995|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3977999|NCT01271855|3799996|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3978000|NCT01271855|3799997|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3978001|NCT01271855|3799995|B3|||Age||years|Mean|29.34|29.34|Standard Deviation|5.74|5.74|||
3978002|NCT01271855|3799996|B2|||Age||years|Mean|29.29|29.29|Standard Deviation|5.76|5.76|||
3978003|NCT01271855|3799997|B1|||Age||years|Mean|29.40|29.4|Standard Deviation|5.78|5.78|||
3978004|NCT01271803|3800008|B13||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3978005|NCT01271803|3800009|B12||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3978006|NCT01271803|3800010|B11||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3978007|NCT01271803|3800011|B10||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3978008|NCT01271803|3800012|B9||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3978009|NCT01271803|3800013|B8||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3978010|NCT01271803|3800014|B7||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3978011|NCT01271803|3800015|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3978012|NCT01271803|3800016|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3978013|NCT01271803|3800017|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3978014|NCT01271803|3800018|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3978015|NCT01271803|3800019|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3978016|NCT01271803|3800020|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3978017|NCT01271803|3800008|B13||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3978018|NCT01271803|3800009|B12||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3978019|NCT01271803|3800010|B11||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3978020|NCT01271803|3800011|B10||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3978021|NCT01271803|3800012|B9||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3978022|NCT01271803|3800013|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3978023|NCT01271803|3800014|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3978024|NCT01271803|3800015|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3978025|NCT01271803|3800016|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3978026|NCT01271803|3800017|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3978027|NCT01271803|3800018|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3978028|NCT01271803|3800019|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3978029|NCT01271803|3800020|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3978030|NCT01271803|3800008|B13|||Age||years|Mean|53.6|53.6|Standard Deviation|13.9|13.9|||
3978031|NCT01271803|3800009|B12|||Age||years|Mean|49.8|49.8|Standard Deviation|15.5|15.5|||
3978032|NCT01271803|3800010|B11|||Age||years|Mean|56.3|56.3|Standard Deviation|11.3|11.3|||
3978033|NCT01271803|3800011|B10|||Age||years|Mean|62.5|62.5|Standard Deviation|9.2|9.2|||
3978034|NCT01271803|3800012|B9|||Age||years|Mean|54.6|54.6|Standard Deviation|13.9|13.9|||
3978035|NCT01271803|3800013|B8|||Age||years|Mean|39.0|39.0|Standard Deviation|14.4|14.4|||
3978036|NCT01271803|3800014|B7|||Age||years|Mean|59.0|59.0|Standard Deviation|9.8|9.8|||
3978037|NCT01271803|3800015|B6|||Age||years|Mean|55.8|55.8|Standard Deviation|9.1|9.1|||
3978038|NCT01271803|3800016|B5|||Age||years|Mean|54.3|54.3|Standard Deviation|10.9|10.9|||
3978039|NCT01271803|3800017|B4|||Age||years|Mean|59.7|59.7|Standard Deviation|7.6|7.6|||
3978040|NCT01271803|3800018|B3|||Age||years|Mean|54.6|54.6|Standard Deviation|16.0|16.0|||
3978041|NCT01271803|3800019|B2|||Age||years|Mean|56.4|56.4|Standard Deviation|11.4|11.4|||
3978042|NCT01271803|3800020|B1|||Age||years|Mean|53.2|53.2|Standard Deviation|14.2|14.2|||
3978043|NCT01271712|3800202|B3|4th line and beyond||Prior anti-cancer drug group|3rd line: 3rd in sequence of multiple therapies: imatinib (1st); sunitinib (2nd). 4th line and beyond: 4th in sequence of multiple therapies: imatinib (1st); sunitinib (2nd); other (3rd).|Participants|Number|86|86.0||||||
3978044|NCT01271712|3800203|B2|4th line and beyond||Prior anti-cancer drug group|3rd line: 3rd in sequence of multiple therapies: imatinib (1st); sunitinib (2nd). 4th line and beyond: 4th in sequence of multiple therapies: imatinib (1st); sunitinib (2nd); other (3rd).|Participants|Number|27|27.0||||||
3978045|NCT01271712|3800204|B1|4th line and beyond||Prior anti-cancer drug group|3rd line: 3rd in sequence of multiple therapies: imatinib (1st); sunitinib (2nd). 4th line and beyond: 4th in sequence of multiple therapies: imatinib (1st); sunitinib (2nd); other (3rd).|Participants|Number|59|59.0||||||
3978046|NCT01271712|3800202|B3|3rd line||Prior anti-cancer drug group|3rd line: 3rd in sequence of multiple therapies: imatinib (1st); sunitinib (2nd). 4th line and beyond: 4th in sequence of multiple therapies: imatinib (1st); sunitinib (2nd); other (3rd).|Participants|Number|113|113.0||||||
3978047|NCT01271712|3800203|B2|3rd line||Prior anti-cancer drug group|3rd line: 3rd in sequence of multiple therapies: imatinib (1st); sunitinib (2nd). 4th line and beyond: 4th in sequence of multiple therapies: imatinib (1st); sunitinib (2nd); other (3rd).|Participants|Number|39|39.0||||||
3978065|NCT01271712|3800203|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3978066|NCT01271712|3800204|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3978048|NCT01271712|3800204|B1|3rd line||Prior anti-cancer drug group|3rd line: 3rd in sequence of multiple therapies: imatinib (1st); sunitinib (2nd). 4th line and beyond: 4th in sequence of multiple therapies: imatinib (1st); sunitinib (2nd); other (3rd).|Participants|Number|74|74.0||||||
3978049|NCT01271712|3800202|B3|Missing||ECOG Performance Status (PS)]|ECOG = Eastern cooperative oncology group PS levels are 0 (Fully active, able to carry on all pre-disease performance), 1 (ambulatory and able to carry out work of a light or sedentary), 2 (Ambulatory and capable of all selfcare but unable to carry out any work activities), 3 (Capable of only limited selfcare, confined to bed or chair more than 50% of awake time), 4 (Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair) and 5 (death).|Participants|Number|0|0.0||||||
3978050|NCT01271712|3800203|B2|Missing||ECOG Performance Status (PS)]|ECOG = Eastern cooperative oncology group PS levels are 0 (Fully active, able to carry on all pre-disease performance), 1 (ambulatory and able to carry out work of a light or sedentary), 2 (Ambulatory and capable of all selfcare but unable to carry out any work activities), 3 (Capable of only limited selfcare, confined to bed or chair more than 50% of awake time), 4 (Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair) and 5 (death).|Participants|Number|0|0.0||||||
3978051|NCT01271712|3800204|B1|Missing||ECOG Performance Status (PS)]|ECOG = Eastern cooperative oncology group PS levels are 0 (Fully active, able to carry on all pre-disease performance), 1 (ambulatory and able to carry out work of a light or sedentary), 2 (Ambulatory and capable of all selfcare but unable to carry out any work activities), 3 (Capable of only limited selfcare, confined to bed or chair more than 50% of awake time), 4 (Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair) and 5 (death).|Participants|Number|0|0.0||||||
3978052|NCT01271712|3800202|B3|PS 2||ECOG Performance Status (PS)]|ECOG = Eastern cooperative oncology group PS levels are 0 (Fully active, able to carry on all pre-disease performance), 1 (ambulatory and able to carry out work of a light or sedentary), 2 (Ambulatory and capable of all selfcare but unable to carry out any work activities), 3 (Capable of only limited selfcare, confined to bed or chair more than 50% of awake time), 4 (Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair) and 5 (death).|Participants|Number|0|0.0||||||
3978053|NCT01271712|3800203|B2|PS 2||ECOG Performance Status (PS)]|ECOG = Eastern cooperative oncology group PS levels are 0 (Fully active, able to carry on all pre-disease performance), 1 (ambulatory and able to carry out work of a light or sedentary), 2 (Ambulatory and capable of all selfcare but unable to carry out any work activities), 3 (Capable of only limited selfcare, confined to bed or chair more than 50% of awake time), 4 (Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair) and 5 (death).|Participants|Number|0|0.0||||||
3978054|NCT01271712|3800204|B1|PS 2||ECOG Performance Status (PS)]|ECOG = Eastern cooperative oncology group PS levels are 0 (Fully active, able to carry on all pre-disease performance), 1 (ambulatory and able to carry out work of a light or sedentary), 2 (Ambulatory and capable of all selfcare but unable to carry out any work activities), 3 (Capable of only limited selfcare, confined to bed or chair more than 50% of awake time), 4 (Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair) and 5 (death).|Participants|Number|0|0.0||||||
3978055|NCT01271712|3800202|B3|PS 1||ECOG Performance Status (PS)]|ECOG = Eastern cooperative oncology group PS levels are 0 (Fully active, able to carry on all pre-disease performance), 1 (ambulatory and able to carry out work of a light or sedentary), 2 (Ambulatory and capable of all selfcare but unable to carry out any work activities), 3 (Capable of only limited selfcare, confined to bed or chair more than 50% of awake time), 4 (Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair) and 5 (death).|Participants|Number|89|89.0||||||
3978056|NCT01271712|3800203|B2|PS 1||ECOG Performance Status (PS)]|ECOG = Eastern cooperative oncology group PS levels are 0 (Fully active, able to carry on all pre-disease performance), 1 (ambulatory and able to carry out work of a light or sedentary), 2 (Ambulatory and capable of all selfcare but unable to carry out any work activities), 3 (Capable of only limited selfcare, confined to bed or chair more than 50% of awake time), 4 (Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair) and 5 (death).|Participants|Number|29|29.0||||||
3978057|NCT01271712|3800204|B1|PS 1||ECOG Performance Status (PS)]|ECOG = Eastern cooperative oncology group PS levels are 0 (Fully active, able to carry on all pre-disease performance), 1 (ambulatory and able to carry out work of a light or sedentary), 2 (Ambulatory and capable of all selfcare but unable to carry out any work activities), 3 (Capable of only limited selfcare, confined to bed or chair more than 50% of awake time), 4 (Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair) and 5 (death).|Participants|Number|60|60.0||||||
3978058|NCT01271712|3800202|B3|PS 0||ECOG Performance Status (PS)]|ECOG = Eastern cooperative oncology group PS levels are 0 (Fully active, able to carry on all pre-disease performance), 1 (ambulatory and able to carry out work of a light or sedentary), 2 (Ambulatory and capable of all selfcare but unable to carry out any work activities), 3 (Capable of only limited selfcare, confined to bed or chair more than 50% of awake time), 4 (Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair) and 5 (death).|Participants|Number|110|110.0||||||
3978059|NCT01271712|3800203|B2|PS 0||ECOG Performance Status (PS)]|ECOG = Eastern cooperative oncology group PS levels are 0 (Fully active, able to carry on all pre-disease performance), 1 (ambulatory and able to carry out work of a light or sedentary), 2 (Ambulatory and capable of all selfcare but unable to carry out any work activities), 3 (Capable of only limited selfcare, confined to bed or chair more than 50% of awake time), 4 (Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair) and 5 (death).|Participants|Number|37|37.0||||||
3978060|NCT01271712|3800204|B1|PS 0||ECOG Performance Status (PS)]|ECOG = Eastern cooperative oncology group PS levels are 0 (Fully active, able to carry on all pre-disease performance), 1 (ambulatory and able to carry out work of a light or sedentary), 2 (Ambulatory and capable of all selfcare but unable to carry out any work activities), 3 (Capable of only limited selfcare, confined to bed or chair more than 50% of awake time), 4 (Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair) and 5 (death).|Participants|Number|73|73.0||||||
3978061|NCT01271712|3800202|B3||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3978062|NCT01271712|3800203|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3978063|NCT01271712|3800204|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3978064|NCT01271712|3800202|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3978067|NCT01271712|3800202|B3|||Age||Years|Mean|58.2|58.2|Standard Deviation|12.9|12.9|||
3978068|NCT01271712|3800203|B2|||Age||Years|Mean|58.1|58.1|Standard Deviation|13.9|13.9|||
3978069|NCT01271712|3800204|B1|||Age||Years|Mean|58.2|58.2|Standard Deviation|12.5|12.5|||
3978070|NCT01271686|3800226|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3978071|NCT01271686|3800226|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978072|NCT01271686|3800226|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3978073|NCT01271686|3800226|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3978074|NCT01271686|3800226|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978075|NCT01271686|3800226|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978076|NCT01271686|3800226|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3978077|NCT01271686|3800226|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3978078|NCT01271686|3800226|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978079|NCT01271686|3800226|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3978080|NCT01271686|3800226|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978081|NCT01271686|3800226|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3978082|NCT01271686|3800226|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3978083|NCT01271686|3800226|B1|||Age||years|Mean|61|61.0|Standard Deviation|8.5|8.5|||
3978084|NCT01271543|3800230|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
3978085|NCT01271543|3800231|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3978086|NCT01271543|3800232|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3978087|NCT01271543|3800230|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3978088|NCT01271543|3800231|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3978089|NCT01271543|3800232|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3978090|NCT01271543|3800230|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3978091|NCT01271543|3800231|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3978092|NCT01271543|3800232|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3978093|NCT01271543|3800230|B3|||Age||years|Mean|39.5|39.5|Standard Deviation|13|13.0|||
3978094|NCT01271543|3800231|B2|||Age||years|Mean|39.6|39.6|Standard Deviation|13|13.0|||
3978095|NCT01271543|3800232|B1|||Age||years|Mean|39.1|39.1|Standard Deviation|11|11.0|||
3978096|NCT01271543|3800230|B3||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
3978097|NCT01271543|3800231|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3978098|NCT01271543|3800232|B1||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
3978099|NCT01271543|3800230|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3978100|NCT01271543|3800231|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3978101|NCT01271543|3800232|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3978102|NCT01271543|3800230|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3978103|NCT01271543|3800231|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3978104|NCT01271543|3800232|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3978105|NCT01271452|3800241|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3978106|NCT01271452|3800242|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3978107|NCT01271452|3800243|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3978108|NCT01271452|3800241|B3||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
3978109|NCT01271452|3800242|B2||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3978110|NCT01271452|3800243|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3978111|NCT01271452|3800241|B3|||Age||years|Mean|45.2|45.2|Standard Deviation|10.30|10.3|||
3978112|NCT01271452|3800242|B2|||Age||years|Mean|45.4|45.4|Standard Deviation|9.82|9.82|||
3978113|NCT01271452|3800243|B1|||Age||years|Mean|45.0|45.0|Standard Deviation|10.80|10.8|||
3978114|NCT01271413|3800264|B3|United States||Region of Enrollment||participants|Number|56|56.0||||||
3978115|NCT01271413|3800265|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
3978116|NCT01271413|3800266|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
3978117|NCT01271413|3800264|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3978118|NCT01271413|3800265|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3978119|NCT01271413|3800266|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3978120|NCT01271413|3800264|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3978121|NCT01271413|3800265|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3978122|NCT01271413|3800266|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3978123|NCT01271413|3800264|B3|||Age||years|Mean|43.4|43.4|Standard Deviation|7.9|7.9|||
3978124|NCT01271413|3800265|B2|||Age||years|Mean|43.5|43.5|Standard Deviation|7.1|7.1|||
3978125|NCT01271413|3800266|B1|||Age||years|Mean|43.3|43.3|Standard Deviation|8.8|8.8|||
3978126|NCT01271244|3800273|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
3978127|NCT01271244|3800274|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
3978128|NCT01271244|3800275|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3978129|NCT01271244|3800273|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3978130|NCT01271244|3800274|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3978131|NCT01271244|3800275|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3978132|NCT01271244|3800273|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3978133|NCT01271244|3800274|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3978134|NCT01271244|3800275|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3978135|NCT01271244|3800273|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3978136|NCT01271244|3800274|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3978137|NCT01271244|3800275|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3978138|NCT01271244|3800273|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3978139|NCT01271244|3800274|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3978140|NCT01271244|3800275|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3978141|NCT01271244|3800273|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3978142|NCT01271244|3800274|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3978143|NCT01271244|3800275|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3978144|NCT01271244|3800273|B3|||Age||YEARS|Mean|29|29.0|Standard Deviation|1.41|1.41|||
3978145|NCT01271244|3800274|B2|||Age||YEARS|Mean|30|30.0|Standard Deviation|4.1|4.1|||
3978146|NCT01271244|3800275|B1|||Age||YEARS|Mean|28.3|28.3|Standard Deviation|2.4|2.4|||
3978147|NCT01271036|3800282|B3|Couple with Both Partners with Sensitive Skin||Total Couples with Sensitive Skin||participants|Number|26|26.0||||||
3978148|NCT01271036|3800283|B2|Couple with Both Partners with Sensitive Skin||Total Couples with Sensitive Skin||participants|Number|13|13.0||||||
3978149|NCT01271036|3800284|B1|Couple with Both Partners with Sensitive Skin||Total Couples with Sensitive Skin||participants|Number|13|13.0||||||
3978150|NCT01271036|3800282|B3|Couple with Female Partner with Sensitive Skin||Total Couples with Sensitive Skin||participants|Number|46|46.0||||||
3978151|NCT01271036|3800283|B2|Couple with Female Partner with Sensitive Skin||Total Couples with Sensitive Skin||participants|Number|46|46.0||||||
3978152|NCT01271036|3800284|B1|Couple with Female Partner with Sensitive Skin||Total Couples with Sensitive Skin||participants|Number|0|0.0||||||
3978153|NCT01271036|3800282|B3|Couple with Male Partner with Sensitive Skin||Total Couples with Sensitive Skin||participants|Number|3|3.0||||||
3978154|NCT01271036|3800283|B2|Couple with Male Partner with Sensitive Skin||Total Couples with Sensitive Skin||participants|Number|0|0.0||||||
3978155|NCT01271036|3800284|B1|Couple with Male Partner with Sensitive Skin||Total Couples with Sensitive Skin||participants|Number|3|3.0||||||
3978156|NCT01271036|3800282|B3|Postmenopausal||Menopausal Status||Participants|Number|16|16.0||||||
3978157|NCT01271036|3800283|B2|Postmenopausal||Menopausal Status||Participants|Number|16|16.0||||||
3978158|NCT01271036|3800284|B1|Postmenopausal||Menopausal Status||Participants|Number|NA|||||||Data Not Available because menopausal status is not applicable to male subjects.
3978159|NCT01271036|3800282|B3|Premenopausal||Menopausal Status||Participants|Number|46|46.0||||||
3978160|NCT01271036|3800283|B2|Premenopausal||Menopausal Status||Participants|Number|46|46.0||||||
3978161|NCT01271036|3800284|B1|Premenopausal||Menopausal Status||Participants|Number|NA|||||||Data Not Available because menopausal status is not applicable to male subjects.
3978162|NCT01271036|3800282|B3|United States||Region of Enrollment||participants|Number|124|124.0||||||
3978163|NCT01271036|3800283|B2|United States||Region of Enrollment||participants|Number|62|62.0||||||
3978164|NCT01271036|3800284|B1|United States||Region of Enrollment||participants|Number|62|62.0||||||
3978165|NCT01271036|3800282|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978166|NCT01271036|3800283|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978167|NCT01271036|3800284|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978168|NCT01271036|3800282|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3978169|NCT01271036|3800283|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3978170|NCT01271036|3800284|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3978171|NCT01271036|3800282|B3||White|Race (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
3978172|NCT01271036|3800283|B2||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3978173|NCT01271036|3800284|B1||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3978174|NCT01271036|3800282|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3978175|NCT01271036|3800283|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3978176|NCT01271036|3800284|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3978177|NCT01271036|3800282|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978178|NCT01271036|3800283|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978179|NCT01271036|3800284|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978180|NCT01271036|3800282|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3978181|NCT01271036|3800283|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3978182|NCT01271036|3800284|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978183|NCT01271036|3800282|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3978184|NCT01271036|3800283|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3978185|NCT01271036|3800284|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978186|NCT01271036|3800282|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
3978187|NCT01271036|3800283|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3978188|NCT01271036|3800284|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3978189|NCT01271036|3800282|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978190|NCT01271036|3800283|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978191|NCT01271036|3800284|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978192|NCT01271036|3800282|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978193|NCT01271036|3800283|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978194|NCT01271036|3800284|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978195|NCT01271036|3800282|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3978196|NCT01271036|3800283|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3978197|NCT01271036|3800284|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3978198|NCT01271036|3800282|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3978199|NCT01271036|3800283|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3978200|NCT01271036|3800284|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3978201|NCT01271036|3800282|B3|||Age||years|Mean|42.8|42.8|Standard Deviation|13.3|13.3|||
3978202|NCT01271036|3800283|B2|||Age||years|Mean|42.0|42.0|Standard Deviation|12.7|12.7|||
3978203|NCT01271036|3800284|B1|||Age||years|Mean|43.6|43.6|Standard Deviation|13.8|13.8|||
3978204|NCT01271010|3800299|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3978205|NCT01271010|3800299|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3978206|NCT01271010|3800299|B1|||Age||years|Mean|55.9|55.9|Standard Deviation|6.39|6.39|||
3978207|NCT01270971|3800312|B3|Mexico||Region of Enrollment||participants|Number|89|89.0||||||
3978208|NCT01270971|3800313|B2|Mexico||Region of Enrollment||participants|Number|30|30.0||||||
3978209|NCT01270971|3800314|B1|Mexico||Region of Enrollment||participants|Number|59|59.0||||||
3978210|NCT01270971|3800312|B3|United States||Region of Enrollment||participants|Number|504|504.0||||||
3978211|NCT01270971|3800313|B2|United States||Region of Enrollment||participants|Number|164|164.0||||||
3978212|NCT01270971|3800314|B1|United States||Region of Enrollment||participants|Number|340|340.0||||||
3978213|NCT01270971|3800312|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
3978214|NCT01270971|3800313|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3978215|NCT01270971|3800314|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3978216|NCT01270971|3800312|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978217|NCT01270971|3800313|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978218|NCT01270971|3800314|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978219|NCT01270971|3800312|B3||White|Race (NIH/OMB)||Participants|Count of Participants|468|468.0||||||
3978220|NCT01270971|3800313|B2||White|Race (NIH/OMB)||Participants|Count of Participants|152|152.0||||||
3978221|NCT01270971|3800314|B1||White|Race (NIH/OMB)||Participants|Count of Participants|316|316.0||||||
3978222|NCT01270971|3800312|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3978223|NCT01270971|3800313|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3978224|NCT01270971|3800314|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3978225|NCT01270971|3800312|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978226|NCT01270971|3800313|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978227|NCT01270971|3800314|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978228|NCT01270971|3800312|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3978229|NCT01270971|3800313|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978230|NCT01270971|3800314|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3978231|NCT01270971|3800312|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978232|NCT01270971|3800313|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978233|NCT01270971|3800314|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978234|NCT01270971|3800312|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978235|NCT01270971|3800313|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978236|NCT01270971|3800314|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978237|NCT01270971|3800312|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|440|440.0||||||
3978238|NCT01270971|3800313|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
3978239|NCT01270971|3800314|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|300|300.0||||||
3978240|NCT01270971|3800312|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|153|153.0||||||
3978241|NCT01270971|3800313|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3978242|NCT01270971|3800314|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
3978243|NCT01270971|3800312|B3||Male|Sex: Female, Male||Participants|Count of Participants|482|482.0||||||
3978244|NCT01270971|3800313|B2||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3978245|NCT01270971|3800314|B1||Male|Sex: Female, Male||Participants|Count of Participants|324|324.0||||||
3978246|NCT01270971|3800312|B3||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3978247|NCT01270971|3800313|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3978248|NCT01270971|3800314|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3978249|NCT01270971|3800312|B3|Age||Age||years|Mean|53.5|53.5|Standard Deviation|12.4|12.4|||
3978250|NCT01270971|3800313|B2|Age||Age||years|Mean|53.4|53.4|Standard Deviation|12.3|12.3|||
3978251|NCT01270971|3800314|B1|Age||Age||years|Mean|53.6|53.6|Standard Deviation|12.5|12.5|||
3978252|NCT01270958|3800327|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3978253|NCT01270958|3800327|B1|Vietnamese||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
3978254|NCT01270958|3800327|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3978255|NCT01270958|3800327|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3978256|NCT01270958|3800327|B1|||Age||Years|Mean|35.5|35.5|Standard Deviation|11.5|11.5|||
3978257|NCT01270880|3800356|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3978258|NCT01270880|3800356|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3978259|NCT01270880|3800356|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3978260|NCT01270880|3800356|B1|||Age||years|Median|68|68.0|Full Range|||51.0|82.0|
3978261|NCT01270867|3800365|B3|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3978262|NCT01270867|3800366|B2|Spain||Region of Enrollment||participants|Number|0|0.0||||||
3978263|NCT01270867|3800367|B1|Spain||Region of Enrollment||participants|Number|1|1.0||||||
3978264|NCT01270867|3800365|B3|United States||Region of Enrollment||participants|Number|177|177.0||||||
3978265|NCT01270867|3800366|B2|United States||Region of Enrollment||participants|Number|88|88.0||||||
3978266|NCT01270867|3800367|B1|United States||Region of Enrollment||participants|Number|89|89.0||||||
3978267|NCT01270867|3800365|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3978268|NCT01270867|3800366|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3978269|NCT01270867|3800367|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3978270|NCT01270867|3800365|B3||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3978271|NCT01270867|3800366|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3978272|NCT01270867|3800367|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3978273|NCT01270867|3800365|B3|||Age||years|Mean|67.2|67.2|Standard Deviation|14.2|14.2|||
3978274|NCT01270867|3800366|B2|||Age||years|Mean|67.4|67.4|Standard Deviation|13.9|13.9|||
3978275|NCT01270867|3800367|B1|||Age||years|Mean|67.0|67.0|Standard Deviation|14.7|14.7|||
3978276|NCT01270841|3800382|B5|||BMI||kg/m2|Mean|32.1|32.1|Standard Deviation|5.1|5.1|||
3978277|NCT01270841|3800383|B4|||BMI||kg/m2|Mean|31.7|31.7|Standard Deviation|4.9|4.9|||
3978278|NCT01270841|3800384|B3|||BMI||kg/m2|Mean|32.6|32.6|Standard Deviation|5.2|5.2|||
3978279|NCT01270841|3800385|B2|||BMI||kg/m2|Mean|33.1|33.1|Standard Deviation|5.9|5.9|||
3978280|NCT01270841|3800386|B1|||BMI||kg/m2|Mean|30.9|30.9|Standard Deviation|4.2|4.2|||
3978281|NCT01270841|3800382|B5|United States||Region of Enrollment||participants|Number|121|121.0||||||
3978282|NCT01270841|3800383|B4|United States||Region of Enrollment||participants|Number|33|33.0||||||
3978283|NCT01270841|3800384|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
3978284|NCT01270841|3800385|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
3978285|NCT01270841|3800386|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
3978286|NCT01270841|3800382|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978287|NCT01270841|3800383|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978288|NCT01270841|3800384|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978289|NCT01270841|3800385|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978290|NCT01270841|3800386|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978291|NCT01270841|3800382|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978292|NCT01270841|3800383|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978293|NCT01270841|3800384|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978294|NCT01270841|3800385|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978295|NCT01270841|3800386|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978296|NCT01270841|3800382|B5||White|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3978297|NCT01270841|3800383|B4||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3978298|NCT01270841|3800384|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3978299|NCT01270841|3800385|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3978300|NCT01270841|3800386|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3978301|NCT01270841|3800382|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3978302|NCT01270841|3800383|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3978303|NCT01270841|3800384|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3978304|NCT01270841|3800385|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3978305|NCT01270841|3800386|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3978306|NCT01270841|3800382|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3978307|NCT01270841|3800383|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978308|NCT01270841|3800384|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3978309|NCT01270841|3800385|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978310|NCT01270841|3800386|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978311|NCT01270841|3800382|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3978312|NCT01270841|3800383|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3978313|NCT01270841|3800384|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3978314|NCT01270841|3800385|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3978315|NCT01270841|3800386|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3978316|NCT01270841|3800382|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3978317|NCT01270841|3800383|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3978318|NCT01270841|3800384|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3978319|NCT01270841|3800385|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978320|NCT01270841|3800386|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978321|NCT01270841|3800382|B5||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3978322|NCT01270841|3800383|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3978323|NCT01270841|3800384|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3978324|NCT01270841|3800385|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3978325|NCT01270841|3800386|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3978326|NCT01270841|3800382|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3978327|NCT01270841|3800383|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3978328|NCT01270841|3800384|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3978329|NCT01270841|3800385|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3978330|NCT01270841|3800386|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3978331|NCT01270841|3800382|B5|||Age||years|Mean|50.6|50.6|Standard Deviation|11.2|11.2|||
3978332|NCT01270841|3800383|B4|||Age||years|Mean|49.2|49.2|Standard Deviation|10.9|10.9|||
3978333|NCT01270841|3800384|B3|||Age||years|Mean|49.7|49.7|Standard Deviation|11.6|11.6|||
3978334|NCT01270841|3800385|B2|||Age||years|Mean|52.0|52.0|Standard Deviation|10.6|10.6|||
3978335|NCT01270841|3800386|B1|||Age||years|Mean|51.6|51.6|Standard Deviation|11.7|11.7|||
3978336|NCT01270828|3800411|B3||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
3978337|NCT01270828|3800412|B2||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3978338|NCT01270828|3800413|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3978339|NCT01270828|3800411|B3||Female|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
3978340|NCT01270828|3800412|B2||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3978341|NCT01270828|3800413|B1||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3978342|NCT01270828|3800411|B3|≥65 years||Age, Customized||Participants|Number|199|199.0||||||
3978343|NCT01270828|3800412|B2|≥65 years||Age, Customized||Participants|Number|103|103.0||||||
3978344|NCT01270828|3800413|B1|≥65 years||Age, Customized||Participants|Number|96|96.0||||||
3978345|NCT01270828|3800411|B3|45-64 years||Age, Customized||Participants|Number|164|164.0||||||
3978346|NCT01270828|3800412|B2|45-64 years||Age, Customized||Participants|Number|78|78.0||||||
3978347|NCT01270828|3800413|B1|45-64 years||Age, Customized||Participants|Number|86|86.0||||||
3978348|NCT01270828|3800411|B3|18-44 years||Age, Customized||Participants|Number|50|50.0||||||
3978349|NCT01270828|3800412|B2|18-44 years||Age, Customized||Participants|Number|24|24.0||||||
3978350|NCT01270828|3800413|B1|18-44 years||Age, Customized||Participants|Number|26|26.0||||||
3978351|NCT01270828|3800411|B3|<18 years||Age, Customized||Participants|Number|0|0.0||||||
3978352|NCT01270828|3800412|B2|<18 years||Age, Customized||Participants|Number|0|0.0||||||
3978353|NCT01270828|3800413|B1|<18 years||Age, Customized||Participants|Number|0|0.0||||||
3978354|NCT01270802|3800455|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3978355|NCT01270802|3800456|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3978356|NCT01270802|3800457|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3978357|NCT01270802|3800455|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3978358|NCT01270802|3800456|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3978359|NCT01270802|3800457|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3978360|NCT01270802|3800455|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3978361|NCT01270802|3800456|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3978362|NCT01270802|3800457|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3978363|NCT01270802|3800455|B3|||Age||years|Mean|39|39.0|Standard Deviation|11|11.0|||
3978364|NCT01270802|3800456|B2|||Age||years|Mean|39|39.0|Standard Deviation|10.6|10.6|||
3978365|NCT01270802|3800457|B1|||Age||years|Mean|38|38.0|Standard Deviation|12|12.0|||
3978366|NCT01270802|3800455|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3978367|NCT01270802|3800456|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3978368|NCT01270802|3800457|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3978369|NCT01270802|3800455|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3978370|NCT01270802|3800456|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3978371|NCT01270802|3800457|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3978372|NCT01270802|3800455|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3978373|NCT01270802|3800456|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3978374|NCT01270802|3800457|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3978375|NCT01270711|3800466|B9||Male|Sex: Female, Male||Participants|Count of Participants|1454|1454.0||||||
3978376|NCT01270711|3800467|B8||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3978377|NCT01270711|3800468|B7||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3978378|NCT01270711|3800469|B6||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3978379|NCT01270711|3800470|B5||Male|Sex: Female, Male||Participants|Count of Participants|556|556.0||||||
3978380|NCT01270711|3800471|B4||Male|Sex: Female, Male||Participants|Count of Participants|306|306.0||||||
3978381|NCT01270711|3800472|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3978382|NCT01270711|3800473|B2||Male|Sex: Female, Male||Participants|Count of Participants|400|400.0||||||
3978383|NCT01270711|3800474|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3978384|NCT01270711|3800466|B9||Female|Sex: Female, Male||Participants|Count of Participants|20560|20560.0||||||
3978385|NCT01270711|3800467|B8||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3978386|NCT01270711|3800468|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3978387|NCT01270711|3800469|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3978388|NCT01270711|3800470|B5||Female|Sex: Female, Male||Participants|Count of Participants|1468|1468.0||||||
3978389|NCT01270711|3800471|B4||Female|Sex: Female, Male||Participants|Count of Participants|5180|5180.0||||||
3978390|NCT01270711|3800472|B3||Female|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
3978391|NCT01270711|3800473|B2||Female|Sex: Female, Male||Participants|Count of Participants|6180|6180.0||||||
3978392|NCT01270711|3800474|B1||Female|Sex: Female, Male||Participants|Count of Participants|7429|7429.0||||||
3978393|NCT01270711|3800466|B9|Part 2, Effectiveness||Age, Customized|Age is stratified by Part 1 and Part 2, in Part 1 age is further stratified by indication, cabergoline use for prolactin reduction indication (ATC [Anatomical Therapeutic Code] G02CB03) and neurological indication (ATC N04BC06).|years|Mean|63.3|63.3|Standard Deviation|12.5|12.5|||
3978394|NCT01270711|3800467|B8|Part 2, Effectiveness||Age, Customized|Age is stratified by Part 1 and Part 2, in Part 1 age is further stratified by indication, cabergoline use for prolactin reduction indication (ATC [Anatomical Therapeutic Code] G02CB03) and neurological indication (ATC N04BC06).|years|Mean|63.7|63.7|Standard Deviation|13.9|13.9|||
3978395|NCT01270711|3800468|B7|Part 2, Effectiveness||Age, Customized|Age is stratified by Part 1 and Part 2, in Part 1 age is further stratified by indication, cabergoline use for prolactin reduction indication (ATC [Anatomical Therapeutic Code] G02CB03) and neurological indication (ATC N04BC06).|years|Mean|58.7|58.7|Standard Deviation|8.5|8.5|||
3978396|NCT01270711|3800469|B6|Part 2, Effectiveness||Age, Customized|Age is stratified by Part 1 and Part 2, in Part 1 age is further stratified by indication, cabergoline use for prolactin reduction indication (ATC [Anatomical Therapeutic Code] G02CB03) and neurological indication (ATC N04BC06).|years|Mean|62.7|62.7|Standard Deviation|5.6|5.6|||
3978397|NCT01270711|3800470|B5|Part 2, Effectiveness||Age, Customized|Age is stratified by Part 1 and Part 2, in Part 1 age is further stratified by indication, cabergoline use for prolactin reduction indication (ATC [Anatomical Therapeutic Code] G02CB03) and neurological indication (ATC N04BC06).|years|Mean|NA||Standard Deviation|NA||||This arm is used for Part 1, Compliance.
3978398|NCT01270711|3800471|B4|Part 2, Effectiveness||Age, Customized|Age is stratified by Part 1 and Part 2, in Part 1 age is further stratified by indication, cabergoline use for prolactin reduction indication (ATC [Anatomical Therapeutic Code] G02CB03) and neurological indication (ATC N04BC06).|years|Mean|NA||Standard Deviation|NA||||This arm is used for Part 1, Compliance.
3978399|NCT01270711|3800472|B3|Part 2, Effectiveness||Age, Customized|Age is stratified by Part 1 and Part 2, in Part 1 age is further stratified by indication, cabergoline use for prolactin reduction indication (ATC [Anatomical Therapeutic Code] G02CB03) and neurological indication (ATC N04BC06).|years|Mean|NA||Standard Deviation|NA||||This arm is used for Part 1, Compliance.
3978400|NCT01270711|3800473|B2|Part 2, Effectiveness||Age, Customized|Age is stratified by Part 1 and Part 2, in Part 1 age is further stratified by indication, cabergoline use for prolactin reduction indication (ATC [Anatomical Therapeutic Code] G02CB03) and neurological indication (ATC N04BC06).|years|Mean|NA||Standard Deviation|NA||||This arm is used for Part 1, Compliance.
3978401|NCT01270711|3800474|B1|Part 2, Effectiveness||Age, Customized|Age is stratified by Part 1 and Part 2, in Part 1 age is further stratified by indication, cabergoline use for prolactin reduction indication (ATC [Anatomical Therapeutic Code] G02CB03) and neurological indication (ATC N04BC06).|years|Mean|NA||Standard Deviation|NA||||This arm is used for Part 1, Compliance.
3978402|NCT01270711|3800466|B9|Part 1, Compliance: N04BC06||Age, Customized|Age is stratified by Part 1 and Part 2, in Part 1 age is further stratified by indication, cabergoline use for prolactin reduction indication (ATC [Anatomical Therapeutic Code] G02CB03) and neurological indication (ATC N04BC06).|years|Mean|70.4|70.4|Standard Deviation|13.0|13.0|||
3978403|NCT01270711|3800467|B8|Part 1, Compliance: N04BC06||Age, Customized|Age is stratified by Part 1 and Part 2, in Part 1 age is further stratified by indication, cabergoline use for prolactin reduction indication (ATC [Anatomical Therapeutic Code] G02CB03) and neurological indication (ATC N04BC06).|years|Mean|NA||Standard Deviation|NA||||This arm is used for Part 2, Effectiveness.
3978404|NCT01270711|3800468|B7|Part 1, Compliance: N04BC06||Age, Customized|Age is stratified by Part 1 and Part 2, in Part 1 age is further stratified by indication, cabergoline use for prolactin reduction indication (ATC [Anatomical Therapeutic Code] G02CB03) and neurological indication (ATC N04BC06).|years|Mean|NA||Standard Deviation|NA||||This arm is used for Part 2, Effectiveness.
3978405|NCT01270711|3800469|B6|Part 1, Compliance: N04BC06||Age, Customized|Age is stratified by Part 1 and Part 2, in Part 1 age is further stratified by indication, cabergoline use for prolactin reduction indication (ATC [Anatomical Therapeutic Code] G02CB03) and neurological indication (ATC N04BC06).|years|Mean|NA||Standard Deviation|NA||||This arm is used for Part 2, Effectiveness.
3978406|NCT01270711|3800470|B5|Part 1, Compliance: N04BC06||Age, Customized|Age is stratified by Part 1 and Part 2, in Part 1 age is further stratified by indication, cabergoline use for prolactin reduction indication (ATC [Anatomical Therapeutic Code] G02CB03) and neurological indication (ATC N04BC06).|years|Mean|69.7|69.7|Standard Deviation|13.6|13.6|||
3978407|NCT01270711|3800471|B4|Part 1, Compliance: N04BC06||Age, Customized|Age is stratified by Part 1 and Part 2, in Part 1 age is further stratified by indication, cabergoline use for prolactin reduction indication (ATC [Anatomical Therapeutic Code] G02CB03) and neurological indication (ATC N04BC06).|years|Mean|NA||Standard Deviation|NA||||Data not reported as no participants were included in this arm for specified indication.
3978408|NCT01270711|3800472|B3|Part 1, Compliance: N04BC06||Age, Customized|Age is stratified by Part 1 and Part 2, in Part 1 age is further stratified by indication, cabergoline use for prolactin reduction indication (ATC [Anatomical Therapeutic Code] G02CB03) and neurological indication (ATC N04BC06).|years|Mean|NA||Standard Deviation|NA||||Data not reported as no participants were included in this arm for specified indication.
3978409|NCT01270711|3800473|B2|Part 1, Compliance: N04BC06||Age, Customized|Age is stratified by Part 1 and Part 2, in Part 1 age is further stratified by indication, cabergoline use for prolactin reduction indication (ATC [Anatomical Therapeutic Code] G02CB03) and neurological indication (ATC N04BC06).|years|Mean|73.1|73.1|Standard Deviation|11.3|11.3|||
3978410|NCT01270711|3800474|B1|Part 1, Compliance: N04BC06||Age, Customized|Age is stratified by Part 1 and Part 2, in Part 1 age is further stratified by indication, cabergoline use for prolactin reduction indication (ATC [Anatomical Therapeutic Code] G02CB03) and neurological indication (ATC N04BC06).|years|Mean|66.4|66.4|Standard Deviation|13.2|13.2|||
3978411|NCT01270711|3800466|B9|Part 1, Compliance: G02CB03||Age, Customized|Age is stratified by Part 1 and Part 2, in Part 1 age is further stratified by indication, cabergoline use for prolactin reduction indication (ATC [Anatomical Therapeutic Code] G02CB03) and neurological indication (ATC N04BC06).|years|Mean|40.8|40.8|Standard Deviation|14.8|14.8|||
3978412|NCT01270711|3800467|B8|Part 1, Compliance: G02CB03||Age, Customized|Age is stratified by Part 1 and Part 2, in Part 1 age is further stratified by indication, cabergoline use for prolactin reduction indication (ATC [Anatomical Therapeutic Code] G02CB03) and neurological indication (ATC N04BC06).|years|Mean|NA||Standard Deviation|NA||||This arm is used for Part 2, Effectiveness.
3978413|NCT01270711|3800468|B7|Part 1, Compliance: G02CB03||Age, Customized|Age is stratified by Part 1 and Part 2, in Part 1 age is further stratified by indication, cabergoline use for prolactin reduction indication (ATC [Anatomical Therapeutic Code] G02CB03) and neurological indication (ATC N04BC06).|years|Mean|NA||Standard Deviation|NA||||This arm is used for Part 2, Effectiveness.
3978414|NCT01270711|3800469|B6|Part 1, Compliance: G02CB03||Age, Customized|Age is stratified by Part 1 and Part 2, in Part 1 age is further stratified by indication, cabergoline use for prolactin reduction indication (ATC [Anatomical Therapeutic Code] G02CB03) and neurological indication (ATC N04BC06).|years|Mean|NA||Standard Deviation|NA||||This arm is used for Part 2, Effectiveness.
3978415|NCT01270711|3800470|B5|Part 1, Compliance: G02CB03||Age, Customized|Age is stratified by Part 1 and Part 2, in Part 1 age is further stratified by indication, cabergoline use for prolactin reduction indication (ATC [Anatomical Therapeutic Code] G02CB03) and neurological indication (ATC N04BC06).|years|Mean|47.1|47.1|Standard Deviation|16.2|16.2|||
3978416|NCT01270711|3800471|B4|Part 1, Compliance: G02CB03||Age, Customized|Age is stratified by Part 1 and Part 2, in Part 1 age is further stratified by indication, cabergoline use for prolactin reduction indication (ATC [Anatomical Therapeutic Code] G02CB03) and neurological indication (ATC N04BC06).|years|Mean|41.3|41.3|Standard Deviation|15.8|15.8|||
3978417|NCT01270711|3800472|B3|Part 1, Compliance: G02CB03||Age, Customized|Age is stratified by Part 1 and Part 2, in Part 1 age is further stratified by indication, cabergoline use for prolactin reduction indication (ATC [Anatomical Therapeutic Code] G02CB03) and neurological indication (ATC N04BC06).|years|Mean|42.1|42.1|Standard Deviation|14.0|14.0|||
3978418|NCT01270711|3800473|B2|Part 1, Compliance: G02CB03||Age, Customized|Age is stratified by Part 1 and Part 2, in Part 1 age is further stratified by indication, cabergoline use for prolactin reduction indication (ATC [Anatomical Therapeutic Code] G02CB03) and neurological indication (ATC N04BC06).|years|Mean|39.0|39.0|Standard Deviation|12.3|12.3|||
3978419|NCT01270711|3800474|B1|Part 1, Compliance: G02CB03||Age, Customized|Age is stratified by Part 1 and Part 2, in Part 1 age is further stratified by indication, cabergoline use for prolactin reduction indication (ATC [Anatomical Therapeutic Code] G02CB03) and neurological indication (ATC N04BC06).|years|Mean|33.6|33.6|Standard Deviation|10.7|10.7|||
3978420|NCT01270659|3800578|B5|United States||Region of Enrollment||participants|Number|60|60.0||||||
3978421|NCT01270659|3800579|B4|United States||Region of Enrollment||participants|Number|25|25.0||||||
3978422|NCT01270659|3800580|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3978423|NCT01270659|3800581|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3978424|NCT01270659|3800582|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3978425|NCT01270659|3800578|B5|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3978426|NCT01270659|3800579|B4|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3978427|NCT01270659|3800580|B3|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3978428|NCT01270659|3800581|B2|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3978429|NCT01270659|3800582|B1|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3978430|NCT01270659|3800578|B5|Race/Ethnicity|American Indian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3978431|NCT01270659|3800579|B4|Race/Ethnicity|American Indian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3978432|NCT01270659|3800580|B3|Race/Ethnicity|American Indian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3978433|NCT01270659|3800581|B2|Race/Ethnicity|American Indian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3978434|NCT01270659|3800582|B1|Race/Ethnicity|American Indian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3978435|NCT01270659|3800578|B5|Race/Ethnicity|Black|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3978436|NCT01270659|3800579|B4|Race/Ethnicity|Black|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3978437|NCT01270659|3800580|B3|Race/Ethnicity|Black|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3978438|NCT01270659|3800581|B2|Race/Ethnicity|Black|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3978439|NCT01270659|3800582|B1|Race/Ethnicity|Black|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3978440|NCT01270659|3800578|B5|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
3978441|NCT01270659|3800579|B4|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3978442|NCT01270659|3800580|B3|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3978443|NCT01270659|3800581|B2|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3978444|NCT01270659|3800582|B1|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3978445|NCT01270659|3800578|B5||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3978446|NCT01270659|3800579|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3978447|NCT01270659|3800580|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3978448|NCT01270659|3800581|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3978449|NCT01270659|3800582|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3978450|NCT01270659|3800578|B5||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3978451|NCT01270659|3800579|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3978452|NCT01270659|3800580|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3978453|NCT01270659|3800581|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3978454|NCT01270659|3800582|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3978455|NCT01270659|3800578|B5|||Age||years|Mean|35.6|35.6|Standard Deviation|12.9|12.9|||
3978456|NCT01270659|3800579|B4|||Age||years|Mean|35.4|35.4|Standard Deviation|11.9|11.9|||
3978457|NCT01270659|3800580|B3|||Age||years|Mean|34.0|34.0|Standard Deviation|13.1|13.1|||
3978458|NCT01270659|3800581|B2|||Age||years|Mean|38.4|38.4|Standard Deviation|13.7|13.7|||
3978459|NCT01270659|3800582|B1|||Age||years|Mean|25.5|25.5|Standard Deviation|10.01|10.01|||
3978460|NCT01270659|3800578|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3978461|NCT01270659|3800579|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3978462|NCT01270659|3800580|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3978463|NCT01270659|3800581|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3978464|NCT01270659|3800582|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3978465|NCT01270659|3800578|B5||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
3978466|NCT01270659|3800579|B4||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3978467|NCT01270659|3800580|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3978468|NCT01270659|3800581|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3978469|NCT01270659|3800582|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3978470|NCT01270659|3800578|B5||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3978471|NCT01270659|3800579|B4||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3978472|NCT01270659|3800580|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3978473|NCT01270659|3800581|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3978474|NCT01270659|3800582|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3978475|NCT01270620|3800603|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
3978476|NCT01270620|3800604|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
3978477|NCT01270620|3800605|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3978478|NCT01270620|3800603|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3978479|NCT01270620|3800604|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3978480|NCT01270620|3800605|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3978481|NCT01270620|3800603|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3978482|NCT01270620|3800604|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3978483|NCT01270620|3800605|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3978484|NCT01270620|3800603|B3|||Age||years|Mean|70.5|70.5|Standard Deviation|4.6|4.6|||
3978485|NCT01270620|3800604|B2|||Age||years|Mean|71|71.0|Standard Deviation|5.8|5.8|||
3978486|NCT01270620|3800605|B1|||Age||years|Mean|70|70.0|Standard Deviation|4.0|4.0|||
3978487|NCT01270620|3800603|B3||>=65 years|Age||Participants|Count of Participants|100|100.0||||||
3978488|NCT01270620|3800604|B2||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
3978489|NCT01270620|3800605|B1||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
3978490|NCT01270620|3800603|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3978491|NCT01270620|3800604|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3978492|NCT01270620|3800605|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3978493|NCT01270620|3800603|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3978494|NCT01270620|3800604|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3978495|NCT01270620|3800605|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3978496|NCT01270581|3800656|B3||Male|Gender||Participants|Count of Participants|1|1.0||||||
3978497|NCT01270581|3800657|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3978498|NCT01270581|3800658|B1||Male|Gender||Participants|Count of Participants|1|1.0||||||
3978499|NCT01270581|3800656|B3||Female|Gender||Participants|Count of Participants|6|6.0||||||
3978500|NCT01270581|3800657|B2||Female|Gender||Participants|Count of Participants|3|3.0||||||
3978501|NCT01270581|3800658|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
3978502|NCT01270581|3800656|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3978503|NCT01270581|3800657|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3978504|NCT01270581|3800658|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3978505|NCT01270581|3800656|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3978506|NCT01270581|3800657|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3978507|NCT01270581|3800658|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3978508|NCT01270581|3800656|B3||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
3978509|NCT01270581|3800657|B2||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3978510|NCT01270581|3800658|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3978511|NCT01270555|3800665|B1|||Beck Depression Inventory (BDI)|minimum (least severe depression) = 0, maximum (most severe) = 63|Units on a scale|Mean|8.9|8.9|Standard Deviation|5.9|5.9|||
3978512|NCT01270555|3800665|B1|||Hamilton Depression rating Scale (HAM-D)|minimum (least severe depression) = 0, maximum (most severe) = 84|Units on a scale|Mean|8.8|8.8|Standard Deviation|9.1|9.1|||
3978513|NCT01270555|3800665|B1|||Hamilton Anxiety Rating Scale (HAM-A)|minimum (least severe anxiety) = 0, maximum (most severe) = 56|Units on a scale|Mean|8.1|8.1|Standard Deviation|6.5|6.5|||
3978514|NCT01270555|3800665|B1|||Clinical Global Impressions (CGI) Score for ADHD Severity|Global Severity 1=not ill, 7=extremely ill|Units on a scale|Mean|5.0|5.0|Standard Deviation|0.7|0.7|||
3978515|NCT01270555|3800665|B1|||Clinical Global Impressions (CGI) Score for SUD Severity|Global Severity 1=not ill, 7=extremely ill|Units on a scale|Mean|4.0|4.0|Standard Deviation|0.9|0.9|||
3978516|NCT01270555|3800665|B1|||Self-reported Weekly substance use|Participants who self-report using at least one of illegal drugs or alcohol, at least once per week.|Participants|Number|32|32.0||||||
3978517|NCT01270555|3800665|B1|||DSM-IV Attention Deficit Hyperactivity Rating Scale (ADHD RS)|Assesses 18 individual criteria symptoms on a severity grid (0=not present, 3=severe; overall minimum score = 0, maximum score = 54)|Units on a scale|Mean|34.1|34.1|Standard Deviation|8.2|8.2|||
3978518|NCT01270555|3800665|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
3978519|NCT01270555|3800665|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3978520|NCT01270555|3800665|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3978521|NCT01270555|3800665|B1|||Age||years|Mean|32|32.0|Standard Deviation|8.5|8.5|||
3978522|NCT01270555|3800665|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3978523|NCT01270555|3800665|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3978524|NCT01270555|3800665|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3978525|NCT01270542|3800675|B3||Male|Sex: Female, Male||Eyes|Count of Units|12|12.0||||||
3978526|NCT01270542|3800676|B2||Male|Sex: Female, Male||Eyes|Count of Units|4|4.0||||||
3978527|NCT01270542|3800677|B1||Male|Sex: Female, Male||Eyes|Count of Units|8|8.0||||||
3978528|NCT01270542|3800675|B3||Female|Sex: Female, Male||Eyes|Count of Units|8|8.0||||||
3978529|NCT01270542|3800676|B2||Female|Sex: Female, Male||Eyes|Count of Units|6|6.0||||||
3978530|NCT01270542|3800677|B1||Female|Sex: Female, Male||Eyes|Count of Units|2|2.0||||||
3978531|NCT01270542|3800675|B3|||Age||years|Median|52|52.0|Full Range|||31.0|64.0|
3978532|NCT01270542|3800676|B2|||Age||years|Median|53|53.0|Full Range|||46.0|64.0|
3978533|NCT01270542|3800677|B1|||Age||years|Median|49|49.0|Full Range|||31.0|62.0|
3978534|NCT01270529|3800688|B4|African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3978535|NCT01270529|3800689|B3|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3978536|NCT01270529|3800690|B2|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3978537|NCT01270529|3800691|B1|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3978538|NCT01270529|3800688|B4|Asian American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3978539|NCT01270529|3800689|B3|Asian American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3978540|NCT01270529|3800690|B2|Asian American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3978541|NCT01270529|3800691|B1|Asian American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3978542|NCT01270529|3800688|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3978543|NCT01270529|3800689|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3978544|NCT01270529|3800690|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3978545|NCT01270529|3800691|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3978546|NCT01270529|3800688|B4|Non-Hispanic white||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3978547|NCT01270529|3800689|B3|Non-Hispanic white||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3978548|NCT01270529|3800690|B2|Non-Hispanic white||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3978549|NCT01270529|3800691|B1|Non-Hispanic white||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3978550|NCT01270529|3800688|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3978551|NCT01270529|3800689|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3978552|NCT01270529|3800690|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3978553|NCT01270529|3800691|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3978554|NCT01270529|3800688|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3978555|NCT01270529|3800689|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3978556|NCT01270529|3800690|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3978557|NCT01270529|3800691|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3978558|NCT01270529|3800688|B4|||Age||years|Mean|15.1|15.1|Standard Deviation|3.4|3.4|||
3978559|NCT01270529|3800689|B3|||Age||years|Mean|14.8|14.8|Standard Deviation|3.6|3.6|||
3978560|NCT01270529|3800690|B2|||Age||years|Mean|14.7|14.7|Standard Deviation|2.1|2.1|||
3978561|NCT01270529|3800691|B1|||Age||years|Mean|16|16.0|Standard Deviation|3.6|3.6|||
3978562|NCT01270503|3800701|B1|Philippines||Region of Enrollment||Participants|Number|538|538.0||||||
3978563|NCT01270503|3800701|B1|Male||Gender|Gender information was missing for 3 participants in the study|participants|Number|263|263.0||||||
3978564|NCT01270503|3800701|B1|Female||Gender|Gender information was missing for 3 participants in the study|participants|Number|272|272.0||||||
3978565|NCT01270503|3800701|B1|Age Continuous||Age||Years|Mean|9.3|9.3|Standard Deviation|10.3|10.3|||
3978566|NCT01270503|3800701|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3978567|NCT01270503|3800701|B1||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
3978568|NCT01270503|3800701|B1||<=18 years|Age||Participants|Count of Participants|468|468.0||||||
3978569|NCT01270464|3800706|B4|||Body Mass Index||kg/m^2|Mean|27.6|27.6|Standard Deviation|6.51|6.51|||
3978570|NCT01270464|3800707|B3|||Body Mass Index||kg/m^2|Mean|27.4|27.4|Standard Deviation|6.87|6.87|||
3978571|NCT01270464|3800708|B2|||Body Mass Index||kg/m^2|Mean|27.6|27.6|Standard Deviation|6.68|6.68|||
3978572|NCT01270464|3800709|B1|||Body Mass Index||kg/m^2|Mean|27.7|27.7|Standard Deviation|6.01|6.01|||
3978573|NCT01270464|3800706|B4|||Height||cm|Mean|166.2|166.2|Standard Deviation|11.12|11.12|||
3978574|NCT01270464|3800707|B3|||Height||cm|Mean|165.9|165.9|Standard Deviation|10.24|10.24|||
3978575|NCT01270464|3800708|B2|||Height||cm|Mean|166.2|166.2|Standard Deviation|12.21|12.21|||
3978576|NCT01270464|3800709|B1|||Height||cm|Mean|166.4|166.4|Standard Deviation|10.93|10.93|||
3978577|NCT01270464|3800706|B4|||Weight||kg|Mean|76.2|76.2|Standard Deviation|19.70|19.7|||
3978578|NCT01270464|3800707|B3|||Weight||kg|Mean|75.7|75.7|Standard Deviation|20.3|20.3|||
3978579|NCT01270464|3800708|B2|||Weight||kg|Mean|75.9|75.9|Standard Deviation|18.8|18.8|||
3978580|NCT01270464|3800709|B1|||Weight||kg|Mean|77.0|77.0|Standard Deviation|20.1|20.1|||
3978581|NCT01270464|3800706|B4|No||Asthma Exacerbation Within the Last 12 Months|A stratification factor with data as reported in the case report form|participants|Number|140|140.0||||||
3978582|NCT01270464|3800707|B3|No||Asthma Exacerbation Within the Last 12 Months|A stratification factor with data as reported in the case report form|participants|Number|46|46.0||||||
3978583|NCT01270464|3800708|B2|No||Asthma Exacerbation Within the Last 12 Months|A stratification factor with data as reported in the case report form|participants|Number|46|46.0||||||
3978584|NCT01270464|3800709|B1|No||Asthma Exacerbation Within the Last 12 Months|A stratification factor with data as reported in the case report form|participants|Number|48|48.0||||||
3978585|NCT01270464|3800706|B4|Yes||Asthma Exacerbation Within the Last 12 Months|A stratification factor with data as reported in the case report form|participants|Number|175|175.0||||||
3978586|NCT01270464|3800707|B3|Yes||Asthma Exacerbation Within the Last 12 Months|A stratification factor with data as reported in the case report form|participants|Number|60|60.0||||||
3978587|NCT01270464|3800708|B2|Yes||Asthma Exacerbation Within the Last 12 Months|A stratification factor with data as reported in the case report form|participants|Number|58|58.0||||||
3978588|NCT01270464|3800709|B1|Yes||Asthma Exacerbation Within the Last 12 Months|A stratification factor with data as reported in the case report form|participants|Number|57|57.0||||||
3978589|NCT01270464|3800706|B4|Unknown||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3978590|NCT01270464|3800707|B3|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3978591|NCT01270464|3800708|B2|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3978592|NCT01270464|3800709|B1|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3978593|NCT01270464|3800706|B4|Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||participants|Number|222|222.0||||||
3978594|NCT01270464|3800707|B3|Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||participants|Number|75|75.0||||||
3978595|NCT01270464|3800708|B2|Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||participants|Number|73|73.0||||||
3978596|NCT01270464|3800709|B1|Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
3978597|NCT01270464|3800706|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|89|89.0||||||
3978598|NCT01270464|3800707|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3978599|NCT01270464|3800708|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3978600|NCT01270464|3800709|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3978601|NCT01270464|3800706|B4|Other||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3978602|NCT01270464|3800707|B3|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3978603|NCT01270464|3800708|B2|Other||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3978604|NCT01270464|3800709|B1|Other||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3978605|NCT01270464|3800706|B4|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3978606|NCT01270464|3800707|B3|Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3978607|NCT01270464|3800708|B2|Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3978608|NCT01270464|3800709|B1|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3978609|NCT01270464|3800706|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3978610|NCT01270464|3800707|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3978611|NCT01270464|3800708|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3978612|NCT01270464|3800709|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3978613|NCT01270464|3800706|B4|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3978614|NCT01270464|3800707|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3978615|NCT01270464|3800708|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3978616|NCT01270464|3800709|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3978617|NCT01270464|3800706|B4|Black||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3978618|NCT01270464|3800707|B3|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3978619|NCT01270464|3800708|B2|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3978620|NCT01270464|3800709|B1|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3978621|NCT01270464|3800706|B4|White||Race/Ethnicity, Customized||participants|Number|255|255.0||||||
3978622|NCT01270464|3800707|B3|White||Race/Ethnicity, Customized||participants|Number|90|90.0||||||
3978623|NCT01270464|3800708|B2|White||Race/Ethnicity, Customized||participants|Number|80|80.0||||||
3978624|NCT01270464|3800709|B1|White||Race/Ethnicity, Customized||participants|Number|85|85.0||||||
3978625|NCT01270464|3800706|B4||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3978626|NCT01270464|3800707|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3978627|NCT01270464|3800708|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3978628|NCT01270464|3800709|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3978629|NCT01270464|3800706|B4||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3978630|NCT01270464|3800707|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3978631|NCT01270464|3800708|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3978632|NCT01270464|3800709|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3978633|NCT01270464|3800706|B4|From 65-84 years||Age, Customized||participants|Number|17|17.0||||||
3978634|NCT01270464|3800707|B3|From 65-84 years||Age, Customized||participants|Number|2|2.0||||||
3978635|NCT01270464|3800708|B2|From 65-84 years||Age, Customized||participants|Number|8|8.0||||||
3978636|NCT01270464|3800709|B1|From 65-84 years||Age, Customized||participants|Number|7|7.0||||||
3978637|NCT01270464|3800706|B4|Adults (18-64 years)||Age, Customized||participants|Number|283|283.0||||||
3978638|NCT01270464|3800707|B3|Adults (18-64 years)||Age, Customized||participants|Number|99|99.0||||||
3978639|NCT01270464|3800708|B2|Adults (18-64 years)||Age, Customized||participants|Number|91|91.0||||||
3978640|NCT01270464|3800709|B1|Adults (18-64 years)||Age, Customized||participants|Number|93|93.0||||||
3978641|NCT01270464|3800706|B4|Adolescents (12-17 years)||Age, Customized||participants|Number|15|15.0||||||
3978642|NCT01270464|3800707|B3|Adolescents (12-17 years)||Age, Customized||participants|Number|5|5.0||||||
3978643|NCT01270464|3800708|B2|Adolescents (12-17 years)||Age, Customized||participants|Number|5|5.0||||||
3978644|NCT01270464|3800709|B1|Adolescents (12-17 years)||Age, Customized||participants|Number|5|5.0||||||
3978645|NCT01270464|3800706|B4|||Age||years|Mean|43.9|43.9|Standard Deviation|14.42|14.42|||
3978646|NCT01270464|3800707|B3|||Age||years|Mean|43.0|43.0|Standard Deviation|14.41|14.41|||
3978647|NCT01270464|3800708|B2|||Age||years|Mean|44.5|44.5|Standard Deviation|14.03|14.03|||
3978648|NCT01270464|3800709|B1|||Age||years|Mean|44.2|44.2|Standard Deviation|14.89|14.89|||
3978649|NCT01270256|3800758|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3978650|NCT01270256|3800759|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3978651|NCT01270256|3800760|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3978652|NCT01270256|3800758|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3978653|NCT01270256|3800759|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3978654|NCT01270256|3800760|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3978655|NCT01270256|3800758|B3|||Age||years|Mean|32.8|32.8|Full Range|||18.0|55.0|
3978656|NCT01270256|3800759|B2|||Age||years|Mean|32.3|32.3|Full Range|||18.0|52.0|
3978657|NCT01270256|3800760|B1|||Age||years|Mean|33.3|33.3|Full Range|||18.0|55.0|
3978658|NCT01270139|3800767|B4|Russian Federation||Region of Enrollment||participants|Number|180|180.0||||||
3978659|NCT01270139|3800768|B3|Russian Federation||Region of Enrollment||participants|Number|60|60.0||||||
3978660|NCT01270139|3800769|B2|Russian Federation||Region of Enrollment||participants|Number|60|60.0||||||
3978661|NCT01270139|3800770|B1|Russian Federation||Region of Enrollment||participants|Number|60|60.0||||||
3978662|NCT01270139|3800767|B4||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3978663|NCT01270139|3800768|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3978664|NCT01270139|3800769|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3978665|NCT01270139|3800770|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3978666|NCT01270139|3800767|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3978667|NCT01270139|3800768|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3978668|NCT01270139|3800769|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3978669|NCT01270139|3800770|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3978670|NCT01270139|3800767|B4|||Age||years|Mean|51.6|51.6|Standard Deviation|8.6|8.6|||
3978671|NCT01270139|3800768|B3|||Age||years|Mean|52.6|52.6|Standard Deviation|6.8|6.8|||
3978672|NCT01270139|3800769|B2|||Age||years|Mean|50.9|50.9|Standard Deviation|8.8|8.8|||
3978673|NCT01270139|3800770|B1|||Age||years|Mean|51.2|51.2|Standard Deviation|10.3|10.3|||
3978674|NCT01270139|3800767|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3978675|NCT01270139|3800768|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3978676|NCT01270139|3800769|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3978677|NCT01270139|3800770|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3978678|NCT01270139|3800767|B4||Between 18 and 65 years|Age||Participants|Count of Participants|180|180.0||||||
3978679|NCT01270139|3800768|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3978680|NCT01270139|3800769|B2||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3978681|NCT01270139|3800770|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3978682|NCT01270139|3800767|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3978683|NCT01270139|3800768|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3978684|NCT01270139|3800769|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3978685|NCT01270139|3800770|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3978686|NCT01270126|3800830|B3|Germany||Region of Enrollment||participants|Number|22|22.0||||||
3978687|NCT01270126|3800831|B2|Germany||Region of Enrollment||participants|Number|10|10.0||||||
3978688|NCT01270126|3800832|B1|Germany||Region of Enrollment||participants|Number|12|12.0||||||
3978689|NCT01270126|3800830|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3978690|NCT01270126|3800831|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3978691|NCT01270126|3800832|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3978692|NCT01270126|3800830|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3978693|NCT01270126|3800831|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3978694|NCT01270126|3800832|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3978695|NCT01270126|3800830|B3|||Age||years|Mean|52.1|52.1|Standard Deviation|15.4|15.4|||
3978696|NCT01270126|3800831|B2|||Age||years|Mean|51.9|51.9|Standard Deviation|17.3|17.3|||
3978697|NCT01270126|3800832|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|14.3|14.3|||
3978698|NCT01270126|3800830|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3978699|NCT01270126|3800831|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3978700|NCT01270126|3800832|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3978701|NCT01270126|3800830|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3978702|NCT01270126|3800831|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3978703|NCT01270126|3800832|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3978704|NCT01270126|3800830|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3978705|NCT01270126|3800831|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3978706|NCT01270126|3800832|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3978707|NCT01269918|3800839|B3||Male|Gender||Participants|Count of Participants|69|69.0||||||
3978708|NCT01269918|3800840|B2||Male|Gender||Participants|Count of Participants|35|35.0||||||
3978709|NCT01269918|3800841|B1||Male|Gender||Participants|Count of Participants|34|34.0||||||
3978710|NCT01269918|3800839|B3||Female|Gender||Participants|Count of Participants|70|70.0||||||
3978711|NCT01269918|3800840|B2||Female|Gender||Participants|Count of Participants|33|33.0||||||
3978712|NCT01269918|3800841|B1||Female|Gender||Participants|Count of Participants|37|37.0||||||
3978713|NCT01269918|3800839|B3|||Age||years|Mean|56|56.0|Standard Deviation|14|14.0|||
3978714|NCT01269918|3800840|B2|||Age||years|Mean|56|56.0|Standard Deviation|14|14.0|||
3978715|NCT01269918|3800841|B1|||Age||years|Mean|55|55.0|Standard Deviation|14|14.0|||
3978716|NCT01269801|3800874|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3978717|NCT01269801|3800875|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3978718|NCT01269801|3800876|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3978719|NCT01269801|3800874|B3||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3978720|NCT01269801|3800875|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3978721|NCT01269801|3800876|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3978722|NCT01269801|3800874|B3|||Age||years|Mean|50.54|50.54|Standard Deviation|7.6|7.6|||
3978723|NCT01269801|3800875|B2|||Age||years|Mean|51.12|51.12|Standard Deviation|7.78|7.78|||
3978724|NCT01269801|3800876|B1|||Age||years|Mean|49.83|49.83|Standard Deviation|7.42|7.42|||
3978725|NCT01269801|3800874|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3978726|NCT01269801|3800875|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3978727|NCT01269801|3800876|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3978728|NCT01269801|3800874|B3||Between 18 and 65 years|Age||Participants|Count of Participants|154|154.0||||||
3978729|NCT01269801|3800875|B2||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
3978730|NCT01269801|3800876|B1||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
3978731|NCT01269801|3800874|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3978732|NCT01269801|3800875|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3978733|NCT01269801|3800876|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3978734|NCT01269749|3800883|B3||Male|Sex: Female, Male|This was a pediatric study. All participants were <18yrs of age. Due to the low number of participants enrolled the data was not sufficient to analyze.|Participants|Count of Participants|2|2.0||||||
3978735|NCT01269749|3800884|B2||Male|Sex: Female, Male|This was a pediatric study. All participants were <18yrs of age. Due to the low number of participants enrolled the data was not sufficient to analyze.|Participants|Count of Participants|1|1.0||||||
3978736|NCT01269749|3800885|B1||Male|Sex: Female, Male|This was a pediatric study. All participants were <18yrs of age. Due to the low number of participants enrolled the data was not sufficient to analyze.|Participants|Count of Participants|1|1.0||||||
3978737|NCT01269749|3800883|B3||Female|Sex: Female, Male|This was a pediatric study. All participants were <18yrs of age. Due to the low number of participants enrolled the data was not sufficient to analyze.|Participants|Count of Participants|17|17.0||||||
3978738|NCT01269749|3800884|B2||Female|Sex: Female, Male|This was a pediatric study. All participants were <18yrs of age. Due to the low number of participants enrolled the data was not sufficient to analyze.|Participants|Count of Participants|2|2.0||||||
3978739|NCT01269749|3800885|B1||Female|Sex: Female, Male|This was a pediatric study. All participants were <18yrs of age. Due to the low number of participants enrolled the data was not sufficient to analyze.|Participants|Count of Participants|15|15.0||||||
3978740|NCT01269749|3800883|B3||>=65 years|Age|This was a pediatric study. All participants were <18yrs of age. Due to the low number of participants enrolled the data was not sufficient to analyze.|Participants|Count of Participants|0|0.0||||||
3978741|NCT01269749|3800884|B2||>=65 years|Age|This was a pediatric study. All participants were <18yrs of age. Due to the low number of participants enrolled the data was not sufficient to analyze.|Participants|Count of Participants|0|0.0||||||
3978742|NCT01269749|3800885|B1||>=65 years|Age|This was a pediatric study. All participants were <18yrs of age. Due to the low number of participants enrolled the data was not sufficient to analyze.|Participants|Count of Participants|0|0.0||||||
3978743|NCT01269749|3800883|B3||Between 18 and 65 years|Age|This was a pediatric study. All participants were <18yrs of age. Due to the low number of participants enrolled the data was not sufficient to analyze.|Participants|Count of Participants|0|0.0||||||
3978744|NCT01269749|3800884|B2||Between 18 and 65 years|Age|This was a pediatric study. All participants were <18yrs of age. Due to the low number of participants enrolled the data was not sufficient to analyze.|Participants|Count of Participants|0|0.0||||||
3978745|NCT01269749|3800885|B1||Between 18 and 65 years|Age|This was a pediatric study. All participants were <18yrs of age. Due to the low number of participants enrolled the data was not sufficient to analyze.|Participants|Count of Participants|0|0.0||||||
3978746|NCT01269749|3800883|B3||<=18 years|Age|This was a pediatric study. All participants were <18yrs of age. Due to the low number of participants enrolled the data was not sufficient to analyze.|Participants|Count of Participants|19|19.0||||||
3978747|NCT01269749|3800884|B2||<=18 years|Age|This was a pediatric study. All participants were <18yrs of age. Due to the low number of participants enrolled the data was not sufficient to analyze.|Participants|Count of Participants|3|3.0||||||
3978748|NCT01269749|3800885|B1||<=18 years|Age|This was a pediatric study. All participants were <18yrs of age. Due to the low number of participants enrolled the data was not sufficient to analyze.|Participants|Count of Participants|16|16.0||||||
3978749|NCT01269736|3800894|B3||Combined|Type of Unit||Participants|Count of Participants|854|854.0||||||
3978750|NCT01269736|3800896|B1||Combined|Type of Unit||Participants|Count of Participants|854|854.0||||||
3978751|NCT01269736|3800894|B3||Surgery|Type of Unit||Participants|Count of Participants|830|830.0||||||
3978752|NCT01269736|3800896|B1||Surgery|Type of Unit||Participants|Count of Participants|830|830.0||||||
3978753|NCT01269736|3800894|B3||Medicine|Type of Unit||Participants|Count of Participants|1329|1329.0||||||
3978754|NCT01269736|3800896|B1||Medicine|Type of Unit||Participants|Count of Participants|1329|1329.0||||||
3978755|NCT01269736|3800894|B3||None of the above|Education||Participants|Count of Participants|10|10.0||||||
3978756|NCT01269736|3800896|B1||None of the above|Education||Participants|Count of Participants|10|10.0||||||
3978757|NCT01269736|3800894|B3||Doctoral Degree|Education||Participants|Count of Participants|11|11.0||||||
3978758|NCT01269736|3800896|B1||Doctoral Degree|Education||Participants|Count of Participants|11|11.0||||||
3978759|NCT01269736|3800894|B3||Master's Degree|Education||Participants|Count of Participants|208|208.0||||||
3978760|NCT01269736|3800896|B1||Master's Degree|Education||Participants|Count of Participants|208|208.0||||||
3978761|NCT01269736|3800894|B3||Bachelor's Degree|Education||Participants|Count of Participants|1959|1959.0||||||
3978762|NCT01269736|3800896|B1||Bachelor's Degree|Education||Participants|Count of Participants|1959|1959.0||||||
3978763|NCT01269736|3800894|B3||Associate's Degree|Education||Participants|Count of Participants|534|534.0||||||
3978764|NCT01269736|3800896|B1||Associate's Degree|Education||Participants|Count of Participants|534|534.0||||||
3978765|NCT01269736|3800894|B3||Diploma|Education||Participants|Count of Participants|291|291.0||||||
3978766|NCT01269736|3800896|B1||Diploma|Education||Participants|Count of Participants|291|291.0||||||
3978767|NCT01269736|3800894|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978768|NCT01269736|3800895|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978902|NCT01268891|3800988|B2|||Age||years|Mean|60.2|60.2|Standard Deviation|8.6|8.6|||
3978769|NCT01269736|3800896|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3978770|NCT01269736|3800894|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7181|7181.0||||||
3978771|NCT01269736|3800895|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4249|4249.0||||||
3978772|NCT01269736|3800896|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2932|2932.0||||||
3978773|NCT01269736|3800894|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|307|307.0||||||
3978774|NCT01269736|3800895|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|226|226.0||||||
3978775|NCT01269736|3800896|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
3978776|NCT01269736|3800894|B3||Male|Sex: Female, Male|Sex missing for 8 patients.|Participants|Count of Participants|2947|2947.0||||||
3978777|NCT01269736|3800895|B2||Male|Sex: Female, Male|Sex missing for 8 patients.|Participants|Count of Participants|2625|2625.0||||||
3978778|NCT01269736|3800896|B1||Male|Sex: Female, Male|Sex missing for 8 patients.|Participants|Count of Participants|322|322.0||||||
3978779|NCT01269736|3800894|B3||Female|Sex: Female, Male|Sex missing for 8 patients.|Participants|Count of Participants|4645|4645.0||||||
3978780|NCT01269736|3800895|B2||Female|Sex: Female, Male|Sex missing for 8 patients.|Participants|Count of Participants|1954|1954.0||||||
3978781|NCT01269736|3800896|B1||Female|Sex: Female, Male|Sex missing for 8 patients.|Participants|Count of Participants|2691|2691.0||||||
3978782|NCT01269736|3800894|B3|||Age|Overall age across study groups was not calculated for the different population samples.|years|Mean|NA||Standard Deviation|NA||||Overall age across study groups was not calculated for the different population samples.
3978783|NCT01269736|3800895|B2|||Age|Overall age across study groups was not calculated for the different population samples.|years|Mean|65.54|65.54|Standard Deviation|5.28|5.28|||
3978784|NCT01269736|3800896|B1|||Age|Overall age across study groups was not calculated for the different population samples.|years|Mean|37.53|37.53|Standard Deviation|11.05|11.05|||
3978785|NCT01269710|3800909|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3978786|NCT01269710|3800909|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3978787|NCT01269710|3800909|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3978788|NCT01269710|3800909|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3978789|NCT01269710|3800909|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3978790|NCT01269346|3800917|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3978791|NCT01269346|3800917|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3978792|NCT01269346|3800917|B1|||Age||Years|Geometric Mean|58.7|58.7|Standard Deviation|10.92|10.92|||
3978793|NCT01269125|3800925|B4|Greece||Region of Enrollment||participants|Number|180|180.0||||||
3978794|NCT01269125|3800926|B3|Greece||Region of Enrollment||participants|Number|60|60.0||||||
3978795|NCT01269125|3800927|B2|Greece||Region of Enrollment||participants|Number|60|60.0||||||
3978796|NCT01269125|3800928|B1|Greece||Region of Enrollment||participants|Number|60|60.0||||||
3978797|NCT01269125|3800925|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3978798|NCT01269125|3800926|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3978799|NCT01269125|3800927|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3978800|NCT01269125|3800928|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3978801|NCT01269125|3800925|B4||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3978802|NCT01269125|3800926|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3978803|NCT01269125|3800927|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3978804|NCT01269125|3800928|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3978805|NCT01269125|3800925|B4|||Age||years|Mean|33.6|33.6|Standard Deviation|2.4|2.4|||
3978806|NCT01269125|3800926|B3|||Age||years|Mean|35.4|35.4|Standard Deviation|1.9|1.9|||
3978807|NCT01269125|3800927|B2|||Age||years|Mean|31.8|31.8|Standard Deviation|2.1|2.1|||
3978808|NCT01269125|3800928|B1|||Age||years|Mean|33.8|33.8|Standard Deviation|3.2|3.2|||
3978809|NCT01269125|3800925|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3978810|NCT01269125|3800926|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3978811|NCT01269125|3800927|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3978812|NCT01269125|3800928|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3978813|NCT01269125|3800925|B4||Between 18 and 65 years|Age||Participants|Count of Participants|180|180.0||||||
3978814|NCT01269125|3800926|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3978815|NCT01269125|3800927|B2||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3978816|NCT01269125|3800928|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3978817|NCT01269125|3800925|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3978818|NCT01269125|3800926|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3978819|NCT01269125|3800927|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3978820|NCT01269125|3800928|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3978821|NCT01269047|3800950|B4|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3978822|NCT01269047|3800951|B3|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3978823|NCT01269047|3800952|B2|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3978824|NCT01269047|3800953|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3978825|NCT01269047|3800950|B4||Mixed (White/AA)|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3978826|NCT01269047|3800951|B3||Mixed (White/AA)|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3978827|NCT01269047|3800952|B2||Mixed (White/AA)|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3978828|NCT01269047|3800953|B1||Mixed (White/AA)|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3978829|NCT01269047|3800950|B4||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3978830|NCT01269047|3800951|B3||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3978831|NCT01269047|3800952|B2||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3978832|NCT01269047|3800953|B1||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3978833|NCT01269047|3800950|B4||African American (AA)|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3978834|NCT01269047|3800951|B3||African American (AA)|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3978835|NCT01269047|3800952|B2||African American (AA)|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3978836|NCT01269047|3800953|B1||African American (AA)|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3978837|NCT01269047|3800950|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3978838|NCT01269047|3800951|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3978839|NCT01269047|3800952|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3978840|NCT01269047|3800953|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3978841|NCT01269047|3800950|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3978842|NCT01269047|3800951|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3978843|NCT01269047|3800952|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3978844|NCT01269047|3800953|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3978845|NCT01269047|3800950|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3978846|NCT01269047|3800951|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3978847|NCT01269047|3800952|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3978848|NCT01269047|3800953|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3978849|NCT01269047|3800950|B4|||Age||years|Mean|15.7|15.7|Standard Deviation|1.1|1.1|||
3978850|NCT01269047|3800951|B3|||Age||years|Mean|15.2|15.2|Standard Deviation|2.1|2.1|||
3978851|NCT01269047|3800952|B2|||Age||years|Mean|15.0|15.0|Standard Deviation|1.7|1.7|||
3978852|NCT01269047|3800953|B1|||Age||years|Mean|17.0|17.0|Standard Deviation|3.4|3.4|||
3978853|NCT01268943|3800970|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3978854|NCT01268943|3800971|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3978855|NCT01268943|3800972|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3978856|NCT01268943|3800973|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3978857|NCT01268943|3800974|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3978858|NCT01268943|3800970|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3978859|NCT01268943|3800971|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3978860|NCT01268943|3800972|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3978861|NCT01268943|3800973|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3978862|NCT01268943|3800974|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3978863|NCT01268943|3800970|B5|||Age||years|Mean|74.5|74.5|Full Range|||70.0|83.0|
3978864|NCT01268943|3800971|B4|||Age||years|Mean|73.5|73.5|Full Range|||70.0|78.0|
3978865|NCT01268943|3800972|B3|||Age||years|Mean|75.7|75.7|Full Range|||71.0|81.0|
3978866|NCT01268943|3800973|B2|||Age||years|Mean|73.7|73.7|Full Range|||73.0|75.0|
3978867|NCT01268943|3800974|B1|||Age||years|Mean|75.5|75.5|Full Range|||72.0|83.0|
3978868|NCT01268943|3800970|B5||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3978869|NCT01268943|3800971|B4||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3978870|NCT01268943|3800972|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3978871|NCT01268943|3800973|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3978872|NCT01268943|3800974|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3978873|NCT01268943|3800970|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3978874|NCT01268943|3800971|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3978875|NCT01268943|3800972|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3978876|NCT01268943|3800973|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3978877|NCT01268943|3800974|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3978878|NCT01268943|3800970|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3978879|NCT01268943|3800971|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3978880|NCT01268943|3800972|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3978881|NCT01268943|3800973|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3978882|NCT01268943|3800974|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3978903|NCT01268891|3800989|B1|||Age||years|Mean|59.5|59.5|Standard Deviation|9.0|9.0|||
3978904|NCT01268683|3801002|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3978905|NCT01268683|3801002|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3978906|NCT01268683|3801002|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3978883|NCT01268891|3800987|B3|||UPDRS Motor Score During ON time|UPDRS is a 42-item rating scale designed to assess Parkinson’s Disease-related disability and impairment using a patient interview and a physical examination. It has 4 parts and 4 subsection scores. A higher score indicates a worst outcome. I: mentation, behaviour and mood symptoms - 0 to 16; II: ADL - 0 to 52; III: motor function - 0 to 108; IV: complications of dopaminergic therapy - 0 to 23. Subsection scores for I to III are used to calculate a total score that ranges from 0 (no disability) to 176 (total dependence).|units on a scale|Mean|18.86|18.86|Standard Deviation|8.57|8.57|||
3978884|NCT01268891|3800988|B2|||UPDRS Motor Score During ON time|UPDRS is a 42-item rating scale designed to assess Parkinson’s Disease-related disability and impairment using a patient interview and a physical examination. It has 4 parts and 4 subsection scores. A higher score indicates a worst outcome. I: mentation, behaviour and mood symptoms - 0 to 16; II: ADL - 0 to 52; III: motor function - 0 to 108; IV: complications of dopaminergic therapy - 0 to 23. Subsection scores for I to III are used to calculate a total score that ranges from 0 (no disability) to 176 (total dependence).|units on a scale|Mean|17.98|17.98|Standard Deviation|8.71|8.71|||
3978885|NCT01268891|3800989|B1|||UPDRS Motor Score During ON time|UPDRS is a 42-item rating scale designed to assess Parkinson’s Disease-related disability and impairment using a patient interview and a physical examination. It has 4 parts and 4 subsection scores. A higher score indicates a worst outcome. I: mentation, behaviour and mood symptoms - 0 to 16; II: ADL - 0 to 52; III: motor function - 0 to 108; IV: complications of dopaminergic therapy - 0 to 23. Subsection scores for I to III are used to calculate a total score that ranges from 0 (no disability) to 176 (total dependence).|units on a scale|Mean|19.81|19.81|Standard Deviation|8.39|8.39|||
3978886|NCT01268891|3800987|B3|||UPDRS-ADL Score During OFF Time|Unified Parkinson’s Disease Rating Scale (UPDRS) is a 42-item rating scale designed to assess Parkinson’s Disease-related disability and impairment using a patient interview and a physical examination. It has 4 parts and 4 subsection scores. A higher score indicates a worst outcome. I: mentation, behaviour and mood symptoms - 0 to 16; II: activities of daily living (ADL) - 0 to 52; III: motor function - 0 to 108; IV: complications of dopaminergic therapy - 0 to 23. Subsection scores for I to III are used to calculate a total score that ranges from 0 (no disability) to 176 (total dependence).|units on a scale|Mean|11.48|11.48|Standard Deviation|6.21|6.21|||
3978887|NCT01268891|3800988|B2|||UPDRS-ADL Score During OFF Time|Unified Parkinson’s Disease Rating Scale (UPDRS) is a 42-item rating scale designed to assess Parkinson’s Disease-related disability and impairment using a patient interview and a physical examination. It has 4 parts and 4 subsection scores. A higher score indicates a worst outcome. I: mentation, behaviour and mood symptoms - 0 to 16; II: activities of daily living (ADL) - 0 to 52; III: motor function - 0 to 108; IV: complications of dopaminergic therapy - 0 to 23. Subsection scores for I to III are used to calculate a total score that ranges from 0 (no disability) to 176 (total dependence).|units on a scale|Mean|11.79|11.79|Standard Deviation|6.58|6.58|||
3978888|NCT01268891|3800989|B1|||UPDRS-ADL Score During OFF Time|Unified Parkinson’s Disease Rating Scale (UPDRS) is a 42-item rating scale designed to assess Parkinson’s Disease-related disability and impairment using a patient interview and a physical examination. It has 4 parts and 4 subsection scores. A higher score indicates a worst outcome. I: mentation, behaviour and mood symptoms - 0 to 16; II: activities of daily living (ADL) - 0 to 52; III: motor function - 0 to 108; IV: complications of dopaminergic therapy - 0 to 23. Subsection scores for I to III are used to calculate a total score that ranges from 0 (no disability) to 176 (total dependence).|units on a scale|Mean|11.15|11.15|Standard Deviation|5.84|5.84|||
3978889|NCT01268891|3800987|B3|||CGI-S|Clinical Global Impression - Severity of Illness (CGI-S) is a single-item rating scale used to evaluate a patient’s severity of illness on a 7-point scale, based on the investigator’s total clinical experience with patients. The scale ranges from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|2.99|2.99|Standard Deviation|1.02|1.02|||
3978890|NCT01268891|3800988|B2|||CGI-S|Clinical Global Impression - Severity of Illness (CGI-S) is a single-item rating scale used to evaluate a patient’s severity of illness on a 7-point scale, based on the investigator’s total clinical experience with patients. The scale ranges from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|2.94|2.94|Standard Deviation|1.11|1.11|||
3978891|NCT01268891|3800989|B1|||CGI-S|Clinical Global Impression - Severity of Illness (CGI-S) is a single-item rating scale used to evaluate a patient’s severity of illness on a 7-point scale, based on the investigator’s total clinical experience with patients. The scale ranges from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|3.05|3.05|Standard Deviation|0.92|0.92|||
3978892|NCT01268891|3800987|B3|||Total Daily OFF Time|Parkinson's Disease Patient Diary is a self-administered diary designed to assess motor fluctuations throughout the day. It is divided into 30-minute intervals, and the patient selects one of four options for each interval: asleep; off; on with no dyskinesia or without troublesome dyskinesia; or on with troublesome dyskinesia.|hours|Mean|6.25|6.25|Standard Deviation|2.50|2.5|||
3978893|NCT01268891|3800988|B2|||Total Daily OFF Time|Parkinson's Disease Patient Diary is a self-administered diary designed to assess motor fluctuations throughout the day. It is divided into 30-minute intervals, and the patient selects one of four options for each interval: asleep; off; on with no dyskinesia or without troublesome dyskinesia; or on with troublesome dyskinesia.|hours|Mean|6.26|6.26|Standard Deviation|2.29|2.29|||
3978894|NCT01268891|3800989|B1|||Total Daily OFF Time|Parkinson's Disease Patient Diary is a self-administered diary designed to assess motor fluctuations throughout the day. It is divided into 30-minute intervals, and the patient selects one of four options for each interval: asleep; off; on with no dyskinesia or without troublesome dyskinesia; or on with troublesome dyskinesia.|hours|Mean|6.24|6.24|Standard Deviation|2.73|2.73|||
3978895|NCT01268891|3800987|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3978896|NCT01268891|3800988|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3978897|NCT01268891|3800989|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3978898|NCT01268891|3800987|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3978899|NCT01268891|3800988|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3978900|NCT01268891|3800989|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3978901|NCT01268891|3800987|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|8.8|8.8|||
3978907|NCT01268683|3801002|B1|||Age||years|Mean|50.5|50.5|Standard Deviation|15.3|15.3|||
3978908|NCT01268683|3801002|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3978909|NCT01268683|3801002|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3978910|NCT01268683|3801002|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3978911|NCT01268566|3801009|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3978912|NCT01268566|3801009|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3978913|NCT01268566|3801009|B1|||Age||Years|Mean|52.9|52.9|Standard Deviation|13.5|13.5|||
3978914|NCT01268553|3801027|B1|||The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR)|CAMPHOR is a questionnaire that measures quality of life of patients with pulmonary hypertension using units on a scale, 0-25, higher = worse|units on a scale|Mean|6.8|6.8|Standard Deviation|6|6.0|||
3978915|NCT01268553|3801027|B1|||ratio of minute ventilation to CO2 output||ratio|Mean|32|32.0|Standard Deviation|2|2.0|||
3978916|NCT01268553|3801027|B1|||peak oxygen consumption||L/min|Mean|1.0|1.0|Standard Deviation|0.2|0.2|||
3978917|NCT01268553|3801027|B1|||6-minute walk distance||meters|Mean|334|334.0|Standard Deviation|132|132.0|||
3978918|NCT01268553|3801027|B1|||pulmonary vascular resistance||Wood Units|Mean|4.2|4.2|Standard Deviation|2.4|2.4|||
3978919|NCT01268553|3801027|B1|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3978920|NCT01268553|3801027|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3978921|NCT01268553|3801027|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3978922|NCT01268553|3801027|B1|||Age||years|Mean|50|50.0|Standard Deviation|17|17.0|||
3978923|NCT01268501|3801036|B1|United States||Region of Enrollment||participants|Number|96|96.0||||||
3978924|NCT01268501|3801036|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3978925|NCT01268501|3801036|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3978926|NCT01268501|3801036|B1|||Age||years|Mean|44.9|44.9|Standard Deviation|2.7|2.7|||
3978927|NCT01268488|3801040|B1|United States||Region of Enrollment||participants|Number|98|98.0||||||
3978928|NCT01268488|3801040|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3978929|NCT01268488|3801040|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3978930|NCT01268488|3801040|B1|||Age||years|Mean|50.8|50.8|Full Range|||19.0|79.0|
3978931|NCT01268306|3801047|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3978932|NCT01268306|3801047|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3978933|NCT01268306|3801047|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3978934|NCT01268306|3801047|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3978935|NCT01268306|3801047|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3978936|NCT01268306|3801047|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3978937|NCT01268293|3801051|B1|Female||Sex/Gender, Customized||Participants|Number|7|7.0||||||
3978938|NCT01268293|3801051|B1|Male||Sex/Gender, Customized||Participants|Number|2|2.0||||||
3978939|NCT01268293|3801051|B1|||Age||Years|Mean|43.6|43.6|Standard Deviation|11.5|11.5|||
3978940|NCT01268267|3801056|B1|United States||Region of Enrollment||participants|Number|93|93.0||||||
3978941|NCT01268267|3801056|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3978942|NCT01268267|3801056|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3978943|NCT01268267|3801056|B1|||Age, Customized||years|Mean|38.3|38.3|Full Range|||18.0|74.0|
3978944|NCT01268189|3801063|B1|||Burn Size||percentage of total skin area|Mean|9.2|9.2|Full Range|||2.0|24.0|
3978945|NCT01268189|3801063|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3978946|NCT01268189|3801063|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3978947|NCT01268189|3801063|B1|||Age||years|Mean|35|35.0|Full Range|||20.0|49.0|
3978948|NCT01268150|3801077|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3978949|NCT01268150|3801077|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3978950|NCT01268150|3801077|B1|||Age||Years|Mean|57.0|57.0|Standard Deviation|10.78|10.78|||
3978951|NCT01268111|3801085|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3978952|NCT01268111|3801086|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3978953|NCT01268111|3801087|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3978954|NCT01268111|3801085|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3978955|NCT01268111|3801086|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3978956|NCT01268111|3801087|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3978957|NCT01268111|3801085|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3978958|NCT01268111|3801086|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3978959|NCT01268111|3801087|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3978960|NCT01268111|3801085|B3|||Age||years|Mean|28.4|28.4|Standard Deviation|3.2|3.2|||
3978961|NCT01268111|3801086|B2|||Age||years|Mean|27.8|27.8|Standard Deviation|2.6|2.6|||
3978962|NCT01268111|3801087|B1|||Age||years|Mean|29|29.0|Standard Deviation|3.6|3.6|||
3978963|NCT01268111|3801085|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3978964|NCT01268111|3801086|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3978965|NCT01268111|3801087|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3978966|NCT01268111|3801085|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3978967|NCT01268111|3801086|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3978968|NCT01268111|3801087|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3978969|NCT01268111|3801085|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3978970|NCT01268111|3801086|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3978971|NCT01268111|3801087|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3978972|NCT01268098|3801094|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
3978973|NCT01268098|3801095|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
3978974|NCT01268098|3801096|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3978975|NCT01268098|3801094|B3|Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3978976|NCT01268098|3801095|B2|Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3978977|NCT01268098|3801096|B1|Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3978978|NCT01268098|3801094|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3978979|NCT01268098|3801095|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3978980|NCT01268098|3801096|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3978981|NCT01268098|3801094|B3|White||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
3978982|NCT01268098|3801095|B2|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3978983|NCT01268098|3801096|B1|White||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3978984|NCT01268098|3801094|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3978985|NCT01268098|3801095|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3978986|NCT01268098|3801096|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3978987|NCT01268098|3801094|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3978988|NCT01268098|3801095|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3978989|NCT01268098|3801096|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3978990|NCT01268098|3801094|B3|>/= 65 years||Age, Customized||participants|Number|3|3.0||||||
3978991|NCT01268098|3801095|B2|>/= 65 years||Age, Customized||participants|Number|0|0.0||||||
3978992|NCT01268098|3801096|B1|>/= 65 years||Age, Customized||participants|Number|3|3.0||||||
3978993|NCT01268098|3801094|B3|45 to 64 years||Age, Customized||participants|Number|25|25.0||||||
3978994|NCT01268098|3801095|B2|45 to 64 years||Age, Customized||participants|Number|15|15.0||||||
3978995|NCT01268098|3801096|B1|45 to 64 years||Age, Customized||participants|Number|10|10.0||||||
3978996|NCT01268098|3801094|B3|< 45 years||Age, Customized||participants|Number|14|14.0||||||
3978997|NCT01268098|3801095|B2|< 45 years||Age, Customized||participants|Number|8|8.0||||||
3978998|NCT01268098|3801096|B1|< 45 years||Age, Customized||participants|Number|6|6.0||||||
3978999|NCT01268046|3801105|B5|United States||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
3979000|NCT01268046|3801106|B4|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3979001|NCT01268046|3801107|B3|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3979002|NCT01268046|3801108|B2|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3979003|NCT01268046|3801109|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3979004|NCT01268046|3801105|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979005|NCT01268046|3801106|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979006|NCT01268046|3801107|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979007|NCT01268046|3801108|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979008|NCT01268046|3801109|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979009|NCT01268046|3801105|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979010|NCT01268046|3801106|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979011|NCT01268046|3801107|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979012|NCT01268046|3801108|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979013|NCT01268046|3801109|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979014|NCT01268046|3801105|B5||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3979015|NCT01268046|3801106|B4||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3979016|NCT01268046|3801107|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3979017|NCT01268046|3801108|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3979018|NCT01268046|3801109|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3979019|NCT01268046|3801105|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3979020|NCT01268046|3801106|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979021|NCT01268046|3801107|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3979022|NCT01268046|3801108|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3979023|NCT01268046|3801109|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3979024|NCT01268046|3801105|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979025|NCT01268046|3801106|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979026|NCT01268046|3801107|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979027|NCT01268046|3801108|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979028|NCT01268046|3801109|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979029|NCT01268046|3801105|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3979030|NCT01268046|3801106|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979031|NCT01268046|3801107|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3979032|NCT01268046|3801108|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979033|NCT01268046|3801109|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979034|NCT01268046|3801105|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979035|NCT01268046|3801106|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979036|NCT01268046|3801107|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979037|NCT01268046|3801108|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979038|NCT01268046|3801109|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979039|NCT01268046|3801105|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979040|NCT01268046|3801106|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979041|NCT01268046|3801107|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979042|NCT01268046|3801108|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979043|NCT01268046|3801109|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979044|NCT01268046|3801105|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3979045|NCT01268046|3801106|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3979046|NCT01268046|3801107|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3979047|NCT01268046|3801108|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3979048|NCT01268046|3801109|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3979049|NCT01268046|3801105|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979050|NCT01268046|3801106|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979051|NCT01268046|3801107|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979052|NCT01268046|3801108|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979053|NCT01268046|3801109|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979054|NCT01268046|3801105|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3979055|NCT01268046|3801106|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3979056|NCT01268046|3801107|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3979057|NCT01268046|3801108|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3979058|NCT01268046|3801109|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3979059|NCT01268046|3801105|B5||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3979060|NCT01268046|3801106|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3979061|NCT01268046|3801107|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3979062|NCT01268046|3801108|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3979063|NCT01268046|3801109|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3979064|NCT01268046|3801105|B5|Age||Age, Customized||years|Mean|61.3|61.3|Standard Deviation|1.5|1.5|||
3979065|NCT01268046|3801106|B4|Age||Age, Customized||years|Mean|71.4|71.4|Standard Deviation|1.1|1.1|||
3979066|NCT01268046|3801107|B3|Age||Age, Customized||years|Mean|51.1|51.1|Standard Deviation|1.0|1.0|||
3979067|NCT01268046|3801108|B2|Age||Age, Customized||years|Mean|69.8|69.8|Standard Deviation|1.1|1.1|||
3979068|NCT01268046|3801109|B1|Age||Age, Customized||years|Mean|51.9|51.9|Standard Deviation|0.7|0.7|||
3979069|NCT01267994|3801122|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3979070|NCT01267994|3801122|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979071|NCT01267994|3801122|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3979072|NCT01267994|3801122|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979073|NCT01267994|3801122|B1||Unknown or Not Reported|Race (NIH/OMB)|14 Non-responders, 1 elected not to participate|Participants|Count of Participants|0|0.0||||||
3979074|NCT01267994|3801122|B1||More than one race|Race (NIH/OMB)|14 Non-responders, 1 elected not to participate|Participants|Count of Participants|0|0.0||||||
3979075|NCT01267994|3801122|B1||White|Race (NIH/OMB)|14 Non-responders, 1 elected not to participate|Participants|Count of Participants|13|13.0||||||
3979076|NCT01267994|3801122|B1||Black or African American|Race (NIH/OMB)|14 Non-responders, 1 elected not to participate|Participants|Count of Participants|0|0.0||||||
3979077|NCT01267994|3801122|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|14 Non-responders, 1 elected not to participate|Participants|Count of Participants|0|0.0||||||
3979078|NCT01267994|3801122|B1||Asian|Race (NIH/OMB)|14 Non-responders, 1 elected not to participate|Participants|Count of Participants|0|0.0||||||
3979079|NCT01267994|3801122|B1||American Indian or Alaska Native|Race (NIH/OMB)|14 Non-responders, 1 elected not to participate|Participants|Count of Participants|0|0.0||||||
3979080|NCT01267994|3801122|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3979081|NCT01267994|3801122|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3979082|NCT01267994|3801122|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3979083|NCT01267994|3801122|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3979084|NCT01267994|3801122|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3979085|NCT01267929|3801127|B3|||Baseline Gross Motor Function Measure (GMFM-66) score|The mean total score of GMFM-66 of each group at entry. The GMFM-66 contains five dimensions of motor measure including lying/rolling (4 items), sitting (15 items), crawling/kneeling (10 items), standing (13 items), and walking/running/jumping (24 items). The GMFM-66 are scored on a 4-point ordinal scale 0=does not initiate, 1=initiates < 10% of activity,2=partially completes 10% to < 100% of activity,3=completes activity). The scores were converted to a continuous scale by using the Winsteps Rasch Software. GMFM-66 score less than 30 that are considered low gross motor skills.|Scores|Mean|47.1|47.1|Standard Deviation|13.5|13.5|||
3979086|NCT01267929|3801128|B2|||Baseline Gross Motor Function Measure (GMFM-66) score|The mean total score of GMFM-66 of each group at entry. The GMFM-66 contains five dimensions of motor measure including lying/rolling (4 items), sitting (15 items), crawling/kneeling (10 items), standing (13 items), and walking/running/jumping (24 items). The GMFM-66 are scored on a 4-point ordinal scale 0=does not initiate, 1=initiates < 10% of activity,2=partially completes 10% to < 100% of activity,3=completes activity). The scores were converted to a continuous scale by using the Winsteps Rasch Software. GMFM-66 score less than 30 that are considered low gross motor skills.|Scores|Mean|49.4|49.4|Standard Deviation|13.1|13.1|||
3979087|NCT01267929|3801129|B1|||Baseline Gross Motor Function Measure (GMFM-66) score|The mean total score of GMFM-66 of each group at entry. The GMFM-66 contains five dimensions of motor measure including lying/rolling (4 items), sitting (15 items), crawling/kneeling (10 items), standing (13 items), and walking/running/jumping (24 items). The GMFM-66 are scored on a 4-point ordinal scale 0=does not initiate, 1=initiates < 10% of activity,2=partially completes 10% to < 100% of activity,3=completes activity). The scores were converted to a continuous scale by using the Winsteps Rasch Software. GMFM-66 score less than 30 that are considered low gross motor skills.|Scores|Mean|44.8|44.8|Standard Deviation|14.0|14.0|||
3979088|NCT01267929|3801127|B3|Thailand||Region of Enrollment||participants|Number|30|30.0||||||
3979089|NCT01267929|3801128|B2|Thailand||Region of Enrollment||participants|Number|15|15.0||||||
3979090|NCT01267929|3801129|B1|Thailand||Region of Enrollment||participants|Number|15|15.0||||||
3979091|NCT01267929|3801127|B3||Male|Sex: Female, Male|The number of males and females of each group|Participants|Count of Participants|19|19.0||||||
3979092|NCT01267929|3801128|B2||Male|Sex: Female, Male|The number of males and females of each group|Participants|Count of Participants|10|10.0||||||
3979093|NCT01267929|3801129|B1||Male|Sex: Female, Male|The number of males and females of each group|Participants|Count of Participants|9|9.0||||||
3979094|NCT01267929|3801127|B3||Female|Sex: Female, Male|The number of males and females of each group|Participants|Count of Participants|11|11.0||||||
3979095|NCT01267929|3801128|B2||Female|Sex: Female, Male|The number of males and females of each group|Participants|Count of Participants|5|5.0||||||
3979096|NCT01267929|3801129|B1||Female|Sex: Female, Male|The number of males and females of each group|Participants|Count of Participants|6|6.0||||||
3979097|NCT01267929|3801127|B3|||Age|The average age of each group|years|Mean|5.9|5.9|Standard Deviation|2.2|2.2|||
3979098|NCT01267929|3801128|B2|||Age|The average age of each group|years|Mean|5.5|5.5|Standard Deviation|2.2|2.2|||
3979099|NCT01267929|3801129|B1|||Age|The average age of each group|years|Mean|6.2|6.2|Standard Deviation|2.2|2.2|||
3979100|NCT01267864|3801136|B4||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3979101|NCT01267864|3801137|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3979102|NCT01267864|3801138|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3979103|NCT01267864|3801139|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3979104|NCT01267864|3801136|B4||Female|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
3979105|NCT01267864|3801137|B3||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3979106|NCT01267864|3801138|B2||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3979107|NCT01267864|3801139|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3979108|NCT01267864|3801136|B4|||Age||years|Median|33|33.0|Inter-Quartile Range|||25.0|43.0|
3979109|NCT01267864|3801137|B3|||Age||years|Median|33|33.0|Inter-Quartile Range|||25.0|41.0|
3979110|NCT01267864|3801138|B2|||Age||years|Median|34|34.0|Inter-Quartile Range|||25.0|44.0|
3979111|NCT01267864|3801139|B1|||Age||years|Median|34|34.0|Inter-Quartile Range|||26.0|44.0|
3979112|NCT01267422|3801171|B1|China||Region of Enrollment||participants|Number|9|9.0||||||
3979113|NCT01267422|3801171|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979114|NCT01267422|3801171|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979115|NCT01267422|3801171|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979116|NCT01267422|3801171|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979117|NCT01267422|3801171|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979118|NCT01267422|3801171|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3979119|NCT01267422|3801171|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979120|NCT01267422|3801171|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979121|NCT01267422|3801171|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3979122|NCT01267422|3801171|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979123|NCT01267422|3801171|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3979124|NCT01267422|3801171|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3979125|NCT01267422|3801171|B1|||Age||years|Median|15|15.0|Inter-Quartile Range|||7.65|30.79|
3979126|NCT01267292|3801190|B3|||Diastolic blood pressure|The baseline reading was assessed on Monday of week 2. Diastolic blood pressure is the blood pressure when the heart muscle is between beats.|mmHg|Mean|74.932485|74.932485|Standard Deviation|8.2695775|8.2695775|||
3979127|NCT01267292|3801191|B2|||Diastolic blood pressure|The baseline reading was assessed on Monday of week 2. Diastolic blood pressure is the blood pressure when the heart muscle is between beats.|mmHg|Mean|75.34091|75.34091|Standard Deviation|8.234265|8.234265|||
3979128|NCT01267292|3801192|B1|||Diastolic blood pressure|The baseline reading was assessed on Monday of week 2. Diastolic blood pressure is the blood pressure when the heart muscle is between beats.|mmHg|Mean|74.52406|74.52406|Standard Deviation|8.30489|8.30489|||
3979129|NCT01267292|3801190|B3|||Systolic blood pressure|The baseline reading was assessed on Monday of week 2. Systolic blood pressure is the amount of pressure in the arteries during contraction of the heart muscle.|mmHg|Mean|115.377|115.377|Standard Deviation|13.040245|13.040245|||
3979130|NCT01267292|3801191|B2|||Systolic blood pressure|The baseline reading was assessed on Monday of week 2. Systolic blood pressure is the amount of pressure in the arteries during contraction of the heart muscle.|mmHg|Mean|113.2727|113.2727|Standard Deviation|11.94963|11.94963|||
3979131|NCT01267292|3801192|B1|||Systolic blood pressure|The baseline reading was assessed on Monday of week 2. Systolic blood pressure is the amount of pressure in the arteries during contraction of the heart muscle.|mmHg|Mean|117.4813|117.4813|Standard Deviation|14.13086|14.13086|||
3979132|NCT01267292|3801190|B3|||Heart rate|The baseline reading was assessed on Monday of week 2. Heart rate is the measure of heart beats per minute.|beats per minute|Mean|64.938335|64.938335|Standard Deviation|11.254135|11.254135|||
3979133|NCT01267292|3801191|B2|||Heart rate|The baseline reading was assessed on Monday of week 2. Heart rate is the measure of heart beats per minute.|beats per minute|Mean|64.44886|64.44886|Standard Deviation|11.28527|11.28527|||
3979134|NCT01267292|3801192|B1|||Heart rate|The baseline reading was assessed on Monday of week 2. Heart rate is the measure of heart beats per minute.|beats per minute|Mean|65.42781|65.42781|Standard Deviation|11.223|11.223|||
3979135|NCT01267292|3801190|B3|||"Subjective Effects as assessed by the elated subscale of the visual analogue scale (VAS)"|"The baseline reading was assessed on Monday of week 2. The VAS presents 100-mm horizontal lines labeled with an adjective: “stimulated”, “high”, “anxious”, “elated”, “hungry”, and “nauseated.” The elated subscale is reported, and this sub scale is anchored by “not at all” (0) on the left and “extremely” (100) on the right, with a score range of 0-100. The higher the score, the worse the outcome."|units on a scale|Mean|21.23234|21.23234|Standard Deviation|26.24241|26.24241|||
3979136|NCT01267292|3801191|B2|||"Subjective Effects as assessed by the elated subscale of the visual analogue scale (VAS)"|"The baseline reading was assessed on Monday of week 2. The VAS presents 100-mm horizontal lines labeled with an adjective: “stimulated”, “high”, “anxious”, “elated”, “hungry”, and “nauseated.” The elated subscale is reported, and this sub scale is anchored by “not at all” (0) on the left and “extremely” (100) on the right, with a score range of 0-100. The higher the score, the worse the outcome."|units on a scale|Mean|20.4593|20.4593|Standard Deviation|26.25991|26.25991|||
3979137|NCT01267292|3801192|B1|||"Subjective Effects as assessed by the elated subscale of the visual analogue scale (VAS)"|"The baseline reading was assessed on Monday of week 2. The VAS presents 100-mm horizontal lines labeled with an adjective: “stimulated”, “high”, “anxious”, “elated”, “hungry”, and “nauseated.” The elated subscale is reported, and this sub scale is anchored by “not at all” (0) on the left and “extremely” (100) on the right, with a score range of 0-100. The higher the score, the worse the outcome."|units on a scale|Mean|22.00538|22.00538|Standard Deviation|26.22491|26.22491|||
3979138|NCT01267292|3801190|B3|||"Subjective Effects as assessed by Score on Feel High Subscale of the Drug Effects Questionnaire"|"The baseline reading was assessed on Monday of week 2. The DEQ is a visual analog scale questionnaire that assesses the extent to which subjects experience four subjective states: “Feel Drug”, “Feel High”, “Like Drug”, and “Want More”. The Feel High subscale is reported, and this subscale is scored on a visual analogue scale (scroll bar on computer screen) ranging from 0-100. 100 represents the highest score for that subjective state, and the higher the score, the worse the outcome."|units on a scale|Mean|11.7246525|11.7246525|Standard Deviation|21.259135|21.259135|||
3979139|NCT01267292|3801191|B2|||"Subjective Effects as assessed by Score on Feel High Subscale of the Drug Effects Questionnaire"|"The baseline reading was assessed on Monday of week 2. The DEQ is a visual analog scale questionnaire that assesses the extent to which subjects experience four subjective states: “Feel Drug”, “Feel High”, “Like Drug”, and “Want More”. The Feel High subscale is reported, and this subscale is scored on a visual analogue scale (scroll bar on computer screen) ranging from 0-100. 100 represents the highest score for that subjective state, and the higher the score, the worse the outcome."|units on a scale|Mean|8.128655|8.128655|Standard Deviation|17.20622|17.20622|||
3979140|NCT01267292|3801192|B1|||"Subjective Effects as assessed by Score on Feel High Subscale of the Drug Effects Questionnaire"|"The baseline reading was assessed on Monday of week 2. The DEQ is a visual analog scale questionnaire that assesses the extent to which subjects experience four subjective states: “Feel Drug”, “Feel High”, “Like Drug”, and “Want More”. The Feel High subscale is reported, and this subscale is scored on a visual analogue scale (scroll bar on computer screen) ranging from 0-100. 100 represents the highest score for that subjective state, and the higher the score, the worse the outcome."|units on a scale|Mean|15.32065|15.32065|Standard Deviation|25.31205|25.31205|||
3979141|NCT01267292|3801190|B3|||Subjective Effects as assessed by score on the Vigor Subscale of the Profile of Mood States (POMS)|The baseline reading was assessed on Monday of week 2. The POMS is a self-rating measure of current mood, consisting of six subscales demonstrated to be sensitive to a range of acute drug effects, including amphetamine, cocaine, and caffeine. A 37-item short form of the POMS was used, which correlates highly with the full scale. The vigor subscale is reported, and the vigor subscale score ranges from 0 to 28, with 28 representing the highest score for that mood state. The higher the value, the worse the outcome.|units on a scale|Mean|5.535086|5.535086|Standard Deviation|5.950416|5.950416|||
3979166|NCT01267279|3801227|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3979167|NCT01267279|3801228|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3979142|NCT01267292|3801191|B2|||Subjective Effects as assessed by score on the Vigor Subscale of the Profile of Mood States (POMS)|The baseline reading was assessed on Monday of week 2. The POMS is a self-rating measure of current mood, consisting of six subscales demonstrated to be sensitive to a range of acute drug effects, including amphetamine, cocaine, and caffeine. A 37-item short form of the POMS was used, which correlates highly with the full scale. The vigor subscale is reported, and the vigor subscale score ranges from 0 to 28, with 28 representing the highest score for that mood state. The higher the value, the worse the outcome.|units on a scale|Mean|5.080925|5.080925|Standard Deviation|5.594259|5.594259|||
3979143|NCT01267292|3801192|B1|||Subjective Effects as assessed by score on the Vigor Subscale of the Profile of Mood States (POMS)|The baseline reading was assessed on Monday of week 2. The POMS is a self-rating measure of current mood, consisting of six subscales demonstrated to be sensitive to a range of acute drug effects, including amphetamine, cocaine, and caffeine. A 37-item short form of the POMS was used, which correlates highly with the full scale. The vigor subscale is reported, and the vigor subscale score ranges from 0 to 28, with 28 representing the highest score for that mood state. The higher the value, the worse the outcome.|units on a scale|Mean|5.989247|5.989247|Standard Deviation|6.306573|6.306573|||
3979144|NCT01267292|3801190|B3|||Risky decision making as assessed by score on the risky decision making task|The baseline reading was assessed on Monday of week 2. The risky decision making task provides subjects with three choice options on each of 100 repeated trials. Options are low, moderate, and high risk, based on variance and probability in gain/loss amounts. The low risk option is more adaptive over many trials. The outcome measure is a risk index (ranging from 0.33 to 100) that factors in tolerance for variability and amount of gains and losses across the three options. 100 is highest risk. 0.33 is lowest risk.|units on a scale|Mean|9.362085|9.362085|Standard Deviation|6.44012|6.44012|||
3979145|NCT01267292|3801191|B2|||Risky decision making as assessed by score on the risky decision making task|The baseline reading was assessed on Monday of week 2. The risky decision making task provides subjects with three choice options on each of 100 repeated trials. Options are low, moderate, and high risk, based on variance and probability in gain/loss amounts. The low risk option is more adaptive over many trials. The outcome measure is a risk index (ranging from 0.33 to 100) that factors in tolerance for variability and amount of gains and losses across the three options. 100 is highest risk. 0.33 is lowest risk.|units on a scale|Mean|8.945935|8.945935|Standard Deviation|5.512101|5.512101|||
3979146|NCT01267292|3801192|B1|||Risky decision making as assessed by score on the risky decision making task|The baseline reading was assessed on Monday of week 2. The risky decision making task provides subjects with three choice options on each of 100 repeated trials. Options are low, moderate, and high risk, based on variance and probability in gain/loss amounts. The low risk option is more adaptive over many trials. The outcome measure is a risk index (ranging from 0.33 to 100) that factors in tolerance for variability and amount of gains and losses across the three options. 100 is highest risk. 0.33 is lowest risk.|units on a scale|Mean|9.778235|9.778235|Standard Deviation|7.368139|7.368139|||
3979147|NCT01267292|3801190|B3|||Attentional Bias as assessed by score on the Stroop task|The baseline reading was assessed on Monday of week 2. Participants are instructed to respond to words shown in different colors on the screen by pressing as quickly and accurately as possible on one of three colored buttons. Attentional bias is measured as the difference in reaction times on cocaine vs. neutral words. The reported score is a difference score in milliseconds (cocaine minus neutral), in which positive means slower to respond to cocaine and thus greater attentional bias, and negative means no attentional bias to cocaine words.|milliseconds|Mean|20.53846|20.53846|Standard Deviation|70.12276|70.12276|||
3979148|NCT01267292|3801191|B2|||Attentional Bias as assessed by score on the Stroop task|The baseline reading was assessed on Monday of week 2. Participants are instructed to respond to words shown in different colors on the screen by pressing as quickly and accurately as possible on one of three colored buttons. Attentional bias is measured as the difference in reaction times on cocaine vs. neutral words. The reported score is a difference score in milliseconds (cocaine minus neutral), in which positive means slower to respond to cocaine and thus greater attentional bias, and negative means no attentional bias to cocaine words.|milliseconds|Mean|28.67933|28.67933|Standard Deviation|69.99501|69.99501|||
3979149|NCT01267292|3801192|B1|||Attentional Bias as assessed by score on the Stroop task|The baseline reading was assessed on Monday of week 2. Participants are instructed to respond to words shown in different colors on the screen by pressing as quickly and accurately as possible on one of three colored buttons. Attentional bias is measured as the difference in reaction times on cocaine vs. neutral words. The reported score is a difference score in milliseconds (cocaine minus neutral), in which positive means slower to respond to cocaine and thus greater attentional bias, and negative means no attentional bias to cocaine words.|milliseconds|Mean|12.39759|12.39759|Standard Deviation|70.25051|70.25051|||
3979150|NCT01267292|3801190|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3979151|NCT01267292|3801191|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3979152|NCT01267292|3801192|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3979153|NCT01267292|3801190|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3979154|NCT01267292|3801191|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3979155|NCT01267292|3801192|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3979156|NCT01267292|3801190|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3979157|NCT01267292|3801191|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3979158|NCT01267292|3801192|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3979159|NCT01267292|3801190|B3|||Age||years|Mean|42.925|42.925|Standard Deviation|7.525|7.525|||
3979160|NCT01267292|3801191|B2|||Age||years|Mean|44.15|44.15|Standard Deviation|7.23|7.23|||
3979161|NCT01267292|3801192|B1|||Age||years|Mean|41.7|41.7|Standard Deviation|7.82|7.82|||
3979162|NCT01267279|3801227|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
3979163|NCT01267279|3801228|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
3979164|NCT01267279|3801229|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3979165|NCT01267279|3801227|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
3979168|NCT01267279|3801229|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3979169|NCT01267279|3801227|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3979170|NCT01267279|3801228|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3979171|NCT01267279|3801229|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3979172|NCT01267279|3801227|B3|||Age||Years|Mean|61.03|61.03|Full Range|||33.0|84.0|
3979173|NCT01267279|3801228|B2|||Age||Years|Mean|60.25|60.25|Full Range|||33.0|84.0|
3979174|NCT01267279|3801229|B1|||Age||Years|Mean|61.8|61.8|Full Range|||51.0|77.0|
3979175|NCT01267266|3801236|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3979176|NCT01267266|3801236|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3979177|NCT01267266|3801236|B1|||Age||years|Median|71|71.0|Full Range|||48.0|87.0|
3979178|NCT01267253|3801250|B1||Male|Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
3979179|NCT01267253|3801250|B1||Female|Sex/Gender, Customized||Participants|Count of Participants|28|28.0||||||
3979180|NCT01267253|3801250|B1|70-79 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
3979181|NCT01267253|3801250|B1|60-69 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
3979182|NCT01267253|3801250|B1|50-59 years||Age, Customized||Participants|Count of Participants|7|7.0||||||
3979183|NCT01267253|3801250|B1|40-49 years||Age, Customized||Participants|Count of Participants|9|9.0||||||
3979184|NCT01267253|3801250|B1|30-39 years||Age, Customized||Participants|Count of Participants|8|8.0||||||
3979185|NCT01267240|3801258|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3979186|NCT01267240|3801258|B1|Canada||Region of Enrollment||participants|Number|22|22.0||||||
3979187|NCT01267240|3801258|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3979188|NCT01267240|3801258|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3979189|NCT01267240|3801258|B1|||Age||years|Median|59|59.0|Full Range|||38.0|85.0|
3979190|NCT01267240|3801258|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3979191|NCT01267240|3801258|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3979192|NCT01267240|3801258|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3979193|NCT01267227|3801264|B5|United States||Region of Enrollment||participants|Number|80|80.0||||||
3979194|NCT01267227|3801265|B4|United States||Region of Enrollment||participants|Number|20|20.0||||||
3979195|NCT01267227|3801266|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3979196|NCT01267227|3801267|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3979197|NCT01267227|3801268|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3979198|NCT01267227|3801264|B5||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3979199|NCT01267227|3801265|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3979200|NCT01267227|3801266|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3979201|NCT01267227|3801267|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3979202|NCT01267227|3801268|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3979203|NCT01267227|3801264|B5||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3979204|NCT01267227|3801265|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3979205|NCT01267227|3801266|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3979206|NCT01267227|3801267|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3979207|NCT01267227|3801268|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3979208|NCT01267227|3801264|B5|||Age||years|Mean|53.6|53.6|Standard Deviation|11.2|11.2|||
3979209|NCT01267227|3801265|B4|||Age||years|Mean|54.4|54.4|Standard Deviation|11.9|11.9|||
3979210|NCT01267227|3801266|B3|||Age||years|Mean|53.0|53.0|Standard Deviation|13.7|13.7|||
3979211|NCT01267227|3801267|B2|||Age||years|Mean|53.6|53.6|Standard Deviation|7.9|7.9|||
3979212|NCT01267227|3801268|B1|||Age||years|Mean|53.6|53.6|Standard Deviation|11.2|11.2|||
3979213|NCT01267227|3801264|B5||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3979214|NCT01267227|3801265|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3979215|NCT01267227|3801266|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3979216|NCT01267227|3801267|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3979217|NCT01267227|3801268|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3979218|NCT01267227|3801264|B5||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
3979219|NCT01267227|3801265|B4||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3979220|NCT01267227|3801266|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3979221|NCT01267227|3801267|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3979222|NCT01267227|3801268|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3979223|NCT01267227|3801264|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3979224|NCT01267227|3801265|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3979225|NCT01267227|3801266|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3979226|NCT01267227|3801267|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3979227|NCT01267227|3801268|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3979228|NCT01267201|3801289|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3979229|NCT01267201|3801289|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3979230|NCT01267201|3801289|B1|||Age||Years|Mean|32.5|32.5|Standard Deviation|7.9|7.9|||
3979231|NCT01267175|3801311|B1|United Kingdom||Region of Enrollment||participants|Number|31|31.0||||||
3979232|NCT01267175|3801311|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3979233|NCT01267175|3801311|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3979234|NCT01267175|3801311|B1|||Age||years|Mean|41.9|41.9|Standard Deviation|10.64|10.64|||
3979235|NCT01267175|3801311|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3979236|NCT01267175|3801311|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3979237|NCT01267175|3801311|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3979238|NCT01267136|3801316|B3|United States||Region of Enrollment||participants|Number|84|84.0||||||
3979239|NCT01267136|3801317|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
3979240|NCT01267136|3801318|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
3979241|NCT01267136|3801316|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3979242|NCT01267136|3801317|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3979243|NCT01267136|3801318|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3979244|NCT01267136|3801316|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3979245|NCT01267136|3801317|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3979246|NCT01267136|3801318|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3979247|NCT01267136|3801316|B3|||Age||years|Mean|6.5|6.5|Standard Deviation|2.3|2.3|||
3979248|NCT01267136|3801317|B2|||Age||years|Mean|6.6|6.6|Standard Deviation|2.3|2.3|||
3979249|NCT01267136|3801318|B1|||Age||years|Mean|6.4|6.4|Standard Deviation|2.3|2.3|||
3979250|NCT01267136|3801316|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3979251|NCT01267136|3801317|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3979252|NCT01267136|3801318|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3979253|NCT01267136|3801316|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3979254|NCT01267136|3801317|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3979255|NCT01267136|3801318|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3979256|NCT01267136|3801316|B3||<=18 years|Age||Participants|Count of Participants|84|84.0||||||
3979257|NCT01267136|3801317|B2||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
3979258|NCT01267136|3801318|B1||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
3979259|NCT01267045|3801327|B3|No respiratory condition diagnosis||Respiratory Conditions||participants|Number|33|33.0||||||
3979260|NCT01267045|3801328|B2|No respiratory condition diagnosis||Respiratory Conditions||participants|Number|17|17.0||||||
3979261|NCT01267045|3801329|B1|No respiratory condition diagnosis||Respiratory Conditions||participants|Number|16|16.0||||||
3979262|NCT01267045|3801327|B3|Current respiratory condition diagnosis||Respiratory Conditions||participants|Number|22|22.0||||||
3979263|NCT01267045|3801328|B2|Current respiratory condition diagnosis||Respiratory Conditions||participants|Number|12|12.0||||||
3979264|NCT01267045|3801329|B1|Current respiratory condition diagnosis||Respiratory Conditions||participants|Number|10|10.0||||||
3979265|NCT01267045|3801327|B3|No GI condition diagnosis||Gastrointestinal Condition||participants|Number|26|26.0||||||
3979266|NCT01267045|3801328|B2|No GI condition diagnosis||Gastrointestinal Condition||participants|Number|10|10.0||||||
3979267|NCT01267045|3801329|B1|No GI condition diagnosis||Gastrointestinal Condition||participants|Number|16|16.0||||||
3979268|NCT01267045|3801327|B3|Current GI condition diagnosis||Gastrointestinal Condition||participants|Number|29|29.0||||||
3979269|NCT01267045|3801328|B2|Current GI condition diagnosis||Gastrointestinal Condition||participants|Number|19|19.0||||||
3979270|NCT01267045|3801329|B1|Current GI condition diagnosis||Gastrointestinal Condition||participants|Number|10|10.0||||||
3979271|NCT01267045|3801327|B3|No neurologic pain diagnosis||Neurologic Pain||participants|Number|26|26.0||||||
3979272|NCT01267045|3801328|B2|No neurologic pain diagnosis||Neurologic Pain||participants|Number|14|14.0||||||
3979273|NCT01267045|3801329|B1|No neurologic pain diagnosis||Neurologic Pain||participants|Number|12|12.0||||||
3979274|NCT01267045|3801327|B3|Current neurologic pain diagnosis||Neurologic Pain||participants|Number|29|29.0||||||
3979275|NCT01267045|3801328|B2|Current neurologic pain diagnosis||Neurologic Pain||participants|Number|15|15.0||||||
3979276|NCT01267045|3801329|B1|Current neurologic pain diagnosis||Neurologic Pain||participants|Number|14|14.0||||||
3979277|NCT01267045|3801327|B3|No musculoskeletal pain diagnosis||Musculoskeletal Pain||participants|Number|8|8.0||||||
3979278|NCT01267045|3801328|B2|No musculoskeletal pain diagnosis||Musculoskeletal Pain||participants|Number|2|2.0||||||
3979279|NCT01267045|3801329|B1|No musculoskeletal pain diagnosis||Musculoskeletal Pain||participants|Number|6|6.0||||||
3979280|NCT01267045|3801327|B3|Current musculoskeletal pain diagnosis||Musculoskeletal Pain||participants|Number|47|47.0||||||
3979281|NCT01267045|3801328|B2|Current musculoskeletal pain diagnosis||Musculoskeletal Pain||participants|Number|27|27.0||||||
3979282|NCT01267045|3801329|B1|Current musculoskeletal pain diagnosis||Musculoskeletal Pain||participants|Number|20|20.0||||||
3979283|NCT01267045|3801327|B3|Amphetamine||Medication Use at Baseline|This is a summary of the prevalence of medication use among the study participants. Since each participant could endorse anywhere from none of these medications to all four types of medication, the total number is unlikely to add up to the exact number of participants.|participants|Number|5|5.0||||||
3979284|NCT01267045|3801328|B2|Amphetamine||Medication Use at Baseline|This is a summary of the prevalence of medication use among the study participants. Since each participant could endorse anywhere from none of these medications to all four types of medication, the total number is unlikely to add up to the exact number of participants.|participants|Number|3|3.0||||||
3979285|NCT01267045|3801329|B1|Amphetamine||Medication Use at Baseline|This is a summary of the prevalence of medication use among the study participants. Since each participant could endorse anywhere from none of these medications to all four types of medication, the total number is unlikely to add up to the exact number of participants.|participants|Number|2|2.0||||||
3979286|NCT01267045|3801327|B3|Benzodiazepine||Medication Use at Baseline|This is a summary of the prevalence of medication use among the study participants. Since each participant could endorse anywhere from none of these medications to all four types of medication, the total number is unlikely to add up to the exact number of participants.|participants|Number|8|8.0||||||
3979287|NCT01267045|3801328|B2|Benzodiazepine||Medication Use at Baseline|This is a summary of the prevalence of medication use among the study participants. Since each participant could endorse anywhere from none of these medications to all four types of medication, the total number is unlikely to add up to the exact number of participants.|participants|Number|4|4.0||||||
3979288|NCT01267045|3801329|B1|Benzodiazepine||Medication Use at Baseline|This is a summary of the prevalence of medication use among the study participants. Since each participant could endorse anywhere from none of these medications to all four types of medication, the total number is unlikely to add up to the exact number of participants.|participants|Number|4|4.0||||||
3979289|NCT01267045|3801327|B3|Antidepressant||Medication Use at Baseline|This is a summary of the prevalence of medication use among the study participants. Since each participant could endorse anywhere from none of these medications to all four types of medication, the total number is unlikely to add up to the exact number of participants.|participants|Number|27|27.0||||||
3979290|NCT01267045|3801328|B2|Antidepressant||Medication Use at Baseline|This is a summary of the prevalence of medication use among the study participants. Since each participant could endorse anywhere from none of these medications to all four types of medication, the total number is unlikely to add up to the exact number of participants.|participants|Number|14|14.0||||||
3979291|NCT01267045|3801329|B1|Antidepressant||Medication Use at Baseline|This is a summary of the prevalence of medication use among the study participants. Since each participant could endorse anywhere from none of these medications to all four types of medication, the total number is unlikely to add up to the exact number of participants.|participants|Number|13|13.0||||||
3979292|NCT01267045|3801327|B3|Opiate||Medication Use at Baseline|This is a summary of the prevalence of medication use among the study participants. Since each participant could endorse anywhere from none of these medications to all four types of medication, the total number is unlikely to add up to the exact number of participants.|participants|Number|19|19.0||||||
3979293|NCT01267045|3801328|B2|Opiate||Medication Use at Baseline|This is a summary of the prevalence of medication use among the study participants. Since each participant could endorse anywhere from none of these medications to all four types of medication, the total number is unlikely to add up to the exact number of participants.|participants|Number|5|5.0||||||
3979294|NCT01267045|3801329|B1|Opiate||Medication Use at Baseline|This is a summary of the prevalence of medication use among the study participants. Since each participant could endorse anywhere from none of these medications to all four types of medication, the total number is unlikely to add up to the exact number of participants.|participants|Number|14|14.0||||||
3979295|NCT01267045|3801327|B3|||PTSD Symptom Scale Interview||units on a scale|Mean|27.5|27.5|Standard Deviation|10.9|10.9|||
3979296|NCT01267045|3801328|B2|||PTSD Symptom Scale Interview||units on a scale|Mean|26.2|26.2|Standard Deviation|10.6|10.6|||
3979297|NCT01267045|3801329|B1|||PTSD Symptom Scale Interview||units on a scale|Mean|29|29.0|Standard Deviation|11.2|11.2|||
3979298|NCT01267045|3801327|B3|||Cognitive Failures Questionnaire|The Cognitive Failure Questionnaire is a 25-item self-report measure of cognitive difficulty during daily living in the past six months. Each item is a question indicating a situation involving a type of cognitive failure (e.g. “Do you find you forget why you went from one part of the house to another?”), and the subject indicates how often that happens to them, on a scale of 0 (never) to 4 (very often).|units on a scale|Mean|58.9|58.9|Standard Deviation|17.5|17.5|||
3979299|NCT01267045|3801328|B2|||Cognitive Failures Questionnaire|The Cognitive Failure Questionnaire is a 25-item self-report measure of cognitive difficulty during daily living in the past six months. Each item is a question indicating a situation involving a type of cognitive failure (e.g. “Do you find you forget why you went from one part of the house to another?”), and the subject indicates how often that happens to them, on a scale of 0 (never) to 4 (very often).|units on a scale|Mean|58.3|58.3|Standard Deviation|18.7|18.7|||
3979300|NCT01267045|3801329|B1|||Cognitive Failures Questionnaire|The Cognitive Failure Questionnaire is a 25-item self-report measure of cognitive difficulty during daily living in the past six months. Each item is a question indicating a situation involving a type of cognitive failure (e.g. “Do you find you forget why you went from one part of the house to another?”), and the subject indicates how often that happens to them, on a scale of 0 (never) to 4 (very often).|units on a scale|Mean|59.6|59.6|Standard Deviation|16.5|16.5|||
3979301|NCT01267045|3801327|B3|Mental Fatigue||Multidimensional Fatigue Inventory|"The Multidimensional Fatigue Inventory is a 20-item self-report measure of various types of fatigue. Each item is a statement, and the subject indicates how much, on a scale of 1 (yes, that is true) to 5 (no, that is not true), he or she agrees with the statement (e.g. I feel very active.)"|units on a scale|Mean|15.5|15.5|Standard Deviation|3.3|3.3|||
3979302|NCT01267045|3801328|B2|Mental Fatigue||Multidimensional Fatigue Inventory|"The Multidimensional Fatigue Inventory is a 20-item self-report measure of various types of fatigue. Each item is a statement, and the subject indicates how much, on a scale of 1 (yes, that is true) to 5 (no, that is not true), he or she agrees with the statement (e.g. I feel very active.)"|units on a scale|Mean|15.6|15.6|Standard Deviation|3.2|3.2|||
3979303|NCT01267045|3801329|B1|Mental Fatigue||Multidimensional Fatigue Inventory|"The Multidimensional Fatigue Inventory is a 20-item self-report measure of various types of fatigue. Each item is a statement, and the subject indicates how much, on a scale of 1 (yes, that is true) to 5 (no, that is not true), he or she agrees with the statement (e.g. I feel very active.)"|units on a scale|Mean|15.5|15.5|Standard Deviation|3.6|3.6|||
3979328|NCT01267045|3801327|B3||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3979329|NCT01267045|3801328|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3979330|NCT01267045|3801329|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3979304|NCT01267045|3801327|B3|Reduced Motivation||Multidimensional Fatigue Inventory|"The Multidimensional Fatigue Inventory is a 20-item self-report measure of various types of fatigue. Each item is a statement, and the subject indicates how much, on a scale of 1 (yes, that is true) to 5 (no, that is not true), he or she agrees with the statement (e.g. I feel very active.)"|units on a scale|Mean|11.5|11.5|Standard Deviation|2.4|2.4|||
3979305|NCT01267045|3801328|B2|Reduced Motivation||Multidimensional Fatigue Inventory|"The Multidimensional Fatigue Inventory is a 20-item self-report measure of various types of fatigue. Each item is a statement, and the subject indicates how much, on a scale of 1 (yes, that is true) to 5 (no, that is not true), he or she agrees with the statement (e.g. I feel very active.)"|units on a scale|Mean|11.6|11.6|Standard Deviation|2.4|2.4|||
3979306|NCT01267045|3801329|B1|Reduced Motivation||Multidimensional Fatigue Inventory|"The Multidimensional Fatigue Inventory is a 20-item self-report measure of various types of fatigue. Each item is a statement, and the subject indicates how much, on a scale of 1 (yes, that is true) to 5 (no, that is not true), he or she agrees with the statement (e.g. I feel very active.)"|units on a scale|Mean|11.5|11.5|Standard Deviation|2.4|2.4|||
3979307|NCT01267045|3801327|B3|Reduced Activity||Multidimensional Fatigue Inventory|"The Multidimensional Fatigue Inventory is a 20-item self-report measure of various types of fatigue. Each item is a statement, and the subject indicates how much, on a scale of 1 (yes, that is true) to 5 (no, that is not true), he or she agrees with the statement (e.g. I feel very active.)"|units on a scale|Mean|14.6|14.6|Standard Deviation|3.9|3.9|||
3979308|NCT01267045|3801328|B2|Reduced Activity||Multidimensional Fatigue Inventory|"The Multidimensional Fatigue Inventory is a 20-item self-report measure of various types of fatigue. Each item is a statement, and the subject indicates how much, on a scale of 1 (yes, that is true) to 5 (no, that is not true), he or she agrees with the statement (e.g. I feel very active.)"|units on a scale|Mean|14.3|14.3|Standard Deviation|3.8|3.8|||
3979309|NCT01267045|3801329|B1|Reduced Activity||Multidimensional Fatigue Inventory|"The Multidimensional Fatigue Inventory is a 20-item self-report measure of various types of fatigue. Each item is a statement, and the subject indicates how much, on a scale of 1 (yes, that is true) to 5 (no, that is not true), he or she agrees with the statement (e.g. I feel very active.)"|units on a scale|Mean|14.9|14.9|Standard Deviation|4.1|4.1|||
3979310|NCT01267045|3801327|B3|Physical Fatigue||Multidimensional Fatigue Inventory|"The Multidimensional Fatigue Inventory is a 20-item self-report measure of various types of fatigue. Each item is a statement, and the subject indicates how much, on a scale of 1 (yes, that is true) to 5 (no, that is not true), he or she agrees with the statement (e.g. I feel very active.)"|units on a scale|Mean|14.9|14.9|Standard Deviation|2.8|2.8|||
3979311|NCT01267045|3801328|B2|Physical Fatigue||Multidimensional Fatigue Inventory|"The Multidimensional Fatigue Inventory is a 20-item self-report measure of various types of fatigue. Each item is a statement, and the subject indicates how much, on a scale of 1 (yes, that is true) to 5 (no, that is not true), he or she agrees with the statement (e.g. I feel very active.)"|units on a scale|Mean|15.3|15.3|Standard Deviation|2.9|2.9|||
3979312|NCT01267045|3801329|B1|Physical Fatigue||Multidimensional Fatigue Inventory|"The Multidimensional Fatigue Inventory is a 20-item self-report measure of various types of fatigue. Each item is a statement, and the subject indicates how much, on a scale of 1 (yes, that is true) to 5 (no, that is not true), he or she agrees with the statement (e.g. I feel very active.)"|units on a scale|Mean|14.4|14.4|Standard Deviation|2.7|2.7|||
3979313|NCT01267045|3801327|B3|General Fatigue||Multidimensional Fatigue Inventory|"The Multidimensional Fatigue Inventory is a 20-item self-report measure of various types of fatigue. Each item is a statement, and the subject indicates how much, on a scale of 1 (yes, that is true) to 5 (no, that is not true), he or she agrees with the statement (e.g. I feel very active.)"|units on a scale|Mean|15.8|15.8|Standard Deviation|3.0|3.0|||
3979314|NCT01267045|3801328|B2|General Fatigue||Multidimensional Fatigue Inventory|"The Multidimensional Fatigue Inventory is a 20-item self-report measure of various types of fatigue. Each item is a statement, and the subject indicates how much, on a scale of 1 (yes, that is true) to 5 (no, that is not true), he or she agrees with the statement (e.g. I feel very active.)"|units on a scale|Mean|15.5|15.5|Standard Deviation|3.2|3.2|||
3979315|NCT01267045|3801329|B1|General Fatigue||Multidimensional Fatigue Inventory|"The Multidimensional Fatigue Inventory is a 20-item self-report measure of various types of fatigue. Each item is a statement, and the subject indicates how much, on a scale of 1 (yes, that is true) to 5 (no, that is not true), he or she agrees with the statement (e.g. I feel very active.)"|units on a scale|Mean|16.0|16.0|Standard Deviation|2.8|2.8|||
3979316|NCT01267045|3801327|B3|||McGill Pain Questionnaire score|The Short-Form McGill Pain Questionnaire is a self-report 22-item measure that assesses various types of pain on a scale of 0 (none) to 10 (worst possible) experienced during the past week.|units on a scale|Mean|77.1|77.1|Standard Deviation|31.3|31.3|||
3979317|NCT01267045|3801328|B2|||McGill Pain Questionnaire score|The Short-Form McGill Pain Questionnaire is a self-report 22-item measure that assesses various types of pain on a scale of 0 (none) to 10 (worst possible) experienced during the past week.|units on a scale|Mean|81.2|81.2|Standard Deviation|41.9|41.9|||
3979318|NCT01267045|3801329|B1|||McGill Pain Questionnaire score|The Short-Form McGill Pain Questionnaire is a self-report 22-item measure that assesses various types of pain on a scale of 0 (none) to 10 (worst possible) experienced during the past week.|units on a scale|Mean|75|75.0|Standard Deviation|32.5|32.5|||
3979319|NCT01267045|3801327|B3|United States||Region of Enrollment||participants|Number|55|55.0||||||
3979320|NCT01267045|3801328|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
3979321|NCT01267045|3801329|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
3979322|NCT01267045|3801327|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3979323|NCT01267045|3801328|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3979324|NCT01267045|3801329|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3979325|NCT01267045|3801327|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979326|NCT01267045|3801328|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979327|NCT01267045|3801329|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979331|NCT01267045|3801327|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3979332|NCT01267045|3801328|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3979333|NCT01267045|3801329|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3979334|NCT01267045|3801327|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979335|NCT01267045|3801328|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979336|NCT01267045|3801329|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979337|NCT01267045|3801327|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3979338|NCT01267045|3801328|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3979339|NCT01267045|3801329|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3979340|NCT01267045|3801327|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3979341|NCT01267045|3801328|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3979342|NCT01267045|3801329|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979343|NCT01267045|3801327|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3979344|NCT01267045|3801328|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3979345|NCT01267045|3801329|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3979346|NCT01267045|3801327|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3979347|NCT01267045|3801328|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3979348|NCT01267045|3801329|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3979349|NCT01267045|3801327|B3|||Age||years|Mean|49.9|49.9|Standard Deviation|6.0|6.0|||
3979350|NCT01267045|3801328|B2|||Age||years|Mean|48.6|48.6|Standard Deviation|7.4|7.4|||
3979351|NCT01267045|3801329|B1|||Age||years|Mean|51.3|51.3|Standard Deviation|6.8|6.8|||
3979352|NCT01267045|3801327|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3979353|NCT01267045|3801328|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3979354|NCT01267045|3801329|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3979355|NCT01267045|3801327|B3||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3979356|NCT01267045|3801328|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3979357|NCT01267045|3801329|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3979358|NCT01267045|3801327|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3979359|NCT01267045|3801328|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3979360|NCT01267045|3801329|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3979361|NCT01267019|3801362|B4||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3979362|NCT01267019|3801363|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3979363|NCT01267019|3801364|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3979364|NCT01267019|3801365|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3979365|NCT01267019|3801362|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3979366|NCT01267019|3801363|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3979367|NCT01267019|3801364|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3979368|NCT01267019|3801365|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3979369|NCT01267019|3801362|B4|||Age||years|Mean|47.3|47.3|Standard Deviation|10.2|10.2|||
3979370|NCT01267019|3801363|B3|||Age||years|Mean|46.7|46.7|Standard Deviation|10.2|10.2|||
3979371|NCT01267019|3801364|B2|||Age||years|Mean|48.8|48.8|Standard Deviation|9.1|9.1|||
3979372|NCT01267019|3801365|B1|||Age||years|Mean|46.3|46.3|Standard Deviation|11.3|11.3|||
3979373|NCT01266967|3801381|B3|Not reported||Race/Ethnicity, Customized|Race was not reported for one participant who recevied prior local therapy.|participants|Number|1|1.0||||||
3979374|NCT01266967|3801382|B2|Not reported||Race/Ethnicity, Customized|Race was not reported for one participant who recevied prior local therapy.|participants|Number|1|1.0||||||
3979375|NCT01266967|3801383|B1|Not reported||Race/Ethnicity, Customized|Race was not reported for one participant who recevied prior local therapy.|participants|Number|0|0.0||||||
3979376|NCT01266967|3801381|B3|White||Race/Ethnicity, Customized|Race was not reported for one participant who recevied prior local therapy.|participants|Number|171|171.0||||||
3979377|NCT01266967|3801382|B2|White||Race/Ethnicity, Customized|Race was not reported for one participant who recevied prior local therapy.|participants|Number|82|82.0||||||
3979378|NCT01266967|3801383|B1|White||Race/Ethnicity, Customized|Race was not reported for one participant who recevied prior local therapy.|participants|Number|89|89.0||||||
3979379|NCT01266967|3801381|B3||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3979380|NCT01266967|3801382|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3979381|NCT01266967|3801383|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3979382|NCT01266967|3801381|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3979383|NCT01266967|3801382|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3979384|NCT01266967|3801383|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3979385|NCT01266967|3801381|B3|||Age||Years|Mean|52.5|52.5|Standard Deviation|13.55|13.55|||
3979386|NCT01266967|3801382|B2|||Age||Years|Mean|52.7|52.7|Standard Deviation|13.83|13.83|||
3979387|NCT01266967|3801383|B1|||Age||Years|Mean|52.3|52.3|Standard Deviation|13.35|13.35|||
3979388|NCT01266876|3801431|B6|||Low Density Lipoprotein Cholesterol (LDL-C) in mg/dL|Calculated LDL-C from Friedewald formula.|mg/dL|Mean|154.9|154.9|Standard Deviation|42.1|42.1|||
3979389|NCT01266876|3801432|B5|||Low Density Lipoprotein Cholesterol (LDL-C) in mg/dL|Calculated LDL-C from Friedewald formula.|mg/dL|Mean|147.2|147.2|Standard Deviation|32.6|32.6|||
3979390|NCT01266876|3801433|B4|||Low Density Lipoprotein Cholesterol (LDL-C) in mg/dL|Calculated LDL-C from Friedewald formula.|mg/dL|Mean|139.6|139.6|Standard Deviation|24.7|24.7|||
3979391|NCT01266876|3801434|B3|||Low Density Lipoprotein Cholesterol (LDL-C) in mg/dL|Calculated LDL-C from Friedewald formula.|mg/dL|Mean|169.8|169.8|Standard Deviation|57.0|57.0|||
3979392|NCT01266876|3801435|B2|||Low Density Lipoprotein Cholesterol (LDL-C) in mg/dL|Calculated LDL-C from Friedewald formula.|mg/dL|Mean|166.7|166.7|Standard Deviation|50.1|50.1|||
3979393|NCT01266876|3801436|B1|||Low Density Lipoprotein Cholesterol (LDL-C) in mg/dL|Calculated LDL-C from Friedewald formula.|mg/dL|Mean|150.8|150.8|Standard Deviation|34.0|34.0|||
3979394|NCT01266876|3801431|B6||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3979395|NCT01266876|3801432|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3979396|NCT01266876|3801433|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3979397|NCT01266876|3801434|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3979398|NCT01266876|3801435|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3979399|NCT01266876|3801436|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3979400|NCT01266876|3801431|B6||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3979401|NCT01266876|3801432|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3979402|NCT01266876|3801433|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3979403|NCT01266876|3801434|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3979404|NCT01266876|3801435|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3979405|NCT01266876|3801436|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3979406|NCT01266876|3801431|B6|||Age||years|Mean|53.4|53.4|Standard Deviation|9.7|9.7|||
3979407|NCT01266876|3801432|B5|||Age||years|Mean|56.3|56.3|Standard Deviation|10.2|10.2|||
3979408|NCT01266876|3801433|B4|||Age||years|Mean|54.3|54.3|Standard Deviation|9.6|9.6|||
3979409|NCT01266876|3801434|B3|||Age||years|Mean|52.9|52.9|Standard Deviation|11.2|11.2|||
3979410|NCT01266876|3801435|B2|||Age||years|Mean|51.3|51.3|Standard Deviation|7.7|7.7|||
3979411|NCT01266876|3801436|B1|||Age||years|Mean|51.9|51.9|Standard Deviation|9.6|9.6|||
3979412|NCT01266850|3801542|B6|United States||Region of Enrollment||participants|Number|1384|1384.0||||||
3979413|NCT01266850|3801543|B5|United States||Region of Enrollment||participants|Number|327|327.0||||||
3979414|NCT01266850|3801544|B4|United States||Region of Enrollment||participants|Number|329|329.0||||||
3979415|NCT01266850|3801545|B3|United States||Region of Enrollment||participants|Number|238|238.0||||||
3979416|NCT01266850|3801546|B2|United States||Region of Enrollment||participants|Number|248|248.0||||||
3979417|NCT01266850|3801547|B1|United States||Region of Enrollment||participants|Number|242|242.0||||||
3979418|NCT01266850|3801542|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979419|NCT01266850|3801543|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979420|NCT01266850|3801544|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979421|NCT01266850|3801545|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979422|NCT01266850|3801546|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979423|NCT01266850|3801547|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979424|NCT01266850|3801542|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1130|1130.0||||||
3979425|NCT01266850|3801543|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|260|260.0||||||
3979426|NCT01266850|3801544|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|277|277.0||||||
3979427|NCT01266850|3801545|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|193|193.0||||||
3979428|NCT01266850|3801546|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|199|199.0||||||
3979429|NCT01266850|3801547|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|201|201.0||||||
3979430|NCT01266850|3801542|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|254|254.0||||||
3979431|NCT01266850|3801543|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3979432|NCT01266850|3801544|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3979433|NCT01266850|3801545|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3979434|NCT01266850|3801546|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3979435|NCT01266850|3801547|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3979436|NCT01266850|3801542|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3979437|NCT01266850|3801543|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3979438|NCT01266850|3801544|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3979439|NCT01266850|3801545|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3979440|NCT01266850|3801546|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3979441|NCT01266850|3801547|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3979442|NCT01266850|3801542|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|176|176.0||||||
3979443|NCT01266850|3801543|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3979444|NCT01266850|3801544|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3979445|NCT01266850|3801545|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3979446|NCT01266850|3801546|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3979447|NCT01266850|3801547|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3979448|NCT01266850|3801542|B6||White|Race (NIH/OMB)||Participants|Count of Participants|819|819.0||||||
3979449|NCT01266850|3801543|B5||White|Race (NIH/OMB)||Participants|Count of Participants|195|195.0||||||
3979450|NCT01266850|3801544|B4||White|Race (NIH/OMB)||Participants|Count of Participants|199|199.0||||||
3979451|NCT01266850|3801545|B3||White|Race (NIH/OMB)||Participants|Count of Participants|139|139.0||||||
3979452|NCT01266850|3801546|B2||White|Race (NIH/OMB)||Participants|Count of Participants|143|143.0||||||
3979453|NCT01266850|3801547|B1||White|Race (NIH/OMB)||Participants|Count of Participants|143|143.0||||||
3979454|NCT01266850|3801542|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|330|330.0||||||
3979455|NCT01266850|3801543|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
3979456|NCT01266850|3801544|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3979457|NCT01266850|3801545|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3979458|NCT01266850|3801546|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3979459|NCT01266850|3801547|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3979460|NCT01266850|3801542|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3979461|NCT01266850|3801543|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979462|NCT01266850|3801544|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3979463|NCT01266850|3801545|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3979464|NCT01266850|3801546|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3979465|NCT01266850|3801547|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979466|NCT01266850|3801542|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3979467|NCT01266850|3801543|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3979468|NCT01266850|3801544|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3979469|NCT01266850|3801545|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3979470|NCT01266850|3801546|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3979471|NCT01266850|3801547|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3979472|NCT01266850|3801542|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3979473|NCT01266850|3801543|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3979474|NCT01266850|3801544|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979475|NCT01266850|3801545|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3979476|NCT01266850|3801546|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979477|NCT01266850|3801547|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3979478|NCT01266850|3801542|B6||Male|Sex: Female, Male||Participants|Count of Participants|698|698.0||||||
3979479|NCT01266850|3801543|B5||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
3979480|NCT01266850|3801544|B4||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3979481|NCT01266850|3801545|B3||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3979482|NCT01266850|3801546|B2||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3979483|NCT01266850|3801547|B1||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3979484|NCT01266850|3801542|B6||Female|Sex: Female, Male||Participants|Count of Participants|686|686.0||||||
3979485|NCT01266850|3801543|B5||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3979486|NCT01266850|3801544|B4||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
3979487|NCT01266850|3801545|B3||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3979488|NCT01266850|3801546|B2||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3979489|NCT01266850|3801547|B1||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3979490|NCT01266850|3801542|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3979491|NCT01266850|3801543|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3979492|NCT01266850|3801544|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3979493|NCT01266850|3801545|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3979494|NCT01266850|3801546|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3979495|NCT01266850|3801547|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3979496|NCT01266850|3801542|B6||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3979497|NCT01266850|3801543|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3979498|NCT01266850|3801544|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3979499|NCT01266850|3801545|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3979500|NCT01266850|3801546|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3979501|NCT01266850|3801547|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3979502|NCT01266850|3801542|B6||<=18 years|Age||Participants|Count of Participants|1384|1384.0||||||
3979503|NCT01266850|3801543|B5||<=18 years|Age||Participants|Count of Participants|327|327.0||||||
3979504|NCT01266850|3801544|B4||<=18 years|Age||Participants|Count of Participants|329|329.0||||||
3979505|NCT01266850|3801545|B3||<=18 years|Age||Participants|Count of Participants|238|238.0||||||
3979506|NCT01266850|3801546|B2||<=18 years|Age||Participants|Count of Participants|248|248.0||||||
3979507|NCT01266850|3801547|B1||<=18 years|Age||Participants|Count of Participants|242|242.0||||||
3979508|NCT01266850|3801542|B6|||Age||weeks|Mean|9.2|9.2|Standard Deviation|1.3|1.3|||
3979509|NCT01266850|3801543|B5|||Age||weeks|Mean|9.2|9.2|Standard Deviation|1.4|1.4|||
3979510|NCT01266850|3801544|B4|||Age||weeks|Mean|9.1|9.1|Standard Deviation|1.2|1.2|||
3979511|NCT01266850|3801545|B3|||Age||weeks|Mean|9.2|9.2|Standard Deviation|1.2|1.2|||
3979512|NCT01266850|3801546|B2|||Age||weeks|Mean|9.1|9.1|Standard Deviation|1.2|1.2|||
3979513|NCT01266850|3801547|B1|||Age||weeks|Mean|9.2|9.2|Standard Deviation|1.4|1.4|||
3979514|NCT01266824|3801603|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3979515|NCT01266824|3801604|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3979516|NCT01266824|3801605|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3979517|NCT01266824|3801603|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3979518|NCT01266824|3801604|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3979519|NCT01266824|3801605|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3979520|NCT01266824|3801603|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3979521|NCT01266824|3801604|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3979522|NCT01266824|3801605|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3979523|NCT01266824|3801603|B3|||Age||years|Mean|0.13|0.13|Standard Deviation|0.016|0.016|||
3979524|NCT01266824|3801604|B2|||Age||years|Mean|0.12|0.12|Standard Deviation|0.006|0.006|||
3979525|NCT01266824|3801605|B1|||Age||years|Mean|0.14|0.14|Standard Deviation|0.028|0.028|||
3979526|NCT01266824|3801603|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3979527|NCT01266824|3801604|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3979528|NCT01266824|3801605|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3979529|NCT01266824|3801603|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3979530|NCT01266824|3801604|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3979531|NCT01266824|3801605|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3979532|NCT01266824|3801603|B3||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3979533|NCT01266824|3801604|B2||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3979534|NCT01266824|3801605|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3979535|NCT01266590|3801618|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3979536|NCT01266590|3801618|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979537|NCT01266590|3801618|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3979538|NCT01266590|3801618|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3979539|NCT01266590|3801618|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3979540|NCT01266590|3801618|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979541|NCT01266590|3801618|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979542|NCT01266590|3801618|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979543|NCT01266590|3801618|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979544|NCT01266590|3801618|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3979545|NCT01266590|3801618|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3979546|NCT01266590|3801618|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3979547|NCT01266590|3801618|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3979548|NCT01266590|3801618|B1|||Age||years|Mean|34.9|34.9|Standard Deviation|10.8|10.8|||
3979549|NCT01266447|3801629|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3979550|NCT01266447|3801629|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3979551|NCT01266447|3801629|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3979552|NCT01266447|3801629|B1|||Age||years|Mean|49.8|49.8|Standard Deviation|10.1|10.1|||
3979553|NCT01266447|3801629|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3979554|NCT01266447|3801629|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3979555|NCT01266447|3801629|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3979556|NCT01266317|3801638|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3979557|NCT01266317|3801638|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979558|NCT01266317|3801638|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979559|NCT01266317|3801638|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3979560|NCT01266317|3801638|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979561|NCT01266317|3801638|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979562|NCT01266317|3801638|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979563|NCT01266317|3801638|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979564|NCT01266317|3801638|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3979565|NCT01266317|3801638|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3979566|NCT01266317|3801638|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3979567|NCT01266317|3801638|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3979568|NCT01266317|3801638|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3979569|NCT01266291|3801643|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3979570|NCT01266291|3801643|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979571|NCT01266291|3801643|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979572|NCT01266291|3801643|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3979573|NCT01266291|3801643|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979574|NCT01266291|3801643|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979575|NCT01266291|3801643|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979576|NCT01266291|3801643|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979577|NCT01266291|3801643|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979578|NCT01266291|3801643|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3979579|NCT01266291|3801643|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979580|NCT01266291|3801643|B1|Treatment|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3979581|NCT01266291|3801643|B1|Treatment|Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3979582|NCT01266291|3801643|B1|||Age||years|Mean|30|30.0|Full Range|||30.0|30.0|
3979583|NCT01266291|3801643|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3979584|NCT01266291|3801643|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3979585|NCT01266291|3801643|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3979586|NCT01266265|3801648|B3|Adempas (riociguat)||Baseline PAH Medication|Patients were instructed to select all that apply.|participants|Number|4|4.0||||||
3979587|NCT01266265|3801649|B2|Adempas (riociguat)||Baseline PAH Medication|Patients were instructed to select all that apply.|participants|Number|2|2.0||||||
3979588|NCT01266265|3801650|B1|Adempas (riociguat)||Baseline PAH Medication|Patients were instructed to select all that apply.|participants|Number|2|2.0||||||
3979589|NCT01266265|3801648|B3|Opsumit (macitentan)||Baseline PAH Medication|Patients were instructed to select all that apply.|participants|Number|6|6.0||||||
3979590|NCT01266265|3801649|B2|Opsumit (macitentan)||Baseline PAH Medication|Patients were instructed to select all that apply.|participants|Number|2|2.0||||||
3979591|NCT01266265|3801650|B1|Opsumit (macitentan)||Baseline PAH Medication|Patients were instructed to select all that apply.|participants|Number|4|4.0||||||
3979592|NCT01266265|3801648|B3|Tracleer (bosentan)||Baseline PAH Medication|Patients were instructed to select all that apply.|participants|Number|367|367.0||||||
3979593|NCT01266265|3801649|B2|Tracleer (bosentan)||Baseline PAH Medication|Patients were instructed to select all that apply.|participants|Number|203|203.0||||||
3979594|NCT01266265|3801650|B1|Tracleer (bosentan)||Baseline PAH Medication|Patients were instructed to select all that apply.|participants|Number|164|164.0||||||
3979595|NCT01266265|3801648|B3|Letairis (ambrisentan)||Baseline PAH Medication|Patients were instructed to select all that apply.|participants|Number|450|450.0||||||
3979596|NCT01266265|3801649|B2|Letairis (ambrisentan)||Baseline PAH Medication|Patients were instructed to select all that apply.|participants|Number|200|200.0||||||
3979597|NCT01266265|3801650|B1|Letairis (ambrisentan)||Baseline PAH Medication|Patients were instructed to select all that apply.|participants|Number|250|250.0||||||
3979598|NCT01266265|3801648|B3|Adcirca (tadalafil)||Baseline PAH Medication|Patients were instructed to select all that apply.|participants|Number|463|463.0||||||
3979599|NCT01266265|3801649|B2|Adcirca (tadalafil)||Baseline PAH Medication|Patients were instructed to select all that apply.|participants|Number|224|224.0||||||
3979600|NCT01266265|3801650|B1|Adcirca (tadalafil)||Baseline PAH Medication|Patients were instructed to select all that apply.|participants|Number|239|239.0||||||
3979601|NCT01266265|3801648|B3|Revatio (sildenafil citrate)||Baseline PAH Medication|Patients were instructed to select all that apply.|participants|Number|530|530.0||||||
3979602|NCT01266265|3801649|B2|Revatio (sildenafil citrate)||Baseline PAH Medication|Patients were instructed to select all that apply.|participants|Number|236|236.0||||||
3979603|NCT01266265|3801650|B1|Revatio (sildenafil citrate)||Baseline PAH Medication|Patients were instructed to select all that apply.|participants|Number|294|294.0||||||
3979604|NCT01266265|3801648|B3|Ventavis (iloprost) inhalation||Baseline PAH Medication|Patients were instructed to select all that apply.|participants|Number|33|33.0||||||
3979605|NCT01266265|3801649|B2|Ventavis (iloprost) inhalation||Baseline PAH Medication|Patients were instructed to select all that apply.|participants|Number|33|33.0||||||
3979606|NCT01266265|3801650|B1|Ventavis (iloprost) inhalation||Baseline PAH Medication|Patients were instructed to select all that apply.|participants|Number|0|0.0||||||
3979607|NCT01266265|3801648|B3|Veletri (epoprostinol)||Baseline PAH Medication|Patients were instructed to select all that apply.|participants|Number|36|36.0||||||
3979608|NCT01266265|3801649|B2|Veletri (epoprostinol)||Baseline PAH Medication|Patients were instructed to select all that apply.|participants|Number|36|36.0||||||
3979609|NCT01266265|3801650|B1|Veletri (epoprostinol)||Baseline PAH Medication|Patients were instructed to select all that apply.|participants|Number|0|0.0||||||
3979610|NCT01266265|3801648|B3|Flolan (epoprostenol)||Baseline PAH Medication|Patients were instructed to select all that apply.|participants|Number|46|46.0||||||
3979611|NCT01266265|3801649|B2|Flolan (epoprostenol)||Baseline PAH Medication|Patients were instructed to select all that apply.|participants|Number|44|44.0||||||
3979612|NCT01266265|3801650|B1|Flolan (epoprostenol)||Baseline PAH Medication|Patients were instructed to select all that apply.|participants|Number|2|2.0||||||
3979613|NCT01266265|3801648|B3|Remodulin (treprostinil)||Baseline PAH Medication|Patients were instructed to select all that apply.|participants|Number|152|152.0||||||
3979614|NCT01266265|3801649|B2|Remodulin (treprostinil)||Baseline PAH Medication|Patients were instructed to select all that apply.|participants|Number|150|150.0||||||
3979615|NCT01266265|3801650|B1|Remodulin (treprostinil)||Baseline PAH Medication|Patients were instructed to select all that apply.|participants|Number|2|2.0||||||
3979616|NCT01266265|3801648|B3|Tyvaso (treprostinil) inhalation||Baseline PAH Medication|Patients were instructed to select all that apply.|participants|Number|666|666.0||||||
3979617|NCT01266265|3801649|B2|Tyvaso (treprostinil) inhalation||Baseline PAH Medication|Patients were instructed to select all that apply.|participants|Number|0|0.0||||||
3979618|NCT01266265|3801650|B1|Tyvaso (treprostinil) inhalation||Baseline PAH Medication|Patients were instructed to select all that apply.|participants|Number|666|666.0||||||
3979619|NCT01266265|3801648|B3|||Years Since PAH Diagnosis||years|Median|2.9|2.9|Full Range|||0.0|32.0|
3979620|NCT01266265|3801649|B2|||Years Since PAH Diagnosis||years|Median|2.9|2.9|Full Range|||0.0|26.0|
3979621|NCT01266265|3801650|B1|||Years Since PAH Diagnosis||years|Median|2.9|2.9|Full Range|||0.0|32.0|
3979622|NCT01266265|3801648|B3|American Indian/Alaska Native||Race|Patients were instructed to select all that apply.|participants|Number|3|3.0||||||
3979623|NCT01266265|3801649|B2|American Indian/Alaska Native||Race|Patients were instructed to select all that apply.|participants|Number|1|1.0||||||
3979624|NCT01266265|3801650|B1|American Indian/Alaska Native||Race|Patients were instructed to select all that apply.|participants|Number|2|2.0||||||
3979625|NCT01266265|3801648|B3|Native Hawaiian/Pacific Islander||Race|Patients were instructed to select all that apply.|participants|Number|4|4.0||||||
3979626|NCT01266265|3801649|B2|Native Hawaiian/Pacific Islander||Race|Patients were instructed to select all that apply.|participants|Number|1|1.0||||||
3979627|NCT01266265|3801650|B1|Native Hawaiian/Pacific Islander||Race|Patients were instructed to select all that apply.|participants|Number|3|3.0||||||
3979628|NCT01266265|3801648|B3|Asian||Race|Patients were instructed to select all that apply.|participants|Number|36|36.0||||||
3979629|NCT01266265|3801649|B2|Asian||Race|Patients were instructed to select all that apply.|participants|Number|15|15.0||||||
3979630|NCT01266265|3801650|B1|Asian||Race|Patients were instructed to select all that apply.|participants|Number|21|21.0||||||
3979631|NCT01266265|3801648|B3|Other/race not disclosed||Race|Patients were instructed to select all that apply.|participants|Number|75|75.0||||||
3979632|NCT01266265|3801649|B2|Other/race not disclosed||Race|Patients were instructed to select all that apply.|participants|Number|33|33.0||||||
3979633|NCT01266265|3801650|B1|Other/race not disclosed||Race|Patients were instructed to select all that apply.|participants|Number|42|42.0||||||
3979634|NCT01266265|3801648|B3|Black/African American||Race|Patients were instructed to select all that apply.|participants|Number|223|223.0||||||
3979635|NCT01266265|3801649|B2|Black/African American||Race|Patients were instructed to select all that apply.|participants|Number|107|107.0||||||
3979636|NCT01266265|3801650|B1|Black/African American||Race|Patients were instructed to select all that apply.|participants|Number|116|116.0||||||
3979637|NCT01266265|3801648|B3|White||Race|Patients were instructed to select all that apply.|participants|Number|993|993.0||||||
3979638|NCT01266265|3801649|B2|White||Race|Patients were instructed to select all that apply.|participants|Number|510|510.0||||||
3979639|NCT01266265|3801650|B1|White||Race|Patients were instructed to select all that apply.|participants|Number|483|483.0||||||
3979640|NCT01266265|3801648|B3|Other||Disease etiology|Patients were instructed to select all that apply.|participants|Number|13|13.0||||||
3979641|NCT01266265|3801649|B2|Other||Disease etiology|Patients were instructed to select all that apply.|participants|Number|4|4.0||||||
3979642|NCT01266265|3801650|B1|Other||Disease etiology|Patients were instructed to select all that apply.|participants|Number|9|9.0||||||
3979643|NCT01266265|3801648|B3|HIV infection/porto-pulmonary||Disease etiology|Patients were instructed to select all that apply.|participants|Number|108|108.0||||||
3979644|NCT01266265|3801649|B2|HIV infection/porto-pulmonary||Disease etiology|Patients were instructed to select all that apply.|participants|Number|55|55.0||||||
3979645|NCT01266265|3801650|B1|HIV infection/porto-pulmonary||Disease etiology|Patients were instructed to select all that apply.|participants|Number|53|53.0||||||
3979646|NCT01266265|3801648|B3|Congential heart disease||Disease etiology|Patients were instructed to select all that apply.|participants|Number|92|92.0||||||
3979647|NCT01266265|3801649|B2|Congential heart disease||Disease etiology|Patients were instructed to select all that apply.|participants|Number|37|37.0||||||
3979648|NCT01266265|3801650|B1|Congential heart disease||Disease etiology|Patients were instructed to select all that apply.|participants|Number|55|55.0||||||
3979649|NCT01266265|3801648|B3|Connective tissue disease||Disease etiology|Patients were instructed to select all that apply.|participants|Number|418|418.0||||||
3979650|NCT01266265|3801649|B2|Connective tissue disease||Disease etiology|Patients were instructed to select all that apply.|participants|Number|195|195.0||||||
3979651|NCT01266265|3801650|B1|Connective tissue disease||Disease etiology|Patients were instructed to select all that apply.|participants|Number|223|223.0||||||
3979652|NCT01266265|3801648|B3|Idiopathic/heritable/drug- or toxin-induced||Disease etiology|Patients were instructed to select all that apply.|participants|Number|730|730.0||||||
3979653|NCT01266265|3801649|B2|Idiopathic/heritable/drug- or toxin-induced||Disease etiology|Patients were instructed to select all that apply.|participants|Number|389|389.0||||||
3979654|NCT01266265|3801650|B1|Idiopathic/heritable/drug- or toxin-induced||Disease etiology|Patients were instructed to select all that apply.|participants|Number|341|341.0||||||
3979655|NCT01266265|3801648|B3||Male|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
3979656|NCT01266265|3801649|B2||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3979657|NCT01266265|3801650|B1||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
3979658|NCT01266265|3801648|B3||Female|Sex: Female, Male||Participants|Count of Participants|1051|1051.0||||||
3979659|NCT01266265|3801649|B2||Female|Sex: Female, Male||Participants|Count of Participants|532|532.0||||||
3979660|NCT01266265|3801650|B1||Female|Sex: Female, Male||Participants|Count of Participants|519|519.0||||||
3979661|NCT01266265|3801648|B3|||Age||years|Median|57.25|57.25|Full Range|||3.0|97.0|
3979662|NCT01266265|3801649|B2|||Age||years|Median|57.0|57.0|Full Range|||3.0|97.0|
3979663|NCT01266265|3801650|B1|||Age||years|Median|57.5|57.5|Full Range|||5.0|90.0|
3979664|NCT01266161|3801657|B3|||Pain Intensity|"A 100-millimeter (mm) visual analog scale-pain severity rating (VAS-PSR) rated intensity of baseline pain. Participants were asked to Draw a single vertical line on the scale that shows how much pain you have at this time. Scores on this 100-mm linear scale measured to nearest millimeter from left. Zero on the scale represented no pain and 100 represented the worst pain. Score of at least 50 mm required for enrolment."|millimeter|Mean|74.8|74.8|Standard Deviation|12.20|12.2|||
3979665|NCT01266161|3801658|B2|||Pain Intensity|"A 100-millimeter (mm) visual analog scale-pain severity rating (VAS-PSR) rated intensity of baseline pain. Participants were asked to Draw a single vertical line on the scale that shows how much pain you have at this time. Scores on this 100-mm linear scale measured to nearest millimeter from left. Zero on the scale represented no pain and 100 represented the worst pain. Score of at least 50 mm required for enrolment."|millimeter|Mean|75.7|75.7|Standard Deviation|12.18|12.18|||
3979666|NCT01266161|3801659|B1|||Pain Intensity|"A 100-millimeter (mm) visual analog scale-pain severity rating (VAS-PSR) rated intensity of baseline pain. Participants were asked to Draw a single vertical line on the scale that shows how much pain you have at this time. Scores on this 100-mm linear scale measured to nearest millimeter from left. Zero on the scale represented no pain and 100 represented the worst pain. Score of at least 50 mm required for enrolment."|millimeter|Mean|73.8|73.8|Standard Deviation|12.25|12.25|||
3979667|NCT01266161|3801657|B3|Severe||Pain Severity|"A 4-point categorical pain severity rating scale was used to rate the severity of baseline pain in response to the query  My starting pain is: Responses ranged and were scored as follows: None (0), Mild (1), Moderate (2), Severe (3). A baseline pain intensity score of at least moderate was required for study enrollment."|participants|Number|30|30.0||||||
3979668|NCT01266161|3801658|B2|Severe||Pain Severity|"A 4-point categorical pain severity rating scale was used to rate the severity of baseline pain in response to the query  My starting pain is: Responses ranged and were scored as follows: None (0), Mild (1), Moderate (2), Severe (3). A baseline pain intensity score of at least moderate was required for study enrollment."|participants|Number|15|15.0||||||
3979669|NCT01266161|3801659|B1|Severe||Pain Severity|"A 4-point categorical pain severity rating scale was used to rate the severity of baseline pain in response to the query  My starting pain is: Responses ranged and were scored as follows: None (0), Mild (1), Moderate (2), Severe (3). A baseline pain intensity score of at least moderate was required for study enrollment."|participants|Number|15|15.0||||||
3979670|NCT01266161|3801657|B3|Moderate||Pain Severity|"A 4-point categorical pain severity rating scale was used to rate the severity of baseline pain in response to the query  My starting pain is: Responses ranged and were scored as follows: None (0), Mild (1), Moderate (2), Severe (3). A baseline pain intensity score of at least moderate was required for study enrollment."|participants|Number|76|76.0||||||
3979671|NCT01266161|3801658|B2|Moderate||Pain Severity|"A 4-point categorical pain severity rating scale was used to rate the severity of baseline pain in response to the query  My starting pain is: Responses ranged and were scored as follows: None (0), Mild (1), Moderate (2), Severe (3). A baseline pain intensity score of at least moderate was required for study enrollment."|participants|Number|39|39.0||||||
3979672|NCT01266161|3801659|B1|Moderate||Pain Severity|"A 4-point categorical pain severity rating scale was used to rate the severity of baseline pain in response to the query  My starting pain is: Responses ranged and were scored as follows: None (0), Mild (1), Moderate (2), Severe (3). A baseline pain intensity score of at least moderate was required for study enrollment."|participants|Number|37|37.0||||||
3979673|NCT01266161|3801657|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3979674|NCT01266161|3801658|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3979675|NCT01266161|3801659|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3979676|NCT01266161|3801657|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3979677|NCT01266161|3801658|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3979678|NCT01266161|3801659|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3979679|NCT01266161|3801657|B3|||Age||years|Mean|21.2|21.2|Standard Deviation|3.4|3.4|||
3979680|NCT01266161|3801658|B2|||Age||years|Mean|21.3|21.3|Standard Deviation|3.6|3.6|||
3979681|NCT01266161|3801659|B1|||Age||years|Mean|21.1|21.1|Standard Deviation|3.3|3.3|||
3979682|NCT01266148|3801690|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3979683|NCT01266148|3801691|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3979684|NCT01266148|3801692|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3979685|NCT01266148|3801690|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3979686|NCT01266148|3801691|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3979687|NCT01266148|3801692|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3979688|NCT01266148|3801690|B3|||Age||years|Mean|51.25|51.25|Standard Deviation|12.59|12.59|||
3979689|NCT01266148|3801691|B2|||Age||years|Mean|51.47|51.47|Standard Deviation|12.36|12.36|||
3979690|NCT01266148|3801692|B1|||Age||years|Mean|51.02|51.02|Standard Deviation|12.93|12.93|||
3979691|NCT01266122|3801719|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3979692|NCT01266122|3801720|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3979693|NCT01266122|3801721|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3979694|NCT01266122|3801719|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3979695|NCT01266122|3801720|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3979696|NCT01266122|3801721|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3979697|NCT01266122|3801719|B3|||Age||years|Mean|29|29.0|Standard Deviation|7.5|7.5|||
3979698|NCT01266122|3801720|B2|||Age||years|Mean|28.4|28.4|Standard Deviation|6.9|6.9|||
3979699|NCT01266122|3801721|B1|||Age||years|Mean|29.7|29.7|Standard Deviation|8.1|8.1|||
3979700|NCT01266070|3801730|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3979701|NCT01266070|3801730|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3979702|NCT01266070|3801730|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3979703|NCT01266070|3801730|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3979704|NCT01266070|3801730|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3979705|NCT01266070|3801730|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979706|NCT01266070|3801730|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979707|NCT01266070|3801730|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979708|NCT01266070|3801730|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3979709|NCT01266070|3801730|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3979710|NCT01266070|3801730|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3979711|NCT01266070|3801730|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
3979712|NCT01266070|3801730|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
3979713|NCT01266070|3801730|B1|||Age||years|Median|44|44.0|Full Range|||18.0|62.0|
3979714|NCT01266031|3801735|B4|United States||Region of Enrollment||participants|Number|96|96.0||||||
3979715|NCT01266031|3801736|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
3979716|NCT01266031|3801737|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
3979717|NCT01266031|3801738|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3979718|NCT01266031|3801735|B4||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3979719|NCT01266031|3801736|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3979720|NCT01266031|3801737|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3979721|NCT01266031|3801738|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3979722|NCT01266031|3801735|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3979723|NCT01266031|3801736|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3979724|NCT01266031|3801737|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3979725|NCT01266031|3801738|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3979726|NCT01266031|3801735|B4|||Age||years|Median|57|57.0|Full Range|||18.0|88.0|
3979727|NCT01266031|3801736|B3|||Age||years|Median|57|57.0|Full Range|||22.0|75.0|
3979728|NCT01266031|3801737|B2|||Age||years|Median|60|60.0|Full Range|||27.0|88.0|
3979729|NCT01266031|3801738|B1|||Age||years|Median|51.5|51.5|Full Range|||18.0|66.0|
3979730|NCT01266018|3801767|B1|<5% cells positive||Argininosuccinate Synthetase (ASS) Assay Result|ASS tumor expression was either negative or < 5% positive tumor cells by immunohistochemistry|participants|Number|11|11.0||||||
3979731|NCT01266018|3801767|B1|Negative||Argininosuccinate Synthetase (ASS) Assay Result|ASS tumor expression was either negative or < 5% positive tumor cells by immunohistochemistry|participants|Number|11|11.0||||||
3979732|NCT01266018|3801767|B1|||Body mass index||kg/m^2|Mean|28.3|28.3|Standard Deviation|5.6|5.6|||
3979733|NCT01266018|3801767|B1|Germany||Region of Enrollment||participants|Number|1|1.0||||||
3979734|NCT01266018|3801767|B1|Australia||Region of Enrollment||participants|Number|0|0.0||||||
3979735|NCT01266018|3801767|B1|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3979736|NCT01266018|3801767|B1|Taiwan||Region of Enrollment||participants|Number|6|6.0||||||
3979737|NCT01266018|3801767|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3979738|NCT01266018|3801767|B1|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
3979739|NCT01266018|3801767|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3979740|NCT01266018|3801767|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979741|NCT01266018|3801767|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3979742|NCT01266018|3801767|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3979743|NCT01266018|3801767|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979744|NCT01266018|3801767|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3979745|NCT01266018|3801767|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979746|NCT01266018|3801767|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3979747|NCT01266018|3801767|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3979748|NCT01266018|3801767|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979749|NCT01266018|3801767|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3979750|NCT01266018|3801767|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3979751|NCT01266018|3801767|B1|||Age||years|Mean|63.4|63.4|Standard Deviation|9.4|9.4|||
3979752|NCT01265992|3801779|B1|Sweden||Region of Enrollment||participants|Number|49|49.0||||||
3979753|NCT01265992|3801779|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3979754|NCT01265992|3801779|B1|American (Indian/Alaska Native)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3979755|NCT01265992|3801779|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3979756|NCT01265992|3801779|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3979757|NCT01265992|3801779|B1|White||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
3979758|NCT01265992|3801779|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3979759|NCT01265992|3801779|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3979760|NCT01265992|3801779|B1|||Age||years|Mean|63.7|63.7|Standard Deviation|11.5|11.5|||
3979761|NCT01265966|3801792|B4||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3979762|NCT01265966|3801793|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3979763|NCT01265966|3801794|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3979764|NCT01265966|3801795|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3979765|NCT01265966|3801792|B4||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3979766|NCT01265966|3801793|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3979767|NCT01265966|3801794|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3979768|NCT01265966|3801795|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3979769|NCT01265966|3801792|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3979770|NCT01265966|3801793|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3979771|NCT01265966|3801794|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3979772|NCT01265966|3801795|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3979773|NCT01265966|3801792|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3979774|NCT01265966|3801793|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3979775|NCT01265966|3801794|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3979776|NCT01265966|3801795|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3979777|NCT01265966|3801792|B4||<=18 years|Age||Participants|Count of Participants|117|117.0||||||
3979778|NCT01265966|3801793|B3||<=18 years|Age||Participants|Count of Participants|29|29.0||||||
3979779|NCT01265966|3801794|B2||<=18 years|Age||Participants|Count of Participants|41|41.0||||||
3979780|NCT01265966|3801795|B1||<=18 years|Age||Participants|Count of Participants|47|47.0||||||
3979781|NCT01265953|3801805|B3|||BMI||kg/m^2|Mean|30.0|30.0|Standard Deviation|7.1|7.1|||
3979782|NCT01265953|3801806|B2|||BMI||kg/m^2|Mean|31.1|31.1|Standard Deviation|6.4|6.4|||
3979783|NCT01265953|3801807|B1|||BMI||kg/m^2|Mean|28.9|28.9|Standard Deviation|7.6|7.6|||
3979784|NCT01265953|3801805|B3|United States||Region of Enrollment||Participants|Count of Participants|98|98.0||||||
3979785|NCT01265953|3801806|B2|United States||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
3979786|NCT01265953|3801807|B1|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
3979787|NCT01265953|3801805|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3979788|NCT01265953|3801806|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3979789|NCT01265953|3801807|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3979790|NCT01265953|3801805|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979791|NCT01265953|3801806|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979792|NCT01265953|3801807|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979793|NCT01265953|3801805|B3||White|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3979794|NCT01265953|3801806|B2||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3979795|NCT01265953|3801807|B1||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
3979796|NCT01265953|3801805|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3979797|NCT01265953|3801806|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3979798|NCT01265953|3801807|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3979799|NCT01265953|3801805|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979800|NCT01265953|3801806|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979801|NCT01265953|3801807|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979802|NCT01265953|3801805|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979803|NCT01265953|3801806|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979804|NCT01265953|3801807|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979805|NCT01265953|3801805|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979806|NCT01265953|3801806|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979807|NCT01265953|3801807|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979808|NCT01265953|3801805|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3979809|NCT01265953|3801806|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3979810|NCT01265953|3801807|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3979811|NCT01265953|3801805|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3979812|NCT01265953|3801806|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3979813|NCT01265953|3801807|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3979814|NCT01265953|3801805|B3|||Age||years|Mean|65.3|65.3|Standard Deviation|5.2|5.2|||
3979815|NCT01265953|3801806|B2|||Age||years|Mean|64.9|64.9|Standard Deviation|5.0|5.0|||
3979816|NCT01265953|3801807|B1|||Age||years|Mean|65.7|65.7|Standard Deviation|5.4|5.4|||
3979817|NCT01265875|3801820|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3979818|NCT01265875|3801820|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3979819|NCT01265875|3801820|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3979820|NCT01265875|3801820|B1|||Age||years|Mean|42|42.0|Standard Deviation|9.7|9.7|||
3979821|NCT01265875|3801820|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3979822|NCT01265875|3801820|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3979823|NCT01265875|3801820|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3979824|NCT01265823|3801828|B1|Mexico||Region of Enrollment||participants|Number|150|150.0||||||
3979825|NCT01265823|3801828|B1||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3979826|NCT01265823|3801828|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3979827|NCT01265823|3801828|B1|||Age||years|Mean|44.6|44.6|Standard Deviation|12.7|12.7|||
3979828|NCT01265797|3801855|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
3979829|NCT01265797|3801856|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
3979830|NCT01265797|3801857|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3979831|NCT01265797|3801855|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3979832|NCT01265797|3801856|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3979833|NCT01265797|3801857|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3979834|NCT01265797|3801855|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3979835|NCT01265797|3801856|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3979836|NCT01265797|3801857|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3979837|NCT01265797|3801855|B3|||Age||years|Mean|43.14|43.14|Standard Deviation|11.17|11.17|||
3979838|NCT01265797|3801856|B2|||Age||years|Mean|43.59|43.59|Standard Deviation|10.25|10.25|||
3979839|NCT01265797|3801857|B1|||Age||years|Mean|42.67|42.67|Standard Deviation|12.33|12.33|||
3979840|NCT01265797|3801855|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3979841|NCT01265797|3801856|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3979842|NCT01265797|3801857|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3979843|NCT01265797|3801855|B3||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3979844|NCT01265797|3801856|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3979845|NCT01265797|3801857|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3979846|NCT01265797|3801855|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3979847|NCT01265797|3801856|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3979848|NCT01265797|3801857|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3979849|NCT01265784|3801886|B4|India||Region of Enrollment||participants|Number|45|45.0||||||
3979850|NCT01265784|3801887|B3|India||Region of Enrollment||participants|Number|9|9.0||||||
3979851|NCT01265784|3801888|B2|India||Region of Enrollment||participants|Number|20|20.0||||||
3979852|NCT01265784|3801889|B1|India||Region of Enrollment||participants|Number|16|16.0||||||
3979853|NCT01265784|3801886|B4|Latvia||Region of Enrollment||participants|Number|21|21.0||||||
3979854|NCT01265784|3801887|B3|Latvia||Region of Enrollment||participants|Number|4|4.0||||||
3979855|NCT01265784|3801888|B2|Latvia||Region of Enrollment||participants|Number|9|9.0||||||
3979856|NCT01265784|3801889|B1|Latvia||Region of Enrollment||participants|Number|8|8.0||||||
3979857|NCT01265784|3801886|B4|Bulgaria||Region of Enrollment||participants|Number|18|18.0||||||
3979858|NCT01265784|3801887|B3|Bulgaria||Region of Enrollment||participants|Number|3|3.0||||||
3979859|NCT01265784|3801888|B2|Bulgaria||Region of Enrollment||participants|Number|6|6.0||||||
3979860|NCT01265784|3801889|B1|Bulgaria||Region of Enrollment||participants|Number|9|9.0||||||
3979861|NCT01265784|3801886|B4|Lithuania||Region of Enrollment||participants|Number|37|37.0||||||
3979862|NCT01265784|3801887|B3|Lithuania||Region of Enrollment||participants|Number|7|7.0||||||
3979863|NCT01265784|3801888|B2|Lithuania||Region of Enrollment||participants|Number|13|13.0||||||
3979864|NCT01265784|3801889|B1|Lithuania||Region of Enrollment||participants|Number|17|17.0||||||
3979865|NCT01265784|3801886|B4|Romania||Region of Enrollment||participants|Number|21|21.0||||||
3979866|NCT01265784|3801887|B3|Romania||Region of Enrollment||participants|Number|6|6.0||||||
3979867|NCT01265784|3801888|B2|Romania||Region of Enrollment||participants|Number|9|9.0||||||
3979868|NCT01265784|3801889|B1|Romania||Region of Enrollment||participants|Number|6|6.0||||||
3979869|NCT01265784|3801886|B4|United States||Region of Enrollment||participants|Number|1|1.0||||||
3979870|NCT01265784|3801887|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3979871|NCT01265784|3801888|B2|United States||Region of Enrollment||participants|Number|0|0.0||||||
3979872|NCT01265784|3801889|B1|United States||Region of Enrollment||participants|Number|0|0.0||||||
3979873|NCT01265784|3801886|B4||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3979874|NCT01265784|3801887|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3979875|NCT01265784|3801888|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3979876|NCT01265784|3801889|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3979877|NCT01265784|3801886|B4||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3979878|NCT01265784|3801887|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3979879|NCT01265784|3801888|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3979880|NCT01265784|3801889|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3979881|NCT01265784|3801886|B4|||Age||years|Mean|42.6|42.6|Standard Deviation|17.64|17.64|||
3979882|NCT01265784|3801887|B3|||Age||years|Mean|41.8|41.8|Standard Deviation|17.60|17.6|||
3979883|NCT01265784|3801888|B2|||Age||years|Mean|42.1|42.1|Standard Deviation|17.16|17.16|||
3979884|NCT01265784|3801889|B1|||Age||years|Mean|43.6|43.6|Standard Deviation|18.39|18.39|||
3979885|NCT01265719|3801957|B3||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3979886|NCT01265719|3801958|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3979887|NCT01265719|3801959|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3979888|NCT01265719|3801957|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3979889|NCT01265719|3801958|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3979890|NCT01265719|3801959|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3979891|NCT01265719|3801957|B3|||Age||Years|Mean|7.8|7.8|Standard Deviation|5.01|5.01|||
3979892|NCT01265719|3801958|B2|||Age||Years|Mean|6.4|6.4|Standard Deviation|4.76|4.76|||
3979893|NCT01265719|3801959|B1|||Age||Years|Mean|8.8|8.8|Standard Deviation|4.96|4.96|||
3979894|NCT01265667|3801992|B3||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
3979895|NCT01265667|3801993|B2||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3979896|NCT01265667|3801994|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3979897|NCT01265667|3801992|B3||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3979898|NCT01265667|3801993|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3979899|NCT01265667|3801994|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3979900|NCT01265667|3801992|B3|||Age||years|Mean|49.2|49.2|Standard Deviation|13.77|13.77|||
3979901|NCT01265667|3801993|B2|||Age||years|Mean|50.0|50.0|Standard Deviation|13.96|13.96|||
3979902|NCT01265667|3801994|B1|||Age||years|Mean|48.3|48.3|Standard Deviation|13.57|13.57|||
3979903|NCT01265615|3802007|B5|Russian Federation||Region of Enrollment||participants|Number|120|120.0||||||
3979904|NCT01265615|3802008|B4|Russian Federation||Region of Enrollment||participants|Number|30|30.0||||||
3979905|NCT01265615|3802009|B3|Russian Federation||Region of Enrollment||participants|Number|30|30.0||||||
3979906|NCT01265615|3802010|B2|Russian Federation||Region of Enrollment||participants|Number|30|30.0||||||
3979907|NCT01265615|3802011|B1|Russian Federation||Region of Enrollment||participants|Number|30|30.0||||||
3979908|NCT01265615|3802007|B5||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3979909|NCT01265615|3802008|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3979910|NCT01265615|3802009|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3979911|NCT01265615|3802010|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3979912|NCT01265615|3802011|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3979913|NCT01265615|3802007|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3979914|NCT01265615|3802008|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3979915|NCT01265615|3802009|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3979916|NCT01265615|3802010|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3979917|NCT01265615|3802011|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3979918|NCT01265615|3802007|B5|||Age||years|Mean|58|58.0|Standard Deviation|9|9.0|||
3979919|NCT01265615|3802008|B4|||Age||years|Mean|57|57.0|Standard Deviation|4|4.0|||
3979920|NCT01265615|3802009|B3|||Age||years|Mean|58|58.0|Standard Deviation|5|5.0|||
3979921|NCT01265615|3802010|B2|||Age||years|Mean|59|59.0|Standard Deviation|4|4.0|||
3979922|NCT01265615|3802011|B1|||Age||years|Mean|56|56.0|Standard Deviation|4|4.0|||
3979923|NCT01265615|3802007|B5||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3979924|NCT01265615|3802008|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3979925|NCT01265615|3802009|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3979926|NCT01265615|3802010|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3979927|NCT01265615|3802011|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3979928|NCT01265615|3802007|B5||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
3979929|NCT01265615|3802008|B4||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3979930|NCT01265615|3802009|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3979931|NCT01265615|3802010|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3979932|NCT01265615|3802011|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3979933|NCT01265615|3802007|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3979934|NCT01265615|3802008|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3979935|NCT01265615|3802009|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3979936|NCT01265615|3802010|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3979937|NCT01265615|3802011|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3979938|NCT01265563|3802060|B6|||Diastolic BP||mmHg|Mean|71.93|71.93|Standard Deviation|12.08|12.08|||
3979939|NCT01265563|3802061|B5|||Diastolic BP||mmHg|Mean|74.25|74.25|Standard Deviation|9.61|9.61|||
3979940|NCT01265563|3802062|B4|||Diastolic BP||mmHg|Mean|70.88|70.88|Standard Deviation|8.37|8.37|||
3979941|NCT01265563|3802063|B3|||Diastolic BP||mmHg|Mean|77.47|77.47|Standard Deviation|9.53|9.53|||
3979942|NCT01265563|3802064|B2|||Diastolic BP||mmHg|Mean|62.71|62.71|Standard Deviation|12.63|12.63|||
3979943|NCT01265563|3802065|B1|||Diastolic BP||mmHg|Mean|70.44|70.44|Standard Deviation|15.83|15.83|||
3979944|NCT01265563|3802060|B6|||Systolic BP||mmHg|Mean|139.15|139.15|Standard Deviation|19.02|19.02|||
3979945|NCT01265563|3802061|B5|||Systolic BP||mmHg|Mean|142.8|142.8|Standard Deviation|12|12.0|||
3979946|NCT01265563|3802062|B4|||Systolic BP||mmHg|Mean|137.13|137.13|Standard Deviation|17.10|17.1|||
3979947|NCT01265563|3802063|B3|||Systolic BP||mmHg|Mean|147.41|147.41|Standard Deviation|16.8|16.8|||
3979948|NCT01265563|3802064|B2|||Systolic BP||mmHg|Mean|125.54|125.54|Standard Deviation|22.77|22.77|||
3979949|NCT01265563|3802065|B1|||Systolic BP||mmHg|Mean|138.5|138.5|Standard Deviation|21.76|21.76|||
3979950|NCT01265563|3802060|B6|||BMI||kg/M^2|Mean|35.31|35.31|Standard Deviation|7.67|7.67|||
3979951|NCT01265563|3802061|B5|||BMI||kg/M^2|Mean|35.72|35.72|Standard Deviation|7.5|7.5|||
3979952|NCT01265563|3802062|B4|||BMI||kg/M^2|Mean|35.65|35.65|Standard Deviation|5.16|5.16|||
3979953|NCT01265563|3802063|B3|||BMI||kg/M^2|Mean|35.86|35.86|Standard Deviation|8.63|8.63|||
3979954|NCT01265563|3802064|B2|||BMI||kg/M^2|Mean|39.9|39.9|Standard Deviation|9.17|9.17|||
3979955|NCT01265563|3802065|B1|||BMI||kg/M^2|Mean|30.21|30.21|Standard Deviation|9.28|9.28|||
3979956|NCT01265563|3802060|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3979957|NCT01265563|3802061|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979958|NCT01265563|3802062|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3979959|NCT01265563|3802063|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979960|NCT01265563|3802064|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979961|NCT01265563|3802065|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979962|NCT01265563|3802060|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979963|NCT01265563|3802061|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979964|NCT01265563|3802062|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979965|NCT01265563|3802063|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979966|NCT01265563|3802064|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979967|NCT01265563|3802065|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979968|NCT01265563|3802060|B6||White|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3979969|NCT01265563|3802061|B5||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3979970|NCT01265563|3802062|B4||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3979971|NCT01265563|3802063|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3979972|NCT01265563|3802064|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3979973|NCT01265563|3802065|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3979974|NCT01265563|3802060|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3979975|NCT01265563|3802061|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3979976|NCT01265563|3802062|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3979977|NCT01265563|3802063|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3979978|NCT01265563|3802064|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3979979|NCT01265563|3802065|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3979980|NCT01265563|3802060|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3979981|NCT01265563|3802061|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979982|NCT01265563|3802062|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979983|NCT01265563|3802063|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3979984|NCT01265563|3802064|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979985|NCT01265563|3802065|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979986|NCT01265563|3802060|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979987|NCT01265563|3802061|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979988|NCT01265563|3802062|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979989|NCT01265563|3802063|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979990|NCT01265563|3802064|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979991|NCT01265563|3802065|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979992|NCT01265563|3802060|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979993|NCT01265563|3802061|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979994|NCT01265563|3802062|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979995|NCT01265563|3802063|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979996|NCT01265563|3802064|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979997|NCT01265563|3802065|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3979998|NCT01265563|3802060|B6||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3979999|NCT01265563|3802061|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3980000|NCT01265563|3802062|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3980001|NCT01265563|3802063|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3980002|NCT01265563|3802064|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3980003|NCT01265563|3802065|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3980004|NCT01265563|3802060|B6||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3980005|NCT01265563|3802061|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3980006|NCT01265563|3802062|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3980007|NCT01265563|3802063|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3980008|NCT01265563|3802064|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3980009|NCT01265563|3802065|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3980010|NCT01265563|3802060|B6|Age||Age, Customized||years|Mean|63.09|63.09|Standard Deviation|7.5|7.5|||
3980011|NCT01265563|3802061|B5|Age||Age, Customized||years|Mean|59.56|59.56|Standard Deviation|7.78|7.78|||
3980012|NCT01265563|3802062|B4|Age||Age, Customized||years|Mean|64.81|64.81|Standard Deviation|8.113|8.113|||
3980013|NCT01265563|3802063|B3|Age||Age, Customized||years|Mean|61.9|61.9|Standard Deviation|8.39|8.39|||
3980014|NCT01265563|3802064|B2|Age||Age, Customized||years|Mean|64|64.0|Standard Deviation|6.4|6.4|||
3980015|NCT01265563|3802065|B1|Age||Age, Customized||years|Mean|65.3|65.3|Standard Deviation|5.74|5.74|||
3980016|NCT01265550|3802091|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3980017|NCT01265550|3802092|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3980018|NCT01265550|3802093|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3980019|NCT01265550|3802094|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3980020|NCT01265550|3802091|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3980021|NCT01265550|3802092|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3980022|NCT01265550|3802093|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3980023|NCT01265550|3802094|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3980024|NCT01265550|3802091|B4||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3980025|NCT01265550|3802092|B3||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3980026|NCT01265550|3802093|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3980027|NCT01265550|3802094|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3980028|NCT01265550|3802091|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3980029|NCT01265550|3802092|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3980030|NCT01265550|3802093|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3980031|NCT01265550|3802094|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3980032|NCT01265550|3802091|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3980033|NCT01265550|3802092|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3980034|NCT01265550|3802093|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980035|NCT01265550|3802094|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980036|NCT01265550|3802091|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980037|NCT01265550|3802092|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980038|NCT01265550|3802093|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980039|NCT01265550|3802094|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980040|NCT01265550|3802091|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980041|NCT01265550|3802092|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980042|NCT01265550|3802093|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980043|NCT01265550|3802094|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980044|NCT01265550|3802091|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3980045|NCT01265550|3802092|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3980046|NCT01265550|3802093|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980047|NCT01265550|3802094|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980048|NCT01265550|3802091|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3980049|NCT01265550|3802092|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3980050|NCT01265550|3802093|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3980051|NCT01265550|3802094|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3980052|NCT01265550|3802091|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3980053|NCT01265550|3802092|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3980054|NCT01265550|3802093|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3980055|NCT01265550|3802094|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3980056|NCT01265550|3802091|B4||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3980057|NCT01265550|3802092|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3980058|NCT01265550|3802093|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3980059|NCT01265550|3802094|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3980060|NCT01265550|3802091|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3980061|NCT01265550|3802092|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3980062|NCT01265550|3802093|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3980063|NCT01265550|3802094|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3980064|NCT01265550|3802091|B4|||Age||years|Mean|45.4|45.4|Standard Deviation|11.8|11.8|||
3980065|NCT01265550|3802092|B3|||Age||years|Mean|47.2|47.2|Standard Deviation|11.7|11.7|||
3980066|NCT01265550|3802093|B2|||Age||years|Mean|44.9|44.9|Standard Deviation|11.8|11.8|||
3980067|NCT01265550|3802094|B1|||Age||years|Mean|43.9|43.9|Standard Deviation|12.2|12.2|||
3980068|NCT01265524|3802146|B3|IV||New York Heart Association (NYHA) Functional Class|NYHA Functional Classes are I, II, III, and IV A brief summary of the classes is included below. Class I: patients with cardiac disease but without resulting limitations of physical activity Class II: patients with cardiac disease with slight limitations to physical activity Class III: patients with cardiac disease with marked limitations of physical activity Class IV: patients with cardiac disease resulting in an inability to carry out physical activity without discomfort|participants|Number|12|12.0||||||
3980069|NCT01265524|3802147|B2|IV||New York Heart Association (NYHA) Functional Class|NYHA Functional Classes are I, II, III, and IV A brief summary of the classes is included below. Class I: patients with cardiac disease but without resulting limitations of physical activity Class II: patients with cardiac disease with slight limitations to physical activity Class III: patients with cardiac disease with marked limitations of physical activity Class IV: patients with cardiac disease resulting in an inability to carry out physical activity without discomfort|participants|Number|5|5.0||||||
3980070|NCT01265524|3802148|B1|IV||New York Heart Association (NYHA) Functional Class|NYHA Functional Classes are I, II, III, and IV A brief summary of the classes is included below. Class I: patients with cardiac disease but without resulting limitations of physical activity Class II: patients with cardiac disease with slight limitations to physical activity Class III: patients with cardiac disease with marked limitations of physical activity Class IV: patients with cardiac disease resulting in an inability to carry out physical activity without discomfort|participants|Number|7|7.0||||||
3980071|NCT01265524|3802146|B3|III||New York Heart Association (NYHA) Functional Class|NYHA Functional Classes are I, II, III, and IV A brief summary of the classes is included below. Class I: patients with cardiac disease but without resulting limitations of physical activity Class II: patients with cardiac disease with slight limitations to physical activity Class III: patients with cardiac disease with marked limitations of physical activity Class IV: patients with cardiac disease resulting in an inability to carry out physical activity without discomfort|participants|Number|97|97.0||||||
3980072|NCT01265524|3802147|B2|III||New York Heart Association (NYHA) Functional Class|NYHA Functional Classes are I, II, III, and IV A brief summary of the classes is included below. Class I: patients with cardiac disease but without resulting limitations of physical activity Class II: patients with cardiac disease with slight limitations to physical activity Class III: patients with cardiac disease with marked limitations of physical activity Class IV: patients with cardiac disease resulting in an inability to carry out physical activity without discomfort|participants|Number|45|45.0||||||
3980073|NCT01265524|3802148|B1|III||New York Heart Association (NYHA) Functional Class|NYHA Functional Classes are I, II, III, and IV A brief summary of the classes is included below. Class I: patients with cardiac disease but without resulting limitations of physical activity Class II: patients with cardiac disease with slight limitations to physical activity Class III: patients with cardiac disease with marked limitations of physical activity Class IV: patients with cardiac disease resulting in an inability to carry out physical activity without discomfort|participants|Number|52|52.0||||||
3980074|NCT01265524|3802146|B3|II||New York Heart Association (NYHA) Functional Class|NYHA Functional Classes are I, II, III, and IV A brief summary of the classes is included below. Class I: patients with cardiac disease but without resulting limitations of physical activity Class II: patients with cardiac disease with slight limitations to physical activity Class III: patients with cardiac disease with marked limitations of physical activity Class IV: patients with cardiac disease resulting in an inability to carry out physical activity without discomfort|participants|Number|2|2.0||||||
3980075|NCT01265524|3802147|B2|II||New York Heart Association (NYHA) Functional Class|NYHA Functional Classes are I, II, III, and IV A brief summary of the classes is included below. Class I: patients with cardiac disease but without resulting limitations of physical activity Class II: patients with cardiac disease with slight limitations to physical activity Class III: patients with cardiac disease with marked limitations of physical activity Class IV: patients with cardiac disease resulting in an inability to carry out physical activity without discomfort|participants|Number|2|2.0||||||
3980076|NCT01265524|3802148|B1|II||New York Heart Association (NYHA) Functional Class|NYHA Functional Classes are I, II, III, and IV A brief summary of the classes is included below. Class I: patients with cardiac disease but without resulting limitations of physical activity Class II: patients with cardiac disease with slight limitations to physical activity Class III: patients with cardiac disease with marked limitations of physical activity Class IV: patients with cardiac disease resulting in an inability to carry out physical activity without discomfort|participants|Number|0|0.0||||||
3980077|NCT01265524|3802146|B3|||eGFR||ml/min/1.73m3|Mean|45|45.0|Standard Deviation|15.8|15.8|||
3980078|NCT01265524|3802147|B2|||eGFR||ml/min/1.73m3|Mean|44.9|44.9|Standard Deviation|17.3|17.3|||
3980079|NCT01265524|3802148|B1|||eGFR||ml/min/1.73m3|Mean|45.0|45.0|Standard Deviation|14.2|14.2|||
3980080|NCT01265524|3802146|B3|||Weight||kg|Mean|75.2|75.2|Standard Deviation|14.9|14.9|||
3980081|NCT01265524|3802147|B2|||Weight||kg|Mean|75.1|75.1|Standard Deviation|16.2|16.2|||
3980082|NCT01265524|3802148|B1|||Weight||kg|Mean|75.3|75.3|Standard Deviation|13.6|13.6|||
3980083|NCT01265524|3802146|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3980084|NCT01265524|3802147|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3980085|NCT01265524|3802148|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3980086|NCT01265524|3802146|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3980087|NCT01265524|3802147|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3980088|NCT01265524|3802148|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3980089|NCT01265524|3802146|B3|||Age, Customized||years|Mean|69|69.0|Standard Deviation|9|9.0|||
3980090|NCT01265524|3802147|B2|||Age, Customized||years|Mean|70|70.0|Standard Deviation|10|10.0|||
3980091|NCT01265524|3802148|B1|||Age, Customized||years|Mean|68|68.0|Standard Deviation|8|8.0|||
3980092|NCT01265511|3802167|B3|||HCV RNA||log10 IU/mL|Mean|6.48|6.48|Standard Deviation|0.58|0.58|||
3980093|NCT01265511|3802168|B2|||HCV RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.49|0.49|||
3980094|NCT01265511|3802169|B1|||HCV RNA||log10 IU/mL|Mean|7.21|7.21|Standard Deviation|0.05|0.05|||
3980095|NCT01265511|3802167|B3|HCV_1b||HCV genotype||participants|Number|2|2.0||||||
3980096|NCT01265511|3802168|B2|HCV_1b||HCV genotype||participants|Number|1|1.0||||||
3980097|NCT01265511|3802169|B1|HCV_1b||HCV genotype||participants|Number|1|1.0||||||
3980098|NCT01265511|3802167|B3|HCV_1a||HCV genotype||participants|Number|8|8.0||||||
3980099|NCT01265511|3802168|B2|HCV_1a||HCV genotype||participants|Number|7|7.0||||||
3980100|NCT01265511|3802169|B1|HCV_1a||HCV genotype||participants|Number|1|1.0||||||
3980101|NCT01265511|3802167|B3|IL28B_TT||IL28B genotype||participants|Number|2|2.0||||||
3980102|NCT01265511|3802168|B2|IL28B_TT||IL28B genotype||participants|Number|2|2.0||||||
3980103|NCT01265511|3802169|B1|IL28B_TT||IL28B genotype||participants|Number|0|0.0||||||
3980104|NCT01265511|3802167|B3|IL28B_CT||IL28B genotype||participants|Number|8|8.0||||||
3980105|NCT01265511|3802168|B2|IL28B_CT||IL28B genotype||participants|Number|6|6.0||||||
3980106|NCT01265511|3802169|B1|IL28B_CT||IL28B genotype||participants|Number|2|2.0||||||
3980107|NCT01265511|3802167|B3|Puerto Rico||Region of Enrollment||participants|Number|5|5.0||||||
3980108|NCT01265511|3802168|B2|Puerto Rico||Region of Enrollment||participants|Number|4|4.0||||||
3980109|NCT01265511|3802169|B1|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
3980110|NCT01265511|3802167|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3980111|NCT01265511|3802168|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3980112|NCT01265511|3802169|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3980113|NCT01265511|3802167|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980114|NCT01265511|3802168|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980115|NCT01265511|3802169|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980116|NCT01265511|3802167|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3980117|NCT01265511|3802168|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3980118|NCT01265511|3802169|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980119|NCT01265511|3802167|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3980120|NCT01265511|3802168|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3980121|NCT01265511|3802169|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3980122|NCT01265511|3802167|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3980123|NCT01265511|3802168|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980124|NCT01265511|3802169|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3980125|NCT01265511|3802167|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980126|NCT01265511|3802168|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980127|NCT01265511|3802169|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980128|NCT01265511|3802167|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980129|NCT01265511|3802168|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980130|NCT01265511|3802169|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980131|NCT01265511|3802167|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980132|NCT01265511|3802168|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980133|NCT01265511|3802169|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980134|NCT01265511|3802167|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3980135|NCT01265511|3802168|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3980136|NCT01265511|3802169|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3980137|NCT01265511|3802167|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3980138|NCT01265511|3802168|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3980139|NCT01265511|3802169|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3980140|NCT01265511|3802167|B3|||Age||years|Mean|45.1|45.1|Standard Deviation|9.29|9.29|||
3980141|NCT01265511|3802168|B2|||Age||years|Mean|44.6|44.6|Standard Deviation|8.67|8.67|||
3980142|NCT01265511|3802169|B1|||Age||years|Mean|47.0|47.0|Standard Deviation|15.56|15.56|||
3980143|NCT01265498|3802182|B3|||Liver histology findings: Biopsy length||mm|Mean|21|21.0|Standard Deviation|10|10.0|||
3980144|NCT01265498|3802183|B2|||Liver histology findings: Biopsy length||mm|Mean|21|21.0|Standard Deviation|10|10.0|||
3980145|NCT01265498|3802184|B1|||Liver histology findings: Biopsy length||mm|Mean|21|21.0|Standard Deviation|10|10.0|||
3980146|NCT01265498|3802182|B3|||Liver histology findings: Portal inflammation score|Portal inflammation was assessed on a scale of 0–2 with higher scores showing more severe inflammation.|units on a scale|Mean|1.1|1.1|Standard Deviation|0.6|0.6|||
3980147|NCT01265498|3802183|B2|||Liver histology findings: Portal inflammation score|Portal inflammation was assessed on a scale of 0–2 with higher scores showing more severe inflammation.|units on a scale|Mean|1.1|1.1|Standard Deviation|0.6|0.6|||
3980148|NCT01265498|3802184|B1|||Liver histology findings: Portal inflammation score|Portal inflammation was assessed on a scale of 0–2 with higher scores showing more severe inflammation.|units on a scale|Mean|1.2|1.2|Standard Deviation|0.6|0.6|||
3980149|NCT01265498|3802182|B3|||Liver histology findings: Lobular inflammation score|Assessed on a scale of 0–3 with higher scores showing more severe lobular inflammation.|units on a scale|Mean|1.8|1.8|Standard Deviation|0.7|0.7|||
3980150|NCT01265498|3802183|B2|||Liver histology findings: Lobular inflammation score|Assessed on a scale of 0–3 with higher scores showing more severe lobular inflammation.|units on a scale|Mean|1.8|1.8|Standard Deviation|0.7|0.7|||
3980151|NCT01265498|3802184|B1|||Liver histology findings: Lobular inflammation score|Assessed on a scale of 0–3 with higher scores showing more severe lobular inflammation.|units on a scale|Mean|1.8|1.8|Standard Deviation|0.7|0.7|||
3980152|NCT01265498|3802182|B3|||Liver histology findings: Steatosis score|Assessed on a scale of 0–3 with higher scores showing more severe steatosis.|units on a scale|Mean|2.0|2.0|Standard Deviation|0.8|0.8|||
3980153|NCT01265498|3802183|B2|||Liver histology findings: Steatosis score|Assessed on a scale of 0–3 with higher scores showing more severe steatosis.|units on a scale|Mean|2.0|2.0|Standard Deviation|0.8|0.8|||
3980154|NCT01265498|3802184|B1|||Liver histology findings: Steatosis score|Assessed on a scale of 0–3 with higher scores showing more severe steatosis.|units on a scale|Mean|2.1|2.1|Standard Deviation|0.8|0.8|||
3980155|NCT01265498|3802182|B3|||Liver histology findings: Hepatocellular ballooning score|Assessed on a scale of 0–2 with higher scores showing more severe ballooning.|units on a scale|Mean|1.4|1.4|Standard Deviation|0.7|0.7|||
3980156|NCT01265498|3802183|B2|||Liver histology findings: Hepatocellular ballooning score|Assessed on a scale of 0–2 with higher scores showing more severe ballooning.|units on a scale|Mean|1.3|1.3|Standard Deviation|0.7|0.7|||
3980157|NCT01265498|3802184|B1|||Liver histology findings: Hepatocellular ballooning score|Assessed on a scale of 0–2 with higher scores showing more severe ballooning.|units on a scale|Mean|1.4|1.4|Standard Deviation|0.7|0.7|||
3980158|NCT01265498|3802182|B3|||Liver histology findings: Total NAFLD activity score|Total non-alcoholic fatty liver disease (NAFLD) activity was assessed on a scale of 0–8, with higher scores indicating more severe disease; the components of this measure are steatosis (assessed on a scale of 0–3), lobular inflammation (assessed on a scale of 0–3), and hepatocellular ballooning assessed on a scale of 0–2).|units on a scale|Mean|5.2|5.2|Standard Deviation|1.3|1.3|||
3980159|NCT01265498|3802183|B2|||Liver histology findings: Total NAFLD activity score|Total non-alcoholic fatty liver disease (NAFLD) activity was assessed on a scale of 0–8, with higher scores indicating more severe disease; the components of this measure are steatosis (assessed on a scale of 0–3), lobular inflammation (assessed on a scale of 0–3), and hepatocellular ballooning assessed on a scale of 0–2).|units on a scale|Mean|5.1|5.1|Standard Deviation|1.3|1.3|||
3980160|NCT01265498|3802184|B1|||Liver histology findings: Total NAFLD activity score|Total non-alcoholic fatty liver disease (NAFLD) activity was assessed on a scale of 0–8, with higher scores indicating more severe disease; the components of this measure are steatosis (assessed on a scale of 0–3), lobular inflammation (assessed on a scale of 0–3), and hepatocellular ballooning assessed on a scale of 0–2).|units on a scale|Mean|5.3|5.3|Standard Deviation|1.3|1.3|||
3980161|NCT01265498|3802182|B3|||Liver histology findings: Fibrosis stage|†Fibrosis was assessed on a scale of 0–4, with higher scores showing more severe fibrosis.|units on a scale|Mean|1.8|1.8|Standard Deviation|1.1|1.1|||
3980162|NCT01265498|3802183|B2|||Liver histology findings: Fibrosis stage|†Fibrosis was assessed on a scale of 0–4, with higher scores showing more severe fibrosis.|units on a scale|Mean|1.8|1.8|Standard Deviation|1.0|1.0|||
3980163|NCT01265498|3802184|B1|||Liver histology findings: Fibrosis stage|†Fibrosis was assessed on a scale of 0–4, with higher scores showing more severe fibrosis.|units on a scale|Mean|1.9|1.9|Standard Deviation|1.1|1.1|||
3980164|NCT01265498|3802182|B3|||Liver histology findings: Definite steatohepatitis||participants|Number|225|225.0||||||
3980165|NCT01265498|3802183|B2|||Liver histology findings: Definite steatohepatitis||participants|Number|111|111.0||||||
3980166|NCT01265498|3802184|B1|||Liver histology findings: Definite steatohepatitis||participants|Number|114|114.0||||||
3980167|NCT01265498|3802182|B3|||Concomitant medications in the past 6 months: Aspirin (81 mg)||participants|Number|70|70.0||||||
3980168|NCT01265498|3802183|B2|||Concomitant medications in the past 6 months: Aspirin (81 mg)||participants|Number|33|33.0||||||
3980169|NCT01265498|3802184|B1|||Concomitant medications in the past 6 months: Aspirin (81 mg)||participants|Number|37|37.0||||||
3980170|NCT01265498|3802182|B3|||Concomitant medications in the past 6 months: Thiazolidinedione||participants|Number|8|8.0||||||
3980171|NCT01265498|3802183|B2|||Concomitant medications in the past 6 months: Thiazolidinedione||participants|Number|5|5.0||||||
3980172|NCT01265498|3802184|B1|||Concomitant medications in the past 6 months: Thiazolidinedione||participants|Number|3|3.0||||||
3980173|NCT01265498|3802182|B3|||Concomitant medications in the past 6 months: Vitamin E||participants|Number|61|61.0||||||
3980174|NCT01265498|3802183|B2|||Concomitant medications in the past 6 months: Vitamin E||participants|Number|32|32.0||||||
3980175|NCT01265498|3802184|B1|||Concomitant medications in the past 6 months: Vitamin E||participants|Number|29|29.0||||||
3980176|NCT01265498|3802182|B3|||Concomitant medications in the past 6 months: Pioglitazone||participants|Number|7|7.0||||||
3980177|NCT01265498|3802183|B2|||Concomitant medications in the past 6 months: Pioglitazone||participants|Number|6|6.0||||||
3980178|NCT01265498|3802184|B1|||Concomitant medications in the past 6 months: Pioglitazone||participants|Number|1|1.0||||||
3980179|NCT01265498|3802182|B3|||Concomitant medications in the past 6 months: Metformin||participants|Number|117|117.0||||||
3980180|NCT01265498|3802183|B2|||Concomitant medications in the past 6 months: Metformin||participants|Number|62|62.0||||||
3980181|NCT01265498|3802184|B1|||Concomitant medications in the past 6 months: Metformin||participants|Number|55|55.0||||||
3980182|NCT01265498|3802182|B3|||Concomitant medications in the past 6 months: Antidiabetic||participants|Number|140|140.0||||||
3980183|NCT01265498|3802183|B2|||Concomitant medications in the past 6 months: Antidiabetic||participants|Number|73|73.0||||||
3980184|NCT01265498|3802184|B1|||Concomitant medications in the past 6 months: Antidiabetic||participants|Number|67|67.0||||||
3980185|NCT01265498|3802182|B3|||Concomitant medications in the past 6 months: Cardiovascular||participants|Number|189|189.0||||||
3980186|NCT01265498|3802183|B2|||Concomitant medications in the past 6 months: Cardiovascular||participants|Number|92|92.0||||||
3980187|NCT01265498|3802184|B1|||Concomitant medications in the past 6 months: Cardiovascular||participants|Number|97|97.0||||||
3980188|NCT01265498|3802182|B3|||Concomitant medications in the past 6 months: Antilipidaemic||participants|Number|136|136.0||||||
3980189|NCT01265498|3802183|B2|||Concomitant medications in the past 6 months: Antilipidaemic||participants|Number|64|64.0||||||
3980190|NCT01265498|3802184|B1|||Concomitant medications in the past 6 months: Antilipidaemic||participants|Number|72|72.0||||||
3980191|NCT01265498|3802182|B3|||Comorbidities: Diabetes||participants|Number|149|149.0||||||
3980192|NCT01265498|3802183|B2|||Comorbidities: Diabetes||participants|Number|74|74.0||||||
3980193|NCT01265498|3802184|B1|||Comorbidities: Diabetes||participants|Number|75|75.0||||||
3980194|NCT01265498|3802182|B3|||Comorbidities: Cardiovascular disease||participants|Number|15|15.0||||||
3980195|NCT01265498|3802183|B2|||Comorbidities: Cardiovascular disease||participants|Number|8|8.0||||||
3980196|NCT01265498|3802184|B1|||Comorbidities: Cardiovascular disease||participants|Number|7|7.0||||||
3980197|NCT01265498|3802182|B3|||Comorbidities: Hypertension||participants|Number|172|172.0||||||
3980198|NCT01265498|3802183|B2|||Comorbidities: Hypertension||participants|Number|85|85.0||||||
3980199|NCT01265498|3802184|B1|||Comorbidities: Hypertension||participants|Number|87|87.0||||||
3980200|NCT01265498|3802182|B3|||Comorbidities: Hyperlipidaemia|History of cholesterol or triglyceride elevations as determined by the site investigator.|participants|Number|173|173.0||||||
3980201|NCT01265498|3802183|B2|||Comorbidities: Hyperlipidaemia|History of cholesterol or triglyceride elevations as determined by the site investigator.|participants|Number|86|86.0||||||
3980202|NCT01265498|3802184|B1|||Comorbidities: Hyperlipidaemia|History of cholesterol or triglyceride elevations as determined by the site investigator.|participants|Number|87|87.0||||||
3980203|NCT01265498|3802182|B3|||Metabolic factors: Diastolic blood pressure||mm Hg|Mean|77|77.0|Standard Deviation|10|10.0|||
3980204|NCT01265498|3802183|B2|||Metabolic factors: Diastolic blood pressure||mm Hg|Mean|78|78.0|Standard Deviation|10|10.0|||
3980205|NCT01265498|3802184|B1|||Metabolic factors: Diastolic blood pressure||mm Hg|Mean|77|77.0|Standard Deviation|11|11.0|||
3980206|NCT01265498|3802182|B3|||Metabolic factors: Systolic blood pressure||mm Hg|Mean|132|132.0|Standard Deviation|16|16.0|||
3980207|NCT01265498|3802183|B2|||Metabolic factors: Systolic blood pressure||mm Hg|Mean|132|132.0|Standard Deviation|15|15.0|||
3980208|NCT01265498|3802184|B1|||Metabolic factors: Systolic blood pressure||mm Hg|Mean|132|132.0|Standard Deviation|17|17.0|||
3980209|NCT01265498|3802182|B3|||Metabolic factors: Waist-to-hip ratio||ratio|Mean|0.95|0.95|Standard Deviation|0.08|0.08|||
3980210|NCT01265498|3802183|B2|||Metabolic factors: Waist-to-hip ratio||ratio|Mean|0.95|0.95|Standard Deviation|0.09|0.09|||
3980211|NCT01265498|3802184|B1|||Metabolic factors: Waist-to-hip ratio||ratio|Mean|0.96|0.96|Standard Deviation|0.07|0.07|||
3980212|NCT01265498|3802182|B3|||Metabolic factors: Waist circumference||cm|Mean|111|111.0|Standard Deviation|15|15.0|||
3980213|NCT01265498|3802183|B2|||Metabolic factors: Waist circumference||cm|Mean|109|109.0|Standard Deviation|14|14.0|||
3980214|NCT01265498|3802184|B1|||Metabolic factors: Waist circumference||cm|Mean|112|112.0|Standard Deviation|15|15.0|||
3980215|NCT01265498|3802182|B3|||Metabolic factors: Body-mass index||kg/m²|Mean|35|35.0|Standard Deviation|6|6.0|||
3980216|NCT01265498|3802183|B2|||Metabolic factors: Body-mass index||kg/m²|Mean|34|34.0|Standard Deviation|6|6.0|||
3980217|NCT01265498|3802184|B1|||Metabolic factors: Body-mass index||kg/m²|Mean|35|35.0|Standard Deviation|7|7.0|||
3980218|NCT01265498|3802182|B3|||Metabolic factors: Weight||kg|Mean|98|98.0|Standard Deviation|21|21.0|||
3980219|NCT01265498|3802183|B2|||Metabolic factors: Weight||kg|Mean|96|96.0|Standard Deviation|18|18.0|||
3980220|NCT01265498|3802184|B1|||Metabolic factors: Weight||kg|Mean|100|100.0|Standard Deviation|23|23.0|||
3980221|NCT01265498|3802182|B3|||Metabolic factors: Glycated haemoglobin A1c||mmol/mol|Mean|47|47.0|Standard Deviation|11|11.0|||
3980222|NCT01265498|3802183|B2|||Metabolic factors: Glycated haemoglobin A1c||mmol/mol|Mean|47|47.0|Standard Deviation|11|11.0|||
3980223|NCT01265498|3802184|B1|||Metabolic factors: Glycated haemoglobin A1c||mmol/mol|Mean|48|48.0|Standard Deviation|12|12.0|||
3980224|NCT01265498|3802182|B3|||Metabolic factors: HOMA-IR||glucose [mmol/L] × insulin [pmol/L]/22.5|Mean|50|50.0|Standard Deviation|61|61.0|||
3980225|NCT01265498|3802183|B2|||Metabolic factors: HOMA-IR||glucose [mmol/L] × insulin [pmol/L]/22.5|Mean|40|40.0|Standard Deviation|42|42.0|||
3980226|NCT01265498|3802184|B1|||Metabolic factors: HOMA-IR||glucose [mmol/L] × insulin [pmol/L]/22.5|Mean|61|61.0|Standard Deviation|74|74.0|||
3980227|NCT01265498|3802182|B3|||Metabolic factors: Insulin||pmol/L|Mean|169|169.0|Standard Deviation|186|186.0|||
3980228|NCT01265498|3802183|B2|||Metabolic factors: Insulin||pmol/L|Mean|138|138.0|Standard Deviation|129|129.0|||
3980229|NCT01265498|3802184|B1|||Metabolic factors: Insulin||pmol/L|Mean|201|201.0|Standard Deviation|226|226.0|||
3980230|NCT01265498|3802182|B3|||Metabolic factors: Fasting serum glucose||mmol/L|Mean|6.4|6.4|Standard Deviation|2.0|2.0|||
3980231|NCT01265498|3802183|B2|||Metabolic factors: Fasting serum glucose||mmol/L|Mean|6.4|6.4|Standard Deviation|2.2|2.2|||
3980232|NCT01265498|3802184|B1|||Metabolic factors: Fasting serum glucose||mmol/L|Mean|6.5|6.5|Standard Deviation|1.8|1.8|||
3980233|NCT01265498|3802182|B3|||Other laboratory results: International normalised ratio||ratio|Mean|1.00|1.0|Standard Deviation|0.07|0.07|||
3980234|NCT01265498|3802183|B2|||Other laboratory results: International normalised ratio||ratio|Mean|1.00|1.0|Standard Deviation|0.07|0.07|||
3980235|NCT01265498|3802184|B1|||Other laboratory results: International normalised ratio||ratio|Mean|1.01|1.01|Standard Deviation|0.08|0.08|||
3980236|NCT01265498|3802182|B3|||Other laboratory results: Prothrombin time||s|Mean|11.7|11.7|Standard Deviation|2.1|2.1|||
3980237|NCT01265498|3802183|B2|||Other laboratory results: Prothrombin time||s|Mean|11.7|11.7|Standard Deviation|2.2|2.2|||
3980238|NCT01265498|3802184|B1|||Other laboratory results: Prothrombin time||s|Mean|11.7|11.7|Standard Deviation|2.1|2.1|||
3980239|NCT01265498|3802182|B3|||Chemistries: Total protein||g/L|Mean|73|73.0|Standard Deviation|5|5.0|||
3980240|NCT01265498|3802183|B2|||Chemistries: Total protein||g/L|Mean|74|74.0|Standard Deviation|5|5.0|||
3980241|NCT01265498|3802184|B1|||Chemistries: Total protein||g/L|Mean|73|73.0|Standard Deviation|5|5.0|||
3980242|NCT01265498|3802182|B3|||Chemistries: Albumin||g/L|Mean|43|43.0|Standard Deviation|4|4.0|||
3980243|NCT01265498|3802183|B2|||Chemistries: Albumin||g/L|Mean|43|43.0|Standard Deviation|4|4.0|||
3980244|NCT01265498|3802184|B1|||Chemistries: Albumin||g/L|Mean|43|43.0|Standard Deviation|4|4.0|||
3980245|NCT01265498|3802182|B3|||Chemistries: Uric acid||μmol/L|Mean|370|370.0|Standard Deviation|87|87.0|||
3980246|NCT01265498|3802183|B2|||Chemistries: Uric acid||μmol/L|Mean|366|366.0|Standard Deviation|86|86.0|||
3980247|NCT01265498|3802184|B1|||Chemistries: Uric acid||μmol/L|Mean|375|375.0|Standard Deviation|89|89.0|||
3980248|NCT01265498|3802182|B3|||Chemistries: Creatinine||μmol/L|Mean|71|71.0|Standard Deviation|17|17.0|||
3980249|NCT01265498|3802183|B2|||Chemistries: Creatinine||μmol/L|Mean|70|70.0|Standard Deviation|16|16.0|||
3980250|NCT01265498|3802184|B1|||Chemistries: Creatinine||μmol/L|Mean|71|71.0|Standard Deviation|18|18.0|||
3980251|NCT01265498|3802182|B3|||Chemistries: Phosphate||mmol/L|Mean|1.1|1.1|Standard Deviation|0.2|0.2|||
3980252|NCT01265498|3802183|B2|||Chemistries: Phosphate||mmol/L|Mean|1.1|1.1|Standard Deviation|0.2|0.2|||
3980253|NCT01265498|3802184|B1|||Chemistries: Phosphate||mmol/L|Mean|1.1|1.1|Standard Deviation|0.2|0.2|||
3980254|NCT01265498|3802182|B3|||Chemistries: Calcium||mmol/L|Mean|2.4|2.4|Standard Deviation|0.1|0.1|||
3980255|NCT01265498|3802183|B2|||Chemistries: Calcium||mmol/L|Mean|2.4|2.4|Standard Deviation|0.1|0.1|||
3980256|NCT01265498|3802184|B1|||Chemistries: Calcium||mmol/L|Mean|2.4|2.4|Standard Deviation|0.1|0.1|||
3980257|NCT01265498|3802182|B3|||Chemistries: Bicarbonate||mmol/L|Mean|26.0|26.0|Standard Deviation|2.5|2.5|||
3980258|NCT01265498|3802183|B2|||Chemistries: Bicarbonate||mmol/L|Mean|26.2|26.2|Standard Deviation|2.6|2.6|||
3980259|NCT01265498|3802184|B1|||Chemistries: Bicarbonate||mmol/L|Mean|25.9|25.9|Standard Deviation|2.5|2.5|||
3980260|NCT01265498|3802182|B3|||Haematology: Platelet count||platelets *10^9 per L|Mean|237|237.0|Standard Deviation|62|62.0|||
3980261|NCT01265498|3802183|B2|||Haematology: Platelet count||platelets *10^9 per L|Mean|237|237.0|Standard Deviation|65|65.0|||
3980262|NCT01265498|3802184|B1|||Haematology: Platelet count||platelets *10^9 per L|Mean|237|237.0|Standard Deviation|59|59.0|||
3980263|NCT01265498|3802182|B3|||Haematology: White blood cell count||white blood cells *10^9 per L|Mean|7.1|7.1|Standard Deviation|2.1|2.1|||
3980264|NCT01265498|3802183|B2|||Haematology: White blood cell count||white blood cells *10^9 per L|Mean|6.9|6.9|Standard Deviation|2.3|2.3|||
3980265|NCT01265498|3802184|B1|||Haematology: White blood cell count||white blood cells *10^9 per L|Mean|7.3|7.3|Standard Deviation|1.9|1.9|||
3980266|NCT01265498|3802182|B3|||Haematology: Mean corpuscular volume||fL|Mean|88.9|88.9|Standard Deviation|5.1|5.1|||
3980267|NCT01265498|3802183|B2|||Haematology: Mean corpuscular volume||fL|Mean|89.0|89.0|Standard Deviation|5.3|5.3|||
3980268|NCT01265498|3802184|B1|||Haematology: Mean corpuscular volume||fL|Mean|88.7|88.7|Standard Deviation|4.8|4.8|||
3980269|NCT01265498|3802182|B3|||Haematology: Haematocrit||proportion of 1·0|Mean|0.41|0.41|Standard Deviation|0.04|0.04|||
3980270|NCT01265498|3802183|B2|||Haematology: Haematocrit||proportion of 1·0|Mean|0.41|0.41|Standard Deviation|0.04|0.04|||
3980271|NCT01265498|3802184|B1|||Haematology: Haematocrit||proportion of 1·0|Mean|0.41|0.41|Standard Deviation|0.04|0.04|||
3980272|NCT01265498|3802182|B3|||Haematology: Haemoglobin||g/L|Mean|140|140.0|Standard Deviation|14|14.0|||
3980273|NCT01265498|3802183|B2|||Haematology: Haemoglobin||g/L|Mean|140|140.0|Standard Deviation|14|14.0|||
3980274|NCT01265498|3802184|B1|||Haematology: Haemoglobin||g/L|Mean|140|140.0|Standard Deviation|15|15.0|||
3980275|NCT01265498|3802182|B3|||Lipids: Triglycerides||mmol/L|Mean|2.1|2.1|Standard Deviation|1.6|1.6|||
3980276|NCT01265498|3802183|B2|||Lipids: Triglycerides||mmol/L|Mean|2.0|2.0|Standard Deviation|1.7|1.7|||
3980277|NCT01265498|3802184|B1|||Lipids: Triglycerides||mmol/L|Mean|2.2|2.2|Standard Deviation|1.5|1.5|||
3980278|NCT01265498|3802182|B3|||Lipids: LDL cholesterol||mmol/L|Mean|2.9|2.9|Standard Deviation|1.0|1.0|||
3980279|NCT01265498|3802183|B2|||Lipids: LDL cholesterol||mmol/L|Mean|2.9|2.9|Standard Deviation|1.1|1.1|||
3980280|NCT01265498|3802184|B1|||Lipids: LDL cholesterol||mmol/L|Mean|2.9|2.9|Standard Deviation|1.0|1.0|||
3980281|NCT01265498|3802182|B3|||Lipids: HDL cholesterol||mmol/L|Mean|1.1|1.1|Standard Deviation|0.3|0.3|||
3980282|NCT01265498|3802183|B2|||Lipids: HDL cholesterol||mmol/L|Mean|1.1|1.1|Standard Deviation|0.4|0.4|||
3980283|NCT01265498|3802184|B1|||Lipids: HDL cholesterol||mmol/L|Mean|1.1|1.1|Standard Deviation|0.3|0.3|||
3980284|NCT01265498|3802182|B3|||Lipids: Total cholesterol||mmol/L|Mean|4.9|4.9|Standard Deviation|1.2|1.2|||
3980285|NCT01265498|3802183|B2|||Lipids: Total cholesterol||mmol/L|Mean|4.8|4.8|Standard Deviation|1.2|1.2|||
3980286|NCT01265498|3802184|B1|||Lipids: Total cholesterol||mmol/L|Mean|4.9|4.9|Standard Deviation|1.2|1.2|||
3980287|NCT01265498|3802182|B3|||Liver enzymes: Total bilirubin||μmol/L|Mean|11.4|11.4|Standard Deviation|6.8|6.8|||
3980288|NCT01265498|3802183|B2|||Liver enzymes: Total bilirubin||μmol/L|Mean|11.3|11.3|Standard Deviation|7.5|7.5|||
3980289|NCT01265498|3802184|B1|||Liver enzymes: Total bilirubin||μmol/L|Mean|11.5|11.5|Standard Deviation|5.9|5.9|||
3980290|NCT01265498|3802182|B3|||Liver enzymes: γ-glutamyl transpeptidase||U/L|Mean|77|77.0|Standard Deviation|91|91.0|||
3980291|NCT01265498|3802183|B2|||Liver enzymes: γ-glutamyl transpeptidase||U/L|Mean|76|76.0|Standard Deviation|97|97.0|||
3980292|NCT01265498|3802184|B1|||Liver enzymes: γ-glutamyl transpeptidase||U/L|Mean|78|78.0|Standard Deviation|85|85.0|||
3980293|NCT01265498|3802182|B3|||Liver enzymes: Alkaline phosphatase||U/L|Mean|82|82.0|Standard Deviation|27|27.0|||
3980294|NCT01265498|3802183|B2|||Liver enzymes: Alkaline phosphatase||U/L|Mean|81|81.0|Standard Deviation|25|25.0|||
3980295|NCT01265498|3802184|B1|||Liver enzymes: Alkaline phosphatase||U/L|Mean|82|82.0|Standard Deviation|29|29.0|||
3980296|NCT01265498|3802182|B3|||Liver enzymes: Aspartate aminotransferase||U/L|Mean|61|61.0|Standard Deviation|36|36.0|||
3980297|NCT01265498|3802183|B2|||Liver enzymes: Aspartate aminotransferase||U/L|Mean|58|58.0|Standard Deviation|34|34.0|||
3980298|NCT01265498|3802184|B1|||Liver enzymes: Aspartate aminotransferase||U/L|Mean|64|64.0|Standard Deviation|38|38.0|||
3980299|NCT01265498|3802182|B3|||Liver enzymes: Alanine aminotransferase||U/L|Mean|83|83.0|Standard Deviation|50|50.0|||
3980300|NCT01265498|3802183|B2|||Liver enzymes: Alanine aminotransferase||U/L|Mean|82|82.0|Standard Deviation|51|51.0|||
3980301|NCT01265498|3802184|B1|||Liver enzymes: Alanine aminotransferase||U/L|Mean|83|83.0|Standard Deviation|49|49.0|||
3980302|NCT01265498|3802182|B3|||SF-36 Quality of life: Mental component summary|Short Form (36) Health Survey The SF-36 evaluates health-related quality of life in 8 domains consisting of two components: physical and mental. The score for each domain ranges from 0 to 100. Norm based scoring (based on the general US population) is used with a mean of 50 and standard deviation of 10. Higher values represent a better outcome.|units on a scale|Mean|48|48.0|Standard Deviation|12|12.0|||
3980303|NCT01265498|3802183|B2|||SF-36 Quality of life: Mental component summary|Short Form (36) Health Survey The SF-36 evaluates health-related quality of life in 8 domains consisting of two components: physical and mental. The score for each domain ranges from 0 to 100. Norm based scoring (based on the general US population) is used with a mean of 50 and standard deviation of 10. Higher values represent a better outcome.|units on a scale|Mean|48|48.0|Standard Deviation|12|12.0|||
3980304|NCT01265498|3802184|B1|||SF-36 Quality of life: Mental component summary|Short Form (36) Health Survey The SF-36 evaluates health-related quality of life in 8 domains consisting of two components: physical and mental. The score for each domain ranges from 0 to 100. Norm based scoring (based on the general US population) is used with a mean of 50 and standard deviation of 10. Higher values represent a better outcome.|units on a scale|Mean|48|48.0|Standard Deviation|12|12.0|||
3980305|NCT01265498|3802182|B3|||SF-36 Quality of life: Physical component summary|Short Form (36) Health Survey The SF-36 evaluates health-related quality of life in 8 domains consisting of two components: physical and mental. The score for each domain ranges from 0 to 100. Norm based scoring (based on the general US population) is used with a mean of 50 and standard deviation of 10. Higher values represent a better outcome.|units on a scale|Mean|44|44.0|Standard Deviation|11|11.0|||
3980306|NCT01265498|3802183|B2|||SF-36 Quality of life: Physical component summary|Short Form (36) Health Survey The SF-36 evaluates health-related quality of life in 8 domains consisting of two components: physical and mental. The score for each domain ranges from 0 to 100. Norm based scoring (based on the general US population) is used with a mean of 50 and standard deviation of 10. Higher values represent a better outcome.|units on a scale|Mean|44|44.0|Standard Deviation|11|11.0|||
3980307|NCT01265498|3802184|B1|||SF-36 Quality of life: Physical component summary|Short Form (36) Health Survey The SF-36 evaluates health-related quality of life in 8 domains consisting of two components: physical and mental. The score for each domain ranges from 0 to 100. Norm based scoring (based on the general US population) is used with a mean of 50 and standard deviation of 10. Higher values represent a better outcome.|units on a scale|Mean|45|45.0|Standard Deviation|11|11.0|||
3980308|NCT01265498|3802182|B3|Other||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
3980309|NCT01265498|3802183|B2|Other||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3980310|NCT01265498|3802184|B1|Other||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3980311|NCT01265498|3802182|B3|White||Race/Ethnicity, Customized||participants|Number|234|234.0||||||
3980312|NCT01265498|3802183|B2|White||Race/Ethnicity, Customized||participants|Number|111|111.0||||||
3980313|NCT01265498|3802184|B1|White||Race/Ethnicity, Customized||participants|Number|123|123.0||||||
3980314|NCT01265498|3802182|B3|Black or African-American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3980315|NCT01265498|3802183|B2|Black or African-American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3980316|NCT01265498|3802184|B1|Black or African-American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3980317|NCT01265498|3802182|B3|Asian||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3980318|NCT01265498|3802183|B2|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3980319|NCT01265498|3802184|B1|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3980320|NCT01265498|3802182|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980321|NCT01265498|3802183|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980322|NCT01265498|3802184|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980323|NCT01265498|3802182|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|240|240.0||||||
3980324|NCT01265498|3802183|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|121|121.0||||||
3980325|NCT01265498|3802184|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
3980326|NCT01265498|3802182|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3980327|NCT01265498|3802183|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3980328|NCT01265498|3802184|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3980329|NCT01265498|3802182|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3980330|NCT01265498|3802183|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3980331|NCT01265498|3802184|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3980332|NCT01265498|3802182|B3||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
3980333|NCT01265498|3802183|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3980334|NCT01265498|3802184|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3980335|NCT01265498|3802182|B3|||Age||years|Mean|51|51.0|Standard Deviation|11|11.0|||
3980336|NCT01265498|3802183|B2|||Age||years|Mean|51|51.0|Standard Deviation|12|12.0|||
3980337|NCT01265498|3802184|B1|||Age||years|Mean|52|52.0|Standard Deviation|11|11.0|||
3980338|NCT01265459|3802285|B4|Sweden||Region of Enrollment||participants|Number|68|68.0||||||
3980339|NCT01265459|3802286|B3|Sweden||Region of Enrollment||participants|Number|22|22.0||||||
3980340|NCT01265459|3802287|B2|Sweden||Region of Enrollment||participants|Number|23|23.0||||||
3980341|NCT01265459|3802288|B1|Sweden||Region of Enrollment||participants|Number|23|23.0||||||
3980342|NCT01265459|3802285|B4||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3980343|NCT01265459|3802286|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3980344|NCT01265459|3802287|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3980345|NCT01265459|3802288|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3980346|NCT01265459|3802285|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3980347|NCT01265459|3802286|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3980348|NCT01265459|3802287|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3980349|NCT01265459|3802288|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3980350|NCT01265459|3802285|B4|||Age||years|Mean|63.1|63.1|Standard Deviation|8.4|8.4|||
3980351|NCT01265459|3802286|B3|||Age||years|Mean|62.8|62.8|Standard Deviation|7.3|7.3|||
3980352|NCT01265459|3802287|B2|||Age||years|Mean|64.1|64.1|Standard Deviation|8.0|8.0|||
3980353|NCT01265459|3802288|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|9.8|9.8|||
3980354|NCT01265459|3802285|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3980355|NCT01265459|3802286|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3980356|NCT01265459|3802287|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3980357|NCT01265459|3802288|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3980358|NCT01265459|3802285|B4||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
3980359|NCT01265459|3802286|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3980360|NCT01265459|3802287|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3980361|NCT01265459|3802288|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3980362|NCT01265459|3802285|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3980363|NCT01265459|3802286|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3980364|NCT01265459|3802287|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3980365|NCT01265459|3802288|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3980366|NCT01265446|3802310|B3|Germany||Region of Enrollment||participants|Number|250|250.0||||||
3980367|NCT01265446|3802311|B2|Germany||Region of Enrollment||participants|Number|125|125.0||||||
3980368|NCT01265446|3802312|B1|Germany||Region of Enrollment||participants|Number|125|125.0||||||
3980369|NCT01265446|3802310|B3||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3980370|NCT01265446|3802311|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3980371|NCT01265446|3802312|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3980372|NCT01265446|3802310|B3||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3980373|NCT01265446|3802311|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3980374|NCT01265446|3802312|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3980375|NCT01265446|3802310|B3|||Age||years|Mean|31.9|31.9|Standard Deviation|12.1|12.1|||
3980376|NCT01265446|3802311|B2|||Age||years|Mean|31.6|31.6|Standard Deviation|11.6|11.6|||
3980377|NCT01265446|3802312|B1|||Age||years|Mean|32.1|32.1|Standard Deviation|12.6|12.6|||
3980378|NCT01265446|3802310|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3980379|NCT01265446|3802311|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3980380|NCT01265446|3802312|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3980381|NCT01265446|3802310|B3||Between 18 and 65 years|Age||Participants|Count of Participants|250|250.0||||||
3980382|NCT01265446|3802311|B2||Between 18 and 65 years|Age||Participants|Count of Participants|125|125.0||||||
3980383|NCT01265446|3802312|B1||Between 18 and 65 years|Age||Participants|Count of Participants|125|125.0||||||
3980384|NCT01265446|3802310|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3980385|NCT01265446|3802311|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3980386|NCT01265446|3802312|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3980387|NCT01265420|3802321|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3980388|NCT01265420|3802321|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3980389|NCT01265420|3802321|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3980390|NCT01265420|3802321|B1|||Age||years|Median|62|62.0|Full Range|||55.0|78.0|
3980391|NCT01265394|3802325|B1|United Kingdom||Region of Enrollment||participants|Number|25|25.0||||||
3980392|NCT01265394|3802325|B1|Finland||Region of Enrollment||participants|Number|19|19.0||||||
3980393|NCT01265394|3802325|B1|Belgium||Region of Enrollment||participants|Number|10|10.0||||||
3980394|NCT01265394|3802325|B1|United States||Region of Enrollment||participants|Number|127|127.0||||||
3980395|NCT01265394|3802325|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3980396|NCT01265394|3802325|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3980397|NCT01265394|3802325|B1|||Age||years|Mean|29|29.0|Standard Deviation|5.9|5.9|||
3980398|NCT01265394|3802325|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3980399|NCT01265394|3802325|B1||Between 18 and 65 years|Age||Participants|Count of Participants|181|181.0||||||
3980400|NCT01265394|3802325|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3980401|NCT01265056|3802330|B3|United States||Region of Enrollment||participants|Number|53|53.0||||||
3980402|NCT01265056|3802331|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
3980403|NCT01265056|3802332|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
3980404|NCT01265056|3802330|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3980405|NCT01265056|3802331|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3980406|NCT01265056|3802332|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3980407|NCT01265056|3802330|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3980408|NCT01265056|3802331|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3980409|NCT01265056|3802332|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3980410|NCT01265056|3802330|B3|||Age||years|Mean|41.8|41.8|Standard Deviation|12.9|12.9|||
3980411|NCT01265056|3802331|B2|||Age||years|Mean|42.9|42.9|Standard Deviation|11.6|11.6|||
3980412|NCT01265056|3802332|B1|||Age||years|Mean|40.6|40.6|Standard Deviation|14.3|14.3|||
3980413|NCT01265056|3802330|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3980414|NCT01265056|3802331|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3980415|NCT01265056|3802332|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3980416|NCT01265056|3802330|B3||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3980417|NCT01265056|3802331|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3980418|NCT01265056|3802332|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3980419|NCT01265056|3802330|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3980420|NCT01265056|3802331|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3980421|NCT01265056|3802332|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3980422|NCT01264952|3802343|B4|Slovenia||Region of Enrollment||participants|Number|16|16.0||||||
3980423|NCT01264952|3802344|B3|Slovenia||Region of Enrollment||participants|Number|8|8.0||||||
3980424|NCT01264952|3802345|B2|Slovenia||Region of Enrollment||participants|Number|2|2.0||||||
3980425|NCT01264952|3802346|B1|Slovenia||Region of Enrollment||participants|Number|6|6.0||||||
3980426|NCT01264952|3802343|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3980427|NCT01264952|3802344|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3980428|NCT01264952|3802345|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3980429|NCT01264952|3802346|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3980430|NCT01264952|3802343|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3980431|NCT01264952|3802344|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3980432|NCT01264952|3802345|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3980433|NCT01264952|3802346|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3980434|NCT01264952|3802343|B4|||Age||years|Median|56.8|56.8|Standard Deviation|10.6|10.6|||
3980435|NCT01264952|3802344|B3|||Age||years|Median|57.3|57.3|Standard Deviation|10.7|10.7|||
3980436|NCT01264952|3802345|B2|||Age||years|Median|45.5|45.5|Standard Deviation|19.1|19.1|||
3980437|NCT01264952|3802346|B1|||Age||years|Median|60.0|60.0|Standard Deviation|6.4|6.4|||
3980438|NCT01264952|3802343|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3980439|NCT01264952|3802344|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3980440|NCT01264952|3802345|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3980441|NCT01264952|3802346|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3980442|NCT01264952|3802343|B4||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3980443|NCT01264952|3802344|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3980444|NCT01264952|3802345|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3980445|NCT01264952|3802346|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3980446|NCT01264952|3802343|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3980447|NCT01264952|3802344|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3980448|NCT01264952|3802345|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3980449|NCT01264952|3802346|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3980450|NCT01264939|3802362|B3||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3980451|NCT01264939|3802363|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3980452|NCT01264939|3802364|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3980453|NCT01264939|3802362|B3||Female|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
3980454|NCT01264939|3802363|B2||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
3980455|NCT01264939|3802364|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3980456|NCT01264939|3802362|B3|||Age||years|Mean|43.1|43.1|Standard Deviation|14.1|14.1|||
3980457|NCT01264939|3802363|B2|||Age||years|Mean|42.7|42.7|Standard Deviation|13.9|13.9|||
3980458|NCT01264939|3802364|B1|||Age||years|Mean|44.3|44.3|Standard Deviation|14.7|14.7|||
3980459|NCT01264887|3802391|B1|Nociceptive (somatic)||Pain type|A participant could be suffering from more than one type of pain. The participant was counted in more than one category and therefore the addition of numbers are higher than the number of participants.|participants|Number|26|26.0||||||
3980460|NCT01264887|3802391|B1|Visceral||Pain type|A participant could be suffering from more than one type of pain. The participant was counted in more than one category and therefore the addition of numbers are higher than the number of participants.|participants|Number|22|22.0||||||
3980461|NCT01264887|3802391|B1|Neuropathic||Pain type|A participant could be suffering from more than one type of pain. The participant was counted in more than one category and therefore the addition of numbers are higher than the number of participants.|participants|Number|23|23.0||||||
3980462|NCT01264887|3802391|B1|||Body Mass Index||kg/m^2|Mean|23.6|23.6|Standard Deviation|4.79|4.79|||
3980463|NCT01264887|3802391|B1|||Height||centimeters|Mean|165.0|165.0|Standard Deviation|10.24|10.24|||
3980464|NCT01264887|3802391|B1|||Weight||kilograms|Mean|64.6|64.6|Standard Deviation|16.45|16.45|||
3980465|NCT01264887|3802391|B1|Moldova, Republic of||Region of Enrollment||participants|Number|6|6.0||||||
3980466|NCT01264887|3802391|B1|Bulgaria||Region of Enrollment||participants|Number|2|2.0||||||
3980467|NCT01264887|3802391|B1|Russian Federation||Region of Enrollment||participants|Number|3|3.0||||||
3980468|NCT01264887|3802391|B1|Romania||Region of Enrollment||participants|Number|5|5.0||||||
3980469|NCT01264887|3802391|B1|Poland||Region of Enrollment||participants|Number|5|5.0||||||
3980470|NCT01264887|3802391|B1|Hungary||Region of Enrollment||participants|Number|4|4.0||||||
3980471|NCT01264887|3802391|B1|Serbia||Region of Enrollment||participants|Number|6|6.0||||||
3980472|NCT01264887|3802391|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980473|NCT01264887|3802391|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980474|NCT01264887|3802391|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3980475|NCT01264887|3802391|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980476|NCT01264887|3802391|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980477|NCT01264887|3802391|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980478|NCT01264887|3802391|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980479|NCT01264887|3802391|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3980480|NCT01264887|3802391|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3980481|NCT01264887|3802391|B1|||Age||years|Mean|55.8|55.8|Standard Deviation|11.91|11.91|||
3980482|NCT01264887|3802391|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3980483|NCT01264887|3802391|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3980484|NCT01264887|3802391|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3980485|NCT01264835|3802402|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3980486|NCT01264835|3802402|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3980487|NCT01264835|3802402|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3980488|NCT01264835|3802402|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3980489|NCT01264835|3802402|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3980490|NCT01264835|3802402|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3980491|NCT01264770|3802406|B7|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3980492|NCT01264770|3802407|B6|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3980493|NCT01264770|3802408|B5|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3980494|NCT01264770|3802409|B4|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3980495|NCT01264770|3802410|B3|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3980496|NCT01264770|3802411|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3980497|NCT01264770|3802412|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3980498|NCT01264770|3802406|B7|Indian or Pakistani||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3980499|NCT01264770|3802407|B6|Indian or Pakistani||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3980500|NCT01264770|3802408|B5|Indian or Pakistani||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3980501|NCT01264770|3802409|B4|Indian or Pakistani||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3980502|NCT01264770|3802410|B3|Indian or Pakistani||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3980503|NCT01264770|3802411|B2|Indian or Pakistani||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3980504|NCT01264770|3802412|B1|Indian or Pakistani||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3980505|NCT01264770|3802406|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3980506|NCT01264770|3802407|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3980507|NCT01264770|3802408|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3980508|NCT01264770|3802409|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3980509|NCT01264770|3802410|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3980510|NCT01264770|3802411|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3980511|NCT01264770|3802412|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3980512|NCT01264770|3802406|B7|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3980513|NCT01264770|3802407|B6|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3980514|NCT01264770|3802408|B5|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3980515|NCT01264770|3802409|B4|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3980516|NCT01264770|3802410|B3|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3980517|NCT01264770|3802411|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3980518|NCT01264770|3802412|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3980519|NCT01264770|3802406|B7|Black or African American||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
3980520|NCT01264770|3802407|B6|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3980521|NCT01264770|3802408|B5|Black or African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3980522|NCT01264770|3802409|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3980523|NCT01264770|3802410|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3980524|NCT01264770|3802411|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3980525|NCT01264770|3802412|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3980526|NCT01264770|3802406|B7|White||Race/Ethnicity, Customized||Participants|Number|240|240.0||||||
3980527|NCT01264770|3802407|B6|White||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
3980528|NCT01264770|3802408|B5|White||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
3980529|NCT01264770|3802409|B4|White||Race/Ethnicity, Customized||Participants|Number|51|51.0||||||
3980530|NCT01264770|3802410|B3|White||Race/Ethnicity, Customized||Participants|Number|48|48.0||||||
3980531|NCT01264770|3802411|B2|White||Race/Ethnicity, Customized||Participants|Number|47|47.0||||||
3980532|NCT01264770|3802412|B1|White||Race/Ethnicity, Customized||Participants|Number|48|48.0||||||
3980533|NCT01264770|3802406|B7||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3980534|NCT01264770|3802407|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3980535|NCT01264770|3802408|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3980536|NCT01264770|3802409|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3980537|NCT01264770|3802410|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3980538|NCT01264770|3802411|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3980539|NCT01264770|3802412|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3980540|NCT01264770|3802406|B7||Female|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
3980541|NCT01264770|3802407|B6||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3980542|NCT01264770|3802408|B5||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3980543|NCT01264770|3802409|B4||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3980544|NCT01264770|3802410|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3980545|NCT01264770|3802411|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3980546|NCT01264770|3802412|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3980547|NCT01264770|3802406|B7|||Age||years|Mean|50|50.0|Standard Deviation|11.8|11.8|||
3980548|NCT01264770|3802407|B6|||Age||years|Mean|53|53.0|Standard Deviation|10.8|10.8|||
3980549|NCT01264770|3802408|B5|||Age||years|Mean|50|50.0|Standard Deviation|12.7|12.7|||
3980550|NCT01264770|3802409|B4|||Age||years|Mean|48|48.0|Standard Deviation|12.4|12.4|||
3980551|NCT01264770|3802410|B3|||Age||years|Mean|50|50.0|Standard Deviation|11.0|11.0|||
3980552|NCT01264770|3802411|B2|||Age||years|Mean|50|50.0|Standard Deviation|12.6|12.6|||
3980553|NCT01264770|3802412|B1|||Age||years|Mean|50|50.0|Standard Deviation|11.5|11.5|||
3980554|NCT01264679|3802501|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980555|NCT01264679|3802501|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3980556|NCT01264679|3802501|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3980557|NCT01264679|3802501|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980558|NCT01264679|3802501|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980559|NCT01264679|3802501|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3980560|NCT01264679|3802501|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980561|NCT01264679|3802501|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3980562|NCT01264679|3802501|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3980563|NCT01264679|3802501|B1|||Age||years|Mean|15.3|15.3|Standard Deviation|1.51|1.51|||
3980564|NCT01264679|3802501|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3980565|NCT01264679|3802501|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3980566|NCT01264679|3802501|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
3980567|NCT01264614|3802507|B3|||Education||years|Mean|11.6|11.6|Full Range|||6.0|16.0|
3980568|NCT01264614|3802508|B2|||Education||years|Mean|11.6|11.6|Full Range|||8.0|13.0|
3980569|NCT01264614|3802509|B1|||Education||years|Mean|11.5|11.5|Full Range|||6.0|16.0|
3980570|NCT01264614|3802507|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
3980571|NCT01264614|3802508|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3980572|NCT01264614|3802509|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3980573|NCT01264614|3802507|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3980574|NCT01264614|3802508|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3980575|NCT01264614|3802509|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3980576|NCT01264614|3802507|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3980577|NCT01264614|3802508|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3980578|NCT01264614|3802509|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3980579|NCT01264614|3802507|B3|||Age||years|Mean|71.5|71.5|Full Range|||55.0|95.0|
3980580|NCT01264614|3802508|B2|||Age||years|Mean|62.8|62.8|Full Range|||55.0|78.0|
3980581|NCT01264614|3802509|B1|||Age||years|Mean|79.3|79.3|Full Range|||60.0|95.0|
3980582|NCT01264601|3802524|B3|||Age at Diagnosis||months|Median|12|12.0|Standard Deviation|17.6|17.6|||
3980583|NCT01264601|3802525|B2|||Age at Diagnosis||months|Median|11|11.0|Standard Deviation|14.4|14.4|||
3980584|NCT01264601|3802526|B1|||Age at Diagnosis||months|Median|12|12.0|Standard Deviation|19.5|19.5|||
3980585|NCT01264601|3802524|B3|||Abdominal Pain||Participants|Count of Participants|5|5.0||||||
3980586|NCT01264601|3802525|B2|||Abdominal Pain||Participants|Count of Participants|3|3.0||||||
3980587|NCT01264601|3802526|B1|||Abdominal Pain||Participants|Count of Participants|2|2.0||||||
3980588|NCT01264601|3802524|B3|||Vomiting||Participants|Count of Participants|19|19.0||||||
3980589|NCT01264601|3802525|B2|||Vomiting||Participants|Count of Participants|9|9.0||||||
3980590|NCT01264601|3802526|B1|||Vomiting||Participants|Count of Participants|10|10.0||||||
3980591|NCT01264601|3802524|B3|||Hypotension||Participants|Count of Participants|2|2.0||||||
3980592|NCT01264601|3802525|B2|||Hypotension||Participants|Count of Participants|1|1.0||||||
3980593|NCT01264601|3802526|B1|||Hypotension||Participants|Count of Participants|1|1.0||||||
3980594|NCT01264601|3802524|B3|||Wheezing||Participants|Count of Participants|4|4.0||||||
3980595|NCT01264601|3802525|B2|||Wheezing||Participants|Count of Participants|2|2.0||||||
3980596|NCT01264601|3802526|B1|||Wheezing||Participants|Count of Participants|2|2.0||||||
3980597|NCT01264601|3802524|B3|||Dyspnea||Participants|Count of Participants|3|3.0||||||
3980598|NCT01264601|3802525|B2|||Dyspnea||Participants|Count of Participants|2|2.0||||||
3980599|NCT01264601|3802526|B1|||Dyspnea||Participants|Count of Participants|1|1.0||||||
3980600|NCT01264601|3802524|B3|||Cough||Participants|Count of Participants|13|13.0||||||
3980601|NCT01264601|3802525|B2|||Cough||Participants|Count of Participants|3|3.0||||||
3980602|NCT01264601|3802526|B1|||Cough||Participants|Count of Participants|10|10.0||||||
3980603|NCT01264601|3802524|B3|||Stridor||Participants|Count of Participants|3|3.0||||||
3980604|NCT01264601|3802525|B2|||Stridor||Participants|Count of Participants|1|1.0||||||
3980605|NCT01264601|3802526|B1|||Stridor||Participants|Count of Participants|2|2.0||||||
3980606|NCT01264601|3802524|B3|||Throat Swelling||Participants|Count of Participants|3|3.0||||||
3980607|NCT01264601|3802525|B2|||Throat Swelling||Participants|Count of Participants|2|2.0||||||
3980608|NCT01264601|3802526|B1|||Throat Swelling||Participants|Count of Participants|1|1.0||||||
3980609|NCT01264601|3802524|B3|||Throat Itching||Participants|Count of Participants|6|6.0||||||
3980610|NCT01264601|3802525|B2|||Throat Itching||Participants|Count of Participants|3|3.0||||||
3980611|NCT01264601|3802526|B1|||Throat Itching||Participants|Count of Participants|3|3.0||||||
3980612|NCT01264601|3802524|B3|||Oral/Facial Angioedema||Participants|Count of Participants|11|11.0||||||
3980613|NCT01264601|3802525|B2|||Oral/Facial Angioedema||Participants|Count of Participants|6|6.0||||||
3980614|NCT01264601|3802526|B1|||Oral/Facial Angioedema||Participants|Count of Participants|5|5.0||||||
3980615|NCT01264601|3802524|B3|||Systemic Urticaria||Participants|Count of Participants|14|14.0||||||
3980616|NCT01264601|3802525|B2|||Systemic Urticaria||Participants|Count of Participants|5|5.0||||||
3980617|NCT01264601|3802526|B1|||Systemic Urticaria||Participants|Count of Participants|9|9.0||||||
3980618|NCT01264601|3802524|B3|||Localized Urticaria||Participants|Count of Participants|11|11.0||||||
3980619|NCT01264601|3802525|B2|||Localized Urticaria||Participants|Count of Participants|5|5.0||||||
3980620|NCT01264601|3802526|B1|||Localized Urticaria||Participants|Count of Participants|6|6.0||||||
3980621|NCT01264601|3802524|B3|||Serum Specific IgE Ovomucoid||kUA/L|Median|4.32|4.32|Standard Deviation|24.4|24.4|||
3980622|NCT01264601|3802525|B2|||Serum Specific IgE Ovomucoid||kUA/L|Median|7|7.0|Standard Deviation|39.8|39.8|||
3980623|NCT01264601|3802526|B1|||Serum Specific IgE Ovomucoid||kUA/L|Median|2.83|2.83|Standard Deviation|28|28.0|||
3980624|NCT01264601|3802524|B3|||Serum Specific IgE Ovalbumin||kUA/L|Median|7.1|7.1|Standard Deviation|25.2|25.2|||
3980625|NCT01264601|3802525|B2|||Serum Specific IgE Ovalbumin||kUA/L|Median|10.45|10.45|Standard Deviation|35.5|35.5|||
3980626|NCT01264601|3802526|B1|||Serum Specific IgE Ovalbumin||kUA/L|Median|4.52|4.52|Standard Deviation|25.2|25.2|||
3980627|NCT01264601|3802524|B3|||Serum Specific IgE Egg White||Measured in kUA/L|Median|10.2|10.2|Standard Deviation|25|25.0|||
3980628|NCT01264601|3802525|B2|||Serum Specific IgE Egg White||Measured in kUA/L|Median|16.2|16.2|Standard Deviation|28.9|28.9|||
3980629|NCT01264601|3802526|B1|||Serum Specific IgE Egg White||Measured in kUA/L|Median|5.3|5.3|Standard Deviation|23.6|23.6|||
3980630|NCT01264601|3802524|B3|||Other Food Allergy||Participants|Count of Participants|19|19.0||||||
3980631|NCT01264601|3802525|B2|||Other Food Allergy||Participants|Count of Participants|7|7.0||||||
3980632|NCT01264601|3802526|B1|||Other Food Allergy||Participants|Count of Participants|12|12.0||||||
3980633|NCT01264601|3802524|B3|||Allergic Rhinitis||Participants|Count of Participants|8|8.0||||||
3980634|NCT01264601|3802525|B2|||Allergic Rhinitis||Participants|Count of Participants|5|5.0||||||
3980635|NCT01264601|3802526|B1|||Allergic Rhinitis||Participants|Count of Participants|3|3.0||||||
3980636|NCT01264601|3802524|B3|||Asthma||Participants|Count of Participants|11|11.0||||||
3980637|NCT01264601|3802525|B2|||Asthma||Participants|Count of Participants|4|4.0||||||
3980638|NCT01264601|3802526|B1|||Asthma||Participants|Count of Participants|7|7.0||||||
3980639|NCT01264601|3802524|B3|||Atopic Dermatitis||Participants|Count of Participants|18|18.0||||||
3980640|NCT01264601|3802525|B2|||Atopic Dermatitis||Participants|Count of Participants|10|10.0||||||
3980641|NCT01264601|3802526|B1|||Atopic Dermatitis||Participants|Count of Participants|8|8.0||||||
3980642|NCT01264601|3802524|B3|||Baked Egg Tolerant||Participants|Count of Participants|10|10.0||||||
3980643|NCT01264601|3802525|B2|||Baked Egg Tolerant||Participants|Count of Participants|5|5.0||||||
3980644|NCT01264601|3802526|B1|||Baked Egg Tolerant||Participants|Count of Participants|5|5.0||||||
3980645|NCT01264601|3802524|B3|||History of Anaphylaxis to Egg||Participants|Count of Participants|14|14.0||||||
3980646|NCT01264601|3802525|B2|||History of Anaphylaxis to Egg||Participants|Count of Participants|6|6.0||||||
3980647|NCT01264601|3802526|B1|||History of Anaphylaxis to Egg||Participants|Count of Participants|8|8.0||||||
3980648|NCT01264601|3802524|B3|||Prior H1N1 Vaccine||Participants|Count of Participants|16|16.0||||||
3980649|NCT01264601|3802525|B2|||Prior H1N1 Vaccine||Participants|Count of Participants|6|6.0||||||
3980650|NCT01264601|3802526|B1|||Prior H1N1 Vaccine||Participants|Count of Participants|10|10.0||||||
3980651|NCT01264601|3802524|B3|||Prior TIV||Participants|Count of Participants|23|23.0||||||
3980652|NCT01264601|3802525|B2|||Prior TIV||Participants|Count of Participants|11|11.0||||||
3980653|NCT01264601|3802526|B1|||Prior TIV||Participants|Count of Participants|12|12.0||||||
3980654|NCT01264601|3802524|B3|||Egg skin test wheal, median, mm||mm|Median|7|7.0|Standard Deviation|3.5|3.5|||
3980655|NCT01264601|3802525|B2|||Egg skin test wheal, median, mm||mm|Median|6|6.0|Standard Deviation|4.2|4.2|||
3980656|NCT01264601|3802526|B1|||Egg skin test wheal, median, mm||mm|Median|9|9.0|Standard Deviation|3.4|3.4|||
3980657|NCT01264601|3802524|B3|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3980658|NCT01264601|3802525|B2|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3980659|NCT01264601|3802526|B1|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3980660|NCT01264601|3802524|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3980661|NCT01264601|3802525|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3980662|NCT01264601|3802526|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3980663|NCT01264601|3802524|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3980664|NCT01264601|3802525|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3980665|NCT01264601|3802526|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3980666|NCT01264601|3802524|B3|||Age||years|Mean|6.2|6.2|Standard Deviation|4.3|4.3|||
3980667|NCT01264601|3802525|B2|||Age||years|Mean|6.3|6.3|Standard Deviation|5.1|5.1|||
3980668|NCT01264601|3802526|B1|||Age||years|Mean|5.6|5.6|Standard Deviation|3.4|3.4|||
3980669|NCT01264601|3802524|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3980670|NCT01264601|3802525|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3980671|NCT01264601|3802526|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3980672|NCT01264601|3802524|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3980673|NCT01264601|3802525|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3980674|NCT01264601|3802526|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3980675|NCT01264601|3802524|B3||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
3980676|NCT01264601|3802525|B2||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
3980677|NCT01264601|3802526|B1||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
3980678|NCT01264380|3802535|B1||Male|Gender||Participants|Count of Participants|10|10.0||||||
3980679|NCT01264380|3802535|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
3980680|NCT01264380|3802535|B1|||Age||years|Mean|60.6|60.6|Standard Deviation|10.31|10.31|||
3980681|NCT01264081|3802558|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
3980682|NCT01264081|3802558|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3980683|NCT01264081|3802558|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980684|NCT01264081|3802558|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3980685|NCT01264081|3802558|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3980686|NCT01264081|3802558|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980687|NCT01264081|3802558|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3980688|NCT01264081|3802558|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980689|NCT01264081|3802558|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3980690|NCT01264081|3802558|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3980691|NCT01264081|3802558|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3980692|NCT01264081|3802558|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3980693|NCT01264081|3802558|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3980694|NCT01264081|3802558|B1|||Age||years|Mean|49|49.0|Standard Deviation|0|0.0|||
3980695|NCT01264081|3802558|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3980696|NCT01264081|3802558|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3980697|NCT01264081|3802558|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3980698|NCT01264016|3802563|B1|United States||Region of Enrollment|One subject withdrew voluntarily; one subject was withdrawn. 94 subjects completed the study.|participants|Number|93|93.0||||||
3980699|NCT01264016|3802563|B1||Male|Sex: Female, Male|94 subjects completed study; 93 subjects had evaluable blood glucose data as described in outcome measure results|Participants|Count of Participants|46|46.0||||||
3980700|NCT01264016|3802563|B1||Female|Sex: Female, Male|94 subjects completed study; 93 subjects had evaluable blood glucose data as described in outcome measure results|Participants|Count of Participants|47|47.0||||||
3980701|NCT01264016|3802563|B1|Mean age (range of ages)||Age||years|Mean|37.8|37.8|Full Range|||18.0|73.0|
3980702|NCT01263925|3802569|B3|||Duration of Primary Disease||years|Mean|4.6|4.6|Standard Deviation|4.8|4.8|||
3980703|NCT01263925|3802570|B2|||Duration of Primary Disease||years|Mean|4.3|4.3|Standard Deviation|4.4|4.4|||
3980704|NCT01263925|3802571|B1|||Duration of Primary Disease||years|Mean|4.9|4.9|Standard Deviation|5.1|5.1|||
3980705|NCT01263925|3802569|B3|||Body Mass Index (BMI)||kilogram/ meter^2 (kg/m^2)|Mean|26.94|26.94|Standard Deviation|3.81|3.81|||
3980706|NCT01263925|3802570|B2|||Body Mass Index (BMI)||kilogram/ meter^2 (kg/m^2)|Mean|27.11|27.11|Standard Deviation|3.75|3.75|||
3980707|NCT01263925|3802571|B1|||Body Mass Index (BMI)||kilogram/ meter^2 (kg/m^2)|Mean|26.77|26.77|Standard Deviation|3.87|3.87|||
3980708|NCT01263925|3802569|B3|||Height||centimeter (cm)|Mean|169.7|169.7|Standard Deviation|8.6|8.6|||
3980709|NCT01263925|3802570|B2|||Height||centimeter (cm)|Mean|169.3|169.3|Standard Deviation|8.6|8.6|||
3980710|NCT01263925|3802571|B1|||Height||centimeter (cm)|Mean|170.2|170.2|Standard Deviation|8.6|8.6|||
3980711|NCT01263925|3802569|B3|||Weight||kilogram (kg)|Mean|77.9|77.9|Standard Deviation|13.7|13.7|||
3980712|NCT01263925|3802570|B2|||Weight||kilogram (kg)|Mean|77.9|77.9|Standard Deviation|13.5|13.5|||
3980713|NCT01263925|3802571|B1|||Weight||kilogram (kg)|Mean|77.8|77.8|Standard Deviation|13.9|13.9|||
3980714|NCT01263925|3802569|B3|>=75||Age categories||participants|Number|100|100.0||||||
3980715|NCT01263925|3802570|B2|>=75||Age categories||participants|Number|53|53.0||||||
3980716|NCT01263925|3802571|B1|>=75||Age categories||participants|Number|47|47.0||||||
3980717|NCT01263925|3802569|B3|>=65 - <75||Age categories||participants|Number|233|233.0||||||
3980718|NCT01263925|3802570|B2|>=65 - <75||Age categories||participants|Number|119|119.0||||||
3980719|NCT01263925|3802571|B1|>=65 - <75||Age categories||participants|Number|114|114.0||||||
3980720|NCT01263925|3802569|B3|>18 - <65||Age categories||participants|Number|208|208.0||||||
3980721|NCT01263925|3802570|B2|>18 - <65||Age categories||participants|Number|100|100.0||||||
3980722|NCT01263925|3802571|B1|>18 - <65||Age categories||participants|Number|108|108.0||||||
3980723|NCT01263925|3802569|B3|Asian||Ethnicity||participants|Number|1|1.0||||||
3980724|NCT01263925|3802570|B2|Asian||Ethnicity||participants|Number|1|1.0||||||
3980725|NCT01263925|3802571|B1|Asian||Ethnicity||participants|Number|0|0.0||||||
3980726|NCT01263925|3802569|B3|Caucasian||Ethnicity||participants|Number|540|540.0||||||
3980727|NCT01263925|3802570|B2|Caucasian||Ethnicity||participants|Number|271|271.0||||||
3980728|NCT01263925|3802571|B1|Caucasian||Ethnicity||participants|Number|269|269.0||||||
3980729|NCT01263925|3802569|B3||Male|Sex: Female, Male||Participants|Count of Participants|368|368.0||||||
3980730|NCT01263925|3802570|B2||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3980731|NCT01263925|3802571|B1||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
3980732|NCT01263925|3802569|B3||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
3980733|NCT01263925|3802570|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3980734|NCT01263925|3802571|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3980735|NCT01263925|3802569|B3|||Age||years|Mean|66.5|66.5|Standard Deviation|8.7|8.7|||
3980736|NCT01263925|3802570|B2|||Age||years|Mean|66.8|66.8|Standard Deviation|8.8|8.8|||
3980737|NCT01263925|3802571|B1|||Age||years|Mean|66.3|66.3|Standard Deviation|8.6|8.6|||
3980738|NCT01263873|3802604|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
3980739|NCT01263873|3802605|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3980740|NCT01263873|3802606|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3980741|NCT01263873|3802604|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3980742|NCT01263873|3802605|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3980743|NCT01263873|3802606|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3980744|NCT01263873|3802604|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3980745|NCT01263873|3802605|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3980746|NCT01263873|3802606|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3980747|NCT01263873|3802604|B3|||Age||years|Mean|53|53.0|Standard Deviation|16|16.0|||
3980748|NCT01263873|3802605|B2|||Age||years|Mean|51|51.0|Standard Deviation|19|19.0|||
3980749|NCT01263873|3802606|B1|||Age||years|Mean|55|55.0|Standard Deviation|14|14.0|||
3980750|NCT01263873|3802604|B3||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3980751|NCT01263873|3802605|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3980752|NCT01263873|3802606|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3980753|NCT01263873|3802604|B3||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3980754|NCT01263873|3802605|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3980755|NCT01263873|3802606|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3980756|NCT01263873|3802604|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3980757|NCT01263873|3802605|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3980758|NCT01263873|3802606|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3980759|NCT01263717|3802617|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3980760|NCT01263717|3802618|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
3980761|NCT01263717|3802619|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
3980762|NCT01263717|3802617|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3980763|NCT01263717|3802618|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3980764|NCT01263717|3802619|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3980765|NCT01263717|3802617|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3980766|NCT01263717|3802618|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3980767|NCT01263717|3802619|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3980768|NCT01263717|3802617|B3|Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3980769|NCT01263717|3802618|B2|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3980770|NCT01263717|3802619|B1|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3980771|NCT01263717|3802617|B3|White||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
3980772|NCT01263717|3802618|B2|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3980773|NCT01263717|3802619|B1|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3980774|NCT01263717|3802617|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3980775|NCT01263717|3802618|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3980776|NCT01263717|3802619|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3980777|NCT01263717|3802617|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3980778|NCT01263717|3802618|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3980779|NCT01263717|3802619|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3980780|NCT01263717|3802617|B3|||Age||years|Median|51.5|51.5|Inter-Quartile Range|||46.0|56.25|
3980781|NCT01263717|3802618|B2|||Age||years|Median|53|53.0|Inter-Quartile Range|||49.0|58.0|
3980782|NCT01263717|3802619|B1|||Age||years|Median|49|49.0|Inter-Quartile Range|||46.0|54.0|
3980783|NCT01263704|3802648|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3980784|NCT01263704|3802648|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3980785|NCT01263704|3802648|B1|||Age||years|Mean|72.9|72.9|Standard Deviation|5.0|5.0|||
3980786|NCT01263691|3802657|B7|||Weight||kilograms|Mean|79.03|79.03|Standard Deviation|17.487|17.487|||
3980787|NCT01263691|3802658|B6|||Weight||kilograms|Mean|79.74|79.74|Standard Deviation|23.140|23.14|||
3980788|NCT01263691|3802659|B5|||Weight||kilograms|Mean|76.24|76.24|Standard Deviation|15.649|15.649|||
3980789|NCT01263691|3802660|B4|||Weight||kilograms|Mean|78.39|78.39|Standard Deviation|19.021|19.021|||
3980790|NCT01263691|3802661|B3|||Weight||kilograms|Mean|75.75|75.75|Standard Deviation|12.232|12.232|||
3980791|NCT01263691|3802662|B2|||Weight||kilograms|Mean|83.99|83.99|Standard Deviation|16.137|16.137|||
3980792|NCT01263691|3802663|B1|||Weight||kilograms|Mean|80.06|80.06|Standard Deviation|18.799|18.799|||
3980793|NCT01263691|3802657|B7|United States||Region of Enrollment||participants|Number|105|105.0||||||
3980794|NCT01263691|3802658|B6|United States||Region of Enrollment||participants|Number|15|15.0||||||
3980795|NCT01263691|3802659|B5|United States||Region of Enrollment||participants|Number|18|18.0||||||
3980796|NCT01263691|3802660|B4|United States||Region of Enrollment||participants|Number|19|19.0||||||
3980797|NCT01263691|3802661|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
3980798|NCT01263691|3802662|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
3980799|NCT01263691|3802663|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3980800|NCT01263691|3802657|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3980801|NCT01263691|3802658|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980802|NCT01263691|3802659|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980803|NCT01263691|3802660|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3980804|NCT01263691|3802661|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3980805|NCT01263691|3802662|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980806|NCT01263691|3802663|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980807|NCT01263691|3802657|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980808|NCT01263691|3802658|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980809|NCT01263691|3802659|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980810|NCT01263691|3802660|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980811|NCT01263691|3802661|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980812|NCT01263691|3802662|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980813|NCT01263691|3802663|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980814|NCT01263691|3802657|B7||White|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3980815|NCT01263691|3802658|B6||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3980816|NCT01263691|3802659|B5||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3980817|NCT01263691|3802660|B4||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3980818|NCT01263691|3802661|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3980819|NCT01263691|3802662|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3980820|NCT01263691|3802663|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3980821|NCT01263691|3802657|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3980822|NCT01263691|3802658|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3980823|NCT01263691|3802659|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3980824|NCT01263691|3802660|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3980825|NCT01263691|3802661|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3980826|NCT01263691|3802662|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3980827|NCT01263691|3802663|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3980828|NCT01263691|3802657|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980829|NCT01263691|3802658|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980830|NCT01263691|3802659|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980831|NCT01263691|3802660|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980832|NCT01263691|3802661|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980833|NCT01263691|3802662|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980834|NCT01263691|3802663|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980835|NCT01263691|3802657|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3980836|NCT01263691|3802658|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980837|NCT01263691|3802659|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980838|NCT01263691|3802660|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980839|NCT01263691|3802661|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980840|NCT01263691|3802662|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980841|NCT01263691|3802663|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3980842|NCT01263691|3802657|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980843|NCT01263691|3802658|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980844|NCT01263691|3802659|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980845|NCT01263691|3802660|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980846|NCT01263691|3802661|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980847|NCT01263691|3802662|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980848|NCT01263691|3802663|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980849|NCT01263691|3802657|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980850|NCT01263691|3802658|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980851|NCT01263691|3802659|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980852|NCT01263691|3802660|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980853|NCT01263691|3802661|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980854|NCT01263691|3802662|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980855|NCT01263691|3802663|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3980856|NCT01263691|3802657|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3980857|NCT01263691|3802658|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3980858|NCT01263691|3802659|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3980859|NCT01263691|3802660|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3980860|NCT01263691|3802661|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3980861|NCT01263691|3802662|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3980862|NCT01263691|3802663|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3980863|NCT01263691|3802657|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3980864|NCT01263691|3802658|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3980865|NCT01263691|3802659|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3980866|NCT01263691|3802660|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3980867|NCT01263691|3802661|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3980868|NCT01263691|3802662|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3980869|NCT01263691|3802663|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3980870|NCT01263691|3802657|B7||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3980871|NCT01263691|3802658|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3980872|NCT01263691|3802659|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3980873|NCT01263691|3802660|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3980874|NCT01263691|3802661|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3980875|NCT01263691|3802662|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3980876|NCT01263691|3802663|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3980877|NCT01263691|3802657|B7||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3980878|NCT01263691|3802658|B6||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3980879|NCT01263691|3802659|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3980880|NCT01263691|3802660|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3980881|NCT01263691|3802661|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3980882|NCT01263691|3802662|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3980883|NCT01263691|3802663|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3980884|NCT01263691|3802657|B7|||Age||years|Mean|32.0|32.0|Standard Deviation|9.64|9.64|||
3980885|NCT01263691|3802658|B6|||Age||years|Mean|31.4|31.4|Standard Deviation|8.61|8.61|||
3980886|NCT01263691|3802659|B5|||Age||years|Mean|31.4|31.4|Standard Deviation|10.72|10.72|||
3980887|NCT01263691|3802660|B4|||Age||years|Mean|32.6|32.6|Standard Deviation|9.15|9.15|||
3980888|NCT01263691|3802661|B3|||Age||years|Mean|32.4|32.4|Standard Deviation|10.75|10.75|||
3980889|NCT01263691|3802662|B2|||Age||years|Mean|32.8|32.8|Standard Deviation|10.31|10.31|||
3980890|NCT01263691|3802663|B1|||Age||years|Mean|31.1|31.1|Standard Deviation|9.27|9.27|||
3980891|NCT01263691|3802657|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3980892|NCT01263691|3802658|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3980893|NCT01263691|3802659|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3980894|NCT01263691|3802660|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3980895|NCT01263691|3802661|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3980896|NCT01263691|3802662|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3980897|NCT01263691|3802663|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3980898|NCT01263691|3802657|B7||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
3980899|NCT01263691|3802658|B6||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3980900|NCT01263691|3802659|B5||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3980901|NCT01263691|3802660|B4||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3980902|NCT01263691|3802661|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3980903|NCT01263691|3802662|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3980904|NCT01263691|3802663|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3980905|NCT01263691|3802657|B7||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3980906|NCT01263691|3802658|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3980907|NCT01263691|3802659|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3980908|NCT01263691|3802660|B4||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3980909|NCT01263691|3802661|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3980910|NCT01263691|3802662|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3980911|NCT01263691|3802663|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3980912|NCT01263665|3802778|B1|Belgium||Region of Enrollment||participants|Number|17|17.0||||||
3980913|NCT01263665|3802778|B1|Germany||Region of Enrollment||participants|Number|51|51.0||||||
3980914|NCT01263665|3802778|B1|Austria||Region of Enrollment||participants|Number|3|3.0||||||
3980915|NCT01263665|3802778|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3980916|NCT01263665|3802778|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3980917|NCT01263665|3802778|B1|||Age||years|Mean|66.7|66.7|Full Range|||44.7|83.0|
3980918|NCT01263639|3802783|B3|United States||Region of Enrollment||participants|Number|228|228.0||||||
3980919|NCT01263639|3802784|B2|United States||Region of Enrollment||participants|Number|121|121.0||||||
3980920|NCT01263639|3802785|B1|United States||Region of Enrollment||participants|Number|107|107.0||||||
3980921|NCT01263639|3802783|B3||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3980922|NCT01263639|3802784|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3980923|NCT01263639|3802785|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3980924|NCT01263639|3802783|B3||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3980925|NCT01263639|3802784|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3980926|NCT01263639|3802785|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3980927|NCT01263639|3802783|B3|||Age||years|Mean|42.3|42.3|Standard Deviation|15.8|15.8|||
3980928|NCT01263639|3802784|B2|||Age||years|Mean|41.9|41.9|Standard Deviation|17.1|17.1|||
3980929|NCT01263639|3802785|B1|||Age||years|Mean|42.7|42.7|Standard Deviation|17.3|17.3|||
3980930|NCT01263639|3802783|B3||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
3980931|NCT01263639|3802784|B2||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
3980932|NCT01263639|3802785|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3980933|NCT01263639|3802783|B3||Between 18 and 65 years|Age||Participants|Count of Participants|168|168.0||||||
3980934|NCT01263639|3802784|B2||Between 18 and 65 years|Age||Participants|Count of Participants|88|88.0||||||
3980935|NCT01263639|3802785|B1||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
3980936|NCT01263639|3802783|B3||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
3980937|NCT01263639|3802784|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3980938|NCT01263639|3802785|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
3980939|NCT01263561|3802792|B3|||visual acuity||logMAR|Mean|.44|0.44|Standard Deviation|.56|0.56|||
3980940|NCT01263561|3802793|B2|||visual acuity||logMAR|Mean|.42|0.42|Standard Deviation|.6|0.6|||
3980941|NCT01263561|3802794|B1|||visual acuity||logMAR|Mean|.48|0.48|Standard Deviation|.6|0.6|||
3980942|NCT01263561|3802792|B3|||glaucoma medications||number of medications|Mean|3.5|3.5|Standard Deviation|1.1|1.1|||
3980943|NCT01263561|3802793|B2|||glaucoma medications||number of medications|Mean|3.5|3.5|Standard Deviation|.9|0.9|||
3980944|NCT01263561|3802794|B1|||glaucoma medications||number of medications|Mean|3.4|3.4|Standard Deviation|1.3|1.3|||
3980945|NCT01263561|3802792|B3|||intraocular pressure||mmHg|Mean|22.3|22.3|Standard Deviation|8.6|8.6|||
3980946|NCT01263561|3802793|B2|||intraocular pressure||mmHg|Mean|22.6|22.6|Standard Deviation|10.2|10.2|||
3980947|NCT01263561|3802794|B1|||intraocular pressure||mmHg|Mean|22|22.0|Standard Deviation|6.8|6.8|||
3980948|NCT01263561|3802792|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3980949|NCT01263561|3802793|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3980950|NCT01263561|3802794|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3980951|NCT01263561|3802792|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3980952|NCT01263561|3802793|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3980953|NCT01263561|3802794|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3980954|NCT01263561|3802792|B3|||Age||years|Mean|63.9|63.9|Standard Deviation|12.7|12.7|||
3980955|NCT01263561|3802793|B2|||Age||years|Mean|62|62.0|Standard Deviation|13.9|13.9|||
3980956|NCT01263561|3802794|B1|||Age||years|Mean|65.9|65.9|Standard Deviation|11.5|11.5|||
3980957|NCT01263509|3802805|B3||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3980958|NCT01263509|3802806|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3980959|NCT01263509|3802807|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3980960|NCT01263509|3802805|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3980961|NCT01263509|3802806|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3980962|NCT01263509|3802807|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3980963|NCT01263509|3802805|B3|≥ 65 years||Age, Customized||participants|Number|91|91.0||||||
3980964|NCT01263509|3802806|B2|≥ 65 years||Age, Customized||participants|Number|52|52.0||||||
3980965|NCT01263509|3802807|B1|≥ 65 years||Age, Customized||participants|Number|39|39.0||||||
3980966|NCT01263509|3802805|B3|≤ 64 years||Age, Customized||participants|Number|122|122.0||||||
3980967|NCT01263509|3802806|B2|≤ 64 years||Age, Customized||participants|Number|53|53.0||||||
3980968|NCT01263509|3802807|B1|≤ 64 years||Age, Customized||participants|Number|69|69.0||||||
3980969|NCT01263496|3802934|B6||Male|Sex: Female, Male||Participants|Count of Participants|341|341.0||||||
3980970|NCT01263496|3802935|B5||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3980971|NCT01263496|3802936|B4||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3980972|NCT01263496|3802937|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3980973|NCT01263496|3802938|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3980974|NCT01263496|3802939|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3980975|NCT01263496|3802934|B6||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3980976|NCT01263496|3802935|B5||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3980977|NCT01263496|3802936|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3980978|NCT01263496|3802937|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3980979|NCT01263496|3802938|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3980980|NCT01263496|3802939|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3980981|NCT01263496|3802934|B6|≥ 65 years||Age, Customized||participants|Number|158|158.0||||||
3980982|NCT01263496|3802935|B5|≥ 65 years||Age, Customized||participants|Number|32|32.0||||||
3980983|NCT01263496|3802936|B4|≥ 65 years||Age, Customized||participants|Number|32|32.0||||||
3980984|NCT01263496|3802937|B3|≥ 65 years||Age, Customized||participants|Number|33|33.0||||||
3980985|NCT01263496|3802938|B2|≥ 65 years||Age, Customized||participants|Number|34|34.0||||||
3980986|NCT01263496|3802939|B1|≥ 65 years||Age, Customized||participants|Number|27|27.0||||||
3980987|NCT01263496|3802934|B6|≤ 64 years||Age, Customized||participants|Number|316|316.0||||||
3980988|NCT01263496|3802935|B5|≤ 64 years||Age, Customized||participants|Number|51|51.0||||||
3980989|NCT01263496|3802936|B4|≤ 64 years||Age, Customized||participants|Number|65|65.0||||||
3980990|NCT01263496|3802937|B3|≤ 64 years||Age, Customized||participants|Number|64|64.0||||||
3980991|NCT01263496|3802938|B2|≤ 64 years||Age, Customized||participants|Number|67|67.0||||||
3980992|NCT01263496|3802939|B1|≤ 64 years||Age, Customized||participants|Number|69|69.0||||||
3980993|NCT01263483|3803239|B4||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3980994|NCT01263483|3803240|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3980995|NCT01263483|3803241|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3980996|NCT01263483|3803242|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3980997|NCT01263483|3803239|B4||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3980998|NCT01263483|3803240|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3980999|NCT01263483|3803241|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3981000|NCT01263483|3803242|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3981001|NCT01263483|3803239|B4|≥ 65 years||Age, Customized||participants|Number|100|100.0||||||
3981002|NCT01263483|3803240|B3|≥ 65 years||Age, Customized||participants|Number|40|40.0||||||
3981003|NCT01263483|3803241|B2|≥ 65 years||Age, Customized||participants|Number|24|24.0||||||
3981004|NCT01263483|3803242|B1|≥ 65 years||Age, Customized||participants|Number|36|36.0||||||
3981005|NCT01263483|3803239|B4|≤ 64 years||Age, Customized||participants|Number|130|130.0||||||
3981006|NCT01263483|3803240|B3|≤ 64 years||Age, Customized||participants|Number|39|39.0||||||
3981007|NCT01263483|3803241|B2|≤ 64 years||Age, Customized||participants|Number|52|52.0||||||
3981008|NCT01263483|3803242|B1|≤ 64 years||Age, Customized||participants|Number|39|39.0||||||
3981009|NCT01263470|3803300|B7||Male|Sex: Female, Male||Participants|Count of Participants|345|345.0||||||
3981010|NCT01263470|3803301|B6||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3981011|NCT01263470|3803302|B5||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3981012|NCT01263470|3803303|B4||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3981013|NCT01263470|3803304|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3981014|NCT01263470|3803305|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3981015|NCT01263470|3803306|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3981016|NCT01263470|3803300|B7||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3981017|NCT01263470|3803301|B6||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3981018|NCT01263470|3803302|B5||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3981019|NCT01263470|3803303|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3981020|NCT01263470|3803304|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3981021|NCT01263470|3803305|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3981022|NCT01263470|3803306|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3981023|NCT01263470|3803300|B7|≥ 65 years||Age, Customized||participants|Number|161|161.0||||||
3981024|NCT01263470|3803301|B6|≥ 65 years||Age, Customized||participants|Number|32|32.0||||||
3981025|NCT01263470|3803302|B5|≥ 65 years||Age, Customized||participants|Number|25|25.0||||||
3981026|NCT01263470|3803303|B4|≥ 65 years||Age, Customized||participants|Number|28|28.0||||||
3981027|NCT01263470|3803304|B3|≥ 65 years||Age, Customized||participants|Number|28|28.0||||||
3981028|NCT01263470|3803305|B2|≥ 65 years||Age, Customized||participants|Number|21|21.0||||||
3981029|NCT01263470|3803306|B1|≥ 65 years||Age, Customized||participants|Number|27|27.0||||||
3981030|NCT01263470|3803300|B7|≤ 64 years||Age, Customized||participants|Number|319|319.0||||||
3981031|NCT01263470|3803301|B6|≤ 64 years||Age, Customized||participants|Number|51|51.0||||||
3981032|NCT01263470|3803302|B5|≤ 64 years||Age, Customized||participants|Number|54|54.0||||||
3981033|NCT01263470|3803303|B4|≤ 64 years||Age, Customized||participants|Number|52|52.0||||||
3981034|NCT01263470|3803304|B3|≤ 64 years||Age, Customized||participants|Number|56|56.0||||||
3981035|NCT01263470|3803305|B2|≤ 64 years||Age, Customized||participants|Number|58|58.0||||||
3981036|NCT01263470|3803306|B1|≤ 64 years||Age, Customized||participants|Number|48|48.0||||||
3981037|NCT01263444|3803421|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3981038|NCT01263444|3803421|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3981039|NCT01263444|3803421|B1|≥ 76 Years||Age, Customized||participants|Number|9|9.0||||||
3981040|NCT01263444|3803421|B1|66-75 Years||Age, Customized||participants|Number|25|25.0||||||
3981041|NCT01263444|3803421|B1|56-65 Years||Age, Customized||participants|Number|10|10.0||||||
3981042|NCT01263444|3803421|B1|≤55 Years||Age, Customized||participants|Number|3|3.0||||||
3981043|NCT01263314|3803428|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3981044|NCT01263314|3803429|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3981045|NCT01263314|3803430|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3981046|NCT01263314|3803428|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3981047|NCT01263314|3803429|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3981048|NCT01263314|3803430|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3981049|NCT01263314|3803428|B3|||Age||Years|Mean|68.4|68.4|Standard Deviation|2.7|2.7|||
3981050|NCT01263314|3803429|B2|||Age||Years|Mean|68.9|68.9|Standard Deviation|2.8|2.8|||
3981051|NCT01263314|3803430|B1|||Age||Years|Mean|68.0|68.0|Standard Deviation|2.8|2.8|||
3981052|NCT01263301|3803543|B3|Taiwan||Region of Enrollment||participants|Number|7|7.0||||||
3981053|NCT01263301|3803544|B2|Taiwan||Region of Enrollment||participants|Number|2|2.0||||||
3981054|NCT01263301|3803545|B1|Taiwan||Region of Enrollment||participants|Number|5|5.0||||||
3981055|NCT01263301|3803543|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3981056|NCT01263301|3803544|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3981057|NCT01263301|3803545|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3981058|NCT01263301|3803543|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3981059|NCT01263301|3803544|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3981060|NCT01263301|3803545|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3981061|NCT01263301|3803543|B3|||Age||years|Mean|59.71|59.71|Standard Deviation|9.21|9.21|||
3981062|NCT01263301|3803544|B2|||Age||years|Mean|52.5|52.5|Standard Deviation|0.70|0.7|||
3981063|NCT01263301|3803545|B1|||Age||years|Mean|62.6|62.6|Standard Deviation|9.53|9.53|||
3981064|NCT01263301|3803543|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3981065|NCT01263301|3803544|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3981066|NCT01263301|3803545|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3981067|NCT01263301|3803543|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3981068|NCT01263301|3803544|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3981069|NCT01263301|3803545|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3981070|NCT01263301|3803543|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3981071|NCT01263301|3803544|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3981072|NCT01263301|3803545|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3981073|NCT01263223|3803558|B1|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3981074|NCT01263223|3803558|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981075|NCT01263223|3803558|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981076|NCT01263223|3803558|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3981077|NCT01263223|3803558|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3981078|NCT01263223|3803558|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981079|NCT01263223|3803558|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981080|NCT01263223|3803558|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3981081|NCT01263223|3803558|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981082|NCT01263223|3803558|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3981083|NCT01263223|3803558|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3981084|NCT01263223|3803558|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3981085|NCT01263223|3803558|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3981086|NCT01263223|3803558|B1|||Age||years|Mean|43.4|43.4|Standard Deviation|13.6|13.6|||
3981087|NCT01263197|3803580|B3|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|27.07|27.07|Standard Deviation|3.47|3.47|||
3981088|NCT01263197|3803581|B2|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|28.04|28.04|Standard Deviation|3.33|3.33|||
3981089|NCT01263197|3803582|B1|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|26.10|26.1|Standard Deviation|3.40|3.4|||
3981090|NCT01263197|3803580|B3|United States||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
3981091|NCT01263197|3803581|B2|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3981092|NCT01263197|3803582|B1|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3981093|NCT01263197|3803580|B3|More than 1 race||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3981094|NCT01263197|3803581|B2|More than 1 race||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3981095|NCT01263197|3803582|B1|More than 1 race||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3981096|NCT01263197|3803580|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
3981097|NCT01263197|3803581|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3981098|NCT01263197|3803582|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3981099|NCT01263197|3803580|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3981100|NCT01263197|3803581|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3981101|NCT01263197|3803582|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3981102|NCT01263197|3803580|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981103|NCT01263197|3803581|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981104|NCT01263197|3803582|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981105|NCT01263197|3803580|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3981106|NCT01263197|3803581|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3981107|NCT01263197|3803582|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3981108|NCT01263197|3803580|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3981109|NCT01263197|3803581|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3981110|NCT01263197|3803582|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3981111|NCT01263197|3803580|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3981112|NCT01263197|3803581|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3981113|NCT01263197|3803582|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3981114|NCT01263197|3803580|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3981115|NCT01263197|3803581|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3981116|NCT01263197|3803582|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3981117|NCT01263197|3803580|B3|||Age||years|Mean|35.9|35.9|Standard Deviation|11.4|11.4|||
3981118|NCT01263197|3803581|B2|||Age||years|Mean|36.3|36.3|Standard Deviation|10.9|10.9|||
3981119|NCT01263197|3803582|B1|||Age||years|Mean|35.5|35.5|Standard Deviation|12.0|12.0|||
3981120|NCT01263132|3803613|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3981121|NCT01263132|3803614|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3981122|NCT01263132|3803615|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3981123|NCT01263132|3803613|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3981124|NCT01263132|3803614|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3981125|NCT01263132|3803615|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3981126|NCT01263132|3803613|B3|||Age||years|Mean|51.9|51.9|Standard Deviation|9.8|9.8|||
3981127|NCT01263132|3803614|B2|||Age||years|Mean|51.1|51.1|Standard Deviation|9.9|9.9|||
3981128|NCT01263132|3803615|B1|||Age||years|Mean|52.6|52.6|Standard Deviation|9.7|9.7|||
3981129|NCT01263119|3803630|B1|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3981130|NCT01263119|3803630|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3981131|NCT01263119|3803630|B1|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3981132|NCT01263119|3803630|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3981133|NCT01263119|3803630|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3981134|NCT01263119|3803630|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3981135|NCT01263119|3803630|B1|||Age||years|Mean|38.2|38.2|Standard Deviation|6.6|6.6|||
3981136|NCT01263093|3803651|B3|United States||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
3981137|NCT01263093|3803652|B2|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
3981138|NCT01263093|3803653|B1|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
3981139|NCT01263093|3803651|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981140|NCT01263093|3803652|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981141|NCT01263093|3803653|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981142|NCT01263093|3803651|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981143|NCT01263093|3803652|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981144|NCT01263093|3803653|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981145|NCT01263093|3803651|B3||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3981146|NCT01263093|3803652|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3981147|NCT01263093|3803653|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3981148|NCT01263093|3803651|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3981149|NCT01263093|3803652|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3981150|NCT01263093|3803653|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3981151|NCT01263093|3803651|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981152|NCT01263093|3803652|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981153|NCT01263093|3803653|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981154|NCT01263093|3803651|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981155|NCT01263093|3803652|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981156|NCT01263093|3803653|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981157|NCT01263093|3803651|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981158|NCT01263093|3803652|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981159|NCT01263093|3803653|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981160|NCT01263093|3803651|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981161|NCT01263093|3803652|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981162|NCT01263093|3803653|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981163|NCT01263093|3803651|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3981164|NCT01263093|3803652|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3981165|NCT01263093|3803653|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3981166|NCT01263093|3803651|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3981167|NCT01263093|3803652|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3981168|NCT01263093|3803653|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3981169|NCT01263093|3803651|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3981170|NCT01263093|3803652|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3981171|NCT01263093|3803653|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3981172|NCT01263093|3803651|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3981173|NCT01263093|3803652|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3981174|NCT01263093|3803653|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3981175|NCT01263093|3803651|B3|||Age||years|Mean|42.5|42.5|Standard Deviation|11.4|11.4|||
3981176|NCT01263093|3803652|B2|||Age||years|Mean|44.5|44.5|Standard Deviation|11.5|11.5|||
3981177|NCT01263093|3803653|B1|||Age||years|Mean|40.7|40.7|Standard Deviation|11.2|11.2|||
3981178|NCT01263054|3803669|B3|United States||Region of Enrollment||participants|Number|63|63.0||||||
3981179|NCT01263054|3803670|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
3981180|NCT01263054|3803671|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3981181|NCT01263054|3803669|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3981182|NCT01263054|3803670|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3981183|NCT01263054|3803671|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3981184|NCT01263054|3803669|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3981185|NCT01263054|3803670|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3981186|NCT01263054|3803671|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3981187|NCT01263054|3803669|B3|||Age||years|Mean|42|42.0|Standard Deviation|11|11.0|||
3981188|NCT01263054|3803670|B2|||Age||years|Mean|43|43.0|Standard Deviation|11|11.0|||
3981189|NCT01263054|3803671|B1|||Age||years|Mean|41|41.0|Standard Deviation|11|11.0|||
3981190|NCT01263054|3803669|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3981191|NCT01263054|3803670|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3981192|NCT01263054|3803671|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3981193|NCT01263054|3803669|B3||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
3981194|NCT01263054|3803670|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3981195|NCT01263054|3803671|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3981196|NCT01263054|3803669|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3981197|NCT01263054|3803670|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3981198|NCT01263054|3803671|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3981199|NCT01263028|3803690|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3981200|NCT01263028|3803690|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3981201|NCT01263028|3803690|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3981202|NCT01263028|3803690|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3981203|NCT01263028|3803690|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3981204|NCT01263028|3803690|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3981205|NCT01263015|3803698|B3|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3981206|NCT01263015|3803699|B2|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3981207|NCT01263015|3803700|B1|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3981208|NCT01263015|3803698|B3|Asian & White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3981209|NCT01263015|3803699|B2|Asian & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3981210|NCT01263015|3803700|B1|Asian & White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3981211|NCT01263015|3803698|B3|American Indian or Alaska Native & White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3981212|NCT01263015|3803699|B2|American Indian or Alaska Native & White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3981213|NCT01263015|3803700|B1|American Indian or Alaska Native & White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3981214|NCT01263015|3803698|B3|Af Am/Af Ht & White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3981215|NCT01263015|3803699|B2|Af Am/Af Ht & White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3981216|NCT01263015|3803700|B1|Af Am/Af Ht & White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3981217|NCT01263015|3803698|B3|Af Am/Af Ht & Nat Hawaiian/other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3981218|NCT01263015|3803699|B2|Af Am/Af Ht & Nat Hawaiian/other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3981219|NCT01263015|3803700|B1|Af Am/Af Ht & Nat Hawaiian/other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3981220|NCT01263015|3803698|B3|Af Am/Af Ht & AI or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3981221|NCT01263015|3803699|B2|Af Am/Af Ht & AI or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3981222|NCT01263015|3803700|B1|Af Am/Af Ht & AI or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3981223|NCT01263015|3803698|B3|White||Race/Ethnicity, Customized||participants|Number|569|569.0||||||
3981224|NCT01263015|3803699|B2|White||Race/Ethnicity, Customized||participants|Number|285|285.0||||||
3981225|NCT01263015|3803700|B1|White||Race/Ethnicity, Customized||participants|Number|284|284.0||||||
3981226|NCT01263015|3803698|B3|Asian||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3981227|NCT01263015|3803699|B2|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3981228|NCT01263015|3803700|B1|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3981229|NCT01263015|3803698|B3|American Indian (AI) or Alaska Native (Nat)||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3981230|NCT01263015|3803699|B2|American Indian (AI) or Alaska Native (Nat)||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3981283|NCT01262976|3803743|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3981231|NCT01263015|3803700|B1|American Indian (AI) or Alaska Native (Nat)||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3981232|NCT01263015|3803698|B3|African American (Af Am)/African Heritage (Af Ht)||Race/Ethnicity, Customized||participants|Number|197|197.0||||||
3981233|NCT01263015|3803699|B2|African American (Af Am)/African Heritage (Af Ht)||Race/Ethnicity, Customized||participants|Number|99|99.0||||||
3981234|NCT01263015|3803700|B1|African American (Af Am)/African Heritage (Af Ht)||Race/Ethnicity, Customized||participants|Number|98|98.0||||||
3981235|NCT01263015|3803698|B3||Male|Sex: Female, Male||Participants|Count of Participants|703|703.0||||||
3981236|NCT01263015|3803699|B2||Male|Sex: Female, Male||Participants|Count of Participants|356|356.0||||||
3981237|NCT01263015|3803700|B1||Male|Sex: Female, Male||Participants|Count of Participants|347|347.0||||||
3981238|NCT01263015|3803698|B3||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3981239|NCT01263015|3803699|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3981240|NCT01263015|3803700|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3981241|NCT01263015|3803698|B3|||Age||Years|Mean|36.4|36.4|Standard Deviation|10.58|10.58|||
3981242|NCT01263015|3803699|B2|||Age||Years|Mean|36.4|36.4|Standard Deviation|10.43|10.43|||
3981243|NCT01263015|3803700|B1|||Age||Years|Mean|36.5|36.5|Standard Deviation|10.74|10.74|||
3981244|NCT01262989|3803727|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3981245|NCT01262989|3803727|B1|Mulatto||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3981246|NCT01262989|3803727|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
3981247|NCT01262989|3803727|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3981248|NCT01262989|3803727|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3981249|NCT01262989|3803727|B1|||Age||Years|Mean|32.65|32.65|Standard Deviation|7.94|7.94|||
3981250|NCT01262976|3803738|B7|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3981251|NCT01262976|3803739|B6|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3981252|NCT01262976|3803740|B5|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3981253|NCT01262976|3803741|B4|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3981254|NCT01262976|3803742|B3|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3981255|NCT01262976|3803743|B2|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3981256|NCT01262976|3803744|B1|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3981257|NCT01262976|3803738|B7|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3981258|NCT01262976|3803739|B6|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3981259|NCT01262976|3803740|B5|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3981260|NCT01262976|3803741|B4|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3981261|NCT01262976|3803742|B3|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3981262|NCT01262976|3803743|B2|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3981263|NCT01262976|3803744|B1|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3981264|NCT01262976|3803738|B7|Geographic ancestry|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|231|231.0||||||
3981265|NCT01262976|3803739|B6|Geographic ancestry|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
3981266|NCT01262976|3803740|B5|Geographic ancestry|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
3981267|NCT01262976|3803741|B4|Geographic ancestry|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3981268|NCT01262976|3803742|B3|Geographic ancestry|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
3981269|NCT01262976|3803743|B2|Geographic ancestry|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3981270|NCT01262976|3803744|B1|Geographic ancestry|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
3981271|NCT01262976|3803738|B7||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3981272|NCT01262976|3803739|B6||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3981273|NCT01262976|3803740|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3981274|NCT01262976|3803741|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3981275|NCT01262976|3803742|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3981276|NCT01262976|3803743|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3981277|NCT01262976|3803744|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3981278|NCT01262976|3803738|B7||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3981279|NCT01262976|3803739|B6||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3981280|NCT01262976|3803740|B5||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3981281|NCT01262976|3803741|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3981282|NCT01262976|3803742|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3981284|NCT01262976|3803744|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3981285|NCT01262976|3803738|B7|||Age||Years|Mean|34.1|34.1|Standard Deviation|6.5|6.5|||
3981286|NCT01262976|3803739|B6|||Age||Years|Mean|34.6|34.6|Standard Deviation|6.4|6.4|||
3981287|NCT01262976|3803740|B5|||Age||Years|Mean|33.9|33.9|Standard Deviation|7.6|7.6|||
3981288|NCT01262976|3803741|B4|||Age||Years|Mean|32.2|32.2|Standard Deviation|5.3|5.3|||
3981289|NCT01262976|3803742|B3|||Age||Years|Mean|32.6|32.6|Standard Deviation|6.5|6.5|||
3981290|NCT01262976|3803743|B2|||Age||Years|Mean|35.5|35.5|Standard Deviation|6.2|6.2|||
3981291|NCT01262976|3803744|B1|||Age||Years|Mean|36.0|36.0|Standard Deviation|6.5|6.5|||
3981292|NCT01262898|3803901|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981293|NCT01262898|3803902|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981294|NCT01262898|3803903|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981295|NCT01262898|3803904|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981296|NCT01262898|3803905|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981297|NCT01262898|3803901|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981298|NCT01262898|3803902|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981299|NCT01262898|3803903|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981300|NCT01262898|3803904|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981301|NCT01262898|3803905|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981302|NCT01262898|3803901|B5||White|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3981303|NCT01262898|3803902|B4||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3981304|NCT01262898|3803903|B3||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3981305|NCT01262898|3803904|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3981306|NCT01262898|3803905|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3981307|NCT01262898|3803901|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3981308|NCT01262898|3803902|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981309|NCT01262898|3803903|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981310|NCT01262898|3803904|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3981311|NCT01262898|3803905|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3981312|NCT01262898|3803901|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3981313|NCT01262898|3803902|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3981314|NCT01262898|3803903|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3981315|NCT01262898|3803904|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3981316|NCT01262898|3803905|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981317|NCT01262898|3803901|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981318|NCT01262898|3803902|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981319|NCT01262898|3803903|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981320|NCT01262898|3803904|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981321|NCT01262898|3803905|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981322|NCT01262898|3803901|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3981323|NCT01262898|3803902|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3981324|NCT01262898|3803903|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981325|NCT01262898|3803904|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981326|NCT01262898|3803905|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981327|NCT01262898|3803901|B5||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3981328|NCT01262898|3803902|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3981329|NCT01262898|3803903|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3981330|NCT01262898|3803904|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3981331|NCT01262898|3803905|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3981332|NCT01262898|3803901|B5||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3981333|NCT01262898|3803902|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3981334|NCT01262898|3803903|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3981335|NCT01262898|3803904|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3981336|NCT01262898|3803905|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3981337|NCT01262898|3803901|B5|||Age||Years|Mean|53.7|53.7|Standard Deviation|12.22|12.22|||
3981338|NCT01262898|3803902|B4|||Age||Years|Mean|51.4|51.4|Standard Deviation|11.34|11.34|||
3981339|NCT01262898|3803903|B3|||Age||Years|Mean|55.2|55.2|Standard Deviation|12.17|12.17|||
3981340|NCT01262898|3803904|B2|||Age||Years|Mean|54.0|54.0|Standard Deviation|11.42|11.42|||
3981341|NCT01262898|3803905|B1|||Age||Years|Mean|54.6|54.6|Standard Deviation|14.23|14.23|||
3981434|NCT01262846|3804298|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981342|NCT01262872|3804028|B9|African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3981343|NCT01262872|3804029|B8|African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|200|200.0||||||
3981344|NCT01262872|3804030|B7|African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|200|200.0||||||
3981345|NCT01262872|3804031|B6|African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|200|200.0||||||
3981346|NCT01262872|3804032|B5|African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|200|200.0||||||
3981347|NCT01262872|3804033|B4|African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|200|200.0||||||
3981348|NCT01262872|3804034|B3|African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|200|200.0||||||
3981349|NCT01262872|3804035|B2|African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|NA|||||||The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.
3981350|NCT01262872|3804036|B1|African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|NA|||||||The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.
3981351|NCT01262872|3804028|B9|African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3981352|NCT01262872|3804029|B8|African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|NA|||||||The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.
3981353|NCT01262872|3804030|B7|African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|NA|||||||The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.
3981354|NCT01262872|3804031|B6|African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|NA|||||||The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.
3981355|NCT01262872|3804032|B5|African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|NA|||||||The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.
3981356|NCT01262872|3804033|B4|African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|NA|||||||The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.
3981357|NCT01262872|3804034|B3|African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|NA|||||||The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.
3981358|NCT01262872|3804035|B2|African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|60|60.0||||||
3981359|NCT01262872|3804036|B1|African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|60|60.0||||||
3981360|NCT01262872|3804028|B9||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3981361|NCT01262872|3804029|B8||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3981362|NCT01262872|3804030|B7||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3981363|NCT01262872|3804031|B6||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3981364|NCT01262872|3804032|B5||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3981365|NCT01262872|3804033|B4||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3981366|NCT01262872|3804034|B3||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3981367|NCT01262872|3804035|B2||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.
3981368|NCT01262872|3804036|B1||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.
3981369|NCT01262872|3804028|B9||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3981370|NCT01262872|3804029|B8||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3981371|NCT01262872|3804030|B7||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3981372|NCT01262872|3804031|B6||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3981373|NCT01262872|3804032|B5||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3981374|NCT01262872|3804033|B4||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3981375|NCT01262872|3804034|B3||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3981376|NCT01262872|3804035|B2||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.
3981377|NCT01262872|3804036|B1||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.
3981378|NCT01262872|3804028|B9||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3981379|NCT01262872|3804029|B8||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.
3981380|NCT01262872|3804030|B7||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.
3981381|NCT01262872|3804031|B6||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.
3981382|NCT01262872|3804032|B5||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.
3981383|NCT01262872|3804033|B4||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.
3981435|NCT01262846|3804296|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981384|NCT01262872|3804034|B3||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.
3981385|NCT01262872|3804035|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3981386|NCT01262872|3804036|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3981387|NCT01262872|3804028|B9||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
3981388|NCT01262872|3804029|B8||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.
3981389|NCT01262872|3804030|B7||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.
3981390|NCT01262872|3804031|B6||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.
3981391|NCT01262872|3804032|B5||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.
3981392|NCT01262872|3804033|B4||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.
3981393|NCT01262872|3804034|B3||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.
3981394|NCT01262872|3804035|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3981395|NCT01262872|3804036|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3981396|NCT01262872|3804028|B9|||Age||Weeks|Mean|8.5|8.5|Standard Deviation|0.66|0.66|||
3981397|NCT01262872|3804029|B8|||Age||Weeks|Mean|8.5|8.5|Standard Deviation|0.70|0.7|||
3981398|NCT01262872|3804030|B7|||Age||Weeks|Mean|8.5|8.5|Standard Deviation|0.70|0.7|||
3981399|NCT01262872|3804031|B6|||Age||Weeks|Mean|8.5|8.5|Standard Deviation|0.69|0.69|||
3981400|NCT01262872|3804032|B5|||Age||Weeks|Mean|8.4|8.4|Standard Deviation|0.63|0.63|||
3981401|NCT01262872|3804033|B4|||Age||Weeks|Mean|8.4|8.4|Standard Deviation|0.61|0.61|||
3981402|NCT01262872|3804034|B3|||Age||Weeks|Mean|8.5|8.5|Standard Deviation|0.64|0.64|||
3981403|NCT01262872|3804035|B2|||Age||Weeks|Mean|NA||Standard Deviation|NA||||The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.
3981404|NCT01262872|3804036|B1|||Age||Weeks|Mean|NA||Standard Deviation|NA||||The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.
3981405|NCT01262872|3804028|B9|||Age||Years|Mean|2.9|2.9|Standard Deviation|0.38|0.38|||
3981406|NCT01262872|3804029|B8|||Age||Years|Mean|NA||Standard Deviation|NA||||The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.
3981407|NCT01262872|3804030|B7|||Age||Years|Mean|NA||Standard Deviation|NA||||The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.
3981408|NCT01262872|3804031|B6|||Age||Years|Mean|NA||Standard Deviation|NA||||The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.
3981409|NCT01262872|3804032|B5|||Age||Years|Mean|NA||Standard Deviation|NA||||The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.
3981410|NCT01262872|3804033|B4|||Age||Years|Mean|NA||Standard Deviation|NA||||The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.
3981411|NCT01262872|3804034|B3|||Age||Years|Mean|NA||Standard Deviation|NA||||The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.
3981412|NCT01262872|3804035|B2|||Age||Years|Mean|2.9|2.9|Standard Deviation|0.36|0.36|||
3981413|NCT01262872|3804036|B1|||Age||Years|Mean|2.8|2.8|Standard Deviation|0.40|0.4|||
3981414|NCT01262846|3804296|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981415|NCT01262846|3804297|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981416|NCT01262846|3804298|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981417|NCT01262846|3804296|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981418|NCT01262846|3804297|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|00|0.0||||||
3981419|NCT01262846|3804298|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981420|NCT01262846|3804296|B3||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3981421|NCT01262846|3804297|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3981422|NCT01262846|3804298|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3981423|NCT01262846|3804296|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|136|136.0||||||
3981424|NCT01262846|3804297|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3981425|NCT01262846|3804298|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3981426|NCT01262846|3804296|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981427|NCT01262846|3804297|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981428|NCT01262846|3804298|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981429|NCT01262846|3804296|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3981430|NCT01262846|3804297|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981431|NCT01262846|3804298|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3981432|NCT01262846|3804296|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981433|NCT01262846|3804297|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981436|NCT01262846|3804297|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981437|NCT01262846|3804298|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981438|NCT01262846|3804296|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|185|185.0||||||
3981439|NCT01262846|3804297|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
3981440|NCT01262846|3804298|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3981441|NCT01262846|3804296|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3981442|NCT01262846|3804297|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3981443|NCT01262846|3804298|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3981444|NCT01262846|3804296|B3||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3981445|NCT01262846|3804297|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3981446|NCT01262846|3804298|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3981447|NCT01262846|3804296|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3981448|NCT01262846|3804297|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3981449|NCT01262846|3804298|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3981450|NCT01262846|3804296|B3|||Age||years|Median|45|45.0|Inter-Quartile Range|||35.0|53.0|
3981451|NCT01262846|3804297|B2|||Age||years|Median|44|44.0|Inter-Quartile Range|||35.0|50.0|
3981452|NCT01262846|3804298|B1|||Age||years|Median|46|46.0|Inter-Quartile Range|||37.0|53.0|
3981453|NCT01262820|3804305|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3981454|NCT01262820|3804305|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981455|NCT01262820|3804305|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981456|NCT01262820|3804305|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3981457|NCT01262820|3804305|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3981458|NCT01262820|3804305|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981459|NCT01262820|3804305|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3981460|NCT01262820|3804305|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981461|NCT01262820|3804305|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3981462|NCT01262820|3804305|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3981463|NCT01262820|3804305|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3981464|NCT01262820|3804305|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3981465|NCT01262820|3804305|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3981466|NCT01262820|3804305|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3981467|NCT01262820|3804305|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3981468|NCT01262820|3804305|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3981469|NCT01262755|3804312|B1|United States||Region of Enrollment||participants|Number|450|450.0||||||
3981470|NCT01262755|3804312|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981471|NCT01262755|3804312|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981472|NCT01262755|3804312|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981473|NCT01262755|3804312|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|450|450.0||||||
3981474|NCT01262755|3804312|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981475|NCT01262755|3804312|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981476|NCT01262755|3804312|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981477|NCT01262755|3804312|B1||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
3981478|NCT01262755|3804312|B1||Female|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
3981479|NCT01262755|3804312|B1|||Age||years|Mean|43.2|43.2|Standard Deviation|6.6|6.6|||
3981480|NCT01262677|3804316|B4||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
3981481|NCT01262677|3804317|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3981482|NCT01262677|3804318|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3981483|NCT01262677|3804319|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3981484|NCT01262677|3804316|B4||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3981485|NCT01262677|3804317|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3981486|NCT01262677|3804318|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3981487|NCT01262677|3804319|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3981488|NCT01262677|3804316|B4|||Age||years|Mean|38.76|38.76|Standard Deviation|13.14|13.14|||
3981489|NCT01262677|3804317|B3|||Age||years|Mean|38.72|38.72|Standard Deviation|13.25|13.25|||
3981490|NCT01262677|3804318|B2|||Age||years|Mean|39.58|39.58|Standard Deviation|13.15|13.15|||
3981491|NCT01262677|3804319|B1|||Age||years|Mean|37.88|37.88|Standard Deviation|13.10|13.1|||
3981492|NCT01262651|3804410|B3||Male|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
3981493|NCT01262651|3804411|B2||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3981494|NCT01262651|3804412|B1||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3981495|NCT01262651|3804410|B3||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
3981496|NCT01262651|3804411|B2||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3981497|NCT01262651|3804412|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3981498|NCT01262651|3804410|B3|||Age||years|Mean|59.9|59.9|Standard Deviation|11.6|11.6|||
3981499|NCT01262651|3804411|B2|||Age||years|Mean|60.7|60.7|Standard Deviation|11.1|11.1|||
3981500|NCT01262651|3804412|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|12.0|12.0|||
3981501|NCT01262599|3804439|B3|||Body Mass Index (BMI)||kg/m2|Mean|24.8|24.8|Standard Deviation|3.2|3.2|||
3981502|NCT01262599|3804440|B2|||Body Mass Index (BMI)||kg/m2|Mean|24.5|24.5|Standard Deviation|3.4|3.4|||
3981503|NCT01262599|3804441|B1|||Body Mass Index (BMI)||kg/m2|Mean|25.1|25.1|Standard Deviation|3.1|3.1|||
3981504|NCT01262599|3804439|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
3981505|NCT01262599|3804440|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3981506|NCT01262599|3804441|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3981507|NCT01262599|3804439|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3981508|NCT01262599|3804440|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3981509|NCT01262599|3804441|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3981510|NCT01262599|3804439|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3981511|NCT01262599|3804440|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3981512|NCT01262599|3804441|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3981513|NCT01262599|3804439|B3|||Age||years|Mean|52.3|52.3|Standard Deviation|9.3|9.3|||
3981514|NCT01262599|3804440|B2|||Age||years|Mean|51.1|51.1|Standard Deviation|9.7|9.7|||
3981515|NCT01262599|3804441|B1|||Age||years|Mean|53.5|53.5|Standard Deviation|9.1|9.1|||
3981516|NCT01262599|3804439|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3981517|NCT01262599|3804440|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3981518|NCT01262599|3804441|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3981519|NCT01262599|3804439|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3981520|NCT01262599|3804440|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3981521|NCT01262599|3804441|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3981522|NCT01262599|3804439|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3981523|NCT01262599|3804440|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3981524|NCT01262599|3804441|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3981525|NCT01262573|3804452|B3|Other||Sexual Function||participants|Number|0|0.0||||||
3981526|NCT01262573|3804453|B2|Other||Sexual Function||participants|Number|0|0.0||||||
3981527|NCT01262573|3804454|B1|Other||Sexual Function||participants|Number|0|0.0||||||
3981528|NCT01262573|3804452|B3|Ongoing problem||Sexual Function||participants|Number|5|5.0||||||
3981529|NCT01262573|3804453|B2|Ongoing problem||Sexual Function||participants|Number|0|0.0||||||
3981530|NCT01262573|3804454|B1|Ongoing problem||Sexual Function||participants|Number|5|5.0||||||
3981531|NCT01262573|3804452|B3|Any male dyspareunia reported||Sexual Function||participants|Number|0|0.0||||||
3981532|NCT01262573|3804453|B2|Any male dyspareunia reported||Sexual Function||participants|Number|0|0.0||||||
3981533|NCT01262573|3804454|B1|Any male dyspareunia reported||Sexual Function||participants|Number|0|0.0||||||
3981534|NCT01262573|3804452|B3|Any female dyspareunia reported||Sexual Function||participants|Number|25|25.0||||||
3981535|NCT01262573|3804453|B2|Any female dyspareunia reported||Sexual Function||participants|Number|13|13.0||||||
3981536|NCT01262573|3804454|B1|Any female dyspareunia reported||Sexual Function||participants|Number|12|12.0||||||
3981537|NCT01262573|3804452|B3|Prior Laparotomy||Medical History||participants|Number|31|31.0||||||
3981538|NCT01262573|3804453|B2|Prior Laparotomy||Medical History||participants|Number|19|19.0||||||
3981539|NCT01262573|3804454|B1|Prior Laparotomy||Medical History||participants|Number|12|12.0||||||
3981540|NCT01262573|3804452|B3|Prior Laparoscopy||Medical History||participants|Number|27|27.0||||||
3981541|NCT01262573|3804453|B2|Prior Laparoscopy||Medical History||participants|Number|12|12.0||||||
3981542|NCT01262573|3804454|B1|Prior Laparoscopy||Medical History||participants|Number|15|15.0||||||
3981543|NCT01262573|3804452|B3|Abnormal Uterine Bleeding||Medical History||participants|Number|51|51.0||||||
3981544|NCT01262573|3804453|B2|Abnormal Uterine Bleeding||Medical History||participants|Number|24|24.0||||||
3981545|NCT01262573|3804454|B1|Abnormal Uterine Bleeding||Medical History||participants|Number|27|27.0||||||
3981546|NCT01262573|3804452|B3|Prolapse||Medical History||participants|Number|0|0.0||||||
3981547|NCT01262573|3804453|B2|Prolapse||Medical History||participants|Number|0|0.0||||||
3981548|NCT01262573|3804454|B1|Prolapse||Medical History||participants|Number|0|0.0||||||
3981549|NCT01262573|3804452|B3|Infertility||Medical History||participants|Number|5|5.0||||||
3981550|NCT01262573|3804453|B2|Infertility||Medical History||participants|Number|2|2.0||||||
3981551|NCT01262573|3804454|B1|Infertility||Medical History||participants|Number|3|3.0||||||
3981552|NCT01262573|3804452|B3|Pelvic Pain||Medical History||participants|Number|47|47.0||||||
3981553|NCT01262573|3804453|B2|Pelvic Pain||Medical History||participants|Number|24|24.0||||||
3981554|NCT01262573|3804454|B1|Pelvic Pain||Medical History||participants|Number|23|23.0||||||
3981555|NCT01262573|3804452|B3|Fibroids||Medical History||participants|Number|41|41.0||||||
3981556|NCT01262573|3804453|B2|Fibroids||Medical History||participants|Number|20|20.0||||||
3981557|NCT01262573|3804454|B1|Fibroids||Medical History||participants|Number|21|21.0||||||
3981558|NCT01262573|3804452|B3|Fellow/Resident||Cuff closure performed by the Attending Surgeon or the Fellow/Resident||participants|Number|32|32.0||||||
3981559|NCT01262573|3804453|B2|Fellow/Resident||Cuff closure performed by the Attending Surgeon or the Fellow/Resident||participants|Number|16|16.0||||||
3981560|NCT01262573|3804454|B1|Fellow/Resident||Cuff closure performed by the Attending Surgeon or the Fellow/Resident||participants|Number|16|16.0||||||
3981561|NCT01262573|3804452|B3|Attending||Cuff closure performed by the Attending Surgeon or the Fellow/Resident||participants|Number|31|31.0||||||
3981562|NCT01262573|3804453|B2|Attending||Cuff closure performed by the Attending Surgeon or the Fellow/Resident||participants|Number|15|15.0||||||
3981563|NCT01262573|3804454|B1|Attending||Cuff closure performed by the Attending Surgeon or the Fellow/Resident||participants|Number|16|16.0||||||
3981564|NCT01262573|3804452|B3|Army Hospital||Hospital||participants|Number|27|27.0||||||
3981565|NCT01262573|3804453|B2|Army Hospital||Hospital||participants|Number|13|13.0||||||
3981566|NCT01262573|3804454|B1|Army Hospital||Hospital||participants|Number|14|14.0||||||
3981567|NCT01262573|3804452|B3|Faulkner Hospital||Hospital||participants|Number|14|14.0||||||
3981568|NCT01262573|3804453|B2|Faulkner Hospital||Hospital||participants|Number|7|7.0||||||
3981569|NCT01262573|3804454|B1|Faulkner Hospital||Hospital||participants|Number|7|7.0||||||
3981570|NCT01262573|3804452|B3|Brigham and Women's Hospital||Hospital||participants|Number|22|22.0||||||
3981571|NCT01262573|3804453|B2|Brigham and Women's Hospital||Hospital||participants|Number|11|11.0||||||
3981572|NCT01262573|3804454|B1|Brigham and Women's Hospital||Hospital||participants|Number|11|11.0||||||
3981573|NCT01262573|3804452|B3|||Marital Status - Married||participants|Number|23|23.0||||||
3981574|NCT01262573|3804453|B2|||Marital Status - Married||participants|Number|12|12.0||||||
3981575|NCT01262573|3804454|B1|||Marital Status - Married||participants|Number|11|11.0||||||
3981576|NCT01262573|3804452|B3|||Smoking Status - Smoker||participants|Number|9|9.0||||||
3981577|NCT01262573|3804453|B2|||Smoking Status - Smoker||participants|Number|7|7.0||||||
3981578|NCT01262573|3804454|B1|||Smoking Status - Smoker||participants|Number|2|2.0||||||
3981579|NCT01262573|3804452|B3|||Parity||Births|Mean|1.7|1.7|Standard Deviation|0|0.0|||
3981580|NCT01262573|3804453|B2|||Parity||Births|Mean|1.7|1.7|Standard Deviation|1.0|1.0|||
3981581|NCT01262573|3804454|B1|||Parity||Births|Mean|1.7|1.7|Standard Deviation|1.3|1.3|||
3981582|NCT01262573|3804452|B3|||BMI||kg/m^2|Mean|28.0|28.0|Standard Deviation|4.2|4.2|||
3981583|NCT01262573|3804453|B2|||BMI||kg/m^2|Mean|26.9|26.9|Standard Deviation|8.6|8.6|||
3981584|NCT01262573|3804454|B1|||BMI||kg/m^2|Mean|29.1|29.1|Standard Deviation|5.9|5.9|||
3981585|NCT01262573|3804452|B3|United States||Region of Enrollment||participants|Number|63|63.0||||||
3981586|NCT01262573|3804453|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
3981587|NCT01262573|3804454|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
3981588|NCT01262573|3804452|B3|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3981589|NCT01262573|3804453|B2|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3981590|NCT01262573|3804454|B1|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3981591|NCT01262573|3804452|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3981592|NCT01262573|3804453|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3981593|NCT01262573|3804454|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3981594|NCT01262573|3804452|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3981595|NCT01262573|3804453|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3981596|NCT01262573|3804454|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3981597|NCT01262573|3804452|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3981598|NCT01262573|3804453|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3981599|NCT01262573|3804454|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3981600|NCT01262573|3804452|B3|Black||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3981601|NCT01262573|3804453|B2|Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3981602|NCT01262573|3804454|B1|Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3981603|NCT01262573|3804452|B3|White||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
3981604|NCT01262573|3804453|B2|White||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3981605|NCT01262573|3804454|B1|White||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3981606|NCT01262573|3804452|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
3981607|NCT01262573|3804453|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
3981608|NCT01262573|3804454|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3981609|NCT01262573|3804452|B3||Female|Gender||Participants|Count of Participants|63|63.0||||||
3981610|NCT01262573|3804453|B2||Female|Gender||Participants|Count of Participants|31|31.0||||||
3981611|NCT01262573|3804454|B1||Female|Gender||Participants|Count of Participants|32|32.0||||||
3981612|NCT01262573|3804452|B3|||Age||years|Mean|44.7|44.7|Standard Deviation|0.71|0.71|||
3981613|NCT01262573|3804453|B2|||Age||years|Mean|43.2|43.2|Standard Deviation|8.1|8.1|||
3981614|NCT01262573|3804454|B1|||Age||years|Mean|46.1|46.1|Standard Deviation|5.6|5.6|||
3981615|NCT01262560|3804463|B4||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3981616|NCT01262560|3804464|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3981617|NCT01262560|3804465|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3981618|NCT01262560|3804466|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3981619|NCT01262560|3804463|B4||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3981620|NCT01262560|3804464|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3981621|NCT01262560|3804465|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3981622|NCT01262560|3804466|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3981623|NCT01262560|3804463|B4|||Age||years|Median|65|65.0|Full Range|||37.0|85.0|
3981624|NCT01262560|3804464|B3|||Age||years|Median|65|65.0|Full Range|||47.0|83.0|
3981625|NCT01262560|3804465|B2|||Age||years|Median|66|66.0|Full Range|||37.0|83.0|
3981626|NCT01262560|3804466|B1|||Age||years|Median|65|65.0|Full Range|||45.0|85.0|
3981627|NCT01262547|3804503|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3981628|NCT01262547|3804503|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3981629|NCT01262547|3804503|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3981630|NCT01262547|3804503|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3981631|NCT01262547|3804503|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3981632|NCT01262547|3804503|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3981633|NCT01262547|3804503|B1|||Age||years|Mean|47|47.0|Full Range|||43.0|53.0|
3981634|NCT01262456|3804514|B4|||Body Mass Index (BMI)||kg/m^2|Mean|29.2|29.2|Standard Deviation|4.95|4.95|||
3981635|NCT01262456|3804515|B3|||Body Mass Index (BMI)||kg/m^2|Mean|29.2|29.2|Standard Deviation|4.79|4.79|||
3981636|NCT01262456|3804516|B2|||Body Mass Index (BMI)||kg/m^2|Mean|29.3|29.3|Standard Deviation|4.77|4.77|||
3981637|NCT01262456|3804517|B1|||Body Mass Index (BMI)||kg/m^2|Mean|29.2|29.2|Standard Deviation|5.25|5.25|||
3981638|NCT01262456|3804514|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|311|311.0||||||
3981639|NCT01262456|3804515|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|95|95.0||||||
3981640|NCT01262456|3804516|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|94|94.0||||||
3981641|NCT01262456|3804517|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|122|122.0||||||
3981642|NCT01262456|3804514|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
3981643|NCT01262456|3804515|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3981644|NCT01262456|3804516|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3981645|NCT01262456|3804517|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3981646|NCT01262456|3804514|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3981647|NCT01262456|3804515|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3981648|NCT01262456|3804516|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3981649|NCT01262456|3804517|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3981650|NCT01262456|3804514|B4|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3981651|NCT01262456|3804515|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3981652|NCT01262456|3804516|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3981653|NCT01262456|3804517|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3981654|NCT01262456|3804514|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
3981655|NCT01262456|3804515|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3981656|NCT01262456|3804516|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3981657|NCT01262456|3804517|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
3981658|NCT01262456|3804514|B4|White||Race/Ethnicity, Customized||participants|Number|310|310.0||||||
3981659|NCT01262456|3804515|B3|White||Race/Ethnicity, Customized||participants|Number|99|99.0||||||
3981660|NCT01262456|3804516|B2|White||Race/Ethnicity, Customized||participants|Number|99|99.0||||||
3981661|NCT01262456|3804517|B1|White||Race/Ethnicity, Customized||participants|Number|112|112.0||||||
3981662|NCT01262456|3804514|B4||Male|Sex: Female, Male||Participants|Count of Participants|385|385.0||||||
3981663|NCT01262456|3804515|B3||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3981664|NCT01262456|3804516|B2||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3981665|NCT01262456|3804517|B1||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3981666|NCT01262456|3804514|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3981667|NCT01262456|3804515|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3981668|NCT01262456|3804516|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3981669|NCT01262456|3804517|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3981670|NCT01262456|3804514|B4|>=65 years||Age, Customized||participants|Number|185|185.0||||||
3981671|NCT01262456|3804515|B3|>=65 years||Age, Customized||participants|Number|60|60.0||||||
3981672|NCT01262456|3804516|B2|>=65 years||Age, Customized||participants|Number|57|57.0||||||
3981673|NCT01262456|3804517|B1|>=65 years||Age, Customized||participants|Number|68|68.0||||||
3981674|NCT01262456|3804514|B4|<65 years||Age, Customized||participants|Number|200|200.0||||||
3981675|NCT01262456|3804515|B3|<65 years||Age, Customized||participants|Number|64|64.0||||||
3981676|NCT01262456|3804516|B2|<65 years||Age, Customized||participants|Number|62|62.0||||||
3981677|NCT01262456|3804517|B1|<65 years||Age, Customized||participants|Number|74|74.0||||||
3981678|NCT01262456|3804514|B4|||Age||years|Mean|60.6|60.6|Standard Deviation|13.1|13.1|||
3981679|NCT01262456|3804515|B3|||Age||years|Mean|60.1|60.1|Standard Deviation|11.6|11.6|||
3981680|NCT01262456|3804516|B2|||Age||years|Mean|60.8|60.8|Standard Deviation|13.2|13.2|||
3981681|NCT01262456|3804517|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|14.2|14.2|||
3981682|NCT01262365|3804560|B4||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3981683|NCT01262365|3804561|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3981684|NCT01262365|3804562|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3981685|NCT01262365|3804563|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3981686|NCT01262365|3804560|B4||Female|Sex: Female, Male||Participants|Count of Participants|735|735.0||||||
3981687|NCT01262365|3804561|B3||Female|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
3981688|NCT01262365|3804562|B2||Female|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
3981689|NCT01262365|3804563|B1||Female|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
3981690|NCT01262365|3804560|B4|||Age||years|Mean|42.1|42.1|Standard Deviation|12.0|12.0|||
3981691|NCT01262365|3804561|B3|||Age||years|Mean|42.3|42.3|Standard Deviation|11.4|11.4|||
3981692|NCT01262365|3804562|B2|||Age||years|Mean|42.5|42.5|Standard Deviation|11.8|11.8|||
3981693|NCT01262365|3804563|B1|||Age||years|Mean|41.4|41.4|Standard Deviation|12.6|12.6|||
3981694|NCT01262365|3804560|B4||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3981695|NCT01262365|3804561|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3981696|NCT01262365|3804562|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3981697|NCT01262365|3804563|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3981698|NCT01262365|3804560|B4||Between 18 and 65 years|Age||Participants|Count of Participants|763|763.0||||||
3981699|NCT01262365|3804561|B3||Between 18 and 65 years|Age||Participants|Count of Participants|257|257.0||||||
3981700|NCT01262365|3804562|B2||Between 18 and 65 years|Age||Participants|Count of Participants|254|254.0||||||
3981701|NCT01262365|3804563|B1||Between 18 and 65 years|Age||Participants|Count of Participants|252|252.0||||||
3981702|NCT01262365|3804560|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3981703|NCT01262365|3804561|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3981704|NCT01262365|3804562|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3981705|NCT01262365|3804563|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3981706|NCT01262352|3804588|B3|||Sweat Chloride||millimoles per liter|Mean|91.92|91.92|Standard Deviation|14.933|14.933|||
3981707|NCT01262352|3804589|B2|||Sweat Chloride||millimoles per liter|Mean|86.17|86.17|Standard Deviation|19.219|19.219|||
3981708|NCT01262352|3804590|B1|||Sweat Chloride||millimoles per liter|Mean|97.10|97.1|Standard Deviation|7.400|7.4|||
3981709|NCT01262352|3804588|B3|||Percent Predicted Forced Expiratory Volume in 1 Second (FEV1)||percentage|Mean|97.20|97.2|Standard Deviation|10.595|10.595|||
3981710|NCT01262352|3804589|B2|||Percent Predicted Forced Expiratory Volume in 1 Second (FEV1)||percentage|Mean|92.58|92.58|Standard Deviation|7.427|7.427|||
3981711|NCT01262352|3804590|B1|||Percent Predicted Forced Expiratory Volume in 1 Second (FEV1)||percentage|Mean|101.83|101.83|Standard Deviation|11.587|11.587|||
3981712|NCT01262352|3804588|B3|||Lung Clearance Index (LCI)|Lung clearance index (LCI) is a measure of ventilation inhomogeneity that is derived from a multiple-breath washout test. The LCI was calculated as the number of lung volume turnovers (cumulative expired volume divided by the functional residual capacity [FRC]) required to reduce end-tidal SF6 concentration to 1/40th of the starting value.|ratio|Mean|9.03|9.03|Standard Deviation|1.528|1.528|||
3981713|NCT01262352|3804589|B2|||Lung Clearance Index (LCI)|Lung clearance index (LCI) is a measure of ventilation inhomogeneity that is derived from a multiple-breath washout test. The LCI was calculated as the number of lung volume turnovers (cumulative expired volume divided by the functional residual capacity [FRC]) required to reduce end-tidal SF6 concentration to 1/40th of the starting value.|ratio|Mean|8.88|8.88|Standard Deviation|1.462|1.462|||
3981714|NCT01262352|3804590|B1|||Lung Clearance Index (LCI)|Lung clearance index (LCI) is a measure of ventilation inhomogeneity that is derived from a multiple-breath washout test. The LCI was calculated as the number of lung volume turnovers (cumulative expired volume divided by the functional residual capacity [FRC]) required to reduce end-tidal SF6 concentration to 1/40th of the starting value.|ratio|Mean|9.17|9.17|Standard Deviation|1.657|1.657|||
3981715|NCT01262352|3804588|B3|||Body Mass Index||kilograms per square meter|Mean|21.01|21.01|Standard Deviation|5.687|5.687|||
3981716|NCT01262352|3804589|B2|||Body Mass Index||kilograms per square meter|Mean|22.66|22.66|Standard Deviation|6.964|6.964|||
3981717|NCT01262352|3804590|B1|||Body Mass Index||kilograms per square meter|Mean|19.36|19.36|Standard Deviation|3.707|3.707|||
3981718|NCT01262352|3804588|B3|||Weight||kilograms|Mean|51.92|51.92|Standard Deviation|26.119|26.119|||
3981719|NCT01262352|3804589|B2|||Weight||kilograms|Mean|58.78|58.78|Standard Deviation|30.576|30.576|||
3981720|NCT01262352|3804590|B1|||Weight||kilograms|Mean|45.06|45.06|Standard Deviation|20.018|20.018|||
3981721|NCT01262352|3804588|B3|||Height||centimeters|Mean|152.5|152.5|Standard Deviation|18.61|18.61|||
3981722|NCT01262352|3804589|B2|||Height||centimeters|Mean|156.0|156.0|Standard Deviation|17.92|17.92|||
3981723|NCT01262352|3804590|B1|||Height||centimeters|Mean|148.9|148.9|Standard Deviation|19.54|19.54|||
3981724|NCT01262352|3804588|B3|Europe||Region of Enrollment||participants|Number|9|9.0||||||
3981725|NCT01262352|3804589|B2|Europe||Region of Enrollment||participants|Number|5|5.0||||||
3981726|NCT01262352|3804590|B1|Europe||Region of Enrollment||participants|Number|4|4.0||||||
3981727|NCT01262352|3804588|B3|North America||Region of Enrollment||participants|Number|11|11.0||||||
3981728|NCT01262352|3804589|B2|North America||Region of Enrollment||participants|Number|5|5.0||||||
3981729|NCT01262352|3804590|B1|North America||Region of Enrollment||participants|Number|6|6.0||||||
3981730|NCT01262352|3804588|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981731|NCT01262352|3804589|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981732|NCT01262352|3804590|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981733|NCT01262352|3804588|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981734|NCT01262352|3804589|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981735|NCT01262352|3804590|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981736|NCT01262352|3804588|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3981737|NCT01262352|3804589|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3981738|NCT01262352|3804590|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3981739|NCT01262352|3804588|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981740|NCT01262352|3804589|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981741|NCT01262352|3804590|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981742|NCT01262352|3804588|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981743|NCT01262352|3804589|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981744|NCT01262352|3804590|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981745|NCT01262352|3804588|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981746|NCT01262352|3804589|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981747|NCT01262352|3804590|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981748|NCT01262352|3804588|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981749|NCT01262352|3804589|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981750|NCT01262352|3804590|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981751|NCT01262352|3804588|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981752|NCT01262352|3804589|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981753|NCT01262352|3804590|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981754|NCT01262352|3804588|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3981755|NCT01262352|3804589|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3981756|NCT01262352|3804590|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3981757|NCT01262352|3804588|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981758|NCT01262352|3804589|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981759|NCT01262352|3804590|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981760|NCT01262352|3804588|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3981761|NCT01262352|3804589|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3981762|NCT01262352|3804590|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3981763|NCT01262352|3804588|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3981764|NCT01262352|3804589|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3981765|NCT01262352|3804590|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3981766|NCT01262352|3804588|B3|||Age||years|Mean|16.6|16.6|Standard Deviation|10.92|10.92|||
3981767|NCT01262352|3804589|B2|||Age||years|Mean|19.8|19.8|Standard Deviation|13.35|13.35|||
3981768|NCT01262352|3804590|B1|||Age||years|Mean|13.4|13.4|Standard Deviation|7.12|7.12|||
3981769|NCT01262352|3804588|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3981770|NCT01262352|3804589|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3981771|NCT01262352|3804590|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3981772|NCT01262352|3804588|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3981773|NCT01262352|3804589|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3981774|NCT01262352|3804590|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3981775|NCT01262352|3804588|B3||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
3981776|NCT01262352|3804589|B2||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
3981777|NCT01262352|3804590|B1||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
3981778|NCT01262339|3804603|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3981779|NCT01262339|3804603|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3981780|NCT01262339|3804603|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3981781|NCT01262339|3804603|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3981782|NCT01262339|3804603|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3981783|NCT01262339|3804603|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3981784|NCT01262287|3804607|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
3981785|NCT01262287|3804608|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3981786|NCT01262287|3804609|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3981787|NCT01262287|3804607|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3981788|NCT01262287|3804608|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981789|NCT01262287|3804609|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3981790|NCT01262287|3804607|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981791|NCT01262287|3804608|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981792|NCT01262287|3804609|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981793|NCT01262287|3804607|B3||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3981794|NCT01262287|3804608|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3981795|NCT01262287|3804609|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3981796|NCT01262287|3804607|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3981797|NCT01262287|3804608|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3981798|NCT01262287|3804609|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3981799|NCT01262287|3804607|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981800|NCT01262287|3804608|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981801|NCT01262287|3804609|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981802|NCT01262287|3804607|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981803|NCT01262287|3804608|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981804|NCT01262287|3804609|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981805|NCT01262287|3804607|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981806|NCT01262287|3804608|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981807|NCT01262287|3804609|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981808|NCT01262287|3804607|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981809|NCT01262287|3804608|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981810|NCT01262287|3804609|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981811|NCT01262287|3804607|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3981812|NCT01262287|3804608|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3981813|NCT01262287|3804609|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3981814|NCT01262287|3804607|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3981815|NCT01262287|3804608|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3981816|NCT01262287|3804609|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3981817|NCT01262287|3804607|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3981818|NCT01262287|3804608|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3981819|NCT01262287|3804609|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3981820|NCT01262287|3804607|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3981821|NCT01262287|3804608|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3981822|NCT01262287|3804609|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3981823|NCT01262287|3804607|B3|||Age||years|Mean|52.90|52.9|Standard Deviation|9.08|9.08|||
3981824|NCT01262287|3804608|B2|||Age||years|Mean|54.95|54.95|Standard Deviation|7.44|7.44|||
3981825|NCT01262287|3804609|B1|||Age||years|Mean|50.95|50.95|Standard Deviation|10.21|10.21|||
3981826|NCT01262287|3804607|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3981827|NCT01262287|3804608|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3981828|NCT01262287|3804609|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3981829|NCT01262287|3804607|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3981830|NCT01262287|3804608|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3981831|NCT01262287|3804609|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3981832|NCT01262287|3804607|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3981833|NCT01262287|3804608|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3981834|NCT01262287|3804609|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3981835|NCT01262131|3804620|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3981836|NCT01262131|3804621|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3981837|NCT01262131|3804622|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3981838|NCT01262131|3804623|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3981839|NCT01262131|3804620|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3981840|NCT01262131|3804621|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3981841|NCT01262131|3804622|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3981842|NCT01262131|3804623|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3981843|NCT01262131|3804620|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3981844|NCT01262131|3804621|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3981845|NCT01262131|3804622|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3981846|NCT01262131|3804623|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3981847|NCT01262131|3804620|B4||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3981848|NCT01262131|3804621|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3981849|NCT01262131|3804622|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3981850|NCT01262131|3804623|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3981851|NCT01262131|3804620|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3981852|NCT01262131|3804621|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3981853|NCT01262131|3804622|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3981854|NCT01262131|3804623|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3981855|NCT01262118|3804633|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3981856|NCT01262118|3804634|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3981857|NCT01262118|3804635|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3981858|NCT01262118|3804633|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3981859|NCT01262118|3804634|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3981860|NCT01262118|3804635|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3981861|NCT01262118|3804633|B3|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|3|3.0||||||
3981862|NCT01262118|3804634|B2|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|1|1.0||||||
3981863|NCT01262118|3804635|B1|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|2|2.0||||||
3981864|NCT01262118|3804633|B3|45 to 64 years||Age, Customized||participants|Number|50|50.0||||||
3981865|NCT01262118|3804634|B2|45 to 64 years||Age, Customized||participants|Number|25|25.0||||||
3981866|NCT01262118|3804635|B1|45 to 64 years||Age, Customized||participants|Number|25|25.0||||||
3981867|NCT01262118|3804633|B3|18 to 44 years||Age, Customized||participants|Number|16|16.0||||||
3981868|NCT01262118|3804634|B2|18 to 44 years||Age, Customized||participants|Number|7|7.0||||||
3981869|NCT01262118|3804635|B1|18 to 44 years||Age, Customized||participants|Number|9|9.0||||||
3981870|NCT01262105|3804660|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
3981871|NCT01262105|3804661|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3981872|NCT01262105|3804662|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3981873|NCT01262105|3804660|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3981874|NCT01262105|3804661|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3981875|NCT01262105|3804662|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3981876|NCT01262105|3804660|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3981877|NCT01262105|3804661|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3981878|NCT01262105|3804662|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3981879|NCT01262105|3804660|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3981880|NCT01262105|3804661|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3981881|NCT01262105|3804662|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3981882|NCT01262105|3804660|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3981883|NCT01262105|3804661|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3981884|NCT01262105|3804662|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3981885|NCT01262105|3804660|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3981886|NCT01262105|3804661|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3981887|NCT01262105|3804662|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3981888|NCT01262092|3804669|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
3981889|NCT01262092|3804670|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3981890|NCT01262092|3804671|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3981891|NCT01262092|3804669|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3981892|NCT01262092|3804670|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3981893|NCT01262092|3804671|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3981894|NCT01262092|3804669|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3981895|NCT01262092|3804670|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3981896|NCT01262092|3804671|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3981897|NCT01262092|3804669|B3|||Age||years|Mean|29.71|29.71|Standard Deviation|10.6|10.6|||
3981898|NCT01262092|3804670|B2|||Age||years|Mean|30.31|30.31|Standard Deviation|10.62|10.62|||
3981899|NCT01262092|3804671|B1|||Age||years|Mean|29.00|29.0|Standard Deviation|11.05|11.05|||
3981900|NCT01262092|3804669|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3981901|NCT01262092|3804670|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3981902|NCT01262092|3804671|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3981903|NCT01262092|3804669|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3981904|NCT01262092|3804670|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3981905|NCT01262092|3804671|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3981906|NCT01262092|3804669|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3981907|NCT01262092|3804670|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3981908|NCT01262092|3804671|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3981909|NCT01262027|3804678|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3981910|NCT01262027|3804678|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3981911|NCT01262027|3804678|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3981912|NCT01262027|3804678|B1|||Age||years|Median|56|56.0|Full Range|||29.0|70.0|
3981913|NCT01261975|3804683|B1|Europe||Region of Enrollment||participants|Number|36|36.0||||||
3981914|NCT01261975|3804683|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3981915|NCT01261975|3804683|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3981916|NCT01261975|3804683|B1|Aged 71 to 81 years||Age, Customized||participants|Number|36|36.0||||||
3981917|NCT01261793|3804702|B4||Male|Sex: Female, Male||Participants|Count of Participants|737|737.0||||||
3981918|NCT01261793|3804703|B3||Male|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
3981919|NCT01261793|3804704|B2||Male|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
3981920|NCT01261793|3804705|B1||Male|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
3981921|NCT01261793|3804702|B4||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3981922|NCT01261793|3804703|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3981923|NCT01261793|3804704|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3981924|NCT01261793|3804705|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3981925|NCT01261793|3804702|B4|||Age||years|Mean|41.0|41.0|Standard Deviation|12.0|12.0|||
3981926|NCT01261793|3804703|B3|||Age||years|Mean|41.2|41.2|Standard Deviation|12.7|12.7|||
3981927|NCT01261793|3804704|B2|||Age||years|Mean|40.8|40.8|Standard Deviation|11.5|11.5|||
3981928|NCT01261793|3804705|B1|||Age||years|Mean|41.1|41.1|Standard Deviation|11.8|11.8|||
3981929|NCT01261793|3804702|B4||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3981930|NCT01261793|3804703|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3981931|NCT01261793|3804704|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3981932|NCT01261793|3804705|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3981933|NCT01261793|3804702|B4||Between 18 and 65 years|Age||Participants|Count of Participants|765|765.0||||||
3981934|NCT01261793|3804703|B3||Between 18 and 65 years|Age||Participants|Count of Participants|254|254.0||||||
3981935|NCT01261793|3804704|B2||Between 18 and 65 years|Age||Participants|Count of Participants|257|257.0||||||
3981936|NCT01261793|3804705|B1||Between 18 and 65 years|Age||Participants|Count of Participants|254|254.0||||||
3981937|NCT01261793|3804702|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3981938|NCT01261793|3804703|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3981939|NCT01261793|3804704|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3981940|NCT01261793|3804705|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3981941|NCT01261780|3804730|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
3981942|NCT01261780|3804731|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
3981943|NCT01261780|3804732|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3981944|NCT01261780|3804730|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981945|NCT01261780|3804731|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981946|NCT01261780|3804732|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981947|NCT01261780|3804730|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981948|NCT01261780|3804731|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981949|NCT01261780|3804732|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981950|NCT01261780|3804730|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3981951|NCT01261780|3804731|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3981952|NCT01261780|3804732|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3981953|NCT01261780|3804730|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981954|NCT01261780|3804731|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981955|NCT01261780|3804732|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981956|NCT01261780|3804730|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981957|NCT01261780|3804731|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981958|NCT01261780|3804732|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981959|NCT01261780|3804730|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981960|NCT01261780|3804731|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981961|NCT01261780|3804732|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981962|NCT01261780|3804730|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981963|NCT01261780|3804731|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981964|NCT01261780|3804732|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981965|NCT01261780|3804730|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981966|NCT01261780|3804731|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981967|NCT01261780|3804732|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981968|NCT01261780|3804730|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3981969|NCT01261780|3804731|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3981970|NCT01261780|3804732|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3981971|NCT01261780|3804730|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981972|NCT01261780|3804731|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981973|NCT01261780|3804732|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3981974|NCT01261780|3804730|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3981975|NCT01261780|3804731|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3981976|NCT01261780|3804732|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3981977|NCT01261780|3804730|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3981978|NCT01261780|3804731|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3981979|NCT01261780|3804732|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3981980|NCT01261780|3804730|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3981981|NCT01261780|3804731|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3981982|NCT01261780|3804732|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3981983|NCT01261780|3804730|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3981984|NCT01261780|3804731|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3981985|NCT01261780|3804732|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3981986|NCT01261780|3804730|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3981987|NCT01261780|3804731|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3981988|NCT01261780|3804732|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3981989|NCT01261624|3804741|B3|||Height||m|Mean|1.379|1.379|Standard Deviation|0.225|0.225|||
3981990|NCT01261624|3804742|B2|||Height||m|Mean|1.365|1.365|Standard Deviation|0.277|0.277|||
3981991|NCT01261624|3804743|B1|||Height||m|Mean|1.388|1.388|Standard Deviation|0.204|0.204|||
3981992|NCT01261624|3804741|B3|||Body Weight||kg|Mean|37.57|37.57|Standard Deviation|16.05|16.05|||
3981993|NCT01261624|3804742|B2|||Body Weight||kg|Mean|37.92|37.92|Standard Deviation|18.59|18.59|||
3981994|NCT01261624|3804743|B1|||Body Weight||kg|Mean|37.36|37.36|Standard Deviation|15.40|15.4|||
3981995|NCT01261624|3804741|B3|Italy||Region of Enrollment||participants|Number|5|5.0||||||
3981996|NCT01261624|3804742|B2|Italy||Region of Enrollment||participants|Number|3|3.0||||||
3981997|NCT01261624|3804743|B1|Italy||Region of Enrollment||participants|Number|2|2.0||||||
3981998|NCT01261624|3804741|B3|Romania||Region of Enrollment||participants|Number|1|1.0||||||
3981999|NCT01261624|3804742|B2|Romania||Region of Enrollment||participants|Number|0|0.0||||||
3982000|NCT01261624|3804743|B1|Romania||Region of Enrollment||participants|Number|1|1.0||||||
3982001|NCT01261624|3804741|B3|Slovenia||Region of Enrollment||participants|Number|2|2.0||||||
3982002|NCT01261624|3804742|B2|Slovenia||Region of Enrollment||participants|Number|1|1.0||||||
3982003|NCT01261624|3804743|B1|Slovenia||Region of Enrollment||participants|Number|1|1.0||||||
3982004|NCT01261624|3804741|B3|Czech Republic||Region of Enrollment||participants|Number|2|2.0||||||
3982005|NCT01261624|3804742|B2|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
3982006|NCT01261624|3804743|B1|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
3982007|NCT01261624|3804741|B3|Serbia||Region of Enrollment||participants|Number|6|6.0||||||
3982008|NCT01261624|3804742|B2|Serbia||Region of Enrollment||participants|Number|1|1.0||||||
3982009|NCT01261624|3804743|B1|Serbia||Region of Enrollment||participants|Number|5|5.0||||||
3982010|NCT01261624|3804741|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982011|NCT01261624|3804742|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982012|NCT01261624|3804743|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982013|NCT01261624|3804741|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982014|NCT01261624|3804742|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982015|NCT01261624|3804743|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982016|NCT01261624|3804741|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3982017|NCT01261624|3804742|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3982018|NCT01261624|3804743|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3982019|NCT01261624|3804741|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982020|NCT01261624|3804742|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982021|NCT01261624|3804743|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982022|NCT01261624|3804741|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982023|NCT01261624|3804742|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982024|NCT01261624|3804743|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982025|NCT01261624|3804741|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982026|NCT01261624|3804742|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982027|NCT01261624|3804743|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982028|NCT01261624|3804741|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982029|NCT01261624|3804742|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982030|NCT01261624|3804743|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982031|NCT01261624|3804741|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3982032|NCT01261624|3804742|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3982033|NCT01261624|3804743|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3982034|NCT01261624|3804741|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3982035|NCT01261624|3804742|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3982036|NCT01261624|3804743|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3982037|NCT01261624|3804741|B3|||Age||years|Mean|10.9|10.9|Standard Deviation|5.4|5.4|||
3982038|NCT01261624|3804742|B2|||Age||years|Mean|9.7|9.7|Standard Deviation|5.7|5.7|||
3982039|NCT01261624|3804743|B1|||Age||years|Mean|11.7|11.7|Standard Deviation|5.5|5.5|||
3982040|NCT01261559|3804761|B3|United States||Region of Enrollment||participants|Number|72|72.0||||||
3982041|NCT01261559|3804762|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
3982042|NCT01261559|3804763|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
3982043|NCT01261559|3804761|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3982044|NCT01261559|3804762|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3982045|NCT01261559|3804763|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3982046|NCT01261559|3804761|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3982047|NCT01261559|3804762|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3982048|NCT01261559|3804763|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3982049|NCT01261559|3804761|B3|||Age||years|Mean|40.3|40.3|Standard Deviation|12.8|12.8|||
3982050|NCT01261559|3804762|B2|||Age||years|Mean|40.3|40.3|Standard Deviation|12.8|12.8|||
3982051|NCT01261559|3804763|B1|||Age||years|Mean|40.2|40.2|Standard Deviation|12.9|12.9|||
3982052|NCT01261559|3804761|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3982053|NCT01261559|3804762|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3982054|NCT01261559|3804763|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3982055|NCT01261559|3804761|B3||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
3982056|NCT01261559|3804762|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3982057|NCT01261559|3804763|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3982058|NCT01261559|3804761|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3982059|NCT01261559|3804762|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3982060|NCT01261559|3804763|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3982061|NCT01261507|3804776|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3982062|NCT01261507|3804776|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3982063|NCT01261507|3804776|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3982064|NCT01261507|3804776|B1||>=65 years|Age|Radiologists interpretations without use of tested software|Participants|Count of Participants|0|0.0||||||
3982065|NCT01261507|3804776|B1||Between 18 and 65 years|Age|Radiologists interpretations without use of tested software|Participants|Count of Participants|15|15.0||||||
3982066|NCT01261507|3804776|B1||<=18 years|Age|Radiologists interpretations without use of tested software|Participants|Count of Participants|0|0.0||||||
3982067|NCT01261390|3804785|B5|||Baseline Quality of Life Measures by Arm - SAQLI|The Calgary Sleep Apnea Quality of Life Index (SAQLI) is a scale intended to measure disease-specific quality of life. The SAQLI score ranges from 1 - 7, with higher scores indicating a higher quality of life.|units on a scale|Mean|4.8|4.8|Standard Deviation|0.9|0.9|||
3982068|NCT01261390|3804786|B4|||Baseline Quality of Life Measures by Arm - SAQLI|The Calgary Sleep Apnea Quality of Life Index (SAQLI) is a scale intended to measure disease-specific quality of life. The SAQLI score ranges from 1 - 7, with higher scores indicating a higher quality of life.|units on a scale|Mean|4.7|4.7|Standard Deviation|1.0|1.0|||
3982069|NCT01261390|3804787|B3|||Baseline Quality of Life Measures by Arm - SAQLI|The Calgary Sleep Apnea Quality of Life Index (SAQLI) is a scale intended to measure disease-specific quality of life. The SAQLI score ranges from 1 - 7, with higher scores indicating a higher quality of life.|units on a scale|Mean|4.9|4.9|Standard Deviation|0.9|0.9|||
3982070|NCT01261390|3804788|B2|||Baseline Quality of Life Measures by Arm - SAQLI|The Calgary Sleep Apnea Quality of Life Index (SAQLI) is a scale intended to measure disease-specific quality of life. The SAQLI score ranges from 1 - 7, with higher scores indicating a higher quality of life.|units on a scale|Mean|4.8|4.8|Standard Deviation|0.8|0.8|||
3982071|NCT01261390|3804789|B1|||Baseline Quality of Life Measures by Arm - SAQLI|The Calgary Sleep Apnea Quality of Life Index (SAQLI) is a scale intended to measure disease-specific quality of life. The SAQLI score ranges from 1 - 7, with higher scores indicating a higher quality of life.|units on a scale|Mean|4.8|4.8|Standard Deviation|0.8|0.8|||
3982072|NCT01261390|3804785|B5|||Baseline Quality of Life Measures by Arm - PHQ-8|The Patient Health Questionnaire (PHQ-8) is a scale intended to measure depression. The PHQ-8 score ranges from 0 - 24, with higher scores indicating increasing severity of depression.|units on a scale|Mean|5.3|5.3|Standard Deviation|4.9|4.9|||
3982073|NCT01261390|3804786|B4|||Baseline Quality of Life Measures by Arm - PHQ-8|The Patient Health Questionnaire (PHQ-8) is a scale intended to measure depression. The PHQ-8 score ranges from 0 - 24, with higher scores indicating increasing severity of depression.|units on a scale|Mean|6.4|6.4|Standard Deviation|5.6|5.6|||
3982074|NCT01261390|3804787|B3|||Baseline Quality of Life Measures by Arm - PHQ-8|The Patient Health Questionnaire (PHQ-8) is a scale intended to measure depression. The PHQ-8 score ranges from 0 - 24, with higher scores indicating increasing severity of depression.|units on a scale|Mean|4.7|4.7|Standard Deviation|5.1|5.1|||
3982168|NCT01261390|3804786|B4|Split-Night||Diagnostic Type||participants|Number|3|3.0||||||
3982075|NCT01261390|3804788|B2|||Baseline Quality of Life Measures by Arm - PHQ-8|The Patient Health Questionnaire (PHQ-8) is a scale intended to measure depression. The PHQ-8 score ranges from 0 - 24, with higher scores indicating increasing severity of depression.|units on a scale|Mean|5.1|5.1|Standard Deviation|4.1|4.1|||
3982076|NCT01261390|3804789|B1|||Baseline Quality of Life Measures by Arm - PHQ-8|The Patient Health Questionnaire (PHQ-8) is a scale intended to measure depression. The PHQ-8 score ranges from 0 - 24, with higher scores indicating increasing severity of depression.|units on a scale|Mean|5.0|5.0|Standard Deviation|4.6|4.6|||
3982077|NCT01261390|3804785|B5|||Baseline Quality of Life Measures by Arm - ESS|"The Epworth Sleepiness Scale (ESS) is a scale intended to measure daytime sleepiness. The ESS score ranges from 0 - 24, with higher scores indicating increasing possibility of specific sleep disorders.~We were not able to collect all values from all participants that completed a baseline visit. The following n-values apply to the respective categories below.~CMT, n=43; Sham, n=40; Active-Beh, n=40; Active+Beh, n=41; Total, n=164"|units on a scale|Mean|8.3|8.3|Standard Deviation|4.5|4.5|||
3982078|NCT01261390|3804786|B4|||Baseline Quality of Life Measures by Arm - ESS|"The Epworth Sleepiness Scale (ESS) is a scale intended to measure daytime sleepiness. The ESS score ranges from 0 - 24, with higher scores indicating increasing possibility of specific sleep disorders.~We were not able to collect all values from all participants that completed a baseline visit. The following n-values apply to the respective categories below.~CMT, n=43; Sham, n=40; Active-Beh, n=40; Active+Beh, n=41; Total, n=164"|units on a scale|Mean|8.4|8.4|Standard Deviation|4.8|4.8|||
3982079|NCT01261390|3804787|B3|||Baseline Quality of Life Measures by Arm - ESS|"The Epworth Sleepiness Scale (ESS) is a scale intended to measure daytime sleepiness. The ESS score ranges from 0 - 24, with higher scores indicating increasing possibility of specific sleep disorders.~We were not able to collect all values from all participants that completed a baseline visit. The following n-values apply to the respective categories below.~CMT, n=43; Sham, n=40; Active-Beh, n=40; Active+Beh, n=41; Total, n=164"|units on a scale|Mean|7.8|7.8|Standard Deviation|4.2|4.2|||
3982080|NCT01261390|3804788|B2|||Baseline Quality of Life Measures by Arm - ESS|"The Epworth Sleepiness Scale (ESS) is a scale intended to measure daytime sleepiness. The ESS score ranges from 0 - 24, with higher scores indicating increasing possibility of specific sleep disorders.~We were not able to collect all values from all participants that completed a baseline visit. The following n-values apply to the respective categories below.~CMT, n=43; Sham, n=40; Active-Beh, n=40; Active+Beh, n=41; Total, n=164"|units on a scale|Mean|8.0|8.0|Standard Deviation|4.2|4.2|||
3982081|NCT01261390|3804789|B1|||Baseline Quality of Life Measures by Arm - ESS|"The Epworth Sleepiness Scale (ESS) is a scale intended to measure daytime sleepiness. The ESS score ranges from 0 - 24, with higher scores indicating increasing possibility of specific sleep disorders.~We were not able to collect all values from all participants that completed a baseline visit. The following n-values apply to the respective categories below.~CMT, n=43; Sham, n=40; Active-Beh, n=40; Active+Beh, n=41; Total, n=164"|units on a scale|Mean|9.0|9.0|Standard Deviation|4.9|4.9|||
3982082|NCT01261390|3804785|B5|SF-36 Physical Subscale||Baseline Quality of Life Measures by Arm - Short Form Health Survey (SF-36)|The SF-36 is a patient-reported survey of patient health. The SF-36 scores range from 0-100, with lower scores indicating the more disability.|units on a scale|Mean|45.0|45.0|Standard Deviation|10.6|10.6|||
3982083|NCT01261390|3804786|B4|SF-36 Physical Subscale||Baseline Quality of Life Measures by Arm - Short Form Health Survey (SF-36)|The SF-36 is a patient-reported survey of patient health. The SF-36 scores range from 0-100, with lower scores indicating the more disability.|units on a scale|Mean|44.4|44.4|Standard Deviation|10.9|10.9|||
3982084|NCT01261390|3804787|B3|SF-36 Physical Subscale||Baseline Quality of Life Measures by Arm - Short Form Health Survey (SF-36)|The SF-36 is a patient-reported survey of patient health. The SF-36 scores range from 0-100, with lower scores indicating the more disability.|units on a scale|Mean|47.1|47.1|Standard Deviation|10.0|10.0|||
3982085|NCT01261390|3804788|B2|SF-36 Physical Subscale||Baseline Quality of Life Measures by Arm - Short Form Health Survey (SF-36)|The SF-36 is a patient-reported survey of patient health. The SF-36 scores range from 0-100, with lower scores indicating the more disability.|units on a scale|Mean|44.3|44.3|Standard Deviation|10.7|10.7|||
3982086|NCT01261390|3804789|B1|SF-36 Physical Subscale||Baseline Quality of Life Measures by Arm - Short Form Health Survey (SF-36)|The SF-36 is a patient-reported survey of patient health. The SF-36 scores range from 0-100, with lower scores indicating the more disability.|units on a scale|Mean|44.1|44.1|Standard Deviation|10.9|10.9|||
3982087|NCT01261390|3804785|B5|SF-36 Emotional Subscale||Baseline Quality of Life Measures by Arm - Short Form Health Survey (SF-36)|The SF-36 is a patient-reported survey of patient health. The SF-36 scores range from 0-100, with lower scores indicating the more disability.|units on a scale|Mean|46.7|46.7|Standard Deviation|11.6|11.6|||
3982088|NCT01261390|3804786|B4|SF-36 Emotional Subscale||Baseline Quality of Life Measures by Arm - Short Form Health Survey (SF-36)|The SF-36 is a patient-reported survey of patient health. The SF-36 scores range from 0-100, with lower scores indicating the more disability.|units on a scale|Mean|45.5|45.5|Standard Deviation|12.3|12.3|||
3982089|NCT01261390|3804787|B3|SF-36 Emotional Subscale||Baseline Quality of Life Measures by Arm - Short Form Health Survey (SF-36)|The SF-36 is a patient-reported survey of patient health. The SF-36 scores range from 0-100, with lower scores indicating the more disability.|units on a scale|Mean|48.4|48.4|Standard Deviation|11.1|11.1|||
3982090|NCT01261390|3804788|B2|SF-36 Emotional Subscale||Baseline Quality of Life Measures by Arm - Short Form Health Survey (SF-36)|The SF-36 is a patient-reported survey of patient health. The SF-36 scores range from 0-100, with lower scores indicating the more disability.|units on a scale|Mean|44.9|44.9|Standard Deviation|12.3|12.3|||
3982091|NCT01261390|3804789|B1|SF-36 Emotional Subscale||Baseline Quality of Life Measures by Arm - Short Form Health Survey (SF-36)|The SF-36 is a patient-reported survey of patient health. The SF-36 scores range from 0-100, with lower scores indicating the more disability.|units on a scale|Mean|47.9|47.9|Standard Deviation|10.7|10.7|||
3982092|NCT01261390|3804785|B5|SF-36 Vitality Subscale||Baseline Quality of Life Measures by Arm - Short Form Health Survey (SF-36)|The SF-36 is a patient-reported survey of patient health. The SF-36 scores range from 0-100, with lower scores indicating the more disability.|units on a scale|Mean|48.9|48.9|Standard Deviation|9.9|9.9|||
3982169|NCT01261390|3804787|B3|Split-Night||Diagnostic Type||participants|Number|3|3.0||||||
3982170|NCT01261390|3804788|B2|Split-Night||Diagnostic Type||participants|Number|3|3.0||||||
3982093|NCT01261390|3804786|B4|SF-36 Vitality Subscale||Baseline Quality of Life Measures by Arm - Short Form Health Survey (SF-36)|The SF-36 is a patient-reported survey of patient health. The SF-36 scores range from 0-100, with lower scores indicating the more disability.|units on a scale|Mean|48.7|48.7|Standard Deviation|9.6|9.6|||
3982094|NCT01261390|3804787|B3|SF-36 Vitality Subscale||Baseline Quality of Life Measures by Arm - Short Form Health Survey (SF-36)|The SF-36 is a patient-reported survey of patient health. The SF-36 scores range from 0-100, with lower scores indicating the more disability.|units on a scale|Mean|49.0|49.0|Standard Deviation|10.4|10.4|||
3982095|NCT01261390|3804788|B2|SF-36 Vitality Subscale||Baseline Quality of Life Measures by Arm - Short Form Health Survey (SF-36)|The SF-36 is a patient-reported survey of patient health. The SF-36 scores range from 0-100, with lower scores indicating the more disability.|units on a scale|Mean|48.0|48.0|Standard Deviation|9.7|9.7|||
3982096|NCT01261390|3804789|B1|SF-36 Vitality Subscale||Baseline Quality of Life Measures by Arm - Short Form Health Survey (SF-36)|The SF-36 is a patient-reported survey of patient health. The SF-36 scores range from 0-100, with lower scores indicating the more disability.|units on a scale|Mean|49.6|49.6|Standard Deviation|10.1|10.1|||
3982097|NCT01261390|3804785|B5|||Baseline Echocardiogram Measures by Arm - Ejection Fraction||percent ejection fraction|Mean|60.5|60.5|Standard Deviation|4.7|4.7|||
3982098|NCT01261390|3804786|B4|||Baseline Echocardiogram Measures by Arm - Ejection Fraction||percent ejection fraction|Mean|59.9|59.9|Standard Deviation|4.6|4.6|||
3982099|NCT01261390|3804787|B3|||Baseline Echocardiogram Measures by Arm - Ejection Fraction||percent ejection fraction|Mean|60.8|60.8|Standard Deviation|6.6|6.6|||
3982100|NCT01261390|3804788|B2|||Baseline Echocardiogram Measures by Arm - Ejection Fraction||percent ejection fraction|Mean|60.9|60.9|Standard Deviation|2.7|2.7|||
3982101|NCT01261390|3804789|B1|||Baseline Echocardiogram Measures by Arm - Ejection Fraction||percent ejection fraction|Mean|60.2|60.2|Standard Deviation|4.1|4.1|||
3982102|NCT01261390|3804785|B5|||Baseline Echocardiogram Measures by Arm - Augmentation Index||percent of central pulse pressure|Mean|30.1|30.1|Standard Deviation|9.3|9.3|||
3982103|NCT01261390|3804786|B4|||Baseline Echocardiogram Measures by Arm - Augmentation Index||percent of central pulse pressure|Mean|29.8|29.8|Standard Deviation|8.7|8.7|||
3982104|NCT01261390|3804787|B3|||Baseline Echocardiogram Measures by Arm - Augmentation Index||percent of central pulse pressure|Mean|29.8|29.8|Standard Deviation|9.3|9.3|||
3982105|NCT01261390|3804788|B2|||Baseline Echocardiogram Measures by Arm - Augmentation Index||percent of central pulse pressure|Mean|30.2|30.2|Standard Deviation|9.7|9.7|||
3982106|NCT01261390|3804789|B1|||Baseline Echocardiogram Measures by Arm - Augmentation Index||percent of central pulse pressure|Mean|30.6|30.6|Standard Deviation|9.6|9.6|||
3982107|NCT01261390|3804785|B5|||Baseline Echocardiogram Measures by Arm - Pulse Wave Velocity||m/s|Mean|9.3|9.3|Standard Deviation|2.1|2.1|||
3982108|NCT01261390|3804786|B4|||Baseline Echocardiogram Measures by Arm - Pulse Wave Velocity||m/s|Mean|9.4|9.4|Standard Deviation|1.8|1.8|||
3982109|NCT01261390|3804787|B3|||Baseline Echocardiogram Measures by Arm - Pulse Wave Velocity||m/s|Mean|8.6|8.6|Standard Deviation|1.8|1.8|||
3982110|NCT01261390|3804788|B2|||Baseline Echocardiogram Measures by Arm - Pulse Wave Velocity||m/s|Mean|9.7|9.7|Standard Deviation|2.4|2.4|||
3982111|NCT01261390|3804789|B1|||Baseline Echocardiogram Measures by Arm - Pulse Wave Velocity||m/s|Mean|9.6|9.6|Standard Deviation|2.1|2.1|||
3982112|NCT01261390|3804785|B5|||Baseline Laboratory Measures by Arm - CRP||mg/L|Mean|4.3|4.3|Standard Deviation|11.2|11.2|||
3982113|NCT01261390|3804786|B4|||Baseline Laboratory Measures by Arm - CRP||mg/L|Mean|3.0|3.0|Standard Deviation|2.7|2.7|||
3982114|NCT01261390|3804787|B3|||Baseline Laboratory Measures by Arm - CRP||mg/L|Mean|4.5|4.5|Standard Deviation|10.4|10.4|||
3982115|NCT01261390|3804788|B2|||Baseline Laboratory Measures by Arm - CRP||mg/L|Mean|5.6|5.6|Standard Deviation|17.6|17.6|||
3982116|NCT01261390|3804789|B1|||Baseline Laboratory Measures by Arm - CRP||mg/L|Mean|3.9|3.9|Standard Deviation|9.0|9.0|||
3982117|NCT01261390|3804785|B5|HDL||Baseline Laboratory Measures by Arm - Triglyceride and HDL||mg/dL|Mean|50.5|50.5|Standard Deviation|14.6|14.6|||
3982118|NCT01261390|3804786|B4|HDL||Baseline Laboratory Measures by Arm - Triglyceride and HDL||mg/dL|Mean|47.4|47.4|Standard Deviation|12.9|12.9|||
3982119|NCT01261390|3804787|B3|HDL||Baseline Laboratory Measures by Arm - Triglyceride and HDL||mg/dL|Mean|55.7|55.7|Standard Deviation|16.9|16.9|||
3982120|NCT01261390|3804788|B2|HDL||Baseline Laboratory Measures by Arm - Triglyceride and HDL||mg/dL|Mean|50.0|50.0|Standard Deviation|12.2|12.2|||
3982121|NCT01261390|3804789|B1|HDL||Baseline Laboratory Measures by Arm - Triglyceride and HDL||mg/dL|Mean|49.1|49.1|Standard Deviation|14.9|14.9|||
3982122|NCT01261390|3804785|B5|Triglyceride||Baseline Laboratory Measures by Arm - Triglyceride and HDL||mg/dL|Mean|127.0|127.0|Standard Deviation|73.2|73.2|||
3982123|NCT01261390|3804786|B4|Triglyceride||Baseline Laboratory Measures by Arm - Triglyceride and HDL||mg/dL|Mean|143.8|143.8|Standard Deviation|81.8|81.8|||
3982124|NCT01261390|3804787|B3|Triglyceride||Baseline Laboratory Measures by Arm - Triglyceride and HDL||mg/dL|Mean|108.3|108.3|Standard Deviation|57.1|57.1|||
3982125|NCT01261390|3804788|B2|Triglyceride||Baseline Laboratory Measures by Arm - Triglyceride and HDL||mg/dL|Mean|125.8|125.8|Standard Deviation|61.6|61.6|||
3982126|NCT01261390|3804789|B1|Triglyceride||Baseline Laboratory Measures by Arm - Triglyceride and HDL||mg/dL|Mean|130.3|130.3|Standard Deviation|85.8|85.8|||
3982127|NCT01261390|3804785|B5|24-hour Mean Arterial Pressure||Baseline 24-Hour Blood Pressure Data by Arm|Blood pressure data was collected using a 24-hour ambulatory blood pressure monitor.|mmHg|Mean|90.3|90.3|Standard Deviation|8.2|8.2|||
3982128|NCT01261390|3804786|B4|24-hour Mean Arterial Pressure||Baseline 24-Hour Blood Pressure Data by Arm|Blood pressure data was collected using a 24-hour ambulatory blood pressure monitor.|mmHg|Mean|89.2|89.2|Standard Deviation|7.4|7.4|||
3982129|NCT01261390|3804787|B3|24-hour Mean Arterial Pressure||Baseline 24-Hour Blood Pressure Data by Arm|Blood pressure data was collected using a 24-hour ambulatory blood pressure monitor.|mmHg|Mean|89.3|89.3|Standard Deviation|6.5|6.5|||
3982171|NCT01261390|3804789|B1|Split-Night||Diagnostic Type||participants|Number|3|3.0||||||
3982130|NCT01261390|3804788|B2|24-hour Mean Arterial Pressure||Baseline 24-Hour Blood Pressure Data by Arm|Blood pressure data was collected using a 24-hour ambulatory blood pressure monitor.|mmHg|Mean|92.0|92.0|Standard Deviation|8.7|8.7|||
3982131|NCT01261390|3804789|B1|24-hour Mean Arterial Pressure||Baseline 24-Hour Blood Pressure Data by Arm|Blood pressure data was collected using a 24-hour ambulatory blood pressure monitor.|mmHg|Mean|90.7|90.7|Standard Deviation|9.8|9.8|||
3982132|NCT01261390|3804785|B5|Sleep Mean Arterial Pressure||Baseline 24-Hour Blood Pressure Data by Arm|Blood pressure data was collected using a 24-hour ambulatory blood pressure monitor.|mmHg|Mean|82.7|82.7|Standard Deviation|10.6|10.6|||
3982133|NCT01261390|3804786|B4|Sleep Mean Arterial Pressure||Baseline 24-Hour Blood Pressure Data by Arm|Blood pressure data was collected using a 24-hour ambulatory blood pressure monitor.|mmHg|Mean|81.5|81.5|Standard Deviation|10.2|10.2|||
3982134|NCT01261390|3804787|B3|Sleep Mean Arterial Pressure||Baseline 24-Hour Blood Pressure Data by Arm|Blood pressure data was collected using a 24-hour ambulatory blood pressure monitor.|mmHg|Mean|81.1|81.1|Standard Deviation|8.0|8.0|||
3982135|NCT01261390|3804788|B2|Sleep Mean Arterial Pressure||Baseline 24-Hour Blood Pressure Data by Arm|Blood pressure data was collected using a 24-hour ambulatory blood pressure monitor.|mmHg|Mean|84.7|84.7|Standard Deviation|11.2|11.2|||
3982136|NCT01261390|3804789|B1|Sleep Mean Arterial Pressure||Baseline 24-Hour Blood Pressure Data by Arm|Blood pressure data was collected using a 24-hour ambulatory blood pressure monitor.|mmHg|Mean|83.3|83.3|Standard Deviation|12.4|12.4|||
3982137|NCT01261390|3804785|B5|24-hour Systolic Blood Pressure||Baseline 24-Hour Blood Pressure Data by Arm|Blood pressure data was collected using a 24-hour ambulatory blood pressure monitor.|mmHg|Mean|124.1|124.1|Standard Deviation|12.8|12.8|||
3982138|NCT01261390|3804786|B4|24-hour Systolic Blood Pressure||Baseline 24-Hour Blood Pressure Data by Arm|Blood pressure data was collected using a 24-hour ambulatory blood pressure monitor.|mmHg|Mean|121.8|121.8|Standard Deviation|11.0|11.0|||
3982139|NCT01261390|3804787|B3|24-hour Systolic Blood Pressure||Baseline 24-Hour Blood Pressure Data by Arm|Blood pressure data was collected using a 24-hour ambulatory blood pressure monitor.|mmHg|Mean|121.3|121.3|Standard Deviation|10.4|10.4|||
3982140|NCT01261390|3804788|B2|24-hour Systolic Blood Pressure||Baseline 24-Hour Blood Pressure Data by Arm|Blood pressure data was collected using a 24-hour ambulatory blood pressure monitor.|mmHg|Mean|128.1|128.1|Standard Deviation|14.4|14.4|||
3982141|NCT01261390|3804789|B1|24-hour Systolic Blood Pressure||Baseline 24-Hour Blood Pressure Data by Arm|Blood pressure data was collected using a 24-hour ambulatory blood pressure monitor.|mmHg|Mean|125.4|125.4|Standard Deviation|14.3|14.3|||
3982142|NCT01261390|3804785|B5|Average Resting Diastolic||Baseline Resting Blood Pressure Data by Arm||mmHg|Mean|70.3|70.3|Standard Deviation|9.2|9.2|||
3982143|NCT01261390|3804786|B4|Average Resting Diastolic||Baseline Resting Blood Pressure Data by Arm||mmHg|Mean|71.3|71.3|Standard Deviation|8.9|8.9|||
3982144|NCT01261390|3804787|B3|Average Resting Diastolic||Baseline Resting Blood Pressure Data by Arm||mmHg|Mean|71.2|71.2|Standard Deviation|10.6|10.6|||
3982145|NCT01261390|3804788|B2|Average Resting Diastolic||Baseline Resting Blood Pressure Data by Arm||mmHg|Mean|68.6|68.6|Standard Deviation|8.5|8.5|||
3982146|NCT01261390|3804789|B1|Average Resting Diastolic||Baseline Resting Blood Pressure Data by Arm||mmHg|Mean|70.1|70.1|Standard Deviation|8.6|8.6|||
3982147|NCT01261390|3804785|B5|Average Resting Systolic||Baseline Resting Blood Pressure Data by Arm||mmHg|Mean|125.2|125.2|Standard Deviation|17.2|17.2|||
3982148|NCT01261390|3804786|B4|Average Resting Systolic||Baseline Resting Blood Pressure Data by Arm||mmHg|Mean|127.5|127.5|Standard Deviation|16.2|16.2|||
3982149|NCT01261390|3804787|B3|Average Resting Systolic||Baseline Resting Blood Pressure Data by Arm||mmHg|Mean|124.8|124.8|Standard Deviation|19.5|19.5|||
3982150|NCT01261390|3804788|B2|Average Resting Systolic||Baseline Resting Blood Pressure Data by Arm||mmHg|Mean|123.6|123.6|Standard Deviation|18.1|18.1|||
3982151|NCT01261390|3804789|B1|Average Resting Systolic||Baseline Resting Blood Pressure Data by Arm||mmHg|Mean|125.1|125.1|Standard Deviation|15.3|15.3|||
3982152|NCT01261390|3804785|B5|||AHI|AHI is an index of sleep apnea severity that combines apneas and hypopneas. The AHI is expressed as the number of respiratory events per hour.|respiratory events per hour|Mean|30.0|30.0|Standard Deviation|17.4|17.4|||
3982153|NCT01261390|3804786|B4|||AHI|AHI is an index of sleep apnea severity that combines apneas and hypopneas. The AHI is expressed as the number of respiratory events per hour.|respiratory events per hour|Mean|26.8|26.8|Standard Deviation|12.4|12.4|||
3982154|NCT01261390|3804787|B3|||AHI|AHI is an index of sleep apnea severity that combines apneas and hypopneas. The AHI is expressed as the number of respiratory events per hour.|respiratory events per hour|Mean|27.6|27.6|Standard Deviation|12.5|12.5|||
3982155|NCT01261390|3804788|B2|||AHI|AHI is an index of sleep apnea severity that combines apneas and hypopneas. The AHI is expressed as the number of respiratory events per hour.|respiratory events per hour|Mean|31.5|31.5|Standard Deviation|20.0|20.0|||
3982156|NCT01261390|3804789|B1|||AHI|AHI is an index of sleep apnea severity that combines apneas and hypopneas. The AHI is expressed as the number of respiratory events per hour.|respiratory events per hour|Mean|33.9|33.9|Standard Deviation|21.8|21.8|||
3982157|NCT01261390|3804785|B5|||Waist Circumference||cm|Mean|110.4|110.4|Standard Deviation|14.1|14.1|||
3982158|NCT01261390|3804786|B4|||Waist Circumference||cm|Mean|110.6|110.6|Standard Deviation|13.3|13.3|||
3982159|NCT01261390|3804787|B3|||Waist Circumference||cm|Mean|108.3|108.3|Standard Deviation|12.2|12.2|||
3982160|NCT01261390|3804788|B2|||Waist Circumference||cm|Mean|112.6|112.6|Standard Deviation|14.5|14.5|||
3982161|NCT01261390|3804789|B1|||Waist Circumference||cm|Mean|110.2|110.2|Standard Deviation|16.1|16.1|||
3982162|NCT01261390|3804785|B5|||BMI||kg/m^2|Mean|31.7|31.7|Standard Deviation|5.9|5.9|||
3982163|NCT01261390|3804786|B4|||BMI||kg/m^2|Mean|31.6|31.6|Standard Deviation|5.9|5.9|||
3982164|NCT01261390|3804787|B3|||BMI||kg/m^2|Mean|30.6|30.6|Standard Deviation|4.5|4.5|||
3982165|NCT01261390|3804788|B2|||BMI||kg/m^2|Mean|32.1|32.1|Standard Deviation|5.7|5.7|||
3982166|NCT01261390|3804789|B1|||BMI||kg/m^2|Mean|32.4|32.4|Standard Deviation|7.2|7.2|||
3982167|NCT01261390|3804785|B5|Split-Night||Diagnostic Type||participants|Number|12|12.0||||||
3982172|NCT01261390|3804785|B5|Full-Night||Diagnostic Type||participants|Number|157|157.0||||||
3982173|NCT01261390|3804786|B4|Full-Night||Diagnostic Type||participants|Number|38|38.0||||||
3982174|NCT01261390|3804787|B3|Full-Night||Diagnostic Type||participants|Number|39|39.0||||||
3982175|NCT01261390|3804788|B2|Full-Night||Diagnostic Type||participants|Number|39|39.0||||||
3982176|NCT01261390|3804789|B1|Full-Night||Diagnostic Type||participants|Number|41|41.0||||||
3982177|NCT01261390|3804785|B5|Established CVD||Cardiovascular Disease (CVD) Status||participants|Number|97|97.0||||||
3982178|NCT01261390|3804786|B4|Established CVD||Cardiovascular Disease (CVD) Status||participants|Number|23|23.0||||||
3982179|NCT01261390|3804787|B3|Established CVD||Cardiovascular Disease (CVD) Status||participants|Number|25|25.0||||||
3982180|NCT01261390|3804788|B2|Established CVD||Cardiovascular Disease (CVD) Status||participants|Number|25|25.0||||||
3982181|NCT01261390|3804789|B1|Established CVD||Cardiovascular Disease (CVD) Status||participants|Number|24|24.0||||||
3982182|NCT01261390|3804785|B5|CVD Risk Factors||Cardiovascular Disease (CVD) Status||participants|Number|72|72.0||||||
3982183|NCT01261390|3804786|B4|CVD Risk Factors||Cardiovascular Disease (CVD) Status||participants|Number|18|18.0||||||
3982184|NCT01261390|3804787|B3|CVD Risk Factors||Cardiovascular Disease (CVD) Status||participants|Number|17|17.0||||||
3982185|NCT01261390|3804788|B2|CVD Risk Factors||Cardiovascular Disease (CVD) Status||participants|Number|17|17.0||||||
3982186|NCT01261390|3804789|B1|CVD Risk Factors||Cardiovascular Disease (CVD) Status||participants|Number|20|20.0||||||
3982187|NCT01261390|3804785|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3982188|NCT01261390|3804786|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3982189|NCT01261390|3804787|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982190|NCT01261390|3804788|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3982191|NCT01261390|3804789|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982192|NCT01261390|3804785|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982193|NCT01261390|3804786|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982194|NCT01261390|3804787|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982195|NCT01261390|3804788|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982196|NCT01261390|3804789|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982197|NCT01261390|3804785|B5||White|Race (NIH/OMB)||Participants|Count of Participants|151|151.0||||||
3982198|NCT01261390|3804786|B4||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3982199|NCT01261390|3804787|B3||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3982200|NCT01261390|3804788|B2||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3982201|NCT01261390|3804789|B1||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3982202|NCT01261390|3804785|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3982203|NCT01261390|3804786|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3982204|NCT01261390|3804787|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3982205|NCT01261390|3804788|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3982206|NCT01261390|3804789|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3982207|NCT01261390|3804785|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982208|NCT01261390|3804786|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982209|NCT01261390|3804787|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982210|NCT01261390|3804788|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982211|NCT01261390|3804789|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982212|NCT01261390|3804785|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3982213|NCT01261390|3804786|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982214|NCT01261390|3804787|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3982215|NCT01261390|3804788|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982216|NCT01261390|3804789|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3982217|NCT01261390|3804785|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982218|NCT01261390|3804786|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982219|NCT01261390|3804787|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982220|NCT01261390|3804788|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982221|NCT01261390|3804789|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982222|NCT01261390|3804785|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982223|NCT01261390|3804786|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982224|NCT01261390|3804787|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982225|NCT01261390|3804788|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982226|NCT01261390|3804789|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982227|NCT01261390|3804785|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|163|163.0||||||
3982228|NCT01261390|3804786|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3982229|NCT01261390|3804787|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3982230|NCT01261390|3804788|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3982231|NCT01261390|3804789|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3982232|NCT01261390|3804785|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3982233|NCT01261390|3804786|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3982234|NCT01261390|3804787|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3982235|NCT01261390|3804788|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3982236|NCT01261390|3804789|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3982237|NCT01261390|3804785|B5||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3982238|NCT01261390|3804786|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3982239|NCT01261390|3804787|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3982240|NCT01261390|3804788|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3982241|NCT01261390|3804789|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3982242|NCT01261390|3804785|B5||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3982243|NCT01261390|3804786|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3982244|NCT01261390|3804787|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3982245|NCT01261390|3804788|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3982246|NCT01261390|3804789|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3982247|NCT01261390|3804785|B5|||Age||years|Mean|63.6|63.6|Standard Deviation|7.3|7.3|||
3982248|NCT01261390|3804786|B4|||Age||years|Mean|63.6|63.6|Standard Deviation|8.2|8.2|||
3982249|NCT01261390|3804787|B3|||Age||years|Mean|63.7|63.7|Standard Deviation|7.3|7.3|||
3982250|NCT01261390|3804788|B2|||Age||years|Mean|63.0|63.0|Standard Deviation|7.5|7.5|||
3982251|NCT01261390|3804789|B1|||Age||years|Mean|64.0|64.0|Standard Deviation|6.3|6.3|||
3982252|NCT01261325|3804954|B4|Missing||Racial Group||participants|Number|8|8.0||||||
3982253|NCT01261325|3804955|B3|Missing||Racial Group||participants|Number|3|3.0||||||
3982254|NCT01261325|3804956|B2|Missing||Racial Group||participants|Number|2|2.0||||||
3982255|NCT01261325|3804957|B1|Missing||Racial Group||participants|Number|3|3.0||||||
3982256|NCT01261325|3804954|B4|Other||Racial Group||participants|Number|56|56.0||||||
3982257|NCT01261325|3804955|B3|Other||Racial Group||participants|Number|18|18.0||||||
3982258|NCT01261325|3804956|B2|Other||Racial Group||participants|Number|21|21.0||||||
3982259|NCT01261325|3804957|B1|Other||Racial Group||participants|Number|17|17.0||||||
3982260|NCT01261325|3804954|B4|White||Racial Group||participants|Number|556|556.0||||||
3982261|NCT01261325|3804955|B3|White||Racial Group||participants|Number|183|183.0||||||
3982262|NCT01261325|3804956|B2|White||Racial Group||participants|Number|183|183.0||||||
3982263|NCT01261325|3804957|B1|White||Racial Group||participants|Number|190|190.0||||||
3982264|NCT01261325|3804954|B4|Black or African American||Racial Group||participants|Number|26|26.0||||||
3982265|NCT01261325|3804955|B3|Black or African American||Racial Group||participants|Number|7|7.0||||||
3982266|NCT01261325|3804956|B2|Black or African American||Racial Group||participants|Number|8|8.0||||||
3982267|NCT01261325|3804957|B1|Black or African American||Racial Group||participants|Number|11|11.0||||||
3982268|NCT01261325|3804954|B4|Asian||Racial Group||participants|Number|93|93.0||||||
3982269|NCT01261325|3804955|B3|Asian||Racial Group||participants|Number|29|29.0||||||
3982270|NCT01261325|3804956|B2|Asian||Racial Group||participants|Number|32|32.0||||||
3982271|NCT01261325|3804957|B1|Asian||Racial Group||participants|Number|32|32.0||||||
3982272|NCT01261325|3804954|B4|American Indian or Alaska Native||Racial Group||participants|Number|29|29.0||||||
3982273|NCT01261325|3804955|B3|American Indian or Alaska Native||Racial Group||participants|Number|11|11.0||||||
3982274|NCT01261325|3804956|B2|American Indian or Alaska Native||Racial Group||participants|Number|8|8.0||||||
3982275|NCT01261325|3804957|B1|American Indian or Alaska Native||Racial Group||participants|Number|10|10.0||||||
3982276|NCT01261325|3804954|B4|||BMI||kg/m^2|Mean|26.6|26.6|Standard Deviation|5.8|5.8|||
3982277|NCT01261325|3804955|B3|||BMI||kg/m^2|Mean|26.4|26.4|Standard Deviation|6.0|6.0|||
3982278|NCT01261325|3804956|B2|||BMI||kg/m^2|Mean|26.7|26.7|Standard Deviation|5.6|5.6|||
3982279|NCT01261325|3804957|B1|||BMI||kg/m^2|Mean|26.6|26.6|Standard Deviation|5.7|5.7|||
3982280|NCT01261325|3804954|B4|||Height||centimeters|Mean|167.9|167.9|Standard Deviation|9.9|9.9|||
3982281|NCT01261325|3804955|B3|||Height||centimeters|Mean|168.7|168.7|Standard Deviation|9.9|9.9|||
3982282|NCT01261325|3804956|B2|||Height||centimeters|Mean|166.6|166.6|Standard Deviation|9.8|9.8|||
3982283|NCT01261325|3804957|B1|||Height||centimeters|Mean|168.4|168.4|Standard Deviation|10.0|10.0|||
3982284|NCT01261325|3804954|B4|||Weight||kilograms|Median|75.2|75.2|Standard Deviation|18.6|18.6|||
3982285|NCT01261325|3804955|B3|||Weight||kilograms|Median|75.5|75.5|Standard Deviation|19.0|19.0|||
3982286|NCT01261325|3804956|B2|||Weight||kilograms|Median|74.1|74.1|Standard Deviation|16.8|16.8|||
3982287|NCT01261325|3804957|B1|||Weight||kilograms|Median|76.1|76.1|Standard Deviation|19.9|19.9|||
3982288|NCT01261325|3804954|B4||Male|Sex: Female, Male||Participants|Count of Participants|371|371.0||||||
3982289|NCT01261325|3804955|B3||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3982290|NCT01261325|3804956|B2||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3982291|NCT01261325|3804957|B1||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3982292|NCT01261325|3804954|B4||Female|Sex: Female, Male||Participants|Count of Participants|397|397.0||||||
3982293|NCT01261325|3804955|B3||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3982294|NCT01261325|3804956|B2||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3982295|NCT01261325|3804957|B1||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3982296|NCT01261325|3804954|B4|||Age||years|Mean|39.5|39.5|Standard Deviation|13.0|13.0|||
3982297|NCT01261325|3804955|B3|||Age||years|Mean|39.7|39.7|Standard Deviation|12.8|12.8|||
3982298|NCT01261325|3804956|B2|||Age||years|Mean|39.0|39.0|Standard Deviation|13.4|13.4|||
3982299|NCT01261325|3804957|B1|||Age||years|Mean|39.8|39.8|Standard Deviation|12.8|12.8|||
3982300|NCT01261247|3804991|B1|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3982301|NCT01261247|3804991|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3982302|NCT01261247|3804991|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3982303|NCT01261247|3804991|B1|||Age||years|Median|61.0|61.0|Full Range|||37.0|86.0|
3982304|NCT01261052|3804998|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3982305|NCT01261052|3804998|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3982306|NCT01261052|3804998|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3982307|NCT01261052|3804998|B1|||Age||years|Mean|46.3|46.3|Standard Deviation|7.2|7.2|||
3982308|NCT01261052|3804998|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3982309|NCT01261052|3804998|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3982310|NCT01261052|3804998|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3982311|NCT01261000|3805004|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3982312|NCT01261000|3805004|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3982313|NCT01261000|3805004|B1|||Age||years|Mean|50|50.0|Standard Deviation|21|21.0|||
3982314|NCT01260948|3805008|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
3982315|NCT01260948|3805009|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3982316|NCT01260948|3805010|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3982317|NCT01260948|3805008|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3982318|NCT01260948|3805009|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3982319|NCT01260948|3805010|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3982320|NCT01260948|3805008|B3|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3982321|NCT01260948|3805009|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3982322|NCT01260948|3805010|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3982323|NCT01260948|3805008|B3|American Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3982324|NCT01260948|3805009|B2|American Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3982325|NCT01260948|3805010|B1|American Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3982326|NCT01260948|3805008|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3982327|NCT01260948|3805009|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3982328|NCT01260948|3805010|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3982329|NCT01260948|3805008|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3982330|NCT01260948|3805009|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3982331|NCT01260948|3805010|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3982332|NCT01260948|3805008|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3982333|NCT01260948|3805009|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3982334|NCT01260948|3805010|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3982335|NCT01260948|3805008|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3982336|NCT01260948|3805009|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3982337|NCT01260948|3805010|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3982338|NCT01260948|3805008|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3982339|NCT01260948|3805009|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3982340|NCT01260948|3805010|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3982341|NCT01260922|3805019|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
3982342|NCT01260922|3805020|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3982343|NCT01260922|3805021|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3982344|NCT01260922|3805019|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3982345|NCT01260922|3805020|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3982346|NCT01260922|3805021|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3982347|NCT01260922|3805019|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3982348|NCT01260922|3805020|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3982349|NCT01260922|3805021|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3982350|NCT01260922|3805019|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3982351|NCT01260922|3805020|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3982352|NCT01260922|3805021|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3982353|NCT01260922|3805019|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3982354|NCT01260922|3805020|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3982355|NCT01260922|3805021|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3982356|NCT01260922|3805019|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3982357|NCT01260922|3805020|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3982358|NCT01260922|3805021|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3982359|NCT01260922|3805019|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3982360|NCT01260922|3805020|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3982361|NCT01260922|3805021|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3982362|NCT01260922|3805019|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3982363|NCT01260922|3805020|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3982364|NCT01260922|3805021|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3982365|NCT01260896|3805030|B3|Canada||Region of Enrollment||participants|Number|24|24.0||||||
3982366|NCT01260896|3805031|B2|Canada||Region of Enrollment||participants|Number|12|12.0||||||
3982367|NCT01260896|3805032|B1|Canada||Region of Enrollment||participants|Number|12|12.0||||||
3982368|NCT01260896|3805030|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3982369|NCT01260896|3805031|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3982370|NCT01260896|3805032|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3982371|NCT01260896|3805030|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3982372|NCT01260896|3805031|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3982373|NCT01260896|3805032|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3982374|NCT01260896|3805030|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3982375|NCT01260896|3805031|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3982376|NCT01260896|3805032|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3982377|NCT01260896|3805030|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3982378|NCT01260896|3805031|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3982379|NCT01260896|3805032|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3982380|NCT01260896|3805030|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3982381|NCT01260896|3805031|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3982382|NCT01260896|3805032|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3982383|NCT01260896|3805030|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3982384|NCT01260896|3805031|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3982385|NCT01260896|3805032|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3982386|NCT01260883|3805049|B4|United States||Region of Enrollment||participants|Number|51|51.0||||||
3982387|NCT01260883|3805050|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
3982388|NCT01260883|3805051|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3982389|NCT01260883|3805052|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3982390|NCT01260883|3805049|B4||Male|Sex: Female, Male|while 77 infants were enrolled, exclusions during screening or lack of intravenous access precluding blood sampling eliminated 26 infants. Gender data was not collected for infants not randomized to receive drug or placebo.|Participants|Count of Participants|25|25.0||||||
3982391|NCT01260883|3805050|B3||Male|Sex: Female, Male|while 77 infants were enrolled, exclusions during screening or lack of intravenous access precluding blood sampling eliminated 26 infants. Gender data was not collected for infants not randomized to receive drug or placebo.|Participants|Count of Participants|10|10.0||||||
3982392|NCT01260883|3805051|B2||Male|Sex: Female, Male|while 77 infants were enrolled, exclusions during screening or lack of intravenous access precluding blood sampling eliminated 26 infants. Gender data was not collected for infants not randomized to receive drug or placebo.|Participants|Count of Participants|5|5.0||||||
3982393|NCT01260883|3805052|B1||Male|Sex: Female, Male|while 77 infants were enrolled, exclusions during screening or lack of intravenous access precluding blood sampling eliminated 26 infants. Gender data was not collected for infants not randomized to receive drug or placebo.|Participants|Count of Participants|10|10.0||||||
3982394|NCT01260883|3805049|B4||Female|Sex: Female, Male|while 77 infants were enrolled, exclusions during screening or lack of intravenous access precluding blood sampling eliminated 26 infants. Gender data was not collected for infants not randomized to receive drug or placebo.|Participants|Count of Participants|26|26.0||||||
3982395|NCT01260883|3805050|B3||Female|Sex: Female, Male|while 77 infants were enrolled, exclusions during screening or lack of intravenous access precluding blood sampling eliminated 26 infants. Gender data was not collected for infants not randomized to receive drug or placebo.|Participants|Count of Participants|8|8.0||||||
3982396|NCT01260883|3805051|B2||Female|Sex: Female, Male|while 77 infants were enrolled, exclusions during screening or lack of intravenous access precluding blood sampling eliminated 26 infants. Gender data was not collected for infants not randomized to receive drug or placebo.|Participants|Count of Participants|6|6.0||||||
3982397|NCT01260883|3805052|B1||Female|Sex: Female, Male|while 77 infants were enrolled, exclusions during screening or lack of intravenous access precluding blood sampling eliminated 26 infants. Gender data was not collected for infants not randomized to receive drug or placebo.|Participants|Count of Participants|12|12.0||||||
3982398|NCT01260883|3805049|B4|||Age||months|Mean|9.1|9.1|Standard Deviation|3.9|3.9|||
3982399|NCT01260883|3805050|B3|||Age||months|Mean|9|9.0|Standard Deviation|3.8|3.8|||
3982400|NCT01260883|3805051|B2|||Age||months|Mean|9.4|9.4|Standard Deviation|4.2|4.2|||
3982401|NCT01260883|3805052|B1|||Age||months|Mean|8.9|8.9|Standard Deviation|3.8|3.8|||
3982402|NCT01260883|3805049|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3982403|NCT01260883|3805050|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3982404|NCT01260883|3805051|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3982405|NCT01260883|3805052|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3982406|NCT01260883|3805049|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3982407|NCT01260883|3805050|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3982408|NCT01260883|3805051|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3982409|NCT01260883|3805052|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3982410|NCT01260883|3805049|B4||<=18 years|Age||Participants|Count of Participants|51|51.0||||||
3982411|NCT01260883|3805050|B3||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
3982412|NCT01260883|3805051|B2||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
3982413|NCT01260883|3805052|B1||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
3982414|NCT01260701|3805091|B1|Unknown||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3982415|NCT01260701|3805091|B1|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3982416|NCT01260701|3805091|B1|White||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
3982417|NCT01260701|3805091|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3982418|NCT01260701|3805091|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3982419|NCT01260701|3805091|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3982420|NCT01260701|3805091|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3982421|NCT01260701|3805091|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3982422|NCT01260701|3805091|B1|||Age||years|Median|60|60.0|Full Range|||30.0|87.0|
3982423|NCT01260688|3805098|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3982424|NCT01260688|3805099|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3982425|NCT01260688|3805100|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3982426|NCT01260688|3805098|B3|Canada||Region of Enrollment||participants|Number|17|17.0||||||
3982427|NCT01260688|3805099|B2|Canada||Region of Enrollment||participants|Number|8|8.0||||||
3982428|NCT01260688|3805100|B1|Canada||Region of Enrollment||participants|Number|9|9.0||||||
3982429|NCT01260688|3805098|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3982430|NCT01260688|3805099|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3982431|NCT01260688|3805100|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3982432|NCT01260688|3805098|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3982433|NCT01260688|3805099|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3982434|NCT01260688|3805100|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3982435|NCT01260688|3805098|B3|||Age||years|Mean|69|69.0|Standard Deviation|7.6|7.6|||
3982436|NCT01260688|3805099|B2|||Age||years|Mean|72.7|72.7|Standard Deviation|6.5|6.5|||
3982437|NCT01260688|3805100|B1|||Age||years|Mean|65.4|65.4|Standard Deviation|7.1|7.1|||
3982438|NCT01260688|3805098|B3||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3982439|NCT01260688|3805099|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3982440|NCT01260688|3805100|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3982441|NCT01260688|3805098|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3982442|NCT01260688|3805099|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3982443|NCT01260688|3805100|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3982444|NCT01260688|3805098|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3982445|NCT01260688|3805099|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3982446|NCT01260688|3805100|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3982447|NCT01260662|3805135|B4|United States||Region of Enrollment||participants|Number|271|271.0||||||
3982448|NCT01260662|3805136|B3|United States||Region of Enrollment||participants|Number|96|96.0||||||
3982449|NCT01260662|3805137|B2|United States||Region of Enrollment||participants|Number|85|85.0||||||
3982450|NCT01260662|3805138|B1|United States||Region of Enrollment||participants|Number|90|90.0||||||
3982451|NCT01260662|3805135|B4||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3982452|NCT01260662|3805136|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3982453|NCT01260662|3805137|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3982454|NCT01260662|3805138|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3982455|NCT01260662|3805135|B4||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3982456|NCT01260662|3805136|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3982457|NCT01260662|3805137|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3982458|NCT01260662|3805138|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3982459|NCT01260662|3805135|B4|||Age||years|Mean|38|38.0|Full Range|||18.0|84.0|
3982460|NCT01260662|3805136|B3|||Age||years|Mean|36|36.0|Full Range|||18.0|84.0|
3982461|NCT01260662|3805137|B2|||Age||years|Mean|39|39.0|Full Range|||18.0|80.0|
3982462|NCT01260662|3805138|B1|||Age||years|Mean|40|40.0|Full Range|||18.0|83.0|
3982463|NCT01260649|3805157|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
3982464|NCT01260649|3805158|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3982465|NCT01260649|3805159|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3982466|NCT01260649|3805157|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3982467|NCT01260649|3805158|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3982468|NCT01260649|3805159|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3982469|NCT01260649|3805157|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3982470|NCT01260649|3805158|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3982471|NCT01260649|3805159|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3982472|NCT01260649|3805157|B3|||Age||years|Mean|48.57|48.57|Standard Deviation|13.20|13.2|||
3982473|NCT01260649|3805158|B2|||Age||years|Mean|48.75|48.75|Standard Deviation|12.22|12.22|||
3982474|NCT01260649|3805159|B1|||Age||years|Mean|41.43|41.43|Standard Deviation|15.62|15.62|||
3982475|NCT01260649|3805157|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3982476|NCT01260649|3805158|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3982477|NCT01260649|3805159|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3982478|NCT01260649|3805157|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3982479|NCT01260649|3805158|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3982480|NCT01260649|3805159|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3982481|NCT01260649|3805157|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3982482|NCT01260649|3805158|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3982483|NCT01260649|3805159|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3982484|NCT01260584|3805168|B5|Missing||CYP2C19 Phenotype Metabolic Extent||participants|Number|1|1.0||||||
3982485|NCT01260584|3805169|B4|Missing||CYP2C19 Phenotype Metabolic Extent||participants|Number|0|0.0||||||
3982486|NCT01260584|3805170|B3|Missing||CYP2C19 Phenotype Metabolic Extent||participants|Number|0|0.0||||||
3982487|NCT01260584|3805171|B2|Missing||CYP2C19 Phenotype Metabolic Extent||participants|Number|0|0.0||||||
3982488|NCT01260584|3805172|B1|Missing||CYP2C19 Phenotype Metabolic Extent||participants|Number|1|1.0||||||
3982489|NCT01260584|3805168|B5|Reduced metabolizers||CYP2C19 Phenotype Metabolic Extent||participants|Number|21|21.0||||||
3982490|NCT01260584|3805169|B4|Reduced metabolizers||CYP2C19 Phenotype Metabolic Extent||participants|Number|6|6.0||||||
3982491|NCT01260584|3805170|B3|Reduced metabolizers||CYP2C19 Phenotype Metabolic Extent||participants|Number|6|6.0||||||
3982492|NCT01260584|3805171|B2|Reduced metabolizers||CYP2C19 Phenotype Metabolic Extent||participants|Number|4|4.0||||||
3982493|NCT01260584|3805172|B1|Reduced metabolizers||CYP2C19 Phenotype Metabolic Extent||participants|Number|5|5.0||||||
3982494|NCT01260584|3805168|B5|Extensive metabolizers||CYP2C19 Phenotype Metabolic Extent||participants|Number|88|88.0||||||
3982495|NCT01260584|3805169|B4|Extensive metabolizers||CYP2C19 Phenotype Metabolic Extent||participants|Number|22|22.0||||||
3982496|NCT01260584|3805170|B3|Extensive metabolizers||CYP2C19 Phenotype Metabolic Extent||participants|Number|21|21.0||||||
3982497|NCT01260584|3805171|B2|Extensive metabolizers||CYP2C19 Phenotype Metabolic Extent||participants|Number|24|24.0||||||
3982498|NCT01260584|3805172|B1|Extensive metabolizers||CYP2C19 Phenotype Metabolic Extent||participants|Number|21|21.0||||||
3982499|NCT01260584|3805168|B5|not reported||CYP2C19 Phenotype Metabolic Rate||participants|Number|1|1.0||||||
3982500|NCT01260584|3805169|B4|not reported||CYP2C19 Phenotype Metabolic Rate||participants|Number|0|0.0||||||
3982501|NCT01260584|3805170|B3|not reported||CYP2C19 Phenotype Metabolic Rate||participants|Number|0|0.0||||||
3982502|NCT01260584|3805171|B2|not reported||CYP2C19 Phenotype Metabolic Rate||participants|Number|0|0.0||||||
3982503|NCT01260584|3805172|B1|not reported||CYP2C19 Phenotype Metabolic Rate||participants|Number|1|1.0||||||
3982504|NCT01260584|3805168|B5|Ultrarapid||CYP2C19 Phenotype Metabolic Rate||participants|Number|5|5.0||||||
3982505|NCT01260584|3805169|B4|Ultrarapid||CYP2C19 Phenotype Metabolic Rate||participants|Number|0|0.0||||||
3982506|NCT01260584|3805170|B3|Ultrarapid||CYP2C19 Phenotype Metabolic Rate||participants|Number|1|1.0||||||
3982507|NCT01260584|3805171|B2|Ultrarapid||CYP2C19 Phenotype Metabolic Rate||participants|Number|1|1.0||||||
3982508|NCT01260584|3805172|B1|Ultrarapid||CYP2C19 Phenotype Metabolic Rate||participants|Number|3|3.0||||||
3982509|NCT01260584|3805168|B5|Extensive||CYP2C19 Phenotype Metabolic Rate||participants|Number|83|83.0||||||
3982510|NCT01260584|3805169|B4|Extensive||CYP2C19 Phenotype Metabolic Rate||participants|Number|22|22.0||||||
3982511|NCT01260584|3805170|B3|Extensive||CYP2C19 Phenotype Metabolic Rate||participants|Number|20|20.0||||||
3982512|NCT01260584|3805171|B2|Extensive||CYP2C19 Phenotype Metabolic Rate||participants|Number|23|23.0||||||
3982513|NCT01260584|3805172|B1|Extensive||CYP2C19 Phenotype Metabolic Rate||participants|Number|18|18.0||||||
3982514|NCT01260584|3805168|B5|Intermediate||CYP2C19 Phenotype Metabolic Rate||participants|Number|19|19.0||||||
3982515|NCT01260584|3805169|B4|Intermediate||CYP2C19 Phenotype Metabolic Rate||participants|Number|4|4.0||||||
3982516|NCT01260584|3805170|B3|Intermediate||CYP2C19 Phenotype Metabolic Rate||participants|Number|6|6.0||||||
3982517|NCT01260584|3805171|B2|Intermediate||CYP2C19 Phenotype Metabolic Rate||participants|Number|4|4.0||||||
3982518|NCT01260584|3805172|B1|Intermediate||CYP2C19 Phenotype Metabolic Rate||participants|Number|5|5.0||||||
3982519|NCT01260584|3805168|B5|Poor||CYP2C19 Phenotype Metabolic Rate||participants|Number|2|2.0||||||
3982520|NCT01260584|3805169|B4|Poor||CYP2C19 Phenotype Metabolic Rate||participants|Number|2|2.0||||||
3982521|NCT01260584|3805170|B3|Poor||CYP2C19 Phenotype Metabolic Rate||participants|Number|0|0.0||||||
3982522|NCT01260584|3805171|B2|Poor||CYP2C19 Phenotype Metabolic Rate||participants|Number|0|0.0||||||
3982523|NCT01260584|3805172|B1|Poor||CYP2C19 Phenotype Metabolic Rate||participants|Number|0|0.0||||||
3982524|NCT01260584|3805168|B5|Peripheral artery disease||Cardiovascular history|Individual categories should not add up to equal total number participants in each arm.|participants|Number|10|10.0||||||
3982525|NCT01260584|3805169|B4|Peripheral artery disease||Cardiovascular history|Individual categories should not add up to equal total number participants in each arm.|participants|Number|2|2.0||||||
3982526|NCT01260584|3805170|B3|Peripheral artery disease||Cardiovascular history|Individual categories should not add up to equal total number participants in each arm.|participants|Number|5|5.0||||||
3982527|NCT01260584|3805171|B2|Peripheral artery disease||Cardiovascular history|Individual categories should not add up to equal total number participants in each arm.|participants|Number|0|0.0||||||
3982528|NCT01260584|3805172|B1|Peripheral artery disease||Cardiovascular history|Individual categories should not add up to equal total number participants in each arm.|participants|Number|3|3.0||||||
3982529|NCT01260584|3805168|B5|Hyperlipidemia||Cardiovascular history|Individual categories should not add up to equal total number participants in each arm.|participants|Number|103|103.0||||||
3982530|NCT01260584|3805169|B4|Hyperlipidemia||Cardiovascular history|Individual categories should not add up to equal total number participants in each arm.|participants|Number|27|27.0||||||
3982531|NCT01260584|3805170|B3|Hyperlipidemia||Cardiovascular history|Individual categories should not add up to equal total number participants in each arm.|participants|Number|26|26.0||||||
3982532|NCT01260584|3805171|B2|Hyperlipidemia||Cardiovascular history|Individual categories should not add up to equal total number participants in each arm.|participants|Number|24|24.0||||||
3982533|NCT01260584|3805172|B1|Hyperlipidemia||Cardiovascular history|Individual categories should not add up to equal total number participants in each arm.|participants|Number|26|26.0||||||
3982534|NCT01260584|3805168|B5|Hypertension||Cardiovascular history|Individual categories should not add up to equal total number participants in each arm.|participants|Number|76|76.0||||||
3982535|NCT01260584|3805169|B4|Hypertension||Cardiovascular history|Individual categories should not add up to equal total number participants in each arm.|participants|Number|20|20.0||||||
3982536|NCT01260584|3805170|B3|Hypertension||Cardiovascular history|Individual categories should not add up to equal total number participants in each arm.|participants|Number|21|21.0||||||
3982537|NCT01260584|3805171|B2|Hypertension||Cardiovascular history|Individual categories should not add up to equal total number participants in each arm.|participants|Number|16|16.0||||||
3982538|NCT01260584|3805172|B1|Hypertension||Cardiovascular history|Individual categories should not add up to equal total number participants in each arm.|participants|Number|19|19.0||||||
3982539|NCT01260584|3805168|B5|Diabetes mellitus||Cardiovascular history|Individual categories should not add up to equal total number participants in each arm.|participants|Number|31|31.0||||||
3982540|NCT01260584|3805169|B4|Diabetes mellitus||Cardiovascular history|Individual categories should not add up to equal total number participants in each arm.|participants|Number|9|9.0||||||
3982541|NCT01260584|3805170|B3|Diabetes mellitus||Cardiovascular history|Individual categories should not add up to equal total number participants in each arm.|participants|Number|8|8.0||||||
3982542|NCT01260584|3805171|B2|Diabetes mellitus||Cardiovascular history|Individual categories should not add up to equal total number participants in each arm.|participants|Number|9|9.0||||||
3982543|NCT01260584|3805172|B1|Diabetes mellitus||Cardiovascular history|Individual categories should not add up to equal total number participants in each arm.|participants|Number|5|5.0||||||
3982544|NCT01260584|3805168|B5|Formerly consumed||Alcohol Usage||participants|Number|18|18.0||||||
3982545|NCT01260584|3805169|B4|Formerly consumed||Alcohol Usage||participants|Number|5|5.0||||||
3982546|NCT01260584|3805170|B3|Formerly consumed||Alcohol Usage||participants|Number|6|6.0||||||
3982547|NCT01260584|3805171|B2|Formerly consumed||Alcohol Usage||participants|Number|3|3.0||||||
3982548|NCT01260584|3805172|B1|Formerly consumed||Alcohol Usage||participants|Number|4|4.0||||||
3982549|NCT01260584|3805168|B5|Currently consumes||Alcohol Usage||participants|Number|61|61.0||||||
3982550|NCT01260584|3805169|B4|Currently consumes||Alcohol Usage||participants|Number|15|15.0||||||
3982551|NCT01260584|3805170|B3|Currently consumes||Alcohol Usage||participants|Number|13|13.0||||||
3982552|NCT01260584|3805171|B2|Currently consumes||Alcohol Usage||participants|Number|16|16.0||||||
3982553|NCT01260584|3805172|B1|Currently consumes||Alcohol Usage||participants|Number|17|17.0||||||
3982554|NCT01260584|3805168|B5|Never consumed||Alcohol Usage||participants|Number|31|31.0||||||
3982555|NCT01260584|3805169|B4|Never consumed||Alcohol Usage||participants|Number|8|8.0||||||
3982556|NCT01260584|3805170|B3|Never consumed||Alcohol Usage||participants|Number|8|8.0||||||
3982557|NCT01260584|3805171|B2|Never consumed||Alcohol Usage||participants|Number|9|9.0||||||
3982558|NCT01260584|3805172|B1|Never consumed||Alcohol Usage||participants|Number|6|6.0||||||
3982559|NCT01260584|3805168|B5|Formerly Smoked||Smoking History||participants|Number|31|31.0||||||
3982560|NCT01260584|3805169|B4|Formerly Smoked||Smoking History||participants|Number|17|17.0||||||
3982561|NCT01260584|3805170|B3|Formerly Smoked||Smoking History||participants|Number|0|0.0||||||
3982562|NCT01260584|3805171|B2|Formerly Smoked||Smoking History||participants|Number|14|14.0||||||
3982563|NCT01260584|3805172|B1|Formerly Smoked||Smoking History||participants|Number|0|0.0||||||
3982564|NCT01260584|3805168|B5|Currently Smoke||Smoking History||participants|Number|54|54.0||||||
3982565|NCT01260584|3805169|B4|Currently Smoke||Smoking History||participants|Number|0|0.0||||||
3982566|NCT01260584|3805170|B3|Currently Smoke||Smoking History||participants|Number|27|27.0||||||
3982567|NCT01260584|3805171|B2|Currently Smoke||Smoking History||participants|Number|0|0.0||||||
3982568|NCT01260584|3805172|B1|Currently Smoke||Smoking History||participants|Number|27|27.0||||||
3982569|NCT01260584|3805168|B5|Never Smoked||Smoking History||participants|Number|25|25.0||||||
3982570|NCT01260584|3805169|B4|Never Smoked||Smoking History||participants|Number|11|11.0||||||
3982571|NCT01260584|3805170|B3|Never Smoked||Smoking History||participants|Number|0|0.0||||||
3982572|NCT01260584|3805171|B2|Never Smoked||Smoking History||participants|Number|14|14.0||||||
3982573|NCT01260584|3805172|B1|Never Smoked||Smoking History||participants|Number|0|0.0||||||
3982574|NCT01260584|3805168|B5|>=30 kg/m^2||Body Mass Index Group|number participants less than 30 kilograms per square meter and number of participants greater than or equal to 30 kilograms per square meter|participants|Number|58|58.0||||||
3982575|NCT01260584|3805169|B4|>=30 kg/m^2||Body Mass Index Group|number participants less than 30 kilograms per square meter and number of participants greater than or equal to 30 kilograms per square meter|participants|Number|18|18.0||||||
3982576|NCT01260584|3805170|B3|>=30 kg/m^2||Body Mass Index Group|number participants less than 30 kilograms per square meter and number of participants greater than or equal to 30 kilograms per square meter|participants|Number|14|14.0||||||
3982577|NCT01260584|3805171|B2|>=30 kg/m^2||Body Mass Index Group|number participants less than 30 kilograms per square meter and number of participants greater than or equal to 30 kilograms per square meter|participants|Number|18|18.0||||||
3982578|NCT01260584|3805172|B1|>=30 kg/m^2||Body Mass Index Group|number participants less than 30 kilograms per square meter and number of participants greater than or equal to 30 kilograms per square meter|participants|Number|8|8.0||||||
3982579|NCT01260584|3805168|B5|<30 kg/m^2||Body Mass Index Group|number participants less than 30 kilograms per square meter and number of participants greater than or equal to 30 kilograms per square meter|participants|Number|52|52.0||||||
3982580|NCT01260584|3805169|B4|<30 kg/m^2||Body Mass Index Group|number participants less than 30 kilograms per square meter and number of participants greater than or equal to 30 kilograms per square meter|participants|Number|10|10.0||||||
3982581|NCT01260584|3805170|B3|<30 kg/m^2||Body Mass Index Group|number participants less than 30 kilograms per square meter and number of participants greater than or equal to 30 kilograms per square meter|participants|Number|13|13.0||||||
3982582|NCT01260584|3805171|B2|<30 kg/m^2||Body Mass Index Group|number participants less than 30 kilograms per square meter and number of participants greater than or equal to 30 kilograms per square meter|participants|Number|10|10.0||||||
3982583|NCT01260584|3805172|B1|<30 kg/m^2||Body Mass Index Group|number participants less than 30 kilograms per square meter and number of participants greater than or equal to 30 kilograms per square meter|participants|Number|19|19.0||||||
3982584|NCT01260584|3805168|B5|||Body Mass Index||kg/m^2|Mean|31.01|31.01|Standard Deviation|5.562|5.562|||
3982585|NCT01260584|3805169|B4|||Body Mass Index||kg/m^2|Mean|32.94|32.94|Standard Deviation|6.592|6.592|||
3982586|NCT01260584|3805170|B3|||Body Mass Index||kg/m^2|Mean|30.70|30.7|Standard Deviation|5.131|5.131|||
3982587|NCT01260584|3805171|B2|||Body Mass Index||kg/m^2|Mean|31.12|31.12|Standard Deviation|5.821|5.821|||
3982588|NCT01260584|3805172|B1|||Body Mass Index||kg/m^2|Mean|29.20|29.2|Standard Deviation|3.945|3.945|||
3982589|NCT01260584|3805168|B5|||Height||cm|Mean|172.8|172.8|Standard Deviation|9.48|9.48|||
3982590|NCT01260584|3805169|B4|||Height||cm|Mean|173.7|173.7|Standard Deviation|8.17|8.17|||
3982591|NCT01260584|3805170|B3|||Height||cm|Mean|172.5|172.5|Standard Deviation|10.72|10.72|||
3982592|NCT01260584|3805171|B2|||Height||cm|Mean|172.5|172.5|Standard Deviation|10.95|10.95|||
3982593|NCT01260584|3805172|B1|||Height||cm|Mean|172.3|172.3|Standard Deviation|8.15|8.15|||
3982594|NCT01260584|3805168|B5|||Weight||kg|Mean|92.85|92.85|Standard Deviation|19.740|19.74|||
3982595|NCT01260584|3805169|B4|||Weight||kg|Mean|99.91|99.91|Standard Deviation|23.096|23.096|||
3982596|NCT01260584|3805170|B3|||Weight||kg|Mean|91.74|91.74|Standard Deviation|20.109|20.109|||
3982597|NCT01260584|3805171|B2|||Weight||kg|Mean|92.45|92.45|Standard Deviation|18.433|18.433|||
3982598|NCT01260584|3805172|B1|||Weight||kg|Mean|87.04|87.04|Standard Deviation|15.243|15.243|||
3982599|NCT01260584|3805168|B5|United States||Region of Enrollment||participants|Number|110|110.0||||||
3982600|NCT01260584|3805169|B4|United States||Region of Enrollment||participants|Number|28|28.0||||||
3982601|NCT01260584|3805170|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
3982602|NCT01260584|3805171|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
3982603|NCT01260584|3805172|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3982604|NCT01260584|3805168|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982605|NCT01260584|3805169|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982606|NCT01260584|3805170|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982607|NCT01260584|3805171|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982608|NCT01260584|3805172|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982609|NCT01260584|3805168|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982610|NCT01260584|3805169|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982611|NCT01260584|3805170|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982612|NCT01260584|3805171|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982613|NCT01260584|3805172|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982614|NCT01260584|3805168|B5||White|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
3982615|NCT01260584|3805169|B4||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3982616|NCT01260584|3805170|B3||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3982617|NCT01260584|3805171|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3982618|NCT01260584|3805172|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3982619|NCT01260584|3805168|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3982620|NCT01260584|3805169|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3982621|NCT01260584|3805170|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3982622|NCT01260584|3805171|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3982623|NCT01260584|3805172|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3982624|NCT01260584|3805168|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982625|NCT01260584|3805169|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982626|NCT01260584|3805170|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982627|NCT01260584|3805171|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982628|NCT01260584|3805172|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982629|NCT01260584|3805168|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982630|NCT01260584|3805169|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982631|NCT01260584|3805170|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982632|NCT01260584|3805171|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982633|NCT01260584|3805172|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982634|NCT01260584|3805168|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3982635|NCT01260584|3805169|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982636|NCT01260584|3805170|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3982637|NCT01260584|3805171|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982638|NCT01260584|3805172|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3982639|NCT01260584|3805168|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982640|NCT01260584|3805169|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982641|NCT01260584|3805170|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982642|NCT01260584|3805171|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982643|NCT01260584|3805172|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3982644|NCT01260584|3805168|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3982645|NCT01260584|3805169|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3982646|NCT01260584|3805170|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3982647|NCT01260584|3805171|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3982648|NCT01260584|3805172|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3982649|NCT01260584|3805168|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3982650|NCT01260584|3805169|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3982651|NCT01260584|3805170|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3982652|NCT01260584|3805171|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3982653|NCT01260584|3805172|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3982654|NCT01260584|3805168|B5||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3982655|NCT01260584|3805169|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3982656|NCT01260584|3805170|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3982657|NCT01260584|3805171|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3982658|NCT01260584|3805172|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3982659|NCT01260584|3805168|B5||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3982660|NCT01260584|3805169|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3982661|NCT01260584|3805170|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3982662|NCT01260584|3805171|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3982663|NCT01260584|3805172|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3982664|NCT01260584|3805168|B5|||Age||years|Mean|59.4|59.4|Standard Deviation|8.27|8.27|||
3982665|NCT01260584|3805169|B4|||Age||years|Mean|61.9|61.9|Standard Deviation|7.86|7.86|||
3982666|NCT01260584|3805170|B3|||Age||years|Mean|56.7|56.7|Standard Deviation|8.03|8.03|||
3982667|NCT01260584|3805171|B2|||Age||years|Mean|59.6|59.6|Standard Deviation|8.60|8.6|||
3982668|NCT01260584|3805172|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|8.19|8.19|||
3982669|NCT01260584|3805168|B5||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
3982670|NCT01260584|3805169|B4||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3982671|NCT01260584|3805170|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3982672|NCT01260584|3805171|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3982673|NCT01260584|3805172|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3982674|NCT01260584|3805168|B5||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
3982675|NCT01260584|3805169|B4||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3982676|NCT01260584|3805170|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3982677|NCT01260584|3805171|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3982678|NCT01260584|3805172|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3982679|NCT01260584|3805168|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3982680|NCT01260584|3805169|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3982681|NCT01260584|3805170|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3982682|NCT01260584|3805171|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3982683|NCT01260584|3805172|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3982684|NCT01260493|3805209|B3|Sweden||Region of Enrollment||participants|Number|161|161.0||||||
3982685|NCT01260493|3805210|B2|Sweden||Region of Enrollment||participants|Number|85|85.0||||||
3982686|NCT01260493|3805211|B1|Sweden||Region of Enrollment||participants|Number|76|76.0||||||
3982687|NCT01260493|3805209|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3982688|NCT01260493|3805210|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3982689|NCT01260493|3805211|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3982690|NCT01260493|3805209|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3982691|NCT01260493|3805210|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3982692|NCT01260493|3805211|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3982693|NCT01260493|3805209|B3|||Age||years|Mean|82.4|82.4|Standard Deviation|5.5|5.5|||
3982694|NCT01260493|3805210|B2|||Age||years|Mean|82.7|82.7|Standard Deviation|5.2|5.2|||
3982695|NCT01260493|3805211|B1|||Age||years|Mean|82.1|82.1|Standard Deviation|5.8|5.8|||
3982696|NCT01260493|3805209|B3||>=65 years|Age||Participants|Count of Participants|161|161.0||||||
3982697|NCT01260493|3805210|B2||>=65 years|Age||Participants|Count of Participants|85|85.0||||||
3982698|NCT01260493|3805211|B1||>=65 years|Age||Participants|Count of Participants|76|76.0||||||
3982699|NCT01260493|3805209|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3982700|NCT01260493|3805210|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3982701|NCT01260493|3805211|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3982702|NCT01260493|3805209|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3982703|NCT01260493|3805210|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3982704|NCT01260493|3805211|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3982705|NCT01260467|3805218|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3982706|NCT01260467|3805218|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3982707|NCT01260467|3805218|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3982708|NCT01260467|3805218|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3982709|NCT01260467|3805218|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3982710|NCT01260467|3805218|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3982711|NCT01260454|3805224|B1|||Pain Relief Experienced with as needed Analgesics|average pain relief perceived after using prescribed analgesics over the 14 day diary period; measured by non-continuous, qualitative word scale (0= no relief, 1= a little, 2=some, 3=a lot and 4= complete relief)|units on a scale|Mean|1.66|1.66|Standard Deviation|0.86|0.86|||
3982712|NCT01260454|3805224|B1|||mean worst pain level|Worst pain was defined as the highest pain experienced on any day over the 14 day diary period; measured by visual analog score. Pain was measured on a 10 point visual analog score with the word 'none' at 0 and 'agonizing' at 10.|Visual Analogue Scale|Mean|7.99|7.99|Standard Deviation|1.83|1.83|||
3982713|NCT01260454|3805224|B1|||mean pain level|Average pain over the 14 day diary period; measured by visual analog score. Pain was measured on a 10 point visual analog score with the word 'none' at 0 and 'agonizing' at 10.|Visual Analogue Scale|Mean|4.15|4.15|Standard Deviation|0.85|0.85|||
3982714|NCT01260454|3805224|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3982715|NCT01260454|3805224|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3982716|NCT01260454|3805224|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3982717|NCT01260454|3805224|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3982718|NCT01260454|3805224|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3982719|NCT01260454|3805224|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3982720|NCT01260350|3805230|B21|No||Cirrhosis Status||participants|Number|272|272.0||||||
3982721|NCT01260350|3805231|B20|No||Cirrhosis Status||participants|Number|25|25.0||||||
3982722|NCT01260350|3805232|B19|No||Cirrhosis Status||participants|Number|13|13.0||||||
3982723|NCT01260350|3805233|B18|No||Cirrhosis Status||participants|Number|10|10.0||||||
3982724|NCT01260350|3805234|B17|No||Cirrhosis Status||participants|Number|0|0.0||||||
3982725|NCT01260350|3805235|B16|No||Cirrhosis Status||participants|Number|0|0.0||||||
3982726|NCT01260350|3805236|B15|No||Cirrhosis Status||participants|Number|25|25.0||||||
3982727|NCT01260350|3805237|B14|No||Cirrhosis Status||participants|Number|10|10.0||||||
3982728|NCT01260350|3805238|B13|No||Cirrhosis Status||participants|Number|25|25.0||||||
3982729|NCT01260350|3805239|B12|No||Cirrhosis Status||participants|Number|9|9.0||||||
3982730|NCT01260350|3805240|B11|No||Cirrhosis Status||participants|Number|10|10.0||||||
3982731|NCT01260350|3805241|B10|No||Cirrhosis Status||participants|Number|25|25.0||||||
3982732|NCT01260350|3805242|B9|No||Cirrhosis Status||participants|Number|25|25.0||||||
3982733|NCT01260350|3805243|B8|No||Cirrhosis Status||participants|Number|25|25.0||||||
3982734|NCT01260350|3805244|B7|No||Cirrhosis Status||participants|Number|10|10.0||||||
3982735|NCT01260350|3805245|B6|No||Cirrhosis Status||participants|Number|10|10.0||||||
3982736|NCT01260350|3805246|B5|No||Cirrhosis Status||participants|Number|10|10.0||||||
3982737|NCT01260350|3805247|B4|No||Cirrhosis Status||participants|Number|11|11.0||||||
3982738|NCT01260350|3805248|B3|No||Cirrhosis Status||participants|Number|10|10.0||||||
3982739|NCT01260350|3805249|B2|No||Cirrhosis Status||participants|Number|9|9.0||||||
3982740|NCT01260350|3805250|B1|No||Cirrhosis Status||participants|Number|10|10.0||||||
3982741|NCT01260350|3805230|B21|Yes||Cirrhosis Status||participants|Number|20|20.0||||||
3982742|NCT01260350|3805231|B20|Yes||Cirrhosis Status||participants|Number|0|0.0||||||
3982743|NCT01260350|3805232|B19|Yes||Cirrhosis Status||participants|Number|1|1.0||||||
3982744|NCT01260350|3805233|B18|Yes||Cirrhosis Status||participants|Number|0|0.0||||||
3982745|NCT01260350|3805234|B17|Yes||Cirrhosis Status||participants|Number|9|9.0||||||
3982746|NCT01260350|3805235|B16|Yes||Cirrhosis Status||participants|Number|10|10.0||||||
3982747|NCT01260350|3805236|B15|Yes||Cirrhosis Status||participants|Number|0|0.0||||||
3982748|NCT01260350|3805237|B14|Yes||Cirrhosis Status||participants|Number|0|0.0||||||
3982749|NCT01260350|3805238|B13|Yes||Cirrhosis Status||participants|Number|0|0.0||||||
3982750|NCT01260350|3805239|B12|Yes||Cirrhosis Status||participants|Number|0|0.0||||||
3982751|NCT01260350|3805240|B11|Yes||Cirrhosis Status||participants|Number|0|0.0||||||
3982752|NCT01260350|3805241|B10|Yes||Cirrhosis Status||participants|Number|0|0.0||||||
3982753|NCT01260350|3805242|B9|Yes||Cirrhosis Status||participants|Number|0|0.0||||||
3982754|NCT01260350|3805243|B8|Yes||Cirrhosis Status||participants|Number|0|0.0||||||
3982755|NCT01260350|3805244|B7|Yes||Cirrhosis Status||participants|Number|0|0.0||||||
3982756|NCT01260350|3805245|B6|Yes||Cirrhosis Status||participants|Number|0|0.0||||||
3982757|NCT01260350|3805246|B5|Yes||Cirrhosis Status||participants|Number|0|0.0||||||
3982758|NCT01260350|3805247|B4|Yes||Cirrhosis Status||participants|Number|0|0.0||||||
3982759|NCT01260350|3805248|B3|Yes||Cirrhosis Status||participants|Number|0|0.0||||||
3982760|NCT01260350|3805249|B2|Yes||Cirrhosis Status||participants|Number|0|0.0||||||
3982761|NCT01260350|3805250|B1|Yes||Cirrhosis Status||participants|Number|0|0.0||||||
3982762|NCT01260350|3805230|B21|TT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|51|51.0||||||
3982763|NCT01260350|3805231|B20|TT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|5|5.0||||||
3982764|NCT01260350|3805232|B19|TT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
3982765|NCT01260350|3805233|B18|TT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3982766|NCT01260350|3805234|B17|TT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|2|2.0||||||
3982767|NCT01260350|3805235|B16|TT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|2|2.0||||||
3982768|NCT01260350|3805236|B15|TT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|4|4.0||||||
3982769|NCT01260350|3805237|B14|TT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3982770|NCT01260350|3805238|B13|TT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|2|2.0||||||
3982771|NCT01260350|3805239|B12|TT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|2|2.0||||||
3982772|NCT01260350|3805240|B11|TT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3982773|NCT01260350|3805241|B10|TT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3982774|NCT01260350|3805242|B9|TT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|19|19.0||||||
3982775|NCT01260350|3805243|B8|TT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3982776|NCT01260350|3805244|B7|TT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3982777|NCT01260350|3805245|B6|TT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3982778|NCT01260350|3805246|B5|TT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|2|2.0||||||
3982779|NCT01260350|3805247|B4|TT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|2|2.0||||||
3982780|NCT01260350|3805248|B3|TT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|2|2.0||||||
3982781|NCT01260350|3805249|B2|TT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3982782|NCT01260350|3805250|B1|TT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3982783|NCT01260350|3805230|B21|CT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|132|132.0||||||
3982784|NCT01260350|3805231|B20|CT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|15|15.0||||||
3982785|NCT01260350|3805232|B19|CT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|7|7.0||||||
3982786|NCT01260350|3805233|B18|CT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|6|6.0||||||
3982787|NCT01260350|3805234|B17|CT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|5|5.0||||||
3982788|NCT01260350|3805235|B16|CT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|4|4.0||||||
3982789|NCT01260350|3805236|B15|CT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|14|14.0||||||
3982790|NCT01260350|3805237|B14|CT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|8|8.0||||||
3982791|NCT01260350|3805238|B13|CT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|14|14.0||||||
3982792|NCT01260350|3805239|B12|CT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|7|7.0||||||
3982793|NCT01260350|3805240|B11|CT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|5|5.0||||||
3982794|NCT01260350|3805241|B10|CT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|12|12.0||||||
3982795|NCT01260350|3805242|B9|CT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|6|6.0||||||
3982796|NCT01260350|3805243|B8|CT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3982797|NCT01260350|3805244|B7|CT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3982798|NCT01260350|3805245|B6|CT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|6|6.0||||||
3982799|NCT01260350|3805246|B5|CT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|6|6.0||||||
3982800|NCT01260350|3805247|B4|CT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|5|5.0||||||
3982801|NCT01260350|3805248|B3|CT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|4|4.0||||||
3982802|NCT01260350|3805249|B2|CT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|4|4.0||||||
3982803|NCT01260350|3805250|B1|CT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|4|4.0||||||
3982804|NCT01260350|3805230|B21|CC||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|109|109.0||||||
3982805|NCT01260350|3805231|B20|CC||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|5|5.0||||||
3982806|NCT01260350|3805232|B19|CC||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|4|4.0||||||
3982807|NCT01260350|3805233|B18|CC||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
3982808|NCT01260350|3805234|B17|CC||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|2|2.0||||||
3982809|NCT01260350|3805235|B16|CC||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|4|4.0||||||
3982810|NCT01260350|3805236|B15|CC||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|7|7.0||||||
3982811|NCT01260350|3805237|B14|CC||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
3982812|NCT01260350|3805238|B13|CC||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|9|9.0||||||
3982813|NCT01260350|3805239|B12|CC||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3982814|NCT01260350|3805240|B11|CC||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|4|4.0||||||
3982815|NCT01260350|3805241|B10|CC||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|13|13.0||||||
3982816|NCT01260350|3805242|B9|CC||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|0|0.0||||||
3982817|NCT01260350|3805243|B8|CC||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|25|25.0||||||
3982818|NCT01260350|3805244|B7|CC||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|10|10.0||||||
3982819|NCT01260350|3805245|B6|CC||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
3982820|NCT01260350|3805246|B5|CC||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|2|2.0||||||
3982821|NCT01260350|3805247|B4|CC||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|4|4.0||||||
3982822|NCT01260350|3805248|B3|CC||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|4|4.0||||||
3982823|NCT01260350|3805249|B2|CC||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|4|4.0||||||
3982824|NCT01260350|3805250|B1|CC||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|5|5.0||||||
3982825|NCT01260350|3805230|B21|Genotype 3||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|99|99.0||||||
3982826|NCT01260350|3805231|B20|Genotype 3||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3982827|NCT01260350|3805232|B19|Genotype 3||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3982828|NCT01260350|3805233|B18|Genotype 3||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|8|8.0||||||
3982829|NCT01260350|3805234|B17|Genotype 3||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3982830|NCT01260350|3805235|B16|Genotype 3||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3982831|NCT01260350|3805236|B15|Genotype 3||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3982832|NCT01260350|3805237|B14|Genotype 3||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3982833|NCT01260350|3805238|B13|Genotype 3||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3982905|NCT01260350|3805247|B4|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|8|8.0||||||
3982834|NCT01260350|3805239|B12|Genotype 3||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3982835|NCT01260350|3805240|B11|Genotype 3||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|10|10.0||||||
3982836|NCT01260350|3805241|B10|Genotype 3||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|20|20.0||||||
3982837|NCT01260350|3805242|B9|Genotype 3||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|19|19.0||||||
3982838|NCT01260350|3805243|B8|Genotype 3||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3982839|NCT01260350|3805244|B7|Genotype 3||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3982840|NCT01260350|3805245|B6|Genotype 3||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|10|10.0||||||
3982841|NCT01260350|3805246|B5|Genotype 3||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|7|7.0||||||
3982842|NCT01260350|3805247|B4|Genotype 3||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|7|7.0||||||
3982843|NCT01260350|3805248|B3|Genotype 3||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|6|6.0||||||
3982844|NCT01260350|3805249|B2|Genotype 3||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|6|6.0||||||
3982845|NCT01260350|3805250|B1|Genotype 3||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|6|6.0||||||
3982846|NCT01260350|3805230|B21|Genotype 2||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|31|31.0||||||
3982847|NCT01260350|3805231|B20|Genotype 2||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3982848|NCT01260350|3805232|B19|Genotype 2||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3982849|NCT01260350|3805233|B18|Genotype 2||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|2|2.0||||||
3982850|NCT01260350|3805234|B17|Genotype 2||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3982851|NCT01260350|3805235|B16|Genotype 2||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3982852|NCT01260350|3805236|B15|Genotype 2||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3982853|NCT01260350|3805237|B14|Genotype 2||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3982854|NCT01260350|3805238|B13|Genotype 2||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3982855|NCT01260350|3805239|B12|Genotype 2||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3982856|NCT01260350|3805240|B11|Genotype 2||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3982857|NCT01260350|3805241|B10|Genotype 2||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|5|5.0||||||
3982858|NCT01260350|3805242|B9|Genotype 2||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|6|6.0||||||
3982859|NCT01260350|3805243|B8|Genotype 2||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3982860|NCT01260350|3805244|B7|Genotype 2||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3982861|NCT01260350|3805245|B6|Genotype 2||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3982862|NCT01260350|3805246|B5|Genotype 2||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|3|3.0||||||
3982863|NCT01260350|3805247|B4|Genotype 2||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|4|4.0||||||
3982864|NCT01260350|3805248|B3|Genotype 2||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|4|4.0||||||
3982906|NCT01260350|3805248|B3|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|7|7.0||||||
3982865|NCT01260350|3805249|B2|Genotype 2||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|3|3.0||||||
3982866|NCT01260350|3805250|B1|Genotype 2||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|4|4.0||||||
3982867|NCT01260350|3805230|B21|Genotype 1||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|162|162.0||||||
3982868|NCT01260350|3805231|B20|Genotype 1||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|25|25.0||||||
3982869|NCT01260350|3805232|B19|Genotype 1||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|14|14.0||||||
3982870|NCT01260350|3805233|B18|Genotype 1||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3982871|NCT01260350|3805234|B17|Genotype 1||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|9|9.0||||||
3982872|NCT01260350|3805235|B16|Genotype 1||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|10|10.0||||||
3982873|NCT01260350|3805236|B15|Genotype 1||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|25|25.0||||||
3982874|NCT01260350|3805237|B14|Genotype 1||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|10|10.0||||||
3982875|NCT01260350|3805238|B13|Genotype 1||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|25|25.0||||||
3982876|NCT01260350|3805239|B12|Genotype 1||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|9|9.0||||||
3982877|NCT01260350|3805240|B11|Genotype 1||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3982878|NCT01260350|3805241|B10|Genotype 1||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3982879|NCT01260350|3805242|B9|Genotype 1||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3982880|NCT01260350|3805243|B8|Genotype 1||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|25|25.0||||||
3982881|NCT01260350|3805244|B7|Genotype 1||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|10|10.0||||||
3982882|NCT01260350|3805245|B6|Genotype 1||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3982883|NCT01260350|3805246|B5|Genotype 1||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3982884|NCT01260350|3805247|B4|Genotype 1||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3982885|NCT01260350|3805248|B3|Genotype 1||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3982886|NCT01260350|3805249|B2|Genotype 1||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3982887|NCT01260350|3805250|B1|Genotype 1||HCV Genotype|There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.|participants|Number|0|0.0||||||
3982888|NCT01260350|3805230|B21|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|205|205.0||||||
3982889|NCT01260350|3805231|B20|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|19|19.0||||||
3982890|NCT01260350|3805232|B19|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|12|12.0||||||
3982891|NCT01260350|3805233|B18|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|5|5.0||||||
3982892|NCT01260350|3805234|B17|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|6|6.0||||||
3982893|NCT01260350|3805235|B16|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|8|8.0||||||
3982894|NCT01260350|3805236|B15|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|17|17.0||||||
3982895|NCT01260350|3805237|B14|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|10|10.0||||||
3982896|NCT01260350|3805238|B13|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|14|14.0||||||
3982897|NCT01260350|3805239|B12|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|9|9.0||||||
3982898|NCT01260350|3805240|B11|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|6|6.0||||||
3982899|NCT01260350|3805241|B10|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|13|13.0||||||
3982900|NCT01260350|3805242|B9|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|20|20.0||||||
3982901|NCT01260350|3805243|B8|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|15|15.0||||||
3982902|NCT01260350|3805244|B7|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|9|9.0||||||
3982903|NCT01260350|3805245|B6|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|5|5.0||||||
3982904|NCT01260350|3805246|B5|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|5|5.0||||||
3982907|NCT01260350|3805249|B2|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|8|8.0||||||
3982908|NCT01260350|3805250|B1|≥ 6 log10 IU/mL||HCV RNA Category||participants|Number|9|9.0||||||
3982909|NCT01260350|3805230|B21|< 6 log10 IU/mL||HCV RNA Category||participants|Number|87|87.0||||||
3982910|NCT01260350|3805231|B20|< 6 log10 IU/mL||HCV RNA Category||participants|Number|6|6.0||||||
3982911|NCT01260350|3805232|B19|< 6 log10 IU/mL||HCV RNA Category||participants|Number|2|2.0||||||
3982912|NCT01260350|3805233|B18|< 6 log10 IU/mL||HCV RNA Category||participants|Number|5|5.0||||||
3982913|NCT01260350|3805234|B17|< 6 log10 IU/mL||HCV RNA Category||participants|Number|3|3.0||||||
3982914|NCT01260350|3805235|B16|< 6 log10 IU/mL||HCV RNA Category||participants|Number|2|2.0||||||
3982915|NCT01260350|3805236|B15|< 6 log10 IU/mL||HCV RNA Category||participants|Number|8|8.0||||||
3982916|NCT01260350|3805237|B14|< 6 log10 IU/mL||HCV RNA Category||participants|Number|0|0.0||||||
3982917|NCT01260350|3805238|B13|< 6 log10 IU/mL||HCV RNA Category||participants|Number|11|11.0||||||
3982918|NCT01260350|3805239|B12|< 6 log10 IU/mL||HCV RNA Category||participants|Number|0|0.0||||||
3982919|NCT01260350|3805240|B11|< 6 log10 IU/mL||HCV RNA Category||participants|Number|4|4.0||||||
3982920|NCT01260350|3805241|B10|< 6 log10 IU/mL||HCV RNA Category||participants|Number|12|12.0||||||
3982921|NCT01260350|3805242|B9|< 6 log10 IU/mL||HCV RNA Category||participants|Number|5|5.0||||||
3982922|NCT01260350|3805243|B8|< 6 log10 IU/mL||HCV RNA Category||participants|Number|10|10.0||||||
3982923|NCT01260350|3805244|B7|< 6 log10 IU/mL||HCV RNA Category||participants|Number|1|1.0||||||
3982924|NCT01260350|3805245|B6|< 6 log10 IU/mL||HCV RNA Category||participants|Number|5|5.0||||||
3982925|NCT01260350|3805246|B5|< 6 log10 IU/mL||HCV RNA Category||participants|Number|5|5.0||||||
3982926|NCT01260350|3805247|B4|< 6 log10 IU/mL||HCV RNA Category||participants|Number|3|3.0||||||
3982927|NCT01260350|3805248|B3|< 6 log10 IU/mL||HCV RNA Category||participants|Number|3|3.0||||||
3982928|NCT01260350|3805249|B2|< 6 log10 IU/mL||HCV RNA Category||participants|Number|1|1.0||||||
3982929|NCT01260350|3805250|B1|< 6 log10 IU/mL||HCV RNA Category||participants|Number|1|1.0||||||
3982930|NCT01260350|3805230|B21|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.73|0.73|||
3982931|NCT01260350|3805231|B20|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.56|0.56|||
3982932|NCT01260350|3805232|B19|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.51|0.51|||
3982933|NCT01260350|3805233|B18|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.1|6.1|Standard Deviation|0.94|0.94|||
3982934|NCT01260350|3805234|B17|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.78|0.78|||
3982935|NCT01260350|3805235|B16|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.57|0.57|||
3982936|NCT01260350|3805236|B15|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.54|0.54|||
3982937|NCT01260350|3805237|B14|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|7.0|7.0|Standard Deviation|0.38|0.38|||
3982938|NCT01260350|3805238|B13|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|5.9|5.9|Standard Deviation|0.85|0.85|||
3982939|NCT01260350|3805239|B12|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.9|6.9|Standard Deviation|0.20|0.2|||
3982940|NCT01260350|3805240|B11|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.2|6.2|Standard Deviation|0.96|0.96|||
3982941|NCT01260350|3805241|B10|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.1|6.1|Standard Deviation|0.80|0.8|||
3982942|NCT01260350|3805242|B9|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.66|0.66|||
3982943|NCT01260350|3805243|B8|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.1|6.1|Standard Deviation|0.75|0.75|||
3982944|NCT01260350|3805244|B7|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.8|6.8|Standard Deviation|0.55|0.55|||
3982945|NCT01260350|3805245|B6|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.1|6.1|Standard Deviation|0.88|0.88|||
3982946|NCT01260350|3805246|B5|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|5.7|5.7|Standard Deviation|0.89|0.89|||
3982947|NCT01260350|3805247|B4|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.76|0.76|||
3982948|NCT01260350|3805248|B3|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.4|6.4|Standard Deviation|0.57|0.57|||
3982949|NCT01260350|3805249|B2|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.6|6.6|Standard Deviation|0.52|0.52|||
3982950|NCT01260350|3805250|B1|||Hepatitis C Virus (HCV) RNA||log10 IU/mL|Mean|6.7|6.7|Standard Deviation|0.42|0.42|||
3982951|NCT01260350|3805230|B21|Other||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
3982952|NCT01260350|3805231|B20|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3982953|NCT01260350|3805232|B19|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3982954|NCT01260350|3805233|B18|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3982955|NCT01260350|3805234|B17|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3982956|NCT01260350|3805235|B16|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3982957|NCT01260350|3805236|B15|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3982958|NCT01260350|3805237|B14|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3982959|NCT01260350|3805238|B13|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3982960|NCT01260350|3805239|B12|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3982961|NCT01260350|3805240|B11|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3982962|NCT01260350|3805241|B10|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3982963|NCT01260350|3805242|B9|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3982964|NCT01260350|3805243|B8|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3982965|NCT01260350|3805244|B7|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3982966|NCT01260350|3805245|B6|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3982967|NCT01260350|3805246|B5|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3982968|NCT01260350|3805247|B4|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3982969|NCT01260350|3805248|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3982970|NCT01260350|3805249|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3982971|NCT01260350|3805250|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3982972|NCT01260350|3805230|B21|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3982973|NCT01260350|3805231|B20|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3982974|NCT01260350|3805232|B19|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3982975|NCT01260350|3805233|B18|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3982976|NCT01260350|3805234|B17|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3982977|NCT01260350|3805235|B16|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3982978|NCT01260350|3805236|B15|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3982979|NCT01260350|3805237|B14|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3982980|NCT01260350|3805238|B13|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3982981|NCT01260350|3805239|B12|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3982982|NCT01260350|3805240|B11|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3982983|NCT01260350|3805241|B10|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3982984|NCT01260350|3805242|B9|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3982985|NCT01260350|3805243|B8|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3982986|NCT01260350|3805244|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3982987|NCT01260350|3805245|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3982988|NCT01260350|3805246|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3982989|NCT01260350|3805247|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3982990|NCT01260350|3805248|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3982991|NCT01260350|3805249|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3982992|NCT01260350|3805250|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3982993|NCT01260350|3805230|B21|Native Hawaiian of Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3982994|NCT01260350|3805231|B20|Native Hawaiian of Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3982995|NCT01260350|3805232|B19|Native Hawaiian of Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3982996|NCT01260350|3805233|B18|Native Hawaiian of Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3982997|NCT01260350|3805234|B17|Native Hawaiian of Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3982998|NCT01260350|3805235|B16|Native Hawaiian of Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3982999|NCT01260350|3805236|B15|Native Hawaiian of Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3983000|NCT01260350|3805237|B14|Native Hawaiian of Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3983001|NCT01260350|3805238|B13|Native Hawaiian of Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3983002|NCT01260350|3805239|B12|Native Hawaiian of Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3983003|NCT01260350|3805240|B11|Native Hawaiian of Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3983004|NCT01260350|3805241|B10|Native Hawaiian of Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3983005|NCT01260350|3805242|B9|Native Hawaiian of Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3983006|NCT01260350|3805243|B8|Native Hawaiian of Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3983007|NCT01260350|3805244|B7|Native Hawaiian of Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3983008|NCT01260350|3805245|B6|Native Hawaiian of Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3983009|NCT01260350|3805246|B5|Native Hawaiian of Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3983010|NCT01260350|3805247|B4|Native Hawaiian of Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3983011|NCT01260350|3805248|B3|Native Hawaiian of Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3983012|NCT01260350|3805249|B2|Native Hawaiian of Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3983013|NCT01260350|3805250|B1|Native Hawaiian of Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3983014|NCT01260350|3805230|B21|Asian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3983015|NCT01260350|3805231|B20|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3983016|NCT01260350|3805232|B19|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3983017|NCT01260350|3805233|B18|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3983018|NCT01260350|3805234|B17|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3983019|NCT01260350|3805235|B16|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3983020|NCT01260350|3805236|B15|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3983021|NCT01260350|3805237|B14|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3983022|NCT01260350|3805238|B13|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3983023|NCT01260350|3805239|B12|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3983024|NCT01260350|3805240|B11|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3983025|NCT01260350|3805241|B10|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3983026|NCT01260350|3805242|B9|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3983027|NCT01260350|3805243|B8|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3983028|NCT01260350|3805244|B7|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3983029|NCT01260350|3805245|B6|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3983030|NCT01260350|3805246|B5|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3983031|NCT01260350|3805247|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3983032|NCT01260350|3805248|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3983033|NCT01260350|3805249|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3983034|NCT01260350|3805250|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3983035|NCT01260350|3805230|B21|White||Race/Ethnicity, Customized||participants|Number|239|239.0||||||
3983036|NCT01260350|3805231|B20|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3983037|NCT01260350|3805232|B19|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3983038|NCT01260350|3805233|B18|White||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3983039|NCT01260350|3805234|B17|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3983040|NCT01260350|3805235|B16|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3983041|NCT01260350|3805236|B15|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3983042|NCT01260350|3805237|B14|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3983043|NCT01260350|3805238|B13|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3983044|NCT01260350|3805239|B12|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3983045|NCT01260350|3805240|B11|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3983046|NCT01260350|3805241|B10|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3983047|NCT01260350|3805242|B9|White||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3983048|NCT01260350|3805243|B8|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3983049|NCT01260350|3805244|B7|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3983050|NCT01260350|3805245|B6|White||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3983051|NCT01260350|3805246|B5|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3983052|NCT01260350|3805247|B4|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3983053|NCT01260350|3805248|B3|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3983054|NCT01260350|3805249|B2|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3983055|NCT01260350|3805250|B1|White||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3983056|NCT01260350|3805230|B21||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983057|NCT01260350|3805231|B20||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983058|NCT01260350|3805232|B19||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983059|NCT01260350|3805233|B18||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983060|NCT01260350|3805234|B17||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983061|NCT01260350|3805235|B16||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983062|NCT01260350|3805236|B15||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983063|NCT01260350|3805237|B14||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983064|NCT01260350|3805238|B13||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983065|NCT01260350|3805239|B12||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983066|NCT01260350|3805240|B11||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983067|NCT01260350|3805241|B10||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983068|NCT01260350|3805242|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983069|NCT01260350|3805243|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983070|NCT01260350|3805244|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983071|NCT01260350|3805245|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983072|NCT01260350|3805246|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983073|NCT01260350|3805247|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983074|NCT01260350|3805248|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983075|NCT01260350|3805249|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983076|NCT01260350|3805250|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983077|NCT01260350|3805230|B21||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|289|289.0||||||
3983078|NCT01260350|3805231|B20||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3983079|NCT01260350|3805232|B19||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3983080|NCT01260350|3805233|B18||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3983081|NCT01260350|3805234|B17||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3983082|NCT01260350|3805235|B16||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3983083|NCT01260350|3805236|B15||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3983084|NCT01260350|3805237|B14||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3983085|NCT01260350|3805238|B13||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3983086|NCT01260350|3805239|B12||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3983087|NCT01260350|3805240|B11||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3983088|NCT01260350|3805241|B10||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3983089|NCT01260350|3805242|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3983090|NCT01260350|3805243|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3983091|NCT01260350|3805244|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3983092|NCT01260350|3805245|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3983093|NCT01260350|3805246|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3983094|NCT01260350|3805247|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3983095|NCT01260350|3805248|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3983096|NCT01260350|3805249|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3983097|NCT01260350|3805250|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3983098|NCT01260350|3805230|B21||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3983099|NCT01260350|3805231|B20||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983100|NCT01260350|3805232|B19||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983101|NCT01260350|3805233|B18||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983102|NCT01260350|3805234|B17||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983103|NCT01260350|3805235|B16||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3983104|NCT01260350|3805236|B15||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983105|NCT01260350|3805237|B14||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983106|NCT01260350|3805238|B13||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983107|NCT01260350|3805239|B12||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983108|NCT01260350|3805240|B11||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983109|NCT01260350|3805241|B10||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983110|NCT01260350|3805242|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983111|NCT01260350|3805243|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983112|NCT01260350|3805244|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983113|NCT01260350|3805245|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3983114|NCT01260350|3805246|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983115|NCT01260350|3805247|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983116|NCT01260350|3805248|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983117|NCT01260350|3805249|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983118|NCT01260350|3805250|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983119|NCT01260350|3805230|B21||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3983120|NCT01260350|3805231|B20||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3983121|NCT01260350|3805232|B19||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3983122|NCT01260350|3805233|B18||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3983123|NCT01260350|3805234|B17||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3983124|NCT01260350|3805235|B16||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3983125|NCT01260350|3805236|B15||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3983126|NCT01260350|3805237|B14||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3983127|NCT01260350|3805238|B13||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3983128|NCT01260350|3805239|B12||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3983129|NCT01260350|3805240|B11||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3983130|NCT01260350|3805241|B10||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3983131|NCT01260350|3805242|B9||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3983132|NCT01260350|3805243|B8||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3983133|NCT01260350|3805244|B7||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3983134|NCT01260350|3805245|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3983135|NCT01260350|3805246|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3983136|NCT01260350|3805247|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3983137|NCT01260350|3805248|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3983138|NCT01260350|3805249|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3983139|NCT01260350|3805250|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3983140|NCT01260350|3805230|B21||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3983141|NCT01260350|3805231|B20||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3983142|NCT01260350|3805232|B19||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3983143|NCT01260350|3805233|B18||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3983144|NCT01260350|3805234|B17||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3983145|NCT01260350|3805235|B16||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3983146|NCT01260350|3805236|B15||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3983147|NCT01260350|3805237|B14||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3983148|NCT01260350|3805238|B13||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3983149|NCT01260350|3805239|B12||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3983150|NCT01260350|3805240|B11||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3983151|NCT01260350|3805241|B10||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3983152|NCT01260350|3805242|B9||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3983153|NCT01260350|3805243|B8||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3983154|NCT01260350|3805244|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3983155|NCT01260350|3805245|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3983156|NCT01260350|3805246|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3983157|NCT01260350|3805247|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3983158|NCT01260350|3805248|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3983159|NCT01260350|3805249|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3983160|NCT01260350|3805250|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3983161|NCT01260350|3805230|B21|||Age||years|Mean|48|48.0|Standard Deviation|10.6|10.6|||
3983162|NCT01260350|3805231|B20|||Age||years|Mean|51|51.0|Standard Deviation|9.0|9.0|||
3983163|NCT01260350|3805232|B19|||Age||years|Mean|54|54.0|Standard Deviation|13.0|13.0|||
3983164|NCT01260350|3805233|B18|||Age||years|Mean|39|39.0|Standard Deviation|10.8|10.8|||
3983165|NCT01260350|3805234|B17|||Age||years|Mean|57|57.0|Standard Deviation|5.2|5.2|||
3983166|NCT01260350|3805235|B16|||Age||years|Mean|61|61.0|Standard Deviation|4.9|4.9|||
3983167|NCT01260350|3805236|B15|||Age||years|Mean|46|46.0|Standard Deviation|9.3|9.3|||
3983168|NCT01260350|3805237|B14|||Age||years|Mean|55|55.0|Standard Deviation|6.0|6.0|||
3983169|NCT01260350|3805238|B13|||Age||years|Mean|45|45.0|Standard Deviation|9.2|9.2|||
3983170|NCT01260350|3805239|B12|||Age||years|Mean|50|50.0|Standard Deviation|13.0|13.0|||
3983171|NCT01260350|3805240|B11|||Age||years|Mean|39|39.0|Standard Deviation|8.9|8.9|||
3983172|NCT01260350|3805241|B10|||Age||years|Mean|48|48.0|Standard Deviation|9.4|9.4|||
3983173|NCT01260350|3805242|B9|||Age||years|Mean|53|53.0|Standard Deviation|7.9|7.9|||
3983174|NCT01260350|3805243|B8|||Age||years|Mean|48|48.0|Standard Deviation|11.4|11.4|||
3983175|NCT01260350|3805244|B7|||Age||years|Mean|48|48.0|Standard Deviation|10.4|10.4|||
3983176|NCT01260350|3805245|B6|||Age||years|Mean|39|39.0|Standard Deviation|12.2|12.2|||
3983177|NCT01260350|3805246|B5|||Age||years|Mean|43|43.0|Standard Deviation|13.5|13.5|||
3983178|NCT01260350|3805247|B4|||Age||years|Mean|46|46.0|Standard Deviation|6.3|6.3|||
3983179|NCT01260350|3805248|B3|||Age||years|Mean|49|49.0|Standard Deviation|9.9|9.9|||
3983180|NCT01260350|3805249|B2|||Age||years|Mean|47|47.0|Standard Deviation|10.2|10.2|||
3983181|NCT01260350|3805250|B1|||Age||years|Mean|47|47.0|Standard Deviation|6.0|6.0|||
3983182|NCT01260324|3805461|B3|West||Number of participants with NAION diagnosis per region of United States|Medical record-adjudicated definite and possible cases and claims algorithm-derived definite and possible cases.|participants|Number|3206|3206.0||||||
3983183|NCT01260324|3805462|B2|West||Number of participants with NAION diagnosis per region of United States|Medical record-adjudicated definite and possible cases and claims algorithm-derived definite and possible cases.|participants|Number|3041|3041.0||||||
3983184|NCT01260324|3805463|B1|West||Number of participants with NAION diagnosis per region of United States|Medical record-adjudicated definite and possible cases and claims algorithm-derived definite and possible cases.|participants|Number|165|165.0||||||
3983185|NCT01260324|3805461|B3|South||Number of participants with NAION diagnosis per region of United States|Medical record-adjudicated definite and possible cases and claims algorithm-derived definite and possible cases.|participants|Number|9814|9814.0||||||
3983186|NCT01260324|3805462|B2|South||Number of participants with NAION diagnosis per region of United States|Medical record-adjudicated definite and possible cases and claims algorithm-derived definite and possible cases.|participants|Number|9158|9158.0||||||
3983187|NCT01260324|3805463|B1|South||Number of participants with NAION diagnosis per region of United States|Medical record-adjudicated definite and possible cases and claims algorithm-derived definite and possible cases.|participants|Number|656|656.0||||||
3983188|NCT01260324|3805461|B3|Midwest||Number of participants with NAION diagnosis per region of United States|Medical record-adjudicated definite and possible cases and claims algorithm-derived definite and possible cases.|participants|Number|5707|5707.0||||||
3983189|NCT01260324|3805462|B2|Midwest||Number of participants with NAION diagnosis per region of United States|Medical record-adjudicated definite and possible cases and claims algorithm-derived definite and possible cases.|participants|Number|5345|5345.0||||||
3983230|NCT01260324|3805461|B3|18 to 34 years||Age, Customized||participants|Number|5997|5997.0||||||
3983190|NCT01260324|3805463|B1|Midwest||Number of participants with NAION diagnosis per region of United States|Medical record-adjudicated definite and possible cases and claims algorithm-derived definite and possible cases.|participants|Number|362|362.0||||||
3983191|NCT01260324|3805461|B3|Northeast||Number of participants with NAION diagnosis per region of United States|Medical record-adjudicated definite and possible cases and claims algorithm-derived definite and possible cases.|participants|Number|2556|2556.0||||||
3983192|NCT01260324|3805462|B2|Northeast||Number of participants with NAION diagnosis per region of United States|Medical record-adjudicated definite and possible cases and claims algorithm-derived definite and possible cases.|participants|Number|2456|2456.0||||||
3983193|NCT01260324|3805463|B1|Northeast||Number of participants with NAION diagnosis per region of United States|Medical record-adjudicated definite and possible cases and claims algorithm-derived definite and possible cases.|participants|Number|100|100.0||||||
3983194|NCT01260324|3805461|B3|Year 2007||Number of participants with NAION diagnosis per calendar year|Medical record-adjudicated definite and possible cases and claims algorithm-derived definite and possible cases.|participants|Number|4086|4086.0||||||
3983195|NCT01260324|3805462|B2|Year 2007||Number of participants with NAION diagnosis per calendar year|Medical record-adjudicated definite and possible cases and claims algorithm-derived definite and possible cases.|participants|Number|3839|3839.0||||||
3983196|NCT01260324|3805463|B1|Year 2007||Number of participants with NAION diagnosis per calendar year|Medical record-adjudicated definite and possible cases and claims algorithm-derived definite and possible cases.|participants|Number|247|247.0||||||
3983197|NCT01260324|3805461|B3|Year 2006||Number of participants with NAION diagnosis per calendar year|Medical record-adjudicated definite and possible cases and claims algorithm-derived definite and possible cases.|participants|Number|4312|4312.0||||||
3983198|NCT01260324|3805462|B2|Year 2006||Number of participants with NAION diagnosis per calendar year|Medical record-adjudicated definite and possible cases and claims algorithm-derived definite and possible cases.|participants|Number|4081|4081.0||||||
3983199|NCT01260324|3805463|B1|Year 2006||Number of participants with NAION diagnosis per calendar year|Medical record-adjudicated definite and possible cases and claims algorithm-derived definite and possible cases.|participants|Number|231|231.0||||||
3983200|NCT01260324|3805461|B3|Year 2005||Number of participants with NAION diagnosis per calendar year|Medical record-adjudicated definite and possible cases and claims algorithm-derived definite and possible cases.|participants|Number|4421|4421.0||||||
3983201|NCT01260324|3805462|B2|Year 2005||Number of participants with NAION diagnosis per calendar year|Medical record-adjudicated definite and possible cases and claims algorithm-derived definite and possible cases.|participants|Number|4137|4137.0||||||
3983202|NCT01260324|3805463|B1|Year 2005||Number of participants with NAION diagnosis per calendar year|Medical record-adjudicated definite and possible cases and claims algorithm-derived definite and possible cases.|participants|Number|284|284.0||||||
3983203|NCT01260324|3805461|B3|Year 2004||Number of participants with NAION diagnosis per calendar year|Medical record-adjudicated definite and possible cases and claims algorithm-derived definite and possible cases.|participants|Number|4226|4226.0||||||
3983204|NCT01260324|3805462|B2|Year 2004||Number of participants with NAION diagnosis per calendar year|Medical record-adjudicated definite and possible cases and claims algorithm-derived definite and possible cases.|participants|Number|3990|3990.0||||||
3983205|NCT01260324|3805463|B1|Year 2004||Number of participants with NAION diagnosis per calendar year|Medical record-adjudicated definite and possible cases and claims algorithm-derived definite and possible cases.|participants|Number|236|236.0||||||
3983206|NCT01260324|3805461|B3|Year 2003||Number of participants with NAION diagnosis per calendar year|Medical record-adjudicated definite and possible cases and claims algorithm-derived definite and possible cases.|participants|Number|4238|4238.0||||||
3983207|NCT01260324|3805462|B2|Year 2003||Number of participants with NAION diagnosis per calendar year|Medical record-adjudicated definite and possible cases and claims algorithm-derived definite and possible cases.|participants|Number|3953|3953.0||||||
3983208|NCT01260324|3805463|B1|Year 2003||Number of participants with NAION diagnosis per calendar year|Medical record-adjudicated definite and possible cases and claims algorithm-derived definite and possible cases.|participants|Number|285|285.0||||||
3983209|NCT01260324|3805461|B3||Male|Sex: Female, Male||Participants|Count of Participants|10019|10019.0||||||
3983210|NCT01260324|3805462|B2||Male|Sex: Female, Male||Participants|Count of Participants|9331|9331.0||||||
3983211|NCT01260324|3805463|B1||Male|Sex: Female, Male||Participants|Count of Participants|688|688.0||||||
3983212|NCT01260324|3805461|B3||Female|Sex: Female, Male||Participants|Count of Participants|11264|11264.0||||||
3983213|NCT01260324|3805462|B2||Female|Sex: Female, Male||Participants|Count of Participants|10669|10669.0||||||
3983214|NCT01260324|3805463|B1||Female|Sex: Female, Male||Participants|Count of Participants|595|595.0||||||
3983215|NCT01260324|3805461|B3|≥75 years||Age, Customized||participants|Number|756|756.0||||||
3983216|NCT01260324|3805462|B2|≥75 years||Age, Customized||participants|Number|511|511.0||||||
3983217|NCT01260324|3805463|B1|≥75 years||Age, Customized||participants|Number|245|245.0||||||
3983218|NCT01260324|3805461|B3|65 to 74 years||Age, Customized||participants|Number|1149|1149.0||||||
3983219|NCT01260324|3805462|B2|65 to 74 years||Age, Customized||participants|Number|902|902.0||||||
3983220|NCT01260324|3805463|B1|65 to 74 years||Age, Customized||participants|Number|247|247.0||||||
3983221|NCT01260324|3805461|B3|55 to 64 years||Age, Customized||participants|Number|3522|3522.0||||||
3983222|NCT01260324|3805462|B2|55 to 64 years||Age, Customized||participants|Number|3041|3041.0||||||
3983223|NCT01260324|3805463|B1|55 to 64 years||Age, Customized||participants|Number|481|481.0||||||
3983224|NCT01260324|3805461|B3|45 to 54 years||Age, Customized||participants|Number|4863|4863.0||||||
3983225|NCT01260324|3805462|B2|45 to 54 years||Age, Customized||participants|Number|4655|4655.0||||||
3983226|NCT01260324|3805463|B1|45 to 54 years||Age, Customized||participants|Number|208|208.0||||||
3983227|NCT01260324|3805461|B3|35 to 44 years||Age, Customized||participants|Number|4996|4996.0||||||
3983228|NCT01260324|3805462|B2|35 to 44 years||Age, Customized||participants|Number|4937|4937.0||||||
3983229|NCT01260324|3805463|B1|35 to 44 years||Age, Customized||participants|Number|59|59.0||||||
3983231|NCT01260324|3805462|B2|18 to 34 years||Age, Customized||participants|Number|5954|5954.0||||||
3983232|NCT01260324|3805463|B1|18 to 34 years||Age, Customized||participants|Number|43|43.0||||||
3983233|NCT01260311|3805478|B1|||Height||centimeter (cm)|Mean|163.2|163.2|Standard Deviation|10.1|10.1|||
3983234|NCT01260311|3805478|B1|||Body Mass Index||kilogram per square meter (kg/m^2)|Mean|24.1|24.1|Standard Deviation|4.1|4.1|||
3983235|NCT01260311|3805478|B1|||Weight||kilogram (kg)|Mean|64.1|64.1|Standard Deviation|11.4|11.4|||
3983236|NCT01260311|3805478|B1||Male|Sex: Female, Male||Participants|Count of Participants|309|309.0||||||
3983237|NCT01260311|3805478|B1||Female|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
3983238|NCT01260311|3805478|B1|||Age||years|Mean|54.5|54.5|Standard Deviation|15.0|15.0|||
3983239|NCT01260272|3805486|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
3983240|NCT01260272|3805487|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
3983241|NCT01260272|3805488|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
3983242|NCT01260272|3805486|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3983243|NCT01260272|3805487|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3983244|NCT01260272|3805488|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3983245|NCT01260272|3805486|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3983246|NCT01260272|3805487|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3983247|NCT01260272|3805488|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3983248|NCT01260272|3805486|B3|||Age||years|Mean|60.57|60.57|Standard Deviation|1|1.0|||
3983249|NCT01260272|3805487|B2|||Age||years|Mean|60.3|60.3|Standard Deviation|1|1.0|||
3983250|NCT01260272|3805488|B1|||Age||years|Mean|61.1|61.1|Standard Deviation|1|1.0|||
3983251|NCT01260272|3805486|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3983252|NCT01260272|3805487|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3983253|NCT01260272|3805488|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3983254|NCT01260272|3805486|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3983255|NCT01260272|3805487|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3983256|NCT01260272|3805488|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3983257|NCT01260272|3805486|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3983258|NCT01260272|3805487|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3983259|NCT01260272|3805488|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3983260|NCT01260194|3805509|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
3983261|NCT01260194|3805509|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
3983262|NCT01260194|3805509|B1|||Age||years|Mean|64.8|64.8|Standard Deviation|7.27|7.27|||
3983263|NCT01260181|3805521|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3983264|NCT01260181|3805521|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983265|NCT01260181|3805521|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983266|NCT01260181|3805521|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983267|NCT01260181|3805521|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983268|NCT01260181|3805521|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983269|NCT01260181|3805521|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983270|NCT01260181|3805521|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3983271|NCT01260181|3805521|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3983272|NCT01260181|3805521|B1|||Age||years|Mean|66.33|66.33|Standard Deviation|9.21|9.21|||
3983273|NCT01260142|3805530|B7||Male|Gender||Participants|Count of Participants|21|21.0||||||
3983274|NCT01260142|3805531|B6||Male|Gender||Participants|Count of Participants|2|2.0||||||
3983275|NCT01260142|3805532|B5||Male|Gender||Participants|Count of Participants|4|4.0||||||
3983276|NCT01260142|3805533|B4||Male|Gender||Participants|Count of Participants|4|4.0||||||
3983277|NCT01260142|3805534|B3||Male|Gender||Participants|Count of Participants|3|3.0||||||
3983278|NCT01260142|3805535|B2||Male|Gender||Participants|Count of Participants|4|4.0||||||
3983279|NCT01260142|3805536|B1||Male|Gender||Participants|Count of Participants|4|4.0||||||
3983280|NCT01260142|3805530|B7||Female|Gender||Participants|Count of Participants|15|15.0||||||
3983281|NCT01260142|3805531|B6||Female|Gender||Participants|Count of Participants|4|4.0||||||
3983282|NCT01260142|3805532|B5||Female|Gender||Participants|Count of Participants|2|2.0||||||
3983283|NCT01260142|3805533|B4||Female|Gender||Participants|Count of Participants|2|2.0||||||
3983284|NCT01260142|3805534|B3||Female|Gender||Participants|Count of Participants|3|3.0||||||
3983285|NCT01260142|3805535|B2||Female|Gender||Participants|Count of Participants|2|2.0||||||
3983286|NCT01260142|3805536|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
3983287|NCT01260142|3805530|B7|||Age||Years|Mean|24.8|24.8|Standard Deviation|3.98|3.98|||
3983288|NCT01260142|3805531|B6|||Age||Years|Mean|23.8|23.8|Standard Deviation|3.37|3.37|||
3983289|NCT01260142|3805532|B5|||Age||Years|Mean|29|29.0|Standard Deviation|4.34|4.34|||
3983290|NCT01260142|3805533|B4|||Age||Years|Mean|22.7|22.7|Standard Deviation|2.88|2.88|||
3983291|NCT01260142|3805534|B3|||Age||Years|Mean|25.3|25.3|Standard Deviation|4.46|4.46|||
3983292|NCT01260142|3805535|B2|||Age||Years|Mean|25.5|25.5|Standard Deviation|3.78|3.78|||
3983293|NCT01260142|3805536|B1|||Age||Years|Mean|22.3|22.3|Standard Deviation|1.51|1.51|||
3983294|NCT01259856|3805591|B3|||Disease Duration||months|Median|2.8|2.8|Full Range|||0.0|84.2|
3983295|NCT01259856|3805592|B2|||Disease Duration||months|Median|3.0|3.0|Full Range|||0.0|84.2|
3983296|NCT01259856|3805593|B1|||Disease Duration||months|Median|2.6|2.6|Full Range|||0.0|41.7|
3983297|NCT01259856|3805591|B3|||Splenomegaly||Participants|Count of Participants|11|11.0||||||
3983298|NCT01259856|3805592|B2|||Splenomegaly||Participants|Count of Participants|6|6.0||||||
3983299|NCT01259856|3805593|B1|||Splenomegaly||Participants|Count of Participants|5|5.0||||||
3983300|NCT01259856|3805591|B3|||Previous Hemorrhage||Participants|Count of Participants|7|7.0||||||
3983301|NCT01259856|3805592|B2|||Previous Hemorrhage||Participants|Count of Participants|4|4.0||||||
3983302|NCT01259856|3805593|B1|||Previous Hemorrhage||Participants|Count of Participants|3|3.0||||||
3983303|NCT01259856|3805591|B3|||Previous Thrombosis||Participants|Count of Participants|46|46.0||||||
3983304|NCT01259856|3805592|B2|||Previous Thrombosis||Participants|Count of Participants|20|20.0||||||
3983305|NCT01259856|3805593|B1|||Previous Thrombosis||Participants|Count of Participants|26|26.0||||||
3983306|NCT01259856|3805591|B3|Polycythemia Vera (PV)||Disease Type||Participants|Count of Participants|87|87.0||||||
3983307|NCT01259856|3805592|B2|Polycythemia Vera (PV)||Disease Type||Participants|Count of Participants|44|44.0||||||
3983308|NCT01259856|3805593|B1|Polycythemia Vera (PV)||Disease Type||Participants|Count of Participants|43|43.0||||||
3983309|NCT01259856|3805591|B3|Essential thrombocythemia (ET)||Disease Type||Participants|Count of Participants|81|81.0||||||
3983310|NCT01259856|3805592|B2|Essential thrombocythemia (ET)||Disease Type||Participants|Count of Participants|42|42.0||||||
3983311|NCT01259856|3805593|B1|Essential thrombocythemia (ET)||Disease Type||Participants|Count of Participants|39|39.0||||||
3983312|NCT01259856|3805591|B3|3+||The Eastern Cooperative Oncology Group (ECOG) Performance Status|"The ECOG measures level of functioning in terms of daily living abilities:~0-Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg.light house work~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about >50% of waking hours~Capable of only limited selfcare; confined to bed or chair >50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|Participants|Count of Participants|2|2.0||||||
3983313|NCT01259856|3805592|B2|3+||The Eastern Cooperative Oncology Group (ECOG) Performance Status|"The ECOG measures level of functioning in terms of daily living abilities:~0-Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg.light house work~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about >50% of waking hours~Capable of only limited selfcare; confined to bed or chair >50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|Participants|Count of Participants|0|0.0||||||
3983314|NCT01259856|3805593|B1|3+||The Eastern Cooperative Oncology Group (ECOG) Performance Status|"The ECOG measures level of functioning in terms of daily living abilities:~0-Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg.light house work~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about >50% of waking hours~Capable of only limited selfcare; confined to bed or chair >50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|Participants|Count of Participants|2|2.0||||||
3983315|NCT01259856|3805591|B3|2||The Eastern Cooperative Oncology Group (ECOG) Performance Status|"The ECOG measures level of functioning in terms of daily living abilities:~0-Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg.light house work~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about >50% of waking hours~Capable of only limited selfcare; confined to bed or chair >50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|Participants|Count of Participants|1|1.0||||||
3983316|NCT01259856|3805592|B2|2||The Eastern Cooperative Oncology Group (ECOG) Performance Status|"The ECOG measures level of functioning in terms of daily living abilities:~0-Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg.light house work~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about >50% of waking hours~Capable of only limited selfcare; confined to bed or chair >50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|Participants|Count of Participants|1|1.0||||||
3983317|NCT01259856|3805593|B1|2||The Eastern Cooperative Oncology Group (ECOG) Performance Status|"The ECOG measures level of functioning in terms of daily living abilities:~0-Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg.light house work~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about >50% of waking hours~Capable of only limited selfcare; confined to bed or chair >50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|Participants|Count of Participants|0|0.0||||||
3983318|NCT01259856|3805591|B3|1||The Eastern Cooperative Oncology Group (ECOG) Performance Status|"The ECOG measures level of functioning in terms of daily living abilities:~0-Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg.light house work~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about >50% of waking hours~Capable of only limited selfcare; confined to bed or chair >50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|Participants|Count of Participants|28|28.0||||||
3983355|NCT01259856|3805592|B2|||Age||years|Mean|61.8|61.8|Standard Deviation|12.8|12.8|||
3983356|NCT01259856|3805593|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|14.8|14.8|||
3983357|NCT01259726|3805614|B5||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3983319|NCT01259856|3805592|B2|1||The Eastern Cooperative Oncology Group (ECOG) Performance Status|"The ECOG measures level of functioning in terms of daily living abilities:~0-Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg.light house work~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about >50% of waking hours~Capable of only limited selfcare; confined to bed or chair >50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|Participants|Count of Participants|13|13.0||||||
3983320|NCT01259856|3805593|B1|1||The Eastern Cooperative Oncology Group (ECOG) Performance Status|"The ECOG measures level of functioning in terms of daily living abilities:~0-Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg.light house work~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about >50% of waking hours~Capable of only limited selfcare; confined to bed or chair >50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|Participants|Count of Participants|15|15.0||||||
3983321|NCT01259856|3805591|B3|0||The Eastern Cooperative Oncology Group (ECOG) Performance Status|"The ECOG measures level of functioning in terms of daily living abilities:~0-Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg.light house work~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about >50% of waking hours~Capable of only limited selfcare; confined to bed or chair >50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|Participants|Count of Participants|137|137.0||||||
3983322|NCT01259856|3805592|B2|0||The Eastern Cooperative Oncology Group (ECOG) Performance Status|"The ECOG measures level of functioning in terms of daily living abilities:~0-Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg.light house work~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about >50% of waking hours~Capable of only limited selfcare; confined to bed or chair >50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|Participants|Count of Participants|72|72.0||||||
3983323|NCT01259856|3805593|B1|0||The Eastern Cooperative Oncology Group (ECOG) Performance Status|"The ECOG measures level of functioning in terms of daily living abilities:~0-Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg.light house work~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about >50% of waking hours~Capable of only limited selfcare; confined to bed or chair >50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|Participants|Count of Participants|65|65.0||||||
3983324|NCT01259856|3805591|B3|||Age > 60 years||Participants|Count of Participants|98|98.0||||||
3983325|NCT01259856|3805592|B2|||Age > 60 years||Participants|Count of Participants|56|56.0||||||
3983326|NCT01259856|3805593|B1|||Age > 60 years||Participants|Count of Participants|42|42.0||||||
3983327|NCT01259856|3805591|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3983328|NCT01259856|3805592|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3983329|NCT01259856|3805593|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3983330|NCT01259856|3805591|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983331|NCT01259856|3805592|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983332|NCT01259856|3805593|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983333|NCT01259856|3805591|B3||White|Race (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
3983334|NCT01259856|3805592|B2||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3983335|NCT01259856|3805593|B1||White|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
3983336|NCT01259856|3805591|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3983337|NCT01259856|3805592|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3983338|NCT01259856|3805593|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3983339|NCT01259856|3805591|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3983340|NCT01259856|3805592|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3983341|NCT01259856|3805593|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983342|NCT01259856|3805591|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3983343|NCT01259856|3805592|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3983344|NCT01259856|3805593|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983345|NCT01259856|3805591|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983346|NCT01259856|3805592|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983347|NCT01259856|3805593|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983348|NCT01259856|3805591|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3983349|NCT01259856|3805592|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3983350|NCT01259856|3805593|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3983351|NCT01259856|3805591|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3983352|NCT01259856|3805592|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3983353|NCT01259856|3805593|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3983354|NCT01259856|3805591|B3|||Age||years|Mean|59.4|59.4|Standard Deviation|14.0|14.0|||
3983358|NCT01259726|3805615|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3983359|NCT01259726|3805616|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3983360|NCT01259726|3805617|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3983361|NCT01259726|3805618|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3983362|NCT01259726|3805614|B5||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3983363|NCT01259726|3805615|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3983364|NCT01259726|3805616|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3983365|NCT01259726|3805617|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3983366|NCT01259726|3805618|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3983367|NCT01259726|3805614|B5|||Age||years|Mean|57.6|57.6|Standard Deviation|17.2|17.2|||
3983368|NCT01259726|3805615|B4|||Age||years|Mean|60.6|60.6|Standard Deviation|16.4|16.4|||
3983369|NCT01259726|3805616|B3|||Age||years|Mean|57.2|57.2|Standard Deviation|18.46|18.46|||
3983370|NCT01259726|3805617|B2|||Age||years|Mean|58.2|58.2|Standard Deviation|14.42|14.42|||
3983371|NCT01259726|3805618|B1|||Age||years|Mean|54.7|54.7|Standard Deviation|19.19|19.19|||
3983372|NCT01259713|3805651|B3|Argentina||Region of Enrollment||participants|Number|8|8.0||||||
3983373|NCT01259713|3805652|B2|Argentina||Region of Enrollment||participants|Number|1|1.0||||||
3983374|NCT01259713|3805653|B1|Argentina||Region of Enrollment||participants|Number|7|7.0||||||
3983375|NCT01259713|3805651|B3|Brazil||Region of Enrollment||participants|Number|15|15.0||||||
3983376|NCT01259713|3805652|B2|Brazil||Region of Enrollment||participants|Number|7|7.0||||||
3983377|NCT01259713|3805653|B1|Brazil||Region of Enrollment||participants|Number|8|8.0||||||
3983378|NCT01259713|3805651|B3|Switzerland||Region of Enrollment||participants|Number|7|7.0||||||
3983379|NCT01259713|3805652|B2|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
3983380|NCT01259713|3805653|B1|Switzerland||Region of Enrollment||participants|Number|6|6.0||||||
3983381|NCT01259713|3805651|B3|Israel||Region of Enrollment||participants|Number|9|9.0||||||
3983382|NCT01259713|3805652|B2|Israel||Region of Enrollment||participants|Number|0|0.0||||||
3983383|NCT01259713|3805653|B1|Israel||Region of Enrollment||participants|Number|9|9.0||||||
3983384|NCT01259713|3805651|B3|Austria||Region of Enrollment||participants|Number|9|9.0||||||
3983385|NCT01259713|3805652|B2|Austria||Region of Enrollment||participants|Number|3|3.0||||||
3983386|NCT01259713|3805653|B1|Austria||Region of Enrollment||participants|Number|6|6.0||||||
3983387|NCT01259713|3805651|B3|Turkey||Region of Enrollment||participants|Number|11|11.0||||||
3983388|NCT01259713|3805652|B2|Turkey||Region of Enrollment||participants|Number|4|4.0||||||
3983389|NCT01259713|3805653|B1|Turkey||Region of Enrollment||participants|Number|7|7.0||||||
3983390|NCT01259713|3805651|B3|Portugal||Region of Enrollment||participants|Number|17|17.0||||||
3983391|NCT01259713|3805652|B2|Portugal||Region of Enrollment||participants|Number|4|4.0||||||
3983392|NCT01259713|3805653|B1|Portugal||Region of Enrollment||participants|Number|13|13.0||||||
3983393|NCT01259713|3805651|B3|Greece||Region of Enrollment||participants|Number|27|27.0||||||
3983394|NCT01259713|3805652|B2|Greece||Region of Enrollment||participants|Number|13|13.0||||||
3983395|NCT01259713|3805653|B1|Greece||Region of Enrollment||participants|Number|14|14.0||||||
3983396|NCT01259713|3805651|B3|Spain||Region of Enrollment||participants|Number|28|28.0||||||
3983397|NCT01259713|3805652|B2|Spain||Region of Enrollment||participants|Number|7|7.0||||||
3983398|NCT01259713|3805653|B1|Spain||Region of Enrollment||participants|Number|21|21.0||||||
3983399|NCT01259713|3805651|B3|Belgium||Region of Enrollment||participants|Number|31|31.0||||||
3983400|NCT01259713|3805652|B2|Belgium||Region of Enrollment||participants|Number|11|11.0||||||
3983401|NCT01259713|3805653|B1|Belgium||Region of Enrollment||participants|Number|20|20.0||||||
3983402|NCT01259713|3805651|B3|France||Region of Enrollment||participants|Number|52|52.0||||||
3983403|NCT01259713|3805652|B2|France||Region of Enrollment||participants|Number|19|19.0||||||
3983404|NCT01259713|3805653|B1|France||Region of Enrollment||participants|Number|33|33.0||||||
3983405|NCT01259713|3805651|B3|Italy||Region of Enrollment||participants|Number|66|66.0||||||
3983406|NCT01259713|3805652|B2|Italy||Region of Enrollment||participants|Number|25|25.0||||||
3983407|NCT01259713|3805653|B1|Italy||Region of Enrollment||participants|Number|41|41.0||||||
3983408|NCT01259713|3805651|B3|Germany||Region of Enrollment||participants|Number|75|75.0||||||
3983409|NCT01259713|3805652|B2|Germany||Region of Enrollment||participants|Number|23|23.0||||||
3983410|NCT01259713|3805653|B1|Germany||Region of Enrollment||participants|Number|52|52.0||||||
3983411|NCT01259713|3805651|B3|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3983412|NCT01259713|3805652|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3983413|NCT01259713|3805653|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3983414|NCT01259713|3805651|B3|Not Permitted||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3983415|NCT01259713|3805652|B2|Not Permitted||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3983416|NCT01259713|3805653|B1|Not Permitted||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3983417|NCT01259713|3805651|B3|White||Race/Ethnicity, Customized||participants|Number|311|311.0||||||
3983418|NCT01259713|3805652|B2|White||Race/Ethnicity, Customized||participants|Number|100|100.0||||||
3983419|NCT01259713|3805653|B1|White||Race/Ethnicity, Customized||participants|Number|211|211.0||||||
3983420|NCT01259713|3805651|B3|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3983421|NCT01259713|3805652|B2|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3983422|NCT01259713|3805653|B1|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3983423|NCT01259713|3805651|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3983424|NCT01259713|3805652|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3983425|NCT01259713|3805653|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3983426|NCT01259713|3805651|B3||Male|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
3983427|NCT01259713|3805652|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3983428|NCT01259713|3805653|B1||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3983429|NCT01259713|3805651|B3||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3983430|NCT01259713|3805652|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3983431|NCT01259713|3805653|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3983432|NCT01259713|3805651|B3|> 60 years||Age, Customized||participants|Number|69|69.0||||||
3983433|NCT01259713|3805652|B2|> 60 years||Age, Customized||participants|Number|29|29.0||||||
3983434|NCT01259713|3805653|B1|> 60 years||Age, Customized||participants|Number|40|40.0||||||
3983435|NCT01259713|3805651|B3|> 25 to ≤ 60 years||Age, Customized||participants|Number|224|224.0||||||
3983436|NCT01259713|3805652|B2|> 25 to ≤ 60 years||Age, Customized||participants|Number|64|64.0||||||
3983437|NCT01259713|3805653|B1|> 25 to ≤ 60 years||Age, Customized||participants|Number|160|160.0||||||
3983438|NCT01259713|3805651|B3|≤ 25 years||Age, Customized||participants|Number|62|62.0||||||
3983439|NCT01259713|3805652|B2|≤ 25 years||Age, Customized||participants|Number|25|25.0||||||
3983440|NCT01259713|3805653|B1|≤ 25 years||Age, Customized||participants|Number|37|37.0||||||
3983441|NCT01259713|3805651|B3|||Age||years|Mean|44.6|44.6|Standard Deviation|15.96|15.96|||
3983442|NCT01259713|3805652|B2|||Age||years|Mean|44.8|44.8|Standard Deviation|17.52|17.52|||
3983443|NCT01259713|3805653|B1|||Age||years|Mean|44.5|44.5|Standard Deviation|15.16|15.16|||
3983444|NCT01259596|3805676|B3|United States||Region of Enrollment||participants|Number|141|141.0||||||
3983445|NCT01259596|3805677|B2|United States||Region of Enrollment||participants|Number|71|71.0||||||
3983446|NCT01259596|3805678|B1|United States||Region of Enrollment||participants|Number|70|70.0||||||
3983447|NCT01259596|3805676|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983448|NCT01259596|3805677|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983449|NCT01259596|3805678|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983450|NCT01259596|3805676|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3983451|NCT01259596|3805677|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3983452|NCT01259596|3805678|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3983453|NCT01259596|3805676|B3||White|Race (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
3983454|NCT01259596|3805677|B2||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3983455|NCT01259596|3805678|B1||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3983456|NCT01259596|3805676|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3983457|NCT01259596|3805677|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3983458|NCT01259596|3805678|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3983459|NCT01259596|3805676|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983460|NCT01259596|3805677|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983461|NCT01259596|3805678|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983462|NCT01259596|3805676|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983463|NCT01259596|3805677|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983464|NCT01259596|3805678|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983465|NCT01259596|3805676|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983466|NCT01259596|3805677|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983467|NCT01259596|3805678|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983468|NCT01259596|3805676|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983469|NCT01259596|3805677|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983470|NCT01259596|3805678|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983471|NCT01259596|3805676|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|141|141.0||||||
3983472|NCT01259596|3805677|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
3983473|NCT01259596|3805678|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3983474|NCT01259596|3805676|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983475|NCT01259596|3805677|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983476|NCT01259596|3805678|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983477|NCT01259596|3805676|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3983478|NCT01259596|3805677|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3983479|NCT01259596|3805678|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3983480|NCT01259596|3805676|B3||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3983481|NCT01259596|3805677|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3983482|NCT01259596|3805678|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3983483|NCT01259596|3805676|B3||>=65 years|Age||Participants|Count of Participants|66|66.0||||||
3983484|NCT01259596|3805677|B2||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
3983485|NCT01259596|3805678|B1||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
3983486|NCT01259596|3805676|B3||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
3983487|NCT01259596|3805677|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3983488|NCT01259596|3805678|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3983489|NCT01259596|3805676|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3983490|NCT01259596|3805677|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3983491|NCT01259596|3805678|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3983492|NCT01259492|3805697|B5|Male||Gender|Period 3|Participants|Number|273|273.0||||||
3983493|NCT01259492|3805698|B4|Male||Gender|Period 3|Participants|Number|71|71.0||||||
3983494|NCT01259492|3805699|B3|Male||Gender|Period 3|Participants|Number|74|74.0||||||
3983495|NCT01259492|3805700|B2|Male||Gender|Period 3|Participants|Number|74|74.0||||||
3983496|NCT01259492|3805701|B1|Male||Gender|Period 3|Participants|Number|54|54.0||||||
3983497|NCT01259492|3805697|B5|Female||Gender|Period 3|Participants|Number|216|216.0||||||
3983498|NCT01259492|3805698|B4|Female||Gender|Period 3|Participants|Number|52|52.0||||||
3983499|NCT01259492|3805699|B3|Female||Gender|Period 3|Participants|Number|46|46.0||||||
3983500|NCT01259492|3805700|B2|Female||Gender|Period 3|Participants|Number|58|58.0||||||
3983501|NCT01259492|3805701|B1|Female||Gender|Period 3|Participants|Number|60|60.0||||||
3983502|NCT01259492|3805697|B5||Male|Sex: Female, Male|Period 1|Participants|Count of Participants|395|395.0||||||
3983503|NCT01259492|3805698|B4||Male|Sex: Female, Male|Period 1|Participants|Count of Participants|101|101.0||||||
3983504|NCT01259492|3805699|B3||Male|Sex: Female, Male|Period 1|Participants|Count of Participants|95|95.0||||||
3983505|NCT01259492|3805700|B2||Male|Sex: Female, Male|Period 1|Participants|Count of Participants|105|105.0||||||
3983506|NCT01259492|3805701|B1||Male|Sex: Female, Male|Period 1|Participants|Count of Participants|94|94.0||||||
3983507|NCT01259492|3805697|B5||Female|Sex: Female, Male|Period 1|Participants|Count of Participants|330|330.0||||||
3983508|NCT01259492|3805698|B4||Female|Sex: Female, Male|Period 1|Participants|Count of Participants|80|80.0||||||
3983509|NCT01259492|3805699|B3||Female|Sex: Female, Male|Period 1|Participants|Count of Participants|86|86.0||||||
3983510|NCT01259492|3805700|B2||Female|Sex: Female, Male|Period 1|Participants|Count of Participants|77|77.0||||||
3983511|NCT01259492|3805701|B1||Female|Sex: Female, Male|Period 1|Participants|Count of Participants|87|87.0||||||
3983512|NCT01259492|3805697|B5|51-60||Age, Customized|Period 3|Participants|Number|50|50.0||||||
3983513|NCT01259492|3805698|B4|51-60||Age, Customized|Period 3|Participants|Number|13|13.0||||||
3983514|NCT01259492|3805699|B3|51-60||Age, Customized|Period 3|Participants|Number|14|14.0||||||
3983515|NCT01259492|3805700|B2|51-60||Age, Customized|Period 3|Participants|Number|13|13.0||||||
3983516|NCT01259492|3805701|B1|51-60||Age, Customized|Period 3|Participants|Number|10|10.0||||||
3983517|NCT01259492|3805697|B5|41-50||Age, Customized|Period 3|Participants|Number|149|149.0||||||
3983518|NCT01259492|3805698|B4|41-50||Age, Customized|Period 3|Participants|Number|31|31.0||||||
3983519|NCT01259492|3805699|B3|41-50||Age, Customized|Period 3|Participants|Number|45|45.0||||||
3983520|NCT01259492|3805700|B2|41-50||Age, Customized|Period 3|Participants|Number|41|41.0||||||
3983521|NCT01259492|3805701|B1|41-50||Age, Customized|Period 3|Participants|Number|32|32.0||||||
3983522|NCT01259492|3805697|B5|31-40||Age, Customized|Period 3|Participants|Number|105|105.0||||||
3983523|NCT01259492|3805698|B4|31-40||Age, Customized|Period 3|Participants|Number|27|27.0||||||
3983524|NCT01259492|3805699|B3|31-40||Age, Customized|Period 3|Participants|Number|27|27.0||||||
3983525|NCT01259492|3805700|B2|31-40||Age, Customized|Period 3|Participants|Number|32|32.0||||||
3983526|NCT01259492|3805701|B1|31-40||Age, Customized|Period 3|Participants|Number|19|19.0||||||
3983527|NCT01259492|3805697|B5|18-30||Age, Customized|Period 3|Participants|Number|185|185.0||||||
3983528|NCT01259492|3805698|B4|18-30||Age, Customized|Period 3|Participants|Number|52|52.0||||||
3983529|NCT01259492|3805699|B3|18-30||Age, Customized|Period 3|Participants|Number|34|34.0||||||
3983530|NCT01259492|3805700|B2|18-30||Age, Customized|Period 3|Participants|Number|46|46.0||||||
3983531|NCT01259492|3805701|B1|18-30||Age, Customized|Period 3|Participants|Number|53|53.0||||||
3983532|NCT01259492|3805697|B5|51-60||Age, Customized|Period 1|Participants|Number|71|71.0||||||
3983533|NCT01259492|3805698|B4|51-60||Age, Customized|Period 1|Participants|Number|30|30.0||||||
3983534|NCT01259492|3805699|B3|51-60||Age, Customized|Period 1|Participants|Number|13|13.0||||||
3983535|NCT01259492|3805700|B2|51-60||Age, Customized|Period 1|Participants|Number|14|14.0||||||
3983536|NCT01259492|3805701|B1|51-60||Age, Customized|Period 1|Participants|Number|14|14.0||||||
3983537|NCT01259492|3805697|B5|41-50||Age, Customized|Period 1|Participants|Number|205|205.0||||||
3983538|NCT01259492|3805698|B4|41-50||Age, Customized|Period 1|Participants|Number|47|47.0||||||
3983539|NCT01259492|3805699|B3|41-50||Age, Customized|Period 1|Participants|Number|57|57.0||||||
3983540|NCT01259492|3805700|B2|41-50||Age, Customized|Period 1|Participants|Number|45|45.0||||||
3983541|NCT01259492|3805701|B1|41-50||Age, Customized|Period 1|Participants|Number|56|56.0||||||
3983542|NCT01259492|3805697|B5|31-40||Age, Customized|Period 1|Participants|Number|162|162.0||||||
3983543|NCT01259492|3805698|B4|31-40||Age, Customized|Period 1|Participants|Number|38|38.0||||||
3983544|NCT01259492|3805699|B3|31-40||Age, Customized|Period 1|Participants|Number|40|40.0||||||
3983545|NCT01259492|3805700|B2|31-40||Age, Customized|Period 1|Participants|Number|45|45.0||||||
3983546|NCT01259492|3805701|B1|31-40||Age, Customized|Period 1|Participants|Number|39|39.0||||||
3983547|NCT01259492|3805697|B5|18-30||Age, Customized|Period 1|Participants|Number|287|287.0||||||
3983548|NCT01259492|3805698|B4|18-30||Age, Customized|Period 1|Participants|Number|66|66.0||||||
3983549|NCT01259492|3805699|B3|18-30||Age, Customized|Period 1|Participants|Number|71|71.0||||||
3983550|NCT01259492|3805700|B2|18-30||Age, Customized|Period 1|Participants|Number|78|78.0||||||
3983551|NCT01259492|3805701|B1|18-30||Age, Customized|Period 1|Participants|Number|72|72.0||||||
3983552|NCT01259466|3805751|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
3983553|NCT01259466|3805752|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
3983554|NCT01259466|3805753|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3983555|NCT01259466|3805751|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3983556|NCT01259466|3805752|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3983557|NCT01259466|3805753|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3983558|NCT01259466|3805751|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3983559|NCT01259466|3805752|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3983560|NCT01259466|3805753|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3983561|NCT01259466|3805751|B3|||Age||years|Mean|45.9|45.9|Standard Deviation|10.5|10.5|||
3983562|NCT01259466|3805752|B2|||Age||years|Mean|45.4|45.4|Standard Deviation|9.6|9.6|||
3983563|NCT01259466|3805753|B1|||Age||years|Mean|46.4|46.4|Standard Deviation|11.6|11.6|||
3983564|NCT01259466|3805751|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3983565|NCT01259466|3805752|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3983566|NCT01259466|3805753|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3983567|NCT01259466|3805751|B3||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
3983568|NCT01259466|3805752|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3983569|NCT01259466|3805753|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3983570|NCT01259466|3805751|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3983571|NCT01259466|3805752|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3983572|NCT01259466|3805753|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3983573|NCT01259440|3805762|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
3983574|NCT01259440|3805763|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3983575|NCT01259440|3805764|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3983576|NCT01259440|3805762|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3983577|NCT01259440|3805763|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3983578|NCT01259440|3805764|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3983579|NCT01259440|3805762|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3983580|NCT01259440|3805763|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3983581|NCT01259440|3805764|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3983582|NCT01259440|3805762|B3|||Age||years|Mean|52.4|52.4|Standard Deviation|9.9|9.9|||
3983583|NCT01259440|3805763|B2|||Age||years|Mean|49.3|49.3|Standard Deviation|11.3|11.3|||
3983584|NCT01259440|3805764|B1|||Age||years|Mean|54.9|54.9|Standard Deviation|8.3|8.3|||
3983585|NCT01259427|3805771|B3||Male|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
3983586|NCT01259427|3805772|B2||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3983587|NCT01259427|3805773|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3983588|NCT01259427|3805771|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3983589|NCT01259427|3805772|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3983590|NCT01259427|3805773|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3983591|NCT01259427|3805771|B3|||Age||years|Mean|53.4|53.4|Standard Deviation|9.2|9.2|||
3983592|NCT01259427|3805772|B2|||Age||years|Mean|53.3|53.3|Standard Deviation|9.5|9.5|||
3983593|NCT01259427|3805773|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|8.8|8.8|||
3983594|NCT01259401|3805790|B3|Non-white||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3983595|NCT01259401|3805791|B2|Non-white||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3983596|NCT01259401|3805792|B1|Non-white||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3983597|NCT01259401|3805790|B3|White||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3983598|NCT01259401|3805791|B2|White||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3983599|NCT01259401|3805792|B1|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3983600|NCT01259401|3805790|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3983601|NCT01259401|3805791|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3983602|NCT01259401|3805792|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3983603|NCT01259401|3805790|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3983604|NCT01259401|3805791|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3983605|NCT01259401|3805792|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3983606|NCT01259401|3805790|B3|||Age||years|Mean|77.1|77.1|Standard Deviation|9.9|9.9|||
3983607|NCT01259401|3805791|B2|||Age||years|Mean|76.4|76.4|Standard Deviation|9.9|9.9|||
3983608|NCT01259401|3805792|B1|||Age||years|Mean|77.7|77.7|Standard Deviation|10.2|10.2|||
3983609|NCT01259375|3805801|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3983610|NCT01259375|3805801|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3983611|NCT01259375|3805801|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3983612|NCT01259375|3805801|B1|||Age||years|Mean|52|52.0|Full Range|||25.0|73.0|
3983613|NCT01259297|3805810|B9||Male|Sex: Female, Male||Participants|Count of Participants|946|946.0||||||
3983614|NCT01259297|3805811|B8||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3983615|NCT01259297|3805812|B7||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3983616|NCT01259297|3805813|B6||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3983617|NCT01259297|3805814|B5||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3983618|NCT01259297|3805815|B4||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3983619|NCT01259297|3805816|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3983620|NCT01259297|3805817|B2||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3983621|NCT01259297|3805818|B1||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3983622|NCT01259297|3805810|B9||Female|Sex: Female, Male||Participants|Count of Participants|813|813.0||||||
3983623|NCT01259297|3805811|B8||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3983624|NCT01259297|3805812|B7||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3983625|NCT01259297|3805813|B6||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3983626|NCT01259297|3805814|B5||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3983627|NCT01259297|3805815|B4||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3983628|NCT01259297|3805816|B3||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3983629|NCT01259297|3805817|B2||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
3983630|NCT01259297|3805818|B1||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3983631|NCT01259297|3805810|B9|>=75 years||Age, Customized||participants|Number|530|530.0||||||
3983632|NCT01259297|3805811|B8|>=75 years||Age, Customized||participants|Number|65|65.0||||||
3983633|NCT01259297|3805812|B7|>=75 years||Age, Customized||participants|Number|61|61.0||||||
3983634|NCT01259297|3805813|B6|>=75 years||Age, Customized||participants|Number|64|64.0||||||
3983635|NCT01259297|3805814|B5|>=75 years||Age, Customized||participants|Number|71|71.0||||||
3983636|NCT01259297|3805815|B4|>=75 years||Age, Customized||participants|Number|70|70.0||||||
3983637|NCT01259297|3805816|B3|>=75 years||Age, Customized||participants|Number|62|62.0||||||
3983638|NCT01259297|3805817|B2|>=75 years||Age, Customized||participants|Number|58|58.0||||||
3983639|NCT01259297|3805818|B1|>=75 years||Age, Customized||participants|Number|79|79.0||||||
3983640|NCT01259297|3805810|B9|>=65 to <75 years||Age, Customized||participants|Number|1229|1229.0||||||
3983641|NCT01259297|3805811|B8|>=65 to <75 years||Age, Customized||participants|Number|134|134.0||||||
3983642|NCT01259297|3805812|B7|>=65 to <75 years||Age, Customized||participants|Number|135|135.0||||||
3983643|NCT01259297|3805813|B6|>=65 to <75 years||Age, Customized||participants|Number|189|189.0||||||
3983644|NCT01259297|3805814|B5|>=65 to <75 years||Age, Customized||participants|Number|180|180.0||||||
3983645|NCT01259297|3805815|B4|>=65 to <75 years||Age, Customized||participants|Number|125|125.0||||||
3983646|NCT01259297|3805816|B3|>=65 to <75 years||Age, Customized||participants|Number|127|127.0||||||
3983647|NCT01259297|3805817|B2|>=65 to <75 years||Age, Customized||participants|Number|174|174.0||||||
3983648|NCT01259297|3805818|B1|>=65 to <75 years||Age, Customized||participants|Number|165|165.0||||||
3983649|NCT01259284|3805853|B4|United States||Region of Enrollment||participants|Number|2|2.0||||||
3983650|NCT01259284|3805856|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3983651|NCT01259284|3805853|B4|Male||Gender||participants|Number|0|0.0||||||
3983652|NCT01259284|3805856|B1|Male||Gender||participants|Number|0|0.0||||||
3983653|NCT01259284|3805853|B4|Female||Gender||participants|Number|2|2.0||||||
3983654|NCT01259284|3805856|B1|Female||Gender||participants|Number|2|2.0||||||
3983655|NCT01259284|3805853|B4|||Age||years|Mean|69|69.0|Full Range|||68.0|70.0|
3983656|NCT01259284|3805856|B1|||Age||years|Mean|69|69.0|Full Range|||68.0|70.0|
3983657|NCT01259245|3805866|B3|||FEV1% Pred|Pred FEV1 percent predicted normal values ; component of lung function parameters measured by spirometry|percentage of predicted normal values|Mean|59.82|59.82|Standard Deviation|23.15|23.15|||
3983658|NCT01259245|3805867|B2|||FEV1% Pred|Pred FEV1 percent predicted normal values ; component of lung function parameters measured by spirometry|percentage of predicted normal values|Mean|56.38|56.38|Standard Deviation|23.81|23.81|||
3983659|NCT01259245|3805868|B1|||FEV1% Pred|Pred FEV1 percent predicted normal values ; component of lung function parameters measured by spirometry|percentage of predicted normal values|Mean|63.1|63.1|Standard Deviation|22.11|22.11|||
3983660|NCT01259245|3805866|B3|||FEV1|Forced expiratory volume in one second ; component of lung function parameters measured by spirometry|liters|Mean|1.16|1.16|Standard Deviation|0.46|0.46|||
3983661|NCT01259245|3805867|B2|||FEV1|Forced expiratory volume in one second ; component of lung function parameters measured by spirometry|liters|Mean|1.10|1.1|Standard Deviation|0.45|0.45|||
3983662|NCT01259245|3805868|B1|||FEV1|Forced expiratory volume in one second ; component of lung function parameters measured by spirometry|liters|Mean|1.23|1.23|Standard Deviation|0.45|0.45|||
3983663|NCT01259245|3805866|B3|||FVC|Forced vital capacity is a component of lung function parameters measured using spirometry|liters|Mean|2.15|2.15|Standard Deviation|0.74|0.74|||
3983664|NCT01259245|3805867|B2|||FVC|Forced vital capacity is a component of lung function parameters measured using spirometry|liters|Mean|2.05|2.05|Standard Deviation|0.66|0.66|||
3983665|NCT01259245|3805868|B1|||FVC|Forced vital capacity is a component of lung function parameters measured using spirometry|liters|Mean|2.26|2.26|Standard Deviation|0.80|0.8|||
3983666|NCT01259245|3805866|B3|||6 MWT|The 6 minute walking distance test measured the self paced distance that a patient could quickly walk on a flat, hard surface in a period of 6 minutes.|Distance in meters|Mean|316.22|316.22|Standard Deviation|68.14|68.14|||
3983667|NCT01259245|3805867|B2|||6 MWT|The 6 minute walking distance test measured the self paced distance that a patient could quickly walk on a flat, hard surface in a period of 6 minutes.|Distance in meters|Mean|312.1|312.1|Standard Deviation|64.15|64.15|||
3983668|NCT01259245|3805868|B1|||6 MWT|The 6 minute walking distance test measured the self paced distance that a patient could quickly walk on a flat, hard surface in a period of 6 minutes.|Distance in meters|Mean|320.2|320.2|Standard Deviation|71.86|71.86|||
3983669|NCT01259245|3805866|B3|||SGRQ-HKC Total|SGRQ HKC-total is the total score calculated from all three components (Symptom, activity and impact)by summing all positive responses in the questionnaire and expressing the result as a percentage of the total weight for the questionnaire. SGRQ total score also range from 0 to 100, where zero indicates best health and 100 indicating maximum disability.|score from 0 to 100|Mean|32.61|32.61|Standard Deviation|17.87|17.87|||
3983670|NCT01259245|3805867|B2|||SGRQ-HKC Total|SGRQ HKC-total is the total score calculated from all three components (Symptom, activity and impact)by summing all positive responses in the questionnaire and expressing the result as a percentage of the total weight for the questionnaire. SGRQ total score also range from 0 to 100, where zero indicates best health and 100 indicating maximum disability.|score from 0 to 100|Mean|34.89|34.89|Standard Deviation|18.39|18.39|||
3983671|NCT01259245|3805868|B1|||SGRQ-HKC Total|SGRQ HKC-total is the total score calculated from all three components (Symptom, activity and impact)by summing all positive responses in the questionnaire and expressing the result as a percentage of the total weight for the questionnaire. SGRQ total score also range from 0 to 100, where zero indicates best health and 100 indicating maximum disability.|score from 0 to 100|Mean|30.44|30.44|Standard Deviation|17.16|17.16|||
3983672|NCT01259245|3805866|B3|||SGRQ HKC-Impact|The Saint George Respiratory Questionnaire (SGRQHKC) is a Hong Kong Chinese validated version of a disease specific measure of health status applicable for use in COPD patients. It consists of 50 items with 76 weighted responses and has three component scores: symptoms, activity and impact. SGRQ HKC-Impact score is calculated by dividing the summed weights by adjusted maximum possible weight for that component and expressing the result as a percentage. Score ranged from 0 to 100, where zero indicates best health and 100 indicating maximum disability.|score from 0 to 100|Mean|25.74|25.74|Standard Deviation|18.74|18.74|||
3983673|NCT01259245|3805867|B2|||SGRQ HKC-Impact|The Saint George Respiratory Questionnaire (SGRQHKC) is a Hong Kong Chinese validated version of a disease specific measure of health status applicable for use in COPD patients. It consists of 50 items with 76 weighted responses and has three component scores: symptoms, activity and impact. SGRQ HKC-Impact score is calculated by dividing the summed weights by adjusted maximum possible weight for that component and expressing the result as a percentage. Score ranged from 0 to 100, where zero indicates best health and 100 indicating maximum disability.|score from 0 to 100|Mean|27.43|27.43|Standard Deviation|20.02|20.02|||
3983674|NCT01259245|3805868|B1|||SGRQ HKC-Impact|The Saint George Respiratory Questionnaire (SGRQHKC) is a Hong Kong Chinese validated version of a disease specific measure of health status applicable for use in COPD patients. It consists of 50 items with 76 weighted responses and has three component scores: symptoms, activity and impact. SGRQ HKC-Impact score is calculated by dividing the summed weights by adjusted maximum possible weight for that component and expressing the result as a percentage. Score ranged from 0 to 100, where zero indicates best health and 100 indicating maximum disability.|score from 0 to 100|Mean|24.11|24.11|Standard Deviation|17.37|17.37|||
3983675|NCT01259245|3805866|B3|||SGRQ HK-Activity|The Saint George Respiratory Questionnaire (SGRQ HKC) is a Hong Kong Chinese validated version of a disease specific measure of health status applicable for use in COPD patients.It consists of 50 items with 76 weighted responses and has three component scores: symptoms, activity and impact. SGRQ HKC-Activity score is calculated by dividing the summed weights by adjusted maximum possible weight for that component and expressing the result as a percentage. Score ranged from 0 to 100, where zero indicates best health and 100 indicating maximum disability.|score from 0 to 100|Mean|46.84|46.84|Standard Deviation|23.36|23.36|||
3983676|NCT01259245|3805867|B2|||SGRQ HK-Activity|The Saint George Respiratory Questionnaire (SGRQ HKC) is a Hong Kong Chinese validated version of a disease specific measure of health status applicable for use in COPD patients.It consists of 50 items with 76 weighted responses and has three component scores: symptoms, activity and impact. SGRQ HKC-Activity score is calculated by dividing the summed weights by adjusted maximum possible weight for that component and expressing the result as a percentage. Score ranged from 0 to 100, where zero indicates best health and 100 indicating maximum disability.|score from 0 to 100|Mean|50.75|50.75|Standard Deviation|22.77|22.77|||
3983677|NCT01259245|3805868|B1|||SGRQ HK-Activity|The Saint George Respiratory Questionnaire (SGRQ HKC) is a Hong Kong Chinese validated version of a disease specific measure of health status applicable for use in COPD patients.It consists of 50 items with 76 weighted responses and has three component scores: symptoms, activity and impact. SGRQ HKC-Activity score is calculated by dividing the summed weights by adjusted maximum possible weight for that component and expressing the result as a percentage. Score ranged from 0 to 100, where zero indicates best health and 100 indicating maximum disability.|score from 0 to 100|Mean|43.08|43.08|Standard Deviation|23.42|23.42|||
3983678|NCT01259245|3805866|B3|||SGRQ HKC Symptom|The Saint George Respiratory Questionnaire (SGRQ HKC) is a Hong Kong Chinese validated version of a disease specific measure of health status applicable for use in COPD patients. It consists of 50 items with 76 weighted responses and has three component scores: symptoms, activity and impact. SGRQ HKC Symptom score is calculated by dividing the summed weights by adjusted maximum possible weight for that component and expressing the result as a percentage. SGRQ-Symptom score ranged from 0 to 100, where zero indicates best health and 100 indicating maximum disability.|score from 0 to 100|Mean|28.65|28.65|Standard Deviation|19.80|19.8|||
3983710|NCT01259102|3805926|B5|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3983711|NCT01259102|3805927|B4|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3983712|NCT01259102|3805928|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3983679|NCT01259245|3805867|B2|||SGRQ HKC Symptom|The Saint George Respiratory Questionnaire (SGRQ HKC) is a Hong Kong Chinese validated version of a disease specific measure of health status applicable for use in COPD patients. It consists of 50 items with 76 weighted responses and has three component scores: symptoms, activity and impact. SGRQ HKC Symptom score is calculated by dividing the summed weights by adjusted maximum possible weight for that component and expressing the result as a percentage. SGRQ-Symptom score ranged from 0 to 100, where zero indicates best health and 100 indicating maximum disability.|score from 0 to 100|Mean|29.77|29.77|Standard Deviation|19.94|19.94|||
3983680|NCT01259245|3805868|B1|||SGRQ HKC Symptom|The Saint George Respiratory Questionnaire (SGRQ HKC) is a Hong Kong Chinese validated version of a disease specific measure of health status applicable for use in COPD patients. It consists of 50 items with 76 weighted responses and has three component scores: symptoms, activity and impact. SGRQ HKC Symptom score is calculated by dividing the summed weights by adjusted maximum possible weight for that component and expressing the result as a percentage. SGRQ-Symptom score ranged from 0 to 100, where zero indicates best health and 100 indicating maximum disability.|score from 0 to 100|Mean|27.57|27.57|Standard Deviation|19.71|19.71|||
3983681|NCT01259245|3805866|B3|||SEMSOB|Self-efficacy for managing shortness of breath is a single question 1-10 scale, valid and reliable instrument that measures patients' overall confidence in keeping breathing difficulties from interfering with what they want to do with higher score indication greater self efficacy.|likert scale|Mean|6.70|6.7|Standard Deviation|2.171|2.171|||
3983682|NCT01259245|3805867|B2|||SEMSOB|Self-efficacy for managing shortness of breath is a single question 1-10 scale, valid and reliable instrument that measures patients' overall confidence in keeping breathing difficulties from interfering with what they want to do with higher score indication greater self efficacy.|likert scale|Mean|6.53|6.53|Standard Deviation|1.98|1.98|||
3983683|NCT01259245|3805868|B1|||SEMSOB|Self-efficacy for managing shortness of breath is a single question 1-10 scale, valid and reliable instrument that measures patients' overall confidence in keeping breathing difficulties from interfering with what they want to do with higher score indication greater self efficacy.|likert scale|Mean|6.86|6.86|Standard Deviation|2.34|2.34|||
3983684|NCT01259245|3805866|B3|||COPD-CSES|"COPD Self-efficacy scale is a 34-item questionnaire which measures a person's confidence in managing or avoiding breathing difficulties in a number of situations categorized under 5 factors or condition. It consists of Likert scale with 5 responses ranging from 1 -not at all confident to 5 - very confident with higher scores representing higher self efficacy. In this study, a rating score which takes account of items that may not be applicable to the patient by reporting the average score based on the number of items answered. Minimum score 0.2 to maximum score of 1(higher self-efficacy)"|rating score 0.2 to 1|Mean|0.661|0.661|Standard Deviation|0.160|0.16|||
3983685|NCT01259245|3805867|B2|||COPD-CSES|"COPD Self-efficacy scale is a 34-item questionnaire which measures a person's confidence in managing or avoiding breathing difficulties in a number of situations categorized under 5 factors or condition. It consists of Likert scale with 5 responses ranging from 1 -not at all confident to 5 - very confident with higher scores representing higher self efficacy. In this study, a rating score which takes account of items that may not be applicable to the patient by reporting the average score based on the number of items answered. Minimum score 0.2 to maximum score of 1(higher self-efficacy)"|rating score 0.2 to 1|Mean|0.638|0.638|Standard Deviation|0.152|0.152|||
3983686|NCT01259245|3805868|B1|||COPD-CSES|"COPD Self-efficacy scale is a 34-item questionnaire which measures a person's confidence in managing or avoiding breathing difficulties in a number of situations categorized under 5 factors or condition. It consists of Likert scale with 5 responses ranging from 1 -not at all confident to 5 - very confident with higher scores representing higher self efficacy. In this study, a rating score which takes account of items that may not be applicable to the patient by reporting the average score based on the number of items answered. Minimum score 0.2 to maximum score of 1(higher self-efficacy)"|rating score 0.2 to 1|Mean|0.684|0.684|Standard Deviation|0.165|0.165|||
3983687|NCT01259245|3805866|B3|Hong Kong||Region of Enrollment||participants|Number|192|192.0||||||
3983688|NCT01259245|3805867|B2|Hong Kong||Region of Enrollment||participants|Number|94|94.0||||||
3983689|NCT01259245|3805868|B1|Hong Kong||Region of Enrollment||participants|Number|98|98.0||||||
3983690|NCT01259245|3805866|B3||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
3983691|NCT01259245|3805867|B2||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3983692|NCT01259245|3805868|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3983693|NCT01259245|3805866|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3983694|NCT01259245|3805867|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3983695|NCT01259245|3805868|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3983696|NCT01259245|3805866|B3|||Age||years|Mean|74|74.0|Standard Deviation|6.624|6.624|||
3983697|NCT01259245|3805867|B2|||Age||years|Mean|74|74.0|Standard Deviation|6.41|6.41|||
3983698|NCT01259245|3805868|B1|||Age||years|Mean|74|74.0|Standard Deviation|6.81|6.81|||
3983699|NCT01259115|3805893|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983700|NCT01259115|3805893|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983701|NCT01259115|3805893|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3983702|NCT01259115|3805893|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3983703|NCT01259115|3805893|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983704|NCT01259115|3805893|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983705|NCT01259115|3805893|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983706|NCT01259115|3805893|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3983707|NCT01259115|3805893|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3983708|NCT01259115|3805893|B1|||Age||years|Mean|31.8|31.8|Standard Deviation|8.62|8.62|||
3983709|NCT01259102|3805925|B6|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3983713|NCT01259102|3805929|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3983714|NCT01259102|3805930|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3983715|NCT01259102|3805925|B6|White||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
3983716|NCT01259102|3805926|B5|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3983717|NCT01259102|3805927|B4|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3983718|NCT01259102|3805928|B3|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3983719|NCT01259102|3805929|B2|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3983720|NCT01259102|3805930|B1|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3983721|NCT01259102|3805925|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3983722|NCT01259102|3805926|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3983723|NCT01259102|3805927|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3983724|NCT01259102|3805928|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3983725|NCT01259102|3805929|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3983726|NCT01259102|3805930|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3983727|NCT01259102|3805925|B6|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3983728|NCT01259102|3805926|B5|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3983729|NCT01259102|3805927|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3983730|NCT01259102|3805928|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3983731|NCT01259102|3805929|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3983732|NCT01259102|3805930|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3983733|NCT01259102|3805925|B6|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3983734|NCT01259102|3805926|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3983735|NCT01259102|3805927|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3983736|NCT01259102|3805928|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3983737|NCT01259102|3805929|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3983738|NCT01259102|3805930|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3983739|NCT01259102|3805925|B6||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3983740|NCT01259102|3805926|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3983741|NCT01259102|3805927|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3983742|NCT01259102|3805928|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3983743|NCT01259102|3805929|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3983744|NCT01259102|3805930|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3983745|NCT01259102|3805925|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3983746|NCT01259102|3805926|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3983747|NCT01259102|3805927|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3983748|NCT01259102|3805928|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3983749|NCT01259102|3805929|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3983750|NCT01259102|3805930|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3983751|NCT01259102|3805925|B6|||Age||years|Mean|25.9|25.9|Standard Deviation|0.8|0.8|||
3983752|NCT01259102|3805926|B5|||Age||years|Mean|25.1|25.1|Standard Deviation|2.3|2.3|||
3983753|NCT01259102|3805927|B4|||Age||years|Mean|26.4|26.4|Standard Deviation|1.9|1.9|||
3983754|NCT01259102|3805928|B3|||Age||years|Mean|23.3|23.3|Standard Deviation|1.1|1.1|||
3983755|NCT01259102|3805929|B2|||Age||years|Mean|26.2|26.2|Standard Deviation|1.6|1.6|||
3983756|NCT01259102|3805930|B1|||Age||years|Mean|28.8|28.8|Standard Deviation|1.9|1.9|||
3983757|NCT01259089|3805991|B1|United States||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
3983758|NCT01259089|3805991|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983759|NCT01259089|3805991|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983760|NCT01259089|3805991|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3983761|NCT01259089|3805991|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3983762|NCT01259089|3805991|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3983763|NCT01259089|3805991|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3983764|NCT01259089|3805991|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983765|NCT01259089|3805991|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983766|NCT01259089|3805991|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3983767|NCT01259089|3805991|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3983768|NCT01259089|3805991|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3983769|NCT01259089|3805991|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3983770|NCT01259089|3805991|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3983771|NCT01259089|3805991|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3983772|NCT01259089|3805991|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3983832|NCT01258985|3806045|B1|United States||Region of Enrollment||participants|Number|106|106.0||||||
3983773|NCT01259063|3806010|B1|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3983774|NCT01259063|3806010|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983775|NCT01259063|3806010|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983776|NCT01259063|3806010|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3983777|NCT01259063|3806010|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3983778|NCT01259063|3806010|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983779|NCT01259063|3806010|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3983780|NCT01259063|3806010|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983781|NCT01259063|3806010|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983782|NCT01259063|3806010|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3983783|NCT01259063|3806010|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3983784|NCT01259063|3806010|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3983785|NCT01259063|3806010|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3983786|NCT01259063|3806010|B1|||Age||years|Median|66|66.0|Full Range|||49.0|81.0|
3983787|NCT01259024|3806019|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3983788|NCT01259024|3806019|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3983789|NCT01259024|3806019|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3983790|NCT01259024|3806019|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3983791|NCT01259024|3806019|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3983792|NCT01259024|3806019|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3983793|NCT01259011|3806026|B3|United States||Region of Enrollment||patients|Number|210|210.0||||||
3983794|NCT01259011|3806027|B2|United States||Region of Enrollment||patients|Number|109|109.0||||||
3983795|NCT01259011|3806028|B1|United States||Region of Enrollment||patients|Number|101|101.0||||||
3983796|NCT01259011|3806026|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983797|NCT01259011|3806027|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983798|NCT01259011|3806028|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983799|NCT01259011|3806026|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983800|NCT01259011|3806027|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983801|NCT01259011|3806028|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983802|NCT01259011|3806026|B3||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3983803|NCT01259011|3806027|B2||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3983804|NCT01259011|3806028|B1||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3983805|NCT01259011|3806026|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|141|141.0||||||
3983806|NCT01259011|3806027|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3983807|NCT01259011|3806028|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3983808|NCT01259011|3806026|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983809|NCT01259011|3806027|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983810|NCT01259011|3806028|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983811|NCT01259011|3806026|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983812|NCT01259011|3806027|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983813|NCT01259011|3806028|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983814|NCT01259011|3806026|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983815|NCT01259011|3806027|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983816|NCT01259011|3806028|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983817|NCT01259011|3806026|B3||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3983818|NCT01259011|3806027|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3983819|NCT01259011|3806028|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3983820|NCT01259011|3806026|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3983821|NCT01259011|3806027|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3983822|NCT01259011|3806028|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3983823|NCT01259011|3806026|B3|||Age||years|Mean|62.1|62.1|Standard Deviation|11.3|11.3|||
3983824|NCT01259011|3806027|B2|||Age||years|Mean|61.1|61.1|Standard Deviation|11.4|11.4|||
3983825|NCT01259011|3806028|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|11.1|11.1|||
3983826|NCT01258998|3806039|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
3983827|NCT01258998|3806039|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3983828|NCT01258998|3806039|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3983829|NCT01258998|3806039|B1|||Age||years|Median|58|58.0|Full Range|||21.0|82.0|
3983830|NCT01258985|3806043|B3|United States||Region of Enrollment||participants|Number|204|204.0||||||
3983831|NCT01258985|3806044|B2|United States||Region of Enrollment||participants|Number|98|98.0||||||
3983833|NCT01258985|3806043|B3|Other||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3983834|NCT01258985|3806044|B2|Other||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3983835|NCT01258985|3806045|B1|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3983836|NCT01258985|3806043|B3|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3983837|NCT01258985|3806044|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3983838|NCT01258985|3806045|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3983839|NCT01258985|3806043|B3|Black||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
3983840|NCT01258985|3806044|B2|Black||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3983841|NCT01258985|3806045|B1|Black||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
3983842|NCT01258985|3806043|B3|White||Race/Ethnicity, Customized||participants|Number|108|108.0||||||
3983843|NCT01258985|3806044|B2|White||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
3983844|NCT01258985|3806045|B1|White||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
3983845|NCT01258985|3806043|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3983846|NCT01258985|3806044|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3983847|NCT01258985|3806045|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3983848|NCT01258985|3806043|B3||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3983849|NCT01258985|3806044|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3983850|NCT01258985|3806045|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3983851|NCT01258985|3806043|B3|||Age||years|Mean|60.2|60.2|Standard Deviation|10.5|10.5|||
3983852|NCT01258985|3806044|B2|||Age||years|Mean|60.1|60.1|Standard Deviation|10.5|10.5|||
3983853|NCT01258985|3806045|B1|||Age||years|Mean|60.3|60.3|Standard Deviation|10.5|10.5|||
3983854|NCT01258803|3806072|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3983855|NCT01258803|3806072|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3983856|NCT01258803|3806072|B1|8-11 years||Age, Customized||participants|Number|75|75.0||||||
3983857|NCT01258803|3806072|B1|5-7 years||Age, Customized||participants|Number|17|17.0||||||
3983858|NCT01258790|3806103|B3|||Yale Global Tic Severity Scale|The tic severity score based on Yale Global Tic Severity Scale ranges from 0 - 50. A person who has no tics would have a score of 0. High score means a person has severe tics.|units on a scale (0 - 50)|Mean|27.2|27.2|Standard Deviation|6.0|6.0|||
3983859|NCT01258790|3806104|B2|||Yale Global Tic Severity Scale|The tic severity score based on Yale Global Tic Severity Scale ranges from 0 - 50. A person who has no tics would have a score of 0. High score means a person has severe tics.|units on a scale (0 - 50)|Mean|26.8|26.8|Standard Deviation|4.8|4.8|||
3983860|NCT01258790|3806105|B1|||Yale Global Tic Severity Scale|The tic severity score based on Yale Global Tic Severity Scale ranges from 0 - 50. A person who has no tics would have a score of 0. High score means a person has severe tics.|units on a scale (0 - 50)|Mean|27.5|27.5|Standard Deviation|7.4|7.4|||
3983861|NCT01258790|3806103|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3983862|NCT01258790|3806104|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3983863|NCT01258790|3806105|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3983864|NCT01258790|3806103|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3983865|NCT01258790|3806104|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3983866|NCT01258790|3806105|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3983867|NCT01258790|3806103|B3|||Age||years|Mean|14.5|14.5|Standard Deviation|3.9|3.9|||
3983868|NCT01258790|3806104|B2|||Age||years|Mean|15.5|15.5|Standard Deviation|4|4.0|||
3983869|NCT01258790|3806105|B1|||Age||years|Mean|13.5|13.5|Standard Deviation|3.9|3.9|||
3983870|NCT01258738|3806112|B3||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3983871|NCT01258738|3806113|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3983872|NCT01258738|3806114|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3983873|NCT01258738|3806112|B3||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3983874|NCT01258738|3806113|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3983875|NCT01258738|3806114|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3983876|NCT01258738|3806112|B3|||Age||Years|Mean|31.9|31.9|Standard Deviation|7.8|7.8|||
3983877|NCT01258738|3806113|B2|||Age||Years|Mean|32.0|32.0|Standard Deviation|7.8|7.8|||
3983878|NCT01258738|3806114|B1|||Age||Years|Mean|31.7|31.7|Standard Deviation|7.8|7.8|||
3983879|NCT01258660|3806251|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3983880|NCT01258660|3806252|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3983881|NCT01258660|3806253|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3983882|NCT01258660|3806251|B3||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
3983883|NCT01258660|3806252|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3983884|NCT01258660|3806253|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3983885|NCT01258660|3806251|B3|||Age||years|Mean|27.7|27.7|Standard Deviation|5.68|5.68|||
3983886|NCT01258660|3806252|B2|||Age||years|Mean|27.0|27.0|Standard Deviation|5.49|5.49|||
3983887|NCT01258660|3806253|B1|||Age||years|Mean|28.4|28.4|Standard Deviation|5.80|5.8|||
3983888|NCT01258608|3806271|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3983889|NCT01258608|3806272|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3983952|NCT01258582|3806338|B2|Spanish||Primary Language||participants|Number|141|141.0||||||
3983890|NCT01258608|3806273|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3983891|NCT01258608|3806271|B3||Asian–East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3983892|NCT01258608|3806272|B2||Asian–East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3983893|NCT01258608|3806273|B1||Asian–East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3983894|NCT01258608|3806271|B3||White/Caucasian – European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|96|96.0||||||
3983895|NCT01258608|3806272|B2||White/Caucasian – European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
3983896|NCT01258608|3806273|B1||White/Caucasian – European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
3983897|NCT01258608|3806271|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3983898|NCT01258608|3806272|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3983899|NCT01258608|3806273|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3983900|NCT01258608|3806271|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3983901|NCT01258608|3806272|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3983902|NCT01258608|3806273|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3983903|NCT01258608|3806271|B3|||Age||Years|Mean|60.4|60.4|Standard Deviation|12.62|12.62|||
3983904|NCT01258608|3806272|B2|||Age||Years|Mean|60.0|60.0|Standard Deviation|11.93|11.93|||
3983905|NCT01258608|3806273|B1|||Age||Years|Mean|60.8|60.8|Standard Deviation|13.36|13.36|||
3983906|NCT01258595|3806320|B3|United States||Region of Enrollment||Participants|Number|300|300.0||||||
3983907|NCT01258595|3806321|B2|United States||Region of Enrollment||Participants|Number|152|152.0||||||
3983908|NCT01258595|3806322|B1|United States||Region of Enrollment||Participants|Number|148|148.0||||||
3983909|NCT01258595|3806320|B3||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3983910|NCT01258595|3806321|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3983911|NCT01258595|3806322|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3983912|NCT01258595|3806320|B3||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
3983913|NCT01258595|3806321|B2||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3983914|NCT01258595|3806322|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3983915|NCT01258595|3806320|B3|||Age||Years|Mean|57.7|57.7|Standard Deviation|4.25|4.25|||
3983916|NCT01258595|3806321|B2|||Age||Years|Mean|57.7|57.7|Standard Deviation|4.14|4.14|||
3983917|NCT01258595|3806322|B1|||Age||Years|Mean|57.6|57.6|Standard Deviation|4.38|4.38|||
3983918|NCT01258595|3806320|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3983919|NCT01258595|3806321|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3983920|NCT01258595|3806322|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3983921|NCT01258595|3806320|B3||Between 18 and 65 years|Age||Participants|Count of Participants|300|300.0||||||
3983922|NCT01258595|3806321|B2||Between 18 and 65 years|Age||Participants|Count of Participants|152|152.0||||||
3983923|NCT01258595|3806322|B1||Between 18 and 65 years|Age||Participants|Count of Participants|148|148.0||||||
3983924|NCT01258595|3806320|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3983925|NCT01258595|3806321|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3983926|NCT01258595|3806322|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3983927|NCT01258582|3806337|B3|Missing||Education||participants|Number|37|37.0||||||
3983928|NCT01258582|3806338|B2|Missing||Education||participants|Number|16|16.0||||||
3983929|NCT01258582|3806339|B1|Missing||Education||participants|Number|21|21.0||||||
3983930|NCT01258582|3806337|B3|Some Post-College/Graduate Degree||Education||participants|Number|149|149.0||||||
3983931|NCT01258582|3806338|B2|Some Post-College/Graduate Degree||Education||participants|Number|82|82.0||||||
3983932|NCT01258582|3806339|B1|Some Post-College/Graduate Degree||Education||participants|Number|67|67.0||||||
3983933|NCT01258582|3806337|B3|College Degree||Education||participants|Number|317|317.0||||||
3983934|NCT01258582|3806338|B2|College Degree||Education||participants|Number|144|144.0||||||
3983935|NCT01258582|3806339|B1|College Degree||Education||participants|Number|173|173.0||||||
3983936|NCT01258582|3806337|B3|Some College||Education||participants|Number|420|420.0||||||
3983937|NCT01258582|3806338|B2|Some College||Education||participants|Number|222|222.0||||||
3983938|NCT01258582|3806339|B1|Some College||Education||participants|Number|198|198.0||||||
3983939|NCT01258582|3806337|B3|High School/General Education Diploma||Education||participants|Number|516|516.0||||||
3983940|NCT01258582|3806338|B2|High School/General Education Diploma||Education||participants|Number|261|261.0||||||
3983941|NCT01258582|3806339|B1|High School/General Education Diploma||Education||participants|Number|255|255.0||||||
3983942|NCT01258582|3806337|B3|Less than High School||Education||participants|Number|212|212.0||||||
3983943|NCT01258582|3806338|B2|Less than High School||Education||participants|Number|96|96.0||||||
3983944|NCT01258582|3806339|B1|Less than High School||Education||participants|Number|116|116.0||||||
3983945|NCT01258582|3806337|B3|Missing||Primary Language||participants|Number|12|12.0||||||
3983946|NCT01258582|3806338|B2|Missing||Primary Language||participants|Number|7|7.0||||||
3983947|NCT01258582|3806339|B1|Missing||Primary Language||participants|Number|5|5.0||||||
3983948|NCT01258582|3806337|B3|Other||Primary Language||participants|Number|63|63.0||||||
3983949|NCT01258582|3806338|B2|Other||Primary Language||participants|Number|29|29.0||||||
3983950|NCT01258582|3806339|B1|Other||Primary Language||participants|Number|34|34.0||||||
3983951|NCT01258582|3806337|B3|Spanish||Primary Language||participants|Number|289|289.0||||||
3983953|NCT01258582|3806339|B1|Spanish||Primary Language||participants|Number|148|148.0||||||
3983954|NCT01258582|3806337|B3|English||Primary Language||participants|Number|1287|1287.0||||||
3983955|NCT01258582|3806338|B2|English||Primary Language||participants|Number|644|644.0||||||
3983956|NCT01258582|3806339|B1|English||Primary Language||participants|Number|643|643.0||||||
3983957|NCT01258582|3806337|B3|Missing||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3983958|NCT01258582|3806338|B2|Missing||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3983959|NCT01258582|3806339|B1|Missing||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3983960|NCT01258582|3806337|B3|Multi-racial/Other||Race/Ethnicity, Customized||participants|Number|177|177.0||||||
3983961|NCT01258582|3806338|B2|Multi-racial/Other||Race/Ethnicity, Customized||participants|Number|92|92.0||||||
3983962|NCT01258582|3806339|B1|Multi-racial/Other||Race/Ethnicity, Customized||participants|Number|85|85.0||||||
3983963|NCT01258582|3806337|B3|Native American/Alaskan Native||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3983964|NCT01258582|3806338|B2|Native American/Alaskan Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3983965|NCT01258582|3806339|B1|Native American/Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3983966|NCT01258582|3806337|B3|Asian/Asain-American||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
3983967|NCT01258582|3806338|B2|Asian/Asain-American||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3983968|NCT01258582|3806339|B1|Asian/Asain-American||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3983969|NCT01258582|3806337|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|626|626.0||||||
3983970|NCT01258582|3806338|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|297|297.0||||||
3983971|NCT01258582|3806339|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|329|329.0||||||
3983972|NCT01258582|3806337|B3|Non-Hispanic Black||Race/Ethnicity, Customized||participants|Number|388|388.0||||||
3983973|NCT01258582|3806338|B2|Non-Hispanic Black||Race/Ethnicity, Customized||participants|Number|200|200.0||||||
3983974|NCT01258582|3806339|B1|Non-Hispanic Black||Race/Ethnicity, Customized||participants|Number|188|188.0||||||
3983975|NCT01258582|3806337|B3|Non-Hispanic White||Race/Ethnicity, Customized||participants|Number|399|399.0||||||
3983976|NCT01258582|3806338|B2|Non-Hispanic White||Race/Ethnicity, Customized||participants|Number|201|201.0||||||
3983977|NCT01258582|3806339|B1|Non-Hispanic White||Race/Ethnicity, Customized||participants|Number|198|198.0||||||
3983978|NCT01258582|3806337|B3|Male||Gender|Numbers in gender category do not add up to total number randomized due to missing data/numbers.|participants|Number|571|571.0||||||
3983979|NCT01258582|3806338|B2|Male||Gender|Numbers in gender category do not add up to total number randomized due to missing data/numbers.|participants|Number|288|288.0||||||
3983980|NCT01258582|3806339|B1|Male||Gender|Numbers in gender category do not add up to total number randomized due to missing data/numbers.|participants|Number|283|283.0||||||
3983981|NCT01258582|3806337|B3|Female||Gender|Numbers in gender category do not add up to total number randomized due to missing data/numbers.|participants|Number|1065|1065.0||||||
3983982|NCT01258582|3806338|B2|Female||Gender|Numbers in gender category do not add up to total number randomized due to missing data/numbers.|participants|Number|529|529.0||||||
3983983|NCT01258582|3806339|B1|Female||Gender|Numbers in gender category do not add up to total number randomized due to missing data/numbers.|participants|Number|536|536.0||||||
3983984|NCT01258582|3806337|B3|||Age||years|Mean|33|33.0|Standard Deviation|13|13.0|||
3983985|NCT01258582|3806338|B2|||Age||years|Mean|33|33.0|Standard Deviation|13|13.0|||
3983986|NCT01258582|3806339|B1|||Age||years|Mean|34|34.0|Standard Deviation|13|13.0|||
3983987|NCT01258504|3806346|B1|Germany||Region of Enrollment||participants|Number|13|13.0||||||
3983988|NCT01258504|3806346|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3983989|NCT01258504|3806346|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3983990|NCT01258504|3806346|B1|||Age||years|Mean|35|35.0|Standard Deviation|11|11.0|||
3983991|NCT01258387|3806357|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983992|NCT01258387|3806358|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983993|NCT01258387|3806359|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983994|NCT01258387|3806360|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983995|NCT01258387|3806361|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983996|NCT01258387|3806362|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983997|NCT01258387|3806363|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983998|NCT01258387|3806364|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3983999|NCT01258387|3806365|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984000|NCT01258387|3806357|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3984001|NCT01258387|3806358|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3984002|NCT01258387|3806359|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3984003|NCT01258387|3806360|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3984004|NCT01258387|3806361|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3984005|NCT01258387|3806362|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3984006|NCT01258387|3806363|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3984007|NCT01258387|3806364|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3984008|NCT01258387|3806365|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3984009|NCT01258387|3806357|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984010|NCT01258387|3806358|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984011|NCT01258387|3806359|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984012|NCT01258387|3806360|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984013|NCT01258387|3806361|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984014|NCT01258387|3806362|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984015|NCT01258387|3806363|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984016|NCT01258387|3806364|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984017|NCT01258387|3806365|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984018|NCT01258387|3806357|B9||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3984019|NCT01258387|3806358|B8||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3984020|NCT01258387|3806359|B7||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3984021|NCT01258387|3806360|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3984022|NCT01258387|3806361|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3984023|NCT01258387|3806362|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3984024|NCT01258387|3806363|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3984025|NCT01258387|3806364|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3984026|NCT01258387|3806365|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3984027|NCT01258387|3806357|B9||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3984028|NCT01258387|3806358|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3984029|NCT01258387|3806359|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3984030|NCT01258387|3806360|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3984031|NCT01258387|3806361|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3984032|NCT01258387|3806362|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3984033|NCT01258387|3806363|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3984034|NCT01258387|3806364|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3984035|NCT01258387|3806365|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3984036|NCT01258387|3806357|B9|||Age||years|Mean|57.4|57.4|Standard Deviation|9.83|9.83|||
3984037|NCT01258387|3806358|B8|||Age||years|Mean|61.0|61.0|Standard Deviation|9.17|9.17|||
3984038|NCT01258387|3806359|B7|||Age||years|Mean|59.0|59.0|Standard Deviation|4.97|4.97|||
3984039|NCT01258387|3806360|B6|||Age||years|Mean|58.5|58.5|Standard Deviation|8.85|8.85|||
3984040|NCT01258387|3806361|B5|||Age||years|Mean|65.3|65.3|Standard Deviation|5.85|5.85|||
3984041|NCT01258387|3806362|B4|||Age||years|Mean|56.8|56.8|Standard Deviation|10.05|10.05|||
3984042|NCT01258387|3806363|B3|||Age||years|Mean|58.5|58.5|Standard Deviation|7.59|7.59|||
3984043|NCT01258387|3806364|B2|||Age||years|Mean|52.0|52.0|Standard Deviation|5.72|5.72|||
3984044|NCT01258387|3806365|B1|||Age||years|Mean|54.7|54.7|Standard Deviation|13.21|13.21|||
3984045|NCT01258348|3806413|B1|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3984046|NCT01258348|3806413|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3984047|NCT01258348|3806413|B1|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3984048|NCT01258348|3806413|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
3984049|NCT01258348|3806413|B1|African||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3984050|NCT01258348|3806413|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3984051|NCT01258348|3806413|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3984052|NCT01258348|3806413|B1|||Age||years|Median|61.4|61.4|Full Range|||40.4|75.6|
3984053|NCT01258153|3806442|B4|Mixed Fed||Feeding Mode|Feeding mode: 1 data missing in high dose - 0.5mg/kg (37 subjects instead of 38)|participants|Number|4|4.0||||||
3984054|NCT01258153|3806443|B3|Mixed Fed||Feeding Mode|Feeding mode: 1 data missing in high dose - 0.5mg/kg (37 subjects instead of 38)|participants|Number|0|0.0||||||
3984055|NCT01258153|3806444|B2|Mixed Fed||Feeding Mode|Feeding mode: 1 data missing in high dose - 0.5mg/kg (37 subjects instead of 38)|participants|Number|1|1.0||||||
3984056|NCT01258153|3806445|B1|Mixed Fed||Feeding Mode|Feeding mode: 1 data missing in high dose - 0.5mg/kg (37 subjects instead of 38)|participants|Number|3|3.0||||||
3984057|NCT01258153|3806442|B4|Formula Fed||Feeding Mode|Feeding mode: 1 data missing in high dose - 0.5mg/kg (37 subjects instead of 38)|participants|Number|23|23.0||||||
3984058|NCT01258153|3806443|B3|Formula Fed||Feeding Mode|Feeding mode: 1 data missing in high dose - 0.5mg/kg (37 subjects instead of 38)|participants|Number|7|7.0||||||
3984059|NCT01258153|3806444|B2|Formula Fed||Feeding Mode|Feeding mode: 1 data missing in high dose - 0.5mg/kg (37 subjects instead of 38)|participants|Number|7|7.0||||||
3984060|NCT01258153|3806445|B1|Formula Fed||Feeding Mode|Feeding mode: 1 data missing in high dose - 0.5mg/kg (37 subjects instead of 38)|participants|Number|9|9.0||||||
3984061|NCT01258153|3806442|B4|Breast Fed||Feeding Mode|Feeding mode: 1 data missing in high dose - 0.5mg/kg (37 subjects instead of 38)|participants|Number|85|85.0||||||
3984062|NCT01258153|3806443|B3|Breast Fed||Feeding Mode|Feeding mode: 1 data missing in high dose - 0.5mg/kg (37 subjects instead of 38)|participants|Number|29|29.0||||||
3984063|NCT01258153|3806444|B2|Breast Fed||Feeding Mode|Feeding mode: 1 data missing in high dose - 0.5mg/kg (37 subjects instead of 38)|participants|Number|29|29.0||||||
3984064|NCT01258153|3806445|B1|Breast Fed||Feeding Mode|Feeding mode: 1 data missing in high dose - 0.5mg/kg (37 subjects instead of 38)|participants|Number|27|27.0||||||
3984065|NCT01258153|3806442|B4|||Weight||kg|Mean|5.35|5.35|Standard Deviation|1.275|1.275|||
3984066|NCT01258153|3806443|B3|||Weight||kg|Mean|5.61|5.61|Standard Deviation|1.419|1.419|||
3984067|NCT01258153|3806444|B2|||Weight||kg|Mean|5.24|5.24|Standard Deviation|1.267|1.267|||
3984068|NCT01258153|3806445|B1|||Weight||kg|Mean|5.22|5.22|Standard Deviation|1.129|1.129|||
3984069|NCT01258153|3806442|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984070|NCT01258153|3806443|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984071|NCT01258153|3806444|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984072|NCT01258153|3806445|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984073|NCT01258153|3806442|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984074|NCT01258153|3806443|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984075|NCT01258153|3806444|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984076|NCT01258153|3806445|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984077|NCT01258153|3806442|B4||White|Race (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
3984078|NCT01258153|3806443|B3||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3984079|NCT01258153|3806444|B2||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3984080|NCT01258153|3806445|B1||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3984081|NCT01258153|3806442|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3984082|NCT01258153|3806443|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984083|NCT01258153|3806444|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3984084|NCT01258153|3806445|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3984085|NCT01258153|3806442|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984086|NCT01258153|3806443|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984087|NCT01258153|3806444|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984088|NCT01258153|3806445|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984089|NCT01258153|3806442|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984090|NCT01258153|3806443|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984091|NCT01258153|3806444|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984092|NCT01258153|3806445|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984093|NCT01258153|3806442|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984094|NCT01258153|3806443|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984095|NCT01258153|3806444|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984096|NCT01258153|3806445|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984097|NCT01258153|3806442|B4||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3984098|NCT01258153|3806443|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3984099|NCT01258153|3806444|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3984100|NCT01258153|3806445|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3984101|NCT01258153|3806442|B4||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3984102|NCT01258153|3806443|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3984103|NCT01258153|3806444|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3984104|NCT01258153|3806445|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3984105|NCT01258153|3806442|B4|||Age||weeks|Mean|11.1|11.1|Standard Deviation|4.881|4.881|||
3984106|NCT01258153|3806443|B3|||Age||weeks|Mean|10.92|10.92|Standard Deviation|4.686|4.686|||
3984107|NCT01258153|3806444|B2|||Age||weeks|Mean|11.34|11.34|Standard Deviation|5.147|5.147|||
3984108|NCT01258153|3806445|B1|||Age||weeks|Mean|11.03|11.03|Standard Deviation|4.909|4.909|||
3984109|NCT01258101|3806470|B5||Male|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
3984110|NCT01258101|3806471|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3984111|NCT01258101|3806472|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3984112|NCT01258101|3806473|B2||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3984113|NCT01258101|3806474|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3984114|NCT01258101|3806470|B5||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3984115|NCT01258101|3806471|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3984116|NCT01258101|3806472|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3984117|NCT01258101|3806473|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3984118|NCT01258101|3806474|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3984119|NCT01258101|3806470|B5|||Age||Years|Mean|36.1|36.1|Standard Deviation|10.6|10.6|||
3984120|NCT01258101|3806471|B4|||Age||Years|Mean|35.2|35.2|Standard Deviation|10.0|10.0|||
3984121|NCT01258101|3806472|B3|||Age||Years|Mean|35.8|35.8|Standard Deviation|11.2|11.2|||
3984122|NCT01258101|3806473|B2|||Age||Years|Mean|35.7|35.7|Standard Deviation|10.2|10.2|||
3984123|NCT01258101|3806474|B1|||Age||Years|Mean|36.8|36.8|Standard Deviation|11.1|11.1|||
3984124|NCT01258049|3806527|B3|||Parasite Count (median)||p falciparum /mcl|Median|76325|76325.0|Full Range|||279.0|843746.0|
3984125|NCT01258049|3806528|B2|||Parasite Count (median)||p falciparum /mcl|Median|66077|66077.0|Full Range|||1225.0|843746.0|
3984126|NCT01258049|3806529|B1|||Parasite Count (median)||p falciparum /mcl|Median|86572|86572.0|Full Range|||279.0|515556.0|
3984127|NCT01258049|3806527|B3|||Parasite Counts||p falciparum /mcl|Mean|144602|144602.0|Standard Deviation|165964|165964.0|||
3984128|NCT01258049|3806528|B2|||Parasite Counts||p falciparum /mcl|Mean|155321|155321.0|Standard Deviation|202213|202213.0|||
3984129|NCT01258049|3806529|B1|||Parasite Counts||p falciparum /mcl|Mean|133884|133884.0|Standard Deviation|129715|129715.0|||
3984130|NCT01258049|3806527|B3|< 5||Blantyre Coma Scale|"Blantyre Coma scale scores out of 5, full consciousness, by adding the scores of the following 3 domains. Any score ≤ 4 is considered abnormal,~Eye Movement~1 Watches or follows 0 Fails to watch or follow~Best Motor Response 2 Localizes painful stimulus 1 Withdraws limb from painful stimulus 0 No response or inappropriate response~Best Verbal Response 2 Cries appropriately with pain, or if verbal, speaks~1 Moan or abnormal cry with pain 0 No vocal response with pain"|participants|Number|38|38.0||||||
3984131|NCT01258049|3806528|B2|< 5||Blantyre Coma Scale|"Blantyre Coma scale scores out of 5, full consciousness, by adding the scores of the following 3 domains. Any score ≤ 4 is considered abnormal,~Eye Movement~1 Watches or follows 0 Fails to watch or follow~Best Motor Response 2 Localizes painful stimulus 1 Withdraws limb from painful stimulus 0 No response or inappropriate response~Best Verbal Response 2 Cries appropriately with pain, or if verbal, speaks~1 Moan or abnormal cry with pain 0 No vocal response with pain"|participants|Number|21|21.0||||||
3984132|NCT01258049|3806529|B1|< 5||Blantyre Coma Scale|"Blantyre Coma scale scores out of 5, full consciousness, by adding the scores of the following 3 domains. Any score ≤ 4 is considered abnormal,~Eye Movement~1 Watches or follows 0 Fails to watch or follow~Best Motor Response 2 Localizes painful stimulus 1 Withdraws limb from painful stimulus 0 No response or inappropriate response~Best Verbal Response 2 Cries appropriately with pain, or if verbal, speaks~1 Moan or abnormal cry with pain 0 No vocal response with pain"|participants|Number|17|17.0||||||
3984133|NCT01258049|3806527|B3|5||Blantyre Coma Scale|"Blantyre Coma scale scores out of 5, full consciousness, by adding the scores of the following 3 domains. Any score ≤ 4 is considered abnormal,~Eye Movement~1 Watches or follows 0 Fails to watch or follow~Best Motor Response 2 Localizes painful stimulus 1 Withdraws limb from painful stimulus 0 No response or inappropriate response~Best Verbal Response 2 Cries appropriately with pain, or if verbal, speaks~1 Moan or abnormal cry with pain 0 No vocal response with pain"|participants|Number|113|113.0||||||
3984134|NCT01258049|3806528|B2|5||Blantyre Coma Scale|"Blantyre Coma scale scores out of 5, full consciousness, by adding the scores of the following 3 domains. Any score ≤ 4 is considered abnormal,~Eye Movement~1 Watches or follows 0 Fails to watch or follow~Best Motor Response 2 Localizes painful stimulus 1 Withdraws limb from painful stimulus 0 No response or inappropriate response~Best Verbal Response 2 Cries appropriately with pain, or if verbal, speaks~1 Moan or abnormal cry with pain 0 No vocal response with pain"|participants|Number|53|53.0||||||
3984135|NCT01258049|3806529|B1|5||Blantyre Coma Scale|"Blantyre Coma scale scores out of 5, full consciousness, by adding the scores of the following 3 domains. Any score ≤ 4 is considered abnormal,~Eye Movement~1 Watches or follows 0 Fails to watch or follow~Best Motor Response 2 Localizes painful stimulus 1 Withdraws limb from painful stimulus 0 No response or inappropriate response~Best Verbal Response 2 Cries appropriately with pain, or if verbal, speaks~1 Moan or abnormal cry with pain 0 No vocal response with pain"|participants|Number|60|60.0||||||
3984136|NCT01258049|3806527|B3|||Respiratory Rate||breaths/min|Mean|36.3|36.3|Standard Deviation|11.2|11.2|||
3984137|NCT01258049|3806528|B2|||Respiratory Rate||breaths/min|Mean|35.9|35.9|Standard Deviation|11.3|11.3|||
3984138|NCT01258049|3806529|B1|||Respiratory Rate||breaths/min|Mean|36.7|36.7|Standard Deviation|11.0|11.0|||
3984139|NCT01258049|3806527|B3|||Tympanic Temperature||Degrees Centigrade|Mean|38.6|38.6|Standard Deviation|1.1|1.1|||
3984140|NCT01258049|3806528|B2|||Tympanic Temperature||Degrees Centigrade|Mean|38.6|38.6|Standard Deviation|1.0|1.0|||
3984141|NCT01258049|3806529|B1|||Tympanic Temperature||Degrees Centigrade|Mean|38.6|38.6|Standard Deviation|1.1|1.1|||
3984142|NCT01258049|3806527|B3|||Pulse rate||bpm|Mean|146|146.0|Standard Deviation|23.3|23.3|||
3984143|NCT01258049|3806528|B2|||Pulse rate||bpm|Mean|147|147.0|Standard Deviation|26.3|26.3|||
3984144|NCT01258049|3806529|B1|||Pulse rate||bpm|Mean|146|146.0|Standard Deviation|20.2|20.2|||
3984145|NCT01258049|3806527|B3|||Weight||kg|Mean|11.4|11.4|Standard Deviation|2.5|2.5|||
3984146|NCT01258049|3806528|B2|||Weight||kg|Mean|11.2|11.2|Standard Deviation|2.5|2.5|||
3984147|NCT01258049|3806529|B1|||Weight||kg|Mean|11.7|11.7|Standard Deviation|2.4|2.4|||
3984148|NCT01258049|3806527|B3|Uncomplicated malaria with GI complications||Disease Definition - Severe or complicated malaria||participants|Number|51|51.0||||||
3984149|NCT01258049|3806528|B2|Uncomplicated malaria with GI complications||Disease Definition - Severe or complicated malaria||participants|Number|23|23.0||||||
3984150|NCT01258049|3806529|B1|Uncomplicated malaria with GI complications||Disease Definition - Severe or complicated malaria||participants|Number|28|28.0||||||
3984151|NCT01258049|3806527|B3|Severe or complicated malaria||Disease Definition - Severe or complicated malaria||participants|Number|100|100.0||||||
3984152|NCT01258049|3806528|B2|Severe or complicated malaria||Disease Definition - Severe or complicated malaria||participants|Number|51|51.0||||||
3984153|NCT01258049|3806529|B1|Severe or complicated malaria||Disease Definition - Severe or complicated malaria||participants|Number|49|49.0||||||
3984154|NCT01258049|3806527|B3|Rwanda||Region of Enrollment||participants|Number|51|51.0||||||
3984155|NCT01258049|3806528|B2|Rwanda||Region of Enrollment||participants|Number|24|24.0||||||
3984156|NCT01258049|3806529|B1|Rwanda||Region of Enrollment||participants|Number|27|27.0||||||
3984157|NCT01258049|3806527|B3|Burkina Faso||Region of Enrollment||participants|Number|50|50.0||||||
3984158|NCT01258049|3806528|B2|Burkina Faso||Region of Enrollment||participants|Number|25|25.0||||||
3984159|NCT01258049|3806529|B1|Burkina Faso||Region of Enrollment||participants|Number|25|25.0||||||
3984160|NCT01258049|3806527|B3|Ghana||Region of Enrollment||participants|Number|50|50.0||||||
3984161|NCT01258049|3806528|B2|Ghana||Region of Enrollment||participants|Number|25|25.0||||||
3984162|NCT01258049|3806529|B1|Ghana||Region of Enrollment||participants|Number|25|25.0||||||
3984163|NCT01258049|3806527|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3984164|NCT01258049|3806528|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3984165|NCT01258049|3806529|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3984166|NCT01258049|3806527|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3984167|NCT01258049|3806528|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3984168|NCT01258049|3806529|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3984169|NCT01258049|3806527|B3|||Age||years|Mean|2.6|2.6|Standard Deviation|1.29|1.29|||
3984170|NCT01258049|3806528|B2|||Age||years|Mean|2.5|2.5|Standard Deviation|1.23|1.23|||
3984171|NCT01258049|3806529|B1|||Age||years|Mean|2.8|2.8|Standard Deviation|1.34|1.34|||
3984172|NCT01257880|3806566|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
3984173|NCT01257880|3806567|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
3984174|NCT01257880|3806568|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3984175|NCT01257880|3806566|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3984176|NCT01257880|3806567|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3984177|NCT01257880|3806568|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3984178|NCT01257880|3806566|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3984179|NCT01257880|3806567|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3984180|NCT01257880|3806568|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3984181|NCT01257880|3806566|B3|||Age||years|Mean|35|35.0|Standard Deviation|11|11.0|||
3984182|NCT01257880|3806567|B2|||Age||years|Mean|35|35.0|Standard Deviation|11|11.0|||
3984183|NCT01257880|3806568|B1|||Age||years|Mean|37|37.0|Standard Deviation|10|10.0|||
3984184|NCT01257880|3806566|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3984185|NCT01257880|3806567|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3984186|NCT01257880|3806568|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3984187|NCT01257880|3806566|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3984188|NCT01257880|3806567|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3984189|NCT01257880|3806568|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3984190|NCT01257880|3806566|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3984191|NCT01257880|3806567|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3984192|NCT01257880|3806568|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3984193|NCT01257802|3806577|B3|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3984194|NCT01257802|3806578|B2|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3984195|NCT01257802|3806579|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3984196|NCT01257802|3806577|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3984197|NCT01257802|3806578|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3984198|NCT01257802|3806579|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3984199|NCT01257802|3806577|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3984200|NCT01257802|3806578|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3984201|NCT01257802|3806579|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3984202|NCT01257802|3806577|B3|||Age||years|Mean|27.93|27.93|Full Range|||20.0|40.0|
3984203|NCT01257802|3806578|B2|||Age||years|Mean|28.25|28.25|Full Range|||21.0|40.0|
3984204|NCT01257802|3806579|B1|||Age||years|Mean|27.5|27.5|Full Range|||20.0|35.0|
3984205|NCT01257750|3806594|B1|||Central Corneal Thickness|Corneal pachymetry is used to measure central corneal thickness. This technique is used to gauge the functional status of the corneal endothelial cell layer.|microns|Mean|572|572.0|Standard Deviation|135|135.0|||
3984206|NCT01257750|3806594|B1|||Intraocular Pressure||mm Hg|Mean|15.7|15.7|Standard Deviation|5.9|5.9|||
3984207|NCT01257750|3806594|B1|||Heart Rate||Beats per Minute|Mean|70.4|70.4|Standard Deviation|8.1|8.1|||
3984208|NCT01257750|3806594|B1|||Mean Arterial Pressure||mm Hg|Mean|92.0|92.0|Standard Deviation|1.7|1.7|||
3984209|NCT01257750|3806594|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3984210|NCT01257750|3806594|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3984211|NCT01257750|3806594|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3984212|NCT01257750|3806594|B1|||Age||years|Mean|54|54.0|Standard Deviation|19|19.0|||
3984213|NCT01257737|3806605|B3||Hyperornithinemia-hyperammonemia-homocitrullinuria|Urea Cycle Disorder Diagnosis||Participants|Count of Participants|3|3.0||||||
3984214|NCT01257737|3806606|B2||Hyperornithinemia-hyperammonemia-homocitrullinuria|Urea Cycle Disorder Diagnosis||Participants|Count of Participants|3|3.0||||||
3984215|NCT01257737|3806607|B1||Hyperornithinemia-hyperammonemia-homocitrullinuria|Urea Cycle Disorder Diagnosis||Participants|Count of Participants|0|0.0||||||
3984216|NCT01257737|3806605|B3||Argininosuccinate lyase (ASL) deficiency|Urea Cycle Disorder Diagnosis||Participants|Count of Participants|13|13.0||||||
3984217|NCT01257737|3806606|B2||Argininosuccinate lyase (ASL) deficiency|Urea Cycle Disorder Diagnosis||Participants|Count of Participants|2|2.0||||||
3984218|NCT01257737|3806607|B1||Argininosuccinate lyase (ASL) deficiency|Urea Cycle Disorder Diagnosis||Participants|Count of Participants|11|11.0||||||
3984219|NCT01257737|3806605|B3||Arginase (ARG) deficiency|Urea Cycle Disorder Diagnosis||Participants|Count of Participants|2|2.0||||||
3984220|NCT01257737|3806606|B2||Arginase (ARG) deficiency|Urea Cycle Disorder Diagnosis||Participants|Count of Participants|1|1.0||||||
3984221|NCT01257737|3806607|B1||Arginase (ARG) deficiency|Urea Cycle Disorder Diagnosis||Participants|Count of Participants|1|1.0||||||
3984222|NCT01257737|3806605|B3||Ornithine transcarbamylase (OTC) deficiency|Urea Cycle Disorder Diagnosis||Participants|Count of Participants|61|61.0||||||
3984223|NCT01257737|3806606|B2||Ornithine transcarbamylase (OTC) deficiency|Urea Cycle Disorder Diagnosis||Participants|Count of Participants|35|35.0||||||
3984224|NCT01257737|3806607|B1||Ornithine transcarbamylase (OTC) deficiency|Urea Cycle Disorder Diagnosis||Participants|Count of Participants|26|26.0||||||
3984225|NCT01257737|3806605|B3||Argininosuccinate synthetase (ASS) deficiency|Urea Cycle Disorder Diagnosis||Participants|Count of Participants|9|9.0||||||
3984226|NCT01257737|3806606|B2||Argininosuccinate synthetase (ASS) deficiency|Urea Cycle Disorder Diagnosis||Participants|Count of Participants|2|2.0||||||
3984227|NCT01257737|3806607|B1||Argininosuccinate synthetase (ASS) deficiency|Urea Cycle Disorder Diagnosis||Participants|Count of Participants|7|7.0||||||
3984228|NCT01257737|3806605|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3984229|NCT01257737|3806606|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3984230|NCT01257737|3806607|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3984231|NCT01257737|3806605|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984232|NCT01257737|3806606|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984233|NCT01257737|3806607|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984234|NCT01257737|3806605|B3||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3984235|NCT01257737|3806606|B2||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3984236|NCT01257737|3806607|B1||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3984237|NCT01257737|3806605|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3984238|NCT01257737|3806606|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3984239|NCT01257737|3806607|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3984240|NCT01257737|3806605|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984241|NCT01257737|3806606|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984242|NCT01257737|3806607|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984243|NCT01257737|3806605|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3984244|NCT01257737|3806606|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3984245|NCT01257737|3806607|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3984246|NCT01257737|3806605|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3984247|NCT01257737|3806606|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3984248|NCT01257737|3806607|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3984249|NCT01257737|3806605|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3984250|NCT01257737|3806606|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3984251|NCT01257737|3806607|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3984252|NCT01257737|3806605|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3984253|NCT01257737|3806606|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3984254|NCT01257737|3806607|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3984255|NCT01257737|3806605|B3|||Age||years|Mean|20.0|20.0|Standard Deviation|15.76|15.76|||
3984256|NCT01257737|3806606|B2|||Age||years|Mean|33.3|33.3|Standard Deviation|11.90|11.9|||
3984257|NCT01257737|3806607|B1|||Age||years|Mean|7.3|7.3|Standard Deviation|4.33|4.33|||
3984258|NCT01257581|3806626|B4|||Baseline VC% Predicted Max|The vital capacity (VC) (percent of predicted normal) was determined using the slow VC method. Vital Capacity is the maximum amount of air a person can expel from the lungs after a maximum inhalation. A subject's VC depends on their age, sex and height. The value is recorded as a percent of predicted normal.|% of predicted max value|Mean|86.80|86.8|Standard Deviation|18.31|18.31|||
3984259|NCT01257581|3806627|B3|||Baseline VC% Predicted Max|The vital capacity (VC) (percent of predicted normal) was determined using the slow VC method. Vital Capacity is the maximum amount of air a person can expel from the lungs after a maximum inhalation. A subject's VC depends on their age, sex and height. The value is recorded as a percent of predicted normal.|% of predicted max value|Mean|81.71|81.71|Standard Deviation|19.93|19.93|||
3984260|NCT01257581|3806628|B2|||Baseline VC% Predicted Max|The vital capacity (VC) (percent of predicted normal) was determined using the slow VC method. Vital Capacity is the maximum amount of air a person can expel from the lungs after a maximum inhalation. A subject's VC depends on their age, sex and height. The value is recorded as a percent of predicted normal.|% of predicted max value|Mean|86.90|86.9|Standard Deviation|13.92|13.92|||
3984261|NCT01257581|3806629|B1|||Baseline VC% Predicted Max|The vital capacity (VC) (percent of predicted normal) was determined using the slow VC method. Vital Capacity is the maximum amount of air a person can expel from the lungs after a maximum inhalation. A subject's VC depends on their age, sex and height. The value is recorded as a percent of predicted normal.|% of predicted max value|Mean|90.64|90.64|Standard Deviation|20.29|20.29|||
3984306|NCT01257581|3806626|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3984307|NCT01257581|3806627|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984262|NCT01257581|3806626|B4|||Baseline ALS Functional Rating Scale - Revised (ALSFRS-R) Total|The ALSFRS-R is a quickly administered (5 min) ordinal rating scale used to determine a subject's assessment of their capability and independence in 12 functional activities. There are 12 questions, graded by the subject 0-4 (4 is normal). Score of 0 (worst) to 48 (best). Reflects speech and swallowing, fine motor skills, large motor skills, and breathing.|Score on a scale|Mean|35.65|35.65|Standard Deviation|6.54|6.54|||
3984263|NCT01257581|3806627|B3|||Baseline ALS Functional Rating Scale - Revised (ALSFRS-R) Total|The ALSFRS-R is a quickly administered (5 min) ordinal rating scale used to determine a subject's assessment of their capability and independence in 12 functional activities. There are 12 questions, graded by the subject 0-4 (4 is normal). Score of 0 (worst) to 48 (best). Reflects speech and swallowing, fine motor skills, large motor skills, and breathing.|Score on a scale|Mean|34.76|34.76|Standard Deviation|6.56|6.56|||
3984264|NCT01257581|3806628|B2|||Baseline ALS Functional Rating Scale - Revised (ALSFRS-R) Total|The ALSFRS-R is a quickly administered (5 min) ordinal rating scale used to determine a subject's assessment of their capability and independence in 12 functional activities. There are 12 questions, graded by the subject 0-4 (4 is normal). Score of 0 (worst) to 48 (best). Reflects speech and swallowing, fine motor skills, large motor skills, and breathing.|Score on a scale|Mean|36.19|36.19|Standard Deviation|6.04|6.04|||
3984265|NCT01257581|3806629|B1|||Baseline ALS Functional Rating Scale - Revised (ALSFRS-R) Total|The ALSFRS-R is a quickly administered (5 min) ordinal rating scale used to determine a subject's assessment of their capability and independence in 12 functional activities. There are 12 questions, graded by the subject 0-4 (4 is normal). Score of 0 (worst) to 48 (best). Reflects speech and swallowing, fine motor skills, large motor skills, and breathing.|Score on a scale|Mean|35.82|35.82|Standard Deviation|7.20|7.2|||
3984266|NCT01257581|3806626|B4|||Years from Symptom Onset to Diagnosis||years|Mean|1.2|1.2|Standard Deviation|1.1|1.1|||
3984267|NCT01257581|3806627|B3|||Years from Symptom Onset to Diagnosis||years|Mean|1.0|1.0|Standard Deviation|0.8|0.8|||
3984268|NCT01257581|3806628|B2|||Years from Symptom Onset to Diagnosis||years|Mean|0.9|0.9|Standard Deviation|0.8|0.8|||
3984269|NCT01257581|3806629|B1|||Years from Symptom Onset to Diagnosis||years|Mean|1.6|1.6|Standard Deviation|1.5|1.5|||
3984270|NCT01257581|3806626|B4|||Years from Diagnosis to Screening||years|Mean|1.1|1.1|Standard Deviation|0.8|0.8|||
3984271|NCT01257581|3806627|B3|||Years from Diagnosis to Screening||years|Mean|1.0|1.0|Standard Deviation|0.8|0.8|||
3984272|NCT01257581|3806628|B2|||Years from Diagnosis to Screening||years|Mean|0.9|0.9|Standard Deviation|0.8|0.8|||
3984273|NCT01257581|3806629|B1|||Years from Diagnosis to Screening||years|Mean|1.3|1.3|Standard Deviation|0.8|0.8|||
3984274|NCT01257581|3806626|B4|||Years from Symptom Onset to Screening||years|Mean|2.3|2.3|Standard Deviation|1.5|1.5|||
3984275|NCT01257581|3806627|B3|||Years from Symptom Onset to Screening||years|Mean|2.0|2.0|Standard Deviation|1.0|1.0|||
3984276|NCT01257581|3806628|B2|||Years from Symptom Onset to Screening||years|Mean|1.9|1.9|Standard Deviation|1.4|1.4|||
3984277|NCT01257581|3806629|B1|||Years from Symptom Onset to Screening||years|Mean|2.8|2.8|Standard Deviation|1.7|1.7|||
3984278|NCT01257581|3806626|B4|United States||Region of Enrollment||participants|Number|60|60.0||||||
3984279|NCT01257581|3806627|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
3984280|NCT01257581|3806628|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
3984281|NCT01257581|3806629|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3984282|NCT01257581|3806626|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984283|NCT01257581|3806627|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984284|NCT01257581|3806628|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984285|NCT01257581|3806629|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984286|NCT01257581|3806626|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984287|NCT01257581|3806627|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984288|NCT01257581|3806628|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984289|NCT01257581|3806629|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984290|NCT01257581|3806626|B4||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3984291|NCT01257581|3806627|B3||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3984292|NCT01257581|3806628|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3984293|NCT01257581|3806629|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3984294|NCT01257581|3806626|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984295|NCT01257581|3806627|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984296|NCT01257581|3806628|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984297|NCT01257581|3806629|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984298|NCT01257581|3806626|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984299|NCT01257581|3806627|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984300|NCT01257581|3806628|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984301|NCT01257581|3806629|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984302|NCT01257581|3806626|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984303|NCT01257581|3806627|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984304|NCT01257581|3806628|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984305|NCT01257581|3806629|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984308|NCT01257581|3806628|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3984309|NCT01257581|3806629|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984310|NCT01257581|3806626|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984311|NCT01257581|3806627|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984312|NCT01257581|3806628|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984313|NCT01257581|3806629|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984314|NCT01257581|3806626|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3984315|NCT01257581|3806627|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3984316|NCT01257581|3806628|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3984317|NCT01257581|3806629|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3984318|NCT01257581|3806626|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984319|NCT01257581|3806627|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984320|NCT01257581|3806628|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984321|NCT01257581|3806629|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984322|NCT01257581|3806626|B4||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3984323|NCT01257581|3806627|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3984324|NCT01257581|3806628|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3984325|NCT01257581|3806629|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3984326|NCT01257581|3806626|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3984327|NCT01257581|3806627|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3984328|NCT01257581|3806628|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3984329|NCT01257581|3806629|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3984330|NCT01257581|3806626|B4|||Age||years|Mean|57.4|57.4|Standard Deviation|11.1|11.1|||
3984331|NCT01257581|3806627|B3|||Age||years|Mean|56.3|56.3|Standard Deviation|11.3|11.3|||
3984332|NCT01257581|3806628|B2|||Age||years|Mean|60.3|60.3|Standard Deviation|10.6|10.6|||
3984333|NCT01257581|3806629|B1|||Age||years|Mean|55.5|55.5|Standard Deviation|11.4|11.4|||
3984334|NCT01257542|3806669|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3984335|NCT01257542|3806670|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3984336|NCT01257542|3806671|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3984337|NCT01257542|3806669|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3984338|NCT01257542|3806670|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3984339|NCT01257542|3806671|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3984340|NCT01257542|3806669|B3|||Age||Years|Mean|8.9|8.9|Standard Deviation|1.7|1.7|||
3984341|NCT01257542|3806670|B2|||Age||Years|Mean|8.9|8.9|Standard Deviation|1.6|1.6|||
3984342|NCT01257542|3806671|B1|||Age||Years|Mean|8.9|8.9|Standard Deviation|1.8|1.8|||
3984343|NCT01257503|3806690|B3|||baseline cold symptom score|sum of scores for runny nose severity, sneeze severity, cough severity and congestion severity rated by parent at study entry. For each symptom, possible scores range from 0 to 3, with 3 indicating most severe. Baseline cold score missing on 1 participant in the homeopathic cold remedy group|units on a scale|Mean|5.3|5.3|Standard Deviation|1.8|1.8|||
3984344|NCT01257503|3806691|B2|||baseline cold symptom score|sum of scores for runny nose severity, sneeze severity, cough severity and congestion severity rated by parent at study entry. For each symptom, possible scores range from 0 to 3, with 3 indicating most severe. Baseline cold score missing on 1 participant in the homeopathic cold remedy group|units on a scale|Mean|5.2|5.2|Standard Deviation|1.8|1.8|||
3984345|NCT01257503|3806692|B1|||baseline cold symptom score|sum of scores for runny nose severity, sneeze severity, cough severity and congestion severity rated by parent at study entry. For each symptom, possible scores range from 0 to 3, with 3 indicating most severe. Baseline cold score missing on 1 participant in the homeopathic cold remedy group|units on a scale|Mean|5.4|5.4|Standard Deviation|1.8|1.8|||
3984346|NCT01257503|3806690|B3|United States||Region of Enrollment||participants|Number|261|261.0||||||
3984347|NCT01257503|3806691|B2|United States||Region of Enrollment||participants|Number|129|129.0||||||
3984348|NCT01257503|3806692|B1|United States||Region of Enrollment||participants|Number|132|132.0||||||
3984349|NCT01257503|3806690|B3|Male||Gender|Gender information missing on 1 participant randomized to the homeopathic cold remedy group|participants|Number|134|134.0||||||
3984350|NCT01257503|3806691|B2|Male||Gender|Gender information missing on 1 participant randomized to the homeopathic cold remedy group|participants|Number|67|67.0||||||
3984351|NCT01257503|3806692|B1|Male||Gender|Gender information missing on 1 participant randomized to the homeopathic cold remedy group|participants|Number|67|67.0||||||
3984352|NCT01257503|3806690|B3|Female||Gender|Gender information missing on 1 participant randomized to the homeopathic cold remedy group|participants|Number|126|126.0||||||
3984353|NCT01257503|3806691|B2|Female||Gender|Gender information missing on 1 participant randomized to the homeopathic cold remedy group|participants|Number|62|62.0||||||
3984354|NCT01257503|3806692|B1|Female||Gender|Gender information missing on 1 participant randomized to the homeopathic cold remedy group|participants|Number|64|64.0||||||
3984355|NCT01257503|3806690|B3|||Age||years|Mean|3.5|3.5|Standard Deviation|1.1|1.1|||
3984356|NCT01257503|3806691|B2|||Age||years|Mean|3.5|3.5|Standard Deviation|1.1|1.1|||
3984357|NCT01257503|3806692|B1|||Age||years|Mean|3.4|3.4|Standard Deviation|1.1|1.1|||
3984358|NCT01257503|3806690|B3||>=65 years|Age|exact age information missing on 2 participants in placebo group, noted to be 2-5 years old|Participants|Count of Participants|0|0.0||||||
3984359|NCT01257503|3806691|B2||>=65 years|Age|exact age information missing on 2 participants in placebo group, noted to be 2-5 years old|Participants|Count of Participants|0|0.0||||||
3984360|NCT01257503|3806692|B1||>=65 years|Age|exact age information missing on 2 participants in placebo group, noted to be 2-5 years old|Participants|Count of Participants|0|0.0||||||
3984361|NCT01257503|3806690|B3||Between 18 and 65 years|Age|exact age information missing on 2 participants in placebo group, noted to be 2-5 years old|Participants|Count of Participants|0|0.0||||||
3984362|NCT01257503|3806691|B2||Between 18 and 65 years|Age|exact age information missing on 2 participants in placebo group, noted to be 2-5 years old|Participants|Count of Participants|0|0.0||||||
3984363|NCT01257503|3806692|B1||Between 18 and 65 years|Age|exact age information missing on 2 participants in placebo group, noted to be 2-5 years old|Participants|Count of Participants|0|0.0||||||
3984364|NCT01257503|3806690|B3||<=18 years|Age|exact age information missing on 2 participants in placebo group, noted to be 2-5 years old|Participants|Count of Participants|261|261.0||||||
3984365|NCT01257503|3806691|B2||<=18 years|Age|exact age information missing on 2 participants in placebo group, noted to be 2-5 years old|Participants|Count of Participants|129|129.0||||||
3984366|NCT01257503|3806692|B1||<=18 years|Age|exact age information missing on 2 participants in placebo group, noted to be 2-5 years old|Participants|Count of Participants|132|132.0||||||
3984367|NCT01257438|3806707|B3|United States||Region of Enrollment||Participants|Count of Participants|275|275.0||||||
3984368|NCT01257438|3806708|B2|United States||Region of Enrollment||Participants|Count of Participants|143|143.0||||||
3984369|NCT01257438|3806709|B1|United States||Region of Enrollment||Participants|Count of Participants|132|132.0||||||
3984370|NCT01257438|3806707|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984371|NCT01257438|3806708|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984372|NCT01257438|3806709|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984373|NCT01257438|3806707|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3984374|NCT01257438|3806708|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3984375|NCT01257438|3806709|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3984376|NCT01257438|3806707|B3||White|Race (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
3984377|NCT01257438|3806708|B2||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3984378|NCT01257438|3806709|B1||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3984379|NCT01257438|3806707|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|156|156.0||||||
3984380|NCT01257438|3806708|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3984381|NCT01257438|3806709|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3984382|NCT01257438|3806707|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3984383|NCT01257438|3806708|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3984384|NCT01257438|3806709|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3984385|NCT01257438|3806707|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3984386|NCT01257438|3806708|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3984387|NCT01257438|3806709|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3984388|NCT01257438|3806707|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3984389|NCT01257438|3806708|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3984390|NCT01257438|3806709|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984391|NCT01257438|3806707|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984392|NCT01257438|3806708|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984393|NCT01257438|3806709|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984394|NCT01257438|3806707|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|236|236.0||||||
3984395|NCT01257438|3806708|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
3984396|NCT01257438|3806709|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
3984397|NCT01257438|3806707|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3984398|NCT01257438|3806708|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3984399|NCT01257438|3806709|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3984400|NCT01257438|3806707|B3||Male|Gender||Participants|Count of Participants|141|141.0||||||
3984401|NCT01257438|3806708|B2||Male|Gender||Participants|Count of Participants|73|73.0||||||
3984402|NCT01257438|3806709|B1||Male|Gender||Participants|Count of Participants|68|68.0||||||
3984403|NCT01257438|3806707|B3||Female|Gender||Participants|Count of Participants|134|134.0||||||
3984404|NCT01257438|3806708|B2||Female|Gender||Participants|Count of Participants|70|70.0||||||
3984405|NCT01257438|3806709|B1||Female|Gender||Participants|Count of Participants|64|64.0||||||
3984406|NCT01257438|3806707|B3|||Age||years|Mean|61.9|61.9|Standard Deviation|13.52|13.52|||
3984407|NCT01257438|3806708|B2|||Age||years|Mean|61.1|61.1|Standard Deviation|13.47|13.47|||
3984408|NCT01257438|3806709|B1|||Age||years|Mean|62.6|62.6|Standard Deviation|13.57|13.57|||
3984439|NCT01257425|3806720|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984409|NCT01257425|3806720|B3|||Tumour-related pain|Analysed from modified ITT population comprised of 98 patients (SC: 49 and IM: 49 patients). Tumour-related pain at baseline was rated by the patient by means of a 10-cm visual analogue scale (VAS), ranging from 0 (no pain) to 10 (maximum pain).|cm|Mean|0.31|0.31|Standard Deviation|0.81|0.81|||
3984410|NCT01257425|3806721|B2|||Tumour-related pain|Analysed from modified ITT population comprised of 98 patients (SC: 49 and IM: 49 patients). Tumour-related pain at baseline was rated by the patient by means of a 10-cm visual analogue scale (VAS), ranging from 0 (no pain) to 10 (maximum pain).|cm|Mean|0.37|0.37|Standard Deviation|0.99|0.99|||
3984411|NCT01257425|3806722|B1|||Tumour-related pain|Analysed from modified ITT population comprised of 98 patients (SC: 49 and IM: 49 patients). Tumour-related pain at baseline was rated by the patient by means of a 10-cm visual analogue scale (VAS), ranging from 0 (no pain) to 10 (maximum pain).|cm|Mean|0.25|0.25|Standard Deviation|0.58|0.58|||
3984412|NCT01257425|3806720|B3|||Testosterone serum level|Analysed from Intent-to-treat (ITT) population comprised of 103 patients (SC:52 patients and IM:51 patients).|ng/mL|Mean|3.18|3.18|Standard Deviation|1.31|1.31|||
3984413|NCT01257425|3806721|B2|||Testosterone serum level|Analysed from Intent-to-treat (ITT) population comprised of 103 patients (SC:52 patients and IM:51 patients).|ng/mL|Mean|3.12|3.12|Standard Deviation|1.36|1.36|||
3984414|NCT01257425|3806722|B1|||Testosterone serum level|Analysed from Intent-to-treat (ITT) population comprised of 103 patients (SC:52 patients and IM:51 patients).|ng/mL|Mean|3.23|3.23|Standard Deviation|1.28|1.28|||
3984415|NCT01257425|3806720|B3|||Prostate specific antigen (PSA) level|Analysed from Intent-to-treat (ITT) population with one missing value in the IM group.|ng/mL|Mean|71.7|71.7|Standard Deviation|286.0|286.0|||
3984416|NCT01257425|3806721|B2|||Prostate specific antigen (PSA) level|Analysed from Intent-to-treat (ITT) population with one missing value in the IM group.|ng/mL|Mean|97.2|97.2|Standard Deviation|368.0|368.0|||
3984417|NCT01257425|3806722|B1|||Prostate specific antigen (PSA) level|Analysed from Intent-to-treat (ITT) population with one missing value in the IM group.|ng/mL|Mean|47.1|47.1|Standard Deviation|174.9|174.9|||
3984418|NCT01257425|3806720|B3|80%||Karnofsky index (%)|Karnofsky index is a measure of performance status to quantify cancer patients' general well-being and activities of daily life. Karnofsky scores run from 100% (perfect health) to 0% (death). Analysed from Intent-to-treat (ITT) population comprised of 103 patients (SC:52 patients and IM:51 patients).|participants|Number|25|25.0||||||
3984419|NCT01257425|3806721|B2|80%||Karnofsky index (%)|Karnofsky index is a measure of performance status to quantify cancer patients' general well-being and activities of daily life. Karnofsky scores run from 100% (perfect health) to 0% (death). Analysed from Intent-to-treat (ITT) population comprised of 103 patients (SC:52 patients and IM:51 patients).|participants|Number|12|12.0||||||
3984420|NCT01257425|3806722|B1|80%||Karnofsky index (%)|Karnofsky index is a measure of performance status to quantify cancer patients' general well-being and activities of daily life. Karnofsky scores run from 100% (perfect health) to 0% (death). Analysed from Intent-to-treat (ITT) population comprised of 103 patients (SC:52 patients and IM:51 patients).|participants|Number|13|13.0||||||
3984421|NCT01257425|3806720|B3|90%||Karnofsky index (%)|Karnofsky index is a measure of performance status to quantify cancer patients' general well-being and activities of daily life. Karnofsky scores run from 100% (perfect health) to 0% (death). Analysed from Intent-to-treat (ITT) population comprised of 103 patients (SC:52 patients and IM:51 patients).|participants|Number|30|30.0||||||
3984422|NCT01257425|3806721|B2|90%||Karnofsky index (%)|Karnofsky index is a measure of performance status to quantify cancer patients' general well-being and activities of daily life. Karnofsky scores run from 100% (perfect health) to 0% (death). Analysed from Intent-to-treat (ITT) population comprised of 103 patients (SC:52 patients and IM:51 patients).|participants|Number|12|12.0||||||
3984423|NCT01257425|3806722|B1|90%||Karnofsky index (%)|Karnofsky index is a measure of performance status to quantify cancer patients' general well-being and activities of daily life. Karnofsky scores run from 100% (perfect health) to 0% (death). Analysed from Intent-to-treat (ITT) population comprised of 103 patients (SC:52 patients and IM:51 patients).|participants|Number|18|18.0||||||
3984424|NCT01257425|3806720|B3|100%||Karnofsky index (%)|Karnofsky index is a measure of performance status to quantify cancer patients' general well-being and activities of daily life. Karnofsky scores run from 100% (perfect health) to 0% (death). Analysed from Intent-to-treat (ITT) population comprised of 103 patients (SC:52 patients and IM:51 patients).|participants|Number|48|48.0||||||
3984425|NCT01257425|3806721|B2|100%||Karnofsky index (%)|Karnofsky index is a measure of performance status to quantify cancer patients' general well-being and activities of daily life. Karnofsky scores run from 100% (perfect health) to 0% (death). Analysed from Intent-to-treat (ITT) population comprised of 103 patients (SC:52 patients and IM:51 patients).|participants|Number|27|27.0||||||
3984426|NCT01257425|3806722|B1|100%||Karnofsky index (%)|Karnofsky index is a measure of performance status to quantify cancer patients' general well-being and activities of daily life. Karnofsky scores run from 100% (perfect health) to 0% (death). Analysed from Intent-to-treat (ITT) population comprised of 103 patients (SC:52 patients and IM:51 patients).|participants|Number|21|21.0||||||
3984427|NCT01257425|3806720|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984428|NCT01257425|3806721|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984429|NCT01257425|3806722|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984430|NCT01257425|3806720|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984431|NCT01257425|3806721|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984432|NCT01257425|3806722|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984433|NCT01257425|3806720|B3||White|Race (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
3984434|NCT01257425|3806721|B2||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3984435|NCT01257425|3806722|B1||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3984436|NCT01257425|3806720|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984437|NCT01257425|3806721|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984438|NCT01257425|3806722|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984440|NCT01257425|3806721|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984441|NCT01257425|3806722|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984442|NCT01257425|3806720|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984443|NCT01257425|3806721|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984444|NCT01257425|3806722|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984445|NCT01257425|3806720|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984446|NCT01257425|3806721|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984447|NCT01257425|3806722|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984448|NCT01257425|3806720|B3||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3984449|NCT01257425|3806721|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3984450|NCT01257425|3806722|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3984451|NCT01257425|3806720|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3984452|NCT01257425|3806721|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3984453|NCT01257425|3806722|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3984454|NCT01257425|3806720|B3|80 to < 90 years||Age, Customized||participants|Number|17|17.0||||||
3984455|NCT01257425|3806721|B2|80 to < 90 years||Age, Customized||participants|Number|7|7.0||||||
3984456|NCT01257425|3806722|B1|80 to < 90 years||Age, Customized||participants|Number|10|10.0||||||
3984457|NCT01257425|3806720|B3|70 to < 80 years||Age, Customized||participants|Number|61|61.0||||||
3984458|NCT01257425|3806721|B2|70 to < 80 years||Age, Customized||participants|Number|31|31.0||||||
3984459|NCT01257425|3806722|B1|70 to < 80 years||Age, Customized||participants|Number|30|30.0||||||
3984460|NCT01257425|3806720|B3|60 to < 70 years||Age, Customized||participants|Number|21|21.0||||||
3984461|NCT01257425|3806721|B2|60 to < 70 years||Age, Customized||participants|Number|11|11.0||||||
3984462|NCT01257425|3806722|B1|60 to < 70 years||Age, Customized||participants|Number|10|10.0||||||
3984463|NCT01257425|3806720|B3|50 to < 60 years||Age, Customized||participants|Number|4|4.0||||||
3984464|NCT01257425|3806721|B2|50 to < 60 years||Age, Customized||participants|Number|2|2.0||||||
3984465|NCT01257425|3806722|B1|50 to < 60 years||Age, Customized||participants|Number|2|2.0||||||
3984466|NCT01257425|3806720|B3|||Age||years|Mean|73.3|73.3|Standard Deviation|6.8|6.8|||
3984467|NCT01257425|3806721|B2|||Age||years|Mean|73.3|73.3|Standard Deviation|7.0|7.0|||
3984468|NCT01257425|3806722|B1|||Age||years|Mean|73.4|73.4|Standard Deviation|6.7|6.7|||
3984469|NCT01257347|3806741|B5|United States||Region of Enrollment||Participants|Number|124|124.0||||||
3984470|NCT01257347|3806742|B4|United States||Region of Enrollment||Participants|Number|65|65.0||||||
3984471|NCT01257347|3806743|B3|United States||Region of Enrollment||Participants|Number|35|35.0||||||
3984472|NCT01257347|3806744|B2|United States||Region of Enrollment||Participants|Number|12|12.0||||||
3984473|NCT01257347|3806745|B1|United States||Region of Enrollment||Participants|Number|12|12.0||||||
3984474|NCT01257347|3806741|B5|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3984475|NCT01257347|3806742|B4|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3984476|NCT01257347|3806743|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3984477|NCT01257347|3806744|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3984478|NCT01257347|3806745|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3984479|NCT01257347|3806741|B5|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3984480|NCT01257347|3806742|B4|More than one race||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3984481|NCT01257347|3806743|B3|More than one race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3984482|NCT01257347|3806744|B2|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3984483|NCT01257347|3806745|B1|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3984484|NCT01257347|3806741|B5|White||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3984485|NCT01257347|3806742|B4|White||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3984486|NCT01257347|3806743|B3|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3984487|NCT01257347|3806744|B2|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3984488|NCT01257347|3806745|B1|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3984489|NCT01257347|3806741|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3984490|NCT01257347|3806742|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3984491|NCT01257347|3806743|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3984492|NCT01257347|3806744|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3984493|NCT01257347|3806745|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3984494|NCT01257347|3806741|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3984495|NCT01257347|3806742|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3984496|NCT01257347|3806743|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3984497|NCT01257347|3806744|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3984498|NCT01257347|3806745|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3984499|NCT01257347|3806741|B5|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3984500|NCT01257347|3806742|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3984501|NCT01257347|3806743|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3984502|NCT01257347|3806744|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3984503|NCT01257347|3806745|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3984504|NCT01257347|3806741|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3984505|NCT01257347|3806742|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3984506|NCT01257347|3806743|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3984507|NCT01257347|3806744|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3984508|NCT01257347|3806745|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3984509|NCT01257347|3806741|B5|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3984510|NCT01257347|3806742|B4|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3984511|NCT01257347|3806743|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3984512|NCT01257347|3806744|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3984513|NCT01257347|3806745|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3984514|NCT01257347|3806741|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3984515|NCT01257347|3806742|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3984516|NCT01257347|3806743|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3984517|NCT01257347|3806744|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3984518|NCT01257347|3806745|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3984519|NCT01257347|3806741|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3984520|NCT01257347|3806742|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
3984521|NCT01257347|3806743|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3984522|NCT01257347|3806744|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3984523|NCT01257347|3806745|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3984524|NCT01257347|3806741|B5|Male||Sex/Gender, Customized||participants|Number|11|11.0||||||
3984525|NCT01257347|3806742|B4|Male||Sex/Gender, Customized||participants|Number|15|15.0||||||
3984526|NCT01257347|3806743|B3|Male||Sex/Gender, Customized||participants|Number|13|13.0||||||
3984527|NCT01257347|3806744|B2|Male||Sex/Gender, Customized||participants|Number|5|5.0||||||
3984528|NCT01257347|3806745|B1|Male||Sex/Gender, Customized||participants|Number|6|6.0||||||
3984529|NCT01257347|3806741|B5|Female||Sex/Gender, Customized||participants|Number|13|13.0||||||
3984530|NCT01257347|3806742|B4|Female||Sex/Gender, Customized||participants|Number|50|50.0||||||
3984531|NCT01257347|3806743|B3|Female||Sex/Gender, Customized||participants|Number|22|22.0||||||
3984532|NCT01257347|3806744|B2|Female||Sex/Gender, Customized||participants|Number|7|7.0||||||
3984533|NCT01257347|3806745|B1|Female||Sex/Gender, Customized||participants|Number|6|6.0||||||
3984534|NCT01257347|3806741|B5|||Age||years|Mean|47|47.0|Standard Deviation|11|11.0|||
3984535|NCT01257347|3806742|B4|||Age||years|Mean|64|64.0|Standard Deviation|8|8.0|||
3984536|NCT01257347|3806743|B3|||Age||years|Mean|64|64.0|Standard Deviation|9|9.0|||
3984537|NCT01257347|3806744|B2|||Age||years|Mean|48|48.0|Standard Deviation|10|10.0|||
3984538|NCT01257347|3806745|B1|||Age||years|Mean|46|46.0|Standard Deviation|11|11.0|||
3984539|NCT01257230|3806762|B4||Male|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
3984540|NCT01257230|3806763|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3984541|NCT01257230|3806764|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3984542|NCT01257230|3806765|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3984543|NCT01257230|3806762|B4||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3984544|NCT01257230|3806763|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3984545|NCT01257230|3806764|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3984546|NCT01257230|3806765|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3984547|NCT01257230|3806762|B4|||Age||years|Mean|14.3|14.3|Standard Deviation|1.7|1.7|||
3984548|NCT01257230|3806763|B3|||Age||years|Mean|14.5|14.5|Standard Deviation|1.6|1.6|||
3984549|NCT01257230|3806764|B2|||Age||years|Mean|14.2|14.2|Standard Deviation|1.8|1.8|||
3984550|NCT01257230|3806765|B1|||Age||years|Mean|14.2|14.2|Standard Deviation|1.7|1.7|||
3984551|NCT01257217|3806820|B3|Spain||Region of Enrollment||participants|Number|25|25.0||||||
3984552|NCT01257217|3806821|B2|Spain||Region of Enrollment||participants|Number|10|10.0||||||
3984553|NCT01257217|3806822|B1|Spain||Region of Enrollment||participants|Number|15|15.0||||||
3984554|NCT01257217|3806820|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3984555|NCT01257217|3806821|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3984556|NCT01257217|3806822|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3984557|NCT01257217|3806820|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3984558|NCT01257217|3806821|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3984559|NCT01257217|3806822|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3984560|NCT01257217|3806820|B3|≥ 21 years||Age, Customized||participants|Number|25|25.0||||||
3984561|NCT01257217|3806821|B2|≥ 21 years||Age, Customized||participants|Number|10|10.0||||||
3984562|NCT01257217|3806822|B1|≥ 21 years||Age, Customized||participants|Number|15|15.0||||||
3984563|NCT01257217|3806820|B3|< 21 years||Age, Customized||participants|Number|0|0.0||||||
3984564|NCT01257217|3806821|B2|< 21 years||Age, Customized||participants|Number|0|0.0||||||
3984565|NCT01257217|3806822|B1|< 21 years||Age, Customized||participants|Number|0|0.0||||||
3984566|NCT01257204|3806841|B4|Not Reported||Cirrhosis Status||participants|Number|5|5.0||||||
3984567|NCT01257204|3806842|B3|Not Reported||Cirrhosis Status||participants|Number|2|2.0||||||
3984568|NCT01257204|3806843|B2|Not Reported||Cirrhosis Status||participants|Number|3|3.0||||||
3984569|NCT01257204|3806844|B1|Not Reported||Cirrhosis Status||participants|Number|0|0.0||||||
3984570|NCT01257204|3806841|B4|Present||Cirrhosis Status||participants|Number|19|19.0||||||
3984571|NCT01257204|3806842|B3|Present||Cirrhosis Status||participants|Number|8|8.0||||||
3984572|NCT01257204|3806843|B2|Present||Cirrhosis Status||participants|Number|4|4.0||||||
3984573|NCT01257204|3806844|B1|Present||Cirrhosis Status||participants|Number|7|7.0||||||
3984574|NCT01257204|3806841|B4|Absent||Cirrhosis Status||participants|Number|127|127.0||||||
3984575|NCT01257204|3806842|B3|Absent||Cirrhosis Status||participants|Number|41|41.0||||||
3984576|NCT01257204|3806843|B2|Absent||Cirrhosis Status||participants|Number|43|43.0||||||
3984577|NCT01257204|3806844|B1|Absent||Cirrhosis Status||participants|Number|43|43.0||||||
3984578|NCT01257204|3806841|B4|HCV Genotype 3||Randomization Stratum||participants|Number|80|80.0||||||
3984579|NCT01257204|3806842|B3|HCV Genotype 3||Randomization Stratum||participants|Number|27|27.0||||||
3984580|NCT01257204|3806843|B2|HCV Genotype 3||Randomization Stratum||participants|Number|27|27.0||||||
3984581|NCT01257204|3806844|B1|HCV Genotype 3||Randomization Stratum||participants|Number|26|26.0||||||
3984582|NCT01257204|3806841|B4|HCV Genotype 2||Randomization Stratum||participants|Number|71|71.0||||||
3984583|NCT01257204|3806842|B3|HCV Genotype 2||Randomization Stratum||participants|Number|24|24.0||||||
3984584|NCT01257204|3806843|B2|HCV Genotype 2||Randomization Stratum||participants|Number|23|23.0||||||
3984585|NCT01257204|3806844|B1|HCV Genotype 2||Randomization Stratum||participants|Number|24|24.0||||||
3984586|NCT01257204|3806841|B4|≥800,000 IU/mL||HCV RNA Distribution||participants|Number|126|126.0||||||
3984587|NCT01257204|3806842|B3|≥800,000 IU/mL||HCV RNA Distribution||participants|Number|45|45.0||||||
3984588|NCT01257204|3806843|B2|≥800,000 IU/mL||HCV RNA Distribution||participants|Number|43|43.0||||||
3984589|NCT01257204|3806844|B1|≥800,000 IU/mL||HCV RNA Distribution||participants|Number|38|38.0||||||
3984590|NCT01257204|3806841|B4|<800,000 IU/mL||HCV RNA Distribution||participants|Number|25|25.0||||||
3984591|NCT01257204|3806842|B3|<800,000 IU/mL||HCV RNA Distribution||participants|Number|6|6.0||||||
3984592|NCT01257204|3806843|B2|<800,000 IU/mL||HCV RNA Distribution||participants|Number|7|7.0||||||
3984593|NCT01257204|3806844|B1|<800,000 IU/mL||HCV RNA Distribution||participants|Number|12|12.0||||||
3984594|NCT01257204|3806841|B4|||Hepatitis C Virus (HCV) RNA (IU/mL)||Log10 IU/mL|Mean|6.5|6.5|Standard Deviation|0.69|0.69|||
3984595|NCT01257204|3806842|B3|||Hepatitis C Virus (HCV) RNA (IU/mL)||Log10 IU/mL|Mean|6.6|6.6|Standard Deviation|0.59|0.59|||
3984596|NCT01257204|3806843|B2|||Hepatitis C Virus (HCV) RNA (IU/mL)||Log10 IU/mL|Mean|6.6|6.6|Standard Deviation|0.62|0.62|||
3984597|NCT01257204|3806844|B1|||Hepatitis C Virus (HCV) RNA (IU/mL)||Log10 IU/mL|Mean|6.4|6.4|Standard Deviation|0.82|0.82|||
3984598|NCT01257204|3806841|B4||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3984599|NCT01257204|3806842|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3984600|NCT01257204|3806843|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3984601|NCT01257204|3806844|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3984602|NCT01257204|3806841|B4||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3984603|NCT01257204|3806842|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3984604|NCT01257204|3806843|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3984605|NCT01257204|3806844|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3984606|NCT01257204|3806841|B4|||Age||years|Mean|47.9|47.9|Standard Deviation|9.09|9.09|||
3984607|NCT01257204|3806842|B3|||Age||years|Mean|48.8|48.8|Standard Deviation|9.73|9.73|||
3984608|NCT01257204|3806843|B2|||Age||years|Mean|47.5|47.5|Standard Deviation|9.20|9.2|||
3984609|NCT01257204|3806844|B1|||Age||years|Mean|47.5|47.5|Standard Deviation|8.42|8.42|||
3984610|NCT01256983|3806890|B3|Switzerland||Region of Enrollment||participants|Number|30|30.0||||||
3984611|NCT01256983|3806891|B2|Switzerland||Region of Enrollment||participants|Number|15|15.0||||||
3984612|NCT01256983|3806892|B1|Switzerland||Region of Enrollment||participants|Number|15|15.0||||||
3984613|NCT01256983|3806890|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3984614|NCT01256983|3806891|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3984615|NCT01256983|3806892|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3984616|NCT01256983|3806890|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3984617|NCT01256983|3806891|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3984618|NCT01256983|3806892|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3984619|NCT01256983|3806890|B3|||Age||years|Mean|59.63|59.63|Standard Deviation|12.65|12.65|||
3984620|NCT01256983|3806891|B2|||Age||years|Mean|58.54|58.54|Standard Deviation|14.91|14.91|||
3984621|NCT01256983|3806892|B1|||Age||years|Mean|60.72|60.72|Standard Deviation|10.33|10.33|||
3984622|NCT01256983|3806890|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3984623|NCT01256983|3806891|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3984624|NCT01256983|3806892|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3984625|NCT01256983|3806890|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3984626|NCT01256983|3806891|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3984627|NCT01256983|3806892|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3984628|NCT01256983|3806890|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3984629|NCT01256983|3806891|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3984630|NCT01256983|3806892|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3984631|NCT01256944|3806899|B3|Taiwan||Region of Enrollment||participants|Number|290|290.0||||||
3984632|NCT01256944|3806900|B2|Taiwan||Region of Enrollment||participants|Number|220|220.0||||||
3984633|NCT01256944|3806901|B1|Taiwan||Region of Enrollment||participants|Number|70|70.0||||||
3984634|NCT01256944|3806899|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3984635|NCT01256944|3806900|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3984636|NCT01256944|3806901|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3984637|NCT01256944|3806899|B3||Female|Sex: Female, Male||Participants|Count of Participants|290|290.0||||||
3984638|NCT01256944|3806900|B2||Female|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
3984639|NCT01256944|3806901|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3984640|NCT01256944|3806899|B3|||Age||years old|Mean|27.68|27.68|Standard Deviation|7.1|7.1|||
3984641|NCT01256944|3806900|B2|||Age||years old|Mean|26.9|26.9|Standard Deviation|5.8|5.8|||
3984642|NCT01256944|3806901|B1|||Age||years old|Mean|28.3|28.3|Standard Deviation|4.4|4.4|||
3984643|NCT01256918|3806930|B1|India||Region of Enrollment||participants|Number|200|200.0||||||
3984644|NCT01256918|3806930|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3984645|NCT01256918|3806930|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3984646|NCT01256918|3806930|B1|||Age||years|Mean|62.7|62.7|Standard Deviation|10.36|10.36|||
3984647|NCT01256918|3806930|B1||>=65 years|Age||Participants|Count of Participants|87|87.0||||||
3984648|NCT01256918|3806930|B1||Between 18 and 65 years|Age||Participants|Count of Participants|113|113.0||||||
3984649|NCT01256918|3806930|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3984650|NCT01256840|3806941|B4|||Cytomegalovirus seropositive||Participants|Count of Participants|33|33.0||||||
3984651|NCT01256840|3806942|B3|||Cytomegalovirus seropositive||Participants|Count of Participants|13|13.0||||||
3984652|NCT01256840|3806943|B2|||Cytomegalovirus seropositive||Participants|Count of Participants|7|7.0||||||
3984653|NCT01256840|3806944|B1|||Cytomegalovirus seropositive||Participants|Count of Participants|13|13.0||||||
3984654|NCT01256840|3806941|B4|||Body Mass Index||kg/m^2|Mean|23.52|23.52|Standard Deviation|5.07|5.07|||
3984655|NCT01256840|3806942|B3|||Body Mass Index||kg/m^2|Mean|29.03|29.03|Standard Deviation|3.38|3.38|||
3984656|NCT01256840|3806943|B2|||Body Mass Index||kg/m^2|Mean|23.27|23.27|Standard Deviation|90.21|90.21|||
3984657|NCT01256840|3806944|B1|||Body Mass Index||kg/m^2|Mean|19.07|19.07|Standard Deviation|1.84|1.84|||
3984658|NCT01256840|3806941|B4|Doctoral||Highest Degree||Participants|Count of Participants|27|27.0||||||
3984659|NCT01256840|3806942|B3|Doctoral||Highest Degree||Participants|Count of Participants|11|11.0||||||
3984660|NCT01256840|3806943|B2|Doctoral||Highest Degree||Participants|Count of Participants|2|2.0||||||
3984661|NCT01256840|3806944|B1|Doctoral||Highest Degree||Participants|Count of Participants|14|14.0||||||
3984662|NCT01256840|3806941|B4|Master's||Highest Degree||Participants|Count of Participants|13|13.0||||||
3984663|NCT01256840|3806942|B3|Master's||Highest Degree||Participants|Count of Participants|2|2.0||||||
3984664|NCT01256840|3806943|B2|Master's||Highest Degree||Participants|Count of Participants|5|5.0||||||
3984665|NCT01256840|3806944|B1|Master's||Highest Degree||Participants|Count of Participants|6|6.0||||||
3984666|NCT01256840|3806941|B4|Bachelor's||Highest Degree||Participants|Count of Participants|13|13.0||||||
3984667|NCT01256840|3806942|B3|Bachelor's||Highest Degree||Participants|Count of Participants|2|2.0||||||
3984668|NCT01256840|3806943|B2|Bachelor's||Highest Degree||Participants|Count of Participants|6|6.0||||||
3984669|NCT01256840|3806944|B1|Bachelor's||Highest Degree||Participants|Count of Participants|5|5.0||||||
3984670|NCT01256840|3806941|B4|Some college||Highest Degree||Participants|Count of Participants|6|6.0||||||
3984671|NCT01256840|3806942|B3|Some college||Highest Degree||Participants|Count of Participants|3|3.0||||||
3984672|NCT01256840|3806943|B2|Some college||Highest Degree||Participants|Count of Participants|1|1.0||||||
3984673|NCT01256840|3806944|B1|Some college||Highest Degree||Participants|Count of Participants|2|2.0||||||
3984674|NCT01256840|3806941|B4|High School||Highest Degree||Participants|Count of Participants|3|3.0||||||
3984675|NCT01256840|3806942|B3|High School||Highest Degree||Participants|Count of Participants|1|1.0||||||
3984676|NCT01256840|3806943|B2|High School||Highest Degree||Participants|Count of Participants|0|0.0||||||
3984677|NCT01256840|3806944|B1|High School||Highest Degree||Participants|Count of Participants|2|2.0||||||
3984678|NCT01256840|3806941|B4|Japan||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3984679|NCT01256840|3806942|B3|Japan||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3984680|NCT01256840|3806943|B2|Japan||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3984681|NCT01256840|3806944|B1|Japan||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3984682|NCT01256840|3806941|B4|United Kingdom||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3984683|NCT01256840|3806942|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3984684|NCT01256840|3806943|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3984685|NCT01256840|3806944|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3984686|NCT01256840|3806941|B4|United States||Region of Enrollment||Participants|Count of Participants|69|69.0||||||
3984687|NCT01256840|3806942|B3|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3984688|NCT01256840|3806943|B2|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3984689|NCT01256840|3806944|B1|United States||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3984690|NCT01256840|3806941|B4|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3984691|NCT01256840|3806942|B3|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3984692|NCT01256840|3806943|B2|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3984693|NCT01256840|3806944|B1|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3984694|NCT01256840|3806941|B4|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|63|63.0||||||
3984695|NCT01256840|3806942|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
3984696|NCT01256840|3806943|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3984697|NCT01256840|3806944|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3984698|NCT01256840|3806941|B4||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3984699|NCT01256840|3806942|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3984700|NCT01256840|3806943|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3984701|NCT01256840|3806944|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3984702|NCT01256840|3806941|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3984703|NCT01256840|3806942|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3984704|NCT01256840|3806943|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3984705|NCT01256840|3806944|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3984706|NCT01256840|3806941|B4|||Age||years|Mean|55.01|55.01|Standard Deviation|14.53|14.53|||
3984707|NCT01256840|3806942|B3|||Age||years|Mean|58.84|58.84|Standard Deviation|13.98|13.98|||
3984708|NCT01256840|3806943|B2|||Age||years|Mean|49.33|49.33|Standard Deviation|12.49|12.49|||
3984709|NCT01256840|3806944|B1|||Age||years|Mean|54.64|54.64|Standard Deviation|15.38|15.38|||
3984710|NCT01256684|3806954|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3984711|NCT01256684|3806955|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3984712|NCT01256684|3806956|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3984713|NCT01256684|3806957|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3984714|NCT01256684|3806954|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3984715|NCT01256684|3806955|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3984716|NCT01256684|3806956|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3984717|NCT01256684|3806957|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3984718|NCT01256684|3806954|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3984719|NCT01256684|3806955|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3984720|NCT01256684|3806956|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3984721|NCT01256684|3806957|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3984722|NCT01256684|3806954|B4|White Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|233|233.0||||||
3984723|NCT01256684|3806955|B3|White Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|83|83.0||||||
3984724|NCT01256684|3806956|B2|White Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|81|81.0||||||
3984725|NCT01256684|3806957|B1|White Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|69|69.0||||||
3984726|NCT01256684|3806954|B4|Female||Sex/Gender, Customized||Participants|Count of Participants|253|253.0||||||
3984727|NCT01256684|3806955|B3|Female||Sex/Gender, Customized||Participants|Count of Participants|87|87.0||||||
3984728|NCT01256684|3806956|B2|Female||Sex/Gender, Customized||Participants|Count of Participants|86|86.0||||||
3984729|NCT01256684|3806957|B1|Female||Sex/Gender, Customized||Participants|Count of Participants|80|80.0||||||
3984730|NCT01256684|3806954|B4|||Age||years|Mean|58.55|58.55|Standard Deviation|6.01|6.01|||
3984731|NCT01256684|3806955|B3|||Age||years|Mean|57.51|57.51|Standard Deviation|5.63|5.63|||
3984732|NCT01256684|3806956|B2|||Age||years|Mean|59.37|59.37|Standard Deviation|6.39|6.39|||
3984733|NCT01256684|3806957|B1|||Age||years|Mean|58.81|58.81|Standard Deviation|5.89|5.89|||
3984734|NCT01256671|3806991|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3984735|NCT01256671|3806991|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3984736|NCT01256671|3806991|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3984737|NCT01256671|3806991|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3984738|NCT01256671|3806991|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
3984739|NCT01256671|3806991|B1|White Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|478|478.0||||||
3984740|NCT01256671|3806991|B1|Female||Sex/Gender, Customized||Participants|Count of Participants|521|521.0||||||
3984741|NCT01256671|3806991|B1|||Age||years|Mean|57.95|57.95|Standard Deviation|5.65|5.65|||
3984742|NCT01256658|3807002|B3||Male|Sex: Female, Male||Participants|Count of Participants|6603|6603.0||||||
3984743|NCT01256658|3807003|B2||Male|Sex: Female, Male||Participants|Count of Participants|3442|3442.0||||||
3984744|NCT01256658|3807004|B1||Male|Sex: Female, Male||Participants|Count of Participants|3161|3161.0||||||
3984745|NCT01256658|3807002|B3||Female|Sex: Female, Male||Participants|Count of Participants|7472|7472.0||||||
3984746|NCT01256658|3807003|B2||Female|Sex: Female, Male||Participants|Count of Participants|3816|3816.0||||||
3984747|NCT01256658|3807004|B1||Female|Sex: Female, Male||Participants|Count of Participants|3656|3656.0||||||
3984748|NCT01256658|3807002|B3|||Age||years|Mean|22.82|22.82|Standard Deviation|20.63|20.63|||
3984749|NCT01256658|3807003|B2|||Age||years|Mean|22.62|22.62|Standard Deviation|20.31|20.31|||
3984750|NCT01256658|3807004|B1|||Age||years|Mean|23.02|23.02|Standard Deviation|20.67|20.67|||
3984751|NCT01256567|3807055|B1|Japan||Region of Enrollment||participants|Number|7|7.0||||||
3984752|NCT01256567|3807055|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3984753|NCT01256567|3807055|B1|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3984754|NCT01256567|3807055|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3984755|NCT01256567|3807055|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3984756|NCT01256567|3807055|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3984757|NCT01256567|3807055|B1|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3984758|NCT01256567|3807055|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3984759|NCT01256567|3807055|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3984760|NCT01256567|3807055|B1|>=65 years||Age, Customized||participants|Number|1|1.0||||||
3984761|NCT01256567|3807055|B1|Between 20 and 65 years||Age, Customized||participants|Number|6|6.0||||||
3984762|NCT01256502|3807065|B1|United States||Region of Enrollment||participants|Number|139|139.0||||||
3984763|NCT01256502|3807065|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3984764|NCT01256502|3807065|B1||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3984765|NCT01256502|3807065|B1|70+ years||Age, Customized||participants|Number|4|4.0||||||
3984766|NCT01256502|3807065|B1|60 to 69 years||Age, Customized||participants|Number|22|22.0||||||
3984767|NCT01256502|3807065|B1|50 to 59 years||Age, Customized||participants|Number|40|40.0||||||
3984768|NCT01256502|3807065|B1|40 to 49 years||Age, Customized||participants|Number|54|54.0||||||
3984769|NCT01256502|3807065|B1|30 to 39 years||Age, Customized||participants|Number|15|15.0||||||
3984770|NCT01256502|3807065|B1|20 to 29 years||Age, Customized||participants|Number|4|4.0||||||
3984771|NCT01256502|3807065|B1|18 to 19 years||Age, Customized||participants|Number|0|0.0||||||
3984772|NCT01256476|3807075|B3|United States||Region of Enrollment||participants|Number|328|328.0||||||
3984773|NCT01256476|3807076|B2|United States||Region of Enrollment||participants|Number|164|164.0||||||
3984774|NCT01256476|3807077|B1|United States||Region of Enrollment||participants|Number|164|164.0||||||
3984775|NCT01256476|3807075|B3||Male|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3984776|NCT01256476|3807076|B2||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3984777|NCT01256476|3807077|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3984778|NCT01256476|3807075|B3||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3984779|NCT01256476|3807076|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3984780|NCT01256476|3807077|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3984781|NCT01256476|3807075|B3|||Age||years|Mean|57.9|57.9|Standard Deviation|9.63|9.63|||
3984782|NCT01256476|3807076|B2|||Age||years|Mean|57.0|57.0|Standard Deviation|10.23|10.23|||
3984783|NCT01256476|3807077|B1|||Age||years|Mean|58.8|58.8|Standard Deviation|8.93|8.93|||
3984784|NCT01256476|3807075|B3||>=65 years|Age||Participants|Count of Participants|79|79.0||||||
3984785|NCT01256476|3807076|B2||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
3984786|NCT01256476|3807077|B1||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
3984787|NCT01256476|3807075|B3||Between 18 and 65 years|Age||Participants|Count of Participants|249|249.0||||||
3984788|NCT01256476|3807076|B2||Between 18 and 65 years|Age||Participants|Count of Participants|127|127.0||||||
3984789|NCT01256476|3807077|B1||Between 18 and 65 years|Age||Participants|Count of Participants|122|122.0||||||
3984790|NCT01256476|3807075|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3984791|NCT01256476|3807076|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3984792|NCT01256476|3807077|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3984793|NCT01256450|3807084|B3|United States||Region of Enrollment||participants|Number|235|235.0||||||
3984794|NCT01256450|3807085|B2|United States||Region of Enrollment||participants|Number|118|118.0||||||
3984795|NCT01256450|3807086|B1|United States||Region of Enrollment||participants|Number|117|117.0||||||
3984796|NCT01256450|3807084|B3||Male|Gender||Participants|Count of Participants|107|107.0||||||
3984797|NCT01256450|3807085|B2||Male|Gender||Participants|Count of Participants|52|52.0||||||
3984798|NCT01256450|3807086|B1||Male|Gender||Participants|Count of Participants|55|55.0||||||
3984799|NCT01256450|3807084|B3||Female|Gender||Participants|Count of Participants|128|128.0||||||
3984800|NCT01256450|3807085|B2||Female|Gender||Participants|Count of Participants|66|66.0||||||
3984801|NCT01256450|3807086|B1||Female|Gender||Participants|Count of Participants|62|62.0||||||
3984802|NCT01256450|3807084|B3|||Age||years|Median|52.0|52.0|Full Range|||20.0|89.0|
3984803|NCT01256450|3807085|B2|||Age||years|Median|51.5|51.5|Full Range|||20.0|77.0|
3984804|NCT01256450|3807086|B1|||Age||years|Median|52.0|52.0|Full Range|||21.0|89.0|
3984805|NCT01256450|3807084|B3||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
3984806|NCT01256450|3807085|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3984807|NCT01256450|3807086|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3984808|NCT01256450|3807084|B3||Between 18 and 65 years|Age||Participants|Count of Participants|200|200.0||||||
3984809|NCT01256450|3807085|B2||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
3984810|NCT01256450|3807086|B1||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
3984811|NCT01256450|3807084|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3984812|NCT01256450|3807085|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3984813|NCT01256450|3807086|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3984814|NCT01256424|3807113|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984815|NCT01256424|3807114|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984816|NCT01256424|3807115|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984817|NCT01256424|3807116|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984818|NCT01256424|3807117|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984819|NCT01256424|3807113|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984820|NCT01256424|3807114|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984821|NCT01256424|3807115|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984822|NCT01256424|3807116|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984823|NCT01256424|3807117|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984824|NCT01256424|3807113|B5||White|Race (NIH/OMB)||Participants|Count of Participants|258|258.0||||||
3984825|NCT01256424|3807114|B4||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3984826|NCT01256424|3807115|B3||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3984827|NCT01256424|3807116|B2||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3984828|NCT01256424|3807117|B1||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3984829|NCT01256424|3807113|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3984830|NCT01256424|3807114|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984831|NCT01256424|3807115|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3984832|NCT01256424|3807116|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3984833|NCT01256424|3807117|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3984834|NCT01256424|3807113|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984835|NCT01256424|3807114|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984836|NCT01256424|3807115|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984837|NCT01256424|3807116|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984838|NCT01256424|3807117|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984839|NCT01256424|3807113|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984840|NCT01256424|3807114|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984841|NCT01256424|3807115|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984842|NCT01256424|3807116|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984843|NCT01256424|3807117|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984844|NCT01256424|3807113|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984845|NCT01256424|3807114|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984846|NCT01256424|3807115|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984847|NCT01256424|3807116|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984848|NCT01256424|3807117|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3984849|NCT01256424|3807113|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3984850|NCT01256424|3807114|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3984851|NCT01256424|3807115|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3984852|NCT01256424|3807116|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3984853|NCT01256424|3807117|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3984854|NCT01256424|3807113|B5||Female|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
3984855|NCT01256424|3807114|B4||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3984856|NCT01256424|3807115|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3984857|NCT01256424|3807116|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3984858|NCT01256424|3807117|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3984859|NCT01256424|3807113|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3984860|NCT01256424|3807114|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3984861|NCT01256424|3807115|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3984862|NCT01256424|3807116|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3984863|NCT01256424|3807117|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3984864|NCT01256424|3807113|B5||Between 18 and 65 years|Age||Participants|Count of Participants|262|262.0||||||
3984865|NCT01256424|3807114|B4||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
3984866|NCT01256424|3807115|B3||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
3984867|NCT01256424|3807116|B2||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
3984868|NCT01256424|3807117|B1||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
3984869|NCT01256424|3807113|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3984870|NCT01256424|3807114|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3984871|NCT01256424|3807115|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3984872|NCT01256424|3807116|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3984873|NCT01256424|3807117|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3984874|NCT01256411|3807142|B5||Male|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
3984875|NCT01256411|3807143|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3984876|NCT01256411|3807144|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3984877|NCT01256411|3807145|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3984878|NCT01256411|3807146|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3984879|NCT01256411|3807142|B5||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3984880|NCT01256411|3807143|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3984881|NCT01256411|3807144|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3984882|NCT01256411|3807145|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3984883|NCT01256411|3807146|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3984884|NCT01256411|3807142|B5|||Age||Years|Mean|51.8|51.8|Standard Deviation|9.73|9.73|||
3984885|NCT01256411|3807143|B4|||Age||Years|Mean|46.3|46.3|Standard Deviation|2.06|2.06|||
3984886|NCT01256411|3807144|B3|||Age||Years|Mean|52.5|52.5|Standard Deviation|9.53|9.53|||
3984887|NCT01256411|3807145|B2|||Age||Years|Mean|50.3|50.3|Standard Deviation|10.14|10.14|||
3984888|NCT01256411|3807146|B1|||Age||Years|Mean|52.2|52.2|Standard Deviation|9.69|9.69|||
3984889|NCT01256385|3807175|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
3984890|NCT01256385|3807176|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
3984891|NCT01256385|3807177|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3984892|NCT01256385|3807175|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3984893|NCT01256385|3807176|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3984894|NCT01256385|3807177|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3984895|NCT01256385|3807175|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3984896|NCT01256385|3807176|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3984897|NCT01256385|3807177|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3984898|NCT01256385|3807175|B3|||Age||years|Median|63|63.0|Full Range|||39.0|86.0|
3984899|NCT01256385|3807176|B2|||Age||years|Median|63|63.0|Full Range|||39.0|81.0|
3984900|NCT01256385|3807177|B1|||Age||years|Median|63|63.0|Full Range|||48.0|86.0|
3984901|NCT01256294|3807198|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3984902|NCT01256294|3807198|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3984903|NCT01256294|3807198|B1|||Age||years|Mean|52.1|52.1|Standard Deviation|12.5|12.5|||
3984904|NCT01256281|3807215|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3984905|NCT01256281|3807215|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3984906|NCT01256281|3807215|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3984907|NCT01256281|3807215|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3984908|NCT01256281|3807215|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3984909|NCT01256190|3807219|B3|Netherlands||Region of Enrollment||participants|Number|56|56.0||||||
3984910|NCT01256190|3807220|B2|Netherlands||Region of Enrollment||participants|Number|17|17.0||||||
3984911|NCT01256190|3807221|B1|Netherlands||Region of Enrollment||participants|Number|39|39.0||||||
3984912|NCT01256190|3807219|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3984913|NCT01256190|3807220|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3984914|NCT01256190|3807221|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3984915|NCT01256190|3807219|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3984916|NCT01256190|3807220|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3984917|NCT01256190|3807221|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3984918|NCT01256190|3807219|B3|||Age||years|Mean|61|61.0|Standard Deviation|12|12.0|||
3984919|NCT01256190|3807220|B2|||Age||years|Mean|64|64.0|Standard Deviation|9|9.0|||
3984920|NCT01256190|3807221|B1|||Age||years|Mean|60|60.0|Standard Deviation|13|13.0|||
3984921|NCT01256190|3807219|B3||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3984922|NCT01256190|3807220|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3984923|NCT01256190|3807221|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3984924|NCT01256190|3807219|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3984925|NCT01256190|3807220|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3984926|NCT01256190|3807221|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3984927|NCT01256190|3807219|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3984928|NCT01256190|3807220|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3984929|NCT01256190|3807221|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3984930|NCT01256177|3807236|B3|||Hamilton Rating Scale for Depression (HAM-D) total score at baseline|HAM-D total score range: 0 to 53, the higher the score, the more severe.|Scores on a scale|Mean|23.3|23.3|Standard Deviation|3.3|3.3|||
3984931|NCT01256177|3807237|B2|||Hamilton Rating Scale for Depression (HAM-D) total score at baseline|HAM-D total score range: 0 to 53, the higher the score, the more severe.|Scores on a scale|Mean|23.5|23.5|Standard Deviation|3.6|3.6|||
3984932|NCT01256177|3807238|B1|||Hamilton Rating Scale for Depression (HAM-D) total score at baseline|HAM-D total score range: 0 to 53, the higher the score, the more severe.|Scores on a scale|Mean|23.2|23.2|Standard Deviation|3.0|3.0|||
3984933|NCT01256177|3807236|B3|Yes||Attempted sucide||Participants|Number|27|27.0||||||
3984934|NCT01256177|3807237|B2|Yes||Attempted sucide||Participants|Number|11|11.0||||||
3984935|NCT01256177|3807238|B1|Yes||Attempted sucide||Participants|Number|16|16.0||||||
3984936|NCT01256177|3807236|B3|No||Attempted sucide||Participants|Number|252|252.0||||||
3984937|NCT01256177|3807237|B2|No||Attempted sucide||Participants|Number|128|128.0||||||
3984938|NCT01256177|3807238|B1|No||Attempted sucide||Participants|Number|124|124.0||||||
3984939|NCT01256177|3807236|B3|||Years since Bipolar diagnosis||Years|Mean|3|3.0|Standard Deviation|4.6|4.6|||
3984940|NCT01256177|3807237|B2|||Years since Bipolar diagnosis||Years|Mean|2.8|2.8|Standard Deviation|4.6|4.6|||
3984941|NCT01256177|3807238|B1|||Years since Bipolar diagnosis||Years|Mean|3.2|3.2|Standard Deviation|4.7|4.7|||
3984942|NCT01256177|3807236|B3|||Duration of present depressive episode||Weeks|Mean|13|13.0|Standard Deviation|10.1|10.1|||
3984943|NCT01256177|3807237|B2|||Duration of present depressive episode||Weeks|Mean|13.7|13.7|Standard Deviation|10.3|10.3|||
3984944|NCT01256177|3807238|B1|||Duration of present depressive episode||Weeks|Mean|12.3|12.3|Standard Deviation|10.0|10.0|||
3984945|NCT01256177|3807236|B3|Yes||Rapid cycling course|Rapid cycling course defined as ≥ 4 mood episodes in the past year.|Participants|Number|13|13.0||||||
3984946|NCT01256177|3807237|B2|Yes||Rapid cycling course|Rapid cycling course defined as ≥ 4 mood episodes in the past year.|Participants|Number|5|5.0||||||
3984947|NCT01256177|3807238|B1|Yes||Rapid cycling course|Rapid cycling course defined as ≥ 4 mood episodes in the past year.|Participants|Number|8|8.0||||||
3984948|NCT01256177|3807236|B3|No||Rapid cycling course|Rapid cycling course defined as ≥ 4 mood episodes in the past year.|Participants|Number|266|266.0||||||
3984949|NCT01256177|3807237|B2|No||Rapid cycling course|Rapid cycling course defined as ≥ 4 mood episodes in the past year.|Participants|Number|134|134.0||||||
3984950|NCT01256177|3807238|B1|No||Rapid cycling course|Rapid cycling course defined as ≥ 4 mood episodes in the past year.|Participants|Number|132|132.0||||||
3984951|NCT01256177|3807236|B3|Bipolar - II||Bipolar Diagnosis|"Bipolar - I disorder is characterized by one or more manic or mixed episodes, usually alternating with major depressive episodes.~Bipolar - II disorder is characterized by one or more major depressive episodes and at least one hypomanic episode."|Participants|Number|137|137.0||||||
3984952|NCT01256177|3807237|B2|Bipolar - II||Bipolar Diagnosis|"Bipolar - I disorder is characterized by one or more manic or mixed episodes, usually alternating with major depressive episodes.~Bipolar - II disorder is characterized by one or more major depressive episodes and at least one hypomanic episode."|Participants|Number|69|69.0||||||
3984953|NCT01256177|3807238|B1|Bipolar - II||Bipolar Diagnosis|"Bipolar - I disorder is characterized by one or more manic or mixed episodes, usually alternating with major depressive episodes.~Bipolar - II disorder is characterized by one or more major depressive episodes and at least one hypomanic episode."|Participants|Number|68|68.0||||||
3984954|NCT01256177|3807236|B3|Bipolar - I||Bipolar Diagnosis|"Bipolar - I disorder is characterized by one or more manic or mixed episodes, usually alternating with major depressive episodes.~Bipolar - II disorder is characterized by one or more major depressive episodes and at least one hypomanic episode."|Participants|Number|142|142.0||||||
3984955|NCT01256177|3807237|B2|Bipolar - I||Bipolar Diagnosis|"Bipolar - I disorder is characterized by one or more manic or mixed episodes, usually alternating with major depressive episodes.~Bipolar - II disorder is characterized by one or more major depressive episodes and at least one hypomanic episode."|Participants|Number|70|70.0||||||
3984956|NCT01256177|3807238|B1|Bipolar - I||Bipolar Diagnosis|"Bipolar - I disorder is characterized by one or more manic or mixed episodes, usually alternating with major depressive episodes.~Bipolar - II disorder is characterized by one or more major depressive episodes and at least one hypomanic episode."|Participants|Number|72|72.0||||||
3984957|NCT01256177|3807236|B3|||MADRS total score at baseline|Montgomery-Asberg Depression Rating Scale (MADRS) total score range: 0 to 60, the higher the score, the more severe.|Scores on a scale|Mean|28.6|28.6|Standard Deviation|5.3|5.3|||
3984958|NCT01256177|3807237|B2|||MADRS total score at baseline|Montgomery-Asberg Depression Rating Scale (MADRS) total score range: 0 to 60, the higher the score, the more severe.|Scores on a scale|Mean|28.5|28.5|Standard Deviation|5.4|5.4|||
3984959|NCT01256177|3807238|B1|||MADRS total score at baseline|Montgomery-Asberg Depression Rating Scale (MADRS) total score range: 0 to 60, the higher the score, the more severe.|Scores on a scale|Mean|28.8|28.8|Standard Deviation|5.3|5.3|||
3984960|NCT01256177|3807236|B3|||Weight||Kilogram (Kg)|Mean|64.5|64.5|Standard Deviation|12.9|12.9|||
3984961|NCT01256177|3807237|B2|||Weight||Kilogram (Kg)|Mean|63.8|63.8|Standard Deviation|13.5|13.5|||
3984962|NCT01256177|3807238|B1|||Weight||Kilogram (Kg)|Mean|65.2|65.2|Standard Deviation|12.3|12.3|||
3984963|NCT01256177|3807236|B3|Ethnicity, Chinese||Race/Ethnicity, Customized|Race, Asian Ethnicity, Chinese|Participants|Number|279|279.0||||||
3984964|NCT01256177|3807237|B2|Ethnicity, Chinese||Race/Ethnicity, Customized|Race, Asian Ethnicity, Chinese|Participants|Number|139|139.0||||||
3984965|NCT01256177|3807238|B1|Ethnicity, Chinese||Race/Ethnicity, Customized|Race, Asian Ethnicity, Chinese|Participants|Number|140|140.0||||||
3984966|NCT01256177|3807236|B3|Race,Asian||Race/Ethnicity, Customized|Race, Asian Ethnicity, Chinese|Participants|Number|279|279.0||||||
3984967|NCT01256177|3807237|B2|Race,Asian||Race/Ethnicity, Customized|Race, Asian Ethnicity, Chinese|Participants|Number|139|139.0||||||
3984968|NCT01256177|3807238|B1|Race,Asian||Race/Ethnicity, Customized|Race, Asian Ethnicity, Chinese|Participants|Number|140|140.0||||||
3984969|NCT01256177|3807236|B3|Male||Sex/Gender, Customized||Participants|Number|134|134.0||||||
3984970|NCT01256177|3807237|B2|Male||Sex/Gender, Customized||Participants|Number|67|67.0||||||
3984971|NCT01256177|3807238|B1|Male||Sex/Gender, Customized||Participants|Number|67|67.0||||||
3984972|NCT01256177|3807236|B3|Female||Sex/Gender, Customized||Participants|Number|145|145.0||||||
3984973|NCT01256177|3807237|B2|Female||Sex/Gender, Customized||Participants|Number|72|72.0||||||
3984974|NCT01256177|3807238|B1|Female||Sex/Gender, Customized||Participants|Number|73|73.0||||||
3984975|NCT01256177|3807236|B3|40 - 65 years||Age, Customized||Participants|Number|72|72.0||||||
3984976|NCT01256177|3807237|B2|40 - 65 years||Age, Customized||Participants|Number|37|37.0||||||
3984977|NCT01256177|3807238|B1|40 - 65 years||Age, Customized||Participants|Number|35|35.0||||||
3984978|NCT01256177|3807236|B3|18 - 39 years||Age, Customized||Participants|Number|207|207.0||||||
3984979|NCT01256177|3807237|B2|18 - 39 years||Age, Customized||Participants|Number|102|102.0||||||
3984980|NCT01256177|3807238|B1|18 - 39 years||Age, Customized||Participants|Number|105|105.0||||||
3984981|NCT01256177|3807236|B3|||Age||Years|Mean|33.1|33.1|Standard Deviation|11.4|11.4|||
3984982|NCT01256177|3807237|B2|||Age||Years|Mean|33.4|33.4|Standard Deviation|11.9|11.9|||
3984983|NCT01256177|3807238|B1|||Age||Years|Mean|32.8|32.8|Standard Deviation|11.0|11.0|||
3984984|NCT01256164|3807261|B3|United States||Region of Enrollment||participants|Number|70|70.0||||||
3984985|NCT01256164|3807262|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
3984986|NCT01256164|3807263|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
3984987|NCT01256164|3807261|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3984988|NCT01256164|3807262|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3984989|NCT01256164|3807263|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3984990|NCT01256164|3807261|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3984991|NCT01256164|3807262|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3984992|NCT01256164|3807263|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3984993|NCT01256164|3807261|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|12.89|12.89|||
3984994|NCT01256164|3807262|B2|||Age||years|Mean|61.3|61.3|Standard Deviation|10.48|10.48|||
3984995|NCT01256164|3807263|B1|||Age||years|Mean|59.0|59.0|Standard Deviation|13.97|13.97|||
3984996|NCT01256164|3807261|B3||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
3984997|NCT01256164|3807262|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3984998|NCT01256164|3807263|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3984999|NCT01256164|3807261|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3985000|NCT01256164|3807262|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3985001|NCT01256164|3807263|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3985002|NCT01256164|3807261|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3985003|NCT01256164|3807262|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3985004|NCT01256164|3807263|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3985005|NCT01256086|3807278|B5|United States||Region of Enrollment||participants|Number|44|44.0||||||
3985006|NCT01256086|3807279|B4|United States||Region of Enrollment||participants|Number|11|11.0||||||
3985007|NCT01256086|3807280|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
3985008|NCT01256086|3807281|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3985009|NCT01256086|3807282|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3985010|NCT01256086|3807278|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3985011|NCT01256086|3807279|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3985012|NCT01256086|3807280|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3985013|NCT01256086|3807281|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3985014|NCT01256086|3807282|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3985015|NCT01256086|3807278|B5||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3985016|NCT01256086|3807279|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3985017|NCT01256086|3807280|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3985018|NCT01256086|3807281|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3985019|NCT01256086|3807282|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3985020|NCT01256086|3807278|B5|||Age||years|Mean|30|30.0|Standard Deviation|12|12.0|||
3985021|NCT01256086|3807279|B4|||Age||years|Mean|28|28.0|Standard Deviation|11|11.0|||
3985022|NCT01256086|3807280|B3|||Age||years|Mean|26|26.0|Standard Deviation|10|10.0|||
3985023|NCT01256086|3807281|B2|||Age||years|Mean|35|35.0|Standard Deviation|13|13.0|||
3985024|NCT01256086|3807282|B1|||Age||years|Mean|31|31.0|Standard Deviation|12|12.0|||
3985025|NCT01256086|3807278|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3985026|NCT01256086|3807279|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3985027|NCT01256086|3807280|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3985028|NCT01256086|3807281|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3985029|NCT01256086|3807282|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3985030|NCT01256086|3807278|B5||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3985031|NCT01256086|3807279|B4||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3985032|NCT01256086|3807280|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3985033|NCT01256086|3807281|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3985034|NCT01256086|3807282|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3985035|NCT01256086|3807278|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3985036|NCT01256086|3807279|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3985037|NCT01256086|3807280|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3985038|NCT01256086|3807281|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3985039|NCT01256086|3807282|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3985040|NCT01256060|3807295|B1|Canada||Region of Enrollment||participants|Number|15|15.0||||||
3985041|NCT01256060|3807295|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3985042|NCT01256060|3807295|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3985043|NCT01256060|3807295|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3985044|NCT01256060|3807295|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3985045|NCT01256060|3807295|B1||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
3985046|NCT01256034|3807305|B3|Japan||Region of Enrollment||participants|Number|50|50.0||||||
3985047|NCT01256034|3807306|B2|Japan||Region of Enrollment||participants|Number|25|25.0||||||
3985048|NCT01256034|3807307|B1|Japan||Region of Enrollment||participants|Number|25|25.0||||||
3985049|NCT01256034|3807305|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3985050|NCT01256034|3807306|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3985051|NCT01256034|3807307|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3985052|NCT01256034|3807305|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3985053|NCT01256034|3807306|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3985054|NCT01256034|3807307|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3985055|NCT01256034|3807305|B3|||Age||years|Mean|65.8|65.8|Standard Deviation|8.5|8.5|||
3985056|NCT01256034|3807306|B2|||Age||years|Mean|65.1|65.1|Standard Deviation|9.5|9.5|||
3985057|NCT01256034|3807307|B1|||Age||years|Mean|66.4|66.4|Standard Deviation|7.5|7.5|||
3985058|NCT01256034|3807305|B3||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
3985059|NCT01256034|3807306|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3985060|NCT01256034|3807307|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3985061|NCT01256034|3807305|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3985062|NCT01256034|3807306|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3985063|NCT01256034|3807307|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3985064|NCT01256034|3807305|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3985065|NCT01256034|3807306|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3985066|NCT01256034|3807307|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3985067|NCT01256008|3807314|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3985068|NCT01256008|3807315|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3985069|NCT01256008|3807316|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3985070|NCT01256008|3807317|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3985071|NCT01256008|3807314|B4||Female|Sex: Female, Male||Participants|Count of Participants|392|392.0||||||
3985072|NCT01256008|3807315|B3||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
3985073|NCT01256008|3807316|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3985074|NCT01256008|3807317|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3985075|NCT01256008|3807314|B4|||Age||years|Mean|47.1|47.1|Standard Deviation|8.6|8.6|||
3985076|NCT01256008|3807315|B3|||Age||years|Mean|47.1|47.1|Standard Deviation|8.3|8.3|||
3985077|NCT01256008|3807316|B2|||Age||years|Mean|46.8|46.8|Standard Deviation|8.9|8.9|||
3985078|NCT01256008|3807317|B1|||Age||years|Mean|47.3|47.3|Standard Deviation|8.7|8.7|||
3985079|NCT01255904|3807339|B3|United States||Region of Enrollment||participants|Number|85|85.0||||||
3985080|NCT01255904|3807340|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
3985081|NCT01255904|3807341|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
3985082|NCT01255904|3807339|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3985083|NCT01255904|3807340|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3985084|NCT01255904|3807341|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3985085|NCT01255904|3807339|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3985086|NCT01255904|3807340|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3985087|NCT01255904|3807341|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3985088|NCT01255904|3807339|B3|||Age||months|Mean|24.40|24.4|Standard Deviation|11.95|11.95|||
3985089|NCT01255904|3807340|B2|||Age||months|Mean|25.55|25.55|Standard Deviation|11.21|11.21|||
3985090|NCT01255904|3807341|B1|||Age||months|Mean|23.33|23.33|Standard Deviation|12.63|12.63|||
3985225|NCT01255787|3807352|B1|Malaysia||Region of Enrollment||participants|Number|2|2.0||||||
3985226|NCT01255787|3807348|B5|Latvia||Region of Enrollment||participants|Number|10|10.0||||||
3985091|NCT01255787|3807348|B5|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 (absent) to 56 (maximum severity). Number of participants for whom HAM-A data were available were 152, 144, 148 and 150 in each treatment arm respectively.|scores on a scale|Mean|18.7|18.7|Standard Deviation|6.53|6.53|||
3985092|NCT01255787|3807349|B4|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 (absent) to 56 (maximum severity). Number of participants for whom HAM-A data were available were 152, 144, 148 and 150 in each treatment arm respectively.|scores on a scale|Mean|18.5|18.5|Standard Deviation|6.12|6.12|||
3985093|NCT01255787|3807350|B3|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 (absent) to 56 (maximum severity). Number of participants for whom HAM-A data were available were 152, 144, 148 and 150 in each treatment arm respectively.|scores on a scale|Mean|18.8|18.8|Standard Deviation|6.66|6.66|||
3985094|NCT01255787|3807351|B2|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 (absent) to 56 (maximum severity). Number of participants for whom HAM-A data were available were 152, 144, 148 and 150 in each treatment arm respectively.|scores on a scale|Mean|18.9|18.9|Standard Deviation|6.55|6.55|||
3985095|NCT01255787|3807352|B1|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 (absent) to 56 (maximum severity). Number of participants for whom HAM-A data were available were 152, 144, 148 and 150 in each treatment arm respectively.|scores on a scale|Mean|18.6|18.6|Standard Deviation|6.83|6.83|||
3985096|NCT01255787|3807348|B5|||Sheehan Disability Scale (SDS) - Total score|The Sheehan Disability Scale assesses functional impairment in 3 domains: work/school, social life or leisure activities, and home life or family responsibilities. The participant rates the extent to which each aspect is impaired on a 10-point visual analog scale, from 0 (not at all) to 10 (extremely). The 3 scores are added together to calculate the total score, which ranges from 0 to 30, with higher scores indicating more impairment. Number of participants for whom SDS data were available were 132, 116, 119 and 121 in each treatment arm respectively.|scores on a scale|Mean|18.2|18.2|Standard Deviation|5.65|5.65|||
3985097|NCT01255787|3807349|B4|||Sheehan Disability Scale (SDS) - Total score|The Sheehan Disability Scale assesses functional impairment in 3 domains: work/school, social life or leisure activities, and home life or family responsibilities. The participant rates the extent to which each aspect is impaired on a 10-point visual analog scale, from 0 (not at all) to 10 (extremely). The 3 scores are added together to calculate the total score, which ranges from 0 to 30, with higher scores indicating more impairment. Number of participants for whom SDS data were available were 132, 116, 119 and 121 in each treatment arm respectively.|scores on a scale|Mean|18.2|18.2|Standard Deviation|5.70|5.7|||
3985098|NCT01255787|3807350|B3|||Sheehan Disability Scale (SDS) - Total score|The Sheehan Disability Scale assesses functional impairment in 3 domains: work/school, social life or leisure activities, and home life or family responsibilities. The participant rates the extent to which each aspect is impaired on a 10-point visual analog scale, from 0 (not at all) to 10 (extremely). The 3 scores are added together to calculate the total score, which ranges from 0 to 30, with higher scores indicating more impairment. Number of participants for whom SDS data were available were 132, 116, 119 and 121 in each treatment arm respectively.|scores on a scale|Mean|18.5|18.5|Standard Deviation|5.42|5.42|||
3985099|NCT01255787|3807351|B2|||Sheehan Disability Scale (SDS) - Total score|The Sheehan Disability Scale assesses functional impairment in 3 domains: work/school, social life or leisure activities, and home life or family responsibilities. The participant rates the extent to which each aspect is impaired on a 10-point visual analog scale, from 0 (not at all) to 10 (extremely). The 3 scores are added together to calculate the total score, which ranges from 0 to 30, with higher scores indicating more impairment. Number of participants for whom SDS data were available were 132, 116, 119 and 121 in each treatment arm respectively.|scores on a scale|Mean|17.9|17.9|Standard Deviation|6.27|6.27|||
3985100|NCT01255787|3807352|B1|||Sheehan Disability Scale (SDS) - Total score|The Sheehan Disability Scale assesses functional impairment in 3 domains: work/school, social life or leisure activities, and home life or family responsibilities. The participant rates the extent to which each aspect is impaired on a 10-point visual analog scale, from 0 (not at all) to 10 (extremely). The 3 scores are added together to calculate the total score, which ranges from 0 to 30, with higher scores indicating more impairment. Number of participants for whom SDS data were available were 132, 116, 119 and 121 in each treatment arm respectively.|scores on a scale|Mean|18.2|18.2|Standard Deviation|5.28|5.28|||
3985101|NCT01255787|3807348|B5|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill. Number of participants for whom CGI-S data were available were 152, 144, 147 and 149 in each treatment arm respectively.|scores on a scale|Mean|4.70|4.7|Standard Deviation|0.65|0.65|||
3985102|NCT01255787|3807349|B4|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill. Number of participants for whom CGI-S data were available were 152, 144, 147 and 149 in each treatment arm respectively.|scores on a scale|Mean|4.7|4.7|Standard Deviation|0.65|0.65|||
3985103|NCT01255787|3807350|B3|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill. Number of participants for whom CGI-S data were available were 152, 144, 147 and 149 in each treatment arm respectively.|scores on a scale|Mean|4.7|4.7|Standard Deviation|0.66|0.66|||
3985104|NCT01255787|3807351|B2|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill. Number of participants for whom CGI-S data were available were 152, 144, 147 and 149 in each treatment arm respectively.|scores on a scale|Mean|4.7|4.7|Standard Deviation|0.65|0.65|||
3985105|NCT01255787|3807352|B1|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill. Number of participants for whom CGI-S data were available were 152, 144, 147 and 149 in each treatment arm respectively.|scores on a scale|Mean|4.7|4.7|Standard Deviation|0.66|0.66|||
3985106|NCT01255787|3807348|B5|||Montgomery Åsberg Depression Rating Scale (MADRS) Total Score|"The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).~Number of participants for whom MADRS data were available were 152, 144, 147 and 149 in each treatment arm respectively."|scores on a scale|Mean|31.7|31.7|Standard Deviation|3.74|3.74|||
3985107|NCT01255787|3807349|B4|||Montgomery Åsberg Depression Rating Scale (MADRS) Total Score|"The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).~Number of participants for whom MADRS data were available were 152, 144, 147 and 149 in each treatment arm respectively."|scores on a scale|Mean|31.7|31.7|Standard Deviation|3.73|3.73|||
3985108|NCT01255787|3807350|B3|||Montgomery Åsberg Depression Rating Scale (MADRS) Total Score|"The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).~Number of participants for whom MADRS data were available were 152, 144, 147 and 149 in each treatment arm respectively."|scores on a scale|Mean|31.8|31.8|Standard Deviation|4.02|4.02|||
3985109|NCT01255787|3807351|B2|||Montgomery Åsberg Depression Rating Scale (MADRS) Total Score|"The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).~Number of participants for whom MADRS data were available were 152, 144, 147 and 149 in each treatment arm respectively."|scores on a scale|Mean|31.6|31.6|Standard Deviation|3.67|3.67|||
3985110|NCT01255787|3807352|B1|||Montgomery Åsberg Depression Rating Scale (MADRS) Total Score|"The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).~Number of participants for whom MADRS data were available were 152, 144, 147 and 149 in each treatment arm respectively."|scores on a scale|Mean|31.6|31.6|Standard Deviation|3.56|3.56|||
3985111|NCT01255787|3807348|B5|No||Pharmacotherapy for Current Major Depressive Episode||participants|Number|323|323.0||||||
3985112|NCT01255787|3807349|B4|No||Pharmacotherapy for Current Major Depressive Episode||participants|Number|79|79.0||||||
3985113|NCT01255787|3807350|B3|No||Pharmacotherapy for Current Major Depressive Episode||participants|Number|81|81.0||||||
3985114|NCT01255787|3807351|B2|No||Pharmacotherapy for Current Major Depressive Episode||participants|Number|84|84.0||||||
3985115|NCT01255787|3807352|B1|No||Pharmacotherapy for Current Major Depressive Episode||participants|Number|79|79.0||||||
3985116|NCT01255787|3807348|B5|Yes||Pharmacotherapy for Current Major Depressive Episode||participants|Number|277|277.0||||||
3985117|NCT01255787|3807349|B4|Yes||Pharmacotherapy for Current Major Depressive Episode||participants|Number|75|75.0||||||
3985118|NCT01255787|3807350|B3|Yes||Pharmacotherapy for Current Major Depressive Episode||participants|Number|69|69.0||||||
3985119|NCT01255787|3807351|B2|Yes||Pharmacotherapy for Current Major Depressive Episode||participants|Number|60|60.0||||||
3985120|NCT01255787|3807352|B1|Yes||Pharmacotherapy for Current Major Depressive Episode||participants|Number|73|73.0||||||
3985121|NCT01255787|3807348|B5|Recurrent episode||Status of Major Depressive Episode (MDE)|An MDE is a period marked by depressed mood, loss of interest or pleasure, disturbed sleep or appetite, low energy, feelings of guilt or low self-worth, and poor concentration.|participants|Number|396|396.0||||||
3985122|NCT01255787|3807349|B4|Recurrent episode||Status of Major Depressive Episode (MDE)|An MDE is a period marked by depressed mood, loss of interest or pleasure, disturbed sleep or appetite, low energy, feelings of guilt or low self-worth, and poor concentration.|participants|Number|105|105.0||||||
3985227|NCT01255787|3807349|B4|Latvia||Region of Enrollment||participants|Number|3|3.0||||||
3985123|NCT01255787|3807350|B3|Recurrent episode||Status of Major Depressive Episode (MDE)|An MDE is a period marked by depressed mood, loss of interest or pleasure, disturbed sleep or appetite, low energy, feelings of guilt or low self-worth, and poor concentration.|participants|Number|101|101.0||||||
3985124|NCT01255787|3807351|B2|Recurrent episode||Status of Major Depressive Episode (MDE)|An MDE is a period marked by depressed mood, loss of interest or pleasure, disturbed sleep or appetite, low energy, feelings of guilt or low self-worth, and poor concentration.|participants|Number|89|89.0||||||
3985125|NCT01255787|3807352|B1|Recurrent episode||Status of Major Depressive Episode (MDE)|An MDE is a period marked by depressed mood, loss of interest or pleasure, disturbed sleep or appetite, low energy, feelings of guilt or low self-worth, and poor concentration.|participants|Number|101|101.0||||||
3985126|NCT01255787|3807348|B5|Single episode||Status of Major Depressive Episode (MDE)|An MDE is a period marked by depressed mood, loss of interest or pleasure, disturbed sleep or appetite, low energy, feelings of guilt or low self-worth, and poor concentration.|participants|Number|204|204.0||||||
3985127|NCT01255787|3807349|B4|Single episode||Status of Major Depressive Episode (MDE)|An MDE is a period marked by depressed mood, loss of interest or pleasure, disturbed sleep or appetite, low energy, feelings of guilt or low self-worth, and poor concentration.|participants|Number|49|49.0||||||
3985128|NCT01255787|3807350|B3|Single episode||Status of Major Depressive Episode (MDE)|An MDE is a period marked by depressed mood, loss of interest or pleasure, disturbed sleep or appetite, low energy, feelings of guilt or low self-worth, and poor concentration.|participants|Number|49|49.0||||||
3985129|NCT01255787|3807351|B2|Single episode||Status of Major Depressive Episode (MDE)|An MDE is a period marked by depressed mood, loss of interest or pleasure, disturbed sleep or appetite, low energy, feelings of guilt or low self-worth, and poor concentration.|participants|Number|55|55.0||||||
3985130|NCT01255787|3807352|B1|Single episode||Status of Major Depressive Episode (MDE)|An MDE is a period marked by depressed mood, loss of interest or pleasure, disturbed sleep or appetite, low energy, feelings of guilt or low self-worth, and poor concentration.|participants|Number|51|51.0||||||
3985131|NCT01255787|3807348|B5|Daily||History of Alcohol Consumption||participants|Number|41|41.0||||||
3985132|NCT01255787|3807349|B4|Daily||History of Alcohol Consumption||participants|Number|10|10.0||||||
3985133|NCT01255787|3807350|B3|Daily||History of Alcohol Consumption||participants|Number|10|10.0||||||
3985134|NCT01255787|3807351|B2|Daily||History of Alcohol Consumption||participants|Number|10|10.0||||||
3985135|NCT01255787|3807352|B1|Daily||History of Alcohol Consumption||participants|Number|11|11.0||||||
3985136|NCT01255787|3807348|B5|2 to 6 times per week||History of Alcohol Consumption||participants|Number|46|46.0||||||
3985137|NCT01255787|3807349|B4|2 to 6 times per week||History of Alcohol Consumption||participants|Number|13|13.0||||||
3985138|NCT01255787|3807350|B3|2 to 6 times per week||History of Alcohol Consumption||participants|Number|10|10.0||||||
3985139|NCT01255787|3807351|B2|2 to 6 times per week||History of Alcohol Consumption||participants|Number|9|9.0||||||
3985140|NCT01255787|3807352|B1|2 to 6 times per week||History of Alcohol Consumption||participants|Number|14|14.0||||||
3985141|NCT01255787|3807348|B5|Once a week||History of Alcohol Consumption||participants|Number|83|83.0||||||
3985142|NCT01255787|3807349|B4|Once a week||History of Alcohol Consumption||participants|Number|22|22.0||||||
3985143|NCT01255787|3807350|B3|Once a week||History of Alcohol Consumption||participants|Number|22|22.0||||||
3985144|NCT01255787|3807351|B2|Once a week||History of Alcohol Consumption||participants|Number|22|22.0||||||
3985145|NCT01255787|3807352|B1|Once a week||History of Alcohol Consumption||participants|Number|17|17.0||||||
3985146|NCT01255787|3807348|B5|Once monthly or less often||History of Alcohol Consumption||participants|Number|200|200.0||||||
3985147|NCT01255787|3807349|B4|Once monthly or less often||History of Alcohol Consumption||participants|Number|53|53.0||||||
3985148|NCT01255787|3807350|B3|Once monthly or less often||History of Alcohol Consumption||participants|Number|54|54.0||||||
3985149|NCT01255787|3807351|B2|Once monthly or less often||History of Alcohol Consumption||participants|Number|41|41.0||||||
3985150|NCT01255787|3807352|B1|Once monthly or less often||History of Alcohol Consumption||participants|Number|52|52.0||||||
3985151|NCT01255787|3807348|B5|Never||History of Alcohol Consumption||participants|Number|230|230.0||||||
3985152|NCT01255787|3807349|B4|Never||History of Alcohol Consumption||participants|Number|56|56.0||||||
3985153|NCT01255787|3807350|B3|Never||History of Alcohol Consumption||participants|Number|54|54.0||||||
3985154|NCT01255787|3807351|B2|Never||History of Alcohol Consumption||participants|Number|62|62.0||||||
3985155|NCT01255787|3807352|B1|Never||History of Alcohol Consumption||participants|Number|58|58.0||||||
3985156|NCT01255787|3807348|B5|Never smoked||Smoking Classification||participants|Number|320|320.0||||||
3985157|NCT01255787|3807349|B4|Never smoked||Smoking Classification||participants|Number|87|87.0||||||
3985158|NCT01255787|3807350|B3|Never smoked||Smoking Classification||participants|Number|79|79.0||||||
3985159|NCT01255787|3807351|B2|Never smoked||Smoking Classification||participants|Number|75|75.0||||||
3985160|NCT01255787|3807352|B1|Never smoked||Smoking Classification||participants|Number|79|79.0||||||
3985161|NCT01255787|3807348|B5|Ex-smoker||Smoking Classification||participants|Number|73|73.0||||||
3985162|NCT01255787|3807349|B4|Ex-smoker||Smoking Classification||participants|Number|11|11.0||||||
3985163|NCT01255787|3807350|B3|Ex-smoker||Smoking Classification||participants|Number|21|21.0||||||
3985164|NCT01255787|3807351|B2|Ex-smoker||Smoking Classification||participants|Number|19|19.0||||||
3985165|NCT01255787|3807352|B1|Ex-smoker||Smoking Classification||participants|Number|22|22.0||||||
3985166|NCT01255787|3807348|B5|Current smoker||Smoking Classification||participants|Number|207|207.0||||||
3985167|NCT01255787|3807349|B4|Current smoker||Smoking Classification||participants|Number|56|56.0||||||
3985168|NCT01255787|3807350|B3|Current smoker||Smoking Classification||participants|Number|50|50.0||||||
3985169|NCT01255787|3807351|B2|Current smoker||Smoking Classification||participants|Number|50|50.0||||||
3985170|NCT01255787|3807352|B1|Current smoker||Smoking Classification||participants|Number|51|51.0||||||
3985171|NCT01255787|3807348|B5|||Body Mass Index (BMI)|Number of participants for whom BMI data were available were 152, 144, 147 and 149 in each treatment group respectively.|kg/m^2|Mean|25.15|25.15|Standard Deviation|5.313|5.313|||
3985172|NCT01255787|3807349|B4|||Body Mass Index (BMI)|Number of participants for whom BMI data were available were 152, 144, 147 and 149 in each treatment group respectively.|kg/m^2|Mean|24.82|24.82|Standard Deviation|5.206|5.206|||
3985173|NCT01255787|3807350|B3|||Body Mass Index (BMI)|Number of participants for whom BMI data were available were 152, 144, 147 and 149 in each treatment group respectively.|kg/m^2|Mean|25.93|25.93|Standard Deviation|5.462|5.462|||
3985174|NCT01255787|3807351|B2|||Body Mass Index (BMI)|Number of participants for whom BMI data were available were 152, 144, 147 and 149 in each treatment group respectively.|kg/m^2|Mean|25.06|25.06|Standard Deviation|5.432|5.432|||
3985175|NCT01255787|3807352|B1|||Body Mass Index (BMI)|Number of participants for whom BMI data were available were 152, 144, 147 and 149 in each treatment group respectively.|kg/m^2|Mean|24.82|24.82|Standard Deviation|5.129|5.129|||
3985176|NCT01255787|3807348|B5|||Weight|Number of participants for whom weight data were available were 152, 144, 147 and 149 in each treatment group respectively.|kg|Mean|70.95|70.95|Standard Deviation|18.095|18.095|||
3985177|NCT01255787|3807349|B4|||Weight|Number of participants for whom weight data were available were 152, 144, 147 and 149 in each treatment group respectively.|kg|Mean|70.21|70.21|Standard Deviation|18.189|18.189|||
3985178|NCT01255787|3807350|B3|||Weight|Number of participants for whom weight data were available were 152, 144, 147 and 149 in each treatment group respectively.|kg|Mean|73.37|73.37|Standard Deviation|19.014|19.014|||
3985179|NCT01255787|3807351|B2|||Weight|Number of participants for whom weight data were available were 152, 144, 147 and 149 in each treatment group respectively.|kg|Mean|70.57|70.57|Standard Deviation|18.214|18.214|||
3985180|NCT01255787|3807352|B1|||Weight|Number of participants for whom weight data were available were 152, 144, 147 and 149 in each treatment group respectively.|kg|Mean|69.70|69.7|Standard Deviation|16.901|16.901|||
3985181|NCT01255787|3807348|B5|||Height||cm|Mean|167.3|167.3|Standard Deviation|9.33|9.33|||
3985182|NCT01255787|3807349|B4|||Height||cm|Mean|167.5|167.5|Standard Deviation|9.61|9.61|||
3985183|NCT01255787|3807350|B3|||Height||cm|Mean|167.5|167.5|Standard Deviation|9.40|9.4|||
3985184|NCT01255787|3807351|B2|||Height||cm|Mean|167.2|167.2|Standard Deviation|9.64|9.64|||
3985185|NCT01255787|3807352|B1|||Height||cm|Mean|167.1|167.1|Standard Deviation|8.75|8.75|||
3985186|NCT01255787|3807348|B5|Ukraine||Region of Enrollment||participants|Number|27|27.0||||||
3985187|NCT01255787|3807349|B4|Ukraine||Region of Enrollment||participants|Number|8|8.0||||||
3985188|NCT01255787|3807350|B3|Ukraine||Region of Enrollment||participants|Number|7|7.0||||||
3985189|NCT01255787|3807351|B2|Ukraine||Region of Enrollment||participants|Number|6|6.0||||||
3985190|NCT01255787|3807352|B1|Ukraine||Region of Enrollment||participants|Number|6|6.0||||||
3985191|NCT01255787|3807348|B5|South Korea||Region of Enrollment||participants|Number|27|27.0||||||
3985192|NCT01255787|3807349|B4|South Korea||Region of Enrollment||participants|Number|8|8.0||||||
3985193|NCT01255787|3807350|B3|South Korea||Region of Enrollment||participants|Number|7|7.0||||||
3985194|NCT01255787|3807351|B2|South Korea||Region of Enrollment||participants|Number|6|6.0||||||
3985195|NCT01255787|3807352|B1|South Korea||Region of Enrollment||participants|Number|6|6.0||||||
3985196|NCT01255787|3807348|B5|Serbia||Region of Enrollment||participants|Number|9|9.0||||||
3985197|NCT01255787|3807349|B4|Serbia||Region of Enrollment||participants|Number|2|2.0||||||
3985198|NCT01255787|3807350|B3|Serbia||Region of Enrollment||participants|Number|3|3.0||||||
3985199|NCT01255787|3807351|B2|Serbia||Region of Enrollment||participants|Number|2|2.0||||||
3985200|NCT01255787|3807352|B1|Serbia||Region of Enrollment||participants|Number|2|2.0||||||
3985201|NCT01255787|3807348|B5|Russia||Region of Enrollment||participants|Number|51|51.0||||||
3985202|NCT01255787|3807349|B4|Russia||Region of Enrollment||participants|Number|13|13.0||||||
3985203|NCT01255787|3807350|B3|Russia||Region of Enrollment||participants|Number|12|12.0||||||
3985204|NCT01255787|3807351|B2|Russia||Region of Enrollment||participants|Number|13|13.0||||||
3985205|NCT01255787|3807352|B1|Russia||Region of Enrollment||participants|Number|13|13.0||||||
3985206|NCT01255787|3807348|B5|Romania||Region of Enrollment||participants|Number|18|18.0||||||
3985207|NCT01255787|3807349|B4|Romania||Region of Enrollment||participants|Number|3|3.0||||||
3985208|NCT01255787|3807350|B3|Romania||Region of Enrollment||participants|Number|6|6.0||||||
3985209|NCT01255787|3807351|B2|Romania||Region of Enrollment||participants|Number|4|4.0||||||
3985210|NCT01255787|3807352|B1|Romania||Region of Enrollment||participants|Number|5|5.0||||||
3985211|NCT01255787|3807348|B5|Poland||Region of Enrollment||participants|Number|79|79.0||||||
3985212|NCT01255787|3807349|B4|Poland||Region of Enrollment||participants|Number|21|21.0||||||
3985213|NCT01255787|3807350|B3|Poland||Region of Enrollment||participants|Number|20|20.0||||||
3985214|NCT01255787|3807351|B2|Poland||Region of Enrollment||participants|Number|18|18.0||||||
3985215|NCT01255787|3807352|B1|Poland||Region of Enrollment||participants|Number|20|20.0||||||
3985216|NCT01255787|3807348|B5|Philippines||Region of Enrollment||participants|Number|13|13.0||||||
3985217|NCT01255787|3807349|B4|Philippines||Region of Enrollment||participants|Number|3|3.0||||||
3985218|NCT01255787|3807350|B3|Philippines||Region of Enrollment||participants|Number|4|4.0||||||
3985219|NCT01255787|3807351|B2|Philippines||Region of Enrollment||participants|Number|2|2.0||||||
3985220|NCT01255787|3807352|B1|Philippines||Region of Enrollment||participants|Number|4|4.0||||||
3985221|NCT01255787|3807348|B5|Malaysia||Region of Enrollment||participants|Number|4|4.0||||||
3985222|NCT01255787|3807349|B4|Malaysia||Region of Enrollment||participants|Number|2|2.0||||||
3985223|NCT01255787|3807350|B3|Malaysia||Region of Enrollment||participants|Number|0|0.0||||||
3985224|NCT01255787|3807351|B2|Malaysia||Region of Enrollment||participants|Number|0|0.0||||||
3985228|NCT01255787|3807350|B3|Latvia||Region of Enrollment||participants|Number|2|2.0||||||
3985229|NCT01255787|3807351|B2|Latvia||Region of Enrollment||participants|Number|2|2.0||||||
3985230|NCT01255787|3807352|B1|Latvia||Region of Enrollment||participants|Number|3|3.0||||||
3985231|NCT01255787|3807348|B5|Japan||Region of Enrollment||participants|Number|129|129.0||||||
3985232|NCT01255787|3807349|B4|Japan||Region of Enrollment||participants|Number|33|33.0||||||
3985233|NCT01255787|3807350|B3|Japan||Region of Enrollment||participants|Number|31|31.0||||||
3985234|NCT01255787|3807351|B2|Japan||Region of Enrollment||participants|Number|32|32.0||||||
3985235|NCT01255787|3807352|B1|Japan||Region of Enrollment||participants|Number|33|33.0||||||
3985236|NCT01255787|3807348|B5|India||Region of Enrollment||participants|Number|11|11.0||||||
3985237|NCT01255787|3807349|B4|India||Region of Enrollment||participants|Number|2|2.0||||||
3985238|NCT01255787|3807350|B3|India||Region of Enrollment||participants|Number|3|3.0||||||
3985239|NCT01255787|3807351|B2|India||Region of Enrollment||participants|Number|3|3.0||||||
3985240|NCT01255787|3807352|B1|India||Region of Enrollment||participants|Number|3|3.0||||||
3985241|NCT01255787|3807348|B5|Germany||Region of Enrollment||participants|Number|199|199.0||||||
3985242|NCT01255787|3807349|B4|Germany||Region of Enrollment||participants|Number|49|49.0||||||
3985243|NCT01255787|3807350|B3|Germany||Region of Enrollment||participants|Number|50|50.0||||||
3985244|NCT01255787|3807351|B2|Germany||Region of Enrollment||participants|Number|50|50.0||||||
3985245|NCT01255787|3807352|B1|Germany||Region of Enrollment||participants|Number|50|50.0||||||
3985246|NCT01255787|3807348|B5|Finland||Region of Enrollment||participants|Number|20|20.0||||||
3985247|NCT01255787|3807349|B4|Finland||Region of Enrollment||participants|Number|5|5.0||||||
3985248|NCT01255787|3807350|B3|Finland||Region of Enrollment||participants|Number|5|5.0||||||
3985249|NCT01255787|3807351|B2|Finland||Region of Enrollment||participants|Number|5|5.0||||||
3985250|NCT01255787|3807352|B1|Finland||Region of Enrollment||participants|Number|5|5.0||||||
3985251|NCT01255787|3807348|B5|Croatia||Region of Enrollment||participants|Number|3|3.0||||||
3985252|NCT01255787|3807349|B4|Croatia||Region of Enrollment||participants|Number|2|2.0||||||
3985253|NCT01255787|3807350|B3|Croatia||Region of Enrollment||participants|Number|0|0.0||||||
3985254|NCT01255787|3807351|B2|Croatia||Region of Enrollment||participants|Number|1|1.0||||||
3985255|NCT01255787|3807352|B1|Croatia||Region of Enrollment||participants|Number|0|0.0||||||
3985256|NCT01255787|3807348|B5|Asian||Race/Ethnicity, Customized||participants|Number|186|186.0||||||
3985257|NCT01255787|3807349|B4|Asian||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
3985258|NCT01255787|3807350|B3|Asian||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
3985259|NCT01255787|3807351|B2|Asian||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
3985260|NCT01255787|3807352|B1|Asian||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
3985261|NCT01255787|3807348|B5|Caucasian (or White, including Hispanic)||Race/Ethnicity, Customized||participants|Number|414|414.0||||||
3985262|NCT01255787|3807349|B4|Caucasian (or White, including Hispanic)||Race/Ethnicity, Customized||participants|Number|105|105.0||||||
3985263|NCT01255787|3807350|B3|Caucasian (or White, including Hispanic)||Race/Ethnicity, Customized||participants|Number|104|104.0||||||
3985264|NCT01255787|3807351|B2|Caucasian (or White, including Hispanic)||Race/Ethnicity, Customized||participants|Number|101|101.0||||||
3985265|NCT01255787|3807352|B1|Caucasian (or White, including Hispanic)||Race/Ethnicity, Customized||participants|Number|104|104.0||||||
3985266|NCT01255787|3807348|B5||Male|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
3985267|NCT01255787|3807349|B4||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3985268|NCT01255787|3807350|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3985269|NCT01255787|3807351|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3985270|NCT01255787|3807352|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3985271|NCT01255787|3807348|B5||Female|Sex: Female, Male||Participants|Count of Participants|375|375.0||||||
3985272|NCT01255787|3807349|B4||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3985273|NCT01255787|3807350|B3||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3985274|NCT01255787|3807351|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3985275|NCT01255787|3807352|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3985276|NCT01255787|3807348|B5|||Age||years|Mean|44.4|44.4|Standard Deviation|11.54|11.54|||
3985277|NCT01255787|3807349|B4|||Age||years|Mean|44.0|44.0|Standard Deviation|11.79|11.79|||
3985278|NCT01255787|3807350|B3|||Age||years|Mean|45.7|45.7|Standard Deviation|10.90|10.9|||
3985279|NCT01255787|3807351|B2|||Age||years|Mean|44.2|44.2|Standard Deviation|11.89|11.89|||
3985280|NCT01255787|3807352|B1|||Age||years|Mean|43.6|43.6|Standard Deviation|11.57|11.57|||
3985281|NCT01255761|3807381|B3|||Body Mass Index (BMI)||kg/ m^2|Mean|30.34|30.34|Standard Deviation|7.08|7.08|||
3985282|NCT01255761|3807382|B2|||Body Mass Index (BMI)||kg/ m^2|Mean|29.82|29.82|Standard Deviation|6.90|6.9|||
3985283|NCT01255761|3807383|B1|||Body Mass Index (BMI)||kg/ m^2|Mean|30.87|30.87|Standard Deviation|7.23|7.23|||
3985284|NCT01255761|3807381|B3|||Height||Centimeters|Mean|164.47|164.47|Standard Deviation|9.59|9.59|||
3985285|NCT01255761|3807382|B2|||Height||Centimeters|Mean|164.00|164.0|Standard Deviation|9.25|9.25|||
3985286|NCT01255761|3807383|B1|||Height||Centimeters|Mean|164.94|164.94|Standard Deviation|9.91|9.91|||
3985287|NCT01255761|3807381|B3|||Weight||Kilogram|Mean|82.13|82.13|Standard Deviation|20.40|20.4|||
3985288|NCT01255761|3807382|B2|||Weight||Kilogram|Mean|80.17|80.17|Standard Deviation|19.23|19.23|||
3985289|NCT01255761|3807383|B1|||Weight||Kilogram|Mean|84.08|84.08|Standard Deviation|21.35|21.35|||
3985290|NCT01255761|3807381|B3|United States||Region of Enrollment||participants|Number|736|736.0||||||
3985291|NCT01255761|3807382|B2|United States||Region of Enrollment||participants|Number|367|367.0||||||
3985292|NCT01255761|3807383|B1|United States||Region of Enrollment||participants|Number|369|369.0||||||
3985293|NCT01255761|3807381|B3||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
3985294|NCT01255761|3807382|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3985295|NCT01255761|3807383|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3985296|NCT01255761|3807381|B3||Female|Sex: Female, Male||Participants|Count of Participants|573|573.0||||||
3985297|NCT01255761|3807382|B2||Female|Sex: Female, Male||Participants|Count of Participants|293|293.0||||||
3985298|NCT01255761|3807383|B1||Female|Sex: Female, Male||Participants|Count of Participants|280|280.0||||||
3985299|NCT01255761|3807381|B3|||Age||years|Mean|54.9|54.9|Standard Deviation|12.7|12.7|||
3985300|NCT01255761|3807382|B2|||Age||years|Mean|55.7|55.7|Standard Deviation|12.8|12.8|||
3985301|NCT01255761|3807383|B1|||Age||years|Mean|54.1|54.1|Standard Deviation|12.5|12.5|||
3985302|NCT01255761|3807381|B3||>=65 years|Age||Participants|Count of Participants|164|164.0||||||
3985303|NCT01255761|3807382|B2||>=65 years|Age||Participants|Count of Participants|90|90.0||||||
3985304|NCT01255761|3807383|B1||>=65 years|Age||Participants|Count of Participants|74|74.0||||||
3985305|NCT01255761|3807381|B3||Between 18 and 65 years|Age||Participants|Count of Participants|571|571.0||||||
3985306|NCT01255761|3807382|B2||Between 18 and 65 years|Age||Participants|Count of Participants|276|276.0||||||
3985307|NCT01255761|3807383|B1||Between 18 and 65 years|Age||Participants|Count of Participants|295|295.0||||||
3985308|NCT01255761|3807381|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3985309|NCT01255761|3807382|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3985310|NCT01255761|3807383|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3985311|NCT01255722|3807466|B4|Italy||Region of Enrollment||participants|Number|72|72.0||||||
3985312|NCT01255722|3807467|B3|Italy||Region of Enrollment||participants|Number|23|23.0||||||
3985313|NCT01255722|3807468|B2|Italy||Region of Enrollment||participants|Number|24|24.0||||||
3985314|NCT01255722|3807469|B1|Italy||Region of Enrollment||participants|Number|25|25.0||||||
3985315|NCT01255722|3807466|B4|Switzerland||Region of Enrollment||participants|Number|28|28.0||||||
3985316|NCT01255722|3807467|B3|Switzerland||Region of Enrollment||participants|Number|10|10.0||||||
3985317|NCT01255722|3807468|B2|Switzerland||Region of Enrollment||participants|Number|9|9.0||||||
3985318|NCT01255722|3807469|B1|Switzerland||Region of Enrollment||participants|Number|9|9.0||||||
3985319|NCT01255722|3807466|B4|Germany||Region of Enrollment||participants|Number|127|127.0||||||
3985320|NCT01255722|3807467|B3|Germany||Region of Enrollment||participants|Number|41|41.0||||||
3985321|NCT01255722|3807468|B2|Germany||Region of Enrollment||participants|Number|45|45.0||||||
3985322|NCT01255722|3807469|B1|Germany||Region of Enrollment||participants|Number|41|41.0||||||
3985323|NCT01255722|3807466|B4|Spain||Region of Enrollment||participants|Number|62|62.0||||||
3985324|NCT01255722|3807467|B3|Spain||Region of Enrollment||participants|Number|20|20.0||||||
3985325|NCT01255722|3807468|B2|Spain||Region of Enrollment||participants|Number|21|21.0||||||
3985326|NCT01255722|3807469|B1|Spain||Region of Enrollment||participants|Number|21|21.0||||||
3985327|NCT01255722|3807466|B4|France||Region of Enrollment||participants|Number|179|179.0||||||
3985328|NCT01255722|3807467|B3|France||Region of Enrollment||participants|Number|59|59.0||||||
3985329|NCT01255722|3807468|B2|France||Region of Enrollment||participants|Number|61|61.0||||||
3985330|NCT01255722|3807469|B1|France||Region of Enrollment||participants|Number|59|59.0||||||
3985331|NCT01255722|3807466|B4||Male|Sex: Female, Male||Participants|Count of Participants|270|270.0||||||
3985332|NCT01255722|3807467|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3985333|NCT01255722|3807468|B2||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3985334|NCT01255722|3807469|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3985335|NCT01255722|3807466|B4||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
3985336|NCT01255722|3807467|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3985337|NCT01255722|3807468|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3985338|NCT01255722|3807469|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3985339|NCT01255722|3807466|B4|||Age||years|Mean|57.8|57.8|Standard Deviation|12.4|12.4|||
3985340|NCT01255722|3807467|B3|||Age||years|Mean|56.9|56.9|Standard Deviation|13.4|13.4|||
3985341|NCT01255722|3807468|B2|||Age||years|Mean|58.7|58.7|Standard Deviation|11.6|11.6|||
3985342|NCT01255722|3807469|B1|||Age||years|Mean|57.9|57.9|Standard Deviation|12.2|12.2|||
3985343|NCT01255722|3807466|B4||>=65 years|Age||Participants|Count of Participants|155|155.0||||||
3985344|NCT01255722|3807467|B3||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
3985345|NCT01255722|3807468|B2||>=65 years|Age||Participants|Count of Participants|59|59.0||||||
3985346|NCT01255722|3807469|B1||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
3985347|NCT01255722|3807466|B4||Between 18 and 65 years|Age||Participants|Count of Participants|313|313.0||||||
3985348|NCT01255722|3807467|B3||Between 18 and 65 years|Age||Participants|Count of Participants|108|108.0||||||
3985349|NCT01255722|3807468|B2||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
3985350|NCT01255722|3807469|B1||Between 18 and 65 years|Age||Participants|Count of Participants|104|104.0||||||
3985351|NCT01255722|3807466|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3985352|NCT01255722|3807467|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3985353|NCT01255722|3807468|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3985354|NCT01255722|3807469|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3985355|NCT01255631|3807494|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3985356|NCT01255631|3807495|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3985357|NCT01255631|3807496|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3985358|NCT01255631|3807494|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3985359|NCT01255631|3807495|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3985360|NCT01255631|3807496|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3985361|NCT01255631|3807494|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3985362|NCT01255631|3807495|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3985363|NCT01255631|3807496|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3985364|NCT01255631|3807494|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3985365|NCT01255631|3807495|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3985366|NCT01255631|3807496|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3985367|NCT01255631|3807494|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3985368|NCT01255631|3807495|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3985369|NCT01255631|3807496|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3985370|NCT01255592|3807513|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3985371|NCT01255592|3807514|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3985372|NCT01255592|3807515|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3985373|NCT01255592|3807513|B3|White||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
3985374|NCT01255592|3807514|B2|White||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3985375|NCT01255592|3807515|B1|White||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3985376|NCT01255592|3807513|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3985377|NCT01255592|3807514|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3985378|NCT01255592|3807515|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3985379|NCT01255592|3807513|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3985380|NCT01255592|3807514|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3985381|NCT01255592|3807515|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3985382|NCT01255592|3807513|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3985383|NCT01255592|3807514|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3985384|NCT01255592|3807515|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3985385|NCT01255592|3807513|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3985386|NCT01255592|3807514|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3985387|NCT01255592|3807515|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3985388|NCT01255592|3807513|B3|||Age||years|Mean|65|65.0|Standard Deviation|7.7|7.7|||
3985389|NCT01255592|3807514|B2|||Age||years|Mean|65|65.0|Standard Deviation|8.8|8.8|||
3985390|NCT01255592|3807515|B1|||Age||years|Mean|66|66.0|Standard Deviation|6.6|6.6|||
3985391|NCT01255449|3807572|B1|Italy||Region of Enrollment||participants|Number|26|26.0||||||
3985392|NCT01255449|3807572|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3985393|NCT01255449|3807572|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3985394|NCT01255449|3807572|B1|||Age||years|Mean|37|37.0|Standard Deviation|14|14.0|||
3985395|NCT01255449|3807572|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3985396|NCT01255449|3807572|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3985397|NCT01255449|3807572|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3985398|NCT01255436|3807577|B3|||Number of prescribed maintenance medications||medications|Median|4|4.0|Full Range|||1.0|13.0|
3985399|NCT01255436|3807578|B2|||Number of prescribed maintenance medications||medications|Median|4|4.0|Full Range|||1.0|13.0|
3985400|NCT01255436|3807579|B1|||Number of prescribed maintenance medications||medications|Median|3|3.0|Full Range|||1.0|10.0|
3985401|NCT01255436|3807577|B3|||Number of prescribed drugs for hypertension||medications|Median|2|2.0|Full Range|||1.0|5.0|
3985402|NCT01255436|3807578|B2|||Number of prescribed drugs for hypertension||medications|Median|2|2.0|Full Range|||1.0|4.0|
3985403|NCT01255436|3807579|B1|||Number of prescribed drugs for hypertension||medications|Median|2|2.0|Full Range|||1.0|5.0|
3985404|NCT01255436|3807577|B3|||Time in years since diagnosis of hypertension||years|Mean|8.5|8.5|Standard Deviation|10.4|10.4|||
3985405|NCT01255436|3807578|B2|||Time in years since diagnosis of hypertension||years|Mean|8.6|8.6|Standard Deviation|8.2|8.2|||
3985406|NCT01255436|3807579|B1|||Time in years since diagnosis of hypertension||years|Mean|8.5|8.5|Standard Deviation|11.1|11.1|||
3985407|NCT01255436|3807577|B3|Other||Educational Attainment||participants|Number|29|29.0||||||
3985408|NCT01255436|3807578|B2|Other||Educational Attainment||participants|Number|14|14.0||||||
3985409|NCT01255436|3807579|B1|Other||Educational Attainment||participants|Number|15|15.0||||||
3985410|NCT01255436|3807577|B3|College||Educational Attainment||participants|Number|171|171.0||||||
3985411|NCT01255436|3807578|B2|College||Educational Attainment||participants|Number|82|82.0||||||
3985412|NCT01255436|3807579|B1|College||Educational Attainment||participants|Number|89|89.0||||||
3985413|NCT01255436|3807577|B3|High school||Educational Attainment||participants|Number|297|297.0||||||
3985414|NCT01255436|3807578|B2|High school||Educational Attainment||participants|Number|152|152.0||||||
3985415|NCT01255436|3807579|B1|High school||Educational Attainment||participants|Number|145|145.0||||||
3985416|NCT01255436|3807577|B3|Elementary||Educational Attainment||participants|Number|163|163.0||||||
3985417|NCT01255436|3807578|B2|Elementary||Educational Attainment||participants|Number|79|79.0||||||
3985418|NCT01255436|3807579|B1|Elementary||Educational Attainment||participants|Number|84|84.0||||||
3985419|NCT01255436|3807577|B3|No formal education||Educational Attainment||participants|Number|2|2.0||||||
3985420|NCT01255436|3807578|B2|No formal education||Educational Attainment||participants|Number|2|2.0||||||
3985421|NCT01255436|3807579|B1|No formal education||Educational Attainment||participants|Number|0|0.0||||||
3985422|NCT01255436|3807577|B3|Retired||Employment Status||participants|Number|47|47.0||||||
3985423|NCT01255436|3807578|B2|Retired||Employment Status||participants|Number|26|26.0||||||
3985424|NCT01255436|3807579|B1|Retired||Employment Status||participants|Number|21|21.0||||||
3985425|NCT01255436|3807577|B3|Employed||Employment Status||participants|Number|135|135.0||||||
3985426|NCT01255436|3807578|B2|Employed||Employment Status||participants|Number|65|65.0||||||
3985427|NCT01255436|3807579|B1|Employed||Employment Status||participants|Number|70|70.0||||||
3985428|NCT01255436|3807577|B3|Unemployed||Employment Status||participants|Number|480|480.0||||||
3985429|NCT01255436|3807578|B2|Unemployed||Employment Status||participants|Number|238|238.0||||||
3985430|NCT01255436|3807579|B1|Unemployed||Employment Status||participants|Number|242|242.0||||||
3985431|NCT01255436|3807577|B3||Male|Gender||Participants|Count of Participants|230|230.0||||||
3985432|NCT01255436|3807578|B2||Male|Gender||Participants|Count of Participants|117|117.0||||||
3985433|NCT01255436|3807579|B1||Male|Gender||Participants|Count of Participants|113|113.0||||||
3985434|NCT01255436|3807577|B3||Female|Gender||Participants|Count of Participants|432|432.0||||||
3985435|NCT01255436|3807578|B2||Female|Gender||Participants|Count of Participants|212|212.0||||||
3985436|NCT01255436|3807579|B1||Female|Gender||Participants|Count of Participants|220|220.0||||||
3985437|NCT01255436|3807577|B3|||Age||years|Mean|59.3|59.3|Standard Deviation|10.9|10.9|||
3985438|NCT01255436|3807578|B2|||Age||years|Mean|59.6|59.6|Standard Deviation|11.1|11.1|||
3985439|NCT01255436|3807579|B1|||Age||years|Mean|59.0|59.0|Standard Deviation|10.7|10.7|||
3985440|NCT01255423|3807592|B3|18 years and above||18 years and above||participants|Number|206|206.0||||||
3985441|NCT01255423|3807593|B2|18 years and above||18 years and above||participants|Number|102|102.0||||||
3985442|NCT01255423|3807594|B1|18 years and above||18 years and above||participants|Number|104|104.0||||||
3985443|NCT01255423|3807592|B3|<=18 years||18 years and above||participants|Number|0|0.0||||||
3985444|NCT01255423|3807593|B2|<=18 years||18 years and above||participants|Number|0|0.0||||||
3985445|NCT01255423|3807594|B1|<=18 years||18 years and above||participants|Number|0|0.0||||||
3985446|NCT01255423|3807592|B3|United States||Region of Enrollment||participants|Number|206|206.0||||||
3985447|NCT01255423|3807593|B2|United States||Region of Enrollment||participants|Number|102|102.0||||||
3985448|NCT01255423|3807594|B1|United States||Region of Enrollment||participants|Number|104|104.0||||||
3985449|NCT01255423|3807592|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3985450|NCT01255423|3807593|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3985451|NCT01255423|3807594|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3985452|NCT01255423|3807592|B3||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3985453|NCT01255423|3807593|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3985454|NCT01255423|3807594|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3985455|NCT01255423|3807592|B3|||Age||years|Mean|30.9|30.9|Standard Deviation|13.5|13.5|||
3985456|NCT01255423|3807593|B2|||Age||years|Mean|30.8|30.8|Standard Deviation|13.9|13.9|||
3985457|NCT01255423|3807594|B1|||Age||years|Mean|31.0|31.0|Standard Deviation|13.1|13.1|||
3985458|NCT01255306|3807609|B3|Croatia||Region of Enrollment||participants|Number|59|59.0||||||
3985459|NCT01255306|3807610|B2|Croatia||Region of Enrollment||participants|Number|33|33.0||||||
3985460|NCT01255306|3807611|B1|Croatia||Region of Enrollment||participants|Number|26|26.0||||||
3985461|NCT01255306|3807609|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3985462|NCT01255306|3807610|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3985463|NCT01255306|3807611|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3985464|NCT01255306|3807609|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3985465|NCT01255306|3807610|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3985466|NCT01255306|3807611|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3985467|NCT01255306|3807609|B3|||Age||years|Mean|60.67|60.67|Standard Deviation|12.77|12.77|||
3985468|NCT01255306|3807610|B2|||Age||years|Mean|58.21|58.21|Standard Deviation|12.26|12.26|||
3985469|NCT01255306|3807611|B1|||Age||years|Mean|63.80|63.8|Standard Deviation|12.97|12.97|||
3985470|NCT01255306|3807609|B3||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
3985471|NCT01255306|3807610|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3985472|NCT01255306|3807611|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3985473|NCT01255306|3807609|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3985474|NCT01255306|3807610|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3985475|NCT01255306|3807611|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3985476|NCT01255306|3807609|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3985477|NCT01255306|3807610|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3985478|NCT01255306|3807611|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3985479|NCT01255163|3807621|B3|||Nausea|Nausea reported by participant|Participants|Count of Participants|0|0.0||||||
3985480|NCT01255163|3807622|B2|||Nausea|Nausea reported by participant|Participants|Count of Participants|0|0.0||||||
3985481|NCT01255163|3807623|B1|||Nausea|Nausea reported by participant|Participants|Count of Participants|0|0.0||||||
3985482|NCT01255163|3807621|B3|||Clinical Dementia Rating (CDR) sum of boxes|"Sum of the Clinical Dementia Rating boxes (memory, orientation, judgment and problem solving, community affairs, home and hobbies, personal care). Each box is rated as 0, 0.5, 1, 2 or 3. Range for the sum of boxes is 0 - 18. Higher scores reflect a greater severity of dementia."|units on a scale|Mean|2.889|2.889|Standard Deviation|1.745|1.745|||
3985483|NCT01255163|3807622|B2|||Clinical Dementia Rating (CDR) sum of boxes|"Sum of the Clinical Dementia Rating boxes (memory, orientation, judgment and problem solving, community affairs, home and hobbies, personal care). Each box is rated as 0, 0.5, 1, 2 or 3. Range for the sum of boxes is 0 - 18. Higher scores reflect a greater severity of dementia."|units on a scale|Mean|3|3.0|Standard Deviation|1.7759|1.7759|||
3985484|NCT01255163|3807623|B1|||Clinical Dementia Rating (CDR) sum of boxes|"Sum of the Clinical Dementia Rating boxes (memory, orientation, judgment and problem solving, community affairs, home and hobbies, personal care). Each box is rated as 0, 0.5, 1, 2 or 3. Range for the sum of boxes is 0 - 18. Higher scores reflect a greater severity of dementia."|units on a scale|Mean|2.769|2.769|Standard Deviation|1.775|1.775|||
3985485|NCT01255163|3807621|B3|||Clinical Dementia Rating (CDR) global score|Clinical Dementia Rating global score range: 0 (no dementia); 0.5 (Mild Cognitive Impairment); 1 (mild dementia); 2 (moderate dementia); 3 (severe dementia). Higher is worse.|units on a scale|Mean|0.593|0.593|Standard Deviation|0.2417|0.2417|||
3985486|NCT01255163|3807622|B2|||Clinical Dementia Rating (CDR) global score|Clinical Dementia Rating global score range: 0 (no dementia); 0.5 (Mild Cognitive Impairment); 1 (mild dementia); 2 (moderate dementia); 3 (severe dementia). Higher is worse.|units on a scale|Mean|0.607|0.607|Standard Deviation|0.2129|0.2129|||
3985487|NCT01255163|3807623|B1|||Clinical Dementia Rating (CDR) global score|Clinical Dementia Rating global score range: 0 (no dementia); 0.5 (Mild Cognitive Impairment); 1 (mild dementia); 2 (moderate dementia); 3 (severe dementia). Higher is worse.|units on a scale|Mean|0.577|0.577|Standard Deviation|0.2774|0.2774|||
3985488|NCT01255163|3807621|B3|||Cerebrospinal fluid (CSF) Total Tau|Measured in CSF using Luminex xMAP technology and INNO-BIA Alz Bio3 kits (Research Use Only) provided by Fujirebio|pg/dl|Mean|80.15|80.15|Standard Deviation|40.744|40.744|||
3985489|NCT01255163|3807622|B2|||Cerebrospinal fluid (CSF) Total Tau|Measured in CSF using Luminex xMAP technology and INNO-BIA Alz Bio3 kits (Research Use Only) provided by Fujirebio|pg/dl|Mean|70.64|70.64|Standard Deviation|22.802|22.802|||
3985490|NCT01255163|3807623|B1|||Cerebrospinal fluid (CSF) Total Tau|Measured in CSF using Luminex xMAP technology and INNO-BIA Alz Bio3 kits (Research Use Only) provided by Fujirebio|pg/dl|Mean|90.38|90.38|Standard Deviation|53.053|53.053|||
3985491|NCT01255163|3807621|B3|||Cerebrospinal fluid phospho181-tau (CSF p181-tau)|Measured in CSF using Luminex xMAP technology and INNO-BIA Alz Bio3 kits (Research Use Only) provided by Fujirebio|pg/dl|Mean|48.33|48.33|Standard Deviation|27.369|27.369|||
3985492|NCT01255163|3807622|B2|||Cerebrospinal fluid phospho181-tau (CSF p181-tau)|Measured in CSF using Luminex xMAP technology and INNO-BIA Alz Bio3 kits (Research Use Only) provided by Fujirebio|pg/dl|Mean|40.64|40.64|Standard Deviation|16.137|16.137|||
3985493|NCT01255163|3807623|B1|||Cerebrospinal fluid phospho181-tau (CSF p181-tau)|Measured in CSF using Luminex xMAP technology and INNO-BIA Alz Bio3 kits (Research Use Only) provided by Fujirebio|pg/dl|Mean|56.62|56.62|Standard Deviation|34.606|34.606|||
3985494|NCT01255163|3807621|B3|||Fasting insulin||uIU/ml|Mean|8.254|8.254|Standard Deviation|4.4628|4.4628|||
3985495|NCT01255163|3807622|B2|||Fasting insulin||uIU/ml|Mean|8.1|8.1|Standard Deviation|4.5361|4.5361|||
3985496|NCT01255163|3807623|B1|||Fasting insulin||uIU/ml|Mean|8.53|8.53|Standard Deviation|4.4337|4.4337|||
3985497|NCT01255163|3807621|B3|||Fasting glucose||mg/dl|Mean|92.44|92.44|Standard Deviation|8.954|8.954|||
3985498|NCT01255163|3807622|B2|||Fasting glucose||mg/dl|Mean|90.14|90.14|Standard Deviation|9.206|9.206|||
3985499|NCT01255163|3807623|B1|||Fasting glucose||mg/dl|Mean|94.92|94.92|Standard Deviation|8.311|8.311|||
3985500|NCT01255163|3807621|B3|||Body Mass Index (BMI)|Body Mass Index defined as a person's weight in kilograms (kg) divided by his or her height in meters squared.|kg/m^2|Mean|26.744|26.744|Standard Deviation|4.3687|4.3687|||
3985501|NCT01255163|3807622|B2|||Body Mass Index (BMI)|Body Mass Index defined as a person's weight in kilograms (kg) divided by his or her height in meters squared.|kg/m^2|Mean|26.85|26.85|Standard Deviation|5.2611|5.2611|||
3985502|NCT01255163|3807623|B1|||Body Mass Index (BMI)|Body Mass Index defined as a person's weight in kilograms (kg) divided by his or her height in meters squared.|kg/m^2|Mean|26.631|26.631|Standard Deviation|3.3673|3.3673|||
3985503|NCT01255163|3807621|B3|||Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog70)|Alzheimer's dementia scale cognitive sub-scale range: 0 - 70 points (higher is worse)|units on a scale|Mean|14.04|14.04|Standard Deviation|6.653|6.653|||
3985504|NCT01255163|3807622|B2|||Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog70)|Alzheimer's dementia scale cognitive sub-scale range: 0 - 70 points (higher is worse)|units on a scale|Mean|13.64|13.64|Standard Deviation|6.879|6.879|||
3985505|NCT01255163|3807623|B1|||Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog70)|Alzheimer's dementia scale cognitive sub-scale range: 0 - 70 points (higher is worse)|units on a scale|Mean|14.46|14.46|Standard Deviation|6.654|6.654|||
3985506|NCT01255163|3807621|B3|||Mini Mental State Examination (MMSE)|Scale range: 0 - 30 points (higher is better)|units on a scale|Mean|25.22|25.22|Standard Deviation|4.61|4.61|||
3985507|NCT01255163|3807622|B2|||Mini Mental State Examination (MMSE)|Scale range: 0 - 30 points (higher is better)|units on a scale|Mean|24.64|24.64|Standard Deviation|5.198|5.198|||
3985508|NCT01255163|3807623|B1|||Mini Mental State Examination (MMSE)|Scale range: 0 - 30 points (higher is better)|units on a scale|Mean|25.85|25.85|Standard Deviation|3.997|3.997|||
3985563|NCT01255137|3807646|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3985509|NCT01255163|3807621|B3|||Cerebrospinal fluid amyloid-beta 42 (CSF Abeta42)|Measured in CSF using Luminex xMAP technology and INNO-BIA Alz Bio3 kits (Research Use Only) provided by Fujirebio|pg/dl|Mean|158.85|158.85|Standard Deviation|37.963|37.963|||
3985510|NCT01255163|3807622|B2|||Cerebrospinal fluid amyloid-beta 42 (CSF Abeta42)|Measured in CSF using Luminex xMAP technology and INNO-BIA Alz Bio3 kits (Research Use Only) provided by Fujirebio|pg/dl|Mean|158.86|158.86|Standard Deviation|33.558|33.558|||
3985511|NCT01255163|3807623|B1|||Cerebrospinal fluid amyloid-beta 42 (CSF Abeta42)|Measured in CSF using Luminex xMAP technology and INNO-BIA Alz Bio3 kits (Research Use Only) provided by Fujirebio|pg/dl|Mean|158.85|158.85|Standard Deviation|43.619|43.619|||
3985512|NCT01255163|3807621|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
3985513|NCT01255163|3807622|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3985514|NCT01255163|3807623|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3985515|NCT01255163|3807621|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985516|NCT01255163|3807622|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985517|NCT01255163|3807623|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985518|NCT01255163|3807621|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985519|NCT01255163|3807622|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985520|NCT01255163|3807623|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985521|NCT01255163|3807621|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3985522|NCT01255163|3807622|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3985523|NCT01255163|3807623|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3985524|NCT01255163|3807621|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3985525|NCT01255163|3807622|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3985526|NCT01255163|3807623|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3985527|NCT01255163|3807621|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985528|NCT01255163|3807622|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985529|NCT01255163|3807623|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985530|NCT01255163|3807621|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3985531|NCT01255163|3807622|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3985532|NCT01255163|3807623|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985533|NCT01255163|3807621|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985534|NCT01255163|3807622|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985535|NCT01255163|3807623|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985536|NCT01255163|3807621|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985537|NCT01255163|3807622|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985538|NCT01255163|3807623|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985539|NCT01255163|3807621|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3985540|NCT01255163|3807622|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3985541|NCT01255163|3807623|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3985542|NCT01255163|3807621|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985543|NCT01255163|3807622|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985544|NCT01255163|3807623|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985545|NCT01255163|3807621|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3985546|NCT01255163|3807622|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3985547|NCT01255163|3807623|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3985548|NCT01255163|3807621|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3985549|NCT01255163|3807622|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3985550|NCT01255163|3807623|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3985551|NCT01255163|3807621|B3|||Age||years|Mean|72.63|72.63|Standard Deviation|7.265|7.265|||
3985552|NCT01255163|3807622|B2|||Age||years|Mean|74.64|74.64|Standard Deviation|7.034|7.034|||
3985553|NCT01255163|3807623|B1|||Age||years|Mean|70.46|70.46|Standard Deviation|7.137|7.137|||
3985554|NCT01255137|3807646|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3985555|NCT01255137|3807646|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985556|NCT01255137|3807646|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985557|NCT01255137|3807646|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3985558|NCT01255137|3807646|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3985559|NCT01255137|3807646|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985560|NCT01255137|3807646|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985561|NCT01255137|3807646|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985562|NCT01255137|3807646|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3985564|NCT01255137|3807646|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985565|NCT01255137|3807646|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3985566|NCT01255137|3807646|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3985567|NCT01255137|3807646|B1|||Age||years|Mean|53.89|53.89|Standard Deviation|11.87|11.87|||
3985568|NCT01255137|3807646|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3985569|NCT01255137|3807646|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3985570|NCT01255137|3807646|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3985571|NCT01254890|3807651|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
3985572|NCT01254890|3807652|B2|United States||Region of Enrollment||participants|Number|57|57.0||||||
3985573|NCT01254890|3807653|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3985574|NCT01254890|3807651|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3985575|NCT01254890|3807652|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3985576|NCT01254890|3807653|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3985577|NCT01254890|3807651|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3985578|NCT01254890|3807652|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3985579|NCT01254890|3807653|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3985580|NCT01254890|3807651|B3|||Age||years|Median|64|64.0|Full Range|||20.0|87.0|
3985581|NCT01254890|3807652|B2|||Age||years|Median|64|64.0|Full Range|||20.0|81.0|
3985582|NCT01254890|3807653|B1|||Age||years|Median|73|73.0|Full Range|||40.0|87.0|
3985583|NCT01254877|3807660|B4|||Number of days abstinent from alcohol/week||days/week|Mean|3.1|3.1|Standard Deviation|2.0|2.0|||
3985584|NCT01254877|3807661|B3|||Number of days abstinent from alcohol/week||days/week|Mean|3.3|3.3|Standard Deviation|1.9|1.9|||
3985585|NCT01254877|3807662|B2|||Number of days abstinent from alcohol/week||days/week|Mean|3.0|3.0|Standard Deviation|2.1|2.1|||
3985586|NCT01254877|3807663|B1|||Number of days abstinent from alcohol/week||days/week|Mean|2.9|2.9|Standard Deviation|1.9|1.9|||
3985587|NCT01254877|3807660|B4|||Number of drinks per drinking day||standard alcohol drink|Mean|9.9|9.9|Standard Deviation|7.3|7.3|||
3985588|NCT01254877|3807661|B3|||Number of drinks per drinking day||standard alcohol drink|Mean|10.0|10.0|Standard Deviation|8.7|8.7|||
3985589|NCT01254877|3807662|B2|||Number of drinks per drinking day||standard alcohol drink|Mean|10.5|10.5|Standard Deviation|7.7|7.7|||
3985590|NCT01254877|3807663|B1|||Number of drinks per drinking day||standard alcohol drink|Mean|9.1|9.1|Standard Deviation|5.5|5.5|||
3985591|NCT01254877|3807660|B4|United States||Region of Enrollment||Participants|Count of Participants|205|205.0||||||
3985592|NCT01254877|3807661|B3|United States||Region of Enrollment||Participants|Count of Participants|69|69.0||||||
3985593|NCT01254877|3807662|B2|United States||Region of Enrollment||Participants|Count of Participants|69|69.0||||||
3985594|NCT01254877|3807663|B1|United States||Region of Enrollment||Participants|Count of Participants|67|67.0||||||
3985595|NCT01254877|3807660|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3985596|NCT01254877|3807661|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3985597|NCT01254877|3807662|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3985598|NCT01254877|3807663|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3985599|NCT01254877|3807660|B4|Black||Race/Ethnicity, Customized||Participants|Count of Participants|195|195.0||||||
3985600|NCT01254877|3807661|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|64|64.0||||||
3985601|NCT01254877|3807662|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|66|66.0||||||
3985602|NCT01254877|3807663|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|65|65.0||||||
3985603|NCT01254877|3807660|B4||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
3985604|NCT01254877|3807661|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3985605|NCT01254877|3807662|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3985606|NCT01254877|3807663|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3985607|NCT01254877|3807660|B4||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3985608|NCT01254877|3807661|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3985609|NCT01254877|3807662|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3985610|NCT01254877|3807663|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3985611|NCT01254877|3807660|B4|||Age||years|Mean|48.7|48.7|Standard Deviation|8.8|8.8|||
3985612|NCT01254877|3807661|B3|||Age||years|Mean|47.8|47.8|Standard Deviation|9.5|9.5|||
3985613|NCT01254877|3807662|B2|||Age||years|Mean|48.7|48.7|Standard Deviation|8.2|8.2|||
3985614|NCT01254877|3807663|B1|||Age||years|Mean|49.7|49.7|Standard Deviation|8.7|8.7|||
3985615|NCT01254851|3807688|B3|United States||Region of Enrollment||participants|Number|146|146.0||||||
3985616|NCT01254851|3807689|B2|United States||Region of Enrollment||participants|Number|77|77.0||||||
3985617|NCT01254851|3807690|B1|United States||Region of Enrollment||participants|Number|69|69.0||||||
3985618|NCT01254851|3807688|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3985619|NCT01254851|3807689|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3985620|NCT01254851|3807690|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3985621|NCT01254851|3807688|B3||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3985622|NCT01254851|3807689|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3985623|NCT01254851|3807690|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3985624|NCT01254851|3807688|B3|||Age||years|Mean|54.98|54.98|Standard Deviation|12.3|12.3|||
3985625|NCT01254851|3807689|B2|||Age||years|Mean|53.9|53.9|Standard Deviation|13.27|13.27|||
3985626|NCT01254851|3807690|B1|||Age||years|Mean|56.1|56.1|Standard Deviation|11.1|11.1|||
3985627|NCT01254851|3807688|B3||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
3985628|NCT01254851|3807689|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3985629|NCT01254851|3807690|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3985630|NCT01254851|3807688|B3||Between 18 and 65 years|Age||Participants|Count of Participants|114|114.0||||||
3985631|NCT01254851|3807689|B2||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
3985632|NCT01254851|3807690|B1||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
3985633|NCT01254851|3807688|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3985634|NCT01254851|3807689|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3985635|NCT01254851|3807690|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3985636|NCT01254760|3807697|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3985637|NCT01254760|3807697|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3985638|NCT01254760|3807697|B1|||Age||years|Mean|50.1|50.1|Standard Deviation|5.7|5.7|||
3985639|NCT01254747|3807712|B5||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3985640|NCT01254747|3807713|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3985641|NCT01254747|3807714|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3985642|NCT01254747|3807715|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3985643|NCT01254747|3807716|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3985644|NCT01254747|3807712|B5||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3985645|NCT01254747|3807713|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3985646|NCT01254747|3807714|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3985647|NCT01254747|3807715|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3985648|NCT01254747|3807716|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3985649|NCT01254747|3807712|B5|||Age|All enrolled and dispensed participants|years|Mean|36.6|36.6|Standard Deviation|10.8|10.8|||
3985650|NCT01254747|3807713|B4|||Age|All enrolled and dispensed participants|years|Mean|37.0|37.0|Standard Deviation|11.4|11.4|||
3985651|NCT01254747|3807714|B3|||Age|All enrolled and dispensed participants|years|Mean|38.4|38.4|Standard Deviation|10.6|10.6|||
3985652|NCT01254747|3807715|B2|||Age|All enrolled and dispensed participants|years|Mean|35.6|35.6|Standard Deviation|11.4|11.4|||
3985653|NCT01254747|3807716|B1|||Age|All enrolled and dispensed participants|years|Mean|35.7|35.7|Standard Deviation|10.4|10.4|||
3985654|NCT01254721|3807757|B3|Mixed Episodes||Bipolar I Disorder|number of patients experiencing manic and mixed episodes in ITT analysis set|Number of Patients in ITT analysis set|Number|13|13.0||||||
3985655|NCT01254721|3807758|B2|Mixed Episodes||Bipolar I Disorder|number of patients experiencing manic and mixed episodes in ITT analysis set|Number of Patients in ITT analysis set|Number|7|7.0||||||
3985656|NCT01254721|3807759|B1|Mixed Episodes||Bipolar I Disorder|number of patients experiencing manic and mixed episodes in ITT analysis set|Number of Patients in ITT analysis set|Number|6|6.0||||||
3985657|NCT01254721|3807757|B3|Manic Episodes||Bipolar I Disorder|number of patients experiencing manic and mixed episodes in ITT analysis set|Number of Patients in ITT analysis set|Number|108|108.0||||||
3985658|NCT01254721|3807758|B2|Manic Episodes||Bipolar I Disorder|number of patients experiencing manic and mixed episodes in ITT analysis set|Number of Patients in ITT analysis set|Number|51|51.0||||||
3985659|NCT01254721|3807759|B1|Manic Episodes||Bipolar I Disorder|number of patients experiencing manic and mixed episodes in ITT analysis set|Number of Patients in ITT analysis set|Number|57|57.0||||||
3985660|NCT01254721|3807757|B3|||Total No. of acute bipolar mania episodes over lifetime||Episodes|Mean|3.76|3.76|Standard Deviation|3.54|3.54|||
3985661|NCT01254721|3807758|B2|||Total No. of acute bipolar mania episodes over lifetime||Episodes|Mean|3.25|3.25|Standard Deviation|2.42|2.42|||
3985662|NCT01254721|3807759|B1|||Total No. of acute bipolar mania episodes over lifetime||Episodes|Mean|4.24|4.24|Standard Deviation|4.31|4.31|||
3985663|NCT01254721|3807757|B3||Male|Sex: Female, Male|Total ITT analysis set is 121|Participants|Count of Participants|50|50.0||||||
3985664|NCT01254721|3807758|B2||Male|Sex: Female, Male|Total ITT analysis set is 121|Participants|Count of Participants|24|24.0||||||
3985665|NCT01254721|3807759|B1||Male|Sex: Female, Male|Total ITT analysis set is 121|Participants|Count of Participants|26|26.0||||||
3985666|NCT01254721|3807757|B3||Female|Sex: Female, Male|Total ITT analysis set is 121|Participants|Count of Participants|71|71.0||||||
3985667|NCT01254721|3807758|B2||Female|Sex: Female, Male|Total ITT analysis set is 121|Participants|Count of Participants|34|34.0||||||
3985668|NCT01254721|3807759|B1||Female|Sex: Female, Male|Total ITT analysis set is 121|Participants|Count of Participants|37|37.0||||||
3985669|NCT01254721|3807757|B3|Age at onset of acute bipolar mania||Age, Customized|Age at onset of acute bipolar mania in ITT analysis set|Years|Mean|30.5|30.5|Standard Deviation|10.9|10.9|||
3985670|NCT01254721|3807758|B2|Age at onset of acute bipolar mania||Age, Customized|Age at onset of acute bipolar mania in ITT analysis set|Years|Mean|30.0|30.0|Standard Deviation|11.3|11.3|||
3985671|NCT01254721|3807759|B1|Age at onset of acute bipolar mania||Age, Customized|Age at onset of acute bipolar mania in ITT analysis set|Years|Mean|31.0|31.0|Standard Deviation|10.6|10.6|||
3985672|NCT01254721|3807757|B3|Age||Age|Age in ITT population.|Years|Mean|37.7|37.7|Standard Deviation|10.7|10.7|||
3985673|NCT01254721|3807758|B2|Age||Age|Age in ITT population.|Years|Mean|36.9|36.9|Standard Deviation|11.7|11.7|||
3985674|NCT01254721|3807759|B1|Age||Age|Age in ITT population.|Years|Mean|38.4|38.4|Standard Deviation|9.8|9.8|||
3985675|NCT01254669|3807768|B3|||knowledge of HPV vaccine|Assessment of HPV knowledge range from 0 (minimal) to 12 ( maximal knowledge)|units on a scale|Mean|5|5.0|Standard Deviation|4|4.0|||
3985676|NCT01254669|3807769|B2|||knowledge of HPV vaccine|Assessment of HPV knowledge range from 0 (minimal) to 12 ( maximal knowledge)|units on a scale|Mean|6|6.0|Standard Deviation|4|4.0|||
3985677|NCT01254669|3807770|B1|||knowledge of HPV vaccine|Assessment of HPV knowledge range from 0 (minimal) to 12 ( maximal knowledge)|units on a scale|Mean|5|5.0|Standard Deviation|4|4.0|||
3985678|NCT01254669|3807768|B3|United States||Region of Enrollment||participants|Number|200|200.0||||||
3985679|NCT01254669|3807769|B2|United States||Region of Enrollment||participants|Number|100|100.0||||||
3985680|NCT01254669|3807770|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
3985681|NCT01254669|3807768|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985682|NCT01254669|3807769|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985683|NCT01254669|3807770|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985684|NCT01254669|3807768|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|200|200.0||||||
3985685|NCT01254669|3807769|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3985686|NCT01254669|3807770|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3985687|NCT01254669|3807768|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985688|NCT01254669|3807769|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985689|NCT01254669|3807770|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985690|NCT01254669|3807768|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985691|NCT01254669|3807769|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985692|NCT01254669|3807770|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985693|NCT01254669|3807768|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985694|NCT01254669|3807769|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985695|NCT01254669|3807770|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985696|NCT01254669|3807768|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985697|NCT01254669|3807769|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985698|NCT01254669|3807770|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985699|NCT01254669|3807768|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|200|200.0||||||
3985700|NCT01254669|3807769|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3985701|NCT01254669|3807770|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3985702|NCT01254669|3807768|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985703|NCT01254669|3807769|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985704|NCT01254669|3807770|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985705|NCT01254669|3807768|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985706|NCT01254669|3807769|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985707|NCT01254669|3807770|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985708|NCT01254669|3807768|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985709|NCT01254669|3807769|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985710|NCT01254669|3807770|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985711|NCT01254669|3807768|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3985712|NCT01254669|3807769|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3985713|NCT01254669|3807770|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3985714|NCT01254669|3807768|B3||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
3985715|NCT01254669|3807769|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3985716|NCT01254669|3807770|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3985717|NCT01254669|3807768|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3985718|NCT01254669|3807769|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3985719|NCT01254669|3807770|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3985720|NCT01254669|3807768|B3||Between 18 and 65 years|Age||Participants|Count of Participants|200|200.0||||||
3985721|NCT01254669|3807769|B2||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
3985722|NCT01254669|3807770|B1||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
3985723|NCT01254669|3807768|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3985724|NCT01254669|3807769|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3985725|NCT01254669|3807770|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3985726|NCT01254669|3807768|B3|age||Age||years|Mean|41|41.0|Standard Deviation|8|8.0|||
3985727|NCT01254669|3807769|B2|age||Age||years|Mean|40|40.0|Standard Deviation|9|9.0|||
3985728|NCT01254669|3807770|B1|age||Age||years|Mean|41|41.0|Standard Deviation|7|7.0|||
3985729|NCT01254656|3807779|B4||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3985730|NCT01254656|3807780|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3985731|NCT01254656|3807781|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3985732|NCT01254656|3807782|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3985733|NCT01254656|3807779|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3985734|NCT01254656|3807780|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3985735|NCT01254656|3807781|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3985736|NCT01254656|3807782|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3985737|NCT01254656|3807779|B4|>= 65 Years||Age, Customized||Participants|Number|0|0.0||||||
3985738|NCT01254656|3807780|B3|>= 65 Years||Age, Customized||Participants|Number|0|0.0||||||
3985739|NCT01254656|3807781|B2|>= 65 Years||Age, Customized||Participants|Number|0|0.0||||||
3985740|NCT01254656|3807782|B1|>= 65 Years||Age, Customized||Participants|Number|0|0.0||||||
3985741|NCT01254656|3807779|B4|45 - 64 Years||Age, Customized||Participants|Number|16|16.0||||||
3985742|NCT01254656|3807780|B3|45 - 64 Years||Age, Customized||Participants|Number|4|4.0||||||
3985743|NCT01254656|3807781|B2|45 - 64 Years||Age, Customized||Participants|Number|6|6.0||||||
3985744|NCT01254656|3807782|B1|45 - 64 Years||Age, Customized||Participants|Number|6|6.0||||||
3985745|NCT01254656|3807779|B4|18 - 44 Years||Age, Customized||Participants|Number|92|92.0||||||
3985746|NCT01254656|3807780|B3|18 - 44 Years||Age, Customized||Participants|Number|14|14.0||||||
3985747|NCT01254656|3807781|B2|18 - 44 Years||Age, Customized||Participants|Number|37|37.0||||||
3985748|NCT01254656|3807782|B1|18 - 44 Years||Age, Customized||Participants|Number|41|41.0||||||
3985749|NCT01254656|3807779|B4|< 18 Years||Age, Customized||Participants|Number|0|0.0||||||
3985750|NCT01254656|3807780|B3|< 18 Years||Age, Customized||Participants|Number|0|0.0||||||
3985751|NCT01254656|3807781|B2|< 18 Years||Age, Customized||Participants|Number|0|0.0||||||
3985752|NCT01254656|3807782|B1|< 18 Years||Age, Customized||Participants|Number|0|0.0||||||
3985753|NCT01254656|3807779|B4|||Age||Years|Mean|36.6|36.6|Standard Deviation|8.4|8.4|||
3985754|NCT01254656|3807780|B3|||Age||Years|Mean|38.5|38.5|Standard Deviation|7.8|7.8|||
3985755|NCT01254656|3807781|B2|||Age||Years|Mean|35.8|35.8|Standard Deviation|8.7|8.7|||
3985756|NCT01254656|3807782|B1|||Age||Years|Mean|36.6|36.6|Standard Deviation|8.4|8.4|||
3985757|NCT01254643|3807810|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3985758|NCT01254643|3807810|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3985759|NCT01254643|3807810|B1|||Age||years|Mean|11.7|11.7|Standard Deviation|1.7|1.7|||
3985760|NCT01254630|3807818|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3985761|NCT01254630|3807819|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3985762|NCT01254630|3807820|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3985763|NCT01254630|3807821|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985764|NCT01254630|3807822|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985765|NCT01254630|3807818|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|601|601.0||||||
3985766|NCT01254630|3807819|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|141|141.0||||||
3985767|NCT01254630|3807820|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|159|159.0||||||
3985768|NCT01254630|3807821|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|157|157.0||||||
3985769|NCT01254630|3807822|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
3985770|NCT01254630|3807818|B5||White|Race (NIH/OMB)||Participants|Count of Participants|4037|4037.0||||||
3985771|NCT01254630|3807819|B4||White|Race (NIH/OMB)||Participants|Count of Participants|986|986.0||||||
3985772|NCT01254630|3807820|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1031|1031.0||||||
3985773|NCT01254630|3807821|B2||White|Race (NIH/OMB)||Participants|Count of Participants|976|976.0||||||
3985774|NCT01254630|3807822|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1044|1044.0||||||
3985775|NCT01254630|3807818|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|276|276.0||||||
3985776|NCT01254630|3807819|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3985777|NCT01254630|3807820|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
3985778|NCT01254630|3807821|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3985779|NCT01254630|3807822|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
3985780|NCT01254630|3807818|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3985781|NCT01254630|3807819|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3985782|NCT01254630|3807820|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3985783|NCT01254630|3807821|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3985784|NCT01254630|3807822|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3985785|NCT01254630|3807818|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|323|323.0||||||
3985786|NCT01254630|3807819|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
3985787|NCT01254630|3807820|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3985788|NCT01254630|3807821|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
3985789|NCT01254630|3807822|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3985790|NCT01254630|3807818|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3985791|NCT01254630|3807819|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3985792|NCT01254630|3807820|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3985793|NCT01254630|3807821|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3985794|NCT01254630|3807822|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3985795|NCT01254630|3807818|B5||Male|Sex: Female, Male||Participants|Count of Participants|2475|2475.0||||||
3985796|NCT01254630|3807819|B4||Male|Sex: Female, Male||Participants|Count of Participants|762|762.0||||||
3985797|NCT01254630|3807820|B3||Male|Sex: Female, Male||Participants|Count of Participants|472|472.0||||||
3985798|NCT01254630|3807821|B2||Male|Sex: Female, Male||Participants|Count of Participants|760|760.0||||||
3985799|NCT01254630|3807822|B1||Male|Sex: Female, Male||Participants|Count of Participants|481|481.0||||||
3985800|NCT01254630|3807818|B5||Female|Sex: Female, Male||Participants|Count of Participants|2810|2810.0||||||
3985801|NCT01254630|3807819|B4||Female|Sex: Female, Male||Participants|Count of Participants|523|523.0||||||
3985802|NCT01254630|3807820|B3||Female|Sex: Female, Male||Participants|Count of Participants|892|892.0||||||
3985803|NCT01254630|3807821|B2||Female|Sex: Female, Male||Participants|Count of Participants|528|528.0||||||
3985804|NCT01254630|3807822|B1||Female|Sex: Female, Male||Participants|Count of Participants|867|867.0||||||
3985805|NCT01254630|3807818|B5|≥50 years||Age, Customized||Participants|Number|4208|4208.0||||||
3985806|NCT01254630|3807819|B4|≥50 years||Age, Customized||Participants|Number|1062|1062.0||||||
3985807|NCT01254630|3807820|B3|≥50 years||Age, Customized||Participants|Number|1044|1044.0||||||
3985808|NCT01254630|3807821|B2|≥50 years||Age, Customized||Participants|Number|1053|1053.0||||||
3985809|NCT01254630|3807822|B1|≥50 years||Age, Customized||Participants|Number|1049|1049.0||||||
3985810|NCT01254630|3807818|B5|<50 years||Age, Customized||Participants|Number|1077|1077.0||||||
3985811|NCT01254630|3807819|B4|<50 years||Age, Customized||Participants|Number|223|223.0||||||
3985812|NCT01254630|3807820|B3|<50 years||Age, Customized||Participants|Number|320|320.0||||||
3985813|NCT01254630|3807821|B2|<50 years||Age, Customized||Participants|Number|235|235.0||||||
3985814|NCT01254630|3807822|B1|<50 years||Age, Customized||Participants|Number|299|299.0||||||
3985815|NCT01254630|3807818|B5|85 years and over||Age, Customized||Participants|Number|57|57.0||||||
3985816|NCT01254630|3807819|B4|85 years and over||Age, Customized||Participants|Number|23|23.0||||||
3985817|NCT01254630|3807820|B3|85 years and over||Age, Customized||Participants|Number|5|5.0||||||
3985818|NCT01254630|3807821|B2|85 years and over||Age, Customized||Participants|Number|25|25.0||||||
3985819|NCT01254630|3807822|B1|85 years and over||Age, Customized||Participants|Number|4|4.0||||||
3985820|NCT01254630|3807818|B5|From 65 to 84 years||Age, Customized||Participants|Number|1904|1904.0||||||
3985821|NCT01254630|3807819|B4|From 65 to 84 years||Age, Customized||Participants|Number|589|589.0||||||
3985822|NCT01254630|3807820|B3|From 65 to 84 years||Age, Customized||Participants|Number|378|378.0||||||
3985823|NCT01254630|3807821|B2|From 65 to 84 years||Age, Customized||Participants|Number|558|558.0||||||
3985824|NCT01254630|3807822|B1|From 65 to 84 years||Age, Customized||Participants|Number|379|379.0||||||
3985825|NCT01254630|3807818|B5|Adults (between 18 and 64 years)||Age, Customized||Participants|Number|3324|3324.0||||||
3985826|NCT01254630|3807819|B4|Adults (between 18 and 64 years)||Age, Customized||Participants|Number|673|673.0||||||
3985827|NCT01254630|3807820|B3|Adults (between 18 and 64 years)||Age, Customized||Participants|Number|981|981.0||||||
3985828|NCT01254630|3807821|B2|Adults (between 18 and 64 years)||Age, Customized||Participants|Number|705|705.0||||||
3985829|NCT01254630|3807822|B1|Adults (between 18 and 64 years)||Age, Customized||Participants|Number|965|965.0||||||
3985830|NCT01254630|3807818|B5|||Age||years|Mean|59.4|59.4|Standard Deviation|13.3|13.3|||
3985831|NCT01254630|3807819|B4|||Age||years|Mean|61.4|61.4|Standard Deviation|14.5|14.5|||
3985832|NCT01254630|3807820|B3|||Age||years|Mean|57.7|57.7|Standard Deviation|11.5|11.5|||
3985833|NCT01254630|3807821|B2|||Age||years|Mean|61.0|61.0|Standard Deviation|14.9|14.9|||
3985834|NCT01254630|3807822|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|11.5|11.5|||
3985835|NCT01254604|3807843|B3|||Intraocular Pressure (IOP) - Study Eye|Baseline IOP was measured at 0800, 1000 and 1600 hours; 2 values obtained at each time. If the 2 values differed by ≤2 mmHg, average of 2 was recorded; if by >2 mmHg, a 3rd measurement was made and median of 3 was recorded. Baseline IOP was mean of the values recorded at the 3 time points. One “study eye” was identified, which was the eye with the higher (i.e., “worse”) IOP at baseline, or if both eyes had the same baseline IOP value, the right eye was designated the “study eye.” Data are for “Per Protocol” population: N=84, 84 and 168 for tafluprost, timolol and Total groups, respectively.|mmHg|Mean|24.9|24.9|Standard Deviation|2.8|2.8|||
3985836|NCT01254604|3807844|B2|||Intraocular Pressure (IOP) - Study Eye|Baseline IOP was measured at 0800, 1000 and 1600 hours; 2 values obtained at each time. If the 2 values differed by ≤2 mmHg, average of 2 was recorded; if by >2 mmHg, a 3rd measurement was made and median of 3 was recorded. Baseline IOP was mean of the values recorded at the 3 time points. One “study eye” was identified, which was the eye with the higher (i.e., “worse”) IOP at baseline, or if both eyes had the same baseline IOP value, the right eye was designated the “study eye.” Data are for “Per Protocol” population: N=84, 84 and 168 for tafluprost, timolol and Total groups, respectively.|mmHg|Mean|24.9|24.9|Standard Deviation|2.6|2.6|||
3985887|NCT01254565|3807858|B7||Hispanic or Latino|Ethnicity||Participants|Count of Participants|8|8.0||||||
3985888|NCT01254565|3807859|B6||Hispanic or Latino|Ethnicity||Participants|Count of Participants|3|3.0||||||
3985889|NCT01254565|3807860|B5||Hispanic or Latino|Ethnicity||Participants|Count of Participants|2|2.0||||||
3985890|NCT01254565|3807861|B4||Hispanic or Latino|Ethnicity||Participants|Count of Participants|2|2.0||||||
3985891|NCT01254565|3807862|B3||Hispanic or Latino|Ethnicity||Participants|Count of Participants|0|0.0||||||
3985837|NCT01254604|3807845|B1|||Intraocular Pressure (IOP) - Study Eye|Baseline IOP was measured at 0800, 1000 and 1600 hours; 2 values obtained at each time. If the 2 values differed by ≤2 mmHg, average of 2 was recorded; if by >2 mmHg, a 3rd measurement was made and median of 3 was recorded. Baseline IOP was mean of the values recorded at the 3 time points. One “study eye” was identified, which was the eye with the higher (i.e., “worse”) IOP at baseline, or if both eyes had the same baseline IOP value, the right eye was designated the “study eye.” Data are for “Per Protocol” population: N=84, 84 and 168 for tafluprost, timolol and Total groups, respectively.|mmHg|Mean|24.8|24.8|Standard Deviation|3.0|3.0|||
3985838|NCT01254604|3807843|B3||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3985839|NCT01254604|3807844|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3985840|NCT01254604|3807845|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3985841|NCT01254604|3807843|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3985842|NCT01254604|3807844|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3985843|NCT01254604|3807845|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3985844|NCT01254604|3807843|B3|||Age||years|Mean|55.8|55.8|Standard Deviation|12.52|12.52|||
3985845|NCT01254604|3807844|B2|||Age||years|Mean|54.9|54.9|Standard Deviation|13.42|13.42|||
3985846|NCT01254604|3807845|B1|||Age||years|Mean|56.7|56.7|Standard Deviation|11.54|11.54|||
3985847|NCT01254565|3807858|B7|||Phosphorus||mg/dL|Mean|5.7|5.7|Standard Deviation|1.49|1.49|||
3985848|NCT01254565|3807859|B6|||Phosphorus||mg/dL|Mean|5.0|5.0|Standard Deviation|1.02|1.02|||
3985849|NCT01254565|3807860|B5|||Phosphorus||mg/dL|Mean|5.2|5.2|Standard Deviation|1.17|1.17|||
3985850|NCT01254565|3807861|B4|||Phosphorus||mg/dL|Mean|5.7|5.7|Standard Deviation|1.18|1.18|||
3985851|NCT01254565|3807862|B3|||Phosphorus||mg/dL|Mean|6.5|6.5|Standard Deviation|1.83|1.83|||
3985852|NCT01254565|3807858|B7|||Corrected Calcium||mg/dL|Mean|9.6|9.6|Standard Deviation|0.63|0.63|||
3985853|NCT01254565|3807859|B6|||Corrected Calcium||mg/dL|Mean|9.7|9.7|Standard Deviation|0.62|0.62|||
3985854|NCT01254565|3807860|B5|||Corrected Calcium||mg/dL|Mean|9.3|9.3|Standard Deviation|0.58|0.58|||
3985855|NCT01254565|3807861|B4|||Corrected Calcium||mg/dL|Mean|9.7|9.7|Standard Deviation|0.59|0.59|||
3985856|NCT01254565|3807862|B3|||Corrected Calcium||mg/dL|Mean|9.8|9.8|Standard Deviation|0.62|0.62|||
3985857|NCT01254565|3807863|B2|||Corrected Calcium||mg/dL|Mean|9.3|9.3|Standard Deviation|0.44|0.44|||
3985858|NCT01254565|3807864|B1|||Corrected Calcium||mg/dL|Mean|9.1|9.1|Standard Deviation|0.84|0.84|||
3985859|NCT01254565|3807858|B7|||Parathyroid Hormone||pg/mL|Mean|659.4|659.4|Standard Deviation|361.28|361.28|||
3985860|NCT01254565|3807859|B6|||Parathyroid Hormone||pg/mL|Mean|662.1|662.1|Standard Deviation|442.01|442.01|||
3985861|NCT01254565|3807860|B5|||Parathyroid Hormone||pg/mL|Mean|619.4|619.4|Standard Deviation|310.35|310.35|||
3985862|NCT01254565|3807861|B4|||Parathyroid Hormone||pg/mL|Mean|765.1|765.1|Standard Deviation|480.82|480.82|||
3985863|NCT01254565|3807862|B3|||Parathyroid Hormone||pg/mL|Mean|601.5|601.5|Standard Deviation|239.20|239.2|||
3985864|NCT01254565|3807863|B2|||Parathyroid Hormone||pg/mL|Mean|588.3|588.3|Standard Deviation|250.52|250.52|||
3985865|NCT01254565|3807864|B1|||Parathyroid Hormone||pg/mL|Mean|636.3|636.3|Standard Deviation|191.64|191.64|||
3985866|NCT01254565|3807858|B7||≥ 600 pg/mL|Stratification Factor: Screening Serum Parathyroid Hormone (PTH)||Participants|Count of Participants|32|32.0||||||
3985867|NCT01254565|3807859|B6||≥ 600 pg/mL|Stratification Factor: Screening Serum Parathyroid Hormone (PTH)||Participants|Count of Participants|4|4.0||||||
3985868|NCT01254565|3807860|B5||≥ 600 pg/mL|Stratification Factor: Screening Serum Parathyroid Hormone (PTH)||Participants|Count of Participants|6|6.0||||||
3985869|NCT01254565|3807861|B4||≥ 600 pg/mL|Stratification Factor: Screening Serum Parathyroid Hormone (PTH)||Participants|Count of Participants|9|9.0||||||
3985870|NCT01254565|3807862|B3||≥ 600 pg/mL|Stratification Factor: Screening Serum Parathyroid Hormone (PTH)||Participants|Count of Participants|10|10.0||||||
3985871|NCT01254565|3807863|B2||≥ 600 pg/mL|Stratification Factor: Screening Serum Parathyroid Hormone (PTH)||Participants|Count of Participants|2|2.0||||||
3985872|NCT01254565|3807864|B1||≥ 600 pg/mL|Stratification Factor: Screening Serum Parathyroid Hormone (PTH)||Participants|Count of Participants|1|1.0||||||
3985873|NCT01254565|3807858|B7||< 600 pg/mL|Stratification Factor: Screening Serum Parathyroid Hormone (PTH)||Participants|Count of Participants|46|46.0||||||
3985874|NCT01254565|3807859|B6||< 600 pg/mL|Stratification Factor: Screening Serum Parathyroid Hormone (PTH)||Participants|Count of Participants|9|9.0||||||
3985875|NCT01254565|3807860|B5||< 600 pg/mL|Stratification Factor: Screening Serum Parathyroid Hormone (PTH)||Participants|Count of Participants|7|7.0||||||
3985876|NCT01254565|3807861|B4||< 600 pg/mL|Stratification Factor: Screening Serum Parathyroid Hormone (PTH)||Participants|Count of Participants|12|12.0||||||
3985877|NCT01254565|3807862|B3||< 600 pg/mL|Stratification Factor: Screening Serum Parathyroid Hormone (PTH)||Participants|Count of Participants|11|11.0||||||
3985878|NCT01254565|3807863|B2||< 600 pg/mL|Stratification Factor: Screening Serum Parathyroid Hormone (PTH)||Participants|Count of Participants|4|4.0||||||
3985879|NCT01254565|3807864|B1||< 600 pg/mL|Stratification Factor: Screening Serum Parathyroid Hormone (PTH)||Participants|Count of Participants|3|3.0||||||
3985880|NCT01254565|3807858|B7||Not Hispanic or Latino|Ethnicity||Participants|Count of Participants|70|70.0||||||
3985881|NCT01254565|3807859|B6||Not Hispanic or Latino|Ethnicity||Participants|Count of Participants|10|10.0||||||
3985882|NCT01254565|3807860|B5||Not Hispanic or Latino|Ethnicity||Participants|Count of Participants|11|11.0||||||
3985883|NCT01254565|3807861|B4||Not Hispanic or Latino|Ethnicity||Participants|Count of Participants|19|19.0||||||
3985884|NCT01254565|3807862|B3||Not Hispanic or Latino|Ethnicity||Participants|Count of Participants|21|21.0||||||
3985885|NCT01254565|3807863|B2||Not Hispanic or Latino|Ethnicity||Participants|Count of Participants|5|5.0||||||
3985886|NCT01254565|3807864|B1||Not Hispanic or Latino|Ethnicity||Participants|Count of Participants|4|4.0||||||
3985892|NCT01254565|3807863|B2||Hispanic or Latino|Ethnicity||Participants|Count of Participants|1|1.0||||||
3985893|NCT01254565|3807864|B1||Hispanic or Latino|Ethnicity||Participants|Count of Participants|0|0.0||||||
3985894|NCT01254565|3807858|B7||Black or African American|Race||Participants|Count of Participants|63|63.0||||||
3985895|NCT01254565|3807859|B6||Black or African American|Race||Participants|Count of Participants|9|9.0||||||
3985896|NCT01254565|3807860|B5||Black or African American|Race||Participants|Count of Participants|9|9.0||||||
3985897|NCT01254565|3807861|B4||Black or African American|Race||Participants|Count of Participants|18|18.0||||||
3985898|NCT01254565|3807862|B3||Black or African American|Race||Participants|Count of Participants|20|20.0||||||
3985899|NCT01254565|3807863|B2||Black or African American|Race||Participants|Count of Participants|5|5.0||||||
3985900|NCT01254565|3807864|B1||Black or African American|Race||Participants|Count of Participants|2|2.0||||||
3985901|NCT01254565|3807858|B7||White|Race||Participants|Count of Participants|15|15.0||||||
3985902|NCT01254565|3807859|B6||White|Race||Participants|Count of Participants|4|4.0||||||
3985903|NCT01254565|3807860|B5||White|Race||Participants|Count of Participants|4|4.0||||||
3985904|NCT01254565|3807861|B4||White|Race||Participants|Count of Participants|3|3.0||||||
3985905|NCT01254565|3807862|B3||White|Race||Participants|Count of Participants|1|1.0||||||
3985906|NCT01254565|3807863|B2||White|Race||Participants|Count of Participants|1|1.0||||||
3985907|NCT01254565|3807864|B1||White|Race||Participants|Count of Participants|2|2.0||||||
3985908|NCT01254565|3807858|B7||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3985909|NCT01254565|3807859|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3985910|NCT01254565|3807860|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3985911|NCT01254565|3807861|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3985912|NCT01254565|3807862|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3985913|NCT01254565|3807863|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3985914|NCT01254565|3807864|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3985915|NCT01254565|3807858|B7||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3985916|NCT01254565|3807859|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3985917|NCT01254565|3807860|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3985918|NCT01254565|3807861|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3985919|NCT01254565|3807862|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3985920|NCT01254565|3807863|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3985921|NCT01254565|3807864|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3985922|NCT01254565|3807858|B7|||Age||years|Mean|53.7|53.7|Standard Deviation|12.88|12.88|||
3985923|NCT01254565|3807859|B6|||Age||years|Mean|59.6|59.6|Standard Deviation|10.99|10.99|||
3985924|NCT01254565|3807860|B5|||Age||years|Mean|56.7|56.7|Standard Deviation|11.61|11.61|||
3985925|NCT01254565|3807861|B4|||Age||years|Mean|50.7|50.7|Standard Deviation|13.60|13.6|||
3985926|NCT01254565|3807862|B3|||Age||years|Mean|52.4|52.4|Standard Deviation|13.65|13.65|||
3985927|NCT01254565|3807863|B2|||Age||years|Mean|54.0|54.0|Standard Deviation|10.00|10.0|||
3985928|NCT01254565|3807864|B1|||Age||years|Mean|47.8|47.8|Standard Deviation|16.66|16.66|||
3985929|NCT01254409|3807919|B5|||DLCO|Diffusing capacity carbon monoxide is the carbon monoxide uptake from a single inspiration in a standard time (usually 10 seconds). DLCO% predicted is the % of the DLCO that would be predicted based on the subject's hemoglobin.|percent|Mean|43.3|43.3|Standard Deviation|10.9|10.9|||
3985930|NCT01254409|3807920|B4|||DLCO|Diffusing capacity carbon monoxide is the carbon monoxide uptake from a single inspiration in a standard time (usually 10 seconds). DLCO% predicted is the % of the DLCO that would be predicted based on the subject's hemoglobin.|percent|Mean|46.0|46.0|Standard Deviation|7.2|7.2|||
3985931|NCT01254409|3807921|B3|||DLCO|Diffusing capacity carbon monoxide is the carbon monoxide uptake from a single inspiration in a standard time (usually 10 seconds). DLCO% predicted is the % of the DLCO that would be predicted based on the subject's hemoglobin.|percent|Mean|52.8|52.8|Standard Deviation|9.8|9.8|||
3985932|NCT01254409|3807922|B2|||DLCO|Diffusing capacity carbon monoxide is the carbon monoxide uptake from a single inspiration in a standard time (usually 10 seconds). DLCO% predicted is the % of the DLCO that would be predicted based on the subject's hemoglobin.|percent|Mean|41.2|41.2|Standard Deviation|10.5|10.5|||
3985933|NCT01254409|3807923|B1|||DLCO|Diffusing capacity carbon monoxide is the carbon monoxide uptake from a single inspiration in a standard time (usually 10 seconds). DLCO% predicted is the % of the DLCO that would be predicted based on the subject's hemoglobin.|percent|Mean|35.2|35.2|Standard Deviation|8.4|8.4|||
3985934|NCT01254409|3807919|B5|||FEV1 % Predicted|Forced Expiratory Volume 1 second: the volume of air expired in the first second during maximal expiratory effort. FEV1% predicted is the FEV1% of the patient divided by the average FEV1% in the population for any person of similar age, sex and body composition|percent|Mean|78.5|78.5|Standard Deviation|16.2|16.2|||
3985935|NCT01254409|3807920|B4|||FEV1 % Predicted|Forced Expiratory Volume 1 second: the volume of air expired in the first second during maximal expiratory effort. FEV1% predicted is the FEV1% of the patient divided by the average FEV1% in the population for any person of similar age, sex and body composition|percent|Mean|73.0|73.0|Standard Deviation|12.1|12.1|||
3985936|NCT01254409|3807921|B3|||FEV1 % Predicted|Forced Expiratory Volume 1 second: the volume of air expired in the first second during maximal expiratory effort. FEV1% predicted is the FEV1% of the patient divided by the average FEV1% in the population for any person of similar age, sex and body composition|percent|Mean|87.0|87.0|Standard Deviation|11.9|11.9|||
3985982|NCT01254409|3807922|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985983|NCT01254409|3807923|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985937|NCT01254409|3807922|B2|||FEV1 % Predicted|Forced Expiratory Volume 1 second: the volume of air expired in the first second during maximal expiratory effort. FEV1% predicted is the FEV1% of the patient divided by the average FEV1% in the population for any person of similar age, sex and body composition|percent|Mean|85.8|85.8|Standard Deviation|16.8|16.8|||
3985938|NCT01254409|3807923|B1|||FEV1 % Predicted|Forced Expiratory Volume 1 second: the volume of air expired in the first second during maximal expiratory effort. FEV1% predicted is the FEV1% of the patient divided by the average FEV1% in the population for any person of similar age, sex and body composition|percent|Mean|68.8|68.8|Standard Deviation|17.7|17.7|||
3985939|NCT01254409|3807919|B5|||FVC % Predicted|The % of the FVC that would be predicted for a subject based on physical characteristics that influence the maximal inhalation: height, age, and gender.|percent|Mean|74.1|74.1|Standard Deviation|15.3|15.3|||
3985940|NCT01254409|3807920|B4|||FVC % Predicted|The % of the FVC that would be predicted for a subject based on physical characteristics that influence the maximal inhalation: height, age, and gender.|percent|Mean|72.8|72.8|Standard Deviation|14.3|14.3|||
3985941|NCT01254409|3807921|B3|||FVC % Predicted|The % of the FVC that would be predicted for a subject based on physical characteristics that influence the maximal inhalation: height, age, and gender.|percent|Mean|80.0|80.0|Standard Deviation|7.8|7.8|||
3985942|NCT01254409|3807922|B2|||FVC % Predicted|The % of the FVC that would be predicted for a subject based on physical characteristics that influence the maximal inhalation: height, age, and gender.|percent|Mean|82.4|82.4|Standard Deviation|15.5|15.5|||
3985943|NCT01254409|3807923|B1|||FVC % Predicted|The % of the FVC that would be predicted for a subject based on physical characteristics that influence the maximal inhalation: height, age, and gender.|percent|Mean|63.2|63.2|Standard Deviation|16.7|16.7|||
3985944|NCT01254409|3807919|B5|||FVC|Forced Vital Capacity: volume of air that can forcibly be blown out after full inspiration, measured in liters|liters|Mean|2.67|2.67|Standard Deviation|0.76|0.76|||
3985945|NCT01254409|3807920|B4|||FVC|Forced Vital Capacity: volume of air that can forcibly be blown out after full inspiration, measured in liters|liters|Mean|2.97|2.97|Standard Deviation|0.71|0.71|||
3985946|NCT01254409|3807921|B3|||FVC|Forced Vital Capacity: volume of air that can forcibly be blown out after full inspiration, measured in liters|liters|Mean|2.78|2.78|Standard Deviation|0.73|0.73|||
3985947|NCT01254409|3807922|B2|||FVC|Forced Vital Capacity: volume of air that can forcibly be blown out after full inspiration, measured in liters|liters|Mean|2.96|2.96|Standard Deviation|0.85|0.85|||
3985948|NCT01254409|3807923|B1|||FVC|Forced Vital Capacity: volume of air that can forcibly be blown out after full inspiration, measured in liters|liters|Mean|2.15|2.15|Standard Deviation|0.64|0.64|||
3985949|NCT01254409|3807919|B5|Netherlands||Region of Enrollment||participants|Number|12|12.0||||||
3985950|NCT01254409|3807920|B4|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
3985951|NCT01254409|3807921|B3|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
3985952|NCT01254409|3807922|B2|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
3985953|NCT01254409|3807923|B1|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
3985954|NCT01254409|3807919|B5|United States||Region of Enrollment||participants|Number|9|9.0||||||
3985955|NCT01254409|3807920|B4|United States||Region of Enrollment||participants|Number|4|4.0||||||
3985956|NCT01254409|3807921|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3985957|NCT01254409|3807922|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3985958|NCT01254409|3807923|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3985959|NCT01254409|3807919|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985960|NCT01254409|3807920|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985961|NCT01254409|3807921|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985962|NCT01254409|3807922|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985963|NCT01254409|3807923|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985964|NCT01254409|3807919|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985965|NCT01254409|3807920|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985966|NCT01254409|3807921|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985967|NCT01254409|3807922|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985968|NCT01254409|3807923|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985969|NCT01254409|3807919|B5||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3985970|NCT01254409|3807920|B4||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3985971|NCT01254409|3807921|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3985972|NCT01254409|3807922|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3985973|NCT01254409|3807923|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3985974|NCT01254409|3807919|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3985975|NCT01254409|3807920|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985976|NCT01254409|3807921|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985977|NCT01254409|3807922|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985978|NCT01254409|3807923|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3985979|NCT01254409|3807919|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985980|NCT01254409|3807920|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985981|NCT01254409|3807921|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985984|NCT01254409|3807919|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985985|NCT01254409|3807920|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985986|NCT01254409|3807921|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985987|NCT01254409|3807922|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985988|NCT01254409|3807923|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985989|NCT01254409|3807919|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985990|NCT01254409|3807920|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985991|NCT01254409|3807921|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985992|NCT01254409|3807922|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985993|NCT01254409|3807923|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3985994|NCT01254409|3807919|B5||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3985995|NCT01254409|3807920|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3985996|NCT01254409|3807921|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3985997|NCT01254409|3807922|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3985998|NCT01254409|3807923|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3985999|NCT01254409|3807919|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3986000|NCT01254409|3807920|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3986001|NCT01254409|3807921|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3986002|NCT01254409|3807922|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3986003|NCT01254409|3807923|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3986004|NCT01254409|3807919|B5|||Age||years|Mean|66.4|66.4|Standard Deviation|9.21|9.21|||
3986005|NCT01254409|3807920|B4|||Age||years|Mean|66.5|66.5|Standard Deviation|5.69|5.69|||
3986006|NCT01254409|3807921|B3|||Age||years|Mean|70.6|70.6|Standard Deviation|8.26|8.26|||
3986007|NCT01254409|3807922|B2|||Age||years|Mean|63.7|63.7|Standard Deviation|8.45|8.45|||
3986008|NCT01254409|3807923|B1|||Age||years|Mean|65.5|65.5|Standard Deviation|12.88|12.88|||
3986009|NCT01254396|3807978|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3986010|NCT01254396|3807978|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3986011|NCT01254396|3807978|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|8.2|8.2|||
3986012|NCT01254344|3807993|B3||Male|Sex: Female, Male||Participants|Count of Participants|335|335.0||||||
3986013|NCT01254344|3807994|B2||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
3986014|NCT01254344|3807995|B1||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3986015|NCT01254344|3807993|B3||Female|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
3986016|NCT01254344|3807994|B2||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3986017|NCT01254344|3807995|B1||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3986018|NCT01254344|3807993|B3|||Age||years|Mean|59.2|59.2|Standard Deviation|11.8|11.8|||
3986019|NCT01254344|3807994|B2|||Age||years|Mean|59.1|59.1|Standard Deviation|12.1|12.1|||
3986020|NCT01254344|3807995|B1|||Age||years|Mean|59.4|59.4|Standard Deviation|11.4|11.4|||
3986021|NCT01254331|3808004|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3986022|NCT01254331|3808004|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3986023|NCT01254331|3808004|B1|||Age||years|Mean|48.01|48.01|Standard Deviation|10.72|10.72|||
3986024|NCT01254318|3808022|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3986025|NCT01254318|3808022|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3986026|NCT01254318|3808022|B1|||Age||Years|Mean|55.28|55.28|Standard Deviation|15.26|15.26|||
3986027|NCT01254305|3808028|B4|||Body Mass Index (BMI)||Kilograms Per Meter Squared|Mean|28.51|28.51|Standard Deviation|5.04|5.04|||
3986028|NCT01254305|3808029|B3|||Body Mass Index (BMI)||Kilograms Per Meter Squared|Mean|28.80|28.8|Standard Deviation|5.10|5.1|||
3986029|NCT01254305|3808030|B2|||Body Mass Index (BMI)||Kilograms Per Meter Squared|Mean|28.61|28.61|Standard Deviation|5.22|5.22|||
3986030|NCT01254305|3808031|B1|||Body Mass Index (BMI)||Kilograms Per Meter Squared|Mean|28.16|28.16|Standard Deviation|4.85|4.85|||
3986031|NCT01254305|3808028|B4|||Weight||kg|Mean|81.75|81.75|Standard Deviation|17.00|17.0|||
3986032|NCT01254305|3808029|B3|||Weight||kg|Mean|83.31|83.31|Standard Deviation|17.61|17.61|||
3986033|NCT01254305|3808030|B2|||Weight||kg|Mean|82.23|82.23|Standard Deviation|18.14|18.14|||
3986034|NCT01254305|3808031|B1|||Weight||kg|Mean|79.95|79.95|Standard Deviation|15.27|15.27|||
3986035|NCT01254305|3808028|B4|United States||Region of Enrollment||participants|Number|251|251.0||||||
3986036|NCT01254305|3808029|B3|United States||Region of Enrollment||participants|Number|77|77.0||||||
3986037|NCT01254305|3808030|B2|United States||Region of Enrollment||participants|Number|85|85.0||||||
3986038|NCT01254305|3808031|B1|United States||Region of Enrollment||participants|Number|89|89.0||||||
3986039|NCT01254305|3808028|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|229|229.0||||||
3986040|NCT01254305|3808029|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
3986041|NCT01254305|3808030|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
3986042|NCT01254305|3808031|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
3986043|NCT01254305|3808028|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3986044|NCT01254305|3808029|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3986045|NCT01254305|3808030|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3986046|NCT01254305|3808031|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3986047|NCT01254305|3808028|B4|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3986048|NCT01254305|3808029|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3986049|NCT01254305|3808030|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3986050|NCT01254305|3808031|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3986051|NCT01254305|3808028|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3986052|NCT01254305|3808029|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3986053|NCT01254305|3808030|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3986054|NCT01254305|3808031|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3986055|NCT01254305|3808028|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3986056|NCT01254305|3808029|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3986057|NCT01254305|3808030|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3986058|NCT01254305|3808031|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3986059|NCT01254305|3808028|B4|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3986060|NCT01254305|3808029|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3986061|NCT01254305|3808030|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3986062|NCT01254305|3808031|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3986063|NCT01254305|3808028|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
3986064|NCT01254305|3808029|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3986065|NCT01254305|3808030|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
3986066|NCT01254305|3808031|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3986067|NCT01254305|3808028|B4|White||Race/Ethnicity, Customized||participants|Number|166|166.0||||||
3986068|NCT01254305|3808029|B3|White||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
3986069|NCT01254305|3808030|B2|White||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
3986070|NCT01254305|3808031|B1|White||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
3986071|NCT01254305|3808028|B4||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3986072|NCT01254305|3808029|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3986073|NCT01254305|3808030|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3986074|NCT01254305|3808031|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3986075|NCT01254305|3808028|B4||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3986076|NCT01254305|3808029|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3986077|NCT01254305|3808030|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3986078|NCT01254305|3808031|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3986079|NCT01254305|3808028|B4|||Age||years|Mean|42.3|42.3|Standard Deviation|12.0|12.0|||
3986080|NCT01254305|3808029|B3|||Age||years|Mean|42.8|42.8|Standard Deviation|11.3|11.3|||
3986081|NCT01254305|3808030|B2|||Age||years|Mean|42.9|42.9|Standard Deviation|12.6|12.6|||
3986082|NCT01254305|3808031|B1|||Age||years|Mean|41.4|41.4|Standard Deviation|12.0|12.0|||
3986083|NCT01254292|3808047|B3|4||Number of births||Participants|Number|1|1.0||||||
3986084|NCT01254292|3808048|B2|4||Number of births||Participants|Number|0|0.0||||||
3986085|NCT01254292|3808049|B1|4||Number of births||Participants|Number|1|1.0||||||
3986086|NCT01254292|3808047|B3|3||Number of births||Participants|Number|6|6.0||||||
3986087|NCT01254292|3808048|B2|3||Number of births||Participants|Number|2|2.0||||||
3986088|NCT01254292|3808049|B1|3||Number of births||Participants|Number|4|4.0||||||
3986089|NCT01254292|3808047|B3|2||Number of births||Participants|Number|43|43.0||||||
3986090|NCT01254292|3808048|B2|2||Number of births||Participants|Number|24|24.0||||||
3986091|NCT01254292|3808049|B1|2||Number of births||Participants|Number|19|19.0||||||
3986092|NCT01254292|3808047|B3|1||Number of births||Participants|Number|88|88.0||||||
3986093|NCT01254292|3808048|B2|1||Number of births||Participants|Number|49|49.0||||||
3986094|NCT01254292|3808049|B1|1||Number of births||Participants|Number|39|39.0||||||
3986095|NCT01254292|3808047|B3|0||Number of births||Participants|Number|422|422.0||||||
3986096|NCT01254292|3808048|B2|0||Number of births||Participants|Number|206|206.0||||||
3986097|NCT01254292|3808049|B1|0||Number of births||Participants|Number|216|216.0||||||
3986098|NCT01254292|3808047|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3986099|NCT01254292|3808048|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3986100|NCT01254292|3808049|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3986101|NCT01254292|3808047|B3||Female|Sex: Female, Male||Participants|Count of Participants|560|560.0||||||
3986102|NCT01254292|3808048|B2||Female|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
3986103|NCT01254292|3808049|B1||Female|Sex: Female, Male||Participants|Count of Participants|279|279.0||||||
3986104|NCT01254292|3808047|B3|||Age||Years|Mean|23.8|23.8|Standard Deviation|3.0|3.0|||
3986105|NCT01254292|3808048|B2|||Age||Years|Mean|23.9|23.9|Standard Deviation|3.0|3.0|||
3986106|NCT01254292|3808049|B1|||Age||Years|Mean|23.7|23.7|Standard Deviation|3.0|3.0|||
3986107|NCT01254214|3808110|B3|United States||Region of Enrollment||participants|Number|55|55.0||||||
3986108|NCT01254214|3808111|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
3986109|NCT01254214|3808112|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
3986110|NCT01254214|3808110|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986111|NCT01254214|3808111|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986112|NCT01254214|3808112|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986113|NCT01254214|3808110|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986114|NCT01254214|3808111|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986115|NCT01254214|3808112|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986116|NCT01254214|3808110|B3||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3986117|NCT01254214|3808111|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3986118|NCT01254214|3808112|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3986119|NCT01254214|3808110|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3986120|NCT01254214|3808111|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3986121|NCT01254214|3808112|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3986122|NCT01254214|3808110|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3986123|NCT01254214|3808111|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986124|NCT01254214|3808112|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3986125|NCT01254214|3808110|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3986126|NCT01254214|3808111|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3986127|NCT01254214|3808112|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3986128|NCT01254214|3808110|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986129|NCT01254214|3808111|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986130|NCT01254214|3808112|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986131|NCT01254214|3808110|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3986132|NCT01254214|3808111|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3986133|NCT01254214|3808112|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3986134|NCT01254214|3808110|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3986135|NCT01254214|3808111|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3986136|NCT01254214|3808112|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3986137|NCT01254214|3808110|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3986138|NCT01254214|3808111|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3986139|NCT01254214|3808112|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3986140|NCT01254214|3808110|B3||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
3986141|NCT01254214|3808111|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3986142|NCT01254214|3808112|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3986143|NCT01254214|3808110|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3986144|NCT01254214|3808111|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3986145|NCT01254214|3808112|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3986146|NCT01254188|3808127|B1||Male|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
3986147|NCT01254188|3808127|B1||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
3986148|NCT01254188|3808127|B1|||Age||years|Mean|47.13|47.13|Standard Deviation|14.892|14.892|||
3986149|NCT01254188|3808127|B1||>=65 years|Age||Participants|Count of Participants|53|53.0||||||
3986150|NCT01254188|3808127|B1||Between 18 and 65 years|Age||Participants|Count of Participants|368|368.0||||||
3986151|NCT01254188|3808127|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3986152|NCT01254045|3808138|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3986153|NCT01254045|3808138|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3986154|NCT01254045|3808138|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3986155|NCT01254045|3808138|B1|||Age||years|Mean|20.89|20.89|Standard Deviation|4.73|4.73|||
3986156|NCT01254045|3808138|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3986157|NCT01254045|3808138|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3986158|NCT01254045|3808138|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3986159|NCT01253980|3808154|B3|South Africa||Region of Enrollment||participants|Number|74|74.0||||||
3986160|NCT01253980|3808155|B2|South Africa||Region of Enrollment||participants|Number|39|39.0||||||
3986161|NCT01253980|3808156|B1|South Africa||Region of Enrollment||participants|Number|35|35.0||||||
3986162|NCT01253980|3808154|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3986163|NCT01253980|3808155|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3986164|NCT01253980|3808156|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3986165|NCT01253980|3808154|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3986166|NCT01253980|3808155|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3986167|NCT01253980|3808156|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3986168|NCT01253980|3808154|B3|||Age||months|Median|19|19.0|Inter-Quartile Range|||16.0|22.0|
3986169|NCT01253980|3808155|B2|||Age||months|Median|20|20.0|Inter-Quartile Range|||16.0|24.0|
3986170|NCT01253980|3808156|B1|||Age||months|Median|19|19.0|Inter-Quartile Range|||15.0|21.0|
3986171|NCT01253980|3808154|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3986172|NCT01253980|3808155|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3986173|NCT01253980|3808156|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3986174|NCT01253980|3808154|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3986175|NCT01253980|3808155|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3986176|NCT01253980|3808156|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3986177|NCT01253980|3808154|B3||<=18 years|Age||Participants|Count of Participants|74|74.0||||||
3986178|NCT01253980|3808155|B2||<=18 years|Age||Participants|Count of Participants|39|39.0||||||
3986179|NCT01253980|3808156|B1||<=18 years|Age||Participants|Count of Participants|35|35.0||||||
3986180|NCT01253902|3808163|B4||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3986181|NCT01253902|3808164|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3986182|NCT01253902|3808165|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3986183|NCT01253902|3808166|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3986184|NCT01253902|3808163|B4||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3986185|NCT01253902|3808164|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3986186|NCT01253902|3808165|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3986187|NCT01253902|3808166|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3986188|NCT01253902|3808163|B4|||Age||Years|Mean|64.3|64.3|Standard Deviation|12.49|12.49|||
3986189|NCT01253902|3808164|B3|||Age||Years|Mean|64.7|64.7|Standard Deviation|12.28|12.28|||
3986190|NCT01253902|3808165|B2|||Age||Years|Mean|63.2|63.2|Standard Deviation|13.57|13.57|||
3986191|NCT01253902|3808166|B1|||Age||Years|Mean|65.1|65.1|Standard Deviation|11.76|11.76|||
3986192|NCT01253824|3808182|B3|||Body weight||kg|Mean|51.5|51.5|Standard Deviation|5.01|5.01|||
3986193|NCT01253824|3808183|B2|||Body weight||kg|Mean|51.86|51.86|Standard Deviation|6.03|6.03|||
3986194|NCT01253824|3808184|B1|||Body weight||kg|Mean|51.14|51.14|Standard Deviation|4.23|4.23|||
3986195|NCT01253824|3808182|B3|Female||Sex/Gender, Customized||participants|Number|14|14.0||||||
3986196|NCT01253824|3808183|B2|Female||Sex/Gender, Customized||participants|Number|7|7.0||||||
3986197|NCT01253824|3808184|B1|Female||Sex/Gender, Customized||participants|Number|7|7.0||||||
3986198|NCT01253824|3808182|B3|||Age||years|Mean|26.4|26.4|Standard Deviation|3.4|3.4|||
3986199|NCT01253824|3808183|B2|||Age||years|Mean|26.1|26.1|Standard Deviation|4.4|4.4|||
3986200|NCT01253824|3808184|B1|||Age||years|Mean|26.6|26.6|Standard Deviation|2.3|2.3|||
3986201|NCT01253811|3808197|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986202|NCT01253811|3808197|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986203|NCT01253811|3808197|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3986204|NCT01253811|3808197|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3986205|NCT01253811|3808197|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986206|NCT01253811|3808197|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3986207|NCT01253811|3808197|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986208|NCT01253811|3808197|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986209|NCT01253811|3808197|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3986210|NCT01253811|3808197|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986211|NCT01253811|3808197|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3986212|NCT01253811|3808197|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3986213|NCT01253811|3808197|B1|||Age||years|Mean|3.0|3.0|Standard Deviation|1.3|1.3|||
3986214|NCT01253642|3808216|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3986215|NCT01253642|3808216|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986216|NCT01253642|3808216|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986217|NCT01253642|3808216|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3986218|NCT01253642|3808216|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986219|NCT01253642|3808216|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986220|NCT01253642|3808216|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986221|NCT01253642|3808216|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986222|NCT01253642|3808216|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986223|NCT01253642|3808216|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3986224|NCT01253642|3808216|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986225|NCT01253642|3808216|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3986226|NCT01253642|3808216|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3986227|NCT01253642|3808216|B1|||Age||years|Median|68|68.0|Full Range|||60.0|76.0|
3986228|NCT01253577|3808228|B1|United States||Region of Enrollment||participants|Number|105|105.0||||||
3986229|NCT01253577|3808228|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3986230|NCT01253577|3808228|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3986231|NCT01253577|3808228|B1|||Age||years|Mean|46.5|46.5|Standard Deviation|12.9|12.9|||
3986232|NCT01253577|3808228|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3986233|NCT01253577|3808228|B1||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
3986234|NCT01253577|3808228|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3986235|NCT01253564|3808236|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3986236|NCT01253564|3808236|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3986237|NCT01253564|3808236|B1|||Age||years|Mean|48.3|48.3|Standard Deviation|13.73|13.73|||
3986238|NCT01253525|3808253|B1|Japan||Region of Enrollment||participants|Number|6|6.0||||||
3986239|NCT01253525|3808253|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986240|NCT01253525|3808253|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986241|NCT01253525|3808253|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986242|NCT01253525|3808253|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986243|NCT01253525|3808253|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986244|NCT01253525|3808253|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3986245|NCT01253525|3808253|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986246|NCT01253525|3808253|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986247|NCT01253525|3808253|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3986248|NCT01253525|3808253|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986249|NCT01253525|3808253|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3986250|NCT01253525|3808253|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3986251|NCT01253525|3808253|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|15.50|15.5|||
3986252|NCT01253447|3808280|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
3986253|NCT01253447|3808280|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3986254|NCT01253447|3808280|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986255|NCT01253447|3808280|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3986256|NCT01253447|3808280|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3986257|NCT01253447|3808280|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986258|NCT01253447|3808280|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3986259|NCT01253447|3808280|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986260|NCT01253447|3808280|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3986261|NCT01253447|3808280|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3986262|NCT01253447|3808280|B1|||Age||years|Mean|72|72.0|Full Range|||31.0|86.0|
3986263|NCT01253421|3808286|B5|||Caffeine today (mg)|Amount of caffeine consumed on the day of testing in milligrams|milligrams|Mean|69.44|69.44|Standard Deviation|79.159|79.159|||
3986264|NCT01253421|3808287|B4|||Caffeine today (mg)|Amount of caffeine consumed on the day of testing in milligrams|milligrams|Mean|67.23|67.23|Standard Deviation|67.268|67.268|||
3986265|NCT01253421|3808288|B3|||Caffeine today (mg)|Amount of caffeine consumed on the day of testing in milligrams|milligrams|Mean|32.13|32.13|Standard Deviation|32.335|32.335|||
3986266|NCT01253421|3808289|B2|||Caffeine today (mg)|Amount of caffeine consumed on the day of testing in milligrams|milligrams|Mean|102.88|102.88|Standard Deviation|108.938|108.938|||
3986267|NCT01253421|3808290|B1|||Caffeine today (mg)|Amount of caffeine consumed on the day of testing in milligrams|milligrams|Mean|81.23|81.23|Standard Deviation|83.400|83.4|||
3986268|NCT01253421|3808286|B5|||Usual caffeine (mg)|Amount of caffeine consumed on a normal day in milligrams|milligrams|Mean|111.05|111.05|Standard Deviation|111.05|111.05|||
3986269|NCT01253421|3808287|B4|||Usual caffeine (mg)|Amount of caffeine consumed on a normal day in milligrams|milligrams|Mean|64.75|64.75|Standard Deviation|41.139|41.139|||
3986270|NCT01253421|3808288|B3|||Usual caffeine (mg)|Amount of caffeine consumed on a normal day in milligrams|milligrams|Mean|82.93|82.93|Standard Deviation|77.308|77.308|||
3986271|NCT01253421|3808289|B2|||Usual caffeine (mg)|Amount of caffeine consumed on a normal day in milligrams|milligrams|Mean|176.50|176.5|Standard Deviation|87.444|87.444|||
3986272|NCT01253421|3808290|B1|||Usual caffeine (mg)|Amount of caffeine consumed on a normal day in milligrams|milligrams|Mean|124.35|124.35|Standard Deviation|74.162|74.162|||
3986273|NCT01253421|3808286|B5|||Drinks in past 24hrs|Average number of drinks in the past 24 hours|equivalent shot/can/glasses|Mean|0.35|0.35|Standard Deviation|0.480|0.48|||
3986274|NCT01253421|3808287|B4|||Drinks in past 24hrs|Average number of drinks in the past 24 hours|equivalent shot/can/glasses|Mean|0.29|0.29|Standard Deviation|0.469|0.469|||
3986275|NCT01253421|3808288|B3|||Drinks in past 24hrs|Average number of drinks in the past 24 hours|equivalent shot/can/glasses|Mean|0.36|0.36|Standard Deviation|0.497|0.497|||
3986276|NCT01253421|3808289|B2|||Drinks in past 24hrs|Average number of drinks in the past 24 hours|equivalent shot/can/glasses|Mean|0.46|0.46|Standard Deviation|0.519|0.519|||
3986277|NCT01253421|3808290|B1|||Drinks in past 24hrs|Average number of drinks in the past 24 hours|equivalent shot/can/glasses|Mean|0.29|0.29|Standard Deviation|0.469|0.469|||
3986278|NCT01253421|3808286|B5|||Current drinkers|Number of subjects who drink alcoholic beverages|Participants|Count of Participants|19|19.0||||||
3986279|NCT01253421|3808287|B4|||Current drinkers|Number of subjects who drink alcoholic beverages|Participants|Count of Participants|4|4.0||||||
3986280|NCT01253421|3808288|B3|||Current drinkers|Number of subjects who drink alcoholic beverages|Participants|Count of Participants|5|5.0||||||
3986281|NCT01253421|3808289|B2|||Current drinkers|Number of subjects who drink alcoholic beverages|Participants|Count of Participants|6|6.0||||||
3986282|NCT01253421|3808290|B1|||Current drinkers|Number of subjects who drink alcoholic beverages|Participants|Count of Participants|4|4.0||||||
3986283|NCT01253421|3808286|B5|||Past smokers|Number of subject who were smokers in the past|Participants|Count of Participants|1|1.0||||||
3986284|NCT01253421|3808287|B4|||Past smokers|Number of subject who were smokers in the past|Participants|Count of Participants|0|0.0||||||
3986285|NCT01253421|3808288|B3|||Past smokers|Number of subject who were smokers in the past|Participants|Count of Participants|0|0.0||||||
3986286|NCT01253421|3808289|B2|||Past smokers|Number of subject who were smokers in the past|Participants|Count of Participants|1|1.0||||||
3986287|NCT01253421|3808290|B1|||Past smokers|Number of subject who were smokers in the past|Participants|Count of Participants|0|0.0||||||
3986288|NCT01253421|3808286|B5|||Current smokers|Number of current smokers per group|Participants|Count of Participants|0|0.0||||||
3986289|NCT01253421|3808287|B4|||Current smokers|Number of current smokers per group|Participants|Count of Participants|0|0.0||||||
3986290|NCT01253421|3808288|B3|||Current smokers|Number of current smokers per group|Participants|Count of Participants|0|0.0||||||
3986291|NCT01253421|3808289|B2|||Current smokers|Number of current smokers per group|Participants|Count of Participants|0|0.0||||||
3986292|NCT01253421|3808290|B1|||Current smokers|Number of current smokers per group|Participants|Count of Participants|0|0.0||||||
3986293|NCT01253421|3808286|B5|||AES|"Apathy Evaluation Scale (AES), assesses apathy during the past 4 weeks. Items: 18 statements about a person feeling interest, initiative, or motivation. Item responses are on a 4-point scale of 1 (Not at all true) to 4 (Very true).~Range: 18-72, lower scores indicate greater apathy."|units on a scale|Mean|51.63|51.63|Standard Deviation|10.218|10.218|||
3986294|NCT01253421|3808287|B4|||AES|"Apathy Evaluation Scale (AES), assesses apathy during the past 4 weeks. Items: 18 statements about a person feeling interest, initiative, or motivation. Item responses are on a 4-point scale of 1 (Not at all true) to 4 (Very true).~Range: 18-72, lower scores indicate greater apathy."|units on a scale|Mean|60.86|60.86|Standard Deviation|4.400|4.4|||
3986295|NCT01253421|3808288|B3|||AES|"Apathy Evaluation Scale (AES), assesses apathy during the past 4 weeks. Items: 18 statements about a person feeling interest, initiative, or motivation. Item responses are on a 4-point scale of 1 (Not at all true) to 4 (Very true).~Range: 18-72, lower scores indicate greater apathy."|units on a scale|Mean|59.53|59.53|Standard Deviation|4.856|4.856|||
3986296|NCT01253421|3808289|B2|||AES|"Apathy Evaluation Scale (AES), assesses apathy during the past 4 weeks. Items: 18 statements about a person feeling interest, initiative, or motivation. Item responses are on a 4-point scale of 1 (Not at all true) to 4 (Very true).~Range: 18-72, lower scores indicate greater apathy."|units on a scale|Mean|42.14|42.14|Standard Deviation|4.786|4.786|||
3986297|NCT01253421|3808290|B1|||AES|"Apathy Evaluation Scale (AES), assesses apathy during the past 4 weeks. Items: 18 statements about a person feeling interest, initiative, or motivation. Item responses are on a 4-point scale of 1 (Not at all true) to 4 (Very true).~Range: 18-72, lower scores indicate greater apathy."|units on a scale|Mean|43.45|43.45|Standard Deviation|7.063|7.063|||
3986298|NCT01253421|3808286|B5|||SHPS-low|"Number of low responses (value is 1 or 2) on the SHPS. Range: 0-14; higher scores indicate better hedonic tone."|Count of 'low' responses (1 or 2)|Mean|6.879|6.879|Standard Deviation|1.9293|1.9293|||
3986299|NCT01253421|3808287|B4|||SHPS-low|"Number of low responses (value is 1 or 2) on the SHPS. Range: 0-14; higher scores indicate better hedonic tone."|Count of 'low' responses (1 or 2)|Mean|6.571|6.571|Standard Deviation|2.9013|2.9013|||
3986300|NCT01253421|3808288|B3|||SHPS-low|"Number of low responses (value is 1 or 2) on the SHPS. Range: 0-14; higher scores indicate better hedonic tone."|Count of 'low' responses (1 or 2)|Mean|6.400|6.4|Standard Deviation|1.8439|1.8439|||
3986301|NCT01253421|3808289|B2|||SHPS-low|"Number of low responses (value is 1 or 2) on the SHPS. Range: 0-14; higher scores indicate better hedonic tone."|Count of 'low' responses (1 or 2)|Mean|6.857|6.857|Standard Deviation|1.0995|1.0995|||
3986302|NCT01253421|3808290|B1|||SHPS-low|"Number of low responses (value is 1 or 2) on the SHPS. Range: 0-14; higher scores indicate better hedonic tone."|Count of 'low' responses (1 or 2)|Mean|7.667|7.667|Standard Deviation|1.3452|1.3452|||
3986303|NCT01253421|3808286|B5|||SHPS total|"Snaith Hamilton Pleasure Scale (SHPS); assesses capacity to experience pleasure (hedonic tone).~Items: 35 statements that a person might enjoy a particular activity. Item responses are on a 4-point scale of 1 (Strongly agree) to 4 (Strongly disagree).~Range: 35-140, higher scores indicate greater anhedonia."|units on a scale|Mean|27.534|27.534|Standard Deviation|8.0970|8.097|||
3986304|NCT01253421|3808287|B4|||SHPS total|"Snaith Hamilton Pleasure Scale (SHPS); assesses capacity to experience pleasure (hedonic tone).~Items: 35 statements that a person might enjoy a particular activity. Item responses are on a 4-point scale of 1 (Strongly agree) to 4 (Strongly disagree).~Range: 35-140, higher scores indicate greater anhedonia."|units on a scale|Mean|23.714|23.714|Standard Deviation|7.4258|7.4258|||
3986305|NCT01253421|3808288|B3|||SHPS total|"Snaith Hamilton Pleasure Scale (SHPS); assesses capacity to experience pleasure (hedonic tone).~Items: 35 statements that a person might enjoy a particular activity. Item responses are on a 4-point scale of 1 (Strongly agree) to 4 (Strongly disagree).~Range: 35-140, higher scores indicate greater anhedonia."|units on a scale|Mean|21.293|21.293|Standard Deviation|5.6623|5.6623|||
3986306|NCT01253421|3808289|B2|||SHPS total|"Snaith Hamilton Pleasure Scale (SHPS); assesses capacity to experience pleasure (hedonic tone).~Items: 35 statements that a person might enjoy a particular activity. Item responses are on a 4-point scale of 1 (Strongly agree) to 4 (Strongly disagree).~Range: 35-140, higher scores indicate greater anhedonia."|units on a scale|Mean|32.450|32.45|Standard Deviation|7.5103|7.5103|||
3986325|NCT01253421|3808288|B3|||MASQ AD|Anhedonic Depression (AD) subscale of the MASQ; 22 items on a scale of 1 to 5; Range: 22-110, higher scores indicate greater severity of anhedonic symptoms.|units on a scale|Mean|44.200|44.2|Standard Deviation|8.4448|8.4448|||
3986307|NCT01253421|3808290|B1|||SHPS total|"Snaith Hamilton Pleasure Scale (SHPS); assesses capacity to experience pleasure (hedonic tone).~Items: 35 statements that a person might enjoy a particular activity. Item responses are on a 4-point scale of 1 (Strongly agree) to 4 (Strongly disagree).~Range: 35-140, higher scores indicate greater anhedonia."|units on a scale|Mean|32.753|32.753|Standard Deviation|4.6489|4.6489|||
3986308|NCT01253421|3808286|B5|||BDI-II|"Beck Depression Inventory-II (BDI-II). Measures the presence and severity of 21 depressive symptoms during the past two weeks, on a scale from 0 (none, or no change) to 3 (persistent, or worsening).~Range: 0 to 63. Higher scores indicate greater symptom severity. Clinical categories for total score: 0-14: absent; 14-19: mild; 20-28: moderate; 29-63: severe."|units on a scale|Mean|13.54|13.54|Standard Deviation|13.828|13.828|||
3986309|NCT01253421|3808287|B4|||BDI-II|"Beck Depression Inventory-II (BDI-II). Measures the presence and severity of 21 depressive symptoms during the past two weeks, on a scale from 0 (none, or no change) to 3 (persistent, or worsening).~Range: 0 to 63. Higher scores indicate greater symptom severity. Clinical categories for total score: 0-14: absent; 14-19: mild; 20-28: moderate; 29-63: severe."|units on a scale|Mean|1.51|1.51|Standard Deviation|3.131|3.131|||
3986310|NCT01253421|3808288|B3|||BDI-II|"Beck Depression Inventory-II (BDI-II). Measures the presence and severity of 21 depressive symptoms during the past two weeks, on a scale from 0 (none, or no change) to 3 (persistent, or worsening).~Range: 0 to 63. Higher scores indicate greater symptom severity. Clinical categories for total score: 0-14: absent; 14-19: mild; 20-28: moderate; 29-63: severe."|units on a scale|Mean|1.31|1.31|Standard Deviation|2.387|2.387|||
3986311|NCT01253421|3808289|B2|||BDI-II|"Beck Depression Inventory-II (BDI-II). Measures the presence and severity of 21 depressive symptoms during the past two weeks, on a scale from 0 (none, or no change) to 3 (persistent, or worsening).~Range: 0 to 63. Higher scores indicate greater symptom severity. Clinical categories for total score: 0-14: absent; 14-19: mild; 20-28: moderate; 29-63: severe."|units on a scale|Mean|27.91|27.91|Standard Deviation|7.877|7.877|||
3986312|NCT01253421|3808290|B1|||BDI-II|"Beck Depression Inventory-II (BDI-II). Measures the presence and severity of 21 depressive symptoms during the past two weeks, on a scale from 0 (none, or no change) to 3 (persistent, or worsening).~Range: 0 to 63. Higher scores indicate greater symptom severity. Clinical categories for total score: 0-14: absent; 14-19: mild; 20-28: moderate; 29-63: severe."|units on a scale|Mean|24.40|24.4|Standard Deviation|8.423|8.423|||
3986313|NCT01253421|3808286|B5|||Defeat Scale|The level of defeat-related feelings the participant has felt in the past week. 16 items, rated on a scale from 0 (never) to 4 (always). Range: 0 to 64; higher scores indicate greater feelings of defeat.|units on a scale|Mean|23.66|23.66|Standard Deviation|17.049|17.049|||
3986314|NCT01253421|3808287|B4|||Defeat Scale|The level of defeat-related feelings the participant has felt in the past week. 16 items, rated on a scale from 0 (never) to 4 (always). Range: 0 to 64; higher scores indicate greater feelings of defeat.|units on a scale|Mean|5.25|5.25|Standard Deviation|5.392|5.392|||
3986315|NCT01253421|3808288|B3|||Defeat Scale|The level of defeat-related feelings the participant has felt in the past week. 16 items, rated on a scale from 0 (never) to 4 (always). Range: 0 to 64; higher scores indicate greater feelings of defeat.|units on a scale|Mean|5.88|5.88|Standard Deviation|3.182|3.182|||
3986316|NCT01253421|3808289|B2|||Defeat Scale|The level of defeat-related feelings the participant has felt in the past week. 16 items, rated on a scale from 0 (never) to 4 (always). Range: 0 to 64; higher scores indicate greater feelings of defeat.|units on a scale|Mean|35.55|35.55|Standard Deviation|9.720|9.72|||
3986317|NCT01253421|3808290|B1|||Defeat Scale|The level of defeat-related feelings the participant has felt in the past week. 16 items, rated on a scale from 0 (never) to 4 (always). Range: 0 to 64; higher scores indicate greater feelings of defeat.|units on a scale|Mean|38.09|38.09|Standard Deviation|6.700|6.7|||
3986318|NCT01253421|3808286|B5|||RSES_Total|"Rosenberg Self Esteem Scale (RSES) total score. A 10-item scale that measures global self-worth by measuring both positive and negative feelings about the self. All items are answered using a Likert scale ranging from strongly disagree (0) to strongly agree (3); scores on negative feelings are inverted.~Range: 0-30, higher scores indicate higher self-esteem."|units on a scale|Mean|21.86|21.86|Standard Deviation|7.651|7.651|||
3986319|NCT01253421|3808287|B4|||RSES_Total|"Rosenberg Self Esteem Scale (RSES) total score. A 10-item scale that measures global self-worth by measuring both positive and negative feelings about the self. All items are answered using a Likert scale ranging from strongly disagree (0) to strongly agree (3); scores on negative feelings are inverted.~Range: 0-30, higher scores indicate higher self-esteem."|units on a scale|Mean|14.33|14.33|Standard Deviation|4.633|4.633|||
3986320|NCT01253421|3808288|B3|||RSES_Total|"Rosenberg Self Esteem Scale (RSES) total score. A 10-item scale that measures global self-worth by measuring both positive and negative feelings about the self. All items are answered using a Likert scale ranging from strongly disagree (0) to strongly agree (3); scores on negative feelings are inverted.~Range: 0-30, higher scores indicate higher self-esteem."|units on a scale|Mean|14.14|14.14|Standard Deviation|3.891|3.891|||
3986321|NCT01253421|3808289|B2|||RSES_Total|"Rosenberg Self Esteem Scale (RSES) total score. A 10-item scale that measures global self-worth by measuring both positive and negative feelings about the self. All items are answered using a Likert scale ranging from strongly disagree (0) to strongly agree (3); scores on negative feelings are inverted.~Range: 0-30, higher scores indicate higher self-esteem."|units on a scale|Mean|26.36|26.36|Standard Deviation|5.988|5.988|||
3986322|NCT01253421|3808290|B1|||RSES_Total|"Rosenberg Self Esteem Scale (RSES) total score. A 10-item scale that measures global self-worth by measuring both positive and negative feelings about the self. All items are answered using a Likert scale ranging from strongly disagree (0) to strongly agree (3); scores on negative feelings are inverted.~Range: 0-30, higher scores indicate higher self-esteem."|units on a scale|Mean|26.36|26.36|Standard Deviation|4.802|4.802|||
3986323|NCT01253421|3808286|B5|||MASQ AD|Anhedonic Depression (AD) subscale of the MASQ; 22 items on a scale of 1 to 5; Range: 22-110, higher scores indicate greater severity of anhedonic symptoms.|units on a scale|Mean|65.795|65.795|Standard Deviation|23.5064|23.5064|||
3986324|NCT01253421|3808287|B4|||MASQ AD|Anhedonic Depression (AD) subscale of the MASQ; 22 items on a scale of 1 to 5; Range: 22-110, higher scores indicate greater severity of anhedonic symptoms.|units on a scale|Mean|44.643|44.643|Standard Deviation|9.6764|9.6764|||
3986419|NCT01253421|3808287|B4||Unknown|Patients with past anxiety disorder|Number of subjects with past comorbid Anxiety Disorders|Participants|Count of Participants|0|0.0||||||
3986326|NCT01253421|3808289|B2|||MASQ AD|Anhedonic Depression (AD) subscale of the MASQ; 22 items on a scale of 1 to 5; Range: 22-110, higher scores indicate greater severity of anhedonic symptoms.|units on a scale|Mean|87.769|87.769|Standard Deviation|6.9180|6.918|||
3986327|NCT01253421|3808290|B1|||MASQ AD|Anhedonic Depression (AD) subscale of the MASQ; 22 items on a scale of 1 to 5; Range: 22-110, higher scores indicate greater severity of anhedonic symptoms.|units on a scale|Mean|88.087|88.087|Standard Deviation|9.1143|9.1143|||
3986328|NCT01253421|3808286|B5|||MASQ AA|Anxious Arousal (AA) subscale of the MASQ; 17 items on a scale of 1 to 5; Range: 17-85, higher scores indicate greater severity of anxious arousal symptoms.|units on a scale|Mean|20.534|20.534|Standard Deviation|3.7852|3.7852|||
3986329|NCT01253421|3808287|B4|||MASQ AA|Anxious Arousal (AA) subscale of the MASQ; 17 items on a scale of 1 to 5; Range: 17-85, higher scores indicate greater severity of anxious arousal symptoms.|units on a scale|Mean|17.643|17.643|Standard Deviation|1.1507|1.1507|||
3986330|NCT01253421|3808288|B3|||MASQ AA|Anxious Arousal (AA) subscale of the MASQ; 17 items on a scale of 1 to 5; Range: 17-85, higher scores indicate greater severity of anxious arousal symptoms.|units on a scale|Mean|19.417|19.417|Standard Deviation|3.3643|3.3643|||
3986331|NCT01253421|3808289|B2|||MASQ AA|Anxious Arousal (AA) subscale of the MASQ; 17 items on a scale of 1 to 5; Range: 17-85, higher scores indicate greater severity of anxious arousal symptoms.|units on a scale|Mean|23.385|23.385|Standard Deviation|4.4260|4.426|||
3986332|NCT01253421|3808290|B1|||MASQ AA|Anxious Arousal (AA) subscale of the MASQ; 17 items on a scale of 1 to 5; Range: 17-85, higher scores indicate greater severity of anxious arousal symptoms.|units on a scale|Mean|21.880|21.88|Standard Deviation|2.9644|2.9644|||
3986333|NCT01253421|3808286|B5|||MASQ GDD|General Distress-Depression (GDD) subscale of the MASQ. 12 items on a scale of 1 to 5. Range: 12-60, higher scores indicate greater severity of depressive symptoms.|units on a scale|Mean|27.375|27.375|Standard Deviation|14.5034|14.5034|||
3986334|NCT01253421|3808287|B4|||MASQ GDD|General Distress-Depression (GDD) subscale of the MASQ. 12 items on a scale of 1 to 5. Range: 12-60, higher scores indicate greater severity of depressive symptoms.|units on a scale|Mean|14.214|14.214|Standard Deviation|2.9136|2.9136|||
3986335|NCT01253421|3808288|B3|||MASQ GDD|General Distress-Depression (GDD) subscale of the MASQ. 12 items on a scale of 1 to 5. Range: 12-60, higher scores indicate greater severity of depressive symptoms.|units on a scale|Mean|14.533|14.533|Standard Deviation|3.6029|3.6029|||
3986336|NCT01253421|3808289|B2|||MASQ GDD|General Distress-Depression (GDD) subscale of the MASQ. 12 items on a scale of 1 to 5. Range: 12-60, higher scores indicate greater severity of depressive symptoms.|units on a scale|Mean|39.538|39.538|Standard Deviation|7.2872|7.2872|||
3986337|NCT01253421|3808290|B1|||MASQ GDD|General Distress-Depression (GDD) subscale of the MASQ. 12 items on a scale of 1 to 5. Range: 12-60, higher scores indicate greater severity of depressive symptoms.|units on a scale|Mean|41.960|41.96|Standard Deviation|7.7346|7.7346|||
3986338|NCT01253421|3808286|B5|||MASQ GDA|General Distress-Anxiety (GDA) subscale of the MASQ. 11 items on a scale of 1 to 5. Range: 11-55, higher scores indicate greater severity of anxiety symptoms.|units on a scale|Mean|17.772|17.772|Standard Deviation|6.8060|6.806|||
3986339|NCT01253421|3808287|B4|||MASQ GDA|General Distress-Anxiety (GDA) subscale of the MASQ. 11 items on a scale of 1 to 5. Range: 11-55, higher scores indicate greater severity of anxiety symptoms.|units on a scale|Mean|12.071|12.071|Standard Deviation|1.9793|1.9793|||
3986340|NCT01253421|3808288|B3|||MASQ GDA|General Distress-Anxiety (GDA) subscale of the MASQ. 11 items on a scale of 1 to 5. Range: 11-55, higher scores indicate greater severity of anxiety symptoms.|units on a scale|Mean|14.200|14.2|Standard Deviation|3.3209|3.3209|||
3986341|NCT01253421|3808289|B2|||MASQ GDA|General Distress-Anxiety (GDA) subscale of the MASQ. 11 items on a scale of 1 to 5. Range: 11-55, higher scores indicate greater severity of anxiety symptoms.|units on a scale|Mean|23.385|23.385|Standard Deviation|6.7520|6.752|||
3986342|NCT01253421|3808290|B1|||MASQ GDA|General Distress-Anxiety (GDA) subscale of the MASQ. 11 items on a scale of 1 to 5. Range: 11-55, higher scores indicate greater severity of anxiety symptoms.|units on a scale|Mean|21.800|21.8|Standard Deviation|6.2244|6.2244|||
3986343|NCT01253421|3808286|B5|||MASQ total|"Mood and Anxiety Symptom Questionnaire (MASQ), short form. Measures the severity of anxiety and depressive symptoms.~62 items, rating of how much you have experienced certain feelings, emotions, or behaviors in the past week; item responses are on a 5-point scale from 1 (not at all) to 5 (extremely).~Range: 62-310; higher scores indicates more severe symptoms."|units on a scale|Mean|131.476|131.476|Standard Deviation|44.6597|44.6597|||
3986344|NCT01253421|3808287|B4|||MASQ total|"Mood and Anxiety Symptom Questionnaire (MASQ), short form. Measures the severity of anxiety and depressive symptoms.~62 items, rating of how much you have experienced certain feelings, emotions, or behaviors in the past week; item responses are on a 5-point scale from 1 (not at all) to 5 (extremely).~Range: 62-310; higher scores indicates more severe symptoms."|units on a scale|Mean|88.571|88.571|Standard Deviation|12.4389|12.4389|||
3986345|NCT01253421|3808288|B3|||MASQ total|"Mood and Anxiety Symptom Questionnaire (MASQ), short form. Measures the severity of anxiety and depressive symptoms.~62 items, rating of how much you have experienced certain feelings, emotions, or behaviors in the past week; item responses are on a 5-point scale from 1 (not at all) to 5 (extremely).~Range: 62-310; higher scores indicates more severe symptoms."|units on a scale|Mean|92.350|92.35|Standard Deviation|16.0618|16.0618|||
3986346|NCT01253421|3808289|B2|||MASQ total|"Mood and Anxiety Symptom Questionnaire (MASQ), short form. Measures the severity of anxiety and depressive symptoms.~62 items, rating of how much you have experienced certain feelings, emotions, or behaviors in the past week; item responses are on a 5-point scale from 1 (not at all) to 5 (extremely).~Range: 62-310; higher scores indicates more severe symptoms."|units on a scale|Mean|174.077|174.077|Standard Deviation|18.5448|18.5448|||
3986347|NCT01253421|3808290|B1|||MASQ total|"Mood and Anxiety Symptom Questionnaire (MASQ), short form. Measures the severity of anxiety and depressive symptoms.~62 items, rating of how much you have experienced certain feelings, emotions, or behaviors in the past week; item responses are on a 5-point scale from 1 (not at all) to 5 (extremely).~Range: 62-310; higher scores indicates more severe symptoms."|units on a scale|Mean|173.727|173.727|Standard Deviation|14.2367|14.2367|||
3986394|NCT01253421|3808287|B4|||TCI NS-4|TCI NS subscale 4 – “Disorderliness v regimentation” ; 7 items, Range: 7-35; Higher scores indicate higher degree of disorderliness.|units on a scale|Mean|20.64|20.64|Standard Deviation|4.551|4.551|||
3986348|NCT01253421|3808286|B5|||BIS Non-planning-2|Non-planning subscale (second order) of the BIS; Sum of the Self-control and Cognitive Complexity subscales; Range 11-44, higher scores indicate less ability to guide according to a plan|units on a scale|Mean|21.333|21.333|Standard Deviation|4.8528|4.8528|||
3986349|NCT01253421|3808287|B4|||BIS Non-planning-2|Non-planning subscale (second order) of the BIS; Sum of the Self-control and Cognitive Complexity subscales; Range 11-44, higher scores indicate less ability to guide according to a plan|units on a scale|Mean|22.911|22.911|Standard Deviation|4.1459|4.1459|||
3986350|NCT01253421|3808288|B3|||BIS Non-planning-2|Non-planning subscale (second order) of the BIS; Sum of the Self-control and Cognitive Complexity subscales; Range 11-44, higher scores indicate less ability to guide according to a plan|units on a scale|Mean|21.000|21.0|Standard Deviation|5.7446|5.7446|||
3986351|NCT01253421|3808289|B2|||BIS Non-planning-2|Non-planning subscale (second order) of the BIS; Sum of the Self-control and Cognitive Complexity subscales; Range 11-44, higher scores indicate less ability to guide according to a plan|units on a scale|Mean|20.589|20.589|Standard Deviation|5.2638|5.2638|||
3986352|NCT01253421|3808290|B1|||BIS Non-planning-2|Non-planning subscale (second order) of the BIS; Sum of the Self-control and Cognitive Complexity subscales; Range 11-44, higher scores indicate less ability to guide according to a plan|units on a scale|Mean|20.857|20.857|Standard Deviation|4.1668|4.1668|||
3986353|NCT01253421|3808286|B5|||BIS Motor-2|Motor impulsivity subscale (second order) of the BIS; Sum of the Motor-1 and Perseverance subscales; Range 11-44, higher scores indicate more impulsive movement|units on a scale|Mean|19.428|19.428|Standard Deviation|3.2791|3.2791|||
3986354|NCT01253421|3808287|B4|||BIS Motor-2|Motor impulsivity subscale (second order) of the BIS; Sum of the Motor-1 and Perseverance subscales; Range 11-44, higher scores indicate more impulsive movement|units on a scale|Mean|19.764|19.764|Standard Deviation|3.7056|3.7056|||
3986355|NCT01253421|3808288|B3|||BIS Motor-2|Motor impulsivity subscale (second order) of the BIS; Sum of the Motor-1 and Perseverance subscales; Range 11-44, higher scores indicate more impulsive movement|units on a scale|Mean|18.980|18.98|Standard Deviation|2.8016|2.8016|||
3986356|NCT01253421|3808289|B2|||BIS Motor-2|Motor impulsivity subscale (second order) of the BIS; Sum of the Motor-1 and Perseverance subscales; Range 11-44, higher scores indicate more impulsive movement|units on a scale|Mean|19.643|19.643|Standard Deviation|3.5865|3.5865|||
3986357|NCT01253421|3808290|B1|||BIS Motor-2|Motor impulsivity subscale (second order) of the BIS; Sum of the Motor-1 and Perseverance subscales; Range 11-44, higher scores indicate more impulsive movement|units on a scale|Mean|19.357|19.357|Standard Deviation|3.2959|3.2959|||
3986358|NCT01253421|3808286|B5|||BIS Attention-2|Attentional Impulsivity subscale (second order) of the BIS; Sum of the Attention-1 and Cognitive Instability subscales; Range 8-32, higher scores indicate less ability to control attention|units on a scale|Mean|15.461|15.461|Standard Deviation|3.2078|3.2078|||
3986359|NCT01253421|3808287|B4|||BIS Attention-2|Attentional Impulsivity subscale (second order) of the BIS; Sum of the Attention-1 and Cognitive Instability subscales; Range 8-32, higher scores indicate less ability to control attention|units on a scale|Mean|16.857|16.857|Standard Deviation|3.2548|3.2548|||
3986360|NCT01253421|3808288|B3|||BIS Attention-2|Attentional Impulsivity subscale (second order) of the BIS; Sum of the Attention-1 and Cognitive Instability subscales; Range 8-32, higher scores indicate less ability to control attention|units on a scale|Mean|14.087|14.087|Standard Deviation|2.8332|2.8332|||
3986361|NCT01253421|3808289|B2|||BIS Attention-2|Attentional Impulsivity subscale (second order) of the BIS; Sum of the Attention-1 and Cognitive Instability subscales; Range 8-32, higher scores indicate less ability to control attention|units on a scale|Mean|15.464|15.464|Standard Deviation|2.7767|2.7767|||
3986362|NCT01253421|3808290|B1|||BIS Attention-2|Attentional Impulsivity subscale (second order) of the BIS; Sum of the Attention-1 and Cognitive Instability subscales; Range 8-32, higher scores indicate less ability to control attention|units on a scale|Mean|15.536|15.536|Standard Deviation|3.6187|3.6187|||
3986363|NCT01253421|3808286|B5|||BIS cognitive complexity|Cognitive Complexity subscale (first order) of the BIS; 5 items, item responses are on a scale from 1 (not impulsive) to 4 (very impulsive); range 5-20, higher scores indicate greater difficulty with complexity|units on a scale|Mean|10.105|10.105|Standard Deviation|2.4016|2.4016|||
3986364|NCT01253421|3808287|B4|||BIS cognitive complexity|Cognitive Complexity subscale (first order) of the BIS; 5 items, item responses are on a scale from 1 (not impulsive) to 4 (very impulsive); range 5-20, higher scores indicate greater difficulty with complexity|units on a scale|Mean|10.554|10.554|Standard Deviation|2.4143|2.4143|||
3986365|NCT01253421|3808288|B3|||BIS cognitive complexity|Cognitive Complexity subscale (first order) of the BIS; 5 items, item responses are on a scale from 1 (not impulsive) to 4 (very impulsive); range 5-20, higher scores indicate greater difficulty with complexity|units on a scale|Mean|9.933|9.933|Standard Deviation|2.3442|2.3442|||
3986366|NCT01253421|3808289|B2|||BIS cognitive complexity|Cognitive Complexity subscale (first order) of the BIS; 5 items, item responses are on a scale from 1 (not impulsive) to 4 (very impulsive); range 5-20, higher scores indicate greater difficulty with complexity|units on a scale|Mean|10.161|10.161|Standard Deviation|2.9509|2.9509|||
3986367|NCT01253421|3808290|B1|||BIS cognitive complexity|Cognitive Complexity subscale (first order) of the BIS; 5 items, item responses are on a scale from 1 (not impulsive) to 4 (very impulsive); range 5-20, higher scores indicate greater difficulty with complexity|units on a scale|Mean|9.786|9.786|Standard Deviation|2.0069|2.0069|||
3986368|NCT01253421|3808286|B5|||BIS self control|Self-control subscale (first order) of the BIS; 6 items, item responses are on a scale from 1 (not impulsive) to 4 (very impulsive); Range 6-24, higher scores indicate less self-control|units on a scale|Mean|11.228|11.228|Standard Deviation|3.3113|3.3113|||
3986369|NCT01253421|3808287|B4|||BIS self control|Self-control subscale (first order) of the BIS; 6 items, item responses are on a scale from 1 (not impulsive) to 4 (very impulsive); Range 6-24, higher scores indicate less self-control|units on a scale|Mean|12.357|12.357|Standard Deviation|3.2959|3.2959|||
3986370|NCT01253421|3808288|B3|||BIS self control|Self-control subscale (first order) of the BIS; 6 items, item responses are on a scale from 1 (not impulsive) to 4 (very impulsive); Range 6-24, higher scores indicate less self-control|units on a scale|Mean|11.067|11.067|Standard Deviation|3.6345|3.6345|||
3986418|NCT01253421|3808286|B5||Unknown|Patients with past anxiety disorder|Number of subjects with past comorbid Anxiety Disorders|Participants|Count of Participants|3|3.0||||||
3986371|NCT01253421|3808289|B2|||BIS self control|Self-control subscale (first order) of the BIS; 6 items, item responses are on a scale from 1 (not impulsive) to 4 (very impulsive); Range 6-24, higher scores indicate less self-control|units on a scale|Mean|10.429|10.429|Standard Deviation|3.0813|3.0813|||
3986372|NCT01253421|3808290|B1|||BIS self control|Self-control subscale (first order) of the BIS; 6 items, item responses are on a scale from 1 (not impulsive) to 4 (very impulsive); Range 6-24, higher scores indicate less self-control|units on a scale|Mean|11.071|11.071|Standard Deviation|3.2455|3.2455|||
3986373|NCT01253421|3808286|B5|||BIS perseverance|Perseverance subscale (first order) of the BIS; 4 items, item responses are on a scale from 1 (not impulsive) to 4 (very impulsive); Range 4-16, higher scores indicate more perseveration|units on a scale|Mean|7.007|7.007|Standard Deviation|1.6593|1.6593|||
3986374|NCT01253421|3808287|B4|||BIS perseverance|Perseverance subscale (first order) of the BIS; 4 items, item responses are on a scale from 1 (not impulsive) to 4 (very impulsive); Range 4-16, higher scores indicate more perseveration|units on a scale|Mean|7.693|7.693|Standard Deviation|1.9408|1.9408|||
3986375|NCT01253421|3808288|B3|||BIS perseverance|Perseverance subscale (first order) of the BIS; 4 items, item responses are on a scale from 1 (not impulsive) to 4 (very impulsive); Range 4-16, higher scores indicate more perseveration|units on a scale|Mean|6.847|6.847|Standard Deviation|1.4426|1.4426|||
3986376|NCT01253421|3808289|B2|||BIS perseverance|Perseverance subscale (first order) of the BIS; 4 items, item responses are on a scale from 1 (not impulsive) to 4 (very impulsive); Range 4-16, higher scores indicate more perseveration|units on a scale|Mean|6.857|6.857|Standard Deviation|1.6104|1.6104|||
3986377|NCT01253421|3808290|B1|||BIS perseverance|Perseverance subscale (first order) of the BIS; 4 items, item responses are on a scale from 1 (not impulsive) to 4 (very impulsive); Range 4-16, higher scores indicate more perseveration|units on a scale|Mean|6.643|6.643|Standard Deviation|1.5984|1.5984|||
3986378|NCT01253421|3808286|B5|||BIS motor-1|Motor subscale (first order) of the BIS; 7 items, item responses are on a scale from 1 (not impulsive) to 4 (very impulsive); Range 7-28, higher scores indicate greater motor impulsivity|units on a scale|Mean|12.421|12.421|Standard Deviation|2.6454|2.6454|||
3986379|NCT01253421|3808287|B4|||BIS motor-1|Motor subscale (first order) of the BIS; 7 items, item responses are on a scale from 1 (not impulsive) to 4 (very impulsive); Range 7-28, higher scores indicate greater motor impulsivity|units on a scale|Mean|12.071|12.071|Standard Deviation|2.9733|2.9733|||
3986380|NCT01253421|3808288|B3|||BIS motor-1|Motor subscale (first order) of the BIS; 7 items, item responses are on a scale from 1 (not impulsive) to 4 (very impulsive); Range 7-28, higher scores indicate greater motor impulsivity|units on a scale|Mean|12.133|12.133|Standard Deviation|2.2636|2.2636|||
3986381|NCT01253421|3808289|B2|||BIS motor-1|Motor subscale (first order) of the BIS; 7 items, item responses are on a scale from 1 (not impulsive) to 4 (very impulsive); Range 7-28, higher scores indicate greater motor impulsivity|units on a scale|Mean|12.786|12.786|Standard Deviation|2.9136|2.9136|||
3986382|NCT01253421|3808290|B1|||BIS motor-1|Motor subscale (first order) of the BIS; 7 items, item responses are on a scale from 1 (not impulsive) to 4 (very impulsive); Range 7-28, higher scores indicate greater motor impulsivity|units on a scale|Mean|12.714|12.714|Standard Deviation|2.6144|2.6144|||
3986383|NCT01253421|3808286|B5|||BIS cognitive instability|Cognitive Instability subscale (first order) of the BIS; 3 items, item responses are on a scale from 1 (not impulsive) to 4 (very impulsive); Range 3-12, higher scores indicate less stable cognition|units on a scale|Mean|5.237|5.237|Standard Deviation|1.6800|1.68|||
3986384|NCT01253421|3808287|B4|||BIS cognitive instability|Cognitive Instability subscale (first order) of the BIS; 3 items, item responses are on a scale from 1 (not impulsive) to 4 (very impulsive); Range 3-12, higher scores indicate less stable cognition|units on a scale|Mean|5.857|5.857|Standard Deviation|1.5619|1.5619|||
3986385|NCT01253421|3808288|B3|||BIS cognitive instability|Cognitive Instability subscale (first order) of the BIS; 3 items, item responses are on a scale from 1 (not impulsive) to 4 (very impulsive); Range 3-12, higher scores indicate less stable cognition|units on a scale|Mean|4.467|4.467|Standard Deviation|1.1255|1.1255|||
3986386|NCT01253421|3808289|B2|||BIS cognitive instability|Cognitive Instability subscale (first order) of the BIS; 3 items, item responses are on a scale from 1 (not impulsive) to 4 (very impulsive); Range 3-12, higher scores indicate less stable cognition|units on a scale|Mean|5.536|5.536|Standard Deviation|1.9852|1.9852|||
3986387|NCT01253421|3808290|B1|||BIS cognitive instability|Cognitive Instability subscale (first order) of the BIS; 3 items, item responses are on a scale from 1 (not impulsive) to 4 (very impulsive); Range 3-12, higher scores indicate less stable cognition|units on a scale|Mean|5.143|5.143|Standard Deviation|1.7913|1.7913|||
3986388|NCT01253421|3808286|B5|||BIS attention-1|Attention subscale (first order) of the Barratt Impulsiveness Scale (BIS); 5 items, item responses are on a scale from 1 (not impulsive) to 4 (very impulsive); Range 5-20, higher scores indicate less stable attention|units on a scale|Mean|10.225|10.225|Standard Deviation|2.1500|2.15|||
3986389|NCT01253421|3808287|B4|||BIS attention-1|Attention subscale (first order) of the Barratt Impulsiveness Scale (BIS); 5 items, item responses are on a scale from 1 (not impulsive) to 4 (very impulsive); Range 5-20, higher scores indicate less stable attention|units on a scale|Mean|11.000|11.0|Standard Deviation|2.3205|2.3205|||
3986390|NCT01253421|3808288|B3|||BIS attention-1|Attention subscale (first order) of the Barratt Impulsiveness Scale (BIS); 5 items, item responses are on a scale from 1 (not impulsive) to 4 (very impulsive); Range 5-20, higher scores indicate less stable attention|units on a scale|Mean|9.620|9.62|Standard Deviation|1.9879|1.9879|||
3986391|NCT01253421|3808289|B2|||BIS attention-1|Attention subscale (first order) of the Barratt Impulsiveness Scale (BIS); 5 items, item responses are on a scale from 1 (not impulsive) to 4 (very impulsive); Range 5-20, higher scores indicate less stable attention|units on a scale|Mean|9.929|9.929|Standard Deviation|1.9400|1.94|||
3986392|NCT01253421|3808290|B1|||BIS attention-1|Attention subscale (first order) of the Barratt Impulsiveness Scale (BIS); 5 items, item responses are on a scale from 1 (not impulsive) to 4 (very impulsive); Range 5-20, higher scores indicate less stable attention|units on a scale|Mean|10.393|10.393|Standard Deviation|2.3053|2.3053|||
3986393|NCT01253421|3808286|B5|||TCI NS-4|TCI NS subscale 4 – “Disorderliness v regimentation” ; 7 items, Range: 7-35; Higher scores indicate higher degree of disorderliness.|units on a scale|Mean|19.04|19.04|Standard Deviation|4.555|4.555|||
3986395|NCT01253421|3808288|B3|||TCI NS-4|TCI NS subscale 4 – “Disorderliness v regimentation” ; 7 items, Range: 7-35; Higher scores indicate higher degree of disorderliness.|units on a scale|Mean|20.07|20.07|Standard Deviation|5.311|5.311|||
3986396|NCT01253421|3808289|B2|||TCI NS-4|TCI NS subscale 4 – “Disorderliness v regimentation” ; 7 items, Range: 7-35; Higher scores indicate higher degree of disorderliness.|units on a scale|Mean|18.77|18.77|Standard Deviation|3.468|3.468|||
3986397|NCT01253421|3808290|B1|||TCI NS-4|TCI NS subscale 4 – “Disorderliness v regimentation” ; 7 items, Range: 7-35; Higher scores indicate higher degree of disorderliness.|units on a scale|Mean|16.73|16.73|Standard Deviation|3.973|3.973|||
3986398|NCT01253421|3808286|B5|||TCI NS-3|TCI NS subscale 3 – “Extravagance v reserve” ; 9 items, Range: 9-45; Higher scores indicate higher degree of extravagance.|units on a scale|Mean|25.581|25.581|Standard Deviation|6.5084|6.5084|||
3986399|NCT01253421|3808287|B4|||TCI NS-3|TCI NS subscale 3 – “Extravagance v reserve” ; 9 items, Range: 9-45; Higher scores indicate higher degree of extravagance.|units on a scale|Mean|26.571|26.571|Standard Deviation|4.3273|4.3273|||
3986400|NCT01253421|3808288|B3|||TCI NS-3|TCI NS subscale 3 – “Extravagance v reserve” ; 9 items, Range: 9-45; Higher scores indicate higher degree of extravagance.|units on a scale|Mean|26.667|26.667|Standard Deviation|5.5891|5.5891|||
3986401|NCT01253421|3808289|B2|||TCI NS-3|TCI NS subscale 3 – “Extravagance v reserve” ; 9 items, Range: 9-45; Higher scores indicate higher degree of extravagance.|units on a scale|Mean|25.231|25.231|Standard Deviation|8.8615|8.8615|||
3986402|NCT01253421|3808290|B1|||TCI NS-3|TCI NS subscale 3 – “Extravagance v reserve” ; 9 items, Range: 9-45; Higher scores indicate higher degree of extravagance.|units on a scale|Mean|23.873|23.873|Standard Deviation|6.9297|6.9297|||
3986403|NCT01253421|3808286|B5|||TCI NS-2|TCI NS subscale 2 – “Impulsiveness v reflection”; 9 items, Range: 9-45; Higher scores indicate higher degree of impulsiveness|units on a scale|Mean|21.54|21.54|Standard Deviation|5.258|5.258|||
3986404|NCT01253421|3808287|B4|||TCI NS-2|TCI NS subscale 2 – “Impulsiveness v reflection”; 9 items, Range: 9-45; Higher scores indicate higher degree of impulsiveness|units on a scale|Mean|22.79|22.79|Standard Deviation|5.860|5.86|||
3986405|NCT01253421|3808288|B3|||TCI NS-2|TCI NS subscale 2 – “Impulsiveness v reflection”; 9 items, Range: 9-45; Higher scores indicate higher degree of impulsiveness|units on a scale|Mean|22.93|22.93|Standard Deviation|4.698|4.698|||
3986406|NCT01253421|3808289|B2|||TCI NS-2|TCI NS subscale 2 – “Impulsiveness v reflection”; 9 items, Range: 9-45; Higher scores indicate higher degree of impulsiveness|units on a scale|Mean|20.85|20.85|Standard Deviation|6.053|6.053|||
3986407|NCT01253421|3808290|B1|||TCI NS-2|TCI NS subscale 2 – “Impulsiveness v reflection”; 9 items, Range: 9-45; Higher scores indicate higher degree of impulsiveness|units on a scale|Mean|19.60|19.6|Standard Deviation|4.137|4.137|||
3986408|NCT01253421|3808286|B5|||TCI NS-1|TCI NS subscale 1 – “Exploratory excitability v stoic rigidity”; 10 items, Range: 10-50; Higher scores indicate higher degree of exploratory excitability|units on a scale|Mean|31.814|31.814|Standard Deviation|6.4070|6.407|||
3986409|NCT01253421|3808287|B4|||TCI NS-1|TCI NS subscale 1 – “Exploratory excitability v stoic rigidity”; 10 items, Range: 10-50; Higher scores indicate higher degree of exploratory excitability|units on a scale|Mean|35.857|35.857|Standard Deviation|5.8159|5.8159|||
3986410|NCT01253421|3808288|B3|||TCI NS-1|TCI NS subscale 1 – “Exploratory excitability v stoic rigidity”; 10 items, Range: 10-50; Higher scores indicate higher degree of exploratory excitability|units on a scale|Mean|34.200|34.2|Standard Deviation|5.7595|5.7595|||
3986411|NCT01253421|3808289|B2|||TCI NS-1|TCI NS subscale 1 – “Exploratory excitability v stoic rigidity”; 10 items, Range: 10-50; Higher scores indicate higher degree of exploratory excitability|units on a scale|Mean|29.385|29.385|Standard Deviation|5.3000|5.3|||
3986412|NCT01253421|3808290|B1|||TCI NS-1|TCI NS subscale 1 – “Exploratory excitability v stoic rigidity”; 10 items, Range: 10-50; Higher scores indicate higher degree of exploratory excitability|units on a scale|Mean|27.760|27.76|Standard Deviation|5.4779|5.4779|||
3986413|NCT01253421|3808286|B5|||TCI Total|"Total score on the Novelty-Seeking (NS) subset of the Temperament and Character Inventory (TCI). The NS subset consists of 35 items from the full 240-item TCI survey.~ITEMS: statements people might use to describe their attitudes, opinions, interests, and other personal feelings. Item responses are on a 5-point scale of 1 (definitely false) to 5 (definitely true); Range: 35-175.~Higher scores indicate higher Novelty-Seeking temperament."|units on a scale|Mean|97.97|97.97|Standard Deviation|16.417|16.417|||
3986414|NCT01253421|3808287|B4|||TCI Total|"Total score on the Novelty-Seeking (NS) subset of the Temperament and Character Inventory (TCI). The NS subset consists of 35 items from the full 240-item TCI survey.~ITEMS: statements people might use to describe their attitudes, opinions, interests, and other personal feelings. Item responses are on a 5-point scale of 1 (definitely false) to 5 (definitely true); Range: 35-175.~Higher scores indicate higher Novelty-Seeking temperament."|units on a scale|Mean|105.9|105.9|Standard Deviation|14.53|14.53|||
3986415|NCT01253421|3808288|B3|||TCI Total|"Total score on the Novelty-Seeking (NS) subset of the Temperament and Character Inventory (TCI). The NS subset consists of 35 items from the full 240-item TCI survey.~ITEMS: statements people might use to describe their attitudes, opinions, interests, and other personal feelings. Item responses are on a 5-point scale of 1 (definitely false) to 5 (definitely true); Range: 35-175.~Higher scores indicate higher Novelty-Seeking temperament."|units on a scale|Mean|103.9|103.9|Standard Deviation|13.99|13.99|||
3986416|NCT01253421|3808289|B2|||TCI Total|"Total score on the Novelty-Seeking (NS) subset of the Temperament and Character Inventory (TCI). The NS subset consists of 35 items from the full 240-item TCI survey.~ITEMS: statements people might use to describe their attitudes, opinions, interests, and other personal feelings. Item responses are on a 5-point scale of 1 (definitely false) to 5 (definitely true); Range: 35-175.~Higher scores indicate higher Novelty-Seeking temperament."|units on a scale|Mean|94.2|94.2|Standard Deviation|17.78|17.78|||
3986417|NCT01253421|3808290|B1|||TCI Total|"Total score on the Novelty-Seeking (NS) subset of the Temperament and Character Inventory (TCI). The NS subset consists of 35 items from the full 240-item TCI survey.~ITEMS: statements people might use to describe their attitudes, opinions, interests, and other personal feelings. Item responses are on a 5-point scale of 1 (definitely false) to 5 (definitely true); Range: 35-175.~Higher scores indicate higher Novelty-Seeking temperament."|units on a scale|Mean|87.97|87.97|Standard Deviation|13.992|13.992|||
3986420|NCT01253421|3808288|B3||Unknown|Patients with past anxiety disorder|Number of subjects with past comorbid Anxiety Disorders|Participants|Count of Participants|0|0.0||||||
3986421|NCT01253421|3808289|B2||Unknown|Patients with past anxiety disorder|Number of subjects with past comorbid Anxiety Disorders|Participants|Count of Participants|0|0.0||||||
3986422|NCT01253421|3808290|B1||Unknown|Patients with past anxiety disorder|Number of subjects with past comorbid Anxiety Disorders|Participants|Count of Participants|3|3.0||||||
3986423|NCT01253421|3808286|B5||No|Patients with past anxiety disorder|Number of subjects with past comorbid Anxiety Disorders|Participants|Count of Participants|47|47.0||||||
3986424|NCT01253421|3808287|B4||No|Patients with past anxiety disorder|Number of subjects with past comorbid Anxiety Disorders|Participants|Count of Participants|14|14.0||||||
3986425|NCT01253421|3808288|B3||No|Patients with past anxiety disorder|Number of subjects with past comorbid Anxiety Disorders|Participants|Count of Participants|16|16.0||||||
3986426|NCT01253421|3808289|B2||No|Patients with past anxiety disorder|Number of subjects with past comorbid Anxiety Disorders|Participants|Count of Participants|8|8.0||||||
3986427|NCT01253421|3808290|B1||No|Patients with past anxiety disorder|Number of subjects with past comorbid Anxiety Disorders|Participants|Count of Participants|9|9.0||||||
3986428|NCT01253421|3808286|B5||Yes|Patients with past anxiety disorder|Number of subjects with past comorbid Anxiety Disorders|Participants|Count of Participants|9|9.0||||||
3986429|NCT01253421|3808287|B4||Yes|Patients with past anxiety disorder|Number of subjects with past comorbid Anxiety Disorders|Participants|Count of Participants|0|0.0||||||
3986430|NCT01253421|3808288|B3||Yes|Patients with past anxiety disorder|Number of subjects with past comorbid Anxiety Disorders|Participants|Count of Participants|0|0.0||||||
3986431|NCT01253421|3808289|B2||Yes|Patients with past anxiety disorder|Number of subjects with past comorbid Anxiety Disorders|Participants|Count of Participants|6|6.0||||||
3986432|NCT01253421|3808290|B1||Yes|Patients with past anxiety disorder|Number of subjects with past comorbid Anxiety Disorders|Participants|Count of Participants|3|3.0||||||
3986433|NCT01253421|3808286|B5||Unknown|Patients with comorbid anxiety disorder|Number of subjects with current comorbid Anxiety Disorders|Participants|Count of Participants|3|3.0||||||
3986434|NCT01253421|3808287|B4||Unknown|Patients with comorbid anxiety disorder|Number of subjects with current comorbid Anxiety Disorders|Participants|Count of Participants|0|0.0||||||
3986435|NCT01253421|3808288|B3||Unknown|Patients with comorbid anxiety disorder|Number of subjects with current comorbid Anxiety Disorders|Participants|Count of Participants|0|0.0||||||
3986436|NCT01253421|3808289|B2||Unknown|Patients with comorbid anxiety disorder|Number of subjects with current comorbid Anxiety Disorders|Participants|Count of Participants|0|0.0||||||
3986437|NCT01253421|3808290|B1||Unknown|Patients with comorbid anxiety disorder|Number of subjects with current comorbid Anxiety Disorders|Participants|Count of Participants|3|3.0||||||
3986438|NCT01253421|3808286|B5||No comorbid Anxiety Disorder|Patients with comorbid anxiety disorder|Number of subjects with current comorbid Anxiety Disorders|Participants|Count of Participants|47|47.0||||||
3986439|NCT01253421|3808287|B4||No comorbid Anxiety Disorder|Patients with comorbid anxiety disorder|Number of subjects with current comorbid Anxiety Disorders|Participants|Count of Participants|14|14.0||||||
3986440|NCT01253421|3808288|B3||No comorbid Anxiety Disorder|Patients with comorbid anxiety disorder|Number of subjects with current comorbid Anxiety Disorders|Participants|Count of Participants|16|16.0||||||
3986441|NCT01253421|3808289|B2||No comorbid Anxiety Disorder|Patients with comorbid anxiety disorder|Number of subjects with current comorbid Anxiety Disorders|Participants|Count of Participants|8|8.0||||||
3986442|NCT01253421|3808290|B1||No comorbid Anxiety Disorder|Patients with comorbid anxiety disorder|Number of subjects with current comorbid Anxiety Disorders|Participants|Count of Participants|9|9.0||||||
3986443|NCT01253421|3808286|B5||Has comorbid Anxiety Disorder|Patients with comorbid anxiety disorder|Number of subjects with current comorbid Anxiety Disorders|Participants|Count of Participants|9|9.0||||||
3986444|NCT01253421|3808287|B4||Has comorbid Anxiety Disorder|Patients with comorbid anxiety disorder|Number of subjects with current comorbid Anxiety Disorders|Participants|Count of Participants|0|0.0||||||
3986445|NCT01253421|3808288|B3||Has comorbid Anxiety Disorder|Patients with comorbid anxiety disorder|Number of subjects with current comorbid Anxiety Disorders|Participants|Count of Participants|0|0.0||||||
3986446|NCT01253421|3808289|B2||Has comorbid Anxiety Disorder|Patients with comorbid anxiety disorder|Number of subjects with current comorbid Anxiety Disorders|Participants|Count of Participants|6|6.0||||||
3986447|NCT01253421|3808290|B1||Has comorbid Anxiety Disorder|Patients with comorbid anxiety disorder|Number of subjects with current comorbid Anxiety Disorders|Participants|Count of Participants|3|3.0||||||
3986448|NCT01253421|3808286|B5|||Length_MDE|Length of the current major depressive episode (months)|months|Mean|16.17|16.17|Standard Deviation|17.771|17.771|||
3986449|NCT01253421|3808289|B2|||Length_MDE|Length of the current major depressive episode (months)|months|Mean|14.00|14.0|Standard Deviation|18.982|18.982|||
3986450|NCT01253421|3808290|B1|||Length_MDE|Length of the current major depressive episode (months)|months|Mean|20.50|20.5|Standard Deviation|16.53|16.53|||
3986451|NCT01253421|3808286|B5|||# MDEs|Number of discrete major depressive episodes (MDE).|Episodes|Mean|3.74|3.74|Standard Deviation|3.230|3.23|||
3986452|NCT01253421|3808289|B2|||# MDEs|Number of discrete major depressive episodes (MDE).|Episodes|Mean|4.79|4.79|Standard Deviation|3.490|3.49|||
3986453|NCT01253421|3808290|B1|||# MDEs|Number of discrete major depressive episodes (MDE).|Episodes|Mean|2.75|2.75|Standard Deviation|2.667|2.667|||
3986454|NCT01253421|3808286|B5|||MDD SCID rating|Diagnostic rating of Major Depressive Disorder (MDD): 3=Meets Criteria; 2=Subthreshold; 1=Absent|units on a scale|Mean|1.93|1.93|Standard Deviation|.99|0.99|||
3986455|NCT01253421|3808287|B4|||MDD SCID rating|Diagnostic rating of Major Depressive Disorder (MDD): 3=Meets Criteria; 2=Subthreshold; 1=Absent|units on a scale|Mean|1|1.0|Standard Deviation|0|0.0|||
3986456|NCT01253421|3808288|B3|||MDD SCID rating|Diagnostic rating of Major Depressive Disorder (MDD): 3=Meets Criteria; 2=Subthreshold; 1=Absent|units on a scale|Mean|1|1.0|Standard Deviation|0|0.0|||
3986457|NCT01253421|3808289|B2|||MDD SCID rating|Diagnostic rating of Major Depressive Disorder (MDD): 3=Meets Criteria; 2=Subthreshold; 1=Absent|units on a scale|Mean|2.9|2.9|Standard Deviation|.27|0.27|||
3986458|NCT01253421|3808290|B1|||MDD SCID rating|Diagnostic rating of Major Depressive Disorder (MDD): 3=Meets Criteria; 2=Subthreshold; 1=Absent|units on a scale|Mean|2.9|2.9|Standard Deviation|.27|0.27|||
3986459|NCT01253421|3808286|B5|||HRSD|Hamilton Rating Scale for Depression (HRSD), 17 item. Range: 0 (no symptoms) to 52 (maximum symptom severity) Clinical categories for total score: 0-7: absent; 8-13: mild; 14-19: moderate; 20-25: severe; 26-52: very severe.|units on a scale|Mean|9.37|9.37|Standard Deviation|8.997|8.997|||
3986460|NCT01253421|3808287|B4|||HRSD|Hamilton Rating Scale for Depression (HRSD), 17 item. Range: 0 (no symptoms) to 52 (maximum symptom severity) Clinical categories for total score: 0-7: absent; 8-13: mild; 14-19: moderate; 20-25: severe; 26-52: very severe.|units on a scale|Mean|0.5|0.5|Standard Deviation|0.66|0.66|||
3986461|NCT01253421|3808288|B3|||HRSD|Hamilton Rating Scale for Depression (HRSD), 17 item. Range: 0 (no symptoms) to 52 (maximum symptom severity) Clinical categories for total score: 0-7: absent; 8-13: mild; 14-19: moderate; 20-25: severe; 26-52: very severe.|units on a scale|Mean|1.0|1.0|Standard Deviation|1.58|1.58|||
3986462|NCT01253421|3808289|B2|||HRSD|Hamilton Rating Scale for Depression (HRSD), 17 item. Range: 0 (no symptoms) to 52 (maximum symptom severity) Clinical categories for total score: 0-7: absent; 8-13: mild; 14-19: moderate; 20-25: severe; 26-52: very severe.|units on a scale|Mean|18.4|18.4|Standard Deviation|5.09|5.09|||
3986463|NCT01253421|3808290|B1|||HRSD|Hamilton Rating Scale for Depression (HRSD), 17 item. Range: 0 (no symptoms) to 52 (maximum symptom severity) Clinical categories for total score: 0-7: absent; 8-13: mild; 14-19: moderate; 20-25: severe; 26-52: very severe.|units on a scale|Mean|16.4|16.4|Standard Deviation|3.37|3.37|||
3986464|NCT01253421|3808286|B5||Unknown|Menstrual phase|Menstrual phase when scanned (females only)|Participants|Count of Participants|17|17.0||||||
3986465|NCT01253421|3808287|B4||Unknown|Menstrual phase|Menstrual phase when scanned (females only)|Participants|Count of Participants|3|3.0||||||
3986466|NCT01253421|3808288|B3||Unknown|Menstrual phase|Menstrual phase when scanned (females only)|Participants|Count of Participants|4|4.0||||||
3986467|NCT01253421|3808289|B2||Unknown|Menstrual phase|Menstrual phase when scanned (females only)|Participants|Count of Participants|3|3.0||||||
3986468|NCT01253421|3808290|B1||Unknown|Menstrual phase|Menstrual phase when scanned (females only)|Participants|Count of Participants|7|7.0||||||
3986469|NCT01253421|3808286|B5||Luteal|Menstrual phase|Menstrual phase when scanned (females only)|Participants|Count of Participants|9|9.0||||||
3986470|NCT01253421|3808287|B4||Luteal|Menstrual phase|Menstrual phase when scanned (females only)|Participants|Count of Participants|3|3.0||||||
3986471|NCT01253421|3808288|B3||Luteal|Menstrual phase|Menstrual phase when scanned (females only)|Participants|Count of Participants|1|1.0||||||
3986472|NCT01253421|3808289|B2||Luteal|Menstrual phase|Menstrual phase when scanned (females only)|Participants|Count of Participants|1|1.0||||||
3986473|NCT01253421|3808290|B1||Luteal|Menstrual phase|Menstrual phase when scanned (females only)|Participants|Count of Participants|4|4.0||||||
3986474|NCT01253421|3808286|B5||Follicular|Menstrual phase|Menstrual phase when scanned (females only)|Participants|Count of Participants|12|12.0||||||
3986475|NCT01253421|3808287|B4||Follicular|Menstrual phase|Menstrual phase when scanned (females only)|Participants|Count of Participants|3|3.0||||||
3986476|NCT01253421|3808288|B3||Follicular|Menstrual phase|Menstrual phase when scanned (females only)|Participants|Count of Participants|6|6.0||||||
3986477|NCT01253421|3808289|B2||Follicular|Menstrual phase|Menstrual phase when scanned (females only)|Participants|Count of Participants|2|2.0||||||
3986478|NCT01253421|3808290|B1||Follicular|Menstrual phase|Menstrual phase when scanned (females only)|Participants|Count of Participants|1|1.0||||||
3986479|NCT01253421|3808286|B5|||Educ-yrs|Years of Education|years|Mean|16.2|16.2|Standard Deviation|2.18|2.18|||
3986480|NCT01253421|3808287|B4|||Educ-yrs|Years of Education|years|Mean|16.5|16.5|Standard Deviation|1.52|1.52|||
3986481|NCT01253421|3808288|B3|||Educ-yrs|Years of Education|years|Mean|16.2|16.2|Standard Deviation|2.13|2.13|||
3986482|NCT01253421|3808289|B2|||Educ-yrs|Years of Education|years|Mean|16.6|16.6|Standard Deviation|2.90|2.9|||
3986483|NCT01253421|3808290|B1|||Educ-yrs|Years of Education|years|Mean|15.6|15.6|Standard Deviation|2.06|2.06|||
3986484|NCT01253421|3808286|B5|United States||Region of Enrollment||Participants|Count of Participants|59|59.0||||||
3986485|NCT01253421|3808287|B4|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3986486|NCT01253421|3808288|B3|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3986487|NCT01253421|3808289|B2|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3986488|NCT01253421|3808290|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3986489|NCT01253421|3808286|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3986490|NCT01253421|3808287|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986491|NCT01253421|3808288|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3986492|NCT01253421|3808289|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986493|NCT01253421|3808290|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986494|NCT01253421|3808286|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3986495|NCT01253421|3808287|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986496|NCT01253421|3808288|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3986497|NCT01253421|3808289|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3986498|NCT01253421|3808290|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3986499|NCT01253421|3808286|B5||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3986500|NCT01253421|3808287|B4||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3986501|NCT01253421|3808288|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3986502|NCT01253421|3808289|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3986503|NCT01253421|3808290|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3986504|NCT01253421|3808286|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3986505|NCT01253421|3808287|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3986506|NCT01253421|3808288|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3986507|NCT01253421|3808289|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3986508|NCT01253421|3808290|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3986509|NCT01253421|3808286|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986510|NCT01253421|3808287|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986511|NCT01253421|3808288|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986512|NCT01253421|3808289|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986513|NCT01253421|3808290|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986514|NCT01253421|3808286|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3986515|NCT01253421|3808287|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3986516|NCT01253421|3808288|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986517|NCT01253421|3808289|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3986518|NCT01253421|3808290|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3986519|NCT01253421|3808286|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3986520|NCT01253421|3808287|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986521|NCT01253421|3808288|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3986522|NCT01253421|3808289|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986523|NCT01253421|3808290|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986524|NCT01253421|3808286|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3986525|NCT01253421|3808287|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986526|NCT01253421|3808288|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3986527|NCT01253421|3808289|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986528|NCT01253421|3808290|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986529|NCT01253421|3808286|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3986530|NCT01253421|3808287|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3986531|NCT01253421|3808288|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3986532|NCT01253421|3808289|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3986533|NCT01253421|3808290|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3986534|NCT01253421|3808286|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3986535|NCT01253421|3808287|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986536|NCT01253421|3808288|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3986537|NCT01253421|3808289|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3986538|NCT01253421|3808290|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3986539|NCT01253421|3808286|B5||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3986540|NCT01253421|3808287|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3986541|NCT01253421|3808288|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3986542|NCT01253421|3808289|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3986543|NCT01253421|3808290|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3986544|NCT01253421|3808286|B5||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3986545|NCT01253421|3808287|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3986546|NCT01253421|3808288|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3986547|NCT01253421|3808289|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3986548|NCT01253421|3808290|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3986549|NCT01253421|3808286|B5|||Age||years|Mean|26|26.0|Standard Deviation|6.79|6.79|||
3986550|NCT01253421|3808287|B4|||Age||years|Mean|24.7|24.7|Standard Deviation|24.7|24.7|||
3986551|NCT01253421|3808288|B3|||Age||years|Mean|25.3|25.3|Standard Deviation|25.3|25.3|||
3986552|NCT01253421|3808289|B2|||Age||years|Mean|25.8|25.8|Standard Deviation|5.35|5.35|||
3986553|NCT01253421|3808290|B1|||Age||years|Mean|27.20|27.2|Standard Deviation|8.6|8.6|||
3986554|NCT01253408|3808340|B4|||Body Mass Index (BMI)||kg/m^2|Mean|30.50|30.5|Standard Deviation|9.46|9.46|||
3986555|NCT01253408|3808341|B3|||Body Mass Index (BMI)||kg/m^2|Mean|30.8|30.8|Standard Deviation|1.8|1.8|||
3986556|NCT01253408|3808342|B2|||Body Mass Index (BMI)||kg/m^2|Mean|31.6|31.6|Standard Deviation|3.9|3.9|||
3986557|NCT01253408|3808343|B1|||Body Mass Index (BMI)||kg/m^2|Mean|28.7|28.7|Standard Deviation|1.5|1.5|||
3986558|NCT01253408|3808340|B4|United States||Region of Enrollment||participants|Number|36|36.0||||||
3986559|NCT01253408|3808341|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
3986560|NCT01253408|3808342|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3986561|NCT01253408|3808343|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3986562|NCT01253408|3808340|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3986563|NCT01253408|3808341|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3986564|NCT01253408|3808342|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3986565|NCT01253408|3808343|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3986566|NCT01253408|3808340|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3986567|NCT01253408|3808341|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3986568|NCT01253408|3808342|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3986569|NCT01253408|3808343|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3986570|NCT01253408|3808340|B4|||Age||years|Mean|41.77|41.77|Standard Deviation|17.74|17.74|||
3986571|NCT01253408|3808341|B3|||Age||years|Mean|36.7|36.7|Standard Deviation|11.02|11.02|||
3986572|NCT01253408|3808342|B2|||Age||years|Mean|42.28|42.28|Standard Deviation|16.36|16.36|||
3986573|NCT01253408|3808343|B1|||Age||years|Mean|47.68|47.68|Standard Deviation|25.08|25.08|||
3986574|NCT01253369|3808368|B1|Chemo-Sensitive||Response to 1st Line Therapy||participants|Number|15|15.0||||||
3986575|NCT01253369|3808368|B1|Chemo-Refractory||Response to 1st Line Therapy||participants|Number|18|18.0||||||
3986576|NCT01253369|3808368|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
3986577|NCT01253369|3808368|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3986578|NCT01253369|3808368|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3986579|NCT01253369|3808368|B1|||Age||years|Mean|61|61.0|Full Range|||32.0|74.0|
3986580|NCT01253343|3808373|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
3986581|NCT01253343|3808374|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3986582|NCT01253343|3808375|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3986583|NCT01253343|3808373|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3986584|NCT01253343|3808374|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3986585|NCT01253343|3808375|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3986586|NCT01253343|3808373|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3986587|NCT01253343|3808374|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3986588|NCT01253343|3808375|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3986589|NCT01253343|3808373|B3|||Age||years|Mean|8|8.0|Standard Deviation|1|1.0|||
3986590|NCT01253343|3808374|B2|||Age||years|Mean|8|8.0|Standard Deviation|1|1.0|||
3986591|NCT01253343|3808375|B1|||Age||years|Mean|8|8.0|Standard Deviation|1|1.0|||
3986592|NCT01253343|3808373|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3986593|NCT01253343|3808374|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3986594|NCT01253343|3808375|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3986595|NCT01253343|3808373|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3986596|NCT01253343|3808374|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3986597|NCT01253343|3808375|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3986598|NCT01253343|3808373|B3||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
3986599|NCT01253343|3808374|B2||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
3986600|NCT01253343|3808375|B1||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
3986601|NCT01253317|3808398|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3986602|NCT01253317|3808398|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986603|NCT01253317|3808398|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3986604|NCT01253317|3808398|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986605|NCT01253317|3808398|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986606|NCT01253317|3808398|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986607|NCT01253317|3808398|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3986608|NCT01253317|3808398|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986609|NCT01253317|3808398|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986610|NCT01253317|3808398|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3986611|NCT01253317|3808398|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986612|NCT01253317|3808398|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3986613|NCT01253317|3808398|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3986614|NCT01253317|3808398|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3986615|NCT01253317|3808398|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3986616|NCT01253317|3808398|B1||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
3986617|NCT01253304|3808406|B5|Germany||Region of Enrollment||participants|Number|26|26.0||||||
3986618|NCT01253304|3808407|B4|Germany||Region of Enrollment||participants|Number|3|3.0||||||
3986619|NCT01253304|3808408|B3|Germany||Region of Enrollment||participants|Number|6|6.0||||||
3986620|NCT01253304|3808409|B2|Germany||Region of Enrollment||participants|Number|6|6.0||||||
3986621|NCT01253304|3808410|B1|Germany||Region of Enrollment||participants|Number|11|11.0||||||
3986622|NCT01253304|3808406|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3986623|NCT01253304|3808407|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3986624|NCT01253304|3808408|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3986625|NCT01253304|3808409|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3986626|NCT01253304|3808410|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3986627|NCT01253304|3808406|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3986628|NCT01253304|3808407|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3986629|NCT01253304|3808408|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3986630|NCT01253304|3808409|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3986631|NCT01253304|3808410|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3986632|NCT01253304|3808406|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986633|NCT01253304|3808407|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986634|NCT01253304|3808408|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986635|NCT01253304|3808409|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986636|NCT01253304|3808410|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986637|NCT01253304|3808406|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3986638|NCT01253304|3808407|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986639|NCT01253304|3808408|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986640|NCT01253304|3808409|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986641|NCT01253304|3808410|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3986642|NCT01253304|3808406|B5||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3986643|NCT01253304|3808407|B4||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3986644|NCT01253304|3808408|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3986645|NCT01253304|3808409|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3986646|NCT01253304|3808410|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3986647|NCT01253304|3808406|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986648|NCT01253304|3808407|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986649|NCT01253304|3808408|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986650|NCT01253304|3808409|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986651|NCT01253304|3808410|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986652|NCT01253304|3808406|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986653|NCT01253304|3808407|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986654|NCT01253304|3808408|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986655|NCT01253304|3808409|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986656|NCT01253304|3808410|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986657|NCT01253304|3808406|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986658|NCT01253304|3808407|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986659|NCT01253304|3808408|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986660|NCT01253304|3808409|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986661|NCT01253304|3808410|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986662|NCT01253304|3808406|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986663|NCT01253304|3808407|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986664|NCT01253304|3808408|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986665|NCT01253304|3808409|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986666|NCT01253304|3808410|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986667|NCT01253304|3808406|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3986668|NCT01253304|3808407|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3986669|NCT01253304|3808408|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3986670|NCT01253304|3808409|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3986671|NCT01253304|3808410|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3986672|NCT01253304|3808406|B5||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3986673|NCT01253304|3808407|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3986674|NCT01253304|3808408|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3986675|NCT01253304|3808409|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3986676|NCT01253304|3808410|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3986677|NCT01253304|3808406|B5|||Age||years|Mean|57.6|57.6|Standard Deviation|7.9|7.9|||
3986678|NCT01253304|3808407|B4|||Age||years|Mean|64.3|64.3|Standard Deviation|6.5|6.5|||
3986679|NCT01253304|3808408|B3|||Age||years|Mean|54.3|54.3|Standard Deviation|4.8|4.8|||
3986680|NCT01253304|3808409|B2|||Age||years|Mean|56.3|56.3|Standard Deviation|9.2|9.2|||
3986681|NCT01253304|3808410|B1|||Age||years|Mean|58.2|58.2|Standard Deviation|8.5|8.5|||
3986682|NCT01253265|3808447|B6|||Weekly dose of Methotrexate (MTX)||milligrams per week (mg/wk)|Mean|8.58|8.58|Standard Deviation|1.10|1.1|||
3986683|NCT01253265|3808448|B5|||Weekly dose of Methotrexate (MTX)||milligrams per week (mg/wk)|Mean|9.06|9.06|Standard Deviation|1.66|1.66|||
3986684|NCT01253265|3808449|B4|||Weekly dose of Methotrexate (MTX)||milligrams per week (mg/wk)|Mean|9.00|9.0|Standard Deviation|1.10|1.1|||
3986685|NCT01253265|3808450|B3|||Weekly dose of Methotrexate (MTX)||milligrams per week (mg/wk)|Mean|8.00|8.0|Standard Deviation|0.00|0.0|||
3986686|NCT01253265|3808451|B2|||Weekly dose of Methotrexate (MTX)||milligrams per week (mg/wk)|Mean|8.33|8.33|Standard Deviation|0.82|0.82|||
3986687|NCT01253265|3808452|B1|||Weekly dose of Methotrexate (MTX)||milligrams per week (mg/wk)|Mean|8.33|8.33|Standard Deviation|0.82|0.82|||
3986688|NCT01253265|3808447|B6|||Duration of Rheumatoid Arthritis (RA)||years|Mean|6.8|6.8|Standard Deviation|8.5|8.5|||
3986689|NCT01253265|3808448|B5|||Duration of Rheumatoid Arthritis (RA)||years|Mean|3.6|3.6|Standard Deviation|3.2|3.2|||
3986690|NCT01253265|3808449|B4|||Duration of Rheumatoid Arthritis (RA)||years|Mean|5.6|5.6|Standard Deviation|4.1|4.1|||
3986691|NCT01253265|3808450|B3|||Duration of Rheumatoid Arthritis (RA)||years|Mean|6.8|6.8|Standard Deviation|12.0|12.0|||
3986692|NCT01253265|3808451|B2|||Duration of Rheumatoid Arthritis (RA)||years|Mean|7.9|7.9|Standard Deviation|9.7|9.7|||
3986693|NCT01253265|3808452|B1|||Duration of Rheumatoid Arthritis (RA)||years|Mean|10.9|10.9|Standard Deviation|11.8|11.8|||
3986694|NCT01253265|3808447|B6|||Lymphocytes||10^9 cells per liter (GI/L)|Median|1.275|1.275|Full Range|||0.42|2.62|
3986695|NCT01253265|3808448|B5|||Lymphocytes||10^9 cells per liter (GI/L)|Median|1.295|1.295|Full Range|||1.06|2.29|
3986696|NCT01253265|3808449|B4|||Lymphocytes||10^9 cells per liter (GI/L)|Median|1.379|1.379|Full Range|||0.67|2.45|
3986697|NCT01253265|3808450|B3|||Lymphocytes||10^9 cells per liter (GI/L)|Median|1.187|1.187|Full Range|||0.88|2.01|
3986698|NCT01253265|3808451|B2|||Lymphocytes||10^9 cells per liter (GI/L)|Median|1.156|1.156|Full Range|||0.69|2.19|
3986699|NCT01253265|3808452|B1|||Lymphocytes||10^9 cells per liter (GI/L)|Median|0.993|0.993|Full Range|||0.42|2.62|
3986700|NCT01253265|3808447|B6|||Neutrophils||10^9 cells per liter (GI/L)|Median|5.261|5.261|Full Range|||2.59|11.12|
3986701|NCT01253265|3808448|B5|||Neutrophils||10^9 cells per liter (GI/L)|Median|6.757|6.757|Full Range|||4.14|8.97|
3986702|NCT01253265|3808449|B4|||Neutrophils||10^9 cells per liter (GI/L)|Median|6.056|6.056|Full Range|||4.63|7.56|
3986703|NCT01253265|3808450|B3|||Neutrophils||10^9 cells per liter (GI/L)|Median|3.857|3.857|Full Range|||2.59|5.26|
3986704|NCT01253265|3808451|B2|||Neutrophils||10^9 cells per liter (GI/L)|Median|4.293|4.293|Full Range|||2.59|11.12|
3986705|NCT01253265|3808452|B1|||Neutrophils||10^9 cells per liter (GI/L)|Median|6.763|6.763|Full Range|||3.13|7.67|
3986706|NCT01253265|3808447|B6|||Erythrocyte Sedimentation Rate (ESR)||millimeters per hour (mm/h)|Median|29.5|29.5|Full Range|||4.0|107.0|
3986707|NCT01253265|3808448|B5|||Erythrocyte Sedimentation Rate (ESR)||millimeters per hour (mm/h)|Median|25.5|25.5|Full Range|||9.0|48.0|
3986708|NCT01253265|3808449|B4|||Erythrocyte Sedimentation Rate (ESR)||millimeters per hour (mm/h)|Median|42.5|42.5|Full Range|||22.0|81.0|
3986709|NCT01253265|3808450|B3|||Erythrocyte Sedimentation Rate (ESR)||millimeters per hour (mm/h)|Median|26.0|26.0|Full Range|||4.0|50.0|
3986710|NCT01253265|3808451|B2|||Erythrocyte Sedimentation Rate (ESR)||millimeters per hour (mm/h)|Median|53.5|53.5|Full Range|||23.0|107.0|
3986711|NCT01253265|3808452|B1|||Erythrocyte Sedimentation Rate (ESR)||millimeters per hour (mm/h)|Median|28.0|28.0|Full Range|||7.0|87.0|
3986712|NCT01253265|3808447|B6|||C-Reactive Protein (CRP)||milligrams per liter (mg/L)|Median|9.700|9.7|Full Range|||1.1|95.2|
3986713|NCT01253265|3808448|B5|||C-Reactive Protein (CRP)||milligrams per liter (mg/L)|Median|5.650|5.65|Full Range|||1.1|50.1|
3986714|NCT01253265|3808449|B4|||C-Reactive Protein (CRP)||milligrams per liter (mg/L)|Median|31.000|31.0|Full Range|||9.3|95.2|
3986715|NCT01253265|3808450|B3|||C-Reactive Protein (CRP)||milligrams per liter (mg/L)|Median|3.500|3.5|Full Range|||2.8|12.8|
3986716|NCT01253265|3808451|B2|||C-Reactive Protein (CRP)||milligrams per liter (mg/L)|Median|11.750|11.75|Full Range|||2.0|50.1|
3986717|NCT01253265|3808452|B1|||C-Reactive Protein (CRP)||milligrams per liter (mg/L)|Median|7.950|7.95|Full Range|||5.0|25.1|
3986718|NCT01253265|3808447|B6|Japan||Region of Enrollment||participants|Number|32|32.0||||||
3986719|NCT01253265|3808448|B5|Japan||Region of Enrollment||participants|Number|8|8.0||||||
3986720|NCT01253265|3808449|B4|Japan||Region of Enrollment||participants|Number|6|6.0||||||
3986721|NCT01253265|3808450|B3|Japan||Region of Enrollment||participants|Number|6|6.0||||||
3986722|NCT01253265|3808451|B2|Japan||Region of Enrollment||participants|Number|6|6.0||||||
3986723|NCT01253265|3808452|B1|Japan||Region of Enrollment||participants|Number|6|6.0||||||
3986724|NCT01253265|3808447|B6|Japanese||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
3986725|NCT01253265|3808448|B5|Japanese||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3986726|NCT01253265|3808449|B4|Japanese||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3986727|NCT01253265|3808450|B3|Japanese||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3986728|NCT01253265|3808451|B2|Japanese||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3986729|NCT01253265|3808452|B1|Japanese||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3986730|NCT01253265|3808447|B6||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3986731|NCT01253265|3808448|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3986732|NCT01253265|3808449|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3986733|NCT01253265|3808450|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3986734|NCT01253265|3808451|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3986735|NCT01253265|3808452|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3986736|NCT01253265|3808447|B6||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3986737|NCT01253265|3808448|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3986738|NCT01253265|3808449|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3986739|NCT01253265|3808450|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3986740|NCT01253265|3808451|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3986741|NCT01253265|3808452|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3986742|NCT01253265|3808447|B6|||Age||years|Mean|57.0|57.0|Standard Deviation|11.2|11.2|||
3986743|NCT01253265|3808448|B5|||Age||years|Mean|60.1|60.1|Standard Deviation|7.7|7.7|||
3986744|NCT01253265|3808449|B4|||Age||years|Mean|52.5|52.5|Standard Deviation|14.0|14.0|||
3986745|NCT01253265|3808450|B3|||Age||years|Mean|61.7|61.7|Standard Deviation|11.3|11.3|||
3986746|NCT01253265|3808451|B2|||Age||years|Mean|56.8|56.8|Standard Deviation|7.2|7.2|||
3986747|NCT01253265|3808452|B1|||Age||years|Mean|53.0|53.0|Standard Deviation|15.4|15.4|||
3986748|NCT01253226|3808500|B6|||C-Reactive Protein (CRP)|CRP is an indicator of inflammation. Higher values indicate a greater amount of inflammation|milligrams per deciliter (mg/dL)|Mean|12.85|12.85|Standard Deviation|16.56|16.56|||
3986749|NCT01253226|3808501|B5|||C-Reactive Protein (CRP)|CRP is an indicator of inflammation. Higher values indicate a greater amount of inflammation|milligrams per deciliter (mg/dL)|Mean|11.07|11.07|Standard Deviation|5.30|5.3|||
3986750|NCT01253226|3808502|B4|||C-Reactive Protein (CRP)|CRP is an indicator of inflammation. Higher values indicate a greater amount of inflammation|milligrams per deciliter (mg/dL)|Mean|8.73|8.73|Standard Deviation|8.26|8.26|||
3986751|NCT01253226|3808503|B3|||C-Reactive Protein (CRP)|CRP is an indicator of inflammation. Higher values indicate a greater amount of inflammation|milligrams per deciliter (mg/dL)|Mean|14.91|14.91|Standard Deviation|9.17|9.17|||
3986752|NCT01253226|3808504|B2|||C-Reactive Protein (CRP)|CRP is an indicator of inflammation. Higher values indicate a greater amount of inflammation|milligrams per deciliter (mg/dL)|Mean|18.69|18.69|Standard Deviation|35.23|35.23|||
3986753|NCT01253226|3808505|B1|||C-Reactive Protein (CRP)|CRP is an indicator of inflammation. Higher values indicate a greater amount of inflammation|milligrams per deciliter (mg/dL)|Mean|11.46|11.46|Standard Deviation|13.90|13.9|||
3986754|NCT01253226|3808500|B6|||Body Weight||kilograms (kg)|Mean|55.8|55.8|Standard Deviation|8.9|8.9|||
3986755|NCT01253226|3808501|B5|||Body Weight||kilograms (kg)|Mean|54.6|54.6|Standard Deviation|7.5|7.5|||
3986756|NCT01253226|3808502|B4|||Body Weight||kilograms (kg)|Mean|58.3|58.3|Standard Deviation|8.3|8.3|||
3986757|NCT01253226|3808503|B3|||Body Weight||kilograms (kg)|Mean|55.9|55.9|Standard Deviation|10.5|10.5|||
3986758|NCT01253226|3808504|B2|||Body Weight||kilograms (kg)|Mean|55.9|55.9|Standard Deviation|13.8|13.8|||
3986759|NCT01253226|3808505|B1|||Body Weight||kilograms (kg)|Mean|54.8|54.8|Standard Deviation|5.5|5.5|||
3986760|NCT01253226|3808500|B6|No||Current Use of Corticosteroids||Participants|Count of Participants|17|17.0||||||
3986761|NCT01253226|3808501|B5|No||Current Use of Corticosteroids||Participants|Count of Participants|2|2.0||||||
3986762|NCT01253226|3808502|B4|No||Current Use of Corticosteroids||Participants|Count of Participants|2|2.0||||||
3986763|NCT01253226|3808503|B3|No||Current Use of Corticosteroids||Participants|Count of Participants|5|5.0||||||
3986764|NCT01253226|3808504|B2|No||Current Use of Corticosteroids||Participants|Count of Participants|5|5.0||||||
3986765|NCT01253226|3808505|B1|No||Current Use of Corticosteroids||Participants|Count of Participants|3|3.0||||||
3986766|NCT01253226|3808500|B6|Yes||Current Use of Corticosteroids||Participants|Count of Participants|15|15.0||||||
3986767|NCT01253226|3808501|B5|Yes||Current Use of Corticosteroids||Participants|Count of Participants|6|6.0||||||
3986768|NCT01253226|3808502|B4|Yes||Current Use of Corticosteroids||Participants|Count of Participants|4|4.0||||||
3986769|NCT01253226|3808503|B3|Yes||Current Use of Corticosteroids||Participants|Count of Participants|1|1.0||||||
3986770|NCT01253226|3808504|B2|Yes||Current Use of Corticosteroids||Participants|Count of Participants|1|1.0||||||
3986771|NCT01253226|3808505|B1|Yes||Current Use of Corticosteroids||Participants|Count of Participants|3|3.0||||||
3986772|NCT01253226|3808500|B6|Japan||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3986773|NCT01253226|3808501|B5|Japan||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3986774|NCT01253226|3808502|B4|Japan||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3986775|NCT01253226|3808503|B3|Japan||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3986776|NCT01253226|3808504|B2|Japan||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3986777|NCT01253226|3808505|B1|Japan||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3986778|NCT01253226|3808500|B6|Japanese||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
3986779|NCT01253226|3808501|B5|Japanese||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3986780|NCT01253226|3808502|B4|Japanese||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3986781|NCT01253226|3808503|B3|Japanese||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3986782|NCT01253226|3808504|B2|Japanese||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3986783|NCT01253226|3808505|B1|Japanese||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3986784|NCT01253226|3808500|B6||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3986785|NCT01253226|3808501|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3986786|NCT01253226|3808502|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3986787|NCT01253226|3808503|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3986788|NCT01253226|3808504|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3986789|NCT01253226|3808505|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3986790|NCT01253226|3808500|B6||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3986791|NCT01253226|3808501|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3986792|NCT01253226|3808502|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3986793|NCT01253226|3808503|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3986794|NCT01253226|3808504|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3986795|NCT01253226|3808505|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3986796|NCT01253226|3808500|B6|||Age||years|Mean|57.4|57.4|Standard Deviation|13.3|13.3|||
3986797|NCT01253226|3808501|B5|||Age||years|Mean|58.4|58.4|Standard Deviation|17.1|17.1|||
3986798|NCT01253226|3808502|B4|||Age||years|Mean|56.7|56.7|Standard Deviation|8.0|8.0|||
3986799|NCT01253226|3808503|B3|||Age||years|Mean|55.5|55.5|Standard Deviation|14.2|14.2|||
3986800|NCT01253226|3808504|B2|||Age||years|Mean|50.0|50.0|Standard Deviation|15.0|15.0|||
3986801|NCT01253226|3808505|B1|||Age||years|Mean|66.0|66.0|Standard Deviation|5.9|5.9|||
3986802|NCT01253200|3808564|B6|United States||Region of Enrollment||participants|Number|302|302.0||||||
3986803|NCT01253200|3808565|B5|United States||Region of Enrollment||participants|Number|5|5.0||||||
3986804|NCT01253200|3808566|B4|United States||Region of Enrollment||participants|Number|17|17.0||||||
3986805|NCT01253200|3808567|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3986806|NCT01253200|3808568|B2|United States||Region of Enrollment||participants|Number|125|125.0||||||
3986807|NCT01253200|3808569|B1|United States||Region of Enrollment||participants|Number|125|125.0||||||
3986808|NCT01253200|3808564|B6||Male|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
3986809|NCT01253200|3808565|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3986810|NCT01253200|3808566|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3986811|NCT01253200|3808567|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3986812|NCT01253200|3808568|B2||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3986813|NCT01253200|3808569|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3986814|NCT01253200|3808564|B6||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3986815|NCT01253200|3808565|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3986816|NCT01253200|3808566|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3986817|NCT01253200|3808567|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3986818|NCT01253200|3808568|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3986819|NCT01253200|3808569|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3986820|NCT01253200|3808564|B6|||Age||years|Mean|65.73|65.73|Standard Deviation|10.54|10.54|||
3986821|NCT01253200|3808565|B5|||Age||years|Mean|72|72.0|Standard Deviation|11|11.0|||
3986822|NCT01253200|3808566|B4|||Age||years|Mean|66|66.0|Standard Deviation|9|9.0|||
3986823|NCT01253200|3808567|B3|||Age||years|Mean|69|69.0|Standard Deviation|10|10.0|||
3986824|NCT01253200|3808568|B2|||Age||years|Mean|66|66.0|Standard Deviation|10|10.0|||
3986825|NCT01253200|3808569|B1|||Age||years|Mean|65|65.0|Standard Deviation|11|11.0|||
3986826|NCT01253187|3808588|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3986827|NCT01253187|3808588|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3986828|NCT01253187|3808588|B1|||Age||Years|Mean|26.3|26.3|Standard Deviation|6.33|6.33|||
3986829|NCT01253174|3808622|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3986830|NCT01253174|3808622|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3986831|NCT01253174|3808622|B1|||Age||years|Mean|29.7|29.7|Standard Deviation|4.62|4.62|||
3986832|NCT01253148|3808656|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3986833|NCT01253148|3808656|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3986834|NCT01253148|3808656|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3986835|NCT01253148|3808656|B1|||Age||years|Median|76|76.0|Full Range|||52.0|84.0|
3986836|NCT01253148|3808656|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3986837|NCT01253148|3808656|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3986838|NCT01253148|3808656|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3986839|NCT01253135|3808662|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3986840|NCT01253135|3808662|B1|Other||Race/Ethnicity, Customized|For amended protocol participants|participants|Number|3|3.0||||||
3986841|NCT01253135|3808662|B1|White/Caucasian||Race/Ethnicity, Customized|For amended protocol participants|participants|Number|18|18.0||||||
3986842|NCT01253135|3808662|B1|Black/African American||Race/Ethnicity, Customized|For amended protocol participants|participants|Number|3|3.0||||||
3986843|NCT01253135|3808662|B1|Asian||Race/Ethnicity, Customized|For amended protocol participants|participants|Number|1|1.0||||||
3986844|NCT01253135|3808662|B1|Non Hispanic/Latino||Race/Ethnicity, Customized|For amended protocol participants|participants|Number|10|10.0||||||
3986845|NCT01253135|3808662|B1|Hispanic/Latino||Race/Ethnicity, Customized|For amended protocol participants|participants|Number|15|15.0||||||
3986846|NCT01253135|3808662|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986847|NCT01253135|3808662|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3986848|NCT01253135|3808662|B1||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3986849|NCT01253135|3808662|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3986850|NCT01253135|3808662|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986851|NCT01253135|3808662|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3986852|NCT01253135|3808662|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986853|NCT01253135|3808662|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986854|NCT01253135|3808662|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3986855|NCT01253135|3808662|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3986856|NCT01253135|3808662|B1|Female amended protocol||Sex/Gender, Customized||participants|Number|12|12.0||||||
3986857|NCT01253135|3808662|B1|Male amended protocol||Sex/Gender, Customized||participants|Number|13|13.0||||||
3986858|NCT01253135|3808662|B1|Female entire study population||Sex/Gender, Customized||participants|Number|20|20.0||||||
3986859|NCT01253135|3808662|B1|Male entire study population||Sex/Gender, Customized||participants|Number|20|20.0||||||
3986860|NCT01253135|3808662|B1|Age for only amended protocol participants||Age, Customized||years|Mean|32.8|32.8|Standard Deviation|11.3|11.3|||
3986861|NCT01253135|3808662|B1|Age for all 40 participants||Age, Customized||years|Mean|30.7|30.7|Standard Deviation|10.2|10.2|||
3986862|NCT01253070|3808670|B1|TKD||FLT3 Mutation|FLT3 (FMS-like tyrosine kinase-3) mutation testing at baseline was performed centrally for all patients. Participants were eligible for the study if they had an ITD (internal tandem duplication) or TKD (tyrosine kinase domain) mutation.|participants|Number|15|15.0||||||
3986863|NCT01253070|3808670|B1|ITD||FLT3 Mutation|FLT3 (FMS-like tyrosine kinase-3) mutation testing at baseline was performed centrally for all patients. Participants were eligible for the study if they had an ITD (internal tandem duplication) or TKD (tyrosine kinase domain) mutation.|participants|Number|39|39.0||||||
3986864|NCT01253070|3808670|B1|United States||Region of Enrollment||participants|Number|54|54.0||||||
3986865|NCT01253070|3808670|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3986866|NCT01253070|3808670|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986867|NCT01253070|3808670|B1||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3986868|NCT01253070|3808670|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3986869|NCT01253070|3808670|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986870|NCT01253070|3808670|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986871|NCT01253070|3808670|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986872|NCT01253070|3808670|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3986873|NCT01253070|3808670|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3986874|NCT01253070|3808670|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3986875|NCT01253070|3808670|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3986876|NCT01253070|3808670|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3986877|NCT01253070|3808670|B1|||Age||years|Median|67.4|67.4|Full Range|||60.3|82.7|
3986878|NCT01253044|3808679|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3986879|NCT01253044|3808680|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3986880|NCT01253044|3808681|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3986881|NCT01253044|3808679|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3986882|NCT01253044|3808680|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3986883|NCT01253044|3808681|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3986884|NCT01253044|3808679|B3||White|Race (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
3986885|NCT01253044|3808680|B2||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3986886|NCT01253044|3808681|B1||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
3986887|NCT01253044|3808679|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3986888|NCT01253044|3808680|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3986889|NCT01253044|3808681|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3986890|NCT01253044|3808679|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986891|NCT01253044|3808680|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986892|NCT01253044|3808681|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986893|NCT01253044|3808679|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3986894|NCT01253044|3808680|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3986895|NCT01253044|3808681|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3986896|NCT01253044|3808679|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986897|NCT01253044|3808680|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986898|NCT01253044|3808681|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986899|NCT01253044|3808679|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3986953|NCT01252966|3808705|B3|United States||Region of Enrollment||participants|Number|213|213.0||||||
3986900|NCT01253044|3808680|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3986901|NCT01253044|3808681|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3986902|NCT01253044|3808679|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|135|135.0||||||
3986903|NCT01253044|3808680|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
3986904|NCT01253044|3808681|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3986905|NCT01253044|3808679|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3986906|NCT01253044|3808680|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3986907|NCT01253044|3808681|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3986908|NCT01253044|3808679|B3||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
3986909|NCT01253044|3808680|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3986910|NCT01253044|3808681|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3986911|NCT01253044|3808679|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3986912|NCT01253044|3808680|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3986913|NCT01253044|3808681|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3986914|NCT01253044|3808679|B3|||Age||years|Mean|34.2|34.2|Standard Deviation|8|8.0|||
3986915|NCT01253044|3808680|B2|||Age||years|Mean|34.0|34.0|Standard Deviation|8.1|8.1|||
3986916|NCT01253044|3808681|B1|||Age||years|Mean|34.5|34.5|Standard Deviation|7.9|7.9|||
3986917|NCT01253018|3808690|B3|Hemorrhagic||Type of Stroke||participants|Number|8|8.0||||||
3986918|NCT01253018|3808691|B2|Hemorrhagic||Type of Stroke||participants|Number|4|4.0||||||
3986919|NCT01253018|3808692|B1|Hemorrhagic||Type of Stroke||participants|Number|4|4.0||||||
3986920|NCT01253018|3808690|B3|Ishemic||Type of Stroke||participants|Number|37|37.0||||||
3986921|NCT01253018|3808691|B2|Ishemic||Type of Stroke||participants|Number|19|19.0||||||
3986922|NCT01253018|3808692|B1|Ishemic||Type of Stroke||participants|Number|18|18.0||||||
3986923|NCT01253018|3808690|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
3986924|NCT01253018|3808691|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
3986925|NCT01253018|3808692|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3986926|NCT01253018|3808690|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3986927|NCT01253018|3808691|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3986928|NCT01253018|3808692|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3986929|NCT01253018|3808690|B3|Asian Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3986930|NCT01253018|3808691|B2|Asian Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3986931|NCT01253018|3808692|B1|Asian Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3986932|NCT01253018|3808690|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3986933|NCT01253018|3808691|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3986934|NCT01253018|3808692|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3986935|NCT01253018|3808690|B3|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3986936|NCT01253018|3808691|B2|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3986937|NCT01253018|3808692|B1|White||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3986938|NCT01253018|3808690|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3986939|NCT01253018|3808691|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3986940|NCT01253018|3808692|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3986941|NCT01253018|3808690|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3986942|NCT01253018|3808691|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3986943|NCT01253018|3808692|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3986944|NCT01253018|3808690|B3|||Age||years|Mean|56.1|56.1|Standard Deviation|11.4|11.4|||
3986945|NCT01253018|3808691|B2|||Age||years|Mean|56.4|56.4|Standard Deviation|12.7|12.7|||
3986946|NCT01253018|3808692|B1|||Age||years|Mean|55.7|55.7|Standard Deviation|10.2|10.2|||
3986947|NCT01252966|3808705|B3|||Fagerström Test for Nicotine Dependence Score|The Fagerström Test for Nicotine Dependence (FTND) will be administered; this is a 6-item measure of nicotine dependence which has good internal consistency and high test-retest reliability (r=.88). Scores may range from 0 to 9, with higher scores indicating greater nicotine dependence.|units on a scale|Mean|4.74|4.74|Standard Deviation|1.94|1.94|||
3986948|NCT01252966|3808706|B2|||Fagerström Test for Nicotine Dependence Score|The Fagerström Test for Nicotine Dependence (FTND) will be administered; this is a 6-item measure of nicotine dependence which has good internal consistency and high test-retest reliability (r=.88). Scores may range from 0 to 9, with higher scores indicating greater nicotine dependence.|units on a scale|Mean|4.65|4.65|Standard Deviation|1.74|1.74|||
3986949|NCT01252966|3808707|B1|||Fagerström Test for Nicotine Dependence Score|The Fagerström Test for Nicotine Dependence (FTND) will be administered; this is a 6-item measure of nicotine dependence which has good internal consistency and high test-retest reliability (r=.88). Scores may range from 0 to 9, with higher scores indicating greater nicotine dependence.|units on a scale|Mean|4.82|4.82|Standard Deviation|2.11|2.11|||
3986950|NCT01252966|3808705|B3|||Cigarettes Per Day||cigarettes smoked per day|Mean|16.08|16.08|Standard Deviation|5.70|5.7|||
3986951|NCT01252966|3808706|B2|||Cigarettes Per Day||cigarettes smoked per day|Mean|15.73|15.73|Standard Deviation|5.23|5.23|||
3986952|NCT01252966|3808707|B1|||Cigarettes Per Day||cigarettes smoked per day|Mean|16.42|16.42|Standard Deviation|6.14|6.14|||
3986954|NCT01252966|3808706|B2|United States||Region of Enrollment||participants|Number|105|105.0||||||
3986955|NCT01252966|3808707|B1|United States||Region of Enrollment||participants|Number|108|108.0||||||
3986956|NCT01252966|3808705|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3986957|NCT01252966|3808706|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3986958|NCT01252966|3808707|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3986959|NCT01252966|3808705|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3986960|NCT01252966|3808706|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3986961|NCT01252966|3808707|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3986962|NCT01252966|3808705|B3||White|Race (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
3986963|NCT01252966|3808706|B2||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3986964|NCT01252966|3808707|B1||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3986965|NCT01252966|3808705|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3986966|NCT01252966|3808706|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3986967|NCT01252966|3808707|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3986968|NCT01252966|3808705|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986969|NCT01252966|3808706|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986970|NCT01252966|3808707|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986971|NCT01252966|3808705|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3986972|NCT01252966|3808706|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3986973|NCT01252966|3808707|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3986974|NCT01252966|3808705|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3986975|NCT01252966|3808706|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986976|NCT01252966|3808707|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3986977|NCT01252966|3808705|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986978|NCT01252966|3808706|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986979|NCT01252966|3808707|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3986980|NCT01252966|3808705|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|207|207.0||||||
3986981|NCT01252966|3808706|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3986982|NCT01252966|3808707|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
3986983|NCT01252966|3808705|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3986984|NCT01252966|3808706|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3986985|NCT01252966|3808707|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3986986|NCT01252966|3808705|B3||Male|Gender||Participants|Count of Participants|106|106.0||||||
3986987|NCT01252966|3808706|B2||Male|Gender||Participants|Count of Participants|51|51.0||||||
3986988|NCT01252966|3808707|B1||Male|Gender||Participants|Count of Participants|55|55.0||||||
3986989|NCT01252966|3808705|B3||Female|Gender||Participants|Count of Participants|107|107.0||||||
3986990|NCT01252966|3808706|B2||Female|Gender||Participants|Count of Participants|54|54.0||||||
3986991|NCT01252966|3808707|B1||Female|Gender||Participants|Count of Participants|53|53.0||||||
3986992|NCT01252966|3808705|B3|||Age||years|Mean|43.28|43.28|Standard Deviation|12.48|12.48|||
3986993|NCT01252966|3808706|B2|||Age||years|Mean|43.39|43.39|Standard Deviation|12.38|12.38|||
3986994|NCT01252966|3808707|B1|||Age||years|Mean|43.18|43.18|Standard Deviation|12.62|12.62|||
3986995|NCT01252953|3808722|B3|||Glomerular Filtration Rate, Continuous||ml/min/1.73m^2|Mean|83|83.0|Standard Deviation|17|17.0|||
3986996|NCT01252953|3808723|B2|||Glomerular Filtration Rate, Continuous||ml/min/1.73m^2|Mean|83|83.0|Standard Deviation|17|17.0|||
3986997|NCT01252953|3808724|B1|||Glomerular Filtration Rate, Continuous||ml/min/1.73m^2|Mean|83|83.0|Standard Deviation|17|17.0|||
3986998|NCT01252953|3808722|B3||≥ 60 ml/min/1.73m^2|Glomerular Filtration Rate, Categorical|"The estimated glomerular filtration rate was calculated with the use of the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation as per Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate.~Ann Intern Med 2009; 150(9): 604-12."|Participants|Count of Participants|27096|27096.0||||||
3986999|NCT01252953|3808723|B2||≥ 60 ml/min/1.73m^2|Glomerular Filtration Rate, Categorical|"The estimated glomerular filtration rate was calculated with the use of the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation as per Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate.~Ann Intern Med 2009; 150(9): 604-12."|Participants|Count of Participants|13526|13526.0||||||
3987000|NCT01252953|3808724|B1||≥ 60 ml/min/1.73m^2|Glomerular Filtration Rate, Categorical|"The estimated glomerular filtration rate was calculated with the use of the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation as per Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate.~Ann Intern Med 2009; 150(9): 604-12."|Participants|Count of Participants|13570|13570.0||||||
3987001|NCT01252953|3808722|B3||< 60 ml/min/1.73m^2|Glomerular Filtration Rate, Categorical|"The estimated glomerular filtration rate was calculated with the use of the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation as per Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate.~Ann Intern Med 2009; 150(9): 604-12."|Participants|Count of Participants|3353|3353.0||||||
3987002|NCT01252953|3808723|B2||< 60 ml/min/1.73m^2|Glomerular Filtration Rate, Categorical|"The estimated glomerular filtration rate was calculated with the use of the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation as per Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate.~Ann Intern Med 2009; 150(9): 604-12."|Participants|Count of Participants|1698|1698.0||||||
3987003|NCT01252953|3808724|B1||< 60 ml/min/1.73m^2|Glomerular Filtration Rate, Categorical|"The estimated glomerular filtration rate was calculated with the use of the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation as per Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate.~Ann Intern Med 2009; 150(9): 604-12."|Participants|Count of Participants|1655|1655.0||||||
3987004|NCT01252953|3808722|B3|||HDL Cholesterol, Continuous||mg/dl|Mean|40|40.0|Standard Deviation|10|10.0|||
3987005|NCT01252953|3808723|B2|||HDL Cholesterol, Continuous||mg/dl|Mean|40|40.0|Standard Deviation|10|10.0|||
3987006|NCT01252953|3808724|B1|||HDL Cholesterol, Continuous||mg/dl|Mean|40|40.0|Standard Deviation|10|10.0|||
3987007|NCT01252953|3808722|B3||≥ 43 mg/dl|HDL Cholesterol, Categorical||Participants|Count of Participants|10569|10569.0||||||
3987008|NCT01252953|3808723|B2||≥ 43 mg/dl|HDL Cholesterol, Categorical||Participants|Count of Participants|5365|5365.0||||||
3987009|NCT01252953|3808724|B1||≥ 43 mg/dl|HDL Cholesterol, Categorical||Participants|Count of Participants|5204|5204.0||||||
3987010|NCT01252953|3808722|B3||≥ 35 to < 43 mg/dl|HDL Cholesterol, Categorical||Participants|Count of Participants|10707|10707.0||||||
3987011|NCT01252953|3808723|B2||≥ 35 to < 43 mg/dl|HDL Cholesterol, Categorical||Participants|Count of Participants|5269|5269.0||||||
3987012|NCT01252953|3808724|B1||≥ 35 to < 43 mg/dl|HDL Cholesterol, Categorical||Participants|Count of Participants|5438|5438.0||||||
3987013|NCT01252953|3808722|B3||< 35 mg/dl|HDL Cholesterol, Categorical||Participants|Count of Participants|9173|9173.0||||||
3987014|NCT01252953|3808723|B2||< 35 mg/dl|HDL Cholesterol, Categorical||Participants|Count of Participants|4590|4590.0||||||
3987015|NCT01252953|3808724|B1||< 35 mg/dl|HDL Cholesterol, Categorical||Participants|Count of Participants|4583|4583.0||||||
3987016|NCT01252953|3808722|B3|||Non-HDL Cholesterol, Continuous||mg/dl|Mean|92|92.0|Standard Deviation|19|19.0|||
3987017|NCT01252953|3808723|B2|||Non-HDL Cholesterol, Continuous||mg/dl|Mean|92|92.0|Standard Deviation|19|19.0|||
3987018|NCT01252953|3808724|B1|||Non-HDL Cholesterol, Continuous||mg/dl|Mean|92|92.0|Standard Deviation|19|19.0|||
3987019|NCT01252953|3808722|B3||≥ 101 mg/dl|Non-HDL Cholesterol, Categorical||Participants|Count of Participants|9357|9357.0||||||
3987020|NCT01252953|3808723|B2||≥ 101 mg/dl|Non-HDL Cholesterol, Categorical||Participants|Count of Participants|4670|4670.0||||||
3987021|NCT01252953|3808724|B1||≥ 101 mg/dl|Non-HDL Cholesterol, Categorical||Participants|Count of Participants|4687|4687.0||||||
3987022|NCT01252953|3808722|B3||≥ 85 to <101 mg/dl|Non-HDL Cholesterol, Categorical||Participants|Count of Participants|9749|9749.0||||||
3987023|NCT01252953|3808723|B2||≥ 85 to <101 mg/dl|Non-HDL Cholesterol, Categorical||Participants|Count of Participants|4853|4853.0||||||
3987024|NCT01252953|3808724|B1||≥ 85 to <101 mg/dl|Non-HDL Cholesterol, Categorical||Participants|Count of Participants|4896|4896.0||||||
3987025|NCT01252953|3808722|B3||< 85 mg/dl|Non-HDL Cholesterol, Categorical||Participants|Count of Participants|11343|11343.0||||||
3987026|NCT01252953|3808723|B2||< 85 mg/dl|Non-HDL Cholesterol, Categorical||Participants|Count of Participants|5701|5701.0||||||
3987027|NCT01252953|3808724|B1||< 85 mg/dl|Non-HDL Cholesterol, Categorical||Participants|Count of Participants|5642|5642.0||||||
3987028|NCT01252953|3808722|B3|||LDL Cholesterol, Continuous||mg/dl|Mean|61|61.0|Standard Deviation|15|15.0|||
3987029|NCT01252953|3808723|B2|||LDL Cholesterol, Continuous||mg/dl|Mean|61|61.0|Standard Deviation|15|15.0|||
3987030|NCT01252953|3808724|B1|||LDL Cholesterol, Continuous||mg/dl|Mean|61|61.0|Standard Deviation|15|15.0|||
3987031|NCT01252953|3808722|B3||≥ 66 mg/dl|LDL Cholesterol, Categorical||Participants|Count of Participants|11001|11001.0||||||
3987032|NCT01252953|3808723|B2||≥ 66 mg/dl|LDL Cholesterol, Categorical||Participants|Count of Participants|5442|5442.0||||||
3987033|NCT01252953|3808724|B1||≥ 66 mg/dl|LDL Cholesterol, Categorical||Participants|Count of Participants|5559|5559.0||||||
3987034|NCT01252953|3808722|B3||≥ 54 to < 66 mg/dl|LDL Cholesterol, Categorical||Participants|Count of Participants|9348|9348.0||||||
3987035|NCT01252953|3808723|B2||≥ 54 to < 66 mg/dl|LDL Cholesterol, Categorical||Participants|Count of Participants|4705|4705.0||||||
3987036|NCT01252953|3808724|B1||≥ 54 to < 66 mg/dl|LDL Cholesterol, Categorical||Participants|Count of Participants|4643|4643.0||||||
3987037|NCT01252953|3808722|B3||< 54 mg/dl|LDL Cholesterol, Categorical||Participants|Count of Participants|10100|10100.0||||||
3987038|NCT01252953|3808723|B2||< 54 mg/dl|LDL Cholesterol, Categorical||Participants|Count of Participants|5077|5077.0||||||
3987039|NCT01252953|3808724|B1||< 54 mg/dl|LDL Cholesterol, Categorical||Participants|Count of Participants|5023|5023.0||||||
3987040|NCT01252953|3808722|B3|||Body Mass Index, Continuous||kg/m^2|Mean|28.6|28.6|Standard Deviation|5.1|5.1|||
3987041|NCT01252953|3808723|B2|||Body Mass Index, Continuous||kg/m^2|Mean|28.6|28.6|Standard Deviation|5.1|5.1|||
3987042|NCT01252953|3808724|B1|||Body Mass Index, Continuous||kg/m^2|Mean|28.6|28.6|Standard Deviation|5.0|5.0|||
3987043|NCT01252953|3808722|B3||≥ 30 kg/m^2|Body Mass Index, Categorical|The body mass index is the weight in kilograms divided by the square of the height in meters.|Participants|Count of Participants|9697|9697.0||||||
3987044|NCT01252953|3808723|B2||≥ 30 kg/m^2|Body Mass Index, Categorical|The body mass index is the weight in kilograms divided by the square of the height in meters.|Participants|Count of Participants|4868|4868.0||||||
3987045|NCT01252953|3808724|B1||≥ 30 kg/m^2|Body Mass Index, Categorical|The body mass index is the weight in kilograms divided by the square of the height in meters.|Participants|Count of Participants|4829|4829.0||||||
3987046|NCT01252953|3808722|B3||≥25 to < 30 kg/m^2|Body Mass Index, Categorical|The body mass index is the weight in kilograms divided by the square of the height in meters.|Participants|Count of Participants|13944|13944.0||||||
3987047|NCT01252953|3808723|B2||≥25 to < 30 kg/m^2|Body Mass Index, Categorical|The body mass index is the weight in kilograms divided by the square of the height in meters.|Participants|Count of Participants|6995|6995.0||||||
3987048|NCT01252953|3808724|B1||≥25 to < 30 kg/m^2|Body Mass Index, Categorical|The body mass index is the weight in kilograms divided by the square of the height in meters.|Participants|Count of Participants|6949|6949.0||||||
3987049|NCT01252953|3808722|B3||<25 kg/m^2|Body Mass Index, Categorical|The body mass index is the weight in kilograms divided by the square of the height in meters.|Participants|Count of Participants|6808|6808.0||||||
3987050|NCT01252953|3808723|B2||<25 kg/m^2|Body Mass Index, Categorical|The body mass index is the weight in kilograms divided by the square of the height in meters.|Participants|Count of Participants|3361|3361.0||||||
3987051|NCT01252953|3808724|B1||<25 kg/m^2|Body Mass Index, Categorical|The body mass index is the weight in kilograms divided by the square of the height in meters.|Participants|Count of Participants|3447|3447.0||||||
3987052|NCT01252953|3808722|B3|||Diastolic Blood Pressure, Continuous||mmHg|Mean|78.1|78.1|Standard Deviation|11.0|11.0|||
3987053|NCT01252953|3808723|B2|||Diastolic Blood Pressure, Continuous||mmHg|Mean|78.0|78.0|Standard Deviation|11.0|11.0|||
3987054|NCT01252953|3808724|B1|||Diastolic Blood Pressure, Continuous||mmHg|Mean|78.1|78.1|Standard Deviation|10.9|10.9|||
3987055|NCT01252953|3808722|B3||≥ 85 mmHg|Diastolic Blood Pressure, Categorical||Participants|Count of Participants|8318|8318.0||||||
3987056|NCT01252953|3808723|B2||≥ 85 mmHg|Diastolic Blood Pressure, Categorical||Participants|Count of Participants|4157|4157.0||||||
3987057|NCT01252953|3808724|B1||≥ 85 mmHg|Diastolic Blood Pressure, Categorical||Participants|Count of Participants|4161|4161.0||||||
3987058|NCT01252953|3808722|B3||≥ 75 to < 85 mmHg|Diastolic Blood Pressure, Categorical||Participants|Count of Participants|10685|10685.0||||||
3987059|NCT01252953|3808723|B2||≥ 75 to < 85 mmHg|Diastolic Blood Pressure, Categorical||Participants|Count of Participants|5277|5277.0||||||
3987060|NCT01252953|3808724|B1||≥ 75 to < 85 mmHg|Diastolic Blood Pressure, Categorical||Participants|Count of Participants|5408|5408.0||||||
3987061|NCT01252953|3808722|B3||< 75 mmHg|Diastolic Blood Pressure, Categorical||Participants|Count of Participants|11446|11446.0||||||
3987062|NCT01252953|3808723|B2||< 75 mmHg|Diastolic Blood Pressure, Categorical||Participants|Count of Participants|5790|5790.0||||||
3987063|NCT01252953|3808724|B1||< 75 mmHg|Diastolic Blood Pressure, Categorical||Participants|Count of Participants|5656|5656.0||||||
3987064|NCT01252953|3808722|B3|||Systolic Blood Pressure, Continuous||mmHg|Mean|131.2|131.2|Standard Deviation|18.5|18.5|||
3987065|NCT01252953|3808723|B2|||Systolic Blood Pressure, Continuous||mmHg|Mean|131.1|131.1|Standard Deviation|18.5|18.5|||
3987066|NCT01252953|3808724|B1|||Systolic Blood Pressure, Continuous||mmHg|Mean|131.3|131.3|Standard Deviation|18.5|18.5|||
3987067|NCT01252953|3808722|B3||≥140 mmHg|Systolic Blood Pressure, Categorical||Participants|Count of Participants|9452|9452.0||||||
3987068|NCT01252953|3808723|B2||≥140 mmHg|Systolic Blood Pressure, Categorical||Participants|Count of Participants|4724|4724.0||||||
3987069|NCT01252953|3808724|B1||≥140 mmHg|Systolic Blood Pressure, Categorical||Participants|Count of Participants|4728|4728.0||||||
3987070|NCT01252953|3808722|B3||≥125 to <140 mmHg|Systolic Blood Pressure, Categorical||Participants|Count of Participants|9559|9559.0||||||
3987071|NCT01252953|3808723|B2||≥125 to <140 mmHg|Systolic Blood Pressure, Categorical||Participants|Count of Participants|4740|4740.0||||||
3987072|NCT01252953|3808724|B1||≥125 to <140 mmHg|Systolic Blood Pressure, Categorical||Participants|Count of Participants|4819|4819.0||||||
3987073|NCT01252953|3808722|B3||<125 mmHg|Systolic Blood Pressure, Categorical||Participants|Count of Participants|11438|11438.0||||||
3987074|NCT01252953|3808723|B2||<125 mmHg|Systolic Blood Pressure, Categorical||Participants|Count of Participants|5760|5760.0||||||
3987075|NCT01252953|3808724|B1||<125 mmHg|Systolic Blood Pressure, Categorical||Participants|Count of Participants|5678|5678.0||||||
3987076|NCT01252953|3808722|B3||China|Region||Participants|Count of Participants|8629|8629.0||||||
3987077|NCT01252953|3808723|B2||China|Region||Participants|Count of Participants|4315|4315.0||||||
3987078|NCT01252953|3808724|B1||China|Region||Participants|Count of Participants|4314|4314.0||||||
3987079|NCT01252953|3808722|B3||North America|Region||Participants|Count of Participants|6082|6082.0||||||
3987080|NCT01252953|3808723|B2||North America|Region||Participants|Count of Participants|3034|3034.0||||||
3987081|NCT01252953|3808724|B1||North America|Region||Participants|Count of Participants|3048|3048.0||||||
3987082|NCT01252953|3808722|B3||Europe|Region||Participants|Count of Participants|15738|15738.0||||||
3987083|NCT01252953|3808723|B2||Europe|Region||Participants|Count of Participants|7875|7875.0||||||
3987084|NCT01252953|3808724|B1||Europe|Region||Participants|Count of Participants|7863|7863.0||||||
3987085|NCT01252953|3808722|B3|Heart failure||Previous disease|The participants could have more than one of these conditions.|Participants|Count of Participants|1771|1771.0||||||
3987086|NCT01252953|3808723|B2|Heart failure||Previous disease|The participants could have more than one of these conditions.|Participants|Count of Participants|869|869.0||||||
3987087|NCT01252953|3808724|B1|Heart failure||Previous disease|The participants could have more than one of these conditions.|Participants|Count of Participants|902|902.0||||||
3987088|NCT01252953|3808722|B3|Diabetes||Previous disease|The participants could have more than one of these conditions.|Participants|Count of Participants|11320|11320.0||||||
3987089|NCT01252953|3808723|B2|Diabetes||Previous disease|The participants could have more than one of these conditions.|Participants|Count of Participants|5666|5666.0||||||
3987090|NCT01252953|3808724|B1|Diabetes||Previous disease|The participants could have more than one of these conditions.|Participants|Count of Participants|5654|5654.0||||||
3987091|NCT01252953|3808722|B3|Peripheral-artery disease||Previous disease|The participants could have more than one of these conditions.|Participants|Count of Participants|2435|2435.0||||||
3987092|NCT01252953|3808723|B2|Peripheral-artery disease||Previous disease|The participants could have more than one of these conditions.|Participants|Count of Participants|1206|1206.0||||||
3987093|NCT01252953|3808724|B1|Peripheral-artery disease||Previous disease|The participants could have more than one of these conditions.|Participants|Count of Participants|1229|1229.0||||||
3987094|NCT01252953|3808722|B3|Cerebrovascular disease||Previous disease|The participants could have more than one of these conditions.|Participants|Count of Participants|6781|6781.0||||||
3987095|NCT01252953|3808723|B2|Cerebrovascular disease||Previous disease|The participants could have more than one of these conditions.|Participants|Count of Participants|3396|3396.0||||||
3987096|NCT01252953|3808724|B1|Cerebrovascular disease||Previous disease|The participants could have more than one of these conditions.|Participants|Count of Participants|3385|3385.0||||||
3987097|NCT01252953|3808722|B3|Coronary heart disease||Previous disease|The participants could have more than one of these conditions.|Participants|Count of Participants|26679|26679.0||||||
3987098|NCT01252953|3808723|B2|Coronary heart disease||Previous disease|The participants could have more than one of these conditions.|Participants|Count of Participants|13354|13354.0||||||
3987099|NCT01252953|3808724|B1|Coronary heart disease||Previous disease|The participants could have more than one of these conditions.|Participants|Count of Participants|13325|13325.0||||||
3987100|NCT01252953|3808722|B3|China||Region of Enrollment||participants|Number|8629|8629.0||||||
3987101|NCT01252953|3808723|B2|China||Region of Enrollment||participants|Number|4315|4315.0||||||
3987102|NCT01252953|3808724|B1|China||Region of Enrollment||participants|Number|4314|4314.0||||||
3987103|NCT01252953|3808722|B3|Canada||Region of Enrollment||participants|Number|752|752.0||||||
3987104|NCT01252953|3808723|B2|Canada||Region of Enrollment||participants|Number|391|391.0||||||
3987105|NCT01252953|3808724|B1|Canada||Region of Enrollment||participants|Number|361|361.0||||||
3987106|NCT01252953|3808722|B3|United States||Region of Enrollment||participants|Number|5330|5330.0||||||
3987107|NCT01252953|3808723|B2|United States||Region of Enrollment||participants|Number|2643|2643.0||||||
3987108|NCT01252953|3808724|B1|United States||Region of Enrollment||participants|Number|2687|2687.0||||||
3987109|NCT01252953|3808722|B3|Italy||Region of Enrollment||participants|Number|1660|1660.0||||||
3987110|NCT01252953|3808723|B2|Italy||Region of Enrollment||participants|Number|834|834.0||||||
3987111|NCT01252953|3808724|B1|Italy||Region of Enrollment||participants|Number|826|826.0||||||
3987112|NCT01252953|3808722|B3|Germany||Region of Enrollment||participants|Number|1529|1529.0||||||
3987113|NCT01252953|3808723|B2|Germany||Region of Enrollment||participants|Number|774|774.0||||||
3987114|NCT01252953|3808724|B1|Germany||Region of Enrollment||participants|Number|755|755.0||||||
3987115|NCT01252953|3808722|B3|Finland||Region of Enrollment||participants|Number|613|613.0||||||
3987116|NCT01252953|3808723|B2|Finland||Region of Enrollment||participants|Number|306|306.0||||||
3987117|NCT01252953|3808724|B1|Finland||Region of Enrollment||participants|Number|307|307.0||||||
3987118|NCT01252953|3808722|B3|Denmark||Region of Enrollment||participants|Number|1850|1850.0||||||
3987119|NCT01252953|3808723|B2|Denmark||Region of Enrollment||participants|Number|932|932.0||||||
3987120|NCT01252953|3808724|B1|Denmark||Region of Enrollment||participants|Number|918|918.0||||||
3987121|NCT01252953|3808722|B3|Sweden||Region of Enrollment||participants|Number|861|861.0||||||
3987122|NCT01252953|3808723|B2|Sweden||Region of Enrollment||participants|Number|434|434.0||||||
3987123|NCT01252953|3808724|B1|Sweden||Region of Enrollment||participants|Number|427|427.0||||||
3987124|NCT01252953|3808722|B3|Norway||Region of Enrollment||participants|Number|844|844.0||||||
3987125|NCT01252953|3808723|B2|Norway||Region of Enrollment||participants|Number|418|418.0||||||
3987126|NCT01252953|3808724|B1|Norway||Region of Enrollment||participants|Number|426|426.0||||||
3987127|NCT01252953|3808722|B3|United Kingdom||Region of Enrollment||participants|Number|8381|8381.0||||||
3987128|NCT01252953|3808723|B2|United Kingdom||Region of Enrollment||participants|Number|4177|4177.0||||||
3987129|NCT01252953|3808724|B1|United Kingdom||Region of Enrollment||participants|Number|4204|4204.0||||||
3987130|NCT01252953|3808722|B3|Race|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3987131|NCT01252953|3808723|B2|Race|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3987132|NCT01252953|3808724|B1|Race|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3987133|NCT01252953|3808722|B3|Race|Mixed|Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
3987134|NCT01252953|3808723|B2|Race|Mixed|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3987135|NCT01252953|3808724|B1|Race|Mixed|Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3987136|NCT01252953|3808722|B3|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|96|96.0||||||
3987137|NCT01252953|3808723|B2|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|49|49.0||||||
3987138|NCT01252953|3808724|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
3987139|NCT01252953|3808722|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|21119|21119.0||||||
3987140|NCT01252953|3808723|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|10558|10558.0||||||
3987141|NCT01252953|3808724|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|10561|10561.0||||||
3987142|NCT01252953|3808722|B3|Race|South East Asian|Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
3987143|NCT01252953|3808723|B2|Race|South East Asian|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3987144|NCT01252953|3808724|B1|Race|South East Asian|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3987145|NCT01252953|3808722|B3|Race|South Asian|Race/Ethnicity, Customized||Participants|Count of Participants|192|192.0||||||
3987146|NCT01252953|3808723|B2|Race|South Asian|Race/Ethnicity, Customized||Participants|Count of Participants|97|97.0||||||
3987147|NCT01252953|3808724|B1|Race|South Asian|Race/Ethnicity, Customized||Participants|Count of Participants|95|95.0||||||
3987148|NCT01252953|3808722|B3|Race|Other North East Asian|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3987149|NCT01252953|3808723|B2|Race|Other North East Asian|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3987150|NCT01252953|3808724|B1|Race|Other North East Asian|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3987151|NCT01252953|3808722|B3|Race|Chinese|Race/Ethnicity, Customized||Participants|Count of Participants|8646|8646.0||||||
3987152|NCT01252953|3808723|B2|Race|Chinese|Race/Ethnicity, Customized||Participants|Count of Participants|4323|4323.0||||||
3987153|NCT01252953|3808724|B1|Race|Chinese|Race/Ethnicity, Customized||Participants|Count of Participants|4323|4323.0||||||
3987154|NCT01252953|3808722|B3|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|328|328.0||||||
3987155|NCT01252953|3808723|B2|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|168|168.0||||||
3987156|NCT01252953|3808724|B1|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|160|160.0||||||
3987157|NCT01252953|3808722|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|25132|25132.0||||||
3987158|NCT01252953|3808723|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|12588|12588.0||||||
3987159|NCT01252953|3808724|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|12544|12544.0||||||
3987160|NCT01252953|3808722|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5082|5082.0||||||
3987161|NCT01252953|3808723|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2522|2522.0||||||
3987162|NCT01252953|3808724|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2560|2560.0||||||
3987163|NCT01252953|3808722|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|235|235.0||||||
3987164|NCT01252953|3808723|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|114|114.0||||||
3987165|NCT01252953|3808724|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|121|121.0||||||
3987166|NCT01252953|3808722|B3||Male|Sex: Female, Male||Participants|Count of Participants|25534|25534.0||||||
3987167|NCT01252953|3808723|B2||Male|Sex: Female, Male||Participants|Count of Participants|12765|12765.0||||||
3987168|NCT01252953|3808724|B1||Male|Sex: Female, Male||Participants|Count of Participants|12769|12769.0||||||
3987169|NCT01252953|3808722|B3||Female|Sex: Female, Male||Participants|Count of Participants|4915|4915.0||||||
3987170|NCT01252953|3808723|B2||Female|Sex: Female, Male||Participants|Count of Participants|2459|2459.0||||||
3987171|NCT01252953|3808724|B1||Female|Sex: Female, Male||Participants|Count of Participants|2456|2456.0||||||
3987172|NCT01252953|3808722|B3|||Age||years|Mean|67|67.0|Standard Deviation|8|8.0|||
3987173|NCT01252953|3808723|B2|||Age||years|Mean|67|67.0|Standard Deviation|8|8.0|||
3987174|NCT01252953|3808724|B1|||Age||years|Mean|67|67.0|Standard Deviation|8|8.0|||
3987175|NCT01252953|3808722|B3||>=65 years|Age||Participants|Count of Participants|17172|17172.0||||||
3987176|NCT01252953|3808723|B2||>=65 years|Age||Participants|Count of Participants|8581|8581.0||||||
3987177|NCT01252953|3808724|B1||>=65 years|Age||Participants|Count of Participants|8591|8591.0||||||
3987178|NCT01252953|3808722|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13277|13277.0||||||
3987179|NCT01252953|3808723|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6643|6643.0||||||
3987180|NCT01252953|3808724|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6634|6634.0||||||
3987181|NCT01252953|3808722|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3987182|NCT01252953|3808723|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3987183|NCT01252953|3808724|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3987184|NCT01252940|3808737|B3|Non-TDF-containing regimen + Other PI+RTV||Stratification based on antiretroviral (ARV) use||participants|Number|62|62.0||||||
3987185|NCT01252940|3808738|B2|Non-TDF-containing regimen + Other PI+RTV||Stratification based on antiretroviral (ARV) use||participants|Number|20|20.0||||||
3987186|NCT01252940|3808739|B1|Non-TDF-containing regimen + Other PI+RTV||Stratification based on antiretroviral (ARV) use||participants|Number|42|42.0||||||
3987187|NCT01252940|3808737|B3|Non-TDF-containing regimen + LPV/RTV||Stratification based on antiretroviral (ARV) use||participants|Number|24|24.0||||||
3987188|NCT01252940|3808738|B2|Non-TDF-containing regimen + LPV/RTV||Stratification based on antiretroviral (ARV) use||participants|Number|9|9.0||||||
3987189|NCT01252940|3808739|B1|Non-TDF-containing regimen + LPV/RTV||Stratification based on antiretroviral (ARV) use||participants|Number|15|15.0||||||
3987190|NCT01252940|3808737|B3|TDF or FTC/TDF + Other PI+RTV||Stratification based on antiretroviral (ARV) use||participants|Number|259|259.0||||||
3987191|NCT01252940|3808738|B2|TDF or FTC/TDF + Other PI+RTV||Stratification based on antiretroviral (ARV) use||participants|Number|81|81.0||||||
3987192|NCT01252940|3808739|B1|TDF or FTC/TDF + Other PI+RTV||Stratification based on antiretroviral (ARV) use||participants|Number|178|178.0||||||
3987193|NCT01252940|3808737|B3|TDF or FTC/TDF + lopinavir (LPV)/ritonavir (RTV)||Stratification based on antiretroviral (ARV) use||participants|Number|131|131.0||||||
3987194|NCT01252940|3808738|B2|TDF or FTC/TDF + lopinavir (LPV)/ritonavir (RTV)||Stratification based on antiretroviral (ARV) use||participants|Number|49|49.0||||||
3987195|NCT01252940|3808739|B1|TDF or FTC/TDF + lopinavir (LPV)/ritonavir (RTV)||Stratification based on antiretroviral (ARV) use||participants|Number|82|82.0||||||
3987196|NCT01252940|3808737|B3|≥ 1000 Copies/mL||Baseline HIV-1 RNA Category||participants|Number|5|5.0||||||
3987197|NCT01252940|3808738|B2|≥ 1000 Copies/mL||Baseline HIV-1 RNA Category||participants|Number|1|1.0||||||
3987198|NCT01252940|3808739|B1|≥ 1000 Copies/mL||Baseline HIV-1 RNA Category||participants|Number|4|4.0||||||
3987199|NCT01252940|3808737|B3|400 to < 1000 Copies/mL||Baseline HIV-1 RNA Category||participants|Number|2|2.0||||||
3987200|NCT01252940|3808738|B2|400 to < 1000 Copies/mL||Baseline HIV-1 RNA Category||participants|Number|0|0.0||||||
3987201|NCT01252940|3808739|B1|400 to < 1000 Copies/mL||Baseline HIV-1 RNA Category||participants|Number|2|2.0||||||
3987202|NCT01252940|3808737|B3|200 to < 400 Copies/mL||Baseline HIV-1 RNA Category||participants|Number|2|2.0||||||
3987203|NCT01252940|3808738|B2|200 to < 400 Copies/mL||Baseline HIV-1 RNA Category||participants|Number|0|0.0||||||
3987253|NCT01252940|3808737|B3|White||Race/Ethnicity, Customized||participants|Number|365|365.0||||||
3987204|NCT01252940|3808739|B1|200 to < 400 Copies/mL||Baseline HIV-1 RNA Category||participants|Number|2|2.0||||||
3987205|NCT01252940|3808737|B3|50 to < 200 Copies/mL||Baseline HIV-1 RNA Category||participants|Number|16|16.0||||||
3987206|NCT01252940|3808738|B2|50 to < 200 Copies/mL||Baseline HIV-1 RNA Category||participants|Number|6|6.0||||||
3987207|NCT01252940|3808739|B1|50 to < 200 Copies/mL||Baseline HIV-1 RNA Category||participants|Number|10|10.0||||||
3987208|NCT01252940|3808737|B3|< 50 Copies/mL||Baseline HIV-1 RNA Category||participants|Number|451|451.0||||||
3987209|NCT01252940|3808738|B2|< 50 Copies/mL||Baseline HIV-1 RNA Category||participants|Number|152|152.0||||||
3987210|NCT01252940|3808739|B1|< 50 Copies/mL||Baseline HIV-1 RNA Category||participants|Number|299|299.0||||||
3987211|NCT01252940|3808737|B3|United States||Region of Enrollment|"Four participants in the Switch to FTC/RPV/TDF group and 2 participants in the Stay on Baseline Regimen (SBR) group were randomized but were not treated. These subjects are included in the analysis of the baseline characteristic Region of Enrollment but are not included in the analysis of other baseline characteristics."|participants|Number|230|230.0||||||
3987212|NCT01252940|3808738|B2|United States||Region of Enrollment|"Four participants in the Switch to FTC/RPV/TDF group and 2 participants in the Stay on Baseline Regimen (SBR) group were randomized but were not treated. These subjects are included in the analysis of the baseline characteristic Region of Enrollment but are not included in the analysis of other baseline characteristics."|participants|Number|81|81.0||||||
3987213|NCT01252940|3808739|B1|United States||Region of Enrollment|"Four participants in the Switch to FTC/RPV/TDF group and 2 participants in the Stay on Baseline Regimen (SBR) group were randomized but were not treated. These subjects are included in the analysis of the baseline characteristic Region of Enrollment but are not included in the analysis of other baseline characteristics."|participants|Number|149|149.0||||||
3987214|NCT01252940|3808737|B3|United Kingdom||Region of Enrollment|"Four participants in the Switch to FTC/RPV/TDF group and 2 participants in the Stay on Baseline Regimen (SBR) group were randomized but were not treated. These subjects are included in the analysis of the baseline characteristic Region of Enrollment but are not included in the analysis of other baseline characteristics."|participants|Number|23|23.0||||||
3987215|NCT01252940|3808738|B2|United Kingdom||Region of Enrollment|"Four participants in the Switch to FTC/RPV/TDF group and 2 participants in the Stay on Baseline Regimen (SBR) group were randomized but were not treated. These subjects are included in the analysis of the baseline characteristic Region of Enrollment but are not included in the analysis of other baseline characteristics."|participants|Number|6|6.0||||||
3987216|NCT01252940|3808739|B1|United Kingdom||Region of Enrollment|"Four participants in the Switch to FTC/RPV/TDF group and 2 participants in the Stay on Baseline Regimen (SBR) group were randomized but were not treated. These subjects are included in the analysis of the baseline characteristic Region of Enrollment but are not included in the analysis of other baseline characteristics."|participants|Number|17|17.0||||||
3987217|NCT01252940|3808737|B3|Spain||Region of Enrollment|"Four participants in the Switch to FTC/RPV/TDF group and 2 participants in the Stay on Baseline Regimen (SBR) group were randomized but were not treated. These subjects are included in the analysis of the baseline characteristic Region of Enrollment but are not included in the analysis of other baseline characteristics."|participants|Number|20|20.0||||||
3987218|NCT01252940|3808738|B2|Spain||Region of Enrollment|"Four participants in the Switch to FTC/RPV/TDF group and 2 participants in the Stay on Baseline Regimen (SBR) group were randomized but were not treated. These subjects are included in the analysis of the baseline characteristic Region of Enrollment but are not included in the analysis of other baseline characteristics."|participants|Number|5|5.0||||||
3987219|NCT01252940|3808739|B1|Spain||Region of Enrollment|"Four participants in the Switch to FTC/RPV/TDF group and 2 participants in the Stay on Baseline Regimen (SBR) group were randomized but were not treated. These subjects are included in the analysis of the baseline characteristic Region of Enrollment but are not included in the analysis of other baseline characteristics."|participants|Number|15|15.0||||||
3987220|NCT01252940|3808737|B3|Puerto Rico||Region of Enrollment|"Four participants in the Switch to FTC/RPV/TDF group and 2 participants in the Stay on Baseline Regimen (SBR) group were randomized but were not treated. These subjects are included in the analysis of the baseline characteristic Region of Enrollment but are not included in the analysis of other baseline characteristics."|participants|Number|18|18.0||||||
3987221|NCT01252940|3808738|B2|Puerto Rico||Region of Enrollment|"Four participants in the Switch to FTC/RPV/TDF group and 2 participants in the Stay on Baseline Regimen (SBR) group were randomized but were not treated. These subjects are included in the analysis of the baseline characteristic Region of Enrollment but are not included in the analysis of other baseline characteristics."|participants|Number|2|2.0||||||
3987222|NCT01252940|3808739|B1|Puerto Rico||Region of Enrollment|"Four participants in the Switch to FTC/RPV/TDF group and 2 participants in the Stay on Baseline Regimen (SBR) group were randomized but were not treated. These subjects are included in the analysis of the baseline characteristic Region of Enrollment but are not included in the analysis of other baseline characteristics."|participants|Number|16|16.0||||||
3987223|NCT01252940|3808737|B3|Italy||Region of Enrollment|"Four participants in the Switch to FTC/RPV/TDF group and 2 participants in the Stay on Baseline Regimen (SBR) group were randomized but were not treated. These subjects are included in the analysis of the baseline characteristic Region of Enrollment but are not included in the analysis of other baseline characteristics."|participants|Number|26|26.0||||||
3987224|NCT01252940|3808738|B2|Italy||Region of Enrollment|"Four participants in the Switch to FTC/RPV/TDF group and 2 participants in the Stay on Baseline Regimen (SBR) group were randomized but were not treated. These subjects are included in the analysis of the baseline characteristic Region of Enrollment but are not included in the analysis of other baseline characteristics."|participants|Number|10|10.0||||||
3987225|NCT01252940|3808739|B1|Italy||Region of Enrollment|"Four participants in the Switch to FTC/RPV/TDF group and 2 participants in the Stay on Baseline Regimen (SBR) group were randomized but were not treated. These subjects are included in the analysis of the baseline characteristic Region of Enrollment but are not included in the analysis of other baseline characteristics."|participants|Number|16|16.0||||||
3987251|NCT01252940|3808738|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
3987252|NCT01252940|3808739|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
3987226|NCT01252940|3808737|B3|Germany||Region of Enrollment|"Four participants in the Switch to FTC/RPV/TDF group and 2 participants in the Stay on Baseline Regimen (SBR) group were randomized but were not treated. These subjects are included in the analysis of the baseline characteristic Region of Enrollment but are not included in the analysis of other baseline characteristics."|participants|Number|43|43.0||||||
3987227|NCT01252940|3808738|B2|Germany||Region of Enrollment|"Four participants in the Switch to FTC/RPV/TDF group and 2 participants in the Stay on Baseline Regimen (SBR) group were randomized but were not treated. These subjects are included in the analysis of the baseline characteristic Region of Enrollment but are not included in the analysis of other baseline characteristics."|participants|Number|12|12.0||||||
3987228|NCT01252940|3808739|B1|Germany||Region of Enrollment|"Four participants in the Switch to FTC/RPV/TDF group and 2 participants in the Stay on Baseline Regimen (SBR) group were randomized but were not treated. These subjects are included in the analysis of the baseline characteristic Region of Enrollment but are not included in the analysis of other baseline characteristics."|participants|Number|31|31.0||||||
3987229|NCT01252940|3808737|B3|France||Region of Enrollment|"Four participants in the Switch to FTC/RPV/TDF group and 2 participants in the Stay on Baseline Regimen (SBR) group were randomized but were not treated. These subjects are included in the analysis of the baseline characteristic Region of Enrollment but are not included in the analysis of other baseline characteristics."|participants|Number|43|43.0||||||
3987230|NCT01252940|3808738|B2|France||Region of Enrollment|"Four participants in the Switch to FTC/RPV/TDF group and 2 participants in the Stay on Baseline Regimen (SBR) group were randomized but were not treated. These subjects are included in the analysis of the baseline characteristic Region of Enrollment but are not included in the analysis of other baseline characteristics."|participants|Number|14|14.0||||||
3987231|NCT01252940|3808739|B1|France||Region of Enrollment|"Four participants in the Switch to FTC/RPV/TDF group and 2 participants in the Stay on Baseline Regimen (SBR) group were randomized but were not treated. These subjects are included in the analysis of the baseline characteristic Region of Enrollment but are not included in the analysis of other baseline characteristics."|participants|Number|29|29.0||||||
3987232|NCT01252940|3808737|B3|Canada||Region of Enrollment|"Four participants in the Switch to FTC/RPV/TDF group and 2 participants in the Stay on Baseline Regimen (SBR) group were randomized but were not treated. These subjects are included in the analysis of the baseline characteristic Region of Enrollment but are not included in the analysis of other baseline characteristics."|participants|Number|25|25.0||||||
3987233|NCT01252940|3808738|B2|Canada||Region of Enrollment|"Four participants in the Switch to FTC/RPV/TDF group and 2 participants in the Stay on Baseline Regimen (SBR) group were randomized but were not treated. These subjects are included in the analysis of the baseline characteristic Region of Enrollment but are not included in the analysis of other baseline characteristics."|participants|Number|10|10.0||||||
3987234|NCT01252940|3808739|B1|Canada||Region of Enrollment|"Four participants in the Switch to FTC/RPV/TDF group and 2 participants in the Stay on Baseline Regimen (SBR) group were randomized but were not treated. These subjects are included in the analysis of the baseline characteristic Region of Enrollment but are not included in the analysis of other baseline characteristics."|participants|Number|15|15.0||||||
3987235|NCT01252940|3808737|B3|Belgium||Region of Enrollment|"Four participants in the Switch to FTC/RPV/TDF group and 2 participants in the Stay on Baseline Regimen (SBR) group were randomized but were not treated. These subjects are included in the analysis of the baseline characteristic Region of Enrollment but are not included in the analysis of other baseline characteristics."|participants|Number|28|28.0||||||
3987236|NCT01252940|3808738|B2|Belgium||Region of Enrollment|"Four participants in the Switch to FTC/RPV/TDF group and 2 participants in the Stay on Baseline Regimen (SBR) group were randomized but were not treated. These subjects are included in the analysis of the baseline characteristic Region of Enrollment but are not included in the analysis of other baseline characteristics."|participants|Number|13|13.0||||||
3987237|NCT01252940|3808739|B1|Belgium||Region of Enrollment|"Four participants in the Switch to FTC/RPV/TDF group and 2 participants in the Stay on Baseline Regimen (SBR) group were randomized but were not treated. These subjects are included in the analysis of the baseline characteristic Region of Enrollment but are not included in the analysis of other baseline characteristics."|participants|Number|15|15.0||||||
3987238|NCT01252940|3808737|B3|Austria||Region of Enrollment|"Four participants in the Switch to FTC/RPV/TDF group and 2 participants in the Stay on Baseline Regimen (SBR) group were randomized but were not treated. These subjects are included in the analysis of the baseline characteristic Region of Enrollment but are not included in the analysis of other baseline characteristics."|participants|Number|26|26.0||||||
3987239|NCT01252940|3808738|B2|Austria||Region of Enrollment|"Four participants in the Switch to FTC/RPV/TDF group and 2 participants in the Stay on Baseline Regimen (SBR) group were randomized but were not treated. These subjects are included in the analysis of the baseline characteristic Region of Enrollment but are not included in the analysis of other baseline characteristics."|participants|Number|8|8.0||||||
3987240|NCT01252940|3808739|B1|Austria||Region of Enrollment|"Four participants in the Switch to FTC/RPV/TDF group and 2 participants in the Stay on Baseline Regimen (SBR) group were randomized but were not treated. These subjects are included in the analysis of the baseline characteristic Region of Enrollment but are not included in the analysis of other baseline characteristics."|participants|Number|18|18.0||||||
3987241|NCT01252940|3808737|B3|Other||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3987242|NCT01252940|3808738|B2|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3987243|NCT01252940|3808739|B1|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3987244|NCT01252940|3808737|B3|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3987245|NCT01252940|3808738|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3987246|NCT01252940|3808739|B1|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3987247|NCT01252940|3808737|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3987248|NCT01252940|3808738|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3987249|NCT01252940|3808739|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3987250|NCT01252940|3808737|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
3987254|NCT01252940|3808738|B2|White||Race/Ethnicity, Customized||participants|Number|124|124.0||||||
3987255|NCT01252940|3808739|B1|White||Race/Ethnicity, Customized||participants|Number|241|241.0||||||
3987256|NCT01252940|3808737|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3987257|NCT01252940|3808738|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987258|NCT01252940|3808739|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3987259|NCT01252940|3808737|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|392|392.0||||||
3987260|NCT01252940|3808738|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
3987261|NCT01252940|3808739|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|264|264.0||||||
3987262|NCT01252940|3808737|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
3987263|NCT01252940|3808738|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3987264|NCT01252940|3808739|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3987265|NCT01252940|3808737|B3||Male|Sex: Female, Male||Participants|Count of Participants|417|417.0||||||
3987266|NCT01252940|3808738|B2||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3987267|NCT01252940|3808739|B1||Male|Sex: Female, Male||Participants|Count of Participants|273|273.0||||||
3987268|NCT01252940|3808737|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3987269|NCT01252940|3808738|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3987270|NCT01252940|3808739|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3987271|NCT01252940|3808737|B3|||Age||years|Mean|42|42.0|Standard Deviation|9.4|9.4|||
3987272|NCT01252940|3808738|B2|||Age||years|Mean|43|43.0|Standard Deviation|9.7|9.7|||
3987273|NCT01252940|3808739|B1|||Age||years|Mean|41|41.0|Standard Deviation|9.2|9.2|||
3987274|NCT01252810|3808769|B3|Canada||Region of Enrollment||participants|Number|16|16.0||||||
3987275|NCT01252810|3808770|B2|Canada||Region of Enrollment||participants|Number|7|7.0||||||
3987276|NCT01252810|3808771|B1|Canada||Region of Enrollment||participants|Number|9|9.0||||||
3987277|NCT01252810|3808769|B3|United States||Region of Enrollment||participants|Number|262|262.0||||||
3987278|NCT01252810|3808770|B2|United States||Region of Enrollment||participants|Number|134|134.0||||||
3987279|NCT01252810|3808771|B1|United States||Region of Enrollment||participants|Number|128|128.0||||||
3987280|NCT01252810|3808769|B3||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
3987281|NCT01252810|3808770|B2||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3987282|NCT01252810|3808771|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3987283|NCT01252810|3808769|B3||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3987284|NCT01252810|3808770|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3987285|NCT01252810|3808771|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3987286|NCT01252810|3808769|B3||>=65 years|Age|Per a Protocol Amendment, A-01, the minimum age changed to male or female greater than or equal to 18 years of age who have a history of chronic renal insufficiently.|Participants|Count of Participants|220|220.0||||||
3987287|NCT01252810|3808770|B2||>=65 years|Age|Per a Protocol Amendment, A-01, the minimum age changed to male or female greater than or equal to 18 years of age who have a history of chronic renal insufficiently.|Participants|Count of Participants|111|111.0||||||
3987288|NCT01252810|3808771|B1||>=65 years|Age|Per a Protocol Amendment, A-01, the minimum age changed to male or female greater than or equal to 18 years of age who have a history of chronic renal insufficiently.|Participants|Count of Participants|109|109.0||||||
3987289|NCT01252810|3808769|B3||Between 18 and 65 years|Age|Per a Protocol Amendment, A-01, the minimum age changed to male or female greater than or equal to 18 years of age who have a history of chronic renal insufficiently.|Participants|Count of Participants|58|58.0||||||
3987290|NCT01252810|3808770|B2||Between 18 and 65 years|Age|Per a Protocol Amendment, A-01, the minimum age changed to male or female greater than or equal to 18 years of age who have a history of chronic renal insufficiently.|Participants|Count of Participants|30|30.0||||||
3987291|NCT01252810|3808771|B1||Between 18 and 65 years|Age|Per a Protocol Amendment, A-01, the minimum age changed to male or female greater than or equal to 18 years of age who have a history of chronic renal insufficiently.|Participants|Count of Participants|28|28.0||||||
3987292|NCT01252810|3808769|B3||<=18 years|Age|Per a Protocol Amendment, A-01, the minimum age changed to male or female greater than or equal to 18 years of age who have a history of chronic renal insufficiently.|Participants|Count of Participants|0|0.0||||||
3987293|NCT01252810|3808770|B2||<=18 years|Age|Per a Protocol Amendment, A-01, the minimum age changed to male or female greater than or equal to 18 years of age who have a history of chronic renal insufficiently.|Participants|Count of Participants|0|0.0||||||
3987294|NCT01252810|3808771|B1||<=18 years|Age|Per a Protocol Amendment, A-01, the minimum age changed to male or female greater than or equal to 18 years of age who have a history of chronic renal insufficiently.|Participants|Count of Participants|0|0.0||||||
3987295|NCT01252745|3808782|B4|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
3987296|NCT01252745|3808783|B3|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3987297|NCT01252745|3808784|B2|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3987298|NCT01252745|3808785|B1|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3987299|NCT01252745|3808782|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987300|NCT01252745|3808783|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987301|NCT01252745|3808784|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987458|NCT01252238|3808872|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3987302|NCT01252745|3808785|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987303|NCT01252745|3808782|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987304|NCT01252745|3808783|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987305|NCT01252745|3808784|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987306|NCT01252745|3808785|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987307|NCT01252745|3808782|B4||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3987308|NCT01252745|3808783|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3987309|NCT01252745|3808784|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3987310|NCT01252745|3808785|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3987311|NCT01252745|3808782|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3987312|NCT01252745|3808783|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3987313|NCT01252745|3808784|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987314|NCT01252745|3808785|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987315|NCT01252745|3808782|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987316|NCT01252745|3808783|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987317|NCT01252745|3808784|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987318|NCT01252745|3808785|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987319|NCT01252745|3808782|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987320|NCT01252745|3808783|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987321|NCT01252745|3808784|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987322|NCT01252745|3808785|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987323|NCT01252745|3808782|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987324|NCT01252745|3808783|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987325|NCT01252745|3808784|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987326|NCT01252745|3808785|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987327|NCT01252745|3808782|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987328|NCT01252745|3808783|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987329|NCT01252745|3808784|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987330|NCT01252745|3808785|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987331|NCT01252745|3808782|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3987332|NCT01252745|3808783|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3987333|NCT01252745|3808784|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3987334|NCT01252745|3808785|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3987335|NCT01252745|3808782|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3987336|NCT01252745|3808783|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3987337|NCT01252745|3808784|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3987338|NCT01252745|3808785|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3987339|NCT01252745|3808782|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3987340|NCT01252745|3808783|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3987341|NCT01252745|3808784|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3987342|NCT01252745|3808785|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3987343|NCT01252745|3808782|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3987344|NCT01252745|3808783|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3987345|NCT01252745|3808784|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3987346|NCT01252745|3808785|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3987347|NCT01252745|3808782|B4|||Age||years|Mean|52.59|52.59|Standard Deviation|10.78|10.78|||
3987348|NCT01252745|3808783|B3|||Age||years|Mean|51.57|51.57|Standard Deviation|9.90|9.9|||
3987349|NCT01252745|3808784|B2|||Age||years|Mean|53.86|53.86|Standard Deviation|11.04|11.04|||
3987350|NCT01252745|3808785|B1|||Age||years|Mean|52.38|52.38|Standard Deviation|12.55|12.55|||
3987351|NCT01252355|3808801|B4|Low dose||Dose Level of Interferon-beta (IFN-beta) Based on IVRS||participants|Number|166|166.0||||||
3987352|NCT01252355|3808802|B3|Low dose||Dose Level of Interferon-beta (IFN-beta) Based on IVRS||participants|Number|59|59.0||||||
3987353|NCT01252355|3808803|B2|Low dose||Dose Level of Interferon-beta (IFN-beta) Based on IVRS||participants|Number|50|50.0||||||
3987354|NCT01252355|3808804|B1|Low dose||Dose Level of Interferon-beta (IFN-beta) Based on IVRS||participants|Number|57|57.0||||||
3987355|NCT01252355|3808801|B4|High dose||Dose Level of Interferon-beta (IFN-beta) Based on IVRS||participants|Number|368|368.0||||||
3987356|NCT01252355|3808802|B3|High dose||Dose Level of Interferon-beta (IFN-beta) Based on IVRS||participants|Number|120|120.0||||||
3987357|NCT01252355|3808803|B2|High dose||Dose Level of Interferon-beta (IFN-beta) Based on IVRS||participants|Number|128|128.0||||||
3987358|NCT01252355|3808804|B1|High dose||Dose Level of Interferon-beta (IFN-beta) Based on IVRS||participants|Number|120|120.0||||||
3987359|NCT01252355|3808801|B4|||Baseline Expanded Disability Status Scale (EDSS) Score|EDSS is an ordinal scale in half-point increments that qualifies disability in participants with MS. It consists of 8 ordinal rating scales assessing seven functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation. EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS).|units on a scale|Mean|2.65|2.65|Standard Deviation|1.26|1.26|||
3987360|NCT01252355|3808802|B3|||Baseline Expanded Disability Status Scale (EDSS) Score|EDSS is an ordinal scale in half-point increments that qualifies disability in participants with MS. It consists of 8 ordinal rating scales assessing seven functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation. EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS).|units on a scale|Mean|2.64|2.64|Standard Deviation|1.18|1.18|||
3987361|NCT01252355|3808803|B2|||Baseline Expanded Disability Status Scale (EDSS) Score|EDSS is an ordinal scale in half-point increments that qualifies disability in participants with MS. It consists of 8 ordinal rating scales assessing seven functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation. EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS).|units on a scale|Mean|2.63|2.63|Standard Deviation|1.37|1.37|||
3987362|NCT01252355|3808804|B1|||Baseline Expanded Disability Status Scale (EDSS) Score|EDSS is an ordinal scale in half-point increments that qualifies disability in participants with MS. It consists of 8 ordinal rating scales assessing seven functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation. EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS).|units on a scale|Mean|2.67|2.67|Standard Deviation|1.25|1.25|||
3987363|NCT01252355|3808801|B4|Progressive Relapsing||MS Subtype||participants|Number|3|3.0||||||
3987364|NCT01252355|3808802|B3|Progressive Relapsing||MS Subtype||participants|Number|0|0.0||||||
3987365|NCT01252355|3808803|B2|Progressive Relapsing||MS Subtype||participants|Number|2|2.0||||||
3987366|NCT01252355|3808804|B1|Progressive Relapsing||MS Subtype||participants|Number|1|1.0||||||
3987367|NCT01252355|3808801|B4|Secondary Progressive||MS Subtype||participants|Number|9|9.0||||||
3987368|NCT01252355|3808802|B3|Secondary Progressive||MS Subtype||participants|Number|4|4.0||||||
3987369|NCT01252355|3808803|B2|Secondary Progressive||MS Subtype||participants|Number|3|3.0||||||
3987370|NCT01252355|3808804|B1|Secondary Progressive||MS Subtype||participants|Number|2|2.0||||||
3987371|NCT01252355|3808801|B4|Relapsing Remitting||MS Subtype||participants|Number|522|522.0||||||
3987372|NCT01252355|3808802|B3|Relapsing Remitting||MS Subtype||participants|Number|175|175.0||||||
3987373|NCT01252355|3808803|B2|Relapsing Remitting||MS Subtype||participants|Number|173|173.0||||||
3987374|NCT01252355|3808804|B1|Relapsing Remitting||MS Subtype||participants|Number|174|174.0||||||
3987375|NCT01252355|3808801|B4|||Time Since Most Recent MS Relapse Onset||months|Median|5.0|5.0|Full Range|10.47|10.47|1.0|174.0|
3987376|NCT01252355|3808802|B3|||Time Since Most Recent MS Relapse Onset||months|Median|4.0|4.0|Full Range|15.36|15.36|1.0|174.0|
3987377|NCT01252355|3808803|B2|||Time Since Most Recent MS Relapse Onset||months|Median|5.0|5.0|Full Range|4.83|4.83|1.0|36.0|
3987378|NCT01252355|3808804|B1|||Time Since Most Recent MS Relapse Onset||months|Median|5.0|5.0|Full Range|8.29|8.29|1.0|75.0|
3987379|NCT01252355|3808801|B4|Within the past 2 years||Number of MS Relapses|"The information was not available for one participant in the Teriflunomide 14 mg + IFN-beta group."|MS relapses|Median|2|2.0|Full Range|||0.0|8.0|
3987380|NCT01252355|3808802|B3|Within the past 2 years||Number of MS Relapses|"The information was not available for one participant in the Teriflunomide 14 mg + IFN-beta group."|MS relapses|Median|2|2.0|Full Range|||0.0|8.0|
3987381|NCT01252355|3808803|B2|Within the past 2 years||Number of MS Relapses|"The information was not available for one participant in the Teriflunomide 14 mg + IFN-beta group."|MS relapses|Median|2|2.0|Full Range|||0.0|8.0|
3987382|NCT01252355|3808804|B1|Within the past 2 years||Number of MS Relapses|"The information was not available for one participant in the Teriflunomide 14 mg + IFN-beta group."|MS relapses|Median|2|2.0|Full Range|||0.0|6.0|
3987383|NCT01252355|3808801|B4|Within the past year||Number of MS Relapses|"The information was not available for one participant in the Teriflunomide 14 mg + IFN-beta group."|MS relapses|Median|1|1.0|Full Range|||0.0|4.0|
3987384|NCT01252355|3808802|B3|Within the past year||Number of MS Relapses|"The information was not available for one participant in the Teriflunomide 14 mg + IFN-beta group."|MS relapses|Median|1|1.0|Full Range|||0.0|4.0|
3987385|NCT01252355|3808803|B2|Within the past year||Number of MS Relapses|"The information was not available for one participant in the Teriflunomide 14 mg + IFN-beta group."|MS relapses|Median|1|1.0|Full Range|||0.0|3.0|
3987386|NCT01252355|3808804|B1|Within the past year||Number of MS Relapses|"The information was not available for one participant in the Teriflunomide 14 mg + IFN-beta group."|MS relapses|Median|1|1.0|Full Range|||0.0|4.0|
3987387|NCT01252355|3808801|B4|||Time Since First Diagnosis of Multiple Sclerosis (MS)||years|Mean|6.8|6.8|Standard Deviation|5.7|5.7|||
3987388|NCT01252355|3808802|B3|||Time Since First Diagnosis of Multiple Sclerosis (MS)||years|Mean|6.8|6.8|Standard Deviation|5.9|5.9|||
3987389|NCT01252355|3808803|B2|||Time Since First Diagnosis of Multiple Sclerosis (MS)||years|Mean|6.6|6.6|Standard Deviation|5.6|5.6|||
3987390|NCT01252355|3808804|B1|||Time Since First Diagnosis of Multiple Sclerosis (MS)||years|Mean|7.0|7.0|Standard Deviation|5.6|5.6|||
3987391|NCT01252355|3808801|B4|Asia, Africa and Australia||Region of Enrollment|"Due to the small sample size in some countries, the countries were pooled as follows:~America: Argentina, Brazil, Canada, Chile, Columbia, The United States~Western Europe: Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Portugal, Spain, Sweden, The United Kingdom~Eastern Europe = Estonia, Greece, Hungary, Lithuania, Russian Federation, Slovakia~Asia, Africa and Australia = Australia, Republic of Korea, Tunisia"|participants|Number|25|25.0||||||
3987459|NCT01252238|3808869|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3987460|NCT01252238|3808870|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3987392|NCT01252355|3808802|B3|Asia, Africa and Australia||Region of Enrollment|"Due to the small sample size in some countries, the countries were pooled as follows:~America: Argentina, Brazil, Canada, Chile, Columbia, The United States~Western Europe: Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Portugal, Spain, Sweden, The United Kingdom~Eastern Europe = Estonia, Greece, Hungary, Lithuania, Russian Federation, Slovakia~Asia, Africa and Australia = Australia, Republic of Korea, Tunisia"|participants|Number|7|7.0||||||
3987393|NCT01252355|3808803|B2|Asia, Africa and Australia||Region of Enrollment|"Due to the small sample size in some countries, the countries were pooled as follows:~America: Argentina, Brazil, Canada, Chile, Columbia, The United States~Western Europe: Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Portugal, Spain, Sweden, The United Kingdom~Eastern Europe = Estonia, Greece, Hungary, Lithuania, Russian Federation, Slovakia~Asia, Africa and Australia = Australia, Republic of Korea, Tunisia"|participants|Number|11|11.0||||||
3987394|NCT01252355|3808804|B1|Asia, Africa and Australia||Region of Enrollment|"Due to the small sample size in some countries, the countries were pooled as follows:~America: Argentina, Brazil, Canada, Chile, Columbia, The United States~Western Europe: Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Portugal, Spain, Sweden, The United Kingdom~Eastern Europe = Estonia, Greece, Hungary, Lithuania, Russian Federation, Slovakia~Asia, Africa and Australia = Australia, Republic of Korea, Tunisia"|participants|Number|7|7.0||||||
3987395|NCT01252355|3808801|B4|Eastern Europe||Region of Enrollment|"Due to the small sample size in some countries, the countries were pooled as follows:~America: Argentina, Brazil, Canada, Chile, Columbia, The United States~Western Europe: Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Portugal, Spain, Sweden, The United Kingdom~Eastern Europe = Estonia, Greece, Hungary, Lithuania, Russian Federation, Slovakia~Asia, Africa and Australia = Australia, Republic of Korea, Tunisia"|participants|Number|158|158.0||||||
3987396|NCT01252355|3808802|B3|Eastern Europe||Region of Enrollment|"Due to the small sample size in some countries, the countries were pooled as follows:~America: Argentina, Brazil, Canada, Chile, Columbia, The United States~Western Europe: Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Portugal, Spain, Sweden, The United Kingdom~Eastern Europe = Estonia, Greece, Hungary, Lithuania, Russian Federation, Slovakia~Asia, Africa and Australia = Australia, Republic of Korea, Tunisia"|participants|Number|56|56.0||||||
3987397|NCT01252355|3808803|B2|Eastern Europe||Region of Enrollment|"Due to the small sample size in some countries, the countries were pooled as follows:~America: Argentina, Brazil, Canada, Chile, Columbia, The United States~Western Europe: Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Portugal, Spain, Sweden, The United Kingdom~Eastern Europe = Estonia, Greece, Hungary, Lithuania, Russian Federation, Slovakia~Asia, Africa and Australia = Australia, Republic of Korea, Tunisia"|participants|Number|51|51.0||||||
3987398|NCT01252355|3808804|B1|Eastern Europe||Region of Enrollment|"Due to the small sample size in some countries, the countries were pooled as follows:~America: Argentina, Brazil, Canada, Chile, Columbia, The United States~Western Europe: Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Portugal, Spain, Sweden, The United Kingdom~Eastern Europe = Estonia, Greece, Hungary, Lithuania, Russian Federation, Slovakia~Asia, Africa and Australia = Australia, Republic of Korea, Tunisia"|participants|Number|51|51.0||||||
3987399|NCT01252355|3808801|B4|Western Europe||Region of Enrollment|"Due to the small sample size in some countries, the countries were pooled as follows:~America: Argentina, Brazil, Canada, Chile, Columbia, The United States~Western Europe: Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Portugal, Spain, Sweden, The United Kingdom~Eastern Europe = Estonia, Greece, Hungary, Lithuania, Russian Federation, Slovakia~Asia, Africa and Australia = Australia, Republic of Korea, Tunisia"|participants|Number|251|251.0||||||
3987400|NCT01252355|3808802|B3|Western Europe||Region of Enrollment|"Due to the small sample size in some countries, the countries were pooled as follows:~America: Argentina, Brazil, Canada, Chile, Columbia, The United States~Western Europe: Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Portugal, Spain, Sweden, The United Kingdom~Eastern Europe = Estonia, Greece, Hungary, Lithuania, Russian Federation, Slovakia~Asia, Africa and Australia = Australia, Republic of Korea, Tunisia"|participants|Number|79|79.0||||||
3987401|NCT01252355|3808803|B2|Western Europe||Region of Enrollment|"Due to the small sample size in some countries, the countries were pooled as follows:~America: Argentina, Brazil, Canada, Chile, Columbia, The United States~Western Europe: Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Portugal, Spain, Sweden, The United Kingdom~Eastern Europe = Estonia, Greece, Hungary, Lithuania, Russian Federation, Slovakia~Asia, Africa and Australia = Australia, Republic of Korea, Tunisia"|participants|Number|86|86.0||||||
3987402|NCT01252355|3808804|B1|Western Europe||Region of Enrollment|"Due to the small sample size in some countries, the countries were pooled as follows:~America: Argentina, Brazil, Canada, Chile, Columbia, The United States~Western Europe: Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Portugal, Spain, Sweden, The United Kingdom~Eastern Europe = Estonia, Greece, Hungary, Lithuania, Russian Federation, Slovakia~Asia, Africa and Australia = Australia, Republic of Korea, Tunisia"|participants|Number|86|86.0||||||
3987403|NCT01252355|3808801|B4|America||Region of Enrollment|"Due to the small sample size in some countries, the countries were pooled as follows:~America: Argentina, Brazil, Canada, Chile, Columbia, The United States~Western Europe: Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Portugal, Spain, Sweden, The United Kingdom~Eastern Europe = Estonia, Greece, Hungary, Lithuania, Russian Federation, Slovakia~Asia, Africa and Australia = Australia, Republic of Korea, Tunisia"|participants|Number|100|100.0||||||
3987404|NCT01252355|3808802|B3|America||Region of Enrollment|"Due to the small sample size in some countries, the countries were pooled as follows:~America: Argentina, Brazil, Canada, Chile, Columbia, The United States~Western Europe: Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Portugal, Spain, Sweden, The United Kingdom~Eastern Europe = Estonia, Greece, Hungary, Lithuania, Russian Federation, Slovakia~Asia, Africa and Australia = Australia, Republic of Korea, Tunisia"|participants|Number|37|37.0||||||
3987405|NCT01252355|3808803|B2|America||Region of Enrollment|"Due to the small sample size in some countries, the countries were pooled as follows:~America: Argentina, Brazil, Canada, Chile, Columbia, The United States~Western Europe: Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Portugal, Spain, Sweden, The United Kingdom~Eastern Europe = Estonia, Greece, Hungary, Lithuania, Russian Federation, Slovakia~Asia, Africa and Australia = Australia, Republic of Korea, Tunisia"|participants|Number|30|30.0||||||
3987406|NCT01252355|3808804|B1|America||Region of Enrollment|"Due to the small sample size in some countries, the countries were pooled as follows:~America: Argentina, Brazil, Canada, Chile, Columbia, The United States~Western Europe: Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Portugal, Spain, Sweden, The United Kingdom~Eastern Europe = Estonia, Greece, Hungary, Lithuania, Russian Federation, Slovakia~Asia, Africa and Australia = Australia, Republic of Korea, Tunisia"|participants|Number|33|33.0||||||
3987407|NCT01252355|3808801|B4||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3987408|NCT01252355|3808802|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3987409|NCT01252355|3808803|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3987410|NCT01252355|3808804|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3987411|NCT01252355|3808801|B4||Female|Sex: Female, Male||Participants|Count of Participants|352|352.0||||||
3987412|NCT01252355|3808802|B3||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3987413|NCT01252355|3808803|B2||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3987414|NCT01252355|3808804|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3987415|NCT01252355|3808801|B4|||Age||years|Mean|38.2|38.2|Standard Deviation|9.2|9.2|||
3987416|NCT01252355|3808802|B3|||Age||years|Mean|37.7|37.7|Standard Deviation|9.2|9.2|||
3987417|NCT01252355|3808803|B2|||Age||years|Mean|38.7|38.7|Standard Deviation|9.5|9.5|||
3987418|NCT01252355|3808804|B1|||Age||years|Mean|38.3|38.3|Standard Deviation|8.9|8.9|||
3987419|NCT01252290|3808844|B1|||5-Year Gail Risk|"Gail Model is one of the models developed to quantify a woman's risk of developing breast cancer. The model incorporates a series of questions related to breast cancer risk factors. Women who have a percentage of risk of 1.66 or higher have a higher than average risk for developing breast cancer.~Measure taken on 27 participants. Eight participants risk could not be calculated because the model does not allow calculation for women with prior ductal carcinoma in situ (DCIS), lobular carcinoma in situ (LCIS), or invasive breast cancer."|percent probablity of breast cancer|Mean|3.4|3.4|Standard Deviation|1.5|1.5|||
3987420|NCT01252290|3808844|B1|||Body Mass Index||kg/m2|Mean|26.2|26.2|Standard Deviation|4.7|4.7|||
3987421|NCT01252290|3808844|B1|||Weight||kilograms|Mean|71|71.0|Standard Deviation|14|14.0|||
3987422|NCT01252290|3808844|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3987423|NCT01252290|3808844|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3987424|NCT01252290|3808844|B1||Female|Gender||Participants|Count of Participants|35|35.0||||||
3987425|NCT01252290|3808844|B1|||Age||years|Mean|53.2|53.2|Standard Deviation|8.4|8.4|||
3987426|NCT01252277|3808852|B1|||Gail 5-year Projected Probability of developing breast cancer||Projected Probability, percent|Mean|2.0|2.0|Standard Deviation|1.1|1.1|||
3987427|NCT01252277|3808852|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
3987428|NCT01252277|3808852|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987429|NCT01252277|3808852|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987430|NCT01252277|3808852|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3987431|NCT01252277|3808852|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3987432|NCT01252277|3808852|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987433|NCT01252277|3808852|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987434|NCT01252277|3808852|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987435|NCT01252277|3808852|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987436|NCT01252277|3808852|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3987437|NCT01252277|3808852|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987438|NCT01252277|3808852|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3987439|NCT01252277|3808852|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3987440|NCT01252277|3808852|B1|||Age||years|Mean|42.9|42.9|Standard Deviation|6.1|6.1|||
3987441|NCT01252251|3808860|B1|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3987442|NCT01252251|3808860|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3987443|NCT01252251|3808860|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987444|NCT01252251|3808860|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3987445|NCT01252251|3808860|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987446|NCT01252251|3808860|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987447|NCT01252251|3808860|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987448|NCT01252251|3808860|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987449|NCT01252251|3808860|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3987450|NCT01252251|3808860|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987451|NCT01252251|3808860|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3987452|NCT01252251|3808860|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3987453|NCT01252251|3808860|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3987454|NCT01252251|3808860|B1|||Age||years|Median|61|61.0|Full Range|||41.0|83.0|
3987455|NCT01252238|3808869|B4|United States||Region of Enrollment||participants|Number|24|24.0||||||
3987456|NCT01252238|3808870|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3987457|NCT01252238|3808871|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
3987461|NCT01252238|3808871|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3987462|NCT01252238|3808872|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3987463|NCT01252238|3808869|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3987464|NCT01252238|3808870|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3987465|NCT01252238|3808871|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3987466|NCT01252238|3808872|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3987467|NCT01252238|3808869|B4|||Age||years|Mean|48|48.0|Standard Deviation|7|7.0|||
3987468|NCT01252238|3808870|B3|||Age||years|Mean|47|47.0|Standard Deviation|5|5.0|||
3987469|NCT01252238|3808871|B2|||Age||years|Mean|51|51.0|Standard Deviation|6|6.0|||
3987470|NCT01252238|3808872|B1|||Age||years|Mean|47|47.0|Standard Deviation|12|12.0|||
3987471|NCT01252238|3808869|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3987472|NCT01252238|3808870|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3987473|NCT01252238|3808871|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3987474|NCT01252238|3808872|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3987475|NCT01252238|3808869|B4||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3987476|NCT01252238|3808870|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3987477|NCT01252238|3808871|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3987478|NCT01252238|3808872|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3987479|NCT01252238|3808869|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3987480|NCT01252238|3808870|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3987481|NCT01252238|3808871|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3987482|NCT01252238|3808872|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3987483|NCT01252186|3808888|B4|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3987484|NCT01252186|3808889|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3987485|NCT01252186|3808890|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3987486|NCT01252186|3808891|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3987487|NCT01252186|3808888|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
3987488|NCT01252186|3808889|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3987489|NCT01252186|3808890|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3987490|NCT01252186|3808891|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3987491|NCT01252186|3808888|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|121|121.0||||||
3987492|NCT01252186|3808889|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
3987493|NCT01252186|3808890|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
3987494|NCT01252186|3808891|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
3987495|NCT01252186|3808888|B4|Black or African-American||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
3987496|NCT01252186|3808889|B3|Black or African-American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3987497|NCT01252186|3808890|B2|Black or African-American||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3987498|NCT01252186|3808891|B1|Black or African-American||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3987499|NCT01252186|3808888|B4|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3987500|NCT01252186|3808889|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3987501|NCT01252186|3808890|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3987502|NCT01252186|3808891|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3987503|NCT01252186|3808888|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3987504|NCT01252186|3808889|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3987505|NCT01252186|3808890|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3987506|NCT01252186|3808891|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3987507|NCT01252186|3808888|B4||Female|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
3987508|NCT01252186|3808889|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3987509|NCT01252186|3808890|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3987510|NCT01252186|3808891|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3987511|NCT01252186|3808888|B4|||Age||years|Mean|27.0|27.0|Standard Deviation|5.94|5.94|||
3987512|NCT01252186|3808889|B3|||Age||years|Mean|27.0|27.0|Standard Deviation|5.75|5.75|||
3987513|NCT01252186|3808890|B2|||Age||years|Mean|26.8|26.8|Standard Deviation|6.22|6.22|||
3987514|NCT01252186|3808891|B1|||Age||years|Mean|27.3|27.3|Standard Deviation|5.87|5.87|||
3987515|NCT01252147|3808961|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3987516|NCT01252147|3808961|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3987517|NCT01252147|3808961|B1|||Age||years|Median|34.0|34.0|Full Range|||20.0|57.0|
3987518|NCT01252134|3808966|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3987519|NCT01252134|3808966|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3987520|NCT01252134|3808966|B1|||Age||years|Mean|24.8|24.8|Standard Deviation|9.5|9.5|||
3987521|NCT01252095|3808988|B3|Australia||Region of Enrollment||participants|Number|4|4.0||||||
3987522|NCT01252095|3808989|B2|Australia||Region of Enrollment||participants|Number|1|1.0||||||
3987523|NCT01252095|3808990|B1|Australia||Region of Enrollment||participants|Number|3|3.0||||||
3987524|NCT01252095|3808988|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3987525|NCT01252095|3808989|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3987526|NCT01252095|3808990|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3987527|NCT01252095|3808988|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3987528|NCT01252095|3808989|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3987529|NCT01252095|3808990|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3987530|NCT01252095|3808988|B3|||Age||years|Mean|62|62.0|Standard Deviation|5|5.0|||
3987531|NCT01252095|3808989|B2|||Age||years|Mean|57|57.0|Standard Deviation|||||
3987532|NCT01252095|3808990|B1|||Age||years|Mean|63|63.0|Standard Deviation|5|5.0|||
3987533|NCT01252095|3808988|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3987534|NCT01252095|3808989|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3987535|NCT01252095|3808990|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3987536|NCT01252095|3808988|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3987537|NCT01252095|3808989|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3987538|NCT01252095|3808990|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3987539|NCT01252095|3808988|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3987540|NCT01252095|3808989|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3987541|NCT01252095|3808990|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3987542|NCT01251978|3808997|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3987543|NCT01251978|3808998|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3987544|NCT01251978|3808999|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3987545|NCT01251978|3808997|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3987546|NCT01251978|3808998|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3987547|NCT01251978|3808999|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3987548|NCT01251978|3808997|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3987549|NCT01251978|3808998|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3987550|NCT01251978|3808999|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3987551|NCT01251978|3808997|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3987552|NCT01251978|3808998|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3987553|NCT01251978|3808999|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3987554|NCT01251978|3808997|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3987555|NCT01251978|3808998|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3987556|NCT01251978|3808999|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3987557|NCT01251952|3809009|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3987558|NCT01251952|3809009|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3987559|NCT01251952|3809009|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3987560|NCT01251952|3809009|B1|||Age||years|Mean|58|58.0|Standard Deviation|10|10.0|||
3987561|NCT01251952|3809009|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3987562|NCT01251952|3809009|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3987563|NCT01251952|3809009|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3987564|NCT01251770|3809013|B3|Argentina||Region of Enrollment||participants|Number|78|78.0||||||
3987565|NCT01251770|3809014|B2|Argentina||Region of Enrollment||participants|Number|36|36.0||||||
3987566|NCT01251770|3809015|B1|Argentina||Region of Enrollment||participants|Number|42|42.0||||||
3987567|NCT01251770|3809013|B3||Male|Gender||Participants|Count of Participants|51|51.0||||||
3987568|NCT01251770|3809014|B2||Male|Gender||Participants|Count of Participants|23|23.0||||||
3987569|NCT01251770|3809015|B1||Male|Gender||Participants|Count of Participants|28|28.0||||||
3987570|NCT01251770|3809013|B3||Female|Gender||Participants|Count of Participants|27|27.0||||||
3987571|NCT01251770|3809014|B2||Female|Gender||Participants|Count of Participants|13|13.0||||||
3987572|NCT01251770|3809015|B1||Female|Gender||Participants|Count of Participants|14|14.0||||||
3987573|NCT01251770|3809013|B3|||Age||months|Mean|100.5|100.5|Standard Deviation|38.7|38.7|||
3987574|NCT01251770|3809014|B2|||Age||months|Mean|94.4|94.4|Standard Deviation|42.2|42.2|||
3987575|NCT01251770|3809015|B1|||Age||months|Mean|105.6|105.6|Standard Deviation|35.1|35.1|||
3987576|NCT01251770|3809013|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3987577|NCT01251770|3809014|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3987578|NCT01251770|3809015|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3987579|NCT01251770|3809013|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3987580|NCT01251770|3809014|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3987581|NCT01251770|3809015|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3987582|NCT01251770|3809013|B3||<=18 years|Age||Participants|Count of Participants|78|78.0||||||
3987583|NCT01251770|3809014|B2||<=18 years|Age||Participants|Count of Participants|36|36.0||||||
3987584|NCT01251770|3809015|B1||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
3987585|NCT01251757|3809024|B4|statin and ACEI/ARB||target medication use||participants|Number|7656|7656.0||||||
3987586|NCT01251757|3809025|B3|statin and ACEI/ARB||target medication use||participants|Number|2508|2508.0||||||
3987587|NCT01251757|3809026|B2|statin and ACEI/ARB||target medication use||participants|Number|2587|2587.0||||||
3987588|NCT01251757|3809027|B1|statin and ACEI/ARB||target medication use||participants|Number|2561|2561.0||||||
3987589|NCT01251757|3809024|B4|ACEI/ARB only||target medication use||participants|Number|5380|5380.0||||||
3987590|NCT01251757|3809025|B3|ACEI/ARB only||target medication use||participants|Number|1820|1820.0||||||
3987591|NCT01251757|3809026|B2|ACEI/ARB only||target medication use||participants|Number|1790|1790.0||||||
3987592|NCT01251757|3809027|B1|ACEI/ARB only||target medication use||participants|Number|1770|1770.0||||||
3987593|NCT01251757|3809024|B4|statin only||target medication use||participants|Number|8716|8716.0||||||
3987594|NCT01251757|3809025|B3|statin only||target medication use||participants|Number|2922|2922.0||||||
3987595|NCT01251757|3809026|B2|statin only||target medication use||participants|Number|2870|2870.0||||||
3987596|NCT01251757|3809027|B1|statin only||target medication use||participants|Number|2924|2924.0||||||
3987597|NCT01251757|3809024|B4|no||co-morbid cardiovascular disease||participants|Number|13849|13849.0||||||
3987598|NCT01251757|3809025|B3|no||co-morbid cardiovascular disease||participants|Number|4589|4589.0||||||
3987599|NCT01251757|3809026|B2|no||co-morbid cardiovascular disease||participants|Number|4631|4631.0||||||
3987600|NCT01251757|3809027|B1|no||co-morbid cardiovascular disease||participants|Number|4629|4629.0||||||
3987601|NCT01251757|3809024|B4|yes||co-morbid cardiovascular disease||participants|Number|7903|7903.0||||||
3987602|NCT01251757|3809025|B3|yes||co-morbid cardiovascular disease||participants|Number|2661|2661.0||||||
3987603|NCT01251757|3809026|B2|yes||co-morbid cardiovascular disease||participants|Number|2616|2616.0||||||
3987604|NCT01251757|3809027|B1|yes||co-morbid cardiovascular disease||participants|Number|2626|2626.0||||||
3987605|NCT01251757|3809024|B4|no||co-morbid diabetes mellitus||participants|Number|4757|4757.0||||||
3987606|NCT01251757|3809025|B3|no||co-morbid diabetes mellitus||participants|Number|1624|1624.0||||||
3987607|NCT01251757|3809026|B2|no||co-morbid diabetes mellitus||participants|Number|1544|1544.0||||||
3987608|NCT01251757|3809027|B1|no||co-morbid diabetes mellitus||participants|Number|1589|1589.0||||||
3987609|NCT01251757|3809024|B4|yes||co-morbid diabetes mellitus||participants|Number|16995|16995.0||||||
3987610|NCT01251757|3809025|B3|yes||co-morbid diabetes mellitus||participants|Number|5626|5626.0||||||
3987611|NCT01251757|3809026|B2|yes||co-morbid diabetes mellitus||participants|Number|5703|5703.0||||||
3987612|NCT01251757|3809027|B1|yes||co-morbid diabetes mellitus||participants|Number|5666|5666.0||||||
3987613|NCT01251757|3809024|B4|no||ever smokers||participants|Number|11173|11173.0||||||
3987614|NCT01251757|3809025|B3|no||ever smokers||participants|Number|3690|3690.0||||||
3987615|NCT01251757|3809026|B2|no||ever smokers||participants|Number|3710|3710.0||||||
3987616|NCT01251757|3809027|B1|no||ever smokers||participants|Number|3773|3773.0||||||
3987617|NCT01251757|3809024|B4|yes||ever smokers||participants|Number|10579|10579.0||||||
3987618|NCT01251757|3809025|B3|yes||ever smokers||participants|Number|3560|3560.0||||||
3987619|NCT01251757|3809026|B2|yes||ever smokers||participants|Number|3537|3537.0||||||
3987620|NCT01251757|3809027|B1|yes||ever smokers||participants|Number|3482|3482.0||||||
3987621|NCT01251757|3809024|B4|United States||Region of Enrollment||participants|Number|21752|21752.0||||||
3987622|NCT01251757|3809025|B3|United States||Region of Enrollment||participants|Number|7250|7250.0||||||
3987623|NCT01251757|3809026|B2|United States||Region of Enrollment||participants|Number|7247|7247.0||||||
3987624|NCT01251757|3809027|B1|United States||Region of Enrollment||participants|Number|7255|7255.0||||||
3987625|NCT01251757|3809024|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1819|1819.0||||||
3987626|NCT01251757|3809025|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|652|652.0||||||
3987627|NCT01251757|3809026|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|602|602.0||||||
3987628|NCT01251757|3809027|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|565|565.0||||||
3987629|NCT01251757|3809024|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987630|NCT01251757|3809025|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987631|NCT01251757|3809026|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987632|NCT01251757|3809027|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987633|NCT01251757|3809024|B4||White|Race (NIH/OMB)||Participants|Count of Participants|10210|10210.0||||||
3987634|NCT01251757|3809025|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3408|3408.0||||||
3987635|NCT01251757|3809026|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3399|3399.0||||||
3987636|NCT01251757|3809027|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3403|3403.0||||||
3987637|NCT01251757|3809024|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3371|3371.0||||||
3987638|NCT01251757|3809025|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1109|1109.0||||||
3987639|NCT01251757|3809026|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1094|1094.0||||||
3987640|NCT01251757|3809027|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1168|1168.0||||||
3987641|NCT01251757|3809024|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2400|2400.0||||||
3987642|NCT01251757|3809025|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|783|783.0||||||
3987643|NCT01251757|3809026|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|819|819.0||||||
3987644|NCT01251757|3809027|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|798|798.0||||||
3987645|NCT01251757|3809024|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3814|3814.0||||||
3987646|NCT01251757|3809025|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1254|1254.0||||||
3987647|NCT01251757|3809026|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1290|1290.0||||||
3987648|NCT01251757|3809027|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1270|1270.0||||||
3987649|NCT01251757|3809024|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
3987650|NCT01251757|3809025|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3987651|NCT01251757|3809026|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3987652|NCT01251757|3809027|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3987653|NCT01251757|3809024|B4||Male|Sex: Female, Male||Participants|Count of Participants|11535|11535.0||||||
3987654|NCT01251757|3809025|B3||Male|Sex: Female, Male||Participants|Count of Participants|3835|3835.0||||||
3987655|NCT01251757|3809026|B2||Male|Sex: Female, Male||Participants|Count of Participants|3877|3877.0||||||
3987656|NCT01251757|3809027|B1||Male|Sex: Female, Male||Participants|Count of Participants|3823|3823.0||||||
3987657|NCT01251757|3809024|B4||Female|Sex: Female, Male||Participants|Count of Participants|10217|10217.0||||||
3987658|NCT01251757|3809025|B3||Female|Sex: Female, Male||Participants|Count of Participants|3415|3415.0||||||
3987659|NCT01251757|3809026|B2||Female|Sex: Female, Male||Participants|Count of Participants|3370|3370.0||||||
3987660|NCT01251757|3809027|B1||Female|Sex: Female, Male||Participants|Count of Participants|3432|3432.0||||||
3987661|NCT01251757|3809024|B4|||Age||years|Mean|63.6|63.6|Standard Deviation|12.2|12.2|||
3987662|NCT01251757|3809025|B3|||Age||years|Mean|63.5|63.5|Standard Deviation|12.2|12.2|||
3987663|NCT01251757|3809026|B2|||Age||years|Mean|63.6|63.6|Standard Deviation|12.1|12.1|||
3987664|NCT01251757|3809027|B1|||Age||years|Mean|63.6|63.6|Standard Deviation|12.2|12.2|||
3987665|NCT01251653|3809058|B10||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3987666|NCT01251653|3809059|B9||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3987667|NCT01251653|3809060|B8||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3987668|NCT01251653|3809061|B7||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3987669|NCT01251653|3809062|B6||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3987670|NCT01251653|3809063|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3987671|NCT01251653|3809064|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3987672|NCT01251653|3809065|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3987673|NCT01251653|3809066|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3987674|NCT01251653|3809067|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3987675|NCT01251653|3809058|B10||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3987676|NCT01251653|3809059|B9||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3987677|NCT01251653|3809060|B8||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3987678|NCT01251653|3809061|B7||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3987679|NCT01251653|3809062|B6||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3987680|NCT01251653|3809063|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3987681|NCT01251653|3809064|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3987682|NCT01251653|3809065|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3987683|NCT01251653|3809066|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3987684|NCT01251653|3809067|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3987685|NCT01251653|3809058|B10|||Age||Years|Mean|56.7|56.7|Standard Deviation|11.2|11.2|||
3987686|NCT01251653|3809059|B9|||Age||Years|Mean|54.5|54.5|Standard Deviation|6.5|6.5|||
3987687|NCT01251653|3809060|B8|||Age||Years|Mean|59.3|59.3|Standard Deviation|10.2|10.2|||
3987688|NCT01251653|3809061|B7|||Age||Years|Mean|59.2|59.2|Standard Deviation|10.6|10.6|||
3987689|NCT01251653|3809062|B6|||Age||Years|Mean|55.4|55.4|Standard Deviation|11.0|11.0|||
3987690|NCT01251653|3809063|B5|||Age||Years|Mean|61.0|61.0|Standard Deviation|1.4|1.4|||
3987691|NCT01251653|3809064|B4|||Age||Years|Mean|52.3|52.3|Standard Deviation|16.5|16.5|||
3987692|NCT01251653|3809065|B3|||Age||Years|Mean|57.7|57.7|Standard Deviation|10.2|10.2|||
3987693|NCT01251653|3809066|B2|||Age||Years|Mean|52.1|52.1|Standard Deviation|13.8|13.8|||
3987694|NCT01251653|3809067|B1|||Age||Years|Mean|55.7|55.7|Standard Deviation|20.8|20.8|||
3987695|NCT01251614|3809200|B4||Severe|Physician's Global Assessment of Psoriasis|The PGA is a 6-point scale used to measure the severity of disease using the following categories: 0 (Cleared): No scaling, erythema, or plaque elevation; 1 (Minimal): Occasional fine scale over < 5% of lesions, faint erythema, minimal plaque elevation; 2 (Mild): Fine scale, light red coloration, mild plaque elevation; 3 (Moderate): Course scale, moderate red coloration, moderate plaque elevation; 4 (Marked): Thick non-tenacious scale dominates, bright red coloration, marked plaque elevation; 5 (Severe): Very thick tenacious scale, dusky to deep red coloration, severe plaque elevation.|Participants|Count of Participants|3|3.0||||||
3987696|NCT01251614|3809201|B3||Severe|Physician's Global Assessment of Psoriasis|The PGA is a 6-point scale used to measure the severity of disease using the following categories: 0 (Cleared): No scaling, erythema, or plaque elevation; 1 (Minimal): Occasional fine scale over < 5% of lesions, faint erythema, minimal plaque elevation; 2 (Mild): Fine scale, light red coloration, mild plaque elevation; 3 (Moderate): Course scale, moderate red coloration, moderate plaque elevation; 4 (Marked): Thick non-tenacious scale dominates, bright red coloration, marked plaque elevation; 5 (Severe): Very thick tenacious scale, dusky to deep red coloration, severe plaque elevation.|Participants|Count of Participants|1|1.0||||||
3987754|NCT01251614|3809203|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3987755|NCT01251614|3809200|B4||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3987697|NCT01251614|3809202|B2||Severe|Physician's Global Assessment of Psoriasis|The PGA is a 6-point scale used to measure the severity of disease using the following categories: 0 (Cleared): No scaling, erythema, or plaque elevation; 1 (Minimal): Occasional fine scale over < 5% of lesions, faint erythema, minimal plaque elevation; 2 (Mild): Fine scale, light red coloration, mild plaque elevation; 3 (Moderate): Course scale, moderate red coloration, moderate plaque elevation; 4 (Marked): Thick non-tenacious scale dominates, bright red coloration, marked plaque elevation; 5 (Severe): Very thick tenacious scale, dusky to deep red coloration, severe plaque elevation.|Participants|Count of Participants|2|2.0||||||
3987698|NCT01251614|3809203|B1||Severe|Physician's Global Assessment of Psoriasis|The PGA is a 6-point scale used to measure the severity of disease using the following categories: 0 (Cleared): No scaling, erythema, or plaque elevation; 1 (Minimal): Occasional fine scale over < 5% of lesions, faint erythema, minimal plaque elevation; 2 (Mild): Fine scale, light red coloration, mild plaque elevation; 3 (Moderate): Course scale, moderate red coloration, moderate plaque elevation; 4 (Marked): Thick non-tenacious scale dominates, bright red coloration, marked plaque elevation; 5 (Severe): Very thick tenacious scale, dusky to deep red coloration, severe plaque elevation.|Participants|Count of Participants|0|0.0||||||
3987699|NCT01251614|3809200|B4||Marked|Physician's Global Assessment of Psoriasis|The PGA is a 6-point scale used to measure the severity of disease using the following categories: 0 (Cleared): No scaling, erythema, or plaque elevation; 1 (Minimal): Occasional fine scale over < 5% of lesions, faint erythema, minimal plaque elevation; 2 (Mild): Fine scale, light red coloration, mild plaque elevation; 3 (Moderate): Course scale, moderate red coloration, moderate plaque elevation; 4 (Marked): Thick non-tenacious scale dominates, bright red coloration, marked plaque elevation; 5 (Severe): Very thick tenacious scale, dusky to deep red coloration, severe plaque elevation.|Participants|Count of Participants|49|49.0||||||
3987700|NCT01251614|3809201|B3||Marked|Physician's Global Assessment of Psoriasis|The PGA is a 6-point scale used to measure the severity of disease using the following categories: 0 (Cleared): No scaling, erythema, or plaque elevation; 1 (Minimal): Occasional fine scale over < 5% of lesions, faint erythema, minimal plaque elevation; 2 (Mild): Fine scale, light red coloration, mild plaque elevation; 3 (Moderate): Course scale, moderate red coloration, moderate plaque elevation; 4 (Marked): Thick non-tenacious scale dominates, bright red coloration, marked plaque elevation; 5 (Severe): Very thick tenacious scale, dusky to deep red coloration, severe plaque elevation.|Participants|Count of Participants|17|17.0||||||
3987701|NCT01251614|3809202|B2||Marked|Physician's Global Assessment of Psoriasis|The PGA is a 6-point scale used to measure the severity of disease using the following categories: 0 (Cleared): No scaling, erythema, or plaque elevation; 1 (Minimal): Occasional fine scale over < 5% of lesions, faint erythema, minimal plaque elevation; 2 (Mild): Fine scale, light red coloration, mild plaque elevation; 3 (Moderate): Course scale, moderate red coloration, moderate plaque elevation; 4 (Marked): Thick non-tenacious scale dominates, bright red coloration, marked plaque elevation; 5 (Severe): Very thick tenacious scale, dusky to deep red coloration, severe plaque elevation.|Participants|Count of Participants|15|15.0||||||
3987702|NCT01251614|3809203|B1||Marked|Physician's Global Assessment of Psoriasis|The PGA is a 6-point scale used to measure the severity of disease using the following categories: 0 (Cleared): No scaling, erythema, or plaque elevation; 1 (Minimal): Occasional fine scale over < 5% of lesions, faint erythema, minimal plaque elevation; 2 (Mild): Fine scale, light red coloration, mild plaque elevation; 3 (Moderate): Course scale, moderate red coloration, moderate plaque elevation; 4 (Marked): Thick non-tenacious scale dominates, bright red coloration, marked plaque elevation; 5 (Severe): Very thick tenacious scale, dusky to deep red coloration, severe plaque elevation.|Participants|Count of Participants|17|17.0||||||
3987703|NCT01251614|3809200|B4||Moderate|Physician's Global Assessment of Psoriasis|The PGA is a 6-point scale used to measure the severity of disease using the following categories: 0 (Cleared): No scaling, erythema, or plaque elevation; 1 (Minimal): Occasional fine scale over < 5% of lesions, faint erythema, minimal plaque elevation; 2 (Mild): Fine scale, light red coloration, mild plaque elevation; 3 (Moderate): Course scale, moderate red coloration, moderate plaque elevation; 4 (Marked): Thick non-tenacious scale dominates, bright red coloration, marked plaque elevation; 5 (Severe): Very thick tenacious scale, dusky to deep red coloration, severe plaque elevation.|Participants|Count of Participants|54|54.0||||||
3987704|NCT01251614|3809201|B3||Moderate|Physician's Global Assessment of Psoriasis|The PGA is a 6-point scale used to measure the severity of disease using the following categories: 0 (Cleared): No scaling, erythema, or plaque elevation; 1 (Minimal): Occasional fine scale over < 5% of lesions, faint erythema, minimal plaque elevation; 2 (Mild): Fine scale, light red coloration, mild plaque elevation; 3 (Moderate): Course scale, moderate red coloration, moderate plaque elevation; 4 (Marked): Thick non-tenacious scale dominates, bright red coloration, marked plaque elevation; 5 (Severe): Very thick tenacious scale, dusky to deep red coloration, severe plaque elevation.|Participants|Count of Participants|17|17.0||||||
3987705|NCT01251614|3809202|B2||Moderate|Physician's Global Assessment of Psoriasis|The PGA is a 6-point scale used to measure the severity of disease using the following categories: 0 (Cleared): No scaling, erythema, or plaque elevation; 1 (Minimal): Occasional fine scale over < 5% of lesions, faint erythema, minimal plaque elevation; 2 (Mild): Fine scale, light red coloration, mild plaque elevation; 3 (Moderate): Course scale, moderate red coloration, moderate plaque elevation; 4 (Marked): Thick non-tenacious scale dominates, bright red coloration, marked plaque elevation; 5 (Severe): Very thick tenacious scale, dusky to deep red coloration, severe plaque elevation.|Participants|Count of Participants|18|18.0||||||
3987706|NCT01251614|3809203|B1||Moderate|Physician's Global Assessment of Psoriasis|The PGA is a 6-point scale used to measure the severity of disease using the following categories: 0 (Cleared): No scaling, erythema, or plaque elevation; 1 (Minimal): Occasional fine scale over < 5% of lesions, faint erythema, minimal plaque elevation; 2 (Mild): Fine scale, light red coloration, mild plaque elevation; 3 (Moderate): Course scale, moderate red coloration, moderate plaque elevation; 4 (Marked): Thick non-tenacious scale dominates, bright red coloration, marked plaque elevation; 5 (Severe): Very thick tenacious scale, dusky to deep red coloration, severe plaque elevation.|Participants|Count of Participants|19|19.0||||||
3987756|NCT01251614|3809201|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3987757|NCT01251614|3809202|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3987758|NCT01251614|3809203|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3987759|NCT01251614|3809200|B4|||Age||years|Mean|13.0|13.0|Standard Deviation|3.76|3.76|||
3987707|NCT01251614|3809200|B4||Mild|Physician's Global Assessment of Psoriasis|The PGA is a 6-point scale used to measure the severity of disease using the following categories: 0 (Cleared): No scaling, erythema, or plaque elevation; 1 (Minimal): Occasional fine scale over < 5% of lesions, faint erythema, minimal plaque elevation; 2 (Mild): Fine scale, light red coloration, mild plaque elevation; 3 (Moderate): Course scale, moderate red coloration, moderate plaque elevation; 4 (Marked): Thick non-tenacious scale dominates, bright red coloration, marked plaque elevation; 5 (Severe): Very thick tenacious scale, dusky to deep red coloration, severe plaque elevation.|Participants|Count of Participants|7|7.0||||||
3987708|NCT01251614|3809201|B3||Mild|Physician's Global Assessment of Psoriasis|The PGA is a 6-point scale used to measure the severity of disease using the following categories: 0 (Cleared): No scaling, erythema, or plaque elevation; 1 (Minimal): Occasional fine scale over < 5% of lesions, faint erythema, minimal plaque elevation; 2 (Mild): Fine scale, light red coloration, mild plaque elevation; 3 (Moderate): Course scale, moderate red coloration, moderate plaque elevation; 4 (Marked): Thick non-tenacious scale dominates, bright red coloration, marked plaque elevation; 5 (Severe): Very thick tenacious scale, dusky to deep red coloration, severe plaque elevation.|Participants|Count of Participants|3|3.0||||||
3987709|NCT01251614|3809202|B2||Mild|Physician's Global Assessment of Psoriasis|The PGA is a 6-point scale used to measure the severity of disease using the following categories: 0 (Cleared): No scaling, erythema, or plaque elevation; 1 (Minimal): Occasional fine scale over < 5% of lesions, faint erythema, minimal plaque elevation; 2 (Mild): Fine scale, light red coloration, mild plaque elevation; 3 (Moderate): Course scale, moderate red coloration, moderate plaque elevation; 4 (Marked): Thick non-tenacious scale dominates, bright red coloration, marked plaque elevation; 5 (Severe): Very thick tenacious scale, dusky to deep red coloration, severe plaque elevation.|Participants|Count of Participants|3|3.0||||||
3987710|NCT01251614|3809203|B1||Mild|Physician's Global Assessment of Psoriasis|The PGA is a 6-point scale used to measure the severity of disease using the following categories: 0 (Cleared): No scaling, erythema, or plaque elevation; 1 (Minimal): Occasional fine scale over < 5% of lesions, faint erythema, minimal plaque elevation; 2 (Mild): Fine scale, light red coloration, mild plaque elevation; 3 (Moderate): Course scale, moderate red coloration, moderate plaque elevation; 4 (Marked): Thick non-tenacious scale dominates, bright red coloration, marked plaque elevation; 5 (Severe): Very thick tenacious scale, dusky to deep red coloration, severe plaque elevation.|Participants|Count of Participants|1|1.0||||||
3987711|NCT01251614|3809200|B4||Minimal|Physician's Global Assessment of Psoriasis|The PGA is a 6-point scale used to measure the severity of disease using the following categories: 0 (Cleared): No scaling, erythema, or plaque elevation; 1 (Minimal): Occasional fine scale over < 5% of lesions, faint erythema, minimal plaque elevation; 2 (Mild): Fine scale, light red coloration, mild plaque elevation; 3 (Moderate): Course scale, moderate red coloration, moderate plaque elevation; 4 (Marked): Thick non-tenacious scale dominates, bright red coloration, marked plaque elevation; 5 (Severe): Very thick tenacious scale, dusky to deep red coloration, severe plaque elevation.|Participants|Count of Participants|1|1.0||||||
3987712|NCT01251614|3809201|B3||Minimal|Physician's Global Assessment of Psoriasis|The PGA is a 6-point scale used to measure the severity of disease using the following categories: 0 (Cleared): No scaling, erythema, or plaque elevation; 1 (Minimal): Occasional fine scale over < 5% of lesions, faint erythema, minimal plaque elevation; 2 (Mild): Fine scale, light red coloration, mild plaque elevation; 3 (Moderate): Course scale, moderate red coloration, moderate plaque elevation; 4 (Marked): Thick non-tenacious scale dominates, bright red coloration, marked plaque elevation; 5 (Severe): Very thick tenacious scale, dusky to deep red coloration, severe plaque elevation.|Participants|Count of Participants|0|0.0||||||
3987713|NCT01251614|3809202|B2||Minimal|Physician's Global Assessment of Psoriasis|The PGA is a 6-point scale used to measure the severity of disease using the following categories: 0 (Cleared): No scaling, erythema, or plaque elevation; 1 (Minimal): Occasional fine scale over < 5% of lesions, faint erythema, minimal plaque elevation; 2 (Mild): Fine scale, light red coloration, mild plaque elevation; 3 (Moderate): Course scale, moderate red coloration, moderate plaque elevation; 4 (Marked): Thick non-tenacious scale dominates, bright red coloration, marked plaque elevation; 5 (Severe): Very thick tenacious scale, dusky to deep red coloration, severe plaque elevation.|Participants|Count of Participants|1|1.0||||||
3987714|NCT01251614|3809203|B1||Minimal|Physician's Global Assessment of Psoriasis|The PGA is a 6-point scale used to measure the severity of disease using the following categories: 0 (Cleared): No scaling, erythema, or plaque elevation; 1 (Minimal): Occasional fine scale over < 5% of lesions, faint erythema, minimal plaque elevation; 2 (Mild): Fine scale, light red coloration, mild plaque elevation; 3 (Moderate): Course scale, moderate red coloration, moderate plaque elevation; 4 (Marked): Thick non-tenacious scale dominates, bright red coloration, marked plaque elevation; 5 (Severe): Very thick tenacious scale, dusky to deep red coloration, severe plaque elevation.|Participants|Count of Participants|0|0.0||||||
3987715|NCT01251614|3809200|B4||Cleared|Physician's Global Assessment of Psoriasis|The PGA is a 6-point scale used to measure the severity of disease using the following categories: 0 (Cleared): No scaling, erythema, or plaque elevation; 1 (Minimal): Occasional fine scale over < 5% of lesions, faint erythema, minimal plaque elevation; 2 (Mild): Fine scale, light red coloration, mild plaque elevation; 3 (Moderate): Course scale, moderate red coloration, moderate plaque elevation; 4 (Marked): Thick non-tenacious scale dominates, bright red coloration, marked plaque elevation; 5 (Severe): Very thick tenacious scale, dusky to deep red coloration, severe plaque elevation.|Participants|Count of Participants|0|0.0||||||
3987716|NCT01251614|3809201|B3||Cleared|Physician's Global Assessment of Psoriasis|The PGA is a 6-point scale used to measure the severity of disease using the following categories: 0 (Cleared): No scaling, erythema, or plaque elevation; 1 (Minimal): Occasional fine scale over < 5% of lesions, faint erythema, minimal plaque elevation; 2 (Mild): Fine scale, light red coloration, mild plaque elevation; 3 (Moderate): Course scale, moderate red coloration, moderate plaque elevation; 4 (Marked): Thick non-tenacious scale dominates, bright red coloration, marked plaque elevation; 5 (Severe): Very thick tenacious scale, dusky to deep red coloration, severe plaque elevation.|Participants|Count of Participants|0|0.0||||||
3987760|NCT01251614|3809201|B3|||Age||years|Mean|13.0|13.0|Standard Deviation|3.29|3.29|||
3987761|NCT01251614|3809202|B2|||Age||years|Mean|12.6|12.6|Standard Deviation|4.43|4.43|||
3987762|NCT01251614|3809203|B1|||Age||years|Mean|13.4|13.4|Standard Deviation|3.49|3.49|||
3987763|NCT01251588|3809277|B3|France||Region of Enrollment||participants|Number|15|15.0||||||
3987764|NCT01251588|3809278|B2|France||Region of Enrollment||participants|Number|7|7.0||||||
3987717|NCT01251614|3809202|B2||Cleared|Physician's Global Assessment of Psoriasis|The PGA is a 6-point scale used to measure the severity of disease using the following categories: 0 (Cleared): No scaling, erythema, or plaque elevation; 1 (Minimal): Occasional fine scale over < 5% of lesions, faint erythema, minimal plaque elevation; 2 (Mild): Fine scale, light red coloration, mild plaque elevation; 3 (Moderate): Course scale, moderate red coloration, moderate plaque elevation; 4 (Marked): Thick non-tenacious scale dominates, bright red coloration, marked plaque elevation; 5 (Severe): Very thick tenacious scale, dusky to deep red coloration, severe plaque elevation.|Participants|Count of Participants|0|0.0||||||
3987718|NCT01251614|3809203|B1||Cleared|Physician's Global Assessment of Psoriasis|The PGA is a 6-point scale used to measure the severity of disease using the following categories: 0 (Cleared): No scaling, erythema, or plaque elevation; 1 (Minimal): Occasional fine scale over < 5% of lesions, faint erythema, minimal plaque elevation; 2 (Mild): Fine scale, light red coloration, mild plaque elevation; 3 (Moderate): Course scale, moderate red coloration, moderate plaque elevation; 4 (Marked): Thick non-tenacious scale dominates, bright red coloration, marked plaque elevation; 5 (Severe): Very thick tenacious scale, dusky to deep red coloration, severe plaque elevation.|Participants|Count of Participants|0|0.0||||||
3987719|NCT01251614|3809200|B4|||Psoriasis Area and Severity Index (PASI)|PASI is a composite score based on the degree of effect on body surface area of psoriasis and the extension of erythema (reddening), induration (plaque thickness), desquamation (scaling) of the lesions and area affected as observed on the day of examination. The score ranges from 0 (no psoriasis) to 72 (very severe psoriasis).|units on a scale|Mean|18.3|18.3|Standard Deviation|8.78|8.78|||
3987720|NCT01251614|3809201|B3|||Psoriasis Area and Severity Index (PASI)|PASI is a composite score based on the degree of effect on body surface area of psoriasis and the extension of erythema (reddening), induration (plaque thickness), desquamation (scaling) of the lesions and area affected as observed on the day of examination. The score ranges from 0 (no psoriasis) to 72 (very severe psoriasis).|units on a scale|Mean|18.9|18.9|Standard Deviation|10.03|10.03|||
3987721|NCT01251614|3809202|B2|||Psoriasis Area and Severity Index (PASI)|PASI is a composite score based on the degree of effect on body surface area of psoriasis and the extension of erythema (reddening), induration (plaque thickness), desquamation (scaling) of the lesions and area affected as observed on the day of examination. The score ranges from 0 (no psoriasis) to 72 (very severe psoriasis).|units on a scale|Mean|16.9|16.9|Standard Deviation|5.76|5.76|||
3987722|NCT01251614|3809203|B1|||Psoriasis Area and Severity Index (PASI)|PASI is a composite score based on the degree of effect on body surface area of psoriasis and the extension of erythema (reddening), induration (plaque thickness), desquamation (scaling) of the lesions and area affected as observed on the day of examination. The score ranges from 0 (no psoriasis) to 72 (very severe psoriasis).|units on a scale|Mean|19.2|19.2|Standard Deviation|10.02|10.02|||
3987723|NCT01251614|3809200|B4|Mutli Race||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3987724|NCT01251614|3809201|B3|Mutli Race||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3987725|NCT01251614|3809202|B2|Mutli Race||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3987726|NCT01251614|3809203|B1|Mutli Race||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3987727|NCT01251614|3809200|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3987728|NCT01251614|3809201|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3987729|NCT01251614|3809202|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3987730|NCT01251614|3809203|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3987731|NCT01251614|3809200|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3987732|NCT01251614|3809201|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3987733|NCT01251614|3809202|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3987734|NCT01251614|3809203|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3987735|NCT01251614|3809200|B4|American Indian/Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3987736|NCT01251614|3809201|B3|American Indian/Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3987737|NCT01251614|3809202|B2|American Indian/Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3987738|NCT01251614|3809203|B1|American Indian/Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3987739|NCT01251614|3809200|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3987740|NCT01251614|3809201|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3987741|NCT01251614|3809202|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3987742|NCT01251614|3809203|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3987743|NCT01251614|3809200|B4|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3987744|NCT01251614|3809201|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3987745|NCT01251614|3809202|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3987746|NCT01251614|3809203|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3987747|NCT01251614|3809200|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|103|103.0||||||
3987748|NCT01251614|3809201|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
3987749|NCT01251614|3809202|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3987750|NCT01251614|3809203|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3987751|NCT01251614|3809200|B4||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3987752|NCT01251614|3809201|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3987753|NCT01251614|3809202|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3987765|NCT01251588|3809279|B1|France||Region of Enrollment||participants|Number|8|8.0||||||
3987766|NCT01251588|3809277|B3|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
3987767|NCT01251588|3809278|B2|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3987768|NCT01251588|3809279|B1|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
3987769|NCT01251588|3809277|B3|Poland||Region of Enrollment||participants|Number|25|25.0||||||
3987770|NCT01251588|3809278|B2|Poland||Region of Enrollment||participants|Number|12|12.0||||||
3987771|NCT01251588|3809279|B1|Poland||Region of Enrollment||participants|Number|13|13.0||||||
3987772|NCT01251588|3809277|B3|Norway||Region of Enrollment||participants|Number|6|6.0||||||
3987773|NCT01251588|3809278|B2|Norway||Region of Enrollment||participants|Number|3|3.0||||||
3987774|NCT01251588|3809279|B1|Norway||Region of Enrollment||participants|Number|3|3.0||||||
3987775|NCT01251588|3809277|B3|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
3987776|NCT01251588|3809278|B2|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
3987777|NCT01251588|3809279|B1|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
3987778|NCT01251588|3809277|B3|Netherlands||Region of Enrollment||participants|Number|58|58.0||||||
3987779|NCT01251588|3809278|B2|Netherlands||Region of Enrollment||participants|Number|30|30.0||||||
3987780|NCT01251588|3809279|B1|Netherlands||Region of Enrollment||participants|Number|28|28.0||||||
3987781|NCT01251588|3809277|B3|Czech Republic||Region of Enrollment||participants|Number|16|16.0||||||
3987782|NCT01251588|3809278|B2|Czech Republic||Region of Enrollment||participants|Number|7|7.0||||||
3987783|NCT01251588|3809279|B1|Czech Republic||Region of Enrollment||participants|Number|9|9.0||||||
3987784|NCT01251588|3809277|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3987785|NCT01251588|3809278|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3987786|NCT01251588|3809279|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3987787|NCT01251588|3809277|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3987788|NCT01251588|3809278|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3987789|NCT01251588|3809279|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3987790|NCT01251588|3809277|B3|||Age|Age at the time of MACI or microfracture treatment|years|Mean|33.6|33.6|Standard Deviation|8.88|8.88|||
3987791|NCT01251588|3809278|B2|||Age|Age at the time of MACI or microfracture treatment|years|Mean|32.7|32.7|Standard Deviation|8.80|8.8|||
3987792|NCT01251588|3809279|B1|||Age|Age at the time of MACI or microfracture treatment|years|Mean|34.4|34.4|Standard Deviation|8.94|8.94|||
3987793|NCT01251380|3809312|B1|Multiple||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
3987794|NCT01251380|3809312|B1|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3987795|NCT01251380|3809312|B1|Caucasian/White||Race/Ethnicity, Customized||participants|Number|159|159.0||||||
3987796|NCT01251380|3809312|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3987797|NCT01251380|3809312|B1||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3987798|NCT01251380|3809312|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3987799|NCT01251380|3809312|B1|Children (10-17 years)||Age, Customized||participants|Number|33|33.0||||||
3987800|NCT01251380|3809312|B1|Children (2-9 years)||Age, Customized||participants|Number|183|183.0||||||
3987801|NCT01251380|3809312|B1|||Age||years|Mean|5.9|5.9|Standard Deviation|3.3|3.3|||
3987802|NCT01251367|3809336|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987803|NCT01251367|3809336|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3987804|NCT01251367|3809336|B1||White|Race (NIH/OMB)||Participants|Count of Participants|313|313.0||||||
3987805|NCT01251367|3809336|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3987806|NCT01251367|3809336|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3987807|NCT01251367|3809336|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3987808|NCT01251367|3809336|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987809|NCT01251367|3809336|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987810|NCT01251367|3809336|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|311|311.0||||||
3987811|NCT01251367|3809336|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3987812|NCT01251367|3809336|B1||Male|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
3987813|NCT01251367|3809336|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3987814|NCT01251367|3809336|B1|||Age||years|Mean|53.1|53.1|Standard Deviation|12.8|12.8|||
3987815|NCT01251367|3809336|B1||>=65 years|Age||Participants|Count of Participants|65|65.0||||||
3987816|NCT01251367|3809336|B1||Between 18 and 65 years|Age||Participants|Count of Participants|280|280.0||||||
3987817|NCT01251367|3809336|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3987818|NCT01251354|3809371|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3987819|NCT01251354|3809371|B1|Canada||Region of Enrollment||participants|Number|4|4.0||||||
3987820|NCT01251354|3809371|B1|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3987821|NCT01251354|3809371|B1|Black / African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3987822|NCT01251354|3809371|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3987823|NCT01251354|3809371|B1|Caucasian / White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3987824|NCT01251354|3809371|B1|Female||Sex/Gender, Customized||participants|Number|6|6.0||||||
3987825|NCT01251354|3809371|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3987826|NCT01251354|3809371|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3987827|NCT01251354|3809371|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3987828|NCT01251315|3809381|B7|United States||Region of Enrollment||participants|Number|24|24.0||||||
3987829|NCT01251315|3809382|B6|United States||Region of Enrollment||participants|Number|4|4.0||||||
3987830|NCT01251315|3809383|B5|United States||Region of Enrollment||participants|Number|4|4.0||||||
3987831|NCT01251315|3809384|B4|United States||Region of Enrollment||participants|Number|4|4.0||||||
3987832|NCT01251315|3809385|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3987833|NCT01251315|3809386|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3987834|NCT01251315|3809387|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3987835|NCT01251315|3809381|B7||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3987836|NCT01251315|3809382|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3987837|NCT01251315|3809383|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3987838|NCT01251315|3809384|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3987839|NCT01251315|3809385|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3987840|NCT01251315|3809386|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3987841|NCT01251315|3809387|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3987842|NCT01251315|3809381|B7||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3987843|NCT01251315|3809382|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3987844|NCT01251315|3809383|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3987845|NCT01251315|3809384|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3987846|NCT01251315|3809385|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3987847|NCT01251315|3809386|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3987848|NCT01251315|3809387|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3987849|NCT01251315|3809381|B7|||Age||years|Mean|40|40.0|Standard Deviation|8.3|8.3|||
3987850|NCT01251315|3809382|B6|||Age||years|Mean|42.5|42.5|Standard Deviation|9.2|9.2|||
3987851|NCT01251315|3809383|B5|||Age||years|Mean|38.0|38.0|Standard Deviation|5.8|5.8|||
3987852|NCT01251315|3809384|B4|||Age||years|Mean|39.3|39.3|Standard Deviation|6.8|6.8|||
3987853|NCT01251315|3809385|B3|||Age||years|Mean|45.5|45.5|Standard Deviation|12.9|12.9|||
3987854|NCT01251315|3809386|B2|||Age||years|Mean|38.2|38.2|Standard Deviation|3.8|3.8|||
3987855|NCT01251315|3809387|B1|||Age||years|Mean|38.7|38.7|Standard Deviation|6.4|6.4|||
3987856|NCT01251276|3809412|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3987857|NCT01251276|3809413|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3987858|NCT01251276|3809414|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3987859|NCT01251276|3809412|B3||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3987860|NCT01251276|3809413|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3987861|NCT01251276|3809414|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3987862|NCT01251276|3809412|B3|||Age|Age at the time of challenge dose|Years|Mean|63.7|63.7|Standard Deviation|7.0|7.0|||
3987863|NCT01251276|3809413|B2|||Age|Age at the time of challenge dose|Years|Mean|63.6|63.6|Standard Deviation|6.7|6.7|||
3987864|NCT01251276|3809414|B1|||Age|Age at the time of challenge dose|Years|Mean|63.8|63.8|Standard Deviation|7.3|7.3|||
3987865|NCT01251146|3809431|B3||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3987866|NCT01251146|3809432|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3987867|NCT01251146|3809433|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3987868|NCT01251146|3809431|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3987869|NCT01251146|3809432|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3987870|NCT01251146|3809433|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3987871|NCT01251146|3809431|B3|||Age||years|Mean|45.88|45.88|Standard Deviation|9.81|9.81|||
3987872|NCT01251146|3809432|B2|||Age||years|Mean|46.30|46.3|Standard Deviation|9.87|9.87|||
3987873|NCT01251146|3809433|B1|||Age||years|Mean|45.44|45.44|Standard Deviation|9.78|9.78|||
3987874|NCT01251120|3809454|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3987875|NCT01251120|3809455|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3987876|NCT01251120|3809456|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3987877|NCT01251120|3809454|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3987878|NCT01251120|3809455|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3987879|NCT01251120|3809456|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3987880|NCT01251120|3809454|B3|||Age||years|Mean|55.7|55.7|Standard Deviation|7.5|7.5|||
3987881|NCT01251120|3809455|B2|||Age||years|Mean|48.2|48.2|Standard Deviation|0.0|0.0|||
3987882|NCT01251120|3809456|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|0.0|0.0|||
3987883|NCT01251042|3809477|B3|Denmark||Region of Enrollment||participants|Number|49|49.0||||||
3987884|NCT01251042|3809478|B2|Denmark||Region of Enrollment||participants|Number|23|23.0||||||
3987885|NCT01251042|3809479|B1|Denmark||Region of Enrollment||participants|Number|26|26.0||||||
3987886|NCT01251042|3809477|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3987887|NCT01251042|3809478|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3987888|NCT01251042|3809479|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3987889|NCT01251042|3809477|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3987890|NCT01251042|3809478|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3987891|NCT01251042|3809479|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3987892|NCT01251042|3809477|B3|||Age||years|Mean|56|56.0|Standard Deviation|14|14.0|||
3987893|NCT01251042|3809478|B2|||Age||years|Mean|59|59.0|Standard Deviation|13|13.0|||
3987894|NCT01251042|3809479|B1|||Age||years|Mean|53|53.0|Standard Deviation|14|14.0|||
3987895|NCT01250990|3809510|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3987896|NCT01250990|3809511|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3987897|NCT01250990|3809512|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3987898|NCT01250990|3809510|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3987899|NCT01250990|3809511|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3987900|NCT01250990|3809512|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3987901|NCT01250990|3809510|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3987902|NCT01250990|3809511|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3987903|NCT01250990|3809512|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3987904|NCT01250990|3809510|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3987905|NCT01250990|3809511|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3987906|NCT01250990|3809512|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3987907|NCT01250990|3809510|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3987908|NCT01250990|3809511|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3987909|NCT01250990|3809512|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3987910|NCT01250925|3809519|B4|United States||Region of Enrollment||participants|Number|94|94.0||||||
3987911|NCT01250925|3809520|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
3987912|NCT01250925|3809521|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
3987913|NCT01250925|3809522|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
3987914|NCT01250925|3809519|B4||Male|Gender||Participants|Count of Participants|39|39.0||||||
3987915|NCT01250925|3809520|B3||Male|Gender||Participants|Count of Participants|18|18.0||||||
3987916|NCT01250925|3809521|B2||Male|Gender||Participants|Count of Participants|13|13.0||||||
3987917|NCT01250925|3809522|B1||Male|Gender||Participants|Count of Participants|8|8.0||||||
3987918|NCT01250925|3809519|B4||Female|Gender||Participants|Count of Participants|55|55.0||||||
3987919|NCT01250925|3809520|B3||Female|Gender||Participants|Count of Participants|14|14.0||||||
3987920|NCT01250925|3809521|B2||Female|Gender||Participants|Count of Participants|18|18.0||||||
3987921|NCT01250925|3809522|B1||Female|Gender||Participants|Count of Participants|23|23.0||||||
3987922|NCT01250925|3809519|B4|||Age||years|Mean|31.4|31.4|Standard Deviation|10.5|10.5|||
3987923|NCT01250925|3809520|B3|||Age||years|Mean|30.6|30.6|Standard Deviation|9.1|9.1|||
3987924|NCT01250925|3809521|B2|||Age||years|Mean|32.9|32.9|Standard Deviation|12.2|12.2|||
3987925|NCT01250925|3809522|B1|||Age||years|Mean|30.7|30.7|Standard Deviation|10.3|10.3|||
3987926|NCT01250925|3809519|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3987927|NCT01250925|3809520|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3987928|NCT01250925|3809521|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3987929|NCT01250925|3809522|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3987930|NCT01250925|3809519|B4||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
3987931|NCT01250925|3809520|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3987932|NCT01250925|3809521|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3987933|NCT01250925|3809522|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3987934|NCT01250925|3809519|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3987935|NCT01250925|3809520|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3987936|NCT01250925|3809521|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3987937|NCT01250925|3809522|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3987938|NCT01250899|3809562|B3||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3987939|NCT01250899|3809563|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3987940|NCT01250899|3809564|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3987941|NCT01250899|3809562|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3987942|NCT01250899|3809563|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3987943|NCT01250899|3809564|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3987944|NCT01250899|3809562|B3|||Age||years|Median|48|48.0|Inter-Quartile Range|||39.0|57.0|
3987945|NCT01250899|3809563|B2|||Age||years|Median|48|48.0|Inter-Quartile Range|||39.0|57.0|
3987946|NCT01250899|3809564|B1|||Age||years|Median|49|49.0|Inter-Quartile Range|||43.0|56.0|
3987947|NCT01250873|3809569|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3987948|NCT01250873|3809569|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987949|NCT01250873|3809569|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3987950|NCT01250873|3809569|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3987951|NCT01250873|3809569|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3987952|NCT01250873|3809569|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987953|NCT01250873|3809569|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987954|NCT01250873|3809569|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987955|NCT01250873|3809569|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987956|NCT01250873|3809569|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3987957|NCT01250873|3809569|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3987958|NCT01250873|3809569|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3987959|NCT01250873|3809569|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3987960|NCT01250873|3809569|B1|||Age||years|Mean|37.8|37.8|Standard Deviation|8.8|8.8|||
3987961|NCT01250834|3809580|B1|United Kingdom||Region of Enrollment||participants|Number|27|27.0||||||
3987962|NCT01250834|3809580|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987963|NCT01250834|3809580|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987964|NCT01250834|3809580|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3987965|NCT01250834|3809580|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3987966|NCT01250834|3809580|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987967|NCT01250834|3809580|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3987968|NCT01250834|3809580|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987969|NCT01250834|3809580|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987970|NCT01250834|3809580|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3987971|NCT01250834|3809580|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3987972|NCT01250834|3809580|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3987973|NCT01250834|3809580|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3987974|NCT01250834|3809580|B1|||Age||years|Mean|42.7|42.7|Standard Deviation|15.1|15.1|||
3987975|NCT01250769|3809597|B5||Male|Sex: Female, Male|"1 subject who discontinued prior to Day 14 is excluded from the Manual Toothbrush 2 group~1 subject who discontinued prior to Day 14 is excluded from Manual Toothbrush + Interproximal Cleaning Device 1 group"|Participants|Count of Participants|56|56.0||||||
3987976|NCT01250769|3809598|B4||Male|Sex: Female, Male|"1 subject who discontinued prior to Day 14 is excluded from the Manual Toothbrush 2 group~1 subject who discontinued prior to Day 14 is excluded from Manual Toothbrush + Interproximal Cleaning Device 1 group"|Participants|Count of Participants|3|3.0||||||
3987977|NCT01250769|3809599|B3||Male|Sex: Female, Male|"1 subject who discontinued prior to Day 14 is excluded from the Manual Toothbrush 2 group~1 subject who discontinued prior to Day 14 is excluded from Manual Toothbrush + Interproximal Cleaning Device 1 group"|Participants|Count of Participants|26|26.0||||||
3987978|NCT01250769|3809600|B2||Male|Sex: Female, Male|"1 subject who discontinued prior to Day 14 is excluded from the Manual Toothbrush 2 group~1 subject who discontinued prior to Day 14 is excluded from Manual Toothbrush + Interproximal Cleaning Device 1 group"|Participants|Count of Participants|24|24.0||||||
3987979|NCT01250769|3809601|B1||Male|Sex: Female, Male|"1 subject who discontinued prior to Day 14 is excluded from the Manual Toothbrush 2 group~1 subject who discontinued prior to Day 14 is excluded from Manual Toothbrush + Interproximal Cleaning Device 1 group"|Participants|Count of Participants|3|3.0||||||
3987980|NCT01250769|3809597|B5||Female|Sex: Female, Male|"1 subject who discontinued prior to Day 14 is excluded from the Manual Toothbrush 2 group~1 subject who discontinued prior to Day 14 is excluded from Manual Toothbrush + Interproximal Cleaning Device 1 group"|Participants|Count of Participants|112|112.0||||||
3987981|NCT01250769|3809598|B4||Female|Sex: Female, Male|"1 subject who discontinued prior to Day 14 is excluded from the Manual Toothbrush 2 group~1 subject who discontinued prior to Day 14 is excluded from Manual Toothbrush + Interproximal Cleaning Device 1 group"|Participants|Count of Participants|8|8.0||||||
3987982|NCT01250769|3809599|B3||Female|Sex: Female, Male|"1 subject who discontinued prior to Day 14 is excluded from the Manual Toothbrush 2 group~1 subject who discontinued prior to Day 14 is excluded from Manual Toothbrush + Interproximal Cleaning Device 1 group"|Participants|Count of Participants|48|48.0||||||
3987983|NCT01250769|3809600|B2||Female|Sex: Female, Male|"1 subject who discontinued prior to Day 14 is excluded from the Manual Toothbrush 2 group~1 subject who discontinued prior to Day 14 is excluded from Manual Toothbrush + Interproximal Cleaning Device 1 group"|Participants|Count of Participants|48|48.0||||||
3987984|NCT01250769|3809601|B1||Female|Sex: Female, Male|"1 subject who discontinued prior to Day 14 is excluded from the Manual Toothbrush 2 group~1 subject who discontinued prior to Day 14 is excluded from Manual Toothbrush + Interproximal Cleaning Device 1 group"|Participants|Count of Participants|8|8.0||||||
3987985|NCT01250769|3809597|B5|||Age|"1 subject who discontinued prior to Day 14 is excluded from the Manual Toothbrush 2 group~1 subject who discontinued prior to Day 14 is excluded from Manual Toothbrush + Interproximal Cleaning Device 1 group"|years|Mean|39.6|39.6|Standard Deviation|11.30|11.3|||
3987986|NCT01250769|3809598|B4|||Age|"1 subject who discontinued prior to Day 14 is excluded from the Manual Toothbrush 2 group~1 subject who discontinued prior to Day 14 is excluded from Manual Toothbrush + Interproximal Cleaning Device 1 group"|years|Mean|41.2|41.2|Standard Deviation|12.80|12.8|||
3987987|NCT01250769|3809599|B3|||Age|"1 subject who discontinued prior to Day 14 is excluded from the Manual Toothbrush 2 group~1 subject who discontinued prior to Day 14 is excluded from Manual Toothbrush + Interproximal Cleaning Device 1 group"|years|Mean|39.6|39.6|Standard Deviation|10.90|10.9|||
3988047|NCT01250418|3809767|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
3987988|NCT01250769|3809600|B2|||Age|"1 subject who discontinued prior to Day 14 is excluded from the Manual Toothbrush 2 group~1 subject who discontinued prior to Day 14 is excluded from Manual Toothbrush + Interproximal Cleaning Device 1 group"|years|Mean|39.6|39.6|Standard Deviation|11.60|11.6|||
3987989|NCT01250769|3809601|B1|||Age|"1 subject who discontinued prior to Day 14 is excluded from the Manual Toothbrush 2 group~1 subject who discontinued prior to Day 14 is excluded from Manual Toothbrush + Interproximal Cleaning Device 1 group"|years|Mean|38.5|38.5|Standard Deviation|12.60|12.6|||
3987990|NCT01250756|3809634|B3||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
3987991|NCT01250756|3809635|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3987992|NCT01250756|3809636|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3987993|NCT01250756|3809634|B3||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3987994|NCT01250756|3809635|B2||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3987995|NCT01250756|3809636|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3987996|NCT01250756|3809634|B3|||Age||months|Mean|3.9|3.9|Standard Deviation|0.93|0.93|||
3987997|NCT01250756|3809635|B2|||Age||months|Mean|3.9|3.9|Standard Deviation|0.94|0.94|||
3987998|NCT01250756|3809636|B1|||Age||months|Mean|3.8|3.8|Standard Deviation|0.91|0.91|||
3987999|NCT01250730|3809687|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3988000|NCT01250730|3809688|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3988001|NCT01250730|3809689|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3988002|NCT01250730|3809690|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3988003|NCT01250730|3809687|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3988004|NCT01250730|3809688|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3988005|NCT01250730|3809689|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3988006|NCT01250730|3809690|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3988007|NCT01250730|3809687|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3988008|NCT01250730|3809688|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3988009|NCT01250730|3809689|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3988010|NCT01250730|3809690|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3988011|NCT01250730|3809687|B4||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3988012|NCT01250730|3809688|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3988013|NCT01250730|3809689|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3988014|NCT01250730|3809690|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3988015|NCT01250730|3809687|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3988016|NCT01250730|3809688|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3988017|NCT01250730|3809689|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3988018|NCT01250730|3809690|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3988019|NCT01250717|3809748|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
3988020|NCT01250717|3809748|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3988021|NCT01250717|3809748|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3988022|NCT01250717|3809748|B1|||Age||years|Median|57|57.0|Full Range|NA||43.0|71.0|
3988023|NCT01250717|3809748|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3988024|NCT01250717|3809748|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3988025|NCT01250717|3809748|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3988026|NCT01250509|3809752|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
3988027|NCT01250509|3809753|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
3988028|NCT01250509|3809754|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3988029|NCT01250509|3809752|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3988030|NCT01250509|3809753|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3988031|NCT01250509|3809754|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3988032|NCT01250509|3809752|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3988033|NCT01250509|3809753|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3988034|NCT01250509|3809754|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3988035|NCT01250509|3809752|B3|||Age||years|Mean|40.9|40.9|Standard Deviation|7.3|7.3|||
3988036|NCT01250509|3809753|B2|||Age||years|Mean|41.4|41.4|Standard Deviation|6.7|6.7|||
3988037|NCT01250509|3809754|B1|||Age||years|Mean|40.4|40.4|Standard Deviation|8.0|8.0|||
3988038|NCT01250509|3809752|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3988039|NCT01250509|3809753|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3988040|NCT01250509|3809754|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3988041|NCT01250509|3809752|B3||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3988042|NCT01250509|3809753|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3988043|NCT01250509|3809754|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3988044|NCT01250509|3809752|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3988045|NCT01250509|3809753|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3988046|NCT01250509|3809754|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3988048|NCT01250418|3809768|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3988049|NCT01250418|3809769|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3988050|NCT01250418|3809767|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3988051|NCT01250418|3809768|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3988052|NCT01250418|3809769|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3988053|NCT01250418|3809767|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3988054|NCT01250418|3809768|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3988055|NCT01250418|3809769|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3988056|NCT01250418|3809767|B3||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3988057|NCT01250418|3809768|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3988058|NCT01250418|3809769|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3988059|NCT01250418|3809767|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3988060|NCT01250418|3809768|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3988061|NCT01250418|3809769|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3988062|NCT01250418|3809767|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3988063|NCT01250418|3809768|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3988064|NCT01250418|3809769|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3988065|NCT01250418|3809767|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3988066|NCT01250418|3809768|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3988067|NCT01250418|3809769|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3988068|NCT01250418|3809767|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3988069|NCT01250418|3809768|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3988070|NCT01250418|3809769|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3988071|NCT01250418|3809767|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3988072|NCT01250418|3809768|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3988073|NCT01250418|3809769|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3988074|NCT01250418|3809767|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3988075|NCT01250418|3809768|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3988076|NCT01250418|3809769|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3988077|NCT01250418|3809767|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3988078|NCT01250418|3809768|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3988079|NCT01250418|3809769|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3988080|NCT01250418|3809767|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3988081|NCT01250418|3809768|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3988082|NCT01250418|3809769|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3988083|NCT01250418|3809767|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3988084|NCT01250418|3809768|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3988085|NCT01250418|3809769|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3988086|NCT01250379|3809776|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3988087|NCT01250379|3809777|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3988088|NCT01250379|3809778|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3988089|NCT01250379|3809776|B3||Female|Sex: Female, Male||Participants|Count of Participants|494|494.0||||||
3988090|NCT01250379|3809777|B2||Female|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
3988091|NCT01250379|3809778|B1||Female|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
3988092|NCT01250379|3809776|B3|||Age||years|Mean|55.2|55.2|Standard Deviation|11.01|11.01|||
3988093|NCT01250379|3809777|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|11.17|11.17|||
3988094|NCT01250379|3809778|B1|||Age||years|Mean|54.7|54.7|Standard Deviation|10.83|10.83|||
3988095|NCT01250210|3809837|B4|United States||Region of Enrollment||Participants|Count of Participants|118|118.0||||||
3988096|NCT01250210|3809838|B3|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3988097|NCT01250210|3809839|B2|United States||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3988098|NCT01250210|3809840|B1|United States||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
3988099|NCT01250210|3809837|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3988100|NCT01250210|3809838|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3988101|NCT01250210|3809839|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3988102|NCT01250210|3809840|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3988103|NCT01250210|3809837|B4||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3988104|NCT01250210|3809838|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3988105|NCT01250210|3809839|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3988106|NCT01250210|3809840|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3988107|NCT01250210|3809837|B4|||Age||years|Mean|31.6|31.6|Standard Deviation|7.3|7.3|||
3988108|NCT01250210|3809838|B3|||Age||years|Mean|32.1|32.1|Standard Deviation|7.8|7.8|||
3988109|NCT01250210|3809839|B2|||Age||years|Mean|31|31.0|Standard Deviation|6.9|6.9|||
3988110|NCT01250210|3809840|B1|||Age||years|Mean|31.7|31.7|Standard Deviation|7.4|7.4|||
3988111|NCT01250210|3809837|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3988112|NCT01250210|3809838|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3988113|NCT01250210|3809839|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3988114|NCT01250210|3809840|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3988115|NCT01250210|3809837|B4||Between 18 and 65 years|Age||Participants|Count of Participants|118|118.0||||||
3988116|NCT01250210|3809838|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3988117|NCT01250210|3809839|B2||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3988118|NCT01250210|3809840|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
3988119|NCT01250210|3809837|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3988120|NCT01250210|3809838|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3988121|NCT01250210|3809839|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3988122|NCT01250210|3809840|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3988123|NCT01250184|3809853|B4|Vitality||Quality of Life SF-36|The SF-36 consists of 36 items addressing the patient’s perception of their quality of life (QoL) in the following eight domains: physical function (PF), role limitations due to physical problems (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), and mental health (MH), and one item change in health. Sub-scale scores range from 0 to 100, with 100 as the best, most positive QoL in that area and 0 is the worst. There is a total scale score, all subscales range from 0 to 100|units on a scale|Mean|56.61|56.61|Standard Deviation|17.85|17.85|||
3988124|NCT01250184|3809854|B3|Vitality||Quality of Life SF-36|The SF-36 consists of 36 items addressing the patient’s perception of their quality of life (QoL) in the following eight domains: physical function (PF), role limitations due to physical problems (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), and mental health (MH), and one item change in health. Sub-scale scores range from 0 to 100, with 100 as the best, most positive QoL in that area and 0 is the worst. There is a total scale score, all subscales range from 0 to 100|units on a scale|Mean|60.7|60.7|Standard Deviation|19.3|19.3|||
3988125|NCT01250184|3809855|B2|Vitality||Quality of Life SF-36|The SF-36 consists of 36 items addressing the patient’s perception of their quality of life (QoL) in the following eight domains: physical function (PF), role limitations due to physical problems (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), and mental health (MH), and one item change in health. Sub-scale scores range from 0 to 100, with 100 as the best, most positive QoL in that area and 0 is the worst. There is a total scale score, all subscales range from 0 to 100|units on a scale|Mean|54.7|54.7|Standard Deviation|19.2|19.2|||
3988126|NCT01250184|3809856|B1|Vitality||Quality of Life SF-36|The SF-36 consists of 36 items addressing the patient’s perception of their quality of life (QoL) in the following eight domains: physical function (PF), role limitations due to physical problems (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), and mental health (MH), and one item change in health. Sub-scale scores range from 0 to 100, with 100 as the best, most positive QoL in that area and 0 is the worst. There is a total scale score, all subscales range from 0 to 100|units on a scale|Mean|54.2|54.2|Standard Deviation|13.9|13.9|||
3988127|NCT01250184|3809853|B4|Mental health||Quality of Life SF-36|The SF-36 consists of 36 items addressing the patient’s perception of their quality of life (QoL) in the following eight domains: physical function (PF), role limitations due to physical problems (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), and mental health (MH), and one item change in health. Sub-scale scores range from 0 to 100, with 100 as the best, most positive QoL in that area and 0 is the worst. There is a total scale score, all subscales range from 0 to 100|units on a scale|Mean|66.93|66.93|Standard Deviation|16.95|16.95|||
3988128|NCT01250184|3809854|B3|Mental health||Quality of Life SF-36|The SF-36 consists of 36 items addressing the patient’s perception of their quality of life (QoL) in the following eight domains: physical function (PF), role limitations due to physical problems (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), and mental health (MH), and one item change in health. Sub-scale scores range from 0 to 100, with 100 as the best, most positive QoL in that area and 0 is the worst. There is a total scale score, all subscales range from 0 to 100|units on a scale|Mean|67.4|67.4|Standard Deviation|17.5|17.5|||
3988129|NCT01250184|3809855|B2|Mental health||Quality of Life SF-36|The SF-36 consists of 36 items addressing the patient’s perception of their quality of life (QoL) in the following eight domains: physical function (PF), role limitations due to physical problems (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), and mental health (MH), and one item change in health. Sub-scale scores range from 0 to 100, with 100 as the best, most positive QoL in that area and 0 is the worst. There is a total scale score, all subscales range from 0 to 100|units on a scale|Mean|65.5|65.5|Standard Deviation|18.9|18.9|||
3988130|NCT01250184|3809856|B1|Mental health||Quality of Life SF-36|The SF-36 consists of 36 items addressing the patient’s perception of their quality of life (QoL) in the following eight domains: physical function (PF), role limitations due to physical problems (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), and mental health (MH), and one item change in health. Sub-scale scores range from 0 to 100, with 100 as the best, most positive QoL in that area and 0 is the worst. There is a total scale score, all subscales range from 0 to 100|units on a scale|Mean|67.8|67.8|Standard Deviation|14.2|14.2|||
3988213|NCT01250184|3809855|B2|Stress||Concomitant factors|A patient could have more than one Concomitant factor|participants|Number|29|29.0||||||
3988131|NCT01250184|3809853|B4|General health||Quality of Life SF-36|The SF-36 consists of 36 items addressing the patient’s perception of their quality of life (QoL) in the following eight domains: physical function (PF), role limitations due to physical problems (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), and mental health (MH), and one item change in health. Sub-scale scores range from 0 to 100, with 100 as the best, most positive QoL in that area and 0 is the worst. There is a total scale score, all subscales range from 0 to 100|units on a scale|Mean|65.12|65.12|Standard Deviation|19.47|19.47|||
3988132|NCT01250184|3809854|B3|General health||Quality of Life SF-36|The SF-36 consists of 36 items addressing the patient’s perception of their quality of life (QoL) in the following eight domains: physical function (PF), role limitations due to physical problems (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), and mental health (MH), and one item change in health. Sub-scale scores range from 0 to 100, with 100 as the best, most positive QoL in that area and 0 is the worst. There is a total scale score, all subscales range from 0 to 100|units on a scale|Mean|70.7|70.7|Standard Deviation|15.4|15.4|||
3988133|NCT01250184|3809855|B2|General health||Quality of Life SF-36|The SF-36 consists of 36 items addressing the patient’s perception of their quality of life (QoL) in the following eight domains: physical function (PF), role limitations due to physical problems (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), and mental health (MH), and one item change in health. Sub-scale scores range from 0 to 100, with 100 as the best, most positive QoL in that area and 0 is the worst. There is a total scale score, all subscales range from 0 to 100|units on a scale|Mean|57.3|57.3|Standard Deviation|21.9|21.9|||
3988134|NCT01250184|3809856|B1|General health||Quality of Life SF-36|The SF-36 consists of 36 items addressing the patient’s perception of their quality of life (QoL) in the following eight domains: physical function (PF), role limitations due to physical problems (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), and mental health (MH), and one item change in health. Sub-scale scores range from 0 to 100, with 100 as the best, most positive QoL in that area and 0 is the worst. There is a total scale score, all subscales range from 0 to 100|units on a scale|Mean|67.4|67.4|Standard Deviation|18.3|18.3|||
3988135|NCT01250184|3809853|B4|Social Function||Quality of Life SF-36|The SF-36 consists of 36 items addressing the patient’s perception of their quality of life (QoL) in the following eight domains: physical function (PF), role limitations due to physical problems (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), and mental health (MH), and one item change in health. Sub-scale scores range from 0 to 100, with 100 as the best, most positive QoL in that area and 0 is the worst. There is a total scale score, all subscales range from 0 to 100|units on a scale|Mean|69.83|69.83|Standard Deviation|24.06|24.06|||
3988136|NCT01250184|3809854|B3|Social Function||Quality of Life SF-36|The SF-36 consists of 36 items addressing the patient’s perception of their quality of life (QoL) in the following eight domains: physical function (PF), role limitations due to physical problems (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), and mental health (MH), and one item change in health. Sub-scale scores range from 0 to 100, with 100 as the best, most positive QoL in that area and 0 is the worst. There is a total scale score, all subscales range from 0 to 100|units on a scale|Mean|71.8|71.8|Standard Deviation|23.6|23.6|||
3988137|NCT01250184|3809855|B2|Social Function||Quality of Life SF-36|The SF-36 consists of 36 items addressing the patient’s perception of their quality of life (QoL) in the following eight domains: physical function (PF), role limitations due to physical problems (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), and mental health (MH), and one item change in health. Sub-scale scores range from 0 to 100, with 100 as the best, most positive QoL in that area and 0 is the worst. There is a total scale score, all subscales range from 0 to 100|units on a scale|Mean|68|68.0|Standard Deviation|26.6|26.6|||
3988138|NCT01250184|3809856|B1|Social Function||Quality of Life SF-36|The SF-36 consists of 36 items addressing the patient’s perception of their quality of life (QoL) in the following eight domains: physical function (PF), role limitations due to physical problems (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), and mental health (MH), and one item change in health. Sub-scale scores range from 0 to 100, with 100 as the best, most positive QoL in that area and 0 is the worst. There is a total scale score, all subscales range from 0 to 100|units on a scale|Mean|69.5|69.5|Standard Deviation|22|22.0|||
3988139|NCT01250184|3809853|B4|Physical functioning||Quality of Life SF-36|The SF-36 consists of 36 items addressing the patient’s perception of their quality of life (QoL) in the following eight domains: physical function (PF), role limitations due to physical problems (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), and mental health (MH), and one item change in health. Sub-scale scores range from 0 to 100, with 100 as the best, most positive QoL in that area and 0 is the worst. There is a total scale score, all subscales range from 0 to 100|units on a scale|Mean|77.91|77.91|Standard Deviation|17.5|17.5|||
3988140|NCT01250184|3809854|B3|Physical functioning||Quality of Life SF-36|The SF-36 consists of 36 items addressing the patient’s perception of their quality of life (QoL) in the following eight domains: physical function (PF), role limitations due to physical problems (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), and mental health (MH), and one item change in health. Sub-scale scores range from 0 to 100, with 100 as the best, most positive QoL in that area and 0 is the worst. There is a total scale score, all subscales range from 0 to 100|units on a scale|Mean|81.7|81.7|Standard Deviation|11.9|11.9|||
3988141|NCT01250184|3809855|B2|Physical functioning||Quality of Life SF-36|The SF-36 consists of 36 items addressing the patient’s perception of their quality of life (QoL) in the following eight domains: physical function (PF), role limitations due to physical problems (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), and mental health (MH), and one item change in health. Sub-scale scores range from 0 to 100, with 100 as the best, most positive QoL in that area and 0 is the worst. There is a total scale score, all subscales range from 0 to 100|units on a scale|Mean|72.5|72.5|Standard Deviation|20.5|20.5|||
3988142|NCT01250184|3809856|B1|Physical functioning||Quality of Life SF-36|The SF-36 consists of 36 items addressing the patient’s perception of their quality of life (QoL) in the following eight domains: physical function (PF), role limitations due to physical problems (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), and mental health (MH), and one item change in health. Sub-scale scores range from 0 to 100, with 100 as the best, most positive QoL in that area and 0 is the worst. There is a total scale score, all subscales range from 0 to 100|units on a scale|Mean|79.5|79.5|Standard Deviation|17.8|17.8|||
3988143|NCT01250184|3809853|B4|Role-physical||Quality of Life SF-36|The SF-36 consists of 36 items addressing the patient’s perception of their quality of life (QoL) in the following eight domains: physical function (PF), role limitations due to physical problems (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), and mental health (MH), and one item change in health. Sub-scale scores range from 0 to 100, with 100 as the best, most positive QoL in that area and 0 is the worst. There is a total scale score, all subscales range from 0 to 100|units on a scale|Mean|48.21|48.21|Standard Deviation|48.36|48.36|||
3988144|NCT01250184|3809854|B3|Role-physical||Quality of Life SF-36|The SF-36 consists of 36 items addressing the patient’s perception of their quality of life (QoL) in the following eight domains: physical function (PF), role limitations due to physical problems (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), and mental health (MH), and one item change in health. Sub-scale scores range from 0 to 100, with 100 as the best, most positive QoL in that area and 0 is the worst. There is a total scale score, all subscales range from 0 to 100|units on a scale|Mean|42.4|42.4|Standard Deviation|37.6|37.6|||
3988145|NCT01250184|3809855|B2|Role-physical||Quality of Life SF-36|The SF-36 consists of 36 items addressing the patient’s perception of their quality of life (QoL) in the following eight domains: physical function (PF), role limitations due to physical problems (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), and mental health (MH), and one item change in health. Sub-scale scores range from 0 to 100, with 100 as the best, most positive QoL in that area and 0 is the worst. There is a total scale score, all subscales range from 0 to 100|units on a scale|Mean|51.1|51.1|Standard Deviation|37.7|37.7|||
3988146|NCT01250184|3809856|B1|Role-physical||Quality of Life SF-36|The SF-36 consists of 36 items addressing the patient’s perception of their quality of life (QoL) in the following eight domains: physical function (PF), role limitations due to physical problems (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), and mental health (MH), and one item change in health. Sub-scale scores range from 0 to 100, with 100 as the best, most positive QoL in that area and 0 is the worst. There is a total scale score, all subscales range from 0 to 100|units on a scale|Mean|51.2|51.2|Standard Deviation|40|40.0|||
3988147|NCT01250184|3809853|B4|Role-emotional||Quality of Life SF-36|The SF-36 consists of 36 items addressing the patient’s perception of their quality of life (QoL) in the following eight domains: physical function (PF), role limitations due to physical problems (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), and mental health (MH), and one item change in health. Sub-scale scores range from 0 to 100, with 100 as the best, most positive QoL in that area and 0 is the worst. There is a total scale score, all subscales range from 0 to 100|units on a scale|Mean|69.92|69.92|Standard Deviation|36.89|36.89|||
3988148|NCT01250184|3809854|B3|Role-emotional||Quality of Life SF-36|The SF-36 consists of 36 items addressing the patient’s perception of their quality of life (QoL) in the following eight domains: physical function (PF), role limitations due to physical problems (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), and mental health (MH), and one item change in health. Sub-scale scores range from 0 to 100, with 100 as the best, most positive QoL in that area and 0 is the worst. There is a total scale score, all subscales range from 0 to 100|units on a scale|Mean|67.2|67.2|Standard Deviation|36.8|36.8|||
3988149|NCT01250184|3809855|B2|Role-emotional||Quality of Life SF-36|The SF-36 consists of 36 items addressing the patient’s perception of their quality of life (QoL) in the following eight domains: physical function (PF), role limitations due to physical problems (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), and mental health (MH), and one item change in health. Sub-scale scores range from 0 to 100, with 100 as the best, most positive QoL in that area and 0 is the worst. There is a total scale score, all subscales range from 0 to 100|units on a scale|Mean|75.8|75.8|Standard Deviation|38.7|38.7|||
3988150|NCT01250184|3809856|B1|Role-emotional||Quality of Life SF-36|The SF-36 consists of 36 items addressing the patient’s perception of their quality of life (QoL) in the following eight domains: physical function (PF), role limitations due to physical problems (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), and mental health (MH), and one item change in health. Sub-scale scores range from 0 to 100, with 100 as the best, most positive QoL in that area and 0 is the worst. There is a total scale score, all subscales range from 0 to 100|units on a scale|Mean|66.4|66.4|Standard Deviation|35.0|35.0|||
3988151|NCT01250184|3809853|B4|Body pain||Quality of Life SF-36|The SF-36 consists of 36 items addressing the patient’s perception of their quality of life (QoL) in the following eight domains: physical function (PF), role limitations due to physical problems (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), and mental health (MH), and one item change in health. Sub-scale scores range from 0 to 100, with 100 as the best, most positive QoL in that area and 0 is the worst. There is a total scale score, all subscales range from 0 to 100|units on a scale|Mean|37.52|37.52|Standard Deviation|15.2|15.2|||
3988152|NCT01250184|3809854|B3|Body pain||Quality of Life SF-36|The SF-36 consists of 36 items addressing the patient’s perception of their quality of life (QoL) in the following eight domains: physical function (PF), role limitations due to physical problems (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), and mental health (MH), and one item change in health. Sub-scale scores range from 0 to 100, with 100 as the best, most positive QoL in that area and 0 is the worst. There is a total scale score, all subscales range from 0 to 100|units on a scale|Mean|38.5|38.5|Standard Deviation|16.4|16.4|||
3988153|NCT01250184|3809855|B2|Body pain||Quality of Life SF-36|The SF-36 consists of 36 items addressing the patient’s perception of their quality of life (QoL) in the following eight domains: physical function (PF), role limitations due to physical problems (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), and mental health (MH), and one item change in health. Sub-scale scores range from 0 to 100, with 100 as the best, most positive QoL in that area and 0 is the worst. There is a total scale score, all subscales range from 0 to 100|units on a scale|Mean|35.2|35.2|Standard Deviation|14.3|14.3|||
3988154|NCT01250184|3809856|B1|Body pain||Quality of Life SF-36|The SF-36 consists of 36 items addressing the patient’s perception of their quality of life (QoL) in the following eight domains: physical function (PF), role limitations due to physical problems (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), and mental health (MH), and one item change in health. Sub-scale scores range from 0 to 100, with 100 as the best, most positive QoL in that area and 0 is the worst. There is a total scale score, all subscales range from 0 to 100|units on a scale|Mean|38.8|38.8|Standard Deviation|14.4|14.4|||
3988155|NCT01250184|3809853|B4|Nearly every day||Patient Health Questionnaire – 9 How often|Here we are reporting how often the patient presents symptoms? The PHQ-9 was developed from the Primary Care Evaluation of Mental Disorders. The self-report instrument asks individuals how much they had been bothered by any of the nine problems over the prior two weeks. Items are scored from 0 (not at all) to 3 (nearly every day). Items are summed and the total score (from 0 to 27) represents the severity of depressive symptoms. 0 - 4 None-minimal None, 5 - 9 Mild, 10 - 14 Moderate, 15 - 19 Moderately Severe, 20 - 27 Severe.|participants|Number|1|1.0||||||
3988156|NCT01250184|3809854|B3|Nearly every day||Patient Health Questionnaire – 9 How often|Here we are reporting how often the patient presents symptoms? The PHQ-9 was developed from the Primary Care Evaluation of Mental Disorders. The self-report instrument asks individuals how much they had been bothered by any of the nine problems over the prior two weeks. Items are scored from 0 (not at all) to 3 (nearly every day). Items are summed and the total score (from 0 to 27) represents the severity of depressive symptoms. 0 - 4 None-minimal None, 5 - 9 Mild, 10 - 14 Moderate, 15 - 19 Moderately Severe, 20 - 27 Severe.|participants|Number|0|0.0||||||
3988157|NCT01250184|3809855|B2|Nearly every day||Patient Health Questionnaire – 9 How often|Here we are reporting how often the patient presents symptoms? The PHQ-9 was developed from the Primary Care Evaluation of Mental Disorders. The self-report instrument asks individuals how much they had been bothered by any of the nine problems over the prior two weeks. Items are scored from 0 (not at all) to 3 (nearly every day). Items are summed and the total score (from 0 to 27) represents the severity of depressive symptoms. 0 - 4 None-minimal None, 5 - 9 Mild, 10 - 14 Moderate, 15 - 19 Moderately Severe, 20 - 27 Severe.|participants|Number|1|1.0||||||
3988158|NCT01250184|3809856|B1|Nearly every day||Patient Health Questionnaire – 9 How often|Here we are reporting how often the patient presents symptoms? The PHQ-9 was developed from the Primary Care Evaluation of Mental Disorders. The self-report instrument asks individuals how much they had been bothered by any of the nine problems over the prior two weeks. Items are scored from 0 (not at all) to 3 (nearly every day). Items are summed and the total score (from 0 to 27) represents the severity of depressive symptoms. 0 - 4 None-minimal None, 5 - 9 Mild, 10 - 14 Moderate, 15 - 19 Moderately Severe, 20 - 27 Severe.|participants|Number|0|0.0||||||
3988159|NCT01250184|3809853|B4|More than half the days||Patient Health Questionnaire – 9 How often|Here we are reporting how often the patient presents symptoms? The PHQ-9 was developed from the Primary Care Evaluation of Mental Disorders. The self-report instrument asks individuals how much they had been bothered by any of the nine problems over the prior two weeks. Items are scored from 0 (not at all) to 3 (nearly every day). Items are summed and the total score (from 0 to 27) represents the severity of depressive symptoms. 0 - 4 None-minimal None, 5 - 9 Mild, 10 - 14 Moderate, 15 - 19 Moderately Severe, 20 - 27 Severe.|participants|Number|6|6.0||||||
3988160|NCT01250184|3809854|B3|More than half the days||Patient Health Questionnaire – 9 How often|Here we are reporting how often the patient presents symptoms? The PHQ-9 was developed from the Primary Care Evaluation of Mental Disorders. The self-report instrument asks individuals how much they had been bothered by any of the nine problems over the prior two weeks. Items are scored from 0 (not at all) to 3 (nearly every day). Items are summed and the total score (from 0 to 27) represents the severity of depressive symptoms. 0 - 4 None-minimal None, 5 - 9 Mild, 10 - 14 Moderate, 15 - 19 Moderately Severe, 20 - 27 Severe.|participants|Number|0|0.0||||||
3988161|NCT01250184|3809855|B2|More than half the days||Patient Health Questionnaire – 9 How often|Here we are reporting how often the patient presents symptoms? The PHQ-9 was developed from the Primary Care Evaluation of Mental Disorders. The self-report instrument asks individuals how much they had been bothered by any of the nine problems over the prior two weeks. Items are scored from 0 (not at all) to 3 (nearly every day). Items are summed and the total score (from 0 to 27) represents the severity of depressive symptoms. 0 - 4 None-minimal None, 5 - 9 Mild, 10 - 14 Moderate, 15 - 19 Moderately Severe, 20 - 27 Severe.|participants|Number|4|4.0||||||
3988162|NCT01250184|3809856|B1|More than half the days||Patient Health Questionnaire – 9 How often|Here we are reporting how often the patient presents symptoms? The PHQ-9 was developed from the Primary Care Evaluation of Mental Disorders. The self-report instrument asks individuals how much they had been bothered by any of the nine problems over the prior two weeks. Items are scored from 0 (not at all) to 3 (nearly every day). Items are summed and the total score (from 0 to 27) represents the severity of depressive symptoms. 0 - 4 None-minimal None, 5 - 9 Mild, 10 - 14 Moderate, 15 - 19 Moderately Severe, 20 - 27 Severe.|participants|Number|2|2.0||||||
3988163|NCT01250184|3809853|B4|Several days||Patient Health Questionnaire – 9 How often|Here we are reporting how often the patient presents symptoms? The PHQ-9 was developed from the Primary Care Evaluation of Mental Disorders. The self-report instrument asks individuals how much they had been bothered by any of the nine problems over the prior two weeks. Items are scored from 0 (not at all) to 3 (nearly every day). Items are summed and the total score (from 0 to 27) represents the severity of depressive symptoms. 0 - 4 None-minimal None, 5 - 9 Mild, 10 - 14 Moderate, 15 - 19 Moderately Severe, 20 - 27 Severe.|participants|Number|31|31.0||||||
3988214|NCT01250184|3809856|B1|Stress||Concomitant factors|A patient could have more than one Concomitant factor|participants|Number|34|34.0||||||
3988215|NCT01250184|3809853|B4|Colombia||Region of Enrollment||participants|Number|127|127.0||||||
3988216|NCT01250184|3809854|B3|Colombia||Region of Enrollment||participants|Number|43|43.0||||||
3988164|NCT01250184|3809854|B3|Several days||Patient Health Questionnaire – 9 How often|Here we are reporting how often the patient presents symptoms? The PHQ-9 was developed from the Primary Care Evaluation of Mental Disorders. The self-report instrument asks individuals how much they had been bothered by any of the nine problems over the prior two weeks. Items are scored from 0 (not at all) to 3 (nearly every day). Items are summed and the total score (from 0 to 27) represents the severity of depressive symptoms. 0 - 4 None-minimal None, 5 - 9 Mild, 10 - 14 Moderate, 15 - 19 Moderately Severe, 20 - 27 Severe.|participants|Number|14|14.0||||||
3988165|NCT01250184|3809855|B2|Several days||Patient Health Questionnaire – 9 How often|Here we are reporting how often the patient presents symptoms? The PHQ-9 was developed from the Primary Care Evaluation of Mental Disorders. The self-report instrument asks individuals how much they had been bothered by any of the nine problems over the prior two weeks. Items are scored from 0 (not at all) to 3 (nearly every day). Items are summed and the total score (from 0 to 27) represents the severity of depressive symptoms. 0 - 4 None-minimal None, 5 - 9 Mild, 10 - 14 Moderate, 15 - 19 Moderately Severe, 20 - 27 Severe.|participants|Number|8|8.0||||||
3988166|NCT01250184|3809856|B1|Several days||Patient Health Questionnaire – 9 How often|Here we are reporting how often the patient presents symptoms? The PHQ-9 was developed from the Primary Care Evaluation of Mental Disorders. The self-report instrument asks individuals how much they had been bothered by any of the nine problems over the prior two weeks. Items are scored from 0 (not at all) to 3 (nearly every day). Items are summed and the total score (from 0 to 27) represents the severity of depressive symptoms. 0 - 4 None-minimal None, 5 - 9 Mild, 10 - 14 Moderate, 15 - 19 Moderately Severe, 20 - 27 Severe.|participants|Number|9|9.0||||||
3988167|NCT01250184|3809853|B4|Not at all||Patient Health Questionnaire – 9 How often|Here we are reporting how often the patient presents symptoms? The PHQ-9 was developed from the Primary Care Evaluation of Mental Disorders. The self-report instrument asks individuals how much they had been bothered by any of the nine problems over the prior two weeks. Items are scored from 0 (not at all) to 3 (nearly every day). Items are summed and the total score (from 0 to 27) represents the severity of depressive symptoms. 0 - 4 None-minimal None, 5 - 9 Mild, 10 - 14 Moderate, 15 - 19 Moderately Severe, 20 - 27 Severe.|participants|Number|89|89.0||||||
3988168|NCT01250184|3809854|B3|Not at all||Patient Health Questionnaire – 9 How often|Here we are reporting how often the patient presents symptoms? The PHQ-9 was developed from the Primary Care Evaluation of Mental Disorders. The self-report instrument asks individuals how much they had been bothered by any of the nine problems over the prior two weeks. Items are scored from 0 (not at all) to 3 (nearly every day). Items are summed and the total score (from 0 to 27) represents the severity of depressive symptoms. 0 - 4 None-minimal None, 5 - 9 Mild, 10 - 14 Moderate, 15 - 19 Moderately Severe, 20 - 27 Severe.|participants|Number|29|29.0||||||
3988169|NCT01250184|3809855|B2|Not at all||Patient Health Questionnaire – 9 How often|Here we are reporting how often the patient presents symptoms? The PHQ-9 was developed from the Primary Care Evaluation of Mental Disorders. The self-report instrument asks individuals how much they had been bothered by any of the nine problems over the prior two weeks. Items are scored from 0 (not at all) to 3 (nearly every day). Items are summed and the total score (from 0 to 27) represents the severity of depressive symptoms. 0 - 4 None-minimal None, 5 - 9 Mild, 10 - 14 Moderate, 15 - 19 Moderately Severe, 20 - 27 Severe.|participants|Number|30|30.0||||||
3988170|NCT01250184|3809856|B1|Not at all||Patient Health Questionnaire – 9 How often|Here we are reporting how often the patient presents symptoms? The PHQ-9 was developed from the Primary Care Evaluation of Mental Disorders. The self-report instrument asks individuals how much they had been bothered by any of the nine problems over the prior two weeks. Items are scored from 0 (not at all) to 3 (nearly every day). Items are summed and the total score (from 0 to 27) represents the severity of depressive symptoms. 0 - 4 None-minimal None, 5 - 9 Mild, 10 - 14 Moderate, 15 - 19 Moderately Severe, 20 - 27 Severe.|participants|Number|30|30.0||||||
3988171|NCT01250184|3809853|B4|||Patient Health Questionnaire – 9|The PHQ-9 was developed from the Primary Care Evaluation of Mental Disorders. The self-report instrument asks individuals how much they had been bothered by any of the nine problems over the prior two weeks. Items are scored from 0 (not at all) to 3 (nearly every day). Items are summed and the total score (from 0 to 27) represents the severity of depressive symptoms. 0 – 4 None-minimal None, 5 – 9 Mild, 10 – 14 Moderate, 15 – 19 Moderately Severe, 20 – 27 Severe|units on a scale|Mean|5.72|5.72|Standard Deviation|3.68|3.68|||
3988172|NCT01250184|3809854|B3|||Patient Health Questionnaire – 9|The PHQ-9 was developed from the Primary Care Evaluation of Mental Disorders. The self-report instrument asks individuals how much they had been bothered by any of the nine problems over the prior two weeks. Items are scored from 0 (not at all) to 3 (nearly every day). Items are summed and the total score (from 0 to 27) represents the severity of depressive symptoms. 0 – 4 None-minimal None, 5 – 9 Mild, 10 – 14 Moderate, 15 – 19 Moderately Severe, 20 – 27 Severe|units on a scale|Mean|5.6|5.6|Standard Deviation|3.5|3.5|||
3988173|NCT01250184|3809855|B2|||Patient Health Questionnaire – 9|The PHQ-9 was developed from the Primary Care Evaluation of Mental Disorders. The self-report instrument asks individuals how much they had been bothered by any of the nine problems over the prior two weeks. Items are scored from 0 (not at all) to 3 (nearly every day). Items are summed and the total score (from 0 to 27) represents the severity of depressive symptoms. 0 – 4 None-minimal None, 5 – 9 Mild, 10 – 14 Moderate, 15 – 19 Moderately Severe, 20 – 27 Severe|units on a scale|Mean|5.9|5.9|Standard Deviation|4.2|4.2|||
3988174|NCT01250184|3809856|B1|||Patient Health Questionnaire – 9|The PHQ-9 was developed from the Primary Care Evaluation of Mental Disorders. The self-report instrument asks individuals how much they had been bothered by any of the nine problems over the prior two weeks. Items are scored from 0 (not at all) to 3 (nearly every day). Items are summed and the total score (from 0 to 27) represents the severity of depressive symptoms. 0 – 4 None-minimal None, 5 – 9 Mild, 10 – 14 Moderate, 15 – 19 Moderately Severe, 20 – 27 Severe|units on a scale|Mean|5.6|5.6|Standard Deviation|3.2|3.2|||
3988175|NCT01250184|3809853|B4|||Visual Analogue Scale for Pain|VAS with a score of 0-100, where 100 is the value representing the highest degree of pain and 0 the lowest. Successful treatment was defined as a reduction in pain of at least 20% of the previous score on the VAS after 4 weeks of the initial evaluation, or 14 mm on the VAS; this scale is a reliable pain assessment measure that has been validated previously|units on a scale|Mean|65.54|65.54|Standard Deviation|15.9|15.9|||
3988217|NCT01250184|3809855|B2|Colombia||Region of Enrollment||participants|Number|43|43.0||||||
3988218|NCT01250184|3809856|B1|Colombia||Region of Enrollment||participants|Number|41|41.0||||||
3988176|NCT01250184|3809854|B3|||Visual Analogue Scale for Pain|VAS with a score of 0-100, where 100 is the value representing the highest degree of pain and 0 the lowest. Successful treatment was defined as a reduction in pain of at least 20% of the previous score on the VAS after 4 weeks of the initial evaluation, or 14 mm on the VAS; this scale is a reliable pain assessment measure that has been validated previously|units on a scale|Mean|64.2|64.2|Standard Deviation|16.2|16.2|||
3988177|NCT01250184|3809855|B2|||Visual Analogue Scale for Pain|VAS with a score of 0-100, where 100 is the value representing the highest degree of pain and 0 the lowest. Successful treatment was defined as a reduction in pain of at least 20% of the previous score on the VAS after 4 weeks of the initial evaluation, or 14 mm on the VAS; this scale is a reliable pain assessment measure that has been validated previously|units on a scale|Mean|68.7|68.7|Standard Deviation|17|17.0|||
3988178|NCT01250184|3809856|B1|||Visual Analogue Scale for Pain|VAS with a score of 0-100, where 100 is the value representing the highest degree of pain and 0 the lowest. Successful treatment was defined as a reduction in pain of at least 20% of the previous score on the VAS after 4 weeks of the initial evaluation, or 14 mm on the VAS; this scale is a reliable pain assessment measure that has been validated previously|units on a scale|Mean|63.5|63.5|Standard Deviation|13.9|13.9|||
3988179|NCT01250184|3809853|B4|Local twitch response||Physical examination|A patient could have more than one alteration on the physical examination.|participants|Number|77|77.0||||||
3988180|NCT01250184|3809854|B3|Local twitch response||Physical examination|A patient could have more than one alteration on the physical examination.|participants|Number|22|22.0||||||
3988181|NCT01250184|3809855|B2|Local twitch response||Physical examination|A patient could have more than one alteration on the physical examination.|participants|Number|26|26.0||||||
3988182|NCT01250184|3809856|B1|Local twitch response||Physical examination|A patient could have more than one alteration on the physical examination.|participants|Number|29|29.0||||||
3988183|NCT01250184|3809853|B4|Referred pain||Physical examination|A patient could have more than one alteration on the physical examination.|participants|Number|81|81.0||||||
3988184|NCT01250184|3809854|B3|Referred pain||Physical examination|A patient could have more than one alteration on the physical examination.|participants|Number|23|23.0||||||
3988185|NCT01250184|3809855|B2|Referred pain||Physical examination|A patient could have more than one alteration on the physical examination.|participants|Number|36|36.0||||||
3988186|NCT01250184|3809856|B1|Referred pain||Physical examination|A patient could have more than one alteration on the physical examination.|participants|Number|22|22.0||||||
3988187|NCT01250184|3809853|B4|Sensitive Alteration||Physical examination|A patient could have more than one alteration on the physical examination.|participants|Number|23|23.0||||||
3988188|NCT01250184|3809854|B3|Sensitive Alteration||Physical examination|A patient could have more than one alteration on the physical examination.|participants|Number|8|8.0||||||
3988189|NCT01250184|3809855|B2|Sensitive Alteration||Physical examination|A patient could have more than one alteration on the physical examination.|participants|Number|7|7.0||||||
3988190|NCT01250184|3809856|B1|Sensitive Alteration||Physical examination|A patient could have more than one alteration on the physical examination.|participants|Number|8|8.0||||||
3988191|NCT01250184|3809853|B4|Infraspinatus muscle||Muscles with trigger point|A patient could have more than one trigger point|participants|Number|37|37.0||||||
3988192|NCT01250184|3809854|B3|Infraspinatus muscle||Muscles with trigger point|A patient could have more than one trigger point|participants|Number|13|13.0||||||
3988193|NCT01250184|3809855|B2|Infraspinatus muscle||Muscles with trigger point|A patient could have more than one trigger point|participants|Number|12|12.0||||||
3988194|NCT01250184|3809856|B1|Infraspinatus muscle||Muscles with trigger point|A patient could have more than one trigger point|participants|Number|12|12.0||||||
3988195|NCT01250184|3809853|B4|Levator scapulae||Muscles with trigger point|A patient could have more than one trigger point|participants|Number|84|84.0||||||
3988196|NCT01250184|3809854|B3|Levator scapulae||Muscles with trigger point|A patient could have more than one trigger point|participants|Number|26|26.0||||||
3988197|NCT01250184|3809855|B2|Levator scapulae||Muscles with trigger point|A patient could have more than one trigger point|participants|Number|27|27.0||||||
3988198|NCT01250184|3809856|B1|Levator scapulae||Muscles with trigger point|A patient could have more than one trigger point|participants|Number|31|31.0||||||
3988199|NCT01250184|3809853|B4|Trapezius muscle||Muscles with trigger point|A patient could have more than one trigger point|participants|Number|118|118.0||||||
3988200|NCT01250184|3809854|B3|Trapezius muscle||Muscles with trigger point|A patient could have more than one trigger point|participants|Number|39|39.0||||||
3988201|NCT01250184|3809855|B2|Trapezius muscle||Muscles with trigger point|A patient could have more than one trigger point|participants|Number|42|42.0||||||
3988202|NCT01250184|3809856|B1|Trapezius muscle||Muscles with trigger point|A patient could have more than one trigger point|participants|Number|37|37.0||||||
3988203|NCT01250184|3809853|B4|Longer positions||Concomitant factors|A patient could have more than one Concomitant factor|participants|Number|90|90.0||||||
3988204|NCT01250184|3809854|B3|Longer positions||Concomitant factors|A patient could have more than one Concomitant factor|participants|Number|29|29.0||||||
3988205|NCT01250184|3809855|B2|Longer positions||Concomitant factors|A patient could have more than one Concomitant factor|participants|Number|34|34.0||||||
3988206|NCT01250184|3809856|B1|Longer positions||Concomitant factors|A patient could have more than one Concomitant factor|participants|Number|27|27.0||||||
3988207|NCT01250184|3809853|B4|Sleeplessness||Concomitant factors|A patient could have more than one Concomitant factor|participants|Number|65|65.0||||||
3988208|NCT01250184|3809854|B3|Sleeplessness||Concomitant factors|A patient could have more than one Concomitant factor|participants|Number|23|23.0||||||
3988209|NCT01250184|3809855|B2|Sleeplessness||Concomitant factors|A patient could have more than one Concomitant factor|participants|Number|18|18.0||||||
3988210|NCT01250184|3809856|B1|Sleeplessness||Concomitant factors|A patient could have more than one Concomitant factor|participants|Number|24|24.0||||||
3988211|NCT01250184|3809853|B4|Stress||Concomitant factors|A patient could have more than one Concomitant factor|participants|Number|93|93.0||||||
3988212|NCT01250184|3809854|B3|Stress||Concomitant factors|A patient could have more than one Concomitant factor|participants|Number|30|30.0||||||
3988219|NCT01250184|3809853|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3988220|NCT01250184|3809854|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3988221|NCT01250184|3809855|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3988222|NCT01250184|3809856|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3988223|NCT01250184|3809853|B4||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3988224|NCT01250184|3809854|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3988225|NCT01250184|3809855|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3988226|NCT01250184|3809856|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3988227|NCT01250184|3809853|B4|||Age||years|Mean|39.19|39.19|Standard Deviation|11.12|11.12|||
3988228|NCT01250184|3809854|B3|||Age||years|Mean|37.7|37.7|Standard Deviation|11.8|11.8|||
3988229|NCT01250184|3809855|B2|||Age||years|Mean|42.6|42.6|Standard Deviation|9.7|9.7|||
3988230|NCT01250184|3809856|B1|||Age||years|Mean|37.2|37.2|Standard Deviation|11.1|11.1|||
3988231|NCT01250171|3809881|B4||Male|Sex: Female, Male|One patient randomized to the secukinumab group did not receive study drug and was not included in the analysis of demographic data.|Participants|Count of Participants|18|18.0||||||
3988232|NCT01250171|3809882|B3||Male|Sex: Female, Male|One patient randomized to the secukinumab group did not receive study drug and was not included in the analysis of demographic data.|Participants|Count of Participants|6|6.0||||||
3988233|NCT01250171|3809883|B2||Male|Sex: Female, Male|One patient randomized to the secukinumab group did not receive study drug and was not included in the analysis of demographic data.|Participants|Count of Participants|5|5.0||||||
3988234|NCT01250171|3809884|B1||Male|Sex: Female, Male|One patient randomized to the secukinumab group did not receive study drug and was not included in the analysis of demographic data.|Participants|Count of Participants|7|7.0||||||
3988235|NCT01250171|3809881|B4||Female|Sex: Female, Male|One patient randomized to the secukinumab group did not receive study drug and was not included in the analysis of demographic data.|Participants|Count of Participants|53|53.0||||||
3988236|NCT01250171|3809882|B3||Female|Sex: Female, Male|One patient randomized to the secukinumab group did not receive study drug and was not included in the analysis of demographic data.|Participants|Count of Participants|18|18.0||||||
3988237|NCT01250171|3809883|B2||Female|Sex: Female, Male|One patient randomized to the secukinumab group did not receive study drug and was not included in the analysis of demographic data.|Participants|Count of Participants|17|17.0||||||
3988238|NCT01250171|3809884|B1||Female|Sex: Female, Male|One patient randomized to the secukinumab group did not receive study drug and was not included in the analysis of demographic data.|Participants|Count of Participants|18|18.0||||||
3988239|NCT01250171|3809881|B4|||Age|One patient randomized to the secukinumab group did not receive study drug and was not included in the analysis of demographic data.|years|Mean|56|56.0|Standard Deviation|13|13.0|||
3988240|NCT01250171|3809882|B3|||Age|One patient randomized to the secukinumab group did not receive study drug and was not included in the analysis of demographic data.|years|Mean|59|59.0|Standard Deviation|13|13.0|||
3988241|NCT01250171|3809883|B2|||Age|One patient randomized to the secukinumab group did not receive study drug and was not included in the analysis of demographic data.|years|Mean|54|54.0|Standard Deviation|11|11.0|||
3988242|NCT01250171|3809884|B1|||Age|One patient randomized to the secukinumab group did not receive study drug and was not included in the analysis of demographic data.|years|Mean|55|55.0|Standard Deviation|13|13.0|||
3988243|NCT01250145|3809915|B3|United Kingdom||Region of Enrollment||participants|Number|74|74.0||||||
3988244|NCT01250145|3809916|B2|United Kingdom||Region of Enrollment||participants|Number|74|74.0||||||
3988245|NCT01250145|3809917|B1|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
3988246|NCT01250145|3809915|B3|Germany||Region of Enrollment||participants|Number|103|103.0||||||
3988247|NCT01250145|3809916|B2|Germany||Region of Enrollment||participants|Number|103|103.0||||||
3988248|NCT01250145|3809917|B1|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3988249|NCT01250145|3809915|B3|United States||Region of Enrollment||participants|Number|74|74.0||||||
3988250|NCT01250145|3809916|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
3988251|NCT01250145|3809917|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
3988252|NCT01250145|3809915|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3988253|NCT01250145|3809916|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3988254|NCT01250145|3809917|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3988255|NCT01250145|3809915|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3988256|NCT01250145|3809916|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3988257|NCT01250145|3809917|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3988258|NCT01250145|3809915|B3||White|Race (NIH/OMB)||Participants|Count of Participants|239|239.0||||||
3988259|NCT01250145|3809916|B2||White|Race (NIH/OMB)||Participants|Count of Participants|201|201.0||||||
3988260|NCT01250145|3809917|B1||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3988261|NCT01250145|3809915|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3988262|NCT01250145|3809916|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3988263|NCT01250145|3809917|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3988264|NCT01250145|3809915|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3988265|NCT01250145|3809916|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3988266|NCT01250145|3809917|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3988267|NCT01250145|3809915|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3988268|NCT01250145|3809916|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3988269|NCT01250145|3809917|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3988270|NCT01250145|3809915|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3988271|NCT01250145|3809916|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3988272|NCT01250145|3809917|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3988273|NCT01250145|3809915|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3988274|NCT01250145|3809916|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3988275|NCT01250145|3809917|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3988276|NCT01250145|3809915|B3||Female|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
3988277|NCT01250145|3809916|B2||Female|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
3988278|NCT01250145|3809917|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3988279|NCT01250145|3809915|B3|||Age||years|Mean|59.9|59.9|Standard Deviation|7.0|7.0|||
3988280|NCT01250145|3809916|B2|||Age||years|Mean|59.9|59.9|Standard Deviation|6.7|6.7|||
3988281|NCT01250145|3809917|B1|||Age||years|Mean|60.2|60.2|Standard Deviation|8.1|8.1|||
3988282|NCT01250119|3809938|B1||Male|Sex: Female, Male||Participants|Count of Participants|389|389.0||||||
3988283|NCT01250119|3809938|B1||Female|Sex: Female, Male||Participants|Count of Participants|299|299.0||||||
3988284|NCT01250119|3809938|B1|||Age||years|Mean|68.0|68.0|Standard Deviation|10.0|10.0|||
3988285|NCT01250054|3809954|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3988286|NCT01250054|3809954|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3988287|NCT01250054|3809954|B1|||Age||years|Mean|48.6|48.6|Standard Deviation|4.9|4.9|||
3988288|NCT01250002|3809961|B3|United States||Region of Enrollment||participants|Number|70|70.0||||||
3988289|NCT01250002|3809962|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
3988290|NCT01250002|3809963|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3988291|NCT01250002|3809961|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3988292|NCT01250002|3809962|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3988293|NCT01250002|3809963|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3988294|NCT01250002|3809961|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3988295|NCT01250002|3809962|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3988296|NCT01250002|3809963|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3988297|NCT01250002|3809961|B3|||Age||years|Mean|38.2|38.2|Standard Deviation|9.0|9.0|||
3988298|NCT01250002|3809962|B2|||Age||years|Mean|39.1|39.1|Standard Deviation|9.3|9.3|||
3988299|NCT01250002|3809963|B1|||Age||years|Mean|37.2|37.2|Standard Deviation|8.6|8.6|||
3988300|NCT01250002|3809961|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3988301|NCT01250002|3809962|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3988302|NCT01250002|3809963|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3988303|NCT01250002|3809961|B3||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
3988304|NCT01250002|3809962|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3988305|NCT01250002|3809963|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3988306|NCT01250002|3809961|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3988307|NCT01250002|3809962|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3988308|NCT01250002|3809963|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3988309|NCT01249872|3809972|B7|||Body Mass Index (BMI)||kg/m2|Mean|58.6|58.6|Standard Deviation|6.2|6.2|||
3988310|NCT01249872|3809973|B6|||Body Mass Index (BMI)||kg/m2|Mean|59.4|59.4|Standard Deviation|7.0|7.0|||
3988311|NCT01249872|3809974|B5|||Body Mass Index (BMI)||kg/m2|Mean|60.0|60.0|Standard Deviation|3.9|3.9|||
3988312|NCT01249872|3809975|B4|||Body Mass Index (BMI)||kg/m2|Mean|58.6|58.6|Standard Deviation|6.9|6.9|||
3988313|NCT01249872|3809976|B3|||Body Mass Index (BMI)||kg/m2|Mean|58.3|58.3|Standard Deviation|7.8|7.8|||
3988314|NCT01249872|3809977|B2|||Body Mass Index (BMI)||kg/m2|Mean|57.5|57.5|Standard Deviation|6.0|6.0|||
3988315|NCT01249872|3809978|B1|||Body Mass Index (BMI)||kg/m2|Mean|57.8|57.8|Standard Deviation|5.6|5.6|||
3988316|NCT01249872|3809972|B7|Greece||Region of Enrollment||participants|Number|96|96.0||||||
3988317|NCT01249872|3809973|B6|Greece||Region of Enrollment||participants|Number|16|16.0||||||
3988318|NCT01249872|3809974|B5|Greece||Region of Enrollment||participants|Number|16|16.0||||||
3988319|NCT01249872|3809975|B4|Greece||Region of Enrollment||participants|Number|16|16.0||||||
3988320|NCT01249872|3809976|B3|Greece||Region of Enrollment||participants|Number|16|16.0||||||
3988321|NCT01249872|3809977|B2|Greece||Region of Enrollment||participants|Number|16|16.0||||||
3988322|NCT01249872|3809978|B1|Greece||Region of Enrollment||participants|Number|16|16.0||||||
3988323|NCT01249872|3809972|B7||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3988324|NCT01249872|3809973|B6||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3988325|NCT01249872|3809974|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3988326|NCT01249872|3809975|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3988327|NCT01249872|3809976|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3988328|NCT01249872|3809977|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3988329|NCT01249872|3809978|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3988330|NCT01249872|3809972|B7||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3988331|NCT01249872|3809973|B6||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3988332|NCT01249872|3809974|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3988333|NCT01249872|3809975|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3988334|NCT01249872|3809976|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3988335|NCT01249872|3809977|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3988336|NCT01249872|3809978|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3988337|NCT01249872|3809972|B7|Age (yr)||Age||years|Mean|34.7|34.7|Standard Deviation|7.3|7.3|||
3988338|NCT01249872|3809973|B6|Age (yr)||Age||years|Mean|35.1|35.1|Standard Deviation|8.5|8.5|||
3988339|NCT01249872|3809974|B5|Age (yr)||Age||years|Mean|35.8|35.8|Standard Deviation|8.1|8.1|||
3988340|NCT01249872|3809975|B4|Age (yr)||Age||years|Mean|34.3|34.3|Standard Deviation|8.4|8.4|||
3988341|NCT01249872|3809976|B3|Age (yr)||Age||years|Mean|34.8|34.8|Standard Deviation|9.2|9.2|||
3988342|NCT01249872|3809977|B2|Age (yr)||Age||years|Mean|32.8|32.8|Standard Deviation|9.5|9.5|||
3988343|NCT01249872|3809978|B1|Age (yr)||Age||years|Mean|35.1|35.1|Standard Deviation|9.4|9.4|||
3988344|NCT01249872|3809972|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3988345|NCT01249872|3809973|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3988346|NCT01249872|3809974|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3988347|NCT01249872|3809975|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3988348|NCT01249872|3809976|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3988349|NCT01249872|3809977|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3988350|NCT01249872|3809978|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3988351|NCT01249872|3809972|B7||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
3988352|NCT01249872|3809973|B6||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3988353|NCT01249872|3809974|B5||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3988354|NCT01249872|3809975|B4||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3988355|NCT01249872|3809976|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3988356|NCT01249872|3809977|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3988357|NCT01249872|3809978|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3988358|NCT01249872|3809972|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3988359|NCT01249872|3809973|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3988360|NCT01249872|3809974|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3988361|NCT01249872|3809975|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3988362|NCT01249872|3809976|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3988363|NCT01249872|3809977|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3988364|NCT01249872|3809978|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3988365|NCT01249833|3810027|B3||Depression|Cognitive/Mood Conditions||Participants|Count of Participants|6|6.0||||||
3988366|NCT01249833|3810028|B2||Depression|Cognitive/Mood Conditions||Participants|Count of Participants|1|1.0||||||
3988367|NCT01249833|3810029|B1||Depression|Cognitive/Mood Conditions||Participants|Count of Participants|5|5.0||||||
3988368|NCT01249833|3810027|B3||Anxiety|Cognitive/Mood Conditions||Participants|Count of Participants|2|2.0||||||
3988369|NCT01249833|3810028|B2||Anxiety|Cognitive/Mood Conditions||Participants|Count of Participants|1|1.0||||||
3988370|NCT01249833|3810029|B1||Anxiety|Cognitive/Mood Conditions||Participants|Count of Participants|1|1.0||||||
3988371|NCT01249833|3810027|B3||ADHD|Cognitive/Mood Conditions||Participants|Count of Participants|1|1.0||||||
3988372|NCT01249833|3810028|B2||ADHD|Cognitive/Mood Conditions||Participants|Count of Participants|1|1.0||||||
3988373|NCT01249833|3810029|B1||ADHD|Cognitive/Mood Conditions||Participants|Count of Participants|0|0.0||||||
3988374|NCT01249833|3810027|B3||None|Cognitive/Mood Conditions||Participants|Count of Participants|113|113.0||||||
3988375|NCT01249833|3810028|B2||None|Cognitive/Mood Conditions||Participants|Count of Participants|60|60.0||||||
3988376|NCT01249833|3810029|B1||None|Cognitive/Mood Conditions||Participants|Count of Participants|53|53.0||||||
3988377|NCT01249833|3810027|B3||Strain B|Influenza Type|Assessed through Rapid Antigen Test|Participants|Count of Participants|17|17.0||||||
3988378|NCT01249833|3810028|B2||Strain B|Influenza Type|Assessed through Rapid Antigen Test|Participants|Count of Participants|11|11.0||||||
3988379|NCT01249833|3810029|B1||Strain B|Influenza Type|Assessed through Rapid Antigen Test|Participants|Count of Participants|6|6.0||||||
3988380|NCT01249833|3810027|B3||Strain A|Influenza Type|Assessed through Rapid Antigen Test|Participants|Count of Participants|105|105.0||||||
3988381|NCT01249833|3810028|B2||Strain A|Influenza Type|Assessed through Rapid Antigen Test|Participants|Count of Participants|52|52.0||||||
3988382|NCT01249833|3810029|B1||Strain A|Influenza Type|Assessed through Rapid Antigen Test|Participants|Count of Participants|53|53.0||||||
3988383|NCT01249833|3810027|B3|||Health Assessment Question|Subjects rated their general health status each day using an 11-point VAS (0 = worst possible health; 10 = normal health for someone your age).|Score|Median|3|3.0|Full Range|||0.0|10.0|
3988384|NCT01249833|3810028|B2|||Health Assessment Question|Subjects rated their general health status each day using an 11-point VAS (0 = worst possible health; 10 = normal health for someone your age).|Score|Median|3|3.0|Full Range|||0.0|10.0|
3988434|NCT01249833|3810027|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3988385|NCT01249833|3810029|B1|||Health Assessment Question|Subjects rated their general health status each day using an 11-point VAS (0 = worst possible health; 10 = normal health for someone your age).|Score|Median|3|3.0|Full Range|||0.0|10.0|
3988386|NCT01249833|3810027|B3|||Body Temperature||Degrees centigrade|Median|38.1|38.1|Full Range|||36.3|39.5|
3988387|NCT01249833|3810028|B2|||Body Temperature||Degrees centigrade|Median|38.1|38.1|Full Range|||36.5|39.3|
3988388|NCT01249833|3810029|B1|||Body Temperature||Degrees centigrade|Median|38.1|38.1|Full Range|||36.3|39.5|
3988389|NCT01249833|3810027|B3|||Baseline Symptom Score|Participants recorded the severity of 7 influenza symptoms (cough, nasal obstruction, sore throat, fatigue, headache, myalgia, and feverishness) using a 4-point scale (0, absent; 3, severe) each day for 14 days. Symptom severity was assessed by summing the severity rating (0-3) for the seven symptoms at each day.|symptom score|Median|14|14.0|Full Range|||3.0|21.0|
3988390|NCT01249833|3810028|B2|||Baseline Symptom Score|Participants recorded the severity of 7 influenza symptoms (cough, nasal obstruction, sore throat, fatigue, headache, myalgia, and feverishness) using a 4-point scale (0, absent; 3, severe) each day for 14 days. Symptom severity was assessed by summing the severity rating (0-3) for the seven symptoms at each day.|symptom score|Median|14|14.0|Full Range|||6.0|21.0|
3988391|NCT01249833|3810029|B1|||Baseline Symptom Score|Participants recorded the severity of 7 influenza symptoms (cough, nasal obstruction, sore throat, fatigue, headache, myalgia, and feverishness) using a 4-point scale (0, absent; 3, severe) each day for 14 days. Symptom severity was assessed by summing the severity rating (0-3) for the seven symptoms at each day.|symptom score|Median|13|13.0|Full Range|||3.0|21.0|
3988392|NCT01249833|3810027|B3|||Time from Symptom Onset||hours|Median|35.0|35.0|Full Range|||2.0|55.0|
3988393|NCT01249833|3810028|B2|||Time from Symptom Onset||hours|Median|36.7|36.7|Full Range|||5.3|55.0|
3988394|NCT01249833|3810029|B1|||Time from Symptom Onset||hours|Median|33.8|33.8|Full Range|||2.0|51.5|
3988395|NCT01249833|3810027|B3|||Current Smoker||Participants|Count of Participants|21|21.0||||||
3988396|NCT01249833|3810028|B2|||Current Smoker||Participants|Count of Participants|14|14.0||||||
3988397|NCT01249833|3810029|B1|||Current Smoker||Participants|Count of Participants|7|7.0||||||
3988398|NCT01249833|3810027|B3||Post-Graduate|Highest Education Level||Participants|Count of Participants|8|8.0||||||
3988399|NCT01249833|3810028|B2||Post-Graduate|Highest Education Level||Participants|Count of Participants|4|4.0||||||
3988400|NCT01249833|3810029|B1||Post-Graduate|Highest Education Level||Participants|Count of Participants|4|4.0||||||
3988401|NCT01249833|3810027|B3||Bachelor's Degree|Highest Education Level||Participants|Count of Participants|29|29.0||||||
3988402|NCT01249833|3810028|B2||Bachelor's Degree|Highest Education Level||Participants|Count of Participants|13|13.0||||||
3988403|NCT01249833|3810029|B1||Bachelor's Degree|Highest Education Level||Participants|Count of Participants|16|16.0||||||
3988404|NCT01249833|3810027|B3||1 - 3 Years College|Highest Education Level||Participants|Count of Participants|44|44.0||||||
3988405|NCT01249833|3810028|B2||1 - 3 Years College|Highest Education Level||Participants|Count of Participants|24|24.0||||||
3988406|NCT01249833|3810029|B1||1 - 3 Years College|Highest Education Level||Participants|Count of Participants|20|20.0||||||
3988407|NCT01249833|3810027|B3||High School Graduate|Highest Education Level||Participants|Count of Participants|31|31.0||||||
3988408|NCT01249833|3810028|B2||High School Graduate|Highest Education Level||Participants|Count of Participants|19|19.0||||||
3988409|NCT01249833|3810029|B1||High School Graduate|Highest Education Level||Participants|Count of Participants|12|12.0||||||
3988410|NCT01249833|3810027|B3||Grade 5 - 11|Highest Education Level||Participants|Count of Participants|10|10.0||||||
3988411|NCT01249833|3810028|B2||Grade 5 - 11|Highest Education Level||Participants|Count of Participants|3|3.0||||||
3988412|NCT01249833|3810029|B1||Grade 5 - 11|Highest Education Level||Participants|Count of Participants|7|7.0||||||
3988413|NCT01249833|3810027|B3|Canada||Region of Enrollment||participants|Number|122|122.0||||||
3988414|NCT01249833|3810028|B2|Canada||Region of Enrollment||participants|Number|63|63.0||||||
3988415|NCT01249833|3810029|B1|Canada||Region of Enrollment||participants|Number|59|59.0||||||
3988416|NCT01249833|3810027|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3988417|NCT01249833|3810028|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3988418|NCT01249833|3810029|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3988419|NCT01249833|3810027|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3988420|NCT01249833|3810028|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3988421|NCT01249833|3810029|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3988422|NCT01249833|3810027|B3||White|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
3988423|NCT01249833|3810028|B2||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
3988424|NCT01249833|3810029|B1||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3988425|NCT01249833|3810027|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3988426|NCT01249833|3810028|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3988427|NCT01249833|3810029|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3988428|NCT01249833|3810027|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3988429|NCT01249833|3810028|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3988430|NCT01249833|3810029|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3988431|NCT01249833|3810027|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3988432|NCT01249833|3810028|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3988433|NCT01249833|3810029|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3988435|NCT01249833|3810028|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3988436|NCT01249833|3810029|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3988437|NCT01249833|3810027|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3988438|NCT01249833|3810028|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3988439|NCT01249833|3810029|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3988440|NCT01249833|3810027|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3988441|NCT01249833|3810028|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3988442|NCT01249833|3810029|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3988443|NCT01249833|3810027|B3|||Age||years|Median|34.0|34.0|Full Range|||17.0|66.0|
3988444|NCT01249833|3810028|B2|||Age||years|Median|32.0|32.0|Full Range|||18.0|57.0|
3988445|NCT01249833|3810029|B1|||Age||years|Median|37.0|37.0|Full Range|||17.0|66.0|
3988446|NCT01249664|3810042|B3|||Baseline axial length||millimeter (mm)|Mean|28.745|28.745|Standard Deviation|1.564|1.564|||
3988447|NCT01249664|3810043|B2|||Baseline axial length||millimeter (mm)|Mean|28.610|28.61|Standard Deviation|1.696|1.696|||
3988448|NCT01249664|3810044|B1|||Baseline axial length||millimeter (mm)|Mean|28.791|28.791|Standard Deviation|1.524|1.524|||
3988449|NCT01249664|3810042|B3|||Duration of disease||days|Mean|153.7|153.7|Standard Deviation|455.6|455.6|||
3988450|NCT01249664|3810043|B2|||Duration of disease||days|Mean|177.1|177.1|Standard Deviation|512.0|512.0|||
3988451|NCT01249664|3810044|B1|||Duration of disease||days|Mean|145.6|145.6|Standard Deviation|437.4|437.4|||
3988452|NCT01249664|3810042|B3|||Baseline area of leakage|Disc Area is a ophthalmological unit of measuring areas. 1 Disc area = 2.54 millimeters squared mm^2.|disc area|Mean|0.6970|0.697|Standard Deviation|0.6507|0.6507|||
3988453|NCT01249664|3810043|B2|||Baseline area of leakage|Disc Area is a ophthalmological unit of measuring areas. 1 Disc area = 2.54 millimeters squared mm^2.|disc area|Mean|0.6867|0.6867|Standard Deviation|0.5563|0.5563|||
3988454|NCT01249664|3810044|B1|||Baseline area of leakage|Disc Area is a ophthalmological unit of measuring areas. 1 Disc area = 2.54 millimeters squared mm^2.|disc area|Mean|0.7005|0.7005|Standard Deviation|0.6830|0.683|||
3988455|NCT01249664|3810042|B3|||Baseline Choroidal neovascularization (CNV) size|Disc Area is a ophthalmological unit of measuring areas. 1 Disc area = 2.54 millimeters squared mm^2.|disc area|Mean|0.3894|0.3894|Standard Deviation|0.4666|0.4666|||
3988456|NCT01249664|3810043|B2|||Baseline Choroidal neovascularization (CNV) size|Disc Area is a ophthalmological unit of measuring areas. 1 Disc area = 2.54 millimeters squared mm^2.|disc area|Mean|0.3334|0.3334|Standard Deviation|0.3413|0.3413|||
3988457|NCT01249664|3810044|B1|||Baseline Choroidal neovascularization (CNV) size|Disc Area is a ophthalmological unit of measuring areas. 1 Disc area = 2.54 millimeters squared mm^2.|disc area|Mean|0.4086|0.4086|Standard Deviation|0.5028|0.5028|||
3988458|NCT01249664|3810042|B3|Unknown or Not Reported||Race||Participants|Number|0|0.0||||||
3988459|NCT01249664|3810043|B2|Unknown or Not Reported||Race||Participants|Number|0|0.0||||||
3988460|NCT01249664|3810044|B1|Unknown or Not Reported||Race||Participants|Number|0|0.0||||||
3988461|NCT01249664|3810042|B3|White||Race||Participants|Number|0|0.0||||||
3988462|NCT01249664|3810043|B2|White||Race||Participants|Number|0|0.0||||||
3988463|NCT01249664|3810044|B1|White||Race||Participants|Number|0|0.0||||||
3988464|NCT01249664|3810042|B3|Asian||Race||Participants|Number|121|121.0||||||
3988465|NCT01249664|3810043|B2|Asian||Race||Participants|Number|31|31.0||||||
3988466|NCT01249664|3810044|B1|Asian||Race||Participants|Number|90|90.0||||||
3988467|NCT01249664|3810042|B3|||European questionnaire 5 dimensions (EQ-5D) total score|The EQ-5D total score ranges from -0.594 to 1.000 with -0.594 being the worst.|score on a scale|Mean|0.88|0.88|Standard Deviation|0.18|0.18|||
3988468|NCT01249664|3810043|B2|||European questionnaire 5 dimensions (EQ-5D) total score|The EQ-5D total score ranges from -0.594 to 1.000 with -0.594 being the worst.|score on a scale|Mean|0.88|0.88|Standard Deviation|0.15|0.15|||
3988469|NCT01249664|3810044|B1|||European questionnaire 5 dimensions (EQ-5D) total score|The EQ-5D total score ranges from -0.594 to 1.000 with -0.594 being the worst.|score on a scale|Mean|0.88|0.88|Standard Deviation|0.18|0.18|||
3988470|NCT01249664|3810042|B3|||Baseline National Eye Institute 25-item Visual Function Questionnaire (NEI VFQ-25) total score|The NEI VFQ-25 total score ranges from 0-100 with a score of 0 being the worst outcome and 100 being the best outcome. The NEI VFQ questionnaire is organized as a collection of subscales which are all scored from 0-100. To reach the overall composite score, each sub-scale score is averaged in order to give each sub-scale equal weight.|scores on a scale|Mean|71.04|71.04|Standard Deviation|13.94|13.94|||
3988471|NCT01249664|3810043|B2|||Baseline National Eye Institute 25-item Visual Function Questionnaire (NEI VFQ-25) total score|The NEI VFQ-25 total score ranges from 0-100 with a score of 0 being the worst outcome and 100 being the best outcome. The NEI VFQ questionnaire is organized as a collection of subscales which are all scored from 0-100. To reach the overall composite score, each sub-scale score is averaged in order to give each sub-scale equal weight.|scores on a scale|Mean|72.73|72.73|Standard Deviation|15.29|15.29|||
3988472|NCT01249664|3810044|B1|||Baseline National Eye Institute 25-item Visual Function Questionnaire (NEI VFQ-25) total score|The NEI VFQ-25 total score ranges from 0-100 with a score of 0 being the worst outcome and 100 being the best outcome. The NEI VFQ questionnaire is organized as a collection of subscales which are all scored from 0-100. To reach the overall composite score, each sub-scale score is averaged in order to give each sub-scale equal weight.|scores on a scale|Mean|70.47|70.47|Standard Deviation|13.48|13.48|||
3988473|NCT01249664|3810042|B3|< 2 months||Number of participants by category of time since mCNV diagnosis||Participants|Number|97|97.0||||||
3988474|NCT01249664|3810043|B2|< 2 months||Number of participants by category of time since mCNV diagnosis||Participants|Number|24|24.0||||||
3988475|NCT01249664|3810044|B1|< 2 months||Number of participants by category of time since mCNV diagnosis||Participants|Number|73|73.0||||||
3988476|NCT01249664|3810042|B3|>= 2 months||Number of participants by category of time since mCNV diagnosis||Participants|Number|24|24.0||||||
3988477|NCT01249664|3810043|B2|>= 2 months||Number of participants by category of time since mCNV diagnosis||Participants|Number|7|7.0||||||
3988478|NCT01249664|3810044|B1|>= 2 months||Number of participants by category of time since mCNV diagnosis||Participants|Number|17|17.0||||||
3988479|NCT01249664|3810042|B3|||Baseline intraocular pressure||mm Hg|Mean|15.4|15.4|Standard Deviation|2.7|2.7|||
3988480|NCT01249664|3810043|B2|||Baseline intraocular pressure||mm Hg|Mean|15.8|15.8|Standard Deviation|2.8|2.8|||
3988481|NCT01249664|3810044|B1|||Baseline intraocular pressure||mm Hg|Mean|15.2|15.2|Standard Deviation|2.7|2.7|||
3988482|NCT01249664|3810042|B3|||Baseline Central Retinal Thickness by Optical Coherence Tomography (OCT)||µm|Mean|350.9|350.9|Standard Deviation|95.2|95.2|||
3988483|NCT01249664|3810043|B2|||Baseline Central Retinal Thickness by Optical Coherence Tomography (OCT)||µm|Mean|354.2|354.2|Standard Deviation|107.2|107.2|||
3988484|NCT01249664|3810044|B1|||Baseline Central Retinal Thickness by Optical Coherence Tomography (OCT)||µm|Mean|349.7|349.7|Standard Deviation|91.3|91.3|||
3988485|NCT01249664|3810042|B3|||Baseline Best Corrected Visual Acuity (BCVA) letter scores|Information retrieved from all baseline participants. Only participants with a ETDRS (Early Treatment Diabetic Retinopathy Study) Best Corrected Visual Acuity letter score of 73 to 35 (= Acuity of 20/40 to 20/200) in the study eye at 4 meters were included; a higher score represents better functioning.|Letters correctly read|Mean|56.5|56.5|Standard Deviation|9.5|9.5|||
3988486|NCT01249664|3810043|B2|||Baseline Best Corrected Visual Acuity (BCVA) letter scores|Information retrieved from all baseline participants. Only participants with a ETDRS (Early Treatment Diabetic Retinopathy Study) Best Corrected Visual Acuity letter score of 73 to 35 (= Acuity of 20/40 to 20/200) in the study eye at 4 meters were included; a higher score represents better functioning.|Letters correctly read|Mean|56.6|56.6|Standard Deviation|8.9|8.9|||
3988487|NCT01249664|3810044|B1|||Baseline Best Corrected Visual Acuity (BCVA) letter scores|Information retrieved from all baseline participants. Only participants with a ETDRS (Early Treatment Diabetic Retinopathy Study) Best Corrected Visual Acuity letter score of 73 to 35 (= Acuity of 20/40 to 20/200) in the study eye at 4 meters were included; a higher score represents better functioning.|Letters correctly read|Mean|56.4|56.4|Standard Deviation|9.8|9.8|||
3988488|NCT01249664|3810042|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3988489|NCT01249664|3810043|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3988490|NCT01249664|3810044|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3988491|NCT01249664|3810042|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3988492|NCT01249664|3810043|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3988493|NCT01249664|3810044|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3988494|NCT01249664|3810042|B3|||Age||Years|Mean|58.2|58.2|Standard Deviation|13.3|13.3|||
3988495|NCT01249664|3810043|B2|||Age||Years|Mean|57.5|57.5|Standard Deviation|12.1|12.1|||
3988496|NCT01249664|3810044|B1|||Age||Years|Mean|58.5|58.5|Standard Deviation|13.7|13.7|||
3988497|NCT01249651|3810095|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3988498|NCT01249651|3810095|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3988499|NCT01249651|3810095|B1|||Age||Year|Mean|51.2|51.2|Standard Deviation|13.71|13.71|||
3988500|NCT01249417|3810102|B4|||Modified Ashworth Scale (MAS) score|The MAS is a 6-point scale which measures the intensity of muscle tone by measuring the resistance of the muscle to passive lengthening or stretching. The Investigator graded muscle tone in the gastrocnemius-soleus complex (GSC) from 0 (no increase in tone) to 4 (affected parts rigid in flexion or extension).|units on a scale|Mean|3.1|3.1|Standard Deviation|0.4|0.4|||
3988501|NCT01249417|3810103|B3|||Modified Ashworth Scale (MAS) score|The MAS is a 6-point scale which measures the intensity of muscle tone by measuring the resistance of the muscle to passive lengthening or stretching. The Investigator graded muscle tone in the gastrocnemius-soleus complex (GSC) from 0 (no increase in tone) to 4 (affected parts rigid in flexion or extension).|units on a scale|Mean|3.2|3.2|Standard Deviation|0.4|0.4|||
3988502|NCT01249417|3810104|B2|||Modified Ashworth Scale (MAS) score|The MAS is a 6-point scale which measures the intensity of muscle tone by measuring the resistance of the muscle to passive lengthening or stretching. The Investigator graded muscle tone in the gastrocnemius-soleus complex (GSC) from 0 (no increase in tone) to 4 (affected parts rigid in flexion or extension).|units on a scale|Mean|3.1|3.1|Standard Deviation|0.3|0.3|||
3988503|NCT01249417|3810105|B1|||Modified Ashworth Scale (MAS) score|The MAS is a 6-point scale which measures the intensity of muscle tone by measuring the resistance of the muscle to passive lengthening or stretching. The Investigator graded muscle tone in the gastrocnemius-soleus complex (GSC) from 0 (no increase in tone) to 4 (affected parts rigid in flexion or extension).|units on a scale|Mean|3.1|3.1|Standard Deviation|0.3|0.3|||
3988504|NCT01249417|3810102|B4|||Body Mass Index (BMI)||kg/m2|Mean|16.0|16.0|Standard Deviation|2.8|2.8|||
3988505|NCT01249417|3810103|B3|||Body Mass Index (BMI)||kg/m2|Mean|16.2|16.2|Standard Deviation|2.7|2.7|||
3988506|NCT01249417|3810104|B2|||Body Mass Index (BMI)||kg/m2|Mean|16.1|16.1|Standard Deviation|2.7|2.7|||
3988507|NCT01249417|3810105|B1|||Body Mass Index (BMI)||kg/m2|Mean|15.8|15.8|Standard Deviation|2.9|2.9|||
3988508|NCT01249417|3810102|B4|||Weight||kg|Mean|22.3|22.3|Standard Deviation|12.0|12.0|||
3988509|NCT01249417|3810103|B3|||Weight||kg|Mean|22.6|22.6|Standard Deviation|11.9|11.9|||
3988510|NCT01249417|3810104|B2|||Weight||kg|Mean|21.1|21.1|Standard Deviation|10.7|10.7|||
3988511|NCT01249417|3810105|B1|||Weight||kg|Mean|23.1|23.1|Standard Deviation|13.4|13.4|||
3988512|NCT01249417|3810102|B4|||Height||cm|Mean|114.4|114.4|Standard Deviation|19.7|19.7|||
3988513|NCT01249417|3810103|B3|||Height||cm|Mean|114.6|114.6|Standard Deviation|19.7|19.7|||
3988514|NCT01249417|3810104|B2|||Height||cm|Mean|111.6|111.6|Standard Deviation|18.5|18.5|||
3988515|NCT01249417|3810105|B1|||Height||cm|Mean|117.1|117.1|Standard Deviation|20.7|20.7|||
3988545|NCT01249417|3810103|B3|Multiple||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3988546|NCT01249417|3810104|B2|Multiple||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3988516|NCT01249417|3810102|B4|GMFCS level 3||Gross Motor Function Classification System (GMFCS)|Participants were staged according to the following GMFCS criteria: level 1 (walks without limitations (best outcome)), level 2 (walks with limitations) and level 3 (walks using a hand held mobility device (worst outcome)). Only participants classified as GMFCS levels 1 to 3 were eligible for entry into the study.|participants|Number|26|26.0||||||
3988517|NCT01249417|3810103|B3|GMFCS level 3||Gross Motor Function Classification System (GMFCS)|Participants were staged according to the following GMFCS criteria: level 1 (walks without limitations (best outcome)), level 2 (walks with limitations) and level 3 (walks using a hand held mobility device (worst outcome)). Only participants classified as GMFCS levels 1 to 3 were eligible for entry into the study.|participants|Number|7|7.0||||||
3988518|NCT01249417|3810104|B2|GMFCS level 3||Gross Motor Function Classification System (GMFCS)|Participants were staged according to the following GMFCS criteria: level 1 (walks without limitations (best outcome)), level 2 (walks with limitations) and level 3 (walks using a hand held mobility device (worst outcome)). Only participants classified as GMFCS levels 1 to 3 were eligible for entry into the study.|participants|Number|10|10.0||||||
3988519|NCT01249417|3810105|B1|GMFCS level 3||Gross Motor Function Classification System (GMFCS)|Participants were staged according to the following GMFCS criteria: level 1 (walks without limitations (best outcome)), level 2 (walks with limitations) and level 3 (walks using a hand held mobility device (worst outcome)). Only participants classified as GMFCS levels 1 to 3 were eligible for entry into the study.|participants|Number|9|9.0||||||
3988520|NCT01249417|3810102|B4|GMFCS level 2||Gross Motor Function Classification System (GMFCS)|Participants were staged according to the following GMFCS criteria: level 1 (walks without limitations (best outcome)), level 2 (walks with limitations) and level 3 (walks using a hand held mobility device (worst outcome)). Only participants classified as GMFCS levels 1 to 3 were eligible for entry into the study.|participants|Number|78|78.0||||||
3988521|NCT01249417|3810103|B3|GMFCS level 2||Gross Motor Function Classification System (GMFCS)|Participants were staged according to the following GMFCS criteria: level 1 (walks without limitations (best outcome)), level 2 (walks with limitations) and level 3 (walks using a hand held mobility device (worst outcome)). Only participants classified as GMFCS levels 1 to 3 were eligible for entry into the study.|participants|Number|30|30.0||||||
3988522|NCT01249417|3810104|B2|GMFCS level 2||Gross Motor Function Classification System (GMFCS)|Participants were staged according to the following GMFCS criteria: level 1 (walks without limitations (best outcome)), level 2 (walks with limitations) and level 3 (walks using a hand held mobility device (worst outcome)). Only participants classified as GMFCS levels 1 to 3 were eligible for entry into the study.|participants|Number|24|24.0||||||
3988523|NCT01249417|3810105|B1|GMFCS level 2||Gross Motor Function Classification System (GMFCS)|Participants were staged according to the following GMFCS criteria: level 1 (walks without limitations (best outcome)), level 2 (walks with limitations) and level 3 (walks using a hand held mobility device (worst outcome)). Only participants classified as GMFCS levels 1 to 3 were eligible for entry into the study.|participants|Number|24|24.0||||||
3988524|NCT01249417|3810102|B4|GMFCS level 1||Gross Motor Function Classification System (GMFCS)|Participants were staged according to the following GMFCS criteria: level 1 (walks without limitations (best outcome)), level 2 (walks with limitations) and level 3 (walks using a hand held mobility device (worst outcome)). Only participants classified as GMFCS levels 1 to 3 were eligible for entry into the study.|participants|Number|131|131.0||||||
3988525|NCT01249417|3810103|B3|GMFCS level 1||Gross Motor Function Classification System (GMFCS)|Participants were staged according to the following GMFCS criteria: level 1 (walks without limitations (best outcome)), level 2 (walks with limitations) and level 3 (walks using a hand held mobility device (worst outcome)). Only participants classified as GMFCS levels 1 to 3 were eligible for entry into the study.|participants|Number|40|40.0||||||
3988526|NCT01249417|3810104|B2|GMFCS level 1||Gross Motor Function Classification System (GMFCS)|Participants were staged according to the following GMFCS criteria: level 1 (walks without limitations (best outcome)), level 2 (walks with limitations) and level 3 (walks using a hand held mobility device (worst outcome)). Only participants classified as GMFCS levels 1 to 3 were eligible for entry into the study.|participants|Number|45|45.0||||||
3988527|NCT01249417|3810105|B1|GMFCS level 1||Gross Motor Function Classification System (GMFCS)|Participants were staged according to the following GMFCS criteria: level 1 (walks without limitations (best outcome)), level 2 (walks with limitations) and level 3 (walks using a hand held mobility device (worst outcome)). Only participants classified as GMFCS levels 1 to 3 were eligible for entry into the study.|participants|Number|46|46.0||||||
3988528|NCT01249417|3810102|B4|2 Legs injected||Number of legs being treated||participants|Number|96|96.0||||||
3988529|NCT01249417|3810103|B3|2 Legs injected||Number of legs being treated||participants|Number|30|30.0||||||
3988530|NCT01249417|3810104|B2|2 Legs injected||Number of legs being treated||participants|Number|29|29.0||||||
3988531|NCT01249417|3810105|B1|2 Legs injected||Number of legs being treated||participants|Number|37|37.0||||||
3988532|NCT01249417|3810102|B4|1 Leg injected||Number of legs being treated||participants|Number|139|139.0||||||
3988533|NCT01249417|3810103|B3|1 Leg injected||Number of legs being treated||participants|Number|47|47.0||||||
3988534|NCT01249417|3810104|B2|1 Leg injected||Number of legs being treated||participants|Number|50|50.0||||||
3988535|NCT01249417|3810105|B1|1 Leg injected||Number of legs being treated||participants|Number|42|42.0||||||
3988536|NCT01249417|3810102|B4|Non-naive||Botulinum toxin Status||participants|Number|113|113.0||||||
3988537|NCT01249417|3810103|B3|Non-naive||Botulinum toxin Status||participants|Number|36|36.0||||||
3988538|NCT01249417|3810104|B2|Non-naive||Botulinum toxin Status||participants|Number|38|38.0||||||
3988539|NCT01249417|3810105|B1|Non-naive||Botulinum toxin Status||participants|Number|39|39.0||||||
3988540|NCT01249417|3810102|B4|Naive||Botulinum toxin Status||participants|Number|122|122.0||||||
3988541|NCT01249417|3810103|B3|Naive||Botulinum toxin Status||participants|Number|41|41.0||||||
3988542|NCT01249417|3810104|B2|Naive||Botulinum toxin Status||participants|Number|41|41.0||||||
3988543|NCT01249417|3810105|B1|Naive||Botulinum toxin Status||participants|Number|40|40.0||||||
3988544|NCT01249417|3810102|B4|Multiple||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
3988547|NCT01249417|3810105|B1|Multiple||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3988548|NCT01249417|3810102|B4|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3988549|NCT01249417|3810103|B3|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3988550|NCT01249417|3810104|B2|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3988551|NCT01249417|3810105|B1|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3988552|NCT01249417|3810102|B4|Caucasian/White||Race/Ethnicity, Customized||participants|Number|172|172.0||||||
3988553|NCT01249417|3810103|B3|Caucasian/White||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
3988554|NCT01249417|3810104|B2|Caucasian/White||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
3988555|NCT01249417|3810105|B1|Caucasian/White||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
3988556|NCT01249417|3810102|B4|Black/African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3988557|NCT01249417|3810103|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3988558|NCT01249417|3810104|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3988559|NCT01249417|3810105|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3988560|NCT01249417|3810102|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3988561|NCT01249417|3810103|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3988562|NCT01249417|3810104|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3988563|NCT01249417|3810105|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3988564|NCT01249417|3810102|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|173|173.0||||||
3988565|NCT01249417|3810103|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3988566|NCT01249417|3810104|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3988567|NCT01249417|3810105|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3988568|NCT01249417|3810102|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
3988569|NCT01249417|3810103|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3988570|NCT01249417|3810104|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3988571|NCT01249417|3810105|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3988572|NCT01249417|3810102|B4||Male|Gender||Participants|Count of Participants|94|94.0||||||
3988573|NCT01249417|3810103|B3||Male|Gender||Participants|Count of Participants|29|29.0||||||
3988574|NCT01249417|3810104|B2||Male|Gender||Participants|Count of Participants|31|31.0||||||
3988575|NCT01249417|3810105|B1||Male|Gender||Participants|Count of Participants|34|34.0||||||
3988576|NCT01249417|3810102|B4||Female|Gender||Participants|Count of Participants|141|141.0||||||
3988577|NCT01249417|3810103|B3||Female|Gender||Participants|Count of Participants|48|48.0||||||
3988578|NCT01249417|3810104|B2||Female|Gender||Participants|Count of Participants|48|48.0||||||
3988579|NCT01249417|3810105|B1||Female|Gender||Participants|Count of Participants|45|45.0||||||
3988580|NCT01249417|3810102|B4|Children (10-17 years)||Age, Customized||participants|Number|36|36.0||||||
3988581|NCT01249417|3810103|B3|Children (10-17 years)||Age, Customized||participants|Number|12|12.0||||||
3988582|NCT01249417|3810104|B2|Children (10-17 years)||Age, Customized||participants|Number|12|12.0||||||
3988583|NCT01249417|3810105|B1|Children (10-17 years)||Age, Customized||participants|Number|12|12.0||||||
3988584|NCT01249417|3810102|B4|Children (2-9 years)||Age, Customized||participants|Number|199|199.0||||||
3988585|NCT01249417|3810103|B3|Children (2-9 years)||Age, Customized||participants|Number|65|65.0||||||
3988586|NCT01249417|3810104|B2|Children (2-9 years)||Age, Customized||participants|Number|67|67.0||||||
3988587|NCT01249417|3810105|B1|Children (2-9 years)||Age, Customized||participants|Number|67|67.0||||||
3988588|NCT01249417|3810102|B4|||Age||years|Mean|5.9|5.9|Standard Deviation|3.3|3.3|||
3988589|NCT01249417|3810103|B3|||Age||years|Mean|5.9|5.9|Standard Deviation|3.5|3.5|||
3988590|NCT01249417|3810104|B2|||Age||years|Mean|5.7|5.7|Standard Deviation|3.2|3.2|||
3988591|NCT01249417|3810105|B1|||Age||years|Mean|6|6.0|Standard Deviation|3.3|3.3|||
3988592|NCT01249404|3810121|B4||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|345|345.0||||||
3988593|NCT01249404|3810122|B3||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|117|117.0||||||
3988594|NCT01249404|3810123|B2||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|117|117.0||||||
3988595|NCT01249404|3810124|B1||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|111|111.0||||||
3988596|NCT01249404|3810121|B4||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
3988597|NCT01249404|3810122|B3||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3988598|NCT01249404|3810123|B2||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
3988599|NCT01249404|3810124|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3988600|NCT01249404|3810121|B4||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3988601|NCT01249404|3810122|B3||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3988602|NCT01249404|3810123|B2||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3988603|NCT01249404|3810124|B1||Multiple|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3988604|NCT01249404|3810121|B4||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3988605|NCT01249404|3810122|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3988606|NCT01249404|3810123|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3988607|NCT01249404|3810124|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3988608|NCT01249404|3810121|B4||Caucasian or White|Race/Ethnicity, Customized||Participants|Count of Participants|344|344.0||||||
3988609|NCT01249404|3810122|B3||Caucasian or White|Race/Ethnicity, Customized||Participants|Count of Participants|119|119.0||||||
3988610|NCT01249404|3810123|B2||Caucasian or White|Race/Ethnicity, Customized||Participants|Count of Participants|109|109.0||||||
3988611|NCT01249404|3810124|B1||Caucasian or White|Race/Ethnicity, Customized||Participants|Count of Participants|116|116.0||||||
3988612|NCT01249404|3810121|B4||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
3988613|NCT01249404|3810122|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3988614|NCT01249404|3810123|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
3988615|NCT01249404|3810124|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3988616|NCT01249404|3810121|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3988617|NCT01249404|3810122|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3988618|NCT01249404|3810123|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3988619|NCT01249404|3810124|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3988620|NCT01249404|3810121|B4||Male|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
3988621|NCT01249404|3810122|B3||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3988622|NCT01249404|3810123|B2||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3988623|NCT01249404|3810124|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3988624|NCT01249404|3810121|B4||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3988625|NCT01249404|3810122|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3988626|NCT01249404|3810123|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3988627|NCT01249404|3810124|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3988628|NCT01249404|3810121|B4|||Age||years|Mean|52.6|52.6|Standard Deviation|12.7|12.7|||
3988629|NCT01249404|3810122|B3|||Age||years|Mean|51.4|51.4|Standard Deviation|12.9|12.9|||
3988630|NCT01249404|3810123|B2|||Age||years|Mean|53.3|53.3|Standard Deviation|12.0|12.0|||
3988631|NCT01249404|3810124|B1|||Age||years|Mean|53.2|53.2|Standard Deviation|13.2|13.2|||
3988632|NCT01249365|3810203|B1|Geographic ancestry|White - Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|116|116.0||||||
3988633|NCT01249365|3810203|B1|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|78|78.0||||||
3988634|NCT01249365|3810203|B1|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3988635|NCT01249365|3810203|B1|Geographic ancestry|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3988636|NCT01249365|3810203|B1|Geographic ancestry|African Heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3988637|NCT01249365|3810203|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3988638|NCT01249365|3810203|B1||Female|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
3988639|NCT01249365|3810203|B1|||Age||Years|Mean|46.9|46.9|Standard Deviation|7.2|7.2|||
3988640|NCT01249274|3810209|B3|no||Post-traumatic stress disorder||participants|Number|39|39.0||||||
3988641|NCT01249274|3810210|B2|no||Post-traumatic stress disorder||participants|Number|19|19.0||||||
3988642|NCT01249274|3810211|B1|no||Post-traumatic stress disorder||participants|Number|20|20.0||||||
3988643|NCT01249274|3810209|B3|yes||Post-traumatic stress disorder||participants|Number|11|11.0||||||
3988644|NCT01249274|3810210|B2|yes||Post-traumatic stress disorder||participants|Number|6|6.0||||||
3988645|NCT01249274|3810211|B1|yes||Post-traumatic stress disorder||participants|Number|5|5.0||||||
3988646|NCT01249274|3810209|B3|no||Generalized anxiety disorder||participants|Number|36|36.0||||||
3988647|NCT01249274|3810210|B2|no||Generalized anxiety disorder||participants|Number|17|17.0||||||
3988648|NCT01249274|3810211|B1|no||Generalized anxiety disorder||participants|Number|19|19.0||||||
3988649|NCT01249274|3810209|B3|yes||Generalized anxiety disorder||participants|Number|14|14.0||||||
3988650|NCT01249274|3810210|B2|yes||Generalized anxiety disorder||participants|Number|8|8.0||||||
3988651|NCT01249274|3810211|B1|yes||Generalized anxiety disorder||participants|Number|6|6.0||||||
3988652|NCT01249274|3810209|B3|no||Obsessive compulsive disorder||participants|Number|46|46.0||||||
3988653|NCT01249274|3810210|B2|no||Obsessive compulsive disorder||participants|Number|25|25.0||||||
3988654|NCT01249274|3810211|B1|no||Obsessive compulsive disorder||participants|Number|21|21.0||||||
3988655|NCT01249274|3810209|B3|yes||Obsessive compulsive disorder||participants|Number|4|4.0||||||
3988656|NCT01249274|3810210|B2|yes||Obsessive compulsive disorder||participants|Number|0|0.0||||||
3988657|NCT01249274|3810211|B1|yes||Obsessive compulsive disorder||participants|Number|4|4.0||||||
3988658|NCT01249274|3810209|B3|No history of social phobia||Social phobia||participants|Number|44|44.0||||||
3988659|NCT01249274|3810210|B2|No history of social phobia||Social phobia||participants|Number|24|24.0||||||
3988660|NCT01249274|3810211|B1|No history of social phobia||Social phobia||participants|Number|20|20.0||||||
3988661|NCT01249274|3810209|B3|History of social phobia||Social phobia||participants|Number|6|6.0||||||
3988662|NCT01249274|3810210|B2|History of social phobia||Social phobia||participants|Number|1|1.0||||||
3988663|NCT01249274|3810211|B1|History of social phobia||Social phobia||participants|Number|5|5.0||||||
3988664|NCT01249274|3810209|B3|No history of MDD||Any lifetime major depressive episode||participants|Number|43|43.0||||||
3988665|NCT01249274|3810210|B2|No history of MDD||Any lifetime major depressive episode||participants|Number|22|22.0||||||
3988666|NCT01249274|3810211|B1|No history of MDD||Any lifetime major depressive episode||participants|Number|21|21.0||||||
3988667|NCT01249274|3810209|B3|History of MDD||Any lifetime major depressive episode||participants|Number|7|7.0||||||
3988668|NCT01249274|3810210|B2|History of MDD||Any lifetime major depressive episode||participants|Number|3|3.0||||||
3988669|NCT01249274|3810211|B1|History of MDD||Any lifetime major depressive episode||participants|Number|4|4.0||||||
3988670|NCT01249274|3810209|B3|not using methadone||Methadone maintained||participants|Number|28|28.0||||||
3988671|NCT01249274|3810210|B2|not using methadone||Methadone maintained||participants|Number|11|11.0||||||
3988672|NCT01249274|3810211|B1|not using methadone||Methadone maintained||participants|Number|17|17.0||||||
3988673|NCT01249274|3810209|B3|Using methadone||Methadone maintained||participants|Number|22|22.0||||||
3988674|NCT01249274|3810210|B2|Using methadone||Methadone maintained||participants|Number|14|14.0||||||
3988675|NCT01249274|3810211|B1|Using methadone||Methadone maintained||participants|Number|8|8.0||||||
3988676|NCT01249274|3810209|B3|Using cocaine at intake||Not using cocaine at intake||participants|Number|9|9.0||||||
3988677|NCT01249274|3810210|B2|Using cocaine at intake||Not using cocaine at intake||participants|Number|6|6.0||||||
3988678|NCT01249274|3810211|B1|Using cocaine at intake||Not using cocaine at intake||participants|Number|3|3.0||||||
3988679|NCT01249274|3810209|B3|Not using cocaine at intake||Not using cocaine at intake||participants|Number|41|41.0||||||
3988680|NCT01249274|3810210|B2|Not using cocaine at intake||Not using cocaine at intake||participants|Number|19|19.0||||||
3988681|NCT01249274|3810211|B1|Not using cocaine at intake||Not using cocaine at intake||participants|Number|22|22.0||||||
3988682|NCT01249274|3810209|B3|||Baseline cocaine use (days per week)|Baseline cocaine use (days of use per week, averaged across 4 weeks prior to baseline, maximum value=7 days)|days|Mean|1.1|1.1|Standard Deviation|1.0|1.0|||
3988683|NCT01249274|3810210|B2|||Baseline cocaine use (days per week)|Baseline cocaine use (days of use per week, averaged across 4 weeks prior to baseline, maximum value=7 days)|days|Mean|1.15|1.15|Standard Deviation|3.84|3.84|||
3988684|NCT01249274|3810211|B1|||Baseline cocaine use (days per week)|Baseline cocaine use (days of use per week, averaged across 4 weeks prior to baseline, maximum value=7 days)|days|Mean|0.41|0.41|Standard Deviation|.91|0.91|||
3988685|NCT01249274|3810209|B3|||EPDS score at intake|The Edinburgh Postnatal Depression scale measures depression and has 10 items with range of 0-30. Higher scores indicate more severe depression.|units on a scale|Mean|11.2|11.2|Standard Deviation|3.9|3.9|||
3988686|NCT01249274|3810210|B2|||EPDS score at intake|The Edinburgh Postnatal Depression scale measures depression and has 10 items with range of 0-30. Higher scores indicate more severe depression.|units on a scale|Mean|11.2|11.2|Standard Deviation|7.2|7.2|||
3988687|NCT01249274|3810211|B1|||EPDS score at intake|The Edinburgh Postnatal Depression scale measures depression and has 10 items with range of 0-30. Higher scores indicate more severe depression.|units on a scale|Mean|11.2|11.2|Standard Deviation|6.7|6.7|||
3988688|NCT01249274|3810209|B3|||Parity||births|Mean|2.4|2.4|Standard Deviation|0.2|0.2|||
3988689|NCT01249274|3810210|B2|||Parity||births|Mean|2.1|2.1|Standard Deviation|1.4|1.4|||
3988690|NCT01249274|3810211|B1|||Parity||births|Mean|2.6|2.6|Standard Deviation|1.6|1.6|||
3988691|NCT01249274|3810209|B3|||Age at first cocaine use (years)||years|Mean|19.9|19.9|Standard Deviation|2.2|2.2|||
3988692|NCT01249274|3810210|B2|||Age at first cocaine use (years)||years|Mean|19.2|19.2|Standard Deviation|4.0|4.0|||
3988693|NCT01249274|3810211|B1|||Age at first cocaine use (years)||years|Mean|20.6|20.6|Standard Deviation|6.3|6.3|||
3988694|NCT01249274|3810209|B3|||Lifetime cocaine use (years)||years|Mean|7.4|7.4|Standard Deviation|2.8|2.8|||
3988695|NCT01249274|3810210|B2|||Lifetime cocaine use (years)||years|Mean|6.2|6.2|Standard Deviation|4.2|4.2|||
3988696|NCT01249274|3810211|B1|||Lifetime cocaine use (years)||years|Mean|8.5|8.5|Standard Deviation|7.2|7.2|||
3988697|NCT01249274|3810209|B3|||Weeks post partum||weeks|Mean|3.5|3.5|Standard Deviation|2.3|2.3|||
3988698|NCT01249274|3810210|B2|||Weeks post partum||weeks|Mean|3.6|3.6|Standard Deviation|4.6|4.6|||
3988699|NCT01249274|3810211|B1|||Weeks post partum||weeks|Mean|3.4|3.4|Standard Deviation|5.1|5.1|||
3988700|NCT01249274|3810209|B3|Unknown||Employment status||participants|Number|3|3.0||||||
3988701|NCT01249274|3810210|B2|Unknown||Employment status||participants|Number|2|2.0||||||
3988702|NCT01249274|3810211|B1|Unknown||Employment status||participants|Number|1|1.0||||||
3988703|NCT01249274|3810209|B3|Not in paid employment||Employment status||participants|Number|37|37.0||||||
3988704|NCT01249274|3810210|B2|Not in paid employment||Employment status||participants|Number|20|20.0||||||
3988705|NCT01249274|3810211|B1|Not in paid employment||Employment status||participants|Number|17|17.0||||||
3988706|NCT01249274|3810209|B3|In paid employment||Employment status||participants|Number|10|10.0||||||
3988707|NCT01249274|3810210|B2|In paid employment||Employment status||participants|Number|3|3.0||||||
3988708|NCT01249274|3810211|B1|In paid employment||Employment status||participants|Number|7|7.0||||||
3988709|NCT01249274|3810209|B3|Single||Marital status||participants|Number|23|23.0||||||
3988710|NCT01249274|3810210|B2|Single||Marital status||participants|Number|14|14.0||||||
3988711|NCT01249274|3810211|B1|Single||Marital status||participants|Number|9|9.0||||||
3988712|NCT01249274|3810209|B3|Dating||Marital status||participants|Number|7|7.0||||||
3988713|NCT01249274|3810210|B2|Dating||Marital status||participants|Number|1|1.0||||||
3988714|NCT01249274|3810211|B1|Dating||Marital status||participants|Number|6|6.0||||||
3988715|NCT01249274|3810209|B3|Separated||Marital status||participants|Number|4|4.0||||||
3988716|NCT01249274|3810210|B2|Separated||Marital status||participants|Number|2|2.0||||||
3988717|NCT01249274|3810211|B1|Separated||Marital status||participants|Number|2|2.0||||||
3988718|NCT01249274|3810209|B3|Divorced||Marital status||participants|Number|4|4.0||||||
3988719|NCT01249274|3810210|B2|Divorced||Marital status||participants|Number|1|1.0||||||
3988720|NCT01249274|3810211|B1|Divorced||Marital status||participants|Number|3|3.0||||||
3988721|NCT01249274|3810209|B3|Married or cohabitating||Marital status||participants|Number|12|12.0||||||
3988722|NCT01249274|3810210|B2|Married or cohabitating||Marital status||participants|Number|7|7.0||||||
3988723|NCT01249274|3810211|B1|Married or cohabitating||Marital status||participants|Number|5|5.0||||||
3988724|NCT01249274|3810209|B3|Post-high school||Education||participants|Number|20|20.0||||||
3988725|NCT01249274|3810210|B2|Post-high school||Education||participants|Number|12|12.0||||||
3988726|NCT01249274|3810211|B1|Post-high school||Education||participants|Number|8|8.0||||||
3988727|NCT01249274|3810209|B3|High school||Education||participants|Number|17|17.0||||||
3988728|NCT01249274|3810210|B2|High school||Education||participants|Number|9|9.0||||||
3988729|NCT01249274|3810211|B1|High school||Education||participants|Number|8|8.0||||||
3988730|NCT01249274|3810209|B3|Less than high shool||Education||participants|Number|13|13.0||||||
3988731|NCT01249274|3810210|B2|Less than high shool||Education||participants|Number|4|4.0||||||
3988732|NCT01249274|3810211|B1|Less than high shool||Education||participants|Number|9|9.0||||||
3988733|NCT01249274|3810209|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3988734|NCT01249274|3810210|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
3988735|NCT01249274|3810211|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3988736|NCT01249274|3810209|B3|Hispanic or other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3988737|NCT01249274|3810210|B2|Hispanic or other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3988738|NCT01249274|3810211|B1|Hispanic or other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3988739|NCT01249274|3810209|B3|Black||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3988740|NCT01249274|3810210|B2|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3988741|NCT01249274|3810211|B1|Black||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3988742|NCT01249274|3810209|B3|White||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3988743|NCT01249274|3810210|B2|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3988744|NCT01249274|3810211|B1|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3988745|NCT01249274|3810209|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3988746|NCT01249274|3810210|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3988747|NCT01249274|3810211|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3988748|NCT01249274|3810209|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3988749|NCT01249274|3810210|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3988750|NCT01249274|3810211|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3988751|NCT01249274|3810209|B3|||Age||years|Mean|31.6|31.6|Standard Deviation|2.4|2.4|||
3988752|NCT01249274|3810210|B2|||Age||years|Mean|30.5|30.5|Standard Deviation|4.5|4.5|||
3988753|NCT01249274|3810211|B1|||Age||years|Mean|32.6|32.6|Standard Deviation|6.3|6.3|||
3988754|NCT01249261|3810236|B3|Sweden||Region of Enrollment||participants|Number|7|7.0||||||
3988755|NCT01249261|3810237|B2|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
3988756|NCT01249261|3810238|B1|Sweden||Region of Enrollment||participants|Number|4|4.0||||||
3988757|NCT01249261|3810236|B3|Italy||Region of Enrollment||participants|Number|4|4.0||||||
3988758|NCT01249261|3810237|B2|Italy||Region of Enrollment||participants|Number|1|1.0||||||
3988759|NCT01249261|3810238|B1|Italy||Region of Enrollment||participants|Number|3|3.0||||||
3988760|NCT01249261|3810236|B3|Australia||Region of Enrollment||participants|Number|7|7.0||||||
3988761|NCT01249261|3810237|B2|Australia||Region of Enrollment||participants|Number|3|3.0||||||
3988762|NCT01249261|3810238|B1|Australia||Region of Enrollment||participants|Number|4|4.0||||||
3988763|NCT01249261|3810236|B3|Denmark||Region of Enrollment||participants|Number|8|8.0||||||
3988764|NCT01249261|3810237|B2|Denmark||Region of Enrollment||participants|Number|3|3.0||||||
3988765|NCT01249261|3810238|B1|Denmark||Region of Enrollment||participants|Number|5|5.0||||||
3988766|NCT01249261|3810236|B3|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
3988767|NCT01249261|3810237|B2|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
3988768|NCT01249261|3810238|B1|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
3988769|NCT01249261|3810236|B3|Poland||Region of Enrollment||participants|Number|17|17.0||||||
3988770|NCT01249261|3810237|B2|Poland||Region of Enrollment||participants|Number|9|9.0||||||
3988771|NCT01249261|3810238|B1|Poland||Region of Enrollment||participants|Number|8|8.0||||||
3988772|NCT01249261|3810236|B3|Spain||Region of Enrollment||participants|Number|12|12.0||||||
3988773|NCT01249261|3810237|B2|Spain||Region of Enrollment||participants|Number|7|7.0||||||
3988774|NCT01249261|3810238|B1|Spain||Region of Enrollment||participants|Number|5|5.0||||||
3988775|NCT01249261|3810236|B3|Finland||Region of Enrollment||participants|Number|4|4.0||||||
3988776|NCT01249261|3810237|B2|Finland||Region of Enrollment||participants|Number|3|3.0||||||
3988777|NCT01249261|3810238|B1|Finland||Region of Enrollment||participants|Number|1|1.0||||||
3988778|NCT01249261|3810236|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
3988779|NCT01249261|3810237|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3988780|NCT01249261|3810238|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3988781|NCT01249261|3810236|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3988782|NCT01249261|3810237|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3988783|NCT01249261|3810238|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3988784|NCT01249261|3810236|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3988785|NCT01249261|3810237|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3988786|NCT01249261|3810238|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3988787|NCT01249261|3810236|B3|> or = 65 years old||Age, Customized||Participants|Number|41|41.0||||||
3988788|NCT01249261|3810237|B2|> or = 65 years old||Age, Customized||Participants|Number|22|22.0||||||
3988789|NCT01249261|3810238|B1|> or = 65 years old||Age, Customized||Participants|Number|19|19.0||||||
3988790|NCT01249261|3810236|B3|< 65 years old||Age, Customized||Participants|Number|20|20.0||||||
3988791|NCT01249261|3810237|B2|< 65 years old||Age, Customized||Participants|Number|9|9.0||||||
3988792|NCT01249261|3810238|B1|< 65 years old||Age, Customized||Participants|Number|11|11.0||||||
3988793|NCT01249261|3810236|B3|||Age||Participants|Mean|67.1|67.1|Standard Deviation|5.97|5.97|||
3988794|NCT01249261|3810237|B2|||Age||Participants|Mean|67.3|67.3|Standard Deviation|5.79|5.79|||
3988795|NCT01249261|3810238|B1|||Age||Participants|Mean|66.9|66.9|Standard Deviation|6.24|6.24|||
3988796|NCT01249157|3810267|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3988797|NCT01249157|3810267|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3988798|NCT01249157|3810267|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3988799|NCT01249157|3810267|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3988800|NCT01249157|3810267|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3988801|NCT01249131|3810271|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3988802|NCT01249131|3810271|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3988803|NCT01249131|3810271|B1|||Age||years|Mean|36|36.0|Full Range|||19.0|52.0|
3988804|NCT01249118|3810296|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3988805|NCT01249118|3810296|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3988806|NCT01249118|3810296|B1|||Age||Years|Mean|35|35.0|Standard Deviation|10.2|10.2|||
3988807|NCT01249092|3810332|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3988808|NCT01249092|3810332|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3988809|NCT01249092|3810332|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3988810|NCT01249092|3810332|B1|||Age||years|Mean|57.7|57.7|Standard Deviation|9.6|9.6|||
3988811|NCT01249092|3810332|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3988812|NCT01249092|3810332|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3988813|NCT01249092|3810332|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3988814|NCT01248949|3810338|B6||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3988815|NCT01248949|3810339|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3988816|NCT01248949|3810340|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3988817|NCT01248949|3810341|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3988818|NCT01248949|3810342|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3988819|NCT01248949|3810343|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3988820|NCT01248949|3810338|B6||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3988821|NCT01248949|3810339|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3988822|NCT01248949|3810340|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3988823|NCT01248949|3810341|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3988824|NCT01248949|3810342|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3988825|NCT01248949|3810343|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3988826|NCT01248949|3810338|B6|||Age||Years|Mean|59.2|59.2|Standard Deviation|11.9|11.9|||
3988827|NCT01248949|3810339|B5|||Age||Years|Mean|56.7|56.7|Standard Deviation|12.3|12.3|||
3988828|NCT01248949|3810340|B4|||Age||Years|Mean|60.4|60.4|Standard Deviation|12.7|12.7|||
3988829|NCT01248949|3810341|B3|||Age||Years|Mean|57.7|57.7|Standard Deviation|11.2|11.2|||
3988830|NCT01248949|3810342|B2|||Age||Years|Mean|57.4|57.4|Standard Deviation|11.9|11.9|||
3988831|NCT01248949|3810343|B1|||Age||Years|Mean|61.4|61.4|Standard Deviation|12.4|12.4|||
3988832|NCT01248936|3810459|B1||Male|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
3988833|NCT01248936|3810459|B1||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3988834|NCT01248936|3810459|B1|Over 85 years||Age, Customized||participants|Number|2|2.0||||||
3988835|NCT01248936|3810459|B1|From 65 – 84 years||Age, Customized||participants|Number|79|79.0||||||
3988836|NCT01248936|3810459|B1|From 18 - 64 years||Age, Customized||participants|Number|289|289.0||||||
3988837|NCT01248936|3810459|B1|Adolescents (12-17 year)||Age, Customized||participants|Number|1|1.0||||||
3988838|NCT01248936|3810459|B1|||Age||years|Mean|53.5|53.5|Standard Deviation|13.8|13.8|||
3988839|NCT01248884|3810469|B4|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|277|277.0||||||
3988840|NCT01248884|3810470|B3|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|92|92.0||||||
3988841|NCT01248884|3810471|B2|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|93|93.0||||||
3988842|NCT01248884|3810472|B1|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|92|92.0||||||
3988843|NCT01248884|3810469|B4|White - Caucasian / European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|432|432.0||||||
3988844|NCT01248884|3810470|B3|White - Caucasian / European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|140|140.0||||||
3988845|NCT01248884|3810471|B2|White - Caucasian / European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|148|148.0||||||
3988846|NCT01248884|3810472|B1|White - Caucasian / European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|144|144.0||||||
3988847|NCT01248884|3810469|B4|White - Arabic / north African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3988848|NCT01248884|3810470|B3|White - Arabic / north African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3988849|NCT01248884|3810471|B2|White - Arabic / north African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3988850|NCT01248884|3810472|B1|White - Arabic / north African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3988851|NCT01248884|3810469|B4|African heritage /African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3988852|NCT01248884|3810470|B3|African heritage /African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3988853|NCT01248884|3810471|B2|African heritage /African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3988854|NCT01248884|3810472|B1|African heritage /African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3988855|NCT01248884|3810469|B4||Male|Sex: Female, Male||Participants|Count of Participants|365|365.0||||||
3988856|NCT01248884|3810470|B3||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3988857|NCT01248884|3810471|B2||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3988858|NCT01248884|3810472|B1||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3988859|NCT01248884|3810469|B4||Female|Sex: Female, Male||Participants|Count of Participants|356|356.0||||||
3988860|NCT01248884|3810470|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3988861|NCT01248884|3810471|B2||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3988862|NCT01248884|3810472|B1||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3988863|NCT01248884|3810469|B4|||Age||Weeks|Mean|9.73|9.73|Standard Deviation|1.29|1.29|||
3988864|NCT01248884|3810470|B3|||Age||Weeks|Mean|9.7|9.7|Standard Deviation|1.21|1.21|||
3988865|NCT01248884|3810471|B2|||Age||Weeks|Mean|9.8|9.8|Standard Deviation|1.29|1.29|||
3988866|NCT01248884|3810472|B1|||Age||Weeks|Mean|9.7|9.7|Standard Deviation|1.36|1.36|||
3988867|NCT01248793|3810530|B3||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
3988868|NCT01248793|3810531|B2||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3988869|NCT01248793|3810532|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3988870|NCT01248793|3810530|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3988871|NCT01248793|3810531|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3988872|NCT01248793|3810532|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3988873|NCT01248793|3810530|B3|||Age||years|Mean|30.5|30.5|Standard Deviation|9.46|9.46|||
3988874|NCT01248793|3810531|B2|||Age||years|Mean|30.5|30.5|Standard Deviation|10.27|10.27|||
3988875|NCT01248793|3810532|B1|||Age||years|Mean|30.6|30.6|Standard Deviation|8.60|8.6|||
3988876|NCT01248780|3810545|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3988877|NCT01248780|3810546|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3988878|NCT01248780|3810547|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3988879|NCT01248780|3810545|B3||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
3988880|NCT01248780|3810546|B2||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3988881|NCT01248780|3810547|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3988882|NCT01248780|3810545|B3|||Age||years|Mean|47.2|47.2|Standard Deviation|11.81|11.81|||
3988883|NCT01248780|3810546|B2|||Age||years|Mean|47.7|47.7|Standard Deviation|11.46|11.46|||
3988884|NCT01248780|3810547|B1|||Age||years|Mean|46.7|46.7|Standard Deviation|12.16|12.16|||
3988885|NCT01248728|3810560|B3|Canada||Region of Enrollment||participants|Number|38|38.0||||||
3988886|NCT01248728|3810561|B2|Canada||Region of Enrollment||participants|Number|19|19.0||||||
3988887|NCT01248728|3810562|B1|Canada||Region of Enrollment||participants|Number|19|19.0||||||
3988888|NCT01248728|3810560|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3988889|NCT01248728|3810561|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3988890|NCT01248728|3810562|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3988891|NCT01248728|3810560|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3988892|NCT01248728|3810561|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3988893|NCT01248728|3810562|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3988894|NCT01248728|3810560|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3988895|NCT01248728|3810561|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3988896|NCT01248728|3810562|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3988897|NCT01248728|3810560|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3988898|NCT01248728|3810561|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3988899|NCT01248728|3810562|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3988900|NCT01248728|3810560|B3||<=18 years|Age||Participants|Count of Participants|38|38.0||||||
3988901|NCT01248728|3810561|B2||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
3988902|NCT01248728|3810562|B1||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
3988903|NCT01248715|3810577|B3|||Nursing home Resident||Participants|Count of Participants|2|2.0||||||
3988904|NCT01248715|3810578|B2|||Nursing home Resident||Participants|Count of Participants|2|2.0||||||
3988905|NCT01248715|3810579|B1|||Nursing home Resident||Participants|Count of Participants|0|0.0||||||
3988906|NCT01248715|3810577|B3|United States||Region of Enrollment||Participants|Count of Participants|96|96.0||||||
3988907|NCT01248715|3810578|B2|United States||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
3988908|NCT01248715|3810579|B1|United States||Region of Enrollment||Participants|Count of Participants|55|55.0||||||
3988909|NCT01248715|3810577|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3988910|NCT01248715|3810578|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3988911|NCT01248715|3810579|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3988912|NCT01248715|3810577|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3988913|NCT01248715|3810578|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3988914|NCT01248715|3810579|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3988915|NCT01248715|3810577|B3|||Age||years|Median|61.7|61.7|Inter-Quartile Range|||42.1|81.2|
3988916|NCT01248715|3810578|B2|||Age||years|Median|60|60.0|Inter-Quartile Range|||43.0|77.0|
3988917|NCT01248715|3810579|B1|||Age||years|Median|63|63.0|Inter-Quartile Range|||41.5|84.5|
3988918|NCT01248468|3810598|B4|United States||Region of Enrollment||participants|Number|752|752.0||||||
3988919|NCT01248468|3810599|B3|United States||Region of Enrollment||participants|Number|149|149.0||||||
3988920|NCT01248468|3810600|B2|United States||Region of Enrollment||participants|Number|304|304.0||||||
3988921|NCT01248468|3810601|B1|United States||Region of Enrollment||participants|Number|299|299.0||||||
3988922|NCT01248468|3810598|B4|Unknown or Not Reported||Race/Ethnicity, Customized|Calculation for randomized subjects|Participants|Number|0|0.0||||||
3988923|NCT01248468|3810599|B3|Unknown or Not Reported||Race/Ethnicity, Customized|Calculation for randomized subjects|Participants|Number|0|0.0||||||
3988924|NCT01248468|3810600|B2|Unknown or Not Reported||Race/Ethnicity, Customized|Calculation for randomized subjects|Participants|Number|0|0.0||||||
3988925|NCT01248468|3810601|B1|Unknown or Not Reported||Race/Ethnicity, Customized|Calculation for randomized subjects|Participants|Number|0|0.0||||||
3988926|NCT01248468|3810598|B4|Other||Race/Ethnicity, Customized|Calculation for randomized subjects|Participants|Number|19|19.0||||||
3988927|NCT01248468|3810599|B3|Other||Race/Ethnicity, Customized|Calculation for randomized subjects|Participants|Number|7|7.0||||||
3988928|NCT01248468|3810600|B2|Other||Race/Ethnicity, Customized|Calculation for randomized subjects|Participants|Number|6|6.0||||||
3988929|NCT01248468|3810601|B1|Other||Race/Ethnicity, Customized|Calculation for randomized subjects|Participants|Number|6|6.0||||||
3988930|NCT01248468|3810598|B4|White||Race/Ethnicity, Customized|Calculation for randomized subjects|Participants|Number|596|596.0||||||
3988931|NCT01248468|3810599|B3|White||Race/Ethnicity, Customized|Calculation for randomized subjects|Participants|Number|113|113.0||||||
3988932|NCT01248468|3810600|B2|White||Race/Ethnicity, Customized|Calculation for randomized subjects|Participants|Number|239|239.0||||||
3988933|NCT01248468|3810601|B1|White||Race/Ethnicity, Customized|Calculation for randomized subjects|Participants|Number|244|244.0||||||
3988934|NCT01248468|3810598|B4|Black or African American||Race/Ethnicity, Customized|Calculation for randomized subjects|Participants|Number|115|115.0||||||
3988935|NCT01248468|3810599|B3|Black or African American||Race/Ethnicity, Customized|Calculation for randomized subjects|Participants|Number|24|24.0||||||
3988936|NCT01248468|3810600|B2|Black or African American||Race/Ethnicity, Customized|Calculation for randomized subjects|Participants|Number|47|47.0||||||
3988937|NCT01248468|3810601|B1|Black or African American||Race/Ethnicity, Customized|Calculation for randomized subjects|Participants|Number|44|44.0||||||
3988938|NCT01248468|3810598|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Calculation for randomized subjects|Participants|Number|3|3.0||||||
3988939|NCT01248468|3810599|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Calculation for randomized subjects|Participants|Number|0|0.0||||||
3988940|NCT01248468|3810600|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Calculation for randomized subjects|Participants|Number|2|2.0||||||
3988941|NCT01248468|3810601|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Calculation for randomized subjects|Participants|Number|1|1.0||||||
3988942|NCT01248468|3810598|B4|Asian||Race/Ethnicity, Customized|Calculation for randomized subjects|Participants|Number|17|17.0||||||
3988943|NCT01248468|3810599|B3|Asian||Race/Ethnicity, Customized|Calculation for randomized subjects|Participants|Number|5|5.0||||||
3988944|NCT01248468|3810600|B2|Asian||Race/Ethnicity, Customized|Calculation for randomized subjects|Participants|Number|9|9.0||||||
3988945|NCT01248468|3810601|B1|Asian||Race/Ethnicity, Customized|Calculation for randomized subjects|Participants|Number|3|3.0||||||
3988946|NCT01248468|3810598|B4|American Indian or Alaska Native||Race/Ethnicity, Customized|Calculation for randomized subjects|Participants|Number|2|2.0||||||
3988947|NCT01248468|3810599|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|Calculation for randomized subjects|Participants|Number|0|0.0||||||
3988948|NCT01248468|3810600|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|Calculation for randomized subjects|Participants|Number|1|1.0||||||
3988949|NCT01248468|3810601|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Calculation for randomized subjects|Participants|Number|1|1.0||||||
3988950|NCT01248468|3810598|B4||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3988951|NCT01248468|3810599|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3988952|NCT01248468|3810600|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3988953|NCT01248468|3810601|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3988954|NCT01248468|3810598|B4||Female|Sex: Female, Male||Participants|Count of Participants|620|620.0||||||
3988955|NCT01248468|3810599|B3||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3988956|NCT01248468|3810600|B2||Female|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
3988957|NCT01248468|3810601|B1||Female|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
3988958|NCT01248468|3810598|B4|||Age||years|Mean|37.8|37.8|Standard Deviation|11.4|11.4|||
3988959|NCT01248468|3810599|B3|||Age||years|Mean|37.6|37.6|Standard Deviation|11.5|11.5|||
3988960|NCT01248468|3810600|B2|||Age||years|Mean|37.8|37.8|Standard Deviation|11.4|11.4|||
3988961|NCT01248468|3810601|B1|||Age||years|Mean|38|38.0|Standard Deviation|11.4|11.4|||
3988962|NCT01248455|3810620|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3988963|NCT01248455|3810620|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3988964|NCT01248455|3810620|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3988965|NCT01248455|3810620|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3988966|NCT01248455|3810620|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3988967|NCT01248455|3810620|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3988968|NCT01248455|3810620|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3988969|NCT01248455|3810620|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3988970|NCT01248455|3810620|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3988971|NCT01248455|3810620|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3988972|NCT01248455|3810620|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3988973|NCT01248455|3810620|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3988974|NCT01248455|3810620|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3988975|NCT01248455|3810620|B1|||Age||years|Mean|61.41|61.41|Standard Deviation|5.28|5.28|||
3988976|NCT01248455|3810620|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3988977|NCT01248455|3810620|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3988978|NCT01248455|3810620|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3988979|NCT01248416|3810625|B4||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3988980|NCT01248416|3810626|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3988981|NCT01248416|3810627|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3988982|NCT01248416|3810628|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3988983|NCT01248416|3810625|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3988984|NCT01248416|3810626|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3988985|NCT01248416|3810627|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3988986|NCT01248416|3810628|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3988987|NCT01248416|3810625|B4|||Age||years|Mean|14.1|14.1|Standard Deviation|1.1|1.1|||
3988988|NCT01248416|3810626|B3|||Age||years|Mean|14.0|14.0|Standard Deviation|1.1|1.1|||
3988989|NCT01248416|3810627|B2|||Age||years|Mean|14.1|14.1|Standard Deviation|1.2|1.2|||
3988990|NCT01248416|3810628|B1|||Age||years|Mean|14.2|14.2|Standard Deviation|1.0|1.0|||
3988991|NCT01248364|3810661|B5||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3988992|NCT01248364|3810662|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3988993|NCT01248364|3810663|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3988994|NCT01248364|3810664|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3988995|NCT01248364|3810665|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3988996|NCT01248364|3810661|B5||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3988997|NCT01248364|3810662|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3988998|NCT01248364|3810663|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3988999|NCT01248364|3810664|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3989000|NCT01248364|3810665|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3989001|NCT01248364|3810661|B5|||Age||years|Mean|58.3|58.3|Standard Deviation|8.9|8.9|||
3989002|NCT01248364|3810662|B4|||Age||years|Mean|47.7|47.7|Standard Deviation|2.3|2.3|||
3989003|NCT01248364|3810663|B3|||Age||years|Mean|50.8|50.8|Standard Deviation|9.8|9.8|||
3989004|NCT01248364|3810664|B2|||Age||years|Mean|63.3|63.3|Standard Deviation|6.5|6.5|||
3989005|NCT01248364|3810665|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|7.0|7.0|||
3989006|NCT01248221|3810714|B3|||Body mass index (BMI)||kg/m^2|Mean|26.98|26.98|Standard Deviation|6.95|6.95|||
3989007|NCT01248221|3810715|B2|||Body mass index (BMI)||kg/m^2|Mean|27.21|27.21|Standard Deviation|6.0|6.0|||
3989008|NCT01248221|3810716|B1|||Body mass index (BMI)||kg/m^2|Mean|26.75|26.75|Standard Deviation|8.0|8.0|||
3989009|NCT01248221|3810714|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3989010|NCT01248221|3810715|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
3989011|NCT01248221|3810716|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3989012|NCT01248221|3810714|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3989013|NCT01248221|3810715|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3989014|NCT01248221|3810716|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3989015|NCT01248221|3810714|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3989016|NCT01248221|3810715|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3989017|NCT01248221|3810716|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3989018|NCT01248221|3810714|B3|||Age||years|Mean|41.54|41.54|Standard Deviation|14.43|14.43|||
3989019|NCT01248221|3810715|B2|||Age||years|Mean|42.01|42.01|Standard Deviation|14.46|14.46|||
3989020|NCT01248221|3810716|B1|||Age||years|Mean|41.08|41.08|Standard Deviation|14.90|14.9|||
3989021|NCT01248130|3810729|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
3989022|NCT01248130|3810730|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3989023|NCT01248130|3810731|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3989024|NCT01248130|3810729|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989025|NCT01248130|3810730|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989026|NCT01248130|3810731|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989027|NCT01248130|3810729|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3989028|NCT01248130|3810730|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3989029|NCT01248130|3810731|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3989030|NCT01248130|3810729|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3989031|NCT01248130|3810730|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3989032|NCT01248130|3810731|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989033|NCT01248130|3810729|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989034|NCT01248130|3810730|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989035|NCT01248130|3810731|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989036|NCT01248130|3810729|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989037|NCT01248130|3810730|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989038|NCT01248130|3810731|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989039|NCT01248130|3810729|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3989040|NCT01248130|3810730|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3989041|NCT01248130|3810731|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3989042|NCT01248130|3810729|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989043|NCT01248130|3810730|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989044|NCT01248130|3810731|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989045|NCT01248130|3810729|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989046|NCT01248130|3810730|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989047|NCT01248130|3810731|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989048|NCT01248130|3810729|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989049|NCT01248130|3810730|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989050|NCT01248130|3810731|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989051|NCT01248130|3810729|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989052|NCT01248130|3810730|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989053|NCT01248130|3810731|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989054|NCT01248130|3810729|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3989055|NCT01248130|3810730|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3989056|NCT01248130|3810731|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3989057|NCT01248130|3810729|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3989058|NCT01248130|3810730|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3989059|NCT01248130|3810731|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3989060|NCT01248130|3810729|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3989061|NCT01248130|3810730|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3989062|NCT01248130|3810731|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3989063|NCT01248130|3810729|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3989064|NCT01248130|3810730|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3989065|NCT01248130|3810731|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3989066|NCT01248130|3810729|B3||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
3989067|NCT01248130|3810730|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3989068|NCT01248130|3810731|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3989069|NCT01248065|3810740|B3|||Sputum eosinophils (%)||% of eosinophils|Median|0.40|0.4|Inter-Quartile Range|||0.0|1.3|
3989127|NCT01247974|3810757|B3|United States||Region of Enrollment||participants|Number|439|439.0||||||
3989070|NCT01248065|3810741|B2|||Sputum eosinophils (%)||% of eosinophils|Median|0.30|0.3|Inter-Quartile Range|||0.0|1.3|
3989071|NCT01248065|3810742|B1|||Sputum eosinophils (%)||% of eosinophils|Median|0.40|0.4|Inter-Quartile Range|||0.0|1.3|
3989072|NCT01248065|3810740|B3|||Methacholine PC20 (mg/mL)||mg/mL|Geometric Mean|1.95|1.95|Standard Deviation|1.65|1.65|||
3989073|NCT01248065|3810741|B2|||Methacholine PC20 (mg/mL)||mg/mL|Geometric Mean|2.05|2.05|Standard Deviation|1.61|1.61|||
3989074|NCT01248065|3810742|B1|||Methacholine PC20 (mg/mL)||mg/mL|Geometric Mean|1.85|1.85|Standard Deviation|1.67|1.67|||
3989075|NCT01248065|3810740|B3|||FEV1 before albuterol use (% predicted)||% predicted|Mean|80.6|80.6|Standard Deviation|14.0|14.0|||
3989076|NCT01248065|3810741|B2|||FEV1 before albuterol use (% predicted)||% predicted|Mean|80.7|80.7|Standard Deviation|13.8|13.8|||
3989077|NCT01248065|3810742|B1|||FEV1 before albuterol use (% predicted)||% predicted|Mean|80.5|80.5|Standard Deviation|14.2|14.2|||
3989078|NCT01248065|3810740|B3|||FEV1 before albuterol use (L)||liters|Mean|2.63|2.63|Standard Deviation|0.80|0.8|||
3989079|NCT01248065|3810741|B2|||FEV1 before albuterol use (L)||liters|Mean|2.63|2.63|Standard Deviation|0.78|0.78|||
3989080|NCT01248065|3810742|B1|||FEV1 before albuterol use (L)||liters|Mean|2.62|2.62|Standard Deviation|0.83|0.83|||
3989081|NCT01248065|3810740|B3|||Level of 25-hydroxyvitamin D||ng/mL|Median|19.2|19.2|Inter-Quartile Range|||13.9|24.3|
3989082|NCT01248065|3810741|B2|||Level of 25-hydroxyvitamin D||ng/mL|Median|19.9|19.9|Inter-Quartile Range|||14.5|25.0|
3989083|NCT01248065|3810742|B1|||Level of 25-hydroxyvitamin D||ng/mL|Median|18.8|18.8|Inter-Quartile Range|||13.4|23.7|
3989084|NCT01248065|3810740|B3|||Symptom score (afternoon and evening)||Avg score of 5 sx: 0=absent to 3=severe|Mean|0.43|0.43|Standard Deviation|0.37|0.37|||
3989085|NCT01248065|3810741|B2|||Symptom score (afternoon and evening)||Avg score of 5 sx: 0=absent to 3=severe|Mean|0.44|0.44|Standard Deviation|0.35|0.35|||
3989086|NCT01248065|3810742|B1|||Symptom score (afternoon and evening)||Avg score of 5 sx: 0=absent to 3=severe|Mean|0.43|0.43|Standard Deviation|0.40|0.4|||
3989087|NCT01248065|3810740|B3|||Symptom score (morning)||Avg score of 5 sx: 0=absent to 3=severe|Mean|0.41|0.41|Standard Deviation|0.35|0.35|||
3989088|NCT01248065|3810741|B2|||Symptom score (morning)||Avg score of 5 sx: 0=absent to 3=severe|Mean|0.41|0.41|Standard Deviation|0.34|0.34|||
3989089|NCT01248065|3810742|B1|||Symptom score (morning)||Avg score of 5 sx: 0=absent to 3=severe|Mean|0.41|0.41|Standard Deviation|0.36|0.36|||
3989090|NCT01248065|3810740|B3|||Body mass index||kg/m^2|Mean|31.8|31.8|Standard Deviation|8.9|8.9|||
3989091|NCT01248065|3810741|B2|||Body mass index||kg/m^2|Mean|32.0|32.0|Standard Deviation|8.2|8.2|||
3989092|NCT01248065|3810742|B1|||Body mass index||kg/m^2|Mean|31.5|31.5|Standard Deviation|9.5|9.5|||
3989093|NCT01248065|3810740|B3|||Duration of asthma||years|Mean|25.0|25.0|Standard Deviation|13.2|13.2|||
3989094|NCT01248065|3810741|B2|||Duration of asthma||years|Mean|24.9|24.9|Standard Deviation|13.5|13.5|||
3989095|NCT01248065|3810742|B1|||Duration of asthma||years|Mean|25.0|25.0|Standard Deviation|12.8|12.8|||
3989096|NCT01248065|3810740|B3|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3989097|NCT01248065|3810741|B2|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3989098|NCT01248065|3810742|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3989099|NCT01248065|3810740|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
3989100|NCT01248065|3810741|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3989101|NCT01248065|3810742|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3989102|NCT01248065|3810740|B3|White||Race/Ethnicity, Customized||participants|Number|216|216.0||||||
3989103|NCT01248065|3810741|B2|White||Race/Ethnicity, Customized||participants|Number|105|105.0||||||
3989104|NCT01248065|3810742|B1|White||Race/Ethnicity, Customized||participants|Number|111|111.0||||||
3989105|NCT01248065|3810740|B3|Black||Race/Ethnicity, Customized||participants|Number|131|131.0||||||
3989106|NCT01248065|3810741|B2|Black||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
3989107|NCT01248065|3810742|B1|Black||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
3989108|NCT01248065|3810740|B3|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3989109|NCT01248065|3810741|B2|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3989110|NCT01248065|3810742|B1|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3989111|NCT01248065|3810740|B3||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
3989112|NCT01248065|3810741|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3989113|NCT01248065|3810742|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3989114|NCT01248065|3810740|B3||Female|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
3989115|NCT01248065|3810741|B2||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3989116|NCT01248065|3810742|B1||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3989117|NCT01248065|3810740|B3|||Age||years|Mean|39.7|39.7|Standard Deviation|12.9|12.9|||
3989118|NCT01248065|3810741|B2|||Age||years|Mean|39.9|39.9|Standard Deviation|13.1|13.1|||
3989119|NCT01248065|3810742|B1|||Age||years|Mean|39.5|39.5|Standard Deviation|12.7|12.7|||
3989120|NCT01248013|3810753|B1|United States||Region of Enrollment||participants|Number|89|89.0||||||
3989121|NCT01248013|3810753|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3989122|NCT01248013|3810753|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3989123|NCT01248013|3810753|B1|||Age||years|Mean|45.9|45.9|Standard Deviation|14.4|14.4|||
3989124|NCT01248013|3810753|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3989125|NCT01248013|3810753|B1||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
3989126|NCT01248013|3810753|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3989128|NCT01247974|3810758|B2|United States||Region of Enrollment||participants|Number|222|222.0||||||
3989129|NCT01247974|3810759|B1|United States||Region of Enrollment||participants|Number|217|217.0||||||
3989130|NCT01247974|3810757|B3||Male|Sex: Female, Male||Participants|Count of Participants|335|335.0||||||
3989131|NCT01247974|3810758|B2||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3989132|NCT01247974|3810759|B1||Male|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
3989133|NCT01247974|3810757|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3989134|NCT01247974|3810758|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3989135|NCT01247974|3810759|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3989136|NCT01247974|3810757|B3|18Y and older||Age, Customized||participants|Number|439|439.0||||||
3989137|NCT01247974|3810758|B2|18Y and older||Age, Customized||participants|Number|222|222.0||||||
3989138|NCT01247974|3810759|B1|18Y and older||Age, Customized||participants|Number|217|217.0||||||
3989139|NCT01247922|3810768|B1|Asian-Indian subcontinent||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3989140|NCT01247922|3810768|B1|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3989141|NCT01247922|3810768|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3989142|NCT01247922|3810768|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3989143|NCT01247922|3810768|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3989144|NCT01247922|3810768|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3989145|NCT01247922|3810768|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3989146|NCT01247675|3810774|B5|||Body Mass Index||kg/m²|Mean|28.0|28.0|Standard Deviation|4.6|4.6|||
3989147|NCT01247675|3810775|B4|||Body Mass Index||kg/m²|Mean|25.7|25.7|Standard Deviation|4.4|4.4|||
3989148|NCT01247675|3810776|B3|||Body Mass Index||kg/m²|Mean|30.7|30.7|Standard Deviation|4.4|4.4|||
3989149|NCT01247675|3810777|B2|||Body Mass Index||kg/m²|Mean|27.9|27.9|Standard Deviation|4.4|4.4|||
3989150|NCT01247675|3810778|B1|||Body Mass Index||kg/m²|Mean|27.6|27.6|Standard Deviation|4.4|4.4|||
3989151|NCT01247675|3810774|B5|||Weight||kg|Mean|82.4|82.4|Standard Deviation|18.9|18.9|||
3989152|NCT01247675|3810775|B4|||Weight||kg|Mean|74.7|74.7|Standard Deviation|16.6|16.6|||
3989153|NCT01247675|3810776|B3|||Weight||kg|Mean|92.5|92.5|Standard Deviation|20.5|20.5|||
3989154|NCT01247675|3810777|B2|||Weight||kg|Mean|79.6|79.6|Standard Deviation|17.0|17.0|||
3989155|NCT01247675|3810778|B1|||Weight||kg|Mean|82.3|82.3|Standard Deviation|19.8|19.8|||
3989156|NCT01247675|3810774|B5||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3989157|NCT01247675|3810775|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3989158|NCT01247675|3810776|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3989159|NCT01247675|3810777|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3989160|NCT01247675|3810778|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3989161|NCT01247675|3810774|B5||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3989162|NCT01247675|3810775|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3989163|NCT01247675|3810776|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3989164|NCT01247675|3810777|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3989165|NCT01247675|3810778|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3989166|NCT01247675|3810774|B5|||Age||years|Mean|49.5|49.5|Standard Deviation|15.4|15.4|||
3989167|NCT01247675|3810775|B4|||Age||years|Mean|44.0|44.0|Standard Deviation|15.7|15.7|||
3989168|NCT01247675|3810776|B3|||Age||years|Mean|51.6|51.6|Standard Deviation|18.1|18.1|||
3989169|NCT01247675|3810777|B2|||Age||years|Mean|45.9|45.9|Standard Deviation|15.0|15.0|||
3989170|NCT01247675|3810778|B1|||Age||years|Mean|55.7|55.7|Standard Deviation|12.6|12.6|||
3989171|NCT01247571|3810803|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3989172|NCT01247571|3810803|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3989173|NCT01247571|3810803|B1|70-79||Age, Customized||participants|Number|7|7.0||||||
3989174|NCT01247571|3810803|B1|60-69||Age, Customized||participants|Number|11|11.0||||||
3989175|NCT01247571|3810803|B1|50-59||Age, Customized||participants|Number|1|1.0||||||
3989176|NCT01247428|3810811|B1|New Zealand||Region of Enrollment||participants|Number|17|17.0||||||
3989177|NCT01247428|3810811|B1|Australia||Region of Enrollment||participants|Number|1|1.0||||||
3989178|NCT01247428|3810811|B1|Belgium||Region of Enrollment||participants|Number|12|12.0||||||
3989179|NCT01247428|3810811|B1||Male|Gender||Participants|Count of Participants|22|22.0||||||
3989180|NCT01247428|3810811|B1||Female|Gender||Participants|Count of Participants|8|8.0||||||
3989181|NCT01247428|3810811|B1|||Age||years|Mean|62.6|62.6|Standard Deviation|9.95|9.95|||
3989182|NCT01247428|3810811|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3989183|NCT01247428|3810811|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3989184|NCT01247428|3810811|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3989185|NCT01247363|3810832|B1|||Glycated Hemoglobin (HbA1c)|HbA1c is a form of hemoglobin which is measured primarily to identify the average plasma glucose concentration over prolonged periods of time.|percentage of glycated hemoglobin|Mean|10.48|10.48|Standard Deviation|0.89|0.89|||
3989186|NCT01247363|3810832|B1|||Fasting Blood Glucose (FBG)||milligram/deciliter (mg/dL)|Mean|233.5|233.5|Standard Deviation|38.61|38.61|||
3989187|NCT01247363|3810832|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3989188|NCT01247363|3810832|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3989189|NCT01247363|3810832|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3989190|NCT01247363|3810832|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3989191|NCT01247363|3810832|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3989192|NCT01247363|3810832|B1|||Age||years|Mean|54.4|54.4|Standard Deviation|8.9|8.9|||
3989193|NCT01247350|3810861|B6|United States||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3989194|NCT01247350|3810862|B5|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3989195|NCT01247350|3810863|B4|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3989196|NCT01247350|3810864|B3|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3989197|NCT01247350|3810865|B2|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3989198|NCT01247350|3810866|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3989199|NCT01247350|3810861|B6|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3989200|NCT01247350|3810862|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3989201|NCT01247350|3810863|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3989202|NCT01247350|3810864|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3989203|NCT01247350|3810865|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3989204|NCT01247350|3810866|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3989205|NCT01247350|3810861|B6||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3989206|NCT01247350|3810862|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3989207|NCT01247350|3810863|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3989208|NCT01247350|3810864|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3989209|NCT01247350|3810865|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3989210|NCT01247350|3810866|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3989211|NCT01247350|3810861|B6||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3989212|NCT01247350|3810862|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3989213|NCT01247350|3810863|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3989214|NCT01247350|3810864|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3989215|NCT01247350|3810865|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3989216|NCT01247350|3810866|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3989217|NCT01247350|3810861|B6|||Age||years|Mean|47.4|47.4|Standard Deviation|10.2|10.2|||
3989218|NCT01247350|3810862|B5|||Age||years|Mean|45.1|45.1|Standard Deviation|10.7|10.7|||
3989219|NCT01247350|3810863|B4|||Age||years|Mean|51.1|51.1|Standard Deviation|6.3|6.3|||
3989220|NCT01247350|3810864|B3|||Age||years|Mean|46.7|46.7|Standard Deviation|9.0|9.0|||
3989221|NCT01247350|3810865|B2|||Age||years|Mean|48.0|48.0|Standard Deviation|15.0|15.0|||
3989222|NCT01247350|3810866|B1|||Age||years|Mean|46.3|46.3|Standard Deviation|10.8|10.8|||
3989223|NCT01247324|3810926|B3||Male|Sex: Female, Male||Participants|Count of Participants|279|279.0||||||
3989224|NCT01247324|3810927|B2||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3989225|NCT01247324|3810928|B1||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3989226|NCT01247324|3810926|B3||Female|Sex: Female, Male||Participants|Count of Participants|542|542.0||||||
3989227|NCT01247324|3810927|B2||Female|Sex: Female, Male||Participants|Count of Participants|270|270.0||||||
3989228|NCT01247324|3810928|B1||Female|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
3989229|NCT01247324|3810926|B3|||Age||years|Mean|37.0|37.0|Standard Deviation|9.3|9.3|||
3989230|NCT01247324|3810927|B2|||Age||years|Mean|37.1|37.1|Standard Deviation|9.3|9.3|||
3989231|NCT01247324|3810928|B1|||Age||years|Mean|36.9|36.9|Standard Deviation|9.3|9.3|||
3989232|NCT01247298|3810960|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989233|NCT01247298|3810960|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989234|NCT01247298|3810960|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3989235|NCT01247298|3810960|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3989236|NCT01247298|3810960|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989237|NCT01247298|3810960|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3989238|NCT01247298|3810960|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989239|NCT01247298|3810960|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3989240|NCT01247298|3810960|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3989241|NCT01247298|3810960|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3989242|NCT01247298|3810960|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3989243|NCT01247298|3810960|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3989244|NCT01247285|3810968|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
3989245|NCT01247285|3810969|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3989246|NCT01247285|3810970|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3989247|NCT01247285|3810968|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3989248|NCT01247285|3810969|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3989249|NCT01247285|3810970|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3989250|NCT01247285|3810968|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3989251|NCT01247285|3810969|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3989252|NCT01247285|3810970|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3989253|NCT01247285|3810968|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3989254|NCT01247285|3810969|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3989255|NCT01247285|3810970|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3989256|NCT01247285|3810968|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3989257|NCT01247285|3810969|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3989258|NCT01247285|3810970|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3989259|NCT01247285|3810968|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3989260|NCT01247285|3810969|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3989261|NCT01247285|3810970|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3989262|NCT01247285|3810968|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3989263|NCT01247285|3810969|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3989264|NCT01247285|3810970|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3989265|NCT01247272|3810987|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
3989266|NCT01247272|3810988|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3989267|NCT01247272|3810989|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3989268|NCT01247272|3810987|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3989269|NCT01247272|3810988|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3989270|NCT01247272|3810989|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3989271|NCT01247272|3810987|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3989272|NCT01247272|3810988|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3989273|NCT01247272|3810989|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3989274|NCT01247272|3810987|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3989275|NCT01247272|3810988|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3989276|NCT01247272|3810989|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3989277|NCT01247272|3810987|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3989278|NCT01247272|3810988|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3989279|NCT01247272|3810989|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3989280|NCT01247272|3810987|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3989281|NCT01247272|3810988|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3989282|NCT01247272|3810989|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3989283|NCT01247272|3810987|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3989284|NCT01247272|3810988|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3989285|NCT01247272|3810989|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3989286|NCT01247220|3811006|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989287|NCT01247220|3811007|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989288|NCT01247220|3811008|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989289|NCT01247220|3811006|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989290|NCT01247220|3811007|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989291|NCT01247220|3811008|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989292|NCT01247220|3811006|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3989293|NCT01247220|3811007|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3989294|NCT01247220|3811008|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3989295|NCT01247220|3811006|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3989296|NCT01247220|3811007|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989297|NCT01247220|3811008|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3989298|NCT01247220|3811006|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989299|NCT01247220|3811007|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989300|NCT01247220|3811008|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989301|NCT01247220|3811006|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989302|NCT01247220|3811007|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989303|NCT01247220|3811008|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989304|NCT01247220|3811006|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989305|NCT01247220|3811007|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989306|NCT01247220|3811008|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989307|NCT01247220|3811006|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3989308|NCT01247220|3811007|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3989309|NCT01247220|3811008|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3989310|NCT01247220|3811006|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3989311|NCT01247220|3811007|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3989312|NCT01247220|3811008|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3989313|NCT01247220|3811006|B3|||Age||years|Mean|69.5|69.5|Standard Deviation|14|14.0|||
3989314|NCT01247220|3811007|B2|||Age||years|Mean|70|70.0|Standard Deviation|10|10.0|||
3989315|NCT01247220|3811008|B1|||Age||years|Mean|69|69.0|Standard Deviation|18|18.0|||
3989316|NCT01247090|3811019|B4|United States||Region of Enrollment||participants|Number|12|12.0||||||
3989317|NCT01247090|3811020|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
3989318|NCT01247090|3811021|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3989319|NCT01247090|3811022|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3989320|NCT01247090|3811019|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989321|NCT01247090|3811020|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989322|NCT01247090|3811021|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989323|NCT01247090|3811022|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989324|NCT01247090|3811019|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3989325|NCT01247090|3811020|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3989326|NCT01247090|3811021|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3989327|NCT01247090|3811022|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3989328|NCT01247090|3811019|B4||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3989329|NCT01247090|3811020|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3989330|NCT01247090|3811021|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989331|NCT01247090|3811022|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989332|NCT01247090|3811019|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3989333|NCT01247090|3811020|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989334|NCT01247090|3811021|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3989335|NCT01247090|3811022|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989336|NCT01247090|3811019|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989337|NCT01247090|3811020|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989338|NCT01247090|3811021|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989339|NCT01247090|3811022|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989340|NCT01247090|3811019|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3989341|NCT01247090|3811020|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989342|NCT01247090|3811021|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3989343|NCT01247090|3811022|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989344|NCT01247090|3811019|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989345|NCT01247090|3811020|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989346|NCT01247090|3811021|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989347|NCT01247090|3811022|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989348|NCT01247090|3811019|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989349|NCT01247090|3811020|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989350|NCT01247090|3811021|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989351|NCT01247090|3811022|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989352|NCT01247090|3811019|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3989353|NCT01247090|3811020|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3989354|NCT01247090|3811021|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3989355|NCT01247090|3811022|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3989356|NCT01247090|3811019|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3989357|NCT01247090|3811020|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3989358|NCT01247090|3811021|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3989359|NCT01247090|3811022|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3989360|NCT01247090|3811019|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3989361|NCT01247090|3811020|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3989362|NCT01247090|3811021|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3989363|NCT01247090|3811022|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3989364|NCT01247090|3811019|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3989365|NCT01247090|3811020|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3989366|NCT01247090|3811021|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3989367|NCT01247090|3811022|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3989368|NCT01247090|3811019|B4|||Age||years|Mean|73|73.0|Standard Deviation|8.1|8.1|||
3989369|NCT01247090|3811020|B3|||Age||years|Mean|72.3|72.3|Standard Deviation|8.66|8.66|||
3989370|NCT01247090|3811021|B2|||Age||years|Mean|71.0|71.0|Standard Deviation|8.98|8.98|||
3989371|NCT01247090|3811022|B1|||Age||years|Mean|76.0|76.0|Standard Deviation|8.04|8.04|||
3989372|NCT01247090|3811019|B4||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3989373|NCT01247090|3811020|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3989374|NCT01247090|3811021|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3989375|NCT01247090|3811022|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3989376|NCT01247090|3811019|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3989377|NCT01247090|3811020|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3989378|NCT01247090|3811021|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3989379|NCT01247090|3811022|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3989380|NCT01247090|3811019|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3989381|NCT01247090|3811020|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3989382|NCT01247090|3811021|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3989383|NCT01247090|3811022|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3989384|NCT01247064|3811032|B3|Missing||Physician Clinical Impression||participants|Number|1|1.0||||||
3989385|NCT01247064|3811033|B2|Missing||Physician Clinical Impression||participants|Number|0|0.0||||||
3989386|NCT01247064|3811034|B1|Missing||Physician Clinical Impression||participants|Number|1|1.0||||||
3989387|NCT01247064|3811032|B3|Moderate||Physician Clinical Impression||participants|Number|41|41.0||||||
3989388|NCT01247064|3811033|B2|Moderate||Physician Clinical Impression||participants|Number|20|20.0||||||
3989389|NCT01247064|3811034|B1|Moderate||Physician Clinical Impression||participants|Number|21|21.0||||||
3989390|NCT01247064|3811032|B3|Mild||Physician Clinical Impression||participants|Number|20|20.0||||||
3989391|NCT01247064|3811033|B2|Mild||Physician Clinical Impression||participants|Number|11|11.0||||||
3989392|NCT01247064|3811034|B1|Mild||Physician Clinical Impression||participants|Number|9|9.0||||||
3989393|NCT01247064|3811032|B3|||Oxygen Saturation||percent|Mean|95.9|95.9|Standard Deviation|3.7|3.7|||
3989394|NCT01247064|3811033|B2|||Oxygen Saturation||percent|Mean|96.3|96.3|Standard Deviation|3.7|3.7|||
3989395|NCT01247064|3811034|B1|||Oxygen Saturation||percent|Mean|95.4|95.4|Standard Deviation|3.8|3.8|||
3989396|NCT01247064|3811032|B3|||Heart Rate||beats per minute|Mean|156.5|156.5|Standard Deviation|20|20.0|||
3989397|NCT01247064|3811033|B2|||Heart Rate||beats per minute|Mean|159.3|159.3|Standard Deviation|21.9|21.9|||
3989398|NCT01247064|3811034|B1|||Heart Rate||beats per minute|Mean|153.4|153.4|Standard Deviation|18.4|18.4|||
3989399|NCT01247064|3811032|B3|||Respiratory Rate||breaths per minute|Mean|50.9|50.9|Standard Deviation|12.3|12.3|||
3989400|NCT01247064|3811033|B2|||Respiratory Rate||breaths per minute|Mean|52.4|52.4|Standard Deviation|12.4|12.4|||
3989401|NCT01247064|3811034|B1|||Respiratory Rate||breaths per minute|Mean|49.6|49.6|Standard Deviation|12.4|12.4|||
3989402|NCT01247064|3811032|B3|||Respiratory Distress Assessment Instrument Score|Scale ranges from 0 to 17. Higher values indicate worse respiratory distress.|units on a scale|Mean|7.6|7.6|Standard Deviation|2.5|2.5|||
3989403|NCT01247064|3811033|B2|||Respiratory Distress Assessment Instrument Score|Scale ranges from 0 to 17. Higher values indicate worse respiratory distress.|units on a scale|Mean|7.4|7.4|Standard Deviation|2.5|2.5|||
3989404|NCT01247064|3811034|B1|||Respiratory Distress Assessment Instrument Score|Scale ranges from 0 to 17. Higher values indicate worse respiratory distress.|units on a scale|Mean|7.8|7.8|Standard Deviation|2.6|2.6|||
3989405|NCT01247064|3811032|B3|Unknown||ICU History||participants|Number|2|2.0||||||
3989406|NCT01247064|3811033|B2|Unknown||ICU History||participants|Number|0|0.0||||||
3989407|NCT01247064|3811034|B1|Unknown||ICU History||participants|Number|2|2.0||||||
3989408|NCT01247064|3811032|B3|Yes||ICU History||participants|Number|10|10.0||||||
3989409|NCT01247064|3811033|B2|Yes||ICU History||participants|Number|4|4.0||||||
3989410|NCT01247064|3811034|B1|Yes||ICU History||participants|Number|6|6.0||||||
3989411|NCT01247064|3811032|B3|No||ICU History||participants|Number|50|50.0||||||
3989412|NCT01247064|3811033|B2|No||ICU History||participants|Number|27|27.0||||||
3989413|NCT01247064|3811034|B1|No||ICU History||participants|Number|23|23.0||||||
3989414|NCT01247064|3811032|B3|Unknown||Smokers in Household||participants|Number|1|1.0||||||
3989415|NCT01247064|3811033|B2|Unknown||Smokers in Household||participants|Number|1|1.0||||||
3989416|NCT01247064|3811034|B1|Unknown||Smokers in Household||participants|Number|0|0.0||||||
3989417|NCT01247064|3811032|B3|Yes||Smokers in Household||participants|Number|30|30.0||||||
3989418|NCT01247064|3811033|B2|Yes||Smokers in Household||participants|Number|13|13.0||||||
3989419|NCT01247064|3811034|B1|Yes||Smokers in Household||participants|Number|17|17.0||||||
3989420|NCT01247064|3811032|B3|No||Smokers in Household||participants|Number|31|31.0||||||
3989421|NCT01247064|3811033|B2|No||Smokers in Household||participants|Number|17|17.0||||||
3989422|NCT01247064|3811034|B1|No||Smokers in Household||participants|Number|14|14.0||||||
3989423|NCT01247064|3811032|B3|||Days of Symptoms||days|Mean|3.4|3.4|Standard Deviation|3.1|3.1|||
3989424|NCT01247064|3811033|B2|||Days of Symptoms||days|Mean|3.4|3.4|Standard Deviation|2.4|2.4|||
3989425|NCT01247064|3811034|B1|||Days of Symptoms||days|Mean|3.4|3.4|Standard Deviation|3.7|3.7|||
3989426|NCT01247064|3811032|B3|Unknown||Family History of Atopy||participants|Number|3|3.0||||||
3989427|NCT01247064|3811033|B2|Unknown||Family History of Atopy||participants|Number|1|1.0||||||
3989428|NCT01247064|3811034|B1|Unknown||Family History of Atopy||participants|Number|2|2.0||||||
3989429|NCT01247064|3811032|B3|Yes||Family History of Atopy||participants|Number|46|46.0||||||
3989430|NCT01247064|3811033|B2|Yes||Family History of Atopy||participants|Number|24|24.0||||||
3989431|NCT01247064|3811034|B1|Yes||Family History of Atopy||participants|Number|22|22.0||||||
3989432|NCT01247064|3811032|B3|No||Family History of Atopy||participants|Number|13|13.0||||||
3989433|NCT01247064|3811033|B2|No||Family History of Atopy||participants|Number|6|6.0||||||
3989434|NCT01247064|3811034|B1|No||Family History of Atopy||participants|Number|7|7.0||||||
3989435|NCT01247064|3811032|B3|Unknown||Eczema History||participants|Number|3|3.0||||||
3989436|NCT01247064|3811033|B2|Unknown||Eczema History||participants|Number|1|1.0||||||
3989437|NCT01247064|3811034|B1|Unknown||Eczema History||participants|Number|2|2.0||||||
3989438|NCT01247064|3811032|B3|No||Eczema History||participants|Number|44|44.0||||||
3989439|NCT01247064|3811033|B2|No||Eczema History||participants|Number|23|23.0||||||
3989440|NCT01247064|3811034|B1|No||Eczema History||participants|Number|21|21.0||||||
3989441|NCT01247064|3811032|B3|Yes||Eczema History||participants|Number|15|15.0||||||
3989442|NCT01247064|3811033|B2|Yes||Eczema History||participants|Number|7|7.0||||||
3989443|NCT01247064|3811034|B1|Yes||Eczema History||participants|Number|8|8.0||||||
3989444|NCT01247064|3811032|B3|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3989445|NCT01247064|3811033|B2|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3989446|NCT01247064|3811034|B1|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3989447|NCT01247064|3811032|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3989448|NCT01247064|3811033|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3989449|NCT01247064|3811034|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3989450|NCT01247064|3811032|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3989451|NCT01247064|3811033|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3989452|NCT01247064|3811034|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3989453|NCT01247064|3811032|B3|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3989454|NCT01247064|3811033|B2|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3989455|NCT01247064|3811034|B1|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3989456|NCT01247064|3811032|B3|African-American||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
3989457|NCT01247064|3811033|B2|African-American||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3989458|NCT01247064|3811034|B1|African-American||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3989459|NCT01247064|3811032|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3989460|NCT01247064|3811033|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3989461|NCT01247064|3811034|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3989462|NCT01247064|3811032|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3989463|NCT01247064|3811033|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3989464|NCT01247064|3811034|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3989465|NCT01247064|3811032|B3|||Age||months|Mean|6.6|6.6|Standard Deviation|4.3|4.3|||
3989466|NCT01247064|3811033|B2|||Age||months|Mean|6.1|6.1|Standard Deviation|3.6|3.6|||
3989467|NCT01247064|3811034|B1|||Age||months|Mean|7.2|7.2|Standard Deviation|5.1|5.1|||
3989468|NCT01246999|3811049|B5|United States||Region of Enrollment||participants|Number|34|34.0||||||
3989469|NCT01246999|3811050|B4|United States||Region of Enrollment||participants|Number|2|2.0||||||
3989470|NCT01246999|3811051|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
3989471|NCT01246999|3811052|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3989472|NCT01246999|3811053|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3989473|NCT01246999|3811049|B5||Male|Gender||Participants|Count of Participants|18|18.0||||||
3989474|NCT01246999|3811050|B4||Male|Gender||Participants|Count of Participants|2|2.0||||||
3989475|NCT01246999|3811051|B3||Male|Gender||Participants|Count of Participants|7|7.0||||||
3989476|NCT01246999|3811052|B2||Male|Gender||Participants|Count of Participants|3|3.0||||||
3989477|NCT01246999|3811053|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
3989478|NCT01246999|3811049|B5||Female|Gender||Participants|Count of Participants|16|16.0||||||
3989479|NCT01246999|3811050|B4||Female|Gender||Participants|Count of Participants|0|0.0||||||
3989480|NCT01246999|3811051|B3||Female|Gender||Participants|Count of Participants|10|10.0||||||
3989481|NCT01246999|3811052|B2||Female|Gender||Participants|Count of Participants|1|1.0||||||
3989482|NCT01246999|3811053|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
3989483|NCT01246999|3811049|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3989484|NCT01246999|3811050|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3989485|NCT01246999|3811051|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3989486|NCT01246999|3811052|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3989487|NCT01246999|3811053|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3989488|NCT01246999|3811049|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3989489|NCT01246999|3811050|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3989490|NCT01246999|3811051|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3989491|NCT01246999|3811052|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3989492|NCT01246999|3811053|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3989493|NCT01246999|3811049|B5||<=18 years|Age||Participants|Count of Participants|34|34.0||||||
3989494|NCT01246999|3811050|B4||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3989495|NCT01246999|3811051|B3||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
3989496|NCT01246999|3811052|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3989497|NCT01246999|3811053|B1||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
3989498|NCT01246973|3811089|B3|United States||Region of Enrollment||participants|Number|686|686.0||||||
3989499|NCT01246973|3811090|B2|United States||Region of Enrollment||participants|Number|342|342.0||||||
3989500|NCT01246973|3811091|B1|United States||Region of Enrollment||participants|Number|344|344.0||||||
3989501|NCT01246973|3811089|B3|other race||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
3989502|NCT01246973|3811090|B2|other race||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3989503|NCT01246973|3811091|B1|other race||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3989504|NCT01246973|3811089|B3|black/african american||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
3989505|NCT01246973|3811090|B2|black/african american||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
3989506|NCT01246973|3811091|B1|black/african american||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
3989507|NCT01246973|3811089|B3|White/caucasian||Race/Ethnicity, Customized||participants|Number|600|600.0||||||
3989508|NCT01246973|3811090|B2|White/caucasian||Race/Ethnicity, Customized||participants|Number|293|293.0||||||
3989509|NCT01246973|3811091|B1|White/caucasian||Race/Ethnicity, Customized||participants|Number|307|307.0||||||
3989510|NCT01246973|3811089|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|172|172.0||||||
3989511|NCT01246973|3811090|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
3989512|NCT01246973|3811091|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
3989513|NCT01246973|3811089|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|501|501.0||||||
3989514|NCT01246973|3811090|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|237|237.0||||||
3989515|NCT01246973|3811091|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|264|264.0||||||
3989516|NCT01246973|3811089|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3989517|NCT01246973|3811090|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3989518|NCT01246973|3811091|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3989519|NCT01246973|3811089|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3989520|NCT01246973|3811090|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3989521|NCT01246973|3811091|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3989522|NCT01246973|3811089|B3||Female|Sex: Female, Male||Participants|Count of Participants|686|686.0||||||
3989523|NCT01246973|3811090|B2||Female|Sex: Female, Male||Participants|Count of Participants|342|342.0||||||
3989524|NCT01246973|3811091|B1||Female|Sex: Female, Male||Participants|Count of Participants|344|344.0||||||
3989525|NCT01246973|3811089|B3|||Age||years|Mean|57.6|57.6|Standard Deviation|0.4|0.4|||
3989526|NCT01246973|3811090|B2|||Age||years|Mean|57.7|57.7|Standard Deviation|0.5|0.5|||
3989527|NCT01246973|3811091|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|0.6|0.6|||
3989528|NCT01246960|3811100|B3|United States||Region of Enrollment||participants|Number|168|168.0||||||
3989529|NCT01246960|3811101|B2|United States||Region of Enrollment||participants|Number|84|84.0||||||
3989530|NCT01246960|3811102|B1|United States||Region of Enrollment||participants|Number|84|84.0||||||
3989531|NCT01246960|3811100|B3|White||Race/Ethnicity, Customized||participants|Number|153|153.0||||||
3989532|NCT01246960|3811101|B2|White||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
3989533|NCT01246960|3811102|B1|White||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
3989534|NCT01246960|3811100|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3989535|NCT01246960|3811101|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3989536|NCT01246960|3811102|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3989537|NCT01246960|3811100|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3989538|NCT01246960|3811101|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3989539|NCT01246960|3811102|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3989540|NCT01246960|3811100|B3|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3989541|NCT01246960|3811101|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3989542|NCT01246960|3811102|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3989543|NCT01246960|3811100|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989544|NCT01246960|3811101|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989545|NCT01246960|3811102|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989546|NCT01246960|3811100|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|155|155.0||||||
3989547|NCT01246960|3811101|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3989548|NCT01246960|3811102|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3989549|NCT01246960|3811100|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3989550|NCT01246960|3811101|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3989551|NCT01246960|3811102|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3989552|NCT01246960|3811100|B3||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3989553|NCT01246960|3811101|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3989554|NCT01246960|3811102|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3989555|NCT01246960|3811100|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3989556|NCT01246960|3811101|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3989557|NCT01246960|3811102|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3989558|NCT01246960|3811100|B3||>=65 years|Age||Participants|Count of Participants|70|70.0||||||
3989559|NCT01246960|3811101|B2||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
3989560|NCT01246960|3811102|B1||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
3989561|NCT01246960|3811100|B3||Between 18 and 65 years|Age||Participants|Count of Participants|98|98.0||||||
3989562|NCT01246960|3811101|B2||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
3989563|NCT01246960|3811102|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3989564|NCT01246960|3811100|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3989565|NCT01246960|3811101|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3989566|NCT01246960|3811102|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3989567|NCT01246895|3811121|B3|Spain||Region of Enrollment||participants|Number|11|11.0||||||
3989568|NCT01246895|3811122|B2|Spain||Region of Enrollment||participants|Number|4|4.0||||||
3989569|NCT01246895|3811123|B1|Spain||Region of Enrollment||participants|Number|7|7.0||||||
3989570|NCT01246895|3811121|B3|Canada||Region of Enrollment||participants|Number|56|56.0||||||
3989571|NCT01246895|3811122|B2|Canada||Region of Enrollment||participants|Number|26|26.0||||||
3989572|NCT01246895|3811123|B1|Canada||Region of Enrollment||participants|Number|30|30.0||||||
3989573|NCT01246895|3811121|B3|Withdrew/Withdrawn||Sex/Gender, Customized||participants|Number|7|7.0||||||
3989574|NCT01246895|3811122|B2|Withdrew/Withdrawn||Sex/Gender, Customized||participants|Number|4|4.0||||||
3989575|NCT01246895|3811123|B1|Withdrew/Withdrawn||Sex/Gender, Customized||participants|Number|3|3.0||||||
3989576|NCT01246895|3811121|B3|Female||Sex/Gender, Customized||participants|Number|24|24.0||||||
3989577|NCT01246895|3811122|B2|Female||Sex/Gender, Customized||participants|Number|12|12.0||||||
3989578|NCT01246895|3811123|B1|Female||Sex/Gender, Customized||participants|Number|12|12.0||||||
3989579|NCT01246895|3811121|B3|Male||Sex/Gender, Customized||participants|Number|36|36.0||||||
3989580|NCT01246895|3811122|B2|Male||Sex/Gender, Customized||participants|Number|14|14.0||||||
3989581|NCT01246895|3811123|B1|Male||Sex/Gender, Customized||participants|Number|22|22.0||||||
3989582|NCT01246895|3811121|B3|||Age||years|Mean|36.8|36.8|Standard Deviation|10.2|10.2|||
3989583|NCT01246895|3811122|B2|||Age||years|Mean|40.1|40.1|Standard Deviation|10.1|10.1|||
3989584|NCT01246895|3811123|B1|||Age||years|Mean|34.3|34.3|Standard Deviation|9.7|9.7|||
3989585|NCT01246791|3811138|B1|||Body weight||kg|Mean|54.46|54.46|Standard Deviation|9.70|9.7|||
3989586|NCT01246791|3811138|B1|||Height||cm|Mean|158.98|158.98|Standard Deviation|6.31|6.31|||
3989587|NCT01246791|3811138|B1|Female||Sex/Gender, Customized||participants|Number|12|12.0||||||
3989588|NCT01246791|3811138|B1|||Age||years|Mean|27.3|27.3|Standard Deviation|5.0|5.0|||
3989589|NCT01246713|3811153|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3989590|NCT01246713|3811153|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3989591|NCT01246713|3811153|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3989592|NCT01246713|3811153|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3989593|NCT01246713|3811153|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3989594|NCT01246713|3811153|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3989595|NCT01246479|3811160|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3989596|NCT01246479|3811160|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3989597|NCT01246479|3811160|B1|||Age||years|Mean|14.3|14.3|Standard Deviation|4.3|4.3|||
3989598|NCT01246401|3811164|B3|Other Opioids||Years Reported use of substances||years|Mean|2.9|2.9|Standard Deviation|6.7|6.7|||
3989599|NCT01246401|3811165|B2|Other Opioids||Years Reported use of substances||years|Mean|3.2|3.2|Standard Deviation|5.4|5.4|||
3989600|NCT01246401|3811166|B1|Other Opioids||Years Reported use of substances||years|Mean|2.8|2.8|Standard Deviation|7.2|7.2|||
3989601|NCT01246401|3811164|B3|Heroin||Years Reported use of substances||years|Mean|19.6|19.6|Standard Deviation|10.9|10.9|||
3989602|NCT01246401|3811165|B2|Heroin||Years Reported use of substances||years|Mean|18.4|18.4|Standard Deviation|10.2|10.2|||
3989603|NCT01246401|3811166|B1|Heroin||Years Reported use of substances||years|Mean|20.1|20.1|Standard Deviation|11.2|11.2|||
3989604|NCT01246401|3811164|B3|Cocaine||Years Reported use of substances||years|Mean|17.9|17.9|Standard Deviation|10.6|10.6|||
3989605|NCT01246401|3811165|B2|Cocaine||Years Reported use of substances||years|Mean|18.7|18.7|Standard Deviation|8.6|8.6|||
3989606|NCT01246401|3811166|B1|Cocaine||Years Reported use of substances||years|Mean|17.5|17.5|Standard Deviation|11.4|11.4|||
3989607|NCT01246401|3811164|B3|Cannabis||Years Reported use of substances||years|Mean|13.6|13.6|Standard Deviation|13.7|13.7|||
3989608|NCT01246401|3811165|B2|Cannabis||Years Reported use of substances||years|Mean|12.8|12.8|Standard Deviation|12.5|12.5|||
3989609|NCT01246401|3811166|B1|Cannabis||Years Reported use of substances||years|Mean|14|14.0|Standard Deviation|14.3|14.3|||
3989610|NCT01246401|3811164|B3|Alcohol||Years Reported use of substances||years|Mean|12.2|12.2|Standard Deviation|14.3|14.3|||
3989611|NCT01246401|3811165|B2|Alcohol||Years Reported use of substances||years|Mean|9.2|9.2|Standard Deviation|11.6|11.6|||
3989612|NCT01246401|3811166|B1|Alcohol||Years Reported use of substances||years|Mean|13.5|13.5|Standard Deviation|15.2|15.2|||
3989613|NCT01246401|3811164|B3|||Opioid craving|Opioid craving scale: a 10 item likert scale from 0 to 10 with 10 being highest craving for opioids and 0 representing no craving. Mean scores taken for each group.|units on a scale|Mean|3.3|3.3|Standard Deviation|3.6|3.6|||
3989614|NCT01246401|3811165|B2|||Opioid craving|Opioid craving scale: a 10 item likert scale from 0 to 10 with 10 being highest craving for opioids and 0 representing no craving. Mean scores taken for each group.|units on a scale|Mean|3.5|3.5|Standard Deviation|3.8|3.8|||
3989615|NCT01246401|3811166|B1|||Opioid craving|Opioid craving scale: a 10 item likert scale from 0 to 10 with 10 being highest craving for opioids and 0 representing no craving. Mean scores taken for each group.|units on a scale|Mean|3.2|3.2|Standard Deviation|3.6|3.6|||
3989616|NCT01246401|3811164|B3||Missing|Alcohol Use Severity (AUDIT score)||Participants|Count of Participants|1|1.0||||||
3989617|NCT01246401|3811165|B2||Missing|Alcohol Use Severity (AUDIT score)||Participants|Count of Participants|0|0.0||||||
3989618|NCT01246401|3811166|B1||Missing|Alcohol Use Severity (AUDIT score)||Participants|Count of Participants|1|1.0||||||
3989619|NCT01246401|3811164|B3||Possible Dependence|Alcohol Use Severity (AUDIT score)||Participants|Count of Participants|12|12.0||||||
3989620|NCT01246401|3811165|B2||Possible Dependence|Alcohol Use Severity (AUDIT score)||Participants|Count of Participants|2|2.0||||||
3989621|NCT01246401|3811166|B1||Possible Dependence|Alcohol Use Severity (AUDIT score)||Participants|Count of Participants|10|10.0||||||
3989622|NCT01246401|3811164|B3||Harmful Drinking|Alcohol Use Severity (AUDIT score)||Participants|Count of Participants|2|2.0||||||
3989623|NCT01246401|3811165|B2||Harmful Drinking|Alcohol Use Severity (AUDIT score)||Participants|Count of Participants|0|0.0||||||
3989624|NCT01246401|3811166|B1||Harmful Drinking|Alcohol Use Severity (AUDIT score)||Participants|Count of Participants|2|2.0||||||
3989625|NCT01246401|3811164|B3||Hazardous Drinking|Alcohol Use Severity (AUDIT score)||Participants|Count of Participants|13|13.0||||||
3989626|NCT01246401|3811165|B2||Hazardous Drinking|Alcohol Use Severity (AUDIT score)||Participants|Count of Participants|2|2.0||||||
3989627|NCT01246401|3811166|B1||Hazardous Drinking|Alcohol Use Severity (AUDIT score)||Participants|Count of Participants|11|11.0||||||
3989628|NCT01246401|3811164|B3||Abstinent or Low-Risk Drinking|Alcohol Use Severity (AUDIT score)||Participants|Count of Participants|65|65.0||||||
3989629|NCT01246401|3811165|B2||Abstinent or Low-Risk Drinking|Alcohol Use Severity (AUDIT score)||Participants|Count of Participants|23|23.0||||||
3989630|NCT01246401|3811166|B1||Abstinent or Low-Risk Drinking|Alcohol Use Severity (AUDIT score)||Participants|Count of Participants|42|42.0||||||
3989631|NCT01246401|3811164|B3|||Currently prescribed ART||Participants|Count of Participants|82|82.0||||||
3989632|NCT01246401|3811165|B2|||Currently prescribed ART||Participants|Count of Participants|24|24.0||||||
3989633|NCT01246401|3811166|B1|||Currently prescribed ART||Participants|Count of Participants|58|58.0||||||
3989634|NCT01246401|3811164|B3||Homeless|Housing status||Participants|Count of Participants|36|36.0||||||
3989635|NCT01246401|3811165|B2||Homeless|Housing status||Participants|Count of Participants|12|12.0||||||
3989636|NCT01246401|3811166|B1||Homeless|Housing status||Participants|Count of Participants|24|24.0||||||
3989637|NCT01246401|3811164|B3||Unstable|Housing status||Participants|Count of Participants|23|23.0||||||
3989638|NCT01246401|3811165|B2||Unstable|Housing status||Participants|Count of Participants|4|4.0||||||
3989639|NCT01246401|3811166|B1||Unstable|Housing status||Participants|Count of Participants|19|19.0||||||
3989640|NCT01246401|3811164|B3||Stable|Housing status||Participants|Count of Participants|34|34.0||||||
3989641|NCT01246401|3811165|B2||Stable|Housing status||Participants|Count of Participants|11|11.0||||||
3989642|NCT01246401|3811166|B1||Stable|Housing status||Participants|Count of Participants|23|23.0||||||
3989643|NCT01246401|3811164|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3989644|NCT01246401|3811165|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3989645|NCT01246401|3811166|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3989646|NCT01246401|3811164|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3989647|NCT01246401|3811165|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3989648|NCT01246401|3811166|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3989649|NCT01246401|3811164|B3|||Age||years|Mean|45.8|45.8|Standard Deviation|8.2|8.2|||
3989650|NCT01246401|3811165|B2|||Age||years|Mean|43.9|43.9|Standard Deviation|7.8|7.8|||
3989651|NCT01246401|3811166|B1|||Age||years|Mean|46.6|46.6|Standard Deviation|8.3|8.3|||
3989652|NCT01246349|3811191|B3|Canada||Region of Enrollment||participants|Number|40|40.0||||||
3989653|NCT01246349|3811192|B2|Canada||Region of Enrollment||participants|Number|20|20.0||||||
3989654|NCT01246349|3811193|B1|Canada||Region of Enrollment||participants|Number|20|20.0||||||
3989655|NCT01246349|3811191|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3989656|NCT01246349|3811192|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3989657|NCT01246349|3811193|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3989658|NCT01246349|3811191|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3989659|NCT01246349|3811192|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3989660|NCT01246349|3811193|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3989661|NCT01246349|3811191|B3|||Age||years|Mean|13.9|13.9|Standard Deviation|1.7|1.7|||
3989662|NCT01246349|3811192|B2|||Age||years|Mean|13.7|13.7|Standard Deviation|1.7|1.7|||
3989663|NCT01246349|3811193|B1|||Age||years|Mean|14.1|14.1|Standard Deviation|1.8|1.8|||
3989664|NCT01246349|3811191|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3989665|NCT01246349|3811192|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3989666|NCT01246349|3811193|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3989667|NCT01246349|3811191|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3989668|NCT01246349|3811192|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3989669|NCT01246349|3811193|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3989670|NCT01246349|3811191|B3||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
3989671|NCT01246349|3811192|B2||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
3989672|NCT01246349|3811193|B1||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
3989673|NCT01246258|3811206|B1|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
3989674|NCT01246258|3811206|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3989675|NCT01246258|3811206|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3989676|NCT01246258|3811206|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3989677|NCT01246258|3811206|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3989678|NCT01246258|3811206|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3989679|NCT01246206|3811211|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3989680|NCT01246206|3811211|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3989681|NCT01246206|3811211|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3989682|NCT01246206|3811211|B1|||Age||years|Median|59.5|59.5|Full Range|||38.0|69.0|
3989683|NCT01246206|3811211|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3989684|NCT01246206|3811211|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3989685|NCT01246206|3811211|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3989686|NCT01246076|3811222|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
3989687|NCT01246076|3811222|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3989688|NCT01246076|3811222|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3989689|NCT01246076|3811222|B1|||Age||years|Median|73|73.0|Full Range|||69.0|87.0|
3989690|NCT01246011|3811231|B4|United States||Region of Enrollment||participants|Number|9|9.0||||||
3989691|NCT01246011|3811232|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
3989692|NCT01246011|3811231|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3989693|NCT01246011|3811232|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3989694|NCT01246011|3811231|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3989695|NCT01246011|3811232|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3989696|NCT01246011|3811231|B4|||Age||years|Mean|61.9|61.9|Standard Deviation|11.3|11.3|||
3989697|NCT01246011|3811232|B3|||Age||years|Mean|61.9|61.9|Standard Deviation|11.3|11.3|||
3989698|NCT01246011|3811231|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3989699|NCT01246011|3811232|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3989700|NCT01246011|3811231|B4||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3989701|NCT01246011|3811232|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3989702|NCT01246011|3811231|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3989703|NCT01246011|3811232|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3989704|NCT01245764|3811247|B5|Native Hawaiian or Other Pacific Island||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3989705|NCT01245764|3811248|B4|Native Hawaiian or Other Pacific Island||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3989706|NCT01245764|3811249|B3|Native Hawaiian or Other Pacific Island||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3989707|NCT01245764|3811250|B2|Native Hawaiian or Other Pacific Island||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3989708|NCT01245764|3811251|B1|Native Hawaiian or Other Pacific Island||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3989709|NCT01245764|3811247|B5|Black||Race/Ethnicity, Customized||Participants|Number|249|249.0||||||
3989710|NCT01245764|3811248|B4|Black||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
3989711|NCT01245764|3811249|B3|Black||Race/Ethnicity, Customized||Participants|Number|119|119.0||||||
3989712|NCT01245764|3811250|B2|Black||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
3989713|NCT01245764|3811251|B1|Black||Race/Ethnicity, Customized||Participants|Number|80|80.0||||||
3989714|NCT01245764|3811247|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3989715|NCT01245764|3811248|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3989716|NCT01245764|3811249|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3989717|NCT01245764|3811250|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3989718|NCT01245764|3811251|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3989719|NCT01245764|3811247|B5||Female|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
3989720|NCT01245764|3811248|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3989721|NCT01245764|3811249|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3989722|NCT01245764|3811250|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3989723|NCT01245764|3811251|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3989724|NCT01245764|3811247|B5|>26 years||Age, Customized||Participants|Number|0|0.0||||||
3989725|NCT01245764|3811248|B4|>26 years||Age, Customized||Participants|Number|0|0.0||||||
3989726|NCT01245764|3811249|B3|>26 years||Age, Customized||Participants|Number|0|0.0||||||
3989727|NCT01245764|3811250|B2|>26 years||Age, Customized||Participants|Number|0|0.0||||||
3989728|NCT01245764|3811251|B1|>26 years||Age, Customized||Participants|Number|0|0.0||||||
3989729|NCT01245764|3811247|B5|16 to 26 years||Age, Customized||Participants|Number|120|120.0||||||
3989730|NCT01245764|3811248|B4|16 to 26 years||Age, Customized||Participants|Number|0|0.0||||||
3989731|NCT01245764|3811249|B3|16 to 26 years||Age, Customized||Participants|Number|120|120.0||||||
3989732|NCT01245764|3811250|B2|16 to 26 years||Age, Customized||Participants|Number|0|0.0||||||
3989733|NCT01245764|3811251|B1|16 to 26 years||Age, Customized||Participants|Number|0|0.0||||||
3989734|NCT01245764|3811247|B5|13 to 15 years||Age, Customized||Participants|Number|30|30.0||||||
3989735|NCT01245764|3811248|B4|13 to 15 years||Age, Customized||Participants|Number|0|0.0||||||
3989736|NCT01245764|3811249|B3|13 to 15 years||Age, Customized||Participants|Number|0|0.0||||||
3989737|NCT01245764|3811250|B2|13 to 15 years||Age, Customized||Participants|Number|30|30.0||||||
3989738|NCT01245764|3811251|B1|13 to 15 years||Age, Customized||Participants|Number|0|0.0||||||
3989739|NCT01245764|3811247|B5|9 to 12 years||Age, Customized||Participants|Number|100|100.0||||||
3989740|NCT01245764|3811248|B4|9 to 12 years||Age, Customized||Participants|Number|20|20.0||||||
3989741|NCT01245764|3811249|B3|9 to 12 years||Age, Customized||Participants|Number|0|0.0||||||
3989742|NCT01245764|3811250|B2|9 to 12 years||Age, Customized||Participants|Number|0|0.0||||||
3989743|NCT01245764|3811251|B1|9 to 12 years||Age, Customized||Participants|Number|80|80.0||||||
3989744|NCT01245764|3811247|B5|<9 years||Age, Customized||Participants|Number|0|0.0||||||
3989745|NCT01245764|3811248|B4|<9 years||Age, Customized||Participants|Number|0|0.0||||||
3989746|NCT01245764|3811249|B3|<9 years||Age, Customized||Participants|Number|0|0.0||||||
3989747|NCT01245764|3811250|B2|<9 years||Age, Customized||Participants|Number|0|0.0||||||
3989748|NCT01245764|3811251|B1|<9 years||Age, Customized||Participants|Number|0|0.0||||||
3989749|NCT01245751|3811288|B5||Male|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
3989750|NCT01245751|3811289|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3989751|NCT01245751|3811290|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3989752|NCT01245751|3811291|B2||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3989753|NCT01245751|3811292|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3989754|NCT01245751|3811288|B5||Female|Sex: Female, Male||Participants|Count of Participants|343|343.0||||||
3989755|NCT01245751|3811289|B4||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3989756|NCT01245751|3811290|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3989757|NCT01245751|3811291|B2||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3989758|NCT01245751|3811292|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3989759|NCT01245751|3811288|B5|||Age||years|Mean|71.1|71.1|Standard Deviation|9.4|9.4|||
3989760|NCT01245751|3811289|B4|||Age||years|Mean|55.5|55.5|Standard Deviation|2.8|2.8|||
3989761|NCT01245751|3811290|B3|||Age||years|Mean|64.1|64.1|Standard Deviation|3.1|3.1|||
3989762|NCT01245751|3811291|B2|||Age||years|Mean|76.3|76.3|Standard Deviation|5.1|5.1|||
3989763|NCT01245751|3811292|B1|||Age||years|Mean|77.1|77.1|Standard Deviation|4.5|4.5|||
3989764|NCT01245738|3811308|B1||Male|Sex: Female, Male||Participants|Count of Participants|380|380.0||||||
3989765|NCT01245738|3811308|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3989766|NCT01245738|3811308|B1|||Age||Years|Mean|54.2|54.2|Standard Deviation|10.6|10.6|||
3989767|NCT01245647|3811325|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
3989768|NCT01245647|3811326|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3989769|NCT01245647|3811327|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3989770|NCT01245647|3811325|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3989771|NCT01245647|3811326|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3989772|NCT01245647|3811327|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3989773|NCT01245647|3811325|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3989774|NCT01245647|3811326|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3989775|NCT01245647|3811327|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3989776|NCT01245647|3811325|B3|||Age||years|Mean|49.3|49.3|Standard Deviation|7.5|7.5|||
3989777|NCT01245647|3811326|B2|||Age||years|Mean|48.7|48.7|Standard Deviation|6.6|6.6|||
3989778|NCT01245647|3811327|B1|||Age||years|Mean|50.2|50.2|Standard Deviation|9.3|9.3|||
3989779|NCT01245647|3811325|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3989780|NCT01245647|3811326|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3989781|NCT01245647|3811327|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3989782|NCT01245647|3811325|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3989783|NCT01245647|3811326|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3989784|NCT01245647|3811327|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3989785|NCT01245647|3811325|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3989786|NCT01245647|3811326|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3989787|NCT01245647|3811327|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3989788|NCT01245595|3811342|B3|United States||Region of Enrollment||participants|Number|144|144.0||||||
3989789|NCT01245595|3811343|B2|United States||Region of Enrollment||participants|Number|72|72.0||||||
3989790|NCT01245595|3811344|B1|United States||Region of Enrollment||participants|Number|72|72.0||||||
3989791|NCT01245595|3811342|B3||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3989792|NCT01245595|3811343|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3989793|NCT01245595|3811344|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3989794|NCT01245595|3811342|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3989795|NCT01245595|3811343|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3989796|NCT01245595|3811344|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3989797|NCT01245595|3811342|B3|||Age|Age, continuous, Days|days|Median|155|155.0|Inter-Quartile Range|||60.0|1039.0|
3989798|NCT01245595|3811343|B2|||Age|Age, continuous, Days|days|Median|165|165.0|Inter-Quartile Range|||58.0|1332.0|
3989799|NCT01245595|3811344|B1|||Age|Age, continuous, Days|days|Median|154|154.0|Inter-Quartile Range|||64.0|656.0|
3989800|NCT01245439|3811351|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3989801|NCT01245439|3811351|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3989802|NCT01245439|3811351|B1|||Age||years|Mean|47.4|47.4|Standard Deviation|10.5|10.5|||
3989803|NCT01245413|3811382|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3989804|NCT01245413|3811382|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3989805|NCT01245413|3811382|B1|||Age||years|Mean|63.6|63.6|Standard Deviation|7.0|7.0|||
3989806|NCT01245387|3811389|B1|Unspecified||Sex/Gender, Customized||participants|Number|5|5.0||||||
3989807|NCT01245387|3811389|B1|Male||Sex/Gender, Customized||participants|Number|330|330.0||||||
3989808|NCT01245387|3811389|B1|Female||Sex/Gender, Customized||participants|Number|666|666.0||||||
3989809|NCT01245387|3811389|B1|||Age||years|Mean|77.4|77.4|Standard Deviation|7.8|7.8|||
3989810|NCT01245374|3811438|B1|||Duration of growth hormone treatment||years|Mean|4.18|4.18|Standard Deviation|2.81|2.81|||
3989811|NCT01245374|3811438|B1|||Body Mass Index (BMI)||kg/m^2|Mean|18.1|18.1|Standard Deviation|4.26|4.26|||
3989812|NCT01245374|3811438|B1|||Weight||kg|Mean|37.3|37.3|Standard Deviation|16.0|16.0|||
3989813|NCT01245374|3811438|B1|||Height||cm|Mean|141.0|141.0|Standard Deviation|16.5|16.5|||
3989814|NCT01245374|3811438|B1|France||Region of Enrollment||participants|Number|103|103.0||||||
3989815|NCT01245374|3811438|B1||Male|Gender||Participants|Count of Participants|60|60.0||||||
3989816|NCT01245374|3811438|B1||Female|Gender||Participants|Count of Participants|43|43.0||||||
3989817|NCT01245374|3811438|B1|||Age||years|Mean|11.7|11.7|Standard Deviation|2.94|2.94|||
3989818|NCT01245283|3811458|B4|United States||Region of Enrollment||participants|Number|90|90.0||||||
3989819|NCT01245283|3811459|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
3989820|NCT01245283|3811460|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
3989821|NCT01245283|3811461|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
3989822|NCT01245283|3811458|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3989823|NCT01245283|3811459|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3989824|NCT01245283|3811460|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3989825|NCT01245283|3811461|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3989826|NCT01245283|3811458|B4||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3989827|NCT01245283|3811459|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3989828|NCT01245283|3811460|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3989829|NCT01245283|3811461|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3989830|NCT01245283|3811458|B4|||Age||years|Mean|68.27|68.27|Standard Deviation|6.45|6.45|||
3989831|NCT01245283|3811459|B3|||Age||years|Mean|66.8|66.8|Standard Deviation|5.4|5.4|||
3989832|NCT01245283|3811460|B2|||Age||years|Mean|69.5|69.5|Standard Deviation|6.5|6.5|||
3989833|NCT01245283|3811461|B1|||Age||years|Mean|68.9|68.9|Standard Deviation|7.1|7.1|||
3989834|NCT01245270|3811495|B3|||BMI||Kg/m2|Mean|30|30.0|Standard Deviation|4|4.0|||
3989835|NCT01245270|3811496|B2|||BMI||Kg/m2|Mean|30|30.0|Standard Deviation|4|4.0|||
3989836|NCT01245270|3811497|B1|||BMI||Kg/m2|Mean|30|30.0|Standard Deviation|4|4.0|||
3989837|NCT01245270|3811495|B3|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3989838|NCT01245270|3811496|B2|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3989839|NCT01245270|3811497|B1|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
3989840|NCT01245270|3811495|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3989841|NCT01245270|3811496|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3989842|NCT01245270|3811497|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3989843|NCT01245270|3811495|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3989844|NCT01245270|3811496|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3989845|NCT01245270|3811497|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3989846|NCT01245270|3811495|B3|||Age||years|Mean|62|62.0|Standard Deviation|5|5.0|||
3989847|NCT01245270|3811496|B2|||Age||years|Mean|62|62.0|Standard Deviation|5|5.0|||
3989848|NCT01245270|3811497|B1|||Age||years|Mean|62|62.0|Standard Deviation|5|5.0|||
3989849|NCT01245270|3811495|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3989850|NCT01245270|3811496|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3989851|NCT01245270|3811497|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3989852|NCT01245270|3811495|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3989853|NCT01245270|3811496|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3989854|NCT01245270|3811497|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3989855|NCT01245270|3811495|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3989856|NCT01245270|3811496|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3989857|NCT01245270|3811497|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3989858|NCT01245140|3811506|B3|North African||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3989859|NCT01245140|3811507|B2|North African||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3989860|NCT01245140|3811508|B1|North African||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3989861|NCT01245140|3811506|B3|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3989862|NCT01245140|3811507|B2|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3989863|NCT01245140|3811508|B1|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3989864|NCT01245140|3811506|B3|Oriental||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3989865|NCT01245140|3811507|B2|Oriental||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3989866|NCT01245140|3811508|B1|Oriental||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3989867|NCT01245140|3811506|B3|Caucasian/White||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
3989868|NCT01245140|3811507|B2|Caucasian/White||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
3989869|NCT01245140|3811508|B1|Caucasian/White||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3989870|NCT01245140|3811506|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3989871|NCT01245140|3811507|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3989872|NCT01245140|3811508|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3989873|NCT01245140|3811506|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3989874|NCT01245140|3811507|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3989875|NCT01245140|3811508|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3989876|NCT01245140|3811506|B3|||Age||Years|Mean|48.88|48.88|Standard Deviation|15.06|15.06|||
3989877|NCT01245140|3811507|B2|||Age||Years|Mean|48.83|48.83|Standard Deviation|14.94|14.94|||
3989878|NCT01245140|3811508|B1|||Age||Years|Mean|49.00|49.0|Standard Deviation|16.32|16.32|||
3989879|NCT01245101|3811563|B3||Male|Gender||Participants|Count of Participants|4|4.0||||||
3989880|NCT01245101|3811565|B1||Male|Gender||Participants|Count of Participants|4|4.0||||||
3989881|NCT01245101|3811563|B3||Female|Gender||Participants|Count of Participants|11|11.0||||||
3989882|NCT01245101|3811565|B1||Female|Gender||Participants|Count of Participants|11|11.0||||||
3989883|NCT01245101|3811563|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3989884|NCT01245101|3811565|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3989885|NCT01245101|3811563|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3989886|NCT01245101|3811565|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3989887|NCT01245101|3811563|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3989888|NCT01245101|3811565|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3989889|NCT01245062|3811574|B3|Race/Ethnicity, Customized|White - Mixed Race|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3989890|NCT01245062|3811575|B2|Race/Ethnicity, Customized|White - Mixed Race|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3989891|NCT01245062|3811576|B1|Race/Ethnicity, Customized|White - Mixed Race|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3989892|NCT01245062|3811574|B3|Race/Ethnicity, Customized|White - White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|319|319.0||||||
3989893|NCT01245062|3811575|B2|Race/Ethnicity, Customized|White - White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|107|107.0||||||
3989894|NCT01245062|3811576|B1|Race/Ethnicity, Customized|White - White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|212|212.0||||||
3989895|NCT01245062|3811574|B3|Race/Ethnicity, Customized|White - Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3989896|NCT01245062|3811575|B2|Race/Ethnicity, Customized|White - Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3989897|NCT01245062|3811576|B1|Race/Ethnicity, Customized|White - Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3989898|NCT01245062|3811574|B3||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
3989899|NCT01245062|3811575|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3989900|NCT01245062|3811576|B1||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3989901|NCT01245062|3811574|B3||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3989902|NCT01245062|3811575|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3989903|NCT01245062|3811576|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3989904|NCT01245062|3811574|B3|||Age||Years|Mean|53.8|53.8|Standard Deviation|13.17|13.17|||
3989905|NCT01245062|3811575|B2|||Age||Years|Mean|52.8|52.8|Standard Deviation|13.56|13.56|||
3989906|NCT01245062|3811576|B1|||Age||Years|Mean|54.3|54.3|Standard Deviation|12.97|12.97|||
3989907|NCT01245049|3811614|B3|Not specified||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
3989908|NCT01245049|3811615|B2|Not specified||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3989909|NCT01245049|3811616|B1|Not specified||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3989967|NCT01244893|3811755|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
3989910|NCT01245049|3811614|B3|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|337|337.0||||||
3989911|NCT01245049|3811615|B2|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|111|111.0||||||
3989912|NCT01245049|3811616|B1|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|226|226.0||||||
3989913|NCT01245049|3811614|B3|White-Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3989914|NCT01245049|3811615|B2|White-Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3989915|NCT01245049|3811616|B1|White-Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3989916|NCT01245049|3811614|B3|Asian-South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3989917|NCT01245049|3811615|B2|Asian-South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3989918|NCT01245049|3811616|B1|Asian-South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3989919|NCT01245049|3811614|B3|Asian-Central/South Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3989920|NCT01245049|3811615|B2|Asian-Central/South Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3989921|NCT01245049|3811616|B1|Asian-Central/South Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3989922|NCT01245049|3811614|B3|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3989923|NCT01245049|3811615|B2|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3989924|NCT01245049|3811616|B1|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3989925|NCT01245049|3811614|B3||Male|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
3989926|NCT01245049|3811615|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3989927|NCT01245049|3811616|B1||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3989928|NCT01245049|3811614|B3||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3989929|NCT01245049|3811615|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3989930|NCT01245049|3811616|B1||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3989931|NCT01245049|3811614|B3|||Age||Years|Mean|3.1|3.1|Standard Deviation|0.2|0.2|||
3989932|NCT01245049|3811615|B2|||Age||Years|Mean|3.1|3.1|Standard Deviation|0.2|0.2|||
3989933|NCT01245049|3811616|B1|||Age||Years|Mean|3.1|3.1|Standard Deviation|0.2|0.2|||
3989934|NCT01244984|3811667|B4|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|243|243.0||||||
3989935|NCT01244984|3811668|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|90|90.0||||||
3989936|NCT01244984|3811669|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|93|93.0||||||
3989937|NCT01244984|3811670|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|60|60.0||||||
3989938|NCT01244984|3811667|B4||Male|Gender||Participants|Count of Participants|102|102.0||||||
3989939|NCT01244984|3811668|B3||Male|Gender||Participants|Count of Participants|36|36.0||||||
3989940|NCT01244984|3811669|B2||Male|Gender||Participants|Count of Participants|44|44.0||||||
3989941|NCT01244984|3811670|B1||Male|Gender||Participants|Count of Participants|22|22.0||||||
3989942|NCT01244984|3811667|B4||Female|Gender||Participants|Count of Participants|141|141.0||||||
3989943|NCT01244984|3811668|B3||Female|Gender||Participants|Count of Participants|54|54.0||||||
3989944|NCT01244984|3811669|B2||Female|Gender||Participants|Count of Participants|49|49.0||||||
3989945|NCT01244984|3811670|B1||Female|Gender||Participants|Count of Participants|38|38.0||||||
3989946|NCT01244984|3811667|B4|||Age||Years|Mean|50.1|50.1|Standard Deviation|15.06|15.06|||
3989947|NCT01244984|3811668|B3|||Age||Years|Mean|46.8|46.8|Standard Deviation|15.46|15.46|||
3989948|NCT01244984|3811669|B2|||Age||Years|Mean|52.6|52.6|Standard Deviation|15.05|15.05|||
3989949|NCT01244984|3811670|B1|||Age||Years|Mean|51.3|51.3|Standard Deviation|13.74|13.74|||
3989950|NCT01244906|3811746|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
3989951|NCT01244906|3811746|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989952|NCT01244906|3811746|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3989953|NCT01244906|3811746|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989954|NCT01244906|3811746|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989955|NCT01244906|3811746|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989956|NCT01244906|3811746|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3989957|NCT01244906|3811746|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3989958|NCT01244906|3811746|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989959|NCT01244906|3811746|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989960|NCT01244906|3811746|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3989961|NCT01244906|3811746|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3989962|NCT01244906|3811746|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3989963|NCT01244906|3811746|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3989964|NCT01244906|3811746|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3989965|NCT01244906|3811746|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3989966|NCT01244906|3811746|B1|||Age||years|Median|61|61.0|Full Range|||25.0|73.0|
3989968|NCT01244893|3811755|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3989969|NCT01244893|3811755|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3989970|NCT01244893|3811755|B1|||Age||years|Mean|28.3|28.3|Standard Deviation|5.66|5.66|||
3989971|NCT01244893|3811755|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3989972|NCT01244893|3811755|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
3989973|NCT01244893|3811755|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3989974|NCT01244828|3811768|B1|||Positive and Negative Syndrome Scale (PANSS) total score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS total score (30 items) ranged from 30 to 210 with a higher score indicating greater severity of symptoms.|score on a scale|Mean|89.99|89.99|Standard Deviation|18.31|18.31|||
3989975|NCT01244828|3811768|B1|||Prolactin||µg/L|Mean|43.92|43.92|Standard Deviation|41.66|41.66|||
3989976|NCT01244828|3811768|B1|||Insulin||µIU/mL|Mean|6.35|6.35|Standard Deviation|4.73|4.73|||
3989977|NCT01244828|3811768|B1|||Fasting glucose|For this measure, N=156|mmol/L|Mean|5.14|5.14|Standard Deviation|0.74|0.74|||
3989978|NCT01244828|3811768|B1|||Hemoglobin A1c (HbA1c)||percent|Mean|5.28|5.28|Standard Deviation|0.47|0.47|||
3989979|NCT01244828|3811768|B1|||Body Mass index (BMI)||kg/m^2|Mean|23.04|23.04|Standard Deviation|4.37|4.37|||
3989980|NCT01244828|3811768|B1|||Weight||kg|Mean|59.45|59.45|Standard Deviation|13.76|13.76|||
3989981|NCT01244828|3811768|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3989982|NCT01244828|3811768|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3989983|NCT01244828|3811768|B1|||Age||years|Mean|56.37|56.37|Standard Deviation|14.17|14.17|||
3989984|NCT01244815|3811780|B5|||PQ-LES-Q overall score (i.e., item 15)|PQ-LES-Q is a questionnaire to assess quality of life enjoyment and satisfaction in children and adolescents. The participant is asked to rate 15 items reflecting quality of life on a scale of 1=very poor to 5=very good. The PQ-LES-Q overall score (Item 15, a global assessment of quality of life) ranged from 1 to 5 with a higher score indicating better quality of life. Summary statistics presented are for efficacy population (Full Analysis Set [FAS]): N=98, 101, 98, 98 and 395 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID, asenapine 10.0 mg BID and Total groups, respectively.|score on a scale|Mean|3.8|3.8|Standard Deviation|1.0|1.0|||
3989985|NCT01244815|3811781|B4|||PQ-LES-Q overall score (i.e., item 15)|PQ-LES-Q is a questionnaire to assess quality of life enjoyment and satisfaction in children and adolescents. The participant is asked to rate 15 items reflecting quality of life on a scale of 1=very poor to 5=very good. The PQ-LES-Q overall score (Item 15, a global assessment of quality of life) ranged from 1 to 5 with a higher score indicating better quality of life. Summary statistics presented are for efficacy population (Full Analysis Set [FAS]): N=98, 101, 98, 98 and 395 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID, asenapine 10.0 mg BID and Total groups, respectively.|score on a scale|Mean|3.8|3.8|Standard Deviation|1.0|1.0|||
3989986|NCT01244815|3811782|B3|||PQ-LES-Q overall score (i.e., item 15)|PQ-LES-Q is a questionnaire to assess quality of life enjoyment and satisfaction in children and adolescents. The participant is asked to rate 15 items reflecting quality of life on a scale of 1=very poor to 5=very good. The PQ-LES-Q overall score (Item 15, a global assessment of quality of life) ranged from 1 to 5 with a higher score indicating better quality of life. Summary statistics presented are for efficacy population (Full Analysis Set [FAS]): N=98, 101, 98, 98 and 395 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID, asenapine 10.0 mg BID and Total groups, respectively.|score on a scale|Mean|3.8|3.8|Standard Deviation|0.9|0.9|||
3989987|NCT01244815|3811783|B2|||PQ-LES-Q overall score (i.e., item 15)|PQ-LES-Q is a questionnaire to assess quality of life enjoyment and satisfaction in children and adolescents. The participant is asked to rate 15 items reflecting quality of life on a scale of 1=very poor to 5=very good. The PQ-LES-Q overall score (Item 15, a global assessment of quality of life) ranged from 1 to 5 with a higher score indicating better quality of life. Summary statistics presented are for efficacy population (Full Analysis Set [FAS]): N=98, 101, 98, 98 and 395 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID, asenapine 10.0 mg BID and Total groups, respectively.|score on a scale|Mean|3.8|3.8|Standard Deviation|1.0|1.0|||
3989988|NCT01244815|3811784|B1|||PQ-LES-Q overall score (i.e., item 15)|PQ-LES-Q is a questionnaire to assess quality of life enjoyment and satisfaction in children and adolescents. The participant is asked to rate 15 items reflecting quality of life on a scale of 1=very poor to 5=very good. The PQ-LES-Q overall score (Item 15, a global assessment of quality of life) ranged from 1 to 5 with a higher score indicating better quality of life. Summary statistics presented are for efficacy population (Full Analysis Set [FAS]): N=98, 101, 98, 98 and 395 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID, asenapine 10.0 mg BID and Total groups, respectively.|score on a scale|Mean|3.7|3.7|Standard Deviation|1.0|1.0|||
3989989|NCT01244815|3811780|B5|||Pediatric Quality of Life Enjoyment and Satisfaction Questionnaire (PQ-LES-Q) total score|PQ-LES-Q is a questionnaire to assess quality of life enjoyment and satisfaction in children and adolescents. The participant is asked to rate 15 items reflecting quality of life on a scale of 1=very poor to 5=very good. The PQ-LES-Q total score (sum of Items 1-14) ranged from 14 to 70 with a higher score indicating better quality of life. Summary statistics presented are for efficacy population (Full Analysis Set [FAS]): N=98, 101, 98, 98 and 395 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID, asenapine 10.0 mg BID and Total groups, respectively.|score on a scale|Mean|49.1|49.1|Standard Deviation|9.7|9.7|||
3989990|NCT01244815|3811781|B4|||Pediatric Quality of Life Enjoyment and Satisfaction Questionnaire (PQ-LES-Q) total score|PQ-LES-Q is a questionnaire to assess quality of life enjoyment and satisfaction in children and adolescents. The participant is asked to rate 15 items reflecting quality of life on a scale of 1=very poor to 5=very good. The PQ-LES-Q total score (sum of Items 1-14) ranged from 14 to 70 with a higher score indicating better quality of life. Summary statistics presented are for efficacy population (Full Analysis Set [FAS]): N=98, 101, 98, 98 and 395 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID, asenapine 10.0 mg BID and Total groups, respectively.|score on a scale|Mean|49.1|49.1|Standard Deviation|10.5|10.5|||
3990036|NCT01244815|3811782|B3|||Age||years|Mean|13.8|13.8|Standard Deviation|2.0|2.0|||
3990037|NCT01244815|3811783|B2|||Age||years|Mean|13.7|13.7|Standard Deviation|2.1|2.1|||
3989991|NCT01244815|3811782|B3|||Pediatric Quality of Life Enjoyment and Satisfaction Questionnaire (PQ-LES-Q) total score|PQ-LES-Q is a questionnaire to assess quality of life enjoyment and satisfaction in children and adolescents. The participant is asked to rate 15 items reflecting quality of life on a scale of 1=very poor to 5=very good. The PQ-LES-Q total score (sum of Items 1-14) ranged from 14 to 70 with a higher score indicating better quality of life. Summary statistics presented are for efficacy population (Full Analysis Set [FAS]): N=98, 101, 98, 98 and 395 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID, asenapine 10.0 mg BID and Total groups, respectively.|score on a scale|Mean|49.5|49.5|Standard Deviation|9.1|9.1|||
3989992|NCT01244815|3811783|B2|||Pediatric Quality of Life Enjoyment and Satisfaction Questionnaire (PQ-LES-Q) total score|PQ-LES-Q is a questionnaire to assess quality of life enjoyment and satisfaction in children and adolescents. The participant is asked to rate 15 items reflecting quality of life on a scale of 1=very poor to 5=very good. The PQ-LES-Q total score (sum of Items 1-14) ranged from 14 to 70 with a higher score indicating better quality of life. Summary statistics presented are for efficacy population (Full Analysis Set [FAS]): N=98, 101, 98, 98 and 395 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID, asenapine 10.0 mg BID and Total groups, respectively.|score on a scale|Mean|49.1|49.1|Standard Deviation|9.6|9.6|||
3989993|NCT01244815|3811784|B1|||Pediatric Quality of Life Enjoyment and Satisfaction Questionnaire (PQ-LES-Q) total score|PQ-LES-Q is a questionnaire to assess quality of life enjoyment and satisfaction in children and adolescents. The participant is asked to rate 15 items reflecting quality of life on a scale of 1=very poor to 5=very good. The PQ-LES-Q total score (sum of Items 1-14) ranged from 14 to 70 with a higher score indicating better quality of life. Summary statistics presented are for efficacy population (Full Analysis Set [FAS]): N=98, 101, 98, 98 and 395 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID, asenapine 10.0 mg BID and Total groups, respectively.|score on a scale|Mean|48.7|48.7|Standard Deviation|9.7|9.7|||
3989994|NCT01244815|3811780|B5|||Children’s Global Assessment Scale (CGAS) total score - current functioning|CGAS is a 100-point scale measuring psychological, social, and school functioning in children aged 6-17. Minimum scores ranged from 1-10, representing the need for constant supervision (worse result) to maximum scores of 91-100, representing superior functioning (better result). Summary statistics presented are for efficacy population (Full Analysis Set [FAS]): N=98, 101, 98, 98 and 395 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID, asenapine 10.0 mg BID and Total groups, respectively.|score on a scale|Mean|49.0|49.0|Standard Deviation|7.4|7.4|||
3989995|NCT01244815|3811781|B4|||Children’s Global Assessment Scale (CGAS) total score - current functioning|CGAS is a 100-point scale measuring psychological, social, and school functioning in children aged 6-17. Minimum scores ranged from 1-10, representing the need for constant supervision (worse result) to maximum scores of 91-100, representing superior functioning (better result). Summary statistics presented are for efficacy population (Full Analysis Set [FAS]): N=98, 101, 98, 98 and 395 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID, asenapine 10.0 mg BID and Total groups, respectively.|score on a scale|Mean|49.1|49.1|Standard Deviation|6.7|6.7|||
3989996|NCT01244815|3811782|B3|||Children’s Global Assessment Scale (CGAS) total score - current functioning|CGAS is a 100-point scale measuring psychological, social, and school functioning in children aged 6-17. Minimum scores ranged from 1-10, representing the need for constant supervision (worse result) to maximum scores of 91-100, representing superior functioning (better result). Summary statistics presented are for efficacy population (Full Analysis Set [FAS]): N=98, 101, 98, 98 and 395 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID, asenapine 10.0 mg BID and Total groups, respectively.|score on a scale|Mean|48.4|48.4|Standard Deviation|7.4|7.4|||
3989997|NCT01244815|3811783|B2|||Children’s Global Assessment Scale (CGAS) total score - current functioning|CGAS is a 100-point scale measuring psychological, social, and school functioning in children aged 6-17. Minimum scores ranged from 1-10, representing the need for constant supervision (worse result) to maximum scores of 91-100, representing superior functioning (better result). Summary statistics presented are for efficacy population (Full Analysis Set [FAS]): N=98, 101, 98, 98 and 395 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID, asenapine 10.0 mg BID and Total groups, respectively.|score on a scale|Mean|49.6|49.6|Standard Deviation|7.4|7.4|||
3989998|NCT01244815|3811784|B1|||Children’s Global Assessment Scale (CGAS) total score - current functioning|CGAS is a 100-point scale measuring psychological, social, and school functioning in children aged 6-17. Minimum scores ranged from 1-10, representing the need for constant supervision (worse result) to maximum scores of 91-100, representing superior functioning (better result). Summary statistics presented are for efficacy population (Full Analysis Set [FAS]): N=98, 101, 98, 98 and 395 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID, asenapine 10.0 mg BID and Total groups, respectively.|score on a scale|Mean|49.0|49.0|Standard Deviation|7.9|7.9|||
3989999|NCT01244815|3811780|B5|||Children's Depression Rating Scale, Revised (CDRS-R) total score|CDRS-R is a 17-item instrument for assessing depression in children. Items are rated on a scale of 1-7 (14 items) or 1-5 (3 items); higher scores indicate more severe symptoms. CDRS-R total score is sum of ratings for the 17 items (range: 17-113). Summary statistics presented are for efficacy population (FAS) except as noted: N=97 (baseline value not available for 1 FAS participant in this group), 99 (baseline value not available for 2 FAS participants in this group), 98, 98 and 392 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID, asenapine 10.0 mg BID and Total groups, respectively.|score on a scale|Mean|34.4|34.4|Standard Deviation|10.1|10.1|||
3990000|NCT01244815|3811781|B4|||Children's Depression Rating Scale, Revised (CDRS-R) total score|CDRS-R is a 17-item instrument for assessing depression in children. Items are rated on a scale of 1-7 (14 items) or 1-5 (3 items); higher scores indicate more severe symptoms. CDRS-R total score is sum of ratings for the 17 items (range: 17-113). Summary statistics presented are for efficacy population (FAS) except as noted: N=97 (baseline value not available for 1 FAS participant in this group), 99 (baseline value not available for 2 FAS participants in this group), 98, 98 and 392 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID, asenapine 10.0 mg BID and Total groups, respectively.|score on a scale|Mean|34.1|34.1|Standard Deviation|9.0|9.0|||
3990013|NCT01244815|3811784|B1|||CGI-BP mania score|CGI-BP mania score is obtained using a 7-point scale assessing the severity of the mania component of the participant’s bipolar illness, with ratings from 1=normal, not ill to 7=very severely ill. Summary statistics presented are for efficacy population (FAS): N=98, 101, 98, 98 and 395 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID, asenapine 10.0 mg BID and Total groups, respectively.|score on a scale|Mean|4.3|4.3|Standard Deviation|0.5|0.5|||
3990001|NCT01244815|3811782|B3|||Children's Depression Rating Scale, Revised (CDRS-R) total score|CDRS-R is a 17-item instrument for assessing depression in children. Items are rated on a scale of 1-7 (14 items) or 1-5 (3 items); higher scores indicate more severe symptoms. CDRS-R total score is sum of ratings for the 17 items (range: 17-113). Summary statistics presented are for efficacy population (FAS) except as noted: N=97 (baseline value not available for 1 FAS participant in this group), 99 (baseline value not available for 2 FAS participants in this group), 98, 98 and 392 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID, asenapine 10.0 mg BID and Total groups, respectively.|score on a scale|Mean|35.2|35.2|Standard Deviation|11.9|11.9|||
3990002|NCT01244815|3811783|B2|||Children's Depression Rating Scale, Revised (CDRS-R) total score|CDRS-R is a 17-item instrument for assessing depression in children. Items are rated on a scale of 1-7 (14 items) or 1-5 (3 items); higher scores indicate more severe symptoms. CDRS-R total score is sum of ratings for the 17 items (range: 17-113). Summary statistics presented are for efficacy population (FAS) except as noted: N=97 (baseline value not available for 1 FAS participant in this group), 99 (baseline value not available for 2 FAS participants in this group), 98, 98 and 392 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID, asenapine 10.0 mg BID and Total groups, respectively.|score on a scale|Mean|33.7|33.7|Standard Deviation|9.0|9.0|||
3990003|NCT01244815|3811784|B1|||Children's Depression Rating Scale, Revised (CDRS-R) total score|CDRS-R is a 17-item instrument for assessing depression in children. Items are rated on a scale of 1-7 (14 items) or 1-5 (3 items); higher scores indicate more severe symptoms. CDRS-R total score is sum of ratings for the 17 items (range: 17-113). Summary statistics presented are for efficacy population (FAS) except as noted: N=97 (baseline value not available for 1 FAS participant in this group), 99 (baseline value not available for 2 FAS participants in this group), 98, 98 and 392 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID, asenapine 10.0 mg BID and Total groups, respectively.|score on a scale|Mean|34.5|34.5|Standard Deviation|10.2|10.2|||
3990004|NCT01244815|3811780|B5|||CGI-BP depression score|CGI-BP depression score is obtained using a 7-point scale assessing the severity of the depression component of the participant’s bipolar illness, with ratings from 1=normal, not ill to 7=very severely ill. Summary statistics presented are for efficacy population (FAS) except as noted: N=97 (baseline value not available for 1 FAS participant in this group), 101, 98, 98 and 394 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID, asenapine 10.0 mg BID and Total groups, respectively.|score on a scale|Mean|2.8|2.8|Standard Deviation|1.3|1.3|||
3990005|NCT01244815|3811781|B4|||CGI-BP depression score|CGI-BP depression score is obtained using a 7-point scale assessing the severity of the depression component of the participant’s bipolar illness, with ratings from 1=normal, not ill to 7=very severely ill. Summary statistics presented are for efficacy population (FAS) except as noted: N=97 (baseline value not available for 1 FAS participant in this group), 101, 98, 98 and 394 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID, asenapine 10.0 mg BID and Total groups, respectively.|score on a scale|Mean|2.8|2.8|Standard Deviation|1.2|1.2|||
3990006|NCT01244815|3811782|B3|||CGI-BP depression score|CGI-BP depression score is obtained using a 7-point scale assessing the severity of the depression component of the participant’s bipolar illness, with ratings from 1=normal, not ill to 7=very severely ill. Summary statistics presented are for efficacy population (FAS) except as noted: N=97 (baseline value not available for 1 FAS participant in this group), 101, 98, 98 and 394 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID, asenapine 10.0 mg BID and Total groups, respectively.|score on a scale|Mean|2.9|2.9|Standard Deviation|1.4|1.4|||
3990007|NCT01244815|3811783|B2|||CGI-BP depression score|CGI-BP depression score is obtained using a 7-point scale assessing the severity of the depression component of the participant’s bipolar illness, with ratings from 1=normal, not ill to 7=very severely ill. Summary statistics presented are for efficacy population (FAS) except as noted: N=97 (baseline value not available for 1 FAS participant in this group), 101, 98, 98 and 394 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID, asenapine 10.0 mg BID and Total groups, respectively.|score on a scale|Mean|2.8|2.8|Standard Deviation|1.3|1.3|||
3990008|NCT01244815|3811784|B1|||CGI-BP depression score|CGI-BP depression score is obtained using a 7-point scale assessing the severity of the depression component of the participant’s bipolar illness, with ratings from 1=normal, not ill to 7=very severely ill. Summary statistics presented are for efficacy population (FAS) except as noted: N=97 (baseline value not available for 1 FAS participant in this group), 101, 98, 98 and 394 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID, asenapine 10.0 mg BID and Total groups, respectively.|score on a scale|Mean|2.9|2.9|Standard Deviation|1.3|1.3|||
3990009|NCT01244815|3811780|B5|||CGI-BP mania score|CGI-BP mania score is obtained using a 7-point scale assessing the severity of the mania component of the participant’s bipolar illness, with ratings from 1=normal, not ill to 7=very severely ill. Summary statistics presented are for efficacy population (FAS): N=98, 101, 98, 98 and 395 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID, asenapine 10.0 mg BID and Total groups, respectively.|score on a scale|Mean|4.4|4.4|Standard Deviation|0.6|0.6|||
3990010|NCT01244815|3811781|B4|||CGI-BP mania score|CGI-BP mania score is obtained using a 7-point scale assessing the severity of the mania component of the participant’s bipolar illness, with ratings from 1=normal, not ill to 7=very severely ill. Summary statistics presented are for efficacy population (FAS): N=98, 101, 98, 98 and 395 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID, asenapine 10.0 mg BID and Total groups, respectively.|score on a scale|Mean|4.4|4.4|Standard Deviation|0.6|0.6|||
3990011|NCT01244815|3811782|B3|||CGI-BP mania score|CGI-BP mania score is obtained using a 7-point scale assessing the severity of the mania component of the participant’s bipolar illness, with ratings from 1=normal, not ill to 7=very severely ill. Summary statistics presented are for efficacy population (FAS): N=98, 101, 98, 98 and 395 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID, asenapine 10.0 mg BID and Total groups, respectively.|score on a scale|Mean|4.4|4.4|Standard Deviation|0.6|0.6|||
3990012|NCT01244815|3811783|B2|||CGI-BP mania score|CGI-BP mania score is obtained using a 7-point scale assessing the severity of the mania component of the participant’s bipolar illness, with ratings from 1=normal, not ill to 7=very severely ill. Summary statistics presented are for efficacy population (FAS): N=98, 101, 98, 98 and 395 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID, asenapine 10.0 mg BID and Total groups, respectively.|score on a scale|Mean|4.5|4.5|Standard Deviation|0.6|0.6|||
3990034|NCT01244815|3811780|B5|||Age||years|Mean|13.8|13.8|Standard Deviation|2.0|2.0|||
3990035|NCT01244815|3811781|B4|||Age||years|Mean|13.9|13.9|Standard Deviation|2.1|2.1|||
3990014|NCT01244815|3811780|B5|||Clinical Global Impression Scale for use in Bipolar Disorder (CGI-BP) overall score|CGI-BP overall score is obtained using a 7-point scale assessing the severity of the participant’s overall bipolar illness, with ratings from 1=normal, not ill to 7=very severely ill. Summary statistics presented are for efficacy population (FAS): N=98, 101, 98, 98 and 395 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID, asenapine 10.0 mg BID and Total groups, respectively.|score on a scale|Mean|4.4|4.4|Standard Deviation|0.6|0.6|||
3990015|NCT01244815|3811781|B4|||Clinical Global Impression Scale for use in Bipolar Disorder (CGI-BP) overall score|CGI-BP overall score is obtained using a 7-point scale assessing the severity of the participant’s overall bipolar illness, with ratings from 1=normal, not ill to 7=very severely ill. Summary statistics presented are for efficacy population (FAS): N=98, 101, 98, 98 and 395 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID, asenapine 10.0 mg BID and Total groups, respectively.|score on a scale|Mean|4.4|4.4|Standard Deviation|0.6|0.6|||
3990016|NCT01244815|3811782|B3|||Clinical Global Impression Scale for use in Bipolar Disorder (CGI-BP) overall score|CGI-BP overall score is obtained using a 7-point scale assessing the severity of the participant’s overall bipolar illness, with ratings from 1=normal, not ill to 7=very severely ill. Summary statistics presented are for efficacy population (FAS): N=98, 101, 98, 98 and 395 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID, asenapine 10.0 mg BID and Total groups, respectively.|score on a scale|Mean|4.4|4.4|Standard Deviation|0.6|0.6|||
3990017|NCT01244815|3811783|B2|||Clinical Global Impression Scale for use in Bipolar Disorder (CGI-BP) overall score|CGI-BP overall score is obtained using a 7-point scale assessing the severity of the participant’s overall bipolar illness, with ratings from 1=normal, not ill to 7=very severely ill. Summary statistics presented are for efficacy population (FAS): N=98, 101, 98, 98 and 395 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID, asenapine 10.0 mg BID and Total groups, respectively.|score on a scale|Mean|4.5|4.5|Standard Deviation|0.6|0.6|||
3990018|NCT01244815|3811784|B1|||Clinical Global Impression Scale for use in Bipolar Disorder (CGI-BP) overall score|CGI-BP overall score is obtained using a 7-point scale assessing the severity of the participant’s overall bipolar illness, with ratings from 1=normal, not ill to 7=very severely ill. Summary statistics presented are for efficacy population (FAS): N=98, 101, 98, 98 and 395 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID, asenapine 10.0 mg BID and Total groups, respectively.|score on a scale|Mean|4.3|4.3|Standard Deviation|0.5|0.5|||
3990019|NCT01244815|3811780|B5|||Young Mania Rating Scale (Y-MRS) total score|Y-MRS is an 11-item instrument for assessing the severity of manic episodes. Seven of the 11 items are rated on a scale of 0-4 and 4 are rated on a scale of 0-8, with higher scores indicating greater severity of symptoms. The Y-MRS total score for each participant is the sum of the ratings for the 11 individual items, and can range from 0-60. Summary statistics presented are for efficacy population (Full Analysis Set [FAS]): N=98, 101, 98, 98 and 395 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID, asenapine 10.0 mg BID and Total groups, respectively.|score on a scale|Mean|30.0|30.0|Standard Deviation|5.7|5.7|||
3990020|NCT01244815|3811781|B4|||Young Mania Rating Scale (Y-MRS) total score|Y-MRS is an 11-item instrument for assessing the severity of manic episodes. Seven of the 11 items are rated on a scale of 0-4 and 4 are rated on a scale of 0-8, with higher scores indicating greater severity of symptoms. The Y-MRS total score for each participant is the sum of the ratings for the 11 individual items, and can range from 0-60. Summary statistics presented are for efficacy population (Full Analysis Set [FAS]): N=98, 101, 98, 98 and 395 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID, asenapine 10.0 mg BID and Total groups, respectively.|score on a scale|Mean|30.2|30.2|Standard Deviation|5.6|5.6|||
3990021|NCT01244815|3811782|B3|||Young Mania Rating Scale (Y-MRS) total score|Y-MRS is an 11-item instrument for assessing the severity of manic episodes. Seven of the 11 items are rated on a scale of 0-4 and 4 are rated on a scale of 0-8, with higher scores indicating greater severity of symptoms. The Y-MRS total score for each participant is the sum of the ratings for the 11 individual items, and can range from 0-60. Summary statistics presented are for efficacy population (Full Analysis Set [FAS]): N=98, 101, 98, 98 and 395 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID, asenapine 10.0 mg BID and Total groups, respectively.|score on a scale|Mean|30.3|30.3|Standard Deviation|5.9|5.9|||
3990022|NCT01244815|3811783|B2|||Young Mania Rating Scale (Y-MRS) total score|Y-MRS is an 11-item instrument for assessing the severity of manic episodes. Seven of the 11 items are rated on a scale of 0-4 and 4 are rated on a scale of 0-8, with higher scores indicating greater severity of symptoms. The Y-MRS total score for each participant is the sum of the ratings for the 11 individual items, and can range from 0-60. Summary statistics presented are for efficacy population (Full Analysis Set [FAS]): N=98, 101, 98, 98 and 395 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID, asenapine 10.0 mg BID and Total groups, respectively.|score on a scale|Mean|29.5|29.5|Standard Deviation|5.7|5.7|||
3990023|NCT01244815|3811784|B1|||Young Mania Rating Scale (Y-MRS) total score|Y-MRS is an 11-item instrument for assessing the severity of manic episodes. Seven of the 11 items are rated on a scale of 0-4 and 4 are rated on a scale of 0-8, with higher scores indicating greater severity of symptoms. The Y-MRS total score for each participant is the sum of the ratings for the 11 individual items, and can range from 0-60. Summary statistics presented are for efficacy population (Full Analysis Set [FAS]): N=98, 101, 98, 98 and 395 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID, asenapine 10.0 mg BID and Total groups, respectively.|score on a scale|Mean|29.9|29.9|Standard Deviation|5.5|5.5|||
3990024|NCT01244815|3811780|B5||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
3990025|NCT01244815|3811781|B4||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3990026|NCT01244815|3811782|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3990027|NCT01244815|3811783|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3990028|NCT01244815|3811784|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3990029|NCT01244815|3811780|B5||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
3990030|NCT01244815|3811781|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3990031|NCT01244815|3811782|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3990032|NCT01244815|3811783|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3990033|NCT01244815|3811784|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3990038|NCT01244815|3811784|B1|||Age||years|Mean|13.7|13.7|Standard Deviation|2.0|2.0|||
3990039|NCT01244724|3811861|B1|||Hamilton Depression Scale|total score of Hamilton Depression Scale ranges from 0 (no depression) to 60 (worst depression possible)|units on a scale|Mean|25.5|25.5|Standard Deviation|5.7|5.7|||
3990040|NCT01244724|3811861|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3990041|NCT01244724|3811861|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3990042|NCT01244724|3811861|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3990043|NCT01244724|3811861|B1|||Age||years|Mean|39.9|39.9|Standard Deviation|10.4|10.4|||
3990044|NCT01244711|3811866|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3990045|NCT01244711|3811866|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3990046|NCT01244711|3811866|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3990047|NCT01244711|3811866|B1|||Age||years|Mean|48|48.0|Full Range|||48.0|48.0|
3990048|NCT01244711|3811866|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3990049|NCT01244711|3811866|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3990050|NCT01244711|3811866|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3990051|NCT01244633|3811870|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3990052|NCT01244633|3811870|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3990053|NCT01244633|3811870|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3990054|NCT01244633|3811870|B1|||Age||years|Mean|36|36.0|Standard Deviation|15|15.0|||
3990055|NCT01244633|3811870|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3990056|NCT01244633|3811870|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3990057|NCT01244633|3811870|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3990058|NCT01244620|3811874|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3990059|NCT01244620|3811874|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3990060|NCT01244620|3811874|B1|||Age||years|Mean|31.9|31.9|Standard Deviation|7.7|7.7|||
3990061|NCT01244529|3811911|B1|United Kingdom||Region of Enrollment||participants|Number|41|41.0||||||
3990062|NCT01244529|3811911|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3990063|NCT01244529|3811911|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3990064|NCT01244529|3811911|B1|||Age||years|Mean|34.0|34.0|Standard Deviation|12.4|12.4|||
3990065|NCT01244516|3811933|B4|United Kingdom||Region of Enrollment||Participants|Count of Participants|501|501.0||||||
3990066|NCT01244516|3811934|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|168|168.0||||||
3990067|NCT01244516|3811935|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|170|170.0||||||
3990068|NCT01244516|3811936|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|163|163.0||||||
3990069|NCT01244516|3811933|B4||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3990070|NCT01244516|3811934|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3990071|NCT01244516|3811935|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3990072|NCT01244516|3811936|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3990073|NCT01244516|3811933|B4||Female|Sex: Female, Male||Participants|Count of Participants|341|341.0||||||
3990074|NCT01244516|3811934|B3||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3990075|NCT01244516|3811935|B2||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3990076|NCT01244516|3811936|B1||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3990077|NCT01244516|3811933|B4|||Age||years|Mean|28.2|28.2|Standard Deviation|5.7|5.7|||
3990078|NCT01244516|3811934|B3|||Age||years|Mean|27.4|27.4|Standard Deviation|5.7|5.7|||
3990079|NCT01244516|3811935|B2|||Age||years|Mean|28.3|28.3|Standard Deviation|5.6|5.6|||
3990080|NCT01244516|3811936|B1|||Age||years|Mean|28.8|28.8|Standard Deviation|5.9|5.9|||
3990081|NCT01244503|3811951|B1|||Height||centimeters|Mean|167|167.0|Standard Deviation|21|21.0|||
3990082|NCT01244503|3811951|B1|||Weight||Kg|Mean|100|100.0|Standard Deviation|22|22.0|||
3990083|NCT01244503|3811951|B1|||Blood pressure systolic||mmHg|Mean|135|135.0|Standard Deviation|18|18.0|||
3990084|NCT01244503|3811951|B1|||Blood pressure diastolic||mmHg|Mean|75|75.0|Standard Deviation|10|10.0|||
3990085|NCT01244503|3811951|B1|Israel||Region of Enrollment||participants|Number|7|7.0||||||
3990086|NCT01244503|3811951|B1|United States||Region of Enrollment||participants|Number|54|54.0||||||
3990087|NCT01244503|3811951|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990088|NCT01244503|3811951|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3990089|NCT01244503|3811951|B1||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3990090|NCT01244503|3811951|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3990091|NCT01244503|3811951|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990092|NCT01244503|3811951|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990093|NCT01244503|3811951|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990094|NCT01244503|3811951|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3990095|NCT01244503|3811951|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3990096|NCT01244503|3811951|B1|||Age||years|Mean|50.1|50.1|Standard Deviation|12.6|12.6|||
3990097|NCT01244490|3811956|B4|UNITED STATES||Region of Enrollment||Participants|Number|56|56.0||||||
3990098|NCT01244490|3811957|B3|UNITED STATES||Region of Enrollment||Participants|Number|19|19.0||||||
3990099|NCT01244490|3811958|B2|UNITED STATES||Region of Enrollment||Participants|Number|19|19.0||||||
3990100|NCT01244490|3811959|B1|UNITED STATES||Region of Enrollment||Participants|Number|18|18.0||||||
3990101|NCT01244490|3811956|B4|UNITED KINGDOM||Region of Enrollment||Participants|Number|2|2.0||||||
3990102|NCT01244490|3811957|B3|UNITED KINGDOM||Region of Enrollment||Participants|Number|1|1.0||||||
3990103|NCT01244490|3811958|B2|UNITED KINGDOM||Region of Enrollment||Participants|Number|0|0.0||||||
3990104|NCT01244490|3811959|B1|UNITED KINGDOM||Region of Enrollment||Participants|Number|1|1.0||||||
3990105|NCT01244490|3811956|B4|UKRAINE||Region of Enrollment||Participants|Number|54|54.0||||||
3990106|NCT01244490|3811957|B3|UKRAINE||Region of Enrollment||Participants|Number|15|15.0||||||
3990107|NCT01244490|3811958|B2|UKRAINE||Region of Enrollment||Participants|Number|18|18.0||||||
3990108|NCT01244490|3811959|B1|UKRAINE||Region of Enrollment||Participants|Number|21|21.0||||||
3990109|NCT01244490|3811956|B4|SWEDEN||Region of Enrollment||Participants|Number|4|4.0||||||
3990110|NCT01244490|3811957|B3|SWEDEN||Region of Enrollment||Participants|Number|2|2.0||||||
3990111|NCT01244490|3811958|B2|SWEDEN||Region of Enrollment||Participants|Number|1|1.0||||||
3990112|NCT01244490|3811959|B1|SWEDEN||Region of Enrollment||Participants|Number|1|1.0||||||
3990113|NCT01244490|3811956|B4|SPAIN||Region of Enrollment||Participants|Number|51|51.0||||||
3990114|NCT01244490|3811957|B3|SPAIN||Region of Enrollment||Participants|Number|17|17.0||||||
3990115|NCT01244490|3811958|B2|SPAIN||Region of Enrollment||Participants|Number|18|18.0||||||
3990116|NCT01244490|3811959|B1|SPAIN||Region of Enrollment||Participants|Number|16|16.0||||||
3990117|NCT01244490|3811956|B4|ROMANIA||Region of Enrollment||Participants|Number|14|14.0||||||
3990118|NCT01244490|3811957|B3|ROMANIA||Region of Enrollment||Participants|Number|6|6.0||||||
3990119|NCT01244490|3811958|B2|ROMANIA||Region of Enrollment||Participants|Number|3|3.0||||||
3990120|NCT01244490|3811959|B1|ROMANIA||Region of Enrollment||Participants|Number|5|5.0||||||
3990121|NCT01244490|3811956|B4|POLAND||Region of Enrollment||Participants|Number|37|37.0||||||
3990122|NCT01244490|3811957|B3|POLAND||Region of Enrollment||Participants|Number|12|12.0||||||
3990123|NCT01244490|3811958|B2|POLAND||Region of Enrollment||Participants|Number|14|14.0||||||
3990124|NCT01244490|3811959|B1|POLAND||Region of Enrollment||Participants|Number|11|11.0||||||
3990125|NCT01244490|3811956|B4|ITALY||Region of Enrollment||Participants|Number|13|13.0||||||
3990126|NCT01244490|3811957|B3|ITALY||Region of Enrollment||Participants|Number|4|4.0||||||
3990127|NCT01244490|3811958|B2|ITALY||Region of Enrollment||Participants|Number|4|4.0||||||
3990128|NCT01244490|3811959|B1|ITALY||Region of Enrollment||Participants|Number|5|5.0||||||
3990129|NCT01244490|3811956|B4|IRELAND||Region of Enrollment||Participants|Number|2|2.0||||||
3990130|NCT01244490|3811957|B3|IRELAND||Region of Enrollment||Participants|Number|1|1.0||||||
3990131|NCT01244490|3811958|B2|IRELAND||Region of Enrollment||Participants|Number|1|1.0||||||
3990132|NCT01244490|3811959|B1|IRELAND||Region of Enrollment||Participants|Number|0|0.0||||||
3990133|NCT01244490|3811956|B4|GERMANY||Region of Enrollment||Participants|Number|68|68.0||||||
3990134|NCT01244490|3811957|B3|GERMANY||Region of Enrollment||Participants|Number|22|22.0||||||
3990135|NCT01244490|3811958|B2|GERMANY||Region of Enrollment||Participants|Number|23|23.0||||||
3990136|NCT01244490|3811959|B1|GERMANY||Region of Enrollment||Participants|Number|23|23.0||||||
3990137|NCT01244490|3811956|B4|FRANCE||Region of Enrollment||Participants|Number|6|6.0||||||
3990138|NCT01244490|3811957|B3|FRANCE||Region of Enrollment||Participants|Number|2|2.0||||||
3990139|NCT01244490|3811958|B2|FRANCE||Region of Enrollment||Participants|Number|2|2.0||||||
3990140|NCT01244490|3811959|B1|FRANCE||Region of Enrollment||Participants|Number|2|2.0||||||
3990141|NCT01244490|3811956|B4|CANADA||Region of Enrollment||Participants|Number|19|19.0||||||
3990142|NCT01244490|3811957|B3|CANADA||Region of Enrollment||Participants|Number|6|6.0||||||
3990143|NCT01244490|3811958|B2|CANADA||Region of Enrollment||Participants|Number|7|7.0||||||
3990144|NCT01244490|3811959|B1|CANADA||Region of Enrollment||Participants|Number|6|6.0||||||
3990145|NCT01244490|3811956|B4|AUSTRIA||Region of Enrollment||Participants|Number|11|11.0||||||
3990146|NCT01244490|3811957|B3|AUSTRIA||Region of Enrollment||Participants|Number|5|5.0||||||
3990147|NCT01244490|3811958|B2|AUSTRIA||Region of Enrollment||Participants|Number|4|4.0||||||
3990148|NCT01244490|3811959|B1|AUSTRIA||Region of Enrollment||Participants|Number|2|2.0||||||
3990149|NCT01244490|3811956|B4||Male|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
3990150|NCT01244490|3811957|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3990151|NCT01244490|3811958|B2||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3990152|NCT01244490|3811959|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3990153|NCT01244490|3811956|B4||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3990154|NCT01244490|3811957|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3990155|NCT01244490|3811958|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3990156|NCT01244490|3811959|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3990157|NCT01244490|3811956|B4|13-17 years||Age, Customized||Participants|Number|95|95.0||||||
3990158|NCT01244490|3811957|B3|13-17 years||Age, Customized||Participants|Number|30|30.0||||||
3990159|NCT01244490|3811958|B2|13-17 years||Age, Customized||Participants|Number|33|33.0||||||
3990160|NCT01244490|3811959|B1|13-17 years||Age, Customized||Participants|Number|32|32.0||||||
3990161|NCT01244490|3811956|B4|6-12 years||Age, Customized||Participants|Number|242|242.0||||||
3990162|NCT01244490|3811957|B3|6-12 years||Age, Customized||Participants|Number|82|82.0||||||
3990163|NCT01244490|3811958|B2|6-12 years||Age, Customized||Participants|Number|81|81.0||||||
3990164|NCT01244490|3811959|B1|6-12 years||Age, Customized||Participants|Number|79|79.0||||||
3990165|NCT01244490|3811956|B4|||Age||Years|Mean|10.8|10.8|Standard Deviation|2.78|2.78|||
3990166|NCT01244490|3811957|B3|||Age||Years|Mean|10.5|10.5|Standard Deviation|2.81|2.81|||
3990167|NCT01244490|3811958|B2|||Age||Years|Mean|10.9|10.9|Standard Deviation|2.77|2.77|||
3990168|NCT01244490|3811959|B1|||Age||Years|Mean|11.0|11.0|Standard Deviation|2.76|2.76|||
3990169|NCT01244477|3812014|B3|Caucasian or White||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
3990170|NCT01244477|3812015|B2|Caucasian or White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3990171|NCT01244477|3812016|B1|Caucasian or White||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3990172|NCT01244477|3812014|B3|Mixed Race||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3990173|NCT01244477|3812015|B2|Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3990174|NCT01244477|3812016|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3990175|NCT01244477|3812014|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3990176|NCT01244477|3812015|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3990177|NCT01244477|3812016|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3990178|NCT01244477|3812014|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3990179|NCT01244477|3812015|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3990180|NCT01244477|3812016|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3990181|NCT01244477|3812014|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3990182|NCT01244477|3812015|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3990183|NCT01244477|3812016|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3990184|NCT01244477|3812014|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3990185|NCT01244477|3812015|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3990186|NCT01244477|3812016|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3990187|NCT01244477|3812014|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3990188|NCT01244477|3812015|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3990189|NCT01244477|3812016|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3990190|NCT01244477|3812014|B3||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
3990191|NCT01244477|3812015|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3990192|NCT01244477|3812016|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
3990193|NCT01244477|3812014|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3990194|NCT01244477|3812015|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3990195|NCT01244477|3812016|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3990196|NCT01244425|3812027|B3|Germany||Region of Enrollment||participants|Number|70|70.0||||||
3990197|NCT01244425|3812028|B2|Germany||Region of Enrollment||participants|Number|35|35.0||||||
3990198|NCT01244425|3812029|B1|Germany||Region of Enrollment||participants|Number|35|35.0||||||
3990199|NCT01244425|3812027|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3990200|NCT01244425|3812028|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3990201|NCT01244425|3812029|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3990202|NCT01244425|3812027|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3990203|NCT01244425|3812028|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3990204|NCT01244425|3812029|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3990205|NCT01244425|3812027|B3|||Age||years|Mean|57.3|57.3|Standard Deviation|13.9|13.9|||
3990206|NCT01244425|3812028|B2|||Age||years|Mean|59.8|59.8|Standard Deviation|12.8|12.8|||
3990207|NCT01244425|3812029|B1|||Age||years|Mean|54.7|54.7|Standard Deviation|14.5|14.5|||
3990208|NCT01244412|3812050|B1|||Acceptability of Hand Held Fundus Photograph in comparison to traditional photgraph|"Scale Image scored as follows~Unacceptable: cannot see fundus detail~Unacceptable: fundus detail visualized, but inadequate for meaningful analysis~Acceptable: fundus detail visualized to make general comments, modest improvement image would be of sufficient quality for use~Good: fundus detail visualized, meaningful analysis possible, std photo superior~Excellent: fundus detail visualized as well as std photo~Superior: fundus detail of higher quality than std photo~Report number of participants with score of 3 or higher"|participants|Number|1|1.0||||||
3990209|NCT01244412|3812050|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3990210|NCT01244412|3812050|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3990211|NCT01244412|3812050|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3990212|NCT01244412|3812050|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3990213|NCT01244412|3812050|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3990214|NCT01244412|3812050|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3990215|NCT01244243|3812054|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
3990216|NCT01244243|3812054|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3990217|NCT01244243|3812054|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3990218|NCT01244243|3812054|B1|||Age||years|Mean|59|59.0|Standard Deviation|14|14.0|||
3990219|NCT01244243|3812054|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3990220|NCT01244243|3812054|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3990221|NCT01244243|3812054|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3990222|NCT01244126|3812059|B4|ASA Physical Status 2||ASA Physical Status in Patients who completed study|"Limited to those who completed study and excluding protocol violations~ASA PHYSICAL STATUS CLASSIFICATION SYSTEM Last approved by the ASA House of Delegates on October 15, 2014 Definition ASA I A normal healthy patient Healthy, non-smoking, no or minimal alcohol use ASA II A patient with mild systemic disease Mild diseases only without substantive functional limitations."|Participants|Number|126|126.0||||||
3990223|NCT01244126|3812060|B3|ASA Physical Status 2||ASA Physical Status in Patients who completed study|"Limited to those who completed study and excluding protocol violations~ASA PHYSICAL STATUS CLASSIFICATION SYSTEM Last approved by the ASA House of Delegates on October 15, 2014 Definition ASA I A normal healthy patient Healthy, non-smoking, no or minimal alcohol use ASA II A patient with mild systemic disease Mild diseases only without substantive functional limitations."|Participants|Number|41|41.0||||||
3990224|NCT01244126|3812061|B2|ASA Physical Status 2||ASA Physical Status in Patients who completed study|"Limited to those who completed study and excluding protocol violations~ASA PHYSICAL STATUS CLASSIFICATION SYSTEM Last approved by the ASA House of Delegates on October 15, 2014 Definition ASA I A normal healthy patient Healthy, non-smoking, no or minimal alcohol use ASA II A patient with mild systemic disease Mild diseases only without substantive functional limitations."|Participants|Number|41|41.0||||||
3990225|NCT01244126|3812062|B1|ASA Physical Status 2||ASA Physical Status in Patients who completed study|"Limited to those who completed study and excluding protocol violations~ASA PHYSICAL STATUS CLASSIFICATION SYSTEM Last approved by the ASA House of Delegates on October 15, 2014 Definition ASA I A normal healthy patient Healthy, non-smoking, no or minimal alcohol use ASA II A patient with mild systemic disease Mild diseases only without substantive functional limitations."|Participants|Number|44|44.0||||||
3990226|NCT01244126|3812059|B4|ASA Physical Status 1||ASA Physical Status in Patients who completed study|"Limited to those who completed study and excluding protocol violations~ASA PHYSICAL STATUS CLASSIFICATION SYSTEM Last approved by the ASA House of Delegates on October 15, 2014 Definition ASA I A normal healthy patient Healthy, non-smoking, no or minimal alcohol use ASA II A patient with mild systemic disease Mild diseases only without substantive functional limitations."|Participants|Number|30|30.0||||||
3990227|NCT01244126|3812060|B3|ASA Physical Status 1||ASA Physical Status in Patients who completed study|"Limited to those who completed study and excluding protocol violations~ASA PHYSICAL STATUS CLASSIFICATION SYSTEM Last approved by the ASA House of Delegates on October 15, 2014 Definition ASA I A normal healthy patient Healthy, non-smoking, no or minimal alcohol use ASA II A patient with mild systemic disease Mild diseases only without substantive functional limitations."|Participants|Number|7|7.0||||||
3990228|NCT01244126|3812061|B2|ASA Physical Status 1||ASA Physical Status in Patients who completed study|"Limited to those who completed study and excluding protocol violations~ASA PHYSICAL STATUS CLASSIFICATION SYSTEM Last approved by the ASA House of Delegates on October 15, 2014 Definition ASA I A normal healthy patient Healthy, non-smoking, no or minimal alcohol use ASA II A patient with mild systemic disease Mild diseases only without substantive functional limitations."|Participants|Number|11|11.0||||||
3990229|NCT01244126|3812062|B1|ASA Physical Status 1||ASA Physical Status in Patients who completed study|"Limited to those who completed study and excluding protocol violations~ASA PHYSICAL STATUS CLASSIFICATION SYSTEM Last approved by the ASA House of Delegates on October 15, 2014 Definition ASA I A normal healthy patient Healthy, non-smoking, no or minimal alcohol use ASA II A patient with mild systemic disease Mild diseases only without substantive functional limitations."|Participants|Number|12|12.0||||||
3990230|NCT01244126|3812059|B4|Female||Gender in patients completing study|Excluding protocol violations|Participants|Number|55|55.0||||||
3990231|NCT01244126|3812060|B3|Female||Gender in patients completing study|Excluding protocol violations|Participants|Number|19|19.0||||||
3990232|NCT01244126|3812061|B2|Female||Gender in patients completing study|Excluding protocol violations|Participants|Number|15|15.0||||||
3990233|NCT01244126|3812062|B1|Female||Gender in patients completing study|Excluding protocol violations|Participants|Number|21|21.0||||||
3990234|NCT01244126|3812059|B4|Male||Gender in patients completing study|Excluding protocol violations|Participants|Number|101|101.0||||||
3990235|NCT01244126|3812060|B3|Male||Gender in patients completing study|Excluding protocol violations|Participants|Number|29|29.0||||||
3990236|NCT01244126|3812061|B2|Male||Gender in patients completing study|Excluding protocol violations|Participants|Number|37|37.0||||||
3990237|NCT01244126|3812062|B1|Male||Gender in patients completing study|Excluding protocol violations|Participants|Number|35|35.0||||||
3990238|NCT01244126|3812059|B4|||Number completing study|15 cases excluded for protocol violations including 3, 3 and 9 in the IM morphine, IV morphine and IN fentanyl groups respectively.|participants|Number|156|156.0||||||
3990239|NCT01244126|3812060|B3|||Number completing study|15 cases excluded for protocol violations including 3, 3 and 9 in the IM morphine, IV morphine and IN fentanyl groups respectively.|participants|Number|48|48.0||||||
3990240|NCT01244126|3812061|B2|||Number completing study|15 cases excluded for protocol violations including 3, 3 and 9 in the IM morphine, IV morphine and IN fentanyl groups respectively.|participants|Number|52|52.0||||||
3990241|NCT01244126|3812062|B1|||Number completing study|15 cases excluded for protocol violations including 3, 3 and 9 in the IM morphine, IV morphine and IN fentanyl groups respectively.|participants|Number|56|56.0||||||
3990242|NCT01244126|3812059|B4|||Weight in Kgs|Excluded 15 patients for protocol violations. These 15 patients did not undergo study procedures Baseline measures only of completed cases|Kgs|Mean|14.2|14.2|Standard Deviation|6.9|6.9|||
3990243|NCT01244126|3812060|B3|||Weight in Kgs|Excluded 15 patients for protocol violations. These 15 patients did not undergo study procedures Baseline measures only of completed cases|Kgs|Mean|13.3|13.3|Standard Deviation|4.6|4.6|||
3990244|NCT01244126|3812061|B2|||Weight in Kgs|Excluded 15 patients for protocol violations. These 15 patients did not undergo study procedures Baseline measures only of completed cases|Kgs|Mean|15.2|15.2|Standard Deviation|8.1|8.1|||
3990245|NCT01244126|3812062|B1|||Weight in Kgs|Excluded 15 patients for protocol violations. These 15 patients did not undergo study procedures Baseline measures only of completed cases|Kgs|Mean|14.1|14.1|Standard Deviation|7.3|7.3|||
3990246|NCT01244126|3812059|B4|United States||Region of Enrollment||participants|Number|171|171.0||||||
3990247|NCT01244126|3812060|B3|United States||Region of Enrollment||participants|Number|57|57.0||||||
3990248|NCT01244126|3812061|B2|United States||Region of Enrollment||participants|Number|55|55.0||||||
3990249|NCT01244126|3812062|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
3990250|NCT01244126|3812059|B4||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3990251|NCT01244126|3812060|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3990252|NCT01244126|3812061|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3990253|NCT01244126|3812062|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3990254|NCT01244126|3812059|B4||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3990255|NCT01244126|3812060|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3990256|NCT01244126|3812061|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3990257|NCT01244126|3812062|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3990258|NCT01244126|3812059|B4|||Age|Limited to patients who completed study|years|Mean|2.4|2.4|Standard Deviation|1.8|1.8|||
3990259|NCT01244126|3812060|B3|||Age|Limited to patients who completed study|years|Mean|2.4|2.4|Standard Deviation|1.7|1.7|||
3990260|NCT01244126|3812061|B2|||Age|Limited to patients who completed study|years|Mean|2.7|2.7|Standard Deviation|2.2|2.2|||
3990261|NCT01244126|3812062|B1|||Age|Limited to patients who completed study|years|Mean|2.3|2.3|Standard Deviation|1.6|1.6|||
3990262|NCT01244126|3812059|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3990263|NCT01244126|3812060|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3990264|NCT01244126|3812061|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3990265|NCT01244126|3812062|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3990266|NCT01244126|3812059|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3990267|NCT01244126|3812060|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3990268|NCT01244126|3812061|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3990269|NCT01244126|3812062|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3990270|NCT01244126|3812059|B4||<=18 years|Age||Participants|Count of Participants|171|171.0||||||
3990271|NCT01244126|3812060|B3||<=18 years|Age||Participants|Count of Participants|57|57.0||||||
3990272|NCT01244126|3812061|B2||<=18 years|Age||Participants|Count of Participants|55|55.0||||||
3990273|NCT01244126|3812062|B1||<=18 years|Age||Participants|Count of Participants|59|59.0||||||
3990274|NCT01244061|3812075|B3||Male|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
3990275|NCT01244061|3812076|B2||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
3990276|NCT01244061|3812077|B1||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3990277|NCT01244061|3812075|B3||Female|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
3990278|NCT01244061|3812076|B2||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3990279|NCT01244061|3812077|B1||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3990280|NCT01244061|3812075|B3|>= 65 years||Age, Customized||number of participants|Number|32|32.0||||||
3990281|NCT01244061|3812076|B2|>= 65 years||Age, Customized||number of participants|Number|12|12.0||||||
3990282|NCT01244061|3812077|B1|>= 65 years||Age, Customized||number of participants|Number|20|20.0||||||
3990283|NCT01244061|3812075|B3|45-64 years||Age, Customized||number of participants|Number|274|274.0||||||
3990284|NCT01244061|3812076|B2|45-64 years||Age, Customized||number of participants|Number|139|139.0||||||
3990285|NCT01244061|3812077|B1|45-64 years||Age, Customized||number of participants|Number|135|135.0||||||
3990286|NCT01244061|3812075|B3|18-44 years||Age, Customized||number of participants|Number|188|188.0||||||
3990287|NCT01244061|3812076|B2|18-44 years||Age, Customized||number of participants|Number|94|94.0||||||
3990288|NCT01244061|3812077|B1|18-44 years||Age, Customized||number of participants|Number|94|94.0||||||
3990289|NCT01244061|3812075|B3|< 18 years||Age, Customized||number of participants|Number|0|0.0||||||
3990290|NCT01244061|3812076|B2|< 18 years||Age, Customized||number of participants|Number|0|0.0||||||
3990291|NCT01244061|3812077|B1|< 18 years||Age, Customized||number of participants|Number|0|0.0||||||
3990292|NCT01243957|3812090|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3990293|NCT01243957|3812090|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990294|NCT01243957|3812090|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990295|NCT01243957|3812090|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3990296|NCT01243957|3812090|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3990297|NCT01243957|3812090|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990298|NCT01243957|3812090|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990299|NCT01243957|3812090|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990300|NCT01243957|3812090|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990301|NCT01243957|3812090|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3990302|NCT01243957|3812090|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3990303|NCT01243957|3812090|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3990304|NCT01243957|3812090|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3990305|NCT01243957|3812090|B1|||Age||years|Mean|38.3|38.3|Standard Deviation|10.8|10.8|||
3990306|NCT01243944|3812101|B3|2||ECOG performance status|Eastern Cooperative Oncology Group (ECOG) - ECOG Status: 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all selfcare but unable to carry out any work activities up and about more than 50% of waking hours|participants|Number|4|4.0||||||
3990307|NCT01243944|3812102|B2|2||ECOG performance status|Eastern Cooperative Oncology Group (ECOG) - ECOG Status: 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all selfcare but unable to carry out any work activities up and about more than 50% of waking hours|participants|Number|1|1.0||||||
3990308|NCT01243944|3812103|B1|2||ECOG performance status|Eastern Cooperative Oncology Group (ECOG) - ECOG Status: 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all selfcare but unable to carry out any work activities up and about more than 50% of waking hours|participants|Number|3|3.0||||||
3990309|NCT01243944|3812101|B3|1||ECOG performance status|Eastern Cooperative Oncology Group (ECOG) - ECOG Status: 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all selfcare but unable to carry out any work activities up and about more than 50% of waking hours|participants|Number|65|65.0||||||
3990310|NCT01243944|3812102|B2|1||ECOG performance status|Eastern Cooperative Oncology Group (ECOG) - ECOG Status: 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all selfcare but unable to carry out any work activities up and about more than 50% of waking hours|participants|Number|34|34.0||||||
3990311|NCT01243944|3812103|B1|1||ECOG performance status|Eastern Cooperative Oncology Group (ECOG) - ECOG Status: 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all selfcare but unable to carry out any work activities up and about more than 50% of waking hours|participants|Number|31|31.0||||||
3990312|NCT01243944|3812101|B3|0||ECOG performance status|Eastern Cooperative Oncology Group (ECOG) - ECOG Status: 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all selfcare but unable to carry out any work activities up and about more than 50% of waking hours|participants|Number|153|153.0||||||
3990313|NCT01243944|3812102|B2|0||ECOG performance status|Eastern Cooperative Oncology Group (ECOG) - ECOG Status: 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all selfcare but unable to carry out any work activities up and about more than 50% of waking hours|participants|Number|77|77.0||||||
3990314|NCT01243944|3812103|B1|0||ECOG performance status|Eastern Cooperative Oncology Group (ECOG) - ECOG Status: 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all selfcare but unable to carry out any work activities up and about more than 50% of waking hours|participants|Number|76|76.0||||||
3990315|NCT01243944|3812101|B3|||Body Mass Index (BMI)||kg/m^2|Mean|25.9|25.9|Standard Deviation|4.03|4.03|||
3990316|NCT01243944|3812102|B2|||Body Mass Index (BMI)||kg/m^2|Mean|26.1|26.1|Standard Deviation|4.24|4.24|||
3990317|NCT01243944|3812103|B1|||Body Mass Index (BMI)||kg/m^2|Mean|25.8|25.8|Standard Deviation|3.82|3.82|||
3990318|NCT01243944|3812101|B3|||Height|Height was missing at study entry for one patient in the ruxolitinib arm.|cm|Mean|172.8|172.8|Standard Deviation|9.14|9.14|||
3990319|NCT01243944|3812102|B2|||Height|Height was missing at study entry for one patient in the ruxolitinib arm.|cm|Mean|173.3|173.3|Standard Deviation|9.79|9.79|||
3990320|NCT01243944|3812103|B1|||Height|Height was missing at study entry for one patient in the ruxolitinib arm.|cm|Mean|172.2|172.2|Standard Deviation|8.44|8.44|||
3990321|NCT01243944|3812101|B3|||Weight||kg|Mean|77.8|77.8|Standard Deviation|15.83|15.83|||
3990322|NCT01243944|3812102|B2|||Weight||kg|Mean|79.0|79.0|Standard Deviation|17.34|17.34|||
3990323|NCT01243944|3812103|B1|||Weight||kg|Mean|76.6|76.6|Standard Deviation|14.09|14.09|||
3990324|NCT01243944|3812101|B3|Asian||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
3990325|NCT01243944|3812102|B2|Asian||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
3990326|NCT01243944|3812103|B1|Asian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3990327|NCT01243944|3812101|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3990328|NCT01243944|3812102|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3990329|NCT01243944|3812103|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3990330|NCT01243944|3812101|B3|White/Caucasian||Race/Ethnicity, Customized||participants|Number|194|194.0||||||
3990331|NCT01243944|3812102|B2|White/Caucasian||Race/Ethnicity, Customized||participants|Number|96|96.0||||||
3990332|NCT01243944|3812103|B1|White/Caucasian||Race/Ethnicity, Customized||participants|Number|98|98.0||||||
3990333|NCT01243944|3812101|B3||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
3990334|NCT01243944|3812102|B2||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3990335|NCT01243944|3812103|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3990336|NCT01243944|3812101|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3990337|NCT01243944|3812102|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3990338|NCT01243944|3812103|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3990339|NCT01243944|3812101|B3|≥ 60 years||Age, Customized||participants|Number|119|119.0||||||
3990340|NCT01243944|3812102|B2|≥ 60 years||Age, Customized||participants|Number|58|58.0||||||
3990341|NCT01243944|3812103|B1|≥ 60 years||Age, Customized||participants|Number|61|61.0||||||
3990342|NCT01243944|3812101|B3|< 60 years||Age, Customized||participants|Number|103|103.0||||||
3990343|NCT01243944|3812102|B2|< 60 years||Age, Customized||participants|Number|54|54.0||||||
3990344|NCT01243944|3812103|B1|< 60 years||Age, Customized||participants|Number|49|49.0||||||
3990345|NCT01243944|3812101|B3|||Age||years|Mean|60.1|60.1|Standard Deviation|10.39|10.39|||
3990346|NCT01243944|3812102|B2|||Age||years|Mean|59.1|59.1|Standard Deviation|10.25|10.25|||
3990347|NCT01243944|3812103|B1|||Age||years|Mean|61.1|61.1|Standard Deviation|10.48|10.48|||
3990348|NCT01243892|3812126|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3990349|NCT01243892|3812127|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3990350|NCT01243892|3812128|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3990351|NCT01243892|3812126|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3990352|NCT01243892|3812127|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3990353|NCT01243892|3812128|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3990354|NCT01243892|3812126|B3|||Age||Years|Mean|9.35|9.35|Standard Deviation|2.16|2.16|||
3990355|NCT01243892|3812127|B2|||Age||Years|Mean|8.11|8.11|Standard Deviation|2.60|2.6|||
3990356|NCT01243892|3812128|B1|||Age||Years|Mean|9.60|9.6|Standard Deviation|2.07|2.07|||
3990357|NCT01243775|3812139|B1|Korea, Republic of||Region of Enrollment||participants|Number|33|33.0||||||
3990358|NCT01243775|3812139|B1|Korean||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
3990359|NCT01243775|3812139|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3990360|NCT01243775|3812139|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3990361|NCT01243775|3812139|B1|||Age||years|Mean|64.0|64.0|Standard Deviation|9.7|9.7|||
3990362|NCT01243762|3812146|B8||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3990363|NCT01243762|3812147|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3990364|NCT01243762|3812148|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3990365|NCT01243762|3812149|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3990366|NCT01243762|3812150|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3990367|NCT01243762|3812151|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3990368|NCT01243762|3812152|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3990369|NCT01243762|3812153|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3990370|NCT01243762|3812146|B8||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3990371|NCT01243762|3812147|B7||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3990372|NCT01243762|3812148|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3990373|NCT01243762|3812149|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3990374|NCT01243762|3812150|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3990375|NCT01243762|3812151|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3990376|NCT01243762|3812152|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3990377|NCT01243762|3812153|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3990378|NCT01243762|3812146|B8|||Age||Years|Mean|60.6|60.6|Standard Deviation|11.6|11.6|||
3990379|NCT01243762|3812147|B7|||Age||Years|Mean|68.8|68.8|Standard Deviation|14.1|14.1|||
3990380|NCT01243762|3812148|B6|||Age||Years|Mean|57.3|57.3|Standard Deviation|10.1|10.1|||
3990381|NCT01243762|3812149|B5|||Age||Years|Mean|65.4|65.4|Standard Deviation|7.0|7.0|||
3990382|NCT01243762|3812150|B4|||Age||Years|Mean|60.4|60.4|Standard Deviation|12.0|12.0|||
3990383|NCT01243762|3812151|B3|||Age||Years|Mean|50.3|50.3|Standard Deviation|12.7|12.7|||
3990384|NCT01243762|3812152|B2|||Age||Years|Mean|59.0|59.0|Standard Deviation|12.2|12.2|||
3990385|NCT01243762|3812153|B1|||Age||Years|Mean|51.8|51.8|Standard Deviation|4.6|4.6|||
3990386|NCT01243671|3812178|B1|||C-Reactive Protein (CRP)|C-Reactive Protein (CRP) normal range was defined as ≤0.3 mg/dL.|mg/dL|Mean|0.8|0.8|Standard Deviation|1.17|1.17|||
3990387|NCT01243671|3812178|B1|Mental Component Summary||Short-Form-36 (SF-36) Summary Scores|The Short-Form-36 (SF-36) Health Survey is a comprehensive quality of life scale. An increase in SF-36 score indicates alleviation of the disease and a decrease in score indicates aggravation of disease. The physical component reflects activity level, activity limitations, pain, and rating of one's health. Score on the physical component ranges from 0 (poorest health) to 100 (best health). The mental component reflects vitality, social functioning, role-emotional, and mental health. Score on the mental component ranges from 0 (poorest health) to 100 (best health).|units on a scale|Mean|34.6|34.6|Standard Deviation|12.43|12.43|||
3990388|NCT01243671|3812178|B1|Physical Component Summary||Short-Form-36 (SF-36) Summary Scores|The Short-Form-36 (SF-36) Health Survey is a comprehensive quality of life scale. An increase in SF-36 score indicates alleviation of the disease and a decrease in score indicates aggravation of disease. The physical component reflects activity level, activity limitations, pain, and rating of one's health. Score on the physical component ranges from 0 (poorest health) to 100 (best health). The mental component reflects vitality, social functioning, role-emotional, and mental health. Score on the mental component ranges from 0 (poorest health) to 100 (best health).|units on a scale|Mean|41.8|41.8|Standard Deviation|5.70|5.7|||
3990474|NCT01243450|3812244|B2||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
3990475|NCT01243450|3812245|B1||Male|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
3990476|NCT01243450|3812242|B4||Female|Sex: Female, Male||Participants|Count of Participants|484|484.0||||||
3990389|NCT01243671|3812178|B1|||Inflammatory Bowel Disease Questionnaire (IBDQ)|Inflammatory Bowel Disease Questionnaire (IBDQ) is the standard questionnaire to assess the quality of life of patients with inflammatory bowel disease. The IBDQ is a 32-item questionnaire consisting of 4 dimensions: bowel-related symptoms, systemic function, social function, and emotional status. The responses to each question within each domain range from 1 (significant impairment) to 7 (no impairment), with total score ranging from 32 (very poor) to 224 (perfect health-related quality of life).|units on a scale|Mean|140.5|140.5|Standard Deviation|36.18|36.18|||
3990390|NCT01243671|3812178|B1|Vulval (Genital) Ulcer Grade 3||Assessment of Behçet's Disease Symptoms (Other Than GI Symptoms) Grade|Investigators assessed oral aphthous, skin symptoms (erythema nodosum rash), eye symptoms (uveitis) and vulval (genital) ulcers during 4 weeks before baseline visit via participant interview at baseline, using the following grades: 0=None; 1=Symptom existed less than 2 weeks, or 1 eye crisis in recent 4 weeks; 2=Symptom existed 2 weeks or more, or 2 eye crises in recent 4 weeks; 3=Symptom existed mostly in recent 4 weeks, or 3 eye crises in recent 4 weeks.|participants|Number|2|2.0||||||
3990391|NCT01243671|3812178|B1|Vulval (Genital) Ulcer Grade 2||Assessment of Behçet's Disease Symptoms (Other Than GI Symptoms) Grade|Investigators assessed oral aphthous, skin symptoms (erythema nodosum rash), eye symptoms (uveitis) and vulval (genital) ulcers during 4 weeks before baseline visit via participant interview at baseline, using the following grades: 0=None; 1=Symptom existed less than 2 weeks, or 1 eye crisis in recent 4 weeks; 2=Symptom existed 2 weeks or more, or 2 eye crises in recent 4 weeks; 3=Symptom existed mostly in recent 4 weeks, or 3 eye crises in recent 4 weeks.|participants|Number|0|0.0||||||
3990392|NCT01243671|3812178|B1|Vulval (Genital) Ulcer Grade 1||Assessment of Behçet's Disease Symptoms (Other Than GI Symptoms) Grade|Investigators assessed oral aphthous, skin symptoms (erythema nodosum rash), eye symptoms (uveitis) and vulval (genital) ulcers during 4 weeks before baseline visit via participant interview at baseline, using the following grades: 0=None; 1=Symptom existed less than 2 weeks, or 1 eye crisis in recent 4 weeks; 2=Symptom existed 2 weeks or more, or 2 eye crises in recent 4 weeks; 3=Symptom existed mostly in recent 4 weeks, or 3 eye crises in recent 4 weeks.|participants|Number|1|1.0||||||
3990393|NCT01243671|3812178|B1|Vulval (Genital) Ulcer Grade 0||Assessment of Behçet's Disease Symptoms (Other Than GI Symptoms) Grade|Investigators assessed oral aphthous, skin symptoms (erythema nodosum rash), eye symptoms (uveitis) and vulval (genital) ulcers during 4 weeks before baseline visit via participant interview at baseline, using the following grades: 0=None; 1=Symptom existed less than 2 weeks, or 1 eye crisis in recent 4 weeks; 2=Symptom existed 2 weeks or more, or 2 eye crises in recent 4 weeks; 3=Symptom existed mostly in recent 4 weeks, or 3 eye crises in recent 4 weeks.|participants|Number|17|17.0||||||
3990394|NCT01243671|3812178|B1|Eye (Uveitis) Grade 3||Assessment of Behçet's Disease Symptoms (Other Than GI Symptoms) Grade|Investigators assessed oral aphthous, skin symptoms (erythema nodosum rash), eye symptoms (uveitis) and vulval (genital) ulcers during 4 weeks before baseline visit via participant interview at baseline, using the following grades: 0=None; 1=Symptom existed less than 2 weeks, or 1 eye crisis in recent 4 weeks; 2=Symptom existed 2 weeks or more, or 2 eye crises in recent 4 weeks; 3=Symptom existed mostly in recent 4 weeks, or 3 eye crises in recent 4 weeks.|participants|Number|0|0.0||||||
3990395|NCT01243671|3812178|B1|Eye (Uveitis) Grade 2||Assessment of Behçet's Disease Symptoms (Other Than GI Symptoms) Grade|Investigators assessed oral aphthous, skin symptoms (erythema nodosum rash), eye symptoms (uveitis) and vulval (genital) ulcers during 4 weeks before baseline visit via participant interview at baseline, using the following grades: 0=None; 1=Symptom existed less than 2 weeks, or 1 eye crisis in recent 4 weeks; 2=Symptom existed 2 weeks or more, or 2 eye crises in recent 4 weeks; 3=Symptom existed mostly in recent 4 weeks, or 3 eye crises in recent 4 weeks.|participants|Number|0|0.0||||||
3990396|NCT01243671|3812178|B1|Eye (Uveitis) Grade 1||Assessment of Behçet's Disease Symptoms (Other Than GI Symptoms) Grade|Investigators assessed oral aphthous, skin symptoms (erythema nodosum rash), eye symptoms (uveitis) and vulval (genital) ulcers during 4 weeks before baseline visit via participant interview at baseline, using the following grades: 0=None; 1=Symptom existed less than 2 weeks, or 1 eye crisis in recent 4 weeks; 2=Symptom existed 2 weeks or more, or 2 eye crises in recent 4 weeks; 3=Symptom existed mostly in recent 4 weeks, or 3 eye crises in recent 4 weeks.|participants|Number|0|0.0||||||
3990397|NCT01243671|3812178|B1|Eye (Uveitis) Grade 0||Assessment of Behçet's Disease Symptoms (Other Than GI Symptoms) Grade|Investigators assessed oral aphthous, skin symptoms (erythema nodosum rash), eye symptoms (uveitis) and vulval (genital) ulcers during 4 weeks before baseline visit via participant interview at baseline, using the following grades: 0=None; 1=Symptom existed less than 2 weeks, or 1 eye crisis in recent 4 weeks; 2=Symptom existed 2 weeks or more, or 2 eye crises in recent 4 weeks; 3=Symptom existed mostly in recent 4 weeks, or 3 eye crises in recent 4 weeks.|participants|Number|20|20.0||||||
3990398|NCT01243671|3812178|B1|Skin (Erythema Nodosum Rash) Grade 3||Assessment of Behçet's Disease Symptoms (Other Than GI Symptoms) Grade|Investigators assessed oral aphthous, skin symptoms (erythema nodosum rash), eye symptoms (uveitis) and vulval (genital) ulcers during 4 weeks before baseline visit via participant interview at baseline, using the following grades: 0=None; 1=Symptom existed less than 2 weeks, or 1 eye crisis in recent 4 weeks; 2=Symptom existed 2 weeks or more, or 2 eye crises in recent 4 weeks; 3=Symptom existed mostly in recent 4 weeks, or 3 eye crises in recent 4 weeks.|participants|Number|3|3.0||||||
3990399|NCT01243671|3812178|B1|Skin (Erythema Nodosum Rash) Grade 2||Assessment of Behçet's Disease Symptoms (Other Than GI Symptoms) Grade|Investigators assessed oral aphthous, skin symptoms (erythema nodosum rash), eye symptoms (uveitis) and vulval (genital) ulcers during 4 weeks before baseline visit via participant interview at baseline, using the following grades: 0=None; 1=Symptom existed less than 2 weeks, or 1 eye crisis in recent 4 weeks; 2=Symptom existed 2 weeks or more, or 2 eye crises in recent 4 weeks; 3=Symptom existed mostly in recent 4 weeks, or 3 eye crises in recent 4 weeks.|participants|Number|1|1.0||||||
3990400|NCT01243671|3812178|B1|Skin (Erythema Nodosum Rash) Grade 1||Assessment of Behçet's Disease Symptoms (Other Than GI Symptoms) Grade|Investigators assessed oral aphthous, skin symptoms (erythema nodosum rash), eye symptoms (uveitis) and vulval (genital) ulcers during 4 weeks before baseline visit via participant interview at baseline, using the following grades: 0=None; 1=Symptom existed less than 2 weeks, or 1 eye crisis in recent 4 weeks; 2=Symptom existed 2 weeks or more, or 2 eye crises in recent 4 weeks; 3=Symptom existed mostly in recent 4 weeks, or 3 eye crises in recent 4 weeks.|participants|Number|4|4.0||||||
3990477|NCT01243450|3812243|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3990401|NCT01243671|3812178|B1|Skin (Erythema Nodosum Rash) Grade 0||Assessment of Behçet's Disease Symptoms (Other Than GI Symptoms) Grade|Investigators assessed oral aphthous, skin symptoms (erythema nodosum rash), eye symptoms (uveitis) and vulval (genital) ulcers during 4 weeks before baseline visit via participant interview at baseline, using the following grades: 0=None; 1=Symptom existed less than 2 weeks, or 1 eye crisis in recent 4 weeks; 2=Symptom existed 2 weeks or more, or 2 eye crises in recent 4 weeks; 3=Symptom existed mostly in recent 4 weeks, or 3 eye crises in recent 4 weeks.|participants|Number|12|12.0||||||
3990402|NCT01243671|3812178|B1|Oral Aphthous Grade 3||Assessment of Behçet's Disease Symptoms (Other Than GI Symptoms) Grade|Investigators assessed oral aphthous, skin symptoms (erythema nodosum rash), eye symptoms (uveitis) and vulval (genital) ulcers during 4 weeks before baseline visit via participant interview at baseline, using the following grades: 0=None; 1=Symptom existed less than 2 weeks, or 1 eye crisis in recent 4 weeks; 2=Symptom existed 2 weeks or more, or 2 eye crises in recent 4 weeks; 3=Symptom existed mostly in recent 4 weeks, or 3 eye crises in recent 4 weeks.|participants|Number|4|4.0||||||
3990403|NCT01243671|3812178|B1|Oral Aphthous Grade 2||Assessment of Behçet's Disease Symptoms (Other Than GI Symptoms) Grade|Investigators assessed oral aphthous, skin symptoms (erythema nodosum rash), eye symptoms (uveitis) and vulval (genital) ulcers during 4 weeks before baseline visit via participant interview at baseline, using the following grades: 0=None; 1=Symptom existed less than 2 weeks, or 1 eye crisis in recent 4 weeks; 2=Symptom existed 2 weeks or more, or 2 eye crises in recent 4 weeks; 3=Symptom existed mostly in recent 4 weeks, or 3 eye crises in recent 4 weeks.|participants|Number|3|3.0||||||
3990404|NCT01243671|3812178|B1|Oral Aphthous Grade 1||Assessment of Behçet's Disease Symptoms (Other Than GI Symptoms) Grade|Investigators assessed oral aphthous, skin symptoms (erythema nodosum rash), eye symptoms (uveitis) and vulval (genital) ulcers during 4 weeks before baseline visit via participant interview at baseline, using the following grades: 0=None; 1=Symptom existed less than 2 weeks, or 1 eye crisis in recent 4 weeks; 2=Symptom existed 2 weeks or more, or 2 eye crises in recent 4 weeks; 3=Symptom existed mostly in recent 4 weeks, or 3 eye crises in recent 4 weeks.|participants|Number|8|8.0||||||
3990405|NCT01243671|3812178|B1|Oral Aphthous Grade 0||Assessment of Behçet's Disease Symptoms (Other Than GI Symptoms) Grade|Investigators assessed oral aphthous, skin symptoms (erythema nodosum rash), eye symptoms (uveitis) and vulval (genital) ulcers during 4 weeks before baseline visit via participant interview at baseline, using the following grades: 0=None; 1=Symptom existed less than 2 weeks, or 1 eye crisis in recent 4 weeks; 2=Symptom existed 2 weeks or more, or 2 eye crises in recent 4 weeks; 3=Symptom existed mostly in recent 4 weeks, or 3 eye crises in recent 4 weeks.|participants|Number|5|5.0||||||
3990406|NCT01243671|3812178|B1|Grade 4||Assessment of Other Symptoms (GI Symptom Component) Grade|Assessment of gastrointestinal symptoms other than abdominal pain or diarrhea (abdominal discomfort/fullness, etc) via a participant-assessed, investigator-confirmed grading of symptoms from 0 to 4: 0=free of symptoms; 1=symptoms existed in past 2 weeks but did not affect participant’s daily life; 2=symptoms existed in past 2 weeks and slightly affected participant’s daily life; 3=symptoms existed in past 2 weeks and affected participant’s daily life; 4=symptoms existed in past 2 weeks and critically affected participant’s daily life. Scores assess symptoms in the 2 weeks prior to Baseline.|participants|Number|3|3.0||||||
3990407|NCT01243671|3812178|B1|Grade 3||Assessment of Other Symptoms (GI Symptom Component) Grade|Assessment of gastrointestinal symptoms other than abdominal pain or diarrhea (abdominal discomfort/fullness, etc) via a participant-assessed, investigator-confirmed grading of symptoms from 0 to 4: 0=free of symptoms; 1=symptoms existed in past 2 weeks but did not affect participant’s daily life; 2=symptoms existed in past 2 weeks and slightly affected participant’s daily life; 3=symptoms existed in past 2 weeks and affected participant’s daily life; 4=symptoms existed in past 2 weeks and critically affected participant’s daily life. Scores assess symptoms in the 2 weeks prior to Baseline.|participants|Number|12|12.0||||||
3990408|NCT01243671|3812178|B1|Grade 2||Assessment of Other Symptoms (GI Symptom Component) Grade|Assessment of gastrointestinal symptoms other than abdominal pain or diarrhea (abdominal discomfort/fullness, etc) via a participant-assessed, investigator-confirmed grading of symptoms from 0 to 4: 0=free of symptoms; 1=symptoms existed in past 2 weeks but did not affect participant’s daily life; 2=symptoms existed in past 2 weeks and slightly affected participant’s daily life; 3=symptoms existed in past 2 weeks and affected participant’s daily life; 4=symptoms existed in past 2 weeks and critically affected participant’s daily life. Scores assess symptoms in the 2 weeks prior to Baseline.|participants|Number|4|4.0||||||
3990409|NCT01243671|3812178|B1|Grade 1||Assessment of Other Symptoms (GI Symptom Component) Grade|Assessment of gastrointestinal symptoms other than abdominal pain or diarrhea (abdominal discomfort/fullness, etc) via a participant-assessed, investigator-confirmed grading of symptoms from 0 to 4: 0=free of symptoms; 1=symptoms existed in past 2 weeks but did not affect participant’s daily life; 2=symptoms existed in past 2 weeks and slightly affected participant’s daily life; 3=symptoms existed in past 2 weeks and affected participant’s daily life; 4=symptoms existed in past 2 weeks and critically affected participant’s daily life. Scores assess symptoms in the 2 weeks prior to Baseline.|participants|Number|1|1.0||||||
3990410|NCT01243671|3812178|B1|Grade 0||Assessment of Other Symptoms (GI Symptom Component) Grade|Assessment of gastrointestinal symptoms other than abdominal pain or diarrhea (abdominal discomfort/fullness, etc) via a participant-assessed, investigator-confirmed grading of symptoms from 0 to 4: 0=free of symptoms; 1=symptoms existed in past 2 weeks but did not affect participant’s daily life; 2=symptoms existed in past 2 weeks and slightly affected participant’s daily life; 3=symptoms existed in past 2 weeks and affected participant’s daily life; 4=symptoms existed in past 2 weeks and critically affected participant’s daily life. Scores assess symptoms in the 2 weeks prior to Baseline.|participants|Number|0|0.0||||||
3990411|NCT01243671|3812178|B1|Grade 4||Assessment of Diarrhea (GI Symptom Component) Grade|Assessment of gastrointestinal symptom component of diarrhea via a participant-assessed, investigator-confirmed grading of symptoms from 0 to 4: 0=free of symptoms; 1=symptoms existed in past 2 weeks but did not affect participant’s daily life; 2=symptoms existed in past 2 weeks and slightly affected participant’s daily life; 3=symptoms existed in past 2 weeks and affected participant’s daily life; 4=symptoms existed in past 2 weeks and critically affected participant’s daily life.|participants|Number|1|1.0||||||
3990478|NCT01243450|3812244|B2||Female|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
3990479|NCT01243450|3812245|B1||Female|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
3990480|NCT01243450|3812242|B4|||Age||years|Median|17.2|17.2|Standard Deviation|6.2|6.2|||
3990412|NCT01243671|3812178|B1|Grade 3||Assessment of Diarrhea (GI Symptom Component) Grade|Assessment of gastrointestinal symptom component of diarrhea via a participant-assessed, investigator-confirmed grading of symptoms from 0 to 4: 0=free of symptoms; 1=symptoms existed in past 2 weeks but did not affect participant’s daily life; 2=symptoms existed in past 2 weeks and slightly affected participant’s daily life; 3=symptoms existed in past 2 weeks and affected participant’s daily life; 4=symptoms existed in past 2 weeks and critically affected participant’s daily life.|participants|Number|9|9.0||||||
3990413|NCT01243671|3812178|B1|Grade 2||Assessment of Diarrhea (GI Symptom Component) Grade|Assessment of gastrointestinal symptom component of diarrhea via a participant-assessed, investigator-confirmed grading of symptoms from 0 to 4: 0=free of symptoms; 1=symptoms existed in past 2 weeks but did not affect participant’s daily life; 2=symptoms existed in past 2 weeks and slightly affected participant’s daily life; 3=symptoms existed in past 2 weeks and affected participant’s daily life; 4=symptoms existed in past 2 weeks and critically affected participant’s daily life.|participants|Number|0|0.0||||||
3990414|NCT01243671|3812178|B1|Grade 1||Assessment of Diarrhea (GI Symptom Component) Grade|Assessment of gastrointestinal symptom component of diarrhea via a participant-assessed, investigator-confirmed grading of symptoms from 0 to 4: 0=free of symptoms; 1=symptoms existed in past 2 weeks but did not affect participant’s daily life; 2=symptoms existed in past 2 weeks and slightly affected participant’s daily life; 3=symptoms existed in past 2 weeks and affected participant’s daily life; 4=symptoms existed in past 2 weeks and critically affected participant’s daily life.|participants|Number|6|6.0||||||
3990415|NCT01243671|3812178|B1|Grade 0||Assessment of Diarrhea (GI Symptom Component) Grade|Assessment of gastrointestinal symptom component of diarrhea via a participant-assessed, investigator-confirmed grading of symptoms from 0 to 4: 0=free of symptoms; 1=symptoms existed in past 2 weeks but did not affect participant’s daily life; 2=symptoms existed in past 2 weeks and slightly affected participant’s daily life; 3=symptoms existed in past 2 weeks and affected participant’s daily life; 4=symptoms existed in past 2 weeks and critically affected participant’s daily life.|participants|Number|4|4.0||||||
3990416|NCT01243671|3812178|B1|Grade 4||Assessment of Abdominal Pain (GI Symptom Component) Grade|Assessment of gastrointestinal symptom component of abdominal pain via a participant-assessed, investigator-confirmed grading of symptoms from 0 to 4: 0=free of symptoms; 1=symptoms existed in past 2 weeks but did not affect participant’s daily life; 2=symptoms existed in past 2 weeks and slightly affected participant’s daily life; 3=symptoms existed in past 2 weeks and affected participant’s daily life; 4=symptoms existed in past 2 weeks and critically affected participant’s daily life.|participants|Number|4|4.0||||||
3990417|NCT01243671|3812178|B1|Grade 3||Assessment of Abdominal Pain (GI Symptom Component) Grade|Assessment of gastrointestinal symptom component of abdominal pain via a participant-assessed, investigator-confirmed grading of symptoms from 0 to 4: 0=free of symptoms; 1=symptoms existed in past 2 weeks but did not affect participant’s daily life; 2=symptoms existed in past 2 weeks and slightly affected participant’s daily life; 3=symptoms existed in past 2 weeks and affected participant’s daily life; 4=symptoms existed in past 2 weeks and critically affected participant’s daily life.|participants|Number|10|10.0||||||
3990418|NCT01243671|3812178|B1|Grade 2||Assessment of Abdominal Pain (GI Symptom Component) Grade|Assessment of gastrointestinal symptom component of abdominal pain via a participant-assessed, investigator-confirmed grading of symptoms from 0 to 4: 0=free of symptoms; 1=symptoms existed in past 2 weeks but did not affect participant’s daily life; 2=symptoms existed in past 2 weeks and slightly affected participant’s daily life; 3=symptoms existed in past 2 weeks and affected participant’s daily life; 4=symptoms existed in past 2 weeks and critically affected participant’s daily life.|participants|Number|3|3.0||||||
3990419|NCT01243671|3812178|B1|Grade 1||Assessment of Abdominal Pain (GI Symptom Component) Grade|Assessment of gastrointestinal symptom component of abdominal pain via a participant-assessed, investigator-confirmed grading of symptoms from 0 to 4: 0=free of symptoms; 1=symptoms existed in past 2 weeks but did not affect participant’s daily life; 2=symptoms existed in past 2 weeks and slightly affected participant’s daily life; 3=symptoms existed in past 2 weeks and affected participant’s daily life; 4=symptoms existed in past 2 weeks and critically affected participant’s daily life.|participants|Number|1|1.0||||||
3990420|NCT01243671|3812178|B1|Grade 0||Assessment of Abdominal Pain (GI Symptom Component) Grade|Assessment of gastrointestinal symptom component of abdominal pain via a participant-assessed, investigator-confirmed grading of symptoms from 0 to 4: 0=free of symptoms; 1=symptoms existed in past 2 weeks but did not affect participant’s daily life; 2=symptoms existed in past 2 weeks and slightly affected participant’s daily life; 3=symptoms existed in past 2 weeks and affected participant’s daily life; 4=symptoms existed in past 2 weeks and critically affected participant’s daily life.|participants|Number|2|2.0||||||
3990421|NCT01243671|3812178|B1|Grade 4||Global Assessment of Gastrointestinal (GI) Symptoms Grade|Global assessment of gastrointestinal symptoms is a participant-assessed, investigator-confirmed grading of global symptoms from 0 to 4: 0=free of symptoms; 1=symptoms existed in past 2 weeks but did not affect participant’s daily life; 2=symptoms existed in past 2 weeks and slightly affected participant’s daily life; 3=symptoms existed in past 2 weeks and affected participant’s daily life; 4=symptoms existed in past 2 weeks and critically affected participant’s daily life.|participants|Number|5|5.0||||||
3990422|NCT01243671|3812178|B1|Grade 3||Global Assessment of Gastrointestinal (GI) Symptoms Grade|Global assessment of gastrointestinal symptoms is a participant-assessed, investigator-confirmed grading of global symptoms from 0 to 4: 0=free of symptoms; 1=symptoms existed in past 2 weeks but did not affect participant’s daily life; 2=symptoms existed in past 2 weeks and slightly affected participant’s daily life; 3=symptoms existed in past 2 weeks and affected participant’s daily life; 4=symptoms existed in past 2 weeks and critically affected participant’s daily life.|participants|Number|15|15.0||||||
3990423|NCT01243671|3812178|B1|Grade 2||Global Assessment of Gastrointestinal (GI) Symptoms Grade|Global assessment of gastrointestinal symptoms is a participant-assessed, investigator-confirmed grading of global symptoms from 0 to 4: 0=free of symptoms; 1=symptoms existed in past 2 weeks but did not affect participant’s daily life; 2=symptoms existed in past 2 weeks and slightly affected participant’s daily life; 3=symptoms existed in past 2 weeks and affected participant’s daily life; 4=symptoms existed in past 2 weeks and critically affected participant’s daily life.|participants|Number|0|0.0||||||
3990481|NCT01243450|3812243|B3|||Age||years|Median|17.6|17.6|Standard Deviation|6.3|6.3|||
3990482|NCT01243450|3812244|B2|||Age||years|Median|17.1|17.1|Standard Deviation|6.1|6.1|||
3990424|NCT01243671|3812178|B1|Grade 1||Global Assessment of Gastrointestinal (GI) Symptoms Grade|Global assessment of gastrointestinal symptoms is a participant-assessed, investigator-confirmed grading of global symptoms from 0 to 4: 0=free of symptoms; 1=symptoms existed in past 2 weeks but did not affect participant’s daily life; 2=symptoms existed in past 2 weeks and slightly affected participant’s daily life; 3=symptoms existed in past 2 weeks and affected participant’s daily life; 4=symptoms existed in past 2 weeks and critically affected participant’s daily life.|participants|Number|0|0.0||||||
3990425|NCT01243671|3812178|B1|Grade 0||Global Assessment of Gastrointestinal (GI) Symptoms Grade|Global assessment of gastrointestinal symptoms is a participant-assessed, investigator-confirmed grading of global symptoms from 0 to 4: 0=free of symptoms; 1=symptoms existed in past 2 weeks but did not affect participant’s daily life; 2=symptoms existed in past 2 weeks and slightly affected participant’s daily life; 3=symptoms existed in past 2 weeks and affected participant’s daily life; 4=symptoms existed in past 2 weeks and critically affected participant’s daily life.|participants|Number|0|0.0||||||
3990426|NCT01243671|3812178|B1|>=3 cm||Longest Diameter of Ileocecal Largest Open Ulcer|Number of participants with longest diameter of ileocecal largest open ulcer in each of 3 categories, as determined by screening (baseline) endoscopy.|participants|Number|7|7.0||||||
3990427|NCT01243671|3812178|B1|>=2 cm to <3 cm||Longest Diameter of Ileocecal Largest Open Ulcer|Number of participants with longest diameter of ileocecal largest open ulcer in each of 3 categories, as determined by screening (baseline) endoscopy.|participants|Number|5|5.0||||||
3990428|NCT01243671|3812178|B1|>=1 cm to <2 cm||Longest Diameter of Ileocecal Largest Open Ulcer|Number of participants with longest diameter of ileocecal largest open ulcer in each of 3 categories, as determined by screening (baseline) endoscopy.|participants|Number|8|8.0||||||
3990429|NCT01243671|3812178|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3990430|NCT01243671|3812178|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3990431|NCT01243671|3812178|B1|>=65 years||Age, Customized||participants|Number|2|2.0||||||
3990432|NCT01243671|3812178|B1|Between 40 and 65 years||Age, Customized||participants|Number|7|7.0||||||
3990433|NCT01243671|3812178|B1|<40 years||Age, Customized||participants|Number|11|11.0||||||
3990434|NCT01243671|3812178|B1|||Age||years|Mean|42.4|42.4|Standard Deviation|13.33|13.33|||
3990435|NCT01243619|3812191|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3990436|NCT01243619|3812191|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3990437|NCT01243619|3812191|B1|||Age||years|Mean|63.4|63.4|Standard Deviation|9.6|9.6|||
3990438|NCT01243580|3812195|B3|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3990439|NCT01243580|3812196|B2|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3990440|NCT01243580|3812197|B1|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3990441|NCT01243580|3812195|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3990442|NCT01243580|3812196|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3990443|NCT01243580|3812197|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3990444|NCT01243580|3812195|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3990445|NCT01243580|3812196|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3990446|NCT01243580|3812197|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3990447|NCT01243580|3812195|B3|||Age||years|Mean|37|37.0|Standard Deviation|6.77|6.77|||
3990448|NCT01243580|3812196|B2|||Age||years|Mean|36.2|36.2|Standard Deviation|7.66|7.66|||
3990449|NCT01243580|3812197|B1|||Age||years|Mean|37.8|37.8|Standard Deviation|5.85|5.85|||
3990450|NCT01243580|3812195|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3990451|NCT01243580|3812196|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3990452|NCT01243580|3812197|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3990453|NCT01243580|3812195|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3990454|NCT01243580|3812196|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3990455|NCT01243580|3812197|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3990456|NCT01243580|3812195|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3990457|NCT01243580|3812196|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3990458|NCT01243580|3812197|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3990459|NCT01243567|3812225|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3990460|NCT01243567|3812226|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3990461|NCT01243567|3812227|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3990462|NCT01243567|3812225|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3990463|NCT01243567|3812226|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3990464|NCT01243567|3812227|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3990465|NCT01243567|3812225|B3|||Age||Years|Mean|64.6|64.6|Standard Deviation|12.01|12.01|||
3990466|NCT01243567|3812226|B2|||Age||Years|Mean|63.1|63.1|Standard Deviation|13.72|13.72|||
3990467|NCT01243567|3812227|B1|||Age||Years|Mean|65.9|65.9|Standard Deviation|10.24|10.24|||
3990468|NCT01243450|3812242|B4|United States||Region of Enrollment||participants|Number|940|940.0||||||
3990469|NCT01243450|3812243|B3|United States||Region of Enrollment||participants|Number|135|135.0||||||
3990470|NCT01243450|3812244|B2|United States||Region of Enrollment||participants|Number|404|404.0||||||
3990471|NCT01243450|3812245|B1|United States||Region of Enrollment||participants|Number|401|401.0||||||
3990472|NCT01243450|3812242|B4||Male|Sex: Female, Male||Participants|Count of Participants|456|456.0||||||
3990473|NCT01243450|3812243|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3990483|NCT01243450|3812245|B1|||Age||years|Median|17.2|17.2|Standard Deviation|6.2|6.2|||
3990484|NCT01243411|3812255|B1|Sweden||Region of Enrollment||participants|Number|33|33.0||||||
3990485|NCT01243411|3812255|B1|New Zealand||Region of Enrollment||participants|Number|54|54.0||||||
3990486|NCT01243411|3812255|B1|United Kingdom||Region of Enrollment||participants|Number|17|17.0||||||
3990487|NCT01243411|3812255|B1|Italy||Region of Enrollment||participants|Number|24|24.0||||||
3990488|NCT01243411|3812255|B1|Germany||Region of Enrollment||participants|Number|41|41.0||||||
3990489|NCT01243411|3812255|B1|Denmark||Region of Enrollment||participants|Number|42|42.0||||||
3990490|NCT01243411|3812255|B1|Spain||Region of Enrollment||participants|Number|21|21.0||||||
3990491|NCT01243411|3812255|B1|United States||Region of Enrollment||participants|Number|102|102.0||||||
3990492|NCT01243411|3812255|B1|France||Region of Enrollment||participants|Number|13|13.0||||||
3990493|NCT01243411|3812255|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3990494|NCT01243411|3812255|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990495|NCT01243411|3812255|B1||White|Race (NIH/OMB)||Participants|Count of Participants|333|333.0||||||
3990496|NCT01243411|3812255|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3990497|NCT01243411|3812255|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990498|NCT01243411|3812255|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3990499|NCT01243411|3812255|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990500|NCT01243411|3812255|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990501|NCT01243411|3812255|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|325|325.0||||||
3990502|NCT01243411|3812255|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3990503|NCT01243411|3812255|B1||Male|Sex: Female, Male||Participants|Count of Participants|347|347.0||||||
3990504|NCT01243411|3812255|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3990505|NCT01243411|3812255|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|9.0|9.0|||
3990506|NCT01243411|3812255|B1||>=65 years|Age||Participants|Count of Participants|58|58.0||||||
3990507|NCT01243411|3812255|B1||Between 18 and 65 years|Age||Participants|Count of Participants|289|289.0||||||
3990508|NCT01243411|3812255|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3990509|NCT01243320|3812267|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3990510|NCT01243320|3812267|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3990511|NCT01243320|3812267|B1|||Age||years|Mean|47|47.0|Standard Deviation|14|14.0|||
3990512|NCT01243294|3812343|B1|France||Region of Enrollment||participants|Number|15|15.0||||||
3990513|NCT01243294|3812343|B1|Denmark||Region of Enrollment||participants|Number|39|39.0||||||
3990514|NCT01243294|3812343|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3990515|NCT01243294|3812343|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3990516|NCT01243294|3812343|B1|||Age||years|Mean|70.5|70.5|Standard Deviation|10.9|10.9|||
3990517|NCT01243268|3812360|B1||Male|Sex: Female, Male||Participants|Count of Participants|339|339.0||||||
3990518|NCT01243268|3812360|B1||Female|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
3990519|NCT01243268|3812360|B1|||Age||years|Mean|61.96|61.96|Standard Deviation|12.43|12.43|||
3990520|NCT01243242|3812368|B3|Israel||Region of Enrollment||participants|Number|120|120.0||||||
3990521|NCT01243242|3812369|B2|Israel||Region of Enrollment||participants|Number|60|60.0||||||
3990522|NCT01243242|3812370|B1|Israel||Region of Enrollment||participants|Number|60|60.0||||||
3990523|NCT01243242|3812368|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3990524|NCT01243242|3812369|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3990525|NCT01243242|3812370|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3990526|NCT01243242|3812368|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3990527|NCT01243242|3812369|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3990528|NCT01243242|3812370|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3990529|NCT01243242|3812368|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3990530|NCT01243242|3812369|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3990531|NCT01243242|3812370|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3990532|NCT01243242|3812368|B3||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
3990533|NCT01243242|3812369|B2||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3990534|NCT01243242|3812370|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3990535|NCT01243242|3812368|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3990536|NCT01243242|3812369|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3990537|NCT01243242|3812370|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3990538|NCT01243177|3812383|B3||Male|Sex: Female, Male||Participants|Count of Participants|475|475.0||||||
3990539|NCT01243177|3812384|B2||Male|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
3990540|NCT01243177|3812385|B1||Male|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
3990541|NCT01243177|3812383|B3||Female|Sex: Female, Male||Participants|Count of Participants|411|411.0||||||
3990542|NCT01243177|3812384|B2||Female|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
3990543|NCT01243177|3812385|B1||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3990544|NCT01243177|3812383|B3|||Age||years|Mean|41.8|41.8|Standard Deviation|17.6|17.6|||
3990545|NCT01243177|3812384|B2|||Age||years|Mean|41.8|41.8|Standard Deviation|17.2|17.2|||
3990546|NCT01243177|3812385|B1|||Age||years|Mean|41.9|41.9|Standard Deviation|17.9|17.9|||
3990547|NCT01243177|3812383|B3||>=65 years|Age||Participants|Count of Participants|119|119.0||||||
3990548|NCT01243177|3812384|B2||>=65 years|Age||Participants|Count of Participants|57|57.0||||||
3990549|NCT01243177|3812385|B1||>=65 years|Age||Participants|Count of Participants|62|62.0||||||
3990550|NCT01243177|3812383|B3||Between 18 and 65 years|Age||Participants|Count of Participants|721|721.0||||||
3990551|NCT01243177|3812384|B2||Between 18 and 65 years|Age||Participants|Count of Participants|366|366.0||||||
3990552|NCT01243177|3812385|B1||Between 18 and 65 years|Age||Participants|Count of Participants|355|355.0||||||
3990553|NCT01243177|3812383|B3||<=18 years|Age||Participants|Count of Participants|46|46.0||||||
3990554|NCT01243177|3812384|B2||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
3990555|NCT01243177|3812385|B1||<=18 years|Age||Participants|Count of Participants|27|27.0||||||
3990556|NCT01243112|3812402|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
3990557|NCT01243112|3812402|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3990558|NCT01243112|3812402|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3990559|NCT01243112|3812402|B1|||Age||years|Mean|36|36.0|Standard Deviation|9.7|9.7|||
3990560|NCT01243112|3812402|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3990561|NCT01243112|3812402|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3990562|NCT01243112|3812402|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3990563|NCT01242813|3812407|B1|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
3990564|NCT01242813|3812407|B1|Italy||Region of Enrollment||participants|Number|10|10.0||||||
3990565|NCT01242813|3812407|B1|Ireland||Region of Enrollment||participants|Number|2|2.0||||||
3990566|NCT01242813|3812407|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3990567|NCT01242813|3812407|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3990568|NCT01242813|3812407|B1|||Age||Years|Mean|34.62|34.62|Standard Deviation|18.362|18.362|||
3990569|NCT01242748|3812427|B3|||Median Baseline Serum Prostate-specific Antigen Levels||ng/mL|Median|18.7|18.7|Full Range|||0.4|12961.0|
3990570|NCT01242748|3812428|B2|||Median Baseline Serum Prostate-specific Antigen Levels||ng/mL|Median|16.6|16.6|Full Range|||1.49|12961.0|
3990571|NCT01242748|3812429|B1|||Median Baseline Serum Prostate-specific Antigen Levels||ng/mL|Median|20.6|20.6|Full Range|||0.4|8762.0|
3990572|NCT01242748|3812427|B3|||Median Baseline Serum Testosterone Levels||nanogram per milliliter (ng/mL)|Median|4.52|4.52|Full Range|||0.68|13.3|
3990573|NCT01242748|3812428|B2|||Median Baseline Serum Testosterone Levels||nanogram per milliliter (ng/mL)|Median|4.65|4.65|Full Range|||1.55|13.2|
3990574|NCT01242748|3812429|B1|||Median Baseline Serum Testosterone Levels||nanogram per milliliter (ng/mL)|Median|4.41|4.41|Full Range|||0.68|13.3|
3990575|NCT01242748|3812427|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990576|NCT01242748|3812428|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990577|NCT01242748|3812429|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990578|NCT01242748|3812427|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990579|NCT01242748|3812428|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990580|NCT01242748|3812429|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990581|NCT01242748|3812427|B3||White|Race (NIH/OMB)||Participants|Count of Participants|222|222.0||||||
3990582|NCT01242748|3812428|B2||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3990583|NCT01242748|3812429|B1||White|Race (NIH/OMB)||Participants|Count of Participants|154|154.0||||||
3990584|NCT01242748|3812427|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3990585|NCT01242748|3812428|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3990586|NCT01242748|3812429|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3990587|NCT01242748|3812427|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990588|NCT01242748|3812428|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990589|NCT01242748|3812429|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990590|NCT01242748|3812427|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3990591|NCT01242748|3812428|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990592|NCT01242748|3812429|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3990593|NCT01242748|3812427|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3990594|NCT01242748|3812428|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3990595|NCT01242748|3812429|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
3990596|NCT01242748|3812427|B3||Male|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
3990597|NCT01242748|3812428|B2||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
3990598|NCT01242748|3812429|B1||Male|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
3990599|NCT01242748|3812427|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3990600|NCT01242748|3812428|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3990601|NCT01242748|3812429|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3990602|NCT01242748|3812427|B3|||Age||years|Mean|72.5|72.5|Standard Deviation|8.0|8.0|||
3990603|NCT01242748|3812428|B2|||Age||years|Mean|71.3|71.3|Standard Deviation|7.0|7.0|||
3990604|NCT01242748|3812429|B1|||Age||years|Mean|73.1|73.1|Standard Deviation|8.4|8.4|||
3990605|NCT01242527|3812450|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990606|NCT01242527|3812451|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990607|NCT01242527|3812452|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990608|NCT01242527|3812453|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990609|NCT01242527|3812454|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990610|NCT01242527|3812450|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|374|374.0||||||
3990611|NCT01242527|3812451|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
3990612|NCT01242527|3812452|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
3990613|NCT01242527|3812453|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
3990614|NCT01242527|3812454|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
3990615|NCT01242527|3812450|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3990616|NCT01242527|3812451|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3990617|NCT01242527|3812452|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3990618|NCT01242527|3812453|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3990619|NCT01242527|3812454|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3990620|NCT01242527|3812450|B5||Male|Sex: Female, Male||Participants|Count of Participants|307|307.0||||||
3990621|NCT01242527|3812451|B4||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3990622|NCT01242527|3812452|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3990623|NCT01242527|3812453|B2||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3990624|NCT01242527|3812454|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3990625|NCT01242527|3812450|B5||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3990626|NCT01242527|3812451|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3990627|NCT01242527|3812452|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3990628|NCT01242527|3812453|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3990629|NCT01242527|3812454|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3990630|NCT01242527|3812450|B5|||Age||Years|Mean|51.5|51.5|Standard Deviation|10.04|10.04|||
3990631|NCT01242527|3812451|B4|||Age||Years|Mean|52.9|52.9|Standard Deviation|10.92|10.92|||
3990632|NCT01242527|3812452|B3|||Age||Years|Mean|51.2|51.2|Standard Deviation|8.75|8.75|||
3990633|NCT01242527|3812453|B2|||Age||Years|Mean|51.1|51.1|Standard Deviation|9.79|9.79|||
3990634|NCT01242527|3812454|B1|||Age||Years|Mean|50.8|50.8|Standard Deviation|10.59|10.59|||
3990635|NCT01242514|3812467|B4|Other||Race/Ethnicity, Customized||Participants|Number|134|134.0||||||
3990636|NCT01242514|3812468|B3|Other||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
3990637|NCT01242514|3812469|B2|Other||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
3990638|NCT01242514|3812470|B1|Other||Race/Ethnicity, Customized||Participants|Number|74|74.0||||||
3990639|NCT01242514|3812467|B4|Indian or Pakistani||Race/Ethnicity, Customized||Participants|Number|91|91.0||||||
3990640|NCT01242514|3812468|B3|Indian or Pakistani||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
3990641|NCT01242514|3812469|B2|Indian or Pakistani||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
3990642|NCT01242514|3812470|B1|Indian or Pakistani||Race/Ethnicity, Customized||Participants|Number|54|54.0||||||
3990643|NCT01242514|3812467|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
3990644|NCT01242514|3812468|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3990645|NCT01242514|3812469|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3990646|NCT01242514|3812470|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
3990647|NCT01242514|3812467|B4|Asian||Race/Ethnicity, Customized||Participants|Number|59|59.0||||||
3990648|NCT01242514|3812468|B3|Asian||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3990649|NCT01242514|3812469|B2|Asian||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3990650|NCT01242514|3812470|B1|Asian||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
3990651|NCT01242514|3812467|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|80|80.0||||||
3990652|NCT01242514|3812468|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3990653|NCT01242514|3812469|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3990654|NCT01242514|3812470|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|63|63.0||||||
3990655|NCT01242514|3812467|B4|White||Race/Ethnicity, Customized||Participants|Number|1511|1511.0||||||
3990656|NCT01242514|3812468|B3|White||Race/Ethnicity, Customized||Participants|Number|141|141.0||||||
3990657|NCT01242514|3812469|B2|White||Race/Ethnicity, Customized||Participants|Number|278|278.0||||||
3990658|NCT01242514|3812470|B1|White||Race/Ethnicity, Customized||Participants|Number|1092|1092.0||||||
3990659|NCT01242514|3812467|B4||Male|Sex: Female, Male||Participants|Count of Participants|336|336.0||||||
3990660|NCT01242514|3812468|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3990661|NCT01242514|3812469|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3990662|NCT01242514|3812470|B1||Male|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
3990663|NCT01242514|3812467|B4||Female|Sex: Female, Male||Participants|Count of Participants|1576|1576.0||||||
3990664|NCT01242514|3812468|B3||Female|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
3990665|NCT01242514|3812469|B2||Female|Sex: Female, Male||Participants|Count of Participants|297|297.0||||||
3990666|NCT01242514|3812470|B1||Female|Sex: Female, Male||Participants|Count of Participants|1086|1086.0||||||
3990667|NCT01242514|3812467|B4|||Age||years|Mean|53|53.0|Standard Deviation|11.8|11.8|||
3990668|NCT01242514|3812468|B3|||Age||years|Mean|53|53.0|Standard Deviation|11.3|11.3|||
3990669|NCT01242514|3812469|B2|||Age||years|Mean|53|53.0|Standard Deviation|11.6|11.6|||
3990670|NCT01242514|3812470|B1|||Age||years|Mean|53|53.0|Standard Deviation|12.0|12.0|||
3990671|NCT01242371|3812489|B3|United States||Region of Enrollment||participants|Number|65|65.0||||||
3990672|NCT01242371|3812490|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
3990673|NCT01242371|3812491|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
3990674|NCT01242371|3812489|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3990675|NCT01242371|3812490|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3990676|NCT01242371|3812491|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3990677|NCT01242371|3812489|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3990678|NCT01242371|3812490|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3990679|NCT01242371|3812491|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3990680|NCT01242371|3812489|B3|||Age||years|Mean|46.2|46.2|Standard Deviation|10.4|10.4|||
3990681|NCT01242371|3812490|B2|||Age||years|Mean|48.1|48.1|Standard Deviation|9.4|9.4|||
3990682|NCT01242371|3812491|B1|||Age||years|Mean|44.4|44.4|Standard Deviation|11.0|11.0|||
3990683|NCT01242371|3812489|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3990684|NCT01242371|3812490|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3990685|NCT01242371|3812491|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3990686|NCT01242371|3812489|B3||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
3990687|NCT01242371|3812490|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3990688|NCT01242371|3812491|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3990689|NCT01242371|3812489|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3990690|NCT01242371|3812490|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3990691|NCT01242371|3812491|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3990692|NCT01242176|3812498|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3990693|NCT01242176|3812498|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3990694|NCT01242176|3812498|B1|||Age||years|Mean|36.3|36.3|Standard Deviation|9.8|9.8|||
3990695|NCT01242111|3812509|B1|United Kingdom||Region of Enrollment||participants|Number|20|20.0||||||
3990696|NCT01242111|3812509|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3990697|NCT01242111|3812509|B1|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3990698|NCT01242111|3812509|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3990699|NCT01242111|3812509|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3990700|NCT01242111|3812509|B1|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3990701|NCT01242111|3812509|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3990702|NCT01242111|3812509|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990703|NCT01242111|3812509|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3990704|NCT01242111|3812509|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990705|NCT01242111|3812509|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3990706|NCT01242111|3812509|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3990707|NCT01242111|3812509|B1|>=10 to <=18 years||Age, Customized||participants|Number|5|5.0||||||
3990708|NCT01242111|3812509|B1|>=8 to <10 years||Age, Customized||participants|Number|5|5.0||||||
3990709|NCT01242111|3812509|B1|>=4 to < 8 years||Age, Customized||participants|Number|10|10.0||||||
3990710|NCT01242111|3812509|B1|||Age||years|Mean|8.4|8.4|Standard Deviation|2.90|2.9|||
3990711|NCT01242085|3812518|B4|||knee replacement participant||participants|Number|64|64.0||||||
3990712|NCT01242085|3812519|B3|||knee replacement participant||participants|Number|1|1.0||||||
3990713|NCT01242085|3812520|B2|||knee replacement participant||participants|Number|30|30.0||||||
3990714|NCT01242085|3812521|B1|||knee replacement participant||participants|Number|33|33.0||||||
3990715|NCT01242085|3812518|B4|United States||Region of Enrollment||participants|Number|64|64.0||||||
3990716|NCT01242085|3812519|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3990717|NCT01242085|3812520|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3990718|NCT01242085|3812521|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
3990719|NCT01242085|3812518|B4||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3990720|NCT01242085|3812519|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3990721|NCT01242085|3812520|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3990722|NCT01242085|3812521|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3990723|NCT01242085|3812518|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3990724|NCT01242085|3812519|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3990725|NCT01242085|3812520|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3990726|NCT01242085|3812521|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3990727|NCT01242085|3812518|B4|||Age||years|Mean|66.1|66.1|Standard Deviation|7.9|7.9|||
3990728|NCT01242085|3812519|B3|||Age||years|Mean|81|81.0|Standard Deviation|0|0.0|||
3990729|NCT01242085|3812520|B2|||Age||years|Mean|67.3|67.3|Standard Deviation|7.7|7.7|||
3990730|NCT01242085|3812521|B1|||Age||years|Mean|65.1|65.1|Standard Deviation|8.3|8.3|||
3990731|NCT01242085|3812518|B4||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3990732|NCT01242085|3812519|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3990733|NCT01242085|3812520|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3990734|NCT01242085|3812521|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3990735|NCT01242085|3812518|B4||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
3990736|NCT01242085|3812519|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3990737|NCT01242085|3812520|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3990738|NCT01242085|3812521|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3990739|NCT01242085|3812518|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3990740|NCT01242085|3812519|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3990741|NCT01242085|3812520|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3990742|NCT01242085|3812521|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3990743|NCT01242020|3812531|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990744|NCT01242020|3812532|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990745|NCT01242020|3812533|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990746|NCT01242020|3812531|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990747|NCT01242020|3812532|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990748|NCT01242020|3812533|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990749|NCT01242020|3812531|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3990750|NCT01242020|3812532|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990751|NCT01242020|3812533|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3990752|NCT01242020|3812531|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3990753|NCT01242020|3812532|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990754|NCT01242020|3812533|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3990755|NCT01242020|3812531|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990756|NCT01242020|3812532|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990757|NCT01242020|3812533|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990758|NCT01242020|3812531|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990759|NCT01242020|3812532|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990760|NCT01242020|3812533|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990761|NCT01242020|3812531|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990762|NCT01242020|3812532|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990763|NCT01242020|3812533|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990764|NCT01242020|3812531|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3990765|NCT01242020|3812532|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3990766|NCT01242020|3812533|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3990767|NCT01242020|3812531|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3990768|NCT01242020|3812532|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3990769|NCT01242020|3812533|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3990770|NCT01242020|3812531|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3990771|NCT01242020|3812532|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3990772|NCT01242020|3812533|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3990773|NCT01242020|3812531|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3990774|NCT01242020|3812532|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3990775|NCT01242020|3812533|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3990776|NCT01242020|3812531|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3990777|NCT01242020|3812532|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3990778|NCT01242020|3812533|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3990779|NCT01241916|3812542|B3|United States||Region of Enrollment||participants|Number|66|66.0||||||
3990780|NCT01241916|3812543|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
3990781|NCT01241916|3812544|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
3990782|NCT01241916|3812542|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3990783|NCT01241916|3812543|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3990784|NCT01241916|3812544|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3990785|NCT01241916|3812542|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3990786|NCT01241916|3812543|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3990787|NCT01241916|3812544|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3990788|NCT01241916|3812542|B3|||Age||years|Mean|44|44.0|Standard Deviation|12|12.0|||
3990789|NCT01241916|3812543|B2|||Age||years|Mean|45|45.0|Standard Deviation|12|12.0|||
3990790|NCT01241916|3812544|B1|||Age||years|Mean|43|43.0|Standard Deviation|13|13.0|||
3990791|NCT01241916|3812542|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3990792|NCT01241916|3812543|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3990793|NCT01241916|3812544|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3990794|NCT01241916|3812542|B3||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
3990795|NCT01241916|3812543|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3990796|NCT01241916|3812544|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3990797|NCT01241916|3812542|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3990798|NCT01241916|3812543|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3990799|NCT01241916|3812544|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3990800|NCT01241903|3812553|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990801|NCT01241903|3812554|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990802|NCT01241903|3812555|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990803|NCT01241903|3812553|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990804|NCT01241903|3812554|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990805|NCT01241903|3812555|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990806|NCT01241903|3812553|B3||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
3990807|NCT01241903|3812554|B2||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3990808|NCT01241903|3812555|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3990809|NCT01241903|3812553|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3990810|NCT01241903|3812554|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3990811|NCT01241903|3812555|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3990812|NCT01241903|3812553|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990813|NCT01241903|3812554|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990814|NCT01241903|3812555|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990815|NCT01241903|3812553|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990816|NCT01241903|3812554|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990817|NCT01241903|3812555|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990818|NCT01241903|3812553|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990819|NCT01241903|3812554|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990820|NCT01241903|3812555|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990821|NCT01241903|3812553|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3990822|NCT01241903|3812554|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3990823|NCT01241903|3812555|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3990824|NCT01241903|3812553|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3990825|NCT01241903|3812554|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3990826|NCT01241903|3812555|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3990827|NCT01241903|3812553|B3|||Age||years|Mean|56.0|56.0|Standard Deviation|10.7|10.7|||
3990828|NCT01241903|3812554|B2|||Age||years|Mean|57.2|57.2|Standard Deviation|10.4|10.4|||
3990829|NCT01241903|3812555|B1|||Age||years|Mean|54.5|54.5|Standard Deviation|10.7|10.7|||
3990830|NCT01241760|3812562|B3|Brazil||Region of Enrollment||participants|Number|41|41.0||||||
3990831|NCT01241760|3812563|B2|Brazil||Region of Enrollment||participants|Number|21|21.0||||||
3990832|NCT01241760|3812564|B1|Brazil||Region of Enrollment||participants|Number|20|20.0||||||
3990833|NCT01241760|3812562|B3|Mexico||Region of Enrollment||participants|Number|9|9.0||||||
3990834|NCT01241760|3812563|B2|Mexico||Region of Enrollment||participants|Number|4|4.0||||||
3990835|NCT01241760|3812564|B1|Mexico||Region of Enrollment||participants|Number|5|5.0||||||
3990836|NCT01241760|3812562|B3|Australia||Region of Enrollment||participants|Number|56|56.0||||||
3990837|NCT01241760|3812563|B2|Australia||Region of Enrollment||participants|Number|28|28.0||||||
3990838|NCT01241760|3812564|B1|Australia||Region of Enrollment||participants|Number|28|28.0||||||
3990839|NCT01241760|3812562|B3|North-America||Region of Enrollment||participants|Number|263|263.0||||||
3990840|NCT01241760|3812563|B2|North-America||Region of Enrollment||participants|Number|137|137.0||||||
3990841|NCT01241760|3812564|B1|North-America||Region of Enrollment||participants|Number|126|126.0||||||
3990842|NCT01241760|3812562|B3|Europe||Region of Enrollment||participants|Number|371|371.0||||||
3990843|NCT01241760|3812563|B2|Europe||Region of Enrollment||participants|Number|179|179.0||||||
3990844|NCT01241760|3812564|B1|Europe||Region of Enrollment||participants|Number|192|192.0||||||
3990845|NCT01241760|3812562|B3||Male|Sex: Female, Male||Participants|Count of Participants|444|444.0||||||
3990846|NCT01241760|3812563|B2||Male|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
3990847|NCT01241760|3812564|B1||Male|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
3990848|NCT01241760|3812562|B3||Female|Sex: Female, Male||Participants|Count of Participants|296|296.0||||||
3990849|NCT01241760|3812563|B2||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
3990850|NCT01241760|3812564|B1||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3990851|NCT01241760|3812562|B3|||Age||years|Mean|47.7|47.7|Full Range|||18.0|70.0|
3990852|NCT01241760|3812563|B2|||Age||years|Mean|47.5|47.5|Full Range|||19.0|70.0|
3990853|NCT01241760|3812564|B1|||Age||years|Mean|48|48.0|Full Range|||18.0|70.0|
3990854|NCT01241760|3812562|B3||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
3990855|NCT01241760|3812563|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3990856|NCT01241760|3812564|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3990857|NCT01241760|3812562|B3||Between 18 and 65 years|Age||Participants|Count of Participants|713|713.0||||||
3990858|NCT01241760|3812563|B2||Between 18 and 65 years|Age||Participants|Count of Participants|362|362.0||||||
3990859|NCT01241760|3812564|B1||Between 18 and 65 years|Age||Participants|Count of Participants|351|351.0||||||
3990860|NCT01241760|3812562|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3990861|NCT01241760|3812563|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3990862|NCT01241760|3812564|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3990863|NCT01241591|3812584|B5||Male|Sex: Female, Male||Participants|Count of Participants|778|778.0||||||
3990864|NCT01241591|3812585|B4||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3990865|NCT01241591|3812586|B3||Male|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
3990866|NCT01241591|3812587|B2||Male|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
3990867|NCT01241591|3812588|B1||Male|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
3990868|NCT01241591|3812584|B5||Female|Sex: Female, Male||Participants|Count of Participants|323|323.0||||||
3990869|NCT01241591|3812585|B4||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3990870|NCT01241591|3812586|B3||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3990871|NCT01241591|3812587|B2||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3990872|NCT01241591|3812588|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
3990873|NCT01241591|3812584|B5|||Age||years|Mean|44.0|44.0|Standard Deviation|12.4|12.4|||
3990874|NCT01241591|3812585|B4|||Age||years|Mean|46.1|46.1|Standard Deviation|13.4|13.4|||
3990875|NCT01241591|3812586|B3|||Age||years|Mean|43.3|43.3|Standard Deviation|12.2|12.2|||
3990876|NCT01241591|3812587|B2|||Age||years|Mean|43.6|43.6|Standard Deviation|12.6|12.6|||
3990877|NCT01241591|3812588|B1|||Age||years|Mean|44.4|44.4|Standard Deviation|12.1|12.1|||
3990878|NCT01241565|3812781|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
3990879|NCT01241565|3812781|B1|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
3990880|NCT01241565|3812781|B1|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
3990881|NCT01241565|3812781|B1|White||Race (NIH/OMB)||participants|Number|40|40.0||||||
3990882|NCT01241565|3812781|B1|Black or African American||Race (NIH/OMB)||participants|Number|5|5.0||||||
3990883|NCT01241565|3812781|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
3990884|NCT01241565|3812781|B1|Asian||Race (NIH/OMB)||participants|Number|2|2.0||||||
3990885|NCT01241565|3812781|B1|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
3990886|NCT01241565|3812781|B1|Male||Gender||participants|Number|17|17.0||||||
3990887|NCT01241565|3812781|B1|Female||Gender||participants|Number|30|30.0||||||
3990888|NCT01241565|3812781|B1|||Age||years|Mean|68.9|68.9|Standard Deviation|10.4|10.4|||
3990889|NCT01241552|3812790|B5||Male|Sex: Female, Male||Participants|Count of Participants|623|623.0||||||
3990890|NCT01241552|3812791|B4||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
3990891|NCT01241552|3812792|B3||Male|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
3990892|NCT01241552|3812793|B2||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3990893|NCT01241552|3812794|B1||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3990894|NCT01241552|3812790|B5||Female|Sex: Female, Male||Participants|Count of Participants|829|829.0||||||
3990895|NCT01241552|3812791|B4||Female|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
3990896|NCT01241552|3812792|B3||Female|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
3990897|NCT01241552|3812793|B2||Female|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
3990898|NCT01241552|3812794|B1||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
3990899|NCT01241552|3812790|B5|||Age||Years|Mean|62.5|62.5|Standard Deviation|18.0|18.0|||
3990900|NCT01241552|3812791|B4|||Age||Years|Mean|62.9|62.9|Standard Deviation|18.3|18.3|||
3990901|NCT01241552|3812792|B3|||Age||Years|Mean|62.5|62.5|Standard Deviation|17.8|17.8|||
3990902|NCT01241552|3812793|B2|||Age||Years|Mean|61.1|61.1|Standard Deviation|18.5|18.5|||
3990903|NCT01241552|3812794|B1|||Age||Years|Mean|64.2|64.2|Standard Deviation|16.8|16.8|||
3990904|NCT01241539|3812863|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3990905|NCT01241539|3812863|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3990906|NCT01241539|3812863|B1|||Age||Years|Mean|38.3|38.3|Standard Deviation|10.9|10.9|||
3990907|NCT01241513|3812882|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
3990908|NCT01241513|3812883|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3990909|NCT01241513|3812884|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3990910|NCT01241513|3812882|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3990911|NCT01241513|3812883|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3990912|NCT01241513|3812884|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3990913|NCT01241513|3812882|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3990914|NCT01241513|3812883|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3990915|NCT01241513|3812884|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3990916|NCT01241513|3812882|B3|||Age||years|Mean|22|22.0|Standard Deviation|3|3.0|||
3990917|NCT01241513|3812883|B2|||Age||years|Mean|22|22.0|Standard Deviation|3|3.0|||
3990918|NCT01241513|3812884|B1|||Age||years|Mean|22|22.0|Standard Deviation|3|3.0|||
3990919|NCT01241513|3812882|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3990920|NCT01241513|3812883|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3990921|NCT01241513|3812884|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3990922|NCT01241513|3812882|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3990923|NCT01241513|3812883|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3990924|NCT01241513|3812884|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3990925|NCT01241513|3812882|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3990926|NCT01241513|3812883|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3990927|NCT01241513|3812884|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3990928|NCT01241461|3812890|B3|1 - Ambulatory, restricted strenuous activity||Eastern Cooperative Oncology Group (ECOG) Performance Status Prior to Cycle 1|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|Participants|Count of Participants|1|1.0||||||
3990929|NCT01241461|3812891|B2|1 - Ambulatory, restricted strenuous activity||Eastern Cooperative Oncology Group (ECOG) Performance Status Prior to Cycle 1|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|Participants|Count of Participants|0|0.0||||||
3990930|NCT01241461|3812892|B1|1 - Ambulatory, restricted strenuous activity||Eastern Cooperative Oncology Group (ECOG) Performance Status Prior to Cycle 1|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|Participants|Count of Participants|1|1.0||||||
3990931|NCT01241461|3812890|B3|0 - Fully active||Eastern Cooperative Oncology Group (ECOG) Performance Status Prior to Cycle 1|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|Participants|Count of Participants|8|8.0||||||
3990932|NCT01241461|3812891|B2|0 - Fully active||Eastern Cooperative Oncology Group (ECOG) Performance Status Prior to Cycle 1|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|Participants|Count of Participants|6|6.0||||||
3990933|NCT01241461|3812892|B1|0 - Fully active||Eastern Cooperative Oncology Group (ECOG) Performance Status Prior to Cycle 1|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|Participants|Count of Participants|2|2.0||||||
3990934|NCT01241461|3812890|B3|Gastrointestinal Stromal Tumors||Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
3990935|NCT01241461|3812891|B2|Gastrointestinal Stromal Tumors||Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
3990936|NCT01241461|3812892|B1|Gastrointestinal Stromal Tumors||Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
3990937|NCT01241461|3812890|B3|Carcinoma, Esophagus||Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
3990938|NCT01241461|3812891|B2|Carcinoma, Esophagus||Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
3990939|NCT01241461|3812892|B1|Carcinoma, Esophagus||Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
3990940|NCT01241461|3812890|B3|Carcinoid Tumor, not otherwise specified (NOS)||Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
3990941|NCT01241461|3812891|B2|Carcinoid Tumor, not otherwise specified (NOS)||Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
3990942|NCT01241461|3812892|B1|Carcinoid Tumor, not otherwise specified (NOS)||Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
3990943|NCT01241461|3812890|B3|Adenocarcinoma, Gastric||Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
3990944|NCT01241461|3812891|B2|Adenocarcinoma, Gastric||Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
3990945|NCT01241461|3812892|B1|Adenocarcinoma, Gastric||Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
3990946|NCT01241461|3812890|B3|Adenocarcinoma, Esophageal||Pathological Diagnosis||Participants|Count of Participants|2|2.0||||||
3990947|NCT01241461|3812891|B2|Adenocarcinoma, Esophageal||Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
3990948|NCT01241461|3812892|B1|Adenocarcinoma, Esophageal||Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
3990949|NCT01241461|3812890|B3|Adenocarcinoma, Colon||Pathological Diagnosis||Participants|Count of Participants|3|3.0||||||
3990950|NCT01241461|3812891|B2|Adenocarcinoma, Colon||Pathological Diagnosis||Participants|Count of Participants|2|2.0||||||
3990951|NCT01241461|3812892|B1|Adenocarcinoma, Colon||Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
3990952|NCT01241461|3812890|B3|Japan||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3990953|NCT01241461|3812891|B2|Japan||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3990954|NCT01241461|3812892|B1|Japan||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3990955|NCT01241461|3812890|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990956|NCT01241461|3812891|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990957|NCT01241461|3812892|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990958|NCT01241461|3812890|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990959|NCT01241461|3812891|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990960|NCT01241461|3812892|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990961|NCT01241461|3812890|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990962|NCT01241461|3812891|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990963|NCT01241461|3812892|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990964|NCT01241461|3812890|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990965|NCT01241461|3812891|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990966|NCT01241461|3812892|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990967|NCT01241461|3812890|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990968|NCT01241461|3812891|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990969|NCT01241461|3812892|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990970|NCT01241461|3812890|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3990971|NCT01241461|3812891|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3990972|NCT01241461|3812892|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3990973|NCT01241461|3812890|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990974|NCT01241461|3812891|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990975|NCT01241461|3812892|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3990976|NCT01241461|3812890|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3990977|NCT01241461|3812891|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3990978|NCT01241461|3812892|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3990979|NCT01241461|3812890|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3990980|NCT01241461|3812891|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3990981|NCT01241461|3812892|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3990982|NCT01241461|3812890|B3|||Age||years|Mean|64.86|64.86|Standard Deviation|5.00|5.0|||
3990983|NCT01241461|3812891|B2|||Age||years|Mean|64.07|64.07|Standard Deviation|4.15|4.15|||
3990984|NCT01241461|3812892|B1|||Age||years|Mean|66.44|66.44|Standard Deviation|7.17|7.17|||
3990985|NCT01241448|3812909|B5|||Hemoglobin A1c (HbA1c)||percentage of Hemoglobin A1c (HbA1c)|Mean|8.0|8.0|Standard Deviation|0.92|0.92|||
3990986|NCT01241448|3812910|B4|||Hemoglobin A1c (HbA1c)||percentage of Hemoglobin A1c (HbA1c)|Mean|8.0|8.0|Standard Deviation|0.92|0.92|||
3990987|NCT01241448|3812911|B3|||Hemoglobin A1c (HbA1c)||percentage of Hemoglobin A1c (HbA1c)|Mean|8.1|8.1|Standard Deviation|0.87|0.87|||
3990988|NCT01241448|3812912|B2|||Hemoglobin A1c (HbA1c)||percentage of Hemoglobin A1c (HbA1c)|Mean|8.1|8.1|Standard Deviation|0.93|0.93|||
3990989|NCT01241448|3812913|B1|||Hemoglobin A1c (HbA1c)||percentage of Hemoglobin A1c (HbA1c)|Mean|8.1|8.1|Standard Deviation|1.00|1.0|||
3990990|NCT01241448|3812909|B5|||Waist Circumference||centimeters (cm)|Mean|107.1|107.1|Standard Deviation|11.97|11.97|||
3990991|NCT01241448|3812910|B4|||Waist Circumference||centimeters (cm)|Mean|106.8|106.8|Standard Deviation|12.28|12.28|||
3990992|NCT01241448|3812911|B3|||Waist Circumference||centimeters (cm)|Mean|107.2|107.2|Standard Deviation|12.24|12.24|||
3990993|NCT01241448|3812912|B2|||Waist Circumference||centimeters (cm)|Mean|107.5|107.5|Standard Deviation|11.16|11.16|||
3990994|NCT01241448|3812913|B1|||Waist Circumference||centimeters (cm)|Mean|106.7|106.7|Standard Deviation|12.41|12.41|||
3990995|NCT01241448|3812909|B5|||Body Mass Index (BMI)||kilograms per meter squared (kg/m^2)|Mean|32.2|32.2|Standard Deviation|4.90|4.9|||
3990996|NCT01241448|3812910|B4|||Body Mass Index (BMI)||kilograms per meter squared (kg/m^2)|Mean|32.6|32.6|Standard Deviation|5.27|5.27|||
3990997|NCT01241448|3812911|B3|||Body Mass Index (BMI)||kilograms per meter squared (kg/m^2)|Mean|32.3|32.3|Standard Deviation|4.91|4.91|||
3990998|NCT01241448|3812912|B2|||Body Mass Index (BMI)||kilograms per meter squared (kg/m^2)|Mean|31.9|31.9|Standard Deviation|4.86|4.86|||
3990999|NCT01241448|3812913|B1|||Body Mass Index (BMI)||kilograms per meter squared (kg/m^2)|Mean|32.1|32.1|Standard Deviation|4.63|4.63|||
3991000|NCT01241448|3812909|B5|||Diabetes Duration||years|Mean|6.0|6.0|Standard Deviation|5.81|5.81|||
3991001|NCT01241448|3812910|B4|||Diabetes Duration||years|Mean|5.8|5.8|Standard Deviation|6.13|6.13|||
3991002|NCT01241448|3812911|B3|||Diabetes Duration||years|Mean|5.5|5.5|Standard Deviation|4.21|4.21|||
3991003|NCT01241448|3812912|B2|||Diabetes Duration||years|Mean|6.9|6.9|Standard Deviation|7.23|7.23|||
3991004|NCT01241448|3812913|B1|||Diabetes Duration||years|Mean|5.8|5.8|Standard Deviation|5.29|5.29|||
3991005|NCT01241448|3812909|B5|Not Reported||Ethnicity||Participants|Count of Participants|59|59.0||||||
3991006|NCT01241448|3812910|B4|Not Reported||Ethnicity||Participants|Count of Participants|14|14.0||||||
3991007|NCT01241448|3812911|B3|Not Reported||Ethnicity||Participants|Count of Participants|16|16.0||||||
3991008|NCT01241448|3812912|B2|Not Reported||Ethnicity||Participants|Count of Participants|18|18.0||||||
3991009|NCT01241448|3812913|B1|Not Reported||Ethnicity||Participants|Count of Participants|11|11.0||||||
3991010|NCT01241448|3812909|B5|Not Hispanic or Latino||Ethnicity||Participants|Count of Participants|139|139.0||||||
3991011|NCT01241448|3812910|B4|Not Hispanic or Latino||Ethnicity||Participants|Count of Participants|37|37.0||||||
3991072|NCT01241448|3812911|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3991012|NCT01241448|3812911|B3|Not Hispanic or Latino||Ethnicity||Participants|Count of Participants|35|35.0||||||
3991013|NCT01241448|3812912|B2|Not Hispanic or Latino||Ethnicity||Participants|Count of Participants|31|31.0||||||
3991014|NCT01241448|3812913|B1|Not Hispanic or Latino||Ethnicity||Participants|Count of Participants|36|36.0||||||
3991015|NCT01241448|3812909|B5|Hispanic or Latino||Ethnicity||Participants|Count of Participants|56|56.0||||||
3991016|NCT01241448|3812910|B4|Hispanic or Latino||Ethnicity||Participants|Count of Participants|13|13.0||||||
3991017|NCT01241448|3812911|B3|Hispanic or Latino||Ethnicity||Participants|Count of Participants|13|13.0||||||
3991018|NCT01241448|3812912|B2|Hispanic or Latino||Ethnicity||Participants|Count of Participants|14|14.0||||||
3991019|NCT01241448|3812913|B1|Hispanic or Latino||Ethnicity||Participants|Count of Participants|16|16.0||||||
3991020|NCT01241448|3812909|B5|White||Race||Participants|Count of Participants|231|231.0||||||
3991021|NCT01241448|3812910|B4|White||Race||Participants|Count of Participants|58|58.0||||||
3991022|NCT01241448|3812911|B3|White||Race||Participants|Count of Participants|61|61.0||||||
3991023|NCT01241448|3812912|B2|White||Race||Participants|Count of Participants|54|54.0||||||
3991024|NCT01241448|3812913|B1|White||Race||Participants|Count of Participants|58|58.0||||||
3991025|NCT01241448|3812909|B5|Black or African American||Race||Participants|Count of Participants|18|18.0||||||
3991026|NCT01241448|3812910|B4|Black or African American||Race||Participants|Count of Participants|6|6.0||||||
3991027|NCT01241448|3812911|B3|Black or African American||Race||Participants|Count of Participants|2|2.0||||||
3991028|NCT01241448|3812912|B2|Black or African American||Race||Participants|Count of Participants|6|6.0||||||
3991029|NCT01241448|3812913|B1|Black or African American||Race||Participants|Count of Participants|4|4.0||||||
3991030|NCT01241448|3812909|B5|Asian||Race||Participants|Count of Participants|5|5.0||||||
3991031|NCT01241448|3812910|B4|Asian||Race||Participants|Count of Participants|0|0.0||||||
3991032|NCT01241448|3812911|B3|Asian||Race||Participants|Count of Participants|1|1.0||||||
3991033|NCT01241448|3812912|B2|Asian||Race||Participants|Count of Participants|3|3.0||||||
3991034|NCT01241448|3812913|B1|Asian||Race||Participants|Count of Participants|1|1.0||||||
3991035|NCT01241448|3812909|B5|Italy||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3991036|NCT01241448|3812910|B4|Italy||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3991037|NCT01241448|3812911|B3|Italy||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3991038|NCT01241448|3812912|B2|Italy||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3991039|NCT01241448|3812913|B1|Italy||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3991040|NCT01241448|3812909|B5|Germany||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3991041|NCT01241448|3812910|B4|Germany||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3991042|NCT01241448|3812911|B3|Germany||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3991043|NCT01241448|3812912|B2|Germany||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3991044|NCT01241448|3812913|B1|Germany||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3991045|NCT01241448|3812909|B5|Romania||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
3991046|NCT01241448|3812910|B4|Romania||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3991047|NCT01241448|3812911|B3|Romania||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3991048|NCT01241448|3812912|B2|Romania||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3991049|NCT01241448|3812913|B1|Romania||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3991050|NCT01241448|3812909|B5|Spain||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3991051|NCT01241448|3812910|B4|Spain||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3991052|NCT01241448|3812911|B3|Spain||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3991053|NCT01241448|3812912|B2|Spain||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3991054|NCT01241448|3812913|B1|Spain||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3991055|NCT01241448|3812909|B5|Puerto Rico||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
3991056|NCT01241448|3812910|B4|Puerto Rico||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3991057|NCT01241448|3812911|B3|Puerto Rico||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3991058|NCT01241448|3812912|B2|Puerto Rico||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3991059|NCT01241448|3812913|B1|Puerto Rico||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3991060|NCT01241448|3812909|B5|Slovakia||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3991061|NCT01241448|3812910|B4|Slovakia||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3991062|NCT01241448|3812911|B3|Slovakia||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3991063|NCT01241448|3812912|B2|Slovakia||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3991064|NCT01241448|3812913|B1|Slovakia||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3991065|NCT01241448|3812909|B5|United States||Region of Enrollment||Participants|Count of Participants|108|108.0||||||
3991066|NCT01241448|3812910|B4|United States||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
3991067|NCT01241448|3812911|B3|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
3991068|NCT01241448|3812912|B2|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3991069|NCT01241448|3812913|B1|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
3991070|NCT01241448|3812909|B5||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3991071|NCT01241448|3812910|B4||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3991073|NCT01241448|3812912|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3991074|NCT01241448|3812913|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3991075|NCT01241448|3812909|B5||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3991076|NCT01241448|3812910|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3991077|NCT01241448|3812911|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3991078|NCT01241448|3812912|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3991079|NCT01241448|3812913|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3991080|NCT01241448|3812909|B5|||Age||years|Mean|55.7|55.7|Standard Deviation|8.49|8.49|||
3991081|NCT01241448|3812910|B4|||Age||years|Mean|55.9|55.9|Standard Deviation|8.82|8.82|||
3991082|NCT01241448|3812911|B3|||Age||years|Mean|54.6|54.6|Standard Deviation|8.05|8.05|||
3991083|NCT01241448|3812912|B2|||Age||years|Mean|57.3|57.3|Standard Deviation|8.23|8.23|||
3991084|NCT01241448|3812913|B1|||Age||years|Mean|55.0|55.0|Standard Deviation|8.79|8.79|||
3991085|NCT01241435|3812980|B5|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
3991086|NCT01241435|3812981|B4|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3991087|NCT01241435|3812982|B3|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3991088|NCT01241435|3812983|B2|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3991089|NCT01241435|3812984|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3991090|NCT01241435|3812980|B5|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3991091|NCT01241435|3812981|B4|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3991092|NCT01241435|3812982|B3|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3991093|NCT01241435|3812983|B2|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3991094|NCT01241435|3812984|B1|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3991095|NCT01241435|3812980|B5|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3991096|NCT01241435|3812981|B4|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3991097|NCT01241435|3812982|B3|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3991098|NCT01241435|3812983|B2|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3991099|NCT01241435|3812984|B1|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3991100|NCT01241435|3812980|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
3991101|NCT01241435|3812981|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3991102|NCT01241435|3812982|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3991103|NCT01241435|3812983|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3991104|NCT01241435|3812984|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3991105|NCT01241435|3812980|B5||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3991106|NCT01241435|3812981|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3991107|NCT01241435|3812982|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3991108|NCT01241435|3812983|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3991109|NCT01241435|3812984|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3991110|NCT01241435|3812980|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3991111|NCT01241435|3812981|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3991112|NCT01241435|3812982|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3991113|NCT01241435|3812983|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3991114|NCT01241435|3812984|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3991115|NCT01241435|3812980|B5|||Age||years|Mean|52.3|52.3|Standard Deviation|6.2|6.2|||
3991116|NCT01241435|3812981|B4|||Age||years|Mean|51.4|51.4|Standard Deviation|6.9|6.9|||
3991117|NCT01241435|3812982|B3|||Age||years|Mean|54.5|54.5|Standard Deviation|5.6|5.6|||
3991118|NCT01241435|3812983|B2|||Age||years|Mean|55.0|55.0|Standard Deviation|4.9|4.9|||
3991119|NCT01241435|3812984|B1|||Age||years|Mean|49.5|49.5|Standard Deviation|6.3|6.3|||
3991120|NCT01241292|3813005|B3|Japan||Region of Enrollment||participants|Number|6|6.0||||||
3991121|NCT01241292|3813006|B2|Japan||Region of Enrollment||participants|Number|3|3.0||||||
3991122|NCT01241292|3813007|B1|Japan||Region of Enrollment||participants|Number|3|3.0||||||
3991123|NCT01241292|3813005|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3991124|NCT01241292|3813006|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3991125|NCT01241292|3813007|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3991126|NCT01241292|3813005|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3991127|NCT01241292|3813006|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3991128|NCT01241292|3813007|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3991129|NCT01241292|3813005|B3|Greater than, equal to 75||Age, Customized||participants|Number|1|1.0||||||
3991130|NCT01241292|3813006|B2|Greater than, equal to 75||Age, Customized||participants|Number|1|1.0||||||
3991131|NCT01241292|3813007|B1|Greater than, equal to 75||Age, Customized||participants|Number|0|0.0||||||
3991132|NCT01241292|3813005|B3|65 to < 75||Age, Customized||participants|Number|2|2.0||||||
3991133|NCT01241292|3813006|B2|65 to < 75||Age, Customized||participants|Number|1|1.0||||||
3991134|NCT01241292|3813007|B1|65 to < 75||Age, Customized||participants|Number|1|1.0||||||
3991135|NCT01241292|3813005|B3|Less than (<) 65||Age, Customized||participants|Number|3|3.0||||||
3991136|NCT01241292|3813006|B2|Less than (<) 65||Age, Customized||participants|Number|1|1.0||||||
3991137|NCT01241292|3813007|B1|Less than (<) 65||Age, Customized||participants|Number|2|2.0||||||
3991138|NCT01241292|3813005|B3|||Age||years|Median|63.5|63.5|Full Range|||52.0|75.0|
3991139|NCT01241292|3813006|B2|||Age||years|Median|66.0|66.0|Full Range|||60.0|75.0|
3991140|NCT01241292|3813007|B1|||Age||years|Median|61.0|61.0|Full Range|||52.0|66.0|
3991141|NCT01241279|3813030|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3991142|NCT01241279|3813031|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3991143|NCT01241279|3813032|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3991144|NCT01241279|3813030|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3991145|NCT01241279|3813031|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3991146|NCT01241279|3813032|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3991147|NCT01241279|3813030|B3|Age 54 to 70 years||Age, Customized||participants|Number|6|6.0||||||
3991148|NCT01241279|3813031|B2|Age 54 to 70 years||Age, Customized||participants|Number|2|2.0||||||
3991149|NCT01241279|3813032|B1|Age 54 to 70 years||Age, Customized||participants|Number|4|4.0||||||
3991150|NCT01241240|3813041|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3991151|NCT01241240|3813042|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3991152|NCT01241240|3813043|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3991153|NCT01241240|3813041|B3||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
3991154|NCT01241240|3813042|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3991155|NCT01241240|3813043|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
3991156|NCT01241240|3813041|B3|>65 years||Age, Customized||Participants|Number|51|51.0||||||
3991157|NCT01241240|3813042|B2|>65 years||Age, Customized||Participants|Number|24|24.0||||||
3991158|NCT01241240|3813043|B1|>65 years||Age, Customized||Participants|Number|27|27.0||||||
3991159|NCT01241240|3813041|B3|≤65 years||Age, Customized||Participants|Number|141|141.0||||||
3991160|NCT01241240|3813042|B2|≤65 years||Age, Customized||Participants|Number|74|74.0||||||
3991161|NCT01241240|3813043|B1|≤65 years||Age, Customized||Participants|Number|67|67.0||||||
3991162|NCT01240915|3813054|B9||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3991163|NCT01240915|3813055|B8||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3991164|NCT01240915|3813056|B7||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3991165|NCT01240915|3813057|B6||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3991166|NCT01240915|3813058|B5||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3991167|NCT01240915|3813059|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3991168|NCT01240915|3813060|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3991169|NCT01240915|3813061|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3991170|NCT01240915|3813062|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3991171|NCT01240915|3813054|B9||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3991172|NCT01240915|3813055|B8||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3991173|NCT01240915|3813056|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3991174|NCT01240915|3813057|B6||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3991175|NCT01240915|3813058|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3991176|NCT01240915|3813059|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3991177|NCT01240915|3813060|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3991178|NCT01240915|3813061|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3991179|NCT01240915|3813062|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3991180|NCT01240915|3813054|B9|||Age||years|Mean|42.2|42.2|Standard Deviation|13.7|13.7|||
3991181|NCT01240915|3813055|B8|||Age||years|Mean|42.5|42.5|Standard Deviation|15.7|15.7|||
3991182|NCT01240915|3813056|B7|||Age||years|Mean|39.8|39.8|Standard Deviation|12.5|12.5|||
3991183|NCT01240915|3813057|B6|||Age||years|Mean|38.8|38.8|Standard Deviation|13.4|13.4|||
3991184|NCT01240915|3813058|B5|||Age||years|Mean|43.4|43.4|Standard Deviation|12.8|12.8|||
3991185|NCT01240915|3813059|B4|||Age||years|Mean|40.0|40.0|Standard Deviation|14.0|14.0|||
3991186|NCT01240915|3813060|B3|||Age||years|Mean|49.3|49.3|Standard Deviation|14.1|14.1|||
3991187|NCT01240915|3813061|B2|||Age||years|Mean|52.0|52.0|Standard Deviation|7.0|7.0|||
3991188|NCT01240915|3813062|B1|||Age||years|Mean|61.0|61.0|Standard Deviation|7.1|7.1|||
3991189|NCT01240902|3813249|B5|||Logistic European System for Cardiac Operative Risk Evaluation (EuroSCORE)|The European System for Cardiac Operative Risk Evaluation (EuroSCORE) is a method of calculating predicted operative mortality for patients undergoing cardiac surgery. If a risk factor is present, a weight/number is assigned. The weights are added to give an approximate percent of predicted mortality. A higher score indicates a higher risk. A lower score indicates a lower risk.|%|Mean|20.3|20.3|Standard Deviation|15.1|15.1|||
3991250|NCT01240902|3813250|B4|Asian||Race/Ethnicity, Customized|Participant Population= Consisted of all subjects with an attempted implant procedure.|participants|Number|1|1.0||||||
3991295|NCT01240863|3813342|B3|>65 years||Age group||Participants|Count of Participants|35|35.0||||||
3991190|NCT01240902|3813250|B4|||Logistic European System for Cardiac Operative Risk Evaluation (EuroSCORE)|The European System for Cardiac Operative Risk Evaluation (EuroSCORE) is a method of calculating predicted operative mortality for patients undergoing cardiac surgery. If a risk factor is present, a weight/number is assigned. The weights are added to give an approximate percent of predicted mortality. A higher score indicates a higher risk. A lower score indicates a lower risk.|%|Mean|18.8|18.8|Standard Deviation|13.2|13.2|||
3991191|NCT01240902|3813251|B3|||Logistic European System for Cardiac Operative Risk Evaluation (EuroSCORE)|The European System for Cardiac Operative Risk Evaluation (EuroSCORE) is a method of calculating predicted operative mortality for patients undergoing cardiac surgery. If a risk factor is present, a weight/number is assigned. The weights are added to give an approximate percent of predicted mortality. A higher score indicates a higher risk. A lower score indicates a lower risk.|%|Mean|17.7|17.7|Standard Deviation|13.0|13.0|||
3991192|NCT01240902|3813252|B2|||Logistic European System for Cardiac Operative Risk Evaluation (EuroSCORE)|The European System for Cardiac Operative Risk Evaluation (EuroSCORE) is a method of calculating predicted operative mortality for patients undergoing cardiac surgery. If a risk factor is present, a weight/number is assigned. The weights are added to give an approximate percent of predicted mortality. A higher score indicates a higher risk. A lower score indicates a lower risk.|%|Mean|22.9|22.9|Standard Deviation|15.9|15.9|||
3991193|NCT01240902|3813253|B1|||Logistic European System for Cardiac Operative Risk Evaluation (EuroSCORE)|The European System for Cardiac Operative Risk Evaluation (EuroSCORE) is a method of calculating predicted operative mortality for patients undergoing cardiac surgery. If a risk factor is present, a weight/number is assigned. The weights are added to give an approximate percent of predicted mortality. A higher score indicates a higher risk. A lower score indicates a lower risk.|%|Mean|22.6|22.6|Standard Deviation|17.1|17.1|||
3991194|NCT01240902|3813249|B5|||Society of Thoracic Surgeons (STS) Risk Score|The Society of Thoracic Surgeons (STS) risk model predicts the risk of operative mortality and morbidity after adult cardiac surgery on the basis of patient demographic and clinical variables. After information has been entered on a given case, the online STS risk calculator provides a risk percentage for each of the outcomes. The risk percentage estimates the chance of a specific outcome for a patient with the indicated risk factors. A higher score indicates a higher risk. A lower score indicates a lower risk.|% risk of mortality or morbidity|Mean|8.8|8.8|Standard Deviation|4.7|4.7|||
3991195|NCT01240902|3813250|B4|||Society of Thoracic Surgeons (STS) Risk Score|The Society of Thoracic Surgeons (STS) risk model predicts the risk of operative mortality and morbidity after adult cardiac surgery on the basis of patient demographic and clinical variables. After information has been entered on a given case, the online STS risk calculator provides a risk percentage for each of the outcomes. The risk percentage estimates the chance of a specific outcome for a patient with the indicated risk factors. A higher score indicates a higher risk. A lower score indicates a lower risk.|% risk of mortality or morbidity|Mean|7.5|7.5|Standard Deviation|3.3|3.3|||
3991196|NCT01240902|3813251|B3|||Society of Thoracic Surgeons (STS) Risk Score|The Society of Thoracic Surgeons (STS) risk model predicts the risk of operative mortality and morbidity after adult cardiac surgery on the basis of patient demographic and clinical variables. After information has been entered on a given case, the online STS risk calculator provides a risk percentage for each of the outcomes. The risk percentage estimates the chance of a specific outcome for a patient with the indicated risk factors. A higher score indicates a higher risk. A lower score indicates a lower risk.|% risk of mortality or morbidity|Mean|7.3|7.3|Standard Deviation|3.0|3.0|||
3991197|NCT01240902|3813252|B2|||Society of Thoracic Surgeons (STS) Risk Score|The Society of Thoracic Surgeons (STS) risk model predicts the risk of operative mortality and morbidity after adult cardiac surgery on the basis of patient demographic and clinical variables. After information has been entered on a given case, the online STS risk calculator provides a risk percentage for each of the outcomes. The risk percentage estimates the chance of a specific outcome for a patient with the indicated risk factors. A higher score indicates a higher risk. A lower score indicates a lower risk.|% risk of mortality or morbidity|Mean|10.7|10.7|Standard Deviation|5.7|5.7|||
3991198|NCT01240902|3813253|B1|||Society of Thoracic Surgeons (STS) Risk Score|The Society of Thoracic Surgeons (STS) risk model predicts the risk of operative mortality and morbidity after adult cardiac surgery on the basis of patient demographic and clinical variables. After information has been entered on a given case, the online STS risk calculator provides a risk percentage for each of the outcomes. The risk percentage estimates the chance of a specific outcome for a patient with the indicated risk factors. A higher score indicates a higher risk. A lower score indicates a lower risk.|% risk of mortality or morbidity|Mean|10.3|10.3|Standard Deviation|5.5|5.5|||
3991199|NCT01240902|3813249|B5|NYHA IV||NYHA Classification|"New York Heart Association (NYHA) Classification:~Class I: Subjects with cardiac disease but without resulting limitations of physical activity.~Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.~Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.~Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort."|participants|Number|317|317.0||||||
3991200|NCT01240902|3813250|B4|NYHA IV||NYHA Classification|"New York Heart Association (NYHA) Classification:~Class I: Subjects with cardiac disease but without resulting limitations of physical activity.~Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.~Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.~Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort."|participants|Number|62|62.0||||||
3991201|NCT01240902|3813251|B3|NYHA IV||NYHA Classification|"New York Heart Association (NYHA) Classification:~Class I: Subjects with cardiac disease but without resulting limitations of physical activity.~Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.~Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.~Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort."|participants|Number|79|79.0||||||
3991202|NCT01240902|3813252|B2|NYHA IV||NYHA Classification|"New York Heart Association (NYHA) Classification:~Class I: Subjects with cardiac disease but without resulting limitations of physical activity.~Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.~Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.~Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort."|participants|Number|40|40.0||||||
3991203|NCT01240902|3813253|B1|NYHA IV||NYHA Classification|"New York Heart Association (NYHA) Classification:~Class I: Subjects with cardiac disease but without resulting limitations of physical activity.~Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.~Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.~Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort."|participants|Number|136|136.0||||||
3991204|NCT01240902|3813249|B5|NYHA III||NYHA Classification|"New York Heart Association (NYHA) Classification:~Class I: Subjects with cardiac disease but without resulting limitations of physical activity.~Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.~Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.~Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort."|participants|Number|916|916.0||||||
3991205|NCT01240902|3813250|B4|NYHA III||NYHA Classification|"New York Heart Association (NYHA) Classification:~Class I: Subjects with cardiac disease but without resulting limitations of physical activity.~Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.~Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.~Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort."|participants|Number|250|250.0||||||
3991206|NCT01240902|3813251|B3|NYHA III||NYHA Classification|"New York Heart Association (NYHA) Classification:~Class I: Subjects with cardiac disease but without resulting limitations of physical activity.~Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.~Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.~Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort."|participants|Number|255|255.0||||||
3991207|NCT01240902|3813252|B2|NYHA III||NYHA Classification|"New York Heart Association (NYHA) Classification:~Class I: Subjects with cardiac disease but without resulting limitations of physical activity.~Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.~Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.~Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort."|participants|Number|98|98.0||||||
3991208|NCT01240902|3813253|B1|NYHA III||NYHA Classification|"New York Heart Association (NYHA) Classification:~Class I: Subjects with cardiac disease but without resulting limitations of physical activity.~Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.~Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.~Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort."|participants|Number|313|313.0||||||
3991209|NCT01240902|3813249|B5|NYHA II||NYHA Classification|"New York Heart Association (NYHA) Classification:~Class I: Subjects with cardiac disease but without resulting limitations of physical activity.~Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.~Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.~Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort."|participants|Number|156|156.0||||||
3991210|NCT01240902|3813250|B4|NYHA II||NYHA Classification|"New York Heart Association (NYHA) Classification:~Class I: Subjects with cardiac disease but without resulting limitations of physical activity.~Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.~Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.~Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort."|participants|Number|47|47.0||||||
3991211|NCT01240902|3813251|B3|NYHA II||NYHA Classification|"New York Heart Association (NYHA) Classification:~Class I: Subjects with cardiac disease but without resulting limitations of physical activity.~Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.~Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.~Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort."|participants|Number|57|57.0||||||
3991212|NCT01240902|3813252|B2|NYHA II||NYHA Classification|"New York Heart Association (NYHA) Classification:~Class I: Subjects with cardiac disease but without resulting limitations of physical activity.~Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.~Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.~Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort."|participants|Number|12|12.0||||||
3991213|NCT01240902|3813253|B1|NYHA II||NYHA Classification|"New York Heart Association (NYHA) Classification:~Class I: Subjects with cardiac disease but without resulting limitations of physical activity.~Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.~Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.~Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort."|participants|Number|40|40.0||||||
3991214|NCT01240902|3813249|B5|NYHA I||NYHA Classification|"New York Heart Association (NYHA) Classification:~Class I: Subjects with cardiac disease but without resulting limitations of physical activity.~Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.~Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.~Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort."|participants|Number|0|0.0||||||
3991215|NCT01240902|3813250|B4|NYHA I||NYHA Classification|"New York Heart Association (NYHA) Classification:~Class I: Subjects with cardiac disease but without resulting limitations of physical activity.~Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.~Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.~Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort."|participants|Number|0|0.0||||||
3991216|NCT01240902|3813251|B3|NYHA I||NYHA Classification|"New York Heart Association (NYHA) Classification:~Class I: Subjects with cardiac disease but without resulting limitations of physical activity.~Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.~Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.~Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort."|participants|Number|0|0.0||||||
3991217|NCT01240902|3813252|B2|NYHA I||NYHA Classification|"New York Heart Association (NYHA) Classification:~Class I: Subjects with cardiac disease but without resulting limitations of physical activity.~Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.~Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.~Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort."|participants|Number|0|0.0||||||
3991218|NCT01240902|3813253|B1|NYHA I||NYHA Classification|"New York Heart Association (NYHA) Classification:~Class I: Subjects with cardiac disease but without resulting limitations of physical activity.~Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.~Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.~Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort."|participants|Number|0|0.0||||||
3991219|NCT01240902|3813249|B5|||Body Surface Area|Participant Population= Consisted of all subjects with an attempted implant procedure.|m^2|Mean|1.8|1.8|Standard Deviation|0.2|0.2|||
3991220|NCT01240902|3813250|B4|||Body Surface Area|Participant Population= Consisted of all subjects with an attempted implant procedure.|m^2|Mean|1.9|1.9|Standard Deviation|0.2|0.2|||
3991221|NCT01240902|3813251|B3|||Body Surface Area|Participant Population= Consisted of all subjects with an attempted implant procedure.|m^2|Mean|1.8|1.8|Standard Deviation|0.2|0.2|||
3991222|NCT01240902|3813252|B2|||Body Surface Area|Participant Population= Consisted of all subjects with an attempted implant procedure.|m^2|Mean|1.8|1.8|Standard Deviation|0.2|0.2|||
3991223|NCT01240902|3813253|B1|||Body Surface Area|Participant Population= Consisted of all subjects with an attempted implant procedure.|m^2|Mean|1.8|1.8|Standard Deviation|0.3|0.3|||
3991224|NCT01240902|3813249|B5|Unknown or Not Reported||Race/Ethnicity, Customized|Participant Population= Consisted of all subjects with an attempted implant procedure.|participants|Number|4|4.0||||||
3991225|NCT01240902|3813250|B4|Unknown or Not Reported||Race/Ethnicity, Customized|Participant Population= Consisted of all subjects with an attempted implant procedure.|participants|Number|2|2.0||||||
3991226|NCT01240902|3813251|B3|Unknown or Not Reported||Race/Ethnicity, Customized|Participant Population= Consisted of all subjects with an attempted implant procedure.|participants|Number|1|1.0||||||
3991227|NCT01240902|3813252|B2|Unknown or Not Reported||Race/Ethnicity, Customized|Participant Population= Consisted of all subjects with an attempted implant procedure.|participants|Number|1|1.0||||||
3991228|NCT01240902|3813253|B1|Unknown or Not Reported||Race/Ethnicity, Customized|Participant Population= Consisted of all subjects with an attempted implant procedure.|participants|Number|0|0.0||||||
3991229|NCT01240902|3813249|B5|More than one race||Race/Ethnicity, Customized|Participant Population= Consisted of all subjects with an attempted implant procedure.|participants|Number|0|0.0||||||
3991230|NCT01240902|3813250|B4|More than one race||Race/Ethnicity, Customized|Participant Population= Consisted of all subjects with an attempted implant procedure.|participants|Number|0|0.0||||||
3991231|NCT01240902|3813251|B3|More than one race||Race/Ethnicity, Customized|Participant Population= Consisted of all subjects with an attempted implant procedure.|participants|Number|0|0.0||||||
3991232|NCT01240902|3813252|B2|More than one race||Race/Ethnicity, Customized|Participant Population= Consisted of all subjects with an attempted implant procedure.|participants|Number|0|0.0||||||
3991233|NCT01240902|3813253|B1|More than one race||Race/Ethnicity, Customized|Participant Population= Consisted of all subjects with an attempted implant procedure.|participants|Number|0|0.0||||||
3991234|NCT01240902|3813249|B5|White||Race/Ethnicity, Customized|Participant Population= Consisted of all subjects with an attempted implant procedure.|participants|Number|1341|1341.0||||||
3991235|NCT01240902|3813250|B4|White||Race/Ethnicity, Customized|Participant Population= Consisted of all subjects with an attempted implant procedure.|participants|Number|343|343.0||||||
3991236|NCT01240902|3813251|B3|White||Race/Ethnicity, Customized|Participant Population= Consisted of all subjects with an attempted implant procedure.|participants|Number|387|387.0||||||
3991237|NCT01240902|3813252|B2|White||Race/Ethnicity, Customized|Participant Population= Consisted of all subjects with an attempted implant procedure.|participants|Number|143|143.0||||||
3991238|NCT01240902|3813253|B1|White||Race/Ethnicity, Customized|Participant Population= Consisted of all subjects with an attempted implant procedure.|participants|Number|468|468.0||||||
3991239|NCT01240902|3813249|B5|Black or African American||Race/Ethnicity, Customized|Participant Population= Consisted of all subjects with an attempted implant procedure.|participants|Number|38|38.0||||||
3991240|NCT01240902|3813250|B4|Black or African American||Race/Ethnicity, Customized|Participant Population= Consisted of all subjects with an attempted implant procedure.|participants|Number|11|11.0||||||
3991241|NCT01240902|3813251|B3|Black or African American||Race/Ethnicity, Customized|Participant Population= Consisted of all subjects with an attempted implant procedure.|participants|Number|3|3.0||||||
3991242|NCT01240902|3813252|B2|Black or African American||Race/Ethnicity, Customized|Participant Population= Consisted of all subjects with an attempted implant procedure.|participants|Number|5|5.0||||||
3991243|NCT01240902|3813253|B1|Black or African American||Race/Ethnicity, Customized|Participant Population= Consisted of all subjects with an attempted implant procedure.|participants|Number|19|19.0||||||
3991244|NCT01240902|3813249|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Participant Population= Consisted of all subjects with an attempted implant procedure.|participants|Number|0|0.0||||||
3991245|NCT01240902|3813250|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Participant Population= Consisted of all subjects with an attempted implant procedure.|participants|Number|0|0.0||||||
3991246|NCT01240902|3813251|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Participant Population= Consisted of all subjects with an attempted implant procedure.|participants|Number|0|0.0||||||
3991247|NCT01240902|3813252|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Participant Population= Consisted of all subjects with an attempted implant procedure.|participants|Number|0|0.0||||||
3991248|NCT01240902|3813253|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Participant Population= Consisted of all subjects with an attempted implant procedure.|participants|Number|0|0.0||||||
3991249|NCT01240902|3813249|B5|Asian||Race/Ethnicity, Customized|Participant Population= Consisted of all subjects with an attempted implant procedure.|participants|Number|4|4.0||||||
3991251|NCT01240902|3813251|B3|Asian||Race/Ethnicity, Customized|Participant Population= Consisted of all subjects with an attempted implant procedure.|participants|Number|0|0.0||||||
3991252|NCT01240902|3813252|B2|Asian||Race/Ethnicity, Customized|Participant Population= Consisted of all subjects with an attempted implant procedure.|participants|Number|1|1.0||||||
3991253|NCT01240902|3813253|B1|Asian||Race/Ethnicity, Customized|Participant Population= Consisted of all subjects with an attempted implant procedure.|participants|Number|2|2.0||||||
3991254|NCT01240902|3813249|B5|American Indian or Alaska Native||Race/Ethnicity, Customized|Participant Population= Consisted of all subjects with an attempted implant procedure.|participants|Number|1|1.0||||||
3991255|NCT01240902|3813250|B4|American Indian or Alaska Native||Race/Ethnicity, Customized|Participant Population= Consisted of all subjects with an attempted implant procedure.|participants|Number|1|1.0||||||
3991256|NCT01240902|3813251|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|Participant Population= Consisted of all subjects with an attempted implant procedure.|participants|Number|0|0.0||||||
3991257|NCT01240902|3813252|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|Participant Population= Consisted of all subjects with an attempted implant procedure.|participants|Number|0|0.0||||||
3991258|NCT01240902|3813253|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Participant Population= Consisted of all subjects with an attempted implant procedure.|participants|Number|0|0.0||||||
3991259|NCT01240902|3813249|B5||Male|Sex: Female, Male|Participant Population= Consisted of all subjects with an attempted implant procedure.|Participants|Count of Participants|697|697.0||||||
3991260|NCT01240902|3813250|B4||Male|Sex: Female, Male|Participant Population= Consisted of all subjects with an attempted implant procedure.|Participants|Count of Participants|188|188.0||||||
3991261|NCT01240902|3813251|B3||Male|Sex: Female, Male|Participant Population= Consisted of all subjects with an attempted implant procedure.|Participants|Count of Participants|207|207.0||||||
3991262|NCT01240902|3813252|B2||Male|Sex: Female, Male|Participant Population= Consisted of all subjects with an attempted implant procedure.|Participants|Count of Participants|68|68.0||||||
3991263|NCT01240902|3813253|B1||Male|Sex: Female, Male|Participant Population= Consisted of all subjects with an attempted implant procedure.|Participants|Count of Participants|234|234.0||||||
3991264|NCT01240902|3813249|B5||Female|Sex: Female, Male|Participant Population= Consisted of all subjects with an attempted implant procedure.|Participants|Count of Participants|692|692.0||||||
3991265|NCT01240902|3813250|B4||Female|Sex: Female, Male|Participant Population= Consisted of all subjects with an attempted implant procedure.|Participants|Count of Participants|171|171.0||||||
3991266|NCT01240902|3813251|B3||Female|Sex: Female, Male|Participant Population= Consisted of all subjects with an attempted implant procedure.|Participants|Count of Participants|184|184.0||||||
3991267|NCT01240902|3813252|B2||Female|Sex: Female, Male|Participant Population= Consisted of all subjects with an attempted implant procedure.|Participants|Count of Participants|82|82.0||||||
3991268|NCT01240902|3813253|B1||Female|Sex: Female, Male|Participant Population= Consisted of all subjects with an attempted implant procedure.|Participants|Count of Participants|255|255.0||||||
3991269|NCT01240902|3813249|B5|||Age|Participant Population= Consisted of all subjects with an attempted implant procedure.|years|Mean|83.0|83.0|Standard Deviation|7.6|7.6|||
3991270|NCT01240902|3813250|B4|||Age|Participant Population= Consisted of all subjects with an attempted implant procedure.|years|Mean|83.3|83.3|Standard Deviation|6.4|6.4|||
3991271|NCT01240902|3813251|B3|||Age|Participant Population= Consisted of all subjects with an attempted implant procedure.|years|Mean|83.2|83.2|Standard Deviation|7.1|7.1|||
3991272|NCT01240902|3813252|B2|||Age|Participant Population= Consisted of all subjects with an attempted implant procedure.|years|Mean|81.3|81.3|Standard Deviation|7.4|7.4|||
3991273|NCT01240902|3813253|B1|||Age|Participant Population= Consisted of all subjects with an attempted implant procedure.|years|Mean|83.2|83.2|Standard Deviation|8.7|8.7|||
3991274|NCT01240863|3813342|B3|||Duration of Opioid Therapy||years|Mean|4.0|4.0|Standard Deviation|4.82|4.82|||
3991275|NCT01240863|3813343|B2|||Duration of Opioid Therapy||years|Mean|3.9|3.9|Standard Deviation|4.76|4.76|||
3991276|NCT01240863|3813344|B1|||Duration of Opioid Therapy||years|Mean|4.1|4.1|Standard Deviation|4.90|4.9|||
3991277|NCT01240863|3813342|B3|Not on opioid therapy||Participants on Opioid Therapy||Participants|Count of Participants|91|91.0||||||
3991278|NCT01240863|3813343|B2|Not on opioid therapy||Participants on Opioid Therapy||Participants|Count of Participants|46|46.0||||||
3991279|NCT01240863|3813344|B1|Not on opioid therapy||Participants on Opioid Therapy||Participants|Count of Participants|45|45.0||||||
3991280|NCT01240863|3813342|B3|On opioid therapy||Participants on Opioid Therapy||Participants|Count of Participants|203|203.0||||||
3991281|NCT01240863|3813343|B2|On opioid therapy||Participants on Opioid Therapy||Participants|Count of Participants|100|100.0||||||
3991282|NCT01240863|3813344|B1|On opioid therapy||Participants on Opioid Therapy||Participants|Count of Participants|103|103.0||||||
3991283|NCT01240863|3813342|B3|||Duration since Diagnosis||years|Mean|12.3|12.3|Standard Deviation|9.51|9.51|||
3991284|NCT01240863|3813343|B2|||Duration since Diagnosis||years|Mean|12.1|12.1|Standard Deviation|9.97|9.97|||
3991285|NCT01240863|3813344|B1|||Duration since Diagnosis||years|Mean|12.5|12.5|Standard Deviation|9.06|9.06|||
3991286|NCT01240863|3813342|B3|Osteoarthritis||Type of Pain||Participants|Count of Participants|83|83.0||||||
3991287|NCT01240863|3813343|B2|Osteoarthritis||Type of Pain||Participants|Count of Participants|42|42.0||||||
3991288|NCT01240863|3813344|B1|Osteoarthritis||Type of Pain||Participants|Count of Participants|41|41.0||||||
3991289|NCT01240863|3813342|B3|Low back pain||Type of Pain||Participants|Count of Participants|211|211.0||||||
3991290|NCT01240863|3813343|B2|Low back pain||Type of Pain||Participants|Count of Participants|104|104.0||||||
3991291|NCT01240863|3813344|B1|Low back pain||Type of Pain||Participants|Count of Participants|107|107.0||||||
3991292|NCT01240863|3813342|B3|||Body Mass Index||kg/m^2|Mean|32.9|32.9|Standard Deviation|7.74|7.74|||
3991293|NCT01240863|3813343|B2|||Body Mass Index||kg/m^2|Mean|33.0|33.0|Standard Deviation|8.16|8.16|||
3991294|NCT01240863|3813344|B1|||Body Mass Index||kg/m^2|Mean|32.8|32.8|Standard Deviation|7.33|7.33|||
3991296|NCT01240863|3813343|B2|>65 years||Age group||Participants|Count of Participants|20|20.0||||||
3991297|NCT01240863|3813344|B1|>65 years||Age group||Participants|Count of Participants|15|15.0||||||
3991298|NCT01240863|3813342|B3|<=65 years||Age group||Participants|Count of Participants|259|259.0||||||
3991299|NCT01240863|3813343|B2|<=65 years||Age group||Participants|Count of Participants|126|126.0||||||
3991300|NCT01240863|3813344|B1|<=65 years||Age group||Participants|Count of Participants|133|133.0||||||
3991301|NCT01240863|3813342|B3|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3991302|NCT01240863|3813343|B2|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3991303|NCT01240863|3813344|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3991304|NCT01240863|3813342|B3|Non-Hispanic and non-Latino||Race/Ethnicity, Customized||Participants|Count of Participants|281|281.0||||||
3991305|NCT01240863|3813343|B2|Non-Hispanic and non-Latino||Race/Ethnicity, Customized||Participants|Count of Participants|137|137.0||||||
3991306|NCT01240863|3813344|B1|Non-Hispanic and non-Latino||Race/Ethnicity, Customized||Participants|Count of Participants|144|144.0||||||
3991307|NCT01240863|3813342|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3991308|NCT01240863|3813343|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3991309|NCT01240863|3813344|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3991310|NCT01240863|3813342|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3991311|NCT01240863|3813343|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3991312|NCT01240863|3813344|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3991313|NCT01240863|3813342|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3991314|NCT01240863|3813343|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3991315|NCT01240863|3813344|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3991316|NCT01240863|3813342|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|69|69.0||||||
3991317|NCT01240863|3813343|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3991318|NCT01240863|3813344|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
3991319|NCT01240863|3813342|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|220|220.0||||||
3991320|NCT01240863|3813343|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|115|115.0||||||
3991321|NCT01240863|3813344|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|105|105.0||||||
3991322|NCT01240863|3813342|B3||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3991323|NCT01240863|3813343|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3991324|NCT01240863|3813344|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3991325|NCT01240863|3813342|B3||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
3991326|NCT01240863|3813343|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3991327|NCT01240863|3813344|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3991328|NCT01240863|3813342|B3|||Age||years|Mean|53.1|53.1|Standard Deviation|11.26|11.26|||
3991329|NCT01240863|3813343|B2|||Age||years|Mean|53.6|53.6|Standard Deviation|10.38|10.38|||
3991330|NCT01240863|3813344|B1|||Age||years|Mean|52.7|52.7|Standard Deviation|12.09|12.09|||
3991331|NCT01240811|3813405|B4|United States||Region of Enrollment||participants|Number|42|42.0||||||
3991332|NCT01240811|3813406|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
3991333|NCT01240811|3813407|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
3991334|NCT01240811|3813408|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
3991335|NCT01240811|3813405|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3991336|NCT01240811|3813406|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3991337|NCT01240811|3813407|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3991338|NCT01240811|3813408|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3991339|NCT01240811|3813405|B4||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3991340|NCT01240811|3813406|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3991341|NCT01240811|3813407|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3991342|NCT01240811|3813408|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3991343|NCT01240811|3813405|B4|||Age||years|Mean|26|26.0|Standard Deviation|5|5.0|||
3991344|NCT01240811|3813406|B3|||Age||years|Mean|27|27.0|Standard Deviation|4|4.0|||
3991345|NCT01240811|3813407|B2|||Age||years|Mean|26|26.0|Standard Deviation|6|6.0|||
3991346|NCT01240811|3813408|B1|||Age||years|Mean|28|28.0|Standard Deviation|6|6.0|||
3991347|NCT01240811|3813405|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3991348|NCT01240811|3813406|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3991349|NCT01240811|3813407|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3991350|NCT01240811|3813408|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3991351|NCT01240811|3813405|B4||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3991352|NCT01240811|3813406|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3991353|NCT01240811|3813407|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3991354|NCT01240811|3813408|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3991355|NCT01240811|3813405|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3991356|NCT01240811|3813406|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3991357|NCT01240811|3813407|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3991358|NCT01240811|3813408|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3991359|NCT01240785|3813424|B3|Finland||Region of Enrollment||participants|Number|217|217.0||||||
3991360|NCT01240785|3813425|B2|Finland||Region of Enrollment||participants|Number|107|107.0||||||
3991361|NCT01240785|3813426|B1|Finland||Region of Enrollment||participants|Number|110|110.0||||||
3991362|NCT01240785|3813424|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3991363|NCT01240785|3813425|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3991364|NCT01240785|3813426|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3991365|NCT01240785|3813424|B3||Female|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
3991366|NCT01240785|3813425|B2||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3991367|NCT01240785|3813426|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3991368|NCT01240785|3813424|B3|||Age||years|Mean|32.0|32.0|Standard Deviation|4.6|4.6|||
3991369|NCT01240785|3813425|B2|||Age||years|Mean|32.1|32.1|Standard Deviation|5.4|5.4|||
3991370|NCT01240785|3813426|B1|||Age||years|Mean|31.9|31.9|Standard Deviation|5.0|5.0|||
3991371|NCT01240746|3813455|B4|United States||Region of Enrollment||Participants|Number|4363|4363.0||||||
3991372|NCT01240746|3813456|B3|United States||Region of Enrollment||Participants|Number|2902|2902.0||||||
3991373|NCT01240746|3813457|B2|United States||Region of Enrollment||Participants|Number|725|725.0||||||
3991374|NCT01240746|3813458|B1|United States||Region of Enrollment||Participants|Number|736|736.0||||||
3991375|NCT01240746|3813455|B4||Male|Sex: Female, Male||Participants|Count of Participants|2210|2210.0||||||
3991376|NCT01240746|3813456|B3||Male|Sex: Female, Male||Participants|Count of Participants|1475|1475.0||||||
3991377|NCT01240746|3813457|B2||Male|Sex: Female, Male||Participants|Count of Participants|366|366.0||||||
3991378|NCT01240746|3813458|B1||Male|Sex: Female, Male||Participants|Count of Participants|369|369.0||||||
3991379|NCT01240746|3813455|B4||Female|Sex: Female, Male||Participants|Count of Participants|2153|2153.0||||||
3991380|NCT01240746|3813456|B3||Female|Sex: Female, Male||Participants|Count of Participants|1427|1427.0||||||
3991381|NCT01240746|3813457|B2||Female|Sex: Female, Male||Participants|Count of Participants|359|359.0||||||
3991382|NCT01240746|3813458|B1||Female|Sex: Female, Male||Participants|Count of Participants|367|367.0||||||
3991383|NCT01240746|3813455|B4|||Age||Months|Mean|49.8|49.8|Standard Deviation|29.4|29.4|||
3991384|NCT01240746|3813456|B3|||Age||Months|Mean|49.8|49.8|Standard Deviation|29.7|29.7|||
3991385|NCT01240746|3813457|B2|||Age||Months|Mean|49.6|49.6|Standard Deviation|28.7|28.7|||
3991386|NCT01240746|3813458|B1|||Age||Months|Mean|49.6|49.6|Standard Deviation|29.0|29.0|||
3991387|NCT01240746|3813455|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3991388|NCT01240746|3813456|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3991389|NCT01240746|3813457|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3991390|NCT01240746|3813458|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3991391|NCT01240746|3813455|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3991392|NCT01240746|3813456|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3991393|NCT01240746|3813457|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3991394|NCT01240746|3813458|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3991395|NCT01240746|3813455|B4||<=18 years|Age||Participants|Count of Participants|4363|4363.0||||||
3991396|NCT01240746|3813456|B3||<=18 years|Age||Participants|Count of Participants|2902|2902.0||||||
3991397|NCT01240746|3813457|B2||<=18 years|Age||Participants|Count of Participants|725|725.0||||||
3991398|NCT01240746|3813458|B1||<=18 years|Age||Participants|Count of Participants|736|736.0||||||
3991399|NCT01240590|3813510|B6|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3991400|NCT01240590|3813511|B5|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3991401|NCT01240590|3813512|B4|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3991402|NCT01240590|3813513|B3|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3991403|NCT01240590|3813514|B2|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3991404|NCT01240590|3813510|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3991405|NCT01240590|3813511|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991406|NCT01240590|3813512|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991407|NCT01240590|3813513|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991408|NCT01240590|3813514|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3991409|NCT01240590|3813510|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991410|NCT01240590|3813511|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991411|NCT01240590|3813512|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991412|NCT01240590|3813513|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991413|NCT01240590|3813514|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991414|NCT01240590|3813510|B6||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3991415|NCT01240590|3813511|B5||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991416|NCT01240590|3813512|B4||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3991417|NCT01240590|3813513|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3991418|NCT01240590|3813514|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3991419|NCT01240590|3813510|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991420|NCT01240590|3813511|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991421|NCT01240590|3813512|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991422|NCT01240590|3813513|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991423|NCT01240590|3813514|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991424|NCT01240590|3813510|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991425|NCT01240590|3813511|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991426|NCT01240590|3813512|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991427|NCT01240590|3813513|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991428|NCT01240590|3813514|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991429|NCT01240590|3813510|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3991430|NCT01240590|3813511|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3991431|NCT01240590|3813512|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991432|NCT01240590|3813513|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991433|NCT01240590|3813514|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991434|NCT01240590|3813510|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991435|NCT01240590|3813511|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991436|NCT01240590|3813512|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991437|NCT01240590|3813513|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991438|NCT01240590|3813514|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991439|NCT01240590|3813510|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991440|NCT01240590|3813511|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991441|NCT01240590|3813512|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991442|NCT01240590|3813513|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991443|NCT01240590|3813514|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991444|NCT01240590|3813510|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3991445|NCT01240590|3813511|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3991446|NCT01240590|3813512|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3991447|NCT01240590|3813513|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3991448|NCT01240590|3813514|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3991449|NCT01240590|3813510|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3991450|NCT01240590|3813511|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991451|NCT01240590|3813512|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3991452|NCT01240590|3813513|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991453|NCT01240590|3813514|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3991454|NCT01240590|3813510|B6||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3991455|NCT01240590|3813511|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3991456|NCT01240590|3813512|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3991457|NCT01240590|3813513|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3991458|NCT01240590|3813514|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3991459|NCT01240590|3813510|B6||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3991460|NCT01240590|3813511|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3991461|NCT01240590|3813512|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3991462|NCT01240590|3813513|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3991463|NCT01240590|3813514|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3991464|NCT01240590|3813510|B6|||Age||years|Mean|60.45|60.45|Standard Deviation|9.42|9.42|||
3991465|NCT01240590|3813511|B5|||Age||years|Mean|70.3|70.3|Standard Deviation|0|0.0|||
3991466|NCT01240590|3813512|B4|||Age||years|Mean|58.76|58.76|Standard Deviation|8.44|8.44|||
3991467|NCT01240590|3813513|B3|||Age||years|Mean|51.53|51.53|Standard Deviation|7.45|7.45|||
3991468|NCT01240590|3813514|B2|||Age||years|Mean|68.03|68.03|Standard Deviation|8.09|8.09|||
3991469|NCT01240590|3813510|B6||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3991470|NCT01240590|3813511|B5||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3991471|NCT01240590|3813512|B4||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3991472|NCT01240590|3813513|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3991473|NCT01240590|3813514|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3991474|NCT01240590|3813510|B6||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3991475|NCT01240590|3813511|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3991476|NCT01240590|3813512|B4||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3991477|NCT01240590|3813513|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3991478|NCT01240590|3813514|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3991479|NCT01240590|3813510|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3991480|NCT01240590|3813511|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3991481|NCT01240590|3813512|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3991482|NCT01240590|3813513|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3991483|NCT01240590|3813514|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3991484|NCT01240551|3813545|B3|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
3991485|NCT01240551|3813546|B2|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3991486|NCT01240551|3813547|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3991487|NCT01240551|3813545|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991488|NCT01240551|3813546|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991489|NCT01240551|3813547|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991490|NCT01240551|3813545|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991491|NCT01240551|3813546|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991492|NCT01240551|3813547|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991493|NCT01240551|3813545|B3||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3991494|NCT01240551|3813546|B2||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3991495|NCT01240551|3813547|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3991496|NCT01240551|3813545|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3991497|NCT01240551|3813546|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3991498|NCT01240551|3813547|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3991499|NCT01240551|3813545|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991500|NCT01240551|3813546|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991501|NCT01240551|3813547|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991502|NCT01240551|3813545|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991503|NCT01240551|3813546|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991504|NCT01240551|3813547|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991505|NCT01240551|3813545|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991506|NCT01240551|3813546|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991507|NCT01240551|3813547|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991508|NCT01240551|3813545|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991509|NCT01240551|3813546|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991510|NCT01240551|3813547|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991511|NCT01240551|3813545|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
3991512|NCT01240551|3813546|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3991513|NCT01240551|3813547|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3991514|NCT01240551|3813545|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3991515|NCT01240551|3813546|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991516|NCT01240551|3813547|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3991517|NCT01240551|3813545|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3991518|NCT01240551|3813546|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3991519|NCT01240551|3813547|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3991520|NCT01240551|3813545|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3991521|NCT01240551|3813546|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3991522|NCT01240551|3813547|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3991523|NCT01240551|3813545|B3|||Age||years|Mean|64.98|64.98|Standard Deviation|8.06|8.06|||
3991524|NCT01240551|3813546|B2|||Age||years|Mean|65.8|65.8|Standard Deviation|8.67|8.67|||
3991525|NCT01240551|3813547|B1|||Age||years|Mean|64.1|64.1|Standard Deviation|7.45|7.45|||
3991526|NCT01240551|3813545|B3||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
3991527|NCT01240551|3813546|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3991528|NCT01240551|3813547|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3991529|NCT01240551|3813545|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3991530|NCT01240551|3813546|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3991531|NCT01240551|3813547|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
3991532|NCT01240551|3813545|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3991533|NCT01240551|3813546|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3991534|NCT01240551|3813547|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3991535|NCT01240382|3813556|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3991536|NCT01240382|3813557|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3991537|NCT01240382|3813558|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3991538|NCT01240382|3813556|B3||Female|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
3991539|NCT01240382|3813557|B2||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
3991540|NCT01240382|3813558|B1||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3991541|NCT01240382|3813556|B3|||Age||years|Mean|56.1|56.1|Standard Deviation|16.9|16.9|||
3991542|NCT01240382|3813557|B2|||Age||years|Mean|57.0|57.0|Standard Deviation|16.8|16.8|||
3991543|NCT01240382|3813558|B1|||Age||years|Mean|55.3|55.3|Standard Deviation|17.1|17.1|||
3991544|NCT01240356|3813567|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
3991545|NCT01240356|3813568|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3991546|NCT01240356|3813569|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3991547|NCT01240356|3813567|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3991548|NCT01240356|3813568|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3991549|NCT01240356|3813569|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3991550|NCT01240356|3813567|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3991551|NCT01240356|3813568|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3991552|NCT01240356|3813569|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3991553|NCT01240356|3813567|B3|||Age||years|Mean|57|57.0|Standard Deviation|17|17.0|||
3991554|NCT01240356|3813568|B2|||Age||years|Mean|63|63.0|Standard Deviation|14|14.0|||
3991555|NCT01240356|3813569|B1|||Age||years|Mean|49|49.0|Standard Deviation|16|16.0|||
3991556|NCT01240356|3813567|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3991557|NCT01240356|3813568|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3991558|NCT01240356|3813569|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3991559|NCT01240356|3813567|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
3991560|NCT01240356|3813568|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3991561|NCT01240356|3813569|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
3991562|NCT01240356|3813567|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3991563|NCT01240356|3813568|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3991564|NCT01240356|3813569|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3991565|NCT01240330|3813581|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
3991566|NCT01240330|3813581|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3991567|NCT01240330|3813581|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3991568|NCT01240330|3813581|B1|||Age||years|Mean|35|35.0|Standard Deviation|11|11.0|||
3991569|NCT01240330|3813581|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||0|0.0|||
3991570|NCT01240330|3813581|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||5.20|5.2|||
3991571|NCT01240330|3813581|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||0|0.0|||
3991572|NCT01240200|3813587|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3991573|NCT01240200|3813588|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3991574|NCT01240200|3813589|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3991575|NCT01240200|3813587|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3991576|NCT01240200|3813588|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3991577|NCT01240200|3813589|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3991578|NCT01240200|3813587|B3|||Age||years|Mean|68.8|68.8|Standard Deviation|5.4|5.4|||
3991579|NCT01240200|3813588|B2|||Age||years|Mean|70.6|70.6|Standard Deviation|4.4|4.4|||
3991580|NCT01240200|3813589|B1|||Age||years|Mean|68.8|68.8|Standard Deviation|5.8|5.8|||
3991581|NCT01240135|3813606|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3991582|NCT01240135|3813607|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3991583|NCT01240135|3813608|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3991584|NCT01240135|3813606|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3991585|NCT01240135|3813607|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3991586|NCT01240135|3813608|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3991587|NCT01240135|3813606|B3|||Age||years|Mean|32.8|32.8|Standard Deviation|10.64|10.64|||
3991588|NCT01240135|3813607|B2|||Age||years|Mean|31.4|31.4|Standard Deviation|9.71|9.71|||
3991589|NCT01240135|3813608|B1|||Age||years|Mean|34.3|34.3|Standard Deviation|11.44|11.44|||
3991590|NCT01240122|3813617|B1|Unknown||Sex/Gender, Customized|Gender was not an analysis endpoint for this study.|participants|Number|29|29.0||||||
3991591|NCT01240122|3813617|B1|Female||Sex/Gender, Customized|Gender was not an analysis endpoint for this study.|participants|Number|0|0.0||||||
3991592|NCT01240122|3813617|B1|Male||Sex/Gender, Customized|Gender was not an analysis endpoint for this study.|participants|Number|0|0.0||||||
3991593|NCT01240122|3813617|B1|18 years of age or older||Age, Customized||participants|Number|29|29.0||||||
3991594|NCT01240122|3813617|B1|<18 years||Age, Customized||participants|Number|0|0.0||||||
3991595|NCT01239992|3813626|B1|Germany||Region of Enrollment||participants|Number|12|12.0||||||
3991596|NCT01239992|3813626|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991597|NCT01239992|3813626|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991598|NCT01239992|3813626|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3991599|NCT01239992|3813626|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991600|NCT01239992|3813626|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991601|NCT01239992|3813626|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991602|NCT01239992|3813626|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991603|NCT01239992|3813626|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3991604|NCT01239992|3813626|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3991605|NCT01239992|3813626|B1|||Age||years|Mean|64|64.0|Standard Deviation|9|9.0|||
3991606|NCT01239797|3813633|B3|Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3991607|NCT01239797|3813634|B2|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3991608|NCT01239797|3813635|B1|Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3991609|NCT01239797|3813633|B3|Other||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3991610|NCT01239797|3813634|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3991611|NCT01239797|3813635|B1|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3991612|NCT01239797|3813633|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3991613|NCT01239797|3813634|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3991614|NCT01239797|3813635|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3991615|NCT01239797|3813633|B3|Asian||Race/Ethnicity, Customized||participants|Number|64|64.0||||||
3991616|NCT01239797|3813634|B2|Asian||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3991617|NCT01239797|3813635|B1|Asian||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
3991618|NCT01239797|3813633|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3991619|NCT01239797|3813634|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3991620|NCT01239797|3813635|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3991621|NCT01239797|3813633|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
3991622|NCT01239797|3813634|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3991623|NCT01239797|3813635|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3991624|NCT01239797|3813633|B3|White||Race/Ethnicity, Customized||participants|Number|544|544.0||||||
3991625|NCT01239797|3813634|B2|White||Race/Ethnicity, Customized||participants|Number|280|280.0||||||
3991626|NCT01239797|3813635|B1|White||Race/Ethnicity, Customized||participants|Number|264|264.0||||||
3991627|NCT01239797|3813633|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|579|579.0||||||
3991628|NCT01239797|3813634|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|291|291.0||||||
3991629|NCT01239797|3813635|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|288|288.0||||||
3991630|NCT01239797|3813633|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3991631|NCT01239797|3813634|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3991632|NCT01239797|3813635|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3991633|NCT01239797|3813633|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3991634|NCT01239797|3813634|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3991635|NCT01239797|3813635|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3991636|NCT01239797|3813633|B3||Male|Sex: Female, Male||Participants|Count of Participants|385|385.0||||||
3991637|NCT01239797|3813634|B2||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
3991638|NCT01239797|3813635|B1||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
3991639|NCT01239797|3813633|B3||Female|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
3991640|NCT01239797|3813634|B2||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3991641|NCT01239797|3813635|B1||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3991642|NCT01239797|3813633|B3|>= 75 years old||Age, Customized||participants|Number|129|129.0||||||
3991643|NCT01239797|3813634|B2|>= 75 years old||Age, Customized||participants|Number|61|61.0||||||
3991644|NCT01239797|3813635|B1|>= 75 years old||Age, Customized||participants|Number|68|68.0||||||
3991645|NCT01239797|3813633|B3|>= 65 and < 75 years old||Age, Customized||participants|Number|241|241.0||||||
3991646|NCT01239797|3813634|B2|>= 65 and < 75 years old||Age, Customized||participants|Number|122|122.0||||||
3991647|NCT01239797|3813635|B1|>= 65 and < 75 years old||Age, Customized||participants|Number|119|119.0||||||
3991648|NCT01239797|3813633|B3|< 65 years old||Age, Customized||participants|Number|276|276.0||||||
3991649|NCT01239797|3813634|B2|< 65 years old||Age, Customized||participants|Number|142|142.0||||||
3991650|NCT01239797|3813635|B1|< 65 years old||Age, Customized||participants|Number|134|134.0||||||
3991651|NCT01239797|3813633|B3|||Age||years|Mean|65.7|65.7|Standard Deviation|9.81|9.81|||
3991652|NCT01239797|3813634|B2|||Age||years|Mean|65.3|65.3|Standard Deviation|10.26|10.26|||
3991653|NCT01239797|3813635|B1|||Age||years|Mean|66.2|66.2|Standard Deviation|9.34|9.34|||
3991654|NCT01239745|3813644|B1|Hypertension||Concomitant morbidities in the past|Participants who had a concomitant morbidity in the past; participants with more than one concomitant morbidity were counted for each of the concomitant morbidity classes applicable.|participants|Number|3|3.0||||||
3991655|NCT01239745|3813644|B1|Reproductive tract disorder||Concomitant morbidities in the past|Participants who had a concomitant morbidity in the past; participants with more than one concomitant morbidity were counted for each of the concomitant morbidity classes applicable.|participants|Number|3|3.0||||||
3991656|NCT01239745|3813644|B1|Cystitis noninfective||Concomitant morbidities in the past|Participants who had a concomitant morbidity in the past; participants with more than one concomitant morbidity were counted for each of the concomitant morbidity classes applicable.|participants|Number|1|1.0||||||
3991657|NCT01239745|3813644|B1|Intracranial aneurysm||Concomitant morbidities in the past|Participants who had a concomitant morbidity in the past; participants with more than one concomitant morbidity were counted for each of the concomitant morbidity classes applicable.|participants|Number|1|1.0||||||
3991658|NCT01239745|3813644|B1|Cholelithiasis||Concomitant morbidities in the past|Participants who had a concomitant morbidity in the past; participants with more than one concomitant morbidity were counted for each of the concomitant morbidity classes applicable.|participants|Number|1|1.0||||||
3991659|NCT01239745|3813644|B1|||Number of participants on radiotherapy|Number of participants who received radiotherapy as measured in radiations per centigray (Rads/cGy).|participants|Number|NA|||||||Data for this pre-specified outcome measure was collected and reported in individual participant listings but not statistically summarized for analysis.
3991660|NCT01239745|3813644|B1|||Number of participants on chemotherapy|Number of participants who received chemotherapy. Chemotherapeutic drugs included doxorubicin, cyclophosphamide, docetaxel, fluorouracil, methotrexate , 5-fluorouracil, epirubicin, endoxan, farmorubicin, adriamycin, cytoxan, trastuzumab.|participants|Number|NA|||||||Data for this pre-specified outcome measure was collected and reported in individual participant listings but not statistically summarized for analysis.
3991661|NCT01239745|3813644|B1|Unknown||Histopathological Grade|The grade of a cancer depends on what the cells look like and the growth-rate. Lower grade indicates a slower-growing cancer and a higher grade indicates a faster-growing one. Grade 1 (resemble normal cells, not growing rapidly), grade 2 (grow faster than normal cells), grade 3 and 4 (abnormal cells, grow and spread aggressively).|participants|Number|10|10.0||||||
3991662|NCT01239745|3813644|B1|Grade 3||Histopathological Grade|The grade of a cancer depends on what the cells look like and the growth-rate. Lower grade indicates a slower-growing cancer and a higher grade indicates a faster-growing one. Grade 1 (resemble normal cells, not growing rapidly), grade 2 (grow faster than normal cells), grade 3 and 4 (abnormal cells, grow and spread aggressively).|participants|Number|7|7.0||||||
3991663|NCT01239745|3813644|B1|Grade 2||Histopathological Grade|The grade of a cancer depends on what the cells look like and the growth-rate. Lower grade indicates a slower-growing cancer and a higher grade indicates a faster-growing one. Grade 1 (resemble normal cells, not growing rapidly), grade 2 (grow faster than normal cells), grade 3 and 4 (abnormal cells, grow and spread aggressively).|participants|Number|19|19.0||||||
3991664|NCT01239745|3813644|B1|Grade 1||Histopathological Grade|The grade of a cancer depends on what the cells look like and the growth-rate. Lower grade indicates a slower-growing cancer and a higher grade indicates a faster-growing one. Grade 1 (resemble normal cells, not growing rapidly), grade 2 (grow faster than normal cells), grade 3 and 4 (abnormal cells, grow and spread aggressively).|participants|Number|10|10.0||||||
3991665|NCT01239745|3813644|B1|Other||Tumor Node Metastasis (TNM) Stage|TNM:based on tumor size, if cancer cells had spread to nearby lymph nodes (LN), or distant (other parts of body) metastasis. Stages included:stage 0(no evidence of cancer cells), stage 1(T1N0M0), stage IIA(T0N1M0, T1N1M0, T2N0M0), stage IIB(T2N1M0, T3N0M0), stage IIIA(T0N2M0, T1N2M0, T2N3M0, T3N1orN2M0), stage IIIb( T4 anyNM0, any TN3M0),stage IIIC(any TN3M0), stage IV(anyT anyNM1), where T0=early form of tumor, T1=<2 centimeter(cm), T2=2-5 cm, T3=>2 cm, T4=large sized, N0=not spread to LN, N1=spread to 1 to 3,N2=spread to 4 to 9,N3=spread >10 axillary LN, M0=no metastasis, M1= Metastasis.|participants|Number|1|1.0||||||
3991666|NCT01239745|3813644|B1|Stage IIIC||Tumor Node Metastasis (TNM) Stage|TNM:based on tumor size, if cancer cells had spread to nearby lymph nodes (LN), or distant (other parts of body) metastasis. Stages included:stage 0(no evidence of cancer cells), stage 1(T1N0M0), stage IIA(T0N1M0, T1N1M0, T2N0M0), stage IIB(T2N1M0, T3N0M0), stage IIIA(T0N2M0, T1N2M0, T2N3M0, T3N1orN2M0), stage IIIb( T4 anyNM0, any TN3M0),stage IIIC(any TN3M0), stage IV(anyT anyNM1), where T0=early form of tumor, T1=<2 centimeter(cm), T2=2-5 cm, T3=>2 cm, T4=large sized, N0=not spread to LN, N1=spread to 1 to 3,N2=spread to 4 to 9,N3=spread >10 axillary LN, M0=no metastasis, M1= Metastasis.|participants|Number|0|0.0||||||
3991667|NCT01239745|3813644|B1|Stage IIIA||Tumor Node Metastasis (TNM) Stage|TNM:based on tumor size, if cancer cells had spread to nearby lymph nodes (LN), or distant (other parts of body) metastasis. Stages included:stage 0(no evidence of cancer cells), stage 1(T1N0M0), stage IIA(T0N1M0, T1N1M0, T2N0M0), stage IIB(T2N1M0, T3N0M0), stage IIIA(T0N2M0, T1N2M0, T2N3M0, T3N1orN2M0), stage IIIb( T4 anyNM0, any TN3M0),stage IIIC(any TN3M0), stage IV(anyT anyNM1), where T0=early form of tumor, T1=<2 centimeter(cm), T2=2-5 cm, T3=>2 cm, T4=large sized, N0=not spread to LN, N1=spread to 1 to 3,N2=spread to 4 to 9,N3=spread >10 axillary LN, M0=no metastasis, M1= Metastasis.|participants|Number|4|4.0||||||
3991668|NCT01239745|3813644|B1|Stage IV||Tumor Node Metastasis (TNM) Stage|TNM:based on tumor size, if cancer cells had spread to nearby lymph nodes (LN), or distant (other parts of body) metastasis. Stages included:stage 0(no evidence of cancer cells), stage 1(T1N0M0), stage IIA(T0N1M0, T1N1M0, T2N0M0), stage IIB(T2N1M0, T3N0M0), stage IIIA(T0N2M0, T1N2M0, T2N3M0, T3N1orN2M0), stage IIIb( T4 anyNM0, any TN3M0),stage IIIC(any TN3M0), stage IV(anyT anyNM1), where T0=early form of tumor, T1=<2 centimeter(cm), T2=2-5 cm, T3=>2 cm, T4=large sized, N0=not spread to LN, N1=spread to 1 to 3,N2=spread to 4 to 9,N3=spread >10 axillary LN, M0=no metastasis, M1= Metastasis.|participants|Number|0|0.0||||||
3991669|NCT01239745|3813644|B1|Stage IIIB||Tumor Node Metastasis (TNM) Stage|TNM:based on tumor size, if cancer cells had spread to nearby lymph nodes (LN), or distant (other parts of body) metastasis. Stages included:stage 0(no evidence of cancer cells), stage 1(T1N0M0), stage IIA(T0N1M0, T1N1M0, T2N0M0), stage IIB(T2N1M0, T3N0M0), stage IIIA(T0N2M0, T1N2M0, T2N3M0, T3N1orN2M0), stage IIIb( T4 anyNM0, any TN3M0),stage IIIC(any TN3M0), stage IV(anyT anyNM1), where T0=early form of tumor, T1=<2 centimeter(cm), T2=2-5 cm, T3=>2 cm, T4=large sized, N0=not spread to LN, N1=spread to 1 to 3,N2=spread to 4 to 9,N3=spread >10 axillary LN, M0=no metastasis, M1= Metastasis.|participants|Number|4|4.0||||||
3991670|NCT01239745|3813644|B1|Stage IIB||Tumor Node Metastasis (TNM) Stage|TNM:based on tumor size, if cancer cells had spread to nearby lymph nodes (LN), or distant (other parts of body) metastasis. Stages included:stage 0(no evidence of cancer cells), stage 1(T1N0M0), stage IIA(T0N1M0, T1N1M0, T2N0M0), stage IIB(T2N1M0, T3N0M0), stage IIIA(T0N2M0, T1N2M0, T2N3M0, T3N1orN2M0), stage IIIb( T4 anyNM0, any TN3M0),stage IIIC(any TN3M0), stage IV(anyT anyNM1), where T0=early form of tumor, T1=<2 centimeter(cm), T2=2-5 cm, T3=>2 cm, T4=large sized, N0=not spread to LN, N1=spread to 1 to 3,N2=spread to 4 to 9,N3=spread >10 axillary LN, M0=no metastasis, M1= Metastasis.|participants|Number|5|5.0||||||
3991671|NCT01239745|3813644|B1|Stage IIA||Tumor Node Metastasis (TNM) Stage|TNM:based on tumor size, if cancer cells had spread to nearby lymph nodes (LN), or distant (other parts of body) metastasis. Stages included:stage 0(no evidence of cancer cells), stage 1(T1N0M0), stage IIA(T0N1M0, T1N1M0, T2N0M0), stage IIB(T2N1M0, T3N0M0), stage IIIA(T0N2M0, T1N2M0, T2N3M0, T3N1orN2M0), stage IIIb( T4 anyNM0, any TN3M0),stage IIIC(any TN3M0), stage IV(anyT anyNM1), where T0=early form of tumor, T1=<2 centimeter(cm), T2=2-5 cm, T3=>2 cm, T4=large sized, N0=not spread to LN, N1=spread to 1 to 3,N2=spread to 4 to 9,N3=spread >10 axillary LN, M0=no metastasis, M1= Metastasis.|participants|Number|14|14.0||||||
3991672|NCT01239745|3813644|B1|Stage I||Tumor Node Metastasis (TNM) Stage|TNM:based on tumor size, if cancer cells had spread to nearby lymph nodes (LN), or distant (other parts of body) metastasis. Stages included:stage 0(no evidence of cancer cells), stage 1(T1N0M0), stage IIA(T0N1M0, T1N1M0, T2N0M0), stage IIB(T2N1M0, T3N0M0), stage IIIA(T0N2M0, T1N2M0, T2N3M0, T3N1orN2M0), stage IIIb( T4 anyNM0, any TN3M0),stage IIIC(any TN3M0), stage IV(anyT anyNM1), where T0=early form of tumor, T1=<2 centimeter(cm), T2=2-5 cm, T3=>2 cm, T4=large sized, N0=not spread to LN, N1=spread to 1 to 3,N2=spread to 4 to 9,N3=spread >10 axillary LN, M0=no metastasis, M1= Metastasis.|participants|Number|18|18.0||||||
3991673|NCT01239745|3813644|B1|||Lymph Node Status||participants|Number|NA|||||||Data for this pre-specified outcome measure was collected and reported in individual participant listings but not statistically summarized for analysis.
3991674|NCT01239745|3813644|B1|||Hormone Receptor Status|Number of participants with positive estrogen receptors.|participants|Number|46|46.0||||||
3991675|NCT01239745|3813644|B1|||Type of Surgery|Number of participants who had undergone different type of surgeries which included mastectomy, axilla evacuation, breast quadrantectomy, dissectio axillae, radical mastectomy, axillary dissection, ablation of both breast, segmentectomy, lymphadenectomy, lumpectomy, core biopsy, sentinel lymph node biopsy, quadrantectomy, re-excision, tumorectomy.|participants|Number|NA|||||||Data for this pre-specified outcome measure was collected and reported in individual participant listings but not statistically summarized for analysis.
3991676|NCT01239745|3813644|B1|Other||Type of Tumor|Number of participants with different types of tumor such as; ductal carcinoma, lobular carcinoma, invasive ductal carcinoma, invasive lobular carcinoma, papillary carcinoma, medullary carcinoma, mucinous (colloid) carcinoma and others.|participants|Number|5|5.0||||||
3991677|NCT01239745|3813644|B1|Mucinous (colloid) carcinoma||Type of Tumor|Number of participants with different types of tumor such as; ductal carcinoma, lobular carcinoma, invasive ductal carcinoma, invasive lobular carcinoma, papillary carcinoma, medullary carcinoma, mucinous (colloid) carcinoma and others.|participants|Number|2|2.0||||||
3991678|NCT01239745|3813644|B1|Medullary carcinoma||Type of Tumor|Number of participants with different types of tumor such as; ductal carcinoma, lobular carcinoma, invasive ductal carcinoma, invasive lobular carcinoma, papillary carcinoma, medullary carcinoma, mucinous (colloid) carcinoma and others.|participants|Number|1|1.0||||||
3991679|NCT01239745|3813644|B1|Papillary carcinoma||Type of Tumor|Number of participants with different types of tumor such as; ductal carcinoma, lobular carcinoma, invasive ductal carcinoma, invasive lobular carcinoma, papillary carcinoma, medullary carcinoma, mucinous (colloid) carcinoma and others.|participants|Number|0|0.0||||||
3991680|NCT01239745|3813644|B1|Invasive lobular carcinoma||Type of Tumor|Number of participants with different types of tumor such as; ductal carcinoma, lobular carcinoma, invasive ductal carcinoma, invasive lobular carcinoma, papillary carcinoma, medullary carcinoma, mucinous (colloid) carcinoma and others.|participants|Number|7|7.0||||||
3991681|NCT01239745|3813644|B1|Invasive ductal carcinoma||Type of Tumor|Number of participants with different types of tumor such as; ductal carcinoma, lobular carcinoma, invasive ductal carcinoma, invasive lobular carcinoma, papillary carcinoma, medullary carcinoma, mucinous (colloid) carcinoma and others.|participants|Number|31|31.0||||||
3991682|NCT01239745|3813644|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3991683|NCT01239745|3813644|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3991684|NCT01239745|3813644|B1|||Age||years|Mean|59.0|59.0|Standard Deviation|10.7|10.7|||
3991685|NCT01239732|3813655|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3991686|NCT01239732|3813655|B1||Female|Sex: Female, Male||Participants|Count of Participants|1021|1021.0||||||
3991687|NCT01239732|3813655|B1|||Age||years|Mean|56.3|56.3|Standard Deviation|10.98|10.98|||
3991688|NCT01239680|3813666|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
3991689|NCT01239680|3813667|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3991690|NCT01239680|3813668|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3991691|NCT01239680|3813666|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3991692|NCT01239680|3813667|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3991693|NCT01239680|3813668|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3991694|NCT01239680|3813666|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3991695|NCT01239680|3813667|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3991696|NCT01239680|3813668|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3991697|NCT01239680|3813666|B3|Age 21-65||Age, Customized|Age 21 to 65 years.|participants|Number|5|5.0||||||
3991698|NCT01239680|3813667|B2|Age 21-65||Age, Customized|Age 21 to 65 years.|participants|Number|2|2.0||||||
3991699|NCT01239680|3813668|B1|Age 21-65||Age, Customized|Age 21 to 65 years.|participants|Number|3|3.0||||||
3991700|NCT01239511|3813675|B5|Taiwan||Region of Enrollment||participants|Number|168|168.0||||||
3991701|NCT01239511|3813676|B4|Taiwan||Region of Enrollment||participants|Number|37|37.0||||||
3991702|NCT01239511|3813677|B3|Taiwan||Region of Enrollment||participants|Number|42|42.0||||||
3991703|NCT01239511|3813678|B2|Taiwan||Region of Enrollment||participants|Number|43|43.0||||||
3991704|NCT01239511|3813679|B1|Taiwan||Region of Enrollment||participants|Number|46|46.0||||||
3991705|NCT01239511|3813675|B5||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3991706|NCT01239511|3813676|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3991707|NCT01239511|3813677|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3991708|NCT01239511|3813678|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3991709|NCT01239511|3813679|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3991710|NCT01239511|3813675|B5||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3991711|NCT01239511|3813676|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3991712|NCT01239511|3813677|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3991713|NCT01239511|3813678|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3991714|NCT01239511|3813679|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3991715|NCT01239511|3813675|B5|||Age||years|Mean|61.0|61.0|Standard Deviation|10.43|10.43|||
3991716|NCT01239511|3813676|B4|||Age||years|Mean|59.6|59.6|Standard Deviation|10.11|10.11|||
3991717|NCT01239511|3813677|B3|||Age||years|Mean|61.4|61.4|Standard Deviation|10.57|10.57|||
3991718|NCT01239511|3813678|B2|||Age||years|Mean|62.1|62.1|Standard Deviation|10.40|10.4|||
3991719|NCT01239511|3813679|B1|||Age||years|Mean|60.6|60.6|Standard Deviation|0.76|0.76|||
3991720|NCT01239511|3813675|B5||>=65 years|Age||Participants|Count of Participants|62|62.0||||||
3991721|NCT01239511|3813676|B4||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3991722|NCT01239511|3813677|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3991723|NCT01239511|3813678|B2||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3991724|NCT01239511|3813679|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3991725|NCT01239511|3813675|B5||Between 18 and 65 years|Age||Participants|Count of Participants|106|106.0||||||
3991726|NCT01239511|3813676|B4||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3991727|NCT01239511|3813677|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3991728|NCT01239511|3813678|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
3991729|NCT01239511|3813679|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3991730|NCT01239511|3813675|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3991731|NCT01239511|3813676|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3991732|NCT01239511|3813677|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3991733|NCT01239511|3813678|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3991734|NCT01239511|3813679|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3991735|NCT01239394|3813692|B1||Small lymphocytic|Lymphoma type||Participants|Count of Participants|10|10.0||||||
3991736|NCT01239394|3813692|B1||Marginal zone|Lymphoma type||Participants|Count of Participants|4|4.0||||||
3991737|NCT01239394|3813692|B1||Follicular|Lymphoma type||Participants|Count of Participants|28|28.0||||||
3991738|NCT01239394|3813692|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
3991739|NCT01239394|3813692|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3991740|NCT01239394|3813692|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3991741|NCT01239394|3813692|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3991742|NCT01239394|3813692|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3991743|NCT01239394|3813692|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991744|NCT01239394|3813692|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991745|NCT01239394|3813692|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991746|NCT01239394|3813692|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3991747|NCT01239394|3813692|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3991748|NCT01239394|3813692|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3991749|NCT01239394|3813692|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3991750|NCT01239394|3813692|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3991751|NCT01239394|3813692|B1|||Age||years|Median|64.4|64.4|Full Range|||33.7|91.9|
3991752|NCT01239381|3813699|B1|> 10 cm||Categorical Tumor size||Participants|Count of Participants|7|7.0||||||
3991753|NCT01239381|3813699|B1|> 5 cm||Categorical Tumor size||Participants|Count of Participants|31|31.0||||||
3991754|NCT01239381|3813699|B1|≤ 5 cm||Categorical Tumor size||Participants|Count of Participants|50|50.0||||||
3991755|NCT01239381|3813699|B1|||Median Tumor Size|Median Tumor size among the 142 tumors analyzed|Centimeters (cm)|Median|2.55|2.55|Full Range|||0.48|11.9|
3991756|NCT01239381|3813699|B1|4 Tumors||Number of Tumors||Participants|Count of Participants|5|5.0||||||
3991757|NCT01239381|3813699|B1|3 Tumors||Number of Tumors||Participants|Count of Participants|10|10.0||||||
3991758|NCT01239381|3813699|B1|2 Tumors||Number of Tumors||Participants|Count of Participants|21|21.0||||||
3991759|NCT01239381|3813699|B1|1 Tumor||Number of Tumors||Participants|Count of Participants|54|54.0||||||
3991760|NCT01239381|3813699|B1|Prostate||Primary Cancer Site||Participants|Count of Participants|1|1.0||||||
3991761|NCT01239381|3813699|B1|Head and Neck||Primary Cancer Site||Participants|Count of Participants|2|2.0||||||
3991762|NCT01239381|3813699|B1|Anal||Primary Cancer Site||Participants|Count of Participants|2|2.0||||||
3991763|NCT01239381|3813699|B1|Small Bowel or Duodenal||Primary Cancer Site||Participants|Count of Participants|3|3.0||||||
3991764|NCT01239381|3813699|B1|Breast||Primary Cancer Site||Participants|Count of Participants|3|3.0||||||
3991765|NCT01239381|3813699|B1|Gallbladder||Primary Cancer Site||Participants|Count of Participants|3|3.0||||||
3991766|NCT01239381|3813699|B1|Lung||Primary Cancer Site||Participants|Count of Participants|5|5.0||||||
3991767|NCT01239381|3813699|B1|Hepatocellular||Primary Cancer Site||Participants|Count of Participants|8|8.0||||||
3991768|NCT01239381|3813699|B1|Esophagogastric||Primary Cancer Site||Participants|Count of Participants|12|12.0||||||
3991769|NCT01239381|3813699|B1|Pancreatic||Primary Cancer Site||Participants|Count of Participants|16|16.0||||||
3991770|NCT01239381|3813699|B1|Colorectal||Primary Cancer Site||Participants|Count of Participants|35|35.0||||||
3991771|NCT01239381|3813699|B1|United States||Region of Enrollment||Participants|Count of Participants|90|90.0||||||
3991772|NCT01239381|3813699|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3991773|NCT01239381|3813699|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3991774|NCT01239381|3813699|B1|||Age||years|Median|68|68.0|Full Range|||34.0|89.0|
3991775|NCT01239368|3813709|B11|United States||Region of Enrollment||participants|Number|31|31.0||||||
3991776|NCT01239368|3813710|B10|United States||Region of Enrollment||participants|Number|5|5.0||||||
3991777|NCT01239368|3813711|B9|United States||Region of Enrollment||participants|Number|1|1.0||||||
3991778|NCT01239368|3813713|B7|United States||Region of Enrollment||participants|Number|7|7.0||||||
3991779|NCT01239368|3813714|B6|United States||Region of Enrollment||participants|Number|5|5.0||||||
3991780|NCT01239368|3813715|B5|United States||Region of Enrollment||participants|Number|7|7.0||||||
3991781|NCT01239368|3813716|B4|United States||Region of Enrollment||participants|Number|2|2.0||||||
3991782|NCT01239368|3813717|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
3991783|NCT01239368|3813718|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3991784|NCT01239368|3813719|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3991785|NCT01239368|3813709|B11||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3991786|NCT01239368|3813710|B10||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3991787|NCT01239368|3813711|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991788|NCT01239368|3813713|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3991789|NCT01239368|3813714|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991790|NCT01239368|3813715|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991791|NCT01239368|3813716|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3991792|NCT01239368|3813717|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991793|NCT01239368|3813718|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3991794|NCT01239368|3813719|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991795|NCT01239368|3813709|B11||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991796|NCT01239368|3813710|B10||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991797|NCT01239368|3813711|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991798|NCT01239368|3813713|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991799|NCT01239368|3813714|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991800|NCT01239368|3813715|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991801|NCT01239368|3813716|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991802|NCT01239368|3813717|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991803|NCT01239368|3813718|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991804|NCT01239368|3813719|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991805|NCT01239368|3813709|B11||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3991806|NCT01239368|3813710|B10||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3991807|NCT01239368|3813711|B9||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3991808|NCT01239368|3813713|B7||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3991809|NCT01239368|3813714|B6||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3991810|NCT01239368|3813715|B5||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3991811|NCT01239368|3813716|B4||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3991812|NCT01239368|3813717|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3991813|NCT01239368|3813718|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991814|NCT01239368|3813719|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3991815|NCT01239368|3813709|B11||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3991816|NCT01239368|3813710|B10||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3991817|NCT01239368|3813711|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991818|NCT01239368|3813713|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991819|NCT01239368|3813714|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3991820|NCT01239368|3813715|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3991821|NCT01239368|3813716|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991822|NCT01239368|3813717|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991823|NCT01239368|3813718|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991824|NCT01239368|3813719|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3991825|NCT01239368|3813709|B11||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991826|NCT01239368|3813710|B10||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991827|NCT01239368|3813711|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991828|NCT01239368|3813713|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991829|NCT01239368|3813714|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991830|NCT01239368|3813715|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991831|NCT01239368|3813716|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991832|NCT01239368|3813717|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991833|NCT01239368|3813718|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991834|NCT01239368|3813719|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991835|NCT01239368|3813709|B11||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991836|NCT01239368|3813710|B10||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991837|NCT01239368|3813711|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991838|NCT01239368|3813713|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991839|NCT01239368|3813714|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991840|NCT01239368|3813715|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991841|NCT01239368|3813716|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991842|NCT01239368|3813717|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991843|NCT01239368|3813718|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991844|NCT01239368|3813719|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991845|NCT01239368|3813709|B11||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991846|NCT01239368|3813710|B10||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991847|NCT01239368|3813711|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991848|NCT01239368|3813713|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991849|NCT01239368|3813714|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991850|NCT01239368|3813715|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991851|NCT01239368|3813716|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991852|NCT01239368|3813717|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991853|NCT01239368|3813718|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991854|NCT01239368|3813719|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991855|NCT01239368|3813709|B11||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991856|NCT01239368|3813710|B10||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991857|NCT01239368|3813711|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991858|NCT01239368|3813713|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991859|NCT01239368|3813714|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991860|NCT01239368|3813715|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991861|NCT01239368|3813716|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991862|NCT01239368|3813717|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991863|NCT01239368|3813718|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991864|NCT01239368|3813719|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991865|NCT01239368|3813709|B11||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3991866|NCT01239368|3813710|B10||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3991867|NCT01239368|3813711|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3991868|NCT01239368|3813713|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3991869|NCT01239368|3813714|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3991870|NCT01239368|3813715|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3991871|NCT01239368|3813716|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3991872|NCT01239368|3813717|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3991873|NCT01239368|3813718|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3991935|NCT01239368|3813717|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3991874|NCT01239368|3813719|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3991875|NCT01239368|3813709|B11||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3991876|NCT01239368|3813710|B10||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3991877|NCT01239368|3813711|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991878|NCT01239368|3813712|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991879|NCT01239368|3813713|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3991880|NCT01239368|3813714|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991881|NCT01239368|3813715|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991882|NCT01239368|3813716|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991883|NCT01239368|3813717|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991884|NCT01239368|3813718|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991885|NCT01239368|3813719|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991886|NCT01239368|3813709|B11||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3991887|NCT01239368|3813710|B10||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3991888|NCT01239368|3813711|B9||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3991889|NCT01239368|3813713|B7||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3991890|NCT01239368|3813714|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3991891|NCT01239368|3813715|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3991892|NCT01239368|3813716|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3991893|NCT01239368|3813717|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3991894|NCT01239368|3813718|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3991895|NCT01239368|3813719|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3991896|NCT01239368|3813709|B11||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3991897|NCT01239368|3813710|B10||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3991898|NCT01239368|3813711|B9||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3991899|NCT01239368|3813713|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3991900|NCT01239368|3813714|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3991901|NCT01239368|3813715|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3991902|NCT01239368|3813716|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3991903|NCT01239368|3813717|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3991904|NCT01239368|3813718|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3991905|NCT01239368|3813719|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3991906|NCT01239368|3813709|B11|||Age||years|Mean|55.8|55.8|Standard Deviation|11.65|11.65|||
3991907|NCT01239368|3813710|B10|||Age||years|Mean|63.6|63.6|Standard Deviation|9.08|9.08|||
3991908|NCT01239368|3813711|B9|||Age||years|Mean|66.9|66.9|Standard Deviation|0|0.0|||
3991909|NCT01239368|3813713|B7|||Age||years|Mean|59.29|59.29|Standard Deviation|9.58|9.58|||
3991910|NCT01239368|3813714|B6|||Age||years|Mean|57.64|57.64|Standard Deviation|6.18|6.18|||
3991911|NCT01239368|3813715|B5|||Age||years|Mean|58.19|58.19|Standard Deviation|13.79|13.79|||
3991912|NCT01239368|3813716|B4|||Age||years|Mean|46.7|46.7|Standard Deviation|15.56|15.56|||
3991913|NCT01239368|3813717|B3|||Age||years|Mean|65.8|65.8|Standard Deviation|0|0.0|||
3991914|NCT01239368|3813718|B2|||Age||years|Mean|41.3|41.3|Standard Deviation|0|0.0|||
3991915|NCT01239368|3813719|B1|||Age||years|Mean|45.4|45.4|Standard Deviation|13.58|13.58|||
3991916|NCT01239368|3813709|B11||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3991917|NCT01239368|3813710|B10||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3991918|NCT01239368|3813711|B9||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3991919|NCT01239368|3813712|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3991920|NCT01239368|3813713|B7||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3991921|NCT01239368|3813714|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3991922|NCT01239368|3813715|B5||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3991923|NCT01239368|3813716|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3991924|NCT01239368|3813717|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3991925|NCT01239368|3813718|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3991926|NCT01239368|3813719|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3991927|NCT01239368|3813709|B11||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3991928|NCT01239368|3813710|B10||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3991929|NCT01239368|3813711|B9||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3991930|NCT01239368|3813712|B8||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3991931|NCT01239368|3813713|B7||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3991932|NCT01239368|3813714|B6||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3991933|NCT01239368|3813715|B5||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3991934|NCT01239368|3813716|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3991936|NCT01239368|3813718|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3991937|NCT01239368|3813719|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3991938|NCT01239368|3813709|B11||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3991939|NCT01239368|3813710|B10||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3991940|NCT01239368|3813711|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3991941|NCT01239368|3813712|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3991942|NCT01239368|3813713|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3991943|NCT01239368|3813714|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3991944|NCT01239368|3813715|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3991945|NCT01239368|3813716|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3991946|NCT01239368|3813717|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3991947|NCT01239368|3813718|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3991948|NCT01239368|3813719|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3991949|NCT01239355|3813772|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3991950|NCT01239355|3813772|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3991951|NCT01239355|3813772|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3991952|NCT01239355|3813772|B1|||Age||years|Median|65|65.0|Full Range|||50.0|85.0|
3991953|NCT01239342|3813778|B3|United States||Region of Enrollment||participants|Number|43|43.0||||||
3991954|NCT01239342|3813779|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
3991955|NCT01239342|3813780|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3991956|NCT01239342|3813778|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991957|NCT01239342|3813779|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991958|NCT01239342|3813780|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991959|NCT01239342|3813778|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991960|NCT01239342|3813779|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991961|NCT01239342|3813780|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991962|NCT01239342|3813778|B3||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3991963|NCT01239342|3813779|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3991964|NCT01239342|3813780|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3991965|NCT01239342|3813778|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3991966|NCT01239342|3813779|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991967|NCT01239342|3813780|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3991968|NCT01239342|3813778|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991969|NCT01239342|3813779|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991970|NCT01239342|3813780|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991971|NCT01239342|3813778|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3991972|NCT01239342|3813779|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991973|NCT01239342|3813780|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3991974|NCT01239342|3813778|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991975|NCT01239342|3813779|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991976|NCT01239342|3813780|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991977|NCT01239342|3813778|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991978|NCT01239342|3813779|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991979|NCT01239342|3813780|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3991980|NCT01239342|3813778|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3991981|NCT01239342|3813779|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3991982|NCT01239342|3813780|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3991983|NCT01239342|3813778|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3991984|NCT01239342|3813779|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3991985|NCT01239342|3813780|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3991986|NCT01239342|3813778|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3991987|NCT01239342|3813779|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3991988|NCT01239342|3813780|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3991989|NCT01239342|3813778|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3991990|NCT01239342|3813779|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3991991|NCT01239342|3813780|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3991992|NCT01239342|3813778|B3|||Age||years|Median|62|62.0|Full Range|||43.0|84.0|
3991993|NCT01239342|3813779|B2|||Age||years|Median|63.5|63.5|Full Range|||48.0|84.0|
3991994|NCT01239342|3813780|B1|||Age||years|Median|59|59.0|Full Range|||43.0|83.0|
3991995|NCT01239316|3813797|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3991996|NCT01239316|3813797|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3991997|NCT01239316|3813797|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3991998|NCT01239316|3813797|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3991999|NCT01239316|3813797|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992000|NCT01239316|3813797|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992001|NCT01239316|3813797|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992002|NCT01239316|3813797|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992003|NCT01239316|3813797|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3992004|NCT01239316|3813797|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3992005|NCT01239316|3813797|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3992006|NCT01239316|3813797|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3992007|NCT01239316|3813797|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3992008|NCT01239316|3813797|B1|||Age|Age at study enrollment|years|Median|10.4|10.4|Full Range|||3.9|20.0|
3992009|NCT01239212|3813805|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3992010|NCT01239212|3813805|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3992011|NCT01239212|3813805|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3992012|NCT01239212|3813805|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3992013|NCT01239212|3813805|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3992014|NCT01239212|3813805|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
3992015|NCT01239121|3813809|B4|United States||Region of Enrollment||participants|Number|396|396.0||||||
3992016|NCT01239121|3813810|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
3992017|NCT01239121|3813811|B2|United States||Region of Enrollment||participants|Number|195|195.0||||||
3992018|NCT01239121|3813812|B1|United States||Region of Enrollment||participants|Number|186|186.0||||||
3992019|NCT01239121|3813809|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3992020|NCT01239121|3813810|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992021|NCT01239121|3813811|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3992022|NCT01239121|3813812|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3992023|NCT01239121|3813809|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3992024|NCT01239121|3813810|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992025|NCT01239121|3813811|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3992026|NCT01239121|3813812|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992027|NCT01239121|3813809|B4||White|Race (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
3992028|NCT01239121|3813810|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3992029|NCT01239121|3813811|B2||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3992030|NCT01239121|3813812|B1||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3992031|NCT01239121|3813809|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|245|245.0||||||
3992032|NCT01239121|3813810|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3992033|NCT01239121|3813811|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
3992034|NCT01239121|3813812|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|121|121.0||||||
3992035|NCT01239121|3813809|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3992036|NCT01239121|3813810|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992037|NCT01239121|3813811|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3992038|NCT01239121|3813812|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992039|NCT01239121|3813809|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992040|NCT01239121|3813810|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992041|NCT01239121|3813811|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992042|NCT01239121|3813812|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992043|NCT01239121|3813809|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992044|NCT01239121|3813810|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992045|NCT01239121|3813811|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992046|NCT01239121|3813812|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992047|NCT01239121|3813809|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3992048|NCT01239121|3813810|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3992049|NCT01239121|3813811|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3992050|NCT01239121|3813812|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3992051|NCT01239121|3813809|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|287|287.0||||||
3992052|NCT01239121|3813810|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3992053|NCT01239121|3813811|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
3992054|NCT01239121|3813812|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
3992055|NCT01239121|3813809|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3992056|NCT01239121|3813810|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992057|NCT01239121|3813811|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3992058|NCT01239121|3813812|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3992059|NCT01239121|3813809|B4||Male|Sex: Female, Male||Participants|Count of Participants|383|383.0||||||
3992060|NCT01239121|3813810|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3992061|NCT01239121|3813811|B2||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3992062|NCT01239121|3813812|B1||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3992063|NCT01239121|3813809|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3992064|NCT01239121|3813810|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3992065|NCT01239121|3813811|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3992066|NCT01239121|3813812|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3992067|NCT01239121|3813809|B4|||Age||years|Mean|60.5|60.5|Standard Deviation|14.1|14.1|||
3992068|NCT01239121|3813810|B3|||Age||years|Mean|86.4|86.4|Standard Deviation|6.8|6.8|||
3992069|NCT01239121|3813811|B2|||Age||years|Mean|60.8|60.8|Standard Deviation|14.5|14.5|||
3992070|NCT01239121|3813812|B1|||Age||years|Mean|59.7|59.7|Standard Deviation|14.4|14.4|||
3992071|NCT01239056|3813828|B1|||Pseudocyst diameter||centimeters|Mean|13.4|13.4|Full Range|||5.5|23.0|
3992072|NCT01239056|3813828|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3992073|NCT01239056|3813828|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3992074|NCT01239056|3813828|B1|||Age||years|Mean|57|57.0|Full Range|||34.0|85.0|
3992075|NCT01239043|3813834|B3|United States||Region of Enrollment||Participants|Number|139|139.0||||||
3992076|NCT01239043|3813835|B2|United States||Region of Enrollment||Participants|Number|103|103.0||||||
3992077|NCT01239043|3813836|B1|United States||Region of Enrollment||Participants|Number|36|36.0||||||
3992078|NCT01239043|3813834|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3992079|NCT01239043|3813835|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3992080|NCT01239043|3813836|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3992081|NCT01239043|3813834|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3992082|NCT01239043|3813835|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3992083|NCT01239043|3813836|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3992084|NCT01239043|3813834|B3|||Age||Years|Mean|71.3|71.3|Standard Deviation|6.9|6.9|||
3992085|NCT01239043|3813835|B2|||Age||Years|Mean|71.1|71.1|Standard Deviation|6.8|6.8|||
3992086|NCT01239043|3813836|B1|||Age||Years|Mean|71.8|71.8|Standard Deviation|7.2|7.2|||
3992087|NCT01239043|3813834|B3||>=65 years|Age||Participants|Count of Participants|103|103.0||||||
3992088|NCT01239043|3813835|B2||>=65 years|Age||Participants|Count of Participants|75|75.0||||||
3992089|NCT01239043|3813836|B1||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
3992090|NCT01239043|3813834|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
3992091|NCT01239043|3813835|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3992092|NCT01239043|3813836|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3992093|NCT01239043|3813834|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3992094|NCT01239043|3813835|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3992095|NCT01239043|3813836|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3992096|NCT01238991|3813855|B11||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3992097|NCT01238991|3813856|B10||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3992098|NCT01238991|3813857|B9||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3992099|NCT01238991|3813858|B8||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3992100|NCT01238991|3813859|B7||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3992101|NCT01238991|3813860|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3992102|NCT01238991|3813861|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3992103|NCT01238991|3813862|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3992104|NCT01238991|3813863|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3992105|NCT01238991|3813864|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3992106|NCT01238991|3813865|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3992107|NCT01238991|3813855|B11||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3992108|NCT01238991|3813856|B10||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3992109|NCT01238991|3813857|B9||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3992110|NCT01238991|3813858|B8||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3992111|NCT01238991|3813859|B7||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3992112|NCT01238991|3813860|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3992113|NCT01238991|3813861|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3992114|NCT01238991|3813862|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3992115|NCT01238991|3813863|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3992116|NCT01238991|3813864|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3992117|NCT01238991|3813865|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3992118|NCT01238991|3813855|B11|||Age||years|Mean|69.2|69.2|Standard Deviation|7.6|7.6|||
3992119|NCT01238991|3813856|B10|||Age||years|Mean|68.5|68.5|Standard Deviation|2.1|2.1|||
3992120|NCT01238991|3813857|B9|||Age||years|Mean|64|64.0|Standard Deviation|7.1|7.1|||
3992121|NCT01238991|3813858|B8|||Age||years|Mean|71.2|71.2|Standard Deviation|2|2.0|||
3992122|NCT01238991|3813859|B7|||Age||years|Mean|73.9|73.9|Standard Deviation|5.4|5.4|||
3992123|NCT01238991|3813860|B6|||Age||years|Mean|70.5|70.5|Standard Deviation|7.8|7.8|||
3992124|NCT01238991|3813861|B5|||Age||years|Mean|65.2|65.2|Standard Deviation|6.7|6.7|||
3992125|NCT01238991|3813862|B4|||Age||years|Mean|69.5|69.5|Standard Deviation|6.9|6.9|||
3992126|NCT01238991|3813863|B3|||Age||years|Mean|67.5|67.5|Standard Deviation|9.8|9.8|||
3992127|NCT01238991|3813864|B2|||Age||years|Mean|73.3|73.3|Standard Deviation|9.2|9.2|||
3992128|NCT01238991|3813865|B1|||Age||years|Mean|69|69.0|Standard Deviation|9.8|9.8|||
3992129|NCT01238900|3813961|B1|number with no history of stenting||number of participants with history of prior stenting||participants|Number|10|10.0||||||
3992130|NCT01238900|3813961|B1|number with prior stenting||number of participants with history of prior stenting||participants|Number|13|13.0||||||
3992131|NCT01238900|3813961|B1|Gallstone related||Stricture etiology||participants|Number|1|1.0||||||
3992132|NCT01238900|3813961|B1|Idiopathic||Stricture etiology||participants|Number|4|4.0||||||
3992133|NCT01238900|3813961|B1|Orthotopic liver transplantation (OLT)||Stricture etiology||participants|Number|4|4.0||||||
3992134|NCT01238900|3813961|B1|Chronic pancreatitis (CP)||Stricture etiology||participants|Number|14|14.0||||||
3992135|NCT01238900|3813961|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
3992136|NCT01238900|3813961|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3992137|NCT01238900|3813961|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3992138|NCT01238900|3813961|B1|||Age, Customized||years|Mean|60|60.0|Full Range|||51.0|70.0|
3992139|NCT01238861|3813969|B7||Male|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
3992140|NCT01238861|3813970|B6||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3992141|NCT01238861|3813971|B5||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3992142|NCT01238861|3813972|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3992143|NCT01238861|3813973|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3992144|NCT01238861|3813974|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3992145|NCT01238861|3813975|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3992146|NCT01238861|3813969|B7||Female|Sex: Female, Male||Participants|Count of Participants|417|417.0||||||
3992147|NCT01238861|3813970|B6||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3992148|NCT01238861|3813971|B5||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3992149|NCT01238861|3813972|B4||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3992150|NCT01238861|3813973|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3992151|NCT01238861|3813974|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3992152|NCT01238861|3813975|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3992153|NCT01238861|3813969|B7|||Age||years|Mean|48.3|48.3|Standard Deviation|12.4|12.4|||
3992154|NCT01238861|3813970|B6|||Age||years|Mean|50.0|50.0|Standard Deviation|11.5|11.5|||
3992155|NCT01238861|3813971|B5|||Age||years|Mean|50.0|50.0|Standard Deviation|12.3|12.3|||
3992156|NCT01238861|3813972|B4|||Age||years|Mean|47.8|47.8|Standard Deviation|12.9|12.9|||
3992157|NCT01238861|3813973|B3|||Age||years|Mean|46.6|46.6|Standard Deviation|13.2|13.2|||
3992158|NCT01238861|3813974|B2|||Age||years|Mean|47.1|47.1|Standard Deviation|12.8|12.8|||
3992159|NCT01238861|3813975|B1|||Age||years|Mean|45.6|45.6|Standard Deviation|11.7|11.7|||
3992160|NCT01238848|3814058|B3||Male|Gender||Participants|Count of Participants|50|50.0||||||
3992161|NCT01238848|3814059|B2||Male|Gender||Participants|Count of Participants|24|24.0||||||
3992162|NCT01238848|3814060|B1||Male|Gender||Participants|Count of Participants|26|26.0||||||
3992163|NCT01238848|3814058|B3||Female|Gender||Participants|Count of Participants|50|50.0||||||
3992164|NCT01238848|3814059|B2||Female|Gender||Participants|Count of Participants|26|26.0||||||
3992165|NCT01238848|3814060|B1||Female|Gender||Participants|Count of Participants|24|24.0||||||
3992166|NCT01238848|3814058|B3|||Age||months|Mean|4.5|4.5|Standard Deviation|3.8|3.8|||
3992167|NCT01238848|3814059|B2|||Age||months|Mean|4.2|4.2|Standard Deviation|2.5|2.5|||
3992168|NCT01238848|3814060|B1|||Age||months|Mean|4.6|4.6|Standard Deviation|4.1|4.1|||
3992169|NCT01238848|3814058|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3992170|NCT01238848|3814059|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3992171|NCT01238848|3814060|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3992172|NCT01238848|3814058|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3992173|NCT01238848|3814059|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3992174|NCT01238848|3814060|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3992175|NCT01238848|3814058|B3||<=18 years|Age||Participants|Count of Participants|100|100.0||||||
3992176|NCT01238848|3814059|B2||<=18 years|Age||Participants|Count of Participants|50|50.0||||||
3992177|NCT01238848|3814060|B1||<=18 years|Age||Participants|Count of Participants|50|50.0||||||
3992178|NCT01238822|3814069|B1|United States||Region of Enrollment||participants|Number|96|96.0||||||
3992179|NCT01238822|3814069|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3992180|NCT01238822|3814069|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3992181|NCT01238822|3814069|B1|||Age||years|Mean|8.11|8.11|Standard Deviation|1.22|1.22|||
3992182|NCT01238822|3814069|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3992183|NCT01238822|3814069|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3992184|NCT01238822|3814069|B1||<=18 years|Age||Participants|Count of Participants|96|96.0||||||
3992185|NCT01238640|3814079|B1|Sweden||Region of Enrollment||participants|Number|84|84.0||||||
3992186|NCT01238640|3814079|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3992187|NCT01238640|3814079|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3992188|NCT01238640|3814079|B1|||Age||years|Mean|32.2|32.2|Standard Deviation|9.32|9.32|||
3992189|NCT01238588|3814096|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3992190|NCT01238588|3814096|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3992191|NCT01238588|3814096|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3992192|NCT01238588|3814096|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3992193|NCT01238588|3814096|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3992194|NCT01238588|3814096|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3992195|NCT01238575|3814107|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992196|NCT01238575|3814108|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992197|NCT01238575|3814109|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992198|NCT01238575|3814107|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3992199|NCT01238575|3814108|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3992200|NCT01238575|3814109|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992201|NCT01238575|3814107|B3||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3992202|NCT01238575|3814108|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3992203|NCT01238575|3814109|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3992204|NCT01238575|3814107|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3992205|NCT01238575|3814108|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3992206|NCT01238575|3814109|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3992207|NCT01238575|3814107|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3992208|NCT01238575|3814108|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992209|NCT01238575|3814109|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992210|NCT01238575|3814107|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3992211|NCT01238575|3814108|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992212|NCT01238575|3814109|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3992213|NCT01238575|3814107|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992214|NCT01238575|3814108|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992215|NCT01238575|3814109|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992216|NCT01238575|3814107|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3992217|NCT01238575|3814108|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3992218|NCT01238575|3814109|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3992219|NCT01238575|3814107|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3992220|NCT01238575|3814108|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3992221|NCT01238575|3814109|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3992222|NCT01238575|3814107|B3|||Age||years|Mean|8.4|8.4|Standard Deviation|2.25|2.25|||
3992223|NCT01238575|3814108|B2|||Age||years|Mean|8.39|8.39|Standard Deviation|2.23|2.23|||
3992224|NCT01238575|3814109|B1|||Age||years|Mean|8.44|8.44|Standard Deviation|2.28|2.28|||
3992225|NCT01238549|3814146|B1|United States||Region of Enrollment||Participants|Count of Participants|248|248.0||||||
3992226|NCT01238549|3814146|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3992227|NCT01238549|3814146|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3992228|NCT01238549|3814146|B1||White|Race (NIH/OMB)||Participants|Count of Participants|168|168.0||||||
3992229|NCT01238549|3814146|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
3992230|NCT01238549|3814146|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992231|NCT01238549|3814146|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3992232|NCT01238549|3814146|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3992233|NCT01238549|3814146|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3992234|NCT01238549|3814146|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|218|218.0||||||
3992235|NCT01238549|3814146|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3992236|NCT01238549|3814146|B1||Male|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
3992237|NCT01238549|3814146|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3992238|NCT01238549|3814146|B1|||Age||years|Mean|56.98|56.98|Standard Deviation|12.56|12.56|||
3992239|NCT01238549|3814146|B1||>=65 years|Age||Participants|Count of Participants|63|63.0||||||
3992240|NCT01238549|3814146|B1||Between 18 and 65 years|Age||Participants|Count of Participants|185|185.0||||||
3992241|NCT01238549|3814146|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3992242|NCT01238536|3814163|B3||Male|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
3992243|NCT01238536|3814164|B2||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3992244|NCT01238536|3814165|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3992245|NCT01238536|3814163|B3||Female|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
3992246|NCT01238536|3814164|B2||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3992247|NCT01238536|3814165|B1||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3992248|NCT01238536|3814163|B3|||Age||years|Mean|68|68.0|Standard Deviation|10.0|10.0|||
3992249|NCT01238536|3814164|B2|||Age||years|Mean|68.1|68.1|Standard Deviation|10.2|10.2|||
3992250|NCT01238536|3814165|B1|||Age||years|Mean|68.0|68.0|Standard Deviation|9.8|9.8|||
3992251|NCT01238471|3814178|B3|Israel||Region of Enrollment||participants|Number|20|20.0||||||
3992252|NCT01238471|3814179|B2|Israel||Region of Enrollment||participants|Number|10|10.0||||||
3992253|NCT01238471|3814180|B1|Israel||Region of Enrollment||participants|Number|10|10.0||||||
3992254|NCT01238471|3814178|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3992255|NCT01238471|3814179|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3992256|NCT01238471|3814180|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3992257|NCT01238471|3814178|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3992258|NCT01238471|3814179|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3992259|NCT01238471|3814180|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3992260|NCT01238471|3814178|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3992261|NCT01238471|3814179|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3992262|NCT01238471|3814180|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3992263|NCT01238471|3814178|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3992264|NCT01238471|3814179|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3992265|NCT01238471|3814180|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3992266|NCT01238471|3814178|B3||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
3992267|NCT01238471|3814179|B2||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
3992268|NCT01238471|3814180|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
3992269|NCT01238471|3814178|B3|||Age||days|Mean|62.6|62.6|Standard Deviation|7.7|7.7|||
3992270|NCT01238471|3814179|B2|||Age||days|Mean|64.4|64.4|Standard Deviation|10.5|10.5|||
3992271|NCT01238471|3814180|B1|||Age||days|Mean|60.9|60.9|Standard Deviation|4.9|4.9|||
3992272|NCT01238341|3814187|B1|Pancreatic leak||Indications for Endoscopic Retrograde Cholangiopancreatography (ERCP)||participants|Number|1|1.0||||||
3992273|NCT01238341|3814187|B1|Bile duct stones||Indications for Endoscopic Retrograde Cholangiopancreatography (ERCP)||participants|Number|1|1.0||||||
3992274|NCT01238341|3814187|B1|Biliary obstruction||Indications for Endoscopic Retrograde Cholangiopancreatography (ERCP)||participants|Number|5|5.0||||||
3992275|NCT01238341|3814187|B1|Billroth II gastrectomy w/ Braun enteroenterostomy||Postsurgical anatomy||participants|Number|1|1.0||||||
3992276|NCT01238341|3814187|B1|Roux-en-Y gastric bypass with hepaticojejunostomy||Postsurgical anatomy||participants|Number|1|1.0||||||
3992277|NCT01238341|3814187|B1|Roux-en-Y gastric bypass||Postsurgical anatomy||participants|Number|3|3.0||||||
3992278|NCT01238341|3814187|B1|Roux-en-Y hepaticojejunostomy||Postsurgical anatomy||participants|Number|2|2.0||||||
3992279|NCT01238341|3814187|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
3992280|NCT01238341|3814187|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3992281|NCT01238341|3814187|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3992282|NCT01238341|3814187|B1|||Age||years|Mean|59.3|59.3|Full Range|||39.0|72.0|
3992283|NCT01238211|3814194|B1|United States||Region of Enrollment||participants|Number|61|61.0||||||
3992284|NCT01238211|3814194|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3992285|NCT01238211|3814194|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992286|NCT01238211|3814194|B1||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
3992287|NCT01238211|3814194|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3992288|NCT01238211|3814194|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992289|NCT01238211|3814194|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992290|NCT01238211|3814194|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992291|NCT01238211|3814194|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3992292|NCT01238211|3814194|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3992293|NCT01238211|3814194|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992294|NCT01238211|3814194|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3992295|NCT01238211|3814194|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3992296|NCT01238211|3814194|B1|||Age||years|Median|51|51.0|Full Range|||19.8|85.0|
3992297|NCT01237678|3814198|B4|No||History of Smoking||participants|Number|14|14.0||||||
3992298|NCT01237678|3814199|B3|No||History of Smoking||participants|Number|1|1.0||||||
3992299|NCT01237678|3814200|B2|No||History of Smoking||participants|Number|1|1.0||||||
3992300|NCT01237678|3814201|B1|No||History of Smoking||participants|Number|12|12.0||||||
3992301|NCT01237678|3814198|B4|Yes||History of Smoking||participants|Number|160|160.0||||||
3992302|NCT01237678|3814199|B3|Yes||History of Smoking||participants|Number|46|46.0||||||
3992303|NCT01237678|3814200|B2|Yes||History of Smoking||participants|Number|93|93.0||||||
3992304|NCT01237678|3814201|B1|Yes||History of Smoking||participants|Number|21|21.0||||||
3992305|NCT01237678|3814198|B4|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 = Fully active, able to carry out all pre-disease performance without restriction.~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature.~= Ambulatory and capable of all self-care but unable to carry out work activities. Up and about more than 50% of waking hours."|Participants|Count of Participants|13|13.0||||||
3992306|NCT01237678|3814199|B3|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 = Fully active, able to carry out all pre-disease performance without restriction.~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature.~= Ambulatory and capable of all self-care but unable to carry out work activities. Up and about more than 50% of waking hours."|Participants|Count of Participants|3|3.0||||||
3992307|NCT01237678|3814200|B2|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 = Fully active, able to carry out all pre-disease performance without restriction.~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature.~= Ambulatory and capable of all self-care but unable to carry out work activities. Up and about more than 50% of waking hours."|Participants|Count of Participants|10|10.0||||||
3992308|NCT01237678|3814201|B1|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 = Fully active, able to carry out all pre-disease performance without restriction.~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature.~= Ambulatory and capable of all self-care but unable to carry out work activities. Up and about more than 50% of waking hours."|Participants|Count of Participants|0|0.0||||||
3992309|NCT01237678|3814198|B4|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 = Fully active, able to carry out all pre-disease performance without restriction.~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature.~= Ambulatory and capable of all self-care but unable to carry out work activities. Up and about more than 50% of waking hours."|Participants|Count of Participants|113|113.0||||||
3992310|NCT01237678|3814199|B3|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 = Fully active, able to carry out all pre-disease performance without restriction.~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature.~= Ambulatory and capable of all self-care but unable to carry out work activities. Up and about more than 50% of waking hours."|Participants|Count of Participants|32|32.0||||||
3992311|NCT01237678|3814200|B2|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 = Fully active, able to carry out all pre-disease performance without restriction.~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature.~= Ambulatory and capable of all self-care but unable to carry out work activities. Up and about more than 50% of waking hours."|Participants|Count of Participants|62|62.0||||||
3992312|NCT01237678|3814201|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 = Fully active, able to carry out all pre-disease performance without restriction.~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature.~= Ambulatory and capable of all self-care but unable to carry out work activities. Up and about more than 50% of waking hours."|Participants|Count of Participants|19|19.0||||||
3992313|NCT01237678|3814198|B4|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 = Fully active, able to carry out all pre-disease performance without restriction.~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature.~= Ambulatory and capable of all self-care but unable to carry out work activities. Up and about more than 50% of waking hours."|Participants|Count of Participants|48|48.0||||||
3992314|NCT01237678|3814199|B3|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 = Fully active, able to carry out all pre-disease performance without restriction.~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature.~= Ambulatory and capable of all self-care but unable to carry out work activities. Up and about more than 50% of waking hours."|Participants|Count of Participants|12|12.0||||||
3992315|NCT01237678|3814200|B2|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 = Fully active, able to carry out all pre-disease performance without restriction.~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature.~= Ambulatory and capable of all self-care but unable to carry out work activities. Up and about more than 50% of waking hours."|Participants|Count of Participants|22|22.0||||||
3992316|NCT01237678|3814201|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 = Fully active, able to carry out all pre-disease performance without restriction.~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature.~= Ambulatory and capable of all self-care but unable to carry out work activities. Up and about more than 50% of waking hours."|Participants|Count of Participants|14|14.0||||||
3992317|NCT01237678|3814198|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992318|NCT01237678|3814199|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992319|NCT01237678|3814200|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992320|NCT01237678|3814201|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992321|NCT01237678|3814198|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992322|NCT01237678|3814199|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992323|NCT01237678|3814200|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992324|NCT01237678|3814201|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992325|NCT01237678|3814198|B4||White|Race (NIH/OMB)||Participants|Count of Participants|164|164.0||||||
3992326|NCT01237678|3814199|B3||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3992327|NCT01237678|3814200|B2||White|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
3992328|NCT01237678|3814201|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3992329|NCT01237678|3814198|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3992330|NCT01237678|3814199|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3992331|NCT01237678|3814200|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3992332|NCT01237678|3814201|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3992333|NCT01237678|3814198|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992334|NCT01237678|3814199|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992335|NCT01237678|3814200|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992336|NCT01237678|3814201|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992337|NCT01237678|3814198|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992338|NCT01237678|3814199|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992339|NCT01237678|3814200|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992340|NCT01237678|3814201|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992341|NCT01237678|3814198|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992342|NCT01237678|3814199|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992343|NCT01237678|3814200|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992344|NCT01237678|3814201|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992345|NCT01237678|3814198|B4||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3992346|NCT01237678|3814199|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3992347|NCT01237678|3814200|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3992348|NCT01237678|3814201|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3992349|NCT01237678|3814198|B4||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3992350|NCT01237678|3814199|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3992351|NCT01237678|3814200|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3992352|NCT01237678|3814201|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3992353|NCT01237678|3814198|B4||>=65 years|Age||Participants|Count of Participants|78|78.0||||||
3992354|NCT01237678|3814199|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
3992355|NCT01237678|3814200|B2||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
3992356|NCT01237678|3814201|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3992357|NCT01237678|3814198|B4||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
3992358|NCT01237678|3814199|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
3992359|NCT01237678|3814200|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
3992360|NCT01237678|3814201|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3992361|NCT01237678|3814198|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3992362|NCT01237678|3814199|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3992363|NCT01237678|3814200|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3992364|NCT01237678|3814201|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3992365|NCT01237613|3814222|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
3992366|NCT01237613|3814222|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3992367|NCT01237613|3814222|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3992368|NCT01237613|3814222|B1|||Age||years|Mean|54|54.0|Full Range|||38.0|63.0|
3992369|NCT01237613|3814222|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3992370|NCT01237613|3814222|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3992371|NCT01237613|3814222|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3992372|NCT01237587|3814246|B3|Total Score||Multidimensional Anxiety Scale for Children (MASC)|"MASC consists of 39 items that comprise 4 factors. Each item is scored on a 0 to 3-point scale (0-never to 3-often).~Physical symptoms (tense/restless and somatic/autonomic) - 12 items with score range 0 to 36.~Social anxiety (humiliation/rejection and public performance fears) - 9 items with score range of 0 to 27.~Harm avoidance (perfectionism and anxious coping) - 9 items with score range of 0 to 27.~Separation anxiety - 9 items with score range of 0 to 27. Total score ranges from 0 to 117. Higher the total score, the more severe the anxiety."|units on a scale|Mean|44.5|44.5|Standard Deviation|17.65|17.65|||
3992396|NCT01237587|3814246|B3|||Clinical Global Impression (CGI) Severity: Overall Illness|Clinical Global Impression of Severity: Overall Illness (CGI-S: Overall Illness) scale evaluates the severity of the overall illness of Juvenile Primary Fibromyalgia Syndrome (JPFS), including all relevant, associated symptoms. The scoring ranges from 1 (normal, not at all ill) to 7 (among the most extremely ill participants). The scoring is based on observed and reported symptoms and behaviors over the past 7 days that are ongoing at the time of the Study Visit.|units on a scale|Mean|4.1|4.1|Standard Deviation|0.9|0.9|||
3992373|NCT01237587|3814247|B2|Total Score||Multidimensional Anxiety Scale for Children (MASC)|"MASC consists of 39 items that comprise 4 factors. Each item is scored on a 0 to 3-point scale (0-never to 3-often).~Physical symptoms (tense/restless and somatic/autonomic) - 12 items with score range 0 to 36.~Social anxiety (humiliation/rejection and public performance fears) - 9 items with score range of 0 to 27.~Harm avoidance (perfectionism and anxious coping) - 9 items with score range of 0 to 27.~Separation anxiety - 9 items with score range of 0 to 27. Total score ranges from 0 to 117. Higher the total score, the more severe the anxiety."|units on a scale|Mean|43.9|43.9|Standard Deviation|18.7|18.7|||
3992374|NCT01237587|3814248|B1|Total Score||Multidimensional Anxiety Scale for Children (MASC)|"MASC consists of 39 items that comprise 4 factors. Each item is scored on a 0 to 3-point scale (0-never to 3-often).~Physical symptoms (tense/restless and somatic/autonomic) - 12 items with score range 0 to 36.~Social anxiety (humiliation/rejection and public performance fears) - 9 items with score range of 0 to 27.~Harm avoidance (perfectionism and anxious coping) - 9 items with score range of 0 to 27.~Separation anxiety - 9 items with score range of 0 to 27. Total score ranges from 0 to 117. Higher the total score, the more severe the anxiety."|units on a scale|Mean|45.1|45.1|Standard Deviation|16.6|16.6|||
3992375|NCT01237587|3814246|B3|Separation/Panic||Multidimensional Anxiety Scale for Children (MASC)|"MASC consists of 39 items that comprise 4 factors. Each item is scored on a 0 to 3-point scale (0-never to 3-often).~Physical symptoms (tense/restless and somatic/autonomic) - 12 items with score range 0 to 36.~Social anxiety (humiliation/rejection and public performance fears) - 9 items with score range of 0 to 27.~Harm avoidance (perfectionism and anxious coping) - 9 items with score range of 0 to 27.~Separation anxiety - 9 items with score range of 0 to 27. Total score ranges from 0 to 117. Higher the total score, the more severe the anxiety."|units on a scale|Mean|6.4|6.4|Standard Deviation|4.7|4.7|||
3992376|NCT01237587|3814247|B2|Separation/Panic||Multidimensional Anxiety Scale for Children (MASC)|"MASC consists of 39 items that comprise 4 factors. Each item is scored on a 0 to 3-point scale (0-never to 3-often).~Physical symptoms (tense/restless and somatic/autonomic) - 12 items with score range 0 to 36.~Social anxiety (humiliation/rejection and public performance fears) - 9 items with score range of 0 to 27.~Harm avoidance (perfectionism and anxious coping) - 9 items with score range of 0 to 27.~Separation anxiety - 9 items with score range of 0 to 27. Total score ranges from 0 to 117. Higher the total score, the more severe the anxiety."|units on a scale|Mean|6.0|6.0|Standard Deviation|4.5|4.5|||
3992377|NCT01237587|3814248|B1|Separation/Panic||Multidimensional Anxiety Scale for Children (MASC)|"MASC consists of 39 items that comprise 4 factors. Each item is scored on a 0 to 3-point scale (0-never to 3-often).~Physical symptoms (tense/restless and somatic/autonomic) - 12 items with score range 0 to 36.~Social anxiety (humiliation/rejection and public performance fears) - 9 items with score range of 0 to 27.~Harm avoidance (perfectionism and anxious coping) - 9 items with score range of 0 to 27.~Separation anxiety - 9 items with score range of 0 to 27. Total score ranges from 0 to 117. Higher the total score, the more severe the anxiety."|units on a scale|Mean|6.7|6.7|Standard Deviation|4.9|4.9|||
3992378|NCT01237587|3814246|B3|Social Anxiety||Multidimensional Anxiety Scale for Children (MASC)|"MASC consists of 39 items that comprise 4 factors. Each item is scored on a 0 to 3-point scale (0-never to 3-often).~Physical symptoms (tense/restless and somatic/autonomic) - 12 items with score range 0 to 36.~Social anxiety (humiliation/rejection and public performance fears) - 9 items with score range of 0 to 27.~Harm avoidance (perfectionism and anxious coping) - 9 items with score range of 0 to 27.~Separation anxiety - 9 items with score range of 0 to 27. Total score ranges from 0 to 117. Higher the total score, the more severe the anxiety."|units on a scale|Mean|9.8|9.8|Standard Deviation|6.6|6.6|||
3992379|NCT01237587|3814247|B2|Social Anxiety||Multidimensional Anxiety Scale for Children (MASC)|"MASC consists of 39 items that comprise 4 factors. Each item is scored on a 0 to 3-point scale (0-never to 3-often).~Physical symptoms (tense/restless and somatic/autonomic) - 12 items with score range 0 to 36.~Social anxiety (humiliation/rejection and public performance fears) - 9 items with score range of 0 to 27.~Harm avoidance (perfectionism and anxious coping) - 9 items with score range of 0 to 27.~Separation anxiety - 9 items with score range of 0 to 27. Total score ranges from 0 to 117. Higher the total score, the more severe the anxiety."|units on a scale|Mean|9.8|9.8|Standard Deviation|6.3|6.3|||
3992380|NCT01237587|3814248|B1|Social Anxiety||Multidimensional Anxiety Scale for Children (MASC)|"MASC consists of 39 items that comprise 4 factors. Each item is scored on a 0 to 3-point scale (0-never to 3-often).~Physical symptoms (tense/restless and somatic/autonomic) - 12 items with score range 0 to 36.~Social anxiety (humiliation/rejection and public performance fears) - 9 items with score range of 0 to 27.~Harm avoidance (perfectionism and anxious coping) - 9 items with score range of 0 to 27.~Separation anxiety - 9 items with score range of 0 to 27. Total score ranges from 0 to 117. Higher the total score, the more severe the anxiety."|units on a scale|Mean|9.8|9.8|Standard Deviation|6.3|6.3|||
3992381|NCT01237587|3814246|B3|Harm Avoidance||Multidimensional Anxiety Scale for Children (MASC)|"MASC consists of 39 items that comprise 4 factors. Each item is scored on a 0 to 3-point scale (0-never to 3-often).~Physical symptoms (tense/restless and somatic/autonomic) - 12 items with score range 0 to 36.~Social anxiety (humiliation/rejection and public performance fears) - 9 items with score range of 0 to 27.~Harm avoidance (perfectionism and anxious coping) - 9 items with score range of 0 to 27.~Separation anxiety - 9 items with score range of 0 to 27. Total score ranges from 0 to 117. Higher the total score, the more severe the anxiety."|units on a scale|Mean|14.7|14.7|Standard Deviation|4.5|4.5|||
3992382|NCT01237587|3814247|B2|Harm Avoidance||Multidimensional Anxiety Scale for Children (MASC)|"MASC consists of 39 items that comprise 4 factors. Each item is scored on a 0 to 3-point scale (0-never to 3-often).~Physical symptoms (tense/restless and somatic/autonomic) - 12 items with score range 0 to 36.~Social anxiety (humiliation/rejection and public performance fears) - 9 items with score range of 0 to 27.~Harm avoidance (perfectionism and anxious coping) - 9 items with score range of 0 to 27.~Separation anxiety - 9 items with score range of 0 to 27. Total score ranges from 0 to 117. Higher the total score, the more severe the anxiety."|units on a scale|Mean|14.4|14.4|Standard Deviation|4.7|4.7|||
3992397|NCT01237587|3814247|B2|||Clinical Global Impression (CGI) Severity: Overall Illness|Clinical Global Impression of Severity: Overall Illness (CGI-S: Overall Illness) scale evaluates the severity of the overall illness of Juvenile Primary Fibromyalgia Syndrome (JPFS), including all relevant, associated symptoms. The scoring ranges from 1 (normal, not at all ill) to 7 (among the most extremely ill participants). The scoring is based on observed and reported symptoms and behaviors over the past 7 days that are ongoing at the time of the Study Visit.|units on a scale|Mean|4.1|4.1|Standard Deviation|0.8|0.8|||
3992383|NCT01237587|3814248|B1|Harm Avoidance||Multidimensional Anxiety Scale for Children (MASC)|"MASC consists of 39 items that comprise 4 factors. Each item is scored on a 0 to 3-point scale (0-never to 3-often).~Physical symptoms (tense/restless and somatic/autonomic) - 12 items with score range 0 to 36.~Social anxiety (humiliation/rejection and public performance fears) - 9 items with score range of 0 to 27.~Harm avoidance (perfectionism and anxious coping) - 9 items with score range of 0 to 27.~Separation anxiety - 9 items with score range of 0 to 27. Total score ranges from 0 to 117. Higher the total score, the more severe the anxiety."|units on a scale|Mean|15.0|15.0|Standard Deviation|4.2|4.2|||
3992384|NCT01237587|3814246|B3|Physical Symptoms||Multidimensional Anxiety Scale for Children (MASC)|"MASC consists of 39 items that comprise 4 factors. Each item is scored on a 0 to 3-point scale (0-never to 3-often).~Physical symptoms (tense/restless and somatic/autonomic) - 12 items with score range 0 to 36.~Social anxiety (humiliation/rejection and public performance fears) - 9 items with score range of 0 to 27.~Harm avoidance (perfectionism and anxious coping) - 9 items with score range of 0 to 27.~Separation anxiety - 9 items with score range of 0 to 27. Total score ranges from 0 to 117. Higher the total score, the more severe the anxiety."|units on a scale|Mean|13.6|13.6|Standard Deviation|7.5|7.5|||
3992385|NCT01237587|3814247|B2|Physical Symptoms||Multidimensional Anxiety Scale for Children (MASC)|"MASC consists of 39 items that comprise 4 factors. Each item is scored on a 0 to 3-point scale (0-never to 3-often).~Physical symptoms (tense/restless and somatic/autonomic) - 12 items with score range 0 to 36.~Social anxiety (humiliation/rejection and public performance fears) - 9 items with score range of 0 to 27.~Harm avoidance (perfectionism and anxious coping) - 9 items with score range of 0 to 27.~Separation anxiety - 9 items with score range of 0 to 27. Total score ranges from 0 to 117. Higher the total score, the more severe the anxiety."|units on a scale|Mean|13.6|13.6|Standard Deviation|7.6|7.6|||
3992386|NCT01237587|3814248|B1|Physical Symptoms||Multidimensional Anxiety Scale for Children (MASC)|"MASC consists of 39 items that comprise 4 factors. Each item is scored on a 0 to 3-point scale (0-never to 3-often).~Physical symptoms (tense/restless and somatic/autonomic) - 12 items with score range 0 to 36.~Social anxiety (humiliation/rejection and public performance fears) - 9 items with score range of 0 to 27.~Harm avoidance (perfectionism and anxious coping) - 9 items with score range of 0 to 27.~Separation anxiety - 9 items with score range of 0 to 27. Total score ranges from 0 to 117. Higher the total score, the more severe the anxiety."|units on a scale|Mean|13.6|13.6|Standard Deviation|7.3|7.3|||
3992387|NCT01237587|3814246|B3|||Children's Depression Inventory (CDI)|Children's Depression Inventory (CDI) is modeled after the Beck Depression Inventory and is a 27-item self-reported, symptom-oriented scale designed for school aged children and adolescents. Each item is scored on a 0-to-2-point scale (in increasing severity) and thus the total score ranges from 0 to 54. The higher the score, the more severe the depression.|units on a scale|Mean|13.3|13.3|Standard Deviation|7.4|7.4|||
3992388|NCT01237587|3814247|B2|||Children's Depression Inventory (CDI)|Children's Depression Inventory (CDI) is modeled after the Beck Depression Inventory and is a 27-item self-reported, symptom-oriented scale designed for school aged children and adolescents. Each item is scored on a 0-to-2-point scale (in increasing severity) and thus the total score ranges from 0 to 54. The higher the score, the more severe the depression.|units on a scale|Mean|13.1|13.1|Standard Deviation|7.7|7.7|||
3992389|NCT01237587|3814248|B1|||Children's Depression Inventory (CDI)|Children's Depression Inventory (CDI) is modeled after the Beck Depression Inventory and is a 27-item self-reported, symptom-oriented scale designed for school aged children and adolescents. Each item is scored on a 0-to-2-point scale (in increasing severity) and thus the total score ranges from 0 to 54. The higher the score, the more severe the depression.|units on a scale|Mean|13.5|13.5|Standard Deviation|7.1|7.1|||
3992390|NCT01237587|3814246|B3|||Functional Disability Inventory (FDI) Parent Score|Functional Disability Inventory-parent form (FDI-parent) contains the same items as FDI-child, but is reported by parent/legal representative. The total score range from 0 to 60. The higher the score, the more physical trouble or difficulty the child has doing regular activities.|units on a scale|Mean|22.4|22.4|Standard Deviation|11.1|11.1|||
3992391|NCT01237587|3814247|B2|||Functional Disability Inventory (FDI) Parent Score|Functional Disability Inventory-parent form (FDI-parent) contains the same items as FDI-child, but is reported by parent/legal representative. The total score range from 0 to 60. The higher the score, the more physical trouble or difficulty the child has doing regular activities.|units on a scale|Mean|22.3|22.3|Standard Deviation|10.7|10.7|||
3992392|NCT01237587|3814248|B1|||Functional Disability Inventory (FDI) Parent Score|Functional Disability Inventory-parent form (FDI-parent) contains the same items as FDI-child, but is reported by parent/legal representative. The total score range from 0 to 60. The higher the score, the more physical trouble or difficulty the child has doing regular activities.|units on a scale|Mean|22.4|22.4|Standard Deviation|11.4|11.4|||
3992393|NCT01237587|3814246|B3|||Functional Disability Inventory (FDI) Child score|Functional Disability Inventory-child form (FDI-child) is a self-reported scale to assess the physical trouble or difficulty the child has doing regular activities. This scale contains 15 items. Each item is scored on a 0- to-4-point scale (0 = no trouble, 1 = a little trouble, 2 = some trouble, 3 = a lot of trouble, 4 = impossible).The total score ranges from 0 to 60. The higher the score, the more physical trouble or difficulty the child has doing regular activities.|units on a scale|Mean|22.8|22.8|Standard Deviation|10.5|10.5|||
3992394|NCT01237587|3814247|B2|||Functional Disability Inventory (FDI) Child score|Functional Disability Inventory-child form (FDI-child) is a self-reported scale to assess the physical trouble or difficulty the child has doing regular activities. This scale contains 15 items. Each item is scored on a 0- to-4-point scale (0 = no trouble, 1 = a little trouble, 2 = some trouble, 3 = a lot of trouble, 4 = impossible).The total score ranges from 0 to 60. The higher the score, the more physical trouble or difficulty the child has doing regular activities.|units on a scale|Mean|22.3|22.3|Standard Deviation|9.9|9.9|||
3992395|NCT01237587|3814248|B1|||Functional Disability Inventory (FDI) Child score|Functional Disability Inventory-child form (FDI-child) is a self-reported scale to assess the physical trouble or difficulty the child has doing regular activities. This scale contains 15 items. Each item is scored on a 0- to-4-point scale (0 = no trouble, 1 = a little trouble, 2 = some trouble, 3 = a lot of trouble, 4 = impossible).The total score ranges from 0 to 60. The higher the score, the more physical trouble or difficulty the child has doing regular activities.|units on a scale|Mean|23.3|23.3|Standard Deviation|11.1|11.1|||
3992458|NCT01237587|3814248|B1|Puerto Rico||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3992398|NCT01237587|3814248|B1|||Clinical Global Impression (CGI) Severity: Overall Illness|Clinical Global Impression of Severity: Overall Illness (CGI-S: Overall Illness) scale evaluates the severity of the overall illness of Juvenile Primary Fibromyalgia Syndrome (JPFS), including all relevant, associated symptoms. The scoring ranges from 1 (normal, not at all ill) to 7 (among the most extremely ill participants). The scoring is based on observed and reported symptoms and behaviors over the past 7 days that are ongoing at the time of the Study Visit.|units on a scale|Mean|4.1|4.1|Standard Deviation|0.9|0.9|||
3992399|NCT01237587|3814246|B3|||Clinical Global Impression (CGI) Severity: Mental Illness|Clinical Global Impression of Severity: Mental Illness (CGI-S: Mental Illness) scale evaluates the severity of any diagnosed, comorbid Axis I/II condition. The scoring ranges from 1 (normal, not at all ill) to 7 (among the most extremely ill participants). Participants without a diagnosed Axis I/II condition should receive a score of 1 (normal, not at all ill).|units on a scale|Mean|2.05|2.05|Standard Deviation|1.15|1.15|||
3992400|NCT01237587|3814247|B2|||Clinical Global Impression (CGI) Severity: Mental Illness|Clinical Global Impression of Severity: Mental Illness (CGI-S: Mental Illness) scale evaluates the severity of any diagnosed, comorbid Axis I/II condition. The scoring ranges from 1 (normal, not at all ill) to 7 (among the most extremely ill participants). Participants without a diagnosed Axis I/II condition should receive a score of 1 (normal, not at all ill).|units on a scale|Mean|2.0|2.0|Standard Deviation|1.1|1.1|||
3992401|NCT01237587|3814248|B1|||Clinical Global Impression (CGI) Severity: Mental Illness|Clinical Global Impression of Severity: Mental Illness (CGI-S: Mental Illness) scale evaluates the severity of any diagnosed, comorbid Axis I/II condition. The scoring ranges from 1 (normal, not at all ill) to 7 (among the most extremely ill participants). Participants without a diagnosed Axis I/II condition should receive a score of 1 (normal, not at all ill).|units on a scale|Mean|2.1|2.1|Standard Deviation|1.2|1.2|||
3992402|NCT01237587|3814246|B3|pain now||Pediatric Pain Questionnaire (PPQ)|"Pediatric Pain Questionnaire (PPQ) is a self-reported scale that measures the severity for pain now, worst pain, and average pain in the past week with 100 millimeter (mm) VAS (Visual Analog Scale). The severity scores range from 0 (no hurting, no discomfort, no pain) to 100 (hurting a whole lot, very uncomfortable, severe pain)."|mm|Mean|51.0|51.0|Standard Deviation|26.4|26.4|||
3992403|NCT01237587|3814247|B2|pain now||Pediatric Pain Questionnaire (PPQ)|"Pediatric Pain Questionnaire (PPQ) is a self-reported scale that measures the severity for pain now, worst pain, and average pain in the past week with 100 millimeter (mm) VAS (Visual Analog Scale). The severity scores range from 0 (no hurting, no discomfort, no pain) to 100 (hurting a whole lot, very uncomfortable, severe pain)."|mm|Mean|52.0|52.0|Standard Deviation|25.2|25.2|||
3992404|NCT01237587|3814248|B1|pain now||Pediatric Pain Questionnaire (PPQ)|"Pediatric Pain Questionnaire (PPQ) is a self-reported scale that measures the severity for pain now, worst pain, and average pain in the past week with 100 millimeter (mm) VAS (Visual Analog Scale). The severity scores range from 0 (no hurting, no discomfort, no pain) to 100 (hurting a whole lot, very uncomfortable, severe pain)."|mm|Mean|50.1|50.1|Standard Deviation|27.5|27.5|||
3992405|NCT01237587|3814246|B3|Worst Pain||Pediatric Pain Questionnaire (PPQ)|"Pediatric Pain Questionnaire (PPQ) is a self-reported scale that measures the severity for pain now, worst pain, and average pain in the past week with 100 millimeter (mm) VAS (Visual Analog Scale). The severity scores range from 0 (no hurting, no discomfort, no pain) to 100 (hurting a whole lot, very uncomfortable, severe pain)."|mm|Mean|76.5|76.5|Standard Deviation|20.4|20.4|||
3992406|NCT01237587|3814247|B2|Worst Pain||Pediatric Pain Questionnaire (PPQ)|"Pediatric Pain Questionnaire (PPQ) is a self-reported scale that measures the severity for pain now, worst pain, and average pain in the past week with 100 millimeter (mm) VAS (Visual Analog Scale). The severity scores range from 0 (no hurting, no discomfort, no pain) to 100 (hurting a whole lot, very uncomfortable, severe pain)."|mm|Mean|75.5|75.5|Standard Deviation|20.4|20.4|||
3992407|NCT01237587|3814248|B1|Worst Pain||Pediatric Pain Questionnaire (PPQ)|"Pediatric Pain Questionnaire (PPQ) is a self-reported scale that measures the severity for pain now, worst pain, and average pain in the past week with 100 millimeter (mm) VAS (Visual Analog Scale). The severity scores range from 0 (no hurting, no discomfort, no pain) to 100 (hurting a whole lot, very uncomfortable, severe pain)."|mm|Mean|77.4|77.4|Standard Deviation|20.3|20.3|||
3992408|NCT01237587|3814246|B3|Average Pain||Pediatric Pain Questionnaire (PPQ)|"Pediatric Pain Questionnaire (PPQ) is a self-reported scale that measures the severity for pain now, worst pain, and average pain in the past week with 100 millimeter (mm) VAS (Visual Analog Scale). The severity scores range from 0 (no hurting, no discomfort, no pain) to 100 (hurting a whole lot, very uncomfortable, severe pain)."|mm|Mean|58.94|58.94|Standard Deviation|20.9|20.9|||
3992409|NCT01237587|3814247|B2|Average Pain||Pediatric Pain Questionnaire (PPQ)|"Pediatric Pain Questionnaire (PPQ) is a self-reported scale that measures the severity for pain now, worst pain, and average pain in the past week with 100 millimeter (mm) VAS (Visual Analog Scale). The severity scores range from 0 (no hurting, no discomfort, no pain) to 100 (hurting a whole lot, very uncomfortable, severe pain)."|mm|Mean|58.1|58.1|Standard Deviation|22.3|22.3|||
3992410|NCT01237587|3814248|B1|Average Pain||Pediatric Pain Questionnaire (PPQ)|"Pediatric Pain Questionnaire (PPQ) is a self-reported scale that measures the severity for pain now, worst pain, and average pain in the past week with 100 millimeter (mm) VAS (Visual Analog Scale). The severity scores range from 0 (no hurting, no discomfort, no pain) to 100 (hurting a whole lot, very uncomfortable, severe pain)."|mm|Mean|61.8|61.8|Standard Deviation|19.5|19.5|||
3992411|NCT01237587|3814246|B3|School Work||Brief Pain Inventory (BPI) Modified short form (SF) Adolescent version (AV)|BPI Modified SF AV is a scale that measures severity & interference of pain. Severity scores range from 0 (no pain) to 10 (pain as bad as you can imagine). 4 questions assessing severity for worst pain, least pain, average pain in past 24 hours, & pain right now.Interference scores range from 0 (does not interfere) to 10 (completely interferes).7 questions assessing interference of pain in past 24 hours on general activity, mood, walking ability, normal work, relations with other people, sleep, & enjoyment of life. Adolescent Version has 8th question for interference of pain on school work.|units on a scale|Mean|4.6|4.6|Standard Deviation|3.1|3.1|||
3992459|NCT01237587|3814246|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3992460|NCT01237587|3814247|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992461|NCT01237587|3814248|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992412|NCT01237587|3814247|B2|School Work||Brief Pain Inventory (BPI) Modified short form (SF) Adolescent version (AV)|BPI Modified SF AV is a scale that measures severity & interference of pain. Severity scores range from 0 (no pain) to 10 (pain as bad as you can imagine). 4 questions assessing severity for worst pain, least pain, average pain in past 24 hours, & pain right now.Interference scores range from 0 (does not interfere) to 10 (completely interferes).7 questions assessing interference of pain in past 24 hours on general activity, mood, walking ability, normal work, relations with other people, sleep, & enjoyment of life. Adolescent Version has 8th question for interference of pain on school work.|units on a scale|Mean|4.3|4.3|Standard Deviation|3.2|3.2|||
3992413|NCT01237587|3814248|B1|School Work||Brief Pain Inventory (BPI) Modified short form (SF) Adolescent version (AV)|BPI Modified SF AV is a scale that measures severity & interference of pain. Severity scores range from 0 (no pain) to 10 (pain as bad as you can imagine). 4 questions assessing severity for worst pain, least pain, average pain in past 24 hours, & pain right now.Interference scores range from 0 (does not interfere) to 10 (completely interferes).7 questions assessing interference of pain in past 24 hours on general activity, mood, walking ability, normal work, relations with other people, sleep, & enjoyment of life. Adolescent Version has 8th question for interference of pain on school work.|units on a scale|Mean|4.8|4.8|Standard Deviation|3.0|3.0|||
3992414|NCT01237587|3814246|B3|Enjoyment of Life||Brief Pain Inventory (BPI) Modified short form (SF) Adolescent version (AV)|BPI Modified SF AV is a scale that measures severity & interference of pain. Severity scores range from 0 (no pain) to 10 (pain as bad as you can imagine). 4 questions assessing severity for worst pain, least pain, average pain in past 24 hours, & pain right now.Interference scores range from 0 (does not interfere) to 10 (completely interferes).7 questions assessing interference of pain in past 24 hours on general activity, mood, walking ability, normal work, relations with other people, sleep, & enjoyment of life. Adolescent Version has 8th question for interference of pain on school work.|units on a scale|Mean|4.2|4.2|Standard Deviation|3.0|3.0|||
3992415|NCT01237587|3814247|B2|Enjoyment of Life||Brief Pain Inventory (BPI) Modified short form (SF) Adolescent version (AV)|BPI Modified SF AV is a scale that measures severity & interference of pain. Severity scores range from 0 (no pain) to 10 (pain as bad as you can imagine). 4 questions assessing severity for worst pain, least pain, average pain in past 24 hours, & pain right now.Interference scores range from 0 (does not interfere) to 10 (completely interferes).7 questions assessing interference of pain in past 24 hours on general activity, mood, walking ability, normal work, relations with other people, sleep, & enjoyment of life. Adolescent Version has 8th question for interference of pain on school work.|units on a scale|Mean|4.3|4.3|Standard Deviation|2.8|2.8|||
3992416|NCT01237587|3814248|B1|Enjoyment of Life||Brief Pain Inventory (BPI) Modified short form (SF) Adolescent version (AV)|BPI Modified SF AV is a scale that measures severity & interference of pain. Severity scores range from 0 (no pain) to 10 (pain as bad as you can imagine). 4 questions assessing severity for worst pain, least pain, average pain in past 24 hours, & pain right now.Interference scores range from 0 (does not interfere) to 10 (completely interferes).7 questions assessing interference of pain in past 24 hours on general activity, mood, walking ability, normal work, relations with other people, sleep, & enjoyment of life. Adolescent Version has 8th question for interference of pain on school work.|units on a scale|Mean|4.1|4.1|Standard Deviation|3.1|3.1|||
3992417|NCT01237587|3814246|B3|Sleep||Brief Pain Inventory (BPI) Modified short form (SF) Adolescent version (AV)|BPI Modified SF AV is a scale that measures severity & interference of pain. Severity scores range from 0 (no pain) to 10 (pain as bad as you can imagine). 4 questions assessing severity for worst pain, least pain, average pain in past 24 hours, & pain right now.Interference scores range from 0 (does not interfere) to 10 (completely interferes).7 questions assessing interference of pain in past 24 hours on general activity, mood, walking ability, normal work, relations with other people, sleep, & enjoyment of life. Adolescent Version has 8th question for interference of pain on school work.|units on a scale|Mean|5.7|5.7|Standard Deviation|2.9|2.9|||
3992418|NCT01237587|3814247|B2|Sleep||Brief Pain Inventory (BPI) Modified short form (SF) Adolescent version (AV)|BPI Modified SF AV is a scale that measures severity & interference of pain. Severity scores range from 0 (no pain) to 10 (pain as bad as you can imagine). 4 questions assessing severity for worst pain, least pain, average pain in past 24 hours, & pain right now.Interference scores range from 0 (does not interfere) to 10 (completely interferes).7 questions assessing interference of pain in past 24 hours on general activity, mood, walking ability, normal work, relations with other people, sleep, & enjoyment of life. Adolescent Version has 8th question for interference of pain on school work.|units on a scale|Mean|5.5|5.5|Standard Deviation|3.0|3.0|||
3992419|NCT01237587|3814248|B1|Sleep||Brief Pain Inventory (BPI) Modified short form (SF) Adolescent version (AV)|BPI Modified SF AV is a scale that measures severity & interference of pain. Severity scores range from 0 (no pain) to 10 (pain as bad as you can imagine). 4 questions assessing severity for worst pain, least pain, average pain in past 24 hours, & pain right now.Interference scores range from 0 (does not interfere) to 10 (completely interferes).7 questions assessing interference of pain in past 24 hours on general activity, mood, walking ability, normal work, relations with other people, sleep, & enjoyment of life. Adolescent Version has 8th question for interference of pain on school work.|units on a scale|Mean|5.9|5.9|Standard Deviation|2.8|2.8|||
3992420|NCT01237587|3814246|B3|Relations with other people||Brief Pain Inventory (BPI) Modified short form (SF) Adolescent version (AV)|BPI Modified SF AV is a scale that measures severity & interference of pain. Severity scores range from 0 (no pain) to 10 (pain as bad as you can imagine). 4 questions assessing severity for worst pain, least pain, average pain in past 24 hours, & pain right now.Interference scores range from 0 (does not interfere) to 10 (completely interferes).7 questions assessing interference of pain in past 24 hours on general activity, mood, walking ability, normal work, relations with other people, sleep, & enjoyment of life. Adolescent Version has 8th question for interference of pain on school work.|units on a scale|Mean|3.7|3.7|Standard Deviation|2.8|2.8|||
3992462|NCT01237587|3814246|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3992463|NCT01237587|3814247|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3992464|NCT01237587|3814248|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3992465|NCT01237587|3814246|B3||White|Race (NIH/OMB)||Participants|Count of Participants|142|142.0||||||
3992466|NCT01237587|3814247|B2||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3992421|NCT01237587|3814247|B2|Relations with other people||Brief Pain Inventory (BPI) Modified short form (SF) Adolescent version (AV)|BPI Modified SF AV is a scale that measures severity & interference of pain. Severity scores range from 0 (no pain) to 10 (pain as bad as you can imagine). 4 questions assessing severity for worst pain, least pain, average pain in past 24 hours, & pain right now.Interference scores range from 0 (does not interfere) to 10 (completely interferes).7 questions assessing interference of pain in past 24 hours on general activity, mood, walking ability, normal work, relations with other people, sleep, & enjoyment of life. Adolescent Version has 8th question for interference of pain on school work.|units on a scale|Mean|3.7|3.7|Standard Deviation|2.8|2.8|||
3992422|NCT01237587|3814248|B1|Relations with other people||Brief Pain Inventory (BPI) Modified short form (SF) Adolescent version (AV)|BPI Modified SF AV is a scale that measures severity & interference of pain. Severity scores range from 0 (no pain) to 10 (pain as bad as you can imagine). 4 questions assessing severity for worst pain, least pain, average pain in past 24 hours, & pain right now.Interference scores range from 0 (does not interfere) to 10 (completely interferes).7 questions assessing interference of pain in past 24 hours on general activity, mood, walking ability, normal work, relations with other people, sleep, & enjoyment of life. Adolescent Version has 8th question for interference of pain on school work.|units on a scale|Mean|3.7|3.7|Standard Deviation|2.7|2.7|||
3992423|NCT01237587|3814246|B3|Normal Work||Brief Pain Inventory (BPI) Modified short form (SF) Adolescent version (AV)|BPI Modified SF AV is a scale that measures severity & interference of pain. Severity scores range from 0 (no pain) to 10 (pain as bad as you can imagine). 4 questions assessing severity for worst pain, least pain, average pain in past 24 hours, & pain right now.Interference scores range from 0 (does not interfere) to 10 (completely interferes).7 questions assessing interference of pain in past 24 hours on general activity, mood, walking ability, normal work, relations with other people, sleep, & enjoyment of life. Adolescent Version has 8th question for interference of pain on school work.|units on a scale|Mean|4.8|4.8|Standard Deviation|2.6|2.6|||
3992424|NCT01237587|3814247|B2|Normal Work||Brief Pain Inventory (BPI) Modified short form (SF) Adolescent version (AV)|BPI Modified SF AV is a scale that measures severity & interference of pain. Severity scores range from 0 (no pain) to 10 (pain as bad as you can imagine). 4 questions assessing severity for worst pain, least pain, average pain in past 24 hours, & pain right now.Interference scores range from 0 (does not interfere) to 10 (completely interferes).7 questions assessing interference of pain in past 24 hours on general activity, mood, walking ability, normal work, relations with other people, sleep, & enjoyment of life. Adolescent Version has 8th question for interference of pain on school work.|units on a scale|Mean|4.9|4.9|Standard Deviation|2.5|2.5|||
3992425|NCT01237587|3814248|B1|Normal Work||Brief Pain Inventory (BPI) Modified short form (SF) Adolescent version (AV)|BPI Modified SF AV is a scale that measures severity & interference of pain. Severity scores range from 0 (no pain) to 10 (pain as bad as you can imagine). 4 questions assessing severity for worst pain, least pain, average pain in past 24 hours, & pain right now.Interference scores range from 0 (does not interfere) to 10 (completely interferes).7 questions assessing interference of pain in past 24 hours on general activity, mood, walking ability, normal work, relations with other people, sleep, & enjoyment of life. Adolescent Version has 8th question for interference of pain on school work.|units on a scale|Mean|4.6|4.6|Standard Deviation|2.6|2.6|||
3992426|NCT01237587|3814246|B3|Walking Ability||Brief Pain Inventory (BPI) Modified short form (SF) Adolescent version (AV)|BPI Modified SF AV is a scale that measures severity & interference of pain. Severity scores range from 0 (no pain) to 10 (pain as bad as you can imagine). 4 questions assessing severity for worst pain, least pain, average pain in past 24 hours, & pain right now.Interference scores range from 0 (does not interfere) to 10 (completely interferes).7 questions assessing interference of pain in past 24 hours on general activity, mood, walking ability, normal work, relations with other people, sleep, & enjoyment of life. Adolescent Version has 8th question for interference of pain on school work.|units on a scale|Mean|4.3|4.3|Standard Deviation|2.8|2.8|||
3992427|NCT01237587|3814247|B2|Walking Ability||Brief Pain Inventory (BPI) Modified short form (SF) Adolescent version (AV)|BPI Modified SF AV is a scale that measures severity & interference of pain. Severity scores range from 0 (no pain) to 10 (pain as bad as you can imagine). 4 questions assessing severity for worst pain, least pain, average pain in past 24 hours, & pain right now.Interference scores range from 0 (does not interfere) to 10 (completely interferes).7 questions assessing interference of pain in past 24 hours on general activity, mood, walking ability, normal work, relations with other people, sleep, & enjoyment of life. Adolescent Version has 8th question for interference of pain on school work.|units on a scale|Mean|4.5|4.5|Standard Deviation|2.8|2.8|||
3992428|NCT01237587|3814248|B1|Walking Ability||Brief Pain Inventory (BPI) Modified short form (SF) Adolescent version (AV)|BPI Modified SF AV is a scale that measures severity & interference of pain. Severity scores range from 0 (no pain) to 10 (pain as bad as you can imagine). 4 questions assessing severity for worst pain, least pain, average pain in past 24 hours, & pain right now.Interference scores range from 0 (does not interfere) to 10 (completely interferes).7 questions assessing interference of pain in past 24 hours on general activity, mood, walking ability, normal work, relations with other people, sleep, & enjoyment of life. Adolescent Version has 8th question for interference of pain on school work.|units on a scale|Mean|4.1|4.1|Standard Deviation|2.8|2.8|||
3992429|NCT01237587|3814246|B3|Mood||Brief Pain Inventory (BPI) Modified short form (SF) Adolescent version (AV)|BPI Modified SF AV is a scale that measures severity & interference of pain. Severity scores range from 0 (no pain) to 10 (pain as bad as you can imagine). 4 questions assessing severity for worst pain, least pain, average pain in past 24 hours, & pain right now.Interference scores range from 0 (does not interfere) to 10 (completely interferes).7 questions assessing interference of pain in past 24 hours on general activity, mood, walking ability, normal work, relations with other people, sleep, & enjoyment of life. Adolescent Version has 8th question for interference of pain on school work.|units on a scale|Mean|5.0|5.0|Standard Deviation|2.6|2.6|||
3992467|NCT01237587|3814248|B1||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
3992468|NCT01237587|3814246|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3992469|NCT01237587|3814247|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3992470|NCT01237587|3814248|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3992471|NCT01237587|3814246|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992430|NCT01237587|3814247|B2|Mood||Brief Pain Inventory (BPI) Modified short form (SF) Adolescent version (AV)|BPI Modified SF AV is a scale that measures severity & interference of pain. Severity scores range from 0 (no pain) to 10 (pain as bad as you can imagine). 4 questions assessing severity for worst pain, least pain, average pain in past 24 hours, & pain right now.Interference scores range from 0 (does not interfere) to 10 (completely interferes).7 questions assessing interference of pain in past 24 hours on general activity, mood, walking ability, normal work, relations with other people, sleep, & enjoyment of life. Adolescent Version has 8th question for interference of pain on school work.|units on a scale|Mean|5.0|5.0|Standard Deviation|2.6|2.6|||
3992431|NCT01237587|3814248|B1|Mood||Brief Pain Inventory (BPI) Modified short form (SF) Adolescent version (AV)|BPI Modified SF AV is a scale that measures severity & interference of pain. Severity scores range from 0 (no pain) to 10 (pain as bad as you can imagine). 4 questions assessing severity for worst pain, least pain, average pain in past 24 hours, & pain right now.Interference scores range from 0 (does not interfere) to 10 (completely interferes).7 questions assessing interference of pain in past 24 hours on general activity, mood, walking ability, normal work, relations with other people, sleep, & enjoyment of life. Adolescent Version has 8th question for interference of pain on school work.|units on a scale|Mean|4.9|4.9|Standard Deviation|2.6|2.6|||
3992432|NCT01237587|3814246|B3|General Activity||Brief Pain Inventory (BPI) Modified short form (SF) Adolescent version (AV)|BPI Modified SF AV is a scale that measures severity & interference of pain. Severity scores range from 0 (no pain) to 10 (pain as bad as you can imagine). 4 questions assessing severity for worst pain, least pain, average pain in past 24 hours, & pain right now.Interference scores range from 0 (does not interfere) to 10 (completely interferes).7 questions assessing interference of pain in past 24 hours on general activity, mood, walking ability, normal work, relations with other people, sleep, & enjoyment of life. Adolescent Version has 8th question for interference of pain on school work.|units on a scale|Mean|5.2|5.2|Standard Deviation|2.3|2.3|||
3992433|NCT01237587|3814247|B2|General Activity||Brief Pain Inventory (BPI) Modified short form (SF) Adolescent version (AV)|BPI Modified SF AV is a scale that measures severity & interference of pain. Severity scores range from 0 (no pain) to 10 (pain as bad as you can imagine). 4 questions assessing severity for worst pain, least pain, average pain in past 24 hours, & pain right now.Interference scores range from 0 (does not interfere) to 10 (completely interferes).7 questions assessing interference of pain in past 24 hours on general activity, mood, walking ability, normal work, relations with other people, sleep, & enjoyment of life. Adolescent Version has 8th question for interference of pain on school work.|units on a scale|Mean|5.1|5.1|Standard Deviation|2.0|2.0|||
3992434|NCT01237587|3814248|B1|General Activity||Brief Pain Inventory (BPI) Modified short form (SF) Adolescent version (AV)|BPI Modified SF AV is a scale that measures severity & interference of pain. Severity scores range from 0 (no pain) to 10 (pain as bad as you can imagine). 4 questions assessing severity for worst pain, least pain, average pain in past 24 hours, & pain right now.Interference scores range from 0 (does not interfere) to 10 (completely interferes).7 questions assessing interference of pain in past 24 hours on general activity, mood, walking ability, normal work, relations with other people, sleep, & enjoyment of life. Adolescent Version has 8th question for interference of pain on school work.|units on a scale|Mean|5.2|5.2|Standard Deviation|2.0|2.0|||
3992435|NCT01237587|3814246|B3|Pain Right Now||Brief Pain Inventory (BPI) Modified short form (SF) Adolescent version (AV)|BPI Modified SF AV is a scale that measures severity & interference of pain. Severity scores range from 0 (no pain) to 10 (pain as bad as you can imagine). 4 questions assessing severity for worst pain, least pain, average pain in past 24 hours, & pain right now.Interference scores range from 0 (does not interfere) to 10 (completely interferes).7 questions assessing interference of pain in past 24 hours on general activity, mood, walking ability, normal work, relations with other people, sleep, & enjoyment of life. Adolescent Version has 8th question for interference of pain on school work.|units on a scale|Mean|5.2|5.2|Standard Deviation|2.4|2.4|||
3992436|NCT01237587|3814247|B2|Pain Right Now||Brief Pain Inventory (BPI) Modified short form (SF) Adolescent version (AV)|BPI Modified SF AV is a scale that measures severity & interference of pain. Severity scores range from 0 (no pain) to 10 (pain as bad as you can imagine). 4 questions assessing severity for worst pain, least pain, average pain in past 24 hours, & pain right now.Interference scores range from 0 (does not interfere) to 10 (completely interferes).7 questions assessing interference of pain in past 24 hours on general activity, mood, walking ability, normal work, relations with other people, sleep, & enjoyment of life. Adolescent Version has 8th question for interference of pain on school work.|units on a scale|Mean|5.2|5.2|Standard Deviation|2.3|2.3|||
3992437|NCT01237587|3814248|B1|Pain Right Now||Brief Pain Inventory (BPI) Modified short form (SF) Adolescent version (AV)|BPI Modified SF AV is a scale that measures severity & interference of pain. Severity scores range from 0 (no pain) to 10 (pain as bad as you can imagine). 4 questions assessing severity for worst pain, least pain, average pain in past 24 hours, & pain right now.Interference scores range from 0 (does not interfere) to 10 (completely interferes).7 questions assessing interference of pain in past 24 hours on general activity, mood, walking ability, normal work, relations with other people, sleep, & enjoyment of life. Adolescent Version has 8th question for interference of pain on school work.|units on a scale|Mean|5.2|5.2|Standard Deviation|2.4|2.4|||
3992438|NCT01237587|3814246|B3|Least Pain||Brief Pain Inventory (BPI) Modified short form (SF) Adolescent version (AV)|BPI Modified SF AV is a scale that measures severity & interference of pain. Severity scores range from 0 (no pain) to 10 (pain as bad as you can imagine). 4 questions assessing severity for worst pain, least pain, average pain in past 24 hours, & pain right now.Interference scores range from 0 (does not interfere) to 10 (completely interferes).7 questions assessing interference of pain in past 24 hours on general activity, mood, walking ability, normal work, relations with other people, sleep, & enjoyment of life. Adolescent Version has 8th question for interference of pain on school work.|units on a scale|Mean|3.8|3.8|Standard Deviation|2.1|2.1|||
3992472|NCT01237587|3814247|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992473|NCT01237587|3814248|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992474|NCT01237587|3814246|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3992475|NCT01237587|3814247|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3992476|NCT01237587|3814248|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3992439|NCT01237587|3814247|B2|Least Pain||Brief Pain Inventory (BPI) Modified short form (SF) Adolescent version (AV)|BPI Modified SF AV is a scale that measures severity & interference of pain. Severity scores range from 0 (no pain) to 10 (pain as bad as you can imagine). 4 questions assessing severity for worst pain, least pain, average pain in past 24 hours, & pain right now.Interference scores range from 0 (does not interfere) to 10 (completely interferes).7 questions assessing interference of pain in past 24 hours on general activity, mood, walking ability, normal work, relations with other people, sleep, & enjoyment of life. Adolescent Version has 8th question for interference of pain on school work.|units on a scale|Mean|3.8|3.8|Standard Deviation|2.0|2.0|||
3992440|NCT01237587|3814248|B1|Least Pain||Brief Pain Inventory (BPI) Modified short form (SF) Adolescent version (AV)|BPI Modified SF AV is a scale that measures severity & interference of pain. Severity scores range from 0 (no pain) to 10 (pain as bad as you can imagine). 4 questions assessing severity for worst pain, least pain, average pain in past 24 hours, & pain right now.Interference scores range from 0 (does not interfere) to 10 (completely interferes).7 questions assessing interference of pain in past 24 hours on general activity, mood, walking ability, normal work, relations with other people, sleep, & enjoyment of life. Adolescent Version has 8th question for interference of pain on school work.|units on a scale|Mean|3.7|3.7|Standard Deviation|2.1|2.1|||
3992441|NCT01237587|3814246|B3|Worst Pain||Brief Pain Inventory (BPI) Modified short form (SF) Adolescent version (AV)|BPI Modified SF AV is a scale that measures severity & interference of pain. Severity scores range from 0 (no pain) to 10 (pain as bad as you can imagine). 4 questions assessing severity for worst pain, least pain, average pain in past 24 hours, & pain right now.Interference scores range from 0 (does not interfere) to 10 (completely interferes).7 questions assessing interference of pain in past 24 hours on general activity, mood, walking ability, normal work, relations with other people, sleep, & enjoyment of life. Adolescent Version has 8th question for interference of pain on school work.|units on a scale|Mean|7.0|7.0|Standard Deviation|1.9|1.9|||
3992442|NCT01237587|3814247|B2|Worst Pain||Brief Pain Inventory (BPI) Modified short form (SF) Adolescent version (AV)|BPI Modified SF AV is a scale that measures severity & interference of pain. Severity scores range from 0 (no pain) to 10 (pain as bad as you can imagine). 4 questions assessing severity for worst pain, least pain, average pain in past 24 hours, & pain right now.Interference scores range from 0 (does not interfere) to 10 (completely interferes).7 questions assessing interference of pain in past 24 hours on general activity, mood, walking ability, normal work, relations with other people, sleep, & enjoyment of life. Adolescent Version has 8th question for interference of pain on school work.|units on a scale|Mean|6.9|6.9|Standard Deviation|1.9|1.9|||
3992443|NCT01237587|3814248|B1|Worst Pain||Brief Pain Inventory (BPI) Modified short form (SF) Adolescent version (AV)|BPI Modified SF AV is a scale that measures severity & interference of pain. Severity scores range from 0 (no pain) to 10 (pain as bad as you can imagine). 4 questions assessing severity for worst pain, least pain, average pain in past 24 hours, & pain right now.Interference scores range from 0 (does not interfere) to 10 (completely interferes).7 questions assessing interference of pain in past 24 hours on general activity, mood, walking ability, normal work, relations with other people, sleep, & enjoyment of life. Adolescent Version has 8th question for interference of pain on school work.|units on a scale|Mean|7.1|7.1|Standard Deviation|1.8|1.8|||
3992444|NCT01237587|3814246|B3|Average Pain||Brief Pain Inventory (BPI) Modified short form (SF) Adolescent version (AV)|BPI Modified SF AV is a scale that measures severity & interference of pain. Severity scores range from 0 (no pain) to 10 (pain as bad as you can imagine). 4 questions assessing severity for worst pain, least pain, average pain in past 24 hours, & pain right now.Interference scores range from 0 (does not interfere) to 10 (completely interferes).7 questions assessing interference of pain in past 24 hours on general activity, mood, walking ability, normal work, relations with other people, sleep, & enjoyment of life. Adolescent Version has 8th question for interference of pain on school work.|units on a scale|Mean|5.65|5.65|Standard Deviation|1.46|1.46|||
3992445|NCT01237587|3814247|B2|Average Pain||Brief Pain Inventory (BPI) Modified short form (SF) Adolescent version (AV)|BPI Modified SF AV is a scale that measures severity & interference of pain. Severity scores range from 0 (no pain) to 10 (pain as bad as you can imagine). 4 questions assessing severity for worst pain, least pain, average pain in past 24 hours, & pain right now.Interference scores range from 0 (does not interfere) to 10 (completely interferes).7 questions assessing interference of pain in past 24 hours on general activity, mood, walking ability, normal work, relations with other people, sleep, & enjoyment of life. Adolescent Version has 8th question for interference of pain on school work.|units on a scale|Mean|5.6|5.6|Standard Deviation|1.55|1.55|||
3992446|NCT01237587|3814248|B1|Average Pain||Brief Pain Inventory (BPI) Modified short form (SF) Adolescent version (AV)|BPI Modified SF AV is a scale that measures severity & interference of pain. Severity scores range from 0 (no pain) to 10 (pain as bad as you can imagine). 4 questions assessing severity for worst pain, least pain, average pain in past 24 hours, & pain right now.Interference scores range from 0 (does not interfere) to 10 (completely interferes).7 questions assessing interference of pain in past 24 hours on general activity, mood, walking ability, normal work, relations with other people, sleep, & enjoyment of life. Adolescent Version has 8th question for interference of pain on school work.|units on a scale|Mean|5.7|5.7|Standard Deviation|1.37|1.37|||
3992447|NCT01237587|3814246|B3|India||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3992448|NCT01237587|3814247|B2|India||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3992449|NCT01237587|3814248|B1|India||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3992450|NCT01237587|3814246|B3|United States||Region of Enrollment||Participants|Count of Participants|128|128.0||||||
3992451|NCT01237587|3814247|B2|United States||Region of Enrollment||Participants|Count of Participants|64|64.0||||||
3992452|NCT01237587|3814248|B1|United States||Region of Enrollment||Participants|Count of Participants|64|64.0||||||
3992453|NCT01237587|3814246|B3|Argentina||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
3992454|NCT01237587|3814247|B2|Argentina||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3992455|NCT01237587|3814248|B1|Argentina||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3992456|NCT01237587|3814246|B3|Puerto Rico||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3992457|NCT01237587|3814247|B2|Puerto Rico||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3992477|NCT01237587|3814246|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992478|NCT01237587|3814247|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992479|NCT01237587|3814248|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992480|NCT01237587|3814246|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992481|NCT01237587|3814247|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992482|NCT01237587|3814248|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992483|NCT01237587|3814246|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
3992484|NCT01237587|3814247|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3992485|NCT01237587|3814248|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3992486|NCT01237587|3814246|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
3992487|NCT01237587|3814247|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3992488|NCT01237587|3814248|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
3992489|NCT01237587|3814246|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3992490|NCT01237587|3814247|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3992491|NCT01237587|3814248|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3992492|NCT01237587|3814246|B3||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
3992493|NCT01237587|3814247|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3992494|NCT01237587|3814248|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3992495|NCT01237587|3814246|B3|||Age||years|Mean|15.53|15.53|Standard Deviation|1.411|1.411|||
3992496|NCT01237587|3814247|B2|||Age||years|Mean|15.33|15.33|Standard Deviation|1.421|1.421|||
3992497|NCT01237587|3814248|B1|||Age||years|Mean|15.74|15.74|Standard Deviation|1.379|1.379|||
3992498|NCT01237353|3814296|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3992499|NCT01237353|3814296|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3992500|NCT01237353|3814296|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3992501|NCT01237353|3814296|B1|||Age||years|Mean|39.83|39.83|Full Range|||25.0|57.0|
3992502|NCT01237353|3814296|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3992503|NCT01237353|3814296|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3992504|NCT01237353|3814296|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3992505|NCT01237340|3814301|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3992506|NCT01237340|3814301|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3992507|NCT01237340|3814301|B1|||Age||years|Mean|44.7|44.7|Standard Deviation|10.3|10.3|||
3992508|NCT01237327|3814313|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3992509|NCT01237327|3814314|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3992510|NCT01237327|3814315|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3992511|NCT01237327|3814313|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3992512|NCT01237327|3814314|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3992513|NCT01237327|3814315|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3992514|NCT01237327|3814313|B3|65 to 79 years||Age, Customized||participants|Number|18|18.0||||||
3992515|NCT01237327|3814314|B2|65 to 79 years||Age, Customized||participants|Number|2|2.0||||||
3992516|NCT01237327|3814315|B1|65 to 79 years||Age, Customized||participants|Number|16|16.0||||||
3992517|NCT01237327|3814313|B3|50 to 64 years||Age, Customized||participants|Number|41|41.0||||||
3992518|NCT01237327|3814314|B2|50 to 64 years||Age, Customized||participants|Number|24|24.0||||||
3992519|NCT01237327|3814315|B1|50 to 64 years||Age, Customized||participants|Number|17|17.0||||||
3992520|NCT01237327|3814313|B3|< 50 years||Age, Customized||participants|Number|25|25.0||||||
3992521|NCT01237327|3814314|B2|< 50 years||Age, Customized||participants|Number|15|15.0||||||
3992522|NCT01237327|3814315|B1|< 50 years||Age, Customized||participants|Number|10|10.0||||||
3992523|NCT01237301|3814330|B3|United States||Region of Enrollment||participants|Number|124|124.0||||||
3992524|NCT01237301|3814331|B2|United States||Region of Enrollment||participants|Number|59|59.0||||||
3992525|NCT01237301|3814332|B1|United States||Region of Enrollment||participants|Number|65|65.0||||||
3992526|NCT01237301|3814330|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3992527|NCT01237301|3814331|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3992528|NCT01237301|3814332|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3992529|NCT01237301|3814330|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3992530|NCT01237301|3814331|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3992531|NCT01237301|3814332|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3992532|NCT01237301|3814330|B3|||Age||years|Mean|59|59.0|Standard Deviation|0.9|0.9|||
3992533|NCT01237301|3814331|B2|||Age||years|Mean|58.8|58.8|Standard Deviation|10|10.0|||
3992534|NCT01237301|3814332|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|8.9|8.9|||
3992535|NCT01237301|3814330|B3||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
3992536|NCT01237301|3814331|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3992537|NCT01237301|3814332|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3992538|NCT01237301|3814330|B3||Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
3992539|NCT01237301|3814331|B2||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3992540|NCT01237301|3814332|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
3992541|NCT01237301|3814330|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3992542|NCT01237301|3814331|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3992543|NCT01237301|3814332|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3992544|NCT01237223|3814345|B7||Male|Sex: Female, Male||Participants|Count of Participants|656|656.0||||||
3992545|NCT01237223|3814346|B6||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3992546|NCT01237223|3814347|B5||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3992547|NCT01237223|3814348|B4||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3992548|NCT01237223|3814349|B3||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
3992549|NCT01237223|3814350|B2||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3992550|NCT01237223|3814351|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3992551|NCT01237223|3814345|B7||Female|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
3992552|NCT01237223|3814346|B6||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3992553|NCT01237223|3814347|B5||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3992554|NCT01237223|3814348|B4||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3992555|NCT01237223|3814349|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3992556|NCT01237223|3814350|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3992557|NCT01237223|3814351|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3992558|NCT01237223|3814345|B7|>=65 years||Age, Customized||participants|Number|178|178.0||||||
3992559|NCT01237223|3814346|B6|>=65 years||Age, Customized||participants|Number|32|32.0||||||
3992560|NCT01237223|3814347|B5|>=65 years||Age, Customized||participants|Number|34|34.0||||||
3992561|NCT01237223|3814348|B4|>=65 years||Age, Customized||participants|Number|32|32.0||||||
3992562|NCT01237223|3814349|B3|>=65 years||Age, Customized||participants|Number|29|29.0||||||
3992563|NCT01237223|3814350|B2|>=65 years||Age, Customized||participants|Number|26|26.0||||||
3992564|NCT01237223|3814351|B1|>=65 years||Age, Customized||participants|Number|25|25.0||||||
3992565|NCT01237223|3814345|B7|< 65 years||Age, Customized||participants|Number|766|766.0||||||
3992566|NCT01237223|3814346|B6|< 65 years||Age, Customized||participants|Number|127|127.0||||||
3992567|NCT01237223|3814347|B5|< 65 years||Age, Customized||participants|Number|125|125.0||||||
3992568|NCT01237223|3814348|B4|< 65 years||Age, Customized||participants|Number|126|126.0||||||
3992569|NCT01237223|3814349|B3|< 65 years||Age, Customized||participants|Number|129|129.0||||||
3992570|NCT01237223|3814350|B2|< 65 years||Age, Customized||participants|Number|131|131.0||||||
3992571|NCT01237223|3814351|B1|< 65 years||Age, Customized||participants|Number|128|128.0||||||
3992572|NCT01237223|3814345|B7|||Age|Baseline measurements were based on randomized patients.|years|Mean|55.1|55.1|Standard Deviation|9.96|9.96|||
3992573|NCT01237223|3814346|B6|||Age|Baseline measurements were based on randomized patients.|years|Mean|55.5|55.5|Standard Deviation|9.86|9.86|||
3992574|NCT01237223|3814347|B5|||Age|Baseline measurements were based on randomized patients.|years|Mean|54.6|54.6|Standard Deviation|11.11|11.11|||
3992575|NCT01237223|3814348|B4|||Age|Baseline measurements were based on randomized patients.|years|Mean|55.8|55.8|Standard Deviation|10.05|10.05|||
3992576|NCT01237223|3814349|B3|||Age|Baseline measurements were based on randomized patients.|years|Mean|54.8|54.8|Standard Deviation|10.25|10.25|||
3992577|NCT01237223|3814350|B2|||Age|Baseline measurements were based on randomized patients.|years|Mean|55.0|55.0|Standard Deviation|9.96|9.96|||
3992578|NCT01237223|3814351|B1|||Age|Baseline measurements were based on randomized patients.|years|Mean|54.6|54.6|Standard Deviation|8.35|8.35|||
3992579|NCT01237197|3814395|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
3992580|NCT01237197|3814396|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
3992581|NCT01237197|3814397|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3992582|NCT01237197|3814395|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3992583|NCT01237197|3814396|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3992584|NCT01237197|3814397|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3992585|NCT01237197|3814395|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3992586|NCT01237197|3814396|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3992587|NCT01237197|3814397|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3992588|NCT01237197|3814395|B3|||Age||years|Mean|15.2|15.2|Standard Deviation|1.8|1.8|||
3992589|NCT01237197|3814396|B2|||Age||years|Mean|15.5|15.5|Standard Deviation|1.88|1.88|||
3992590|NCT01237197|3814397|B1|||Age||years|Mean|14.9|14.9|Standard Deviation|1.76|1.76|||
3992591|NCT01237197|3814395|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3992592|NCT01237197|3814396|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3992593|NCT01237197|3814397|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3992594|NCT01237197|3814395|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3992595|NCT01237197|3814396|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3992596|NCT01237197|3814397|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3992597|NCT01237197|3814395|B3||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
3992598|NCT01237197|3814396|B2||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
3992599|NCT01237197|3814397|B1||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
3992600|NCT01237080|3814404|B3|Denmark||Region of Enrollment||participants|Number|100|100.0||||||
3992601|NCT01237080|3814405|B2|Denmark||Region of Enrollment||participants|Number|50|50.0||||||
3992602|NCT01237080|3814406|B1|Denmark||Region of Enrollment||participants|Number|50|50.0||||||
3992603|NCT01237080|3814404|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3992604|NCT01237080|3814405|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3992605|NCT01237080|3814406|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3992606|NCT01237080|3814404|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3992607|NCT01237080|3814405|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3992608|NCT01237080|3814406|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3992609|NCT01237080|3814404|B3|||Age||years|Mean|42|42.0|Full Range|999999|999999.0|19.0|60.0|
3992610|NCT01237080|3814405|B2|||Age||years|Mean|43|43.0|Full Range|NA||19.0|60.0|
3992611|NCT01237080|3814406|B1|||Age||years|Mean|42|42.0|Full Range|NA||19.0|59.0|
3992612|NCT01237080|3814404|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3992613|NCT01237080|3814405|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3992614|NCT01237080|3814406|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3992615|NCT01237080|3814404|B3||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
3992616|NCT01237080|3814405|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3992617|NCT01237080|3814406|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3992618|NCT01237080|3814404|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3992619|NCT01237080|3814405|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3992620|NCT01237080|3814406|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3992621|NCT01237054|3814415|B1|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
3992622|NCT01237054|3814415|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992623|NCT01237054|3814415|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
3992624|NCT01237054|3814415|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992625|NCT01237054|3814415|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992626|NCT01237054|3814415|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992627|NCT01237054|3814415|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3992628|NCT01237054|3814415|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3992629|NCT01237054|3814415|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992630|NCT01237054|3814415|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992631|NCT01237054|3814415|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992632|NCT01237054|3814415|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3992633|NCT01237054|3814415|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3992634|NCT01237054|3814415|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3992635|NCT01237054|3814415|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3992636|NCT01237054|3814415|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3992637|NCT01237054|3814415|B1|||Age||years|Mean|62.89|62.89|Standard Deviation|10.58|10.58|||
3992638|NCT01237041|3814436|B6|United States||Region of Enrollment||participants|Number|17|17.0||||||
3992639|NCT01237041|3814437|B5|United States||Region of Enrollment||participants|Number|5|5.0||||||
3992640|NCT01237041|3814438|B4|United States||Region of Enrollment||participants|Number|5|5.0||||||
3992641|NCT01237041|3814439|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3992642|NCT01237041|3814440|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3992643|NCT01237041|3814441|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
3992644|NCT01237041|3814436|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992645|NCT01237041|3814437|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992646|NCT01237041|3814438|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992647|NCT01237041|3814439|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992648|NCT01237041|3814440|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992649|NCT01237041|3814441|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992650|NCT01237041|3814436|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992651|NCT01237041|3814437|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992652|NCT01237041|3814438|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992653|NCT01237041|3814439|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992654|NCT01237041|3814440|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992655|NCT01237041|3814441|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992656|NCT01237041|3814436|B6||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3992657|NCT01237041|3814437|B5||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3992658|NCT01237041|3814438|B4||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3992659|NCT01237041|3814439|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992660|NCT01237041|3814440|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3992661|NCT01237041|3814441|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3992662|NCT01237041|3814436|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3992663|NCT01237041|3814437|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3992664|NCT01237041|3814438|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3992665|NCT01237041|3814439|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3992666|NCT01237041|3814440|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992667|NCT01237041|3814441|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992668|NCT01237041|3814436|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992669|NCT01237041|3814437|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992670|NCT01237041|3814438|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992671|NCT01237041|3814439|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992672|NCT01237041|3814440|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992673|NCT01237041|3814441|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992674|NCT01237041|3814436|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992675|NCT01237041|3814437|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992676|NCT01237041|3814438|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992677|NCT01237041|3814439|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992678|NCT01237041|3814440|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992679|NCT01237041|3814441|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992680|NCT01237041|3814436|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992681|NCT01237041|3814437|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992682|NCT01237041|3814438|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992683|NCT01237041|3814439|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992684|NCT01237041|3814440|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992685|NCT01237041|3814441|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992686|NCT01237041|3814436|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992687|NCT01237041|3814437|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992688|NCT01237041|3814438|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992689|NCT01237041|3814439|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992690|NCT01237041|3814440|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992691|NCT01237041|3814441|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992692|NCT01237041|3814436|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3992693|NCT01237041|3814437|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3992694|NCT01237041|3814438|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3992695|NCT01237041|3814439|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3992696|NCT01237041|3814440|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3992697|NCT01237041|3814441|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992698|NCT01237041|3814436|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992699|NCT01237041|3814437|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992700|NCT01237041|3814438|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992701|NCT01237041|3814439|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992702|NCT01237041|3814440|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992703|NCT01237041|3814441|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992704|NCT01237041|3814436|B6||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3992705|NCT01237041|3814437|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3992706|NCT01237041|3814438|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3992707|NCT01237041|3814439|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3992708|NCT01237041|3814440|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3992709|NCT01237041|3814441|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3992710|NCT01237041|3814436|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3992711|NCT01237041|3814437|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3992712|NCT01237041|3814438|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3992713|NCT01237041|3814439|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3992714|NCT01237041|3814440|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3992715|NCT01237041|3814441|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3992716|NCT01237041|3814436|B6|||Age||years|Mean|10.1|10.1|Standard Deviation|1.8|1.8|||
3992717|NCT01237041|3814437|B5|||Age||years|Mean|9.3|9.3|Standard Deviation|1.9|1.9|||
3992718|NCT01237041|3814438|B4|||Age||years|Mean|9.7|9.7|Standard Deviation|2.0|2.0|||
3992719|NCT01237041|3814439|B3|||Age||years|Mean|10.5|10.5|Standard Deviation|2.2|2.2|||
3992720|NCT01237041|3814440|B2|||Age||years|Mean|10.8|10.8|Standard Deviation|1.3|1.3|||
3992721|NCT01237041|3814441|B1|||Age||years|Mean|11.4|11.4|Standard Deviation|2.3|2.3|||
3992722|NCT01236768|3814467|B3|United States||Region of Enrollment||Participants|Count of Participants|365|365.0||||||
3992723|NCT01236768|3814468|B2|United States||Region of Enrollment||Participants|Count of Participants|188|188.0||||||
3992724|NCT01236768|3814469|B1|United States||Region of Enrollment||Participants|Count of Participants|177|177.0||||||
3992725|NCT01236768|3814467|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3992726|NCT01236768|3814468|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3992727|NCT01236768|3814469|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3992728|NCT01236768|3814467|B3||Female|Sex: Female, Male||Participants|Count of Participants|365|365.0||||||
3992729|NCT01236768|3814468|B2||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3992730|NCT01236768|3814469|B1||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
3992731|NCT01236768|3814467|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3992732|NCT01236768|3814468|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3992733|NCT01236768|3814469|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3992734|NCT01236768|3814467|B3||Between 18 and 65 years|Age||Participants|Count of Participants|365|365.0||||||
3992735|NCT01236768|3814468|B2||Between 18 and 65 years|Age||Participants|Count of Participants|188|188.0||||||
3992736|NCT01236768|3814469|B1||Between 18 and 65 years|Age||Participants|Count of Participants|177|177.0||||||
3992737|NCT01236768|3814467|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3992738|NCT01236768|3814468|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3992739|NCT01236768|3814469|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3992740|NCT01236742|3814484|B4|||Axial length||mm|Mean|24.72|24.72|Standard Deviation|0.823|0.823|||
3992741|NCT01236742|3814485|B3|||Axial length||mm|Mean|24.72|24.72|Standard Deviation|0.850|0.85|||
3992742|NCT01236742|3814486|B2|||Axial length||mm|Mean|24.62|24.62|Standard Deviation|0.772|0.772|||
3992743|NCT01236742|3814487|B1|||Axial length||mm|Mean|24.83|24.83|Standard Deviation|0.881|0.881|||
3992744|NCT01236742|3814484|B4|China||Region of Enrollment||Participants|Count of Participants|53|53.0||||||
3992745|NCT01236742|3814485|B3|China||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
3992746|NCT01236742|3814486|B2|China||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3992747|NCT01236742|3814487|B1|China||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
3992748|NCT01236742|3814484|B4|Chinese||Race/Ethnicity, Customized||Participants|Count of Participants|53|53.0||||||
3992749|NCT01236742|3814485|B3|Chinese||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3992750|NCT01236742|3814486|B2|Chinese||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3992751|NCT01236742|3814487|B1|Chinese||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3992752|NCT01236742|3814484|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3992753|NCT01236742|3814485|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3992754|NCT01236742|3814486|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3992755|NCT01236742|3814487|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3992756|NCT01236742|3814484|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3992757|NCT01236742|3814485|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3992758|NCT01236742|3814486|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3992759|NCT01236742|3814487|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3992760|NCT01236742|3814484|B4|||Age||years|Median|11|11.0|Full Range|||9.0|13.0|
3992761|NCT01236742|3814485|B3|||Age||years|Median|11|11.0|Full Range|||9.0|13.0|
3992762|NCT01236742|3814486|B2|||Age||years|Median|11|11.0|Full Range|||9.0|12.0|
3992763|NCT01236742|3814487|B1|||Age||years|Median|10|10.0|Full Range|||10.0|14.0|
3992764|NCT01236573|3814500|B12|United States||Region of Enrollment||participants|Number|34|34.0||||||
3992765|NCT01236573|3814501|B11|United States||Region of Enrollment||participants|Number|6|6.0||||||
3992766|NCT01236573|3814502|B10|United States||Region of Enrollment||participants|Number|4|4.0||||||
3992767|NCT01236573|3814503|B9|United States||Region of Enrollment||participants|Number|4|4.0||||||
3992768|NCT01236573|3814504|B8|United States||Region of Enrollment||participants|Number|3|3.0||||||
3992769|NCT01236573|3814505|B7|United States||Region of Enrollment||participants|Number|3|3.0||||||
3992770|NCT01236573|3814506|B6|United States||Region of Enrollment||participants|Number|4|4.0||||||
3992771|NCT01236573|3814507|B5|United States||Region of Enrollment||participants|Number|1|1.0||||||
3992772|NCT01236573|3814508|B4|United States||Region of Enrollment||participants|Number|1|1.0||||||
3992773|NCT01236573|3814509|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3992774|NCT01236573|3814510|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3992775|NCT01236573|3814511|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3992776|NCT01236573|3814500|B12||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992777|NCT01236573|3814501|B11||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992778|NCT01236573|3814502|B10||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992779|NCT01236573|3814503|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992780|NCT01236573|3814504|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992781|NCT01236573|3814505|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992782|NCT01236573|3814506|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992783|NCT01236573|3814507|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992784|NCT01236573|3814508|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992785|NCT01236573|3814509|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992786|NCT01236573|3814510|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992787|NCT01236573|3814511|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992788|NCT01236573|3814500|B12||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992789|NCT01236573|3814501|B11||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992790|NCT01236573|3814502|B10||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992791|NCT01236573|3814503|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992792|NCT01236573|3814504|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992793|NCT01236573|3814505|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992794|NCT01236573|3814506|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992795|NCT01236573|3814507|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992796|NCT01236573|3814508|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992797|NCT01236573|3814509|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992798|NCT01236573|3814510|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992799|NCT01236573|3814511|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992800|NCT01236573|3814500|B12||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3992801|NCT01236573|3814501|B11||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3992802|NCT01236573|3814502|B10||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3992803|NCT01236573|3814503|B9||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3992804|NCT01236573|3814504|B8||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3992805|NCT01236573|3814505|B7||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3992806|NCT01236573|3814506|B6||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3992807|NCT01236573|3814507|B5||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992808|NCT01236573|3814508|B4||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992809|NCT01236573|3814509|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3992810|NCT01236573|3814510|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992811|NCT01236573|3814511|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992812|NCT01236573|3814500|B12||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992813|NCT01236573|3814501|B11||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992814|NCT01236573|3814502|B10||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992815|NCT01236573|3814503|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992816|NCT01236573|3814504|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992817|NCT01236573|3814505|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992818|NCT01236573|3814506|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992819|NCT01236573|3814507|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992820|NCT01236573|3814508|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992821|NCT01236573|3814509|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992822|NCT01236573|3814510|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992823|NCT01236573|3814511|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992824|NCT01236573|3814500|B12||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992825|NCT01236573|3814501|B11||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992826|NCT01236573|3814502|B10||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992827|NCT01236573|3814503|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992828|NCT01236573|3814504|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992829|NCT01236573|3814505|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992830|NCT01236573|3814506|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992831|NCT01236573|3814507|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992832|NCT01236573|3814508|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992833|NCT01236573|3814509|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992834|NCT01236573|3814510|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992835|NCT01236573|3814511|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992836|NCT01236573|3814500|B12||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992837|NCT01236573|3814501|B11||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992838|NCT01236573|3814502|B10||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992839|NCT01236573|3814503|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992840|NCT01236573|3814504|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992841|NCT01236573|3814505|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992842|NCT01236573|3814506|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992843|NCT01236573|3814507|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992844|NCT01236573|3814508|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992845|NCT01236573|3814509|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992846|NCT01236573|3814510|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992847|NCT01236573|3814511|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992848|NCT01236573|3814500|B12||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992849|NCT01236573|3814501|B11||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992850|NCT01236573|3814502|B10||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992851|NCT01236573|3814503|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992852|NCT01236573|3814504|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992853|NCT01236573|3814505|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992854|NCT01236573|3814506|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992855|NCT01236573|3814507|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992856|NCT01236573|3814508|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992857|NCT01236573|3814509|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992858|NCT01236573|3814510|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992859|NCT01236573|3814511|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992860|NCT01236573|3814500|B12||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992861|NCT01236573|3814501|B11||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992862|NCT01236573|3814502|B10||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992863|NCT01236573|3814503|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992864|NCT01236573|3814504|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992865|NCT01236573|3814505|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992866|NCT01236573|3814506|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992867|NCT01236573|3814507|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992868|NCT01236573|3814508|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992869|NCT01236573|3814509|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992870|NCT01236573|3814510|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992871|NCT01236573|3814511|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992872|NCT01236573|3814500|B12||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3992873|NCT01236573|3814501|B11||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3992874|NCT01236573|3814502|B10||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3992875|NCT01236573|3814503|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3992876|NCT01236573|3814504|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3992877|NCT01236573|3814505|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3992878|NCT01236573|3814506|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3992879|NCT01236573|3814507|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992880|NCT01236573|3814508|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992881|NCT01236573|3814509|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3992882|NCT01236573|3814510|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992883|NCT01236573|3814511|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992884|NCT01236573|3814500|B12||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3992885|NCT01236573|3814501|B11||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992886|NCT01236573|3814502|B10||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992887|NCT01236573|3814503|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992888|NCT01236573|3814504|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3992889|NCT01236573|3814505|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992890|NCT01236573|3814506|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992891|NCT01236573|3814507|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992892|NCT01236573|3814508|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992893|NCT01236573|3814509|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992894|NCT01236573|3814510|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992895|NCT01236573|3814511|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992896|NCT01236573|3814500|B12||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3992897|NCT01236573|3814501|B11||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3992898|NCT01236573|3814502|B10||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3992899|NCT01236573|3814503|B9||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3992900|NCT01236573|3814504|B8||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3992901|NCT01236573|3814505|B7||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3992902|NCT01236573|3814506|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3992903|NCT01236573|3814507|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3992904|NCT01236573|3814508|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3992905|NCT01236573|3814509|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3992906|NCT01236573|3814510|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3992907|NCT01236573|3814511|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3992908|NCT01236573|3814500|B12||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3992909|NCT01236573|3814501|B11||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3992910|NCT01236573|3814502|B10||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3992911|NCT01236573|3814503|B9||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3992912|NCT01236573|3814504|B8||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3992913|NCT01236573|3814505|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3992914|NCT01236573|3814506|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3992915|NCT01236573|3814507|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3992916|NCT01236573|3814508|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3992917|NCT01236573|3814509|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3992918|NCT01236573|3814510|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3992919|NCT01236573|3814511|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3992920|NCT01236573|3814500|B12|||Age||years|Mean|50.7|50.7|Standard Deviation|13.0|13.0|||
3992921|NCT01236573|3814501|B11|||Age||years|Mean|49.3|49.3|Standard Deviation|16.5|16.5|||
3992922|NCT01236573|3814502|B10|||Age||years|Mean|55.8|55.8|Standard Deviation|12.2|12.2|||
3992923|NCT01236573|3814503|B9|||Age||years|Mean|53.5|53.5|Standard Deviation|16.2|16.2|||
3992924|NCT01236573|3814504|B8|||Age||years|Mean|56.0|56.0|Standard Deviation|9.6|9.6|||
3992925|NCT01236573|3814505|B7|||Age||years|Mean|49.0|49.0|Standard Deviation|14.5|14.5|||
3992926|NCT01236573|3814506|B6|||Age||years|Mean|57.3|57.3|Standard Deviation|10.9|10.9|||
3992927|NCT01236573|3814507|B5|||Age||years|Mean|60.0|60.0|Standard Deviation|0|0.0|||
3992928|NCT01236573|3814508|B4|||Age||years|Mean|48.0|48.0|Standard Deviation|0|0.0|||
3992929|NCT01236573|3814509|B3|||Age||years|Mean|39.0|39.0|Standard Deviation|11.5|11.5|||
3992930|NCT01236573|3814510|B2|||Age||years|Mean|50.0|50.0|Standard Deviation|0|0.0|||
3992931|NCT01236573|3814511|B1|||Age||years|Mean|56.0|56.0|Standard Deviation|0|0.0|||
3992932|NCT01236573|3814500|B12||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3992933|NCT01236573|3814501|B11||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3992934|NCT01236573|3814502|B10||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3992935|NCT01236573|3814503|B9||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3992936|NCT01236573|3814504|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3992937|NCT01236573|3814505|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3992938|NCT01236573|3814506|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3992939|NCT01236573|3814507|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3992940|NCT01236573|3814508|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3992941|NCT01236573|3814509|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3992942|NCT01236573|3814510|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3992943|NCT01236573|3814511|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3992944|NCT01236573|3814500|B12||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
3992945|NCT01236573|3814501|B11||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3992946|NCT01236573|3814502|B10||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3992947|NCT01236573|3814503|B9||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3992948|NCT01236573|3814504|B8||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3992949|NCT01236573|3814505|B7||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3992950|NCT01236573|3814506|B6||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3992951|NCT01236573|3814507|B5||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3992952|NCT01236573|3814508|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3992953|NCT01236573|3814509|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3992954|NCT01236573|3814510|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3992955|NCT01236573|3814511|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3992956|NCT01236573|3814500|B12||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3992957|NCT01236573|3814501|B11||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3992958|NCT01236573|3814502|B10||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3992959|NCT01236573|3814503|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3992960|NCT01236573|3814504|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3992961|NCT01236573|3814505|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3992962|NCT01236573|3814506|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3992963|NCT01236573|3814507|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3992964|NCT01236573|3814508|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3992965|NCT01236573|3814509|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3992966|NCT01236573|3814510|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3992967|NCT01236573|3814511|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3992968|NCT01236534|3814557|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
3992969|NCT01236534|3814558|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
3992970|NCT01236534|3814559|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3992971|NCT01236534|3814557|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3992972|NCT01236534|3814558|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3992973|NCT01236534|3814559|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3992974|NCT01236534|3814557|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3992975|NCT01236534|3814558|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3992976|NCT01236534|3814559|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3992977|NCT01236534|3814557|B3|||Age||years|Mean|44.7|44.7|Standard Deviation|12.4|12.4|||
3992978|NCT01236534|3814558|B2|||Age||years|Mean|41.6|41.6|Standard Deviation|8.8|8.8|||
3992979|NCT01236534|3814559|B1|||Age||years|Mean|47.6|47.6|Standard Deviation|14.8|14.8|||
3992980|NCT01236534|3814557|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3992981|NCT01236534|3814558|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3992982|NCT01236534|3814559|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3992983|NCT01236534|3814557|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3992984|NCT01236534|3814558|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3992985|NCT01236534|3814559|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3992986|NCT01236534|3814557|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3992987|NCT01236534|3814558|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3992988|NCT01236534|3814559|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3992989|NCT01236521|3814568|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3992990|NCT01236521|3814569|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3992991|NCT01236521|3814570|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3992992|NCT01236521|3814568|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3992993|NCT01236521|3814569|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3992994|NCT01236521|3814570|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3992995|NCT01236521|3814568|B3||White|Race (NIH/OMB)||Participants|Count of Participants|191|191.0||||||
3992996|NCT01236521|3814569|B2||White|Race (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
3992997|NCT01236521|3814570|B1||White|Race (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
3992998|NCT01236521|3814568|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
3992999|NCT01236521|3814569|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3993000|NCT01236521|3814570|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3993001|NCT01236521|3814568|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3993002|NCT01236521|3814569|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3993003|NCT01236521|3814570|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3993004|NCT01236521|3814568|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3993005|NCT01236521|3814569|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3993006|NCT01236521|3814570|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3993007|NCT01236521|3814568|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3993008|NCT01236521|3814569|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3993009|NCT01236521|3814570|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3993010|NCT01236521|3814568|B3||Male|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
3993011|NCT01236521|3814569|B2||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3993012|NCT01236521|3814570|B1||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3993013|NCT01236521|3814568|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3993014|NCT01236521|3814569|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3993015|NCT01236521|3814570|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3993016|NCT01236521|3814568|B3|||Age||years|Mean|57.9|57.9|Standard Deviation|9.5|9.5|||
3993017|NCT01236521|3814569|B2|||Age||years|Mean|58.2|58.2|Standard Deviation|9.2|9.2|||
3993018|NCT01236521|3814570|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|9.8|9.8|||
3993019|NCT01236391|3814599|B1|United Kingdom||Region of Enrollment||participants|Number|20|20.0||||||
3993020|NCT01236391|3814599|B1|Germany||Region of Enrollment||participants|Number|3|3.0||||||
3993021|NCT01236391|3814599|B1|Poland||Region of Enrollment||participants|Number|10|10.0||||||
3993022|NCT01236391|3814599|B1|United States||Region of Enrollment||participants|Number|78|78.0||||||
3993023|NCT01236391|3814599|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3993024|NCT01236391|3814599|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3993025|NCT01236391|3814599|B1|||Age||years|Mean|67.1|67.1|Standard Deviation|8.6|8.6|||
3993026|NCT01236391|3814599|B1||>=65 years|Age||Participants|Count of Participants|70|70.0||||||
3993027|NCT01236391|3814599|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3993028|NCT01236391|3814599|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3993029|NCT01236378|3814607|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3993030|NCT01236378|3814607|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3993031|NCT01236378|3814607|B1|45 to 64 years||Age, Customized||participants|Number|8|8.0||||||
3993032|NCT01236378|3814607|B1|18 to 44 years||Age, Customized||participants|Number|16|16.0||||||
3993033|NCT01236365|3814619|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
3993034|NCT01236365|3814620|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
3993035|NCT01236365|3814621|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
3993036|NCT01236365|3814619|B3|Other||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
3993037|NCT01236365|3814620|B2|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3993038|NCT01236365|3814621|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3993039|NCT01236365|3814619|B3|non-Hispanic white||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3993040|NCT01236365|3814620|B2|non-Hispanic white||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3993041|NCT01236365|3814621|B1|non-Hispanic white||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3993042|NCT01236365|3814619|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3993043|NCT01236365|3814620|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3993044|NCT01236365|3814621|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3993045|NCT01236365|3814619|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3993046|NCT01236365|3814620|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3993047|NCT01236365|3814621|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3993048|NCT01236365|3814619|B3|||Age||years|Mean|15.1|15.1|Standard Deviation|2.4|2.4|||
3993049|NCT01236365|3814620|B2|||Age||years|Mean|15.4|15.4|Standard Deviation|2.7|2.7|||
3993050|NCT01236365|3814621|B1|||Age||years|Mean|14.9|14.9|Standard Deviation|2.2|2.2|||
3993051|NCT01236339|3814634|B3|Canada||Region of Enrollment||participants|Number|6|6.0||||||
3993052|NCT01236339|3814635|B2|Canada||Region of Enrollment||participants|Number|4|4.0||||||
3993053|NCT01236339|3814636|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
3993054|NCT01236339|3814634|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
3993055|NCT01236339|3814635|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
3993056|NCT01236339|3814636|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
3993057|NCT01236339|3814634|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3993058|NCT01236339|3814635|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3993059|NCT01236339|3814636|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3993060|NCT01236339|3814634|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3993061|NCT01236339|3814635|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3993062|NCT01236339|3814636|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3993063|NCT01236339|3814634|B3|||Age||years|Mean|58.0|58.0|Standard Deviation|7.2|7.2|||
3993064|NCT01236339|3814635|B2|||Age||years|Mean|57.5|57.5|Standard Deviation|8.0|8.0|||
3993065|NCT01236339|3814636|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|6.6|6.6|||
3993066|NCT01236326|3814655|B3|No||Multiple Arteries||participants|Number|88|88.0||||||
3993067|NCT01236326|3814656|B2|No||Multiple Arteries||participants|Number|45|45.0||||||
3993068|NCT01236326|3814657|B1|No||Multiple Arteries||participants|Number|43|43.0||||||
3993069|NCT01236326|3814655|B3|Yes||Multiple Arteries||participants|Number|12|12.0||||||
3993070|NCT01236326|3814656|B2|Yes||Multiple Arteries||participants|Number|6|6.0||||||
3993071|NCT01236326|3814657|B1|Yes||Multiple Arteries||participants|Number|6|6.0||||||
3993072|NCT01236326|3814655|B3|BMI >= 30||Body Mass Index (BMI)||participants|Number|28|28.0||||||
3993073|NCT01236326|3814656|B2|BMI >= 30||Body Mass Index (BMI)||participants|Number|15|15.0||||||
3993074|NCT01236326|3814657|B1|BMI >= 30||Body Mass Index (BMI)||participants|Number|13|13.0||||||
3993075|NCT01236326|3814655|B3|BMI < 30||Body Mass Index (BMI)||participants|Number|72|72.0||||||
3993076|NCT01236326|3814656|B2|BMI < 30||Body Mass Index (BMI)||participants|Number|36|36.0||||||
3993077|NCT01236326|3814657|B1|BMI < 30||Body Mass Index (BMI)||participants|Number|36|36.0||||||
3993078|NCT01236326|3814655|B3|Right||Side of Donation (left)||participants|Number|7|7.0||||||
3993079|NCT01236326|3814656|B2|Right||Side of Donation (left)||participants|Number|3|3.0||||||
3993080|NCT01236326|3814657|B1|Right||Side of Donation (left)||participants|Number|4|4.0||||||
3993081|NCT01236326|3814655|B3|Left||Side of Donation (left)||participants|Number|93|93.0||||||
3993082|NCT01236326|3814656|B2|Left||Side of Donation (left)||participants|Number|48|48.0||||||
3993083|NCT01236326|3814657|B1|Left||Side of Donation (left)||participants|Number|45|45.0||||||
3993084|NCT01236326|3814655|B3|Living Unrelated||Relationship to Recipient||participants|Number|55|55.0||||||
3993085|NCT01236326|3814656|B2|Living Unrelated||Relationship to Recipient||participants|Number|27|27.0||||||
3993086|NCT01236326|3814657|B1|Living Unrelated||Relationship to Recipient||participants|Number|28|28.0||||||
3993087|NCT01236326|3814655|B3|Living Related||Relationship to Recipient||participants|Number|45|45.0||||||
3993088|NCT01236326|3814656|B2|Living Related||Relationship to Recipient||participants|Number|24|24.0||||||
3993089|NCT01236326|3814657|B1|Living Related||Relationship to Recipient||participants|Number|21|21.0||||||
3993090|NCT01236326|3814655|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
3993091|NCT01236326|3814656|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
3993092|NCT01236326|3814657|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
3993093|NCT01236326|3814655|B3|All Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3993094|NCT01236326|3814656|B2|All Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3993095|NCT01236326|3814657|B1|All Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3993096|NCT01236326|3814655|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3993097|NCT01236326|3814656|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3993098|NCT01236326|3814657|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3993099|NCT01236326|3814655|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
3993100|NCT01236326|3814656|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
3993101|NCT01236326|3814657|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3993102|NCT01236326|3814655|B3|African American||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3993103|NCT01236326|3814656|B2|African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3993104|NCT01236326|3814657|B1|African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3993105|NCT01236326|3814655|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3993106|NCT01236326|3814656|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3993107|NCT01236326|3814657|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3993108|NCT01236326|3814655|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3993109|NCT01236326|3814656|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3993110|NCT01236326|3814657|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3993111|NCT01236326|3814655|B3|||Age||years|Mean|47.1|47.1|Standard Deviation|11.6|11.6|||
3993112|NCT01236326|3814656|B2|||Age||years|Mean|47.4|47.4|Standard Deviation|11.5|11.5|||
3993113|NCT01236326|3814657|B1|||Age||years|Mean|46.8|46.8|Standard Deviation|11.9|11.9|||
3993114|NCT01236300|3814672|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3993115|NCT01236300|3814672|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3993116|NCT01236300|3814672|B1|||Age||years|Mean|63.1|63.1|Full Range|||27.0|89.0|
3993117|NCT01236196|3814680|B3|||Education||years|Mean|15|15.0|Standard Deviation|2|2.0|||
3993118|NCT01236196|3814681|B2|||Education||years|Mean|15|15.0|Standard Deviation|2|2.0|||
3993119|NCT01236196|3814682|B1|||Education||years|Mean|15|15.0|Standard Deviation|2|2.0|||
3993120|NCT01236196|3814680|B3|Not married||Marital status||participants|Number|27|27.0||||||
3993121|NCT01236196|3814681|B2|Not married||Marital status||participants|Number|14|14.0||||||
3993122|NCT01236196|3814682|B1|Not married||Marital status||participants|Number|13|13.0||||||
3993123|NCT01236196|3814680|B3|Married||Marital status||participants|Number|12|12.0||||||
3993124|NCT01236196|3814681|B2|Married||Marital status||participants|Number|7|7.0||||||
3993125|NCT01236196|3814682|B1|Married||Marital status||participants|Number|5|5.0||||||
3993126|NCT01236196|3814680|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
3993127|NCT01236196|3814681|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
3993128|NCT01236196|3814682|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3993129|NCT01236196|3814680|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3993130|NCT01236196|3814681|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3993131|NCT01236196|3814682|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3993132|NCT01236196|3814680|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3993133|NCT01236196|3814681|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3993134|NCT01236196|3814682|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3993135|NCT01236196|3814680|B3||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3993136|NCT01236196|3814681|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3993137|NCT01236196|3814682|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3993138|NCT01236196|3814680|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3993139|NCT01236196|3814681|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3993140|NCT01236196|3814682|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3993141|NCT01236196|3814680|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3993142|NCT01236196|3814681|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3993143|NCT01236196|3814682|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3993144|NCT01236196|3814680|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3993145|NCT01236196|3814681|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3993146|NCT01236196|3814682|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3993147|NCT01236196|3814680|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3993148|NCT01236196|3814681|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3993149|NCT01236196|3814682|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3993150|NCT01236196|3814680|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3993151|NCT01236196|3814681|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3993152|NCT01236196|3814682|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3993153|NCT01236196|3814680|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3993154|NCT01236196|3814681|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3993155|NCT01236196|3814682|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3993156|NCT01236196|3814680|B3|||Age||years|Mean|35|35.0|Standard Deviation|10|10.0|||
3993157|NCT01236196|3814681|B2|||Age||years|Mean|34|34.0|Standard Deviation|10|10.0|||
3993158|NCT01236196|3814682|B1|||Age||years|Mean|37|37.0|Standard Deviation|11|11.0|||
3993159|NCT01236170|3814695|B1|United States||Region of Enrollment||participants|Number|482|482.0||||||
3993160|NCT01236170|3814695|B1|Male||Gender|The sum of participants in both categories for the measure does not equal to overall number of baseline participants because one participant had missing data for this measure.|participants|Number|462|462.0||||||
3993161|NCT01236170|3814695|B1|Female||Gender|The sum of participants in both categories for the measure does not equal to overall number of baseline participants because one participant had missing data for this measure.|participants|Number|19|19.0||||||
3993162|NCT01236170|3814695|B1|>=65 years||Age|The sum of participants in all categories for this measure does not equal the overal number of baseline participants because 4 participants had missing data for this measure.|participants|Number|151|151.0||||||
3993163|NCT01236170|3814695|B1|Between 18 and 65 years||Age|The sum of participants in all categories for this measure does not equal the overal number of baseline participants because 4 participants had missing data for this measure.|participants|Number|327|327.0||||||
3993164|NCT01236170|3814695|B1|<=18 years||Age|The sum of participants in all categories for this measure does not equal the overal number of baseline participants because 4 participants had missing data for this measure.|participants|Number|0|0.0||||||
3993165|NCT01236118|3814702|B4|Placebo||Number of Participants Given Doses in Study I1F-JE-RHAL (NCT01253265)||participants|Number|6|6.0||||||
3993166|NCT01236118|3814703|B3|Placebo||Number of Participants Given Doses in Study I1F-JE-RHAL (NCT01253265)||participants|Number|3|3.0||||||
3993167|NCT01236118|3814704|B2|Placebo||Number of Participants Given Doses in Study I1F-JE-RHAL (NCT01253265)||participants|Number|1|1.0||||||
3993168|NCT01236118|3814705|B1|Placebo||Number of Participants Given Doses in Study I1F-JE-RHAL (NCT01253265)||participants|Number|2|2.0||||||
3993169|NCT01236118|3814702|B4|LY2439821||Number of Participants Given Doses in Study I1F-JE-RHAL (NCT01253265)||participants|Number|22|22.0||||||
3993170|NCT01236118|3814703|B3|LY2439821||Number of Participants Given Doses in Study I1F-JE-RHAL (NCT01253265)||participants|Number|14|14.0||||||
3993171|NCT01236118|3814704|B2|LY2439821||Number of Participants Given Doses in Study I1F-JE-RHAL (NCT01253265)||participants|Number|4|4.0||||||
3993172|NCT01236118|3814705|B1|LY2439821||Number of Participants Given Doses in Study I1F-JE-RHAL (NCT01253265)||participants|Number|4|4.0||||||
3993173|NCT01236118|3814702|B4|||Weekly Dose of Methotrexate (MTX)||milligrams per week (mg/week)|Mean|8.52|8.52|Standard Deviation|1.10|1.1|||
3993174|NCT01236118|3814703|B3|||Weekly Dose of Methotrexate (MTX)||milligrams per week (mg/week)|Mean|8.35|8.35|Standard Deviation|0.79|0.79|||
3993175|NCT01236118|3814704|B2|||Weekly Dose of Methotrexate (MTX)||milligrams per week (mg/week)|Mean|8.40|8.4|Standard Deviation|0.89|0.89|||
3993176|NCT01236118|3814705|B1|||Weekly Dose of Methotrexate (MTX)||milligrams per week (mg/week)|Mean|9.08|9.08|Standard Deviation|1.86|1.86|||
3993177|NCT01236118|3814702|B4|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight in kilograms divided by height squared in meters.|kilograms per square meter (kg/m^2)|Mean|23.15|23.15|Standard Deviation|4.60|4.6|||
3993178|NCT01236118|3814703|B3|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight in kilograms divided by height squared in meters.|kilograms per square meter (kg/m^2)|Mean|23.95|23.95|Standard Deviation|5.28|5.28|||
3993179|NCT01236118|3814704|B2|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight in kilograms divided by height squared in meters.|kilograms per square meter (kg/m^2)|Mean|23.38|23.38|Standard Deviation|3.50|3.5|||
3993180|NCT01236118|3814705|B1|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight in kilograms divided by height squared in meters.|kilograms per square meter (kg/m^2)|Mean|20.68|20.68|Standard Deviation|2.37|2.37|||
3993181|NCT01236118|3814702|B4|||Height||centimeters (cm)|Mean|158.69|158.69|Standard Deviation|8.90|8.9|||
3993182|NCT01236118|3814703|B3|||Height||centimeters (cm)|Mean|159.52|159.52|Standard Deviation|8.87|8.87|||
3993183|NCT01236118|3814704|B2|||Height||centimeters (cm)|Mean|152.34|152.34|Standard Deviation|6.20|6.2|||
3993184|NCT01236118|3814705|B1|||Height||centimeters (cm)|Mean|161.62|161.62|Standard Deviation|9.62|9.62|||
3993185|NCT01236118|3814702|B4|||Weight||kilograms (kg)|Mean|58.47|58.47|Standard Deviation|13.48|13.48|||
3993186|NCT01236118|3814703|B3|||Weight||kilograms (kg)|Mean|61.25|61.25|Standard Deviation|15.55|15.55|||
3993187|NCT01236118|3814704|B2|||Weight||kilograms (kg)|Mean|54.12|54.12|Standard Deviation|7.66|7.66|||
3993188|NCT01236118|3814705|B1|||Weight||kilograms (kg)|Mean|54.23|54.23|Standard Deviation|9.69|9.69|||
3993189|NCT01236118|3814702|B4|Japan||Region of Enrollment||participants|Number|28|28.0||||||
3993190|NCT01236118|3814703|B3|Japan||Region of Enrollment||participants|Number|17|17.0||||||
3993191|NCT01236118|3814704|B2|Japan||Region of Enrollment||participants|Number|5|5.0||||||
3993192|NCT01236118|3814705|B1|Japan||Region of Enrollment||participants|Number|6|6.0||||||
3993193|NCT01236118|3814702|B4|Asian||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
3993194|NCT01236118|3814703|B3|Asian||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
3993195|NCT01236118|3814704|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3993196|NCT01236118|3814705|B1|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3993197|NCT01236118|3814702|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3993198|NCT01236118|3814703|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3993199|NCT01236118|3814704|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3993200|NCT01236118|3814705|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3993201|NCT01236118|3814702|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3993202|NCT01236118|3814703|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3993203|NCT01236118|3814704|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3993204|NCT01236118|3814705|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3993205|NCT01236118|3814702|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3993206|NCT01236118|3814703|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3993207|NCT01236118|3814704|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3993208|NCT01236118|3814705|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3993209|NCT01236118|3814702|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3993210|NCT01236118|3814703|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3993211|NCT01236118|3814704|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3993212|NCT01236118|3814705|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3993213|NCT01236118|3814702|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3993214|NCT01236118|3814703|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3993215|NCT01236118|3814704|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3993216|NCT01236118|3814705|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3993217|NCT01236118|3814702|B4|||Age||years|Mean|57.3|57.3|Standard Deviation|11.6|11.6|||
3993218|NCT01236118|3814703|B3|||Age||years|Mean|57.6|57.6|Standard Deviation|11.4|11.4|||
3993219|NCT01236118|3814704|B2|||Age||years|Mean|61.2|61.2|Standard Deviation|8.1|8.1|||
3993220|NCT01236118|3814705|B1|||Age||years|Mean|53.2|53.2|Standard Deviation|15.0|15.0|||
3993221|NCT01236105|3814715|B1|United Kingdom||Region of Enrollment||participants|Number|21|21.0||||||
3993222|NCT01236105|3814715|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3993223|NCT01236105|3814715|B1|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
3993224|NCT01236105|3814715|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3993225|NCT01236105|3814715|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3993226|NCT01236105|3814715|B1|||Age||years|Mean|32.3|32.3|Standard Deviation|11.7|11.7|||
3993227|NCT01236053|3814729|B23|Upper gastro-intestinal disorder||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|3302|3302.0||||||
3993228|NCT01236053|3814730|B22|Upper gastro-intestinal disorder||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993756|NCT01236053|3814729|B23|Never Smoked||Number of participants with the indicated smoking status||participants|Number|1162688|1162688.0||||||
3993229|NCT01236053|3814731|B21|Upper gastro-intestinal disorder||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993230|NCT01236053|3814732|B20|Upper gastro-intestinal disorder||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993231|NCT01236053|3814733|B19|Upper gastro-intestinal disorder||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993232|NCT01236053|3814734|B18|Upper gastro-intestinal disorder||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993233|NCT01236053|3814735|B17|Upper gastro-intestinal disorder||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993234|NCT01236053|3814736|B16|Upper gastro-intestinal disorder||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993235|NCT01236053|3814737|B15|Upper gastro-intestinal disorder||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993236|NCT01236053|3814738|B14|Upper gastro-intestinal disorder||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993237|NCT01236053|3814739|B13|Upper gastro-intestinal disorder||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993238|NCT01236053|3814740|B12|Upper gastro-intestinal disorder||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993239|NCT01236053|3814741|B11|Upper gastro-intestinal disorder||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993757|NCT01236053|3814730|B22|Never Smoked||Number of participants with the indicated smoking status||participants|Number|5875|5875.0||||||
3993240|NCT01236053|3814742|B10|Upper gastro-intestinal disorder||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993241|NCT01236053|3814743|B9|Upper gastro-intestinal disorder||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993242|NCT01236053|3814744|B8|Upper gastro-intestinal disorder||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993243|NCT01236053|3814745|B7|Upper gastro-intestinal disorder||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993244|NCT01236053|3814746|B6|Upper gastro-intestinal disorder||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993245|NCT01236053|3814747|B5|Upper gastro-intestinal disorder||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993246|NCT01236053|3814748|B4|Upper gastro-intestinal disorder||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|2860|2860.0||||||
3993247|NCT01236053|3814749|B3|Upper gastro-intestinal disorder||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|442|442.0||||||
3993248|NCT01236053|3814750|B2|Upper gastro-intestinal disorder||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993249|NCT01236053|3814751|B1|Upper gastro-intestinal disorder||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993250|NCT01236053|3814729|B23|Prior estrogen||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|67643|67643.0||||||
3993758|NCT01236053|3814731|B21|Never Smoked||Number of participants with the indicated smoking status||participants|Number|570|570.0||||||
3993251|NCT01236053|3814730|B22|Prior estrogen||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993252|NCT01236053|3814731|B21|Prior estrogen||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993253|NCT01236053|3814732|B20|Prior estrogen||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993254|NCT01236053|3814733|B19|Prior estrogen||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993255|NCT01236053|3814734|B18|Prior estrogen||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993256|NCT01236053|3814735|B17|Prior estrogen||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993257|NCT01236053|3814736|B16|Prior estrogen||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993258|NCT01236053|3814737|B15|Prior estrogen||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993259|NCT01236053|3814738|B14|Prior estrogen||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993260|NCT01236053|3814739|B13|Prior estrogen||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993261|NCT01236053|3814740|B12|Prior estrogen||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|60840|60840.0||||||
3993759|NCT01236053|3814732|B20|Never Smoked||Number of participants with the indicated smoking status||participants|Number|10455|10455.0||||||
3993760|NCT01236053|3814733|B19|Never Smoked||Number of participants with the indicated smoking status||participants|Number|929|929.0||||||
3993262|NCT01236053|3814741|B11|Prior estrogen||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|6803|6803.0||||||
3993263|NCT01236053|3814742|B10|Prior estrogen||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993264|NCT01236053|3814743|B9|Prior estrogen||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993265|NCT01236053|3814744|B8|Prior estrogen||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993266|NCT01236053|3814745|B7|Prior estrogen||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993267|NCT01236053|3814746|B6|Prior estrogen||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993268|NCT01236053|3814747|B5|Prior estrogen||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993269|NCT01236053|3814748|B4|Prior estrogen||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993270|NCT01236053|3814749|B3|Prior estrogen||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993271|NCT01236053|3814750|B2|Prior estrogen||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993272|NCT01236053|3814751|B1|Prior estrogen||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993761|NCT01236053|3814734|B18|Never Smoked||Number of participants with the indicated smoking status||participants|Number|176|176.0||||||
3993762|NCT01236053|3814735|B17|Never Smoked||Number of participants with the indicated smoking status||participants|Number|17|17.0||||||
3993273|NCT01236053|3814729|B23|Phimosis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|85|85.0||||||
3993274|NCT01236053|3814730|B22|Phimosis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993275|NCT01236053|3814731|B21|Phimosis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993276|NCT01236053|3814732|B20|Phimosis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993277|NCT01236053|3814733|B19|Phimosis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993278|NCT01236053|3814734|B18|Phimosis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993279|NCT01236053|3814735|B17|Phimosis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993280|NCT01236053|3814736|B16|Phimosis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993281|NCT01236053|3814737|B15|Phimosis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993282|NCT01236053|3814738|B14|Phimosis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|31|31.0||||||
3993283|NCT01236053|3814739|B13|Phimosis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|54|54.0||||||
3993763|NCT01236053|3814736|B16|Never Smoked||Number of participants with the indicated smoking status||participants|Number|20018|20018.0||||||
3993764|NCT01236053|3814737|B15|Never Smoked||Number of participants with the indicated smoking status||participants|Number|1636|1636.0||||||
3994273|NCT01236053|3814740|B12|60-69 years||Age, Customized||participants|Number|44769|44769.0||||||
3993284|NCT01236053|3814740|B12|Phimosis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993285|NCT01236053|3814741|B11|Phimosis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993286|NCT01236053|3814742|B10|Phimosis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993287|NCT01236053|3814743|B9|Phimosis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993288|NCT01236053|3814744|B8|Phimosis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993289|NCT01236053|3814745|B7|Phimosis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993290|NCT01236053|3814746|B6|Phimosis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993291|NCT01236053|3814747|B5|Phimosis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993292|NCT01236053|3814748|B4|Phimosis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993293|NCT01236053|3814749|B3|Phimosis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993294|NCT01236053|3814750|B2|Phimosis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993765|NCT01236053|3814738|B14|Never Smoked||Number of participants with the indicated smoking status||participants|Number|587|587.0||||||
3993766|NCT01236053|3814739|B13|Never Smoked||Number of participants with the indicated smoking status||participants|Number|58|58.0||||||
3994274|NCT01236053|3814741|B11|60-69 years||Age, Customized||participants|Number|4665|4665.0||||||
3993295|NCT01236053|3814751|B1|Phimosis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993296|NCT01236053|3814729|B23|Neuropathic pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|466531|466531.0||||||
3993297|NCT01236053|3814730|B22|Neuropathic pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|2434|2434.0||||||
3993298|NCT01236053|3814731|B21|Neuropathic pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|275|275.0||||||
3993299|NCT01236053|3814732|B20|Neuropathic pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|4195|4195.0||||||
3993300|NCT01236053|3814733|B19|Neuropathic pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|474|474.0||||||
3993301|NCT01236053|3814734|B18|Neuropathic pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|71|71.0||||||
3993302|NCT01236053|3814735|B17|Neuropathic pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|15|15.0||||||
3993303|NCT01236053|3814736|B16|Neuropathic pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|8539|8539.0||||||
3993304|NCT01236053|3814737|B15|Neuropathic pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|998|998.0||||||
3993305|NCT01236053|3814738|B14|Neuropathic pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|229|229.0||||||
3993767|NCT01236053|3814740|B12|Never Smoked||Number of participants with the indicated smoking status||participants|Number|109463|109463.0||||||
3993768|NCT01236053|3814741|B11|Never Smoked||Number of participants with the indicated smoking status||participants|Number|11396|11396.0||||||
3993306|NCT01236053|3814739|B13|Neuropathic pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|25|25.0||||||
3993307|NCT01236053|3814740|B12|Neuropathic pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|39494|39494.0||||||
3993308|NCT01236053|3814741|B11|Neuropathic pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|4055|4055.0||||||
3993309|NCT01236053|3814742|B10|Neuropathic pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|387|387.0||||||
3993310|NCT01236053|3814743|B9|Neuropathic pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|49|49.0||||||
3993311|NCT01236053|3814744|B8|Neuropathic pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|21202|21202.0||||||
3993312|NCT01236053|3814745|B7|Neuropathic pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|2485|2485.0||||||
3993313|NCT01236053|3814746|B6|Neuropathic pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|406|406.0||||||
3993314|NCT01236053|3814747|B5|Neuropathic pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|47|47.0||||||
3993315|NCT01236053|3814748|B4|Neuropathic pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|3485|3485.0||||||
3993316|NCT01236053|3814749|B3|Neuropathic pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|382|382.0||||||
3993769|NCT01236053|3814742|B10|Never Smoked||Number of participants with the indicated smoking status||participants|Number|1255|1255.0||||||
3993770|NCT01236053|3814743|B9|Never Smoked||Number of participants with the indicated smoking status||participants|Number|133|133.0||||||
3993317|NCT01236053|3814750|B2|Neuropathic pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|338723|338723.0||||||
3993318|NCT01236053|3814751|B1|Neuropathic pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|38561|38561.0||||||
3993319|NCT01236053|3814729|B23|Hysterectomy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|37853|37853.0||||||
3993320|NCT01236053|3814730|B22|Hysterectomy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993321|NCT01236053|3814731|B21|Hysterectomy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993322|NCT01236053|3814732|B20|Hysterectomy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993323|NCT01236053|3814733|B19|Hysterectomy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993324|NCT01236053|3814734|B18|Hysterectomy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993325|NCT01236053|3814735|B17|Hysterectomy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993326|NCT01236053|3814736|B16|Hysterectomy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993327|NCT01236053|3814737|B15|Hysterectomy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993771|NCT01236053|3814744|B8|Never Smoked||Number of participants with the indicated smoking status||participants|Number|48127|48127.0||||||
3993772|NCT01236053|3814745|B7|Never Smoked||Number of participants with the indicated smoking status||participants|Number|1766|1766.0||||||
3993328|NCT01236053|3814738|B14|Hysterectomy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993329|NCT01236053|3814739|B13|Hysterectomy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993330|NCT01236053|3814740|B12|Hysterectomy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|34290|34290.0||||||
3993331|NCT01236053|3814741|B11|Hysterectomy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|3563|3563.0||||||
3993332|NCT01236053|3814742|B10|Hysterectomy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993333|NCT01236053|3814743|B9|Hysterectomy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993334|NCT01236053|3814744|B8|Hysterectomy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993335|NCT01236053|3814745|B7|Hysterectomy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993336|NCT01236053|3814746|B6|Hysterectomy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993337|NCT01236053|3814747|B5|Hysterectomy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993338|NCT01236053|3814748|B4|Hysterectomy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993773|NCT01236053|3814746|B6|Never Smoked||Number of participants with the indicated smoking status||participants|Number|1048|1048.0||||||
3993774|NCT01236053|3814747|B5|Never Smoked||Number of participants with the indicated smoking status||participants|Number|83|83.0||||||
3993339|NCT01236053|3814749|B3|Hysterectomy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993340|NCT01236053|3814750|B2|Hysterectomy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993341|NCT01236053|3814751|B1|Hysterectomy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993342|NCT01236053|3814729|B23|Hypertension||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|6329|6329.0||||||
3993343|NCT01236053|3814730|B22|Hypertension||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|5580|5580.0||||||
3993344|NCT01236053|3814731|B21|Hypertension||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|749|749.0||||||
3993345|NCT01236053|3814732|B20|Hypertension||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993346|NCT01236053|3814733|B19|Hypertension||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993347|NCT01236053|3814734|B18|Hypertension||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993348|NCT01236053|3814735|B17|Hypertension||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993349|NCT01236053|3814736|B16|Hypertension||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993775|NCT01236053|3814748|B4|Never Smoked||Number of participants with the indicated smoking status||participants|Number|8540|8540.0||||||
3993776|NCT01236053|3814749|B3|Never Smoked||Number of participants with the indicated smoking status||participants|Number|810|810.0||||||
3993350|NCT01236053|3814737|B15|Hypertension||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993351|NCT01236053|3814738|B14|Hypertension||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993352|NCT01236053|3814739|B13|Hypertension||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993353|NCT01236053|3814740|B12|Hypertension||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993354|NCT01236053|3814741|B11|Hypertension||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993355|NCT01236053|3814742|B10|Hypertension||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993356|NCT01236053|3814743|B9|Hypertension||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993357|NCT01236053|3814744|B8|Hypertension||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993358|NCT01236053|3814745|B7|Hypertension||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993359|NCT01236053|3814746|B6|Hypertension||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993360|NCT01236053|3814747|B5|Hypertension||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993777|NCT01236053|3814750|B2|Never Smoked||Number of participants with the indicated smoking status||participants|Number|854263|854263.0||||||
3993778|NCT01236053|3814751|B1|Never Smoked||Number of participants with the indicated smoking status||participants|Number|85483|85483.0||||||
3993361|NCT01236053|3814748|B4|Hypertension||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993362|NCT01236053|3814749|B3|Hypertension||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993363|NCT01236053|3814750|B2|Hypertension||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993364|NCT01236053|3814751|B1|Hypertension||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993365|NCT01236053|3814729|B23|Human papillomavirus (HPV) (genital)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|43|43.0||||||
3993366|NCT01236053|3814730|B22|Human papillomavirus (HPV) (genital)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993367|NCT01236053|3814731|B21|Human papillomavirus (HPV) (genital)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993368|NCT01236053|3814732|B20|Human papillomavirus (HPV) (genital)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993369|NCT01236053|3814733|B19|Human papillomavirus (HPV) (genital)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993370|NCT01236053|3814734|B18|Human papillomavirus (HPV) (genital)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993371|NCT01236053|3814735|B17|Human papillomavirus (HPV) (genital)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993779|NCT01236053|3814729|B23|Ex-Smoker||Number of participants with the indicated smoking status||participants|Number|481341|481341.0||||||
3993372|NCT01236053|3814736|B16|Human papillomavirus (HPV) (genital)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993373|NCT01236053|3814737|B15|Human papillomavirus (HPV) (genital)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993374|NCT01236053|3814738|B14|Human papillomavirus (HPV) (genital)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|12|12.0||||||
3993375|NCT01236053|3814739|B13|Human papillomavirus (HPV) (genital)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|9|9.0||||||
3993376|NCT01236053|3814740|B12|Human papillomavirus (HPV) (genital)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993377|NCT01236053|3814741|B11|Human papillomavirus (HPV) (genital)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993378|NCT01236053|3814742|B10|Human papillomavirus (HPV) (genital)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993379|NCT01236053|3814743|B9|Human papillomavirus (HPV) (genital)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993380|NCT01236053|3814744|B8|Human papillomavirus (HPV) (genital)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993381|NCT01236053|3814745|B7|Human papillomavirus (HPV) (genital)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993382|NCT01236053|3814746|B6|Human papillomavirus (HPV) (genital)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|7|7.0||||||
3993780|NCT01236053|3814730|B22|Ex-Smoker||Number of participants with the indicated smoking status||participants|Number|2768|2768.0||||||
3993383|NCT01236053|3814747|B5|Human papillomavirus (HPV) (genital)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|15|15.0||||||
3993384|NCT01236053|3814748|B4|Human papillomavirus (HPV) (genital)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993385|NCT01236053|3814749|B3|Human papillomavirus (HPV) (genital)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993386|NCT01236053|3814750|B2|Human papillomavirus (HPV) (genital)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993387|NCT01236053|3814751|B1|Human papillomavirus (HPV) (genital)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993388|NCT01236053|3814729|B23|Human immunodeficiency virus (HIV)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|3|3.0||||||
3993389|NCT01236053|3814730|B22|Human immunodeficiency virus (HIV)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993390|NCT01236053|3814731|B21|Human immunodeficiency virus (HIV)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993391|NCT01236053|3814732|B20|Human immunodeficiency virus (HIV)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993392|NCT01236053|3814733|B19|Human immunodeficiency virus (HIV)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993393|NCT01236053|3814734|B18|Human immunodeficiency virus (HIV)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993781|NCT01236053|3814731|B21|Ex-Smoker||Number of participants with the indicated smoking status||participants|Number|319|319.0||||||
3993394|NCT01236053|3814735|B17|Human immunodeficiency virus (HIV)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993395|NCT01236053|3814736|B16|Human immunodeficiency virus (HIV)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993396|NCT01236053|3814737|B15|Human immunodeficiency virus (HIV)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993397|NCT01236053|3814738|B14|Human immunodeficiency virus (HIV)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993398|NCT01236053|3814739|B13|Human immunodeficiency virus (HIV)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993399|NCT01236053|3814740|B12|Human immunodeficiency virus (HIV)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993400|NCT01236053|3814741|B11|Human immunodeficiency virus (HIV)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993401|NCT01236053|3814742|B10|Human immunodeficiency virus (HIV)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993402|NCT01236053|3814743|B9|Human immunodeficiency virus (HIV)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993403|NCT01236053|3814744|B8|Human immunodeficiency virus (HIV)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993404|NCT01236053|3814745|B7|Human immunodeficiency virus (HIV)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993782|NCT01236053|3814732|B20|Ex-Smoker||Number of participants with the indicated smoking status||participants|Number|4247|4247.0||||||
3993405|NCT01236053|3814746|B6|Human immunodeficiency virus (HIV)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993406|NCT01236053|3814747|B5|Human immunodeficiency virus (HIV)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|3|3.0||||||
3993407|NCT01236053|3814748|B4|Human immunodeficiency virus (HIV)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993408|NCT01236053|3814749|B3|Human immunodeficiency virus (HIV)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993409|NCT01236053|3814750|B2|Human immunodeficiency virus (HIV)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993410|NCT01236053|3814751|B1|Human immunodeficiency virus (HIV)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993411|NCT01236053|3814729|B23|Epilepsy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|33460|33460.0||||||
3993412|NCT01236053|3814730|B22|Epilepsy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|176|176.0||||||
3993413|NCT01236053|3814731|B21|Epilepsy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|20|20.0||||||
3993414|NCT01236053|3814732|B20|Epilepsy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|289|289.0||||||
3993415|NCT01236053|3814733|B19|Epilepsy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|35|35.0||||||
3993783|NCT01236053|3814733|B19|Ex-Smoker||Number of participants with the indicated smoking status||participants|Number|499|499.0||||||
3994275|NCT01236053|3814742|B10|60-69 years||Age, Customized||participants|Number|360|360.0||||||
3993416|NCT01236053|3814734|B18|Epilepsy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|4|4.0||||||
3993417|NCT01236053|3814735|B17|Epilepsy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|3|3.0||||||
3993418|NCT01236053|3814736|B16|Epilepsy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|654|654.0||||||
3993419|NCT01236053|3814737|B15|Epilepsy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|78|78.0||||||
3993420|NCT01236053|3814738|B14|Epilepsy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|28|28.0||||||
3993421|NCT01236053|3814739|B13|Epilepsy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993422|NCT01236053|3814740|B12|Epilepsy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|2486|2486.0||||||
3993423|NCT01236053|3814741|B11|Epilepsy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|285|285.0||||||
3993424|NCT01236053|3814742|B10|Epilepsy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|33|33.0||||||
3993425|NCT01236053|3814743|B9|Epilepsy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|3|3.0||||||
3993426|NCT01236053|3814744|B8|Epilepsy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|1577|1577.0||||||
3993784|NCT01236053|3814734|B18|Ex-Smoker||Number of participants with the indicated smoking status||participants|Number|77|77.0||||||
3993785|NCT01236053|3814735|B17|Ex-Smoker||Number of participants with the indicated smoking status||participants|Number|6|6.0||||||
3993427|NCT01236053|3814745|B7|Epilepsy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|214|214.0||||||
3993428|NCT01236053|3814746|B6|Epilepsy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|23|23.0||||||
3993429|NCT01236053|3814747|B5|Epilepsy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|8|8.0||||||
3993430|NCT01236053|3814748|B4|Epilepsy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|271|271.0||||||
3993431|NCT01236053|3814749|B3|Epilepsy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|32|32.0||||||
3993432|NCT01236053|3814750|B2|Epilepsy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|24226|24226.0||||||
3993433|NCT01236053|3814751|B1|Epilepsy||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|3015|3015.0||||||
3993434|NCT01236053|3814729|B23|Diuretic use (at any time up to the index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|4369|4369.0||||||
3993435|NCT01236053|3814730|B22|Diuretic use (at any time up to the index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|3815|3815.0||||||
3993436|NCT01236053|3814731|B21|Diuretic use (at any time up to the index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|554|554.0||||||
3993437|NCT01236053|3814732|B20|Diuretic use (at any time up to the index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993786|NCT01236053|3814736|B16|Ex-Smoker||Number of participants with the indicated smoking status||participants|Number|11070|11070.0||||||
3993438|NCT01236053|3814733|B19|Diuretic use (at any time up to the index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993439|NCT01236053|3814734|B18|Diuretic use (at any time up to the index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993440|NCT01236053|3814735|B17|Diuretic use (at any time up to the index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993441|NCT01236053|3814736|B16|Diuretic use (at any time up to the index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993442|NCT01236053|3814737|B15|Diuretic use (at any time up to the index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993443|NCT01236053|3814738|B14|Diuretic use (at any time up to the index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993444|NCT01236053|3814739|B13|Diuretic use (at any time up to the index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993445|NCT01236053|3814740|B12|Diuretic use (at any time up to the index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993446|NCT01236053|3814741|B11|Diuretic use (at any time up to the index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993447|NCT01236053|3814742|B10|Diuretic use (at any time up to the index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993448|NCT01236053|3814743|B9|Diuretic use (at any time up to the index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993449|NCT01236053|3814744|B8|Diuretic use (at any time up to the index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993450|NCT01236053|3814745|B7|Diuretic use (at any time up to the index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993451|NCT01236053|3814746|B6|Diuretic use (at any time up to the index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993452|NCT01236053|3814747|B5|Diuretic use (at any time up to the index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993453|NCT01236053|3814748|B4|Diuretic use (at any time up to the index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993454|NCT01236053|3814749|B3|Diuretic use (at any time up to the index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993455|NCT01236053|3814750|B2|Diuretic use (at any time up to the index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993456|NCT01236053|3814751|B1|Diuretic use (at any time up to the index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993457|NCT01236053|3814729|B23|Diabetes||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|176793|176793.0||||||
3993458|NCT01236053|3814730|B22|Diabetes||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|968|968.0||||||
3993459|NCT01236053|3814731|B21|Diabetes||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|155|155.0||||||
3994276|NCT01236053|3814743|B9|60-69 years||Age, Customized||participants|Number|38|38.0||||||
3993460|NCT01236053|3814732|B20|Diabetes||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|1415|1415.0||||||
3993461|NCT01236053|3814733|B19|Diabetes||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|241|241.0||||||
3993462|NCT01236053|3814734|B18|Diabetes||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|32|32.0||||||
3993463|NCT01236053|3814735|B17|Diabetes||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|3|3.0||||||
3993464|NCT01236053|3814736|B16|Diabetes||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|4087|4087.0||||||
3993465|NCT01236053|3814737|B15|Diabetes||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|559|559.0||||||
3993466|NCT01236053|3814738|B14|Diabetes||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|104|104.0||||||
3993467|NCT01236053|3814739|B13|Diabetes||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|18|18.0||||||
3993468|NCT01236053|3814740|B12|Diabetes||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|9899|9899.0||||||
3993469|NCT01236053|3814741|B11|Diabetes||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|1162|1162.0||||||
3993470|NCT01236053|3814742|B10|Diabetes||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|155|155.0||||||
3993787|NCT01236053|3814737|B15|Ex-Smoker||Number of participants with the indicated smoking status||participants|Number|1307|1307.0||||||
3993788|NCT01236053|3814738|B14|Ex-Smoker||Number of participants with the indicated smoking status||participants|Number|334|334.0||||||
3993471|NCT01236053|3814743|B9|Diabetes||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|15|15.0||||||
3993472|NCT01236053|3814744|B8|Diabetes||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|9448|9448.0||||||
3993473|NCT01236053|3814745|B7|Diabetes||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|1086|1086.0||||||
3993474|NCT01236053|3814746|B6|Diabetes||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|139|139.0||||||
3993475|NCT01236053|3814747|B5|Diabetes||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|17|17.0||||||
3993476|NCT01236053|3814748|B4|Diabetes||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|1592|1592.0||||||
3993477|NCT01236053|3814749|B3|Diabetes||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|208|208.0||||||
3993478|NCT01236053|3814750|B2|Diabetes||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|130210|130210.0||||||
3993479|NCT01236053|3814751|B1|Diabetes||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|15280|15280.0||||||
3993480|NCT01236053|3814729|B23|Current estrogen (within 6 months of index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|25492|25492.0||||||
3993481|NCT01236053|3814730|B22|Current estrogen (within 6 months of index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993789|NCT01236053|3814739|B13|Ex-Smoker||Number of participants with the indicated smoking status||participants|Number|29|29.0||||||
3993790|NCT01236053|3814740|B12|Ex-Smoker||Number of participants with the indicated smoking status||participants|Number|28210|28210.0||||||
3993482|NCT01236053|3814731|B21|Current estrogen (within 6 months of index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993483|NCT01236053|3814732|B20|Current estrogen (within 6 months of index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993484|NCT01236053|3814733|B19|Current estrogen (within 6 months of index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993485|NCT01236053|3814734|B18|Current estrogen (within 6 months of index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993486|NCT01236053|3814735|B17|Current estrogen (within 6 months of index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993487|NCT01236053|3814736|B16|Current estrogen (within 6 months of index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993488|NCT01236053|3814737|B15|Current estrogen (within 6 months of index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993489|NCT01236053|3814738|B14|Current estrogen (within 6 months of index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993490|NCT01236053|3814739|B13|Current estrogen (within 6 months of index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993491|NCT01236053|3814740|B12|Current estrogen (within 6 months of index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|22576|22576.0||||||
3993492|NCT01236053|3814741|B11|Current estrogen (within 6 months of index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|2916|2916.0||||||
3993493|NCT01236053|3814742|B10|Current estrogen (within 6 months of index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993494|NCT01236053|3814743|B9|Current estrogen (within 6 months of index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993495|NCT01236053|3814744|B8|Current estrogen (within 6 months of index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993496|NCT01236053|3814745|B7|Current estrogen (within 6 months of index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993497|NCT01236053|3814746|B6|Current estrogen (within 6 months of index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993498|NCT01236053|3814747|B5|Current estrogen (within 6 months of index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993499|NCT01236053|3814748|B4|Current estrogen (within 6 months of index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993500|NCT01236053|3814749|B3|Current estrogen (within 6 months of index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993501|NCT01236053|3814750|B2|Current estrogen (within 6 months of index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993502|NCT01236053|3814751|B1|Current estrogen (within 6 months of index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993503|NCT01236053|3814729|B23|Chronic pancreatitis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|21|21.0||||||
3993504|NCT01236053|3814730|B22|Chronic pancreatitis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993505|NCT01236053|3814731|B21|Chronic pancreatitis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993506|NCT01236053|3814732|B20|Chronic pancreatitis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|8|8.0||||||
3993507|NCT01236053|3814733|B19|Chronic pancreatitis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|13|13.0||||||
3993508|NCT01236053|3814734|B18|Chronic pancreatitis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993509|NCT01236053|3814735|B17|Chronic pancreatitis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993510|NCT01236053|3814736|B16|Chronic pancreatitis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993511|NCT01236053|3814737|B15|Chronic pancreatitis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993512|NCT01236053|3814738|B14|Chronic pancreatitis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993513|NCT01236053|3814739|B13|Chronic pancreatitis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993514|NCT01236053|3814740|B12|Chronic pancreatitis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993791|NCT01236053|3814741|B11|Ex-Smoker||Number of participants with the indicated smoking status||participants|Number|3156|3156.0||||||
3993792|NCT01236053|3814742|B10|Ex-Smoker||Number of participants with the indicated smoking status||participants|Number|385|385.0||||||
3993515|NCT01236053|3814741|B11|Chronic pancreatitis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993516|NCT01236053|3814742|B10|Chronic pancreatitis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993517|NCT01236053|3814743|B9|Chronic pancreatitis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993518|NCT01236053|3814744|B8|Chronic pancreatitis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993519|NCT01236053|3814745|B7|Chronic pancreatitis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993520|NCT01236053|3814746|B6|Chronic pancreatitis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993521|NCT01236053|3814747|B5|Chronic pancreatitis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993522|NCT01236053|3814748|B4|Chronic pancreatitis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993523|NCT01236053|3814749|B3|Chronic pancreatitis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993524|NCT01236053|3814750|B2|Chronic pancreatitis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993525|NCT01236053|3814751|B1|Chronic pancreatitis||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993793|NCT01236053|3814743|B9|Ex-Smoker||Number of participants with the indicated smoking status||participants|Number|43|43.0||||||
3993794|NCT01236053|3814744|B8|Ex-Smoker||Number of participants with the indicated smoking status||participants|Number|24290|24290.0||||||
3993526|NCT01236053|3814729|B23|Chronic obstructive pulmonary disease (COPD)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|9171|9171.0||||||
3993527|NCT01236053|3814730|B22|Chronic obstructive pulmonary disease (COPD)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993528|NCT01236053|3814731|B21|Chronic obstructive pulmonary disease (COPD)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993529|NCT01236053|3814732|B20|Chronic obstructive pulmonary disease (COPD)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993530|NCT01236053|3814733|B19|Chronic obstructive pulmonary disease (COPD)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993531|NCT01236053|3814734|B18|Chronic obstructive pulmonary disease (COPD)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993532|NCT01236053|3814735|B17|Chronic obstructive pulmonary disease (COPD)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993533|NCT01236053|3814736|B16|Chronic obstructive pulmonary disease (COPD)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993534|NCT01236053|3814737|B15|Chronic obstructive pulmonary disease (COPD)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993535|NCT01236053|3814738|B14|Chronic obstructive pulmonary disease (COPD)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993536|NCT01236053|3814739|B13|Chronic obstructive pulmonary disease (COPD)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993537|NCT01236053|3814740|B12|Chronic obstructive pulmonary disease (COPD)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993538|NCT01236053|3814741|B11|Chronic obstructive pulmonary disease (COPD)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993539|NCT01236053|3814742|B10|Chronic obstructive pulmonary disease (COPD)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993540|NCT01236053|3814743|B9|Chronic obstructive pulmonary disease (COPD)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993541|NCT01236053|3814744|B8|Chronic obstructive pulmonary disease (COPD)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|6639|6639.0||||||
3993542|NCT01236053|3814745|B7|Chronic obstructive pulmonary disease (COPD)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|2532|2532.0||||||
3993543|NCT01236053|3814746|B6|Chronic obstructive pulmonary disease (COPD)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993544|NCT01236053|3814747|B5|Chronic obstructive pulmonary disease (COPD)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993545|NCT01236053|3814748|B4|Chronic obstructive pulmonary disease (COPD)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993546|NCT01236053|3814749|B3|Chronic obstructive pulmonary disease (COPD)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993547|NCT01236053|3814750|B2|Chronic obstructive pulmonary disease (COPD)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993548|NCT01236053|3814751|B1|Chronic obstructive pulmonary disease (COPD)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993549|NCT01236053|3814729|B23|Benign breast disease||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|6402|6402.0||||||
3993550|NCT01236053|3814730|B22|Benign breast disease||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993551|NCT01236053|3814731|B21|Benign breast disease||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993552|NCT01236053|3814732|B20|Benign breast disease||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993553|NCT01236053|3814733|B19|Benign breast disease||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993554|NCT01236053|3814734|B18|Benign breast disease||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993555|NCT01236053|3814735|B17|Benign breast disease||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993556|NCT01236053|3814736|B16|Benign breast disease||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993557|NCT01236053|3814737|B15|Benign breast disease||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993558|NCT01236053|3814738|B14|Benign breast disease||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993795|NCT01236053|3814745|B7|Ex-Smoker||Number of participants with the indicated smoking status||participants|Number|3594|3594.0||||||
3993559|NCT01236053|3814739|B13|Benign breast disease||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993560|NCT01236053|3814740|B12|Benign breast disease||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|5508|5508.0||||||
3993561|NCT01236053|3814741|B11|Benign breast disease||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|894|894.0||||||
3993562|NCT01236053|3814742|B10|Benign breast disease||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993563|NCT01236053|3814743|B9|Benign breast disease||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993564|NCT01236053|3814744|B8|Benign breast disease||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993565|NCT01236053|3814745|B7|Benign breast disease||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993566|NCT01236053|3814746|B6|Benign breast disease||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993567|NCT01236053|3814747|B5|Benign breast disease||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993568|NCT01236053|3814748|B4|Benign breast disease||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993569|NCT01236053|3814749|B3|Benign breast disease||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993796|NCT01236053|3814746|B6|Ex-Smoker||Number of participants with the indicated smoking status||participants|Number|380|380.0||||||
3993797|NCT01236053|3814747|B5|Ex-Smoker||Number of participants with the indicated smoking status||participants|Number|41|41.0||||||
3993570|NCT01236053|3814750|B2|Benign breast disease||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993571|NCT01236053|3814751|B1|Benign breast disease||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993572|NCT01236053|3814729|B23|Back pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|1055224|1055224.0||||||
3993573|NCT01236053|3814730|B22|Back pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|5473|5473.0||||||
3993574|NCT01236053|3814731|B21|Back pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|678|678.0||||||
3993575|NCT01236053|3814732|B20|Back pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|9186|9186.0||||||
3993576|NCT01236053|3814733|B19|Back pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|1081|1081.0||||||
3993577|NCT01236053|3814734|B18|Back pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|192|192.0||||||
3993578|NCT01236053|3814735|B17|Back pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|23|23.0||||||
3993579|NCT01236053|3814736|B16|Back pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|18811|18811.0||||||
3993580|NCT01236053|3814737|B15|Back pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|2149|2149.0||||||
3993798|NCT01236053|3814748|B4|Ex-Smoker||Number of participants with the indicated smoking status||participants|Number|4134|4134.0||||||
3993799|NCT01236053|3814749|B3|Ex-Smoker||Number of participants with the indicated smoking status||participants|Number|531|531.0||||||
3993581|NCT01236053|3814738|B14|Back pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|569|569.0||||||
3993582|NCT01236053|3814739|B13|Back pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|59|59.0||||||
3993583|NCT01236053|3814740|B12|Back pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|91302|91302.0||||||
3993584|NCT01236053|3814741|B11|Back pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|9603|9603.0||||||
3993585|NCT01236053|3814742|B10|Back pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|1008|1008.0||||||
3993586|NCT01236053|3814743|B9|Back pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|130|130.0||||||
3993587|NCT01236053|3814744|B8|Back pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|46417|46417.0||||||
3993588|NCT01236053|3814745|B7|Back pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|5626|5626.0||||||
3993589|NCT01236053|3814746|B6|Back pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|924|924.0||||||
3993590|NCT01236053|3814747|B5|Back pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|92|92.0||||||
3993591|NCT01236053|3814748|B4|Back pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|7779|7779.0||||||
3993800|NCT01236053|3814750|B2|Ex-Smoker||Number of participants with the indicated smoking status||participants|Number|354651|354651.0||||||
3993801|NCT01236053|3814751|B1|Ex-Smoker||Number of participants with the indicated smoking status||participants|Number|41270|41270.0||||||
3993592|NCT01236053|3814749|B3|Back pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|924|924.0||||||
3993593|NCT01236053|3814750|B2|Back pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|765861|765861.0||||||
3993594|NCT01236053|3814751|B1|Back pain||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|87337|87337.0||||||
3993595|NCT01236053|3814729|B23|Acid suppressing drugs (>6 mo. before index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|5998|5998.0||||||
3993596|NCT01236053|3814730|B22|Acid suppressing drugs (>6 mo. before index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993597|NCT01236053|3814731|B21|Acid suppressing drugs (>6 mo. before index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993598|NCT01236053|3814732|B20|Acid suppressing drugs (>6 mo. before index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993599|NCT01236053|3814733|B19|Acid suppressing drugs (>6 mo. before index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993600|NCT01236053|3814734|B18|Acid suppressing drugs (>6 mo. before index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993601|NCT01236053|3814735|B17|Acid suppressing drugs (>6 mo. before index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993602|NCT01236053|3814736|B16|Acid suppressing drugs (>6 mo. before index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993603|NCT01236053|3814737|B15|Acid suppressing drugs (>6 mo. before index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993604|NCT01236053|3814738|B14|Acid suppressing drugs (>6 mo. before index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993605|NCT01236053|3814739|B13|Acid suppressing drugs (>6 mo. before index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993606|NCT01236053|3814740|B12|Acid suppressing drugs (>6 mo. before index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993607|NCT01236053|3814741|B11|Acid suppressing drugs (>6 mo. before index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993608|NCT01236053|3814742|B10|Acid suppressing drugs (>6 mo. before index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993609|NCT01236053|3814743|B9|Acid suppressing drugs (>6 mo. before index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993610|NCT01236053|3814744|B8|Acid suppressing drugs (>6 mo. before index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993611|NCT01236053|3814745|B7|Acid suppressing drugs (>6 mo. before index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993612|NCT01236053|3814746|B6|Acid suppressing drugs (>6 mo. before index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993613|NCT01236053|3814747|B5|Acid suppressing drugs (>6 mo. before index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993614|NCT01236053|3814748|B4|Acid suppressing drugs (>6 mo. before index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|5202|5202.0||||||
3993615|NCT01236053|3814749|B3|Acid suppressing drugs (>6 mo. before index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|796|796.0||||||
3993616|NCT01236053|3814750|B2|Acid suppressing drugs (>6 mo. before index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993617|NCT01236053|3814751|B1|Acid suppressing drugs (>6 mo. before index date)||Number of participants using indicated class of medications or having the indicated comorbidities|Medication use was defined by British National Formulary codes for the medications. Comorbid conditions were defined by READ/OXMIS codes at any time up to the index date, except for diabetes, which was assessed up to 2 years prior to index date for the pancreatic cancer analysis. A zero (0) indicates that data were not collected for the respective comorbidity, except for the following: HIV (Anal Cancer Controls, Penile Cancer Cases & Controls,) and Epilepsy (Penile Cancer Cases). mo., months.|participants|Number|0|0.0||||||
3993618|NCT01236053|3814729|B23|Missing||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|579173|579173.0||||||
3993619|NCT01236053|3814730|B22|Missing||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993620|NCT01236053|3814731|B21|Missing||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993621|NCT01236053|3814732|B20|Missing||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993622|NCT01236053|3814733|B19|Missing||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993623|NCT01236053|3814734|B18|Missing||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993624|NCT01236053|3814735|B17|Missing||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993625|NCT01236053|3814736|B16|Missing||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993626|NCT01236053|3814737|B15|Missing||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993627|NCT01236053|3814738|B14|Missing||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993802|NCT01236053|3814729|B23|Current Smoker||Number of participants with the indicated smoking status||participants|Number|426275|426275.0||||||
3993803|NCT01236053|3814730|B22|Current Smoker||Number of participants with the indicated smoking status||participants|Number|2324|2324.0||||||
3993628|NCT01236053|3814739|B13|Missing||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993629|NCT01236053|3814740|B12|Missing||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|45194|45194.0||||||
3993630|NCT01236053|3814741|B11|Missing||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|4447|4447.0||||||
3993631|NCT01236053|3814742|B10|Missing||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993632|NCT01236053|3814743|B9|Missing||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993633|NCT01236053|3814744|B8|Missing||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|26621|26621.0||||||
3993634|NCT01236053|3814745|B7|Missing||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|2712|2712.0||||||
3993635|NCT01236053|3814746|B6|Missing||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993636|NCT01236053|3814747|B5|Missing||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993637|NCT01236053|3814748|B4|Missing||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|5102|5102.0||||||
3993638|NCT01236053|3814749|B3|Missing||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|483|483.0||||||
3993639|NCT01236053|3814750|B2|Missing||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|451953|451953.0||||||
3993640|NCT01236053|3814751|B1|Missing||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|42661|42661.0||||||
3993641|NCT01236053|3814729|B23|7+ units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|18964|18964.0||||||
3993642|NCT01236053|3814730|B22|7+ units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993643|NCT01236053|3814731|B21|7+ units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993804|NCT01236053|3814731|B21|Current Smoker||Number of participants with the indicated smoking status||participants|Number|309|309.0||||||
3993805|NCT01236053|3814732|B20|Current Smoker||Number of participants with the indicated smoking status||participants|Number|3368|3368.0||||||
3994277|NCT01236053|3814744|B8|60-69 years||Age, Customized||participants|Number|28526|28526.0||||||
3993644|NCT01236053|3814732|B20|7+ units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993645|NCT01236053|3814733|B19|7+ units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993646|NCT01236053|3814734|B18|7+ units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993647|NCT01236053|3814735|B17|7+ units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993648|NCT01236053|3814736|B16|7+ units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993649|NCT01236053|3814737|B15|7+ units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993650|NCT01236053|3814738|B14|7+ units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993651|NCT01236053|3814739|B13|7+ units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993652|NCT01236053|3814740|B12|7+ units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|399|399.0||||||
3993653|NCT01236053|3814741|B11|7+ units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|50|50.0||||||
3993654|NCT01236053|3814742|B10|7+ units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993655|NCT01236053|3814743|B9|7+ units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993656|NCT01236053|3814744|B8|7+ units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|1132|1132.0||||||
3993657|NCT01236053|3814745|B7|7+ units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|202|202.0||||||
3993658|NCT01236053|3814746|B6|7+ units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993659|NCT01236053|3814747|B5|7+ units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993806|NCT01236053|3814733|B19|Current Smoker||Number of participants with the indicated smoking status||participants|Number|518|518.0||||||
3993807|NCT01236053|3814734|B18|Current Smoker||Number of participants with the indicated smoking status||participants|Number|71|71.0||||||
3993660|NCT01236053|3814748|B4|7+ units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|157|157.0||||||
3993661|NCT01236053|3814749|B3|7+ units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|18|18.0||||||
3993662|NCT01236053|3814750|B2|7+ units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|15014|15014.0||||||
3993663|NCT01236053|3814751|B1|7+ units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|1992|1992.0||||||
3993664|NCT01236053|3814729|B23|3-6 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|128153|128153.0||||||
3993665|NCT01236053|3814730|B22|3-6 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993666|NCT01236053|3814731|B21|3-6 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993667|NCT01236053|3814732|B20|3-6 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993668|NCT01236053|3814733|B19|3-6 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993669|NCT01236053|3814734|B18|3-6 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993670|NCT01236053|3814735|B17|3-6 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993671|NCT01236053|3814736|B16|3-6 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993672|NCT01236053|3814737|B15|3-6 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993673|NCT01236053|3814738|B14|3-6 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993674|NCT01236053|3814739|B13|3-6 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993675|NCT01236053|3814740|B12|3-6 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|4544|4544.0||||||
3993808|NCT01236053|3814735|B17|Current Smoker||Number of participants with the indicated smoking status||participants|Number|10|10.0||||||
3993809|NCT01236053|3814736|B16|Current Smoker||Number of participants with the indicated smoking status||participants|Number|7502|7502.0||||||
3993676|NCT01236053|3814741|B11|3-6 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|535|535.0||||||
3993677|NCT01236053|3814742|B10|3-6 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993678|NCT01236053|3814743|B9|3-6 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993679|NCT01236053|3814744|B8|3-6 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|6843|6843.0||||||
3993680|NCT01236053|3814745|B7|3-6 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|868|868.0||||||
3993681|NCT01236053|3814746|B6|3-6 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993682|NCT01236053|3814747|B5|3-6 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993683|NCT01236053|3814748|B4|3-6 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|1118|1118.0||||||
3993684|NCT01236053|3814749|B3|3-6 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|115|115.0||||||
3993685|NCT01236053|3814750|B2|3-6 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|102201|102201.0||||||
3993686|NCT01236053|3814751|B1|3-6 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|11929|11929.0||||||
3993687|NCT01236053|3814729|B23|1-2 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|1051644|1051644.0||||||
3993688|NCT01236053|3814730|B22|1-2 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993689|NCT01236053|3814731|B21|1-2 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993690|NCT01236053|3814732|B20|1-2 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993691|NCT01236053|3814733|B19|1-2 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993810|NCT01236053|3814737|B15|Current Smoker||Number of participants with the indicated smoking status||participants|Number|1310|1310.0||||||
3993811|NCT01236053|3814738|B14|Current Smoker||Number of participants with the indicated smoking status||participants|Number|297|297.0||||||
3993692|NCT01236053|3814734|B18|1-2 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993693|NCT01236053|3814735|B17|1-2 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993694|NCT01236053|3814736|B16|1-2 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993695|NCT01236053|3814737|B15|1-2 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993696|NCT01236053|3814738|B14|1-2 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993697|NCT01236053|3814739|B13|1-2 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993698|NCT01236053|3814740|B12|1-2 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|93964|93964.0||||||
3993699|NCT01236053|3814741|B11|1-2 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|9947|9947.0||||||
3993700|NCT01236053|3814742|B10|1-2 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993701|NCT01236053|3814743|B9|1-2 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993702|NCT01236053|3814744|B8|1-2 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|46769|46769.0||||||
3993703|NCT01236053|3814745|B7|1-2 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|4661|4661.0||||||
3993704|NCT01236053|3814746|B6|1-2 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993705|NCT01236053|3814747|B5|1-2 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993706|NCT01236053|3814748|B4|1-2 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|7659|7659.0||||||
3993707|NCT01236053|3814749|B3|1-2 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|839|839.0||||||
3993812|NCT01236053|3814739|B13|Current Smoker||Number of participants with the indicated smoking status||participants|Number|51|51.0||||||
3993813|NCT01236053|3814740|B12|Current Smoker||Number of participants with the indicated smoking status||participants|Number|34818|34818.0||||||
3993708|NCT01236053|3814750|B2|1-2 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|801383|801383.0||||||
3993709|NCT01236053|3814751|B1|1-2 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|86422|86422.0||||||
3993710|NCT01236053|3814729|B23|0 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|454063|454063.0||||||
3993711|NCT01236053|3814730|B22|0 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993712|NCT01236053|3814731|B21|0 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993713|NCT01236053|3814732|B20|0 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993714|NCT01236053|3814733|B19|0 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993715|NCT01236053|3814734|B18|0 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993716|NCT01236053|3814735|B17|0 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993717|NCT01236053|3814736|B16|0 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993718|NCT01236053|3814737|B15|0 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993719|NCT01236053|3814738|B14|0 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993720|NCT01236053|3814739|B13|0 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993721|NCT01236053|3814740|B12|0 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|44823|44823.0||||||
3993722|NCT01236053|3814741|B11|0 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|4585|4585.0||||||
3993723|NCT01236053|3814742|B10|0 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993814|NCT01236053|3814741|B11|Current Smoker||Number of participants with the indicated smoking status||participants|Number|3572|3572.0||||||
3993815|NCT01236053|3814742|B10|Current Smoker||Number of participants with the indicated smoking status||participants|Number|476|476.0||||||
3993724|NCT01236053|3814743|B9|0 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993725|NCT01236053|3814744|B8|0 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|21471|21471.0||||||
3993726|NCT01236053|3814745|B7|0 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|2412|2412.0||||||
3993727|NCT01236053|3814746|B6|0 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993728|NCT01236053|3814747|B5|0 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|0|0.0||||||
3993729|NCT01236053|3814748|B4|0 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|3817|3817.0||||||
3993730|NCT01236053|3814749|B3|0 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|422|422.0||||||
3993731|NCT01236053|3814750|B2|0 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|340399|340399.0||||||
3993732|NCT01236053|3814751|B1|0 units/day||Number of participants with the indicated alcohol consumption (per day)|One unit of alcohol was defined as the equivalent of 10 milliliters (ml) of ethyl alcohol. A zero (0) has been entered for the cases and controls of the following cancers because data were not collected in participants: anal, bone/joint, penile, bladder, other nervous system, pancreatic, and renal.|participants|Number|36134|36134.0||||||
3993733|NCT01236053|3814729|B23|Unknown||Number of participants with the indicated smoking status||participants|Number|253304|253304.0||||||
3993734|NCT01236053|3814730|B22|Unknown||Number of participants with the indicated smoking status||participants|Number|1200|1200.0||||||
3993735|NCT01236053|3814731|B21|Unknown||Number of participants with the indicated smoking status||participants|Number|74|74.0||||||
3993736|NCT01236053|3814732|B20|Unknown||Number of participants with the indicated smoking status||participants|Number|2312|2312.0||||||
3993737|NCT01236053|3814733|B19|Unknown||Number of participants with the indicated smoking status||participants|Number|209|209.0||||||
3993738|NCT01236053|3814734|B18|Unknown||Number of participants with the indicated smoking status||participants|Number|56|56.0||||||
3993739|NCT01236053|3814735|B17|Unknown||Number of participants with the indicated smoking status||participants|Number|5|5.0||||||
3993740|NCT01236053|3814736|B16|Unknown||Number of participants with the indicated smoking status||participants|Number|4969|4969.0||||||
3993741|NCT01236053|3814737|B15|Unknown||Number of participants with the indicated smoking status||participants|Number|347|347.0||||||
3993742|NCT01236053|3814738|B14|Unknown||Number of participants with the indicated smoking status||participants|Number|178|178.0||||||
3993743|NCT01236053|3814739|B13|Unknown||Number of participants with the indicated smoking status||participants|Number|10|10.0||||||
3993744|NCT01236053|3814740|B12|Unknown||Number of participants with the indicated smoking status||participants|Number|16433|16433.0||||||
3993745|NCT01236053|3814741|B11|Unknown||Number of participants with the indicated smoking status||participants|Number|1440|1440.0||||||
3993746|NCT01236053|3814742|B10|Unknown||Number of participants with the indicated smoking status||participants|Number|819|819.0||||||
3993747|NCT01236053|3814743|B9|Unknown||Number of participants with the indicated smoking status||participants|Number|73|73.0||||||
3993748|NCT01236053|3814744|B8|Unknown||Number of participants with the indicated smoking status||participants|Number|11563|11563.0||||||
3993749|NCT01236053|3814745|B7|Unknown||Number of participants with the indicated smoking status||participants|Number|689|689.0||||||
3993750|NCT01236053|3814746|B6|Unknown||Number of participants with the indicated smoking status||participants|Number|260|260.0||||||
3993751|NCT01236053|3814747|B5|Unknown||Number of participants with the indicated smoking status||participants|Number|25|25.0||||||
3993752|NCT01236053|3814748|B4|Unknown||Number of participants with the indicated smoking status||participants|Number|2277|2277.0||||||
3993753|NCT01236053|3814749|B3|Unknown||Number of participants with the indicated smoking status||participants|Number|161|161.0||||||
3993754|NCT01236053|3814750|B2|Unknown||Number of participants with the indicated smoking status||participants|Number|195852|195852.0||||||
3993755|NCT01236053|3814751|B1|Unknown||Number of participants with the indicated smoking status||participants|Number|14352|14352.0||||||
3993816|NCT01236053|3814743|B9|Current Smoker||Number of participants with the indicated smoking status||participants|Number|51|51.0||||||
3993817|NCT01236053|3814744|B8|Current Smoker||Number of participants with the indicated smoking status||participants|Number|18856|18856.0||||||
3993818|NCT01236053|3814745|B7|Current Smoker||Number of participants with the indicated smoking status||participants|Number|4806|4806.0||||||
3993819|NCT01236053|3814746|B6|Current Smoker||Number of participants with the indicated smoking status||participants|Number|379|379.0||||||
3993820|NCT01236053|3814747|B5|Current Smoker||Number of participants with the indicated smoking status||participants|Number|63|63.0||||||
3993821|NCT01236053|3814748|B4|Current Smoker||Number of participants with the indicated smoking status||participants|Number|2902|2902.0||||||
3993822|NCT01236053|3814749|B3|Current Smoker||Number of participants with the indicated smoking status||participants|Number|375|375.0||||||
3993823|NCT01236053|3814750|B2|Current Smoker||Number of participants with the indicated smoking status||participants|Number|306184|306184.0||||||
3993824|NCT01236053|3814751|B1|Current Smoker||Number of participants with the indicated smoking status||participants|Number|38033|38033.0||||||
3993825|NCT01236053|3814729|B23|BMI: Missing||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|539674|539674.0||||||
3993826|NCT01236053|3814730|B22|BMI: Missing||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|2702|2702.0||||||
3993827|NCT01236053|3814731|B21|BMI: Missing||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|242|242.0||||||
3993828|NCT01236053|3814732|B20|BMI: Missing||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|5027|5027.0||||||
3993829|NCT01236053|3814733|B19|BMI: Missing||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|507|507.0||||||
3993830|NCT01236053|3814734|B18|BMI: Missing||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|122|122.0||||||
3993831|NCT01236053|3814735|B17|BMI: Missing||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|9|9.0||||||
3993832|NCT01236053|3814736|B16|BMI: Missing||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|10448|10448.0||||||
3993833|NCT01236053|3814737|B15|BMI: Missing||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|962|962.0||||||
3993834|NCT01236053|3814738|B14|BMI: Missing||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|366|366.0||||||
3993835|NCT01236053|3814739|B13|BMI: Missing||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|33|33.0||||||
3993836|NCT01236053|3814740|B12|BMI: Missing||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|36541|36541.0||||||
3993837|NCT01236053|3814741|B11|BMI: Missing||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|3657|3657.0||||||
3993838|NCT01236053|3814742|B10|BMI: Missing||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|1291|1291.0||||||
3993839|NCT01236053|3814743|B9|BMI: Missing||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|126|126.0||||||
3993840|NCT01236053|3814744|B8|BMI: Missing||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|24119|24119.0||||||
3993841|NCT01236053|3814745|B7|BMI: Missing||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|2521|2521.0||||||
3994184|NCT01236053|3814743|B9||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3994185|NCT01236053|3814744|B8||Male|Sex: Female, Male||Participants|Count of Participants|62491|62491.0||||||
3993842|NCT01236053|3814746|B6|BMI: Missing||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|528|528.0||||||
3993843|NCT01236053|3814747|B5|BMI: Missing||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|49|49.0||||||
3993844|NCT01236053|3814748|B4|BMI: Missing||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|4750|4750.0||||||
3993845|NCT01236053|3814749|B3|BMI: Missing||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|443|443.0||||||
3993846|NCT01236053|3814750|B2|BMI: Missing||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|407022|407022.0||||||
3993847|NCT01236053|3814751|B1|BMI: Missing||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|38209|38209.0||||||
3993848|NCT01236053|3814729|B23|BMI: 30 kg/m^2 or greater||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|284287|284287.0||||||
3993849|NCT01236053|3814730|B22|BMI: 30 kg/m^2 or greater||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|1626|1626.0||||||
3993850|NCT01236053|3814731|B21|BMI: 30 kg/m^2 or greater||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|245|245.0||||||
3993851|NCT01236053|3814732|B20|BMI: 30 kg/m^2 or greater||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|2492|2492.0||||||
3993852|NCT01236053|3814733|B19|BMI: 30 kg/m^2 or greater||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|294|294.0||||||
3993853|NCT01236053|3814734|B18|BMI: 30 kg/m^2 or greater||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|37|37.0||||||
3993854|NCT01236053|3814735|B17|BMI: 30 kg/m^2 or greater||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|7|7.0||||||
3993855|NCT01236053|3814736|B16|BMI: 30 kg/m^2 or greater||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|5117|5117.0||||||
3993856|NCT01236053|3814737|B15|BMI: 30 kg/m^2 or greater||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|587|587.0||||||
3993857|NCT01236053|3814738|B14|BMI: 30 kg/m^2 or greater||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|142|142.0||||||
3993858|NCT01236053|3814739|B13|BMI: 30 kg/m^2 or greater||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|22|22.0||||||
3993859|NCT01236053|3814740|B12|BMI: 30 kg/m^2 or greater||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|25819|25819.0||||||
3993860|NCT01236053|3814741|B11|BMI: 30 kg/m^2 or greater||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|2773|2773.0||||||
3993861|NCT01236053|3814742|B10|BMI: 30 kg/m^2 or greater||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|285|285.0||||||
3993862|NCT01236053|3814743|B9|BMI: 30 kg/m^2 or greater||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|25|25.0||||||
3993863|NCT01236053|3814744|B8|BMI: 30 kg/m^2 or greater||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|12814|12814.0||||||
3993864|NCT01236053|3814745|B7|BMI: 30 kg/m^2 or greater||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|1097|1097.0||||||
3993865|NCT01236053|3814746|B6|BMI: 30 kg/m^2 or greater||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|254|254.0||||||
3993866|NCT01236053|3814747|B5|BMI: 30 kg/m^2 or greater||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|21|21.0||||||
3993867|NCT01236053|3814748|B4|BMI: 30 kg/m^2 or greater||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|2001|2001.0||||||
3993868|NCT01236053|3814749|B3|BMI: 30 kg/m^2 or greater||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|245|245.0||||||
3993869|NCT01236053|3814750|B2|BMI: 30 kg/m^2 or greater||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|206232|206232.0||||||
3993870|NCT01236053|3814751|B1|BMI: 30 kg/m^2 or greater||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|22152|22152.0||||||
3993871|NCT01236053|3814729|B23|BMI: 25 to 29.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|687070|687070.0||||||
3993872|NCT01236053|3814730|B22|BMI: 25 to 29.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|3958|3958.0||||||
3993873|NCT01236053|3814731|B21|BMI: 25 to 29.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|447|447.0||||||
3993874|NCT01236053|3814732|B20|BMI: 25 to 29.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|6313|6313.0||||||
3993875|NCT01236053|3814733|B19|BMI: 25 to 29.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|662|662.0||||||
3993876|NCT01236053|3814734|B18|BMI: 25 to 29.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|111|111.0||||||
3993877|NCT01236053|3814735|B17|BMI: 25 to 29.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|11|11.0||||||
3993878|NCT01236053|3814736|B16|BMI: 25 to 29.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|14390|14390.0||||||
3993879|NCT01236053|3814737|B15|BMI: 25 to 29.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|1591|1591.0||||||
3993880|NCT01236053|3814738|B14|BMI: 25 to 29.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|461|461.0||||||
3993881|NCT01236053|3814739|B13|BMI: 25 to 29.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|50|50.0||||||
3993882|NCT01236053|3814740|B12|BMI: 25 to 29.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|47989|47989.0||||||
3993883|NCT01236053|3814741|B11|BMI: 25 to 29.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|5054|5054.0||||||
3993884|NCT01236053|3814742|B10|BMI: 25 to 29.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|580|580.0||||||
3993885|NCT01236053|3814743|B9|BMI: 25 to 29.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|70|70.0||||||
3993886|NCT01236053|3814744|B8|BMI: 25 to 29.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|33035|33035.0||||||
3993887|NCT01236053|3814745|B7|BMI: 25 to 29.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|3070|3070.0||||||
3993888|NCT01236053|3814746|B6|BMI: 25 to 29.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|581|581.0||||||
3993889|NCT01236053|3814747|B5|BMI: 25 to 29.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|55|55.0||||||
3993890|NCT01236053|3814748|B4|BMI: 25 to 29.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|5483|5483.0||||||
3993891|NCT01236053|3814749|B3|BMI: 25 to 29.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|579|579.0||||||
3993892|NCT01236053|3814750|B2|BMI: 25 to 29.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|508109|508109.0||||||
3993893|NCT01236053|3814751|B1|BMI: 25 to 29.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|54471|54471.0||||||
3993894|NCT01236053|3814729|B23|BMI: 18.5 to 24.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|784515|784515.0||||||
3993895|NCT01236053|3814730|B22|BMI: 18.5 to 24.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|3753|3753.0||||||
3993896|NCT01236053|3814731|B21|BMI: 18.5 to 24.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|331|331.0||||||
3993897|NCT01236053|3814732|B20|BMI: 18.5 to 24.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|6313|6313.0||||||
3993898|NCT01236053|3814733|B19|BMI: 18.5 to 24.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|662|662.0||||||
3993899|NCT01236053|3814734|B18|BMI: 18.5 to 24.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|106|106.0||||||
3993900|NCT01236053|3814735|B17|BMI: 18.5 to 24.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|11|11.0||||||
3993901|NCT01236053|3814736|B16|BMI: 18.5 to 24.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|13224|13224.0||||||
3993902|NCT01236053|3814737|B15|BMI: 18.5 to 24.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|1408|1408.0||||||
3993903|NCT01236053|3814738|B14|BMI: 18.5 to 24.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|420|420.0||||||
3993904|NCT01236053|3814739|B13|BMI: 18.5 to 24.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|42|42.0||||||
3993905|NCT01236053|3814740|B12|BMI: 18.5 to 24.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|75516|75516.0||||||
3993906|NCT01236053|3814741|B11|BMI: 18.5 to 24.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|7813|7813.0||||||
3993907|NCT01236053|3814742|B10|BMI: 18.5 to 24.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|741|741.0||||||
3993908|NCT01236053|3814743|B9|BMI: 18.5 to 24.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|72|72.0||||||
3993909|NCT01236053|3814744|B8|BMI: 18.5 to 24.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|31787|31787.0||||||
3993910|NCT01236053|3814745|B7|BMI: 18.5 to 24.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|3912|3912.0||||||
3993911|NCT01236053|3814746|B6|BMI: 18.5 to 24.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|674|674.0||||||
3993912|NCT01236053|3814747|B5|BMI: 18.5 to 24.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|82|82.0||||||
3993913|NCT01236053|3814748|B4|BMI: 18.5 to 24.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|5429|5429.0||||||
3993914|NCT01236053|3814749|B3|BMI: 18.5 to 24.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|580|580.0||||||
3993915|NCT01236053|3814750|B2|BMI: 18.5 to 24.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|569726|569726.0||||||
3993916|NCT01236053|3814751|B1|BMI: 18.5 to 24.99 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|61913|61913.0||||||
3993917|NCT01236053|3814729|B23|BMI: < 18.5 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|28057|28057.0||||||
3993918|NCT01236053|3814730|B22|BMI: < 18.5 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|128|128.0||||||
3993919|NCT01236053|3814731|B21|BMI: < 18.5 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|7|7.0||||||
3993920|NCT01236053|3814732|B20|BMI: < 18.5 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|232|232.0||||||
3993921|NCT01236053|3814733|B19|BMI: < 18.5 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|30|30.0||||||
3993922|NCT01236053|3814734|B18|BMI: < 18.5 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|4|4.0||||||
3993923|NCT01236053|3814735|B17|BMI: < 18.5 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|0|0.0||||||
3993924|NCT01236053|3814736|B16|BMI: < 18.5 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|380|380.0||||||
3993925|NCT01236053|3814737|B15|BMI: < 18.5 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|52|52.0||||||
3993926|NCT01236053|3814738|B14|BMI: < 18.5 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|7|7.0||||||
3993927|NCT01236053|3814739|B13|BMI: < 18.5 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|1|1.0||||||
3993928|NCT01236053|3814740|B12|BMI: < 18.5 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|3059|3059.0||||||
3993929|NCT01236053|3814741|B11|BMI: < 18.5 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|267|267.0||||||
3993930|NCT01236053|3814742|B10|BMI: < 18.5 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|38|38.0||||||
3993931|NCT01236053|3814743|B9|BMI: < 18.5 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|7|7.0||||||
3993932|NCT01236053|3814744|B8|BMI: < 18.5 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|1081|1081.0||||||
3993933|NCT01236053|3814745|B7|BMI: < 18.5 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|255|255.0||||||
3993934|NCT01236053|3814746|B6|BMI: < 18.5 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|30|30.0||||||
3993935|NCT01236053|3814747|B5|BMI: < 18.5 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|5|5.0||||||
3993936|NCT01236053|3814748|B4|BMI: < 18.5 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|190|190.0||||||
3993937|NCT01236053|3814749|B3|BMI: < 18.5 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|30|30.0||||||
3993938|NCT01236053|3814750|B2|BMI: < 18.5 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|19861|19861.0||||||
3993939|NCT01236053|3814751|B1|BMI: < 18.5 kg/m^2||Number of participants with the indicated Body Mass Index (BMI)|BMI is calculated as weight in kilograms (kg) (closest to cohort entry date, up to one year prior to index date) divided by height in meters squared (m^2) (one year or longer prior to index date).|participants|Number|2393|2393.0||||||
3993940|NCT01236053|3814729|B23|8+ years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|1378318|1378318.0||||||
3993941|NCT01236053|3814730|B22|8+ years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|7511|7511.0||||||
3993942|NCT01236053|3814731|B21|8+ years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|772|772.0||||||
3993943|NCT01236053|3814732|B20|8+ years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|11979|11979.0||||||
3993944|NCT01236053|3814733|B19|8+ years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|1244|1244.0||||||
3993945|NCT01236053|3814734|B18|8+ years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|280|280.0||||||
3994186|NCT01236053|3814745|B7||Male|Sex: Female, Male||Participants|Count of Participants|6596|6596.0||||||
3994187|NCT01236053|3814746|B6||Male|Sex: Female, Male||Participants|Count of Participants|773|773.0||||||
3993946|NCT01236053|3814735|B17|8+ years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|28|28.0||||||
3993947|NCT01236053|3814736|B16|8+ years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|26882|26882.0||||||
3993948|NCT01236053|3814737|B15|8+ years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|2781|2781.0||||||
3993949|NCT01236053|3814738|B14|8+ years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|761|761.0||||||
3993950|NCT01236053|3814739|B13|8+ years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|79|79.0||||||
3993951|NCT01236053|3814740|B12|8+ years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|110195|110195.0||||||
3993952|NCT01236053|3814741|B11|8+ years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|11232|11232.0||||||
3993953|NCT01236053|3814742|B10|8+ years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|1536|1536.0||||||
3993954|NCT01236053|3814743|B9|8+ years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|155|155.0||||||
3993955|NCT01236053|3814744|B8|8+ years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|59682|59682.0||||||
3993956|NCT01236053|3814745|B7|8+ years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|6162|6162.0||||||
3993957|NCT01236053|3814746|B6|8+ years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|1203|1203.0||||||
3993958|NCT01236053|3814747|B5|8+ years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|122|122.0||||||
3993959|NCT01236053|3814748|B4|8+ years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|9901|9901.0||||||
3993960|NCT01236053|3814749|B3|8+ years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|1014|1014.0||||||
3993961|NCT01236053|3814750|B2|8+ years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|1020085|1020085.0||||||
3993962|NCT01236053|3814751|B1|8+ years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|104714|104714.0||||||
3993963|NCT01236053|3814729|B23|6-7 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|328429|328429.0||||||
3993964|NCT01236053|3814730|B22|6-7 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|1564|1564.0||||||
3994188|NCT01236053|3814747|B5||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3994189|NCT01236053|3814748|B4||Male|Sex: Female, Male||Participants|Count of Participants|11064|11064.0||||||
3993965|NCT01236053|3814731|B21|6-7 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|165|165.0||||||
3993966|NCT01236053|3814732|B20|6-7 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|2972|2972.0||||||
3993967|NCT01236053|3814733|B19|6-7 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|318|318.0||||||
3993968|NCT01236053|3814734|B18|6-7 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|60|60.0||||||
3993969|NCT01236053|3814735|B17|6-7 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|6|6.0||||||
3993970|NCT01236053|3814736|B16|6-7 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|5824|5824.0||||||
3993971|NCT01236053|3814737|B15|6-7 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|618|618.0||||||
3993972|NCT01236053|3814738|B14|6-7 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|159|159.0||||||
3993973|NCT01236053|3814739|B13|6-7 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|17|17.0||||||
3993974|NCT01236053|3814740|B12|6-7 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|27109|27109.0||||||
3993975|NCT01236053|3814741|B11|6-7 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|2830|2830.0||||||
3993976|NCT01236053|3814742|B10|6-7 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|490|490.0||||||
3993977|NCT01236053|3814743|B9|6-7 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|49|49.0||||||
3993978|NCT01236053|3814744|B8|6-7 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|14855|14855.0||||||
3993979|NCT01236053|3814745|B7|6-7 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|1577|1577.0||||||
3993980|NCT01236053|3814746|B6|6-7 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|257|257.0||||||
3993981|NCT01236053|3814747|B5|6-7 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|26|26.0||||||
3993982|NCT01236053|3814748|B4|6-7 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|2108|2108.0||||||
3993983|NCT01236053|3814749|B3|6-7 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|231|231.0||||||
3994190|NCT01236053|3814749|B3||Male|Sex: Female, Male||Participants|Count of Participants|1161|1161.0||||||
3994191|NCT01236053|3814750|B2||Male|Sex: Female, Male||Participants|Count of Participants|827619|827619.0||||||
3993984|NCT01236053|3814750|B2|6-7 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|241586|241586.0||||||
3993985|NCT01236053|3814751|B1|6-7 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|25608|25608.0||||||
3993986|NCT01236053|3814729|B23|4-5 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|305162|305162.0||||||
3993987|NCT01236053|3814730|B22|4-5 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|1388|1388.0||||||
3993988|NCT01236053|3814731|B21|4-5 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|149|149.0||||||
3993989|NCT01236053|3814732|B20|4-5 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|2596|2596.0||||||
3993990|NCT01236053|3814733|B19|4-5 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|283|283.0||||||
3993991|NCT01236053|3814734|B18|4-5 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|20|20.0||||||
3993992|NCT01236053|3814735|B17|4-5 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|2|2.0||||||
3993993|NCT01236053|3814736|B16|4-5 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|5502|5502.0||||||
3993994|NCT01236053|3814737|B15|4-5 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|609|609.0||||||
3993995|NCT01236053|3814738|B14|4-5 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|264|264.0||||||
3993996|NCT01236053|3814739|B13|4-5 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|28|28.0||||||
3993997|NCT01236053|3814740|B12|4-5 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|25616|25616.0||||||
3993998|NCT01236053|3814741|B11|4-5 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|2718|2718.0||||||
3993999|NCT01236053|3814742|B10|4-5 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|451|451.0||||||
3994000|NCT01236053|3814743|B9|4-5 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|48|48.0||||||
3994001|NCT01236053|3814744|B8|4-5 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|13563|13563.0||||||
3994002|NCT01236053|3814745|B7|4-5 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|1489|1489.0||||||
3994192|NCT01236053|3814751|B1||Male|Sex: Female, Male||Participants|Count of Participants|87039|87039.0||||||
3994193|NCT01236053|3814729|B23||Female|Sex: Female, Male||Participants|Count of Participants|1269049|1269049.0||||||
3994003|NCT01236053|3814746|B6|4-5 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|288|288.0||||||
3994004|NCT01236053|3814747|B5|4-5 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|32|32.0||||||
3994005|NCT01236053|3814748|B4|4-5 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|2628|2628.0||||||
3994006|NCT01236053|3814749|B3|4-5 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|281|281.0||||||
3994007|NCT01236053|3814750|B2|4-5 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|223084|223084.0||||||
3994008|NCT01236053|3814751|B1|4-5 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|24123|24123.0||||||
3994009|NCT01236053|3814729|B23|2-3 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|311699|311699.0||||||
3994010|NCT01236053|3814730|B22|2-3 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|1704|1704.0||||||
3994011|NCT01236053|3814731|B21|2-3 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|186|186.0||||||
3994012|NCT01236053|3814732|B20|2-3 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|2835|2835.0||||||
3994013|NCT01236053|3814733|B19|2-3 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|310|310.0||||||
3994014|NCT01236053|3814734|B18|2-3 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|20|20.0||||||
3994015|NCT01236053|3814735|B17|2-3 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|2|2.0||||||
3994016|NCT01236053|3814736|B16|2-3 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|5351|5351.0||||||
3994017|NCT01236053|3814737|B15|2-3 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|592|592.0||||||
3994018|NCT01236053|3814738|B14|2-3 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|212|212.0||||||
3994019|NCT01236053|3814739|B13|2-3 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|24|24.0||||||
3994020|NCT01236053|3814740|B12|2-3 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|26004|26004.0||||||
3994021|NCT01236053|3814741|B11|2-3 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|2784|2784.0||||||
3994194|NCT01236053|3814730|B22||Female|Sex: Female, Male||Participants|Count of Participants|4820|4820.0||||||
3994195|NCT01236053|3814731|B21||Female|Sex: Female, Male||Participants|Count of Participants|507|507.0||||||
3994022|NCT01236053|3814742|B10|2-3 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|458|458.0||||||
3994023|NCT01236053|3814743|B9|2-3 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|48|48.0||||||
3994024|NCT01236053|3814744|B8|2-3 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|14736|14736.0||||||
3994025|NCT01236053|3814745|B7|2-3 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|1627|1627.0||||||
3994026|NCT01236053|3814746|B6|2-3 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|319|319.0||||||
3994027|NCT01236053|3814747|B5|2-3 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|32|32.0||||||
3994028|NCT01236053|3814748|B4|2-3 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|3216|3216.0||||||
3994029|NCT01236053|3814749|B3|2-3 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|351|351.0||||||
3994030|NCT01236053|3814750|B2|2-3 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|226195|226195.0||||||
3994031|NCT01236053|3814751|B1|2-3 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|24693|24693.0||||||
3994032|NCT01236053|3814729|B23|0-1 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|3216|3216.0||||||
3994033|NCT01236053|3814730|B22|0-1 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994034|NCT01236053|3814731|B21|0-1 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994035|NCT01236053|3814732|B20|0-1 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994036|NCT01236053|3814733|B19|0-1 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994037|NCT01236053|3814734|B18|0-1 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994038|NCT01236053|3814735|B17|0-1 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994039|NCT01236053|3814736|B16|0-1 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994040|NCT01236053|3814737|B15|0-1 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994196|NCT01236053|3814732|B20||Female|Sex: Female, Male||Participants|Count of Participants|10530|10530.0||||||
3994197|NCT01236053|3814733|B19||Female|Sex: Female, Male||Participants|Count of Participants|1109|1109.0||||||
3994041|NCT01236053|3814738|B14|0-1 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994042|NCT01236053|3814739|B13|0-1 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994043|NCT01236053|3814740|B12|0-1 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994044|NCT01236053|3814741|B11|0-1 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994045|NCT01236053|3814742|B10|0-1 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994046|NCT01236053|3814743|B9|0-1 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994047|NCT01236053|3814744|B8|0-1 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994048|NCT01236053|3814745|B7|0-1 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994049|NCT01236053|3814746|B6|0-1 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994050|NCT01236053|3814747|B5|0-1 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994051|NCT01236053|3814748|B4|0-1 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|3216|3216.0||||||
3994052|NCT01236053|3814749|B3|0-1 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994053|NCT01236053|3814750|B2|0-1 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994054|NCT01236053|3814751|B1|0-1 years||Number of participants with the indicated duration of follow-up from cohort entry to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994055|NCT01236053|3814729|B23|8+ years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|1875128|1875128.0||||||
3994056|NCT01236053|3814730|B22|8+ years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|9871|9871.0||||||
3994057|NCT01236053|3814731|B21|8+ years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|1014|1014.0||||||
3994058|NCT01236053|3814732|B20|8+ years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|16968|16968.0||||||
3994059|NCT01236053|3814733|B19|8+ years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|1742|1742.0||||||
3994198|NCT01236053|3814734|B18||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3994199|NCT01236053|3814735|B17||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3994060|NCT01236053|3814734|B18|8+ years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|326|326.0||||||
3994061|NCT01236053|3814735|B17|8+ years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|31|31.0||||||
3994062|NCT01236053|3814736|B16|8+ years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|36455|36455.0||||||
3994063|NCT01236053|3814737|B15|8+ years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|3762|3762.0||||||
3994064|NCT01236053|3814738|B14|8+ years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|1083|1083.0||||||
3994065|NCT01236053|3814739|B13|8+ years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|112|112.0||||||
3994066|NCT01236053|3814740|B12|8+ years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|150317|150317.0||||||
3994067|NCT01236053|3814741|B11|8+ years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|15269|15269.0||||||
3994068|NCT01236053|3814742|B10|8+ years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|2032|2032.0||||||
3994069|NCT01236053|3814743|B9|8+ years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|201|201.0||||||
3994070|NCT01236053|3814744|B8|8+ years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|84976|84976.0||||||
3994071|NCT01236053|3814745|B7|8+ years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|8681|8681.0||||||
3994072|NCT01236053|3814746|B6|8+ years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|1647|1647.0||||||
3994073|NCT01236053|3814747|B5|8+ years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|165|165.0||||||
3994074|NCT01236053|3814748|B4|8+ years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|14618|14618.0||||||
3994075|NCT01236053|3814749|B3|8+ years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|1482|1482.0||||||
3994076|NCT01236053|3814750|B2|8+ years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|1383317|1383317.0||||||
3994077|NCT01236053|3814751|B1|8+ years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|141059|141059.0||||||
3994078|NCT01236053|3814729|B23|6-7 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|164009|164009.0||||||
3994200|NCT01236053|3814736|B16||Female|Sex: Female, Male||Participants|Count of Participants|11552|11552.0||||||
3994278|NCT01236053|3814745|B7|60-69 years||Age, Customized||participants|Number|2944|2944.0||||||
3994079|NCT01236053|3814730|B22|6-7 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|839|839.0||||||
3994080|NCT01236053|3814731|B21|6-7 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|95|95.0||||||
3994081|NCT01236053|3814732|B20|6-7 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|1418|1418.0||||||
3994082|NCT01236053|3814733|B19|6-7 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|173|173.0||||||
3994083|NCT01236053|3814734|B18|6-7 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|41|41.0||||||
3994084|NCT01236053|3814735|B17|6-7 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|5|5.0||||||
3994085|NCT01236053|3814736|B16|6-7 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|2694|2694.0||||||
3994086|NCT01236053|3814737|B15|6-7 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|304|304.0||||||
3994087|NCT01236053|3814738|B14|6-7 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|104|104.0||||||
3994088|NCT01236053|3814739|B13|6-7 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|12|12.0||||||
3994089|NCT01236053|3814740|B12|6-7 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|14037|14037.0||||||
3994090|NCT01236053|3814741|B11|6-7 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|1508|1508.0||||||
3994091|NCT01236053|3814742|B10|6-7 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|264|264.0||||||
3994092|NCT01236053|3814743|B9|6-7 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|29|29.0||||||
3994093|NCT01236053|3814744|B8|6-7 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|6978|6978.0||||||
3994094|NCT01236053|3814745|B7|6-7 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|802|802.0||||||
3994095|NCT01236053|3814746|B6|6-7 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|121|121.0||||||
3994096|NCT01236053|3814747|B5|6-7 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|13|13.0||||||
3994097|NCT01236053|3814748|B4|6-7 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|1321|1321.0||||||
3994201|NCT01236053|3814737|B15||Female|Sex: Female, Male||Participants|Count of Participants|1229|1229.0||||||
3994202|NCT01236053|3814738|B14||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3994098|NCT01236053|3814749|B3|6-7 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|157|157.0||||||
3994099|NCT01236053|3814750|B2|6-7 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|119691|119691.0||||||
3994100|NCT01236053|3814751|B1|6-7 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|13403|13403.0||||||
3994101|NCT01236053|3814729|B23|4-5 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|147965|147965.0||||||
3994102|NCT01236053|3814730|B22|4-5 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|695|695.0||||||
3994103|NCT01236053|3814731|B21|4-5 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|72|72.0||||||
3994104|NCT01236053|3814732|B20|4-5 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|1028|1028.0||||||
3994105|NCT01236053|3814733|B19|4-5 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|122|122.0||||||
3994106|NCT01236053|3814734|B18|4-5 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994107|NCT01236053|3814735|B17|4-5 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994108|NCT01236053|3814736|B16|4-5 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|2403|2403.0||||||
3994109|NCT01236053|3814737|B15|4-5 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|283|283.0||||||
3994110|NCT01236053|3814738|B14|4-5 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|136|136.0||||||
3994111|NCT01236053|3814739|B13|4-5 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|15|15.0||||||
3994112|NCT01236053|3814740|B12|4-5 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|12724|12724.0||||||
3994113|NCT01236053|3814741|B11|4-5 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|1426|1426.0||||||
3994114|NCT01236053|3814742|B10|4-5 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|308|308.0||||||
3994115|NCT01236053|3814743|B9|4-5 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|35|35.0||||||
3994116|NCT01236053|3814744|B8|4-5 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|5868|5868.0||||||
3994203|NCT01236053|3814739|B13||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3994204|NCT01236053|3814740|B12||Female|Sex: Female, Male||Participants|Count of Participants|188924|188924.0||||||
3994117|NCT01236053|3814745|B7|4-5 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|708|708.0||||||
3994118|NCT01236053|3814746|B6|4-5 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|164|164.0||||||
3994119|NCT01236053|3814747|B5|4-5 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|20|20.0||||||
3994120|NCT01236053|3814748|B4|4-5 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|1048|1048.0||||||
3994121|NCT01236053|3814749|B3|4-5 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|123|123.0||||||
3994122|NCT01236053|3814750|B2|4-5 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|108112|108112.0||||||
3994123|NCT01236053|3814751|B1|4-5 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|12675|12675.0||||||
3994124|NCT01236053|3814729|B23|2-3 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|136486|136486.0||||||
3994125|NCT01236053|3814730|B22|2-3 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|762|762.0||||||
3994126|NCT01236053|3814731|B21|2-3 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|91|91.0||||||
3994127|NCT01236053|3814732|B20|2-3 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|968|968.0||||||
3994128|NCT01236053|3814733|B19|2-3 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|118|118.0||||||
3994129|NCT01236053|3814734|B18|2-3 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|13|13.0||||||
3994130|NCT01236053|3814735|B17|2-3 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|2|2.0||||||
3994131|NCT01236053|3814736|B16|2-3 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|2007|2007.0||||||
3994132|NCT01236053|3814737|B15|2-3 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|251|251.0||||||
3994133|NCT01236053|3814738|B14|2-3 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|73|73.0||||||
3994134|NCT01236053|3814739|B13|2-3 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|9|9.0||||||
3994135|NCT01236053|3814740|B12|2-3 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|11846|11846.0||||||
3994205|NCT01236053|3814741|B11||Female|Sex: Female, Male||Participants|Count of Participants|19564|19564.0||||||
3994206|NCT01236053|3814742|B10||Female|Sex: Female, Male||Participants|Count of Participants|1538|1538.0||||||
3994136|NCT01236053|3814741|B11|2-3 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|1361|1361.0||||||
3994137|NCT01236053|3814742|B10|2-3 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|331|331.0||||||
3994138|NCT01236053|3814743|B9|2-3 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|35|35.0||||||
3994139|NCT01236053|3814744|B8|2-3 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|5014|5014.0||||||
3994140|NCT01236053|3814745|B7|2-3 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|644|644.0||||||
3994141|NCT01236053|3814746|B6|2-3 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|135|135.0||||||
3994142|NCT01236053|3814747|B5|2-3 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|14|14.0||||||
3994143|NCT01236053|3814748|B4|2-3 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|866|866.0||||||
3994144|NCT01236053|3814749|B3|2-3 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|115|115.0||||||
3994145|NCT01236053|3814750|B2|2-3 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|99830|99830.0||||||
3994146|NCT01236053|3814751|B1|2-3 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|12001|12001.0||||||
3994147|NCT01236053|3814729|B23|0-1 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|11846|11846.0||||||
3994148|NCT01236053|3814730|B22|0-1 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994149|NCT01236053|3814731|B21|0-1 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994150|NCT01236053|3814732|B20|0-1 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994151|NCT01236053|3814733|B19|0-1 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994152|NCT01236053|3814734|B18|0-1 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994153|NCT01236053|3814735|B17|0-1 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994154|NCT01236053|3814736|B16|0-1 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994207|NCT01236053|3814743|B9||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
3994208|NCT01236053|3814744|B8||Female|Sex: Female, Male||Participants|Count of Participants|40345|40345.0||||||
3994155|NCT01236053|3814737|B15|0-1 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994156|NCT01236053|3814738|B14|0-1 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994157|NCT01236053|3814739|B13|0-1 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994158|NCT01236053|3814740|B12|0-1 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|11846|11846.0||||||
3994159|NCT01236053|3814741|B11|0-1 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994160|NCT01236053|3814742|B10|0-1 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994161|NCT01236053|3814743|B9|0-1 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994162|NCT01236053|3814744|B8|0-1 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994163|NCT01236053|3814745|B7|0-1 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994164|NCT01236053|3814746|B6|0-1 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994165|NCT01236053|3814747|B5|0-1 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994166|NCT01236053|3814748|B4|0-1 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994167|NCT01236053|3814749|B3|0-1 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994168|NCT01236053|3814750|B2|0-1 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994169|NCT01236053|3814751|B1|0-1 years||Number of participants with the indicated duration of follow-up from registration to index date|Entry into the GPRD study cohort began January 1, 1993, or at the time of GPRD registration if after January 1, 1993. Participants were required to have at least 2 years of follow-up prior to the index date.|participants|Number|0|0.0||||||
3994170|NCT01236053|3814729|B23||Male|Sex: Female, Male||Participants|Count of Participants|1054559|1054559.0||||||
3994171|NCT01236053|3814730|B22||Male|Sex: Female, Male||Participants|Count of Participants|7347|7347.0||||||
3994172|NCT01236053|3814731|B21||Male|Sex: Female, Male||Participants|Count of Participants|765|765.0||||||
3994173|NCT01236053|3814732|B20||Male|Sex: Female, Male||Participants|Count of Participants|9852|9852.0||||||
3994174|NCT01236053|3814733|B19||Male|Sex: Female, Male||Participants|Count of Participants|1046|1046.0||||||
3994175|NCT01236053|3814734|B18||Male|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
3994176|NCT01236053|3814735|B17||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3994177|NCT01236053|3814736|B16||Male|Sex: Female, Male||Participants|Count of Participants|32007|32007.0||||||
3994178|NCT01236053|3814737|B15||Male|Sex: Female, Male||Participants|Count of Participants|3371|3371.0||||||
3994179|NCT01236053|3814738|B14||Male|Sex: Female, Male||Participants|Count of Participants|1396|1396.0||||||
3994180|NCT01236053|3814739|B13||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3994181|NCT01236053|3814740|B12||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3994182|NCT01236053|3814741|B11||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3994183|NCT01236053|3814742|B10||Male|Sex: Female, Male||Participants|Count of Participants|1397|1397.0||||||
3994209|NCT01236053|3814745|B7||Female|Sex: Female, Male||Participants|Count of Participants|4259|4259.0||||||
3994210|NCT01236053|3814746|B6||Female|Sex: Female, Male||Participants|Count of Participants|1294|1294.0||||||
3994211|NCT01236053|3814747|B5||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
3994212|NCT01236053|3814748|B4||Female|Sex: Female, Male||Participants|Count of Participants|6789|6789.0||||||
3994213|NCT01236053|3814749|B3||Female|Sex: Female, Male||Participants|Count of Participants|716|716.0||||||
3994214|NCT01236053|3814750|B2||Female|Sex: Female, Male||Participants|Count of Participants|883331|883331.0||||||
3994215|NCT01236053|3814751|B1||Female|Sex: Female, Male||Participants|Count of Participants|92099|92099.0||||||
3994216|NCT01236053|3814729|B23|80+ years||Age, Customized||participants|Number|412265|412265.0||||||
3994217|NCT01236053|3814730|B22|80+ years||Age, Customized||participants|Number|1557|1557.0||||||
3994218|NCT01236053|3814731|B21|80+ years||Age, Customized||participants|Number|170|170.0||||||
3994219|NCT01236053|3814732|B20|80+ years||Age, Customized||participants|Number|5161|5161.0||||||
3994220|NCT01236053|3814733|B19|80+ years||Age, Customized||participants|Number|587|587.0||||||
3994221|NCT01236053|3814734|B18|80+ years||Age, Customized||participants|Number|68|68.0||||||
3994222|NCT01236053|3814735|B17|80+ years||Age, Customized||participants|Number|7|7.0||||||
3994223|NCT01236053|3814736|B16|80+ years||Age, Customized||participants|Number|9934|9934.0||||||
3994224|NCT01236053|3814737|B15|80+ years||Age, Customized||participants|Number|1106|1106.0||||||
3994225|NCT01236053|3814738|B14|80+ years||Age, Customized||participants|Number|144|144.0||||||
3994226|NCT01236053|3814739|B13|80+ years||Age, Customized||participants|Number|17|17.0||||||
3994227|NCT01236053|3814740|B12|80+ years||Age, Customized||participants|Number|22325|22325.0||||||
3994228|NCT01236053|3814741|B11|80+ years||Age, Customized||participants|Number|2504|2504.0||||||
3994229|NCT01236053|3814742|B10|80+ years||Age, Customized||participants|Number|225|225.0||||||
3994230|NCT01236053|3814743|B9|80+ years||Age, Customized||participants|Number|24|24.0||||||
3994231|NCT01236053|3814744|B8|80+ years||Age, Customized||participants|Number|20023|20023.0||||||
3994232|NCT01236053|3814745|B7|80+ years||Age, Customized||participants|Number|2233|2233.0||||||
3994233|NCT01236053|3814746|B6|80+ years||Age, Customized||participants|Number|378|378.0||||||
3994234|NCT01236053|3814747|B5|80+ years||Age, Customized||participants|Number|40|40.0||||||
3994235|NCT01236053|3814748|B4|80+ years||Age, Customized||participants|Number|5432|5432.0||||||
3994236|NCT01236053|3814749|B3|80+ years||Age, Customized||participants|Number|604|604.0||||||
3994237|NCT01236053|3814750|B2|80+ years||Age, Customized||participants|Number|305487|305487.0||||||
3994238|NCT01236053|3814751|B1|80+ years||Age, Customized||participants|Number|34239|34239.0||||||
3994239|NCT01236053|3814729|B23|70-79 years||Age, Customized||participants|Number|641161|641161.0||||||
3994240|NCT01236053|3814730|B22|70-79 years||Age, Customized||participants|Number|3399|3399.0||||||
3994241|NCT01236053|3814731|B21|70-79 years||Age, Customized||participants|Number|361|361.0||||||
3994242|NCT01236053|3814732|B20|70-79 years||Age, Customized||participants|Number|6813|6813.0||||||
3994243|NCT01236053|3814733|B19|70-79 years||Age, Customized||participants|Number|716|716.0||||||
3994244|NCT01236053|3814734|B18|70-79 years||Age, Customized||participants|Number|48|48.0||||||
3994245|NCT01236053|3814735|B17|70-79 years||Age, Customized||participants|Number|4|4.0||||||
3994246|NCT01236053|3814736|B16|70-79 years||Age, Customized||participants|Number|15471|15471.0||||||
3994247|NCT01236053|3814737|B15|70-79 years||Age, Customized||participants|Number|1644|1644.0||||||
3994248|NCT01236053|3814738|B14|70-79 years||Age, Customized||participants|Number|388|388.0||||||
3994249|NCT01236053|3814739|B13|70-79 years||Age, Customized||participants|Number|44|44.0||||||
3994250|NCT01236053|3814740|B12|70-79 years||Age, Customized||participants|Number|32051|32051.0||||||
3994251|NCT01236053|3814741|B11|70-79 years||Age, Customized||participants|Number|3334|3334.0||||||
3994252|NCT01236053|3814742|B10|70-79 years||Age, Customized||participants|Number|501|501.0||||||
3994253|NCT01236053|3814743|B9|70-79 years||Age, Customized||participants|Number|51|51.0||||||
3994254|NCT01236053|3814744|B8|70-79 years||Age, Customized||participants|Number|38557|38557.0||||||
3994255|NCT01236053|3814745|B7|70-79 years||Age, Customized||participants|Number|4092|4092.0||||||
3994256|NCT01236053|3814746|B6|70-79 years||Age, Customized||participants|Number|440|440.0||||||
3994257|NCT01236053|3814747|B5|70-79 years||Age, Customized||participants|Number|50|50.0||||||
3994258|NCT01236053|3814748|B4|70-79 years||Age, Customized||participants|Number|6559|6559.0||||||
3994259|NCT01236053|3814749|B3|70-79 years||Age, Customized||participants|Number|679|679.0||||||
3994260|NCT01236053|3814750|B2|70-79 years||Age, Customized||participants|Number|475887|475887.0||||||
3994261|NCT01236053|3814751|B1|70-79 years||Age, Customized||participants|Number|50072|50072.0||||||
3994262|NCT01236053|3814729|B23|60-69 years||Age, Customized||participants|Number|566705|566705.0||||||
3994263|NCT01236053|3814730|B22|60-69 years||Age, Customized||participants|Number|3498|3498.0||||||
3994264|NCT01236053|3814731|B21|60-69 years||Age, Customized||participants|Number|362|362.0||||||
3994265|NCT01236053|3814732|B20|60-69 years||Age, Customized||participants|Number|5043|5043.0||||||
3994266|NCT01236053|3814733|B19|60-69 years||Age, Customized||participants|Number|515|515.0||||||
3994267|NCT01236053|3814734|B18|60-69 years||Age, Customized||participants|Number|78|78.0||||||
3994268|NCT01236053|3814735|B17|60-69 years||Age, Customized||participants|Number|9|9.0||||||
3994269|NCT01236053|3814736|B16|60-69 years||Age, Customized||participants|Number|11021|11021.0||||||
3994270|NCT01236053|3814737|B15|60-69 years||Age, Customized||participants|Number|1127|1127.0||||||
3994271|NCT01236053|3814738|B14|60-69 years||Age, Customized||participants|Number|320|320.0||||||
3994272|NCT01236053|3814739|B13|60-69 years||Age, Customized||participants|Number|32|32.0||||||
3994279|NCT01236053|3814746|B6|60-69 years||Age, Customized||participants|Number|464|464.0||||||
3994280|NCT01236053|3814747|B5|60-69 years||Age, Customized||participants|Number|45|45.0||||||
3994281|NCT01236053|3814748|B4|60-69 years||Age, Customized||participants|Number|3850|3850.0||||||
3994282|NCT01236053|3814749|B3|60-69 years||Age, Customized||participants|Number|395|395.0||||||
3994283|NCT01236053|3814750|B2|60-69 years||Age, Customized||participants|Number|415567|415567.0||||||
3994284|NCT01236053|3814751|B1|60-69 years||Age, Customized||participants|Number|43077|43077.0||||||
3994285|NCT01236053|3814729|B23|50-59 years||Age, Customized||participants|Number|392635|392635.0||||||
3994286|NCT01236053|3814730|B22|50-59 years||Age, Customized||participants|Number|2406|2406.0||||||
3994287|NCT01236053|3814731|B21|50-59 years||Age, Customized||participants|Number|249|249.0||||||
3994288|NCT01236053|3814732|B20|50-59 years||Age, Customized||participants|Number|2564|2564.0||||||
3994289|NCT01236053|3814733|B19|50-59 years||Age, Customized||participants|Number|261|261.0||||||
3994290|NCT01236053|3814734|B18|50-59 years||Age, Customized||participants|Number|54|54.0||||||
3994291|NCT01236053|3814735|B17|50-59 years||Age, Customized||participants|Number|5|5.0||||||
3994292|NCT01236053|3814736|B16|50-59 years||Age, Customized||participants|Number|5296|5296.0||||||
3994293|NCT01236053|3814737|B15|50-59 years||Age, Customized||participants|Number|547|547.0||||||
3994294|NCT01236053|3814738|B14|50-59 years||Age, Customized||participants|Number|300|300.0||||||
3994295|NCT01236053|3814739|B13|50-59 years||Age, Customized||participants|Number|30|30.0||||||
3994296|NCT01236053|3814740|B12|50-59 years||Age, Customized||participants|Number|51266|51266.0||||||
3994297|NCT01236053|3814741|B11|50-59 years||Age, Customized||participants|Number|5319|5319.0||||||
3994298|NCT01236053|3814742|B10|50-59 years||Age, Customized||participants|Number|422|422.0||||||
3994299|NCT01236053|3814743|B9|50-59 years||Age, Customized||participants|Number|46|46.0||||||
3994300|NCT01236053|3814744|B8|50-59 years||Age, Customized||participants|Number|12388|12388.0||||||
3994301|NCT01236053|3814745|B7|50-59 years||Age, Customized||participants|Number|1256|1256.0||||||
3994302|NCT01236053|3814746|B6|50-59 years||Age, Customized||participants|Number|467|467.0||||||
3994303|NCT01236053|3814747|B5|50-59 years||Age, Customized||participants|Number|47|47.0||||||
3994304|NCT01236053|3814748|B4|50-59 years||Age, Customized||participants|Number|1388|1388.0||||||
3994305|NCT01236053|3814749|B3|50-59 years||Age, Customized||participants|Number|135|135.0||||||
3994306|NCT01236053|3814750|B2|50-59 years||Age, Customized||participants|Number|279797|279797.0||||||
3994307|NCT01236053|3814751|B1|50-59 years||Age, Customized||participants|Number|28392|28392.0||||||
3994308|NCT01236053|3814729|B23|40-49 years||Age, Customized||participants|Number|185111|185111.0||||||
3994309|NCT01236053|3814730|B22|40-49 years||Age, Customized||participants|Number|990|990.0||||||
3994310|NCT01236053|3814731|B21|40-49 years||Age, Customized||participants|Number|99|99.0||||||
3994311|NCT01236053|3814732|B20|40-49 years||Age, Customized||participants|Number|669|669.0||||||
3994312|NCT01236053|3814733|B19|40-49 years||Age, Customized||participants|Number|65|65.0||||||
3994313|NCT01236053|3814734|B18|40-49 years||Age, Customized||participants|Number|78|78.0||||||
3994314|NCT01236053|3814735|B17|40-49 years||Age, Customized||participants|Number|8|8.0||||||
3994315|NCT01236053|3814736|B16|40-49 years||Age, Customized||participants|Number|1285|1285.0||||||
3994316|NCT01236053|3814737|B15|40-49 years||Age, Customized||participants|Number|120|120.0||||||
3994317|NCT01236053|3814738|B14|40-49 years||Age, Customized||participants|Number|154|154.0||||||
3994318|NCT01236053|3814739|B13|40-49 years||Age, Customized||participants|Number|16|16.0||||||
3994319|NCT01236053|3814740|B12|40-49 years||Age, Customized||participants|Number|29167|29167.0||||||
3994320|NCT01236053|3814741|B11|40-49 years||Age, Customized||participants|Number|2827|2827.0||||||
3994321|NCT01236053|3814742|B10|40-49 years||Age, Customized||participants|Number|254|254.0||||||
3994322|NCT01236053|3814743|B9|40-49 years||Age, Customized||participants|Number|21|21.0||||||
3994323|NCT01236053|3814744|B8|40-49 years||Age, Customized||participants|Number|2973|2973.0||||||
3994324|NCT01236053|3814745|B7|40-49 years||Age, Customized||participants|Number|294|294.0||||||
3994325|NCT01236053|3814746|B6|40-49 years||Age, Customized||participants|Number|200|200.0||||||
3994326|NCT01236053|3814747|B5|40-49 years||Age, Customized||participants|Number|18|18.0||||||
3994327|NCT01236053|3814748|B4|40-49 years||Age, Customized||participants|Number|469|469.0||||||
3994328|NCT01236053|3814749|B3|40-49 years||Age, Customized||participants|Number|48|48.0||||||
3994329|NCT01236053|3814750|B2|40-49 years||Age, Customized||participants|Number|132244|132244.0||||||
3994330|NCT01236053|3814751|B1|40-49 years||Age, Customized||participants|Number|13112|13112.0||||||
3994331|NCT01236053|3814729|B23|< 40 years||Age, Customized||participants|Number|125731|125731.0||||||
3994332|NCT01236053|3814730|B22|< 40 years||Age, Customized||participants|Number|317|317.0||||||
3994333|NCT01236053|3814731|B21|< 40 years||Age, Customized||participants|Number|31|31.0||||||
3994334|NCT01236053|3814732|B20|< 40 years||Age, Customized||participants|Number|132|132.0||||||
3994335|NCT01236053|3814733|B19|< 40 years||Age, Customized||participants|Number|11|11.0||||||
3994336|NCT01236053|3814734|B18|< 40 years||Age, Customized||participants|Number|54|54.0||||||
3994337|NCT01236053|3814735|B17|< 40 years||Age, Customized||participants|Number|5|5.0||||||
3994338|NCT01236053|3814736|B16|< 40 years||Age, Customized||participants|Number|552|552.0||||||
3994339|NCT01236053|3814737|B15|< 40 years||Age, Customized||participants|Number|56|56.0||||||
3994340|NCT01236053|3814738|B14|< 40 years||Age, Customized||participants|Number|90|90.0||||||
3994341|NCT01236053|3814739|B13|< 40 years||Age, Customized||participants|Number|9|9.0||||||
3994342|NCT01236053|3814740|B12|< 40 years||Age, Customized||participants|Number|9346|9346.0||||||
3994343|NCT01236053|3814741|B11|< 40 years||Age, Customized||participants|Number|915|915.0||||||
3994344|NCT01236053|3814742|B10|< 40 years||Age, Customized||participants|Number|1173|1173.0||||||
3994345|NCT01236053|3814743|B9|< 40 years||Age, Customized||participants|Number|120|120.0||||||
3994346|NCT01236053|3814744|B8|< 40 years||Age, Customized||participants|Number|369|369.0||||||
3994347|NCT01236053|3814745|B7|< 40 years||Age, Customized||participants|Number|36|36.0||||||
3994348|NCT01236053|3814746|B6|< 40 years||Age, Customized||participants|Number|118|118.0||||||
3994349|NCT01236053|3814747|B5|< 40 years||Age, Customized||participants|Number|12|12.0||||||
3994350|NCT01236053|3814748|B4|< 40 years||Age, Customized||participants|Number|155|155.0||||||
3994351|NCT01236053|3814749|B3|< 40 years||Age, Customized||participants|Number|16|16.0||||||
3994352|NCT01236053|3814750|B2|< 40 years||Age, Customized||participants|Number|101968|101968.0||||||
3994353|NCT01236053|3814751|B1|< 40 years||Age, Customized||participants|Number|10246|10246.0||||||
3994354|NCT01236001|3814906|B3|Belgium||Region of Enrollment||participants|Number|192|192.0||||||
3994355|NCT01236001|3814907|B2|Belgium||Region of Enrollment||participants|Number|87|87.0||||||
3994356|NCT01236001|3814908|B1|Belgium||Region of Enrollment||participants|Number|105|105.0||||||
3994357|NCT01236001|3814906|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3994358|NCT01236001|3814907|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3994359|NCT01236001|3814908|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3994360|NCT01236001|3814906|B3||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3994361|NCT01236001|3814907|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3994362|NCT01236001|3814908|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3994363|NCT01236001|3814906|B3|||Age||years|Mean|41.5|41.5|Standard Deviation|13.7|13.7|||
3994364|NCT01236001|3814907|B2|||Age||years|Mean|43.3|43.3|Standard Deviation|14.0|14.0|||
3994365|NCT01236001|3814908|B1|||Age||years|Mean|40.1|40.1|Standard Deviation|13.4|13.4|||
3994366|NCT01236001|3814906|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3994367|NCT01236001|3814907|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3994368|NCT01236001|3814908|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3994369|NCT01236001|3814906|B3||Between 18 and 65 years|Age||Participants|Count of Participants|178|178.0||||||
3994370|NCT01236001|3814907|B2||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
3994371|NCT01236001|3814908|B1||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
3994372|NCT01236001|3814906|B3||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3994373|NCT01236001|3814907|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3994374|NCT01236001|3814908|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
3994375|NCT01235975|3814939|B3|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|369|369.0||||||
3994376|NCT01235975|3814940|B2|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|95|95.0||||||
3994377|NCT01235975|3814941|B1|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|274|274.0||||||
3994378|NCT01235975|3814939|B3||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3994379|NCT01235975|3814940|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3994380|NCT01235975|3814941|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3994381|NCT01235975|3814939|B3||Female|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
3994382|NCT01235975|3814940|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3994383|NCT01235975|3814941|B1||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
3994384|NCT01235975|3814939|B3|||Age||Years|Mean|64.15|64.15|Standard Deviation|7.25|7.25|||
3994385|NCT01235975|3814940|B2|||Age||Years|Mean|64.3|64.3|Standard Deviation|7.39|7.39|||
3994386|NCT01235975|3814941|B1|||Age||Years|Mean|64.1|64.1|Standard Deviation|7.22|7.22|||
3994387|NCT01235923|3814974|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3994388|NCT01235923|3814975|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3994389|NCT01235923|3814976|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3994390|NCT01235923|3814974|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3994391|NCT01235923|3814975|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3994392|NCT01235923|3814976|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3994393|NCT01235923|3814974|B3|||Age, Customized||days|Mean|17|17.0|Standard Deviation|3|3.0|||
3994394|NCT01235923|3814975|B2|||Age, Customized||days|Mean|18|18.0|Standard Deviation|3|3.0|||
3994395|NCT01235923|3814976|B1|||Age, Customized||days|Mean|15|15.0|Standard Deviation|4|4.0|||
3994396|NCT01235910|3814985|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3994397|NCT01235910|3814985|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3994398|NCT01235910|3814985|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3994399|NCT01235910|3814985|B1|||Age||years|Mean|58|58.0|Standard Deviation|0|0.0|||
3994400|NCT01235910|3814985|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3994401|NCT01235910|3814985|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3994402|NCT01235910|3814985|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3994403|NCT01235897|3814991|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
3994404|NCT01235897|3814991|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3994405|NCT01235897|3814991|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3994406|NCT01235897|3814991|B1|||Age||years|Mean|52|52.0|Full Range|||31.0|78.0|
3994407|NCT01235793|3814996|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3994408|NCT01235793|3814996|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994409|NCT01235793|3814996|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3994410|NCT01235793|3814996|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994411|NCT01235793|3814996|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994412|NCT01235793|3814996|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994413|NCT01235793|3814996|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994414|NCT01235793|3814996|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994415|NCT01235793|3814996|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3994416|NCT01235793|3814996|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3994417|NCT01235793|3814996|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3994418|NCT01235793|3814996|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3994419|NCT01235793|3814996|B1|||Age||Age in years|Median|58|58.0|Full Range|||32.0|69.0|
3994420|NCT01235793|3814996|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3994421|NCT01235793|3814996|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3994422|NCT01235793|3814996|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3994423|NCT01235741|3815001|B4|||Body Mass Index|Body Mass Index (BMI) at enrollment measured in kilograms per meter of height squared (kg/m^2).|kg/m^2|Mean|39.38|39.38|Standard Deviation|2.937|2.937|||
3994424|NCT01235741|3815002|B3|||Body Mass Index|Body Mass Index (BMI) at enrollment measured in kilograms per meter of height squared (kg/m^2).|kg/m^2|Mean|39.09|39.09|Standard Deviation|2.869|2.869|||
3994425|NCT01235741|3815003|B2|||Body Mass Index|Body Mass Index (BMI) at enrollment measured in kilograms per meter of height squared (kg/m^2).|kg/m^2|Mean|39.17|39.17|Standard Deviation|3.279|3.279|||
3994426|NCT01235741|3815004|B1|||Body Mass Index|Body Mass Index (BMI) at enrollment measured in kilograms per meter of height squared (kg/m^2).|kg/m^2|Mean|39.51|39.51|Standard Deviation|2.875|2.875|||
3994427|NCT01235741|3815001|B4|||Body Weight|Body weight at enrollment measured in kilograms (kg).|kg|Mean|110.13|110.13|Standard Deviation|13.678|13.678|||
3994428|NCT01235741|3815002|B3|||Body Weight|Body weight at enrollment measured in kilograms (kg).|kg|Mean|108.34|108.34|Standard Deviation|12.032|12.032|||
3994429|NCT01235741|3815003|B2|||Body Weight|Body weight at enrollment measured in kilograms (kg).|kg|Mean|109.10|109.1|Standard Deviation|16.850|16.85|||
3994430|NCT01235741|3815004|B1|||Body Weight|Body weight at enrollment measured in kilograms (kg).|kg|Mean|110.86|110.86|Standard Deviation|13.210|13.21|||
3994431|NCT01235741|3815001|B4|United States||Region of Enrollment||participants|Number|213|213.0||||||
3994432|NCT01235741|3815002|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
3994433|NCT01235741|3815003|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
3994434|NCT01235741|3815004|B1|United States||Region of Enrollment||participants|Number|141|141.0||||||
3994435|NCT01235741|3815001|B4||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3994436|NCT01235741|3815002|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3994437|NCT01235741|3815003|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3994438|NCT01235741|3815004|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3994439|NCT01235741|3815001|B4||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
3994440|NCT01235741|3815002|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3994441|NCT01235741|3815003|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3994442|NCT01235741|3815004|B1||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3994443|NCT01235741|3815001|B4|||Age|Age at Screening is presented.|years|Mean|46.1|46.1|Standard Deviation|11.38|11.38|||
3994444|NCT01235741|3815002|B3|||Age|Age at Screening is presented.|years|Mean|46.4|46.4|Standard Deviation|10.45|10.45|||
3994445|NCT01235741|3815003|B2|||Age|Age at Screening is presented.|years|Mean|46.2|46.2|Standard Deviation|10.84|10.84|||
3994446|NCT01235741|3815004|B1|||Age|Age at Screening is presented.|years|Mean|46.1|46.1|Standard Deviation|11.81|11.81|||
3994447|NCT01235728|3815033|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3994448|NCT01235728|3815033|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3994449|NCT01235728|3815033|B1|||Age||Years|Mean|43.3|43.3|Full Range|||30.0|59.0|
3994450|NCT01235715|3815048|B3|United States||Region of Enrollment||participants|Number|200|200.0||||||
3994451|NCT01235715|3815049|B2|United States||Region of Enrollment||participants|Number|102|102.0||||||
3994452|NCT01235715|3815050|B1|United States||Region of Enrollment||participants|Number|98|98.0||||||
3994453|NCT01235715|3815048|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3994454|NCT01235715|3815049|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3994455|NCT01235715|3815050|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3994456|NCT01235715|3815048|B3||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3994457|NCT01235715|3815049|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3994458|NCT01235715|3815050|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3994459|NCT01235715|3815048|B3|||Age||years|Mean|67|67.0|Standard Deviation|10|10.0|||
3994460|NCT01235715|3815049|B2|||Age||years|Mean|66.38|66.38|Standard Deviation|8.47|8.47|||
3994461|NCT01235715|3815050|B1|||Age||years|Mean|68.12|68.12|Standard Deviation|9.88|9.88|||
3994462|NCT01235715|3815048|B3||>=65 years|Age||Participants|Count of Participants|125|125.0||||||
3994463|NCT01235715|3815049|B2||>=65 years|Age||Participants|Count of Participants|61|61.0||||||
3994464|NCT01235715|3815050|B1||>=65 years|Age||Participants|Count of Participants|64|64.0||||||
3994465|NCT01235715|3815048|B3||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
3994466|NCT01235715|3815049|B2||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
3994467|NCT01235715|3815050|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3994468|NCT01235715|3815048|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3994469|NCT01235715|3815049|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3994470|NCT01235715|3815050|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3994471|NCT01235689|3815089|B3|||Crohn's Disease Activity Index (CDAI)|CDAI is a tool used to quantify the symptoms of patients with Crohn's disease. Participants were asked to record the frequency of stools, abdominal pain and general well-being on a daily basis. In addition to the diary data, the investigator assessed the following for the calculation of CDAI: presence of complications, the use of antidiarrheal medicines, presence of an abdominal mass, hematocrit, and body weight. The CDAI is the sum of the products of each item multiplied by a weighting factor and generally ranges from 0 up to 600, where higher scores indicate more severe disease.|units on a scale|Mean|270.5|270.5|Standard Deviation|58.86|58.86|||
3994472|NCT01235689|3815090|B2|||Crohn's Disease Activity Index (CDAI)|CDAI is a tool used to quantify the symptoms of patients with Crohn's disease. Participants were asked to record the frequency of stools, abdominal pain and general well-being on a daily basis. In addition to the diary data, the investigator assessed the following for the calculation of CDAI: presence of complications, the use of antidiarrheal medicines, presence of an abdominal mass, hematocrit, and body weight. The CDAI is the sum of the products of each item multiplied by a weighting factor and generally ranges from 0 up to 600, where higher scores indicate more severe disease.|units on a scale|Mean|273.3|273.3|Standard Deviation|59.48|59.48|||
3994473|NCT01235689|3815091|B1|||Crohn's Disease Activity Index (CDAI)|CDAI is a tool used to quantify the symptoms of patients with Crohn's disease. Participants were asked to record the frequency of stools, abdominal pain and general well-being on a daily basis. In addition to the diary data, the investigator assessed the following for the calculation of CDAI: presence of complications, the use of antidiarrheal medicines, presence of an abdominal mass, hematocrit, and body weight. The CDAI is the sum of the products of each item multiplied by a weighting factor and generally ranges from 0 up to 600, where higher scores indicate more severe disease.|units on a scale|Mean|267.7|267.7|Standard Deviation|58.35|58.35|||
3994474|NCT01235689|3815089|B3|||Crohn's Disease Endoscopy Index of Severity (CDEIS)|CDEIS is an index for determining the severity of Crohn's disease. The CDEIS considers deep ulcerations, superficial ulcerations, ulcerated and non-ulcerated surface, and the presence of ulcerated/non-ulcerated stenosis evaluated in 5 pre-defined segments of the colon (ileum, ascending colon, transverse colon, descending colon and sigmoid loop, and rectum). The score ranges from 0 to 44 where higher scores indicate more severe endoscopic activity.|units on a scale|Mean|13.82|13.82|Standard Deviation|6.503|6.503|||
3994475|NCT01235689|3815090|B2|||Crohn's Disease Endoscopy Index of Severity (CDEIS)|CDEIS is an index for determining the severity of Crohn's disease. The CDEIS considers deep ulcerations, superficial ulcerations, ulcerated and non-ulcerated surface, and the presence of ulcerated/non-ulcerated stenosis evaluated in 5 pre-defined segments of the colon (ileum, ascending colon, transverse colon, descending colon and sigmoid loop, and rectum). The score ranges from 0 to 44 where higher scores indicate more severe endoscopic activity.|units on a scale|Mean|13.38|13.38|Standard Deviation|6.049|6.049|||
3994476|NCT01235689|3815091|B1|||Crohn's Disease Endoscopy Index of Severity (CDEIS)|CDEIS is an index for determining the severity of Crohn's disease. The CDEIS considers deep ulcerations, superficial ulcerations, ulcerated and non-ulcerated surface, and the presence of ulcerated/non-ulcerated stenosis evaluated in 5 pre-defined segments of the colon (ileum, ascending colon, transverse colon, descending colon and sigmoid loop, and rectum). The score ranges from 0 to 44 where higher scores indicate more severe endoscopic activity.|units on a scale|Mean|14.26|14.26|Standard Deviation|6.925|6.925|||
3994477|NCT01235689|3815089|B3||> 2 years|Disease Duration||Participants|Count of Participants|32|32.0||||||
3994478|NCT01235689|3815090|B2||> 2 years|Disease Duration||Participants|Count of Participants|16|16.0||||||
3994479|NCT01235689|3815091|B1||> 2 years|Disease Duration||Participants|Count of Participants|16|16.0||||||
3994480|NCT01235689|3815089|B3||≤ 2 years|Disease Duration||Participants|Count of Participants|212|212.0||||||
3994481|NCT01235689|3815090|B2||≤ 2 years|Disease Duration||Participants|Count of Participants|106|106.0||||||
3994482|NCT01235689|3815091|B1||≤ 2 years|Disease Duration||Participants|Count of Participants|106|106.0||||||
3994483|NCT01235689|3815089|B3||No|Current Tobacco Use||Participants|Count of Participants|180|180.0||||||
3994484|NCT01235689|3815090|B2||No|Current Tobacco Use||Participants|Count of Participants|91|91.0||||||
3994485|NCT01235689|3815091|B1||No|Current Tobacco Use||Participants|Count of Participants|89|89.0||||||
3994486|NCT01235689|3815089|B3||Yes|Current Tobacco Use||Participants|Count of Participants|64|64.0||||||
3994487|NCT01235689|3815090|B2||Yes|Current Tobacco Use||Participants|Count of Participants|31|31.0||||||
3994488|NCT01235689|3815091|B1||Yes|Current Tobacco Use||Participants|Count of Participants|33|33.0||||||
3994489|NCT01235689|3815089|B3||≥ 70 kg|Weight||Participants|Count of Participants|84|84.0||||||
3994490|NCT01235689|3815090|B2||≥ 70 kg|Weight||Participants|Count of Participants|41|41.0||||||
3994491|NCT01235689|3815091|B1||≥ 70 kg|Weight||Participants|Count of Participants|43|43.0||||||
3994492|NCT01235689|3815089|B3||< 70 kg|Weight||Participants|Count of Participants|160|160.0||||||
3994493|NCT01235689|3815090|B2||< 70 kg|Weight||Participants|Count of Participants|81|81.0||||||
3994494|NCT01235689|3815091|B1||< 70 kg|Weight||Participants|Count of Participants|79|79.0||||||
3994495|NCT01235689|3815089|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3994496|NCT01235689|3815090|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3994497|NCT01235689|3815091|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3994498|NCT01235689|3815089|B3||Multi-race|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3994499|NCT01235689|3815090|B2||Multi-race|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3994500|NCT01235689|3815091|B1||Multi-race|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3994501|NCT01235689|3815089|B3||Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3994502|NCT01235689|3815090|B2||Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3994503|NCT01235689|3815091|B1||Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3994504|NCT01235689|3815089|B3||American Indian/Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3994505|NCT01235689|3815090|B2||American Indian/Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3994506|NCT01235689|3815091|B1||American Indian/Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3994507|NCT01235689|3815089|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3994508|NCT01235689|3815090|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3994509|NCT01235689|3815091|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3994510|NCT01235689|3815089|B3||Black|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
3994511|NCT01235689|3815090|B2||Black|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3994512|NCT01235689|3815091|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3994513|NCT01235689|3815089|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|226|226.0||||||
3994514|NCT01235689|3815090|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|113|113.0||||||
3994515|NCT01235689|3815091|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|113|113.0||||||
3994516|NCT01235689|3815089|B3||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3994517|NCT01235689|3815090|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3994518|NCT01235689|3815091|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3994519|NCT01235689|3815089|B3||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3994520|NCT01235689|3815090|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3994521|NCT01235689|3815091|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3994522|NCT01235689|3815089|B3||≥ 65 years|Age, Customized||Participants|Count of Participants|4|4.0||||||
3994523|NCT01235689|3815090|B2||≥ 65 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
3994524|NCT01235689|3815091|B1||≥ 65 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
3994525|NCT01235689|3815089|B3||40 to < 65 years|Age, Customized||Participants|Count of Participants|47|47.0||||||
3994526|NCT01235689|3815090|B2||40 to < 65 years|Age, Customized||Participants|Count of Participants|24|24.0||||||
3994527|NCT01235689|3815091|B1||40 to < 65 years|Age, Customized||Participants|Count of Participants|23|23.0||||||
3994528|NCT01235689|3815089|B3||< 40 years|Age, Customized||Participants|Count of Participants|193|193.0||||||
3994529|NCT01235689|3815090|B2||< 40 years|Age, Customized||Participants|Count of Participants|96|96.0||||||
3994530|NCT01235689|3815091|B1||< 40 years|Age, Customized||Participants|Count of Participants|97|97.0||||||
3994531|NCT01235689|3815089|B3|||Age||years|Mean|31.60|31.6|Standard Deviation|11.67|11.67|||
3994532|NCT01235689|3815090|B2|||Age||years|Mean|32.10|32.1|Standard Deviation|11.97|11.97|||
3994533|NCT01235689|3815091|B1|||Age||years|Mean|31.10|31.1|Standard Deviation|11.40|11.4|||
3994534|NCT01235598|3815162|B3|Sweden||Region of Enrollment||participants|Number|10|10.0||||||
3994535|NCT01235598|3815163|B2|Sweden||Region of Enrollment||participants|Number|6|6.0||||||
3994536|NCT01235598|3815164|B1|Sweden||Region of Enrollment||participants|Number|4|4.0||||||
3994537|NCT01235598|3815162|B3|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
3994538|NCT01235598|3815163|B2|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
3994539|NCT01235598|3815164|B1|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
3994540|NCT01235598|3815162|B3|Denmark||Region of Enrollment||participants|Number|17|17.0||||||
3994541|NCT01235598|3815163|B2|Denmark||Region of Enrollment||participants|Number|11|11.0||||||
3994542|NCT01235598|3815164|B1|Denmark||Region of Enrollment||participants|Number|6|6.0||||||
3994543|NCT01235598|3815162|B3|Poland||Region of Enrollment||participants|Number|9|9.0||||||
3994544|NCT01235598|3815163|B2|Poland||Region of Enrollment||participants|Number|7|7.0||||||
3994545|NCT01235598|3815164|B1|Poland||Region of Enrollment||participants|Number|2|2.0||||||
3994546|NCT01235598|3815162|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3994547|NCT01235598|3815163|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3994548|NCT01235598|3815164|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3994549|NCT01235598|3815162|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3994550|NCT01235598|3815163|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3994551|NCT01235598|3815164|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3994552|NCT01235598|3815162|B3|||Age||years|Mean|50.4|50.4|Standard Deviation|13.1|13.1|||
3994553|NCT01235598|3815163|B2|||Age||years|Mean|51.3|51.3|Standard Deviation|12.6|12.6|||
3994554|NCT01235598|3815164|B1|||Age||years|Mean|48.3|48.3|Standard Deviation|14.4|14.4|||
3994555|NCT01235598|3815162|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3994556|NCT01235598|3815163|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3994557|NCT01235598|3815164|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3994558|NCT01235598|3815162|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
3994559|NCT01235598|3815163|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3994560|NCT01235598|3815164|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3994561|NCT01235598|3815162|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3994562|NCT01235598|3815163|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3994563|NCT01235598|3815164|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3994564|NCT01235546|3815208|B3|||Smoking Prevalence||Participants|Count of Participants|219|219.0||||||
3994565|NCT01235546|3815209|B2|||Smoking Prevalence||Participants|Count of Participants|97|97.0||||||
3994566|NCT01235546|3815210|B1|||Smoking Prevalence||Participants|Count of Participants|122|122.0||||||
3994567|NCT01235546|3815208|B3|United States||Region of Enrollment||participants|Number|2013|2013.0||||||
3994568|NCT01235546|3815209|B2|United States||Region of Enrollment||participants|Number|1019|1019.0||||||
3994569|NCT01235546|3815210|B1|United States||Region of Enrollment||participants|Number|994|994.0||||||
3994570|NCT01235546|3815208|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3994571|NCT01235546|3815209|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3994572|NCT01235546|3815210|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3994573|NCT01235546|3815208|B3||Female|Sex: Female, Male||Participants|Count of Participants|2013|2013.0||||||
3994574|NCT01235546|3815209|B2||Female|Sex: Female, Male||Participants|Count of Participants|1019|1019.0||||||
3994575|NCT01235546|3815210|B1||Female|Sex: Female, Male||Participants|Count of Participants|994|994.0||||||
3994576|NCT01235546|3815208|B3|||Age||years|Median|28.3|28.3|Standard Deviation|6.3|6.3|||
3994577|NCT01235546|3815209|B2|||Age||years|Median|28.2|28.2|Standard Deviation|6.1|6.1|||
3994578|NCT01235546|3815210|B1|||Age||years|Median|28.4|28.4|Standard Deviation|6.5|6.5|||
3994579|NCT01235507|3815235|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3994580|NCT01235507|3815235|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3994581|NCT01235507|3815235|B1|||Age||years|Mean|49.76|49.76|Standard Deviation|12.37|12.37|||
3994582|NCT01235442|3815247|B3|||Duration of psoriasis||Years|Mean|17.53|17.53|Standard Deviation|11.59|11.59|||
3994583|NCT01235442|3815248|B2|||Duration of psoriasis||Years|Mean|17.39|17.39|Standard Deviation|11.89|11.89|||
3994584|NCT01235442|3815249|B1|||Duration of psoriasis||Years|Mean|17.68|17.68|Standard Deviation|11.31|11.31|||
3994585|NCT01235442|3815247|B3|No||Psoriatic arthritis||Participants|Number|440|440.0||||||
3994586|NCT01235442|3815248|B2|No||Psoriatic arthritis||Participants|Number|227|227.0||||||
3994587|NCT01235442|3815249|B1|No||Psoriatic arthritis||Participants|Number|213|213.0||||||
3994588|NCT01235442|3815247|B3|Yes||Psoriatic arthritis||Participants|Number|152|152.0||||||
3994589|NCT01235442|3815248|B2|Yes||Psoriatic arthritis||Participants|Number|68|68.0||||||
3994590|NCT01235442|3815249|B1|Yes||Psoriatic arthritis||Participants|Number|84|84.0||||||
3994591|NCT01235442|3815247|B3|Unknown||Patient assessment of treatment satisfaction|A measure of a participant's level of satisfaction with the medication’s control of psoriasis, ranging from “very satisfied” to “very dissatisfied.”|Participants|Number|40|40.0||||||
3994592|NCT01235442|3815248|B2|Unknown||Patient assessment of treatment satisfaction|A measure of a participant's level of satisfaction with the medication’s control of psoriasis, ranging from “very satisfied” to “very dissatisfied.”|Participants|Number|21|21.0||||||
3994593|NCT01235442|3815249|B1|Unknown||Patient assessment of treatment satisfaction|A measure of a participant's level of satisfaction with the medication’s control of psoriasis, ranging from “very satisfied” to “very dissatisfied.”|Participants|Number|19|19.0||||||
3994594|NCT01235442|3815247|B3|Very satisfied||Patient assessment of treatment satisfaction|A measure of a participant's level of satisfaction with the medication’s control of psoriasis, ranging from “very satisfied” to “very dissatisfied.”|Participants|Number|20|20.0||||||
3994595|NCT01235442|3815248|B2|Very satisfied||Patient assessment of treatment satisfaction|A measure of a participant's level of satisfaction with the medication’s control of psoriasis, ranging from “very satisfied” to “very dissatisfied.”|Participants|Number|11|11.0||||||
3994596|NCT01235442|3815249|B1|Very satisfied||Patient assessment of treatment satisfaction|A measure of a participant's level of satisfaction with the medication’s control of psoriasis, ranging from “very satisfied” to “very dissatisfied.”|Participants|Number|9|9.0||||||
3994597|NCT01235442|3815247|B3|Satisfied||Patient assessment of treatment satisfaction|A measure of a participant's level of satisfaction with the medication’s control of psoriasis, ranging from “very satisfied” to “very dissatisfied.”|Participants|Number|23|23.0||||||
3994598|NCT01235442|3815248|B2|Satisfied||Patient assessment of treatment satisfaction|A measure of a participant's level of satisfaction with the medication’s control of psoriasis, ranging from “very satisfied” to “very dissatisfied.”|Participants|Number|13|13.0||||||
3994599|NCT01235442|3815249|B1|Satisfied||Patient assessment of treatment satisfaction|A measure of a participant's level of satisfaction with the medication’s control of psoriasis, ranging from “very satisfied” to “very dissatisfied.”|Participants|Number|10|10.0||||||
3994600|NCT01235442|3815247|B3|Neither satisfied nor dissatisfied||Patient assessment of treatment satisfaction|A measure of a participant's level of satisfaction with the medication’s control of psoriasis, ranging from “very satisfied” to “very dissatisfied.”|Participants|Number|209|209.0||||||
3994601|NCT01235442|3815248|B2|Neither satisfied nor dissatisfied||Patient assessment of treatment satisfaction|A measure of a participant's level of satisfaction with the medication’s control of psoriasis, ranging from “very satisfied” to “very dissatisfied.”|Participants|Number|100|100.0||||||
3994703|NCT01235442|3815248|B2|||Age||Years|Mean|43.7|43.7|Standard Deviation|14.2|14.2|||
3994602|NCT01235442|3815249|B1|Neither satisfied nor dissatisfied||Patient assessment of treatment satisfaction|A measure of a participant's level of satisfaction with the medication’s control of psoriasis, ranging from “very satisfied” to “very dissatisfied.”|Participants|Number|109|109.0||||||
3994603|NCT01235442|3815247|B3|Dissatisfied||Patient assessment of treatment satisfaction|A measure of a participant's level of satisfaction with the medication’s control of psoriasis, ranging from “very satisfied” to “very dissatisfied.”|Participants|Number|87|87.0||||||
3994604|NCT01235442|3815248|B2|Dissatisfied||Patient assessment of treatment satisfaction|A measure of a participant's level of satisfaction with the medication’s control of psoriasis, ranging from “very satisfied” to “very dissatisfied.”|Participants|Number|47|47.0||||||
3994605|NCT01235442|3815249|B1|Dissatisfied||Patient assessment of treatment satisfaction|A measure of a participant's level of satisfaction with the medication’s control of psoriasis, ranging from “very satisfied” to “very dissatisfied.”|Participants|Number|40|40.0||||||
3994606|NCT01235442|3815247|B3|Very dissatisfied||Patient assessment of treatment satisfaction|A measure of a participant's level of satisfaction with the medication’s control of psoriasis, ranging from “very satisfied” to “very dissatisfied.”|Participants|Number|213|213.0||||||
3994607|NCT01235442|3815248|B2|Very dissatisfied||Patient assessment of treatment satisfaction|A measure of a participant's level of satisfaction with the medication’s control of psoriasis, ranging from “very satisfied” to “very dissatisfied.”|Participants|Number|103|103.0||||||
3994608|NCT01235442|3815249|B1|Very dissatisfied||Patient assessment of treatment satisfaction|A measure of a participant's level of satisfaction with the medication’s control of psoriasis, ranging from “very satisfied” to “very dissatisfied.”|Participants|Number|110|110.0||||||
3994609|NCT01235442|3815247|B3|||Dermatology life quality index (DLQI)|A skin disease-specific instrument to evaluate health related quality of life ranging from 0 (best possible score) to 30 (worst possible score).||Mean|14.3|14.3|Standard Deviation|7.1|7.1|||
3994610|NCT01235442|3815248|B2|||Dermatology life quality index (DLQI)|A skin disease-specific instrument to evaluate health related quality of life ranging from 0 (best possible score) to 30 (worst possible score).||Mean|14.1|14.1|Standard Deviation|7.4|7.4|||
3994611|NCT01235442|3815249|B1|||Dermatology life quality index (DLQI)|A skin disease-specific instrument to evaluate health related quality of life ranging from 0 (best possible score) to 30 (worst possible score).||Mean|14.6|14.6|Standard Deviation|6.9|6.9|||
3994612|NCT01235442|3815247|B3|Unkown||Patient global assessment of psoriasis|A 6-point scale rated by participants ranging from 0 (no symptoms) to 5 (severe symptoms) to indicate his or her symptom severity.|Participants|Number|9|9.0||||||
3994613|NCT01235442|3815248|B2|Unkown||Patient global assessment of psoriasis|A 6-point scale rated by participants ranging from 0 (no symptoms) to 5 (severe symptoms) to indicate his or her symptom severity.|Participants|Number|6|6.0||||||
3994614|NCT01235442|3815249|B1|Unkown||Patient global assessment of psoriasis|A 6-point scale rated by participants ranging from 0 (no symptoms) to 5 (severe symptoms) to indicate his or her symptom severity.|Participants|Number|3|3.0||||||
3994615|NCT01235442|3815247|B3|5||Patient global assessment of psoriasis|A 6-point scale rated by participants ranging from 0 (no symptoms) to 5 (severe symptoms) to indicate his or her symptom severity.|Participants|Number|251|251.0||||||
3994616|NCT01235442|3815248|B2|5||Patient global assessment of psoriasis|A 6-point scale rated by participants ranging from 0 (no symptoms) to 5 (severe symptoms) to indicate his or her symptom severity.|Participants|Number|127|127.0||||||
3994617|NCT01235442|3815249|B1|5||Patient global assessment of psoriasis|A 6-point scale rated by participants ranging from 0 (no symptoms) to 5 (severe symptoms) to indicate his or her symptom severity.|Participants|Number|124|124.0||||||
3994618|NCT01235442|3815247|B3|4||Patient global assessment of psoriasis|A 6-point scale rated by participants ranging from 0 (no symptoms) to 5 (severe symptoms) to indicate his or her symptom severity.|Participants|Number|212|212.0||||||
3994619|NCT01235442|3815248|B2|4||Patient global assessment of psoriasis|A 6-point scale rated by participants ranging from 0 (no symptoms) to 5 (severe symptoms) to indicate his or her symptom severity.|Participants|Number|95|95.0||||||
3994620|NCT01235442|3815249|B1|4||Patient global assessment of psoriasis|A 6-point scale rated by participants ranging from 0 (no symptoms) to 5 (severe symptoms) to indicate his or her symptom severity.|Participants|Number|117|117.0||||||
3994621|NCT01235442|3815247|B3|3||Patient global assessment of psoriasis|A 6-point scale rated by participants ranging from 0 (no symptoms) to 5 (severe symptoms) to indicate his or her symptom severity.|Participants|Number|107|107.0||||||
3994622|NCT01235442|3815248|B2|3||Patient global assessment of psoriasis|A 6-point scale rated by participants ranging from 0 (no symptoms) to 5 (severe symptoms) to indicate his or her symptom severity.|Participants|Number|58|58.0||||||
3994623|NCT01235442|3815249|B1|3||Patient global assessment of psoriasis|A 6-point scale rated by participants ranging from 0 (no symptoms) to 5 (severe symptoms) to indicate his or her symptom severity.|Participants|Number|49|49.0||||||
3994624|NCT01235442|3815247|B3|2||Patient global assessment of psoriasis|A 6-point scale rated by participants ranging from 0 (no symptoms) to 5 (severe symptoms) to indicate his or her symptom severity.|Participants|Number|10|10.0||||||
3994625|NCT01235442|3815248|B2|2||Patient global assessment of psoriasis|A 6-point scale rated by participants ranging from 0 (no symptoms) to 5 (severe symptoms) to indicate his or her symptom severity.|Participants|Number|6|6.0||||||
3994626|NCT01235442|3815249|B1|2||Patient global assessment of psoriasis|A 6-point scale rated by participants ranging from 0 (no symptoms) to 5 (severe symptoms) to indicate his or her symptom severity.|Participants|Number|4|4.0||||||
3994627|NCT01235442|3815247|B3|1||Patient global assessment of psoriasis|A 6-point scale rated by participants ranging from 0 (no symptoms) to 5 (severe symptoms) to indicate his or her symptom severity.|Participants|Number|3|3.0||||||
3994628|NCT01235442|3815248|B2|1||Patient global assessment of psoriasis|A 6-point scale rated by participants ranging from 0 (no symptoms) to 5 (severe symptoms) to indicate his or her symptom severity.|Participants|Number|3|3.0||||||
3994629|NCT01235442|3815249|B1|1||Patient global assessment of psoriasis|A 6-point scale rated by participants ranging from 0 (no symptoms) to 5 (severe symptoms) to indicate his or her symptom severity.|Participants|Number|0|0.0||||||
3994630|NCT01235442|3815247|B3|0||Patient global assessment of psoriasis|A 6-point scale rated by participants ranging from 0 (no symptoms) to 5 (severe symptoms) to indicate his or her symptom severity.|Participants|Number|0|0.0||||||
3994631|NCT01235442|3815248|B2|0||Patient global assessment of psoriasis|A 6-point scale rated by participants ranging from 0 (no symptoms) to 5 (severe symptoms) to indicate his or her symptom severity.|Participants|Number|0|0.0||||||
3994632|NCT01235442|3815249|B1|0||Patient global assessment of psoriasis|A 6-point scale rated by participants ranging from 0 (no symptoms) to 5 (severe symptoms) to indicate his or her symptom severity.|Participants|Number|0|0.0||||||
3994633|NCT01235442|3815247|B3|Unknown||Static physician global assessment of psoriasis (sPGA)|A physician’s global assessment of the participant's psoriasis based on severity of induration, scaling, and erythema. The sPGA of psoriasis comprises a 6-point scale ranging from 0 (clear) to 5 with increasing severity.|Participants|Number|2|2.0||||||
3994634|NCT01235442|3815248|B2|Unknown||Static physician global assessment of psoriasis (sPGA)|A physician’s global assessment of the participant's psoriasis based on severity of induration, scaling, and erythema. The sPGA of psoriasis comprises a 6-point scale ranging from 0 (clear) to 5 with increasing severity.|Participants|Number|2|2.0||||||
3994635|NCT01235442|3815249|B1|Unknown||Static physician global assessment of psoriasis (sPGA)|A physician’s global assessment of the participant's psoriasis based on severity of induration, scaling, and erythema. The sPGA of psoriasis comprises a 6-point scale ranging from 0 (clear) to 5 with increasing severity.|Participants|Number|0|0.0||||||
3994636|NCT01235442|3815247|B3|5||Static physician global assessment of psoriasis (sPGA)|A physician’s global assessment of the participant's psoriasis based on severity of induration, scaling, and erythema. The sPGA of psoriasis comprises a 6-point scale ranging from 0 (clear) to 5 with increasing severity.|Participants|Number|18|18.0||||||
3994637|NCT01235442|3815248|B2|5||Static physician global assessment of psoriasis (sPGA)|A physician’s global assessment of the participant's psoriasis based on severity of induration, scaling, and erythema. The sPGA of psoriasis comprises a 6-point scale ranging from 0 (clear) to 5 with increasing severity.|Participants|Number|8|8.0||||||
3994638|NCT01235442|3815249|B1|5||Static physician global assessment of psoriasis (sPGA)|A physician’s global assessment of the participant's psoriasis based on severity of induration, scaling, and erythema. The sPGA of psoriasis comprises a 6-point scale ranging from 0 (clear) to 5 with increasing severity.|Participants|Number|10|10.0||||||
3994639|NCT01235442|3815247|B3|4||Static physician global assessment of psoriasis (sPGA)|A physician’s global assessment of the participant's psoriasis based on severity of induration, scaling, and erythema. The sPGA of psoriasis comprises a 6-point scale ranging from 0 (clear) to 5 with increasing severity.|Participants|Number|148|148.0||||||
3994640|NCT01235442|3815248|B2|4||Static physician global assessment of psoriasis (sPGA)|A physician’s global assessment of the participant's psoriasis based on severity of induration, scaling, and erythema. The sPGA of psoriasis comprises a 6-point scale ranging from 0 (clear) to 5 with increasing severity.|Participants|Number|74|74.0||||||
3994641|NCT01235442|3815249|B1|4||Static physician global assessment of psoriasis (sPGA)|A physician’s global assessment of the participant's psoriasis based on severity of induration, scaling, and erythema. The sPGA of psoriasis comprises a 6-point scale ranging from 0 (clear) to 5 with increasing severity.|Participants|Number|74|74.0||||||
3994642|NCT01235442|3815247|B3|3||Static physician global assessment of psoriasis (sPGA)|A physician’s global assessment of the participant's psoriasis based on severity of induration, scaling, and erythema. The sPGA of psoriasis comprises a 6-point scale ranging from 0 (clear) to 5 with increasing severity.|Participants|Number|340|340.0||||||
3994643|NCT01235442|3815248|B2|3||Static physician global assessment of psoriasis (sPGA)|A physician’s global assessment of the participant's psoriasis based on severity of induration, scaling, and erythema. The sPGA of psoriasis comprises a 6-point scale ranging from 0 (clear) to 5 with increasing severity.|Participants|Number|164|164.0||||||
3994644|NCT01235442|3815249|B1|3||Static physician global assessment of psoriasis (sPGA)|A physician’s global assessment of the participant's psoriasis based on severity of induration, scaling, and erythema. The sPGA of psoriasis comprises a 6-point scale ranging from 0 (clear) to 5 with increasing severity.|Participants|Number|176|176.0||||||
3994645|NCT01235442|3815247|B3|2||Static physician global assessment of psoriasis (sPGA)|A physician’s global assessment of the participant's psoriasis based on severity of induration, scaling, and erythema. The sPGA of psoriasis comprises a 6-point scale ranging from 0 (clear) to 5 with increasing severity.|Participants|Number|82|82.0||||||
3994646|NCT01235442|3815248|B2|2||Static physician global assessment of psoriasis (sPGA)|A physician’s global assessment of the participant's psoriasis based on severity of induration, scaling, and erythema. The sPGA of psoriasis comprises a 6-point scale ranging from 0 (clear) to 5 with increasing severity.|Participants|Number|46|46.0||||||
3994647|NCT01235442|3815249|B1|2||Static physician global assessment of psoriasis (sPGA)|A physician’s global assessment of the participant's psoriasis based on severity of induration, scaling, and erythema. The sPGA of psoriasis comprises a 6-point scale ranging from 0 (clear) to 5 with increasing severity.|Participants|Number|36|36.0||||||
3994648|NCT01235442|3815247|B3|1||Static physician global assessment of psoriasis (sPGA)|A physician’s global assessment of the participant's psoriasis based on severity of induration, scaling, and erythema. The sPGA of psoriasis comprises a 6-point scale ranging from 0 (clear) to 5 with increasing severity.|Participants|Number|2|2.0||||||
3994649|NCT01235442|3815248|B2|1||Static physician global assessment of psoriasis (sPGA)|A physician’s global assessment of the participant's psoriasis based on severity of induration, scaling, and erythema. The sPGA of psoriasis comprises a 6-point scale ranging from 0 (clear) to 5 with increasing severity.|Participants|Number|1|1.0||||||
3994650|NCT01235442|3815249|B1|1||Static physician global assessment of psoriasis (sPGA)|A physician’s global assessment of the participant's psoriasis based on severity of induration, scaling, and erythema. The sPGA of psoriasis comprises a 6-point scale ranging from 0 (clear) to 5 with increasing severity.|Participants|Number|1|1.0||||||
3994651|NCT01235442|3815247|B3|0||Static physician global assessment of psoriasis (sPGA)|A physician’s global assessment of the participant's psoriasis based on severity of induration, scaling, and erythema. The sPGA of psoriasis comprises a 6-point scale ranging from 0 (clear) to 5 with increasing severity.|Participants|Number|0|0.0||||||
3994704|NCT01235442|3815249|B1|||Age||Years|Mean|44.6|44.6|Standard Deviation|13.7|13.7|||
3994652|NCT01235442|3815248|B2|0||Static physician global assessment of psoriasis (sPGA)|A physician’s global assessment of the participant's psoriasis based on severity of induration, scaling, and erythema. The sPGA of psoriasis comprises a 6-point scale ranging from 0 (clear) to 5 with increasing severity.|Participants|Number|0|0.0||||||
3994653|NCT01235442|3815249|B1|0||Static physician global assessment of psoriasis (sPGA)|A physician’s global assessment of the participant's psoriasis based on severity of induration, scaling, and erythema. The sPGA of psoriasis comprises a 6-point scale ranging from 0 (clear) to 5 with increasing severity.|Participants|Number|0|0.0||||||
3994654|NCT01235442|3815247|B3|||Psoriasis Body Surface Area(BSA)||%|Mean|25.01|25.01|Standard Deviation|17.44|17.44|||
3994655|NCT01235442|3815248|B2|||Psoriasis Body Surface Area(BSA)||%|Mean|25.93|25.93|Standard Deviation|17.65|17.65|||
3994656|NCT01235442|3815249|B1|||Psoriasis Body Surface Area(BSA)||%|Mean|24.09|24.09|Standard Deviation|17.22|17.22|||
3994657|NCT01235442|3815247|B3|||Psoriasis area severity index (PASI)|PASI is an assessment of psoriasis based on severity of erythema, infiltration, and desquamation as well as area of involvement. The PASI score ranges from 0 to 72. The higher score represents the worse symptom severity.|Scores on a scale|Mean|18.51|18.51|Standard Deviation|8.72|8.72|||
3994658|NCT01235442|3815248|B2|||Psoriasis area severity index (PASI)|PASI is an assessment of psoriasis based on severity of erythema, infiltration, and desquamation as well as area of involvement. The PASI score ranges from 0 to 72. The higher score represents the worse symptom severity.|Scores on a scale|Mean|18.85|18.85|Standard Deviation|9.16|9.16|||
3994659|NCT01235442|3815249|B1|||Psoriasis area severity index (PASI)|PASI is an assessment of psoriasis based on severity of erythema, infiltration, and desquamation as well as area of involvement. The PASI score ranges from 0 to 72. The higher score represents the worse symptom severity.|Scores on a scale|Mean|18.17|18.17|Standard Deviation|8.25|8.25|||
3994660|NCT01235442|3815247|B3|> 35 kg/m^2||BMI Categorical||Participants|Number|149|149.0||||||
3994661|NCT01235442|3815248|B2|> 35 kg/m^2||BMI Categorical||Participants|Number|74|74.0||||||
3994662|NCT01235442|3815249|B1|> 35 kg/m^2||BMI Categorical||Participants|Number|75|75.0||||||
3994663|NCT01235442|3815247|B3|≤ 35 kg/m^2||BMI Categorical||Participants|Number|443|443.0||||||
3994664|NCT01235442|3815248|B2|≤ 35 kg/m^2||BMI Categorical||Participants|Number|221|221.0||||||
3994665|NCT01235442|3815249|B1|≤ 35 kg/m^2||BMI Categorical||Participants|Number|222|222.0||||||
3994666|NCT01235442|3815247|B3|Unknown||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3994667|NCT01235442|3815248|B2|Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3994668|NCT01235442|3815249|B1|Unknown||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3994669|NCT01235442|3815247|B3|Other||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
3994670|NCT01235442|3815248|B2|Other||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3994671|NCT01235442|3815249|B1|Other||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3994672|NCT01235442|3815247|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3994673|NCT01235442|3815248|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3994674|NCT01235442|3815249|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3994675|NCT01235442|3815247|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3994676|NCT01235442|3815248|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3994677|NCT01235442|3815249|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3994678|NCT01235442|3815247|B3|Native Hawaiian or Other Pacific||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3994679|NCT01235442|3815248|B2|Native Hawaiian or Other Pacific||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3994680|NCT01235442|3815249|B1|Native Hawaiian or Other Pacific||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3994681|NCT01235442|3815247|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|31|31.0||||||
3994682|NCT01235442|3815248|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
3994683|NCT01235442|3815249|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
3994684|NCT01235442|3815247|B3|Asian||Race/Ethnicity, Customized||Participants|Number|36|36.0||||||
3994685|NCT01235442|3815248|B2|Asian||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
3994686|NCT01235442|3815249|B1|Asian||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
3994687|NCT01235442|3815247|B3|White||Race/Ethnicity, Customized||Participants|Number|491|491.0||||||
3994688|NCT01235442|3815248|B2|White||Race/Ethnicity, Customized||Participants|Number|237|237.0||||||
3994689|NCT01235442|3815249|B1|White||Race/Ethnicity, Customized||Participants|Number|254|254.0||||||
3994690|NCT01235442|3815247|B3||Male|Sex: Female, Male||Participants|Count of Participants|391|391.0||||||
3994691|NCT01235442|3815248|B2||Male|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
3994692|NCT01235442|3815249|B1||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
3994693|NCT01235442|3815247|B3||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3994694|NCT01235442|3815248|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3994695|NCT01235442|3815249|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3994696|NCT01235442|3815247|B3|>=65 years||Age, Customized||Participants|Number|46|46.0||||||
3994697|NCT01235442|3815248|B2|>=65 years||Age, Customized||Participants|Number|22|22.0||||||
3994698|NCT01235442|3815249|B1|>=65 years||Age, Customized||Participants|Number|24|24.0||||||
3994699|NCT01235442|3815247|B3|< 65 years||Age, Customized||Participants|Number|546|546.0||||||
3994700|NCT01235442|3815248|B2|< 65 years||Age, Customized||Participants|Number|273|273.0||||||
3994701|NCT01235442|3815249|B1|< 65 years||Age, Customized||Participants|Number|273|273.0||||||
3994702|NCT01235442|3815247|B3|||Age||Years|Mean|44.1|44.1|Standard Deviation|13.9|13.9|||
3994705|NCT01235403|3815268|B1|France||Region of Enrollment||participants|Number|100|100.0||||||
3994706|NCT01235403|3815268|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3994707|NCT01235403|3815268|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3994708|NCT01235403|3815268|B1|||Age||years|Mean|44.5|44.5|Standard Deviation|16.22|16.22|||
3994709|NCT01235403|3815268|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3994710|NCT01235403|3815268|B1||Between 18 and 65 years|Age||Participants|Count of Participants|88|88.0||||||
3994711|NCT01235403|3815268|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3994712|NCT01235377|3815274|B3||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
3994713|NCT01235377|3815275|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3994714|NCT01235377|3815276|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3994715|NCT01235377|3815274|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3994716|NCT01235377|3815275|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3994717|NCT01235377|3815276|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3994718|NCT01235377|3815274|B3|||Age||years|Mean|60.7|60.7|Standard Deviation|11.8|11.8|||
3994719|NCT01235377|3815275|B2|||Age||years|Mean|60.4|60.4|Standard Deviation|13.1|13.1|||
3994720|NCT01235377|3815276|B1|||Age||years|Mean|60.9|60.9|Standard Deviation|10.8|10.8|||
3994721|NCT01235338|3815283|B3|United States||Region of Enrollment||participants|Number|77|77.0||||||
3994722|NCT01235338|3815284|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
3994723|NCT01235338|3815285|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3994724|NCT01235338|3815283|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3994725|NCT01235338|3815284|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3994726|NCT01235338|3815285|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3994727|NCT01235338|3815283|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3994728|NCT01235338|3815284|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3994729|NCT01235338|3815285|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3994730|NCT01235338|3815283|B3|Between 18 and 45 years||Age, Customized||participants|Number|77|77.0||||||
3994731|NCT01235338|3815284|B2|Between 18 and 45 years||Age, Customized||participants|Number|37|37.0||||||
3994732|NCT01235338|3815285|B1|Between 18 and 45 years||Age, Customized||participants|Number|40|40.0||||||
3994733|NCT01235338|3815283|B3|||Age|The Safety Analysis Set (n = 77) was used to calculate Baseline Measures. The Safety Analysis Set is defined as all enrolled subjects who took at least 1 dose of investigational product and had at least 1 post-dose safety assessment. 80 subjects were enrolled but 3 never received investigational product.|years|Mean|33.5|33.5|Standard Deviation|7.10|7.1|||
3994734|NCT01235338|3815284|B2|||Age|The Safety Analysis Set (n = 77) was used to calculate Baseline Measures. The Safety Analysis Set is defined as all enrolled subjects who took at least 1 dose of investigational product and had at least 1 post-dose safety assessment. 80 subjects were enrolled but 3 never received investigational product.|years|Mean|33.8|33.8|Standard Deviation|7.29|7.29|||
3994735|NCT01235338|3815285|B1|||Age|The Safety Analysis Set (n = 77) was used to calculate Baseline Measures. The Safety Analysis Set is defined as all enrolled subjects who took at least 1 dose of investigational product and had at least 1 post-dose safety assessment. 80 subjects were enrolled but 3 never received investigational product.|years|Mean|33.2|33.2|Standard Deviation|7.01|7.01|||
3994736|NCT01235234|3815328|B4|Israel||Region of Enrollment||participants|Number|236|236.0||||||
3994737|NCT01235234|3815329|B3|Israel||Region of Enrollment||participants|Number|81|81.0||||||
3994738|NCT01235234|3815330|B2|Israel||Region of Enrollment||participants|Number|78|78.0||||||
3994739|NCT01235234|3815331|B1|Israel||Region of Enrollment||participants|Number|77|77.0||||||
3994740|NCT01235234|3815328|B4||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3994741|NCT01235234|3815329|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3994742|NCT01235234|3815330|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3994743|NCT01235234|3815331|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3994744|NCT01235234|3815328|B4||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3994745|NCT01235234|3815329|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3994746|NCT01235234|3815330|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3994747|NCT01235234|3815331|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3994748|NCT01235234|3815328|B4|||Age||years|Mean|55.5|55.5|Full Range|||19.0|90.0|
3994749|NCT01235234|3815329|B3|||Age||years|Mean|55.1|55.1|Full Range|||20.0|86.0|
3994750|NCT01235234|3815330|B2|||Age||years|Mean|54.5|54.5|Full Range|||19.0|90.0|
3994751|NCT01235234|3815331|B1|||Age||years|Mean|56.8|56.8|Full Range|||22.0|82.0|
3994752|NCT01235234|3815328|B4||>=65 years|Age||Participants|Count of Participants|64|64.0||||||
3994753|NCT01235234|3815329|B3||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3994754|NCT01235234|3815330|B2||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
3994755|NCT01235234|3815331|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3994756|NCT01235234|3815328|B4||Between 18 and 65 years|Age||Participants|Count of Participants|172|172.0||||||
3994757|NCT01235234|3815329|B3||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
3994758|NCT01235234|3815330|B2||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
3994759|NCT01235234|3815331|B1||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
3994760|NCT01235234|3815328|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3994761|NCT01235234|3815329|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3994762|NCT01235234|3815330|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3994763|NCT01235234|3815331|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3994764|NCT01235195|3815341|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3994765|NCT01235195|3815341|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3994766|NCT01235195|3815341|B1|||Age||years|Mean|30.4|30.4|Standard Deviation|8.6|8.6|||
3994767|NCT01234922|3815358|B5|United States||Region of Enrollment||participants|Number|6|6.0||||||
3994768|NCT01234922|3815359|B4|United States||Region of Enrollment||participants|Number|2|2.0||||||
3994769|NCT01234922|3815360|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
3994770|NCT01234922|3815361|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3994771|NCT01234922|3815362|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3994772|NCT01234922|3815358|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994773|NCT01234922|3815359|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994774|NCT01234922|3815360|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994775|NCT01234922|3815361|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994776|NCT01234922|3815362|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994777|NCT01234922|3815358|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994778|NCT01234922|3815359|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994779|NCT01234922|3815360|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994780|NCT01234922|3815361|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994781|NCT01234922|3815362|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994782|NCT01234922|3815358|B5||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3994783|NCT01234922|3815359|B4||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3994784|NCT01234922|3815360|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3994785|NCT01234922|3815361|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3994786|NCT01234922|3815362|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3994787|NCT01234922|3815358|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994788|NCT01234922|3815359|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994789|NCT01234922|3815360|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994790|NCT01234922|3815361|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994791|NCT01234922|3815362|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994792|NCT01234922|3815358|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994793|NCT01234922|3815359|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994794|NCT01234922|3815360|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994795|NCT01234922|3815361|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994796|NCT01234922|3815362|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994797|NCT01234922|3815358|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994798|NCT01234922|3815359|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994799|NCT01234922|3815360|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994800|NCT01234922|3815361|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994801|NCT01234922|3815362|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994802|NCT01234922|3815358|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994803|NCT01234922|3815359|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994804|NCT01234922|3815360|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994805|NCT01234922|3815361|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994806|NCT01234922|3815362|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994807|NCT01234922|3815358|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994808|NCT01234922|3815359|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994809|NCT01234922|3815360|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994810|NCT01234922|3815361|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994811|NCT01234922|3815362|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994812|NCT01234922|3815358|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3994813|NCT01234922|3815359|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3994814|NCT01234922|3815360|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3994815|NCT01234922|3815361|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3994816|NCT01234922|3815362|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3994817|NCT01234922|3815358|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994818|NCT01234922|3815359|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994819|NCT01234922|3815360|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994820|NCT01234922|3815361|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994821|NCT01234922|3815362|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994822|NCT01234922|3815358|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3994823|NCT01234922|3815359|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3994824|NCT01234922|3815360|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3994825|NCT01234922|3815361|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3994826|NCT01234922|3815362|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3994827|NCT01234922|3815358|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3994828|NCT01234922|3815359|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3994829|NCT01234922|3815360|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3994830|NCT01234922|3815361|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3994831|NCT01234922|3815362|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3994832|NCT01234922|3815358|B5|||Age||years|Mean|61.7|61.7|Standard Deviation|8.19|8.19|||
3994833|NCT01234922|3815359|B4|||Age||years|Mean|65.5|65.5|Standard Deviation|6.15|6.15|||
3994834|NCT01234922|3815360|B3|||Age||years|Mean|62.2|62.2|Standard Deviation|1.45|1.45|||
3994835|NCT01234922|3815361|B2|||Age||years|Mean|68.8|68.8|Standard Deviation|0|0.0|||
3994836|NCT01234922|3815362|B1|||Age||years|Mean|46.1|46.1|Standard Deviation|0|0.0|||
3994837|NCT01234922|3815358|B5||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3994838|NCT01234922|3815359|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3994839|NCT01234922|3815360|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3994840|NCT01234922|3815361|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3994841|NCT01234922|3815362|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3994842|NCT01234922|3815358|B5||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3994843|NCT01234922|3815359|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3994844|NCT01234922|3815360|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
3994845|NCT01234922|3815361|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3994846|NCT01234922|3815362|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3994847|NCT01234922|3815358|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3994848|NCT01234922|3815359|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3994849|NCT01234922|3815360|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3994850|NCT01234922|3815361|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3994851|NCT01234922|3815362|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3994852|NCT01234883|3815379|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3994853|NCT01234883|3815380|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3994854|NCT01234883|3815381|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3994855|NCT01234883|3815379|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3994856|NCT01234883|3815380|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3994857|NCT01234883|3815381|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3994858|NCT01234883|3815379|B3|||Age||months|Mean|46.85|46.85|Standard Deviation|33.09|33.09|0.5|11.0|
3994859|NCT01234883|3815380|B2|||Age||months|Mean|38.14|38.14|Standard Deviation|31.35|31.35|0.5|0.0|
3994860|NCT01234883|3815381|B1|||Age||months|Mean|55.22|55.22|Standard Deviation|32.84|32.84|0.5|11.0|
3994861|NCT01234870|3815388|B1|||Body Mass Index (BMI)||kg/m^2|Mean|29.57|29.57|Standard Deviation|5.83|5.83|||
3994862|NCT01234870|3815388|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
3994863|NCT01234870|3815388|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3994864|NCT01234870|3815388|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3994865|NCT01234870|3815388|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3994866|NCT01234870|3815388|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3994867|NCT01234870|3815388|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994868|NCT01234870|3815388|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3994869|NCT01234870|3815388|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3994870|NCT01234870|3815388|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994871|NCT01234870|3815388|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994872|NCT01234870|3815388|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994873|NCT01234870|3815388|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3994874|NCT01234870|3815388|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3994875|NCT01234870|3815388|B1|||Age||years|Mean|60.9|60.9|Standard Deviation|8.21|8.21|||
3994876|NCT01234831|3815393|B3|United States||Region of Enrollment||participants|Number|463|463.0||||||
3994877|NCT01234831|3815394|B2|United States||Region of Enrollment||participants|Number|202|202.0||||||
3994878|NCT01234831|3815395|B1|United States||Region of Enrollment||participants|Number|261|261.0||||||
3994879|NCT01234831|3815393|B3||Male|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
3994880|NCT01234831|3815394|B2||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3994881|NCT01234831|3815395|B1||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
3994882|NCT01234831|3815393|B3||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
3994883|NCT01234831|3815394|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3994884|NCT01234831|3815395|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3994885|NCT01234831|3815393|B3|||Age||years|Mean|63.47|63.47|Standard Deviation|17.51|17.51|||
3994886|NCT01234831|3815394|B2|||Age||years|Mean|62.9|62.9|Standard Deviation|18.45|18.45|||
3994887|NCT01234831|3815395|B1|||Age||years|Mean|63.9|63.9|Standard Deviation|16.77|16.77|||
3994888|NCT01234831|3815393|B3||>=65 years|Age||Participants|Count of Participants|241|241.0||||||
3994889|NCT01234831|3815394|B2||>=65 years|Age||Participants|Count of Participants|106|106.0||||||
3994890|NCT01234831|3815395|B1||>=65 years|Age||Participants|Count of Participants|135|135.0||||||
3994891|NCT01234831|3815393|B3||Between 18 and 65 years|Age||Participants|Count of Participants|222|222.0||||||
3994892|NCT01234831|3815394|B2||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
3994893|NCT01234831|3815395|B1||Between 18 and 65 years|Age||Participants|Count of Participants|126|126.0||||||
3994894|NCT01234831|3815393|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3994895|NCT01234831|3815394|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3994896|NCT01234831|3815395|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3994897|NCT01234766|3815408|B1|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
3994898|NCT01234766|3815408|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3994899|NCT01234766|3815408|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3994900|NCT01234766|3815408|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3994901|NCT01234766|3815408|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
3994902|NCT01234766|3815408|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3994903|NCT01234714|3815412|B1|Switzerland||Region of Enrollment||participants|Number|84|84.0||||||
3994904|NCT01234714|3815412|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3994905|NCT01234714|3815412|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3994906|NCT01234714|3815412|B1|||Age||years|Mean|54|54.0|Standard Deviation|15|15.0|||
3994907|NCT01234714|3815412|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
3994908|NCT01234714|3815412|B1||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
3994909|NCT01234714|3815412|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3994910|NCT01234675|3815429|B1|REM Sleep||Percent of Total Sleep Time||percentage of total sleep time|Mean|18.0|18.0|Standard Deviation|7.3|7.3|||
3994911|NCT01234675|3815429|B1|Stage N3||Percent of Total Sleep Time||percentage of total sleep time|Mean|4.2|4.2|Standard Deviation|8.4|8.4|||
3994912|NCT01234675|3815429|B1|Stage N2||Percent of Total Sleep Time||percentage of total sleep time|Mean|59.0|59.0|Standard Deviation|13|13.0|||
3994913|NCT01234675|3815429|B1|Stage N1||Percent of Total Sleep Time||percentage of total sleep time|Mean|18.9|18.9|Standard Deviation|6.6|6.6|||
3994914|NCT01234675|3815429|B1|||REM latency|Time to rapid eye movement|minutes|Mean|126.5|126.5|Standard Deviation|91.3|91.3|||
3994915|NCT01234675|3815429|B1|||Total Stage Shifts|Sleep stage shifts: stage 1, stage 2, stage 3, REM sleep|Stage shifts|Mean|147.4|147.4|Standard Deviation|42.2|42.2|||
3994916|NCT01234675|3815429|B1|||Arousal Index|Number of arousals per hour|arousals per hour|Mean|24.8|24.8|Standard Deviation|9.8|9.8|||
3994917|NCT01234675|3815429|B1|||Sleep Efficiency||percentage of total sleep time|Mean|72.3|72.3|Standard Deviation|15.8|15.8|||
3994918|NCT01234675|3815429|B1|||Number of awakenings after sleep onset||awakenings|Mean|31.9|31.9|Standard Deviation|12.9|12.9|||
3994919|NCT01234675|3815429|B1|Wake after sleep onset||Baseline Polysomnography recorded sleep parameters||minutes|Mean|97.2|97.2|Standard Deviation|70.6|70.6|||
3994920|NCT01234675|3815429|B1|Total Sleep Time||Baseline Polysomnography recorded sleep parameters||minutes|Mean|340.7|340.7|Standard Deviation|78.9|78.9|||
3994921|NCT01234675|3815429|B1|Latency to persistent sleep||Baseline Polysomnography recorded sleep parameters||minutes|Mean|49.4|49.4|Standard Deviation|43.4|43.4|||
3994922|NCT01234675|3815429|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3994923|NCT01234675|3815429|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3994924|NCT01234675|3815429|B1|||Age||years|Mean|49.2|49.2|Full Range|||28.0|72.0|
3994925|NCT01234467|3815444|B1||Not Classified|Pathology Subtype|Diffuse Large B-Cell Lymphoma (DLBCL) staging involves molecular classification into subtypes. Germinal Center has shown typically better survival than Non-Germinal Center|Participants|Count of Participants|4|4.0||||||
3994926|NCT01234467|3815444|B1||Germinal Center|Pathology Subtype|Diffuse Large B-Cell Lymphoma (DLBCL) staging involves molecular classification into subtypes. Germinal Center has shown typically better survival than Non-Germinal Center|Participants|Count of Participants|7|7.0||||||
3994927|NCT01234467|3815444|B1||Non-Germinal Center|Pathology Subtype|Diffuse Large B-Cell Lymphoma (DLBCL) staging involves molecular classification into subtypes. Germinal Center has shown typically better survival than Non-Germinal Center|Participants|Count of Participants|12|12.0||||||
3994928|NCT01234467|3815444|B1||Elevated|Lactate Dehydrogenase (LDH)|Lactate dehydrogenase (LDH) is an enzyme that helps the process of turning sugar into energy for your cells to use. It is often elevated in patients with lymphoma, but normal levels are associated with better response to therapy and longer survival.|Participants|Count of Participants|15|15.0||||||
3994988|NCT01234337|3815453|B3|Other||Region of Enrollment|Other countries in the below category included Argentina, Australia, China, Israel and Japan.|Participants|Number|154|154.0||||||
3994929|NCT01234467|3815444|B1||Normal|Lactate Dehydrogenase (LDH)|Lactate dehydrogenase (LDH) is an enzyme that helps the process of turning sugar into energy for your cells to use. It is often elevated in patients with lymphoma, but normal levels are associated with better response to therapy and longer survival.|Participants|Count of Participants|8|8.0||||||
3994930|NCT01234467|3815444|B1||5|International Prognostic Index (IPI)|International Prognosis Index is a clinical tool developed by oncologists to aid in predicting the prognosis of patients with aggressive non-Hodgkin's lymphoma. 0 points represent low-risk and higher numbers represent higher risk.|Participants|Count of Participants|5|5.0||||||
3994931|NCT01234467|3815444|B1||4|International Prognostic Index (IPI)|International Prognosis Index is a clinical tool developed by oncologists to aid in predicting the prognosis of patients with aggressive non-Hodgkin's lymphoma. 0 points represent low-risk and higher numbers represent higher risk.|Participants|Count of Participants|8|8.0||||||
3994932|NCT01234467|3815444|B1||3|International Prognostic Index (IPI)|International Prognosis Index is a clinical tool developed by oncologists to aid in predicting the prognosis of patients with aggressive non-Hodgkin's lymphoma. 0 points represent low-risk and higher numbers represent higher risk.|Participants|Count of Participants|5|5.0||||||
3994933|NCT01234467|3815444|B1||2|International Prognostic Index (IPI)|International Prognosis Index is a clinical tool developed by oncologists to aid in predicting the prognosis of patients with aggressive non-Hodgkin's lymphoma. 0 points represent low-risk and higher numbers represent higher risk.|Participants|Count of Participants|5|5.0||||||
3994934|NCT01234467|3815444|B1||3|ECOG Performance Status|The ECOG Performance Status was developed by the Eastern Cooperative Oncology Group. It describes a patient’s level of functioning in terms of their ability to care for themselves, daily activity, and physical ability (walking, working, etc.). 0 being fully active, able to carry on all pre-disease performance without restriction and 5 being dead.|Participants|Count of Participants|6|6.0||||||
3994935|NCT01234467|3815444|B1||2|ECOG Performance Status|The ECOG Performance Status was developed by the Eastern Cooperative Oncology Group. It describes a patient’s level of functioning in terms of their ability to care for themselves, daily activity, and physical ability (walking, working, etc.). 0 being fully active, able to carry on all pre-disease performance without restriction and 5 being dead.|Participants|Count of Participants|6|6.0||||||
3994936|NCT01234467|3815444|B1||1|ECOG Performance Status|The ECOG Performance Status was developed by the Eastern Cooperative Oncology Group. It describes a patient’s level of functioning in terms of their ability to care for themselves, daily activity, and physical ability (walking, working, etc.). 0 being fully active, able to carry on all pre-disease performance without restriction and 5 being dead.|Participants|Count of Participants|9|9.0||||||
3994937|NCT01234467|3815444|B1||0|ECOG Performance Status|The ECOG Performance Status was developed by the Eastern Cooperative Oncology Group. It describes a patient’s level of functioning in terms of their ability to care for themselves, daily activity, and physical ability (walking, working, etc.). 0 being fully active, able to carry on all pre-disease performance without restriction and 5 being dead.|Participants|Count of Participants|2|2.0||||||
3994938|NCT01234467|3815444|B1||IV|Stage|stage I: 1 group of lymph nodes affected stage II: 2 or more groups of lymph nodes affected either above or below the diaphragm (muscle that separates the chest from the abdomen) stage III: lymph nodes affected on both sides of the diaphragm stage IV: lymphoma is found in organs outside the lymphatic system or in the bone marrow.|Participants|Count of Participants|12|12.0||||||
3994939|NCT01234467|3815444|B1||III|Stage|stage I: 1 group of lymph nodes affected stage II: 2 or more groups of lymph nodes affected either above or below the diaphragm (muscle that separates the chest from the abdomen) stage III: lymph nodes affected on both sides of the diaphragm stage IV: lymphoma is found in organs outside the lymphatic system or in the bone marrow.|Participants|Count of Participants|7|7.0||||||
3994940|NCT01234467|3815444|B1||II|Stage|stage I: 1 group of lymph nodes affected stage II: 2 or more groups of lymph nodes affected either above or below the diaphragm (muscle that separates the chest from the abdomen) stage III: lymph nodes affected on both sides of the diaphragm stage IV: lymphoma is found in organs outside the lymphatic system or in the bone marrow.|Participants|Count of Participants|4|4.0||||||
3994941|NCT01234467|3815444|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
3994942|NCT01234467|3815444|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994943|NCT01234467|3815444|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994944|NCT01234467|3815444|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3994945|NCT01234467|3815444|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3994946|NCT01234467|3815444|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994947|NCT01234467|3815444|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994948|NCT01234467|3815444|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3994949|NCT01234467|3815444|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3994950|NCT01234467|3815444|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3994951|NCT01234467|3815444|B1|||Age||years|Median|80|80.0|Full Range|||65.0|89.0|
3994952|NCT01234337|3815453|B3||Yes|Visceral Disease at Baseline||Participants|Count of Participants|412|412.0||||||
3994953|NCT01234337|3815454|B2||Yes|Visceral Disease at Baseline||Participants|Count of Participants|213|213.0||||||
3994954|NCT01234337|3815455|B1||Yes|Visceral Disease at Baseline||Participants|Count of Participants|199|199.0||||||
3994955|NCT01234337|3815453|B3||No|Visceral Disease at Baseline||Participants|Count of Participants|123|123.0||||||
3994956|NCT01234337|3815454|B2||No|Visceral Disease at Baseline||Participants|Count of Participants|57|57.0||||||
3994957|NCT01234337|3815455|B1||No|Visceral Disease at Baseline||Participants|Count of Participants|66|66.0||||||
3994958|NCT01234337|3815453|B3||Missing|Visceral Disease at Baseline||Participants|Count of Participants|2|2.0||||||
3994959|NCT01234337|3815454|B2||Missing|Visceral Disease at Baseline||Participants|Count of Participants|1|1.0||||||
3994960|NCT01234337|3815455|B1||Missing|Visceral Disease at Baseline||Participants|Count of Participants|1|1.0||||||
3994961|NCT01234337|3815453|B3||Positive|Hormone Receptor Status|The hormone receptor status was assessed by IVRS, and considered as follows: in case, the tumor expressed estrogen and/or progesterone receptor, the participant was considered to have positive hormone receptor status. Otherwise, if both receptors were not expressed, then participant was considered to have a negative hormone receptor status.|Participants|Count of Participants|370|370.0||||||
3994962|NCT01234337|3815454|B2||Positive|Hormone Receptor Status|The hormone receptor status was assessed by IVRS, and considered as follows: in case, the tumor expressed estrogen and/or progesterone receptor, the participant was considered to have positive hormone receptor status. Otherwise, if both receptors were not expressed, then participant was considered to have a negative hormone receptor status.|Participants|Count of Participants|187|187.0||||||
3994963|NCT01234337|3815455|B1||Positive|Hormone Receptor Status|The hormone receptor status was assessed by IVRS, and considered as follows: in case, the tumor expressed estrogen and/or progesterone receptor, the participant was considered to have positive hormone receptor status. Otherwise, if both receptors were not expressed, then participant was considered to have a negative hormone receptor status.|Participants|Count of Participants|183|183.0||||||
3994964|NCT01234337|3815453|B3||Negative|Hormone Receptor Status|The hormone receptor status was assessed by IVRS, and considered as follows: in case, the tumor expressed estrogen and/or progesterone receptor, the participant was considered to have positive hormone receptor status. Otherwise, if both receptors were not expressed, then participant was considered to have a negative hormone receptor status.|Participants|Count of Participants|167|167.0||||||
3994965|NCT01234337|3815454|B2||Negative|Hormone Receptor Status|The hormone receptor status was assessed by IVRS, and considered as follows: in case, the tumor expressed estrogen and/or progesterone receptor, the participant was considered to have positive hormone receptor status. Otherwise, if both receptors were not expressed, then participant was considered to have a negative hormone receptor status.|Participants|Count of Participants|84|84.0||||||
3994966|NCT01234337|3815455|B1||Negative|Hormone Receptor Status|The hormone receptor status was assessed by IVRS, and considered as follows: in case, the tumor expressed estrogen and/or progesterone receptor, the participant was considered to have positive hormone receptor status. Otherwise, if both receptors were not expressed, then participant was considered to have a negative hormone receptor status.|Participants|Count of Participants|83|83.0||||||
3994967|NCT01234337|3815453|B3||Prior chemotherapies=1|Number of Prior Chemotherapies for Metastatic Disease|Assessed by Interactive voice response system (IVRS). Participants with more than 1 actual number of prior chemotherapies were combined with participants with 1 prior chemotherapy.|Participants|Count of Participants|305|305.0||||||
3994968|NCT01234337|3815454|B2||Prior chemotherapies=1|Number of Prior Chemotherapies for Metastatic Disease|Assessed by Interactive voice response system (IVRS). Participants with more than 1 actual number of prior chemotherapies were combined with participants with 1 prior chemotherapy.|Participants|Count of Participants|153|153.0||||||
3994969|NCT01234337|3815455|B1||Prior chemotherapies=1|Number of Prior Chemotherapies for Metastatic Disease|Assessed by Interactive voice response system (IVRS). Participants with more than 1 actual number of prior chemotherapies were combined with participants with 1 prior chemotherapy.|Participants|Count of Participants|152|152.0||||||
3994970|NCT01234337|3815453|B3||Prior chemotherapies=0|Number of Prior Chemotherapies for Metastatic Disease|Assessed by Interactive voice response system (IVRS). Participants with more than 1 actual number of prior chemotherapies were combined with participants with 1 prior chemotherapy.|Participants|Count of Participants|232|232.0||||||
3994971|NCT01234337|3815454|B2||Prior chemotherapies=0|Number of Prior Chemotherapies for Metastatic Disease|Assessed by Interactive voice response system (IVRS). Participants with more than 1 actual number of prior chemotherapies were combined with participants with 1 prior chemotherapy.|Participants|Count of Participants|118|118.0||||||
3994972|NCT01234337|3815455|B1||Prior chemotherapies=0|Number of Prior Chemotherapies for Metastatic Disease|Assessed by Interactive voice response system (IVRS). Participants with more than 1 actual number of prior chemotherapies were combined with participants with 1 prior chemotherapy.|Participants|Count of Participants|114|114.0||||||
3994973|NCT01234337|3815453|B3||ECOG status=4|Eastern Cooperative Oncology Group (ECOG)|ECOG status 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory, able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2=Ambulatory, capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.|Participants|Count of Participants|0|0.0||||||
3994974|NCT01234337|3815454|B2||ECOG status=4|Eastern Cooperative Oncology Group (ECOG)|ECOG status 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory, able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2=Ambulatory, capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.|Participants|Count of Participants|0|0.0||||||
3994975|NCT01234337|3815455|B1||ECOG status=4|Eastern Cooperative Oncology Group (ECOG)|ECOG status 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory, able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2=Ambulatory, capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.|Participants|Count of Participants|0|0.0||||||
3994976|NCT01234337|3815453|B3||ECOG status=3|Eastern Cooperative Oncology Group (ECOG)|ECOG status 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory, able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2=Ambulatory, capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.|Participants|Count of Participants|0|0.0||||||
3994977|NCT01234337|3815454|B2||ECOG status=3|Eastern Cooperative Oncology Group (ECOG)|ECOG status 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory, able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2=Ambulatory, capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.|Participants|Count of Participants|0|0.0||||||
3994978|NCT01234337|3815455|B1||ECOG status=3|Eastern Cooperative Oncology Group (ECOG)|ECOG status 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory, able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2=Ambulatory, capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.|Participants|Count of Participants|0|0.0||||||
3994979|NCT01234337|3815453|B3||ECOG status=2|Eastern Cooperative Oncology Group (ECOG)|ECOG status 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory, able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2=Ambulatory, capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.|Participants|Count of Participants|0|0.0||||||
3994980|NCT01234337|3815454|B2||ECOG status=2|Eastern Cooperative Oncology Group (ECOG)|ECOG status 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory, able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2=Ambulatory, capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.|Participants|Count of Participants|0|0.0||||||
3994981|NCT01234337|3815455|B1||ECOG status=2|Eastern Cooperative Oncology Group (ECOG)|ECOG status 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory, able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2=Ambulatory, capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.|Participants|Count of Participants|0|0.0||||||
3994982|NCT01234337|3815453|B3||ECOG status=1|Eastern Cooperative Oncology Group (ECOG)|ECOG status 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory, able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2=Ambulatory, capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.|Participants|Count of Participants|224|224.0||||||
3994983|NCT01234337|3815454|B2||ECOG status=1|Eastern Cooperative Oncology Group (ECOG)|ECOG status 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory, able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2=Ambulatory, capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.|Participants|Count of Participants|110|110.0||||||
3994984|NCT01234337|3815455|B1||ECOG status=1|Eastern Cooperative Oncology Group (ECOG)|ECOG status 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory, able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2=Ambulatory, capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.|Participants|Count of Participants|114|114.0||||||
3994985|NCT01234337|3815453|B3||ECOG status=0|Eastern Cooperative Oncology Group (ECOG)|ECOG status 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory, able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2=Ambulatory, capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.|Participants|Count of Participants|313|313.0||||||
3994986|NCT01234337|3815454|B2||ECOG status=0|Eastern Cooperative Oncology Group (ECOG)|ECOG status 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory, able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2=Ambulatory, capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.|Participants|Count of Participants|161|161.0||||||
3994987|NCT01234337|3815455|B1||ECOG status=0|Eastern Cooperative Oncology Group (ECOG)|ECOG status 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory, able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2=Ambulatory, capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.|Participants|Count of Participants|152|152.0||||||
3995043|NCT01234103|3815507|B1||1|Sexually transmitted infection diagnosed-ever||Participants|Count of Participants|23|23.0||||||
3994989|NCT01234337|3815454|B2|Other||Region of Enrollment|Other countries in the below category included Argentina, Australia, China, Israel and Japan.|Participants|Number|77|77.0||||||
3994990|NCT01234337|3815455|B1|Other||Region of Enrollment|Other countries in the below category included Argentina, Australia, China, Israel and Japan.|Participants|Number|77|77.0||||||
3994991|NCT01234337|3815453|B3|North America||Region of Enrollment|Other countries in the below category included Argentina, Australia, China, Israel and Japan.|Participants|Number|49|49.0||||||
3994992|NCT01234337|3815454|B2|North America||Region of Enrollment|Other countries in the below category included Argentina, Australia, China, Israel and Japan.|Participants|Number|26|26.0||||||
3994993|NCT01234337|3815455|B1|North America||Region of Enrollment|Other countries in the below category included Argentina, Australia, China, Israel and Japan.|Participants|Number|23|23.0||||||
3994994|NCT01234337|3815453|B3|Europe||Region of Enrollment|Other countries in the below category included Argentina, Australia, China, Israel and Japan.|Participants|Number|334|334.0||||||
3994995|NCT01234337|3815454|B2|Europe||Region of Enrollment|Other countries in the below category included Argentina, Australia, China, Israel and Japan.|Participants|Number|168|168.0||||||
3994996|NCT01234337|3815455|B1|Europe||Region of Enrollment|Other countries in the below category included Argentina, Australia, China, Israel and Japan.|Participants|Number|166|166.0||||||
3994997|NCT01234337|3815453|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3994998|NCT01234337|3815454|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3994999|NCT01234337|3815455|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3995000|NCT01234337|3815453|B3|Asian||Race/Ethnicity, Customized||Participants|Number|100|100.0||||||
3995001|NCT01234337|3815454|B2|Asian||Race/Ethnicity, Customized||Participants|Number|50|50.0||||||
3995002|NCT01234337|3815455|B1|Asian||Race/Ethnicity, Customized||Participants|Number|50|50.0||||||
3995003|NCT01234337|3815453|B3|Black||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3995004|NCT01234337|3815454|B2|Black||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3995005|NCT01234337|3815455|B1|Black||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3995006|NCT01234337|3815453|B3|White||Race/Ethnicity, Customized||Participants|Number|417|417.0||||||
3995007|NCT01234337|3815454|B2|White||Race/Ethnicity, Customized||Participants|Number|212|212.0||||||
3995008|NCT01234337|3815455|B1|White||Race/Ethnicity, Customized||Participants|Number|205|205.0||||||
3995009|NCT01234337|3815453|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3995010|NCT01234337|3815454|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3995011|NCT01234337|3815455|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3995012|NCT01234337|3815453|B3||Female|Sex: Female, Male||Participants|Count of Participants|533|533.0||||||
3995013|NCT01234337|3815454|B2||Female|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
3995014|NCT01234337|3815455|B1||Female|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
3995015|NCT01234337|3815453|B3|||Age||years|Mean|53.9|53.9|Standard Deviation|10.6|10.6|||
3995016|NCT01234337|3815454|B2|||Age||years|Mean|54.4|54.4|Standard Deviation|10.9|10.9|||
3995017|NCT01234337|3815455|B1|||Age||years|Mean|53.3|53.3|Standard Deviation|10.2|10.2|||
3995018|NCT01234207|3815484|B1|United States||Region of Enrollment||participants|Number|95|95.0||||||
3995019|NCT01234207|3815484|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3995020|NCT01234207|3815484|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995021|NCT01234207|3815484|B1||White|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
3995022|NCT01234207|3815484|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3995023|NCT01234207|3815484|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995024|NCT01234207|3815484|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3995025|NCT01234207|3815484|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3995026|NCT01234207|3815484|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3995027|NCT01234207|3815484|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3995028|NCT01234207|3815484|B1|||Age||years|Mean|58.1|58.1|Standard Deviation|6.5|6.5|||
3995029|NCT01234207|3815484|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3995030|NCT01234207|3815484|B1||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
3995031|NCT01234207|3815484|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3995032|NCT01234103|3815505|B3||Missing Data|Sexually transmitted infection diagnosed-ever||Participants|Count of Participants|5|5.0||||||
3995033|NCT01234103|3815506|B2||Missing Data|Sexually transmitted infection diagnosed-ever||Participants|Count of Participants|5|5.0||||||
3995034|NCT01234103|3815507|B1||Missing Data|Sexually transmitted infection diagnosed-ever||Participants|Count of Participants|0|0.0||||||
3995035|NCT01234103|3815505|B3||3|Sexually transmitted infection diagnosed-ever||Participants|Count of Participants|2|2.0||||||
3995036|NCT01234103|3815506|B2||3|Sexually transmitted infection diagnosed-ever||Participants|Count of Participants|2|2.0||||||
3995037|NCT01234103|3815507|B1||3|Sexually transmitted infection diagnosed-ever||Participants|Count of Participants|0|0.0||||||
3995038|NCT01234103|3815505|B3||2|Sexually transmitted infection diagnosed-ever||Participants|Count of Participants|13|13.0||||||
3995039|NCT01234103|3815506|B2||2|Sexually transmitted infection diagnosed-ever||Participants|Count of Participants|8|8.0||||||
3995040|NCT01234103|3815507|B1||2|Sexually transmitted infection diagnosed-ever||Participants|Count of Participants|5|5.0||||||
3995041|NCT01234103|3815505|B3||1|Sexually transmitted infection diagnosed-ever||Participants|Count of Participants|38|38.0||||||
3995042|NCT01234103|3815506|B2||1|Sexually transmitted infection diagnosed-ever||Participants|Count of Participants|15|15.0||||||
3995044|NCT01234103|3815505|B3||None|Sexually transmitted infection diagnosed-ever||Participants|Count of Participants|875|875.0||||||
3995045|NCT01234103|3815506|B2||None|Sexually transmitted infection diagnosed-ever||Participants|Count of Participants|363|363.0||||||
3995046|NCT01234103|3815507|B1||None|Sexually transmitted infection diagnosed-ever||Participants|Count of Participants|512|512.0||||||
3995047|NCT01234103|3815505|B3||Missing Data|Number of pregnancies unintended||Participants|Count of Participants|12|12.0||||||
3995048|NCT01234103|3815506|B2||Missing Data|Number of pregnancies unintended||Participants|Count of Participants|5|5.0||||||
3995049|NCT01234103|3815507|B1||Missing Data|Number of pregnancies unintended||Participants|Count of Participants|7|7.0||||||
3995050|NCT01234103|3815505|B3||3-5|Number of pregnancies unintended||Participants|Count of Participants|18|18.0||||||
3995051|NCT01234103|3815506|B2||3-5|Number of pregnancies unintended||Participants|Count of Participants|7|7.0||||||
3995052|NCT01234103|3815507|B1||3-5|Number of pregnancies unintended||Participants|Count of Participants|11|11.0||||||
3995053|NCT01234103|3815505|B3||2|Number of pregnancies unintended||Participants|Count of Participants|40|40.0||||||
3995054|NCT01234103|3815506|B2||2|Number of pregnancies unintended||Participants|Count of Participants|14|14.0||||||
3995055|NCT01234103|3815507|B1||2|Number of pregnancies unintended||Participants|Count of Participants|26|26.0||||||
3995056|NCT01234103|3815505|B3||1|Number of pregnancies unintended||Participants|Count of Participants|118|118.0||||||
3995057|NCT01234103|3815506|B2||1|Number of pregnancies unintended||Participants|Count of Participants|50|50.0||||||
3995058|NCT01234103|3815507|B1||1|Number of pregnancies unintended||Participants|Count of Participants|68|68.0||||||
3995059|NCT01234103|3815505|B3||None|Number of pregnancies unintended||Participants|Count of Participants|745|745.0||||||
3995060|NCT01234103|3815506|B2||None|Number of pregnancies unintended||Participants|Count of Participants|317|317.0||||||
3995061|NCT01234103|3815507|B1||None|Number of pregnancies unintended||Participants|Count of Participants|428|428.0||||||
3995062|NCT01234103|3815505|B3||Missing Data|Number of pregnancies (males and females)||Participants|Count of Participants|8|8.0||||||
3995063|NCT01234103|3815506|B2||Missing Data|Number of pregnancies (males and females)||Participants|Count of Participants|3|3.0||||||
3995064|NCT01234103|3815507|B1||Missing Data|Number of pregnancies (males and females)||Participants|Count of Participants|5|5.0||||||
3995065|NCT01234103|3815505|B3||3-5|Number of pregnancies (males and females)||Participants|Count of Participants|39|39.0||||||
3995066|NCT01234103|3815506|B2||3-5|Number of pregnancies (males and females)||Participants|Count of Participants|16|16.0||||||
3995067|NCT01234103|3815507|B1||3-5|Number of pregnancies (males and females)||Participants|Count of Participants|23|23.0||||||
3995068|NCT01234103|3815505|B3||2|Number of pregnancies (males and females)||Participants|Count of Participants|60|60.0||||||
3995069|NCT01234103|3815506|B2||2|Number of pregnancies (males and females)||Participants|Count of Participants|23|23.0||||||
3995070|NCT01234103|3815507|B1||2|Number of pregnancies (males and females)||Participants|Count of Participants|37|37.0||||||
3995071|NCT01234103|3815505|B3||1|Number of pregnancies (males and females)||Participants|Count of Participants|136|136.0||||||
3995072|NCT01234103|3815506|B2||1|Number of pregnancies (males and females)||Participants|Count of Participants|58|58.0||||||
3995073|NCT01234103|3815507|B1||1|Number of pregnancies (males and females)||Participants|Count of Participants|78|78.0||||||
3995074|NCT01234103|3815505|B3||None|Number of pregnancies (males and females)||Participants|Count of Participants|690|690.0||||||
3995075|NCT01234103|3815506|B2||None|Number of pregnancies (males and females)||Participants|Count of Participants|293|293.0||||||
3995076|NCT01234103|3815507|B1||None|Number of pregnancies (males and females)||Participants|Count of Participants|397|397.0||||||
3995077|NCT01234103|3815505|B3|||Number of sex partners -ever||sex partners|Mean|9.36|9.36|Standard Deviation|20.967|20.967|||
3995078|NCT01234103|3815506|B2|||Number of sex partners -ever||sex partners|Mean|8.39|8.39|Standard Deviation|10.272|10.272|||
3995079|NCT01234103|3815507|B1|||Number of sex partners -ever||sex partners|Mean|10.09|10.09|Standard Deviation|26.300|26.3|||
3995080|NCT01234103|3815505|B3||Missing|5 or more drinks of alcohol on 1 occassion-past 3 months||Participants|Count of Participants|8|8.0||||||
3995081|NCT01234103|3815506|B2||Missing|5 or more drinks of alcohol on 1 occassion-past 3 months||Participants|Count of Participants|4|4.0||||||
3995082|NCT01234103|3815507|B1||Missing|5 or more drinks of alcohol on 1 occassion-past 3 months||Participants|Count of Participants|4|4.0||||||
3995083|NCT01234103|3815505|B3||1 or more times/week|5 or more drinks of alcohol on 1 occassion-past 3 months||Participants|Count of Participants|71|71.0||||||
3995084|NCT01234103|3815506|B2||1 or more times/week|5 or more drinks of alcohol on 1 occassion-past 3 months||Participants|Count of Participants|27|27.0||||||
3995085|NCT01234103|3815507|B1||1 or more times/week|5 or more drinks of alcohol on 1 occassion-past 3 months||Participants|Count of Participants|44|44.0||||||
3995086|NCT01234103|3815505|B3||2-3 times/month|5 or more drinks of alcohol on 1 occassion-past 3 months||Participants|Count of Participants|58|58.0||||||
3995087|NCT01234103|3815506|B2||2-3 times/month|5 or more drinks of alcohol on 1 occassion-past 3 months||Participants|Count of Participants|32|32.0||||||
3995088|NCT01234103|3815507|B1||2-3 times/month|5 or more drinks of alcohol on 1 occassion-past 3 months||Participants|Count of Participants|26|26.0||||||
3995089|NCT01234103|3815505|B3||Once/month or less|5 or more drinks of alcohol on 1 occassion-past 3 months||Participants|Count of Participants|122|122.0||||||
3995090|NCT01234103|3815506|B2||Once/month or less|5 or more drinks of alcohol on 1 occassion-past 3 months||Participants|Count of Participants|63|63.0||||||
3995091|NCT01234103|3815507|B1||Once/month or less|5 or more drinks of alcohol on 1 occassion-past 3 months||Participants|Count of Participants|59|59.0||||||
3995092|NCT01234103|3815505|B3||Never|5 or more drinks of alcohol on 1 occassion-past 3 months||Participants|Count of Participants|62|62.0||||||
3995093|NCT01234103|3815506|B2||Never|5 or more drinks of alcohol on 1 occassion-past 3 months||Participants|Count of Participants|21|21.0||||||
3995094|NCT01234103|3815507|B1||Never|5 or more drinks of alcohol on 1 occassion-past 3 months||Participants|Count of Participants|41|41.0||||||
3995095|NCT01234103|3815505|B3||No alcohol past 3 months|5 or more drinks of alcohol on 1 occassion-past 3 months||Participants|Count of Participants|612|612.0||||||
3995096|NCT01234103|3815506|B2||No alcohol past 3 months|5 or more drinks of alcohol on 1 occassion-past 3 months||Participants|Count of Participants|246|246.0||||||
3995097|NCT01234103|3815507|B1||No alcohol past 3 months|5 or more drinks of alcohol on 1 occassion-past 3 months||Participants|Count of Participants|366|366.0||||||
3995098|NCT01234103|3815505|B3||Missing|Marital Status||Participants|Count of Participants|1|1.0||||||
3995099|NCT01234103|3815506|B2||Missing|Marital Status||Participants|Count of Participants|0|0.0||||||
3995100|NCT01234103|3815507|B1||Missing|Marital Status||Participants|Count of Participants|1|1.0||||||
3995101|NCT01234103|3815505|B3||Separated/Divorce|Marital Status||Participants|Count of Participants|9|9.0||||||
3995102|NCT01234103|3815506|B2||Separated/Divorce|Marital Status||Participants|Count of Participants|6|6.0||||||
3995103|NCT01234103|3815507|B1||Separated/Divorce|Marital Status||Participants|Count of Participants|3|3.0||||||
3995104|NCT01234103|3815505|B3||Married|Marital Status||Participants|Count of Participants|126|126.0||||||
3995105|NCT01234103|3815506|B2||Married|Marital Status||Participants|Count of Participants|50|50.0||||||
3995106|NCT01234103|3815507|B1||Married|Marital Status||Participants|Count of Participants|76|76.0||||||
3995107|NCT01234103|3815505|B3||Single/Never Married|Marital Status||Participants|Count of Participants|797|797.0||||||
3995108|NCT01234103|3815506|B2||Single/Never Married|Marital Status||Participants|Count of Participants|337|337.0||||||
3995109|NCT01234103|3815507|B1||Single/Never Married|Marital Status||Participants|Count of Participants|460|460.0||||||
3995110|NCT01234103|3815505|B3||Missing Data|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3995111|NCT01234103|3815506|B2||Missing Data|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3995112|NCT01234103|3815507|B1||Missing Data|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3995113|NCT01234103|3815505|B3||Other/Mixed Race|Race/Ethnicity, Customized||Participants|Count of Participants|45|45.0||||||
3995114|NCT01234103|3815506|B2||Other/Mixed Race|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
3995115|NCT01234103|3815507|B1||Other/Mixed Race|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
3995116|NCT01234103|3815505|B3||Caucasian/White|Race/Ethnicity, Customized||Participants|Count of Participants|485|485.0||||||
3995117|NCT01234103|3815506|B2||Caucasian/White|Race/Ethnicity, Customized||Participants|Count of Participants|206|206.0||||||
3995118|NCT01234103|3815507|B1||Caucasian/White|Race/Ethnicity, Customized||Participants|Count of Participants|279|279.0||||||
3995119|NCT01234103|3815505|B3||Hispanic/Latino/a|Race/Ethnicity, Customized||Participants|Count of Participants|151|151.0||||||
3995120|NCT01234103|3815506|B2||Hispanic/Latino/a|Race/Ethnicity, Customized||Participants|Count of Participants|67|67.0||||||
3995121|NCT01234103|3815507|B1||Hispanic/Latino/a|Race/Ethnicity, Customized||Participants|Count of Participants|84|84.0||||||
3995122|NCT01234103|3815505|B3||African American/Black|Race/Ethnicity, Customized||Participants|Count of Participants|198|198.0||||||
3995123|NCT01234103|3815506|B2||African American/Black|Race/Ethnicity, Customized||Participants|Count of Participants|83|83.0||||||
3995124|NCT01234103|3815507|B1||African American/Black|Race/Ethnicity, Customized||Participants|Count of Participants|115|115.0||||||
3995125|NCT01234103|3815505|B3||Asian/Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
3995126|NCT01234103|3815506|B2||Asian/Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3995127|NCT01234103|3815507|B1||Asian/Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
3995128|NCT01234103|3815505|B3||American Indian|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3995129|NCT01234103|3815506|B2||American Indian|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3995130|NCT01234103|3815507|B1||American Indian|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3995131|NCT01234103|3815505|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3995132|NCT01234103|3815506|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3995133|NCT01234103|3815507|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3995134|NCT01234103|3815505|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|780|780.0||||||
3995135|NCT01234103|3815506|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|325|325.0||||||
3995136|NCT01234103|3815507|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|455|455.0||||||
3995137|NCT01234103|3815505|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|151|151.0||||||
3995138|NCT01234103|3815506|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
3995139|NCT01234103|3815507|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
3995140|NCT01234103|3815505|B3||Male|Sex: Female, Male||Participants|Count of Participants|809|809.0||||||
3995141|NCT01234103|3815506|B2||Male|Sex: Female, Male||Participants|Count of Participants|337|337.0||||||
3995142|NCT01234103|3815507|B1||Male|Sex: Female, Male||Participants|Count of Participants|472|472.0||||||
3995143|NCT01234103|3815505|B3||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3995144|NCT01234103|3815506|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3995145|NCT01234103|3815507|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3995146|NCT01234103|3815505|B3|||Age||years|Mean|20.77|20.77|Standard Deviation|3.121|3.121|||
3995147|NCT01234103|3815506|B2|||Age||years|Mean|20.77|20.77|Standard Deviation|3.124|3.124|||
3995148|NCT01234103|3815507|B1|||Age||years|Mean|20.77|20.77|Standard Deviation|3.121|3.121|||
3995149|NCT01233999|3815516|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
3995150|NCT01233999|3815516|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3995151|NCT01233999|3815516|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3995152|NCT01233999|3815516|B1|||Age||years|Mean|30|30.0|Standard Deviation|1|1.0|||
3995153|NCT01233999|3815516|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3995154|NCT01233999|3815516|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3995155|NCT01233999|3815516|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3995156|NCT01233921|3815520|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3995157|NCT01233921|3815521|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3995158|NCT01233921|3815522|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3995159|NCT01233921|3815520|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3995160|NCT01233921|3815521|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3995161|NCT01233921|3815522|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3995162|NCT01233921|3815520|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3995163|NCT01233921|3815521|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3995164|NCT01233921|3815522|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3995165|NCT01233921|3815520|B3|||Age||years|Mean|43|43.0|Standard Deviation|11|11.0|||
3995166|NCT01233921|3815521|B2|||Age||years|Mean|41|41.0|Standard Deviation|11|11.0|||
3995167|NCT01233921|3815522|B1|||Age||years|Mean|44|44.0|Standard Deviation|13|13.0|||
3995168|NCT01233921|3815520|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3995169|NCT01233921|3815521|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3995170|NCT01233921|3815522|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3995171|NCT01233921|3815520|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3995172|NCT01233921|3815521|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3995173|NCT01233921|3815522|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3995174|NCT01233921|3815520|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3995175|NCT01233921|3815521|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3995176|NCT01233921|3815522|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3995177|NCT01233869|3815531|B5||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3995178|NCT01233869|3815532|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3995179|NCT01233869|3815533|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3995180|NCT01233869|3815534|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3995181|NCT01233869|3815535|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3995182|NCT01233869|3815531|B5||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
3995183|NCT01233869|3815532|B4||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3995184|NCT01233869|3815533|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3995185|NCT01233869|3815534|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3995186|NCT01233869|3815535|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3995187|NCT01233869|3815531|B5|||Age||years|Mean|38.5|38.5|Standard Deviation|7.4|7.4|||
3995188|NCT01233869|3815532|B4|||Age||years|Mean|38.5|38.5|Standard Deviation|7.4|7.4|||
3995189|NCT01233869|3815533|B3|||Age||years|Mean|36.4|36.4|Standard Deviation|7.8|7.8|||
3995190|NCT01233869|3815534|B2|||Age||years|Mean|41.3|41.3|Standard Deviation|4.9|4.9|||
3995191|NCT01233869|3815535|B1|||Age||years|Mean|37.9|37.9|Standard Deviation|8.0|8.0|||
3995192|NCT01233817|3815624|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3995193|NCT01233817|3815624|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3995194|NCT01233817|3815624|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3995195|NCT01233817|3815624|B1|||Age||years|Mean|9.56|9.56|Standard Deviation|3.94|3.94|||
3995196|NCT01233817|3815624|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3995197|NCT01233817|3815624|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3995198|NCT01233817|3815624|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
3995199|NCT01233726|3815628|B4|||Diagnostic group: Surgery||participants|Number|22|22.0||||||
3995200|NCT01233726|3815629|B3|||Diagnostic group: Surgery||participants|Number|7|7.0||||||
3995201|NCT01233726|3815630|B2|||Diagnostic group: Surgery||participants|Number|8|8.0||||||
3995202|NCT01233726|3815631|B1|||Diagnostic group: Surgery||participants|Number|7|7.0||||||
3995203|NCT01233726|3815628|B4|||Diagnostic group: Trauma||participants|Number|37|37.0||||||
3995204|NCT01233726|3815629|B3|||Diagnostic group: Trauma||participants|Number|15|15.0||||||
3995205|NCT01233726|3815630|B2|||Diagnostic group: Trauma||participants|Number|9|9.0||||||
3995206|NCT01233726|3815631|B1|||Diagnostic group: Trauma||participants|Number|13|13.0||||||
3995207|NCT01233726|3815628|B4|||Diagnostic group: Medical||participants|Number|98|98.0||||||
3995208|NCT01233726|3815629|B3|||Diagnostic group: Medical||participants|Number|30|30.0||||||
3995209|NCT01233726|3815630|B2|||Diagnostic group: Medical||participants|Number|36|36.0||||||
3995210|NCT01233726|3815631|B1|||Diagnostic group: Medical||participants|Number|32|32.0||||||
3995211|NCT01233726|3815628|B4|||Infection|Number of patients with infection from any source|participants|Number|36|36.0||||||
3995212|NCT01233726|3815629|B3|||Infection|Number of patients with infection from any source|participants|Number|8|8.0||||||
3995213|NCT01233726|3815630|B2|||Infection|Number of patients with infection from any source|participants|Number|15|15.0||||||
3995214|NCT01233726|3815631|B1|||Infection|Number of patients with infection from any source|participants|Number|13|13.0||||||
3995215|NCT01233726|3815628|B4|||HOMA2 %S|HOMA2: Homeostasis Model Assessment S: Insulin Sensitivity|% of insulin sensitivity|Mean|72.27|72.27|Standard Deviation|63.6|63.6|||
3995216|NCT01233726|3815629|B3|||HOMA2 %S|HOMA2: Homeostasis Model Assessment S: Insulin Sensitivity|% of insulin sensitivity|Mean|68.09|68.09|Standard Deviation|66.9|66.9|||
3995217|NCT01233726|3815630|B2|||HOMA2 %S|HOMA2: Homeostasis Model Assessment S: Insulin Sensitivity|% of insulin sensitivity|Mean|69.6|69.6|Standard Deviation|48.7|48.7|||
3995218|NCT01233726|3815631|B1|||HOMA2 %S|HOMA2: Homeostasis Model Assessment S: Insulin Sensitivity|% of insulin sensitivity|Mean|79.12|79.12|Standard Deviation|75.2|75.2|||
3995219|NCT01233726|3815628|B4|||HOMA2 %B|"HOMA 2: Homeostasis Model Assessment B: Beta cell function.~Homeostatic model assessment (HOMA) is a method for assessing β-cell function and insulin resistance (IR) from basal (fasting) glucose and insulin or C-peptide concentrations."|% of beta cell function|Mean|103.21|103.21|Standard Deviation|72.41|72.41|||
3995220|NCT01233726|3815629|B3|||HOMA2 %B|"HOMA 2: Homeostasis Model Assessment B: Beta cell function.~Homeostatic model assessment (HOMA) is a method for assessing β-cell function and insulin resistance (IR) from basal (fasting) glucose and insulin or C-peptide concentrations."|% of beta cell function|Mean|96.55|96.55|Standard Deviation|85.09|85.09|||
3995221|NCT01233726|3815630|B2|||HOMA2 %B|"HOMA 2: Homeostasis Model Assessment B: Beta cell function.~Homeostatic model assessment (HOMA) is a method for assessing β-cell function and insulin resistance (IR) from basal (fasting) glucose and insulin or C-peptide concentrations."|% of beta cell function|Mean|110.5|110.5|Standard Deviation|74.34|74.34|||
3995222|NCT01233726|3815631|B1|||HOMA2 %B|"HOMA 2: Homeostasis Model Assessment B: Beta cell function.~Homeostatic model assessment (HOMA) is a method for assessing β-cell function and insulin resistance (IR) from basal (fasting) glucose and insulin or C-peptide concentrations."|% of beta cell function|Mean|102.6|102.6|Standard Deviation|57.81|57.81|||
3995223|NCT01233726|3815628|B4|||HOMA2 IR|"HOMA 2: Homeostasis Model Assessment IR: Insulin Resistance. Homeostatic model assessment (HOMA) is a method for assessing β-cell function and insulin resistance (IR) from basal (fasting) glucose and insulin or C-peptide concentrations.~The HOMA model compares favorably with other models and has the advantage of requiring only a single plasma sample assayed for insulin and glucose. Higher values represent higher insulinemia."|units on a scale|Mean|2.93|2.93|Standard Deviation|3.11|3.11|||
3995224|NCT01233726|3815629|B3|||HOMA2 IR|"HOMA 2: Homeostasis Model Assessment IR: Insulin Resistance. Homeostatic model assessment (HOMA) is a method for assessing β-cell function and insulin resistance (IR) from basal (fasting) glucose and insulin or C-peptide concentrations.~The HOMA model compares favorably with other models and has the advantage of requiring only a single plasma sample assayed for insulin and glucose. Higher values represent higher insulinemia."|units on a scale|Mean|3.38|3.38|Standard Deviation|2.37|2.37|||
3995225|NCT01233726|3815630|B2|||HOMA2 IR|"HOMA 2: Homeostasis Model Assessment IR: Insulin Resistance. Homeostatic model assessment (HOMA) is a method for assessing β-cell function and insulin resistance (IR) from basal (fasting) glucose and insulin or C-peptide concentrations.~The HOMA model compares favorably with other models and has the advantage of requiring only a single plasma sample assayed for insulin and glucose. Higher values represent higher insulinemia."|units on a scale|Mean|2.48|2.48|Standard Deviation|2.76|2.76|||
3995226|NCT01233726|3815631|B1|||HOMA2 IR|"HOMA 2: Homeostasis Model Assessment IR: Insulin Resistance. Homeostatic model assessment (HOMA) is a method for assessing β-cell function and insulin resistance (IR) from basal (fasting) glucose and insulin or C-peptide concentrations.~The HOMA model compares favorably with other models and has the advantage of requiring only a single plasma sample assayed for insulin and glucose. Higher values represent higher insulinemia."|units on a scale|Mean|2.94|2.94|Standard Deviation|4.19|4.19|||
3995227|NCT01233726|3815628|B4|||C-peptide|Measured after fasting and without insulin infusion for at least 8 hours|ng/mL|Mean|4.46|4.46|Standard Deviation|3.28|3.28|||
3995228|NCT01233726|3815629|B3|||C-peptide|Measured after fasting and without insulin infusion for at least 8 hours|ng/mL|Mean|4.27|4.27|Standard Deviation|3.67|3.67|||
3995229|NCT01233726|3815630|B2|||C-peptide|Measured after fasting and without insulin infusion for at least 8 hours|ng/mL|Mean|4.49|4.49|Standard Deviation|2.92|2.92|||
3995230|NCT01233726|3815631|B1|||C-peptide|Measured after fasting and without insulin infusion for at least 8 hours|ng/mL|Mean|4.61|4.61|Standard Deviation|3.24|3.24|||
3995231|NCT01233726|3815628|B4|||Insulinemia|Measured after fasting and without insulin infusion for at least 8 hours|microU/mL|Mean|19.38|19.38|Standard Deviation|26.78|26.78|||
3995232|NCT01233726|3815629|B3|||Insulinemia|Measured after fasting and without insulin infusion for at least 8 hours|microU/mL|Mean|19.15|19.15|Standard Deviation|20.5|20.5|||
3995233|NCT01233726|3815630|B2|||Insulinemia|Measured after fasting and without insulin infusion for at least 8 hours|microU/mL|Mean|17.39|17.39|Standard Deviation|23.77|23.77|||
3995234|NCT01233726|3815631|B1|||Insulinemia|Measured after fasting and without insulin infusion for at least 8 hours|microU/mL|Mean|21.59|21.59|Standard Deviation|36.06|36.06|||
3995235|NCT01233726|3815628|B4|||Plasma glucose level|Measured after fasting and without insulin infusion for at least 8 hours|mg/dL|Mean|150.4|150.4|Standard Deviation|55.88|55.88|||
3995236|NCT01233726|3815629|B3|||Plasma glucose level|Measured after fasting and without insulin infusion for at least 8 hours|mg/dL|Mean|152.1|152.1|Standard Deviation|57.12|57.12|||
3995237|NCT01233726|3815630|B2|||Plasma glucose level|Measured after fasting and without insulin infusion for at least 8 hours|mg/dL|Mean|147.01|147.01|Standard Deviation|55.93|55.93|||
3995238|NCT01233726|3815631|B1|||Plasma glucose level|Measured after fasting and without insulin infusion for at least 8 hours|mg/dL|Mean|152.1|152.1|Standard Deviation|54.6|54.6|||
3995239|NCT01233726|3815628|B4|||Capillary glucose level|Measured after fasting and without insulin infusion for at least 8 hours|mg/dL|Mean|150|150.0|Standard Deviation|38.98|38.98|||
3995284|NCT01233687|3815671|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3995240|NCT01233726|3815629|B3|||Capillary glucose level|Measured after fasting and without insulin infusion for at least 8 hours|mg/dL|Mean|151.5|151.5|Standard Deviation|39.23|39.23|||
3995241|NCT01233726|3815630|B2|||Capillary glucose level|Measured after fasting and without insulin infusion for at least 8 hours|mg/dL|Mean|149.9|149.9|Standard Deviation|38.9|38.9|||
3995242|NCT01233726|3815631|B1|||Capillary glucose level|Measured after fasting and without insulin infusion for at least 8 hours|mg/dL|Mean|148.8|148.8|Standard Deviation|38.8|38.8|||
3995243|NCT01233726|3815628|B4|||HbA1c||percentaje of glycated hemoglobin|Mean|6.1|6.1|Standard Deviation|1.24|1.24|||
3995244|NCT01233726|3815629|B3|||HbA1c||percentaje of glycated hemoglobin|Mean|6.07|6.07|Standard Deviation|1.39|1.39|||
3995245|NCT01233726|3815630|B2|||HbA1c||percentaje of glycated hemoglobin|Mean|5.76|5.76|Standard Deviation|0.95|0.95|||
3995246|NCT01233726|3815631|B1|||HbA1c||percentaje of glycated hemoglobin|Mean|6.34|6.34|Standard Deviation|1.38|1.38|||
3995247|NCT01233726|3815628|B4|||Noninsulin-dependent diabetes||participants|Number|30|30.0||||||
3995248|NCT01233726|3815629|B3|||Noninsulin-dependent diabetes||participants|Number|12|12.0||||||
3995249|NCT01233726|3815630|B2|||Noninsulin-dependent diabetes||participants|Number|7|7.0||||||
3995250|NCT01233726|3815631|B1|||Noninsulin-dependent diabetes||participants|Number|11|11.0||||||
3995251|NCT01233726|3815628|B4|||Start of EN|Start of Enteral Nutrition: elapsed time from admission to start enteral nutrition|hours|Median|25.1|25.1|Inter-Quartile Range|||18.1|28.0|
3995252|NCT01233726|3815629|B3|||Start of EN|Start of Enteral Nutrition: elapsed time from admission to start enteral nutrition|hours|Median|26.7|26.7|Inter-Quartile Range|||21.3|28.0|
3995253|NCT01233726|3815630|B2|||Start of EN|Start of Enteral Nutrition: elapsed time from admission to start enteral nutrition|hours|Median|25.1|25.1|Inter-Quartile Range|||19.6|26.2|
3995254|NCT01233726|3815631|B1|||Start of EN|Start of Enteral Nutrition: elapsed time from admission to start enteral nutrition|hours|Median|23.4|23.4|Inter-Quartile Range|||18.1|27.2|
3995255|NCT01233726|3815628|B4|||Calorie requirements||kcal/day|Geometric Mean|1708.6|1708.6|Standard Deviation|323.2|323.2|||
3995256|NCT01233726|3815629|B3|||Calorie requirements||kcal/day|Geometric Mean|1728.2|1728.2|Standard Deviation|309.2|309.2|||
3995257|NCT01233726|3815630|B2|||Calorie requirements||kcal/day|Geometric Mean|1707.1|1707.1|Standard Deviation|275.4|275.4|||
3995258|NCT01233726|3815631|B1|||Calorie requirements||kcal/day|Geometric Mean|1690.4|1690.4|Standard Deviation|384.9|384.9|||
3995259|NCT01233726|3815628|B4|||SOFA score|"Sepsis-related Organ Failure Assessment score.~Score:~0-6: 10% of mortality; 7-9: 15-20% of mortality; 10-12: 40-50% of mortality; 13-14: 50-60 % of mortality; 15: >80% of mortality; 16-24: >90% of mortality."|units on a scale|Median|8|8.0|Inter-Quartile Range|||4.0|14.0|
3995260|NCT01233726|3815629|B3|||SOFA score|"Sepsis-related Organ Failure Assessment score.~Score:~0-6: 10% of mortality; 7-9: 15-20% of mortality; 10-12: 40-50% of mortality; 13-14: 50-60 % of mortality; 15: >80% of mortality; 16-24: >90% of mortality."|units on a scale|Median|7|7.0|Inter-Quartile Range|||4.0|12.0|
3995261|NCT01233726|3815630|B2|||SOFA score|"Sepsis-related Organ Failure Assessment score.~Score:~0-6: 10% of mortality; 7-9: 15-20% of mortality; 10-12: 40-50% of mortality; 13-14: 50-60 % of mortality; 15: >80% of mortality; 16-24: >90% of mortality."|units on a scale|Median|7|7.0|Inter-Quartile Range|||5.0|12.0|
3995262|NCT01233726|3815631|B1|||SOFA score|"Sepsis-related Organ Failure Assessment score.~Score:~0-6: 10% of mortality; 7-9: 15-20% of mortality; 10-12: 40-50% of mortality; 13-14: 50-60 % of mortality; 15: >80% of mortality; 16-24: >90% of mortality."|units on a scale|Median|8|8.0|Inter-Quartile Range|||6.0|14.0|
3995263|NCT01233726|3815628|B4|||APACHE II|"Acute Physiology and Chronic Health Evaluation II~Scale: 0 to 71: based on several measures: at higher score, more severe illness and greater risk of death."|units on a scale|Median|19|19.0|Inter-Quartile Range|||14.0|23.0|
3995264|NCT01233726|3815629|B3|||APACHE II|"Acute Physiology and Chronic Health Evaluation II~Scale: 0 to 71: based on several measures: at higher score, more severe illness and greater risk of death."|units on a scale|Median|19|19.0|Inter-Quartile Range|||16.0|23.0|
3995265|NCT01233726|3815630|B2|||APACHE II|"Acute Physiology and Chronic Health Evaluation II~Scale: 0 to 71: based on several measures: at higher score, more severe illness and greater risk of death."|units on a scale|Median|19|19.0|Inter-Quartile Range|||15.0|22.0|
3995266|NCT01233726|3815631|B1|||APACHE II|"Acute Physiology and Chronic Health Evaluation II~Scale: 0 to 71: based on several measures: at higher score, more severe illness and greater risk of death."|units on a scale|Median|17|17.0|Inter-Quartile Range|||14.0|23.0|
3995267|NCT01233726|3815628|B4|||Body Mass Index (BMI)||kg/m^2|Median|26|26.0|Inter-Quartile Range|||24.0|29.0|
3995268|NCT01233726|3815629|B3|||Body Mass Index (BMI)||kg/m^2|Median|26|26.0|Inter-Quartile Range|||24.0|27.0|
3995269|NCT01233726|3815630|B2|||Body Mass Index (BMI)||kg/m^2|Median|26|26.0|Inter-Quartile Range|||24.0|28.0|
3995270|NCT01233726|3815631|B1|||Body Mass Index (BMI)||kg/m^2|Median|26|26.0|Inter-Quartile Range|||24.0|29.0|
3995271|NCT01233726|3815628|B4||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3995272|NCT01233726|3815629|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3995273|NCT01233726|3815630|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3995274|NCT01233726|3815631|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3995275|NCT01233726|3815628|B4||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3995276|NCT01233726|3815629|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3995277|NCT01233726|3815630|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3995278|NCT01233726|3815631|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3995279|NCT01233726|3815628|B4|||Age||years|Median|58|58.0|Inter-Quartile Range|||43.0|71.0|
3995280|NCT01233726|3815629|B3|||Age||years|Median|58|58.0|Inter-Quartile Range|||46.0|68.0|
3995281|NCT01233726|3815630|B2|||Age||years|Median|60|60.0|Inter-Quartile Range|||45.0|71.0|
3995282|NCT01233726|3815631|B1|||Age||years|Median|57|57.0|Inter-Quartile Range|||43.0|70.0|
3995283|NCT01233687|3815671|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3995285|NCT01233687|3815671|B1|||Age||years|Median|65|65.0|Full Range|||35.0|82.0|
3995286|NCT01233609|3815679|B3|RHO and ROM1||Genetic Mutations|Summary of participants' gene mutation or combination of mutations identified and thought to be responsible for autosomal dominant retinitis pigmentosa|Participants|Count of Participants|1|1.0||||||
3995287|NCT01233609|3815680|B2|RHO and ROM1||Genetic Mutations|Summary of participants' gene mutation or combination of mutations identified and thought to be responsible for autosomal dominant retinitis pigmentosa|Participants|Count of Participants|1|1.0||||||
3995288|NCT01233609|3815681|B1|RHO and ROM1||Genetic Mutations|Summary of participants' gene mutation or combination of mutations identified and thought to be responsible for autosomal dominant retinitis pigmentosa|Participants|Count of Participants|0|0.0||||||
3995289|NCT01233609|3815679|B3|NR2E3 and TOPORS||Genetic Mutations|Summary of participants' gene mutation or combination of mutations identified and thought to be responsible for autosomal dominant retinitis pigmentosa|Participants|Count of Participants|1|1.0||||||
3995290|NCT01233609|3815680|B2|NR2E3 and TOPORS||Genetic Mutations|Summary of participants' gene mutation or combination of mutations identified and thought to be responsible for autosomal dominant retinitis pigmentosa|Participants|Count of Participants|1|1.0||||||
3995291|NCT01233609|3815681|B1|NR2E3 and TOPORS||Genetic Mutations|Summary of participants' gene mutation or combination of mutations identified and thought to be responsible for autosomal dominant retinitis pigmentosa|Participants|Count of Participants|0|0.0||||||
3995292|NCT01233609|3815679|B3|KLHL7||Genetic Mutations|Summary of participants' gene mutation or combination of mutations identified and thought to be responsible for autosomal dominant retinitis pigmentosa|Participants|Count of Participants|1|1.0||||||
3995293|NCT01233609|3815680|B2|KLHL7||Genetic Mutations|Summary of participants' gene mutation or combination of mutations identified and thought to be responsible for autosomal dominant retinitis pigmentosa|Participants|Count of Participants|0|0.0||||||
3995294|NCT01233609|3815681|B1|KLHL7||Genetic Mutations|Summary of participants' gene mutation or combination of mutations identified and thought to be responsible for autosomal dominant retinitis pigmentosa|Participants|Count of Participants|1|1.0||||||
3995295|NCT01233609|3815679|B3|IMPDH1||Genetic Mutations|Summary of participants' gene mutation or combination of mutations identified and thought to be responsible for autosomal dominant retinitis pigmentosa|Participants|Count of Participants|1|1.0||||||
3995296|NCT01233609|3815680|B2|IMPDH1||Genetic Mutations|Summary of participants' gene mutation or combination of mutations identified and thought to be responsible for autosomal dominant retinitis pigmentosa|Participants|Count of Participants|0|0.0||||||
3995297|NCT01233609|3815681|B1|IMPDH1||Genetic Mutations|Summary of participants' gene mutation or combination of mutations identified and thought to be responsible for autosomal dominant retinitis pigmentosa|Participants|Count of Participants|1|1.0||||||
3995298|NCT01233609|3815679|B3|TOPORS||Genetic Mutations|Summary of participants' gene mutation or combination of mutations identified and thought to be responsible for autosomal dominant retinitis pigmentosa|Participants|Count of Participants|2|2.0||||||
3995299|NCT01233609|3815680|B2|TOPORS||Genetic Mutations|Summary of participants' gene mutation or combination of mutations identified and thought to be responsible for autosomal dominant retinitis pigmentosa|Participants|Count of Participants|2|2.0||||||
3995300|NCT01233609|3815681|B1|TOPORS||Genetic Mutations|Summary of participants' gene mutation or combination of mutations identified and thought to be responsible for autosomal dominant retinitis pigmentosa|Participants|Count of Participants|0|0.0||||||
3995301|NCT01233609|3815679|B3|SNRNP200/ASCC3L1||Genetic Mutations|Summary of participants' gene mutation or combination of mutations identified and thought to be responsible for autosomal dominant retinitis pigmentosa|Participants|Count of Participants|2|2.0||||||
3995302|NCT01233609|3815680|B2|SNRNP200/ASCC3L1||Genetic Mutations|Summary of participants' gene mutation or combination of mutations identified and thought to be responsible for autosomal dominant retinitis pigmentosa|Participants|Count of Participants|0|0.0||||||
3995303|NCT01233609|3815681|B1|SNRNP200/ASCC3L1||Genetic Mutations|Summary of participants' gene mutation or combination of mutations identified and thought to be responsible for autosomal dominant retinitis pigmentosa|Participants|Count of Participants|2|2.0||||||
3995304|NCT01233609|3815679|B3|RHO and PRPH2||Genetic Mutations|Summary of participants' gene mutation or combination of mutations identified and thought to be responsible for autosomal dominant retinitis pigmentosa|Participants|Count of Participants|2|2.0||||||
3995305|NCT01233609|3815680|B2|RHO and PRPH2||Genetic Mutations|Summary of participants' gene mutation or combination of mutations identified and thought to be responsible for autosomal dominant retinitis pigmentosa|Participants|Count of Participants|0|0.0||||||
3995306|NCT01233609|3815681|B1|RHO and PRPH2||Genetic Mutations|Summary of participants' gene mutation or combination of mutations identified and thought to be responsible for autosomal dominant retinitis pigmentosa|Participants|Count of Participants|2|2.0||||||
3995307|NCT01233609|3815679|B3|NR2E3||Genetic Mutations|Summary of participants' gene mutation or combination of mutations identified and thought to be responsible for autosomal dominant retinitis pigmentosa|Participants|Count of Participants|2|2.0||||||
3995308|NCT01233609|3815680|B2|NR2E3||Genetic Mutations|Summary of participants' gene mutation or combination of mutations identified and thought to be responsible for autosomal dominant retinitis pigmentosa|Participants|Count of Participants|2|2.0||||||
3995309|NCT01233609|3815681|B1|NR2E3||Genetic Mutations|Summary of participants' gene mutation or combination of mutations identified and thought to be responsible for autosomal dominant retinitis pigmentosa|Participants|Count of Participants|0|0.0||||||
3995310|NCT01233609|3815679|B3|PRPH2||Genetic Mutations|Summary of participants' gene mutation or combination of mutations identified and thought to be responsible for autosomal dominant retinitis pigmentosa|Participants|Count of Participants|4|4.0||||||
3995311|NCT01233609|3815680|B2|PRPH2||Genetic Mutations|Summary of participants' gene mutation or combination of mutations identified and thought to be responsible for autosomal dominant retinitis pigmentosa|Participants|Count of Participants|2|2.0||||||
3995312|NCT01233609|3815681|B1|PRPH2||Genetic Mutations|Summary of participants' gene mutation or combination of mutations identified and thought to be responsible for autosomal dominant retinitis pigmentosa|Participants|Count of Participants|2|2.0||||||
3995357|NCT01233609|3815681|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3995313|NCT01233609|3815679|B3|PRPF8||Genetic Mutations|Summary of participants' gene mutation or combination of mutations identified and thought to be responsible for autosomal dominant retinitis pigmentosa|Participants|Count of Participants|4|4.0||||||
3995314|NCT01233609|3815680|B2|PRPF8||Genetic Mutations|Summary of participants' gene mutation or combination of mutations identified and thought to be responsible for autosomal dominant retinitis pigmentosa|Participants|Count of Participants|1|1.0||||||
3995315|NCT01233609|3815681|B1|PRPF8||Genetic Mutations|Summary of participants' gene mutation or combination of mutations identified and thought to be responsible for autosomal dominant retinitis pigmentosa|Participants|Count of Participants|3|3.0||||||
3995316|NCT01233609|3815679|B3|RP1||Genetic Mutations|Summary of participants' gene mutation or combination of mutations identified and thought to be responsible for autosomal dominant retinitis pigmentosa|Participants|Count of Participants|13|13.0||||||
3995317|NCT01233609|3815680|B2|RP1||Genetic Mutations|Summary of participants' gene mutation or combination of mutations identified and thought to be responsible for autosomal dominant retinitis pigmentosa|Participants|Count of Participants|9|9.0||||||
3995318|NCT01233609|3815681|B1|RP1||Genetic Mutations|Summary of participants' gene mutation or combination of mutations identified and thought to be responsible for autosomal dominant retinitis pigmentosa|Participants|Count of Participants|4|4.0||||||
3995319|NCT01233609|3815679|B3|PRPF31||Genetic Mutations|Summary of participants' gene mutation or combination of mutations identified and thought to be responsible for autosomal dominant retinitis pigmentosa|Participants|Count of Participants|14|14.0||||||
3995320|NCT01233609|3815680|B2|PRPF31||Genetic Mutations|Summary of participants' gene mutation or combination of mutations identified and thought to be responsible for autosomal dominant retinitis pigmentosa|Participants|Count of Participants|9|9.0||||||
3995321|NCT01233609|3815681|B1|PRPF31||Genetic Mutations|Summary of participants' gene mutation or combination of mutations identified and thought to be responsible for autosomal dominant retinitis pigmentosa|Participants|Count of Participants|5|5.0||||||
3995322|NCT01233609|3815679|B3|RHO||Genetic Mutations|Summary of participants' gene mutation or combination of mutations identified and thought to be responsible for autosomal dominant retinitis pigmentosa|Participants|Count of Participants|41|41.0||||||
3995323|NCT01233609|3815680|B2|RHO||Genetic Mutations|Summary of participants' gene mutation or combination of mutations identified and thought to be responsible for autosomal dominant retinitis pigmentosa|Participants|Count of Participants|19|19.0||||||
3995324|NCT01233609|3815681|B1|RHO||Genetic Mutations|Summary of participants' gene mutation or combination of mutations identified and thought to be responsible for autosomal dominant retinitis pigmentosa|Participants|Count of Participants|22|22.0||||||
3995325|NCT01233609|3815679|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3995326|NCT01233609|3815680|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995327|NCT01233609|3815681|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3995328|NCT01233609|3815679|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3995329|NCT01233609|3815680|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3995330|NCT01233609|3815681|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995331|NCT01233609|3815679|B3||White|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
3995332|NCT01233609|3815680|B2||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
3995333|NCT01233609|3815681|B1||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
3995334|NCT01233609|3815679|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3995335|NCT01233609|3815680|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3995336|NCT01233609|3815681|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995337|NCT01233609|3815679|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995338|NCT01233609|3815680|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995339|NCT01233609|3815681|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995340|NCT01233609|3815679|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995341|NCT01233609|3815680|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995342|NCT01233609|3815681|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995343|NCT01233609|3815679|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995344|NCT01233609|3815680|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995345|NCT01233609|3815681|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995346|NCT01233609|3815679|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995347|NCT01233609|3815680|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995348|NCT01233609|3815681|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995349|NCT01233609|3815679|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
3995350|NCT01233609|3815680|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3995351|NCT01233609|3815681|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3995352|NCT01233609|3815679|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3995353|NCT01233609|3815680|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3995354|NCT01233609|3815681|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3995355|NCT01233609|3815679|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3995356|NCT01233609|3815680|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3995358|NCT01233609|3815679|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3995359|NCT01233609|3815680|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3995360|NCT01233609|3815681|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3995361|NCT01233609|3815679|B3|||Age||years|Mean|50.4|50.4|Standard Deviation|11.6|11.6|||
3995362|NCT01233609|3815680|B2|||Age||years|Mean|49.3|49.3|Standard Deviation|12.3|12.3|||
3995363|NCT01233609|3815681|B1|||Age||years|Mean|51.6|51.6|Standard Deviation|10.9|10.9|||
3995364|NCT01233284|3815706|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3995365|NCT01233284|3815706|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3995366|NCT01233284|3815706|B1|||Age||years|Mean|49.3|49.3|Standard Deviation|13.3|13.3|||
3995367|NCT01233258|3815788|B4||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
3995368|NCT01233258|3815789|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3995369|NCT01233258|3815790|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3995370|NCT01233258|3815791|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3995371|NCT01233258|3815788|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3995372|NCT01233258|3815789|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3995373|NCT01233258|3815790|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3995374|NCT01233258|3815791|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3995375|NCT01233258|3815788|B4|||Age||years|Mean|29.6|29.6|Standard Deviation|11.0|11.0|||
3995376|NCT01233258|3815789|B3|||Age||years|Mean|29.1|29.1|Standard Deviation|11.5|11.5|||
3995377|NCT01233258|3815790|B2|||Age||years|Mean|28.8|28.8|Standard Deviation|10.9|10.9|||
3995378|NCT01233258|3815791|B1|||Age||years|Mean|31.4|31.4|Standard Deviation|10.9|10.9|||
3995379|NCT01233232|3815813|B4|III Severe||GOLD classification|The spirometric classification of severity COPD now includes four stages: Stage I: Mild; Stage II: Moderate; Stage III: Severe; Stage IV: Very Severe.|Participants|Number|34|34.0||||||
3995380|NCT01233232|3815814|B3|III Severe||GOLD classification|The spirometric classification of severity COPD now includes four stages: Stage I: Mild; Stage II: Moderate; Stage III: Severe; Stage IV: Very Severe.|Participants|Number|12|12.0||||||
3995381|NCT01233232|3815815|B2|III Severe||GOLD classification|The spirometric classification of severity COPD now includes four stages: Stage I: Mild; Stage II: Moderate; Stage III: Severe; Stage IV: Very Severe.|Participants|Number|10|10.0||||||
3995382|NCT01233232|3815816|B1|III Severe||GOLD classification|The spirometric classification of severity COPD now includes four stages: Stage I: Mild; Stage II: Moderate; Stage III: Severe; Stage IV: Very Severe.|Participants|Number|12|12.0||||||
3995383|NCT01233232|3815813|B4|II Moderate||GOLD classification|The spirometric classification of severity COPD now includes four stages: Stage I: Mild; Stage II: Moderate; Stage III: Severe; Stage IV: Very Severe.|Participants|Number|53|53.0||||||
3995384|NCT01233232|3815814|B3|II Moderate||GOLD classification|The spirometric classification of severity COPD now includes four stages: Stage I: Mild; Stage II: Moderate; Stage III: Severe; Stage IV: Very Severe.|Participants|Number|16|16.0||||||
3995385|NCT01233232|3815815|B2|II Moderate||GOLD classification|The spirometric classification of severity COPD now includes four stages: Stage I: Mild; Stage II: Moderate; Stage III: Severe; Stage IV: Very Severe.|Participants|Number|20|20.0||||||
3995386|NCT01233232|3815816|B1|II Moderate||GOLD classification|The spirometric classification of severity COPD now includes four stages: Stage I: Mild; Stage II: Moderate; Stage III: Severe; Stage IV: Very Severe.|Participants|Number|17|17.0||||||
3995387|NCT01233232|3815813|B4|||Nicotine pack years|one pack year= 1 pack (20 cigrettes) per day for 1 year, or equivalent|Pack Year|Mean|37|37.0|Standard Deviation|20.4|20.4|||
3995388|NCT01233232|3815814|B3|||Nicotine pack years|one pack year= 1 pack (20 cigrettes) per day for 1 year, or equivalent|Pack Year|Mean|34|34.0|Standard Deviation|17.9|17.9|||
3995389|NCT01233232|3815815|B2|||Nicotine pack years|one pack year= 1 pack (20 cigrettes) per day for 1 year, or equivalent|Pack Year|Mean|39|39.0|Standard Deviation|22|22.0|||
3995390|NCT01233232|3815816|B1|||Nicotine pack years|one pack year= 1 pack (20 cigrettes) per day for 1 year, or equivalent|Pack Year|Mean|38|38.0|Standard Deviation|21.4|21.4|||
3995391|NCT01233232|3815813|B4|||FEV1/FVC at screening||%|Mean|52.91|52.91|Standard Deviation|10.58|10.58|||
3995392|NCT01233232|3815814|B3|||FEV1/FVC at screening||%|Mean|54.52|54.52|Standard Deviation|10.51|10.51|||
3995393|NCT01233232|3815815|B2|||FEV1/FVC at screening||%|Mean|51.75|51.75|Standard Deviation|11.65|11.65|||
3995394|NCT01233232|3815816|B1|||FEV1/FVC at screening||%|Mean|52.54|52.54|Standard Deviation|9.62|9.62|||
3995395|NCT01233232|3815813|B4|||% Predicted FEV1 at screening||%|Mean|56|56.0|Standard Deviation|13.2|13.2|||
3995396|NCT01233232|3815814|B3|||% Predicted FEV1 at screening||%|Mean|54|54.0|Standard Deviation|12.1|12.1|||
3995397|NCT01233232|3815815|B2|||% Predicted FEV1 at screening||%|Mean|57|57.0|Standard Deviation|13.6|13.6|||
3995398|NCT01233232|3815816|B1|||% Predicted FEV1 at screening||%|Mean|56|56.0|Standard Deviation|13.9|13.9|||
3995399|NCT01233232|3815813|B4|||Weight||Kg|Mean|76|76.0|Standard Deviation|11.59|11.59|||
3995400|NCT01233232|3815814|B3|||Weight||Kg|Mean|75.4|75.4|Standard Deviation|10.90|10.9|||
3995401|NCT01233232|3815815|B2|||Weight||Kg|Mean|78.9|78.9|Standard Deviation|9.18|9.18|||
3995402|NCT01233232|3815816|B1|||Weight||Kg|Mean|73.7|73.7|Standard Deviation|14.02|14.02|||
3995403|NCT01233232|3815813|B4|||Body Mass Index||kg/m^2|Mean|26.118|26.118|Standard Deviation|3.14|3.14|||
3995404|NCT01233232|3815814|B3|||Body Mass Index||kg/m^2|Mean|25.803|25.803|Standard Deviation|3.18|3.18|||
3995405|NCT01233232|3815815|B2|||Body Mass Index||kg/m^2|Mean|27.645|27.645|Standard Deviation|2.89|2.89|||
3995406|NCT01233232|3815816|B1|||Body Mass Index||kg/m^2|Mean|24.842|24.842|Standard Deviation|2.77|2.77|||
3995407|NCT01233232|3815813|B4||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3995408|NCT01233232|3815814|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3995409|NCT01233232|3815815|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3995410|NCT01233232|3815816|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3995411|NCT01233232|3815813|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3995412|NCT01233232|3815814|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3995413|NCT01233232|3815815|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3995414|NCT01233232|3815816|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3995415|NCT01233232|3815813|B4|||Age||Years|Mean|64|64.0|Standard Deviation|7.4|7.4|||
3995416|NCT01233232|3815814|B3|||Age||Years|Mean|65|65.0|Standard Deviation|7.4|7.4|||
3995417|NCT01233232|3815815|B2|||Age||Years|Mean|65|65.0|Standard Deviation|6.9|6.9|||
3995418|NCT01233232|3815816|B1|||Age||Years|Mean|62|62.0|Standard Deviation|7.9|7.9|||
3995419|NCT01233076|3815871|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3995420|NCT01233076|3815871|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3995421|NCT01233076|3815871|B1|||Age||years|Mean|30.6|30.6|Standard Deviation|12.4|12.4|||
3995422|NCT01233050|3815878|B3|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3995423|NCT01233050|3815879|B2|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3995424|NCT01233050|3815880|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3995425|NCT01233050|3815878|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3995426|NCT01233050|3815879|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3995427|NCT01233050|3815880|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3995428|NCT01233050|3815878|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
3995429|NCT01233050|3815879|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3995430|NCT01233050|3815880|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3995431|NCT01233050|3815878|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
3995432|NCT01233050|3815879|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3995433|NCT01233050|3815880|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
3995434|NCT01233050|3815878|B3|African American or Black||Race/Ethnicity, Customized||Participants|Count of Participants|119|119.0||||||
3995435|NCT01233050|3815879|B2|African American or Black||Race/Ethnicity, Customized||Participants|Count of Participants|55|55.0||||||
3995436|NCT01233050|3815880|B1|African American or Black||Race/Ethnicity, Customized||Participants|Count of Participants|64|64.0||||||
3995437|NCT01233050|3815878|B3|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|629|629.0||||||
3995438|NCT01233050|3815879|B2|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|322|322.0||||||
3995439|NCT01233050|3815880|B1|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|307|307.0||||||
3995440|NCT01233050|3815878|B3||Male|Sex: Female, Male||Participants|Count of Participants|383|383.0||||||
3995441|NCT01233050|3815879|B2||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
3995442|NCT01233050|3815880|B1||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
3995443|NCT01233050|3815878|B3||Female|Sex: Female, Male||Participants|Count of Participants|405|405.0||||||
3995444|NCT01233050|3815879|B2||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
3995445|NCT01233050|3815880|B1||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
3995446|NCT01233050|3815878|B3|||Age||years|Mean|57.04|57.04|Standard Deviation|16.22|16.22|||
3995447|NCT01233050|3815879|B2|||Age||years|Mean|56.75|56.75|Standard Deviation|15.81|15.81|||
3995448|NCT01233050|3815880|B1|||Age||years|Mean|57.33|57.33|Standard Deviation|16.65|16.65|||
3995449|NCT01232920|3815897|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3995450|NCT01232920|3815898|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3995451|NCT01232920|3815899|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3995452|NCT01232920|3815897|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3995453|NCT01232920|3815898|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3995454|NCT01232920|3815899|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3995455|NCT01232920|3815897|B3|||Age||years|Mean|40.4|40.4|Standard Deviation|12.2|12.2|||
3995456|NCT01232920|3815898|B2|||Age||years|Mean|40.5|40.5|Standard Deviation|14.2|14.2|||
3995457|NCT01232920|3815899|B1|||Age||years|Mean|38.6|38.6|Standard Deviation|10.3|10.3|||
3995458|NCT01232894|3815912|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3995459|NCT01232894|3815913|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3995460|NCT01232894|3815914|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3995461|NCT01232894|3815912|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3995462|NCT01232894|3815913|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3995463|NCT01232894|3815914|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3995464|NCT01232894|3815912|B3|||Age||years|Mean|65.2|65.2|Standard Deviation|9.9|9.9|||
3995465|NCT01232894|3815913|B2|||Age||years|Mean|64.8|64.8|Standard Deviation|9.9|9.9|||
3995466|NCT01232894|3815914|B1|||Age||years|Mean|65.4|65.4|Standard Deviation|9.9|9.9|||
3995467|NCT01232868|3815921|B3|United States||Region of Enrollment||participants|Number|66|66.0||||||
3995468|NCT01232868|3815922|B2|United States||Region of Enrollment||participants|Number|44|44.0||||||
3995469|NCT01232868|3815923|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
3995470|NCT01232868|3815921|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3995471|NCT01232868|3815922|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3995472|NCT01232868|3815923|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995473|NCT01232868|3815921|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995474|NCT01232868|3815922|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995475|NCT01232868|3815923|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995476|NCT01232868|3815921|B3||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
3995477|NCT01232868|3815922|B2||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3995478|NCT01232868|3815923|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3995479|NCT01232868|3815921|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3995480|NCT01232868|3815922|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3995481|NCT01232868|3815923|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3995482|NCT01232868|3815921|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995483|NCT01232868|3815922|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995484|NCT01232868|3815923|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995485|NCT01232868|3815921|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3995486|NCT01232868|3815922|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995487|NCT01232868|3815923|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3995488|NCT01232868|3815921|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995489|NCT01232868|3815922|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995490|NCT01232868|3815923|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995491|NCT01232868|3815921|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995492|NCT01232868|3815922|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995493|NCT01232868|3815923|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995494|NCT01232868|3815921|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3995495|NCT01232868|3815922|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3995496|NCT01232868|3815923|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3995497|NCT01232868|3815921|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3995498|NCT01232868|3815922|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3995499|NCT01232868|3815923|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3995500|NCT01232868|3815921|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3995501|NCT01232868|3815922|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3995502|NCT01232868|3815923|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3995503|NCT01232868|3815921|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3995504|NCT01232868|3815922|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3995505|NCT01232868|3815923|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3995506|NCT01232868|3815921|B3||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
3995507|NCT01232868|3815922|B2||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
3995508|NCT01232868|3815923|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3995509|NCT01232868|3815921|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3995510|NCT01232868|3815922|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3995511|NCT01232868|3815923|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3995512|NCT01232868|3815921|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3995513|NCT01232868|3815922|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3995514|NCT01232868|3815923|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3995515|NCT01232829|3815932|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
3995516|NCT01232829|3815932|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995517|NCT01232829|3815932|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3995518|NCT01232829|3815932|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3995519|NCT01232829|3815932|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995520|NCT01232829|3815932|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995521|NCT01232829|3815932|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3995522|NCT01232829|3815932|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3995523|NCT01232829|3815932|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995524|NCT01232829|3815932|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995525|NCT01232829|3815932|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995526|NCT01232829|3815932|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3995527|NCT01232829|3815932|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3995528|NCT01232829|3815932|B1|||Age||Years|Mean|65.0|65.0|Standard Deviation|11.9|11.9|||
3995529|NCT01232790|3815938|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3995530|NCT01232790|3815938|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3995531|NCT01232790|3815938|B1|||Age||years|Mean|48.64|48.64|Standard Deviation|10.58|10.58|||
3995532|NCT01232738|3815993|B1|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
3995533|NCT01232738|3815993|B1|Canada||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3995534|NCT01232738|3815993|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3995535|NCT01232738|3815993|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3995536|NCT01232738|3815993|B1|||Age||years|Mean|61.1|61.1|Standard Deviation|12.0|12.0|||
3995537|NCT01232569|3816007|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3995538|NCT01232569|3816008|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3995539|NCT01232569|3816009|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3995540|NCT01232569|3816007|B3||Female|Sex: Female, Male||Participants|Count of Participants|555|555.0||||||
3995541|NCT01232569|3816008|B2||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
3995542|NCT01232569|3816009|B1||Female|Sex: Female, Male||Participants|Count of Participants|375|375.0||||||
3995543|NCT01232569|3816007|B3|||Age||years|Mean|52.1|52.1|Standard Deviation|11.54|11.54|||
3995544|NCT01232569|3816008|B2|||Age||years|Mean|52.0|52.0|Standard Deviation|11.67|11.67|||
3995545|NCT01232569|3816009|B1|||Age||years|Mean|52.1|52.1|Standard Deviation|11.49|11.49|||
3995546|NCT01232556|3816053|B3||Male|Sex: Female, Male|Gender|Participants|Count of Participants|188|188.0||||||
3995547|NCT01232556|3816054|B2||Male|Sex: Female, Male|Gender|Participants|Count of Participants|97|97.0||||||
3995548|NCT01232556|3816055|B1||Male|Sex: Female, Male|Gender|Participants|Count of Participants|91|91.0||||||
3995549|NCT01232556|3816053|B3||Female|Sex: Female, Male|Gender|Participants|Count of Participants|150|150.0||||||
3995550|NCT01232556|3816054|B2||Female|Sex: Female, Male|Gender|Participants|Count of Participants|75|75.0||||||
3995551|NCT01232556|3816055|B1||Female|Sex: Female, Male|Gender|Participants|Count of Participants|75|75.0||||||
3995552|NCT01232556|3816053|B3|||Age|Age measure using mean with Standard deviation|Years|Mean|67.7|67.7|Standard Deviation|11.86|11.86|||
3995553|NCT01232556|3816054|B2|||Age|Age measure using mean with Standard deviation|Years|Mean|66.9|66.9|Standard Deviation|11.40|11.4|||
3995554|NCT01232556|3816055|B1|||Age|Age measure using mean with Standard deviation|Years|Mean|68.6|68.6|Standard Deviation|12.29|12.29|||
3995555|NCT01232504|3816076|B4|China||Region of Enrollment||participants|Number|206|206.0||||||
3995556|NCT01232504|3816077|B3|China||Region of Enrollment||participants|Number|69|69.0||||||
3995557|NCT01232504|3816078|B2|China||Region of Enrollment||participants|Number|69|69.0||||||
3995558|NCT01232504|3816079|B1|China||Region of Enrollment||participants|Number|68|68.0||||||
3995559|NCT01232504|3816076|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995560|NCT01232504|3816077|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995561|NCT01232504|3816078|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995562|NCT01232504|3816079|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995563|NCT01232504|3816076|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995564|NCT01232504|3816077|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995565|NCT01232504|3816078|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995566|NCT01232504|3816079|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995567|NCT01232504|3816076|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995568|NCT01232504|3816077|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995569|NCT01232504|3816078|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995570|NCT01232504|3816079|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995571|NCT01232504|3816076|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995572|NCT01232504|3816077|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995573|NCT01232504|3816078|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995574|NCT01232504|3816079|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995575|NCT01232504|3816076|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995576|NCT01232504|3816077|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995577|NCT01232504|3816078|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995578|NCT01232504|3816079|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995579|NCT01232504|3816076|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|206|206.0||||||
3995580|NCT01232504|3816077|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3995581|NCT01232504|3816078|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3995582|NCT01232504|3816079|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3995583|NCT01232504|3816076|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995584|NCT01232504|3816077|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995585|NCT01232504|3816078|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995586|NCT01232504|3816079|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995587|NCT01232504|3816076|B4||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3995588|NCT01232504|3816077|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3995589|NCT01232504|3816078|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3995590|NCT01232504|3816079|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3995591|NCT01232504|3816076|B4||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3995592|NCT01232504|3816077|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3995593|NCT01232504|3816078|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3995594|NCT01232504|3816079|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3995595|NCT01232504|3816076|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3995596|NCT01232504|3816077|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3995597|NCT01232504|3816078|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3995598|NCT01232504|3816079|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3995599|NCT01232504|3816076|B4||Between 18 and 65 years|Age||Participants|Count of Participants|184|184.0||||||
3995600|NCT01232504|3816077|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3995601|NCT01232504|3816078|B2||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
3995602|NCT01232504|3816079|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
3995603|NCT01232504|3816076|B4||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
3995604|NCT01232504|3816077|B3||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
3995605|NCT01232504|3816078|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3995606|NCT01232504|3816079|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
3995607|NCT01232504|3816076|B4|||Age||years|Median|31.75|31.75|Full Range|||14.0|60.0|
3995608|NCT01232504|3816077|B3|||Age||years|Median|32.04|32.04|Full Range|||15.0|53.0|
3995609|NCT01232504|3816078|B2|||Age||years|Median|32.55|32.55|Full Range|||14.0|56.0|
3995610|NCT01232504|3816079|B1|||Age||years|Median|30.68|30.68|Full Range|||14.0|60.0|
3995611|NCT01232491|3816113|B3|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|7.9|7.9|Standard Deviation|0.6|0.6|||
3995612|NCT01232491|3816114|B2|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|7.9|7.9|Standard Deviation|0.6|0.6|||
3995613|NCT01232491|3816115|B1|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.0|8.0|Standard Deviation|0.7|0.7|||
3995614|NCT01232491|3816113|B3|||Fasting plasma glucose (FPG)|The number of subjects (N) analysed in the Control group was 298 instead of 301.|mmol/L|Mean|9.2|9.2|Standard Deviation|2.2|2.2|||
3995615|NCT01232491|3816114|B2|||Fasting plasma glucose (FPG)|The number of subjects (N) analysed in the Control group was 298 instead of 301.|mmol/L|Mean|9.2|9.2|Standard Deviation|2.0|2.0|||
3995616|NCT01232491|3816115|B1|||Fasting plasma glucose (FPG)|The number of subjects (N) analysed in the Control group was 298 instead of 301.|mmol/L|Mean|9.3|9.3|Standard Deviation|2.3|2.3|||
3995617|NCT01232491|3816113|B3|||Duration of diabetes|The number of subjects (N) analysed in the Dietician group was 303 instead of 305.|years|Mean|8.6|8.6|Standard Deviation|5.9|5.9|||
3995618|NCT01232491|3816114|B2|||Duration of diabetes|The number of subjects (N) analysed in the Dietician group was 303 instead of 305.|years|Mean|8.5|8.5|Standard Deviation|6.0|6.0|||
3995619|NCT01232491|3816115|B1|||Duration of diabetes|The number of subjects (N) analysed in the Dietician group was 303 instead of 305.|years|Mean|8.6|8.6|Standard Deviation|5.8|5.8|||
3995620|NCT01232491|3816113|B3|||Body mass index (BMI)||kg/m^2|Mean|34.4|34.4|Standard Deviation|5.5|5.5|||
3995621|NCT01232491|3816114|B2|||Body mass index (BMI)||kg/m^2|Mean|34.3|34.3|Standard Deviation|5.6|5.6|||
3995622|NCT01232491|3816115|B1|||Body mass index (BMI)||kg/m^2|Mean|34.4|34.4|Standard Deviation|5.4|5.4|||
3995623|NCT01232491|3816113|B3|||Body weight||kg|Mean|96.7|96.7|Standard Deviation|19.3|19.3|||
3995624|NCT01232491|3816114|B2|||Body weight||kg|Mean|97.0|97.0|Standard Deviation|20.4|20.4|||
3995625|NCT01232491|3816115|B1|||Body weight||kg|Mean|96.4|96.4|Standard Deviation|18.2|18.2|||
3995626|NCT01232491|3816113|B3|||Height||meters|Mean|1.67|1.67|Standard Deviation|0.10|0.1|||
3995627|NCT01232491|3816114|B2|||Height||meters|Mean|1.68|1.68|Standard Deviation|0.10|0.1|||
3995628|NCT01232491|3816115|B1|||Height||meters|Mean|1.67|1.67|Standard Deviation|0.10|0.1|||
3995629|NCT01232491|3816113|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|465|465.0||||||
3995630|NCT01232491|3816114|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|223|223.0||||||
3995631|NCT01232491|3816115|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|242|242.0||||||
3995632|NCT01232491|3816113|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|141|141.0||||||
3995633|NCT01232491|3816114|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|78|78.0||||||
3995634|NCT01232491|3816115|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
3995635|NCT01232491|3816113|B3|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3995636|NCT01232491|3816114|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3995637|NCT01232491|3816115|B1|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3995638|NCT01232491|3816113|B3|Native Hawaiian or Oth. Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3995639|NCT01232491|3816114|B2|Native Hawaiian or Oth. Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3995640|NCT01232491|3816115|B1|Native Hawaiian or Oth. Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3995641|NCT01232491|3816113|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3995642|NCT01232491|3816114|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3995643|NCT01232491|3816115|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3995644|NCT01232491|3816113|B3|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3995645|NCT01232491|3816114|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
3995646|NCT01232491|3816115|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3995647|NCT01232491|3816113|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
3995648|NCT01232491|3816114|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
3995649|NCT01232491|3816115|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3995650|NCT01232491|3816113|B3|White||Race/Ethnicity, Customized||participants|Number|542|542.0||||||
3995651|NCT01232491|3816114|B2|White||Race/Ethnicity, Customized||participants|Number|268|268.0||||||
3995652|NCT01232491|3816115|B1|White||Race/Ethnicity, Customized||participants|Number|274|274.0||||||
3995653|NCT01232491|3816113|B3||Male|Sex: Female, Male||Participants|Count of Participants|311|311.0||||||
3995654|NCT01232491|3816114|B2||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
3995655|NCT01232491|3816115|B1||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
3995656|NCT01232491|3816113|B3||Female|Sex: Female, Male||Participants|Count of Participants|295|295.0||||||
3995657|NCT01232491|3816114|B2||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
3995658|NCT01232491|3816115|B1||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
3995659|NCT01232491|3816113|B3|||Age||years|Mean|57.4|57.4|Standard Deviation|9.9|9.9|||
3995660|NCT01232491|3816114|B2|||Age||years|Mean|56.5|56.5|Standard Deviation|10.0|10.0|||
3995661|NCT01232491|3816115|B1|||Age||years|Mean|58.2|58.2|Standard Deviation|9.7|9.7|||
3995662|NCT01232465|3816134|B3|United States||Region of Enrollment||participants|Number|739|739.0||||||
3995663|NCT01232465|3816135|B2|United States||Region of Enrollment||participants|Number|402|402.0||||||
3995664|NCT01232465|3816136|B1|United States||Region of Enrollment||participants|Number|337|337.0||||||
3995665|NCT01232465|3816134|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3995666|NCT01232465|3816135|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3995667|NCT01232465|3816136|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3995668|NCT01232465|3816134|B3||Female|Sex: Female, Male||Participants|Count of Participants|739|739.0||||||
3995669|NCT01232465|3816135|B2||Female|Sex: Female, Male||Participants|Count of Participants|402|402.0||||||
3995670|NCT01232465|3816136|B1||Female|Sex: Female, Male||Participants|Count of Participants|337|337.0||||||
3995671|NCT01232465|3816134|B3|||Age||years|Mean|34.8|34.8|Standard Deviation|2.6|2.6|||
3995672|NCT01232465|3816135|B2|||Age||years|Mean|34.9|34.9|Standard Deviation|2.5|2.5|||
3995673|NCT01232465|3816136|B1|||Age||years|Mean|34.7|34.7|Standard Deviation|2.6|2.6|||
3995674|NCT01232465|3816134|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3995675|NCT01232465|3816135|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3995676|NCT01232465|3816136|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3995677|NCT01232465|3816134|B3||Between 18 and 65 years|Age||Participants|Count of Participants|739|739.0||||||
3995678|NCT01232465|3816135|B2||Between 18 and 65 years|Age||Participants|Count of Participants|402|402.0||||||
3995679|NCT01232465|3816136|B1||Between 18 and 65 years|Age||Participants|Count of Participants|337|337.0||||||
3995680|NCT01232465|3816134|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3995681|NCT01232465|3816135|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3995682|NCT01232465|3816136|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3995683|NCT01232452|3816143|B3|Spain||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3995684|NCT01232452|3816144|B2|Spain||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3995685|NCT01232452|3816145|B1|Spain||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3995686|NCT01232452|3816143|B3|Germany||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
3995687|NCT01232452|3816144|B2|Germany||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3995688|NCT01232452|3816145|B1|Germany||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3995689|NCT01232452|3816143|B3|France||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3995690|NCT01232452|3816144|B2|France||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3995691|NCT01232452|3816145|B1|France||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3995692|NCT01232452|3816143|B3|Israel||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3995693|NCT01232452|3816144|B2|Israel||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3995694|NCT01232452|3816145|B1|Israel||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3995695|NCT01232452|3816143|B3|Italy||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
3995696|NCT01232452|3816144|B2|Italy||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3995697|NCT01232452|3816145|B1|Italy||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3995698|NCT01232452|3816143|B3|Brazil||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
3995699|NCT01232452|3816144|B2|Brazil||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
3995700|NCT01232452|3816145|B1|Brazil||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3995701|NCT01232452|3816143|B3|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3995702|NCT01232452|3816144|B2|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3995703|NCT01232452|3816145|B1|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3995704|NCT01232452|3816143|B3|Belgium||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3995705|NCT01232452|3816144|B2|Belgium||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3995706|NCT01232452|3816145|B1|Belgium||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3995707|NCT01232452|3816143|B3|Turkey||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
3995708|NCT01232452|3816144|B2|Turkey||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
3995709|NCT01232452|3816145|B1|Turkey||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3995710|NCT01232452|3816143|B3|Argentina||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3995711|NCT01232452|3816144|B2|Argentina||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
3995712|NCT01232452|3816145|B1|Argentina||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3995713|NCT01232452|3816143|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
3995714|NCT01232452|3816144|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3995715|NCT01232452|3816145|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3995716|NCT01232452|3816143|B3|Canada||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3995717|NCT01232452|3816144|B2|Canada||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3995718|NCT01232452|3816145|B1|Canada||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3995719|NCT01232452|3816143|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3995720|NCT01232452|3816144|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3995721|NCT01232452|3816145|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3995722|NCT01232452|3816143|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995723|NCT01232452|3816144|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995724|NCT01232452|3816145|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995725|NCT01232452|3816143|B3||White|Race (NIH/OMB)||Participants|Count of Participants|161|161.0||||||
3995726|NCT01232452|3816144|B2||White|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
3995727|NCT01232452|3816145|B1||White|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
3995728|NCT01232452|3816143|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3995729|NCT01232452|3816144|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3995730|NCT01232452|3816145|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3995731|NCT01232452|3816143|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995732|NCT01232452|3816144|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995733|NCT01232452|3816145|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995734|NCT01232452|3816143|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3995735|NCT01232452|3816144|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995736|NCT01232452|3816145|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3995737|NCT01232452|3816143|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3995738|NCT01232452|3816144|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3995739|NCT01232452|3816145|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995740|NCT01232452|3816143|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
3995741|NCT01232452|3816144|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
3995742|NCT01232452|3816145|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3995743|NCT01232452|3816143|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
3995744|NCT01232452|3816144|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3995745|NCT01232452|3816145|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3995746|NCT01232452|3816143|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3995747|NCT01232452|3816144|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3995748|NCT01232452|3816145|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3995749|NCT01232452|3816143|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
3995750|NCT01232452|3816144|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3995751|NCT01232452|3816145|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3995752|NCT01232452|3816143|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3995753|NCT01232452|3816144|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3995754|NCT01232452|3816145|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3995755|NCT01232452|3816143|B3|||Age||years|Mean|59.4|59.4|Standard Deviation|9.89|9.89|||
3995756|NCT01232452|3816144|B2|||Age||years|Mean|59.3|59.3|Standard Deviation|9.96|9.96|||
3995757|NCT01232452|3816145|B1|||Age||years|Mean|59.5|59.5|Standard Deviation|9.87|9.87|||
3995758|NCT01232296|3816170|B3||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
3995759|NCT01232296|3816171|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3995760|NCT01232296|3816172|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3995761|NCT01232296|3816170|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3995762|NCT01232296|3816171|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3995763|NCT01232296|3816172|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3995764|NCT01232296|3816170|B3|||Age||Years|Mean|55.8|55.8|Standard Deviation|11.91|11.91|||
3995765|NCT01232296|3816171|B2|||Age||Years|Mean|56.2|56.2|Standard Deviation|11.72|11.72|||
3995766|NCT01232296|3816172|B1|||Age||Years|Mean|55.5|55.5|Standard Deviation|12.16|12.16|||
3995767|NCT01232283|3816188|B3|||Duration of Plaque Psoriasis|All participants enrolled were required to have a diagnosis of plaque psoriasis at least 12 months prior to screening, but the duration was not required for enrollment. Overall baseline population for duration of plaque psoriasis in the apremilast arm were 271 participants and 135 for those in the placebo arm.|years|Mean|18.19|18.19|Standard Deviation|11.602|11.602|||
3995768|NCT01232283|3816189|B2|||Duration of Plaque Psoriasis|All participants enrolled were required to have a diagnosis of plaque psoriasis at least 12 months prior to screening, but the duration was not required for enrollment. Overall baseline population for duration of plaque psoriasis in the apremilast arm were 271 participants and 135 for those in the placebo arm.|years|Mean|18.68|18.68|Standard Deviation|12.088|12.088|||
3995769|NCT01232283|3816190|B1|||Duration of Plaque Psoriasis|All participants enrolled were required to have a diagnosis of plaque psoriasis at least 12 months prior to screening, but the duration was not required for enrollment. Overall baseline population for duration of plaque psoriasis in the apremilast arm were 271 participants and 135 for those in the placebo arm.|years|Mean|17.94|17.94|Standard Deviation|11.367|11.367|||
3995770|NCT01232283|3816188|B3|Other-not specified||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3995771|NCT01232283|3816189|B2|Other-not specified||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3995772|NCT01232283|3816190|B1|Other-not specified||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3995773|NCT01232283|3816188|B3|White||Race/Ethnicity, Customized||participants|Number|378|378.0||||||
3995774|NCT01232283|3816189|B2|White||Race/Ethnicity, Customized||participants|Number|128|128.0||||||
3995775|NCT01232283|3816190|B1|White||Race/Ethnicity, Customized||participants|Number|250|250.0||||||
3995776|NCT01232283|3816188|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3995777|NCT01232283|3816189|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3995778|NCT01232283|3816190|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3995779|NCT01232283|3816188|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3995780|NCT01232283|3816189|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3995781|NCT01232283|3816190|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3995782|NCT01232283|3816188|B3|Asian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
3995783|NCT01232283|3816189|B2|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3995784|NCT01232283|3816190|B1|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3995785|NCT01232283|3816188|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3995786|NCT01232283|3816189|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3995787|NCT01232283|3816190|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3995788|NCT01232283|3816188|B3||Male|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
3995789|NCT01232283|3816189|B2||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3995790|NCT01232283|3816190|B1||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
3995791|NCT01232283|3816188|B3||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3995792|NCT01232283|3816189|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3995793|NCT01232283|3816190|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
3995794|NCT01232283|3816188|B3|||Age||years|Mean|45.4|45.4|Standard Deviation|13.15|13.15|||
3995795|NCT01232283|3816189|B2|||Age||years|Mean|45.7|45.7|Standard Deviation|13.38|13.38|||
3995796|NCT01232283|3816190|B1|||Age||years|Mean|45.3|45.3|Standard Deviation|13.05|13.05|||
3995797|NCT01232205|3816231|B3|Indonesia||Region of Enrollment||participants|Number|110|110.0||||||
3995798|NCT01232205|3816232|B2|Indonesia||Region of Enrollment||participants|Number|58|58.0||||||
3995799|NCT01232205|3816233|B1|Indonesia||Region of Enrollment||participants|Number|52|52.0||||||
3995800|NCT01232205|3816231|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3995801|NCT01232205|3816232|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3995802|NCT01232205|3816233|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3995803|NCT01232205|3816231|B3||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
3995804|NCT01232205|3816232|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3995805|NCT01232205|3816233|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3995806|NCT01232205|3816231|B3|||Age||years|Mean|28.9|28.9|Standard Deviation|5.1|5.1|||
3995807|NCT01232205|3816232|B2|||Age||years|Mean|29.7|29.7|Standard Deviation|5.07|5.07|||
3995808|NCT01232205|3816233|B1|||Age||years|Mean|28.1|28.1|Standard Deviation|5.08|5.08|||
3995809|NCT01232205|3816231|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3995810|NCT01232205|3816232|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3995811|NCT01232205|3816233|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3995812|NCT01232205|3816231|B3||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
3995813|NCT01232205|3816232|B2||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
3995814|NCT01232205|3816233|B1||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3995815|NCT01232205|3816231|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3995816|NCT01232205|3816232|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3995817|NCT01232205|3816233|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3995818|NCT01232127|3816240|B1|||CD4 Percent of Total|n=23 (n=evaluable participants)For 2 participants, baseline CD4 percent total and absolute count were performed as an unscheduled visit after the initial screening visit and thus, are not included in this summary.|Percent of participants|Mean|32.1|32.1|Standard Deviation|7.10|7.1|||
3995819|NCT01232127|3816240|B1|||CD4 Absolute Count|n=23 (n=evaluable participants)|Cells/μL|Mean|584.8|584.8|Standard Deviation|194.09|194.09|||
3995820|NCT01232127|3816240|B1|||Age||Years|Mean|39.8|39.8|Full Range|||23.0|62.0|
3995821|NCT01232127|3816240|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995822|NCT01232127|3816240|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995823|NCT01232127|3816240|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3995824|NCT01232127|3816240|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3995825|NCT01232127|3816240|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995826|NCT01232127|3816240|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995827|NCT01232127|3816240|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3995828|NCT01232127|3816240|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3995829|NCT01232127|3816240|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3995830|NCT01232127|3816240|B1|65 years and older||Age, Customized||Participants|Number|0|0.0||||||
3995831|NCT01232127|3816240|B1|Younger than 65 years||Age, Customized||Participants|Number|25|25.0||||||
3995832|NCT01231984|3816264|B3|United States||Region of Enrollment||participants|Number|274|274.0||||||
3995833|NCT01231984|3816265|B2|United States||Region of Enrollment||participants|Number|135|135.0||||||
3995834|NCT01231984|3816266|B1|United States||Region of Enrollment||participants|Number|139|139.0||||||
3995835|NCT01231984|3816264|B3||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
3995836|NCT01231984|3816265|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3995837|NCT01231984|3816266|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3995838|NCT01231984|3816264|B3||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
3995839|NCT01231984|3816265|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3995840|NCT01231984|3816266|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3995841|NCT01231984|3816264|B3|||Age||years|Mean|56.7|56.7|Standard Deviation|11.0|11.0|||
3995842|NCT01231984|3816265|B2|||Age||years|Mean|55.9|55.9|Standard Deviation|11.3|11.3|||
3995843|NCT01231984|3816266|B1|||Age||years|Mean|57.5|57.5|Standard Deviation|10.6|10.6|||
3995844|NCT01231841|3816290|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3995845|NCT01231841|3816290|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3995846|NCT01231841|3816290|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3995847|NCT01231841|3816290|B1|||Age||years|Mean|51.95|51.95|Standard Deviation|18.43|18.43|||
3995848|NCT01231841|3816290|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3995849|NCT01231841|3816290|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3995850|NCT01231841|3816290|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3995851|NCT01231750|3816294|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
3995852|NCT01231750|3816295|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
3995853|NCT01231750|3816296|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3995854|NCT01231750|3816294|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3995855|NCT01231750|3816295|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3995856|NCT01231750|3816296|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3995857|NCT01231750|3816294|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3995858|NCT01231750|3816295|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3995859|NCT01231750|3816296|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3995860|NCT01231750|3816294|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3995861|NCT01231750|3816295|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3995862|NCT01231750|3816296|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3995863|NCT01231750|3816294|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
3995864|NCT01231750|3816295|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3995865|NCT01231750|3816296|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3995866|NCT01231750|3816294|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3995867|NCT01231750|3816295|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3995868|NCT01231750|3816296|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3995869|NCT01231646|3816313|B3|||BMI||kg/m^2|Mean|26.44|26.44|Standard Deviation|5.77|5.77|||
3995870|NCT01231646|3816314|B2|||BMI||kg/m^2|Mean|30.47|30.47|Standard Deviation|7.2|7.2|||
3995871|NCT01231646|3816315|B1|||BMI||kg/m^2|Mean|24.95|24.95|Standard Deviation|4.3|4.3|||
3995872|NCT01231646|3816313|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3995873|NCT01231646|3816314|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3995874|NCT01231646|3816315|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3995875|NCT01231646|3816313|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3995876|NCT01231646|3816314|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3995877|NCT01231646|3816315|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3995878|NCT01231646|3816313|B3|||Age||years|Mean|34.7|34.7|Standard Deviation|9.89|9.89|||
3995879|NCT01231646|3816314|B2|||Age||years|Mean|39.1|39.1|Standard Deviation|7.77|7.77|||
3995880|NCT01231646|3816315|B1|||Age||years|Mean|33|33.0|Standard Deviation|10.22|10.22|||
3995881|NCT01231633|3816322|B3|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
3995882|NCT01231633|3816323|B2|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3995883|NCT01231633|3816324|B1|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
3995884|NCT01231633|3816322|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3995885|NCT01231633|3816323|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3995886|NCT01231633|3816324|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3995887|NCT01231633|3816322|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3995888|NCT01231633|3816323|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3995889|NCT01231633|3816324|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3995890|NCT01231633|3816322|B3|||Age||years|Mean|71.3|71.3|Full Range|||43.0|92.0|
3995891|NCT01231633|3816323|B2|||Age||years|Mean|74.3|74.3|Full Range|||62.0|86.0|
3995892|NCT01231633|3816324|B1|||Age||years|Mean|68.8|68.8|Full Range|||43.0|92.0|
3995893|NCT01231633|3816322|B3||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
3995894|NCT01231633|3816323|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3995895|NCT01231633|3816324|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3995896|NCT01231633|3816322|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
3995897|NCT01231633|3816323|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3995898|NCT01231633|3816324|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3995899|NCT01231633|3816322|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3995900|NCT01231633|3816323|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3995901|NCT01231633|3816324|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3995902|NCT01231620|3816335|B4|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3995903|NCT01231620|3816336|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3995904|NCT01231620|3816337|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3995905|NCT01231620|3816338|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3995906|NCT01231620|3816335|B4|Unknown||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3995907|NCT01231620|3816336|B3|Unknown||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3995908|NCT01231620|3816337|B2|Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3995909|NCT01231620|3816338|B1|Unknown||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3995910|NCT01231620|3816335|B4|White -White or Caucasian or European||Race/Ethnicity, Customized||Participants|Number|466|466.0||||||
3995911|NCT01231620|3816336|B3|White -White or Caucasian or European||Race/Ethnicity, Customized||Participants|Number|154|154.0||||||
3995912|NCT01231620|3816337|B2|White -White or Caucasian or European||Race/Ethnicity, Customized||Participants|Number|162|162.0||||||
3995913|NCT01231620|3816338|B1|White -White or Caucasian or European||Race/Ethnicity, Customized||Participants|Number|150|150.0||||||
3995914|NCT01231620|3816335|B4|White - Arabic or North African||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
3995915|NCT01231620|3816336|B3|White - Arabic or North African||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3995916|NCT01231620|3816337|B2|White - Arabic or North African||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3995917|NCT01231620|3816338|B1|White - Arabic or North African||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3995918|NCT01231620|3816335|B4|Native Hawaiian or Other Pacific||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3995919|NCT01231620|3816336|B3|Native Hawaiian or Other Pacific||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3995920|NCT01231620|3816337|B2|Native Hawaiian or Other Pacific||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3995921|NCT01231620|3816338|B1|Native Hawaiian or Other Pacific||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3995922|NCT01231620|3816335|B4|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
3995923|NCT01231620|3816336|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
3995924|NCT01231620|3816337|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3995925|NCT01231620|3816338|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3995926|NCT01231620|3816335|B4|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|43|43.0||||||
3995927|NCT01231620|3816336|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
3995928|NCT01231620|3816337|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
3995929|NCT01231620|3816338|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3995930|NCT01231620|3816335|B4|Asian - Central South Asian||Race/Ethnicity, Customized||Participants|Number|38|38.0||||||
3995931|NCT01231620|3816336|B3|Asian - Central South Asian||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
3995932|NCT01231620|3816337|B2|Asian - Central South Asian||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
3995933|NCT01231620|3816338|B1|Asian - Central South Asian||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
3995934|NCT01231620|3816335|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
3995935|NCT01231620|3816336|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3995936|NCT01231620|3816337|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3995937|NCT01231620|3816338|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3995938|NCT01231620|3816335|B4|African American or African Heritage||Race/Ethnicity, Customized||Participants|Number|26|26.0||||||
3995939|NCT01231620|3816336|B3|African American or African Heritage||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
3995940|NCT01231620|3816337|B2|African American or African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
3995941|NCT01231620|3816338|B1|African American or African Heritage||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
3995942|NCT01231620|3816335|B4||Male|Sex: Female, Male||Participants|Count of Participants|330|330.0||||||
3995943|NCT01231620|3816336|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3995944|NCT01231620|3816337|B2||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
3995945|NCT01231620|3816338|B1||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3995946|NCT01231620|3816335|B4||Female|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
3995947|NCT01231620|3816336|B3||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3995948|NCT01231620|3816337|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3995949|NCT01231620|3816338|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3995950|NCT01231620|3816335|B4|||Age||Years|Mean|56.2|56.2|Standard Deviation|18.32|18.32|||
3995951|NCT01231620|3816336|B3|||Age||Years|Mean|55.9|55.9|Standard Deviation|18.7|18.7|||
3995952|NCT01231620|3816337|B2|||Age||Years|Mean|57.3|57.3|Standard Deviation|17.39|17.39|||
3995953|NCT01231620|3816338|B1|||Age||Years|Mean|55.2|55.2|Standard Deviation|18.88|18.88|||
3995954|NCT01231607|3816441|B6|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|220|220.0||||||
3995955|NCT01231607|3816442|B5|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|42|42.0||||||
3995956|NCT01231607|3816443|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|43|43.0||||||
3995957|NCT01231607|3816444|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|44|44.0||||||
3995958|NCT01231607|3816445|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|47|47.0||||||
3995959|NCT01231607|3816446|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|44|44.0||||||
3995960|NCT01231607|3816441|B6|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3995961|NCT01231607|3816442|B5|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3995962|NCT01231607|3816443|B4|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3995963|NCT01231607|3816444|B3|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3995964|NCT01231607|3816445|B2|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3995965|NCT01231607|3816446|B1|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3995966|NCT01231607|3816441|B6|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|96|96.0||||||
3995967|NCT01231607|3816442|B5|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
3995968|NCT01231607|3816443|B4|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
3995969|NCT01231607|3816444|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
3995970|NCT01231607|3816445|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
3995971|NCT01231607|3816446|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
3995972|NCT01231607|3816441|B6|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|211|211.0||||||
3995973|NCT01231607|3816442|B5|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|41|41.0||||||
3995974|NCT01231607|3816443|B4|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|41|41.0||||||
3995975|NCT01231607|3816444|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|42|42.0||||||
3995976|NCT01231607|3816445|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|43|43.0||||||
3995977|NCT01231607|3816446|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|44|44.0||||||
3995978|NCT01231607|3816441|B6|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3995979|NCT01231607|3816442|B5|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3995980|NCT01231607|3816443|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3995981|NCT01231607|3816444|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3995982|NCT01231607|3816445|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3995983|NCT01231607|3816446|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3995984|NCT01231607|3816441|B6|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|188|188.0||||||
3995985|NCT01231607|3816442|B5|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|38|38.0||||||
3995986|NCT01231607|3816443|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|36|36.0||||||
3995987|NCT01231607|3816444|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|39|39.0||||||
3995988|NCT01231607|3816445|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|38|38.0||||||
3995989|NCT01231607|3816446|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
3995990|NCT01231607|3816441|B6|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|199|199.0||||||
3995991|NCT01231607|3816442|B5|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|39|39.0||||||
3995992|NCT01231607|3816443|B4|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
3995993|NCT01231607|3816444|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
3995994|NCT01231607|3816445|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
3995995|NCT01231607|3816446|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
3995996|NCT01231607|3816441|B6||Male|Sex: Female, Male||Participants|Count of Participants|917|917.0||||||
3995997|NCT01231607|3816442|B5||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
3995998|NCT01231607|3816443|B4||Male|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
3995999|NCT01231607|3816444|B3||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3996000|NCT01231607|3816445|B2||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3996001|NCT01231607|3816446|B1||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
3996002|NCT01231607|3816441|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3996003|NCT01231607|3816442|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3996004|NCT01231607|3816443|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3996005|NCT01231607|3816444|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3996006|NCT01231607|3816445|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3996007|NCT01231607|3816446|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3996008|NCT01231607|3816441|B6|||Age||Years|Mean|38.5|38.5|Standard Deviation|7.80|7.8|||
3996009|NCT01231607|3816442|B5|||Age||Years|Mean|38.7|38.7|Standard Deviation|8.43|8.43|||
3996010|NCT01231607|3816443|B4|||Age||Years|Mean|38.0|38.0|Standard Deviation|7.81|7.81|||
3996011|NCT01231607|3816444|B3|||Age||Years|Mean|38.6|38.6|Standard Deviation|7.66|7.66|||
3996012|NCT01231607|3816445|B2|||Age||Years|Mean|38.7|38.7|Standard Deviation|7.44|7.44|||
3996013|NCT01231607|3816446|B1|||Age||Years|Mean|38.5|38.5|Standard Deviation|7.72|7.72|||
3996014|NCT01231581|3816540|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3996015|NCT01231581|3816541|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3996016|NCT01231581|3816542|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3996017|NCT01231581|3816540|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3996018|NCT01231581|3816541|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3996019|NCT01231581|3816542|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3996020|NCT01231581|3816540|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3996021|NCT01231581|3816541|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3996022|NCT01231581|3816542|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3996023|NCT01231581|3816540|B3|African American Africa||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3996024|NCT01231581|3816541|B2|African American Africa||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
3996025|NCT01231581|3816542|B1|African American Africa||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
3996026|NCT01231581|3816540|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
3996027|NCT01231581|3816541|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
3996028|NCT01231581|3816542|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
3996029|NCT01231581|3816540|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|109|109.0||||||
3996030|NCT01231581|3816541|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|59|59.0||||||
3996031|NCT01231581|3816542|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|50|50.0||||||
3996032|NCT01231581|3816540|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3996033|NCT01231581|3816541|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3996034|NCT01231581|3816542|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3996035|NCT01231581|3816540|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3996036|NCT01231581|3816541|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3996037|NCT01231581|3816542|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3996038|NCT01231581|3816540|B3|||Age||Years|Mean|62.3|62.3|Standard Deviation|9.93|9.93|||
3996039|NCT01231581|3816541|B2|||Age||Years|Mean|62.2|62.2|Standard Deviation|9.56|9.56|||
3996040|NCT01231581|3816542|B1|||Age||Years|Mean|62.3|62.3|Standard Deviation|10.35|10.35|||
3996041|NCT01231555|3816561|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996042|NCT01231555|3816562|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996043|NCT01231555|3816563|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996044|NCT01231555|3816564|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996045|NCT01231555|3816561|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996046|NCT01231555|3816562|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996047|NCT01231555|3816563|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996048|NCT01231555|3816564|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996049|NCT01231555|3816561|B4||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
3996050|NCT01231555|3816562|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3996051|NCT01231555|3816563|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3996052|NCT01231555|3816564|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3996053|NCT01231555|3816561|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3996054|NCT01231555|3816562|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996055|NCT01231555|3816563|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996056|NCT01231555|3816564|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3996057|NCT01231555|3816561|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996058|NCT01231555|3816562|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996059|NCT01231555|3816563|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996060|NCT01231555|3816564|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996061|NCT01231555|3816561|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996062|NCT01231555|3816562|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996063|NCT01231555|3816563|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996064|NCT01231555|3816564|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996065|NCT01231555|3816561|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996066|NCT01231555|3816562|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996067|NCT01231555|3816563|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996068|NCT01231555|3816564|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996069|NCT01231555|3816561|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3996070|NCT01231555|3816562|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3996071|NCT01231555|3816563|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3996072|NCT01231555|3816564|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3996073|NCT01231555|3816561|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3996074|NCT01231555|3816562|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3996075|NCT01231555|3816563|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3996076|NCT01231555|3816564|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3996077|NCT01231555|3816561|B4|||Age||Years|Mean|36.9|36.9|Standard Deviation|7.35|7.35|||
3996078|NCT01231555|3816562|B3|||Age||Years|Mean|35.9|35.9|Standard Deviation|7.97|7.97|||
3996079|NCT01231555|3816563|B2|||Age||Years|Mean|35.9|35.9|Standard Deviation|6.47|6.47|||
3996080|NCT01231555|3816564|B1|||Age||Years|Mean|38.8|38.8|Standard Deviation|8.01|8.01|||
3996081|NCT01231516|3816595|B3|Unknown||Race/Ethnicity, Customized|Baseline Characteristic data are reported for members of the modified Intent-To-Treat Exposed Population, all randomized participants who received at least one dose of IP excluding four participants at one site, which was closed due to Good Clinical Practice (GCP) non-compliance issues in another ViiV sponsored trial.|Participants|Number|2|2.0||||||
3996082|NCT01231516|3816596|B2|Unknown||Race/Ethnicity, Customized|Baseline Characteristic data are reported for members of the modified Intent-To-Treat Exposed Population, all randomized participants who received at least one dose of IP excluding four participants at one site, which was closed due to Good Clinical Practice (GCP) non-compliance issues in another ViiV sponsored trial.|Participants|Number|1|1.0||||||
3996083|NCT01231516|3816597|B1|Unknown||Race/Ethnicity, Customized|Baseline Characteristic data are reported for members of the modified Intent-To-Treat Exposed Population, all randomized participants who received at least one dose of IP excluding four participants at one site, which was closed due to Good Clinical Practice (GCP) non-compliance issues in another ViiV sponsored trial.|Participants|Number|1|1.0||||||
3996084|NCT01231516|3816595|B3|Mixed Race||Race/Ethnicity, Customized|Baseline Characteristic data are reported for members of the modified Intent-To-Treat Exposed Population, all randomized participants who received at least one dose of IP excluding four participants at one site, which was closed due to Good Clinical Practice (GCP) non-compliance issues in another ViiV sponsored trial.|Participants|Number|14|14.0||||||
3996085|NCT01231516|3816596|B2|Mixed Race||Race/Ethnicity, Customized|Baseline Characteristic data are reported for members of the modified Intent-To-Treat Exposed Population, all randomized participants who received at least one dose of IP excluding four participants at one site, which was closed due to Good Clinical Practice (GCP) non-compliance issues in another ViiV sponsored trial.|Participants|Number|2|2.0||||||
3996086|NCT01231516|3816597|B1|Mixed Race||Race/Ethnicity, Customized|Baseline Characteristic data are reported for members of the modified Intent-To-Treat Exposed Population, all randomized participants who received at least one dose of IP excluding four participants at one site, which was closed due to Good Clinical Practice (GCP) non-compliance issues in another ViiV sponsored trial.|Participants|Number|12|12.0||||||
3996087|NCT01231516|3816595|B3|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized|Baseline Characteristic data are reported for members of the modified Intent-To-Treat Exposed Population, all randomized participants who received at least one dose of IP excluding four participants at one site, which was closed due to Good Clinical Practice (GCP) non-compliance issues in another ViiV sponsored trial.|Participants|Number|347|347.0||||||
3996088|NCT01231516|3816596|B2|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized|Baseline Characteristic data are reported for members of the modified Intent-To-Treat Exposed Population, all randomized participants who received at least one dose of IP excluding four participants at one site, which was closed due to Good Clinical Practice (GCP) non-compliance issues in another ViiV sponsored trial.|Participants|Number|172|172.0||||||
3996089|NCT01231516|3816597|B1|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized|Baseline Characteristic data are reported for members of the modified Intent-To-Treat Exposed Population, all randomized participants who received at least one dose of IP excluding four participants at one site, which was closed due to Good Clinical Practice (GCP) non-compliance issues in another ViiV sponsored trial.|Participants|Number|175|175.0||||||
3996090|NCT01231516|3816595|B3|White-Arabic/North African Heritage||Race/Ethnicity, Customized|Baseline Characteristic data are reported for members of the modified Intent-To-Treat Exposed Population, all randomized participants who received at least one dose of IP excluding four participants at one site, which was closed due to Good Clinical Practice (GCP) non-compliance issues in another ViiV sponsored trial.|Participants|Number|6|6.0||||||
3996091|NCT01231516|3816596|B2|White-Arabic/North African Heritage||Race/Ethnicity, Customized|Baseline Characteristic data are reported for members of the modified Intent-To-Treat Exposed Population, all randomized participants who received at least one dose of IP excluding four participants at one site, which was closed due to Good Clinical Practice (GCP) non-compliance issues in another ViiV sponsored trial.|Participants|Number|3|3.0||||||
3996092|NCT01231516|3816597|B1|White-Arabic/North African Heritage||Race/Ethnicity, Customized|Baseline Characteristic data are reported for members of the modified Intent-To-Treat Exposed Population, all randomized participants who received at least one dose of IP excluding four participants at one site, which was closed due to Good Clinical Practice (GCP) non-compliance issues in another ViiV sponsored trial.|Participants|Number|3|3.0||||||
3996093|NCT01231516|3816595|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Baseline Characteristic data are reported for members of the modified Intent-To-Treat Exposed Population, all randomized participants who received at least one dose of IP excluding four participants at one site, which was closed due to Good Clinical Practice (GCP) non-compliance issues in another ViiV sponsored trial.|Participants|Number|1|1.0||||||
3996094|NCT01231516|3816596|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Baseline Characteristic data are reported for members of the modified Intent-To-Treat Exposed Population, all randomized participants who received at least one dose of IP excluding four participants at one site, which was closed due to Good Clinical Practice (GCP) non-compliance issues in another ViiV sponsored trial.|Participants|Number|0|0.0||||||
3996095|NCT01231516|3816597|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Baseline Characteristic data are reported for members of the modified Intent-To-Treat Exposed Population, all randomized participants who received at least one dose of IP excluding four participants at one site, which was closed due to Good Clinical Practice (GCP) non-compliance issues in another ViiV sponsored trial.|Participants|Number|1|1.0||||||
3996096|NCT01231516|3816595|B3|Asian-South East Asian Heritage||Race/Ethnicity, Customized|Baseline Characteristic data are reported for members of the modified Intent-To-Treat Exposed Population, all randomized participants who received at least one dose of IP excluding four participants at one site, which was closed due to Good Clinical Practice (GCP) non-compliance issues in another ViiV sponsored trial.|Participants|Number|1|1.0||||||
3996097|NCT01231516|3816596|B2|Asian-South East Asian Heritage||Race/Ethnicity, Customized|Baseline Characteristic data are reported for members of the modified Intent-To-Treat Exposed Population, all randomized participants who received at least one dose of IP excluding four participants at one site, which was closed due to Good Clinical Practice (GCP) non-compliance issues in another ViiV sponsored trial.|Participants|Number|0|0.0||||||
3996098|NCT01231516|3816597|B1|Asian-South East Asian Heritage||Race/Ethnicity, Customized|Baseline Characteristic data are reported for members of the modified Intent-To-Treat Exposed Population, all randomized participants who received at least one dose of IP excluding four participants at one site, which was closed due to Good Clinical Practice (GCP) non-compliance issues in another ViiV sponsored trial.|Participants|Number|1|1.0||||||
3996099|NCT01231516|3816595|B3|Asian-East Asian Heritage||Race/Ethnicity, Customized|Baseline Characteristic data are reported for members of the modified Intent-To-Treat Exposed Population, all randomized participants who received at least one dose of IP excluding four participants at one site, which was closed due to Good Clinical Practice (GCP) non-compliance issues in another ViiV sponsored trial.|Participants|Number|10|10.0||||||
3996100|NCT01231516|3816596|B2|Asian-East Asian Heritage||Race/Ethnicity, Customized|Baseline Characteristic data are reported for members of the modified Intent-To-Treat Exposed Population, all randomized participants who received at least one dose of IP excluding four participants at one site, which was closed due to Good Clinical Practice (GCP) non-compliance issues in another ViiV sponsored trial.|Participants|Number|4|4.0||||||
3996101|NCT01231516|3816597|B1|Asian-East Asian Heritage||Race/Ethnicity, Customized|Baseline Characteristic data are reported for members of the modified Intent-To-Treat Exposed Population, all randomized participants who received at least one dose of IP excluding four participants at one site, which was closed due to Good Clinical Practice (GCP) non-compliance issues in another ViiV sponsored trial.|Participants|Number|6|6.0||||||
3996102|NCT01231516|3816595|B3|Asian-Central/South Asian Heritage||Race/Ethnicity, Customized|Baseline Characteristic data are reported for members of the modified Intent-To-Treat Exposed Population, all randomized participants who received at least one dose of IP excluding four participants at one site, which was closed due to Good Clinical Practice (GCP) non-compliance issues in another ViiV sponsored trial.|Participants|Number|4|4.0||||||
3996103|NCT01231516|3816596|B2|Asian-Central/South Asian Heritage||Race/Ethnicity, Customized|Baseline Characteristic data are reported for members of the modified Intent-To-Treat Exposed Population, all randomized participants who received at least one dose of IP excluding four participants at one site, which was closed due to Good Clinical Practice (GCP) non-compliance issues in another ViiV sponsored trial.|Participants|Number|2|2.0||||||
3996104|NCT01231516|3816597|B1|Asian-Central/South Asian Heritage||Race/Ethnicity, Customized|Baseline Characteristic data are reported for members of the modified Intent-To-Treat Exposed Population, all randomized participants who received at least one dose of IP excluding four participants at one site, which was closed due to Good Clinical Practice (GCP) non-compliance issues in another ViiV sponsored trial.|Participants|Number|2|2.0||||||
3996105|NCT01231516|3816595|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|Baseline Characteristic data are reported for members of the modified Intent-To-Treat Exposed Population, all randomized participants who received at least one dose of IP excluding four participants at one site, which was closed due to Good Clinical Practice (GCP) non-compliance issues in another ViiV sponsored trial.|Participants|Number|27|27.0||||||
3996106|NCT01231516|3816596|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|Baseline Characteristic data are reported for members of the modified Intent-To-Treat Exposed Population, all randomized participants who received at least one dose of IP excluding four participants at one site, which was closed due to Good Clinical Practice (GCP) non-compliance issues in another ViiV sponsored trial.|Participants|Number|17|17.0||||||
3996107|NCT01231516|3816597|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Baseline Characteristic data are reported for members of the modified Intent-To-Treat Exposed Population, all randomized participants who received at least one dose of IP excluding four participants at one site, which was closed due to Good Clinical Practice (GCP) non-compliance issues in another ViiV sponsored trial.|Participants|Number|10|10.0||||||
3996108|NCT01231516|3816595|B3|African American/African Heritage||Race/Ethnicity, Customized|Baseline Characteristic data are reported for members of the modified Intent-To-Treat Exposed Population, all randomized participants who received at least one dose of IP excluding four participants at one site, which was closed due to Good Clinical Practice (GCP) non-compliance issues in another ViiV sponsored trial.|Participants|Number|303|303.0||||||
3996109|NCT01231516|3816596|B2|African American/African Heritage||Race/Ethnicity, Customized|Baseline Characteristic data are reported for members of the modified Intent-To-Treat Exposed Population, all randomized participants who received at least one dose of IP excluding four participants at one site, which was closed due to Good Clinical Practice (GCP) non-compliance issues in another ViiV sponsored trial.|Participants|Number|160|160.0||||||
3996110|NCT01231516|3816597|B1|African American/African Heritage||Race/Ethnicity, Customized|Baseline Characteristic data are reported for members of the modified Intent-To-Treat Exposed Population, all randomized participants who received at least one dose of IP excluding four participants at one site, which was closed due to Good Clinical Practice (GCP) non-compliance issues in another ViiV sponsored trial.|Participants|Number|143|143.0||||||
3996111|NCT01231516|3816595|B3||Male|Sex: Female, Male|Baseline Characteristic data are reported for members of the modified Intent-To-Treat Exposed Population, all randomized participants who received at least one dose of IP excluding four participants at one site, which was closed due to Good Clinical Practice (GCP) non-compliance issues in another ViiV sponsored trial.|Participants|Count of Participants|485|485.0||||||
3996112|NCT01231516|3816596|B2||Male|Sex: Female, Male|Baseline Characteristic data are reported for members of the modified Intent-To-Treat Exposed Population, all randomized participants who received at least one dose of IP excluding four participants at one site, which was closed due to Good Clinical Practice (GCP) non-compliance issues in another ViiV sponsored trial.|Participants|Count of Participants|238|238.0||||||
3996113|NCT01231516|3816597|B1||Male|Sex: Female, Male|Baseline Characteristic data are reported for members of the modified Intent-To-Treat Exposed Population, all randomized participants who received at least one dose of IP excluding four participants at one site, which was closed due to Good Clinical Practice (GCP) non-compliance issues in another ViiV sponsored trial.|Participants|Count of Participants|247|247.0||||||
3996114|NCT01231516|3816595|B3||Female|Sex: Female, Male|Baseline Characteristic data are reported for members of the modified Intent-To-Treat Exposed Population, all randomized participants who received at least one dose of IP excluding four participants at one site, which was closed due to Good Clinical Practice (GCP) non-compliance issues in another ViiV sponsored trial.|Participants|Count of Participants|230|230.0||||||
3996115|NCT01231516|3816596|B2||Female|Sex: Female, Male|Baseline Characteristic data are reported for members of the modified Intent-To-Treat Exposed Population, all randomized participants who received at least one dose of IP excluding four participants at one site, which was closed due to Good Clinical Practice (GCP) non-compliance issues in another ViiV sponsored trial.|Participants|Count of Participants|123|123.0||||||
3996116|NCT01231516|3816597|B1||Female|Sex: Female, Male|Baseline Characteristic data are reported for members of the modified Intent-To-Treat Exposed Population, all randomized participants who received at least one dose of IP excluding four participants at one site, which was closed due to Good Clinical Practice (GCP) non-compliance issues in another ViiV sponsored trial.|Participants|Count of Participants|107|107.0||||||
3996117|NCT01231516|3816595|B3|||Age|Baseline Characteristic data are reported for members of the modified Intent-To-Treat Exposed Population, all randomized participants who received at least one dose of IP excluding four participants at one site, which was closed due to Good Clinical Practice (GCP) non-compliance issues in another ViiV sponsored trial.|Years|Mean|42.5|42.5|Standard Deviation|10.13|10.13|||
3996118|NCT01231516|3816596|B2|||Age|Baseline Characteristic data are reported for members of the modified Intent-To-Treat Exposed Population, all randomized participants who received at least one dose of IP excluding four participants at one site, which was closed due to Good Clinical Practice (GCP) non-compliance issues in another ViiV sponsored trial.|Years|Mean|42.5|42.5|Standard Deviation|9.81|9.81|||
3996119|NCT01231516|3816597|B1|||Age|Baseline Characteristic data are reported for members of the modified Intent-To-Treat Exposed Population, all randomized participants who received at least one dose of IP excluding four participants at one site, which was closed due to Good Clinical Practice (GCP) non-compliance issues in another ViiV sponsored trial.|Years|Mean|42.6|42.6|Standard Deviation|10.45|10.45|||
3996120|NCT01231503|3816620|B9||Male|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
3996121|NCT01231503|3816621|B8||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3996122|NCT01231503|3816622|B7||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3996123|NCT01231503|3816623|B6||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3996124|NCT01231503|3816624|B5||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3996125|NCT01231503|3816625|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3996126|NCT01231503|3816626|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3996127|NCT01231503|3816627|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3996128|NCT01231503|3816628|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3996129|NCT01231503|3816620|B9||Female|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
3996130|NCT01231503|3816621|B8||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3996131|NCT01231503|3816622|B7||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3996132|NCT01231503|3816623|B6||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3996133|NCT01231503|3816624|B5||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3996134|NCT01231503|3816625|B4||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3996135|NCT01231503|3816626|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3996136|NCT01231503|3816627|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3996137|NCT01231503|3816628|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3996138|NCT01231503|3816620|B9|||Age||Days|Mean|0.3|0.3|Standard Deviation|1.03|1.03|||
3996139|NCT01231503|3816621|B8|||Age||Days|Mean|0.4|0.4|Standard Deviation|1.2|1.2|||
3996140|NCT01231503|3816622|B7|||Age||Days|Mean|0.2|0.2|Standard Deviation|0.9|0.9|||
3996141|NCT01231503|3816623|B6|||Age||Days|Mean|0.2|0.2|Standard Deviation|0.8|0.8|||
3996142|NCT01231503|3816624|B5|||Age||Days|Mean|0.5|0.5|Standard Deviation|1.4|1.4|||
3996143|NCT01231503|3816625|B4|||Age||Days|Mean|0.2|0.2|Standard Deviation|0.8|0.8|||
3996144|NCT01231503|3816626|B3|||Age||Days|Mean|0.2|0.2|Standard Deviation|1.0|1.0|||
3996145|NCT01231503|3816627|B2|||Age||Days|Mean|0.4|0.4|Standard Deviation|1.2|1.2|||
3996146|NCT01231503|3816628|B1|||Age||Days|Mean|0.4|0.4|Standard Deviation|1.1|1.1|||
3996147|NCT01231464|3816873|B3|Not Chinese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3996148|NCT01231464|3816874|B2|Not Chinese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3996149|NCT01231464|3816875|B1|Not Chinese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3996150|NCT01231464|3816873|B3|Chinese||Race/Ethnicity, Customized||participants|Number|363|363.0||||||
3996151|NCT01231464|3816874|B2|Chinese||Race/Ethnicity, Customized||participants|Number|182|182.0||||||
3996152|NCT01231464|3816875|B1|Chinese||Race/Ethnicity, Customized||participants|Number|181|181.0||||||
3996153|NCT01231464|3816873|B3||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3996154|NCT01231464|3816874|B2||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
3996155|NCT01231464|3816875|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3996156|NCT01231464|3816873|B3||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
3996157|NCT01231464|3816874|B2||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
3996158|NCT01231464|3816875|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3996159|NCT01231464|3816873|B3|||Age|Baseline characteristics are summarized for the Full Analysis Set (FAS), comprised of all participants who were randomized and received at least one dose of study medication.|Years|Mean|32.4|32.4|Standard Deviation|10.84|10.84|||
3996160|NCT01231464|3816874|B2|||Age|Baseline characteristics are summarized for the Full Analysis Set (FAS), comprised of all participants who were randomized and received at least one dose of study medication.|Years|Mean|33.0|33.0|Standard Deviation|10.95|10.95|||
3996161|NCT01231464|3816875|B1|||Age|Baseline characteristics are summarized for the Full Analysis Set (FAS), comprised of all participants who were randomized and received at least one dose of study medication.|Years|Mean|31.8|31.8|Standard Deviation|10.72|10.72|||
3996162|NCT01231412|3816886|B4|Germany||Region of Enrollment||participants|Number|3|3.0||||||
3996163|NCT01231412|3816887|B3|Germany||Region of Enrollment||participants|Number|0|0.0||||||
3996164|NCT01231412|3816888|B2|Germany||Region of Enrollment||participants|Number|1|1.0||||||
3996165|NCT01231412|3816889|B1|Germany||Region of Enrollment||participants|Number|2|2.0||||||
3996166|NCT01231412|3816886|B4|Denmark||Region of Enrollment||participants|Number|22|22.0||||||
3996167|NCT01231412|3816887|B3|Denmark||Region of Enrollment||participants|Number|0|0.0||||||
3996168|NCT01231412|3816888|B2|Denmark||Region of Enrollment||participants|Number|12|12.0||||||
3996169|NCT01231412|3816889|B1|Denmark||Region of Enrollment||participants|Number|10|10.0||||||
3996170|NCT01231412|3816886|B4|United States||Region of Enrollment||participants|Number|149|149.0||||||
3996171|NCT01231412|3816887|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3996172|NCT01231412|3816888|B2|United States||Region of Enrollment||participants|Number|78|78.0||||||
3996173|NCT01231412|3816889|B1|United States||Region of Enrollment||participants|Number|65|65.0||||||
3996174|NCT01231412|3816886|B4||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
3996175|NCT01231412|3816887|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3996176|NCT01231412|3816888|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3996177|NCT01231412|3816889|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3996178|NCT01231412|3816886|B4||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3996179|NCT01231412|3816887|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3996180|NCT01231412|3816888|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3996181|NCT01231412|3816889|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3996182|NCT01231412|3816886|B4|||Age||years|Median|62.655|62.655|Full Range|||18.2|79.0|
3996183|NCT01231412|3816887|B3|||Age||years|Median|59.515|59.515|Full Range|||36.47|67.83|
3996184|NCT01231412|3816888|B2|||Age||years|Median|63.75|63.75|Full Range|||41.02|79.0|
3996185|NCT01231412|3816889|B1|||Age||years|Median|61.94|61.94|Full Range|||18.2|77.09|
3996186|NCT01231412|3816886|B4||>=65 years|Age||Participants|Count of Participants|68|68.0||||||
3996187|NCT01231412|3816887|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3996188|NCT01231412|3816888|B2||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
3996189|NCT01231412|3816889|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
3996190|NCT01231412|3816886|B4||Between 18 and 65 years|Age||Participants|Count of Participants|106|106.0||||||
3996191|NCT01231412|3816887|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3996192|NCT01231412|3816888|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3996193|NCT01231412|3816889|B1||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
3996194|NCT01231412|3816886|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3996195|NCT01231412|3816887|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3996196|NCT01231412|3816888|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3996197|NCT01231412|3816889|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3996198|NCT01231399|3816914|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3996199|NCT01231399|3816914|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3996200|NCT01231399|3816914|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3996201|NCT01231399|3816914|B1|||Age||years|Median|58|58.0|Full Range|||36.0|86.0|
3996202|NCT01231373|3816921|B5|||Calculated BMI||kg/m^2|Mean|29.5|29.5|Standard Deviation|6.03|6.03|||
3996203|NCT01231373|3816922|B4|||Calculated BMI||kg/m^2|Mean|28.4|28.4|Standard Deviation|6.45|6.45|||
3996204|NCT01231373|3816923|B3|||Calculated BMI||kg/m^2|Mean|30.7|30.7|Standard Deviation|6.28|6.28|||
3996205|NCT01231373|3816924|B2|||Calculated BMI||kg/m^2|Mean|30.1|30.1|Standard Deviation|19.48|19.48|||
3996206|NCT01231373|3816925|B1|||Calculated BMI||kg/m^2|Mean|28.8|28.8|Standard Deviation|5.76|5.76|||
3996207|NCT01231373|3816921|B5|||Height||centimeters|Mean|169.3|169.3|Standard Deviation|9.61|9.61|||
3996208|NCT01231373|3816922|B4|||Height||centimeters|Mean|169.1|169.1|Standard Deviation|9.27|9.27|||
3996209|NCT01231373|3816923|B3|||Height||centimeters|Mean|169.6|169.6|Standard Deviation|10.47|10.47|||
3996210|NCT01231373|3816924|B2|||Height||centimeters|Mean|168.6|168.6|Standard Deviation|9.38|9.38|||
3996211|NCT01231373|3816925|B1|||Height||centimeters|Mean|169.7|169.7|Standard Deviation|9.45|9.45|||
3996212|NCT01231373|3816921|B5|||Weight||kilograms|Mean|84.8|84.8|Standard Deviation|20.11|20.11|||
3996213|NCT01231373|3816922|B4|||Weight||kilograms|Mean|81.4|81.4|Standard Deviation|20.22|20.22|||
3996214|NCT01231373|3816923|B3|||Weight||kilograms|Mean|88.8|88.8|Standard Deviation|22.66|22.66|||
3996215|NCT01231373|3816924|B2|||Weight||kilograms|Mean|85.3|85.3|Standard Deviation|16.41|16.41|||
3996216|NCT01231373|3816925|B1|||Weight||kilograms|Mean|83.0|83.0|Standard Deviation|20.22|20.22|||
3996217|NCT01231373|3816921|B5|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3996218|NCT01231373|3816922|B4|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3996219|NCT01231373|3816923|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3996220|NCT01231373|3816924|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3996221|NCT01231373|3816925|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3996222|NCT01231373|3816921|B5|American Indian/Eskimo||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3996223|NCT01231373|3816922|B4|American Indian/Eskimo||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3996224|NCT01231373|3816923|B3|American Indian/Eskimo||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3996225|NCT01231373|3816924|B2|American Indian/Eskimo||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3996226|NCT01231373|3816925|B1|American Indian/Eskimo||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3996227|NCT01231373|3816921|B5|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3996228|NCT01231373|3816922|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3996229|NCT01231373|3816923|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3996230|NCT01231373|3816924|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3996231|NCT01231373|3816925|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3996232|NCT01231373|3816921|B5|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3996233|NCT01231373|3816922|B4|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3996234|NCT01231373|3816923|B3|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
3996235|NCT01231373|3816924|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3996236|NCT01231373|3816925|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3996237|NCT01231373|3816921|B5|White||Race/Ethnicity, Customized||participants|Number|215|215.0||||||
3996238|NCT01231373|3816922|B4|White||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
3996239|NCT01231373|3816923|B3|White||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
3996240|NCT01231373|3816924|B2|White||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
3996241|NCT01231373|3816925|B1|White||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
3996242|NCT01231373|3816921|B5||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3996243|NCT01231373|3816922|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3996244|NCT01231373|3816923|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3996245|NCT01231373|3816924|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3996246|NCT01231373|3816925|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3996247|NCT01231373|3816921|B5||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
3996248|NCT01231373|3816922|B4||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3996249|NCT01231373|3816923|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3996250|NCT01231373|3816924|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3996251|NCT01231373|3816925|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3996252|NCT01231373|3816921|B5|||Age||years|Mean|50.8|50.8|Standard Deviation|10.47|10.47|||
3996253|NCT01231373|3816922|B4|||Age||years|Mean|50.4|50.4|Standard Deviation|11.42|11.42|||
3996254|NCT01231373|3816923|B3|||Age||years|Mean|50.4|50.4|Standard Deviation|9.89|9.89|||
3996255|NCT01231373|3816924|B2|||Age||years|Mean|52.8|52.8|Standard Deviation|10.06|10.06|||
3996256|NCT01231373|3816925|B1|||Age||years|Mean|49.8|49.8|Standard Deviation|10.44|10.44|||
3996257|NCT01231334|3816946|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3996258|NCT01231334|3816947|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3996259|NCT01231334|3816948|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3996260|NCT01231334|3816946|B3||Female|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
3996261|NCT01231334|3816947|B2||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
3996262|NCT01231334|3816948|B1||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3996263|NCT01231334|3816946|B3|||Age||Years|Mean|27.6|27.6|Standard Deviation|6.8|6.8|||
3996264|NCT01231334|3816947|B2|||Age||Years|Mean|27.9|27.9|Standard Deviation|7.1|7.1|||
3996265|NCT01231334|3816948|B1|||Age||Years|Mean|27.2|27.2|Standard Deviation|6.5|6.5|||
3996266|NCT01231321|3816967|B1|Russian Federation||Region of Enrollment||participants|Number|100|100.0||||||
3996267|NCT01231321|3816967|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3996268|NCT01231321|3816967|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3996269|NCT01231321|3816967|B1|||Age||years|Mean|50.9|50.9|Standard Deviation|11.1|11.1|||
3996270|NCT01231321|3816967|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3996271|NCT01231321|3816967|B1||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
3996272|NCT01231321|3816967|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3996273|NCT01231230|3816978|B1|||Airway blood flow (Qaw)|Qaw was measured with a previously validated soluble inert gas uptake method. It is based on quantifying the disappearance of the soluble gas dimethylether (DME) from the anatomical dead space. The method involves the inhalation of a gas mixture containing 10 % DME and 90% nitrogen from 500 ml below the total lung capacity position to total lung capacity, followed by a breathhold (5 or 15 sec) and subsequent exhalation while the instantaneous concentrations of DME and nitrogen are recorded.|µl.min-1.ml-1|Mean|54.8|54.8|Standard Deviation|2.6|2.6|||
3996274|NCT01231230|3816978|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3996275|NCT01231230|3816978|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996276|NCT01231230|3816978|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996277|NCT01231230|3816978|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3996278|NCT01231230|3816978|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3996279|NCT01231230|3816978|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996280|NCT01231230|3816978|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996281|NCT01231230|3816978|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996282|NCT01231230|3816978|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3996283|NCT01231230|3816978|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3996284|NCT01231230|3816978|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3996285|NCT01231230|3816978|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3996286|NCT01231230|3816978|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3996287|NCT01230931|3816988|B3|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
3996288|NCT01230931|3816989|B2|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3996289|NCT01230931|3816990|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
3996290|NCT01230931|3816988|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3996291|NCT01230931|3816989|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3996292|NCT01230931|3816990|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3996293|NCT01230931|3816988|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3996294|NCT01230931|3816989|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3996295|NCT01230931|3816990|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3996296|NCT01230931|3816988|B3|||Age||years|Mean|33.8|33.8|Standard Deviation|8.8|8.8|||
3996297|NCT01230931|3816989|B2|||Age||years|Mean|36.4|36.4|Standard Deviation|8.5|8.5|||
3996298|NCT01230931|3816990|B1|||Age||years|Mean|31.2|31.2|Standard Deviation|8.7|8.7|||
3996299|NCT01230892|3817013|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
3996300|NCT01230892|3817014|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
3996301|NCT01230892|3817015|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3996302|NCT01230892|3817013|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996303|NCT01230892|3817014|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996304|NCT01230892|3817015|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996305|NCT01230892|3817013|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996306|NCT01230892|3817014|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996307|NCT01230892|3817015|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996308|NCT01230892|3817013|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
3996309|NCT01230892|3817014|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3996310|NCT01230892|3817015|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3996311|NCT01230892|3817013|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3996312|NCT01230892|3817014|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3996313|NCT01230892|3817015|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3996314|NCT01230892|3817013|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996315|NCT01230892|3817014|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996316|NCT01230892|3817015|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996317|NCT01230892|3817013|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996318|NCT01230892|3817014|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996319|NCT01230892|3817015|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996320|NCT01230892|3817013|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996321|NCT01230892|3817014|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996322|NCT01230892|3817015|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996323|NCT01230892|3817013|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3996324|NCT01230892|3817014|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3996325|NCT01230892|3817015|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3996326|NCT01230892|3817013|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3996327|NCT01230892|3817014|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3996328|NCT01230892|3817015|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3996329|NCT01230892|3817013|B3|||Age||years|Mean|52|52.0|Standard Deviation|10|10.0|||
3996330|NCT01230892|3817014|B2|||Age||years|Mean|50|50.0|Standard Deviation|11|11.0|||
3996331|NCT01230892|3817015|B1|||Age||years|Mean|55|55.0|Standard Deviation|10|10.0|||
3996332|NCT01230827|3817022|B5|United States||Region of Enrollment||participants|Number|21|21.0||||||
3996333|NCT01230827|3817023|B4|United States||Region of Enrollment||participants|Number|7|7.0||||||
3996334|NCT01230827|3817024|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
3996335|NCT01230827|3817025|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
3996336|NCT01230827|3817026|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3996337|NCT01230827|3817022|B5|Russian Federation||Region of Enrollment||participants|Number|29|29.0||||||
3996338|NCT01230827|3817023|B4|Russian Federation||Region of Enrollment||participants|Number|12|12.0||||||
3996339|NCT01230827|3817024|B3|Russian Federation||Region of Enrollment||participants|Number|12|12.0||||||
3996340|NCT01230827|3817025|B2|Russian Federation||Region of Enrollment||participants|Number|1|1.0||||||
3996341|NCT01230827|3817026|B1|Russian Federation||Region of Enrollment||participants|Number|4|4.0||||||
3996342|NCT01230827|3817022|B5|Poland||Region of Enrollment||participants|Number|7|7.0||||||
3996343|NCT01230827|3817023|B4|Poland||Region of Enrollment||participants|Number|4|4.0||||||
3996344|NCT01230827|3817024|B3|Poland||Region of Enrollment||participants|Number|1|1.0||||||
3996345|NCT01230827|3817025|B2|Poland||Region of Enrollment||participants|Number|0|0.0||||||
3996346|NCT01230827|3817026|B1|Poland||Region of Enrollment||participants|Number|2|2.0||||||
3996347|NCT01230827|3817022|B5|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
3996348|NCT01230827|3817023|B4|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
3996349|NCT01230827|3817024|B3|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
3996350|NCT01230827|3817025|B2|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
3996351|NCT01230827|3817026|B1|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
3996352|NCT01230827|3817022|B5|Mexico||Region of Enrollment||participants|Number|22|22.0||||||
3996353|NCT01230827|3817023|B4|Mexico||Region of Enrollment||participants|Number|11|11.0||||||
3996354|NCT01230827|3817024|B3|Mexico||Region of Enrollment||participants|Number|8|8.0||||||
3996355|NCT01230827|3817025|B2|Mexico||Region of Enrollment||participants|Number|1|1.0||||||
3996356|NCT01230827|3817026|B1|Mexico||Region of Enrollment||participants|Number|2|2.0||||||
3996357|NCT01230827|3817022|B5|Lithuania||Region of Enrollment||participants|Number|10|10.0||||||
3996358|NCT01230827|3817023|B4|Lithuania||Region of Enrollment||participants|Number|4|4.0||||||
3996359|NCT01230827|3817024|B3|Lithuania||Region of Enrollment||participants|Number|6|6.0||||||
3996360|NCT01230827|3817025|B2|Lithuania||Region of Enrollment||participants|Number|0|0.0||||||
3996361|NCT01230827|3817026|B1|Lithuania||Region of Enrollment||participants|Number|0|0.0||||||
3996362|NCT01230827|3817022|B5|Germany||Region of Enrollment||participants|Number|49|49.0||||||
3996363|NCT01230827|3817023|B4|Germany||Region of Enrollment||participants|Number|24|24.0||||||
3996364|NCT01230827|3817024|B3|Germany||Region of Enrollment||participants|Number|14|14.0||||||
3996365|NCT01230827|3817025|B2|Germany||Region of Enrollment||participants|Number|7|7.0||||||
3996366|NCT01230827|3817026|B1|Germany||Region of Enrollment||participants|Number|4|4.0||||||
3996367|NCT01230827|3817022|B5|Finland||Region of Enrollment||participants|Number|1|1.0||||||
3996368|NCT01230827|3817023|B4|Finland||Region of Enrollment||participants|Number|1|1.0||||||
3996369|NCT01230827|3817024|B3|Finland||Region of Enrollment||participants|Number|0|0.0||||||
3996370|NCT01230827|3817025|B2|Finland||Region of Enrollment||participants|Number|0|0.0||||||
3996371|NCT01230827|3817026|B1|Finland||Region of Enrollment||participants|Number|0|0.0||||||
3996372|NCT01230827|3817022|B5|Canada||Region of Enrollment||participants|Number|7|7.0||||||
3996373|NCT01230827|3817023|B4|Canada||Region of Enrollment||participants|Number|5|5.0||||||
3996374|NCT01230827|3817024|B3|Canada||Region of Enrollment||participants|Number|0|0.0||||||
3996375|NCT01230827|3817025|B2|Canada||Region of Enrollment||participants|Number|0|0.0||||||
3996376|NCT01230827|3817026|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
3996377|NCT01230827|3817022|B5|Brazil||Region of Enrollment||participants|Number|8|8.0||||||
3996378|NCT01230827|3817023|B4|Brazil||Region of Enrollment||participants|Number|4|4.0||||||
3996379|NCT01230827|3817024|B3|Brazil||Region of Enrollment||participants|Number|3|3.0||||||
3996380|NCT01230827|3817025|B2|Brazil||Region of Enrollment||participants|Number|0|0.0||||||
3996381|NCT01230827|3817026|B1|Brazil||Region of Enrollment||participants|Number|1|1.0||||||
3996382|NCT01230827|3817022|B5|Belgium||Region of Enrollment||participants|Number|10|10.0||||||
3996383|NCT01230827|3817023|B4|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
3996384|NCT01230827|3817024|B3|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
3996385|NCT01230827|3817025|B2|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
3996386|NCT01230827|3817026|B1|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
3996387|NCT01230827|3817022|B5|Austria||Region of Enrollment||participants|Number|5|5.0||||||
3996388|NCT01230827|3817023|B4|Austria||Region of Enrollment||participants|Number|2|2.0||||||
3996389|NCT01230827|3817024|B3|Austria||Region of Enrollment||participants|Number|2|2.0||||||
3996390|NCT01230827|3817025|B2|Austria||Region of Enrollment||participants|Number|0|0.0||||||
3996391|NCT01230827|3817026|B1|Austria||Region of Enrollment||participants|Number|1|1.0||||||
3996392|NCT01230827|3817022|B5||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
3996393|NCT01230827|3817023|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3996394|NCT01230827|3817024|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3996395|NCT01230827|3817025|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3996396|NCT01230827|3817026|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3996397|NCT01230827|3817022|B5||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3996398|NCT01230827|3817023|B4||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3996399|NCT01230827|3817024|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
3996400|NCT01230827|3817025|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3996401|NCT01230827|3817026|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3996402|NCT01230827|3817022|B5|||Age||years|Mean|11.2|11.2|Standard Deviation|4.44|4.44|||
3996403|NCT01230827|3817023|B4|||Age||years|Mean|11.1|11.1|Standard Deviation|4.43|4.43|||
3996404|NCT01230827|3817024|B3|||Age||years|Mean|10.7|10.7|Standard Deviation|4.66|4.66|||
3996405|NCT01230827|3817025|B2|||Age||years|Mean|13.6|13.6|Standard Deviation|2.2|2.2|||
3996406|NCT01230827|3817026|B1|||Age||years|Mean|11.8|11.8|Standard Deviation|4.4|4.4|||
3996407|NCT01230814|3817043|B3|Kenya||Region of Enrollment||participants|Number|176|176.0||||||
3996408|NCT01230814|3817044|B2|Kenya||Region of Enrollment||participants|Number|87|87.0||||||
3996409|NCT01230814|3817045|B1|Kenya||Region of Enrollment||participants|Number|89|89.0||||||
3996410|NCT01230814|3817043|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
3996411|NCT01230814|3817044|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
3996412|NCT01230814|3817045|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
3996413|NCT01230814|3817043|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996414|NCT01230814|3817044|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996415|NCT01230814|3817045|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996416|NCT01230814|3817043|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|233|233.0||||||
3996417|NCT01230814|3817044|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
3996418|NCT01230814|3817045|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|118|118.0||||||
3996419|NCT01230814|3817043|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3996420|NCT01230814|3817044|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3996421|NCT01230814|3817045|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996422|NCT01230814|3817043|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996539|NCT01230801|3817060|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3996423|NCT01230814|3817044|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996424|NCT01230814|3817045|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996425|NCT01230814|3817043|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3996426|NCT01230814|3817044|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3996427|NCT01230814|3817045|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996428|NCT01230814|3817043|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3996429|NCT01230814|3817044|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3996430|NCT01230814|3817045|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996431|NCT01230814|3817043|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|229|229.0||||||
3996432|NCT01230814|3817044|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
3996433|NCT01230814|3817045|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|118|118.0||||||
3996434|NCT01230814|3817043|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996435|NCT01230814|3817044|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996436|NCT01230814|3817045|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996437|NCT01230814|3817043|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996438|NCT01230814|3817044|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996439|NCT01230814|3817045|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996440|NCT01230814|3817043|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996441|NCT01230814|3817044|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996442|NCT01230814|3817045|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996443|NCT01230814|3817043|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3996444|NCT01230814|3817044|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3996445|NCT01230814|3817045|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3996446|NCT01230814|3817043|B3||Female|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
3996447|NCT01230814|3817044|B2||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
3996448|NCT01230814|3817045|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
3996449|NCT01230814|3817043|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3996450|NCT01230814|3817044|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3996451|NCT01230814|3817045|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3996452|NCT01230814|3817043|B3||Between 18 and 65 years|Age||Participants|Count of Participants|232|232.0||||||
3996453|NCT01230814|3817044|B2||Between 18 and 65 years|Age||Participants|Count of Participants|115|115.0||||||
3996454|NCT01230814|3817045|B1||Between 18 and 65 years|Age||Participants|Count of Participants|117|117.0||||||
3996455|NCT01230814|3817043|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
3996456|NCT01230814|3817044|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3996457|NCT01230814|3817045|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3996458|NCT01230814|3817043|B3|||Age||years|Median|29|29.0|Inter-Quartile Range|||24.0|34.0|
3996459|NCT01230814|3817044|B2|||Age||years|Median|29|29.0|Inter-Quartile Range|||23.0|35.0|
3996460|NCT01230814|3817045|B1|||Age||years|Median|29|29.0|Inter-Quartile Range|||24.0|34.0|
3996461|NCT01230801|3817058|B4|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
3996462|NCT01230801|3817059|B3|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3996463|NCT01230801|3817060|B2|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3996464|NCT01230801|3817061|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
3996465|NCT01230801|3817058|B4|United Kingdom||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3996466|NCT01230801|3817059|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
3996467|NCT01230801|3817060|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3996468|NCT01230801|3817061|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3996469|NCT01230801|3817058|B4|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3996470|NCT01230801|3817059|B3|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
3996471|NCT01230801|3817060|B2|Germany||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3996472|NCT01230801|3817061|B1|Germany||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3996473|NCT01230801|3817058|B4|France||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3996474|NCT01230801|3817059|B3|France||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
3996475|NCT01230801|3817060|B2|France||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3996476|NCT01230801|3817061|B1|France||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3996477|NCT01230801|3817058|B4|Australia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3996478|NCT01230801|3817059|B3|Australia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
3996479|NCT01230801|3817060|B2|Australia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3996480|NCT01230801|3817061|B1|Australia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
3996481|NCT01230801|3817058|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3996482|NCT01230801|3817059|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3996483|NCT01230801|3817060|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3996484|NCT01230801|3817061|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3996485|NCT01230801|3817058|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3996486|NCT01230801|3817059|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
3996487|NCT01230801|3817060|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3996488|NCT01230801|3817061|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3996489|NCT01230801|3817058|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3996490|NCT01230801|3817059|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3996491|NCT01230801|3817060|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3996492|NCT01230801|3817061|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3996493|NCT01230801|3817058|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3996494|NCT01230801|3817059|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3996495|NCT01230801|3817060|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3996496|NCT01230801|3817061|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3996497|NCT01230801|3817058|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3996498|NCT01230801|3817059|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3996499|NCT01230801|3817060|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3996500|NCT01230801|3817061|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3996501|NCT01230801|3817058|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3996502|NCT01230801|3817059|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3996503|NCT01230801|3817060|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3996504|NCT01230801|3817061|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3996505|NCT01230801|3817058|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996506|NCT01230801|3817059|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996507|NCT01230801|3817060|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996508|NCT01230801|3817061|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996509|NCT01230801|3817058|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3996510|NCT01230801|3817059|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3996511|NCT01230801|3817060|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3996512|NCT01230801|3817061|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3996513|NCT01230801|3817058|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3996514|NCT01230801|3817059|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996515|NCT01230801|3817060|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3996516|NCT01230801|3817061|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996517|NCT01230801|3817058|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3996518|NCT01230801|3817059|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3996519|NCT01230801|3817060|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3996520|NCT01230801|3817061|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3996521|NCT01230801|3817058|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3996522|NCT01230801|3817059|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3996523|NCT01230801|3817060|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3996524|NCT01230801|3817061|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3996525|NCT01230801|3817058|B4|||Age||years|Mean|49.3|49.3|Standard Deviation|7.00|7.0|||
3996526|NCT01230801|3817059|B3|||Age||years|Mean|50.1|50.1|Standard Deviation|5.37|5.37|||
3996527|NCT01230801|3817060|B2|||Age||years|Mean|42.3|42.3|Standard Deviation|12.90|12.9|||
3996528|NCT01230801|3817061|B1|||Age||years|Mean|51.7|51.7|Standard Deviation|6.81|6.81|||
3996529|NCT01230801|3817058|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3996530|NCT01230801|3817059|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3996531|NCT01230801|3817060|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3996532|NCT01230801|3817061|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3996533|NCT01230801|3817058|B4||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
3996534|NCT01230801|3817059|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3996535|NCT01230801|3817060|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3996536|NCT01230801|3817061|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3996537|NCT01230801|3817058|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3996538|NCT01230801|3817059|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3996540|NCT01230801|3817061|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3996541|NCT01230788|3817096|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3996542|NCT01230788|3817096|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3996543|NCT01230788|3817096|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3996544|NCT01230788|3817096|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3996545|NCT01230788|3817096|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3996546|NCT01230749|3817104|B5||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3996547|NCT01230749|3817105|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3996548|NCT01230749|3817106|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3996549|NCT01230749|3817107|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3996550|NCT01230749|3817108|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3996551|NCT01230749|3817104|B5||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3996552|NCT01230749|3817105|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3996553|NCT01230749|3817106|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3996554|NCT01230749|3817107|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3996555|NCT01230749|3817108|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3996556|NCT01230749|3817104|B5|||Age||years|Mean|54|54.0|Standard Deviation|7.96|7.96|||
3996557|NCT01230749|3817105|B4|||Age||years|Mean|57.1|57.1|Standard Deviation|6.03|6.03|||
3996558|NCT01230749|3817106|B3|||Age||years|Mean|51.7|51.7|Standard Deviation|7.06|7.06|||
3996559|NCT01230749|3817107|B2|||Age||years|Mean|54.5|54.5|Standard Deviation|8.93|8.93|||
3996560|NCT01230749|3817108|B1|||Age||years|Mean|52.7|52.7|Standard Deviation|8.93|8.93|||
3996561|NCT01230710|3817146|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3996562|NCT01230710|3817146|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3996563|NCT01230710|3817146|B1|||Age||years|Mean|55.5|55.5|Standard Deviation|9.9|9.9|||
3996564|NCT01230593|3817154|B4|||Initial lesion size (mm)||millimeters|Mean|6.19|6.19|Standard Deviation|3|3.0|||
3996565|NCT01230593|3817155|B3|||Initial lesion size (mm)||millimeters|Mean|6.38|6.38|Standard Deviation|3|3.0|||
3996566|NCT01230593|3817156|B2|||Initial lesion size (mm)||millimeters|Mean|6.16|6.16|Standard Deviation|3|3.0|||
3996567|NCT01230593|3817157|B1|||Initial lesion size (mm)||millimeters|Mean|6.05|6.05|Standard Deviation|3|3.0|||
3996568|NCT01230593|3817154|B4|||Pre-treatment lesion duration (months)||months|Mean|3.96|3.96|Standard Deviation|8|8.0|||
3996569|NCT01230593|3817155|B3|||Pre-treatment lesion duration (months)||months|Mean|5.72|5.72|Standard Deviation|13|13.0|||
3996570|NCT01230593|3817156|B2|||Pre-treatment lesion duration (months)||months|Mean|2.88|2.88|Standard Deviation|3|3.0|||
3996571|NCT01230593|3817157|B1|||Pre-treatment lesion duration (months)||months|Mean|3.55|3.55|Standard Deviation|6|6.0|||
3996572|NCT01230593|3817154|B4|United States||Region of Enrollment||participants|Number|122|122.0||||||
3996573|NCT01230593|3817155|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
3996574|NCT01230593|3817156|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
3996575|NCT01230593|3817157|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
3996576|NCT01230593|3817154|B4|Canada||Region of Enrollment||participants|Number|27|27.0||||||
3996577|NCT01230593|3817155|B3|Canada||Region of Enrollment||participants|Number|14|14.0||||||
3996578|NCT01230593|3817156|B2|Canada||Region of Enrollment||participants|Number|5|5.0||||||
3996579|NCT01230593|3817157|B1|Canada||Region of Enrollment||participants|Number|8|8.0||||||
3996580|NCT01230593|3817154|B4||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3996581|NCT01230593|3817155|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3996582|NCT01230593|3817156|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3996583|NCT01230593|3817157|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3996584|NCT01230593|3817154|B4||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3996585|NCT01230593|3817155|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3996586|NCT01230593|3817156|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3996587|NCT01230593|3817157|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3996588|NCT01230593|3817154|B4|||Age||years|Mean|47.41|47.41|Standard Deviation|17|17.0|||
3996589|NCT01230593|3817155|B3|||Age||years|Mean|47.52|47.52|Standard Deviation|17|17.0|||
3996590|NCT01230593|3817156|B2|||Age||years|Mean|46.42|46.42|Standard Deviation|19|19.0|||
3996591|NCT01230593|3817157|B1|||Age||years|Mean|45.50|45.5|Standard Deviation|15|15.0|||
3996592|NCT01230502|3817170|B4|United States||Region of Enrollment||participants|Number|9|9.0||||||
3996593|NCT01230502|3817173|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3996594|NCT01230502|3817170|B4|Male||Gender||participants|Number|6|6.0||||||
3996595|NCT01230502|3817173|B1|Male||Gender||participants|Number|6|6.0||||||
3996596|NCT01230502|3817170|B4|Female||Gender||participants|Number|3|3.0||||||
3996597|NCT01230502|3817173|B1|Female||Gender||participants|Number|3|3.0||||||
3996598|NCT01230502|3817170|B4|>=65 years||Age||participants|Number|1|1.0||||||
3996599|NCT01230502|3817173|B1|>=65 years||Age||participants|Number|1|1.0||||||
3996600|NCT01230502|3817170|B4|Between 18 and 65 years||Age||participants|Number|8|8.0||||||
3996601|NCT01230502|3817173|B1|Between 18 and 65 years||Age||participants|Number|8|8.0||||||
3996602|NCT01230502|3817170|B4|<=18 years||Age||participants|Number|0|0.0||||||
3996603|NCT01230502|3817173|B1|<=18 years||Age||participants|Number|0|0.0||||||
3996604|NCT01230502|3817170|B4|||Age||years|Mean|51|51.0|Standard Deviation|14.76|14.76|||
3996605|NCT01230502|3817173|B1|||Age||years|Mean|51|51.0|Standard Deviation|14.757|14.757|||
3996606|NCT01230489|3817186|B1|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
3996607|NCT01230489|3817186|B1|Unknown||Sex/Gender, Customized||Participants|Count of Participants|13|13.0||||||
3996608|NCT01230489|3817186|B1|Age 18 - 90 years||Age, Customized||Participants|Count of Participants|13|13.0||||||
3996609|NCT01230424|3817190|B3|United States||Region of Enrollment||participants|Number|140|140.0||||||
3996610|NCT01230424|3817191|B2|United States||Region of Enrollment||participants|Number|70|70.0||||||
3996611|NCT01230424|3817192|B1|United States||Region of Enrollment||participants|Number|70|70.0||||||
3996612|NCT01230424|3817190|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3996613|NCT01230424|3817191|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3996614|NCT01230424|3817192|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3996615|NCT01230424|3817190|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3996616|NCT01230424|3817191|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3996617|NCT01230424|3817192|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3996618|NCT01230424|3817190|B3|||Age||years|Mean|58.1|58.1|Standard Deviation|8.0|8.0|||
3996619|NCT01230424|3817191|B2|||Age||years|Mean|57.2|57.2|Standard Deviation|7.6|7.6|||
3996620|NCT01230424|3817192|B1|||Age||years|Mean|59.1|59.1|Standard Deviation|8.3|8.3|||
3996621|NCT01230424|3817190|B3||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
3996622|NCT01230424|3817191|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
3996623|NCT01230424|3817192|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
3996624|NCT01230424|3817190|B3||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
3996625|NCT01230424|3817191|B2||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
3996626|NCT01230424|3817192|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3996627|NCT01230424|3817190|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3996628|NCT01230424|3817191|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3996629|NCT01230424|3817192|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3996630|NCT01230307|3817219|B3|||Baseline Vit D level (ng/mL)|Baseline Vit D level nanograms per milliliter of blood.|ng/mL|Mean|17.8|17.8|Standard Deviation|4|4.0|||
3996631|NCT01230307|3817220|B2|||Baseline Vit D level (ng/mL)|Baseline Vit D level nanograms per milliliter of blood.|ng/mL|Mean|19.6|19.6|Standard Deviation|3|3.0|||
3996632|NCT01230307|3817221|B1|||Baseline Vit D level (ng/mL)|Baseline Vit D level nanograms per milliliter of blood.|ng/mL|Mean|16.3|16.3|Standard Deviation|5|5.0|||
3996633|NCT01230307|3817219|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996634|NCT01230307|3817220|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996635|NCT01230307|3817221|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996636|NCT01230307|3817219|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996637|NCT01230307|3817220|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996638|NCT01230307|3817221|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996639|NCT01230307|3817219|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3996640|NCT01230307|3817220|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3996641|NCT01230307|3817221|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3996642|NCT01230307|3817219|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3996643|NCT01230307|3817220|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3996644|NCT01230307|3817221|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3996645|NCT01230307|3817219|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996646|NCT01230307|3817220|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996647|NCT01230307|3817221|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996648|NCT01230307|3817219|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996649|NCT01230307|3817220|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996650|NCT01230307|3817221|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996651|NCT01230307|3817219|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996652|NCT01230307|3817220|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996653|NCT01230307|3817221|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996654|NCT01230307|3817219|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3996655|NCT01230307|3817220|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3996656|NCT01230307|3817221|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3996657|NCT01230307|3817219|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3996658|NCT01230307|3817220|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3996659|NCT01230307|3817221|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3996660|NCT01230307|3817219|B3|46 - 78 Years||Age, Customized||participants|Number|12|12.0||||||
3996661|NCT01230307|3817220|B2|46 - 78 Years||Age, Customized||participants|Number|6|6.0||||||
3996662|NCT01230307|3817221|B1|46 - 78 Years||Age, Customized||participants|Number|6|6.0||||||
3996663|NCT01230177|3817234|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
3996664|NCT01230177|3817234|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
3996665|NCT01230177|3817234|B1|>=65 years||Age, Customized||participants|Number|3|3.0||||||
3996666|NCT01230177|3817234|B1|<65 years||Age, Customized||participants|Number|0|0.0||||||
3996667|NCT01230060|3817242|B1|United States||Region of Enrollment||participants|Number|122|122.0||||||
3996668|NCT01230060|3817242|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3996669|NCT01230060|3817242|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3996670|NCT01230060|3817242|B1|||Age||years|Mean|69.0|69.0|Standard Deviation|8.0|8.0|||
3996671|NCT01230021|3817246|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996672|NCT01230021|3817246|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996673|NCT01230021|3817246|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3996674|NCT01230021|3817246|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3996675|NCT01230021|3817246|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996676|NCT01230021|3817246|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3996677|NCT01230021|3817246|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996678|NCT01230021|3817246|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996679|NCT01230021|3817246|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3996680|NCT01230021|3817246|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996681|NCT01230021|3817246|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
3996682|NCT01230021|3817246|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
3996683|NCT01230021|3817246|B1|||Age||years|Mean|2.67|2.67|Standard Deviation|1.03|1.03|||
3996684|NCT01229943|3817266|B3|United States||Region of Enrollment||participants|Number|139|139.0||||||
3996685|NCT01229943|3817267|B2|United States||Region of Enrollment||participants|Number|69|69.0||||||
3996686|NCT01229943|3817268|B1|United States||Region of Enrollment||participants|Number|70|70.0||||||
3996687|NCT01229943|3817266|B3|Canada||Region of Enrollment||participants|Number|11|11.0||||||
3996688|NCT01229943|3817267|B2|Canada||Region of Enrollment||participants|Number|6|6.0||||||
3996689|NCT01229943|3817268|B1|Canada||Region of Enrollment||participants|Number|5|5.0||||||
3996690|NCT01229943|3817266|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3996691|NCT01229943|3817267|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3996692|NCT01229943|3817268|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3996693|NCT01229943|3817266|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996694|NCT01229943|3817267|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996695|NCT01229943|3817268|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996696|NCT01229943|3817266|B3||White|Race (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
3996697|NCT01229943|3817267|B2||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3996698|NCT01229943|3817268|B1||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
3996699|NCT01229943|3817266|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3996700|NCT01229943|3817267|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3996701|NCT01229943|3817268|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3996702|NCT01229943|3817266|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3996703|NCT01229943|3817267|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996704|NCT01229943|3817268|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3996705|NCT01229943|3817266|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3996706|NCT01229943|3817267|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3996707|NCT01229943|3817268|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3996708|NCT01229943|3817266|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3996709|NCT01229943|3817267|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3996710|NCT01229943|3817268|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996711|NCT01229943|3817266|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3996712|NCT01229943|3817267|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3996713|NCT01229943|3817268|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3996714|NCT01229943|3817266|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|139|139.0||||||
3996715|NCT01229943|3817267|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
3996716|NCT01229943|3817268|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
3996717|NCT01229943|3817266|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3996718|NCT01229943|3817267|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3996719|NCT01229943|3817268|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3996720|NCT01229943|3817266|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3996721|NCT01229943|3817267|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3996722|NCT01229943|3817268|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3996723|NCT01229943|3817266|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3996724|NCT01229943|3817267|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3996725|NCT01229943|3817268|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3996726|NCT01229943|3817266|B3|||Age||years|Median|58.5|58.5|Full Range|||21.0|86.0|
3996727|NCT01229943|3817267|B2|||Age||years|Median|58|58.0|Full Range|||21.0|86.0|
3996728|NCT01229943|3817268|B1|||Age||years|Median|59|59.0|Full Range|||23.0|80.0|
3996729|NCT01229891|3817279|B4|||HDL|serum High density lipoprotein concentration|mg/dL|Mean|48|48.0|Standard Deviation|9.2|9.2|||
3996730|NCT01229891|3817280|B3|||HDL|serum High density lipoprotein concentration|mg/dL|Mean|47.2|47.2|Standard Deviation|9.4|9.4|||
3996731|NCT01229891|3817281|B2|||HDL|serum High density lipoprotein concentration|mg/dL|Mean|46|46.0|Standard Deviation|9.6|9.6|||
3996732|NCT01229891|3817282|B1|||HDL|serum High density lipoprotein concentration|mg/dL|Mean|50.8|50.8|Standard Deviation|8.2|8.2|||
3996733|NCT01229891|3817279|B4|||LDL|serum low density lipoprotein concentration|mg/dL|Mean|88.7|88.7|Standard Deviation|26.0|26.0|||
3996734|NCT01229891|3817280|B3|||LDL|serum low density lipoprotein concentration|mg/dL|Mean|90.2|90.2|Standard Deviation|27.9|27.9|||
3996735|NCT01229891|3817281|B2|||LDL|serum low density lipoprotein concentration|mg/dL|Mean|87.2|87.2|Standard Deviation|25.1|25.1|||
3996736|NCT01229891|3817282|B1|||LDL|serum low density lipoprotein concentration|mg/dL|Mean|88.6|88.6|Standard Deviation|25.9|25.9|||
3996737|NCT01229891|3817279|B4|||Tchol|serum total cholesterol concentration|mg/dL|Mean|182.4|182.4|Standard Deviation|43.8|43.8|||
3996738|NCT01229891|3817280|B3|||Tchol|serum total cholesterol concentration|mg/dL|Mean|187.7|187.7|Standard Deviation|46.6|46.6|||
3996739|NCT01229891|3817281|B2|||Tchol|serum total cholesterol concentration|mg/dL|Mean|177.5|177.5|Standard Deviation|41.9|41.9|||
3996740|NCT01229891|3817282|B1|||Tchol|serum total cholesterol concentration|mg/dL|Mean|187.5|187.5|Standard Deviation|43.3|43.3|||
3996741|NCT01229891|3817279|B4|||TG|serum triglyceride concentration|mg/dL|Mean|164.2|164.2|Standard Deviation|86.6|86.6|||
3996742|NCT01229891|3817280|B3|||TG|serum triglyceride concentration|mg/dL|Mean|176.6|176.6|Standard Deviation|91.0|91.0|||
3996743|NCT01229891|3817281|B2|||TG|serum triglyceride concentration|mg/dL|Mean|155.4|155.4|Standard Deviation|65.9|65.9|||
3996744|NCT01229891|3817282|B1|||TG|serum triglyceride concentration|mg/dL|Mean|160.5|160.5|Standard Deviation|100.7|100.7|||
3996745|NCT01229891|3817279|B4|||HbA1c|Hemoglobin A1c|percent|Mean|7.6|7.6|Standard Deviation|1.7|1.7|||
3996746|NCT01229891|3817280|B3|||HbA1c|Hemoglobin A1c|percent|Mean|7.8|7.8|Standard Deviation|1.9|1.9|||
3996747|NCT01229891|3817281|B2|||HbA1c|Hemoglobin A1c|percent|Mean|7.4|7.4|Standard Deviation|1.8|1.8|||
3996748|NCT01229891|3817282|B1|||HbA1c|Hemoglobin A1c|percent|Mean|7.5|7.5|Standard Deviation|1.5|1.5|||
3996749|NCT01229891|3817279|B4|||Insulin|Fasting serum Insulin concentration|mU/L|Mean|7.6|7.6|Standard Deviation|4.1|4.1|||
3996750|NCT01229891|3817280|B3|||Insulin|Fasting serum Insulin concentration|mU/L|Mean|7.6|7.6|Standard Deviation|4.6|4.6|||
3996751|NCT01229891|3817281|B2|||Insulin|Fasting serum Insulin concentration|mU/L|Mean|7.7|7.7|Standard Deviation|4.6|4.6|||
3996752|NCT01229891|3817282|B1|||Insulin|Fasting serum Insulin concentration|mU/L|Mean|7.7|7.7|Standard Deviation|3.2|3.2|||
3996753|NCT01229891|3817279|B4|||Fasting serum glucose (FSG)|Fasting serum glucose concentration|mg/dL|Mean|185|185.0|Standard Deviation|58.8|58.8|||
3996754|NCT01229891|3817280|B3|||Fasting serum glucose (FSG)|Fasting serum glucose concentration|mg/dL|Mean|184|184.0|Standard Deviation|57.3|57.3|||
3996755|NCT01229891|3817281|B2|||Fasting serum glucose (FSG)|Fasting serum glucose concentration|mg/dL|Mean|184.1|184.1|Standard Deviation|63.8|63.8|||
3996756|NCT01229891|3817282|B1|||Fasting serum glucose (FSG)|Fasting serum glucose concentration|mg/dL|Mean|187|187.0|Standard Deviation|57.1|57.1|||
3996757|NCT01229891|3817279|B4|||25-hydroxyvitamin D||nmol/L|Mean|48.8|48.8|Standard Deviation|38.4|38.4|||
3996758|NCT01229891|3817280|B3|||25-hydroxyvitamin D||nmol/L|Mean|51.3|51.3|Standard Deviation|43|43.0|||
3996759|NCT01229891|3817281|B2|||25-hydroxyvitamin D||nmol/L|Mean|47.5|47.5|Standard Deviation|27|27.0|||
3996760|NCT01229891|3817282|B1|||25-hydroxyvitamin D||nmol/L|Mean|50|50.0|Standard Deviation|26|26.0|||
3996761|NCT01229891|3817279|B4||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3996762|NCT01229891|3817280|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3996763|NCT01229891|3817281|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3996764|NCT01229891|3817282|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3996765|NCT01229891|3817279|B4||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3996766|NCT01229891|3817280|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3996767|NCT01229891|3817281|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3996768|NCT01229891|3817282|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3996769|NCT01229891|3817279|B4|||Age||years|Mean|50.7|50.7|Standard Deviation|6.1|6.1|||
3996770|NCT01229891|3817280|B3|||Age||years|Mean|49.9|49.9|Standard Deviation|6.2|6.2|||
3996771|NCT01229891|3817281|B2|||Age||years|Mean|51.4|51.4|Standard Deviation|5.4|5.4|||
3996772|NCT01229891|3817282|B1|||Age||years|Mean|50.8|50.8|Standard Deviation|6.6|6.6|||
3996773|NCT01229735|3817313|B3||Male|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
3996774|NCT01229735|3817314|B2||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3996775|NCT01229735|3817315|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3996776|NCT01229735|3817313|B3||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3996777|NCT01229735|3817314|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3996778|NCT01229735|3817315|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3996779|NCT01229735|3817313|B3|||Age||years|Mean|40.3|40.3|Standard Deviation|12.8|12.8|||
3996780|NCT01229735|3817314|B2|||Age||years|Mean|39.7|39.7|Standard Deviation|11.8|11.8|||
3996781|NCT01229735|3817315|B1|||Age||years|Mean|40.9|40.9|Standard Deviation|13.6|13.6|||
3996782|NCT01229735|3817313|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
3996783|NCT01229735|3817314|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3996784|NCT01229735|3817315|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3996785|NCT01229735|3817313|B3||Between 18 and 65 years|Age||Participants|Count of Participants|327|327.0||||||
3996786|NCT01229735|3817314|B2||Between 18 and 65 years|Age||Participants|Count of Participants|162|162.0||||||
3996787|NCT01229735|3817315|B1||Between 18 and 65 years|Age||Participants|Count of Participants|165|165.0||||||
3996788|NCT01229735|3817313|B3||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3996789|NCT01229735|3817314|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3996790|NCT01229735|3817315|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3996791|NCT01229722|3817330|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3996792|NCT01229722|3817331|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3996793|NCT01229722|3817332|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3996794|NCT01229722|3817330|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3996795|NCT01229722|3817331|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3996796|NCT01229722|3817332|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3996797|NCT01229722|3817330|B3|||Age||years|Mean|47.48|47.48|Standard Deviation|9.81|9.81|||
3996798|NCT01229722|3817331|B2|||Age||years|Mean|48.11|48.11|Standard Deviation|10.49|10.49|||
3996799|NCT01229722|3817332|B1|||Age||years|Mean|46.73|46.73|Standard Deviation|9.04|9.04|||
3996800|NCT01229527|3817339|B4|Italy||Region of Enrollment||participants|Number|90|90.0||||||
3996801|NCT01229527|3817340|B3|Italy||Region of Enrollment||participants|Number|30|30.0||||||
3996802|NCT01229527|3817341|B2|Italy||Region of Enrollment||participants|Number|30|30.0||||||
3996803|NCT01229527|3817342|B1|Italy||Region of Enrollment||participants|Number|30|30.0||||||
3996804|NCT01229527|3817339|B4||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3996805|NCT01229527|3817340|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3996806|NCT01229527|3817341|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3996807|NCT01229527|3817342|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3996808|NCT01229527|3817339|B4||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3996809|NCT01229527|3817340|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3996810|NCT01229527|3817341|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3996811|NCT01229527|3817342|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3996812|NCT01229527|3817339|B4|||Age||years|Mean|58.13|58.13|Standard Deviation|11.26|11.26|||
3996813|NCT01229527|3817340|B3|||Age||years|Mean|60.37|60.37|Standard Deviation|10.48|10.48|||
3996814|NCT01229527|3817341|B2|||Age||years|Mean|55.10|55.1|Standard Deviation|11.82|11.82|||
3996815|NCT01229527|3817342|B1|||Age||years|Mean|58.93|58.93|Standard Deviation|11.15|11.15|||
3996816|NCT01229527|3817339|B4||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
3996817|NCT01229527|3817340|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
3996818|NCT01229527|3817341|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
3996819|NCT01229527|3817342|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
3996820|NCT01229527|3817339|B4||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
3996821|NCT01229527|3817340|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3996822|NCT01229527|3817341|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3996823|NCT01229527|3817342|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3996824|NCT01229527|3817339|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3996825|NCT01229527|3817340|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3996826|NCT01229527|3817341|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3996827|NCT01229527|3817342|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3996828|NCT01229462|3817355|B3||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
3996829|NCT01229462|3817356|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3996830|NCT01229462|3817357|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3996831|NCT01229462|3817355|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3996832|NCT01229462|3817356|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3996833|NCT01229462|3817357|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3996834|NCT01229462|3817355|B3|||Age||Years|Mean|47.2|47.2|Standard Deviation|15.38|15.38|||
3996835|NCT01229462|3817356|B2|||Age||Years|Mean|48.2|48.2|Standard Deviation|15.57|15.57|||
3996836|NCT01229462|3817357|B1|||Age||Years|Mean|46.2|46.2|Standard Deviation|15.18|15.18|||
3996837|NCT01229449|3817364|B6|||Used drugs of abuse||participants|Number|126|126.0||||||
3996838|NCT01229449|3817365|B5|||Used drugs of abuse||participants|Number|8|8.0||||||
3996839|NCT01229449|3817366|B4|||Used drugs of abuse||participants|Number|18|18.0||||||
3996840|NCT01229449|3817367|B3|||Used drugs of abuse||participants|Number|37|37.0||||||
3996841|NCT01229449|3817368|B2|||Used drugs of abuse||participants|Number|31|31.0||||||
3996842|NCT01229449|3817369|B1|||Used drugs of abuse||participants|Number|32|32.0||||||
3996843|NCT01229449|3817364|B6|||Current smoker||participants|Number|67|67.0||||||
3996844|NCT01229449|3817365|B5|||Current smoker||participants|Number|5|5.0||||||
3996845|NCT01229449|3817366|B4|||Current smoker||participants|Number|14|14.0||||||
3996846|NCT01229449|3817367|B3|||Current smoker||participants|Number|16|16.0||||||
3996847|NCT01229449|3817368|B2|||Current smoker||participants|Number|16|16.0||||||
3996848|NCT01229449|3817369|B1|||Current smoker||participants|Number|16|16.0||||||
3996849|NCT01229449|3817364|B6|||Former smoker||participants|Number|92|92.0||||||
3996850|NCT01229449|3817365|B5|||Former smoker||participants|Number|9|9.0||||||
3996851|NCT01229449|3817366|B4|||Former smoker||participants|Number|13|13.0||||||
3996852|NCT01229449|3817367|B3|||Former smoker||participants|Number|20|20.0||||||
3996853|NCT01229449|3817368|B2|||Former smoker||participants|Number|23|23.0||||||
3996854|NCT01229449|3817369|B1|||Former smoker||participants|Number|27|27.0||||||
3996855|NCT01229449|3817364|B6|||Drink alcohol||participants|Number|236|236.0||||||
3996856|NCT01229449|3817365|B5|||Drink alcohol||participants|Number|15|15.0||||||
3996857|NCT01229449|3817366|B4|||Drink alcohol||participants|Number|36|36.0||||||
3996858|NCT01229449|3817367|B3|||Drink alcohol||participants|Number|61|61.0||||||
3996859|NCT01229449|3817368|B2|||Drink alcohol||participants|Number|61|61.0||||||
3996860|NCT01229449|3817369|B1|||Drink alcohol||participants|Number|63|63.0||||||
3996861|NCT01229449|3817364|B6|||Height||cm|Mean|168.9|168.9|Standard Deviation|9.9|9.9|||
3996862|NCT01229449|3817365|B5|||Height||cm|Mean|168.7|168.7|Standard Deviation|9.5|9.5|||
3996863|NCT01229449|3817366|B4|||Height||cm|Mean|168.5|168.5|Standard Deviation|9.7|9.7|||
3996864|NCT01229449|3817367|B3|||Height||cm|Mean|169.5|169.5|Standard Deviation|9.8|9.8|||
3996865|NCT01229449|3817368|B2|||Height||cm|Mean|169.3|169.3|Standard Deviation|10.1|10.1|||
3996866|NCT01229449|3817369|B1|||Height||cm|Mean|168.5|168.5|Standard Deviation|10.0|10.0|||
3996867|NCT01229449|3817364|B6|||Weight||kg|Mean|69.2|69.2|Standard Deviation|15.5|15.5|||
3996868|NCT01229449|3817365|B5|||Weight||kg|Mean|71.0|71.0|Standard Deviation|18.7|18.7|||
3996869|NCT01229449|3817366|B4|||Weight||kg|Mean|70.8|70.8|Standard Deviation|16.1|16.1|||
3996870|NCT01229449|3817367|B3|||Weight||kg|Mean|68.8|68.8|Standard Deviation|15.3|15.3|||
3996871|NCT01229449|3817368|B2|||Weight||kg|Mean|69.0|69.0|Standard Deviation|15.2|15.2|||
3996872|NCT01229449|3817369|B1|||Weight||kg|Mean|68.1|68.1|Standard Deviation|14.5|14.5|||
3996873|NCT01229449|3817364|B6|United States||Region of Enrollment||participants|Number|678|678.0||||||
3996874|NCT01229449|3817365|B5|United States||Region of Enrollment||participants|Number|55|55.0||||||
3996875|NCT01229449|3817366|B4|United States||Region of Enrollment||participants|Number|113|113.0||||||
3996876|NCT01229449|3817367|B3|United States||Region of Enrollment||participants|Number|169|169.0||||||
3996877|NCT01229449|3817368|B2|United States||Region of Enrollment||participants|Number|168|168.0||||||
3996878|NCT01229449|3817369|B1|United States||Region of Enrollment||participants|Number|173|173.0||||||
3996879|NCT01229449|3817364|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3996880|NCT01229449|3817365|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996881|NCT01229449|3817366|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3996882|NCT01229449|3817367|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3996883|NCT01229449|3817368|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3996884|NCT01229449|3817369|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996885|NCT01229449|3817364|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996886|NCT01229449|3817365|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996887|NCT01229449|3817366|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996888|NCT01229449|3817367|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996889|NCT01229449|3817368|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996890|NCT01229449|3817369|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996891|NCT01229449|3817364|B6||White|Race (NIH/OMB)||Participants|Count of Participants|635|635.0||||||
3996892|NCT01229449|3817365|B5||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3996893|NCT01229449|3817366|B4||White|Race (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
3996894|NCT01229449|3817367|B3||White|Race (NIH/OMB)||Participants|Count of Participants|154|154.0||||||
3996895|NCT01229449|3817368|B2||White|Race (NIH/OMB)||Participants|Count of Participants|158|158.0||||||
3996896|NCT01229449|3817369|B1||White|Race (NIH/OMB)||Participants|Count of Participants|165|165.0||||||
3996897|NCT01229449|3817364|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3996898|NCT01229449|3817365|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3996899|NCT01229449|3817366|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3996900|NCT01229449|3817367|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3996961|NCT01229397|3817491|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3996901|NCT01229449|3817368|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3996902|NCT01229449|3817369|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3996903|NCT01229449|3817364|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3996904|NCT01229449|3817365|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996905|NCT01229449|3817366|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3996906|NCT01229449|3817367|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3996907|NCT01229449|3817368|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996908|NCT01229449|3817369|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3996909|NCT01229449|3817364|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3996910|NCT01229449|3817365|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3996911|NCT01229449|3817366|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3996912|NCT01229449|3817367|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3996913|NCT01229449|3817368|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3996914|NCT01229449|3817369|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3996915|NCT01229449|3817364|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3996916|NCT01229449|3817365|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996917|NCT01229449|3817366|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996918|NCT01229449|3817367|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3996919|NCT01229449|3817368|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3996920|NCT01229449|3817369|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3996921|NCT01229449|3817364|B6||Male|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
3996922|NCT01229449|3817365|B5||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3996923|NCT01229449|3817366|B4||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
3996924|NCT01229449|3817367|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3996925|NCT01229449|3817368|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3996926|NCT01229449|3817369|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3996927|NCT01229449|3817364|B6||Female|Sex: Female, Male||Participants|Count of Participants|407|407.0||||||
3996928|NCT01229449|3817365|B5||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3996929|NCT01229449|3817366|B4||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3996930|NCT01229449|3817367|B3||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3996931|NCT01229449|3817368|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3996932|NCT01229449|3817369|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
3996933|NCT01229449|3817364|B6|||Age||years|Mean|20.0|20.0|Standard Deviation|3.3|3.3|||
3996934|NCT01229449|3817365|B5|||Age||years|Mean|19.8|19.8|Standard Deviation|3.6|3.6|||
3996935|NCT01229449|3817366|B4|||Age||years|Mean|19.7|19.7|Standard Deviation|3.3|3.3|||
3996936|NCT01229449|3817367|B3|||Age||years|Mean|20.1|20.1|Standard Deviation|3.4|3.4|||
3996937|NCT01229449|3817368|B2|||Age||years|Mean|19.8|19.8|Standard Deviation|3.2|3.2|||
3996938|NCT01229449|3817369|B1|||Age||years|Mean|20.2|20.2|Standard Deviation|3.3|3.3|||
3996939|NCT01229436|3817430|B1||Male|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
3996940|NCT01229436|3817430|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3996941|NCT01229436|3817430|B1|||Age||years|Mean|60.2|60.2|Standard Deviation|7.37|7.37|||
3996942|NCT01229423|3817468|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3996943|NCT01229423|3817468|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3996944|NCT01229423|3817468|B1|||Age||years|Mean|37.3|37.3|Standard Deviation|6.69|6.69|||
3996945|NCT01229410|3817477|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3996946|NCT01229410|3817478|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3996947|NCT01229410|3817479|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3996948|NCT01229410|3817477|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3996949|NCT01229410|3817478|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3996950|NCT01229410|3817479|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3996951|NCT01229410|3817477|B3|||Age||Years|Mean|68.1|68.1|Full Range|||53.0|78.0|
3996952|NCT01229410|3817478|B2|||Age||Years|Mean|66.5|66.5|Full Range|9.67|9.67|53.0|78.0|
3996953|NCT01229410|3817479|B1|||Age||Years|Mean|69.7|69.7|Full Range|2.87|2.87|64.0|75.0|
3996954|NCT01229397|3817490|B3|Italy||Region of Enrollment||participants|Number|205|205.0||||||
3996955|NCT01229397|3817491|B2|Italy||Region of Enrollment||participants|Number|102|102.0||||||
3996956|NCT01229397|3817492|B1|Italy||Region of Enrollment||participants|Number|103|103.0||||||
3996957|NCT01229397|3817490|B3||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
3996958|NCT01229397|3817491|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3996959|NCT01229397|3817492|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3996960|NCT01229397|3817490|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3996962|NCT01229397|3817492|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3996963|NCT01229397|3817490|B3|||Age||years|Mean|1.8|1.8|Standard Deviation|0.57|0.57|||
3996964|NCT01229397|3817491|B2|||Age||years|Mean|1.8|1.8|Standard Deviation|0.61|0.61|||
3996965|NCT01229397|3817492|B1|||Age||years|Mean|1.8|1.8|Standard Deviation|0.52|0.52|||
3996966|NCT01229397|3817490|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3996967|NCT01229397|3817491|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3996968|NCT01229397|3817492|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3996969|NCT01229397|3817490|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3996970|NCT01229397|3817491|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3996971|NCT01229397|3817492|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3996972|NCT01229397|3817490|B3||<=18 years|Age||Participants|Count of Participants|205|205.0||||||
3996973|NCT01229397|3817491|B2||<=18 years|Age||Participants|Count of Participants|102|102.0||||||
3996974|NCT01229397|3817492|B1||<=18 years|Age||Participants|Count of Participants|103|103.0||||||
3996975|NCT01229371|3817507|B5|Switzerland||Region of Enrollment||participants|Number|440|440.0||||||
3996976|NCT01229371|3817508|B4|Switzerland||Region of Enrollment||participants|Number|110|110.0||||||
3996977|NCT01229371|3817509|B3|Switzerland||Region of Enrollment||participants|Number|110|110.0||||||
3996978|NCT01229371|3817510|B2|Switzerland||Region of Enrollment||participants|Number|111|111.0||||||
3996979|NCT01229371|3817511|B1|Switzerland||Region of Enrollment||participants|Number|109|109.0||||||
3996980|NCT01229371|3817507|B5||Male|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
3996981|NCT01229371|3817508|B4||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3996982|NCT01229371|3817509|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3996983|NCT01229371|3817510|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3996984|NCT01229371|3817511|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3996985|NCT01229371|3817507|B5||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
3996986|NCT01229371|3817508|B4||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3996987|NCT01229371|3817509|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3996988|NCT01229371|3817510|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3996989|NCT01229371|3817511|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
3996990|NCT01229371|3817507|B5|||Age||years|Mean|53.1|53.1|Standard Deviation|16.14|16.14|||
3996991|NCT01229371|3817508|B4|||Age||years|Mean|66.4|66.4|Standard Deviation|5.06|5.06|||
3996992|NCT01229371|3817509|B3|||Age||years|Mean|66.5|66.5|Standard Deviation|5.50|5.5|||
3996993|NCT01229371|3817510|B2|||Age||years|Mean|39.9|39.9|Standard Deviation|12.10|12.1|||
3996994|NCT01229371|3817511|B1|||Age||years|Mean|39.5|39.5|Standard Deviation|11.18|11.18|||
3996995|NCT01229371|3817507|B5||>=65 years|Age||Participants|Count of Participants|120|120.0||||||
3996996|NCT01229371|3817508|B4||>=65 years|Age||Participants|Count of Participants|57|57.0||||||
3996997|NCT01229371|3817509|B3||>=65 years|Age||Participants|Count of Participants|63|63.0||||||
3996998|NCT01229371|3817510|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3996999|NCT01229371|3817511|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3997000|NCT01229371|3817507|B5||Between 18 and 65 years|Age||Participants|Count of Participants|320|320.0||||||
3997001|NCT01229371|3817508|B4||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
3997002|NCT01229371|3817509|B3||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
3997003|NCT01229371|3817510|B2||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
3997004|NCT01229371|3817511|B1||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
3997005|NCT01229371|3817507|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3997006|NCT01229371|3817508|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3997007|NCT01229371|3817509|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3997008|NCT01229371|3817510|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3997009|NCT01229371|3817511|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3997010|NCT01229267|3817536|B6||Not reported|Intended duration of antiviral prophylaxis||Participants|Count of Participants|2|2.0||||||
3997011|NCT01229267|3817537|B5||Not reported|Intended duration of antiviral prophylaxis||Participants|Count of Participants|1|1.0||||||
3997012|NCT01229267|3817538|B4||Not reported|Intended duration of antiviral prophylaxis||Participants|Count of Participants|0|0.0||||||
3997013|NCT01229267|3817539|B3||Not reported|Intended duration of antiviral prophylaxis||Participants|Count of Participants|0|0.0||||||
3997014|NCT01229267|3817540|B2||Not reported|Intended duration of antiviral prophylaxis||Participants|Count of Participants|1|1.0||||||
3997015|NCT01229267|3817541|B1||Not reported|Intended duration of antiviral prophylaxis||Participants|Count of Participants|0|0.0||||||
3997016|NCT01229267|3817536|B6||>3 to ≤6 months post auto-HCT|Intended duration of antiviral prophylaxis||Participants|Count of Participants|691|691.0||||||
3997017|NCT01229267|3817537|B5||>3 to ≤6 months post auto-HCT|Intended duration of antiviral prophylaxis||Participants|Count of Participants|308|308.0||||||
3997018|NCT01229267|3817538|B4||>3 to ≤6 months post auto-HCT|Intended duration of antiviral prophylaxis||Participants|Count of Participants|63|63.0||||||
3997019|NCT01229267|3817539|B3||>3 to ≤6 months post auto-HCT|Intended duration of antiviral prophylaxis||Participants|Count of Participants|108|108.0||||||
3997020|NCT01229267|3817540|B2||>3 to ≤6 months post auto-HCT|Intended duration of antiviral prophylaxis||Participants|Count of Participants|103|103.0||||||
3997021|NCT01229267|3817541|B1||>3 to ≤6 months post auto-HCT|Intended duration of antiviral prophylaxis||Participants|Count of Participants|109|109.0||||||
3997022|NCT01229267|3817536|B6||≤3 months post auto-HCT|Intended duration of antiviral prophylaxis||Participants|Count of Participants|537|537.0||||||
3997023|NCT01229267|3817537|B5||≤3 months post auto-HCT|Intended duration of antiviral prophylaxis||Participants|Count of Participants|255|255.0||||||
3997024|NCT01229267|3817538|B4||≤3 months post auto-HCT|Intended duration of antiviral prophylaxis||Participants|Count of Participants|43|43.0||||||
3997025|NCT01229267|3817539|B3||≤3 months post auto-HCT|Intended duration of antiviral prophylaxis||Participants|Count of Participants|79|79.0||||||
3997026|NCT01229267|3817540|B2||≤3 months post auto-HCT|Intended duration of antiviral prophylaxis||Participants|Count of Participants|80|80.0||||||
3997027|NCT01229267|3817541|B1||≤3 months post auto-HCT|Intended duration of antiviral prophylaxis||Participants|Count of Participants|80|80.0||||||
3997028|NCT01229267|3817536|B6||From 70-79 years|Age||Participants|Count of Participants|69|69.0||||||
3997029|NCT01229267|3817537|B5||From 70-79 years|Age||Participants|Count of Participants|30|30.0||||||
3997030|NCT01229267|3817538|B4||From 70-79 years|Age||Participants|Count of Participants|6|6.0||||||
3997031|NCT01229267|3817539|B3||From 70-79 years|Age||Participants|Count of Participants|4|4.0||||||
3997032|NCT01229267|3817540|B2||From 70-79 years|Age||Participants|Count of Participants|12|12.0||||||
3997033|NCT01229267|3817541|B1||From 70-79 years|Age||Participants|Count of Participants|17|17.0||||||
3997034|NCT01229267|3817536|B6||From 60-69 years|Age||Participants|Count of Participants|408|408.0||||||
3997035|NCT01229267|3817537|B5||From 60-69 years|Age||Participants|Count of Participants|188|188.0||||||
3997036|NCT01229267|3817538|B4||From 60-69 years|Age||Participants|Count of Participants|31|31.0||||||
3997037|NCT01229267|3817539|B3||From 60-69 years|Age||Participants|Count of Participants|65|65.0||||||
3997038|NCT01229267|3817540|B2||From 60-69 years|Age||Participants|Count of Participants|61|61.0||||||
3997039|NCT01229267|3817541|B1||From 60-69 years|Age||Participants|Count of Participants|63|63.0||||||
3997040|NCT01229267|3817536|B6||From 50-59 years|Age||Participants|Count of Participants|407|407.0||||||
3997041|NCT01229267|3817537|B5||From 50-59 years|Age||Participants|Count of Participants|187|187.0||||||
3997042|NCT01229267|3817538|B4||From 50-59 years|Age||Participants|Count of Participants|40|40.0||||||
3997043|NCT01229267|3817539|B3||From 50-59 years|Age||Participants|Count of Participants|64|64.0||||||
3997044|NCT01229267|3817540|B2||From 50-59 years|Age||Participants|Count of Participants|60|60.0||||||
3997045|NCT01229267|3817541|B1||From 50-59 years|Age||Participants|Count of Participants|56|56.0||||||
3997046|NCT01229267|3817536|B6||From 18-49 years|Age||Participants|Count of Participants|346|346.0||||||
3997047|NCT01229267|3817537|B5||From 18-49 years|Age||Participants|Count of Participants|159|159.0||||||
3997048|NCT01229267|3817538|B4||From 18-49 years|Age||Participants|Count of Participants|29|29.0||||||
3997049|NCT01229267|3817539|B3||From 18-49 years|Age||Participants|Count of Participants|54|54.0||||||
3997050|NCT01229267|3817540|B2||From 18-49 years|Age||Participants|Count of Participants|51|51.0||||||
3997051|NCT01229267|3817541|B1||From 18-49 years|Age||Participants|Count of Participants|53|53.0||||||
3997052|NCT01229267|3817536|B6||Male|Sex: Female, Male||Participants|Count of Participants|775|775.0||||||
3997053|NCT01229267|3817537|B5||Male|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
3997054|NCT01229267|3817538|B4||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3997055|NCT01229267|3817539|B3||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
3997056|NCT01229267|3817540|B2||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
3997057|NCT01229267|3817541|B1||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
3997058|NCT01229267|3817536|B6||Female|Sex: Female, Male||Participants|Count of Participants|455|455.0||||||
3997059|NCT01229267|3817537|B5||Female|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
3997060|NCT01229267|3817538|B4||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3997061|NCT01229267|3817539|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3997062|NCT01229267|3817540|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3997063|NCT01229267|3817541|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
3997064|NCT01229267|3817536|B6|||Age||Years|Mean|54.1|54.1|Standard Deviation|12.4|12.4|||
3997065|NCT01229267|3817537|B5|||Age||Years|Mean|54.1|54.1|Standard Deviation|12.2|12.2|||
3997066|NCT01229267|3817538|B4|||Age||Years|Mean|54.3|54.3|Standard Deviation|12.2|12.2|||
3997067|NCT01229267|3817539|B3|||Age||Years|Mean|53.4|53.4|Standard Deviation|12.4|12.4|||
3997068|NCT01229267|3817540|B2|||Age||Years|Mean|54.2|54.2|Standard Deviation|12.6|12.6|||
3997069|NCT01229267|3817541|B1|||Age||Years|Mean|54.6|54.6|Standard Deviation|12.8|12.8|||
3997070|NCT01229254|3817561|B4||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3997071|NCT01229254|3817562|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3997072|NCT01229254|3817563|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3997073|NCT01229254|3817564|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3997074|NCT01229254|3817561|B4||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3997075|NCT01229254|3817562|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3997076|NCT01229254|3817563|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3997077|NCT01229254|3817564|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3997078|NCT01229254|3817561|B4|>=75 years||Age, Customized||Participants|Count of Participants|96|96.0||||||
3997079|NCT01229254|3817562|B3|>=75 years||Age, Customized||Participants|Count of Participants|27|27.0||||||
3997080|NCT01229254|3817563|B2|>=75 years||Age, Customized||Participants|Count of Participants|50|50.0||||||
3997081|NCT01229254|3817564|B1|>=75 years||Age, Customized||Participants|Count of Participants|19|19.0||||||
3997082|NCT01229254|3817561|B4|<75 years||Age, Customized||Participants|Count of Participants|93|93.0||||||
3997083|NCT01229254|3817562|B3|<75 years||Age, Customized||Participants|Count of Participants|46|46.0||||||
3997084|NCT01229254|3817563|B2|<75 years||Age, Customized||Participants|Count of Participants|24|24.0||||||
3997085|NCT01229254|3817564|B1|<75 years||Age, Customized||Participants|Count of Participants|23|23.0||||||
3997086|NCT01229254|3817561|B4|||Age||years|Mean|73.8|73.8|Standard Deviation|8.98|8.98|||
3997087|NCT01229254|3817562|B3|||Age||years|Mean|71.2|71.2|Standard Deviation|9.21|9.21|||
3997088|NCT01229254|3817563|B2|||Age||years|Mean|77.1|77.1|Standard Deviation|7.12|7.12|||
3997089|NCT01229254|3817564|B1|||Age||years|Mean|72.4|72.4|Standard Deviation|9.87|9.87|||
3997090|NCT01229228|3817575|B6|United States||Region of Enrollment||participants|Number|254|254.0||||||
3997091|NCT01229228|3817576|B5|United States||Region of Enrollment||participants|Number|51|51.0||||||
3997092|NCT01229228|3817577|B4|United States||Region of Enrollment||participants|Number|51|51.0||||||
3997093|NCT01229228|3817578|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
3997094|NCT01229228|3817579|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
3997095|NCT01229228|3817580|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
3997096|NCT01229228|3817575|B6||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
3997097|NCT01229228|3817576|B5||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3997098|NCT01229228|3817577|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3997099|NCT01229228|3817578|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3997100|NCT01229228|3817579|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3997101|NCT01229228|3817580|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3997102|NCT01229228|3817575|B6||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
3997103|NCT01229228|3817576|B5||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3997104|NCT01229228|3817577|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3997105|NCT01229228|3817578|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3997106|NCT01229228|3817579|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3997107|NCT01229228|3817580|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3997108|NCT01229228|3817575|B6|||Age||years|Mean|21.0|21.0|Standard Deviation|2.87|2.87|||
3997109|NCT01229228|3817576|B5|||Age||years|Mean|21.1|21.1|Standard Deviation|3.02|3.02|||
3997110|NCT01229228|3817577|B4|||Age||years|Mean|20.9|20.9|Standard Deviation|2.88|2.88|||
3997111|NCT01229228|3817578|B3|||Age||years|Mean|20.7|20.7|Standard Deviation|2.20|2.2|||
3997112|NCT01229228|3817579|B2|||Age||years|Mean|21.1|21.1|Standard Deviation|3.29|3.29|||
3997113|NCT01229228|3817580|B1|||Age||years|Mean|21.1|21.1|Standard Deviation|2.93|2.93|||
3997114|NCT01229228|3817575|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3997115|NCT01229228|3817576|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3997116|NCT01229228|3817577|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3997117|NCT01229228|3817578|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3997118|NCT01229228|3817579|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3997119|NCT01229228|3817580|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3997120|NCT01229228|3817575|B6||Between 18 and 65 years|Age||Participants|Count of Participants|254|254.0||||||
3997121|NCT01229228|3817576|B5||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3997122|NCT01229228|3817577|B4||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3997123|NCT01229228|3817578|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
3997124|NCT01229228|3817579|B2||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3997125|NCT01229228|3817580|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
3997126|NCT01229228|3817575|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3997127|NCT01229228|3817576|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3997128|NCT01229228|3817577|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3997129|NCT01229228|3817578|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3997130|NCT01229228|3817579|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3997131|NCT01229228|3817580|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3997132|NCT01229176|3817596|B9|India||Region of Enrollment||participants|Number|40|40.0||||||
3997133|NCT01229176|3817597|B8|India||Region of Enrollment||participants|Number|0|0.0||||||
3997134|NCT01229176|3817598|B7|India||Region of Enrollment||participants|Number|0|0.0||||||
3997135|NCT01229176|3817599|B6|India||Region of Enrollment||participants|Number|0|0.0||||||
3997136|NCT01229176|3817600|B5|India||Region of Enrollment||participants|Number|0|0.0||||||
3997137|NCT01229176|3817601|B4|India||Region of Enrollment||participants|Number|0|0.0||||||
3997138|NCT01229176|3817602|B3|India||Region of Enrollment||participants|Number|0|0.0||||||
3997139|NCT01229176|3817603|B2|India||Region of Enrollment||participants|Number|20|20.0||||||
3997140|NCT01229176|3817604|B1|India||Region of Enrollment||participants|Number|20|20.0||||||
3997141|NCT01229176|3817596|B9|Pakistan||Region of Enrollment||participants|Number|160|160.0||||||
3997142|NCT01229176|3817597|B8|Pakistan||Region of Enrollment||participants|Number|20|20.0||||||
3997143|NCT01229176|3817598|B7|Pakistan||Region of Enrollment||participants|Number|20|20.0||||||
3997144|NCT01229176|3817599|B6|Pakistan||Region of Enrollment||participants|Number|20|20.0||||||
3997145|NCT01229176|3817600|B5|Pakistan||Region of Enrollment||participants|Number|20|20.0||||||
3997146|NCT01229176|3817601|B4|Pakistan||Region of Enrollment||participants|Number|20|20.0||||||
3997147|NCT01229176|3817602|B3|Pakistan||Region of Enrollment||participants|Number|20|20.0||||||
3997148|NCT01229176|3817603|B2|Pakistan||Region of Enrollment||participants|Number|20|20.0||||||
3997149|NCT01229176|3817604|B1|Pakistan||Region of Enrollment||participants|Number|20|20.0||||||
3997150|NCT01229176|3817596|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997151|NCT01229176|3817597|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997152|NCT01229176|3817598|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997153|NCT01229176|3817599|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997154|NCT01229176|3817600|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997155|NCT01229176|3817601|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997156|NCT01229176|3817602|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997157|NCT01229176|3817603|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997158|NCT01229176|3817604|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997159|NCT01229176|3817596|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997160|NCT01229176|3817597|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997161|NCT01229176|3817598|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997162|NCT01229176|3817599|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997163|NCT01229176|3817600|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997164|NCT01229176|3817601|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997165|NCT01229176|3817602|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997166|NCT01229176|3817603|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997167|NCT01229176|3817604|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997168|NCT01229176|3817596|B9||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997169|NCT01229176|3817597|B8||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997170|NCT01229176|3817598|B7||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997171|NCT01229176|3817599|B6||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997172|NCT01229176|3817600|B5||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997173|NCT01229176|3817601|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997174|NCT01229176|3817602|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997175|NCT01229176|3817603|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997176|NCT01229176|3817604|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997177|NCT01229176|3817596|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997178|NCT01229176|3817597|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997179|NCT01229176|3817598|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997180|NCT01229176|3817599|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997181|NCT01229176|3817600|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997182|NCT01229176|3817601|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997183|NCT01229176|3817602|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997184|NCT01229176|3817603|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997185|NCT01229176|3817604|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997186|NCT01229176|3817596|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997187|NCT01229176|3817597|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997188|NCT01229176|3817598|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997189|NCT01229176|3817599|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997190|NCT01229176|3817600|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997191|NCT01229176|3817601|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997192|NCT01229176|3817602|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997193|NCT01229176|3817603|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997194|NCT01229176|3817604|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997195|NCT01229176|3817596|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|200|200.0||||||
3997196|NCT01229176|3817597|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3997197|NCT01229176|3817598|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3997198|NCT01229176|3817599|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3997199|NCT01229176|3817600|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3997200|NCT01229176|3817601|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3997201|NCT01229176|3817602|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3997202|NCT01229176|3817603|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3997203|NCT01229176|3817604|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3997204|NCT01229176|3817596|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997205|NCT01229176|3817597|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997206|NCT01229176|3817598|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997207|NCT01229176|3817599|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997208|NCT01229176|3817600|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997209|NCT01229176|3817601|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997210|NCT01229176|3817602|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997211|NCT01229176|3817603|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997212|NCT01229176|3817604|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997213|NCT01229176|3817596|B9||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
3997214|NCT01229176|3817597|B8||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3997215|NCT01229176|3817598|B7||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3997216|NCT01229176|3817599|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3997217|NCT01229176|3817600|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3997218|NCT01229176|3817601|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3997219|NCT01229176|3817602|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3997220|NCT01229176|3817603|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3997221|NCT01229176|3817604|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3997222|NCT01229176|3817596|B9||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3997223|NCT01229176|3817597|B8||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3997224|NCT01229176|3817598|B7||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3997225|NCT01229176|3817599|B6||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3997226|NCT01229176|3817600|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3997227|NCT01229176|3817601|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3997228|NCT01229176|3817602|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3997229|NCT01229176|3817603|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3997230|NCT01229176|3817604|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3997231|NCT01229176|3817596|B9|18 years to 45 years (adults)||Age, Customized||participants|Number|80|80.0||||||
3997232|NCT01229176|3817597|B8|18 years to 45 years (adults)||Age, Customized||participants|Number|0|0.0||||||
3997233|NCT01229176|3817598|B7|18 years to 45 years (adults)||Age, Customized||participants|Number|0|0.0||||||
3997234|NCT01229176|3817599|B6|18 years to 45 years (adults)||Age, Customized||participants|Number|0|0.0||||||
3997235|NCT01229176|3817600|B5|18 years to 45 years (adults)||Age, Customized||participants|Number|0|0.0||||||
3997236|NCT01229176|3817601|B4|18 years to 45 years (adults)||Age, Customized||participants|Number|0|0.0||||||
3997237|NCT01229176|3817602|B3|18 years to 45 years (adults)||Age, Customized||participants|Number|0|0.0||||||
3997238|NCT01229176|3817603|B2|18 years to 45 years (adults)||Age, Customized||participants|Number|40|40.0||||||
3997239|NCT01229176|3817604|B1|18 years to 45 years (adults)||Age, Customized||participants|Number|40|40.0||||||
3997240|NCT01229176|3817596|B9|24 months 59 months (children)||Age, Customized||participants|Number|40|40.0||||||
3997241|NCT01229176|3817597|B8|24 months 59 months (children)||Age, Customized||participants|Number|0|0.0||||||
3997242|NCT01229176|3817598|B7|24 months 59 months (children)||Age, Customized||participants|Number|0|0.0||||||
3997243|NCT01229176|3817599|B6|24 months 59 months (children)||Age, Customized||participants|Number|0|0.0||||||
3997244|NCT01229176|3817600|B5|24 months 59 months (children)||Age, Customized||participants|Number|0|0.0||||||
3997245|NCT01229176|3817601|B4|24 months 59 months (children)||Age, Customized||participants|Number|20|20.0||||||
3997246|NCT01229176|3817602|B3|24 months 59 months (children)||Age, Customized||participants|Number|20|20.0||||||
3997247|NCT01229176|3817603|B2|24 months 59 months (children)||Age, Customized||participants|Number|0|0.0||||||
3997248|NCT01229176|3817604|B1|24 months 59 months (children)||Age, Customized||participants|Number|0|0.0||||||
3997249|NCT01229176|3817596|B9|9 months to 12 months (older infants)||Age, Customized||participants|Number|40|40.0||||||
3997250|NCT01229176|3817597|B8|9 months to 12 months (older infants)||Age, Customized||participants|Number|0|0.0||||||
3997251|NCT01229176|3817598|B7|9 months to 12 months (older infants)||Age, Customized||participants|Number|0|0.0||||||
3997252|NCT01229176|3817599|B6|9 months to 12 months (older infants)||Age, Customized||participants|Number|20|20.0||||||
3997253|NCT01229176|3817600|B5|9 months to 12 months (older infants)||Age, Customized||participants|Number|20|20.0||||||
3997254|NCT01229176|3817601|B4|9 months to 12 months (older infants)||Age, Customized||participants|Number|0|0.0||||||
3997255|NCT01229176|3817602|B3|9 months to 12 months (older infants)||Age, Customized||participants|Number|0|0.0||||||
3997256|NCT01229176|3817603|B2|9 months to 12 months (older infants)||Age, Customized||participants|Number|0|0.0||||||
3997257|NCT01229176|3817604|B1|9 months to 12 months (older infants)||Age, Customized||participants|Number|0|0.0||||||
3997258|NCT01229176|3817596|B9|6 weeks to 8 weeks (infants)||Age, Customized||participants|Number|40|40.0||||||
3997259|NCT01229176|3817597|B8|6 weeks to 8 weeks (infants)||Age, Customized||participants|Number|20|20.0||||||
3997260|NCT01229176|3817598|B7|6 weeks to 8 weeks (infants)||Age, Customized||participants|Number|20|20.0||||||
3997261|NCT01229176|3817599|B6|6 weeks to 8 weeks (infants)||Age, Customized||participants|Number|0|0.0||||||
3997262|NCT01229176|3817600|B5|6 weeks to 8 weeks (infants)||Age, Customized||participants|Number|0|0.0||||||
3997263|NCT01229176|3817601|B4|6 weeks to 8 weeks (infants)||Age, Customized||participants|Number|0|0.0||||||
3997264|NCT01229176|3817602|B3|6 weeks to 8 weeks (infants)||Age, Customized||participants|Number|0|0.0||||||
3997265|NCT01229176|3817603|B2|6 weeks to 8 weeks (infants)||Age, Customized||participants|Number|0|0.0||||||
3997266|NCT01229176|3817604|B1|6 weeks to 8 weeks (infants)||Age, Customized||participants|Number|0|0.0||||||
3997267|NCT01229150|3817661|B5|Never-smoker||Smoking||Participants|Count of Participants|9|9.0||||||
3997268|NCT01229150|3817662|B4|Never-smoker||Smoking||Participants|Count of Participants|3|3.0||||||
3997269|NCT01229150|3817663|B3|Never-smoker||Smoking||Participants|Count of Participants|6|6.0||||||
3997270|NCT01229150|3817664|B2|Never-smoker||Smoking||Participants|Count of Participants|0|0.0||||||
3997271|NCT01229150|3817665|B1|Never-smoker||Smoking||Participants|Count of Participants|0|0.0||||||
3997272|NCT01229150|3817661|B5|Former||Smoking||Participants|Count of Participants|61|61.0||||||
3997273|NCT01229150|3817662|B4|Former||Smoking||Participants|Count of Participants|16|16.0||||||
3997274|NCT01229150|3817663|B3|Former||Smoking||Participants|Count of Participants|13|13.0||||||
3997275|NCT01229150|3817664|B2|Former||Smoking||Participants|Count of Participants|11|11.0||||||
3997276|NCT01229150|3817665|B1|Former||Smoking||Participants|Count of Participants|21|21.0||||||
3997277|NCT01229150|3817661|B5|Current||Smoking||Participants|Count of Participants|9|9.0||||||
3997278|NCT01229150|3817662|B4|Current||Smoking||Participants|Count of Participants|0|0.0||||||
3997279|NCT01229150|3817663|B3|Current||Smoking||Participants|Count of Participants|0|0.0||||||
3997280|NCT01229150|3817664|B2|Current||Smoking||Participants|Count of Participants|0|0.0||||||
3997281|NCT01229150|3817665|B1|Current||Smoking||Participants|Count of Participants|9|9.0||||||
3997282|NCT01229150|3817661|B5|2||No. of Prior Regimens||Participants|Count of Participants|43|43.0||||||
3997283|NCT01229150|3817662|B4|2||No. of Prior Regimens||Participants|Count of Participants|11|11.0||||||
3997284|NCT01229150|3817663|B3|2||No. of Prior Regimens||Participants|Count of Participants|9|9.0||||||
3997285|NCT01229150|3817664|B2|2||No. of Prior Regimens||Participants|Count of Participants|5|5.0||||||
3997286|NCT01229150|3817665|B1|2||No. of Prior Regimens||Participants|Count of Participants|18|18.0||||||
3997287|NCT01229150|3817661|B5|1||No. of Prior Regimens||Participants|Count of Participants|36|36.0||||||
3997288|NCT01229150|3817662|B4|1||No. of Prior Regimens||Participants|Count of Participants|8|8.0||||||
3997289|NCT01229150|3817663|B3|1||No. of Prior Regimens||Participants|Count of Participants|10|10.0||||||
3997290|NCT01229150|3817664|B2|1||No. of Prior Regimens||Participants|Count of Participants|6|6.0||||||
3997291|NCT01229150|3817665|B1|1||No. of Prior Regimens||Participants|Count of Participants|12|12.0||||||
3997292|NCT01229150|3817661|B5|2||Eastern Cooperative Oncology Group (ECOG)|ECOG Performance Status criteria: Grade 0 is normal activity. Fully active, able to carry on all pre-disease performance without restriction. Grade 1 is symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work). Grade 2 is in bed <50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hours.|Participants|Count of Participants|34|34.0||||||
3997293|NCT01229150|3817662|B4|2||Eastern Cooperative Oncology Group (ECOG)|ECOG Performance Status criteria: Grade 0 is normal activity. Fully active, able to carry on all pre-disease performance without restriction. Grade 1 is symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work). Grade 2 is in bed <50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hours.|Participants|Count of Participants|10|10.0||||||
3997294|NCT01229150|3817663|B3|2||Eastern Cooperative Oncology Group (ECOG)|ECOG Performance Status criteria: Grade 0 is normal activity. Fully active, able to carry on all pre-disease performance without restriction. Grade 1 is symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work). Grade 2 is in bed <50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hours.|Participants|Count of Participants|6|6.0||||||
3997295|NCT01229150|3817664|B2|2||Eastern Cooperative Oncology Group (ECOG)|ECOG Performance Status criteria: Grade 0 is normal activity. Fully active, able to carry on all pre-disease performance without restriction. Grade 1 is symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work). Grade 2 is in bed <50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hours.|Participants|Count of Participants|5|5.0||||||
3997296|NCT01229150|3817665|B1|2||Eastern Cooperative Oncology Group (ECOG)|ECOG Performance Status criteria: Grade 0 is normal activity. Fully active, able to carry on all pre-disease performance without restriction. Grade 1 is symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work). Grade 2 is in bed <50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hours.|Participants|Count of Participants|13|13.0||||||
3997404|NCT01229150|3817663|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997405|NCT01229150|3817664|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997297|NCT01229150|3817661|B5|1||Eastern Cooperative Oncology Group (ECOG)|ECOG Performance Status criteria: Grade 0 is normal activity. Fully active, able to carry on all pre-disease performance without restriction. Grade 1 is symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work). Grade 2 is in bed <50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hours.|Participants|Count of Participants|37|37.0||||||
3997298|NCT01229150|3817662|B4|1||Eastern Cooperative Oncology Group (ECOG)|ECOG Performance Status criteria: Grade 0 is normal activity. Fully active, able to carry on all pre-disease performance without restriction. Grade 1 is symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work). Grade 2 is in bed <50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hours.|Participants|Count of Participants|7|7.0||||||
3997299|NCT01229150|3817663|B3|1||Eastern Cooperative Oncology Group (ECOG)|ECOG Performance Status criteria: Grade 0 is normal activity. Fully active, able to carry on all pre-disease performance without restriction. Grade 1 is symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work). Grade 2 is in bed <50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hours.|Participants|Count of Participants|11|11.0||||||
3997300|NCT01229150|3817664|B2|1||Eastern Cooperative Oncology Group (ECOG)|ECOG Performance Status criteria: Grade 0 is normal activity. Fully active, able to carry on all pre-disease performance without restriction. Grade 1 is symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work). Grade 2 is in bed <50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hours.|Participants|Count of Participants|5|5.0||||||
3997301|NCT01229150|3817665|B1|1||Eastern Cooperative Oncology Group (ECOG)|ECOG Performance Status criteria: Grade 0 is normal activity. Fully active, able to carry on all pre-disease performance without restriction. Grade 1 is symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work). Grade 2 is in bed <50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hours.|Participants|Count of Participants|14|14.0||||||
3997302|NCT01229150|3817661|B5|0||Eastern Cooperative Oncology Group (ECOG)|ECOG Performance Status criteria: Grade 0 is normal activity. Fully active, able to carry on all pre-disease performance without restriction. Grade 1 is symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work). Grade 2 is in bed <50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hours.|Participants|Count of Participants|8|8.0||||||
3997303|NCT01229150|3817662|B4|0||Eastern Cooperative Oncology Group (ECOG)|ECOG Performance Status criteria: Grade 0 is normal activity. Fully active, able to carry on all pre-disease performance without restriction. Grade 1 is symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work). Grade 2 is in bed <50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hours.|Participants|Count of Participants|2|2.0||||||
3997304|NCT01229150|3817663|B3|0||Eastern Cooperative Oncology Group (ECOG)|ECOG Performance Status criteria: Grade 0 is normal activity. Fully active, able to carry on all pre-disease performance without restriction. Grade 1 is symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work). Grade 2 is in bed <50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hours.|Participants|Count of Participants|2|2.0||||||
3997305|NCT01229150|3817664|B2|0||Eastern Cooperative Oncology Group (ECOG)|ECOG Performance Status criteria: Grade 0 is normal activity. Fully active, able to carry on all pre-disease performance without restriction. Grade 1 is symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work). Grade 2 is in bed <50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hours.|Participants|Count of Participants|1|1.0||||||
3997306|NCT01229150|3817665|B1|0||Eastern Cooperative Oncology Group (ECOG)|ECOG Performance Status criteria: Grade 0 is normal activity. Fully active, able to carry on all pre-disease performance without restriction. Grade 1 is symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work). Grade 2 is in bed <50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hours.|Participants|Count of Participants|3|3.0||||||
3997307|NCT01229150|3817661|B5|KRAS||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|0|0.0||||||
3997308|NCT01229150|3817662|B4|KRAS||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|0|0.0||||||
3997309|NCT01229150|3817663|B3|KRAS||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|0|0.0||||||
3997406|NCT01229150|3817665|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997310|NCT01229150|3817664|B2|KRAS||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|0|0.0||||||
3997311|NCT01229150|3817665|B1|KRAS||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|0|0.0||||||
3997312|NCT01229150|3817661|B5|KRAS Q61L||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|2|2.0||||||
3997313|NCT01229150|3817662|B4|KRAS Q61L||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|0|0.0||||||
3997314|NCT01229150|3817663|B3|KRAS Q61L||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|0|0.0||||||
3997315|NCT01229150|3817664|B2|KRAS Q61L||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|0|0.0||||||
3997316|NCT01229150|3817665|B1|KRAS Q61L||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|2|2.0||||||
3997317|NCT01229150|3817661|B5|KRAS Q61H||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|2|2.0||||||
3997318|NCT01229150|3817662|B4|KRAS Q61H||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|0|0.0||||||
3997319|NCT01229150|3817663|B3|KRAS Q61H||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|0|0.0||||||
3997320|NCT01229150|3817664|B2|KRAS Q61H||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|0|0.0||||||
3997321|NCT01229150|3817665|B1|KRAS Q61H||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|2|2.0||||||
3997322|NCT01229150|3817661|B5|KRAS G12V||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|13|13.0||||||
3997323|NCT01229150|3817662|B4|KRAS G12V||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|0|0.0||||||
3997324|NCT01229150|3817663|B3|KRAS G12V||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|0|0.0||||||
3997325|NCT01229150|3817664|B2|KRAS G12V||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|4|4.0||||||
3997326|NCT01229150|3817665|B1|KRAS G12V||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|9|9.0||||||
3997407|NCT01229150|3817661|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3997408|NCT01229150|3817662|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3997409|NCT01229150|3817663|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997327|NCT01229150|3817661|B5|KRAS G12S||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|1|1.0||||||
3997328|NCT01229150|3817662|B4|KRAS G12S||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|0|0.0||||||
3997329|NCT01229150|3817663|B3|KRAS G12S||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|0|0.0||||||
3997330|NCT01229150|3817664|B2|KRAS G12S||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|0|0.0||||||
3997331|NCT01229150|3817665|B1|KRAS G12S||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|1|1.0||||||
3997332|NCT01229150|3817661|B5|KRAS G12R||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|1|1.0||||||
3997333|NCT01229150|3817662|B4|KRAS G12R||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|0|0.0||||||
3997334|NCT01229150|3817663|B3|KRAS G12R||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|0|0.0||||||
3997335|NCT01229150|3817664|B2|KRAS G12R||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|1|1.0||||||
3997336|NCT01229150|3817665|B1|KRAS G12R||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|0|0.0||||||
3997337|NCT01229150|3817661|B5|KRAS G12K||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|2|2.0||||||
3997338|NCT01229150|3817662|B4|KRAS G12K||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|0|0.0||||||
3997339|NCT01229150|3817663|B3|KRAS G12K||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|0|0.0||||||
3997340|NCT01229150|3817664|B2|KRAS G12K||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|1|1.0||||||
3997341|NCT01229150|3817665|B1|KRAS G12K||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|1|1.0||||||
3997342|NCT01229150|3817661|B5|KRAS G12D||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|2|2.0||||||
3997343|NCT01229150|3817662|B4|KRAS G12D||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|0|0.0||||||
3997410|NCT01229150|3817664|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3997411|NCT01229150|3817665|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3997412|NCT01229150|3817661|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997344|NCT01229150|3817663|B3|KRAS G12D||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|0|0.0||||||
3997345|NCT01229150|3817664|B2|KRAS G12D||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|1|1.0||||||
3997346|NCT01229150|3817665|B1|KRAS G12D||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|1|1.0||||||
3997347|NCT01229150|3817661|B5|KRAS G12C||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|12|12.0||||||
3997348|NCT01229150|3817662|B4|KRAS G12C||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|0|0.0||||||
3997349|NCT01229150|3817663|B3|KRAS G12C||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|0|0.0||||||
3997350|NCT01229150|3817664|B2|KRAS G12C||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|4|4.0||||||
3997351|NCT01229150|3817665|B1|KRAS G12C||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|8|8.0||||||
3997352|NCT01229150|3817661|B5|KRAS G12A||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|6|6.0||||||
3997353|NCT01229150|3817662|B4|KRAS G12A||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|0|0.0||||||
3997354|NCT01229150|3817663|B3|KRAS G12A||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|0|0.0||||||
3997355|NCT01229150|3817664|B2|KRAS G12A||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|0|0.0||||||
3997356|NCT01229150|3817665|B1|KRAS G12A||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|6|6.0||||||
3997357|NCT01229150|3817661|B5|EGFR Wild Type||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|36|36.0||||||
3997358|NCT01229150|3817662|B4|EGFR Wild Type||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|18|18.0||||||
3997359|NCT01229150|3817663|B3|EGFR Wild Type||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|18|18.0||||||
3997360|NCT01229150|3817664|B2|EGFR Wild Type||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|0|0.0||||||
3997413|NCT01229150|3817662|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997414|NCT01229150|3817663|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997361|NCT01229150|3817665|B1|EGFR Wild Type||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|0|0.0||||||
3997362|NCT01229150|3817661|B5|EGFR Mutated (L858R)||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|43|43.0||||||
3997363|NCT01229150|3817662|B4|EGFR Mutated (L858R)||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|1|1.0||||||
3997364|NCT01229150|3817663|B3|EGFR Mutated (L858R)||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|1|1.0||||||
3997365|NCT01229150|3817664|B2|EGFR Mutated (L858R)||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|11|11.0||||||
3997366|NCT01229150|3817665|B1|EGFR Mutated (L858R)||Mutational Status|EGFR (epidermal growth factor receptor); KRAS (Kirsten Rat Sarcoma Viral Oncogene homolog). KRAS G12A (e.g. G is glycine, 12 is the codon or position and A is amino acid alanine); C is cysteine, D is aspartic acid, K is lysine, R is arginine, S is serine, V is valine, Q is glutamine, H is histidine, and L is leucine.|Participants|Count of Participants|30|30.0||||||
3997367|NCT01229150|3817661|B5|Squamous cell||Histology||Participants|Count of Participants|8|8.0||||||
3997368|NCT01229150|3817662|B4|Squamous cell||Histology||Participants|Count of Participants|4|4.0||||||
3997369|NCT01229150|3817663|B3|Squamous cell||Histology||Participants|Count of Participants|4|4.0||||||
3997370|NCT01229150|3817664|B2|Squamous cell||Histology||Participants|Count of Participants|0|0.0||||||
3997371|NCT01229150|3817665|B1|Squamous cell||Histology||Participants|Count of Participants|0|0.0||||||
3997372|NCT01229150|3817661|B5|Lung Cancer Adenocarcinoma||Histology||Participants|Count of Participants|71|71.0||||||
3997373|NCT01229150|3817662|B4|Lung Cancer Adenocarcinoma||Histology||Participants|Count of Participants|15|15.0||||||
3997374|NCT01229150|3817663|B3|Lung Cancer Adenocarcinoma||Histology||Participants|Count of Participants|15|15.0||||||
3997375|NCT01229150|3817664|B2|Lung Cancer Adenocarcinoma||Histology||Participants|Count of Participants|11|11.0||||||
3997376|NCT01229150|3817665|B1|Lung Cancer Adenocarcinoma||Histology||Participants|Count of Participants|30|30.0||||||
3997377|NCT01229150|3817661|B5|United States||Region of Enrollment||Participants|Count of Participants|79|79.0||||||
3997378|NCT01229150|3817662|B4|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3997379|NCT01229150|3817663|B3|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
3997380|NCT01229150|3817664|B2|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
3997381|NCT01229150|3817665|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3997382|NCT01229150|3817661|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3997383|NCT01229150|3817662|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3997384|NCT01229150|3817663|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3997385|NCT01229150|3817664|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997386|NCT01229150|3817665|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997387|NCT01229150|3817661|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997388|NCT01229150|3817662|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997389|NCT01229150|3817663|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997390|NCT01229150|3817664|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997391|NCT01229150|3817665|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997392|NCT01229150|3817661|B5||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3997393|NCT01229150|3817662|B4||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3997394|NCT01229150|3817663|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3997395|NCT01229150|3817664|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3997396|NCT01229150|3817665|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3997397|NCT01229150|3817661|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
3997398|NCT01229150|3817662|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3997399|NCT01229150|3817663|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3997400|NCT01229150|3817664|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3997401|NCT01229150|3817665|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3997402|NCT01229150|3817661|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997403|NCT01229150|3817662|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997415|NCT01229150|3817664|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997416|NCT01229150|3817665|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997417|NCT01229150|3817661|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3997418|NCT01229150|3817662|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3997419|NCT01229150|3817663|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3997420|NCT01229150|3817664|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997421|NCT01229150|3817665|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3997422|NCT01229150|3817661|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3997423|NCT01229150|3817662|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
3997424|NCT01229150|3817663|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3997425|NCT01229150|3817664|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3997426|NCT01229150|3817665|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3997427|NCT01229150|3817661|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3997428|NCT01229150|3817662|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3997429|NCT01229150|3817663|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3997430|NCT01229150|3817664|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3997431|NCT01229150|3817665|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3997432|NCT01229150|3817661|B5||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3997433|NCT01229150|3817662|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3997434|NCT01229150|3817663|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3997435|NCT01229150|3817664|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3997436|NCT01229150|3817665|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3997437|NCT01229150|3817661|B5||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3997438|NCT01229150|3817662|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3997439|NCT01229150|3817663|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3997440|NCT01229150|3817664|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3997441|NCT01229150|3817665|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3997442|NCT01229150|3817661|B5|||Age||years|Mean|65.22|65.22|Standard Deviation|9.46|9.46|||
3997443|NCT01229150|3817662|B4|||Age||years|Mean|64.84|64.84|Standard Deviation|8.10|8.1|||
3997444|NCT01229150|3817663|B3|||Age||years|Mean|63.75|63.75|Standard Deviation|13.6|13.6|||
3997445|NCT01229150|3817664|B2|||Age||years|Mean|64.31|64.31|Standard Deviation|13.76|13.76|||
3997446|NCT01229150|3817665|B1|||Age||years|Mean|66.05|66.05|Standard Deviation|9.648|9.648|||
3997447|NCT01229150|3817661|B5||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
3997448|NCT01229150|3817662|B4||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
3997449|NCT01229150|3817663|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3997450|NCT01229150|3817664|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3997451|NCT01229150|3817665|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
3997452|NCT01229150|3817661|B5||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3997453|NCT01229150|3817662|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
3997454|NCT01229150|3817663|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3997455|NCT01229150|3817664|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3997456|NCT01229150|3817665|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3997457|NCT01229150|3817661|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3997458|NCT01229150|3817662|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3997459|NCT01229150|3817663|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3997460|NCT01229150|3817664|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3997461|NCT01229150|3817665|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3997462|NCT01229111|3817725|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
3997463|NCT01229111|3817725|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997464|NCT01229111|3817725|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997465|NCT01229111|3817725|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3997466|NCT01229111|3817725|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3997467|NCT01229111|3817725|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997468|NCT01229111|3817725|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3997469|NCT01229111|3817725|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997470|NCT01229111|3817725|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997471|NCT01229111|3817725|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3997472|NCT01229111|3817725|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997473|NCT01229111|3817725|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3997474|NCT01229111|3817725|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3997475|NCT01229111|3817725|B1|70-79 years||Age, Customized||participants|Number|1|1.0||||||
3997476|NCT01229111|3817725|B1|60-69 years||Age, Customized||participants|Number|8|8.0||||||
3997477|NCT01229111|3817725|B1|50-59 years||Age, Customized||participants|Number|3|3.0||||||
3997478|NCT01229111|3817725|B1|40-49 years||Age, Customized||participants|Number|1|1.0||||||
3997479|NCT01229111|3817725|B1|30-39 years||Age, Customized||participants|Number|1|1.0||||||
3997480|NCT01228968|3817733|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
3997481|NCT01228968|3817733|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3997482|NCT01228968|3817733|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3997483|NCT01228968|3817733|B1|||Age||years|Mean|39.8|39.8|Standard Deviation|9.3|9.3|||
3997484|NCT01228968|3817733|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3997485|NCT01228968|3817733|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3997486|NCT01228968|3817733|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3997487|NCT01228929|3817740|B4|United States||Region of Enrollment||participants|Number|18|18.0||||||
3997488|NCT01228929|3817741|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
3997489|NCT01228929|3817742|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
3997490|NCT01228929|3817743|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3997491|NCT01228929|3817740|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3997492|NCT01228929|3817741|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3997493|NCT01228929|3817742|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3997494|NCT01228929|3817743|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3997495|NCT01228929|3817740|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3997496|NCT01228929|3817741|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3997497|NCT01228929|3817742|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3997498|NCT01228929|3817743|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3997499|NCT01228929|3817740|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3997500|NCT01228929|3817741|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3997501|NCT01228929|3817742|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3997502|NCT01228929|3817743|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3997503|NCT01228929|3817740|B4||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3997504|NCT01228929|3817741|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3997505|NCT01228929|3817742|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3997506|NCT01228929|3817743|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3997507|NCT01228929|3817740|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3997508|NCT01228929|3817741|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3997509|NCT01228929|3817742|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3997510|NCT01228929|3817743|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3997511|NCT01228903|3817753|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
3997512|NCT01228903|3817754|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
3997513|NCT01228903|3817755|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
3997514|NCT01228903|3817753|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3997515|NCT01228903|3817754|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3997516|NCT01228903|3817755|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3997517|NCT01228903|3817753|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3997518|NCT01228903|3817754|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3997519|NCT01228903|3817755|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3997520|NCT01228903|3817753|B3|||Age||years|Mean|57.4|57.4|Standard Deviation|11.5|11.5|||
3997521|NCT01228903|3817754|B2|||Age||years|Mean|55.9|55.9|Standard Deviation|13.7|13.7|||
3997522|NCT01228903|3817755|B1|||Age||years|Mean|58.9|58.9|Standard Deviation|9.3|9.3|||
3997523|NCT01228747|3817772|B3|Japan||Region of Enrollment||participants|Number|43|43.0||||||
3997524|NCT01228747|3817773|B2|Japan||Region of Enrollment||participants|Number|22|22.0||||||
3997525|NCT01228747|3817774|B1|Japan||Region of Enrollment||participants|Number|21|21.0||||||
3997526|NCT01228747|3817772|B3|China||Region of Enrollment||participants|Number|208|208.0||||||
3997527|NCT01228747|3817773|B2|China||Region of Enrollment||participants|Number|104|104.0||||||
3997528|NCT01228747|3817774|B1|China||Region of Enrollment||participants|Number|104|104.0||||||
3997529|NCT01228747|3817772|B3||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
3997530|NCT01228747|3817773|B2||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3997531|NCT01228747|3817774|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3997532|NCT01228747|3817772|B3||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
3997533|NCT01228747|3817773|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3997534|NCT01228747|3817774|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3997535|NCT01228747|3817772|B3|||Age||years|Mean|32.2|32.2|Standard Deviation|11.9|11.9|||
3997536|NCT01228747|3817773|B2|||Age||years|Mean|31.5|31.5|Standard Deviation|11.3|11.3|||
3997537|NCT01228747|3817774|B1|||Age||years|Mean|32.8|32.8|Standard Deviation|12.5|12.5|||
3997538|NCT01228747|3817772|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3997539|NCT01228747|3817773|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3997540|NCT01228747|3817774|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3997541|NCT01228747|3817772|B3||Between 18 and 65 years|Age||Participants|Count of Participants|228|228.0||||||
3997542|NCT01228747|3817773|B2||Between 18 and 65 years|Age||Participants|Count of Participants|115|115.0||||||
3997543|NCT01228747|3817774|B1||Between 18 and 65 years|Age||Participants|Count of Participants|113|113.0||||||
3997544|NCT01228747|3817772|B3||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
3997545|NCT01228747|3817773|B2||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
3997546|NCT01228747|3817774|B1||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
3997547|NCT01228734|3817789|B3||Male|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
3997548|NCT01228734|3817790|B2||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
3997549|NCT01228734|3817791|B1||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3997550|NCT01228734|3817789|B3||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3997551|NCT01228734|3817790|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3997552|NCT01228734|3817791|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3997553|NCT01228734|3817789|B3|||Age||years|Mean|54.9|54.9|Standard Deviation|11.5|11.5|||
3997554|NCT01228734|3817790|B2|||Age||years|Mean|55.1|55.1|Standard Deviation|11.2|11.2|||
3997555|NCT01228734|3817791|B1|||Age||years|Mean|54.8|54.8|Standard Deviation|11.8|11.8|||
3997556|NCT01228591|3817806|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
3997557|NCT01228591|3817806|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3997558|NCT01228591|3817806|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3997559|NCT01228591|3817806|B1|||Age||years|Mean|29.8|29.8|Standard Deviation|5.66|5.66|||
3997560|NCT01228591|3817806|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3997561|NCT01228591|3817806|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
3997562|NCT01228591|3817806|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3997563|NCT01228435|3817823|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3997564|NCT01228435|3817824|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3997565|NCT01228435|3817825|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
3997566|NCT01228435|3817823|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3997567|NCT01228435|3817824|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3997568|NCT01228435|3817825|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3997569|NCT01228435|3817823|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3997570|NCT01228435|3817824|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3997571|NCT01228435|3817825|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3997572|NCT01228435|3817823|B3|||Age||years|Mean|71.3|71.3|Standard Deviation|12.4|12.4|||
3997573|NCT01228435|3817824|B2|||Age||years|Mean|67.5|67.5|Standard Deviation|14.8|14.8|||
3997574|NCT01228435|3817825|B1|||Age||years|Mean|79|79.0|Standard Deviation|||||
3997575|NCT01228435|3817823|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3997576|NCT01228435|3817824|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3997577|NCT01228435|3817825|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3997578|NCT01228435|3817823|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3997579|NCT01228435|3817824|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3997580|NCT01228435|3817825|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3997581|NCT01228435|3817823|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3997582|NCT01228435|3817824|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3997583|NCT01228435|3817825|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3997584|NCT01228318|3817834|B3|||Height||inches|Median|70|70.0|Full Range|||61.0|77.0|
3997585|NCT01228318|3817835|B2|||Height||inches|Median|70|70.0|Full Range|||61.0|77.0|
3997586|NCT01228318|3817836|B1|||Height||inches|Median|69|69.0|Full Range|||61.0|76.0|
3997587|NCT01228318|3817834|B3|||Age||years|Median|38|38.0|Full Range|||30.0|51.0|
3997588|NCT01228318|3817835|B2|||Age||years|Median|37|37.0|Full Range|||30.0|51.0|
3997589|NCT01228318|3817836|B1|||Age||years|Median|38|38.0|Full Range|||30.0|50.0|
3997590|NCT01228318|3817834|B3|||Weight||kilograms|Median|73.3|73.3|Full Range|||49.8|118.2|
3997591|NCT01228318|3817835|B2|||Weight||kilograms|Median|73.3|73.3|Full Range|||54.9|107.2|
3997592|NCT01228318|3817836|B1|||Weight||kilograms|Median|72.9|72.9|Full Range|||49.8|118.2|
3997593|NCT01228318|3817834|B3|||HIV-1 Viral Load||log10 copies/ml|Median|4.96|4.96|Full Range|||2.51|6.44|
3997594|NCT01228318|3817835|B2|||HIV-1 Viral Load||log10 copies/ml|Median|4.93|4.93|Full Range|||2.51|6.06|
3997595|NCT01228318|3817836|B1|||HIV-1 Viral Load||log10 copies/ml|Median|4.97|4.97|Full Range|||3.69|6.44|
3997596|NCT01228318|3817834|B3|||Cluster of differentiation 4 (CD4) T-cell count||cells/uL|Median|101|101.0|Full Range|||3.0|574.0|
3997597|NCT01228318|3817835|B2|||Cluster of differentiation 4 (CD4) T-cell count||cells/uL|Median|117|117.0|Full Range|||3.0|574.0|
3997598|NCT01228318|3817836|B1|||Cluster of differentiation 4 (CD4) T-cell count||cells/uL|Median|91.5|91.5|Full Range|||5.0|239.0|
3997599|NCT01228318|3817834|B3|||Body Mass Index (BMI)||kg/m^2|Median|23.8|23.8|Full Range|||16.9|41.2|
3997600|NCT01228318|3817835|B2|||Body Mass Index (BMI)||kg/m^2|Median|23.8|23.8|Full Range|||16.9|38.7|
3997601|NCT01228318|3817836|B1|||Body Mass Index (BMI)||kg/m^2|Median|24.4|24.4|Full Range|||18.9|41.2|
3997602|NCT01228318|3817834|B3|United States||Region of Enrollment||participants|Number|63|63.0||||||
3997603|NCT01228318|3817835|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
3997604|NCT01228318|3817836|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
3997605|NCT01228318|3817834|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997606|NCT01228318|3817835|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997607|NCT01228318|3817836|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997608|NCT01228318|3817834|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997609|NCT01228318|3817835|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997610|NCT01228318|3817836|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997611|NCT01228318|3817834|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3997612|NCT01228318|3817835|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3997613|NCT01228318|3817836|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3997614|NCT01228318|3817834|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
3997615|NCT01228318|3817835|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
3997616|NCT01228318|3817836|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3997617|NCT01228318|3817834|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997618|NCT01228318|3817835|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997619|NCT01228318|3817836|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997620|NCT01228318|3817834|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997621|NCT01228318|3817835|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997622|NCT01228318|3817836|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997623|NCT01228318|3817834|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997624|NCT01228318|3817835|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997625|NCT01228318|3817836|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997626|NCT01228318|3817834|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997627|NCT01228318|3817835|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997628|NCT01228318|3817836|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997629|NCT01228318|3817834|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
3997630|NCT01228318|3817835|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
3997631|NCT01228318|3817836|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
3997632|NCT01228318|3817834|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3997633|NCT01228318|3817835|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997634|NCT01228318|3817836|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3997635|NCT01228318|3817834|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3997636|NCT01228318|3817835|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3997637|NCT01228318|3817836|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3997638|NCT01228318|3817834|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
3997639|NCT01228318|3817835|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3997640|NCT01228318|3817836|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3997641|NCT01228318|3817834|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3997642|NCT01228318|3817835|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3997643|NCT01228318|3817836|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3997644|NCT01228318|3817834|B3||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
3997645|NCT01228318|3817835|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3997646|NCT01228318|3817836|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3997647|NCT01228318|3817834|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3997648|NCT01228318|3817835|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3997649|NCT01228318|3817836|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3997650|NCT01228175|3817851|B3|United States||Region of Enrollment||Participants|Count of Participants|218|218.0||||||
3997651|NCT01228175|3817852|B2|United States||Region of Enrollment||Participants|Count of Participants|99|99.0||||||
3997652|NCT01228175|3817853|B1|United States||Region of Enrollment||Participants|Count of Participants|119|119.0||||||
3997653|NCT01228175|3817851|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3997654|NCT01228175|3817852|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3997655|NCT01228175|3817853|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3997656|NCT01228175|3817851|B3||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3997657|NCT01228175|3817852|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3997658|NCT01228175|3817853|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
3997659|NCT01228175|3817851|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3997660|NCT01228175|3817852|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3997661|NCT01228175|3817853|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3997662|NCT01228175|3817851|B3||Between 18 and 65 years|Age||Participants|Count of Participants|218|218.0||||||
3997663|NCT01228175|3817852|B2||Between 18 and 65 years|Age||Participants|Count of Participants|99|99.0||||||
3997664|NCT01228175|3817853|B1||Between 18 and 65 years|Age||Participants|Count of Participants|119|119.0||||||
3997665|NCT01228175|3817851|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3997666|NCT01228175|3817852|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3997667|NCT01228175|3817853|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3997668|NCT01228149|3817860|B3|Germany||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
3997669|NCT01228149|3817861|B2|Germany||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
3997670|NCT01228149|3817862|B1|Germany||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
3997671|NCT01228149|3817860|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3997672|NCT01228149|3817861|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3997673|NCT01228149|3817862|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3997674|NCT01228149|3817860|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3997675|NCT01228149|3817861|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3997676|NCT01228149|3817862|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3997677|NCT01228149|3817860|B3|||Age||years|Mean|64.98|64.98|Standard Deviation|9.68|9.68|||
3997678|NCT01228149|3817861|B2|||Age||years|Mean|65.8|65.8|Standard Deviation|8.82|8.82|||
3997679|NCT01228149|3817862|B1|||Age||years|Mean|64.2|64.2|Standard Deviation|10.51|10.51|||
3997680|NCT01228149|3817860|B3||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
3997681|NCT01228149|3817861|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
3997682|NCT01228149|3817862|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
3997683|NCT01228149|3817860|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
3997684|NCT01228149|3817861|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
3997685|NCT01228149|3817862|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3997686|NCT01228149|3817860|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3997687|NCT01228149|3817861|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3997688|NCT01228149|3817862|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3997689|NCT01228084|3817885|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3997690|NCT01228084|3817885|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3997691|NCT01228084|3817885|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3997692|NCT01228084|3817885|B1|||Age||years|Mean|70.6|70.6|Standard Deviation|6.8|6.8|||
3997693|NCT01228084|3817885|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
3997694|NCT01228084|3817885|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3997695|NCT01228084|3817885|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3997696|NCT01228071|3817896|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
3997697|NCT01228071|3817896|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3997698|NCT01228071|3817896|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3997699|NCT01228071|3817896|B1|||Age||years|Mean|51.8|51.8|Standard Deviation|10.01|10.01|||
3997700|NCT01228071|3817896|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3997701|NCT01228071|3817896|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
3997702|NCT01228071|3817896|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3997703|NCT01228019|3817902|B1||Male|Sex: Female, Male||Participants|Count of Participants|594|594.0||||||
3997704|NCT01228019|3817902|B1||Female|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
3997705|NCT01228019|3817902|B1|||Age||years|Mean|59.03|59.03|Standard Deviation|10.92|10.92|||
3997706|NCT01227993|3817917|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3997707|NCT01227993|3817917|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3997708|NCT01227993|3817917|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3997709|NCT01227993|3817917|B1|||Age||years|Mean|53.3|53.3|Standard Deviation|10.6|10.6|||
3997710|NCT01227993|3817917|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3997711|NCT01227993|3817917|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3997712|NCT01227993|3817917|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3997713|NCT01227980|3817927|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3997714|NCT01227980|3817928|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3997715|NCT01227980|3817929|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3997716|NCT01227980|3817927|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3997717|NCT01227980|3817928|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997718|NCT01227980|3817929|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3997719|NCT01227980|3817927|B3||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3997720|NCT01227980|3817928|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3997721|NCT01227980|3817929|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3997722|NCT01227980|3817927|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
3997723|NCT01227980|3817928|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3997724|NCT01227980|3817929|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3997725|NCT01227980|3817927|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997726|NCT01227980|3817928|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997727|NCT01227980|3817929|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997728|NCT01227980|3817927|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3997729|NCT01227980|3817928|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3997730|NCT01227980|3817929|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3997731|NCT01227980|3817927|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997732|NCT01227980|3817928|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997733|NCT01227980|3817929|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997734|NCT01227980|3817927|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997735|NCT01227980|3817928|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997736|NCT01227980|3817929|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997737|NCT01227980|3817927|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
3997738|NCT01227980|3817928|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
3997739|NCT01227980|3817929|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
3997740|NCT01227980|3817927|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3997741|NCT01227980|3817928|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3997742|NCT01227980|3817929|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3997743|NCT01227980|3817927|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3997744|NCT01227980|3817928|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3997745|NCT01227980|3817929|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3997746|NCT01227980|3817927|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3997747|NCT01227980|3817928|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3997748|NCT01227980|3817929|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3997749|NCT01227980|3817927|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3997750|NCT01227980|3817928|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3997751|NCT01227980|3817929|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3997752|NCT01227980|3817927|B3||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
3997753|NCT01227980|3817928|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
3997754|NCT01227980|3817929|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3997755|NCT01227980|3817927|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3997756|NCT01227980|3817928|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3997757|NCT01227980|3817929|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3997758|NCT01227967|3817966|B3|BMI >= 40|No|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|125|125.0||||||
3997759|NCT01227967|3817967|B2|BMI >= 40|No|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|51|51.0||||||
3997760|NCT01227967|3817968|B1|BMI >= 40|No|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|74|74.0||||||
3997761|NCT01227967|3817966|B3|BMI >= 40|Yes|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|501|501.0||||||
3997762|NCT01227967|3817967|B2|BMI >= 40|Yes|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|261|261.0||||||
3997763|NCT01227967|3817968|B1|BMI >= 40|Yes|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|240|240.0||||||
3997764|NCT01227967|3817966|B3|Weakened immune system|No|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|90|90.0||||||
3997765|NCT01227967|3817967|B2|Weakened immune system|No|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|46|46.0||||||
3997766|NCT01227967|3817968|B1|Weakened immune system|No|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|44|44.0||||||
3998275|NCT01227967|3817967|B2|United States||Region of Enrollment||participants|Number|216|216.0||||||
3997767|NCT01227967|3817966|B3|Weakened immune system|Yes|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|536|536.0||||||
3997768|NCT01227967|3817967|B2|Weakened immune system|Yes|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|266|266.0||||||
3997769|NCT01227967|3817968|B1|Weakened immune system|Yes|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|270|270.0||||||
3997770|NCT01227967|3817966|B3|Metabolic|No|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|20|20.0||||||
3997771|NCT01227967|3817967|B2|Metabolic|No|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|8|8.0||||||
3997772|NCT01227967|3817968|B1|Metabolic|No|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|12|12.0||||||
3997773|NCT01227967|3817966|B3|Metabolic|Yes|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|606|606.0||||||
3997774|NCT01227967|3817967|B2|Metabolic|Yes|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|304|304.0||||||
3997775|NCT01227967|3817968|B1|Metabolic|Yes|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|302|302.0||||||
3997776|NCT01227967|3817966|B3|Liver disorder|No|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|10|10.0||||||
3997777|NCT01227967|3817967|B2|Liver disorder|No|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|7|7.0||||||
3997778|NCT01227967|3817968|B1|Liver disorder|No|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|3|3.0||||||
3997779|NCT01227967|3817966|B3|Liver disorder|Yes|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|616|616.0||||||
3997780|NCT01227967|3817967|B2|Liver disorder|Yes|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|305|305.0||||||
3997781|NCT01227967|3817968|B1|Liver disorder|Yes|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|311|311.0||||||
3997782|NCT01227967|3817966|B3|Kidney|No|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|14|14.0||||||
3997783|NCT01227967|3817967|B2|Kidney|No|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|6|6.0||||||
3997784|NCT01227967|3817968|B1|Kidney|No|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|8|8.0||||||
3997785|NCT01227967|3817966|B3|Kidney|Yes|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|612|612.0||||||
3997786|NCT01227967|3817967|B2|Kidney|Yes|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|306|306.0||||||
3997787|NCT01227967|3817968|B1|Kidney|Yes|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|306|306.0||||||
3997788|NCT01227967|3817966|B3|Endocrine|No|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|175|175.0||||||
3997789|NCT01227967|3817967|B2|Endocrine|No|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|88|88.0||||||
3997790|NCT01227967|3817968|B1|Endocrine|No|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|87|87.0||||||
3997791|NCT01227967|3817966|B3|Endocrine|Yes|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|451|451.0||||||
3997792|NCT01227967|3817967|B2|Endocrine|Yes|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|224|224.0||||||
3997793|NCT01227967|3817968|B1|Endocrine|Yes|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|227|227.0||||||
3997794|NCT01227967|3817966|B3|Blood disorder|No|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|13|13.0||||||
3997795|NCT01227967|3817967|B2|Blood disorder|No|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|5|5.0||||||
3997796|NCT01227967|3817968|B1|Blood disorder|No|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|8|8.0||||||
3997797|NCT01227967|3817966|B3|Blood disorder|Yes|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|613|613.0||||||
3997798|NCT01227967|3817967|B2|Blood disorder|Yes|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|307|307.0||||||
3997799|NCT01227967|3817968|B1|Blood disorder|Yes|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|306|306.0||||||
3997800|NCT01227967|3817966|B3|Heart disease|No|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|69|69.0||||||
3997801|NCT01227967|3817967|B2|Heart disease|No|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|39|39.0||||||
3997802|NCT01227967|3817968|B1|Heart disease|No|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|30|30.0||||||
3997803|NCT01227967|3817966|B3|Heart disease|Yes|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|557|557.0||||||
3997804|NCT01227967|3817967|B2|Heart disease|Yes|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|273|273.0||||||
3997805|NCT01227967|3817968|B1|Heart disease|Yes|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|284|284.0||||||
3997806|NCT01227967|3817966|B3|Chronic Lung disease|No|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|38|38.0||||||
3997807|NCT01227967|3817967|B2|Chronic Lung disease|No|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|21|21.0||||||
3997808|NCT01227967|3817968|B1|Chronic Lung disease|No|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|17|17.0||||||
3997809|NCT01227967|3817966|B3|Chronic Lung disease|Yes|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|588|588.0||||||
3997810|NCT01227967|3817967|B2|Chronic Lung disease|Yes|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|291|291.0||||||
3997811|NCT01227967|3817968|B1|Chronic Lung disease|Yes|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|297|297.0||||||
3997812|NCT01227967|3817966|B3|Neurological condition|No|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|36|36.0||||||
3997813|NCT01227967|3817967|B2|Neurological condition|No|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|19|19.0||||||
3997814|NCT01227967|3817968|B1|Neurological condition|No|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|17|17.0||||||
3997815|NCT01227967|3817966|B3|Neurological condition|Yes|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|590|590.0||||||
3997816|NCT01227967|3817967|B2|Neurological condition|Yes|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|293|293.0||||||
3997817|NCT01227967|3817968|B1|Neurological condition|Yes|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|297|297.0||||||
3997818|NCT01227967|3817966|B3|Asthma|No|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|199|199.0||||||
3997819|NCT01227967|3817967|B2|Asthma|No|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|99|99.0||||||
3997820|NCT01227967|3817968|B1|Asthma|No|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|100|100.0||||||
3997821|NCT01227967|3817966|B3|Asthma|Yes|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|427|427.0||||||
3997822|NCT01227967|3817967|B2|Asthma|Yes|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|213|213.0||||||
3997823|NCT01227967|3817968|B1|Asthma|Yes|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|214|214.0||||||
3997869|NCT01227967|3817966|B3|Otitis Media|Unable to assess|Complications of Influenza||Participants|Count of Participants|2|2.0||||||
3997824|NCT01227967|3817966|B3|>= 65 years|No|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|128|128.0||||||
3997825|NCT01227967|3817967|B2|>= 65 years|No|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|65|65.0||||||
3997826|NCT01227967|3817968|B1|>= 65 years|No|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|63|63.0||||||
3997827|NCT01227967|3817966|B3|>= 65 years|Yes|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|498|498.0||||||
3997828|NCT01227967|3817967|B2|>= 65 years|Yes|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|247|247.0||||||
3997829|NCT01227967|3817968|B1|>= 65 years|Yes|Medical Conditions|Medication conditions that may increase risk of complications from influenza which are used to determine eligibility for the study.|Participants|Count of Participants|251|251.0||||||
3997830|NCT01227967|3817966|B3|Using antibiotic for other reasons|Missing|Complications of Influenza||Participants|Count of Participants|3|3.0||||||
3997831|NCT01227967|3817967|B2|Using antibiotic for other reasons|Missing|Complications of Influenza||Participants|Count of Participants|0|0.0||||||
3997832|NCT01227967|3817968|B1|Using antibiotic for other reasons|Missing|Complications of Influenza||Participants|Count of Participants|3|3.0||||||
3997833|NCT01227967|3817966|B3|Using antibiotic for other reasons|Unable to assess|Complications of Influenza||Participants|Count of Participants|0|0.0||||||
3997834|NCT01227967|3817967|B2|Using antibiotic for other reasons|Unable to assess|Complications of Influenza||Participants|Count of Participants|0|0.0||||||
3997835|NCT01227967|3817968|B1|Using antibiotic for other reasons|Unable to assess|Complications of Influenza||Participants|Count of Participants|0|0.0||||||
3997836|NCT01227967|3817966|B3|Using antibiotic for other reasons|No|Complications of Influenza||Participants|Count of Participants|582|582.0||||||
3997837|NCT01227967|3817967|B2|Using antibiotic for other reasons|No|Complications of Influenza||Participants|Count of Participants|291|291.0||||||
3997838|NCT01227967|3817968|B1|Using antibiotic for other reasons|No|Complications of Influenza||Participants|Count of Participants|291|291.0||||||
3997839|NCT01227967|3817966|B3|Using antibiotic for other reasons|Yes|Complications of Influenza||Participants|Count of Participants|41|41.0||||||
3997840|NCT01227967|3817967|B2|Using antibiotic for other reasons|Yes|Complications of Influenza||Participants|Count of Participants|21|21.0||||||
3997841|NCT01227967|3817968|B1|Using antibiotic for other reasons|Yes|Complications of Influenza||Participants|Count of Participants|20|20.0||||||
3997842|NCT01227967|3817966|B3|Pneumonia|Missing|Complications of Influenza||Participants|Count of Participants|3|3.0||||||
3997843|NCT01227967|3817967|B2|Pneumonia|Missing|Complications of Influenza||Participants|Count of Participants|0|0.0||||||
3997844|NCT01227967|3817968|B1|Pneumonia|Missing|Complications of Influenza||Participants|Count of Participants|3|3.0||||||
3997845|NCT01227967|3817966|B3|Pneumonia|Unable to assess|Complications of Influenza||Participants|Count of Participants|2|2.0||||||
3997846|NCT01227967|3817967|B2|Pneumonia|Unable to assess|Complications of Influenza||Participants|Count of Participants|0|0.0||||||
3997847|NCT01227967|3817968|B1|Pneumonia|Unable to assess|Complications of Influenza||Participants|Count of Participants|2|2.0||||||
3997848|NCT01227967|3817966|B3|Pneumonia|No|Complications of Influenza||Participants|Count of Participants|607|607.0||||||
3997849|NCT01227967|3817967|B2|Pneumonia|No|Complications of Influenza||Participants|Count of Participants|303|303.0||||||
3997850|NCT01227967|3817968|B1|Pneumonia|No|Complications of Influenza||Participants|Count of Participants|304|304.0||||||
3997851|NCT01227967|3817966|B3|Pneumonia|Yes|Complications of Influenza||Participants|Count of Participants|14|14.0||||||
3997852|NCT01227967|3817967|B2|Pneumonia|Yes|Complications of Influenza||Participants|Count of Participants|9|9.0||||||
3997853|NCT01227967|3817968|B1|Pneumonia|Yes|Complications of Influenza||Participants|Count of Participants|5|5.0||||||
3997854|NCT01227967|3817966|B3|Bronchitis/Bronchiolitis|Missing|Complications of Influenza||Participants|Count of Participants|3|3.0||||||
3997855|NCT01227967|3817967|B2|Bronchitis/Bronchiolitis|Missing|Complications of Influenza||Participants|Count of Participants|0|0.0||||||
3997856|NCT01227967|3817968|B1|Bronchitis/Bronchiolitis|Missing|Complications of Influenza||Participants|Count of Participants|3|3.0||||||
3997857|NCT01227967|3817966|B3|Bronchitis/Bronchiolitis|Unable to assess|Complications of Influenza||Participants|Count of Participants|2|2.0||||||
3997858|NCT01227967|3817967|B2|Bronchitis/Bronchiolitis|Unable to assess|Complications of Influenza||Participants|Count of Participants|0|0.0||||||
3997859|NCT01227967|3817968|B1|Bronchitis/Bronchiolitis|Unable to assess|Complications of Influenza||Participants|Count of Participants|2|2.0||||||
3997860|NCT01227967|3817966|B3|Bronchitis/Bronchiolitis|No|Complications of Influenza||Participants|Count of Participants|599|599.0||||||
3997861|NCT01227967|3817967|B2|Bronchitis/Bronchiolitis|No|Complications of Influenza||Participants|Count of Participants|298|298.0||||||
3997862|NCT01227967|3817968|B1|Bronchitis/Bronchiolitis|No|Complications of Influenza||Participants|Count of Participants|301|301.0||||||
3997863|NCT01227967|3817966|B3|Bronchitis/Bronchiolitis|Yes|Complications of Influenza||Participants|Count of Participants|22|22.0||||||
3997864|NCT01227967|3817967|B2|Bronchitis/Bronchiolitis|Yes|Complications of Influenza||Participants|Count of Participants|14|14.0||||||
3997865|NCT01227967|3817968|B1|Bronchitis/Bronchiolitis|Yes|Complications of Influenza||Participants|Count of Participants|8|8.0||||||
3997866|NCT01227967|3817966|B3|Otitis Media|Missing|Complications of Influenza||Participants|Count of Participants|3|3.0||||||
3997867|NCT01227967|3817967|B2|Otitis Media|Missing|Complications of Influenza||Participants|Count of Participants|0|0.0||||||
3997868|NCT01227967|3817968|B1|Otitis Media|Missing|Complications of Influenza||Participants|Count of Participants|3|3.0||||||
3997870|NCT01227967|3817967|B2|Otitis Media|Unable to assess|Complications of Influenza||Participants|Count of Participants|0|0.0||||||
3997871|NCT01227967|3817968|B1|Otitis Media|Unable to assess|Complications of Influenza||Participants|Count of Participants|2|2.0||||||
3997872|NCT01227967|3817966|B3|Otitis Media|No|Complications of Influenza||Participants|Count of Participants|615|615.0||||||
3997873|NCT01227967|3817967|B2|Otitis Media|No|Complications of Influenza||Participants|Count of Participants|308|308.0||||||
3997874|NCT01227967|3817968|B1|Otitis Media|No|Complications of Influenza||Participants|Count of Participants|307|307.0||||||
3997875|NCT01227967|3817966|B3|Otitis Media|Yes|Complications of Influenza||Participants|Count of Participants|6|6.0||||||
3997876|NCT01227967|3817967|B2|Otitis Media|Yes|Complications of Influenza||Participants|Count of Participants|4|4.0||||||
3997877|NCT01227967|3817968|B1|Otitis Media|Yes|Complications of Influenza||Participants|Count of Participants|2|2.0||||||
3997878|NCT01227967|3817966|B3|Sinusitis|Missing|Complications of Influenza||Participants|Count of Participants|3|3.0||||||
3997879|NCT01227967|3817967|B2|Sinusitis|Missing|Complications of Influenza||Participants|Count of Participants|0|0.0||||||
3997880|NCT01227967|3817968|B1|Sinusitis|Missing|Complications of Influenza||Participants|Count of Participants|3|3.0||||||
3997881|NCT01227967|3817966|B3|Sinusitis|Unable to assess|Complications of Influenza||Participants|Count of Participants|2|2.0||||||
3997882|NCT01227967|3817967|B2|Sinusitis|Unable to assess|Complications of Influenza||Participants|Count of Participants|0|0.0||||||
3997883|NCT01227967|3817968|B1|Sinusitis|Unable to assess|Complications of Influenza||Participants|Count of Participants|2|2.0||||||
3997884|NCT01227967|3817966|B3|Sinusitis|No|Complications of Influenza||Participants|Count of Participants|596|596.0||||||
3997885|NCT01227967|3817967|B2|Sinusitis|No|Complications of Influenza||Participants|Count of Participants|298|298.0||||||
3997886|NCT01227967|3817968|B1|Sinusitis|No|Complications of Influenza||Participants|Count of Participants|298|298.0||||||
3997887|NCT01227967|3817966|B3|Sinusitis|Yes|Complications of Influenza||Participants|Count of Participants|25|25.0||||||
3997888|NCT01227967|3817967|B2|Sinusitis|Yes|Complications of Influenza||Participants|Count of Participants|14|14.0||||||
3997889|NCT01227967|3817968|B1|Sinusitis|Yes|Complications of Influenza||Participants|Count of Participants|11|11.0||||||
3997890|NCT01227967|3817966|B3|Subject functions as well today as before flu|Missing|Global assessment||Participants|Count of Participants|7|7.0||||||
3997891|NCT01227967|3817967|B2|Subject functions as well today as before flu|Missing|Global assessment||Participants|Count of Participants|3|3.0||||||
3997892|NCT01227967|3817968|B1|Subject functions as well today as before flu|Missing|Global assessment||Participants|Count of Participants|4|4.0||||||
3997893|NCT01227967|3817966|B3|Subject functions as well today as before flu|No|Global assessment||Participants|Count of Participants|576|576.0||||||
3997894|NCT01227967|3817967|B2|Subject functions as well today as before flu|No|Global assessment||Participants|Count of Participants|289|289.0||||||
3997895|NCT01227967|3817968|B1|Subject functions as well today as before flu|No|Global assessment||Participants|Count of Participants|287|287.0||||||
3997896|NCT01227967|3817966|B3|Subject functions as well today as before flu|Yes|Global assessment||Participants|Count of Participants|43|43.0||||||
3997897|NCT01227967|3817967|B2|Subject functions as well today as before flu|Yes|Global assessment||Participants|Count of Participants|20|20.0||||||
3997898|NCT01227967|3817968|B1|Subject functions as well today as before flu|Yes|Global assessment||Participants|Count of Participants|23|23.0||||||
3997899|NCT01227967|3817966|B3|Subject feels as good today as before flu|Missing|Global assessment||Participants|Count of Participants|7|7.0||||||
3997900|NCT01227967|3817967|B2|Subject feels as good today as before flu|Missing|Global assessment||Participants|Count of Participants|3|3.0||||||
3997901|NCT01227967|3817968|B1|Subject feels as good today as before flu|Missing|Global assessment||Participants|Count of Participants|4|4.0||||||
3997902|NCT01227967|3817966|B3|Subject feels as good today as before flu|No|Global assessment||Participants|Count of Participants|603|603.0||||||
3997903|NCT01227967|3817967|B2|Subject feels as good today as before flu|No|Global assessment||Participants|Count of Participants|302|302.0||||||
3997904|NCT01227967|3817968|B1|Subject feels as good today as before flu|No|Global assessment||Participants|Count of Participants|301|301.0||||||
3997905|NCT01227967|3817966|B3|Subject feels as good today as before flu|Yes|Global assessment||Participants|Count of Participants|16|16.0||||||
3997906|NCT01227967|3817967|B2|Subject feels as good today as before flu|Yes|Global assessment||Participants|Count of Participants|7|7.0||||||
3997907|NCT01227967|3817968|B1|Subject feels as good today as before flu|Yes|Global assessment||Participants|Count of Participants|9|9.0||||||
3997908|NCT01227967|3817966|B3|||Average Functional Status|Average functional status was calculated as the average of the ten items assessed (so ignoring missing values), scoring 0='yes, limited a lot', 50='yes, limited a little', 100='no, not limited at all'. The possible range of the functional status score is therefore 0 (worst possible status) to 100 (best possible status). Participants with missing evaluations for all items were given a missing average functional status.|units on a scale|Median|35|35.0|Inter-Quartile Range|||15.0|60.0|
3997909|NCT01227967|3817967|B2|||Average Functional Status|Average functional status was calculated as the average of the ten items assessed (so ignoring missing values), scoring 0='yes, limited a lot', 50='yes, limited a little', 100='no, not limited at all'. The possible range of the functional status score is therefore 0 (worst possible status) to 100 (best possible status). Participants with missing evaluations for all items were given a missing average functional status.|units on a scale|Median|35|35.0|Inter-Quartile Range|||15.0|55.0|
3997910|NCT01227967|3817968|B1|||Average Functional Status|Average functional status was calculated as the average of the ten items assessed (so ignoring missing values), scoring 0='yes, limited a lot', 50='yes, limited a little', 100='no, not limited at all'. The possible range of the functional status score is therefore 0 (worst possible status) to 100 (best possible status). Participants with missing evaluations for all items were given a missing average functional status.|units on a scale|Median|35|35.0|Inter-Quartile Range|||20.0|60.0|
3997911|NCT01227967|3817966|B3|Bathing/dressing self|Missing|Functional status||Participants|Count of Participants|7|7.0||||||
3997912|NCT01227967|3817967|B2|Bathing/dressing self|Missing|Functional status||Participants|Count of Participants|3|3.0||||||
3997913|NCT01227967|3817968|B1|Bathing/dressing self|Missing|Functional status||Participants|Count of Participants|4|4.0||||||
3997914|NCT01227967|3817966|B3|Bathing/dressing self|Not limited at all = 100|Functional status||Participants|Count of Participants|362|362.0||||||
3997915|NCT01227967|3817967|B2|Bathing/dressing self|Not limited at all = 100|Functional status||Participants|Count of Participants|172|172.0||||||
3997916|NCT01227967|3817968|B1|Bathing/dressing self|Not limited at all = 100|Functional status||Participants|Count of Participants|190|190.0||||||
3997917|NCT01227967|3817966|B3|Bathing/dressing self|Limited a little = 50|Functional status||Participants|Count of Participants|155|155.0||||||
3997918|NCT01227967|3817967|B2|Bathing/dressing self|Limited a little = 50|Functional status||Participants|Count of Participants|83|83.0||||||
3997919|NCT01227967|3817968|B1|Bathing/dressing self|Limited a little = 50|Functional status||Participants|Count of Participants|72|72.0||||||
3997920|NCT01227967|3817966|B3|Bathing/dressing self|Limited a lot = 0|Functional status||Participants|Count of Participants|102|102.0||||||
3997921|NCT01227967|3817967|B2|Bathing/dressing self|Limited a lot = 0|Functional status||Participants|Count of Participants|54|54.0||||||
3997922|NCT01227967|3817968|B1|Bathing/dressing self|Limited a lot = 0|Functional status||Participants|Count of Participants|48|48.0||||||
3997923|NCT01227967|3817966|B3|Walking a block|Missing|Functional status||Participants|Count of Participants|7|7.0||||||
3997924|NCT01227967|3817967|B2|Walking a block|Missing|Functional status||Participants|Count of Participants|3|3.0||||||
3997925|NCT01227967|3817968|B1|Walking a block|Missing|Functional status||Participants|Count of Participants|4|4.0||||||
3997926|NCT01227967|3817966|B3|Walking a block|Not limited at all = 100|Functional status||Participants|Count of Participants|176|176.0||||||
3997927|NCT01227967|3817967|B2|Walking a block|Not limited at all = 100|Functional status||Participants|Count of Participants|90|90.0||||||
3997928|NCT01227967|3817968|B1|Walking a block|Not limited at all = 100|Functional status||Participants|Count of Participants|86|86.0||||||
3997929|NCT01227967|3817966|B3|Walking a block|Limited a little = 50|Functional status||Participants|Count of Participants|234|234.0||||||
3997930|NCT01227967|3817967|B2|Walking a block|Limited a little = 50|Functional status||Participants|Count of Participants|111|111.0||||||
3997931|NCT01227967|3817968|B1|Walking a block|Limited a little = 50|Functional status||Participants|Count of Participants|123|123.0||||||
3997932|NCT01227967|3817966|B3|Walking a block|Limited a lot = 0|Functional status||Participants|Count of Participants|209|209.0||||||
3997933|NCT01227967|3817967|B2|Walking a block|Limited a lot = 0|Functional status||Participants|Count of Participants|108|108.0||||||
3997934|NCT01227967|3817968|B1|Walking a block|Limited a lot = 0|Functional status||Participants|Count of Participants|101|101.0||||||
3997935|NCT01227967|3817966|B3|Walking blocks|Missing|Functional status||Participants|Count of Participants|7|7.0||||||
3997936|NCT01227967|3817967|B2|Walking blocks|Missing|Functional status||Participants|Count of Participants|3|3.0||||||
3997937|NCT01227967|3817968|B1|Walking blocks|Missing|Functional status||Participants|Count of Participants|4|4.0||||||
3997938|NCT01227967|3817966|B3|Walking blocks|Not limited at all = 100|Functional status||Participants|Count of Participants|82|82.0||||||
3997939|NCT01227967|3817967|B2|Walking blocks|Not limited at all = 100|Functional status||Participants|Count of Participants|41|41.0||||||
3997940|NCT01227967|3817968|B1|Walking blocks|Not limited at all = 100|Functional status||Participants|Count of Participants|41|41.0||||||
3997941|NCT01227967|3817966|B3|Walking blocks|Limited a little = 50|Functional status||Participants|Count of Participants|191|191.0||||||
3997942|NCT01227967|3817967|B2|Walking blocks|Limited a little = 50|Functional status||Participants|Count of Participants|91|91.0||||||
3997943|NCT01227967|3817968|B1|Walking blocks|Limited a little = 50|Functional status||Participants|Count of Participants|100|100.0||||||
3997944|NCT01227967|3817966|B3|Walking blocks|Limited a lot = 0|Functional status||Participants|Count of Participants|346|346.0||||||
3997945|NCT01227967|3817967|B2|Walking blocks|Limited a lot = 0|Functional status||Participants|Count of Participants|177|177.0||||||
3997946|NCT01227967|3817968|B1|Walking blocks|Limited a lot = 0|Functional status||Participants|Count of Participants|169|169.0||||||
3997947|NCT01227967|3817966|B3|Walking > 1 mile|Missing|Functional status||Participants|Count of Participants|7|7.0||||||
3997948|NCT01227967|3817967|B2|Walking > 1 mile|Missing|Functional status||Participants|Count of Participants|3|3.0||||||
3997949|NCT01227967|3817968|B1|Walking > 1 mile|Missing|Functional status||Participants|Count of Participants|4|4.0||||||
3997950|NCT01227967|3817966|B3|Walking > 1 mile|Not limited at all = 100|Functional status||Participants|Count of Participants|59|59.0||||||
3997951|NCT01227967|3817967|B2|Walking > 1 mile|Not limited at all = 100|Functional status||Participants|Count of Participants|29|29.0||||||
3997952|NCT01227967|3817968|B1|Walking > 1 mile|Not limited at all = 100|Functional status||Participants|Count of Participants|30|30.0||||||
3997953|NCT01227967|3817966|B3|Walking > 1 mile|Limited a little = 50|Functional status||Participants|Count of Participants|159|159.0||||||
3997954|NCT01227967|3817967|B2|Walking > 1 mile|Limited a little = 50|Functional status||Participants|Count of Participants|78|78.0||||||
3997955|NCT01227967|3817968|B1|Walking > 1 mile|Limited a little = 50|Functional status||Participants|Count of Participants|81|81.0||||||
3997956|NCT01227967|3817966|B3|Walking > 1 mile|Limited a lot = 0|Functional status||Participants|Count of Participants|401|401.0||||||
3997957|NCT01227967|3817967|B2|Walking > 1 mile|Limited a lot = 0|Functional status||Participants|Count of Participants|202|202.0||||||
3997958|NCT01227967|3817968|B1|Walking > 1 mile|Limited a lot = 0|Functional status||Participants|Count of Participants|199|199.0||||||
3997959|NCT01227967|3817966|B3|Bending or kneeling|Missing|Functional status||Participants|Count of Participants|7|7.0||||||
3997960|NCT01227967|3817967|B2|Bending or kneeling|Missing|Functional status||Participants|Count of Participants|3|3.0||||||
3997961|NCT01227967|3817968|B1|Bending or kneeling|Missing|Functional status||Participants|Count of Participants|4|4.0||||||
3997962|NCT01227967|3817966|B3|Bending or kneeling|Not limited at all = 100|Functional status||Participants|Count of Participants|197|197.0||||||
3997963|NCT01227967|3817967|B2|Bending or kneeling|Not limited at all = 100|Functional status||Participants|Count of Participants|94|94.0||||||
3997964|NCT01227967|3817968|B1|Bending or kneeling|Not limited at all = 100|Functional status||Participants|Count of Participants|103|103.0||||||
3997965|NCT01227967|3817966|B3|Bending or kneeling|Limited a little = 50|Functional status||Participants|Count of Participants|251|251.0||||||
3997966|NCT01227967|3817967|B2|Bending or kneeling|Limited a little = 50|Functional status||Participants|Count of Participants|133|133.0||||||
3997967|NCT01227967|3817968|B1|Bending or kneeling|Limited a little = 50|Functional status||Participants|Count of Participants|118|118.0||||||
3997968|NCT01227967|3817966|B3|Bending or kneeling|Limited a lot = 0|Functional status||Participants|Count of Participants|171|171.0||||||
3997969|NCT01227967|3817967|B2|Bending or kneeling|Limited a lot = 0|Functional status||Participants|Count of Participants|82|82.0||||||
3997970|NCT01227967|3817968|B1|Bending or kneeling|Limited a lot = 0|Functional status||Participants|Count of Participants|89|89.0||||||
3997971|NCT01227967|3817966|B3|Climbing 1 flight|Missing|Functional status||Participants|Count of Participants|7|7.0||||||
3997972|NCT01227967|3817967|B2|Climbing 1 flight|Missing|Functional status||Participants|Count of Participants|3|3.0||||||
3997973|NCT01227967|3817968|B1|Climbing 1 flight|Missing|Functional status||Participants|Count of Participants|4|4.0||||||
3997974|NCT01227967|3817966|B3|Climbing 1 flight|Not limited at all = 100|Functional status||Participants|Count of Participants|144|144.0||||||
3997975|NCT01227967|3817967|B2|Climbing 1 flight|Not limited at all = 100|Functional status||Participants|Count of Participants|77|77.0||||||
3997976|NCT01227967|3817968|B1|Climbing 1 flight|Not limited at all = 100|Functional status||Participants|Count of Participants|67|67.0||||||
3997977|NCT01227967|3817966|B3|Climbing 1 flight|Limited a little = 50|Functional status||Participants|Count of Participants|275|275.0||||||
3997978|NCT01227967|3817967|B2|Climbing 1 flight|Limited a little = 50|Functional status||Participants|Count of Participants|129|129.0||||||
3997979|NCT01227967|3817968|B1|Climbing 1 flight|Limited a little = 50|Functional status||Participants|Count of Participants|146|146.0||||||
3997980|NCT01227967|3817966|B3|Climbing 1 flight|Limited a lot = 0|Functional status||Participants|Count of Participants|200|200.0||||||
3997981|NCT01227967|3817967|B2|Climbing 1 flight|Limited a lot = 0|Functional status||Participants|Count of Participants|103|103.0||||||
3997982|NCT01227967|3817968|B1|Climbing 1 flight|Limited a lot = 0|Functional status||Participants|Count of Participants|97|97.0||||||
3997983|NCT01227967|3817966|B3|Climbing stairs|Missing|Functional status||Participants|Count of Participants|7|7.0||||||
3997984|NCT01227967|3817967|B2|Climbing stairs|Missing|Functional status||Participants|Count of Participants|3|3.0||||||
3997985|NCT01227967|3817968|B1|Climbing stairs|Missing|Functional status||Participants|Count of Participants|4|4.0||||||
3997986|NCT01227967|3817966|B3|Climbing stairs|Not limited at all = 100|Functional status||Participants|Count of Participants|63|63.0||||||
3997987|NCT01227967|3817967|B2|Climbing stairs|Not limited at all = 100|Functional status||Participants|Count of Participants|32|32.0||||||
3997988|NCT01227967|3817968|B1|Climbing stairs|Not limited at all = 100|Functional status||Participants|Count of Participants|31|31.0||||||
3997989|NCT01227967|3817966|B3|Climbing stairs|Limited a little = 50|Functional status||Participants|Count of Participants|202|202.0||||||
3997990|NCT01227967|3817967|B2|Climbing stairs|Limited a little = 50|Functional status||Participants|Count of Participants|105|105.0||||||
3997991|NCT01227967|3817968|B1|Climbing stairs|Limited a little = 50|Functional status||Participants|Count of Participants|97|97.0||||||
3997992|NCT01227967|3817966|B3|Climbing stairs|Limited a lot = 0|Functional status||Participants|Count of Participants|354|354.0||||||
3997993|NCT01227967|3817967|B2|Climbing stairs|Limited a lot = 0|Functional status||Participants|Count of Participants|172|172.0||||||
3997994|NCT01227967|3817968|B1|Climbing stairs|Limited a lot = 0|Functional status||Participants|Count of Participants|182|182.0||||||
3997995|NCT01227967|3817966|B3|Lifting groceries|Missing|Functional status||Participants|Count of Participants|7|7.0||||||
3997996|NCT01227967|3817967|B2|Lifting groceries|Missing|Functional status||Participants|Count of Participants|3|3.0||||||
3997997|NCT01227967|3817968|B1|Lifting groceries|Missing|Functional status||Participants|Count of Participants|4|4.0||||||
3997998|NCT01227967|3817966|B3|Lifting groceries|Not limited at all = 100|Functional status||Participants|Count of Participants|161|161.0||||||
3997999|NCT01227967|3817967|B2|Lifting groceries|Not limited at all = 100|Functional status||Participants|Count of Participants|79|79.0||||||
3998000|NCT01227967|3817968|B1|Lifting groceries|Not limited at all = 100|Functional status||Participants|Count of Participants|82|82.0||||||
3998001|NCT01227967|3817966|B3|Lifting groceries|Limited a little = 50|Functional status||Participants|Count of Participants|243|243.0||||||
3998002|NCT01227967|3817967|B2|Lifting groceries|Limited a little = 50|Functional status||Participants|Count of Participants|114|114.0||||||
3998003|NCT01227967|3817968|B1|Lifting groceries|Limited a little = 50|Functional status||Participants|Count of Participants|129|129.0||||||
3998004|NCT01227967|3817966|B3|Lifting groceries|Limited a lot = 0|Functional status||Participants|Count of Participants|215|215.0||||||
3998005|NCT01227967|3817967|B2|Lifting groceries|Limited a lot = 0|Functional status||Participants|Count of Participants|116|116.0||||||
3998006|NCT01227967|3817968|B1|Lifting groceries|Limited a lot = 0|Functional status||Participants|Count of Participants|99|99.0||||||
3998007|NCT01227967|3817966|B3|Moderate activities|Missing|Functional status||Participants|Count of Participants|7|7.0||||||
3998008|NCT01227967|3817967|B2|Moderate activities|Missing|Functional status||Participants|Count of Participants|3|3.0||||||
3998009|NCT01227967|3817968|B1|Moderate activities|Missing|Functional status||Participants|Count of Participants|4|4.0||||||
3998010|NCT01227967|3817966|B3|Moderate activities|Not limited at all = 100|Functional status||Participants|Count of Participants|60|60.0||||||
3998011|NCT01227967|3817967|B2|Moderate activities|Not limited at all = 100|Functional status||Participants|Count of Participants|31|31.0||||||
3998012|NCT01227967|3817968|B1|Moderate activities|Not limited at all = 100|Functional status||Participants|Count of Participants|29|29.0||||||
3998013|NCT01227967|3817966|B3|Moderate activities|Limited a little = 50|Functional status||Participants|Count of Participants|221|221.0||||||
3998014|NCT01227967|3817967|B2|Moderate activities|Limited a little = 50|Functional status||Participants|Count of Participants|107|107.0||||||
3998015|NCT01227967|3817968|B1|Moderate activities|Limited a little = 50|Functional status||Participants|Count of Participants|114|114.0||||||
3998016|NCT01227967|3817966|B3|Moderate activities|Limited a lot = 0|Functional status||Participants|Count of Participants|338|338.0||||||
3998017|NCT01227967|3817967|B2|Moderate activities|Limited a lot = 0|Functional status||Participants|Count of Participants|171|171.0||||||
3998018|NCT01227967|3817968|B1|Moderate activities|Limited a lot = 0|Functional status||Participants|Count of Participants|167|167.0||||||
3998019|NCT01227967|3817966|B3|Vigorous activities|Missing|Functional status||Participants|Count of Participants|7|7.0||||||
3998020|NCT01227967|3817967|B2|Vigorous activities|Missing|Functional status||Participants|Count of Participants|3|3.0||||||
3998021|NCT01227967|3817968|B1|Vigorous activities|Missing|Functional status||Participants|Count of Participants|4|4.0||||||
3998022|NCT01227967|3817966|B3|Vigorous activities|Not limited at all = 100|Functional status||Participants|Count of Participants|26|26.0||||||
3998023|NCT01227967|3817967|B2|Vigorous activities|Not limited at all = 100|Functional status||Participants|Count of Participants|12|12.0||||||
3998024|NCT01227967|3817968|B1|Vigorous activities|Not limited at all = 100|Functional status||Participants|Count of Participants|14|14.0||||||
3998025|NCT01227967|3817966|B3|Vigorous activities|Limited a little = 50|Functional status||Participants|Count of Participants|117|117.0||||||
3998026|NCT01227967|3817967|B2|Vigorous activities|Limited a little = 50|Functional status||Participants|Count of Participants|59|59.0||||||
3998027|NCT01227967|3817968|B1|Vigorous activities|Limited a little = 50|Functional status||Participants|Count of Participants|58|58.0||||||
3998028|NCT01227967|3817966|B3|Vigorous activities|Limited a lot = 0|Functional status||Participants|Count of Participants|476|476.0||||||
3998029|NCT01227967|3817967|B2|Vigorous activities|Limited a lot = 0|Functional status||Participants|Count of Participants|238|238.0||||||
3998030|NCT01227967|3817968|B1|Vigorous activities|Limited a lot = 0|Functional status||Participants|Count of Participants|238|238.0||||||
3998031|NCT01227967|3817966|B3|||Overall Symptom Score|Overall symptom score was the sum of available scores for each of the 11 symptoms assessed (so ignoring missing values). The possible range of the overall symptom score is therefore 0 (no symptoms) to 44 (severe for all 10 symptoms). Participants with missing evaluations for all symptoms were given a missing overall symptom score.|units on a scale|Median|15|15.0|Inter-Quartile Range|||11.0|19.0|
3998032|NCT01227967|3817967|B2|||Overall Symptom Score|Overall symptom score was the sum of available scores for each of the 11 symptoms assessed (so ignoring missing values). The possible range of the overall symptom score is therefore 0 (no symptoms) to 44 (severe for all 10 symptoms). Participants with missing evaluations for all symptoms were given a missing overall symptom score.|units on a scale|Median|15|15.0|Inter-Quartile Range|||11.0|19.0|
3998033|NCT01227967|3817968|B1|||Overall Symptom Score|Overall symptom score was the sum of available scores for each of the 11 symptoms assessed (so ignoring missing values). The possible range of the overall symptom score is therefore 0 (no symptoms) to 44 (severe for all 10 symptoms). Participants with missing evaluations for all symptoms were given a missing overall symptom score.|units on a scale|Median|15|15.0|Inter-Quartile Range|||11.0|19.0|
3998034|NCT01227967|3817966|B3|Rhinorrhea|Missing|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|10|10.0||||||
3998035|NCT01227967|3817967|B2|Rhinorrhea|Missing|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|4|4.0||||||
3998036|NCT01227967|3817968|B1|Rhinorrhea|Missing|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|6|6.0||||||
3998037|NCT01227967|3817966|B3|Rhinorrhea|Severe|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|130|130.0||||||
3998038|NCT01227967|3817967|B2|Rhinorrhea|Severe|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|74|74.0||||||
3998039|NCT01227967|3817968|B1|Rhinorrhea|Severe|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|56|56.0||||||
3998040|NCT01227967|3817966|B3|Rhinorrhea|Moderate|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|180|180.0||||||
3998041|NCT01227967|3817967|B2|Rhinorrhea|Moderate|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|84|84.0||||||
3998042|NCT01227967|3817968|B1|Rhinorrhea|Moderate|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|96|96.0||||||
3998043|NCT01227967|3817966|B3|Rhinorrhea|Mild|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|175|175.0||||||
3998044|NCT01227967|3817967|B2|Rhinorrhea|Mild|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|96|96.0||||||
3998045|NCT01227967|3817968|B1|Rhinorrhea|Mild|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|79|79.0||||||
3998046|NCT01227967|3817966|B3|Rhinorrhea|Absent|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|131|131.0||||||
3998047|NCT01227967|3817967|B2|Rhinorrhea|Absent|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|54|54.0||||||
3998048|NCT01227967|3817968|B1|Rhinorrhea|Absent|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|77|77.0||||||
3998049|NCT01227967|3817966|B3|Stuffy nose|Missing|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|8|8.0||||||
3998050|NCT01227967|3817967|B2|Stuffy nose|Missing|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|4|4.0||||||
3998051|NCT01227967|3817968|B1|Stuffy nose|Missing|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|4|4.0||||||
3998052|NCT01227967|3817966|B3|Stuffy nose|Severe|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|137|137.0||||||
3998053|NCT01227967|3817967|B2|Stuffy nose|Severe|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|78|78.0||||||
3998054|NCT01227967|3817968|B1|Stuffy nose|Severe|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|59|59.0||||||
3998055|NCT01227967|3817966|B3|Stuffy nose|Moderate|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|203|203.0||||||
3998056|NCT01227967|3817967|B2|Stuffy nose|Moderate|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|96|96.0||||||
3998057|NCT01227967|3817968|B1|Stuffy nose|Moderate|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|107|107.0||||||
3998058|NCT01227967|3817966|B3|Stuffy nose|Mild|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|130|130.0||||||
3998059|NCT01227967|3817967|B2|Stuffy nose|Mild|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|68|68.0||||||
3998060|NCT01227967|3817968|B1|Stuffy nose|Mild|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|62|62.0||||||
3998061|NCT01227967|3817966|B3|Stuffy nose|Absent|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|148|148.0||||||
3998062|NCT01227967|3817967|B2|Stuffy nose|Absent|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|66|66.0||||||
3998063|NCT01227967|3817968|B1|Stuffy nose|Absent|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|82|82.0||||||
3998064|NCT01227967|3817966|B3|Sore throat|Missing|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|7|7.0||||||
3998065|NCT01227967|3817967|B2|Sore throat|Missing|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|3|3.0||||||
3998066|NCT01227967|3817968|B1|Sore throat|Missing|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|4|4.0||||||
3998067|NCT01227967|3817966|B3|Sore throat|Severe|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|81|81.0||||||
3998068|NCT01227967|3817967|B2|Sore throat|Severe|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|47|47.0||||||
3998069|NCT01227967|3817968|B1|Sore throat|Severe|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|34|34.0||||||
3998070|NCT01227967|3817966|B3|Sore throat|Moderate|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|193|193.0||||||
3998071|NCT01227967|3817967|B2|Sore throat|Moderate|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|91|91.0||||||
3998072|NCT01227967|3817968|B1|Sore throat|Moderate|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|102|102.0||||||
3998073|NCT01227967|3817966|B3|Sore throat|Mild|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|185|185.0||||||
3998074|NCT01227967|3817967|B2|Sore throat|Mild|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|91|91.0||||||
3998075|NCT01227967|3817968|B1|Sore throat|Mild|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|94|94.0||||||
3998076|NCT01227967|3817966|B3|Sore throat|Absent|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|160|160.0||||||
3998077|NCT01227967|3817967|B2|Sore throat|Absent|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|80|80.0||||||
3998078|NCT01227967|3817968|B1|Sore throat|Absent|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|80|80.0||||||
3998079|NCT01227967|3817966|B3|Nausea|Missing|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|10|10.0||||||
3998080|NCT01227967|3817967|B2|Nausea|Missing|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|4|4.0||||||
3998081|NCT01227967|3817968|B1|Nausea|Missing|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|6|6.0||||||
3998082|NCT01227967|3817966|B3|Nausea|Severe|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|43|43.0||||||
3998083|NCT01227967|3817967|B2|Nausea|Severe|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|24|24.0||||||
3998084|NCT01227967|3817968|B1|Nausea|Severe|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|19|19.0||||||
3998085|NCT01227967|3817966|B3|Nausea|Moderate|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|73|73.0||||||
3998273|NCT01227967|3817968|B1|Mexico||Region of Enrollment||participants|Number|17|17.0||||||
3998086|NCT01227967|3817967|B2|Nausea|Moderate|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|35|35.0||||||
3998087|NCT01227967|3817968|B1|Nausea|Moderate|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|38|38.0||||||
3998088|NCT01227967|3817966|B3|Nausea|Mild|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|105|105.0||||||
3998089|NCT01227967|3817967|B2|Nausea|Mild|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|51|51.0||||||
3998090|NCT01227967|3817968|B1|Nausea|Mild|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|54|54.0||||||
3998091|NCT01227967|3817966|B3|Nausea|Absent|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|395|395.0||||||
3998092|NCT01227967|3817967|B2|Nausea|Absent|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|198|198.0||||||
3998093|NCT01227967|3817968|B1|Nausea|Absent|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|197|197.0||||||
3998094|NCT01227967|3817966|B3|Headache|Missing|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|7|7.0||||||
3998095|NCT01227967|3817967|B2|Headache|Missing|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|3|3.0||||||
3998096|NCT01227967|3817968|B1|Headache|Missing|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|4|4.0||||||
3998097|NCT01227967|3817966|B3|Headache|Severe|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|149|149.0||||||
3998098|NCT01227967|3817967|B2|Headache|Severe|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|74|74.0||||||
3998099|NCT01227967|3817968|B1|Headache|Severe|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|75|75.0||||||
3998100|NCT01227967|3817966|B3|Headache|Moderate|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|198|198.0||||||
3998101|NCT01227967|3817967|B2|Headache|Moderate|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|99|99.0||||||
3998102|NCT01227967|3817968|B1|Headache|Moderate|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|99|99.0||||||
3998103|NCT01227967|3817966|B3|Headache|Mild|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|157|157.0||||||
3998104|NCT01227967|3817967|B2|Headache|Mild|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|81|81.0||||||
3998105|NCT01227967|3817968|B1|Headache|Mild|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|76|76.0||||||
3998106|NCT01227967|3817966|B3|Headache|Absent|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|115|115.0||||||
3998107|NCT01227967|3817967|B2|Headache|Absent|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|55|55.0||||||
3998108|NCT01227967|3817968|B1|Headache|Absent|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|60|60.0||||||
3998109|NCT01227967|3817966|B3|Vomiting|Missing|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|10|10.0||||||
3998110|NCT01227967|3817967|B2|Vomiting|Missing|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|4|4.0||||||
3998111|NCT01227967|3817968|B1|Vomiting|Missing|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|6|6.0||||||
3998112|NCT01227967|3817966|B3|Vomiting|Severe|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|15|15.0||||||
3998113|NCT01227967|3817967|B2|Vomiting|Severe|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|9|9.0||||||
3998114|NCT01227967|3817968|B1|Vomiting|Severe|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|6|6.0||||||
3998115|NCT01227967|3817966|B3|Vomiting|Moderate|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|28|28.0||||||
3998116|NCT01227967|3817967|B2|Vomiting|Moderate|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|12|12.0||||||
3998117|NCT01227967|3817968|B1|Vomiting|Moderate|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|16|16.0||||||
3998118|NCT01227967|3817966|B3|Vomiting|Mild|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|36|36.0||||||
3998119|NCT01227967|3817967|B2|Vomiting|Mild|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|18|18.0||||||
3998120|NCT01227967|3817968|B1|Vomiting|Mild|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|18|18.0||||||
3998121|NCT01227967|3817966|B3|Vomiting|Absent|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|537|537.0||||||
3998122|NCT01227967|3817967|B2|Vomiting|Absent|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|269|269.0||||||
3998123|NCT01227967|3817968|B1|Vomiting|Absent|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|268|268.0||||||
3998124|NCT01227967|3817966|B3|Muscle aches|Missing|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|7|7.0||||||
3998125|NCT01227967|3817967|B2|Muscle aches|Missing|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|3|3.0||||||
3998126|NCT01227967|3817968|B1|Muscle aches|Missing|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|4|4.0||||||
3998127|NCT01227967|3817966|B3|Muscle aches|Severe|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|239|239.0||||||
3998128|NCT01227967|3817967|B2|Muscle aches|Severe|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|124|124.0||||||
3998129|NCT01227967|3817968|B1|Muscle aches|Severe|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|115|115.0||||||
3998130|NCT01227967|3817966|B3|Muscle aches|Moderate|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|199|199.0||||||
3998131|NCT01227967|3817967|B2|Muscle aches|Moderate|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|99|99.0||||||
3998132|NCT01227967|3817968|B1|Muscle aches|Moderate|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|100|100.0||||||
3998133|NCT01227967|3817966|B3|Muscle aches|Mild|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|107|107.0||||||
3998134|NCT01227967|3817967|B2|Muscle aches|Mild|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|56|56.0||||||
3998135|NCT01227967|3817968|B1|Muscle aches|Mild|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|51|51.0||||||
3998136|NCT01227967|3817966|B3|Muscle aches|Absent|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|74|74.0||||||
3998137|NCT01227967|3817967|B2|Muscle aches|Absent|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|30|30.0||||||
3998138|NCT01227967|3817968|B1|Muscle aches|Absent|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|44|44.0||||||
3998139|NCT01227967|3817966|B3|Diarrhea|Missing|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|9|9.0||||||
3998140|NCT01227967|3817967|B2|Diarrhea|Missing|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|3|3.0||||||
3998141|NCT01227967|3817968|B1|Diarrhea|Missing|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|6|6.0||||||
3998142|NCT01227967|3817966|B3|Diarrhea|Severe|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|25|25.0||||||
3998143|NCT01227967|3817967|B2|Diarrhea|Severe|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|10|10.0||||||
3998144|NCT01227967|3817968|B1|Diarrhea|Severe|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|15|15.0||||||
3998145|NCT01227967|3817966|B3|Diarrhea|Moderate|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|46|46.0||||||
3998146|NCT01227967|3817967|B2|Diarrhea|Moderate|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|20|20.0||||||
3998147|NCT01227967|3817968|B1|Diarrhea|Moderate|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|26|26.0||||||
3998148|NCT01227967|3817966|B3|Diarrhea|Mild|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|62|62.0||||||
3998149|NCT01227967|3817967|B2|Diarrhea|Mild|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|26|26.0||||||
3998150|NCT01227967|3817968|B1|Diarrhea|Mild|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|36|36.0||||||
3998151|NCT01227967|3817966|B3|Diarrhea|Absent|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|484|484.0||||||
3998152|NCT01227967|3817967|B2|Diarrhea|Absent|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|253|253.0||||||
3998153|NCT01227967|3817968|B1|Diarrhea|Absent|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|231|231.0||||||
3998154|NCT01227967|3817966|B3|Feverishness|Missing|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|8|8.0||||||
3998155|NCT01227967|3817967|B2|Feverishness|Missing|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|4|4.0||||||
3998156|NCT01227967|3817968|B1|Feverishness|Missing|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|4|4.0||||||
3998157|NCT01227967|3817966|B3|Feverishness|Severe|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|148|148.0||||||
3998158|NCT01227967|3817967|B2|Feverishness|Severe|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|80|80.0||||||
3998159|NCT01227967|3817968|B1|Feverishness|Severe|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|68|68.0||||||
3998160|NCT01227967|3817966|B3|Feverishness|Moderate|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|209|209.0||||||
3998161|NCT01227967|3817967|B2|Feverishness|Moderate|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|98|98.0||||||
3998162|NCT01227967|3817968|B1|Feverishness|Moderate|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|111|111.0||||||
3998163|NCT01227967|3817966|B3|Feverishness|Mild|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|129|129.0||||||
3998164|NCT01227967|3817967|B2|Feverishness|Mild|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|68|68.0||||||
3998165|NCT01227967|3817968|B1|Feverishness|Mild|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|61|61.0||||||
3998166|NCT01227967|3817966|B3|Feverishness|Absent|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|132|132.0||||||
3998167|NCT01227967|3817967|B2|Feverishness|Absent|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|62|62.0||||||
3998168|NCT01227967|3817968|B1|Feverishness|Absent|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|70|70.0||||||
3998169|NCT01227967|3817966|B3|Fatigue|Missing|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|8|8.0||||||
3998170|NCT01227967|3817967|B2|Fatigue|Missing|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|4|4.0||||||
3998171|NCT01227967|3817968|B1|Fatigue|Missing|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|4|4.0||||||
3998172|NCT01227967|3817966|B3|Fatigue|Severe|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|277|277.0||||||
3998173|NCT01227967|3817967|B2|Fatigue|Severe|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|145|145.0||||||
3998174|NCT01227967|3817968|B1|Fatigue|Severe|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|132|132.0||||||
3998175|NCT01227967|3817966|B3|Fatigue|Moderate|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|222|222.0||||||
3998176|NCT01227967|3817967|B2|Fatigue|Moderate|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|105|105.0||||||
3998177|NCT01227967|3817968|B1|Fatigue|Moderate|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|117|117.0||||||
3998178|NCT01227967|3817966|B3|Fatigue|Mild|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|76|76.0||||||
3998179|NCT01227967|3817967|B2|Fatigue|Mild|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|43|43.0||||||
3998180|NCT01227967|3817968|B1|Fatigue|Mild|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|33|33.0||||||
3998181|NCT01227967|3817966|B3|Fatigue|Absent|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|43|43.0||||||
3998182|NCT01227967|3817967|B2|Fatigue|Absent|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|15|15.0||||||
3998183|NCT01227967|3817968|B1|Fatigue|Absent|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|28|28.0||||||
3998184|NCT01227967|3817966|B3|Cough|Missing|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|8|8.0||||||
3998185|NCT01227967|3817967|B2|Cough|Missing|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|4|4.0||||||
3998186|NCT01227967|3817968|B1|Cough|Missing|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|4|4.0||||||
3998187|NCT01227967|3817966|B3|Cough|Severe|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|163|163.0||||||
3998188|NCT01227967|3817967|B2|Cough|Severe|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|78|78.0||||||
3998189|NCT01227967|3817968|B1|Cough|Severe|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|85|85.0||||||
3998190|NCT01227967|3817966|B3|Cough|Moderate|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|269|269.0||||||
3998191|NCT01227967|3817967|B2|Cough|Moderate|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|130|130.0||||||
3998192|NCT01227967|3817968|B1|Cough|Moderate|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|139|139.0||||||
3998193|NCT01227967|3817966|B3|Cough|Mild|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|154|154.0||||||
3998194|NCT01227967|3817967|B2|Cough|Mild|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|86|86.0||||||
3998195|NCT01227967|3817968|B1|Cough|Mild|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|68|68.0||||||
3998196|NCT01227967|3817966|B3|Cough|Absent|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|32|32.0||||||
3998197|NCT01227967|3817967|B2|Cough|Absent|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|14|14.0||||||
3998198|NCT01227967|3817968|B1|Cough|Absent|Symptom Score|Symptoms were scored on a 4-point scale : 0=absent, 1=mild, 2=moderate, 3=severe|Participants|Count of Participants|18|18.0||||||
3998199|NCT01227967|3817966|B3||Missing|Presence of fever||Participants|Count of Participants|7|7.0||||||
3998200|NCT01227967|3817967|B2||Missing|Presence of fever||Participants|Count of Participants|3|3.0||||||
3998201|NCT01227967|3817968|B1||Missing|Presence of fever||Participants|Count of Participants|4|4.0||||||
3998202|NCT01227967|3817966|B3||No|Presence of fever||Participants|Count of Participants|432|432.0||||||
3998203|NCT01227967|3817967|B2||No|Presence of fever||Participants|Count of Participants|216|216.0||||||
3998204|NCT01227967|3817968|B1||No|Presence of fever||Participants|Count of Participants|216|216.0||||||
3998205|NCT01227967|3817966|B3||Yes|Presence of fever||Participants|Count of Participants|187|187.0||||||
3998206|NCT01227967|3817967|B2||Yes|Presence of fever||Participants|Count of Participants|93|93.0||||||
3998207|NCT01227967|3817968|B1||Yes|Presence of fever||Participants|Count of Participants|94|94.0||||||
3998208|NCT01227967|3817966|B3|||Quantitative PCR Viral Shedding|"Limit of detection (LOD)/lower limit of quantification (LLOQ) for Flu A and Flu B by qPCR is 3.2/3.9 and 3.4/4.0, respectively.~Results <LOD were imputed as LOD; results >=LOD and <LLOQ were imputed as LLOQ, and results >ULOQ were imputed as ULOQ"|log10 copies/mL|Median|6.5|6.5|Inter-Quartile Range|||5.4|7.4|
3998209|NCT01227967|3817967|B2|||Quantitative PCR Viral Shedding|"Limit of detection (LOD)/lower limit of quantification (LLOQ) for Flu A and Flu B by qPCR is 3.2/3.9 and 3.4/4.0, respectively.~Results <LOD were imputed as LOD; results >=LOD and <LLOQ were imputed as LLOQ, and results >ULOQ were imputed as ULOQ"|log10 copies/mL|Median|6.7|6.7|Inter-Quartile Range|||5.1|7.7|
3998210|NCT01227967|3817968|B1|||Quantitative PCR Viral Shedding|"Limit of detection (LOD)/lower limit of quantification (LLOQ) for Flu A and Flu B by qPCR is 3.2/3.9 and 3.4/4.0, respectively.~Results <LOD were imputed as LOD; results >=LOD and <LLOQ were imputed as LLOQ, and results >ULOQ were imputed as ULOQ"|log10 copies/mL|Median|6.4|6.4|Inter-Quartile Range|||5.6|7.2|
3998211|NCT01227967|3817966|B3||Missing|Influenza Type/Subtype By Central Testing|Influenza type/subtype by central lab testing was from site-collected swab on Day 0 (the first one if more than one was collected) and if that was missing, then from a Day -1 sample, if collected|Participants|Count of Participants|3|3.0||||||
3998212|NCT01227967|3817967|B2||Missing|Influenza Type/Subtype By Central Testing|Influenza type/subtype by central lab testing was from site-collected swab on Day 0 (the first one if more than one was collected) and if that was missing, then from a Day -1 sample, if collected|Participants|Count of Participants|2|2.0||||||
3998213|NCT01227967|3817968|B1||Missing|Influenza Type/Subtype By Central Testing|Influenza type/subtype by central lab testing was from site-collected swab on Day 0 (the first one if more than one was collected) and if that was missing, then from a Day -1 sample, if collected|Participants|Count of Participants|1|1.0||||||
3998214|NCT01227967|3817966|B3||Negative|Influenza Type/Subtype By Central Testing|Influenza type/subtype by central lab testing was from site-collected swab on Day 0 (the first one if more than one was collected) and if that was missing, then from a Day -1 sample, if collected|Participants|Count of Participants|169|169.0||||||
3998215|NCT01227967|3817967|B2||Negative|Influenza Type/Subtype By Central Testing|Influenza type/subtype by central lab testing was from site-collected swab on Day 0 (the first one if more than one was collected) and if that was missing, then from a Day -1 sample, if collected|Participants|Count of Participants|86|86.0||||||
3998216|NCT01227967|3817968|B1||Negative|Influenza Type/Subtype By Central Testing|Influenza type/subtype by central lab testing was from site-collected swab on Day 0 (the first one if more than one was collected) and if that was missing, then from a Day -1 sample, if collected|Participants|Count of Participants|83|83.0||||||
3998217|NCT01227967|3817966|B3||Influenza B|Influenza Type/Subtype By Central Testing|Influenza type/subtype by central lab testing was from site-collected swab on Day 0 (the first one if more than one was collected) and if that was missing, then from a Day -1 sample, if collected|Participants|Count of Participants|106|106.0||||||
3998218|NCT01227967|3817967|B2||Influenza B|Influenza Type/Subtype By Central Testing|Influenza type/subtype by central lab testing was from site-collected swab on Day 0 (the first one if more than one was collected) and if that was missing, then from a Day -1 sample, if collected|Participants|Count of Participants|57|57.0||||||
3998219|NCT01227967|3817968|B1||Influenza B|Influenza Type/Subtype By Central Testing|Influenza type/subtype by central lab testing was from site-collected swab on Day 0 (the first one if more than one was collected) and if that was missing, then from a Day -1 sample, if collected|Participants|Count of Participants|49|49.0||||||
3998220|NCT01227967|3817966|B3||Influenza A/H1N1|Influenza Type/Subtype By Central Testing|Influenza type/subtype by central lab testing was from site-collected swab on Day 0 (the first one if more than one was collected) and if that was missing, then from a Day -1 sample, if collected|Participants|Count of Participants|104|104.0||||||
3998221|NCT01227967|3817967|B2||Influenza A/H1N1|Influenza Type/Subtype By Central Testing|Influenza type/subtype by central lab testing was from site-collected swab on Day 0 (the first one if more than one was collected) and if that was missing, then from a Day -1 sample, if collected|Participants|Count of Participants|49|49.0||||||
3998222|NCT01227967|3817968|B1||Influenza A/H1N1|Influenza Type/Subtype By Central Testing|Influenza type/subtype by central lab testing was from site-collected swab on Day 0 (the first one if more than one was collected) and if that was missing, then from a Day -1 sample, if collected|Participants|Count of Participants|55|55.0||||||
3998223|NCT01227967|3817966|B3||Influenza A/H3N2|Influenza Type/Subtype By Central Testing|Influenza type/subtype by central lab testing was from site-collected swab on Day 0 (the first one if more than one was collected) and if that was missing, then from a Day -1 sample, if collected|Participants|Count of Participants|244|244.0||||||
3998224|NCT01227967|3817967|B2||Influenza A/H3N2|Influenza Type/Subtype By Central Testing|Influenza type/subtype by central lab testing was from site-collected swab on Day 0 (the first one if more than one was collected) and if that was missing, then from a Day -1 sample, if collected|Participants|Count of Participants|118|118.0||||||
3998274|NCT01227967|3817966|B3|United States||Region of Enrollment||participants|Number|436|436.0||||||
3998225|NCT01227967|3817968|B1||Influenza A/H3N2|Influenza Type/Subtype By Central Testing|Influenza type/subtype by central lab testing was from site-collected swab on Day 0 (the first one if more than one was collected) and if that was missing, then from a Day -1 sample, if collected|Participants|Count of Participants|126|126.0||||||
3998226|NCT01227967|3817966|B3||No|Confirmed Influenza Infection Status By Central Testing||Participants|Count of Participants|172|172.0||||||
3998227|NCT01227967|3817967|B2||No|Confirmed Influenza Infection Status By Central Testing||Participants|Count of Participants|88|88.0||||||
3998228|NCT01227967|3817968|B1||No|Confirmed Influenza Infection Status By Central Testing||Participants|Count of Participants|84|84.0||||||
3998229|NCT01227967|3817966|B3||Yes|Confirmed Influenza Infection Status By Central Testing||Participants|Count of Participants|454|454.0||||||
3998230|NCT01227967|3817967|B2||Yes|Confirmed Influenza Infection Status By Central Testing||Participants|Count of Participants|224|224.0||||||
3998231|NCT01227967|3817968|B1||Yes|Confirmed Influenza Infection Status By Central Testing||Participants|Count of Participants|230|230.0||||||
3998232|NCT01227967|3817966|B3||Multiple types/subtypes|Result of Influenza Test By Local Testing||Participants|Count of Participants|16|16.0||||||
3998233|NCT01227967|3817967|B2||Multiple types/subtypes|Result of Influenza Test By Local Testing||Participants|Count of Participants|10|10.0||||||
3998234|NCT01227967|3817968|B1||Multiple types/subtypes|Result of Influenza Test By Local Testing||Participants|Count of Participants|6|6.0||||||
3998235|NCT01227967|3817966|B3||Influenza positive (unknown A or B)|Result of Influenza Test By Local Testing||Participants|Count of Participants|15|15.0||||||
3998236|NCT01227967|3817967|B2||Influenza positive (unknown A or B)|Result of Influenza Test By Local Testing||Participants|Count of Participants|5|5.0||||||
3998237|NCT01227967|3817968|B1||Influenza positive (unknown A or B)|Result of Influenza Test By Local Testing||Participants|Count of Participants|10|10.0||||||
3998238|NCT01227967|3817966|B3||Influenza B|Result of Influenza Test By Local Testing||Participants|Count of Participants|155|155.0||||||
3998239|NCT01227967|3817967|B2||Influenza B|Result of Influenza Test By Local Testing||Participants|Count of Participants|80|80.0||||||
3998240|NCT01227967|3817968|B1||Influenza B|Result of Influenza Test By Local Testing||Participants|Count of Participants|75|75.0||||||
3998241|NCT01227967|3817966|B3||Influenza A not typed|Result of Influenza Test By Local Testing||Participants|Count of Participants|360|360.0||||||
3998242|NCT01227967|3817967|B2||Influenza A not typed|Result of Influenza Test By Local Testing||Participants|Count of Participants|180|180.0||||||
3998243|NCT01227967|3817968|B1||Influenza A not typed|Result of Influenza Test By Local Testing||Participants|Count of Participants|180|180.0||||||
3998244|NCT01227967|3817966|B3||Influenza A unsubtypable|Result of Influenza Test By Local Testing||Participants|Count of Participants|51|51.0||||||
3998245|NCT01227967|3817967|B2||Influenza A unsubtypable|Result of Influenza Test By Local Testing||Participants|Count of Participants|22|22.0||||||
3998246|NCT01227967|3817968|B1||Influenza A unsubtypable|Result of Influenza Test By Local Testing||Participants|Count of Participants|29|29.0||||||
3998247|NCT01227967|3817966|B3||Influenza A/H3N2|Result of Influenza Test By Local Testing||Participants|Count of Participants|2|2.0||||||
3998248|NCT01227967|3817967|B2||Influenza A/H3N2|Result of Influenza Test By Local Testing||Participants|Count of Participants|1|1.0||||||
3998249|NCT01227967|3817968|B1||Influenza A/H3N2|Result of Influenza Test By Local Testing||Participants|Count of Participants|1|1.0||||||
3998250|NCT01227967|3817966|B3||Influenza A/H1N1|Result of Influenza Test By Local Testing||Participants|Count of Participants|27|27.0||||||
3998251|NCT01227967|3817967|B2||Influenza A/H1N1|Result of Influenza Test By Local Testing||Participants|Count of Participants|14|14.0||||||
3998252|NCT01227967|3817968|B1||Influenza A/H1N1|Result of Influenza Test By Local Testing||Participants|Count of Participants|13|13.0||||||
3998253|NCT01227967|3817966|B3|||Positive Influenza Test by Local Testing||Participants|Count of Participants|626|626.0||||||
3998254|NCT01227967|3817967|B2|||Positive Influenza Test by Local Testing||Participants|Count of Participants|312|312.0||||||
3998255|NCT01227967|3817968|B1|||Positive Influenza Test by Local Testing||Participants|Count of Participants|314|314.0||||||
3998256|NCT01227967|3817966|B3||Isothermal nucleic acid amplification technology|Influenza Diagnostic Test by Local Testing||Participants|Count of Participants|1|1.0||||||
3998257|NCT01227967|3817967|B2||Isothermal nucleic acid amplification technology|Influenza Diagnostic Test by Local Testing||Participants|Count of Participants|1|1.0||||||
3998258|NCT01227967|3817968|B1||Isothermal nucleic acid amplification technology|Influenza Diagnostic Test by Local Testing||Participants|Count of Participants|0|0.0||||||
3998259|NCT01227967|3817966|B3||Rapid antigen test|Influenza Diagnostic Test by Local Testing||Participants|Count of Participants|562|562.0||||||
3998260|NCT01227967|3817967|B2||Rapid antigen test|Influenza Diagnostic Test by Local Testing||Participants|Count of Participants|281|281.0||||||
3998261|NCT01227967|3817968|B1||Rapid antigen test|Influenza Diagnostic Test by Local Testing||Participants|Count of Participants|281|281.0||||||
3998262|NCT01227967|3817966|B3||RT-PCR/PCR|Influenza Diagnostic Test by Local Testing||Participants|Count of Participants|63|63.0||||||
3998263|NCT01227967|3817967|B2||RT-PCR/PCR|Influenza Diagnostic Test by Local Testing||Participants|Count of Participants|30|30.0||||||
3998264|NCT01227967|3817968|B1||RT-PCR/PCR|Influenza Diagnostic Test by Local Testing||Participants|Count of Participants|33|33.0||||||
3998265|NCT01227967|3817966|B3|Thailand||Region of Enrollment||participants|Number|131|131.0||||||
3998266|NCT01227967|3817967|B2|Thailand||Region of Enrollment||participants|Number|66|66.0||||||
3998267|NCT01227967|3817968|B1|Thailand||Region of Enrollment||participants|Number|65|65.0||||||
3998268|NCT01227967|3817966|B3|Australia||Region of Enrollment||participants|Number|2|2.0||||||
3998269|NCT01227967|3817967|B2|Australia||Region of Enrollment||participants|Number|2|2.0||||||
3998270|NCT01227967|3817968|B1|Australia||Region of Enrollment||participants|Number|0|0.0||||||
3998271|NCT01227967|3817966|B3|Mexico||Region of Enrollment||participants|Number|35|35.0||||||
3998272|NCT01227967|3817967|B2|Mexico||Region of Enrollment||participants|Number|18|18.0||||||
3998276|NCT01227967|3817968|B1|United States||Region of Enrollment||participants|Number|220|220.0||||||
3998277|NCT01227967|3817966|B3|Argentina||Region of Enrollment||participants|Number|22|22.0||||||
3998278|NCT01227967|3817967|B2|Argentina||Region of Enrollment||participants|Number|10|10.0||||||
3998279|NCT01227967|3817968|B1|Argentina||Region of Enrollment||participants|Number|12|12.0||||||
3998280|NCT01227967|3817966|B3||Subject does not know|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3998281|NCT01227967|3817967|B2||Subject does not know|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3998282|NCT01227967|3817968|B1||Subject does not know|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3998283|NCT01227967|3817966|B3||Subject does not want to report|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3998284|NCT01227967|3817967|B2||Subject does not want to report|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3998285|NCT01227967|3817968|B1||Subject does not want to report|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3998286|NCT01227967|3817966|B3||Race not available to clinic|Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
3998287|NCT01227967|3817967|B2||Race not available to clinic|Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3998288|NCT01227967|3817968|B1||Race not available to clinic|Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
3998289|NCT01227967|3817966|B3||American Indian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
3998290|NCT01227967|3817967|B2||American Indian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3998291|NCT01227967|3817968|B1||American Indian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3998292|NCT01227967|3817966|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
3998293|NCT01227967|3817967|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
3998294|NCT01227967|3817968|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
3998295|NCT01227967|3817966|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|143|143.0||||||
3998296|NCT01227967|3817967|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|73|73.0||||||
3998297|NCT01227967|3817968|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|70|70.0||||||
3998298|NCT01227967|3817966|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|392|392.0||||||
3998299|NCT01227967|3817967|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|189|189.0||||||
3998300|NCT01227967|3817968|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|203|203.0||||||
3998301|NCT01227967|3817966|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3998302|NCT01227967|3817967|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3998303|NCT01227967|3817968|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3998304|NCT01227967|3817966|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|512|512.0||||||
3998305|NCT01227967|3817967|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|254|254.0||||||
3998306|NCT01227967|3817968|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|258|258.0||||||
3998307|NCT01227967|3817966|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
3998308|NCT01227967|3817967|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
3998309|NCT01227967|3817968|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
3998310|NCT01227967|3817966|B3||Male|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
3998311|NCT01227967|3817967|B2||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
3998312|NCT01227967|3817968|B1||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3998313|NCT01227967|3817966|B3||Female|Sex: Female, Male||Participants|Count of Participants|385|385.0||||||
3998314|NCT01227967|3817967|B2||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
3998315|NCT01227967|3817968|B1||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
3998316|NCT01227967|3817966|B3|||Age||years|Median|49.5|49.5|Inter-Quartile Range|||36.0|61.0|
3998317|NCT01227967|3817967|B2|||Age||years|Median|49.5|49.5|Inter-Quartile Range|||35.5|61.0|
3998318|NCT01227967|3817968|B1|||Age||years|Median|49.5|49.5|Inter-Quartile Range|||37.0|61.0|
3998319|NCT01227967|3817966|B3||>=65 years|Age||Participants|Count of Participants|128|128.0||||||
3998320|NCT01227967|3817967|B2||>=65 years|Age||Participants|Count of Participants|67|67.0||||||
3998321|NCT01227967|3817968|B1||>=65 years|Age||Participants|Count of Participants|61|61.0||||||
3998322|NCT01227967|3817966|B3||Between 18 and 65 years|Age||Participants|Count of Participants|493|493.0||||||
3998323|NCT01227967|3817967|B2||Between 18 and 65 years|Age||Participants|Count of Participants|241|241.0||||||
3998324|NCT01227967|3817968|B1||Between 18 and 65 years|Age||Participants|Count of Participants|252|252.0||||||
3998325|NCT01227967|3817966|B3||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
3998326|NCT01227967|3817967|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
3998327|NCT01227967|3817968|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
3998328|NCT01227954|3818003|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
3998329|NCT01227954|3818003|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3998330|NCT01227954|3818003|B1|||Age||years|Median|61|61.0|Full Range|||28.0|83.0|
3998331|NCT01227928|3818015|B3|Asian||Race/Ethnicity, Customized||participants|Number|145|145.0||||||
3998332|NCT01227928|3818016|B2|Asian||Race/Ethnicity, Customized||participants|Number|73|73.0||||||
3998333|NCT01227928|3818017|B1|Asian||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
3998334|NCT01227928|3818015|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3998335|NCT01227928|3818016|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3998336|NCT01227928|3818017|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3998337|NCT01227928|3818015|B3||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3998338|NCT01227928|3818016|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3998339|NCT01227928|3818017|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
3998340|NCT01227928|3818015|B3|||Age||Years|Mean|52.9|52.9|Standard Deviation|10.09|10.09|||
3998341|NCT01227928|3818016|B2|||Age||Years|Mean|51.7|51.7|Standard Deviation|9.62|9.62|||
3998342|NCT01227928|3818017|B1|||Age||Years|Mean|54.1|54.1|Standard Deviation|10.46|10.46|||
3998343|NCT01227902|3818052|B5|White - White/Caucasian/European||Race/Ethnicity, Customized|Baseline data were collected in members of the Safety Population, comprised of those participants who took at least one dose of RTG.|participants|Number|188|188.0||||||
3998344|NCT01227902|3818053|B4|White - White/Caucasian/European||Race/Ethnicity, Customized|Baseline data were collected in members of the Safety Population, comprised of those participants who took at least one dose of RTG.|participants|Number|49|49.0||||||
3998345|NCT01227902|3818054|B3|White - White/Caucasian/European||Race/Ethnicity, Customized|Baseline data were collected in members of the Safety Population, comprised of those participants who took at least one dose of RTG.|participants|Number|39|39.0||||||
3998346|NCT01227902|3818055|B2|White - White/Caucasian/European||Race/Ethnicity, Customized|Baseline data were collected in members of the Safety Population, comprised of those participants who took at least one dose of RTG.|participants|Number|45|45.0||||||
3998347|NCT01227902|3818056|B1|White - White/Caucasian/European||Race/Ethnicity, Customized|Baseline data were collected in members of the Safety Population, comprised of those participants who took at least one dose of RTG.|participants|Number|55|55.0||||||
3998348|NCT01227902|3818052|B5|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Baseline data were collected in members of the Safety Population, comprised of those participants who took at least one dose of RTG.|participants|Number|13|13.0||||||
3998349|NCT01227902|3818053|B4|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Baseline data were collected in members of the Safety Population, comprised of those participants who took at least one dose of RTG.|participants|Number|3|3.0||||||
3998350|NCT01227902|3818054|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Baseline data were collected in members of the Safety Population, comprised of those participants who took at least one dose of RTG.|participants|Number|5|5.0||||||
3998351|NCT01227902|3818055|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Baseline data were collected in members of the Safety Population, comprised of those participants who took at least one dose of RTG.|participants|Number|5|5.0||||||
3998352|NCT01227902|3818056|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Baseline data were collected in members of the Safety Population, comprised of those participants who took at least one dose of RTG.|participants|Number|0|0.0||||||
3998353|NCT01227902|3818052|B5|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Baseline data were collected in members of the Safety Population, comprised of those participants who took at least one dose of RTG.|participants|Number|2|2.0||||||
3998354|NCT01227902|3818053|B4|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Baseline data were collected in members of the Safety Population, comprised of those participants who took at least one dose of RTG.|participants|Number|0|0.0||||||
3998355|NCT01227902|3818054|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Baseline data were collected in members of the Safety Population, comprised of those participants who took at least one dose of RTG.|participants|Number|0|0.0||||||
3998356|NCT01227902|3818055|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Baseline data were collected in members of the Safety Population, comprised of those participants who took at least one dose of RTG.|participants|Number|1|1.0||||||
3998357|NCT01227902|3818056|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Baseline data were collected in members of the Safety Population, comprised of those participants who took at least one dose of RTG.|participants|Number|1|1.0||||||
3998358|NCT01227902|3818052|B5||Male|Sex: Female, Male|Baseline data were collected in members of the Safety Population, comprised of those participants who took at least one dose of RTG.|Participants|Count of Participants|93|93.0||||||
3998359|NCT01227902|3818053|B4||Male|Sex: Female, Male|Baseline data were collected in members of the Safety Population, comprised of those participants who took at least one dose of RTG.|Participants|Count of Participants|26|26.0||||||
3998360|NCT01227902|3818054|B3||Male|Sex: Female, Male|Baseline data were collected in members of the Safety Population, comprised of those participants who took at least one dose of RTG.|Participants|Count of Participants|19|19.0||||||
3998361|NCT01227902|3818055|B2||Male|Sex: Female, Male|Baseline data were collected in members of the Safety Population, comprised of those participants who took at least one dose of RTG.|Participants|Count of Participants|25|25.0||||||
3998362|NCT01227902|3818056|B1||Male|Sex: Female, Male|Baseline data were collected in members of the Safety Population, comprised of those participants who took at least one dose of RTG.|Participants|Count of Participants|23|23.0||||||
3998363|NCT01227902|3818052|B5||Female|Sex: Female, Male|Baseline data were collected in members of the Safety Population, comprised of those participants who took at least one dose of RTG.|Participants|Count of Participants|110|110.0||||||
3998364|NCT01227902|3818053|B4||Female|Sex: Female, Male|Baseline data were collected in members of the Safety Population, comprised of those participants who took at least one dose of RTG.|Participants|Count of Participants|26|26.0||||||
3998365|NCT01227902|3818054|B3||Female|Sex: Female, Male|Baseline data were collected in members of the Safety Population, comprised of those participants who took at least one dose of RTG.|Participants|Count of Participants|25|25.0||||||
3998366|NCT01227902|3818055|B2||Female|Sex: Female, Male|Baseline data were collected in members of the Safety Population, comprised of those participants who took at least one dose of RTG.|Participants|Count of Participants|26|26.0||||||
3998367|NCT01227902|3818056|B1||Female|Sex: Female, Male|Baseline data were collected in members of the Safety Population, comprised of those participants who took at least one dose of RTG.|Participants|Count of Participants|33|33.0||||||
3998368|NCT01227902|3818052|B5|||Age|Baseline data were collected in members of the Safety Population, comprised of those participants who took at least one dose of RTG.|Years|Mean|39.1|39.1|Standard Deviation|14.00|14.0|||
3998369|NCT01227902|3818053|B4|||Age|Baseline data were collected in members of the Safety Population, comprised of those participants who took at least one dose of RTG.|Years|Mean|40.3|40.3|Standard Deviation|14.05|14.05|||
3998370|NCT01227902|3818054|B3|||Age|Baseline data were collected in members of the Safety Population, comprised of those participants who took at least one dose of RTG.|Years|Mean|37.0|37.0|Standard Deviation|14.94|14.94|||
3998371|NCT01227902|3818055|B2|||Age|Baseline data were collected in members of the Safety Population, comprised of those participants who took at least one dose of RTG.|Years|Mean|38.2|38.2|Standard Deviation|11.91|11.91|||
3998372|NCT01227902|3818056|B1|||Age|Baseline data were collected in members of the Safety Population, comprised of those participants who took at least one dose of RTG.|Years|Mean|40.6|40.6|Standard Deviation|14.99|14.99|||
3998373|NCT01227889|3818150|B3|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3998374|NCT01227889|3818151|B2|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3998375|NCT01227889|3818152|B1|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3998376|NCT01227889|3818150|B3|White||Race/Ethnicity, Customized||participants|Number|249|249.0||||||
3998377|NCT01227889|3818151|B2|White||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
3998378|NCT01227889|3818152|B1|White||Race/Ethnicity, Customized||participants|Number|186|186.0||||||
3998379|NCT01227889|3818150|B3||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
3998380|NCT01227889|3818151|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3998381|NCT01227889|3818152|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3998382|NCT01227889|3818150|B3||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
3998383|NCT01227889|3818151|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3998384|NCT01227889|3818152|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3998385|NCT01227889|3818150|B3|||Age||Years|Mean|53.0|53.0|Standard Deviation|13.87|13.87|||
3998386|NCT01227889|3818151|B2|||Age||Years|Mean|51.6|51.6|Standard Deviation|14.22|14.22|||
3998387|NCT01227889|3818152|B1|||Age||Years|Mean|53.5|53.5|Standard Deviation|13.76|13.76|||
3998388|NCT01227824|3818178|B3|Asian and White||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3998389|NCT01227824|3818179|B2|Asian and White||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3998390|NCT01227824|3818180|B1|Asian and White||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3998391|NCT01227824|3818178|B3|African American/African Her and Asian and White||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3998392|NCT01227824|3818179|B2|African American/African Her and Asian and White||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3998393|NCT01227824|3818180|B1|African American/African Her and Asian and White||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
3998394|NCT01227824|3818178|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|698|698.0||||||
3998395|NCT01227824|3818179|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|352|352.0||||||
3998396|NCT01227824|3818180|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|346|346.0||||||
3998397|NCT01227824|3818178|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3998398|NCT01227824|3818179|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3998399|NCT01227824|3818180|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3998400|NCT01227824|3818178|B3|Japanese/East Asian Her/South East Asian Her||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
3998401|NCT01227824|3818179|B2|Japanese/East Asian Her/South East Asian Her||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
3998402|NCT01227824|3818180|B1|Japanese/East Asian Her/South East Asian Her||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
3998403|NCT01227824|3818178|B3|Central/South Asian Her||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3998404|NCT01227824|3818179|B2|Central/South Asian Her||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
3998405|NCT01227824|3818180|B1|Central/South Asian Her||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
3998406|NCT01227824|3818178|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
3998407|NCT01227824|3818179|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
3998408|NCT01227824|3818180|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
3998409|NCT01227824|3818178|B3|African American/African Heritage (Her)||Race/Ethnicity, Customized||Participants|Count of Participants|88|88.0||||||
3998410|NCT01227824|3818179|B2|African American/African Heritage (Her)||Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
3998411|NCT01227824|3818180|B1|African American/African Heritage (Her)||Race/Ethnicity, Customized||Participants|Count of Participants|49|49.0||||||
3998412|NCT01227824|3818178|B3||Male|Sex: Female, Male||Participants|Count of Participants|703|703.0||||||
3998413|NCT01227824|3818179|B2||Male|Sex: Female, Male||Participants|Count of Participants|355|355.0||||||
3998414|NCT01227824|3818180|B1||Male|Sex: Female, Male||Participants|Count of Participants|348|348.0||||||
3998415|NCT01227824|3818178|B3||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
3998416|NCT01227824|3818179|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
3998417|NCT01227824|3818180|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3998418|NCT01227824|3818178|B3|||Age||Years|Mean|37.0|37.0|Standard Deviation|9.61|9.61|||
3998419|NCT01227824|3818179|B2|||Age||Years|Mean|36.6|36.6|Standard Deviation|10.02|10.02|||
3998420|NCT01227824|3818180|B1|||Age||Years|Mean|37.3|37.3|Standard Deviation|9.19|9.19|||
3998421|NCT01227785|3818211|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3998422|NCT01227785|3818211|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3998423|NCT01227785|3818211|B1|CRT-D||Age, Customized||years|Mean|67.4|67.4|Standard Deviation|10.1|10.1|||
3998424|NCT01227785|3818211|B1|ICD||Age, Customized||years|Mean|62.7|62.7|Standard Deviation|10.6|10.6|||
3998425|NCT01227707|3818277|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3998426|NCT01227707|3818277|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3998427|NCT01227707|3818277|B1|||Age||years|Mean|61.49|61.49|Standard Deviation|10.85|10.85|||
3998428|NCT01227681|3818293|B4|Taiwan||Region of Enrollment||participants|Number|4|4.0||||||
3998429|NCT01227681|3818296|B1|Taiwan||Region of Enrollment||participants|Number|4|4.0||||||
3998430|NCT01227681|3818293|B4|Male||Gender||participants|Number|4|4.0||||||
3998431|NCT01227681|3818296|B1|Male||Gender||participants|Number|4|4.0||||||
3998432|NCT01227681|3818293|B4|Female||Gender||participants|Number|0|0.0||||||
3998433|NCT01227681|3818296|B1|Female||Gender||participants|Number|0|0.0||||||
3998434|NCT01227681|3818293|B4|||Age||years|Mean|49.25|49.25|Full Range|||42.0|56.0|
3998435|NCT01227681|3818296|B1|||Age||years|Mean|49.25|49.25|Full Range|||42.0|56.0|
3998436|NCT01227681|3818293|B4|>=65 years||Age||participants|Number|0|0.0||||||
3998437|NCT01227681|3818296|B1|>=65 years||Age||participants|Number|0|0.0||||||
3998438|NCT01227681|3818293|B4|Between 18 and 65 years||Age||participants|Number|4|4.0||||||
3998439|NCT01227681|3818296|B1|Between 18 and 65 years||Age||participants|Number|4|4.0||||||
3998440|NCT01227681|3818293|B4|<=18 years||Age||participants|Number|0|0.0||||||
3998441|NCT01227681|3818296|B1|<=18 years||Age||participants|Number|0|0.0||||||
3998442|NCT01227668|3818302|B3|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3998443|NCT01227668|3818303|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3998444|NCT01227668|3818304|B1|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
3998445|NCT01227668|3818302|B3|White||Race/Ethnicity, Customized||Participants|Number|59|59.0||||||
3998446|NCT01227668|3818303|B2|White||Race/Ethnicity, Customized||Participants|Number|28|28.0||||||
3998447|NCT01227668|3818304|B1|White||Race/Ethnicity, Customized||Participants|Number|31|31.0||||||
3998448|NCT01227668|3818302|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
3998449|NCT01227668|3818303|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
3998450|NCT01227668|3818304|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
3998451|NCT01227668|3818302|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3998452|NCT01227668|3818303|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3998453|NCT01227668|3818304|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3998454|NCT01227668|3818302|B3|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3998455|NCT01227668|3818303|B2|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
3998456|NCT01227668|3818304|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3998457|NCT01227668|3818302|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3998458|NCT01227668|3818303|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3998459|NCT01227668|3818304|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
3998460|NCT01227668|3818302|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
3998461|NCT01227668|3818303|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3998462|NCT01227668|3818304|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3998463|NCT01227668|3818302|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3998464|NCT01227668|3818303|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3998465|NCT01227668|3818304|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3998466|NCT01227668|3818302|B3|||Age, Customized||Years|Median|10.0|10.0|Full Range|||6.0|17.0|
3998467|NCT01227668|3818303|B2|||Age, Customized||Years|Median|11.0|11.0|Full Range|||6.0|17.0|
3998468|NCT01227668|3818304|B1|||Age, Customized||Years|Median|10.0|10.0|Full Range|||6.0|16.0|
3998469|NCT01227668|3818302|B3|||Age, Customized||years|Mean|10.4|10.4|Standard Deviation|2.79|2.79|||
3998470|NCT01227668|3818303|B2|||Age, Customized||years|Mean|10.8|10.8|Standard Deviation|2.77|2.77|||
3998471|NCT01227668|3818304|B1|||Age, Customized||years|Mean|10.1|10.1|Standard Deviation|2.80|2.8|||
3998472|NCT01227655|3818319|B4||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
3998473|NCT01227655|3818320|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3998474|NCT01227655|3818321|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
3998475|NCT01227655|3818322|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3998476|NCT01227655|3818319|B4||Female|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
3998477|NCT01227655|3818320|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3998478|NCT01227655|3818321|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
3998479|NCT01227655|3818322|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3998480|NCT01227655|3818319|B4|≥70 years||Age, Customized||participants|Number|108|108.0||||||
3998481|NCT01227655|3818320|B3|≥70 years||Age, Customized||participants|Number|28|28.0||||||
3998482|NCT01227655|3818321|B2|≥70 years||Age, Customized||participants|Number|51|51.0||||||
3998483|NCT01227655|3818322|B1|≥70 years||Age, Customized||participants|Number|29|29.0||||||
3998484|NCT01227655|3818319|B4|<70 years||Age, Customized||participants|Number|299|299.0||||||
3998485|NCT01227655|3818320|B3|<70 years||Age, Customized||participants|Number|107|107.0||||||
3998486|NCT01227655|3818321|B2|<70 years||Age, Customized||participants|Number|96|96.0||||||
3998487|NCT01227655|3818322|B1|<70 years||Age, Customized||participants|Number|96|96.0||||||
3998488|NCT01227629|3818341|B11|||aPTT at baseline N=(57;20;27;98;34;33;96;33;29;57;484)||seconds|Mean|33.1|33.1|Standard Deviation|8.2|8.2|||
3998489|NCT01227629|3818342|B10|||aPTT at baseline N=(57;20;27;98;34;33;96;33;29;57;484)||seconds|Mean|33.2|33.2|Standard Deviation|3.7|3.7|||
3998490|NCT01227629|3818343|B9|||aPTT at baseline N=(57;20;27;98;34;33;96;33;29;57;484)||seconds|Mean|32.9|32.9|Standard Deviation|6.7|6.7|||
3998491|NCT01227629|3818344|B8|||aPTT at baseline N=(57;20;27;98;34;33;96;33;29;57;484)||seconds|Mean|32.6|32.6|Standard Deviation|3.4|3.4|||
3998492|NCT01227629|3818345|B7|||aPTT at baseline N=(57;20;27;98;34;33;96;33;29;57;484)||seconds|Mean|32.8|32.8|Standard Deviation|5.7|5.7|||
3998493|NCT01227629|3818346|B6|||aPTT at baseline N=(57;20;27;98;34;33;96;33;29;57;484)||seconds|Mean|34.2|34.2|Standard Deviation|6.7|6.7|||
3998494|NCT01227629|3818347|B5|||aPTT at baseline N=(57;20;27;98;34;33;96;33;29;57;484)||seconds|Mean|33.5|33.5|Standard Deviation|7.6|7.6|||
3998495|NCT01227629|3818348|B4|||aPTT at baseline N=(57;20;27;98;34;33;96;33;29;57;484)||seconds|Mean|34.2|34.2|Standard Deviation|15.2|15.2|||
3998496|NCT01227629|3818349|B3|||aPTT at baseline N=(57;20;27;98;34;33;96;33;29;57;484)||seconds|Mean|32.4|32.4|Standard Deviation|3.6|3.6|||
3998497|NCT01227629|3818350|B2|||aPTT at baseline N=(57;20;27;98;34;33;96;33;29;57;484)||seconds|Mean|31.2|31.2|Standard Deviation|3.5|3.5|||
3998498|NCT01227629|3818351|B1|||aPTT at baseline N=(57;20;27;98;34;33;96;33;29;57;484)||seconds|Mean|32.5|32.5|Standard Deviation|3.0|3.0|||
3998499|NCT01227629|3818341|B11|||ECT at baseline N=(57;20;27;98;34;33;95;33;29;56;482)||seconds|Mean|32.4|32.4|Standard Deviation|6.2|6.2|||
3998500|NCT01227629|3818342|B10|||ECT at baseline N=(57;20;27;98;34;33;95;33;29;56;482)||seconds|Mean|32.0|32.0|Standard Deviation|2.4|2.4|||
3998501|NCT01227629|3818343|B9|||ECT at baseline N=(57;20;27;98;34;33;95;33;29;56;482)||seconds|Mean|32.2|32.2|Standard Deviation|2.6|2.6|||
3998502|NCT01227629|3818344|B8|||ECT at baseline N=(57;20;27;98;34;33;95;33;29;56;482)||seconds|Mean|31.9|31.9|Standard Deviation|1.8|1.8|||
3998503|NCT01227629|3818345|B7|||ECT at baseline N=(57;20;27;98;34;33;95;33;29;56;482)||seconds|Mean|33.6|33.6|Standard Deviation|13.3|13.3|||
3998504|NCT01227629|3818346|B6|||ECT at baseline N=(57;20;27;98;34;33;95;33;29;56;482)||seconds|Mean|32.6|32.6|Standard Deviation|2.4|2.4|||
3998505|NCT01227629|3818347|B5|||ECT at baseline N=(57;20;27;98;34;33;95;33;29;56;482)||seconds|Mean|32.0|32.0|Standard Deviation|1.9|1.9|||
3998506|NCT01227629|3818348|B4|||ECT at baseline N=(57;20;27;98;34;33;95;33;29;56;482)||seconds|Mean|31.9|31.9|Standard Deviation|2.2|2.2|||
3998507|NCT01227629|3818349|B3|||ECT at baseline N=(57;20;27;98;34;33;95;33;29;56;482)||seconds|Mean|31.9|31.9|Standard Deviation|2.2|2.2|||
3998508|NCT01227629|3818350|B2|||ECT at baseline N=(57;20;27;98;34;33;95;33;29;56;482)||seconds|Mean|31.8|31.8|Standard Deviation|1.9|1.9|||
3998509|NCT01227629|3818351|B1|||ECT at baseline N=(57;20;27;98;34;33;95;33;29;56;482)||seconds|Mean|32.3|32.3|Standard Deviation|2.0|2.0|||
3998510|NCT01227629|3818341|B11|||Thromboxane B2 (TXB2) measured at baseline N=(53;20;23;93;30;30;90;31;30;67;467)||pg/mg Creatinine|Mean|4051.6|4051.6|Standard Deviation|2367.7|2367.7|||
3998511|NCT01227629|3818342|B10|||Thromboxane B2 (TXB2) measured at baseline N=(53;20;23;93;30;30;90;31;30;67;467)||pg/mg Creatinine|Mean|4177.9|4177.9|Standard Deviation|2661.2|2661.2|||
3998512|NCT01227629|3818343|B9|||Thromboxane B2 (TXB2) measured at baseline N=(53;20;23;93;30;30;90;31;30;67;467)||pg/mg Creatinine|Mean|3735.6|3735.6|Standard Deviation|2440.6|2440.6|||
3998513|NCT01227629|3818344|B8|||Thromboxane B2 (TXB2) measured at baseline N=(53;20;23;93;30;30;90;31;30;67;467)||pg/mg Creatinine|Mean|4450.8|4450.8|Standard Deviation|2653.7|2653.7|||
3998514|NCT01227629|3818345|B7|||Thromboxane B2 (TXB2) measured at baseline N=(53;20;23;93;30;30;90;31;30;67;467)||pg/mg Creatinine|Mean|3619.0|3619.0|Standard Deviation|2020.6|2020.6|||
3998515|NCT01227629|3818346|B6|||Thromboxane B2 (TXB2) measured at baseline N=(53;20;23;93;30;30;90;31;30;67;467)||pg/mg Creatinine|Mean|4084.9|4084.9|Standard Deviation|2253.5|2253.5|||
3998516|NCT01227629|3818347|B5|||Thromboxane B2 (TXB2) measured at baseline N=(53;20;23;93;30;30;90;31;30;67;467)||pg/mg Creatinine|Mean|4485.7|4485.7|Standard Deviation|2147.8|2147.8|||
3998517|NCT01227629|3818348|B4|||Thromboxane B2 (TXB2) measured at baseline N=(53;20;23;93;30;30;90;31;30;67;467)||pg/mg Creatinine|Mean|4138.1|4138.1|Standard Deviation|2184.6|2184.6|||
3998518|NCT01227629|3818349|B3|||Thromboxane B2 (TXB2) measured at baseline N=(53;20;23;93;30;30;90;31;30;67;467)||pg/mg Creatinine|Mean|4705.6|4705.6|Standard Deviation|3047.5|3047.5|||
3998519|NCT01227629|3818350|B2|||Thromboxane B2 (TXB2) measured at baseline N=(53;20;23;93;30;30;90;31;30;67;467)||pg/mg Creatinine|Mean|3795.9|3795.9|Standard Deviation|2252.9|2252.9|||
3998520|NCT01227629|3818351|B1|||Thromboxane B2 (TXB2) measured at baseline N=(53;20;23;93;30;30;90;31;30;67;467)||pg/mg Creatinine|Mean|3968.5|3968.5|Standard Deviation|2530.4|2530.4|||
3998521|NCT01227629|3818341|B11|||Soluble fibrin at baseline N=(53;16;23;88;27;29;92;30;25;65;448)||µg/ml|Mean|6.8|6.8|Standard Deviation|11.9|11.9|||
3998522|NCT01227629|3818342|B10|||Soluble fibrin at baseline N=(53;16;23;88;27;29;92;30;25;65;448)||µg/ml|Mean|7.2|7.2|Standard Deviation|10.4|10.4|||
3998523|NCT01227629|3818343|B9|||Soluble fibrin at baseline N=(53;16;23;88;27;29;92;30;25;65;448)||µg/ml|Mean|6.5|6.5|Standard Deviation|9.2|9.2|||
3998524|NCT01227629|3818344|B8|||Soluble fibrin at baseline N=(53;16;23;88;27;29;92;30;25;65;448)||µg/ml|Mean|9.2|9.2|Standard Deviation|26.0|26.0|||
3998525|NCT01227629|3818345|B7|||Soluble fibrin at baseline N=(53;16;23;88;27;29;92;30;25;65;448)||µg/ml|Mean|7.4|7.4|Standard Deviation|11.5|11.5|||
3998526|NCT01227629|3818346|B6|||Soluble fibrin at baseline N=(53;16;23;88;27;29;92;30;25;65;448)||µg/ml|Mean|7.6|7.6|Standard Deviation|14.8|14.8|||
3998527|NCT01227629|3818347|B5|||Soluble fibrin at baseline N=(53;16;23;88;27;29;92;30;25;65;448)||µg/ml|Mean|9.1|9.1|Standard Deviation|15.5|15.5|||
3998528|NCT01227629|3818348|B4|||Soluble fibrin at baseline N=(53;16;23;88;27;29;92;30;25;65;448)||µg/ml|Mean|5.8|5.8|Standard Deviation|8.8|8.8|||
3998529|NCT01227629|3818349|B3|||Soluble fibrin at baseline N=(53;16;23;88;27;29;92;30;25;65;448)||µg/ml|Mean|5.4|5.4|Standard Deviation|5.9|5.9|||
3998530|NCT01227629|3818350|B2|||Soluble fibrin at baseline N=(53;16;23;88;27;29;92;30;25;65;448)||µg/ml|Mean|5.3|5.3|Standard Deviation|7.9|7.9|||
3998531|NCT01227629|3818351|B1|||Soluble fibrin at baseline N=(53;16;23;88;27;29;92;30;25;65;448)||µg/ml|Mean|4.9|4.9|Standard Deviation|4.4|4.4|||
3998532|NCT01227629|3818341|B11|||D-dimer at baseline N=(56;19;25;88;29;32;85;31;29;63;457)||ng/ml|Mean|120.9|120.9|Standard Deviation|173.7|173.7|||
3998533|NCT01227629|3818342|B10|||D-dimer at baseline N=(56;19;25;88;29;32;85;31;29;63;457)||ng/ml|Mean|139.9|139.9|Standard Deviation|251.9|251.9|||
3998534|NCT01227629|3818343|B9|||D-dimer at baseline N=(56;19;25;88;29;32;85;31;29;63;457)||ng/ml|Mean|83.8|83.8|Standard Deviation|48.8|48.8|||
3998535|NCT01227629|3818344|B8|||D-dimer at baseline N=(56;19;25;88;29;32;85;31;29;63;457)||ng/ml|Mean|119.4|119.4|Standard Deviation|95.5|95.5|||
3998536|NCT01227629|3818345|B7|||D-dimer at baseline N=(56;19;25;88;29;32;85;31;29;63;457)||ng/ml|Mean|146.8|146.8|Standard Deviation|210.9|210.9|||
3998537|NCT01227629|3818346|B6|||D-dimer at baseline N=(56;19;25;88;29;32;85;31;29;63;457)||ng/ml|Mean|96.3|96.3|Standard Deviation|64.3|64.3|||
3998538|NCT01227629|3818347|B5|||D-dimer at baseline N=(56;19;25;88;29;32;85;31;29;63;457)||ng/ml|Mean|120.3|120.3|Standard Deviation|95.4|95.4|||
3998539|NCT01227629|3818348|B4|||D-dimer at baseline N=(56;19;25;88;29;32;85;31;29;63;457)||ng/ml|Mean|100.8|100.8|Standard Deviation|94.5|94.5|||
3998540|NCT01227629|3818349|B3|||D-dimer at baseline N=(56;19;25;88;29;32;85;31;29;63;457)||ng/ml|Mean|176.9|176.9|Standard Deviation|389.9|389.9|||
3998541|NCT01227629|3818350|B2|||D-dimer at baseline N=(56;19;25;88;29;32;85;31;29;63;457)||ng/ml|Mean|104.5|104.5|Standard Deviation|62.9|62.9|||
3998542|NCT01227629|3818351|B1|||D-dimer at baseline N=(56;19;25;88;29;32;85;31;29;63;457)||ng/ml|Mean|106.8|106.8|Standard Deviation|104.1|104.1|||
3998543|NCT01227629|3818341|B11|yes||Coronary Artery Disease|Documentation of Coronary Artery Disease as inclusion criterion or specific risk factor|participants|Number|306|306.0||||||
3998544|NCT01227629|3818342|B10|yes||Coronary Artery Disease|Documentation of Coronary Artery Disease as inclusion criterion or specific risk factor|participants|Number|42|42.0||||||
3998545|NCT01227629|3818343|B9|yes||Coronary Artery Disease|Documentation of Coronary Artery Disease as inclusion criterion or specific risk factor|participants|Number|29|29.0||||||
3998546|NCT01227629|3818344|B8|yes||Coronary Artery Disease|Documentation of Coronary Artery Disease as inclusion criterion or specific risk factor|participants|Number|31|31.0||||||
3998547|NCT01227629|3818345|B7|yes||Coronary Artery Disease|Documentation of Coronary Artery Disease as inclusion criterion or specific risk factor|participants|Number|36|36.0||||||
3998548|NCT01227629|3818346|B6|yes||Coronary Artery Disease|Documentation of Coronary Artery Disease as inclusion criterion or specific risk factor|participants|Number|29|29.0||||||
3998549|NCT01227629|3818347|B5|yes||Coronary Artery Disease|Documentation of Coronary Artery Disease as inclusion criterion or specific risk factor|participants|Number|31|31.0||||||
3998550|NCT01227629|3818348|B4|yes||Coronary Artery Disease|Documentation of Coronary Artery Disease as inclusion criterion or specific risk factor|participants|Number|44|44.0||||||
3998551|NCT01227629|3818349|B3|yes||Coronary Artery Disease|Documentation of Coronary Artery Disease as inclusion criterion or specific risk factor|participants|Number|26|26.0||||||
3998552|NCT01227629|3818350|B2|yes||Coronary Artery Disease|Documentation of Coronary Artery Disease as inclusion criterion or specific risk factor|participants|Number|19|19.0||||||
3998553|NCT01227629|3818351|B1|yes||Coronary Artery Disease|Documentation of Coronary Artery Disease as inclusion criterion or specific risk factor|participants|Number|19|19.0||||||
3998554|NCT01227629|3818341|B11|no||Coronary Artery Disease|Documentation of Coronary Artery Disease as inclusion criterion or specific risk factor|participants|Number|196|196.0||||||
3998555|NCT01227629|3818342|B10|no||Coronary Artery Disease|Documentation of Coronary Artery Disease as inclusion criterion or specific risk factor|participants|Number|28|28.0||||||
3998556|NCT01227629|3818343|B9|no||Coronary Artery Disease|Documentation of Coronary Artery Disease as inclusion criterion or specific risk factor|participants|Number|1|1.0||||||
3998557|NCT01227629|3818344|B8|no||Coronary Artery Disease|Documentation of Coronary Artery Disease as inclusion criterion or specific risk factor|participants|Number|2|2.0||||||
3998558|NCT01227629|3818345|B7|no||Coronary Artery Disease|Documentation of Coronary Artery Disease as inclusion criterion or specific risk factor|participants|Number|62|62.0||||||
3998559|NCT01227629|3818346|B6|no||Coronary Artery Disease|Documentation of Coronary Artery Disease as inclusion criterion or specific risk factor|participants|Number|4|4.0||||||
3998560|NCT01227629|3818347|B5|no||Coronary Artery Disease|Documentation of Coronary Artery Disease as inclusion criterion or specific risk factor|participants|Number|3|3.0||||||
3998561|NCT01227629|3818348|B4|no||Coronary Artery Disease|Documentation of Coronary Artery Disease as inclusion criterion or specific risk factor|participants|Number|55|55.0||||||
3998562|NCT01227629|3818349|B3|no||Coronary Artery Disease|Documentation of Coronary Artery Disease as inclusion criterion or specific risk factor|participants|Number|1|1.0||||||
3998563|NCT01227629|3818350|B2|no||Coronary Artery Disease|Documentation of Coronary Artery Disease as inclusion criterion or specific risk factor|participants|Number|1|1.0||||||
3998564|NCT01227629|3818351|B1|no||Coronary Artery Disease|Documentation of Coronary Artery Disease as inclusion criterion or specific risk factor|participants|Number|39|39.0||||||
3998565|NCT01227629|3818341|B11|Yes||Baseline documentation regarding symptomatic heart failure or left ventricular dysfunction|Documentation of symptomatic heart failure or left ventricular dysfunction as specific risk factor|Participants|Number|225|225.0||||||
3998566|NCT01227629|3818342|B10|Yes||Baseline documentation regarding symptomatic heart failure or left ventricular dysfunction|Documentation of symptomatic heart failure or left ventricular dysfunction as specific risk factor|Participants|Number|36|36.0||||||
3998567|NCT01227629|3818343|B9|Yes||Baseline documentation regarding symptomatic heart failure or left ventricular dysfunction|Documentation of symptomatic heart failure or left ventricular dysfunction as specific risk factor|Participants|Number|18|18.0||||||
3998568|NCT01227629|3818344|B8|Yes||Baseline documentation regarding symptomatic heart failure or left ventricular dysfunction|Documentation of symptomatic heart failure or left ventricular dysfunction as specific risk factor|Participants|Number|19|19.0||||||
3998569|NCT01227629|3818345|B7|Yes||Baseline documentation regarding symptomatic heart failure or left ventricular dysfunction|Documentation of symptomatic heart failure or left ventricular dysfunction as specific risk factor|Participants|Number|27|27.0||||||
3998570|NCT01227629|3818346|B6|Yes||Baseline documentation regarding symptomatic heart failure or left ventricular dysfunction|Documentation of symptomatic heart failure or left ventricular dysfunction as specific risk factor|Participants|Number|16|16.0||||||
3998571|NCT01227629|3818347|B5|Yes||Baseline documentation regarding symptomatic heart failure or left ventricular dysfunction|Documentation of symptomatic heart failure or left ventricular dysfunction as specific risk factor|Participants|Number|19|19.0||||||
3998572|NCT01227629|3818348|B4|Yes||Baseline documentation regarding symptomatic heart failure or left ventricular dysfunction|Documentation of symptomatic heart failure or left ventricular dysfunction as specific risk factor|Participants|Number|44|44.0||||||
3998573|NCT01227629|3818349|B3|Yes||Baseline documentation regarding symptomatic heart failure or left ventricular dysfunction|Documentation of symptomatic heart failure or left ventricular dysfunction as specific risk factor|Participants|Number|13|13.0||||||
3998574|NCT01227629|3818350|B2|Yes||Baseline documentation regarding symptomatic heart failure or left ventricular dysfunction|Documentation of symptomatic heart failure or left ventricular dysfunction as specific risk factor|Participants|Number|10|10.0||||||
3998575|NCT01227629|3818351|B1|Yes||Baseline documentation regarding symptomatic heart failure or left ventricular dysfunction|Documentation of symptomatic heart failure or left ventricular dysfunction as specific risk factor|Participants|Number|23|23.0||||||
3998576|NCT01227629|3818341|B11|No||Baseline documentation regarding symptomatic heart failure or left ventricular dysfunction|Documentation of symptomatic heart failure or left ventricular dysfunction as specific risk factor|Participants|Number|277|277.0||||||
3998577|NCT01227629|3818342|B10|No||Baseline documentation regarding symptomatic heart failure or left ventricular dysfunction|Documentation of symptomatic heart failure or left ventricular dysfunction as specific risk factor|Participants|Number|34|34.0||||||
3998578|NCT01227629|3818343|B9|No||Baseline documentation regarding symptomatic heart failure or left ventricular dysfunction|Documentation of symptomatic heart failure or left ventricular dysfunction as specific risk factor|Participants|Number|12|12.0||||||
3998579|NCT01227629|3818344|B8|No||Baseline documentation regarding symptomatic heart failure or left ventricular dysfunction|Documentation of symptomatic heart failure or left ventricular dysfunction as specific risk factor|Participants|Number|14|14.0||||||
3998580|NCT01227629|3818345|B7|No||Baseline documentation regarding symptomatic heart failure or left ventricular dysfunction|Documentation of symptomatic heart failure or left ventricular dysfunction as specific risk factor|Participants|Number|71|71.0||||||
3998581|NCT01227629|3818346|B6|No||Baseline documentation regarding symptomatic heart failure or left ventricular dysfunction|Documentation of symptomatic heart failure or left ventricular dysfunction as specific risk factor|Participants|Number|17|17.0||||||
3998582|NCT01227629|3818347|B5|No||Baseline documentation regarding symptomatic heart failure or left ventricular dysfunction|Documentation of symptomatic heart failure or left ventricular dysfunction as specific risk factor|Participants|Number|15|15.0||||||
3998583|NCT01227629|3818348|B4|No||Baseline documentation regarding symptomatic heart failure or left ventricular dysfunction|Documentation of symptomatic heart failure or left ventricular dysfunction as specific risk factor|Participants|Number|55|55.0||||||
3998584|NCT01227629|3818349|B3|No||Baseline documentation regarding symptomatic heart failure or left ventricular dysfunction|Documentation of symptomatic heart failure or left ventricular dysfunction as specific risk factor|Participants|Number|14|14.0||||||
3998585|NCT01227629|3818350|B2|No||Baseline documentation regarding symptomatic heart failure or left ventricular dysfunction|Documentation of symptomatic heart failure or left ventricular dysfunction as specific risk factor|Participants|Number|10|10.0||||||
3998586|NCT01227629|3818351|B1|No||Baseline documentation regarding symptomatic heart failure or left ventricular dysfunction|Documentation of symptomatic heart failure or left ventricular dysfunction as specific risk factor|Participants|Number|35|35.0||||||
3998587|NCT01227629|3818341|B11|Yes||Baseline documentation regarding left ventricular dysfunction|Documentation of left ventricular dysfunction as specific risk factor|Participants|Number|165|165.0||||||
3998588|NCT01227629|3818342|B10|Yes||Baseline documentation regarding left ventricular dysfunction|Documentation of left ventricular dysfunction as specific risk factor|Participants|Number|26|26.0||||||
3998589|NCT01227629|3818343|B9|Yes||Baseline documentation regarding left ventricular dysfunction|Documentation of left ventricular dysfunction as specific risk factor|Participants|Number|16|16.0||||||
3998590|NCT01227629|3818344|B8|Yes||Baseline documentation regarding left ventricular dysfunction|Documentation of left ventricular dysfunction as specific risk factor|Participants|Number|13|13.0||||||
3998591|NCT01227629|3818345|B7|Yes||Baseline documentation regarding left ventricular dysfunction|Documentation of left ventricular dysfunction as specific risk factor|Participants|Number|20|20.0||||||
3998592|NCT01227629|3818346|B6|Yes||Baseline documentation regarding left ventricular dysfunction|Documentation of left ventricular dysfunction as specific risk factor|Participants|Number|14|14.0||||||
3998593|NCT01227629|3818347|B5|Yes||Baseline documentation regarding left ventricular dysfunction|Documentation of left ventricular dysfunction as specific risk factor|Participants|Number|12|12.0||||||
3998594|NCT01227629|3818348|B4|Yes||Baseline documentation regarding left ventricular dysfunction|Documentation of left ventricular dysfunction as specific risk factor|Participants|Number|31|31.0||||||
3998595|NCT01227629|3818349|B3|Yes||Baseline documentation regarding left ventricular dysfunction|Documentation of left ventricular dysfunction as specific risk factor|Participants|Number|10|10.0||||||
3998596|NCT01227629|3818350|B2|Yes||Baseline documentation regarding left ventricular dysfunction|Documentation of left ventricular dysfunction as specific risk factor|Participants|Number|6|6.0||||||
3998597|NCT01227629|3818351|B1|Yes||Baseline documentation regarding left ventricular dysfunction|Documentation of left ventricular dysfunction as specific risk factor|Participants|Number|17|17.0||||||
3998598|NCT01227629|3818341|B11|No||Baseline documentation regarding left ventricular dysfunction|Documentation of left ventricular dysfunction as specific risk factor|Participants|Number|337|337.0||||||
3998599|NCT01227629|3818342|B10|No||Baseline documentation regarding left ventricular dysfunction|Documentation of left ventricular dysfunction as specific risk factor|Participants|Number|44|44.0||||||
3998600|NCT01227629|3818343|B9|No||Baseline documentation regarding left ventricular dysfunction|Documentation of left ventricular dysfunction as specific risk factor|Participants|Number|14|14.0||||||
3998601|NCT01227629|3818344|B8|No||Baseline documentation regarding left ventricular dysfunction|Documentation of left ventricular dysfunction as specific risk factor|Participants|Number|20|20.0||||||
3998602|NCT01227629|3818345|B7|No||Baseline documentation regarding left ventricular dysfunction|Documentation of left ventricular dysfunction as specific risk factor|Participants|Number|78|78.0||||||
3998603|NCT01227629|3818346|B6|No||Baseline documentation regarding left ventricular dysfunction|Documentation of left ventricular dysfunction as specific risk factor|Participants|Number|19|19.0||||||
3998604|NCT01227629|3818347|B5|No||Baseline documentation regarding left ventricular dysfunction|Documentation of left ventricular dysfunction as specific risk factor|Participants|Number|22|22.0||||||
3998605|NCT01227629|3818348|B4|No||Baseline documentation regarding left ventricular dysfunction|Documentation of left ventricular dysfunction as specific risk factor|Participants|Number|68|68.0||||||
3998606|NCT01227629|3818349|B3|No||Baseline documentation regarding left ventricular dysfunction|Documentation of left ventricular dysfunction as specific risk factor|Participants|Number|17|17.0||||||
3998607|NCT01227629|3818350|B2|No||Baseline documentation regarding left ventricular dysfunction|Documentation of left ventricular dysfunction as specific risk factor|Participants|Number|14|14.0||||||
3998608|NCT01227629|3818351|B1|No||Baseline documentation regarding left ventricular dysfunction|Documentation of left ventricular dysfunction as specific risk factor|Participants|Number|41|41.0||||||
3998609|NCT01227629|3818341|B11|Yes||Baseline documentation regarding symptomatic heart failure|Documentation of symptomatic heart failure as specific risk factor|Participants|Number|147|147.0||||||
3998610|NCT01227629|3818342|B10|Yes||Baseline documentation regarding symptomatic heart failure|Documentation of symptomatic heart failure as specific risk factor|Participants|Number|24|24.0||||||
3998611|NCT01227629|3818343|B9|Yes||Baseline documentation regarding symptomatic heart failure|Documentation of symptomatic heart failure as specific risk factor|Participants|Number|10|10.0||||||
3998612|NCT01227629|3818344|B8|Yes||Baseline documentation regarding symptomatic heart failure|Documentation of symptomatic heart failure as specific risk factor|Participants|Number|13|13.0||||||
3998613|NCT01227629|3818345|B7|Yes||Baseline documentation regarding symptomatic heart failure|Documentation of symptomatic heart failure as specific risk factor|Participants|Number|13|13.0||||||
3998614|NCT01227629|3818346|B6|Yes||Baseline documentation regarding symptomatic heart failure|Documentation of symptomatic heart failure as specific risk factor|Participants|Number|12|12.0||||||
3998615|NCT01227629|3818347|B5|Yes||Baseline documentation regarding symptomatic heart failure|Documentation of symptomatic heart failure as specific risk factor|Participants|Number|14|14.0||||||
3998616|NCT01227629|3818348|B4|Yes||Baseline documentation regarding symptomatic heart failure|Documentation of symptomatic heart failure as specific risk factor|Participants|Number|26|26.0||||||
3998617|NCT01227629|3818349|B3|Yes||Baseline documentation regarding symptomatic heart failure|Documentation of symptomatic heart failure as specific risk factor|Participants|Number|10|10.0||||||
3998618|NCT01227629|3818350|B2|Yes||Baseline documentation regarding symptomatic heart failure|Documentation of symptomatic heart failure as specific risk factor|Participants|Number|8|8.0||||||
3998619|NCT01227629|3818351|B1|Yes||Baseline documentation regarding symptomatic heart failure|Documentation of symptomatic heart failure as specific risk factor|Participants|Number|17|17.0||||||
3998620|NCT01227629|3818341|B11|No||Baseline documentation regarding symptomatic heart failure|Documentation of symptomatic heart failure as specific risk factor|Participants|Number|355|355.0||||||
3998621|NCT01227629|3818342|B10|No||Baseline documentation regarding symptomatic heart failure|Documentation of symptomatic heart failure as specific risk factor|Participants|Number|46|46.0||||||
3998622|NCT01227629|3818343|B9|No||Baseline documentation regarding symptomatic heart failure|Documentation of symptomatic heart failure as specific risk factor|Participants|Number|20|20.0||||||
3998623|NCT01227629|3818344|B8|No||Baseline documentation regarding symptomatic heart failure|Documentation of symptomatic heart failure as specific risk factor|Participants|Number|20|20.0||||||
3998624|NCT01227629|3818345|B7|No||Baseline documentation regarding symptomatic heart failure|Documentation of symptomatic heart failure as specific risk factor|Participants|Number|85|85.0||||||
3998625|NCT01227629|3818346|B6|No||Baseline documentation regarding symptomatic heart failure|Documentation of symptomatic heart failure as specific risk factor|Participants|Number|21|21.0||||||
3998626|NCT01227629|3818347|B5|No||Baseline documentation regarding symptomatic heart failure|Documentation of symptomatic heart failure as specific risk factor|Participants|Number|20|20.0||||||
3998627|NCT01227629|3818348|B4|No||Baseline documentation regarding symptomatic heart failure|Documentation of symptomatic heart failure as specific risk factor|Participants|Number|73|73.0||||||
3998628|NCT01227629|3818349|B3|No||Baseline documentation regarding symptomatic heart failure|Documentation of symptomatic heart failure as specific risk factor|Participants|Number|17|17.0||||||
3998629|NCT01227629|3818350|B2|No||Baseline documentation regarding symptomatic heart failure|Documentation of symptomatic heart failure as specific risk factor|Participants|Number|12|12.0||||||
3998630|NCT01227629|3818351|B1|No||Baseline documentation regarding symptomatic heart failure|Documentation of symptomatic heart failure as specific risk factor|Participants|Number|41|41.0||||||
3998631|NCT01227629|3818341|B11|Yes||Baseline documentation regarding hypertension|Documentation of hypertension as specific risk factor|Participants|Number|356|356.0||||||
3998632|NCT01227629|3818342|B10|Yes||Baseline documentation regarding hypertension|Documentation of hypertension as specific risk factor|Participants|Number|49|49.0||||||
3998633|NCT01227629|3818343|B9|Yes||Baseline documentation regarding hypertension|Documentation of hypertension as specific risk factor|Participants|Number|20|20.0||||||
3998634|NCT01227629|3818344|B8|Yes||Baseline documentation regarding hypertension|Documentation of hypertension as specific risk factor|Participants|Number|25|25.0||||||
3998635|NCT01227629|3818345|B7|Yes||Baseline documentation regarding hypertension|Documentation of hypertension as specific risk factor|Participants|Number|74|74.0||||||
3998636|NCT01227629|3818346|B6|Yes||Baseline documentation regarding hypertension|Documentation of hypertension as specific risk factor|Participants|Number|19|19.0||||||
3998637|NCT01227629|3818347|B5|Yes||Baseline documentation regarding hypertension|Documentation of hypertension as specific risk factor|Participants|Number|21|21.0||||||
3998638|NCT01227629|3818348|B4|Yes||Baseline documentation regarding hypertension|Documentation of hypertension as specific risk factor|Participants|Number|78|78.0||||||
3998639|NCT01227629|3818349|B3|Yes||Baseline documentation regarding hypertension|Documentation of hypertension as specific risk factor|Participants|Number|19|19.0||||||
3998640|NCT01227629|3818350|B2|Yes||Baseline documentation regarding hypertension|Documentation of hypertension as specific risk factor|Participants|Number|10|10.0||||||
3998641|NCT01227629|3818351|B1|Yes||Baseline documentation regarding hypertension|Documentation of hypertension as specific risk factor|Participants|Number|41|41.0||||||
3998642|NCT01227629|3818341|B11|No||Baseline documentation regarding hypertension|Documentation of hypertension as specific risk factor|Participants|Number|146|146.0||||||
3998643|NCT01227629|3818342|B10|No||Baseline documentation regarding hypertension|Documentation of hypertension as specific risk factor|Participants|Number|21|21.0||||||
3998644|NCT01227629|3818343|B9|No||Baseline documentation regarding hypertension|Documentation of hypertension as specific risk factor|Participants|Number|10|10.0||||||
3998645|NCT01227629|3818344|B8|No||Baseline documentation regarding hypertension|Documentation of hypertension as specific risk factor|Participants|Number|8|8.0||||||
3998646|NCT01227629|3818345|B7|No||Baseline documentation regarding hypertension|Documentation of hypertension as specific risk factor|Participants|Number|24|24.0||||||
3998647|NCT01227629|3818346|B6|No||Baseline documentation regarding hypertension|Documentation of hypertension as specific risk factor|Participants|Number|14|14.0||||||
3998648|NCT01227629|3818347|B5|No||Baseline documentation regarding hypertension|Documentation of hypertension as specific risk factor|Participants|Number|13|13.0||||||
3998649|NCT01227629|3818348|B4|No||Baseline documentation regarding hypertension|Documentation of hypertension as specific risk factor|Participants|Number|21|21.0||||||
3998650|NCT01227629|3818349|B3|No||Baseline documentation regarding hypertension|Documentation of hypertension as specific risk factor|Participants|Number|8|8.0||||||
3998651|NCT01227629|3818350|B2|No||Baseline documentation regarding hypertension|Documentation of hypertension as specific risk factor|Participants|Number|10|10.0||||||
3998652|NCT01227629|3818351|B1|No||Baseline documentation regarding hypertension|Documentation of hypertension as specific risk factor|Participants|Number|17|17.0||||||
3998653|NCT01227629|3818341|B11|Yes||Baseline documentation regarding transient ischemic attack or stroke|Documentation of transient ischemic attack or stroke as specific risk factor|Participants|Number|87|87.0||||||
3998654|NCT01227629|3818342|B10|Yes||Baseline documentation regarding transient ischemic attack or stroke|Documentation of transient ischemic attack or stroke as specific risk factor|Participants|Number|13|13.0||||||
3998655|NCT01227629|3818343|B9|Yes||Baseline documentation regarding transient ischemic attack or stroke|Documentation of transient ischemic attack or stroke as specific risk factor|Participants|Number|8|8.0||||||
3998656|NCT01227629|3818344|B8|Yes||Baseline documentation regarding transient ischemic attack or stroke|Documentation of transient ischemic attack or stroke as specific risk factor|Participants|Number|5|5.0||||||
3998657|NCT01227629|3818345|B7|Yes||Baseline documentation regarding transient ischemic attack or stroke|Documentation of transient ischemic attack or stroke as specific risk factor|Participants|Number|13|13.0||||||
3998658|NCT01227629|3818346|B6|Yes||Baseline documentation regarding transient ischemic attack or stroke|Documentation of transient ischemic attack or stroke as specific risk factor|Participants|Number|5|5.0||||||
3998659|NCT01227629|3818347|B5|Yes||Baseline documentation regarding transient ischemic attack or stroke|Documentation of transient ischemic attack or stroke as specific risk factor|Participants|Number|7|7.0||||||
3998660|NCT01227629|3818348|B4|Yes||Baseline documentation regarding transient ischemic attack or stroke|Documentation of transient ischemic attack or stroke as specific risk factor|Participants|Number|17|17.0||||||
3998661|NCT01227629|3818349|B3|Yes||Baseline documentation regarding transient ischemic attack or stroke|Documentation of transient ischemic attack or stroke as specific risk factor|Participants|Number|4|4.0||||||
3998662|NCT01227629|3818350|B2|Yes||Baseline documentation regarding transient ischemic attack or stroke|Documentation of transient ischemic attack or stroke as specific risk factor|Participants|Number|2|2.0||||||
3998663|NCT01227629|3818351|B1|Yes||Baseline documentation regarding transient ischemic attack or stroke|Documentation of transient ischemic attack or stroke as specific risk factor|Participants|Number|13|13.0||||||
3998664|NCT01227629|3818341|B11|No||Baseline documentation regarding transient ischemic attack or stroke|Documentation of transient ischemic attack or stroke as specific risk factor|Participants|Number|415|415.0||||||
3998665|NCT01227629|3818342|B10|No||Baseline documentation regarding transient ischemic attack or stroke|Documentation of transient ischemic attack or stroke as specific risk factor|Participants|Number|57|57.0||||||
3998666|NCT01227629|3818343|B9|No||Baseline documentation regarding transient ischemic attack or stroke|Documentation of transient ischemic attack or stroke as specific risk factor|Participants|Number|22|22.0||||||
3998667|NCT01227629|3818344|B8|No||Baseline documentation regarding transient ischemic attack or stroke|Documentation of transient ischemic attack or stroke as specific risk factor|Participants|Number|28|28.0||||||
3998705|NCT01227629|3818349|B3|Yes||Baseline documentation regarding stroke|Documentation of stroke as specific risk factor|Participants|Number|3|3.0||||||
3998668|NCT01227629|3818345|B7|No||Baseline documentation regarding transient ischemic attack or stroke|Documentation of transient ischemic attack or stroke as specific risk factor|Participants|Number|85|85.0||||||
3998669|NCT01227629|3818346|B6|No||Baseline documentation regarding transient ischemic attack or stroke|Documentation of transient ischemic attack or stroke as specific risk factor|Participants|Number|28|28.0||||||
3998670|NCT01227629|3818347|B5|No||Baseline documentation regarding transient ischemic attack or stroke|Documentation of transient ischemic attack or stroke as specific risk factor|Participants|Number|27|27.0||||||
3998671|NCT01227629|3818348|B4|No||Baseline documentation regarding transient ischemic attack or stroke|Documentation of transient ischemic attack or stroke as specific risk factor|Participants|Number|82|82.0||||||
3998672|NCT01227629|3818349|B3|No||Baseline documentation regarding transient ischemic attack or stroke|Documentation of transient ischemic attack or stroke as specific risk factor|Participants|Number|23|23.0||||||
3998673|NCT01227629|3818350|B2|No||Baseline documentation regarding transient ischemic attack or stroke|Documentation of transient ischemic attack or stroke as specific risk factor|Participants|Number|18|18.0||||||
3998674|NCT01227629|3818351|B1|No||Baseline documentation regarding transient ischemic attack or stroke|Documentation of transient ischemic attack or stroke as specific risk factor|Participants|Number|45|45.0||||||
3998675|NCT01227629|3818341|B11|Yes||Baseline documentation regarding transient ischemic attack|Documentation of transient ischemic attack as specific risk factor|Participants|Number|49|49.0||||||
3998676|NCT01227629|3818342|B10|Yes||Baseline documentation regarding transient ischemic attack|Documentation of transient ischemic attack as specific risk factor|Participants|Number|7|7.0||||||
3998677|NCT01227629|3818343|B9|Yes||Baseline documentation regarding transient ischemic attack|Documentation of transient ischemic attack as specific risk factor|Participants|Number|4|4.0||||||
3998678|NCT01227629|3818344|B8|Yes||Baseline documentation regarding transient ischemic attack|Documentation of transient ischemic attack as specific risk factor|Participants|Number|3|3.0||||||
3998679|NCT01227629|3818345|B7|Yes||Baseline documentation regarding transient ischemic attack|Documentation of transient ischemic attack as specific risk factor|Participants|Number|8|8.0||||||
3998680|NCT01227629|3818346|B6|Yes||Baseline documentation regarding transient ischemic attack|Documentation of transient ischemic attack as specific risk factor|Participants|Number|2|2.0||||||
3998681|NCT01227629|3818347|B5|Yes||Baseline documentation regarding transient ischemic attack|Documentation of transient ischemic attack as specific risk factor|Participants|Number|3|3.0||||||
3998682|NCT01227629|3818348|B4|Yes||Baseline documentation regarding transient ischemic attack|Documentation of transient ischemic attack as specific risk factor|Participants|Number|11|11.0||||||
3998683|NCT01227629|3818349|B3|Yes||Baseline documentation regarding transient ischemic attack|Documentation of transient ischemic attack as specific risk factor|Participants|Number|2|2.0||||||
3998684|NCT01227629|3818350|B2|Yes||Baseline documentation regarding transient ischemic attack|Documentation of transient ischemic attack as specific risk factor|Participants|Number|0|0.0||||||
3998685|NCT01227629|3818351|B1|Yes||Baseline documentation regarding transient ischemic attack|Documentation of transient ischemic attack as specific risk factor|Participants|Number|9|9.0||||||
3998686|NCT01227629|3818341|B11|No||Baseline documentation regarding transient ischemic attack|Documentation of transient ischemic attack as specific risk factor|Participants|Number|453|453.0||||||
3998687|NCT01227629|3818342|B10|No||Baseline documentation regarding transient ischemic attack|Documentation of transient ischemic attack as specific risk factor|Participants|Number|63|63.0||||||
3998688|NCT01227629|3818343|B9|No||Baseline documentation regarding transient ischemic attack|Documentation of transient ischemic attack as specific risk factor|Participants|Number|26|26.0||||||
3998689|NCT01227629|3818344|B8|No||Baseline documentation regarding transient ischemic attack|Documentation of transient ischemic attack as specific risk factor|Participants|Number|30|30.0||||||
3998690|NCT01227629|3818345|B7|No||Baseline documentation regarding transient ischemic attack|Documentation of transient ischemic attack as specific risk factor|Participants|Number|90|90.0||||||
3998691|NCT01227629|3818346|B6|No||Baseline documentation regarding transient ischemic attack|Documentation of transient ischemic attack as specific risk factor|Participants|Number|31|31.0||||||
3998692|NCT01227629|3818347|B5|No||Baseline documentation regarding transient ischemic attack|Documentation of transient ischemic attack as specific risk factor|Participants|Number|31|31.0||||||
3998693|NCT01227629|3818348|B4|No||Baseline documentation regarding transient ischemic attack|Documentation of transient ischemic attack as specific risk factor|Participants|Number|88|88.0||||||
3998694|NCT01227629|3818349|B3|No||Baseline documentation regarding transient ischemic attack|Documentation of transient ischemic attack as specific risk factor|Participants|Number|25|25.0||||||
3998695|NCT01227629|3818350|B2|No||Baseline documentation regarding transient ischemic attack|Documentation of transient ischemic attack as specific risk factor|Participants|Number|20|20.0||||||
3998696|NCT01227629|3818351|B1|No||Baseline documentation regarding transient ischemic attack|Documentation of transient ischemic attack as specific risk factor|Participants|Number|49|49.0||||||
3998697|NCT01227629|3818341|B11|Yes||Baseline documentation regarding stroke|Documentation of stroke as specific risk factor|Participants|Number|43|43.0||||||
3998698|NCT01227629|3818342|B10|Yes||Baseline documentation regarding stroke|Documentation of stroke as specific risk factor|Participants|Number|8|8.0||||||
3998699|NCT01227629|3818343|B9|Yes||Baseline documentation regarding stroke|Documentation of stroke as specific risk factor|Participants|Number|4|4.0||||||
3998700|NCT01227629|3818344|B8|Yes||Baseline documentation regarding stroke|Documentation of stroke as specific risk factor|Participants|Number|2|2.0||||||
3998701|NCT01227629|3818345|B7|Yes||Baseline documentation regarding stroke|Documentation of stroke as specific risk factor|Participants|Number|7|7.0||||||
3998702|NCT01227629|3818346|B6|Yes||Baseline documentation regarding stroke|Documentation of stroke as specific risk factor|Participants|Number|3|3.0||||||
3998703|NCT01227629|3818347|B5|Yes||Baseline documentation regarding stroke|Documentation of stroke as specific risk factor|Participants|Number|4|4.0||||||
3998704|NCT01227629|3818348|B4|Yes||Baseline documentation regarding stroke|Documentation of stroke as specific risk factor|Participants|Number|6|6.0||||||
3998706|NCT01227629|3818350|B2|Yes||Baseline documentation regarding stroke|Documentation of stroke as specific risk factor|Participants|Number|2|2.0||||||
3998707|NCT01227629|3818351|B1|Yes||Baseline documentation regarding stroke|Documentation of stroke as specific risk factor|Participants|Number|4|4.0||||||
3998708|NCT01227629|3818341|B11|No||Baseline documentation regarding stroke|Documentation of stroke as specific risk factor|Participants|Number|459|459.0||||||
3998709|NCT01227629|3818342|B10|No||Baseline documentation regarding stroke|Documentation of stroke as specific risk factor|Participants|Number|62|62.0||||||
3998710|NCT01227629|3818343|B9|No||Baseline documentation regarding stroke|Documentation of stroke as specific risk factor|Participants|Number|26|26.0||||||
3998711|NCT01227629|3818344|B8|No||Baseline documentation regarding stroke|Documentation of stroke as specific risk factor|Participants|Number|31|31.0||||||
3998712|NCT01227629|3818345|B7|No||Baseline documentation regarding stroke|Documentation of stroke as specific risk factor|Participants|Number|91|91.0||||||
3998713|NCT01227629|3818346|B6|No||Baseline documentation regarding stroke|Documentation of stroke as specific risk factor|Participants|Number|30|30.0||||||
3998714|NCT01227629|3818347|B5|No||Baseline documentation regarding stroke|Documentation of stroke as specific risk factor|Participants|Number|30|30.0||||||
3998715|NCT01227629|3818348|B4|No||Baseline documentation regarding stroke|Documentation of stroke as specific risk factor|Participants|Number|93|93.0||||||
3998716|NCT01227629|3818349|B3|No||Baseline documentation regarding stroke|Documentation of stroke as specific risk factor|Participants|Number|24|24.0||||||
3998717|NCT01227629|3818350|B2|No||Baseline documentation regarding stroke|Documentation of stroke as specific risk factor|Participants|Number|18|18.0||||||
3998718|NCT01227629|3818351|B1|No||Baseline documentation regarding stroke|Documentation of stroke as specific risk factor|Participants|Number|54|54.0||||||
3998719|NCT01227629|3818341|B11|Paroxysmal||Baseline documentation regarding the atrial fibrillation||Participants|Number|115|115.0||||||
3998720|NCT01227629|3818342|B10|Paroxysmal||Baseline documentation regarding the atrial fibrillation||Participants|Number|17|17.0||||||
3998721|NCT01227629|3818343|B9|Paroxysmal||Baseline documentation regarding the atrial fibrillation||Participants|Number|4|4.0||||||
3998722|NCT01227629|3818344|B8|Paroxysmal||Baseline documentation regarding the atrial fibrillation||Participants|Number|9|9.0||||||
3998723|NCT01227629|3818345|B7|Paroxysmal||Baseline documentation regarding the atrial fibrillation||Participants|Number|24|24.0||||||
3998724|NCT01227629|3818346|B6|Paroxysmal||Baseline documentation regarding the atrial fibrillation||Participants|Number|7|7.0||||||
3998725|NCT01227629|3818347|B5|Paroxysmal||Baseline documentation regarding the atrial fibrillation||Participants|Number|10|10.0||||||
3998726|NCT01227629|3818348|B4|Paroxysmal||Baseline documentation regarding the atrial fibrillation||Participants|Number|21|21.0||||||
3998727|NCT01227629|3818349|B3|Paroxysmal||Baseline documentation regarding the atrial fibrillation||Participants|Number|6|6.0||||||
3998728|NCT01227629|3818350|B2|Paroxysmal||Baseline documentation regarding the atrial fibrillation||Participants|Number|2|2.0||||||
3998729|NCT01227629|3818351|B1|Paroxysmal||Baseline documentation regarding the atrial fibrillation||Participants|Number|15|15.0||||||
3998730|NCT01227629|3818341|B11|Permanent||Baseline documentation regarding the atrial fibrillation||Participants|Number|192|192.0||||||
3998731|NCT01227629|3818342|B10|Permanent||Baseline documentation regarding the atrial fibrillation||Participants|Number|26|26.0||||||
3998732|NCT01227629|3818343|B9|Permanent||Baseline documentation regarding the atrial fibrillation||Participants|Number|14|14.0||||||
3998733|NCT01227629|3818344|B8|Permanent||Baseline documentation regarding the atrial fibrillation||Participants|Number|10|10.0||||||
3998734|NCT01227629|3818345|B7|Permanent||Baseline documentation regarding the atrial fibrillation||Participants|Number|37|37.0||||||
3998735|NCT01227629|3818346|B6|Permanent||Baseline documentation regarding the atrial fibrillation||Participants|Number|16|16.0||||||
3998736|NCT01227629|3818347|B5|Permanent||Baseline documentation regarding the atrial fibrillation||Participants|Number|11|11.0||||||
3998737|NCT01227629|3818348|B4|Permanent||Baseline documentation regarding the atrial fibrillation||Participants|Number|35|35.0||||||
3998738|NCT01227629|3818349|B3|Permanent||Baseline documentation regarding the atrial fibrillation||Participants|Number|11|11.0||||||
3998739|NCT01227629|3818350|B2|Permanent||Baseline documentation regarding the atrial fibrillation||Participants|Number|9|9.0||||||
3998740|NCT01227629|3818351|B1|Permanent||Baseline documentation regarding the atrial fibrillation||Participants|Number|23|23.0||||||
3998741|NCT01227629|3818341|B11|Persistent||Baseline documentation regarding the atrial fibrillation||Participants|Number|195|195.0||||||
3998742|NCT01227629|3818342|B10|Persistent||Baseline documentation regarding the atrial fibrillation||Participants|Number|27|27.0||||||
3998743|NCT01227629|3818343|B9|Persistent||Baseline documentation regarding the atrial fibrillation||Participants|Number|12|12.0||||||
3998744|NCT01227629|3818344|B8|Persistent||Baseline documentation regarding the atrial fibrillation||Participants|Number|14|14.0||||||
3998745|NCT01227629|3818345|B7|Persistent||Baseline documentation regarding the atrial fibrillation||Participants|Number|37|37.0||||||
3998746|NCT01227629|3818346|B6|Persistent||Baseline documentation regarding the atrial fibrillation||Participants|Number|10|10.0||||||
3998747|NCT01227629|3818347|B5|Persistent||Baseline documentation regarding the atrial fibrillation||Participants|Number|13|13.0||||||
3998748|NCT01227629|3818348|B4|Persistent||Baseline documentation regarding the atrial fibrillation||Participants|Number|43|43.0||||||
3998749|NCT01227629|3818349|B3|Persistent||Baseline documentation regarding the atrial fibrillation||Participants|Number|10|10.0||||||
3998750|NCT01227629|3818350|B2|Persistent||Baseline documentation regarding the atrial fibrillation||Participants|Number|9|9.0||||||
3998751|NCT01227629|3818351|B1|Persistent||Baseline documentation regarding the atrial fibrillation||Participants|Number|20|20.0||||||
3998752|NCT01227629|3818341|B11||Male|Sex: Female, Male||Participants|Count of Participants|411|411.0||||||
3998753|NCT01227629|3818342|B10||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
3998754|NCT01227629|3818343|B9||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
3998755|NCT01227629|3818344|B8||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3998756|NCT01227629|3818345|B7||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
3998757|NCT01227629|3818346|B6||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3998758|NCT01227629|3818347|B5||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3998759|NCT01227629|3818348|B4||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
3998760|NCT01227629|3818349|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3998761|NCT01227629|3818350|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3998762|NCT01227629|3818351|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
3998763|NCT01227629|3818341|B11||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
3998764|NCT01227629|3818342|B10||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3998765|NCT01227629|3818343|B9||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3998766|NCT01227629|3818344|B8||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3998767|NCT01227629|3818345|B7||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3998768|NCT01227629|3818346|B6||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3998769|NCT01227629|3818347|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3998770|NCT01227629|3818348|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3998771|NCT01227629|3818349|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3998772|NCT01227629|3818350|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3998773|NCT01227629|3818351|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3998774|NCT01227629|3818341|B11|||Age||Years|Mean|69.7|69.7|Standard Deviation|8.3|8.3|||
3998775|NCT01227629|3818342|B10|||Age||Years|Mean|69.0|69.0|Standard Deviation|8.3|8.3|||
3998776|NCT01227629|3818343|B9|||Age||Years|Mean|68.6|68.6|Standard Deviation|7.1|7.1|||
3998777|NCT01227629|3818344|B8|||Age||Years|Mean|71.8|71.8|Standard Deviation|7.2|7.2|||
3998778|NCT01227629|3818345|B7|||Age||Years|Mean|69.0|69.0|Standard Deviation|9.1|9.1|||
3998779|NCT01227629|3818346|B6|||Age||Years|Mean|69.7|69.7|Standard Deviation|8.0|8.0|||
3998780|NCT01227629|3818347|B5|||Age||Years|Mean|72.1|72.1|Standard Deviation|9.0|9.0|||
3998781|NCT01227629|3818348|B4|||Age||Years|Mean|69.7|69.7|Standard Deviation|7.7|7.7|||
3998782|NCT01227629|3818349|B3|||Age||Years|Mean|71.6|71.6|Standard Deviation|8.1|8.1|||
3998783|NCT01227629|3818350|B2|||Age||Years|Mean|70.1|70.1|Standard Deviation|9.4|9.4|||
3998784|NCT01227629|3818351|B1|||Age||Years|Mean|69.0|69.0|Standard Deviation|8.8|8.8|||
3998785|NCT01227577|3818596|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3998786|NCT01227577|3818596|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3998787|NCT01227577|3818596|B1|||Age||Years|Mean|55.6|55.6|Standard Deviation|14.99|14.99|||
3998788|NCT01227564|3818608|B4|||MMSE Score|The MMSE is a brief, structured examination of cognitive function consisting of the 11 item: Orientation-What, Orientation-Where, Registration-Objects, Attention and Calculation, Recall, Language-Naming, Language-Repetition, Language-Comprehension, Language-Reading, Language-Writing, and Language- Drawing. MMSE total score was the sum of the 11 item scores and it ranges from 0 to 30 with higher score indicating greater cognitive functioning. If any individual item is missing, then the MMSE total score is set to missing.|score|Mean|27.6|27.6|Standard Deviation|1.58|1.58|||
3998789|NCT01227564|3818609|B3|||MMSE Score|The MMSE is a brief, structured examination of cognitive function consisting of the 11 item: Orientation-What, Orientation-Where, Registration-Objects, Attention and Calculation, Recall, Language-Naming, Language-Repetition, Language-Comprehension, Language-Reading, Language-Writing, and Language- Drawing. MMSE total score was the sum of the 11 item scores and it ranges from 0 to 30 with higher score indicating greater cognitive functioning. If any individual item is missing, then the MMSE total score is set to missing.|score|Mean|28.0|28.0|Standard Deviation|1.47|1.47|||
3998790|NCT01227564|3818610|B2|||MMSE Score|The MMSE is a brief, structured examination of cognitive function consisting of the 11 item: Orientation-What, Orientation-Where, Registration-Objects, Attention and Calculation, Recall, Language-Naming, Language-Repetition, Language-Comprehension, Language-Reading, Language-Writing, and Language- Drawing. MMSE total score was the sum of the 11 item scores and it ranges from 0 to 30 with higher score indicating greater cognitive functioning. If any individual item is missing, then the MMSE total score is set to missing.|score|Mean|27.7|27.7|Standard Deviation|1.63|1.63|||
3998791|NCT01227564|3818611|B1|||MMSE Score|The MMSE is a brief, structured examination of cognitive function consisting of the 11 item: Orientation-What, Orientation-Where, Registration-Objects, Attention and Calculation, Recall, Language-Naming, Language-Repetition, Language-Comprehension, Language-Reading, Language-Writing, and Language- Drawing. MMSE total score was the sum of the 11 item scores and it ranges from 0 to 30 with higher score indicating greater cognitive functioning. If any individual item is missing, then the MMSE total score is set to missing.|score|Mean|27.3|27.3|Standard Deviation|1.64|1.64|||
3998792|NCT01227564|3818608|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
3998793|NCT01227564|3818609|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3998794|NCT01227564|3818610|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3998795|NCT01227564|3818611|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3998796|NCT01227564|3818608|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3998797|NCT01227564|3818609|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3998798|NCT01227564|3818610|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3998799|NCT01227564|3818611|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3998800|NCT01227564|3818608|B4|||Age||years|Mean|68.3|68.3|Standard Deviation|7.04|7.04|||
3998801|NCT01227564|3818609|B3|||Age||years|Mean|69.6|69.6|Standard Deviation|6.82|6.82|||
3998802|NCT01227564|3818610|B2|||Age||years|Mean|68.5|68.5|Standard Deviation|7.02|7.02|||
3998803|NCT01227564|3818611|B1|||Age||years|Mean|66.8|66.8|Standard Deviation|7.31|7.31|||
3998804|NCT01227551|3818744|B1|||Weight||kilograms|Mean|86.16|86.16|Standard Deviation|21.869|21.869|||
3998805|NCT01227551|3818744|B1|||Height||centimeters|Mean|172.7|172.7|Standard Deviation|11.84|11.84|||
3998806|NCT01227551|3818744|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3998807|NCT01227551|3818744|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3998808|NCT01227551|3818744|B1||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3998809|NCT01227551|3818744|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3998810|NCT01227551|3818744|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3998811|NCT01227551|3818744|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3998812|NCT01227551|3818744|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3998813|NCT01227551|3818744|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3998814|NCT01227551|3818744|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
3998815|NCT01227551|3818744|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3998816|NCT01227551|3818744|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
3998817|NCT01227551|3818744|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3998818|NCT01227551|3818744|B1|||Age||participants|Mean|64.7|64.7|Standard Deviation|14.91|14.91|||
3998819|NCT01227512|3818749|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
3998820|NCT01227512|3818750|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3998821|NCT01227512|3818751|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3998822|NCT01227512|3818749|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
3998823|NCT01227512|3818750|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3998824|NCT01227512|3818751|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3998825|NCT01227512|3818749|B3|||Age||Years|Mean|66.7|66.7|Standard Deviation|15.7|15.7|||
3998826|NCT01227512|3818750|B2|||Age||Years|Mean|67.7|67.7|Standard Deviation|15.6|15.6|||
3998827|NCT01227512|3818751|B1|||Age||Years|Mean|65.7|65.7|Standard Deviation|15.8|15.8|||
3998828|NCT01227434|3818772|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
3998829|NCT01227434|3818773|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
3998830|NCT01227434|3818774|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3998831|NCT01227434|3818772|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3998832|NCT01227434|3818773|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3998833|NCT01227434|3818774|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3998834|NCT01227434|3818772|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3998835|NCT01227434|3818773|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3998836|NCT01227434|3818774|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3998837|NCT01227434|3818772|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3998838|NCT01227434|3818773|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3998839|NCT01227434|3818774|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3998840|NCT01227434|3818772|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3998841|NCT01227434|3818773|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
3998842|NCT01227434|3818774|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
3998843|NCT01227434|3818772|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3998844|NCT01227434|3818773|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3998845|NCT01227434|3818774|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3998846|NCT01227421|3818783|B4|United States||Region of Enrollment||participants|Number|624|624.0||||||
3998847|NCT01227421|3818784|B3|United States||Region of Enrollment||participants|Number|211|211.0||||||
3998848|NCT01227421|3818785|B2|United States||Region of Enrollment||participants|Number|212|212.0||||||
3998849|NCT01227421|3818786|B1|United States||Region of Enrollment||participants|Number|201|201.0||||||
3998850|NCT01227421|3818783|B4||Male|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
3998851|NCT01227421|3818784|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
3998852|NCT01227421|3818785|B2||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
3998853|NCT01227421|3818786|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
3998854|NCT01227421|3818783|B4||Female|Sex: Female, Male||Participants|Count of Participants|355|355.0||||||
3998855|NCT01227421|3818784|B3||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
3998856|NCT01227421|3818785|B2||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
3998857|NCT01227421|3818786|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
3998858|NCT01227421|3818783|B4|||Age||years|Mean|31|31.0|Standard Deviation|13.0|13.0|||
3998859|NCT01227421|3818784|B3|||Age||years|Mean|32|32.0|Standard Deviation|13.2|13.2|||
3998860|NCT01227421|3818785|B2|||Age||years|Mean|31|31.0|Standard Deviation|13.3|13.3|||
3998861|NCT01227421|3818786|B1|||Age||years|Mean|31|31.0|Standard Deviation|12.6|12.6|||
3998862|NCT01227421|3818783|B4||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
3998863|NCT01227421|3818784|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3998864|NCT01227421|3818785|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3998865|NCT01227421|3818786|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3998866|NCT01227421|3818783|B4||Between 18 and 65 years|Age||Participants|Count of Participants|553|553.0||||||
3998867|NCT01227421|3818784|B3||Between 18 and 65 years|Age||Participants|Count of Participants|188|188.0||||||
3998868|NCT01227421|3818785|B2||Between 18 and 65 years|Age||Participants|Count of Participants|189|189.0||||||
3998869|NCT01227421|3818786|B1||Between 18 and 65 years|Age||Participants|Count of Participants|176|176.0||||||
3998870|NCT01227421|3818783|B4||<=18 years|Age||Participants|Count of Participants|66|66.0||||||
3998871|NCT01227421|3818784|B3||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
3998872|NCT01227421|3818785|B2||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
3998873|NCT01227421|3818786|B1||<=18 years|Age||Participants|Count of Participants|25|25.0||||||
3998874|NCT01227395|3818838|B3||Male|Sex: Female, Male||Participants|Count of Participants|435|435.0||||||
3998875|NCT01227395|3818839|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3998876|NCT01227395|3818840|B1||Male|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
3998877|NCT01227395|3818838|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
3998878|NCT01227395|3818839|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3998879|NCT01227395|3818840|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3998880|NCT01227395|3818838|B3|>=65 years||Age, Customized||participants|Number|11|11.0||||||
3998881|NCT01227395|3818839|B2|>=65 years||Age, Customized||participants|Number|1|1.0||||||
3998882|NCT01227395|3818840|B1|>=65 years||Age, Customized||participants|Number|10|10.0||||||
3998883|NCT01227395|3818838|B3|<65 years||Age, Customized||participants|Number|464|464.0||||||
3998884|NCT01227395|3818839|B2|<65 years||Age, Customized||participants|Number|83|83.0||||||
3998885|NCT01227395|3818840|B1|<65 years||Age, Customized||participants|Number|381|381.0||||||
3998886|NCT01227382|3818869|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
3998887|NCT01227382|3818869|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3998888|NCT01227382|3818869|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3998889|NCT01227382|3818869|B1|||Age||years|Mean|67.92|67.92|Standard Deviation|13.37|13.37|||
3998890|NCT01227278|3818879|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3998891|NCT01227278|3818880|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3998892|NCT01227278|3818881|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3998893|NCT01227278|3818879|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
3998894|NCT01227278|3818880|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3998895|NCT01227278|3818881|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3998896|NCT01227278|3818879|B3|||Age||years|Mean|63.7|63.7|Standard Deviation|7.9|7.9|||
3998897|NCT01227278|3818880|B2|||Age||years|Mean|62.9|62.9|Standard Deviation|8.2|8.2|||
3998898|NCT01227278|3818881|B1|||Age||years|Mean|64.6|64.6|Standard Deviation|7.5|7.5|||
3998899|NCT01227265|3818906|B4||Male|Sex: Female, Male||Participants|Count of Participants|289|289.0||||||
3998900|NCT01227265|3818907|B3||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
3998901|NCT01227265|3818908|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3998902|NCT01227265|3818909|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
3998903|NCT01227265|3818906|B4||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
3998904|NCT01227265|3818907|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
3998905|NCT01227265|3818908|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
3998906|NCT01227265|3818909|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
3998907|NCT01227265|3818906|B4|||Age||Years|Mean|63.8|63.8|Standard Deviation|8.9|8.9|||
3998908|NCT01227265|3818907|B3|||Age||Years|Mean|64.2|64.2|Standard Deviation|8.9|8.9|||
3998909|NCT01227265|3818908|B2|||Age||Years|Mean|64.2|64.2|Standard Deviation|8.7|8.7|||
3998910|NCT01227265|3818909|B1|||Age||Years|Mean|62.9|62.9|Standard Deviation|9.0|9.0|||
3998911|NCT01227057|3818937|B3|||Clinician Global Improvement - Severity scale|Total score is 1-7, with higher scores indicating worse severity of mental illness.|units on a scale|Mean|3.81|3.81|Standard Deviation|1.06|1.06|||
3998912|NCT01227057|3818938|B2|||Clinician Global Improvement - Severity scale|Total score is 1-7, with higher scores indicating worse severity of mental illness.|units on a scale|Mean|3.96|3.96|Standard Deviation|1.19|1.19|||
3998913|NCT01227057|3818939|B1|||Clinician Global Improvement - Severity scale|Total score is 1-7, with higher scores indicating worse severity of mental illness.|units on a scale|Mean|3.67|3.67|Standard Deviation|.92|0.92|||
3998914|NCT01227057|3818937|B3|Hospital Anxiety and Depression - Depression||Hospital Anxiety and Depression|Total score for each subscale is 0-21, with higher scores indicating worse anxiety or depression severity.|units on a scale|Mean|7.79|7.79|Standard Deviation|4.16|4.16|||
3998915|NCT01227057|3818938|B2|Hospital Anxiety and Depression - Depression||Hospital Anxiety and Depression|Total score for each subscale is 0-21, with higher scores indicating worse anxiety or depression severity.|units on a scale|Mean|8.56|8.56|Standard Deviation|4.97|4.97|||
3998960|NCT01227057|3818938|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3998961|NCT01227057|3818939|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3998916|NCT01227057|3818939|B1|Hospital Anxiety and Depression - Depression||Hospital Anxiety and Depression|Total score for each subscale is 0-21, with higher scores indicating worse anxiety or depression severity.|units on a scale|Mean|7.13|7.13|Standard Deviation|3.23|3.23|||
3998917|NCT01227057|3818937|B3|Hospital Anxiety and Depression - Anxiety||Hospital Anxiety and Depression|Total score for each subscale is 0-21, with higher scores indicating worse anxiety or depression severity.|units on a scale|Mean|9.56|9.56|Standard Deviation|3.98|3.98|||
3998918|NCT01227057|3818938|B2|Hospital Anxiety and Depression - Anxiety||Hospital Anxiety and Depression|Total score for each subscale is 0-21, with higher scores indicating worse anxiety or depression severity.|units on a scale|Mean|10.15|10.15|Standard Deviation|3.41|3.41|||
3998919|NCT01227057|3818939|B1|Hospital Anxiety and Depression - Anxiety||Hospital Anxiety and Depression|Total score for each subscale is 0-21, with higher scores indicating worse anxiety or depression severity.|units on a scale|Mean|9.06|9.06|Standard Deviation|4.39|4.39|||
3998920|NCT01227057|3818937|B3|||Activities of Daily Living - Hoarding|Mean score is 1-75, with higher scores indicating worse impairment due to hoarding.|units on a scale|Mean|31.31|31.31|Standard Deviation|11.23|11.23|||
3998921|NCT01227057|3818938|B2|||Activities of Daily Living - Hoarding|Mean score is 1-75, with higher scores indicating worse impairment due to hoarding.|units on a scale|Mean|31.90|31.9|Standard Deviation|13.53|13.53|||
3998922|NCT01227057|3818939|B1|||Activities of Daily Living - Hoarding|Mean score is 1-75, with higher scores indicating worse impairment due to hoarding.|units on a scale|Mean|30.85|30.85|Standard Deviation|9.3|9.3|||
3998923|NCT01227057|3818937|B3|||University of California, Los Angeles Hoarding Severity Scale|Total score is 0-40, with higher scores indicating worse hoarding severity.|units on a scale|Mean|27.52|27.52|Standard Deviation|5.65|5.65|||
3998924|NCT01227057|3818938|B2|||University of California, Los Angeles Hoarding Severity Scale|Total score is 0-40, with higher scores indicating worse hoarding severity.|units on a scale|Mean|28.85|28.85|Standard Deviation|5.82|5.82|||
3998925|NCT01227057|3818939|B1|||University of California, Los Angeles Hoarding Severity Scale|Total score is 0-40, with higher scores indicating worse hoarding severity.|units on a scale|Mean|26.35|26.35|Standard Deviation|5.31|5.31|||
3998926|NCT01227057|3818937|B3|||Clutter Image Rating|Mean score is 1-9, with higher scores indicating worse clutter severity.|units on a scale|Mean|4.24|4.24|Standard Deviation|1.89|1.89|||
3998927|NCT01227057|3818938|B2|||Clutter Image Rating|Mean score is 1-9, with higher scores indicating worse clutter severity.|units on a scale|Mean|4.33|4.33|Standard Deviation|2.11|2.11|||
3998928|NCT01227057|3818939|B1|||Clutter Image Rating|Mean score is 1-9, with higher scores indicating worse clutter severity.|units on a scale|Mean|4.15|4.15|Standard Deviation|1.71|1.71|||
3998929|NCT01227057|3818937|B3|||Saving Inventory Revised|Total score is 0-92, with higher scores indicating worse hoarding severity.|units on a scale|Mean|58.34|58.34|Standard Deviation|12.08|12.08|||
3998930|NCT01227057|3818938|B2|||Saving Inventory Revised|Total score is 0-92, with higher scores indicating worse hoarding severity.|units on a scale|Mean|59.48|59.48|Standard Deviation|14.01|14.01|||
3998931|NCT01227057|3818939|B1|||Saving Inventory Revised|Total score is 0-92, with higher scores indicating worse hoarding severity.|units on a scale|Mean|57.35|57.35|Standard Deviation|10.23|10.23|||
3998932|NCT01227057|3818937|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
3998933|NCT01227057|3818938|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
3998934|NCT01227057|3818939|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
3998935|NCT01227057|3818937|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3998936|NCT01227057|3818938|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3998937|NCT01227057|3818939|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3998938|NCT01227057|3818937|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3998939|NCT01227057|3818938|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3998940|NCT01227057|3818939|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3998941|NCT01227057|3818937|B3||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
3998942|NCT01227057|3818938|B2||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
3998943|NCT01227057|3818939|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
3998944|NCT01227057|3818937|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3998945|NCT01227057|3818938|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3998946|NCT01227057|3818939|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3998947|NCT01227057|3818937|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3998948|NCT01227057|3818938|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3998949|NCT01227057|3818939|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3998950|NCT01227057|3818937|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3998951|NCT01227057|3818938|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3998952|NCT01227057|3818939|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3998953|NCT01227057|3818937|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3998954|NCT01227057|3818938|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3998955|NCT01227057|3818939|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3998956|NCT01227057|3818937|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3998957|NCT01227057|3818938|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3998958|NCT01227057|3818939|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3998959|NCT01227057|3818937|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
3998962|NCT01227057|3818937|B3|||Age||years|Mean|66.95|66.95|Standard Deviation|6.48|6.48|||
3998963|NCT01227057|3818938|B2|||Age||years|Mean|64.19|64.19|Standard Deviation|5.35|5.35|||
3998964|NCT01227057|3818939|B1|||Age||years|Mean|69.35|69.35|Standard Deviation|6.49|6.49|||
3998965|NCT01227018|3818950|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3998966|NCT01227018|3818950|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3998967|NCT01227018|3818950|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3998968|NCT01227018|3818950|B1|||Age||years|Median|65|65.0|Full Range|11|11.0|33.0|77.0|
3998969|NCT01227018|3818950|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3998970|NCT01227018|3818950|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
3998971|NCT01227018|3818950|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3998972|NCT01227005|3818958|B3|United States||Region of Enrollment||participants|Number|107|107.0||||||
3998973|NCT01227005|3818959|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
3998974|NCT01227005|3818960|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
3998975|NCT01227005|3818958|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
3998976|NCT01227005|3818959|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3998977|NCT01227005|3818960|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3998978|NCT01227005|3818958|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3998979|NCT01227005|3818959|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3998980|NCT01227005|3818960|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3998981|NCT01227005|3818958|B3|||Age||years|Median|39|39.0|Inter-Quartile Range|||30.0|56.0|
3998982|NCT01227005|3818959|B2|||Age||years|Median|38|38.0|Inter-Quartile Range|||32.0|56.0|
3998983|NCT01227005|3818960|B1|||Age||years|Median|40|40.0|Inter-Quartile Range|||29.0|56.0|
3998984|NCT01226745|3818971|B7||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3998985|NCT01226745|3818972|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3998986|NCT01226745|3818973|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3998987|NCT01226745|3818974|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3998988|NCT01226745|3818975|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3998989|NCT01226745|3818976|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3998990|NCT01226745|3818977|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3998991|NCT01226745|3818971|B7||Female|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
3998992|NCT01226745|3818972|B6||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
3998993|NCT01226745|3818973|B5||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3998994|NCT01226745|3818974|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3998995|NCT01226745|3818975|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
3998996|NCT01226745|3818976|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
3998997|NCT01226745|3818977|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
3998998|NCT01226745|3818971|B7|||Age||Years|Mean|36.9|36.9|Standard Deviation|8.66|8.66|||
3998999|NCT01226745|3818972|B6|||Age||Years|Mean|38.7|38.7|Standard Deviation|9.48|9.48|||
3999000|NCT01226745|3818973|B5|||Age||Years|Mean|37.0|37.0|Standard Deviation|6.96|6.96|||
3999001|NCT01226745|3818974|B4|||Age||Years|Mean|35.6|35.6|Standard Deviation|9.59|9.59|||
3999002|NCT01226745|3818975|B3|||Age||Years|Mean|38.2|38.2|Standard Deviation|8.66|8.66|||
3999003|NCT01226745|3818976|B2|||Age||Years|Mean|36.0|36.0|Standard Deviation|8.64|8.64|||
3999004|NCT01226745|3818977|B1|||Age||Years|Mean|36.3|36.3|Standard Deviation|8.47|8.47|||
3999005|NCT01226732|3819056|B7|United States||Region of Enrollment||participants|Number|23|23.0||||||
3999006|NCT01226732|3819057|B6|United States||Region of Enrollment||participants|Number|6|6.0||||||
3999007|NCT01226732|3819058|B5|United States||Region of Enrollment||participants|Number|3|3.0||||||
3999008|NCT01226732|3819059|B4|United States||Region of Enrollment||participants|Number|5|5.0||||||
3999009|NCT01226732|3819060|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
3999010|NCT01226732|3819061|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
3999011|NCT01226732|3819062|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
3999012|NCT01226732|3819056|B7||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3999013|NCT01226732|3819057|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3999014|NCT01226732|3819058|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3999015|NCT01226732|3819059|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3999016|NCT01226732|3819060|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3999017|NCT01226732|3819061|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3999018|NCT01226732|3819062|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3999019|NCT01226732|3819056|B7||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3999020|NCT01226732|3819057|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3999021|NCT01226732|3819058|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3999022|NCT01226732|3819059|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3999023|NCT01226732|3819060|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3999024|NCT01226732|3819061|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3999025|NCT01226732|3819062|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3999026|NCT01226732|3819056|B7|||Age||years|Median|60|60.0|Full Range|||37.0|71.0|
3999027|NCT01226732|3819057|B6|||Age||years|Median|65.5|65.5|Full Range|||54.0|71.0|
3999028|NCT01226732|3819058|B5|||Age||years|Median|58|58.0|Full Range|||49.0|63.0|
3999029|NCT01226732|3819059|B4|||Age||years|Median|60|60.0|Full Range|||47.0|68.0|
3999030|NCT01226732|3819060|B3|||Age||years|Median|64|64.0|Full Range|||45.0|65.0|
3999031|NCT01226732|3819061|B2|||Age||years|Median|51|51.0|Full Range|||37.0|64.0|
3999032|NCT01226732|3819062|B1|||Age||years|Median|59|59.0|Full Range|||53.0|66.0|
3999033|NCT01226719|3819083|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
3999034|NCT01226719|3819083|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3999035|NCT01226719|3819083|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3999036|NCT01226719|3819083|B1|||Age||years|Median|55|55.0|Full Range|||39.0|70.0|
3999037|NCT01226706|3819091|B3|Canada||Region of Enrollment||participants|Number|21|21.0||||||
3999038|NCT01226706|3819092|B2|Canada||Region of Enrollment||participants|Number|11|11.0||||||
3999039|NCT01226706|3819093|B1|Canada||Region of Enrollment||participants|Number|10|10.0||||||
3999040|NCT01226706|3819091|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3999041|NCT01226706|3819092|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3999042|NCT01226706|3819093|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3999043|NCT01226706|3819091|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3999044|NCT01226706|3819092|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3999045|NCT01226706|3819093|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3999046|NCT01226706|3819091|B3|||Age||years|Mean|63.38|63.38|Standard Deviation|10.04|10.04|||
3999047|NCT01226706|3819092|B2|||Age||years|Mean|63|63.0|Standard Deviation|9.4|9.4|||
3999048|NCT01226706|3819093|B1|||Age||years|Mean|63.8|63.8|Standard Deviation|11.2|11.2|||
3999049|NCT01226511|3819176|B3|South Africa||Region of Enrollment||participants|Number|23|23.0||||||
3999050|NCT01226511|3819177|B2|South Africa||Region of Enrollment||participants|Number|12|12.0||||||
3999051|NCT01226511|3819178|B1|South Africa||Region of Enrollment||participants|Number|11|11.0||||||
3999052|NCT01226511|3819176|B3|Mexico||Region of Enrollment||participants|Number|52|52.0||||||
3999053|NCT01226511|3819177|B2|Mexico||Region of Enrollment||participants|Number|26|26.0||||||
3999054|NCT01226511|3819178|B1|Mexico||Region of Enrollment||participants|Number|26|26.0||||||
3999055|NCT01226511|3819176|B3|United States||Region of Enrollment||participants|Number|197|197.0||||||
3999056|NCT01226511|3819177|B2|United States||Region of Enrollment||participants|Number|99|99.0||||||
3999057|NCT01226511|3819178|B1|United States||Region of Enrollment||participants|Number|98|98.0||||||
3999058|NCT01226511|3819176|B3|More than 1 race||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
3999059|NCT01226511|3819177|B2|More than 1 race||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3999060|NCT01226511|3819178|B1|More than 1 race||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3999061|NCT01226511|3819176|B3|White||Race/Ethnicity, Customized||participants|Number|223|223.0||||||
3999062|NCT01226511|3819177|B2|White||Race/Ethnicity, Customized||participants|Number|111|111.0||||||
3999063|NCT01226511|3819178|B1|White||Race/Ethnicity, Customized||participants|Number|112|112.0||||||
3999064|NCT01226511|3819176|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
3999065|NCT01226511|3819177|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
3999066|NCT01226511|3819178|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3999067|NCT01226511|3819176|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3999068|NCT01226511|3819177|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3999069|NCT01226511|3819178|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3999070|NCT01226511|3819176|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3999071|NCT01226511|3819177|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3999072|NCT01226511|3819178|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3999073|NCT01226511|3819176|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3999074|NCT01226511|3819177|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3999075|NCT01226511|3819178|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3999076|NCT01226511|3819176|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|176|176.0||||||
3999077|NCT01226511|3819177|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3999078|NCT01226511|3819178|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
3999079|NCT01226511|3819176|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
3999080|NCT01226511|3819177|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
3999081|NCT01226511|3819178|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
3999082|NCT01226511|3819176|B3||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
3999083|NCT01226511|3819177|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3999084|NCT01226511|3819178|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3999085|NCT01226511|3819176|B3||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
3999086|NCT01226511|3819177|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
3999087|NCT01226511|3819178|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3999088|NCT01226511|3819176|B3|12 to 17 years||Age, Customized||participants|Number|144|144.0||||||
3999089|NCT01226511|3819177|B2|12 to 17 years||Age, Customized||participants|Number|71|71.0||||||
3999090|NCT01226511|3819178|B1|12 to 17 years||Age, Customized||participants|Number|73|73.0||||||
3999091|NCT01226511|3819176|B3|7 to 11 years||Age, Customized||participants|Number|128|128.0||||||
3999092|NCT01226511|3819177|B2|7 to 11 years||Age, Customized||participants|Number|66|66.0||||||
3999093|NCT01226511|3819178|B1|7 to 11 years||Age, Customized||participants|Number|62|62.0||||||
3999094|NCT01226459|3819215|B3|Unknown or Not Reported||Race (NIH/OMB)|One participant in minoxidil foam group had no information on race and hair loss duration|participants|Number|1|1.0||||||
3999095|NCT01226459|3819216|B2|Unknown or Not Reported||Race (NIH/OMB)|One participant in minoxidil foam group had no information on race and hair loss duration|participants|Number|1|1.0||||||
3999096|NCT01226459|3819217|B1|Unknown or Not Reported||Race (NIH/OMB)|One participant in minoxidil foam group had no information on race and hair loss duration|participants|Number|0|0.0||||||
3999097|NCT01226459|3819215|B3|More than one race||Race (NIH/OMB)|One participant in minoxidil foam group had no information on race and hair loss duration|participants|Number|0|0.0||||||
3999098|NCT01226459|3819216|B2|More than one race||Race (NIH/OMB)|One participant in minoxidil foam group had no information on race and hair loss duration|participants|Number|0|0.0||||||
3999099|NCT01226459|3819217|B1|More than one race||Race (NIH/OMB)|One participant in minoxidil foam group had no information on race and hair loss duration|participants|Number|0|0.0||||||
3999100|NCT01226459|3819215|B3|White||Race (NIH/OMB)|One participant in minoxidil foam group had no information on race and hair loss duration|participants|Number|285|285.0||||||
3999101|NCT01226459|3819216|B2|White||Race (NIH/OMB)|One participant in minoxidil foam group had no information on race and hair loss duration|participants|Number|145|145.0||||||
3999102|NCT01226459|3819217|B1|White||Race (NIH/OMB)|One participant in minoxidil foam group had no information on race and hair loss duration|participants|Number|140|140.0||||||
3999103|NCT01226459|3819215|B3|Black or African American||Race (NIH/OMB)|One participant in minoxidil foam group had no information on race and hair loss duration|participants|Number|105|105.0||||||
3999104|NCT01226459|3819216|B2|Black or African American||Race (NIH/OMB)|One participant in minoxidil foam group had no information on race and hair loss duration|participants|Number|50|50.0||||||
3999105|NCT01226459|3819217|B1|Black or African American||Race (NIH/OMB)|One participant in minoxidil foam group had no information on race and hair loss duration|participants|Number|55|55.0||||||
3999106|NCT01226459|3819215|B3|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|One participant in minoxidil foam group had no information on race and hair loss duration|participants|Number|1|1.0||||||
3999107|NCT01226459|3819216|B2|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|One participant in minoxidil foam group had no information on race and hair loss duration|participants|Number|1|1.0||||||
3999108|NCT01226459|3819217|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|One participant in minoxidil foam group had no information on race and hair loss duration|participants|Number|0|0.0||||||
3999109|NCT01226459|3819215|B3|Asian||Race (NIH/OMB)|One participant in minoxidil foam group had no information on race and hair loss duration|participants|Number|7|7.0||||||
3999110|NCT01226459|3819216|B2|Asian||Race (NIH/OMB)|One participant in minoxidil foam group had no information on race and hair loss duration|participants|Number|4|4.0||||||
3999111|NCT01226459|3819217|B1|Asian||Race (NIH/OMB)|One participant in minoxidil foam group had no information on race and hair loss duration|participants|Number|3|3.0||||||
3999112|NCT01226459|3819215|B3|American Indian or Alaska Native||Race (NIH/OMB)|One participant in minoxidil foam group had no information on race and hair loss duration|participants|Number|4|4.0||||||
3999113|NCT01226459|3819216|B2|American Indian or Alaska Native||Race (NIH/OMB)|One participant in minoxidil foam group had no information on race and hair loss duration|participants|Number|1|1.0||||||
3999114|NCT01226459|3819217|B1|American Indian or Alaska Native||Race (NIH/OMB)|One participant in minoxidil foam group had no information on race and hair loss duration|participants|Number|3|3.0||||||
3999115|NCT01226459|3819215|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3999116|NCT01226459|3819216|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3999117|NCT01226459|3819217|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3999118|NCT01226459|3819215|B3||Female|Sex: Female, Male||Participants|Count of Participants|404|404.0||||||
3999119|NCT01226459|3819216|B2||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
3999120|NCT01226459|3819217|B1||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
3999121|NCT01226459|3819215|B3||>=65 years|Age||Participants|Count of Participants|99|99.0||||||
3999122|NCT01226459|3819216|B2||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
3999123|NCT01226459|3819217|B1||>=65 years|Age||Participants|Count of Participants|53|53.0||||||
3999124|NCT01226459|3819215|B3||Between 18 and 65 years|Age||Participants|Count of Participants|305|305.0||||||
3999125|NCT01226459|3819216|B2||Between 18 and 65 years|Age||Participants|Count of Participants|157|157.0||||||
3999126|NCT01226459|3819217|B1||Between 18 and 65 years|Age||Participants|Count of Participants|148|148.0||||||
3999127|NCT01226459|3819215|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3999128|NCT01226459|3819216|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3999129|NCT01226459|3819217|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3999130|NCT01226420|3819228|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3999131|NCT01226420|3819228|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3999132|NCT01226420|3819228|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3999133|NCT01226420|3819228|B1|||Age||years|Mean|51|51.0|Standard Deviation|15|15.0|||
3999134|NCT01226420|3819228|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3999135|NCT01226420|3819228|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3999136|NCT01226420|3819228|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3999137|NCT01226121|3819233|B4|United States||Region of Enrollment||participants|Number|37|37.0||||||
3999138|NCT01226121|3819234|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
3999139|NCT01226121|3819235|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
3999140|NCT01226121|3819236|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
3999141|NCT01226121|3819233|B4||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
3999142|NCT01226121|3819234|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3999143|NCT01226121|3819235|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3999144|NCT01226121|3819236|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3999145|NCT01226121|3819233|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3999146|NCT01226121|3819234|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3999147|NCT01226121|3819235|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3999148|NCT01226121|3819236|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3999149|NCT01226121|3819233|B4|||Age||years|Mean|65.44|65.44|Standard Deviation|9.02|9.02|||
3999150|NCT01226121|3819234|B3|||Age||years|Mean|65.5|65.5|Standard Deviation|10.2|10.2|||
3999151|NCT01226121|3819235|B2|||Age||years|Mean|67|67.0|Standard Deviation|6.4|6.4|||
3999152|NCT01226121|3819236|B1|||Age||years|Mean|63.9|63.9|Standard Deviation|10.3|10.3|||
3999153|NCT01226095|3819249|B1|Egypt||Region of Enrollment||participants|Number|519|519.0||||||
3999154|NCT01226095|3819249|B1||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
3999155|NCT01226095|3819249|B1||Female|Sex: Female, Male||Participants|Count of Participants|348|348.0||||||
3999156|NCT01226095|3819249|B1|||Age||years|Median|55|55.0|Full Range|||23.0|82.0|
3999157|NCT01226095|3819249|B1|||Age||years|Mean|54.66|54.66|Standard Deviation|10.36|10.36|||
3999158|NCT01226043|3819272|B3|||Body Mass Index||kg/m^2|Mean|34.83|34.83|Standard Deviation|7.35|7.35|||
3999159|NCT01226043|3819273|B2|||Body Mass Index||kg/m^2|Mean|33.73|33.73|Standard Deviation|6.64|6.64|||
3999160|NCT01226043|3819274|B1|||Body Mass Index||kg/m^2|Mean|35.93|35.93|Standard Deviation|7.87|7.87|||
3999161|NCT01226043|3819272|B3|||Body Weight||kg|Mean|101.13|101.13|Standard Deviation|23.87|23.87|||
3999162|NCT01226043|3819273|B2|||Body Weight||kg|Mean|98.48|98.48|Standard Deviation|20.75|20.75|||
3999163|NCT01226043|3819274|B1|||Body Weight||kg|Mean|103.80|103.8|Standard Deviation|26.43|26.43|||
3999164|NCT01226043|3819272|B3||Male|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
3999165|NCT01226043|3819273|B2||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
3999166|NCT01226043|3819274|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
3999167|NCT01226043|3819272|B3||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
3999168|NCT01226043|3819273|B2||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
3999169|NCT01226043|3819274|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
3999170|NCT01226043|3819272|B3|||Age||years|Mean|57.9|57.9|Standard Deviation|10.5|10.5|||
3999171|NCT01226043|3819273|B2|||Age||years|Mean|58.1|58.1|Standard Deviation|10.9|10.9|||
3999172|NCT01226043|3819274|B1|||Age||years|Mean|57.7|57.7|Standard Deviation|10.1|10.1|||
3999173|NCT01226043|3819272|B3||>=65 years|Age||Participants|Count of Participants|106|106.0||||||
3999174|NCT01226043|3819273|B2||>=65 years|Age||Participants|Count of Participants|57|57.0||||||
3999175|NCT01226043|3819274|B1||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
3999176|NCT01226043|3819272|B3||Between 18 and 65 years|Age||Participants|Count of Participants|299|299.0||||||
3999177|NCT01226043|3819273|B2||Between 18 and 65 years|Age||Participants|Count of Participants|146|146.0||||||
3999178|NCT01226043|3819274|B1||Between 18 and 65 years|Age||Participants|Count of Participants|153|153.0||||||
3999179|NCT01226043|3819272|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3999180|NCT01226043|3819273|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3999181|NCT01226043|3819274|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3999182|NCT01225991|3819315|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
3999183|NCT01225991|3819315|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3999184|NCT01225991|3819315|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3999185|NCT01225991|3819315|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
3999186|NCT01225991|3819315|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
3999187|NCT01225991|3819315|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3999188|NCT01225991|3819315|B1|||Age||years|Mean|67.5|67.5|Full Range|||58.0|89.0|
3999189|NCT01225952|3819323|B4|Philippines||Region of Enrollment||participants|Number|93|93.0||||||
3999190|NCT01225952|3819324|B3|Philippines||Region of Enrollment||participants|Number|31|31.0||||||
3999191|NCT01225952|3819325|B2|Philippines||Region of Enrollment||participants|Number|31|31.0||||||
3999192|NCT01225952|3819326|B1|Philippines||Region of Enrollment||participants|Number|31|31.0||||||
3999193|NCT01225952|3819323|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3999194|NCT01225952|3819324|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3999195|NCT01225952|3819325|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3999196|NCT01225952|3819326|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3999197|NCT01225952|3819323|B4||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
3999198|NCT01225952|3819324|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
3999199|NCT01225952|3819325|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3999200|NCT01225952|3819326|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3999201|NCT01225952|3819323|B4|>/= 80 years||Age, Customized||participants|Number|1|1.0||||||
3999202|NCT01225952|3819324|B3|>/= 80 years||Age, Customized||participants|Number|1|1.0||||||
3999203|NCT01225952|3819325|B2|>/= 80 years||Age, Customized||participants|Number|0|0.0||||||
3999204|NCT01225952|3819326|B1|>/= 80 years||Age, Customized||participants|Number|0|0.0||||||
3999205|NCT01225952|3819323|B4|70 - 79 years||Age, Customized||participants|Number|25|25.0||||||
3999206|NCT01225952|3819324|B3|70 - 79 years||Age, Customized||participants|Number|7|7.0||||||
3999207|NCT01225952|3819325|B2|70 - 79 years||Age, Customized||participants|Number|8|8.0||||||
3999208|NCT01225952|3819326|B1|70 - 79 years||Age, Customized||participants|Number|10|10.0||||||
3999209|NCT01225952|3819323|B4|60 - 69 years||Age, Customized||participants|Number|43|43.0||||||
3999210|NCT01225952|3819324|B3|60 - 69 years||Age, Customized||participants|Number|16|16.0||||||
3999211|NCT01225952|3819325|B2|60 - 69 years||Age, Customized||participants|Number|14|14.0||||||
3999212|NCT01225952|3819326|B1|60 - 69 years||Age, Customized||participants|Number|13|13.0||||||
3999213|NCT01225952|3819323|B4|50 - 59 years||Age, Customized||participants|Number|21|21.0||||||
3999214|NCT01225952|3819324|B3|50 - 59 years||Age, Customized||participants|Number|7|7.0||||||
3999215|NCT01225952|3819325|B2|50 - 59 years||Age, Customized||participants|Number|8|8.0||||||
3999216|NCT01225952|3819326|B1|50 - 59 years||Age, Customized||participants|Number|6|6.0||||||
3999217|NCT01225952|3819323|B4|40 - 49 years||Age, Customized||participants|Number|3|3.0||||||
3999218|NCT01225952|3819324|B3|40 - 49 years||Age, Customized||participants|Number|0|0.0||||||
3999219|NCT01225952|3819325|B2|40 - 49 years||Age, Customized||participants|Number|1|1.0||||||
3999220|NCT01225952|3819326|B1|40 - 49 years||Age, Customized||participants|Number|2|2.0||||||
3999221|NCT01225952|3819323|B4|< 40 years||Age, Customized||participants|Number|0|0.0||||||
3999222|NCT01225952|3819324|B3|< 40 years||Age, Customized||participants|Number|0|0.0||||||
3999223|NCT01225952|3819325|B2|< 40 years||Age, Customized||participants|Number|0|0.0||||||
3999224|NCT01225952|3819326|B1|< 40 years||Age, Customized||participants|Number|0|0.0||||||
3999225|NCT01225926|3819411|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3999226|NCT01225926|3819412|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3999227|NCT01225926|3819413|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3999228|NCT01225926|3819411|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3999229|NCT01225926|3819412|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3999230|NCT01225926|3819413|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
3999231|NCT01225926|3819411|B3|||Age||years|Mean|51.8|51.8|Standard Deviation|17.63|17.63|||
3999232|NCT01225926|3819412|B2|||Age||years|Mean|55.5|55.5|Standard Deviation|16.52|16.52|||
3999233|NCT01225926|3819413|B1|||Age||years|Mean|48.2|48.2|Standard Deviation|18.64|18.64|||
3999234|NCT01225887|3819420|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3999235|NCT01225887|3819420|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3999236|NCT01225887|3819420|B1|80-89 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
3999237|NCT01225887|3819420|B1|70-79 years||Age, Customized||Participants|Count of Participants|10|10.0||||||
3999238|NCT01225887|3819420|B1|60-69 years||Age, Customized||Participants|Count of Participants|14|14.0||||||
3999239|NCT01225887|3819420|B1|50-59 years||Age, Customized||Participants|Count of Participants|4|4.0||||||
3999240|NCT01225887|3819420|B1|30-39 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
3999241|NCT01225887|3819420|B1|||Age||years|Mean|67.1|67.1|Standard Deviation|9.8|9.8|||
3999242|NCT01225835|3819428|B3|Missing values||Aetiology of Infertility||participants|Number|1|1.0||||||
3999243|NCT01225835|3819429|B2|Missing values||Aetiology of Infertility||participants|Number|0|0.0||||||
3999244|NCT01225835|3819430|B1|Missing values||Aetiology of Infertility||participants|Number|1|1.0||||||
3999245|NCT01225835|3819428|B3|Other||Aetiology of Infertility||participants|Number|9|9.0||||||
3999246|NCT01225835|3819429|B2|Other||Aetiology of Infertility||participants|Number|8|8.0||||||
3999247|NCT01225835|3819430|B1|Other||Aetiology of Infertility||participants|Number|1|1.0||||||
3999248|NCT01225835|3819428|B3|Idiopathic||Aetiology of Infertility||participants|Number|69|69.0||||||
3999249|NCT01225835|3819429|B2|Idiopathic||Aetiology of Infertility||participants|Number|33|33.0||||||
3999250|NCT01225835|3819430|B1|Idiopathic||Aetiology of Infertility||participants|Number|36|36.0||||||
3999251|NCT01225835|3819428|B3|Endometriosis||Aetiology of Infertility||participants|Number|7|7.0||||||
3999252|NCT01225835|3819429|B2|Endometriosis||Aetiology of Infertility||participants|Number|3|3.0||||||
3999253|NCT01225835|3819430|B1|Endometriosis||Aetiology of Infertility||participants|Number|4|4.0||||||
3999254|NCT01225835|3819428|B3|Tubal factor||Aetiology of Infertility||participants|Number|38|38.0||||||
3999255|NCT01225835|3819429|B2|Tubal factor||Aetiology of Infertility||participants|Number|18|18.0||||||
3999256|NCT01225835|3819430|B1|Tubal factor||Aetiology of Infertility||participants|Number|20|20.0||||||
3999257|NCT01225835|3819428|B3|Missing Values||Participants with Gonadotrophin Stimulated Assisted Reproductive Technology (ART) Cycle||participants|Number|93|93.0||||||
3999375|NCT01225289|3819733|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3999258|NCT01225835|3819429|B2|Missing Values||Participants with Gonadotrophin Stimulated Assisted Reproductive Technology (ART) Cycle||participants|Number|44|44.0||||||
3999259|NCT01225835|3819430|B1|Missing Values||Participants with Gonadotrophin Stimulated Assisted Reproductive Technology (ART) Cycle||participants|Number|49|49.0||||||
3999260|NCT01225835|3819428|B3|Yes||Participants with Gonadotrophin Stimulated Assisted Reproductive Technology (ART) Cycle||participants|Number|31|31.0||||||
3999261|NCT01225835|3819429|B2|Yes||Participants with Gonadotrophin Stimulated Assisted Reproductive Technology (ART) Cycle||participants|Number|18|18.0||||||
3999262|NCT01225835|3819430|B1|Yes||Participants with Gonadotrophin Stimulated Assisted Reproductive Technology (ART) Cycle||participants|Number|13|13.0||||||
3999263|NCT01225835|3819428|B3|No||Participants with Gonadotrophin Stimulated Assisted Reproductive Technology (ART) Cycle||participants|Number|0|0.0||||||
3999264|NCT01225835|3819429|B2|No||Participants with Gonadotrophin Stimulated Assisted Reproductive Technology (ART) Cycle||participants|Number|0|0.0||||||
3999265|NCT01225835|3819430|B1|No||Participants with Gonadotrophin Stimulated Assisted Reproductive Technology (ART) Cycle||participants|Number|0|0.0||||||
3999266|NCT01225835|3819428|B3|Yes||Former Treatment for Infertility||participants|Number|76|76.0||||||
3999267|NCT01225835|3819429|B2|Yes||Former Treatment for Infertility||participants|Number|38|38.0||||||
3999268|NCT01225835|3819430|B1|Yes||Former Treatment for Infertility||participants|Number|38|38.0||||||
3999269|NCT01225835|3819428|B3|No||Former Treatment for Infertility||participants|Number|48|48.0||||||
3999270|NCT01225835|3819429|B2|No||Former Treatment for Infertility||participants|Number|24|24.0||||||
3999271|NCT01225835|3819430|B1|No||Former Treatment for Infertility||participants|Number|24|24.0||||||
3999272|NCT01225835|3819428|B3|||Length of Menstrual Cycle||days|Mean|28.2|28.2|Standard Deviation|1.6|1.6|||
3999273|NCT01225835|3819429|B2|||Length of Menstrual Cycle||days|Mean|28.2|28.2|Standard Deviation|1.5|1.5|||
3999274|NCT01225835|3819430|B1|||Length of Menstrual Cycle||days|Mean|28.3|28.3|Standard Deviation|1.7|1.7|||
3999275|NCT01225835|3819428|B3|Irregular||Menstrual Cycle||participants|Number|0|0.0||||||
3999276|NCT01225835|3819429|B2|Irregular||Menstrual Cycle||participants|Number|0|0.0||||||
3999277|NCT01225835|3819430|B1|Irregular||Menstrual Cycle||participants|Number|0|0.0||||||
3999278|NCT01225835|3819428|B3|Regular||Menstrual Cycle||participants|Number|124|124.0||||||
3999279|NCT01225835|3819429|B2|Regular||Menstrual Cycle||participants|Number|62|62.0||||||
3999280|NCT01225835|3819430|B1|Regular||Menstrual Cycle||participants|Number|62|62.0||||||
3999281|NCT01225835|3819428|B3|||Duration of Infertility||months|Mean|43.2|43.2|Standard Deviation|30.7|30.7|||
3999282|NCT01225835|3819429|B2|||Duration of Infertility||months|Mean|40.6|40.6|Standard Deviation|25.6|25.6|||
3999283|NCT01225835|3819430|B1|||Duration of Infertility||months|Mean|45.7|45.7|Standard Deviation|35.0|35.0|||
3999284|NCT01225835|3819428|B3|||Weight||kg|Mean|63.9|63.9|Standard Deviation|8.4|8.4|||
3999285|NCT01225835|3819429|B2|||Weight||kg|Mean|63.5|63.5|Standard Deviation|8.7|8.7|||
3999286|NCT01225835|3819430|B1|||Weight||kg|Mean|64.3|64.3|Standard Deviation|8.2|8.2|||
3999287|NCT01225835|3819428|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3999288|NCT01225835|3819429|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3999289|NCT01225835|3819430|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3999290|NCT01225835|3819428|B3||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
3999291|NCT01225835|3819429|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3999292|NCT01225835|3819430|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
3999293|NCT01225835|3819428|B3|>=39 years||Age, Customized||participants|Number|25|25.0||||||
3999294|NCT01225835|3819429|B2|>=39 years||Age, Customized||participants|Number|13|13.0||||||
3999295|NCT01225835|3819430|B1|>=39 years||Age, Customized||participants|Number|12|12.0||||||
3999296|NCT01225835|3819428|B3|< 39 years||Age, Customized||participants|Number|99|99.0||||||
3999297|NCT01225835|3819429|B2|< 39 years||Age, Customized||participants|Number|49|49.0||||||
3999298|NCT01225835|3819430|B1|< 39 years||Age, Customized||participants|Number|50|50.0||||||
3999299|NCT01225835|3819428|B3|||Age||years|Mean|36.6|36.6|Standard Deviation|2.4|2.4|||
3999300|NCT01225835|3819429|B2|||Age||years|Mean|36.7|36.7|Standard Deviation|2.3|2.3|||
3999301|NCT01225835|3819430|B1|||Age||years|Mean|36.5|36.5|Standard Deviation|2.4|2.4|||
3999302|NCT01225822|3819474|B6||Male|Sex: Female, Male|Safety set population|Participants|Count of Participants|758|758.0||||||
3999303|NCT01225822|3819475|B5||Male|Sex: Female, Male|Safety set population|Participants|Count of Participants|151|151.0||||||
3999304|NCT01225822|3819476|B4||Male|Sex: Female, Male|Safety set population|Participants|Count of Participants|139|139.0||||||
3999305|NCT01225822|3819477|B3||Male|Sex: Female, Male|Safety set population|Participants|Count of Participants|164|164.0||||||
3999306|NCT01225822|3819478|B2||Male|Sex: Female, Male|Safety set population|Participants|Count of Participants|138|138.0||||||
3999307|NCT01225822|3819479|B1||Male|Sex: Female, Male|Safety set population|Participants|Count of Participants|166|166.0||||||
3999308|NCT01225822|3819474|B6||Female|Sex: Female, Male|Safety set population|Participants|Count of Participants|1191|1191.0||||||
3999309|NCT01225822|3819475|B5||Female|Sex: Female, Male|Safety set population|Participants|Count of Participants|241|241.0||||||
3999310|NCT01225822|3819476|B4||Female|Sex: Female, Male|Safety set population|Participants|Count of Participants|246|246.0||||||
3999311|NCT01225822|3819477|B3||Female|Sex: Female, Male|Safety set population|Participants|Count of Participants|229|229.0||||||
3999312|NCT01225822|3819478|B2||Female|Sex: Female, Male|Safety set population|Participants|Count of Participants|252|252.0||||||
3999313|NCT01225822|3819479|B1||Female|Sex: Female, Male|Safety set population|Participants|Count of Participants|223|223.0||||||
3999376|NCT01225289|3819734|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3999314|NCT01225822|3819474|B6|||Age, Customized|Safety set population|years|Mean|65.86|65.86|Standard Deviation|10.61|10.61|||
3999315|NCT01225822|3819475|B5|||Age, Customized|Safety set population|years|Mean|65.03|65.03|Standard Deviation|11.03|11.03|||
3999316|NCT01225822|3819476|B4|||Age, Customized|Safety set population|years|Mean|66.47|66.47|Standard Deviation|10.37|10.37|||
3999317|NCT01225822|3819477|B3|||Age, Customized|Safety set population|years|Mean|65.87|65.87|Standard Deviation|10.63|10.63|||
3999318|NCT01225822|3819478|B2|||Age, Customized|Safety set population|years|Mean|65.86|65.86|Standard Deviation|10.77|10.77|||
3999319|NCT01225822|3819479|B1|||Age, Customized|Safety set population|years|Mean|66.07|66.07|Standard Deviation|10.23|10.23|||
3999320|NCT01225731|3819545|B6||Male|Sex: Female, Male||Participants|Count of Participants|270|270.0||||||
3999321|NCT01225731|3819546|B5||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3999322|NCT01225731|3819547|B4||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
3999323|NCT01225731|3819548|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
3999324|NCT01225731|3819549|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
3999325|NCT01225731|3819550|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3999326|NCT01225731|3819545|B6||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
3999327|NCT01225731|3819546|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3999328|NCT01225731|3819547|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3999329|NCT01225731|3819548|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3999330|NCT01225731|3819549|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3999331|NCT01225731|3819550|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3999332|NCT01225731|3819545|B6|||Age||years|Mean|44.9|44.9|Standard Deviation|12.9|12.9|||
3999333|NCT01225731|3819546|B5|||Age||years|Mean|45.9|45.9|Standard Deviation|11.7|11.7|||
3999334|NCT01225731|3819547|B4|||Age||years|Mean|43.2|43.2|Standard Deviation|12.6|12.6|||
3999335|NCT01225731|3819548|B3|||Age||years|Mean|45.5|45.5|Standard Deviation|12.8|12.8|||
3999336|NCT01225731|3819549|B2|||Age||years|Mean|46.3|46.3|Standard Deviation|13.7|13.7|||
3999337|NCT01225731|3819550|B1|||Age||years|Mean|43.2|43.2|Standard Deviation|12.9|12.9|||
3999338|NCT01225562|3819654|B4||Male|Sex: Female, Male||Participants|Count of Participants|16102|16102.0||||||
3999339|NCT01225562|3819655|B3||Male|Sex: Female, Male||Participants|Count of Participants|5350|5350.0||||||
3999340|NCT01225562|3819656|B2||Male|Sex: Female, Male||Participants|Count of Participants|5384|5384.0||||||
3999341|NCT01225562|3819657|B1||Male|Sex: Female, Male||Participants|Count of Participants|5368|5368.0||||||
3999342|NCT01225562|3819654|B4||Female|Sex: Female, Male||Participants|Count of Participants|5060|5060.0||||||
3999343|NCT01225562|3819655|B3||Female|Sex: Female, Male||Participants|Count of Participants|1717|1717.0||||||
3999344|NCT01225562|3819656|B2||Female|Sex: Female, Male||Participants|Count of Participants|1661|1661.0||||||
3999345|NCT01225562|3819657|B1||Female|Sex: Female, Male||Participants|Count of Participants|1682|1682.0||||||
3999346|NCT01225562|3819654|B4|||Age||years|Mean|65.3|65.3|Standard Deviation|8.3|8.3|||
3999347|NCT01225562|3819655|B3|||Age||years|Mean|65.4|65.4|Standard Deviation|8.3|8.3|||
3999348|NCT01225562|3819656|B2|||Age||years|Mean|65.2|65.2|Standard Deviation|8.4|8.4|||
3999349|NCT01225562|3819657|B1|||Age||years|Mean|65.4|65.4|Standard Deviation|8.4|8.4|||
3999350|NCT01225549|3819676|B1|Others||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
3999351|NCT01225549|3819676|B1|White||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
3999352|NCT01225549|3819676|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3999353|NCT01225549|3819676|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3999354|NCT01225549|3819676|B1|||Age||Years|Mean|29.6|29.6|Full Range|||18.0|60.0|
3999355|NCT01225354|3819727|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3999356|NCT01225354|3819727|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3999357|NCT01225354|3819727|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3999358|NCT01225354|3819727|B1|||Age||years|Mean|48.2|48.2|Standard Deviation|9.71|9.71|||
3999359|NCT01225354|3819727|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3999360|NCT01225354|3819727|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3999361|NCT01225354|3819727|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3999362|NCT01225289|3819732|B3|Iran, Islamic Republic of||Region of Enrollment||participants|Number|35|35.0||||||
3999363|NCT01225289|3819733|B2|Iran, Islamic Republic of||Region of Enrollment||participants|Number|17|17.0||||||
3999364|NCT01225289|3819734|B1|Iran, Islamic Republic of||Region of Enrollment||participants|Number|18|18.0||||||
3999365|NCT01225289|3819732|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3999366|NCT01225289|3819733|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3999367|NCT01225289|3819734|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3999368|NCT01225289|3819732|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
3999369|NCT01225289|3819733|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3999370|NCT01225289|3819734|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3999371|NCT01225289|3819732|B3|||Age||years|Mean|32.17|32.17|Standard Deviation|6.64|6.64|||
3999372|NCT01225289|3819733|B2|||Age||years|Mean|31.05|31.05|Standard Deviation|5.94|5.94|||
3999373|NCT01225289|3819734|B1|||Age||years|Mean|33.22|33.22|Standard Deviation|7.26|7.26|||
3999374|NCT01225289|3819732|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3999377|NCT01225289|3819732|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
3999378|NCT01225289|3819733|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
3999379|NCT01225289|3819734|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3999380|NCT01225289|3819732|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3999381|NCT01225289|3819733|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3999382|NCT01225289|3819734|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3999383|NCT01225263|3819747|B3|||Recorded Migraine Days/Past 3m, Median (Interquartile Range)||days|Median|20|20.0|Inter-Quartile Range|||14.0|28.0|
3999384|NCT01225263|3819748|B2|||Recorded Migraine Days/Past 3m, Median (Interquartile Range)||days|Median|18.0|18.0|Inter-Quartile Range|||14.0|23.0|
3999385|NCT01225263|3819749|B1|||Recorded Migraine Days/Past 3m, Median (Interquartile Range)||days|Median|25.5|25.5|Inter-Quartile Range|||14.5|34.0|
3999386|NCT01225263|3819747|B3|Other||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
3999387|NCT01225263|3819748|B2|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
3999388|NCT01225263|3819749|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
3999389|NCT01225263|3819747|B3|Non-Hispanic White||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
3999390|NCT01225263|3819748|B2|Non-Hispanic White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
3999391|NCT01225263|3819749|B1|Non-Hispanic White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
3999392|NCT01225263|3819747|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3999393|NCT01225263|3819748|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3999394|NCT01225263|3819749|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3999395|NCT01225263|3819747|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
3999396|NCT01225263|3819748|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
3999397|NCT01225263|3819749|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
3999398|NCT01225263|3819747|B3|Age||Age, Customized||years|Median|33|33.0|Inter-Quartile Range|||21.0|44.0|
3999399|NCT01225263|3819748|B2|Age||Age, Customized||years|Median|28|28.0|Inter-Quartile Range|||21.0|34.0|
3999400|NCT01225263|3819749|B1|Age||Age, Customized||years|Median|40|40.0|Inter-Quartile Range|||23.0|46.0|
3999401|NCT01225211|3819758|B11||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
3999402|NCT01225211|3819759|B10||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3999403|NCT01225211|3819760|B9||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
3999404|NCT01225211|3819761|B8||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3999405|NCT01225211|3819762|B7||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
3999406|NCT01225211|3819763|B6||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3999407|NCT01225211|3819764|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3999408|NCT01225211|3819765|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
3999409|NCT01225211|3819766|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3999410|NCT01225211|3819767|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3999411|NCT01225211|3819768|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3999412|NCT01225211|3819758|B11||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
3999413|NCT01225211|3819759|B10||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3999414|NCT01225211|3819760|B9||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3999415|NCT01225211|3819761|B8||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3999416|NCT01225211|3819762|B7||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3999417|NCT01225211|3819763|B6||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3999418|NCT01225211|3819764|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3999419|NCT01225211|3819765|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3999420|NCT01225211|3819766|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
3999421|NCT01225211|3819767|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
3999422|NCT01225211|3819768|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3999423|NCT01225211|3819758|B11||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3999424|NCT01225211|3819759|B10||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3999425|NCT01225211|3819760|B9||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3999426|NCT01225211|3819761|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3999427|NCT01225211|3819762|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3999428|NCT01225211|3819763|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3999429|NCT01225211|3819764|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3999430|NCT01225211|3819765|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3999431|NCT01225211|3819766|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3999432|NCT01225211|3819767|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3999433|NCT01225211|3819768|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3999434|NCT01225211|3819758|B11||Between 18 and 65 years|Age||Participants|Count of Participants|311|311.0||||||
3999435|NCT01225211|3819759|B10||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
3999436|NCT01225211|3819760|B9||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
3999437|NCT01225211|3819761|B8||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
3999438|NCT01225211|3819762|B7||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
3999439|NCT01225211|3819763|B6||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3999440|NCT01225211|3819764|B5||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
3999441|NCT01225211|3819765|B4||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
3999442|NCT01225211|3819766|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3999443|NCT01225211|3819767|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3999444|NCT01225211|3819768|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
3999445|NCT01225211|3819758|B11||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3999446|NCT01225211|3819759|B10||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3999447|NCT01225211|3819760|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3999448|NCT01225211|3819761|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3999449|NCT01225211|3819762|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3999450|NCT01225211|3819763|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3999451|NCT01225211|3819764|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3999452|NCT01225211|3819765|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3999453|NCT01225211|3819766|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3999454|NCT01225211|3819767|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3999455|NCT01225211|3819768|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3999456|NCT01225159|3819878|B3|No||Underlying disease:DM||participants|Number|164|164.0||||||
3999457|NCT01225159|3819879|B2|No||Underlying disease:DM||participants|Number|83|83.0||||||
3999458|NCT01225159|3819880|B1|No||Underlying disease:DM||participants|Number|81|81.0||||||
3999459|NCT01225159|3819878|B3|Yes||Underlying disease:DM||participants|Number|35|35.0||||||
3999460|NCT01225159|3819879|B2|Yes||Underlying disease:DM||participants|Number|17|17.0||||||
3999461|NCT01225159|3819880|B1|Yes||Underlying disease:DM||participants|Number|18|18.0||||||
3999462|NCT01225159|3819878|B3|Emergency||Case status||participants|Number|51|51.0||||||
3999463|NCT01225159|3819879|B2|Emergency||Case status||participants|Number|28|28.0||||||
3999464|NCT01225159|3819880|B1|Emergency||Case status||participants|Number|23|23.0||||||
3999465|NCT01225159|3819878|B3|Elective||Case status||participants|Number|148|148.0||||||
3999466|NCT01225159|3819879|B2|Elective||Case status||participants|Number|72|72.0||||||
3999467|NCT01225159|3819880|B1|Elective||Case status||participants|Number|76|76.0||||||
3999468|NCT01225159|3819878|B3|Others||Operation||participants|Number|8|8.0||||||
3999469|NCT01225159|3819879|B2|Others||Operation||participants|Number|3|3.0||||||
3999470|NCT01225159|3819880|B1|Others||Operation||participants|Number|5|5.0||||||
3999471|NCT01225159|3819878|B3|More than 1 operation||Operation||participants|Number|15|15.0||||||
3999472|NCT01225159|3819879|B2|More than 1 operation||Operation||participants|Number|8|8.0||||||
3999473|NCT01225159|3819880|B1|More than 1 operation||Operation||participants|Number|7|7.0||||||
3999474|NCT01225159|3819878|B3|Aneurysmectomy of thoracic aortic aneurysm (TAA)||Operation||participants|Number|3|3.0||||||
3999475|NCT01225159|3819879|B2|Aneurysmectomy of thoracic aortic aneurysm (TAA)||Operation||participants|Number|3|3.0||||||
3999476|NCT01225159|3819880|B1|Aneurysmectomy of thoracic aortic aneurysm (TAA)||Operation||participants|Number|0|0.0||||||
3999477|NCT01225159|3819878|B3|Bentall's operation||Operation||participants|Number|2|2.0||||||
3999478|NCT01225159|3819879|B2|Bentall's operation||Operation||participants|Number|1|1.0||||||
3999479|NCT01225159|3819880|B1|Bentall's operation||Operation||participants|Number|1|1.0||||||
3999480|NCT01225159|3819878|B3|Closure of septal defects||Operation||participants|Number|15|15.0||||||
3999481|NCT01225159|3819879|B2|Closure of septal defects||Operation||participants|Number|5|5.0||||||
3999482|NCT01225159|3819880|B1|Closure of septal defects||Operation||participants|Number|10|10.0||||||
3999483|NCT01225159|3819878|B3|Coronary artery bypass graft||Operation||participants|Number|74|74.0||||||
3999484|NCT01225159|3819879|B2|Coronary artery bypass graft||Operation||participants|Number|37|37.0||||||
3999485|NCT01225159|3819880|B1|Coronary artery bypass graft||Operation||participants|Number|37|37.0||||||
3999486|NCT01225159|3819878|B3|Valve replacement / repairment||Operation||participants|Number|82|82.0||||||
3999487|NCT01225159|3819879|B2|Valve replacement / repairment||Operation||participants|Number|43|43.0||||||
3999488|NCT01225159|3819880|B1|Valve replacement / repairment||Operation||participants|Number|39|39.0||||||
3999489|NCT01225159|3819878|B3|5||American Society of Anesthesiologists (ASA) class|"ASA classification defined according to American Society of Anesthesiologists that divided into 4 classes:~ASA class 1: healthy patient ASA class 2: mild systemic disease ASA class 3: uncontrolled systemic disease ASA class 4: incapacitated patient ASA class 5: moribund"|participants|Number|4|4.0||||||
3999490|NCT01225159|3819879|B2|5||American Society of Anesthesiologists (ASA) class|"ASA classification defined according to American Society of Anesthesiologists that divided into 4 classes:~ASA class 1: healthy patient ASA class 2: mild systemic disease ASA class 3: uncontrolled systemic disease ASA class 4: incapacitated patient ASA class 5: moribund"|participants|Number|3|3.0||||||
3999491|NCT01225159|3819880|B1|5||American Society of Anesthesiologists (ASA) class|"ASA classification defined according to American Society of Anesthesiologists that divided into 4 classes:~ASA class 1: healthy patient ASA class 2: mild systemic disease ASA class 3: uncontrolled systemic disease ASA class 4: incapacitated patient ASA class 5: moribund"|participants|Number|1|1.0||||||
3999562|NCT01225146|3819890|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3999793|NCT01224639|3820003|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3999492|NCT01225159|3819878|B3|4||American Society of Anesthesiologists (ASA) class|"ASA classification defined according to American Society of Anesthesiologists that divided into 4 classes:~ASA class 1: healthy patient ASA class 2: mild systemic disease ASA class 3: uncontrolled systemic disease ASA class 4: incapacitated patient ASA class 5: moribund"|participants|Number|22|22.0||||||
3999493|NCT01225159|3819879|B2|4||American Society of Anesthesiologists (ASA) class|"ASA classification defined according to American Society of Anesthesiologists that divided into 4 classes:~ASA class 1: healthy patient ASA class 2: mild systemic disease ASA class 3: uncontrolled systemic disease ASA class 4: incapacitated patient ASA class 5: moribund"|participants|Number|10|10.0||||||
3999494|NCT01225159|3819880|B1|4||American Society of Anesthesiologists (ASA) class|"ASA classification defined according to American Society of Anesthesiologists that divided into 4 classes:~ASA class 1: healthy patient ASA class 2: mild systemic disease ASA class 3: uncontrolled systemic disease ASA class 4: incapacitated patient ASA class 5: moribund"|participants|Number|12|12.0||||||
3999495|NCT01225159|3819878|B3|3||American Society of Anesthesiologists (ASA) class|"ASA classification defined according to American Society of Anesthesiologists that divided into 4 classes:~ASA class 1: healthy patient ASA class 2: mild systemic disease ASA class 3: uncontrolled systemic disease ASA class 4: incapacitated patient ASA class 5: moribund"|participants|Number|173|173.0||||||
3999496|NCT01225159|3819879|B2|3||American Society of Anesthesiologists (ASA) class|"ASA classification defined according to American Society of Anesthesiologists that divided into 4 classes:~ASA class 1: healthy patient ASA class 2: mild systemic disease ASA class 3: uncontrolled systemic disease ASA class 4: incapacitated patient ASA class 5: moribund"|participants|Number|87|87.0||||||
3999497|NCT01225159|3819880|B1|3||American Society of Anesthesiologists (ASA) class|"ASA classification defined according to American Society of Anesthesiologists that divided into 4 classes:~ASA class 1: healthy patient ASA class 2: mild systemic disease ASA class 3: uncontrolled systemic disease ASA class 4: incapacitated patient ASA class 5: moribund"|participants|Number|86|86.0||||||
3999498|NCT01225159|3819878|B3|4||New York Heart Association (NYHA) class|Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity, Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, Class IV: Severe limitations. Experiences symptoms even while at rest.|participants|Number|9|9.0||||||
3999499|NCT01225159|3819879|B2|4||New York Heart Association (NYHA) class|Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity, Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, Class IV: Severe limitations. Experiences symptoms even while at rest.|participants|Number|5|5.0||||||
3999500|NCT01225159|3819880|B1|4||New York Heart Association (NYHA) class|Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity, Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, Class IV: Severe limitations. Experiences symptoms even while at rest.|participants|Number|4|4.0||||||
3999501|NCT01225159|3819878|B3|3||New York Heart Association (NYHA) class|Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity, Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, Class IV: Severe limitations. Experiences symptoms even while at rest.|participants|Number|57|57.0||||||
3999502|NCT01225159|3819879|B2|3||New York Heart Association (NYHA) class|Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity, Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, Class IV: Severe limitations. Experiences symptoms even while at rest.|participants|Number|25|25.0||||||
3999503|NCT01225159|3819880|B1|3||New York Heart Association (NYHA) class|Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity, Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, Class IV: Severe limitations. Experiences symptoms even while at rest.|participants|Number|32|32.0||||||
3999504|NCT01225159|3819878|B3|2||New York Heart Association (NYHA) class|Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity, Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, Class IV: Severe limitations. Experiences symptoms even while at rest.|participants|Number|120|120.0||||||
3999505|NCT01225159|3819879|B2|2||New York Heart Association (NYHA) class|Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity, Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, Class IV: Severe limitations. Experiences symptoms even while at rest.|participants|Number|65|65.0||||||
3999506|NCT01225159|3819880|B1|2||New York Heart Association (NYHA) class|Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity, Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, Class IV: Severe limitations. Experiences symptoms even while at rest.|participants|Number|55|55.0||||||
3999507|NCT01225159|3819878|B3|1||New York Heart Association (NYHA) class|Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity, Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, Class IV: Severe limitations. Experiences symptoms even while at rest.|participants|Number|13|13.0||||||
3999563|NCT01225146|3819891|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3999564|NCT01225146|3819889|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999565|NCT01225146|3819890|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999508|NCT01225159|3819879|B2|1||New York Heart Association (NYHA) class|Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity, Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, Class IV: Severe limitations. Experiences symptoms even while at rest.|participants|Number|5|5.0||||||
3999509|NCT01225159|3819880|B1|1||New York Heart Association (NYHA) class|Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity, Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, Class IV: Severe limitations. Experiences symptoms even while at rest.|participants|Number|8|8.0||||||
3999510|NCT01225159|3819878|B3|No data||Smoking status||participants|Number|6|6.0||||||
3999511|NCT01225159|3819879|B2|No data||Smoking status||participants|Number|4|4.0||||||
3999512|NCT01225159|3819880|B1|No data||Smoking status||participants|Number|2|2.0||||||
3999513|NCT01225159|3819878|B3|Never||Smoking status||participants|Number|101|101.0||||||
3999514|NCT01225159|3819879|B2|Never||Smoking status||participants|Number|53|53.0||||||
3999515|NCT01225159|3819880|B1|Never||Smoking status||participants|Number|48|48.0||||||
3999516|NCT01225159|3819878|B3|Former||Smoking status||participants|Number|60|60.0||||||
3999517|NCT01225159|3819879|B2|Former||Smoking status||participants|Number|32|32.0||||||
3999518|NCT01225159|3819880|B1|Former||Smoking status||participants|Number|28|28.0||||||
3999519|NCT01225159|3819878|B3|Current||Smoking status||participants|Number|32|32.0||||||
3999520|NCT01225159|3819879|B2|Current||Smoking status||participants|Number|11|11.0||||||
3999521|NCT01225159|3819880|B1|Current||Smoking status||participants|Number|21|21.0||||||
3999522|NCT01225159|3819878|B3|||Mean body mass index (SD), kg/m^2||kg/m^2|Mean|22.8|22.8|Standard Deviation|4.1|4.1|||
3999523|NCT01225159|3819879|B2|||Mean body mass index (SD), kg/m^2||kg/m^2|Mean|23.3|23.3|Standard Deviation|4.4|4.4|||
3999524|NCT01225159|3819880|B1|||Mean body mass index (SD), kg/m^2||kg/m^2|Mean|22.7|22.7|Standard Deviation|3.9|3.9|||
3999525|NCT01225159|3819878|B3||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
3999526|NCT01225159|3819879|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
3999527|NCT01225159|3819880|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
3999528|NCT01225159|3819878|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
3999529|NCT01225159|3819879|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3999530|NCT01225159|3819880|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
3999531|NCT01225159|3819878|B3|||Age||years|Median|54|54.0|Inter-Quartile Range|||41.5|65.0|
3999532|NCT01225159|3819879|B2|||Age||years|Median|54|54.0|Inter-Quartile Range|||45.0|65.2|
3999533|NCT01225159|3819880|B1|||Age||years|Median|54|54.0|Inter-Quartile Range|||38.0|63.5|
3999534|NCT01225146|3819889|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
3999535|NCT01225146|3819890|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
3999536|NCT01225146|3819891|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
3999537|NCT01225146|3819889|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999538|NCT01225146|3819890|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999539|NCT01225146|3819891|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999540|NCT01225146|3819889|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999541|NCT01225146|3819890|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999542|NCT01225146|3819891|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999543|NCT01225146|3819889|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3999544|NCT01225146|3819890|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3999545|NCT01225146|3819891|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3999546|NCT01225146|3819889|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3999547|NCT01225146|3819890|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999548|NCT01225146|3819891|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3999549|NCT01225146|3819889|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999550|NCT01225146|3819890|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999551|NCT01225146|3819891|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999552|NCT01225146|3819889|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3999553|NCT01225146|3819890|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3999554|NCT01225146|3819891|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999555|NCT01225146|3819889|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999556|NCT01225146|3819890|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999557|NCT01225146|3819891|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999558|NCT01225146|3819889|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999559|NCT01225146|3819890|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999560|NCT01225146|3819891|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999561|NCT01225146|3819889|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3999566|NCT01225146|3819891|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999567|NCT01225146|3819889|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3999568|NCT01225146|3819890|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3999569|NCT01225146|3819891|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3999570|NCT01225146|3819889|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3999571|NCT01225146|3819890|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3999572|NCT01225146|3819891|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3999573|NCT01225146|3819889|B3|||Age||years|Mean|62.6|62.6|Full Range|||42.0|76.0|
3999574|NCT01225146|3819890|B2|||Age||years|Mean|56.5|56.5|Full Range|||42.0|71.0|
3999575|NCT01225146|3819891|B1|||Age||years|Mean|64.7|64.7|Full Range|||47.0|76.0|
3999576|NCT01225146|3819889|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3999577|NCT01225146|3819890|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
3999578|NCT01225146|3819891|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
3999579|NCT01225146|3819889|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
3999580|NCT01225146|3819890|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
3999581|NCT01225146|3819891|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
3999582|NCT01225146|3819889|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3999583|NCT01225146|3819890|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3999584|NCT01225146|3819891|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3999585|NCT01225068|3819908|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
3999586|NCT01225068|3819909|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3999587|NCT01225068|3819910|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3999588|NCT01225068|3819908|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
3999589|NCT01225068|3819909|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
3999590|NCT01225068|3819910|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3999591|NCT01225068|3819908|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3999592|NCT01225068|3819909|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3999593|NCT01225068|3819910|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3999594|NCT01225068|3819908|B3|||Age||years|Mean|47.7|47.7|Standard Deviation|10.3|10.3|||
3999595|NCT01225068|3819909|B2|||Age||years|Mean|48.3|48.3|Standard Deviation|9.1|9.1|||
3999596|NCT01225068|3819910|B1|||Age||years|Mean|47.1|47.1|Standard Deviation|11.6|11.6|||
3999597|NCT01225068|3819908|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3999598|NCT01225068|3819909|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3999599|NCT01225068|3819910|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3999600|NCT01225068|3819908|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
3999601|NCT01225068|3819909|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3999602|NCT01225068|3819910|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
3999603|NCT01225068|3819908|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3999604|NCT01225068|3819909|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3999605|NCT01225068|3819910|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3999606|NCT01225055|3819917|B4|United States||Region of Enrollment||participants|Number|60|60.0||||||
3999607|NCT01225055|3819918|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
3999608|NCT01225055|3819919|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
3999609|NCT01225055|3819920|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
3999610|NCT01225055|3819917|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999611|NCT01225055|3819918|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999612|NCT01225055|3819919|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999613|NCT01225055|3819920|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999614|NCT01225055|3819917|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999615|NCT01225055|3819918|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999616|NCT01225055|3819919|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999617|NCT01225055|3819920|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999618|NCT01225055|3819917|B4||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
3999619|NCT01225055|3819918|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3999620|NCT01225055|3819919|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
3999621|NCT01225055|3819920|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
3999622|NCT01225055|3819917|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
3999623|NCT01225055|3819918|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3999624|NCT01225055|3819919|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
3999625|NCT01225055|3819920|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3999626|NCT01225055|3819917|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3999627|NCT01225055|3819918|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999628|NCT01225055|3819919|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3999629|NCT01225055|3819920|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999630|NCT01225055|3819917|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3999631|NCT01225055|3819918|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999632|NCT01225055|3819919|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3999633|NCT01225055|3819920|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999634|NCT01225055|3819917|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999635|NCT01225055|3819918|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999636|NCT01225055|3819919|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999637|NCT01225055|3819920|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999638|NCT01225055|3819917|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999639|NCT01225055|3819918|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999640|NCT01225055|3819919|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999641|NCT01225055|3819920|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999642|NCT01225055|3819917|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
3999643|NCT01225055|3819918|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
3999644|NCT01225055|3819919|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3999645|NCT01225055|3819920|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3999646|NCT01225055|3819917|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
3999647|NCT01225055|3819918|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3999648|NCT01225055|3819919|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3999649|NCT01225055|3819920|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
3999650|NCT01225055|3819917|B4||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
3999651|NCT01225055|3819918|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3999652|NCT01225055|3819919|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3999653|NCT01225055|3819920|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3999654|NCT01225055|3819917|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3999655|NCT01225055|3819918|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3999656|NCT01225055|3819919|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3999657|NCT01225055|3819920|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3999658|NCT01225055|3819917|B4|||Age||years|Mean|45.4|45.4|Standard Deviation|16.3|16.3|||
3999659|NCT01225055|3819918|B3|||Age||years|Mean|46.6|46.6|Standard Deviation|15.4|15.4|||
3999660|NCT01225055|3819919|B2|||Age||years|Mean|40.9|40.9|Standard Deviation|16.4|16.4|||
3999661|NCT01225055|3819920|B1|||Age||years|Mean|47.6|47.6|Standard Deviation|16.3|16.3|||
3999662|NCT01225055|3819917|B4||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
3999663|NCT01225055|3819918|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3999664|NCT01225055|3819919|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
3999665|NCT01225055|3819920|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
3999666|NCT01225055|3819917|B4||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
3999667|NCT01225055|3819918|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
3999668|NCT01225055|3819919|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
3999669|NCT01225055|3819920|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
3999670|NCT01225055|3819917|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3999671|NCT01225055|3819918|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3999672|NCT01225055|3819919|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3999673|NCT01225055|3819920|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3999674|NCT01225029|3819945|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3999675|NCT01225029|3819946|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999676|NCT01225029|3819947|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3999677|NCT01225029|3819945|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999678|NCT01225029|3819946|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999679|NCT01225029|3819947|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999680|NCT01225029|3819945|B3||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
3999681|NCT01225029|3819946|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
3999682|NCT01225029|3819947|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3999683|NCT01225029|3819945|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
3999684|NCT01225029|3819946|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3999685|NCT01225029|3819947|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
3999686|NCT01225029|3819945|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999687|NCT01225029|3819946|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999688|NCT01225029|3819947|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999689|NCT01225029|3819945|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3999690|NCT01225029|3819946|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3999691|NCT01225029|3819947|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3999692|NCT01225029|3819945|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999693|NCT01225029|3819946|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999694|NCT01225029|3819947|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999695|NCT01225029|3819945|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
3999696|NCT01225029|3819946|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3999697|NCT01225029|3819947|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3999698|NCT01225029|3819945|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3999699|NCT01225029|3819946|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3999700|NCT01225029|3819947|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3999701|NCT01225029|3819945|B3|||Age, Customized||weeks|Mean|36.1|36.1|Standard Deviation|1.5|1.5|||
3999702|NCT01225029|3819946|B2|||Age, Customized||weeks|Mean|36.4|36.4|Standard Deviation|1.5|1.5|||
3999703|NCT01225029|3819947|B1|||Age, Customized||weeks|Mean|35.8|35.8|Standard Deviation|1.6|1.6|||
3999704|NCT01224821|3819958|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3999705|NCT01224821|3819958|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
3999706|NCT01224821|3819958|B1|White||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
3999707|NCT01224821|3819958|B1||Male|Gender||Participants|Count of Participants|25|25.0||||||
3999708|NCT01224821|3819958|B1||Female|Gender||Participants|Count of Participants|22|22.0||||||
3999709|NCT01224821|3819958|B1|||Age||Years|Mean|50.6|50.6|Standard Deviation|12|12.0|||
3999710|NCT01224782|3819977|B1|||Baseline Intact Parathyroid Hormone (iPTH)||pmol/L|Mean|36.33|36.33|Standard Deviation|53.7|53.7|||
3999711|NCT01224782|3819977|B1|Chronic Kidney Disease Stage 4||Baseline Chronic Kidney Disease Stage|Stage 3: Glomerular Filtration Rate 30 - 59 mL/min/1.73 m^2; Stage 4: Glomerular Filtration Rate 15 - 29 mL/min/1.73 m^2.|percentage of participants|Number|59.2|59.2||||||
3999712|NCT01224782|3819977|B1|Chronic Kidney Disease Stage 3||Baseline Chronic Kidney Disease Stage|Stage 3: Glomerular Filtration Rate 30 - 59 mL/min/1.73 m^2; Stage 4: Glomerular Filtration Rate 15 - 29 mL/min/1.73 m^2.|percentage of participants|Number|40.8|40.8||||||
3999713|NCT01224782|3819977|B1||Male|Sex: Female, Male||Participants|Count of Participants|517|517.0||||||
3999714|NCT01224782|3819977|B1||Female|Sex: Female, Male||Participants|Count of Participants|477|477.0||||||
3999715|NCT01224782|3819977|B1|||Age||years|Mean|64.29|64.29|Standard Deviation|13.14|13.14|||
3999716|NCT01224678|3819986|B3|United States||Region of Enrollment||Participants|Count of Participants|300|300.0||||||
3999717|NCT01224678|3819987|B2|United States||Region of Enrollment||Participants|Count of Participants|150|150.0||||||
3999718|NCT01224678|3819988|B1|United States||Region of Enrollment||Participants|Count of Participants|150|150.0||||||
3999719|NCT01224678|3819986|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3999720|NCT01224678|3819987|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3999721|NCT01224678|3819988|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3999722|NCT01224678|3819986|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3999723|NCT01224678|3819987|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
3999724|NCT01224678|3819988|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3999725|NCT01224678|3819986|B3||White|Race (NIH/OMB)||Participants|Count of Participants|238|238.0||||||
3999726|NCT01224678|3819987|B2||White|Race (NIH/OMB)||Participants|Count of Participants|114|114.0||||||
3999727|NCT01224678|3819988|B1||White|Race (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
3999728|NCT01224678|3819986|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
3999729|NCT01224678|3819987|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
3999730|NCT01224678|3819988|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3999731|NCT01224678|3819986|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3999732|NCT01224678|3819987|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3999733|NCT01224678|3819988|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999734|NCT01224678|3819986|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
3999735|NCT01224678|3819987|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3999736|NCT01224678|3819988|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
3999737|NCT01224678|3819986|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3999738|NCT01224678|3819987|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
3999739|NCT01224678|3819988|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
3999740|NCT01224678|3819986|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
3999741|NCT01224678|3819987|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
3999742|NCT01224678|3819988|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
3999743|NCT01224678|3819986|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|253|253.0||||||
3999744|NCT01224678|3819987|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
3999745|NCT01224678|3819988|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
3999746|NCT01224678|3819986|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
3999747|NCT01224678|3819987|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
3999748|NCT01224678|3819988|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
3999749|NCT01224678|3819986|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3999750|NCT01224678|3819987|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3999751|NCT01224678|3819988|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
3999752|NCT01224678|3819986|B3||Female|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
3999753|NCT01224678|3819987|B2||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3999754|NCT01224678|3819988|B1||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
3999755|NCT01224678|3819986|B3|||Age||years|Median|43|43.0|Full Range|||22.7|59.4|
3999756|NCT01224678|3819987|B2|||Age||years|Median|42.7|42.7|Full Range|||22.7|59.4|
3999757|NCT01224678|3819988|B1|||Age||years|Median|44.3|44.3|Full Range|||24.8|55.1|
3999758|NCT01224639|3819995|B9|Other||Race/Ethnicity, Customized|"The baseline measure category other refers to mixed race."|participants|Number|89|89.0||||||
3999759|NCT01224639|3819996|B8|Other||Race/Ethnicity, Customized|"The baseline measure category other refers to mixed race."|participants|Number|4|4.0||||||
3999760|NCT01224639|3819997|B7|Other||Race/Ethnicity, Customized|"The baseline measure category other refers to mixed race."|participants|Number|18|18.0||||||
3999761|NCT01224639|3819998|B6|Other||Race/Ethnicity, Customized|"The baseline measure category other refers to mixed race."|participants|Number|4|4.0||||||
3999762|NCT01224639|3819999|B5|Other||Race/Ethnicity, Customized|"The baseline measure category other refers to mixed race."|participants|Number|21|21.0||||||
3999763|NCT01224639|3820000|B4|Other||Race/Ethnicity, Customized|"The baseline measure category other refers to mixed race."|participants|Number|3|3.0||||||
3999764|NCT01224639|3820001|B3|Other||Race/Ethnicity, Customized|"The baseline measure category other refers to mixed race."|participants|Number|17|17.0||||||
3999765|NCT01224639|3820002|B2|Other||Race/Ethnicity, Customized|"The baseline measure category other refers to mixed race."|participants|Number|5|5.0||||||
3999766|NCT01224639|3820003|B1|Other||Race/Ethnicity, Customized|"The baseline measure category other refers to mixed race."|participants|Number|17|17.0||||||
3999767|NCT01224639|3819995|B9|White||Race/Ethnicity, Customized|"The baseline measure category other refers to mixed race."|participants|Number|7|7.0||||||
3999768|NCT01224639|3819996|B8|White||Race/Ethnicity, Customized|"The baseline measure category other refers to mixed race."|participants|Number|1|1.0||||||
3999769|NCT01224639|3819997|B7|White||Race/Ethnicity, Customized|"The baseline measure category other refers to mixed race."|participants|Number|0|0.0||||||
3999770|NCT01224639|3819998|B6|White||Race/Ethnicity, Customized|"The baseline measure category other refers to mixed race."|participants|Number|0|0.0||||||
3999771|NCT01224639|3819999|B5|White||Race/Ethnicity, Customized|"The baseline measure category other refers to mixed race."|participants|Number|0|0.0||||||
3999772|NCT01224639|3820000|B4|White||Race/Ethnicity, Customized|"The baseline measure category other refers to mixed race."|participants|Number|0|0.0||||||
3999773|NCT01224639|3820001|B3|White||Race/Ethnicity, Customized|"The baseline measure category other refers to mixed race."|participants|Number|4|4.0||||||
3999774|NCT01224639|3820002|B2|White||Race/Ethnicity, Customized|"The baseline measure category other refers to mixed race."|participants|Number|0|0.0||||||
3999775|NCT01224639|3820003|B1|White||Race/Ethnicity, Customized|"The baseline measure category other refers to mixed race."|participants|Number|2|2.0||||||
3999776|NCT01224639|3819995|B9||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3999777|NCT01224639|3819996|B8||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3999778|NCT01224639|3819997|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
3999779|NCT01224639|3819998|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3999780|NCT01224639|3819999|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3999781|NCT01224639|3820000|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3999782|NCT01224639|3820001|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
3999783|NCT01224639|3820002|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
3999784|NCT01224639|3820003|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
3999785|NCT01224639|3819995|B9||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
3999786|NCT01224639|3819996|B8||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3999787|NCT01224639|3819997|B7||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
3999788|NCT01224639|3819998|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
3999789|NCT01224639|3819999|B5||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
3999790|NCT01224639|3820000|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
3999791|NCT01224639|3820001|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
3999792|NCT01224639|3820002|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
3999794|NCT01224639|3819995|B9|>=65 years||Age, Customized||participants|Number|0|0.0||||||
3999795|NCT01224639|3819996|B8|>=65 years||Age, Customized||participants|Number|0|0.0||||||
3999796|NCT01224639|3819997|B7|>=65 years||Age, Customized||participants|Number|0|0.0||||||
3999797|NCT01224639|3819998|B6|>=65 years||Age, Customized||participants|Number|0|0.0||||||
3999798|NCT01224639|3819999|B5|>=65 years||Age, Customized||participants|Number|0|0.0||||||
3999799|NCT01224639|3820000|B4|>=65 years||Age, Customized||participants|Number|0|0.0||||||
3999800|NCT01224639|3820001|B3|>=65 years||Age, Customized||participants|Number|0|0.0||||||
3999801|NCT01224639|3820002|B2|>=65 years||Age, Customized||participants|Number|0|0.0||||||
3999802|NCT01224639|3820003|B1|>=65 years||Age, Customized||participants|Number|0|0.0||||||
3999803|NCT01224639|3819995|B9|Greater than or equal to (>=) 18 and <65 years||Age, Customized||participants|Number|96|96.0||||||
3999804|NCT01224639|3819996|B8|Greater than or equal to (>=) 18 and <65 years||Age, Customized||participants|Number|5|5.0||||||
3999805|NCT01224639|3819997|B7|Greater than or equal to (>=) 18 and <65 years||Age, Customized||participants|Number|18|18.0||||||
3999806|NCT01224639|3819998|B6|Greater than or equal to (>=) 18 and <65 years||Age, Customized||participants|Number|4|4.0||||||
3999807|NCT01224639|3819999|B5|Greater than or equal to (>=) 18 and <65 years||Age, Customized||participants|Number|21|21.0||||||
3999808|NCT01224639|3820000|B4|Greater than or equal to (>=) 18 and <65 years||Age, Customized||participants|Number|3|3.0||||||
3999809|NCT01224639|3820001|B3|Greater than or equal to (>=) 18 and <65 years||Age, Customized||participants|Number|21|21.0||||||
3999810|NCT01224639|3820002|B2|Greater than or equal to (>=) 18 and <65 years||Age, Customized||participants|Number|5|5.0||||||
3999811|NCT01224639|3820003|B1|Greater than or equal to (>=) 18 and <65 years||Age, Customized||participants|Number|19|19.0||||||
3999812|NCT01224639|3819995|B9|Less than (<) 18 years||Age, Customized||participants|Number|0|0.0||||||
3999813|NCT01224639|3819996|B8|Less than (<) 18 years||Age, Customized||participants|Number|0|0.0||||||
3999814|NCT01224639|3819997|B7|Less than (<) 18 years||Age, Customized||participants|Number|0|0.0||||||
3999815|NCT01224639|3819998|B6|Less than (<) 18 years||Age, Customized||participants|Number|0|0.0||||||
3999816|NCT01224639|3819999|B5|Less than (<) 18 years||Age, Customized||participants|Number|0|0.0||||||
3999817|NCT01224639|3820000|B4|Less than (<) 18 years||Age, Customized||participants|Number|0|0.0||||||
3999818|NCT01224639|3820001|B3|Less than (<) 18 years||Age, Customized||participants|Number|0|0.0||||||
3999819|NCT01224639|3820002|B2|Less than (<) 18 years||Age, Customized||participants|Number|0|0.0||||||
3999820|NCT01224639|3820003|B1|Less than (<) 18 years||Age, Customized||participants|Number|0|0.0||||||
3999821|NCT01224626|3820116|B1|Absent||Complications|"Complications is the patient's current experiences with illnesses, operations, injuries and treatments.~The physician of this survey made the diagnosis. (e.g. hypertension, diabetes, etc.)"|participants|Number|0|0.0||||||
3999822|NCT01224626|3820116|B1|Present||Complications|"Complications is the patient's current experiences with illnesses, operations, injuries and treatments.~The physician of this survey made the diagnosis. (e.g. hypertension, diabetes, etc.)"|participants|Number|41|41.0||||||
3999823|NCT01224626|3820116|B1|Unknown||Past medical history|"Past medical history is the patient's past experiences with illnesses, operations, injuries and treatments.~The physician of this survey made the diagnosis or took from the participants."|participants|Number|1|1.0||||||
3999824|NCT01224626|3820116|B1|Absent||Past medical history|"Past medical history is the patient's past experiences with illnesses, operations, injuries and treatments.~The physician of this survey made the diagnosis or took from the participants."|participants|Number|18|18.0||||||
3999825|NCT01224626|3820116|B1|Present||Past medical history|"Past medical history is the patient's past experiences with illnesses, operations, injuries and treatments.~The physician of this survey made the diagnosis or took from the participants."|participants|Number|22|22.0||||||
3999826|NCT01224626|3820116|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
3999827|NCT01224626|3820116|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
3999828|NCT01224626|3820116|B1|>=65 years||Age, Customized||participants|Number|29|29.0||||||
3999829|NCT01224626|3820116|B1|<65 years||Age, Customized||participants|Number|12|12.0||||||
3999830|NCT01224444|3820122|B1|United States||Region of Enrollment||participants|Number|269|269.0||||||
3999831|NCT01224444|3820122|B1||Male|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
3999832|NCT01224444|3820122|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
3999833|NCT01224444|3820122|B1||>=65 years|Age||Participants|Count of Participants|102|102.0||||||
3999834|NCT01224444|3820122|B1||Between 18 and 65 years|Age||Participants|Count of Participants|167|167.0||||||
3999835|NCT01224444|3820122|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
3999836|NCT01224444|3820122|B1|||Age||years|Mean|63.4|63.4|Standard Deviation|9.1|9.1|||
3999837|NCT01224431|3820126|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
3999838|NCT01224431|3820127|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
3999839|NCT01224431|3820128|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
3999840|NCT01224431|3820126|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
3999841|NCT01224431|3820127|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3999842|NCT01224431|3820128|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
3999843|NCT01224431|3820126|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
3999844|NCT01224431|3820127|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
3999845|NCT01224431|3820128|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
3999846|NCT01224431|3820126|B3|||Age|In days of age not years|days|Mean|44|44.0|Standard Deviation|17|17.0|||
3999847|NCT01224431|3820127|B2|||Age|In days of age not years|days|Mean|40|40.0|Standard Deviation|18|18.0|||
3999848|NCT01224431|3820128|B1|||Age|In days of age not years|days|Mean|48|48.0|Standard Deviation|15|15.0|||
3999849|NCT01224431|3820126|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3999850|NCT01224431|3820127|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3999851|NCT01224431|3820128|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
3999852|NCT01224431|3820126|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3999853|NCT01224431|3820127|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3999854|NCT01224431|3820128|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
3999855|NCT01224431|3820126|B3||<=18 years|Age||Participants|Count of Participants|60|60.0||||||
3999856|NCT01224431|3820127|B2||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
3999857|NCT01224431|3820128|B1||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
3999858|NCT01224236|3820137|B3|United States||Region of Enrollment||participants|Number|150|150.0||||||
3999859|NCT01224236|3820138|B2|United States||Region of Enrollment||participants|Number|74|74.0||||||
3999860|NCT01224236|3820139|B1|United States||Region of Enrollment||participants|Number|76|76.0||||||
3999861|NCT01224236|3820137|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
3999862|NCT01224236|3820138|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
3999863|NCT01224236|3820139|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3999864|NCT01224236|3820137|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
3999865|NCT01224236|3820138|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
3999866|NCT01224236|3820139|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
3999867|NCT01224236|3820137|B3|||Age|Age is reported as postmenstrual age (PMA), which is the gestational age in weeks plus the postnatal age in weeks.|weeks|Mean|29.7|29.7|Standard Deviation|1.5|1.5|||
3999868|NCT01224236|3820138|B2|||Age|Age is reported as postmenstrual age (PMA), which is the gestational age in weeks plus the postnatal age in weeks.|weeks|Mean|29.7|29.7|Standard Deviation|1.4|1.4|||
3999869|NCT01224236|3820139|B1|||Age|Age is reported as postmenstrual age (PMA), which is the gestational age in weeks plus the postnatal age in weeks.|weeks|Mean|29.7|29.7|Standard Deviation|1.5|1.5|||
3999870|NCT01224171|3820148|B3|No||Extraintestinal Manifestations at Baseline||participants|Number|170|170.0||||||
3999871|NCT01224171|3820149|B2|No||Extraintestinal Manifestations at Baseline||participants|Number|93|93.0||||||
3999872|NCT01224171|3820150|B1|No||Extraintestinal Manifestations at Baseline||participants|Number|77|77.0||||||
3999873|NCT01224171|3820148|B3|Yes||Extraintestinal Manifestations at Baseline||participants|Number|246|246.0||||||
3999874|NCT01224171|3820149|B2|Yes||Extraintestinal Manifestations at Baseline||participants|Number|116|116.0||||||
3999875|NCT01224171|3820150|B1|Yes||Extraintestinal Manifestations at Baseline||participants|Number|130|130.0||||||
3999876|NCT01224171|3820148|B3|No Fistula||Draining Fistula at Baseline||participants|Number|365|365.0||||||
3999877|NCT01224171|3820149|B2|No Fistula||Draining Fistula at Baseline||participants|Number|183|183.0||||||
3999878|NCT01224171|3820150|B1|No Fistula||Draining Fistula at Baseline||participants|Number|182|182.0||||||
3999879|NCT01224171|3820148|B3|All Closed||Draining Fistula at Baseline||participants|Number|1|1.0||||||
3999880|NCT01224171|3820149|B2|All Closed||Draining Fistula at Baseline||participants|Number|1|1.0||||||
3999881|NCT01224171|3820150|B1|All Closed||Draining Fistula at Baseline||participants|Number|0|0.0||||||
3999882|NCT01224171|3820148|B3|Yes||Draining Fistula at Baseline||participants|Number|50|50.0||||||
3999883|NCT01224171|3820149|B2|Yes||Draining Fistula at Baseline||participants|Number|25|25.0||||||
3999884|NCT01224171|3820150|B1|Yes||Draining Fistula at Baseline||participants|Number|25|25.0||||||
3999885|NCT01224171|3820148|B3|No||History of Fistulizing Disease||participants|Number|268|268.0||||||
3999886|NCT01224171|3820149|B2|No||History of Fistulizing Disease||participants|Number|138|138.0||||||
3999887|NCT01224171|3820150|B1|No||History of Fistulizing Disease||participants|Number|130|130.0||||||
3999888|NCT01224171|3820148|B3|Yes||History of Fistulizing Disease||participants|Number|148|148.0||||||
3999889|NCT01224171|3820149|B2|Yes||History of Fistulizing Disease||participants|Number|71|71.0||||||
3999890|NCT01224171|3820150|B1|Yes||History of Fistulizing Disease||participants|Number|77|77.0||||||
3999891|NCT01224171|3820148|B3|Former Smoker||Smoking Status||participants|Number|98|98.0||||||
3999892|NCT01224171|3820149|B2|Former Smoker||Smoking Status||participants|Number|51|51.0||||||
3999893|NCT01224171|3820150|B1|Former Smoker||Smoking Status||participants|Number|47|47.0||||||
3999894|NCT01224171|3820148|B3|Never Smoked||Smoking Status||participants|Number|195|195.0||||||
3999895|NCT01224171|3820149|B2|Never Smoked||Smoking Status||participants|Number|93|93.0||||||
3999896|NCT01224171|3820150|B1|Never Smoked||Smoking Status||participants|Number|102|102.0||||||
3999897|NCT01224171|3820148|B3|Current Smoker||Smoking Status||participants|Number|123|123.0||||||
3999898|NCT01224171|3820149|B2|Current Smoker||Smoking Status||participants|Number|65|65.0||||||
3999899|NCT01224171|3820150|B1|Current Smoker||Smoking Status||participants|Number|58|58.0||||||
3999900|NCT01224171|3820148|B3|No||History of Prior Surgery for Crohn's Disease||participants|Number|235|235.0||||||
3999901|NCT01224171|3820149|B2|No||History of Prior Surgery for Crohn's Disease||participants|Number|117|117.0||||||
3999902|NCT01224171|3820150|B1|No||History of Prior Surgery for Crohn's Disease||participants|Number|118|118.0||||||
3999903|NCT01224171|3820148|B3|Yes||History of Prior Surgery for Crohn's Disease||participants|Number|181|181.0||||||
3999904|NCT01224171|3820149|B2|Yes||History of Prior Surgery for Crohn's Disease||participants|Number|92|92.0||||||
3999905|NCT01224171|3820150|B1|Yes||History of Prior Surgery for Crohn's Disease||participants|Number|89|89.0||||||
3999906|NCT01224171|3820148|B3|Ileocolonic (both ileum and colon)||Disease Localization||participants|Number|254|254.0||||||
3999907|NCT01224171|3820149|B2|Ileocolonic (both ileum and colon)||Disease Localization||participants|Number|128|128.0||||||
3999908|NCT01224171|3820150|B1|Ileocolonic (both ileum and colon)||Disease Localization||participants|Number|126|126.0||||||
3999909|NCT01224171|3820148|B3|Colon only||Disease Localization||participants|Number|100|100.0||||||
3999910|NCT01224171|3820149|B2|Colon only||Disease Localization||participants|Number|48|48.0||||||
3999911|NCT01224171|3820150|B1|Colon only||Disease Localization||participants|Number|52|52.0||||||
3999912|NCT01224171|3820148|B3|Ileum only||Disease Localization||participants|Number|62|62.0||||||
3999913|NCT01224171|3820149|B2|Ileum only||Disease Localization||participants|Number|33|33.0||||||
3999914|NCT01224171|3820150|B1|Ileum only||Disease Localization||participants|Number|29|29.0||||||
3999915|NCT01224171|3820148|B3|Missing||Fecal Calprotectin - Categorical||participants|Number|6|6.0||||||
3999916|NCT01224171|3820149|B2|Missing||Fecal Calprotectin - Categorical||participants|Number|5|5.0||||||
3999917|NCT01224171|3820150|B1|Missing||Fecal Calprotectin - Categorical||participants|Number|1|1.0||||||
3999918|NCT01224171|3820148|B3|> 500 μg/g||Fecal Calprotectin - Categorical||participants|Number|241|241.0||||||
3999919|NCT01224171|3820149|B2|> 500 μg/g||Fecal Calprotectin - Categorical||participants|Number|117|117.0||||||
3999920|NCT01224171|3820150|B1|> 500 μg/g||Fecal Calprotectin - Categorical||participants|Number|124|124.0||||||
3999921|NCT01224171|3820148|B3|> 250 to ≤ 500 μg/g||Fecal Calprotectin - Categorical||participants|Number|70|70.0||||||
3999922|NCT01224171|3820149|B2|> 250 to ≤ 500 μg/g||Fecal Calprotectin - Categorical||participants|Number|35|35.0||||||
3999923|NCT01224171|3820150|B1|> 250 to ≤ 500 μg/g||Fecal Calprotectin - Categorical||participants|Number|35|35.0||||||
3999924|NCT01224171|3820148|B3|≤ 250 μg/g||Fecal Calprotectin - Categorical||participants|Number|99|99.0||||||
3999925|NCT01224171|3820149|B2|≤ 250 μg/g||Fecal Calprotectin - Categorical||participants|Number|52|52.0||||||
3999926|NCT01224171|3820150|B1|≤ 250 μg/g||Fecal Calprotectin - Categorical||participants|Number|47|47.0||||||
3999927|NCT01224171|3820148|B3|||Fecal Calprotectin|Number of participants for whom baseline fecal calprotectin data were available were 206 and 204, respectively.|μg/g|Mean|1288.0|1288.0|Standard Deviation|2134.79|2134.79|||
3999928|NCT01224171|3820149|B2|||Fecal Calprotectin|Number of participants for whom baseline fecal calprotectin data were available were 206 and 204, respectively.|μg/g|Mean|1148.1|1148.1|Standard Deviation|1878.58|1878.58|||
3999929|NCT01224171|3820150|B1|||Fecal Calprotectin|Number of participants for whom baseline fecal calprotectin data were available were 206 and 204, respectively.|μg/g|Mean|1426.5|1426.5|Standard Deviation|2357.76|2357.76|||
3999930|NCT01224171|3820148|B3|> 10 mg/L||CRP - Categorical||participants|Number|206|206.0||||||
3999931|NCT01224171|3820149|B2|> 10 mg/L||CRP - Categorical||participants|Number|101|101.0||||||
3999932|NCT01224171|3820150|B1|> 10 mg/L||CRP - Categorical||participants|Number|105|105.0||||||
3999933|NCT01224171|3820148|B3|> 5 to ≤ 10 mg/L||CRP - Categorical||participants|Number|90|90.0||||||
3999934|NCT01224171|3820149|B2|> 5 to ≤ 10 mg/L||CRP - Categorical||participants|Number|48|48.0||||||
3999935|NCT01224171|3820150|B1|> 5 to ≤ 10 mg/L||CRP - Categorical||participants|Number|42|42.0||||||
3999936|NCT01224171|3820148|B3|> 2.87 to ≤ 5 mg/L||CRP - Categorical||participants|Number|33|33.0||||||
3999937|NCT01224171|3820149|B2|> 2.87 to ≤ 5 mg/L||CRP - Categorical||participants|Number|14|14.0||||||
3999938|NCT01224171|3820150|B1|> 2.87 to ≤ 5 mg/L||CRP - Categorical||participants|Number|19|19.0||||||
3999939|NCT01224171|3820148|B3|≤ 2.87 mg/L||CRP - Categorical||participants|Number|87|87.0||||||
3999940|NCT01224171|3820149|B2|≤ 2.87 mg/L||CRP - Categorical||participants|Number|46|46.0||||||
3999941|NCT01224171|3820150|B1|≤ 2.87 mg/L||CRP - Categorical||participants|Number|41|41.0||||||
3999942|NCT01224171|3820148|B3|||C-reactive Protein (CRP)||mg/L|Mean|18.8|18.8|Standard Deviation|22.56|22.56|||
3999943|NCT01224171|3820149|B2|||C-reactive Protein (CRP)||mg/L|Mean|19.0|19.0|Standard Deviation|23.17|23.17|||
3999944|NCT01224171|3820150|B1|||C-reactive Protein (CRP)||mg/L|Mean|18.5|18.5|Standard Deviation|21.98|21.98|||
3999945|NCT01224171|3820148|B3|CDAI > 330||Baseline Disease Activity – Categorical||participants|Number|136|136.0||||||
3999946|NCT01224171|3820149|B2|CDAI > 330||Baseline Disease Activity – Categorical||participants|Number|77|77.0||||||
3999947|NCT01224171|3820150|B1|CDAI > 330||Baseline Disease Activity – Categorical||participants|Number|59|59.0||||||
3999948|NCT01224171|3820148|B3|CDAI ≤ 330||Baseline Disease Activity – Categorical||participants|Number|280|280.0||||||
3999949|NCT01224171|3820149|B2|CDAI ≤ 330||Baseline Disease Activity – Categorical||participants|Number|132|132.0||||||
3999950|NCT01224171|3820150|B1|CDAI ≤ 330||Baseline Disease Activity – Categorical||participants|Number|148|148.0||||||
3999951|NCT01224171|3820148|B3|||Baseline Disease Activity – Crohn’s Disease Activity Index (CDAI)|Baseline disease activity represents the baseline CDAI score. The CDAI is a numerical calculation derived from the sum of products from a list of 8 disease variables: number of liquid stools, extent of abdominal pain, general well-being, occurrence of extraintestinal symptoms, need for antidiarrheal drugs, presence of abdominal masses, hematocrit, and body weight. CDAI scores range from 0 to ~600 points with lower scores indicating disease remission and higher scores indicating disease worsening.|units on a scale|Mean|307.7|307.7|Standard Deviation|54.38|54.38|||
3999952|NCT01224171|3820149|B2|||Baseline Disease Activity – Crohn’s Disease Activity Index (CDAI)|Baseline disease activity represents the baseline CDAI score. The CDAI is a numerical calculation derived from the sum of products from a list of 8 disease variables: number of liquid stools, extent of abdominal pain, general well-being, occurrence of extraintestinal symptoms, need for antidiarrheal drugs, presence of abdominal masses, hematocrit, and body weight. CDAI scores range from 0 to ~600 points with lower scores indicating disease remission and higher scores indicating disease worsening.|units on a scale|Mean|313.9|313.9|Standard Deviation|53.17|53.17|||
4000008|NCT01224171|3820148|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|403|403.0||||||
4000009|NCT01224171|3820149|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|204|204.0||||||
3999953|NCT01224171|3820150|B1|||Baseline Disease Activity – Crohn’s Disease Activity Index (CDAI)|Baseline disease activity represents the baseline CDAI score. The CDAI is a numerical calculation derived from the sum of products from a list of 8 disease variables: number of liquid stools, extent of abdominal pain, general well-being, occurrence of extraintestinal symptoms, need for antidiarrheal drugs, presence of abdominal masses, hematocrit, and body weight. CDAI scores range from 0 to ~600 points with lower scores indicating disease remission and higher scores indicating disease worsening.|units on a scale|Mean|301.3|301.3|Standard Deviation|54.97|54.97|||
3999954|NCT01224171|3820148|B3|≥ 7 years||Duration of Crohn's Disease - Categorical||participants|Number|236|236.0||||||
3999955|NCT01224171|3820149|B2|≥ 7 years||Duration of Crohn's Disease - Categorical||participants|Number|118|118.0||||||
3999956|NCT01224171|3820150|B1|≥ 7 years||Duration of Crohn's Disease - Categorical||participants|Number|118|118.0||||||
3999957|NCT01224171|3820148|B3|≥ 3 to < 7 years||Duration of Crohn's Disease - Categorical||participants|Number|104|104.0||||||
3999958|NCT01224171|3820149|B2|≥ 3 to < 7 years||Duration of Crohn's Disease - Categorical||participants|Number|52|52.0||||||
3999959|NCT01224171|3820150|B1|≥ 3 to < 7 years||Duration of Crohn's Disease - Categorical||participants|Number|52|52.0||||||
3999960|NCT01224171|3820148|B3|≥ 1 to < 3 years||Duration of Crohn's Disease - Categorical||participants|Number|53|53.0||||||
3999961|NCT01224171|3820149|B2|≥ 1 to < 3 years||Duration of Crohn's Disease - Categorical||participants|Number|28|28.0||||||
3999962|NCT01224171|3820150|B1|≥ 1 to < 3 years||Duration of Crohn's Disease - Categorical||participants|Number|25|25.0||||||
3999963|NCT01224171|3820148|B3|< 1 year||Duration of Crohn's Disease - Categorical||participants|Number|23|23.0||||||
3999964|NCT01224171|3820149|B2|< 1 year||Duration of Crohn's Disease - Categorical||participants|Number|11|11.0||||||
3999965|NCT01224171|3820150|B1|< 1 year||Duration of Crohn's Disease - Categorical||participants|Number|12|12.0||||||
3999966|NCT01224171|3820148|B3|||Duration of Crohn's Disease (CD)||years|Mean|10.3|10.3|Standard Deviation|8.37|8.37|||
3999967|NCT01224171|3820149|B2|||Duration of Crohn's Disease (CD)||years|Mean|10.6|10.6|Standard Deviation|8.75|8.75|||
3999968|NCT01224171|3820150|B1|||Duration of Crohn's Disease (CD)||years|Mean|10.0|10.0|Standard Deviation|7.98|7.98|||
3999969|NCT01224171|3820148|B3|Asia/Australia/Africa||Geographic Region||participants|Number|32|32.0||||||
3999970|NCT01224171|3820149|B2|Asia/Australia/Africa||Geographic Region||participants|Number|18|18.0||||||
3999971|NCT01224171|3820150|B1|Asia/Australia/Africa||Geographic Region||participants|Number|14|14.0||||||
3999972|NCT01224171|3820148|B3|Eastern Europe||Geographic Region||participants|Number|25|25.0||||||
3999973|NCT01224171|3820149|B2|Eastern Europe||Geographic Region||participants|Number|10|10.0||||||
3999974|NCT01224171|3820150|B1|Eastern Europe||Geographic Region||participants|Number|15|15.0||||||
3999975|NCT01224171|3820148|B3|Central Europe||Geographic Region||participants|Number|87|87.0||||||
3999976|NCT01224171|3820149|B2|Central Europe||Geographic Region||participants|Number|41|41.0||||||
3999977|NCT01224171|3820150|B1|Central Europe||Geographic Region||participants|Number|46|46.0||||||
3999978|NCT01224171|3820148|B3|Western/Northern Europe||Geographic Region||participants|Number|75|75.0||||||
3999979|NCT01224171|3820149|B2|Western/Northern Europe||Geographic Region||participants|Number|38|38.0||||||
3999980|NCT01224171|3820150|B1|Western/Northern Europe||Geographic Region||participants|Number|37|37.0||||||
3999981|NCT01224171|3820148|B3|North America||Geographic Region||participants|Number|197|197.0||||||
3999982|NCT01224171|3820149|B2|North America||Geographic Region||participants|Number|102|102.0||||||
3999983|NCT01224171|3820150|B1|North America||Geographic Region||participants|Number|95|95.0||||||
3999984|NCT01224171|3820148|B3|||Body Mass Index||kg/m^2|Mean|24.3|24.3|Standard Deviation|5.65|5.65|||
3999985|NCT01224171|3820149|B2|||Body Mass Index||kg/m^2|Mean|24.0|24.0|Standard Deviation|5.13|5.13|||
3999986|NCT01224171|3820150|B1|||Body Mass Index||kg/m^2|Mean|24.6|24.6|Standard Deviation|6.13|6.13|||
3999987|NCT01224171|3820148|B3|||Body Weight||kg|Mean|70.4|70.4|Standard Deviation|18.50|18.5|||
3999988|NCT01224171|3820149|B2|||Body Weight||kg|Mean|69.5|69.5|Standard Deviation|17.76|17.76|||
3999989|NCT01224171|3820150|B1|||Body Weight||kg|Mean|71.3|71.3|Standard Deviation|19.22|19.22|||
3999990|NCT01224171|3820148|B3|Not Reported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3999991|NCT01224171|3820149|B2|Not Reported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
3999992|NCT01224171|3820150|B1|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
3999993|NCT01224171|3820148|B3|Other||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
3999994|NCT01224171|3820149|B2|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
3999995|NCT01224171|3820150|B1|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
3999996|NCT01224171|3820148|B3|Asian||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
3999997|NCT01224171|3820149|B2|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3999998|NCT01224171|3820150|B1|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
3999999|NCT01224171|3820148|B3|Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4000000|NCT01224171|3820149|B2|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4000001|NCT01224171|3820150|B1|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4000002|NCT01224171|3820148|B3|White||Race/Ethnicity, Customized||participants|Number|374|374.0||||||
4000003|NCT01224171|3820149|B2|White||Race/Ethnicity, Customized||participants|Number|188|188.0||||||
4000004|NCT01224171|3820150|B1|White||Race/Ethnicity, Customized||participants|Number|186|186.0||||||
4000005|NCT01224171|3820148|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4000006|NCT01224171|3820149|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4000007|NCT01224171|3820150|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4000010|NCT01224171|3820150|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|199|199.0||||||
4000011|NCT01224171|3820148|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4000012|NCT01224171|3820149|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4000013|NCT01224171|3820150|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4000014|NCT01224171|3820148|B3||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4000015|NCT01224171|3820149|B2||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4000016|NCT01224171|3820150|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4000017|NCT01224171|3820148|B3||Female|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
4000018|NCT01224171|3820149|B2||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4000019|NCT01224171|3820150|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4000020|NCT01224171|3820148|B3|≥ 65 years||Age, Customized||participants|Number|8|8.0||||||
4000021|NCT01224171|3820149|B2|≥ 65 years||Age, Customized||participants|Number|3|3.0||||||
4000022|NCT01224171|3820150|B1|≥ 65 years||Age, Customized||participants|Number|5|5.0||||||
4000023|NCT01224171|3820148|B3|< 65 years||Age, Customized||participants|Number|408|408.0||||||
4000024|NCT01224171|3820149|B2|< 65 years||Age, Customized||participants|Number|206|206.0||||||
4000025|NCT01224171|3820150|B1|< 65 years||Age, Customized||participants|Number|202|202.0||||||
4000026|NCT01224171|3820148|B3|≥ 35 years||Age, Customized||participants|Number|223|223.0||||||
4000027|NCT01224171|3820149|B2|≥ 35 years||Age, Customized||participants|Number|121|121.0||||||
4000028|NCT01224171|3820150|B1|≥ 35 years||Age, Customized||participants|Number|102|102.0||||||
4000029|NCT01224171|3820148|B3|< 35 years||Age, Customized||participants|Number|193|193.0||||||
4000030|NCT01224171|3820149|B2|< 35 years||Age, Customized||participants|Number|88|88.0||||||
4000031|NCT01224171|3820150|B1|< 35 years||Age, Customized||participants|Number|105|105.0||||||
4000032|NCT01224171|3820148|B3|||Age||years|Mean|37.9|37.9|Standard Deviation|12.66|12.66|||
4000033|NCT01224171|3820149|B2|||Age||years|Mean|38.6|38.6|Standard Deviation|12.14|12.14|||
4000034|NCT01224171|3820150|B1|||Age||years|Mean|37.1|37.1|Standard Deviation|13.15|13.15|||
4000035|NCT01224015|3820171|B4||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4000036|NCT01224015|3820172|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4000037|NCT01224015|3820173|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4000038|NCT01224015|3820174|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4000039|NCT01224015|3820171|B4||Female|Sex: Female, Male||Participants|Count of Participants|598|598.0||||||
4000040|NCT01224015|3820172|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4000041|NCT01224015|3820173|B2||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4000042|NCT01224015|3820174|B1||Female|Sex: Female, Male||Participants|Count of Participants|315|315.0||||||
4000043|NCT01224015|3820171|B4|>65 Years||Age, Customized||Participants|Number|30|30.0||||||
4000044|NCT01224015|3820172|B3|>65 Years||Age, Customized||Participants|Number|4|4.0||||||
4000045|NCT01224015|3820173|B2|>65 Years||Age, Customized||Participants|Number|11|11.0||||||
4000046|NCT01224015|3820174|B1|>65 Years||Age, Customized||Participants|Number|15|15.0||||||
4000047|NCT01224015|3820171|B4|45 to 65 Years||Age, Customized||Participants|Number|448|448.0||||||
4000048|NCT01224015|3820172|B3|45 to 65 Years||Age, Customized||Participants|Number|59|59.0||||||
4000049|NCT01224015|3820173|B2|45 to 65 Years||Age, Customized||Participants|Number|148|148.0||||||
4000050|NCT01224015|3820174|B1|45 to 65 Years||Age, Customized||Participants|Number|241|241.0||||||
4000051|NCT01224015|3820171|B4|<45 Years||Age, Customized||Participants|Number|206|206.0||||||
4000052|NCT01224015|3820172|B3|<45 Years||Age, Customized||Participants|Number|33|33.0||||||
4000053|NCT01224015|3820173|B2|<45 Years||Age, Customized||Participants|Number|68|68.0||||||
4000054|NCT01224015|3820174|B1|<45 Years||Age, Customized||Participants|Number|105|105.0||||||
4000055|NCT01223963|3820184|B1|Sweden||Region of Enrollment||participants|Number|93|93.0||||||
4000056|NCT01223963|3820184|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4000057|NCT01223963|3820184|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4000058|NCT01223963|3820184|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4000059|NCT01223963|3820184|B1||Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
4000060|NCT01223963|3820184|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4000061|NCT01223937|3820189|B3|||Body Mass Index||kg/m^2|Mean|30.3|30.3|Standard Deviation|6.9|6.9|||
4000062|NCT01223937|3820190|B2|||Body Mass Index||kg/m^2|Mean|31.4|31.4|Standard Deviation|7.03|7.03|||
4000063|NCT01223937|3820191|B1|||Body Mass Index||kg/m^2|Mean|29.1|29.1|Standard Deviation|6.58|6.58|||
4000064|NCT01223937|3820189|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|218|218.0||||||
4000065|NCT01223937|3820190|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|107|107.0||||||
4000066|NCT01223937|3820191|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|111|111.0||||||
4000067|NCT01223937|3820189|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4000068|NCT01223937|3820190|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4000069|NCT01223937|3820191|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4000070|NCT01223937|3820189|B3|Native Hawaiian/other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4000071|NCT01223937|3820190|B2|Native Hawaiian/other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4000072|NCT01223937|3820191|B1|Native Hawaiian/other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4000073|NCT01223937|3820189|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4000074|NCT01223937|3820190|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4000075|NCT01223937|3820191|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4000076|NCT01223937|3820189|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4000077|NCT01223937|3820190|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4000078|NCT01223937|3820191|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4000079|NCT01223937|3820189|B3|White||Race/Ethnicity, Customized||participants|Number|213|213.0||||||
4000080|NCT01223937|3820190|B2|White||Race/Ethnicity, Customized||participants|Number|109|109.0||||||
4000081|NCT01223937|3820191|B1|White||Race/Ethnicity, Customized||participants|Number|104|104.0||||||
4000082|NCT01223937|3820189|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4000083|NCT01223937|3820190|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4000084|NCT01223937|3820191|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4000085|NCT01223937|3820189|B3||Female|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
4000086|NCT01223937|3820190|B2||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4000087|NCT01223937|3820191|B1||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4000088|NCT01223937|3820189|B3|>=65 years||Age, Customized||participants|Number|125|125.0||||||
4000089|NCT01223937|3820190|B2|>=65 years||Age, Customized||participants|Number|62|62.0||||||
4000090|NCT01223937|3820191|B1|>=65 years||Age, Customized||participants|Number|63|63.0||||||
4000091|NCT01223937|3820189|B3|< 65 years||Age, Customized||participants|Number|136|136.0||||||
4000092|NCT01223937|3820190|B2|< 65 years||Age, Customized||participants|Number|71|71.0||||||
4000093|NCT01223937|3820191|B1|< 65 years||Age, Customized||participants|Number|65|65.0||||||
4000094|NCT01223937|3820189|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|14.2|14.2|||
4000095|NCT01223937|3820190|B2|||Age||years|Mean|59.5|59.5|Standard Deviation|14.3|14.3|||
4000096|NCT01223937|3820191|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|14.1|14.1|||
4000097|NCT01223703|3820214|B3||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4000098|NCT01223703|3820215|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4000099|NCT01223703|3820216|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4000100|NCT01223703|3820214|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4000101|NCT01223703|3820215|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4000102|NCT01223703|3820216|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4000103|NCT01223703|3820214|B3|||Age||years|Mean|62.9|62.9|Standard Deviation|10.1|10.1|||
4000104|NCT01223703|3820215|B2|||Age||years|Mean|64|64.0|Standard Deviation|9|9.0|||
4000105|NCT01223703|3820216|B1|||Age||years|Mean|61|61.0|Standard Deviation|11|11.0|||
4000106|NCT01223469|3820229|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4000107|NCT01223469|3820230|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4000108|NCT01223469|3820231|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4000109|NCT01223469|3820229|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4000110|NCT01223469|3820230|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4000111|NCT01223469|3820231|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4000112|NCT01223469|3820229|B3||>=65 years|Age||Participants|Count of Participants|57|57.0||||||
4000113|NCT01223469|3820230|B2||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4000114|NCT01223469|3820231|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4000115|NCT01223469|3820229|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4000116|NCT01223469|3820230|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4000117|NCT01223469|3820231|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4000118|NCT01223469|3820229|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4000119|NCT01223469|3820230|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4000120|NCT01223469|3820231|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4000121|NCT01223404|3820238|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4000122|NCT01223404|3820238|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000123|NCT01223404|3820238|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000124|NCT01223404|3820238|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4000125|NCT01223404|3820238|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4000126|NCT01223404|3820238|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000127|NCT01223404|3820238|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4000128|NCT01223404|3820238|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000129|NCT01223404|3820238|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4000130|NCT01223404|3820238|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4000131|NCT01223404|3820238|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4000132|NCT01223404|3820238|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4000133|NCT01223404|3820238|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4000134|NCT01223378|3820266|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4000135|NCT01223378|3820267|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000136|NCT01223378|3820268|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4000137|NCT01223378|3820269|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000138|NCT01223378|3820270|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000139|NCT01223378|3820271|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000140|NCT01223378|3820266|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000141|NCT01223378|3820267|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000142|NCT01223378|3820268|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000143|NCT01223378|3820269|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000144|NCT01223378|3820270|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000145|NCT01223378|3820271|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000146|NCT01223378|3820266|B6||White|Race (NIH/OMB)||Participants|Count of Participants|306|306.0||||||
4000147|NCT01223378|3820267|B5||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4000148|NCT01223378|3820268|B4||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4000149|NCT01223378|3820269|B3||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4000150|NCT01223378|3820270|B2||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4000151|NCT01223378|3820271|B1||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4000152|NCT01223378|3820266|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
4000153|NCT01223378|3820267|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4000154|NCT01223378|3820268|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4000155|NCT01223378|3820269|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4000156|NCT01223378|3820270|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4000157|NCT01223378|3820271|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4000158|NCT01223378|3820266|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000159|NCT01223378|3820267|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000160|NCT01223378|3820268|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000161|NCT01223378|3820269|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000162|NCT01223378|3820270|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000163|NCT01223378|3820271|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000164|NCT01223378|3820266|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4000165|NCT01223378|3820267|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000166|NCT01223378|3820268|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4000167|NCT01223378|3820269|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000168|NCT01223378|3820270|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000169|NCT01223378|3820271|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000170|NCT01223378|3820266|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4000171|NCT01223378|3820267|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000172|NCT01223378|3820268|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000173|NCT01223378|3820269|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000174|NCT01223378|3820270|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4000175|NCT01223378|3820271|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000176|NCT01223378|3820266|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000177|NCT01223378|3820267|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000178|NCT01223378|3820268|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000179|NCT01223378|3820269|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000180|NCT01223378|3820270|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000181|NCT01223378|3820271|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000182|NCT01223378|3820266|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|381|381.0||||||
4000183|NCT01223378|3820267|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
4000184|NCT01223378|3820268|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4000185|NCT01223378|3820269|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4000186|NCT01223378|3820270|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
4000187|NCT01223378|3820271|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
4000281|NCT01223352|3820349|B2|Ukraine||Region of Enrollment||Participants|Number|0|0.0||||||
4000188|NCT01223378|3820266|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4000189|NCT01223378|3820267|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4000190|NCT01223378|3820268|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4000191|NCT01223378|3820269|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4000192|NCT01223378|3820270|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4000193|NCT01223378|3820271|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4000194|NCT01223378|3820266|B6||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4000195|NCT01223378|3820267|B5||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4000196|NCT01223378|3820268|B4||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4000197|NCT01223378|3820269|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4000198|NCT01223378|3820270|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4000199|NCT01223378|3820271|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4000200|NCT01223378|3820266|B6||Female|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
4000201|NCT01223378|3820267|B5||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4000202|NCT01223378|3820268|B4||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4000203|NCT01223378|3820269|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4000204|NCT01223378|3820270|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4000205|NCT01223378|3820271|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4000206|NCT01223378|3820266|B6|||Age||years|Mean|61.0|61.0|Standard Deviation|11.44|11.44|||
4000207|NCT01223378|3820267|B5|||Age||years|Mean|61.2|61.2|Standard Deviation|11.92|11.92|||
4000208|NCT01223378|3820268|B4|||Age||years|Mean|60.3|60.3|Standard Deviation|12.89|12.89|||
4000209|NCT01223378|3820269|B3|||Age||years|Mean|60.8|60.8|Standard Deviation|11.47|11.47|||
4000210|NCT01223378|3820270|B2|||Age||years|Mean|61.6|61.6|Standard Deviation|9.58|9.58|||
4000211|NCT01223378|3820271|B1|||Age||years|Mean|60.9|60.9|Standard Deviation|11.39|11.39|||
4000212|NCT01223365|3820307|B1|||Duration on Opioid Therapy||years|Mean|4.4|4.4|Standard Deviation|5.27|5.27|||
4000213|NCT01223365|3820307|B1|||Duration Since Diagnosis||years|Mean|12.3|12.3|Standard Deviation|9.54|9.54|||
4000214|NCT01223365|3820307|B1|Other||Type of Pain||Participants|Count of Participants|2|2.0||||||
4000215|NCT01223365|3820307|B1|Rheumatoid arthritis||Type of Pain||Participants|Count of Participants|2|2.0||||||
4000216|NCT01223365|3820307|B1|Complex regional pain syndrome||Type of Pain||Participants|Count of Participants|3|3.0||||||
4000217|NCT01223365|3820307|B1|Neck pain||Type of Pain||Participants|Count of Participants|10|10.0||||||
4000218|NCT01223365|3820307|B1|Traumatic injury||Type of Pain||Participants|Count of Participants|3|3.0||||||
4000219|NCT01223365|3820307|B1|Postherpetic neuralgia||Type of Pain||Participants|Count of Participants|0|0.0||||||
4000220|NCT01223365|3820307|B1|Diabetic peripheral neuropathy||Type of Pain||Participants|Count of Participants|12|12.0||||||
4000221|NCT01223365|3820307|B1|Osteoarthritis||Type of Pain||Participants|Count of Participants|82|82.0||||||
4000222|NCT01223365|3820307|B1|Back pain||Type of Pain||Participants|Count of Participants|103|103.0||||||
4000223|NCT01223365|3820307|B1|Low back pain||Type of Pain||Participants|Count of Participants|113|113.0||||||
4000224|NCT01223365|3820307|B1|||Body Mass Index||kg/m^2|Mean|33.1|33.1|Standard Deviation|7.38|7.38|||
4000225|NCT01223365|3820307|B1|||Height||cm|Mean|169.7|169.7|Standard Deviation|10.57|10.57|||
4000226|NCT01223365|3820307|B1|||Weight||kg|Mean|95.6|95.6|Standard Deviation|23.97|23.97|||
4000227|NCT01223365|3820307|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4000228|NCT01223365|3820307|B1|Non-Hispanic and non-Latino||Race/Ethnicity, Customized||Participants|Count of Participants|319|319.0||||||
4000229|NCT01223365|3820307|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4000230|NCT01223365|3820307|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4000231|NCT01223365|3820307|B1|Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4000232|NCT01223365|3820307|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4000233|NCT01223365|3820307|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|66|66.0||||||
4000234|NCT01223365|3820307|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|260|260.0||||||
4000235|NCT01223365|3820307|B1||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4000236|NCT01223365|3820307|B1||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4000237|NCT01223365|3820307|B1|||Age||years|Mean|54.4|54.4|Standard Deviation|11.51|11.51|||
4000238|NCT01223352|3820348|B3|None||PAH-specific therapy at baseline|PAH-specific therapy at Day 1, before first study drug administration, are reported as baseline values here.|Participants|Number|22|22.0||||||
4000239|NCT01223352|3820349|B2|None||PAH-specific therapy at baseline|PAH-specific therapy at Day 1, before first study drug administration, are reported as baseline values here.|Participants|Number|13|13.0||||||
4000240|NCT01223352|3820350|B1|None||PAH-specific therapy at baseline|PAH-specific therapy at Day 1, before first study drug administration, are reported as baseline values here.|Participants|Number|9|9.0||||||
4000241|NCT01223352|3820348|B3|Bosentan /PDE-5 inhibitor /Prostanoid combination||PAH-specific therapy at baseline|PAH-specific therapy at Day 1, before first study drug administration, are reported as baseline values here.|Participants|Number|7|7.0||||||
4000242|NCT01223352|3820349|B2|Bosentan /PDE-5 inhibitor /Prostanoid combination||PAH-specific therapy at baseline|PAH-specific therapy at Day 1, before first study drug administration, are reported as baseline values here.|Participants|Number|5|5.0||||||
4000243|NCT01223352|3820350|B1|Bosentan /PDE-5 inhibitor /Prostanoid combination||PAH-specific therapy at baseline|PAH-specific therapy at Day 1, before first study drug administration, are reported as baseline values here.|Participants|Number|2|2.0||||||
4000244|NCT01223352|3820348|B3|Bosentan / PDE-5 inhibitor combination||PAH-specific therapy at baseline|PAH-specific therapy at Day 1, before first study drug administration, are reported as baseline values here.|Participants|Number|4|4.0||||||
4000245|NCT01223352|3820349|B2|Bosentan / PDE-5 inhibitor combination||PAH-specific therapy at baseline|PAH-specific therapy at Day 1, before first study drug administration, are reported as baseline values here.|Participants|Number|2|2.0||||||
4000246|NCT01223352|3820350|B1|Bosentan / PDE-5 inhibitor combination||PAH-specific therapy at baseline|PAH-specific therapy at Day 1, before first study drug administration, are reported as baseline values here.|Participants|Number|2|2.0||||||
4000247|NCT01223352|3820348|B3|Phosphodiesterase type-5 (PDE-5) inhibitor||PAH-specific therapy at baseline|PAH-specific therapy at Day 1, before first study drug administration, are reported as baseline values here.|Participants|Number|23|23.0||||||
4000248|NCT01223352|3820349|B2|Phosphodiesterase type-5 (PDE-5) inhibitor||PAH-specific therapy at baseline|PAH-specific therapy at Day 1, before first study drug administration, are reported as baseline values here.|Participants|Number|10|10.0||||||
4000249|NCT01223352|3820350|B1|Phosphodiesterase type-5 (PDE-5) inhibitor||PAH-specific therapy at baseline|PAH-specific therapy at Day 1, before first study drug administration, are reported as baseline values here.|Participants|Number|13|13.0||||||
4000250|NCT01223352|3820348|B3|Prostanoid||PAH-specific therapy at baseline|PAH-specific therapy at Day 1, before first study drug administration, are reported as baseline values here.|Participants|Number|1|1.0||||||
4000251|NCT01223352|3820349|B2|Prostanoid||PAH-specific therapy at baseline|PAH-specific therapy at Day 1, before first study drug administration, are reported as baseline values here.|Participants|Number|0|0.0||||||
4000252|NCT01223352|3820350|B1|Prostanoid||PAH-specific therapy at baseline|PAH-specific therapy at Day 1, before first study drug administration, are reported as baseline values here.|Participants|Number|1|1.0||||||
4000253|NCT01223352|3820348|B3|Bosentan (adult tablet formulation)||PAH-specific therapy at baseline|PAH-specific therapy at Day 1, before first study drug administration, are reported as baseline values here.|Participants|Number|7|7.0||||||
4000254|NCT01223352|3820349|B2|Bosentan (adult tablet formulation)||PAH-specific therapy at baseline|PAH-specific therapy at Day 1, before first study drug administration, are reported as baseline values here.|Participants|Number|3|3.0||||||
4000255|NCT01223352|3820350|B1|Bosentan (adult tablet formulation)||PAH-specific therapy at baseline|PAH-specific therapy at Day 1, before first study drug administration, are reported as baseline values here.|Participants|Number|4|4.0||||||
4000256|NCT01223352|3820348|B3|FC III||World Health Organization functional class (WHO FC)|"The World Health Organization (WHO) defines 4 classes to classify the functional status of patients with pulmonary hypertension:~Class I (FC I): No limitation of physical activity; Class II (FC II): Slight limitation of physical activity; Class IIII (FC III): Marked limitation of physical activity; Class IV (FC IV): Inability to carry out any physical activity without symptoms.~WHO FC at Day 1, before first study drug administration, are reported as baseline values here."|Participants|Number|18|18.0||||||
4000257|NCT01223352|3820349|B2|FC III||World Health Organization functional class (WHO FC)|"The World Health Organization (WHO) defines 4 classes to classify the functional status of patients with pulmonary hypertension:~Class I (FC I): No limitation of physical activity; Class II (FC II): Slight limitation of physical activity; Class IIII (FC III): Marked limitation of physical activity; Class IV (FC IV): Inability to carry out any physical activity without symptoms.~WHO FC at Day 1, before first study drug administration, are reported as baseline values here."|Participants|Number|12|12.0||||||
4000258|NCT01223352|3820350|B1|FC III||World Health Organization functional class (WHO FC)|"The World Health Organization (WHO) defines 4 classes to classify the functional status of patients with pulmonary hypertension:~Class I (FC I): No limitation of physical activity; Class II (FC II): Slight limitation of physical activity; Class IIII (FC III): Marked limitation of physical activity; Class IV (FC IV): Inability to carry out any physical activity without symptoms.~WHO FC at Day 1, before first study drug administration, are reported as baseline values here."|Participants|Number|6|6.0||||||
4000259|NCT01223352|3820348|B3|FC II||World Health Organization functional class (WHO FC)|"The World Health Organization (WHO) defines 4 classes to classify the functional status of patients with pulmonary hypertension:~Class I (FC I): No limitation of physical activity; Class II (FC II): Slight limitation of physical activity; Class IIII (FC III): Marked limitation of physical activity; Class IV (FC IV): Inability to carry out any physical activity without symptoms.~WHO FC at Day 1, before first study drug administration, are reported as baseline values here."|Participants|Number|27|27.0||||||
4000260|NCT01223352|3820349|B2|FC II||World Health Organization functional class (WHO FC)|"The World Health Organization (WHO) defines 4 classes to classify the functional status of patients with pulmonary hypertension:~Class I (FC I): No limitation of physical activity; Class II (FC II): Slight limitation of physical activity; Class IIII (FC III): Marked limitation of physical activity; Class IV (FC IV): Inability to carry out any physical activity without symptoms.~WHO FC at Day 1, before first study drug administration, are reported as baseline values here."|Participants|Number|12|12.0||||||
4000261|NCT01223352|3820350|B1|FC II||World Health Organization functional class (WHO FC)|"The World Health Organization (WHO) defines 4 classes to classify the functional status of patients with pulmonary hypertension:~Class I (FC I): No limitation of physical activity; Class II (FC II): Slight limitation of physical activity; Class IIII (FC III): Marked limitation of physical activity; Class IV (FC IV): Inability to carry out any physical activity without symptoms.~WHO FC at Day 1, before first study drug administration, are reported as baseline values here."|Participants|Number|15|15.0||||||
4000262|NCT01223352|3820348|B3|FC I||World Health Organization functional class (WHO FC)|"The World Health Organization (WHO) defines 4 classes to classify the functional status of patients with pulmonary hypertension:~Class I (FC I): No limitation of physical activity; Class II (FC II): Slight limitation of physical activity; Class IIII (FC III): Marked limitation of physical activity; Class IV (FC IV): Inability to carry out any physical activity without symptoms.~WHO FC at Day 1, before first study drug administration, are reported as baseline values here."|Participants|Number|19|19.0||||||
4000282|NCT01223352|3820350|B1|Ukraine||Region of Enrollment||Participants|Number|1|1.0||||||
4000283|NCT01223352|3820348|B3|USA||Region of Enrollment||Participants|Number|2|2.0||||||
4000263|NCT01223352|3820349|B2|FC I||World Health Organization functional class (WHO FC)|"The World Health Organization (WHO) defines 4 classes to classify the functional status of patients with pulmonary hypertension:~Class I (FC I): No limitation of physical activity; Class II (FC II): Slight limitation of physical activity; Class IIII (FC III): Marked limitation of physical activity; Class IV (FC IV): Inability to carry out any physical activity without symptoms.~WHO FC at Day 1, before first study drug administration, are reported as baseline values here."|Participants|Number|9|9.0||||||
4000264|NCT01223352|3820350|B1|FC I||World Health Organization functional class (WHO FC)|"The World Health Organization (WHO) defines 4 classes to classify the functional status of patients with pulmonary hypertension:~Class I (FC I): No limitation of physical activity; Class II (FC II): Slight limitation of physical activity; Class IIII (FC III): Marked limitation of physical activity; Class IV (FC IV): Inability to carry out any physical activity without symptoms.~WHO FC at Day 1, before first study drug administration, are reported as baseline values here."|Participants|Number|10|10.0||||||
4000265|NCT01223352|3820348|B3|Missing data||Etiology of pulmonary arterial hypertension (PAH)|"Children included in the study had a diagnosis of PAH belonging to one of the following categories:~Idiopathic PAH~Heritable PAH~Associated PAH persisting after complete repair of a congenital heart defect~PAH-congenital heart disease (PAH-CHD) associated with open shunts"|Participants|Count of Participants|1|1.0||||||
4000266|NCT01223352|3820349|B2|Missing data||Etiology of pulmonary arterial hypertension (PAH)|"Children included in the study had a diagnosis of PAH belonging to one of the following categories:~Idiopathic PAH~Heritable PAH~Associated PAH persisting after complete repair of a congenital heart defect~PAH-congenital heart disease (PAH-CHD) associated with open shunts"|Participants|Count of Participants|0|0.0||||||
4000267|NCT01223352|3820350|B1|Missing data||Etiology of pulmonary arterial hypertension (PAH)|"Children included in the study had a diagnosis of PAH belonging to one of the following categories:~Idiopathic PAH~Heritable PAH~Associated PAH persisting after complete repair of a congenital heart defect~PAH-congenital heart disease (PAH-CHD) associated with open shunts"|Participants|Count of Participants|1|1.0||||||
4000268|NCT01223352|3820348|B3|Associated PAH||Etiology of pulmonary arterial hypertension (PAH)|"Children included in the study had a diagnosis of PAH belonging to one of the following categories:~Idiopathic PAH~Heritable PAH~Associated PAH persisting after complete repair of a congenital heart defect~PAH-congenital heart disease (PAH-CHD) associated with open shunts"|Participants|Count of Participants|24|24.0||||||
4000269|NCT01223352|3820349|B2|Associated PAH||Etiology of pulmonary arterial hypertension (PAH)|"Children included in the study had a diagnosis of PAH belonging to one of the following categories:~Idiopathic PAH~Heritable PAH~Associated PAH persisting after complete repair of a congenital heart defect~PAH-congenital heart disease (PAH-CHD) associated with open shunts"|Participants|Count of Participants|11|11.0||||||
4000270|NCT01223352|3820350|B1|Associated PAH||Etiology of pulmonary arterial hypertension (PAH)|"Children included in the study had a diagnosis of PAH belonging to one of the following categories:~Idiopathic PAH~Heritable PAH~Associated PAH persisting after complete repair of a congenital heart defect~PAH-congenital heart disease (PAH-CHD) associated with open shunts"|Participants|Count of Participants|13|13.0||||||
4000271|NCT01223352|3820348|B3|PAH-Congenital heart disease||Etiology of pulmonary arterial hypertension (PAH)|"Children included in the study had a diagnosis of PAH belonging to one of the following categories:~Idiopathic PAH~Heritable PAH~Associated PAH persisting after complete repair of a congenital heart defect~PAH-congenital heart disease (PAH-CHD) associated with open shunts"|Participants|Count of Participants|8|8.0||||||
4000272|NCT01223352|3820349|B2|PAH-Congenital heart disease||Etiology of pulmonary arterial hypertension (PAH)|"Children included in the study had a diagnosis of PAH belonging to one of the following categories:~Idiopathic PAH~Heritable PAH~Associated PAH persisting after complete repair of a congenital heart defect~PAH-congenital heart disease (PAH-CHD) associated with open shunts"|Participants|Count of Participants|6|6.0||||||
4000273|NCT01223352|3820350|B1|PAH-Congenital heart disease||Etiology of pulmonary arterial hypertension (PAH)|"Children included in the study had a diagnosis of PAH belonging to one of the following categories:~Idiopathic PAH~Heritable PAH~Associated PAH persisting after complete repair of a congenital heart defect~PAH-congenital heart disease (PAH-CHD) associated with open shunts"|Participants|Count of Participants|2|2.0||||||
4000274|NCT01223352|3820348|B3|Heritable||Etiology of pulmonary arterial hypertension (PAH)|"Children included in the study had a diagnosis of PAH belonging to one of the following categories:~Idiopathic PAH~Heritable PAH~Associated PAH persisting after complete repair of a congenital heart defect~PAH-congenital heart disease (PAH-CHD) associated with open shunts"|Participants|Count of Participants|2|2.0||||||
4000275|NCT01223352|3820349|B2|Heritable||Etiology of pulmonary arterial hypertension (PAH)|"Children included in the study had a diagnosis of PAH belonging to one of the following categories:~Idiopathic PAH~Heritable PAH~Associated PAH persisting after complete repair of a congenital heart defect~PAH-congenital heart disease (PAH-CHD) associated with open shunts"|Participants|Count of Participants|2|2.0||||||
4000276|NCT01223352|3820350|B1|Heritable||Etiology of pulmonary arterial hypertension (PAH)|"Children included in the study had a diagnosis of PAH belonging to one of the following categories:~Idiopathic PAH~Heritable PAH~Associated PAH persisting after complete repair of a congenital heart defect~PAH-congenital heart disease (PAH-CHD) associated with open shunts"|Participants|Count of Participants|0|0.0||||||
4000277|NCT01223352|3820348|B3|Idiopathic||Etiology of pulmonary arterial hypertension (PAH)|"Children included in the study had a diagnosis of PAH belonging to one of the following categories:~Idiopathic PAH~Heritable PAH~Associated PAH persisting after complete repair of a congenital heart defect~PAH-congenital heart disease (PAH-CHD) associated with open shunts"|Participants|Count of Participants|29|29.0||||||
4000278|NCT01223352|3820349|B2|Idiopathic||Etiology of pulmonary arterial hypertension (PAH)|"Children included in the study had a diagnosis of PAH belonging to one of the following categories:~Idiopathic PAH~Heritable PAH~Associated PAH persisting after complete repair of a congenital heart defect~PAH-congenital heart disease (PAH-CHD) associated with open shunts"|Participants|Count of Participants|14|14.0||||||
4000279|NCT01223352|3820350|B1|Idiopathic||Etiology of pulmonary arterial hypertension (PAH)|"Children included in the study had a diagnosis of PAH belonging to one of the following categories:~Idiopathic PAH~Heritable PAH~Associated PAH persisting after complete repair of a congenital heart defect~PAH-congenital heart disease (PAH-CHD) associated with open shunts"|Participants|Count of Participants|15|15.0||||||
4000280|NCT01223352|3820348|B3|Ukraine||Region of Enrollment||Participants|Number|1|1.0||||||
4000284|NCT01223352|3820349|B2|USA||Region of Enrollment||Participants|Number|1|1.0||||||
4000285|NCT01223352|3820350|B1|USA||Region of Enrollment||Participants|Number|1|1.0||||||
4000286|NCT01223352|3820348|B3|Spain||Region of Enrollment||Participants|Number|3|3.0||||||
4000287|NCT01223352|3820349|B2|Spain||Region of Enrollment||Participants|Number|2|2.0||||||
4000288|NCT01223352|3820350|B1|Spain||Region of Enrollment||Participants|Number|1|1.0||||||
4000289|NCT01223352|3820348|B3|South Africa||Region of Enrollment||Participants|Number|6|6.0||||||
4000290|NCT01223352|3820349|B2|South Africa||Region of Enrollment||Participants|Number|2|2.0||||||
4000291|NCT01223352|3820350|B1|South Africa||Region of Enrollment||Participants|Number|4|4.0||||||
4000292|NCT01223352|3820348|B3|Serbia||Region of Enrollment||Participants|Number|5|5.0||||||
4000293|NCT01223352|3820349|B2|Serbia||Region of Enrollment||Participants|Number|3|3.0||||||
4000294|NCT01223352|3820350|B1|Serbia||Region of Enrollment||Participants|Number|2|2.0||||||
4000295|NCT01223352|3820348|B3|Russia||Region of Enrollment||Participants|Number|10|10.0||||||
4000296|NCT01223352|3820349|B2|Russia||Region of Enrollment||Participants|Number|6|6.0||||||
4000297|NCT01223352|3820350|B1|Russia||Region of Enrollment||Participants|Number|4|4.0||||||
4000298|NCT01223352|3820348|B3|Poland||Region of Enrollment||Participants|Number|5|5.0||||||
4000299|NCT01223352|3820349|B2|Poland||Region of Enrollment||Participants|Number|3|3.0||||||
4000300|NCT01223352|3820350|B1|Poland||Region of Enrollment||Participants|Number|2|2.0||||||
4000301|NCT01223352|3820348|B3|Mexico||Region of Enrollment||Participants|Number|1|1.0||||||
4000302|NCT01223352|3820349|B2|Mexico||Region of Enrollment||Participants|Number|0|0.0||||||
4000303|NCT01223352|3820350|B1|Mexico||Region of Enrollment||Participants|Number|1|1.0||||||
4000304|NCT01223352|3820348|B3|Italy||Region of Enrollment||Participants|Number|1|1.0||||||
4000305|NCT01223352|3820349|B2|Italy||Region of Enrollment||Participants|Number|0|0.0||||||
4000306|NCT01223352|3820350|B1|Italy||Region of Enrollment||Participants|Number|1|1.0||||||
4000307|NCT01223352|3820348|B3|Israel||Region of Enrollment||Participants|Number|2|2.0||||||
4000308|NCT01223352|3820349|B2|Israel||Region of Enrollment||Participants|Number|2|2.0||||||
4000309|NCT01223352|3820350|B1|Israel||Region of Enrollment||Participants|Number|0|0.0||||||
4000310|NCT01223352|3820348|B3|India||Region of Enrollment||Participants|Number|3|3.0||||||
4000311|NCT01223352|3820349|B2|India||Region of Enrollment||Participants|Number|2|2.0||||||
4000312|NCT01223352|3820350|B1|India||Region of Enrollment||Participants|Number|1|1.0||||||
4000313|NCT01223352|3820348|B3|Hungary||Region of Enrollment||Participants|Number|3|3.0||||||
4000314|NCT01223352|3820349|B2|Hungary||Region of Enrollment||Participants|Number|0|0.0||||||
4000315|NCT01223352|3820350|B1|Hungary||Region of Enrollment||Participants|Number|3|3.0||||||
4000316|NCT01223352|3820348|B3|Germany||Region of Enrollment||Participants|Number|4|4.0||||||
4000317|NCT01223352|3820349|B2|Germany||Region of Enrollment||Participants|Number|1|1.0||||||
4000318|NCT01223352|3820350|B1|Germany||Region of Enrollment||Participants|Number|3|3.0||||||
4000319|NCT01223352|3820348|B3|France||Region of Enrollment||Participants|Number|5|5.0||||||
4000320|NCT01223352|3820349|B2|France||Region of Enrollment||Participants|Number|4|4.0||||||
4000321|NCT01223352|3820350|B1|France||Region of Enrollment||Participants|Number|1|1.0||||||
4000322|NCT01223352|3820348|B3|Czech Republic||Region of Enrollment||Participants|Number|2|2.0||||||
4000323|NCT01223352|3820349|B2|Czech Republic||Region of Enrollment||Participants|Number|1|1.0||||||
4000324|NCT01223352|3820350|B1|Czech Republic||Region of Enrollment||Participants|Number|1|1.0||||||
4000325|NCT01223352|3820348|B3|China||Region of Enrollment||Participants|Number|6|6.0||||||
4000326|NCT01223352|3820349|B2|China||Region of Enrollment||Participants|Number|4|4.0||||||
4000327|NCT01223352|3820350|B1|China||Region of Enrollment||Participants|Number|2|2.0||||||
4000328|NCT01223352|3820348|B3|Belarus||Region of Enrollment||Participants|Number|3|3.0||||||
4000329|NCT01223352|3820349|B2|Belarus||Region of Enrollment||Participants|Number|2|2.0||||||
4000330|NCT01223352|3820350|B1|Belarus||Region of Enrollment||Participants|Number|1|1.0||||||
4000331|NCT01223352|3820348|B3|Australia||Region of Enrollment||Participants|Number|2|2.0||||||
4000332|NCT01223352|3820349|B2|Australia||Region of Enrollment||Participants|Number|0|0.0||||||
4000333|NCT01223352|3820350|B1|Australia||Region of Enrollment||Participants|Number|2|2.0||||||
4000334|NCT01223352|3820348|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4000335|NCT01223352|3820349|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4000336|NCT01223352|3820350|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4000337|NCT01223352|3820348|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4000338|NCT01223352|3820349|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4000339|NCT01223352|3820350|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4000340|NCT01223352|3820348|B3|||Age|This is the age reported at the screening visit which had to be performed within 4 weeks prior to randomization|Years|Mean|4.8|4.8|Standard Deviation|3.57|3.57|||
4000341|NCT01223352|3820349|B2|||Age|This is the age reported at the screening visit which had to be performed within 4 weeks prior to randomization|Years|Mean|4.5|4.5|Standard Deviation|3.35|3.35|||
4000342|NCT01223352|3820350|B1|||Age|This is the age reported at the screening visit which had to be performed within 4 weeks prior to randomization|Years|Mean|5.2|5.2|Standard Deviation|3.81|3.81|||
4000343|NCT01223235|3820371|B1|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4000344|NCT01223235|3820371|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000345|NCT01223235|3820371|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000346|NCT01223235|3820371|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4000347|NCT01223235|3820371|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000348|NCT01223235|3820371|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000349|NCT01223235|3820371|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000350|NCT01223235|3820371|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000351|NCT01223235|3820371|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000352|NCT01223235|3820371|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4000353|NCT01223235|3820371|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000354|NCT01223235|3820371|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4000355|NCT01223235|3820371|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4000356|NCT01223235|3820371|B1|||Age||years|Median|56|56.0|Full Range|||49.0|70.0|
4000357|NCT01223196|3820377|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4000358|NCT01223196|3820378|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4000359|NCT01223196|3820379|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4000360|NCT01223196|3820377|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4000361|NCT01223196|3820378|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4000362|NCT01223196|3820379|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4000363|NCT01223196|3820377|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4000364|NCT01223196|3820378|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4000365|NCT01223196|3820379|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4000366|NCT01223196|3820377|B3|||Age||years|Mean|55.7|55.7|Standard Deviation|8.03|8.03|||
4000367|NCT01223196|3820378|B2|||Age||years|Mean|56.6|56.6|Standard Deviation|9.3|9.3|||
4000368|NCT01223196|3820379|B1|||Age||years|Mean|55|55.0|Standard Deviation|7|7.0|||
4000369|NCT01223196|3820377|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4000370|NCT01223196|3820378|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4000371|NCT01223196|3820379|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4000372|NCT01223196|3820377|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4000373|NCT01223196|3820378|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4000374|NCT01223196|3820379|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4000375|NCT01223196|3820377|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4000376|NCT01223196|3820378|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4000377|NCT01223196|3820379|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4000378|NCT01223183|3820390|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4000379|NCT01223183|3820391|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4000380|NCT01223183|3820392|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4000381|NCT01223183|3820390|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4000382|NCT01223183|3820391|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4000383|NCT01223183|3820392|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4000384|NCT01223183|3820390|B3|||Age||years|Mean|26|26.0|Standard Deviation|8|8.0|||
4000385|NCT01223183|3820391|B2|||Age||years|Mean|24|24.0|Standard Deviation|5|5.0|||
4000386|NCT01223183|3820392|B1|||Age||years|Mean|27|27.0|Standard Deviation|11|11.0|||
4000387|NCT01223027|3820401|B3|Missing||Memorial Sloan Kettering Cancer Center Risk Criteria (MSKCC) risk group|"Pts were place into 3 distinct risk groups based on the number of risk factors that the patient had at baseline:~Low Karnofsky Performance Status: <80%, Low serum hemoglobin: males (≤ 13 g/dL); females (≤ 11.5 g/dL), High corrected serum calcium: ≥ 10 mg/dL. Pts in the favorable group are expected to live longer while patients in the poor risk group are expected to die sooner than the patients in the other groups.~Favorable = Pt. had none of the risks; Intermediate = Patient had 1 risk factor; Poor = Pt. had 2 or 3 risk factors Missing = not enough information at baseline to categorize"|Participants|Number|9|9.0||||||
4000388|NCT01223027|3820402|B2|Missing||Memorial Sloan Kettering Cancer Center Risk Criteria (MSKCC) risk group|"Pts were place into 3 distinct risk groups based on the number of risk factors that the patient had at baseline:~Low Karnofsky Performance Status: <80%, Low serum hemoglobin: males (≤ 13 g/dL); females (≤ 11.5 g/dL), High corrected serum calcium: ≥ 10 mg/dL. Pts in the favorable group are expected to live longer while patients in the poor risk group are expected to die sooner than the patients in the other groups.~Favorable = Pt. had none of the risks; Intermediate = Patient had 1 risk factor; Poor = Pt. had 2 or 3 risk factors Missing = not enough information at baseline to categorize"|Participants|Number|5|5.0||||||
4000389|NCT01223027|3820403|B1|Missing||Memorial Sloan Kettering Cancer Center Risk Criteria (MSKCC) risk group|"Pts were place into 3 distinct risk groups based on the number of risk factors that the patient had at baseline:~Low Karnofsky Performance Status: <80%, Low serum hemoglobin: males (≤ 13 g/dL); females (≤ 11.5 g/dL), High corrected serum calcium: ≥ 10 mg/dL. Pts in the favorable group are expected to live longer while patients in the poor risk group are expected to die sooner than the patients in the other groups.~Favorable = Pt. had none of the risks; Intermediate = Patient had 1 risk factor; Poor = Pt. had 2 or 3 risk factors Missing = not enough information at baseline to categorize"|Participants|Number|4|4.0||||||
4000406|NCT01223027|3820402|B2|90 - Able to carry on normal activity||Karnofsky performance score||Participants|Number|101|101.0||||||
4000407|NCT01223027|3820403|B1|90 - Able to carry on normal activity||Karnofsky performance score||Participants|Number|93|93.0||||||
4000390|NCT01223027|3820401|B3|Poor||Memorial Sloan Kettering Cancer Center Risk Criteria (MSKCC) risk group|"Pts were place into 3 distinct risk groups based on the number of risk factors that the patient had at baseline:~Low Karnofsky Performance Status: <80%, Low serum hemoglobin: males (≤ 13 g/dL); females (≤ 11.5 g/dL), High corrected serum calcium: ≥ 10 mg/dL. Pts in the favorable group are expected to live longer while patients in the poor risk group are expected to die sooner than the patients in the other groups.~Favorable = Pt. had none of the risks; Intermediate = Patient had 1 risk factor; Poor = Pt. had 2 or 3 risk factors Missing = not enough information at baseline to categorize"|Participants|Number|115|115.0||||||
4000391|NCT01223027|3820402|B2|Poor||Memorial Sloan Kettering Cancer Center Risk Criteria (MSKCC) risk group|"Pts were place into 3 distinct risk groups based on the number of risk factors that the patient had at baseline:~Low Karnofsky Performance Status: <80%, Low serum hemoglobin: males (≤ 13 g/dL); females (≤ 11.5 g/dL), High corrected serum calcium: ≥ 10 mg/dL. Pts in the favorable group are expected to live longer while patients in the poor risk group are expected to die sooner than the patients in the other groups.~Favorable = Pt. had none of the risks; Intermediate = Patient had 1 risk factor; Poor = Pt. had 2 or 3 risk factors Missing = not enough information at baseline to categorize"|Participants|Number|61|61.0||||||
4000392|NCT01223027|3820403|B1|Poor||Memorial Sloan Kettering Cancer Center Risk Criteria (MSKCC) risk group|"Pts were place into 3 distinct risk groups based on the number of risk factors that the patient had at baseline:~Low Karnofsky Performance Status: <80%, Low serum hemoglobin: males (≤ 13 g/dL); females (≤ 11.5 g/dL), High corrected serum calcium: ≥ 10 mg/dL. Pts in the favorable group are expected to live longer while patients in the poor risk group are expected to die sooner than the patients in the other groups.~Favorable = Pt. had none of the risks; Intermediate = Patient had 1 risk factor; Poor = Pt. had 2 or 3 risk factors Missing = not enough information at baseline to categorize"|Participants|Number|54|54.0||||||
4000393|NCT01223027|3820401|B3|Intermediate||Memorial Sloan Kettering Cancer Center Risk Criteria (MSKCC) risk group|"Pts were place into 3 distinct risk groups based on the number of risk factors that the patient had at baseline:~Low Karnofsky Performance Status: <80%, Low serum hemoglobin: males (≤ 13 g/dL); females (≤ 11.5 g/dL), High corrected serum calcium: ≥ 10 mg/dL. Pts in the favorable group are expected to live longer while patients in the poor risk group are expected to die sooner than the patients in the other groups.~Favorable = Pt. had none of the risks; Intermediate = Patient had 1 risk factor; Poor = Pt. had 2 or 3 risk factors Missing = not enough information at baseline to categorize"|Participants|Number|311|311.0||||||
4000394|NCT01223027|3820402|B2|Intermediate||Memorial Sloan Kettering Cancer Center Risk Criteria (MSKCC) risk group|"Pts were place into 3 distinct risk groups based on the number of risk factors that the patient had at baseline:~Low Karnofsky Performance Status: <80%, Low serum hemoglobin: males (≤ 13 g/dL); females (≤ 11.5 g/dL), High corrected serum calcium: ≥ 10 mg/dL. Pts in the favorable group are expected to live longer while patients in the poor risk group are expected to die sooner than the patients in the other groups.~Favorable = Pt. had none of the risks; Intermediate = Patient had 1 risk factor; Poor = Pt. had 2 or 3 risk factors Missing = not enough information at baseline to categorize"|Participants|Number|155|155.0||||||
4000395|NCT01223027|3820403|B1|Intermediate||Memorial Sloan Kettering Cancer Center Risk Criteria (MSKCC) risk group|"Pts were place into 3 distinct risk groups based on the number of risk factors that the patient had at baseline:~Low Karnofsky Performance Status: <80%, Low serum hemoglobin: males (≤ 13 g/dL); females (≤ 11.5 g/dL), High corrected serum calcium: ≥ 10 mg/dL. Pts in the favorable group are expected to live longer while patients in the poor risk group are expected to die sooner than the patients in the other groups.~Favorable = Pt. had none of the risks; Intermediate = Patient had 1 risk factor; Poor = Pt. had 2 or 3 risk factors Missing = not enough information at baseline to categorize"|Participants|Number|156|156.0||||||
4000396|NCT01223027|3820401|B3|Favorable||Memorial Sloan Kettering Cancer Center Risk Criteria (MSKCC) risk group|"Pts were place into 3 distinct risk groups based on the number of risk factors that the patient had at baseline:~Low Karnofsky Performance Status: <80%, Low serum hemoglobin: males (≤ 13 g/dL); females (≤ 11.5 g/dL), High corrected serum calcium: ≥ 10 mg/dL. Pts in the favorable group are expected to live longer while patients in the poor risk group are expected to die sooner than the patients in the other groups.~Favorable = Pt. had none of the risks; Intermediate = Patient had 1 risk factor; Poor = Pt. had 2 or 3 risk factors Missing = not enough information at baseline to categorize"|Participants|Number|135|135.0||||||
4000397|NCT01223027|3820402|B2|Favorable||Memorial Sloan Kettering Cancer Center Risk Criteria (MSKCC) risk group|"Pts were place into 3 distinct risk groups based on the number of risk factors that the patient had at baseline:~Low Karnofsky Performance Status: <80%, Low serum hemoglobin: males (≤ 13 g/dL); females (≤ 11.5 g/dL), High corrected serum calcium: ≥ 10 mg/dL. Pts in the favorable group are expected to live longer while patients in the poor risk group are expected to die sooner than the patients in the other groups.~Favorable = Pt. had none of the risks; Intermediate = Patient had 1 risk factor; Poor = Pt. had 2 or 3 risk factors Missing = not enough information at baseline to categorize"|Participants|Number|65|65.0||||||
4000398|NCT01223027|3820403|B1|Favorable||Memorial Sloan Kettering Cancer Center Risk Criteria (MSKCC) risk group|"Pts were place into 3 distinct risk groups based on the number of risk factors that the patient had at baseline:~Low Karnofsky Performance Status: <80%, Low serum hemoglobin: males (≤ 13 g/dL); females (≤ 11.5 g/dL), High corrected serum calcium: ≥ 10 mg/dL. Pts in the favorable group are expected to live longer while patients in the poor risk group are expected to die sooner than the patients in the other groups.~Favorable = Pt. had none of the risks; Intermediate = Patient had 1 risk factor; Poor = Pt. had 2 or 3 risk factors Missing = not enough information at baseline to categorize"|Participants|Number|70|70.0||||||
4000399|NCT01223027|3820401|B3|70 - Cares for self||Karnofsky performance score||Participants|Number|64|64.0||||||
4000400|NCT01223027|3820402|B2|70 - Cares for self||Karnofsky performance score||Participants|Number|29|29.0||||||
4000401|NCT01223027|3820403|B1|70 - Cares for self||Karnofsky performance score||Participants|Number|35|35.0||||||
4000402|NCT01223027|3820401|B3|80 - Normal activity with efforts||Karnofsky performance score||Participants|Number|156|156.0||||||
4000403|NCT01223027|3820402|B2|80 - Normal activity with efforts||Karnofsky performance score||Participants|Number|83|83.0||||||
4000404|NCT01223027|3820403|B1|80 - Normal activity with efforts||Karnofsky performance score||Participants|Number|73|73.0||||||
4000405|NCT01223027|3820401|B3|90 - Able to carry on normal activity||Karnofsky performance score||Participants|Number|194|194.0||||||
4000408|NCT01223027|3820401|B3|100 -Normal no complaints; no evidence of disease||Karnofsky performance score||Participants|Number|156|156.0||||||
4000409|NCT01223027|3820402|B2|100 -Normal no complaints; no evidence of disease||Karnofsky performance score||Participants|Number|73|73.0||||||
4000410|NCT01223027|3820403|B1|100 -Normal no complaints; no evidence of disease||Karnofsky performance score||Participants|Number|83|83.0||||||
4000411|NCT01223027|3820401|B3|||Weight||kg|Mean|75.2|75.2|Standard Deviation|15.67|15.67|||
4000412|NCT01223027|3820402|B2|||Weight||kg|Mean|75.5|75.5|Standard Deviation|15.96|15.96|||
4000413|NCT01223027|3820403|B1|||Weight||kg|Mean|74.9|74.9|Standard Deviation|15.39|15.39|||
4000414|NCT01223027|3820401|B3|Other||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4000415|NCT01223027|3820402|B2|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4000416|NCT01223027|3820403|B1|Other||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4000417|NCT01223027|3820401|B3|Unknown||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4000418|NCT01223027|3820402|B2|Unknown||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4000419|NCT01223027|3820403|B1|Unknown||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4000420|NCT01223027|3820401|B3|Black||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4000421|NCT01223027|3820402|B2|Black||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4000422|NCT01223027|3820403|B1|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4000423|NCT01223027|3820401|B3|Asian||Race/Ethnicity, Customized||Participants|Number|82|82.0||||||
4000424|NCT01223027|3820402|B2|Asian||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
4000425|NCT01223027|3820403|B1|Asian||Race/Ethnicity, Customized||Participants|Number|42|42.0||||||
4000426|NCT01223027|3820401|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|465|465.0||||||
4000427|NCT01223027|3820402|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|232|232.0||||||
4000428|NCT01223027|3820403|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|233|233.0||||||
4000429|NCT01223027|3820401|B3||Male|Sex: Female, Male||Participants|Count of Participants|432|432.0||||||
4000430|NCT01223027|3820402|B2||Male|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
4000431|NCT01223027|3820403|B1||Male|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
4000432|NCT01223027|3820401|B3||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4000433|NCT01223027|3820402|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4000434|NCT01223027|3820403|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4000435|NCT01223027|3820401|B3|>= 65 years||Age, Customized||Participants|Number|218|218.0||||||
4000436|NCT01223027|3820402|B2|>= 65 years||Age, Customized||Participants|Number|121|121.0||||||
4000437|NCT01223027|3820403|B1|>= 65 years||Age, Customized||Participants|Number|97|97.0||||||
4000438|NCT01223027|3820401|B3|< 65 years||Age, Customized||Participants|Number|352|352.0||||||
4000439|NCT01223027|3820402|B2|< 65 years||Age, Customized||Participants|Number|165|165.0||||||
4000440|NCT01223027|3820403|B1|< 65 years||Age, Customized||Participants|Number|187|187.0||||||
4000441|NCT01223001|3820425|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4000442|NCT01223001|3820426|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4000443|NCT01223001|3820427|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4000444|NCT01223001|3820425|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4000445|NCT01223001|3820426|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4000446|NCT01223001|3820427|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4000447|NCT01223001|3820425|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4000448|NCT01223001|3820426|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4000449|NCT01223001|3820427|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4000450|NCT01223001|3820425|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4000451|NCT01223001|3820426|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4000452|NCT01223001|3820427|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4000453|NCT01223001|3820425|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4000454|NCT01223001|3820426|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4000455|NCT01223001|3820427|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4000456|NCT01223001|3820425|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4000457|NCT01223001|3820426|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4000458|NCT01223001|3820427|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4000459|NCT01222884|3820434|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4000460|NCT01222884|3820435|B2|United States||Region of Enrollment||participants|Number|0|0.0||||||
4000461|NCT01222884|3820436|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4000462|NCT01222884|3820434|B3|Denmark||Region of Enrollment||participants|Number|11|11.0||||||
4000463|NCT01222884|3820435|B2|Denmark||Region of Enrollment||participants|Number|5|5.0||||||
4000464|NCT01222884|3820436|B1|Denmark||Region of Enrollment||participants|Number|6|6.0||||||
4000465|NCT01222884|3820434|B3|Romania||Region of Enrollment||participants|Number|26|26.0||||||
4000466|NCT01222884|3820435|B2|Romania||Region of Enrollment||participants|Number|12|12.0||||||
4000467|NCT01222884|3820436|B1|Romania||Region of Enrollment||participants|Number|14|14.0||||||
4000468|NCT01222884|3820434|B3|Switzerland||Region of Enrollment||participants|Number|19|19.0||||||
4000469|NCT01222884|3820435|B2|Switzerland||Region of Enrollment||participants|Number|6|6.0||||||
4000470|NCT01222884|3820436|B1|Switzerland||Region of Enrollment||participants|Number|13|13.0||||||
4000471|NCT01222884|3820434|B3|Sweden||Region of Enrollment||participants|Number|10|10.0||||||
4000472|NCT01222884|3820435|B2|Sweden||Region of Enrollment||participants|Number|4|4.0||||||
4000473|NCT01222884|3820436|B1|Sweden||Region of Enrollment||participants|Number|6|6.0||||||
4000474|NCT01222884|3820434|B3|Poland||Region of Enrollment||participants|Number|13|13.0||||||
4000475|NCT01222884|3820435|B2|Poland||Region of Enrollment||participants|Number|3|3.0||||||
4000476|NCT01222884|3820436|B1|Poland||Region of Enrollment||participants|Number|10|10.0||||||
4000477|NCT01222884|3820434|B3|Russian Federation||Region of Enrollment||participants|Number|9|9.0||||||
4000478|NCT01222884|3820435|B2|Russian Federation||Region of Enrollment||participants|Number|3|3.0||||||
4000479|NCT01222884|3820436|B1|Russian Federation||Region of Enrollment||participants|Number|6|6.0||||||
4000480|NCT01222884|3820434|B3|United Kingdom||Region of Enrollment||participants|Number|187|187.0||||||
4000481|NCT01222884|3820435|B2|United Kingdom||Region of Enrollment||participants|Number|56|56.0||||||
4000482|NCT01222884|3820436|B1|United Kingdom||Region of Enrollment||participants|Number|131|131.0||||||
4000483|NCT01222884|3820434|B3|India||Region of Enrollment||participants|Number|72|72.0||||||
4000484|NCT01222884|3820435|B2|India||Region of Enrollment||participants|Number|28|28.0||||||
4000485|NCT01222884|3820436|B1|India||Region of Enrollment||participants|Number|44|44.0||||||
4000486|NCT01222884|3820434|B3||Male|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
4000487|NCT01222884|3820435|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4000488|NCT01222884|3820436|B1||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4000489|NCT01222884|3820434|B3||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4000490|NCT01222884|3820435|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4000491|NCT01222884|3820436|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4000492|NCT01222884|3820434|B3|||Age||years|Mean|60.0|60.0|Standard Deviation|15.9|15.9|||
4000493|NCT01222884|3820435|B2|||Age||years|Mean|59.5|59.5|Standard Deviation|15.4|15.4|||
4000494|NCT01222884|3820436|B1|||Age||years|Mean|60.2|60.2|Standard Deviation|16.2|16.2|||
4000495|NCT01222884|3820434|B3||>=65 years|Age||Participants|Count of Participants|156|156.0||||||
4000496|NCT01222884|3820435|B2||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
4000497|NCT01222884|3820436|B1||>=65 years|Age||Participants|Count of Participants|105|105.0||||||
4000498|NCT01222884|3820434|B3||Between 18 and 65 years|Age||Participants|Count of Participants|195|195.0||||||
4000499|NCT01222884|3820435|B2||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4000500|NCT01222884|3820436|B1||Between 18 and 65 years|Age||Participants|Count of Participants|129|129.0||||||
4000501|NCT01222884|3820434|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4000502|NCT01222884|3820435|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4000503|NCT01222884|3820436|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4000504|NCT01222832|3820455|B3|United States||Region of Enrollment||participants|Number|226|226.0||||||
4000505|NCT01222832|3820456|B2|United States||Region of Enrollment||participants|Number|113|113.0||||||
4000506|NCT01222832|3820457|B1|United States||Region of Enrollment||participants|Number|113|113.0||||||
4000507|NCT01222832|3820455|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4000508|NCT01222832|3820455|B3||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4000509|NCT01222832|3820456|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4000510|NCT01222832|3820457|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4000511|NCT01222832|3820455|B3||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4000512|NCT01222832|3820456|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4000513|NCT01222832|3820457|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4000514|NCT01222832|3820455|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4000515|NCT01222832|3820456|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4000516|NCT01222832|3820457|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4000517|NCT01222832|3820455|B3||Between 18 and 65 years|Age||Participants|Count of Participants|226|226.0||||||
4000518|NCT01222832|3820456|B2||Between 18 and 65 years|Age||Participants|Count of Participants|113|113.0||||||
4000519|NCT01222832|3820457|B1||Between 18 and 65 years|Age||Participants|Count of Participants|113|113.0||||||
4000520|NCT01222832|3820455|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4000521|NCT01222832|3820456|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4000522|NCT01222832|3820457|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4000523|NCT01222715|3820464|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4000524|NCT01222715|3820465|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4000525|NCT01222715|3820466|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4000526|NCT01222715|3820464|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000527|NCT01222715|3820465|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000528|NCT01222715|3820466|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000529|NCT01222715|3820464|B3||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4000530|NCT01222715|3820465|B2||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4000531|NCT01222715|3820466|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4000532|NCT01222715|3820464|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4000533|NCT01222715|3820465|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4000534|NCT01222715|3820466|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4000535|NCT01222715|3820464|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4000536|NCT01222715|3820465|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4000537|NCT01222715|3820466|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4000538|NCT01222715|3820464|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000539|NCT01222715|3820465|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000540|NCT01222715|3820466|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000541|NCT01222715|3820464|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4000542|NCT01222715|3820465|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4000543|NCT01222715|3820466|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4000544|NCT01222715|3820464|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4000545|NCT01222715|3820465|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4000546|NCT01222715|3820466|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000547|NCT01222715|3820464|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4000548|NCT01222715|3820465|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4000549|NCT01222715|3820466|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4000550|NCT01222715|3820464|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4000551|NCT01222715|3820465|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4000552|NCT01222715|3820466|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4000553|NCT01222715|3820464|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4000554|NCT01222715|3820465|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4000555|NCT01222715|3820466|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4000556|NCT01222715|3820464|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4000557|NCT01222715|3820465|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4000558|NCT01222715|3820466|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4000559|NCT01222715|3820464|B3|||Age||Months|Mean|128.36|128.36|Standard Deviation|74.94|74.94|||
4000560|NCT01222715|3820465|B2|||Age||Months|Mean|140.65|140.65|Standard Deviation|75.93|75.93|||
4000561|NCT01222715|3820466|B1|||Age||Months|Mean|116.35|116.35|Standard Deviation|72.82|72.82|||
4000562|NCT01222689|3820477|B1|status = 1||Eastern Cooperative Oncology Group (ECOG) performance status|"Patient Performance Scale:~0=Fully active, can carry on all pre-disease performance without rest~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours~Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair~Dead"|participants|Number|14|14.0||||||
4000563|NCT01222689|3820477|B1|status = 0||Eastern Cooperative Oncology Group (ECOG) performance status|"Patient Performance Scale:~0=Fully active, can carry on all pre-disease performance without rest~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours~Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair~Dead"|participants|Number|32|32.0||||||
4000564|NCT01222689|3820477|B1|||Elevated baseline Cancer Antigen 19-9(CA19-9) > 2x Upper Limit of Normal (ULN)||participants|Number|34|34.0||||||
4000565|NCT01222689|3820477|B1|||Prior radiation||participants|Number|7|7.0||||||
4000566|NCT01222689|3820477|B1|||Prior surgery||participants|Number|14|14.0||||||
4000567|NCT01222689|3820477|B1|Other||Prior chemotherapy||participants|Number|2|2.0||||||
4000568|NCT01222689|3820477|B1|FOLFIRINOX||Prior chemotherapy||participants|Number|10|10.0||||||
4000569|NCT01222689|3820477|B1|Gemcitabine-based||Prior chemotherapy||participants|Number|34|34.0||||||
4000570|NCT01222689|3820477|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4000571|NCT01222689|3820477|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4000572|NCT01222689|3820477|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4000573|NCT01222689|3820477|B1|||Age||years|Median|67|67.0|Full Range|||40.0|84.0|
4000574|NCT01222585|3820490|B1|||Birth Weight||grams|Median|740|740.0|Full Range|||431.0|1466.0|
4000575|NCT01222585|3820490|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4000576|NCT01222585|3820490|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000577|NCT01222585|3820490|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000578|NCT01222585|3820490|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4000579|NCT01222585|3820490|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4000580|NCT01222585|3820490|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4000581|NCT01222585|3820490|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000582|NCT01222585|3820490|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000583|NCT01222585|3820490|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000584|NCT01222585|3820490|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4000585|NCT01222585|3820490|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4000586|NCT01222585|3820490|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4000587|NCT01222585|3820490|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4000588|NCT01222585|3820490|B1|||Age|Gestational age (weeks)|weeks|Mean|25|25.0|Full Range|||23.0|31.0|
4000589|NCT01222585|3820490|B1|||Age|Post Natal Age (Days)|days|Median|27|27.0|Full Range|||1.0|82.0|
4000590|NCT01222572|3820500|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4000591|NCT01222572|3820500|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4000592|NCT01222572|3820500|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4000593|NCT01222572|3820500|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4000594|NCT01222572|3820500|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4000595|NCT01222572|3820500|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4000596|NCT01222572|3820500|B1|||Age||years|Mean|68|68.0|Full Range|||68.0|68.0|
4000597|NCT01222533|3820506|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4000598|NCT01222533|3820506|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4000599|NCT01222533|3820506|B1|||Age||years|Mean|63.1|63.1|Standard Deviation|7.8|7.8|||
4000600|NCT01222520|3820643|B3||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4000601|NCT01222520|3820644|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4000602|NCT01222520|3820645|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4000603|NCT01222520|3820643|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4000604|NCT01222520|3820644|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4000605|NCT01222520|3820645|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4000606|NCT01222520|3820643|B3|||Age||year|Mean|54.6|54.6|Standard Deviation|8.8|8.8|||
4000607|NCT01222520|3820644|B2|||Age||year|Mean|54.8|54.8|Standard Deviation|8.6|8.6|||
4000608|NCT01222520|3820645|B1|||Age||year|Mean|54.5|54.5|Standard Deviation|9.0|9.0|||
4000609|NCT01222507|3820664|B1|United States||Region of Enrollment||participants|Number|62|62.0||||||
4000610|NCT01222507|3820664|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4000611|NCT01222507|3820664|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4000612|NCT01222507|3820664|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4000613|NCT01222507|3820664|B1||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4000614|NCT01222507|3820664|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4000615|NCT01222494|3820668|B4|||Child Behavior Checklist (CBCL)|The CBCL/ABCL is a 113 item scale that serves as a general screening measure of behavior problems, competencies, and school functioning. Each item is scored a 0, 1, or 2. A lower score is better. The eight empirically-based syndrome scales are: Aggressive Behavior, Anxious/Depressed, Attention Problems, Rule-Breaking Behavior, Somatic Complaints, Social Problems, Thought Problems and Withdrawn/Depressed.|units on a scale|Mean|40.61|40.61|Standard Deviation|31.80|31.8|||
4000616|NCT01222494|3820669|B3|||Child Behavior Checklist (CBCL)|The CBCL/ABCL is a 113 item scale that serves as a general screening measure of behavior problems, competencies, and school functioning. Each item is scored a 0, 1, or 2. A lower score is better. The eight empirically-based syndrome scales are: Aggressive Behavior, Anxious/Depressed, Attention Problems, Rule-Breaking Behavior, Somatic Complaints, Social Problems, Thought Problems and Withdrawn/Depressed.|units on a scale|Mean|16.67|16.67|Standard Deviation|15.20|15.2|||
4000617|NCT01222494|3820670|B2|||Child Behavior Checklist (CBCL)|The CBCL/ABCL is a 113 item scale that serves as a general screening measure of behavior problems, competencies, and school functioning. Each item is scored a 0, 1, or 2. A lower score is better. The eight empirically-based syndrome scales are: Aggressive Behavior, Anxious/Depressed, Attention Problems, Rule-Breaking Behavior, Somatic Complaints, Social Problems, Thought Problems and Withdrawn/Depressed.|units on a scale|Mean|57.06|57.06|Standard Deviation|28.39|28.39|||
4000618|NCT01222494|3820671|B1|||Child Behavior Checklist (CBCL)|The CBCL/ABCL is a 113 item scale that serves as a general screening measure of behavior problems, competencies, and school functioning. Each item is scored a 0, 1, or 2. A lower score is better. The eight empirically-based syndrome scales are: Aggressive Behavior, Anxious/Depressed, Attention Problems, Rule-Breaking Behavior, Somatic Complaints, Social Problems, Thought Problems and Withdrawn/Depressed.|units on a scale|Mean|70.14|70.14|Standard Deviation|26.34|26.34|||
4000619|NCT01222494|3820668|B4|Irritability||Aberrant Behavior Checklist (ABC)|This instrument is a five-factor scale comprising 58 items under the categories of (I) Irritability, Agitation, Crying; (II) Lethargy, Social Withdrawal; (III) Stereotypic Behavior; (IV) Hyperactivity, Noncompliance; and (V) Inappropriate Speech. The 15-item Irritability subscale score ranges from 0 to 45. The cut-off of ≥ 18 on this subscale will identify individuals that are 1.3 to 1.5 SD above the mean. A lower score is better.The total score can range from a minimum of 0 (no problem behaviors) to a maximum of 174, with higher scores indicating a worse outcome/more symptoms.|units on a scale|Mean|8.15|8.15|Standard Deviation|9.13|9.13|||
4000643|NCT01222494|3820668|B4|Glucose||Baseline Fasting Laboratory Values||mg/dl|Mean|90.02|90.02|Standard Deviation|7.13|7.13|||
4000644|NCT01222494|3820669|B3|Glucose||Baseline Fasting Laboratory Values||mg/dl|Mean|87.62|87.62|Standard Deviation|4.99|4.99|||
4000645|NCT01222494|3820670|B2|Glucose||Baseline Fasting Laboratory Values||mg/dl|Mean|91.32|91.32|Standard Deviation|7.42|7.42|||
4000646|NCT01222494|3820671|B1|Glucose||Baseline Fasting Laboratory Values||mg/dl|Mean|93.71|93.71|Standard Deviation|10.01|10.01|||
4000620|NCT01222494|3820669|B3|Irritability||Aberrant Behavior Checklist (ABC)|This instrument is a five-factor scale comprising 58 items under the categories of (I) Irritability, Agitation, Crying; (II) Lethargy, Social Withdrawal; (III) Stereotypic Behavior; (IV) Hyperactivity, Noncompliance; and (V) Inappropriate Speech. The 15-item Irritability subscale score ranges from 0 to 45. The cut-off of ≥ 18 on this subscale will identify individuals that are 1.3 to 1.5 SD above the mean. A lower score is better.The total score can range from a minimum of 0 (no problem behaviors) to a maximum of 174, with higher scores indicating a worse outcome/more symptoms.|units on a scale|Mean|2.19|2.19|Standard Deviation|4.81|4.81|||
4000621|NCT01222494|3820670|B2|Irritability||Aberrant Behavior Checklist (ABC)|This instrument is a five-factor scale comprising 58 items under the categories of (I) Irritability, Agitation, Crying; (II) Lethargy, Social Withdrawal; (III) Stereotypic Behavior; (IV) Hyperactivity, Noncompliance; and (V) Inappropriate Speech. The 15-item Irritability subscale score ranges from 0 to 45. The cut-off of ≥ 18 on this subscale will identify individuals that are 1.3 to 1.5 SD above the mean. A lower score is better.The total score can range from a minimum of 0 (no problem behaviors) to a maximum of 174, with higher scores indicating a worse outcome/more symptoms.|units on a scale|Mean|11.06|11.06|Standard Deviation|8.30|8.3|||
4000622|NCT01222494|3820671|B1|Irritability||Aberrant Behavior Checklist (ABC)|This instrument is a five-factor scale comprising 58 items under the categories of (I) Irritability, Agitation, Crying; (II) Lethargy, Social Withdrawal; (III) Stereotypic Behavior; (IV) Hyperactivity, Noncompliance; and (V) Inappropriate Speech. The 15-item Irritability subscale score ranges from 0 to 45. The cut-off of ≥ 18 on this subscale will identify individuals that are 1.3 to 1.5 SD above the mean. A lower score is better.The total score can range from a minimum of 0 (no problem behaviors) to a maximum of 174, with higher scores indicating a worse outcome/more symptoms.|units on a scale|Mean|18.57|18.57|Standard Deviation|8.75|8.75|||
4000623|NCT01222494|3820668|B4|Total Score||Aberrant Behavior Checklist (ABC)|This instrument is a five-factor scale comprising 58 items under the categories of (I) Irritability, Agitation, Crying; (II) Lethargy, Social Withdrawal; (III) Stereotypic Behavior; (IV) Hyperactivity, Noncompliance; and (V) Inappropriate Speech. The 15-item Irritability subscale score ranges from 0 to 45. The cut-off of ≥ 18 on this subscale will identify individuals that are 1.3 to 1.5 SD above the mean. A lower score is better.The total score can range from a minimum of 0 (no problem behaviors) to a maximum of 174, with higher scores indicating a worse outcome/more symptoms.|units on a scale|Mean|25.17|25.17|Standard Deviation|26.11|26.11|||
4000624|NCT01222494|3820669|B3|Total Score||Aberrant Behavior Checklist (ABC)|This instrument is a five-factor scale comprising 58 items under the categories of (I) Irritability, Agitation, Crying; (II) Lethargy, Social Withdrawal; (III) Stereotypic Behavior; (IV) Hyperactivity, Noncompliance; and (V) Inappropriate Speech. The 15-item Irritability subscale score ranges from 0 to 45. The cut-off of ≥ 18 on this subscale will identify individuals that are 1.3 to 1.5 SD above the mean. A lower score is better.The total score can range from a minimum of 0 (no problem behaviors) to a maximum of 174, with higher scores indicating a worse outcome/more symptoms.|units on a scale|Mean|6.81|6.81|Standard Deviation|13.39|13.39|||
4000625|NCT01222494|3820670|B2|Total Score||Aberrant Behavior Checklist (ABC)|This instrument is a five-factor scale comprising 58 items under the categories of (I) Irritability, Agitation, Crying; (II) Lethargy, Social Withdrawal; (III) Stereotypic Behavior; (IV) Hyperactivity, Noncompliance; and (V) Inappropriate Speech. The 15-item Irritability subscale score ranges from 0 to 45. The cut-off of ≥ 18 on this subscale will identify individuals that are 1.3 to 1.5 SD above the mean. A lower score is better.The total score can range from a minimum of 0 (no problem behaviors) to a maximum of 174, with higher scores indicating a worse outcome/more symptoms.|units on a scale|Mean|35.61|35.61|Standard Deviation|24.29|24.29|||
4000626|NCT01222494|3820671|B1|Total Score||Aberrant Behavior Checklist (ABC)|This instrument is a five-factor scale comprising 58 items under the categories of (I) Irritability, Agitation, Crying; (II) Lethargy, Social Withdrawal; (III) Stereotypic Behavior; (IV) Hyperactivity, Noncompliance; and (V) Inappropriate Speech. The 15-item Irritability subscale score ranges from 0 to 45. The cut-off of ≥ 18 on this subscale will identify individuals that are 1.3 to 1.5 SD above the mean. A lower score is better.The total score can range from a minimum of 0 (no problem behaviors) to a maximum of 174, with higher scores indicating a worse outcome/more symptoms.|units on a scale|Mean|53.43|53.43|Standard Deviation|20.14|20.14|||
4000627|NCT01222494|3820668|B4|LDL Cholesterol||Baseline Fasting Laboratory Values||mg/dl|Mean|95.32|95.32|Standard Deviation|24.49|24.49|||
4000628|NCT01222494|3820669|B3|LDL Cholesterol||Baseline Fasting Laboratory Values||mg/dl|Mean|87.24|87.24|Standard Deviation|23.40|23.4|||
4000629|NCT01222494|3820670|B2|LDL Cholesterol||Baseline Fasting Laboratory Values||mg/dl|Mean|101.68|101.68|Standard Deviation|27.32|27.32|||
4000630|NCT01222494|3820671|B1|LDL Cholesterol||Baseline Fasting Laboratory Values||mg/dl|Mean|102.29|102.29|Standard Deviation|10.95|10.95|||
4000631|NCT01222494|3820668|B4|HDL Cholesterol||Baseline Fasting Laboratory Values||mg/dl|Mean|48.34|48.34|Standard Deviation|10.04|10.04|||
4000632|NCT01222494|3820669|B3|HDL Cholesterol||Baseline Fasting Laboratory Values||mg/dl|Mean|50.71|50.71|Standard Deviation|10.74|10.74|||
4000633|NCT01222494|3820670|B2|HDL Cholesterol||Baseline Fasting Laboratory Values||mg/dl|Mean|46.95|46.95|Standard Deviation|10.20|10.2|||
4000634|NCT01222494|3820671|B1|HDL Cholesterol||Baseline Fasting Laboratory Values||mg/dl|Mean|45.00|45.0|Standard Deviation|6.16|6.16|||
4000635|NCT01222494|3820668|B4|Triglycerides||Baseline Fasting Laboratory Values||mg/dl|Mean|104.30|104.3|Standard Deviation|57.35|57.35|||
4000636|NCT01222494|3820669|B3|Triglycerides||Baseline Fasting Laboratory Values||mg/dl|Mean|99.14|99.14|Standard Deviation|61.30|61.3|||
4000637|NCT01222494|3820670|B2|Triglycerides||Baseline Fasting Laboratory Values||mg/dl|Mean|106.26|106.26|Standard Deviation|59.11|59.11|||
4000638|NCT01222494|3820671|B1|Triglycerides||Baseline Fasting Laboratory Values||mg/dl|Mean|114.43|114.43|Standard Deviation|44.49|44.49|||
4000639|NCT01222494|3820668|B4|Total Cholesterol||Baseline Fasting Laboratory Values||mg/dl|Mean|164.36|164.36|Standard Deviation|31.10|31.1|||
4000640|NCT01222494|3820669|B3|Total Cholesterol||Baseline Fasting Laboratory Values||mg/dl|Mean|157.81|157.81|Standard Deviation|29.09|29.09|||
4000641|NCT01222494|3820670|B2|Total Cholesterol||Baseline Fasting Laboratory Values||mg/dl|Mean|169.47|169.47|Standard Deviation|37.55|37.55|||
4000642|NCT01222494|3820671|B1|Total Cholesterol||Baseline Fasting Laboratory Values||mg/dl|Mean|170.14|170.14|Standard Deviation|9.67|9.67|||
4000647|NCT01222494|3820668|B4|||Waist Circumference||centimeters|Mean|100.83|100.83|Standard Deviation|16.58|16.58|||
4000648|NCT01222494|3820669|B3|||Waist Circumference||centimeters|Mean|102.40|102.4|Standard Deviation|16.07|16.07|||
4000649|NCT01222494|3820670|B2|||Waist Circumference||centimeters|Mean|99.45|99.45|Standard Deviation|19.35|19.35|||
4000650|NCT01222494|3820671|B1|||Waist Circumference||centimeters|Mean|99.86|99.86|Standard Deviation|10.35|10.35|||
4000651|NCT01222494|3820668|B4|||Body Mass Index (BMI) Z-Score|The BMI Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean of a reference population (i.e., healthy, age and sex-matched children). Negative numbers indicate values lower than the reference population and positive numbers indicate values higher than the reference population.|z-score|Mean|2.06|2.06|Standard Deviation|0.40|0.4|||
4000652|NCT01222494|3820669|B3|||Body Mass Index (BMI) Z-Score|The BMI Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean of a reference population (i.e., healthy, age and sex-matched children). Negative numbers indicate values lower than the reference population and positive numbers indicate values higher than the reference population.|z-score|Mean|2.13|2.13|Standard Deviation|0.38|0.38|||
4000653|NCT01222494|3820670|B2|||Body Mass Index (BMI) Z-Score|The BMI Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean of a reference population (i.e., healthy, age and sex-matched children). Negative numbers indicate values lower than the reference population and positive numbers indicate values higher than the reference population.|z-score|Mean|1.99|1.99|Standard Deviation|0.47|0.47|||
4000654|NCT01222494|3820671|B1|||Body Mass Index (BMI) Z-Score|The BMI Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean of a reference population (i.e., healthy, age and sex-matched children). Negative numbers indicate values lower than the reference population and positive numbers indicate values higher than the reference population.|z-score|Mean|2.05|2.05|Standard Deviation|0.23|0.23|||
4000655|NCT01222494|3820668|B4|||Body Mass Index (BMI) Percentile||percentile|Mean|97.24|97.24|Standard Deviation|2.60|2.6|||
4000656|NCT01222494|3820669|B3|||Body Mass Index (BMI) Percentile||percentile|Mean|97.69|97.69|Standard Deviation|2.16|2.16|||
4000657|NCT01222494|3820670|B2|||Body Mass Index (BMI) Percentile||percentile|Mean|96.55|96.55|Standard Deviation|3.30|3.3|||
4000658|NCT01222494|3820671|B1|||Body Mass Index (BMI) Percentile||percentile|Mean|97.77|97.77|Standard Deviation|1.03|1.03|||
4000659|NCT01222494|3820668|B4|||Body Mass Index (BMI)||kilograms per meter-squared|Mean|30.52|30.52|Standard Deviation|5.69|5.69|||
4000660|NCT01222494|3820669|B3|||Body Mass Index (BMI)||kilograms per meter-squared|Mean|31.86|31.86|Standard Deviation|5.25|5.25|||
4000661|NCT01222494|3820670|B2|||Body Mass Index (BMI)||kilograms per meter-squared|Mean|29.70|29.7|Standard Deviation|6.83|6.83|||
4000662|NCT01222494|3820671|B1|||Body Mass Index (BMI)||kilograms per meter-squared|Mean|28.72|28.72|Standard Deviation|2.09|2.09|||
4000663|NCT01222494|3820668|B4|||Carotid Intima Media Thickness||centimeters|Mean|0.0484|0.0484|Standard Deviation|0.0070|0.007|||
4000664|NCT01222494|3820669|B3|||Carotid Intima Media Thickness||centimeters|Mean|0.0504|0.0504|Standard Deviation|0.0065|0.0065|||
4000665|NCT01222494|3820670|B2|||Carotid Intima Media Thickness||centimeters|Mean|0.0451|0.0451|Standard Deviation|0.0074|0.0074|||
4000666|NCT01222494|3820671|B1|||Carotid Intima Media Thickness||centimeters|Mean|0.0494|0.0494|Standard Deviation|0.0058|0.0058|||
4000667|NCT01222494|3820668|B4|||Proton Density Fat Fraction (PDFF)||percentile|Mean|6.58|6.58|Standard Deviation|8.54|8.54|||
4000668|NCT01222494|3820669|B3|||Proton Density Fat Fraction (PDFF)||percentile|Mean|4.72|4.72|Standard Deviation|8.61|8.61|||
4000669|NCT01222494|3820670|B2|||Proton Density Fat Fraction (PDFF)||percentile|Mean|6.52|6.52|Standard Deviation|8.21|8.21|||
4000670|NCT01222494|3820671|B1|||Proton Density Fat Fraction (PDFF)||percentile|Mean|12.01|12.01|Standard Deviation|7.82|7.82|||
4000671|NCT01222494|3820668|B4|DEXA Total Percent Lean||DEXA-Measured Body Composition||percentage of body composition|Mean|54.77|54.77|Standard Deviation|6.73|6.73|||
4000672|NCT01222494|3820669|B3|DEXA Total Percent Lean||DEXA-Measured Body Composition||percentage of body composition|Mean|55.01|55.01|Standard Deviation|5.15|5.15|||
4000673|NCT01222494|3820670|B2|DEXA Total Percent Lean||DEXA-Measured Body Composition||percentage of body composition|Mean|55.48|55.48|Standard Deviation|8.23|8.23|||
4000674|NCT01222494|3820671|B1|DEXA Total Percent Lean||DEXA-Measured Body Composition||percentage of body composition|Mean|52.12|52.12|Standard Deviation|6.81|6.81|||
4000675|NCT01222494|3820668|B4|DEXA Total Percent Fat||DEXA-Measured Body Composition||percentage of body composition|Mean|42.51|42.51|Standard Deviation|6.97|6.97|||
4000676|NCT01222494|3820669|B3|DEXA Total Percent Fat||DEXA-Measured Body Composition||percentage of body composition|Mean|42.24|42.24|Standard Deviation|5.38|5.38|||
4000677|NCT01222494|3820670|B2|DEXA Total Percent Fat||DEXA-Measured Body Composition||percentage of body composition|Mean|41.76|41.76|Standard Deviation|8.53|8.53|||
4000678|NCT01222494|3820671|B1|DEXA Total Percent Fat||DEXA-Measured Body Composition||percentage of body composition|Mean|45.40|45.4|Standard Deviation|6.76|6.76|||
4000679|NCT01222494|3820668|B4|||Weight||kilograms|Mean|80.26|80.26|Standard Deviation|26.62|26.62|||
4000680|NCT01222494|3820669|B3|||Weight||kilograms|Mean|85.76|85.76|Standard Deviation|23.07|23.07|||
4000681|NCT01222494|3820670|B2|||Weight||kilograms|Mean|77.08|77.08|Standard Deviation|32.60|32.6|||
4000682|NCT01222494|3820671|B1|||Weight||kilograms|Mean|72.37|72.37|Standard Deviation|16.11|16.11|||
4000683|NCT01222494|3820668|B4|||Height||meters|Mean|1.60|1.6|Standard Deviation|0.14|0.14|||
4000684|NCT01222494|3820669|B3|||Height||meters|Mean|1.63|1.63|Standard Deviation|0.11|0.11|||
4000685|NCT01222494|3820670|B2|||Height||meters|Mean|1.58|1.58|Standard Deviation|0.15|0.15|||
4000686|NCT01222494|3820671|B1|||Height||meters|Mean|1.58|1.58|Standard Deviation|0.17|0.17|||
4000687|NCT01222494|3820668|B4|Psychosis||Primary Diagnosis||Participants|Count of Participants|1|1.0||||||
4000688|NCT01222494|3820669|B3|Psychosis||Primary Diagnosis||Participants|Count of Participants|0|0.0||||||
4000689|NCT01222494|3820670|B2|Psychosis||Primary Diagnosis||Participants|Count of Participants|1|1.0||||||
4000690|NCT01222494|3820671|B1|Psychosis||Primary Diagnosis||Participants|Count of Participants|0|0.0||||||
4000691|NCT01222494|3820668|B4|Anxiety Disorder||Primary Diagnosis||Participants|Count of Participants|1|1.0||||||
4000692|NCT01222494|3820669|B3|Anxiety Disorder||Primary Diagnosis||Participants|Count of Participants|0|0.0||||||
4000693|NCT01222494|3820670|B2|Anxiety Disorder||Primary Diagnosis||Participants|Count of Participants|1|1.0||||||
4000694|NCT01222494|3820671|B1|Anxiety Disorder||Primary Diagnosis||Participants|Count of Participants|0|0.0||||||
4000695|NCT01222494|3820668|B4|Mood Disorder||Primary Diagnosis||Participants|Count of Participants|3|3.0||||||
4000696|NCT01222494|3820669|B3|Mood Disorder||Primary Diagnosis||Participants|Count of Participants|0|0.0||||||
4000697|NCT01222494|3820670|B2|Mood Disorder||Primary Diagnosis||Participants|Count of Participants|2|2.0||||||
4000698|NCT01222494|3820671|B1|Mood Disorder||Primary Diagnosis||Participants|Count of Participants|1|1.0||||||
4000699|NCT01222494|3820668|B4|Attention Deficit Hyperactivity Disorder (ADHD)||Primary Diagnosis||Participants|Count of Participants|5|5.0||||||
4000700|NCT01222494|3820669|B3|Attention Deficit Hyperactivity Disorder (ADHD)||Primary Diagnosis||Participants|Count of Participants|0|0.0||||||
4000701|NCT01222494|3820670|B2|Attention Deficit Hyperactivity Disorder (ADHD)||Primary Diagnosis||Participants|Count of Participants|4|4.0||||||
4000702|NCT01222494|3820671|B1|Attention Deficit Hyperactivity Disorder (ADHD)||Primary Diagnosis||Participants|Count of Participants|1|1.0||||||
4000703|NCT01222494|3820668|B4|Pervasive Development Disorder (PDD)||Primary Diagnosis||Participants|Count of Participants|1|1.0||||||
4000704|NCT01222494|3820669|B3|Pervasive Development Disorder (PDD)||Primary Diagnosis||Participants|Count of Participants|0|0.0||||||
4000705|NCT01222494|3820670|B2|Pervasive Development Disorder (PDD)||Primary Diagnosis||Participants|Count of Participants|0|0.0||||||
4000706|NCT01222494|3820671|B1|Pervasive Development Disorder (PDD)||Primary Diagnosis||Participants|Count of Participants|1|1.0||||||
4000707|NCT01222494|3820668|B4|Autism||Primary Diagnosis||Participants|Count of Participants|15|15.0||||||
4000708|NCT01222494|3820669|B3|Autism||Primary Diagnosis||Participants|Count of Participants|0|0.0||||||
4000709|NCT01222494|3820670|B2|Autism||Primary Diagnosis||Participants|Count of Participants|11|11.0||||||
4000710|NCT01222494|3820671|B1|Autism||Primary Diagnosis||Participants|Count of Participants|4|4.0||||||
4000711|NCT01222494|3820668|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000712|NCT01222494|3820669|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000713|NCT01222494|3820670|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000714|NCT01222494|3820671|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000715|NCT01222494|3820668|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4000716|NCT01222494|3820669|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4000717|NCT01222494|3820670|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4000718|NCT01222494|3820671|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000719|NCT01222494|3820668|B4||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4000720|NCT01222494|3820669|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4000721|NCT01222494|3820670|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4000722|NCT01222494|3820671|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4000723|NCT01222494|3820668|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4000724|NCT01222494|3820669|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4000725|NCT01222494|3820670|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4000726|NCT01222494|3820671|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000727|NCT01222494|3820668|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000728|NCT01222494|3820669|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000729|NCT01222494|3820670|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000730|NCT01222494|3820671|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000731|NCT01222494|3820668|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000732|NCT01222494|3820669|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000733|NCT01222494|3820670|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000734|NCT01222494|3820671|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000735|NCT01222494|3820668|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000736|NCT01222494|3820669|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000737|NCT01222494|3820670|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000738|NCT01222494|3820671|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000739|NCT01222494|3820668|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000740|NCT01222494|3820669|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000741|NCT01222494|3820670|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000742|NCT01222494|3820671|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000743|NCT01222494|3820668|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4000744|NCT01222494|3820669|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4000745|NCT01222494|3820670|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4000746|NCT01222494|3820671|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4000747|NCT01222494|3820668|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4000748|NCT01222494|3820669|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4000749|NCT01222494|3820670|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000750|NCT01222494|3820671|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000751|NCT01222494|3820668|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4000752|NCT01222494|3820669|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4000753|NCT01222494|3820670|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4000754|NCT01222494|3820671|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4000755|NCT01222494|3820668|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4000756|NCT01222494|3820669|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4000757|NCT01222494|3820670|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4000758|NCT01222494|3820671|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4000759|NCT01222494|3820668|B4|||Age||years|Mean|13.30|13.3|Standard Deviation|2.43|2.43|||
4000760|NCT01222494|3820669|B3|||Age||years|Mean|13.42|13.42|Standard Deviation|2.46|2.46|||
4000761|NCT01222494|3820670|B2|||Age||years|Mean|13.35|13.35|Standard Deviation|2.57|2.57|||
4000762|NCT01222494|3820671|B1|||Age||years|Mean|12.80|12.8|Standard Deviation|2.21|2.21|||
4000763|NCT01222416|3820690|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4000764|NCT01222416|3820692|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4000765|NCT01222416|3820690|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4000766|NCT01222416|3820692|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4000767|NCT01222416|3820690|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000768|NCT01222416|3820692|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000769|NCT01222416|3820690|B3||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4000770|NCT01222416|3820692|B1||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4000771|NCT01222416|3820690|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4000772|NCT01222416|3820692|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4000773|NCT01222416|3820690|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000774|NCT01222416|3820692|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000775|NCT01222416|3820690|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000776|NCT01222416|3820692|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000777|NCT01222416|3820690|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4000778|NCT01222416|3820692|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4000779|NCT01222416|3820690|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000780|NCT01222416|3820692|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4000781|NCT01222416|3820690|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4000782|NCT01222416|3820692|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4000783|NCT01222416|3820690|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4000784|NCT01222416|3820692|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4000785|NCT01222416|3820690|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4000786|NCT01222416|3820692|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4000787|NCT01222416|3820690|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4000788|NCT01222416|3820692|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4000789|NCT01222416|3820690|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4000790|NCT01222416|3820692|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4000791|NCT01222416|3820690|B3||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4000792|NCT01222416|3820692|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4000793|NCT01222416|3820690|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4000794|NCT01222416|3820691|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4000795|NCT01222416|3820692|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4000796|NCT01222403|3820701|B3||Male|Sex: Female, Male||Participants|Count of Participants|309|309.0||||||
4000797|NCT01222403|3820702|B2||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4000798|NCT01222403|3820703|B1||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4000799|NCT01222403|3820701|B3||Female|Sex: Female, Male||Participants|Count of Participants|456|456.0||||||
4000800|NCT01222403|3820702|B2||Female|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
4000801|NCT01222403|3820703|B1||Female|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
4000802|NCT01222403|3820701|B3|||Age||years|Mean|73.4|73.4|Standard Deviation|6.3|6.3|||
4000803|NCT01222403|3820702|B2|||Age||years|Mean|73.2|73.2|Standard Deviation|6.5|6.5|||
4000804|NCT01222403|3820703|B1|||Age||years|Mean|73.6|73.6|Standard Deviation|6.0|6.0|||
4000805|NCT01222390|3820714|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4000806|NCT01222390|3820714|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4000807|NCT01222390|3820714|B1|||Age||years|Mean|57|57.0|Standard Deviation|14.2440|14.244|||
4000808|NCT01222286|3820718|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4000809|NCT01222286|3820719|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4000810|NCT01222286|3820720|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4000811|NCT01222286|3820718|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4000812|NCT01222286|3820719|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4000813|NCT01222286|3820720|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4000814|NCT01222286|3820718|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4000815|NCT01222286|3820719|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4000816|NCT01222286|3820720|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4000817|NCT01222286|3820718|B3|||Age||years|Mean|61.2|61.2|Standard Deviation|10.69|10.69|||
4000818|NCT01222286|3820719|B2|||Age||years|Mean|58.4|58.4|Standard Deviation|13.11|13.11|||
4000819|NCT01222286|3820720|B1|||Age||years|Mean|63.6|63.6|Standard Deviation|7.62|7.62|||
4000820|NCT01222286|3820718|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4000821|NCT01222286|3820719|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4000822|NCT01222286|3820720|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4000823|NCT01222286|3820718|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4000824|NCT01222286|3820719|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4000825|NCT01222286|3820720|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4000826|NCT01222286|3820718|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4000827|NCT01222286|3820719|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4000828|NCT01222286|3820720|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4000829|NCT01222273|3820733|B1||ΔF508/R1162X|Genotype||Participants|Count of Participants|1|1.0||||||
4000830|NCT01222273|3820733|B1||ΔF508/1213delT|Genotype||Participants|Count of Participants|1|1.0||||||
4000831|NCT01222273|3820733|B1||MEG/G542X|Genotype||Participants|Count of Participants|1|1.0||||||
4000832|NCT01222273|3820733|B1||ΔF508/ΔF508|Genotype||Participants|Count of Participants|1|1.0||||||
4000833|NCT01222273|3820733|B1||neg/ΔF508|Genotype||Participants|Count of Participants|1|1.0||||||
4000834|NCT01222273|3820733|B1||ΔF508/612+ 1G-T|Genotype||Participants|Count of Participants|1|1.0||||||
4000835|NCT01222273|3820733|B1||ΔF508/R553X|Genotype||Participants|Count of Participants|1|1.0||||||
4000836|NCT01222273|3820733|B1|||Asp IgE||kUA/I|Mean|18.4|18.4|Standard Deviation|14.7|14.7|||
4000837|NCT01222273|3820733|B1|||IgE||IU/mL|Mean|344.6|344.6|Standard Deviation|284.9|284.9|||
4000838|NCT01222273|3820733|B1|||BMI||kg/m^2|Mean|22.5|22.5|Standard Deviation|10.68|10.68|||
4000839|NCT01222273|3820733|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4000840|NCT01222273|3820733|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4000841|NCT01222273|3820733|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4000842|NCT01222273|3820733|B1|||Age||years|Mean|21.91|21.91|Standard Deviation|2.69|2.69|||
4000843|NCT01222273|3820733|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4000844|NCT01222273|3820733|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4000845|NCT01222273|3820733|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4000846|NCT01222234|3820739|B4|United States||Region of Enrollment||participants|Number|56|56.0||||||
4000847|NCT01222234|3820740|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4000848|NCT01222234|3820741|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4000849|NCT01222234|3820742|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4000850|NCT01222234|3820739|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4000851|NCT01222234|3820740|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4000852|NCT01222234|3820741|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4000853|NCT01222234|3820742|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4000854|NCT01222234|3820739|B4||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4000855|NCT01222234|3820740|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4000856|NCT01222234|3820741|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4000857|NCT01222234|3820742|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4000858|NCT01222234|3820739|B4|||Age||years|Mean|56.1|56.1|Standard Deviation|13.0|13.0|||
4000859|NCT01222234|3820740|B3|||Age||years|Mean|48.5|48.5|Standard Deviation|14.2|14.2|||
4000860|NCT01222234|3820741|B2|||Age||years|Mean|59.8|59.8|Standard Deviation|11.6|11.6|||
4000861|NCT01222234|3820742|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|13.3|13.3|||
4000862|NCT01222234|3820739|B4||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4000863|NCT01222234|3820740|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4000864|NCT01222234|3820741|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4000865|NCT01222234|3820742|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4000866|NCT01222234|3820739|B4||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4000867|NCT01222234|3820740|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4000868|NCT01222234|3820741|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4000869|NCT01222234|3820742|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4000870|NCT01222234|3820739|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4000871|NCT01222234|3820740|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4000872|NCT01222234|3820741|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4000873|NCT01222234|3820742|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4000874|NCT01222195|3820753|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4000875|NCT01222195|3820753|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4000876|NCT01222195|3820753|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4000877|NCT01222195|3820753|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4000878|NCT01222195|3820753|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4000879|NCT01222195|3820753|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4000880|NCT01222117|3820757|B12|Ukraine||Region of Enrollment||participants|Number|2|2.0||||||
4000881|NCT01222117|3820758|B11|Ukraine||Region of Enrollment||participants|Number|0|0.0||||||
4000882|NCT01222117|3820759|B10|Ukraine||Region of Enrollment||participants|Number|0|0.0||||||
4000883|NCT01222117|3820760|B9|Ukraine||Region of Enrollment||participants|Number|0|0.0||||||
4000884|NCT01222117|3820761|B8|Ukraine||Region of Enrollment||participants|Number|0|0.0||||||
4000885|NCT01222117|3820762|B7|Ukraine||Region of Enrollment||participants|Number|0|0.0||||||
4000886|NCT01222117|3820763|B6|Ukraine||Region of Enrollment||participants|Number|1|1.0||||||
4000887|NCT01222117|3820764|B5|Ukraine||Region of Enrollment||participants|Number|0|0.0||||||
4000888|NCT01222117|3820765|B4|Ukraine||Region of Enrollment||participants|Number|0|0.0||||||
4000889|NCT01222117|3820766|B3|Ukraine||Region of Enrollment||participants|Number|0|0.0||||||
4000890|NCT01222117|3820767|B2|Ukraine||Region of Enrollment||participants|Number|1|1.0||||||
4000891|NCT01222117|3820768|B1|Ukraine||Region of Enrollment||participants|Number|0|0.0||||||
4000892|NCT01222117|3820757|B12|India||Region of Enrollment||participants|Number|4|4.0||||||
4000893|NCT01222117|3820758|B11|India||Region of Enrollment||participants|Number|0|0.0||||||
4000894|NCT01222117|3820759|B10|India||Region of Enrollment||participants|Number|0|0.0||||||
4000895|NCT01222117|3820760|B9|India||Region of Enrollment||participants|Number|0|0.0||||||
4000896|NCT01222117|3820761|B8|India||Region of Enrollment||participants|Number|0|0.0||||||
4000897|NCT01222117|3820762|B7|India||Region of Enrollment||participants|Number|0|0.0||||||
4000898|NCT01222117|3820763|B6|India||Region of Enrollment||participants|Number|0|0.0||||||
4000899|NCT01222117|3820764|B5|India||Region of Enrollment||participants|Number|0|0.0||||||
4000900|NCT01222117|3820765|B4|India||Region of Enrollment||participants|Number|0|0.0||||||
4000901|NCT01222117|3820766|B3|India||Region of Enrollment||participants|Number|1|1.0||||||
4000902|NCT01222117|3820767|B2|India||Region of Enrollment||participants|Number|2|2.0||||||
4000903|NCT01222117|3820768|B1|India||Region of Enrollment||participants|Number|1|1.0||||||
4000904|NCT01222117|3820757|B12|Germany||Region of Enrollment||participants|Number|3|3.0||||||
4000905|NCT01222117|3820758|B11|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4000906|NCT01222117|3820759|B10|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4000907|NCT01222117|3820760|B9|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4000908|NCT01222117|3820761|B8|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4000909|NCT01222117|3820762|B7|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4000910|NCT01222117|3820763|B6|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4000911|NCT01222117|3820764|B5|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4000912|NCT01222117|3820765|B4|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4000913|NCT01222117|3820766|B3|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4000914|NCT01222117|3820767|B2|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4000915|NCT01222117|3820768|B1|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4000916|NCT01222117|3820757|B12|Peru||Region of Enrollment||participants|Number|4|4.0||||||
4000917|NCT01222117|3820758|B11|Peru||Region of Enrollment||participants|Number|0|0.0||||||
4000918|NCT01222117|3820759|B10|Peru||Region of Enrollment||participants|Number|0|0.0||||||
4000919|NCT01222117|3820760|B9|Peru||Region of Enrollment||participants|Number|0|0.0||||||
4000920|NCT01222117|3820761|B8|Peru||Region of Enrollment||participants|Number|0|0.0||||||
4000921|NCT01222117|3820762|B7|Peru||Region of Enrollment||participants|Number|0|0.0||||||
4000922|NCT01222117|3820763|B6|Peru||Region of Enrollment||participants|Number|0|0.0||||||
4000923|NCT01222117|3820764|B5|Peru||Region of Enrollment||participants|Number|0|0.0||||||
4000924|NCT01222117|3820765|B4|Peru||Region of Enrollment||participants|Number|3|3.0||||||
4000925|NCT01222117|3820766|B3|Peru||Region of Enrollment||participants|Number|0|0.0||||||
4000926|NCT01222117|3820767|B2|Peru||Region of Enrollment||participants|Number|0|0.0||||||
4000927|NCT01222117|3820768|B1|Peru||Region of Enrollment||participants|Number|1|1.0||||||
4000928|NCT01222117|3820757|B12|Bulgaria||Region of Enrollment||participants|Number|5|5.0||||||
4000929|NCT01222117|3820758|B11|Bulgaria||Region of Enrollment||participants|Number|0|0.0||||||
4000930|NCT01222117|3820759|B10|Bulgaria||Region of Enrollment||participants|Number|0|0.0||||||
4000931|NCT01222117|3820760|B9|Bulgaria||Region of Enrollment||participants|Number|1|1.0||||||
4000932|NCT01222117|3820761|B8|Bulgaria||Region of Enrollment||participants|Number|0|0.0||||||
4000933|NCT01222117|3820762|B7|Bulgaria||Region of Enrollment||participants|Number|0|0.0||||||
4000934|NCT01222117|3820763|B6|Bulgaria||Region of Enrollment||participants|Number|0|0.0||||||
4000935|NCT01222117|3820764|B5|Bulgaria||Region of Enrollment||participants|Number|0|0.0||||||
4000936|NCT01222117|3820765|B4|Bulgaria||Region of Enrollment||participants|Number|0|0.0||||||
4000937|NCT01222117|3820766|B3|Bulgaria||Region of Enrollment||participants|Number|2|2.0||||||
4000938|NCT01222117|3820767|B2|Bulgaria||Region of Enrollment||participants|Number|1|1.0||||||
4000939|NCT01222117|3820768|B1|Bulgaria||Region of Enrollment||participants|Number|1|1.0||||||
4000940|NCT01222117|3820757|B12|Serbia||Region of Enrollment||participants|Number|43|43.0||||||
4000941|NCT01222117|3820758|B11|Serbia||Region of Enrollment||participants|Number|0|0.0||||||
4000942|NCT01222117|3820759|B10|Serbia||Region of Enrollment||participants|Number|3|3.0||||||
4000943|NCT01222117|3820760|B9|Serbia||Region of Enrollment||participants|Number|1|1.0||||||
4000944|NCT01222117|3820761|B8|Serbia||Region of Enrollment||participants|Number|5|5.0||||||
4000945|NCT01222117|3820762|B7|Serbia||Region of Enrollment||participants|Number|4|4.0||||||
4000946|NCT01222117|3820763|B6|Serbia||Region of Enrollment||participants|Number|6|6.0||||||
4000947|NCT01222117|3820764|B5|Serbia||Region of Enrollment||participants|Number|4|4.0||||||
4000948|NCT01222117|3820765|B4|Serbia||Region of Enrollment||participants|Number|4|4.0||||||
4000949|NCT01222117|3820766|B3|Serbia||Region of Enrollment||participants|Number|3|3.0||||||
4000950|NCT01222117|3820767|B2|Serbia||Region of Enrollment||participants|Number|7|7.0||||||
4000951|NCT01222117|3820768|B1|Serbia||Region of Enrollment||participants|Number|6|6.0||||||
4000952|NCT01222117|3820757|B12|Slovakia||Region of Enrollment||participants|Number|40|40.0||||||
4000953|NCT01222117|3820758|B11|Slovakia||Region of Enrollment||participants|Number|5|5.0||||||
4000954|NCT01222117|3820759|B10|Slovakia||Region of Enrollment||participants|Number|9|9.0||||||
4000955|NCT01222117|3820760|B9|Slovakia||Region of Enrollment||participants|Number|11|11.0||||||
4000956|NCT01222117|3820761|B8|Slovakia||Region of Enrollment||participants|Number|2|2.0||||||
4000957|NCT01222117|3820762|B7|Slovakia||Region of Enrollment||participants|Number|2|2.0||||||
4000958|NCT01222117|3820763|B6|Slovakia||Region of Enrollment||participants|Number|0|0.0||||||
4000959|NCT01222117|3820764|B5|Slovakia||Region of Enrollment||participants|Number|1|1.0||||||
4000960|NCT01222117|3820765|B4|Slovakia||Region of Enrollment||participants|Number|1|1.0||||||
4000961|NCT01222117|3820766|B3|Slovakia||Region of Enrollment||participants|Number|4|4.0||||||
4000962|NCT01222117|3820767|B2|Slovakia||Region of Enrollment||participants|Number|2|2.0||||||
4000963|NCT01222117|3820768|B1|Slovakia||Region of Enrollment||participants|Number|3|3.0||||||
4000964|NCT01222117|3820757|B12|Poland||Region of Enrollment||participants|Number|5|5.0||||||
4000965|NCT01222117|3820758|B11|Poland||Region of Enrollment||participants|Number|0|0.0||||||
4000966|NCT01222117|3820759|B10|Poland||Region of Enrollment||participants|Number|0|0.0||||||
4000967|NCT01222117|3820760|B9|Poland||Region of Enrollment||participants|Number|0|0.0||||||
4000968|NCT01222117|3820761|B8|Poland||Region of Enrollment||participants|Number|0|0.0||||||
4000969|NCT01222117|3820762|B7|Poland||Region of Enrollment||participants|Number|1|1.0||||||
4000970|NCT01222117|3820763|B6|Poland||Region of Enrollment||participants|Number|0|0.0||||||
4000971|NCT01222117|3820764|B5|Poland||Region of Enrollment||participants|Number|0|0.0||||||
4000972|NCT01222117|3820765|B4|Poland||Region of Enrollment||participants|Number|2|2.0||||||
4000973|NCT01222117|3820766|B3|Poland||Region of Enrollment||participants|Number|1|1.0||||||
4000974|NCT01222117|3820767|B2|Poland||Region of Enrollment||participants|Number|1|1.0||||||
4000975|NCT01222117|3820768|B1|Poland||Region of Enrollment||participants|Number|0|0.0||||||
4000976|NCT01222117|3820757|B12|United States||Region of Enrollment||participants|Number|5|5.0||||||
4000977|NCT01222117|3820758|B11|United States||Region of Enrollment||participants|Number|0|0.0||||||
4000978|NCT01222117|3820759|B10|United States||Region of Enrollment||participants|Number|0|0.0||||||
4000979|NCT01222117|3820760|B9|United States||Region of Enrollment||participants|Number|0|0.0||||||
4000980|NCT01222117|3820761|B8|United States||Region of Enrollment||participants|Number|0|0.0||||||
4000981|NCT01222117|3820762|B7|United States||Region of Enrollment||participants|Number|0|0.0||||||
4000982|NCT01222117|3820763|B6|United States||Region of Enrollment||participants|Number|0|0.0||||||
4000983|NCT01222117|3820764|B5|United States||Region of Enrollment||participants|Number|1|1.0||||||
4000984|NCT01222117|3820765|B4|United States||Region of Enrollment||participants|Number|1|1.0||||||
4000985|NCT01222117|3820766|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4000986|NCT01222117|3820767|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4000987|NCT01222117|3820768|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4000988|NCT01222117|3820757|B12|Belgium||Region of Enrollment||participants|Number|15|15.0||||||
4000989|NCT01222117|3820758|B11|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
4000990|NCT01222117|3820759|B10|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
4000991|NCT01222117|3820760|B9|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4000992|NCT01222117|3820761|B8|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
4000993|NCT01222117|3820762|B7|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4000994|NCT01222117|3820763|B6|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
4000995|NCT01222117|3820764|B5|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
4000996|NCT01222117|3820765|B4|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
4000997|NCT01222117|3820766|B3|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
4000998|NCT01222117|3820767|B2|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4000999|NCT01222117|3820768|B1|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
4001000|NCT01222117|3820757|B12|Romania||Region of Enrollment||participants|Number|3|3.0||||||
4001001|NCT01222117|3820758|B11|Romania||Region of Enrollment||participants|Number|0|0.0||||||
4001002|NCT01222117|3820759|B10|Romania||Region of Enrollment||participants|Number|0|0.0||||||
4001003|NCT01222117|3820760|B9|Romania||Region of Enrollment||participants|Number|0|0.0||||||
4001004|NCT01222117|3820761|B8|Romania||Region of Enrollment||participants|Number|0|0.0||||||
4001005|NCT01222117|3820762|B7|Romania||Region of Enrollment||participants|Number|0|0.0||||||
4001006|NCT01222117|3820763|B6|Romania||Region of Enrollment||participants|Number|0|0.0||||||
4001007|NCT01222117|3820764|B5|Romania||Region of Enrollment||participants|Number|0|0.0||||||
4001008|NCT01222117|3820765|B4|Romania||Region of Enrollment||participants|Number|0|0.0||||||
4001009|NCT01222117|3820766|B3|Romania||Region of Enrollment||participants|Number|3|3.0||||||
4001010|NCT01222117|3820767|B2|Romania||Region of Enrollment||participants|Number|0|0.0||||||
4001011|NCT01222117|3820768|B1|Romania||Region of Enrollment||participants|Number|0|0.0||||||
4001012|NCT01222117|3820757|B12|Czech Republic||Region of Enrollment||participants|Number|45|45.0||||||
4001013|NCT01222117|3820758|B11|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
4001014|NCT01222117|3820759|B10|Czech Republic||Region of Enrollment||participants|Number|7|7.0||||||
4001015|NCT01222117|3820760|B9|Czech Republic||Region of Enrollment||participants|Number|9|9.0||||||
4001016|NCT01222117|3820761|B8|Czech Republic||Region of Enrollment||participants|Number|5|5.0||||||
4001017|NCT01222117|3820762|B7|Czech Republic||Region of Enrollment||participants|Number|5|5.0||||||
4001018|NCT01222117|3820763|B6|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
4001019|NCT01222117|3820764|B5|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
4001020|NCT01222117|3820765|B4|Czech Republic||Region of Enrollment||participants|Number|5|5.0||||||
4001021|NCT01222117|3820766|B3|Czech Republic||Region of Enrollment||participants|Number|3|3.0||||||
4001022|NCT01222117|3820767|B2|Czech Republic||Region of Enrollment||participants|Number|4|4.0||||||
4001023|NCT01222117|3820768|B1|Czech Republic||Region of Enrollment||participants|Number|4|4.0||||||
4001024|NCT01222117|3820757|B12||Male|Gender||Participants|Count of Participants|135|135.0||||||
4001025|NCT01222117|3820758|B11||Male|Gender||Participants|Count of Participants|5|5.0||||||
4001026|NCT01222117|3820759|B10||Male|Gender||Participants|Count of Participants|14|14.0||||||
4001027|NCT01222117|3820760|B9||Male|Gender||Participants|Count of Participants|16|16.0||||||
4001028|NCT01222117|3820761|B8||Male|Gender||Participants|Count of Participants|9|9.0||||||
4001029|NCT01222117|3820762|B7||Male|Gender||Participants|Count of Participants|11|11.0||||||
4001030|NCT01222117|3820763|B6||Male|Gender||Participants|Count of Participants|7|7.0||||||
4001031|NCT01222117|3820764|B5||Male|Gender||Participants|Count of Participants|9|9.0||||||
4001032|NCT01222117|3820765|B4||Male|Gender||Participants|Count of Participants|13|13.0||||||
4001033|NCT01222117|3820766|B3||Male|Gender||Participants|Count of Participants|17|17.0||||||
4001034|NCT01222117|3820767|B2||Male|Gender||Participants|Count of Participants|17|17.0||||||
4001035|NCT01222117|3820768|B1||Male|Gender||Participants|Count of Participants|17|17.0||||||
4001036|NCT01222117|3820757|B12||Female|Gender||Participants|Count of Participants|39|39.0||||||
4001037|NCT01222117|3820758|B11||Female|Gender||Participants|Count of Participants|1|1.0||||||
4001038|NCT01222117|3820759|B10||Female|Gender||Participants|Count of Participants|5|5.0||||||
4001039|NCT01222117|3820760|B9||Female|Gender||Participants|Count of Participants|7|7.0||||||
4001040|NCT01222117|3820761|B8||Female|Gender||Participants|Count of Participants|3|3.0||||||
4001041|NCT01222117|3820762|B7||Female|Gender||Participants|Count of Participants|2|2.0||||||
4001042|NCT01222117|3820763|B6||Female|Gender||Participants|Count of Participants|3|3.0||||||
4001043|NCT01222117|3820764|B5||Female|Gender||Participants|Count of Participants|0|0.0||||||
4001044|NCT01222117|3820765|B4||Female|Gender||Participants|Count of Participants|7|7.0||||||
4001045|NCT01222117|3820766|B3||Female|Gender||Participants|Count of Participants|5|5.0||||||
4001046|NCT01222117|3820767|B2||Female|Gender||Participants|Count of Participants|3|3.0||||||
4001047|NCT01222117|3820768|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
4001048|NCT01222117|3820757|B12|>=65 years||Age, Customized||participants|Number|79|79.0||||||
4001049|NCT01222117|3820758|B11|>=65 years||Age, Customized||participants|Number|3|3.0||||||
4001050|NCT01222117|3820759|B10|>=65 years||Age, Customized||participants|Number|7|7.0||||||
4001051|NCT01222117|3820760|B9|>=65 years||Age, Customized||participants|Number|10|10.0||||||
4001052|NCT01222117|3820761|B8|>=65 years||Age, Customized||participants|Number|5|5.0||||||
4001053|NCT01222117|3820762|B7|>=65 years||Age, Customized||participants|Number|5|5.0||||||
4001054|NCT01222117|3820763|B6|>=65 years||Age, Customized||participants|Number|5|5.0||||||
4001055|NCT01222117|3820764|B5|>=65 years||Age, Customized||participants|Number|4|4.0||||||
4001056|NCT01222117|3820765|B4|>=65 years||Age, Customized||participants|Number|10|10.0||||||
4001057|NCT01222117|3820766|B3|>=65 years||Age, Customized||participants|Number|12|12.0||||||
4001058|NCT01222117|3820767|B2|>=65 years||Age, Customized||participants|Number|10|10.0||||||
4001059|NCT01222117|3820768|B1|>=65 years||Age, Customized||participants|Number|8|8.0||||||
4001060|NCT01222117|3820757|B12|<65 years||Age, Customized||participants|Number|95|95.0||||||
4001061|NCT01222117|3820758|B11|<65 years||Age, Customized||participants|Number|3|3.0||||||
4001062|NCT01222117|3820759|B10|<65 years||Age, Customized||participants|Number|12|12.0||||||
4001063|NCT01222117|3820760|B9|<65 years||Age, Customized||participants|Number|13|13.0||||||
4001064|NCT01222117|3820761|B8|<65 years||Age, Customized||participants|Number|7|7.0||||||
4001065|NCT01222117|3820762|B7|<65 years||Age, Customized||participants|Number|8|8.0||||||
4001066|NCT01222117|3820763|B6|<65 years||Age, Customized||participants|Number|5|5.0||||||
4001067|NCT01222117|3820764|B5|<65 years||Age, Customized||participants|Number|5|5.0||||||
4001068|NCT01222117|3820765|B4|<65 years||Age, Customized||participants|Number|10|10.0||||||
4001069|NCT01222117|3820766|B3|<65 years||Age, Customized||participants|Number|10|10.0||||||
4001070|NCT01222117|3820767|B2|<65 years||Age, Customized||participants|Number|10|10.0||||||
4001071|NCT01222117|3820768|B1|<65 years||Age, Customized||participants|Number|12|12.0||||||
4001072|NCT01222104|3820813|B1|United States||Region of Enrollment||participants|Number|634|634.0||||||
4001073|NCT01222104|3820813|B1||Male|Sex: Female, Male||Participants|Count of Participants|306|306.0||||||
4001074|NCT01222104|3820813|B1||Female|Sex: Female, Male||Participants|Count of Participants|328|328.0||||||
4001075|NCT01222104|3820813|B1|||Age||years|Mean|59.6|59.6|Standard Deviation|14.2|14.2|||
4001076|NCT01222091|3820827|B1|||Height||centimeters|Mean|178|178.0|Full Range|||168.0|194.0|
4001077|NCT01222091|3820827|B1|||Weight||kilograms|Mean|78.8|78.8|Full Range|||57.0|130.0|
4001078|NCT01222091|3820827|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4001079|NCT01222091|3820827|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4001080|NCT01222091|3820827|B1|||Age||years|Mean|23.8|23.8|Full Range|||18.0|32.0|
4001081|NCT01222078|3820836|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001082|NCT01222078|3820836|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4001083|NCT01222078|3820836|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001084|NCT01222078|3820836|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4001085|NCT01222078|3820836|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4001086|NCT01222078|3820836|B1|||Age||Years|Mean|31|31.0|Standard Deviation|NA||||Only one participant enrolled
4001087|NCT01221948|3820870|B1|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4001088|NCT01221948|3820870|B1|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4001089|NCT01221948|3820870|B1|Germany||Region of Enrollment||participants|Number|9|9.0||||||
4001090|NCT01221948|3820870|B1|Austria||Region of Enrollment||participants|Number|12|12.0||||||
4001091|NCT01221948|3820870|B1|Spain||Region of Enrollment||participants|Number|11|11.0||||||
4001092|NCT01221948|3820870|B1|France||Region of Enrollment||participants|Number|1|1.0||||||
4001093|NCT01221948|3820870|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4001094|NCT01221948|3820870|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4001095|NCT01221948|3820870|B1|>70 years||Age, Customized||participants|Number|3|3.0||||||
4001096|NCT01221948|3820870|B1|61-70 years||Age, Customized||participants|Number|18|18.0||||||
4001097|NCT01221948|3820870|B1|<=60 years||Age, Customized||participants|Number|19|19.0||||||
4001098|NCT01221753|3820881|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4001099|NCT01221753|3820881|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4001100|NCT01221753|3820881|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001101|NCT01221753|3820881|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4001102|NCT01221753|3820881|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001103|NCT01221753|3820881|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001104|NCT01221753|3820881|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001105|NCT01221753|3820881|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001106|NCT01221753|3820881|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001107|NCT01221753|3820881|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4001108|NCT01221753|3820881|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4001109|NCT01221753|3820881|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4001110|NCT01221753|3820881|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4001111|NCT01221753|3820881|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4001112|NCT01221753|3820881|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4001113|NCT01221753|3820881|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001114|NCT01221727|3820886|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001115|NCT01221727|3820887|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001116|NCT01221727|3820888|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001117|NCT01221727|3820886|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001118|NCT01221727|3820887|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001119|NCT01221727|3820888|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001120|NCT01221727|3820886|B3||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4001121|NCT01221727|3820887|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4001122|NCT01221727|3820888|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4001123|NCT01221727|3820886|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4001124|NCT01221727|3820887|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4001125|NCT01221727|3820888|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4001126|NCT01221727|3820886|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001127|NCT01221727|3820887|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001128|NCT01221727|3820888|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001129|NCT01221727|3820886|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4001130|NCT01221727|3820887|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4001131|NCT01221727|3820888|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4001132|NCT01221727|3820886|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001133|NCT01221727|3820887|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001134|NCT01221727|3820888|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001135|NCT01221727|3820886|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001136|NCT01221727|3820887|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001137|NCT01221727|3820888|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001138|NCT01221727|3820886|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4001139|NCT01221727|3820887|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4001140|NCT01221727|3820888|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4001141|NCT01221727|3820886|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4001142|NCT01221727|3820887|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4001143|NCT01221727|3820888|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4001144|NCT01221727|3820886|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4001145|NCT01221727|3820887|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4001146|NCT01221727|3820888|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4001147|NCT01221727|3820886|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4001148|NCT01221727|3820887|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4001149|NCT01221727|3820888|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4001150|NCT01221727|3820886|B3|>=75 years||Age, Customized||Participants|Number|1|1.0||||||
4001151|NCT01221727|3820887|B2|>=75 years||Age, Customized||Participants|Number|1|1.0||||||
4001152|NCT01221727|3820888|B1|>=75 years||Age, Customized||Participants|Number|0|0.0||||||
4001153|NCT01221727|3820886|B3|>=65 years and <75 years||Age, Customized||Participants|Number|16|16.0||||||
4001154|NCT01221727|3820887|B2|>=65 years and <75 years||Age, Customized||Participants|Number|4|4.0||||||
4001155|NCT01221727|3820888|B1|>=65 years and <75 years||Age, Customized||Participants|Number|12|12.0||||||
4001156|NCT01221727|3820886|B3|<65 years||Age, Customized||Participants|Number|10|10.0||||||
4001157|NCT01221727|3820887|B2|<65 years||Age, Customized||Participants|Number|3|3.0||||||
4001158|NCT01221727|3820888|B1|<65 years||Age, Customized||Participants|Number|7|7.0||||||
4001159|NCT01221727|3820886|B3|||Age||years|Mean|64.96|64.96|Standard Deviation|5.89|5.89|||
4001160|NCT01221727|3820887|B2|||Age||years|Mean|66.25|66.25|Standard Deviation|5.34|5.34|||
4001161|NCT01221727|3820888|B1|||Age||years|Mean|64.42|64.42|Standard Deviation|6.16|6.16|||
4001162|NCT01221623|3820908|B3|Australia||Region of Enrollment||participants|Number|57|57.0||||||
4001163|NCT01221623|3820909|B2|Australia||Region of Enrollment||participants|Number|17|17.0||||||
4001164|NCT01221623|3820910|B1|Australia||Region of Enrollment||participants|Number|40|40.0||||||
4001165|NCT01221623|3820908|B3|United States||Region of Enrollment||participants|Number|358|358.0||||||
4001166|NCT01221623|3820909|B2|United States||Region of Enrollment||participants|Number|124|124.0||||||
4001167|NCT01221623|3820910|B1|United States||Region of Enrollment||participants|Number|234|234.0||||||
4001168|NCT01221623|3820908|B3||Male|Sex: Female, Male||Participants|Count of Participants|415|415.0||||||
4001169|NCT01221623|3820909|B2||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4001170|NCT01221623|3820910|B1||Male|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
4001171|NCT01221623|3820908|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4001172|NCT01221623|3820909|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4001173|NCT01221623|3820910|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4001174|NCT01221623|3820908|B3|||Age||years|Mean|57.4|57.4|Standard Deviation|8.36|8.36|||
4001175|NCT01221623|3820909|B2|||Age||years|Mean|57.6|57.6|Standard Deviation|7.52|7.52|||
4001176|NCT01221623|3820910|B1|||Age||years|Mean|57.3|57.3|Standard Deviation|8.77|8.77|||
4001177|NCT01221623|3820908|B3||>=65 years|Age||Participants|Count of Participants|78|78.0||||||
4001178|NCT01221623|3820909|B2||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4001179|NCT01221623|3820910|B1||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
4001180|NCT01221623|3820908|B3||Between 18 and 65 years|Age||Participants|Count of Participants|337|337.0||||||
4001181|NCT01221623|3820909|B2||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
4001182|NCT01221623|3820910|B1||Between 18 and 65 years|Age||Participants|Count of Participants|225|225.0||||||
4001183|NCT01221623|3820908|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001184|NCT01221623|3820909|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001185|NCT01221623|3820910|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001186|NCT01221597|3820933|B3|Australia||Region of Enrollment||participants|Number|81|81.0||||||
4001187|NCT01221597|3820934|B2|Australia||Region of Enrollment||participants|Number|27|27.0||||||
4001188|NCT01221597|3820935|B1|Australia||Region of Enrollment||participants|Number|54|54.0||||||
4001189|NCT01221597|3820933|B3|United States||Region of Enrollment||participants|Number|336|336.0||||||
4001190|NCT01221597|3820934|B2|United States||Region of Enrollment||participants|Number|113|113.0||||||
4001191|NCT01221597|3820935|B1|United States||Region of Enrollment||participants|Number|223|223.0||||||
4001192|NCT01221597|3820933|B3||Male|Sex: Female, Male||Participants|Count of Participants|417|417.0||||||
4001193|NCT01221597|3820934|B2||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4001194|NCT01221597|3820935|B1||Male|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
4001195|NCT01221597|3820933|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4001196|NCT01221597|3820934|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4001197|NCT01221597|3820935|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4001198|NCT01221597|3820933|B3|||Age||years|Mean|58.0|58.0|Standard Deviation|8.46|8.46|||
4001199|NCT01221597|3820934|B2|||Age||years|Mean|58.2|58.2|Standard Deviation|8.94|8.94|||
4001200|NCT01221597|3820935|B1|||Age||years|Mean|57.9|57.9|Standard Deviation|8.22|8.22|||
4001201|NCT01221597|3820933|B3||>=65 years|Age||Participants|Count of Participants|83|83.0||||||
4001202|NCT01221597|3820934|B2||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4001203|NCT01221597|3820935|B1||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
4001204|NCT01221597|3820933|B3||Between 18 and 65 years|Age||Participants|Count of Participants|334|334.0||||||
4001205|NCT01221597|3820934|B2||Between 18 and 65 years|Age||Participants|Count of Participants|108|108.0||||||
4001206|NCT01221597|3820935|B1||Between 18 and 65 years|Age||Participants|Count of Participants|226|226.0||||||
4001207|NCT01221597|3820933|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001208|NCT01221597|3820934|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001209|NCT01221597|3820935|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001210|NCT01221441|3820958|B3|||Body Mass Index (BMI)||kg/m^2|Mean|29.6|29.6|Standard Deviation|5.70|5.7|||
4001211|NCT01221441|3820959|B2|||Body Mass Index (BMI)||kg/m^2|Mean|29.6|29.6|Standard Deviation|5.62|5.62|||
4001212|NCT01221441|3820960|B1|||Body Mass Index (BMI)||kg/m^2|Mean|29.6|29.6|Standard Deviation|5.87|5.87|||
4001213|NCT01221441|3820958|B3|United States||Region of Enrollment||participants|Number|102|102.0||||||
4001214|NCT01221441|3820959|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
4001215|NCT01221441|3820960|B1|United States||Region of Enrollment||participants|Number|67|67.0||||||
4001216|NCT01221441|3820958|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4001217|NCT01221441|3820959|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4001218|NCT01221441|3820960|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4001219|NCT01221441|3820958|B3|Black||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4001220|NCT01221441|3820959|B2|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4001221|NCT01221441|3820960|B1|Black||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4001222|NCT01221441|3820958|B3|Caucasian/White||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
4001223|NCT01221441|3820959|B2|Caucasian/White||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4001224|NCT01221441|3820960|B1|Caucasian/White||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
4001225|NCT01221441|3820958|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4001226|NCT01221441|3820959|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4001227|NCT01221441|3820960|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4001228|NCT01221441|3820958|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4001229|NCT01221441|3820959|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4001230|NCT01221441|3820960|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4001231|NCT01221441|3820958|B3|||Age||Years|Mean|56.6|56.6|Standard Deviation|8.21|8.21|||
4001232|NCT01221441|3820959|B2|||Age||Years|Mean|56.5|56.5|Standard Deviation|8.62|8.62|||
4001233|NCT01221441|3820960|B1|||Age||Years|Mean|56.7|56.7|Standard Deviation|7.89|7.89|||
4001234|NCT01221441|3820958|B3||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
4001235|NCT01221441|3820959|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4001236|NCT01221441|3820960|B1||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4001237|NCT01221441|3820958|B3||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4001238|NCT01221441|3820959|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4001239|NCT01221441|3820960|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4001240|NCT01221441|3820958|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001241|NCT01221441|3820959|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001242|NCT01221441|3820960|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001243|NCT01221363|3820991|B3|Denmark||Region of Enrollment||participants|Number|166|166.0||||||
4001244|NCT01221363|3820992|B2|Denmark||Region of Enrollment||participants|Number|73|73.0||||||
4001245|NCT01221363|3820993|B1|Denmark||Region of Enrollment||participants|Number|93|93.0||||||
4001246|NCT01221363|3820991|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4001247|NCT01221363|3820992|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4001248|NCT01221363|3820993|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4001249|NCT01221363|3820991|B3||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4001250|NCT01221363|3820992|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4001251|NCT01221363|3820993|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4001252|NCT01221363|3820991|B3|||Age||years|Mean|52|52.0|Standard Deviation|14|14.0|||
4001253|NCT01221363|3820992|B2|||Age||years|Mean|51.8|51.8|Standard Deviation|14.3|14.3|||
4001254|NCT01221363|3820993|B1|||Age||years|Mean|52.2|52.2|Standard Deviation|13.8|13.8|||
4001255|NCT01221350|3821002|B3|||Body mass index (BMI)||Kg/m^2|Mean|29.0|29.0|Standard Deviation|5.2|5.2|||
4001256|NCT01221350|3821003|B2|||Body mass index (BMI)||Kg/m^2|Mean|28.0|28.0|Standard Deviation|5.0|5.0|||
4001257|NCT01221350|3821004|B1|||Body mass index (BMI)||Kg/m^2|Mean|29.9|29.9|Standard Deviation|5.4|5.4|||
4001258|NCT01221350|3821002|B3|||Weight||Kg|Mean|73.8|73.8|Standard Deviation|16.0|16.0|||
4001259|NCT01221350|3821003|B2|||Weight||Kg|Mean|74.1|74.1|Standard Deviation|15.9|15.9|||
4001260|NCT01221350|3821004|B1|||Weight||Kg|Mean|73.6|73.6|Standard Deviation|16.1|16.1|||
4001261|NCT01221350|3821002|B3|Mexico||Region of Enrollment||participants|Number|55|55.0||||||
4001262|NCT01221350|3821003|B2|Mexico||Region of Enrollment||participants|Number|27|27.0||||||
4001263|NCT01221350|3821004|B1|Mexico||Region of Enrollment||participants|Number|28|28.0||||||
4001264|NCT01221350|3821002|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4001265|NCT01221350|3821003|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4001266|NCT01221350|3821004|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4001267|NCT01221350|3821002|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4001268|NCT01221350|3821003|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4001269|NCT01221350|3821004|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4001270|NCT01221350|3821002|B3|||Age||years|Mean|42.3|42.3|Standard Deviation|13.6|13.6|||
4001271|NCT01221350|3821003|B2|||Age||years|Mean|43.8|43.8|Standard Deviation|16.6|16.6|||
4001272|NCT01221350|3821004|B1|||Age||years|Mean|40.9|40.9|Standard Deviation|10.5|10.5|||
4001273|NCT01221311|3821045|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4001274|NCT01221311|3821045|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4001275|NCT01221311|3821046|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4001276|NCT01221311|3821047|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4001277|NCT01221311|3821045|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4001278|NCT01221311|3821046|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4001279|NCT01221311|3821047|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4001280|NCT01221311|3821045|B3|||Age||years|Mean|55.9|55.9|Standard Deviation|10.7|10.7|||
4001281|NCT01221311|3821046|B2|||Age||years|Mean|56.7|56.7|Standard Deviation|11|11.0|||
4001282|NCT01221311|3821047|B1|||Age||years|Mean|54.5|54.5|Standard Deviation|10.4|10.4|||
4001283|NCT01221298|3821054|B1|Missing||Interleukin 28B (IL28B) Genotype||participants|Number|0|0.0||||||
4001284|NCT01221298|3821054|B1|TT||Interleukin 28B (IL28B) Genotype||participants|Number|0|0.0||||||
4001285|NCT01221298|3821054|B1|CT||Interleukin 28B (IL28B) Genotype||participants|Number|0|0.0||||||
4001286|NCT01221298|3821054|B1|CC||Interleukin 28B (IL28B) Genotype||participants|Number|11|11.0||||||
4001287|NCT01221298|3821054|B1|1B||Hepatitis C Virus (HCV) Genotype/ Subtype||participants|Number|3|3.0||||||
4001288|NCT01221298|3821054|B1|1A||Hepatitis C Virus (HCV) Genotype/ Subtype||participants|Number|8|8.0||||||
4001289|NCT01221298|3821054|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4001290|NCT01221298|3821054|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4001291|NCT01221298|3821054|B1|||Age||years|Mean|56.4|56.4|Standard Deviation|7.35|7.35|||
4001292|NCT01221285|3821064|B1|||German Cockroach-Specific Serum Immunoglobulin E (IgE) Levels|German cockroach-specific serum IgE levels at screening.|kU/L|Median|3.8|3.8|Full Range|||0.9|24.9|
4001293|NCT01221285|3821064|B1|||Glycerinated German Cockroach Prick Skin Test Wheal Size|German cockroach prick skin test wheal size at screening. A measurable wheal when exposed to cockroach allergen extract by prick skin test (as compared to the negative control wheal) is a sign of allergic sensitization (“allergy”) to cockroach. Higher wheal sizes indicate greater allergic reaction or sensitization.|mm|Median|6.8|6.8|Full Range|||3.0|9.0|
4001294|NCT01221285|3821064|B1|||Participants with Perennial Allergic Rhinitis|Participants reporting sneezing, nasal congestion or runny nose symptoms greater or equal to 3 days per week for 4 or more months in the year preceding study enrollment|participants|Number|6|6.0||||||
4001295|NCT01221285|3821064|B1|||Participants with Asthma|Participants who were diagnosed with asthma by a physician for a minimum of 1 year prior to study enrollment|participants|Number|7|7.0||||||
4001296|NCT01221285|3821064|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4001297|NCT01221285|3821064|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4001298|NCT01221285|3821064|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4001299|NCT01221285|3821064|B1|||Age||years|Median|37.5|37.5|Full Range|||24.0|52.0|
4001300|NCT01221272|3821073|B1|||Weight||kg|Mean|88.6|88.6|Standard Deviation|14.2|14.2|||
4001301|NCT01221272|3821073|B1|||Body mass index||kg/m^2|Mean|29.6|29.6|Standard Deviation|3.8|3.8|||
4001302|NCT01221272|3821073|B1|Israel||Region of Enrollment||participants|Number|14|14.0||||||
4001303|NCT01221272|3821073|B1|Canada||Region of Enrollment||participants|Number|27|27.0||||||
4001304|NCT01221272|3821073|B1|Czech Republic||Region of Enrollment||participants|Number|2|2.0||||||
4001305|NCT01221272|3821073|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4001306|NCT01221272|3821073|B1|Unknown||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4001307|NCT01221272|3821073|B1|Not Reported||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4001308|NCT01221272|3821073|B1|Not Hispanic Or Latino||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
4001309|NCT01221272|3821073|B1|Hispanic Or Latino||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4001310|NCT01221272|3821073|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4001311|NCT01221272|3821073|B1|African-American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4001312|NCT01221272|3821073|B1|White||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
4001313|NCT01221272|3821073|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4001314|NCT01221272|3821073|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4001315|NCT01221272|3821073|B1|≥ 75 years||Age, Customized||participants|Number|13|13.0||||||
4001316|NCT01221272|3821073|B1|65 to 74 years||Age, Customized||participants|Number|39|39.0||||||
4001317|NCT01221272|3821073|B1|40 to 64 years||Age, Customized||participants|Number|29|29.0||||||
4001318|NCT01221272|3821073|B1|18 to 39 years||Age, Customized||participants|Number|0|0.0||||||
4001319|NCT01221272|3821073|B1|||Age||years|Mean|66|66.0|Standard Deviation|9.0|9.0|||
4001320|NCT01221090|3821089|B5|||HbA1c||%|Mean|9.3|9.3|Standard Deviation|1.6|1.6|||
4001321|NCT01221090|3821090|B4|||HbA1c||%|Mean|9.2|9.2|Standard Deviation|1.6|1.6|||
4001322|NCT01221090|3821091|B3|||HbA1c||%|Mean|9.2|9.2|Standard Deviation|1.4|1.4|||
4001323|NCT01221090|3821092|B2|||HbA1c||%|Mean|9.3|9.3|Standard Deviation|1.6|1.6|||
4001324|NCT01221090|3821093|B1|||HbA1c||%|Mean|9.4|9.4|Standard Deviation|1.7|1.7|||
4001325|NCT01221090|3821089|B5|||Diastolic Blood Pressure||mm/Hg|Mean|77|77.0|Standard Deviation|11.7|11.7|||
4001326|NCT01221090|3821090|B4|||Diastolic Blood Pressure||mm/Hg|Mean|75.8|75.8|Standard Deviation|13.6|13.6|||
4001327|NCT01221090|3821091|B3|||Diastolic Blood Pressure||mm/Hg|Mean|78.8|78.8|Standard Deviation|11.4|11.4|||
4001328|NCT01221090|3821092|B2|||Diastolic Blood Pressure||mm/Hg|Mean|73.6|73.6|Standard Deviation|11|11.0|||
4001329|NCT01221090|3821093|B1|||Diastolic Blood Pressure||mm/Hg|Mean|79.4|79.4|Standard Deviation|9.8|9.8|||
4001330|NCT01221090|3821089|B5|||Systolic Blood Pressure||mm/Hg|Mean|134.8|134.8|Standard Deviation|19.3|19.3|||
4001331|NCT01221090|3821090|B4|||Systolic Blood Pressure||mm/Hg|Mean|132.9|132.9|Standard Deviation|21.7|21.7|||
4001332|NCT01221090|3821091|B3|||Systolic Blood Pressure||mm/Hg|Mean|136.2|136.2|Standard Deviation|19.1|19.1|||
4001333|NCT01221090|3821092|B2|||Systolic Blood Pressure||mm/Hg|Mean|138.5|138.5|Standard Deviation|21.2|21.2|||
4001334|NCT01221090|3821093|B1|||Systolic Blood Pressure||mm/Hg|Mean|131.9|131.9|Standard Deviation|14.1|14.1|||
4001335|NCT01221090|3821089|B5|||BMI||kg/m^2|Mean|34.3|34.3|Standard Deviation|7.4|7.4|||
4001336|NCT01221090|3821090|B4|||BMI||kg/m^2|Mean|33.9|33.9|Standard Deviation|7.7|7.7|||
4001337|NCT01221090|3821091|B3|||BMI||kg/m^2|Mean|34.6|34.6|Standard Deviation|6.3|6.3|||
4001338|NCT01221090|3821092|B2|||BMI||kg/m^2|Mean|35.3|35.3|Standard Deviation|7.3|7.3|||
4001339|NCT01221090|3821093|B1|||BMI||kg/m^2|Mean|33.5|33.5|Standard Deviation|8|8.0|||
4001340|NCT01221090|3821089|B5|Prefer not to answer||Income||Participants|Number|27|27.0||||||
4001341|NCT01221090|3821090|B4|Prefer not to answer||Income||Participants|Number|9|9.0||||||
4001342|NCT01221090|3821091|B3|Prefer not to answer||Income||Participants|Number|4|4.0||||||
4001343|NCT01221090|3821092|B2|Prefer not to answer||Income||Participants|Number|1|1.0||||||
4001344|NCT01221090|3821093|B1|Prefer not to answer||Income||Participants|Number|13|13.0||||||
4001345|NCT01221090|3821089|B5|> $75,000||Income||Participants|Number|46|46.0||||||
4001346|NCT01221090|3821090|B4|> $75,000||Income||Participants|Number|14|14.0||||||
4001347|NCT01221090|3821091|B3|> $75,000||Income||Participants|Number|14|14.0||||||
4001348|NCT01221090|3821092|B2|> $75,000||Income||Participants|Number|6|6.0||||||
4001349|NCT01221090|3821093|B1|> $75,000||Income||Participants|Number|12|12.0||||||
4001350|NCT01221090|3821089|B5|$50,000 - $75,000||Income||Participants|Number|64|64.0||||||
4001351|NCT01221090|3821090|B4|$50,000 - $75,000||Income||Participants|Number|17|17.0||||||
4001352|NCT01221090|3821091|B3|$50,000 - $75,000||Income||Participants|Number|23|23.0||||||
4001353|NCT01221090|3821092|B2|$50,000 - $75,000||Income||Participants|Number|12|12.0||||||
4001354|NCT01221090|3821093|B1|$50,000 - $75,000||Income||Participants|Number|12|12.0||||||
4001355|NCT01221090|3821089|B5|$25,000 - $49,999||Income||Participants|Number|140|140.0||||||
4001356|NCT01221090|3821090|B4|$25,000 - $49,999||Income||Participants|Number|30|30.0||||||
4001357|NCT01221090|3821091|B3|$25,000 - $49,999||Income||Participants|Number|32|32.0||||||
4001358|NCT01221090|3821092|B2|$25,000 - $49,999||Income||Participants|Number|37|37.0||||||
4001359|NCT01221090|3821093|B1|$25,000 - $49,999||Income||Participants|Number|41|41.0||||||
4001360|NCT01221090|3821089|B5|$15,000 - $24,999||Income||Participants|Number|60|60.0||||||
4001361|NCT01221090|3821090|B4|$15,000 - $24,999||Income||Participants|Number|16|16.0||||||
4001362|NCT01221090|3821091|B3|$15,000 - $24,999||Income||Participants|Number|19|19.0||||||
4001363|NCT01221090|3821092|B2|$15,000 - $24,999||Income||Participants|Number|14|14.0||||||
4001364|NCT01221090|3821093|B1|$15,000 - $24,999||Income||Participants|Number|11|11.0||||||
4001365|NCT01221090|3821089|B5|< $15,000||Income||Participants|Number|39|39.0||||||
4001366|NCT01221090|3821090|B4|< $15,000||Income||Participants|Number|9|9.0||||||
4001367|NCT01221090|3821091|B3|< $15,000||Income||Participants|Number|7|7.0||||||
4001368|NCT01221090|3821092|B2|< $15,000||Income||Participants|Number|11|11.0||||||
4001369|NCT01221090|3821093|B1|< $15,000||Income||Participants|Number|12|12.0||||||
4001370|NCT01221090|3821089|B5|Graduate school||Education||Participants|Number|47|47.0||||||
4001371|NCT01221090|3821090|B4|Graduate school||Education||Participants|Number|13|13.0||||||
4001372|NCT01221090|3821091|B3|Graduate school||Education||Participants|Number|14|14.0||||||
4001373|NCT01221090|3821092|B2|Graduate school||Education||Participants|Number|7|7.0||||||
4001374|NCT01221090|3821093|B1|Graduate school||Education||Participants|Number|13|13.0||||||
4001375|NCT01221090|3821089|B5|College graduate||Education||Participants|Number|74|74.0||||||
4001376|NCT01221090|3821090|B4|College graduate||Education||Participants|Number|21|21.0||||||
4001377|NCT01221090|3821091|B3|College graduate||Education||Participants|Number|24|24.0||||||
4001378|NCT01221090|3821092|B2|College graduate||Education||Participants|Number|13|13.0||||||
4001379|NCT01221090|3821093|B1|College graduate||Education||Participants|Number|16|16.0||||||
4001380|NCT01221090|3821089|B5|Some college/vocational school||Education||Participants|Number|149|149.0||||||
4001381|NCT01221090|3821090|B4|Some college/vocational school||Education||Participants|Number|36|36.0||||||
4001382|NCT01221090|3821091|B3|Some college/vocational school||Education||Participants|Number|33|33.0||||||
4001383|NCT01221090|3821092|B2|Some college/vocational school||Education||Participants|Number|34|34.0||||||
4001384|NCT01221090|3821093|B1|Some college/vocational school||Education||Participants|Number|46|46.0||||||
4001385|NCT01221090|3821089|B5|High school graduate||Education||Participants|Number|74|74.0||||||
4001386|NCT01221090|3821090|B4|High school graduate||Education||Participants|Number|21|21.0||||||
4001387|NCT01221090|3821091|B3|High school graduate||Education||Participants|Number|17|17.0||||||
4001388|NCT01221090|3821092|B2|High school graduate||Education||Participants|Number|20|20.0||||||
4001389|NCT01221090|3821093|B1|High school graduate||Education||Participants|Number|16|16.0||||||
4001390|NCT01221090|3821089|B5|Some high school||Education||Participants|Number|16|16.0||||||
4001391|NCT01221090|3821090|B4|Some high school||Education||Participants|Number|1|1.0||||||
4001392|NCT01221090|3821091|B3|Some high school||Education||Participants|Number|8|8.0||||||
4001393|NCT01221090|3821092|B2|Some high school||Education||Participants|Number|3|3.0||||||
4001394|NCT01221090|3821093|B1|Some high school||Education||Participants|Number|4|4.0||||||
4001395|NCT01221090|3821089|B5|Less than high school||Education||Participants|Number|16|16.0||||||
4001396|NCT01221090|3821090|B4|Less than high school||Education||Participants|Number|3|3.0||||||
4001397|NCT01221090|3821091|B3|Less than high school||Education||Participants|Number|3|3.0||||||
4001398|NCT01221090|3821092|B2|Less than high school||Education||Participants|Number|4|4.0||||||
4001399|NCT01221090|3821093|B1|Less than high school||Education||Participants|Number|6|6.0||||||
4001400|NCT01221090|3821089|B5|Other||Race-Ethnicity||Participants|Number|13|13.0||||||
4001401|NCT01221090|3821090|B4|Other||Race-Ethnicity||Participants|Number|5|5.0||||||
4001402|NCT01221090|3821091|B3|Other||Race-Ethnicity||Participants|Number|4|4.0||||||
4001403|NCT01221090|3821092|B2|Other||Race-Ethnicity||Participants|Number|2|2.0||||||
4001404|NCT01221090|3821093|B1|Other||Race-Ethnicity||Participants|Number|2|2.0||||||
4001405|NCT01221090|3821089|B5|Hispanic||Race-Ethnicity||Participants|Number|76|76.0||||||
4001406|NCT01221090|3821090|B4|Hispanic||Race-Ethnicity||Participants|Number|15|15.0||||||
4001407|NCT01221090|3821091|B3|Hispanic||Race-Ethnicity||Participants|Number|22|22.0||||||
4001408|NCT01221090|3821092|B2|Hispanic||Race-Ethnicity||Participants|Number|19|19.0||||||
4001409|NCT01221090|3821093|B1|Hispanic||Race-Ethnicity||Participants|Number|20|20.0||||||
4001410|NCT01221090|3821089|B5|Non-Hispanic Black||Race-Ethnicity||Participants|Number|61|61.0||||||
4001411|NCT01221090|3821090|B4|Non-Hispanic Black||Race-Ethnicity||Participants|Number|17|17.0||||||
4001412|NCT01221090|3821091|B3|Non-Hispanic Black||Race-Ethnicity||Participants|Number|12|12.0||||||
4001413|NCT01221090|3821092|B2|Non-Hispanic Black||Race-Ethnicity||Participants|Number|11|11.0||||||
4001414|NCT01221090|3821093|B1|Non-Hispanic Black||Race-Ethnicity||Participants|Number|21|21.0||||||
4001415|NCT01221090|3821089|B5|Non-Hispanic White||Race-Ethnicity||Participants|Number|226|226.0||||||
4001416|NCT01221090|3821090|B4|Non-Hispanic White||Race-Ethnicity||Participants|Number|58|58.0||||||
4001417|NCT01221090|3821091|B3|Non-Hispanic White||Race-Ethnicity||Participants|Number|61|61.0||||||
4001418|NCT01221090|3821092|B2|Non-Hispanic White||Race-Ethnicity||Participants|Number|49|49.0||||||
4001419|NCT01221090|3821093|B1|Non-Hispanic White||Race-Ethnicity||Participants|Number|58|58.0||||||
4001420|NCT01221090|3821089|B5|Yes||Minority|Individuals categorized as minority were those who self-reported as either African American or Hispanic|Participants|Number|137|137.0||||||
4001421|NCT01221090|3821090|B4|Yes||Minority|Individuals categorized as minority were those who self-reported as either African American or Hispanic|Participants|Number|32|32.0||||||
4001422|NCT01221090|3821091|B3|Yes||Minority|Individuals categorized as minority were those who self-reported as either African American or Hispanic|Participants|Number|34|34.0||||||
4001423|NCT01221090|3821092|B2|Yes||Minority|Individuals categorized as minority were those who self-reported as either African American or Hispanic|Participants|Number|30|30.0||||||
4001424|NCT01221090|3821093|B1|Yes||Minority|Individuals categorized as minority were those who self-reported as either African American or Hispanic|Participants|Number|41|41.0||||||
4001425|NCT01221090|3821089|B5|No||Minority|Individuals categorized as minority were those who self-reported as either African American or Hispanic|Participants|Number|239|239.0||||||
4001426|NCT01221090|3821090|B4|No||Minority|Individuals categorized as minority were those who self-reported as either African American or Hispanic|Participants|Number|63|63.0||||||
4001427|NCT01221090|3821091|B3|No||Minority|Individuals categorized as minority were those who self-reported as either African American or Hispanic|Participants|Number|65|65.0||||||
4001428|NCT01221090|3821092|B2|No||Minority|Individuals categorized as minority were those who self-reported as either African American or Hispanic|Participants|Number|51|51.0||||||
4001429|NCT01221090|3821093|B1|No||Minority|Individuals categorized as minority were those who self-reported as either African American or Hispanic|Participants|Number|60|60.0||||||
4001430|NCT01221090|3821089|B5|United States||Region of Enrollment||participants|Number|376|376.0||||||
4001431|NCT01221090|3821090|B4|United States||Region of Enrollment||participants|Number|95|95.0||||||
4001432|NCT01221090|3821091|B3|United States||Region of Enrollment||participants|Number|99|99.0||||||
4001433|NCT01221090|3821092|B2|United States||Region of Enrollment||participants|Number|81|81.0||||||
4001434|NCT01221090|3821093|B1|United States||Region of Enrollment||participants|Number|101|101.0||||||
4001435|NCT01221090|3821089|B5||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4001436|NCT01221090|3821090|B4||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4001437|NCT01221090|3821091|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4001438|NCT01221090|3821092|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4001439|NCT01221090|3821093|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4001440|NCT01221090|3821089|B5||Female|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4001441|NCT01221090|3821090|B4||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4001442|NCT01221090|3821091|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4001443|NCT01221090|3821092|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4001444|NCT01221090|3821093|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4001445|NCT01221090|3821089|B5|||Age||years|Mean|57.6|57.6|Standard Deviation|10.9|10.9|||
4001446|NCT01221090|3821090|B4|||Age||years|Mean|58.5|58.5|Standard Deviation|11.9|11.9|||
4001447|NCT01221090|3821091|B3|||Age||years|Mean|57.7|57.7|Standard Deviation|10.3|10.3|||
4001448|NCT01221090|3821092|B2|||Age||years|Mean|57.7|57.7|Standard Deviation|10.8|10.8|||
4001449|NCT01221090|3821093|B1|||Age||years|Mean|56.4|56.4|Standard Deviation|10.8|10.8|||
4001450|NCT01221090|3821089|B5||>=65 years|Age||Participants|Count of Participants|96|96.0||||||
4001451|NCT01221090|3821090|B4||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4001452|NCT01221090|3821091|B3||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4001453|NCT01221090|3821092|B2||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4001454|NCT01221090|3821093|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4001455|NCT01221090|3821089|B5||Between 18 and 65 years|Age||Participants|Count of Participants|280|280.0||||||
4001456|NCT01221090|3821090|B4||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4001457|NCT01221090|3821091|B3||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4001458|NCT01221090|3821092|B2||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4001459|NCT01221090|3821093|B1||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
4001460|NCT01221090|3821089|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001461|NCT01221090|3821090|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001462|NCT01221090|3821091|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001463|NCT01221090|3821092|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001464|NCT01221090|3821093|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001465|NCT01220973|3821122|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4001466|NCT01220973|3821122|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001467|NCT01220973|3821122|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001468|NCT01220973|3821122|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4001469|NCT01220973|3821122|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4001470|NCT01220973|3821122|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001471|NCT01220973|3821122|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001472|NCT01220973|3821122|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001473|NCT01220973|3821122|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001474|NCT01220973|3821122|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4001475|NCT01220973|3821122|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001476|NCT01220973|3821122|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4001477|NCT01220973|3821122|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4001478|NCT01220973|3821122|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4001479|NCT01220973|3821122|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4001480|NCT01220973|3821122|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001481|NCT01220869|3821126|B1|Taiwan||Region of Enrollment||participants|Number|110|110.0||||||
4001482|NCT01220869|3821126|B1||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4001483|NCT01220869|3821126|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4001484|NCT01220869|3821126|B1|||Age||years|Mean|73.8|73.8|Standard Deviation|8.3|8.3|||
4001485|NCT01220869|3821126|B1||>=65 years|Age||Participants|Count of Participants|91|91.0||||||
4001486|NCT01220869|3821126|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4001487|NCT01220869|3821126|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001488|NCT01220739|3821134|B3|||Post-tPA Baseline/Treatment NIH Stroke Scale|Total score is reported. Minimum score = 0 (better outcome); Maximum score = 42 (worse outcome)|score on a scale|Mean|9.1|9.1|Standard Deviation|5.2|5.2|||
4001489|NCT01220739|3821135|B2|||Post-tPA Baseline/Treatment NIH Stroke Scale|Total score is reported. Minimum score = 0 (better outcome); Maximum score = 42 (worse outcome)|score on a scale|Mean|9.6|9.6|Standard Deviation|5.4|5.4|||
4001490|NCT01220739|3821136|B1|||Post-tPA Baseline/Treatment NIH Stroke Scale|Total score is reported. Minimum score = 0 (better outcome); Maximum score = 42 (worse outcome)|score on a scale|Mean|8.7|8.7|Standard Deviation|5.4|5.4|||
4001491|NCT01220739|3821134|B3|||Randomization NIH Stroke Scale|Total score is reported. Minimum score = 0 (better outcome); Maximum score = 42 (worse outcome)|score on a scale|Mean|13.4|13.4|Standard Deviation|3.1|3.1|||
4001492|NCT01220739|3821135|B2|||Randomization NIH Stroke Scale|Total score is reported. Minimum score = 0 (better outcome); Maximum score = 42 (worse outcome)|score on a scale|Mean|15.0|15.0|Standard Deviation|2.4|2.4|||
4001493|NCT01220739|3821136|B1|||Randomization NIH Stroke Scale|Total score is reported. Minimum score = 0 (better outcome); Maximum score = 42 (worse outcome)|score on a scale|Mean|12.3|12.3|Standard Deviation|3.2|3.2|||
4001494|NCT01220739|3821134|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4001495|NCT01220739|3821135|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4001496|NCT01220739|3821136|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4001497|NCT01220739|3821134|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4001498|NCT01220739|3821135|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4001499|NCT01220739|3821136|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4001500|NCT01220739|3821134|B3|||Age||years|Mean|65.2|65.2|Standard Deviation|10.0|10.0|||
4001501|NCT01220739|3821135|B2|||Age||years|Mean|66.8|66.8|Standard Deviation|12.7|12.7|||
4001502|NCT01220739|3821136|B1|||Age||years|Mean|64.1|64.1|Standard Deviation|8.5|8.5|||
4001503|NCT01220609|3821145|B1|Carcinosarcoma, malignant mixed Mullerian tumor||Histologic Type||participants|Number|1|1.0||||||
4001504|NCT01220609|3821145|B1|Leiomyosarcoma||Histologic Type||participants|Number|22|22.0||||||
4001505|NCT01220609|3821145|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4001506|NCT01220609|3821145|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4001507|NCT01220609|3821145|B1|60-69 years||Age, Customized||participants|Number|6|6.0||||||
4001508|NCT01220609|3821145|B1|50-59 years||Age, Customized||participants|Number|12|12.0||||||
4001509|NCT01220609|3821145|B1|40-49 years||Age, Customized||participants|Number|5|5.0||||||
4001510|NCT01220609|3821145|B1|||Age||years|Mean|55.5|55.5|Standard Deviation|7.1|7.1|||
4001511|NCT01220557|3821157|B3|Germany||Region of Enrollment||participants|Number|160|160.0||||||
4001512|NCT01220557|3821158|B2|Germany||Region of Enrollment||participants|Number|79|79.0||||||
4001513|NCT01220557|3821159|B1|Germany||Region of Enrollment||participants|Number|81|81.0||||||
4001514|NCT01220557|3821157|B3||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4001515|NCT01220557|3821158|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4001516|NCT01220557|3821159|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4001517|NCT01220557|3821157|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4001518|NCT01220557|3821158|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4001519|NCT01220557|3821159|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4001520|NCT01220557|3821157|B3|||Age||years|Mean|45.5|45.5|Standard Deviation|13.5|13.5|||
4001521|NCT01220557|3821158|B2|||Age||years|Mean|45.1|45.1|Standard Deviation|13.4|13.4|||
4001522|NCT01220557|3821159|B1|||Age||years|Mean|45.9|45.9|Standard Deviation|13.8|13.8|||
4001523|NCT01220557|3821157|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4001524|NCT01220557|3821158|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4001525|NCT01220557|3821159|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4001526|NCT01220557|3821157|B3||Between 18 and 65 years|Age||Participants|Count of Participants|151|151.0||||||
4001527|NCT01220557|3821158|B2||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
4001528|NCT01220557|3821159|B1||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
4001529|NCT01220557|3821157|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001530|NCT01220557|3821158|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001531|NCT01220557|3821159|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001532|NCT01220466|3821166|B4|Canada||Region of Enrollment||participants|Number|77|77.0||||||
4001533|NCT01220466|3821167|B3|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4001534|NCT01220466|3821168|B2|Canada||Region of Enrollment||participants|Number|56|56.0||||||
4001535|NCT01220466|3821169|B1|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4001536|NCT01220466|3821166|B4||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4001537|NCT01220466|3821167|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4001538|NCT01220466|3821168|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4001539|NCT01220466|3821169|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4001540|NCT01220466|3821166|B4||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4001541|NCT01220466|3821167|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4001542|NCT01220466|3821168|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4001543|NCT01220466|3821169|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4001544|NCT01220466|3821166|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4001545|NCT01220466|3821167|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4001546|NCT01220466|3821168|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4001547|NCT01220466|3821169|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4001548|NCT01220466|3821166|B4||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
4001549|NCT01220466|3821167|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4001550|NCT01220466|3821168|B2||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4001551|NCT01220466|3821169|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4001552|NCT01220466|3821166|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001553|NCT01220466|3821167|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001554|NCT01220466|3821168|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001555|NCT01220466|3821169|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001556|NCT01220414|3821191|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
4001557|NCT01220414|3821192|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4001558|NCT01220414|3821193|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4001559|NCT01220414|3821191|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4001560|NCT01220414|3821192|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4001561|NCT01220414|3821193|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4001562|NCT01220414|3821191|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4001563|NCT01220414|3821192|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4001564|NCT01220414|3821193|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4001565|NCT01220414|3821191|B3|||Age||years|Mean|21|21.0|Standard Deviation|3|3.0|||
4001566|NCT01220414|3821192|B2|||Age||years|Mean|21|21.0|Standard Deviation|3|3.0|||
4001567|NCT01220414|3821193|B1|||Age||years|Mean|21|21.0|Standard Deviation|3|3.0|||
4001568|NCT01220414|3821191|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4001569|NCT01220414|3821192|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4001570|NCT01220414|3821193|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4001571|NCT01220414|3821191|B3||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4001572|NCT01220414|3821192|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4001573|NCT01220414|3821193|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4001574|NCT01220414|3821191|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001575|NCT01220414|3821192|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001576|NCT01220414|3821193|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001577|NCT01220401|3821203|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4001578|NCT01220401|3821203|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001579|NCT01220401|3821203|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4001580|NCT01220401|3821203|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4001581|NCT01220401|3821203|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001582|NCT01220401|3821203|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001583|NCT01220401|3821203|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001584|NCT01220401|3821203|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4001585|NCT01220401|3821203|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4001586|NCT01220401|3821203|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4001587|NCT01220401|3821203|B1|||Age, Customized||years|Mean|56.6|56.6|Standard Deviation|12.5|12.5|||
4001588|NCT01220297|3821210|B3|Biphenotypic Acute Leukaemia (BAL)||Disease Characteristics||Participants|Count of Participants|1|1.0||||||
4001589|NCT01220297|3821211|B2|Biphenotypic Acute Leukaemia (BAL)||Disease Characteristics||Participants|Count of Participants|1|1.0||||||
4001590|NCT01220297|3821210|B3|Acute Myeloid Leukemia (AML)||Disease Characteristics||Participants|Count of Participants|1|1.0||||||
4001591|NCT01220297|3821211|B2|Acute Myeloid Leukemia (AML)||Disease Characteristics||Participants|Count of Participants|1|1.0||||||
4001592|NCT01220297|3821210|B3|Acute Lymphoblastic Leukemia (ALL)||Disease Characteristics||Participants|Count of Participants|1|1.0||||||
4001593|NCT01220297|3821211|B2|Acute Lymphoblastic Leukemia (ALL)||Disease Characteristics||Participants|Count of Participants|1|1.0||||||
4001594|NCT01220297|3821210|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4001595|NCT01220297|3821211|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4001596|NCT01220297|3821210|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001597|NCT01220297|3821211|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001598|NCT01220297|3821210|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001599|NCT01220297|3821211|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001600|NCT01220297|3821210|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001601|NCT01220297|3821211|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001602|NCT01220297|3821210|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001603|NCT01220297|3821211|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001604|NCT01220297|3821210|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4001605|NCT01220297|3821211|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4001606|NCT01220297|3821210|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001607|NCT01220297|3821211|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001608|NCT01220297|3821210|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4001609|NCT01220297|3821211|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4001610|NCT01220297|3821210|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4001611|NCT01220297|3821211|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4001612|NCT01220297|3821210|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4001613|NCT01220297|3821211|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4001614|NCT01220297|3821210|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4001615|NCT01220297|3821211|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4001616|NCT01220297|3821212|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4001617|NCT01220297|3821210|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4001618|NCT01220297|3821211|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4001619|NCT01220297|3821210|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4001620|NCT01220297|3821211|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4001621|NCT01220297|3821210|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4001622|NCT01220297|3821211|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4001623|NCT01220297|3821210|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001624|NCT01220297|3821211|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001625|NCT01220180|3821226|B4||Male|Sex: Female, Male||Participants|Count of Participants|2038|2038.0||||||
4001626|NCT01220180|3821227|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4001627|NCT01220180|3821228|B2||Male|Sex: Female, Male||Participants|Count of Participants|1577|1577.0||||||
4001628|NCT01220180|3821229|B1||Male|Sex: Female, Male||Participants|Count of Participants|423|423.0||||||
4001629|NCT01220180|3821226|B4||Female|Sex: Female, Male||Participants|Count of Participants|2136|2136.0||||||
4001630|NCT01220180|3821227|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4001631|NCT01220180|3821228|B2||Female|Sex: Female, Male||Participants|Count of Participants|1689|1689.0||||||
4001632|NCT01220180|3821229|B1||Female|Sex: Female, Male||Participants|Count of Participants|364|364.0||||||
4001633|NCT01220180|3821226|B4|Greater than and equal to 70 years||Age, Customized||Participants|Number|852|852.0||||||
4001634|NCT01220180|3821227|B3|Greater than and equal to 70 years||Age, Customized||Participants|Number|16|16.0||||||
4001635|NCT01220180|3821228|B2|Greater than and equal to 70 years||Age, Customized||Participants|Number|790|790.0||||||
4001636|NCT01220180|3821229|B1|Greater than and equal to 70 years||Age, Customized||Participants|Number|46|46.0||||||
4001637|NCT01220180|3821226|B4|60 to 69 years||Age, Customized||Participants|Number|1211|1211.0||||||
4001638|NCT01220180|3821227|B3|60 to 69 years||Age, Customized||Participants|Number|28|28.0||||||
4001639|NCT01220180|3821228|B2|60 to 69 years||Age, Customized||Participants|Number|1094|1094.0||||||
4001640|NCT01220180|3821229|B1|60 to 69 years||Age, Customized||Participants|Number|89|89.0||||||
4001641|NCT01220180|3821226|B4|50 to 59 years||Age, Customized||Participants|Number|995|995.0||||||
4001642|NCT01220180|3821227|B3|50 to 59 years||Age, Customized||Participants|Number|36|36.0||||||
4001643|NCT01220180|3821228|B2|50 to 59 years||Age, Customized||Participants|Number|840|840.0||||||
4001644|NCT01220180|3821229|B1|50 to 59 years||Age, Customized||Participants|Number|119|119.0||||||
4001645|NCT01220180|3821226|B4|40 to 49 years||Age, Customized||Participants|Number|585|585.0||||||
4001646|NCT01220180|3821227|B3|40 to 49 years||Age, Customized||Participants|Number|30|30.0||||||
4001647|NCT01220180|3821228|B2|40 to 49 years||Age, Customized||Participants|Number|409|409.0||||||
4001648|NCT01220180|3821229|B1|40 to 49 years||Age, Customized||Participants|Number|146|146.0||||||
4001649|NCT01220180|3821226|B4|30 to 39 years||Age, Customized||Participants|Number|271|271.0||||||
4001650|NCT01220180|3821227|B3|30 to 39 years||Age, Customized||Participants|Number|8|8.0||||||
4001651|NCT01220180|3821228|B2|30 to 39 years||Age, Customized||Participants|Number|105|105.0||||||
4001652|NCT01220180|3821229|B1|30 to 39 years||Age, Customized||Participants|Number|158|158.0||||||
4001653|NCT01220180|3821226|B4|20 to 29 years||Age, Customized||Participants|Number|221|221.0||||||
4001654|NCT01220180|3821227|B3|20 to 29 years||Age, Customized||Participants|Number|3|3.0||||||
4001655|NCT01220180|3821228|B2|20 to 29 years||Age, Customized||Participants|Number|26|26.0||||||
4001656|NCT01220180|3821229|B1|20 to 29 years||Age, Customized||Participants|Number|192|192.0||||||
4001657|NCT01220180|3821226|B4|Less than 20 years||Age, Customized||Participants|Number|39|39.0||||||
4001658|NCT01220180|3821227|B3|Less than 20 years||Age, Customized||Participants|Number|0|0.0||||||
4001659|NCT01220180|3821228|B2|Less than 20 years||Age, Customized||Participants|Number|2|2.0||||||
4001660|NCT01220180|3821229|B1|Less than 20 years||Age, Customized||Participants|Number|37|37.0||||||
4001661|NCT01220128|3821252|B8||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4001662|NCT01220128|3821253|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4001663|NCT01220128|3821254|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4001664|NCT01220128|3821255|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4001665|NCT01220128|3821256|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4001666|NCT01220128|3821257|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4001667|NCT01220128|3821258|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4001668|NCT01220128|3821259|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4001669|NCT01220128|3821252|B8||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4001670|NCT01220128|3821253|B7||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4001671|NCT01220128|3821254|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4001672|NCT01220128|3821255|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4001673|NCT01220128|3821256|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4001674|NCT01220128|3821257|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4001675|NCT01220128|3821258|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4001676|NCT01220128|3821259|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4001677|NCT01220128|3821252|B8|||Age||Years|Mean|58.9|58.9|Standard Deviation|10.2|10.2|||
4001678|NCT01220128|3821253|B7|||Age||Years|Mean|49.6|49.6|Standard Deviation|8.7|8.7|||
4001679|NCT01220128|3821254|B6|||Age||Years|Mean|53.3|53.3|Standard Deviation|6.2|6.2|||
4001680|NCT01220128|3821255|B5|||Age||Years|Mean|52.9|52.9|Standard Deviation|10.6|10.6|||
4001681|NCT01220128|3821256|B4|||Age||Years|Mean|60.7|60.7|Standard Deviation|9.8|9.8|||
4001682|NCT01220128|3821257|B3|||Age||Years|Mean|49.3|49.3|Standard Deviation|15.6|15.6|||
4001683|NCT01220128|3821258|B2|||Age||Years|Mean|70.9|70.9|Standard Deviation|7.1|7.1|||
4001684|NCT01220128|3821259|B1|||Age||Years|Mean|69.3|69.3|Standard Deviation|10.4|10.4|||
4001685|NCT01219985|3821470|B1|France||Region of Enrollment||participants|Number|50|50.0||||||
4001686|NCT01219985|3821470|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4001687|NCT01219985|3821470|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4001688|NCT01219985|3821470|B1|||Age||years|Mean|61|61.0|Standard Deviation|11|11.0|||
4001689|NCT01219985|3821470|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4001690|NCT01219985|3821470|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4001691|NCT01219985|3821470|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001692|NCT01219933|3821476|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4001693|NCT01219933|3821476|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4001694|NCT01219933|3821476|B1|||Age||years|Mean|58.0|58.0|Standard Deviation|12.2|12.2|||
4001695|NCT01219881|3821513|B3|United States||Region of Enrollment||participants|Number|75|75.0||||||
4001696|NCT01219881|3821514|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4001697|NCT01219881|3821515|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4001698|NCT01219881|3821513|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4001699|NCT01219881|3821514|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4001700|NCT01219881|3821515|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4001701|NCT01219881|3821513|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4001702|NCT01219881|3821514|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4001703|NCT01219881|3821515|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4001704|NCT01219881|3821513|B3|||Age||years|Mean|61.2|61.2|Standard Deviation|7.3|7.3|||
4001705|NCT01219881|3821514|B2|||Age||years|Mean|61.3|61.3|Standard Deviation|6.6|6.6|||
4001706|NCT01219881|3821515|B1|||Age||years|Mean|61.1|61.1|Standard Deviation|7.7|7.7|||
4001707|NCT01219881|3821513|B3||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4001708|NCT01219881|3821514|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4001709|NCT01219881|3821515|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4001710|NCT01219881|3821513|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4001711|NCT01219881|3821514|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4001712|NCT01219881|3821515|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4001713|NCT01219881|3821513|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001714|NCT01219881|3821514|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001715|NCT01219881|3821515|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001716|NCT01219855|3821528|B6||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4001717|NCT01219855|3821529|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4001718|NCT01219855|3821530|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4001719|NCT01219855|3821531|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4001720|NCT01219855|3821532|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4001721|NCT01219855|3821533|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4001722|NCT01219855|3821528|B6||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4001723|NCT01219855|3821529|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4001724|NCT01219855|3821530|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4001725|NCT01219855|3821531|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4001726|NCT01219855|3821532|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4001727|NCT01219855|3821533|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4001728|NCT01219855|3821528|B6|||Age||years|Mean|63.0|63.0|Standard Deviation|13.39|13.39|||
4001729|NCT01219855|3821529|B5|||Age||years|Mean|63.9|63.9|Standard Deviation|11.47|11.47|||
4001730|NCT01219855|3821530|B4|||Age||years|Mean|58.2|58.2|Standard Deviation|16.14|16.14|||
4001731|NCT01219855|3821531|B3|||Age||years|Mean|61.9|61.9|Standard Deviation|17.79|17.79|||
4001732|NCT01219855|3821532|B2|||Age||years|Mean|64.6|64.6|Standard Deviation|11.41|11.41|||
4001733|NCT01219855|3821533|B1|||Age||years|Mean|64.7|64.7|Standard Deviation|9.20|9.2|||
4001734|NCT01219777|3821573|B1|United States||Region of Enrollment||patients|Number|9|9.0||||||
4001735|NCT01219777|3821573|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001736|NCT01219777|3821573|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001737|NCT01219777|3821573|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4001738|NCT01219777|3821573|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001739|NCT01219777|3821573|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001740|NCT01219777|3821573|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001741|NCT01219777|3821573|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001742|NCT01219777|3821573|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001743|NCT01219777|3821573|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4001744|NCT01219777|3821573|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001745|NCT01219777|3821573|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4001746|NCT01219777|3821573|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4001747|NCT01219777|3821573|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4001748|NCT01219777|3821573|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4001749|NCT01219777|3821573|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001750|NCT01219738|3821578|B1|||Airway blood flow||μl/min/ml|Mean|52.3|52.3|Standard Deviation|3.5|3.5|||
4001751|NCT01219738|3821578|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4001752|NCT01219738|3821578|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4001753|NCT01219738|3821578|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4001754|NCT01219738|3821578|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4001755|NCT01219738|3821578|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4001756|NCT01219738|3821578|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001757|NCT01219738|3821578|B1|||Age||years|Mean|43|43.0|Full Range|||22.0|66.0|
4001758|NCT01219673|3821591|B9|United States||Region of Enrollment||participants|Number|1|1.0||||||
4001759|NCT01219673|3821597|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4001760|NCT01219673|3821591|B9|Male||Gender||participants|Number|1|1.0||||||
4001761|NCT01219673|3821597|B3|Male||Gender||participants|Number|1|1.0||||||
4001762|NCT01219673|3821591|B9|Female||Gender||participants|Number|0|0.0||||||
4001763|NCT01219673|3821597|B3|Female||Gender||participants|Number|0|0.0||||||
4001764|NCT01219673|3821591|B9|>=65 years||Age||participants|Number|0|0.0||||||
4001765|NCT01219673|3821597|B3|>=65 years||Age||participants|Number|0|0.0||||||
4001766|NCT01219673|3821591|B9|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
4001767|NCT01219673|3821597|B3|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
4001768|NCT01219673|3821591|B9|<=18 years||Age||participants|Number|0|0.0||||||
4001769|NCT01219673|3821597|B3|<=18 years||Age||participants|Number|0|0.0||||||
4001770|NCT01218997|3821624|B3|United States||Region of Enrollment||participants|Number|436|436.0||||||
4001771|NCT01218997|3821625|B2|United States||Region of Enrollment||participants|Number|65|65.0||||||
4001772|NCT01218997|3821626|B1|United States||Region of Enrollment||participants|Number|371|371.0||||||
4001773|NCT01218997|3821624|B3||Male|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4001774|NCT01218997|3821625|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4001775|NCT01218997|3821626|B1||Male|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
4001776|NCT01218997|3821624|B3||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4001777|NCT01218997|3821625|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4001778|NCT01218997|3821626|B1||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4001779|NCT01218997|3821624|B3|||Age||years|Mean|40.7|40.7|Standard Deviation|11.3|11.3|||
4001780|NCT01218997|3821625|B2|||Age||years|Mean|40.5|40.5|Standard Deviation|11.4|11.4|||
4001781|NCT01218997|3821626|B1|||Age||years|Mean|40.7|40.7|Standard Deviation|11.2|11.2|||
4001782|NCT01218997|3821624|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4001783|NCT01218997|3821625|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4001784|NCT01218997|3821626|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4001785|NCT01218997|3821624|B3||Between 18 and 65 years|Age||Participants|Count of Participants|428|428.0||||||
4001786|NCT01218997|3821625|B2||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4001787|NCT01218997|3821626|B1||Between 18 and 65 years|Age||Participants|Count of Participants|364|364.0||||||
4001788|NCT01218997|3821624|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4001789|NCT01218997|3821625|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001790|NCT01218997|3821626|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4001791|NCT01218984|3821633|B4|United States||Region of Enrollment||participants|Number|27|27.0||||||
4001792|NCT01218984|3821634|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4001793|NCT01218984|3821635|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4001794|NCT01218984|3821636|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4001795|NCT01218984|3821633|B4||Male|Gender||Participants|Count of Participants|24|24.0||||||
4001796|NCT01218984|3821634|B3||Male|Gender||Participants|Count of Participants|8|8.0||||||
4001797|NCT01218984|3821635|B2||Male|Gender||Participants|Count of Participants|8|8.0||||||
4001798|NCT01218984|3821636|B1||Male|Gender||Participants|Count of Participants|8|8.0||||||
4001799|NCT01218984|3821633|B4||Female|Gender||Participants|Count of Participants|3|3.0||||||
4001800|NCT01218984|3821634|B3||Female|Gender||Participants|Count of Participants|2|2.0||||||
4001801|NCT01218984|3821635|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
4001802|NCT01218984|3821636|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
4001803|NCT01218984|3821633|B4|||Age||years|Mean|36.48|36.48|Standard Deviation|8.60|8.6|||
4001804|NCT01218984|3821634|B3|||Age||years|Mean|32.5|32.5|Standard Deviation|8.02|8.02|||
4001805|NCT01218984|3821635|B2|||Age||years|Mean|42.88|42.88|Standard Deviation|4.70|4.7|||
4001806|NCT01218984|3821636|B1|||Age||years|Mean|35.22|35.22|Standard Deviation|9.28|9.28|||
4001807|NCT01218984|3821633|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4001808|NCT01218984|3821634|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4001809|NCT01218984|3821635|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4001810|NCT01218984|3821636|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4001811|NCT01218984|3821633|B4||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4001812|NCT01218984|3821634|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4001813|NCT01218984|3821635|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4001814|NCT01218984|3821636|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4001815|NCT01218984|3821633|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001816|NCT01218984|3821634|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001817|NCT01218984|3821635|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001818|NCT01218984|3821636|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001819|NCT01218971|3821646|B3|United States||Region of Enrollment||participants|Number|332|332.0||||||
4001820|NCT01218971|3821647|B2|United States||Region of Enrollment||participants|Number|157|157.0||||||
4001821|NCT01218971|3821648|B1|United States||Region of Enrollment||participants|Number|175|175.0||||||
4001822|NCT01218971|3821646|B3||Male|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
4001823|NCT01218971|3821647|B2||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4001824|NCT01218971|3821648|B1||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4001825|NCT01218971|3821646|B3||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4001826|NCT01218971|3821647|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4001827|NCT01218971|3821648|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4001828|NCT01218971|3821646|B3|||Age||years|Mean|46.4|46.4|Standard Deviation|10.0|10.0|||
4001829|NCT01218971|3821647|B2|||Age||years|Mean|47.4|47.4|Standard Deviation|10.5|10.5|||
4001830|NCT01218971|3821648|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|9.6|9.6|||
4001831|NCT01218971|3821646|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4001832|NCT01218971|3821647|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4001833|NCT01218971|3821648|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4001834|NCT01218971|3821646|B3||Between 18 and 65 years|Age||Participants|Count of Participants|317|317.0||||||
4001835|NCT01218971|3821647|B2||Between 18 and 65 years|Age||Participants|Count of Participants|149|149.0||||||
4001836|NCT01218971|3821648|B1||Between 18 and 65 years|Age||Participants|Count of Participants|168|168.0||||||
4001837|NCT01218971|3821646|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001838|NCT01218971|3821647|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001839|NCT01218971|3821648|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001840|NCT01218958|3821659|B4|United States||Region of Enrollment||participants|Number|624|624.0||||||
4001841|NCT01218958|3821660|B3|United States||Region of Enrollment||participants|Number|209|209.0||||||
4001842|NCT01218958|3821661|B2|United States||Region of Enrollment||participants|Number|205|205.0||||||
4001843|NCT01218958|3821662|B1|United States||Region of Enrollment||participants|Number|210|210.0||||||
4001844|NCT01218958|3821659|B4||Male|Sex: Female, Male||Participants|Count of Participants|423|423.0||||||
4001845|NCT01218958|3821660|B3||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4001846|NCT01218958|3821661|B2||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4001847|NCT01218958|3821662|B1||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4001848|NCT01218958|3821659|B4||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4001849|NCT01218958|3821660|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4001850|NCT01218958|3821661|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4001851|NCT01218958|3821662|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4001852|NCT01218958|3821659|B4|||Age||years|Mean|44.7|44.7|Standard Deviation|10.6|10.6|||
4001853|NCT01218958|3821660|B3|||Age||years|Mean|44.7|44.7|Standard Deviation|10.8|10.8|||
4001854|NCT01218958|3821661|B2|||Age||years|Mean|45.0|45.0|Standard Deviation|10.1|10.1|||
4001855|NCT01218958|3821662|B1|||Age||years|Mean|44.6|44.6|Standard Deviation|10.8|10.8|||
4001856|NCT01218958|3821659|B4||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4001857|NCT01218958|3821660|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4001858|NCT01218958|3821661|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4001859|NCT01218958|3821662|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4001860|NCT01218958|3821659|B4||Between 18 and 65 years|Age||Participants|Count of Participants|602|602.0||||||
4001861|NCT01218958|3821660|B3||Between 18 and 65 years|Age||Participants|Count of Participants|199|199.0||||||
4001862|NCT01218958|3821661|B2||Between 18 and 65 years|Age||Participants|Count of Participants|200|200.0||||||
4001863|NCT01218958|3821662|B1||Between 18 and 65 years|Age||Participants|Count of Participants|203|203.0||||||
4001864|NCT01218958|3821659|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001865|NCT01218958|3821660|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001866|NCT01218958|3821661|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001867|NCT01218958|3821662|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4001868|NCT01218867|3821675|B12|United States||Region of Enrollment||participants|Number|24|24.0||||||
4001869|NCT01218867|3821676|B11|United States||Region of Enrollment||participants|Number|2|2.0||||||
4001870|NCT01218867|3821677|B10|United States||Region of Enrollment||participants|Number|4|4.0||||||
4001871|NCT01218867|3821678|B9|United States||Region of Enrollment||participants|Number|3|3.0||||||
4001872|NCT01218867|3821679|B8|United States||Region of Enrollment||participants|Number|3|3.0||||||
4001873|NCT01218867|3821680|B7|United States||Region of Enrollment||participants|Number|4|4.0||||||
4001874|NCT01218867|3821681|B6|United States||Region of Enrollment||participants|Number|1|1.0||||||
4001875|NCT01218867|3821682|B5|United States||Region of Enrollment||participants|Number|1|1.0||||||
4001876|NCT01218867|3821683|B4|United States||Region of Enrollment||participants|Number|1|1.0||||||
4001877|NCT01218867|3821684|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4001878|NCT01218867|3821685|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4001879|NCT01218867|3821686|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4001880|NCT01218867|3821675|B12||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001881|NCT01218867|3821676|B11||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001882|NCT01218867|3821677|B10||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001883|NCT01218867|3821678|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001884|NCT01218867|3821679|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001885|NCT01218867|3821680|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001886|NCT01218867|3821681|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001887|NCT01218867|3821682|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001888|NCT01218867|3821683|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001889|NCT01218867|3821684|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001890|NCT01218867|3821685|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001891|NCT01218867|3821686|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001892|NCT01218867|3821675|B12||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4001893|NCT01218867|3821676|B11||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4001894|NCT01218867|3821677|B10||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001895|NCT01218867|3821678|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001896|NCT01218867|3821679|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4001897|NCT01218867|3821680|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4001898|NCT01218867|3821681|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4001899|NCT01218867|3821682|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001900|NCT01218867|3821683|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001901|NCT01218867|3821684|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001902|NCT01218867|3821685|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001903|NCT01218867|3821686|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001904|NCT01218867|3821675|B12||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4001905|NCT01218867|3821676|B11||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4001906|NCT01218867|3821677|B10||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4001907|NCT01218867|3821678|B9||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4001908|NCT01218867|3821679|B8||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4001909|NCT01218867|3821680|B7||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4001910|NCT01218867|3821681|B6||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001911|NCT01218867|3821682|B5||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4001912|NCT01218867|3821683|B4||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4001913|NCT01218867|3821684|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4001914|NCT01218867|3821685|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4001915|NCT01218867|3821686|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4001916|NCT01218867|3821675|B12||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001917|NCT01218867|3821676|B11||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001918|NCT01218867|3821677|B10||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001919|NCT01218867|3821678|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001920|NCT01218867|3821679|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001921|NCT01218867|3821680|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001922|NCT01218867|3821681|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001923|NCT01218867|3821682|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001924|NCT01218867|3821683|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001925|NCT01218867|3821684|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001926|NCT01218867|3821685|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001927|NCT01218867|3821686|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001928|NCT01218867|3821675|B12||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001929|NCT01218867|3821676|B11||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001930|NCT01218867|3821677|B10||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001931|NCT01218867|3821678|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001932|NCT01218867|3821679|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001933|NCT01218867|3821680|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001934|NCT01218867|3821681|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001935|NCT01218867|3821682|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001936|NCT01218867|3821683|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001937|NCT01218867|3821684|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001938|NCT01218867|3821685|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001939|NCT01218867|3821686|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001940|NCT01218867|3821675|B12||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001941|NCT01218867|3821676|B11||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001942|NCT01218867|3821677|B10||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001943|NCT01218867|3821678|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001944|NCT01218867|3821679|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001945|NCT01218867|3821680|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001946|NCT01218867|3821681|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001947|NCT01218867|3821682|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001948|NCT01218867|3821683|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001949|NCT01218867|3821684|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001950|NCT01218867|3821685|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001951|NCT01218867|3821686|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001952|NCT01218867|3821675|B12||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001953|NCT01218867|3821676|B11||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001954|NCT01218867|3821677|B10||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001955|NCT01218867|3821678|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001956|NCT01218867|3821679|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001957|NCT01218867|3821680|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001958|NCT01218867|3821681|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001959|NCT01218867|3821682|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001960|NCT01218867|3821683|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001961|NCT01218867|3821684|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001962|NCT01218867|3821685|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001963|NCT01218867|3821686|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001964|NCT01218867|3821675|B12||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001965|NCT01218867|3821676|B11||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001966|NCT01218867|3821677|B10||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001967|NCT01218867|3821678|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001968|NCT01218867|3821679|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001969|NCT01218867|3821680|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001970|NCT01218867|3821681|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001971|NCT01218867|3821682|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001972|NCT01218867|3821683|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001973|NCT01218867|3821684|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001974|NCT01218867|3821685|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001975|NCT01218867|3821686|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001976|NCT01218867|3821675|B12||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4001977|NCT01218867|3821676|B11||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4001978|NCT01218867|3821677|B10||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4001979|NCT01218867|3821678|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4001980|NCT01218867|3821679|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4001981|NCT01218867|3821680|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4001982|NCT01218867|3821681|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001983|NCT01218867|3821682|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4001984|NCT01218867|3821683|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4001985|NCT01218867|3821684|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4001986|NCT01218867|3821685|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4001987|NCT01218867|3821686|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4001988|NCT01218867|3821675|B12||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4001989|NCT01218867|3821676|B11||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001990|NCT01218867|3821677|B10||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001991|NCT01218867|3821678|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4001992|NCT01218867|3821679|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001993|NCT01218867|3821680|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001994|NCT01218867|3821681|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4001995|NCT01218867|3821682|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001996|NCT01218867|3821683|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001997|NCT01218867|3821684|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001998|NCT01218867|3821685|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4001999|NCT01218867|3821686|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002000|NCT01218867|3821675|B12||Male|Gender||Participants|Count of Participants|17|17.0||||||
4002001|NCT01218867|3821676|B11||Male|Gender||Participants|Count of Participants|2|2.0||||||
4002002|NCT01218867|3821677|B10||Male|Gender||Participants|Count of Participants|2|2.0||||||
4002003|NCT01218867|3821678|B9||Male|Gender||Participants|Count of Participants|2|2.0||||||
4002004|NCT01218867|3821679|B8||Male|Gender||Participants|Count of Participants|2|2.0||||||
4002005|NCT01218867|3821680|B7||Male|Gender||Participants|Count of Participants|3|3.0||||||
4002006|NCT01218867|3821681|B6||Male|Gender||Participants|Count of Participants|1|1.0||||||
4002007|NCT01218867|3821682|B5||Male|Gender||Participants|Count of Participants|1|1.0||||||
4002008|NCT01218867|3821683|B4||Male|Gender||Participants|Count of Participants|1|1.0||||||
4002009|NCT01218867|3821684|B3||Male|Gender||Participants|Count of Participants|1|1.0||||||
4002010|NCT01218867|3821685|B2||Male|Gender||Participants|Count of Participants|1|1.0||||||
4002011|NCT01218867|3821686|B1||Male|Gender||Participants|Count of Participants|1|1.0||||||
4002012|NCT01218867|3821675|B12||Female|Gender||Participants|Count of Participants|7|7.0||||||
4002013|NCT01218867|3821676|B11||Female|Gender||Participants|Count of Participants|0|0.0||||||
4002014|NCT01218867|3821677|B10||Female|Gender||Participants|Count of Participants|2|2.0||||||
4002015|NCT01218867|3821678|B9||Female|Gender||Participants|Count of Participants|1|1.0||||||
4002016|NCT01218867|3821679|B8||Female|Gender||Participants|Count of Participants|1|1.0||||||
4002017|NCT01218867|3821680|B7||Female|Gender||Participants|Count of Participants|1|1.0||||||
4002018|NCT01218867|3821681|B6||Female|Gender||Participants|Count of Participants|0|0.0||||||
4002019|NCT01218867|3821682|B5||Female|Gender||Participants|Count of Participants|0|0.0||||||
4002020|NCT01218867|3821683|B4||Female|Gender||Participants|Count of Participants|0|0.0||||||
4002021|NCT01218867|3821684|B3||Female|Gender||Participants|Count of Participants|2|2.0||||||
4002022|NCT01218867|3821685|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
4002023|NCT01218867|3821686|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
4002024|NCT01218867|3821675|B12|||Age||years|Mean|47.9|47.9|Standard Deviation|11.8|11.8|||
4002025|NCT01218867|3821676|B11|||Age||years|Mean|41.5|41.5|Standard Deviation|10.6|10.6|||
4002026|NCT01218867|3821677|B10|||Age||years|Mean|46.3|46.3|Standard Deviation|5.6|5.6|||
4002027|NCT01218867|3821678|B9|||Age||years|Mean|54.7|54.7|Standard Deviation|11.9|11.9|||
4002028|NCT01218867|3821679|B8|||Age||years|Mean|37.0|37.0|Standard Deviation|18.0|18.0|||
4002029|NCT01218867|3821680|B7|||Age||years|Mean|45.5|45.5|Standard Deviation|11.3|11.3|||
4002030|NCT01218867|3821681|B6|||Age||years|Mean|35.0|35.0|Standard Deviation|0|0.0|||
4002031|NCT01218867|3821682|B5|||Age||years|Mean|55.0|55.0|Standard Deviation|0|0.0|||
4002032|NCT01218867|3821683|B4|||Age||years|Mean|65.0|65.0|Standard Deviation|0|0.0|||
4002033|NCT01218867|3821684|B3|||Age||years|Mean|52.7|52.7|Standard Deviation|12.1|12.1|||
4002034|NCT01218867|3821685|B2|||Age||years|Mean|51.0|51.0|Standard Deviation|0|0.0|||
4002035|NCT01218867|3821686|B1|||Age||years|Mean|61.0|61.0|Standard Deviation|0|0.0|||
4002036|NCT01218867|3821675|B12||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4002037|NCT01218867|3821676|B11||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4002038|NCT01218867|3821677|B10||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4002039|NCT01218867|3821678|B9||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4002040|NCT01218867|3821679|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4002041|NCT01218867|3821680|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4002042|NCT01218867|3821681|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4002043|NCT01218867|3821682|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4002044|NCT01218867|3821683|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4002045|NCT01218867|3821684|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4002046|NCT01218867|3821685|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4002047|NCT01218867|3821686|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4002048|NCT01218867|3821675|B12||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4002049|NCT01218867|3821676|B11||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4002050|NCT01218867|3821677|B10||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4002051|NCT01218867|3821678|B9||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4002052|NCT01218867|3821679|B8||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4002053|NCT01218867|3821680|B7||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4002054|NCT01218867|3821681|B6||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4002055|NCT01218867|3821682|B5||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4002056|NCT01218867|3821683|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4002057|NCT01218867|3821684|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4002058|NCT01218867|3821685|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4002059|NCT01218867|3821686|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4002060|NCT01218867|3821675|B12||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002061|NCT01218867|3821676|B11||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002062|NCT01218867|3821677|B10||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002063|NCT01218867|3821678|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002064|NCT01218867|3821679|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002065|NCT01218867|3821680|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002066|NCT01218867|3821681|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002067|NCT01218867|3821682|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002068|NCT01218867|3821683|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002069|NCT01218867|3821684|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002070|NCT01218867|3821685|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002071|NCT01218867|3821686|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002072|NCT01218802|3821742|B3|||Mean Absolute CD4 Count||10^6 cells/L|Mean|640|640.0|Standard Deviation|299|299.0|||
4002073|NCT01218802|3821743|B2|||Mean Absolute CD4 Count||10^6 cells/L|Mean|636|636.0|Standard Deviation|312|312.0|||
4002074|NCT01218802|3821744|B1|||Mean Absolute CD4 Count||10^6 cells/L|Mean|644|644.0|Standard Deviation|285|285.0|||
4002075|NCT01218802|3821742|B3|||Undetectable Viral Load (<48)||participants|Number|106|106.0||||||
4002076|NCT01218802|3821743|B2|||Undetectable Viral Load (<48)||participants|Number|56|56.0||||||
4002077|NCT01218802|3821744|B1|||Undetectable Viral Load (<48)||participants|Number|50|50.0||||||
4002078|NCT01218802|3821742|B3|||Mean ARV Duration||months|Mean|86|86.0|Standard Deviation|62|62.0|||
4002079|NCT01218802|3821743|B2|||Mean ARV Duration||months|Mean|87|87.0|Standard Deviation|62|62.0|||
4002080|NCT01218802|3821744|B1|||Mean ARV Duration||months|Mean|84|84.0|Standard Deviation|63|63.0|||
4002081|NCT01218802|3821742|B3|||Mean HIV Duration||months|Mean|146|146.0|Standard Deviation|83|83.0|||
4002082|NCT01218802|3821743|B2|||Mean HIV Duration||months|Mean|152|152.0|Standard Deviation|86|86.0|||
4002083|NCT01218802|3821744|B1|||Mean HIV Duration||months|Mean|140|140.0|Standard Deviation|79|79.0|||
4002084|NCT01218802|3821742|B3|United States||Region of Enrollment||participants|Number|147|147.0||||||
4002085|NCT01218802|3821743|B2|United States||Region of Enrollment||participants|Number|75|75.0||||||
4002086|NCT01218802|3821744|B1|United States||Region of Enrollment||participants|Number|72|72.0||||||
4002087|NCT01218802|3821742|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4002088|NCT01218802|3821743|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4002089|NCT01218802|3821744|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4002090|NCT01218802|3821742|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4002091|NCT01218802|3821743|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4002092|NCT01218802|3821744|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4002093|NCT01218802|3821742|B3||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4002094|NCT01218802|3821743|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4002095|NCT01218802|3821744|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4002096|NCT01218802|3821742|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
4002097|NCT01218802|3821743|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4002098|NCT01218802|3821744|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4002099|NCT01218802|3821742|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002100|NCT01218802|3821743|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002101|NCT01218802|3821744|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002102|NCT01218802|3821742|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002103|NCT01218802|3821743|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002104|NCT01218802|3821744|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002105|NCT01218802|3821742|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002106|NCT01218802|3821743|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002107|NCT01218802|3821744|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002108|NCT01218802|3821742|B3||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4002109|NCT01218802|3821743|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4002110|NCT01218802|3821744|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4002111|NCT01218802|3821742|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4002112|NCT01218802|3821743|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4002113|NCT01218802|3821744|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4002114|NCT01218802|3821742|B3|||Age||years|Mean|45|45.0|Standard Deviation|9.8|9.8|||
4002115|NCT01218802|3821743|B2|||Age||years|Mean|45|45.0|Standard Deviation|10|10.0|||
4002116|NCT01218802|3821744|B1|||Age||years|Mean|45|45.0|Standard Deviation|9|9.0|||
4002117|NCT01218802|3821742|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4002118|NCT01218802|3821743|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4002119|NCT01218802|3821744|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4002120|NCT01218802|3821742|B3||Between 18 and 65 years|Age||Participants|Count of Participants|146|146.0||||||
4002121|NCT01218802|3821743|B2||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4002122|NCT01218802|3821744|B1||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4002123|NCT01218802|3821742|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002124|NCT01218802|3821743|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002125|NCT01218802|3821744|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002126|NCT01218659|3821753|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4002127|NCT01218659|3821754|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4002128|NCT01218659|3821755|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4002129|NCT01218659|3821753|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4002130|NCT01218659|3821754|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4002131|NCT01218659|3821755|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4002132|NCT01218659|3821753|B3|||Age||years|Mean|48.9|48.9|Standard Deviation|14.21|14.21|||
4002133|NCT01218659|3821754|B2|||Age||years|Mean|46.3|46.3|Standard Deviation|14.91|14.91|||
4002134|NCT01218659|3821755|B1|||Age||years|Mean|50.5|50.5|Standard Deviation|13.76|13.76|||
4002135|NCT01218646|3821768|B5|United States||Region of Enrollment||Participants|Number|739|739.0||||||
4002136|NCT01218646|3821769|B4|United States||Region of Enrollment||Participants|Number|64|64.0||||||
4002137|NCT01218646|3821770|B3|United States||Region of Enrollment||Participants|Number|225|225.0||||||
4002138|NCT01218646|3821771|B2|United States||Region of Enrollment||Participants|Number|225|225.0||||||
4002139|NCT01218646|3821772|B1|United States||Region of Enrollment||Participants|Number|225|225.0||||||
4002140|NCT01218646|3821768|B5||Male|Sex: Female, Male||Participants|Count of Participants|336|336.0||||||
4002141|NCT01218646|3821769|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4002142|NCT01218646|3821770|B3||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4002143|NCT01218646|3821771|B2||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4002144|NCT01218646|3821772|B1||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4002145|NCT01218646|3821768|B5||Female|Sex: Female, Male||Participants|Count of Participants|403|403.0||||||
4002146|NCT01218646|3821769|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4002147|NCT01218646|3821770|B3||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4002148|NCT01218646|3821771|B2||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4002149|NCT01218646|3821772|B1||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4002150|NCT01218646|3821768|B5|||Age||Years|Mean|70.4|70.4|Standard Deviation|9.8|9.8|||
4002151|NCT01218646|3821769|B4|||Age||Years|Mean|46.0|46.0|Standard Deviation|11.6|11.6|||
4002152|NCT01218646|3821770|B3|||Age||Years|Mean|72.8|72.8|Standard Deviation|5.3|5.3|||
4002153|NCT01218646|3821771|B2|||Age||Years|Mean|72.8|72.8|Standard Deviation|5.6|5.6|||
4002154|NCT01218646|3821772|B1|||Age||Years|Mean|72.4|72.4|Standard Deviation|5.7|5.7|||
4002155|NCT01218646|3821768|B5||>=65 years|Age||Participants|Count of Participants|675|675.0||||||
4002156|NCT01218646|3821769|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4002157|NCT01218646|3821770|B3||>=65 years|Age||Participants|Count of Participants|225|225.0||||||
4002158|NCT01218646|3821771|B2||>=65 years|Age||Participants|Count of Participants|225|225.0||||||
4002159|NCT01218646|3821772|B1||>=65 years|Age||Participants|Count of Participants|225|225.0||||||
4002160|NCT01218646|3821768|B5||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4002161|NCT01218646|3821769|B4||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4002162|NCT01218646|3821770|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4002163|NCT01218646|3821771|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4002164|NCT01218646|3821772|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4002165|NCT01218646|3821768|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002166|NCT01218646|3821769|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002167|NCT01218646|3821770|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002168|NCT01218646|3821771|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002169|NCT01218646|3821772|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002170|NCT01218594|3821813|B1|China||Region of Enrollment||participants|Number|48|48.0||||||
4002171|NCT01218594|3821813|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4002172|NCT01218594|3821813|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4002173|NCT01218594|3821813|B1|||Age||years|Mean|55|55.0|Standard Deviation|10|10.0|||
4002174|NCT01218594|3821813|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4002175|NCT01218594|3821813|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4002176|NCT01218594|3821813|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002177|NCT01218477|3821817|B5|Suboptimal response||Primary reason for eligibility||Participants|Number|14|14.0||||||
4002178|NCT01218477|3821818|B4|Suboptimal response||Primary reason for eligibility||Participants|Number|1|1.0||||||
4002179|NCT01218477|3821819|B3|Suboptimal response||Primary reason for eligibility||Participants|Number|6|6.0||||||
4002180|NCT01218477|3821820|B2|Suboptimal response||Primary reason for eligibility||Participants|Number|6|6.0||||||
4002181|NCT01218477|3821821|B1|Suboptimal response||Primary reason for eligibility||Participants|Number|1|1.0||||||
4002182|NCT01218477|3821817|B5|Hematologic progression||Primary reason for eligibility||Participants|Number|7|7.0||||||
4002183|NCT01218477|3821818|B4|Hematologic progression||Primary reason for eligibility||Participants|Number|1|1.0||||||
4002184|NCT01218477|3821819|B3|Hematologic progression||Primary reason for eligibility||Participants|Number|4|4.0||||||
4002185|NCT01218477|3821820|B2|Hematologic progression||Primary reason for eligibility||Participants|Number|1|1.0||||||
4002186|NCT01218477|3821821|B1|Hematologic progression||Primary reason for eligibility||Participants|Number|1|1.0||||||
4002187|NCT01218477|3821817|B5|Cytogenetic progression||Primary reason for eligibility||Participants|Number|6|6.0||||||
4002188|NCT01218477|3821818|B4|Cytogenetic progression||Primary reason for eligibility||Participants|Number|0|0.0||||||
4002189|NCT01218477|3821819|B3|Cytogenetic progression||Primary reason for eligibility||Participants|Number|4|4.0||||||
4002190|NCT01218477|3821820|B2|Cytogenetic progression||Primary reason for eligibility||Participants|Number|1|1.0||||||
4002191|NCT01218477|3821821|B1|Cytogenetic progression||Primary reason for eligibility||Participants|Number|1|1.0||||||
4002192|NCT01218477|3821817|B5|Nilotinib||Previous medication for chronic myeloid leukemia||Participants|Number|9|9.0||||||
4002193|NCT01218477|3821818|B4|Nilotinib||Previous medication for chronic myeloid leukemia||Participants|Number|1|1.0||||||
4002194|NCT01218477|3821819|B3|Nilotinib||Previous medication for chronic myeloid leukemia||Participants|Number|5|5.0||||||
4002195|NCT01218477|3821820|B2|Nilotinib||Previous medication for chronic myeloid leukemia||Participants|Number|1|1.0||||||
4002196|NCT01218477|3821821|B1|Nilotinib||Previous medication for chronic myeloid leukemia||Participants|Number|2|2.0||||||
4002197|NCT01218477|3821817|B5|Imatinib||Previous medication for chronic myeloid leukemia||Participants|Number|7|7.0||||||
4002198|NCT01218477|3821818|B4|Imatinib||Previous medication for chronic myeloid leukemia||Participants|Number|0|0.0||||||
4002199|NCT01218477|3821819|B3|Imatinib||Previous medication for chronic myeloid leukemia||Participants|Number|5|5.0||||||
4002200|NCT01218477|3821820|B2|Imatinib||Previous medication for chronic myeloid leukemia||Participants|Number|1|1.0||||||
4002201|NCT01218477|3821821|B1|Imatinib||Previous medication for chronic myeloid leukemia||Participants|Number|1|1.0||||||
4002202|NCT01218477|3821817|B5|Dasatinib||Previous medication for chronic myeloid leukemia||Participants|Number|11|11.0||||||
4002203|NCT01218477|3821818|B4|Dasatinib||Previous medication for chronic myeloid leukemia||Participants|Number|1|1.0||||||
4002204|NCT01218477|3821819|B3|Dasatinib||Previous medication for chronic myeloid leukemia||Participants|Number|4|4.0||||||
4002205|NCT01218477|3821820|B2|Dasatinib||Previous medication for chronic myeloid leukemia||Participants|Number|6|6.0||||||
4002206|NCT01218477|3821821|B1|Dasatinib||Previous medication for chronic myeloid leukemia||Participants|Number|0|0.0||||||
4002207|NCT01218477|3821817|B5|CML-chronic phase||Current disease phase||Participants|Number|19|19.0||||||
4002208|NCT01218477|3821818|B4|CML-chronic phase||Current disease phase||Participants|Number|2|2.0||||||
4002209|NCT01218477|3821819|B3|CML-chronic phase||Current disease phase||Participants|Number|8|8.0||||||
4002210|NCT01218477|3821820|B2|CML-chronic phase||Current disease phase||Participants|Number|8|8.0||||||
4002211|NCT01218477|3821821|B1|CML-chronic phase||Current disease phase||Participants|Number|1|1.0||||||
4002212|NCT01218477|3821817|B5|CML-advanced phase||Current disease phase||Participants|Number|8|8.0||||||
4002213|NCT01218477|3821818|B4|CML-advanced phase||Current disease phase||Participants|Number|0|0.0||||||
4002214|NCT01218477|3821819|B3|CML-advanced phase||Current disease phase||Participants|Number|6|6.0||||||
4002215|NCT01218477|3821820|B2|CML-advanced phase||Current disease phase||Participants|Number|0|0.0||||||
4002216|NCT01218477|3821821|B1|CML-advanced phase||Current disease phase||Participants|Number|2|2.0||||||
4002217|NCT01218477|3821817|B5|Ph+ ALL||Current leukemia diagnosis|CML=chronic myeloid leukemia; ALL=acute lymphoblastic leukemia; Ph+=Philadelphia chromosome positive; Ph+ ALL=Philadelphia chromosome positive-acute lymphoblastic leukemia|Participants|Number|4|4.0||||||
4002218|NCT01218477|3821818|B4|Ph+ ALL||Current leukemia diagnosis|CML=chronic myeloid leukemia; ALL=acute lymphoblastic leukemia; Ph+=Philadelphia chromosome positive; Ph+ ALL=Philadelphia chromosome positive-acute lymphoblastic leukemia|Participants|Number|0|0.0||||||
4002219|NCT01218477|3821819|B3|Ph+ ALL||Current leukemia diagnosis|CML=chronic myeloid leukemia; ALL=acute lymphoblastic leukemia; Ph+=Philadelphia chromosome positive; Ph+ ALL=Philadelphia chromosome positive-acute lymphoblastic leukemia|Participants|Number|4|4.0||||||
4002220|NCT01218477|3821820|B2|Ph+ ALL||Current leukemia diagnosis|CML=chronic myeloid leukemia; ALL=acute lymphoblastic leukemia; Ph+=Philadelphia chromosome positive; Ph+ ALL=Philadelphia chromosome positive-acute lymphoblastic leukemia|Participants|Number|0|0.0||||||
4002221|NCT01218477|3821821|B1|Ph+ ALL||Current leukemia diagnosis|CML=chronic myeloid leukemia; ALL=acute lymphoblastic leukemia; Ph+=Philadelphia chromosome positive; Ph+ ALL=Philadelphia chromosome positive-acute lymphoblastic leukemia|Participants|Number|0|0.0||||||
4002222|NCT01218477|3821817|B5|Myeloid blast||Current leukemia diagnosis|CML=chronic myeloid leukemia; ALL=acute lymphoblastic leukemia; Ph+=Philadelphia chromosome positive; Ph+ ALL=Philadelphia chromosome positive-acute lymphoblastic leukemia|Participants|Number|1|1.0||||||
4002223|NCT01218477|3821818|B4|Myeloid blast||Current leukemia diagnosis|CML=chronic myeloid leukemia; ALL=acute lymphoblastic leukemia; Ph+=Philadelphia chromosome positive; Ph+ ALL=Philadelphia chromosome positive-acute lymphoblastic leukemia|Participants|Number|0|0.0||||||
4002224|NCT01218477|3821819|B3|Myeloid blast||Current leukemia diagnosis|CML=chronic myeloid leukemia; ALL=acute lymphoblastic leukemia; Ph+=Philadelphia chromosome positive; Ph+ ALL=Philadelphia chromosome positive-acute lymphoblastic leukemia|Participants|Number|0|0.0||||||
4002225|NCT01218477|3821820|B2|Myeloid blast||Current leukemia diagnosis|CML=chronic myeloid leukemia; ALL=acute lymphoblastic leukemia; Ph+=Philadelphia chromosome positive; Ph+ ALL=Philadelphia chromosome positive-acute lymphoblastic leukemia|Participants|Number|0|0.0||||||
4002226|NCT01218477|3821821|B1|Myeloid blast||Current leukemia diagnosis|CML=chronic myeloid leukemia; ALL=acute lymphoblastic leukemia; Ph+=Philadelphia chromosome positive; Ph+ ALL=Philadelphia chromosome positive-acute lymphoblastic leukemia|Participants|Number|1|1.0||||||
4002227|NCT01218477|3821817|B5|Chronic phase Ph+ CML||Current leukemia diagnosis|CML=chronic myeloid leukemia; ALL=acute lymphoblastic leukemia; Ph+=Philadelphia chromosome positive; Ph+ ALL=Philadelphia chromosome positive-acute lymphoblastic leukemia|Participants|Number|19|19.0||||||
4002228|NCT01218477|3821818|B4|Chronic phase Ph+ CML||Current leukemia diagnosis|CML=chronic myeloid leukemia; ALL=acute lymphoblastic leukemia; Ph+=Philadelphia chromosome positive; Ph+ ALL=Philadelphia chromosome positive-acute lymphoblastic leukemia|Participants|Number|2|2.0||||||
4002229|NCT01218477|3821819|B3|Chronic phase Ph+ CML||Current leukemia diagnosis|CML=chronic myeloid leukemia; ALL=acute lymphoblastic leukemia; Ph+=Philadelphia chromosome positive; Ph+ ALL=Philadelphia chromosome positive-acute lymphoblastic leukemia|Participants|Number|8|8.0||||||
4002230|NCT01218477|3821820|B2|Chronic phase Ph+ CML||Current leukemia diagnosis|CML=chronic myeloid leukemia; ALL=acute lymphoblastic leukemia; Ph+=Philadelphia chromosome positive; Ph+ ALL=Philadelphia chromosome positive-acute lymphoblastic leukemia|Participants|Number|8|8.0||||||
4002231|NCT01218477|3821821|B1|Chronic phase Ph+ CML||Current leukemia diagnosis|CML=chronic myeloid leukemia; ALL=acute lymphoblastic leukemia; Ph+=Philadelphia chromosome positive; Ph+ ALL=Philadelphia chromosome positive-acute lymphoblastic leukemia|Participants|Number|1|1.0||||||
4002232|NCT01218477|3821817|B5|Accelerated phase Ph+ CML||Current leukemia diagnosis|CML=chronic myeloid leukemia; ALL=acute lymphoblastic leukemia; Ph+=Philadelphia chromosome positive; Ph+ ALL=Philadelphia chromosome positive-acute lymphoblastic leukemia|Participants|Number|3|3.0||||||
4002233|NCT01218477|3821818|B4|Accelerated phase Ph+ CML||Current leukemia diagnosis|CML=chronic myeloid leukemia; ALL=acute lymphoblastic leukemia; Ph+=Philadelphia chromosome positive; Ph+ ALL=Philadelphia chromosome positive-acute lymphoblastic leukemia|Participants|Number|0|0.0||||||
4002234|NCT01218477|3821819|B3|Accelerated phase Ph+ CML||Current leukemia diagnosis|CML=chronic myeloid leukemia; ALL=acute lymphoblastic leukemia; Ph+=Philadelphia chromosome positive; Ph+ ALL=Philadelphia chromosome positive-acute lymphoblastic leukemia|Participants|Number|2|2.0||||||
4002235|NCT01218477|3821820|B2|Accelerated phase Ph+ CML||Current leukemia diagnosis|CML=chronic myeloid leukemia; ALL=acute lymphoblastic leukemia; Ph+=Philadelphia chromosome positive; Ph+ ALL=Philadelphia chromosome positive-acute lymphoblastic leukemia|Participants|Number|0|0.0||||||
4002236|NCT01218477|3821821|B1|Accelerated phase Ph+ CML||Current leukemia diagnosis|CML=chronic myeloid leukemia; ALL=acute lymphoblastic leukemia; Ph+=Philadelphia chromosome positive; Ph+ ALL=Philadelphia chromosome positive-acute lymphoblastic leukemia|Participants|Number|1|1.0||||||
4002237|NCT01218477|3821817|B5|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Physicians use the ECOG scales and criteria to help determine the progression of a patient's disease, the disease's affect on the patient’s daily living abilities, and appropriate treatment and prognosis. The scale runs from 0 (normal health) to 5 (death). Higher score=greater impairment. ECOG status scores: 0=fully active; 1=unable to perform strenuous activities, but light activity possible; 2=able to walk and manage self-care, but confined to a bed or chair <50% of the day; 3=confined to a bed or chair >50% of the day, but not bedridden; 4=completely disabled, bedridden; 5=dead.|Participants|Number|1|1.0||||||
4002238|NCT01218477|3821818|B4|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Physicians use the ECOG scales and criteria to help determine the progression of a patient's disease, the disease's affect on the patient’s daily living abilities, and appropriate treatment and prognosis. The scale runs from 0 (normal health) to 5 (death). Higher score=greater impairment. ECOG status scores: 0=fully active; 1=unable to perform strenuous activities, but light activity possible; 2=able to walk and manage self-care, but confined to a bed or chair <50% of the day; 3=confined to a bed or chair >50% of the day, but not bedridden; 4=completely disabled, bedridden; 5=dead.|Participants|Number|0|0.0||||||
4002239|NCT01218477|3821819|B3|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Physicians use the ECOG scales and criteria to help determine the progression of a patient's disease, the disease's affect on the patient’s daily living abilities, and appropriate treatment and prognosis. The scale runs from 0 (normal health) to 5 (death). Higher score=greater impairment. ECOG status scores: 0=fully active; 1=unable to perform strenuous activities, but light activity possible; 2=able to walk and manage self-care, but confined to a bed or chair <50% of the day; 3=confined to a bed or chair >50% of the day, but not bedridden; 4=completely disabled, bedridden; 5=dead.|Participants|Number|0|0.0||||||
4002240|NCT01218477|3821820|B2|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Physicians use the ECOG scales and criteria to help determine the progression of a patient's disease, the disease's affect on the patient’s daily living abilities, and appropriate treatment and prognosis. The scale runs from 0 (normal health) to 5 (death). Higher score=greater impairment. ECOG status scores: 0=fully active; 1=unable to perform strenuous activities, but light activity possible; 2=able to walk and manage self-care, but confined to a bed or chair <50% of the day; 3=confined to a bed or chair >50% of the day, but not bedridden; 4=completely disabled, bedridden; 5=dead.|Participants|Number|0|0.0||||||
4002241|NCT01218477|3821821|B1|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Physicians use the ECOG scales and criteria to help determine the progression of a patient's disease, the disease's affect on the patient’s daily living abilities, and appropriate treatment and prognosis. The scale runs from 0 (normal health) to 5 (death). Higher score=greater impairment. ECOG status scores: 0=fully active; 1=unable to perform strenuous activities, but light activity possible; 2=able to walk and manage self-care, but confined to a bed or chair <50% of the day; 3=confined to a bed or chair >50% of the day, but not bedridden; 4=completely disabled, bedridden; 5=dead.|Participants|Number|1|1.0||||||
4002242|NCT01218477|3821817|B5|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Physicians use the ECOG scales and criteria to help determine the progression of a patient's disease, the disease's affect on the patient’s daily living abilities, and appropriate treatment and prognosis. The scale runs from 0 (normal health) to 5 (death). Higher score=greater impairment. ECOG status scores: 0=fully active; 1=unable to perform strenuous activities, but light activity possible; 2=able to walk and manage self-care, but confined to a bed or chair <50% of the day; 3=confined to a bed or chair >50% of the day, but not bedridden; 4=completely disabled, bedridden; 5=dead.|Participants|Number|10|10.0||||||
4002243|NCT01218477|3821818|B4|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Physicians use the ECOG scales and criteria to help determine the progression of a patient's disease, the disease's affect on the patient’s daily living abilities, and appropriate treatment and prognosis. The scale runs from 0 (normal health) to 5 (death). Higher score=greater impairment. ECOG status scores: 0=fully active; 1=unable to perform strenuous activities, but light activity possible; 2=able to walk and manage self-care, but confined to a bed or chair <50% of the day; 3=confined to a bed or chair >50% of the day, but not bedridden; 4=completely disabled, bedridden; 5=dead.|Participants|Number|1|1.0||||||
4002244|NCT01218477|3821819|B3|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Physicians use the ECOG scales and criteria to help determine the progression of a patient's disease, the disease's affect on the patient’s daily living abilities, and appropriate treatment and prognosis. The scale runs from 0 (normal health) to 5 (death). Higher score=greater impairment. ECOG status scores: 0=fully active; 1=unable to perform strenuous activities, but light activity possible; 2=able to walk and manage self-care, but confined to a bed or chair <50% of the day; 3=confined to a bed or chair >50% of the day, but not bedridden; 4=completely disabled, bedridden; 5=dead.|Participants|Number|3|3.0||||||
4002245|NCT01218477|3821820|B2|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Physicians use the ECOG scales and criteria to help determine the progression of a patient's disease, the disease's affect on the patient’s daily living abilities, and appropriate treatment and prognosis. The scale runs from 0 (normal health) to 5 (death). Higher score=greater impairment. ECOG status scores: 0=fully active; 1=unable to perform strenuous activities, but light activity possible; 2=able to walk and manage self-care, but confined to a bed or chair <50% of the day; 3=confined to a bed or chair >50% of the day, but not bedridden; 4=completely disabled, bedridden; 5=dead.|Participants|Number|6|6.0||||||
4002246|NCT01218477|3821821|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Physicians use the ECOG scales and criteria to help determine the progression of a patient's disease, the disease's affect on the patient’s daily living abilities, and appropriate treatment and prognosis. The scale runs from 0 (normal health) to 5 (death). Higher score=greater impairment. ECOG status scores: 0=fully active; 1=unable to perform strenuous activities, but light activity possible; 2=able to walk and manage self-care, but confined to a bed or chair <50% of the day; 3=confined to a bed or chair >50% of the day, but not bedridden; 4=completely disabled, bedridden; 5=dead.|Participants|Number|0|0.0||||||
4002247|NCT01218477|3821817|B5|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Physicians use the ECOG scales and criteria to help determine the progression of a patient's disease, the disease's affect on the patient’s daily living abilities, and appropriate treatment and prognosis. The scale runs from 0 (normal health) to 5 (death). Higher score=greater impairment. ECOG status scores: 0=fully active; 1=unable to perform strenuous activities, but light activity possible; 2=able to walk and manage self-care, but confined to a bed or chair <50% of the day; 3=confined to a bed or chair >50% of the day, but not bedridden; 4=completely disabled, bedridden; 5=dead.|Participants|Number|16|16.0||||||
4002292|NCT01218399|3821995|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4002293|NCT01218399|3821996|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4002294|NCT01218399|3821994|B3|||Age||years|Mean|24|24.0|Standard Deviation|5|5.0|||
4002295|NCT01218399|3821995|B2|||Age||years|Mean|25|25.0|Standard Deviation|6|6.0|||
4002296|NCT01218399|3821996|B1|||Age||years|Mean|24|24.0|Standard Deviation|5|5.0|||
4002248|NCT01218477|3821818|B4|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Physicians use the ECOG scales and criteria to help determine the progression of a patient's disease, the disease's affect on the patient’s daily living abilities, and appropriate treatment and prognosis. The scale runs from 0 (normal health) to 5 (death). Higher score=greater impairment. ECOG status scores: 0=fully active; 1=unable to perform strenuous activities, but light activity possible; 2=able to walk and manage self-care, but confined to a bed or chair <50% of the day; 3=confined to a bed or chair >50% of the day, but not bedridden; 4=completely disabled, bedridden; 5=dead.|Participants|Number|1|1.0||||||
4002249|NCT01218477|3821819|B3|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Physicians use the ECOG scales and criteria to help determine the progression of a patient's disease, the disease's affect on the patient’s daily living abilities, and appropriate treatment and prognosis. The scale runs from 0 (normal health) to 5 (death). Higher score=greater impairment. ECOG status scores: 0=fully active; 1=unable to perform strenuous activities, but light activity possible; 2=able to walk and manage self-care, but confined to a bed or chair <50% of the day; 3=confined to a bed or chair >50% of the day, but not bedridden; 4=completely disabled, bedridden; 5=dead.|Participants|Number|11|11.0||||||
4002250|NCT01218477|3821820|B2|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Physicians use the ECOG scales and criteria to help determine the progression of a patient's disease, the disease's affect on the patient’s daily living abilities, and appropriate treatment and prognosis. The scale runs from 0 (normal health) to 5 (death). Higher score=greater impairment. ECOG status scores: 0=fully active; 1=unable to perform strenuous activities, but light activity possible; 2=able to walk and manage self-care, but confined to a bed or chair <50% of the day; 3=confined to a bed or chair >50% of the day, but not bedridden; 4=completely disabled, bedridden; 5=dead.|Participants|Number|2|2.0||||||
4002251|NCT01218477|3821821|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Physicians use the ECOG scales and criteria to help determine the progression of a patient's disease, the disease's affect on the patient’s daily living abilities, and appropriate treatment and prognosis. The scale runs from 0 (normal health) to 5 (death). Higher score=greater impairment. ECOG status scores: 0=fully active; 1=unable to perform strenuous activities, but light activity possible; 2=able to walk and manage self-care, but confined to a bed or chair <50% of the day; 3=confined to a bed or chair >50% of the day, but not bedridden; 4=completely disabled, bedridden; 5=dead.|Participants|Number|2|2.0||||||
4002252|NCT01218477|3821817|B5|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4002253|NCT01218477|3821818|B4|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4002254|NCT01218477|3821819|B3|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4002255|NCT01218477|3821820|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4002256|NCT01218477|3821821|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4002257|NCT01218477|3821817|B5|Black/African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4002258|NCT01218477|3821818|B4|Black/African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4002259|NCT01218477|3821819|B3|Black/African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4002260|NCT01218477|3821820|B2|Black/African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4002261|NCT01218477|3821821|B1|Black/African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4002262|NCT01218477|3821817|B5|White||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
4002263|NCT01218477|3821818|B4|White||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4002264|NCT01218477|3821819|B3|White||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4002265|NCT01218477|3821820|B2|White||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4002266|NCT01218477|3821821|B1|White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4002267|NCT01218477|3821817|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4002268|NCT01218477|3821818|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4002269|NCT01218477|3821819|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4002270|NCT01218477|3821820|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4002271|NCT01218477|3821821|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4002272|NCT01218477|3821817|B5||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4002273|NCT01218477|3821818|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4002274|NCT01218477|3821819|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4002275|NCT01218477|3821820|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4002276|NCT01218477|3821821|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4002277|NCT01218477|3821817|B5|||Age||Years|Median|56.0|56.0|Full Range|||25.0|74.0|
4002278|NCT01218477|3821818|B4|||Age||Years|Median|64.5|64.5|Full Range|||56.0|73.0|
4002279|NCT01218477|3821819|B3|||Age||Years|Median|55.5|55.5|Full Range|||25.0|74.0|
4002280|NCT01218477|3821820|B2|||Age||Years|Median|57.5|57.5|Full Range|||36.0|68.0|
4002281|NCT01218477|3821821|B1|||Age||Years|Median|43.0|43.0|Full Range|||26.0|50.0|
4002282|NCT01218438|3821841|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4002283|NCT01218438|3821841|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4002284|NCT01218438|3821841|B1|||Age||Years|Median|36.0|36.0|Full Range|||3.0|83.0|
4002285|NCT01218399|3821994|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4002286|NCT01218399|3821995|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4002287|NCT01218399|3821996|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4002288|NCT01218399|3821994|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4002289|NCT01218399|3821995|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4002290|NCT01218399|3821996|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4002291|NCT01218399|3821994|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4002297|NCT01218399|3821994|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4002298|NCT01218399|3821995|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4002299|NCT01218399|3821996|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4002300|NCT01218399|3821994|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4002301|NCT01218399|3821995|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4002302|NCT01218399|3821996|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4002303|NCT01218399|3821994|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002304|NCT01218399|3821995|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002305|NCT01218399|3821996|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002306|NCT01218308|3822005|B3||Male|Sex: Female, Male||Participants|Count of Participants|2672|2672.0||||||
4002307|NCT01218308|3822006|B2||Male|Sex: Female, Male||Participants|Count of Participants|1339|1339.0||||||
4002308|NCT01218308|3822007|B1||Male|Sex: Female, Male||Participants|Count of Participants|1333|1333.0||||||
4002309|NCT01218308|3822005|B3||Female|Sex: Female, Male||Participants|Count of Participants|2496|2496.0||||||
4002310|NCT01218308|3822006|B2||Female|Sex: Female, Male||Participants|Count of Participants|1245|1245.0||||||
4002311|NCT01218308|3822007|B1||Female|Sex: Female, Male||Participants|Count of Participants|1251|1251.0||||||
4002312|NCT01218308|3822005|B3|||Age||Years|Mean|5.4|5.4|Standard Deviation|1.65|1.65|||
4002313|NCT01218308|3822006|B2|||Age||Years|Mean|5.4|5.4|Standard Deviation|1.65|1.65|||
4002314|NCT01218308|3822007|B1|||Age||Years|Mean|5.4|5.4|Standard Deviation|1.66|1.66|||
4002315|NCT01218243|3822050|B3|||maximum urinary flow rate (Qmax)||ml/s|Mean|14.51|14.51|Standard Deviation|7.15|7.15|||
4002316|NCT01218243|3822051|B2|||maximum urinary flow rate (Qmax)||ml/s|Mean|15.93|15.93|Standard Deviation|7.33|7.33|||
4002317|NCT01218243|3822052|B1|||maximum urinary flow rate (Qmax)||ml/s|Mean|13.04|13.04|Standard Deviation|6.73|6.73|||
4002318|NCT01218243|3822050|B3|||bladder residual urine||ml|Median|20|20.0|Full Range|||0.0|128.0|
4002319|NCT01218243|3822051|B2|||bladder residual urine||ml|Median|16|16.0|Full Range|||0.0|128.0|
4002320|NCT01218243|3822052|B1|||bladder residual urine||ml|Median|20|20.0|Full Range|||0.0|128.0|
4002321|NCT01218243|3822050|B3|||International Prostate Symptom Score (IPSS)|Score range:0-35(0 is best，35 is worst, ordinal)|units on a scale|Mean|19.43|19.43|Standard Deviation|6.30|6.3|||
4002322|NCT01218243|3822051|B2|||International Prostate Symptom Score (IPSS)|Score range:0-35(0 is best，35 is worst, ordinal)|units on a scale|Mean|18.76|18.76|Standard Deviation|6.06|6.06|||
4002323|NCT01218243|3822052|B1|||International Prostate Symptom Score (IPSS)|Score range:0-35(0 is best，35 is worst, ordinal)|units on a scale|Mean|20.10|20.1|Standard Deviation|6.52|6.52|||
4002324|NCT01218243|3822050|B3|China||Region of Enrollment||participants|Number|100|100.0||||||
4002325|NCT01218243|3822051|B2|China||Region of Enrollment||participants|Number|50|50.0||||||
4002326|NCT01218243|3822052|B1|China||Region of Enrollment||participants|Number|50|50.0||||||
4002327|NCT01218243|3822050|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4002328|NCT01218243|3822051|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4002329|NCT01218243|3822052|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4002330|NCT01218243|3822050|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4002331|NCT01218243|3822051|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4002332|NCT01218243|3822052|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4002333|NCT01218243|3822050|B3|||Age||years|Mean|65.37|65.37|Standard Deviation|6.89|6.89|||
4002334|NCT01218243|3822051|B2|||Age||years|Mean|65.9|65.9|Standard Deviation|6.74|6.74|||
4002335|NCT01218243|3822052|B1|||Age||years|Mean|64.8|64.8|Standard Deviation|7.05|7.05|||
4002336|NCT01218243|3822050|B3||>=65 years|Age||Participants|Count of Participants|53|53.0||||||
4002337|NCT01218243|3822051|B2||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4002338|NCT01218243|3822052|B1||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4002339|NCT01218243|3822050|B3||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4002340|NCT01218243|3822051|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4002341|NCT01218243|3822052|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4002342|NCT01218243|3822050|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002343|NCT01218243|3822051|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002344|NCT01218243|3822052|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002345|NCT01218204|3822067|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4002346|NCT01218204|3822068|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4002347|NCT01218204|3822069|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4002348|NCT01218204|3822067|B3|White - Mixed Race||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4002349|NCT01218204|3822068|B2|White - Mixed Race||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4002350|NCT01218204|3822069|B1|White - Mixed Race||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4002351|NCT01218204|3822067|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|235|235.0||||||
4002352|NCT01218204|3822068|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|230|230.0||||||
4002353|NCT01218204|3822069|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4002460|NCT01218113|3822378|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4002354|NCT01218204|3822067|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4002355|NCT01218204|3822068|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4002356|NCT01218204|3822069|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4002357|NCT01218204|3822067|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4002358|NCT01218204|3822068|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4002359|NCT01218204|3822069|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4002360|NCT01218204|3822067|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4002361|NCT01218204|3822068|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4002362|NCT01218204|3822069|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4002363|NCT01218204|3822067|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4002364|NCT01218204|3822068|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4002365|NCT01218204|3822069|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4002366|NCT01218204|3822067|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4002367|NCT01218204|3822068|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4002368|NCT01218204|3822069|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4002369|NCT01218204|3822067|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4002370|NCT01218204|3822068|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4002371|NCT01218204|3822069|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4002372|NCT01218204|3822067|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
4002373|NCT01218204|3822068|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
4002374|NCT01218204|3822069|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4002375|NCT01218204|3822067|B3||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4002376|NCT01218204|3822068|B2||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4002377|NCT01218204|3822069|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4002378|NCT01218204|3822067|B3||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4002379|NCT01218204|3822068|B2||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4002380|NCT01218204|3822069|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4002381|NCT01218204|3822067|B3|||Age|Data is presented for Part B|Years|Mean|57.7|57.7|Standard Deviation|9.97|9.97|||
4002382|NCT01218204|3822068|B2|||Age|Data is presented for Part B|Years|Mean|57.7|57.7|Standard Deviation|9.97|9.97|||
4002383|NCT01218204|3822067|B3|||Age|Data is presented for Part A|Years|Mean|49.2|49.2|Standard Deviation|5.34|5.34|||
4002384|NCT01218204|3822069|B1|||Age|Data is presented for Part A|Years|Mean|49.2|49.2|Standard Deviation|5.34|5.34|||
4002385|NCT01218126|3822332|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002386|NCT01218126|3822333|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002387|NCT01218126|3822334|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002388|NCT01218126|3822335|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002389|NCT01218126|3822336|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002390|NCT01218126|3822332|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002391|NCT01218126|3822333|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002392|NCT01218126|3822334|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002393|NCT01218126|3822335|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002394|NCT01218126|3822336|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002395|NCT01218126|3822332|B5||White|Race (NIH/OMB)||Participants|Count of Participants|512|512.0||||||
4002396|NCT01218126|3822333|B4||White|Race (NIH/OMB)||Participants|Count of Participants|118|118.0||||||
4002397|NCT01218126|3822334|B3||White|Race (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
4002398|NCT01218126|3822335|B2||White|Race (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
4002399|NCT01218126|3822336|B1||White|Race (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
4002400|NCT01218126|3822332|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4002401|NCT01218126|3822333|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4002402|NCT01218126|3822334|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4002403|NCT01218126|3822335|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4002404|NCT01218126|3822336|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4002405|NCT01218126|3822332|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002406|NCT01218126|3822333|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002407|NCT01218126|3822334|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002408|NCT01218126|3822335|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002409|NCT01218126|3822336|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002410|NCT01218126|3822332|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
4002411|NCT01218126|3822333|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4002412|NCT01218126|3822334|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4002413|NCT01218126|3822335|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4002414|NCT01218126|3822336|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4002415|NCT01218126|3822332|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002416|NCT01218126|3822333|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002417|NCT01218126|3822334|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002418|NCT01218126|3822335|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002419|NCT01218126|3822336|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002420|NCT01218126|3822332|B5||Male|Sex: Female, Male||Participants|Count of Participants|413|413.0||||||
4002421|NCT01218126|3822333|B4||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4002422|NCT01218126|3822334|B3||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4002423|NCT01218126|3822335|B2||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4002424|NCT01218126|3822336|B1||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4002425|NCT01218126|3822332|B5||Female|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4002426|NCT01218126|3822333|B4||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4002427|NCT01218126|3822334|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4002428|NCT01218126|3822335|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4002429|NCT01218126|3822336|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4002430|NCT01218126|3822332|B5|||Age||Years|Mean|65.2|65.2|Standard Deviation|8.62|8.62|||
4002431|NCT01218126|3822333|B4|||Age||Years|Mean|64.8|64.8|Standard Deviation|9.26|9.26|||
4002432|NCT01218126|3822334|B3|||Age||Years|Mean|66.1|66.1|Standard Deviation|7.76|7.76|||
4002433|NCT01218126|3822335|B2|||Age||Years|Mean|66.1|66.1|Standard Deviation|8.64|8.64|||
4002434|NCT01218126|3822336|B1|||Age||Years|Mean|63.9|63.9|Standard Deviation|8.64|8.64|||
4002435|NCT01218113|3822377|B4|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4002436|NCT01218113|3822378|B3|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4002437|NCT01218113|3822379|B2|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4002438|NCT01218113|3822380|B1|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4002439|NCT01218113|3822377|B4|Race/Ethnicity|White-Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|136|136.0||||||
4002440|NCT01218113|3822378|B3|Race/Ethnicity|White-Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
4002441|NCT01218113|3822379|B2|Race/Ethnicity|White-Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
4002442|NCT01218113|3822380|B1|Race/Ethnicity|White-Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
4002443|NCT01218113|3822377|B4|Race/Ethnicity|White-Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4002444|NCT01218113|3822378|B3|Race/Ethnicity|White-Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4002445|NCT01218113|3822379|B2|Race/Ethnicity|White-Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4002446|NCT01218113|3822380|B1|Race/Ethnicity|White-Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4002447|NCT01218113|3822377|B4|Race/Ethnicity|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4002448|NCT01218113|3822378|B3|Race/Ethnicity|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4002449|NCT01218113|3822379|B2|Race/Ethnicity|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4002450|NCT01218113|3822380|B1|Race/Ethnicity|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4002451|NCT01218113|3822377|B4|Race/Ethnicity|African heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
4002452|NCT01218113|3822378|B3|Race/Ethnicity|African heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
4002453|NCT01218113|3822379|B2|Race/Ethnicity|African heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4002454|NCT01218113|3822380|B1|Race/Ethnicity|African heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4002455|NCT01218113|3822377|B4||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4002456|NCT01218113|3822378|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4002457|NCT01218113|3822379|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4002458|NCT01218113|3822380|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4002459|NCT01218113|3822377|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4002461|NCT01218113|3822379|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4002462|NCT01218113|3822380|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4002463|NCT01218113|3822377|B4|||Age||Years|Mean|35.9|35.9|Standard Deviation|8.1|8.1|||
4002464|NCT01218113|3822378|B3|||Age||Years|Mean|35.9|35.9|Standard Deviation|8.4|8.4|||
4002465|NCT01218113|3822379|B2|||Age||Years|Mean|37.0|37.0|Standard Deviation|8.2|8.2|||
4002466|NCT01218113|3822380|B1|||Age||Years|Mean|34.9|34.9|Standard Deviation|7.6|7.6|||
4002467|NCT01218100|3822559|B5|United States||Region of Enrollment||participants|Number|661|661.0||||||
4002468|NCT01218100|3822560|B4|United States||Region of Enrollment||participants|Number|189|189.0||||||
4002469|NCT01218100|3822561|B3|United States||Region of Enrollment||participants|Number|188|188.0||||||
4002470|NCT01218100|3822562|B2|United States||Region of Enrollment||participants|Number|189|189.0||||||
4002471|NCT01218100|3822563|B1|United States||Region of Enrollment||participants|Number|95|95.0||||||
4002472|NCT01218100|3822559|B5||Male|Sex: Female, Male||Participants|Count of Participants|383|383.0||||||
4002473|NCT01218100|3822560|B4||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4002474|NCT01218100|3822561|B3||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4002475|NCT01218100|3822562|B2||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4002476|NCT01218100|3822563|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4002477|NCT01218100|3822559|B5||Female|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
4002478|NCT01218100|3822560|B4||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4002479|NCT01218100|3822561|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4002480|NCT01218100|3822562|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4002481|NCT01218100|3822563|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4002482|NCT01218100|3822559|B5|||Age||years|Mean|49.2|49.2|Standard Deviation|8.5|8.5|||
4002483|NCT01218100|3822560|B4|||Age||years|Mean|50.1|50.1|Standard Deviation|8|8.0|||
4002484|NCT01218100|3822561|B3|||Age||years|Mean|49.7|49.7|Standard Deviation|8.4|8.4|||
4002485|NCT01218100|3822562|B2|||Age||years|Mean|48.8|48.8|Standard Deviation|8.4|8.4|||
4002486|NCT01218100|3822563|B1|||Age||years|Mean|47.4|47.4|Standard Deviation|9.7|9.7|||
4002487|NCT01218100|3822559|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4002488|NCT01218100|3822560|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4002489|NCT01218100|3822561|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4002490|NCT01218100|3822562|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4002491|NCT01218100|3822563|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4002492|NCT01218100|3822559|B5||Between 18 and 65 years|Age||Participants|Count of Participants|661|661.0||||||
4002493|NCT01218100|3822560|B4||Between 18 and 65 years|Age||Participants|Count of Participants|189|189.0||||||
4002494|NCT01218100|3822561|B3||Between 18 and 65 years|Age||Participants|Count of Participants|188|188.0||||||
4002495|NCT01218100|3822562|B2||Between 18 and 65 years|Age||Participants|Count of Participants|189|189.0||||||
4002496|NCT01218100|3822563|B1||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
4002497|NCT01218100|3822559|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002498|NCT01218100|3822560|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002499|NCT01218100|3822561|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002500|NCT01218100|3822562|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002501|NCT01218100|3822563|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002502|NCT01218087|3822580|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
4002503|NCT01218087|3822581|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
4002504|NCT01218087|3822582|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4002505|NCT01218087|3822580|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4002506|NCT01218087|3822581|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4002507|NCT01218087|3822582|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4002508|NCT01218087|3822580|B3|Native Hawaiian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4002509|NCT01218087|3822581|B2|Native Hawaiian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4002510|NCT01218087|3822582|B1|Native Hawaiian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4002511|NCT01218087|3822580|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4002512|NCT01218087|3822581|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4002513|NCT01218087|3822582|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4002514|NCT01218087|3822580|B3|African American||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4002515|NCT01218087|3822581|B2|African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4002516|NCT01218087|3822582|B1|African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4002517|NCT01218087|3822580|B3|White||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4002518|NCT01218087|3822581|B2|White||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4002519|NCT01218087|3822582|B1|White||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4002520|NCT01218087|3822580|B3||Male|Gender||Participants|Count of Participants|40|40.0||||||
4002521|NCT01218087|3822581|B2||Male|Gender||Participants|Count of Participants|22|22.0||||||
4002522|NCT01218087|3822582|B1||Male|Gender||Participants|Count of Participants|18|18.0||||||
4002523|NCT01218087|3822580|B3||Female|Gender||Participants|Count of Participants|22|22.0||||||
4002524|NCT01218087|3822581|B2||Female|Gender||Participants|Count of Participants|13|13.0||||||
4002525|NCT01218087|3822582|B1||Female|Gender||Participants|Count of Participants|9|9.0||||||
4002526|NCT01218087|3822580|B3|||Age||days|Median|0|0.0|Full Range|||0.0|12.0|
4002527|NCT01218087|3822581|B2|||Age||days|Median|0|0.0|Full Range|||0.0|12.0|
4002528|NCT01218087|3822582|B1|||Age||days|Median|0|0.0|Full Range|||0.0|7.0|
4002529|NCT01218048|3822591|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4002530|NCT01218048|3822591|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4002531|NCT01218048|3822591|B1|||Age||years|Mean|58.6|58.6|Full Range|||38.0|89.0|
4002532|NCT01218009|3822603|B3|||Weight||pounds|Mean|182|182.0|Standard Deviation|48.9|48.9|||
4002533|NCT01218009|3822604|B2|||Weight||pounds|Mean|179|179.0|Standard Deviation|48.2|48.2|||
4002534|NCT01218009|3822605|B1|||Weight||pounds|Mean|184|184.0|Standard Deviation|49.7|49.7|||
4002535|NCT01218009|3822603|B3|||Height||inches|Mean|65.9|65.9|Standard Deviation|3.73|3.73|||
4002536|NCT01218009|3822604|B2|||Height||inches|Mean|65.7|65.7|Standard Deviation|3.86|3.86|||
4002537|NCT01218009|3822605|B1|||Height||inches|Mean|66.1|66.1|Standard Deviation|3.59|3.59|||
4002538|NCT01218009|3822603|B3|Not Hispanic||Ethnicity||participants|Number|290|290.0||||||
4002539|NCT01218009|3822604|B2|Not Hispanic||Ethnicity||participants|Number|144|144.0||||||
4002540|NCT01218009|3822605|B1|Not Hispanic||Ethnicity||participants|Number|146|146.0||||||
4002541|NCT01218009|3822603|B3|Hispanic||Ethnicity||participants|Number|41|41.0||||||
4002542|NCT01218009|3822604|B2|Hispanic||Ethnicity||participants|Number|21|21.0||||||
4002543|NCT01218009|3822605|B1|Hispanic||Ethnicity||participants|Number|20|20.0||||||
4002544|NCT01218009|3822603|B3|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4002545|NCT01218009|3822604|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4002546|NCT01218009|3822605|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4002547|NCT01218009|3822603|B3|North American or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4002548|NCT01218009|3822604|B2|North American or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4002549|NCT01218009|3822605|B1|North American or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4002550|NCT01218009|3822603|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4002551|NCT01218009|3822604|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4002552|NCT01218009|3822605|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4002553|NCT01218009|3822603|B3|Black||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4002554|NCT01218009|3822604|B2|Black||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4002555|NCT01218009|3822605|B1|Black||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4002556|NCT01218009|3822603|B3|White||Race/Ethnicity, Customized||participants|Number|272|272.0||||||
4002557|NCT01218009|3822604|B2|White||Race/Ethnicity, Customized||participants|Number|132|132.0||||||
4002558|NCT01218009|3822605|B1|White||Race/Ethnicity, Customized||participants|Number|140|140.0||||||
4002559|NCT01218009|3822603|B3||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4002560|NCT01218009|3822604|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4002561|NCT01218009|3822605|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4002562|NCT01218009|3822603|B3||Female|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
4002563|NCT01218009|3822604|B2||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4002564|NCT01218009|3822605|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4002565|NCT01218009|3822603|B3|||Age||years|Mean|37.9|37.9|Standard Deviation|14.47|14.47|||
4002566|NCT01218009|3822604|B2|||Age||years|Mean|38.0|38.0|Standard Deviation|14.91|14.91|||
4002567|NCT01218009|3822605|B1|||Age||years|Mean|37.9|37.9|Standard Deviation|14.07|14.07|||
4002568|NCT01217957|3822624|B6|||Body Surface Area|Body surface area is defined as [Height(cm) x Weight (kg)]/3600)^1/2. Body surface area data was available for 3, 3, 6, 3, 48 and 51 participants in each treatment arm, respectively.|m^2|Mean|1.994|1.994|Standard Deviation|0.2565|0.2565|||
4002569|NCT01217957|3822625|B5|||Body Surface Area|Body surface area is defined as [Height(cm) x Weight (kg)]/3600)^1/2. Body surface area data was available for 3, 3, 6, 3, 48 and 51 participants in each treatment arm, respectively.|m^2|Mean|2.011|2.011|Standard Deviation|0.2343|0.2343|||
4002570|NCT01217957|3822626|B4|||Body Surface Area|Body surface area is defined as [Height(cm) x Weight (kg)]/3600)^1/2. Body surface area data was available for 3, 3, 6, 3, 48 and 51 participants in each treatment arm, respectively.|m^2|Mean|2.348|2.348|Standard Deviation|0.3050|0.305|||
4002571|NCT01217957|3822627|B3|||Body Surface Area|Body surface area is defined as [Height(cm) x Weight (kg)]/3600)^1/2. Body surface area data was available for 3, 3, 6, 3, 48 and 51 participants in each treatment arm, respectively.|m^2|Mean|1.826|1.826|Standard Deviation|0.2272|0.2272|||
4002572|NCT01217957|3822628|B2|||Body Surface Area|Body surface area is defined as [Height(cm) x Weight (kg)]/3600)^1/2. Body surface area data was available for 3, 3, 6, 3, 48 and 51 participants in each treatment arm, respectively.|m^2|Mean|1.665|1.665|Standard Deviation|0.1923|0.1923|||
4002573|NCT01217957|3822629|B1|||Body Surface Area|Body surface area is defined as [Height(cm) x Weight (kg)]/3600)^1/2. Body surface area data was available for 3, 3, 6, 3, 48 and 51 participants in each treatment arm, respectively.|m^2|Mean|2.024|2.024|Standard Deviation|0.2180|0.218|||
4002574|NCT01217957|3822624|B6|||Weight||kg|Mean|85.39|85.39|Standard Deviation|19.247|19.247|||
4002575|NCT01217957|3822625|B5|||Weight||kg|Mean|86.13|86.13|Standard Deviation|17.695|17.695|||
4002576|NCT01217957|3822626|B4|||Weight||kg|Mean|116.63|116.63|Standard Deviation|25.480|25.48|||
4002577|NCT01217957|3822627|B3|||Weight||kg|Mean|72.82|72.82|Standard Deviation|14.557|14.557|||
4002578|NCT01217957|3822628|B2|||Weight||kg|Mean|64.93|64.93|Standard Deviation|16.045|16.045|||
4002579|NCT01217957|3822629|B1|||Weight||kg|Mean|87.43|87.43|Standard Deviation|12.683|12.683|||
4002580|NCT01217957|3822624|B6|||Height|Height data was available for 3, 3, 6, 3, 48 and 51 participants in each treatment arm, respectively.|cm|Mean|168.5|168.5|Standard Deviation|11.30|11.3|||
4002581|NCT01217957|3822625|B5|||Height|Height data was available for 3, 3, 6, 3, 48 and 51 participants in each treatment arm, respectively.|cm|Mean|169.4|169.4|Standard Deviation|11.57|11.57|||
4002582|NCT01217957|3822626|B4|||Height|Height data was available for 3, 3, 6, 3, 48 and 51 participants in each treatment arm, respectively.|cm|Mean|171.1|171.1|Standard Deviation|8.07|8.07|||
4002583|NCT01217957|3822627|B3|||Height|Height data was available for 3, 3, 6, 3, 48 and 51 participants in each treatment arm, respectively.|cm|Mean|165.9|165.9|Standard Deviation|10.21|10.21|||
4002584|NCT01217957|3822628|B2|||Height|Height data was available for 3, 3, 6, 3, 48 and 51 participants in each treatment arm, respectively.|cm|Mean|155.4|155.4|Standard Deviation|3.20|3.2|||
4002585|NCT01217957|3822629|B1|||Height|Height data was available for 3, 3, 6, 3, 48 and 51 participants in each treatment arm, respectively.|cm|Mean|168.9|168.9|Standard Deviation|12.90|12.9|||
4002586|NCT01217957|3822624|B6|United States||Region of Enrollment||participants|Number|65|65.0||||||
4002587|NCT01217957|3822625|B5|United States||Region of Enrollment||participants|Number|50|50.0||||||
4002588|NCT01217957|3822626|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
4002589|NCT01217957|3822627|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4002590|NCT01217957|3822628|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4002591|NCT01217957|3822629|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4002592|NCT01217957|3822624|B6|United States||Region of Enrollment||participants|Number|65|65.0||||||
4002593|NCT01217957|3822625|B5|United States||Region of Enrollment||participants|Number|50|50.0||||||
4002594|NCT01217957|3822626|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
4002595|NCT01217957|3822627|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4002596|NCT01217957|3822628|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4002597|NCT01217957|3822629|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4002598|NCT01217957|3822624|B6|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4002599|NCT01217957|3822625|B5|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4002600|NCT01217957|3822626|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4002601|NCT01217957|3822627|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4002602|NCT01217957|3822628|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4002603|NCT01217957|3822629|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4002604|NCT01217957|3822624|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4002605|NCT01217957|3822625|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4002606|NCT01217957|3822626|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4002607|NCT01217957|3822627|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4002608|NCT01217957|3822628|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4002609|NCT01217957|3822629|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4002610|NCT01217957|3822624|B6|White||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
4002611|NCT01217957|3822625|B5|White||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4002612|NCT01217957|3822626|B4|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4002613|NCT01217957|3822627|B3|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4002614|NCT01217957|3822628|B2|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4002615|NCT01217957|3822629|B1|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4002616|NCT01217957|3822624|B6|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|64|64.0||||||
4002617|NCT01217957|3822625|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4002618|NCT01217957|3822626|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4002619|NCT01217957|3822627|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4002620|NCT01217957|3822628|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4002621|NCT01217957|3822629|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4002622|NCT01217957|3822624|B6|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4002623|NCT01217957|3822625|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4002624|NCT01217957|3822626|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4002625|NCT01217957|3822627|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4002626|NCT01217957|3822628|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4002627|NCT01217957|3822629|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4002628|NCT01217957|3822624|B6||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4002629|NCT01217957|3822625|B5||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4002630|NCT01217957|3822626|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4002631|NCT01217957|3822627|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4002632|NCT01217957|3822628|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4002633|NCT01217957|3822629|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4002634|NCT01217957|3822624|B6||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4002635|NCT01217957|3822625|B5||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4002636|NCT01217957|3822626|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4002637|NCT01217957|3822627|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4002638|NCT01217957|3822628|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4002639|NCT01217957|3822629|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4002640|NCT01217957|3822624|B6|||Age||years|Mean|64.4|64.4|Standard Deviation|10.67|10.67|||
4002641|NCT01217957|3822625|B5|||Age||years|Mean|64.2|64.2|Standard Deviation|11.16|11.16|||
4002642|NCT01217957|3822626|B4|||Age||years|Mean|64.7|64.7|Standard Deviation|9.29|9.29|||
4002643|NCT01217957|3822627|B3|||Age||years|Mean|63.2|63.2|Standard Deviation|12.19|12.19|||
4002644|NCT01217957|3822628|B2|||Age||years|Mean|72.3|72.3|Standard Deviation|4.51|4.51|||
4002645|NCT01217957|3822629|B1|||Age||years|Mean|62.7|62.7|Standard Deviation|3.21|3.21|||
4002646|NCT01217944|3822689|B4||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4002647|NCT01217944|3822690|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4002648|NCT01217944|3822691|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4002649|NCT01217944|3822692|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4002650|NCT01217944|3822689|B4||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4002651|NCT01217944|3822690|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4002652|NCT01217944|3822691|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4002653|NCT01217944|3822692|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4002654|NCT01217944|3822689|B4|>=65||Age, Customized||Participants|Number|80|80.0||||||
4002655|NCT01217944|3822690|B3|>=65||Age, Customized||Participants|Number|18|18.0||||||
4002656|NCT01217944|3822691|B2|>=65||Age, Customized||Participants|Number|37|37.0||||||
4002657|NCT01217944|3822692|B1|>=65||Age, Customized||Participants|Number|25|25.0||||||
4002658|NCT01217944|3822689|B4|55-<65 years||Age, Customized||Participants|Number|78|78.0||||||
4002659|NCT01217944|3822690|B3|55-<65 years||Age, Customized||Participants|Number|14|14.0||||||
4002660|NCT01217944|3822691|B2|55-<65 years||Age, Customized||Participants|Number|34|34.0||||||
4002661|NCT01217944|3822692|B1|55-<65 years||Age, Customized||Participants|Number|30|30.0||||||
4002662|NCT01217944|3822689|B4|45 -< 55 years||Age, Customized||Participants|Number|64|64.0||||||
4002663|NCT01217944|3822690|B3|45 -< 55 years||Age, Customized||Participants|Number|16|16.0||||||
4002664|NCT01217944|3822691|B2|45 -< 55 years||Age, Customized||Participants|Number|21|21.0||||||
4002665|NCT01217944|3822692|B1|45 -< 55 years||Age, Customized||Participants|Number|27|27.0||||||
4002666|NCT01217944|3822689|B4|<45 years||Age, Customized||Participants|Number|55|55.0||||||
4002667|NCT01217944|3822690|B3|<45 years||Age, Customized||Participants|Number|7|7.0||12.7|12.7|||
4002668|NCT01217944|3822691|B2|<45 years||Age, Customized||Participants|Number|24|24.0||20.7|20.7|||
4002669|NCT01217944|3822692|B1|<45 years||Age, Customized||Participants|Number|24|24.0||22.6|22.6|||
4002670|NCT01217892|3822733|B5|||Body weight||kg|Mean|91.37|91.37|Standard Deviation|16.716|16.716|||
4002671|NCT01217892|3822734|B4|||Body weight||kg|Mean|88.82|88.82|Standard Deviation|15.327|15.327|||
4002672|NCT01217892|3822735|B3|||Body weight||kg|Mean|90.58|90.58|Standard Deviation|15.929|15.929|||
4002673|NCT01217892|3822736|B2|||Body weight||kg|Mean|93.62|93.62|Standard Deviation|16.641|16.641|||
4002674|NCT01217892|3822737|B1|||Body weight||kg|Mean|92.49|92.49|Standard Deviation|18.632|18.632|||
4002675|NCT01217892|3822733|B5|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|155.4|155.4|Standard Deviation|34.30|34.3|||
4002676|NCT01217892|3822734|B4|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|157.8|157.8|Standard Deviation|35.93|35.93|||
4002677|NCT01217892|3822735|B3|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|155.3|155.3|Standard Deviation|36.26|36.26|||
4002678|NCT01217892|3822736|B2|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|155.3|155.3|Standard Deviation|31.92|31.92|||
4002679|NCT01217892|3822737|B1|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|153.3|153.3|Standard Deviation|33.27|33.27|||
4002680|NCT01217892|3822733|B5|||HbA1c||Percent [%]|Mean|7.80|7.8|Standard Deviation|0.770|0.77|||
4002681|NCT01217892|3822734|B4|||HbA1c||Percent [%]|Mean|7.94|7.94|Standard Deviation|0.848|0.848|||
4002682|NCT01217892|3822735|B3|||HbA1c||Percent [%]|Mean|7.71|7.71|Standard Deviation|0.709|0.709|||
4002683|NCT01217892|3822736|B2|||HbA1c||Percent [%]|Mean|7.78|7.78|Standard Deviation|0.762|0.762|||
4002684|NCT01217892|3822737|B1|||HbA1c||Percent [%]|Mean|7.77|7.77|Standard Deviation|0.747|0.747|||
4002685|NCT01217892|3822733|B5||Male|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4002686|NCT01217892|3822734|B4||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4002687|NCT01217892|3822735|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4002688|NCT01217892|3822736|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4002689|NCT01217892|3822737|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4002690|NCT01217892|3822733|B5||Female|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
4002691|NCT01217892|3822734|B4||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4002692|NCT01217892|3822735|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4002693|NCT01217892|3822736|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4002694|NCT01217892|3822737|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4002695|NCT01217892|3822733|B5|||Age||Years|Mean|57.7|57.7|Standard Deviation|9.45|9.45|||
4002696|NCT01217892|3822734|B4|||Age||Years|Mean|58.5|58.5|Standard Deviation|9.40|9.4|||
4002697|NCT01217892|3822735|B3|||Age||Years|Mean|58.5|58.5|Standard Deviation|9.78|9.78|||
4002698|NCT01217892|3822736|B2|||Age||Years|Mean|55.3|55.3|Standard Deviation|9.34|9.34|||
4002699|NCT01217892|3822737|B1|||Age||Years|Mean|58.3|58.3|Standard Deviation|9.01|9.01|||
4002700|NCT01217840|3822766|B3|||25OH vitamin D||ng/mL|Mean|21.8|21.8|Full Range|||10.0|59.0|
4002701|NCT01217840|3822767|B2|||25OH vitamin D||ng/mL|Mean|24.2|24.2|Full Range|||12.0|59.0|
4002702|NCT01217840|3822768|B1|||25OH vitamin D||ng/mL|Mean|19.4|19.4|Full Range|||10.0|30.0|
4002703|NCT01217840|3822766|B3|||BMI||kg/m^2|Mean|33.22|33.22|Full Range|||23.47|48.72|
4002704|NCT01217840|3822767|B2|||BMI||kg/m^2|Mean|31|31.0|Full Range|||23.47|41.3|
4002705|NCT01217840|3822768|B1|||BMI||kg/m^2|Mean|36|36.0|Full Range|||25.33|48.72|
4002706|NCT01217840|3822766|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4002707|NCT01217840|3822767|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4002708|NCT01217840|3822768|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4002709|NCT01217840|3822766|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002710|NCT01217840|3822767|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002711|NCT01217840|3822768|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002712|NCT01217840|3822766|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4002713|NCT01217840|3822767|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4002714|NCT01217840|3822768|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4002715|NCT01217840|3822766|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4002716|NCT01217840|3822767|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4002717|NCT01217840|3822768|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4002718|NCT01217840|3822766|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4002719|NCT01217840|3822767|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4002720|NCT01217840|3822768|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4002721|NCT01217840|3822766|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4002722|NCT01217840|3822767|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4002723|NCT01217840|3822768|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4002724|NCT01217840|3822766|B3|||Age||years|Mean|14.35|14.35|Full Range|||11.2|17.6|
4002725|NCT01217840|3822767|B2|||Age||years|Mean|13.6|13.6|Full Range|||11.2|16.8|
4002726|NCT01217840|3822768|B1|||Age||years|Mean|15.1|15.1|Full Range|||12.4|17.6|
4002727|NCT01217827|3822791|B3|United States||Region of Enrollment||participants|Number|89|89.0||||||
4002728|NCT01217827|3822792|B2|United States||Region of Enrollment||participants|Number|43|43.0||||||
4002729|NCT01217827|3822793|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4002730|NCT01217827|3822791|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4002731|NCT01217827|3822792|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4002732|NCT01217827|3822793|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4002733|NCT01217827|3822791|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4002734|NCT01217827|3822792|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4002735|NCT01217827|3822793|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4002736|NCT01217827|3822791|B3|||Age||years|Mean|65|65.0|Standard Deviation|8|8.0|||
4002737|NCT01217827|3822792|B2|||Age||years|Mean|64|64.0|Standard Deviation|8|8.0|||
4002738|NCT01217827|3822793|B1|||Age||years|Mean|66|66.0|Standard Deviation|8|8.0|||
4002739|NCT01217814|3822800|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4002740|NCT01217814|3822801|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4002741|NCT01217814|3822802|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4002742|NCT01217814|3822803|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4002743|NCT01217814|3822800|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4002744|NCT01217814|3822801|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4002745|NCT01217814|3822802|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4002746|NCT01217814|3822803|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4002747|NCT01217814|3822800|B4|||Age||years|Mean|54.5|54.5|Standard Deviation|13.2|13.2|||
4002748|NCT01217814|3822801|B3|||Age||years|Mean|54.0|54.0|Standard Deviation|11.1|11.1|||
4002749|NCT01217814|3822802|B2|||Age||years|Mean|62.6|62.6|Standard Deviation|7.6|7.6|||
4002750|NCT01217814|3822803|B1|||Age||years|Mean|45.3|45.3|Standard Deviation|17.9|17.9|||
4002751|NCT01217801|3822829|B3|India||Region of Enrollment||participants|Number|48|48.0||||||
4002752|NCT01217801|3822830|B2|India||Region of Enrollment||participants|Number|48|48.0||||||
4002753|NCT01217801|3822831|B1|India||Region of Enrollment||participants|Number|48|48.0||||||
4002754|NCT01217801|3822829|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4002755|NCT01217801|3822830|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4002756|NCT01217801|3822831|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4002757|NCT01217801|3822829|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4002758|NCT01217801|3822830|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4002759|NCT01217801|3822831|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4002760|NCT01217801|3822829|B3|||Age||years|Mean|26.78|26.78|Standard Deviation|5.8|5.8|||
4002761|NCT01217801|3822830|B2|||Age||years|Mean|26.78|26.78|Standard Deviation|5.8|5.8|||
4002762|NCT01217801|3822831|B1|||Age||years|Mean|26.78|26.78|Standard Deviation|5.8|5.8|||
4002763|NCT01217801|3822829|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4002764|NCT01217801|3822830|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4002765|NCT01217801|3822831|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4002766|NCT01217801|3822829|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4002767|NCT01217801|3822830|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4002768|NCT01217801|3822831|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4002769|NCT01217801|3822829|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002770|NCT01217801|3822830|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002771|NCT01217801|3822831|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002772|NCT01217749|3822838|B4|United States||Region of Enrollment||participants|Number|71|71.0||||||
4002773|NCT01217749|3822839|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4002774|NCT01217749|3822840|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4002775|NCT01217749|3822841|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4002776|NCT01217749|3822838|B4||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4002777|NCT01217749|3822839|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4002778|NCT01217749|3822840|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4002779|NCT01217749|3822841|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4002780|NCT01217749|3822838|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4002781|NCT01217749|3822839|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4002782|NCT01217749|3822840|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4002783|NCT01217749|3822841|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4002784|NCT01217749|3822838|B4||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4002785|NCT01217749|3822839|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4002786|NCT01217749|3822840|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4002787|NCT01217749|3822841|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4002788|NCT01217749|3822838|B4||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4002789|NCT01217749|3822839|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4002790|NCT01217749|3822840|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4002791|NCT01217749|3822841|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4002792|NCT01217749|3822838|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002793|NCT01217749|3822839|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002794|NCT01217749|3822840|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002795|NCT01217749|3822841|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002796|NCT01217606|3822859|B3||Male|Gender||Participants|Count of Participants|69|69.0||||||
4002797|NCT01217606|3822860|B2||Male|Gender||Participants|Count of Participants|32|32.0||||||
4002798|NCT01217606|3822861|B1||Male|Gender||Participants|Count of Participants|37|37.0||||||
4002799|NCT01217606|3822859|B3||Female|Gender||Participants|Count of Participants|116|116.0||||||
4002800|NCT01217606|3822860|B2||Female|Gender||Participants|Count of Participants|63|63.0||||||
4002801|NCT01217606|3822861|B1||Female|Gender||Participants|Count of Participants|53|53.0||||||
4002802|NCT01217606|3822859|B3|>65 years||Age, Customized||Participants|Number|55|55.0||||||
4002803|NCT01217606|3822860|B2|>65 years||Age, Customized||Participants|Number|33|33.0||||||
4002804|NCT01217606|3822861|B1|>65 years||Age, Customized||Participants|Number|22|22.0||||||
4002805|NCT01217606|3822859|B3|≤65 years||Age, Customized||Participants|Number|130|130.0||||||
4002806|NCT01217606|3822860|B2|≤65 years||Age, Customized||Participants|Number|62|62.0||||||
4002807|NCT01217606|3822861|B1|≤65 years||Age, Customized||Participants|Number|68|68.0||||||
4002808|NCT01217515|3822872|B4|United Kingdom||Region of Enrollment||participants|Number|14|14.0||||||
4002809|NCT01217515|3822873|B3|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4002810|NCT01217515|3822874|B2|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4002811|NCT01217515|3822875|B1|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4002812|NCT01217515|3822872|B4|Germany||Region of Enrollment||participants|Number|30|30.0||||||
4002813|NCT01217515|3822873|B3|Germany||Region of Enrollment||participants|Number|8|8.0||||||
4002814|NCT01217515|3822874|B2|Germany||Region of Enrollment||participants|Number|10|10.0||||||
4002815|NCT01217515|3822875|B1|Germany||Region of Enrollment||participants|Number|12|12.0||||||
4002816|NCT01217515|3822872|B4|Bulgaria||Region of Enrollment||participants|Number|86|86.0||||||
4002817|NCT01217515|3822873|B3|Bulgaria||Region of Enrollment||participants|Number|30|30.0||||||
4002818|NCT01217515|3822874|B2|Bulgaria||Region of Enrollment||participants|Number|28|28.0||||||
4002819|NCT01217515|3822875|B1|Bulgaria||Region of Enrollment||participants|Number|28|28.0||||||
4002820|NCT01217515|3822872|B4|Lithuania||Region of Enrollment||participants|Number|17|17.0||||||
4002821|NCT01217515|3822873|B3|Lithuania||Region of Enrollment||participants|Number|6|6.0||||||
4002822|NCT01217515|3822874|B2|Lithuania||Region of Enrollment||participants|Number|6|6.0||||||
4002823|NCT01217515|3822875|B1|Lithuania||Region of Enrollment||participants|Number|5|5.0||||||
4002824|NCT01217515|3822872|B4|Romania||Region of Enrollment||participants|Number|309|309.0||||||
4002825|NCT01217515|3822873|B3|Romania||Region of Enrollment||participants|Number|103|103.0||||||
4002826|NCT01217515|3822874|B2|Romania||Region of Enrollment||participants|Number|105|105.0||||||
4002827|NCT01217515|3822875|B1|Romania||Region of Enrollment||participants|Number|101|101.0||||||
4002828|NCT01217515|3822872|B4|Spain||Region of Enrollment||participants|Number|9|9.0||||||
4002829|NCT01217515|3822873|B3|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4002830|NCT01217515|3822874|B2|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4002831|NCT01217515|3822875|B1|Spain||Region of Enrollment||participants|Number|3|3.0||||||
4002832|NCT01217515|3822872|B4||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4002833|NCT01217515|3822873|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4002834|NCT01217515|3822874|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4002835|NCT01217515|3822875|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4002836|NCT01217515|3822872|B4||Female|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
4002837|NCT01217515|3822873|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4002838|NCT01217515|3822874|B2||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4002839|NCT01217515|3822875|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4002840|NCT01217515|3822872|B4|||Age||years|Mean|43.3|43.3|Standard Deviation|13.4|13.4|||
4002841|NCT01217515|3822873|B3|||Age||years|Mean|43.2|43.2|Standard Deviation|12.5|12.5|||
4002842|NCT01217515|3822874|B2|||Age||years|Mean|42.5|42.5|Standard Deviation|13.6|13.6|||
4002843|NCT01217515|3822875|B1|||Age||years|Mean|44.2|44.2|Standard Deviation|14.2|14.2|||
4002844|NCT01217515|3822872|B4||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4002845|NCT01217515|3822873|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4002846|NCT01217515|3822874|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4002847|NCT01217515|3822875|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4002848|NCT01217515|3822872|B4||Between 18 and 65 years|Age||Participants|Count of Participants|440|440.0||||||
4002849|NCT01217515|3822873|B3||Between 18 and 65 years|Age||Participants|Count of Participants|149|149.0||||||
4002850|NCT01217515|3822874|B2||Between 18 and 65 years|Age||Participants|Count of Participants|146|146.0||||||
4002851|NCT01217515|3822875|B1||Between 18 and 65 years|Age||Participants|Count of Participants|145|145.0||||||
4002852|NCT01217515|3822872|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002853|NCT01217515|3822873|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002854|NCT01217515|3822874|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002855|NCT01217515|3822875|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002856|NCT01217476|3822891|B3|||BMI||kg/m2|Mean|30.25|30.25|Standard Deviation|5.02|5.02|||
4002857|NCT01217476|3822892|B2|||BMI||kg/m2|Mean|30.31|30.31|Standard Deviation|4.92|4.92|||
4002858|NCT01217476|3822893|B1|||BMI||kg/m2|Mean|30.19|30.19|Standard Deviation|5.15|5.15|||
4002859|NCT01217476|3822891|B3|||Peripheral blood perfusion Normal||participants|Number|174|174.0||||||
4002860|NCT01217476|3822892|B2|||Peripheral blood perfusion Normal||participants|Number|86|86.0||||||
4002861|NCT01217476|3822893|B1|||Peripheral blood perfusion Normal||participants|Number|88|88.0||||||
4002862|NCT01217476|3822891|B3|||Peripheral blood perfusion Impaired||participants|Number|33|33.0||||||
4002863|NCT01217476|3822892|B2|||Peripheral blood perfusion Impaired||participants|Number|16|16.0||||||
4002864|NCT01217476|3822893|B1|||Peripheral blood perfusion Impaired||participants|Number|17|17.0||||||
4002865|NCT01217476|3822891|B3|||Wound size >5cm^2||participants|Number|46|46.0||||||
4002866|NCT01217476|3822892|B2|||Wound size >5cm^2||participants|Number|22|22.0||||||
4002867|NCT01217476|3822893|B1|||Wound size >5cm^2||participants|Number|24|24.0||||||
4002868|NCT01217476|3822891|B3|||Wound size ≤5cm^2||participants|Number|161|161.0||||||
4002869|NCT01217476|3822892|B2|||Wound size ≤5cm^2||participants|Number|80|80.0||||||
4002870|NCT01217476|3822893|B1|||Wound size ≤5cm^2||participants|Number|81|81.0||||||
4002871|NCT01217476|3822891|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4002872|NCT01217476|3822892|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002873|NCT01217476|3822893|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4002874|NCT01217476|3822891|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002875|NCT01217476|3822892|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002876|NCT01217476|3822893|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002877|NCT01217476|3822891|B3||White|Race (NIH/OMB)||Participants|Count of Participants|206|206.0||||||
4002878|NCT01217476|3822892|B2||White|Race (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
4002879|NCT01217476|3822893|B1||White|Race (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
4002880|NCT01217476|3822891|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002881|NCT01217476|3822892|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002882|NCT01217476|3822893|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002883|NCT01217476|3822891|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002884|NCT01217476|3822892|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002885|NCT01217476|3822893|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002886|NCT01217476|3822891|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002887|NCT01217476|3822892|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002888|NCT01217476|3822893|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002889|NCT01217476|3822891|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002890|NCT01217476|3822892|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002891|NCT01217476|3822893|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002892|NCT01217476|3822891|B3||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4002893|NCT01217476|3822892|B2||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4002894|NCT01217476|3822893|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4002895|NCT01217476|3822891|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4002896|NCT01217476|3822892|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4002897|NCT01217476|3822893|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4002898|NCT01217476|3822891|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|9.7|9.7|||
4002899|NCT01217476|3822892|B2|||Age||years|Mean|59.4|59.4|Standard Deviation|10.4|10.4|||
4002900|NCT01217476|3822893|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|9.0|9.0|||
4002901|NCT01217463|3822902|B3|||BMI||Kg/m2|Mean|30.78|30.78|Standard Deviation|4.71|4.71|||
4002902|NCT01217463|3822903|B2|||BMI||Kg/m2|Mean|30.65|30.65|Standard Deviation|5.00|5.0|||
4002903|NCT01217463|3822904|B1|||BMI||Kg/m2|Mean|30.91|30.91|Standard Deviation|4.42|4.42|||
4002904|NCT01217463|3822902|B3|||Peripheral blood perfusion Normal||participants|Number|127|127.0||||||
4002905|NCT01217463|3822903|B2|||Peripheral blood perfusion Normal||participants|Number|64|64.0||||||
4002906|NCT01217463|3822904|B1|||Peripheral blood perfusion Normal||participants|Number|63|63.0||||||
4002907|NCT01217463|3822902|B3|||Peripheral blood perfusion Impaired||participants|Number|74|74.0||||||
4002908|NCT01217463|3822903|B2|||Peripheral blood perfusion Impaired||participants|Number|38|38.0||||||
4002909|NCT01217463|3822904|B1|||Peripheral blood perfusion Impaired||participants|Number|36|36.0||||||
4002910|NCT01217463|3822902|B3|||Wound size >5cm^2||participants|Number|44|44.0||||||
4002911|NCT01217463|3822903|B2|||Wound size >5cm^2||participants|Number|22|22.0||||||
4002912|NCT01217463|3822904|B1|||Wound size >5cm^2||participants|Number|22|22.0||||||
4002913|NCT01217463|3822902|B3|||Wound size ≤5cm^2||participants|Number|157|157.0||||||
4002914|NCT01217463|3822903|B2|||Wound size ≤5cm^2||participants|Number|80|80.0||||||
4002915|NCT01217463|3822904|B1|||Wound size ≤5cm^2||participants|Number|77|77.0||||||
4002916|NCT01217463|3822902|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4002917|NCT01217463|3822903|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4002918|NCT01217463|3822904|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002919|NCT01217463|3822902|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002920|NCT01217463|3822903|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002921|NCT01217463|3822904|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002922|NCT01217463|3822902|B3||White|Race (NIH/OMB)||Participants|Count of Participants|199|199.0||||||
4002923|NCT01217463|3822903|B2||White|Race (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
4002924|NCT01217463|3822904|B1||White|Race (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
4002925|NCT01217463|3822902|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002926|NCT01217463|3822903|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002927|NCT01217463|3822904|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002928|NCT01217463|3822902|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002929|NCT01217463|3822903|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002930|NCT01217463|3822904|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002931|NCT01217463|3822902|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002932|NCT01217463|3822903|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002933|NCT01217463|3822904|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002934|NCT01217463|3822902|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002935|NCT01217463|3822903|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002936|NCT01217463|3822904|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4002937|NCT01217463|3822902|B3||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4002938|NCT01217463|3822903|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4002939|NCT01217463|3822904|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4002940|NCT01217463|3822902|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4002941|NCT01217463|3822903|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4002942|NCT01217463|3822904|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4002943|NCT01217463|3822902|B3|||Age||years|Mean|61.9|61.9|Standard Deviation|9.6|9.6|||
4002944|NCT01217463|3822903|B2|||Age||years|Mean|61.7|61.7|Standard Deviation|9.4|9.4|||
4002945|NCT01217463|3822904|B1|||Age||years|Mean|62.0|62.0|Standard Deviation|10.0|10.0|||
4002946|NCT01217411|3822913|B4|United States||Region of Enrollment||participants|Number|5|5.0||||||
4002947|NCT01217411|3822916|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4002948|NCT01217411|3822913|B4|Male||Gender||participants|Number|4|4.0||||||
4002949|NCT01217411|3822916|B1|Male||Gender||participants|Number|4|4.0||||||
4002950|NCT01217411|3822913|B4|Female||Gender||participants|Number|1|1.0||||||
4002951|NCT01217411|3822916|B1|Female||Gender||participants|Number|1|1.0||||||
4002952|NCT01217411|3822913|B4|||Age||years|Median|49|49.0|Full Range|||30.0|56.0|
4002953|NCT01217411|3822916|B1|||Age||years|Median|49|49.0|Full Range|||30.0|56.0|
4002954|NCT01217307|3822923|B3||Male|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
4002955|NCT01217307|3822924|B2||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4002956|NCT01217307|3822925|B1||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4002957|NCT01217307|3822923|B3||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4002958|NCT01217307|3822924|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4002959|NCT01217307|3822925|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4002960|NCT01217307|3822923|B3|||Age||years|Mean|58.8|58.8|Standard Deviation|11.6|11.6|||
4002961|NCT01217307|3822924|B2|||Age||years|Mean|58.8|58.8|Standard Deviation|11.5|11.5|||
4002962|NCT01217307|3822925|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|11.8|11.8|||
4002963|NCT01217229|3822932|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4002964|NCT01217229|3822932|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4002965|NCT01217229|3822932|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4002966|NCT01217229|3822932|B1|||Age||years|Mean|40.9|40.9|Standard Deviation|19.05|19.05|||
4002967|NCT01217229|3822932|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4002968|NCT01217229|3822932|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4002969|NCT01217229|3822932|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4002970|NCT01217112|3822936|B6|United Kingdom||Region of Enrollment||participants|Number|62|62.0||||||
4002971|NCT01217112|3822937|B5|United Kingdom||Region of Enrollment||participants|Number|14|14.0||||||
4002972|NCT01217112|3822938|B4|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
4002973|NCT01217112|3822939|B3|United Kingdom||Region of Enrollment||participants|Number|13|13.0||||||
4002974|NCT01217112|3822940|B2|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
4002975|NCT01217112|3822941|B1|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
4002976|NCT01217112|3822936|B6||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4002977|NCT01217112|3822937|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4002978|NCT01217112|3822938|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4002979|NCT01217112|3822939|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4002980|NCT01217112|3822940|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4002981|NCT01217112|3822941|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4002982|NCT01217112|3822936|B6||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4002983|NCT01217112|3822937|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4002984|NCT01217112|3822938|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4002985|NCT01217112|3822939|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4002986|NCT01217112|3822940|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4002987|NCT01217112|3822941|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4002988|NCT01217112|3822936|B6|||Age||years|Mean|58.98|58.98|Standard Deviation|9.41|9.41|||
4002989|NCT01217112|3822937|B5|||Age||years|Mean|58.63|58.63|Standard Deviation|7.72|7.72|||
4002990|NCT01217112|3822938|B4|||Age||years|Mean|62.45|62.45|Standard Deviation|12.58|12.58|||
4002991|NCT01217112|3822939|B3|||Age||years|Mean|56.80|56.8|Standard Deviation|9.92|9.92|||
4002992|NCT01217112|3822940|B2|||Age||years|Mean|57.96|57.96|Standard Deviation|8.11|8.11|||
4002993|NCT01217112|3822941|B1|||Age||years|Mean|59.33|59.33|Standard Deviation|8.75|8.75|||
4002994|NCT01217112|3822936|B6||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4002995|NCT01217112|3822937|B5||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4002996|NCT01217112|3822938|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4002997|NCT01217112|3822939|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4002998|NCT01217112|3822940|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4002999|NCT01217112|3822941|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4003000|NCT01217112|3822936|B6||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4003001|NCT01217112|3822937|B5||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4003002|NCT01217112|3822938|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4003003|NCT01217112|3822939|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4003004|NCT01217112|3822940|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4003005|NCT01217112|3822941|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4003006|NCT01217112|3822936|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4003007|NCT01217112|3822937|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4003008|NCT01217112|3822938|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4003009|NCT01217112|3822939|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4003010|NCT01217112|3822940|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4003011|NCT01217112|3822941|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4003012|NCT01217073|3823172|B7|||Fasting plasma glucose (FPG)|Participants with data: Omariglptin 0.25 mg, n=113; Omariglptin 1 mg, n=115; Omariglptin 3 mg, n=114; Omariglptin 10 mg, n=115; Omariglptin 25 mg, n=114; Placebo, n=113; Total, n=684|mg/dL|Mean|170.2|170.2|Standard Deviation|43.0|43.0|||
4003013|NCT01217073|3823173|B6|||Fasting plasma glucose (FPG)|Participants with data: Omariglptin 0.25 mg, n=113; Omariglptin 1 mg, n=115; Omariglptin 3 mg, n=114; Omariglptin 10 mg, n=115; Omariglptin 25 mg, n=114; Placebo, n=113; Total, n=684|mg/dL|Mean|171.9|171.9|Standard Deviation|42.8|42.8|||
4003014|NCT01217073|3823174|B5|||Fasting plasma glucose (FPG)|Participants with data: Omariglptin 0.25 mg, n=113; Omariglptin 1 mg, n=115; Omariglptin 3 mg, n=114; Omariglptin 10 mg, n=115; Omariglptin 25 mg, n=114; Placebo, n=113; Total, n=684|mg/dL|Mean|173.9|173.9|Standard Deviation|47.6|47.6|||
4003015|NCT01217073|3823175|B4|||Fasting plasma glucose (FPG)|Participants with data: Omariglptin 0.25 mg, n=113; Omariglptin 1 mg, n=115; Omariglptin 3 mg, n=114; Omariglptin 10 mg, n=115; Omariglptin 25 mg, n=114; Placebo, n=113; Total, n=684|mg/dL|Mean|166.8|166.8|Standard Deviation|37.6|37.6|||
4003016|NCT01217073|3823176|B3|||Fasting plasma glucose (FPG)|Participants with data: Omariglptin 0.25 mg, n=113; Omariglptin 1 mg, n=115; Omariglptin 3 mg, n=114; Omariglptin 10 mg, n=115; Omariglptin 25 mg, n=114; Placebo, n=113; Total, n=684|mg/dL|Mean|169.0|169.0|Standard Deviation|42.6|42.6|||
4003017|NCT01217073|3823177|B2|||Fasting plasma glucose (FPG)|Participants with data: Omariglptin 0.25 mg, n=113; Omariglptin 1 mg, n=115; Omariglptin 3 mg, n=114; Omariglptin 10 mg, n=115; Omariglptin 25 mg, n=114; Placebo, n=113; Total, n=684|mg/dL|Mean|169.4|169.4|Standard Deviation|42.4|42.4|||
4003018|NCT01217073|3823178|B1|||Fasting plasma glucose (FPG)|Participants with data: Omariglptin 0.25 mg, n=113; Omariglptin 1 mg, n=115; Omariglptin 3 mg, n=114; Omariglptin 10 mg, n=115; Omariglptin 25 mg, n=114; Placebo, n=113; Total, n=684|mg/dL|Mean|170.3|170.3|Standard Deviation|45.3|45.3|||
4003019|NCT01217073|3823172|B7|||2-hour post meal glucose (2-hr PMG)|Participants with data: Omariglptin 0.25 mg, n=111; Omariglptin 1 mg, n=113; Omariglptin 3 mg, n=113; Omariglptin 10 mg, n=112; Omariglptin 25 mg, n=111; Placebo, n=110; Total, n=670|mg/dL|Mean|235.2|235.2|Standard Deviation|73.2|73.2|||
4003020|NCT01217073|3823173|B6|||2-hour post meal glucose (2-hr PMG)|Participants with data: Omariglptin 0.25 mg, n=111; Omariglptin 1 mg, n=113; Omariglptin 3 mg, n=113; Omariglptin 10 mg, n=112; Omariglptin 25 mg, n=111; Placebo, n=110; Total, n=670|mg/dL|Mean|241.4|241.4|Standard Deviation|72.2|72.2|||
4003021|NCT01217073|3823174|B5|||2-hour post meal glucose (2-hr PMG)|Participants with data: Omariglptin 0.25 mg, n=111; Omariglptin 1 mg, n=113; Omariglptin 3 mg, n=113; Omariglptin 10 mg, n=112; Omariglptin 25 mg, n=111; Placebo, n=110; Total, n=670|mg/dL|Mean|245.3|245.3|Standard Deviation|82.7|82.7|||
4003022|NCT01217073|3823175|B4|||2-hour post meal glucose (2-hr PMG)|Participants with data: Omariglptin 0.25 mg, n=111; Omariglptin 1 mg, n=113; Omariglptin 3 mg, n=113; Omariglptin 10 mg, n=112; Omariglptin 25 mg, n=111; Placebo, n=110; Total, n=670|mg/dL|Mean|231.6|231.6|Standard Deviation|72.3|72.3|||
4003023|NCT01217073|3823176|B3|||2-hour post meal glucose (2-hr PMG)|Participants with data: Omariglptin 0.25 mg, n=111; Omariglptin 1 mg, n=113; Omariglptin 3 mg, n=113; Omariglptin 10 mg, n=112; Omariglptin 25 mg, n=111; Placebo, n=110; Total, n=670|mg/dL|Mean|234.7|234.7|Standard Deviation|81.7|81.7|||
4003024|NCT01217073|3823177|B2|||2-hour post meal glucose (2-hr PMG)|Participants with data: Omariglptin 0.25 mg, n=111; Omariglptin 1 mg, n=113; Omariglptin 3 mg, n=113; Omariglptin 10 mg, n=112; Omariglptin 25 mg, n=111; Placebo, n=110; Total, n=670|mg/dL|Mean|229.3|229.3|Standard Deviation|64.5|64.5|||
4003025|NCT01217073|3823178|B1|||2-hour post meal glucose (2-hr PMG)|Participants with data: Omariglptin 0.25 mg, n=111; Omariglptin 1 mg, n=113; Omariglptin 3 mg, n=113; Omariglptin 10 mg, n=112; Omariglptin 25 mg, n=111; Placebo, n=110; Total, n=670|mg/dL|Mean|229.4|229.4|Standard Deviation|63.7|63.7|||
4003026|NCT01217073|3823172|B7|||Hemoglobin A1c (A1C)|Participants with data: Omariglptin 0.25 mg, n=113; Omariglptin 1 mg, n=115; Omariglptin 3 mg, n=114; Omariglptin 10 mg, n=115; Omariglptin 25 mg, n=113; Placebo, n=113; Total, n=683|Percent|Mean|8.1|8.1|Standard Deviation|0.9|0.9|||
4003027|NCT01217073|3823173|B6|||Hemoglobin A1c (A1C)|Participants with data: Omariglptin 0.25 mg, n=113; Omariglptin 1 mg, n=115; Omariglptin 3 mg, n=114; Omariglptin 10 mg, n=115; Omariglptin 25 mg, n=113; Placebo, n=113; Total, n=683|Percent|Mean|8.1|8.1|Standard Deviation|0.9|0.9|||
4003028|NCT01217073|3823174|B5|||Hemoglobin A1c (A1C)|Participants with data: Omariglptin 0.25 mg, n=113; Omariglptin 1 mg, n=115; Omariglptin 3 mg, n=114; Omariglptin 10 mg, n=115; Omariglptin 25 mg, n=113; Placebo, n=113; Total, n=683|Percent|Mean|8.1|8.1|Standard Deviation|1.0|1.0|||
4003029|NCT01217073|3823175|B4|||Hemoglobin A1c (A1C)|Participants with data: Omariglptin 0.25 mg, n=113; Omariglptin 1 mg, n=115; Omariglptin 3 mg, n=114; Omariglptin 10 mg, n=115; Omariglptin 25 mg, n=113; Placebo, n=113; Total, n=683|Percent|Mean|8.0|8.0|Standard Deviation|0.9|0.9|||
4003030|NCT01217073|3823176|B3|||Hemoglobin A1c (A1C)|Participants with data: Omariglptin 0.25 mg, n=113; Omariglptin 1 mg, n=115; Omariglptin 3 mg, n=114; Omariglptin 10 mg, n=115; Omariglptin 25 mg, n=113; Placebo, n=113; Total, n=683|Percent|Mean|7.9|7.9|Standard Deviation|0.9|0.9|||
4003031|NCT01217073|3823177|B2|||Hemoglobin A1c (A1C)|Participants with data: Omariglptin 0.25 mg, n=113; Omariglptin 1 mg, n=115; Omariglptin 3 mg, n=114; Omariglptin 10 mg, n=115; Omariglptin 25 mg, n=113; Placebo, n=113; Total, n=683|Percent|Mean|8.0|8.0|Standard Deviation|0.9|0.9|||
4003032|NCT01217073|3823178|B1|||Hemoglobin A1c (A1C)|Participants with data: Omariglptin 0.25 mg, n=113; Omariglptin 1 mg, n=115; Omariglptin 3 mg, n=114; Omariglptin 10 mg, n=115; Omariglptin 25 mg, n=113; Placebo, n=113; Total, n=683|Percent|Mean|8.1|8.1|Standard Deviation|0.9|0.9|||
4003033|NCT01217073|3823172|B7||Male|Sex: Female, Male||Participants|Count of Participants|387|387.0||||||
4003034|NCT01217073|3823173|B6||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4003035|NCT01217073|3823174|B5||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4003036|NCT01217073|3823175|B4||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4003037|NCT01217073|3823176|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4003038|NCT01217073|3823177|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4003039|NCT01217073|3823178|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4003040|NCT01217073|3823172|B7||Female|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
4003041|NCT01217073|3823173|B6||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4003042|NCT01217073|3823174|B5||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4003043|NCT01217073|3823175|B4||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4003044|NCT01217073|3823176|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4003045|NCT01217073|3823177|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4003046|NCT01217073|3823178|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4003047|NCT01217073|3823172|B7|||Age||Years|Mean|55.1|55.1|Standard Deviation|8.8|8.8|||
4003048|NCT01217073|3823173|B6|||Age||Years|Mean|55.9|55.9|Standard Deviation|8.4|8.4|||
4003049|NCT01217073|3823174|B5|||Age||Years|Mean|55.1|55.1|Standard Deviation|8.5|8.5|||
4003050|NCT01217073|3823175|B4|||Age||Years|Mean|54.4|54.4|Standard Deviation|10.0|10.0|||
4003051|NCT01217073|3823176|B3|||Age||Years|Mean|55.3|55.3|Standard Deviation|8.5|8.5|||
4003052|NCT01217073|3823177|B2|||Age||Years|Mean|55.7|55.7|Standard Deviation|8.5|8.5|||
4003053|NCT01217073|3823178|B1|||Age||Years|Mean|54.3|54.3|Standard Deviation|8.9|8.9|||
4003054|NCT01216943|3823253|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4003055|NCT01216943|3823253|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4003056|NCT01216943|3823253|B1|>65 years||Age, Customized||Participants|Number|31|31.0||||||
4003057|NCT01216943|3823253|B1|45 to 65 years||Age, Customized||Participants|Number|84|84.0||||||
4003058|NCT01216943|3823253|B1|<45 years||Age, Customized||Participants|Number|11|11.0||||||
4003059|NCT01216761|3823257|B1|Unknown||Sex/Gender, Customized|Gender data were not collected for this study|participants|Number|3879|3879.0||||||
4003060|NCT01216761|3823257|B1|Female||Sex/Gender, Customized|Gender data were not collected for this study|participants|Number|0|0.0||||||
4003061|NCT01216761|3823257|B1|Male||Sex/Gender, Customized|Gender data were not collected for this study|participants|Number|0|0.0||||||
4003062|NCT01216761|3823257|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|17.9|17.9|||
4003063|NCT01216748|3823267|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4003064|NCT01216748|3823267|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4003065|NCT01216748|3823267|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4003066|NCT01216748|3823267|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4003067|NCT01216748|3823267|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4003068|NCT01216748|3823267|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4003069|NCT01216748|3823267|B1|||Age||years|Median|45|45.0|Full Range|||23.0|54.0|
4003070|NCT01216735|3823272|B3|||Airway blood flow (Qaw)||um/ml/ul|Mean|48.2|48.2|Standard Deviation|3.4|3.4|||
4003071|NCT01216735|3823273|B2|||Airway blood flow (Qaw)||um/ml/ul|Mean|46.2|46.2|Standard Deviation|3.5|3.5|||
4003072|NCT01216735|3823274|B1|||Airway blood flow (Qaw)||um/ml/ul|Mean|50.3|50.3|Standard Deviation|3.7|3.7|||
4003073|NCT01216735|3823272|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4003074|NCT01216735|3823273|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4003075|NCT01216735|3823274|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4003076|NCT01216735|3823272|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4003077|NCT01216735|3823273|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4003078|NCT01216735|3823274|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4003079|NCT01216735|3823272|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4003080|NCT01216735|3823273|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4003081|NCT01216735|3823274|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4003082|NCT01216735|3823272|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4003083|NCT01216735|3823273|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4003084|NCT01216735|3823274|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4003085|NCT01216735|3823272|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4003086|NCT01216735|3823273|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4003087|NCT01216735|3823274|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4003088|NCT01216735|3823272|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4003089|NCT01216735|3823273|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4003090|NCT01216735|3823274|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4003091|NCT01216735|3823272|B3|age||Age||years|Mean|42|42.0|Full Range|||32.0|58.0|
4003092|NCT01216735|3823273|B2|age||Age||years|Mean|38|38.0|Full Range|||32.0|54.0|
4003093|NCT01216735|3823274|B1|age||Age||years|Mean|44|44.0|Full Range|||36.0|58.0|
4003094|NCT01216631|3823283|B4|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4003095|NCT01216631|3823284|B3|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4003096|NCT01216631|3823283|B4|Male||Gender||participants|Number|1|1.0||||||
4003097|NCT01216631|3823284|B3|Male||Gender||participants|Number|1|1.0||||||
4003098|NCT01216631|3823283|B4|Female||Gender||participants|Number|0|0.0||||||
4003099|NCT01216631|3823284|B3|Female||Gender||participants|Number|0|0.0||||||
4003100|NCT01216631|3823283|B4|>=65 years||Age||participants|Number|0|0.0||||||
4003101|NCT01216631|3823284|B3|>=65 years||Age||participants|Number|0|0.0||||||
4003102|NCT01216631|3823283|B4|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
4003103|NCT01216631|3823284|B3|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
4003104|NCT01216631|3823283|B4|<=18 years||Age||participants|Number|0|0.0||||||
4003105|NCT01216631|3823284|B3|<=18 years||Age||participants|Number|0|0.0||||||
4003106|NCT01216410|3823296|B4|Canada||Region of Enrollment||participants|Number|141|141.0||||||
4003107|NCT01216410|3823297|B3|Canada||Region of Enrollment||participants|Number|45|45.0||||||
4003108|NCT01216410|3823298|B2|Canada||Region of Enrollment||participants|Number|48|48.0||||||
4003109|NCT01216410|3823299|B1|Canada||Region of Enrollment||participants|Number|48|48.0||||||
4003110|NCT01216410|3823296|B4|United States||Region of Enrollment||participants|Number|165|165.0||||||
4003111|NCT01216410|3823297|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
4003112|NCT01216410|3823298|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
4003113|NCT01216410|3823299|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4003114|NCT01216410|3823296|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4003115|NCT01216410|3823297|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4003116|NCT01216410|3823298|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4003117|NCT01216410|3823299|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4003118|NCT01216410|3823296|B4||Female|Sex: Female, Male||Participants|Count of Participants|306|306.0||||||
4003119|NCT01216410|3823297|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4003120|NCT01216410|3823298|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4003121|NCT01216410|3823299|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4003122|NCT01216410|3823296|B4|||Age||years|Mean|31|31.0|Standard Deviation|6|6.0|||
4003123|NCT01216410|3823297|B3|||Age||years|Mean|32|32.0|Standard Deviation|6|6.0|||
4003124|NCT01216410|3823298|B2|||Age||years|Mean|31|31.0|Standard Deviation|5|5.0|||
4003125|NCT01216410|3823299|B1|||Age||years|Mean|31|31.0|Standard Deviation|6|6.0|||
4003126|NCT01216410|3823296|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4003127|NCT01216410|3823297|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4003128|NCT01216410|3823298|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4003129|NCT01216410|3823299|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4003130|NCT01216410|3823296|B4||Between 18 and 65 years|Age||Participants|Count of Participants|306|306.0||||||
4003131|NCT01216410|3823297|B3||Between 18 and 65 years|Age||Participants|Count of Participants|103|103.0||||||
4003132|NCT01216410|3823298|B2||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4003133|NCT01216410|3823299|B1||Between 18 and 65 years|Age||Participants|Count of Participants|103|103.0||||||
4003134|NCT01216410|3823296|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4003135|NCT01216410|3823297|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4003136|NCT01216410|3823298|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4003137|NCT01216410|3823299|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4003138|NCT01216397|3823321|B1|||Body mass index||kg/m^2|Mean|23.74|23.74|Standard Deviation|2.74|2.74|||
4003139|NCT01216397|3823321|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4003140|NCT01216397|3823321|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4003141|NCT01216397|3823321|B1|||Age||Years|Mean|36.8|36.8|Standard Deviation|6.8|6.8|||
4003142|NCT01216319|3823374|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4003143|NCT01216319|3823374|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4003144|NCT01216319|3823374|B1|||Age||years|Mean|52|52.0|Standard Deviation|8.7|8.7|||
4003145|NCT01216241|3823379|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4003146|NCT01216241|3823380|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4003147|NCT01216241|3823381|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4003148|NCT01216241|3823379|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4003149|NCT01216241|3823380|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4003150|NCT01216241|3823381|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4003151|NCT01216241|3823379|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4003152|NCT01216241|3823380|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4003153|NCT01216241|3823381|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4003154|NCT01216241|3823379|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4003155|NCT01216241|3823380|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4003156|NCT01216241|3823381|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4003157|NCT01216241|3823379|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4003158|NCT01216241|3823380|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4003159|NCT01216241|3823381|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4003160|NCT01216241|3823379|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4003161|NCT01216241|3823380|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4003162|NCT01216241|3823381|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4003163|NCT01216163|3823388|B4|Severe||Number of Participants with Pain Severity Score|Pain severity score was assessed on a 4-point categorical scale. Total possible pain severity score range was 0 to 3, where 0 = none, 1 = mild, 2 = moderate and 3 = severe.|participants|Number|61|61.0||||||
4003164|NCT01216163|3823389|B3|Severe||Number of Participants with Pain Severity Score|Pain severity score was assessed on a 4-point categorical scale. Total possible pain severity score range was 0 to 3, where 0 = none, 1 = mild, 2 = moderate and 3 = severe.|participants|Number|25|25.0||||||
4003165|NCT01216163|3823390|B2|Severe||Number of Participants with Pain Severity Score|Pain severity score was assessed on a 4-point categorical scale. Total possible pain severity score range was 0 to 3, where 0 = none, 1 = mild, 2 = moderate and 3 = severe.|participants|Number|24|24.0||||||
4003166|NCT01216163|3823391|B1|Severe||Number of Participants with Pain Severity Score|Pain severity score was assessed on a 4-point categorical scale. Total possible pain severity score range was 0 to 3, where 0 = none, 1 = mild, 2 = moderate and 3 = severe.|participants|Number|12|12.0||||||
4003167|NCT01216163|3823388|B4|Moderate||Number of Participants with Pain Severity Score|Pain severity score was assessed on a 4-point categorical scale. Total possible pain severity score range was 0 to 3, where 0 = none, 1 = mild, 2 = moderate and 3 = severe.|participants|Number|157|157.0||||||
4003168|NCT01216163|3823389|B3|Moderate||Number of Participants with Pain Severity Score|Pain severity score was assessed on a 4-point categorical scale. Total possible pain severity score range was 0 to 3, where 0 = none, 1 = mild, 2 = moderate and 3 = severe.|participants|Number|60|60.0||||||
4003169|NCT01216163|3823390|B2|Moderate||Number of Participants with Pain Severity Score|Pain severity score was assessed on a 4-point categorical scale. Total possible pain severity score range was 0 to 3, where 0 = none, 1 = mild, 2 = moderate and 3 = severe.|participants|Number|64|64.0||||||
4003170|NCT01216163|3823391|B1|Moderate||Number of Participants with Pain Severity Score|Pain severity score was assessed on a 4-point categorical scale. Total possible pain severity score range was 0 to 3, where 0 = none, 1 = mild, 2 = moderate and 3 = severe.|participants|Number|33|33.0||||||
4003171|NCT01216163|3823388|B4||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4003172|NCT01216163|3823389|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4003173|NCT01216163|3823390|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4003174|NCT01216163|3823391|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4003175|NCT01216163|3823388|B4||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4003176|NCT01216163|3823389|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4003177|NCT01216163|3823390|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4003178|NCT01216163|3823391|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4003179|NCT01216163|3823388|B4|||Age||years|Mean|19.2|19.2|Standard Deviation|2.5|2.5|||
4003180|NCT01216163|3823389|B3|||Age||years|Mean|19.1|19.1|Standard Deviation|2.5|2.5|||
4003181|NCT01216163|3823390|B2|||Age||years|Mean|19.2|19.2|Standard Deviation|2.8|2.8|||
4003182|NCT01216163|3823391|B1|||Age||years|Mean|19.2|19.2|Standard Deviation|2.1|2.1|||
4003183|NCT01216072|3823443|B3||Male|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
4003184|NCT01216072|3823444|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4003185|NCT01216072|3823445|B1||Male|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4003186|NCT01216072|3823443|B3||Female|Sex: Female, Male||Participants|Count of Participants|809|809.0||||||
4003187|NCT01216072|3823444|B2||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4003188|NCT01216072|3823445|B1||Female|Sex: Female, Male||Participants|Count of Participants|601|601.0||||||
4003189|NCT01216072|3823443|B3|||Age||years|Mean|45.8|45.8|Standard Deviation|9.82|9.82|||
4003190|NCT01216072|3823444|B2|||Age||years|Mean|45.1|45.1|Standard Deviation|9.82|9.82|||
4003191|NCT01216072|3823445|B1|||Age||years|Mean|46|46.0|Standard Deviation|9.82|9.82|||
4003192|NCT01215981|3823472|B3|United States||Region of Enrollment||participants|Number|65|65.0||||||
4003193|NCT01215981|3823473|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
4003194|NCT01215981|3823474|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4003195|NCT01215981|3823472|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4003196|NCT01215981|3823473|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4003197|NCT01215981|3823474|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4003198|NCT01215981|3823472|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4003199|NCT01215981|3823473|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4003200|NCT01215981|3823474|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4003201|NCT01215981|3823472|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4003202|NCT01215981|3823473|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4003203|NCT01215981|3823474|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4003204|NCT01215981|3823472|B3||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4003205|NCT01215981|3823473|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4003206|NCT01215981|3823474|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4003207|NCT01215981|3823472|B3||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
4003208|NCT01215981|3823473|B2||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4003209|NCT01215981|3823474|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4003210|NCT01215968|3823483|B3|United Kingdom||Region of Enrollment||participants|Number|38|38.0||||||
4003211|NCT01215968|3823484|B2|United Kingdom||Region of Enrollment||participants|Number|25|25.0||||||
4003212|NCT01215968|3823485|B1|United Kingdom||Region of Enrollment||participants|Number|13|13.0||||||
4003213|NCT01215968|3823483|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003214|NCT01215968|3823484|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003215|NCT01215968|3823485|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003216|NCT01215968|3823483|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003217|NCT01215968|3823484|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003218|NCT01215968|3823485|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003219|NCT01215968|3823483|B3||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4003220|NCT01215968|3823484|B2||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4003221|NCT01215968|3823485|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4003222|NCT01215968|3823483|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003223|NCT01215968|3823484|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003224|NCT01215968|3823485|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003225|NCT01215968|3823483|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003226|NCT01215968|3823484|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003227|NCT01215968|3823485|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003228|NCT01215968|3823483|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4003229|NCT01215968|3823484|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4003230|NCT01215968|3823485|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4003231|NCT01215968|3823483|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003232|NCT01215968|3823484|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003233|NCT01215968|3823485|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003234|NCT01215968|3823483|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003235|NCT01215968|3823484|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003236|NCT01215968|3823485|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003237|NCT01215968|3823483|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4003238|NCT01215968|3823484|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4003239|NCT01215968|3823485|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4003240|NCT01215968|3823483|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003241|NCT01215968|3823484|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003242|NCT01215968|3823485|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003243|NCT01215968|3823483|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4003244|NCT01215968|3823484|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4003245|NCT01215968|3823485|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4003246|NCT01215968|3823483|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4003247|NCT01215968|3823484|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4003248|NCT01215968|3823485|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4003249|NCT01215968|3823483|B3|||Age||years|Mean|56.5|56.5|Standard Deviation|11.7|11.7|||
4003250|NCT01215968|3823484|B2|||Age||years|Mean|58.9|58.9|Standard Deviation|9.8|9.8|||
4003251|NCT01215968|3823485|B1|||Age||years|Mean|52.0|52.0|Standard Deviation|14.0|14.0|||
4003252|NCT01215955|3823502|B5|United States||Region of Enrollment||participants|Number|533|533.0||||||
4003253|NCT01215955|3823503|B4|United States||Region of Enrollment||participants|Number|127|127.0||||||
4003254|NCT01215955|3823504|B3|United States||Region of Enrollment||participants|Number|139|139.0||||||
4003255|NCT01215955|3823505|B2|United States||Region of Enrollment||participants|Number|136|136.0||||||
4003256|NCT01215955|3823506|B1|United States||Region of Enrollment||participants|Number|131|131.0||||||
4003257|NCT01215955|3823502|B5|South Africa||Region of Enrollment||participants|Number|27|27.0||||||
4003258|NCT01215955|3823503|B4|South Africa||Region of Enrollment||participants|Number|13|13.0||||||
4003259|NCT01215955|3823504|B3|South Africa||Region of Enrollment||participants|Number|11|11.0||||||
4003260|NCT01215955|3823505|B2|South Africa||Region of Enrollment||participants|Number|2|2.0||||||
4003261|NCT01215955|3823506|B1|South Africa||Region of Enrollment||participants|Number|1|1.0||||||
4003262|NCT01215955|3823502|B5|Russian Federation||Region of Enrollment||participants|Number|56|56.0||||||
4003263|NCT01215955|3823503|B4|Russian Federation||Region of Enrollment||participants|Number|16|16.0||||||
4003264|NCT01215955|3823504|B3|Russian Federation||Region of Enrollment||participants|Number|15|15.0||||||
4003265|NCT01215955|3823505|B2|Russian Federation||Region of Enrollment||participants|Number|13|13.0||||||
4003266|NCT01215955|3823506|B1|Russian Federation||Region of Enrollment||participants|Number|12|12.0||||||
4003267|NCT01215955|3823502|B5|Romania||Region of Enrollment||participants|Number|36|36.0||||||
4003268|NCT01215955|3823503|B4|Romania||Region of Enrollment||participants|Number|10|10.0||||||
4003269|NCT01215955|3823504|B3|Romania||Region of Enrollment||participants|Number|11|11.0||||||
4003270|NCT01215955|3823505|B2|Romania||Region of Enrollment||participants|Number|6|6.0||||||
4003271|NCT01215955|3823506|B1|Romania||Region of Enrollment||participants|Number|9|9.0||||||
4003272|NCT01215955|3823502|B5|Puerto Rico||Region of Enrollment||participants|Number|59|59.0||||||
4003273|NCT01215955|3823503|B4|Puerto Rico||Region of Enrollment||participants|Number|7|7.0||||||
4003274|NCT01215955|3823504|B3|Puerto Rico||Region of Enrollment||participants|Number|7|7.0||||||
4003275|NCT01215955|3823505|B2|Puerto Rico||Region of Enrollment||participants|Number|19|19.0||||||
4003276|NCT01215955|3823506|B1|Puerto Rico||Region of Enrollment||participants|Number|26|26.0||||||
4003277|NCT01215955|3823502|B5|Poland||Region of Enrollment||participants|Number|47|47.0||||||
4003278|NCT01215955|3823503|B4|Poland||Region of Enrollment||participants|Number|15|15.0||||||
4003279|NCT01215955|3823504|B3|Poland||Region of Enrollment||participants|Number|15|15.0||||||
4003280|NCT01215955|3823505|B2|Poland||Region of Enrollment||participants|Number|8|8.0||||||
4003281|NCT01215955|3823506|B1|Poland||Region of Enrollment||participants|Number|9|9.0||||||
4003282|NCT01215955|3823502|B5|Mexico||Region of Enrollment||participants|Number|108|108.0||||||
4003283|NCT01215955|3823503|B4|Mexico||Region of Enrollment||participants|Number|25|25.0||||||
4003284|NCT01215955|3823504|B3|Mexico||Region of Enrollment||participants|Number|21|21.0||||||
4003285|NCT01215955|3823505|B2|Mexico||Region of Enrollment||participants|Number|31|31.0||||||
4003286|NCT01215955|3823506|B1|Mexico||Region of Enrollment||participants|Number|31|31.0||||||
4003287|NCT01215955|3823502|B5|Lithuania||Region of Enrollment||participants|Number|15|15.0||||||
4003288|NCT01215955|3823503|B4|Lithuania||Region of Enrollment||participants|Number|5|5.0||||||
4003289|NCT01215955|3823504|B3|Lithuania||Region of Enrollment||participants|Number|4|4.0||||||
4003290|NCT01215955|3823505|B2|Lithuania||Region of Enrollment||participants|Number|4|4.0||||||
4003291|NCT01215955|3823506|B1|Lithuania||Region of Enrollment||participants|Number|2|2.0||||||
4003292|NCT01215955|3823502|B5|France||Region of Enrollment||participants|Number|7|7.0||||||
4003293|NCT01215955|3823503|B4|France||Region of Enrollment||participants|Number|3|3.0||||||
4003294|NCT01215955|3823504|B3|France||Region of Enrollment||participants|Number|1|1.0||||||
4003295|NCT01215955|3823505|B2|France||Region of Enrollment||participants|Number|0|0.0||||||
4003296|NCT01215955|3823506|B1|France||Region of Enrollment||participants|Number|3|3.0||||||
4003297|NCT01215955|3823502|B5|Denmark||Region of Enrollment||participants|Number|6|6.0||||||
4003298|NCT01215955|3823503|B4|Denmark||Region of Enrollment||participants|Number|0|0.0||||||
4003299|NCT01215955|3823504|B3|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
4003300|NCT01215955|3823505|B2|Denmark||Region of Enrollment||participants|Number|0|0.0||||||
4003301|NCT01215955|3823506|B1|Denmark||Region of Enrollment||participants|Number|5|5.0||||||
4003302|NCT01215955|3823502|B5|Croatia||Region of Enrollment||participants|Number|15|15.0||||||
4003303|NCT01215955|3823503|B4|Croatia||Region of Enrollment||participants|Number|5|5.0||||||
4003304|NCT01215955|3823504|B3|Croatia||Region of Enrollment||participants|Number|4|4.0||||||
4003305|NCT01215955|3823505|B2|Croatia||Region of Enrollment||participants|Number|3|3.0||||||
4003306|NCT01215955|3823506|B1|Croatia||Region of Enrollment||participants|Number|3|3.0||||||
4003307|NCT01215955|3823502|B5|Canada||Region of Enrollment||participants|Number|29|29.0||||||
4003308|NCT01215955|3823503|B4|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4003309|NCT01215955|3823504|B3|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4003310|NCT01215955|3823505|B2|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4003311|NCT01215955|3823506|B1|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4003312|NCT01215955|3823502|B5|Brazil||Region of Enrollment||participants|Number|31|31.0||||||
4003313|NCT01215955|3823503|B4|Brazil||Region of Enrollment||participants|Number|14|14.0||||||
4003314|NCT01215955|3823504|B3|Brazil||Region of Enrollment||participants|Number|11|11.0||||||
4003315|NCT01215955|3823505|B2|Brazil||Region of Enrollment||participants|Number|4|4.0||||||
4003316|NCT01215955|3823506|B1|Brazil||Region of Enrollment||participants|Number|2|2.0||||||
4003317|NCT01215955|3823502|B5|Austria||Region of Enrollment||participants|Number|6|6.0||||||
4003318|NCT01215955|3823503|B4|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4003319|NCT01215955|3823504|B3|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4003320|NCT01215955|3823505|B2|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4003321|NCT01215955|3823506|B1|Austria||Region of Enrollment||participants|Number|0|0.0||||||
4003322|NCT01215955|3823502|B5|Argentina||Region of Enrollment||participants|Number|131|131.0||||||
4003323|NCT01215955|3823503|B4|Argentina||Region of Enrollment||participants|Number|38|38.0||||||
4003324|NCT01215955|3823504|B3|Argentina||Region of Enrollment||participants|Number|37|37.0||||||
4003325|NCT01215955|3823505|B2|Argentina||Region of Enrollment||participants|Number|28|28.0||||||
4003326|NCT01215955|3823506|B1|Argentina||Region of Enrollment||participants|Number|28|28.0||||||
4003327|NCT01215955|3823502|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4003328|NCT01215955|3823503|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4003329|NCT01215955|3823504|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4003330|NCT01215955|3823505|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003331|NCT01215955|3823506|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4003332|NCT01215955|3823502|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4003333|NCT01215955|3823503|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4003334|NCT01215955|3823504|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4003335|NCT01215955|3823505|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4003336|NCT01215955|3823506|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4003337|NCT01215955|3823502|B5||White|Race (NIH/OMB)||Participants|Count of Participants|905|905.0||||||
4003338|NCT01215955|3823503|B4||White|Race (NIH/OMB)||Participants|Count of Participants|240|240.0||||||
4003339|NCT01215955|3823504|B3||White|Race (NIH/OMB)||Participants|Count of Participants|228|228.0||||||
4003340|NCT01215955|3823505|B2||White|Race (NIH/OMB)||Participants|Count of Participants|218|218.0||||||
4003341|NCT01215955|3823506|B1||White|Race (NIH/OMB)||Participants|Count of Participants|219|219.0||||||
4003342|NCT01215955|3823502|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
4003343|NCT01215955|3823503|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4003344|NCT01215955|3823504|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4003345|NCT01215955|3823505|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4003346|NCT01215955|3823506|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4003347|NCT01215955|3823502|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4003348|NCT01215955|3823503|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003349|NCT01215955|3823504|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003350|NCT01215955|3823505|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4003351|NCT01215955|3823506|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003352|NCT01215955|3823502|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4003353|NCT01215955|3823503|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4003354|NCT01215955|3823504|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4003355|NCT01215955|3823505|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4003356|NCT01215955|3823506|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4003357|NCT01215955|3823502|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4003358|NCT01215955|3823503|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4003359|NCT01215955|3823504|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4003360|NCT01215955|3823505|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4003361|NCT01215955|3823506|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4003362|NCT01215955|3823502|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4003363|NCT01215955|3823503|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4003364|NCT01215955|3823504|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4003365|NCT01215955|3823505|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4003366|NCT01215955|3823506|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4003367|NCT01215955|3823502|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|662|662.0||||||
4003368|NCT01215955|3823503|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|177|177.0||||||
4003369|NCT01215955|3823504|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|182|182.0||||||
4003370|NCT01215955|3823505|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|153|153.0||||||
4003371|NCT01215955|3823506|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|150|150.0||||||
4003372|NCT01215955|3823502|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|382|382.0||||||
4003373|NCT01215955|3823503|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
4003374|NCT01215955|3823504|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
4003375|NCT01215955|3823505|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4003376|NCT01215955|3823506|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
4003377|NCT01215955|3823502|B5||Male|Sex: Female, Male||Participants|Count of Participants|525|525.0||||||
4003378|NCT01215955|3823503|B4||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4003379|NCT01215955|3823504|B3||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4003380|NCT01215955|3823505|B2||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4003381|NCT01215955|3823506|B1||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4003382|NCT01215955|3823502|B5||Female|Sex: Female, Male||Participants|Count of Participants|581|581.0||||||
4003383|NCT01215955|3823503|B4||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4003384|NCT01215955|3823504|B3||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4003385|NCT01215955|3823505|B2||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4003386|NCT01215955|3823506|B1||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4003387|NCT01215955|3823502|B5|||Age||years|Mean|57.83|57.83|Standard Deviation|10.03|10.03|||
4003388|NCT01215955|3823503|B4|||Age||years|Mean|57.01|57.01|Standard Deviation|10.61|10.61|||
4003389|NCT01215955|3823504|B3|||Age||years|Mean|57.71|57.71|Standard Deviation|9.71|9.71|||
4003390|NCT01215955|3823505|B2|||Age||years|Mean|58.82|58.82|Standard Deviation|9.46|9.46|||
4003391|NCT01215955|3823506|B1|||Age||years|Mean|57.89|57.89|Standard Deviation|10.25|10.25|||
4003392|NCT01215942|3823575|B3|New Zealand||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4003393|NCT01215942|3823576|B2|New Zealand||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4003394|NCT01215942|3823577|B1|New Zealand||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4003395|NCT01215942|3823575|B3|Japan||Region of Enrollment||Participants|Count of Participants|116|116.0||||||
4003396|NCT01215942|3823576|B2|Japan||Region of Enrollment||Participants|Count of Participants|72|72.0||||||
4003397|NCT01215942|3823577|B1|Japan||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
4003398|NCT01215942|3823575|B3|Germany||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4003399|NCT01215942|3823576|B2|Germany||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4003400|NCT01215942|3823577|B1|Germany||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4003401|NCT01215942|3823575|B3|Bulgaria||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
4003402|NCT01215942|3823576|B2|Bulgaria||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4003403|NCT01215942|3823577|B1|Bulgaria||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4003404|NCT01215942|3823575|B3|Romania||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4003405|NCT01215942|3823576|B2|Romania||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4003406|NCT01215942|3823577|B1|Romania||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4003407|NCT01215942|3823575|B3|Croatia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4003408|NCT01215942|3823576|B2|Croatia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4003409|NCT01215942|3823577|B1|Croatia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4003410|NCT01215942|3823575|B3|Brazil||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4003411|NCT01215942|3823576|B2|Brazil||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4003412|NCT01215942|3823577|B1|Brazil||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4003413|NCT01215942|3823575|B3|Poland||Region of Enrollment||Participants|Count of Participants|78|78.0||||||
4003414|NCT01215942|3823576|B2|Poland||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
4003415|NCT01215942|3823577|B1|Poland||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
4003416|NCT01215942|3823575|B3|Argentina||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4003417|NCT01215942|3823576|B2|Argentina||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4003418|NCT01215942|3823577|B1|Argentina||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4003419|NCT01215942|3823575|B3|Mexico||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
4003420|NCT01215942|3823576|B2|Mexico||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4003421|NCT01215942|3823577|B1|Mexico||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4003422|NCT01215942|3823575|B3|Hungary||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4003423|NCT01215942|3823576|B2|Hungary||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4003424|NCT01215942|3823577|B1|Hungary||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4003425|NCT01215942|3823575|B3|Lithuania||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
4003426|NCT01215942|3823576|B2|Lithuania||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4003427|NCT01215942|3823577|B1|Lithuania||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4003428|NCT01215942|3823575|B3|South Korea||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
4003429|NCT01215942|3823576|B2|South Korea||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4003430|NCT01215942|3823577|B1|South Korea||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4003431|NCT01215942|3823575|B3|South Africa||Region of Enrollment||Participants|Count of Participants|82|82.0||||||
4003432|NCT01215942|3823576|B2|South Africa||Region of Enrollment||Participants|Count of Participants|59|59.0||||||
4003433|NCT01215942|3823577|B1|South Africa||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4003434|NCT01215942|3823575|B3|Australia||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4003435|NCT01215942|3823576|B2|Australia||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4003436|NCT01215942|3823577|B1|Australia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4003437|NCT01215942|3823575|B3|Malaysia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4003438|NCT01215942|3823576|B2|Malaysia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4003439|NCT01215942|3823577|B1|Malaysia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4003440|NCT01215942|3823575|B3|India||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4003441|NCT01215942|3823576|B2|India||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4003442|NCT01215942|3823577|B1|India||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4003443|NCT01215942|3823575|B3|Sri Lanka||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4003444|NCT01215942|3823576|B2|Sri Lanka||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4003445|NCT01215942|3823577|B1|Sri Lanka||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4003446|NCT01215942|3823575|B3|Colombia||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
4003447|NCT01215942|3823576|B2|Colombia||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4003448|NCT01215942|3823577|B1|Colombia||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4003449|NCT01215942|3823575|B3|Russia||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
4003450|NCT01215942|3823576|B2|Russia||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
4003451|NCT01215942|3823577|B1|Russia||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4003452|NCT01215942|3823575|B3|Ukraine||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
4003453|NCT01215942|3823576|B2|Ukraine||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
4003454|NCT01215942|3823577|B1|Ukraine||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4003455|NCT01215942|3823575|B3|Greece||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4003456|NCT01215942|3823576|B2|Greece||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4003457|NCT01215942|3823577|B1|Greece||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4003458|NCT01215942|3823575|B3|Slovakia||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4003459|NCT01215942|3823576|B2|Slovakia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4003460|NCT01215942|3823577|B1|Slovakia||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4003461|NCT01215942|3823575|B3|Taiwan||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4003462|NCT01215942|3823576|B2|Taiwan||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4003463|NCT01215942|3823577|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4003464|NCT01215942|3823575|B3|United States||Region of Enrollment||Participants|Count of Participants|442|442.0||||||
4003465|NCT01215942|3823576|B2|United States||Region of Enrollment||Participants|Count of Participants|294|294.0||||||
4003466|NCT01215942|3823577|B1|United States||Region of Enrollment||Participants|Count of Participants|148|148.0||||||
4003467|NCT01215942|3823575|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4003468|NCT01215942|3823576|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4003469|NCT01215942|3823577|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003470|NCT01215942|3823575|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4003471|NCT01215942|3823576|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4003472|NCT01215942|3823577|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4003473|NCT01215942|3823575|B3||White|Race (NIH/OMB)||Participants|Count of Participants|735|735.0||||||
4003474|NCT01215942|3823576|B2||White|Race (NIH/OMB)||Participants|Count of Participants|450|450.0||||||
4003475|NCT01215942|3823577|B1||White|Race (NIH/OMB)||Participants|Count of Participants|285|285.0||||||
4003476|NCT01215942|3823575|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4003477|NCT01215942|3823576|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4003478|NCT01215942|3823577|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4003479|NCT01215942|3823575|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4003480|NCT01215942|3823576|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4003481|NCT01215942|3823577|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4003482|NCT01215942|3823575|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|207|207.0||||||
4003483|NCT01215942|3823576|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
4003484|NCT01215942|3823577|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
4003485|NCT01215942|3823575|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4003486|NCT01215942|3823576|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4003487|NCT01215942|3823577|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4003488|NCT01215942|3823575|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|351|351.0||||||
4003489|NCT01215942|3823576|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|207|207.0||||||
4003490|NCT01215942|3823577|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
4003491|NCT01215942|3823575|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|583|583.0||||||
4003492|NCT01215942|3823576|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|365|365.0||||||
4003493|NCT01215942|3823577|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|218|218.0||||||
4003494|NCT01215942|3823575|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|152|152.0||||||
4003495|NCT01215942|3823576|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
4003496|NCT01215942|3823577|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4003497|NCT01215942|3823575|B3||Male|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4003498|NCT01215942|3823576|B2||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4003499|NCT01215942|3823577|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4003500|NCT01215942|3823575|B3||Female|Sex: Female, Male||Participants|Count of Participants|877|877.0||||||
4003501|NCT01215942|3823576|B2||Female|Sex: Female, Male||Participants|Count of Participants|538|538.0||||||
4003502|NCT01215942|3823577|B1||Female|Sex: Female, Male||Participants|Count of Participants|339|339.0||||||
4003503|NCT01215942|3823575|B3|||Age||years|Mean|52.6|52.6|Standard Deviation|11.4|11.4|||
4003504|NCT01215942|3823576|B2|||Age||years|Mean|52.4|52.4|Standard Deviation|11.7|11.7|||
4003505|NCT01215942|3823577|B1|||Age||years|Mean|52.9|52.9|Standard Deviation|10.9|10.9|||
4003506|NCT01215929|3823693|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
4003507|NCT01215929|3823694|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4003508|NCT01215929|3823695|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4003509|NCT01215929|3823693|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003510|NCT01215929|3823694|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003511|NCT01215929|3823695|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003512|NCT01215929|3823693|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003513|NCT01215929|3823694|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003514|NCT01215929|3823695|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003515|NCT01215929|3823693|B3||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4003516|NCT01215929|3823694|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4003517|NCT01215929|3823695|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4003518|NCT01215929|3823693|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003519|NCT01215929|3823694|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003520|NCT01215929|3823695|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003521|NCT01215929|3823693|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003522|NCT01215929|3823694|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003523|NCT01215929|3823695|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003524|NCT01215929|3823693|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003525|NCT01215929|3823694|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003526|NCT01215929|3823695|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003527|NCT01215929|3823693|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003528|NCT01215929|3823694|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003529|NCT01215929|3823695|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003530|NCT01215929|3823693|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4003531|NCT01215929|3823694|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4003532|NCT01215929|3823695|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4003533|NCT01215929|3823693|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4003534|NCT01215929|3823694|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4003535|NCT01215929|3823695|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4003536|NCT01215929|3823693|B3|||Age||years|Mean|35.36|35.36|Standard Deviation|8.86|8.86|||
4003537|NCT01215929|3823694|B2|||Age||years|Mean|33.67|33.67|Standard Deviation|6.34|6.34|||
4003538|NCT01215929|3823695|B1|||Age||years|Mean|41.00|41.0|Standard Deviation|9.76|9.76|||
4003539|NCT01215851|3823702|B7|South Africa||Region of Enrollment||participants|Number|85|85.0||||||
4003540|NCT01215851|3823703|B6|South Africa||Region of Enrollment||participants|Number|15|15.0||||||
4003541|NCT01215851|3823704|B5|South Africa||Region of Enrollment||participants|Number|10|10.0||||||
4003542|NCT01215851|3823705|B4|South Africa||Region of Enrollment||participants|Number|15|15.0||||||
4003543|NCT01215851|3823706|B3|South Africa||Region of Enrollment||participants|Number|15|15.0||||||
4003544|NCT01215851|3823707|B2|South Africa||Region of Enrollment||participants|Number|15|15.0||||||
4003545|NCT01215851|3823708|B1|South Africa||Region of Enrollment||participants|Number|15|15.0||||||
4003546|NCT01215851|3823702|B7||Male|Gender||Participants|Count of Participants|63|63.0||||||
4003547|NCT01215851|3823703|B6||Male|Gender||Participants|Count of Participants|11|11.0||||||
4003548|NCT01215851|3823704|B5||Male|Gender||Participants|Count of Participants|6|6.0||||||
4003549|NCT01215851|3823705|B4||Male|Gender||Participants|Count of Participants|12|12.0||||||
4003550|NCT01215851|3823706|B3||Male|Gender||Participants|Count of Participants|11|11.0||||||
4003551|NCT01215851|3823707|B2||Male|Gender||Participants|Count of Participants|12|12.0||||||
4003552|NCT01215851|3823708|B1||Male|Gender||Participants|Count of Participants|11|11.0||||||
4003553|NCT01215851|3823702|B7||Female|Gender||Participants|Count of Participants|22|22.0||||||
4003554|NCT01215851|3823703|B6||Female|Gender||Participants|Count of Participants|4|4.0||||||
4003555|NCT01215851|3823704|B5||Female|Gender||Participants|Count of Participants|4|4.0||||||
4003556|NCT01215851|3823705|B4||Female|Gender||Participants|Count of Participants|3|3.0||||||
4003557|NCT01215851|3823706|B3||Female|Gender||Participants|Count of Participants|4|4.0||||||
4003558|NCT01215851|3823707|B2||Female|Gender||Participants|Count of Participants|3|3.0||||||
4003559|NCT01215851|3823708|B1||Female|Gender||Participants|Count of Participants|4|4.0||||||
4003560|NCT01215851|3823702|B7|||Age||years|Mean|30.0|30.0|Standard Deviation|9.13|9.13|||
4003561|NCT01215851|3823703|B6|||Age||years|Mean|33.3|33.3|Standard Deviation|8.47|8.47|||
4003562|NCT01215851|3823704|B5|||Age||years|Mean|27.0|27.0|Standard Deviation|6.63|6.63|||
4003563|NCT01215851|3823705|B4|||Age||years|Mean|28.3|28.3|Standard Deviation|9.34|9.34|||
4003564|NCT01215851|3823706|B3|||Age||years|Mean|29.7|29.7|Standard Deviation|8.93|8.93|||
4003565|NCT01215851|3823707|B2|||Age||years|Mean|29.1|29.1|Standard Deviation|8.67|8.67|||
4003566|NCT01215851|3823708|B1|||Age||years|Mean|31.3|31.3|Standard Deviation|11.60|11.6|||
4003567|NCT01215851|3823702|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4003568|NCT01215851|3823703|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4003569|NCT01215851|3823704|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4003570|NCT01215851|3823705|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4003571|NCT01215851|3823706|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4003572|NCT01215851|3823707|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4003573|NCT01215851|3823708|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4003574|NCT01215851|3823702|B7||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
4003575|NCT01215851|3823703|B6||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4003576|NCT01215851|3823704|B5||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4003577|NCT01215851|3823705|B4||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4003578|NCT01215851|3823706|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4003579|NCT01215851|3823707|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4003580|NCT01215851|3823708|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4003581|NCT01215851|3823702|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4003582|NCT01215851|3823703|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4003583|NCT01215851|3823704|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4003584|NCT01215851|3823705|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4003585|NCT01215851|3823706|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4003586|NCT01215851|3823707|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4003587|NCT01215851|3823708|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4003588|NCT01215786|3823751|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4003589|NCT01215786|3823752|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4003590|NCT01215786|3823753|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4003591|NCT01215786|3823754|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4003592|NCT01215786|3823751|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4003593|NCT01215786|3823752|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4003594|NCT01215786|3823753|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4003595|NCT01215786|3823754|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4003596|NCT01215786|3823751|B4|>65 years||Age, Customized||participants|Number|33|33.0||||||
4003597|NCT01215786|3823752|B3|>65 years||Age, Customized||participants|Number|7|7.0||||||
4003598|NCT01215786|3823753|B2|>65 years||Age, Customized||participants|Number|12|12.0||||||
4003599|NCT01215786|3823754|B1|>65 years||Age, Customized||participants|Number|14|14.0||||||
4003600|NCT01215786|3823751|B4|Between 45 and 65 years||Age, Customized||participants|Number|16|16.0||||||
4003601|NCT01215786|3823752|B3|Between 45 and 65 years||Age, Customized||participants|Number|2|2.0||||||
4003602|NCT01215786|3823753|B2|Between 45 and 65 years||Age, Customized||participants|Number|7|7.0||||||
4003603|NCT01215786|3823754|B1|Between 45 and 65 years||Age, Customized||participants|Number|7|7.0||||||
4003604|NCT01215786|3823751|B4|<45 years||Age, Customized||participants|Number|1|1.0||||||
4003605|NCT01215786|3823752|B3|<45 years||Age, Customized||participants|Number|1|1.0||||||
4003606|NCT01215786|3823753|B2|<45 years||Age, Customized||participants|Number|0|0.0||||||
4003607|NCT01215786|3823754|B1|<45 years||Age, Customized||participants|Number|0|0.0||||||
4003608|NCT01215734|3823770|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
4003609|NCT01215734|3823771|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4003610|NCT01215734|3823772|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4003611|NCT01215734|3823770|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4003612|NCT01215734|3823771|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4003613|NCT01215734|3823772|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4003614|NCT01215734|3823770|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4003615|NCT01215734|3823771|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4003616|NCT01215734|3823772|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4003617|NCT01215734|3823770|B3|||Age||years|Mean|50|50.0|Standard Deviation|12|12.0|||
4003618|NCT01215734|3823771|B2|||Age||years|Mean|49|49.0|Standard Deviation|14|14.0|||
4003619|NCT01215734|3823772|B1|||Age||years|Mean|50|50.0|Standard Deviation|12|12.0|||
4003620|NCT01215734|3823770|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4003621|NCT01215734|3823771|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4003622|NCT01215734|3823772|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4003623|NCT01215734|3823770|B3||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4003624|NCT01215734|3823771|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4003625|NCT01215734|3823772|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4003626|NCT01215734|3823770|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4003627|NCT01215734|3823771|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4003628|NCT01215734|3823772|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4003629|NCT01215721|3823781|B1|||Severely Incontinent Men Post RARP|Only men who were experiencing severe incontinence were screened for possible enrollment on to the study. Men who were utilizing 3 or more pads at post-catheter day 6 or 7 were deemed severely incontinent, and were invited to participate int he trial.|Participants|Number|40|40.0||||||
4003630|NCT01215721|3823781|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4003631|NCT01215721|3823781|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4003632|NCT01215721|3823781|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4003633|NCT01215721|3823781|B1|||Age||years|Mean|64.5|64.5|Standard Deviation|7.3|7.3|||
4003634|NCT01215721|3823781|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4003635|NCT01215721|3823781|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4003636|NCT01215721|3823781|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4003637|NCT01215695|3823785|B3|United States||Region of Enrollment||participants|Number|140|140.0||||||
4003638|NCT01215695|3823786|B2|United States||Region of Enrollment||participants|Number|70|70.0||||||
4003639|NCT01215695|3823787|B1|United States||Region of Enrollment||participants|Number|70|70.0||||||
4003640|NCT01215695|3823785|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4003641|NCT01215695|3823786|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4003642|NCT01215695|3823787|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4003643|NCT01215695|3823785|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4003644|NCT01215695|3823786|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4003645|NCT01215695|3823787|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4003646|NCT01215695|3823785|B3|||Age||years|Mean|45|45.0|Standard Deviation|13|13.0|||
4003647|NCT01215695|3823786|B2|||Age||years|Mean|46|46.0|Standard Deviation|14|14.0|||
4003648|NCT01215695|3823787|B1|||Age||years|Mean|45|45.0|Standard Deviation|13|13.0|||
4003649|NCT01215643|3823802|B6||Male|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
4003650|NCT01215643|3823803|B5||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4003651|NCT01215643|3823804|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4003652|NCT01215643|3823805|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4003653|NCT01215643|3823806|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4003654|NCT01215643|3823807|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4003655|NCT01215643|3823802|B6||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4003656|NCT01215643|3823803|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4003657|NCT01215643|3823804|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4003658|NCT01215643|3823805|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4003659|NCT01215643|3823806|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4003660|NCT01215643|3823807|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4003661|NCT01215643|3823802|B6|||Age||years|Mean|41.8|41.8|Standard Deviation|11.25|11.25|||
4003662|NCT01215643|3823803|B5|||Age||years|Mean|39.9|39.9|Standard Deviation|11.20|11.2|||
4003663|NCT01215643|3823804|B4|||Age||years|Mean|43.2|43.2|Standard Deviation|10.56|10.56|||
4003664|NCT01215643|3823805|B3|||Age||years|Mean|42.6|42.6|Standard Deviation|11.00|11.0|||
4003665|NCT01215643|3823806|B2|||Age||years|Mean|42.8|42.8|Standard Deviation|11.77|11.77|||
4003666|NCT01215643|3823807|B1|||Age||years|Mean|40.2|40.2|Standard Deviation|11.27|11.27|||
4003667|NCT01215513|3823913|B1|Korea, Republic of||Region of Enrollment||participants|Number|156|156.0||||||
4003668|NCT01215513|3823913|B1||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4003669|NCT01215513|3823913|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4003670|NCT01215513|3823913|B1|||Age||years|Mean|72.6|72.6|Standard Deviation|8.06|8.06|||
4003671|NCT01215435|3823920|B3|||Fasting plasma glucose (FPG)||mg/dL|Mean|196.0|196.0|Standard Deviation|66.16|66.16|||
4003672|NCT01215435|3823921|B2|||Fasting plasma glucose (FPG)||mg/dL|Mean|199.3|199.3|Standard Deviation|63.80|63.8|||
4003673|NCT01215435|3823922|B1|||Fasting plasma glucose (FPG)||mg/dL|Mean|192.7|192.7|Standard Deviation|68.56|68.56|||
4003674|NCT01215435|3823920|B3|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|9.2|9.2|Standard Deviation|1.04|1.04|||
4003675|NCT01215435|3823921|B2|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|9.2|9.2|Standard Deviation|1.00|1.0|||
4003676|NCT01215435|3823922|B1|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|9.1|9.1|Standard Deviation|1.07|1.07|||
4003677|NCT01215435|3823920|B3||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4003678|NCT01215435|3823921|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4003679|NCT01215435|3823922|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4003680|NCT01215435|3823920|B3||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4003681|NCT01215435|3823921|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4003682|NCT01215435|3823922|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4003683|NCT01215435|3823920|B3|||Age||years|Mean|55.2|55.2|Standard Deviation|9.82|9.82|||
4003684|NCT01215435|3823921|B2|||Age||years|Mean|54.8|54.8|Standard Deviation|10.32|10.32|||
4003685|NCT01215435|3823922|B1|||Age||years|Mean|55.6|55.6|Standard Deviation|9.32|9.32|||
4003686|NCT01215422|3823933|B5|Female||Sex/Gender, Customized|Gender of the children was not recorded as it was not thought to be of relevance for intubation participants.|participants|Number|7|7.0||||||
4003687|NCT01215422|3823934|B4|Female||Sex/Gender, Customized|Gender of the children was not recorded as it was not thought to be of relevance for intubation participants.|participants|Number|0|0.0||||||
4003688|NCT01215422|3823935|B3|Female||Sex/Gender, Customized|Gender of the children was not recorded as it was not thought to be of relevance for intubation participants.|participants|Number|0|0.0||||||
4003689|NCT01215422|3823936|B2|Female||Sex/Gender, Customized|Gender of the children was not recorded as it was not thought to be of relevance for intubation participants.|participants|Number|0|0.0||||||
4003690|NCT01215422|3823937|B1|Female||Sex/Gender, Customized|Gender of the children was not recorded as it was not thought to be of relevance for intubation participants.|participants|Number|7|7.0||||||
4003691|NCT01215422|3823933|B5|Male||Sex/Gender, Customized|Gender of the children was not recorded as it was not thought to be of relevance for intubation participants.|participants|Number|6|6.0||||||
4003692|NCT01215422|3823934|B4|Male||Sex/Gender, Customized|Gender of the children was not recorded as it was not thought to be of relevance for intubation participants.|participants|Number|0|0.0||||||
4003693|NCT01215422|3823935|B3|Male||Sex/Gender, Customized|Gender of the children was not recorded as it was not thought to be of relevance for intubation participants.|participants|Number|0|0.0||||||
4003694|NCT01215422|3823936|B2|Male||Sex/Gender, Customized|Gender of the children was not recorded as it was not thought to be of relevance for intubation participants.|participants|Number|0|0.0||||||
4003695|NCT01215422|3823937|B1|Male||Sex/Gender, Customized|Gender of the children was not recorded as it was not thought to be of relevance for intubation participants.|participants|Number|6|6.0||||||
4003696|NCT01215422|3823933|B5|Unknown||Sex/Gender, Customized|Gender of the children was not recorded as it was not thought to be of relevance for intubation participants.|participants|Number|646|646.0||||||
4003697|NCT01215422|3823934|B4|Unknown||Sex/Gender, Customized|Gender of the children was not recorded as it was not thought to be of relevance for intubation participants.|participants|Number|201|201.0||||||
4003698|NCT01215422|3823935|B3|Unknown||Sex/Gender, Customized|Gender of the children was not recorded as it was not thought to be of relevance for intubation participants.|participants|Number|196|196.0||||||
4003699|NCT01215422|3823936|B2|Unknown||Sex/Gender, Customized|Gender of the children was not recorded as it was not thought to be of relevance for intubation participants.|participants|Number|249|249.0||||||
4003700|NCT01215422|3823937|B1|Unknown||Sex/Gender, Customized|Gender of the children was not recorded as it was not thought to be of relevance for intubation participants.|participants|Number|0|0.0||||||
4003701|NCT01215422|3823933|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4003702|NCT01215422|3823934|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4003703|NCT01215422|3823935|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4003704|NCT01215422|3823936|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4003705|NCT01215422|3823937|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4003706|NCT01215422|3823933|B5||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4003707|NCT01215422|3823934|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4003708|NCT01215422|3823935|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4003709|NCT01215422|3823936|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4003710|NCT01215422|3823937|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4003711|NCT01215422|3823933|B5||<=18 years|Age||Participants|Count of Participants|646|646.0||||||
4003712|NCT01215422|3823934|B4||<=18 years|Age||Participants|Count of Participants|201|201.0||||||
4003713|NCT01215422|3823935|B3||<=18 years|Age||Participants|Count of Participants|196|196.0||||||
4003714|NCT01215422|3823936|B2||<=18 years|Age||Participants|Count of Participants|249|249.0||||||
4003715|NCT01215422|3823937|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4003716|NCT01215357|3823962|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4003717|NCT01215357|3823962|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4003718|NCT01215357|3823962|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4003719|NCT01215357|3823962|B1|||Age||years|Mean|44.8|44.8|Standard Deviation|13.35|13.35|||
4003720|NCT01215357|3823962|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4003721|NCT01215357|3823962|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4003722|NCT01215357|3823962|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4003723|NCT01215344|3823966|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4003724|NCT01215344|3823967|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4003725|NCT01215344|3823968|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4003726|NCT01215344|3823966|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4003727|NCT01215344|3823967|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4003728|NCT01215344|3823968|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4003729|NCT01215344|3823966|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4003730|NCT01215344|3823967|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4003731|NCT01215344|3823968|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4003732|NCT01215344|3823966|B3|||Age||years|Median|58.5|58.5|Standard Deviation|8.803890|8.80389|||
4003733|NCT01215344|3823967|B2|||Age||years|Median|48|48.0|Standard Deviation|4.642796|4.642796|||
4003734|NCT01215344|3823968|B1|||Age||years|Median|60|60.0|Standard Deviation|8.71411|8.71411|||
4003735|NCT01215344|3823966|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4003736|NCT01215344|3823967|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4003737|NCT01215344|3823968|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4003738|NCT01215344|3823966|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4003739|NCT01215344|3823967|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4003740|NCT01215344|3823968|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4003741|NCT01215344|3823966|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4003742|NCT01215344|3823967|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4003743|NCT01215344|3823968|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4003744|NCT01215292|3823977|B6|||Serum LH|serum luteinizing hormone|IU/L|Median|4.8|4.8|Inter-Quartile Range|||3.9|6.4|
4003745|NCT01215292|3823978|B5|||Serum LH|serum luteinizing hormone|IU/L|Median|4.9|4.9|Inter-Quartile Range|||4.2|6.6|
4003746|NCT01215292|3823979|B4|||Serum LH|serum luteinizing hormone|IU/L|Median|5.8|5.8|Inter-Quartile Range|||4.7|7.4|
4003747|NCT01215292|3823980|B3|||Serum LH|serum luteinizing hormone|IU/L|Median|4.3|4.3|Inter-Quartile Range|||3.3|5.2|
4003748|NCT01215292|3823981|B2|||Serum LH|serum luteinizing hormone|IU/L|Median|4.7|4.7|Inter-Quartile Range|||4.2|5.4|
4003749|NCT01215292|3823982|B1|||Serum LH|serum luteinizing hormone|IU/L|Median|5|5.0|Inter-Quartile Range|||3.1|6.6|
4003750|NCT01215292|3823977|B6|||Serum 17-OHP|serum 17-hydroxyprogesterone|ng/mL|Median|6.1|6.1|Inter-Quartile Range|||4.7|8.1|
4003751|NCT01215292|3823978|B5|||Serum 17-OHP|serum 17-hydroxyprogesterone|ng/mL|Median|6|6.0|Inter-Quartile Range|||4.6|9.0|
4003752|NCT01215292|3823979|B4|||Serum 17-OHP|serum 17-hydroxyprogesterone|ng/mL|Median|4.8|4.8|Inter-Quartile Range|||4.2|6.7|
4003753|NCT01215292|3823980|B3|||Serum 17-OHP|serum 17-hydroxyprogesterone|ng/mL|Median|7.2|7.2|Inter-Quartile Range|||5.9|9.5|
4003754|NCT01215292|3823981|B2|||Serum 17-OHP|serum 17-hydroxyprogesterone|ng/mL|Median|6.1|6.1|Inter-Quartile Range|||5.1|9.1|
4003755|NCT01215292|3823982|B1|||Serum 17-OHP|serum 17-hydroxyprogesterone|ng/mL|Median|6|6.0|Inter-Quartile Range|||4.2|7.9|
4003756|NCT01215292|3823977|B6|||Serum DHEA|serum dehydroepiandrosterone|ng/mL|Median|3.9|3.9|Inter-Quartile Range|||2.9|6.1|
4003757|NCT01215292|3823978|B5|||Serum DHEA|serum dehydroepiandrosterone|ng/mL|Median|3.8|3.8|Inter-Quartile Range|||2.8|4.4|
4003758|NCT01215292|3823979|B4|||Serum DHEA|serum dehydroepiandrosterone|ng/mL|Median|4.6|4.6|Inter-Quartile Range|||2.8|5.9|
4003759|NCT01215292|3823980|B3|||Serum DHEA|serum dehydroepiandrosterone|ng/mL|Median|4.2|4.2|Inter-Quartile Range|||3.3|6.5|
4003760|NCT01215292|3823981|B2|||Serum DHEA|serum dehydroepiandrosterone|ng/mL|Median|3.9|3.9|Inter-Quartile Range|||3.2|6.6|
4003761|NCT01215292|3823982|B1|||Serum DHEA|serum dehydroepiandrosterone|ng/mL|Median|3.9|3.9|Inter-Quartile Range|||2.7|7.1|
4003762|NCT01215292|3823977|B6|||Serum ADD|Serum androstenedione|ng/mL|Median|0.67|0.67|Inter-Quartile Range|||0.57|0.95|
4003763|NCT01215292|3823978|B5|||Serum ADD|Serum androstenedione|ng/mL|Median|0.65|0.65|Inter-Quartile Range|||0.6|0.81|
4003764|NCT01215292|3823979|B4|||Serum ADD|Serum androstenedione|ng/mL|Median|0.69|0.69|Inter-Quartile Range|||0.59|0.76|
4003765|NCT01215292|3823980|B3|||Serum ADD|Serum androstenedione|ng/mL|Median|0.76|0.76|Inter-Quartile Range|||0.52|1.12|
4003766|NCT01215292|3823981|B2|||Serum ADD|Serum androstenedione|ng/mL|Median|0.75|0.75|Inter-Quartile Range|||0.5|1.1|
4003767|NCT01215292|3823982|B1|||Serum ADD|Serum androstenedione|ng/mL|Median|0.7|0.7|Inter-Quartile Range|||0.57|1.1|
4003768|NCT01215292|3823977|B6|||Serum E2||pg/mL|Median|28.3|28.3|Inter-Quartile Range|||20.9|53.9|
4003769|NCT01215292|3823978|B5|||Serum E2||pg/mL|Median|39.4|39.4|Inter-Quartile Range|||21.1|51.2|
4003770|NCT01215292|3823979|B4|||Serum E2||pg/mL|Median|39|39.0|Inter-Quartile Range|||23.4|69.4|
4003771|NCT01215292|3823980|B3|||Serum E2||pg/mL|Median|28.3|28.3|Inter-Quartile Range|||21.3|39.6|
4003772|NCT01215292|3823981|B2|||Serum E2||pg/mL|Median|24|24.0|Inter-Quartile Range|||20.9|30.0|
4003773|NCT01215292|3823982|B1|||Serum E2||pg/mL|Median|39|39.0|Inter-Quartile Range|||16.5|65.8|
4003774|NCT01215292|3823977|B6|||Serum DHT||ng/mL|Median|0.46|0.46|Inter-Quartile Range|||0.36|0.56|
4003775|NCT01215292|3823978|B5|||Serum DHT||ng/mL|Median|0.42|0.42|Inter-Quartile Range|||0.3|0.5|
4003776|NCT01215292|3823979|B4|||Serum DHT||ng/mL|Median|0.44|0.44|Inter-Quartile Range|||0.35|0.53|
4003777|NCT01215292|3823980|B3|||Serum DHT||ng/mL|Median|0.5|0.5|Inter-Quartile Range|||0.37|0.59|
4003778|NCT01215292|3823981|B2|||Serum DHT||ng/mL|Median|0.5|0.5|Inter-Quartile Range|||0.43|0.89|
4003779|NCT01215292|3823982|B1|||Serum DHT||ng/mL|Median|0.44|0.44|Inter-Quartile Range|||0.35|0.54|
4003780|NCT01215292|3823977|B6|||Serum Testosterone||ng/mL|Median|5.3|5.3|Inter-Quartile Range|||4.8|6.2|
4003781|NCT01215292|3823978|B5|||Serum Testosterone||ng/mL|Median|5.2|5.2|Inter-Quartile Range|||4.2|5.8|
4003782|NCT01215292|3823979|B4|||Serum Testosterone||ng/mL|Median|5.3|5.3|Inter-Quartile Range|||4.7|6.3|
4003783|NCT01215292|3823980|B3|||Serum Testosterone||ng/mL|Median|5.2|5.2|Inter-Quartile Range|||4.6|6.3|
4003784|NCT01215292|3823981|B2|||Serum Testosterone||ng/mL|Median|5.4|5.4|Inter-Quartile Range|||4.4|6.4|
4003785|NCT01215292|3823982|B1|||Serum Testosterone||ng/mL|Median|5.5|5.5|Inter-Quartile Range|||5.2|6.2|
4003786|NCT01215292|3823977|B6|||Serum FSH|serum follicle-stimulating hormone|IU/L|Median|2.6|2.6|Inter-Quartile Range|||1.7|3.0|
4003787|NCT01215292|3823978|B5|||Serum FSH|serum follicle-stimulating hormone|IU/L|Median|2.3|2.3|Inter-Quartile Range|||1.4|3.0|
4003788|NCT01215292|3823979|B4|||Serum FSH|serum follicle-stimulating hormone|IU/L|Median|2.4|2.4|Inter-Quartile Range|||1.7|2.8|
4003789|NCT01215292|3823980|B3|||Serum FSH|serum follicle-stimulating hormone|IU/L|Median|2.7|2.7|Inter-Quartile Range|||2.3|2.9|
4003790|NCT01215292|3823981|B2|||Serum FSH|serum follicle-stimulating hormone|IU/L|Median|2.7|2.7|Inter-Quartile Range|||1.8|3.0|
4003791|NCT01215292|3823982|B1|||Serum FSH|serum follicle-stimulating hormone|IU/L|Median|2.3|2.3|Inter-Quartile Range|||1.5|3.5|
4003792|NCT01215292|3823977|B6|United States||Region of Enrollment||participants|Number|40|40.0||||||
4003793|NCT01215292|3823978|B5|United States||Region of Enrollment||participants|Number|8|8.0||||||
4003794|NCT01215292|3823979|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
4003795|NCT01215292|3823980|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4003796|NCT01215292|3823981|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4003797|NCT01215292|3823982|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4003798|NCT01215292|3823977|B6||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4003799|NCT01215292|3823978|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4003800|NCT01215292|3823979|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4003801|NCT01215292|3823980|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4003802|NCT01215292|3823981|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4003803|NCT01215292|3823982|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4003804|NCT01215292|3823977|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4003805|NCT01215292|3823978|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4003806|NCT01215292|3823979|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4003807|NCT01215292|3823980|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4003808|NCT01215292|3823981|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4003809|NCT01215292|3823982|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4003810|NCT01215292|3823977|B6|||Age||years|Median|22|22.0|Inter-Quartile Range|||20.0|26.0|
4003811|NCT01215292|3823978|B5|||Age||years|Median|21.5|21.5|Inter-Quartile Range|||20.5|24.5|
4003812|NCT01215292|3823979|B4|||Age||years|Median|22|22.0|Inter-Quartile Range|||20.5|25.5|
4003813|NCT01215292|3823980|B3|||Age||years|Median|24|24.0|Inter-Quartile Range|||21.0|35.5|
4003814|NCT01215292|3823981|B2|||Age||years|Median|21.5|21.5|Inter-Quartile Range|||20.0|24.0|
4003815|NCT01215292|3823982|B1|||Age||years|Median|22.5|22.5|Inter-Quartile Range|||20.0|26.0|
4003816|NCT01215279|3824008|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4003817|NCT01215279|3824009|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4003818|NCT01215279|3824010|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4003819|NCT01215279|3824008|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4003820|NCT01215279|3824009|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4003821|NCT01215279|3824010|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4003822|NCT01215279|3824008|B3|||Age||Years|Mean|61.6|61.6|Standard Deviation|7.5|7.5|||
4003823|NCT01215279|3824009|B2|||Age||Years|Mean|60.6|60.6|Standard Deviation|7.2|7.2|||
4003824|NCT01215279|3824010|B1|||Age||Years|Mean|62.5|62.5|Standard Deviation|7.8|7.8|||
4003825|NCT01215253|3824075|B3|United States||Region of Enrollment||Participants|Count of Participants|950|950.0||||||
4003826|NCT01215253|3824076|B2|United States||Region of Enrollment||Participants|Count of Participants|471|471.0||||||
4003827|NCT01215253|3824077|B1|United States||Region of Enrollment||Participants|Count of Participants|479|479.0||||||
4003828|NCT01215253|3824075|B3|Canada||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
4003829|NCT01215253|3824076|B2|Canada||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
4003830|NCT01215253|3824077|B1|Canada||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
4003831|NCT01215253|3824075|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4003832|NCT01215253|3824076|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4003833|NCT01215253|3824077|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4003834|NCT01215253|3824075|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4003835|NCT01215253|3824076|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4003836|NCT01215253|3824077|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4003837|NCT01215253|3824075|B3||White|Race (NIH/OMB)||Participants|Count of Participants|814|814.0||||||
4003838|NCT01215253|3824076|B2||White|Race (NIH/OMB)||Participants|Count of Participants|410|410.0||||||
4003839|NCT01215253|3824077|B1||White|Race (NIH/OMB)||Participants|Count of Participants|404|404.0||||||
4003840|NCT01215253|3824075|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|170|170.0||||||
4003841|NCT01215253|3824076|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
4003842|NCT01215253|3824077|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
4003843|NCT01215253|3824075|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4003844|NCT01215253|3824076|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003845|NCT01215253|3824077|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4003846|NCT01215253|3824075|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4003847|NCT01215253|3824076|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4003848|NCT01215253|3824077|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4003849|NCT01215253|3824075|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4003850|NCT01215253|3824076|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4003851|NCT01215253|3824077|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4003852|NCT01215253|3824075|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003853|NCT01215253|3824076|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003854|NCT01215253|3824077|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003855|NCT01215253|3824075|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|983|983.0||||||
4003856|NCT01215253|3824076|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|490|490.0||||||
4003857|NCT01215253|3824077|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|493|493.0||||||
4003858|NCT01215253|3824075|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4003859|NCT01215253|3824076|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4003860|NCT01215253|3824077|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4003861|NCT01215253|3824075|B3||Male|Sex: Female, Male||Participants|Count of Participants|826|826.0||||||
4003862|NCT01215253|3824076|B2||Male|Sex: Female, Male||Participants|Count of Participants|416|416.0||||||
4003863|NCT01215253|3824077|B1||Male|Sex: Female, Male||Participants|Count of Participants|410|410.0||||||
4003864|NCT01215253|3824075|B3||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4003865|NCT01215253|3824076|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4003866|NCT01215253|3824077|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4003867|NCT01215253|3824075|B3|||Age||years|Mean|64.3|64.3|Standard Deviation|11.1|11.1|||
4003868|NCT01215253|3824076|B2|||Age||years|Mean|64.2|64.2|Standard Deviation|9.9|9.9|||
4003869|NCT01215253|3824077|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|10.3|10.3|||
4003870|NCT01215227|3824106|B7||Male|Sex: Female, Male||Participants|Count of Participants|495|495.0||||||
4003871|NCT01215227|3824107|B6||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4003872|NCT01215227|3824108|B5||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4003873|NCT01215227|3824109|B4||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4003874|NCT01215227|3824110|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4003875|NCT01215227|3824111|B2||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4003876|NCT01215227|3824112|B1||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4003877|NCT01215227|3824106|B7||Female|Sex: Female, Male||Participants|Count of Participants|341|341.0||||||
4003878|NCT01215227|3824107|B6||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4003879|NCT01215227|3824108|B5||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4003880|NCT01215227|3824109|B4||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4003881|NCT01215227|3824110|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4003882|NCT01215227|3824111|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4003883|NCT01215227|3824112|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4003884|NCT01215227|3824106|B7|||Age||Years|Mean|63.3|63.3|Standard Deviation|8.6|8.6|||
4003885|NCT01215227|3824107|B6|||Age||Years|Mean|63.9|63.9|Standard Deviation|7.8|7.8|||
4003886|NCT01215227|3824108|B5|||Age||Years|Mean|63.8|63.8|Standard Deviation|9.9|9.9|||
4003887|NCT01215227|3824109|B4|||Age||Years|Mean|63.9|63.9|Standard Deviation|8.0|8.0|||
4003888|NCT01215227|3824110|B3|||Age||Years|Mean|64.4|64.4|Standard Deviation|8.7|8.7|||
4003889|NCT01215227|3824111|B2|||Age||Years|Mean|63.0|63.0|Standard Deviation|8.7|8.7|||
4003890|NCT01215227|3824112|B1|||Age||Years|Mean|62.4|62.4|Standard Deviation|8.5|8.5|||
4003891|NCT01215123|3824161|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4003892|NCT01215123|3824161|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4003893|NCT01215123|3824161|B1|||Age||years|Mean|54|54.0|Standard Deviation|9|9.0|||
4003894|NCT01215110|3824166|B6|||Baseline time to sputum culture positivity (TTP) in liquid culture media||hours|Mean|105.3|105.3|Standard Deviation|26.9|26.9|||
4003895|NCT01215110|3824167|B5|||Baseline time to sputum culture positivity (TTP) in liquid culture media||hours|Mean|106.7|106.7|Standard Deviation|28.8|28.8|||
4003896|NCT01215110|3824168|B4|||Baseline time to sputum culture positivity (TTP) in liquid culture media||hours|Mean|88.5|88.5|Standard Deviation|10.8|10.8|||
4003897|NCT01215110|3824169|B3|||Baseline time to sputum culture positivity (TTP) in liquid culture media||hours|Mean|115.7|115.7|Standard Deviation|40.8|40.8|||
4003898|NCT01215110|3824170|B2|||Baseline time to sputum culture positivity (TTP) in liquid culture media||hours|Mean|111.1|111.1|Standard Deviation|30.6|30.6|||
4003899|NCT01215110|3824171|B1|||Baseline time to sputum culture positivity (TTP) in liquid culture media||hours|Mean|104.8|104.8|Standard Deviation|23.5|23.5|||
4003900|NCT01215110|3824166|B6|||Baseline log10 colony forming units (CFU) of M. Tuberculosis per ml sputum||log(10) CFU/ml|Mean|6.199|6.199|Standard Deviation|0.892|0.892|||
4003901|NCT01215110|3824167|B5|||Baseline log10 colony forming units (CFU) of M. Tuberculosis per ml sputum||log(10) CFU/ml|Mean|5.995|5.995|Standard Deviation|1.018|1.018|||
4003902|NCT01215110|3824168|B4|||Baseline log10 colony forming units (CFU) of M. Tuberculosis per ml sputum||log(10) CFU/ml|Mean|6.625|6.625|Standard Deviation|0.756|0.756|||
4003903|NCT01215110|3824169|B3|||Baseline log10 colony forming units (CFU) of M. Tuberculosis per ml sputum||log(10) CFU/ml|Mean|6.071|6.071|Standard Deviation|1.087|1.087|||
4003904|NCT01215110|3824170|B2|||Baseline log10 colony forming units (CFU) of M. Tuberculosis per ml sputum||log(10) CFU/ml|Mean|6.001|6.001|Standard Deviation|0.903|0.903|||
4003905|NCT01215110|3824171|B1|||Baseline log10 colony forming units (CFU) of M. Tuberculosis per ml sputum||log(10) CFU/ml|Mean|6.302|6.302|Standard Deviation|0.697|0.697|||
4003906|NCT01215110|3824166|B6|Negative||HIV Status||participants|Number|62|62.0||||||
4003907|NCT01215110|3824167|B5|Negative||HIV Status||participants|Number|7|7.0||||||
4003908|NCT01215110|3824168|B4|Negative||HIV Status||participants|Number|13|13.0||||||
4003909|NCT01215110|3824169|B3|Negative||HIV Status||participants|Number|14|14.0||||||
4003910|NCT01215110|3824170|B2|Negative||HIV Status||participants|Number|14|14.0||||||
4003911|NCT01215110|3824171|B1|Negative||HIV Status||participants|Number|14|14.0||||||
4003912|NCT01215110|3824166|B6|Positive||HIV Status||participants|Number|6|6.0||||||
4003913|NCT01215110|3824167|B5|Positive||HIV Status||participants|Number|1|1.0||||||
4003914|NCT01215110|3824168|B4|Positive||HIV Status||participants|Number|2|2.0||||||
4003915|NCT01215110|3824169|B3|Positive||HIV Status||participants|Number|1|1.0||||||
4003916|NCT01215110|3824170|B2|Positive||HIV Status||participants|Number|1|1.0||||||
4003917|NCT01215110|3824171|B1|Positive||HIV Status||participants|Number|1|1.0||||||
4003918|NCT01215110|3824166|B6|||Body Mass Index (BMI)||kg/m^2|Mean|18.77|18.77|Standard Deviation|2.459|2.459|||
4003919|NCT01215110|3824167|B5|||Body Mass Index (BMI)||kg/m^2|Mean|17.83|17.83|Standard Deviation|2.018|2.018|||
4003920|NCT01215110|3824168|B4|||Body Mass Index (BMI)||kg/m^2|Mean|18.36|18.36|Standard Deviation|2.174|2.174|||
4003921|NCT01215110|3824169|B3|||Body Mass Index (BMI)||kg/m^2|Mean|18.80|18.8|Standard Deviation|2.754|2.754|||
4003922|NCT01215110|3824170|B2|||Body Mass Index (BMI)||kg/m^2|Mean|18.63|18.63|Standard Deviation|1.955|1.955|||
4003923|NCT01215110|3824171|B1|||Body Mass Index (BMI)||kg/m^2|Mean|19.80|19.8|Standard Deviation|2.988|2.988|||
4003924|NCT01215110|3824166|B6|||Weight at Day 1||kilograms (kg)|Mean|51.8|51.8|Standard Deviation|7.23|7.23|||
4003925|NCT01215110|3824167|B5|||Weight at Day 1||kilograms (kg)|Mean|49.1|49.1|Standard Deviation|6.69|6.69|||
4003926|NCT01215110|3824168|B4|||Weight at Day 1||kilograms (kg)|Mean|50.6|50.6|Standard Deviation|5.96|5.96|||
4003927|NCT01215110|3824169|B3|||Weight at Day 1||kilograms (kg)|Mean|52.7|52.7|Standard Deviation|8.20|8.2|||
4003928|NCT01215110|3824170|B2|||Weight at Day 1||kilograms (kg)|Mean|52.5|52.5|Standard Deviation|7.55|7.55|||
4003929|NCT01215110|3824171|B1|||Weight at Day 1||kilograms (kg)|Mean|53.0|53.0|Standard Deviation|7.74|7.74|||
4003930|NCT01215110|3824166|B6|||Height||meters (m)|Mean|1.662|1.662|Standard Deviation|0.080|0.08|||
4003931|NCT01215110|3824167|B5|||Height||meters (m)|Mean|1.660|1.66|Standard Deviation|0.087|0.087|||
4003932|NCT01215110|3824168|B4|||Height||meters (m)|Mean|1.660|1.66|Standard Deviation|0.057|0.057|||
4003933|NCT01215110|3824169|B3|||Height||meters (m)|Mean|1.674|1.674|Standard Deviation|0.082|0.082|||
4003934|NCT01215110|3824170|B2|||Height||meters (m)|Mean|1.677|1.677|Standard Deviation|0.094|0.094|||
4003935|NCT01215110|3824171|B1|||Height||meters (m)|Mean|1.638|1.638|Standard Deviation|0.082|0.082|||
4003936|NCT01215110|3824166|B6|Mixed Ethnic||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4003937|NCT01215110|3824167|B5|Mixed Ethnic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4003938|NCT01215110|3824168|B4|Mixed Ethnic||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4003939|NCT01215110|3824169|B3|Mixed Ethnic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4003940|NCT01215110|3824170|B2|Mixed Ethnic||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4003941|NCT01215110|3824171|B1|Mixed Ethnic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4003942|NCT01215110|3824166|B6|Black||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4003943|NCT01215110|3824167|B5|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4003944|NCT01215110|3824168|B4|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4003945|NCT01215110|3824169|B3|Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4003946|NCT01215110|3824170|B2|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4003947|NCT01215110|3824171|B1|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4003948|NCT01215110|3824166|B6||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4003949|NCT01215110|3824167|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4003950|NCT01215110|3824168|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4003951|NCT01215110|3824169|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4003952|NCT01215110|3824170|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4003953|NCT01215110|3824171|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4003954|NCT01215110|3824166|B6||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4003955|NCT01215110|3824167|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4003956|NCT01215110|3824168|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4003957|NCT01215110|3824169|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4003958|NCT01215110|3824170|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4003959|NCT01215110|3824171|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4003960|NCT01215110|3824166|B6|||Age||years|Mean|27|27.0|Standard Deviation|11.45|11.45|||
4003961|NCT01215110|3824167|B5|||Age||years|Mean|26.1|26.1|Standard Deviation|4.9|4.9|||
4003962|NCT01215110|3824168|B4|||Age||years|Mean|31.8|31.8|Standard Deviation|10.9|10.9|||
4003963|NCT01215110|3824169|B3|||Age||years|Mean|31.4|31.4|Standard Deviation|7.4|7.4|||
4003964|NCT01215110|3824170|B2|||Age||years|Mean|34.7|34.7|Standard Deviation|18.1|18.1|||
4003965|NCT01215110|3824171|B1|||Age||years|Mean|29.5|29.5|Standard Deviation|9.4|9.4|||
4003966|NCT01215097|3824234|B3|||Baseline fasting plasma glucose|Baseline fasting plasma glucose|mg/dL|Mean|159.6|159.6|Standard Deviation|39.0|39.0|||
4003967|NCT01215097|3824235|B2|||Baseline fasting plasma glucose|Baseline fasting plasma glucose|mg/dL|Mean|160.5|160.5|Standard Deviation|40.1|40.1|||
4003968|NCT01215097|3824236|B1|||Baseline fasting plasma glucose|Baseline fasting plasma glucose|mg/dL|Mean|157.7|157.7|Standard Deviation|36.8|36.8|||
4003969|NCT01215097|3824234|B3|||Baseline HbA1c|Baseline HbA1c|%|Mean|7.99|7.99|Standard Deviation|0.82|0.82|||
4003970|NCT01215097|3824235|B2|||Baseline HbA1c|Baseline HbA1c|%|Mean|7.99|7.99|Standard Deviation|0.83|0.83|||
4003971|NCT01215097|3824236|B1|||Baseline HbA1c|Baseline HbA1c|%|Mean|8.00|8.0|Standard Deviation|0.80|0.8|||
4003972|NCT01215097|3824234|B3|||BMI|Baseline body mass index (BMI)|kg/m^2|Mean|25.6|25.6|Standard Deviation|4.0|4.0|||
4003973|NCT01215097|3824235|B2|||BMI|Baseline body mass index (BMI)|kg/m^2|Mean|25.5|25.5|Standard Deviation|3.9|3.9|||
4003974|NCT01215097|3824236|B1|||BMI|Baseline body mass index (BMI)|kg/m^2|Mean|25.8|25.8|Standard Deviation|4.0|4.0|||
4003975|NCT01215097|3824234|B3||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4003976|NCT01215097|3824235|B2||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4003977|NCT01215097|3824236|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4003978|NCT01215097|3824234|B3||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4003979|NCT01215097|3824235|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4003980|NCT01215097|3824236|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4003981|NCT01215097|3824234|B3|||Age||years|Mean|55.5|55.5|Standard Deviation|10.1|10.1|||
4003982|NCT01215097|3824235|B2|||Age||years|Mean|55.1|55.1|Standard Deviation|10.7|10.7|||
4003983|NCT01215097|3824236|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|8.7|8.7|||
4003984|NCT01215032|3824269|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4003985|NCT01215032|3824269|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4003986|NCT01215032|3824269|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003987|NCT01215032|3824269|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4003988|NCT01215032|3824269|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4003989|NCT01215032|3824269|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003990|NCT01215032|3824269|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003991|NCT01215032|3824269|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003992|NCT01215032|3824269|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4003993|NCT01215032|3824269|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4003994|NCT01215032|3824269|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4003995|NCT01215032|3824269|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4003996|NCT01215032|3824269|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4003997|NCT01215032|3824269|B1|||Age||years|Mean|65.86|65.86|Standard Deviation|7.23|7.23|||
4003998|NCT01215032|3824269|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4003999|NCT01215032|3824269|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4004000|NCT01215032|3824269|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4004001|NCT01214980|3824277|B3|||Baseline donor site size||centimeters squared|Median|136.0|136.0|Full Range|||36.0|216.0|
4004002|NCT01214980|3824278|B2|||Baseline donor site size||centimeters squared|Median|136.0|136.0|Full Range|||36.0|216.0|
4004003|NCT01214980|3824279|B1|||Baseline donor site size||centimeters squared|Median|139.5|139.5|Full Range|||36.0|200.0|
4004004|NCT01214980|3824277|B3|||Number of donor sites||number of sites|Median|2|2.0|Full Range|||1.0|5.0|
4004005|NCT01214980|3824278|B2|||Number of donor sites||number of sites|Median|1.5|1.5|Full Range|||1.0|5.0|
4004006|NCT01214980|3824279|B1|||Number of donor sites||number of sites|Median|2|2.0|Full Range|||1.0|4.0|
4004007|NCT01214980|3824277|B3|||BMI||kilograms per meter squared|Median|24.7|24.7|Full Range|||16.8|41.4|
4004008|NCT01214980|3824278|B2|||BMI||kilograms per meter squared|Median|25.0|25.0|Full Range|||20.3|34.0|
4004009|NCT01214980|3824279|B1|||BMI||kilograms per meter squared|Median|24.7|24.7|Full Range|||16.8|41.1|
4004010|NCT01214980|3824277|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4004011|NCT01214980|3824278|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4004012|NCT01214980|3824279|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4004013|NCT01214980|3824277|B3|African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4004014|NCT01214980|3824278|B2|African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4004015|NCT01214980|3824279|B1|African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4004016|NCT01214980|3824277|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4004017|NCT01214980|3824278|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4004018|NCT01214980|3824279|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4004019|NCT01214980|3824277|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4004020|NCT01214980|3824278|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4004021|NCT01214980|3824279|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4004022|NCT01214980|3824277|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4004023|NCT01214980|3824278|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4004024|NCT01214980|3824279|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4004025|NCT01214980|3824277|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4004026|NCT01214980|3824278|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4004027|NCT01214980|3824279|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4004028|NCT01214980|3824277|B3|||Age||years|Median|49|49.0|Full Range|||20.0|91.0|
4004029|NCT01214980|3824278|B2|||Age||years|Median|54|54.0|Full Range|||25.0|82.0|
4004030|NCT01214980|3824279|B1|||Age||years|Median|32|32.0|Full Range|||20.0|91.0|
4004031|NCT01214915|3824294|B1|JAPAN||Region of Enrollment||Participants|Number|53|53.0||||||
4004032|NCT01214915|3824294|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4004033|NCT01214915|3824294|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4004034|NCT01214915|3824294|B1|>= 80 years||Age, Customized||Participants|Number|1|1.0||||||
4004035|NCT01214915|3824294|B1|70 - 79 years||Age, Customized||Participants|Number|17|17.0||||||
4004036|NCT01214915|3824294|B1|60 - 69 years||Age, Customized||Participants|Number|18|18.0||||||
4004037|NCT01214915|3824294|B1|50 - 59 years||Age, Customized||Participants|Number|5|5.0||||||
4004038|NCT01214915|3824294|B1|< 50 years||Age, Customized||Participants|Number|12|12.0||||||
4004039|NCT01214915|3824294|B1|||Age||Years|Mean|61.6|61.6|Standard Deviation|13.1|13.1|||
4004040|NCT01214850|3824302|B4||Male|Sex: Female, Male||Participants|Count of Participants|1358|1358.0||||||
4004041|NCT01214850|3824303|B3||Male|Sex: Female, Male||Participants|Count of Participants|440|440.0||||||
4004042|NCT01214850|3824304|B2||Male|Sex: Female, Male||Participants|Count of Participants|455|455.0||||||
4004043|NCT01214850|3824305|B1||Male|Sex: Female, Male||Participants|Count of Participants|463|463.0||||||
4004044|NCT01214850|3824302|B4||Female|Sex: Female, Male||Participants|Count of Participants|1596|1596.0||||||
4004045|NCT01214850|3824303|B3||Female|Sex: Female, Male||Participants|Count of Participants|547|547.0||||||
4004046|NCT01214850|3824304|B2||Female|Sex: Female, Male||Participants|Count of Participants|533|533.0||||||
4004047|NCT01214850|3824305|B1||Female|Sex: Female, Male||Participants|Count of Participants|516|516.0||||||
4004048|NCT01214850|3824302|B4|||Age||years|Mean|19.9|19.9|Standard Deviation|1.6|1.6|||
4004049|NCT01214850|3824303|B3|||Age||years|Mean|19.8|19.8|Standard Deviation|1.6|1.6|||
4004050|NCT01214850|3824304|B2|||Age||years|Mean|19.9|19.9|Standard Deviation|1.6|1.6|||
4004051|NCT01214850|3824305|B1|||Age||years|Mean|19.9|19.9|Standard Deviation|1.6|1.6|||
4004052|NCT01214837|3824388|B4||Male|Sex: Female, Male||Participants|Count of Participants|396|396.0||||||
4004053|NCT01214837|3824389|B3||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4004054|NCT01214837|3824390|B2||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4004055|NCT01214837|3824391|B1||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4004056|NCT01214837|3824388|B4||Female|Sex: Female, Male||Participants|Count of Participants|355|355.0||||||
4004057|NCT01214837|3824389|B3||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4004058|NCT01214837|3824390|B2||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4004059|NCT01214837|3824391|B1||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4004060|NCT01214837|3824388|B4|||Age||Days|Mean|66.6|66.6|Standard Deviation|7.2|7.2|||
4004061|NCT01214837|3824389|B3|||Age||Days|Mean|66.7|66.7|Standard Deviation|7.0|7.0|||
4004062|NCT01214837|3824390|B2|||Age||Days|Mean|66.7|66.7|Standard Deviation|7.4|7.4|||
4004063|NCT01214837|3824391|B1|||Age||Days|Mean|66.4|66.4|Standard Deviation|7.1|7.1|||
4004064|NCT01214824|3824430|B1|||HbA1c||%|Mean|9.3|9.3|Full Range|||8.0|13.2|
4004065|NCT01214824|3824430|B1|||Number of blood glucose measurements per day||Tests|Mean|4.5|4.5|Full Range|||4.0|10.0|
4004066|NCT01214824|3824430|B1|||Number of injections per day||Injections|Mean|4.1|4.1|Full Range|||3.0|6.0|
4004067|NCT01214824|3824430|B1|||Daily Total Insulin Dosage-Bolus||Units|Mean|28.0|28.0|Full Range|||10.0|60.0|
4004068|NCT01214824|3824430|B1|||Daily Total Insulin Dosage-Basal||Units|Mean|24.9|24.9|Full Range|||0.0|62.0|
4004069|NCT01214824|3824430|B1|||Years since diagnosis||Years|Mean|17.6|17.6|Full Range|||0.7|48.0|
4004070|NCT01214824|3824430|B1|||Weight||Kg|Mean|73.7|73.7|Full Range|||49.0|115.0|
4004071|NCT01214824|3824430|B1|||Body Mass Index (BMI)||kg/m^2|Mean|26.3|26.3|Full Range|||19.6|37.0|
4004072|NCT01214824|3824430|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4004073|NCT01214824|3824430|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4004074|NCT01214824|3824430|B1|||Age||years|Mean|42.5|42.5|Full Range|||18.0|63.0|
4004075|NCT01214824|3824430|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4004076|NCT01214824|3824430|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4004077|NCT01214824|3824430|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4004078|NCT01214811|3824437|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4004079|NCT01214811|3824437|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4004080|NCT01214811|3824437|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4004081|NCT01214811|3824437|B1|||Age||years|Mean|57.3|57.3|Standard Deviation|17.2|17.2|||
4004082|NCT01214811|3824437|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4004083|NCT01214811|3824437|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4004084|NCT01214811|3824437|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4004085|NCT01214759|3824441|B1|United States||Region of Enrollment||participants|Number|103|103.0||||||
4004086|NCT01214759|3824441|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4004087|NCT01214759|3824441|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4004088|NCT01214759|3824441|B1|||Age||years|Mean|32|32.0|Standard Deviation|8.9|8.9|||
4004089|NCT01214720|3824447|B3||Male|Sex: Female, Male||Participants|Count of Participants|362|362.0||||||
4004090|NCT01214720|3824448|B2||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4004091|NCT01214720|3824449|B1||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4004092|NCT01214720|3824447|B3||Female|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4004093|NCT01214720|3824448|B2||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4004094|NCT01214720|3824449|B1||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4004095|NCT01214720|3824447|B3|||Age||years|Mean|61.2|61.2|Standard Deviation|10.19|10.19|||
4004096|NCT01214720|3824448|B2|||Age||years|Mean|61.0|61.0|Standard Deviation|10.03|10.03|||
4004097|NCT01214720|3824449|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|10.36|10.36|||
4004098|NCT01214668|3824467|B7|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
4004099|NCT01214668|3824468|B6|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4004100|NCT01214668|3824469|B5|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4004101|NCT01214668|3824470|B4|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4004102|NCT01214668|3824471|B3|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4004103|NCT01214668|3824472|B2|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4004104|NCT01214668|3824473|B1|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4004105|NCT01214668|3824467|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004106|NCT01214668|3824468|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004107|NCT01214668|3824469|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004108|NCT01214668|3824470|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004109|NCT01214668|3824471|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004110|NCT01214668|3824472|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004111|NCT01214668|3824473|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004112|NCT01214668|3824467|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4004113|NCT01214668|3824468|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004114|NCT01214668|3824469|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004115|NCT01214668|3824470|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004116|NCT01214668|3824471|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004117|NCT01214668|3824472|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004118|NCT01214668|3824473|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4004119|NCT01214668|3824467|B7||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4004120|NCT01214668|3824468|B6||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4004121|NCT01214668|3824469|B5||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4004122|NCT01214668|3824470|B4||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4004123|NCT01214668|3824471|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4004124|NCT01214668|3824472|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4004125|NCT01214668|3824473|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4004126|NCT01214668|3824467|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004127|NCT01214668|3824468|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004128|NCT01214668|3824469|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004129|NCT01214668|3824470|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004130|NCT01214668|3824471|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004131|NCT01214668|3824472|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004132|NCT01214668|3824473|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004133|NCT01214668|3824467|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004134|NCT01214668|3824468|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004135|NCT01214668|3824469|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004136|NCT01214668|3824470|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004137|NCT01214668|3824471|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004138|NCT01214668|3824472|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004139|NCT01214668|3824473|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004140|NCT01214668|3824467|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004141|NCT01214668|3824468|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004142|NCT01214668|3824469|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004143|NCT01214668|3824470|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004144|NCT01214668|3824471|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004145|NCT01214668|3824472|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004146|NCT01214668|3824473|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004147|NCT01214668|3824467|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4004148|NCT01214668|3824468|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004149|NCT01214668|3824469|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4004150|NCT01214668|3824470|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004151|NCT01214668|3824471|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4004152|NCT01214668|3824472|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004153|NCT01214668|3824473|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004154|NCT01214668|3824467|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004155|NCT01214668|3824468|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004156|NCT01214668|3824469|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004157|NCT01214668|3824470|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004158|NCT01214668|3824471|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004159|NCT01214668|3824472|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004160|NCT01214668|3824473|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004161|NCT01214668|3824467|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4004162|NCT01214668|3824468|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4004163|NCT01214668|3824469|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4004164|NCT01214668|3824470|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4004165|NCT01214668|3824471|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4004166|NCT01214668|3824472|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4004167|NCT01214668|3824473|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4004168|NCT01214668|3824467|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4004169|NCT01214668|3824468|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004170|NCT01214668|3824469|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4004171|NCT01214668|3824470|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4004172|NCT01214668|3824471|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004173|NCT01214668|3824472|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4004174|NCT01214668|3824473|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4004175|NCT01214668|3824467|B7||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4004176|NCT01214668|3824468|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4004177|NCT01214668|3824469|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4004178|NCT01214668|3824470|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4004179|NCT01214668|3824471|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4004180|NCT01214668|3824472|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4004181|NCT01214668|3824473|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4004182|NCT01214668|3824467|B7||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4004183|NCT01214668|3824468|B6||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4004184|NCT01214668|3824469|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4004185|NCT01214668|3824470|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4004186|NCT01214668|3824471|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4004187|NCT01214668|3824472|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4004188|NCT01214668|3824473|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4004189|NCT01214668|3824467|B7|||Age||years|Mean|57.54|57.54|Standard Deviation|10.93|10.93|||
4004190|NCT01214668|3824468|B6|||Age||years|Mean|57.82|57.82|Standard Deviation|12.97|12.97|||
4004191|NCT01214668|3824469|B5|||Age||years|Mean|52.24|52.24|Standard Deviation|15.08|15.08|||
4004192|NCT01214668|3824470|B4|||Age||years|Mean|58.57|58.57|Standard Deviation|2.71|2.71|||
4004193|NCT01214668|3824471|B3|||Age||years|Mean|64.65|64.65|Standard Deviation|7.53|7.53|||
4004194|NCT01214668|3824472|B2|||Age||years|Mean|51.54|51.54|Standard Deviation|8.55|8.55|||
4004195|NCT01214668|3824473|B1|||Age||years|Mean|57.39|57.39|Standard Deviation|13.60|13.6|||
4004196|NCT01214642|3824512|B13|United States||Region of Enrollment||participants|Number|63|63.0||||||
4004197|NCT01214642|3824513|B12|United States||Region of Enrollment||participants|Number|6|6.0||||||
4004198|NCT01214642|3824514|B11|United States||Region of Enrollment||participants|Number|4|4.0||||||
4004199|NCT01214642|3824515|B10|United States||Region of Enrollment||participants|Number|4|4.0||||||
4004200|NCT01214642|3824516|B9|United States||Region of Enrollment||participants|Number|13|13.0||||||
4004201|NCT01214642|3824517|B8|United States||Region of Enrollment||participants|Number|3|3.0||||||
4004202|NCT01214642|3824518|B7|United States||Region of Enrollment||participants|Number|6|6.0||||||
4004203|NCT01214642|3824519|B6|United States||Region of Enrollment||participants|Number|3|3.0||||||
4004204|NCT01214642|3824520|B5|United States||Region of Enrollment||participants|Number|6|6.0||||||
4004205|NCT01214642|3824521|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
4004206|NCT01214642|3824522|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4004207|NCT01214642|3824523|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4004208|NCT01214642|3824524|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4004209|NCT01214642|3824512|B13||West Asian (Indian sub-continent)|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4004210|NCT01214642|3824513|B12||West Asian (Indian sub-continent)|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004211|NCT01214642|3824514|B11||West Asian (Indian sub-continent)|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004212|NCT01214642|3824515|B10||West Asian (Indian sub-continent)|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004213|NCT01214642|3824516|B9||West Asian (Indian sub-continent)|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004214|NCT01214642|3824517|B8||West Asian (Indian sub-continent)|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004215|NCT01214642|3824518|B7||West Asian (Indian sub-continent)|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004216|NCT01214642|3824519|B6||West Asian (Indian sub-continent)|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004217|NCT01214642|3824520|B5||West Asian (Indian sub-continent)|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4004218|NCT01214642|3824521|B4||West Asian (Indian sub-continent)|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004219|NCT01214642|3824522|B3||West Asian (Indian sub-continent)|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004220|NCT01214642|3824523|B2||West Asian (Indian sub-continent)|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004221|NCT01214642|3824524|B1||West Asian (Indian sub-continent)|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004222|NCT01214642|3824512|B13||East Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4004223|NCT01214642|3824513|B12||East Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004224|NCT01214642|3824514|B11||East Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004225|NCT01214642|3824515|B10||East Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004226|NCT01214642|3824516|B9||East Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4004227|NCT01214642|3824517|B8||East Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004228|NCT01214642|3824518|B7||East Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004229|NCT01214642|3824519|B6||East Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004230|NCT01214642|3824520|B5||East Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004231|NCT01214642|3824521|B4||East Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004232|NCT01214642|3824522|B3||East Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004233|NCT01214642|3824523|B2||East Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004234|NCT01214642|3824524|B1||East Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004235|NCT01214642|3824512|B13||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4004236|NCT01214642|3824513|B12||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004237|NCT01214642|3824514|B11||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004238|NCT01214642|3824515|B10||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004239|NCT01214642|3824516|B9||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4004240|NCT01214642|3824517|B8||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004241|NCT01214642|3824518|B7||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004242|NCT01214642|3824519|B6||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004243|NCT01214642|3824520|B5||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4004244|NCT01214642|3824521|B4||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004245|NCT01214642|3824522|B3||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4004246|NCT01214642|3824523|B2||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4004247|NCT01214642|3824524|B1||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4004248|NCT01214642|3824512|B13||African|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4004249|NCT01214642|3824513|B12||African|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004250|NCT01214642|3824514|B11||African|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4004251|NCT01214642|3824515|B10||African|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004252|NCT01214642|3824516|B9||African|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4004253|NCT01214642|3824517|B8||African|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004254|NCT01214642|3824518|B7||African|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004255|NCT01214642|3824519|B6||African|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004256|NCT01214642|3824520|B5||African|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004257|NCT01214642|3824521|B4||African|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004258|NCT01214642|3824522|B3||African|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4004259|NCT01214642|3824523|B2||African|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004260|NCT01214642|3824524|B1||African|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4004261|NCT01214642|3824512|B13||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
4004262|NCT01214642|3824513|B12||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4004263|NCT01214642|3824514|B11||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4004264|NCT01214642|3824515|B10||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4004265|NCT01214642|3824516|B9||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4004266|NCT01214642|3824517|B8||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4004267|NCT01214642|3824518|B7||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4004268|NCT01214642|3824519|B6||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4004269|NCT01214642|3824520|B5||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4004270|NCT01214642|3824521|B4||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4004271|NCT01214642|3824522|B3||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4004272|NCT01214642|3824523|B2||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4004273|NCT01214642|3824524|B1||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4004274|NCT01214642|3824512|B13||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4004275|NCT01214642|3824513|B12||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4004276|NCT01214642|3824514|B11||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4004277|NCT01214642|3824515|B10||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4004278|NCT01214642|3824516|B9||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4004279|NCT01214642|3824517|B8||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4004280|NCT01214642|3824518|B7||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4004281|NCT01214642|3824519|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4004282|NCT01214642|3824520|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4004283|NCT01214642|3824521|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4004284|NCT01214642|3824522|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4004285|NCT01214642|3824523|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4004286|NCT01214642|3824524|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4004287|NCT01214642|3824512|B13||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4004288|NCT01214642|3824513|B12||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4004289|NCT01214642|3824514|B11||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4004290|NCT01214642|3824515|B10||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4004291|NCT01214642|3824516|B9||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4004292|NCT01214642|3824517|B8||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4004293|NCT01214642|3824518|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4004294|NCT01214642|3824519|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4004295|NCT01214642|3824520|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4004296|NCT01214642|3824521|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4004297|NCT01214642|3824522|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4004298|NCT01214642|3824523|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4004299|NCT01214642|3824524|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4004300|NCT01214642|3824512|B13|||Age||years|Mean|60.08|60.08|Standard Deviation|11.471|11.471|||
4004301|NCT01214642|3824513|B12|||Age||years|Mean|59.43|59.43|Standard Deviation|18.595|18.595|||
4004302|NCT01214642|3824514|B11|||Age||years|Mean|60.18|60.18|Standard Deviation|10.205|10.205|||
4004303|NCT01214642|3824515|B10|||Age||years|Mean|57.10|57.1|Standard Deviation|25.069|25.069|||
4004304|NCT01214642|3824516|B9|||Age||years|Mean|62.02|62.02|Standard Deviation|7.598|7.598|||
4004305|NCT01214642|3824517|B8|||Age||years|Mean|67.10|67.1|Standard Deviation|1.212|1.212|||
4004306|NCT01214642|3824518|B7|||Age||years|Mean|59.77|59.77|Standard Deviation|6.959|6.959|||
4004307|NCT01214642|3824519|B6|||Age||years|Mean|56.73|56.73|Standard Deviation|7.267|7.267|||
4004308|NCT01214642|3824520|B5|||Age||years|Mean|58.45|58.45|Standard Deviation|12.425|12.425|||
4004309|NCT01214642|3824521|B4|||Age||years|Mean|61.67|61.67|Standard Deviation|9.352|9.352|||
4004310|NCT01214642|3824522|B3|||Age||years|Mean|59.73|59.73|Standard Deviation|7.541|7.541|||
4004311|NCT01214642|3824523|B2|||Age||years|Mean|48.07|48.07|Standard Deviation|19.657|19.657|||
4004312|NCT01214642|3824524|B1|||Age||years|Mean|66.60|66.6|Standard Deviation|5.484|5.484|||
4004313|NCT01214629|3824604|B12|United States||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
4004314|NCT01214629|3824605|B11|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4004315|NCT01214629|3824606|B10|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4004316|NCT01214629|3824607|B9|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4004317|NCT01214629|3824608|B8|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4004318|NCT01214629|3824609|B7|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4004319|NCT01214629|3824610|B6|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4004320|NCT01214629|3824611|B5|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4004321|NCT01214629|3824612|B4|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4004322|NCT01214629|3824613|B3|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4004323|NCT01214629|3824614|B2|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4004324|NCT01214629|3824615|B1|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4004325|NCT01214629|3824604|B12||Native American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4004326|NCT01214629|3824605|B11||Native American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004327|NCT01214629|3824606|B10||Native American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4004328|NCT01214629|3824607|B9||Native American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004329|NCT01214629|3824608|B8||Native American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004330|NCT01214629|3824609|B7||Native American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004331|NCT01214629|3824610|B6||Native American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004332|NCT01214629|3824611|B5||Native American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004333|NCT01214629|3824612|B4||Native American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004334|NCT01214629|3824613|B3||Native American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004335|NCT01214629|3824614|B2||Native American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004336|NCT01214629|3824615|B1||Native American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004337|NCT01214629|3824604|B12||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4004338|NCT01214629|3824605|B11||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004339|NCT01214629|3824606|B10||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4004340|NCT01214629|3824607|B9||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4004341|NCT01214629|3824608|B8||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004342|NCT01214629|3824609|B7||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004343|NCT01214629|3824610|B6||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004344|NCT01214629|3824611|B5||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004345|NCT01214629|3824612|B4||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004346|NCT01214629|3824613|B3||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004347|NCT01214629|3824614|B2||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4004348|NCT01214629|3824615|B1||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004349|NCT01214629|3824604|B12||East Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004350|NCT01214629|3824605|B11||East Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004351|NCT01214629|3824606|B10||East Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004352|NCT01214629|3824607|B9||East Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004353|NCT01214629|3824608|B8||East Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004354|NCT01214629|3824609|B7||East Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004355|NCT01214629|3824610|B6||East Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004356|NCT01214629|3824611|B5||East Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004357|NCT01214629|3824612|B4||East Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004358|NCT01214629|3824613|B3||East Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004359|NCT01214629|3824614|B2||East Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004360|NCT01214629|3824615|B1||East Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004361|NCT01214629|3824604|B12||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
4004362|NCT01214629|3824605|B11||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4004363|NCT01214629|3824606|B10||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4004364|NCT01214629|3824607|B9||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4004365|NCT01214629|3824608|B8||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4004366|NCT01214629|3824609|B7||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4004367|NCT01214629|3824610|B6||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4004368|NCT01214629|3824611|B5||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4004369|NCT01214629|3824612|B4||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4004370|NCT01214629|3824613|B3||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4004371|NCT01214629|3824614|B2||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004372|NCT01214629|3824615|B1||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004373|NCT01214629|3824604|B12||African|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4004435|NCT01214616|3824690|B1|||Age||years|Mean|63.0|63.0|Standard Deviation|2.0|2.0|||
4004374|NCT01214629|3824605|B11||African|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4004375|NCT01214629|3824606|B10||African|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4004376|NCT01214629|3824607|B9||African|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004377|NCT01214629|3824608|B8||African|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004378|NCT01214629|3824609|B7||African|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004379|NCT01214629|3824610|B6||African|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4004380|NCT01214629|3824611|B5||African|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4004381|NCT01214629|3824612|B4||African|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004382|NCT01214629|3824613|B3||African|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004383|NCT01214629|3824614|B2||African|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4004384|NCT01214629|3824615|B1||African|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4004385|NCT01214629|3824604|B12||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4004386|NCT01214629|3824605|B11||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4004387|NCT01214629|3824606|B10||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4004388|NCT01214629|3824607|B9||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4004389|NCT01214629|3824608|B8||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4004390|NCT01214629|3824609|B7||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4004391|NCT01214629|3824610|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4004392|NCT01214629|3824611|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4004393|NCT01214629|3824612|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4004394|NCT01214629|3824613|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4004395|NCT01214629|3824614|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4004396|NCT01214629|3824615|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4004397|NCT01214629|3824604|B12||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4004398|NCT01214629|3824605|B11||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4004399|NCT01214629|3824606|B10||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4004400|NCT01214629|3824607|B9||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4004401|NCT01214629|3824608|B8||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4004402|NCT01214629|3824609|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4004403|NCT01214629|3824610|B6||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4004404|NCT01214629|3824611|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4004405|NCT01214629|3824612|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4004406|NCT01214629|3824613|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4004407|NCT01214629|3824614|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4004408|NCT01214629|3824615|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4004409|NCT01214629|3824604|B12|||Age||years|Mean|60.27|60.27|Standard Deviation|10.78|10.78|||
4004410|NCT01214629|3824605|B11|||Age||years|Mean|60.13|60.13|Standard Deviation|0.49|0.49|||
4004411|NCT01214629|3824606|B10|||Age||years|Mean|56.82|56.82|Standard Deviation|12.09|12.09|||
4004412|NCT01214629|3824607|B9|||Age||years|Mean|66.97|66.97|Standard Deviation|17.19|17.19|||
4004413|NCT01214629|3824608|B8|||Age||years|Mean|67.26|67.26|Standard Deviation|5.88|5.88|||
4004414|NCT01214629|3824609|B7|||Age||years|Mean|63.38|63.38|Standard Deviation|12.50|12.5|||
4004415|NCT01214629|3824610|B6|||Age||years|Mean|59.79|59.79|Standard Deviation|8.75|8.75|||
4004416|NCT01214629|3824611|B5|||Age||years|Mean|61.30|61.3|Standard Deviation|13.91|13.91|||
4004417|NCT01214629|3824612|B4|||Age||years|Mean|60.78|60.78|Standard Deviation|12.84|12.84|||
4004418|NCT01214629|3824613|B3|||Age||years|Mean|52.37|52.37|Standard Deviation|NA||||N of 1, no standard deviation
4004419|NCT01214629|3824614|B2|||Age||years|Mean|71.20|71.2|Standard Deviation|NA||||N of 1, no standard deviation
4004420|NCT01214629|3824615|B1|||Age||years|Mean|65.01|65.01|Standard Deviation|NA||||N of 1, no standard deviation
4004421|NCT01214616|3824686|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4004422|NCT01214616|3824687|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4004423|NCT01214616|3824688|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4004424|NCT01214616|3824689|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4004425|NCT01214616|3824690|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4004426|NCT01214616|3824686|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4004427|NCT01214616|3824687|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4004428|NCT01214616|3824688|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4004429|NCT01214616|3824689|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4004430|NCT01214616|3824690|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4004431|NCT01214616|3824686|B5|||Age||years|Mean|56.2|56.2|Standard Deviation|8.9|8.9|||
4004432|NCT01214616|3824687|B4|||Age||years|Mean|52.3|52.3|Standard Deviation|11.0|11.0|||
4004433|NCT01214616|3824688|B3|||Age||years|Mean|52.7|52.7|Standard Deviation|11.8|11.8|||
4004434|NCT01214616|3824689|B2|||Age||years|Mean|58.8|58.8|Standard Deviation|4.1|4.1|||
4004436|NCT01214603|3824727|B4|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4004437|NCT01214603|3824728|B3|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4004438|NCT01214603|3824729|B2|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4004439|NCT01214603|3824730|B1|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4004440|NCT01214603|3824727|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004441|NCT01214603|3824728|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004442|NCT01214603|3824729|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004443|NCT01214603|3824730|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004444|NCT01214603|3824727|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004445|NCT01214603|3824728|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004446|NCT01214603|3824729|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004447|NCT01214603|3824730|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004448|NCT01214603|3824727|B4||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4004449|NCT01214603|3824728|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4004450|NCT01214603|3824729|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4004451|NCT01214603|3824730|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4004452|NCT01214603|3824727|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4004453|NCT01214603|3824728|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4004454|NCT01214603|3824729|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004455|NCT01214603|3824730|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004456|NCT01214603|3824727|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004457|NCT01214603|3824728|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004458|NCT01214603|3824729|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004459|NCT01214603|3824730|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004460|NCT01214603|3824727|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004461|NCT01214603|3824728|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004462|NCT01214603|3824729|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004463|NCT01214603|3824730|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004464|NCT01214603|3824727|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004465|NCT01214603|3824728|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004466|NCT01214603|3824729|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004467|NCT01214603|3824730|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004468|NCT01214603|3824727|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004469|NCT01214603|3824728|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004470|NCT01214603|3824729|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004471|NCT01214603|3824730|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004472|NCT01214603|3824727|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4004473|NCT01214603|3824728|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4004474|NCT01214603|3824729|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4004475|NCT01214603|3824730|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4004476|NCT01214603|3824727|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004477|NCT01214603|3824728|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004478|NCT01214603|3824729|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004479|NCT01214603|3824730|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004480|NCT01214603|3824727|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4004481|NCT01214603|3824728|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4004482|NCT01214603|3824729|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4004483|NCT01214603|3824730|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4004484|NCT01214603|3824727|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4004485|NCT01214603|3824728|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4004486|NCT01214603|3824729|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4004487|NCT01214603|3824730|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4004488|NCT01214603|3824727|B4|||Age||years|Mean|68.5|68.5|Standard Deviation|11.73|11.73|||
4004489|NCT01214603|3824728|B3|||Age||years|Mean|67.6|67.6|Standard Deviation|9.81|9.81|||
4004490|NCT01214603|3824729|B2|||Age||years|Mean|61.7|61.7|Standard Deviation|14.98|14.98|||
4004491|NCT01214603|3824730|B1|||Age||years|Mean|75.3|75.3|Standard Deviation|7.16|7.16|||
4004492|NCT01214434|3824753|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4004493|NCT01214434|3824754|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4004494|NCT01214434|3824755|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4004495|NCT01214434|3824753|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4004496|NCT01214434|3824754|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4004497|NCT01214434|3824755|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4004498|NCT01214434|3824753|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4004499|NCT01214434|3824754|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4004500|NCT01214434|3824755|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4004501|NCT01214434|3824753|B3|||Age||years|Mean|1.0|1.0|Standard Deviation|2.3|2.3|||
4004502|NCT01214434|3824754|B2|||Age||years|Mean|0.8|0.8|Standard Deviation|1.6|1.6|||
4004503|NCT01214434|3824755|B1|||Age||years|Mean|1.5|1.5|Standard Deviation|3.5|3.5|||
4004504|NCT01214434|3824753|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4004505|NCT01214434|3824754|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4004506|NCT01214434|3824755|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4004507|NCT01214434|3824753|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4004508|NCT01214434|3824754|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4004509|NCT01214434|3824755|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4004510|NCT01214434|3824753|B3||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
4004511|NCT01214434|3824754|B2||<=18 years|Age||Participants|Count of Participants|27|27.0||||||
4004512|NCT01214434|3824755|B1||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4004513|NCT01214395|3824772|B1|Australia||Region of Enrollment||participants|Number|5|5.0||||||
4004514|NCT01214395|3824772|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4004515|NCT01214395|3824772|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4004516|NCT01214395|3824772|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4004517|NCT01214395|3824772|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4004518|NCT01214395|3824772|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4004519|NCT01214395|3824772|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4004520|NCT01214395|3824772|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4004521|NCT01214395|3824772|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4004522|NCT01214356|3824777|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
4004523|NCT01214356|3824778|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4004524|NCT01214356|3824779|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4004525|NCT01214356|3824777|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004526|NCT01214356|3824778|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004527|NCT01214356|3824779|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004528|NCT01214356|3824777|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004529|NCT01214356|3824778|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004530|NCT01214356|3824779|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004531|NCT01214356|3824777|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004532|NCT01214356|3824778|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004533|NCT01214356|3824779|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004534|NCT01214356|3824777|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4004535|NCT01214356|3824778|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4004536|NCT01214356|3824779|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4004537|NCT01214356|3824777|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004538|NCT01214356|3824778|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004539|NCT01214356|3824779|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004540|NCT01214356|3824777|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004541|NCT01214356|3824778|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004542|NCT01214356|3824779|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004543|NCT01214356|3824777|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004544|NCT01214356|3824778|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004545|NCT01214356|3824779|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004546|NCT01214356|3824777|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4004547|NCT01214356|3824778|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4004548|NCT01214356|3824779|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4004549|NCT01214356|3824777|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4004550|NCT01214356|3824778|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4004551|NCT01214356|3824779|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4004552|NCT01214356|3824777|B3|||Age||years|Mean|53.4|53.4|Standard Deviation|10.7|10.7|||
4004553|NCT01214356|3824778|B2|||Age||years|Mean|53.4|53.4|Standard Deviation|10.7|10.7|||
4004554|NCT01214356|3824779|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|10.7|10.7|||
4004555|NCT01214330|3824786|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4004556|NCT01214330|3824786|B1||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4004557|NCT01214330|3824786|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4004558|NCT01214330|3824786|B1||Between 18 and 65 years|Age||Participants|Count of Participants|102|102.0||||||
4004559|NCT01214330|3824786|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4004560|NCT01214252|3824790|B1|United States||Region of Enrollment||participants|Number|234|234.0||||||
4004561|NCT01214252|3824790|B1|Europe||Region of Enrollment||participants|Number|109|109.0||||||
4004562|NCT01214252|3824790|B1||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4004563|NCT01214252|3824790|B1||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4004564|NCT01214252|3824790|B1|||Age||years|Mean|57.1|57.1|Standard Deviation|14.0|14.0|||
4004565|NCT01214252|3824790|B1||>=65 years|Age||Participants|Count of Participants|107|107.0||||||
4004566|NCT01214252|3824790|B1||Between 18 and 65 years|Age||Participants|Count of Participants|236|236.0||||||
4004567|NCT01214252|3824790|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4004568|NCT01214239|3824796|B3|||Baseline fasting plasma glucose|Baseline fasting plasma glucose|mg/dL|Mean|154.6|154.6|Standard Deviation|35.2|35.2|||
4004569|NCT01214239|3824797|B2|||Baseline fasting plasma glucose|Baseline fasting plasma glucose|mg/dL|Mean|151.4|151.4|Standard Deviation|32.4|32.4|||
4004570|NCT01214239|3824798|B1|||Baseline fasting plasma glucose|Baseline fasting plasma glucose|mg/dL|Mean|161.4|161.4|Standard Deviation|39.9|39.9|||
4004571|NCT01214239|3824796|B3|||Baseline HbA1c|Baseline HbA1c|%|Mean|7.99|7.99|Standard Deviation|0.90|0.9|||
4004572|NCT01214239|3824797|B2|||Baseline HbA1c|Baseline HbA1c|%|Mean|7.95|7.95|Standard Deviation|0.89|0.89|||
4004573|NCT01214239|3824798|B1|||Baseline HbA1c|Baseline HbA1c|%|Mean|8.09|8.09|Standard Deviation|0.91|0.91|||
4004574|NCT01214239|3824796|B3|||BMI|Baseline body mass index (BMI)|kg/m2|Mean|25.4|25.4|Standard Deviation|3.4|3.4|||
4004575|NCT01214239|3824797|B2|||BMI|Baseline body mass index (BMI)|kg/m2|Mean|25.5|25.5|Standard Deviation|3.3|3.3|||
4004576|NCT01214239|3824798|B1|||BMI|Baseline body mass index (BMI)|kg/m2|Mean|25.1|25.1|Standard Deviation|3.4|3.4|||
4004577|NCT01214239|3824796|B3||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4004578|NCT01214239|3824797|B2||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4004579|NCT01214239|3824798|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4004580|NCT01214239|3824796|B3||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4004581|NCT01214239|3824797|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4004582|NCT01214239|3824798|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4004583|NCT01214239|3824796|B3|||Age||years|Mean|54.4|54.4|Standard Deviation|9.8|9.8|||
4004584|NCT01214239|3824797|B2|||Age||years|Mean|54.6|54.6|Standard Deviation|10.1|10.1|||
4004585|NCT01214239|3824798|B1|||Age||years|Mean|54.1|54.1|Standard Deviation|9.3|9.3|||
4004586|NCT01214187|3824831|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
4004587|NCT01214187|3824832|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4004588|NCT01214187|3824833|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4004589|NCT01214187|3824831|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004590|NCT01214187|3824832|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004591|NCT01214187|3824833|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004592|NCT01214187|3824831|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4004593|NCT01214187|3824832|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4004594|NCT01214187|3824833|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4004595|NCT01214187|3824831|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4004596|NCT01214187|3824832|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4004597|NCT01214187|3824833|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4004598|NCT01214187|3824831|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4004599|NCT01214187|3824832|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4004600|NCT01214187|3824833|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4004601|NCT01214187|3824831|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4004602|NCT01214187|3824832|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4004603|NCT01214187|3824833|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4004604|NCT01214187|3824831|B3|||Age||years|Mean|68|68.0|Standard Deviation|7|7.0|||
4004605|NCT01214187|3824832|B2|||Age||years|Mean|68.6|68.6|Standard Deviation|8.4|8.4|||
4004606|NCT01214187|3824833|B1|||Age||years|Mean|66.6|66.6|Standard Deviation|6.1|6.1|||
4004607|NCT01214174|3824848|B4|United States||Region of Enrollment||participants|Number|42|42.0||||||
4004608|NCT01214174|3824849|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4004609|NCT01214174|3824850|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4004610|NCT01214174|3824851|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4004611|NCT01214174|3824848|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4004612|NCT01214174|3824849|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4004613|NCT01214174|3824850|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4004614|NCT01214174|3824851|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4004615|NCT01214174|3824848|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4004616|NCT01214174|3824849|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4004617|NCT01214174|3824850|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4004618|NCT01214174|3824851|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4004619|NCT01214174|3824848|B4|||Age||years|Mean|72.3|72.3|Standard Deviation|7.4|7.4|||
4004620|NCT01214174|3824849|B3|||Age||years|Mean|73.5|73.5|Standard Deviation|7.2|7.2|||
4004621|NCT01214174|3824850|B2|||Age||years|Mean|72.4|72.4|Standard Deviation|8.9|8.9|||
4004622|NCT01214174|3824851|B1|||Age||years|Mean|70.9|70.9|Standard Deviation|5.5|5.5|||
4004623|NCT01214174|3824848|B4||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
4004624|NCT01214174|3824849|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4004625|NCT01214174|3824850|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4004626|NCT01214174|3824851|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4004627|NCT01214174|3824848|B4||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4004628|NCT01214174|3824849|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4004629|NCT01214174|3824850|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4004630|NCT01214174|3824851|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4004631|NCT01214174|3824848|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4004632|NCT01214174|3824849|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4004633|NCT01214174|3824850|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4004634|NCT01214174|3824851|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4004635|NCT01214161|3824861|B3|Copper IUD||IUD type||participants|Number|138|138.0||||||
4004636|NCT01214161|3824862|B2|Copper IUD||IUD type||participants|Number|68|68.0||||||
4004637|NCT01214161|3824863|B1|Copper IUD||IUD type||participants|Number|70|70.0||||||
4004638|NCT01214161|3824861|B3|Levonogestrel IUD||IUD type||participants|Number|62|62.0||||||
4004639|NCT01214161|3824862|B2|Levonogestrel IUD||IUD type||participants|Number|32|32.0||||||
4004640|NCT01214161|3824863|B1|Levonogestrel IUD||IUD type||participants|Number|30|30.0||||||
4004641|NCT01214161|3824861|B3|||Anticipated pain|"The 100 mm visual analogue scale measures pain from 0-100. It is a straight line from no pain to worst pain and it goes from 0 pain on the left to the maximum pain on the right. A higher number reflects more pain. The place where the patient marks her pain is measured from the left and is read as mm."|units on a 100 mm visual analogue scale|Mean|56.6|56.6|Standard Deviation|27|27.0|||
4004642|NCT01214161|3824862|B2|||Anticipated pain|"The 100 mm visual analogue scale measures pain from 0-100. It is a straight line from no pain to worst pain and it goes from 0 pain on the left to the maximum pain on the right. A higher number reflects more pain. The place where the patient marks her pain is measured from the left and is read as mm."|units on a 100 mm visual analogue scale|Mean|57.2|57.2|Standard Deviation|28|28.0|||
4004643|NCT01214161|3824863|B1|||Anticipated pain|"The 100 mm visual analogue scale measures pain from 0-100. It is a straight line from no pain to worst pain and it goes from 0 pain on the left to the maximum pain on the right. A higher number reflects more pain. The place where the patient marks her pain is measured from the left and is read as mm."|units on a 100 mm visual analogue scale|Mean|56.0|56.0|Standard Deviation|26|26.0|||
4004644|NCT01214161|3824861|B3|||Dysmenorrhea|"The 100 mm visual analogue scale measures pain from 0-100. It is a straight line from no pain to worst pain and it goes from 0 pain on the left to the maximum pain on the right. A higher number reflects more pain. The place where the patient marks her pain is measured from the left and is read as mm."|units on a 100mm Visual Analogue Scale|Mean|34.6|34.6|Standard Deviation|28|28.0|||
4004645|NCT01214161|3824862|B2|||Dysmenorrhea|"The 100 mm visual analogue scale measures pain from 0-100. It is a straight line from no pain to worst pain and it goes from 0 pain on the left to the maximum pain on the right. A higher number reflects more pain. The place where the patient marks her pain is measured from the left and is read as mm."|units on a 100mm Visual Analogue Scale|Mean|32.3|32.3|Standard Deviation|28|28.0|||
4004646|NCT01214161|3824863|B1|||Dysmenorrhea|"The 100 mm visual analogue scale measures pain from 0-100. It is a straight line from no pain to worst pain and it goes from 0 pain on the left to the maximum pain on the right. A higher number reflects more pain. The place where the patient marks her pain is measured from the left and is read as mm."|units on a 100mm Visual Analogue Scale|Mean|36.8|36.8|Standard Deviation|29|29.0|||
4004647|NCT01214161|3824861|B3|Parous||Parity||participants|Number|140|140.0||||||
4004648|NCT01214161|3824862|B2|Parous||Parity||participants|Number|79|79.0||||||
4004649|NCT01214161|3824863|B1|Parous||Parity||participants|Number|61|61.0||||||
4004650|NCT01214161|3824861|B3|Nulliparous||Parity||participants|Number|60|60.0||||||
4004651|NCT01214161|3824862|B2|Nulliparous||Parity||participants|Number|21|21.0||||||
4004652|NCT01214161|3824863|B1|Nulliparous||Parity||participants|Number|39|39.0||||||
4004653|NCT01214161|3824861|B3|Other||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4004654|NCT01214161|3824862|B2|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4004655|NCT01214161|3824863|B1|Other||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4004656|NCT01214161|3824861|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4004657|NCT01214161|3824862|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4004658|NCT01214161|3824863|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4004659|NCT01214161|3824861|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|153|153.0||||||
4004660|NCT01214161|3824862|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
4004661|NCT01214161|3824863|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
4004662|NCT01214161|3824861|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4004663|NCT01214161|3824862|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4004664|NCT01214161|3824863|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4004665|NCT01214161|3824861|B3||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4004666|NCT01214161|3824862|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4004667|NCT01214161|3824863|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4004668|NCT01214161|3824861|B3|||Age||years|Mean|27.4|27.4|Standard Deviation|6|6.0|||
4004669|NCT01214161|3824862|B2|||Age||years|Mean|27.6|27.6|Standard Deviation|6|6.0|||
4004670|NCT01214161|3824863|B1|||Age||years|Mean|27.1|27.1|Standard Deviation|6|6.0|||
4004671|NCT01214109|3824874|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4004672|NCT01214109|3824874|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4004673|NCT01214109|3824874|B1|||Age||years|Mean|31|31.0|Standard Deviation|2.2|2.2|||
4004674|NCT01214083|3824966|B4|United States||Region of Enrollment||Participants|Count of Participants|95|95.0||||||
4004675|NCT01214083|3824967|B3|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
4004676|NCT01214083|3824968|B2|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
4004677|NCT01214083|3824969|B1|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
4004678|NCT01214083|3824966|B4||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4004679|NCT01214083|3824967|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4004680|NCT01214083|3824968|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4004681|NCT01214083|3824969|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4004682|NCT01214083|3824966|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4004683|NCT01214083|3824967|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4004684|NCT01214083|3824968|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4004685|NCT01214083|3824969|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4004686|NCT01214083|3824966|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4004687|NCT01214083|3824967|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4004688|NCT01214083|3824968|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4004689|NCT01214083|3824969|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4004690|NCT01214083|3824966|B4||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
4004691|NCT01214083|3824967|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4004692|NCT01214083|3824968|B2||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4004693|NCT01214083|3824969|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4004694|NCT01214083|3824966|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4004695|NCT01214083|3824967|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4004696|NCT01214083|3824968|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4004697|NCT01214083|3824969|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4004698|NCT01213966|3825003|B5|Thailand||Region of Enrollment||participants|Number|82|82.0||||||
4004699|NCT01213966|3825004|B4|Thailand||Region of Enrollment||participants|Number|21|21.0||||||
4004700|NCT01213966|3825005|B3|Thailand||Region of Enrollment||participants|Number|20|20.0||||||
4004701|NCT01213966|3825006|B2|Thailand||Region of Enrollment||participants|Number|21|21.0||||||
4004702|NCT01213966|3825007|B1|Thailand||Region of Enrollment||participants|Number|20|20.0||||||
4004703|NCT01213966|3825003|B5||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4004704|NCT01213966|3825004|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4004705|NCT01213966|3825005|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4004706|NCT01213966|3825006|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4004707|NCT01213966|3825007|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4004708|NCT01213966|3825003|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4004709|NCT01213966|3825004|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4004710|NCT01213966|3825005|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4004711|NCT01213966|3825006|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4004712|NCT01213966|3825007|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4004713|NCT01213966|3825003|B5|||Age||years|Mean|28.1|28.1|Standard Deviation|8.97|8.97|||
4004714|NCT01213966|3825004|B4|||Age||years|Mean|29.3|29.3|Standard Deviation|8.19|8.19|||
4004715|NCT01213966|3825005|B3|||Age||years|Mean|26.7|26.7|Standard Deviation|9.75|9.75|||
4004716|NCT01213966|3825006|B2|||Age||years|Mean|29.1|29.1|Standard Deviation|9.82|9.82|||
4004717|NCT01213966|3825007|B1|||Age||years|Mean|27.2|27.2|Standard Deviation|8.37|8.37|||
4004718|NCT01213966|3825003|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4004719|NCT01213966|3825004|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4004720|NCT01213966|3825005|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4004721|NCT01213966|3825006|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4004722|NCT01213966|3825007|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4004723|NCT01213966|3825003|B5||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
4004724|NCT01213966|3825004|B4||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4004725|NCT01213966|3825005|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4004726|NCT01213966|3825006|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4004727|NCT01213966|3825007|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4004728|NCT01213966|3825003|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4004729|NCT01213966|3825004|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4004730|NCT01213966|3825005|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4004731|NCT01213966|3825006|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4004732|NCT01213966|3825007|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4004733|NCT01213836|3825020|B3|Italy||Region of Enrollment||participants|Number|31|31.0||||||
4004734|NCT01213836|3825021|B2|Italy||Region of Enrollment||participants|Number|18|18.0||||||
4004735|NCT01213836|3825022|B1|Italy||Region of Enrollment||participants|Number|13|13.0||||||
4004736|NCT01213836|3825020|B3|Germany||Region of Enrollment||participants|Number|28|28.0||||||
4004737|NCT01213836|3825021|B2|Germany||Region of Enrollment||participants|Number|10|10.0||||||
4004738|NCT01213836|3825022|B1|Germany||Region of Enrollment||participants|Number|18|18.0||||||
4004739|NCT01213836|3825020|B3|Austria||Region of Enrollment||participants|Number|3|3.0||||||
4004740|NCT01213836|3825021|B2|Austria||Region of Enrollment||participants|Number|2|2.0||||||
4004741|NCT01213836|3825022|B1|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4004742|NCT01213836|3825020|B3|Denmark||Region of Enrollment||participants|Number|2|2.0||||||
4004743|NCT01213836|3825021|B2|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
4004744|NCT01213836|3825022|B1|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
4004745|NCT01213836|3825020|B3|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4004746|NCT01213836|3825021|B2|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4004747|NCT01213836|3825022|B1|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4004748|NCT01213836|3825020|B3|Male||Gender|Of the 66 patients randomised to treatment with XR or IR only 65 patients took any study drug. One patient withdrew before taking any study drug. 65 patients were analysed for baseline measure gender.|participants|Number|45|45.0||||||
4004749|NCT01213836|3825021|B2|Male||Gender|Of the 66 patients randomised to treatment with XR or IR only 65 patients took any study drug. One patient withdrew before taking any study drug. 65 patients were analysed for baseline measure gender.|participants|Number|22|22.0||||||
4004750|NCT01213836|3825022|B1|Male||Gender|Of the 66 patients randomised to treatment with XR or IR only 65 patients took any study drug. One patient withdrew before taking any study drug. 65 patients were analysed for baseline measure gender.|participants|Number|23|23.0||||||
4004751|NCT01213836|3825020|B3|Female||Gender|Of the 66 patients randomised to treatment with XR or IR only 65 patients took any study drug. One patient withdrew before taking any study drug. 65 patients were analysed for baseline measure gender.|participants|Number|20|20.0||||||
4004752|NCT01213836|3825021|B2|Female||Gender|Of the 66 patients randomised to treatment with XR or IR only 65 patients took any study drug. One patient withdrew before taking any study drug. 65 patients were analysed for baseline measure gender.|participants|Number|9|9.0||||||
4004753|NCT01213836|3825022|B1|Female||Gender|Of the 66 patients randomised to treatment with XR or IR only 65 patients took any study drug. One patient withdrew before taking any study drug. 65 patients were analysed for baseline measure gender.|participants|Number|11|11.0||||||
4004754|NCT01213836|3825020|B3|||Age|Of the 66 patients randomised to treatment with XR or IR only 65 patients took any study drug. One patient withdrew before taking any study drug. 65 patients were analysed for baseline measure age.|years|Mean|37.8|37.8|Standard Deviation|6.9|6.9|||
4004755|NCT01213836|3825021|B2|||Age|Of the 66 patients randomised to treatment with XR or IR only 65 patients took any study drug. One patient withdrew before taking any study drug. 65 patients were analysed for baseline measure age.|years|Mean|37.0|37.0|Standard Deviation|5.2|5.2|||
4004756|NCT01213836|3825022|B1|||Age|Of the 66 patients randomised to treatment with XR or IR only 65 patients took any study drug. One patient withdrew before taking any study drug. 65 patients were analysed for baseline measure age.|years|Mean|38.6|38.6|Standard Deviation|8.2|8.2|||
4004757|NCT01213836|3825020|B3|>50 years||Age|Of the 66 patients randomised to treatment with XR or IR only 65 patients took any study drug. One patient withdrew before taking any study drug. 65 patients were analysed for baseline age.|participants|Number|2|2.0||||||
4004758|NCT01213836|3825021|B2|>50 years||Age|Of the 66 patients randomised to treatment with XR or IR only 65 patients took any study drug. One patient withdrew before taking any study drug. 65 patients were analysed for baseline age.|participants|Number|0|0.0||||||
4004759|NCT01213836|3825022|B1|>50 years||Age|Of the 66 patients randomised to treatment with XR or IR only 65 patients took any study drug. One patient withdrew before taking any study drug. 65 patients were analysed for baseline age.|participants|Number|2|2.0||||||
4004760|NCT01213836|3825020|B3|Between 30 and 50 years||Age|Of the 66 patients randomised to treatment with XR or IR only 65 patients took any study drug. One patient withdrew before taking any study drug. 65 patients were analysed for baseline age.|participants|Number|54|54.0||||||
4004761|NCT01213836|3825021|B2|Between 30 and 50 years||Age|Of the 66 patients randomised to treatment with XR or IR only 65 patients took any study drug. One patient withdrew before taking any study drug. 65 patients were analysed for baseline age.|participants|Number|28|28.0||||||
4004762|NCT01213836|3825022|B1|Between 30 and 50 years||Age|Of the 66 patients randomised to treatment with XR or IR only 65 patients took any study drug. One patient withdrew before taking any study drug. 65 patients were analysed for baseline age.|participants|Number|26|26.0||||||
4004821|NCT01213589|3825059|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|14.1|14.1|||
4004763|NCT01213836|3825020|B3|between 18 and 29 years||Age|Of the 66 patients randomised to treatment with XR or IR only 65 patients took any study drug. One patient withdrew before taking any study drug. 65 patients were analysed for baseline age.|participants|Number|9|9.0||||||
4004764|NCT01213836|3825021|B2|between 18 and 29 years||Age|Of the 66 patients randomised to treatment with XR or IR only 65 patients took any study drug. One patient withdrew before taking any study drug. 65 patients were analysed for baseline age.|participants|Number|3|3.0||||||
4004765|NCT01213836|3825022|B1|between 18 and 29 years||Age|Of the 66 patients randomised to treatment with XR or IR only 65 patients took any study drug. One patient withdrew before taking any study drug. 65 patients were analysed for baseline age.|participants|Number|6|6.0||||||
4004766|NCT01213823|3825041|B3||Male|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
4004767|NCT01213823|3825042|B2||Male|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4004768|NCT01213823|3825043|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4004769|NCT01213823|3825041|B3||Female|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
4004770|NCT01213823|3825042|B2||Female|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4004771|NCT01213823|3825043|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4004772|NCT01213823|3825041|B3|Greater than or equal to (>=) 75 years||Age, Customized||Participants|Number|140|140.0||||||
4004773|NCT01213823|3825042|B2|Greater than or equal to (>=) 75 years||Age, Customized||Participants|Number|127|127.0||||||
4004774|NCT01213823|3825043|B1|Greater than or equal to (>=) 75 years||Age, Customized||Participants|Number|13|13.0||||||
4004775|NCT01213823|3825041|B3|65-74 years||Age, Customized||Participants|Number|129|129.0||||||
4004776|NCT01213823|3825042|B2|65-74 years||Age, Customized||Participants|Number|111|111.0||||||
4004777|NCT01213823|3825043|B1|65-74 years||Age, Customized||Participants|Number|18|18.0||||||
4004778|NCT01213823|3825041|B3|55-64 years||Age, Customized||Participants|Number|92|92.0||||||
4004779|NCT01213823|3825042|B2|55-64 years||Age, Customized||Participants|Number|76|76.0||||||
4004780|NCT01213823|3825043|B1|55-64 years||Age, Customized||Participants|Number|16|16.0||||||
4004781|NCT01213823|3825041|B3|45-54 years||Age, Customized||Participants|Number|88|88.0||||||
4004782|NCT01213823|3825042|B2|45-54 years||Age, Customized||Participants|Number|73|73.0||||||
4004783|NCT01213823|3825043|B1|45-54 years||Age, Customized||Participants|Number|15|15.0||||||
4004784|NCT01213823|3825041|B3|35-44 years||Age, Customized||Participants|Number|47|47.0||||||
4004785|NCT01213823|3825042|B2|35-44 years||Age, Customized||Participants|Number|42|42.0||||||
4004786|NCT01213823|3825043|B1|35-44 years||Age, Customized||Participants|Number|5|5.0||||||
4004787|NCT01213823|3825041|B3|25-34 years||Age, Customized||Participants|Number|27|27.0||||||
4004788|NCT01213823|3825042|B2|25-34 years||Age, Customized||Participants|Number|26|26.0||||||
4004789|NCT01213823|3825043|B1|25-34 years||Age, Customized||Participants|Number|1|1.0||||||
4004790|NCT01213823|3825041|B3|18-24 years||Age, Customized||Participants|Number|13|13.0||||||
4004791|NCT01213823|3825042|B2|18-24 years||Age, Customized||Participants|Number|12|12.0||||||
4004792|NCT01213823|3825043|B1|18-24 years||Age, Customized||Participants|Number|1|1.0||||||
4004793|NCT01213706|3825050|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4004794|NCT01213706|3825050|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004795|NCT01213706|3825050|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004796|NCT01213706|3825050|B1||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4004797|NCT01213706|3825050|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4004798|NCT01213706|3825050|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004799|NCT01213706|3825050|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004800|NCT01213706|3825050|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4004801|NCT01213706|3825050|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4004802|NCT01213706|3825050|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4004803|NCT01213706|3825050|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4004804|NCT01213706|3825050|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4004805|NCT01213706|3825050|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4004806|NCT01213589|3825056|B4|Europe||Region of Enrollment||participants|Number|100|100.0||||||
4004807|NCT01213589|3825057|B3|Europe||Region of Enrollment||participants|Number|26|26.0||||||
4004808|NCT01213589|3825058|B2|Europe||Region of Enrollment||participants|Number|24|24.0||||||
4004809|NCT01213589|3825059|B1|Europe||Region of Enrollment||participants|Number|50|50.0||||||
4004810|NCT01213589|3825056|B4||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4004811|NCT01213589|3825057|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4004812|NCT01213589|3825058|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4004813|NCT01213589|3825059|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4004814|NCT01213589|3825056|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4004815|NCT01213589|3825057|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4004816|NCT01213589|3825058|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4004817|NCT01213589|3825059|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4004818|NCT01213589|3825056|B4|||Age||years|Mean|61.2|61.2|Standard Deviation|12.7|12.7|||
4004819|NCT01213589|3825057|B3|||Age||years|Mean|58.8|58.8|Standard Deviation|10.9|10.9|||
4004820|NCT01213589|3825058|B2|||Age||years|Mean|59.7|59.7|Standard Deviation|11.0|11.0|||
4004822|NCT01213589|3825056|B4||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4004823|NCT01213589|3825057|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4004824|NCT01213589|3825058|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4004825|NCT01213589|3825059|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4004826|NCT01213589|3825056|B4||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4004827|NCT01213589|3825057|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4004828|NCT01213589|3825058|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4004829|NCT01213589|3825059|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4004830|NCT01213589|3825056|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4004831|NCT01213589|3825057|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4004832|NCT01213589|3825058|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4004833|NCT01213589|3825059|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4004834|NCT01213576|3825087|B5|||Eosinophil count||cells/uL|Geometric Mean|1300|1300.0|Full Range|||1000.0|1800.0|
4004835|NCT01213576|3825088|B4|||Eosinophil count||cells/uL|Geometric Mean|1100|1100.0|Full Range|||900.0|1500.0|
4004836|NCT01213576|3825089|B3|||Eosinophil count||cells/uL|Geometric Mean|1600|1600.0|Full Range|||1100.0|2100.0|
4004837|NCT01213576|3825090|B2|||Eosinophil count||cells/uL|Geometric Mean|1400|1400.0|Full Range|||1000.0|1900.0|
4004838|NCT01213576|3825091|B1|||Eosinophil count||cells/uL|Geometric Mean|1300|1300.0|Full Range|||1000.0|1700.0|
4004839|NCT01213576|3825087|B5|||HIV status||participants|Number|0|0.0||||||
4004840|NCT01213576|3825088|B4|||HIV status||participants|Number|0|0.0||||||
4004841|NCT01213576|3825089|B3|||HIV status||participants|Number|0|0.0||||||
4004842|NCT01213576|3825090|B2|||HIV status||participants|Number|0|0.0||||||
4004843|NCT01213576|3825091|B1|||HIV status||participants|Number|0|0.0||||||
4004844|NCT01213576|3825087|B5|||Microfilarial count /uL||microfilaria/uL|Geometric Mean|298.6|298.6|Full Range|||207.3|389.4|
4004845|NCT01213576|3825088|B4|||Microfilarial count /uL||microfilaria/uL|Geometric Mean|264.7|264.7|Full Range|||175.0|400.4|
4004846|NCT01213576|3825089|B3|||Microfilarial count /uL||microfilaria/uL|Geometric Mean|204.5|204.5|Full Range|||204.5|287.8|
4004847|NCT01213576|3825090|B2|||Microfilarial count /uL||microfilaria/uL|Geometric Mean|338.7|338.7|Full Range|||198.7|577.4|
4004848|NCT01213576|3825091|B1|||Microfilarial count /uL||microfilaria/uL|Geometric Mean|464.7|464.7|Full Range|||250.1|863.4|
4004849|NCT01213576|3825087|B5|Malawi||Region of Enrollment||participants|Number|70|70.0||||||
4004850|NCT01213576|3825088|B4|Malawi||Region of Enrollment||participants|Number|17|17.0||||||
4004851|NCT01213576|3825089|B3|Malawi||Region of Enrollment||participants|Number|18|18.0||||||
4004852|NCT01213576|3825090|B2|Malawi||Region of Enrollment||participants|Number|17|17.0||||||
4004853|NCT01213576|3825091|B1|Malawi||Region of Enrollment||participants|Number|18|18.0||||||
4004854|NCT01213576|3825087|B5||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4004855|NCT01213576|3825088|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4004856|NCT01213576|3825089|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4004857|NCT01213576|3825090|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4004858|NCT01213576|3825091|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4004859|NCT01213576|3825087|B5||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4004860|NCT01213576|3825088|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4004861|NCT01213576|3825089|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4004862|NCT01213576|3825090|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4004863|NCT01213576|3825091|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4004864|NCT01213576|3825087|B5|||Age||years|Median|33|33.0|Full Range|||18.0|55.0|
4004865|NCT01213576|3825088|B4|||Age||years|Median|35|35.0|Full Range|||20.0|54.0|
4004866|NCT01213576|3825089|B3|||Age||years|Median|27.5|27.5|Full Range|||18.0|55.0|
4004867|NCT01213576|3825090|B2|||Age||years|Median|31|31.0|Full Range|||20.0|53.0|
4004868|NCT01213576|3825091|B1|||Age||years|Median|32.5|32.5|Full Range|||21.0|50.0|
4004869|NCT01213329|3825108|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
4004870|NCT01213329|3825109|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4004871|NCT01213329|3825110|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4004872|NCT01213329|3825108|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4004873|NCT01213329|3825109|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4004874|NCT01213329|3825110|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4004875|NCT01213329|3825108|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4004876|NCT01213329|3825109|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4004877|NCT01213329|3825110|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4004878|NCT01213329|3825108|B3|||Age||years|Mean|42|42.0|Standard Deviation|31.46|31.46|||
4004879|NCT01213329|3825109|B2|||Age||years|Mean|43|43.0|Standard Deviation|9.46|9.46|||
4004880|NCT01213329|3825110|B1|||Age||years|Mean|41|41.0|Standard Deviation|22|22.0|||
4004881|NCT01213329|3825108|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4004882|NCT01213329|3825109|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4004883|NCT01213329|3825110|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4004884|NCT01213329|3825108|B3||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4004885|NCT01213329|3825109|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4004886|NCT01213329|3825110|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4004887|NCT01213329|3825108|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4004888|NCT01213329|3825109|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4004889|NCT01213329|3825110|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4004890|NCT01213316|3825117|B1||Male|Sex: Female, Male||Participants|Count of Participants|382|382.0||||||
4004891|NCT01213316|3825117|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4004892|NCT01213316|3825117|B1|||Age||Years|Mean|50.8|50.8|Standard Deviation|11.5|11.5|||
4004893|NCT01213264|3825133|B4||Male|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
4004894|NCT01213264|3825134|B3||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4004895|NCT01213264|3825135|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4004896|NCT01213264|3825136|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4004897|NCT01213264|3825133|B4||Female|Sex: Female, Male||Participants|Count of Participants|425|425.0||||||
4004898|NCT01213264|3825134|B3||Female|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4004899|NCT01213264|3825135|B2||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4004900|NCT01213264|3825136|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4004901|NCT01213264|3825133|B4|||Age||years|Mean|43.2|43.2|Standard Deviation|13.2|13.2|||
4004902|NCT01213264|3825134|B3|||Age||years|Mean|42.7|42.7|Standard Deviation|12.7|12.7|||
4004903|NCT01213264|3825135|B2|||Age||years|Mean|45.3|45.3|Standard Deviation|13.6|13.6|||
4004904|NCT01213264|3825136|B1|||Age||years|Mean|41.7|41.7|Standard Deviation|13.7|13.7|||
4004905|NCT01213251|3825155|B4|||Minnesota Living with Heart Failure Questionnaire (MLWHF)|Minnesota Living with Heart Failure Questionnaire (MLWHF) is a health-related quality of life questionnaire. The scale ranges from 0 to 105. In particular, the lower the score the better is the patient’s quality of life.|units on a scale|Mean|28|28.0|Standard Deviation|27|27.0|||
4004906|NCT01213251|3825156|B3|||Minnesota Living with Heart Failure Questionnaire (MLWHF)|Minnesota Living with Heart Failure Questionnaire (MLWHF) is a health-related quality of life questionnaire. The scale ranges from 0 to 105. In particular, the lower the score the better is the patient’s quality of life.|units on a scale|Mean|32|32.0|Standard Deviation|29|29.0|||
4004907|NCT01213251|3825157|B2|||Minnesota Living with Heart Failure Questionnaire (MLWHF)|Minnesota Living with Heart Failure Questionnaire (MLWHF) is a health-related quality of life questionnaire. The scale ranges from 0 to 105. In particular, the lower the score the better is the patient’s quality of life.|units on a scale|Mean|29|29.0|Standard Deviation|26|26.0|||
4004908|NCT01213251|3825158|B1|||Minnesota Living with Heart Failure Questionnaire (MLWHF)|Minnesota Living with Heart Failure Questionnaire (MLWHF) is a health-related quality of life questionnaire. The scale ranges from 0 to 105. In particular, the lower the score the better is the patient’s quality of life.|units on a scale|Mean|21|21.0|Standard Deviation|25|25.0|||
4004909|NCT01213251|3825155|B4|Missing||NYHA|The New York Heart Association (NYHA) score classifies patients' heart failure according to the severity of their symptoms. In particular, Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Unable to carry on any physical activity without discomfort.|participants|Number|1|1.0||||||
4004910|NCT01213251|3825156|B3|Missing||NYHA|The New York Heart Association (NYHA) score classifies patients' heart failure according to the severity of their symptoms. In particular, Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Unable to carry on any physical activity without discomfort.|participants|Number|1|1.0||||||
4004911|NCT01213251|3825157|B2|Missing||NYHA|The New York Heart Association (NYHA) score classifies patients' heart failure according to the severity of their symptoms. In particular, Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Unable to carry on any physical activity without discomfort.|participants|Number|0|0.0||||||
4004912|NCT01213251|3825158|B1|Missing||NYHA|The New York Heart Association (NYHA) score classifies patients' heart failure according to the severity of their symptoms. In particular, Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Unable to carry on any physical activity without discomfort.|participants|Number|0|0.0||||||
4004913|NCT01213251|3825155|B4|Subject does not have heart failure||NYHA|The New York Heart Association (NYHA) score classifies patients' heart failure according to the severity of their symptoms. In particular, Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Unable to carry on any physical activity without discomfort.|participants|Number|21|21.0||||||
4004914|NCT01213251|3825156|B3|Subject does not have heart failure||NYHA|The New York Heart Association (NYHA) score classifies patients' heart failure according to the severity of their symptoms. In particular, Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Unable to carry on any physical activity without discomfort.|participants|Number|8|8.0||||||
4004915|NCT01213251|3825157|B2|Subject does not have heart failure||NYHA|The New York Heart Association (NYHA) score classifies patients' heart failure according to the severity of their symptoms. In particular, Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Unable to carry on any physical activity without discomfort.|participants|Number|7|7.0||||||
4004916|NCT01213251|3825158|B1|Subject does not have heart failure||NYHA|The New York Heart Association (NYHA) score classifies patients' heart failure according to the severity of their symptoms. In particular, Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Unable to carry on any physical activity without discomfort.|participants|Number|6|6.0||||||
4004917|NCT01213251|3825155|B4|IV||NYHA|The New York Heart Association (NYHA) score classifies patients' heart failure according to the severity of their symptoms. In particular, Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Unable to carry on any physical activity without discomfort.|participants|Number|0|0.0||||||
4004918|NCT01213251|3825156|B3|IV||NYHA|The New York Heart Association (NYHA) score classifies patients' heart failure according to the severity of their symptoms. In particular, Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Unable to carry on any physical activity without discomfort.|participants|Number|0|0.0||||||
4004919|NCT01213251|3825157|B2|IV||NYHA|The New York Heart Association (NYHA) score classifies patients' heart failure according to the severity of their symptoms. In particular, Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Unable to carry on any physical activity without discomfort.|participants|Number|0|0.0||||||
4004920|NCT01213251|3825158|B1|IV||NYHA|The New York Heart Association (NYHA) score classifies patients' heart failure according to the severity of their symptoms. In particular, Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Unable to carry on any physical activity without discomfort.|participants|Number|0|0.0||||||
4004921|NCT01213251|3825155|B4|III||NYHA|The New York Heart Association (NYHA) score classifies patients' heart failure according to the severity of their symptoms. In particular, Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Unable to carry on any physical activity without discomfort.|participants|Number|36|36.0||||||
4004922|NCT01213251|3825156|B3|III||NYHA|The New York Heart Association (NYHA) score classifies patients' heart failure according to the severity of their symptoms. In particular, Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Unable to carry on any physical activity without discomfort.|participants|Number|9|9.0||||||
4004923|NCT01213251|3825157|B2|III||NYHA|The New York Heart Association (NYHA) score classifies patients' heart failure according to the severity of their symptoms. In particular, Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Unable to carry on any physical activity without discomfort.|participants|Number|12|12.0||||||
4004924|NCT01213251|3825158|B1|III||NYHA|The New York Heart Association (NYHA) score classifies patients' heart failure according to the severity of their symptoms. In particular, Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Unable to carry on any physical activity without discomfort.|participants|Number|15|15.0||||||
4004925|NCT01213251|3825155|B4|II||NYHA|The New York Heart Association (NYHA) score classifies patients' heart failure according to the severity of their symptoms. In particular, Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Unable to carry on any physical activity without discomfort.|participants|Number|36|36.0||||||
4004926|NCT01213251|3825156|B3|II||NYHA|The New York Heart Association (NYHA) score classifies patients' heart failure according to the severity of their symptoms. In particular, Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Unable to carry on any physical activity without discomfort.|participants|Number|16|16.0||||||
4004927|NCT01213251|3825157|B2|II||NYHA|The New York Heart Association (NYHA) score classifies patients' heart failure according to the severity of their symptoms. In particular, Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Unable to carry on any physical activity without discomfort.|participants|Number|10|10.0||||||
4004928|NCT01213251|3825158|B1|II||NYHA|The New York Heart Association (NYHA) score classifies patients' heart failure according to the severity of their symptoms. In particular, Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Unable to carry on any physical activity without discomfort.|participants|Number|10|10.0||||||
4004929|NCT01213251|3825155|B4|I||NYHA|The New York Heart Association (NYHA) score classifies patients' heart failure according to the severity of their symptoms. In particular, Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Unable to carry on any physical activity without discomfort.|participants|Number|32|32.0||||||
4004930|NCT01213251|3825156|B3|I||NYHA|The New York Heart Association (NYHA) score classifies patients' heart failure according to the severity of their symptoms. In particular, Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Unable to carry on any physical activity without discomfort.|participants|Number|11|11.0||||||
4004931|NCT01213251|3825157|B2|I||NYHA|The New York Heart Association (NYHA) score classifies patients' heart failure according to the severity of their symptoms. In particular, Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Unable to carry on any physical activity without discomfort.|participants|Number|12|12.0||||||
4004932|NCT01213251|3825158|B1|I||NYHA|The New York Heart Association (NYHA) score classifies patients' heart failure according to the severity of their symptoms. In particular, Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Unable to carry on any physical activity without discomfort.|participants|Number|9|9.0||||||
4004933|NCT01213251|3825155|B4|||QRS Width (msec)||msec|Mean|93|93.0|Standard Deviation|16|16.0|||
4004934|NCT01213251|3825156|B3|||QRS Width (msec)||msec|Mean|88|88.0|Standard Deviation|13|13.0|||
4004935|NCT01213251|3825157|B2|||QRS Width (msec)||msec|Mean|97|97.0|Standard Deviation|17|17.0|||
4004936|NCT01213251|3825158|B1|||QRS Width (msec)||msec|Mean|94|94.0|Standard Deviation|17|17.0|||
4004937|NCT01213251|3825155|B4|||Left Ventricular End Systolic Volume (LVESV)||mL|Mean|63|63.0|Standard Deviation|23|23.0|||
4004938|NCT01213251|3825156|B3|||Left Ventricular End Systolic Volume (LVESV)||mL|Mean|65|65.0|Standard Deviation|24|24.0|||
4004939|NCT01213251|3825157|B2|||Left Ventricular End Systolic Volume (LVESV)||mL|Mean|62|62.0|Standard Deviation|22|22.0|||
4004940|NCT01213251|3825158|B1|||Left Ventricular End Systolic Volume (LVESV)||mL|Mean|62|62.0|Standard Deviation|23|23.0|||
4004941|NCT01213251|3825155|B4|||Left Ventricular End Diastolic Volume (LVEDV)||mL|Mean|111|111.0|Standard Deviation|29|29.0|||
4004942|NCT01213251|3825156|B3|||Left Ventricular End Diastolic Volume (LVEDV)||mL|Mean|116|116.0|Standard Deviation|29|29.0|||
4004943|NCT01213251|3825157|B2|||Left Ventricular End Diastolic Volume (LVEDV)||mL|Mean|107|107.0|Standard Deviation|31|31.0|||
4004944|NCT01213251|3825158|B1|||Left Ventricular End Diastolic Volume (LVEDV)||mL|Mean|107|107.0|Standard Deviation|25|25.0|||
4004945|NCT01213251|3825155|B4|||Left Ventricular Ejection Fraction (LVEF)||%|Mean|44|44.0|Standard Deviation|9|9.0|||
4004946|NCT01213251|3825156|B3|||Left Ventricular Ejection Fraction (LVEF)||%|Mean|45|45.0|Standard Deviation|9|9.0|||
4004947|NCT01213251|3825157|B2|||Left Ventricular Ejection Fraction (LVEF)||%|Mean|43|43.0|Standard Deviation|10|10.0|||
4004948|NCT01213251|3825158|B1|||Left Ventricular Ejection Fraction (LVEF)||%|Mean|43|43.0|Standard Deviation|9|9.0|||
4004949|NCT01213251|3825155|B4|||Heart Rate from Physical Exam (BPM)||BPM|Mean|79|79.0|Standard Deviation|14|14.0|||
4004950|NCT01213251|3825156|B3|||Heart Rate from Physical Exam (BPM)||BPM|Mean|79|79.0|Standard Deviation|14|14.0|||
4004951|NCT01213251|3825157|B2|||Heart Rate from Physical Exam (BPM)||BPM|Mean|80|80.0|Standard Deviation|13|13.0|||
4004952|NCT01213251|3825158|B1|||Heart Rate from Physical Exam (BPM)||BPM|Mean|80|80.0|Standard Deviation|15|15.0|||
4004953|NCT01213251|3825155|B4|||Diastolic Blood Pressure (mmHg)||mmHg|Mean|73|73.0|Standard Deviation|11|11.0|||
4004954|NCT01213251|3825156|B3|||Diastolic Blood Pressure (mmHg)||mmHg|Mean|74|74.0|Standard Deviation|11|11.0|||
4004955|NCT01213251|3825157|B2|||Diastolic Blood Pressure (mmHg)||mmHg|Mean|71|71.0|Standard Deviation|12|12.0|||
4004956|NCT01213251|3825158|B1|||Diastolic Blood Pressure (mmHg)||mmHg|Mean|73|73.0|Standard Deviation|11|11.0|||
4004957|NCT01213251|3825155|B4|||Systolic Blood Pressure (mmHg)||mmHg|Mean|117|117.0|Standard Deviation|18|18.0|||
4004958|NCT01213251|3825156|B3|||Systolic Blood Pressure (mmHg)||mmHg|Mean|119|119.0|Standard Deviation|17|17.0|||
4004959|NCT01213251|3825157|B2|||Systolic Blood Pressure (mmHg)||mmHg|Mean|118|118.0|Standard Deviation|21|21.0|||
4004960|NCT01213251|3825158|B1|||Systolic Blood Pressure (mmHg)||mmHg|Mean|114|114.0|Standard Deviation|16|16.0|||
4004961|NCT01213251|3825155|B4|||BMI (kg/m^2)||kg/m^2|Mean|29|29.0|Standard Deviation|5|5.0|||
4004962|NCT01213251|3825156|B3|||BMI (kg/m^2)||kg/m^2|Mean|29|29.0|Standard Deviation|4|4.0|||
4004963|NCT01213251|3825157|B2|||BMI (kg/m^2)||kg/m^2|Mean|30|30.0|Standard Deviation|5|5.0|||
4004964|NCT01213251|3825158|B1|||BMI (kg/m^2)||kg/m^2|Mean|28|28.0|Standard Deviation|6|6.0|||
4004965|NCT01213251|3825155|B4|Not reportable per local laws or regulations||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
4004966|NCT01213251|3825156|B3|Not reportable per local laws or regulations||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4004967|NCT01213251|3825157|B2|Not reportable per local laws or regulations||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4004968|NCT01213251|3825158|B1|Not reportable per local laws or regulations||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4004969|NCT01213251|3825155|B4|White or Caucasian||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
4004970|NCT01213251|3825156|B3|White or Caucasian||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4004971|NCT01213251|3825157|B2|White or Caucasian||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4004972|NCT01213251|3825158|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4004973|NCT01213251|3825155|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4004974|NCT01213251|3825156|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4004975|NCT01213251|3825157|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4004976|NCT01213251|3825158|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4004977|NCT01213251|3825155|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4004978|NCT01213251|3825156|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4004979|NCT01213251|3825157|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4004980|NCT01213251|3825158|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4004981|NCT01213251|3825155|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4004982|NCT01213251|3825156|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4004983|NCT01213251|3825157|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4004984|NCT01213251|3825158|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4004985|NCT01213251|3825155|B4||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4004986|NCT01213251|3825156|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4004987|NCT01213251|3825157|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4004988|NCT01213251|3825158|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4004989|NCT01213251|3825155|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4004990|NCT01213251|3825156|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4004991|NCT01213251|3825157|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4004992|NCT01213251|3825158|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4004993|NCT01213251|3825155|B4|||Age||years|Mean|58|58.0|Standard Deviation|11|11.0|||
4004994|NCT01213251|3825156|B3|||Age||years|Mean|54|54.0|Standard Deviation|11|11.0|||
4004995|NCT01213251|3825157|B2|||Age||years|Mean|60|60.0|Standard Deviation|12|12.0|||
4004996|NCT01213251|3825158|B1|||Age||years|Mean|59|59.0|Standard Deviation|10|10.0|||
4004997|NCT01213199|3825181|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4004998|NCT01213199|3825181|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4004999|NCT01213199|3825181|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4005000|NCT01213199|3825181|B1|||Age||years|Mean|35.7|35.7|Standard Deviation|8.71|8.71|||
4005001|NCT01213173|3825185|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4005002|NCT01213173|3825186|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4005003|NCT01213173|3825187|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4005004|NCT01213173|3825185|B3||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4005005|NCT01213173|3825186|B2||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4005006|NCT01213173|3825187|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4005007|NCT01213173|3825185|B3|||Age||Year|Mean|59.2|59.2|Standard Deviation|8.53|8.53|||
4005008|NCT01213173|3825186|B2|||Age||Year|Mean|59.2|59.2|Standard Deviation|9.25|9.25|||
4005009|NCT01213173|3825187|B1|||Age||Year|Mean|59.3|59.3|Standard Deviation|7.81|7.81|||
4005010|NCT01213082|3825218|B4|||best corrected visual acuity||logMAR BCVA|Mean|0.62|0.62|Standard Deviation|0.38|0.38|||
4005011|NCT01213082|3825219|B3|||best corrected visual acuity||logMAR BCVA|Mean|0.55|0.55|Standard Deviation|0.18|0.18|||
4005012|NCT01213082|3825220|B2|||best corrected visual acuity||logMAR BCVA|Mean|0.59|0.59|Standard Deviation|0.51|0.51|||
4005013|NCT01213082|3825221|B1|||best corrected visual acuity||logMAR BCVA|Mean|0.72|0.72|Standard Deviation|0.39|0.39|||
4005014|NCT01213082|3825218|B4|United States||Region of Enrollment||participants|Number|34|34.0||||||
4005015|NCT01213082|3825219|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4005016|NCT01213082|3825220|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4005017|NCT01213082|3825221|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4005018|NCT01213082|3825218|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005019|NCT01213082|3825219|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005020|NCT01213082|3825220|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005021|NCT01213082|3825221|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005022|NCT01213082|3825218|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005023|NCT01213082|3825219|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005024|NCT01213082|3825220|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005025|NCT01213082|3825221|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005026|NCT01213082|3825218|B4||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4005027|NCT01213082|3825219|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4005028|NCT01213082|3825220|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4005029|NCT01213082|3825221|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4005030|NCT01213082|3825218|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005031|NCT01213082|3825219|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005032|NCT01213082|3825220|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005033|NCT01213082|3825221|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005034|NCT01213082|3825218|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005035|NCT01213082|3825219|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005036|NCT01213082|3825220|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005037|NCT01213082|3825221|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005038|NCT01213082|3825218|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005039|NCT01213082|3825219|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005040|NCT01213082|3825220|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005041|NCT01213082|3825221|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005042|NCT01213082|3825218|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005043|NCT01213082|3825219|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005044|NCT01213082|3825220|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005045|NCT01213082|3825221|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005046|NCT01213082|3825218|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4005047|NCT01213082|3825219|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4005048|NCT01213082|3825220|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4005049|NCT01213082|3825221|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4005050|NCT01213082|3825218|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4005051|NCT01213082|3825219|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4005052|NCT01213082|3825220|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4005053|NCT01213082|3825221|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4005054|NCT01213082|3825218|B4||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
4005055|NCT01213082|3825219|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4005056|NCT01213082|3825220|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4005057|NCT01213082|3825221|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4005058|NCT01213082|3825218|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4005059|NCT01213082|3825219|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4005060|NCT01213082|3825220|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4005061|NCT01213082|3825221|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4005062|NCT01213082|3825218|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4005063|NCT01213082|3825219|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4005064|NCT01213082|3825220|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4005065|NCT01213082|3825221|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4005066|NCT01213043|3825234|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005067|NCT01213043|3825235|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005068|NCT01213043|3825236|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005069|NCT01213043|3825234|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005070|NCT01213043|3825235|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005071|NCT01213043|3825236|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005072|NCT01213043|3825234|B3||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4005073|NCT01213043|3825235|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4005074|NCT01213043|3825236|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4005075|NCT01213043|3825234|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005076|NCT01213043|3825235|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005077|NCT01213043|3825236|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005078|NCT01213043|3825234|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005079|NCT01213043|3825235|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005080|NCT01213043|3825236|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005081|NCT01213043|3825234|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005082|NCT01213043|3825235|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005083|NCT01213043|3825236|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005084|NCT01213043|3825234|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005085|NCT01213043|3825235|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005086|NCT01213043|3825236|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005087|NCT01213043|3825234|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4005088|NCT01213043|3825235|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4005089|NCT01213043|3825236|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4005090|NCT01213043|3825234|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4005091|NCT01213043|3825235|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4005092|NCT01213043|3825236|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4005093|NCT01213043|3825234|B3|||Age||years|Mean|58.6|58.6|Standard Deviation|6.62|6.62|||
4005094|NCT01213043|3825235|B2|||Age||years|Mean|57.4|57.4|Standard Deviation|6.34|6.34|||
4005095|NCT01213043|3825236|B1|||Age||years|Mean|59.7|59.7|Standard Deviation|6.89|6.89|||
4005096|NCT01212991|3825263|B3|Korea, Republic of||Region of Enrollment||participants|Number|78|78.0||||||
4005097|NCT01212991|3825264|B2|Korea, Republic of||Region of Enrollment||participants|Number|38|38.0||||||
4005098|NCT01212991|3825265|B1|Korea, Republic of||Region of Enrollment||participants|Number|40|40.0||||||
4005099|NCT01212991|3825263|B3|Sweden||Region of Enrollment||participants|Number|39|39.0||||||
4005100|NCT01212991|3825264|B2|Sweden||Region of Enrollment||participants|Number|18|18.0||||||
4005101|NCT01212991|3825265|B1|Sweden||Region of Enrollment||participants|Number|21|21.0||||||
4005102|NCT01212991|3825263|B3|Japan||Region of Enrollment||participants|Number|61|61.0||||||
4005103|NCT01212991|3825264|B2|Japan||Region of Enrollment||participants|Number|33|33.0||||||
4005104|NCT01212991|3825265|B1|Japan||Region of Enrollment||participants|Number|28|28.0||||||
4005105|NCT01212991|3825263|B3|Germany||Region of Enrollment||participants|Number|83|83.0||||||
4005106|NCT01212991|3825264|B2|Germany||Region of Enrollment||participants|Number|42|42.0||||||
4005107|NCT01212991|3825265|B1|Germany||Region of Enrollment||participants|Number|41|41.0||||||
4005108|NCT01212991|3825263|B3|Netherlands||Region of Enrollment||participants|Number|28|28.0||||||
4005109|NCT01212991|3825264|B2|Netherlands||Region of Enrollment||participants|Number|13|13.0||||||
4005110|NCT01212991|3825265|B1|Netherlands||Region of Enrollment||participants|Number|15|15.0||||||
4005111|NCT01212991|3825263|B3|Denmark||Region of Enrollment||participants|Number|87|87.0||||||
4005112|NCT01212991|3825264|B2|Denmark||Region of Enrollment||participants|Number|44|44.0||||||
4005113|NCT01212991|3825265|B1|Denmark||Region of Enrollment||participants|Number|43|43.0||||||
4005114|NCT01212991|3825263|B3|Australia||Region of Enrollment||participants|Number|232|232.0||||||
4005115|NCT01212991|3825264|B2|Australia||Region of Enrollment||participants|Number|116|116.0||||||
4005116|NCT01212991|3825265|B1|Australia||Region of Enrollment||participants|Number|116|116.0||||||
4005117|NCT01212991|3825263|B3|Singapore||Region of Enrollment||participants|Number|9|9.0||||||
4005118|NCT01212991|3825264|B2|Singapore||Region of Enrollment||participants|Number|4|4.0||||||
4005119|NCT01212991|3825265|B1|Singapore||Region of Enrollment||participants|Number|5|5.0||||||
4005120|NCT01212991|3825263|B3|Belgium||Region of Enrollment||participants|Number|57|57.0||||||
4005121|NCT01212991|3825264|B2|Belgium||Region of Enrollment||participants|Number|29|29.0||||||
4005122|NCT01212991|3825265|B1|Belgium||Region of Enrollment||participants|Number|28|28.0||||||
4005123|NCT01212991|3825263|B3|Poland||Region of Enrollment||participants|Number|39|39.0||||||
4005124|NCT01212991|3825264|B2|Poland||Region of Enrollment||participants|Number|18|18.0||||||
4005125|NCT01212991|3825265|B1|Poland||Region of Enrollment||participants|Number|21|21.0||||||
4005126|NCT01212991|3825263|B3|Canada||Region of Enrollment||participants|Number|179|179.0||||||
4005127|NCT01212991|3825264|B2|Canada||Region of Enrollment||participants|Number|88|88.0||||||
4005128|NCT01212991|3825265|B1|Canada||Region of Enrollment||participants|Number|91|91.0||||||
4005129|NCT01212991|3825263|B3|France||Region of Enrollment||participants|Number|175|175.0||||||
4005130|NCT01212991|3825264|B2|France||Region of Enrollment||participants|Number|90|90.0||||||
4005131|NCT01212991|3825265|B1|France||Region of Enrollment||participants|Number|85|85.0||||||
4005132|NCT01212991|3825263|B3|Italy||Region of Enrollment||participants|Number|30|30.0||||||
4005133|NCT01212991|3825264|B2|Italy||Region of Enrollment||participants|Number|15|15.0||||||
4005134|NCT01212991|3825265|B1|Italy||Region of Enrollment||participants|Number|15|15.0||||||
4005135|NCT01212991|3825263|B3|United Kingdom||Region of Enrollment||participants|Number|153|153.0||||||
4005136|NCT01212991|3825264|B2|United Kingdom||Region of Enrollment||participants|Number|75|75.0||||||
4005137|NCT01212991|3825265|B1|United Kingdom||Region of Enrollment||participants|Number|78|78.0||||||
4005138|NCT01212991|3825263|B3|Israel||Region of Enrollment||participants|Number|25|25.0||||||
4005139|NCT01212991|3825264|B2|Israel||Region of Enrollment||participants|Number|11|11.0||||||
4005140|NCT01212991|3825265|B1|Israel||Region of Enrollment||participants|Number|14|14.0||||||
4005141|NCT01212991|3825263|B3|Russian Federation||Region of Enrollment||participants|Number|22|22.0||||||
4005142|NCT01212991|3825264|B2|Russian Federation||Region of Enrollment||participants|Number|10|10.0||||||
4005143|NCT01212991|3825265|B1|Russian Federation||Region of Enrollment||participants|Number|12|12.0||||||
4005144|NCT01212991|3825263|B3|Austria||Region of Enrollment||participants|Number|18|18.0||||||
4005145|NCT01212991|3825264|B2|Austria||Region of Enrollment||participants|Number|9|9.0||||||
4005146|NCT01212991|3825265|B1|Austria||Region of Enrollment||participants|Number|9|9.0||||||
4005147|NCT01212991|3825263|B3|Lithuania||Region of Enrollment||participants|Number|14|14.0||||||
4005148|NCT01212991|3825264|B2|Lithuania||Region of Enrollment||participants|Number|6|6.0||||||
4005149|NCT01212991|3825265|B1|Lithuania||Region of Enrollment||participants|Number|8|8.0||||||
4005150|NCT01212991|3825263|B3|Spain||Region of Enrollment||participants|Number|81|81.0||||||
4005151|NCT01212991|3825264|B2|Spain||Region of Enrollment||participants|Number|37|37.0||||||
4005152|NCT01212991|3825265|B1|Spain||Region of Enrollment||participants|Number|44|44.0||||||
4005153|NCT01212991|3825263|B3|Finland||Region of Enrollment||participants|Number|33|33.0||||||
4005154|NCT01212991|3825264|B2|Finland||Region of Enrollment||participants|Number|15|15.0||||||
4005155|NCT01212991|3825265|B1|Finland||Region of Enrollment||participants|Number|18|18.0||||||
4005156|NCT01212991|3825263|B3|Slovakia||Region of Enrollment||participants|Number|27|27.0||||||
4005157|NCT01212991|3825264|B2|Slovakia||Region of Enrollment||participants|Number|14|14.0||||||
4005158|NCT01212991|3825265|B1|Slovakia||Region of Enrollment||participants|Number|13|13.0||||||
4005159|NCT01212991|3825263|B3|United States||Region of Enrollment||participants|Number|247|247.0||||||
4005160|NCT01212991|3825264|B2|United States||Region of Enrollment||participants|Number|120|120.0||||||
4005161|NCT01212991|3825265|B1|United States||Region of Enrollment||participants|Number|127|127.0||||||
4005162|NCT01212991|3825263|B3||Male|Sex: Female, Male||Participants|Count of Participants|1717|1717.0||||||
4005163|NCT01212991|3825264|B2||Male|Sex: Female, Male||Participants|Count of Participants|845|845.0||||||
4005164|NCT01212991|3825265|B1||Male|Sex: Female, Male||Participants|Count of Participants|872|872.0||||||
4005165|NCT01212991|3825263|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4005166|NCT01212991|3825264|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4005167|NCT01212991|3825265|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4005168|NCT01212991|3825263|B3||>=65 years|Age||Participants|Count of Participants|1359|1359.0||||||
4005169|NCT01212991|3825264|B2||>=65 years|Age||Participants|Count of Participants|666|666.0||||||
4005170|NCT01212991|3825265|B1||>=65 years|Age||Participants|Count of Participants|693|693.0||||||
4005171|NCT01212991|3825263|B3||Between 18 and 65 years|Age||Participants|Count of Participants|358|358.0||||||
4005172|NCT01212991|3825264|B2||Between 18 and 65 years|Age||Participants|Count of Participants|179|179.0||||||
4005173|NCT01212991|3825265|B1||Between 18 and 65 years|Age||Participants|Count of Participants|179|179.0||||||
4005174|NCT01212991|3825263|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4005175|NCT01212991|3825264|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4005176|NCT01212991|3825265|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4005177|NCT01212991|3825263|B3|||Age||years|Mean|71.3|71.3|Standard Deviation|8.47|8.47|||
4005178|NCT01212991|3825264|B2|||Age||years|Mean|71.2|71.2|Standard Deviation|8.42|8.42|||
4005179|NCT01212991|3825265|B1|||Age||years|Mean|71.3|71.3|Standard Deviation|8.51|8.51|||
4005180|NCT01212900|3825284|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4005181|NCT01212900|3825285|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005182|NCT01212900|3825286|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4005183|NCT01212900|3825284|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4005184|NCT01212900|3825285|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4005185|NCT01212900|3825286|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005186|NCT01212900|3825284|B3||White|Race (NIH/OMB)||Participants|Count of Participants|200|200.0||||||
4005187|NCT01212900|3825285|B2||White|Race (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
4005188|NCT01212900|3825286|B1||White|Race (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
4005189|NCT01212900|3825284|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4005190|NCT01212900|3825285|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4005191|NCT01212900|3825286|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4005192|NCT01212900|3825284|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005193|NCT01212900|3825285|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005194|NCT01212900|3825286|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005195|NCT01212900|3825284|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4005196|NCT01212900|3825285|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4005197|NCT01212900|3825286|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4005198|NCT01212900|3825284|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4005199|NCT01212900|3825285|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4005200|NCT01212900|3825286|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005201|NCT01212900|3825284|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005202|NCT01212900|3825285|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005203|NCT01212900|3825286|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005204|NCT01212900|3825284|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|225|225.0||||||
4005205|NCT01212900|3825285|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
4005206|NCT01212900|3825286|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
4005207|NCT01212900|3825284|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4005208|NCT01212900|3825285|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4005209|NCT01212900|3825286|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4005210|NCT01212900|3825284|B3||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4005211|NCT01212900|3825285|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4005212|NCT01212900|3825286|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4005213|NCT01212900|3825284|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4005214|NCT01212900|3825285|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4005215|NCT01212900|3825286|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4005216|NCT01212900|3825284|B3||>=65 years|Age||Participants|Count of Participants|118|118.0||||||
4005217|NCT01212900|3825285|B2||>=65 years|Age||Participants|Count of Participants|63|63.0||||||
4005218|NCT01212900|3825286|B1||>=65 years|Age||Participants|Count of Participants|55|55.0||||||
4005219|NCT01212900|3825284|B3||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
4005220|NCT01212900|3825285|B2||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4005221|NCT01212900|3825286|B1||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4005222|NCT01212900|3825284|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4005223|NCT01212900|3825285|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4005224|NCT01212900|3825286|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4005225|NCT01212874|3825293|B3|||Body mass index kg/m^2||kg/m^2|Mean|29.6|29.6|Standard Deviation|6.7|6.7|||
4005226|NCT01212874|3825294|B2|||Body mass index kg/m^2||kg/m^2|Mean|29.5|29.5|Standard Deviation|7.7|7.7|||
4005227|NCT01212874|3825295|B1|||Body mass index kg/m^2||kg/m^2|Mean|29.8|29.8|Standard Deviation|5.6|5.6|||
4005228|NCT01212874|3825293|B3|United States||Region of Enrollment||participants|Number|70|70.0||||||
4005229|NCT01212874|3825294|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
4005230|NCT01212874|3825295|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4005231|NCT01212874|3825293|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4005232|NCT01212874|3825294|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4005233|NCT01212874|3825295|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4005234|NCT01212874|3825293|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4005235|NCT01212874|3825294|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4005236|NCT01212874|3825295|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4005237|NCT01212874|3825293|B3|||Age||years|Mean|61.5|61.5|Standard Deviation|12.4|12.4|||
4005238|NCT01212874|3825294|B2|||Age||years|Mean|61.6|61.6|Standard Deviation|13.2|13.2|||
4005239|NCT01212874|3825295|B1|||Age||years|Mean|61.4|61.4|Standard Deviation|11.6|11.6|||
4005240|NCT01212874|3825293|B3||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4005241|NCT01212874|3825294|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4005242|NCT01212874|3825295|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4005243|NCT01212874|3825293|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4005244|NCT01212874|3825294|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4005245|NCT01212874|3825295|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4005246|NCT01212874|3825293|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4005247|NCT01212874|3825294|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4005248|NCT01212874|3825295|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4005249|NCT01212770|3825304|B4|||Duration of psoriatic arthritis||years|Mean|7.33|7.33|Standard Deviation|7.284|7.284|||
4005250|NCT01212770|3825305|B3|||Duration of psoriatic arthritis||years|Mean|7.48|7.48|Standard Deviation|7.646|7.646|||
4005251|NCT01212770|3825306|B2|||Duration of psoriatic arthritis||years|Mean|7.74|7.74|Standard Deviation|7.690|7.69|||
4005252|NCT01212770|3825307|B1|||Duration of psoriatic arthritis||years|Mean|6.78|6.78|Standard Deviation|6.463|6.463|||
4005253|NCT01212770|3825304|B4||Male|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
4005254|NCT01212770|3825305|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4005255|NCT01212770|3825306|B2||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4005256|NCT01212770|3825307|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4005257|NCT01212770|3825304|B4||Female|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
4005258|NCT01212770|3825305|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4005259|NCT01212770|3825306|B2||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4005260|NCT01212770|3825307|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4005261|NCT01212770|3825304|B4|||Age||years|Mean|49.7|49.7|Standard Deviation|11.69|11.69|||
4005262|NCT01212770|3825305|B3|||Age||years|Mean|49.9|49.9|Standard Deviation|11.38|11.38|||
4005263|NCT01212770|3825306|B2|||Age||years|Mean|49.6|49.6|Standard Deviation|12.10|12.1|||
4005264|NCT01212770|3825307|B1|||Age||years|Mean|49.5|49.5|Standard Deviation|11.64|11.64|||
4005265|NCT01212757|3825509|B4|||Duration of Psoriatic Arthritis||years|Mean|7.47|7.47|Standard Deviation|8.163|8.163|||
4005266|NCT01212757|3825510|B3|||Duration of Psoriatic Arthritis||years|Mean|6.82|6.82|Standard Deviation|7.592|7.592|||
4005267|NCT01212757|3825511|B2|||Duration of Psoriatic Arthritis||years|Mean|7.83|7.83|Standard Deviation|8.621|8.621|||
4005268|NCT01212757|3825512|B1|||Duration of Psoriatic Arthritis||years|Mean|7.76|7.76|Standard Deviation|8.254|8.254|||
4005269|NCT01212757|3825509|B4||Male|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4005270|NCT01212757|3825510|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4005271|NCT01212757|3825511|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4005272|NCT01212757|3825512|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4005273|NCT01212757|3825509|B4||Female|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4005274|NCT01212757|3825510|B3||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4005275|NCT01212757|3825511|B2||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4005276|NCT01212757|3825512|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4005277|NCT01212757|3825509|B4|||Age||years|Mean|50.9|50.9|Standard Deviation|11.32|11.32|||
4005278|NCT01212757|3825510|B3|||Age||years|Mean|50.5|50.5|Standard Deviation|11.20|11.2|||
4005279|NCT01212757|3825511|B2|||Age||years|Mean|50.9|50.9|Standard Deviation|11.82|11.82|||
4005280|NCT01212757|3825512|B1|||Age||years|Mean|51.2|51.2|Standard Deviation|10.97|10.97|||
4005281|NCT01212627|3825704|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4005282|NCT01212627|3825704|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4005283|NCT01212627|3825704|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4005284|NCT01212627|3825704|B1|||Age||years|Mean|57.8|57.8|Full Range|||42.0|69.0|
4005285|NCT01212627|3825704|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4005286|NCT01212627|3825704|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4005287|NCT01212627|3825704|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4005288|NCT01212484|3825708|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4005289|NCT01212484|3825708|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4005290|NCT01212484|3825708|B1|||Age||years|Mean|18.5|18.5|Standard Deviation|6.45|6.45|||
4005291|NCT01212484|3825708|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4005292|NCT01212484|3825708|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4005293|NCT01212484|3825708|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4005294|NCT01212445|3825719|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4005295|NCT01212445|3825720|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4005296|NCT01212445|3825721|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4005297|NCT01212445|3825722|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4005298|NCT01212445|3825719|B4||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4005299|NCT01212445|3825720|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4005300|NCT01212445|3825721|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4005301|NCT01212445|3825722|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4005302|NCT01212445|3825719|B4|||Age||years|Mean|46.5|46.5|Standard Deviation|14.85|14.85|||
4005303|NCT01212445|3825720|B3|||Age||years|Mean|43.3|43.3|Standard Deviation|13.8|13.8|||
4005304|NCT01212445|3825721|B2|||Age||years|Mean|50.4|50.4|Standard Deviation|14.27|14.27|||
4005305|NCT01212445|3825722|B1|||Age||years|Mean|45.9|45.9|Standard Deviation|16.31|16.31|||
4005306|NCT01212302|3825753|B1|Germany||Region of Enrollment||participants|Number|504|504.0||||||
4005307|NCT01212302|3825753|B1||Male|Sex: Female, Male||Participants|Count of Participants|350|350.0||||||
4005308|NCT01212302|3825753|B1||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4005309|NCT01212302|3825753|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|11.7|11.7|||
4005310|NCT01212302|3825753|B1||>=65 years|Age||Participants|Count of Participants|210|210.0||||||
4005311|NCT01212302|3825753|B1||Between 18 and 65 years|Age||Participants|Count of Participants|294|294.0||||||
4005312|NCT01212302|3825753|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4005313|NCT01212185|3825757|B3|||Standard drinks/day over the past 2 weeks|A standard drink is defined as: 12-ounces of beer, 8-ounces of malt liquor, 5-ounces of wine, 1.5-ounces of 80-proof distilled spirits or liquor.|standard drinks/day|Mean|16.4|16.4|Standard Deviation|4.7|4.7|||
4005314|NCT01212185|3825758|B2|||Standard drinks/day over the past 2 weeks|A standard drink is defined as: 12-ounces of beer, 8-ounces of malt liquor, 5-ounces of wine, 1.5-ounces of 80-proof distilled spirits or liquor.|standard drinks/day|Mean|17.7|17.7|Standard Deviation|6.0|6.0|||
4005315|NCT01212185|3825759|B1|||Standard drinks/day over the past 2 weeks|A standard drink is defined as: 12-ounces of beer, 8-ounces of malt liquor, 5-ounces of wine, 1.5-ounces of 80-proof distilled spirits or liquor.|standard drinks/day|Mean|14.5|14.5|Standard Deviation|1.7|1.7|||
4005316|NCT01212185|3825757|B3|||CIWA-Ar score|Clinical Institute Withdrawal Assessment for Alcohol (CIWA) scale modified to include vital sign measurements. The CIWA scale measures each of 10 alcohol withdrawal symptoms between 0 and 6 (least to worst). Also in the modified CIWA score are ratings of body temperature (0-3, normal range to increasingly elevated), pulse (0-6), respirations (0-2), and diastolic blood pressure (0-6). So the range of possible total scores on the modified CIWA is 0-77.|units on a scale|Mean|4.5|4.5|Standard Deviation|5.7|5.7|||
4005317|NCT01212185|3825758|B2|||CIWA-Ar score|Clinical Institute Withdrawal Assessment for Alcohol (CIWA) scale modified to include vital sign measurements. The CIWA scale measures each of 10 alcohol withdrawal symptoms between 0 and 6 (least to worst). Also in the modified CIWA score are ratings of body temperature (0-3, normal range to increasingly elevated), pulse (0-6), respirations (0-2), and diastolic blood pressure (0-6). So the range of possible total scores on the modified CIWA is 0-77.|units on a scale|Mean|2.5|2.5|Standard Deviation|1.4|1.4|||
4005318|NCT01212185|3825759|B1|||CIWA-Ar score|Clinical Institute Withdrawal Assessment for Alcohol (CIWA) scale modified to include vital sign measurements. The CIWA scale measures each of 10 alcohol withdrawal symptoms between 0 and 6 (least to worst). Also in the modified CIWA score are ratings of body temperature (0-3, normal range to increasingly elevated), pulse (0-6), respirations (0-2), and diastolic blood pressure (0-6). So the range of possible total scores on the modified CIWA is 0-77.|units on a scale|Mean|9.25|9.25|Standard Deviation|6.6|6.6|||
4005319|NCT01212185|3825757|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4005320|NCT01212185|3825758|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4005321|NCT01212185|3825759|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4005322|NCT01212185|3825757|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005323|NCT01212185|3825758|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005324|NCT01212185|3825759|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005325|NCT01212185|3825757|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4005326|NCT01212185|3825758|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4005327|NCT01212185|3825759|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4005328|NCT01212185|3825757|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005329|NCT01212185|3825758|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005330|NCT01212185|3825759|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005331|NCT01212185|3825757|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005332|NCT01212185|3825758|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005333|NCT01212185|3825759|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005334|NCT01212185|3825757|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005335|NCT01212185|3825758|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005336|NCT01212185|3825759|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005337|NCT01212185|3825757|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4005338|NCT01212185|3825758|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4005339|NCT01212185|3825759|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4005340|NCT01212185|3825757|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4005341|NCT01212185|3825758|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005342|NCT01212185|3825759|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4005523|NCT01211873|3825827|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4005343|NCT01212185|3825757|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005344|NCT01212185|3825758|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005345|NCT01212185|3825759|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005346|NCT01212185|3825757|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005347|NCT01212185|3825758|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005348|NCT01212185|3825759|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005349|NCT01212185|3825757|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005350|NCT01212185|3825758|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005351|NCT01212185|3825759|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005352|NCT01212185|3825757|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4005353|NCT01212185|3825758|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4005354|NCT01212185|3825759|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4005355|NCT01212185|3825757|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4005356|NCT01212185|3825758|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4005357|NCT01212185|3825759|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4005358|NCT01212185|3825757|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4005359|NCT01212185|3825758|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4005360|NCT01212185|3825759|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4005361|NCT01212185|3825757|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4005362|NCT01212185|3825758|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4005363|NCT01212185|3825759|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4005364|NCT01212185|3825757|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4005365|NCT01212185|3825758|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4005366|NCT01212185|3825759|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4005367|NCT01212185|3825757|B3|||Age||years|Mean|41.27|41.27|Standard Deviation|14.67|14.67|||
4005368|NCT01212185|3825758|B2|||Age||years|Mean|42.23|42.23|Standard Deviation|10.87|10.87|||
4005369|NCT01212185|3825759|B1|||Age||years|Mean|40.09|40.09|Standard Deviation|8.32|8.32|||
4005370|NCT01212172|3825768|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4005371|NCT01212172|3825768|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4005372|NCT01212172|3825768|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4005373|NCT01212172|3825768|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4005374|NCT01212172|3825768|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4005375|NCT01212172|3825768|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4005376|NCT01212159|3825777|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
4005377|NCT01212159|3825778|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
4005378|NCT01212159|3825779|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4005379|NCT01212159|3825777|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4005380|NCT01212159|3825778|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4005381|NCT01212159|3825779|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4005382|NCT01212159|3825777|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4005383|NCT01212159|3825778|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4005384|NCT01212159|3825779|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005385|NCT01212159|3825777|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4005386|NCT01212159|3825778|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4005387|NCT01212159|3825779|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4005388|NCT01212159|3825777|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4005389|NCT01212159|3825778|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4005390|NCT01212159|3825779|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4005391|NCT01212159|3825777|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005392|NCT01212159|3825778|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005393|NCT01212159|3825779|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005394|NCT01212159|3825777|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4005395|NCT01212159|3825778|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4005396|NCT01212159|3825779|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4005397|NCT01212159|3825777|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005398|NCT01212159|3825778|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005399|NCT01212159|3825779|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005400|NCT01212159|3825777|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4005401|NCT01212159|3825778|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4005402|NCT01212159|3825779|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4005403|NCT01212159|3825777|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4005404|NCT01212159|3825778|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4005405|NCT01212159|3825779|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4005406|NCT01212159|3825777|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4005407|NCT01212159|3825778|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4005408|NCT01212159|3825779|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4005409|NCT01212159|3825777|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4005410|NCT01212159|3825778|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4005411|NCT01212159|3825779|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4005412|NCT01212159|3825777|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4005413|NCT01212159|3825778|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4005414|NCT01212159|3825779|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4005415|NCT01212159|3825777|B3|||Age||years|Mean|54.6|54.6|Standard Deviation|9.9|9.9|||
4005416|NCT01212159|3825778|B2|||Age||years|Mean|52.5|52.5|Standard Deviation|9.3|9.3|||
4005417|NCT01212159|3825779|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|10.6|10.6|||
4005418|NCT01212094|3825790|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4005419|NCT01212094|3825791|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4005420|NCT01212094|3825792|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005421|NCT01212094|3825793|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005422|NCT01212094|3825790|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4005423|NCT01212094|3825791|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4005424|NCT01212094|3825792|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005425|NCT01212094|3825793|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005426|NCT01212094|3825790|B4||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4005427|NCT01212094|3825791|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4005428|NCT01212094|3825792|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4005429|NCT01212094|3825793|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4005430|NCT01212094|3825790|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4005431|NCT01212094|3825791|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4005432|NCT01212094|3825792|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005433|NCT01212094|3825793|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4005434|NCT01212094|3825790|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005435|NCT01212094|3825791|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005436|NCT01212094|3825792|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005437|NCT01212094|3825793|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005438|NCT01212094|3825790|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005439|NCT01212094|3825791|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005440|NCT01212094|3825792|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005441|NCT01212094|3825793|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005442|NCT01212094|3825790|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005443|NCT01212094|3825791|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005444|NCT01212094|3825792|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005445|NCT01212094|3825793|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005446|NCT01212094|3825790|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4005447|NCT01212094|3825791|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4005448|NCT01212094|3825792|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4005449|NCT01212094|3825793|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4005450|NCT01212094|3825790|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4005451|NCT01212094|3825791|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4005452|NCT01212094|3825792|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4005453|NCT01212094|3825793|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4005454|NCT01212094|3825790|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4005455|NCT01212094|3825791|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4005456|NCT01212094|3825792|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4005457|NCT01212094|3825793|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4005458|NCT01212094|3825790|B4||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4005459|NCT01212094|3825791|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4005460|NCT01212094|3825792|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4005461|NCT01212094|3825793|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4005462|NCT01212094|3825790|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4005463|NCT01212094|3825791|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4005464|NCT01212094|3825792|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4005465|NCT01212094|3825793|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4005466|NCT01211873|3825826|B4|Korea, Republic of||Region of Enrollment||participants|Number|40|40.0||||||
4005467|NCT01211873|3825827|B3|Korea, Republic of||Region of Enrollment||participants|Number|0|0.0||||||
4005468|NCT01211873|3825828|B2|Korea, Republic of||Region of Enrollment||participants|Number|26|26.0||||||
4005469|NCT01211873|3825829|B1|Korea, Republic of||Region of Enrollment||participants|Number|14|14.0||||||
4005470|NCT01211873|3825826|B4|Italy||Region of Enrollment||participants|Number|22|22.0||||||
4005471|NCT01211873|3825827|B3|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4005472|NCT01211873|3825828|B2|Italy||Region of Enrollment||participants|Number|15|15.0||||||
4005473|NCT01211873|3825829|B1|Italy||Region of Enrollment||participants|Number|7|7.0||||||
4005474|NCT01211873|3825826|B4|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
4005475|NCT01211873|3825827|B3|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4005476|NCT01211873|3825828|B2|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4005477|NCT01211873|3825829|B1|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4005478|NCT01211873|3825826|B4|Germany||Region of Enrollment||participants|Number|60|60.0||||||
4005479|NCT01211873|3825827|B3|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4005480|NCT01211873|3825828|B2|Germany||Region of Enrollment||participants|Number|40|40.0||||||
4005481|NCT01211873|3825829|B1|Germany||Region of Enrollment||participants|Number|20|20.0||||||
4005482|NCT01211873|3825826|B4|Chile||Region of Enrollment||participants|Number|11|11.0||||||
4005483|NCT01211873|3825827|B3|Chile||Region of Enrollment||participants|Number|3|3.0||||||
4005484|NCT01211873|3825828|B2|Chile||Region of Enrollment||participants|Number|5|5.0||||||
4005485|NCT01211873|3825829|B1|Chile||Region of Enrollment||participants|Number|3|3.0||||||
4005486|NCT01211873|3825826|B4|Austria||Region of Enrollment||participants|Number|30|30.0||||||
4005487|NCT01211873|3825827|B3|Austria||Region of Enrollment||participants|Number|0|0.0||||||
4005488|NCT01211873|3825828|B2|Austria||Region of Enrollment||participants|Number|20|20.0||||||
4005489|NCT01211873|3825829|B1|Austria||Region of Enrollment||participants|Number|10|10.0||||||
4005490|NCT01211873|3825826|B4|Spain||Region of Enrollment||participants|Number|10|10.0||||||
4005491|NCT01211873|3825827|B3|Spain||Region of Enrollment||participants|Number|0|0.0||||||
4005492|NCT01211873|3825828|B2|Spain||Region of Enrollment||participants|Number|8|8.0||||||
4005493|NCT01211873|3825829|B1|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4005494|NCT01211873|3825826|B4|Brazil||Region of Enrollment||participants|Number|17|17.0||||||
4005495|NCT01211873|3825827|B3|Brazil||Region of Enrollment||participants|Number|4|4.0||||||
4005496|NCT01211873|3825828|B2|Brazil||Region of Enrollment||participants|Number|8|8.0||||||
4005497|NCT01211873|3825829|B1|Brazil||Region of Enrollment||participants|Number|5|5.0||||||
4005498|NCT01211873|3825826|B4|Argentina||Region of Enrollment||participants|Number|48|48.0||||||
4005499|NCT01211873|3825827|B3|Argentina||Region of Enrollment||participants|Number|14|14.0||||||
4005500|NCT01211873|3825828|B2|Argentina||Region of Enrollment||participants|Number|22|22.0||||||
4005501|NCT01211873|3825829|B1|Argentina||Region of Enrollment||participants|Number|12|12.0||||||
4005502|NCT01211873|3825826|B4|France||Region of Enrollment||participants|Number|43|43.0||||||
4005503|NCT01211873|3825827|B3|France||Region of Enrollment||participants|Number|0|0.0||||||
4005504|NCT01211873|3825828|B2|France||Region of Enrollment||participants|Number|30|30.0||||||
4005505|NCT01211873|3825829|B1|France||Region of Enrollment||participants|Number|13|13.0||||||
4005506|NCT01211873|3825826|B4|United States||Region of Enrollment||participants|Number|112|112.0||||||
4005507|NCT01211873|3825827|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4005508|NCT01211873|3825828|B2|United States||Region of Enrollment||participants|Number|65|65.0||||||
4005509|NCT01211873|3825829|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4005510|NCT01211873|3825826|B4||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4005511|NCT01211873|3825827|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4005512|NCT01211873|3825828|B2||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4005513|NCT01211873|3825829|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4005514|NCT01211873|3825826|B4||Female|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4005515|NCT01211873|3825827|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4005516|NCT01211873|3825828|B2||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4005517|NCT01211873|3825829|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4005518|NCT01211873|3825826|B4|||Age||years|Mean|49.8|49.8|Standard Deviation|19.0|19.0|||
4005519|NCT01211873|3825827|B3|||Age||years|Mean|9.29|9.29|Standard Deviation|4.49|4.49|||
4005520|NCT01211873|3825828|B2|||Age||years|Mean|53.17|53.17|Standard Deviation|14.35|14.35|||
4005521|NCT01211873|3825829|B1|||Age||years|Mean|55.95|55.95|Standard Deviation|14.43|14.43|||
4005522|NCT01211873|3825826|B4||>=65 years|Age||Participants|Count of Participants|90|90.0||||||
4005524|NCT01211873|3825828|B2||>=65 years|Age||Participants|Count of Participants|60|60.0||||||
4005525|NCT01211873|3825829|B1||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4005526|NCT01211873|3825826|B4||Between 18 and 65 years|Age||Participants|Count of Participants|274|274.0||||||
4005527|NCT01211873|3825827|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4005528|NCT01211873|3825828|B2||Between 18 and 65 years|Age||Participants|Count of Participants|185|185.0||||||
4005529|NCT01211873|3825829|B1||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
4005530|NCT01211873|3825826|B4||<=18 years|Age||Participants|Count of Participants|38|38.0||||||
4005531|NCT01211873|3825827|B3||<=18 years|Age||Participants|Count of Participants|38|38.0||||||
4005532|NCT01211873|3825828|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4005533|NCT01211873|3825829|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4005534|NCT01211769|3825838|B5|Brazil||Region of Enrollment||participants|Number|80|80.0||||||
4005535|NCT01211769|3825839|B4|Brazil||Region of Enrollment||participants|Number|20|20.0||||||
4005536|NCT01211769|3825840|B3|Brazil||Region of Enrollment||participants|Number|20|20.0||||||
4005537|NCT01211769|3825841|B2|Brazil||Region of Enrollment||participants|Number|20|20.0||||||
4005538|NCT01211769|3825842|B1|Brazil||Region of Enrollment||participants|Number|20|20.0||||||
4005539|NCT01211769|3825838|B5||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4005540|NCT01211769|3825839|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4005541|NCT01211769|3825840|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4005542|NCT01211769|3825841|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4005543|NCT01211769|3825842|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4005544|NCT01211769|3825838|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4005545|NCT01211769|3825839|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4005546|NCT01211769|3825840|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4005547|NCT01211769|3825841|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4005548|NCT01211769|3825842|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4005549|NCT01211769|3825838|B5|||Age||years|Mean|42.67|42.67|Standard Deviation|5.72|5.72|||
4005550|NCT01211769|3825839|B4|||Age||years|Mean|43.33|43.33|Standard Deviation|4.84|4.84|||
4005551|NCT01211769|3825840|B3|||Age||years|Mean|40.66|40.66|Standard Deviation|6.74|6.74|||
4005552|NCT01211769|3825841|B2|||Age||years|Mean|42.0|42.0|Standard Deviation|6.44|6.44|||
4005553|NCT01211769|3825842|B1|||Age||years|Mean|45.0|45.0|Standard Deviation|3.94|3.94|||
4005554|NCT01211769|3825838|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4005555|NCT01211769|3825839|B4||>=65 years|Age||Participants|Count of Participants|00|0.0||||||
4005556|NCT01211769|3825840|B3||>=65 years|Age||Participants|Count of Participants|00|0.0||||||
4005557|NCT01211769|3825841|B2||>=65 years|Age||Participants|Count of Participants|00|0.0||||||
4005558|NCT01211769|3825842|B1||>=65 years|Age||Participants|Count of Participants|00|0.0||||||
4005559|NCT01211769|3825838|B5||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4005560|NCT01211769|3825839|B4||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4005561|NCT01211769|3825840|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4005562|NCT01211769|3825841|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4005563|NCT01211769|3825842|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4005564|NCT01211769|3825838|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4005565|NCT01211769|3825839|B4||<=18 years|Age||Participants|Count of Participants|00|0.0||||||
4005566|NCT01211769|3825840|B3||<=18 years|Age||Participants|Count of Participants|00|0.0||||||
4005567|NCT01211769|3825841|B2||<=18 years|Age||Participants|Count of Participants|00|0.0||||||
4005568|NCT01211769|3825842|B1||<=18 years|Age||Participants|Count of Participants|00|0.0||||||
4005569|NCT01211730|3825863|B3|Hepatitis C Negative||Hepatitis C positive||participants|Number|96|96.0||||||
4005570|NCT01211730|3825864|B2|Hepatitis C Negative||Hepatitis C positive||participants|Number|50|50.0||||||
4005571|NCT01211730|3825865|B1|Hepatitis C Negative||Hepatitis C positive||participants|Number|46|46.0||||||
4005572|NCT01211730|3825863|B3|Hepatitis C Positive||Hepatitis C positive||participants|Number|68|68.0||||||
4005573|NCT01211730|3825864|B2|Hepatitis C Positive||Hepatitis C positive||participants|Number|32|32.0||||||
4005574|NCT01211730|3825865|B1|Hepatitis C Positive||Hepatitis C positive||participants|Number|36|36.0||||||
4005575|NCT01211730|3825863|B3|Liver Plus Kidney||Liver only Transplant||participants|Number|25|25.0||||||
4005576|NCT01211730|3825864|B2|Liver Plus Kidney||Liver only Transplant||participants|Number|14|14.0||||||
4005577|NCT01211730|3825865|B1|Liver Plus Kidney||Liver only Transplant||participants|Number|11|11.0||||||
4005578|NCT01211730|3825863|B3|Liver Only||Liver only Transplant||participants|Number|139|139.0||||||
4005579|NCT01211730|3825864|B2|Liver Only||Liver only Transplant||participants|Number|68|68.0||||||
4005580|NCT01211730|3825865|B1|Liver Only||Liver only Transplant||participants|Number|71|71.0||||||
4005581|NCT01211730|3825863|B3|||Model for End-stage Liver DIsease (MELD) Score|"The MELD Score uses the patient's values for serum bilirubin, serum creatinine, and the international normalized ratio for prothrombin time (INR) to predict survival. It is calculated according to the following formula: MELD = 3.78×ln[serum bilirubin (mg/dL)] + 11.2×ln[INR] + 9.57×ln[serum creatinine (mg/dL)] + 6.43.~In interpreting the MELD Score in hospitalized patients, the 3 month mortality is:~40 or more — 71.3% mortality 30–39 — 52.6% mortality 20–29 — 19.6% mortality 10–19 — 6.0% mortality <9 — 1.9% mortality"|units on a scale|Mean|27.8|27.8|Standard Deviation|8.6|8.6|||
4005582|NCT01211730|3825864|B2|||Model for End-stage Liver DIsease (MELD) Score|"The MELD Score uses the patient's values for serum bilirubin, serum creatinine, and the international normalized ratio for prothrombin time (INR) to predict survival. It is calculated according to the following formula: MELD = 3.78×ln[serum bilirubin (mg/dL)] + 11.2×ln[INR] + 9.57×ln[serum creatinine (mg/dL)] + 6.43.~In interpreting the MELD Score in hospitalized patients, the 3 month mortality is:~40 or more — 71.3% mortality 30–39 — 52.6% mortality 20–29 — 19.6% mortality 10–19 — 6.0% mortality <9 — 1.9% mortality"|units on a scale|Mean|28.2|28.2|Standard Deviation|7.6|7.6|||
4005583|NCT01211730|3825865|B1|||Model for End-stage Liver DIsease (MELD) Score|"The MELD Score uses the patient's values for serum bilirubin, serum creatinine, and the international normalized ratio for prothrombin time (INR) to predict survival. It is calculated according to the following formula: MELD = 3.78×ln[serum bilirubin (mg/dL)] + 11.2×ln[INR] + 9.57×ln[serum creatinine (mg/dL)] + 6.43.~In interpreting the MELD Score in hospitalized patients, the 3 month mortality is:~40 or more — 71.3% mortality 30–39 — 52.6% mortality 20–29 — 19.6% mortality 10–19 — 6.0% mortality <9 — 1.9% mortality"|units on a scale|Mean|27.3|27.3|Standard Deviation|9.4|9.4|||
4005584|NCT01211730|3825863|B3|||body mass index||kg/m^2|Mean|30.1|30.1|Standard Deviation|6.3|6.3|||
4005585|NCT01211730|3825864|B2|||body mass index||kg/m^2|Mean|30.0|30.0|Standard Deviation|6.6|6.6|||
4005586|NCT01211730|3825865|B1|||body mass index||kg/m^2|Mean|30.3|30.3|Standard Deviation|6.0|6.0|||
4005587|NCT01211730|3825863|B3|United States||Region of Enrollment||participants|Number|164|164.0||||||
4005588|NCT01211730|3825864|B2|United States||Region of Enrollment||participants|Number|82|82.0||||||
4005589|NCT01211730|3825865|B1|United States||Region of Enrollment||participants|Number|82|82.0||||||
4005590|NCT01211730|3825863|B3|Unknown||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4005591|NCT01211730|3825864|B2|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4005592|NCT01211730|3825865|B1|Unknown||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4005593|NCT01211730|3825863|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4005594|NCT01211730|3825864|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4005595|NCT01211730|3825865|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4005596|NCT01211730|3825863|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4005597|NCT01211730|3825864|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4005598|NCT01211730|3825865|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4005599|NCT01211730|3825863|B3|Black||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4005600|NCT01211730|3825864|B2|Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4005601|NCT01211730|3825865|B1|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4005602|NCT01211730|3825863|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|120|120.0||||||
4005603|NCT01211730|3825864|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
4005604|NCT01211730|3825865|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
4005605|NCT01211730|3825863|B3||Male|Gender||Participants|Count of Participants|106|106.0||||||
4005606|NCT01211730|3825864|B2||Male|Gender||Participants|Count of Participants|53|53.0||||||
4005607|NCT01211730|3825865|B1||Male|Gender||Participants|Count of Participants|53|53.0||||||
4005608|NCT01211730|3825863|B3||Female|Gender||Participants|Count of Participants|58|58.0||||||
4005609|NCT01211730|3825864|B2||Female|Gender||Participants|Count of Participants|29|29.0||||||
4005610|NCT01211730|3825865|B1||Female|Gender||Participants|Count of Participants|29|29.0||||||
4005611|NCT01211730|3825863|B3|||Age||years|Mean|57.5|57.5|Standard Deviation|7.8|7.8|||
4005612|NCT01211730|3825864|B2|||Age||years|Mean|56.9|56.9|Standard Deviation|7.6|7.6|||
4005613|NCT01211730|3825865|B1|||Age||years|Mean|58.1|58.1|Standard Deviation|8.0|8.0|||
4005614|NCT01211665|3825882|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4005615|NCT01211665|3825883|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4005616|NCT01211665|3825884|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4005617|NCT01211665|3825882|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4005618|NCT01211665|3825883|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4005619|NCT01211665|3825884|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4005620|NCT01211665|3825882|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4005621|NCT01211665|3825883|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4005622|NCT01211665|3825884|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4005623|NCT01211665|3825882|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4005624|NCT01211665|3825883|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4005625|NCT01211665|3825884|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4005626|NCT01211665|3825882|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4005627|NCT01211665|3825883|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4005628|NCT01211665|3825884|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4005629|NCT01211613|3825909|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005630|NCT01211613|3825910|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005631|NCT01211613|3825911|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005632|NCT01211613|3825912|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005633|NCT01211613|3825909|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4005634|NCT01211613|3825910|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005635|NCT01211613|3825911|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4005636|NCT01211613|3825912|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4005637|NCT01211613|3825909|B4||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4005638|NCT01211613|3825910|B3||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4005639|NCT01211613|3825911|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4005640|NCT01211613|3825912|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4005641|NCT01211613|3825909|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4005642|NCT01211613|3825910|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4005643|NCT01211613|3825911|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4005644|NCT01211613|3825912|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4005645|NCT01211613|3825909|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005646|NCT01211613|3825910|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005647|NCT01211613|3825911|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005648|NCT01211613|3825912|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005649|NCT01211613|3825909|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4005650|NCT01211613|3825910|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4005651|NCT01211613|3825911|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005652|NCT01211613|3825912|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4005653|NCT01211613|3825909|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005654|NCT01211613|3825910|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005655|NCT01211613|3825911|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005656|NCT01211613|3825912|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005657|NCT01211613|3825909|B4||Male|Gender||Participants|Count of Participants|40|40.0||||||
4005658|NCT01211613|3825910|B3||Male|Gender||Participants|Count of Participants|14|14.0||||||
4005659|NCT01211613|3825911|B2||Male|Gender||Participants|Count of Participants|14|14.0||||||
4005660|NCT01211613|3825912|B1||Male|Gender||Participants|Count of Participants|12|12.0||||||
4005661|NCT01211613|3825909|B4||Female|Gender||Participants|Count of Participants|67|67.0||||||
4005662|NCT01211613|3825910|B3||Female|Gender||Participants|Count of Participants|21|21.0||||||
4005663|NCT01211613|3825911|B2||Female|Gender||Participants|Count of Participants|21|21.0||||||
4005664|NCT01211613|3825912|B1||Female|Gender||Participants|Count of Participants|25|25.0||||||
4005665|NCT01211613|3825909|B4|||Age||years|Mean|41.1|41.1|Standard Deviation|28.8|28.8|||
4005666|NCT01211613|3825910|B3|||Age||years|Mean|41.3|41.3|Standard Deviation|27.4|27.4|||
4005667|NCT01211613|3825911|B2|||Age||years|Mean|40.4|40.4|Standard Deviation|28.8|28.8|||
4005668|NCT01211613|3825912|B1|||Age||years|Mean|41.4|41.4|Standard Deviation|15.3|15.3|||
4005669|NCT01211535|3825925|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4005670|NCT01211535|3825926|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4005671|NCT01211535|3825927|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4005672|NCT01211535|3825925|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4005673|NCT01211535|3825926|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4005674|NCT01211535|3825927|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4005675|NCT01211535|3825925|B3|||Age||years|Mean|34.3|34.3|Standard Deviation|10.71|10.71|||
4005676|NCT01211535|3825926|B2|||Age||years|Mean|35.4|35.4|Standard Deviation|10.96|10.96|||
4005677|NCT01211535|3825927|B1|||Age||years|Mean|33.3|33.3|Standard Deviation|10.4|10.4|||
4005678|NCT01211340|3825934|B3|United States||Region of Enrollment||participants|Number|446|446.0||||||
4005679|NCT01211340|3825935|B2|United States||Region of Enrollment||participants|Number|223|223.0||||||
4005680|NCT01211340|3825936|B1|United States||Region of Enrollment||participants|Number|223|223.0||||||
4005681|NCT01211340|3825934|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4005682|NCT01211340|3825935|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4005683|NCT01211340|3825936|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4005684|NCT01211340|3825934|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4005685|NCT01211340|3825935|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4005686|NCT01211340|3825936|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4005687|NCT01211340|3825934|B3||White|Race (NIH/OMB)||Participants|Count of Participants|409|409.0||||||
4005688|NCT01211340|3825935|B2||White|Race (NIH/OMB)||Participants|Count of Participants|204|204.0||||||
4005689|NCT01211340|3825936|B1||White|Race (NIH/OMB)||Participants|Count of Participants|205|205.0||||||
4005690|NCT01211340|3825934|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4005691|NCT01211340|3825935|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4005692|NCT01211340|3825936|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4005693|NCT01211340|3825934|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005694|NCT01211340|3825935|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005695|NCT01211340|3825936|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005696|NCT01211340|3825934|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005697|NCT01211340|3825935|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005698|NCT01211340|3825936|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005699|NCT01211340|3825934|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4005700|NCT01211340|3825935|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4005701|NCT01211340|3825936|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4005702|NCT01211340|3825934|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005703|NCT01211340|3825935|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005704|NCT01211340|3825936|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005705|NCT01211340|3825934|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|441|441.0||||||
4005706|NCT01211340|3825935|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|220|220.0||||||
4005707|NCT01211340|3825936|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|221|221.0||||||
4005708|NCT01211340|3825934|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4005709|NCT01211340|3825935|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4005710|NCT01211340|3825936|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4005711|NCT01211340|3825934|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4005712|NCT01211340|3825935|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4005713|NCT01211340|3825936|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4005714|NCT01211340|3825934|B3||Female|Sex: Female, Male||Participants|Count of Participants|350|350.0||||||
4005715|NCT01211340|3825935|B2||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4005716|NCT01211340|3825936|B1||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4005717|NCT01211340|3825934|B3|||Age||years|Mean|59.7|59.7|Standard Deviation|12.9|12.9|||
4005718|NCT01211340|3825935|B2|||Age||years|Mean|60.1|60.1|Standard Deviation|12.5|12.5|||
4005719|NCT01211340|3825936|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|13.3|13.3|||
4005720|NCT01211197|3825947|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4005721|NCT01211197|3825947|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4005722|NCT01211197|3825947|B1|||Age||years|Mean|35.8|35.8|Standard Deviation|7.7|7.7|||
4005723|NCT01211184|3825996|B4|Sweden||Region of Enrollment||participants|Number|60|60.0||||||
4005724|NCT01211184|3825997|B3|Sweden||Region of Enrollment||participants|Number|20|20.0||||||
4005725|NCT01211184|3825998|B2|Sweden||Region of Enrollment||participants|Number|20|20.0||||||
4005726|NCT01211184|3825999|B1|Sweden||Region of Enrollment||participants|Number|20|20.0||||||
4005727|NCT01211184|3825996|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4005728|NCT01211184|3825997|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4005729|NCT01211184|3825998|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4005730|NCT01211184|3825999|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4005731|NCT01211184|3825996|B4||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4005732|NCT01211184|3825997|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4005733|NCT01211184|3825998|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4005734|NCT01211184|3825999|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4005735|NCT01211184|3825996|B4|||Age||years|Mean|66.9|66.9|Standard Deviation|9.8|9.8|||
4005736|NCT01211184|3825997|B3|||Age||years|Mean|65.2|65.2|Standard Deviation|8.0|8.0|||
4005737|NCT01211184|3825998|B2|||Age||years|Mean|66.4|66.4|Standard Deviation|10.6|10.6|||
4005738|NCT01211184|3825999|B1|||Age||years|Mean|68.5|68.5|Standard Deviation|9.6|9.6|||
4005739|NCT01211184|3825996|B4||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
4005740|NCT01211184|3825997|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4005741|NCT01211184|3825998|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4005742|NCT01211184|3825999|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4005743|NCT01211184|3825996|B4||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4005744|NCT01211184|3825997|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4005745|NCT01211184|3825998|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4005746|NCT01211184|3825999|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4005747|NCT01211184|3825996|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4005748|NCT01211184|3825997|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4005749|NCT01211184|3825998|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4005750|NCT01211184|3825999|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4005751|NCT01211145|3826012|B5||Male|Sex: Female, Male|All randomized patients|Participants|Count of Participants|305|305.0||||||
4005752|NCT01211145|3826013|B4||Male|Sex: Female, Male|All randomized patients|Participants|Count of Participants|116|116.0||||||
4005753|NCT01211145|3826014|B3||Male|Sex: Female, Male|All randomized patients|Participants|Count of Participants|37|37.0||||||
4005754|NCT01211145|3826015|B2||Male|Sex: Female, Male|All randomized patients|Participants|Count of Participants|44|44.0||||||
4005755|NCT01211145|3826016|B1||Male|Sex: Female, Male|All randomized patients|Participants|Count of Participants|108|108.0||||||
4005756|NCT01211145|3826012|B5||Female|Sex: Female, Male|All randomized patients|Participants|Count of Participants|493|493.0||||||
4005757|NCT01211145|3826013|B4||Female|Sex: Female, Male|All randomized patients|Participants|Count of Participants|172|172.0||||||
4005758|NCT01211145|3826014|B3||Female|Sex: Female, Male|All randomized patients|Participants|Count of Participants|62|62.0||||||
4005759|NCT01211145|3826015|B2||Female|Sex: Female, Male|All randomized patients|Participants|Count of Participants|71|71.0||||||
4005760|NCT01211145|3826016|B1||Female|Sex: Female, Male|All randomized patients|Participants|Count of Participants|188|188.0||||||
4005761|NCT01211145|3826012|B5|||Age|All randomized patients|Years|Mean|14.4|14.4|Standard Deviation|1.69|1.69|||
4005762|NCT01211145|3826013|B4|||Age|All randomized patients|Years|Mean|14.5|14.5|Standard Deviation|1.67|1.67|||
4005763|NCT01211145|3826014|B3|||Age|All randomized patients|Years|Mean|14.6|14.6|Standard Deviation|1.77|1.77|||
4005764|NCT01211145|3826015|B2|||Age|All randomized patients|Years|Mean|14.5|14.5|Standard Deviation|1.72|1.72|||
4005765|NCT01211145|3826016|B1|||Age|All randomized patients|Years|Mean|14.3|14.3|Standard Deviation|1.67|1.67|||
4005766|NCT01211106|3826049|B3|||Percent days of heavy drinking||percent days heavy drinking|Mean|53.8|53.8|Standard Deviation|29.6|29.6|||
4005767|NCT01211106|3826050|B2|||Percent days of heavy drinking||percent days heavy drinking|Mean|56.0|56.0|Standard Deviation|29.6|29.6|||
4005768|NCT01211106|3826051|B1|||Percent days of heavy drinking||percent days heavy drinking|Mean|51.7|51.7|Standard Deviation|29.5|29.5|||
4005769|NCT01211106|3826049|B3|||PTSD Checklist score|PTSD Checklist score is a standardized self-report rating scale for PTSD comprising 17 items that correspond to the key symptoms of PTSD. Respondents indicate how much they have been bothered by a symptom over the past month using a 5-point (1-5) scale, circling their responses. Responses range from 1 Not at All - 5 Extremely thus the total score ranges from 17 - 85. Lower scores are associated with less severity/symptoms.|units on a scale|Mean|63.0|63.0|Standard Deviation|10.9|10.9|||
4005770|NCT01211106|3826050|B2|||PTSD Checklist score|PTSD Checklist score is a standardized self-report rating scale for PTSD comprising 17 items that correspond to the key symptoms of PTSD. Respondents indicate how much they have been bothered by a symptom over the past month using a 5-point (1-5) scale, circling their responses. Responses range from 1 Not at All - 5 Extremely thus the total score ranges from 17 - 85. Lower scores are associated with less severity/symptoms.|units on a scale|Mean|63.6|63.6|Standard Deviation|10.3|10.3|||
4005771|NCT01211106|3826051|B1|||PTSD Checklist score|PTSD Checklist score is a standardized self-report rating scale for PTSD comprising 17 items that correspond to the key symptoms of PTSD. Respondents indicate how much they have been bothered by a symptom over the past month using a 5-point (1-5) scale, circling their responses. Responses range from 1 Not at All - 5 Extremely thus the total score ranges from 17 - 85. Lower scores are associated with less severity/symptoms.|units on a scale|Mean|62.5|62.5|Standard Deviation|11.3|11.3|||
4005772|NCT01211106|3826049|B3|United States||Region of Enrollment||participants|Number|183|183.0||||||
4005773|NCT01211106|3826050|B2|United States||Region of Enrollment||participants|Number|88|88.0||||||
4005774|NCT01211106|3826051|B1|United States||Region of Enrollment||participants|Number|95|95.0||||||
4005775|NCT01211106|3826049|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4005776|NCT01211106|3826050|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4005777|NCT01211106|3826051|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4005778|NCT01211106|3826049|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4005779|NCT01211106|3826050|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4005780|NCT01211106|3826051|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4005781|NCT01211106|3826049|B3||White|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4005782|NCT01211106|3826050|B2||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4005783|NCT01211106|3826051|B1||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4005784|NCT01211106|3826049|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
4005785|NCT01211106|3826050|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4005786|NCT01211106|3826051|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4005787|NCT01211106|3826049|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4005788|NCT01211106|3826050|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4005789|NCT01211106|3826051|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4005790|NCT01211106|3826049|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4005791|NCT01211106|3826050|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005792|NCT01211106|3826051|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4005793|NCT01211106|3826049|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4005794|NCT01211106|3826050|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4005795|NCT01211106|3826051|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4005796|NCT01211106|3826049|B3||Male|Gender||Participants|Count of Participants|169|169.0||||||
4005797|NCT01211106|3826050|B2||Male|Gender||Participants|Count of Participants|79|79.0||||||
4005798|NCT01211106|3826051|B1||Male|Gender||Participants|Count of Participants|90|90.0||||||
4005799|NCT01211106|3826049|B3||Female|Gender||Participants|Count of Participants|14|14.0||||||
4005800|NCT01211106|3826050|B2||Female|Gender||Participants|Count of Participants|9|9.0||||||
4005801|NCT01211106|3826051|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
4005802|NCT01211106|3826049|B3|||Age||years|Mean|44.1|44.1|Standard Deviation|13.0|13.0|||
4005803|NCT01211106|3826050|B2|||Age||years|Mean|43.8|43.8|Standard Deviation|13.0|13.0|||
4005804|NCT01211106|3826051|B1|||Age||years|Mean|44.1|44.1|Standard Deviation|13.1|13.1|||
4005805|NCT01210820|3826060|B3|Austria||Region of Enrollment||participants|Number|21|21.0||||||
4005806|NCT01210820|3826061|B2|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4005807|NCT01210820|3826062|B1|Austria||Region of Enrollment||participants|Number|17|17.0||||||
4005808|NCT01210820|3826060|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4005809|NCT01210820|3826061|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4005810|NCT01210820|3826062|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4005811|NCT01210820|3826060|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4005812|NCT01210820|3826061|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4005813|NCT01210820|3826062|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4005814|NCT01210820|3826060|B3|||Age||years|Mean|65|65.0|Standard Deviation|12.2|12.2|||
4005815|NCT01210820|3826061|B2|||Age||years|Mean|61|61.0|Standard Deviation|12.1|12.1|||
4005816|NCT01210820|3826062|B1|||Age||years|Mean|66|66.0|Standard Deviation|12.4|12.4|||
4005817|NCT01210807|3826071|B3||Male|Sex: Female, Male|A total of 34 ZMB00 multifocal and 33 ZCB00 monofocal subjects were implanted bilaterally. Data analysis for baseline characteristics was completed on these 67 subjects.|Participants|Count of Participants|27|27.0||||||
4005818|NCT01210807|3826072|B2||Male|Sex: Female, Male|A total of 34 ZMB00 multifocal and 33 ZCB00 monofocal subjects were implanted bilaterally. Data analysis for baseline characteristics was completed on these 67 subjects.|Participants|Count of Participants|16|16.0||||||
4005819|NCT01210807|3826073|B1||Male|Sex: Female, Male|A total of 34 ZMB00 multifocal and 33 ZCB00 monofocal subjects were implanted bilaterally. Data analysis for baseline characteristics was completed on these 67 subjects.|Participants|Count of Participants|11|11.0||||||
4005820|NCT01210807|3826071|B3||Female|Sex: Female, Male|A total of 34 ZMB00 multifocal and 33 ZCB00 monofocal subjects were implanted bilaterally. Data analysis for baseline characteristics was completed on these 67 subjects.|Participants|Count of Participants|40|40.0||||||
4005821|NCT01210807|3826072|B2||Female|Sex: Female, Male|A total of 34 ZMB00 multifocal and 33 ZCB00 monofocal subjects were implanted bilaterally. Data analysis for baseline characteristics was completed on these 67 subjects.|Participants|Count of Participants|17|17.0||||||
4005822|NCT01210807|3826073|B1||Female|Sex: Female, Male|A total of 34 ZMB00 multifocal and 33 ZCB00 monofocal subjects were implanted bilaterally. Data analysis for baseline characteristics was completed on these 67 subjects.|Participants|Count of Participants|23|23.0||||||
4005823|NCT01210807|3826071|B3|||Age|A total of 34 ZMB00 multifocal and 33 ZCB00 monofocal subjects were implanted bilaterally. Data analysis for baseline characteristics was completed on these 67 subjects.|years|Mean|65.9|65.9|Standard Deviation|11.6|11.6|||
4005824|NCT01210807|3826072|B2|||Age|A total of 34 ZMB00 multifocal and 33 ZCB00 monofocal subjects were implanted bilaterally. Data analysis for baseline characteristics was completed on these 67 subjects.|years|Mean|68.3|68.3|Standard Deviation|11.3|11.3|||
4005825|NCT01210807|3826073|B1|||Age|A total of 34 ZMB00 multifocal and 33 ZCB00 monofocal subjects were implanted bilaterally. Data analysis for baseline characteristics was completed on these 67 subjects.|years|Mean|63.1|63.1|Standard Deviation|11.4|11.4|||
4005826|NCT01210716|3826082|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4005827|NCT01210716|3826082|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4005828|NCT01210716|3826082|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4005829|NCT01210716|3826082|B1|||Age||years|Mean|50.7|50.7|Standard Deviation|13.7|13.7|||
4005830|NCT01210716|3826082|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4005831|NCT01210716|3826082|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4005832|NCT01210716|3826082|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4005833|NCT01210690|3826089|B1|||Height||centimeter|Mean|64.16|64.16|Standard Deviation|8.04|8.04|||
4005834|NCT01210690|3826089|B1|||Weight||kilogram|Mean|7.00|7.0|Standard Deviation|1.94|1.94|||
4005835|NCT01210690|3826089|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4005836|NCT01210690|3826089|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4005837|NCT01210690|3826089|B1|>11 months||Age, Customized||participants|Number|0|0.0||||||
4005838|NCT01210690|3826089|B1|≥6 - ≤11 months||Age, Customized||participants|Number|46|46.0||||||
4005839|NCT01210690|3826089|B1|≥1 - ≤6 months||Age, Customized||participants|Number|53|53.0||||||
4005840|NCT01210690|3826089|B1|<1 month||Age, Customized||participants|Number|2|2.0||||||
4005841|NCT01210690|3826089|B1|||Age||months|Mean|6.0|6.0|Standard Deviation|3.0|3.0|||
4005842|NCT01210664|3826102|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4005843|NCT01210664|3826102|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005844|NCT01210664|3826102|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005845|NCT01210664|3826102|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4005846|NCT01210664|3826102|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4005847|NCT01210664|3826102|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005848|NCT01210664|3826102|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005849|NCT01210664|3826102|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005850|NCT01210664|3826102|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4005851|NCT01210664|3826102|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4005852|NCT01210664|3826102|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4005853|NCT01210664|3826102|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4005854|NCT01210664|3826102|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4005855|NCT01210664|3826102|B1|||Age||years|Mean|30.3|30.3|Standard Deviation|8.7|8.7|||
4005856|NCT01210651|3826131|B3|||Screening Score on Folstein Mini Mental Status Exam|The Folstein Mini Mental Status Exam (MMSE) is a validated, clinician-administered instrument for assessing cognition via tests of orientation, attention, calculation, memory, and both written and spoken language. Scores from each cognitive test are summed to derive a total score ranging from 0 (worst score) to 30 (best score). Cognitive performance as measured by the MMSE varies within the population by age and educational level, but scores below 24 may suggest cognitive impairment.|points on a scale|Mean|28.0|28.0|Standard Deviation|1.6|1.6|||
4005857|NCT01210651|3826132|B2|||Screening Score on Folstein Mini Mental Status Exam|The Folstein Mini Mental Status Exam (MMSE) is a validated, clinician-administered instrument for assessing cognition via tests of orientation, attention, calculation, memory, and both written and spoken language. Scores from each cognitive test are summed to derive a total score ranging from 0 (worst score) to 30 (best score). Cognitive performance as measured by the MMSE varies within the population by age and educational level, but scores below 24 may suggest cognitive impairment.|points on a scale|Mean|28.4|28.4|Standard Deviation|1.2|1.2|||
4005858|NCT01210651|3826133|B1|||Screening Score on Folstein Mini Mental Status Exam|The Folstein Mini Mental Status Exam (MMSE) is a validated, clinician-administered instrument for assessing cognition via tests of orientation, attention, calculation, memory, and both written and spoken language. Scores from each cognitive test are summed to derive a total score ranging from 0 (worst score) to 30 (best score). Cognitive performance as measured by the MMSE varies within the population by age and educational level, but scores below 24 may suggest cognitive impairment.|points on a scale|Mean|27.7|27.7|Standard Deviation|1.8|1.8|||
4005859|NCT01210651|3826131|B3|||Screening Score on Beck Depression Inventory-II|The Beck Depression Inventory-II (BDI) is a 21-item validated instrument for the self-report of depressive symptoms, with individual item scores summed to yield a total possible BDI score that ranges from 0-63. BDI scores from 0-13 suggest absent to minimal depressive symptoms, from 14-19 mild symptoms, from 20-28 moderate symptoms, and from 29-63 severe symptoms.|points on a scale|Mean|22.4|22.4|Standard Deviation|4.5|4.5|||
4005860|NCT01210651|3826132|B2|||Screening Score on Beck Depression Inventory-II|The Beck Depression Inventory-II (BDI) is a 21-item validated instrument for the self-report of depressive symptoms, with individual item scores summed to yield a total possible BDI score that ranges from 0-63. BDI scores from 0-13 suggest absent to minimal depressive symptoms, from 14-19 mild symptoms, from 20-28 moderate symptoms, and from 29-63 severe symptoms.|points on a scale|Mean|22.4|22.4|Standard Deviation|4.6|4.6|||
4005861|NCT01210651|3826133|B1|||Screening Score on Beck Depression Inventory-II|The Beck Depression Inventory-II (BDI) is a 21-item validated instrument for the self-report of depressive symptoms, with individual item scores summed to yield a total possible BDI score that ranges from 0-63. BDI scores from 0-13 suggest absent to minimal depressive symptoms, from 14-19 mild symptoms, from 20-28 moderate symptoms, and from 29-63 severe symptoms.|points on a scale|Mean|22.8|22.8|Standard Deviation|4.4|4.4|||
4005862|NCT01210651|3826131|B3|Participants with 4+ prior trials||Participants with Prior Antidepressant Trials|During the Mini International Neuro-Psychiatric Interview conducted at screening, participant reported on the total number of anti-depressant medication trials, if any, received as treatment during any prior depressive episodes.|Participants|Count of Participants|1|1.0||||||
4005863|NCT01210651|3826132|B2|Participants with 4+ prior trials||Participants with Prior Antidepressant Trials|During the Mini International Neuro-Psychiatric Interview conducted at screening, participant reported on the total number of anti-depressant medication trials, if any, received as treatment during any prior depressive episodes.|Participants|Count of Participants|1|1.0||||||
4005864|NCT01210651|3826133|B1|Participants with 4+ prior trials||Participants with Prior Antidepressant Trials|During the Mini International Neuro-Psychiatric Interview conducted at screening, participant reported on the total number of anti-depressant medication trials, if any, received as treatment during any prior depressive episodes.|Participants|Count of Participants|0|0.0||||||
4005865|NCT01210651|3826131|B3|Participants with 3 prior trials||Participants with Prior Antidepressant Trials|During the Mini International Neuro-Psychiatric Interview conducted at screening, participant reported on the total number of anti-depressant medication trials, if any, received as treatment during any prior depressive episodes.|Participants|Count of Participants|4|4.0||||||
4005866|NCT01210651|3826132|B2|Participants with 3 prior trials||Participants with Prior Antidepressant Trials|During the Mini International Neuro-Psychiatric Interview conducted at screening, participant reported on the total number of anti-depressant medication trials, if any, received as treatment during any prior depressive episodes.|Participants|Count of Participants|1|1.0||||||
4005867|NCT01210651|3826133|B1|Participants with 3 prior trials||Participants with Prior Antidepressant Trials|During the Mini International Neuro-Psychiatric Interview conducted at screening, participant reported on the total number of anti-depressant medication trials, if any, received as treatment during any prior depressive episodes.|Participants|Count of Participants|3|3.0||||||
4005868|NCT01210651|3826131|B3|Participants with 2 prior trials||Participants with Prior Antidepressant Trials|During the Mini International Neuro-Psychiatric Interview conducted at screening, participant reported on the total number of anti-depressant medication trials, if any, received as treatment during any prior depressive episodes.|Participants|Count of Participants|5|5.0||||||
4005869|NCT01210651|3826132|B2|Participants with 2 prior trials||Participants with Prior Antidepressant Trials|During the Mini International Neuro-Psychiatric Interview conducted at screening, participant reported on the total number of anti-depressant medication trials, if any, received as treatment during any prior depressive episodes.|Participants|Count of Participants|3|3.0||||||
4005870|NCT01210651|3826133|B1|Participants with 2 prior trials||Participants with Prior Antidepressant Trials|During the Mini International Neuro-Psychiatric Interview conducted at screening, participant reported on the total number of anti-depressant medication trials, if any, received as treatment during any prior depressive episodes.|Participants|Count of Participants|2|2.0||||||
4005871|NCT01210651|3826131|B3|Participants with 1 prior trial||Participants with Prior Antidepressant Trials|During the Mini International Neuro-Psychiatric Interview conducted at screening, participant reported on the total number of anti-depressant medication trials, if any, received as treatment during any prior depressive episodes.|Participants|Count of Participants|15|15.0||||||
4005872|NCT01210651|3826132|B2|Participants with 1 prior trial||Participants with Prior Antidepressant Trials|During the Mini International Neuro-Psychiatric Interview conducted at screening, participant reported on the total number of anti-depressant medication trials, if any, received as treatment during any prior depressive episodes.|Participants|Count of Participants|10|10.0||||||
4005873|NCT01210651|3826133|B1|Participants with 1 prior trial||Participants with Prior Antidepressant Trials|During the Mini International Neuro-Psychiatric Interview conducted at screening, participant reported on the total number of anti-depressant medication trials, if any, received as treatment during any prior depressive episodes.|Participants|Count of Participants|5|5.0||||||
4005874|NCT01210651|3826131|B3|Participants with 0 prior trials||Participants with Prior Antidepressant Trials|During the Mini International Neuro-Psychiatric Interview conducted at screening, participant reported on the total number of anti-depressant medication trials, if any, received as treatment during any prior depressive episodes.|Participants|Count of Participants|13|13.0||||||
4005875|NCT01210651|3826132|B2|Participants with 0 prior trials||Participants with Prior Antidepressant Trials|During the Mini International Neuro-Psychiatric Interview conducted at screening, participant reported on the total number of anti-depressant medication trials, if any, received as treatment during any prior depressive episodes.|Participants|Count of Participants|3|3.0||||||
4005876|NCT01210651|3826133|B1|Participants with 0 prior trials||Participants with Prior Antidepressant Trials|During the Mini International Neuro-Psychiatric Interview conducted at screening, participant reported on the total number of anti-depressant medication trials, if any, received as treatment during any prior depressive episodes.|Participants|Count of Participants|10|10.0||||||
4005877|NCT01210651|3826131|B3|Participants with 3 prior episodes||Participants with Prior Depressive Episodes|During the Mini International Neuro-Psychiatric Interview conducted at screening, participant was asked questions to ascertain the number of any prior discrete mood episodes meeting criteria for unipolar major depression.|Participants|Count of Participants|3|3.0||||||
4005878|NCT01210651|3826132|B2|Participants with 3 prior episodes||Participants with Prior Depressive Episodes|During the Mini International Neuro-Psychiatric Interview conducted at screening, participant was asked questions to ascertain the number of any prior discrete mood episodes meeting criteria for unipolar major depression.|Participants|Count of Participants|2|2.0||||||
4005879|NCT01210651|3826133|B1|Participants with 3 prior episodes||Participants with Prior Depressive Episodes|During the Mini International Neuro-Psychiatric Interview conducted at screening, participant was asked questions to ascertain the number of any prior discrete mood episodes meeting criteria for unipolar major depression.|Participants|Count of Participants|1|1.0||||||
4005880|NCT01210651|3826131|B3|Participants with 2 prior episodes||Participants with Prior Depressive Episodes|During the Mini International Neuro-Psychiatric Interview conducted at screening, participant was asked questions to ascertain the number of any prior discrete mood episodes meeting criteria for unipolar major depression.|Participants|Count of Participants|9|9.0||||||
4005881|NCT01210651|3826132|B2|Participants with 2 prior episodes||Participants with Prior Depressive Episodes|During the Mini International Neuro-Psychiatric Interview conducted at screening, participant was asked questions to ascertain the number of any prior discrete mood episodes meeting criteria for unipolar major depression.|Participants|Count of Participants|5|5.0||||||
4005882|NCT01210651|3826133|B1|Participants with 2 prior episodes||Participants with Prior Depressive Episodes|During the Mini International Neuro-Psychiatric Interview conducted at screening, participant was asked questions to ascertain the number of any prior discrete mood episodes meeting criteria for unipolar major depression.|Participants|Count of Participants|4|4.0||||||
4005883|NCT01210651|3826131|B3|Participants with 1 prior episode||Participants with Prior Depressive Episodes|During the Mini International Neuro-Psychiatric Interview conducted at screening, participant was asked questions to ascertain the number of any prior discrete mood episodes meeting criteria for unipolar major depression.|Participants|Count of Participants|22|22.0||||||
4005884|NCT01210651|3826132|B2|Participants with 1 prior episode||Participants with Prior Depressive Episodes|During the Mini International Neuro-Psychiatric Interview conducted at screening, participant was asked questions to ascertain the number of any prior discrete mood episodes meeting criteria for unipolar major depression.|Participants|Count of Participants|10|10.0||||||
4005885|NCT01210651|3826133|B1|Participants with 1 prior episode||Participants with Prior Depressive Episodes|During the Mini International Neuro-Psychiatric Interview conducted at screening, participant was asked questions to ascertain the number of any prior discrete mood episodes meeting criteria for unipolar major depression.|Participants|Count of Participants|12|12.0||||||
4005886|NCT01210651|3826131|B3|Participants with 0 prior episodes||Participants with Prior Depressive Episodes|During the Mini International Neuro-Psychiatric Interview conducted at screening, participant was asked questions to ascertain the number of any prior discrete mood episodes meeting criteria for unipolar major depression.|Participants|Count of Participants|4|4.0||||||
4005887|NCT01210651|3826132|B2|Participants with 0 prior episodes||Participants with Prior Depressive Episodes|During the Mini International Neuro-Psychiatric Interview conducted at screening, participant was asked questions to ascertain the number of any prior discrete mood episodes meeting criteria for unipolar major depression.|Participants|Count of Participants|1|1.0||||||
4005888|NCT01210651|3826133|B1|Participants with 0 prior episodes||Participants with Prior Depressive Episodes|During the Mini International Neuro-Psychiatric Interview conducted at screening, participant was asked questions to ascertain the number of any prior discrete mood episodes meeting criteria for unipolar major depression.|Participants|Count of Participants|3|3.0||||||
4005889|NCT01210651|3826131|B3|||Prior Yoga Exposure|Prior yoga exposure was defined as the report during screening of any past participation in any individual or group yoga classes/exercises.|Participants|Count of Participants|24|24.0||||||
4005890|NCT01210651|3826132|B2|||Prior Yoga Exposure|Prior yoga exposure was defined as the report during screening of any past participation in any individual or group yoga classes/exercises.|Participants|Count of Participants|14|14.0||||||
4005983|NCT01210495|3826250|B5|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4005891|NCT01210651|3826133|B1|||Prior Yoga Exposure|Prior yoga exposure was defined as the report during screening of any past participation in any individual or group yoga classes/exercises.|Participants|Count of Participants|10|10.0||||||
4005892|NCT01210651|3826131|B3|Unemployed||Employment||Participants|Count of Participants|9|9.0||||||
4005893|NCT01210651|3826132|B2|Unemployed||Employment||Participants|Count of Participants|2|2.0||||||
4005894|NCT01210651|3826133|B1|Unemployed||Employment||Participants|Count of Participants|7|7.0||||||
4005895|NCT01210651|3826131|B3|Retired||Employment||Participants|Count of Participants|5|5.0||||||
4005896|NCT01210651|3826132|B2|Retired||Employment||Participants|Count of Participants|2|2.0||||||
4005897|NCT01210651|3826133|B1|Retired||Employment||Participants|Count of Participants|3|3.0||||||
4005898|NCT01210651|3826131|B3|Student||Employment||Participants|Count of Participants|4|4.0||||||
4005899|NCT01210651|3826132|B2|Student||Employment||Participants|Count of Participants|2|2.0||||||
4005900|NCT01210651|3826133|B1|Student||Employment||Participants|Count of Participants|2|2.0||||||
4005901|NCT01210651|3826131|B3|Employed||Employment||Participants|Count of Participants|20|20.0||||||
4005902|NCT01210651|3826132|B2|Employed||Employment||Participants|Count of Participants|12|12.0||||||
4005903|NCT01210651|3826133|B1|Employed||Employment||Participants|Count of Participants|8|8.0||||||
4005904|NCT01210651|3826131|B3|Four-year college degree or higher||Highest Education|Participant provided information on highest level of education attained at the time of the office screening visit.|Participants|Count of Participants|24|24.0||||||
4005905|NCT01210651|3826132|B2|Four-year college degree or higher||Highest Education|Participant provided information on highest level of education attained at the time of the office screening visit.|Participants|Count of Participants|9|9.0||||||
4005906|NCT01210651|3826133|B1|Four-year college degree or higher||Highest Education|Participant provided information on highest level of education attained at the time of the office screening visit.|Participants|Count of Participants|15|15.0||||||
4005907|NCT01210651|3826131|B3|Two years of college||Highest Education|Participant provided information on highest level of education attained at the time of the office screening visit.|Participants|Count of Participants|12|12.0||||||
4005908|NCT01210651|3826132|B2|Two years of college||Highest Education|Participant provided information on highest level of education attained at the time of the office screening visit.|Participants|Count of Participants|7|7.0||||||
4005909|NCT01210651|3826133|B1|Two years of college||Highest Education|Participant provided information on highest level of education attained at the time of the office screening visit.|Participants|Count of Participants|5|5.0||||||
4005910|NCT01210651|3826131|B3|High school diploma||Highest Education|Participant provided information on highest level of education attained at the time of the office screening visit.|Participants|Count of Participants|2|2.0||||||
4005911|NCT01210651|3826132|B2|High school diploma||Highest Education|Participant provided information on highest level of education attained at the time of the office screening visit.|Participants|Count of Participants|2|2.0||||||
4005912|NCT01210651|3826133|B1|High school diploma||Highest Education|Participant provided information on highest level of education attained at the time of the office screening visit.|Participants|Count of Participants|0|0.0||||||
4005913|NCT01210651|3826131|B3|||Married|Participant provided information on marital status at the time of the office screening visit.|Participants|Count of Participants|4|4.0||||||
4005914|NCT01210651|3826132|B2|||Married|Participant provided information on marital status at the time of the office screening visit.|Participants|Count of Participants|3|3.0||||||
4005915|NCT01210651|3826133|B1|||Married|Participant provided information on marital status at the time of the office screening visit.|Participants|Count of Participants|1|1.0||||||
4005916|NCT01210651|3826131|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
4005917|NCT01210651|3826132|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4005918|NCT01210651|3826133|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4005919|NCT01210651|3826131|B3|Multi-ethnic descent||Race/Ethnicity, Customized|Participant provided self-described ethnic identity at the time of the office screening visit.|Participants|Count of Participants|3|3.0||||||
4005920|NCT01210651|3826132|B2|Multi-ethnic descent||Race/Ethnicity, Customized|Participant provided self-described ethnic identity at the time of the office screening visit.|Participants|Count of Participants|1|1.0||||||
4005921|NCT01210651|3826133|B1|Multi-ethnic descent||Race/Ethnicity, Customized|Participant provided self-described ethnic identity at the time of the office screening visit.|Participants|Count of Participants|2|2.0||||||
4005922|NCT01210651|3826131|B3|African descent||Race/Ethnicity, Customized|Participant provided self-described ethnic identity at the time of the office screening visit.|Participants|Count of Participants|3|3.0||||||
4005923|NCT01210651|3826132|B2|African descent||Race/Ethnicity, Customized|Participant provided self-described ethnic identity at the time of the office screening visit.|Participants|Count of Participants|2|2.0||||||
4005924|NCT01210651|3826133|B1|African descent||Race/Ethnicity, Customized|Participant provided self-described ethnic identity at the time of the office screening visit.|Participants|Count of Participants|1|1.0||||||
4005925|NCT01210651|3826131|B3|Latino descent||Race/Ethnicity, Customized|Participant provided self-described ethnic identity at the time of the office screening visit.|Participants|Count of Participants|4|4.0||||||
4005926|NCT01210651|3826132|B2|Latino descent||Race/Ethnicity, Customized|Participant provided self-described ethnic identity at the time of the office screening visit.|Participants|Count of Participants|2|2.0||||||
4005927|NCT01210651|3826133|B1|Latino descent||Race/Ethnicity, Customized|Participant provided self-described ethnic identity at the time of the office screening visit.|Participants|Count of Participants|2|2.0||||||
4005928|NCT01210651|3826131|B3|Asian descent||Race/Ethnicity, Customized|Participant provided self-described ethnic identity at the time of the office screening visit.|Participants|Count of Participants|6|6.0||||||
4005929|NCT01210651|3826132|B2|Asian descent||Race/Ethnicity, Customized|Participant provided self-described ethnic identity at the time of the office screening visit.|Participants|Count of Participants|4|4.0||||||
4005984|NCT01210495|3826251|B4|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4005930|NCT01210651|3826133|B1|Asian descent||Race/Ethnicity, Customized|Participant provided self-described ethnic identity at the time of the office screening visit.|Participants|Count of Participants|2|2.0||||||
4005931|NCT01210651|3826131|B3|European descent||Race/Ethnicity, Customized|Participant provided self-described ethnic identity at the time of the office screening visit.|Participants|Count of Participants|22|22.0||||||
4005932|NCT01210651|3826132|B2|European descent||Race/Ethnicity, Customized|Participant provided self-described ethnic identity at the time of the office screening visit.|Participants|Count of Participants|9|9.0||||||
4005933|NCT01210651|3826133|B1|European descent||Race/Ethnicity, Customized|Participant provided self-described ethnic identity at the time of the office screening visit.|Participants|Count of Participants|13|13.0||||||
4005934|NCT01210651|3826131|B3||Male|Gender||Participants|Count of Participants|12|12.0||||||
4005935|NCT01210651|3826132|B2||Male|Gender||Participants|Count of Participants|7|7.0||||||
4005936|NCT01210651|3826133|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
4005937|NCT01210651|3826131|B3||Female|Gender||Participants|Count of Participants|26|26.0||||||
4005938|NCT01210651|3826132|B2||Female|Gender||Participants|Count of Participants|11|11.0||||||
4005939|NCT01210651|3826133|B1||Female|Gender||Participants|Count of Participants|15|15.0||||||
4005940|NCT01210651|3826131|B3|Highest age among participants||Age, Customized|Age range of participants, with ages calculated as of the screening visit date.|years|Number|72|72.0||||||
4005941|NCT01210651|3826132|B2|Highest age among participants||Age, Customized|Age range of participants, with ages calculated as of the screening visit date.|years|Number|72|72.0||||||
4005942|NCT01210651|3826133|B1|Highest age among participants||Age, Customized|Age range of participants, with ages calculated as of the screening visit date.|years|Number|64|64.0||||||
4005943|NCT01210651|3826131|B3|Lowest age among participants||Age, Customized|Age range of participants, with ages calculated as of the screening visit date.|years|Number|22|22.0||||||
4005944|NCT01210651|3826132|B2|Lowest age among participants||Age, Customized|Age range of participants, with ages calculated as of the screening visit date.|years|Number|23|23.0||||||
4005945|NCT01210651|3826133|B1|Lowest age among participants||Age, Customized|Age range of participants, with ages calculated as of the screening visit date.|years|Number|22|22.0||||||
4005946|NCT01210651|3826131|B3|||Age|Participant provided birthdate at the time of the office screening visit, and age was calculated as of the screening date.|years|Mean|43.4|43.4|Standard Deviation|14.8|14.8|||
4005947|NCT01210651|3826132|B2|||Age|Participant provided birthdate at the time of the office screening visit, and age was calculated as of the screening date.|years|Mean|43.8|43.8|Standard Deviation|14.7|14.7|||
4005948|NCT01210651|3826133|B1|||Age|Participant provided birthdate at the time of the office screening visit, and age was calculated as of the screening date.|years|Mean|43.1|43.1|Standard Deviation|15.2|15.2|||
4005949|NCT01210560|3826148|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4005950|NCT01210560|3826149|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4005951|NCT01210560|3826150|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4005952|NCT01210560|3826148|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4005953|NCT01210560|3826149|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4005954|NCT01210560|3826150|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4005955|NCT01210560|3826148|B3|||Age||Years|Mean|38.0|38.0|Standard Deviation|7.1|7.1|||
4005956|NCT01210560|3826149|B2|||Age||Years|Mean|36.8|36.8|Standard Deviation|9.0|9.0|||
4005957|NCT01210560|3826150|B1|||Age||Years|Mean|39.4|39.4|Standard Deviation|4.3|4.3|||
4005958|NCT01210495|3826250|B5||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4005959|NCT01210495|3826251|B4||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4005960|NCT01210495|3826252|B3||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4005961|NCT01210495|3826253|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4005962|NCT01210495|3826254|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4005963|NCT01210495|3826250|B5||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4005964|NCT01210495|3826251|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4005965|NCT01210495|3826252|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4005966|NCT01210495|3826253|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4005967|NCT01210495|3826254|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4005968|NCT01210495|3826250|B5|>=65 years||Age, Customized||Participants|Number|93|93.0||||||
4005969|NCT01210495|3826251|B4|>=65 years||Age, Customized||Participants|Number|32|32.0||||||
4005970|NCT01210495|3826252|B3|>=65 years||Age, Customized||Participants|Number|53|53.0||||||
4005971|NCT01210495|3826253|B2|>=65 years||Age, Customized||Participants|Number|2|2.0||||||
4005972|NCT01210495|3826254|B1|>=65 years||Age, Customized||Participants|Number|6|6.0||||||
4005973|NCT01210495|3826250|B5|45-64 years||Age, Customized||Participants|Number|116|116.0||||||
4005974|NCT01210495|3826251|B4|45-64 years||Age, Customized||Participants|Number|32|32.0||||||
4005975|NCT01210495|3826252|B3|45-64 years||Age, Customized||Participants|Number|74|74.0||||||
4005976|NCT01210495|3826253|B2|45-64 years||Age, Customized||Participants|Number|5|5.0||||||
4005977|NCT01210495|3826254|B1|45-64 years||Age, Customized||Participants|Number|5|5.0||||||
4005978|NCT01210495|3826250|B5|18-44 years||Age, Customized||Participants|Number|15|15.0||||||
4005979|NCT01210495|3826251|B4|18-44 years||Age, Customized||Participants|Number|4|4.0||||||
4005980|NCT01210495|3826252|B3|18-44 years||Age, Customized||Participants|Number|7|7.0||||||
4005981|NCT01210495|3826253|B2|18-44 years||Age, Customized||Participants|Number|0|0.0||||||
4005982|NCT01210495|3826254|B1|18-44 years||Age, Customized||Participants|Number|4|4.0||||||
4005985|NCT01210495|3826252|B3|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4005986|NCT01210495|3826253|B2|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4005987|NCT01210495|3826254|B1|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4005988|NCT01210443|3826319|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4005989|NCT01210443|3826319|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4005990|NCT01210443|3826319|B1|>=65 years||Age, Customized||Participants|Number|1|1.0||||||
4005991|NCT01210443|3826319|B1|19-64 years||Age, Customized||Participants|Number|1|1.0||||||
4005992|NCT01210443|3826319|B1|<=18 years||Age, Customized||Participants|Number|0|0.0||||||
4005993|NCT01210222|3826327|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4005994|NCT01210222|3826327|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4005995|NCT01210222|3826327|B1|70 - 79 years||Age, Customized||Participants|Count of Participants|14|14.0||||||
4005996|NCT01210222|3826327|B1|60 - 69 years||Age, Customized||Participants|Count of Participants|11|11.0||||||
4005997|NCT01210222|3826327|B1|50 - 59 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
4005998|NCT01210222|3826327|B1|40 - 49 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
4005999|NCT01210170|3826340|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4006000|NCT01210170|3826340|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4006001|NCT01210170|3826340|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4006002|NCT01210170|3826340|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4006003|NCT01210170|3826340|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4006004|NCT01210144|3826361|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4006005|NCT01210144|3826362|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4006006|NCT01210144|3826363|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4006007|NCT01210144|3826361|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4006008|NCT01210144|3826362|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4006009|NCT01210144|3826363|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4006010|NCT01210144|3826361|B3|||Age||years|Mean|30.4|30.4|Standard Deviation|4.3|4.3|||
4006011|NCT01210144|3826362|B2|||Age||years|Mean|31.0|31.0|Standard Deviation|4.4|4.4|||
4006012|NCT01210144|3826363|B1|||Age||years|Mean|29.8|29.8|Standard Deviation|4.2|4.2|||
4006013|NCT01210118|3826384|B3|Greece||Region of Enrollment||participants|Number|84|84.0||||||
4006014|NCT01210118|3826385|B2|Greece||Region of Enrollment||participants|Number|42|42.0||||||
4006015|NCT01210118|3826386|B1|Greece||Region of Enrollment||participants|Number|42|42.0||||||
4006016|NCT01210118|3826384|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4006017|NCT01210118|3826385|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4006018|NCT01210118|3826386|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4006019|NCT01210118|3826384|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4006020|NCT01210118|3826385|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4006021|NCT01210118|3826386|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4006022|NCT01210118|3826384|B3|||Age||years|Mean|31.9|31.9|Standard Deviation|5.2|5.2|||
4006023|NCT01210118|3826385|B2|||Age||years|Mean|32.4|32.4|Standard Deviation|4.5|4.5|||
4006024|NCT01210118|3826386|B1|||Age||years|Mean|31.4|31.4|Standard Deviation|5.9|5.9|||
4006025|NCT01210118|3826384|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4006026|NCT01210118|3826385|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4006027|NCT01210118|3826386|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4006028|NCT01210118|3826384|B3||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
4006029|NCT01210118|3826385|B2||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4006030|NCT01210118|3826386|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4006031|NCT01210118|3826384|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4006032|NCT01210118|3826385|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4006033|NCT01210118|3826386|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4006034|NCT01210079|3826399|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4006035|NCT01210079|3826400|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4006036|NCT01210079|3826401|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4006037|NCT01210079|3826399|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4006038|NCT01210079|3826400|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4006039|NCT01210079|3826401|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4006040|NCT01210079|3826399|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4006041|NCT01210079|3826400|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4006042|NCT01210079|3826401|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4006043|NCT01210079|3826399|B3|||Age||years|Mean|47.9|47.9|Standard Deviation|5.05|5.05|||
4006044|NCT01210079|3826400|B2|||Age||years|Mean|49.5|49.5|Standard Deviation|4.96|4.96|||
4006045|NCT01210079|3826401|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|4.46|4.46|||
4006046|NCT01210079|3826399|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4006047|NCT01210079|3826400|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4006048|NCT01210079|3826401|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4006049|NCT01210079|3826399|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4006050|NCT01210079|3826400|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4006051|NCT01210079|3826401|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4006052|NCT01210079|3826399|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4006053|NCT01210079|3826400|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4006054|NCT01210079|3826401|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4006055|NCT01210001|3826408|B4||Male|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
4006056|NCT01210001|3826409|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4006057|NCT01210001|3826410|B2||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4006058|NCT01210001|3826411|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4006059|NCT01210001|3826408|B4||Female|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
4006060|NCT01210001|3826409|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4006061|NCT01210001|3826410|B2||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4006062|NCT01210001|3826411|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4006063|NCT01210001|3826408|B4|||Age||years|Mean|54.5|54.5|Standard Deviation|9.8|9.8|||
4006064|NCT01210001|3826409|B3|||Age||years|Mean|54.2|54.2|Standard Deviation|8.9|8.9|||
4006065|NCT01210001|3826410|B2|||Age||years|Mean|54.7|54.7|Standard Deviation|9.9|9.9|||
4006066|NCT01210001|3826411|B1|||Age||years|Mean|54.6|54.6|Standard Deviation|10.5|10.5|||
4006067|NCT01209949|3826433|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4006068|NCT01209949|3826433|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4006069|NCT01209949|3826433|B1|||Age||years|Mean|17.5|17.5|Standard Deviation|1.68|1.68|||
4006070|NCT01209780|3826439|B5||Male|Sex: Female, Male||Participants|Count of Participants|1405|1405.0||||||
4006071|NCT01209780|3826440|B4||Male|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4006072|NCT01209780|3826441|B3||Male|Sex: Female, Male||Participants|Count of Participants|419|419.0||||||
4006073|NCT01209780|3826442|B2||Male|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
4006074|NCT01209780|3826443|B1||Male|Sex: Female, Male||Participants|Count of Participants|525|525.0||||||
4006075|NCT01209780|3826439|B5||Female|Sex: Female, Male||Participants|Count of Participants|1399|1399.0||||||
4006076|NCT01209780|3826440|B4||Female|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
4006077|NCT01209780|3826441|B3||Female|Sex: Female, Male||Participants|Count of Participants|398|398.0||||||
4006078|NCT01209780|3826442|B2||Female|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
4006079|NCT01209780|3826443|B1||Female|Sex: Female, Male||Participants|Count of Participants|517|517.0||||||
4006080|NCT01209780|3826439|B5|||Age||years|Mean|8.6|8.6|Standard Deviation|3.9|3.9|||
4006081|NCT01209780|3826440|B4|||Age||years|Mean|12.3|12.3|Standard Deviation|2.3|2.3|||
4006082|NCT01209780|3826441|B3|||Age||years|Mean|12.4|12.4|Standard Deviation|2.4|2.4|||
4006083|NCT01209780|3826442|B2|||Age||years|Mean|5.6|5.6|Standard Deviation|1.6|1.6|||
4006084|NCT01209780|3826443|B1|||Age||years|Mean|5.6|5.6|Standard Deviation|1.6|1.6|||
4006085|NCT01209767|3826473|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4006086|NCT01209767|3826473|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4006087|NCT01209767|3826473|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4006088|NCT01209767|3826473|B1|||Age||years|Mean|39.4|39.4|Standard Deviation|11.2|11.2|||
4006089|NCT01209767|3826473|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4006090|NCT01209767|3826473|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4006091|NCT01209767|3826473|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4006092|NCT01209702|3826481|B3|Male||Gender - Part 1 Population|Demographic data for the Part 1 population: Placebo = 51 participants, Tocilizumab = 51 participants, total = 102 participants.|participants|Number|76|76.0||||||
4006093|NCT01209702|3826482|B2|Male||Gender - Part 1 Population|Demographic data for the Part 1 population: Placebo = 51 participants, Tocilizumab = 51 participants, total = 102 participants.|participants|Number|36|36.0||||||
4006094|NCT01209702|3826483|B1|Male||Gender - Part 1 Population|Demographic data for the Part 1 population: Placebo = 51 participants, Tocilizumab = 51 participants, total = 102 participants.|participants|Number|40|40.0||||||
4006095|NCT01209702|3826481|B3|Female||Gender - Part 1 Population|Demographic data for the Part 1 population: Placebo = 51 participants, Tocilizumab = 51 participants, total = 102 participants.|participants|Number|26|26.0||||||
4006096|NCT01209702|3826482|B2|Female||Gender - Part 1 Population|Demographic data for the Part 1 population: Placebo = 51 participants, Tocilizumab = 51 participants, total = 102 participants.|participants|Number|15|15.0||||||
4006097|NCT01209702|3826483|B1|Female||Gender - Part 1 Population|Demographic data for the Part 1 population: Placebo = 51 participants, Tocilizumab = 51 participants, total = 102 participants.|participants|Number|11|11.0||||||
4006098|NCT01209702|3826481|B3|||Age - Part 1 population|Demographic data for the Part 1 population: Placebo = 51 participants, Tocilizumab = 51 participants, total = 102 participants.|years|Mean|42.1|42.1|Standard Deviation|11.91|11.91|||
4006099|NCT01209702|3826482|B2|||Age - Part 1 population|Demographic data for the Part 1 population: Placebo = 51 participants, Tocilizumab = 51 participants, total = 102 participants.|years|Mean|41.6|41.6|Standard Deviation|11.22|11.22|||
4006100|NCT01209702|3826483|B1|||Age - Part 1 population|Demographic data for the Part 1 population: Placebo = 51 participants, Tocilizumab = 51 participants, total = 102 participants.|years|Mean|42.7|42.7|Standard Deviation|12.64|12.64|||
4006101|NCT01209702|3826481|B3||Male|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4006102|NCT01209702|3826482|B2||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4006103|NCT01209702|3826483|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4006104|NCT01209702|3826481|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4006105|NCT01209702|3826482|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4006106|NCT01209702|3826483|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4006107|NCT01209702|3826481|B3|||Age|Demographic data are provided for all participants who received at least one tocilizumab/placebo infusion.|years|Mean|40.7|40.7|Standard Deviation|11.38|11.38|||
4006108|NCT01209702|3826482|B2|||Age|Demographic data are provided for all participants who received at least one tocilizumab/placebo infusion.|years|Mean|40.4|40.4|Standard Deviation|11.42|11.42|||
4006109|NCT01209702|3826483|B1|||Age|Demographic data are provided for all participants who received at least one tocilizumab/placebo infusion.|years|Mean|41.2|41.2|Standard Deviation|11.33|11.33|||
4006110|NCT01209689|3826540|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4006111|NCT01209689|3826541|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4006112|NCT01209689|3826542|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4006113|NCT01209689|3826540|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4006114|NCT01209689|3826541|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4006115|NCT01209689|3826542|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4006116|NCT01209689|3826540|B3|||Age||years|Mean|44.3|44.3|Standard Deviation|12.14|12.14|||
4006117|NCT01209689|3826541|B2|||Age||years|Mean|45.0|45.0|Standard Deviation|12.66|12.66|||
4006118|NCT01209689|3826542|B1|||Age||years|Mean|44.1|44.1|Standard Deviation|12.08|12.08|||
4006119|NCT01209624|3826549|B1|||Optic Disc Hemorrhage|Presence of optic disc hemorrhages assessed by slip lamp examination. Only data for eye were treated with Xalatan® was used; if both eyes were treated, the value of the right eye was analyzed. Participants may be represented in more than 1 category. Results based on participants in PP population with a non-missing response at baseline.|Participants|Number|21|21.0||||||
4006120|NCT01209624|3826549|B1|||Retinal Nerve Fiber Layer Thickness|Mean retinal nerve fiber layer (RNFL) thickness in millimeters (mm) right and left eye assessed by HRT imaging. Valid range: 0.100 to 0.400 mm. Only the RNFL for the eye treated with Xalatan® was used; if both eyes were treated, the value of the right eye was analyzed. Participants may be represented in more than 1 category. Results based on participants in PP population with a non-missing response at baseline.|mm|Mean|0.21|0.21|Standard Deviation|0.07|0.07|||
4006121|NCT01209624|3826549|B1|||Cup Shape Measure|Cup shape measure right and left eye assessed by HRT imaging. Valid range: -0.400 to -0.010. Only the cup shape measure for the eye treated with Xalatan® was used; if both eyes were treated, the value of the right eye was analyzed. Participants may be represented in more than 1 category. Results based on participants in PP population with a non-missing response at baseline.|Cup shape measure|Mean|-0.12|-0.12|Standard Deviation|0.09|0.09|||
4006122|NCT01209624|3826549|B1|||Rim Volume|Rim volume (mm3) right and left eye assessed by HRT imaging. Valid range: 0.080 to 0.700 mm3. Only the rim volume for the eye treated with Xalatan® was used; if both eyes were treated, the value of the right eye was analyzed. Participants may be represented in more than 1 category. Results based on participants in PP population with a non-missing response at baseline.|mm^3|Mean|0.30|0.3|Standard Deviation|0.14|0.14|||
4006123|NCT01209624|3826549|B1|||Rim Area|Rim area (millimeter [mm]2) right and left eye assessed by HRT imaging. Valid range: 0.500 to 1.900 mm2. Only the rim area for the eye treated with Xalatan® was used; if both eyes were treated, the value of the right eye was analyzed. Participants may represent more than 1 category. Results based on participants in PP population with a non-missing response at baseline.|mm^2|Mean|1.26|1.26|Standard Deviation|0.30|0.3|||
4006124|NCT01209624|3826549|B1|||Vertical Cup to Disc Ratio|Mean vertical cup to disc ratio measured by slit lamp examination to assess progression of glaucoma; calculated as the ratio of the diameter of the depression (cup) to that of the optical nerve head (disc). Valid range: 0.1-1.0. Only data for the eye treated with Xalatan® was used; if both eyes were treated, the value of the right eye was analyzed. Participants may be represented in more than 1 category. Results based on participants in PP population with a non-missing response at baseline.|Ratio|Mean|0.56|0.56|Standard Deviation|0.22|0.22|||
4006125|NCT01209624|3826549|B1|||Horizontal Cup to Disc Ratio|Mean horizontal cup to disc ratio measured by slit lamp examination to assess progression of glaucoma; calculated as the ratio of the diameter of the depression (cup) to that of the optical nerve head (disc). Valid range: 0.1-1.0. Only data for the eye treated with Xalatan® was used; if both eyes were treated, the value of the right eye was analyzed. Participants may be represented in more than 1 category. Results based on participants in PP population with a non-missing response at baseline.|Ratio|Mean|0.53|0.53|Standard Deviation|0.22|0.22|||
4006126|NCT01209624|3826549|B1|||Raw Intraocular Pressure|Mean IOP value measured by applanation tonometry or noncontact method; valid range: 8-40 millimeters of mercury (mmHg). Only the IOP reading for the eye treated with Xalatan® was used; if both eyes were treated, the value of the right eye was analyzed. Participants may represented in more than 1 category. Results based on participants in PP population with a non-missing response at baseline.|mmHg|Mean|18.14|18.14|Standard Deviation|3.62|3.62|||
4006127|NCT01209624|3826549|B1|Unspecified||Sex/Gender, Customized||participants|Number|10|10.0||||||
4006128|NCT01209624|3826549|B1|Male||Sex/Gender, Customized||participants|Number|347|347.0||||||
4006129|NCT01209624|3826549|B1|Female||Sex/Gender, Customized||participants|Number|545|545.0||||||
4006130|NCT01209624|3826549|B1|unspecified||Age, Customized||participants|Number|20|20.0||||||
4006131|NCT01209624|3826549|B1|>= 65 years||Age, Customized||participants|Number|528|528.0||||||
4006132|NCT01209624|3826549|B1|45 to 64 years||Age, Customized||participants|Number|281|281.0||||||
4006133|NCT01209624|3826549|B1|18 to 44 years||Age, Customized||participants|Number|68|68.0||||||
4006134|NCT01209624|3826549|B1|< 18 years||Age, Customized||participants|Number|5|5.0||13.1|13.1|||
4006135|NCT01209598|3826580|B3|United States||Region of Enrollment||participants|Number|90|90.0||||||
4006136|NCT01209598|3826581|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
4006137|NCT01209598|3826582|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4006138|NCT01209598|3826580|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4006139|NCT01209598|3826581|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4006140|NCT01209598|3826582|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4006141|NCT01209598|3826580|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4006142|NCT01209598|3826581|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4006143|NCT01209598|3826582|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4006144|NCT01209598|3826580|B3|||Age||years|Median|62|62.0|Full Range|||35.0|92.0|
4006145|NCT01209598|3826581|B2|||Age||years|Median|61.5|61.5|Full Range|||35.0|87.0|
4006146|NCT01209598|3826582|B1|||Age||years|Median|65|65.0|Full Range|||37.0|83.0|
4006147|NCT01209520|3826591|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4006148|NCT01209520|3826591|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4006149|NCT01209520|3826591|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4006150|NCT01209520|3826591|B1|||Age||years|Mean|74.5|74.5|Full Range|||61.0|78.0|
4006151|NCT01209520|3826591|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4006152|NCT01209520|3826591|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4006153|NCT01209520|3826591|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4006154|NCT01209286|3826596|B4|No prior allogeneic HSCT||Prior Allogeneic Hematopoietic Stem cell Transplantation (HSCT)||participants|Number|21|21.0||||||
4006155|NCT01209286|3826597|B3|No prior allogeneic HSCT||Prior Allogeneic Hematopoietic Stem cell Transplantation (HSCT)||participants|Number|4|4.0||||||
4006156|NCT01209286|3826598|B2|No prior allogeneic HSCT||Prior Allogeneic Hematopoietic Stem cell Transplantation (HSCT)||participants|Number|13|13.0||||||
4006157|NCT01209286|3826599|B1|No prior allogeneic HSCT||Prior Allogeneic Hematopoietic Stem cell Transplantation (HSCT)||participants|Number|4|4.0||||||
4006158|NCT01209286|3826596|B4|Yes, Haploidentical (mother/father)||Prior Allogeneic Hematopoietic Stem cell Transplantation (HSCT)||participants|Number|0|0.0||||||
4006159|NCT01209286|3826597|B3|Yes, Haploidentical (mother/father)||Prior Allogeneic Hematopoietic Stem cell Transplantation (HSCT)||participants|Number|0|0.0||||||
4006160|NCT01209286|3826598|B2|Yes, Haploidentical (mother/father)||Prior Allogeneic Hematopoietic Stem cell Transplantation (HSCT)||participants|Number|0|0.0||||||
4006161|NCT01209286|3826599|B1|Yes, Haploidentical (mother/father)||Prior Allogeneic Hematopoietic Stem cell Transplantation (HSCT)||participants|Number|0|0.0||||||
4006162|NCT01209286|3826596|B4|Yes, Unrelated||Prior Allogeneic Hematopoietic Stem cell Transplantation (HSCT)||participants|Number|12|12.0||||||
4006163|NCT01209286|3826597|B3|Yes, Unrelated||Prior Allogeneic Hematopoietic Stem cell Transplantation (HSCT)||participants|Number|1|1.0||||||
4006164|NCT01209286|3826598|B2|Yes, Unrelated||Prior Allogeneic Hematopoietic Stem cell Transplantation (HSCT)||participants|Number|9|9.0||||||
4006165|NCT01209286|3826599|B1|Yes, Unrelated||Prior Allogeneic Hematopoietic Stem cell Transplantation (HSCT)||participants|Number|2|2.0||||||
4006166|NCT01209286|3826596|B4|Yes, Sibling||Prior Allogeneic Hematopoietic Stem cell Transplantation (HSCT)||participants|Number|3|3.0||||||
4006167|NCT01209286|3826597|B3|Yes, Sibling||Prior Allogeneic Hematopoietic Stem cell Transplantation (HSCT)||participants|Number|1|1.0||||||
4006168|NCT01209286|3826598|B2|Yes, Sibling||Prior Allogeneic Hematopoietic Stem cell Transplantation (HSCT)||participants|Number|1|1.0||||||
4006169|NCT01209286|3826599|B1|Yes, Sibling||Prior Allogeneic Hematopoietic Stem cell Transplantation (HSCT)||participants|Number|1|1.0||||||
4006170|NCT01209286|3826596|B4|Relapsed||Relapsed / refractory Status||participants|Number|33|33.0||||||
4006171|NCT01209286|3826597|B3|Relapsed||Relapsed / refractory Status||participants|Number|5|5.0||||||
4006172|NCT01209286|3826598|B2|Relapsed||Relapsed / refractory Status||participants|Number|21|21.0||||||
4006173|NCT01209286|3826599|B1|Relapsed||Relapsed / refractory Status||participants|Number|7|7.0||||||
4006174|NCT01209286|3826596|B4|Primary Refractory||Relapsed / refractory Status||participants|Number|3|3.0||||||
4006175|NCT01209286|3826597|B3|Primary Refractory||Relapsed / refractory Status||participants|Number|1|1.0||||||
4006176|NCT01209286|3826598|B2|Primary Refractory||Relapsed / refractory Status||participants|Number|2|2.0||||||
4006177|NCT01209286|3826599|B1|Primary Refractory||Relapsed / refractory Status||participants|Number|0|0.0||||||
4006178|NCT01209286|3826596|B4|3||Number of Prior Relapses||participants|Number|1|1.0||||||
4006179|NCT01209286|3826597|B3|3||Number of Prior Relapses||participants|Number|1|1.0||||||
4006180|NCT01209286|3826598|B2|3||Number of Prior Relapses||participants|Number|0|0.0||||||
4006181|NCT01209286|3826599|B1|3||Number of Prior Relapses||participants|Number|0|0.0||||||
4006182|NCT01209286|3826596|B4|2||Number of Prior Relapses||participants|Number|9|9.0||||||
4006183|NCT01209286|3826597|B3|2||Number of Prior Relapses||participants|Number|1|1.0||||||
4006184|NCT01209286|3826598|B2|2||Number of Prior Relapses||participants|Number|6|6.0||||||
4006185|NCT01209286|3826599|B1|2||Number of Prior Relapses||participants|Number|2|2.0||||||
4006186|NCT01209286|3826596|B4|1||Number of Prior Relapses||participants|Number|23|23.0||||||
4006187|NCT01209286|3826597|B3|1||Number of Prior Relapses||participants|Number|3|3.0||||||
4006188|NCT01209286|3826598|B2|1||Number of Prior Relapses||participants|Number|15|15.0||||||
4006189|NCT01209286|3826599|B1|1||Number of Prior Relapses||participants|Number|5|5.0||||||
4006190|NCT01209286|3826596|B4|0||Number of Prior Relapses||participants|Number|3|3.0||||||
4006191|NCT01209286|3826597|B3|0||Number of Prior Relapses||participants|Number|1|1.0||||||
4006192|NCT01209286|3826598|B2|0||Number of Prior Relapses||participants|Number|2|2.0||||||
4006193|NCT01209286|3826599|B1|0||Number of Prior Relapses||participants|Number|0|0.0||||||
4006194|NCT01209286|3826596|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006195|NCT01209286|3826597|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006196|NCT01209286|3826598|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006197|NCT01209286|3826599|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006198|NCT01209286|3826596|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006199|NCT01209286|3826597|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006200|NCT01209286|3826598|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006201|NCT01209286|3826599|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006202|NCT01209286|3826596|B4||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4006203|NCT01209286|3826597|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4006204|NCT01209286|3826598|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4006205|NCT01209286|3826599|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4006206|NCT01209286|3826596|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006207|NCT01209286|3826597|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006208|NCT01209286|3826598|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006209|NCT01209286|3826599|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006210|NCT01209286|3826596|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006211|NCT01209286|3826597|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006212|NCT01209286|3826598|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006213|NCT01209286|3826599|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006214|NCT01209286|3826596|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4006215|NCT01209286|3826597|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006216|NCT01209286|3826598|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4006217|NCT01209286|3826599|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006218|NCT01209286|3826596|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006219|NCT01209286|3826597|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006220|NCT01209286|3826598|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006221|NCT01209286|3826599|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006222|NCT01209286|3826596|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4006223|NCT01209286|3826597|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4006224|NCT01209286|3826598|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4006225|NCT01209286|3826599|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4006226|NCT01209286|3826596|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4006227|NCT01209286|3826597|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4006228|NCT01209286|3826598|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4006229|NCT01209286|3826599|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4006230|NCT01209286|3826596|B4|||Age||years|Mean|40.0|40.0|Standard Deviation|18.4|18.4|||
4006231|NCT01209286|3826597|B3|||Age||years|Mean|42.5|42.5|Standard Deviation|23.2|23.2|||
4006232|NCT01209286|3826598|B2|||Age||years|Mean|38.1|38.1|Standard Deviation|16.7|16.7|||
4006233|NCT01209286|3826599|B1|||Age||years|Mean|44.0|44.0|Standard Deviation|21.5|21.5|||
4006234|NCT01209260|3826652|B3|No previous transseptal puncture||History of transseptal puncture||participants|Number|50|50.0||||||
4006235|NCT01209260|3826653|B2|No previous transseptal puncture||History of transseptal puncture||participants|Number|26|26.0||||||
4006236|NCT01209260|3826654|B1|No previous transseptal puncture||History of transseptal puncture||participants|Number|24|24.0||||||
4006237|NCT01209260|3826652|B3|Previous transseptal puncture||History of transseptal puncture||participants|Number|22|22.0||||||
4006238|NCT01209260|3826653|B2|Previous transseptal puncture||History of transseptal puncture||participants|Number|10|10.0||||||
4006239|NCT01209260|3826654|B1|Previous transseptal puncture||History of transseptal puncture||participants|Number|12|12.0||||||
4006240|NCT01209260|3826652|B3|Accessory pathway||Indication for transseptal puncture||participants|Number|2|2.0||||||
4006241|NCT01209260|3826653|B2|Accessory pathway||Indication for transseptal puncture||participants|Number|1|1.0||||||
4006242|NCT01209260|3826654|B1|Accessory pathway||Indication for transseptal puncture||participants|Number|1|1.0||||||
4006243|NCT01209260|3826652|B3|Atrial fibrillation||Indication for transseptal puncture||participants|Number|70|70.0||||||
4006244|NCT01209260|3826653|B2|Atrial fibrillation||Indication for transseptal puncture||participants|Number|35|35.0||||||
4006245|NCT01209260|3826654|B1|Atrial fibrillation||Indication for transseptal puncture||participants|Number|35|35.0||||||
4006246|NCT01209260|3826652|B3|No previous stroke or TIA||Previous stroke or transient ischemic attack (TIA)||participants|Number|67|67.0||||||
4006247|NCT01209260|3826653|B2|No previous stroke or TIA||Previous stroke or transient ischemic attack (TIA)||participants|Number|33|33.0||||||
4006305|NCT01209195|3826669|B1|||Age||years|Mean|57.4|57.4|Standard Deviation|9.62|9.62|||
4006248|NCT01209260|3826654|B1|No previous stroke or TIA||Previous stroke or transient ischemic attack (TIA)||participants|Number|34|34.0||||||
4006249|NCT01209260|3826652|B3|Previous stroke or TIA||Previous stroke or transient ischemic attack (TIA)||participants|Number|5|5.0||||||
4006250|NCT01209260|3826653|B2|Previous stroke or TIA||Previous stroke or transient ischemic attack (TIA)||participants|Number|3|3.0||||||
4006251|NCT01209260|3826654|B1|Previous stroke or TIA||Previous stroke or transient ischemic attack (TIA)||participants|Number|2|2.0||||||
4006252|NCT01209260|3826652|B3|United States||Region of Enrollment||participants|Number|72|72.0||||||
4006253|NCT01209260|3826653|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
4006254|NCT01209260|3826654|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4006255|NCT01209260|3826652|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4006256|NCT01209260|3826653|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4006257|NCT01209260|3826654|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4006258|NCT01209260|3826652|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4006259|NCT01209260|3826653|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4006260|NCT01209260|3826654|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4006261|NCT01209260|3826652|B3|||Age||years|Mean|60.5|60.5|Standard Deviation|11.4|11.4|||
4006262|NCT01209260|3826653|B2|||Age||years|Mean|61.1|61.1|Standard Deviation|11.7|11.7|||
4006263|NCT01209260|3826654|B1|||Age||years|Mean|59.9|59.9|Standard Deviation|11.3|11.3|||
4006264|NCT01209195|3826667|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
4006265|NCT01209195|3826668|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
4006266|NCT01209195|3826669|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4006267|NCT01209195|3826667|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4006268|NCT01209195|3826668|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4006269|NCT01209195|3826669|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006270|NCT01209195|3826667|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006271|NCT01209195|3826668|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006272|NCT01209195|3826669|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006273|NCT01209195|3826667|B3||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4006274|NCT01209195|3826668|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4006275|NCT01209195|3826669|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4006276|NCT01209195|3826667|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4006277|NCT01209195|3826668|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4006278|NCT01209195|3826669|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006279|NCT01209195|3826667|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006280|NCT01209195|3826668|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006281|NCT01209195|3826669|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006282|NCT01209195|3826667|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4006283|NCT01209195|3826668|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4006284|NCT01209195|3826669|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006285|NCT01209195|3826667|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006286|NCT01209195|3826668|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006287|NCT01209195|3826669|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006288|NCT01209195|3826667|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006289|NCT01209195|3826668|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006290|NCT01209195|3826669|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006291|NCT01209195|3826667|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4006292|NCT01209195|3826668|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4006293|NCT01209195|3826669|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4006294|NCT01209195|3826667|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4006295|NCT01209195|3826668|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4006296|NCT01209195|3826669|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4006297|NCT01209195|3826667|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4006298|NCT01209195|3826668|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4006299|NCT01209195|3826669|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4006300|NCT01209195|3826667|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4006301|NCT01209195|3826668|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4006302|NCT01209195|3826669|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4006303|NCT01209195|3826667|B3|||Age||years|Mean|56.45|56.45|Standard Deviation|10.025|10.025|||
4006304|NCT01209195|3826668|B2|||Age||years|Mean|55.5|55.5|Standard Deviation|10.43|10.43|||
4006306|NCT01209143|3826708|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4006307|NCT01209143|3826709|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4006308|NCT01209143|3826710|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4006309|NCT01209143|3826708|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4006310|NCT01209143|3826709|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4006311|NCT01209143|3826710|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4006312|NCT01209143|3826708|B3|||Age||years|Mean|60.5|60.5|Standard Deviation|14.4|14.4|||
4006313|NCT01209143|3826709|B2|||Age||years|Mean|59.2|59.2|Standard Deviation|14.6|14.6|||
4006314|NCT01209143|3826710|B1|||Age||years|Mean|62.1|62.1|Standard Deviation|14.4|14.4|||
4006315|NCT01209078|3826719|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006316|NCT01209078|3826720|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006317|NCT01209078|3826721|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006318|NCT01209078|3826719|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4006319|NCT01209078|3826720|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006320|NCT01209078|3826721|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4006321|NCT01209078|3826719|B3||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4006322|NCT01209078|3826720|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4006323|NCT01209078|3826721|B1||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4006324|NCT01209078|3826719|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4006325|NCT01209078|3826720|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4006326|NCT01209078|3826721|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4006327|NCT01209078|3826719|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4006328|NCT01209078|3826720|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4006329|NCT01209078|3826721|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4006330|NCT01209078|3826719|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4006331|NCT01209078|3826720|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006332|NCT01209078|3826721|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4006333|NCT01209078|3826719|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4006334|NCT01209078|3826720|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006335|NCT01209078|3826721|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4006336|NCT01209078|3826719|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4006337|NCT01209078|3826720|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4006338|NCT01209078|3826721|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4006339|NCT01209078|3826719|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4006340|NCT01209078|3826720|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4006341|NCT01209078|3826721|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4006342|NCT01209078|3826719|B3|||Age||Years|Mean|43.5|43.5|Standard Deviation|11.61|11.61|||
4006343|NCT01209078|3826720|B2|||Age||Years|Mean|41.5|41.5|Standard Deviation|11.00|11.0|||
4006344|NCT01209078|3826721|B1|||Age||Years|Mean|44.4|44.4|Standard Deviation|11.87|11.87|||
4006345|NCT01208961|3826797|B1|United States||Region of Enrollment||participants|Number|54|54.0||||||
4006346|NCT01208961|3826797|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006347|NCT01208961|3826797|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4006348|NCT01208961|3826797|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4006349|NCT01208961|3826797|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4006350|NCT01208961|3826797|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4006351|NCT01208961|3826797|B1|||Age||years|Mean|44.6|44.6|Standard Deviation|11.96|11.96|||
4006352|NCT01208870|3826807|B3|||Parent Body Mass Index (kg/m^2)||kg/m^2|Mean|38.1|38.1|Standard Deviation|7.5|7.5|||
4006353|NCT01208870|3826808|B2|||Parent Body Mass Index (kg/m^2)||kg/m^2|Mean|37.2|37.2|Standard Deviation|6.8|6.8|||
4006354|NCT01208870|3826809|B1|||Parent Body Mass Index (kg/m^2)||kg/m^2|Mean|38.9|38.9|Standard Deviation|8.2|8.2|||
4006355|NCT01208870|3826807|B3|||Parent Weight (lb.)||pounds|Mean|234.7|234.7|Standard Deviation|47.0|47.0|||
4006356|NCT01208870|3826808|B2|||Parent Weight (lb.)||pounds|Mean|232.5|232.5|Standard Deviation|46.2|46.2|||
4006357|NCT01208870|3826809|B1|||Parent Weight (lb.)||pounds|Mean|236.8|236.8|Standard Deviation|48.7|48.7|||
4006358|NCT01208870|3826807|B3|||Child z-Body Mass Index|"The formula for calculating LMS z-BMI scores based on age and sex is LMS method z-BMI = ((BMI/M L) – 1))/(L*S), where BMI = an individual’s BMI, M =the median BMI for age and gender, L = power in the Box-Cox transformation for age and gender, and S =standard deviation for age and gender (Kuczmarski et al., 2002). A reference is Z-score of 0 is equal to the mean. Negative z-scores indicate values lower than the average and positive numbers indicate values higher than the average."|[1] z-BMI see description|Mean|2.2|2.2|Standard Deviation|0.4|0.4|||
4006402|NCT01208870|3826809|B1||Female|Sex: Female, Male|Gender (male/female)|Participants|Count of Participants|35|35.0||||||
4006359|NCT01208870|3826808|B2|||Child z-Body Mass Index|"The formula for calculating LMS z-BMI scores based on age and sex is LMS method z-BMI = ((BMI/M L) – 1))/(L*S), where BMI = an individual’s BMI, M =the median BMI for age and gender, L = power in the Box-Cox transformation for age and gender, and S =standard deviation for age and gender (Kuczmarski et al., 2002). A reference is Z-score of 0 is equal to the mean. Negative z-scores indicate values lower than the average and positive numbers indicate values higher than the average."|[1] z-BMI see description|Mean|2.2|2.2|Standard Deviation|0.4|0.4|||
4006360|NCT01208870|3826809|B1|||Child z-Body Mass Index|"The formula for calculating LMS z-BMI scores based on age and sex is LMS method z-BMI = ((BMI/M L) – 1))/(L*S), where BMI = an individual’s BMI, M =the median BMI for age and gender, L = power in the Box-Cox transformation for age and gender, and S =standard deviation for age and gender (Kuczmarski et al., 2002). A reference is Z-score of 0 is equal to the mean. Negative z-scores indicate values lower than the average and positive numbers indicate values higher than the average."|[1] z-BMI see description|Mean|2.2|2.2|Standard Deviation|0.4|0.4|||
4006361|NCT01208870|3826807|B3|||Child percent overweight (%)|Percent overweight or percent overBMI is calculated as %OverBMI= [(BMI – BMI at 50th percentile)/BMI at 50th percentile]*100.|Percent overweight based on BMI charts|Mean|74.5|74.5|Standard Deviation|33.6|33.6|||
4006362|NCT01208870|3826808|B2|||Child percent overweight (%)|Percent overweight or percent overBMI is calculated as %OverBMI= [(BMI – BMI at 50th percentile)/BMI at 50th percentile]*100.|Percent overweight based on BMI charts|Mean|71.8|71.8|Standard Deviation|29.2|29.2|||
4006363|NCT01208870|3826809|B1|||Child percent overweight (%)|Percent overweight or percent overBMI is calculated as %OverBMI= [(BMI – BMI at 50th percentile)/BMI at 50th percentile]*100.|Percent overweight based on BMI charts|Mean|77.1|77.1|Standard Deviation|40|40.0|||
4006364|NCT01208870|3826807|B3|United States||Region of Enrollment||participants|Number|90|90.0||||||
4006365|NCT01208870|3826808|B2|United States||Region of Enrollment||participants|Number|44|44.0||||||
4006366|NCT01208870|3826809|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4006367|NCT01208870|3826807|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006368|NCT01208870|3826808|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006369|NCT01208870|3826809|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006370|NCT01208870|3826807|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4006371|NCT01208870|3826808|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4006372|NCT01208870|3826809|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4006373|NCT01208870|3826807|B3||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4006374|NCT01208870|3826808|B2||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4006375|NCT01208870|3826809|B1||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4006376|NCT01208870|3826807|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4006377|NCT01208870|3826808|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4006378|NCT01208870|3826809|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4006379|NCT01208870|3826807|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006380|NCT01208870|3826808|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006381|NCT01208870|3826809|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006382|NCT01208870|3826807|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006383|NCT01208870|3826808|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006384|NCT01208870|3826809|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006385|NCT01208870|3826807|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4006386|NCT01208870|3826808|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006387|NCT01208870|3826809|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4006388|NCT01208870|3826807|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)|Ethnicity (NIH/OMB) parent and child|Participants|Count of Participants|0|0.0||||||
4006389|NCT01208870|3826808|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)|Ethnicity (NIH/OMB) parent and child|Participants|Count of Participants|0|0.0||||||
4006390|NCT01208870|3826809|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|Ethnicity (NIH/OMB) parent and child|Participants|Count of Participants|0|0.0||||||
4006391|NCT01208870|3826807|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity (NIH/OMB) parent and child|Participants|Count of Participants|88|88.0||||||
4006392|NCT01208870|3826808|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity (NIH/OMB) parent and child|Participants|Count of Participants|42|42.0||||||
4006393|NCT01208870|3826809|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity (NIH/OMB) parent and child|Participants|Count of Participants|46|46.0||||||
4006394|NCT01208870|3826807|B3||Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity (NIH/OMB) parent and child|Participants|Count of Participants|2|2.0||||||
4006395|NCT01208870|3826808|B2||Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity (NIH/OMB) parent and child|Participants|Count of Participants|2|2.0||||||
4006396|NCT01208870|3826809|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity (NIH/OMB) parent and child|Participants|Count of Participants|0|0.0||||||
4006397|NCT01208870|3826807|B3||Male|Sex: Female, Male|Gender (male/female)|Participants|Count of Participants|22|22.0||||||
4006398|NCT01208870|3826808|B2||Male|Sex: Female, Male|Gender (male/female)|Participants|Count of Participants|11|11.0||||||
4006399|NCT01208870|3826809|B1||Male|Sex: Female, Male|Gender (male/female)|Participants|Count of Participants|11|11.0||||||
4006400|NCT01208870|3826807|B3||Female|Sex: Female, Male|Gender (male/female)|Participants|Count of Participants|68|68.0||||||
4006401|NCT01208870|3826808|B2||Female|Sex: Female, Male|Gender (male/female)|Participants|Count of Participants|33|33.0||||||
4006403|NCT01208870|3826807|B3|Child Age n=23 Experimental n=22 Control||Age, Customized||years|Mean|10.7|10.7|Standard Deviation|1.3|1.3|||
4006404|NCT01208870|3826808|B2|Child Age n=23 Experimental n=22 Control||Age, Customized||years|Mean|10.8|10.8|Standard Deviation|1.4|1.4|||
4006405|NCT01208870|3826809|B1|Child Age n=23 Experimental n=22 Control||Age, Customized||years|Mean|10.6|10.6|Standard Deviation|1.3|1.3|||
4006406|NCT01208870|3826807|B3|Parent Age n=23 Experimental, n=22 Control||Age, Customized||years|Mean|43.1|43.1|Standard Deviation|6.4|6.4|||
4006407|NCT01208870|3826808|B2|Parent Age n=23 Experimental, n=22 Control||Age, Customized||years|Mean|43.0|43.0|Standard Deviation|6.4|6.4|||
4006408|NCT01208870|3826809|B1|Parent Age n=23 Experimental, n=22 Control||Age, Customized||years|Mean|43.2|43.2|Standard Deviation|6.6|6.6|||
4006409|NCT01208415|3826826|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4006410|NCT01208415|3826826|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4006411|NCT01208415|3826826|B1|||Age||years|Mean|69|69.0|Standard Deviation|7.1|7.1|||
4006412|NCT01208402|3826830|B3|United States||Region of Enrollment||participants|Number|59|59.0||||||
4006413|NCT01208402|3826831|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4006414|NCT01208402|3826832|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4006415|NCT01208402|3826830|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4006416|NCT01208402|3826831|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4006417|NCT01208402|3826832|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4006418|NCT01208402|3826830|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4006419|NCT01208402|3826831|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4006420|NCT01208402|3826832|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4006421|NCT01208402|3826830|B3|18 years and older||Age, Customized||participants|Number|59|59.0||||||
4006422|NCT01208402|3826831|B2|18 years and older||Age, Customized||participants|Number|28|28.0||||||
4006423|NCT01208402|3826832|B1|18 years and older||Age, Customized||participants|Number|31|31.0||||||
4006424|NCT01208337|3826849|B1|||Primary Isolated Intestine Transplant||participants|Number|21|21.0||||||
4006425|NCT01208337|3826849|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006426|NCT01208337|3826849|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006427|NCT01208337|3826849|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4006428|NCT01208337|3826849|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4006429|NCT01208337|3826849|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006430|NCT01208337|3826849|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4006431|NCT01208337|3826849|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006432|NCT01208337|3826849|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006433|NCT01208337|3826849|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4006434|NCT01208337|3826849|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4006435|NCT01208337|3826849|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4006436|NCT01208337|3826849|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4006437|NCT01208337|3826849|B1|||Age||years|Median|5.7|5.7|Full Range|||0.75|20.9|
4006438|NCT01208233|3826857|B7||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4006439|NCT01208233|3826858|B6||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4006440|NCT01208233|3826859|B5||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4006441|NCT01208233|3826860|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4006442|NCT01208233|3826861|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4006443|NCT01208233|3826862|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4006444|NCT01208233|3826863|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4006445|NCT01208233|3826857|B7||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4006446|NCT01208233|3826858|B6||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4006447|NCT01208233|3826859|B5||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4006448|NCT01208233|3826860|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4006449|NCT01208233|3826861|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4006450|NCT01208233|3826862|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4006451|NCT01208233|3826863|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4006452|NCT01208233|3826857|B7|||Age||years|Mean|65.1|65.1|Standard Deviation|12.0|12.0|||
4006453|NCT01208233|3826858|B6|||Age||years|Mean|65.6|65.6|Standard Deviation|11.3|11.3|||
4006454|NCT01208233|3826859|B5|||Age||years|Mean|64.2|64.2|Standard Deviation|13.1|13.1|||
4006455|NCT01208233|3826860|B4|||Age||years|Mean|65.8|65.8|Standard Deviation|13.4|13.4|||
4006456|NCT01208233|3826861|B3|||Age||years|Mean|69.8|69.8|Standard Deviation|8.3|8.3|||
4006457|NCT01208233|3826862|B2|||Age||years|Mean|64.7|64.7|Standard Deviation|6.0|6.0|||
4006458|NCT01208233|3826863|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|14.3|14.3|||
4006459|NCT01208220|3826979|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4006460|NCT01208220|3826980|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4006461|NCT01208220|3826981|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4006462|NCT01208220|3826979|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4006463|NCT01208220|3826980|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4006464|NCT01208220|3826981|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4006465|NCT01208220|3826979|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4006466|NCT01208220|3826980|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4006467|NCT01208220|3826981|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4006468|NCT01208220|3826979|B3|||Age||years|Mean|54|54.0|Standard Deviation|3|3.0|||
4006469|NCT01208220|3826980|B2|||Age||years|Mean|57|57.0|Standard Deviation|0|0.0|||
4006470|NCT01208220|3826981|B1|||Age||years|Mean|52|52.0|Standard Deviation|0|0.0|||
4006471|NCT01208220|3826979|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4006472|NCT01208220|3826980|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4006473|NCT01208220|3826981|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4006474|NCT01208220|3826979|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4006475|NCT01208220|3826980|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4006476|NCT01208220|3826981|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4006477|NCT01208220|3826979|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4006478|NCT01208220|3826980|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4006479|NCT01208220|3826981|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4006480|NCT01208207|3826990|B4|||Spinal Pain Intensity|Visual Analogue Scale from 0-100 mm with a lower value representing a better response.|mm VAS|Mean|76.8|76.8|Standard Deviation|14.3|14.3|||
4006481|NCT01208207|3826991|B3|||Spinal Pain Intensity|Visual Analogue Scale from 0-100 mm with a lower value representing a better response.|mm VAS|Mean|77.0|77.0|Standard Deviation|14.0|14.0|||
4006482|NCT01208207|3826992|B2|||Spinal Pain Intensity|Visual Analogue Scale from 0-100 mm with a lower value representing a better response.|mm VAS|Mean|76.7|76.7|Standard Deviation|15.2|15.2|||
4006483|NCT01208207|3826993|B1|||Spinal Pain Intensity|Visual Analogue Scale from 0-100 mm with a lower value representing a better response.|mm VAS|Mean|76.7|76.7|Standard Deviation|14.2|14.2|||
4006484|NCT01208207|3826990|B4||Male|Sex: Female, Male||Participants|Count of Participants|720|720.0||||||
4006485|NCT01208207|3826991|B3||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4006486|NCT01208207|3826992|B2||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4006487|NCT01208207|3826993|B1||Male|Sex: Female, Male||Participants|Count of Participants|493|493.0||||||
4006488|NCT01208207|3826990|B4||Female|Sex: Female, Male||Participants|Count of Participants|295|295.0||||||
4006489|NCT01208207|3826991|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4006490|NCT01208207|3826992|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4006491|NCT01208207|3826993|B1||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4006492|NCT01208207|3826990|B4|||Age||Years|Mean|45.2|45.2|Standard Deviation|12.2|12.2|||
4006493|NCT01208207|3826991|B3|||Age||Years|Mean|44.5|44.5|Standard Deviation|12.3|12.3|||
4006494|NCT01208207|3826992|B2|||Age||Years|Mean|45.2|45.2|Standard Deviation|11.3|11.3|||
4006495|NCT01208207|3826993|B1|||Age||Years|Mean|45.4|45.4|Standard Deviation|12.4|12.4|||
4006496|NCT01208181|3827023|B4|||Patient Global Assessment of Pain|"A participant overall assessment of pain on a visual analog scale (VAS) were assessed with a question concerning the amount of pain due to arthritis during the past 48 hours. Pain was assessed on an 100 mm VAS scale with a left-hand marker no pain (0 mm) or right-hand marker extreme pain (100 mm). (N = 751, 430, 108 for Etoricoxib 60 mg, Etoricoxib 90 mg, and Placebo)"|Scores on a scale|Mean|71.02|71.02|Standard Deviation|15.24|15.24|||
4006497|NCT01208181|3827024|B3|||Patient Global Assessment of Pain|"A participant overall assessment of pain on a visual analog scale (VAS) were assessed with a question concerning the amount of pain due to arthritis during the past 48 hours. Pain was assessed on an 100 mm VAS scale with a left-hand marker no pain (0 mm) or right-hand marker extreme pain (100 mm). (N = 751, 430, 108 for Etoricoxib 60 mg, Etoricoxib 90 mg, and Placebo)"|Scores on a scale|Mean|74.08|74.08|Standard Deviation|14.23|14.23|||
4006498|NCT01208181|3827025|B2|||Patient Global Assessment of Pain|"A participant overall assessment of pain on a visual analog scale (VAS) were assessed with a question concerning the amount of pain due to arthritis during the past 48 hours. Pain was assessed on an 100 mm VAS scale with a left-hand marker no pain (0 mm) or right-hand marker extreme pain (100 mm). (N = 751, 430, 108 for Etoricoxib 60 mg, Etoricoxib 90 mg, and Placebo)"|Scores on a scale|Mean|70.58|70.58|Standard Deviation|15.02|15.02|||
4006499|NCT01208181|3827026|B1|||Patient Global Assessment of Pain|"A participant overall assessment of pain on a visual analog scale (VAS) were assessed with a question concerning the amount of pain due to arthritis during the past 48 hours. Pain was assessed on an 100 mm VAS scale with a left-hand marker no pain (0 mm) or right-hand marker extreme pain (100 mm). (N = 751, 430, 108 for Etoricoxib 60 mg, Etoricoxib 90 mg, and Placebo)"|Scores on a scale|Mean|70.84|70.84|Standard Deviation|15.50|15.5|||
4006500|NCT01208181|3827023|B4|||Disease Activity Score using C reactive protein (DAS28-CRP)|The DAS28-CRP index (0 - 10 Range) is a composite score of weighted components including tender joint counts of 28, swollen joint counts of 28, patient global assessment of disease activity, and C-reactive protein (CRP). For each observation (Baseline, Week 2, 4, 6, 10, 12), components were combined into a single DAS28-CRP score using the following algorithm: 0.56*square root (sqrt) (tender joint count [28])+0.28*sqrt(swollen joint count [28] )+0.36* ln(crp+1) + 0.014* Patient Global Assessment of Disease Activity + 0.96. (N = 732, 426, 103 for Etoricoxib 60 mg, Etoricoxib 90 mg, and Placebo).|Scores on a scale|Mean|5.63|5.63|Standard Deviation|1.00|1.0|||
4006548|NCT01207765|3827081|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006549|NCT01207765|3827081|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006501|NCT01208181|3827024|B3|||Disease Activity Score using C reactive protein (DAS28-CRP)|The DAS28-CRP index (0 - 10 Range) is a composite score of weighted components including tender joint counts of 28, swollen joint counts of 28, patient global assessment of disease activity, and C-reactive protein (CRP). For each observation (Baseline, Week 2, 4, 6, 10, 12), components were combined into a single DAS28-CRP score using the following algorithm: 0.56*square root (sqrt) (tender joint count [28])+0.28*sqrt(swollen joint count [28] )+0.36* ln(crp+1) + 0.014* Patient Global Assessment of Disease Activity + 0.96. (N = 732, 426, 103 for Etoricoxib 60 mg, Etoricoxib 90 mg, and Placebo).|Scores on a scale|Mean|5.65|5.65|Standard Deviation|1.12|1.12|||
4006502|NCT01208181|3827025|B2|||Disease Activity Score using C reactive protein (DAS28-CRP)|The DAS28-CRP index (0 - 10 Range) is a composite score of weighted components including tender joint counts of 28, swollen joint counts of 28, patient global assessment of disease activity, and C-reactive protein (CRP). For each observation (Baseline, Week 2, 4, 6, 10, 12), components were combined into a single DAS28-CRP score using the following algorithm: 0.56*square root (sqrt) (tender joint count [28])+0.28*sqrt(swollen joint count [28] )+0.36* ln(crp+1) + 0.014* Patient Global Assessment of Disease Activity + 0.96. (N = 732, 426, 103 for Etoricoxib 60 mg, Etoricoxib 90 mg, and Placebo).|Scores on a scale|Mean|5.62|5.62|Standard Deviation|1.00|1.0|||
4006503|NCT01208181|3827026|B1|||Disease Activity Score using C reactive protein (DAS28-CRP)|The DAS28-CRP index (0 - 10 Range) is a composite score of weighted components including tender joint counts of 28, swollen joint counts of 28, patient global assessment of disease activity, and C-reactive protein (CRP). For each observation (Baseline, Week 2, 4, 6, 10, 12), components were combined into a single DAS28-CRP score using the following algorithm: 0.56*square root (sqrt) (tender joint count [28])+0.28*sqrt(swollen joint count [28] )+0.36* ln(crp+1) + 0.014* Patient Global Assessment of Disease Activity + 0.96. (N = 732, 426, 103 for Etoricoxib 60 mg, Etoricoxib 90 mg, and Placebo).|Scores on a scale|Mean|5.64|5.64|Standard Deviation|0.99|0.99|||
4006504|NCT01208181|3827023|B4||Male|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
4006505|NCT01208181|3827024|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4006506|NCT01208181|3827025|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4006507|NCT01208181|3827026|B1||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4006508|NCT01208181|3827023|B4||Female|Sex: Female, Male||Participants|Count of Participants|1172|1172.0||||||
4006509|NCT01208181|3827024|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4006510|NCT01208181|3827025|B2||Female|Sex: Female, Male||Participants|Count of Participants|395|395.0||||||
4006511|NCT01208181|3827026|B1||Female|Sex: Female, Male||Participants|Count of Participants|677|677.0||||||
4006512|NCT01208181|3827023|B4|||Age||Years|Mean|53.8|53.8|Standard Deviation|12.0|12.0|||
4006513|NCT01208181|3827024|B3|||Age||Years|Mean|53.6|53.6|Standard Deviation|11.0|11.0|||
4006514|NCT01208181|3827025|B2|||Age||Years|Mean|54.0|54.0|Standard Deviation|12.3|12.3|||
4006515|NCT01208181|3827026|B1|||Age||Years|Mean|53.8|53.8|Standard Deviation|11.9|11.9|||
4006516|NCT01207934|3827059|B4|United States||Region of Enrollment||participants|Number|18|18.0||||||
4006517|NCT01207934|3827060|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4006518|NCT01207934|3827061|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4006519|NCT01207934|3827062|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4006520|NCT01207934|3827059|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4006521|NCT01207934|3827060|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4006522|NCT01207934|3827061|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4006523|NCT01207934|3827062|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4006524|NCT01207934|3827059|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4006525|NCT01207934|3827060|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4006526|NCT01207934|3827061|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4006527|NCT01207934|3827062|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4006528|NCT01207934|3827059|B4|||Age||years|Mean|56|56.0|Standard Deviation|1.9|1.9|||
4006529|NCT01207934|3827060|B3|||Age||years|Mean|54|54.0|Standard Deviation|1.6|1.6|||
4006530|NCT01207934|3827061|B2|||Age||years|Mean|53|53.0|Standard Deviation|2.9|2.9|||
4006531|NCT01207934|3827062|B1|||Age||years|Mean|60|60.0|Standard Deviation|1.2|1.2|||
4006532|NCT01207934|3827059|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4006533|NCT01207934|3827060|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4006534|NCT01207934|3827061|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4006535|NCT01207934|3827062|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4006536|NCT01207934|3827059|B4||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4006537|NCT01207934|3827060|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4006538|NCT01207934|3827061|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4006539|NCT01207934|3827062|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4006540|NCT01207934|3827059|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4006541|NCT01207934|3827060|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4006542|NCT01207934|3827061|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4006543|NCT01207934|3827062|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4006544|NCT01207765|3827081|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4006545|NCT01207765|3827081|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006546|NCT01207765|3827081|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4006547|NCT01207765|3827081|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4006550|NCT01207765|3827081|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006551|NCT01207765|3827081|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006552|NCT01207765|3827081|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4006553|NCT01207765|3827081|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4006554|NCT01207765|3827081|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4006555|NCT01207765|3827081|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4006556|NCT01207765|3827081|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4006557|NCT01207687|3827087|B1|||word recognition score of target ear|The word recognition score (WRS) is the percentage of phonetically-balanced, monosyllabic words that a patient can accurately repeat presented at either most comfortable level or most intelligible level|units on a scale|Median|60.5|60.5|Full Range|||13.0|82.0|
4006558|NCT01207687|3827087|B1|||Karnofsky performance status scale|The Karnofsky performance status (KPS) scale is a provider reported measure of functional status. Decile scores are assigned, ranging from 0 to 100. A lower score (minimum 0) represents greater functional impairment. A higher score (maximum 100) represents less functional impairment. KPS can be used measure changes in a patient's functional status.|units on a scale|Median|80|80.0|Full Range|||70.0|90.0|
4006559|NCT01207687|3827087|B1|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4006560|NCT01207687|3827087|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4006561|NCT01207687|3827087|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006562|NCT01207687|3827087|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4006563|NCT01207687|3827087|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006564|NCT01207687|3827087|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006565|NCT01207687|3827087|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4006566|NCT01207687|3827087|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006567|NCT01207687|3827087|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4006568|NCT01207687|3827087|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4006569|NCT01207687|3827087|B1|||Age||years|Median|30.5|30.5|Full Range|||14.0|79.0|
4006570|NCT01207687|3827087|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4006571|NCT01207687|3827087|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4006572|NCT01207687|3827087|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4006573|NCT01207648|3827117|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4006574|NCT01207648|3827117|B1||Female|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4006575|NCT01207648|3827117|B1|||Age||years|Mean|14.0|14.0|Standard Deviation|3.0|3.0|||
4006576|NCT01207596|3827125|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4006577|NCT01207596|3827125|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4006578|NCT01207596|3827125|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4006579|NCT01207596|3827125|B1|||Age||years|Mean|58|58.0|Standard Deviation|10|10.0|||
4006580|NCT01207596|3827125|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4006581|NCT01207596|3827125|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4006582|NCT01207596|3827125|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4006583|NCT01207583|3827135|B4||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4006584|NCT01207583|3827136|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4006585|NCT01207583|3827137|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4006586|NCT01207583|3827138|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4006587|NCT01207583|3827135|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4006588|NCT01207583|3827136|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4006589|NCT01207583|3827137|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4006590|NCT01207583|3827138|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4006591|NCT01207583|3827135|B4|12 to 23 months||Age, Customized||Participants|Number|55|55.0||||||
4006592|NCT01207583|3827136|B3|12 to 23 months||Age, Customized||Participants|Number|55|55.0||||||
4006593|NCT01207583|3827137|B2|12 to 23 months||Age, Customized||Participants|Number|0|0.0||||||
4006594|NCT01207583|3827138|B1|12 to 23 months||Age, Customized||Participants|Number|0|0.0||||||
4006595|NCT01207583|3827135|B4|7 to 11 months||Age, Customized||Participants|Number|31|31.0||||||
4006596|NCT01207583|3827136|B3|7 to 11 months||Age, Customized||Participants|Number|0|0.0||||||
4006597|NCT01207583|3827137|B2|7 to 11 months||Age, Customized||Participants|Number|31|31.0||||||
4006598|NCT01207583|3827138|B1|7 to 11 months||Age, Customized||Participants|Number|0|0.0||||||
4006599|NCT01207583|3827135|B4|3 to 6 months||Age, Customized||Participants|Number|14|14.0||||||
4006600|NCT01207583|3827136|B3|3 to 6 months||Age, Customized||Participants|Number|0|0.0||||||
4006601|NCT01207583|3827137|B2|3 to 6 months||Age, Customized||Participants|Number|0|0.0||||||
4006602|NCT01207583|3827138|B1|3 to 6 months||Age, Customized||Participants|Number|14|14.0||||||
4006603|NCT01207570|3827178|B3|Hong Kong||Region of Enrollment||participants|Number|54|54.0||||||
4006604|NCT01207570|3827179|B2|Hong Kong||Region of Enrollment||participants|Number|31|31.0||||||
4006605|NCT01207570|3827180|B1|Hong Kong||Region of Enrollment||participants|Number|23|23.0||||||
4006606|NCT01207570|3827178|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4006607|NCT01207570|3827179|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4006608|NCT01207570|3827180|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4006609|NCT01207570|3827178|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4006610|NCT01207570|3827179|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4006611|NCT01207570|3827180|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4006612|NCT01207570|3827178|B3|||Age||years|Mean|4.8|4.8|Standard Deviation|1.3|1.3|||
4006613|NCT01207570|3827179|B2|||Age||years|Mean|4.9|4.9|Standard Deviation|1.2|1.2|||
4006614|NCT01207570|3827180|B1|||Age||years|Mean|4.7|4.7|Standard Deviation|1.5|1.5|||
4006615|NCT01207570|3827178|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4006616|NCT01207570|3827179|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4006617|NCT01207570|3827180|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4006618|NCT01207570|3827178|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4006619|NCT01207570|3827179|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4006620|NCT01207570|3827180|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4006621|NCT01207570|3827178|B3||<=18 years|Age||Participants|Count of Participants|54|54.0||||||
4006622|NCT01207570|3827179|B2||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
4006623|NCT01207570|3827180|B1||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
4006624|NCT01207492|3827193|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4006625|NCT01207492|3827193|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4006626|NCT01207492|3827193|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4006627|NCT01207492|3827193|B1|||Age||years|Mean|45.35|45.35|Standard Deviation|13.54|13.54|||
4006628|NCT01207492|3827193|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4006629|NCT01207492|3827193|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4006630|NCT01207492|3827193|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4006631|NCT01207466|3827199|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4006632|NCT01207466|3827199|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4006633|NCT01207466|3827199|B1|||Age||years|Mean|35.8|35.8|Standard Deviation|12.2|12.2|||
4006634|NCT01207453|3827206|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4006635|NCT01207453|3827207|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4006636|NCT01207453|3827208|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4006637|NCT01207453|3827206|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4006638|NCT01207453|3827207|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4006639|NCT01207453|3827208|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4006640|NCT01207453|3827206|B3|Age||Age||Year|Mean|57.32|57.32|Standard Deviation|13.34|13.34|||
4006641|NCT01207453|3827207|B2|Age||Age||Year|Mean|58.50|58.5|Standard Deviation|14.79|14.79|||
4006642|NCT01207453|3827208|B1|Age||Age||Year|Mean|56.39|56.39|Standard Deviation|12.35|12.35|||
4006643|NCT01207427|3827228|B4||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4006644|NCT01207427|3827229|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4006645|NCT01207427|3827230|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4006646|NCT01207427|3827231|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4006647|NCT01207427|3827228|B4||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4006648|NCT01207427|3827229|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4006649|NCT01207427|3827230|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4006650|NCT01207427|3827231|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4006651|NCT01207427|3827228|B4||GTE65|Age||Participants|Count of Participants|7|7.0||||||
4006652|NCT01207427|3827229|B3||GTE65|Age||Participants|Count of Participants|3|3.0||||||
4006653|NCT01207427|3827230|B2||GTE65|Age||Participants|Count of Participants|1|1.0||||||
4006654|NCT01207427|3827231|B1||GTE65|Age||Participants|Count of Participants|3|3.0||||||
4006655|NCT01207427|3827228|B4||BTWN|Age||Participants|Count of Participants|124|124.0||||||
4006656|NCT01207427|3827229|B3||BTWN|Age||Participants|Count of Participants|40|40.0||||||
4006657|NCT01207427|3827230|B2||BTWN|Age||Participants|Count of Participants|44|44.0||||||
4006658|NCT01207427|3827231|B1||BTWN|Age||Participants|Count of Participants|40|40.0||||||
4006659|NCT01207427|3827228|B4||LTE18|Age||Participants|Count of Participants|0|0.0||||||
4006660|NCT01207427|3827229|B3||LTE18|Age||Participants|Count of Participants|0|0.0||||||
4006661|NCT01207427|3827230|B2||LTE18|Age||Participants|Count of Participants|0|0.0||||||
4006662|NCT01207427|3827231|B1||LTE18|Age||Participants|Count of Participants|0|0.0||||||
4006663|NCT01207414|3827241|B3||Male|Sex: Female, Male||Participants|Count of Participants|335|335.0||||||
4006664|NCT01207414|3827242|B2||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4006665|NCT01207414|3827243|B1||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4006666|NCT01207414|3827241|B3||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4006667|NCT01207414|3827242|B2||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4006668|NCT01207414|3827243|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4006669|NCT01207414|3827241|B3|||Age|Baseline Measures are based on the Safety Population that includes all randomized participants who received study drug.|years|Mean|43.3|43.3|Standard Deviation|10.98|10.98|||
4006670|NCT01207414|3827242|B2|||Age|Baseline Measures are based on the Safety Population that includes all randomized participants who received study drug.|years|Mean|44.2|44.2|Standard Deviation|10.92|10.92|||
4006671|NCT01207414|3827243|B1|||Age|Baseline Measures are based on the Safety Population that includes all randomized participants who received study drug.|years|Mean|42.3|42.3|Standard Deviation|10.98|10.98|||
4006672|NCT01207401|3827260|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4006673|NCT01207401|3827261|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4006674|NCT01207401|3827262|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4006675|NCT01207401|3827260|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4006676|NCT01207401|3827261|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4006677|NCT01207401|3827262|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4006678|NCT01207401|3827260|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4006679|NCT01207401|3827261|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4006680|NCT01207401|3827262|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4006681|NCT01207401|3827260|B3|||Age||years|Mean|32.6|32.6|Standard Deviation|6.0|6.0|||
4006682|NCT01207401|3827261|B2|||Age||years|Mean|33.2|33.2|Standard Deviation|6.2|6.2|||
4006683|NCT01207401|3827262|B1|||Age||years|Mean|31.9|31.9|Standard Deviation|5.9|5.9|||
4006684|NCT01207401|3827260|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4006685|NCT01207401|3827261|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4006686|NCT01207401|3827262|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4006687|NCT01207401|3827260|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4006688|NCT01207401|3827261|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4006689|NCT01207401|3827262|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4006690|NCT01207401|3827260|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4006691|NCT01207401|3827261|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4006692|NCT01207401|3827262|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4006693|NCT01207388|3827269|B1|Unknown||White Blood Cells at First Diagnosis||participants|Number|20|20.0||||||
4006694|NCT01207388|3827269|B1|> 30,000/mL||White Blood Cells at First Diagnosis||participants|Number|18|18.0||||||
4006695|NCT01207388|3827269|B1|≤ 30,000/mL||White Blood Cells at First Diagnosis||participants|Number|78|78.0||||||
4006696|NCT01207388|3827269|B1|Unknown||MRD Level at Baseline by Central Laboratory|Measured by polymerase chain reaction (PCR) performed on bone marrow and assessed by the central laboratory; Lower limit of quantification was at least 10^-4 leukemic cells.|participants|Number|2|2.0||||||
4006697|NCT01207388|3827269|B1|Below Lower Limit of Quantification||MRD Level at Baseline by Central Laboratory|Measured by polymerase chain reaction (PCR) performed on bone marrow and assessed by the central laboratory; Lower limit of quantification was at least 10^-4 leukemic cells.|participants|Number|5|5.0||||||
4006698|NCT01207388|3827269|B1|< 10^-3||MRD Level at Baseline by Central Laboratory|Measured by polymerase chain reaction (PCR) performed on bone marrow and assessed by the central laboratory; Lower limit of quantification was at least 10^-4 leukemic cells.|participants|Number|3|3.0||||||
4006699|NCT01207388|3827269|B1|≥ 10^-3 and < 10^-2||MRD Level at Baseline by Central Laboratory|Measured by polymerase chain reaction (PCR) performed on bone marrow and assessed by the central laboratory; Lower limit of quantification was at least 10^-4 leukemic cells.|participants|Number|52|52.0||||||
4006700|NCT01207388|3827269|B1|≥ 10^-2 and < 10^-1||MRD Level at Baseline by Central Laboratory|Measured by polymerase chain reaction (PCR) performed on bone marrow and assessed by the central laboratory; Lower limit of quantification was at least 10^-4 leukemic cells.|participants|Number|45|45.0||||||
4006701|NCT01207388|3827269|B1|≥ 10^-1 and < 1||MRD Level at Baseline by Central Laboratory|Measured by polymerase chain reaction (PCR) performed on bone marrow and assessed by the central laboratory; Lower limit of quantification was at least 10^-4 leukemic cells.|participants|Number|9|9.0||||||
4006702|NCT01207388|3827269|B1|||Confirmed t(4;11) Translocation / MLL-AF4+ ALL|t(4;11)(q21;q23) translocation, resulting in the fusion of the mixed lineage leukemia (MLL) gene on chromosome 11 and the AF4 gene on chromosome 4|participants|Number|5|5.0||||||
4006703|NCT01207388|3827269|B1|Negative||Philadelphia Chromosome Disease Status||participants|Number|111|111.0||||||
4006704|NCT01207388|3827269|B1|Positive||Philadelphia Chromosome Disease Status||participants|Number|5|5.0||||||
4006705|NCT01207388|3827269|B1|Unknown||Race/Ethnicity, Customized|Race was not permitted to be collected in France.|participants|Number|12|12.0||||||
4006706|NCT01207388|3827269|B1|Mixed||Race/Ethnicity, Customized|Race was not permitted to be collected in France.|participants|Number|1|1.0||||||
4006707|NCT01207388|3827269|B1|Asian||Race/Ethnicity, Customized|Race was not permitted to be collected in France.|participants|Number|1|1.0||||||
4006708|NCT01207388|3827269|B1|White||Race/Ethnicity, Customized|Race was not permitted to be collected in France.|participants|Number|102|102.0||||||
4006709|NCT01207388|3827269|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4006710|NCT01207388|3827269|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4006711|NCT01207388|3827269|B1|≥ 65 years||Age, Customized||participants|Number|15|15.0||||||
4006712|NCT01207388|3827269|B1|≥ 55 and < 65 years||Age, Customized||participants|Number|24|24.0||||||
4006713|NCT01207388|3827269|B1|≥ 35 and < 55 years||Age, Customized||participants|Number|41|41.0||||||
4006714|NCT01207388|3827269|B1|≥ 18 and <35 years||Age, Customized||participants|Number|36|36.0||||||
4006715|NCT01207388|3827269|B1|||Age||years|Mean|44.6|44.6|Standard Deviation|16.4|16.4|||
4006758|NCT01207219|3827291|B2|No substance abuse||Substance abuse||participants|Number|37|37.0||||||
4006759|NCT01207219|3827292|B1|No substance abuse||Substance abuse||participants|Number|40|40.0||||||
4006716|NCT01207219|3827289|B4|||Calgary Depression Scale (CDS) total score|CDS total score is computed by summing the scores of nine items of the scale. The range of CDS total score is from 0 to 27, with higher values representing worse outcome.|units on a scale|Mean|3.6|3.6|Standard Deviation|4.1|4.1|||
4006717|NCT01207219|3827290|B3|||Calgary Depression Scale (CDS) total score|CDS total score is computed by summing the scores of nine items of the scale. The range of CDS total score is from 0 to 27, with higher values representing worse outcome.|units on a scale|Mean|3.7|3.7|Standard Deviation|4.7|4.7|||
4006718|NCT01207219|3827291|B2|||Calgary Depression Scale (CDS) total score|CDS total score is computed by summing the scores of nine items of the scale. The range of CDS total score is from 0 to 27, with higher values representing worse outcome.|units on a scale|Mean|3.4|3.4|Standard Deviation|4.1|4.1|||
4006719|NCT01207219|3827292|B1|||Calgary Depression Scale (CDS) total score|CDS total score is computed by summing the scores of nine items of the scale. The range of CDS total score is from 0 to 27, with higher values representing worse outcome.|units on a scale|Mean|3.6|3.6|Standard Deviation|3.4|3.4|||
4006720|NCT01207219|3827289|B4|||Positive and Negative Syndrome Scale (PANSS) total score|PANSS total score is computed by summing the scores of positive, negative and general symptom subscores. The range of PANSS total score is from 30 to 210, with higher values representing worse outcome.|units on a scale|Mean|46.4|46.4|Standard Deviation|15.7|15.7|||
4006721|NCT01207219|3827290|B3|||Positive and Negative Syndrome Scale (PANSS) total score|PANSS total score is computed by summing the scores of positive, negative and general symptom subscores. The range of PANSS total score is from 30 to 210, with higher values representing worse outcome.|units on a scale|Mean|45.4|45.4|Standard Deviation|15.2|15.2|||
4006722|NCT01207219|3827291|B2|||Positive and Negative Syndrome Scale (PANSS) total score|PANSS total score is computed by summing the scores of positive, negative and general symptom subscores. The range of PANSS total score is from 30 to 210, with higher values representing worse outcome.|units on a scale|Mean|46.8|46.8|Standard Deviation|16.4|16.4|||
4006723|NCT01207219|3827292|B1|||Positive and Negative Syndrome Scale (PANSS) total score|PANSS total score is computed by summing the scores of positive, negative and general symptom subscores. The range of PANSS total score is from 30 to 210, with higher values representing worse outcome.|units on a scale|Mean|46.9|46.9|Standard Deviation|15.8|15.8|||
4006724|NCT01207219|3827289|B4|||Antipsychotic medication dose, Chlorpromazine (CPZ)|"CPZ-EQ is used here to describe the antipsychotics dose. It is a standard unit representing 100 mg of oral dose of chlorpromazine. Mean dose per day is reported here."|mg/day|Mean|305|305.0|Standard Deviation|244|244.0|||
4006725|NCT01207219|3827290|B3|||Antipsychotic medication dose, Chlorpromazine (CPZ)|"CPZ-EQ is used here to describe the antipsychotics dose. It is a standard unit representing 100 mg of oral dose of chlorpromazine. Mean dose per day is reported here."|mg/day|Mean|260|260.0|Standard Deviation|211|211.0|||
4006726|NCT01207219|3827291|B2|||Antipsychotic medication dose, Chlorpromazine (CPZ)|"CPZ-EQ is used here to describe the antipsychotics dose. It is a standard unit representing 100 mg of oral dose of chlorpromazine. Mean dose per day is reported here."|mg/day|Mean|301|301.0|Standard Deviation|245|245.0|||
4006727|NCT01207219|3827292|B1|||Antipsychotic medication dose, Chlorpromazine (CPZ)|"CPZ-EQ is used here to describe the antipsychotics dose. It is a standard unit representing 100 mg of oral dose of chlorpromazine. Mean dose per day is reported here."|mg/day|Mean|348|348.0|Standard Deviation|268|268.0|||
4006728|NCT01207219|3827289|B4|Delusional disorder||Diagnosis||participants|Number|4|4.0||||||
4006729|NCT01207219|3827290|B3|Delusional disorder||Diagnosis||participants|Number|1|1.0||||||
4006730|NCT01207219|3827291|B2|Delusional disorder||Diagnosis||participants|Number|2|2.0||||||
4006731|NCT01207219|3827292|B1|Delusional disorder||Diagnosis||participants|Number|1|1.0||||||
4006732|NCT01207219|3827289|B4|Psychosis not otherwise specified||Diagnosis||participants|Number|36|36.0||||||
4006733|NCT01207219|3827290|B3|Psychosis not otherwise specified||Diagnosis||participants|Number|15|15.0||||||
4006734|NCT01207219|3827291|B2|Psychosis not otherwise specified||Diagnosis||participants|Number|8|8.0||||||
4006735|NCT01207219|3827292|B1|Psychosis not otherwise specified||Diagnosis||participants|Number|13|13.0||||||
4006736|NCT01207219|3827289|B4|Brief psychosis||Diagnosis||participants|Number|2|2.0||||||
4006737|NCT01207219|3827290|B3|Brief psychosis||Diagnosis||participants|Number|0|0.0||||||
4006738|NCT01207219|3827291|B2|Brief psychosis||Diagnosis||participants|Number|1|1.0||||||
4006739|NCT01207219|3827292|B1|Brief psychosis||Diagnosis||participants|Number|1|1.0||||||
4006740|NCT01207219|3827289|B4|Schizophreniform disorder||Diagnosis||participants|Number|1|1.0||||||
4006741|NCT01207219|3827290|B3|Schizophreniform disorder||Diagnosis||participants|Number|0|0.0||||||
4006742|NCT01207219|3827291|B2|Schizophreniform disorder||Diagnosis||participants|Number|1|1.0||||||
4006743|NCT01207219|3827292|B1|Schizophreniform disorder||Diagnosis||participants|Number|0|0.0||||||
4006744|NCT01207219|3827289|B4|Schizoaffective disorder||Diagnosis||participants|Number|13|13.0||||||
4006745|NCT01207219|3827290|B3|Schizoaffective disorder||Diagnosis||participants|Number|3|3.0||||||
4006746|NCT01207219|3827291|B2|Schizoaffective disorder||Diagnosis||participants|Number|6|6.0||||||
4006747|NCT01207219|3827292|B1|Schizoaffective disorder||Diagnosis||participants|Number|4|4.0||||||
4006748|NCT01207219|3827289|B4|Schizophrenia||Diagnosis||participants|Number|59|59.0||||||
4006749|NCT01207219|3827290|B3|Schizophrenia||Diagnosis||participants|Number|19|19.0||||||
4006750|NCT01207219|3827291|B2|Schizophrenia||Diagnosis||participants|Number|19|19.0||||||
4006751|NCT01207219|3827292|B1|Schizophrenia||Diagnosis||participants|Number|21|21.0||||||
4006752|NCT01207219|3827289|B4|Substance abuse||Substance abuse||participants|Number|0|0.0||||||
4006753|NCT01207219|3827290|B3|Substance abuse||Substance abuse||participants|Number|0|0.0||||||
4006754|NCT01207219|3827291|B2|Substance abuse||Substance abuse||participants|Number|0|0.0||||||
4006755|NCT01207219|3827292|B1|Substance abuse||Substance abuse||participants|Number|0|0.0||||||
4006756|NCT01207219|3827289|B4|No substance abuse||Substance abuse||participants|Number|115|115.0||||||
4006757|NCT01207219|3827290|B3|No substance abuse||Substance abuse||participants|Number|38|38.0||||||
4006760|NCT01207219|3827289|B4|Current smoker||Smoking||participants|Number|8|8.0||||||
4006761|NCT01207219|3827290|B3|Current smoker||Smoking||participants|Number|1|1.0||||||
4006762|NCT01207219|3827291|B2|Current smoker||Smoking||participants|Number|4|4.0||||||
4006763|NCT01207219|3827292|B1|Current smoker||Smoking||participants|Number|3|3.0||||||
4006764|NCT01207219|3827289|B4|Past smoker||Smoking||participants|Number|1|1.0||||||
4006765|NCT01207219|3827290|B3|Past smoker||Smoking||participants|Number|0|0.0||||||
4006766|NCT01207219|3827291|B2|Past smoker||Smoking||participants|Number|1|1.0||||||
4006767|NCT01207219|3827292|B1|Past smoker||Smoking||participants|Number|0|0.0||||||
4006768|NCT01207219|3827289|B4|Never smoker||Smoking||participants|Number|106|106.0||||||
4006769|NCT01207219|3827290|B3|Never smoker||Smoking||participants|Number|37|37.0||||||
4006770|NCT01207219|3827291|B2|Never smoker||Smoking||participants|Number|32|32.0||||||
4006771|NCT01207219|3827292|B1|Never smoker||Smoking||participants|Number|37|37.0||||||
4006772|NCT01207219|3827289|B4|||Length of illness||years|Mean|1.8|1.8|Standard Deviation|1.9|1.9|||
4006773|NCT01207219|3827290|B3|||Length of illness||years|Mean|1.8|1.8|Standard Deviation|1.9|1.9|||
4006774|NCT01207219|3827291|B2|||Length of illness||years|Mean|2.5|2.5|Standard Deviation|2.0|2.0|||
4006775|NCT01207219|3827292|B1|||Length of illness||years|Mean|2.4|2.4|Standard Deviation|1.9|1.9|||
4006776|NCT01207219|3827289|B4|||Years of education||years|Mean|12.3|12.3|Standard Deviation|2.7|2.7|||
4006777|NCT01207219|3827290|B3|||Years of education||years|Mean|12.3|12.3|Standard Deviation|2.6|2.6|||
4006778|NCT01207219|3827291|B2|||Years of education||years|Mean|12.8|12.8|Standard Deviation|3.2|3.2|||
4006779|NCT01207219|3827292|B1|||Years of education||years|Mean|11.9|11.9|Standard Deviation|2.1|2.1|||
4006780|NCT01207219|3827289|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4006781|NCT01207219|3827290|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4006782|NCT01207219|3827291|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4006783|NCT01207219|3827292|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4006784|NCT01207219|3827289|B4||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4006785|NCT01207219|3827290|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4006786|NCT01207219|3827291|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4006787|NCT01207219|3827292|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4006788|NCT01207219|3827289|B4|||Age||years|Mean|24.4|24.4|Standard Deviation|7.0|7.0|||
4006789|NCT01207219|3827290|B3|||Age||years|Mean|25.3|25.3|Standard Deviation|8.2|8.2|||
4006790|NCT01207219|3827291|B2|||Age||years|Mean|23.6|23.6|Standard Deviation|5.6|5.6|||
4006791|NCT01207219|3827292|B1|||Age||years|Mean|24.2|24.2|Standard Deviation|6.9|6.9|||
4006792|NCT01207102|3827314|B1|China||Region of Enrollment||participants|Number|7|7.0||||||
4006793|NCT01207102|3827314|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4006794|NCT01207102|3827314|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006795|NCT01207102|3827314|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006796|NCT01207102|3827314|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4006797|NCT01207102|3827314|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4006798|NCT01207102|3827314|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006799|NCT01207102|3827314|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4006800|NCT01207102|3827314|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4006801|NCT01207102|3827314|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4006802|NCT01207102|3827314|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4006803|NCT01207102|3827314|B1|||Age||years|Mean|54.5|54.5|Standard Deviation|8.1|8.1|||
4006804|NCT01207102|3827314|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4006805|NCT01207102|3827314|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4006806|NCT01207102|3827314|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4006807|NCT01206777|3827319|B1|United States||Region of Enrollment||patients|Number|52|52.0||||||
4006808|NCT01206777|3827319|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4006809|NCT01206777|3827319|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4006810|NCT01206777|3827319|B1|||Age||years|Median|63|63.0|Full Range|||19.0|85.0|
4006811|NCT01206738|3827325|B4|United Kingdom||Region of Enrollment||participants|Number|198|198.0||||||
4006812|NCT01206738|3827326|B3|United Kingdom||Region of Enrollment||participants|Number|61|61.0||||||
4006813|NCT01206738|3827327|B2|United Kingdom||Region of Enrollment||participants|Number|74|74.0||||||
4006814|NCT01206738|3827328|B1|United Kingdom||Region of Enrollment||participants|Number|63|63.0||||||
4006815|NCT01206738|3827325|B4|Male||Sex/Gender, Customized|Some participants chose not to respond to the gender question.|participants|Number|103|103.0||||||
4006816|NCT01206738|3827326|B3|Male||Sex/Gender, Customized|Some participants chose not to respond to the gender question.|participants|Number|32|32.0||||||
4006817|NCT01206738|3827327|B2|Male||Sex/Gender, Customized|Some participants chose not to respond to the gender question.|participants|Number|36|36.0||||||
4006818|NCT01206738|3827328|B1|Male||Sex/Gender, Customized|Some participants chose not to respond to the gender question.|participants|Number|35|35.0||||||
4006819|NCT01206738|3827325|B4|Female||Sex/Gender, Customized|Some participants chose not to respond to the gender question.|participants|Number|88|88.0||||||
4006820|NCT01206738|3827326|B3|Female||Sex/Gender, Customized|Some participants chose not to respond to the gender question.|participants|Number|27|27.0||||||
4006821|NCT01206738|3827327|B2|Female||Sex/Gender, Customized|Some participants chose not to respond to the gender question.|participants|Number|34|34.0||||||
4006822|NCT01206738|3827328|B1|Female||Sex/Gender, Customized|Some participants chose not to respond to the gender question.|participants|Number|27|27.0||||||
4006823|NCT01206738|3827325|B4|Years qualified||Age, Customized|Age was not collected; we collected years a GP had been qualified|years|Mean|21|21.0|Standard Deviation|9|9.0|||
4006824|NCT01206738|3827326|B3|Years qualified||Age, Customized|Age was not collected; we collected years a GP had been qualified|years|Mean|22|22.0|Standard Deviation|8|8.0|||
4006825|NCT01206738|3827327|B2|Years qualified||Age, Customized|Age was not collected; we collected years a GP had been qualified|years|Mean|20|20.0|Standard Deviation|9|9.0|||
4006826|NCT01206738|3827328|B1|Years qualified||Age, Customized|Age was not collected; we collected years a GP had been qualified|years|Mean|22|22.0|Standard Deviation|9|9.0|||
4006827|NCT01206660|3827340|B3|United States||Region of Enrollment||participants|Number|120|120.0||||||
4006828|NCT01206660|3827341|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
4006829|NCT01206660|3827342|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4006830|NCT01206660|3827340|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4006831|NCT01206660|3827341|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4006832|NCT01206660|3827342|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4006833|NCT01206660|3827340|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4006834|NCT01206660|3827341|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4006835|NCT01206660|3827342|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4006836|NCT01206660|3827340|B3||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4006837|NCT01206660|3827341|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4006838|NCT01206660|3827342|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4006839|NCT01206660|3827340|B3||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4006840|NCT01206660|3827341|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4006841|NCT01206660|3827342|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4006842|NCT01206660|3827340|B3||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4006843|NCT01206660|3827341|B2||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4006844|NCT01206660|3827342|B1||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
4006845|NCT01206660|3827340|B3|||Age||years|Mean|50.79|50.79|Standard Deviation|14.56|14.56|||
4006846|NCT01206660|3827341|B2|||Age||years|Mean|53.55|53.55|Standard Deviation|14.82|14.82|||
4006847|NCT01206660|3827342|B1|||Age||years|Mean|48.03|48.03|Standard Deviation|14.29|14.29|||
4006848|NCT01206608|3827353|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4006849|NCT01206608|3827354|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4006850|NCT01206608|3827355|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4006851|NCT01206608|3827353|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4006852|NCT01206608|3827354|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4006853|NCT01206608|3827355|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4006854|NCT01206608|3827353|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4006855|NCT01206608|3827354|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4006856|NCT01206608|3827355|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4006857|NCT01206608|3827353|B3|||Age||years|Mean|29.6|29.6|Standard Deviation|6.5|6.5|||
4006858|NCT01206608|3827354|B2|||Age||years|Mean|28.4|28.4|Standard Deviation|6|6.0|||
4006859|NCT01206608|3827355|B1|||Age||years|Mean|30.7|30.7|Standard Deviation|7|7.0|||
4006860|NCT01206608|3827353|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4006861|NCT01206608|3827354|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4006862|NCT01206608|3827355|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4006863|NCT01206608|3827353|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4006864|NCT01206608|3827354|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4006865|NCT01206608|3827355|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4006866|NCT01206608|3827353|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4006867|NCT01206608|3827354|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4006868|NCT01206608|3827355|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4006869|NCT01206595|3827362|B3|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
4006870|NCT01206595|3827363|B2|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4006871|NCT01206595|3827364|B1|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
4006872|NCT01206595|3827362|B3|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4006873|NCT01206595|3827363|B2|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4006874|NCT01206595|3827364|B1|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4006875|NCT01206595|3827362|B3|Belgium||Region of Enrollment||participants|Number|41|41.0||||||
4006876|NCT01206595|3827363|B2|Belgium||Region of Enrollment||participants|Number|12|12.0||||||
4006877|NCT01206595|3827364|B1|Belgium||Region of Enrollment||participants|Number|29|29.0||||||
4006878|NCT01206595|3827362|B3|Australia||Region of Enrollment||participants|Number|8|8.0||||||
4006879|NCT01206595|3827363|B2|Australia||Region of Enrollment||participants|Number|5|5.0||||||
4006880|NCT01206595|3827364|B1|Australia||Region of Enrollment||participants|Number|3|3.0||||||
4006881|NCT01206595|3827362|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4006882|NCT01206595|3827363|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4006883|NCT01206595|3827364|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4006884|NCT01206595|3827362|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4006885|NCT01206595|3827363|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4006886|NCT01206595|3827364|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4006887|NCT01206595|3827362|B3|||Age||years|Mean|54.8|54.8|Standard Deviation|14.1|14.1|||
4006888|NCT01206595|3827363|B2|||Age||years|Mean|55.7|55.7|Standard Deviation|14.22|14.22|||
4006889|NCT01206595|3827364|B1|||Age||years|Mean|54.3|54.3|Standard Deviation|14.04|14.04|||
4006890|NCT01206595|3827362|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4006891|NCT01206595|3827363|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4006892|NCT01206595|3827364|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4006893|NCT01206595|3827362|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4006894|NCT01206595|3827363|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4006895|NCT01206595|3827364|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4006896|NCT01206595|3827362|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4006897|NCT01206595|3827363|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4006898|NCT01206595|3827364|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4006899|NCT01206582|3827373|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4006900|NCT01206582|3827374|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4006901|NCT01206582|3827375|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4006902|NCT01206582|3827373|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4006903|NCT01206582|3827374|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4006904|NCT01206582|3827375|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4006905|NCT01206582|3827373|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4006906|NCT01206582|3827374|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4006907|NCT01206582|3827375|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4006908|NCT01206582|3827373|B3|||Age||years|Mean|41.1|41.1|Standard Deviation|15.3|15.3|||
4006909|NCT01206582|3827374|B2|||Age||years|Mean|35.2|35.2|Standard Deviation|14.9|14.9|||
4006910|NCT01206582|3827375|B1|||Age||years|Mean|45.9|45.9|Standard Deviation|14.4|14.4|||
4006911|NCT01206517|3827402|B7||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4006912|NCT01206517|3827403|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4006913|NCT01206517|3827404|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4006914|NCT01206517|3827405|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4006915|NCT01206517|3827406|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4006916|NCT01206517|3827407|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4006917|NCT01206517|3827408|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4006918|NCT01206517|3827402|B7||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4006919|NCT01206517|3827403|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4006920|NCT01206517|3827404|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4006921|NCT01206517|3827405|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4006922|NCT01206517|3827406|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4006923|NCT01206517|3827407|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4006924|NCT01206517|3827408|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4006925|NCT01206517|3827402|B7|||Age||years|Mean|12.1|12.1|Standard Deviation|2.3|2.3|||
4006926|NCT01206517|3827403|B6|||Age||years|Mean|16.5|16.5|Standard Deviation|0.6|0.6|||
4006927|NCT01206517|3827404|B5|||Age||years|Mean|14.5|14.5|Standard Deviation|0.6|0.6|||
4006928|NCT01206517|3827405|B4|||Age||years|Mean|12.5|12.5|Standard Deviation|0.6|0.6|||
4006929|NCT01206517|3827406|B3|||Age||years|Mean|10.3|10.3|Standard Deviation|0.5|0.5|||
4006930|NCT01206517|3827407|B2|||Age||years|Mean|10.5|10.5|Standard Deviation|0.8|0.8|||
4006931|NCT01206517|3827408|B1|||Age||years|Mean|10.8|10.8|Standard Deviation|0.4|0.4|||
4006932|NCT01206478|3827442|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4006933|NCT01206478|3827443|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4006934|NCT01206478|3827444|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4006935|NCT01206478|3827442|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4006936|NCT01206478|3827443|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4006937|NCT01206478|3827444|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4006938|NCT01206478|3827442|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4006939|NCT01206478|3827443|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4006940|NCT01206478|3827444|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4006941|NCT01206478|3827442|B3|||Age||age (years)|Mean|3.73|3.73|Standard Deviation|1.99|1.99|||
4006942|NCT01206478|3827443|B2|||Age||age (years)|Mean|3.89|3.89|Standard Deviation|1.84|1.84|||
4006943|NCT01206478|3827444|B1|||Age||age (years)|Mean|3.54|3.54|Standard Deviation|2.25|2.25|||
4006944|NCT01206465|3827453|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4006945|NCT01206465|3827453|B1|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4006946|NCT01206465|3827453|B1|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4006947|NCT01206465|3827453|B1|Race/Ethnicity|Black, not of hispanic origin|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4006948|NCT01206465|3827453|B1|Race/Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
4006949|NCT01206465|3827453|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4006950|NCT01206465|3827453|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4006951|NCT01206465|3827453|B1|||Age||years|Median|61|61.0|Full Range|||30.0|80.0|
4006952|NCT01206452|3827476|B3|||AF Duration||years|Mean|6.45|6.45|Standard Deviation|6.45|6.45|||
4006953|NCT01206452|3827477|B2|||AF Duration||years|Mean|4.98|4.98|Standard Deviation|4.81|4.81|||
4006954|NCT01206452|3827478|B1|||AF Duration||years|Mean|7.92|7.92|Standard Deviation|7.66|7.66|||
4006955|NCT01206452|3827476|B3|||Body Mass Index (BMI)||kg/m^2|Mean|29.51|29.51|Standard Deviation|5.63|5.63|||
4006956|NCT01206452|3827477|B2|||Body Mass Index (BMI)||kg/m^2|Mean|30.53|30.53|Standard Deviation|5.93|5.93|||
4006957|NCT01206452|3827478|B1|||Body Mass Index (BMI)||kg/m^2|Mean|28.48|28.48|Standard Deviation|5.19|5.19|||
4006958|NCT01206452|3827476|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4006959|NCT01206452|3827477|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4006960|NCT01206452|3827478|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4006961|NCT01206452|3827476|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4006962|NCT01206452|3827477|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4006963|NCT01206452|3827478|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4006964|NCT01206452|3827476|B3|||Age||years|Mean|63.12|63.12|Standard Deviation|8.75|8.75|||
4006965|NCT01206452|3827477|B2|||Age||years|Mean|63|63.0|Standard Deviation|8.69|8.69|||
4006966|NCT01206452|3827478|B1|||Age||years|Mean|63.23|63.23|Standard Deviation|8.95|8.95|||
4006967|NCT01206439|3827493|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4006968|NCT01206439|3827493|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4006969|NCT01206439|3827493|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4006970|NCT01206439|3827493|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4006971|NCT01206439|3827493|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4006972|NCT01206387|3827497|B3|United States||Region of Enrollment||participants|Number|120|120.0||||||
4006973|NCT01206387|3827498|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
4006974|NCT01206387|3827499|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4006975|NCT01206387|3827497|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4006976|NCT01206387|3827498|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4006977|NCT01206387|3827499|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4006978|NCT01206387|3827497|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4006979|NCT01206387|3827498|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4006980|NCT01206387|3827499|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4006981|NCT01206387|3827497|B3||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4006982|NCT01206387|3827498|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4006983|NCT01206387|3827499|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4006984|NCT01206387|3827497|B3||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4006985|NCT01206387|3827498|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4006986|NCT01206387|3827499|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4006987|NCT01206387|3827497|B3||<=18 years|Age||Participants|Count of Participants|28|28.0||||||
4006988|NCT01206387|3827498|B2||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4006989|NCT01206387|3827499|B1||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4006990|NCT01206387|3827497|B3|||Age||years|Mean|51.61|51.61|Standard Deviation|14.71|14.71|||
4006991|NCT01206387|3827498|B2|||Age||years|Mean|52.55|52.55|Standard Deviation|15.56|15.56|||
4006992|NCT01206387|3827499|B1|||Age||years|Mean|50.67|50.67|Standard Deviation|13.86|13.86|||
4006993|NCT01206322|3827514|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
4006994|NCT01206322|3827515|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4006995|NCT01206322|3827516|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4006996|NCT01206322|3827514|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4006997|NCT01206322|3827515|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4006998|NCT01206322|3827516|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4006999|NCT01206322|3827514|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4007000|NCT01206322|3827515|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4007001|NCT01206322|3827516|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4007002|NCT01206322|3827514|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4007003|NCT01206322|3827515|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4007004|NCT01206322|3827516|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4007005|NCT01206322|3827514|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4007006|NCT01206322|3827515|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4007007|NCT01206322|3827516|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4007008|NCT01206322|3827514|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4007009|NCT01206322|3827515|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4007010|NCT01206322|3827516|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4007011|NCT01206322|3827514|B3|||Age||years|Mean|61.1|61.1|Standard Deviation|8.81|8.81|||
4007012|NCT01206322|3827515|B2|||Age||years|Mean|62.0|62.0|Standard Deviation|7.9|7.9|||
4007013|NCT01206322|3827516|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|9.9|9.9|||
4007014|NCT01206140|3827533|B3|United States||Region of Enrollment||participants|Number|69|69.0||||||
4007015|NCT01206140|3827534|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
4007016|NCT01206140|3827535|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4007017|NCT01206140|3827533|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4007018|NCT01206140|3827534|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4007019|NCT01206140|3827535|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4007020|NCT01206140|3827533|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4007021|NCT01206140|3827534|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4007022|NCT01206140|3827535|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4007023|NCT01206140|3827533|B3|||Age||years|Median|56|56.0|Full Range|||20.0|84.0|
4007024|NCT01206140|3827534|B2|||Age||years|Median|56|56.0|Full Range|||20.0|83.0|
4007025|NCT01206140|3827535|B1|||Age||years|Median|56|56.0|Full Range|||34.0|84.0|
4007026|NCT01206101|3827546|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4007027|NCT01206101|3827547|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4007028|NCT01206101|3827548|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4007029|NCT01206101|3827546|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4007030|NCT01206101|3827547|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4007031|NCT01206101|3827548|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4007032|NCT01206101|3827546|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4007033|NCT01206101|3827547|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4007034|NCT01206101|3827548|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4007035|NCT01206101|3827546|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4007036|NCT01206101|3827547|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4007037|NCT01206101|3827548|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4007038|NCT01206101|3827546|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4007039|NCT01206101|3827547|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4007040|NCT01206101|3827548|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4007041|NCT01206062|3827565|B3|||Not using antihypertensive agents — no. (%)||Participants|Count of Participants|882|882.0||||||
4007042|NCT01206062|3827566|B2|||Not using antihypertensive agents — no. (%)||Participants|Count of Participants|450|450.0||||||
4007043|NCT01206062|3827567|B1|||Not using antihypertensive agents — no. (%)||Participants|Count of Participants|432|432.0||||||
4007044|NCT01206062|3827565|B3|||Antihypertensive agents — no./patient||agents per patient|Mean|1.8|1.8|Standard Deviation|1.0|1.0|||
4007045|NCT01206062|3827566|B2|||Antihypertensive agents — no./patient||agents per patient|Mean|1.8|1.8|Standard Deviation|1.0|1.0|||
4007046|NCT01206062|3827567|B1|||Antihypertensive agents — no./patient||agents per patient|Mean|1.8|1.8|Standard Deviation|1.0|1.0|||
4007047|NCT01206062|3827565|B3|||Body-mass index|The body-mass index is the weight in kilograms divided by the square of the height in meters.|kg/m^2|Mean|29.9|29.9|Standard Deviation|5.8|5.8|||
4007048|NCT01206062|3827566|B2|||Body-mass index|The body-mass index is the weight in kilograms divided by the square of the height in meters.|kg/m^2|Mean|29.8|29.8|Standard Deviation|5.7|5.7|||
4007049|NCT01206062|3827567|B1|||Body-mass index|The body-mass index is the weight in kilograms divided by the square of the height in meters.|kg/m^2|Mean|29.9|29.9|Standard Deviation|5.8|5.8|||
4007050|NCT01206062|3827565|B3|||Framingham 10-yr cardiovascular disease risk score|The Framingham Risk Score is a gender-specific algorithm used to estimate the 10-year cardiovascular risk of an individual. It presents risk as the probability of developing coronary heart disease (CHD) within the next 10 years. Individuals with low risk have 10% or less CHD risk at 10 years, with intermediate risk 10-20%, and with high risk 20% or more.|probability|Mean|24.8|24.8|Standard Deviation|12.5|12.5|||
4007051|NCT01206062|3827566|B2|||Framingham 10-yr cardiovascular disease risk score|The Framingham Risk Score is a gender-specific algorithm used to estimate the 10-year cardiovascular risk of an individual. It presents risk as the probability of developing coronary heart disease (CHD) within the next 10 years. Individuals with low risk have 10% or less CHD risk at 10 years, with intermediate risk 10-20%, and with high risk 20% or more.|probability|Mean|24.8|24.8|Standard Deviation|12.5|12.5|||
4007104|NCT01206062|3827565|B3|> 132 mm Hg to < 145 mm Hg||Distribution of systolic blood pressure||Participants|Count of Participants|3038|3038.0||||||
4007105|NCT01206062|3827566|B2|> 132 mm Hg to < 145 mm Hg||Distribution of systolic blood pressure||Participants|Count of Participants|1549|1549.0||||||
4007052|NCT01206062|3827567|B1|||Framingham 10-yr cardiovascular disease risk score|The Framingham Risk Score is a gender-specific algorithm used to estimate the 10-year cardiovascular risk of an individual. It presents risk as the probability of developing coronary heart disease (CHD) within the next 10 years. Individuals with low risk have 10% or less CHD risk at 10 years, with intermediate risk 10-20%, and with high risk 20% or more.|probability|Mean|24.8|24.8|Standard Deviation|12.6|12.6|||
4007053|NCT01206062|3827565|B3|Missing data||Smoking status — no. (%)||Participants|Count of Participants|26|26.0||||||
4007054|NCT01206062|3827566|B2|Missing data||Smoking status — no. (%)||Participants|Count of Participants|14|14.0||||||
4007055|NCT01206062|3827567|B1|Missing data||Smoking status — no. (%)||Participants|Count of Participants|12|12.0||||||
4007056|NCT01206062|3827565|B3|Current smoker||Smoking status — no. (%)||Participants|Count of Participants|1240|1240.0||||||
4007057|NCT01206062|3827566|B2|Current smoker||Smoking status — no. (%)||Participants|Count of Participants|601|601.0||||||
4007058|NCT01206062|3827567|B1|Current smoker||Smoking status — no. (%)||Participants|Count of Participants|639|639.0||||||
4007059|NCT01206062|3827565|B3|Former smoker||Smoking status — no. (%)||Participants|Count of Participants|3973|3973.0||||||
4007060|NCT01206062|3827566|B2|Former smoker||Smoking status — no. (%)||Participants|Count of Participants|1996|1996.0||||||
4007061|NCT01206062|3827567|B1|Former smoker||Smoking status — no. (%)||Participants|Count of Participants|1977|1977.0||||||
4007062|NCT01206062|3827565|B3|Never smoked||Smoking status — no. (%)||Participants|Count of Participants|4122|4122.0||||||
4007063|NCT01206062|3827566|B2|Never smoked||Smoking status — no. (%)||Participants|Count of Participants|2072|2072.0||||||
4007064|NCT01206062|3827567|B1|Never smoked||Smoking status — no. (%)||Participants|Count of Participants|2050|2050.0||||||
4007065|NCT01206062|3827565|B3||Unknown Aspirin Use|Aspirin use||Participants|Count of Participants|34|34.0||||||
4007066|NCT01206062|3827566|B2||Unknown Aspirin Use|Aspirin use||Participants|Count of Participants|17|17.0||||||
4007067|NCT01206062|3827567|B1||Unknown Aspirin Use|Aspirin use||Participants|Count of Participants|17|17.0||||||
4007068|NCT01206062|3827565|B3||No Aspirin Use|Aspirin use||Participants|Count of Participants|4571|4571.0||||||
4007069|NCT01206062|3827566|B2||No Aspirin Use|Aspirin use||Participants|Count of Participants|2316|2316.0||||||
4007070|NCT01206062|3827567|B1||No Aspirin Use|Aspirin use||Participants|Count of Participants|2255|2255.0||||||
4007071|NCT01206062|3827565|B3||Aspirin Use|Aspirin use||Participants|Count of Participants|4756|4756.0||||||
4007072|NCT01206062|3827566|B2||Aspirin Use|Aspirin use||Participants|Count of Participants|2350|2350.0||||||
4007073|NCT01206062|3827567|B1||Aspirin Use|Aspirin use||Participants|Count of Participants|2406|2406.0||||||
4007074|NCT01206062|3827565|B3||Unknown Statin Use|Statin use||Participants|Count of Participants|76|76.0||||||
4007075|NCT01206062|3827566|B2||Unknown Statin Use|Statin use||Participants|Count of Participants|43|43.0||||||
4007076|NCT01206062|3827567|B1||Unknown Statin Use|Statin use||Participants|Count of Participants|33|33.0||||||
4007077|NCT01206062|3827565|B3||No Statin Use|Statin use||Participants|Count of Participants|5231|5231.0||||||
4007078|NCT01206062|3827566|B2||No Statin Use|Statin use||Participants|Count of Participants|2564|2564.0||||||
4007079|NCT01206062|3827567|B1||No Statin Use|Statin use||Participants|Count of Participants|2667|2667.0||||||
4007080|NCT01206062|3827565|B3||Statin Use|Statin use||Participants|Count of Participants|4054|4054.0||||||
4007081|NCT01206062|3827566|B2||Statin Use|Statin use||Participants|Count of Participants|2076|2076.0||||||
4007082|NCT01206062|3827567|B1||Statin Use|Statin use||Participants|Count of Participants|1978|1978.0||||||
4007083|NCT01206062|3827565|B3|||Fasting plasma glucose — mg/dl||mg/dl|Mean|98.8|98.8|Standard Deviation|13.5|13.5|||
4007084|NCT01206062|3827566|B2|||Fasting plasma glucose — mg/dl||mg/dl|Mean|98.8|98.8|Standard Deviation|13.4|13.4|||
4007085|NCT01206062|3827567|B1|||Fasting plasma glucose — mg/dl||mg/dl|Mean|98.8|98.8|Standard Deviation|13.7|13.7|||
4007086|NCT01206062|3827565|B3|||Fasting total triglycerides — mg/dl||mg/dl|Mean|125.9|125.9|Standard Deviation|90.5|90.5|||
4007087|NCT01206062|3827566|B2|||Fasting total triglycerides — mg/dl||mg/dl|Mean|127.1|127.1|Standard Deviation|95.0|95.0|||
4007088|NCT01206062|3827567|B1|||Fasting total triglycerides — mg/dl||mg/dl|Mean|124.8|124.8|Standard Deviation|85.8|85.8|||
4007089|NCT01206062|3827565|B3|||Fasting HDL cholesterol - mg/dl||mg/dl|Mean|52.9|52.9|Standard Deviation|14.5|14.5|||
4007090|NCT01206062|3827566|B2|||Fasting HDL cholesterol - mg/dl||mg/dl|Mean|52.8|52.8|Standard Deviation|14.6|14.6|||
4007091|NCT01206062|3827567|B1|||Fasting HDL cholesterol - mg/dl||mg/dl|Mean|52.9|52.9|Standard Deviation|14.3|14.3|||
4007092|NCT01206062|3827565|B3|||Fasting total cholesterol - mg/dl||mg/dl|Mean|190.1|190.1|Standard Deviation|41.2|41.2|||
4007093|NCT01206062|3827566|B2|||Fasting total cholesterol - mg/dl||mg/dl|Mean|190.0|190.0|Standard Deviation|40.9|40.9|||
4007094|NCT01206062|3827567|B1|||Fasting total cholesterol - mg/dl||mg/dl|Mean|190.2|190.2|Standard Deviation|41.4|41.4|||
4007095|NCT01206062|3827565|B3|||Ratio of urinary albumin (mg) to creatinine (g)||ratio|Mean|42.6|42.6|Standard Deviation|166.3|166.3|||
4007096|NCT01206062|3827566|B2|||Ratio of urinary albumin (mg) to creatinine (g)||ratio|Mean|41.1|41.1|Standard Deviation|152.9|152.9|||
4007097|NCT01206062|3827567|B1|||Ratio of urinary albumin (mg) to creatinine (g)||ratio|Mean|44.1|44.1|Standard Deviation|178.7|178.7|||
4007098|NCT01206062|3827565|B3|||Serum creatinine||mg/dl|Mean|1.07|1.07|Standard Deviation|0.34|0.34|||
4007099|NCT01206062|3827566|B2|||Serum creatinine||mg/dl|Mean|1.08|1.08|Standard Deviation|0.34|0.34|||
4007100|NCT01206062|3827567|B1|||Serum creatinine||mg/dl|Mean|1.07|1.07|Standard Deviation|0.34|0.34|||
4007101|NCT01206062|3827565|B3|> 145 mm Hg||Distribution of systolic blood pressure||Participants|Count of Participants|3187|3187.0||||||
4007102|NCT01206062|3827566|B2|> 145 mm Hg||Distribution of systolic blood pressure||Participants|Count of Participants|1581|1581.0||||||
4007103|NCT01206062|3827567|B1|> 145 mm Hg||Distribution of systolic blood pressure||Participants|Count of Participants|1606|1606.0||||||
4007106|NCT01206062|3827567|B1|> 132 mm Hg to < 145 mm Hg||Distribution of systolic blood pressure||Participants|Count of Participants|1489|1489.0||||||
4007107|NCT01206062|3827565|B3|< 132 mm Hg||Distribution of systolic blood pressure||Participants|Count of Participants|3136|3136.0||||||
4007108|NCT01206062|3827566|B2|< 132 mm Hg||Distribution of systolic blood pressure||Participants|Count of Participants|1553|1553.0||||||
4007109|NCT01206062|3827567|B1|< 132 mm Hg||Distribution of systolic blood pressure||Participants|Count of Participants|1583|1583.0||||||
4007110|NCT01206062|3827565|B3|Diastolic||Baseline BP mm Hg||mm Hg|Mean|78.1|78.1|Standard Deviation|11.9|11.9|||
4007111|NCT01206062|3827566|B2|Diastolic||Baseline BP mm Hg||mm Hg|Mean|78.0|78.0|Standard Deviation|12.0|12.0|||
4007112|NCT01206062|3827567|B1|Diastolic||Baseline BP mm Hg||mm Hg|Mean|78.2|78.2|Standard Deviation|11.9|11.9|||
4007113|NCT01206062|3827565|B3|Systolic||Baseline BP mm Hg||mm Hg|Mean|139.7|139.7|Standard Deviation|15.6|15.6|||
4007114|NCT01206062|3827566|B2|Systolic||Baseline BP mm Hg||mm Hg|Mean|139.7|139.7|Standard Deviation|15.4|15.4|||
4007115|NCT01206062|3827567|B1|Systolic||Baseline BP mm Hg||mm Hg|Mean|139.7|139.7|Standard Deviation|15.8|15.8|||
4007116|NCT01206062|3827565|B3|||Black race|Black race includes Hispanic black and black as part of a multiracial identification.|Participants|Count of Participants|2947|2947.0||||||
4007117|NCT01206062|3827566|B2|||Black race|Black race includes Hispanic black and black as part of a multiracial identification.|Participants|Count of Participants|1493|1493.0||||||
4007118|NCT01206062|3827567|B1|||Black race|Black race includes Hispanic black and black as part of a multiracial identification.|Participants|Count of Participants|1454|1454.0||||||
4007119|NCT01206062|3827565|B3|Framingham CVD risk score >= 15%||Criterion for increased cardiovascular risk|"Increased cardiovascular risk was one of the inclusion criteria.~Chronic kidney disease was defined as an estimated glomerular filtration rate of less than 60 ml per minute per 1.73 m squared of body-surface area."|Participants|Count of Participants|5737|5737.0||||||
4007120|NCT01206062|3827566|B2|Framingham CVD risk score >= 15%||Criterion for increased cardiovascular risk|"Increased cardiovascular risk was one of the inclusion criteria.~Chronic kidney disease was defined as an estimated glomerular filtration rate of less than 60 ml per minute per 1.73 m squared of body-surface area."|Participants|Count of Participants|2867|2867.0||||||
4007121|NCT01206062|3827567|B1|Framingham CVD risk score >= 15%||Criterion for increased cardiovascular risk|"Increased cardiovascular risk was one of the inclusion criteria.~Chronic kidney disease was defined as an estimated glomerular filtration rate of less than 60 ml per minute per 1.73 m squared of body-surface area."|Participants|Count of Participants|2870|2870.0||||||
4007122|NCT01206062|3827565|B3|Cardiovascular disease subclinical||Criterion for increased cardiovascular risk|"Increased cardiovascular risk was one of the inclusion criteria.~Chronic kidney disease was defined as an estimated glomerular filtration rate of less than 60 ml per minute per 1.73 m squared of body-surface area."|Participants|Count of Participants|493|493.0||||||
4007123|NCT01206062|3827566|B2|Cardiovascular disease subclinical||Criterion for increased cardiovascular risk|"Increased cardiovascular risk was one of the inclusion criteria.~Chronic kidney disease was defined as an estimated glomerular filtration rate of less than 60 ml per minute per 1.73 m squared of body-surface area."|Participants|Count of Participants|246|246.0||||||
4007124|NCT01206062|3827567|B1|Cardiovascular disease subclinical||Criterion for increased cardiovascular risk|"Increased cardiovascular risk was one of the inclusion criteria.~Chronic kidney disease was defined as an estimated glomerular filtration rate of less than 60 ml per minute per 1.73 m squared of body-surface area."|Participants|Count of Participants|247|247.0||||||
4007125|NCT01206062|3827565|B3|Cardiovascular disease clinical||Criterion for increased cardiovascular risk|"Increased cardiovascular risk was one of the inclusion criteria.~Chronic kidney disease was defined as an estimated glomerular filtration rate of less than 60 ml per minute per 1.73 m squared of body-surface area."|Participants|Count of Participants|1562|1562.0||||||
4007126|NCT01206062|3827566|B2|Cardiovascular disease clinical||Criterion for increased cardiovascular risk|"Increased cardiovascular risk was one of the inclusion criteria.~Chronic kidney disease was defined as an estimated glomerular filtration rate of less than 60 ml per minute per 1.73 m squared of body-surface area."|Participants|Count of Participants|783|783.0||||||
4007127|NCT01206062|3827567|B1|Cardiovascular disease clinical||Criterion for increased cardiovascular risk|"Increased cardiovascular risk was one of the inclusion criteria.~Chronic kidney disease was defined as an estimated glomerular filtration rate of less than 60 ml per minute per 1.73 m squared of body-surface area."|Participants|Count of Participants|779|779.0||||||
4007128|NCT01206062|3827565|B3|Cardiovascular disease||Criterion for increased cardiovascular risk|"Increased cardiovascular risk was one of the inclusion criteria.~Chronic kidney disease was defined as an estimated glomerular filtration rate of less than 60 ml per minute per 1.73 m squared of body-surface area."|Participants|Count of Participants|1877|1877.0||||||
4007129|NCT01206062|3827566|B2|Cardiovascular disease||Criterion for increased cardiovascular risk|"Increased cardiovascular risk was one of the inclusion criteria.~Chronic kidney disease was defined as an estimated glomerular filtration rate of less than 60 ml per minute per 1.73 m squared of body-surface area."|Participants|Count of Participants|937|937.0||||||
4007130|NCT01206062|3827567|B1|Cardiovascular disease||Criterion for increased cardiovascular risk|"Increased cardiovascular risk was one of the inclusion criteria.~Chronic kidney disease was defined as an estimated glomerular filtration rate of less than 60 ml per minute per 1.73 m squared of body-surface area."|Participants|Count of Participants|940|940.0||||||
4007131|NCT01206062|3827565|B3|Chronic kidney disease||Criterion for increased cardiovascular risk|"Increased cardiovascular risk was one of the inclusion criteria.~Chronic kidney disease was defined as an estimated glomerular filtration rate of less than 60 ml per minute per 1.73 m squared of body-surface area."|Participants|Count of Participants|2646|2646.0||||||
4007132|NCT01206062|3827566|B2|Chronic kidney disease||Criterion for increased cardiovascular risk|"Increased cardiovascular risk was one of the inclusion criteria.~Chronic kidney disease was defined as an estimated glomerular filtration rate of less than 60 ml per minute per 1.73 m squared of body-surface area."|Participants|Count of Participants|1316|1316.0||||||
4007177|NCT01205828|3827580|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4007178|NCT01205828|3827580|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4007133|NCT01206062|3827567|B1|Chronic kidney disease||Criterion for increased cardiovascular risk|"Increased cardiovascular risk was one of the inclusion criteria.~Chronic kidney disease was defined as an estimated glomerular filtration rate of less than 60 ml per minute per 1.73 m squared of body-surface area."|Participants|Count of Participants|1330|1330.0||||||
4007134|NCT01206062|3827565|B3|Age > 75 years||Criterion for increased cardiovascular risk|"Increased cardiovascular risk was one of the inclusion criteria.~Chronic kidney disease was defined as an estimated glomerular filtration rate of less than 60 ml per minute per 1.73 m squared of body-surface area."|Participants|Count of Participants|2636|2636.0||||||
4007135|NCT01206062|3827566|B2|Age > 75 years||Criterion for increased cardiovascular risk|"Increased cardiovascular risk was one of the inclusion criteria.~Chronic kidney disease was defined as an estimated glomerular filtration rate of less than 60 ml per minute per 1.73 m squared of body-surface area."|Participants|Count of Participants|1319|1319.0||||||
4007136|NCT01206062|3827567|B1|Age > 75 years||Criterion for increased cardiovascular risk|"Increased cardiovascular risk was one of the inclusion criteria.~Chronic kidney disease was defined as an estimated glomerular filtration rate of less than 60 ml per minute per 1.73 m squared of body-surface area."|Participants|Count of Participants|1317|1317.0||||||
4007137|NCT01206062|3827565|B3|Among those with estimated GFR < 60 ml/min/1.73 m||Estimated GFR||ml/min/1.73 m2|Mean|47.8|47.8|Standard Deviation|9.5|9.5|||
4007138|NCT01206062|3827566|B2|Among those with estimated GFR < 60 ml/min/1.73 m||Estimated GFR||ml/min/1.73 m2|Mean|47.9|47.9|Standard Deviation|9.5|9.5|||
4007139|NCT01206062|3827567|B1|Among those with estimated GFR < 60 ml/min/1.73 m||Estimated GFR||ml/min/1.73 m2|Mean|47.8|47.8|Standard Deviation|9.5|9.5|||
4007140|NCT01206062|3827565|B3|Among those with estimated GFR >= 60 ml/min/1.73 m||Estimated GFR||ml/min/1.73 m2|Mean|81.2|81.2|Standard Deviation|15.5|15.5|||
4007141|NCT01206062|3827566|B2|Among those with estimated GFR >= 60 ml/min/1.73 m||Estimated GFR||ml/min/1.73 m2|Mean|81.1|81.1|Standard Deviation|15.5|15.5|||
4007142|NCT01206062|3827567|B1|Among those with estimated GFR >= 60 ml/min/1.73 m||Estimated GFR||ml/min/1.73 m2|Mean|81.3|81.3|Standard Deviation|15.5|15.5|||
4007143|NCT01206062|3827565|B3|Among all participants||Estimated GFR||ml/min/1.73 m2|Mean|71.7|71.7|Standard Deviation|20.6|20.6|||
4007144|NCT01206062|3827566|B2|Among all participants||Estimated GFR||ml/min/1.73 m2|Mean|71.7|71.7|Standard Deviation|20.5|20.5|||
4007145|NCT01206062|3827567|B1|Among all participants||Estimated GFR||ml/min/1.73 m2|Mean|71.8|71.8|Standard Deviation|20.7|20.7|||
4007146|NCT01206062|3827565|B3|Other||Race/Ethnicity, Customized|Race and ethnic group were self-reported.|Participants|Count of Participants|176|176.0||||||
4007147|NCT01206062|3827566|B2|Other||Race/Ethnicity, Customized|Race and ethnic group were self-reported.|Participants|Count of Participants|78|78.0||||||
4007148|NCT01206062|3827567|B1|Other||Race/Ethnicity, Customized|Race and ethnic group were self-reported.|Participants|Count of Participants|98|98.0||||||
4007149|NCT01206062|3827565|B3|Non-Hispanic white||Race/Ethnicity, Customized|Race and ethnic group were self-reported.|Participants|Count of Participants|5399|5399.0||||||
4007150|NCT01206062|3827566|B2|Non-Hispanic white||Race/Ethnicity, Customized|Race and ethnic group were self-reported.|Participants|Count of Participants|2701|2701.0||||||
4007151|NCT01206062|3827567|B1|Non-Hispanic white||Race/Ethnicity, Customized|Race and ethnic group were self-reported.|Participants|Count of Participants|2698|2698.0||||||
4007152|NCT01206062|3827565|B3|Hispanic||Race/Ethnicity, Customized|Race and ethnic group were self-reported.|Participants|Count of Participants|984|984.0||||||
4007153|NCT01206062|3827566|B2|Hispanic||Race/Ethnicity, Customized|Race and ethnic group were self-reported.|Participants|Count of Participants|481|481.0||||||
4007154|NCT01206062|3827567|B1|Hispanic||Race/Ethnicity, Customized|Race and ethnic group were self-reported.|Participants|Count of Participants|503|503.0||||||
4007155|NCT01206062|3827565|B3|Non-Hispanic black||Race/Ethnicity, Customized|Race and ethnic group were self-reported.|Participants|Count of Participants|2802|2802.0||||||
4007156|NCT01206062|3827566|B2|Non-Hispanic black||Race/Ethnicity, Customized|Race and ethnic group were self-reported.|Participants|Count of Participants|1423|1423.0||||||
4007157|NCT01206062|3827567|B1|Non-Hispanic black||Race/Ethnicity, Customized|Race and ethnic group were self-reported.|Participants|Count of Participants|1379|1379.0||||||
4007158|NCT01206062|3827565|B3||Male|Sex: Female, Male||Participants|Count of Participants|6029|6029.0||||||
4007159|NCT01206062|3827566|B2||Male|Sex: Female, Male||Participants|Count of Participants|3035|3035.0||||||
4007160|NCT01206062|3827567|B1||Male|Sex: Female, Male||Participants|Count of Participants|2994|2994.0||||||
4007161|NCT01206062|3827565|B3||Female|Sex: Female, Male||Participants|Count of Participants|3332|3332.0||||||
4007162|NCT01206062|3827566|B2||Female|Sex: Female, Male||Participants|Count of Participants|1648|1648.0||||||
4007163|NCT01206062|3827567|B1||Female|Sex: Female, Male||Participants|Count of Participants|1684|1684.0||||||
4007164|NCT01206062|3827565|B3|Among those >= 75||Age||year|Mean|79.9|79.9|Standard Deviation|4|4.0|||
4007165|NCT01206062|3827566|B2|Among those >= 75||Age||year|Mean|79.9|79.9|Standard Deviation|4.1|4.1|||
4007166|NCT01206062|3827567|B1|Among those >= 75||Age||year|Mean|79.8|79.8|Standard Deviation|3.9|3.9|||
4007167|NCT01206062|3827565|B3|Age overall||Age||year|Mean|67.9|67.9|Standard Deviation|9.4|9.4|||
4007168|NCT01206062|3827566|B2|Age overall||Age||year|Mean|67.9|67.9|Standard Deviation|9.5|9.5|||
4007169|NCT01206062|3827567|B1|Age overall||Age||year|Mean|67.9|67.9|Standard Deviation|9.4|9.4|||
4007170|NCT01205828|3827580|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4007171|NCT01205828|3827580|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007172|NCT01205828|3827580|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4007173|NCT01205828|3827580|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4007174|NCT01205828|3827580|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007175|NCT01205828|3827580|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4007176|NCT01205828|3827580|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007179|NCT01205828|3827580|B1|||Age||years|Mean|61|61.0|Full Range|||40.0|77.0|
4007180|NCT01205828|3827580|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4007181|NCT01205828|3827580|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4007182|NCT01205828|3827580|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4007183|NCT01205776|3827588|B3|South America||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
4007184|NCT01205776|3827589|B2|South America||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
4007185|NCT01205776|3827590|B1|South America||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4007186|NCT01205776|3827588|B3|Australia||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4007187|NCT01205776|3827589|B2|Australia||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4007188|NCT01205776|3827590|B1|Australia||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4007189|NCT01205776|3827588|B3|Southeast Asia||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4007190|NCT01205776|3827589|B2|Southeast Asia||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4007191|NCT01205776|3827590|B1|Southeast Asia||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4007192|NCT01205776|3827588|B3|Canada||Region of Enrollment||Participants|Count of Participants|203|203.0||||||
4007193|NCT01205776|3827589|B2|Canada||Region of Enrollment||Participants|Count of Participants|100|100.0||||||
4007194|NCT01205776|3827590|B1|Canada||Region of Enrollment||Participants|Count of Participants|103|103.0||||||
4007195|NCT01205776|3827588|B3|United States||Region of Enrollment||Participants|Count of Participants|549|549.0||||||
4007196|NCT01205776|3827589|B2|United States||Region of Enrollment||Participants|Count of Participants|271|271.0||||||
4007197|NCT01205776|3827590|B1|United States||Region of Enrollment||Participants|Count of Participants|278|278.0||||||
4007198|NCT01205776|3827588|B3|Europe||Region of Enrollment||Participants|Count of Participants|1075|1075.0||||||
4007199|NCT01205776|3827589|B2|Europe||Region of Enrollment||Participants|Count of Participants|541|541.0||||||
4007200|NCT01205776|3827590|B1|Europe||Region of Enrollment||Participants|Count of Participants|534|534.0||||||
4007201|NCT01205776|3827588|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4007202|NCT01205776|3827589|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4007203|NCT01205776|3827590|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4007204|NCT01205776|3827588|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4007205|NCT01205776|3827589|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4007206|NCT01205776|3827590|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4007207|NCT01205776|3827588|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1697|1697.0||||||
4007208|NCT01205776|3827589|B2||White|Race (NIH/OMB)||Participants|Count of Participants|853|853.0||||||
4007209|NCT01205776|3827590|B1||White|Race (NIH/OMB)||Participants|Count of Participants|844|844.0||||||
4007210|NCT01205776|3827588|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4007211|NCT01205776|3827589|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4007212|NCT01205776|3827590|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4007213|NCT01205776|3827588|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007214|NCT01205776|3827589|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007215|NCT01205776|3827590|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007216|NCT01205776|3827588|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4007217|NCT01205776|3827589|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4007218|NCT01205776|3827590|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4007219|NCT01205776|3827588|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007220|NCT01205776|3827589|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007221|NCT01205776|3827590|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007222|NCT01205776|3827588|B3||Male|Sex: Female, Male||Participants|Count of Participants|441|441.0||||||
4007223|NCT01205776|3827589|B2||Male|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
4007224|NCT01205776|3827590|B1||Male|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
4007225|NCT01205776|3827588|B3||Female|Sex: Female, Male||Participants|Count of Participants|1464|1464.0||||||
4007226|NCT01205776|3827589|B2||Female|Sex: Female, Male||Participants|Count of Participants|742|742.0||||||
4007227|NCT01205776|3827590|B1||Female|Sex: Female, Male||Participants|Count of Participants|722|722.0||||||
4007228|NCT01205776|3827588|B3|||Age||years|Mean|66.0|66.0|Standard Deviation|9.6|9.6|||
4007229|NCT01205776|3827589|B2|||Age||years|Mean|65.9|65.9|Standard Deviation|9.5|9.5|||
4007230|NCT01205776|3827590|B1|||Age||years|Mean|66.0|66.0|Standard Deviation|9.6|9.6|||
4007231|NCT01205685|3827731|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4007232|NCT01205685|3827731|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4007233|NCT01205685|3827731|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4007234|NCT01205685|3827731|B1|||Age||years|Mean|59|59.0|Standard Deviation|1|1.0|||
4007235|NCT01205685|3827731|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4007236|NCT01205685|3827731|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4007237|NCT01205685|3827731|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4007238|NCT01205646|3827738|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4007239|NCT01205646|3827738|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4007240|NCT01205646|3827738|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4007241|NCT01205646|3827738|B1|||Age||years|Mean|64.09|64.09|Standard Deviation|4.53|4.53|||
4007242|NCT01205581|3827745|B7||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4007243|NCT01205581|3827746|B6||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4007244|NCT01205581|3827747|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4007245|NCT01205581|3827748|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4007246|NCT01205581|3827749|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4007247|NCT01205581|3827750|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4007248|NCT01205581|3827751|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4007249|NCT01205581|3827745|B7||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4007250|NCT01205581|3827746|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4007251|NCT01205581|3827747|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4007252|NCT01205581|3827748|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4007253|NCT01205581|3827749|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4007254|NCT01205581|3827750|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4007255|NCT01205581|3827751|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4007256|NCT01205581|3827745|B7|||Age||years|Mean|14.6|14.6|Standard Deviation|5.9|5.9|||
4007257|NCT01205581|3827746|B6|||Age||years|Mean|19.9|19.9|Standard Deviation|1.8|1.8|||
4007258|NCT01205581|3827747|B5|||Age||years|Mean|16.7|16.7|Standard Deviation|5.6|5.6|||
4007259|NCT01205581|3827748|B4|||Age||years|Mean|11.7|11.7|Standard Deviation|4.5|4.5|||
4007260|NCT01205581|3827749|B3|||Age||years|Mean|12.4|12.4|Standard Deviation|4.2|4.2|||
4007261|NCT01205581|3827750|B2|||Age||years|Mean|11.8|11.8|Standard Deviation|5.1|5.1|||
4007262|NCT01205581|3827751|B1|||Age||years|Mean|10.8|10.8|Standard Deviation|5.7|5.7|||
4007263|NCT01205568|3827820|B1|||Cyanosis in part due to PA stenosis||Participants|Count of Participants|19|19.0||||||
4007264|NCT01205568|3827820|B1|||Elevated PA pressure (mean >20)||Participants|Count of Participants|47|47.0||||||
4007265|NCT01205568|3827820|B1|||Regional decrease in pulmonary flow||Participants|Count of Participants|58|58.0||||||
4007266|NCT01205568|3827820|B1|||Greater than 1/2 systemic RV pressure||Participants|Count of Participants|60|60.0||||||
4007267|NCT01205568|3827820|B1|United States||Region of Enrollment||participants|Number|73|73.0||||||
4007268|NCT01205568|3827820|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4007269|NCT01205568|3827820|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4007270|NCT01205568|3827820|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4007271|NCT01205568|3827820|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4007272|NCT01205568|3827820|B1||<=18 years|Age||Participants|Count of Participants|72|72.0||||||
4007273|NCT01205529|3827826|B1|United States||Region of Enrollment||participants|Number|161|161.0||||||
4007274|NCT01205529|3827826|B1||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4007275|NCT01205529|3827826|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4007276|NCT01205529|3827826|B1|||Age||years|Mean|55|55.0|Full Range|||20.0|81.0|
4007277|NCT01205503|3827830|B3|||Log TNF Receptor 2||log(pg/ml)|Mean|8.23|8.23|Standard Deviation|0.71|0.71|||
4007278|NCT01205503|3827831|B2|||Log TNF Receptor 2||log(pg/ml)|Mean|8.15|8.15|Standard Deviation|0.74|0.74|||
4007279|NCT01205503|3827832|B1|||Log TNF Receptor 2||log(pg/ml)|Mean|8.31|8.31|Standard Deviation|0.68|0.68|||
4007280|NCT01205503|3827830|B3|||Log 3-nitrotyrosine (3NT)|This baseline measurement is standardized to the control on the plate and then log transformed. The resulting ratio of plate assay value relative to control can be < 1 resulting in a negative log value.|log(ng/mg protein)|Mean|-0.08|-0.08|Standard Deviation|0.21|0.21|||
4007281|NCT01205503|3827831|B2|||Log 3-nitrotyrosine (3NT)|This baseline measurement is standardized to the control on the plate and then log transformed. The resulting ratio of plate assay value relative to control can be < 1 resulting in a negative log value.|log(ng/mg protein)|Mean|-0.05|-0.05|Standard Deviation|0.16|0.16|||
4007282|NCT01205503|3827832|B1|||Log 3-nitrotyrosine (3NT)|This baseline measurement is standardized to the control on the plate and then log transformed. The resulting ratio of plate assay value relative to control can be < 1 resulting in a negative log value.|log(ng/mg protein)|Mean|-0.11|-0.11|Standard Deviation|0.26|0.26|||
4007283|NCT01205503|3827830|B3|||Log Plasma 4-hydroxynonenal (HNE)|This baseline measurement is standardized to the control on the plate and then log transformed. The resulting ratio of plate assay value relative to control can be < 1 resulting in a negative log value.|log(pmol/mg)|Mean|-0.29|-0.29|Standard Deviation|0.21|0.21|||
4007284|NCT01205503|3827831|B2|||Log Plasma 4-hydroxynonenal (HNE)|This baseline measurement is standardized to the control on the plate and then log transformed. The resulting ratio of plate assay value relative to control can be < 1 resulting in a negative log value.|log(pmol/mg)|Mean|-0.28|-0.28|Standard Deviation|0.20|0.2|||
4007285|NCT01205503|3827832|B1|||Log Plasma 4-hydroxynonenal (HNE)|This baseline measurement is standardized to the control on the plate and then log transformed. The resulting ratio of plate assay value relative to control can be < 1 resulting in a negative log value.|log(pmol/mg)|Mean|-0.31|-0.31|Standard Deviation|0.22|0.22|||
4007286|NCT01205503|3827830|B3|||Log Protein Carbonyl (PC)||log(nmol/mg protein)|Mean|4.36|4.36|Standard Deviation|0.36|0.36|||
4007287|NCT01205503|3827831|B2|||Log Protein Carbonyl (PC)||log(nmol/mg protein)|Mean|4.33|4.33|Standard Deviation|0.38|0.38|||
4007288|NCT01205503|3827832|B1|||Log Protein Carbonyl (PC)||log(nmol/mg protein)|Mean|4.39|4.39|Standard Deviation|0.34|0.34|||
4007289|NCT01205503|3827830|B3|||Log interleukin (IL)-18||log(pg/ml)|Mean|6.11|6.11|Standard Deviation|0.84|0.84|||
4007290|NCT01205503|3827831|B2|||Log interleukin (IL)-18||log(pg/ml)|Mean|6.16|6.16|Standard Deviation|0.76|0.76|||
4007291|NCT01205503|3827832|B1|||Log interleukin (IL)-18||log(pg/ml)|Mean|6.06|6.06|Standard Deviation|0.93|0.93|||
4007292|NCT01205503|3827830|B3|||log TNF receptor 1||log(pg/ml)|Mean|7.17|7.17|Standard Deviation|0.46|0.46|||
4007293|NCT01205503|3827831|B2|||log TNF receptor 1||log(pg/ml)|Mean|7.04|7.04|Standard Deviation|0.46|0.46|||
4007294|NCT01205503|3827832|B1|||log TNF receptor 1||log(pg/ml)|Mean|7.29|7.29|Standard Deviation|0.44|0.44|||
4007295|NCT01205503|3827830|B3|||log TNF Alpha||log(pg/ml)|Mean|1.28|1.28|Standard Deviation|1.12|1.12|||
4007296|NCT01205503|3827831|B2|||log TNF Alpha||log(pg/ml)|Mean|1.30|1.3|Standard Deviation|1.16|1.16|||
4007297|NCT01205503|3827832|B1|||log TNF Alpha||log(pg/ml)|Mean|1.27|1.27|Standard Deviation|1.11|1.11|||
4007298|NCT01205503|3827830|B3|||Body Surface Area (BSA)||m^2|Mean|1.97|1.97|Standard Deviation|0.25|0.25|||
4007299|NCT01205503|3827831|B2|||Body Surface Area (BSA)||m^2|Mean|1.93|1.93|Standard Deviation|0.26|0.26|||
4007300|NCT01205503|3827832|B1|||Body Surface Area (BSA)||m^2|Mean|2.01|2.01|Standard Deviation|0.23|0.23|||
4007301|NCT01205503|3827830|B3|Lymphoma||Cancer Diagnosis||participants|Number|19|19.0||||||
4007302|NCT01205503|3827831|B2|Lymphoma||Cancer Diagnosis||participants|Number|10|10.0||||||
4007303|NCT01205503|3827832|B1|Lymphoma||Cancer Diagnosis||participants|Number|9|9.0||||||
4007304|NCT01205503|3827830|B3|Breast||Cancer Diagnosis||participants|Number|13|13.0||||||
4007305|NCT01205503|3827831|B2|Breast||Cancer Diagnosis||participants|Number|6|6.0||||||
4007306|NCT01205503|3827832|B1|Breast||Cancer Diagnosis||participants|Number|7|7.0||||||
4007307|NCT01205503|3827830|B3|1- Restricted||Eastern Cooperative Oncology Group (ECOG) Performance Status||participants|Number|14|14.0||||||
4007308|NCT01205503|3827831|B2|1- Restricted||Eastern Cooperative Oncology Group (ECOG) Performance Status||participants|Number|8|8.0||||||
4007309|NCT01205503|3827832|B1|1- Restricted||Eastern Cooperative Oncology Group (ECOG) Performance Status||participants|Number|6|6.0||||||
4007310|NCT01205503|3827830|B3|0- Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status||participants|Number|18|18.0||||||
4007311|NCT01205503|3827831|B2|0- Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status||participants|Number|8|8.0||||||
4007312|NCT01205503|3827832|B1|0- Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status||participants|Number|10|10.0||||||
4007313|NCT01205503|3827830|B3|Doxorubicin, cyclophosphamide and docetaxel (TAC)||Treatment Type||participants|Number|2|2.0||||||
4007314|NCT01205503|3827831|B2|Doxorubicin, cyclophosphamide and docetaxel (TAC)||Treatment Type||participants|Number|1|1.0||||||
4007315|NCT01205503|3827832|B1|Doxorubicin, cyclophosphamide and docetaxel (TAC)||Treatment Type||participants|Number|1|1.0||||||
4007316|NCT01205503|3827830|B3|AC, vincristine, and prednisone (CHOP)||Treatment Type||participants|Number|19|19.0||||||
4007317|NCT01205503|3827831|B2|AC, vincristine, and prednisone (CHOP)||Treatment Type||participants|Number|10|10.0||||||
4007318|NCT01205503|3827832|B1|AC, vincristine, and prednisone (CHOP)||Treatment Type||participants|Number|9|9.0||||||
4007319|NCT01205503|3827830|B3|Doxorubicin and cyclophosphamide (AC)||Treatment Type||participants|Number|11|11.0||||||
4007320|NCT01205503|3827831|B2|Doxorubicin and cyclophosphamide (AC)||Treatment Type||participants|Number|5|5.0||||||
4007321|NCT01205503|3827832|B1|Doxorubicin and cyclophosphamide (AC)||Treatment Type||participants|Number|6|6.0||||||
4007322|NCT01205503|3827830|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4007323|NCT01205503|3827831|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4007324|NCT01205503|3827832|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4007325|NCT01205503|3827830|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007326|NCT01205503|3827831|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007327|NCT01205503|3827832|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007328|NCT01205503|3827830|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007329|NCT01205503|3827831|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007330|NCT01205503|3827832|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007331|NCT01205503|3827830|B3||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4007332|NCT01205503|3827831|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4007333|NCT01205503|3827832|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4007334|NCT01205503|3827830|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4007335|NCT01205503|3827831|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4007336|NCT01205503|3827832|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4007337|NCT01205503|3827830|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007338|NCT01205503|3827831|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007339|NCT01205503|3827832|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007340|NCT01205503|3827830|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007341|NCT01205503|3827831|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007342|NCT01205503|3827832|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007343|NCT01205503|3827830|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007344|NCT01205503|3827831|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007345|NCT01205503|3827832|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007346|NCT01205503|3827830|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007347|NCT01205503|3827831|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007348|NCT01205503|3827832|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007349|NCT01205503|3827830|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4007350|NCT01205503|3827831|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4007351|NCT01205503|3827832|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4007352|NCT01205503|3827830|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007353|NCT01205503|3827831|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007354|NCT01205503|3827832|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007355|NCT01205503|3827830|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4007356|NCT01205503|3827831|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4007357|NCT01205503|3827832|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4007358|NCT01205503|3827830|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4007359|NCT01205503|3827831|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4007360|NCT01205503|3827832|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4007361|NCT01205503|3827830|B3|||Age||years|Mean|54.78|54.78|Standard Deviation|1.97|1.97|||
4007362|NCT01205503|3827831|B2|||Age||years|Mean|51.75|51.75|Standard Deviation|15.51|15.51|||
4007363|NCT01205503|3827832|B1|||Age||years|Mean|57.81|57.81|Standard Deviation|11.70|11.7|||
4007364|NCT01205451|3827847|B3|Presence||Number of participants with the absence or presence of thumb spasticity|Baseline characteristics are summarized for members of the Full Analysis Set (FAS), comprised of all enrolled and treated participants with at least one post-treatment MAS wrist score. Three participants (all receiving placebo in the original DB study) didn't have any post-treatment MAS wrist score; therefore, the FAS included 106 participants (53 participants in each group).|participants|Number|94|94.0||||||
4007365|NCT01205451|3827848|B2|Presence||Number of participants with the absence or presence of thumb spasticity|Baseline characteristics are summarized for members of the Full Analysis Set (FAS), comprised of all enrolled and treated participants with at least one post-treatment MAS wrist score. Three participants (all receiving placebo in the original DB study) didn't have any post-treatment MAS wrist score; therefore, the FAS included 106 participants (53 participants in each group).|participants|Number|47|47.0||||||
4007366|NCT01205451|3827849|B1|Presence||Number of participants with the absence or presence of thumb spasticity|Baseline characteristics are summarized for members of the Full Analysis Set (FAS), comprised of all enrolled and treated participants with at least one post-treatment MAS wrist score. Three participants (all receiving placebo in the original DB study) didn't have any post-treatment MAS wrist score; therefore, the FAS included 106 participants (53 participants in each group).|participants|Number|47|47.0||||||
4007367|NCT01205451|3827847|B3|Absence||Number of participants with the absence or presence of thumb spasticity|Baseline characteristics are summarized for members of the Full Analysis Set (FAS), comprised of all enrolled and treated participants with at least one post-treatment MAS wrist score. Three participants (all receiving placebo in the original DB study) didn't have any post-treatment MAS wrist score; therefore, the FAS included 106 participants (53 participants in each group).|participants|Number|12|12.0||||||
4007368|NCT01205451|3827848|B2|Absence||Number of participants with the absence or presence of thumb spasticity|Baseline characteristics are summarized for members of the Full Analysis Set (FAS), comprised of all enrolled and treated participants with at least one post-treatment MAS wrist score. Three participants (all receiving placebo in the original DB study) didn't have any post-treatment MAS wrist score; therefore, the FAS included 106 participants (53 participants in each group).|participants|Number|6|6.0||||||
4007369|NCT01205451|3827849|B1|Absence||Number of participants with the absence or presence of thumb spasticity|Baseline characteristics are summarized for members of the Full Analysis Set (FAS), comprised of all enrolled and treated participants with at least one post-treatment MAS wrist score. Three participants (all receiving placebo in the original DB study) didn't have any post-treatment MAS wrist score; therefore, the FAS included 106 participants (53 participants in each group).|participants|Number|6|6.0||||||
4007370|NCT01205451|3827847|B3|Chinese||Race/Ethnicity, Customized|Baseline characteristics are summarized for members of the Full Analysis Set (FAS), comprised of all enrolled and treated participants with at least one post-treatment MAS wrist score. Three participants (all receiving placebo in the original DB study) didn't have any post-treatment MAS wrist score; therefore, the FAS included 106 participants (53 participants in each group).|participants|Number|106|106.0||||||
4007371|NCT01205451|3827848|B2|Chinese||Race/Ethnicity, Customized|Baseline characteristics are summarized for members of the Full Analysis Set (FAS), comprised of all enrolled and treated participants with at least one post-treatment MAS wrist score. Three participants (all receiving placebo in the original DB study) didn't have any post-treatment MAS wrist score; therefore, the FAS included 106 participants (53 participants in each group).|participants|Number|53|53.0||||||
4007372|NCT01205451|3827849|B1|Chinese||Race/Ethnicity, Customized|Baseline characteristics are summarized for members of the Full Analysis Set (FAS), comprised of all enrolled and treated participants with at least one post-treatment MAS wrist score. Three participants (all receiving placebo in the original DB study) didn't have any post-treatment MAS wrist score; therefore, the FAS included 106 participants (53 participants in each group).|participants|Number|53|53.0||||||
4007436|NCT01205438|3827894|B2|||Anti-dsDNA Antibody Level||International Unit / Milliliter (IU/mL)|Mean|110.6|110.6|Standard Deviation|113.51|113.51|||
4007437|NCT01205438|3827895|B1|||Anti-dsDNA Antibody Level||International Unit / Milliliter (IU/mL)|Mean|116.8|116.8|Standard Deviation|118.17|118.17|||
4007373|NCT01205451|3827847|B3||Male|Gender|Baseline characteristics are summarized for members of the Full Analysis Set (FAS), comprised of all enrolled and treated participants with at least one post-treatment MAS wrist score. Three participants (all receiving placebo in the original DB study) didn't have any post-treatment MAS wrist score; therefore, the FAS included 106 participants (53 participants in each group).|Participants|Count of Participants|86|86.0||||||
4007374|NCT01205451|3827848|B2||Male|Gender|Baseline characteristics are summarized for members of the Full Analysis Set (FAS), comprised of all enrolled and treated participants with at least one post-treatment MAS wrist score. Three participants (all receiving placebo in the original DB study) didn't have any post-treatment MAS wrist score; therefore, the FAS included 106 participants (53 participants in each group).|Participants|Count of Participants|43|43.0||||||
4007375|NCT01205451|3827849|B1||Male|Gender|Baseline characteristics are summarized for members of the Full Analysis Set (FAS), comprised of all enrolled and treated participants with at least one post-treatment MAS wrist score. Three participants (all receiving placebo in the original DB study) didn't have any post-treatment MAS wrist score; therefore, the FAS included 106 participants (53 participants in each group).|Participants|Count of Participants|43|43.0||||||
4007376|NCT01205451|3827847|B3||Female|Gender|Baseline characteristics are summarized for members of the Full Analysis Set (FAS), comprised of all enrolled and treated participants with at least one post-treatment MAS wrist score. Three participants (all receiving placebo in the original DB study) didn't have any post-treatment MAS wrist score; therefore, the FAS included 106 participants (53 participants in each group).|Participants|Count of Participants|20|20.0||||||
4007377|NCT01205451|3827848|B2||Female|Gender|Baseline characteristics are summarized for members of the Full Analysis Set (FAS), comprised of all enrolled and treated participants with at least one post-treatment MAS wrist score. Three participants (all receiving placebo in the original DB study) didn't have any post-treatment MAS wrist score; therefore, the FAS included 106 participants (53 participants in each group).|Participants|Count of Participants|10|10.0||||||
4007378|NCT01205451|3827849|B1||Female|Gender|Baseline characteristics are summarized for members of the Full Analysis Set (FAS), comprised of all enrolled and treated participants with at least one post-treatment MAS wrist score. Three participants (all receiving placebo in the original DB study) didn't have any post-treatment MAS wrist score; therefore, the FAS included 106 participants (53 participants in each group).|Participants|Count of Participants|10|10.0||||||
4007379|NCT01205451|3827847|B3|||Age|Baseline characteristics are summarized for members of the Full Analysis Set (FAS), comprised of all enrolled and treated participants with at least one post-treatment modified Ashworth scale (MAS) wrist score. Three participants (all receiving placebo in the original DB study) didn't have any post-treatment MAS wrist score; therefore, the FAS included 106 participants (53 participants in each group).|Years|Mean|54.9|54.9|Standard Deviation|11.70|11.7|||
4007380|NCT01205451|3827848|B2|||Age|Baseline characteristics are summarized for members of the Full Analysis Set (FAS), comprised of all enrolled and treated participants with at least one post-treatment modified Ashworth scale (MAS) wrist score. Three participants (all receiving placebo in the original DB study) didn't have any post-treatment MAS wrist score; therefore, the FAS included 106 participants (53 participants in each group).|Years|Mean|55.4|55.4|Standard Deviation|12.53|12.53|||
4007381|NCT01205451|3827849|B1|||Age|Baseline characteristics are summarized for members of the Full Analysis Set (FAS), comprised of all enrolled and treated participants with at least one post-treatment modified Ashworth scale (MAS) wrist score. Three participants (all receiving placebo in the original DB study) didn't have any post-treatment MAS wrist score; therefore, the FAS included 106 participants (53 participants in each group).|Years|Mean|54.4|54.4|Standard Deviation|10.90|10.9|||
4007382|NCT01205438|3827892|B4|||Brief Fatigue Inventory (BFI) Score|BFI is a participants-reported scale that measures the severity of fatigue based on the worst fatigue experienced during the past 24-hours. The severity scores ranged from 0 (no fatigue) to 10 (fatigue as severe as you can imagine).|units on a scale|Mean|5.6|5.6|Standard Deviation|2.73|2.73|||
4007383|NCT01205438|3827893|B3|||Brief Fatigue Inventory (BFI) Score|BFI is a participants-reported scale that measures the severity of fatigue based on the worst fatigue experienced during the past 24-hours. The severity scores ranged from 0 (no fatigue) to 10 (fatigue as severe as you can imagine).|units on a scale|Mean|5.6|5.6|Standard Deviation|2.81|2.81|||
4007384|NCT01205438|3827894|B2|||Brief Fatigue Inventory (BFI) Score|BFI is a participants-reported scale that measures the severity of fatigue based on the worst fatigue experienced during the past 24-hours. The severity scores ranged from 0 (no fatigue) to 10 (fatigue as severe as you can imagine).|units on a scale|Mean|5.6|5.6|Standard Deviation|2.81|2.81|||
4007385|NCT01205438|3827895|B1|||Brief Fatigue Inventory (BFI) Score|BFI is a participants-reported scale that measures the severity of fatigue based on the worst fatigue experienced during the past 24-hours. The severity scores ranged from 0 (no fatigue) to 10 (fatigue as severe as you can imagine).|units on a scale|Mean|5.8|5.8|Standard Deviation|2.57|2.57|||
4007386|NCT01205438|3827892|B4|Burden to Others||Lupus Quality of Life (LupusQOL) Domain Scores|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|51.3|51.3|Standard Deviation|31.15|31.15|||
4007387|NCT01205438|3827893|B3|Burden to Others||Lupus Quality of Life (LupusQOL) Domain Scores|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|49.3|49.3|Standard Deviation|32.39|32.39|||
4007388|NCT01205438|3827894|B2|Burden to Others||Lupus Quality of Life (LupusQOL) Domain Scores|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|51.9|51.9|Standard Deviation|30.31|30.31|||
4007438|NCT01205438|3827892|B4|Tunisia||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
4007389|NCT01205438|3827895|B1|Burden to Others||Lupus Quality of Life (LupusQOL) Domain Scores|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|52.8|52.8|Standard Deviation|30.70|30.7|||
4007390|NCT01205438|3827892|B4|Intimate Relationships||Lupus Quality of Life (LupusQOL) Domain Scores|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|58.8|58.8|Standard Deviation|33.36|33.36|||
4007391|NCT01205438|3827893|B3|Intimate Relationships||Lupus Quality of Life (LupusQOL) Domain Scores|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|56.8|56.8|Standard Deviation|34.21|34.21|||
4007392|NCT01205438|3827894|B2|Intimate Relationships||Lupus Quality of Life (LupusQOL) Domain Scores|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|63.3|63.3|Standard Deviation|31.53|31.53|||
4007393|NCT01205438|3827895|B1|Intimate Relationships||Lupus Quality of Life (LupusQOL) Domain Scores|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|56.2|56.2|Standard Deviation|33.92|33.92|||
4007394|NCT01205438|3827892|B4|Fatigue||Lupus Quality of Life (LupusQOL) Domain Scores|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|54.6|54.6|Standard Deviation|26.36|26.36|||
4007395|NCT01205438|3827893|B3|Fatigue||Lupus Quality of Life (LupusQOL) Domain Scores|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|53.4|53.4|Standard Deviation|27.14|27.14|||
4007396|NCT01205438|3827894|B2|Fatigue||Lupus Quality of Life (LupusQOL) Domain Scores|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|54.4|54.4|Standard Deviation|25.54|25.54|||
4007397|NCT01205438|3827895|B1|Fatigue||Lupus Quality of Life (LupusQOL) Domain Scores|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|56.0|56.0|Standard Deviation|26.39|26.39|||
4007398|NCT01205438|3827892|B4|Planning||Lupus Quality of Life (LupusQOL) Domain Scores|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|60.8|60.8|Standard Deviation|30.01|30.01|||
4007399|NCT01205438|3827893|B3|Planning||Lupus Quality of Life (LupusQOL) Domain Scores|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|59.0|59.0|Standard Deviation|30.92|30.92|||
4007400|NCT01205438|3827894|B2|Planning||Lupus Quality of Life (LupusQOL) Domain Scores|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|62.1|62.1|Standard Deviation|28.69|28.69|||
4007401|NCT01205438|3827895|B1|Planning||Lupus Quality of Life (LupusQOL) Domain Scores|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|61.2|61.2|Standard Deviation|30.37|30.37|||
4007402|NCT01205438|3827892|B4|Pain||Lupus Quality of Life (LupusQOL) Domain Scores|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|55.5|55.5|Standard Deviation|27.95|27.95|||
4007439|NCT01205438|3827893|B3|Tunisia||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4007403|NCT01205438|3827893|B3|Pain||Lupus Quality of Life (LupusQOL) Domain Scores|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|53.6|53.6|Standard Deviation|28.62|28.62|||
4007404|NCT01205438|3827894|B2|Pain||Lupus Quality of Life (LupusQOL) Domain Scores|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|56.9|56.9|Standard Deviation|26.75|26.75|||
4007405|NCT01205438|3827895|B1|Pain||Lupus Quality of Life (LupusQOL) Domain Scores|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|56.1|56.1|Standard Deviation|28.40|28.4|||
4007406|NCT01205438|3827892|B4|Body Image||Lupus Quality of Life (LupusQOL) Domain Scores|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|62.1|62.1|Standard Deviation|28.61|28.61|||
4007407|NCT01205438|3827893|B3|Body Image||Lupus Quality of Life (LupusQOL) Domain Scores|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|61.9|61.9|Standard Deviation|29.20|29.2|||
4007408|NCT01205438|3827894|B2|Body Image||Lupus Quality of Life (LupusQOL) Domain Scores|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|63.2|63.2|Standard Deviation|27.67|27.67|||
4007409|NCT01205438|3827895|B1|Body Image||Lupus Quality of Life (LupusQOL) Domain Scores|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|61.1|61.1|Standard Deviation|28.99|28.99|||
4007410|NCT01205438|3827892|B4|Emotional Health||Lupus Quality of Life (LupusQOL) Domain Scores|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|65.7|65.7|Standard Deviation|25.14|25.14|||
4007411|NCT01205438|3827893|B3|Emotional Health||Lupus Quality of Life (LupusQOL) Domain Scores|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|64.6|64.6|Standard Deviation|26.22|26.22|||
4007412|NCT01205438|3827894|B2|Emotional Health||Lupus Quality of Life (LupusQOL) Domain Scores|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|66.7|66.7|Standard Deviation|23.99|23.99|||
4007413|NCT01205438|3827895|B1|Emotional Health||Lupus Quality of Life (LupusQOL) Domain Scores|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|65.7|65.7|Standard Deviation|25.19|25.19|||
4007414|NCT01205438|3827892|B4|Physical Health||Lupus Quality of Life (LupusQOL) Domain Scores|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|58.4|58.4|Standard Deviation|25.43|25.43|||
4007415|NCT01205438|3827893|B3|Physical Health||Lupus Quality of Life (LupusQOL) Domain Scores|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|56.9|56.9|Standard Deviation|26.17|26.17|||
4007416|NCT01205438|3827894|B2|Physical Health||Lupus Quality of Life (LupusQOL) Domain Scores|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|59.1|59.1|Standard Deviation|25.13|25.13|||
4007440|NCT01205438|3827894|B2|Tunisia||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4007417|NCT01205438|3827895|B1|Physical Health||Lupus Quality of Life (LupusQOL) Domain Scores|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|59.2|59.2|Standard Deviation|24.98|24.98|||
4007418|NCT01205438|3827892|B4|||Time of Onset of Lupus||years|Mean|8.01|8.01|Standard Deviation|7.748|7.748|||
4007419|NCT01205438|3827893|B3|||Time of Onset of Lupus||years|Mean|7.74|7.74|Standard Deviation|7.078|7.078|||
4007420|NCT01205438|3827894|B2|||Time of Onset of Lupus||years|Mean|7.94|7.94|Standard Deviation|7.615|7.615|||
4007421|NCT01205438|3827895|B1|||Time of Onset of Lupus||years|Mean|8.36|8.36|Standard Deviation|8.500|8.5|||
4007422|NCT01205438|3827892|B4|||At Least One BILAG A or Two BILAG B Disease Activity Scores|"The British Isles Lupus Assessment Group (BILAG) instrument assesses global disease activity across 9 organ system domains. BILAG flare is assessed for each of the 9 organ domains using BILAG2004 index flare rules; A is a severe flare and B is a moderate flare.~The sum of participants in all Categories for the Measure does not equal the Overall Number of Baseline Participants in the Arm/Group because not all participants will have at least one BILAG A or Two BILAG B Disease Activity scores."|Participants|Count of Participants|657|657.0||||||
4007423|NCT01205438|3827893|B3|||At Least One BILAG A or Two BILAG B Disease Activity Scores|"The British Isles Lupus Assessment Group (BILAG) instrument assesses global disease activity across 9 organ system domains. BILAG flare is assessed for each of the 9 organ domains using BILAG2004 index flare rules; A is a severe flare and B is a moderate flare.~The sum of participants in all Categories for the Measure does not equal the Overall Number of Baseline Participants in the Arm/Group because not all participants will have at least one BILAG A or Two BILAG B Disease Activity scores."|Participants|Count of Participants|209|209.0||||||
4007424|NCT01205438|3827894|B2|||At Least One BILAG A or Two BILAG B Disease Activity Scores|"The British Isles Lupus Assessment Group (BILAG) instrument assesses global disease activity across 9 organ system domains. BILAG flare is assessed for each of the 9 organ domains using BILAG2004 index flare rules; A is a severe flare and B is a moderate flare.~The sum of participants in all Categories for the Measure does not equal the Overall Number of Baseline Participants in the Arm/Group because not all participants will have at least one BILAG A or Two BILAG B Disease Activity scores."|Participants|Count of Participants|218|218.0||||||
4007425|NCT01205438|3827895|B1|||At Least One BILAG A or Two BILAG B Disease Activity Scores|"The British Isles Lupus Assessment Group (BILAG) instrument assesses global disease activity across 9 organ system domains. BILAG flare is assessed for each of the 9 organ domains using BILAG2004 index flare rules; A is a severe flare and B is a moderate flare.~The sum of participants in all Categories for the Measure does not equal the Overall Number of Baseline Participants in the Arm/Group because not all participants will have at least one BILAG A or Two BILAG B Disease Activity scores."|Participants|Count of Participants|230|230.0||||||
4007426|NCT01205438|3827892|B4|||Physician's Global Assessment (PGA) Score|PGA is a single-item clinician rated assessment of the participant's current level of disease activity measured on a continuous 100-millimeter (mm) visual analytic scale with benchmarks of 0, 1, 2, and 3 from left to right corresponding to no, mild, moderate, and severe SLE disease activity.Scores are presented from 0 to 100. No worsening is defined as increase of ≥0.3 points.|units on a scale|Mean|46.3|46.3|Standard Deviation|15.90|15.9|||
4007427|NCT01205438|3827893|B3|||Physician's Global Assessment (PGA) Score|PGA is a single-item clinician rated assessment of the participant's current level of disease activity measured on a continuous 100-millimeter (mm) visual analytic scale with benchmarks of 0, 1, 2, and 3 from left to right corresponding to no, mild, moderate, and severe SLE disease activity.Scores are presented from 0 to 100. No worsening is defined as increase of ≥0.3 points.|units on a scale|Mean|44.9|44.9|Standard Deviation|16.57|16.57|||
4007428|NCT01205438|3827894|B2|||Physician's Global Assessment (PGA) Score|PGA is a single-item clinician rated assessment of the participant's current level of disease activity measured on a continuous 100-millimeter (mm) visual analytic scale with benchmarks of 0, 1, 2, and 3 from left to right corresponding to no, mild, moderate, and severe SLE disease activity.Scores are presented from 0 to 100. No worsening is defined as increase of ≥0.3 points.|units on a scale|Mean|46.8|46.8|Standard Deviation|15.60|15.6|||
4007429|NCT01205438|3827895|B1|||Physician's Global Assessment (PGA) Score|PGA is a single-item clinician rated assessment of the participant's current level of disease activity measured on a continuous 100-millimeter (mm) visual analytic scale with benchmarks of 0, 1, 2, and 3 from left to right corresponding to no, mild, moderate, and severe SLE disease activity.Scores are presented from 0 to 100. No worsening is defined as increase of ≥0.3 points.|units on a scale|Mean|47.2|47.2|Standard Deviation|15.45|15.45|||
4007430|NCT01205438|3827892|B4|||Safety of Estrogens in Lupus Erythematosus National Assessment (SELENA-SLEDAI) Score|SELENA SLEDAI is calculated from 24 individual descriptors across 9 organ systems; 0 indicates inactive disease and the maximum theoretical score is 105; scores > 20 are rare.|units on a scale|Mean|10.2|10.2|Standard Deviation|3.86|3.86|||
4007431|NCT01205438|3827893|B3|||Safety of Estrogens in Lupus Erythematosus National Assessment (SELENA-SLEDAI) Score|SELENA SLEDAI is calculated from 24 individual descriptors across 9 organ systems; 0 indicates inactive disease and the maximum theoretical score is 105; scores > 20 are rare.|units on a scale|Mean|9.8|9.8|Standard Deviation|3.28|3.28|||
4007432|NCT01205438|3827894|B2|||Safety of Estrogens in Lupus Erythematosus National Assessment (SELENA-SLEDAI) Score|SELENA SLEDAI is calculated from 24 individual descriptors across 9 organ systems; 0 indicates inactive disease and the maximum theoretical score is 105; scores > 20 are rare.|units on a scale|Mean|10.4|10.4|Standard Deviation|4.17|4.17|||
4007433|NCT01205438|3827895|B1|||Safety of Estrogens in Lupus Erythematosus National Assessment (SELENA-SLEDAI) Score|SELENA SLEDAI is calculated from 24 individual descriptors across 9 organ systems; 0 indicates inactive disease and the maximum theoretical score is 105; scores > 20 are rare.|units on a scale|Mean|10.4|10.4|Standard Deviation|4.07|4.07|||
4007434|NCT01205438|3827892|B4|||Anti-dsDNA Antibody Level||International Unit / Milliliter (IU/mL)|Mean|113.1|113.1|Standard Deviation|116.03|116.03|||
4007435|NCT01205438|3827893|B3|||Anti-dsDNA Antibody Level||International Unit / Milliliter (IU/mL)|Mean|112.0|112.0|Standard Deviation|116.60|116.6|||
4007611|NCT01205230|3827997|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4007441|NCT01205438|3827895|B1|Tunisia||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
4007442|NCT01205438|3827892|B4|France||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4007443|NCT01205438|3827893|B3|France||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4007444|NCT01205438|3827894|B2|France||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4007445|NCT01205438|3827895|B1|France||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4007446|NCT01205438|3827892|B4|Australia||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4007447|NCT01205438|3827893|B3|Australia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4007448|NCT01205438|3827894|B2|Australia||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4007449|NCT01205438|3827895|B1|Australia||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4007450|NCT01205438|3827892|B4|Serbia||Region of Enrollment||Participants|Count of Participants|76|76.0||||||
4007451|NCT01205438|3827893|B3|Serbia||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
4007452|NCT01205438|3827894|B2|Serbia||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4007453|NCT01205438|3827895|B1|Serbia||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4007454|NCT01205438|3827892|B4|Israel||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
4007455|NCT01205438|3827893|B3|Israel||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4007456|NCT01205438|3827894|B2|Israel||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4007457|NCT01205438|3827895|B1|Israel||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4007458|NCT01205438|3827892|B4|South Africa||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
4007459|NCT01205438|3827893|B3|South Africa||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4007460|NCT01205438|3827894|B2|South Africa||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
4007461|NCT01205438|3827895|B1|South Africa||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4007462|NCT01205438|3827892|B4|Mexico||Region of Enrollment||Participants|Count of Participants|64|64.0||||||
4007463|NCT01205438|3827893|B3|Mexico||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4007464|NCT01205438|3827894|B2|Mexico||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4007465|NCT01205438|3827895|B1|Mexico||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4007466|NCT01205438|3827892|B4|Brazil||Region of Enrollment||Participants|Count of Participants|70|70.0||||||
4007467|NCT01205438|3827893|B3|Brazil||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4007468|NCT01205438|3827894|B2|Brazil||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4007469|NCT01205438|3827895|B1|Brazil||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4007470|NCT01205438|3827892|B4|Taiwan||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
4007471|NCT01205438|3827893|B3|Taiwan||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4007472|NCT01205438|3827894|B2|Taiwan||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4007473|NCT01205438|3827895|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4007474|NCT01205438|3827892|B4|Latvia||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4007475|NCT01205438|3827893|B3|Latvia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4007476|NCT01205438|3827894|B2|Latvia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4007477|NCT01205438|3827895|B1|Latvia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4007478|NCT01205438|3827892|B4|Canada||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4007479|NCT01205438|3827893|B3|Canada||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4007480|NCT01205438|3827894|B2|Canada||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4007481|NCT01205438|3827895|B1|Canada||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4007482|NCT01205438|3827892|B4|New Zealand||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4007483|NCT01205438|3827893|B3|New Zealand||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4007484|NCT01205438|3827894|B2|New Zealand||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4007485|NCT01205438|3827895|B1|New Zealand||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4007486|NCT01205438|3827892|B4|Spain||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4007487|NCT01205438|3827893|B3|Spain||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4007488|NCT01205438|3827894|B2|Spain||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4007489|NCT01205438|3827895|B1|Spain||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4007490|NCT01205438|3827892|B4|India||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
4007491|NCT01205438|3827893|B3|India||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4007492|NCT01205438|3827894|B2|India||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4007493|NCT01205438|3827895|B1|India||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4007494|NCT01205438|3827892|B4|Malaysia||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4007495|NCT01205438|3827893|B3|Malaysia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4007496|NCT01205438|3827894|B2|Malaysia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4007497|NCT01205438|3827895|B1|Malaysia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4007498|NCT01205438|3827892|B4|United Kingdom||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4007499|NCT01205438|3827893|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4007500|NCT01205438|3827894|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4007501|NCT01205438|3827895|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4007502|NCT01205438|3827892|B4|United States||Region of Enrollment||Participants|Count of Participants|428|428.0||||||
4007503|NCT01205438|3827893|B3|United States||Region of Enrollment||Participants|Count of Participants|148|148.0||||||
4007504|NCT01205438|3827894|B2|United States||Region of Enrollment||Participants|Count of Participants|137|137.0||||||
4007505|NCT01205438|3827895|B1|United States||Region of Enrollment||Participants|Count of Participants|143|143.0||||||
4007506|NCT01205438|3827892|B4|Hungary||Region of Enrollment||Participants|Count of Participants|53|53.0||||||
4007507|NCT01205438|3827893|B3|Hungary||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4007508|NCT01205438|3827894|B2|Hungary||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
4007509|NCT01205438|3827895|B1|Hungary||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4007510|NCT01205438|3827892|B4|Romania||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4007511|NCT01205438|3827893|B3|Romania||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4007512|NCT01205438|3827894|B2|Romania||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4007513|NCT01205438|3827895|B1|Romania||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4007514|NCT01205438|3827892|B4|Russia||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
4007515|NCT01205438|3827893|B3|Russia||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4007516|NCT01205438|3827894|B2|Russia||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4007517|NCT01205438|3827895|B1|Russia||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4007518|NCT01205438|3827892|B4|Ecuador||Region of Enrollment||Participants|Count of Participants|49|49.0||||||
4007519|NCT01205438|3827893|B3|Ecuador||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4007520|NCT01205438|3827894|B2|Ecuador||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
4007521|NCT01205438|3827895|B1|Ecuador||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4007522|NCT01205438|3827892|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007523|NCT01205438|3827893|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007524|NCT01205438|3827894|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007525|NCT01205438|3827895|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007526|NCT01205438|3827892|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4007527|NCT01205438|3827893|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4007528|NCT01205438|3827894|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4007529|NCT01205438|3827895|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4007530|NCT01205438|3827892|B4||White|Race (NIH/OMB)||Participants|Count of Participants|741|741.0||||||
4007531|NCT01205438|3827893|B3||White|Race (NIH/OMB)||Participants|Count of Participants|249|249.0||||||
4007532|NCT01205438|3827894|B2||White|Race (NIH/OMB)||Participants|Count of Participants|247|247.0||||||
4007533|NCT01205438|3827895|B1||White|Race (NIH/OMB)||Participants|Count of Participants|245|245.0||||||
4007534|NCT01205438|3827892|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
4007535|NCT01205438|3827893|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4007536|NCT01205438|3827894|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4007537|NCT01205438|3827895|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4007538|NCT01205438|3827892|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4007539|NCT01205438|3827893|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007540|NCT01205438|3827894|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4007541|NCT01205438|3827895|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4007542|NCT01205438|3827892|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|112|112.0||||||
4007543|NCT01205438|3827893|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4007544|NCT01205438|3827894|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4007545|NCT01205438|3827895|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4007546|NCT01205438|3827892|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
4007547|NCT01205438|3827893|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4007548|NCT01205438|3827894|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4007549|NCT01205438|3827895|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4007550|NCT01205438|3827892|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
4007551|NCT01205438|3827893|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4007552|NCT01205438|3827894|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4007553|NCT01205438|3827895|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4007554|NCT01205438|3827892|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|697|697.0||||||
4007555|NCT01205438|3827893|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|235|235.0||||||
4007556|NCT01205438|3827894|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|233|233.0||||||
4007557|NCT01205438|3827895|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|229|229.0||||||
4007558|NCT01205438|3827892|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|301|301.0||||||
4007559|NCT01205438|3827893|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
4007560|NCT01205438|3827894|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
4007561|NCT01205438|3827895|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
4007562|NCT01205438|3827892|B4||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4007563|NCT01205438|3827893|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4007564|NCT01205438|3827894|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4007565|NCT01205438|3827895|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4007566|NCT01205438|3827892|B4||Female|Sex: Female, Male||Participants|Count of Participants|1037|1037.0||||||
4007567|NCT01205438|3827893|B3||Female|Sex: Female, Male||Participants|Count of Participants|349|349.0||||||
4007568|NCT01205438|3827894|B2||Female|Sex: Female, Male||Participants|Count of Participants|346|346.0||||||
4007569|NCT01205438|3827895|B1||Female|Sex: Female, Male||Participants|Count of Participants|342|342.0||||||
4007570|NCT01205438|3827892|B4|||Age||years|Mean|41.8|41.8|Standard Deviation|12.40|12.4|||
4007571|NCT01205438|3827893|B3|||Age||years|Mean|41.9|41.9|Standard Deviation|12.08|12.08|||
4007572|NCT01205438|3827894|B2|||Age||years|Mean|41.2|41.2|Standard Deviation|12.73|12.73|||
4007573|NCT01205438|3827895|B1|||Age||years|Mean|42.3|42.3|Standard Deviation|12.41|12.41|||
4007574|NCT01205399|3827947|B1|||Body Mass Index||kilograms per square meter|Mean|36.7|36.7|Standard Deviation|9.92|9.92|||
4007575|NCT01205399|3827947|B1|United States||Region of Enrollment||participants|Number|78|78.0||||||
4007576|NCT01205399|3827947|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007577|NCT01205399|3827947|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007578|NCT01205399|3827947|B1||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4007579|NCT01205399|3827947|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4007580|NCT01205399|3827947|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007581|NCT01205399|3827947|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007582|NCT01205399|3827947|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4007583|NCT01205399|3827947|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007584|NCT01205399|3827947|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4007585|NCT01205399|3827947|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4007586|NCT01205399|3827947|B1||Male|Gender||Participants|Count of Participants|35|35.0||||||
4007587|NCT01205399|3827947|B1||Female|Gender||Participants|Count of Participants|43|43.0||||||
4007588|NCT01205399|3827947|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|11.07|11.07|||
4007589|NCT01205269|3827953|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4007590|NCT01205269|3827953|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4007591|NCT01205269|3827953|B1|||Age||years|Mean|63.2|63.2|Full Range|||52.0|81.0|
4007592|NCT01205230|3827996|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4007593|NCT01205230|3827997|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4007594|NCT01205230|3827998|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4007595|NCT01205230|3827996|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4007596|NCT01205230|3827997|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4007597|NCT01205230|3827998|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4007598|NCT01205230|3827996|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4007599|NCT01205230|3827997|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4007600|NCT01205230|3827998|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4007601|NCT01205230|3827996|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4007602|NCT01205230|3827997|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4007603|NCT01205230|3827998|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4007604|NCT01205230|3827996|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4007605|NCT01205230|3827997|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4007606|NCT01205230|3827998|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4007607|NCT01205230|3827996|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4007608|NCT01205230|3827997|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4007609|NCT01205230|3827998|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4007610|NCT01205230|3827996|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4007612|NCT01205230|3827998|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4007613|NCT01205230|3827996|B3|Years||Age||Years|Mean|59.2|59.2|Standard Deviation|12.43|12.43|||
4007614|NCT01205230|3827997|B2|Years||Age||Years|Mean|57.9|57.9|Standard Deviation|13.09|13.09|||
4007615|NCT01205230|3827998|B1|Years||Age||Years|Mean|60.0|60.0|Standard Deviation|12.27|12.27|||
4007616|NCT01205165|3828042|B1|Korea||Region of Enrollment||Participants|Number|104|104.0||||||
4007617|NCT01205165|3828042|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4007618|NCT01205165|3828042|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4007619|NCT01205165|3828042|B1|||Age||Years|Mean|35.3|35.3|Standard Deviation|10.4|10.4|||
4007620|NCT01205152|3828055|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007621|NCT01205152|3828055|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007622|NCT01205152|3828055|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4007623|NCT01205152|3828055|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007624|NCT01205152|3828055|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007625|NCT01205152|3828055|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007626|NCT01205152|3828055|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007627|NCT01205152|3828055|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007628|NCT01205152|3828055|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4007629|NCT01205152|3828055|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4007630|NCT01205152|3828055|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4007631|NCT01205152|3828055|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4007632|NCT01205152|3828055|B1|||Age|Mean (SD) age at time of first dose in ENB-002-08 (NCT00744042)|weeks|Mean|56.44|56.44|Standard Deviation|61.888|61.888|||
4007633|NCT01205126|3828066|B3||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4007634|NCT01205126|3828067|B2||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4007635|NCT01205126|3828068|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4007636|NCT01205126|3828066|B3||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4007637|NCT01205126|3828067|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4007638|NCT01205126|3828068|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4007639|NCT01205126|3828066|B3|||Age||Years|Mean|53.1|53.1|Standard Deviation|10.79|10.79|||
4007640|NCT01205126|3828067|B2|||Age||Years|Mean|52.7|52.7|Standard Deviation|10.75|10.75|||
4007641|NCT01205126|3828068|B1|||Age||Years|Mean|53.5|53.5|Standard Deviation|10.86|10.86|||
4007642|NCT01205035|3828085|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4007643|NCT01205035|3828086|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4007644|NCT01205035|3828087|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4007645|NCT01205035|3828085|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4007646|NCT01205035|3828086|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4007647|NCT01205035|3828087|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4007648|NCT01205035|3828085|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4007649|NCT01205035|3828086|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4007650|NCT01205035|3828087|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4007651|NCT01205035|3828085|B3|||Age||years|Mean|66.5|66.5|Full Range|||52.0|76.0|
4007652|NCT01205035|3828086|B2|||Age||years|Mean|65|65.0|Full Range|||52.0|76.0|
4007653|NCT01205035|3828087|B1|||Age||years|Mean|68|68.0|Full Range|||52.0|76.0|
4007654|NCT01204918|3828102|B4|No||Antidepressant (Y/N)||Participants|Count of Participants|39|39.0||||||
4007655|NCT01204918|3828103|B3|No||Antidepressant (Y/N)||Participants|Count of Participants|16|16.0||||||
4007656|NCT01204918|3828104|B2|No||Antidepressant (Y/N)||Participants|Count of Participants|14|14.0||||||
4007657|NCT01204918|3828105|B1|No||Antidepressant (Y/N)||Participants|Count of Participants|9|9.0||||||
4007658|NCT01204918|3828102|B4|Yes||Antidepressant (Y/N)||Participants|Count of Participants|65|65.0||||||
4007659|NCT01204918|3828103|B3|Yes||Antidepressant (Y/N)||Participants|Count of Participants|24|24.0||||||
4007660|NCT01204918|3828104|B2|Yes||Antidepressant (Y/N)||Participants|Count of Participants|25|25.0||||||
4007661|NCT01204918|3828105|B1|Yes||Antidepressant (Y/N)||Participants|Count of Participants|16|16.0||||||
4007662|NCT01204918|3828102|B4||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4007663|NCT01204918|3828103|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4007664|NCT01204918|3828104|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4007665|NCT01204918|3828105|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4007666|NCT01204918|3828102|B4||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4007667|NCT01204918|3828103|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4007668|NCT01204918|3828104|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4007669|NCT01204918|3828105|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4007670|NCT01204918|3828102|B4|||Age||years|Mean|46.3|46.3|Standard Deviation|12.3|12.3|||
4007671|NCT01204918|3828103|B3|||Age||years|Mean|46.3|46.3|Standard Deviation|12.7|12.7|||
4007672|NCT01204918|3828104|B2|||Age||years|Mean|47.3|47.3|Standard Deviation|12.1|12.1|||
4007673|NCT01204918|3828105|B1|||Age||years|Mean|46.3|46.3|Standard Deviation|12.7|12.7|||
4007674|NCT01204905|3828124|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4007675|NCT01204905|3828124|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007676|NCT01204905|3828124|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007677|NCT01204905|3828124|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4007678|NCT01204905|3828124|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4007679|NCT01204905|3828124|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007680|NCT01204905|3828124|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007681|NCT01204905|3828124|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007682|NCT01204905|3828124|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4007683|NCT01204905|3828124|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4007684|NCT01204905|3828124|B1|||Age||years|Mean|40|40.0|Full Range|||26.0|61.0|
4007685|NCT01204905|3828124|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4007686|NCT01204905|3828124|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4007687|NCT01204905|3828124|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4007688|NCT01204853|3828129|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4007689|NCT01204853|3828129|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4007690|NCT01204853|3828129|B1|>=65 years||Age, Customized||Participant|Number|1|1.0||||||
4007691|NCT01204853|3828129|B1|19-64 years||Age, Customized||Participant|Number|1|1.0||||||
4007692|NCT01204853|3828129|B1|<=18 years||Age, Customized||Participant|Number|0|0.0||||||
4007693|NCT01204788|3828139|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4007694|NCT01204788|3828140|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4007695|NCT01204788|3828141|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4007696|NCT01204788|3828139|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4007697|NCT01204788|3828140|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4007698|NCT01204788|3828141|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4007699|NCT01204788|3828139|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4007700|NCT01204788|3828140|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4007701|NCT01204788|3828141|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4007702|NCT01204788|3828139|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4007703|NCT01204788|3828140|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4007704|NCT01204788|3828141|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4007705|NCT01204788|3828139|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4007706|NCT01204788|3828140|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4007707|NCT01204788|3828141|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4007708|NCT01204788|3828139|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4007709|NCT01204788|3828140|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4007710|NCT01204788|3828141|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4007711|NCT01204775|3828148|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4007712|NCT01204775|3828149|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4007713|NCT01204775|3828150|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4007714|NCT01204775|3828148|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4007715|NCT01204775|3828149|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4007716|NCT01204775|3828150|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4007717|NCT01204775|3828148|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4007718|NCT01204775|3828149|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4007719|NCT01204775|3828150|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4007720|NCT01204775|3828148|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4007721|NCT01204775|3828149|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4007722|NCT01204775|3828150|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4007723|NCT01204775|3828148|B3||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4007724|NCT01204775|3828149|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4007725|NCT01204775|3828150|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4007726|NCT01204736|3828157|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4007727|NCT01204736|3828158|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4007728|NCT01204736|3828159|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4007729|NCT01204736|3828160|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4007730|NCT01204736|3828161|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4007731|NCT01204736|3828157|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4007732|NCT01204736|3828158|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4007733|NCT01204736|3828159|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4007734|NCT01204736|3828160|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4007735|NCT01204736|3828161|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4007736|NCT01204736|3828157|B5|||Age||years|Mean|37.3|37.3|Standard Deviation|12.1|12.1|||
4007737|NCT01204736|3828158|B4|||Age||years|Mean|33.5|33.5|Standard Deviation|0.7|0.7|||
4007738|NCT01204736|3828159|B3|||Age||years|Mean|45.2|45.2|Standard Deviation|11.5|11.5|||
4007739|NCT01204736|3828160|B2|||Age||years|Mean|26.6|26.6|Standard Deviation|8.2|8.2|||
4007740|NCT01204736|3828161|B1|||Age||years|Mean|43.8|43.8|Standard Deviation|7.3|7.3|||
4007741|NCT01204710|3828174|B3|Italy||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4007742|NCT01204710|3828175|B2|Italy||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4007743|NCT01204710|3828176|B1|Italy||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4007744|NCT01204710|3828174|B3|Germany||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
4007745|NCT01204710|3828175|B2|Germany||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4007746|NCT01204710|3828176|B1|Germany||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4007747|NCT01204710|3828174|B3|Belgium||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4007748|NCT01204710|3828175|B2|Belgium||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4007749|NCT01204710|3828176|B1|Belgium||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4007750|NCT01204710|3828174|B3|Poland||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
4007751|NCT01204710|3828175|B2|Poland||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4007752|NCT01204710|3828176|B1|Poland||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4007753|NCT01204710|3828174|B3|Spain||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
4007754|NCT01204710|3828175|B2|Spain||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4007755|NCT01204710|3828176|B1|Spain||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
4007756|NCT01204710|3828174|B3|Czechia||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4007757|NCT01204710|3828175|B2|Czechia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4007758|NCT01204710|3828176|B1|Czechia||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4007759|NCT01204710|3828174|B3|Hungary||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4007760|NCT01204710|3828175|B2|Hungary||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4007761|NCT01204710|3828176|B1|Hungary||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4007762|NCT01204710|3828174|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007763|NCT01204710|3828175|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007764|NCT01204710|3828176|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007765|NCT01204710|3828174|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4007766|NCT01204710|3828175|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4007767|NCT01204710|3828176|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007768|NCT01204710|3828174|B3||White|Race (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
4007769|NCT01204710|3828175|B2||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4007770|NCT01204710|3828176|B1||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4007771|NCT01204710|3828174|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007772|NCT01204710|3828175|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007773|NCT01204710|3828176|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007774|NCT01204710|3828174|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007775|NCT01204710|3828175|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007776|NCT01204710|3828176|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007777|NCT01204710|3828174|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007778|NCT01204710|3828175|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007779|NCT01204710|3828176|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007780|NCT01204710|3828174|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007781|NCT01204710|3828175|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007782|NCT01204710|3828176|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007783|NCT01204710|3828174|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007784|NCT01204710|3828175|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007785|NCT01204710|3828176|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007786|NCT01204710|3828174|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|116|116.0||||||
4007787|NCT01204710|3828175|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4007788|NCT01204710|3828176|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4007789|NCT01204710|3828174|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4007790|NCT01204710|3828175|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4007791|NCT01204710|3828176|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4007792|NCT01204710|3828174|B3||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4007793|NCT01204710|3828175|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4007794|NCT01204710|3828176|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4007795|NCT01204710|3828174|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4007796|NCT01204710|3828175|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4007797|NCT01204710|3828176|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4007798|NCT01204710|3828174|B3||>=65 years|Age||Participants|Count of Participants|86|86.0||||||
4007799|NCT01204710|3828175|B2||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
4007800|NCT01204710|3828176|B1||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
4007801|NCT01204710|3828174|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4007802|NCT01204710|3828175|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4007803|NCT01204710|3828176|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4007804|NCT01204710|3828174|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4007805|NCT01204710|3828175|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4007806|NCT01204710|3828176|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4007807|NCT01204697|3828211|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4007808|NCT01204697|3828212|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4007809|NCT01204697|3828213|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4007810|NCT01204697|3828211|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4007811|NCT01204697|3828212|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4007812|NCT01204697|3828213|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4007813|NCT01204697|3828211|B3|||Age||years|Mean|67.2|67.2|Standard Deviation|8.2|8.2|||
4007814|NCT01204697|3828212|B2|||Age||years|Mean|65.9|65.9|Standard Deviation|8.1|8.1|||
4007815|NCT01204697|3828213|B1|||Age||years|Mean|68.4|68.4|Standard Deviation|8.3|8.3|||
4007816|NCT01204671|3828230|B6||Male|Sex: Female, Male||Participants|Count of Participants|2020|2020.0||||||
4007817|NCT01204671|3828231|B5||Male|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
4007818|NCT01204671|3828232|B4||Male|Sex: Female, Male||Participants|Count of Participants|462|462.0||||||
4007819|NCT01204671|3828233|B3||Male|Sex: Female, Male||Participants|Count of Participants|442|442.0||||||
4007820|NCT01204671|3828234|B2||Male|Sex: Female, Male||Participants|Count of Participants|435|435.0||||||
4007821|NCT01204671|3828235|B1||Male|Sex: Female, Male||Participants|Count of Participants|414|414.0||||||
4007822|NCT01204671|3828230|B6||Female|Sex: Female, Male||Participants|Count of Participants|2636|2636.0||||||
4007823|NCT01204671|3828231|B5||Female|Sex: Female, Male||Participants|Count of Participants|343|343.0||||||
4007824|NCT01204671|3828232|B4||Female|Sex: Female, Male||Participants|Count of Participants|548|548.0||||||
4007825|NCT01204671|3828233|B3||Female|Sex: Female, Male||Participants|Count of Participants|569|569.0||||||
4007826|NCT01204671|3828234|B2||Female|Sex: Female, Male||Participants|Count of Participants|578|578.0||||||
4007827|NCT01204671|3828235|B1||Female|Sex: Female, Male||Participants|Count of Participants|598|598.0||||||
4007828|NCT01204671|3828230|B6|||Age||Years|Mean|58.0|58.0|Standard Deviation|17.75|17.75|||
4007829|NCT01204671|3828231|B5|||Age||Years|Mean|58.1|58.1|Standard Deviation|17.92|17.92|||
4007830|NCT01204671|3828232|B4|||Age||Years|Mean|58.1|58.1|Standard Deviation|17.83|17.83|||
4007831|NCT01204671|3828233|B3|||Age||Years|Mean|57.9|57.9|Standard Deviation|17.80|17.8|||
4007832|NCT01204671|3828234|B2|||Age||Years|Mean|58.0|58.0|Standard Deviation|17.41|17.41|||
4007833|NCT01204671|3828235|B1|||Age||Years|Mean|57.7|57.7|Standard Deviation|17.90|17.9|||
4007834|NCT01204658|3828297|B5||Male|Sex: Female, Male||Participants|Count of Participants|307|307.0||||||
4007835|NCT01204658|3828298|B4||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4007836|NCT01204658|3828299|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4007837|NCT01204658|3828300|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4007838|NCT01204658|3828301|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4007839|NCT01204658|3828297|B5||Female|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
4007840|NCT01204658|3828298|B4||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4007841|NCT01204658|3828299|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4007842|NCT01204658|3828300|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4007843|NCT01204658|3828301|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4007844|NCT01204658|3828297|B5|||Age||Weeks|Mean|10.2|10.2|Standard Deviation|2.61|2.61|||
4007845|NCT01204658|3828298|B4|||Age||Weeks|Mean|10.2|10.2|Standard Deviation|2.64|2.64|||
4007846|NCT01204658|3828299|B3|||Age||Weeks|Mean|10.1|10.1|Standard Deviation|2.61|2.61|||
4007847|NCT01204658|3828300|B2|||Age||Weeks|Mean|10.1|10.1|Standard Deviation|2.70|2.7|||
4007848|NCT01204658|3828301|B1|||Age||Weeks|Mean|10.3|10.3|Standard Deviation|2.49|2.49|||
4007849|NCT01204398|3828422|B1|||Mean 24-hour mean Systolic blood pressure (SBP)||mmHg|Mean|150.24|150.24|Standard Deviation|17.30|17.3|||
4007850|NCT01204398|3828422|B1|||Mean 24-hour mean Diastolic blood pressure (DBP)||mmHg|Mean|95.79|95.79|Standard Deviation|7.74|7.74|||
4007851|NCT01204398|3828422|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4007852|NCT01204398|3828422|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4007853|NCT01204398|3828422|B1|||Age||Years|Mean|52.0|52.0|Standard Deviation|8.7|8.7|||
4007854|NCT01204294|3828432|B8||Male|Sex: Female, Male||Participants|Count of Participants|401|401.0||||||
4007855|NCT01204294|3828433|B7||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4007856|NCT01204294|3828434|B6||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4007857|NCT01204294|3828435|B5||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4007858|NCT01204294|3828436|B4||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4007859|NCT01204294|3828437|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4007860|NCT01204294|3828438|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4007861|NCT01204294|3828439|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4007862|NCT01204294|3828432|B8||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4007863|NCT01204294|3828433|B7||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4007864|NCT01204294|3828434|B6||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4007865|NCT01204294|3828435|B5||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4007866|NCT01204294|3828436|B4||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4007867|NCT01204294|3828437|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4007868|NCT01204294|3828438|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4007869|NCT01204294|3828439|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4007870|NCT01204294|3828432|B8|||Age, Customized||years|Mean|60.9|60.9|Standard Deviation|10.2|10.2|||
4007871|NCT01204294|3828433|B7|||Age, Customized||years|Mean|59.3|59.3|Standard Deviation|10.3|10.3|||
4007872|NCT01204294|3828434|B6|||Age, Customized||years|Mean|61.2|61.2|Standard Deviation|10.6|10.6|||
4007873|NCT01204294|3828435|B5|||Age, Customized||years|Mean|62.0|62.0|Standard Deviation|10.4|10.4|||
4007874|NCT01204294|3828436|B4|||Age, Customized||years|Mean|61.8|61.8|Standard Deviation|10.8|10.8|||
4007875|NCT01204294|3828437|B3|||Age, Customized||years|Mean|60.4|60.4|Standard Deviation|9.4|9.4|||
4007876|NCT01204294|3828438|B2|||Age, Customized||years|Mean|62.6|62.6|Standard Deviation|8.8|8.8|||
4007877|NCT01204294|3828439|B1|||Age, Customized||years|Mean|58.4|58.4|Standard Deviation|9.9|9.9|||
4007878|NCT01204255|3828468|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4007879|NCT01204255|3828468|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4007880|NCT01204255|3828468|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4007881|NCT01204255|3828468|B1|||Age||years|Mean|37.7|37.7|Standard Deviation|13.5|13.5|||
4007882|NCT01204255|3828468|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4007883|NCT01204255|3828468|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4007884|NCT01204255|3828468|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4007885|NCT01204203|3828473|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4007886|NCT01204203|3828473|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4007887|NCT01204203|3828473|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4007888|NCT01204203|3828473|B1|||Age||years|Median|62|62.0|Full Range|||49.0|77.0|
4007889|NCT01203956|3828479|B1|||AHI (apnea-hypopnea index)||events / hour|Mean|39.8|39.8|Standard Deviation|21.5|21.5|||
4007890|NCT01203956|3828479|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4007891|NCT01203956|3828479|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4007892|NCT01203956|3828479|B1|||Age||years|Mean|48.4|48.4|Standard Deviation|9.9|9.9|||
4007893|NCT01203930|3828487|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4007894|NCT01203930|3828488|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4007895|NCT01203930|3828489|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4007896|NCT01203930|3828487|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4007897|NCT01203930|3828488|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4007898|NCT01203930|3828489|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4007899|NCT01203930|3828487|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4007900|NCT01203930|3828488|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4007901|NCT01203930|3828489|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4007902|NCT01203930|3828487|B3|White/Caucasian||Race/Ethnicity, Customized||participants|Number|101|101.0||||||
4007903|NCT01203930|3828488|B2|White/Caucasian||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4007904|NCT01203930|3828489|B1|White/Caucasian||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
4007905|NCT01203930|3828487|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007906|NCT01203930|3828488|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007907|NCT01203930|3828489|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007908|NCT01203930|3828487|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
4007909|NCT01203930|3828488|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4007910|NCT01203930|3828489|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4007911|NCT01203930|3828487|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4007912|NCT01203930|3828488|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4007913|NCT01203930|3828489|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4007914|NCT01203930|3828487|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4007915|NCT01203930|3828488|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4007916|NCT01203930|3828489|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4007917|NCT01203930|3828487|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4007918|NCT01203930|3828488|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4007919|NCT01203930|3828489|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4007920|NCT01203930|3828487|B3|≥ 70 Years||Age, Customized||participants|Number|62|62.0||||||
4007921|NCT01203930|3828488|B2|≥ 70 Years||Age, Customized||participants|Number|27|27.0||||||
4007922|NCT01203930|3828489|B1|≥ 70 Years||Age, Customized||participants|Number|35|35.0||||||
4007923|NCT01203930|3828487|B3|< 70 Years||Age, Customized||participants|Number|43|43.0||||||
4007924|NCT01203930|3828488|B2|< 70 Years||Age, Customized||participants|Number|14|14.0||||||
4007925|NCT01203930|3828489|B1|< 70 Years||Age, Customized||participants|Number|29|29.0||||||
4007926|NCT01203917|3828512|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4007927|NCT01203917|3828512|B1|White||Race/Ethnicity, Customized||Participants|Number|106|106.0||||||
4007928|NCT01203917|3828512|B1||Male|Gender||Participants|Count of Participants|31|31.0||||||
4007929|NCT01203917|3828512|B1||Female|Gender||Participants|Count of Participants|75|75.0||||||
4007930|NCT01203917|3828512|B1|> =75 Years||Age, Customized||Participants|Number|26|26.0||||||
4007931|NCT01203917|3828512|B1|> =65 to < 75 Years||Age, Customized||Participants|Number|28|28.0||||||
4007932|NCT01203917|3828512|B1|> =18 to < 65 Years||Age, Customized||Participants|Number|52|52.0||||||
4007933|NCT01203917|3828512|B1|||Age||Years|Mean|64.0|64.0|Standard Deviation|11.81|11.81|||
4007934|NCT01203878|3828522|B4|||Total facial actinic keratosis count||Patient facial actinic keratosis count|Mean|19.0|19.0|Standard Deviation|5.1|5.1|||
4007935|NCT01203878|3828523|B3|||Total facial actinic keratosis count||Patient facial actinic keratosis count|Mean|18.0|18.0|Standard Deviation|2.6|2.6|||
4007936|NCT01203878|3828524|B2|||Total facial actinic keratosis count||Patient facial actinic keratosis count|Mean|19.9|19.9|Standard Deviation|5.6|5.6|||
4007937|NCT01203878|3828525|B1|||Total facial actinic keratosis count||Patient facial actinic keratosis count|Mean|18.3|18.3|Standard Deviation|5.6|5.6|||
4007938|NCT01203878|3828522|B4|United States||Region of Enrollment||participants|Number|21|21.0||||||
4007939|NCT01203878|3828523|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4007940|NCT01203878|3828524|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4007941|NCT01203878|3828525|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4007942|NCT01203878|3828522|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4007943|NCT01203878|3828523|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4007944|NCT01203878|3828524|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4007945|NCT01203878|3828525|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4007946|NCT01203878|3828522|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4007947|NCT01203878|3828523|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4007948|NCT01203878|3828524|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4007949|NCT01203878|3828525|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4007950|NCT01203878|3828522|B4|||Age||years|Mean|62|62.0|Standard Deviation|7|7.0|||
4007951|NCT01203878|3828523|B3|||Age||years|Mean|66|66.0|Standard Deviation|11|11.0|||
4007952|NCT01203878|3828524|B2|||Age||years|Mean|61|61.0|Standard Deviation|6|6.0|||
4007953|NCT01203878|3828525|B1|||Age||years|Mean|63|63.0|Standard Deviation|7|7.0|||
4007954|NCT01203878|3828522|B4||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4007955|NCT01203878|3828523|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4007956|NCT01203878|3828524|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4007957|NCT01203878|3828525|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4007958|NCT01203878|3828522|B4||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4007959|NCT01203878|3828523|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4007960|NCT01203878|3828524|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4007961|NCT01203878|3828525|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4007962|NCT01203878|3828522|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4007963|NCT01203878|3828523|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4007964|NCT01203878|3828524|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4007965|NCT01203878|3828525|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4007966|NCT01203852|3828538|B1|United States||Region of Enrollment||participants|Number|839|839.0||||||
4007967|NCT01203852|3828538|B1||Male|Sex: Female, Male||Participants|Count of Participants|410|410.0||||||
4007968|NCT01203852|3828538|B1||Female|Sex: Female, Male||Participants|Count of Participants|429|429.0||||||
4007969|NCT01203852|3828538|B1|||Age||years|Mean|50.3|50.3|Standard Deviation|9.0|9.0|||
4007970|NCT01203852|3828538|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4007971|NCT01203852|3828538|B1||Between 18 and 65 years|Age||Participants|Count of Participants|839|839.0||||||
4007972|NCT01203852|3828538|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4007973|NCT01203826|3828545|B3|||Tanner Stage 1|n %; Tanner Stage 1 = Prepubertal children|Participants|Count of Participants|12|12.0||||||
4007974|NCT01203826|3828546|B2|||Tanner Stage 1|n %; Tanner Stage 1 = Prepubertal children|Participants|Count of Participants|6|6.0||||||
4007975|NCT01203826|3828547|B1|||Tanner Stage 1|n %; Tanner Stage 1 = Prepubertal children|Participants|Count of Participants|6|6.0||||||
4007976|NCT01203826|3828545|B3|||Age at Onset of Hypophosphatasia Symptoms||Months|Mean|11.2|11.2|Standard Deviation|6.94|6.94|||
4007977|NCT01203826|3828546|B2|||Age at Onset of Hypophosphatasia Symptoms||Months|Mean|11.5|11.5|Standard Deviation|5.54|5.54|||
4007978|NCT01203826|3828547|B1|||Age at Onset of Hypophosphatasia Symptoms||Months|Mean|10.8|10.8|Standard Deviation|8.66|8.66|||
4007979|NCT01203826|3828545|B3||Juvenile (≥ 6 months to < 18 yrs)|Hypophosphatasia Phenotype|n %|Participants|Count of Participants|8|8.0||||||
4007980|NCT01203826|3828546|B2||Juvenile (≥ 6 months to < 18 yrs)|Hypophosphatasia Phenotype|n %|Participants|Count of Participants|5|5.0||||||
4007981|NCT01203826|3828547|B1||Juvenile (≥ 6 months to < 18 yrs)|Hypophosphatasia Phenotype|n %|Participants|Count of Participants|3|3.0||||||
4007982|NCT01203826|3828545|B3||Infantile (< 6 months)|Hypophosphatasia Phenotype|n %|Participants|Count of Participants|4|4.0||||||
4007983|NCT01203826|3828546|B2||Infantile (< 6 months)|Hypophosphatasia Phenotype|n %|Participants|Count of Participants|1|1.0||||||
4007984|NCT01203826|3828547|B1||Infantile (< 6 months)|Hypophosphatasia Phenotype|n %|Participants|Count of Participants|3|3.0||||||
4007985|NCT01203826|3828545|B3|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4007986|NCT01203826|3828546|B2|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4007987|NCT01203826|3828547|B1|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4007988|NCT01203826|3828545|B3|Canada||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4007989|NCT01203826|3828546|B2|Canada||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4007990|NCT01203826|3828547|B1|Canada||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4007991|NCT01203826|3828545|B3||Unknown or Not Reported|Race (NIH/OMB)|n %|Participants|Count of Participants|0|0.0||||||
4007992|NCT01203826|3828546|B2||Unknown or Not Reported|Race (NIH/OMB)|n %|Participants|Count of Participants|0|0.0||||||
4007993|NCT01203826|3828547|B1||Unknown or Not Reported|Race (NIH/OMB)|n %|Participants|Count of Participants|0|0.0||||||
4007994|NCT01203826|3828545|B3||More than one race|Race (NIH/OMB)|n %|Participants|Count of Participants|0|0.0||||||
4007995|NCT01203826|3828546|B2||More than one race|Race (NIH/OMB)|n %|Participants|Count of Participants|0|0.0||||||
4007996|NCT01203826|3828547|B1||More than one race|Race (NIH/OMB)|n %|Participants|Count of Participants|0|0.0||||||
4007997|NCT01203826|3828545|B3||White|Race (NIH/OMB)|n %|Participants|Count of Participants|12|12.0||||||
4007998|NCT01203826|3828546|B2||White|Race (NIH/OMB)|n %|Participants|Count of Participants|6|6.0||||||
4007999|NCT01203826|3828547|B1||White|Race (NIH/OMB)|n %|Participants|Count of Participants|6|6.0||||||
4008000|NCT01203826|3828545|B3||Black or African American|Race (NIH/OMB)|n %|Participants|Count of Participants|0|0.0||||||
4008001|NCT01203826|3828546|B2||Black or African American|Race (NIH/OMB)|n %|Participants|Count of Participants|0|0.0||||||
4008002|NCT01203826|3828547|B1||Black or African American|Race (NIH/OMB)|n %|Participants|Count of Participants|0|0.0||||||
4008003|NCT01203826|3828545|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|n %|Participants|Count of Participants|0|0.0||||||
4008004|NCT01203826|3828546|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|n %|Participants|Count of Participants|0|0.0||||||
4008005|NCT01203826|3828547|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|n %|Participants|Count of Participants|0|0.0||||||
4008006|NCT01203826|3828545|B3||Asian|Race (NIH/OMB)|n %|Participants|Count of Participants|0|0.0||||||
4008007|NCT01203826|3828546|B2||Asian|Race (NIH/OMB)|n %|Participants|Count of Participants|0|0.0||||||
4008008|NCT01203826|3828547|B1||Asian|Race (NIH/OMB)|n %|Participants|Count of Participants|0|0.0||||||
4008009|NCT01203826|3828545|B3||American Indian or Alaska Native|Race (NIH/OMB)|n %|Participants|Count of Participants|0|0.0||||||
4008010|NCT01203826|3828546|B2||American Indian or Alaska Native|Race (NIH/OMB)|n %|Participants|Count of Participants|0|0.0||||||
4008011|NCT01203826|3828547|B1||American Indian or Alaska Native|Race (NIH/OMB)|n %|Participants|Count of Participants|0|0.0||||||
4008012|NCT01203826|3828545|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)|n %|Participants|Count of Participants|0|0.0||||||
4008013|NCT01203826|3828546|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)|n %|Participants|Count of Participants|0|0.0||||||
4008014|NCT01203826|3828547|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|n %|Participants|Count of Participants|0|0.0||||||
4008015|NCT01203826|3828545|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)|n %|Participants|Count of Participants|11|11.0||||||
4008016|NCT01203826|3828546|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)|n %|Participants|Count of Participants|6|6.0||||||
4008017|NCT01203826|3828547|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|n %|Participants|Count of Participants|5|5.0||||||
4008018|NCT01203826|3828545|B3||Hispanic or Latino|Ethnicity (NIH/OMB)|n %|Participants|Count of Participants|1|1.0||||||
4008019|NCT01203826|3828546|B2||Hispanic or Latino|Ethnicity (NIH/OMB)|n %|Participants|Count of Participants|0|0.0||||||
4008020|NCT01203826|3828547|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|n %|Participants|Count of Participants|1|1.0||||||
4008021|NCT01203826|3828545|B3||Male|Sex: Female, Male|n %|Participants|Count of Participants|10|10.0||||||
4008022|NCT01203826|3828546|B2||Male|Sex: Female, Male|n %|Participants|Count of Participants|5|5.0||||||
4008023|NCT01203826|3828547|B1||Male|Sex: Female, Male|n %|Participants|Count of Participants|5|5.0||||||
4008024|NCT01203826|3828545|B3||Female|Sex: Female, Male|n %|Participants|Count of Participants|2|2.0||||||
4008025|NCT01203826|3828546|B2||Female|Sex: Female, Male|n %|Participants|Count of Participants|1|1.0||||||
4008026|NCT01203826|3828547|B1||Female|Sex: Female, Male|n %|Participants|Count of Participants|1|1.0||||||
4008027|NCT01203826|3828545|B3|Age Group at Enrollment: 12 to 17 Years; %||Age, Customized|n %|Participants|Count of Participants|2|2.0||||||
4008028|NCT01203826|3828546|B2|Age Group at Enrollment: 12 to 17 Years; %||Age, Customized|n %|Participants|Count of Participants|1|1.0||||||
4008029|NCT01203826|3828547|B1|Age Group at Enrollment: 12 to 17 Years; %||Age, Customized|n %|Participants|Count of Participants|1|1.0||||||
4008030|NCT01203826|3828545|B3|Age Group at Enrollment: 2 to 11 Years; %||Age, Customized|n %|Participants|Count of Participants|10|10.0||||||
4008031|NCT01203826|3828546|B2|Age Group at Enrollment: 2 to 11 Years; %||Age, Customized|n %|Participants|Count of Participants|5|5.0||||||
4008032|NCT01203826|3828547|B1|Age Group at Enrollment: 2 to 11 Years; %||Age, Customized|n %|Participants|Count of Participants|5|5.0||||||
4008033|NCT01203826|3828545|B3|||Age|Age at Enrollment|years|Mean|8.7|8.7|Standard Deviation|2.27|2.27|||
4008034|NCT01203826|3828546|B2|||Age|Age at Enrollment|years|Mean|9.0|9.0|Standard Deviation|2.51|2.51|||
4008035|NCT01203826|3828547|B1|||Age|Age at Enrollment|years|Mean|8.4|8.4|Standard Deviation|2.21|2.21|||
4008036|NCT01203787|3828554|B3|United States||Region of Enrollment||participants|Number|120|120.0||||||
4008037|NCT01203787|3828555|B2|United States||Region of Enrollment||participants|Number|57|57.0||||||
4008038|NCT01203787|3828556|B1|United States||Region of Enrollment||participants|Number|63|63.0||||||
4008039|NCT01203787|3828554|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4008040|NCT01203787|3828555|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4008041|NCT01203787|3828556|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4008042|NCT01203787|3828554|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4008043|NCT01203787|3828555|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4008044|NCT01203787|3828556|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4008045|NCT01203787|3828554|B3|||Age||years|Mean|62.7|62.7|Standard Deviation|7.2|7.2|||
4008046|NCT01203787|3828555|B2|||Age||years|Mean|63.5|63.5|Standard Deviation|7.5|7.5|||
4008047|NCT01203787|3828556|B1|||Age||years|Mean|62.0|62.0|Standard Deviation|6.8|6.8|||
4008048|NCT01203787|3828554|B3||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
4008049|NCT01203787|3828555|B2||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4008050|NCT01203787|3828556|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4008051|NCT01203787|3828554|B3||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
4008052|NCT01203787|3828555|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4008053|NCT01203787|3828556|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4008054|NCT01203787|3828554|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4008055|NCT01203787|3828555|B2||<=18 years|Age||Participants|Count of Participants|00|0.0||||||
4008056|NCT01203787|3828556|B1||<=18 years|Age||Participants|Count of Participants|00|0.0||||||
4008057|NCT01203644|3828575|B3|Netherlands||Region of Enrollment||participants|Number|10|10.0||||||
4008058|NCT01203644|3828576|B2|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
4008059|NCT01203644|3828577|B1|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
4008060|NCT01203644|3828575|B3|United Kingdom||Region of Enrollment||participants|Number|16|16.0||||||
4008061|NCT01203644|3828576|B2|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
4008062|NCT01203644|3828577|B1|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4008063|NCT01203644|3828575|B3|Australia||Region of Enrollment||participants|Number|42|42.0||||||
4008064|NCT01203644|3828576|B2|Australia||Region of Enrollment||participants|Number|26|26.0||||||
4008065|NCT01203644|3828577|B1|Australia||Region of Enrollment||participants|Number|16|16.0||||||
4008066|NCT01203644|3828575|B3|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
4008067|NCT01203644|3828576|B2|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
4008068|NCT01203644|3828577|B1|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
4008069|NCT01203644|3828575|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4008070|NCT01203644|3828576|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4008071|NCT01203644|3828577|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4008072|NCT01203644|3828575|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4008073|NCT01203644|3828576|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4008074|NCT01203644|3828577|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4008075|NCT01203644|3828575|B3|||Age||years|Mean|53.8|53.8|Standard Deviation|14.5|14.5|||
4008076|NCT01203644|3828576|B2|||Age||years|Mean|55.1|55.1|Standard Deviation|16|16.0|||
4008077|NCT01203644|3828577|B1|||Age||years|Mean|51.3|51.3|Standard Deviation|12.6|12.6|||
4008078|NCT01203644|3828575|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4008079|NCT01203644|3828576|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4008080|NCT01203644|3828577|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4008081|NCT01203644|3828575|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4008082|NCT01203644|3828576|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4008083|NCT01203644|3828577|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4008084|NCT01203644|3828575|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4008085|NCT01203644|3828576|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4008086|NCT01203644|3828577|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4008087|NCT01203319|3828587|B4||Male|Sex: Female, Male||Participants|Count of Participants|530|530.0||||||
4008088|NCT01203319|3828588|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4008089|NCT01203319|3828589|B2||Male|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
4008090|NCT01203319|3828590|B1||Male|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4008091|NCT01203319|3828587|B4||Female|Sex: Female, Male||Participants|Count of Participants|561|561.0||||||
4008092|NCT01203319|3828588|B3||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4008093|NCT01203319|3828589|B2||Female|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
4008094|NCT01203319|3828590|B1||Female|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
4008095|NCT01203319|3828587|B4|||Age||years|Mean|43.0|43.0|Full Range|||16.0|60.0|
4008096|NCT01203319|3828588|B3|||Age||years|Mean|42.6|42.6|Full Range|||16.0|60.0|
4008097|NCT01203319|3828589|B2|||Age||years|Mean|43.3|43.3|Full Range|||16.0|60.0|
4008098|NCT01203319|3828590|B1|||Age||years|Mean|42.7|42.7|Full Range|||16.0|60.0|
4008099|NCT01203189|3828606|B4|United States||Region of Enrollment||participants|Number|23|23.0||||||
4008100|NCT01203189|3828607|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4008101|NCT01203189|3828608|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4008102|NCT01203189|3828609|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4008103|NCT01203189|3828606|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4008104|NCT01203189|3828607|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4008105|NCT01203189|3828608|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4008106|NCT01203189|3828609|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4008107|NCT01203189|3828606|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4008108|NCT01203189|3828607|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4008109|NCT01203189|3828608|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4008110|NCT01203189|3828609|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4008111|NCT01203189|3828606|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4008112|NCT01203189|3828607|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4008113|NCT01203189|3828608|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4008114|NCT01203189|3828609|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4008115|NCT01203189|3828606|B4||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4008116|NCT01203189|3828607|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4008117|NCT01203189|3828608|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4008118|NCT01203189|3828609|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4008119|NCT01203189|3828606|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4008120|NCT01203189|3828607|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4008121|NCT01203189|3828608|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4008122|NCT01203189|3828609|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4008123|NCT01203098|3828625|B4|Japan||Region of Enrollment||participants|Number|215|215.0||||||
4008124|NCT01203098|3828626|B3|Japan||Region of Enrollment||participants|Number|70|70.0||||||
4008125|NCT01203098|3828627|B2|Japan||Region of Enrollment||participants|Number|70|70.0||||||
4008126|NCT01203098|3828628|B1|Japan||Region of Enrollment||participants|Number|75|75.0||||||
4008127|NCT01203098|3828625|B4|Taiwan||Region of Enrollment||participants|Number|9|9.0||||||
4008128|NCT01203098|3828626|B3|Taiwan||Region of Enrollment||participants|Number|4|4.0||||||
4008129|NCT01203098|3828627|B2|Taiwan||Region of Enrollment||participants|Number|2|2.0||||||
4008130|NCT01203098|3828628|B1|Taiwan||Region of Enrollment||participants|Number|3|3.0||||||
4008131|NCT01203098|3828625|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008132|NCT01203098|3828626|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008133|NCT01203098|3828627|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008134|NCT01203098|3828628|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008135|NCT01203098|3828625|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008136|NCT01203098|3828626|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008137|NCT01203098|3828627|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008138|NCT01203098|3828628|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008139|NCT01203098|3828625|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008140|NCT01203098|3828626|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008141|NCT01203098|3828627|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008142|NCT01203098|3828628|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008143|NCT01203098|3828625|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008144|NCT01203098|3828626|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008145|NCT01203098|3828627|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008146|NCT01203098|3828628|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008147|NCT01203098|3828625|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008148|NCT01203098|3828626|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008149|NCT01203098|3828627|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008150|NCT01203098|3828628|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008151|NCT01203098|3828625|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|224|224.0||||||
4008152|NCT01203098|3828626|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4008153|NCT01203098|3828627|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4008154|NCT01203098|3828628|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
4008155|NCT01203098|3828625|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008156|NCT01203098|3828626|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008157|NCT01203098|3828627|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008158|NCT01203098|3828628|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008159|NCT01203098|3828625|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4008160|NCT01203098|3828626|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4008161|NCT01203098|3828627|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4008162|NCT01203098|3828628|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4008163|NCT01203098|3828625|B4||Female|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4008164|NCT01203098|3828626|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4008165|NCT01203098|3828627|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4008166|NCT01203098|3828628|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4008167|NCT01203098|3828625|B4|||Age||years|Mean|60.3|60.3|Standard Deviation|10.2|10.2|||
4008168|NCT01203098|3828626|B3|||Age||years|Mean|58.9|58.9|Standard Deviation|10.7|10.7|||
4008169|NCT01203098|3828627|B2|||Age||years|Mean|60.6|60.6|Standard Deviation|9.6|9.6|||
4008170|NCT01203098|3828628|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|10.3|10.3|||
4008171|NCT01203072|3828641|B6|Japan||Region of Enrollment||participants|Number|445|445.0||||||
4008172|NCT01203072|3828642|B5|Japan||Region of Enrollment||participants|Number|89|89.0||||||
4008173|NCT01203072|3828643|B4|Japan||Region of Enrollment||participants|Number|88|88.0||||||
4008174|NCT01203072|3828644|B3|Japan||Region of Enrollment||participants|Number|88|88.0||||||
4008175|NCT01203072|3828645|B2|Japan||Region of Enrollment||participants|Number|92|92.0||||||
4008176|NCT01203072|3828646|B1|Japan||Region of Enrollment||participants|Number|88|88.0||||||
4008177|NCT01203072|3828641|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008178|NCT01203072|3828642|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008179|NCT01203072|3828643|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008180|NCT01203072|3828644|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008181|NCT01203072|3828645|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008182|NCT01203072|3828646|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008183|NCT01203072|3828641|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008184|NCT01203072|3828642|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008185|NCT01203072|3828643|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008186|NCT01203072|3828644|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008187|NCT01203072|3828645|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008188|NCT01203072|3828646|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008189|NCT01203072|3828641|B6||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008190|NCT01203072|3828642|B5||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008191|NCT01203072|3828643|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008192|NCT01203072|3828644|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008193|NCT01203072|3828645|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008194|NCT01203072|3828646|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008195|NCT01203072|3828641|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008196|NCT01203072|3828642|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008197|NCT01203072|3828643|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008198|NCT01203072|3828644|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008199|NCT01203072|3828645|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008200|NCT01203072|3828646|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008201|NCT01203072|3828641|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008202|NCT01203072|3828642|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008203|NCT01203072|3828643|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008204|NCT01203072|3828644|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008205|NCT01203072|3828645|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008206|NCT01203072|3828646|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008207|NCT01203072|3828641|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|445|445.0||||||
4008208|NCT01203072|3828642|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
4008209|NCT01203072|3828643|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
4008210|NCT01203072|3828644|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
4008211|NCT01203072|3828645|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
4008212|NCT01203072|3828646|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
4008213|NCT01203072|3828641|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008214|NCT01203072|3828642|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008215|NCT01203072|3828643|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008216|NCT01203072|3828644|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008217|NCT01203072|3828645|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008218|NCT01203072|3828646|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008219|NCT01203072|3828641|B6||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4008220|NCT01203072|3828642|B5||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4008221|NCT01203072|3828643|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4008222|NCT01203072|3828644|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4008223|NCT01203072|3828645|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4008224|NCT01203072|3828646|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4008225|NCT01203072|3828641|B6||Female|Sex: Female, Male||Participants|Count of Participants|347|347.0||||||
4008226|NCT01203072|3828642|B5||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4008227|NCT01203072|3828643|B4||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4008228|NCT01203072|3828644|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4008229|NCT01203072|3828645|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4008230|NCT01203072|3828646|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4008231|NCT01203072|3828641|B6|||Age||years|Mean|71.2|71.2|Standard Deviation|7.3|7.3|||
4008232|NCT01203072|3828642|B5|||Age||years|Mean|70.3|70.3|Standard Deviation|6.5|6.5|||
4008233|NCT01203072|3828643|B4|||Age||years|Mean|72.1|72.1|Standard Deviation|7.0|7.0|||
4008234|NCT01203072|3828644|B3|||Age||years|Mean|71.6|71.6|Standard Deviation|8.1|8.1|||
4008235|NCT01203072|3828645|B2|||Age||years|Mean|71.7|71.7|Standard Deviation|7.0|7.0|||
4008236|NCT01203072|3828646|B1|||Age||years|Mean|70.2|70.2|Standard Deviation|7.7|7.7|||
4008237|NCT01203046|3828667|B3|SW||Type of trauma|To describe the mechanism of penetrating abdominal trauma: Gun shot wound (GSW) or Stab wound (SW)|participants|Number|10|10.0||||||
4008238|NCT01203046|3828668|B2|SW||Type of trauma|To describe the mechanism of penetrating abdominal trauma: Gun shot wound (GSW) or Stab wound (SW)|participants|Number|6|6.0||||||
4008239|NCT01203046|3828669|B1|SW||Type of trauma|To describe the mechanism of penetrating abdominal trauma: Gun shot wound (GSW) or Stab wound (SW)|participants|Number|4|4.0||||||
4008240|NCT01203046|3828667|B3|GSW||Type of trauma|To describe the mechanism of penetrating abdominal trauma: Gun shot wound (GSW) or Stab wound (SW)|participants|Number|46|46.0||||||
4008241|NCT01203046|3828668|B2|GSW||Type of trauma|To describe the mechanism of penetrating abdominal trauma: Gun shot wound (GSW) or Stab wound (SW)|participants|Number|22|22.0||||||
4008242|NCT01203046|3828669|B1|GSW||Type of trauma|To describe the mechanism of penetrating abdominal trauma: Gun shot wound (GSW) or Stab wound (SW)|participants|Number|24|24.0||||||
4008243|NCT01203046|3828667|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4008244|NCT01203046|3828668|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4008245|NCT01203046|3828669|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4008246|NCT01203046|3828667|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4008247|NCT01203046|3828668|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4008248|NCT01203046|3828669|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4008249|NCT01203046|3828667|B3|||Age||years|Mean|27.3929|27.3929|Standard Deviation|9.6929|9.6929|||
4008250|NCT01203046|3828668|B2|||Age||years|Mean|28.5000|28.5|Standard Deviation|9.8639|9.8639|||
4008251|NCT01203046|3828669|B1|||Age||years|Mean|26.2857|26.2857|Standard Deviation|9.5450|9.545|||
4008252|NCT01203046|3828667|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4008253|NCT01203046|3828668|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4008254|NCT01203046|3828669|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4008255|NCT01203046|3828667|B3||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4008256|NCT01203046|3828668|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4008257|NCT01203046|3828669|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4008258|NCT01203046|3828667|B3||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4008259|NCT01203046|3828668|B2||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4008260|NCT01203046|3828669|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4008261|NCT01202994|3828678|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4008262|NCT01202994|3828678|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008263|NCT01202994|3828678|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008264|NCT01202994|3828678|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4008265|NCT01202994|3828678|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008266|NCT01202994|3828678|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008267|NCT01202994|3828678|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008268|NCT01202994|3828678|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008269|NCT01202994|3828678|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008270|NCT01202994|3828678|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4008271|NCT01202994|3828678|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008272|NCT01202994|3828678|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4008273|NCT01202994|3828678|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4008274|NCT01202994|3828678|B1||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4008275|NCT01202994|3828678|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4008276|NCT01202994|3828678|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4008277|NCT01202955|3828683|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4008278|NCT01202955|3828684|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4008279|NCT01202955|3828685|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4008280|NCT01202955|3828683|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4008281|NCT01202955|3828684|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4008282|NCT01202955|3828685|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4008283|NCT01202955|3828683|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4008284|NCT01202955|3828684|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4008285|NCT01202955|3828685|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4008286|NCT01202955|3828683|B3|||Age||years|Mean|38.63|38.63|Standard Deviation|11.45|11.45|||
4008287|NCT01202955|3828684|B2|||Age||years|Mean|40.5|40.5|Standard Deviation|11.77|11.77|||
4008288|NCT01202955|3828685|B1|||Age||years|Mean|36.55|36.55|Standard Deviation|11.41|11.41|||
4008289|NCT01202955|3828683|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4008290|NCT01202955|3828684|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4008291|NCT01202955|3828685|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4008292|NCT01202955|3828683|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4008293|NCT01202955|3828684|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4008294|NCT01202955|3828685|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4008295|NCT01202955|3828683|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4008296|NCT01202955|3828684|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4008297|NCT01202955|3828685|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4008298|NCT01202903|3828696|B3||Male|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
4008299|NCT01202903|3828697|B2||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4008300|NCT01202903|3828698|B1||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4008301|NCT01202903|3828696|B3||Female|Sex: Female, Male||Participants|Count of Participants|328|328.0||||||
4008302|NCT01202903|3828697|B2||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4008303|NCT01202903|3828698|B1||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4008304|NCT01202903|3828696|B3|65<=75 years||Age, Customized||Participants|Number|34|34.0||||||
4008305|NCT01202903|3828697|B2|65<=75 years||Age, Customized||Participants|Number|14|14.0||||||
4008306|NCT01202903|3828698|B1|65<=75 years||Age, Customized||Participants|Number|20|20.0||||||
4008307|NCT01202903|3828696|B3|18-<65 years||Age, Customized||Participants|Number|575|575.0||||||
4008308|NCT01202903|3828697|B2|18-<65 years||Age, Customized||Participants|Number|285|285.0||||||
4008309|NCT01202903|3828698|B1|18-<65 years||Age, Customized||Participants|Number|290|290.0||||||
4008310|NCT01202903|3828696|B3|||Age||Years|Mean|46.5|46.5|Standard Deviation|11.85|11.85|||
4008311|NCT01202903|3828697|B2|||Age||Years|Mean|47.1|47.1|Standard Deviation|11.64|11.64|||
4008312|NCT01202903|3828698|B1|||Age||Years|Mean|45.8|45.8|Standard Deviation|12.03|12.03|||
4008313|NCT01202877|3828723|B4|United States||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
4008314|NCT01202877|3828724|B3|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
4008315|NCT01202877|3828725|B2|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4008316|NCT01202877|3828726|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4008317|NCT01202877|3828723|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4008318|NCT01202877|3828724|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4008319|NCT01202877|3828725|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4008320|NCT01202877|3828726|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4008321|NCT01202877|3828723|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4008322|NCT01202877|3828724|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4008323|NCT01202877|3828725|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4008324|NCT01202877|3828726|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4008325|NCT01202877|3828723|B4|||Age||years|Median|65|65.0|Full Range|||21.0|85.0|
4008326|NCT01202877|3828724|B3|||Age||years|Median|67|67.0|Full Range|||21.0|83.0|
4008327|NCT01202877|3828725|B2|||Age||years|Median|62|62.0|Full Range|||38.0|85.0|
4008328|NCT01202877|3828726|B1|||Age||years|Median|60|60.0|Full Range|||40.0|68.0|
4008329|NCT01202773|3828739|B4|South Korea||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4008330|NCT01202773|3828740|B3|South Korea||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4008331|NCT01202773|3828741|B2|South Korea||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4008332|NCT01202773|3828742|B1|South Korea||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4008333|NCT01202773|3828739|B4|Japan||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4008334|NCT01202773|3828740|B3|Japan||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4008335|NCT01202773|3828741|B2|Japan||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4008336|NCT01202773|3828742|B1|Japan||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4008337|NCT01202773|3828739|B4|New Zealand||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4008338|NCT01202773|3828740|B3|New Zealand||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4008339|NCT01202773|3828741|B2|New Zealand||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4008340|NCT01202773|3828742|B1|New Zealand||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4008341|NCT01202773|3828739|B4|Germany||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4008342|NCT01202773|3828740|B3|Germany||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4008343|NCT01202773|3828741|B2|Germany||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4008344|NCT01202773|3828742|B1|Germany||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4008345|NCT01202773|3828739|B4|South Africa||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4008346|NCT01202773|3828740|B3|South Africa||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4008347|NCT01202773|3828741|B2|South Africa||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4008348|NCT01202773|3828742|B1|South Africa||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4008349|NCT01202773|3828739|B4|Australia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4008350|NCT01202773|3828740|B3|Australia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4008351|NCT01202773|3828741|B2|Australia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4008352|NCT01202773|3828742|B1|Australia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4008353|NCT01202773|3828739|B4|Poland||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
4008354|NCT01202773|3828740|B3|Poland||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4008355|NCT01202773|3828741|B2|Poland||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4008356|NCT01202773|3828742|B1|Poland||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4008357|NCT01202773|3828739|B4|Brazil||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
4008358|NCT01202773|3828740|B3|Brazil||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4008359|NCT01202773|3828741|B2|Brazil||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4008360|NCT01202773|3828742|B1|Brazil||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4008361|NCT01202773|3828739|B4|Malaysia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4008362|NCT01202773|3828740|B3|Malaysia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4008363|NCT01202773|3828741|B2|Malaysia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4008364|NCT01202773|3828742|B1|Malaysia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4008365|NCT01202773|3828739|B4|Argentina||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4008366|NCT01202773|3828740|B3|Argentina||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4008367|NCT01202773|3828741|B2|Argentina||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4008368|NCT01202773|3828742|B1|Argentina||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4008369|NCT01202773|3828739|B4|Mexico||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4008370|NCT01202773|3828740|B3|Mexico||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4008371|NCT01202773|3828741|B2|Mexico||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4008372|NCT01202773|3828742|B1|Mexico||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4008373|NCT01202773|3828739|B4|France||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4008374|NCT01202773|3828740|B3|France||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4008375|NCT01202773|3828741|B2|France||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4008376|NCT01202773|3828742|B1|France||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4008377|NCT01202773|3828739|B4|Colombia||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
4008378|NCT01202773|3828740|B3|Colombia||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4008379|NCT01202773|3828741|B2|Colombia||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4008380|NCT01202773|3828742|B1|Colombia||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4008381|NCT01202773|3828739|B4|Russia||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4008382|NCT01202773|3828740|B3|Russia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4008383|NCT01202773|3828741|B2|Russia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4008384|NCT01202773|3828742|B1|Russia||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4008385|NCT01202773|3828739|B4|Spain||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4008386|NCT01202773|3828740|B3|Spain||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4008387|NCT01202773|3828741|B2|Spain||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4008388|NCT01202773|3828742|B1|Spain||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4008389|NCT01202773|3828739|B4|Greece||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4008390|NCT01202773|3828740|B3|Greece||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4008391|NCT01202773|3828741|B2|Greece||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4008392|NCT01202773|3828742|B1|Greece||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4008393|NCT01202773|3828739|B4|Taiwan||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4008394|NCT01202773|3828740|B3|Taiwan||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4008395|NCT01202773|3828741|B2|Taiwan||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4008396|NCT01202773|3828742|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4008397|NCT01202773|3828739|B4|United States||Region of Enrollment||Participants|Count of Participants|268|268.0||||||
4008398|NCT01202773|3828740|B3|United States||Region of Enrollment||Participants|Count of Participants|89|89.0||||||
4008399|NCT01202773|3828741|B2|United States||Region of Enrollment||Participants|Count of Participants|90|90.0||||||
4008400|NCT01202773|3828742|B1|United States||Region of Enrollment||Participants|Count of Participants|89|89.0||||||
4008401|NCT01202773|3828739|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4008402|NCT01202773|3828740|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4008403|NCT01202773|3828741|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4008404|NCT01202773|3828742|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4008405|NCT01202773|3828739|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4008406|NCT01202773|3828740|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4008407|NCT01202773|3828741|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4008408|NCT01202773|3828742|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008409|NCT01202773|3828739|B4||White|Race (NIH/OMB)||Participants|Count of Participants|339|339.0||||||
4008410|NCT01202773|3828740|B3||White|Race (NIH/OMB)||Participants|Count of Participants|112|112.0||||||
4008411|NCT01202773|3828741|B2||White|Race (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
4008412|NCT01202773|3828742|B1||White|Race (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
4008413|NCT01202773|3828739|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4008414|NCT01202773|3828740|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4008415|NCT01202773|3828741|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4008416|NCT01202773|3828742|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4008417|NCT01202773|3828739|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008418|NCT01202773|3828740|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008419|NCT01202773|3828741|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008420|NCT01202773|3828742|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008421|NCT01202773|3828739|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4008422|NCT01202773|3828740|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4008423|NCT01202773|3828741|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4008424|NCT01202773|3828742|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4008425|NCT01202773|3828739|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4008426|NCT01202773|3828740|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4008427|NCT01202773|3828741|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4008428|NCT01202773|3828742|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4008429|NCT01202773|3828739|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4008430|NCT01202773|3828740|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4008431|NCT01202773|3828741|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4008432|NCT01202773|3828742|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4008433|NCT01202773|3828739|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|289|289.0||||||
4008434|NCT01202773|3828740|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
4008435|NCT01202773|3828741|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
4008436|NCT01202773|3828742|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
4008437|NCT01202773|3828739|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
4008438|NCT01202773|3828740|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4008439|NCT01202773|3828741|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4008440|NCT01202773|3828742|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4008441|NCT01202773|3828739|B4||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4008442|NCT01202773|3828740|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4008443|NCT01202773|3828741|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4008444|NCT01202773|3828742|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4008445|NCT01202773|3828739|B4||Female|Sex: Female, Male||Participants|Count of Participants|381|381.0||||||
4008446|NCT01202773|3828740|B3||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4008447|NCT01202773|3828741|B2||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4008448|NCT01202773|3828742|B1||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4008449|NCT01202773|3828739|B4|||Age||years|Mean|53.2|53.2|Standard Deviation|11.5|11.5|||
4008450|NCT01202773|3828740|B3|||Age||years|Mean|54.0|54.0|Standard Deviation|11.1|11.1|||
4008451|NCT01202773|3828741|B2|||Age||years|Mean|51.3|51.3|Standard Deviation|11.7|11.7|||
4008452|NCT01202773|3828742|B1|||Age||years|Mean|54.2|54.2|Standard Deviation|11.6|11.6|||
4008453|NCT01202760|3828818|B4|||Swollen Joint Count (66 Count)|Swollen joint count is the number of swollen joints determined for each participant by examination of 66 joints. Joints were classified as either swollen or not swollen. Swelling was defined as palpable fluctuating synovitis of the joint.|joint count|Mean|14.8|14.8|Standard Deviation|11.4|11.4|||
4008454|NCT01202760|3828819|B3|||Swollen Joint Count (66 Count)|Swollen joint count is the number of swollen joints determined for each participant by examination of 66 joints. Joints were classified as either swollen or not swollen. Swelling was defined as palpable fluctuating synovitis of the joint.|joint count|Mean|14.3|14.3|Standard Deviation|10.6|10.6|||
4008455|NCT01202760|3828820|B2|||Swollen Joint Count (66 Count)|Swollen joint count is the number of swollen joints determined for each participant by examination of 66 joints. Joints were classified as either swollen or not swollen. Swelling was defined as palpable fluctuating synovitis of the joint.|joint count|Mean|15.3|15.3|Standard Deviation|11.6|11.6|||
4008456|NCT01202760|3828821|B1|||Swollen Joint Count (66 Count)|Swollen joint count is the number of swollen joints determined for each participant by examination of 66 joints. Joints were classified as either swollen or not swollen. Swelling was defined as palpable fluctuating synovitis of the joint.|joint count|Mean|14.8|14.8|Standard Deviation|11.6|11.6|||
4008457|NCT01202760|3828818|B4|||Tender Joint Count (68 Count)|Tender joint count is the number of tender and painful joints determined for each participant by examination of 68 joints. Joints were assessed by pressure and joint manipulation on physical examination. Participants were asked for pain sensations on these manipulations and watched for spontaneous pain reactions. Any positive response on pressure, movement, or both is translated into a single tender-versus-nontender dichotomy.|joint count|Mean|23.2|23.2|Standard Deviation|16.0|16.0|||
4008458|NCT01202760|3828819|B3|||Tender Joint Count (68 Count)|Tender joint count is the number of tender and painful joints determined for each participant by examination of 68 joints. Joints were assessed by pressure and joint manipulation on physical examination. Participants were asked for pain sensations on these manipulations and watched for spontaneous pain reactions. Any positive response on pressure, movement, or both is translated into a single tender-versus-nontender dichotomy.|joint count|Mean|22.8|22.8|Standard Deviation|15.2|15.2|||
4008459|NCT01202760|3828820|B2|||Tender Joint Count (68 Count)|Tender joint count is the number of tender and painful joints determined for each participant by examination of 68 joints. Joints were assessed by pressure and joint manipulation on physical examination. Participants were asked for pain sensations on these manipulations and watched for spontaneous pain reactions. Any positive response on pressure, movement, or both is translated into a single tender-versus-nontender dichotomy.|joint count|Mean|23.7|23.7|Standard Deviation|17.1|17.1|||
4008460|NCT01202760|3828821|B1|||Tender Joint Count (68 Count)|Tender joint count is the number of tender and painful joints determined for each participant by examination of 68 joints. Joints were assessed by pressure and joint manipulation on physical examination. Participants were asked for pain sensations on these manipulations and watched for spontaneous pain reactions. Any positive response on pressure, movement, or both is translated into a single tender-versus-nontender dichotomy.|joint count|Mean|22.8|22.8|Standard Deviation|15.5|15.5|||
4008461|NCT01202760|3828818|B4|Taiwan||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4008462|NCT01202760|3828819|B3|Taiwan||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4008463|NCT01202760|3828820|B2|Taiwan||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4008464|NCT01202760|3828821|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4008465|NCT01202760|3828818|B4|South Africa||Region of Enrollment||Participants|Count of Participants|94|94.0||||||
4008466|NCT01202760|3828819|B3|South Africa||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
4008467|NCT01202760|3828820|B2|South Africa||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
4008468|NCT01202760|3828821|B1|South Africa||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
4008469|NCT01202760|3828818|B4|Sri Lanka||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4008470|NCT01202760|3828819|B3|Sri Lanka||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4008471|NCT01202760|3828820|B2|Sri Lanka||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4008472|NCT01202760|3828821|B1|Sri Lanka||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4008473|NCT01202760|3828818|B4|New Zealand||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4008474|NCT01202760|3828819|B3|New Zealand||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4008475|NCT01202760|3828820|B2|New Zealand||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4008476|NCT01202760|3828821|B1|New Zealand||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4008477|NCT01202760|3828818|B4|Malaysia||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4008478|NCT01202760|3828819|B3|Malaysia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4008479|NCT01202760|3828820|B2|Malaysia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4008480|NCT01202760|3828821|B1|Malaysia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4008481|NCT01202760|3828818|B4|South Korea||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4008482|NCT01202760|3828819|B3|South Korea||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4008483|NCT01202760|3828820|B2|South Korea||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4008484|NCT01202760|3828821|B1|South Korea||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4008485|NCT01202760|3828818|B4|Japan||Region of Enrollment||Participants|Count of Participants|114|114.0||||||
4008486|NCT01202760|3828819|B3|Japan||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
4008487|NCT01202760|3828820|B2|Japan||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
4008488|NCT01202760|3828821|B1|Japan||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
4008489|NCT01202760|3828818|B4|India||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
4008490|NCT01202760|3828819|B3|India||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4008491|NCT01202760|3828820|B2|India||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4008492|NCT01202760|3828821|B1|India||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4008493|NCT01202760|3828818|B4|Australia||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4008494|NCT01202760|3828819|B3|Australia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4008495|NCT01202760|3828820|B2|Australia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4008496|NCT01202760|3828821|B1|Australia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4008497|NCT01202760|3828818|B4|Ukraine||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
4008498|NCT01202760|3828819|B3|Ukraine||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4008499|NCT01202760|3828820|B2|Ukraine||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4008500|NCT01202760|3828821|B1|Ukraine||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4008501|NCT01202760|3828818|B4|Slovakia||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4008502|NCT01202760|3828819|B3|Slovakia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4008503|NCT01202760|3828820|B2|Slovakia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4008504|NCT01202760|3828821|B1|Slovakia||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4008505|NCT01202760|3828818|B4|Russia||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
4008506|NCT01202760|3828819|B3|Russia||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4008507|NCT01202760|3828820|B2|Russia||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4008508|NCT01202760|3828821|B1|Russia||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4008509|NCT01202760|3828818|B4|Romania||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4008510|NCT01202760|3828819|B3|Romania||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4008511|NCT01202760|3828820|B2|Romania||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4008512|NCT01202760|3828821|B1|Romania||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4008513|NCT01202760|3828818|B4|Poland||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
4008514|NCT01202760|3828819|B3|Poland||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4008515|NCT01202760|3828820|B2|Poland||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4008516|NCT01202760|3828821|B1|Poland||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
4008517|NCT01202760|3828818|B4|Lithuania||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
4008518|NCT01202760|3828819|B3|Lithuania||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4008519|NCT01202760|3828820|B2|Lithuania||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4008520|NCT01202760|3828821|B1|Lithuania||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4008521|NCT01202760|3828818|B4|Hungary||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
4008522|NCT01202760|3828819|B3|Hungary||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4008523|NCT01202760|3828820|B2|Hungary||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4008524|NCT01202760|3828821|B1|Hungary||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4008525|NCT01202760|3828818|B4|Croatia||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4008526|NCT01202760|3828819|B3|Croatia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4008527|NCT01202760|3828820|B2|Croatia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4008528|NCT01202760|3828821|B1|Croatia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4008529|NCT01202760|3828818|B4|Bulgaria||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
4008530|NCT01202760|3828819|B3|Bulgaria||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4008531|NCT01202760|3828820|B2|Bulgaria||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4008532|NCT01202760|3828821|B1|Bulgaria||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4008533|NCT01202760|3828818|B4|Mexico||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
4008534|NCT01202760|3828819|B3|Mexico||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4008535|NCT01202760|3828820|B2|Mexico||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4008536|NCT01202760|3828821|B1|Mexico||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4008537|NCT01202760|3828818|B4|Colombia||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4008538|NCT01202760|3828819|B3|Colombia||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4008539|NCT01202760|3828820|B2|Colombia||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4008540|NCT01202760|3828821|B1|Colombia||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4008541|NCT01202760|3828818|B4|Argentina||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4008542|NCT01202760|3828819|B3|Argentina||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4008543|NCT01202760|3828820|B2|Argentina||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4008544|NCT01202760|3828821|B1|Argentina||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4008545|NCT01202760|3828818|B4|United States||Region of Enrollment||Participants|Count of Participants|334|334.0||||||
4008546|NCT01202760|3828819|B3|United States||Region of Enrollment||Participants|Count of Participants|83|83.0||||||
4008547|NCT01202760|3828820|B2|United States||Region of Enrollment||Participants|Count of Participants|125|125.0||||||
4008548|NCT01202760|3828821|B1|United States||Region of Enrollment||Participants|Count of Participants|126|126.0||||||
4008549|NCT01202760|3828818|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4008550|NCT01202760|3828819|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4008551|NCT01202760|3828820|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4008552|NCT01202760|3828821|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4008553|NCT01202760|3828818|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4008554|NCT01202760|3828819|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4008555|NCT01202760|3828820|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4008556|NCT01202760|3828821|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4008557|NCT01202760|3828818|B4||White|Race (NIH/OMB)||Participants|Count of Participants|651|651.0||||||
4008558|NCT01202760|3828819|B3||White|Race (NIH/OMB)||Participants|Count of Participants|162|162.0||||||
4008559|NCT01202760|3828820|B2||White|Race (NIH/OMB)||Participants|Count of Participants|235|235.0||||||
4008560|NCT01202760|3828821|B1||White|Race (NIH/OMB)||Participants|Count of Participants|254|254.0||||||
4008561|NCT01202760|3828818|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4008562|NCT01202760|3828819|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4008563|NCT01202760|3828820|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4008564|NCT01202760|3828821|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4008565|NCT01202760|3828818|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4008566|NCT01202760|3828819|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008567|NCT01202760|3828820|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4008568|NCT01202760|3828821|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4008569|NCT01202760|3828818|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|248|248.0||||||
4008570|NCT01202760|3828819|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4008571|NCT01202760|3828820|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
4008572|NCT01202760|3828821|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4008573|NCT01202760|3828818|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4008574|NCT01202760|3828819|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4008575|NCT01202760|3828820|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4008576|NCT01202760|3828821|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4008577|NCT01202760|3828818|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|384|384.0||||||
4008578|NCT01202760|3828819|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
4008579|NCT01202760|3828820|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|142|142.0||||||
4008580|NCT01202760|3828821|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|148|148.0||||||
4008581|NCT01202760|3828818|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|511|511.0||||||
4008582|NCT01202760|3828819|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|133|133.0||||||
4008583|NCT01202760|3828820|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|185|185.0||||||
4008584|NCT01202760|3828821|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|193|193.0||||||
4008585|NCT01202760|3828818|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|109|109.0||||||
4008586|NCT01202760|3828819|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4008587|NCT01202760|3828820|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4008588|NCT01202760|3828821|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4008589|NCT01202760|3828818|B4||Male|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4008590|NCT01202760|3828819|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4008591|NCT01202760|3828820|B2||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4008592|NCT01202760|3828821|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4008593|NCT01202760|3828818|B4||Female|Sex: Female, Male||Participants|Count of Participants|797|797.0||||||
4008594|NCT01202760|3828819|B3||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4008595|NCT01202760|3828820|B2||Female|Sex: Female, Male||Participants|Count of Participants|295|295.0||||||
4008596|NCT01202760|3828821|B1||Female|Sex: Female, Male||Participants|Count of Participants|293|293.0||||||
4008597|NCT01202760|3828818|B4|||Age||years|Mean|51.4|51.4|Standard Deviation|11.8|11.8|||
4008598|NCT01202760|3828819|B3|||Age||years|Mean|51.0|51.0|Standard Deviation|12.0|12.0|||
4008599|NCT01202760|3828820|B2|||Age||years|Mean|50.6|50.6|Standard Deviation|12.2|12.2|||
4008600|NCT01202760|3828821|B1|||Age||years|Mean|52.4|52.4|Standard Deviation|11.2|11.2|||
4008601|NCT01202747|3828891|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4008602|NCT01202747|3828891|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4008603|NCT01202747|3828891|B1|||Age||years|Mean|49.8|49.8|Standard Deviation|15.9|15.9|||
4008604|NCT01202656|3828895|B3|||AntiMulerian Hormone (AMH)||ng/mL|Mean|2.03|2.03|Standard Deviation|2.26|2.26|||
4008605|NCT01202656|3828896|B2|||AntiMulerian Hormone (AMH)||ng/mL|Mean|1.99|1.99|Standard Deviation|2.38|2.38|||
4008606|NCT01202656|3828897|B1|||AntiMulerian Hormone (AMH)||ng/mL|Mean|2.07|2.07|Standard Deviation|2.17|2.17|||
4008607|NCT01202656|3828895|B3|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4008608|NCT01202656|3828896|B2|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4008609|NCT01202656|3828897|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4008610|NCT01202656|3828895|B3|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4008611|NCT01202656|3828896|B2|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4008612|NCT01202656|3828897|B1|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4008613|NCT01202656|3828895|B3|United States||Region of Enrollment||participants|Number|127|127.0||||||
4008614|NCT01202656|3828896|B2|United States||Region of Enrollment||participants|Number|61|61.0||||||
4008615|NCT01202656|3828897|B1|United States||Region of Enrollment||participants|Number|66|66.0||||||
4008616|NCT01202656|3828895|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008617|NCT01202656|3828896|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008618|NCT01202656|3828897|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008619|NCT01202656|3828895|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008620|NCT01202656|3828896|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008621|NCT01202656|3828897|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008622|NCT01202656|3828895|B3||White|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4008623|NCT01202656|3828896|B2||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4008624|NCT01202656|3828897|B1||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4008625|NCT01202656|3828895|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4008626|NCT01202656|3828896|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4008627|NCT01202656|3828897|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4008628|NCT01202656|3828895|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008629|NCT01202656|3828896|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008630|NCT01202656|3828897|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008631|NCT01202656|3828895|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4008632|NCT01202656|3828896|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4008633|NCT01202656|3828897|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4008634|NCT01202656|3828895|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008635|NCT01202656|3828896|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008636|NCT01202656|3828897|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008637|NCT01202656|3828895|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4008638|NCT01202656|3828896|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4008639|NCT01202656|3828897|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4008640|NCT01202656|3828895|B3||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4008641|NCT01202656|3828896|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4008642|NCT01202656|3828897|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4008643|NCT01202656|3828895|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4008644|NCT01202656|3828896|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4008645|NCT01202656|3828897|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4008646|NCT01202656|3828895|B3||Between 18 and 65 years|Age||Participants|Count of Participants|129|129.0||||||
4008647|NCT01202656|3828896|B2||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4008648|NCT01202656|3828897|B1||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
4008649|NCT01202656|3828895|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4008650|NCT01202656|3828896|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4008651|NCT01202656|3828897|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4008652|NCT01202643|3828906|B3|||Endometrial Thickness||mm|Mean|5.8|5.8|Standard Deviation|0.46|0.46|||
4008653|NCT01202643|3828907|B2|||Endometrial Thickness||mm|Mean|6.2|6.2|Standard Deviation|0.69|0.69|||
4008654|NCT01202643|3828908|B1|||Endometrial Thickness||mm|Mean|5.6|5.6|Standard Deviation|0.22|0.22|||
4008655|NCT01202643|3828906|B3|||FSH|Day 3 Follicle Stimulating Hormone as a measure of baseline ovarian reserve|mIU/mL|Mean|8.46|8.46|Standard Deviation|3.95|3.95|||
4008656|NCT01202643|3828907|B2|||FSH|Day 3 Follicle Stimulating Hormone as a measure of baseline ovarian reserve|mIU/mL|Mean|8.27|8.27|Standard Deviation|4.01|4.01|||
4008657|NCT01202643|3828908|B1|||FSH|Day 3 Follicle Stimulating Hormone as a measure of baseline ovarian reserve|mIU/mL|Mean|8.64|8.64|Standard Deviation|3.92|3.92|||
4008658|NCT01202643|3828906|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008659|NCT01202643|3828907|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008660|NCT01202643|3828908|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008661|NCT01202643|3828906|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008662|NCT01202643|3828907|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008663|NCT01202643|3828908|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008664|NCT01202643|3828906|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4008665|NCT01202643|3828907|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4008666|NCT01202643|3828908|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4008667|NCT01202643|3828906|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4008668|NCT01202643|3828907|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008669|NCT01202643|3828908|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4008670|NCT01202643|3828906|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008671|NCT01202643|3828907|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008672|NCT01202643|3828908|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008673|NCT01202643|3828906|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008674|NCT01202643|3828907|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008675|NCT01202643|3828908|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008676|NCT01202643|3828906|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008677|NCT01202643|3828907|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008678|NCT01202643|3828908|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4008679|NCT01202643|3828906|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4008680|NCT01202643|3828907|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4008681|NCT01202643|3828908|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4008682|NCT01202643|3828906|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4008683|NCT01202643|3828907|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4008684|NCT01202643|3828908|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4008685|NCT01202643|3828906|B3|||Age||Years|Mean|39.59|39.59|Standard Deviation|5.56|5.56|||
4008686|NCT01202643|3828907|B2|||Age||Years|Mean|39.38|39.38|Standard Deviation|6.03|6.03|||
4008687|NCT01202643|3828908|B1|||Age||Years|Mean|39.79|39.79|Standard Deviation|5.13|5.13|||
4008688|NCT01202643|3828906|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4008689|NCT01202643|3828907|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4008690|NCT01202643|3828908|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4008691|NCT01202643|3828906|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4008692|NCT01202643|3828907|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4008693|NCT01202643|3828908|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4008694|NCT01202643|3828906|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4008695|NCT01202643|3828907|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4008696|NCT01202643|3828908|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4008697|NCT01202591|3828917|B7|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4008698|NCT01202591|3828918|B6|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4008699|NCT01202591|3828919|B5|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4008700|NCT01202591|3828920|B4|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4008701|NCT01202591|3828921|B3|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4008702|NCT01202591|3828922|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4008703|NCT01202591|3828923|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4008704|NCT01202591|3828917|B7|White||Race/Ethnicity, Customized||Participants|Number|38|38.0||||||
4008705|NCT01202591|3828918|B6|White||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4008706|NCT01202591|3828919|B5|White||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4008707|NCT01202591|3828920|B4|White||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4008708|NCT01202591|3828921|B3|White||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4008709|NCT01202591|3828922|B2|White||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4008710|NCT01202591|3828923|B1|White||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4008711|NCT01202591|3828917|B7|Other||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
4008712|NCT01202591|3828918|B6|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4008713|NCT01202591|3828919|B5|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4008714|NCT01202591|3828920|B4|Other||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4008715|NCT01202591|3828921|B3|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4008716|NCT01202591|3828922|B2|Other||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4008717|NCT01202591|3828923|B1|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4008718|NCT01202591|3828917|B7|Not Applicable||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4008719|NCT01202591|3828918|B6|Not Applicable||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4008720|NCT01202591|3828919|B5|Not Applicable||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4008721|NCT01202591|3828920|B4|Not Applicable||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4008722|NCT01202591|3828921|B3|Not Applicable||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4008723|NCT01202591|3828922|B2|Not Applicable||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4008724|NCT01202591|3828923|B1|Not Applicable||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4008725|NCT01202591|3828917|B7|Asian (Other Than Chinese And Japanese)||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4008726|NCT01202591|3828918|B6|Asian (Other Than Chinese And Japanese)||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4008727|NCT01202591|3828919|B5|Asian (Other Than Chinese And Japanese)||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4008728|NCT01202591|3828920|B4|Asian (Other Than Chinese And Japanese)||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4008729|NCT01202591|3828921|B3|Asian (Other Than Chinese And Japanese)||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4008730|NCT01202591|3828922|B2|Asian (Other Than Chinese And Japanese)||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4008731|NCT01202591|3828923|B1|Asian (Other Than Chinese And Japanese)||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4008732|NCT01202591|3828917|B7|Female||Sex/Gender, Customized||Participants|Number|40|40.0||||||
4008733|NCT01202591|3828918|B6|Female||Sex/Gender, Customized||Participants|Number|4|4.0||||||
4008734|NCT01202591|3828919|B5|Female||Sex/Gender, Customized||Participants|Number|5|5.0||||||
4008735|NCT01202591|3828920|B4|Female||Sex/Gender, Customized||Participants|Number|9|9.0||||||
4008736|NCT01202591|3828921|B3|Female||Sex/Gender, Customized||Participants|Number|12|12.0||||||
4008737|NCT01202591|3828922|B2|Female||Sex/Gender, Customized||Participants|Number|5|5.0||||||
4008738|NCT01202591|3828923|B1|Female||Sex/Gender, Customized||Participants|Number|5|5.0||||||
4008739|NCT01202591|3828917|B7|>= 65||Age, Customized||Participants|Number|22|22.0||||||
4008740|NCT01202591|3828918|B6|>= 65||Age, Customized||Participants|Number|3|3.0||||||
4008741|NCT01202591|3828919|B5|>= 65||Age, Customized||Participants|Number|1|1.0||||||
4008742|NCT01202591|3828920|B4|>= 65||Age, Customized||Participants|Number|6|6.0||||||
4008743|NCT01202591|3828921|B3|>= 65||Age, Customized||Participants|Number|8|8.0||||||
4008744|NCT01202591|3828922|B2|>= 65||Age, Customized||Participants|Number|2|2.0||||||
4008745|NCT01202591|3828923|B1|>= 65||Age, Customized||Participants|Number|2|2.0||||||
4008746|NCT01202591|3828917|B7|50 >= - <65||Age, Customized||Participants|Number|15|15.0||||||
4008747|NCT01202591|3828918|B6|50 >= - <65||Age, Customized||Participants|Number|1|1.0||||||
4008748|NCT01202591|3828919|B5|50 >= - <65||Age, Customized||Participants|Number|4|4.0||||||
4008749|NCT01202591|3828920|B4|50 >= - <65||Age, Customized||Participants|Number|3|3.0||||||
4008750|NCT01202591|3828921|B3|50 >= - <65||Age, Customized||Participants|Number|3|3.0||||||
4008751|NCT01202591|3828922|B2|50 >= - <65||Age, Customized||Participants|Number|2|2.0||||||
4008752|NCT01202591|3828923|B1|50 >= - <65||Age, Customized||Participants|Number|2|2.0||||||
4008753|NCT01202591|3828917|B7|35 >= - < 50||Age, Customized||Participants|Number|2|2.0||||||
4008754|NCT01202591|3828918|B6|35 >= - < 50||Age, Customized||Participants|Number|0|0.0||||||
4008755|NCT01202591|3828919|B5|35 >= - < 50||Age, Customized||Participants|Number|0|0.0||||||
4008756|NCT01202591|3828920|B4|35 >= - < 50||Age, Customized||Participants|Number|0|0.0||||||
4008757|NCT01202591|3828921|B3|35 >= - < 50||Age, Customized||Participants|Number|1|1.0||||||
4008758|NCT01202591|3828922|B2|35 >= - < 50||Age, Customized||Participants|Number|1|1.0||||||
4008759|NCT01202591|3828923|B1|35 >= - < 50||Age, Customized||Participants|Number|0|0.0||||||
4008760|NCT01202591|3828917|B7|< 35||Age, Customized||Participants|Number|1|1.0||||||
4008761|NCT01202591|3828918|B6|< 35||Age, Customized||Participants|Number|0|0.0||||||
4008762|NCT01202591|3828919|B5|< 35||Age, Customized||Participants|Number|0|0.0||||||
4008763|NCT01202591|3828920|B4|< 35||Age, Customized||Participants|Number|0|0.0||||||
4008764|NCT01202591|3828921|B3|< 35||Age, Customized||Participants|Number|0|0.0||||||
4008765|NCT01202591|3828922|B2|< 35||Age, Customized||Participants|Number|0|0.0||||||
4008766|NCT01202591|3828923|B1|< 35||Age, Customized||Participants|Number|1|1.0||||||
4008767|NCT01202591|3828917|B7|||Age||Years|Mean|64.6|64.6|Standard Deviation|10.58|10.58|30.0|77.0|
4008768|NCT01202591|3828918|B6|||Age||Years|Mean|67.3|67.3|Standard Deviation|9.46|9.46|||
4008769|NCT01202591|3828919|B5|||Age||Years|Mean|61.0|61.0|Standard Deviation|6.82|6.82|||
4008770|NCT01202591|3828920|B4|||Age||Years|Mean|67.3|67.3|Standard Deviation|9.66|9.66|50.0|77.0|
4008771|NCT01202591|3828921|B3|||Age||Years|Mean|66.5|66.5|Standard Deviation|8.46|8.46|49.0|77.0|
4008772|NCT01202591|3828922|B2|||Age||Years|Mean|61.2|61.2|Standard Deviation|9.36|9.36|30.0|72.0|
4008773|NCT01202591|3828923|B1|||Age||Years|Mean|58.4|58.4|Standard Deviation|16.70|16.7|49.0|74.0|
4008774|NCT01202578|3828942|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
4008775|NCT01202578|3828942|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4008776|NCT01202578|3828942|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4008777|NCT01202578|3828942|B1|>5 years||Age, Customized||participants|Number|6|6.0||||||
4008778|NCT01202578|3828942|B1|<=5 years||Age, Customized||participants|Number|47|47.0||||||
4008779|NCT01202578|3828942|B1|||Age||years|Mean|2.68|2.68|Standard Deviation|2.49|2.49|||
4008780|NCT01202565|3828949|B1|||Dermatology Life Quality Index (DLQI) Score|The DLQI questionnaire asks participants to evaluate the degree that psoriasis has affected their quality of life in the last week, and includes the following parameters: symptoms and feelings, daily activities, leisure activities, work or school activities, personal relationships and treatment related feelings. Participants answer 10 questions on a scale from 0 (not at all) to 3 (very much); the range of the total score is 0 (best) to 30 (worst). Baseline DLQI data were available for 459 participants.|units on a scale|Mean|20.0|20.0|Standard Deviation|6.5|6.5|||
4008781|NCT01202565|3828949|B1|||Psoriasis Area and Severity Index (PASI) Score|The Psoriasis Area and Severity Index (PASI) score is a combination of the intensity of psoriasis, assessed by the erythema (reddening), induration (plaque thickness) and desquamation (scaling) on a scale from none (0), mild (1), moderate (2), severe (3) or very severe (4), together with the percentage of the area affected, rated on a scale from 0 to 6. PASI scoring is performed at four body areas, the head, arms, trunk, and legs. The total PASI score ranges from 0 to 72. The higher the total score, the more severe the disease. PASI data were missing for 2 participants at Baseline.|units on a scale|Mean|22.0|22.0|Standard Deviation|9.7|9.7|||
4008782|NCT01202565|3828949|B1|||Psoriasis Scalp Severity Index (PSSI) Score|PSSI consists of an assessment of scalp area involved and an assessment of the 3 clinical symptoms erythema, induration and desquamation. Involved scalp area is measured on a scale from 0 (0% of scalp involved) to 6 (90-100% of scalp involved), clinical symptoms are each rated from 0 (absent) to 4 (severest possible). The total score ranges from 0 (best) to 72 (worst) and is derived from the sum of symptom scores multiplied by the score of involved scalp area. Data are reported for the Scalp Psoriasis Set (SPS), which includes participants with a Baseline PSSI value ≥ 10 (404 participants).|units on a scale|Mean|26.8|26.8|Standard Deviation|14.1|14.1|||
4008783|NCT01202565|3828949|B1|||Nail Psoriasis Severity Index (NAPSI) Score|The NAPSI grades nails for both nail matrix psoriasis and nail bed psoriasis. The sum of these two scores is the total score for that nail. In this study the 2 most affected nails on either hands or feet were evaluated for a score ranging from 0 (no nail psoriasis) to 16 (psoriasis in 4/4 nail quadrants). Data are reported for the Nail Psoriasis Set (NPS), which includes participants with a Baseline NAPSI value ≥ 10 (157 participants).|units on a scale|Mean|13.0|13.0|Standard Deviation|2.1|2.1|||
4008784|NCT01202565|3828949|B1||Male|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
4008785|NCT01202565|3828949|B1||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4008786|NCT01202565|3828949|B1|||Age||years|Mean|47.0|47.0|Standard Deviation|12.6|12.6|||
4008787|NCT01202279|3828972|B3|United States||Region of Enrollment||participants|Number|1179|1179.0||||||
4008788|NCT01202279|3828973|B2|United States||Region of Enrollment||participants|Number|588|588.0||||||
4008789|NCT01202279|3828974|B1|United States||Region of Enrollment||participants|Number|591|591.0||||||
4008790|NCT01202279|3828972|B3||Male|Sex: Female, Male||Participants|Count of Participants|380|380.0||||||
4008791|NCT01202279|3828973|B2||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4008792|NCT01202279|3828974|B1||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4008793|NCT01202279|3828972|B3||Female|Sex: Female, Male||Participants|Count of Participants|799|799.0||||||
4008794|NCT01202279|3828973|B2||Female|Sex: Female, Male||Participants|Count of Participants|404|404.0||||||
4008795|NCT01202279|3828974|B1||Female|Sex: Female, Male||Participants|Count of Participants|395|395.0||||||
4008796|NCT01202279|3828972|B3|||Age||years|Mean|38.1|38.1|Standard Deviation|13.7|13.7|||
4008797|NCT01202279|3828973|B2|||Age||years|Mean|38.8|38.8|Standard Deviation|13.7|13.7|||
4008798|NCT01202279|3828974|B1|||Age||years|Mean|37.4|37.4|Standard Deviation|13.7|13.7|||
4008799|NCT01202279|3828972|B3||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4008800|NCT01202279|3828973|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4008801|NCT01202279|3828974|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4008802|NCT01202279|3828972|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1150|1150.0||||||
4008803|NCT01202279|3828973|B2||Between 18 and 65 years|Age||Participants|Count of Participants|575|575.0||||||
4008804|NCT01202279|3828974|B1||Between 18 and 65 years|Age||Participants|Count of Participants|575|575.0||||||
4008805|NCT01202279|3828972|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4008806|NCT01202279|3828973|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4008807|NCT01202279|3828974|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4008808|NCT01202253|3828983|B1|||Duration of antiviral courses||days|Median|NA||Inter-Quartile Range|||0.0|0.0|Data was not analyzed as the study was retrospective and duration of antiviral courses was not available for the participants.
4008809|NCT01202253|3828983|B1|Valganciclovir||Percentage of participants prescribed with antiviral courses||percentage of participants|Number|20|20.0||||||
4008810|NCT01202253|3828983|B1|Oseltamivir||Percentage of participants prescribed with antiviral courses||percentage of participants|Number|2|2.0||||||
4008811|NCT01202253|3828983|B1|Ganciclovir||Percentage of participants prescribed with antiviral courses||percentage of participants|Number|6|6.0||||||
4008812|NCT01202253|3828983|B1|Aciclovir||Percentage of participants prescribed with antiviral courses||percentage of participants|Number|2|2.0||||||
4008813|NCT01202253|3828983|B1|||Duration of antibiotic course||days|Median|16.00|16.0|Inter-Quartile Range|||11.0|21.75|
4008814|NCT01202253|3828983|B1|5 antibiotics||Number of participants with concomitant antibiotics prescribed|Participants were categorized into 6 categories, 0 to 5 based on the number of concomitant antibiotics prescribed to them.|participants|Number|1|1.0||||||
4008815|NCT01202253|3828983|B1|4 antibiotics||Number of participants with concomitant antibiotics prescribed|Participants were categorized into 6 categories, 0 to 5 based on the number of concomitant antibiotics prescribed to them.|participants|Number|7|7.0||||||
4008816|NCT01202253|3828983|B1|3 antibiotics||Number of participants with concomitant antibiotics prescribed|Participants were categorized into 6 categories, 0 to 5 based on the number of concomitant antibiotics prescribed to them.|participants|Number|8|8.0||||||
4008817|NCT01202253|3828983|B1|2 antibiotics||Number of participants with concomitant antibiotics prescribed|Participants were categorized into 6 categories, 0 to 5 based on the number of concomitant antibiotics prescribed to them.|participants|Number|22|22.0||||||
4008818|NCT01202253|3828983|B1|1 antibiotic||Number of participants with concomitant antibiotics prescribed|Participants were categorized into 6 categories, 0 to 5 based on the number of concomitant antibiotics prescribed to them.|participants|Number|8|8.0||||||
4008819|NCT01202253|3828983|B1|0 antibiotic||Number of participants with concomitant antibiotics prescribed|Participants were categorized into 6 categories, 0 to 5 based on the number of concomitant antibiotics prescribed to them.|participants|Number|4|4.0||||||
4008820|NCT01202253|3828983|B1|Vancomycin||Percentage of participants prescribed with concomitant antibiotics||percentage of participants|Number|38|38.0||||||
4008821|NCT01202253|3828983|B1|Tazocin||Percentage of participants prescribed with concomitant antibiotics||percentage of participants|Number|34|34.0||||||
4008822|NCT01202253|3828983|B1|Metronidazole||Percentage of participants prescribed with concomitant antibiotics||percentage of participants|Number|4|4.0||||||
4008823|NCT01202253|3828983|B1|Linezolid||Percentage of participants prescribed with concomitant antibiotics||percentage of participants|Number|28|28.0||||||
4008824|NCT01202253|3828983|B1|Gentamicin||Percentage of participants prescribed with concomitant antibiotics||percentage of participants|Number|4|4.0||||||
4008825|NCT01202253|3828983|B1|Erythromycin||Percentage of participants prescribed with concomitant antibiotics||percentage of participants|Number|4|4.0||||||
4008826|NCT01202253|3828983|B1|Co-trimoxazole||Percentage of participants prescribed with concomitant antibiotics||percentage of participants|Number|8|8.0||||||
4008827|NCT01202253|3828983|B1|Colistin||Percentage of participants prescribed with concomitant antibiotics||percentage of participants|Number|4|4.0||||||
4008828|NCT01202253|3828983|B1|Clarithromycin||Percentage of participants prescribed with concomitant antibiotics||percentage of participants|Number|2|2.0||||||
4008829|NCT01202253|3828983|B1|Ciprofloxacin||Percentage of participants prescribed with concomitant antibiotics||percentage of participants|Number|2|2.0||||||
4008830|NCT01202253|3828983|B1|Amikacin||Percentage of participants prescribed with concomitant antibiotics||percentage of participants|Number|22|22.0||||||
4008831|NCT01202253|3828983|B1|Fluconazole||Percentage of participants prescribed with concomitant systemic antifungals||percentage of participants|Number|12|12.0||||||
4008832|NCT01202253|3828983|B1|Amphotericin||Percentage of participants prescribed with concomitant systemic antifungals||percentage of participants|Number|2|2.0||||||
4008833|NCT01202253|3828983|B1|Tacrolimus or tacrolimus modified release (MR)||Percentage of participants prescribed with immunosuppressant drugs||percentage of participants|Number|50|50.0||||||
4008834|NCT01202253|3828983|B1|Prednisolone||Percentage of participants prescribed with immunosuppressant drugs||percentage of participants|Number|44|44.0||||||
4008835|NCT01202253|3828983|B1|Methylprednisolone||Percentage of participants prescribed with immunosuppressant drugs||percentage of participants|Number|2|2.0||||||
4008836|NCT01202253|3828983|B1|Ciclosporin||Percentage of participants prescribed with immunosuppressant drugs||percentage of participants|Number|2|2.0||||||
4008837|NCT01202253|3828983|B1|Azathioprine||Percentage of participants prescribed with immunosuppressant drugs||percentage of participants|Number|2|2.0||||||
4008838|NCT01202253|3828983|B1|||Percentage of participants with creatinine clearance outside normal range|Normal values for creatinine clearance for an adult are below 80 milliliter/minute (mL/min).|percentage of participants|Number|NA|||||||Data was not analyzed as the study was retrospective and data for creatinine clearance was not available for the participants.
4008839|NCT01202253|3828983|B1|Greater than 6.7 mmol/L||Number of participants with urea levels||participants|Number|34|34.0||||||
4008840|NCT01202253|3828983|B1|3.3 to 6.7 mmol/L||Number of participants with urea levels||participants|Number|15|15.0||||||
4008841|NCT01202253|3828983|B1|Less than 3.3 millimole/Liter (mmol/L)||Number of participants with urea levels||participants|Number|1|1.0||||||
4008842|NCT01202253|3828983|B1|Not done||Number of participants with C-reactive protein (CRP) levels|CRP levels were categorized either less than 5 mg/L and greater than or equal to 5 mg/L. Those participants with CRP levels not analyzed were reported under 'not done' category.|participants|Number|4|4.0||||||
4008843|NCT01202253|3828983|B1|Greater than or equal to 5 mg/L||Number of participants with C-reactive protein (CRP) levels|CRP levels were categorized either less than 5 mg/L and greater than or equal to 5 mg/L. Those participants with CRP levels not analyzed were reported under 'not done' category.|participants|Number|44|44.0||||||
4008844|NCT01202253|3828983|B1|Less than 5 mg/liter (mg/L)||Number of participants with C-reactive protein (CRP) levels|CRP levels were categorized either less than 5 mg/L and greater than or equal to 5 mg/L. Those participants with CRP levels not analyzed were reported under 'not done' category.|participants|Number|2|2.0||||||
4008845|NCT01202253|3828983|B1|Greater than 1.6||Number of participants with International Normalized Ratio (INR) results|Prothrombin time is a measure of the extrinsic pathway of coagulation that is used to determine the clotting tendency of blood. INR is the ratio of a participant's prothrombin time to a normal (control) sample.|participants|Number|18|18.0||||||
4008846|NCT01202253|3828983|B1|0.8 to 1.6||Number of participants with International Normalized Ratio (INR) results|Prothrombin time is a measure of the extrinsic pathway of coagulation that is used to determine the clotting tendency of blood. INR is the ratio of a participant's prothrombin time to a normal (control) sample.|participants|Number|32|32.0||||||
4008847|NCT01202253|3828983|B1|Less than 0.8||Number of participants with International Normalized Ratio (INR) results|Prothrombin time is a measure of the extrinsic pathway of coagulation that is used to determine the clotting tendency of blood. INR is the ratio of a participant's prothrombin time to a normal (control) sample.|participants|Number|0|0.0||||||
4008848|NCT01202253|3828983|B1|Greater than 11 * 10^9/Liter||Number of participants with total white cell count||participants|Number|39|39.0||||||
4008849|NCT01202253|3828983|B1|4 to 11 * 10^9/Liter||Number of participants with total white cell count||participants|Number|3|3.0||||||
4008850|NCT01202253|3828983|B1|Less than 4 * 10^9/Liter||Number of participants with total white cell count||participants|Number|8|8.0||||||
4008851|NCT01202253|3828983|B1|||Number of participants with disease severity score|Disease severity score was based on acute physiological assessment and chronic health evaluation (APACHE), used for assessing severity of illness in acutely ill participants in intensive care units (ICUs). Total possible score range: 0 to 71 where higher score represented higher predicted mortality.|participants|Number|NA|||||||Data was not analyzed as the study was retrospective and disease severity score was not available for the participants.
4008852|NCT01202253|3828983|B1|Greater than or equal to 40||Percentage of participants with Model for End-Stage Liver Disease (MELD) score|MELD is a scoring system for assessing the severity of chronic liver disease. MELD uses the participant's values for serum bilirubin, serum creatinine, and the INR for prothrombin time to predict survival. In interpreting the MELD score in hospitalized participants, the 3 month mortality is: greater than or equal to 40 - 71.3% mortality; 30-39 - 52.6% mortality; 20-29 - 19.6% mortality; 10-19 - 6.0% mortality; less than 10 — 1.9% mortality.|percentage of participants|Number|7|7.0||||||
4008853|NCT01202253|3828983|B1|30 to 39||Percentage of participants with Model for End-Stage Liver Disease (MELD) score|MELD is a scoring system for assessing the severity of chronic liver disease. MELD uses the participant's values for serum bilirubin, serum creatinine, and the INR for prothrombin time to predict survival. In interpreting the MELD score in hospitalized participants, the 3 month mortality is: greater than or equal to 40 - 71.3% mortality; 30-39 - 52.6% mortality; 20-29 - 19.6% mortality; 10-19 - 6.0% mortality; less than 10 — 1.9% mortality.|percentage of participants|Number|37|37.0||||||
4008854|NCT01202253|3828983|B1|20 to 29||Percentage of participants with Model for End-Stage Liver Disease (MELD) score|MELD is a scoring system for assessing the severity of chronic liver disease. MELD uses the participant's values for serum bilirubin, serum creatinine, and the INR for prothrombin time to predict survival. In interpreting the MELD score in hospitalized participants, the 3 month mortality is: greater than or equal to 40 - 71.3% mortality; 30-39 - 52.6% mortality; 20-29 - 19.6% mortality; 10-19 - 6.0% mortality; less than 10 — 1.9% mortality.|percentage of participants|Number|37|37.0||||||
4008855|NCT01202253|3828983|B1|10 to 19||Percentage of participants with Model for End-Stage Liver Disease (MELD) score|MELD is a scoring system for assessing the severity of chronic liver disease. MELD uses the participant's values for serum bilirubin, serum creatinine, and the INR for prothrombin time to predict survival. In interpreting the MELD score in hospitalized participants, the 3 month mortality is: greater than or equal to 40 - 71.3% mortality; 30-39 - 52.6% mortality; 20-29 - 19.6% mortality; 10-19 - 6.0% mortality; less than 10 — 1.9% mortality.|percentage of participants|Number|13|13.0||||||
4008856|NCT01202253|3828983|B1|Less than 10||Percentage of participants with Model for End-Stage Liver Disease (MELD) score|MELD is a scoring system for assessing the severity of chronic liver disease. MELD uses the participant's values for serum bilirubin, serum creatinine, and the INR for prothrombin time to predict survival. In interpreting the MELD score in hospitalized participants, the 3 month mortality is: greater than or equal to 40 - 71.3% mortality; 30-39 - 52.6% mortality; 20-29 - 19.6% mortality; 10-19 - 6.0% mortality; less than 10 — 1.9% mortality.|percentage of participants|Number|7|7.0||||||
4008857|NCT01202253|3828983|B1|Renal failure||Number of participants with markers of illness severity||participants|Number|31|31.0||||||
4008858|NCT01202253|3828983|B1|Major surgery||Number of participants with markers of illness severity||participants|Number|37|37.0||||||
4008859|NCT01202253|3828983|B1|Intubated on admission||Number of participants with markers of illness severity||participants|Number|15|15.0||||||
4008860|NCT01202253|3828983|B1|Total parenteral nutrition||Number of participants with markers of illness severity||participants|Number|26|26.0||||||
4008861|NCT01202253|3828983|B1|Central line of admission||Number of participants with markers of illness severity||participants|Number|25|25.0||||||
4008862|NCT01202253|3828983|B1|Upper gastrointestinal (GI) bleed||Number of participants with markers of illness severity||participants|Number|21|21.0||||||
4008863|NCT01202253|3828983|B1|Other||Number of participants with relevant co-morbidities|Other co-morbidities included renal failure or impairment, multi-organ failure, previous liver transplants, liver abscess and hepatic artery thrombosis.|participants|Number|37|37.0||||||
4008864|NCT01202253|3828983|B1|Malignancy||Number of participants with relevant co-morbidities|Other co-morbidities included renal failure or impairment, multi-organ failure, previous liver transplants, liver abscess and hepatic artery thrombosis.|participants|Number|12|12.0||||||
4008865|NCT01202253|3828983|B1|Hepatitis C||Number of participants with relevant co-morbidities|Other co-morbidities included renal failure or impairment, multi-organ failure, previous liver transplants, liver abscess and hepatic artery thrombosis.|participants|Number|5|5.0||||||
4008866|NCT01202253|3828983|B1|Diabetes||Number of participants with relevant co-morbidities|Other co-morbidities included renal failure or impairment, multi-organ failure, previous liver transplants, liver abscess and hepatic artery thrombosis.|participants|Number|18|18.0||||||
4008867|NCT01202253|3828983|B1|History of alcohol abuse||Number of participants with relevant co-morbidities|Other co-morbidities included renal failure or impairment, multi-organ failure, previous liver transplants, liver abscess and hepatic artery thrombosis.|participants|Number|19|19.0||||||
4008868|NCT01202253|3828983|B1|Liver laceration||Number of participants with underlying liver disease||participants|Number|1|1.0||||||
4008869|NCT01202253|3828983|B1|Liver transplant, chronic disease, pancreatitis||Number of participants with underlying liver disease||participants|Number|1|1.0||||||
4008870|NCT01202253|3828983|B1|Liver transplant, chronic disease, acute failure||Number of participants with underlying liver disease||participants|Number|1|1.0||||||
4008871|NCT01202253|3828983|B1|Liver transplant, chronic liver disease||Number of participants with underlying liver disease||participants|Number|11|11.0||||||
4008872|NCT01202253|3828983|B1|Liver transplant, acute liver disease, failure||Number of participants with underlying liver disease||participants|Number|1|1.0||||||
4008873|NCT01202253|3828983|B1|Liver transplant, acute liver failure||Number of participants with underlying liver disease||participants|Number|1|1.0||||||
4008874|NCT01202253|3828983|B1|Liver transplant, acute liver disease||Number of participants with underlying liver disease||participants|Number|3|3.0||||||
4008875|NCT01202253|3828983|B1|Liver transplant||Number of participants with underlying liver disease||participants|Number|4|4.0||||||
4008876|NCT01202253|3828983|B1|Hepatopancreaticobiliary disease, pancreatitis||Number of participants with underlying liver disease||participants|Number|3|3.0||||||
4008877|NCT01202253|3828983|B1|Hepatopancreaticobiliary disease||Number of participants with underlying liver disease||participants|Number|12|12.0||||||
4008878|NCT01202253|3828983|B1|Chronic and acute liver disease||Number of participants with underlying liver disease||participants|Number|3|3.0||||||
4008879|NCT01202253|3828983|B1|Chronic liver disease||Number of participants with underlying liver disease||participants|Number|8|8.0||||||
4008880|NCT01202253|3828983|B1|Acute liver disease||Number of participants with underlying liver disease||participants|Number|1|1.0||||||
4008881|NCT01202253|3828983|B1|||Overall duration of hospital stay||days|Mean|86.46|86.46|Inter-Quartile Range|||50.0|99.5|
4008882|NCT01202253|3828983|B1|Emergency admission||Percentage of participants with elective or emergency hospital admission||percentage of participants|Number|28|28.0||||||
4008883|NCT01202253|3828983|B1|Elective admission||Percentage of participants with elective or emergency hospital admission||percentage of participants|Number|72|72.0||||||
4008884|NCT01202253|3828983|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4008885|NCT01202253|3828983|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4008886|NCT01202253|3828983|B1|||Age, Customized||years|Mean|50.5|50.5|Inter-Quartile Range|16.4|16.4|36.4|63.5|
4008887|NCT01202227|3829027|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4008888|NCT01202227|3829027|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4008889|NCT01202227|3829027|B1|>=65 years||Age, Customized||Participants|Number|28|28.0||||||
4008890|NCT01202227|3829027|B1|>= 45 and <65 years||Age, Customized||Participants|Number|60|60.0||||||
4008891|NCT01202227|3829027|B1|>=18 and <45 years||Age, Customized||Participants|Number|15|15.0||||||
4008892|NCT01202188|3829046|B6||Male|Sex: Female, Male||Participants|Count of Participants|1610|1610.0||||||
4008893|NCT01202188|3829047|B5||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4008894|NCT01202188|3829048|B4||Male|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
4008895|NCT01202188|3829049|B3||Male|Sex: Female, Male||Participants|Count of Participants|365|365.0||||||
4008896|NCT01202188|3829050|B2||Male|Sex: Female, Male||Participants|Count of Participants|354|354.0||||||
4008897|NCT01202188|3829051|B1||Male|Sex: Female, Male||Participants|Count of Participants|362|362.0||||||
4008898|NCT01202188|3829046|B6||Female|Sex: Female, Male||Participants|Count of Participants|525|525.0||||||
4008899|NCT01202188|3829047|B5||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4008900|NCT01202188|3829048|B4||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4008901|NCT01202188|3829049|B3||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4008902|NCT01202188|3829050|B2||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4008903|NCT01202188|3829051|B1||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4008904|NCT01202188|3829046|B6|||Age||years|Mean|63.9|63.9|Standard Deviation|8.83|8.83|||
4008905|NCT01202188|3829047|B5|||Age||years|Mean|64.4|64.4|Standard Deviation|8.58|8.58|||
4008906|NCT01202188|3829048|B4|||Age||years|Mean|63.5|63.5|Standard Deviation|8.73|8.73|||
4008907|NCT01202188|3829049|B3|||Age||years|Mean|64.3|64.3|Standard Deviation|9.04|9.04|||
4008908|NCT01202188|3829050|B2|||Age||years|Mean|63.6|63.6|Standard Deviation|8.78|8.78|||
4008909|NCT01202188|3829051|B1|||Age||years|Mean|64.0|64.0|Standard Deviation|8.88|8.88|||
4008910|NCT01202162|3829161|B3|United States||Region of Enrollment||participants|Number|85|85.0||||||
4008911|NCT01202162|3829162|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
4008912|NCT01202162|3829163|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4008913|NCT01202162|3829161|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4008914|NCT01202162|3829162|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4008915|NCT01202162|3829163|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4008916|NCT01202162|3829161|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4008917|NCT01202162|3829162|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4008918|NCT01202162|3829163|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4008919|NCT01202162|3829161|B3|||Age||years|Mean|40.6|40.6|Standard Deviation|8.1|8.1|||
4008920|NCT01202162|3829162|B2|||Age||years|Mean|39.9|39.9|Standard Deviation|7.7|7.7|||
4008921|NCT01202162|3829163|B1|||Age||years|Mean|41.2|41.2|Standard Deviation|8.3|8.3|||
4008922|NCT01202162|3829161|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4008923|NCT01202162|3829162|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4008924|NCT01202162|3829163|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4008925|NCT01202162|3829161|B3||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
4008926|NCT01202162|3829162|B2||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4008927|NCT01202162|3829163|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4008928|NCT01202162|3829161|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4008929|NCT01202162|3829162|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4008930|NCT01202162|3829163|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4008931|NCT01202110|3829174|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4008932|NCT01202110|3829174|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4008933|NCT01202110|3829174|B1|||Age||years|Mean|27.7|27.7|Standard Deviation|11.4|11.4|||
4008969|NCT01201967|3829200|B3|||Age||years|Mean|60.5|60.5|Standard Deviation|12.7|12.7|||
4008934|NCT01202071|3829179|B1|CYP2C19 Poor Metabolizers 'PM'||Baseline Percentage Duration With An Intragastric pH >= 4 During The Entire 24 Hours on Day 1|The 24-hour intragastric pH monitoring was performed before the start of administration in Period I. Data was displayed based on the participant's CYP2C19 genotype: CYP2C19-EM are extensive metabolizers who have normal metabolizing capacity. CYP2C19-PM are poor metabolizers with a metabolizing capacity deficiency or remarkably decreased metabolizing capacity.|Percentage of Time in a 24 Hour Period|Mean|9.91|9.91|Standard Deviation|8.50|8.5|||
4008935|NCT01202071|3829179|B1|CYP2C19 Extensive Metabolizers 'EM'||Baseline Percentage Duration With An Intragastric pH >= 4 During The Entire 24 Hours on Day 1|The 24-hour intragastric pH monitoring was performed before the start of administration in Period I. Data was displayed based on the participant's CYP2C19 genotype: CYP2C19-EM are extensive metabolizers who have normal metabolizing capacity. CYP2C19-PM are poor metabolizers with a metabolizing capacity deficiency or remarkably decreased metabolizing capacity.|Percentage of Time in a 24 Hour Period|Mean|12.57|12.57|Standard Deviation|7.55|7.55|||
4008936|NCT01202071|3829179|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4008937|NCT01202071|3829179|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4008938|NCT01202071|3829179|B1|||Age||years|Mean|27.7|27.7|Standard Deviation|4.5|4.5|||
4008939|NCT01201967|3829200|B3|||Euro Quality of Life-5 Domain|The Euro Quality of Life-5 Domain is a 5-item scale that assesses quality of life. Each question asks about difficulties with certain areas of health (mobility, self-care, usual activities, pain/discomfort, anxiety/depression) and offer three possible answers: No problems, Moderate problems, Extreme problems. Scores can range from 0.000-1.000, with lower scores indicating less quality of life, and higher scores indicating higher quality of life.|units on a scale|Mean|0.42|0.42|Standard Deviation|0.34|0.34|||
4008940|NCT01201967|3829201|B2|||Euro Quality of Life-5 Domain|The Euro Quality of Life-5 Domain is a 5-item scale that assesses quality of life. Each question asks about difficulties with certain areas of health (mobility, self-care, usual activities, pain/discomfort, anxiety/depression) and offer three possible answers: No problems, Moderate problems, Extreme problems. Scores can range from 0.000-1.000, with lower scores indicating less quality of life, and higher scores indicating higher quality of life.|units on a scale|Mean|0.44|0.44|Standard Deviation|0.33|0.33|||
4008941|NCT01201967|3829202|B1|||Euro Quality of Life-5 Domain|The Euro Quality of Life-5 Domain is a 5-item scale that assesses quality of life. Each question asks about difficulties with certain areas of health (mobility, self-care, usual activities, pain/discomfort, anxiety/depression) and offer three possible answers: No problems, Moderate problems, Extreme problems. Scores can range from 0.000-1.000, with lower scores indicating less quality of life, and higher scores indicating higher quality of life.|units on a scale|Mean|0.40|0.4|Standard Deviation|0.34|0.34|||
4008942|NCT01201967|3829200|B3|||SF-12 Physical Component Score|The SF-12 Physical Component Score is a 6-item scale that assesses physical health-related quality of life. Each question provides the option of 2-6 answers. Some questions are Yes/No (2 options), while others ask how often something occurs (6 options, etc.). Scores are calculated using a formula and can range from 0 to 100. A score of 50 indicates average physical health-related quality of life. Higher scores represent higher than average physical health-related quality of life, and lower scores represent lower physical health-related quality of life.|units on a scale|Mean|32.9|32.9|Standard Deviation|10.5|10.5|||
4008943|NCT01201967|3829201|B2|||SF-12 Physical Component Score|The SF-12 Physical Component Score is a 6-item scale that assesses physical health-related quality of life. Each question provides the option of 2-6 answers. Some questions are Yes/No (2 options), while others ask how often something occurs (6 options, etc.). Scores are calculated using a formula and can range from 0 to 100. A score of 50 indicates average physical health-related quality of life. Higher scores represent higher than average physical health-related quality of life, and lower scores represent lower physical health-related quality of life.|units on a scale|Mean|33.8|33.8|Standard Deviation|11.0|11.0|||
4008944|NCT01201967|3829202|B1|||SF-12 Physical Component Score|The SF-12 Physical Component Score is a 6-item scale that assesses physical health-related quality of life. Each question provides the option of 2-6 answers. Some questions are Yes/No (2 options), while others ask how often something occurs (6 options, etc.). Scores are calculated using a formula and can range from 0 to 100. A score of 50 indicates average physical health-related quality of life. Higher scores represent higher than average physical health-related quality of life, and lower scores represent lower physical health-related quality of life.|units on a scale|Mean|32.9|32.9|Standard Deviation|10.8|10.8|||
4008945|NCT01201967|3829200|B3|||SF-12 Mental Component Score|The SF-12 Mental Component Score is a 6-item scale that assesses mental health-related quality of life. Each question provides the option of 2-6 answers. Some questions are Yes/No (2 options), while others ask how often something occurs (6 options, etc.). Scores are calculated using a formula and can range from 0 to 100. A score of 50 indicates average mental health-related quality of life. Higher scores represent higher than average mental health-related quality of life, and lower scores represent lower mental health-related quality of life.|units on a scale|Mean|35.2|35.2|Standard Deviation|9.3|9.3|||
4008946|NCT01201967|3829201|B2|||SF-12 Mental Component Score|The SF-12 Mental Component Score is a 6-item scale that assesses mental health-related quality of life. Each question provides the option of 2-6 answers. Some questions are Yes/No (2 options), while others ask how often something occurs (6 options, etc.). Scores are calculated using a formula and can range from 0 to 100. A score of 50 indicates average mental health-related quality of life. Higher scores represent higher than average mental health-related quality of life, and lower scores represent lower mental health-related quality of life.|units on a scale|Mean|36.3|36.3|Standard Deviation|8.9|8.9|||
4008947|NCT01201967|3829202|B1|||SF-12 Mental Component Score|The SF-12 Mental Component Score is a 6-item scale that assesses mental health-related quality of life. Each question provides the option of 2-6 answers. Some questions are Yes/No (2 options), while others ask how often something occurs (6 options, etc.). Scores are calculated using a formula and can range from 0 to 100. A score of 50 indicates average mental health-related quality of life. Higher scores represent higher than average mental health-related quality of life, and lower scores represent lower mental health-related quality of life.|units on a scale|Mean|34.2|34.2|Standard Deviation|9.7|9.7|||
4008970|NCT01201967|3829201|B2|||Age||years|Mean|60.1|60.1|Standard Deviation|12.8|12.8|||
4008971|NCT01201967|3829202|B1|||Age||years|Mean|60.9|60.9|Standard Deviation|12.7|12.7|||
4008948|NCT01201967|3829200|B3|||Medical Outcomes Study - Specific Adherence Scale|The MOS-SAS is a 3-item scale used to assess medication adherence, physical activity adherence, and diet adherence. Each question asks how often the subject adheres to the behavior, providing the following options: 1 = None of the time, 2 = A little of the time, 3 = Some of the time, 4 = A good bit of the time, 5 = Most of the time, 6 = All of the time. Scores are totaled and range from (3 to 18). A low score indicates poorer adherence to healthy behaviors.|units on a scale|Mean|13.6|13.6|Standard Deviation|3.3|3.3|||
4008949|NCT01201967|3829201|B2|||Medical Outcomes Study - Specific Adherence Scale|The MOS-SAS is a 3-item scale used to assess medication adherence, physical activity adherence, and diet adherence. Each question asks how often the subject adheres to the behavior, providing the following options: 1 = None of the time, 2 = A little of the time, 3 = Some of the time, 4 = A good bit of the time, 5 = Most of the time, 6 = All of the time. Scores are totaled and range from (3 to 18). A low score indicates poorer adherence to healthy behaviors.|units on a scale|Mean|14.2|14.2|Standard Deviation|3.1|3.1|||
4008950|NCT01201967|3829202|B1|||Medical Outcomes Study - Specific Adherence Scale|The MOS-SAS is a 3-item scale used to assess medication adherence, physical activity adherence, and diet adherence. Each question asks how often the subject adheres to the behavior, providing the following options: 1 = None of the time, 2 = A little of the time, 3 = Some of the time, 4 = A good bit of the time, 5 = Most of the time, 6 = All of the time. Scores are totaled and range from (3 to 18). A low score indicates poorer adherence to healthy behaviors.|units on a scale|Mean|13.0|13.0|Standard Deviation|3.5|3.5|||
4008951|NCT01201967|3829200|B3|||Duke Activity Status Index|The DASI is a 12-item scale that measures physical function. Each question asks about whether the subject can complete a physical activity and are given the following options: Scores range from 0 to 58.2. Lower scores indicate lower levels of physical function.|units on a scale|Mean|20.5|20.5|Standard Deviation|16.3|16.3|||
4008952|NCT01201967|3829201|B2|||Duke Activity Status Index|The DASI is a 12-item scale that measures physical function. Each question asks about whether the subject can complete a physical activity and are given the following options: Scores range from 0 to 58.2. Lower scores indicate lower levels of physical function.|units on a scale|Mean|21.4|21.4|Standard Deviation|16.9|16.9|||
4008953|NCT01201967|3829202|B1|||Duke Activity Status Index|The DASI is a 12-item scale that measures physical function. Each question asks about whether the subject can complete a physical activity and are given the following options: Scores range from 0 to 58.2. Lower scores indicate lower levels of physical function.|units on a scale|Mean|19.7|19.7|Standard Deviation|15.8|15.8|||
4008954|NCT01201967|3829200|B3|||Hospital Anxiety and Depression Scale - Anxiety Subscale|The HADS-A is a 7-item scale used to measure anxiety severity. Each question asks about a specific symptom of anxiety and offers four answers: 0 = Never / Not at all, 1 = A little / Time to time, 2 = Quite often / Usually, 3 = Most of the time / Very often. Scores are totaled and range from 0-21. A higher score means more anxiety.|units on a scale|Mean|11.2|11.2|Standard Deviation|3.9|3.9|||
4008955|NCT01201967|3829201|B2|||Hospital Anxiety and Depression Scale - Anxiety Subscale|The HADS-A is a 7-item scale used to measure anxiety severity. Each question asks about a specific symptom of anxiety and offers four answers: 0 = Never / Not at all, 1 = A little / Time to time, 2 = Quite often / Usually, 3 = Most of the time / Very often. Scores are totaled and range from 0-21. A higher score means more anxiety.|units on a scale|Mean|11.5|11.5|Standard Deviation|3.9|3.9|||
4008956|NCT01201967|3829202|B1|||Hospital Anxiety and Depression Scale - Anxiety Subscale|The HADS-A is a 7-item scale used to measure anxiety severity. Each question asks about a specific symptom of anxiety and offers four answers: 0 = Never / Not at all, 1 = A little / Time to time, 2 = Quite often / Usually, 3 = Most of the time / Very often. Scores are totaled and range from 0-21. A higher score means more anxiety.|units on a scale|Mean|10.9|10.9|Standard Deviation|4.0|4.0|||
4008957|NCT01201967|3829200|B3|||Patient Health Questionnaire-9|The PHQ-9 is a 9-item scale that measures depression severity. Each question asks how often the subject experiences symptoms of depression and offers four answers: 0 = Not at all, 1 = Several days, 2 = More than half the days, 3 = Nearly every day. Scores are totaled and range from 0-27. To be considered depressed, subjects had to (a) have a total score of 10 or more, (b) answer five questions with a score of 2 or 3, and (c) one of the five questions had to be question 1 or question 2 (or both). Anyone who did not meet these criteria were not considered depressed.|units on a scale|Mean|15.8|15.8|Standard Deviation|4.6|4.6|||
4008958|NCT01201967|3829201|B2|||Patient Health Questionnaire-9|The PHQ-9 is a 9-item scale that measures depression severity. Each question asks how often the subject experiences symptoms of depression and offers four answers: 0 = Not at all, 1 = Several days, 2 = More than half the days, 3 = Nearly every day. Scores are totaled and range from 0-27. To be considered depressed, subjects had to (a) have a total score of 10 or more, (b) answer five questions with a score of 2 or 3, and (c) one of the five questions had to be question 1 or question 2 (or both). Anyone who did not meet these criteria were not considered depressed.|units on a scale|Mean|15.6|15.6|Standard Deviation|5.0|5.0|||
4008959|NCT01201967|3829202|B1|||Patient Health Questionnaire-9|The PHQ-9 is a 9-item scale that measures depression severity. Each question asks how often the subject experiences symptoms of depression and offers four answers: 0 = Not at all, 1 = Several days, 2 = More than half the days, 3 = Nearly every day. Scores are totaled and range from 0-27. To be considered depressed, subjects had to (a) have a total score of 10 or more, (b) answer five questions with a score of 2 or 3, and (c) one of the five questions had to be question 1 or question 2 (or both). Anyone who did not meet these criteria were not considered depressed.|units on a scale|Mean|15.9|15.9|Standard Deviation|4.2|4.2|||
4008960|NCT01201967|3829200|B3|United States||Region of Enrollment||participants|Number|183|183.0||||||
4008961|NCT01201967|3829201|B2|United States||Region of Enrollment||participants|Number|91|91.0||||||
4008962|NCT01201967|3829202|B1|United States||Region of Enrollment||participants|Number|92|92.0||||||
4008963|NCT01201967|3829200|B3||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4008964|NCT01201967|3829201|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4008965|NCT01201967|3829202|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4008966|NCT01201967|3829200|B3||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4008967|NCT01201967|3829201|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4008968|NCT01201967|3829202|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4008972|NCT01201915|3829225|B4||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4008973|NCT01201915|3829226|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4008974|NCT01201915|3829227|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4008975|NCT01201915|3829228|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4008976|NCT01201915|3829225|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4008977|NCT01201915|3829226|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4008978|NCT01201915|3829227|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4008979|NCT01201915|3829228|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4008980|NCT01201915|3829225|B4|||Age||years|Mean|63.6|63.6|Standard Deviation|12.1|12.1|||
4008981|NCT01201915|3829226|B3|||Age||years|Mean|65.1|65.1|Standard Deviation|11.8|11.8|||
4008982|NCT01201915|3829227|B2|||Age||years|Mean|65.2|65.2|Standard Deviation|13.3|13.3|||
4008983|NCT01201915|3829228|B1|||Age||years|Mean|60.5|60.5|Standard Deviation|11.2|11.2|||
4008984|NCT01201811|3829241|B1|High Risk (≥ 2.5)||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The IPSS prognostic subgroups consist of low-, intermediate-1-, intermediate-2-, and high-risk groups. The scale is 0-3.5 at 0.5 increments. Scores of 0=Low; 0.5-1.0=Int-1; 1.5-2.0=Int-2; 2.5-3.5=High risk which corresponds to poorer prognosis. The assessment was performed by the local investigator|participants|Number|26|26.0||||||
4008985|NCT01201811|3829241|B1|Intermediate-2 (1.5 - 2.0)||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The IPSS prognostic subgroups consist of low-, intermediate-1-, intermediate-2-, and high-risk groups. The scale is 0-3.5 at 0.5 increments. Scores of 0=Low; 0.5-1.0=Int-1; 1.5-2.0=Int-2; 2.5-3.5=High risk which corresponds to poorer prognosis. The assessment was performed by the local investigator|participants|Number|16|16.0||||||
4008986|NCT01201811|3829241|B1|Intermediate-1 (0.5 - 1.0)||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The IPSS prognostic subgroups consist of low-, intermediate-1-, intermediate-2-, and high-risk groups. The scale is 0-3.5 at 0.5 increments. Scores of 0=Low; 0.5-1.0=Int-1; 1.5-2.0=Int-2; 2.5-3.5=High risk which corresponds to poorer prognosis. The assessment was performed by the local investigator|participants|Number|2|2.0||||||
4008987|NCT01201811|3829241|B1|Low risk (0)||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The IPSS prognostic subgroups consist of low-, intermediate-1-, intermediate-2-, and high-risk groups. The scale is 0-3.5 at 0.5 increments. Scores of 0=Low; 0.5-1.0=Int-1; 1.5-2.0=Int-2; 2.5-3.5=High risk which corresponds to poorer prognosis. The assessment was performed by the local investigator|participants|Number|0|0.0||||||
4008988|NCT01201811|3829241|B1|Myelodysplastic Syndrome - Unclassified (MDS-U)||World Health Organization (WHO) Classification|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|0|0.0||||||
4008989|NCT01201811|3829241|B1|Refractory Cytopenia Multilineage Dysplasia (RCMD)||World Health Organization (WHO) Classification|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|0|0.0||||||
4008990|NCT01201811|3829241|B1|RA with ringed sideroblasts (RARS)||World Health Organization (WHO) Classification|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|0|0.0||||||
4008991|NCT01201811|3829241|B1|Refractory anemia (RA)||World Health Organization (WHO) Classification|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|0|0.0||||||
4008992|NCT01201811|3829241|B1|Chronic myelomonocytic leukemia (CMML-2)||World Health Organization (WHO) Classification|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|0|0.0||||||
4008993|NCT01201811|3829241|B1|Chronic myelomonocytic leukemia (CMML -1)||World Health Organization (WHO) Classification|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|1|1.0||||||
4008994|NCT01201811|3829241|B1|Acute myelogenous leukemia (AML)||World Health Organization (WHO) Classification|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|5|5.0||||||
4009042|NCT01201772|3829293|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4009043|NCT01201772|3829294|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4009044|NCT01201772|3829295|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4008995|NCT01201811|3829241|B1|Refractory anemia with excess blasts (RAEB-2)||World Health Organization (WHO) Classification|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|23|23.0||||||
4008996|NCT01201811|3829241|B1|Refractory anemia with excess blasts (RAEB-1)||World Health Organization (WHO) Classification|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|15|15.0||||||
4008997|NCT01201811|3829241|B1|Acute myelogenous leukemia (AML)||Myelodysplastic Syndrome (MDS) French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Local Reviewer.|participants|Number|0|0.0||||||
4008998|NCT01201811|3829241|B1|Chronic myelomonocytic leukemia (Modified CMML)||Myelodysplastic Syndrome (MDS) French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Local Reviewer.|participants|Number|2|2.0||||||
4008999|NCT01201811|3829241|B1|RAEB in transformation||Myelodysplastic Syndrome (MDS) French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Local Reviewer.|participants|Number|7|7.0||||||
4009000|NCT01201811|3829241|B1|Refractory anemia with excess blasts (RAEB)||Myelodysplastic Syndrome (MDS) French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Local Reviewer.|participants|Number|35|35.0||||||
4009001|NCT01201811|3829241|B1|Asian||Race/Ethnicity, Customized|Taiwanese origin|participants|Number|44|44.0||||||
4009002|NCT01201811|3829241|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4009003|NCT01201811|3829241|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4009004|NCT01201811|3829241|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|11.76|11.76|||
4009005|NCT01201798|3829261|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4009006|NCT01201798|3829262|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4009007|NCT01201798|3829263|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4009008|NCT01201798|3829261|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4009009|NCT01201798|3829262|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4009010|NCT01201798|3829263|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4009011|NCT01201798|3829261|B3|||Age||years|Mean|47.7|47.7|Standard Deviation|16.85|16.85|||
4009012|NCT01201798|3829262|B2|||Age||years|Mean|45.5|45.5|Standard Deviation|18.29|18.29|||
4009013|NCT01201798|3829263|B1|||Age||years|Mean|49.8|49.8|Standard Deviation|15.20|15.2|||
4009014|NCT01201785|3829288|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4009015|NCT01201785|3829288|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4009016|NCT01201785|3829288|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4009017|NCT01201785|3829288|B1|||Age||years|Mean|59|59.0|Standard Deviation|7|7.0|||
4009018|NCT01201785|3829288|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4009019|NCT01201785|3829288|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4009020|NCT01201785|3829288|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4009021|NCT01201772|3829292|B4|United States||Region of Enrollment||participants|Number|65|65.0||||||
4009022|NCT01201772|3829293|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4009023|NCT01201772|3829294|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4009024|NCT01201772|3829295|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4009025|NCT01201772|3829292|B4||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4009026|NCT01201772|3829293|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4009027|NCT01201772|3829294|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4009028|NCT01201772|3829295|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4009029|NCT01201772|3829292|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4009030|NCT01201772|3829293|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4009031|NCT01201772|3829294|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4009032|NCT01201772|3829295|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4009033|NCT01201772|3829292|B4|||Age||years|Mean|54|54.0|Standard Deviation|7|7.0|||
4009034|NCT01201772|3829293|B3|||Age||years|Mean|52|52.0|Standard Deviation|9|9.0|||
4009035|NCT01201772|3829294|B2|||Age||years|Mean|54|54.0|Standard Deviation|7|7.0|||
4009036|NCT01201772|3829295|B1|||Age||years|Mean|56|56.0|Standard Deviation|7|7.0|||
4009037|NCT01201772|3829292|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4009038|NCT01201772|3829293|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4009039|NCT01201772|3829294|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4009040|NCT01201772|3829295|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4009041|NCT01201772|3829292|B4||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4009045|NCT01201772|3829292|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4009046|NCT01201772|3829293|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4009047|NCT01201772|3829294|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4009048|NCT01201772|3829295|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4009049|NCT01201759|3829303|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4009050|NCT01201759|3829304|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4009051|NCT01201759|3829305|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4009052|NCT01201759|3829303|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4009053|NCT01201759|3829304|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4009054|NCT01201759|3829305|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4009055|NCT01201759|3829303|B3|||Age||years|Mean|33|33.0|Standard Deviation|11|11.0|||
4009056|NCT01201759|3829304|B2|||Age||years|Mean|25|25.0|Standard Deviation|3|3.0|||
4009057|NCT01201759|3829305|B1|||Age||years|Mean|36|36.0|Standard Deviation|10|10.0|||
4009058|NCT01201759|3829303|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4009059|NCT01201759|3829304|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4009060|NCT01201759|3829305|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4009061|NCT01201759|3829303|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4009062|NCT01201759|3829304|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4009063|NCT01201759|3829305|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4009064|NCT01201759|3829303|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4009065|NCT01201759|3829304|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4009066|NCT01201759|3829305|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4009067|NCT01201629|3829318|B3|||Functional Independence Measures (TFIM)|The FIM has 18 items and each item is scored on an ordinal scale ranging from 1 to 7. The total FIM score (TFIM) quantifies level of independence and ranges from 18 (total dependence) to 126 (total independence)|units on a scale|Mean|60|60.0|Standard Deviation|14|14.0|||
4009068|NCT01201629|3829319|B2|||Functional Independence Measures (TFIM)|The FIM has 18 items and each item is scored on an ordinal scale ranging from 1 to 7. The total FIM score (TFIM) quantifies level of independence and ranges from 18 (total dependence) to 126 (total independence)|units on a scale|Mean|59|59.0|Standard Deviation|12|12.0|||
4009069|NCT01201629|3829320|B1|||Functional Independence Measures (TFIM)|The FIM has 18 items and each item is scored on an ordinal scale ranging from 1 to 7. The total FIM score (TFIM) quantifies level of independence and ranges from 18 (total dependence) to 126 (total independence)|units on a scale|Mean|61|61.0|Standard Deviation|17|17.0|||
4009070|NCT01201629|3829318|B3|||Action Research Arm Test (ARAT)|Action Research Arm Test (ARAT), a standardized ordinal scale that measures UE function. 23 ARAT is based on the assumption that complex UE movements used in daily life can be explained and assessed by 4 basic movements: grasp, grip, pinch and gross movements of extension and flexion at the elbow and shoulder (Appendix 1). The ARAT is graded on a 4-point scale (0 is worse and 57 points is normal). ARAT scoring was undertaken as per instructions.|units on a scale|Mean|2.9|2.9|Standard Deviation|8.1|8.1|||
4009071|NCT01201629|3829319|B2|||Action Research Arm Test (ARAT)|Action Research Arm Test (ARAT), a standardized ordinal scale that measures UE function. 23 ARAT is based on the assumption that complex UE movements used in daily life can be explained and assessed by 4 basic movements: grasp, grip, pinch and gross movements of extension and flexion at the elbow and shoulder (Appendix 1). The ARAT is graded on a 4-point scale (0 is worse and 57 points is normal). ARAT scoring was undertaken as per instructions.|units on a scale|Mean|1.9|1.9|Standard Deviation|4.2|4.2|||
4009072|NCT01201629|3829320|B1|||Action Research Arm Test (ARAT)|Action Research Arm Test (ARAT), a standardized ordinal scale that measures UE function. 23 ARAT is based on the assumption that complex UE movements used in daily life can be explained and assessed by 4 basic movements: grasp, grip, pinch and gross movements of extension and flexion at the elbow and shoulder (Appendix 1). The ARAT is graded on a 4-point scale (0 is worse and 57 points is normal). ARAT scoring was undertaken as per instructions.|units on a scale|Mean|4|4.0|Standard Deviation|10.9|10.9|||
4009073|NCT01201629|3829318|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4009074|NCT01201629|3829319|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4009075|NCT01201629|3829320|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4009076|NCT01201629|3829318|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4009077|NCT01201629|3829319|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4009078|NCT01201629|3829320|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4009079|NCT01201629|3829318|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4009080|NCT01201629|3829319|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4009081|NCT01201629|3829320|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4009082|NCT01201629|3829318|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4009083|NCT01201629|3829319|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4009084|NCT01201629|3829320|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4009085|NCT01201629|3829318|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4009086|NCT01201629|3829319|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4009087|NCT01201629|3829320|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4009088|NCT01201629|3829318|B3|||Age||Years|Mean|62|62.0|Standard Deviation|9|9.0|||
4009089|NCT01201629|3829319|B2|||Age||Years|Mean|63|63.0|Standard Deviation|6|6.0|||
4009090|NCT01201629|3829320|B1|||Age||Years|Mean|62|62.0|Standard Deviation|11|11.0|||
4009091|NCT01201486|3829331|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4009092|NCT01201486|3829331|B1||Female|Sex: Female, Male||Participants|Count of Participants|6781|6781.0||||||
4009093|NCT01201486|3829331|B1|||Age||years|Median|29|29.0|Full Range|||16.0|49.0|
4009094|NCT01201343|3829335|B1||Male|Sex: Female, Male|Out of a total of 79 participants, data for baseline measure (gender) was available for 70 participants with at least one interferon-beta intake and with at least one evaluation of the primary criterion.|Participants|Count of Participants|14|14.0||||||
4009095|NCT01201343|3829335|B1||Female|Sex: Female, Male|Out of a total of 79 participants, data for baseline measure (gender) was available for 70 participants with at least one interferon-beta intake and with at least one evaluation of the primary criterion.|Participants|Count of Participants|56|56.0||||||
4009096|NCT01201343|3829335|B1|||Age|Out of a total of 79 participants, data for baseline measure (age) was available for 70 participants with at least one interferon-beta intake and with at least one evaluation of the primary criterion.|years|Mean|37.0|37.0|Standard Deviation|11.5|11.5|||
4009097|NCT01201317|3829346|B4||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4009098|NCT01201317|3829347|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4009099|NCT01201317|3829348|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4009100|NCT01201317|3829349|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4009101|NCT01201317|3829346|B4||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4009102|NCT01201317|3829347|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4009103|NCT01201317|3829348|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4009104|NCT01201317|3829349|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4009105|NCT01201317|3829346|B4|||Age||Years|Mean|58|58.0|Standard Deviation|8|8.0|||
4009106|NCT01201317|3829347|B3|||Age||Years|Mean|56.4|56.4|Standard Deviation|8.4|8.4|||
4009107|NCT01201317|3829348|B2|||Age||Years|Mean|59.6|59.6|Standard Deviation|8.4|8.4|||
4009108|NCT01201317|3829349|B1|||Age||Years|Mean|57.8|57.8|Standard Deviation|6.9|6.9|||
4009109|NCT01201265|3829371|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4009110|NCT01201265|3829371|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4009111|NCT01201265|3829371|B1|||Age||years|Mean|47.5|47.5|Standard Deviation|10.68|10.68|||
4009112|NCT01200992|3829383|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4009113|NCT01200992|3829384|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4009114|NCT01200992|3829385|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4009115|NCT01200992|3829383|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4009116|NCT01200992|3829384|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4009117|NCT01200992|3829385|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4009118|NCT01200992|3829383|B3|||Age||years|Mean|71.8|71.8|Standard Deviation|9.84|9.84|||
4009119|NCT01200992|3829384|B2|||Age||years|Mean|70.7|70.7|Standard Deviation|11.18|11.18|||
4009120|NCT01200992|3829385|B1|||Age||years|Mean|73.0|73.0|Standard Deviation|7.99|7.99|||
4009121|NCT01200875|3829394|B1|United States||Region of Enrollment|California, United States|participants|Number|25|25.0||||||
4009122|NCT01200875|3829394|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4009123|NCT01200875|3829394|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4009124|NCT01200875|3829394|B1|||Age||years|Mean|38.5|38.5|Standard Deviation|11.3|11.3|||
4009125|NCT01200810|3829398|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4009126|NCT01200810|3829399|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4009127|NCT01200810|3829400|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4009128|NCT01200810|3829398|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009129|NCT01200810|3829399|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009130|NCT01200810|3829400|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009131|NCT01200810|3829398|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4009132|NCT01200810|3829399|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4009133|NCT01200810|3829400|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4009134|NCT01200810|3829398|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009135|NCT01200810|3829399|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009136|NCT01200810|3829400|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009137|NCT01200810|3829398|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009138|NCT01200810|3829399|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009139|NCT01200810|3829400|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009140|NCT01200810|3829398|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009141|NCT01200810|3829399|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009142|NCT01200810|3829400|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009143|NCT01200810|3829398|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4009144|NCT01200810|3829399|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4009145|NCT01200810|3829400|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4009206|NCT01200524|3829533|B3|White||Race/Ethnicity, Customized||Participants|Number|44|44.0||||||
4009146|NCT01200810|3829398|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4009147|NCT01200810|3829399|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4009148|NCT01200810|3829400|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4009149|NCT01200810|3829398|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009150|NCT01200810|3829399|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009151|NCT01200810|3829400|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009152|NCT01200810|3829398|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4009153|NCT01200810|3829399|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009154|NCT01200810|3829400|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4009155|NCT01200810|3829398|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009156|NCT01200810|3829399|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009157|NCT01200810|3829400|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009158|NCT01200810|3829398|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4009159|NCT01200810|3829399|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4009160|NCT01200810|3829400|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4009161|NCT01200810|3829398|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4009162|NCT01200810|3829399|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4009163|NCT01200810|3829400|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4009164|NCT01200810|3829398|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4009165|NCT01200810|3829399|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4009166|NCT01200810|3829400|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4009167|NCT01200810|3829398|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4009168|NCT01200810|3829399|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4009169|NCT01200810|3829400|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4009170|NCT01200810|3829398|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4009171|NCT01200810|3829399|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4009172|NCT01200810|3829400|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4009173|NCT01200810|3829398|B3|||Age||years|Mean|64.8|64.8|Standard Deviation|7.16|7.16|||
4009174|NCT01200810|3829399|B2|||Age||years|Mean|67.6|67.6|Standard Deviation|7.5|7.5|||
4009175|NCT01200810|3829400|B1|||Age||years|Mean|62|62.0|Standard Deviation|6.28|6.28|||
4009176|NCT01200797|3829421|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4009177|NCT01200797|3829421|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4009178|NCT01200797|3829421|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4009179|NCT01200797|3829421|B1|||Age||years|Mean|60.57895|60.57895|Full Range|||35.0|75.0|
4009180|NCT01200797|3829421|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4009181|NCT01200797|3829421|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4009182|NCT01200797|3829421|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4009183|NCT01200758|3829429|B3||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4009184|NCT01200758|3829430|B2||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4009185|NCT01200758|3829431|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4009186|NCT01200758|3829429|B3||Female|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
4009187|NCT01200758|3829430|B2||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4009188|NCT01200758|3829431|B1||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4009189|NCT01200758|3829429|B3|||Age||years|Mean|56.5|56.5|Standard Deviation|12.67|12.67|28.0|86.0|
4009190|NCT01200758|3829430|B2|||Age||years|Mean|56.1|56.1|Standard Deviation|12.66|12.66|28.0|85.0|
4009191|NCT01200758|3829431|B1|||Age||years|Mean|56.9|56.9|Standard Deviation|12.69|12.69|28.0|86.0|
4009192|NCT01200589|3829505|B3||Male|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4009193|NCT01200589|3829506|B2||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4009194|NCT01200589|3829507|B1||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4009195|NCT01200589|3829505|B3||Female|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
4009196|NCT01200589|3829506|B2||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4009197|NCT01200589|3829507|B1||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4009198|NCT01200589|3829505|B3|||Age||Years|Mean|60.8|60.8|Standard Deviation|11.54|11.54|||
4009199|NCT01200589|3829506|B2|||Age||Years|Mean|60.7|60.7|Standard Deviation|11.84|11.84|||
4009200|NCT01200589|3829507|B1|||Age||Years|Mean|60.8|60.8|Standard Deviation|11.27|11.27|||
4009201|NCT01200524|3829532|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4009202|NCT01200524|3829533|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4009203|NCT01200524|3829534|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4009204|NCT01200524|3829535|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4009205|NCT01200524|3829532|B4|White||Race/Ethnicity, Customized||Participants|Number|132|132.0||||||
4009207|NCT01200524|3829534|B2|White||Race/Ethnicity, Customized||Participants|Number|47|47.0||||||
4009208|NCT01200524|3829535|B1|White||Race/Ethnicity, Customized||Participants|Number|41|41.0||||||
4009209|NCT01200524|3829532|B4||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4009210|NCT01200524|3829533|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4009211|NCT01200524|3829534|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4009212|NCT01200524|3829535|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4009213|NCT01200524|3829532|B4||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4009214|NCT01200524|3829533|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4009215|NCT01200524|3829534|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4009216|NCT01200524|3829535|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4009217|NCT01200524|3829532|B4|||Age||Years|Mean|53.1|53.1|Standard Deviation|10.9|10.9|||
4009218|NCT01200524|3829533|B3|||Age||Years|Mean|55.1|55.1|Standard Deviation|10.9|10.9|||
4009219|NCT01200524|3829534|B2|||Age||Years|Mean|53.1|53.1|Standard Deviation|10.9|10.9|||
4009220|NCT01200524|3829535|B1|||Age||Years|Mean|50.9|50.9|Standard Deviation|10.9|10.9|||
4009221|NCT01200511|3829557|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4009222|NCT01200511|3829557|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4009223|NCT01200511|3829557|B1|||Age||years|Mean|62.52|62.52|Standard Deviation|7.49|7.49|||
4009224|NCT01200498|3829565|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4009225|NCT01200498|3829565|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4009226|NCT01200498|3829565|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4009227|NCT01200498|3829565|B1|||Age||years|Median|67|67.0|Full Range|||51.0|74.0|
4009228|NCT01200433|3829569|B3|Others||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4009229|NCT01200433|3829570|B2|Others||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4009230|NCT01200433|3829571|B1|Others||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4009231|NCT01200433|3829569|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4009232|NCT01200433|3829570|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4009233|NCT01200433|3829571|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4009234|NCT01200433|3829569|B3||Male|Gender||Participants|Count of Participants|36|36.0||||||
4009235|NCT01200433|3829570|B2||Male|Gender||Participants|Count of Participants|18|18.0||||||
4009236|NCT01200433|3829571|B1||Male|Gender||Participants|Count of Participants|18|18.0||||||
4009237|NCT01200433|3829569|B3||Female|Gender||Participants|Count of Participants|8|8.0||||||
4009238|NCT01200433|3829570|B2||Female|Gender||Participants|Count of Participants|5|5.0||||||
4009239|NCT01200433|3829571|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
4009240|NCT01200433|3829569|B3|||Age||years|Mean|64.5|64.5|Standard Deviation|8.7|8.7|||
4009241|NCT01200433|3829570|B2|||Age||years|Mean|65.4|65.4|Standard Deviation|6.8|6.8|||
4009242|NCT01200433|3829571|B1|||Age||years|Mean|63.5|63.5|Standard Deviation|10.5|10.5|||
4009243|NCT01200368|3829592|B4||Male|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
4009244|NCT01200368|3829593|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4009245|NCT01200368|3829594|B2||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4009246|NCT01200368|3829595|B1||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4009247|NCT01200368|3829592|B4||Female|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
4009248|NCT01200368|3829593|B3||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4009249|NCT01200368|3829594|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4009250|NCT01200368|3829595|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4009251|NCT01200368|3829592|B4|||Age||months|Mean|4.1|4.1|Standard Deviation|0.97|0.97|||
4009252|NCT01200368|3829593|B3|||Age||months|Mean|4.2|4.2|Standard Deviation|0.96|0.96|||
4009253|NCT01200368|3829594|B2|||Age||months|Mean|4.1|4.1|Standard Deviation|0.97|0.97|||
4009254|NCT01200368|3829595|B1|||Age||months|Mean|4.1|4.1|Standard Deviation|0.97|0.97|||
4009255|NCT01200355|3829661|B3|United States||Region of Enrollment||Participants|Count of Participants|113|113.0||||||
4009256|NCT01200355|3829662|B2|United States||Region of Enrollment||Participants|Count of Participants|55|55.0||||||
4009257|NCT01200355|3829663|B1|United States||Region of Enrollment||Participants|Count of Participants|58|58.0||||||
4009258|NCT01200355|3829661|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4009259|NCT01200355|3829662|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4009260|NCT01200355|3829663|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4009261|NCT01200355|3829661|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009262|NCT01200355|3829662|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009263|NCT01200355|3829663|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009264|NCT01200355|3829661|B3||White|Race (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
4009265|NCT01200355|3829662|B2||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4009266|NCT01200355|3829663|B1||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4009267|NCT01200355|3829661|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4009268|NCT01200355|3829662|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4009269|NCT01200355|3829663|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4009270|NCT01200355|3829661|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009271|NCT01200355|3829662|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009272|NCT01200355|3829663|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009273|NCT01200355|3829661|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4009274|NCT01200355|3829662|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4009275|NCT01200355|3829663|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4009276|NCT01200355|3829661|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009277|NCT01200355|3829662|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009278|NCT01200355|3829663|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009279|NCT01200355|3829661|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4009280|NCT01200355|3829662|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4009281|NCT01200355|3829663|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4009282|NCT01200355|3829661|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4009283|NCT01200355|3829662|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4009284|NCT01200355|3829663|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4009285|NCT01200355|3829661|B3|||Age||years|Median|61|61.0|Full Range|||32.0|75.0|
4009286|NCT01200355|3829662|B2|||Age||years|Median|59|59.0|Full Range|||26.0|74.0|
4009287|NCT01200355|3829663|B1|||Age||years|Median|61|61.0|Full Range|||32.0|75.0|
4009288|NCT01200342|3829678|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4009289|NCT01200342|3829678|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4009290|NCT01200342|3829678|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4009291|NCT01200342|3829678|B1|||Age||years|Median|61|61.0|Full Range|||61.0|65.0|
4009292|NCT01200290|3829683|B1|||Panel Reactive Antibodies (PRA)|The PRA value is calculated and expressed as a percentage, which can range from 0 percent (%) to 100%. The value represents a summation of the total HLA antibody burden that the participant has and how frequently those HLA antigens appear in organ donor population. A calculated PRA of 20% means the participant has antibodies that represent an antigen frequency that exists in approximately 20% of the population.|percentage of population|Mean|93.111|93.111|Standard Deviation|10.593|10.593|||
4009293|NCT01200290|3829683|B1|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4009294|NCT01200290|3829683|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009295|NCT01200290|3829683|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009296|NCT01200290|3829683|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4009297|NCT01200290|3829683|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4009298|NCT01200290|3829683|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009299|NCT01200290|3829683|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4009300|NCT01200290|3829683|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009301|NCT01200290|3829683|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009302|NCT01200290|3829683|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4009303|NCT01200290|3829683|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009304|NCT01200290|3829683|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4009305|NCT01200290|3829683|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4009306|NCT01200290|3829683|B1|||Age||years|Mean|44.2|44.2|Standard Deviation|12.09|12.09|||
4009307|NCT01200238|3829694|B3|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
4009308|NCT01200238|3829695|B2|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4009309|NCT01200238|3829696|B1|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4009310|NCT01200238|3829694|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4009311|NCT01200238|3829695|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4009312|NCT01200238|3829696|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4009313|NCT01200238|3829694|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4009314|NCT01200238|3829695|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4009315|NCT01200238|3829696|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4009316|NCT01200238|3829694|B3|||Age||years|Mean|58.0|58.0|Standard Deviation|14.3|14.3|||
4009317|NCT01200238|3829695|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|18.4|18.4|||
4009318|NCT01200238|3829696|B1|||Age||years|Mean|57.3|57.3|Standard Deviation|6.5|6.5|||
4009319|NCT01200160|3829715|B1|Colombia||Region of Enrollment||participants|Number|15|15.0||||||
4009320|NCT01200160|3829715|B1|Venezuela||Region of Enrollment||participants|Number|60|60.0||||||
4009321|NCT01200160|3829715|B1|Mexico||Region of Enrollment||participants|Number|53|53.0||||||
4009322|NCT01200160|3829715|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4009323|NCT01200160|3829715|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4009324|NCT01200160|3829715|B1|||Age||years|Mean|55|55.0|Standard Deviation|13|13.0|||
4009325|NCT01200160|3829715|B1|>=65 years||Age|There were 128 recruited patients, however for one patient information about birth date is missing, then age is not possible to be calculated. Then descriptive data for “age” is for 127 patients.|participants|Number|31|31.0||||||
4009326|NCT01200160|3829715|B1|Between 18 and 65 years||Age|There were 128 recruited patients, however for one patient information about birth date is missing, then age is not possible to be calculated. Then descriptive data for “age” is for 127 patients.|participants|Number|96|96.0||||||
4009327|NCT01200160|3829715|B1|<=18 years||Age|There were 128 recruited patients, however for one patient information about birth date is missing, then age is not possible to be calculated. Then descriptive data for “age” is for 127 patients.|participants|Number|0|0.0||||||
4009328|NCT01200069|3829719|B3|||Mini Mental State Examination >23|examination of participants to confirm cognitive ability. Questions such as who is the president, what is the day of the week, the date. The scale is from 0-30. Value of 24 or higher indicates absence of cognitive impairment|participants|Number|14|14.0||||||
4009329|NCT01200069|3829720|B2|||Mini Mental State Examination >23|examination of participants to confirm cognitive ability. Questions such as who is the president, what is the day of the week, the date. The scale is from 0-30. Value of 24 or higher indicates absence of cognitive impairment|participants|Number|6|6.0||||||
4009330|NCT01200069|3829721|B1|||Mini Mental State Examination >23|examination of participants to confirm cognitive ability. Questions such as who is the president, what is the day of the week, the date. The scale is from 0-30. Value of 24 or higher indicates absence of cognitive impairment|participants|Number|8|8.0||||||
4009331|NCT01200069|3829719|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4009332|NCT01200069|3829720|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4009333|NCT01200069|3829721|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4009334|NCT01200069|3829719|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4009335|NCT01200069|3829720|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4009336|NCT01200069|3829721|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4009337|NCT01200069|3829719|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4009338|NCT01200069|3829720|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4009339|NCT01200069|3829721|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4009340|NCT01200069|3829719|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4009341|NCT01200069|3829720|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4009342|NCT01200069|3829721|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4009343|NCT01200069|3829719|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4009344|NCT01200069|3829720|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4009345|NCT01200069|3829721|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4009346|NCT01200069|3829719|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4009347|NCT01200069|3829720|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4009348|NCT01200069|3829721|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4009349|NCT01199965|3829774|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4009350|NCT01199965|3829775|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4009351|NCT01199965|3829776|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4009352|NCT01199965|3829774|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4009353|NCT01199965|3829775|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4009354|NCT01199965|3829776|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4009355|NCT01199965|3829774|B3|||Age||years|Mean|31.79|31.79|Standard Deviation|8|8.0|||
4009356|NCT01199965|3829775|B2|||Age||years|Mean|30.71|30.71|Standard Deviation|8.8|8.8|||
4009357|NCT01199965|3829776|B1|||Age||years|Mean|32.91|32.91|Standard Deviation|7.1|7.1|||
4009358|NCT01199939|3829791|B1|USA||Region of Enrollment||participants|Number|50|50.0||||||
4009359|NCT01199939|3829791|B1|Puerto Rico||Region of Enrollment||participants|Number|4|4.0||||||
4009360|NCT01199939|3829791|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4009361|NCT01199939|3829791|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4009362|NCT01199939|3829791|B1|||Age||years|Mean|44.4|44.4|Standard Deviation|12.82|12.82|||
4009363|NCT01199926|3829808|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
4009364|NCT01199926|3829809|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4009365|NCT01199926|3829810|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4009366|NCT01199926|3829808|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4009367|NCT01199926|3829809|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4009368|NCT01199926|3829810|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4009369|NCT01199926|3829808|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4009370|NCT01199926|3829809|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4009371|NCT01199926|3829810|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4009372|NCT01199926|3829808|B3|||Age||years|Mean|26.1|26.1|Standard Deviation|4.8|4.8|||
4009373|NCT01199926|3829809|B2|||Age||years|Mean|26.2|26.2|Standard Deviation|5.1|5.1|||
4009374|NCT01199926|3829810|B1|||Age||years|Mean|26|26.0|Standard Deviation|4.5|4.5|||
4009375|NCT01199926|3829808|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4009376|NCT01199926|3829809|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4009377|NCT01199926|3829810|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4009378|NCT01199926|3829808|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4009379|NCT01199926|3829809|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4009380|NCT01199926|3829810|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4009381|NCT01199926|3829808|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4009382|NCT01199926|3829809|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4009383|NCT01199926|3829810|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4009384|NCT01199861|3829821|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4009385|NCT01199861|3829822|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4009386|NCT01199861|3829823|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4009387|NCT01199861|3829821|B3||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4009388|NCT01199861|3829822|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4009389|NCT01199861|3829823|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4009390|NCT01199861|3829821|B3|41-55||Age, Customized||participants|Number|56|56.0||||||
4009391|NCT01199861|3829822|B2|41-55||Age, Customized||participants|Number|21|21.0||||||
4009392|NCT01199861|3829823|B1|41-55||Age, Customized||participants|Number|35|35.0||||||
4009393|NCT01199861|3829821|B3|31-40||Age, Customized||participants|Number|49|49.0||||||
4009394|NCT01199861|3829822|B2|31-40||Age, Customized||participants|Number|14|14.0||||||
4009395|NCT01199861|3829823|B1|31-40||Age, Customized||participants|Number|35|35.0||||||
4009396|NCT01199861|3829821|B3|18-30||Age, Customized||participants|Number|33|33.0||||||
4009397|NCT01199861|3829822|B2|18-30||Age, Customized||participants|Number|8|8.0||||||
4009398|NCT01199861|3829823|B1|18-30||Age, Customized||participants|Number|25|25.0||||||
4009399|NCT01199861|3829821|B3|||Age||years|Mean|37.9|37.9|Standard Deviation|8.48|8.48|||
4009400|NCT01199861|3829822|B2|||Age||years|Mean|39.2|39.2|Standard Deviation|8.67|8.67|||
4009401|NCT01199861|3829823|B1|||Age||years|Mean|37.4|37.4|Standard Deviation|8.37|8.37|||
4009402|NCT01199822|3829842|B4|Japan||Region of Enrollment||participants|Number|16|16.0||||||
4009403|NCT01199822|3829843|B3|Japan||Region of Enrollment||participants|Number|6|6.0||||||
4009404|NCT01199822|3829844|B2|Japan||Region of Enrollment||participants|Number|7|7.0||||||
4009405|NCT01199822|3829845|B1|Japan||Region of Enrollment||participants|Number|3|3.0||||||
4009406|NCT01199822|3829842|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009407|NCT01199822|3829843|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009408|NCT01199822|3829844|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009409|NCT01199822|3829845|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009410|NCT01199822|3829842|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009411|NCT01199822|3829843|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009412|NCT01199822|3829844|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009413|NCT01199822|3829845|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009414|NCT01199822|3829842|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009415|NCT01199822|3829843|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009416|NCT01199822|3829844|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009417|NCT01199822|3829845|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009418|NCT01199822|3829842|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009419|NCT01199822|3829843|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009420|NCT01199822|3829844|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009421|NCT01199822|3829845|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009422|NCT01199822|3829842|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009423|NCT01199822|3829843|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009424|NCT01199822|3829844|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009425|NCT01199822|3829845|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009426|NCT01199822|3829842|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4009427|NCT01199822|3829843|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4009428|NCT01199822|3829844|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4009429|NCT01199822|3829845|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4009430|NCT01199822|3829842|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009431|NCT01199822|3829843|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009432|NCT01199822|3829844|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009433|NCT01199822|3829845|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009434|NCT01199822|3829842|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4009435|NCT01199822|3829843|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4009436|NCT01199822|3829844|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4009437|NCT01199822|3829845|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4009438|NCT01199822|3829842|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4009439|NCT01199822|3829843|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4009440|NCT01199822|3829844|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4009441|NCT01199822|3829845|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4009442|NCT01199822|3829842|B4|≥65 Years||Age, Customized||participants|Number|5|5.0||||||
4009443|NCT01199822|3829843|B3|≥65 Years||Age, Customized||participants|Number|2|2.0||||||
4009444|NCT01199822|3829844|B2|≥65 Years||Age, Customized||participants|Number|1|1.0||||||
4009445|NCT01199822|3829845|B1|≥65 Years||Age, Customized||participants|Number|2|2.0||||||
4009446|NCT01199822|3829842|B4|20 - <65 Years||Age, Customized||participants|Number|11|11.0||||||
4009447|NCT01199822|3829843|B3|20 - <65 Years||Age, Customized||participants|Number|4|4.0||||||
4009448|NCT01199822|3829844|B2|20 - <65 Years||Age, Customized||participants|Number|6|6.0||||||
4009449|NCT01199822|3829845|B1|20 - <65 Years||Age, Customized||participants|Number|1|1.0||||||
4009450|NCT01199744|3829880|B1||Male|Sex: Female, Male||Participants|Count of Participants|748|748.0||||||
4009451|NCT01199744|3829880|B1||Female|Sex: Female, Male||Participants|Count of Participants|827|827.0||||||
4009452|NCT01199744|3829880|B1|>=65 to <74 years||Age, Customized||participants|Number|4|4.0||||||
4009453|NCT01199744|3829880|B1|>=15 to <65 years||Age, Customized||participants|Number|586|586.0||||||
4009454|NCT01199744|3829880|B1|>=7 to <15 years||Age, Customized||participants|Number|790|790.0||||||
4009455|NCT01199744|3829880|B1|>=3 to <7 years||Age, Customized||participants|Number|195|195.0||||||
4009456|NCT01199731|3829893|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4009457|NCT01199731|3829894|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009458|NCT01199731|3829895|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4009459|NCT01199731|3829896|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009460|NCT01199731|3829893|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009461|NCT01199731|3829894|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009462|NCT01199731|3829895|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009463|NCT01199731|3829896|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009464|NCT01199731|3829893|B4||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4009465|NCT01199731|3829894|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4009466|NCT01199731|3829895|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4009467|NCT01199731|3829896|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4009468|NCT01199731|3829893|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4009469|NCT01199731|3829894|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4009470|NCT01199731|3829895|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4009471|NCT01199731|3829896|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4009472|NCT01199731|3829893|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009473|NCT01199731|3829894|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009474|NCT01199731|3829895|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009475|NCT01199731|3829896|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009476|NCT01199731|3829893|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4009477|NCT01199731|3829894|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009478|NCT01199731|3829895|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009479|NCT01199731|3829896|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4009480|NCT01199731|3829893|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009481|NCT01199731|3829894|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009482|NCT01199731|3829895|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009483|NCT01199731|3829896|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009484|NCT01199731|3829893|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4009485|NCT01199731|3829894|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4009486|NCT01199731|3829895|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4009487|NCT01199731|3829896|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4009488|NCT01199731|3829893|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4009489|NCT01199731|3829894|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4009490|NCT01199731|3829895|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4009491|NCT01199731|3829896|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4009492|NCT01199731|3829893|B4|||Age||years|Mean|43.6|43.6|Standard Deviation|9.74|9.74|||
4009493|NCT01199731|3829894|B3|||Age||years|Mean|43.2|43.2|Standard Deviation|8.75|8.75|||
4009494|NCT01199731|3829895|B2|||Age||years|Mean|42.4|42.4|Standard Deviation|11.60|11.6|||
4009495|NCT01199731|3829896|B1|||Age||years|Mean|45.4|45.4|Standard Deviation|9.11|9.11|||
4009496|NCT01199705|3829936|B1|Hyper-Immunoglobulin M (IgM) Syndrome||Primary Immunodeficiency Type||Participants|Number|1|1.0||||||
4009497|NCT01199705|3829936|B1|Autosomal Recessive Agammaglobulinemia (ARAG)||Primary Immunodeficiency Type||Participants|Number|1|1.0||||||
4009498|NCT01199705|3829936|B1|X-Linked Agammaglobulinemia (XLA)||Primary Immunodeficiency Type||Participants|Number|13|13.0||||||
4009499|NCT01199705|3829936|B1|Common Variable Immunodeficiency (CVID)||Primary Immunodeficiency Type||Participants|Number|10|10.0||||||
4009500|NCT01199705|3829936|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4009501|NCT01199705|3829936|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4009502|NCT01199705|3829936|B1|≥ 65 years||Age, Customized||Participants|Number|0|0.0||||||
4009503|NCT01199705|3829936|B1|> 16 to < 65 years||Age, Customized||Participants|Number|14|14.0||||||
4009504|NCT01199705|3829936|B1|≥ 12 to ≤ 16 years||Age, Customized||Participants|Number|4|4.0||||||
4009505|NCT01199705|3829936|B1|≥ 2 to < 12 years||Age, Customized||Participants|Number|7|7.0||||||
4009506|NCT01199705|3829936|B1|< 2 years||Age, Customized||Participants|Number|0|0.0||||||
4009507|NCT01199705|3829936|B1|||Age||Years|Mean|20.6|20.6|Standard Deviation|13.23|13.23|||
4009508|NCT01199601|3829966|B3|Afghanistan||Region of Enrollment||participants|Number|844|844.0||||||
4009509|NCT01199601|3829967|B2|Afghanistan||Region of Enrollment||participants|Number|422|422.0||||||
4009510|NCT01199601|3829968|B1|Afghanistan||Region of Enrollment||participants|Number|422|422.0||||||
4009511|NCT01199601|3829966|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4009512|NCT01199601|3829967|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4009513|NCT01199601|3829968|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4009514|NCT01199601|3829966|B3||Female|Sex: Female, Male||Participants|Count of Participants|844|844.0||||||
4009515|NCT01199601|3829967|B2||Female|Sex: Female, Male||Participants|Count of Participants|422|422.0||||||
4009516|NCT01199601|3829968|B1||Female|Sex: Female, Male||Participants|Count of Participants|422|422.0||||||
4009517|NCT01199601|3829966|B3|||Age||years|Mean|24.9|24.9|Standard Deviation|5.5|5.5|||
4009518|NCT01199601|3829967|B2|||Age||years|Mean|24.8|24.8|Standard Deviation|5.5|5.5|||
4009519|NCT01199601|3829968|B1|||Age||years|Mean|25.1|25.1|Standard Deviation|5.6|5.6|||
4009520|NCT01199601|3829966|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4009521|NCT01199601|3829967|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4009522|NCT01199601|3829968|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4009523|NCT01199601|3829966|B3||Between 18 and 65 years|Age||Participants|Count of Participants|779|779.0||||||
4009524|NCT01199601|3829967|B2||Between 18 and 65 years|Age||Participants|Count of Participants|391|391.0||||||
4009525|NCT01199601|3829968|B1||Between 18 and 65 years|Age||Participants|Count of Participants|388|388.0||||||
4009526|NCT01199601|3829966|B3||<=18 years|Age||Participants|Count of Participants|65|65.0||||||
4009527|NCT01199601|3829967|B2||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
4009528|NCT01199601|3829968|B1||<=18 years|Age||Participants|Count of Participants|34|34.0||||||
4009529|NCT01199575|3829979|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4009530|NCT01199575|3829979|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009531|NCT01199575|3829979|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009532|NCT01199575|3829979|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4009533|NCT01199575|3829979|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009534|NCT01199575|3829979|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009535|NCT01199575|3829979|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009536|NCT01199575|3829979|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009537|NCT01199575|3829979|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4009538|NCT01199575|3829979|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4009539|NCT01199575|3829979|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4009540|NCT01199575|3829979|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4009541|NCT01199575|3829979|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4009542|NCT01199471|3829984|B1|China||Region of Enrollment||participants|Number|3997|3997.0||||||
4009543|NCT01199471|3829984|B1||Male|Sex: Female, Male||Participants|Count of Participants|1653|1653.0||||||
4009544|NCT01199471|3829984|B1||Female|Sex: Female, Male||Participants|Count of Participants|2344|2344.0||||||
4009545|NCT01199471|3829984|B1|||Age||years|Mean|45.26|45.26|Standard Deviation|13.52|13.52|||
4009546|NCT01199471|3829984|B1|||Age||years|Median|46|46.0|Inter-Quartile Range|||35.0|56.0|
4009547|NCT01199237|3829993|B3|United States||Region of Enrollment||participants|Number|81|81.0||||||
4009548|NCT01199237|3829994|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4009549|NCT01199237|3829995|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4009550|NCT01199237|3829993|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4009551|NCT01199237|3829994|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4009552|NCT01199237|3829995|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4009553|NCT01199237|3829993|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4009554|NCT01199237|3829994|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4009555|NCT01199237|3829995|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4009556|NCT01199237|3829993|B3|||Age||years|Mean|44.3|44.3|Full Range|||40.2|48.7|
4009557|NCT01199237|3829994|B2|||Age||years|Mean|43.3|43.3|Full Range|||40.2|46.5|
4009558|NCT01199237|3829995|B1|||Age||years|Mean|45.3|45.3|Full Range|||42.0|48.7|
4009559|NCT01199146|3830010|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4009560|NCT01199146|3830010|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4009561|NCT01199146|3830010|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4009562|NCT01199146|3830010|B1|||Age||years|Median|71|71.0|Full Range|||59.0|93.0|
4009563|NCT01199042|3830016|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4009564|NCT01199042|3830016|B1|African American, Irish, Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4009565|NCT01199042|3830016|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4009566|NCT01199042|3830016|B1|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4009567|NCT01199042|3830016|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4009568|NCT01199042|3830016|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4009569|NCT01199042|3830016|B1|||Age||years|Mean|59|59.0|Standard Deviation|12|12.0|||
4009570|NCT01199016|3830025|B1||Male|Gender||Participants|Count of Participants|121|121.0||||||
4009571|NCT01199016|3830025|B1||Female|Gender||Participants|Count of Participants|115|115.0||||||
4009572|NCT01199016|3830025|B1|||Age||months|Mean|7.4|7.4|Standard Deviation|2.61|2.61|||
4009573|NCT01198977|3830032|B3|United States||Region of Enrollment||participants|Number|64|64.0||||||
4009574|NCT01198977|3830033|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4009575|NCT01198977|3830034|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4009576|NCT01198977|3830032|B3|Other||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4009577|NCT01198977|3830033|B2|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4009578|NCT01198977|3830034|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4009579|NCT01198977|3830032|B3|Non-Hispanic, White||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
4009580|NCT01198977|3830033|B2|Non-Hispanic, White||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4009581|NCT01198977|3830034|B1|Non-Hispanic, White||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4009582|NCT01198977|3830032|B3||Male|Gender||Participants|Count of Participants|41|41.0||||||
4009583|NCT01198977|3830033|B2||Male|Gender||Participants|Count of Participants|19|19.0||||||
4009584|NCT01198977|3830034|B1||Male|Gender||Participants|Count of Participants|22|22.0||||||
4009585|NCT01198977|3830032|B3||Female|Gender||Participants|Count of Participants|23|23.0||||||
4009586|NCT01198977|3830033|B2||Female|Gender||Participants|Count of Participants|14|14.0||||||
4009587|NCT01198977|3830034|B1||Female|Gender||Participants|Count of Participants|9|9.0||||||
4009588|NCT01198977|3830032|B3|||Age||years|Mean|53.1|53.1|Standard Deviation|12.3|12.3|||
4009589|NCT01198977|3830033|B2|||Age||years|Mean|53.6|53.6|Standard Deviation|13.1|13.1|||
4009590|NCT01198977|3830034|B1|||Age||years|Mean|52.7|52.7|Standard Deviation|11.6|11.6|||
4009591|NCT01198977|3830032|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4009592|NCT01198977|3830033|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4009593|NCT01198977|3830034|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4009594|NCT01198977|3830032|B3||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4009595|NCT01198977|3830033|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4009596|NCT01198977|3830034|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4009597|NCT01198977|3830032|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4009598|NCT01198977|3830033|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4009599|NCT01198977|3830034|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4009600|NCT01198873|3830045|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4009601|NCT01198873|3830046|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4009602|NCT01198873|3830047|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4009603|NCT01198873|3830045|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4009604|NCT01198873|3830046|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4009605|NCT01198873|3830047|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4009606|NCT01198873|3830045|B3|||Age||years|Mean|72.0|72.0|Standard Deviation|9.1|9.1|||
4009607|NCT01198873|3830046|B2|||Age||years|Mean|74.1|74.1|Standard Deviation|9.7|9.7|||
4009608|NCT01198873|3830047|B1|||Age||years|Mean|70.3|70.3|Standard Deviation|8.2|8.2|||
4009609|NCT01198795|3830062|B1|||BMI(Body Mass Index), mean||kg/m2|Mean|20.86|20.86|Standard Deviation|5.83|5.83|||
4009610|NCT01198795|3830062|B1|||Height, mean||cm|Mean|141.27|141.27|Standard Deviation|10.22|10.22|||
4009611|NCT01198795|3830062|B1|||Weight, mean||kg|Mean|42.71|42.71|Standard Deviation|16.67|16.67|||
4009612|NCT01198795|3830062|B1|United States||Region of Enrollment||participants|Number|118|118.0||||||
4009613|NCT01198795|3830062|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|102|102.0||||||
4009614|NCT01198795|3830062|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4009615|NCT01198795|3830062|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4009616|NCT01198795|3830062|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4009617|NCT01198795|3830062|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4009618|NCT01198795|3830062|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4009619|NCT01198795|3830062|B1|Black||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4009620|NCT01198795|3830062|B1|White||Race/Ethnicity, Customized||participants|Number|85|85.0||||||
4009621|NCT01198795|3830062|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4009622|NCT01198795|3830062|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4009623|NCT01198795|3830062|B1|Age 11 Years||Age, Customized||participants|Number|25|25.0||||||
4009624|NCT01198795|3830062|B1|Ages 9 Years to 10 Years||Age, Customized||participants|Number|62|62.0||||||
4009625|NCT01198795|3830062|B1|Ages 7 Years to 8 Years||Age, Customized||participants|Number|31|31.0||||||
4009626|NCT01198795|3830062|B1|||Age||Years|Mean|9.4|9.4|Standard Deviation|1.2|1.2|||
4009627|NCT01198769|3830066|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4009628|NCT01198769|3830066|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4009629|NCT01198769|3830066|B1|||Age||Weeks|Mean|8.9|8.9|Standard Deviation|0.80|0.8|||
4009630|NCT01198756|3830075|B5||Male|Sex: Female, Male||Participants|Count of Participants|1598|1598.0||||||
4009631|NCT01198756|3830076|B4||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4009632|NCT01198756|3830077|B3||Male|Sex: Female, Male||Participants|Count of Participants|468|468.0||||||
4009633|NCT01198756|3830078|B2||Male|Sex: Female, Male||Participants|Count of Participants|474|474.0||||||
4009634|NCT01198756|3830079|B1||Male|Sex: Female, Male||Participants|Count of Participants|498|498.0||||||
4009635|NCT01198756|3830075|B5||Female|Sex: Female, Male||Participants|Count of Participants|1496|1496.0||||||
4009636|NCT01198756|3830076|B4||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4009637|NCT01198756|3830077|B3||Female|Sex: Female, Male||Participants|Count of Participants|464|464.0||||||
4009638|NCT01198756|3830078|B2||Female|Sex: Female, Male||Participants|Count of Participants|455|455.0||||||
4009639|NCT01198756|3830079|B1||Female|Sex: Female, Male||Participants|Count of Participants|434|434.0||||||
4009640|NCT01198756|3830075|B5|||Age||Years|Mean|8.1|8.1|Standard Deviation|4.60|4.6|||
4009641|NCT01198756|3830076|B4|||Age||Years|Mean|1.2|1.2|Standard Deviation|0.73|0.73|||
4009642|NCT01198756|3830077|B3|||Age||Years|Mean|8.9|8.9|Standard Deviation|4.17|4.17|||
4009643|NCT01198756|3830078|B2|||Age||Years|Mean|8.9|8.9|Standard Deviation|4.23|4.23|||
4009644|NCT01198756|3830079|B1|||Age||Years|Mean|8.9|8.9|Standard Deviation|4.21|4.21|||
4009645|NCT01198691|3830178|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
4009646|NCT01198691|3830179|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
4009647|NCT01198691|3830180|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4009648|NCT01198691|3830178|B3|Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4009649|NCT01198691|3830179|B2|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4009650|NCT01198691|3830180|B1|Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4009651|NCT01198691|3830178|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4009652|NCT01198691|3830179|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4009653|NCT01198691|3830180|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4009654|NCT01198691|3830178|B3|White/Caucasian||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
4009655|NCT01198691|3830179|B2|White/Caucasian||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4009656|NCT01198691|3830180|B1|White/Caucasian||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4009657|NCT01198691|3830178|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4009658|NCT01198691|3830179|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4009659|NCT01198691|3830180|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4009660|NCT01198691|3830178|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4009661|NCT01198691|3830179|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4009662|NCT01198691|3830180|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4009663|NCT01198691|3830178|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4009664|NCT01198691|3830179|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4009665|NCT01198691|3830180|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4009666|NCT01198691|3830178|B3|||Age||years|Mean|27.85|27.85|Standard Deviation|5.89|5.89|||
4009667|NCT01198691|3830179|B2|||Age||years|Mean|27.38|27.38|Standard Deviation|6.15|6.15|||
4009668|NCT01198691|3830180|B1|||Age||years|Mean|28.32|28.32|Standard Deviation|5.63|5.63|||
4009669|NCT01198600|3830193|B1|Canada||Region of Enrollment||participants|Number|78|78.0||||||
4009670|NCT01198600|3830193|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4009671|NCT01198600|3830193|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4009672|NCT01198600|3830193|B1|||Age||years|Mean|25.7|25.7|Standard Deviation|7.9|7.9|||
4009673|NCT01198587|3830218|B5|United States||Region of Enrollment||Participants|Count of Participants|71|71.0||||||
4009674|NCT01198587|3830219|B4|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4009675|NCT01198587|3830220|B3|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4009676|NCT01198587|3830221|B2|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4009677|NCT01198587|3830222|B1|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
4009678|NCT01198587|3830218|B5||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4009679|NCT01198587|3830219|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4009680|NCT01198587|3830220|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4009681|NCT01198587|3830221|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4009682|NCT01198587|3830222|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4009683|NCT01198587|3830218|B5||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4009684|NCT01198587|3830219|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4009685|NCT01198587|3830220|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4009686|NCT01198587|3830221|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4009687|NCT01198587|3830222|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4009688|NCT01198587|3830218|B5|||Age||years|Mean|2.7|2.7|Inter-Quartile Range|||1.52|3.4|
4009689|NCT01198587|3830219|B4|||Age||years|Mean|3.6|3.6|Inter-Quartile Range|||1.4|5.1|
4009690|NCT01198587|3830220|B3|||Age||years|Mean|2|2.0|Inter-Quartile Range|||0.98|2.6|
4009691|NCT01198587|3830221|B2|||Age||years|Mean|2.9|2.9|Inter-Quartile Range|||2.0|3.1|
4009692|NCT01198587|3830222|B1|||Age||years|Mean|2.3|2.3|Inter-Quartile Range|||1.1|3.0|
4009693|NCT01198574|3830243|B5|Myanmar||Region of Enrollment||participants|Number|402|402.0||||||
4009694|NCT01198574|3830244|B4|Myanmar||Region of Enrollment||participants|Number|102|102.0||||||
4009695|NCT01198574|3830245|B3|Myanmar||Region of Enrollment||participants|Number|100|100.0||||||
4009696|NCT01198574|3830246|B2|Myanmar||Region of Enrollment||participants|Number|102|102.0||||||
4009697|NCT01198574|3830247|B1|Myanmar||Region of Enrollment||participants|Number|98|98.0||||||
4009698|NCT01198574|3830243|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4009699|NCT01198574|3830244|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4009700|NCT01198574|3830245|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4009701|NCT01198574|3830246|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4009702|NCT01198574|3830247|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4009703|NCT01198574|3830243|B5||Female|Sex: Female, Male||Participants|Count of Participants|402|402.0||||||
4009704|NCT01198574|3830244|B4||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4009705|NCT01198574|3830245|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4009706|NCT01198574|3830246|B2||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4009707|NCT01198574|3830247|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4009708|NCT01198574|3830243|B5|||Age||years|Mean|16.0|16.0|Standard Deviation|1.2|1.2|||
4009709|NCT01198574|3830244|B4|||Age||years|Mean|15.8|15.8|Standard Deviation|1.1|1.1|||
4009710|NCT01198574|3830245|B3|||Age||years|Mean|16.1|16.1|Standard Deviation|1.2|1.2|||
4009711|NCT01198574|3830246|B2|||Age||years|Mean|16.1|16.1|Standard Deviation|1.2|1.2|||
4009712|NCT01198574|3830247|B1|||Age||years|Mean|15.9|15.9|Standard Deviation|1.2|1.2|||
4009713|NCT01198574|3830243|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4009714|NCT01198574|3830244|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4009715|NCT01198574|3830245|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4009716|NCT01198574|3830246|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4009717|NCT01198574|3830247|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4009718|NCT01198574|3830243|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4009719|NCT01198574|3830244|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4009720|NCT01198574|3830245|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4009721|NCT01198574|3830246|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4009722|NCT01198574|3830247|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4009723|NCT01198574|3830243|B5||<=18 years|Age||Participants|Count of Participants|402|402.0||||||
4009724|NCT01198574|3830244|B4||<=18 years|Age||Participants|Count of Participants|102|102.0||||||
4009725|NCT01198574|3830245|B3||<=18 years|Age||Participants|Count of Participants|100|100.0||||||
4009726|NCT01198574|3830246|B2||<=18 years|Age||Participants|Count of Participants|102|102.0||||||
4009727|NCT01198574|3830247|B1||<=18 years|Age||Participants|Count of Participants|98|98.0||||||
4009728|NCT01198548|3830268|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4009729|NCT01198548|3830268|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4009730|NCT01198548|3830268|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4009731|NCT01198548|3830268|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4009732|NCT01198548|3830268|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4009733|NCT01198548|3830268|B1|||Age||years|Mean|57|57.0|Standard Deviation|8.43|8.43|||
4009734|NCT01198509|3830277|B7|United States||Region of Enrollment||participants|Number|178|178.0||||||
4009735|NCT01198509|3830278|B6|United States||Region of Enrollment||participants|Number|58|58.0||||||
4009736|NCT01198509|3830279|B5|United States||Region of Enrollment||participants|Number|20|20.0||||||
4009737|NCT01198509|3830280|B4|United States||Region of Enrollment||participants|Number|66|66.0||||||
4009738|NCT01198509|3830281|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4009739|NCT01198509|3830282|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4009740|NCT01198509|3830283|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4009741|NCT01198509|3830277|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009742|NCT01198509|3830278|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009743|NCT01198509|3830279|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009744|NCT01198509|3830280|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009745|NCT01198509|3830281|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009746|NCT01198509|3830282|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009747|NCT01198509|3830283|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009748|NCT01198509|3830277|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4009749|NCT01198509|3830278|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4009750|NCT01198509|3830279|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4009751|NCT01198509|3830280|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4009752|NCT01198509|3830281|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4009753|NCT01198509|3830282|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4009754|NCT01198509|3830283|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4009755|NCT01198509|3830277|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|117|117.0||||||
4009756|NCT01198509|3830278|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4009757|NCT01198509|3830279|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4009758|NCT01198509|3830280|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4009759|NCT01198509|3830281|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4009760|NCT01198509|3830282|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4009761|NCT01198509|3830283|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4009762|NCT01198509|3830277|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009763|NCT01198509|3830278|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009764|NCT01198509|3830279|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009765|NCT01198509|3830280|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009766|NCT01198509|3830281|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009767|NCT01198509|3830282|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009768|NCT01198509|3830283|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009769|NCT01198509|3830277|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
4009770|NCT01198509|3830278|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4009771|NCT01198509|3830279|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4009772|NCT01198509|3830280|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4009773|NCT01198509|3830281|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4009774|NCT01198509|3830282|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4009775|NCT01198509|3830283|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4009776|NCT01198509|3830277|B7||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4009777|NCT01198509|3830278|B6||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4009778|NCT01198509|3830279|B5||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4009779|NCT01198509|3830280|B4||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4009780|NCT01198509|3830281|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4009781|NCT01198509|3830282|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4009782|NCT01198509|3830283|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4009783|NCT01198509|3830277|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4009784|NCT01198509|3830278|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4009785|NCT01198509|3830279|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4009786|NCT01198509|3830280|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4009787|NCT01198509|3830281|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4009788|NCT01198509|3830282|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4009789|NCT01198509|3830283|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4009790|NCT01198509|3830277|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009791|NCT01198509|3830278|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009792|NCT01198509|3830279|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009793|NCT01198509|3830280|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009794|NCT01198509|3830281|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009795|NCT01198509|3830282|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009796|NCT01198509|3830283|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009797|NCT01198509|3830277|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4009798|NCT01198509|3830278|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4009799|NCT01198509|3830279|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4009800|NCT01198509|3830280|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4009801|NCT01198509|3830281|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4009802|NCT01198509|3830282|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4009803|NCT01198509|3830283|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009804|NCT01198509|3830277|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009805|NCT01198509|3830278|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009806|NCT01198509|3830279|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009807|NCT01198509|3830280|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009808|NCT01198509|3830281|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009809|NCT01198509|3830282|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009810|NCT01198509|3830283|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4009811|NCT01198509|3830277|B7||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4009812|NCT01198509|3830278|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4009813|NCT01198509|3830279|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4009814|NCT01198509|3830280|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4009815|NCT01198509|3830281|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4009816|NCT01198509|3830282|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4009817|NCT01198509|3830283|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4009818|NCT01198509|3830277|B7||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4009819|NCT01198509|3830278|B6||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4009820|NCT01198509|3830279|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4009821|NCT01198509|3830280|B4||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4009822|NCT01198509|3830281|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4009823|NCT01198509|3830282|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4009824|NCT01198509|3830283|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4009825|NCT01198509|3830277|B7||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4009826|NCT01198509|3830278|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4009827|NCT01198509|3830279|B5||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4009828|NCT01198509|3830280|B4||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4009829|NCT01198509|3830281|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4009830|NCT01198509|3830282|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4009831|NCT01198509|3830283|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4009832|NCT01198509|3830277|B7||Between 18 and 65 years|Age||Participants|Count of Participants|167|167.0||||||
4009833|NCT01198509|3830278|B6||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4009834|NCT01198509|3830279|B5||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4009835|NCT01198509|3830280|B4||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4009836|NCT01198509|3830281|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4009837|NCT01198509|3830282|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4009838|NCT01198509|3830283|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4009839|NCT01198509|3830277|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4009840|NCT01198509|3830278|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4009841|NCT01198509|3830279|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4009842|NCT01198509|3830280|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4009843|NCT01198509|3830281|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4009844|NCT01198509|3830282|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4009845|NCT01198509|3830283|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4009846|NCT01198509|3830277|B7|||Age||years|Mean|44.2|44.2|Full Range|||20.0|85.0|
4009847|NCT01198509|3830278|B6|||Age||years|Mean|40.7|40.7|Full Range|||21.0|62.0|
4009848|NCT01198509|3830279|B5|||Age||years|Mean|45.5|45.5|Full Range|||26.0|73.0|
4009849|NCT01198509|3830280|B4|||Age||years|Mean|49.1|49.1|Full Range|||20.0|85.0|
4009850|NCT01198509|3830281|B3|||Age||years|Mean|39.2|39.2|Full Range|||26.0|69.0|
4009851|NCT01198509|3830282|B2|||Age||years|Mean|41.5|41.5|Full Range|||24.0|63.0|
4009852|NCT01198509|3830283|B1|||Age||years|Mean|44.0|44.0|Full Range|||31.0|68.0|
4009853|NCT01198470|3830305|B1|||Weight||pounds|Mean|178.1|178.1|Standard Deviation|26.1|26.1|||
4009854|NCT01198470|3830305|B1|||Height||inches|Mean|67.2|67.2|Standard Deviation|3.0|3.0|||
4009855|NCT01198470|3830305|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4009856|NCT01198470|3830305|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4009857|NCT01198470|3830305|B1|||Age||years|Mean|37.9|37.9|Standard Deviation|9.8|9.8|||
4009858|NCT01198366|3830312|B7|Kenya||Region of Enrollment|Two sites in South Africa - Worcester and Soweto. Soweto only participated in Group 5.|participants|Number|285|285.0||||||
4009910|NCT01198366|3830315|B4|Black||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4009859|NCT01198366|3830313|B6|Kenya||Region of Enrollment|Two sites in South Africa - Worcester and Soweto. Soweto only participated in Group 5.|participants|Number|71|71.0||||||
4009860|NCT01198366|3830314|B5|Kenya||Region of Enrollment|Two sites in South Africa - Worcester and Soweto. Soweto only participated in Group 5.|participants|Number|70|70.0||||||
4009861|NCT01198366|3830315|B4|Kenya||Region of Enrollment|Two sites in South Africa - Worcester and Soweto. Soweto only participated in Group 5.|participants|Number|36|36.0||||||
4009862|NCT01198366|3830316|B3|Kenya||Region of Enrollment|Two sites in South Africa - Worcester and Soweto. Soweto only participated in Group 5.|participants|Number|36|36.0||||||
4009863|NCT01198366|3830317|B2|Kenya||Region of Enrollment|Two sites in South Africa - Worcester and Soweto. Soweto only participated in Group 5.|participants|Number|36|36.0||||||
4009864|NCT01198366|3830318|B1|Kenya||Region of Enrollment|Two sites in South Africa - Worcester and Soweto. Soweto only participated in Group 5.|participants|Number|36|36.0||||||
4009865|NCT01198366|3830312|B7|South Africa||Region of Enrollment|Two sites in South Africa - Worcester and Soweto. Soweto only participated in Group 5.|participants|Number|188|188.0||||||
4009866|NCT01198366|3830313|B6|South Africa||Region of Enrollment|Two sites in South Africa - Worcester and Soweto. Soweto only participated in Group 5.|participants|Number|70|70.0||||||
4009867|NCT01198366|3830314|B5|South Africa||Region of Enrollment|Two sites in South Africa - Worcester and Soweto. Soweto only participated in Group 5.|participants|Number|70|70.0||||||
4009868|NCT01198366|3830315|B4|South Africa||Region of Enrollment|Two sites in South Africa - Worcester and Soweto. Soweto only participated in Group 5.|participants|Number|12|12.0||||||
4009869|NCT01198366|3830316|B3|South Africa||Region of Enrollment|Two sites in South Africa - Worcester and Soweto. Soweto only participated in Group 5.|participants|Number|12|12.0||||||
4009870|NCT01198366|3830317|B2|South Africa||Region of Enrollment|Two sites in South Africa - Worcester and Soweto. Soweto only participated in Group 5.|participants|Number|12|12.0||||||
4009871|NCT01198366|3830318|B1|South Africa||Region of Enrollment|Two sites in South Africa - Worcester and Soweto. Soweto only participated in Group 5.|participants|Number|12|12.0||||||
4009872|NCT01198366|3830312|B7|Mozambique||Region of Enrollment|Two sites in South Africa - Worcester and Soweto. Soweto only participated in Group 5.|participants|Number|14|14.0||||||
4009873|NCT01198366|3830313|B6|Mozambique||Region of Enrollment|Two sites in South Africa - Worcester and Soweto. Soweto only participated in Group 5.|participants|Number|0|0.0||||||
4009874|NCT01198366|3830314|B5|Mozambique||Region of Enrollment|Two sites in South Africa - Worcester and Soweto. Soweto only participated in Group 5.|participants|Number|0|0.0||||||
4009875|NCT01198366|3830315|B4|Mozambique||Region of Enrollment|Two sites in South Africa - Worcester and Soweto. Soweto only participated in Group 5.|participants|Number|4|4.0||||||
4009876|NCT01198366|3830316|B3|Mozambique||Region of Enrollment|Two sites in South Africa - Worcester and Soweto. Soweto only participated in Group 5.|participants|Number|3|3.0||||||
4009877|NCT01198366|3830317|B2|Mozambique||Region of Enrollment|Two sites in South Africa - Worcester and Soweto. Soweto only participated in Group 5.|participants|Number|3|3.0||||||
4009878|NCT01198366|3830318|B1|Mozambique||Region of Enrollment|Two sites in South Africa - Worcester and Soweto. Soweto only participated in Group 5.|participants|Number|4|4.0||||||
4009879|NCT01198366|3830312|B7|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4009880|NCT01198366|3830313|B6|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4009881|NCT01198366|3830314|B5|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4009882|NCT01198366|3830315|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4009883|NCT01198366|3830316|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4009884|NCT01198366|3830317|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4009885|NCT01198366|3830318|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4009886|NCT01198366|3830312|B7|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4009887|NCT01198366|3830313|B6|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4009888|NCT01198366|3830314|B5|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4009889|NCT01198366|3830315|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4009890|NCT01198366|3830316|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4009891|NCT01198366|3830317|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4009892|NCT01198366|3830318|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4009893|NCT01198366|3830312|B7|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4009894|NCT01198366|3830313|B6|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4009895|NCT01198366|3830314|B5|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4009896|NCT01198366|3830315|B4|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4009897|NCT01198366|3830316|B3|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4009898|NCT01198366|3830317|B2|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4009899|NCT01198366|3830318|B1|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4009900|NCT01198366|3830312|B7|Coloured||Race/Ethnicity, Customized||participants|Number|117|117.0||||||
4009901|NCT01198366|3830313|B6|Coloured||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4009902|NCT01198366|3830314|B5|Coloured||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4009903|NCT01198366|3830315|B4|Coloured||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4009904|NCT01198366|3830316|B3|Coloured||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4009905|NCT01198366|3830317|B2|Coloured||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4009906|NCT01198366|3830318|B1|Coloured||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4009907|NCT01198366|3830312|B7|Black||Race/Ethnicity, Customized||participants|Number|370|370.0||||||
4009908|NCT01198366|3830313|B6|Black||Race/Ethnicity, Customized||participants|Number|98|98.0||||||
4009909|NCT01198366|3830314|B5|Black||Race/Ethnicity, Customized||participants|Number|102|102.0||||||
4009911|NCT01198366|3830316|B3|Black||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4009912|NCT01198366|3830317|B2|Black||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4009913|NCT01198366|3830318|B1|Black||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4009914|NCT01198366|3830312|B7||Male|Sex: Female, Male||Participants|Count of Participants|270|270.0||||||
4009915|NCT01198366|3830313|B6||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4009916|NCT01198366|3830314|B5||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4009917|NCT01198366|3830315|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4009918|NCT01198366|3830316|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4009919|NCT01198366|3830317|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4009920|NCT01198366|3830318|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4009921|NCT01198366|3830312|B7||Female|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
4009922|NCT01198366|3830313|B6||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4009923|NCT01198366|3830314|B5||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4009924|NCT01198366|3830315|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4009925|NCT01198366|3830316|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4009926|NCT01198366|3830317|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4009927|NCT01198366|3830318|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4009928|NCT01198366|3830312|B7|Age at Study Day 0 in Days||Age, Customized|≥112 days (16 weeks) and ≤182 days (26 weeks) on Study Day 0|Days|Mean|146.3|146.3|Standard Deviation|19.97|19.97|||
4009929|NCT01198366|3830313|B6|Age at Study Day 0 in Days||Age, Customized|≥112 days (16 weeks) and ≤182 days (26 weeks) on Study Day 0|Days|Mean|150.2|150.2|Standard Deviation|20.22|20.22|||
4009930|NCT01198366|3830314|B5|Age at Study Day 0 in Days||Age, Customized|≥112 days (16 weeks) and ≤182 days (26 weeks) on Study Day 0|Days|Mean|145.2|145.2|Standard Deviation|19.98|19.98|||
4009931|NCT01198366|3830315|B4|Age at Study Day 0 in Days||Age, Customized|≥112 days (16 weeks) and ≤182 days (26 weeks) on Study Day 0|Days|Mean|149.1|149.1|Standard Deviation|21.44|21.44|||
4009932|NCT01198366|3830316|B3|Age at Study Day 0 in Days||Age, Customized|≥112 days (16 weeks) and ≤182 days (26 weeks) on Study Day 0|Days|Mean|138.6|138.6|Standard Deviation|19.45|19.45|||
4009933|NCT01198366|3830317|B2|Age at Study Day 0 in Days||Age, Customized|≥112 days (16 weeks) and ≤182 days (26 weeks) on Study Day 0|Days|Mean|144.5|144.5|Standard Deviation|17.83|17.83|||
4009934|NCT01198366|3830318|B1|Age at Study Day 0 in Days||Age, Customized|≥112 days (16 weeks) and ≤182 days (26 weeks) on Study Day 0|Days|Mean|145.3|145.3|Standard Deviation|18.15|18.15|||
4009935|NCT01198327|3830361|B1|United States||Region of Enrollment||participants|Number|66|66.0||||||
4009936|NCT01198327|3830361|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4009937|NCT01198327|3830361|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4009938|NCT01198327|3830361|B1|||Age||years|Mean|67.9|67.9|Standard Deviation|10.8|10.8|||
4009939|NCT01198327|3830361|B1||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
4009940|NCT01198327|3830361|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4009941|NCT01198327|3830361|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4009942|NCT01198275|3830369|B3||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4009943|NCT01198275|3830370|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4009944|NCT01198275|3830371|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4009945|NCT01198275|3830369|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4009946|NCT01198275|3830370|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4009947|NCT01198275|3830371|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4009948|NCT01198275|3830369|B3|||Age||years|Mean|69.6|69.6|Standard Deviation|7.5|7.5|||
4009949|NCT01198275|3830370|B2|||Age||years|Mean|69|69.0|Standard Deviation|9|9.0|||
4009950|NCT01198275|3830371|B1|||Age||years|Mean|70|70.0|Standard Deviation|6|6.0|||
4009951|NCT01198145|3830378|B3|United States||Region of Enrollment||participants|Number|84|84.0||||||
4009952|NCT01198145|3830379|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
4009953|NCT01198145|3830380|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4009954|NCT01198145|3830378|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4009955|NCT01198145|3830379|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4009956|NCT01198145|3830380|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4009957|NCT01198145|3830378|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4009958|NCT01198145|3830379|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4009959|NCT01198145|3830380|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4009960|NCT01198145|3830378|B3|||Age||years|Median|58|58.0|Full Range|||37.0|84.0|
4009961|NCT01198145|3830379|B2|||Age||years|Median|56.5|56.5|Full Range|||37.0|81.0|
4009962|NCT01198145|3830380|B1|||Age||years|Median|59|59.0|Full Range|||37.0|84.0|
4009963|NCT01198132|3830401|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4009964|NCT01198132|3830402|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4009965|NCT01198132|3830403|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4009966|NCT01198132|3830401|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4009967|NCT01198132|3830402|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4009968|NCT01198132|3830403|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4009969|NCT01198132|3830401|B3|||Age||years|Mean|37.7|37.7|Standard Deviation|8.81|8.81|||
4009970|NCT01198132|3830402|B2|||Age||years|Mean|36.9|36.9|Standard Deviation|8.34|8.34|||
4009971|NCT01198132|3830403|B1|||Age||years|Mean|38.5|38.5|Standard Deviation|9.29|9.29|||
4009972|NCT01198002|3830428|B4|South Korea||Region of Enrollment||Participants|Count of Participants|68|68.0||||||
4009973|NCT01198002|3830429|B3|South Korea||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4009974|NCT01198002|3830430|B2|South Korea||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4009975|NCT01198002|3830431|B1|South Korea||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4009976|NCT01198002|3830428|B4|New Zealand||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4009977|NCT01198002|3830429|B3|New Zealand||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4009978|NCT01198002|3830430|B2|New Zealand||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4009979|NCT01198002|3830431|B1|New Zealand||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4009980|NCT01198002|3830428|B4|Japan||Region of Enrollment||Participants|Count of Participants|158|158.0||||||
4009981|NCT01198002|3830429|B3|Japan||Region of Enrollment||Participants|Count of Participants|53|53.0||||||
4009982|NCT01198002|3830430|B2|Japan||Region of Enrollment||Participants|Count of Participants|53|53.0||||||
4009983|NCT01198002|3830431|B1|Japan||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
4009984|NCT01198002|3830428|B4|Bulgaria||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
4009985|NCT01198002|3830429|B3|Bulgaria||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4009986|NCT01198002|3830430|B2|Bulgaria||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4009987|NCT01198002|3830431|B1|Bulgaria||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4009988|NCT01198002|3830428|B4|South Africa||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
4009989|NCT01198002|3830429|B3|South Africa||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4009990|NCT01198002|3830430|B2|South Africa||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4009991|NCT01198002|3830431|B1|South Africa||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4009992|NCT01198002|3830428|B4|Romania||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4009993|NCT01198002|3830429|B3|Romania||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4009994|NCT01198002|3830430|B2|Romania||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4009995|NCT01198002|3830431|B1|Romania||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4009996|NCT01198002|3830428|B4|Croatia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4009997|NCT01198002|3830429|B3|Croatia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4009998|NCT01198002|3830430|B2|Croatia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4009999|NCT01198002|3830431|B1|Croatia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4010000|NCT01198002|3830428|B4|Poland||Region of Enrollment||Participants|Count of Participants|100|100.0||||||
4010001|NCT01198002|3830429|B3|Poland||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
4010002|NCT01198002|3830430|B2|Poland||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
4010003|NCT01198002|3830431|B1|Poland||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
4010004|NCT01198002|3830428|B4|Brazil||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
4010005|NCT01198002|3830429|B3|Brazil||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4010006|NCT01198002|3830430|B2|Brazil||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4010007|NCT01198002|3830431|B1|Brazil||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4010008|NCT01198002|3830428|B4|Malaysia||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4010009|NCT01198002|3830429|B3|Malaysia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4010010|NCT01198002|3830430|B2|Malaysia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4010011|NCT01198002|3830431|B1|Malaysia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4010012|NCT01198002|3830428|B4|Argentina||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
4010013|NCT01198002|3830429|B3|Argentina||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4010014|NCT01198002|3830430|B2|Argentina||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
4010015|NCT01198002|3830431|B1|Argentina||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
4010016|NCT01198002|3830428|B4|Mexico||Region of Enrollment||Participants|Count of Participants|64|64.0||||||
4010017|NCT01198002|3830429|B3|Mexico||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
4010018|NCT01198002|3830430|B2|Mexico||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4010019|NCT01198002|3830431|B1|Mexico||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4010020|NCT01198002|3830428|B4|Hungary||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4010021|NCT01198002|3830429|B3|Hungary||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4010022|NCT01198002|3830430|B2|Hungary||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4010023|NCT01198002|3830431|B1|Hungary||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4010024|NCT01198002|3830428|B4|India||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4010025|NCT01198002|3830429|B3|India||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4010026|NCT01198002|3830430|B2|India||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4010027|NCT01198002|3830431|B1|India||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4010028|NCT01198002|3830428|B4|Sri Lanka||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4010029|NCT01198002|3830429|B3|Sri Lanka||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4010030|NCT01198002|3830430|B2|Sri Lanka||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4010031|NCT01198002|3830431|B1|Sri Lanka||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4010032|NCT01198002|3830428|B4|Colombia||Region of Enrollment||Participants|Count of Participants|51|51.0||||||
4010033|NCT01198002|3830429|B3|Colombia||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4010034|NCT01198002|3830430|B2|Colombia||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
4010035|NCT01198002|3830431|B1|Colombia||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4010036|NCT01198002|3830428|B4|Russia||Region of Enrollment||Participants|Count of Participants|72|72.0||||||
4010037|NCT01198002|3830429|B3|Russia||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
4010038|NCT01198002|3830430|B2|Russia||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4010039|NCT01198002|3830431|B1|Russia||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4010040|NCT01198002|3830428|B4|Lithuania||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4010041|NCT01198002|3830429|B3|Lithuania||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4010042|NCT01198002|3830430|B2|Lithuania||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4010043|NCT01198002|3830431|B1|Lithuania||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4010044|NCT01198002|3830428|B4|Ukraine||Region of Enrollment||Participants|Count of Participants|68|68.0||||||
4010045|NCT01198002|3830429|B3|Ukraine||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4010046|NCT01198002|3830430|B2|Ukraine||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4010047|NCT01198002|3830431|B1|Ukraine||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4010048|NCT01198002|3830428|B4|Slovakia||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4010049|NCT01198002|3830429|B3|Slovakia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4010050|NCT01198002|3830430|B2|Slovakia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4010051|NCT01198002|3830431|B1|Slovakia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4010052|NCT01198002|3830428|B4|Taiwan||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
4010053|NCT01198002|3830429|B3|Taiwan||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4010054|NCT01198002|3830430|B2|Taiwan||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4010055|NCT01198002|3830431|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4010056|NCT01198002|3830428|B4|United States||Region of Enrollment||Participants|Count of Participants|167|167.0||||||
4010057|NCT01198002|3830429|B3|United States||Region of Enrollment||Participants|Count of Participants|56|56.0||||||
4010058|NCT01198002|3830430|B2|United States||Region of Enrollment||Participants|Count of Participants|55|55.0||||||
4010059|NCT01198002|3830431|B1|United States||Region of Enrollment||Participants|Count of Participants|56|56.0||||||
4010060|NCT01198002|3830428|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4010061|NCT01198002|3830429|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4010062|NCT01198002|3830430|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4010063|NCT01198002|3830431|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4010064|NCT01198002|3830428|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4010065|NCT01198002|3830429|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4010066|NCT01198002|3830430|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4010067|NCT01198002|3830431|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4010068|NCT01198002|3830428|B4||White|Race (NIH/OMB)||Participants|Count of Participants|588|588.0||||||
4010069|NCT01198002|3830429|B3||White|Race (NIH/OMB)||Participants|Count of Participants|200|200.0||||||
4010070|NCT01198002|3830430|B2||White|Race (NIH/OMB)||Participants|Count of Participants|197|197.0||||||
4010071|NCT01198002|3830431|B1||White|Race (NIH/OMB)||Participants|Count of Participants|191|191.0||||||
4010072|NCT01198002|3830428|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4010073|NCT01198002|3830429|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4010074|NCT01198002|3830430|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4010075|NCT01198002|3830431|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4010076|NCT01198002|3830428|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4010077|NCT01198002|3830429|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010078|NCT01198002|3830430|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4010079|NCT01198002|3830431|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010080|NCT01198002|3830428|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|303|303.0||||||
4010081|NCT01198002|3830429|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
4010082|NCT01198002|3830430|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
4010083|NCT01198002|3830431|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
4010084|NCT01198002|3830428|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4010085|NCT01198002|3830429|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4010086|NCT01198002|3830430|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4010087|NCT01198002|3830431|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4010088|NCT01198002|3830428|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|439|439.0||||||
4010089|NCT01198002|3830429|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|148|148.0||||||
4010090|NCT01198002|3830430|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|149|149.0||||||
4010091|NCT01198002|3830431|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|142|142.0||||||
4010092|NCT01198002|3830428|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|411|411.0||||||
4010093|NCT01198002|3830429|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
4010094|NCT01198002|3830430|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
4010095|NCT01198002|3830431|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
4010096|NCT01198002|3830428|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|191|191.0||||||
4010097|NCT01198002|3830429|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4010098|NCT01198002|3830430|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4010099|NCT01198002|3830431|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4010100|NCT01198002|3830428|B4||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4010101|NCT01198002|3830429|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4010102|NCT01198002|3830430|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4010103|NCT01198002|3830431|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4010104|NCT01198002|3830428|B4||Female|Sex: Female, Male||Participants|Count of Participants|877|877.0||||||
4010105|NCT01198002|3830429|B3||Female|Sex: Female, Male||Participants|Count of Participants|292|292.0||||||
4010106|NCT01198002|3830430|B2||Female|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
4010107|NCT01198002|3830431|B1||Female|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
4010108|NCT01198002|3830428|B4|||Age||years|Mean|53.2|53.2|Standard Deviation|11.4|11.4|||
4010109|NCT01198002|3830429|B3|||Age||years|Mean|52.9|52.9|Standard Deviation|11.5|11.5|||
4010110|NCT01198002|3830430|B2|||Age||years|Mean|52.8|52.8|Standard Deviation|10.9|10.9|||
4010111|NCT01198002|3830431|B1|||Age||years|Mean|53.7|53.7|Standard Deviation|11.8|11.8|||
4010112|NCT01197911|3830545|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4010113|NCT01197911|3830546|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4010114|NCT01197911|3830547|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4010115|NCT01197911|3830548|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4010116|NCT01197911|3830545|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4010117|NCT01197911|3830546|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4010118|NCT01197911|3830547|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4010119|NCT01197911|3830548|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4010120|NCT01197911|3830545|B4|||Age||years|Mean|49.3|49.3|Standard Deviation|6.69|6.69|||
4010121|NCT01197911|3830546|B3|||Age||years|Mean|52.8|52.8|Standard Deviation|6.14|6.14|||
4010122|NCT01197911|3830547|B2|||Age||years|Mean|46.7|46.7|Standard Deviation|8.39|8.39|||
4010123|NCT01197911|3830548|B1|||Age||years|Mean|48.7|48.7|Standard Deviation|5.36|5.36|||
4010124|NCT01197898|3830633|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4010125|NCT01197898|3830634|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4010126|NCT01197898|3830635|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4010127|NCT01197898|3830633|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4010128|NCT01197898|3830634|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4010129|NCT01197898|3830635|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4010130|NCT01197898|3830633|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4010131|NCT01197898|3830634|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4010132|NCT01197898|3830635|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4010133|NCT01197898|3830633|B3|||Age||years|Mean|61.5|61.5|Standard Deviation|14.5|14.5|||
4010134|NCT01197898|3830634|B2|||Age||years|Mean|50.6|50.6|Standard Deviation|10.2|10.2|||
4010135|NCT01197898|3830635|B1|||Age||years|Mean|72.4|72.4|Standard Deviation|8.3|8.3|||
4010136|NCT01197898|3830633|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4010137|NCT01197898|3830634|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4010138|NCT01197898|3830635|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4010139|NCT01197898|3830633|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4010140|NCT01197898|3830634|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4010141|NCT01197898|3830635|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4010142|NCT01197898|3830633|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4010143|NCT01197898|3830634|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4010144|NCT01197898|3830635|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4010145|NCT01197833|3830642|B4|||BMI||kg^m2|Mean|28.3|28.3|Standard Deviation|5.32|5.32|||
4010146|NCT01197833|3830643|B3|||BMI||kg^m2|Mean|28.1|28.1|Standard Deviation|5.25|5.25|||
4010147|NCT01197833|3830644|B2|||BMI||kg^m2|Mean|27.7|27.7|Standard Deviation|4.58|4.58|||
4010148|NCT01197833|3830645|B1|||BMI||kg^m2|Mean|29.3|29.3|Standard Deviation|6.04|6.04|||
4010149|NCT01197833|3830642|B4||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4010150|NCT01197833|3830643|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4010151|NCT01197833|3830644|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4010152|NCT01197833|3830645|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4010153|NCT01197833|3830642|B4||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4010154|NCT01197833|3830643|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4010155|NCT01197833|3830644|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4010156|NCT01197833|3830645|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4010157|NCT01197833|3830642|B4|||Age||years|Mean|52.0|52.0|Standard Deviation|11.18|11.18|||
4010158|NCT01197833|3830643|B3|||Age||years|Mean|51.8|51.8|Standard Deviation|9.75|9.75|||
4010159|NCT01197833|3830644|B2|||Age||years|Mean|50.1|50.1|Standard Deviation|11.60|11.6|||
4010160|NCT01197833|3830645|B1|||Age||years|Mean|54.1|54.1|Standard Deviation|12.05|12.05|||
4010161|NCT01197794|3830658|B8|||Total daily dose of inhaled glucocorticosteroids (ICS)||µg|Mean|407.30|407.3|Full Range|||100.0|1000.0|
4010162|NCT01197794|3830659|B7|||Total daily dose of inhaled glucocorticosteroids (ICS)||µg|Mean|410.99|410.99|Full Range|||160.0|1000.0|
4010163|NCT01197794|3830660|B6|||Total daily dose of inhaled glucocorticosteroids (ICS)||µg|Mean|418.19|418.19|Full Range|||125.0|1000.0|
4010164|NCT01197794|3830661|B5|||Total daily dose of inhaled glucocorticosteroids (ICS)||µg|Mean|405.56|405.56|Full Range|||160.0|1000.0|
4010165|NCT01197794|3830662|B4|||Total daily dose of inhaled glucocorticosteroids (ICS)||µg|Mean|396.46|396.46|Full Range|||150.0|500.0|
4010166|NCT01197794|3830663|B3|||Total daily dose of inhaled glucocorticosteroids (ICS)||µg|Mean|413.70|413.7|Full Range|||125.0|1000.0|
4010167|NCT01197794|3830664|B2|||Total daily dose of inhaled glucocorticosteroids (ICS)||µg|Mean|399.75|399.75|Full Range|||100.0|1000.0|
4010168|NCT01197794|3830665|B1|||Total daily dose of inhaled glucocorticosteroids (ICS)||µg|Mean|406.31|406.31|Full Range|||125.0|1000.0|
4010169|NCT01197794|3830658|B8|||Pre-bronchodilator FEV1 percentage of predicted normal (PN) at randomization||Percentage of predicted normal|Mean|68.73|68.73|Standard Deviation|11.615|11.615|||
4010170|NCT01197794|3830659|B7|||Pre-bronchodilator FEV1 percentage of predicted normal (PN) at randomization||Percentage of predicted normal|Mean|68.52|68.52|Standard Deviation|11.319|11.319|||
4010171|NCT01197794|3830660|B6|||Pre-bronchodilator FEV1 percentage of predicted normal (PN) at randomization||Percentage of predicted normal|Mean|69.06|69.06|Standard Deviation|12.132|12.132|||
4010172|NCT01197794|3830661|B5|||Pre-bronchodilator FEV1 percentage of predicted normal (PN) at randomization||Percentage of predicted normal|Mean|67.28|67.28|Standard Deviation|11.732|11.732|||
4010173|NCT01197794|3830662|B4|||Pre-bronchodilator FEV1 percentage of predicted normal (PN) at randomization||Percentage of predicted normal|Mean|68.56|68.56|Standard Deviation|12.186|12.186|||
4010174|NCT01197794|3830663|B3|||Pre-bronchodilator FEV1 percentage of predicted normal (PN) at randomization||Percentage of predicted normal|Mean|68.86|68.86|Standard Deviation|11.774|11.774|||
4010175|NCT01197794|3830664|B2|||Pre-bronchodilator FEV1 percentage of predicted normal (PN) at randomization||Percentage of predicted normal|Mean|68.86|68.86|Standard Deviation|11.580|11.58|||
4010176|NCT01197794|3830665|B1|||Pre-bronchodilator FEV1 percentage of predicted normal (PN) at randomization||Percentage of predicted normal|Mean|70.03|70.03|Standard Deviation|10.544|10.544|||
4010177|NCT01197794|3830658|B8|Never||Smoking status||Participants|Number|997|997.0||||||
4010178|NCT01197794|3830659|B7|Never||Smoking status||Participants|Number|146|146.0||||||
4010179|NCT01197794|3830660|B6|Never||Smoking status||Participants|Number|144|144.0||||||
4010180|NCT01197794|3830661|B5|Never||Smoking status||Participants|Number|136|136.0||||||
4010181|NCT01197794|3830662|B4|Never||Smoking status||Participants|Number|143|143.0||||||
4010182|NCT01197794|3830663|B3|Never||Smoking status||Participants|Number|152|152.0||||||
4010183|NCT01197794|3830664|B2|Never||Smoking status||Participants|Number|137|137.0||||||
4010184|NCT01197794|3830665|B1|Never||Smoking status||Participants|Number|139|139.0||||||
4010185|NCT01197794|3830658|B8|Former smoker||Smoking status||Participants|Number|144|144.0||||||
4010186|NCT01197794|3830659|B7|Former smoker||Smoking status||Participants|Number|15|15.0||||||
4010187|NCT01197794|3830660|B6|Former smoker||Smoking status||Participants|Number|19|19.0||||||
4010188|NCT01197794|3830661|B5|Former smoker||Smoking status||Participants|Number|26|26.0||||||
4010189|NCT01197794|3830662|B4|Former smoker||Smoking status||Participants|Number|21|21.0||||||
4010190|NCT01197794|3830663|B3|Former smoker||Smoking status||Participants|Number|14|14.0||||||
4010191|NCT01197794|3830664|B2|Former smoker||Smoking status||Participants|Number|24|24.0||||||
4010192|NCT01197794|3830665|B1|Former smoker||Smoking status||Participants|Number|25|25.0||||||
4010193|NCT01197794|3830658|B8|||Time since asthma diagnosis||Years|Mean|18.1|18.1|Standard Deviation|13.70|13.7|||
4010194|NCT01197794|3830659|B7|||Time since asthma diagnosis||Years|Mean|17.5|17.5|Standard Deviation|13.27|13.27|||
4010195|NCT01197794|3830660|B6|||Time since asthma diagnosis||Years|Mean|17.3|17.3|Standard Deviation|12.40|12.4|||
4010196|NCT01197794|3830661|B5|||Time since asthma diagnosis||Years|Mean|18.0|18.0|Standard Deviation|14.35|14.35|||
4010197|NCT01197794|3830662|B4|||Time since asthma diagnosis||Years|Mean|18.3|18.3|Standard Deviation|13.04|13.04|||
4010198|NCT01197794|3830663|B3|||Time since asthma diagnosis||Years|Mean|18.6|18.6|Standard Deviation|14.74|14.74|||
4010199|NCT01197794|3830664|B2|||Time since asthma diagnosis||Years|Mean|18.5|18.5|Standard Deviation|14.25|14.25|||
4010200|NCT01197794|3830665|B1|||Time since asthma diagnosis||Years|Mean|18.6|18.6|Standard Deviation|13.87|13.87|||
4010201|NCT01197794|3830658|B8|Other||Race/Ethnicity, Customized||Participants|Number|94|94.0||||||
4010202|NCT01197794|3830659|B7|Other||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4010203|NCT01197794|3830660|B6|Other||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4010204|NCT01197794|3830661|B5|Other||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4010205|NCT01197794|3830662|B4|Other||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4010206|NCT01197794|3830663|B3|Other||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4010207|NCT01197794|3830664|B2|Other||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4010208|NCT01197794|3830665|B1|Other||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4010209|NCT01197794|3830658|B8|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4010210|NCT01197794|3830659|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4010211|NCT01197794|3830660|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4010212|NCT01197794|3830661|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4010213|NCT01197794|3830662|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4010214|NCT01197794|3830663|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4010215|NCT01197794|3830664|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4010216|NCT01197794|3830665|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4010217|NCT01197794|3830658|B8|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4010218|NCT01197794|3830659|B7|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4010219|NCT01197794|3830660|B6|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4010220|NCT01197794|3830661|B5|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4010221|NCT01197794|3830662|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4010222|NCT01197794|3830663|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4010223|NCT01197794|3830664|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4010224|NCT01197794|3830665|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4010225|NCT01197794|3830658|B8|Asian||Race/Ethnicity, Customized||Participants|Number|195|195.0||||||
4010226|NCT01197794|3830659|B7|Asian||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
4010227|NCT01197794|3830660|B6|Asian||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
4010228|NCT01197794|3830661|B5|Asian||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
4010229|NCT01197794|3830662|B4|Asian||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
4010230|NCT01197794|3830663|B3|Asian||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
4010231|NCT01197794|3830664|B2|Asian||Race/Ethnicity, Customized||Participants|Number|26|26.0||||||
4010232|NCT01197794|3830665|B1|Asian||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
4010233|NCT01197794|3830658|B8|Black or African American||Race/Ethnicity, Customized||Participants|Number|26|26.0||||||
4010234|NCT01197794|3830659|B7|Black or African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4010235|NCT01197794|3830660|B6|Black or African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4010236|NCT01197794|3830661|B5|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4010237|NCT01197794|3830662|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4010238|NCT01197794|3830663|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4010239|NCT01197794|3830664|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4010240|NCT01197794|3830665|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4010241|NCT01197794|3830658|B8|White||Race/Ethnicity, Customized||Participants|Number|824|824.0||||||
4010242|NCT01197794|3830659|B7|White||Race/Ethnicity, Customized||Participants|Number|119|119.0||||||
4010243|NCT01197794|3830660|B6|White||Race/Ethnicity, Customized||Participants|Number|113|113.0||||||
4010244|NCT01197794|3830661|B5|White||Race/Ethnicity, Customized||Participants|Number|121|121.0||||||
4010245|NCT01197794|3830662|B4|White||Race/Ethnicity, Customized||Participants|Number|119|119.0||||||
4010246|NCT01197794|3830663|B3|White||Race/Ethnicity, Customized||Participants|Number|120|120.0||||||
4010247|NCT01197794|3830664|B2|White||Race/Ethnicity, Customized||Participants|Number|115|115.0||||||
4010248|NCT01197794|3830665|B1|White||Race/Ethnicity, Customized||Participants|Number|117|117.0||||||
4010249|NCT01197794|3830658|B8||Male|Sex: Female, Male||Participants|Count of Participants|580|580.0||||||
4010250|NCT01197794|3830659|B7||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4010251|NCT01197794|3830660|B6||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4010252|NCT01197794|3830661|B5||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4010253|NCT01197794|3830662|B4||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4010254|NCT01197794|3830663|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4010255|NCT01197794|3830664|B2||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4010256|NCT01197794|3830665|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4010257|NCT01197794|3830658|B8||Female|Sex: Female, Male||Participants|Count of Participants|561|561.0||||||
4010258|NCT01197794|3830659|B7||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4010259|NCT01197794|3830660|B6||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4010260|NCT01197794|3830661|B5||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4010261|NCT01197794|3830662|B4||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4010262|NCT01197794|3830663|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4010263|NCT01197794|3830664|B2||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4010264|NCT01197794|3830665|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4010265|NCT01197794|3830658|B8|||Age||Years|Mean|45.9|45.9|Standard Deviation|13.58|13.58|||
4010266|NCT01197794|3830659|B7|||Age||Years|Mean|45.7|45.7|Standard Deviation|13.50|13.5|||
4010267|NCT01197794|3830660|B6|||Age||Years|Mean|44.5|44.5|Standard Deviation|13.76|13.76|||
4010268|NCT01197794|3830661|B5|||Age||Years|Mean|46.3|46.3|Standard Deviation|13.15|13.15|||
4010269|NCT01197794|3830662|B4|||Age||Years|Mean|45.4|45.4|Standard Deviation|13.22|13.22|||
4010270|NCT01197794|3830663|B3|||Age||Years|Mean|46.4|46.4|Standard Deviation|14.65|14.65|||
4010271|NCT01197794|3830664|B2|||Age||Years|Mean|46.7|46.7|Standard Deviation|12.84|12.84|||
4010272|NCT01197794|3830665|B1|||Age||Years|Mean|46.6|46.6|Standard Deviation|13.98|13.98|||
4010273|NCT01197755|3830750|B4|Other||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
4010274|NCT01197755|3830751|B3|Other||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4010275|NCT01197755|3830752|B2|Other||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4010276|NCT01197755|3830753|B1|Other||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4010277|NCT01197755|3830750|B4|Indian or Pakistani||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4010278|NCT01197755|3830751|B3|Indian or Pakistani||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4010279|NCT01197755|3830752|B2|Indian or Pakistani||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4010280|NCT01197755|3830753|B1|Indian or Pakistani||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4010281|NCT01197755|3830750|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4010282|NCT01197755|3830751|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4010283|NCT01197755|3830752|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4010284|NCT01197755|3830753|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4010285|NCT01197755|3830750|B4|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4010286|NCT01197755|3830751|B3|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4010287|NCT01197755|3830752|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4010288|NCT01197755|3830753|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4010289|NCT01197755|3830750|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
4010290|NCT01197755|3830751|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4010291|NCT01197755|3830752|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4010292|NCT01197755|3830753|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4010293|NCT01197755|3830750|B4|White||Race/Ethnicity, Customized||Participants|Number|269|269.0||||||
4010294|NCT01197755|3830751|B3|White||Race/Ethnicity, Customized||Participants|Number|91|91.0||||||
4010295|NCT01197755|3830752|B2|White||Race/Ethnicity, Customized||Participants|Number|92|92.0||||||
4010296|NCT01197755|3830753|B1|White||Race/Ethnicity, Customized||Participants|Number|86|86.0||||||
4010297|NCT01197755|3830750|B4||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4010298|NCT01197755|3830751|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4010299|NCT01197755|3830752|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4010300|NCT01197755|3830753|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4010301|NCT01197755|3830750|B4||Female|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
4010302|NCT01197755|3830751|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4010303|NCT01197755|3830752|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4010304|NCT01197755|3830753|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4010305|NCT01197755|3830750|B4|||Age||years|Mean|53|53.0|Standard Deviation|12.3|12.3|||
4010306|NCT01197755|3830751|B3|||Age||years|Mean|53|53.0|Standard Deviation|13.0|13.0|||
4010307|NCT01197755|3830752|B2|||Age||years|Mean|51|51.0|Standard Deviation|12.0|12.0|||
4010308|NCT01197755|3830753|B1|||Age||years|Mean|54|54.0|Standard Deviation|11.9|11.9|||
4010309|NCT01197612|3830795|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4010310|NCT01197612|3830795|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010311|NCT01197612|3830795|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010312|NCT01197612|3830795|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4010313|NCT01197612|3830795|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4010314|NCT01197612|3830795|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010315|NCT01197612|3830795|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010316|NCT01197612|3830795|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010317|NCT01197612|3830795|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4010318|NCT01197612|3830795|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4010319|NCT01197612|3830795|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4010320|NCT01197612|3830795|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4010321|NCT01197612|3830795|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4010322|NCT01197573|3830806|B5|United States||Region of Enrollment||Participants|Count of Participants|103|103.0||||||
4010323|NCT01197573|3830807|B4|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4010324|NCT01197573|3830808|B3|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4010325|NCT01197573|3830809|B2|United States||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
4010326|NCT01197573|3830810|B1|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
4010327|NCT01197573|3830806|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010328|NCT01197573|3830807|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010329|NCT01197573|3830808|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010330|NCT01197573|3830809|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010331|NCT01197573|3830810|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010332|NCT01197573|3830806|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010333|NCT01197573|3830807|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010334|NCT01197573|3830808|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010335|NCT01197573|3830809|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010336|NCT01197573|3830810|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010337|NCT01197573|3830806|B5||White|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
4010338|NCT01197573|3830807|B4||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4010339|NCT01197573|3830808|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4010340|NCT01197573|3830809|B2||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4010341|NCT01197573|3830810|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4010342|NCT01197573|3830806|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4010343|NCT01197573|3830807|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4010344|NCT01197573|3830808|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4010345|NCT01197573|3830809|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4010346|NCT01197573|3830810|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4010347|NCT01197573|3830806|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010348|NCT01197573|3830807|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010349|NCT01197573|3830808|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010350|NCT01197573|3830809|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010351|NCT01197573|3830810|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010352|NCT01197573|3830806|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4010353|NCT01197573|3830807|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010354|NCT01197573|3830808|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010355|NCT01197573|3830809|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4010356|NCT01197573|3830810|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010357|NCT01197573|3830806|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010358|NCT01197573|3830807|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010359|NCT01197573|3830808|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010360|NCT01197573|3830809|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010361|NCT01197573|3830810|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010362|NCT01197573|3830806|B5||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4010363|NCT01197573|3830807|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4010364|NCT01197573|3830808|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4010365|NCT01197573|3830809|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4010366|NCT01197573|3830810|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4010367|NCT01197573|3830806|B5||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4010368|NCT01197573|3830807|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4010369|NCT01197573|3830808|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4010370|NCT01197573|3830809|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4010371|NCT01197573|3830810|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4010372|NCT01197573|3830806|B5||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4010373|NCT01197573|3830807|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4010374|NCT01197573|3830808|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4010375|NCT01197573|3830809|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4010376|NCT01197573|3830810|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4010377|NCT01197573|3830806|B5||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
4010378|NCT01197573|3830807|B4||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4010379|NCT01197573|3830808|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4010380|NCT01197573|3830809|B2||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4010381|NCT01197573|3830810|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4010382|NCT01197573|3830806|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4010383|NCT01197573|3830807|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4010384|NCT01197573|3830808|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4010385|NCT01197573|3830809|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4010386|NCT01197573|3830810|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4010387|NCT01197560|3830825|B3|Non-Germinal Center B-Cell Type||Diffuse Large B-Cell Lymphoma (DLBCL) Subtypes - Germinal Center B-Cell (GCB) and non-GCB|Diffuse Large B Cell Lymphoma (DLBCL) is comprised of different pathophysiological subtypes that influence patient prognosis and response to treatment. Based on immunohistochemistry (IHC), DLBCL can be classified into germinal center B-cell (GCB) and non-GCB subtypes. Patients with non-GCB have a worse prognosis compared with the GCB subtype|participants|Number|54|54.0||||||
4010388|NCT01197560|3830826|B2|Non-Germinal Center B-Cell Type||Diffuse Large B-Cell Lymphoma (DLBCL) Subtypes - Germinal Center B-Cell (GCB) and non-GCB|Diffuse Large B Cell Lymphoma (DLBCL) is comprised of different pathophysiological subtypes that influence patient prognosis and response to treatment. Based on immunohistochemistry (IHC), DLBCL can be classified into germinal center B-cell (GCB) and non-GCB subtypes. Patients with non-GCB have a worse prognosis compared with the GCB subtype|participants|Number|26|26.0||||||
4010389|NCT01197560|3830827|B1|Non-Germinal Center B-Cell Type||Diffuse Large B-Cell Lymphoma (DLBCL) Subtypes - Germinal Center B-Cell (GCB) and non-GCB|Diffuse Large B Cell Lymphoma (DLBCL) is comprised of different pathophysiological subtypes that influence patient prognosis and response to treatment. Based on immunohistochemistry (IHC), DLBCL can be classified into germinal center B-cell (GCB) and non-GCB subtypes. Patients with non-GCB have a worse prognosis compared with the GCB subtype|participants|Number|28|28.0||||||
4010390|NCT01197560|3830825|B3|Germinal Center B-Cell Type||Diffuse Large B-Cell Lymphoma (DLBCL) Subtypes - Germinal Center B-Cell (GCB) and non-GCB|Diffuse Large B Cell Lymphoma (DLBCL) is comprised of different pathophysiological subtypes that influence patient prognosis and response to treatment. Based on immunohistochemistry (IHC), DLBCL can be classified into germinal center B-cell (GCB) and non-GCB subtypes. Patients with non-GCB have a worse prognosis compared with the GCB subtype|participants|Number|48|48.0||||||
4010391|NCT01197560|3830826|B2|Germinal Center B-Cell Type||Diffuse Large B-Cell Lymphoma (DLBCL) Subtypes - Germinal Center B-Cell (GCB) and non-GCB|Diffuse Large B Cell Lymphoma (DLBCL) is comprised of different pathophysiological subtypes that influence patient prognosis and response to treatment. Based on immunohistochemistry (IHC), DLBCL can be classified into germinal center B-cell (GCB) and non-GCB subtypes. Patients with non-GCB have a worse prognosis compared with the GCB subtype|participants|Number|25|25.0||||||
4010392|NCT01197560|3830827|B1|Germinal Center B-Cell Type||Diffuse Large B-Cell Lymphoma (DLBCL) Subtypes - Germinal Center B-Cell (GCB) and non-GCB|Diffuse Large B Cell Lymphoma (DLBCL) is comprised of different pathophysiological subtypes that influence patient prognosis and response to treatment. Based on immunohistochemistry (IHC), DLBCL can be classified into germinal center B-cell (GCB) and non-GCB subtypes. Patients with non-GCB have a worse prognosis compared with the GCB subtype|participants|Number|23|23.0||||||
4010393|NCT01197560|3830825|B3|Missing||Disease Stage of DLBCL at Diagnosis|"The criteria for Clinical Stage (Ann Arbor staging) are as below: I: involvement of a single nodal region. II: involvement of 2 or more lymph node regions on the same side of the diaphragm. III: involvement of lymph node regions on both sides of the diaphragm. IV: disseminated involvement of 1 or more extra-lymphatic sites with or without associated lymph node involvement. A or B: the absence of constitutional (B-type) symptoms is denoted by adding an A to the stage; the presence is denoted by adding a B to the stage."|participants|Number|1|1.0||||||
4010394|NCT01197560|3830826|B2|Missing||Disease Stage of DLBCL at Diagnosis|"The criteria for Clinical Stage (Ann Arbor staging) are as below: I: involvement of a single nodal region. II: involvement of 2 or more lymph node regions on the same side of the diaphragm. III: involvement of lymph node regions on both sides of the diaphragm. IV: disseminated involvement of 1 or more extra-lymphatic sites with or without associated lymph node involvement. A or B: the absence of constitutional (B-type) symptoms is denoted by adding an A to the stage; the presence is denoted by adding a B to the stage."|participants|Number|1|1.0||||||
4010395|NCT01197560|3830827|B1|Missing||Disease Stage of DLBCL at Diagnosis|"The criteria for Clinical Stage (Ann Arbor staging) are as below: I: involvement of a single nodal region. II: involvement of 2 or more lymph node regions on the same side of the diaphragm. III: involvement of lymph node regions on both sides of the diaphragm. IV: disseminated involvement of 1 or more extra-lymphatic sites with or without associated lymph node involvement. A or B: the absence of constitutional (B-type) symptoms is denoted by adding an A to the stage; the presence is denoted by adding a B to the stage."|participants|Number|0|0.0||||||
4010396|NCT01197560|3830825|B3|IVB||Disease Stage of DLBCL at Diagnosis|"The criteria for Clinical Stage (Ann Arbor staging) are as below: I: involvement of a single nodal region. II: involvement of 2 or more lymph node regions on the same side of the diaphragm. III: involvement of lymph node regions on both sides of the diaphragm. IV: disseminated involvement of 1 or more extra-lymphatic sites with or without associated lymph node involvement. A or B: the absence of constitutional (B-type) symptoms is denoted by adding an A to the stage; the presence is denoted by adding a B to the stage."|participants|Number|19|19.0||||||
4010434|NCT01197560|3830827|B1|4 (Completely Disabled)||Eastern Cooperative Oncology Performance Status (ECOG)]|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis|participants|Number|1|1.0||||||
4010397|NCT01197560|3830826|B2|IVB||Disease Stage of DLBCL at Diagnosis|"The criteria for Clinical Stage (Ann Arbor staging) are as below: I: involvement of a single nodal region. II: involvement of 2 or more lymph node regions on the same side of the diaphragm. III: involvement of lymph node regions on both sides of the diaphragm. IV: disseminated involvement of 1 or more extra-lymphatic sites with or without associated lymph node involvement. A or B: the absence of constitutional (B-type) symptoms is denoted by adding an A to the stage; the presence is denoted by adding a B to the stage."|participants|Number|11|11.0||||||
4010398|NCT01197560|3830827|B1|IVB||Disease Stage of DLBCL at Diagnosis|"The criteria for Clinical Stage (Ann Arbor staging) are as below: I: involvement of a single nodal region. II: involvement of 2 or more lymph node regions on the same side of the diaphragm. III: involvement of lymph node regions on both sides of the diaphragm. IV: disseminated involvement of 1 or more extra-lymphatic sites with or without associated lymph node involvement. A or B: the absence of constitutional (B-type) symptoms is denoted by adding an A to the stage; the presence is denoted by adding a B to the stage."|participants|Number|8|8.0||||||
4010399|NCT01197560|3830825|B3|IVA||Disease Stage of DLBCL at Diagnosis|"The criteria for Clinical Stage (Ann Arbor staging) are as below: I: involvement of a single nodal region. II: involvement of 2 or more lymph node regions on the same side of the diaphragm. III: involvement of lymph node regions on both sides of the diaphragm. IV: disseminated involvement of 1 or more extra-lymphatic sites with or without associated lymph node involvement. A or B: the absence of constitutional (B-type) symptoms is denoted by adding an A to the stage; the presence is denoted by adding a B to the stage."|participants|Number|23|23.0||||||
4010400|NCT01197560|3830826|B2|IVA||Disease Stage of DLBCL at Diagnosis|"The criteria for Clinical Stage (Ann Arbor staging) are as below: I: involvement of a single nodal region. II: involvement of 2 or more lymph node regions on the same side of the diaphragm. III: involvement of lymph node regions on both sides of the diaphragm. IV: disseminated involvement of 1 or more extra-lymphatic sites with or without associated lymph node involvement. A or B: the absence of constitutional (B-type) symptoms is denoted by adding an A to the stage; the presence is denoted by adding a B to the stage."|participants|Number|13|13.0||||||
4010401|NCT01197560|3830827|B1|IVA||Disease Stage of DLBCL at Diagnosis|"The criteria for Clinical Stage (Ann Arbor staging) are as below: I: involvement of a single nodal region. II: involvement of 2 or more lymph node regions on the same side of the diaphragm. III: involvement of lymph node regions on both sides of the diaphragm. IV: disseminated involvement of 1 or more extra-lymphatic sites with or without associated lymph node involvement. A or B: the absence of constitutional (B-type) symptoms is denoted by adding an A to the stage; the presence is denoted by adding a B to the stage."|participants|Number|10|10.0||||||
4010402|NCT01197560|3830825|B3|IIIB||Disease Stage of DLBCL at Diagnosis|"The criteria for Clinical Stage (Ann Arbor staging) are as below: I: involvement of a single nodal region. II: involvement of 2 or more lymph node regions on the same side of the diaphragm. III: involvement of lymph node regions on both sides of the diaphragm. IV: disseminated involvement of 1 or more extra-lymphatic sites with or without associated lymph node involvement. A or B: the absence of constitutional (B-type) symptoms is denoted by adding an A to the stage; the presence is denoted by adding a B to the stage."|participants|Number|10|10.0||||||
4010403|NCT01197560|3830826|B2|IIIB||Disease Stage of DLBCL at Diagnosis|"The criteria for Clinical Stage (Ann Arbor staging) are as below: I: involvement of a single nodal region. II: involvement of 2 or more lymph node regions on the same side of the diaphragm. III: involvement of lymph node regions on both sides of the diaphragm. IV: disseminated involvement of 1 or more extra-lymphatic sites with or without associated lymph node involvement. A or B: the absence of constitutional (B-type) symptoms is denoted by adding an A to the stage; the presence is denoted by adding a B to the stage."|participants|Number|8|8.0||||||
4010404|NCT01197560|3830827|B1|IIIB||Disease Stage of DLBCL at Diagnosis|"The criteria for Clinical Stage (Ann Arbor staging) are as below: I: involvement of a single nodal region. II: involvement of 2 or more lymph node regions on the same side of the diaphragm. III: involvement of lymph node regions on both sides of the diaphragm. IV: disseminated involvement of 1 or more extra-lymphatic sites with or without associated lymph node involvement. A or B: the absence of constitutional (B-type) symptoms is denoted by adding an A to the stage; the presence is denoted by adding a B to the stage."|participants|Number|2|2.0||||||
4010405|NCT01197560|3830825|B3|IIIA||Disease Stage of DLBCL at Diagnosis|"The criteria for Clinical Stage (Ann Arbor staging) are as below: I: involvement of a single nodal region. II: involvement of 2 or more lymph node regions on the same side of the diaphragm. III: involvement of lymph node regions on both sides of the diaphragm. IV: disseminated involvement of 1 or more extra-lymphatic sites with or without associated lymph node involvement. A or B: the absence of constitutional (B-type) symptoms is denoted by adding an A to the stage; the presence is denoted by adding a B to the stage."|participants|Number|15|15.0||||||
4010406|NCT01197560|3830826|B2|IIIA||Disease Stage of DLBCL at Diagnosis|"The criteria for Clinical Stage (Ann Arbor staging) are as below: I: involvement of a single nodal region. II: involvement of 2 or more lymph node regions on the same side of the diaphragm. III: involvement of lymph node regions on both sides of the diaphragm. IV: disseminated involvement of 1 or more extra-lymphatic sites with or without associated lymph node involvement. A or B: the absence of constitutional (B-type) symptoms is denoted by adding an A to the stage; the presence is denoted by adding a B to the stage."|participants|Number|7|7.0||||||
4010407|NCT01197560|3830827|B1|IIIA||Disease Stage of DLBCL at Diagnosis|"The criteria for Clinical Stage (Ann Arbor staging) are as below: I: involvement of a single nodal region. II: involvement of 2 or more lymph node regions on the same side of the diaphragm. III: involvement of lymph node regions on both sides of the diaphragm. IV: disseminated involvement of 1 or more extra-lymphatic sites with or without associated lymph node involvement. A or B: the absence of constitutional (B-type) symptoms is denoted by adding an A to the stage; the presence is denoted by adding a B to the stage."|participants|Number|8|8.0||||||
4010408|NCT01197560|3830825|B3|IIB||Disease Stage of DLBCL at Diagnosis|"The criteria for Clinical Stage (Ann Arbor staging) are as below: I: involvement of a single nodal region. II: involvement of 2 or more lymph node regions on the same side of the diaphragm. III: involvement of lymph node regions on both sides of the diaphragm. IV: disseminated involvement of 1 or more extra-lymphatic sites with or without associated lymph node involvement. A or B: the absence of constitutional (B-type) symptoms is denoted by adding an A to the stage; the presence is denoted by adding a B to the stage."|participants|Number|10|10.0||||||
4010467|NCT01197560|3830827|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4010409|NCT01197560|3830826|B2|IIB||Disease Stage of DLBCL at Diagnosis|"The criteria for Clinical Stage (Ann Arbor staging) are as below: I: involvement of a single nodal region. II: involvement of 2 or more lymph node regions on the same side of the diaphragm. III: involvement of lymph node regions on both sides of the diaphragm. IV: disseminated involvement of 1 or more extra-lymphatic sites with or without associated lymph node involvement. A or B: the absence of constitutional (B-type) symptoms is denoted by adding an A to the stage; the presence is denoted by adding a B to the stage."|participants|Number|1|1.0||||||
4010410|NCT01197560|3830827|B1|IIB||Disease Stage of DLBCL at Diagnosis|"The criteria for Clinical Stage (Ann Arbor staging) are as below: I: involvement of a single nodal region. II: involvement of 2 or more lymph node regions on the same side of the diaphragm. III: involvement of lymph node regions on both sides of the diaphragm. IV: disseminated involvement of 1 or more extra-lymphatic sites with or without associated lymph node involvement. A or B: the absence of constitutional (B-type) symptoms is denoted by adding an A to the stage; the presence is denoted by adding a B to the stage."|participants|Number|9|9.0||||||
4010411|NCT01197560|3830825|B3|IIA||Disease Stage of DLBCL at Diagnosis|"The criteria for Clinical Stage (Ann Arbor staging) are as below: I: involvement of a single nodal region. II: involvement of 2 or more lymph node regions on the same side of the diaphragm. III: involvement of lymph node regions on both sides of the diaphragm. IV: disseminated involvement of 1 or more extra-lymphatic sites with or without associated lymph node involvement. A or B: the absence of constitutional (B-type) symptoms is denoted by adding an A to the stage; the presence is denoted by adding a B to the stage."|participants|Number|18|18.0||||||
4010412|NCT01197560|3830826|B2|IIA||Disease Stage of DLBCL at Diagnosis|"The criteria for Clinical Stage (Ann Arbor staging) are as below: I: involvement of a single nodal region. II: involvement of 2 or more lymph node regions on the same side of the diaphragm. III: involvement of lymph node regions on both sides of the diaphragm. IV: disseminated involvement of 1 or more extra-lymphatic sites with or without associated lymph node involvement. A or B: the absence of constitutional (B-type) symptoms is denoted by adding an A to the stage; the presence is denoted by adding a B to the stage."|participants|Number|8|8.0||||||
4010413|NCT01197560|3830827|B1|IIA||Disease Stage of DLBCL at Diagnosis|"The criteria for Clinical Stage (Ann Arbor staging) are as below: I: involvement of a single nodal region. II: involvement of 2 or more lymph node regions on the same side of the diaphragm. III: involvement of lymph node regions on both sides of the diaphragm. IV: disseminated involvement of 1 or more extra-lymphatic sites with or without associated lymph node involvement. A or B: the absence of constitutional (B-type) symptoms is denoted by adding an A to the stage; the presence is denoted by adding a B to the stage."|participants|Number|10|10.0||||||
4010414|NCT01197560|3830825|B3|IB||Disease Stage of DLBCL at Diagnosis|"The criteria for Clinical Stage (Ann Arbor staging) are as below: I: involvement of a single nodal region. II: involvement of 2 or more lymph node regions on the same side of the diaphragm. III: involvement of lymph node regions on both sides of the diaphragm. IV: disseminated involvement of 1 or more extra-lymphatic sites with or without associated lymph node involvement. A or B: the absence of constitutional (B-type) symptoms is denoted by adding an A to the stage; the presence is denoted by adding a B to the stage."|participants|Number|0|0.0||||||
4010415|NCT01197560|3830826|B2|IB||Disease Stage of DLBCL at Diagnosis|"The criteria for Clinical Stage (Ann Arbor staging) are as below: I: involvement of a single nodal region. II: involvement of 2 or more lymph node regions on the same side of the diaphragm. III: involvement of lymph node regions on both sides of the diaphragm. IV: disseminated involvement of 1 or more extra-lymphatic sites with or without associated lymph node involvement. A or B: the absence of constitutional (B-type) symptoms is denoted by adding an A to the stage; the presence is denoted by adding a B to the stage."|participants|Number|0|0.0||||||
4010416|NCT01197560|3830827|B1|IB||Disease Stage of DLBCL at Diagnosis|"The criteria for Clinical Stage (Ann Arbor staging) are as below: I: involvement of a single nodal region. II: involvement of 2 or more lymph node regions on the same side of the diaphragm. III: involvement of lymph node regions on both sides of the diaphragm. IV: disseminated involvement of 1 or more extra-lymphatic sites with or without associated lymph node involvement. A or B: the absence of constitutional (B-type) symptoms is denoted by adding an A to the stage; the presence is denoted by adding a B to the stage."|participants|Number|0|0.0||||||
4010417|NCT01197560|3830825|B3|IA||Disease Stage of DLBCL at Diagnosis|"The criteria for Clinical Stage (Ann Arbor staging) are as below: I: involvement of a single nodal region. II: involvement of 2 or more lymph node regions on the same side of the diaphragm. III: involvement of lymph node regions on both sides of the diaphragm. IV: disseminated involvement of 1 or more extra-lymphatic sites with or without associated lymph node involvement. A or B: the absence of constitutional (B-type) symptoms is denoted by adding an A to the stage; the presence is denoted by adding a B to the stage."|participants|Number|6|6.0||||||
4010418|NCT01197560|3830826|B2|IA||Disease Stage of DLBCL at Diagnosis|"The criteria for Clinical Stage (Ann Arbor staging) are as below: I: involvement of a single nodal region. II: involvement of 2 or more lymph node regions on the same side of the diaphragm. III: involvement of lymph node regions on both sides of the diaphragm. IV: disseminated involvement of 1 or more extra-lymphatic sites with or without associated lymph node involvement. A or B: the absence of constitutional (B-type) symptoms is denoted by adding an A to the stage; the presence is denoted by adding a B to the stage."|participants|Number|2|2.0||||||
4010419|NCT01197560|3830827|B1|IA||Disease Stage of DLBCL at Diagnosis|"The criteria for Clinical Stage (Ann Arbor staging) are as below: I: involvement of a single nodal region. II: involvement of 2 or more lymph node regions on the same side of the diaphragm. III: involvement of lymph node regions on both sides of the diaphragm. IV: disseminated involvement of 1 or more extra-lymphatic sites with or without associated lymph node involvement. A or B: the absence of constitutional (B-type) symptoms is denoted by adding an A to the stage; the presence is denoted by adding a B to the stage."|participants|Number|4|4.0||||||
4010420|NCT01197560|3830825|B3|Missing||Creatinine Clearance (CrCl)|Creatinine is a waste product from the normal breakdown of muscle tissue. As creatinine is produced, it's filtered through the kidneys and excreted in urine. Doctors measure the blood creatinine level as a test of kidney function. Participants with a CrCl (as calculated by the Cockcroft-Gault formula, utilizing actual body weight or ideal body weight, whichever was less) of ≥ 60 mL/min received a starting dose of 25 mg lenalidomide once daily. Participants with moderate renal insufficiency (ie, CrCl ≥ 30 mL/min but < 60 mL/min) received a starting dose of 10 mg lenalidomide once daily|participants|Number|2|2.0||||||
4010468|NCT01197560|3830825|B3|||Age||years|Mean|63.75|63.75|Standard Deviation|13.69|13.69|||
4010421|NCT01197560|3830826|B2|Missing||Creatinine Clearance (CrCl)|Creatinine is a waste product from the normal breakdown of muscle tissue. As creatinine is produced, it's filtered through the kidneys and excreted in urine. Doctors measure the blood creatinine level as a test of kidney function. Participants with a CrCl (as calculated by the Cockcroft-Gault formula, utilizing actual body weight or ideal body weight, whichever was less) of ≥ 60 mL/min received a starting dose of 25 mg lenalidomide once daily. Participants with moderate renal insufficiency (ie, CrCl ≥ 30 mL/min but < 60 mL/min) received a starting dose of 10 mg lenalidomide once daily|participants|Number|1|1.0||||||
4010422|NCT01197560|3830827|B1|Missing||Creatinine Clearance (CrCl)|Creatinine is a waste product from the normal breakdown of muscle tissue. As creatinine is produced, it's filtered through the kidneys and excreted in urine. Doctors measure the blood creatinine level as a test of kidney function. Participants with a CrCl (as calculated by the Cockcroft-Gault formula, utilizing actual body weight or ideal body weight, whichever was less) of ≥ 60 mL/min received a starting dose of 25 mg lenalidomide once daily. Participants with moderate renal insufficiency (ie, CrCl ≥ 30 mL/min but < 60 mL/min) received a starting dose of 10 mg lenalidomide once daily|participants|Number|1|1.0||||||
4010423|NCT01197560|3830825|B3|≥ 30 but < 60 mL/min||Creatinine Clearance (CrCl)|Creatinine is a waste product from the normal breakdown of muscle tissue. As creatinine is produced, it's filtered through the kidneys and excreted in urine. Doctors measure the blood creatinine level as a test of kidney function. Participants with a CrCl (as calculated by the Cockcroft-Gault formula, utilizing actual body weight or ideal body weight, whichever was less) of ≥ 60 mL/min received a starting dose of 25 mg lenalidomide once daily. Participants with moderate renal insufficiency (ie, CrCl ≥ 30 mL/min but < 60 mL/min) received a starting dose of 10 mg lenalidomide once daily|participants|Number|25|25.0||||||
4010424|NCT01197560|3830826|B2|≥ 30 but < 60 mL/min||Creatinine Clearance (CrCl)|Creatinine is a waste product from the normal breakdown of muscle tissue. As creatinine is produced, it's filtered through the kidneys and excreted in urine. Doctors measure the blood creatinine level as a test of kidney function. Participants with a CrCl (as calculated by the Cockcroft-Gault formula, utilizing actual body weight or ideal body weight, whichever was less) of ≥ 60 mL/min received a starting dose of 25 mg lenalidomide once daily. Participants with moderate renal insufficiency (ie, CrCl ≥ 30 mL/min but < 60 mL/min) received a starting dose of 10 mg lenalidomide once daily|participants|Number|7|7.0||||||
4010425|NCT01197560|3830827|B1|≥ 30 but < 60 mL/min||Creatinine Clearance (CrCl)|Creatinine is a waste product from the normal breakdown of muscle tissue. As creatinine is produced, it's filtered through the kidneys and excreted in urine. Doctors measure the blood creatinine level as a test of kidney function. Participants with a CrCl (as calculated by the Cockcroft-Gault formula, utilizing actual body weight or ideal body weight, whichever was less) of ≥ 60 mL/min received a starting dose of 25 mg lenalidomide once daily. Participants with moderate renal insufficiency (ie, CrCl ≥ 30 mL/min but < 60 mL/min) received a starting dose of 10 mg lenalidomide once daily|participants|Number|18|18.0||||||
4010426|NCT01197560|3830825|B3|≥ 60 mL/min||Creatinine Clearance (CrCl)|Creatinine is a waste product from the normal breakdown of muscle tissue. As creatinine is produced, it's filtered through the kidneys and excreted in urine. Doctors measure the blood creatinine level as a test of kidney function. Participants with a CrCl (as calculated by the Cockcroft-Gault formula, utilizing actual body weight or ideal body weight, whichever was less) of ≥ 60 mL/min received a starting dose of 25 mg lenalidomide once daily. Participants with moderate renal insufficiency (ie, CrCl ≥ 30 mL/min but < 60 mL/min) received a starting dose of 10 mg lenalidomide once daily|participants|Number|75|75.0||||||
4010427|NCT01197560|3830826|B2|≥ 60 mL/min||Creatinine Clearance (CrCl)|Creatinine is a waste product from the normal breakdown of muscle tissue. As creatinine is produced, it's filtered through the kidneys and excreted in urine. Doctors measure the blood creatinine level as a test of kidney function. Participants with a CrCl (as calculated by the Cockcroft-Gault formula, utilizing actual body weight or ideal body weight, whichever was less) of ≥ 60 mL/min received a starting dose of 25 mg lenalidomide once daily. Participants with moderate renal insufficiency (ie, CrCl ≥ 30 mL/min but < 60 mL/min) received a starting dose of 10 mg lenalidomide once daily|participants|Number|43|43.0||||||
4010428|NCT01197560|3830827|B1|≥ 60 mL/min||Creatinine Clearance (CrCl)|Creatinine is a waste product from the normal breakdown of muscle tissue. As creatinine is produced, it's filtered through the kidneys and excreted in urine. Doctors measure the blood creatinine level as a test of kidney function. Participants with a CrCl (as calculated by the Cockcroft-Gault formula, utilizing actual body weight or ideal body weight, whichever was less) of ≥ 60 mL/min received a starting dose of 25 mg lenalidomide once daily. Participants with moderate renal insufficiency (ie, CrCl ≥ 30 mL/min but < 60 mL/min) received a starting dose of 10 mg lenalidomide once daily|participants|Number|32|32.0||||||
4010429|NCT01197560|3830825|B3|Missing||Eastern Cooperative Oncology Performance Status (ECOG)]|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis|participants|Number|1|1.0||||||
4010430|NCT01197560|3830826|B2|Missing||Eastern Cooperative Oncology Performance Status (ECOG)]|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis|participants|Number|0|0.0||||||
4010431|NCT01197560|3830827|B1|Missing||Eastern Cooperative Oncology Performance Status (ECOG)]|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis|participants|Number|1|1.0||||||
4010432|NCT01197560|3830825|B3|4 (Completely Disabled)||Eastern Cooperative Oncology Performance Status (ECOG)]|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis|participants|Number|1|1.0||||||
4010433|NCT01197560|3830826|B2|4 (Completely Disabled)||Eastern Cooperative Oncology Performance Status (ECOG)]|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis|participants|Number|0|0.0||||||
4010435|NCT01197560|3830825|B3|3 (Limited Self-Care)||Eastern Cooperative Oncology Performance Status (ECOG)]|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis|participants|Number|0|0.0||||||
4010436|NCT01197560|3830826|B2|3 (Limited Self-Care)||Eastern Cooperative Oncology Performance Status (ECOG)]|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis|participants|Number|0|0.0||||||
4010437|NCT01197560|3830827|B1|3 (Limited Self-Care)||Eastern Cooperative Oncology Performance Status (ECOG)]|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis|participants|Number|0|0.0||||||
4010438|NCT01197560|3830825|B3|2 (Ambulatory but Unable to Work)||Eastern Cooperative Oncology Performance Status (ECOG)]|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis|participants|Number|15|15.0||||||
4010439|NCT01197560|3830826|B2|2 (Ambulatory but Unable to Work)||Eastern Cooperative Oncology Performance Status (ECOG)]|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis|participants|Number|8|8.0||||||
4010440|NCT01197560|3830827|B1|2 (Ambulatory but Unable to Work)||Eastern Cooperative Oncology Performance Status (ECOG)]|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis|participants|Number|7|7.0||||||
4010441|NCT01197560|3830825|B3|1 (Restrictive but Ambulatory)||Eastern Cooperative Oncology Performance Status (ECOG)]|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis|participants|Number|52|52.0||||||
4010442|NCT01197560|3830826|B2|1 (Restrictive but Ambulatory)||Eastern Cooperative Oncology Performance Status (ECOG)]|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis|participants|Number|28|28.0||||||
4010443|NCT01197560|3830827|B1|1 (Restrictive but Ambulatory)||Eastern Cooperative Oncology Performance Status (ECOG)]|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis|participants|Number|24|24.0||||||
4010444|NCT01197560|3830825|B3|0 = (Fully Active)||Eastern Cooperative Oncology Performance Status (ECOG)]|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis|participants|Number|33|33.0||||||
4010445|NCT01197560|3830826|B2|0 = (Fully Active)||Eastern Cooperative Oncology Performance Status (ECOG)]|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis|participants|Number|15|15.0||||||
4010446|NCT01197560|3830827|B1|0 = (Fully Active)||Eastern Cooperative Oncology Performance Status (ECOG)]|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis|participants|Number|18|18.0||||||
4010447|NCT01197560|3830825|B3|Other (Unspecified)||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4010448|NCT01197560|3830826|B2|Other (Unspecified)||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4010449|NCT01197560|3830827|B1|Other (Unspecified)||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4010450|NCT01197560|3830825|B3|Missing||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4010451|NCT01197560|3830826|B2|Missing||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4010452|NCT01197560|3830827|B1|Missing||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4010453|NCT01197560|3830825|B3|White||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
4010454|NCT01197560|3830826|B2|White||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4010455|NCT01197560|3830827|B1|White||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4010456|NCT01197560|3830825|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4010457|NCT01197560|3830826|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4010458|NCT01197560|3830827|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4010459|NCT01197560|3830825|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4010460|NCT01197560|3830826|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4010461|NCT01197560|3830827|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4010462|NCT01197560|3830825|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4010463|NCT01197560|3830826|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4010464|NCT01197560|3830827|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4010465|NCT01197560|3830825|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4010466|NCT01197560|3830826|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4010469|NCT01197560|3830826|B2|||Age||years|Mean|62.8|62.8|Standard Deviation|13.94|13.94|||
4010470|NCT01197560|3830827|B1|||Age||years|Mean|64.7|64.7|Standard Deviation|13.43|13.43|||
4010471|NCT01197547|3830852|B1|United States||Region of Enrollment||participants|Number|1014|1014.0||||||
4010472|NCT01197547|3830852|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4010473|NCT01197547|3830852|B1||Female|Sex: Female, Male||Participants|Count of Participants|1014|1014.0||||||
4010474|NCT01197547|3830852|B1|||Age||years|Mean|41|41.0|Standard Deviation|6.8|6.8|||
4010475|NCT01197547|3830852|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4010476|NCT01197547|3830852|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1013|1013.0||||||
4010477|NCT01197547|3830852|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4010478|NCT01197534|3830858|B4|Other||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4010479|NCT01197534|3830859|B3|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4010480|NCT01197534|3830860|B2|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4010481|NCT01197534|3830861|B1|Other||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4010482|NCT01197534|3830858|B4|Indian or Pakistani||Race/Ethnicity, Customized||Participants|Number|84|84.0||||||
4010483|NCT01197534|3830859|B3|Indian or Pakistani||Race/Ethnicity, Customized||Participants|Number|28|28.0||||||
4010484|NCT01197534|3830860|B2|Indian or Pakistani||Race/Ethnicity, Customized||Participants|Number|31|31.0||||||
4010485|NCT01197534|3830861|B1|Indian or Pakistani||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
4010486|NCT01197534|3830858|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4010487|NCT01197534|3830859|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4010488|NCT01197534|3830860|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4010489|NCT01197534|3830861|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4010490|NCT01197534|3830858|B4|Asian||Race/Ethnicity, Customized||Participants|Number|49|49.0||||||
4010491|NCT01197534|3830859|B3|Asian||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
4010492|NCT01197534|3830860|B2|Asian||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4010493|NCT01197534|3830861|B1|Asian||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4010494|NCT01197534|3830858|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
4010495|NCT01197534|3830859|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4010496|NCT01197534|3830860|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4010497|NCT01197534|3830861|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4010498|NCT01197534|3830858|B4|White||Race/Ethnicity, Customized||Participants|Number|730|730.0||||||
4010499|NCT01197534|3830859|B3|White||Race/Ethnicity, Customized||Participants|Number|241|241.0||||||
4010500|NCT01197534|3830860|B2|White||Race/Ethnicity, Customized||Participants|Number|235|235.0||||||
4010501|NCT01197534|3830861|B1|White||Race/Ethnicity, Customized||Participants|Number|254|254.0||||||
4010502|NCT01197534|3830858|B4||Male|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4010503|NCT01197534|3830859|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4010504|NCT01197534|3830860|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4010505|NCT01197534|3830861|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4010506|NCT01197534|3830858|B4||Female|Sex: Female, Male||Participants|Count of Participants|742|742.0||||||
4010507|NCT01197534|3830859|B3||Female|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
4010508|NCT01197534|3830860|B2||Female|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4010509|NCT01197534|3830861|B1||Female|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4010510|NCT01197534|3830858|B4|||Age||years|Mean|53|53.0|Standard Deviation|11.9|11.9|||
4010511|NCT01197534|3830859|B3|||Age||years|Mean|53|53.0|Standard Deviation|11.8|11.8|||
4010512|NCT01197534|3830860|B2|||Age||years|Mean|54|54.0|Standard Deviation|11.6|11.6|||
4010513|NCT01197534|3830861|B1|||Age||years|Mean|53|53.0|Standard Deviation|12.3|12.3|||
4010514|NCT01197521|3830904|B4|Other||Race/Ethnicity, Customized||Participants|Number|145|145.0||||||
4010515|NCT01197521|3830905|B3|Other||Race/Ethnicity, Customized||Participants|Number|49|49.0||||||
4010516|NCT01197521|3830906|B2|Other||Race/Ethnicity, Customized||Participants|Number|50|50.0||||||
4010517|NCT01197521|3830907|B1|Other||Race/Ethnicity, Customized||Participants|Number|46|46.0||||||
4010518|NCT01197521|3830904|B4|Indian or Pakistani||Race/Ethnicity, Customized||Participants|Number|53|53.0||||||
4010519|NCT01197521|3830905|B3|Indian or Pakistani||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4010520|NCT01197521|3830906|B2|Indian or Pakistani||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4010521|NCT01197521|3830907|B1|Indian or Pakistani||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
4010522|NCT01197521|3830904|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
4010523|NCT01197521|3830905|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4010524|NCT01197521|3830906|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4010525|NCT01197521|3830907|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4010526|NCT01197521|3830904|B4|Asian||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4010527|NCT01197521|3830905|B3|Asian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4010528|NCT01197521|3830906|B2|Asian||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4010529|NCT01197521|3830907|B1|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4010530|NCT01197521|3830904|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
4010531|NCT01197521|3830905|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4010532|NCT01197521|3830906|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4010533|NCT01197521|3830907|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4010534|NCT01197521|3830904|B4|White||Race/Ethnicity, Customized||Participants|Number|640|640.0||||||
4010535|NCT01197521|3830905|B3|White||Race/Ethnicity, Customized||Participants|Number|209|209.0||||||
4010536|NCT01197521|3830906|B2|White||Race/Ethnicity, Customized||Participants|Number|213|213.0||||||
4010537|NCT01197521|3830907|B1|White||Race/Ethnicity, Customized||Participants|Number|218|218.0||||||
4010538|NCT01197521|3830904|B4||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4010539|NCT01197521|3830905|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4010540|NCT01197521|3830906|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4010541|NCT01197521|3830907|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4010542|NCT01197521|3830904|B4||Female|Sex: Female, Male||Participants|Count of Participants|770|770.0||||||
4010543|NCT01197521|3830905|B3||Female|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
4010544|NCT01197521|3830906|B2||Female|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
4010545|NCT01197521|3830907|B1||Female|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
4010546|NCT01197521|3830904|B4|||Age||years|Mean|52|52.0|Standard Deviation|12.0|12.0|||
4010547|NCT01197521|3830905|B3|||Age||years|Mean|53|53.0|Standard Deviation|11.9|11.9|||
4010548|NCT01197521|3830906|B2|||Age||years|Mean|52|52.0|Standard Deviation|12.0|12.0|||
4010549|NCT01197521|3830907|B1|||Age||years|Mean|52|52.0|Standard Deviation|12.2|12.2|||
4010550|NCT01197508|3830950|B5|||Montgomery-Asberg Depression Rating Scale (MADRS) total score at randomization|A 10-item scale for the evaluation of depressive symptoms. Each MADRS item is rated on a 0 to 6 scale. The MADRS total score is calculated as the sum of the 10 individual item scores; the total score can range from 0 to 60. Higher MADRS scores indicate higher levels of depressive symptoms.|Scores on a scale|Mean|24.62|24.62|Standard Deviation|5.152|5.152|||
4010551|NCT01197508|3830951|B4|||Montgomery-Asberg Depression Rating Scale (MADRS) total score at randomization|A 10-item scale for the evaluation of depressive symptoms. Each MADRS item is rated on a 0 to 6 scale. The MADRS total score is calculated as the sum of the 10 individual item scores; the total score can range from 0 to 60. Higher MADRS scores indicate higher levels of depressive symptoms.|Scores on a scale|Mean|24.11|24.11|Standard Deviation|4.992|4.992|||
4010552|NCT01197508|3830952|B3|||Montgomery-Asberg Depression Rating Scale (MADRS) total score at randomization|A 10-item scale for the evaluation of depressive symptoms. Each MADRS item is rated on a 0 to 6 scale. The MADRS total score is calculated as the sum of the 10 individual item scores; the total score can range from 0 to 60. Higher MADRS scores indicate higher levels of depressive symptoms.|Scores on a scale|Mean|25.03|25.03|Standard Deviation|5.137|5.137|||
4010553|NCT01197508|3830953|B2|||Montgomery-Asberg Depression Rating Scale (MADRS) total score at randomization|A 10-item scale for the evaluation of depressive symptoms. Each MADRS item is rated on a 0 to 6 scale. The MADRS total score is calculated as the sum of the 10 individual item scores; the total score can range from 0 to 60. Higher MADRS scores indicate higher levels of depressive symptoms.|Scores on a scale|Mean|24.67|24.67|Standard Deviation|5.389|5.389|||
4010554|NCT01197508|3830954|B1|||Montgomery-Asberg Depression Rating Scale (MADRS) total score at randomization|A 10-item scale for the evaluation of depressive symptoms. Each MADRS item is rated on a 0 to 6 scale. The MADRS total score is calculated as the sum of the 10 individual item scores; the total score can range from 0 to 60. Higher MADRS scores indicate higher levels of depressive symptoms.|Scores on a scale|Mean|24.69|24.69|Standard Deviation|5.086|5.086|||
4010555|NCT01197508|3830950|B5|||Hamilton Rating Scale for Depression-17 items (HAMD-17) total score at randomization|A 17-item, clinician-rated scale that assesses depressive symptoms. The HAMD-17 consists of 17 symptoms, each of which is rated from 0 to 2 or 0 to 4, where 0 is none/absent. The HAMD-17 total score is calculated as the sum of the 17 individual symptom scores; the total score can range from 0 to 52. Higher HAMD-17 scores indicate more severe depression.|Scores on a scale|Mean|21.30|21.3|Standard Deviation|3.517|3.517|||
4010556|NCT01197508|3830951|B4|||Hamilton Rating Scale for Depression-17 items (HAMD-17) total score at randomization|A 17-item, clinician-rated scale that assesses depressive symptoms. The HAMD-17 consists of 17 symptoms, each of which is rated from 0 to 2 or 0 to 4, where 0 is none/absent. The HAMD-17 total score is calculated as the sum of the 17 individual symptom scores; the total score can range from 0 to 52. Higher HAMD-17 scores indicate more severe depression.|Scores on a scale|Mean|21.26|21.26|Standard Deviation|3.614|3.614|||
4010557|NCT01197508|3830952|B3|||Hamilton Rating Scale for Depression-17 items (HAMD-17) total score at randomization|A 17-item, clinician-rated scale that assesses depressive symptoms. The HAMD-17 consists of 17 symptoms, each of which is rated from 0 to 2 or 0 to 4, where 0 is none/absent. The HAMD-17 total score is calculated as the sum of the 17 individual symptom scores; the total score can range from 0 to 52. Higher HAMD-17 scores indicate more severe depression.|Scores on a scale|Mean|21.50|21.5|Standard Deviation|3.674|3.674|||
4010558|NCT01197508|3830953|B2|||Hamilton Rating Scale for Depression-17 items (HAMD-17) total score at randomization|A 17-item, clinician-rated scale that assesses depressive symptoms. The HAMD-17 consists of 17 symptoms, each of which is rated from 0 to 2 or 0 to 4, where 0 is none/absent. The HAMD-17 total score is calculated as the sum of the 17 individual symptom scores; the total score can range from 0 to 52. Higher HAMD-17 scores indicate more severe depression.|Scores on a scale|Mean|20.98|20.98|Standard Deviation|3.182|3.182|||
4010616|NCT01197417|3831067|B1|United States||Region of Enrollment||participants|Number|104|104.0||||||
4010617|NCT01197417|3831065|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4010618|NCT01197417|3831066|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4010619|NCT01197417|3831067|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4010559|NCT01197508|3830954|B1|||Hamilton Rating Scale for Depression-17 items (HAMD-17) total score at randomization|A 17-item, clinician-rated scale that assesses depressive symptoms. The HAMD-17 consists of 17 symptoms, each of which is rated from 0 to 2 or 0 to 4, where 0 is none/absent. The HAMD-17 total score is calculated as the sum of the 17 individual symptom scores; the total score can range from 0 to 52. Higher HAMD-17 scores indicate more severe depression.|Scores on a scale|Mean|21.49|21.49|Standard Deviation|3.587|3.587|||
4010560|NCT01197508|3830950|B5|Other||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
4010561|NCT01197508|3830951|B4|Other||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4010562|NCT01197508|3830952|B3|Other||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4010563|NCT01197508|3830953|B2|Other||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4010564|NCT01197508|3830954|B1|Other||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4010565|NCT01197508|3830950|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4010566|NCT01197508|3830951|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4010567|NCT01197508|3830952|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4010568|NCT01197508|3830953|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4010569|NCT01197508|3830954|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4010570|NCT01197508|3830950|B5|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4010571|NCT01197508|3830951|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4010572|NCT01197508|3830952|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4010573|NCT01197508|3830953|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4010574|NCT01197508|3830954|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4010575|NCT01197508|3830950|B5|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4010576|NCT01197508|3830951|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4010577|NCT01197508|3830952|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4010578|NCT01197508|3830953|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4010579|NCT01197508|3830954|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4010580|NCT01197508|3830950|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4010581|NCT01197508|3830951|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4010582|NCT01197508|3830952|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4010583|NCT01197508|3830953|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4010584|NCT01197508|3830954|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4010585|NCT01197508|3830950|B5|White||Race/Ethnicity, Customized||participants|Number|632|632.0||||||
4010586|NCT01197508|3830951|B4|White||Race/Ethnicity, Customized||participants|Number|158|158.0||||||
4010587|NCT01197508|3830952|B3|White||Race/Ethnicity, Customized||participants|Number|157|157.0||||||
4010588|NCT01197508|3830953|B2|White||Race/Ethnicity, Customized||participants|Number|156|156.0||||||
4010589|NCT01197508|3830954|B1|White||Race/Ethnicity, Customized||participants|Number|161|161.0||||||
4010590|NCT01197508|3830950|B5||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4010591|NCT01197508|3830951|B4||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4010592|NCT01197508|3830952|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4010593|NCT01197508|3830953|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4010594|NCT01197508|3830954|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4010595|NCT01197508|3830950|B5||Female|Sex: Female, Male||Participants|Count of Participants|498|498.0||||||
4010596|NCT01197508|3830951|B4||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4010597|NCT01197508|3830952|B3||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4010598|NCT01197508|3830953|B2||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4010599|NCT01197508|3830954|B1||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4010600|NCT01197508|3830950|B5|||Age||years|Mean|45.6|45.6|Standard Deviation|11.21|11.21|||
4010601|NCT01197508|3830951|B4|||Age||years|Mean|45.8|45.8|Standard Deviation|11.75|11.75|||
4010602|NCT01197508|3830952|B3|||Age||years|Mean|45.6|45.6|Standard Deviation|10.72|10.72|||
4010603|NCT01197508|3830953|B2|||Age||years|Mean|45.0|45.0|Standard Deviation|11.72|11.72|||
4010604|NCT01197508|3830954|B1|||Age||years|Mean|46.0|46.0|Standard Deviation|10.66|10.66|||
4010605|NCT01197495|3831051|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4010606|NCT01197495|3831052|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4010607|NCT01197495|3831053|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4010608|NCT01197495|3831051|B3||Female|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4010609|NCT01197495|3831052|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4010610|NCT01197495|3831053|B1||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4010611|NCT01197495|3831051|B3|||Age||Years|Mean|48.8|48.8|Standard Deviation|11.01|11.01|||
4010612|NCT01197495|3831052|B2|||Age||Years|Mean|49.2|49.2|Standard Deviation|9.72|9.72|||
4010613|NCT01197495|3831053|B1|||Age||Years|Mean|48.6|48.6|Standard Deviation|11.46|11.46|||
4010614|NCT01197417|3831065|B3|United States||Region of Enrollment||participants|Number|208|208.0||||||
4010615|NCT01197417|3831066|B2|United States||Region of Enrollment||participants|Number|104|104.0||||||
4010620|NCT01197417|3831065|B3|Unknown or not reported||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4010621|NCT01197417|3831066|B2|Unknown or not reported||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4010622|NCT01197417|3831067|B1|Unknown or not reported||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4010623|NCT01197417|3831065|B3|More than one race||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4010624|NCT01197417|3831066|B2|More than one race||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4010625|NCT01197417|3831067|B1|More than one race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4010626|NCT01197417|3831065|B3|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4010627|NCT01197417|3831066|B2|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4010628|NCT01197417|3831067|B1|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4010629|NCT01197417|3831065|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|193|193.0||||||
4010630|NCT01197417|3831066|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|94|94.0||||||
4010631|NCT01197417|3831067|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|99|99.0||||||
4010632|NCT01197417|3831065|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4010633|NCT01197417|3831066|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4010634|NCT01197417|3831067|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4010635|NCT01197417|3831065|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4010636|NCT01197417|3831066|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4010637|NCT01197417|3831067|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4010638|NCT01197417|3831065|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4010639|NCT01197417|3831066|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4010640|NCT01197417|3831067|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4010641|NCT01197417|3831065|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4010642|NCT01197417|3831066|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4010643|NCT01197417|3831067|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4010644|NCT01197417|3831065|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|190|190.0||||||
4010645|NCT01197417|3831066|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
4010646|NCT01197417|3831067|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4010647|NCT01197417|3831065|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4010648|NCT01197417|3831066|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4010649|NCT01197417|3831067|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4010650|NCT01197417|3831065|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4010651|NCT01197417|3831066|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4010652|NCT01197417|3831067|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4010653|NCT01197417|3831065|B3||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4010654|NCT01197417|3831066|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4010655|NCT01197417|3831067|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4010656|NCT01197417|3831065|B3|||Age||years|Mean|13.6|13.6|Standard Deviation|4.7|4.7|||
4010657|NCT01197417|3831066|B2|||Age||years|Mean|13.8|13.8|Standard Deviation|4.8|4.8|||
4010658|NCT01197417|3831067|B1|||Age||years|Mean|13.4|13.4|Standard Deviation|4.5|4.5|||
4010659|NCT01197417|3831065|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4010660|NCT01197417|3831066|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4010661|NCT01197417|3831067|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4010662|NCT01197417|3831065|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4010663|NCT01197417|3831066|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4010664|NCT01197417|3831067|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4010665|NCT01197417|3831065|B3||<=18 years|Age||Participants|Count of Participants|181|181.0||||||
4010666|NCT01197417|3831066|B2||<=18 years|Age||Participants|Count of Participants|88|88.0||||||
4010667|NCT01197417|3831067|B1||<=18 years|Age||Participants|Count of Participants|93|93.0||||||
4010668|NCT01197378|3831086|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4010669|NCT01197378|3831086|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|58|58.0||||||
4010670|NCT01197378|3831086|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010671|NCT01197378|3831086|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4010672|NCT01197378|3831086|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4010673|NCT01197378|3831086|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4010674|NCT01197378|3831086|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4010675|NCT01197378|3831086|B1||> 21 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
4010676|NCT01197378|3831086|B1||> 12 to ≤ 21 years|Age, Customized||Participants|Count of Participants|19|19.0||||||
4010677|NCT01197378|3831086|B1||> 6 to ≤ 12 years|Age, Customized||Participants|Count of Participants|25|25.0||||||
4010678|NCT01197378|3831086|B1||≤ 6 years|Age, Customized||Participants|Count of Participants|13|13.0||||||
4010679|NCT01197378|3831086|B1|||Age||years|Mean|10.9|10.9|Standard Deviation|6.00|6.0|||
4010680|NCT01197326|3831092|B3|United Kingdom||Region of Enrollment||participants|Number|35|35.0||||||
4010681|NCT01197326|3831093|B2|United Kingdom||Region of Enrollment||participants|Number|24|24.0||||||
4010682|NCT01197326|3831094|B1|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
4010683|NCT01197326|3831092|B3|Netherlands||Region of Enrollment||participants|Number|16|16.0||||||
4010684|NCT01197326|3831093|B2|Netherlands||Region of Enrollment||participants|Number|9|9.0||||||
4010685|NCT01197326|3831094|B1|Netherlands||Region of Enrollment||participants|Number|7|7.0||||||
4010686|NCT01197326|3831092|B3|Sweden||Region of Enrollment||participants|Number|41|41.0||||||
4010687|NCT01197326|3831093|B2|Sweden||Region of Enrollment||participants|Number|20|20.0||||||
4010688|NCT01197326|3831094|B1|Sweden||Region of Enrollment||participants|Number|21|21.0||||||
4010689|NCT01197326|3831092|B3|United States||Region of Enrollment||participants|Number|242|242.0||||||
4010690|NCT01197326|3831093|B2|United States||Region of Enrollment||participants|Number|118|118.0||||||
4010691|NCT01197326|3831094|B1|United States||Region of Enrollment||participants|Number|124|124.0||||||
4010692|NCT01197326|3831092|B3|Australia||Region of Enrollment||participants|Number|80|80.0||||||
4010693|NCT01197326|3831093|B2|Australia||Region of Enrollment||participants|Number|38|38.0||||||
4010694|NCT01197326|3831094|B1|Australia||Region of Enrollment||participants|Number|42|42.0||||||
4010695|NCT01197326|3831092|B3||Male|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4010696|NCT01197326|3831093|B2||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4010697|NCT01197326|3831094|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4010698|NCT01197326|3831092|B3||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4010699|NCT01197326|3831093|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4010700|NCT01197326|3831094|B1||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4010701|NCT01197326|3831092|B3|||Age||years|Mean|69.3|69.3|Standard Deviation|15.9|15.9|||
4010702|NCT01197326|3831093|B2|||Age||years|Mean|70.1|70.1|Standard Deviation|15.6|15.6|||
4010703|NCT01197326|3831094|B1|||Age||years|Mean|68.4|68.4|Standard Deviation|13.2|13.2|||
4010704|NCT01197326|3831092|B3||>=65 years|Age||Participants|Count of Participants|259|259.0||||||
4010705|NCT01197326|3831093|B2||>=65 years|Age||Participants|Count of Participants|136|136.0||||||
4010706|NCT01197326|3831094|B1||>=65 years|Age||Participants|Count of Participants|123|123.0||||||
4010707|NCT01197326|3831092|B3||Between 18 and 65 years|Age||Participants|Count of Participants|155|155.0||||||
4010708|NCT01197326|3831093|B2||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4010709|NCT01197326|3831094|B1||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
4010710|NCT01197326|3831092|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4010711|NCT01197326|3831093|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4010712|NCT01197326|3831094|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4010713|NCT01196988|3831103|B5||Male|Sex: Female, Male||Participants|Count of Participants|1575|1575.0||||||
4010714|NCT01196988|3831104|B4||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4010715|NCT01196988|3831105|B3||Male|Sex: Female, Male||Participants|Count of Participants|471|471.0||||||
4010716|NCT01196988|3831106|B2||Male|Sex: Female, Male||Participants|Count of Participants|473|473.0||||||
4010717|NCT01196988|3831107|B1||Male|Sex: Female, Male||Participants|Count of Participants|472|472.0||||||
4010718|NCT01196988|3831103|B5||Female|Sex: Female, Male||Participants|Count of Participants|1440|1440.0||||||
4010719|NCT01196988|3831104|B4||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4010720|NCT01196988|3831105|B3||Female|Sex: Female, Male||Participants|Count of Participants|440|440.0||||||
4010721|NCT01196988|3831106|B2||Female|Sex: Female, Male||Participants|Count of Participants|439|439.0||||||
4010722|NCT01196988|3831107|B1||Female|Sex: Female, Male||Participants|Count of Participants|443|443.0||||||
4010723|NCT01196988|3831103|B5|||Age||Months|Mean|79.6|79.6|Standard Deviation|35.53|35.53|||
4010724|NCT01196988|3831104|B4|||Age||Months|Mean|22.1|22.1|Standard Deviation|8.02|8.02|||
4010725|NCT01196988|3831105|B3|||Age||Months|Mean|99.6|99.6|Standard Deviation|44.20|44.2|||
4010726|NCT01196988|3831106|B2|||Age||Months|Mean|98.2|98.2|Standard Deviation|45.50|45.5|||
4010727|NCT01196988|3831107|B1|||Age||Months|Mean|98.5|98.5|Standard Deviation|44.40|44.4|||
4010728|NCT01196975|3831199|B6||Male|Sex: Female, Male||Participants|Count of Participants|659|659.0||||||
4010729|NCT01196975|3831200|B5||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4010730|NCT01196975|3831201|B4||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4010731|NCT01196975|3831202|B3||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4010732|NCT01196975|3831203|B2||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4010733|NCT01196975|3831204|B1||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4010734|NCT01196975|3831199|B6||Female|Sex: Female, Male||Participants|Count of Participants|1044|1044.0||||||
4010735|NCT01196975|3831200|B5||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4010736|NCT01196975|3831201|B4||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4010737|NCT01196975|3831202|B3||Female|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
4010738|NCT01196975|3831203|B2||Female|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
4010739|NCT01196975|3831204|B1||Female|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4010740|NCT01196975|3831199|B6|||Age||Years|Mean|50.1|50.1|Standard Deviation|19.32|19.32|||
4010741|NCT01196975|3831200|B5|||Age||Years|Mean|49.6|49.6|Standard Deviation|19.34|19.34|||
4010742|NCT01196975|3831201|B4|||Age||Years|Mean|50.8|50.8|Standard Deviation|18.58|18.58|||
4010743|NCT01196975|3831202|B3|||Age||Years|Mean|49.8|49.8|Standard Deviation|20.10|20.1|||
4010744|NCT01196975|3831203|B2|||Age||Years|Mean|50.4|50.4|Standard Deviation|19.07|19.07|||
4010745|NCT01196975|3831204|B1|||Age||Years|Mean|49.9|49.9|Standard Deviation|19.49|19.49|||
4010746|NCT01196923|3831340|B1|Italy||Region of Enrollment||participants|Number|20|20.0||||||
4010747|NCT01196923|3831340|B1|Male||Gender||participants with data available|Number|16|16.0||||||
4010748|NCT01196923|3831340|B1|Female||Gender||participants with data available|Number|3|3.0||||||
4010749|NCT01196923|3831340|B1|Average age, reported data||Age, Customized||years|Mean|59|59.0|Full Range|||43.0|74.0|
4010750|NCT01196871|3831344|B7|Stage 2|Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4010751|NCT01196871|3831345|B6|Stage 2|Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4010752|NCT01196871|3831346|B5|Stage 2|Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4010753|NCT01196871|3831347|B4|Stage 2|Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4010754|NCT01196871|3831344|B7|Stage 2|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4010755|NCT01196871|3831345|B6|Stage 2|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4010756|NCT01196871|3831346|B5|Stage 2|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4010757|NCT01196871|3831347|B4|Stage 2|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4010758|NCT01196871|3831344|B7|Stage 1|Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4010759|NCT01196871|3831348|B3|Stage 1|Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4010760|NCT01196871|3831349|B2|Stage 1|Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4010761|NCT01196871|3831350|B1|Stage 1|Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4010762|NCT01196871|3831344|B7|Stage 1|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4010763|NCT01196871|3831348|B3|Stage 1|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4010764|NCT01196871|3831349|B2|Stage 1|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4010765|NCT01196871|3831350|B1|Stage 1|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4010766|NCT01196871|3831344|B7|Stage 2||Age||years|Mean|40.1|40.1|Standard Deviation|11.11|11.11|||
4010767|NCT01196871|3831345|B6|Stage 2||Age||years|Mean|38.5|38.5|Standard Deviation|9.15|9.15|||
4010768|NCT01196871|3831346|B5|Stage 2||Age||years|Mean|38.7|38.7|Standard Deviation|12.16|12.16|||
4010769|NCT01196871|3831347|B4|Stage 2||Age||years|Mean|53.5|53.5|Standard Deviation|2.12|2.12|||
4010770|NCT01196871|3831344|B7|Stage 1||Age||years|Mean|47.0|47.0|Standard Deviation|6.84|6.84|||
4010771|NCT01196871|3831348|B3|Stage 1||Age||years|Mean|43.5|43.5|Standard Deviation|5.07|5.07|||
4010772|NCT01196871|3831349|B2|Stage 1||Age||years|Mean|45.7|45.7|Standard Deviation|8.02|8.02|||
4010773|NCT01196871|3831350|B1|Stage 1||Age||years|Mean|50.6|50.6|Standard Deviation|6.88|6.88|||
4010774|NCT01196819|3831438|B3|China||Region of Enrollment||participants|Number|458|458.0||||||
4010775|NCT01196819|3831439|B2|China||Region of Enrollment||participants|Number|227|227.0||||||
4010776|NCT01196819|3831440|B1|China||Region of Enrollment||participants|Number|231|231.0||||||
4010777|NCT01196819|3831438|B3||Male|Sex: Female, Male||Participants|Count of Participants|315|315.0||||||
4010778|NCT01196819|3831439|B2||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4010779|NCT01196819|3831440|B1||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4010780|NCT01196819|3831438|B3||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4010781|NCT01196819|3831439|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4010782|NCT01196819|3831440|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4010783|NCT01196819|3831438|B3|||Age||years|Median|59|59.0|Standard Deviation|9|9.0|||
4010784|NCT01196819|3831439|B2|||Age||years|Median|58.95|58.95|Standard Deviation|9.42|9.42|||
4010785|NCT01196819|3831440|B1|||Age||years|Median|59.97|59.97|Standard Deviation|9.39|9.39|||
4010786|NCT01196741|3831461|B3|||Number of lines of Prior Chemotherapy||lines of chemotherapy|Median|2.0|2.0|Full Range|||1.0|7.0|
4010787|NCT01196741|3831462|B2|||Number of lines of Prior Chemotherapy||lines of chemotherapy|Median|2.0|2.0|Full Range|||1.0|6.0|
4010788|NCT01196741|3831463|B1|||Number of lines of Prior Chemotherapy||lines of chemotherapy|Median|2.0|2.0|Full Range|||1.0|7.0|
4010789|NCT01196741|3831461|B3|Unknown||Number of lines of Prior Chemotherapy||participants|Number|2|2.0||||||
4010790|NCT01196741|3831462|B2|Unknown||Number of lines of Prior Chemotherapy||participants|Number|0|0.0||||||
4010791|NCT01196741|3831463|B1|Unknown||Number of lines of Prior Chemotherapy||participants|Number|2|2.0||||||
4010792|NCT01196741|3831461|B3|>2||Number of lines of Prior Chemotherapy||participants|Number|43|43.0||||||
4010793|NCT01196741|3831462|B2|>2||Number of lines of Prior Chemotherapy||participants|Number|17|17.0||||||
4010794|NCT01196741|3831463|B1|>2||Number of lines of Prior Chemotherapy||participants|Number|26|26.0||||||
4010795|NCT01196741|3831461|B3|1-2||Number of lines of Prior Chemotherapy||participants|Number|62|62.0||||||
4010796|NCT01196741|3831462|B2|1-2||Number of lines of Prior Chemotherapy||participants|Number|19|19.0||||||
4010797|NCT01196741|3831463|B1|1-2||Number of lines of Prior Chemotherapy||participants|Number|43|43.0||||||
4010798|NCT01196741|3831461|B3|>=6 months/None||Prior Taxane Interval||participants|Number|84|84.0||||||
4010799|NCT01196741|3831462|B2|>=6 months/None||Prior Taxane Interval||participants|Number|28|28.0||||||
4010800|NCT01196741|3831463|B1|>=6 months/None||Prior Taxane Interval||participants|Number|56|56.0||||||
4010801|NCT01196741|3831461|B3|<6 months||Prior Taxane Interval||participants|Number|23|23.0||||||
4010802|NCT01196741|3831462|B2|<6 months||Prior Taxane Interval||participants|Number|8|8.0||||||
4010803|NCT01196741|3831463|B1|<6 months||Prior Taxane Interval||participants|Number|15|15.0||||||
4010804|NCT01196741|3831461|B3|Unknown||Prior Surgery||participants|Number|2|2.0||||||
4010805|NCT01196741|3831462|B2|Unknown||Prior Surgery||participants|Number|0|0.0||||||
4010806|NCT01196741|3831463|B1|Unknown||Prior Surgery||participants|Number|2|2.0||||||
4010807|NCT01196741|3831461|B3|No||Prior Surgery||participants|Number|7|7.0||||||
4010808|NCT01196741|3831462|B2|No||Prior Surgery||participants|Number|5|5.0||||||
4010809|NCT01196741|3831463|B1|No||Prior Surgery||participants|Number|2|2.0||||||
4010810|NCT01196741|3831461|B3|Yes||Prior Surgery||participants|Number|98|98.0||||||
4010811|NCT01196741|3831462|B2|Yes||Prior Surgery||participants|Number|31|31.0||||||
4010812|NCT01196741|3831463|B1|Yes||Prior Surgery||participants|Number|67|67.0||||||
4010813|NCT01196741|3831461|B3|Unknown||Histological subtype||participants|Number|4|4.0||||||
4010814|NCT01196741|3831462|B2|Unknown||Histological subtype||participants|Number|1|1.0||||||
4010815|NCT01196741|3831463|B1|Unknown||Histological subtype||participants|Number|3|3.0||||||
4010816|NCT01196741|3831461|B3|Undifferentiated||Histological subtype||participants|Number|9|9.0||||||
4010817|NCT01196741|3831462|B2|Undifferentiated||Histological subtype||participants|Number|2|2.0||||||
4010818|NCT01196741|3831463|B1|Undifferentiated||Histological subtype||participants|Number|7|7.0||||||
4010819|NCT01196741|3831461|B3|Grade 1/2 endometrioid||Histological subtype||participants|Number|4|4.0||||||
4010820|NCT01196741|3831462|B2|Grade 1/2 endometrioid||Histological subtype||participants|Number|1|1.0||||||
4010821|NCT01196741|3831463|B1|Grade 1/2 endometrioid||Histological subtype||participants|Number|3|3.0||||||
4010822|NCT01196741|3831461|B3|Grade 3 endometrioid||Histological subtype||participants|Number|4|4.0||||||
4010823|NCT01196741|3831462|B2|Grade 3 endometrioid||Histological subtype||participants|Number|2|2.0||||||
4010824|NCT01196741|3831463|B1|Grade 3 endometrioid||Histological subtype||participants|Number|2|2.0||||||
4010825|NCT01196741|3831461|B3|Clear cell||Histological subtype||participants|Number|7|7.0||||||
4010826|NCT01196741|3831462|B2|Clear cell||Histological subtype||participants|Number|1|1.0||||||
4010827|NCT01196741|3831463|B1|Clear cell||Histological subtype||participants|Number|6|6.0||||||
4010828|NCT01196741|3831461|B3|Low grade serous||Histological subtype||participants|Number|6|6.0||||||
4010829|NCT01196741|3831462|B2|Low grade serous||Histological subtype||participants|Number|2|2.0||||||
4010830|NCT01196741|3831463|B1|Low grade serous||Histological subtype||participants|Number|4|4.0||||||
4010831|NCT01196741|3831461|B3|High grade serous||Histological subtype||participants|Number|73|73.0||||||
4010832|NCT01196741|3831462|B2|High grade serous||Histological subtype||participants|Number|27|27.0||||||
4010833|NCT01196741|3831463|B1|High grade serous||Histological subtype||participants|Number|46|46.0||||||
4010834|NCT01196741|3831461|B3|Unknown||International Federation of Gynecology and Obstetrics(FIGO) Ovarian Cancer Staging at diagnosis|"STAGE I: Tumour confined to ovaries~STAGE II: Tumour involves one or both ovaries with pelvic extension (below the pelvic brim) or primary peritoneal cancer~STAGE III: Tumour involves one or both ovaries with cytologically or histologically confirmed spread to the peritoneum outside the pelvis and/or metastasis to the retroperitoneal lymph nodes~STAGE IV: Distant metastasis excluding peritoneal metastasis"|participants|Number|5|5.0||||||
4010835|NCT01196741|3831462|B2|Unknown||International Federation of Gynecology and Obstetrics(FIGO) Ovarian Cancer Staging at diagnosis|"STAGE I: Tumour confined to ovaries~STAGE II: Tumour involves one or both ovaries with pelvic extension (below the pelvic brim) or primary peritoneal cancer~STAGE III: Tumour involves one or both ovaries with cytologically or histologically confirmed spread to the peritoneum outside the pelvis and/or metastasis to the retroperitoneal lymph nodes~STAGE IV: Distant metastasis excluding peritoneal metastasis"|participants|Number|1|1.0||||||
4010836|NCT01196741|3831463|B1|Unknown||International Federation of Gynecology and Obstetrics(FIGO) Ovarian Cancer Staging at diagnosis|"STAGE I: Tumour confined to ovaries~STAGE II: Tumour involves one or both ovaries with pelvic extension (below the pelvic brim) or primary peritoneal cancer~STAGE III: Tumour involves one or both ovaries with cytologically or histologically confirmed spread to the peritoneum outside the pelvis and/or metastasis to the retroperitoneal lymph nodes~STAGE IV: Distant metastasis excluding peritoneal metastasis"|participants|Number|4|4.0||||||
4010837|NCT01196741|3831461|B3|IV||International Federation of Gynecology and Obstetrics(FIGO) Ovarian Cancer Staging at diagnosis|"STAGE I: Tumour confined to ovaries~STAGE II: Tumour involves one or both ovaries with pelvic extension (below the pelvic brim) or primary peritoneal cancer~STAGE III: Tumour involves one or both ovaries with cytologically or histologically confirmed spread to the peritoneum outside the pelvis and/or metastasis to the retroperitoneal lymph nodes~STAGE IV: Distant metastasis excluding peritoneal metastasis"|participants|Number|12|12.0||||||
4010838|NCT01196741|3831462|B2|IV||International Federation of Gynecology and Obstetrics(FIGO) Ovarian Cancer Staging at diagnosis|"STAGE I: Tumour confined to ovaries~STAGE II: Tumour involves one or both ovaries with pelvic extension (below the pelvic brim) or primary peritoneal cancer~STAGE III: Tumour involves one or both ovaries with cytologically or histologically confirmed spread to the peritoneum outside the pelvis and/or metastasis to the retroperitoneal lymph nodes~STAGE IV: Distant metastasis excluding peritoneal metastasis"|participants|Number|1|1.0||||||
4010839|NCT01196741|3831463|B1|IV||International Federation of Gynecology and Obstetrics(FIGO) Ovarian Cancer Staging at diagnosis|"STAGE I: Tumour confined to ovaries~STAGE II: Tumour involves one or both ovaries with pelvic extension (below the pelvic brim) or primary peritoneal cancer~STAGE III: Tumour involves one or both ovaries with cytologically or histologically confirmed spread to the peritoneum outside the pelvis and/or metastasis to the retroperitoneal lymph nodes~STAGE IV: Distant metastasis excluding peritoneal metastasis"|participants|Number|11|11.0||||||
4010905|NCT01196429|3831489|B2|20-29 years||Age, Customized||participants|Number|1|1.0||||||
4010906|NCT01196429|3831490|B1|20-29 years||Age, Customized||participants|Number|1|1.0||||||
4010907|NCT01196416|3831507|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4010840|NCT01196741|3831461|B3|III||International Federation of Gynecology and Obstetrics(FIGO) Ovarian Cancer Staging at diagnosis|"STAGE I: Tumour confined to ovaries~STAGE II: Tumour involves one or both ovaries with pelvic extension (below the pelvic brim) or primary peritoneal cancer~STAGE III: Tumour involves one or both ovaries with cytologically or histologically confirmed spread to the peritoneum outside the pelvis and/or metastasis to the retroperitoneal lymph nodes~STAGE IV: Distant metastasis excluding peritoneal metastasis"|participants|Number|76|76.0||||||
4010841|NCT01196741|3831462|B2|III||International Federation of Gynecology and Obstetrics(FIGO) Ovarian Cancer Staging at diagnosis|"STAGE I: Tumour confined to ovaries~STAGE II: Tumour involves one or both ovaries with pelvic extension (below the pelvic brim) or primary peritoneal cancer~STAGE III: Tumour involves one or both ovaries with cytologically or histologically confirmed spread to the peritoneum outside the pelvis and/or metastasis to the retroperitoneal lymph nodes~STAGE IV: Distant metastasis excluding peritoneal metastasis"|participants|Number|31|31.0||||||
4010842|NCT01196741|3831463|B1|III||International Federation of Gynecology and Obstetrics(FIGO) Ovarian Cancer Staging at diagnosis|"STAGE I: Tumour confined to ovaries~STAGE II: Tumour involves one or both ovaries with pelvic extension (below the pelvic brim) or primary peritoneal cancer~STAGE III: Tumour involves one or both ovaries with cytologically or histologically confirmed spread to the peritoneum outside the pelvis and/or metastasis to the retroperitoneal lymph nodes~STAGE IV: Distant metastasis excluding peritoneal metastasis"|participants|Number|45|45.0||||||
4010843|NCT01196741|3831461|B3|II||International Federation of Gynecology and Obstetrics(FIGO) Ovarian Cancer Staging at diagnosis|"STAGE I: Tumour confined to ovaries~STAGE II: Tumour involves one or both ovaries with pelvic extension (below the pelvic brim) or primary peritoneal cancer~STAGE III: Tumour involves one or both ovaries with cytologically or histologically confirmed spread to the peritoneum outside the pelvis and/or metastasis to the retroperitoneal lymph nodes~STAGE IV: Distant metastasis excluding peritoneal metastasis"|participants|Number|6|6.0||||||
4010844|NCT01196741|3831462|B2|II||International Federation of Gynecology and Obstetrics(FIGO) Ovarian Cancer Staging at diagnosis|"STAGE I: Tumour confined to ovaries~STAGE II: Tumour involves one or both ovaries with pelvic extension (below the pelvic brim) or primary peritoneal cancer~STAGE III: Tumour involves one or both ovaries with cytologically or histologically confirmed spread to the peritoneum outside the pelvis and/or metastasis to the retroperitoneal lymph nodes~STAGE IV: Distant metastasis excluding peritoneal metastasis"|participants|Number|1|1.0||||||
4010845|NCT01196741|3831463|B1|II||International Federation of Gynecology and Obstetrics(FIGO) Ovarian Cancer Staging at diagnosis|"STAGE I: Tumour confined to ovaries~STAGE II: Tumour involves one or both ovaries with pelvic extension (below the pelvic brim) or primary peritoneal cancer~STAGE III: Tumour involves one or both ovaries with cytologically or histologically confirmed spread to the peritoneum outside the pelvis and/or metastasis to the retroperitoneal lymph nodes~STAGE IV: Distant metastasis excluding peritoneal metastasis"|participants|Number|5|5.0||||||
4010846|NCT01196741|3831461|B3|I||International Federation of Gynecology and Obstetrics(FIGO) Ovarian Cancer Staging at diagnosis|"STAGE I: Tumour confined to ovaries~STAGE II: Tumour involves one or both ovaries with pelvic extension (below the pelvic brim) or primary peritoneal cancer~STAGE III: Tumour involves one or both ovaries with cytologically or histologically confirmed spread to the peritoneum outside the pelvis and/or metastasis to the retroperitoneal lymph nodes~STAGE IV: Distant metastasis excluding peritoneal metastasis"|participants|Number|8|8.0||||||
4010847|NCT01196741|3831462|B2|I||International Federation of Gynecology and Obstetrics(FIGO) Ovarian Cancer Staging at diagnosis|"STAGE I: Tumour confined to ovaries~STAGE II: Tumour involves one or both ovaries with pelvic extension (below the pelvic brim) or primary peritoneal cancer~STAGE III: Tumour involves one or both ovaries with cytologically or histologically confirmed spread to the peritoneum outside the pelvis and/or metastasis to the retroperitoneal lymph nodes~STAGE IV: Distant metastasis excluding peritoneal metastasis"|participants|Number|2|2.0||||||
4010848|NCT01196741|3831463|B1|I||International Federation of Gynecology and Obstetrics(FIGO) Ovarian Cancer Staging at diagnosis|"STAGE I: Tumour confined to ovaries~STAGE II: Tumour involves one or both ovaries with pelvic extension (below the pelvic brim) or primary peritoneal cancer~STAGE III: Tumour involves one or both ovaries with cytologically or histologically confirmed spread to the peritoneum outside the pelvis and/or metastasis to the retroperitoneal lymph nodes~STAGE IV: Distant metastasis excluding peritoneal metastasis"|participants|Number|6|6.0||||||
4010849|NCT01196741|3831461|B3|2||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|"ECOG PS 0 = Fully active, able to carry out all normal (pre-disease) activity without restriction~ECOG PS 1 = Restricted in physically strenuous activity but ambulatory and able to carry out light work, e.g. light house work, office work~ECOG PS 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours"|participants|Number|4|4.0||||||
4010850|NCT01196741|3831462|B2|2||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|"ECOG PS 0 = Fully active, able to carry out all normal (pre-disease) activity without restriction~ECOG PS 1 = Restricted in physically strenuous activity but ambulatory and able to carry out light work, e.g. light house work, office work~ECOG PS 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours"|participants|Number|1|1.0||||||
4010851|NCT01196741|3831463|B1|2||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|"ECOG PS 0 = Fully active, able to carry out all normal (pre-disease) activity without restriction~ECOG PS 1 = Restricted in physically strenuous activity but ambulatory and able to carry out light work, e.g. light house work, office work~ECOG PS 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours"|participants|Number|3|3.0||||||
4010852|NCT01196741|3831461|B3|1||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|"ECOG PS 0 = Fully active, able to carry out all normal (pre-disease) activity without restriction~ECOG PS 1 = Restricted in physically strenuous activity but ambulatory and able to carry out light work, e.g. light house work, office work~ECOG PS 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours"|participants|Number|65|65.0||||||
4010853|NCT01196741|3831462|B2|1||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|"ECOG PS 0 = Fully active, able to carry out all normal (pre-disease) activity without restriction~ECOG PS 1 = Restricted in physically strenuous activity but ambulatory and able to carry out light work, e.g. light house work, office work~ECOG PS 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours"|participants|Number|20|20.0||||||
4010854|NCT01196741|3831463|B1|1||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|"ECOG PS 0 = Fully active, able to carry out all normal (pre-disease) activity without restriction~ECOG PS 1 = Restricted in physically strenuous activity but ambulatory and able to carry out light work, e.g. light house work, office work~ECOG PS 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours"|participants|Number|45|45.0||||||
4010855|NCT01196741|3831461|B3|0||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|"ECOG PS 0 = Fully active, able to carry out all normal (pre-disease) activity without restriction~ECOG PS 1 = Restricted in physically strenuous activity but ambulatory and able to carry out light work, e.g. light house work, office work~ECOG PS 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours"|participants|Number|38|38.0||||||
4010856|NCT01196741|3831462|B2|0||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|"ECOG PS 0 = Fully active, able to carry out all normal (pre-disease) activity without restriction~ECOG PS 1 = Restricted in physically strenuous activity but ambulatory and able to carry out light work, e.g. light house work, office work~ECOG PS 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours"|participants|Number|15|15.0||||||
4010857|NCT01196741|3831463|B1|0||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|"ECOG PS 0 = Fully active, able to carry out all normal (pre-disease) activity without restriction~ECOG PS 1 = Restricted in physically strenuous activity but ambulatory and able to carry out light work, e.g. light house work, office work~ECOG PS 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours"|participants|Number|23|23.0||||||
4010858|NCT01196741|3831461|B3|||Cancer Antigen 125 (CA125)||U/mL|Median|648|648.0|Full Range|||8.0|12945.0|
4010859|NCT01196741|3831462|B2|||Cancer Antigen 125 (CA125)||U/mL|Median|667|667.0|Full Range|||24.0|7758.0|
4010860|NCT01196741|3831463|B1|||Cancer Antigen 125 (CA125)||U/mL|Median|628|628.0|Full Range|||8.0|12945.0|
4010861|NCT01196741|3831461|B3|United Kingdom||Region of Enrollment||participants|Number|107|107.0||||||
4010862|NCT01196741|3831462|B2|United Kingdom||Region of Enrollment||participants|Number|36|36.0||||||
4010863|NCT01196741|3831463|B1|United Kingdom||Region of Enrollment||participants|Number|71|71.0||||||
4010864|NCT01196741|3831461|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4010865|NCT01196741|3831462|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4010866|NCT01196741|3831463|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4010867|NCT01196741|3831461|B3||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4010868|NCT01196741|3831462|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4010869|NCT01196741|3831463|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4010870|NCT01196741|3831461|B3|||Age||years|Median|63.4|63.4|Full Range|||20.0|82.1|
4010871|NCT01196741|3831462|B2|||Age||years|Median|66.9|66.9|Full Range|||20.0|82.1|
4010872|NCT01196741|3831463|B1|||Age||years|Median|62.8|62.8|Full Range|||34.5|78.8|
4010873|NCT01196442|3831478|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4010874|NCT01196442|3831478|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4010875|NCT01196442|3831478|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4010876|NCT01196442|3831478|B1|||Age||years|Mean|59|59.0|Standard Deviation|0.7|0.7|||
4010877|NCT01196442|3831478|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4010878|NCT01196442|3831478|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4010879|NCT01196442|3831478|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4010880|NCT01196429|3831488|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4010881|NCT01196429|3831489|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4010882|NCT01196429|3831490|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4010883|NCT01196429|3831488|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4010884|NCT01196429|3831489|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4010885|NCT01196429|3831490|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4010886|NCT01196429|3831488|B3|80-89 years||Age, Customized||participants|Number|0|0.0||||||
4010887|NCT01196429|3831489|B2|80-89 years||Age, Customized||participants|Number|0|0.0||||||
4010888|NCT01196429|3831490|B1|80-89 years||Age, Customized||participants|Number|0|0.0||||||
4010889|NCT01196429|3831488|B3|70-79 years||Age, Customized||participants|Number|3|3.0||||||
4010890|NCT01196429|3831489|B2|70-79 years||Age, Customized||participants|Number|3|3.0||||||
4010891|NCT01196429|3831490|B1|70-79 years||Age, Customized||participants|Number|0|0.0||||||
4010892|NCT01196429|3831488|B3|60-69 years||Age, Customized||participants|Number|14|14.0||||||
4010893|NCT01196429|3831489|B2|60-69 years||Age, Customized||participants|Number|8|8.0||||||
4010894|NCT01196429|3831490|B1|60-69 years||Age, Customized||participants|Number|6|6.0||||||
4010895|NCT01196429|3831488|B3|50-59 years||Age, Customized||participants|Number|42|42.0||||||
4010896|NCT01196429|3831489|B2|50-59 years||Age, Customized||participants|Number|21|21.0||||||
4010897|NCT01196429|3831490|B1|50-59 years||Age, Customized||participants|Number|21|21.0||||||
4010898|NCT01196429|3831488|B3|40-49 years||Age, Customized||participants|Number|21|21.0||||||
4010899|NCT01196429|3831489|B2|40-49 years||Age, Customized||participants|Number|9|9.0||||||
4010900|NCT01196429|3831490|B1|40-49 years||Age, Customized||participants|Number|12|12.0||||||
4010901|NCT01196429|3831488|B3|30-39 years||Age, Customized||participants|Number|5|5.0||||||
4010902|NCT01196429|3831489|B2|30-39 years||Age, Customized||participants|Number|3|3.0||||||
4010903|NCT01196429|3831490|B1|30-39 years||Age, Customized||participants|Number|2|2.0||||||
4010904|NCT01196429|3831488|B3|20-29 years||Age, Customized||participants|Number|2|2.0||||||
4010908|NCT01196416|3831507|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4010909|NCT01196416|3831507|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4010910|NCT01196416|3831507|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4010911|NCT01196416|3831507|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4010912|NCT01196377|3831514|B5|United States||Region of Enrollment||participants|Number|16|16.0||||||
4010913|NCT01196377|3831515|B4|United States||Region of Enrollment||participants|Number|4|4.0||||||
4010914|NCT01196377|3831516|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4010915|NCT01196377|3831517|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4010916|NCT01196377|3831518|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4010917|NCT01196377|3831514|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4010918|NCT01196377|3831515|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4010919|NCT01196377|3831516|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4010920|NCT01196377|3831517|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4010921|NCT01196377|3831518|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4010922|NCT01196377|3831514|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4010923|NCT01196377|3831515|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4010924|NCT01196377|3831516|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4010925|NCT01196377|3831517|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4010926|NCT01196377|3831518|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4010927|NCT01196377|3831514|B5|||Age||years|Mean|7.7|7.7|Standard Deviation|2|2.0|||
4010928|NCT01196377|3831515|B4|||Age||years|Mean|7.7|7.7|Standard Deviation|2|2.0|||
4010929|NCT01196377|3831516|B3|||Age||years|Mean|7.6|7.6|Standard Deviation|4|4.0|||
4010930|NCT01196377|3831517|B2|||Age||years|Mean|7.9|7.9|Standard Deviation|2|2.0|||
4010931|NCT01196377|3831518|B1|||Age||years|Mean|7.8|7.8|Standard Deviation|2|2.0|||
4010932|NCT01196104|3831531|B3|||HbA1c|HbA1c (%) at randomization (NOTE: Aspart group only had 17 with HbA1c measurements at baseline)|%|Mean|7.85|7.85|Full Range|||6.3|10.3|
4010933|NCT01196104|3831532|B2|||HbA1c|HbA1c (%) at randomization (NOTE: Aspart group only had 17 with HbA1c measurements at baseline)|%|Mean|7.94|7.94|Full Range|1.098|1.098|6.7|10.3|
4010934|NCT01196104|3831533|B1|||HbA1c|HbA1c (%) at randomization (NOTE: Aspart group only had 17 with HbA1c measurements at baseline)|%|Mean|7.76|7.76|Full Range|1.097|1.097|6.3|10.2|
4010935|NCT01196104|3831531|B3|||Body Mass Index|Body Mass Index (kg/m2) at Randomization|kg/m2|Mean|33.2|33.2|Full Range|||19.3|44.1|
4010936|NCT01196104|3831532|B2|||Body Mass Index|Body Mass Index (kg/m2) at Randomization|kg/m2|Mean|33.3|33.3|Full Range|5.51|5.51|24.3|44.1|
4010937|NCT01196104|3831533|B1|||Body Mass Index|Body Mass Index (kg/m2) at Randomization|kg/m2|Mean|33.2|33.2|Full Range|5.78|5.78|19.3|42.9|
4010938|NCT01196104|3831531|B3|||Body Weight|Body Weight (kg) at Randomization|kg|Mean|100.9|100.9|Full Range|||54.1|141.9|
4010939|NCT01196104|3831532|B2|||Body Weight|Body Weight (kg) at Randomization|kg|Mean|100.8|100.8|Full Range|20.30|20.3|66.4|138.6|
4010940|NCT01196104|3831533|B1|||Body Weight|Body Weight (kg) at Randomization|kg|Mean|100.9|100.9|Full Range|21.84|21.84|54.1|141.9|
4010941|NCT01196104|3831531|B3|||Duration of Diabetes||years|Mean|15.1|15.1|Full Range|||2.5|43.1|
4010942|NCT01196104|3831532|B2|||Duration of Diabetes||years|Mean|15.6|15.6|Full Range|10.67|10.67|2.5|43.1|
4010943|NCT01196104|3831533|B1|||Duration of Diabetes||years|Mean|14.6|14.6|Full Range|7.95|7.95|3.7|35.9|
4010944|NCT01196104|3831531|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
4010945|NCT01196104|3831532|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4010946|NCT01196104|3831533|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4010947|NCT01196104|3831531|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010948|NCT01196104|3831532|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010949|NCT01196104|3831533|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010950|NCT01196104|3831531|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010951|NCT01196104|3831532|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010952|NCT01196104|3831533|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010953|NCT01196104|3831531|B3||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4010954|NCT01196104|3831532|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4010955|NCT01196104|3831533|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4010956|NCT01196104|3831531|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4010957|NCT01196104|3831532|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4010958|NCT01196104|3831533|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4010959|NCT01196104|3831531|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4010960|NCT01196104|3831532|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4010961|NCT01196104|3831533|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010962|NCT01196104|3831531|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4010963|NCT01196104|3831532|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4010964|NCT01196104|3831533|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010965|NCT01196104|3831531|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010966|NCT01196104|3831532|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010967|NCT01196104|3831533|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4010968|NCT01196104|3831531|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4010969|NCT01196104|3831532|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4010970|NCT01196104|3831533|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4010971|NCT01196104|3831531|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4010972|NCT01196104|3831532|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4010973|NCT01196104|3831533|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4010974|NCT01196104|3831531|B3|||Age||years|Mean|59.4|59.4|Full Range|||42.0|78.0|
4010975|NCT01196104|3831532|B2|||Age||years|Mean|58.1|58.1|Full Range|10.67|10.67|42.0|78.0|
4010976|NCT01196104|3831533|B1|||Age||years|Mean|60.6|60.6|Full Range|7.95|7.95|47.0|72.0|
4010977|NCT01196091|3831574|B4|||Brief Fatigue Inventory (BFI) Score (Worst Level of Fatigue in the Last 24 Hours)|BFI is a participants-reported scale that measures the severity of fatigue based on the worst fatigue experienced during the past 24-hours. The severity scores ranged from 0 (no fatigue) to 10 (fatigue as severe as you can imagine).|units on a scale|Mean|5.6|5.6|Standard Deviation|2.73|2.73|||
4010978|NCT01196091|3831575|B3|||Brief Fatigue Inventory (BFI) Score (Worst Level of Fatigue in the Last 24 Hours)|BFI is a participants-reported scale that measures the severity of fatigue based on the worst fatigue experienced during the past 24-hours. The severity scores ranged from 0 (no fatigue) to 10 (fatigue as severe as you can imagine).|units on a scale|Mean|5.6|5.6|Standard Deviation|2.81|2.81|||
4010979|NCT01196091|3831576|B2|||Brief Fatigue Inventory (BFI) Score (Worst Level of Fatigue in the Last 24 Hours)|BFI is a participants-reported scale that measures the severity of fatigue based on the worst fatigue experienced during the past 24-hours. The severity scores ranged from 0 (no fatigue) to 10 (fatigue as severe as you can imagine).|units on a scale|Mean|5.6|5.6|Standard Deviation|2.81|2.81|||
4010980|NCT01196091|3831577|B1|||Brief Fatigue Inventory (BFI) Score (Worst Level of Fatigue in the Last 24 Hours)|BFI is a participants-reported scale that measures the severity of fatigue based on the worst fatigue experienced during the past 24-hours. The severity scores ranged from 0 (no fatigue) to 10 (fatigue as severe as you can imagine).|units on a scale|Mean|5.8|5.8|Standard Deviation|2.57|2.57|||
4010981|NCT01196091|3831574|B4|Burden to Others||Lupus Quality of Life (lupus QOL) Domain Score|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|51.3|51.3|Standard Deviation|31.15|31.15|||
4010982|NCT01196091|3831575|B3|Burden to Others||Lupus Quality of Life (lupus QOL) Domain Score|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|49.3|49.3|Standard Deviation|32.39|32.39|||
4010983|NCT01196091|3831576|B2|Burden to Others||Lupus Quality of Life (lupus QOL) Domain Score|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|51.9|51.9|Standard Deviation|30.31|30.31|||
4010984|NCT01196091|3831577|B1|Burden to Others||Lupus Quality of Life (lupus QOL) Domain Score|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|52.8|52.8|Standard Deviation|30.70|30.7|||
4010985|NCT01196091|3831574|B4|Intimate Relationships||Lupus Quality of Life (lupus QOL) Domain Score|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|58.8|58.8|Standard Deviation|33.36|33.36|||
4010986|NCT01196091|3831575|B3|Intimate Relationships||Lupus Quality of Life (lupus QOL) Domain Score|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|56.8|56.8|Standard Deviation|34.21|34.21|||
4010987|NCT01196091|3831576|B2|Intimate Relationships||Lupus Quality of Life (lupus QOL) Domain Score|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|63.3|63.3|Standard Deviation|31.53|31.53|||
4010988|NCT01196091|3831577|B1|Intimate Relationships||Lupus Quality of Life (lupus QOL) Domain Score|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|56.2|56.2|Standard Deviation|33.92|33.92|||
4011151|NCT01196091|3831576|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4010989|NCT01196091|3831574|B4|Fatigue||Lupus Quality of Life (lupus QOL) Domain Score|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|54.6|54.6|Standard Deviation|26.36|26.36|||
4010990|NCT01196091|3831575|B3|Fatigue||Lupus Quality of Life (lupus QOL) Domain Score|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|53.4|53.4|Standard Deviation|27.14|27.14|||
4010991|NCT01196091|3831576|B2|Fatigue||Lupus Quality of Life (lupus QOL) Domain Score|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|54.4|54.4|Standard Deviation|25.54|25.54|||
4010992|NCT01196091|3831577|B1|Fatigue||Lupus Quality of Life (lupus QOL) Domain Score|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|56.0|56.0|Standard Deviation|26.39|26.39|||
4010993|NCT01196091|3831574|B4|Planning||Lupus Quality of Life (lupus QOL) Domain Score|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|60.8|60.8|Standard Deviation|30.01|30.01|||
4010994|NCT01196091|3831575|B3|Planning||Lupus Quality of Life (lupus QOL) Domain Score|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|59.0|59.0|Standard Deviation|30.92|30.92|||
4010995|NCT01196091|3831576|B2|Planning||Lupus Quality of Life (lupus QOL) Domain Score|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|62.1|62.1|Standard Deviation|28.69|28.69|||
4010996|NCT01196091|3831577|B1|Planning||Lupus Quality of Life (lupus QOL) Domain Score|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|61.2|61.2|Standard Deviation|30.37|30.37|||
4010997|NCT01196091|3831574|B4|Pain||Lupus Quality of Life (lupus QOL) Domain Score|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|55.5|55.5|Standard Deviation|27.95|27.95|||
4010998|NCT01196091|3831575|B3|Pain||Lupus Quality of Life (lupus QOL) Domain Score|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|53.6|53.6|Standard Deviation|28.62|28.62|||
4010999|NCT01196091|3831576|B2|Pain||Lupus Quality of Life (lupus QOL) Domain Score|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|56.9|56.9|Standard Deviation|26.75|26.75|||
4011000|NCT01196091|3831577|B1|Pain||Lupus Quality of Life (lupus QOL) Domain Score|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|56.1|56.1|Standard Deviation|28.40|28.4|||
4011001|NCT01196091|3831574|B4|Body Image||Lupus Quality of Life (lupus QOL) Domain Score|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|62.1|62.1|Standard Deviation|28.61|28.61|||
4011002|NCT01196091|3831575|B3|Body Image||Lupus Quality of Life (lupus QOL) Domain Score|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|61.9|61.9|Standard Deviation|29.20|29.2|||
4011086|NCT01196091|3831575|B3|Belarus||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4011087|NCT01196091|3831576|B2|Belarus||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4011003|NCT01196091|3831576|B2|Body Image||Lupus Quality of Life (lupus QOL) Domain Score|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|63.2|63.2|Standard Deviation|27.67|27.67|||
4011004|NCT01196091|3831577|B1|Body Image||Lupus Quality of Life (lupus QOL) Domain Score|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|61.1|61.1|Standard Deviation|28.99|28.99|||
4011005|NCT01196091|3831574|B4|Emotional Health||Lupus Quality of Life (lupus QOL) Domain Score|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|65.7|65.7|Standard Deviation|25.14|25.14|||
4011006|NCT01196091|3831575|B3|Emotional Health||Lupus Quality of Life (lupus QOL) Domain Score|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|64.6|64.6|Standard Deviation|26.22|26.22|||
4011007|NCT01196091|3831576|B2|Emotional Health||Lupus Quality of Life (lupus QOL) Domain Score|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|66.7|66.7|Standard Deviation|23.99|23.99|||
4011008|NCT01196091|3831577|B1|Emotional Health||Lupus Quality of Life (lupus QOL) Domain Score|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|65.7|65.7|Standard Deviation|25.19|25.19|||
4011009|NCT01196091|3831574|B4|Physical Health||Lupus Quality of Life (lupus QOL) Domain Score|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|58.4|58.4|Standard Deviation|25.43|25.43|||
4011010|NCT01196091|3831575|B3|Physical Health||Lupus Quality of Life (lupus QOL) Domain Score|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|56.9|56.9|Standard Deviation|26.17|26.17|||
4011011|NCT01196091|3831576|B2|Physical Health||Lupus Quality of Life (lupus QOL) Domain Score|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|59.1|59.1|Standard Deviation|25.13|25.13|||
4011012|NCT01196091|3831577|B1|Physical Health||Lupus Quality of Life (lupus QOL) Domain Score|The LupusQoL is a disease-specific, 34-item, self-report questionnaire designed to measure the health-related quality of life (HRQoL) of participants with SLE within 8 domains.Responses are based on a 5-point Likert scale where 0 (all of the time) to 4 (never). A LupusQoL score for each domain is reported on a 0 to 100 scale, with greater values indicating better HRQoL.|units on a scale|Mean|59.2|59.2|Standard Deviation|24.98|24.98|||
4011013|NCT01196091|3831574|B4|No||At Least One BILAG A or Two BILAG B Disease Activity Scores|"The British Isles Lupus Assessment Group (BILAG) instrument assesses global disease activity across 9 organ system domains. BILAG flare is assessed for each of the 9 organ domains using BILAG2004 index flare rules; A is a severe flare and B is a moderate flare.~The sum of participants in all Categories for the Measure does not equal the Overall Number of Baseline Participants in the Arm/Group because not all participants will have at least one BILAG A or Two BILAG B Disease Activity scores."|Participants|Count of Participants|90|90.0||||||
4011014|NCT01196091|3831575|B3|No||At Least One BILAG A or Two BILAG B Disease Activity Scores|"The British Isles Lupus Assessment Group (BILAG) instrument assesses global disease activity across 9 organ system domains. BILAG flare is assessed for each of the 9 organ domains using BILAG2004 index flare rules; A is a severe flare and B is a moderate flare.~The sum of participants in all Categories for the Measure does not equal the Overall Number of Baseline Participants in the Arm/Group because not all participants will have at least one BILAG A or Two BILAG B Disease Activity scores."|Participants|Count of Participants|31|31.0||||||
4011015|NCT01196091|3831576|B2|No||At Least One BILAG A or Two BILAG B Disease Activity Scores|"The British Isles Lupus Assessment Group (BILAG) instrument assesses global disease activity across 9 organ system domains. BILAG flare is assessed for each of the 9 organ domains using BILAG2004 index flare rules; A is a severe flare and B is a moderate flare.~The sum of participants in all Categories for the Measure does not equal the Overall Number of Baseline Participants in the Arm/Group because not all participants will have at least one BILAG A or Two BILAG B Disease Activity scores."|Participants|Count of Participants|38|38.0||||||
4011088|NCT01196091|3831577|B1|Belarus||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4011089|NCT01196091|3831574|B4|Thailand||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
4011090|NCT01196091|3831575|B3|Thailand||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4011016|NCT01196091|3831577|B1|No||At Least One BILAG A or Two BILAG B Disease Activity Scores|"The British Isles Lupus Assessment Group (BILAG) instrument assesses global disease activity across 9 organ system domains. BILAG flare is assessed for each of the 9 organ domains using BILAG2004 index flare rules; A is a severe flare and B is a moderate flare.~The sum of participants in all Categories for the Measure does not equal the Overall Number of Baseline Participants in the Arm/Group because not all participants will have at least one BILAG A or Two BILAG B Disease Activity scores."|Participants|Count of Participants|21|21.0||||||
4011017|NCT01196091|3831574|B4|Yes||At Least One BILAG A or Two BILAG B Disease Activity Scores|"The British Isles Lupus Assessment Group (BILAG) instrument assesses global disease activity across 9 organ system domains. BILAG flare is assessed for each of the 9 organ domains using BILAG2004 index flare rules; A is a severe flare and B is a moderate flare.~The sum of participants in all Categories for the Measure does not equal the Overall Number of Baseline Participants in the Arm/Group because not all participants will have at least one BILAG A or Two BILAG B Disease Activity scores."|Participants|Count of Participants|1047|1047.0||||||
4011018|NCT01196091|3831575|B3|Yes||At Least One BILAG A or Two BILAG B Disease Activity Scores|"The British Isles Lupus Assessment Group (BILAG) instrument assesses global disease activity across 9 organ system domains. BILAG flare is assessed for each of the 9 organ domains using BILAG2004 index flare rules; A is a severe flare and B is a moderate flare.~The sum of participants in all Categories for the Measure does not equal the Overall Number of Baseline Participants in the Arm/Group because not all participants will have at least one BILAG A or Two BILAG B Disease Activity scores."|Participants|Count of Participants|347|347.0||||||
4011019|NCT01196091|3831576|B2|Yes||At Least One BILAG A or Two BILAG B Disease Activity Scores|"The British Isles Lupus Assessment Group (BILAG) instrument assesses global disease activity across 9 organ system domains. BILAG flare is assessed for each of the 9 organ domains using BILAG2004 index flare rules; A is a severe flare and B is a moderate flare.~The sum of participants in all Categories for the Measure does not equal the Overall Number of Baseline Participants in the Arm/Group because not all participants will have at least one BILAG A or Two BILAG B Disease Activity scores."|Participants|Count of Participants|340|340.0||||||
4011020|NCT01196091|3831577|B1|Yes||At Least One BILAG A or Two BILAG B Disease Activity Scores|"The British Isles Lupus Assessment Group (BILAG) instrument assesses global disease activity across 9 organ system domains. BILAG flare is assessed for each of the 9 organ domains using BILAG2004 index flare rules; A is a severe flare and B is a moderate flare.~The sum of participants in all Categories for the Measure does not equal the Overall Number of Baseline Participants in the Arm/Group because not all participants will have at least one BILAG A or Two BILAG B Disease Activity scores."|Participants|Count of Participants|360|360.0||||||
4011021|NCT01196091|3831574|B4|||Time of Onset of Lupus||years|Mean|7.3|7.3|Standard Deviation|7.4|7.4|||
4011022|NCT01196091|3831575|B3|||Time of Onset of Lupus||years|Mean|6.4|6.4|Standard Deviation|6.8|6.8|||
4011023|NCT01196091|3831576|B2|||Time of Onset of Lupus||years|Mean|8.1|8.1|Standard Deviation|7.9|7.9|||
4011024|NCT01196091|3831577|B1|||Time of Onset of Lupus||years|Mean|7.5|7.5|Standard Deviation|7.4|7.4|||
4011025|NCT01196091|3831574|B4|||Physician's Global Assessment (PGA) Score|PGA is a single-item clinician rated assessment of the participant's current level of disease activity measured on a continuous 0 to 100-millimeter (mm) visual analytic scale with benchmarks of 0, 1, 2, and 3 from left to right corresponding to no, mild, moderate, and severe SLE disease activity. Scores range from 0, being worst possible to 100 being very active or best possible.|millimeters (mm)|Mean|46.5|46.5|Standard Deviation|16.0|16.0|||
4011026|NCT01196091|3831575|B3|||Physician's Global Assessment (PGA) Score|PGA is a single-item clinician rated assessment of the participant's current level of disease activity measured on a continuous 0 to 100-millimeter (mm) visual analytic scale with benchmarks of 0, 1, 2, and 3 from left to right corresponding to no, mild, moderate, and severe SLE disease activity. Scores range from 0, being worst possible to 100 being very active or best possible.|millimeters (mm)|Mean|47.1|47.1|Standard Deviation|16.10|16.1|||
4011027|NCT01196091|3831576|B2|||Physician's Global Assessment (PGA) Score|PGA is a single-item clinician rated assessment of the participant's current level of disease activity measured on a continuous 0 to 100-millimeter (mm) visual analytic scale with benchmarks of 0, 1, 2, and 3 from left to right corresponding to no, mild, moderate, and severe SLE disease activity. Scores range from 0, being worst possible to 100 being very active or best possible.|millimeters (mm)|Mean|46.1|46.1|Standard Deviation|16.2|16.2|||
4011028|NCT01196091|3831577|B1|||Physician's Global Assessment (PGA) Score|PGA is a single-item clinician rated assessment of the participant's current level of disease activity measured on a continuous 0 to 100-millimeter (mm) visual analytic scale with benchmarks of 0, 1, 2, and 3 from left to right corresponding to no, mild, moderate, and severe SLE disease activity. Scores range from 0, being worst possible to 100 being very active or best possible.|millimeters (mm)|Mean|46.3|46.3|Standard Deviation|15.7|15.7|||
4011029|NCT01196091|3831574|B4|||Safety of Estrogens in Lupus Erythematosus National Assessment (SELENA-SLEDAI) Score|Safety of Estrogens in Lupus Erythematosus National Assessment - SLE Disease Activity Index (SELENA-SLEDAI) score is a weighted, cumulative index of lupus disease activity. SELENA-SLEDAI is calculated from 24 individual descriptors across 9 organ systems; 0 indicates inactive disease and the maximum theoretical score is 105.|units on a scale|Mean|10.4|10.4|Standard Deviation|3.7|3.7|||
4011030|NCT01196091|3831575|B3|||Safety of Estrogens in Lupus Erythematosus National Assessment (SELENA-SLEDAI) Score|Safety of Estrogens in Lupus Erythematosus National Assessment - SLE Disease Activity Index (SELENA-SLEDAI) score is a weighted, cumulative index of lupus disease activity. SELENA-SLEDAI is calculated from 24 individual descriptors across 9 organ systems; 0 indicates inactive disease and the maximum theoretical score is 105.|units on a scale|Mean|10.7|10.7|Standard Deviation|3.9|3.9|||
4011031|NCT01196091|3831576|B2|||Safety of Estrogens in Lupus Erythematosus National Assessment (SELENA-SLEDAI) Score|Safety of Estrogens in Lupus Erythematosus National Assessment - SLE Disease Activity Index (SELENA-SLEDAI) score is a weighted, cumulative index of lupus disease activity. SELENA-SLEDAI is calculated from 24 individual descriptors across 9 organ systems; 0 indicates inactive disease and the maximum theoretical score is 105.|units on a scale|Mean|10.4|10.4|Standard Deviation|3.6|3.6|||
4011091|NCT01196091|3831576|B2|Thailand||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4011092|NCT01196091|3831577|B1|Thailand||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4011032|NCT01196091|3831577|B1|||Safety of Estrogens in Lupus Erythematosus National Assessment (SELENA-SLEDAI) Score|Safety of Estrogens in Lupus Erythematosus National Assessment - SLE Disease Activity Index (SELENA-SLEDAI) score is a weighted, cumulative index of lupus disease activity. SELENA-SLEDAI is calculated from 24 individual descriptors across 9 organ systems; 0 indicates inactive disease and the maximum theoretical score is 105.|units on a scale|Mean|10.2|10.2|Standard Deviation|3.5|3.5|||
4011033|NCT01196091|3831574|B4|||Anti-dsDNA Antibody Level||International Units/Milliliter (IU/mL)|Mean|108.2|108.2|Standard Deviation|112.41|112.41|||
4011034|NCT01196091|3831575|B3|||Anti-dsDNA Antibody Level||International Units/Milliliter (IU/mL)|Mean|107.1|107.1|Standard Deviation|112.40|112.4|||
4011035|NCT01196091|3831576|B2|||Anti-dsDNA Antibody Level||International Units/Milliliter (IU/mL)|Mean|110.4|110.4|Standard Deviation|111.58|111.58|||
4011036|NCT01196091|3831577|B1|||Anti-dsDNA Antibody Level||International Units/Milliliter (IU/mL)|Mean|107.2|107.2|Standard Deviation|113.50|113.5|||
4011037|NCT01196091|3831574|B4|Croatia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4011038|NCT01196091|3831575|B3|Croatia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4011039|NCT01196091|3831576|B2|Croatia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4011040|NCT01196091|3831577|B1|Croatia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4011041|NCT01196091|3831574|B4|Germany||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
4011042|NCT01196091|3831575|B3|Germany||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4011043|NCT01196091|3831576|B2|Germany||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4011044|NCT01196091|3831577|B1|Germany||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4011045|NCT01196091|3831574|B4|Peru||Region of Enrollment||Participants|Count of Participants|99|99.0||||||
4011046|NCT01196091|3831575|B3|Peru||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
4011047|NCT01196091|3831576|B2|Peru||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
4011048|NCT01196091|3831577|B1|Peru||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
4011049|NCT01196091|3831574|B4|Chile||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4011050|NCT01196091|3831575|B3|Chile||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4011051|NCT01196091|3831576|B2|Chile||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4011052|NCT01196091|3831577|B1|Chile||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4011053|NCT01196091|3831574|B4|Bulgaria||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
4011054|NCT01196091|3831575|B3|Bulgaria||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4011055|NCT01196091|3831576|B2|Bulgaria||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4011056|NCT01196091|3831577|B1|Bulgaria||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4011057|NCT01196091|3831574|B4|Italy||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4011058|NCT01196091|3831575|B3|Italy||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4011059|NCT01196091|3831576|B2|Italy||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4011060|NCT01196091|3831577|B1|Italy||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4011061|NCT01196091|3831574|B4|South Korea||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
4011062|NCT01196091|3831575|B3|South Korea||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4011063|NCT01196091|3831576|B2|South Korea||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4011064|NCT01196091|3831577|B1|South Korea||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4011065|NCT01196091|3831574|B4|Guatemala||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
4011066|NCT01196091|3831575|B3|Guatemala||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4011067|NCT01196091|3831576|B2|Guatemala||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
4011068|NCT01196091|3831577|B1|Guatemala||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4011069|NCT01196091|3831574|B4|Poland||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
4011070|NCT01196091|3831575|B3|Poland||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4011071|NCT01196091|3831576|B2|Poland||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4011072|NCT01196091|3831577|B1|Poland||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4011073|NCT01196091|3831574|B4|Macedonia||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4011074|NCT01196091|3831575|B3|Macedonia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4011075|NCT01196091|3831576|B2|Macedonia||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4011076|NCT01196091|3831577|B1|Macedonia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4011077|NCT01196091|3831574|B4|Austria||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4011078|NCT01196091|3831575|B3|Austria||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4011079|NCT01196091|3831576|B2|Austria||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4011080|NCT01196091|3831577|B1|Austria||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4011081|NCT01196091|3831574|B4|Canada||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4011082|NCT01196091|3831575|B3|Canada||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4011083|NCT01196091|3831576|B2|Canada||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4011084|NCT01196091|3831577|B1|Canada||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4011085|NCT01196091|3831574|B4|Belarus||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4011150|NCT01196091|3831575|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4011093|NCT01196091|3831574|B4|Ukraine||Region of Enrollment||Participants|Count of Participants|74|74.0||||||
4011094|NCT01196091|3831575|B3|Ukraine||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
4011095|NCT01196091|3831576|B2|Ukraine||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4011096|NCT01196091|3831577|B1|Ukraine||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4011097|NCT01196091|3831574|B4|Egypt||Region of Enrollment||Participants|Count of Participants|59|59.0||||||
4011098|NCT01196091|3831575|B3|Egypt||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
4011099|NCT01196091|3831576|B2|Egypt||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4011100|NCT01196091|3831577|B1|Egypt||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4011101|NCT01196091|3831574|B4|Japan||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
4011102|NCT01196091|3831575|B3|Japan||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4011103|NCT01196091|3831576|B2|Japan||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4011104|NCT01196091|3831577|B1|Japan||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4011105|NCT01196091|3831574|B4|Philippines||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
4011106|NCT01196091|3831575|B3|Philippines||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4011107|NCT01196091|3831576|B2|Philippines||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4011108|NCT01196091|3831577|B1|Philippines||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
4011109|NCT01196091|3831574|B4|United States||Region of Enrollment||Participants|Count of Participants|377|377.0||||||
4011110|NCT01196091|3831575|B3|United States||Region of Enrollment||Participants|Count of Participants|116|116.0||||||
4011111|NCT01196091|3831576|B2|United States||Region of Enrollment||Participants|Count of Participants|133|133.0||||||
4011112|NCT01196091|3831577|B1|United States||Region of Enrollment||Participants|Count of Participants|128|128.0||||||
4011113|NCT01196091|3831574|B4|Singapore||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4011114|NCT01196091|3831575|B3|Singapore||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4011115|NCT01196091|3831576|B2|Singapore||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4011116|NCT01196091|3831577|B1|Singapore||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4011117|NCT01196091|3831574|B4|Puerto Rico||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
4011118|NCT01196091|3831575|B3|Puerto Rico||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4011119|NCT01196091|3831576|B2|Puerto Rico||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4011120|NCT01196091|3831577|B1|Puerto Rico||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4011121|NCT01196091|3831574|B4|Argentina||Region of Enrollment||Participants|Count of Participants|66|66.0||||||
4011122|NCT01196091|3831575|B3|Argentina||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4011123|NCT01196091|3831576|B2|Argentina||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
4011124|NCT01196091|3831577|B1|Argentina||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4011125|NCT01196091|3831574|B4|Colombia||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
4011126|NCT01196091|3831575|B3|Colombia||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4011127|NCT01196091|3831576|B2|Colombia||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4011128|NCT01196091|3831577|B1|Colombia||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4011129|NCT01196091|3831574|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011130|NCT01196091|3831575|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011131|NCT01196091|3831576|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011132|NCT01196091|3831577|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011133|NCT01196091|3831574|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4011134|NCT01196091|3831575|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4011135|NCT01196091|3831576|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4011136|NCT01196091|3831577|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4011137|NCT01196091|3831574|B4||White|Race (NIH/OMB)||Participants|Count of Participants|627|627.0||||||
4011138|NCT01196091|3831575|B3||White|Race (NIH/OMB)||Participants|Count of Participants|205|205.0||||||
4011139|NCT01196091|3831576|B2||White|Race (NIH/OMB)||Participants|Count of Participants|218|218.0||||||
4011140|NCT01196091|3831577|B1||White|Race (NIH/OMB)||Participants|Count of Participants|204|204.0||||||
4011141|NCT01196091|3831574|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
4011142|NCT01196091|3831575|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4011143|NCT01196091|3831576|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4011144|NCT01196091|3831577|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4011145|NCT01196091|3831574|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4011146|NCT01196091|3831575|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011147|NCT01196091|3831576|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4011148|NCT01196091|3831577|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011149|NCT01196091|3831574|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|195|195.0||||||
4011152|NCT01196091|3831577|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4011153|NCT01196091|3831574|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|187|187.0||||||
4011154|NCT01196091|3831575|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4011155|NCT01196091|3831576|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4011156|NCT01196091|3831577|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4011157|NCT01196091|3831574|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
4011158|NCT01196091|3831575|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4011159|NCT01196091|3831576|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4011160|NCT01196091|3831577|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4011161|NCT01196091|3831574|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|687|687.0||||||
4011162|NCT01196091|3831575|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|229|229.0||||||
4011163|NCT01196091|3831576|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|225|225.0||||||
4011164|NCT01196091|3831577|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|233|233.0||||||
4011165|NCT01196091|3831574|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|357|357.0||||||
4011166|NCT01196091|3831575|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
4011167|NCT01196091|3831576|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|116|116.0||||||
4011168|NCT01196091|3831577|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
4011169|NCT01196091|3831574|B4||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4011170|NCT01196091|3831575|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4011171|NCT01196091|3831576|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4011172|NCT01196091|3831577|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4011173|NCT01196091|3831574|B4||Female|Sex: Female, Male||Participants|Count of Participants|1066|1066.0||||||
4011174|NCT01196091|3831575|B3||Female|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
4011175|NCT01196091|3831576|B2||Female|Sex: Female, Male||Participants|Count of Participants|352|352.0||||||
4011176|NCT01196091|3831577|B1||Female|Sex: Female, Male||Participants|Count of Participants|354|354.0||||||
4011177|NCT01196091|3831574|B4|||Age||years|Mean|39.7|39.7|Standard Deviation|11.82|11.82|||
4011178|NCT01196091|3831575|B3|||Age||years|Mean|39.1|39.1|Standard Deviation|11.69|11.69|||
4011179|NCT01196091|3831576|B2|||Age||years|Mean|40.2|40.2|Standard Deviation|11.21|11.21|||
4011180|NCT01196091|3831577|B1|||Age||years|Mean|39.8|39.8|Standard Deviation|12.51|12.51|||
4011181|NCT01196078|3831629|B3||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4011182|NCT01196078|3831630|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4011183|NCT01196078|3831631|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4011184|NCT01196078|3831629|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4011185|NCT01196078|3831630|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4011186|NCT01196078|3831631|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4011187|NCT01196078|3831629|B3|||Age||years|Mean|78|78.0|Standard Deviation|5.60|5.6|||
4011188|NCT01196078|3831630|B2|||Age||years|Mean|78|78.0|Standard Deviation|5.32|5.32|||
4011189|NCT01196078|3831631|B1|||Age||years|Mean|78|78.0|Standard Deviation|4.98|4.98|||
4011190|NCT01196052|3831660|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4011191|NCT01196052|3831660|B1||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4011192|NCT01196052|3831660|B1|||Age||years|Mean|51.1|51.1|Standard Deviation|11.23|11.23|||
4011193|NCT01196026|3831671|B7||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4011194|NCT01196026|3831672|B6||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4011195|NCT01196026|3831673|B5||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4011196|NCT01196026|3831674|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4011197|NCT01196026|3831675|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4011198|NCT01196026|3831676|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4011199|NCT01196026|3831677|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4011200|NCT01196026|3831671|B7||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4011201|NCT01196026|3831672|B6||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4011202|NCT01196026|3831673|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4011203|NCT01196026|3831674|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4011204|NCT01196026|3831675|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4011205|NCT01196026|3831676|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4011206|NCT01196026|3831677|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4011207|NCT01196026|3831671|B7|||Age||Years|Mean|3.58|3.58|Standard Deviation|2.54|2.54|||
4011208|NCT01196026|3831672|B6|||Age||Years|Mean|7.5|7.5|Standard Deviation|1.53|1.53|||
4011209|NCT01196026|3831673|B5|||Age||Years|Mean|2.4|2.4|Standard Deviation|0.58|0.58|||
4011210|NCT01196026|3831674|B4|||Age||Years|Mean|1.0|1.0|Standard Deviation|0.00|0.0|||
4011211|NCT01196026|3831675|B3|||Age||Years|Mean|6.4|6.4|Standard Deviation|1.99|1.99|||
4011212|NCT01196026|3831676|B2|||Age||Years|Mean|2.3|2.3|Standard Deviation|0.52|0.52|||
4011213|NCT01196026|3831677|B1|||Age||Years|Mean|1.0|1.0|Standard Deviation|0.00|0.0|||
4011214|NCT01195948|3831913|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4011215|NCT01195948|3831914|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4011216|NCT01195948|3831915|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4011217|NCT01195948|3831916|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4011218|NCT01195948|3831913|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4011219|NCT01195948|3831914|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4011220|NCT01195948|3831915|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4011221|NCT01195948|3831916|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4011222|NCT01195948|3831913|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4011223|NCT01195948|3831914|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4011224|NCT01195948|3831915|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4011225|NCT01195948|3831916|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4011226|NCT01195948|3831913|B4||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4011227|NCT01195948|3831914|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4011228|NCT01195948|3831915|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4011229|NCT01195948|3831916|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4011230|NCT01195948|3831913|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4011231|NCT01195948|3831914|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4011232|NCT01195948|3831915|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4011233|NCT01195948|3831916|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4011234|NCT01195948|3831913|B4|||Age||years|Mean|45|45.0|Standard Deviation|14.0|14.0|||
4011235|NCT01195948|3831914|B3|||Age||years|Mean|43|43.0|Standard Deviation|15.6|15.6|||
4011236|NCT01195948|3831915|B2|||Age||years|Mean|43|43.0|Standard Deviation|14.7|14.7|||
4011237|NCT01195948|3831916|B1|||Age||years|Mean|50|50.0|Standard Deviation|11.8|11.8|||
4011238|NCT01195922|3831950|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4011239|NCT01195922|3831950|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4011240|NCT01195922|3831950|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4011241|NCT01195922|3831950|B1|||Age||years|Median|63|63.0|Standard Deviation|11.48|11.48|||
4011242|NCT01195883|3831956|B3||Male|Sex: Female, Male||Participants|Count of Participants|547|547.0||||||
4011243|NCT01195883|3831957|B2||Male|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
4011244|NCT01195883|3831958|B1||Male|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
4011245|NCT01195883|3831956|B3||Female|Sex: Female, Male||Participants|Count of Participants|510|510.0||||||
4011246|NCT01195883|3831957|B2||Female|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
4011247|NCT01195883|3831958|B1||Female|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
4011248|NCT01195883|3831956|B3|||Age||years|Mean|52|52.0|Standard Deviation|16|16.0|||
4011249|NCT01195883|3831957|B2|||Age||years|Mean|52|52.0|Standard Deviation|16|16.0|||
4011250|NCT01195883|3831958|B1|||Age||years|Mean|52|52.0|Standard Deviation|16|16.0|||
4011251|NCT01195844|3831971|B1|No||Rotavirus Vaccination Received||Participants|Number|15|15.0||||||
4011252|NCT01195844|3831971|B1|Yes||Rotavirus Vaccination Received||Participants|Number|175|175.0||||||
4011253|NCT01195844|3831971|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4011254|NCT01195844|3831971|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4011255|NCT01195844|3831971|B1|||Age, Customized||participants|Number|190|190.0||||||
4011256|NCT01195831|3831986|B3|China||Region of Enrollment||participants|Number|244|244.0||||||
4011257|NCT01195831|3831987|B2|China||Region of Enrollment||participants|Number|124|124.0||||||
4011258|NCT01195831|3831988|B1|China||Region of Enrollment||participants|Number|120|120.0||||||
4011259|NCT01195831|3831986|B3||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4011260|NCT01195831|3831987|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4011261|NCT01195831|3831988|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4011262|NCT01195831|3831986|B3||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4011263|NCT01195831|3831987|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4011264|NCT01195831|3831988|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4011265|NCT01195831|3831986|B3|||Age||years|Mean|39.29|39.29|Standard Deviation|12.500|12.5|||
4011266|NCT01195831|3831987|B2|||Age||years|Mean|38.73|38.73|Standard Deviation|11.869|11.869|||
4011267|NCT01195831|3831988|B1|||Age||years|Mean|39.87|39.87|Standard Deviation|13.145|13.145|||
4011268|NCT01195779|3832003|B15||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4011269|NCT01195779|3832004|B14||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4011270|NCT01195779|3832006|B12||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4011271|NCT01195779|3832010|B8||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4011272|NCT01195779|3832013|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4011273|NCT01195779|3832003|B15||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4011274|NCT01195779|3832004|B14||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4011275|NCT01195779|3832006|B12||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4011276|NCT01195779|3832010|B8||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4011277|NCT01195779|3832013|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4011278|NCT01195779|3832003|B15|Months||Age||Months|Mean|18.25|18.25|Standard Deviation|6.65|6.65|||
4011279|NCT01195779|3832004|B14|Months||Age||Months|Mean|14|14.0|Standard Deviation|NA||||Since only a single subject was enrolled in 4 of the study groups, there was insufficient data to calculate the within-group standard deviation.
4011280|NCT01195779|3832006|B12|Months||Age||Months|Mean|14|14.0|Standard Deviation|NA||||Since only a single subject was enrolled in 4 of the study groups, there was insufficient data to calculate the within-group standard deviation.
4011281|NCT01195779|3832010|B8|Months||Age||Months|Mean|17|17.0|Standard Deviation|NA||||Since only a single subject was enrolled in 4 of the study groups, there was insufficient data to calculate the within-group standard deviation.
4011282|NCT01195779|3832013|B5|Months||Age||Months|Mean|28|28.0|Standard Deviation|NA||||Since only a single subject was enrolled in 4 of the study groups, there was insufficient data to calculate the within-group standard deviation.
4011283|NCT01195701|3832200|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011284|NCT01195701|3832201|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011285|NCT01195701|3832202|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011286|NCT01195701|3832200|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011287|NCT01195701|3832201|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011288|NCT01195701|3832202|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011289|NCT01195701|3832200|B3||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4011290|NCT01195701|3832201|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4011291|NCT01195701|3832202|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4011292|NCT01195701|3832200|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4011293|NCT01195701|3832201|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011294|NCT01195701|3832202|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4011295|NCT01195701|3832200|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011296|NCT01195701|3832201|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011297|NCT01195701|3832202|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011298|NCT01195701|3832200|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4011299|NCT01195701|3832201|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4011300|NCT01195701|3832202|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4011301|NCT01195701|3832200|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011302|NCT01195701|3832201|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011303|NCT01195701|3832202|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011304|NCT01195701|3832200|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4011305|NCT01195701|3832201|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4011306|NCT01195701|3832202|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4011307|NCT01195701|3832200|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4011308|NCT01195701|3832201|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4011309|NCT01195701|3832202|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4011310|NCT01195701|3832200|B3|||Age||years|Mean|31.6|31.6|Standard Deviation|7.4|7.4|||
4011311|NCT01195701|3832201|B2|||Age||years|Mean|31.6|31.6|Standard Deviation|7.2|7.2|||
4011312|NCT01195701|3832202|B1|||Age||years|Mean|31.7|31.7|Standard Deviation|8.2|8.2|||
4011313|NCT01195675|3832229|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4011314|NCT01195675|3832229|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4011315|NCT01195675|3832229|B1|||Age||years|Mean|34.5|34.5|Standard Deviation|10.6|10.6|||
4011316|NCT01195662|3832259|B4|Calcium channel and beta blockers, insulin||Hypertension Medication|"The following categories served as a randomization stratification factor:~category 1: thiazide or thiazide-like diuretics and no insulin category 2: calcium channel blockers, beta blockers, central alpha adrenergic agonist or alpha adrenergic blockers and no insulin category 3: thiazide or thiazide-like diuretics and insulin category 4: calcium channel blockers, beta blockers, central alpha adrenergic agonist or alpha adrenergic blockers and insulin"|participants|Number|23|23.0||||||
4011317|NCT01195662|3832260|B3|Calcium channel and beta blockers, insulin||Hypertension Medication|"The following categories served as a randomization stratification factor:~category 1: thiazide or thiazide-like diuretics and no insulin category 2: calcium channel blockers, beta blockers, central alpha adrenergic agonist or alpha adrenergic blockers and no insulin category 3: thiazide or thiazide-like diuretics and insulin category 4: calcium channel blockers, beta blockers, central alpha adrenergic agonist or alpha adrenergic blockers and insulin"|participants|Number|0|0.0||||||
4011318|NCT01195662|3832261|B2|Calcium channel and beta blockers, insulin||Hypertension Medication|"The following categories served as a randomization stratification factor:~category 1: thiazide or thiazide-like diuretics and no insulin category 2: calcium channel blockers, beta blockers, central alpha adrenergic agonist or alpha adrenergic blockers and no insulin category 3: thiazide or thiazide-like diuretics and insulin category 4: calcium channel blockers, beta blockers, central alpha adrenergic agonist or alpha adrenergic blockers and insulin"|participants|Number|12|12.0||||||
4011319|NCT01195662|3832262|B1|Calcium channel and beta blockers, insulin||Hypertension Medication|"The following categories served as a randomization stratification factor:~category 1: thiazide or thiazide-like diuretics and no insulin category 2: calcium channel blockers, beta blockers, central alpha adrenergic agonist or alpha adrenergic blockers and no insulin category 3: thiazide or thiazide-like diuretics and insulin category 4: calcium channel blockers, beta blockers, central alpha adrenergic agonist or alpha adrenergic blockers and insulin"|participants|Number|11|11.0||||||
4011320|NCT01195662|3832259|B4|Thiazide or thiazide-like diuretics, insulin||Hypertension Medication|"The following categories served as a randomization stratification factor:~category 1: thiazide or thiazide-like diuretics and no insulin category 2: calcium channel blockers, beta blockers, central alpha adrenergic agonist or alpha adrenergic blockers and no insulin category 3: thiazide or thiazide-like diuretics and insulin category 4: calcium channel blockers, beta blockers, central alpha adrenergic agonist or alpha adrenergic blockers and insulin"|participants|Number|11|11.0||||||
4011321|NCT01195662|3832260|B3|Thiazide or thiazide-like diuretics, insulin||Hypertension Medication|"The following categories served as a randomization stratification factor:~category 1: thiazide or thiazide-like diuretics and no insulin category 2: calcium channel blockers, beta blockers, central alpha adrenergic agonist or alpha adrenergic blockers and no insulin category 3: thiazide or thiazide-like diuretics and insulin category 4: calcium channel blockers, beta blockers, central alpha adrenergic agonist or alpha adrenergic blockers and insulin"|participants|Number|0|0.0||||||
4011322|NCT01195662|3832261|B2|Thiazide or thiazide-like diuretics, insulin||Hypertension Medication|"The following categories served as a randomization stratification factor:~category 1: thiazide or thiazide-like diuretics and no insulin category 2: calcium channel blockers, beta blockers, central alpha adrenergic agonist or alpha adrenergic blockers and no insulin category 3: thiazide or thiazide-like diuretics and insulin category 4: calcium channel blockers, beta blockers, central alpha adrenergic agonist or alpha adrenergic blockers and insulin"|participants|Number|6|6.0||||||
4011323|NCT01195662|3832262|B1|Thiazide or thiazide-like diuretics, insulin||Hypertension Medication|"The following categories served as a randomization stratification factor:~category 1: thiazide or thiazide-like diuretics and no insulin category 2: calcium channel blockers, beta blockers, central alpha adrenergic agonist or alpha adrenergic blockers and no insulin category 3: thiazide or thiazide-like diuretics and insulin category 4: calcium channel blockers, beta blockers, central alpha adrenergic agonist or alpha adrenergic blockers and insulin"|participants|Number|5|5.0||||||
4011324|NCT01195662|3832259|B4|Calcium channel and beta blockers, no insulin||Hypertension Medication|"The following categories served as a randomization stratification factor:~category 1: thiazide or thiazide-like diuretics and no insulin category 2: calcium channel blockers, beta blockers, central alpha adrenergic agonist or alpha adrenergic blockers and no insulin category 3: thiazide or thiazide-like diuretics and insulin category 4: calcium channel blockers, beta blockers, central alpha adrenergic agonist or alpha adrenergic blockers and insulin"|participants|Number|305|305.0||||||
4011325|NCT01195662|3832260|B3|Calcium channel and beta blockers, no insulin||Hypertension Medication|"The following categories served as a randomization stratification factor:~category 1: thiazide or thiazide-like diuretics and no insulin category 2: calcium channel blockers, beta blockers, central alpha adrenergic agonist or alpha adrenergic blockers and no insulin category 3: thiazide or thiazide-like diuretics and insulin category 4: calcium channel blockers, beta blockers, central alpha adrenergic agonist or alpha adrenergic blockers and insulin"|participants|Number|79|79.0||||||
4011326|NCT01195662|3832261|B2|Calcium channel and beta blockers, no insulin||Hypertension Medication|"The following categories served as a randomization stratification factor:~category 1: thiazide or thiazide-like diuretics and no insulin category 2: calcium channel blockers, beta blockers, central alpha adrenergic agonist or alpha adrenergic blockers and no insulin category 3: thiazide or thiazide-like diuretics and insulin category 4: calcium channel blockers, beta blockers, central alpha adrenergic agonist or alpha adrenergic blockers and insulin"|participants|Number|112|112.0||||||
4011327|NCT01195662|3832262|B1|Calcium channel and beta blockers, no insulin||Hypertension Medication|"The following categories served as a randomization stratification factor:~category 1: thiazide or thiazide-like diuretics and no insulin category 2: calcium channel blockers, beta blockers, central alpha adrenergic agonist or alpha adrenergic blockers and no insulin category 3: thiazide or thiazide-like diuretics and insulin category 4: calcium channel blockers, beta blockers, central alpha adrenergic agonist or alpha adrenergic blockers and insulin"|participants|Number|114|114.0||||||
4011328|NCT01195662|3832259|B4|Thiazide or thiazide-like diuretics, no insulin||Hypertension Medication|"The following categories served as a randomization stratification factor:~category 1: thiazide or thiazide-like diuretics and no insulin category 2: calcium channel blockers, beta blockers, central alpha adrenergic agonist or alpha adrenergic blockers and no insulin category 3: thiazide or thiazide-like diuretics and insulin category 4: calcium channel blockers, beta blockers, central alpha adrenergic agonist or alpha adrenergic blockers and insulin"|participants|Number|243|243.0||||||
4011329|NCT01195662|3832260|B3|Thiazide or thiazide-like diuretics, no insulin||Hypertension Medication|"The following categories served as a randomization stratification factor:~category 1: thiazide or thiazide-like diuretics and no insulin category 2: calcium channel blockers, beta blockers, central alpha adrenergic agonist or alpha adrenergic blockers and no insulin category 3: thiazide or thiazide-like diuretics and insulin category 4: calcium channel blockers, beta blockers, central alpha adrenergic agonist or alpha adrenergic blockers and insulin"|participants|Number|54|54.0||||||
4011330|NCT01195662|3832261|B2|Thiazide or thiazide-like diuretics, no insulin||Hypertension Medication|"The following categories served as a randomization stratification factor:~category 1: thiazide or thiazide-like diuretics and no insulin category 2: calcium channel blockers, beta blockers, central alpha adrenergic agonist or alpha adrenergic blockers and no insulin category 3: thiazide or thiazide-like diuretics and insulin category 4: calcium channel blockers, beta blockers, central alpha adrenergic agonist or alpha adrenergic blockers and insulin"|participants|Number|95|95.0||||||
4011331|NCT01195662|3832262|B1|Thiazide or thiazide-like diuretics, no insulin||Hypertension Medication|"The following categories served as a randomization stratification factor:~category 1: thiazide or thiazide-like diuretics and no insulin category 2: calcium channel blockers, beta blockers, central alpha adrenergic agonist or alpha adrenergic blockers and no insulin category 3: thiazide or thiazide-like diuretics and insulin category 4: calcium channel blockers, beta blockers, central alpha adrenergic agonist or alpha adrenergic blockers and insulin"|participants|Number|94|94.0||||||
4011332|NCT01195662|3832259|B4|>=30 kg/m^2||Body Mass Index (BMI)|BMI is measured by weight in kilograms (kg) divided by height in meters (m) squared (kg/m^2). Less than (<); Greater than, equal to (>=).|participants|Number|361|361.0||||||
4011333|NCT01195662|3832260|B3|>=30 kg/m^2||Body Mass Index (BMI)|BMI is measured by weight in kilograms (kg) divided by height in meters (m) squared (kg/m^2). Less than (<); Greater than, equal to (>=).|participants|Number|73|73.0||||||
4011334|NCT01195662|3832261|B2|>=30 kg/m^2||Body Mass Index (BMI)|BMI is measured by weight in kilograms (kg) divided by height in meters (m) squared (kg/m^2). Less than (<); Greater than, equal to (>=).|participants|Number|141|141.0||||||
4011335|NCT01195662|3832262|B1|>=30 kg/m^2||Body Mass Index (BMI)|BMI is measured by weight in kilograms (kg) divided by height in meters (m) squared (kg/m^2). Less than (<); Greater than, equal to (>=).|participants|Number|147|147.0||||||
4011336|NCT01195662|3832259|B4|>=27 kg/m^2||Body Mass Index (BMI)|BMI is measured by weight in kilograms (kg) divided by height in meters (m) squared (kg/m^2). Less than (<); Greater than, equal to (>=).|participants|Number|458|458.0||||||
4011337|NCT01195662|3832260|B3|>=27 kg/m^2||Body Mass Index (BMI)|BMI is measured by weight in kilograms (kg) divided by height in meters (m) squared (kg/m^2). Less than (<); Greater than, equal to (>=).|participants|Number|101|101.0||||||
4011338|NCT01195662|3832261|B2|>=27 kg/m^2||Body Mass Index (BMI)|BMI is measured by weight in kilograms (kg) divided by height in meters (m) squared (kg/m^2). Less than (<); Greater than, equal to (>=).|participants|Number|178|178.0||||||
4011339|NCT01195662|3832262|B1|>=27 kg/m^2||Body Mass Index (BMI)|BMI is measured by weight in kilograms (kg) divided by height in meters (m) squared (kg/m^2). Less than (<); Greater than, equal to (>=).|participants|Number|179|179.0||||||
4011340|NCT01195662|3832259|B4|>=25 kg/m^2||Body Mass Index (BMI)|BMI is measured by weight in kilograms (kg) divided by height in meters (m) squared (kg/m^2). Less than (<); Greater than, equal to (>=).|participants|Number|535|535.0||||||
4011341|NCT01195662|3832260|B3|>=25 kg/m^2||Body Mass Index (BMI)|BMI is measured by weight in kilograms (kg) divided by height in meters (m) squared (kg/m^2). Less than (<); Greater than, equal to (>=).|participants|Number|124|124.0||||||
4011342|NCT01195662|3832261|B2|>=25 kg/m^2||Body Mass Index (BMI)|BMI is measured by weight in kilograms (kg) divided by height in meters (m) squared (kg/m^2). Less than (<); Greater than, equal to (>=).|participants|Number|208|208.0||||||
4011343|NCT01195662|3832262|B1|>=25 kg/m^2||Body Mass Index (BMI)|BMI is measured by weight in kilograms (kg) divided by height in meters (m) squared (kg/m^2). Less than (<); Greater than, equal to (>=).|participants|Number|203|203.0||||||
4011344|NCT01195662|3832259|B4|< 25 kg/m^2||Body Mass Index (BMI)|BMI is measured by weight in kilograms (kg) divided by height in meters (m) squared (kg/m^2). Less than (<); Greater than, equal to (>=).|participants|Number|47|47.0||||||
4011345|NCT01195662|3832260|B3|< 25 kg/m^2||Body Mass Index (BMI)|BMI is measured by weight in kilograms (kg) divided by height in meters (m) squared (kg/m^2). Less than (<); Greater than, equal to (>=).|participants|Number|9|9.0||||||
4011346|NCT01195662|3832261|B2|< 25 kg/m^2||Body Mass Index (BMI)|BMI is measured by weight in kilograms (kg) divided by height in meters (m) squared (kg/m^2). Less than (<); Greater than, equal to (>=).|participants|Number|17|17.0||||||
4011347|NCT01195662|3832262|B1|< 25 kg/m^2||Body Mass Index (BMI)|BMI is measured by weight in kilograms (kg) divided by height in meters (m) squared (kg/m^2). Less than (<); Greater than, equal to (>=).|participants|Number|21|21.0||||||
4011348|NCT01195662|3832259|B4|Ethnicity Not Reported||Race/Ethnicity, Customized|Ethnicity was collected and summarized only for USA participants.|participants|Number|379|379.0||||||
4011349|NCT01195662|3832260|B3|Ethnicity Not Reported||Race/Ethnicity, Customized|Ethnicity was collected and summarized only for USA participants.|participants|Number|96|96.0||||||
4011350|NCT01195662|3832261|B2|Ethnicity Not Reported||Race/Ethnicity, Customized|Ethnicity was collected and summarized only for USA participants.|participants|Number|140|140.0||||||
4011351|NCT01195662|3832262|B1|Ethnicity Not Reported||Race/Ethnicity, Customized|Ethnicity was collected and summarized only for USA participants.|participants|Number|143|143.0||||||
4011352|NCT01195662|3832259|B4|Ethnicity Not Hispanic/Latino||Race/Ethnicity, Customized|Ethnicity was collected and summarized only for USA participants.|participants|Number|94|94.0||||||
4011353|NCT01195662|3832260|B3|Ethnicity Not Hispanic/Latino||Race/Ethnicity, Customized|Ethnicity was collected and summarized only for USA participants.|participants|Number|16|16.0||||||
4011354|NCT01195662|3832261|B2|Ethnicity Not Hispanic/Latino||Race/Ethnicity, Customized|Ethnicity was collected and summarized only for USA participants.|participants|Number|38|38.0||||||
4011355|NCT01195662|3832262|B1|Ethnicity Not Hispanic/Latino||Race/Ethnicity, Customized|Ethnicity was collected and summarized only for USA participants.|participants|Number|40|40.0||||||
4011356|NCT01195662|3832259|B4|Ethnicity Hispanic/Latino||Race/Ethnicity, Customized|Ethnicity was collected and summarized only for USA participants.|participants|Number|109|109.0||||||
4011357|NCT01195662|3832260|B3|Ethnicity Hispanic/Latino||Race/Ethnicity, Customized|Ethnicity was collected and summarized only for USA participants.|participants|Number|21|21.0||||||
4011358|NCT01195662|3832261|B2|Ethnicity Hispanic/Latino||Race/Ethnicity, Customized|Ethnicity was collected and summarized only for USA participants.|participants|Number|47|47.0||||||
4011359|NCT01195662|3832262|B1|Ethnicity Hispanic/Latino||Race/Ethnicity, Customized|Ethnicity was collected and summarized only for USA participants.|participants|Number|41|41.0||||||
4011360|NCT01195662|3832259|B4|Other Race||Race/Ethnicity, Customized|Ethnicity was collected and summarized only for USA participants.|participants|Number|28|28.0||||||
4011361|NCT01195662|3832260|B3|Other Race||Race/Ethnicity, Customized|Ethnicity was collected and summarized only for USA participants.|participants|Number|4|4.0||||||
4011362|NCT01195662|3832261|B2|Other Race||Race/Ethnicity, Customized|Ethnicity was collected and summarized only for USA participants.|participants|Number|12|12.0||||||
4011363|NCT01195662|3832262|B1|Other Race||Race/Ethnicity, Customized|Ethnicity was collected and summarized only for USA participants.|participants|Number|12|12.0||||||
4011364|NCT01195662|3832259|B4|Asian||Race/Ethnicity, Customized|Ethnicity was collected and summarized only for USA participants.|participants|Number|108|108.0||||||
4011365|NCT01195662|3832260|B3|Asian||Race/Ethnicity, Customized|Ethnicity was collected and summarized only for USA participants.|participants|Number|36|36.0||||||
4011366|NCT01195662|3832261|B2|Asian||Race/Ethnicity, Customized|Ethnicity was collected and summarized only for USA participants.|participants|Number|34|34.0||||||
4011367|NCT01195662|3832262|B1|Asian||Race/Ethnicity, Customized|Ethnicity was collected and summarized only for USA participants.|participants|Number|38|38.0||||||
4011368|NCT01195662|3832259|B4|Black or African American||Race/Ethnicity, Customized|Ethnicity was collected and summarized only for USA participants.|participants|Number|45|45.0||||||
4011369|NCT01195662|3832260|B3|Black or African American||Race/Ethnicity, Customized|Ethnicity was collected and summarized only for USA participants.|participants|Number|9|9.0||||||
4011370|NCT01195662|3832261|B2|Black or African American||Race/Ethnicity, Customized|Ethnicity was collected and summarized only for USA participants.|participants|Number|19|19.0||||||
4011371|NCT01195662|3832262|B1|Black or African American||Race/Ethnicity, Customized|Ethnicity was collected and summarized only for USA participants.|participants|Number|17|17.0||||||
4011372|NCT01195662|3832259|B4|White||Race/Ethnicity, Customized|Ethnicity was collected and summarized only for USA participants.|participants|Number|401|401.0||||||
4011373|NCT01195662|3832260|B3|White||Race/Ethnicity, Customized|Ethnicity was collected and summarized only for USA participants.|participants|Number|84|84.0||||||
4011374|NCT01195662|3832261|B2|White||Race/Ethnicity, Customized|Ethnicity was collected and summarized only for USA participants.|participants|Number|160|160.0||||||
4011375|NCT01195662|3832262|B1|White||Race/Ethnicity, Customized|Ethnicity was collected and summarized only for USA participants.|participants|Number|157|157.0||||||
4011376|NCT01195662|3832259|B4||Male|Gender||Participants|Count of Participants|328|328.0||||||
4011377|NCT01195662|3832260|B3||Male|Gender||Participants|Count of Participants|81|81.0||||||
4011378|NCT01195662|3832261|B2||Male|Gender||Participants|Count of Participants|118|118.0||||||
4011379|NCT01195662|3832262|B1||Male|Gender||Participants|Count of Participants|129|129.0||||||
4011380|NCT01195662|3832259|B4||Female|Gender||Participants|Count of Participants|254|254.0||||||
4011381|NCT01195662|3832260|B3||Female|Gender||Participants|Count of Participants|52|52.0||||||
4011382|NCT01195662|3832261|B2||Female|Gender||Participants|Count of Participants|107|107.0||||||
4011383|NCT01195662|3832262|B1||Female|Gender||Participants|Count of Participants|95|95.0||||||
4011384|NCT01195662|3832259|B4|>= 75 years||Age, Customized||participants|Number|6|6.0||||||
4011385|NCT01195662|3832260|B3|>= 75 years||Age, Customized||participants|Number|1|1.0||||||
4011386|NCT01195662|3832261|B2|>= 75 years||Age, Customized||participants|Number|4|4.0||||||
4011387|NCT01195662|3832262|B1|>= 75 years||Age, Customized||participants|Number|1|1.0||||||
4011388|NCT01195662|3832259|B4|Greater than, equal (>=) to 65 and < 75 years||Age, Customized||participants|Number|62|62.0||||||
4011389|NCT01195662|3832260|B3|Greater than, equal (>=) to 65 and < 75 years||Age, Customized||participants|Number|14|14.0||||||
4011390|NCT01195662|3832261|B2|Greater than, equal (>=) to 65 and < 75 years||Age, Customized||participants|Number|23|23.0||||||
4011391|NCT01195662|3832262|B1|Greater than, equal (>=) to 65 and < 75 years||Age, Customized||participants|Number|25|25.0||||||
4011392|NCT01195662|3832259|B4|Less than (<) 65 years||Age, Customized||participants|Number|514|514.0||||||
4011393|NCT01195662|3832260|B3|Less than (<) 65 years||Age, Customized||participants|Number|118|118.0||||||
4011394|NCT01195662|3832261|B2|Less than (<) 65 years||Age, Customized||participants|Number|198|198.0||||||
4011395|NCT01195662|3832262|B1|Less than (<) 65 years||Age, Customized||participants|Number|198|198.0||||||
4011396|NCT01195636|3832292|B3|United States||Region of Enrollment||participants|Number|70|70.0||||||
4011397|NCT01195636|3832293|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
4011398|NCT01195636|3832294|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4011399|NCT01195636|3832292|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4011400|NCT01195636|3832293|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4011401|NCT01195636|3832294|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4011402|NCT01195636|3832292|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4011403|NCT01195636|3832293|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4011404|NCT01195636|3832294|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4011405|NCT01195636|3832292|B3|||Age||years|Mean|60.7|60.7|Standard Deviation|11.98|11.98|||
4011406|NCT01195636|3832293|B2|||Age||years|Mean|63.1|63.1|Standard Deviation|9.73|9.73|||
4011407|NCT01195636|3832294|B1|||Age||years|Mean|58.3|58.3|Standard Deviation|13.58|13.58|||
4011408|NCT01195636|3832292|B3||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4011409|NCT01195636|3832293|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4011410|NCT01195636|3832294|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4011411|NCT01195636|3832292|B3||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4011412|NCT01195636|3832293|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4011413|NCT01195636|3832294|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4011414|NCT01195636|3832292|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4011415|NCT01195636|3832293|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4011416|NCT01195636|3832294|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4011417|NCT01195623|3832319|B3|Sweden||Region of Enrollment||participants|Number|293|293.0||||||
4011418|NCT01195623|3832320|B2|Sweden||Region of Enrollment||participants|Number|145|145.0||||||
4011419|NCT01195623|3832321|B1|Sweden||Region of Enrollment||participants|Number|148|148.0||||||
4011420|NCT01195623|3832319|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4011421|NCT01195623|3832320|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4011422|NCT01195623|3832321|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4011423|NCT01195623|3832319|B3||Female|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
4011424|NCT01195623|3832320|B2||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4011425|NCT01195623|3832321|B1||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4011426|NCT01195623|3832319|B3|||Age||years|Mean|54|54.0|Standard Deviation|11|11.0|||
4011427|NCT01195623|3832320|B2|||Age||years|Mean|52.6|52.6|Standard Deviation|12.9|12.9|||
4011428|NCT01195623|3832321|B1|||Age||years|Mean|56.3|56.3|Standard Deviation|10.6|10.6|||
4011429|NCT01195597|3832330|B1|Italy||Region of Enrollment||participants|Number|40|40.0||||||
4011430|NCT01195597|3832330|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4011431|NCT01195597|3832330|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4011432|NCT01195597|3832330|B1|||Age||years|Mean|42.9|42.9|Standard Deviation|8.8|8.8|||
4011433|NCT01195597|3832330|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4011434|NCT01195597|3832330|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4011435|NCT01195597|3832330|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4011436|NCT01195584|3832335|B4|Austria||Region of Enrollment||participants|Number|72|72.0||||||
4011437|NCT01195584|3832336|B3|Austria||Region of Enrollment||participants|Number|27|27.0||||||
4011438|NCT01195584|3832337|B2|Austria||Region of Enrollment||participants|Number|25|25.0||||||
4011439|NCT01195584|3832338|B1|Austria||Region of Enrollment||participants|Number|20|20.0||||||
4011440|NCT01195584|3832335|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4011441|NCT01195584|3832336|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4011442|NCT01195584|3832337|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4011443|NCT01195584|3832338|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4011444|NCT01195584|3832335|B4||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4011445|NCT01195584|3832336|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4011446|NCT01195584|3832337|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4011447|NCT01195584|3832338|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4011448|NCT01195584|3832335|B4|||Age||years|Mean|61.8|61.8|Standard Deviation|13.1|13.1|||
4011449|NCT01195584|3832336|B3|||Age||years|Mean|62.8|62.8|Standard Deviation|11.3|11.3|||
4011450|NCT01195584|3832337|B2|||Age||years|Mean|67.2|67.2|Standard Deviation|12.7|12.7|||
4011451|NCT01195584|3832338|B1|||Age||years|Mean|53.5|53.5|Standard Deviation|12.1|12.1|||
4011452|NCT01195584|3832335|B4||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4011453|NCT01195584|3832336|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4011454|NCT01195584|3832337|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4011455|NCT01195584|3832338|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4011456|NCT01195584|3832335|B4||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4011457|NCT01195584|3832336|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4011458|NCT01195584|3832337|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4011459|NCT01195584|3832338|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4011460|NCT01195584|3832335|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4011461|NCT01195584|3832336|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4011462|NCT01195584|3832337|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4011463|NCT01195584|3832338|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4011464|NCT01195545|3832351|B1|||BMI||kg/m^2|Median|28.7|28.7|Full Range|||21.9|40.2|
4011465|NCT01195545|3832351|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4011466|NCT01195545|3832351|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4011467|NCT01195545|3832351|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4011468|NCT01195545|3832351|B1|Age||Age, Customized||years|Median|66|66.0|Full Range|||47.0|89.0|
4011469|NCT01195467|3832358|B1|United Kingdom||Region of Enrollment||participants|Number|40|40.0||||||
4011470|NCT01195467|3832358|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4011471|NCT01195467|3832358|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4011472|NCT01195467|3832358|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4011473|NCT01195467|3832358|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4011474|NCT01195467|3832358|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4011475|NCT01195415|3832363|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4011476|NCT01195415|3832363|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4011477|NCT01195415|3832363|B1|||Age||years|Median|65|65.0|Full Range|||46.0|80.0|
4011478|NCT01195363|3832370|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
4011479|NCT01195363|3832371|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4011480|NCT01195363|3832372|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4011481|NCT01195363|3832370|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4011482|NCT01195363|3832371|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4011483|NCT01195363|3832372|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4011484|NCT01195363|3832370|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4011485|NCT01195363|3832371|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4011486|NCT01195363|3832372|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4011487|NCT01195363|3832370|B3|||Age||years|Mean|34|34.0|Standard Deviation|9.9|9.9|||
4011488|NCT01195363|3832371|B2|||Age||years|Mean|32.1|32.1|Standard Deviation|9.8|9.8|||
4011489|NCT01195363|3832372|B1|||Age||years|Mean|35.5|35.5|Standard Deviation|10.1|10.1|||
4011490|NCT01195363|3832370|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4011491|NCT01195363|3832371|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4011492|NCT01195363|3832372|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4011493|NCT01195363|3832370|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4011494|NCT01195363|3832371|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4011495|NCT01195363|3832372|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4011496|NCT01195363|3832370|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4011497|NCT01195363|3832371|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4011498|NCT01195363|3832372|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4011499|NCT01195272|3832379|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4011500|NCT01195272|3832379|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4011501|NCT01195272|3832379|B1|||Age||Years|Mean|49.2|49.2|Standard Deviation|11.2|11.2|||
4011502|NCT01195116|3832396|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
4011503|NCT01195116|3832397|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4011504|NCT01195116|3832398|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4011505|NCT01195116|3832396|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4011506|NCT01195116|3832397|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4011507|NCT01195116|3832398|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4011508|NCT01195116|3832396|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4011509|NCT01195116|3832397|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4011510|NCT01195116|3832398|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4011511|NCT01195116|3832396|B3|||Age||years|Mean|47|47.0|Standard Deviation|13.24|13.24|||
4011512|NCT01195116|3832397|B2|||Age||years|Mean|45.25|45.25|Standard Deviation|15.25|15.25|||
4011513|NCT01195116|3832398|B1|||Age||years|Mean|48.32|48.32|Standard Deviation|10.98|10.98|||
4011514|NCT01195103|3832405|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4011515|NCT01195103|3832406|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4011516|NCT01195103|3832407|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4011517|NCT01195103|3832408|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4011518|NCT01195103|3832405|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4011519|NCT01195103|3832406|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4011520|NCT01195103|3832407|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4011521|NCT01195103|3832408|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4011522|NCT01195103|3832405|B4|||Age||years|Mean|72.6|72.6|Standard Deviation|8.2|8.2|||
4011523|NCT01195103|3832406|B3|||Age||years|Mean|72|72.0|Standard Deviation|12|12.0|||
4011524|NCT01195103|3832407|B2|||Age||years|Mean|71.5|71.5|Standard Deviation|4.3|4.3|||
4011525|NCT01195103|3832408|B1|||Age||years|Mean|73.2|73.2|Standard Deviation|7.0|7.0|||
4011526|NCT01195090|3832418|B3|Taiwan||Region of Enrollment||participants|Number|120|120.0||||||
4011527|NCT01195090|3832419|B2|Taiwan||Region of Enrollment||participants|Number|60|60.0||||||
4011528|NCT01195090|3832420|B1|Taiwan||Region of Enrollment||participants|Number|60|60.0||||||
4011529|NCT01195090|3832418|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4011530|NCT01195090|3832419|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4011531|NCT01195090|3832420|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4011532|NCT01195090|3832418|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4011533|NCT01195090|3832419|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4011534|NCT01195090|3832420|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4011535|NCT01195090|3832418|B3|||Age||years|Mean|59.1|59.1|Standard Deviation|8.6|8.6|||
4011536|NCT01195090|3832419|B2|||Age||years|Mean|58.1|58.1|Standard Deviation|8.3|8.3|||
4011537|NCT01195090|3832420|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|8.9|8.9|||
4011538|NCT01195090|3832418|B3||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4011539|NCT01195090|3832419|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4011540|NCT01195090|3832420|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4011541|NCT01195090|3832418|B3||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
4011542|NCT01195090|3832419|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4011543|NCT01195090|3832420|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4011544|NCT01195090|3832418|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4011545|NCT01195090|3832419|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4011546|NCT01195090|3832420|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4011547|NCT01195025|3832479|B1|Sweden||Region of Enrollment||participants|Number|10|10.0||||||
4011548|NCT01195025|3832479|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4011549|NCT01195025|3832479|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4011550|NCT01195025|3832479|B1|||Age||years|Mean|22|22.0|Standard Deviation|3.4|3.4|||
4011551|NCT01195025|3832479|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4011552|NCT01195025|3832479|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4011553|NCT01195025|3832479|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4011554|NCT01194999|3832490|B1|Canada||Region of Enrollment||participants|Number|132|132.0||||||
4011555|NCT01194999|3832490|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4011556|NCT01194999|3832490|B1||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4011557|NCT01194999|3832490|B1|||Age||years|Mean|51.35|51.35|Standard Deviation|11.28|11.28|||
4011558|NCT01194999|3832490|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4011559|NCT01194999|3832490|B1||Between 18 and 65 years|Age||Participants|Count of Participants|118|118.0||||||
4011560|NCT01194999|3832490|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4011561|NCT01194973|3832494|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011562|NCT01194973|3832494|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011563|NCT01194973|3832494|B1||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4011564|NCT01194973|3832494|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4011565|NCT01194973|3832494|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011566|NCT01194973|3832494|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4011567|NCT01194973|3832494|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011568|NCT01194973|3832494|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4011569|NCT01194973|3832494|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4011570|NCT01194973|3832494|B1|||Age||Years|Mean|40.3|40.3|Standard Deviation|15.33|15.33|||
4011571|NCT01194908|3832509|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4011572|NCT01194908|3832509|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4011573|NCT01194908|3832509|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4011574|NCT01194908|3832509|B1|50-59 years||Age, Customized||participants|Number|2|2.0||||||
4011575|NCT01194908|3832509|B1|40-49 years||Age, Customized||participants|Number|2|2.0||||||
4011576|NCT01194908|3832509|B1|30-39 years||Age, Customized||participants|Number|1|1.0||||||
4011577|NCT01194869|3832514|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4011578|NCT01194869|3832514|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011579|NCT01194869|3832514|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011580|NCT01194869|3832514|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4011581|NCT01194869|3832514|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4011582|NCT01194869|3832514|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011583|NCT01194869|3832514|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011584|NCT01194869|3832514|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011585|NCT01194869|3832514|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011586|NCT01194869|3832514|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4011587|NCT01194869|3832514|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011588|NCT01194869|3832514|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4011589|NCT01194869|3832514|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4011590|NCT01194869|3832514|B1|||Age||years|Median|42|42.0|Full Range|||34.0|66.0|
4011591|NCT01194856|3832520|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4011592|NCT01194856|3832522|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4011593|NCT01194856|3832520|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4011594|NCT01194856|3832522|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4011595|NCT01194856|3832520|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4011596|NCT01194856|3832522|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4011597|NCT01194856|3832520|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4011598|NCT01194856|3832522|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4011599|NCT01194856|3832520|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4011600|NCT01194856|3832522|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4011601|NCT01194856|3832520|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4011602|NCT01194856|3832522|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4011603|NCT01194830|3832543|B3|Drinks - possible interference with study||Alcohol status|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|0|0.0||||||
4011604|NCT01194830|3832544|B2|Drinks - possible interference with study||Alcohol status|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|0|0.0||||||
4011605|NCT01194830|3832545|B1|Drinks - possible interference with study||Alcohol status|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|0|0.0||||||
4011606|NCT01194830|3832543|B3|Drinks - no interference with study||Alcohol status|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|95|95.0||||||
4011607|NCT01194830|3832544|B2|Drinks - no interference with study||Alcohol status|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|45|45.0||||||
4011608|NCT01194830|3832545|B1|Drinks - no interference with study||Alcohol status|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|50|50.0||||||
4011609|NCT01194830|3832543|B3|Non drinker||Alcohol status|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|131|131.0||||||
4011610|NCT01194830|3832544|B2|Non drinker||Alcohol status|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|61|61.0||||||
4011611|NCT01194830|3832545|B1|Non drinker||Alcohol status|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|70|70.0||||||
4011612|NCT01194830|3832543|B3|Currently smokes||Smoking status|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|45|45.0||||||
4011613|NCT01194830|3832544|B2|Currently smokes||Smoking status|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|29|29.0||||||
4011614|NCT01194830|3832545|B1|Currently smokes||Smoking status|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|16|16.0||||||
4011615|NCT01194830|3832543|B3|Ex-smoker||Smoking status|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|43|43.0||||||
4011616|NCT01194830|3832544|B2|Ex-smoker||Smoking status|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|21|21.0||||||
4011617|NCT01194830|3832545|B1|Ex-smoker||Smoking status|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|22|22.0||||||
4011618|NCT01194830|3832543|B3|Never smoked||Smoking status|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|138|138.0||||||
4011619|NCT01194830|3832544|B2|Never smoked||Smoking status|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|56|56.0||||||
4011620|NCT01194830|3832545|B1|Never smoked||Smoking status|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|82|82.0||||||
4011621|NCT01194830|3832543|B3|||Waist circumference|4 subjects in each treatment arm were excluded from analysis|centimeters|Mean|107.7|107.7|Standard Deviation|18.8|18.8|||
4011622|NCT01194830|3832544|B2|||Waist circumference|4 subjects in each treatment arm were excluded from analysis|centimeters|Mean|103.5|103.5|Standard Deviation|20.2|20.2|||
4011623|NCT01194830|3832545|B1|||Waist circumference|4 subjects in each treatment arm were excluded from analysis|centimeters|Mean|111.5|111.5|Standard Deviation|16.7|16.7|||
4011624|NCT01194830|3832543|B3|||Height|4 subjects in each treatment arm were excluded from analysis|centimeters|Mean|172.4|172.4|Standard Deviation|10.6|10.6|||
4011625|NCT01194830|3832544|B2|||Height|4 subjects in each treatment arm were excluded from analysis|centimeters|Mean|172.8|172.8|Standard Deviation|10.3|10.3|||
4011626|NCT01194830|3832545|B1|||Height|4 subjects in each treatment arm were excluded from analysis|centimeters|Mean|172.1|172.1|Standard Deviation|10.9|10.9|||
4011627|NCT01194830|3832543|B3|>= 30 kilograms/square meter||Body Mass Index (BMI) categories|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|148|148.0||||||
4011628|NCT01194830|3832544|B2|>= 30 kilograms/square meter||Body Mass Index (BMI) categories|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|61|61.0||||||
4011629|NCT01194830|3832545|B1|>= 30 kilograms/square meter||Body Mass Index (BMI) categories|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|87|87.0||||||
4011630|NCT01194830|3832543|B3|< 30 kilograms/square meter||Body Mass Index (BMI) categories|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|78|78.0||||||
4011631|NCT01194830|3832544|B2|< 30 kilograms/square meter||Body Mass Index (BMI) categories|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|45|45.0||||||
4011632|NCT01194830|3832545|B1|< 30 kilograms/square meter||Body Mass Index (BMI) categories|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|33|33.0||||||
4011633|NCT01194830|3832543|B3|||Body Mass Index (BMI)|4 subjects in each treatment arm were excluded from analysis|kilograms per square meter|Mean|32.74|32.74|Standard Deviation|5.74|5.74|||
4011634|NCT01194830|3832544|B2|||Body Mass Index (BMI)|4 subjects in each treatment arm were excluded from analysis|kilograms per square meter|Mean|32.04|32.04|Standard Deviation|6.10|6.1|||
4011635|NCT01194830|3832545|B1|||Body Mass Index (BMI)|4 subjects in each treatment arm were excluded from analysis|kilograms per square meter|Mean|33.35|33.35|Standard Deviation|5.36|5.36|||
4011636|NCT01194830|3832543|B3|> 90 kilograms||Weight categories|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|126|126.0||||||
4011637|NCT01194830|3832544|B2|> 90 kilograms||Weight categories|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|54|54.0||||||
4011638|NCT01194830|3832545|B1|> 90 kilograms||Weight categories|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|72|72.0||||||
4011639|NCT01194830|3832543|B3|> 80 to 90 kilograms||Weight categories|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|51|51.0||||||
4011640|NCT01194830|3832544|B2|> 80 to 90 kilograms||Weight categories|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|26|26.0||||||
4011641|NCT01194830|3832545|B1|> 80 to 90 kilograms||Weight categories|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|25|25.0||||||
4011642|NCT01194830|3832543|B3|> 70 to 80 kilograms||Weight categories|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|39|39.0||||||
4011643|NCT01194830|3832544|B2|> 70 to 80 kilograms||Weight categories|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|18|18.0||||||
4011644|NCT01194830|3832545|B1|> 70 to 80 kilograms||Weight categories|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|21|21.0||||||
4011645|NCT01194830|3832543|B3|<= 70 kilograms||Weight categories|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|10|10.0||||||
4011697|NCT01194479|3832610|B3|||HbA1c (%)||%|Mean|6.1|6.1|Standard Deviation|1.0|1.0|||
4011646|NCT01194830|3832544|B2|<= 70 kilograms||Weight categories|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|8|8.0||||||
4011647|NCT01194830|3832545|B1|<= 70 kilograms||Weight categories|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|2|2.0||||||
4011648|NCT01194830|3832543|B3|||Weight|4 subjects in each treatment arm were excluded from analysis|kilograms|Mean|97.52|97.52|Standard Deviation|20.55|20.55|||
4011649|NCT01194830|3832544|B2|||Weight|4 subjects in each treatment arm were excluded from analysis|kilograms|Mean|95.83|95.83|Standard Deviation|20.96|20.96|||
4011650|NCT01194830|3832545|B1|||Weight|4 subjects in each treatment arm were excluded from analysis|kilograms|Mean|99.02|99.02|Standard Deviation|20.16|20.16|||
4011651|NCT01194830|3832543|B3||Male|Sex: Female, Male|4 subjects in each treatment arm were excluded from analysis|Participants|Count of Participants|121|121.0||||||
4011652|NCT01194830|3832544|B2||Male|Sex: Female, Male|4 subjects in each treatment arm were excluded from analysis|Participants|Count of Participants|60|60.0||||||
4011653|NCT01194830|3832545|B1||Male|Sex: Female, Male|4 subjects in each treatment arm were excluded from analysis|Participants|Count of Participants|61|61.0||||||
4011654|NCT01194830|3832543|B3||Female|Sex: Female, Male|4 subjects in each treatment arm were excluded from analysis|Participants|Count of Participants|105|105.0||||||
4011655|NCT01194830|3832544|B2||Female|Sex: Female, Male|4 subjects in each treatment arm were excluded from analysis|Participants|Count of Participants|46|46.0||||||
4011656|NCT01194830|3832545|B1||Female|Sex: Female, Male|4 subjects in each treatment arm were excluded from analysis|Participants|Count of Participants|59|59.0||||||
4011657|NCT01194830|3832543|B3|>= 75 years||Age, Customized|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|7|7.0||||||
4011658|NCT01194830|3832544|B2|>= 75 years||Age, Customized|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|3|3.0||||||
4011659|NCT01194830|3832545|B1|>= 75 years||Age, Customized|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|4|4.0||||||
4011660|NCT01194830|3832543|B3|65 to 74 years||Age, Customized|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|26|26.0||||||
4011661|NCT01194830|3832544|B2|65 to 74 years||Age, Customized|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|14|14.0||||||
4011662|NCT01194830|3832545|B1|65 to 74 years||Age, Customized|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|12|12.0||||||
4011663|NCT01194830|3832543|B3|< 65 years||Age, Customized|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|193|193.0||||||
4011664|NCT01194830|3832544|B2|< 65 years||Age, Customized|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|89|89.0||||||
4011665|NCT01194830|3832545|B1|< 65 years||Age, Customized|4 subjects in each treatment arm were excluded from analysis|Number of participants|Number|104|104.0||||||
4011666|NCT01194830|3832543|B3|||Age|4 subjects in each treatment arm were excluded from analysis|years|Mean|53.9|53.9|Standard Deviation|9.9|9.9|||
4011667|NCT01194830|3832544|B2|||Age|4 subjects in each treatment arm were excluded from analysis|years|Mean|53.7|53.7|Standard Deviation|10.1|10.1|||
4011668|NCT01194830|3832545|B1|||Age|4 subjects in each treatment arm were excluded from analysis|years|Mean|54.1|54.1|Standard Deviation|9.9|9.9|||
4011669|NCT01194674|3832568|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4011670|NCT01194674|3832568|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4011671|NCT01194674|3832568|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4011672|NCT01194674|3832568|B1|||Age||years|Mean|40.50|40.5|Full Range|17.68|17.68|28.0|53.0|
4011673|NCT01194674|3832568|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4011674|NCT01194674|3832568|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4011675|NCT01194674|3832568|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4011676|NCT01194570|3832580|B3||Male|Sex: Female, Male||Participants|Count of Participants|371|371.0||||||
4011677|NCT01194570|3832581|B2||Male|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4011678|NCT01194570|3832582|B1||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4011679|NCT01194570|3832580|B3||Female|Sex: Female, Male||Participants|Count of Participants|361|361.0||||||
4011680|NCT01194570|3832581|B2||Female|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
4011681|NCT01194570|3832582|B1||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4011682|NCT01194570|3832580|B3|||Age||years|Mean|44.6|44.6|Standard Deviation|8.0|8.0|||
4011683|NCT01194570|3832581|B2|||Age||years|Mean|44.7|44.7|Standard Deviation|7.9|7.9|||
4011684|NCT01194570|3832582|B1|||Age||years|Mean|44.4|44.4|Standard Deviation|8.3|8.3|||
4011685|NCT01194531|3832601|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4011686|NCT01194531|3832602|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4011687|NCT01194531|3832603|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4011688|NCT01194531|3832601|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4011689|NCT01194531|3832602|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4011690|NCT01194531|3832603|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4011691|NCT01194531|3832601|B3|||Age||years|Mean|37.7|37.7|Full Range|||35.0|42.0|
4011692|NCT01194531|3832602|B2|||Age||years|Mean|37.3|37.3|Full Range|||35.0|42.0|
4011693|NCT01194531|3832603|B1|||Age||years|Mean|38|38.0|Full Range|||35.0|41.0|
4011694|NCT01194479|3832610|B3|||HbA1c (mmol/mol)||mmol/mol|Mean|43.5|43.5|Standard Deviation|10.7|10.7|||
4011695|NCT01194479|3832611|B2|||HbA1c (mmol/mol)||mmol/mol|Mean|51.3|51.3|Standard Deviation|8.5|8.5|||
4011696|NCT01194479|3832612|B1|||HbA1c (mmol/mol)||mmol/mol|Mean|34.5|34.5|Standard Deviation|2.6|2.6|||
4011698|NCT01194479|3832611|B2|||HbA1c (%)||%|Mean|6.8|6.8|Standard Deviation|2.6|2.6|||
4011699|NCT01194479|3832612|B1|||HbA1c (%)||%|Mean|5.3|5.3|Standard Deviation|2.6|2.6|||
4011700|NCT01194479|3832610|B3|||Weight (kg)||kg|Mean|70.1|70.1|Standard Deviation|11.3|11.3|||
4011701|NCT01194479|3832611|B2|||Weight (kg)||kg|Mean|70.2|70.2|Standard Deviation|10.6|10.6|||
4011702|NCT01194479|3832612|B1|||Weight (kg)||kg|Mean|70.0|70.0|Standard Deviation|12.9|12.9|||
4011703|NCT01194479|3832610|B3|||Body Mass Index (BMI, kg/m^2)||kg/m^2|Mean|24.8|24.8|Standard Deviation|2.7|2.7|||
4011704|NCT01194479|3832611|B2|||Body Mass Index (BMI, kg/m^2)||kg/m^2|Mean|25.8|25.8|Standard Deviation|2.9|2.9|||
4011705|NCT01194479|3832612|B1|||Body Mass Index (BMI, kg/m^2)||kg/m^2|Mean|23.7|23.7|Standard Deviation|2.1|2.1|||
4011706|NCT01194479|3832610|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4011707|NCT01194479|3832611|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4011708|NCT01194479|3832612|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4011709|NCT01194479|3832610|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4011710|NCT01194479|3832611|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4011711|NCT01194479|3832612|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4011712|NCT01194479|3832610|B3|||Age||years|Mean|33.2|33.2|Standard Deviation|9.7|9.7|||
4011713|NCT01194479|3832611|B2|||Age||years|Mean|31|31.0|Standard Deviation|11|11.0|||
4011714|NCT01194479|3832612|B1|||Age||years|Mean|36|36.0|Standard Deviation|8|8.0|||
4011715|NCT01194453|3832637|B3|China||Region of Enrollment||participants|Number|288|288.0||||||
4011716|NCT01194453|3832638|B2|China||Region of Enrollment||participants|Number|144|144.0||||||
4011717|NCT01194453|3832639|B1|China||Region of Enrollment||participants|Number|144|144.0||||||
4011718|NCT01194453|3832637|B3||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4011719|NCT01194453|3832638|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4011720|NCT01194453|3832639|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4011721|NCT01194453|3832637|B3||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4011722|NCT01194453|3832638|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4011723|NCT01194453|3832639|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4011724|NCT01194453|3832637|B3||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4011725|NCT01194453|3832638|B2||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4011726|NCT01194453|3832639|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4011727|NCT01194453|3832637|B3||Between 18 and 65 years|Age||Participants|Count of Participants|249|249.0||||||
4011728|NCT01194453|3832638|B2||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
4011729|NCT01194453|3832639|B1||Between 18 and 65 years|Age||Participants|Count of Participants|129|129.0||||||
4011730|NCT01194453|3832637|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4011731|NCT01194453|3832638|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4011732|NCT01194453|3832639|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4011733|NCT01194440|3832648|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
4011734|NCT01194440|3832648|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4011735|NCT01194440|3832648|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4011736|NCT01194440|3832648|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4011737|NCT01194440|3832648|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4011738|NCT01194440|3832648|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4011739|NCT01194427|3832655|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4011740|NCT01194427|3832655|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4011741|NCT01194427|3832655|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4011742|NCT01194427|3832655|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4011743|NCT01194427|3832655|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4011744|NCT01194427|3832655|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4011745|NCT01194414|3832659|B3||Male|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
4011746|NCT01194414|3832660|B2||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4011747|NCT01194414|3832661|B1||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4011748|NCT01194414|3832659|B3||Female|Sex: Female, Male||Participants|Count of Participants|1041|1041.0||||||
4011749|NCT01194414|3832660|B2||Female|Sex: Female, Male||Participants|Count of Participants|521|521.0||||||
4011750|NCT01194414|3832661|B1||Female|Sex: Female, Male||Participants|Count of Participants|520|520.0||||||
4011751|NCT01194414|3832659|B3|||Age||years|Mean|52.7|52.7|Standard Deviation|12.44|12.44|18.0|86.0|
4011752|NCT01194414|3832660|B2|||Age||years|Mean|52.8|52.8|Standard Deviation|12.53|12.53|18.0|86.0|
4011753|NCT01194414|3832661|B1|||Age||years|Mean|52.7|52.7|Standard Deviation|12.35|12.35|18.0|83.0|
4011754|NCT01194297|3832724|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4011755|NCT01194297|3832725|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4011756|NCT01194297|3832726|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4011757|NCT01194297|3832724|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4011758|NCT01194297|3832725|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4011759|NCT01194297|3832726|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4011760|NCT01194297|3832724|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4011761|NCT01194297|3832725|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4011762|NCT01194297|3832726|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4011763|NCT01194297|3832724|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4011764|NCT01194297|3832725|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4011765|NCT01194297|3832726|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4011766|NCT01194297|3832724|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4011767|NCT01194297|3832725|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4011768|NCT01194297|3832726|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4011769|NCT01194297|3832724|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4011770|NCT01194297|3832725|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4011771|NCT01194297|3832726|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4011772|NCT01194258|3832735|B1|United States||Region of Enrollment||participants|Number|132|132.0||||||
4011773|NCT01194258|3832735|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011774|NCT01194258|3832735|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
4011775|NCT01194258|3832735|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4011776|NCT01194258|3832735|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4011777|NCT01194258|3832735|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4011778|NCT01194258|3832735|B1||White|Race (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
4011779|NCT01194258|3832735|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4011780|NCT01194258|3832735|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4011781|NCT01194258|3832735|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4011782|NCT01194258|3832735|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011783|NCT01194258|3832735|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4011784|NCT01194258|3832735|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4011785|NCT01194258|3832735|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|9.85|9.85|||
4011786|NCT01194245|3832758|B6|United States||Region of Enrollment||participants|Number|135|135.0||||||
4011787|NCT01194245|3832759|B5|United States||Region of Enrollment||participants|Number|30|30.0||||||
4011788|NCT01194245|3832760|B4|United States||Region of Enrollment||participants|Number|30|30.0||||||
4011789|NCT01194245|3832761|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
4011790|NCT01194245|3832762|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4011791|NCT01194245|3832763|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4011792|NCT01194245|3832758|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011793|NCT01194245|3832759|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011794|NCT01194245|3832760|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011795|NCT01194245|3832761|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011796|NCT01194245|3832762|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011797|NCT01194245|3832763|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011798|NCT01194245|3832758|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
4011799|NCT01194245|3832759|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4011800|NCT01194245|3832760|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4011801|NCT01194245|3832761|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4011802|NCT01194245|3832762|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4011803|NCT01194245|3832763|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4011804|NCT01194245|3832758|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4011805|NCT01194245|3832759|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4011806|NCT01194245|3832760|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4011807|NCT01194245|3832761|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4011808|NCT01194245|3832762|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4011809|NCT01194245|3832763|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4011810|NCT01194245|3832758|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011811|NCT01194245|3832759|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011812|NCT01194245|3832760|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011813|NCT01194245|3832761|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011814|NCT01194245|3832762|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011815|NCT01194245|3832763|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011816|NCT01194245|3832758|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4011817|NCT01194245|3832759|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011818|NCT01194245|3832760|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011819|NCT01194245|3832761|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011820|NCT01194245|3832762|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4011821|NCT01194245|3832763|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011822|NCT01194245|3832758|B6||White|Race (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
4011823|NCT01194245|3832759|B5||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4011824|NCT01194245|3832760|B4||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4011825|NCT01194245|3832761|B3||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4011826|NCT01194245|3832762|B2||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4011827|NCT01194245|3832763|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4011828|NCT01194245|3832758|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4011829|NCT01194245|3832759|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4011830|NCT01194245|3832760|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011831|NCT01194245|3832761|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4011832|NCT01194245|3832762|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011833|NCT01194245|3832763|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011834|NCT01194245|3832758|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011835|NCT01194245|3832759|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011836|NCT01194245|3832760|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011837|NCT01194245|3832761|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011838|NCT01194245|3832762|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011839|NCT01194245|3832763|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011840|NCT01194245|3832758|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4011841|NCT01194245|3832759|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011842|NCT01194245|3832760|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011843|NCT01194245|3832761|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011844|NCT01194245|3832762|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011845|NCT01194245|3832763|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4011846|NCT01194245|3832758|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011847|NCT01194245|3832759|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011848|NCT01194245|3832760|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011849|NCT01194245|3832761|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011850|NCT01194245|3832762|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011851|NCT01194245|3832763|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4011852|NCT01194245|3832758|B6||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4011853|NCT01194245|3832759|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4011854|NCT01194245|3832760|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4011855|NCT01194245|3832761|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4011856|NCT01194245|3832762|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4011857|NCT01194245|3832763|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4011858|NCT01194245|3832758|B6||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4011859|NCT01194245|3832759|B5||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4011860|NCT01194245|3832760|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4011861|NCT01194245|3832761|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4011862|NCT01194245|3832762|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4011863|NCT01194245|3832763|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4011864|NCT01194245|3832758|B6|||Age||years|Mean|42.6|42.6|Standard Deviation|14.41|14.41|||
4011865|NCT01194245|3832759|B5|||Age||years|Mean|42.5|42.5|Standard Deviation|14.70|14.7|||
4011866|NCT01194245|3832760|B4|||Age||years|Mean|42.8|42.8|Standard Deviation|14.13|14.13|||
4011867|NCT01194245|3832761|B3|||Age||years|Mean|45.7|45.7|Standard Deviation|14.94|14.94|||
4011868|NCT01194245|3832762|B2|||Age||years|Mean|44.6|44.6|Standard Deviation|14.56|14.56|||
4011869|NCT01194245|3832763|B1|||Age||years|Mean|34.8|34.8|Standard Deviation|11.71|11.71|||
4011870|NCT01194219|3832786|B3|Missing||Duration of Plaque Psoriasis|All participants enrolled were required to have a diagnosis of plaque psoriasis at least 12 months prior to screening, but the duration was not required for enrollment. Overall baseline population for duration of plaque psoriasis in the apremilast arm were 562 participants and 282 for those in the placebo arm.|years|Number|2|2.0||||||
4011905|NCT01194219|3832788|B1||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4011906|NCT01194219|3832786|B3|||Age||years|Mean|46.0|46.0|Standard Deviation|12.95|12.95|||
4011871|NCT01194219|3832787|B2|Missing||Duration of Plaque Psoriasis|All participants enrolled were required to have a diagnosis of plaque psoriasis at least 12 months prior to screening, but the duration was not required for enrollment. Overall baseline population for duration of plaque psoriasis in the apremilast arm were 562 participants and 282 for those in the placebo arm.|years|Number|2|2.0||||||
4011872|NCT01194219|3832788|B1|Missing||Duration of Plaque Psoriasis|All participants enrolled were required to have a diagnosis of plaque psoriasis at least 12 months prior to screening, but the duration was not required for enrollment. Overall baseline population for duration of plaque psoriasis in the apremilast arm were 562 participants and 282 for those in the placebo arm.|years|Number|0|0.0||||||
4011873|NCT01194219|3832786|B3|≥ 20 years||Duration of Plaque Psoriasis|All participants enrolled were required to have a diagnosis of plaque psoriasis at least 12 months prior to screening, but the duration was not required for enrollment. Overall baseline population for duration of plaque psoriasis in the apremilast arm were 562 participants and 282 for those in the placebo arm.|years|Number|375|375.0||||||
4011874|NCT01194219|3832787|B2|≥ 20 years||Duration of Plaque Psoriasis|All participants enrolled were required to have a diagnosis of plaque psoriasis at least 12 months prior to screening, but the duration was not required for enrollment. Overall baseline population for duration of plaque psoriasis in the apremilast arm were 562 participants and 282 for those in the placebo arm.|years|Number|122|122.0||||||
4011875|NCT01194219|3832788|B1|≥ 20 years||Duration of Plaque Psoriasis|All participants enrolled were required to have a diagnosis of plaque psoriasis at least 12 months prior to screening, but the duration was not required for enrollment. Overall baseline population for duration of plaque psoriasis in the apremilast arm were 562 participants and 282 for those in the placebo arm.|years|Number|253|253.0||||||
4011876|NCT01194219|3832786|B3|10 to < 20 years||Duration of Plaque Psoriasis|All participants enrolled were required to have a diagnosis of plaque psoriasis at least 12 months prior to screening, but the duration was not required for enrollment. Overall baseline population for duration of plaque psoriasis in the apremilast arm were 562 participants and 282 for those in the placebo arm.|years|Number|232|232.0||||||
4011877|NCT01194219|3832787|B2|10 to < 20 years||Duration of Plaque Psoriasis|All participants enrolled were required to have a diagnosis of plaque psoriasis at least 12 months prior to screening, but the duration was not required for enrollment. Overall baseline population for duration of plaque psoriasis in the apremilast arm were 562 participants and 282 for those in the placebo arm.|years|Number|73|73.0||||||
4011878|NCT01194219|3832788|B1|10 to < 20 years||Duration of Plaque Psoriasis|All participants enrolled were required to have a diagnosis of plaque psoriasis at least 12 months prior to screening, but the duration was not required for enrollment. Overall baseline population for duration of plaque psoriasis in the apremilast arm were 562 participants and 282 for those in the placebo arm.|years|Number|159|159.0||||||
4011879|NCT01194219|3832786|B3|<10 years||Duration of Plaque Psoriasis|All participants enrolled were required to have a diagnosis of plaque psoriasis at least 12 months prior to screening, but the duration was not required for enrollment. Overall baseline population for duration of plaque psoriasis in the apremilast arm were 562 participants and 282 for those in the placebo arm.|years|Number|235|235.0||||||
4011880|NCT01194219|3832787|B2|<10 years||Duration of Plaque Psoriasis|All participants enrolled were required to have a diagnosis of plaque psoriasis at least 12 months prior to screening, but the duration was not required for enrollment. Overall baseline population for duration of plaque psoriasis in the apremilast arm were 562 participants and 282 for those in the placebo arm.|years|Number|85|85.0||||||
4011881|NCT01194219|3832788|B1|<10 years||Duration of Plaque Psoriasis|All participants enrolled were required to have a diagnosis of plaque psoriasis at least 12 months prior to screening, but the duration was not required for enrollment. Overall baseline population for duration of plaque psoriasis in the apremilast arm were 562 participants and 282 for those in the placebo arm.|years|Number|150|150.0||||||
4011882|NCT01194219|3832786|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4011883|NCT01194219|3832787|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4011884|NCT01194219|3832788|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4011885|NCT01194219|3832786|B3|White||Race/Ethnicity, Customized||participants|Number|757|757.0||||||
4011886|NCT01194219|3832787|B2|White||Race/Ethnicity, Customized||participants|Number|250|250.0||||||
4011887|NCT01194219|3832788|B1|White||Race/Ethnicity, Customized||participants|Number|507|507.0||||||
4011888|NCT01194219|3832786|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4011889|NCT01194219|3832787|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4011890|NCT01194219|3832788|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4011891|NCT01194219|3832786|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4011892|NCT01194219|3832787|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4011893|NCT01194219|3832788|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4011894|NCT01194219|3832786|B3|Asian||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4011895|NCT01194219|3832787|B2|Asian||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4011896|NCT01194219|3832788|B1|Asian||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4011897|NCT01194219|3832786|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4011898|NCT01194219|3832787|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4011899|NCT01194219|3832788|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4011900|NCT01194219|3832786|B3||Male|Sex: Female, Male||Participants|Count of Participants|573|573.0||||||
4011901|NCT01194219|3832787|B2||Male|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4011902|NCT01194219|3832788|B1||Male|Sex: Female, Male||Participants|Count of Participants|379|379.0||||||
4011903|NCT01194219|3832786|B3||Female|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
4011904|NCT01194219|3832787|B2||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4011907|NCT01194219|3832787|B2|||Age||years|Mean|46.5|46.5|Standard Deviation|12.72|12.72|||
4011908|NCT01194219|3832788|B1|||Age||years|Mean|45.8|45.8|Standard Deviation|13.07|13.07|||
4011909|NCT01194154|3832829|B3||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4011910|NCT01194154|3832830|B2||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4011911|NCT01194154|3832831|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4011912|NCT01194154|3832829|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4011913|NCT01194154|3832830|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4011914|NCT01194154|3832831|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4011915|NCT01194154|3832829|B3|||Age||years|Mean|63.17|63.17|Standard Deviation|13.31|13.31|||
4011916|NCT01194154|3832830|B2|||Age||years|Mean|62.97|62.97|Standard Deviation|14.30|14.3|||
4011917|NCT01194154|3832831|B1|||Age||years|Mean|63.37|63.37|Standard Deviation|12.26|12.26|||
4011918|NCT01194089|3832850|B3|United States||Region of Enrollment||participants|Number|89|89.0||||||
4011919|NCT01194089|3832851|B2|United States||Region of Enrollment||participants|Number|47|47.0||||||
4011920|NCT01194089|3832852|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4011921|NCT01194089|3832850|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4011922|NCT01194089|3832851|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4011923|NCT01194089|3832852|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4011924|NCT01194089|3832850|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4011925|NCT01194089|3832851|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4011926|NCT01194089|3832852|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4011927|NCT01194089|3832850|B3|||Age||years|Mean|45.8|45.8|Standard Deviation|9.9|9.9|||
4011928|NCT01194089|3832851|B2|||Age||years|Mean|44.9|44.9|Standard Deviation|10.6|10.6|||
4011929|NCT01194089|3832852|B1|||Age||years|Mean|46.0|46.0|Standard Deviation|9.1|9.1|||
4011930|NCT01193920|3832863|B11|South Africa||Region of Enrollment||participants|Number|697|697.0||||||
4011931|NCT01193920|3832864|B10|South Africa||Region of Enrollment||participants|Number|81|81.0||||||
4011932|NCT01193920|3832865|B9|South Africa||Region of Enrollment||participants|Number|76|76.0||||||
4011933|NCT01193920|3832866|B8|South Africa||Region of Enrollment||participants|Number|80|80.0||||||
4011934|NCT01193920|3832867|B7|South Africa||Region of Enrollment||participants|Number|80|80.0||||||
4011935|NCT01193920|3832868|B6|South Africa||Region of Enrollment||participants|Number|80|80.0||||||
4011936|NCT01193920|3832869|B5|South Africa||Region of Enrollment||participants|Number|80|80.0||||||
4011937|NCT01193920|3832870|B4|South Africa||Region of Enrollment||participants|Number|80|80.0||||||
4011938|NCT01193920|3832871|B3|South Africa||Region of Enrollment||participants|Number|80|80.0||||||
4011939|NCT01193920|3832872|B2|South Africa||Region of Enrollment||participants|Number|20|20.0||||||
4011940|NCT01193920|3832873|B1|South Africa||Region of Enrollment||participants|Number|40|40.0||||||
4011941|NCT01193920|3832863|B11||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4011942|NCT01193920|3832864|B10||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4011943|NCT01193920|3832865|B9||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4011944|NCT01193920|3832866|B8||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4011945|NCT01193920|3832867|B7||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4011946|NCT01193920|3832868|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4011947|NCT01193920|3832869|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4011948|NCT01193920|3832870|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4011949|NCT01193920|3832871|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4011950|NCT01193920|3832872|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4011951|NCT01193920|3832873|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4011952|NCT01193920|3832863|B11||Female|Sex: Female, Male||Participants|Count of Participants|544|544.0||||||
4011953|NCT01193920|3832864|B10||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4011954|NCT01193920|3832865|B9||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4011955|NCT01193920|3832866|B8||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4011956|NCT01193920|3832867|B7||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4011957|NCT01193920|3832868|B6||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4011958|NCT01193920|3832869|B5||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4011959|NCT01193920|3832870|B4||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4011960|NCT01193920|3832871|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4011961|NCT01193920|3832872|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4011962|NCT01193920|3832873|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4011963|NCT01193920|3832863|B11|||Age, Customized||days|Mean|4.0|4.0|Standard Deviation|10.3|10.3|||
4011964|NCT01193920|3832864|B10|||Age, Customized||days|Mean|3.5|3.5|Standard Deviation|8.8|8.8|||
4011965|NCT01193920|3832865|B9|||Age, Customized||days|Mean|5.5|5.5|Standard Deviation|16.9|16.9|||
4011966|NCT01193920|3832866|B8|||Age, Customized||days|Mean|4.0|4.0|Standard Deviation|7.8|7.8|||
4011967|NCT01193920|3832867|B7|||Age, Customized||days|Mean|3.0|3.0|Standard Deviation|3.3|3.3|||
4011968|NCT01193920|3832868|B6|||Age, Customized||days|Mean|NA||Standard Deviation|NA||||presented elsewhere
4011969|NCT01193920|3832869|B5|||Age, Customized||days|Mean|NA||Standard Deviation|NA||||presented elsewhere
4011970|NCT01193920|3832870|B4|||Age, Customized||days|Mean|NA||Standard Deviation|NA||||presented elsewhere
4011971|NCT01193920|3832871|B3|||Age, Customized||days|Mean|NA||Standard Deviation|NA||||presented elsewhere
4011972|NCT01193920|3832872|B2|||Age, Customized||days|Mean|NA||Standard Deviation|NA||||presented elsewhere
4011973|NCT01193920|3832873|B1|||Age, Customized||days|Mean|NA||Standard Deviation|NA||||presented elsewhere
4011974|NCT01193920|3832863|B11|Maternal subjects||Age, Customized||years|Mean|25.1|25.1|Standard Deviation|5.1|5.1|||
4011975|NCT01193920|3832864|B10|Maternal subjects||Age, Customized||years|Mean|NA||Standard Deviation|NA||||presented elsewhere
4011976|NCT01193920|3832865|B9|Maternal subjects||Age, Customized||years|Mean|NA||Standard Deviation|NA||||presented elsewhere
4011977|NCT01193920|3832866|B8|Maternal subjects||Age, Customized||years|Mean|NA||Standard Deviation|NA||||presented elsewhere
4011978|NCT01193920|3832867|B7|Maternal subjects||Age, Customized||years|Mean|NA||Standard Deviation|NA||||presented elsewhere
4011979|NCT01193920|3832868|B6|Maternal subjects||Age, Customized||years|Mean|25.7|25.7|Standard Deviation|5.4|5.4|||
4011980|NCT01193920|3832869|B5|Maternal subjects||Age, Customized||years|Mean|24.2|24.2|Standard Deviation|4.7|4.7|||
4011981|NCT01193920|3832870|B4|Maternal subjects||Age, Customized||years|Mean|25.3|25.3|Standard Deviation|5.2|5.2|||
4011982|NCT01193920|3832871|B3|Maternal subjects||Age, Customized||years|Mean|25.3|25.3|Standard Deviation|5.2|5.2|||
4011983|NCT01193920|3832872|B2|Maternal subjects||Age, Customized||years|Mean|NA||Standard Deviation|NA||||presented elsewhere
4011984|NCT01193920|3832873|B1|Maternal subjects||Age, Customized||years|Mean|NA||Standard Deviation|NA||||presented elsewhere
4011985|NCT01193920|3832863|B11|Non pregnant subjects||Age, Customized||years|Mean|28.8|28.8|Standard Deviation|5.0|5.0|||
4011986|NCT01193920|3832864|B10|Non pregnant subjects||Age, Customized||years|Mean|NA||Standard Deviation|NA||||presented elsewhere
4011987|NCT01193920|3832865|B9|Non pregnant subjects||Age, Customized||years|Mean|NA||Standard Deviation|NA||||presented elsewhere
4011988|NCT01193920|3832866|B8|Non pregnant subjects||Age, Customized||years|Mean|NA||Standard Deviation|NA||||presented elsewhere
4011989|NCT01193920|3832867|B7|Non pregnant subjects||Age, Customized||years|Mean|NA||Standard Deviation|NA||||presented elsewhere
4011990|NCT01193920|3832868|B6|Non pregnant subjects||Age, Customized||years|Mean|NA||Standard Deviation|NA||||presented elsewhere
4011991|NCT01193920|3832869|B5|Non pregnant subjects||Age, Customized||years|Mean|NA||Standard Deviation|NA||||presented elsewhere
4011992|NCT01193920|3832870|B4|Non pregnant subjects||Age, Customized||years|Mean|NA||Standard Deviation|NA||||presented elsewhere
4011993|NCT01193920|3832871|B3|Non pregnant subjects||Age, Customized||years|Mean|NA||Standard Deviation|NA||||presented elsewhere
4011994|NCT01193920|3832872|B2|Non pregnant subjects||Age, Customized||years|Mean|29.4|29.4|Standard Deviation|5.1|5.1|||
4011995|NCT01193920|3832873|B1|Non pregnant subjects||Age, Customized||years|Mean|28.6|28.6|Standard Deviation|5.0|5.0|||
4011996|NCT01193907|3832932|B5|Belgium||Region of Enrollment||participants|Number|88|88.0||||||
4011997|NCT01193907|3832933|B4|Belgium||Region of Enrollment||participants|Number|22|22.0||||||
4011998|NCT01193907|3832934|B3|Belgium||Region of Enrollment||participants|Number|22|22.0||||||
4011999|NCT01193907|3832935|B2|Belgium||Region of Enrollment||participants|Number|22|22.0||||||
4012000|NCT01193907|3832936|B1|Belgium||Region of Enrollment||participants|Number|22|22.0||||||
4012001|NCT01193907|3832932|B5||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4012002|NCT01193907|3832933|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4012003|NCT01193907|3832934|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4012004|NCT01193907|3832935|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4012005|NCT01193907|3832936|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4012006|NCT01193907|3832932|B5||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4012007|NCT01193907|3832933|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4012008|NCT01193907|3832934|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4012009|NCT01193907|3832935|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4012010|NCT01193907|3832936|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4012011|NCT01193907|3832932|B5|||Age||years|Mean|24.1|24.1|Standard Deviation|5.3|5.3|||
4012012|NCT01193907|3832933|B4|||Age||years|Mean|23.8|23.8|Standard Deviation|5.5|5.5|||
4012013|NCT01193907|3832934|B3|||Age||years|Mean|24.0|24.0|Standard Deviation|5.7|5.7|||
4012014|NCT01193907|3832935|B2|||Age||years|Mean|24.3|24.3|Standard Deviation|5.4|5.4|||
4012015|NCT01193907|3832936|B1|||Age||years|Mean|24.3|24.3|Standard Deviation|4.9|4.9|||
4012016|NCT01193907|3832932|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4012017|NCT01193907|3832933|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4012018|NCT01193907|3832934|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4012019|NCT01193907|3832935|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4012020|NCT01193907|3832936|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4012021|NCT01193907|3832932|B5||Between 18 and 65 years|Age||Participants|Count of Participants|88|88.0||||||
4012022|NCT01193907|3832933|B4||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4012023|NCT01193907|3832934|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4012024|NCT01193907|3832935|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4012025|NCT01193907|3832936|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4012026|NCT01193907|3832932|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4012027|NCT01193907|3832933|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4012028|NCT01193907|3832934|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4012029|NCT01193907|3832935|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4012030|NCT01193907|3832936|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4012031|NCT01193868|3832961|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4012032|NCT01193868|3832961|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4012033|NCT01193868|3832961|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4012034|NCT01193868|3832961|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4012035|NCT01193868|3832961|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4012036|NCT01193868|3832961|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4012037|NCT01193868|3832961|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4012038|NCT01193868|3832961|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4012039|NCT01193868|3832961|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4012040|NCT01193868|3832961|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4012041|NCT01193868|3832961|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4012042|NCT01193868|3832961|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4012043|NCT01193868|3832961|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4012044|NCT01193868|3832961|B1|||Age||years|Median|65|65.0|Full Range|||52.0|75.0|
4012045|NCT01193842|3832973|B6|United States||Region of Enrollment||Participants|Count of Participants|103|103.0||||||
4012046|NCT01193842|3832974|B5|United States||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
4012047|NCT01193842|3832975|B4|United States||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
4012048|NCT01193842|3832976|B3|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4012049|NCT01193842|3832977|B2|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4012050|NCT01193842|3832978|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4012051|NCT01193842|3832973|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4012052|NCT01193842|3832974|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4012053|NCT01193842|3832975|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4012054|NCT01193842|3832976|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4012055|NCT01193842|3832977|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4012056|NCT01193842|3832978|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4012057|NCT01193842|3832973|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4012058|NCT01193842|3832974|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4012059|NCT01193842|3832975|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4012060|NCT01193842|3832976|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4012061|NCT01193842|3832977|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4012062|NCT01193842|3832978|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4012063|NCT01193842|3832973|B6||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4012064|NCT01193842|3832974|B5||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4012065|NCT01193842|3832975|B4||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4012066|NCT01193842|3832976|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4012067|NCT01193842|3832977|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4012068|NCT01193842|3832978|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4012069|NCT01193842|3832973|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4012070|NCT01193842|3832974|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4012071|NCT01193842|3832975|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4012072|NCT01193842|3832976|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4012073|NCT01193842|3832977|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4012074|NCT01193842|3832978|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4012075|NCT01193842|3832973|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4012076|NCT01193842|3832974|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4012077|NCT01193842|3832975|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4012078|NCT01193842|3832976|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4012079|NCT01193842|3832977|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4012080|NCT01193842|3832978|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4012081|NCT01193842|3832973|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4012082|NCT01193842|3832974|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4012083|NCT01193842|3832975|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4012084|NCT01193842|3832976|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4012085|NCT01193842|3832977|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4012086|NCT01193842|3832978|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4012087|NCT01193842|3832973|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4012088|NCT01193842|3832974|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4012089|NCT01193842|3832975|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4012090|NCT01193842|3832976|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4012091|NCT01193842|3832977|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4012092|NCT01193842|3832978|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4012093|NCT01193842|3832973|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4012094|NCT01193842|3832974|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4012095|NCT01193842|3832975|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4012096|NCT01193842|3832976|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4012097|NCT01193842|3832977|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4012098|NCT01193842|3832978|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4012099|NCT01193842|3832973|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4012100|NCT01193842|3832974|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4012101|NCT01193842|3832975|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4012102|NCT01193842|3832976|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4012103|NCT01193842|3832977|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4012104|NCT01193842|3832978|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4012105|NCT01193842|3832973|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4012106|NCT01193842|3832974|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4012107|NCT01193842|3832975|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4012108|NCT01193842|3832976|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4012109|NCT01193842|3832977|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4012110|NCT01193842|3832978|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4012111|NCT01193842|3832973|B6||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4012112|NCT01193842|3832974|B5||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4012113|NCT01193842|3832975|B4||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4012114|NCT01193842|3832976|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4012115|NCT01193842|3832977|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4012116|NCT01193842|3832978|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4012117|NCT01193842|3832973|B6||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4012118|NCT01193842|3832974|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4012119|NCT01193842|3832975|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4012120|NCT01193842|3832976|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4012121|NCT01193842|3832977|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4012122|NCT01193842|3832978|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4012123|NCT01193842|3832973|B6|||Age||years|Mean|47.2|47.2|Standard Deviation|9.8|9.8|||
4012124|NCT01193842|3832974|B5|||Age||years|Mean|45|45.0|Standard Deviation|9.2|9.2|||
4012125|NCT01193842|3832975|B4|||Age||years|Mean|49.2|49.2|Standard Deviation|10.1|10.1|||
4012126|NCT01193842|3832976|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|0|0.0|||
4012127|NCT01193842|3832977|B2|||Age||years|Mean|50.4|50.4|Standard Deviation|10.1|10.1|||
4012128|NCT01193842|3832978|B1|||Age||years|Mean|45.7|45.7|Standard Deviation|12.4|12.4|||
4012129|NCT01193686|3833015|B3|||Post Traumatic Growth Inventory|This measure assesses emotional/psychological growth acquired by surviving a traumatic experience. Elements of post-traumatic growth can include increased sense of self, deepened relationships, appreciation for life, increased spirituality. Possible scores range from 0-105 with higher scores indicating more growth.|units on a scale|Mean|NA||Full Range|||0.0|0.0|Only administered to Veteran Peer Visitors
4012130|NCT01193686|3833016|B2|||Post Traumatic Growth Inventory|This measure assesses emotional/psychological growth acquired by surviving a traumatic experience. Elements of post-traumatic growth can include increased sense of self, deepened relationships, appreciation for life, increased spirituality. Possible scores range from 0-105 with higher scores indicating more growth.|units on a scale|Mean|NA||Full Range|||0.0|0.0|This measure was not administered to Recipients of Peer Visitors
4012131|NCT01193686|3833017|B1|||Post Traumatic Growth Inventory|This measure assesses emotional/psychological growth acquired by surviving a traumatic experience. Elements of post-traumatic growth can include increased sense of self, deepened relationships, appreciation for life, increased spirituality. Possible scores range from 0-105 with higher scores indicating more growth.|units on a scale|Mean|64.6|64.6|Full Range|||23.0|98.0|
4012154|NCT01193660|3833033|B3|Korea, Republic of||Region of Enrollment||participants|Number|34|34.0||||||
4012155|NCT01193660|3833034|B2|Korea, Republic of||Region of Enrollment||participants|Number|36|36.0||||||
4012132|NCT01193686|3833015|B3|||Patient Activation|This measure was based on the Patient Activation Measure, and included 13 items reflecting self-efficacy for managing health/health care, active engagement in health care, and knowledge of health condition and treatment options. Possible scores ranged from 0-52, with higher scores indicating higher levels of efficacy, activation, and knowledge.|units on a scale|Mean|NA||Full Range|||0.0|0.0|Only administered to Recipients of Peer VIsitors
4012133|NCT01193686|3833016|B2|||Patient Activation|This measure was based on the Patient Activation Measure, and included 13 items reflecting self-efficacy for managing health/health care, active engagement in health care, and knowledge of health condition and treatment options. Possible scores ranged from 0-52, with higher scores indicating higher levels of efficacy, activation, and knowledge.|units on a scale|Mean|39|39.0|Full Range|||14.0|43.0|
4012134|NCT01193686|3833017|B1|||Patient Activation|This measure was based on the Patient Activation Measure, and included 13 items reflecting self-efficacy for managing health/health care, active engagement in health care, and knowledge of health condition and treatment options. Possible scores ranged from 0-52, with higher scores indicating higher levels of efficacy, activation, and knowledge.|units on a scale|Mean|NA||Full Range|||0.0|0.0|This measure was not administered to Veteran Peer Visitors
4012135|NCT01193686|3833015|B3|||PTSD check-list (PCL) Military Version|"The PCL-M assesses the degree to which each of the 17 symptoms of PTSD outlined in the DSM-IV have been experienced in the past month. Possible response options range from 1 = not at all to 5 = extremely. The scale also includes two questions that ask about the presence of traumatic events: When the event(s) occurred, did you feel terrified? and When the event(s) occurred, did you feel helpless?, with the same response options. Total possible scores range from 19-95, with higher scores indicating greater PTSD symptomatology."|units on a scale|Mean|56|56.0|Full Range|||21.0|82.0|
4012136|NCT01193686|3833016|B2|||PTSD check-list (PCL) Military Version|"The PCL-M assesses the degree to which each of the 17 symptoms of PTSD outlined in the DSM-IV have been experienced in the past month. Possible response options range from 1 = not at all to 5 = extremely. The scale also includes two questions that ask about the presence of traumatic events: When the event(s) occurred, did you feel terrified? and When the event(s) occurred, did you feel helpless?, with the same response options. Total possible scores range from 19-95, with higher scores indicating greater PTSD symptomatology."|units on a scale|Mean|68|68.0|Full Range|||53.0|82.0|
4012137|NCT01193686|3833017|B1|||PTSD check-list (PCL) Military Version|"The PCL-M assesses the degree to which each of the 17 symptoms of PTSD outlined in the DSM-IV have been experienced in the past month. Possible response options range from 1 = not at all to 5 = extremely. The scale also includes two questions that ask about the presence of traumatic events: When the event(s) occurred, did you feel terrified? and When the event(s) occurred, did you feel helpless?, with the same response options. Total possible scores range from 19-95, with higher scores indicating greater PTSD symptomatology."|units on a scale|Mean|34|34.0|Full Range|||21.0|46.0|
4012138|NCT01193686|3833015|B3|||Self-Reported Anger|"This measure was developed for this study and included 5 items measuring how angry you have felt in the last month. Sample items include: I feel out of control with my anger and I'm so angry I feel like yelling or cursing at someone. Response options ranged from 1 = strongly disagree to 7 = strongly agree. Possible total scores ranged from 5 to 35 with higher scores indicating greater feelings of anger."|units on a scale|Mean|NA||Full Range|||0.0|0.0|Only administered to Recipients of Peer Visitors
4012139|NCT01193686|3833016|B2|||Self-Reported Anger|"This measure was developed for this study and included 5 items measuring how angry you have felt in the last month. Sample items include: I feel out of control with my anger and I'm so angry I feel like yelling or cursing at someone. Response options ranged from 1 = strongly disagree to 7 = strongly agree. Possible total scores ranged from 5 to 35 with higher scores indicating greater feelings of anger."|units on a scale|Mean|28.5|28.5|Full Range|||17.0|35.0|
4012140|NCT01193686|3833017|B1|||Self-Reported Anger|"This measure was developed for this study and included 5 items measuring how angry you have felt in the last month. Sample items include: I feel out of control with my anger and I'm so angry I feel like yelling or cursing at someone. Response options ranged from 1 = strongly disagree to 7 = strongly agree. Possible total scores ranged from 5 to 35 with higher scores indicating greater feelings of anger."|units on a scale|Mean|NA||Full Range|||0.0|0.0|Not administered to Veteran Peer Visitors
4012141|NCT01193686|3833015|B3|||Patient Health Questionnaire-9|"The PHQ-9 assesses 9 symptoms of depression. Respondents are asked to indicate how often they have been bothered by each of the symptoms in the past two weeks, with response options ranging from 1 = not at all to 4 = nearly every day. Possible total scores range from 9 (no symptoms of depression) to 36 (most severe depressive symptoms)."|units on a scale|Mean|18.2|18.2|Full Range|||9.0|32.0|
4012142|NCT01193686|3833016|B2|||Patient Health Questionnaire-9|"The PHQ-9 assesses 9 symptoms of depression. Respondents are asked to indicate how often they have been bothered by each of the symptoms in the past two weeks, with response options ranging from 1 = not at all to 4 = nearly every day. Possible total scores range from 9 (no symptoms of depression) to 36 (most severe depressive symptoms)."|units on a scale|Mean|27.4|27.4|Full Range|||21.0|32.0|
4012143|NCT01193686|3833017|B1|||Patient Health Questionnaire-9|"The PHQ-9 assesses 9 symptoms of depression. Respondents are asked to indicate how often they have been bothered by each of the symptoms in the past two weeks, with response options ranging from 1 = not at all to 4 = nearly every day. Possible total scores range from 9 (no symptoms of depression) to 36 (most severe depressive symptoms)."|units on a scale|Mean|12|12.0|Full Range|||9.0|15.0|
4012144|NCT01193686|3833015|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4012145|NCT01193686|3833016|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4012146|NCT01193686|3833017|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4012147|NCT01193686|3833015|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4012148|NCT01193686|3833016|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4012149|NCT01193686|3833017|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4012150|NCT01193686|3833015|B3|||Age||years|Mean|35|35.0|Full Range|||23.0|62.0|
4012151|NCT01193686|3833016|B2|||Age||years|Mean|36.5|36.5|Full Range|||23.0|48.0|
4012152|NCT01193686|3833017|B1|||Age||years|Mean|34.1|34.1|Full Range|||26.0|62.0|
4012153|NCT01193660|3833032|B4|Korea, Republic of||Region of Enrollment||participants|Number|105|105.0||||||
4012156|NCT01193660|3833035|B1|Korea, Republic of||Region of Enrollment||participants|Number|35|35.0||||||
4012157|NCT01193660|3833032|B4||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4012158|NCT01193660|3833033|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4012159|NCT01193660|3833034|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4012160|NCT01193660|3833035|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4012161|NCT01193660|3833032|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4012162|NCT01193660|3833033|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4012163|NCT01193660|3833034|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4012164|NCT01193660|3833035|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4012165|NCT01193660|3833032|B4|||Age||months|Mean|47.30|47.3|Standard Deviation|21.07|21.07|||
4012166|NCT01193660|3833033|B3|||Age||months|Mean|46.0|46.0|Standard Deviation|19.58|19.58|||
4012167|NCT01193660|3833034|B2|||Age||months|Mean|50.05|50.05|Standard Deviation|24.45|24.45|||
4012168|NCT01193660|3833035|B1|||Age||months|Mean|45.71|45.71|Standard Deviation|18.91|18.91|||
4012169|NCT01193660|3833032|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4012170|NCT01193660|3833033|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4012171|NCT01193660|3833034|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4012172|NCT01193660|3833035|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4012173|NCT01193660|3833032|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4012174|NCT01193660|3833033|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4012175|NCT01193660|3833034|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4012176|NCT01193660|3833035|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4012177|NCT01193660|3833032|B4||<=18 years|Age||Participants|Count of Participants|105|105.0||||||
4012178|NCT01193660|3833033|B3||<=18 years|Age||Participants|Count of Participants|34|34.0||||||
4012179|NCT01193660|3833034|B2||<=18 years|Age||Participants|Count of Participants|36|36.0||||||
4012180|NCT01193660|3833035|B1||<=18 years|Age||Participants|Count of Participants|35|35.0||||||
4012181|NCT01193608|3833075|B7|Asian||Race/Ethnicity, Customized||Participants|Number|38|38.0||||||
4012182|NCT01193608|3833076|B6|Asian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4012183|NCT01193608|3833077|B5|Asian||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4012184|NCT01193608|3833078|B4|Asian||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4012185|NCT01193608|3833079|B3|Asian||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4012186|NCT01193608|3833080|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4012187|NCT01193608|3833081|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4012188|NCT01193608|3833075|B7|Black||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4012189|NCT01193608|3833076|B6|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4012190|NCT01193608|3833077|B5|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4012191|NCT01193608|3833078|B4|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4012192|NCT01193608|3833079|B3|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4012193|NCT01193608|3833080|B2|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4012194|NCT01193608|3833081|B1|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4012195|NCT01193608|3833075|B7|White||Race/Ethnicity, Customized||Participants|Number|41|41.0||||||
4012196|NCT01193608|3833076|B6|White||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4012197|NCT01193608|3833077|B5|White||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4012198|NCT01193608|3833078|B4|White||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4012199|NCT01193608|3833079|B3|White||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4012200|NCT01193608|3833080|B2|White||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4012201|NCT01193608|3833081|B1|White||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4012202|NCT01193608|3833075|B7||Male|Gender||Participants|Count of Participants|36|36.0||||||
4012203|NCT01193608|3833076|B6||Male|Gender||Participants|Count of Participants|11|11.0||||||
4012204|NCT01193608|3833077|B5||Male|Gender||Participants|Count of Participants|10|10.0||||||
4012205|NCT01193608|3833078|B4||Male|Gender||Participants|Count of Participants|8|8.0||||||
4012206|NCT01193608|3833079|B3||Male|Gender||Participants|Count of Participants|2|2.0||||||
4012207|NCT01193608|3833080|B2||Male|Gender||Participants|Count of Participants|3|3.0||||||
4012208|NCT01193608|3833081|B1||Male|Gender||Participants|Count of Participants|2|2.0||||||
4012209|NCT01193608|3833075|B7||Female|Gender||Participants|Count of Participants|52|52.0||||||
4012210|NCT01193608|3833076|B6||Female|Gender||Participants|Count of Participants|8|8.0||||||
4012211|NCT01193608|3833077|B5||Female|Gender||Participants|Count of Participants|14|14.0||||||
4012212|NCT01193608|3833078|B4||Female|Gender||Participants|Count of Participants|9|9.0||||||
4012213|NCT01193608|3833079|B3||Female|Gender||Participants|Count of Participants|14|14.0||||||
4012214|NCT01193608|3833080|B2||Female|Gender||Participants|Count of Participants|3|3.0||||||
4012215|NCT01193608|3833081|B1||Female|Gender||Participants|Count of Participants|4|4.0||||||
4012216|NCT01193608|3833075|B7|||Age||Years|Mean|68.6|68.6|Standard Deviation|8.8|8.8|||
4012217|NCT01193608|3833076|B6|||Age||Years|Mean|71.1|71.1|Standard Deviation|7.6|7.6|||
4012218|NCT01193608|3833077|B5|||Age||Years|Mean|64.5|64.5|Standard Deviation|7.6|7.6|||
4012219|NCT01193608|3833078|B4|||Age||Years|Mean|71.5|71.5|Standard Deviation|8.8|8.8|||
4012220|NCT01193608|3833079|B3|||Age||Years|Mean|70.7|70.7|Standard Deviation|10.8|10.8|||
4012221|NCT01193608|3833080|B2|||Age||Years|Mean|67.2|67.2|Standard Deviation|7.4|7.4|||
4012222|NCT01193608|3833081|B1|||Age||Years|Mean|64.5|64.5|Standard Deviation|6.4|6.4|||
4012223|NCT01193582|3833319|B5||Male|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4012224|NCT01193582|3833320|B4||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4012225|NCT01193582|3833321|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4012226|NCT01193582|3833322|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4012227|NCT01193582|3833323|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4012228|NCT01193582|3833319|B5||Female|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
4012229|NCT01193582|3833320|B4||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4012230|NCT01193582|3833321|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4012231|NCT01193582|3833322|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4012232|NCT01193582|3833323|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4012233|NCT01193582|3833319|B5|||Age|Age at first Vaccination|Months|Mean|24.0|24.0|Standard Deviation|18.5|18.5|||
4012234|NCT01193582|3833320|B4|||Age|Age at first Vaccination|Months|Mean|44.5|44.5|Standard Deviation|13.0|13.0|||
4012235|NCT01193582|3833321|B3|||Age|Age at first Vaccination|Months|Mean|17.5|17.5|Standard Deviation|4.2|4.2|||
4012236|NCT01193582|3833322|B2|||Age|Age at first Vaccination|Months|Mean|9.8|9.8|Standard Deviation|1.4|1.4|||
4012237|NCT01193582|3833323|B1|||Age|Age at first Vaccination|Months|Mean|5.3|5.3|Standard Deviation|0.9|0.9|||
4012238|NCT01193556|3833354|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
4012239|NCT01193556|3833355|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4012240|NCT01193556|3833356|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4012241|NCT01193556|3833354|B3|Male||Gender||partipants|Number|0|0.0||||||
4012242|NCT01193556|3833355|B2|Male||Gender||partipants|Number|NA|||||||An integrity audit found that the data for this study could not be analyzed owing to unverifiable source documentation.
4012243|NCT01193556|3833356|B1|Male||Gender||partipants|Number|NA|||||||An integrity audit found that the data for this study could not be analyzed owing to unverifiable source documentation.
4012244|NCT01193556|3833354|B3|Female||Gender||partipants|Number|0|0.0||||||
4012245|NCT01193556|3833355|B2|Female||Gender||partipants|Number|NA|||||||An integrity audit found that the data for this study could not be analyzed owing to unverifiable source documentation.
4012246|NCT01193556|3833356|B1|Female||Gender||partipants|Number|NA|||||||An integrity audit found that the data for this study could not be analyzed owing to unverifiable source documentation.
4012247|NCT01193556|3833354|B3|Adults (18 years and older)||Age, Customized||participants|Number|24|24.0||||||
4012248|NCT01193556|3833355|B2|Adults (18 years and older)||Age, Customized||participants|Number|12|12.0||||||
4012249|NCT01193556|3833356|B1|Adults (18 years and older)||Age, Customized||participants|Number|12|12.0||||||
4012250|NCT01193556|3833354|B3|Children (3-17 years)||Age, Customized||participants|Number|27|27.0||||||
4012251|NCT01193556|3833355|B2|Children (3-17 years)||Age, Customized||participants|Number|13|13.0||||||
4012252|NCT01193556|3833356|B1|Children (3-17 years)||Age, Customized||participants|Number|14|14.0||||||
4012253|NCT01193348|3833365|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4012254|NCT01193348|3833365|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4012255|NCT01193348|3833365|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4012256|NCT01193348|3833365|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4012257|NCT01193348|3833365|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4012258|NCT01193348|3833365|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4012259|NCT01193348|3833365|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4012260|NCT01193348|3833365|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4012261|NCT01193348|3833365|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4012262|NCT01193348|3833365|B1|||Age||Years|Mean|6.6|6.6|Standard Deviation|6.06|6.06|||
4012263|NCT01193335|3833383|B3||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4012264|NCT01193335|3833384|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4012265|NCT01193335|3833385|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4012266|NCT01193335|3833383|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4012267|NCT01193335|3833384|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4012268|NCT01193335|3833385|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4012269|NCT01193335|3833383|B3|||Age||months|Mean|1.7|1.7|Standard Deviation|0.6|0.6|||
4012270|NCT01193335|3833384|B2|||Age||months|Mean|1.5|1.5|Standard Deviation|0.5|0.5|||
4012271|NCT01193335|3833385|B1|||Age||months|Mean|1.8|1.8|Standard Deviation|0.6|0.6|||
4012272|NCT01193283|3833481|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4012273|NCT01193283|3833481|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4012274|NCT01193283|3833481|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4012275|NCT01193283|3833481|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4012276|NCT01193283|3833481|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4012277|NCT01193283|3833481|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4012278|NCT01193283|3833481|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4012279|NCT01193283|3833481|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4012280|NCT01193283|3833481|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4012281|NCT01193257|3833485|B3|||Body mass index (BMI)|BMI data was available for 1095 participants as follows: n= 364, 731.|kilogram per square meter (kg/m^2)|Mean|27.54|27.54|Standard Deviation|4.418|4.418|||
4012282|NCT01193257|3833486|B2|||Body mass index (BMI)|BMI data was available for 1095 participants as follows: n= 364, 731.|kilogram per square meter (kg/m^2)|Mean|27.73|27.73|Standard Deviation|4.370|4.37|||
4012283|NCT01193257|3833487|B1|||Body mass index (BMI)|BMI data was available for 1095 participants as follows: n= 364, 731.|kilogram per square meter (kg/m^2)|Mean|27.14|27.14|Standard Deviation|4.491|4.491|||
4012284|NCT01193257|3833485|B3|||Weight|Weight data was available for 1098 participants as follows: n= 365, 733.|kilogram (kg)|Mean|81.80|81.8|Standard Deviation|15.249|15.249|||
4012285|NCT01193257|3833486|B2|||Weight|Weight data was available for 1098 participants as follows: n= 365, 733.|kilogram (kg)|Mean|82.77|82.77|Standard Deviation|15.200|15.2|||
4012286|NCT01193257|3833487|B1|||Weight|Weight data was available for 1098 participants as follows: n= 365, 733.|kilogram (kg)|Mean|79.85|79.85|Standard Deviation|15.183|15.183|||
4012287|NCT01193257|3833485|B3|||Height|Height data was available for 1096 participants as follows: n= 364, 732.|centimeter (cm)|Mean|172.12|172.12|Standard Deviation|7.350|7.35|||
4012288|NCT01193257|3833486|B2|||Height|Height data was available for 1096 participants as follows: n= 364, 732.|centimeter (cm)|Mean|172.52|172.52|Standard Deviation|7.156|7.156|||
4012289|NCT01193257|3833487|B1|||Height|Height data was available for 1096 participants as follows: n= 364, 732.|centimeter (cm)|Mean|171.33|171.33|Standard Deviation|7.675|7.675|||
4012290|NCT01193257|3833485|B3|Korea, Republic Of||Region of Enrollment||participants|Number|33|33.0||||||
4012291|NCT01193257|3833486|B2|Korea, Republic Of||Region of Enrollment||participants|Number|18|18.0||||||
4012292|NCT01193257|3833487|B1|Korea, Republic Of||Region of Enrollment||participants|Number|15|15.0||||||
4012293|NCT01193257|3833485|B3|Taiwan, Province Of China||Region of Enrollment||participants|Number|14|14.0||||||
4012294|NCT01193257|3833486|B2|Taiwan, Province Of China||Region of Enrollment||participants|Number|7|7.0||||||
4012295|NCT01193257|3833487|B1|Taiwan, Province Of China||Region of Enrollment||participants|Number|7|7.0||||||
4012296|NCT01193257|3833485|B3|South Africa||Region of Enrollment||participants|Number|18|18.0||||||
4012297|NCT01193257|3833486|B2|South Africa||Region of Enrollment||participants|Number|14|14.0||||||
4012298|NCT01193257|3833487|B1|South Africa||Region of Enrollment||participants|Number|4|4.0||||||
4012299|NCT01193257|3833485|B3|Singapore||Region of Enrollment||participants|Number|2|2.0||||||
4012300|NCT01193257|3833486|B2|Singapore||Region of Enrollment||participants|Number|1|1.0||||||
4012301|NCT01193257|3833487|B1|Singapore||Region of Enrollment||participants|Number|1|1.0||||||
4012302|NCT01193257|3833485|B3|New Zealand||Region of Enrollment||participants|Number|12|12.0||||||
4012303|NCT01193257|3833486|B2|New Zealand||Region of Enrollment||participants|Number|6|6.0||||||
4012304|NCT01193257|3833487|B1|New Zealand||Region of Enrollment||participants|Number|6|6.0||||||
4012305|NCT01193257|3833485|B3|Mexico||Region of Enrollment||participants|Number|5|5.0||||||
4012306|NCT01193257|3833486|B2|Mexico||Region of Enrollment||participants|Number|4|4.0||||||
4012307|NCT01193257|3833487|B1|Mexico||Region of Enrollment||participants|Number|1|1.0||||||
4012308|NCT01193257|3833485|B3|Japan||Region of Enrollment||participants|Number|50|50.0||||||
4012309|NCT01193257|3833486|B2|Japan||Region of Enrollment||participants|Number|33|33.0||||||
4012310|NCT01193257|3833487|B1|Japan||Region of Enrollment||participants|Number|17|17.0||||||
4012311|NCT01193257|3833485|B3|Israel||Region of Enrollment||participants|Number|14|14.0||||||
4012312|NCT01193257|3833486|B2|Israel||Region of Enrollment||participants|Number|9|9.0||||||
4012313|NCT01193257|3833487|B1|Israel||Region of Enrollment||participants|Number|5|5.0||||||
4012314|NCT01193257|3833485|B3|Colombia||Region of Enrollment||participants|Number|4|4.0||||||
4012315|NCT01193257|3833486|B2|Colombia||Region of Enrollment||participants|Number|4|4.0||||||
4012316|NCT01193257|3833487|B1|Colombia||Region of Enrollment||participants|Number|0|0.0||||||
4012317|NCT01193257|3833485|B3|China||Region of Enrollment||participants|Number|11|11.0||||||
4012318|NCT01193257|3833486|B2|China||Region of Enrollment||participants|Number|6|6.0||||||
4012319|NCT01193257|3833487|B1|China||Region of Enrollment||participants|Number|5|5.0||||||
4012320|NCT01193257|3833485|B3|Chile||Region of Enrollment||participants|Number|12|12.0||||||
4012321|NCT01193257|3833486|B2|Chile||Region of Enrollment||participants|Number|7|7.0||||||
4012322|NCT01193257|3833487|B1|Chile||Region of Enrollment||participants|Number|5|5.0||||||
4012323|NCT01193257|3833485|B3|Brazil||Region of Enrollment||participants|Number|119|119.0||||||
4012324|NCT01193257|3833486|B2|Brazil||Region of Enrollment||participants|Number|82|82.0||||||
4012325|NCT01193257|3833487|B1|Brazil||Region of Enrollment||participants|Number|37|37.0||||||
4012326|NCT01193257|3833485|B3|Australia||Region of Enrollment||participants|Number|94|94.0||||||
4012327|NCT01193257|3833486|B2|Australia||Region of Enrollment||participants|Number|66|66.0||||||
4012328|NCT01193257|3833487|B1|Australia||Region of Enrollment||participants|Number|28|28.0||||||
4012329|NCT01193257|3833485|B3|Argentina||Region of Enrollment||participants|Number|9|9.0||||||
4012330|NCT01193257|3833486|B2|Argentina||Region of Enrollment||participants|Number|8|8.0||||||
4012331|NCT01193257|3833487|B1|Argentina||Region of Enrollment||participants|Number|1|1.0||||||
4012332|NCT01193257|3833485|B3|United Kingdom||Region of Enrollment||participants|Number|107|107.0||||||
4012333|NCT01193257|3833486|B2|United Kingdom||Region of Enrollment||participants|Number|75|75.0||||||
4012334|NCT01193257|3833487|B1|United Kingdom||Region of Enrollment||participants|Number|32|32.0||||||
4012335|NCT01193257|3833485|B3|Switzerland||Region of Enrollment||participants|Number|3|3.0||||||
4012336|NCT01193257|3833486|B2|Switzerland||Region of Enrollment||participants|Number|2|2.0||||||
4012337|NCT01193257|3833487|B1|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4012338|NCT01193257|3833485|B3|Sweden||Region of Enrollment||participants|Number|26|26.0||||||
4012339|NCT01193257|3833486|B2|Sweden||Region of Enrollment||participants|Number|16|16.0||||||
4012340|NCT01193257|3833487|B1|Sweden||Region of Enrollment||participants|Number|10|10.0||||||
4012341|NCT01193257|3833485|B3|Spain||Region of Enrollment||participants|Number|41|41.0||||||
4012342|NCT01193257|3833486|B2|Spain||Region of Enrollment||participants|Number|25|25.0||||||
4012343|NCT01193257|3833487|B1|Spain||Region of Enrollment||participants|Number|16|16.0||||||
4012344|NCT01193257|3833485|B3|Slovakia||Region of Enrollment||participants|Number|15|15.0||||||
4012345|NCT01193257|3833486|B2|Slovakia||Region of Enrollment||participants|Number|10|10.0||||||
4012346|NCT01193257|3833487|B1|Slovakia||Region of Enrollment||participants|Number|5|5.0||||||
4012347|NCT01193257|3833485|B3|Serbia||Region of Enrollment||participants|Number|4|4.0||||||
4012348|NCT01193257|3833486|B2|Serbia||Region of Enrollment||participants|Number|3|3.0||||||
4012349|NCT01193257|3833487|B1|Serbia||Region of Enrollment||participants|Number|1|1.0||||||
4012350|NCT01193257|3833485|B3|Russia||Region of Enrollment||participants|Number|4|4.0||||||
4012351|NCT01193257|3833486|B2|Russia||Region of Enrollment||participants|Number|2|2.0||||||
4012352|NCT01193257|3833487|B1|Russia||Region of Enrollment||participants|Number|2|2.0||||||
4012353|NCT01193257|3833485|B3|Poland||Region of Enrollment||participants|Number|22|22.0||||||
4012354|NCT01193257|3833486|B2|Poland||Region of Enrollment||participants|Number|17|17.0||||||
4012355|NCT01193257|3833487|B1|Poland||Region of Enrollment||participants|Number|5|5.0||||||
4012356|NCT01193257|3833485|B3|Netherlands||Region of Enrollment||participants|Number|18|18.0||||||
4012357|NCT01193257|3833486|B2|Netherlands||Region of Enrollment||participants|Number|12|12.0||||||
4012358|NCT01193257|3833487|B1|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
4012359|NCT01193257|3833485|B3|Lithuania||Region of Enrollment||participants|Number|31|31.0||||||
4012360|NCT01193257|3833486|B2|Lithuania||Region of Enrollment||participants|Number|22|22.0||||||
4012361|NCT01193257|3833487|B1|Lithuania||Region of Enrollment||participants|Number|9|9.0||||||
4012362|NCT01193257|3833485|B3|Czech Republic||Region of Enrollment||participants|Number|2|2.0||||||
4012363|NCT01193257|3833486|B2|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
4012364|NCT01193257|3833487|B1|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
4012365|NCT01193257|3833485|B3|Croatia||Region of Enrollment||participants|Number|3|3.0||||||
4012366|NCT01193257|3833486|B2|Croatia||Region of Enrollment||participants|Number|3|3.0||||||
4012367|NCT01193257|3833487|B1|Croatia||Region of Enrollment||participants|Number|0|0.0||||||
4012368|NCT01193257|3833485|B3|Romania||Region of Enrollment||participants|Number|12|12.0||||||
4012369|NCT01193257|3833486|B2|Romania||Region of Enrollment||participants|Number|12|12.0||||||
4012370|NCT01193257|3833487|B1|Romania||Region of Enrollment||participants|Number|0|0.0||||||
4012371|NCT01193257|3833485|B3|Portugal||Region of Enrollment||participants|Number|16|16.0||||||
4012372|NCT01193257|3833486|B2|Portugal||Region of Enrollment||participants|Number|8|8.0||||||
4012373|NCT01193257|3833487|B1|Portugal||Region of Enrollment||participants|Number|8|8.0||||||
4012374|NCT01193257|3833485|B3|Italy||Region of Enrollment||participants|Number|21|21.0||||||
4012375|NCT01193257|3833486|B2|Italy||Region of Enrollment||participants|Number|14|14.0||||||
4012376|NCT01193257|3833487|B1|Italy||Region of Enrollment||participants|Number|7|7.0||||||
4012377|NCT01193257|3833485|B3|Ireland||Region of Enrollment||participants|Number|9|9.0||||||
4012378|NCT01193257|3833486|B2|Ireland||Region of Enrollment||participants|Number|6|6.0||||||
4012379|NCT01193257|3833487|B1|Ireland||Region of Enrollment||participants|Number|3|3.0||||||
4012380|NCT01193257|3833485|B3|Hungary||Region of Enrollment||participants|Number|9|9.0||||||
4012381|NCT01193257|3833486|B2|Hungary||Region of Enrollment||participants|Number|7|7.0||||||
4012382|NCT01193257|3833487|B1|Hungary||Region of Enrollment||participants|Number|2|2.0||||||
4012383|NCT01193257|3833485|B3|Greece||Region of Enrollment||participants|Number|60|60.0||||||
4012384|NCT01193257|3833486|B2|Greece||Region of Enrollment||participants|Number|38|38.0||||||
4012385|NCT01193257|3833487|B1|Greece||Region of Enrollment||participants|Number|22|22.0||||||
4012386|NCT01193257|3833485|B3|Germany||Region of Enrollment||participants|Number|46|46.0||||||
4012387|NCT01193257|3833486|B2|Germany||Region of Enrollment||participants|Number|35|35.0||||||
4012388|NCT01193257|3833487|B1|Germany||Region of Enrollment||participants|Number|11|11.0||||||
4012389|NCT01193257|3833485|B3|France||Region of Enrollment||participants|Number|79|79.0||||||
4012390|NCT01193257|3833486|B2|France||Region of Enrollment||participants|Number|44|44.0||||||
4012391|NCT01193257|3833487|B1|France||Region of Enrollment||participants|Number|35|35.0||||||
4012392|NCT01193257|3833485|B3|Finland||Region of Enrollment||participants|Number|11|11.0||||||
4012393|NCT01193257|3833486|B2|Finland||Region of Enrollment||participants|Number|7|7.0||||||
4012394|NCT01193257|3833487|B1|Finland||Region of Enrollment||participants|Number|4|4.0||||||
4012395|NCT01193257|3833485|B3|Estonia||Region of Enrollment||participants|Number|5|5.0||||||
4012396|NCT01193257|3833486|B2|Estonia||Region of Enrollment||participants|Number|2|2.0||||||
4012397|NCT01193257|3833487|B1|Estonia||Region of Enrollment||participants|Number|3|3.0||||||
4012398|NCT01193257|3833485|B3|Bulgaria||Region of Enrollment||participants|Number|4|4.0||||||
4012399|NCT01193257|3833486|B2|Bulgaria||Region of Enrollment||participants|Number|3|3.0||||||
4012400|NCT01193257|3833487|B1|Bulgaria||Region of Enrollment||participants|Number|1|1.0||||||
4012401|NCT01193257|3833485|B3|Belgium||Region of Enrollment||participants|Number|13|13.0||||||
4012402|NCT01193257|3833486|B2|Belgium||Region of Enrollment||participants|Number|12|12.0||||||
4012403|NCT01193257|3833487|B1|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4012404|NCT01193257|3833485|B3|Belarus||Region of Enrollment||participants|Number|10|10.0||||||
4012405|NCT01193257|3833486|B2|Belarus||Region of Enrollment||participants|Number|4|4.0||||||
4012406|NCT01193257|3833487|B1|Belarus||Region of Enrollment||participants|Number|6|6.0||||||
4012407|NCT01193257|3833485|B3|Austria||Region of Enrollment||participants|Number|19|19.0||||||
4012408|NCT01193257|3833486|B2|Austria||Region of Enrollment||participants|Number|14|14.0||||||
4012409|NCT01193257|3833487|B1|Austria||Region of Enrollment||participants|Number|5|5.0||||||
4012410|NCT01193257|3833485|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
4012411|NCT01193257|3833486|B2|United States||Region of Enrollment||participants|Number|54|54.0||||||
4012412|NCT01193257|3833487|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4012413|NCT01193257|3833485|B3|Canada||Region of Enrollment||participants|Number|32|32.0||||||
4012414|NCT01193257|3833486|B2|Canada||Region of Enrollment||participants|Number|21|21.0||||||
4012415|NCT01193257|3833487|B1|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4012416|NCT01193257|3833485|B3|Other||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4012417|NCT01193257|3833486|B2|Other||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4012418|NCT01193257|3833487|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4012419|NCT01193257|3833485|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4012420|NCT01193257|3833486|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4012421|NCT01193257|3833487|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4012422|NCT01193257|3833485|B3|White||Race/Ethnicity, Customized||participants|Number|925|925.0||||||
4012423|NCT01193257|3833486|B2|White||Race/Ethnicity, Customized||participants|Number|620|620.0||||||
4012424|NCT01193257|3833487|B1|White||Race/Ethnicity, Customized||participants|Number|305|305.0||||||
4012425|NCT01193257|3833485|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4012426|NCT01193257|3833486|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4012427|NCT01193257|3833487|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4012428|NCT01193257|3833485|B3|Asian||Race/Ethnicity, Customized||participants|Number|125|125.0||||||
4012429|NCT01193257|3833486|B2|Asian||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
4012430|NCT01193257|3833487|B1|Asian||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
4012431|NCT01193257|3833485|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4012432|NCT01193257|3833486|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4012433|NCT01193257|3833487|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4012434|NCT01193257|3833485|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4012435|NCT01193257|3833486|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4012436|NCT01193257|3833487|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4012437|NCT01193257|3833485|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|890|890.0||||||
4012438|NCT01193257|3833486|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|588|588.0||||||
4012439|NCT01193257|3833487|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|302|302.0||||||
4012440|NCT01193257|3833485|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|152|152.0||||||
4012441|NCT01193257|3833486|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
4012442|NCT01193257|3833487|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4012443|NCT01193257|3833485|B3||Male|Sex: Female, Male||Participants|Count of Participants|1099|1099.0||||||
4012444|NCT01193257|3833486|B2||Male|Sex: Female, Male||Participants|Count of Participants|734|734.0||||||
4012445|NCT01193257|3833487|B1||Male|Sex: Female, Male||Participants|Count of Participants|365|365.0||||||
4012446|NCT01193257|3833485|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4012447|NCT01193257|3833486|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4012448|NCT01193257|3833487|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4012449|NCT01193257|3833485|B3|||Age||years|Mean|69.3|69.3|Standard Deviation|7.86|7.86|||
4012450|NCT01193257|3833486|B2|||Age||years|Mean|69.2|69.2|Standard Deviation|7.82|7.82|||
4012451|NCT01193257|3833487|B1|||Age||years|Mean|69.4|69.4|Standard Deviation|7.95|7.95|||
4012452|NCT01193244|3833536|B3|||Body Mass Index (BMI)|BMI data was available for 1557 participants as follows: n= 777, 780.|kilogram per square meter (kg/m^2)|Mean|28.19|28.19|Standard Deviation|4.690|4.69|||
4012453|NCT01193244|3833537|B2|||Body Mass Index (BMI)|BMI data was available for 1557 participants as follows: n= 777, 780.|kilogram per square meter (kg/m^2)|Mean|28.28|28.28|Standard Deviation|4.730|4.73|||
4012454|NCT01193244|3833538|B1|||Body Mass Index (BMI)|BMI data was available for 1557 participants as follows: n= 777, 780.|kilogram per square meter (kg/m^2)|Mean|28.09|28.09|Standard Deviation|4.651|4.651|||
4012455|NCT01193244|3833536|B3|||Weight|Weight data was available for 1559 participants as follows: n= 778, 781.|kilogram|Mean|84.57|84.57|Standard Deviation|16.071|16.071|||
4012456|NCT01193244|3833537|B2|||Weight|Weight data was available for 1559 participants as follows: n= 778, 781.|kilogram|Mean|85.09|85.09|Standard Deviation|16.286|16.286|||
4012457|NCT01193244|3833538|B1|||Weight|Weight data was available for 1559 participants as follows: n= 778, 781.|kilogram|Mean|84.04|84.04|Standard Deviation|15.846|15.846|||
4012458|NCT01193244|3833536|B3|||Height|Height data was available for 1558 participants as follows: n= 778, 780.|centimeter|Mean|173.02|173.02|Standard Deviation|7.675|7.675|||
4012459|NCT01193244|3833537|B2|||Height|Height data was available for 1558 participants as follows: n= 778, 780.|centimeter|Mean|173.26|173.26|Standard Deviation|7.858|7.858|||
4012460|NCT01193244|3833538|B1|||Height|Height data was available for 1558 participants as follows: n= 778, 780.|centimeter|Mean|172.77|172.77|Standard Deviation|7.485|7.485|||
4012461|NCT01193244|3833536|B3|Russia||Region of Enrollment||participants|Number|11|11.0||||||
4012462|NCT01193244|3833537|B2|Russia||Region of Enrollment||participants|Number|5|5.0||||||
4012463|NCT01193244|3833538|B1|Russia||Region of Enrollment||participants|Number|6|6.0||||||
4012464|NCT01193244|3833536|B3|Taiwan, Province Of China||Region of Enrollment||participants|Number|22|22.0||||||
4012465|NCT01193244|3833537|B2|Taiwan, Province Of China||Region of Enrollment||participants|Number|10|10.0||||||
4012466|NCT01193244|3833538|B1|Taiwan, Province Of China||Region of Enrollment||participants|Number|12|12.0||||||
4012467|NCT01193244|3833536|B3|South Africa||Region of Enrollment||participants|Number|10|10.0||||||
4012468|NCT01193244|3833537|B2|South Africa||Region of Enrollment||participants|Number|4|4.0||||||
4012469|NCT01193244|3833538|B1|South Africa||Region of Enrollment||participants|Number|6|6.0||||||
4012470|NCT01193244|3833536|B3|Singapore||Region of Enrollment||participants|Number|7|7.0||||||
4012471|NCT01193244|3833537|B2|Singapore||Region of Enrollment||participants|Number|2|2.0||||||
4012472|NCT01193244|3833538|B1|Singapore||Region of Enrollment||participants|Number|5|5.0||||||
4012473|NCT01193244|3833536|B3|Puerto Rico||Region of Enrollment||participants|Number|2|2.0||||||
4012474|NCT01193244|3833537|B2|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
4012475|NCT01193244|3833538|B1|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
4012476|NCT01193244|3833536|B3|Peru||Region of Enrollment||participants|Number|16|16.0||||||
4012477|NCT01193244|3833537|B2|Peru||Region of Enrollment||participants|Number|10|10.0||||||
4012478|NCT01193244|3833538|B1|Peru||Region of Enrollment||participants|Number|6|6.0||||||
4012479|NCT01193244|3833536|B3|New Zealand||Region of Enrollment||participants|Number|51|51.0||||||
4012480|NCT01193244|3833537|B2|New Zealand||Region of Enrollment||participants|Number|26|26.0||||||
4012481|NCT01193244|3833538|B1|New Zealand||Region of Enrollment||participants|Number|25|25.0||||||
4012482|NCT01193244|3833536|B3|Mexico||Region of Enrollment||participants|Number|16|16.0||||||
4012483|NCT01193244|3833537|B2|Mexico||Region of Enrollment||participants|Number|9|9.0||||||
4012484|NCT01193244|3833538|B1|Mexico||Region of Enrollment||participants|Number|7|7.0||||||
4012485|NCT01193244|3833536|B3|Japan||Region of Enrollment||participants|Number|40|40.0||||||
4012486|NCT01193244|3833537|B2|Japan||Region of Enrollment||participants|Number|18|18.0||||||
4012487|NCT01193244|3833538|B1|Japan||Region of Enrollment||participants|Number|22|22.0||||||
4012488|NCT01193244|3833536|B3|Israel||Region of Enrollment||participants|Number|18|18.0||||||
4012489|NCT01193244|3833537|B2|Israel||Region of Enrollment||participants|Number|4|4.0||||||
4012490|NCT01193244|3833538|B1|Israel||Region of Enrollment||participants|Number|14|14.0||||||
4012491|NCT01193244|3833536|B3|Hong Kong||Region of Enrollment||participants|Number|4|4.0||||||
4012492|NCT01193244|3833537|B2|Hong Kong||Region of Enrollment||participants|Number|3|3.0||||||
4012493|NCT01193244|3833538|B1|Hong Kong||Region of Enrollment||participants|Number|1|1.0||||||
4012494|NCT01193244|3833536|B3|Colombia||Region of Enrollment||participants|Number|9|9.0||||||
4012495|NCT01193244|3833537|B2|Colombia||Region of Enrollment||participants|Number|6|6.0||||||
4012496|NCT01193244|3833538|B1|Colombia||Region of Enrollment||participants|Number|3|3.0||||||
4012497|NCT01193244|3833536|B3|Chile||Region of Enrollment||participants|Number|40|40.0||||||
4012498|NCT01193244|3833537|B2|Chile||Region of Enrollment||participants|Number|20|20.0||||||
4012499|NCT01193244|3833538|B1|Chile||Region of Enrollment||participants|Number|20|20.0||||||
4012500|NCT01193244|3833536|B3|Brazil||Region of Enrollment||participants|Number|91|91.0||||||
4012501|NCT01193244|3833537|B2|Brazil||Region of Enrollment||participants|Number|50|50.0||||||
4012502|NCT01193244|3833538|B1|Brazil||Region of Enrollment||participants|Number|41|41.0||||||
4012503|NCT01193244|3833536|B3|Australia||Region of Enrollment||participants|Number|54|54.0||||||
4012504|NCT01193244|3833537|B2|Australia||Region of Enrollment||participants|Number|27|27.0||||||
4012505|NCT01193244|3833538|B1|Australia||Region of Enrollment||participants|Number|27|27.0||||||
4012506|NCT01193244|3833536|B3|United Kingdom||Region of Enrollment||participants|Number|95|95.0||||||
4012507|NCT01193244|3833537|B2|United Kingdom||Region of Enrollment||participants|Number|53|53.0||||||
4012508|NCT01193244|3833538|B1|United Kingdom||Region of Enrollment||participants|Number|42|42.0||||||
4012509|NCT01193244|3833536|B3|Ukraine||Region of Enrollment||participants|Number|48|48.0||||||
4012510|NCT01193244|3833537|B2|Ukraine||Region of Enrollment||participants|Number|23|23.0||||||
4012511|NCT01193244|3833538|B1|Ukraine||Region of Enrollment||participants|Number|25|25.0||||||
4012512|NCT01193244|3833536|B3|Switzerland||Region of Enrollment||participants|Number|18|18.0||||||
4012513|NCT01193244|3833537|B2|Switzerland||Region of Enrollment||participants|Number|8|8.0||||||
4012514|NCT01193244|3833538|B1|Switzerland||Region of Enrollment||participants|Number|10|10.0||||||
4012515|NCT01193244|3833536|B3|Sweden||Region of Enrollment||participants|Number|17|17.0||||||
4012516|NCT01193244|3833537|B2|Sweden||Region of Enrollment||participants|Number|6|6.0||||||
4012517|NCT01193244|3833538|B1|Sweden||Region of Enrollment||participants|Number|11|11.0||||||
4012518|NCT01193244|3833536|B3|Spain||Region of Enrollment||participants|Number|26|26.0||||||
4012519|NCT01193244|3833537|B2|Spain||Region of Enrollment||participants|Number|12|12.0||||||
4012520|NCT01193244|3833538|B1|Spain||Region of Enrollment||participants|Number|14|14.0||||||
4012521|NCT01193244|3833536|B3|Slovakia||Region of Enrollment||participants|Number|20|20.0||||||
4012522|NCT01193244|3833537|B2|Slovakia||Region of Enrollment||participants|Number|11|11.0||||||
4012523|NCT01193244|3833538|B1|Slovakia||Region of Enrollment||participants|Number|9|9.0||||||
4012524|NCT01193244|3833536|B3|Romania||Region of Enrollment||participants|Number|33|33.0||||||
4012525|NCT01193244|3833537|B2|Romania||Region of Enrollment||participants|Number|13|13.0||||||
4012526|NCT01193244|3833538|B1|Romania||Region of Enrollment||participants|Number|20|20.0||||||
4012527|NCT01193244|3833536|B3|Portugal||Region of Enrollment||participants|Number|8|8.0||||||
4012528|NCT01193244|3833537|B2|Portugal||Region of Enrollment||participants|Number|4|4.0||||||
4012529|NCT01193244|3833538|B1|Portugal||Region of Enrollment||participants|Number|4|4.0||||||
4012530|NCT01193244|3833536|B3|Poland||Region of Enrollment||participants|Number|4|4.0||||||
4012531|NCT01193244|3833537|B2|Poland||Region of Enrollment||participants|Number|4|4.0||||||
4012532|NCT01193244|3833538|B1|Poland||Region of Enrollment||participants|Number|0|0.0||||||
4012533|NCT01193244|3833536|B3|Netherlands||Region of Enrollment||participants|Number|73|73.0||||||
4012534|NCT01193244|3833537|B2|Netherlands||Region of Enrollment||participants|Number|38|38.0||||||
4012535|NCT01193244|3833538|B1|Netherlands||Region of Enrollment||participants|Number|35|35.0||||||
4012536|NCT01193244|3833536|B3|Lithuania||Region of Enrollment||participants|Number|37|37.0||||||
4012537|NCT01193244|3833537|B2|Lithuania||Region of Enrollment||participants|Number|18|18.0||||||
4012538|NCT01193244|3833538|B1|Lithuania||Region of Enrollment||participants|Number|19|19.0||||||
4012539|NCT01193244|3833536|B3|Latvia||Region of Enrollment||participants|Number|26|26.0||||||
4012540|NCT01193244|3833537|B2|Latvia||Region of Enrollment||participants|Number|14|14.0||||||
4012541|NCT01193244|3833538|B1|Latvia||Region of Enrollment||participants|Number|12|12.0||||||
4012542|NCT01193244|3833536|B3|Italy||Region of Enrollment||participants|Number|18|18.0||||||
4012543|NCT01193244|3833537|B2|Italy||Region of Enrollment||participants|Number|8|8.0||||||
4012544|NCT01193244|3833538|B1|Italy||Region of Enrollment||participants|Number|10|10.0||||||
4012545|NCT01193244|3833536|B3|Ireland||Region of Enrollment||participants|Number|24|24.0||||||
4012546|NCT01193244|3833537|B2|Ireland||Region of Enrollment||participants|Number|13|13.0||||||
4012547|NCT01193244|3833538|B1|Ireland||Region of Enrollment||participants|Number|11|11.0||||||
4012548|NCT01193244|3833536|B3|Hungary||Region of Enrollment||participants|Number|7|7.0||||||
4012549|NCT01193244|3833537|B2|Hungary||Region of Enrollment||participants|Number|4|4.0||||||
4012550|NCT01193244|3833538|B1|Hungary||Region of Enrollment||participants|Number|3|3.0||||||
4012551|NCT01193244|3833536|B3|Greece||Region of Enrollment||participants|Number|39|39.0||||||
4012552|NCT01193244|3833537|B2|Greece||Region of Enrollment||participants|Number|16|16.0||||||
4012553|NCT01193244|3833538|B1|Greece||Region of Enrollment||participants|Number|23|23.0||||||
4012554|NCT01193244|3833536|B3|Germany||Region of Enrollment||participants|Number|69|69.0||||||
4012555|NCT01193244|3833537|B2|Germany||Region of Enrollment||participants|Number|40|40.0||||||
4012556|NCT01193244|3833538|B1|Germany||Region of Enrollment||participants|Number|29|29.0||||||
4012557|NCT01193244|3833536|B3|France||Region of Enrollment||participants|Number|121|121.0||||||
4012558|NCT01193244|3833537|B2|France||Region of Enrollment||participants|Number|55|55.0||||||
4012559|NCT01193244|3833538|B1|France||Region of Enrollment||participants|Number|66|66.0||||||
4012560|NCT01193244|3833536|B3|Finland||Region of Enrollment||participants|Number|13|13.0||||||
4012561|NCT01193244|3833537|B2|Finland||Region of Enrollment||participants|Number|4|4.0||||||
4012562|NCT01193244|3833538|B1|Finland||Region of Enrollment||participants|Number|9|9.0||||||
4012563|NCT01193244|3833536|B3|Estonia||Region of Enrollment||participants|Number|6|6.0||||||
4012564|NCT01193244|3833537|B2|Estonia||Region of Enrollment||participants|Number|4|4.0||||||
4012565|NCT01193244|3833538|B1|Estonia||Region of Enrollment||participants|Number|2|2.0||||||
4012566|NCT01193244|3833536|B3|Czech Republic||Region of Enrollment||participants|Number|31|31.0||||||
4012567|NCT01193244|3833537|B2|Czech Republic||Region of Enrollment||participants|Number|18|18.0||||||
4012568|NCT01193244|3833538|B1|Czech Republic||Region of Enrollment||participants|Number|13|13.0||||||
4012569|NCT01193244|3833536|B3|Croatia||Region of Enrollment||participants|Number|6|6.0||||||
4012570|NCT01193244|3833537|B2|Croatia||Region of Enrollment||participants|Number|1|1.0||||||
4012571|NCT01193244|3833538|B1|Croatia||Region of Enrollment||participants|Number|5|5.0||||||
4012572|NCT01193244|3833536|B3|Bulgaria||Region of Enrollment||participants|Number|12|12.0||||||
4012573|NCT01193244|3833537|B2|Bulgaria||Region of Enrollment||participants|Number|6|6.0||||||
4012574|NCT01193244|3833538|B1|Bulgaria||Region of Enrollment||participants|Number|6|6.0||||||
4012575|NCT01193244|3833536|B3|Belgium||Region of Enrollment||participants|Number|39|39.0||||||
4012576|NCT01193244|3833537|B2|Belgium||Region of Enrollment||participants|Number|21|21.0||||||
4012577|NCT01193244|3833538|B1|Belgium||Region of Enrollment||participants|Number|18|18.0||||||
4012578|NCT01193244|3833536|B3|Belarus||Region of Enrollment||participants|Number|16|16.0||||||
4012579|NCT01193244|3833537|B2|Belarus||Region of Enrollment||participants|Number|10|10.0||||||
4012580|NCT01193244|3833538|B1|Belarus||Region of Enrollment||participants|Number|6|6.0||||||
4012581|NCT01193244|3833536|B3|Austria||Region of Enrollment||participants|Number|24|24.0||||||
4012582|NCT01193244|3833537|B2|Austria||Region of Enrollment||participants|Number|12|12.0||||||
4012583|NCT01193244|3833538|B1|Austria||Region of Enrollment||participants|Number|12|12.0||||||
4012584|NCT01193244|3833536|B3|United States||Region of Enrollment||participants|Number|295|295.0||||||
4012585|NCT01193244|3833537|B2|United States||Region of Enrollment||participants|Number|148|148.0||||||
4012586|NCT01193244|3833538|B1|United States||Region of Enrollment||participants|Number|147|147.0||||||
4012587|NCT01193244|3833536|B3|Canada||Region of Enrollment||participants|Number|44|44.0||||||
4012588|NCT01193244|3833537|B2|Canada||Region of Enrollment||participants|Number|22|22.0||||||
4012589|NCT01193244|3833538|B1|Canada||Region of Enrollment||participants|Number|22|22.0||||||
4012590|NCT01193244|3833536|B3|Other||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4012591|NCT01193244|3833537|B2|Other||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4012592|NCT01193244|3833538|B1|Other||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4012593|NCT01193244|3833536|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4012594|NCT01193244|3833537|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4012595|NCT01193244|3833538|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4012596|NCT01193244|3833536|B3|White||Race/Ethnicity, Customized||participants|Number|1355|1355.0||||||
4012597|NCT01193244|3833537|B2|White||Race/Ethnicity, Customized||participants|Number|685|685.0||||||
4012598|NCT01193244|3833538|B1|White||Race/Ethnicity, Customized||participants|Number|670|670.0||||||
4012599|NCT01193244|3833536|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4012600|NCT01193244|3833537|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4012601|NCT01193244|3833538|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4012602|NCT01193244|3833536|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4012603|NCT01193244|3833537|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4012604|NCT01193244|3833538|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4012605|NCT01193244|3833536|B3|Asian||Race/Ethnicity, Customized||participants|Number|89|89.0||||||
4012606|NCT01193244|3833537|B2|Asian||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4012607|NCT01193244|3833538|B1|Asian||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4012608|NCT01193244|3833536|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4012609|NCT01193244|3833537|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4012610|NCT01193244|3833538|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4012611|NCT01193244|3833536|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4012612|NCT01193244|3833537|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4012613|NCT01193244|3833538|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4012614|NCT01193244|3833536|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1341|1341.0||||||
4012615|NCT01193244|3833537|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|669|669.0||||||
4012616|NCT01193244|3833538|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|672|672.0||||||
4012617|NCT01193244|3833536|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|197|197.0||||||
4012618|NCT01193244|3833537|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
4012619|NCT01193244|3833538|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4012620|NCT01193244|3833536|B3||Male|Sex: Female, Male||Participants|Count of Participants|1560|1560.0||||||
4012621|NCT01193244|3833537|B2||Male|Sex: Female, Male||Participants|Count of Participants|781|781.0||||||
4012622|NCT01193244|3833538|B1||Male|Sex: Female, Male||Participants|Count of Participants|779|779.0||||||
4012623|NCT01193244|3833536|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4012624|NCT01193244|3833537|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4012625|NCT01193244|3833538|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4012626|NCT01193244|3833536|B3|||Age||years|Mean|71.0|71.0|Standard Deviation|8.22|8.22|||
4012627|NCT01193244|3833537|B2|||Age||years|Mean|70.9|70.9|Standard Deviation|8.26|8.26|||
4012628|NCT01193244|3833538|B1|||Age||years|Mean|71.1|71.1|Standard Deviation|8.19|8.19|||
4012629|NCT01193218|3833589|B6||Male|Sex: Female, Male||Participants|Count of Participants|410|410.0||||||
4012630|NCT01193218|3833590|B5||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4012631|NCT01193218|3833591|B4||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4012632|NCT01193218|3833592|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4012633|NCT01193218|3833593|B2||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4012634|NCT01193218|3833594|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4012635|NCT01193218|3833589|B6||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4012636|NCT01193218|3833590|B5||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4012637|NCT01193218|3833591|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4012638|NCT01193218|3833592|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4012639|NCT01193218|3833593|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4012640|NCT01193218|3833594|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4012641|NCT01193218|3833589|B6|||Age||years|Mean|57.5|57.5|Standard Deviation|9.9|9.9|||
4012642|NCT01193218|3833590|B5|||Age||years|Mean|56.6|56.6|Standard Deviation|10.3|10.3|||
4012643|NCT01193218|3833591|B4|||Age||years|Mean|57.2|57.2|Standard Deviation|9.7|9.7|||
4012644|NCT01193218|3833592|B3|||Age||years|Mean|57.9|57.9|Standard Deviation|9.4|9.4|||
4012645|NCT01193218|3833593|B2|||Age||years|Mean|57.3|57.3|Standard Deviation|11.2|11.2|||
4012646|NCT01193218|3833594|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|8.7|8.7|||
4012647|NCT01193153|3833632|B1||Male|Sex: Female, Male||Participants|Count of Participants|357|357.0||||||
4012648|NCT01193153|3833632|B1||Female|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
4012649|NCT01193153|3833632|B1|||Age||years|Mean|39.5|39.5|Standard Deviation|10.70|10.7|||
4012650|NCT01193127|3833664|B5||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4012651|NCT01193127|3833665|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4012652|NCT01193127|3833666|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4012653|NCT01193127|3833667|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4012654|NCT01193127|3833668|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4012655|NCT01193127|3833664|B5||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4012656|NCT01193127|3833665|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4012657|NCT01193127|3833666|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4012658|NCT01193127|3833667|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4012659|NCT01193127|3833668|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4012660|NCT01193127|3833664|B5|||Age||years|Mean|67.3|67.3|Standard Deviation|10.0|10.0|||
4012661|NCT01193127|3833665|B4|||Age||years|Mean|66.4|66.4|Standard Deviation|11.2|11.2|||
4012662|NCT01193127|3833666|B3|||Age||years|Mean|66.8|66.8|Standard Deviation|8.6|8.6|||
4012663|NCT01193127|3833667|B2|||Age||years|Mean|67.6|67.6|Standard Deviation|10.6|10.6|||
4012664|NCT01193127|3833668|B1|||Age||years|Mean|68.5|68.5|Standard Deviation|9.6|9.6|||
4012665|NCT01193114|3833973|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4012666|NCT01193114|3833974|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4012667|NCT01193114|3833975|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4012668|NCT01193114|3833973|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4012669|NCT01193114|3833974|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4012670|NCT01193114|3833975|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4012671|NCT01193114|3833973|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4012672|NCT01193114|3833974|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4012673|NCT01193114|3833975|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4012674|NCT01193114|3833973|B3|||Age||years|Mean|26.30|26.3|Standard Deviation|6.01|6.01|||
4012675|NCT01193114|3833974|B2|||Age||years|Mean|27|27.0|Standard Deviation|6.46|6.46|||
4012676|NCT01193114|3833975|B1|||Age||years|Mean|25.60|25.6|Standard Deviation|5.54|5.54|||
4012677|NCT01193114|3833973|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4012678|NCT01193114|3833974|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4012679|NCT01193114|3833975|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4012680|NCT01193114|3833973|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4012681|NCT01193114|3833974|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4012682|NCT01193114|3833975|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4012683|NCT01193114|3833973|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4012684|NCT01193114|3833974|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4012685|NCT01193114|3833975|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4012686|NCT01193101|3833992|B5||Male|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4012687|NCT01193101|3833993|B4||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4012688|NCT01193101|3833994|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4012689|NCT01193101|3833995|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4012690|NCT01193101|3833996|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4012691|NCT01193101|3833992|B5||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4012692|NCT01193101|3833993|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4012693|NCT01193101|3833994|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4012694|NCT01193101|3833995|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4012695|NCT01193101|3833996|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4012696|NCT01193101|3833992|B5|||Age||Years|Mean|51.6|51.6|Standard Deviation|9.82|9.82|||
4012697|NCT01193101|3833993|B4|||Age||Years|Mean|50.9|50.9|Standard Deviation|10.65|10.65|||
4012698|NCT01193101|3833994|B3|||Age||Years|Mean|50.9|50.9|Standard Deviation|9.81|9.81|||
4012699|NCT01193101|3833995|B2|||Age||Years|Mean|52.1|52.1|Standard Deviation|8.82|8.82|||
4012700|NCT01193101|3833996|B1|||Age||Years|Mean|52.5|52.5|Standard Deviation|10.03|10.03|||
4012701|NCT01193049|3834055|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4012702|NCT01193049|3834055|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4012703|NCT01193049|3834055|B1|||Age||years|Mean|33.5|33.5|Standard Deviation|7.6|7.6|||
4012743|NCT01192776|3834103|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
4012744|NCT01192776|3834104|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
4012704|NCT01192828|3834086|B1|Categories|Other|Race/Ethnicity, Customized|Total number of participant enrolled in study was 15. One subject who enrolled per phone had to postpone study visit due to acute illness. This individual failed to reschedule for study visit and was eventually removed from the study. Number of subjects who completed study and analyzed is therefore 14|Participants|Count of Participants|0|0.0||||||
4012705|NCT01192828|3834086|B1|Categories|Hispanic|Race/Ethnicity, Customized|Total number of participant enrolled in study was 15. One subject who enrolled per phone had to postpone study visit due to acute illness. This individual failed to reschedule for study visit and was eventually removed from the study. Number of subjects who completed study and analyzed is therefore 14|Participants|Count of Participants|3|3.0||||||
4012706|NCT01192828|3834086|B1|Categories|White|Race/Ethnicity, Customized|Total number of participant enrolled in study was 15. One subject who enrolled per phone had to postpone study visit due to acute illness. This individual failed to reschedule for study visit and was eventually removed from the study. Number of subjects who completed study and analyzed is therefore 14|Participants|Count of Participants|9|9.0||||||
4012707|NCT01192828|3834086|B1|Categories|Black|Race/Ethnicity, Customized|Total number of participant enrolled in study was 15. One subject who enrolled per phone had to postpone study visit due to acute illness. This individual failed to reschedule for study visit and was eventually removed from the study. Number of subjects who completed study and analyzed is therefore 14|Participants|Count of Participants|2|2.0||||||
4012708|NCT01192828|3834086|B1|Categories|Asian|Race/Ethnicity, Customized|Total number of participant enrolled in study was 15. One subject who enrolled per phone had to postpone study visit due to acute illness. This individual failed to reschedule for study visit and was eventually removed from the study. Number of subjects who completed study and analyzed is therefore 14|Participants|Count of Participants|0|0.0||||||
4012709|NCT01192828|3834086|B1|Categories|Native American|Race/Ethnicity, Customized|Total number of participant enrolled in study was 15. One subject who enrolled per phone had to postpone study visit due to acute illness. This individual failed to reschedule for study visit and was eventually removed from the study. Number of subjects who completed study and analyzed is therefore 14|Participants|Count of Participants|0|0.0||||||
4012710|NCT01192828|3834086|B1||Male|Sex: Female, Male|Total number of participant enrolled in study was 15. One subject who enrolled per phone had to postpone study visit due to acute illness. This individual failed to reschedule for study visit and was eventually removed from the study. Number of subjects who completed study and analyzed is therefore 14.|Participants|Count of Participants|8|8.0||||||
4012711|NCT01192828|3834086|B1||Female|Sex: Female, Male|Total number of participant enrolled in study was 15. One subject who enrolled per phone had to postpone study visit due to acute illness. This individual failed to reschedule for study visit and was eventually removed from the study. Number of subjects who completed study and analyzed is therefore 14.|Participants|Count of Participants|6|6.0||||||
4012712|NCT01192828|3834086|B1|Age Distribution by Meaningful Groups|Older Adults (30-50 years)|Age, Customized||Participants|Count of Participants|2|2.0||||||
4012713|NCT01192828|3834086|B1|Age Distribution by Meaningful Groups|Young Adults (20-<30 years)|Age, Customized||Participants|Count of Participants|4|4.0||||||
4012714|NCT01192828|3834086|B1|Age Distribution by Meaningful Groups|Teenagers (12-<20 years)|Age, Customized||Participants|Count of Participants|4|4.0||||||
4012715|NCT01192828|3834086|B1|Age Distribution by Meaningful Groups|Prepubertal (8-12 years)|Age, Customized||Participants|Count of Participants|4|4.0||||||
4012716|NCT01192776|3834101|B5||Severe|Level of encephalopathy||Participants|Count of Participants|84|84.0||||||
4012717|NCT01192776|3834102|B4||Severe|Level of encephalopathy||Participants|Count of Participants|25|25.0||||||
4012718|NCT01192776|3834103|B3||Severe|Level of encephalopathy||Participants|Count of Participants|18|18.0||||||
4012719|NCT01192776|3834104|B2||Severe|Level of encephalopathy||Participants|Count of Participants|20|20.0||||||
4012720|NCT01192776|3834105|B1||Severe|Level of encephalopathy||Participants|Count of Participants|21|21.0||||||
4012721|NCT01192776|3834101|B5||Moderate|Level of encephalopathy||Participants|Count of Participants|280|280.0||||||
4012722|NCT01192776|3834102|B4||Moderate|Level of encephalopathy||Participants|Count of Participants|58|58.0||||||
4012723|NCT01192776|3834103|B3||Moderate|Level of encephalopathy||Participants|Count of Participants|78|78.0||||||
4012724|NCT01192776|3834104|B2||Moderate|Level of encephalopathy||Participants|Count of Participants|70|70.0||||||
4012725|NCT01192776|3834105|B1||Moderate|Level of encephalopathy||Participants|Count of Participants|74|74.0||||||
4012726|NCT01192776|3834101|B5|||Birthweight||grams|Mean|3359|3359.0|Standard Deviation|599|599.0|||
4012727|NCT01192776|3834102|B4|||Birthweight||grams|Mean|3511|3511.0|Standard Deviation|615|615.0|||
4012728|NCT01192776|3834103|B3|||Birthweight||grams|Mean|3354|3354.0|Standard Deviation|676|676.0|||
4012729|NCT01192776|3834104|B2|||Birthweight||grams|Mean|3360|3360.0|Standard Deviation|544|544.0|||
4012730|NCT01192776|3834105|B1|||Birthweight||grams|Mean|3230|3230.0|Standard Deviation|528|528.0|||
4012731|NCT01192776|3834101|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
4012732|NCT01192776|3834102|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4012733|NCT01192776|3834103|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4012734|NCT01192776|3834104|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4012735|NCT01192776|3834105|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4012736|NCT01192776|3834101|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|219|219.0||||||
4012737|NCT01192776|3834102|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
4012738|NCT01192776|3834103|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|55|55.0||||||
4012739|NCT01192776|3834104|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|56|56.0||||||
4012740|NCT01192776|3834105|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|60|60.0||||||
4012741|NCT01192776|3834101|B5|Black||Race/Ethnicity, Customized||Participants|Count of Participants|114|114.0||||||
4012742|NCT01192776|3834102|B4|Black||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
4012745|NCT01192776|3834105|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
4012746|NCT01192776|3834101|B5|Ambiguous||Sex/Gender, Customized||Participants|Count of Participants|1|1.0||||||
4012747|NCT01192776|3834102|B4|Ambiguous||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
4012748|NCT01192776|3834103|B3|Ambiguous||Sex/Gender, Customized||Participants|Count of Participants|1|1.0||||||
4012749|NCT01192776|3834104|B2|Ambiguous||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
4012750|NCT01192776|3834105|B1|Ambiguous||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
4012751|NCT01192776|3834101|B5|Female||Sex/Gender, Customized||Participants|Count of Participants|151|151.0||||||
4012752|NCT01192776|3834102|B4|Female||Sex/Gender, Customized||Participants|Count of Participants|27|27.0||||||
4012753|NCT01192776|3834103|B3|Female||Sex/Gender, Customized||Participants|Count of Participants|44|44.0||||||
4012754|NCT01192776|3834104|B2|Female||Sex/Gender, Customized||Participants|Count of Participants|37|37.0||||||
4012755|NCT01192776|3834105|B1|Female||Sex/Gender, Customized||Participants|Count of Participants|43|43.0||||||
4012756|NCT01192776|3834101|B5|Male||Sex/Gender, Customized||Participants|Count of Participants|212|212.0||||||
4012757|NCT01192776|3834102|B4|Male||Sex/Gender, Customized||Participants|Count of Participants|56|56.0||||||
4012758|NCT01192776|3834103|B3|Male||Sex/Gender, Customized||Participants|Count of Participants|51|51.0||||||
4012759|NCT01192776|3834104|B2|Male||Sex/Gender, Customized||Participants|Count of Participants|53|53.0||||||
4012760|NCT01192776|3834105|B1|Male||Sex/Gender, Customized||Participants|Count of Participants|52|52.0||||||
4012761|NCT01192776|3834101|B5|||Age|Age at Randomization|hours|Mean|4.9|4.9|Standard Deviation|1.2|1.2|||
4012762|NCT01192776|3834102|B4|||Age|Age at Randomization|hours|Mean|5.0|5.0|Standard Deviation|1.6|1.6|||
4012763|NCT01192776|3834103|B3|||Age|Age at Randomization|hours|Mean|4.8|4.8|Standard Deviation|1.1|1.1|||
4012764|NCT01192776|3834104|B2|||Age|Age at Randomization|hours|Mean|4.9|4.9|Standard Deviation|1.2|1.2|||
4012765|NCT01192776|3834105|B1|||Age|Age at Randomization|hours|Mean|5.1|5.1|Standard Deviation|1.0|1.0|||
4012766|NCT01192698|3834158|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4012767|NCT01192698|3834159|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4012768|NCT01192698|3834160|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4012769|NCT01192698|3834158|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4012770|NCT01192698|3834159|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4012771|NCT01192698|3834160|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4012772|NCT01192698|3834158|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4012773|NCT01192698|3834159|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4012774|NCT01192698|3834160|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4012775|NCT01192698|3834158|B3|||Age||years|Mean|56.4|56.4|Full Range|||49.0|64.0|
4012776|NCT01192698|3834159|B2|||Age||years|Mean|55.8|55.8|Full Range|||49.0|63.0|
4012777|NCT01192698|3834160|B1|||Age||years|Mean|57|57.0|Full Range|||49.0|64.0|
4012778|NCT01192698|3834158|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4012779|NCT01192698|3834159|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4012780|NCT01192698|3834160|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4012781|NCT01192698|3834158|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4012782|NCT01192698|3834159|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4012783|NCT01192698|3834160|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4012784|NCT01192698|3834158|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4012785|NCT01192698|3834159|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4012786|NCT01192698|3834160|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4012787|NCT01192542|3834167|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4012788|NCT01192542|3834167|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4012789|NCT01192542|3834167|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4012790|NCT01192542|3834167|B1|||Age||years|Mean|28.2|28.2|Standard Deviation|6.58|6.58|||
4012791|NCT01192516|3834179|B4|United States||Region of Enrollment|All participants were recruited in the Southeastern Michigan Area|participants|Number|195|195.0||||||
4012792|NCT01192516|3834180|B3|United States||Region of Enrollment|All participants were recruited in the Southeastern Michigan Area|participants|Number|63|63.0||||||
4012793|NCT01192516|3834181|B2|United States||Region of Enrollment|All participants were recruited in the Southeastern Michigan Area|participants|Number|66|66.0||||||
4012794|NCT01192516|3834182|B1|United States||Region of Enrollment|All participants were recruited in the Southeastern Michigan Area|participants|Number|66|66.0||||||
4012795|NCT01192516|3834179|B4||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4012796|NCT01192516|3834180|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4012797|NCT01192516|3834181|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4012798|NCT01192516|3834182|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4012799|NCT01192516|3834179|B4||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4012800|NCT01192516|3834180|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4012801|NCT01192516|3834181|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4012802|NCT01192516|3834182|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4012803|NCT01192516|3834179|B4|||Age||years|Mean|64.8|64.8|Standard Deviation|8.4|8.4|||
4012804|NCT01192516|3834180|B3|||Age||years|Mean|65.8|65.8|Standard Deviation|8.7|8.7|||
4012805|NCT01192516|3834181|B2|||Age||years|Mean|64.1|64.1|Standard Deviation|8.3|8.3|||
4012806|NCT01192516|3834182|B1|||Age||years|Mean|64.5|64.5|Standard Deviation|8.1|8.1|||
4012807|NCT01192516|3834179|B4||>=65 years|Age||Participants|Count of Participants|84|84.0||||||
4012808|NCT01192516|3834180|B3||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4012809|NCT01192516|3834181|B2||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4012810|NCT01192516|3834182|B1||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4012811|NCT01192516|3834179|B4||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
4012812|NCT01192516|3834180|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4012813|NCT01192516|3834181|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4012814|NCT01192516|3834182|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4012815|NCT01192516|3834179|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4012816|NCT01192516|3834180|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4012817|NCT01192516|3834181|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4012818|NCT01192516|3834182|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4012819|NCT01192412|3834216|B3|||Gestational diabetes at enrollment||participants|Number|63|63.0||||||
4012820|NCT01192412|3834217|B2|||Gestational diabetes at enrollment||participants|Number|31|31.0||||||
4012821|NCT01192412|3834218|B1|||Gestational diabetes at enrollment||participants|Number|32|32.0||||||
4012822|NCT01192412|3834216|B3|||Currently monitoring blood pressure at home||participants|Number|379|379.0||||||
4012823|NCT01192412|3834217|B2|||Currently monitoring blood pressure at home||participants|Number|194|194.0||||||
4012824|NCT01192412|3834218|B1|||Currently monitoring blood pressure at home||participants|Number|185|185.0||||||
4012825|NCT01192412|3834216|B3|Diastolic||Blood pressure within 1 wk before randomization||mmHg|Mean|92.4|92.4|Standard Deviation|5.0|5.0|||
4012826|NCT01192412|3834217|B2|Diastolic||Blood pressure within 1 wk before randomization||mmHg|Mean|92.2|92.2|Standard Deviation|5.2|5.2|||
4012827|NCT01192412|3834218|B1|Diastolic||Blood pressure within 1 wk before randomization||mmHg|Mean|92.6|92.6|Standard Deviation|4.8|4.8|||
4012828|NCT01192412|3834216|B3|Systolic||Blood pressure within 1 wk before randomization||mmHg|Mean|140.1|140.1|Standard Deviation|9.8|9.8|||
4012829|NCT01192412|3834217|B2|Systolic||Blood pressure within 1 wk before randomization||mmHg|Mean|139.7|139.7|Standard Deviation|9.8|9.8|||
4012830|NCT01192412|3834218|B1|Systolic||Blood pressure within 1 wk before randomization||mmHg|Mean|140.4|140.4|Standard Deviation|9.7|9.7|||
4012831|NCT01192412|3834216|B3|||Antihypertensive medication at enrollment||participants|Number|566|566.0||||||
4012832|NCT01192412|3834217|B2|||Antihypertensive medication at enrollment||participants|Number|287|287.0||||||
4012833|NCT01192412|3834218|B1|||Antihypertensive medication at enrollment||participants|Number|279|279.0||||||
4012834|NCT01192412|3834216|B3|||Prior blood pressure ≥160 mm Hg systolic or ≥110 mm Hg diastolic during this pregnancy||participants|Number|141|141.0||||||
4012835|NCT01192412|3834217|B2|||Prior blood pressure ≥160 mm Hg systolic or ≥110 mm Hg diastolic during this pregnancy||participants|Number|59|59.0||||||
4012836|NCT01192412|3834218|B1|||Prior blood pressure ≥160 mm Hg systolic or ≥110 mm Hg diastolic during this pregnancy||participants|Number|82|82.0||||||
4012837|NCT01192412|3834216|B3|Gestational hypertension||Type of nonproteinuric hypertension||participants|Number|251|251.0||||||
4012838|NCT01192412|3834217|B2|Gestational hypertension||Type of nonproteinuric hypertension||participants|Number|125|125.0||||||
4012839|NCT01192412|3834218|B1|Gestational hypertension||Type of nonproteinuric hypertension||participants|Number|126|126.0||||||
4012840|NCT01192412|3834216|B3|Preexisting hypertension||Type of nonproteinuric hypertension||participants|Number|736|736.0||||||
4012841|NCT01192412|3834217|B2|Preexisting hypertension||Type of nonproteinuric hypertension||participants|Number|365|365.0||||||
4012842|NCT01192412|3834218|B1|Preexisting hypertension||Type of nonproteinuric hypertension||participants|Number|371|371.0||||||
4012843|NCT01192412|3834216|B3|||Weeks of gestation||weeks|Mean|23.9|23.9|Standard Deviation|6.3|6.3|||
4012844|NCT01192412|3834217|B2|||Weeks of gestation||weeks|Mean|24.2|24.2|Standard Deviation|6.3|6.3|||
4012845|NCT01192412|3834218|B1|||Weeks of gestation||weeks|Mean|23.7|23.7|Standard Deviation|6.3|6.3|||
4012846|NCT01192412|3834216|B3|||Nulliparous|Women who were never pregnant before (i.e., first pregnancy)|participants|Number|329|329.0||||||
4012847|NCT01192412|3834217|B2|||Nulliparous|Women who were never pregnant before (i.e., first pregnancy)|participants|Number|168|168.0||||||
4012848|NCT01192412|3834218|B1|||Nulliparous|Women who were never pregnant before (i.e., first pregnancy)|participants|Number|161|161.0||||||
4012849|NCT01192412|3834216|B3|||Cigarette smoking during this pregnancy||participants|Number|63|63.0||||||
4012850|NCT01192412|3834217|B2|||Cigarette smoking during this pregnancy||participants|Number|28|28.0||||||
4012851|NCT01192412|3834218|B1|||Cigarette smoking during this pregnancy||participants|Number|35|35.0||||||
4012852|NCT01192412|3834216|B3|≥30.0 kg/m^2||Body-mass index|Available in 493 women in 'Less-tight' control, and 485 women in 'Tight' control|participants|Number|481|481.0||||||
4012853|NCT01192412|3834217|B2|≥30.0 kg/m^2||Body-mass index|Available in 493 women in 'Less-tight' control, and 485 women in 'Tight' control|participants|Number|236|236.0||||||
4012854|NCT01192412|3834218|B1|≥30.0 kg/m^2||Body-mass index|Available in 493 women in 'Less-tight' control, and 485 women in 'Tight' control|participants|Number|245|245.0||||||
4012855|NCT01192412|3834216|B3|25.0-29.9 kg/m^2||Body-mass index|Available in 493 women in 'Less-tight' control, and 485 women in 'Tight' control|participants|Number|266|266.0||||||
4012856|NCT01192412|3834217|B2|25.0-29.9 kg/m^2||Body-mass index|Available in 493 women in 'Less-tight' control, and 485 women in 'Tight' control|participants|Number|135|135.0||||||
4012857|NCT01192412|3834218|B1|25.0-29.9 kg/m^2||Body-mass index|Available in 493 women in 'Less-tight' control, and 485 women in 'Tight' control|participants|Number|131|131.0||||||
4012858|NCT01192412|3834216|B3|18.5-24.9 kg/m^2||Body-mass index|Available in 493 women in 'Less-tight' control, and 485 women in 'Tight' control|participants|Number|228|228.0||||||
4012859|NCT01192412|3834217|B2|18.5-24.9 kg/m^2||Body-mass index|Available in 493 women in 'Less-tight' control, and 485 women in 'Tight' control|participants|Number|112|112.0||||||
4012860|NCT01192412|3834218|B1|18.5-24.9 kg/m^2||Body-mass index|Available in 493 women in 'Less-tight' control, and 485 women in 'Tight' control|participants|Number|116|116.0||||||
4012861|NCT01192412|3834216|B3|<18.5 kg/m^2||Body-mass index|Available in 493 women in 'Less-tight' control, and 485 women in 'Tight' control|participants|Number|3|3.0||||||
4012862|NCT01192412|3834217|B2|<18.5 kg/m^2||Body-mass index|Available in 493 women in 'Less-tight' control, and 485 women in 'Tight' control|participants|Number|2|2.0||||||
4012863|NCT01192412|3834218|B1|<18.5 kg/m^2||Body-mass index|Available in 493 women in 'Less-tight' control, and 485 women in 'Tight' control|participants|Number|1|1.0||||||
4012864|NCT01192412|3834216|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
4012865|NCT01192412|3834217|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
4012866|NCT01192412|3834218|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4012867|NCT01192412|3834216|B3||Female|Gender||Participants|Count of Participants|987|987.0||||||
4012868|NCT01192412|3834217|B2||Female|Gender||Participants|Count of Participants|490|490.0||||||
4012869|NCT01192412|3834218|B1||Female|Gender||Participants|Count of Participants|497|497.0||||||
4012870|NCT01192412|3834216|B3|||Age||years|Mean|33.8|33.8|Standard Deviation|5.8|5.8|||
4012871|NCT01192412|3834217|B2|||Age||years|Mean|33.7|33.7|Standard Deviation|5.8|5.8|||
4012872|NCT01192412|3834218|B1|||Age||years|Mean|34.0|34.0|Standard Deviation|5.7|5.7|||
4012873|NCT01192399|3834227|B1|Japan||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
4012874|NCT01192399|3834227|B1|Japanese||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
4012875|NCT01192399|3834227|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4012876|NCT01192399|3834227|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4012877|NCT01192399|3834227|B1|||Age||years|Mean|47.0|47.0|Standard Deviation|12.39|12.39|||
4012878|NCT01192347|3834237|B1|France||Region of Enrollment|All enrolled subjects|participants|Number|177|177.0||||||
4012879|NCT01192347|3834237|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4012880|NCT01192347|3834237|B1||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4012881|NCT01192347|3834237|B1|>60 years||Age, Customized||participants|Number|133|133.0||||||
4012882|NCT01192347|3834237|B1|<=60 years||Age, Customized||participants|Number|42|42.0||||||
4012883|NCT01192347|3834237|B1|||Age||years|Mean|67.0|67.0|Standard Deviation|15.4|15.4|||
4012884|NCT01192295|3834258|B3|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4012885|NCT01192295|3834259|B2|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4012886|NCT01192295|3834260|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4012887|NCT01192295|3834258|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4012888|NCT01192295|3834259|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4012889|NCT01192295|3834260|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4012890|NCT01192295|3834258|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4012891|NCT01192295|3834259|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4012892|NCT01192295|3834260|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4012893|NCT01192295|3834258|B3|White||Race/Ethnicity, Customized||participants|Number|108|108.0||||||
4012894|NCT01192295|3834259|B2|White||Race/Ethnicity, Customized||participants|Number|88|88.0||||||
4012895|NCT01192295|3834260|B1|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4012896|NCT01192295|3834258|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4012897|NCT01192295|3834259|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4012898|NCT01192295|3834260|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4012899|NCT01192295|3834258|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4012900|NCT01192295|3834259|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4012901|NCT01192295|3834260|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4012902|NCT01192295|3834258|B3|||Age||years|Mean|13.7|13.7|Standard Deviation|2.33|2.33|||
4012903|NCT01192295|3834259|B2|||Age||years|Mean|14.5|14.5|Standard Deviation|1.34|1.34|||
4012904|NCT01192295|3834260|B1|||Age||years|Mean|9.6|9.6|Standard Deviation|1.65|1.65|||
4012905|NCT01192282|3834275|B4|TCA + Electrocautery||Treatment Modalities||Participants|Number|3|3.0||||||
4012906|NCT01192282|3834276|B3|TCA + Electrocautery||Treatment Modalities||Participants|Number|0|0.0||||||
4012907|NCT01192282|3834277|B2|TCA + Electrocautery||Treatment Modalities||Participants|Number|1|1.0||||||
4012908|NCT01192282|3834278|B1|TCA + Electrocautery||Treatment Modalities||Participants|Number|2|2.0||||||
4012909|NCT01192282|3834275|B4|Electrocautery / Laser Ablation under GA||Treatment Modalities||Participants|Number|33|33.0||||||
4012910|NCT01192282|3834276|B3|Electrocautery / Laser Ablation under GA||Treatment Modalities||Participants|Number|7|7.0||||||
4012911|NCT01192282|3834277|B2|Electrocautery / Laser Ablation under GA||Treatment Modalities||Participants|Number|9|9.0||||||
4012912|NCT01192282|3834278|B1|Electrocautery / Laser Ablation under GA||Treatment Modalities||Participants|Number|17|17.0||||||
4012913|NCT01192282|3834275|B4|Electrocautery under LA||Treatment Modalities||Participants|Number|109|109.0||||||
4012977|NCT01192282|3834275|B4|Married||Marital Status||Participants|Number|21|21.0||||||
4012914|NCT01192282|3834276|B3|Electrocautery under LA||Treatment Modalities||Participants|Number|13|13.0||||||
4012915|NCT01192282|3834277|B2|Electrocautery under LA||Treatment Modalities||Participants|Number|28|28.0||||||
4012916|NCT01192282|3834278|B1|Electrocautery under LA||Treatment Modalities||Participants|Number|68|68.0||||||
4012917|NCT01192282|3834275|B4|Local Ablation with Tricholoroacetic Acid (TCA)||Treatment Modalities||Participants|Number|11|11.0||||||
4012918|NCT01192282|3834276|B3|Local Ablation with Tricholoroacetic Acid (TCA)||Treatment Modalities||Participants|Number|2|2.0||||||
4012919|NCT01192282|3834277|B2|Local Ablation with Tricholoroacetic Acid (TCA)||Treatment Modalities||Participants|Number|2|2.0||||||
4012920|NCT01192282|3834278|B1|Local Ablation with Tricholoroacetic Acid (TCA)||Treatment Modalities||Participants|Number|7|7.0||||||
4012921|NCT01192282|3834275|B4|Unknown||HIV Status||Participants|Number|4|4.0||||||
4012922|NCT01192282|3834276|B3|Unknown||HIV Status||Participants|Number|1|1.0||||||
4012923|NCT01192282|3834277|B2|Unknown||HIV Status||Participants|Number|1|1.0||||||
4012924|NCT01192282|3834278|B1|Unknown||HIV Status||Participants|Number|2|2.0||||||
4012925|NCT01192282|3834275|B4|Negative||HIV Status||Participants|Number|29|29.0||||||
4012926|NCT01192282|3834276|B3|Negative||HIV Status||Participants|Number|5|5.0||||||
4012927|NCT01192282|3834277|B2|Negative||HIV Status||Participants|Number|3|3.0||||||
4012928|NCT01192282|3834278|B1|Negative||HIV Status||Participants|Number|21|21.0||||||
4012929|NCT01192282|3834275|B4|Positive||HIV Status||Participants|Number|123|123.0||||||
4012930|NCT01192282|3834276|B3|Positive||HIV Status||Participants|Number|16|16.0||||||
4012931|NCT01192282|3834277|B2|Positive||HIV Status||Participants|Number|36|36.0||||||
4012932|NCT01192282|3834278|B1|Positive||HIV Status||Participants|Number|71|71.0||||||
4012933|NCT01192282|3834275|B4|Previously||Smoking||Participants|Number|14|14.0||||||
4012934|NCT01192282|3834276|B3|Previously||Smoking||Participants|Number|3|3.0||||||
4012935|NCT01192282|3834277|B2|Previously||Smoking||Participants|Number|3|3.0||||||
4012936|NCT01192282|3834278|B1|Previously||Smoking||Participants|Number|8|8.0||||||
4012937|NCT01192282|3834275|B4|No||Smoking||Participants|Number|126|126.0||||||
4012938|NCT01192282|3834276|B3|No||Smoking||Participants|Number|15|15.0||||||
4012939|NCT01192282|3834277|B2|No||Smoking||Participants|Number|34|34.0||||||
4012940|NCT01192282|3834278|B1|No||Smoking||Participants|Number|77|77.0||||||
4012941|NCT01192282|3834275|B4|Yes||Smoking||Participants|Number|16|16.0||||||
4012942|NCT01192282|3834276|B3|Yes||Smoking||Participants|Number|4|4.0||||||
4012943|NCT01192282|3834277|B2|Yes||Smoking||Participants|Number|3|3.0||||||
4012944|NCT01192282|3834278|B1|Yes||Smoking||Participants|Number|9|9.0||||||
4012945|NCT01192282|3834275|B4|Tertiary||Education Level||Participants|Number|24|24.0||||||
4012946|NCT01192282|3834276|B3|Tertiary||Education Level||Participants|Number|6|6.0||||||
4012947|NCT01192282|3834277|B2|Tertiary||Education Level||Participants|Number|4|4.0||||||
4012948|NCT01192282|3834278|B1|Tertiary||Education Level||Participants|Number|14|14.0||||||
4012949|NCT01192282|3834275|B4|Secondary||Education Level||Participants|Number|116|116.0||||||
4012950|NCT01192282|3834276|B3|Secondary||Education Level||Participants|Number|13|13.0||||||
4012951|NCT01192282|3834277|B2|Secondary||Education Level||Participants|Number|36|36.0||||||
4012952|NCT01192282|3834278|B1|Secondary||Education Level||Participants|Number|67|67.0||||||
4012953|NCT01192282|3834275|B4|Primary||Education Level||Participants|Number|16|16.0||||||
4012954|NCT01192282|3834276|B3|Primary||Education Level||Participants|Number|3|3.0||||||
4012955|NCT01192282|3834277|B2|Primary||Education Level||Participants|Number|0|0.0||||||
4012956|NCT01192282|3834278|B1|Primary||Education Level||Participants|Number|13|13.0||||||
4012957|NCT01192282|3834275|B4|Virgo Intacta (Years)||Age at First Sexual Intercourse||Participants|Number|1|1.0||||||
4012958|NCT01192282|3834276|B3|Virgo Intacta (Years)||Age at First Sexual Intercourse||Participants|Number|1|1.0||||||
4012959|NCT01192282|3834277|B2|Virgo Intacta (Years)||Age at First Sexual Intercourse||Participants|Number|0|0.0||||||
4012960|NCT01192282|3834278|B1|Virgo Intacta (Years)||Age at First Sexual Intercourse||Participants|Number|0|0.0||||||
4012961|NCT01192282|3834275|B4|20 and Above (Years)||Age at First Sexual Intercourse||Participants|Number|27|27.0||||||
4012962|NCT01192282|3834276|B3|20 and Above (Years)||Age at First Sexual Intercourse||Participants|Number|6|6.0||||||
4012963|NCT01192282|3834277|B2|20 and Above (Years)||Age at First Sexual Intercourse||Participants|Number|5|5.0||||||
4012964|NCT01192282|3834278|B1|20 and Above (Years)||Age at First Sexual Intercourse||Participants|Number|16|16.0||||||
4012965|NCT01192282|3834275|B4|15 - 19 (Years)||Age at First Sexual Intercourse||Participants|Number|116|116.0||||||
4012966|NCT01192282|3834276|B3|15 - 19 (Years)||Age at First Sexual Intercourse||Participants|Number|14|14.0||||||
4012967|NCT01192282|3834277|B2|15 - 19 (Years)||Age at First Sexual Intercourse||Participants|Number|33|33.0||||||
4012968|NCT01192282|3834278|B1|15 - 19 (Years)||Age at First Sexual Intercourse||Participants|Number|69|69.0||||||
4012969|NCT01192282|3834275|B4|14 or Less (Years)||Age at First Sexual Intercourse||Participants|Number|12|12.0||||||
4012970|NCT01192282|3834276|B3|14 or Less (Years)||Age at First Sexual Intercourse||Participants|Number|1|1.0||||||
4012971|NCT01192282|3834277|B2|14 or Less (Years)||Age at First Sexual Intercourse||Participants|Number|2|2.0||||||
4012972|NCT01192282|3834278|B1|14 or Less (Years)||Age at First Sexual Intercourse||Participants|Number|9|9.0||||||
4012973|NCT01192282|3834275|B4|Separated / Divorced / Widow||Marital Status||Participants|Number|13|13.0||||||
4012974|NCT01192282|3834276|B3|Separated / Divorced / Widow||Marital Status||Participants|Number|4|4.0||||||
4012975|NCT01192282|3834277|B2|Separated / Divorced / Widow||Marital Status||Participants|Number|3|3.0||||||
4012976|NCT01192282|3834278|B1|Separated / Divorced / Widow||Marital Status||Participants|Number|6|6.0||||||
4012978|NCT01192282|3834276|B3|Married||Marital Status||Participants|Number|4|4.0||||||
4012979|NCT01192282|3834277|B2|Married||Marital Status||Participants|Number|4|4.0||||||
4012980|NCT01192282|3834278|B1|Married||Marital Status||Participants|Number|13|13.0||||||
4012981|NCT01192282|3834275|B4|Single, Sexually Active||Marital Status||Participants|Number|92|92.0||||||
4012982|NCT01192282|3834276|B3|Single, Sexually Active||Marital Status||Participants|Number|9|9.0||||||
4012983|NCT01192282|3834277|B2|Single, Sexually Active||Marital Status||Participants|Number|27|27.0||||||
4012984|NCT01192282|3834278|B1|Single, Sexually Active||Marital Status||Participants|Number|56|56.0||||||
4012985|NCT01192282|3834275|B4|Single, Not Sexually Active||Marital Status||Participants|Number|30|30.0||||||
4012986|NCT01192282|3834276|B3|Single, Not Sexually Active||Marital Status||Participants|Number|5|5.0||||||
4012987|NCT01192282|3834277|B2|Single, Not Sexually Active||Marital Status||Participants|Number|6|6.0||||||
4012988|NCT01192282|3834278|B1|Single, Not Sexually Active||Marital Status||Participants|Number|19|19.0||||||
4012989|NCT01192282|3834275|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4012990|NCT01192282|3834276|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4012991|NCT01192282|3834277|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4012992|NCT01192282|3834278|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4012993|NCT01192282|3834275|B4||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4012994|NCT01192282|3834276|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4012995|NCT01192282|3834277|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4012996|NCT01192282|3834278|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4012997|NCT01192282|3834275|B4|||Age, Customized||Years|Mean|29.21|29.21|Full Range|||15.0|53.0|
4012998|NCT01192282|3834276|B3|||Age, Customized||Years|Mean|29.91|29.91|Full Range|||17.0|50.0|
4012999|NCT01192282|3834277|B2|||Age, Customized||Years|Mean|30.18|30.18|Full Range|||18.0|49.0|
4013000|NCT01192282|3834278|B1|||Age, Customized||Years|Mean|28.64|28.64|Full Range|||15.0|53.0|
4013001|NCT01192204|3834293|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
4013002|NCT01192204|3834294|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4013003|NCT01192204|3834295|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4013004|NCT01192204|3834293|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4013005|NCT01192204|3834294|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4013006|NCT01192204|3834295|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4013007|NCT01192204|3834293|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4013008|NCT01192204|3834294|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4013009|NCT01192204|3834295|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4013010|NCT01192204|3834293|B3|||Age||years|Mean|59.9|59.9|Standard Deviation|2.4|2.4|||
4013011|NCT01192204|3834294|B2|||Age||years|Mean|57.7|57.7|Standard Deviation|2.9|2.9|||
4013012|NCT01192204|3834295|B1|||Age||years|Mean|62.2|62.2|Standard Deviation|1.8|1.8|||
4013013|NCT01192204|3834293|B3||>=65 years|Age|The patients were randomly assigned by computer generated numbers to either the BRB or the placebo gel groups.|Participants|Count of Participants|19|19.0||||||
4013014|NCT01192204|3834294|B2||>=65 years|Age|The patients were randomly assigned by computer generated numbers to either the BRB or the placebo gel groups.|Participants|Count of Participants|13|13.0||||||
4013015|NCT01192204|3834295|B1||>=65 years|Age|The patients were randomly assigned by computer generated numbers to either the BRB or the placebo gel groups.|Participants|Count of Participants|6|6.0||||||
4013016|NCT01192204|3834293|B3||Between 18 and 65 years|Age|The patients were randomly assigned by computer generated numbers to either the BRB or the placebo gel groups.|Participants|Count of Participants|22|22.0||||||
4013017|NCT01192204|3834294|B2||Between 18 and 65 years|Age|The patients were randomly assigned by computer generated numbers to either the BRB or the placebo gel groups.|Participants|Count of Participants|5|5.0||||||
4013018|NCT01192204|3834295|B1||Between 18 and 65 years|Age|The patients were randomly assigned by computer generated numbers to either the BRB or the placebo gel groups.|Participants|Count of Participants|17|17.0||||||
4013019|NCT01192204|3834293|B3||<=18 years|Age|The patients were randomly assigned by computer generated numbers to either the BRB or the placebo gel groups.|Participants|Count of Participants|0|0.0||||||
4013020|NCT01192204|3834294|B2||<=18 years|Age|The patients were randomly assigned by computer generated numbers to either the BRB or the placebo gel groups.|Participants|Count of Participants|0|0.0||||||
4013021|NCT01192204|3834295|B1||<=18 years|Age|The patients were randomly assigned by computer generated numbers to either the BRB or the placebo gel groups.|Participants|Count of Participants|0|0.0||||||
4013022|NCT01192191|3834306|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|187|187.0||||||
4013023|NCT01192191|3834307|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|127|127.0||||||
4013024|NCT01192191|3834308|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|60|60.0||||||
4013025|NCT01192191|3834306|B3||Male|Gender||Participants|Count of Participants|174|174.0||||||
4013026|NCT01192191|3834307|B2||Male|Gender||Participants|Count of Participants|116|116.0||||||
4013027|NCT01192191|3834308|B1||Male|Gender||Participants|Count of Participants|58|58.0||||||
4013028|NCT01192191|3834306|B3||Female|Gender||Participants|Count of Participants|13|13.0||||||
4013029|NCT01192191|3834307|B2||Female|Gender||Participants|Count of Participants|11|11.0||||||
4013030|NCT01192191|3834308|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
4013031|NCT01192191|3834306|B3|||Age||Years|Mean|70.5|70.5|Standard Deviation|7.49|7.49|||
4013032|NCT01192191|3834307|B2|||Age||Years|Mean|71.0|71.0|Standard Deviation|7.39|7.39|||
4013033|NCT01192191|3834308|B1|||Age||Years|Mean|69.5|69.5|Standard Deviation|7.66|7.66|||
4013034|NCT01192178|3834333|B3|Native Hawaiian or Other Pacific Islander & White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4013035|NCT01192178|3834334|B2|Native Hawaiian or Other Pacific Islander & White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4013036|NCT01192178|3834335|B1|Native Hawaiian or Other Pacific Islander & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013037|NCT01192178|3834333|B3|Asian and White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4013038|NCT01192178|3834334|B2|Asian and White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013039|NCT01192178|3834335|B1|Asian and White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4013040|NCT01192178|3834333|B3|Asian & Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4013041|NCT01192178|3834334|B2|Asian & Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013042|NCT01192178|3834335|B1|Asian & Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4013043|NCT01192178|3834333|B3|African American/African Heritage and White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4013044|NCT01192178|3834334|B2|African American/African Heritage and White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4013045|NCT01192178|3834335|B1|African American/African Heritage and White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4013046|NCT01192178|3834333|B3|White||Race/Ethnicity, Customized||participants|Number|256|256.0||||||
4013047|NCT01192178|3834334|B2|White||Race/Ethnicity, Customized||participants|Number|127|127.0||||||
4013048|NCT01192178|3834335|B1|White||Race/Ethnicity, Customized||participants|Number|129|129.0||||||
4013049|NCT01192178|3834333|B3|American Indian or Alaska Native and White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4013050|NCT01192178|3834334|B2|American Indian or Alaska Native and White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013051|NCT01192178|3834335|B1|American Indian or Alaska Native and White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4013052|NCT01192178|3834333|B3|Asian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4013053|NCT01192178|3834334|B2|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4013054|NCT01192178|3834335|B1|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4013055|NCT01192178|3834333|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4013056|NCT01192178|3834334|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013057|NCT01192178|3834335|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4013058|NCT01192178|3834333|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
4013059|NCT01192178|3834334|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4013060|NCT01192178|3834335|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4013061|NCT01192178|3834333|B3||Male|Gender||Participants|Count of Participants|220|220.0||||||
4013062|NCT01192178|3834334|B2||Male|Gender||Participants|Count of Participants|112|112.0||||||
4013063|NCT01192178|3834335|B1||Male|Gender||Participants|Count of Participants|108|108.0||||||
4013064|NCT01192178|3834333|B3||Female|Gender||Participants|Count of Participants|119|119.0||||||
4013065|NCT01192178|3834334|B2||Female|Gender||Participants|Count of Participants|56|56.0||||||
4013066|NCT01192178|3834335|B1||Female|Gender||Participants|Count of Participants|63|63.0||||||
4013067|NCT01192178|3834333|B3|||Age||Years|Mean|7.4|7.4|Standard Deviation|2.09|2.09|||
4013068|NCT01192178|3834334|B2|||Age||Years|Mean|7.4|7.4|Standard Deviation|2.08|2.08|||
4013069|NCT01192178|3834335|B1|||Age||Years|Mean|7.5|7.5|Standard Deviation|2.11|2.11|||
4013070|NCT01192152|3834356|B1|||Body Mass Index||kg/m^2|Mean|25.69|25.69|Standard Deviation|2.70|2.7|||
4013071|NCT01192152|3834356|B1|||Weight||kg|Mean|71.56|71.56|Standard Deviation|9.39|9.39|||
4013072|NCT01192152|3834356|B1|||Height||cm|Mean|166.85|166.85|Standard Deviation|9.02|9.02|||
4013073|NCT01192152|3834356|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4013074|NCT01192152|3834356|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4013075|NCT01192152|3834356|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4013076|NCT01192152|3834356|B1|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4013077|NCT01192152|3834356|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4013078|NCT01192152|3834356|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4013079|NCT01192152|3834356|B1|||Age||years|Mean|31.6|31.6|Standard Deviation|7.76|7.76|||
4013080|NCT01192139|3834458|B1|||Body Mass Index||kg/m^2|Mean|26.97|26.97|Standard Deviation|3.07|3.07|||
4013081|NCT01192139|3834458|B1|||Weight||kg|Mean|78.31|78.31|Standard Deviation|13.74|13.74|||
4013082|NCT01192139|3834458|B1|||Height||cm|Mean|170.0|170.0|Standard Deviation|9.22|9.22|||
4013083|NCT01192139|3834458|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4013084|NCT01192139|3834458|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4013085|NCT01192139|3834458|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4013086|NCT01192139|3834458|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4013087|NCT01192139|3834458|B1|White||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4013088|NCT01192139|3834458|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4013089|NCT01192139|3834458|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4013090|NCT01192139|3834458|B1|||Age||years|Mean|29.1|29.1|Standard Deviation|8.0|8.0|||
4013091|NCT01192126|3834528|B1|United States||Region of Enrollment||participants|Number|102|102.0||||||
4013092|NCT01192126|3834528|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4013093|NCT01192126|3834528|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4013094|NCT01192126|3834528|B1|||Age||years|Mean|28.0|28.0|Standard Deviation|7.8|7.8|||
4013095|NCT01192022|3834537|B5|Not applicable||Fertility Status: Adult Population||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4013096|NCT01192022|3834538|B4|Not applicable||Fertility Status: Adult Population||participants|Number|NA|||||||Fertility status data was not collected for the pediatric population.
4013097|NCT01192022|3834539|B3|Not applicable||Fertility Status: Adult Population||participants|Number|NA|||||||Fertility status data was not collected for the pediatric population.
4013098|NCT01192022|3834540|B2|Not applicable||Fertility Status: Adult Population||participants|Number|59|59.0||||||
4013099|NCT01192022|3834541|B1|Not applicable||Fertility Status: Adult Population||participants|Number|60|60.0||||||
4013100|NCT01192022|3834537|B5|Surgically sterile||Fertility Status: Adult Population||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4013101|NCT01192022|3834538|B4|Surgically sterile||Fertility Status: Adult Population||participants|Number|NA|||||||Fertility status data was not collected for the pediatric population.
4013102|NCT01192022|3834539|B3|Surgically sterile||Fertility Status: Adult Population||participants|Number|NA|||||||Fertility status data was not collected for the pediatric population.
4013103|NCT01192022|3834540|B2|Surgically sterile||Fertility Status: Adult Population||participants|Number|22|22.0||||||
4013104|NCT01192022|3834541|B1|Surgically sterile||Fertility Status: Adult Population||participants|Number|22|22.0||||||
4013105|NCT01192022|3834537|B5|Postmenstrual||Fertility Status: Adult Population||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4013106|NCT01192022|3834538|B4|Postmenstrual||Fertility Status: Adult Population||participants|Number|NA|||||||Fertility status data was not collected for the pediatric population.
4013107|NCT01192022|3834539|B3|Postmenstrual||Fertility Status: Adult Population||participants|Number|NA|||||||Fertility status data was not collected for the pediatric population.
4013108|NCT01192022|3834540|B2|Postmenstrual||Fertility Status: Adult Population||participants|Number|24|24.0||||||
4013109|NCT01192022|3834541|B1|Postmenstrual||Fertility Status: Adult Population||participants|Number|26|26.0||||||
4013110|NCT01192022|3834537|B5|Menstrual||Fertility Status: Adult Population||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4013111|NCT01192022|3834538|B4|Menstrual||Fertility Status: Adult Population||participants|Number|NA|||||||Fertility status data was not collected for the pediatric population.
4013112|NCT01192022|3834539|B3|Menstrual||Fertility Status: Adult Population||participants|Number|NA|||||||Fertility status data was not collected for the pediatric population.
4013113|NCT01192022|3834540|B2|Menstrual||Fertility Status: Adult Population||participants|Number|5|5.0||||||
4013114|NCT01192022|3834541|B1|Menstrual||Fertility Status: Adult Population||participants|Number|6|6.0||||||
4013115|NCT01192022|3834537|B5|||Body Mass Index (BMI): Pediatric Population|Number of participants for whom pediatric BMI data were available were 19 and 7 in each treatment arm, respectively.|kg/m^2|Mean|17.24|17.24|Standard Deviation|2.962|2.962|||
4013116|NCT01192022|3834538|B4|||Body Mass Index (BMI): Pediatric Population|Number of participants for whom pediatric BMI data were available were 19 and 7 in each treatment arm, respectively.|kg/m^2|Mean|16.57|16.57|Standard Deviation|2.637|2.637|||
4013117|NCT01192022|3834539|B3|||Body Mass Index (BMI): Pediatric Population|Number of participants for whom pediatric BMI data were available were 19 and 7 in each treatment arm, respectively.|kg/m^2|Mean|17.49|17.49|Standard Deviation|3.103|3.103|||
4013118|NCT01192022|3834540|B2|||Body Mass Index (BMI): Pediatric Population|Number of participants for whom pediatric BMI data were available were 19 and 7 in each treatment arm, respectively.|kg/m^2|Mean|NA||Standard Deviation|NA||||Adult BMI is reported separately.
4013119|NCT01192022|3834541|B1|||Body Mass Index (BMI): Pediatric Population|Number of participants for whom pediatric BMI data were available were 19 and 7 in each treatment arm, respectively.|kg/m^2|Mean|NA||Standard Deviation|NA||||Adult BMI is reported separately.
4013120|NCT01192022|3834537|B5|||Body Mass Index (BMI): Adult Population||kg/m^2|Mean|27.64|27.64|Standard Deviation|5.593|5.593|||
4013121|NCT01192022|3834538|B4|||Body Mass Index (BMI): Adult Population||kg/m^2|Mean|NA||Standard Deviation|NA||||Pediatric BMI is reported separately.
4013122|NCT01192022|3834539|B3|||Body Mass Index (BMI): Adult Population||kg/m^2|Mean|NA||Standard Deviation|NA||||Pediatric BMI is reported separately.
4013123|NCT01192022|3834540|B2|||Body Mass Index (BMI): Adult Population||kg/m^2|Mean|27.16|27.16|Standard Deviation|5.653|5.653|||
4013124|NCT01192022|3834541|B1|||Body Mass Index (BMI): Adult Population||kg/m^2|Mean|28.09|28.09|Standard Deviation|5.521|5.521|||
4013125|NCT01192022|3834537|B5|||Weight: Pediatric Population|Number of participants for whom pediatric weight data were available were 19 and 8 in each treatment arm, respectively.|kg|Mean|17.00|17.0|Standard Deviation|15.848|15.848|||
4013126|NCT01192022|3834538|B4|||Weight: Pediatric Population|Number of participants for whom pediatric weight data were available were 19 and 8 in each treatment arm, respectively.|kg|Mean|11.11|11.11|Standard Deviation|7.963|7.963|||
4013127|NCT01192022|3834539|B3|||Weight: Pediatric Population|Number of participants for whom pediatric weight data were available were 19 and 8 in each treatment arm, respectively.|kg|Mean|19.48|19.48|Standard Deviation|17.783|17.783|||
4013128|NCT01192022|3834540|B2|||Weight: Pediatric Population|Number of participants for whom pediatric weight data were available were 19 and 8 in each treatment arm, respectively.|kg|Mean|NA||Standard Deviation|NA||||Adult weight is reported separately.
4013129|NCT01192022|3834541|B1|||Weight: Pediatric Population|Number of participants for whom pediatric weight data were available were 19 and 8 in each treatment arm, respectively.|kg|Mean|NA||Standard Deviation|NA||||Adult weight is reported separately.
4013130|NCT01192022|3834537|B5|||Weight: Adult Population||kg|Mean|79.75|79.75|Standard Deviation|17.737|17.737|||
4013237|NCT01191944|3834568|B1||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4013131|NCT01192022|3834538|B4|||Weight: Adult Population||kg|Mean|NA||Standard Deviation|NA||||Pediatric weight is reported separately.
4013132|NCT01192022|3834539|B3|||Weight: Adult Population||kg|Mean|NA||Standard Deviation|NA||||Pediatric weight is reported separately.
4013133|NCT01192022|3834540|B2|||Weight: Adult Population||kg|Mean|79.03|79.03|Standard Deviation|18.545|18.545|||
4013134|NCT01192022|3834541|B1|||Weight: Adult Population||kg|Mean|80.46|80.46|Standard Deviation|16.968|16.968|||
4013135|NCT01192022|3834537|B5|||Height: Pediatric Population|Number of participants for whom pediatric height data were available were 19 and 7 in each treatment arm, respectively.|cm|Mean|91.25|91.25|Standard Deviation|34.400|34.4|||
4013136|NCT01192022|3834538|B4|||Height: Pediatric Population|Number of participants for whom pediatric height data were available were 19 and 7 in each treatment arm, respectively.|cm|Mean|77.39|77.39|Standard Deviation|24.650|24.65|||
4013137|NCT01192022|3834539|B3|||Height: Pediatric Population|Number of participants for whom pediatric height data were available were 19 and 7 in each treatment arm, respectively.|cm|Mean|96.36|96.36|Standard Deviation|36.588|36.588|||
4013138|NCT01192022|3834540|B2|||Height: Pediatric Population|Number of participants for whom pediatric height data were available were 19 and 7 in each treatment arm, respectively.|cm|Mean|NA||Standard Deviation|NA||||Adult height is reported separately.
4013139|NCT01192022|3834541|B1|||Height: Pediatric Population|Number of participants for whom pediatric height data were available were 19 and 7 in each treatment arm, respectively.|cm|Mean|NA||Standard Deviation|NA||||Adult height is reported separately.
4013140|NCT01192022|3834537|B5|||Height: Adult Population||cm|Mean|169.81|169.81|Standard Deviation|9.919|9.919|||
4013141|NCT01192022|3834538|B4|||Height: Adult Population||cm|Mean|NA||Standard Deviation|NA||||Pediatric height is reported separately.
4013142|NCT01192022|3834539|B3|||Height: Adult Population||cm|Mean|NA||Standard Deviation|NA||||Pediatric height is reported separately.
4013143|NCT01192022|3834540|B2|||Height: Adult Population||cm|Mean|170.33|170.33|Standard Deviation|9.929|9.929|||
4013144|NCT01192022|3834541|B1|||Height: Adult Population||cm|Mean|169.30|169.3|Standard Deviation|9.927|9.927|||
4013145|NCT01192022|3834537|B5|12-16 years||Age, Categorical: Pediatric Population||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4013146|NCT01192022|3834538|B4|12-16 years||Age, Categorical: Pediatric Population||participants|Number|1|1.0||||||
4013147|NCT01192022|3834539|B3|12-16 years||Age, Categorical: Pediatric Population||participants|Number|3|3.0||||||
4013148|NCT01192022|3834540|B2|12-16 years||Age, Categorical: Pediatric Population||participants|Number|NA|||||||Adult age is reported separately.
4013149|NCT01192022|3834541|B1|12-16 years||Age, Categorical: Pediatric Population||participants|Number|NA|||||||Adult age is reported separately.
4013150|NCT01192022|3834537|B5|2-11 years||Age, Categorical: Pediatric Population||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4013151|NCT01192022|3834538|B4|2-11 years||Age, Categorical: Pediatric Population||participants|Number|3|3.0||||||
4013152|NCT01192022|3834539|B3|2-11 years||Age, Categorical: Pediatric Population||participants|Number|8|8.0||||||
4013153|NCT01192022|3834540|B2|2-11 years||Age, Categorical: Pediatric Population||participants|Number|NA|||||||Adult age is reported separately.
4013154|NCT01192022|3834541|B1|2-11 years||Age, Categorical: Pediatric Population||participants|Number|NA|||||||Adult age is reported separately.
4013155|NCT01192022|3834537|B5|0-23 months||Age, Categorical: Pediatric Population||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4013156|NCT01192022|3834538|B4|0-23 months||Age, Categorical: Pediatric Population||participants|Number|5|5.0||||||
4013157|NCT01192022|3834539|B3|0-23 months||Age, Categorical: Pediatric Population||participants|Number|9|9.0||||||
4013158|NCT01192022|3834540|B2|0-23 months||Age, Categorical: Pediatric Population||participants|Number|NA|||||||Adult age is reported separately.
4013159|NCT01192022|3834541|B1|0-23 months||Age, Categorical: Pediatric Population||participants|Number|NA|||||||Adult age is reported separately.
4013160|NCT01192022|3834537|B5|>65 years||Age, Categorical: Adult Population||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4013161|NCT01192022|3834538|B4|>65 years||Age, Categorical: Adult Population||participants|Number|NA|||||||Pediatric age is reported separately.
4013162|NCT01192022|3834539|B3|>65 years||Age, Categorical: Adult Population||participants|Number|NA|||||||Pediatric age is reported separately.
4013163|NCT01192022|3834540|B2|>65 years||Age, Categorical: Adult Population||participants|Number|34|34.0||||||
4013164|NCT01192022|3834541|B1|>65 years||Age, Categorical: Adult Population||participants|Number|33|33.0||||||
4013165|NCT01192022|3834537|B5|≤65 years||Age, Categorical: Adult Population||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4013166|NCT01192022|3834538|B4|≤65 years||Age, Categorical: Adult Population||participants|Number|NA|||||||Pediatric age is reported separately.
4013167|NCT01192022|3834539|B3|≤65 years||Age, Categorical: Adult Population||participants|Number|NA|||||||Pediatric age is reported separately.
4013168|NCT01192022|3834540|B2|≤65 years||Age, Categorical: Adult Population||participants|Number|76|76.0||||||
4013169|NCT01192022|3834541|B1|≤65 years||Age, Categorical: Adult Population||participants|Number|81|81.0||||||
4013170|NCT01192022|3834537|B5|Unknown||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4013171|NCT01192022|3834538|B4|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4013172|NCT01192022|3834539|B3|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4013173|NCT01192022|3834540|B2|Unknown||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4013174|NCT01192022|3834541|B1|Unknown||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4013175|NCT01192022|3834537|B5|Non-Hispanic/Non-Latino||Race/Ethnicity, Customized||participants|Number|216|216.0||||||
4013176|NCT01192022|3834538|B4|Non-Hispanic/Non-Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4013177|NCT01192022|3834539|B3|Non-Hispanic/Non-Latino||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4013178|NCT01192022|3834540|B2|Non-Hispanic/Non-Latino||Race/Ethnicity, Customized||participants|Number|98|98.0||||||
4013179|NCT01192022|3834541|B1|Non-Hispanic/Non-Latino||Race/Ethnicity, Customized||participants|Number|98|98.0||||||
4013180|NCT01192022|3834537|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4013181|NCT01192022|3834538|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4013182|NCT01192022|3834539|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4013183|NCT01192022|3834540|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4013184|NCT01192022|3834541|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4013185|NCT01192022|3834537|B5|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4013186|NCT01192022|3834538|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4013187|NCT01192022|3834539|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4013188|NCT01192022|3834540|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4013189|NCT01192022|3834541|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4013190|NCT01192022|3834537|B5|Mixed race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4013191|NCT01192022|3834538|B4|Mixed race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013192|NCT01192022|3834539|B3|Mixed race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013193|NCT01192022|3834540|B2|Mixed race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013194|NCT01192022|3834541|B1|Mixed race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4013195|NCT01192022|3834537|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4013196|NCT01192022|3834538|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013197|NCT01192022|3834539|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4013198|NCT01192022|3834540|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4013199|NCT01192022|3834541|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4013200|NCT01192022|3834537|B5|Asian||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4013201|NCT01192022|3834538|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4013202|NCT01192022|3834539|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4013203|NCT01192022|3834540|B2|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4013204|NCT01192022|3834541|B1|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4013205|NCT01192022|3834537|B5|White/Caucasian||Race/Ethnicity, Customized||participants|Number|203|203.0||||||
4013206|NCT01192022|3834538|B4|White/Caucasian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4013207|NCT01192022|3834539|B3|White/Caucasian||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4013208|NCT01192022|3834540|B2|White/Caucasian||Race/Ethnicity, Customized||participants|Number|87|87.0||||||
4013209|NCT01192022|3834541|B1|White/Caucasian||Race/Ethnicity, Customized||participants|Number|93|93.0||||||
4013210|NCT01192022|3834537|B5||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4013211|NCT01192022|3834538|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4013212|NCT01192022|3834539|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4013213|NCT01192022|3834540|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4013214|NCT01192022|3834541|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4013215|NCT01192022|3834537|B5||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4013216|NCT01192022|3834538|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4013217|NCT01192022|3834539|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4013218|NCT01192022|3834540|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4013219|NCT01192022|3834541|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4013220|NCT01192022|3834537|B5|||Age||Years|Mean|NA||Standard Deviation|NA||||Total Mean and SD not calculated for the 4 Arms combined.
4013221|NCT01192022|3834538|B4|||Age||Years|Mean|3.77|3.77|Standard Deviation|5.107|5.107|||
4013222|NCT01192022|3834539|B3|||Age||Years|Mean|4.58|4.58|Standard Deviation|4.716|4.716|||
4013223|NCT01192022|3834540|B2|||Age||Years|Mean|57.8|57.8|Standard Deviation|14.27|14.27|||
4013224|NCT01192022|3834541|B1|||Age||Years|Mean|58.4|58.4|Standard Deviation|13.69|13.69|||
4013225|NCT01192022|3834537|B5|||Age|Pediatric Participants|years|Mean|4.33|4.33|Standard Deviation|4.764|4.764|||
4013226|NCT01192022|3834538|B4|||Age|Pediatric Participants|years|Mean|3.77|3.77|Standard Deviation|5.107|5.107|||
4013227|NCT01192022|3834539|B3|||Age|Pediatric Participants|years|Mean|4.58|4.58|Standard Deviation|4.716|4.716|||
4013228|NCT01192022|3834540|B2|||Age|Pediatric Participants|years|Mean|NA||Standard Deviation|NA||||Adult participants reported separately.
4013229|NCT01192022|3834541|B1|||Age|Pediatric Participants|years|Mean|NA||Standard Deviation|NA||||Adult participants reported separately.
4013230|NCT01192022|3834537|B5|||Age|Adult Participants|years|Mean|58.1|58.1|Standard Deviation|13.95|13.95|||
4013231|NCT01192022|3834538|B4|||Age|Adult Participants|years|Mean|NA||Standard Deviation|NA||||Pediatric population reported separately
4013232|NCT01192022|3834539|B3|||Age|Adult Participants|years|Mean|NA||Standard Deviation|NA||||Pediatric population reported separately.
4013233|NCT01192022|3834540|B2|||Age|Adult Participants|years|Mean|57.8|57.8|Standard Deviation|14.27|14.27|||
4013234|NCT01192022|3834541|B1|||Age|Adult Participants|years|Mean|58.4|58.4|Standard Deviation|13.69|13.69|||
4013235|NCT01191944|3834566|B3||Male|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
4013236|NCT01191944|3834567|B2||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4013238|NCT01191944|3834566|B3||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4013239|NCT01191944|3834567|B2||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4013240|NCT01191944|3834568|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4013241|NCT01191944|3834566|B3|||Age||years|Mean|62.0|62.0|Standard Deviation|9.06|9.06|||
4013242|NCT01191944|3834567|B2|||Age||years|Mean|61.8|61.8|Standard Deviation|9.03|9.03|||
4013243|NCT01191944|3834568|B1|||Age||years|Mean|62.2|62.2|Standard Deviation|9.10|9.1|||
4013244|NCT01191840|3834613|B3|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
4013245|NCT01191840|3834614|B2|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4013246|NCT01191840|3834615|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4013247|NCT01191840|3834613|B3|Race|More than one race|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4013248|NCT01191840|3834614|B2|Race|More than one race|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4013249|NCT01191840|3834615|B1|Race|More than one race|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4013250|NCT01191840|3834613|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|349|349.0||||||
4013251|NCT01191840|3834614|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|175|175.0||||||
4013252|NCT01191840|3834615|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|174|174.0||||||
4013253|NCT01191840|3834613|B3|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|123|123.0||||||
4013254|NCT01191840|3834614|B2|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|63|63.0||||||
4013255|NCT01191840|3834615|B1|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|60|60.0||||||
4013256|NCT01191840|3834613|B3|Race|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4013257|NCT01191840|3834614|B2|Race|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4013258|NCT01191840|3834615|B1|Race|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4013259|NCT01191840|3834613|B3|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4013260|NCT01191840|3834614|B2|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4013261|NCT01191840|3834615|B1|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4013262|NCT01191840|3834613|B3|Race|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4013263|NCT01191840|3834614|B2|Race|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4013264|NCT01191840|3834615|B1|Race|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4013265|NCT01191840|3834613|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4013266|NCT01191840|3834614|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4013267|NCT01191840|3834615|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4013268|NCT01191840|3834613|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|465|465.0||||||
4013269|NCT01191840|3834614|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|234|234.0||||||
4013270|NCT01191840|3834615|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|231|231.0||||||
4013271|NCT01191840|3834613|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4013272|NCT01191840|3834614|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4013273|NCT01191840|3834615|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4013274|NCT01191840|3834613|B3||Male|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
4013275|NCT01191840|3834614|B2||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4013276|NCT01191840|3834615|B1||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4013277|NCT01191840|3834613|B3||Female|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
4013278|NCT01191840|3834614|B2||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4013279|NCT01191840|3834615|B1||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4013280|NCT01191840|3834613|B3|||Age||years|Mean|56.6|56.6|Standard Deviation|16.8|16.8|||
4013281|NCT01191840|3834614|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|16.5|16.5|||
4013282|NCT01191840|3834615|B1|||Age||years|Mean|57.4|57.4|Standard Deviation|17.1|17.1|||
4013283|NCT01191827|3834630|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4013284|NCT01191827|3834631|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4013285|NCT01191827|3834632|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4013286|NCT01191827|3834630|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4013287|NCT01191827|3834631|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4013288|NCT01191827|3834632|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4013289|NCT01191827|3834630|B3|||Age||years|Mean|34.9|34.9|Standard Deviation|9.7|9.7|||
4013290|NCT01191827|3834631|B2|||Age||years|Mean|34.0|34.0|Standard Deviation|8.5|8.5|||
4013291|NCT01191827|3834632|B1|||Age||years|Mean|35.8|35.8|Standard Deviation|10.9|10.9|||
4013292|NCT01191801|3834639|B3|Germany||Region of Enrollment||participants|Number|58|58.0||||||
4013293|NCT01191801|3834640|B2|Germany||Region of Enrollment||participants|Number|31|31.0||||||
4013294|NCT01191801|3834641|B1|Germany||Region of Enrollment||participants|Number|27|27.0||||||
4013295|NCT01191801|3834639|B3|France||Region of Enrollment||participants|Number|88|88.0||||||
4013296|NCT01191801|3834640|B2|France||Region of Enrollment||participants|Number|50|50.0||||||
4013297|NCT01191801|3834641|B1|France||Region of Enrollment||participants|Number|38|38.0||||||
4013298|NCT01191801|3834639|B3|Australia||Region of Enrollment||participants|Number|45|45.0||||||
4013299|NCT01191801|3834640|B2|Australia||Region of Enrollment||participants|Number|20|20.0||||||
4013300|NCT01191801|3834641|B1|Australia||Region of Enrollment||participants|Number|25|25.0||||||
4013301|NCT01191801|3834639|B3|Italy||Region of Enrollment||participants|Number|38|38.0||||||
4013302|NCT01191801|3834640|B2|Italy||Region of Enrollment||participants|Number|18|18.0||||||
4013303|NCT01191801|3834641|B1|Italy||Region of Enrollment||participants|Number|20|20.0||||||
4013304|NCT01191801|3834639|B3|Korea, Republic of||Region of Enrollment||participants|Number|15|15.0||||||
4013305|NCT01191801|3834640|B2|Korea, Republic of||Region of Enrollment||participants|Number|5|5.0||||||
4013306|NCT01191801|3834641|B1|Korea, Republic of||Region of Enrollment||participants|Number|10|10.0||||||
4013307|NCT01191801|3834639|B3|Poland||Region of Enrollment||participants|Number|4|4.0||||||
4013308|NCT01191801|3834640|B2|Poland||Region of Enrollment||participants|Number|1|1.0||||||
4013309|NCT01191801|3834641|B1|Poland||Region of Enrollment||participants|Number|3|3.0||||||
4013310|NCT01191801|3834639|B3|Belgium||Region of Enrollment||participants|Number|36|36.0||||||
4013311|NCT01191801|3834640|B2|Belgium||Region of Enrollment||participants|Number|19|19.0||||||
4013312|NCT01191801|3834641|B1|Belgium||Region of Enrollment||participants|Number|17|17.0||||||
4013313|NCT01191801|3834639|B3|Austria||Region of Enrollment||participants|Number|8|8.0||||||
4013314|NCT01191801|3834640|B2|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4013315|NCT01191801|3834641|B1|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4013316|NCT01191801|3834639|B3|Czech Republic||Region of Enrollment||participants|Number|11|11.0||||||
4013317|NCT01191801|3834640|B2|Czech Republic||Region of Enrollment||participants|Number|6|6.0||||||
4013318|NCT01191801|3834641|B1|Czech Republic||Region of Enrollment||participants|Number|5|5.0||||||
4013319|NCT01191801|3834639|B3|Canada||Region of Enrollment||participants|Number|20|20.0||||||
4013320|NCT01191801|3834640|B2|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4013321|NCT01191801|3834641|B1|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4013322|NCT01191801|3834639|B3|New Zealand||Region of Enrollment||participants|Number|7|7.0||||||
4013323|NCT01191801|3834640|B2|New Zealand||Region of Enrollment||participants|Number|3|3.0||||||
4013324|NCT01191801|3834641|B1|New Zealand||Region of Enrollment||participants|Number|4|4.0||||||
4013325|NCT01191801|3834639|B3|Spain||Region of Enrollment||participants|Number|17|17.0||||||
4013326|NCT01191801|3834640|B2|Spain||Region of Enrollment||participants|Number|8|8.0||||||
4013327|NCT01191801|3834641|B1|Spain||Region of Enrollment||participants|Number|9|9.0||||||
4013328|NCT01191801|3834639|B3|United Kingdom||Region of Enrollment||participants|Number|25|25.0||||||
4013329|NCT01191801|3834640|B2|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
4013330|NCT01191801|3834641|B1|United Kingdom||Region of Enrollment||participants|Number|15|15.0||||||
4013331|NCT01191801|3834639|B3|United States||Region of Enrollment||participants|Number|320|320.0||||||
4013332|NCT01191801|3834640|B2|United States||Region of Enrollment||participants|Number|159|159.0||||||
4013333|NCT01191801|3834641|B1|United States||Region of Enrollment||participants|Number|161|161.0||||||
4013334|NCT01191801|3834639|B3|Hungary||Region of Enrollment||participants|Number|19|19.0||||||
4013335|NCT01191801|3834640|B2|Hungary||Region of Enrollment||participants|Number|11|11.0||||||
4013336|NCT01191801|3834641|B1|Hungary||Region of Enrollment||participants|Number|8|8.0||||||
4013337|NCT01191801|3834639|B3||Male|Sex: Female, Male||Participants|Count of Participants|394|394.0||||||
4013338|NCT01191801|3834640|B2||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4013339|NCT01191801|3834641|B1||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4013340|NCT01191801|3834639|B3||Female|Sex: Female, Male||Participants|Count of Participants|317|317.0||||||
4013341|NCT01191801|3834640|B2||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4013342|NCT01191801|3834641|B1||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4013343|NCT01191801|3834639|B3|||Age||years|Mean|60.6|60.6|Standard Deviation|12.01|12.01|||
4013344|NCT01191801|3834640|B2|||Age||years|Mean|60.2|60.2|Standard Deviation|12.49|12.49|||
4013345|NCT01191801|3834641|B1|||Age||years|Mean|61|61.0|Standard Deviation|11.51|11.51|||
4013346|NCT01191788|3834660|B3|United States||Region of Enrollment||participants|Number|299|299.0||||||
4013347|NCT01191788|3834661|B2|United States||Region of Enrollment||participants|Number|159|159.0||||||
4013348|NCT01191788|3834662|B1|United States||Region of Enrollment||participants|Number|140|140.0||||||
4013349|NCT01191788|3834660|B3||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4013350|NCT01191788|3834661|B2||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4013351|NCT01191788|3834662|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4013352|NCT01191788|3834660|B3||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4013353|NCT01191788|3834661|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4013354|NCT01191788|3834662|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4013355|NCT01191788|3834660|B3|||Age||years|Mean|36.23|36.23|Standard Deviation|10.34|10.34|||
4013356|NCT01191788|3834661|B2|||Age||years|Mean|37.04|37.04|Standard Deviation|10.53|10.53|||
4013357|NCT01191788|3834662|B1|||Age||years|Mean|35.31|35.31|Standard Deviation|10.08|10.08|||
4013358|NCT01191788|3834660|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4013359|NCT01191788|3834661|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4013360|NCT01191788|3834662|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4013361|NCT01191788|3834660|B3||Between 18 and 65 years|Age||Participants|Count of Participants|298|298.0||||||
4013362|NCT01191788|3834661|B2||Between 18 and 65 years|Age||Participants|Count of Participants|159|159.0||||||
4013363|NCT01191788|3834662|B1||Between 18 and 65 years|Age||Participants|Count of Participants|139|139.0||||||
4013364|NCT01191788|3834660|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4013365|NCT01191788|3834661|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4013366|NCT01191788|3834662|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4013367|NCT01191762|3834671|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
4013368|NCT01191762|3834672|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4013369|NCT01191762|3834673|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4013370|NCT01191762|3834671|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4013371|NCT01191762|3834672|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4013372|NCT01191762|3834673|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4013373|NCT01191762|3834671|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4013374|NCT01191762|3834672|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4013375|NCT01191762|3834673|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4013376|NCT01191762|3834671|B3|||Age||years|Mean|71.8|71.8|Standard Deviation|9.6|9.6|||
4013377|NCT01191762|3834672|B2|||Age||years|Mean|70.1|70.1|Standard Deviation|10.5|10.5|||
4013378|NCT01191762|3834673|B1|||Age||years|Mean|73.7|73.7|Standard Deviation|8.5|8.5|||
4013379|NCT01191762|3834671|B3||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4013380|NCT01191762|3834672|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4013381|NCT01191762|3834673|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4013382|NCT01191762|3834671|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4013383|NCT01191762|3834672|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4013384|NCT01191762|3834673|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4013385|NCT01191762|3834671|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4013386|NCT01191762|3834672|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4013387|NCT01191762|3834673|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4013388|NCT01191749|3834680|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4013389|NCT01191749|3834680|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4013390|NCT01191749|3834680|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4013391|NCT01191749|3834680|B1|||Age||years|Median|62|62.0|Full Range|||60.0|74.0|
4013392|NCT01191749|3834680|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4013393|NCT01191749|3834680|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4013394|NCT01191749|3834680|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4013395|NCT01191736|3834684|B8|United States||Region of Enrollment||participants|Number|336|336.0||||||
4013396|NCT01191736|3834685|B7|United States||Region of Enrollment||participants|Number|45|45.0||||||
4013397|NCT01191736|3834686|B6|United States||Region of Enrollment||participants|Number|50|50.0||||||
4013398|NCT01191736|3834687|B5|United States||Region of Enrollment||participants|Number|48|48.0||||||
4013399|NCT01191736|3834688|B4|United States||Region of Enrollment||participants|Number|46|46.0||||||
4013400|NCT01191736|3834689|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
4013401|NCT01191736|3834690|B2|United States||Region of Enrollment||participants|Number|47|47.0||||||
4013402|NCT01191736|3834691|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4013403|NCT01191736|3834684|B8||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4013404|NCT01191736|3834685|B7||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4013405|NCT01191736|3834686|B6||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4013406|NCT01191736|3834687|B5||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4013407|NCT01191736|3834688|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4013408|NCT01191736|3834689|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4013409|NCT01191736|3834690|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4013410|NCT01191736|3834691|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4013411|NCT01191736|3834684|B8||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4013412|NCT01191736|3834685|B7||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4013413|NCT01191736|3834686|B6||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4013414|NCT01191736|3834687|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4013415|NCT01191736|3834688|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4013416|NCT01191736|3834689|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4013417|NCT01191736|3834690|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4013418|NCT01191736|3834691|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4013419|NCT01191736|3834684|B8|||Age||years|Mean|47.1|47.1|Standard Deviation|13.8|13.8|||
4013420|NCT01191736|3834685|B7|||Age||years|Mean|47.4|47.4|Standard Deviation|11.9|11.9|||
4013421|NCT01191736|3834686|B6|||Age||years|Mean|45.3|45.3|Standard Deviation|13.8|13.8|||
4013422|NCT01191736|3834687|B5|||Age||years|Mean|48.1|48.1|Standard Deviation|14.5|14.5|||
4013423|NCT01191736|3834688|B4|||Age||years|Mean|41.7|41.7|Standard Deviation|14.2|14.2|||
4013424|NCT01191736|3834689|B3|||Age||years|Mean|50.5|50.5|Standard Deviation|13.3|13.3|||
4013425|NCT01191736|3834690|B2|||Age||years|Mean|51.7|51.7|Standard Deviation|15.2|15.2|||
4013426|NCT01191736|3834691|B1|||Age||years|Mean|44.8|44.8|Standard Deviation|11.8|11.8|||
4013427|NCT01191736|3834684|B8||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
4013428|NCT01191736|3834685|B7||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4013429|NCT01191736|3834686|B6||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4013430|NCT01191736|3834687|B5||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4013431|NCT01191736|3834688|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4013432|NCT01191736|3834689|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4013433|NCT01191736|3834690|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4013434|NCT01191736|3834691|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4013435|NCT01191736|3834684|B8||Between 18 and 65 years|Age||Participants|Count of Participants|289|289.0||||||
4013436|NCT01191736|3834685|B7||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4013437|NCT01191736|3834686|B6||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4013438|NCT01191736|3834687|B5||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4013439|NCT01191736|3834688|B4||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4013440|NCT01191736|3834689|B3||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4013441|NCT01191736|3834690|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4013442|NCT01191736|3834691|B1||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4013443|NCT01191736|3834684|B8||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4013444|NCT01191736|3834685|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4013445|NCT01191736|3834686|B6||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4013446|NCT01191736|3834687|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4013447|NCT01191736|3834688|B4||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4013448|NCT01191736|3834689|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4013449|NCT01191736|3834690|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4013450|NCT01191736|3834691|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4013451|NCT01191723|3834720|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4013452|NCT01191723|3834720|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4013453|NCT01191723|3834720|B1|||Age||years|Mean|28.0|28.0|Standard Deviation|6.79|6.79|||
4013454|NCT01191476|3834743|B4|China||Region of Enrollment||participants|Number|334|334.0||||||
4013455|NCT01191476|3834744|B3|China||Region of Enrollment||participants|Number|111|111.0||||||
4013456|NCT01191476|3834745|B2|China||Region of Enrollment||participants|Number|111|111.0||||||
4013457|NCT01191476|3834746|B1|China||Region of Enrollment||participants|Number|112|112.0||||||
4013458|NCT01191476|3834743|B4||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4013459|NCT01191476|3834744|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4013460|NCT01191476|3834745|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4013461|NCT01191476|3834746|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4013462|NCT01191476|3834743|B4||Female|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
4013463|NCT01191476|3834744|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4013464|NCT01191476|3834745|B2||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4013465|NCT01191476|3834746|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4013466|NCT01191476|3834743|B4|||Age||years|Mean|42.71|42.71|Standard Deviation|11.96|11.96|||
4013467|NCT01191476|3834744|B3|||Age||years|Mean|42.51|42.51|Standard Deviation|11.81|11.81|||
4013468|NCT01191476|3834745|B2|||Age||years|Mean|43.26|43.26|Standard Deviation|12.05|12.05|||
4013469|NCT01191476|3834746|B1|||Age||years|Mean|42.29|42.29|Standard Deviation|12.15|12.15|||
4013470|NCT01191476|3834743|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4013471|NCT01191476|3834744|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4013472|NCT01191476|3834745|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4013473|NCT01191476|3834746|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4013474|NCT01191476|3834743|B4||Between 18 and 65 years|Age||Participants|Count of Participants|334|334.0||||||
4013475|NCT01191476|3834744|B3||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
4013476|NCT01191476|3834745|B2||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
4013477|NCT01191476|3834746|B1||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
4013478|NCT01191476|3834743|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4013479|NCT01191476|3834744|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4013480|NCT01191476|3834745|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4013481|NCT01191476|3834746|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4013482|NCT01191411|3834768|B4|Spanish||Primary Language||participants|Number|985|985.0||||||
4013483|NCT01191411|3834769|B3|Spanish||Primary Language||participants|Number|645|645.0||||||
4013484|NCT01191411|3834770|B2|Spanish||Primary Language||participants|Number|69|69.0||||||
4013485|NCT01191411|3834771|B1|Spanish||Primary Language||participants|Number|271|271.0||||||
4013486|NCT01191411|3834768|B4|English||Primary Language||participants|Number|4985|4985.0||||||
4013487|NCT01191411|3834769|B3|English||Primary Language||participants|Number|3253|3253.0||||||
4013488|NCT01191411|3834770|B2|English||Primary Language||participants|Number|410|410.0||||||
4013489|NCT01191411|3834771|B1|English||Primary Language||participants|Number|1322|1322.0||||||
4013490|NCT01191411|3834768|B4|Other||Race/Ethnicity, Customized||participants|Number|404|404.0||||||
4013491|NCT01191411|3834769|B3|Other||Race/Ethnicity, Customized||participants|Number|245|245.0||||||
4013492|NCT01191411|3834770|B2|Other||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4013493|NCT01191411|3834771|B1|Other||Race/Ethnicity, Customized||participants|Number|125|125.0||||||
4013494|NCT01191411|3834768|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|1707|1707.0||||||
4013495|NCT01191411|3834769|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1140|1140.0||||||
4013496|NCT01191411|3834770|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|122|122.0||||||
4013497|NCT01191411|3834771|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|445|445.0||||||
4013498|NCT01191411|3834768|B4|Black||Race/Ethnicity, Customized||participants|Number|1411|1411.0||||||
4013499|NCT01191411|3834769|B3|Black||Race/Ethnicity, Customized||participants|Number|913|913.0||||||
4013500|NCT01191411|3834770|B2|Black||Race/Ethnicity, Customized||participants|Number|128|128.0||||||
4013501|NCT01191411|3834771|B1|Black||Race/Ethnicity, Customized||participants|Number|370|370.0||||||
4013502|NCT01191411|3834768|B4|White||Race/Ethnicity, Customized||participants|Number|2448|2448.0||||||
4013503|NCT01191411|3834769|B3|White||Race/Ethnicity, Customized||participants|Number|1600|1600.0||||||
4013504|NCT01191411|3834770|B2|White||Race/Ethnicity, Customized||participants|Number|195|195.0||||||
4013505|NCT01191411|3834771|B1|White||Race/Ethnicity, Customized||participants|Number|653|653.0||||||
4013506|NCT01191411|3834768|B4||Male|Sex: Female, Male||Participants|Count of Participants|2174|2174.0||||||
4013507|NCT01191411|3834769|B3||Male|Sex: Female, Male||Participants|Count of Participants|1381|1381.0||||||
4013508|NCT01191411|3834770|B2||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4013509|NCT01191411|3834771|B1||Male|Sex: Female, Male||Participants|Count of Participants|600|600.0||||||
4013510|NCT01191411|3834768|B4||Female|Sex: Female, Male||Participants|Count of Participants|3796|3796.0||||||
4013511|NCT01191411|3834769|B3||Female|Sex: Female, Male||Participants|Count of Participants|2517|2517.0||||||
4013512|NCT01191411|3834770|B2||Female|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
4013513|NCT01191411|3834771|B1||Female|Sex: Female, Male||Participants|Count of Participants|993|993.0||||||
4013514|NCT01191411|3834768|B4|||Age||years|Mean|59|59.0|Standard Deviation|3|3.0|||
4013515|NCT01191411|3834769|B3|||Age||years|Mean|59|59.0|Standard Deviation|3|3.0|||
4013516|NCT01191411|3834770|B2|||Age||years|Mean|59|59.0|Standard Deviation|3|3.0|||
4013517|NCT01191411|3834771|B1|||Age||years|Mean|59|59.0|Standard Deviation|3|3.0|||
4013518|NCT01191398|3834781|B4|United States||Region of Enrollment||participants|Number|52|52.0||||||
4013519|NCT01191398|3834782|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4013520|NCT01191398|3834783|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4013521|NCT01191398|3834784|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4013522|NCT01191398|3834781|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4013523|NCT01191398|3834782|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4013524|NCT01191398|3834783|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4013525|NCT01191398|3834784|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4013526|NCT01191398|3834781|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4013527|NCT01191398|3834782|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4013528|NCT01191398|3834783|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4013529|NCT01191398|3834784|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4013530|NCT01191398|3834781|B4|||Age||years|Mean|4.85|4.85|Standard Deviation|3.01|3.01|||
4013531|NCT01191398|3834782|B3|||Age||years|Mean|4.48|4.48|Standard Deviation|3.09|3.09|||
4013532|NCT01191398|3834783|B2|||Age||years|Mean|5.09|5.09|Standard Deviation|3.76|3.76|||
4013533|NCT01191398|3834784|B1|||Age||years|Mean|5.34|5.34|Standard Deviation|4.07|4.07|||
4013534|NCT01191333|3834797|B3|||Montgomery Asberg Depression Rating Scale (MADRS)|As another measure of depression, the Montgomery-Asberg Depression Rating Scale (MADRS) has been used with increasing frequency in recent years to measure outcome in antidepressant efficacy trials. It offers an alternative view of depressive illness, and may be sensitive to depressive symptoms that are not easily captured in the context of the HRSD, such as hypersomnia, increased appetite, and concentration/indecision. The MADRS is a 10-item clinician rating of depressive symptoms. Each item is scored on a 7-point scale (0 to 6) (range 0–60).|units on a scale|Mean|25.5|25.5|Standard Deviation|7.3|7.3|||
4013535|NCT01191333|3834798|B2|||Montgomery Asberg Depression Rating Scale (MADRS)|As another measure of depression, the Montgomery-Asberg Depression Rating Scale (MADRS) has been used with increasing frequency in recent years to measure outcome in antidepressant efficacy trials. It offers an alternative view of depressive illness, and may be sensitive to depressive symptoms that are not easily captured in the context of the HRSD, such as hypersomnia, increased appetite, and concentration/indecision. The MADRS is a 10-item clinician rating of depressive symptoms. Each item is scored on a 7-point scale (0 to 6) (range 0–60).|units on a scale|Mean|26.2|26.2|Standard Deviation|6.9|6.9|||
4013536|NCT01191333|3834799|B1|||Montgomery Asberg Depression Rating Scale (MADRS)|As another measure of depression, the Montgomery-Asberg Depression Rating Scale (MADRS) has been used with increasing frequency in recent years to measure outcome in antidepressant efficacy trials. It offers an alternative view of depressive illness, and may be sensitive to depressive symptoms that are not easily captured in the context of the HRSD, such as hypersomnia, increased appetite, and concentration/indecision. The MADRS is a 10-item clinician rating of depressive symptoms. Each item is scored on a 7-point scale (0 to 6) (range 0–60).|units on a scale|Mean|24.7|24.7|Standard Deviation|7.6|7.6|||
4013537|NCT01191333|3834797|B3|||VR-36 Physical Component Summary (PCS)|Standardized scoring ranging from 0-100. A higher score represents a better outcome|units on a scale|Mean|41.3|41.3|Standard Deviation|10.8|10.8|||
4013538|NCT01191333|3834798|B2|||VR-36 Physical Component Summary (PCS)|Standardized scoring ranging from 0-100. A higher score represents a better outcome|units on a scale|Mean|40.2|40.2|Standard Deviation|10.0|10.0|||
4013539|NCT01191333|3834799|B1|||VR-36 Physical Component Summary (PCS)|Standardized scoring ranging from 0-100. A higher score represents a better outcome|units on a scale|Mean|42.4|42.4|Standard Deviation|11.5|11.5|||
4013540|NCT01191333|3834797|B3|||VR-36 Mental Component Summary (MCS)|Standardized scoring ranging from 0-100. A higher score represents a better outcome|units on a scale|Mean|26.2|26.2|Standard Deviation|10.8|10.8|||
4013541|NCT01191333|3834798|B2|||VR-36 Mental Component Summary (MCS)|Standardized scoring ranging from 0-100. A higher score represents a better outcome|units on a scale|Mean|25.1|25.1|Standard Deviation|10.0|10.0|||
4013542|NCT01191333|3834799|B1|||VR-36 Mental Component Summary (MCS)|Standardized scoring ranging from 0-100. A higher score represents a better outcome|units on a scale|Mean|27.2|27.2|Standard Deviation|11.6|11.6|||
4013543|NCT01191333|3834797|B3|||Beck Depression Inventory (BDI)|This measure is a 21-item self-report test presented in a multiple choice format which measures presence and extent of depression with overall score range from 0 - 63. A higher score represents a worse outcome.|units on a scale|Mean|24.5|24.5|Standard Deviation|10.3|10.3|||
4013544|NCT01191333|3834798|B2|||Beck Depression Inventory (BDI)|This measure is a 21-item self-report test presented in a multiple choice format which measures presence and extent of depression with overall score range from 0 - 63. A higher score represents a worse outcome.|units on a scale|Mean|26.5|26.5|Standard Deviation|10.0|10.0|||
4013545|NCT01191333|3834799|B1|||Beck Depression Inventory (BDI)|This measure is a 21-item self-report test presented in a multiple choice format which measures presence and extent of depression with overall score range from 0 - 63. A higher score represents a worse outcome.|units on a scale|Mean|22.6|22.6|Standard Deviation|10.3|10.3|||
4013546|NCT01191333|3834797|B3|||Beck Scale for Suicide Ideation (BSI)|This self-report measure consists of 21 items with overall score range from 0 - 38, with the last two items not counted in scoring. A high score represents a worse outcome.|units on a scale|Mean|4.7|4.7|Standard Deviation|6.5|6.5|||
4013547|NCT01191333|3834798|B2|||Beck Scale for Suicide Ideation (BSI)|This self-report measure consists of 21 items with overall score range from 0 - 38, with the last two items not counted in scoring. A high score represents a worse outcome.|units on a scale|Mean|5.6|5.6|Standard Deviation|6.7|6.7|||
4013548|NCT01191333|3834799|B1|||Beck Scale for Suicide Ideation (BSI)|This self-report measure consists of 21 items with overall score range from 0 - 38, with the last two items not counted in scoring. A high score represents a worse outcome.|units on a scale|Mean|3.7|3.7|Standard Deviation|6.0|6.0|||
4013549|NCT01191333|3834797|B3|United States||Region of Enrollment||Participants|Count of Participants|164|164.0||||||
4013550|NCT01191333|3834798|B2|United States||Region of Enrollment||Participants|Count of Participants|83|83.0||||||
4013551|NCT01191333|3834799|B1|United States||Region of Enrollment||Participants|Count of Participants|81|81.0||||||
4013552|NCT01191333|3834797|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4013553|NCT01191333|3834798|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4013554|NCT01191333|3834799|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4013555|NCT01191333|3834797|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4013556|NCT01191333|3834798|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4013557|NCT01191333|3834799|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4013558|NCT01191333|3834797|B3||White|Race (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
4013559|NCT01191333|3834798|B2||White|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4013560|NCT01191333|3834799|B1||White|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4013561|NCT01191333|3834797|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4013562|NCT01191333|3834798|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4013563|NCT01191333|3834799|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4013564|NCT01191333|3834797|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4013565|NCT01191333|3834798|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4013566|NCT01191333|3834799|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4013567|NCT01191333|3834797|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4013568|NCT01191333|3834798|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4013569|NCT01191333|3834799|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4013570|NCT01191333|3834797|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4013571|NCT01191333|3834798|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4013572|NCT01191333|3834799|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4013573|NCT01191333|3834797|B3||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4013574|NCT01191333|3834798|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4013575|NCT01191333|3834799|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4013576|NCT01191333|3834797|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4013577|NCT01191333|3834798|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4013578|NCT01191333|3834799|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4013579|NCT01191333|3834797|B3|||Age||years|Mean|55.2|55.2|Standard Deviation|12.4|12.4|||
4013580|NCT01191333|3834798|B2|||Age||years|Mean|54.8|54.8|Standard Deviation|12.6|12.6|||
4013581|NCT01191333|3834799|B1|||Age||years|Mean|55.6|55.6|Standard Deviation|12.2|12.2|||
4013582|NCT01191320|3834816|B4|||HgbA1c ratio||Ratio|Mean|0.08|0.08|Standard Deviation|0.014|0.014|||
4013583|NCT01191320|3834817|B3|||HgbA1c ratio||Ratio|Mean|0.09|0.09|Standard Deviation|0.017|0.017|||
4013584|NCT01191320|3834818|B2|||HgbA1c ratio||Ratio|Mean|0.08|0.08|Standard Deviation|0.013|0.013|||
4013585|NCT01191320|3834819|B1|||HgbA1c ratio||Ratio|Mean|0.08|0.08|Standard Deviation|0.012|0.012|||
4013586|NCT01191320|3834816|B4|United States||Region of Enrollment||participants|Number|119|119.0||||||
4013587|NCT01191320|3834817|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
4013588|NCT01191320|3834818|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
4013589|NCT01191320|3834819|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4013590|NCT01191320|3834816|B4||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4013591|NCT01191320|3834817|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4013592|NCT01191320|3834818|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4013593|NCT01191320|3834819|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4013594|NCT01191320|3834816|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4013595|NCT01191320|3834817|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4013596|NCT01191320|3834818|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4013597|NCT01191320|3834819|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4013598|NCT01191320|3834816|B4|||Age||years|Mean|57.0|57.0|Standard Deviation|8.7|8.7|||
4013599|NCT01191320|3834817|B3|||Age||years|Mean|57.6|57.6|Standard Deviation|8.4|8.4|||
4013600|NCT01191320|3834818|B2|||Age||years|Mean|55.9|55.9|Standard Deviation|9.5|9.5|||
4013601|NCT01191320|3834819|B1|||Age||years|Mean|57.3|57.3|Standard Deviation|8.4|8.4|||
4013602|NCT01191268|3834829|B4|||Duration of Diabetes||years|Mean|12.73|12.73|Standard Deviation|6.97|6.97|||
4013603|NCT01191268|3834830|B3|||Duration of Diabetes||years|Mean|12.96|12.96|Standard Deviation|6.80|6.8|||
4013604|NCT01191268|3834831|B2|||Duration of Diabetes||years|Mean|12.43|12.43|Standard Deviation|6.92|6.92|||
4013605|NCT01191268|3834832|B1|||Duration of Diabetes||years|Mean|12.80|12.8|Standard Deviation|7.19|7.19|||
4013606|NCT01191268|3834829|B4|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|8.46|8.46|Standard Deviation|1.05|1.05|||
4013607|NCT01191268|3834830|B3|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|8.53|8.53|Standard Deviation|1.03|1.03|||
4013608|NCT01191268|3834831|B2|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|8.40|8.4|Standard Deviation|1.03|1.03|||
4013609|NCT01191268|3834832|B1|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|8.46|8.46|Standard Deviation|1.08|1.08|||
4013610|NCT01191268|3834829|B4|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|32.49|32.49|Standard Deviation|5.21|5.21|||
4013611|NCT01191268|3834830|B3|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|32.41|32.41|Standard Deviation|5.33|5.33|||
4013612|NCT01191268|3834831|B2|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|33.08|33.08|Standard Deviation|5.15|5.15|||
4013613|NCT01191268|3834832|B1|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|31.99|31.99|Standard Deviation|5.11|5.11|||
4013614|NCT01191268|3834829|B4|||Body Weight||kilograms (kg)|Mean|91.14|91.14|Standard Deviation|18.37|18.37|||
4013615|NCT01191268|3834830|B3|||Body Weight||kilograms (kg)|Mean|90.75|90.75|Standard Deviation|18.87|18.87|||
4013616|NCT01191268|3834831|B2|||Body Weight||kilograms (kg)|Mean|91.69|91.69|Standard Deviation|18.03|18.03|||
4013617|NCT01191268|3834832|B1|||Body Weight||kilograms (kg)|Mean|91.00|91.0|Standard Deviation|18.24|18.24|||
4013618|NCT01191268|3834829|B4|Sweden||Region of Enrollment||participants|Number|34|34.0||||||
4013619|NCT01191268|3834830|B3|Sweden||Region of Enrollment||participants|Number|12|12.0||||||
4013620|NCT01191268|3834831|B2|Sweden||Region of Enrollment||participants|Number|11|11.0||||||
4013621|NCT01191268|3834832|B1|Sweden||Region of Enrollment||participants|Number|11|11.0||||||
4013622|NCT01191268|3834829|B4|Australia||Region of Enrollment||participants|Number|26|26.0||||||
4013623|NCT01191268|3834830|B3|Australia||Region of Enrollment||participants|Number|8|8.0||||||
4013624|NCT01191268|3834831|B2|Australia||Region of Enrollment||participants|Number|8|8.0||||||
4013625|NCT01191268|3834832|B1|Australia||Region of Enrollment||participants|Number|10|10.0||||||
4013626|NCT01191268|3834829|B4|Denmark||Region of Enrollment||participants|Number|12|12.0||||||
4013627|NCT01191268|3834830|B3|Denmark||Region of Enrollment||participants|Number|4|4.0||||||
4013628|NCT01191268|3834831|B2|Denmark||Region of Enrollment||participants|Number|4|4.0||||||
4013629|NCT01191268|3834832|B1|Denmark||Region of Enrollment||participants|Number|4|4.0||||||
4013630|NCT01191268|3834829|B4|Belgium||Region of Enrollment||participants|Number|14|14.0||||||
4013631|NCT01191268|3834830|B3|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
4013632|NCT01191268|3834831|B2|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
4013633|NCT01191268|3834832|B1|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
4013634|NCT01191268|3834829|B4|Brazil||Region of Enrollment||participants|Number|95|95.0||||||
4013635|NCT01191268|3834830|B3|Brazil||Region of Enrollment||participants|Number|32|32.0||||||
4013636|NCT01191268|3834831|B2|Brazil||Region of Enrollment||participants|Number|30|30.0||||||
4013637|NCT01191268|3834832|B1|Brazil||Region of Enrollment||participants|Number|33|33.0||||||
4013638|NCT01191268|3834829|B4|Poland||Region of Enrollment||participants|Number|40|40.0||||||
4013639|NCT01191268|3834830|B3|Poland||Region of Enrollment||participants|Number|14|14.0||||||
4013640|NCT01191268|3834831|B2|Poland||Region of Enrollment||participants|Number|13|13.0||||||
4013641|NCT01191268|3834832|B1|Poland||Region of Enrollment||participants|Number|13|13.0||||||
4013642|NCT01191268|3834829|B4|Argentina||Region of Enrollment||participants|Number|81|81.0||||||
4013643|NCT01191268|3834830|B3|Argentina||Region of Enrollment||participants|Number|28|28.0||||||
4013644|NCT01191268|3834831|B2|Argentina||Region of Enrollment||participants|Number|27|27.0||||||
4013645|NCT01191268|3834832|B1|Argentina||Region of Enrollment||participants|Number|26|26.0||||||
4013646|NCT01191268|3834829|B4|Puerto Rico||Region of Enrollment||participants|Number|51|51.0||||||
4013647|NCT01191268|3834830|B3|Puerto Rico||Region of Enrollment||participants|Number|18|18.0||||||
4013648|NCT01191268|3834831|B2|Puerto Rico||Region of Enrollment||participants|Number|20|20.0||||||
4013649|NCT01191268|3834832|B1|Puerto Rico||Region of Enrollment||participants|Number|13|13.0||||||
4013650|NCT01191268|3834829|B4|Canada||Region of Enrollment||participants|Number|26|26.0||||||
4013651|NCT01191268|3834830|B3|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4013652|NCT01191268|3834831|B2|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4013653|NCT01191268|3834832|B1|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4013654|NCT01191268|3834829|B4|Mexico||Region of Enrollment||participants|Number|55|55.0||||||
4013655|NCT01191268|3834830|B3|Mexico||Region of Enrollment||participants|Number|17|17.0||||||
4013656|NCT01191268|3834831|B2|Mexico||Region of Enrollment||participants|Number|19|19.0||||||
4013657|NCT01191268|3834832|B1|Mexico||Region of Enrollment||participants|Number|19|19.0||||||
4013658|NCT01191268|3834829|B4|Hungary||Region of Enrollment||participants|Number|57|57.0||||||
4013659|NCT01191268|3834830|B3|Hungary||Region of Enrollment||participants|Number|19|19.0||||||
4013660|NCT01191268|3834831|B2|Hungary||Region of Enrollment||participants|Number|19|19.0||||||
4013661|NCT01191268|3834832|B1|Hungary||Region of Enrollment||participants|Number|19|19.0||||||
4013662|NCT01191268|3834829|B4|Russian Federation||Region of Enrollment||participants|Number|23|23.0||||||
4013663|NCT01191268|3834830|B3|Russian Federation||Region of Enrollment||participants|Number|9|9.0||||||
4013664|NCT01191268|3834831|B2|Russian Federation||Region of Enrollment||participants|Number|8|8.0||||||
4013665|NCT01191268|3834832|B1|Russian Federation||Region of Enrollment||participants|Number|6|6.0||||||
4013666|NCT01191268|3834829|B4|Spain||Region of Enrollment||participants|Number|27|27.0||||||
4013667|NCT01191268|3834830|B3|Spain||Region of Enrollment||participants|Number|9|9.0||||||
4013668|NCT01191268|3834831|B2|Spain||Region of Enrollment||participants|Number|10|10.0||||||
4013669|NCT01191268|3834832|B1|Spain||Region of Enrollment||participants|Number|8|8.0||||||
4013670|NCT01191268|3834829|B4|Greece||Region of Enrollment||participants|Number|23|23.0||||||
4013671|NCT01191268|3834830|B3|Greece||Region of Enrollment||participants|Number|8|8.0||||||
4013672|NCT01191268|3834831|B2|Greece||Region of Enrollment||participants|Number|7|7.0||||||
4013673|NCT01191268|3834832|B1|Greece||Region of Enrollment||participants|Number|8|8.0||||||
4013674|NCT01191268|3834829|B4|Taiwan||Region of Enrollment||participants|Number|26|26.0||||||
4013675|NCT01191268|3834830|B3|Taiwan||Region of Enrollment||participants|Number|9|9.0||||||
4013676|NCT01191268|3834831|B2|Taiwan||Region of Enrollment||participants|Number|9|9.0||||||
4013677|NCT01191268|3834832|B1|Taiwan||Region of Enrollment||participants|Number|8|8.0||||||
4013678|NCT01191268|3834829|B4|United States||Region of Enrollment||participants|Number|294|294.0||||||
4013679|NCT01191268|3834830|B3|United States||Region of Enrollment||participants|Number|96|96.0||||||
4013680|NCT01191268|3834831|B2|United States||Region of Enrollment||participants|Number|95|95.0||||||
4013681|NCT01191268|3834832|B1|United States||Region of Enrollment||participants|Number|103|103.0||||||
4013682|NCT01191268|3834829|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4013683|NCT01191268|3834830|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4013684|NCT01191268|3834831|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4013685|NCT01191268|3834832|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4013686|NCT01191268|3834829|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4013687|NCT01191268|3834830|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4013688|NCT01191268|3834831|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4013689|NCT01191268|3834832|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4013690|NCT01191268|3834829|B4||White|Race (NIH/OMB)||Participants|Count of Participants|697|697.0||||||
4013691|NCT01191268|3834830|B3||White|Race (NIH/OMB)||Participants|Count of Participants|231|231.0||||||
4013692|NCT01191268|3834831|B2||White|Race (NIH/OMB)||Participants|Count of Participants|235|235.0||||||
4013693|NCT01191268|3834832|B1||White|Race (NIH/OMB)||Participants|Count of Participants|231|231.0||||||
4013694|NCT01191268|3834829|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
4013695|NCT01191268|3834830|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4013696|NCT01191268|3834831|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4013697|NCT01191268|3834832|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4013698|NCT01191268|3834829|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4013699|NCT01191268|3834830|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4013700|NCT01191268|3834831|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4013701|NCT01191268|3834832|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4013702|NCT01191268|3834829|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4013703|NCT01191268|3834830|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4013704|NCT01191268|3834831|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4013705|NCT01191268|3834832|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4013706|NCT01191268|3834829|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4013707|NCT01191268|3834830|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4013708|NCT01191268|3834831|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4013709|NCT01191268|3834832|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4013710|NCT01191268|3834829|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4013711|NCT01191268|3834830|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4013712|NCT01191268|3834831|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4013713|NCT01191268|3834832|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4013714|NCT01191268|3834829|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|581|581.0||||||
4013715|NCT01191268|3834830|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|196|196.0||||||
4013716|NCT01191268|3834831|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|192|192.0||||||
4013717|NCT01191268|3834832|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|193|193.0||||||
4013718|NCT01191268|3834829|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|303|303.0||||||
4013719|NCT01191268|3834830|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
4013720|NCT01191268|3834831|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
4013721|NCT01191268|3834832|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
4013722|NCT01191268|3834829|B4||Male|Sex: Female, Male||Participants|Count of Participants|473|473.0||||||
4013723|NCT01191268|3834830|B3||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4013724|NCT01191268|3834831|B2||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4013725|NCT01191268|3834832|B1||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4013726|NCT01191268|3834829|B4||Female|Sex: Female, Male||Participants|Count of Participants|411|411.0||||||
4013727|NCT01191268|3834830|B3||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4013728|NCT01191268|3834831|B2||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4013729|NCT01191268|3834832|B1||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4013730|NCT01191268|3834829|B4|||Age||years|Mean|59.36|59.36|Standard Deviation|9.21|9.21|||
4013731|NCT01191268|3834830|B3|||Age||years|Mean|59.90|59.9|Standard Deviation|9.08|9.08|||
4013732|NCT01191268|3834831|B2|||Age||years|Mean|59.31|59.31|Standard Deviation|8.98|8.98|||
4013733|NCT01191268|3834832|B1|||Age||years|Mean|58.88|58.88|Standard Deviation|9.55|9.55|||
4013734|NCT01191255|3834927|B5|Unknown or Not Reported (EAP)||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4013735|NCT01191255|3834928|B4|Unknown or Not Reported (EAP)||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4013736|NCT01191255|3834929|B3|Unknown or Not Reported (EAP)||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4013737|NCT01191255|3834930|B2|Unknown or Not Reported (EAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013738|NCT01191255|3834931|B1|Unknown or Not Reported (EAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013739|NCT01191255|3834927|B5|More Than One Race (EAP)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4013740|NCT01191255|3834928|B4|More Than One Race (EAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013741|NCT01191255|3834929|B3|More Than One Race (EAP)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4013742|NCT01191255|3834930|B2|More Than One Race (EAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013743|NCT01191255|3834931|B1|More Than One Race (EAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013744|NCT01191255|3834927|B5|White (EAP)||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
4013745|NCT01191255|3834928|B4|White (EAP)||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4013746|NCT01191255|3834929|B3|White (EAP)||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4013747|NCT01191255|3834930|B2|White (EAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013748|NCT01191255|3834931|B1|White (EAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013749|NCT01191255|3834927|B5|Black or African American (EAP)||Race/Ethnicity, Customized||participants|Number|107|107.0||||||
4013863|NCT01191255|3834931|B1|Age <65 years (EAP)||Age, Customized||participants|Number|0|0.0||||||
4013750|NCT01191255|3834928|B4|Black or African American (EAP)||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
4013751|NCT01191255|3834929|B3|Black or African American (EAP)||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
4013752|NCT01191255|3834930|B2|Black or African American (EAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013753|NCT01191255|3834931|B1|Black or African American (EAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013754|NCT01191255|3834927|B5|Native Hawaiian or Other Pacific Islander (EAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013755|NCT01191255|3834928|B4|Native Hawaiian or Other Pacific Islander (EAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013756|NCT01191255|3834929|B3|Native Hawaiian or Other Pacific Islander (EAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013757|NCT01191255|3834930|B2|Native Hawaiian or Other Pacific Islander (EAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013758|NCT01191255|3834931|B1|Native Hawaiian or Other Pacific Islander (EAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013759|NCT01191255|3834927|B5|Asian (EAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013760|NCT01191255|3834928|B4|Asian (EAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013761|NCT01191255|3834929|B3|Asian (EAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013762|NCT01191255|3834930|B2|Asian (EAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013763|NCT01191255|3834931|B1|Asian (EAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013764|NCT01191255|3834927|B5|American Indian or Alaska Native (EAP)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4013765|NCT01191255|3834928|B4|American Indian or Alaska Native (EAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013766|NCT01191255|3834929|B3|American Indian or Alaska Native (EAP)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4013767|NCT01191255|3834930|B2|American Indian or Alaska Native (EAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013768|NCT01191255|3834931|B1|American Indian or Alaska Native (EAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013769|NCT01191255|3834927|B5|Unknown or Not Reported (SAP)||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4013770|NCT01191255|3834928|B4|Unknown or Not Reported (SAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013771|NCT01191255|3834929|B3|Unknown or Not Reported (SAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013772|NCT01191255|3834930|B2|Unknown or Not Reported (SAP)||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4013773|NCT01191255|3834931|B1|Unknown or Not Reported (SAP)||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4013774|NCT01191255|3834927|B5|More Than One Race (SAP)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4013775|NCT01191255|3834928|B4|More Than One Race (SAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013776|NCT01191255|3834929|B3|More Than One Race (SAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013777|NCT01191255|3834930|B2|More Than One Race (SAP)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4013778|NCT01191255|3834931|B1|More Than One Race (SAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013779|NCT01191255|3834927|B5|White (SAP)||Race/Ethnicity, Customized||participants|Number|175|175.0||||||
4013780|NCT01191255|3834928|B4|White (SAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013781|NCT01191255|3834929|B3|White (SAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013782|NCT01191255|3834930|B2|White (SAP)||Race/Ethnicity, Customized||participants|Number|114|114.0||||||
4013783|NCT01191255|3834931|B1|White (SAP)||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
4013784|NCT01191255|3834927|B5|Black or African American (SAP)||Race/Ethnicity, Customized||participants|Number|230|230.0||||||
4013785|NCT01191255|3834928|B4|Black or African American (SAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013786|NCT01191255|3834929|B3|Black or African American (SAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013787|NCT01191255|3834930|B2|Black or African American (SAP)||Race/Ethnicity, Customized||participants|Number|153|153.0||||||
4013788|NCT01191255|3834931|B1|Black or African American (SAP)||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
4013789|NCT01191255|3834927|B5|Native Hawaiian or Other Pacific Islander (SAP)||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4013790|NCT01191255|3834928|B4|Native Hawaiian or Other Pacific Islander (SAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013791|NCT01191255|3834929|B3|Native Hawaiian or Other Pacific Islander (SAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013792|NCT01191255|3834930|B2|Native Hawaiian or Other Pacific Islander (SAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013793|NCT01191255|3834931|B1|Native Hawaiian or Other Pacific Islander (SAP)||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4013794|NCT01191255|3834927|B5|Asian (SAP)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4013795|NCT01191255|3834928|B4|Asian (SAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013796|NCT01191255|3834929|B3|Asian (SAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013797|NCT01191255|3834930|B2|Asian (SAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013798|NCT01191255|3834931|B1|Asian (SAP)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4013799|NCT01191255|3834927|B5|American Indian or Alaska Native (SAP)||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4013800|NCT01191255|3834928|B4|American Indian or Alaska Native (SAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013801|NCT01191255|3834929|B3|American Indian or Alaska Native (SAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013802|NCT01191255|3834930|B2|American Indian or Alaska Native (SAP)||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4013803|NCT01191255|3834931|B1|American Indian or Alaska Native (SAP)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4013864|NCT01191255|3834927|B5|Age >= 65 years (SAP)||Age, Customized||participants|Number|86|86.0||||||
4013804|NCT01191255|3834927|B5|Unknown or not reported (EAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013805|NCT01191255|3834928|B4|Unknown or not reported (EAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013806|NCT01191255|3834929|B3|Unknown or not reported (EAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013807|NCT01191255|3834930|B2|Unknown or not reported (EAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013808|NCT01191255|3834931|B1|Unknown or not reported (EAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013809|NCT01191255|3834927|B5|Not Hispanic or Latino (EAP)||Race/Ethnicity, Customized||participants|Number|159|159.0||||||
4013810|NCT01191255|3834928|B4|Not Hispanic or Latino (EAP)||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
4013811|NCT01191255|3834929|B3|Not Hispanic or Latino (EAP)||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
4013812|NCT01191255|3834930|B2|Not Hispanic or Latino (EAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013813|NCT01191255|3834931|B1|Not Hispanic or Latino (EAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013814|NCT01191255|3834927|B5|Hispanic or Latino (EAP)||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4013815|NCT01191255|3834928|B4|Hispanic or Latino (EAP)||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4013816|NCT01191255|3834929|B3|Hispanic or Latino (EAP)||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4013817|NCT01191255|3834930|B2|Hispanic or Latino (EAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013818|NCT01191255|3834931|B1|Hispanic or Latino (EAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013819|NCT01191255|3834927|B5|Unknown or not reported (SAP)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4013820|NCT01191255|3834928|B4|Unknown or not reported (SAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013821|NCT01191255|3834929|B3|Unknown or not reported (SAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013822|NCT01191255|3834930|B2|Unknown or not reported (SAP)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4013823|NCT01191255|3834931|B1|Unknown or not reported (SAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013824|NCT01191255|3834927|B5|Not Hispanic or Latino (SAP)||Race/Ethnicity, Customized||participants|Number|362|362.0||||||
4013825|NCT01191255|3834928|B4|Not Hispanic or Latino (SAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013826|NCT01191255|3834929|B3|Not Hispanic or Latino (SAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013827|NCT01191255|3834930|B2|Not Hispanic or Latino (SAP)||Race/Ethnicity, Customized||participants|Number|239|239.0||||||
4013828|NCT01191255|3834931|B1|Not Hispanic or Latino (SAP)||Race/Ethnicity, Customized||participants|Number|123|123.0||||||
4013829|NCT01191255|3834927|B5|Hispanic or Latino (SAP)||Race/Ethnicity, Customized||participants|Number|64|64.0||||||
4013830|NCT01191255|3834928|B4|Hispanic or Latino (SAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013831|NCT01191255|3834929|B3|Hispanic or Latino (SAP)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4013832|NCT01191255|3834930|B2|Hispanic or Latino (SAP)||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4013833|NCT01191255|3834931|B1|Hispanic or Latino (SAP)||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4013834|NCT01191255|3834927|B5|Male (EAP)||Sex/Gender, Customized||participants|Number|32|32.0||||||
4013835|NCT01191255|3834928|B4|Male (EAP)||Sex/Gender, Customized||participants|Number|18|18.0||||||
4013836|NCT01191255|3834929|B3|Male (EAP)||Sex/Gender, Customized||participants|Number|14|14.0||||||
4013837|NCT01191255|3834930|B2|Male (EAP)||Sex/Gender, Customized||participants|Number|0|0.0||||||
4013838|NCT01191255|3834931|B1|Male (EAP)||Sex/Gender, Customized||participants|Number|0|0.0||||||
4013839|NCT01191255|3834927|B5|Female (EAP)||Sex/Gender, Customized||participants|Number|150|150.0||||||
4013840|NCT01191255|3834928|B4|Female (EAP)||Sex/Gender, Customized||participants|Number|73|73.0||||||
4013841|NCT01191255|3834929|B3|Female (EAP)||Sex/Gender, Customized||participants|Number|77|77.0||||||
4013842|NCT01191255|3834930|B2|Female (EAP)||Sex/Gender, Customized||participants|Number|0|0.0||||||
4013843|NCT01191255|3834931|B1|Female (EAP)||Sex/Gender, Customized||participants|Number|0|0.0||||||
4013844|NCT01191255|3834927|B5|Male (SAP)||Sex/Gender, Customized||participants|Number|259|259.0||||||
4013845|NCT01191255|3834928|B4|Male (SAP)||Sex/Gender, Customized||participants|Number|0|0.0||||||
4013846|NCT01191255|3834929|B3|Male (SAP)||Sex/Gender, Customized||participants|Number|0|0.0||||||
4013847|NCT01191255|3834930|B2|Male (SAP)||Sex/Gender, Customized||participants|Number|175|175.0||||||
4013848|NCT01191255|3834931|B1|Male (SAP)||Sex/Gender, Customized||participants|Number|84|84.0||||||
4013849|NCT01191255|3834927|B5|Female (SAP)||Sex/Gender, Customized||participants|Number|168|168.0||||||
4013850|NCT01191255|3834928|B4|Female (SAP)||Sex/Gender, Customized||participants|Number|0|0.0||||||
4013851|NCT01191255|3834929|B3|Female (SAP)||Sex/Gender, Customized||participants|Number|0|0.0||||||
4013852|NCT01191255|3834930|B2|Female (SAP)||Sex/Gender, Customized||participants|Number|106|106.0||||||
4013853|NCT01191255|3834931|B1|Female (SAP)||Sex/Gender, Customized||participants|Number|62|62.0||||||
4013854|NCT01191255|3834927|B5|Age >= 65 years (EAP)||Age, Customized||participants|Number|32|32.0||||||
4013855|NCT01191255|3834928|B4|Age >= 65 years (EAP)||Age, Customized||participants|Number|18|18.0||||||
4013856|NCT01191255|3834929|B3|Age >= 65 years (EAP)||Age, Customized||participants|Number|14|14.0||||||
4013857|NCT01191255|3834930|B2|Age >= 65 years (EAP)||Age, Customized||participants|Number|0|0.0||||||
4013858|NCT01191255|3834931|B1|Age >= 65 years (EAP)||Age, Customized||participants|Number|0|0.0||||||
4013859|NCT01191255|3834927|B5|Age <65 years (EAP)||Age, Customized||participants|Number|150|150.0||||||
4013860|NCT01191255|3834928|B4|Age <65 years (EAP)||Age, Customized||participants|Number|73|73.0||||||
4013861|NCT01191255|3834929|B3|Age <65 years (EAP)||Age, Customized||participants|Number|77|77.0||||||
4013862|NCT01191255|3834930|B2|Age <65 years (EAP)||Age, Customized||participants|Number|0|0.0||||||
4013865|NCT01191255|3834928|B4|Age >= 65 years (SAP)||Age, Customized||participants|Number|0|0.0||||||
4013866|NCT01191255|3834929|B3|Age >= 65 years (SAP)||Age, Customized||participants|Number|0|0.0||||||
4013867|NCT01191255|3834930|B2|Age >= 65 years (SAP)||Age, Customized||participants|Number|58|58.0||||||
4013868|NCT01191255|3834931|B1|Age >= 65 years (SAP)||Age, Customized||participants|Number|28|28.0||||||
4013869|NCT01191255|3834927|B5|Age <65 years (SAP)||Age, Customized||participants|Number|341|341.0||||||
4013870|NCT01191255|3834928|B4|Age <65 years (SAP)||Age, Customized||participants|Number|0|0.0||||||
4013871|NCT01191255|3834929|B3|Age <65 years (SAP)||Age, Customized||participants|Number|0|0.0||||||
4013872|NCT01191255|3834930|B2|Age <65 years (SAP)||Age, Customized||participants|Number|223|223.0||||||
4013873|NCT01191255|3834931|B1|Age <65 years (SAP)||Age, Customized||participants|Number|118|118.0||||||
4013874|NCT01191242|3834960|B1|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
4013875|NCT01191242|3834960|B1|Native American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4013876|NCT01191242|3834960|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4013877|NCT01191242|3834960|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4013878|NCT01191242|3834960|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
4013879|NCT01191242|3834960|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4013880|NCT01191242|3834960|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4013881|NCT01191242|3834960|B1|||Age||years|Mean|30.3|30.3|Standard Deviation|9.9|9.9|||
4013882|NCT01191190|3834975|B1|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
4013883|NCT01191190|3834975|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4013884|NCT01191190|3834975|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4013885|NCT01191190|3834975|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4013886|NCT01191190|3834975|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4013887|NCT01191190|3834975|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4013888|NCT01191086|3834988|B1||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4013889|NCT01191086|3834988|B1||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4013890|NCT01191086|3834988|B1|||Age||years|Mean|37.5|37.5|Standard Deviation|11.09|11.09|||
4013891|NCT01191008|3834992|B1||Male|Sex: Female, Male||Participants|Count of Participants|289|289.0||||||
4013892|NCT01191008|3834992|B1||Female|Sex: Female, Male||Participants|Count of Participants|329|329.0||||||
4013893|NCT01191008|3834992|B1|˃=65 years||Age, Customized||Participants|Number|391|391.0||||||
4013894|NCT01191008|3834992|B1|>=15 and <65 years||Age, Customized||Participants|Number|227|227.0||||||
4013895|NCT01190891|3834998|B3|United States||Region of Enrollment||participants|Number|98|98.0||||||
4013896|NCT01190891|3834999|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
4013897|NCT01190891|3835000|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4013898|NCT01190891|3834998|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4013899|NCT01190891|3834999|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4013900|NCT01190891|3835000|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4013901|NCT01190891|3834998|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4013902|NCT01190891|3834999|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4013903|NCT01190891|3835000|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4013904|NCT01190891|3834998|B3|||Age||years|Mean|41|41.0|Standard Deviation|12|12.0|||
4013905|NCT01190891|3834999|B2|||Age||years|Mean|42|42.0|Standard Deviation|12|12.0|||
4013906|NCT01190891|3835000|B1|||Age||years|Mean|40|40.0|Standard Deviation|12|12.0|||
4013907|NCT01190878|3835009|B5||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4013908|NCT01190878|3835010|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4013909|NCT01190878|3835011|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4013910|NCT01190878|3835012|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4013911|NCT01190878|3835013|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4013912|NCT01190878|3835009|B5||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4013913|NCT01190878|3835010|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4013914|NCT01190878|3835011|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4013915|NCT01190878|3835012|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4013916|NCT01190878|3835013|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4013917|NCT01190878|3835009|B5|>70 years||Age, Customized||participants|Number|75|75.0||||||
4013918|NCT01190878|3835010|B4|>70 years||Age, Customized||participants|Number|15|15.0||||||
4013919|NCT01190878|3835011|B3|>70 years||Age, Customized||participants|Number|19|19.0||||||
4013920|NCT01190878|3835012|B2|>70 years||Age, Customized||participants|Number|23|23.0||||||
4013921|NCT01190878|3835013|B1|>70 years||Age, Customized||participants|Number|18|18.0||||||
4013922|NCT01190878|3835009|B5|51-70 years||Age, Customized||participants|Number|91|91.0||||||
4013923|NCT01190878|3835010|B4|51-70 years||Age, Customized||participants|Number|25|25.0||||||
4013924|NCT01190878|3835011|B3|51-70 years||Age, Customized||participants|Number|22|22.0||||||
4013925|NCT01190878|3835012|B2|51-70 years||Age, Customized||participants|Number|22|22.0||||||
4013926|NCT01190878|3835013|B1|51-70 years||Age, Customized||participants|Number|22|22.0||||||
4013927|NCT01190878|3835009|B5|31-50 years||Age, Customized||participants|Number|2|2.0||||||
4013928|NCT01190878|3835010|B4|31-50 years||Age, Customized||participants|Number|2|2.0||||||
4013929|NCT01190878|3835011|B3|31-50 years||Age, Customized||participants|Number|0|0.0||||||
4013930|NCT01190878|3835012|B2|31-50 years||Age, Customized||participants|Number|0|0.0||||||
4013931|NCT01190878|3835013|B1|31-50 years||Age, Customized||participants|Number|0|0.0||||||
4013932|NCT01190878|3835009|B5|18-30 years||Age, Customized||participants|Number|1|1.0||||||
4013933|NCT01190878|3835010|B4|18-30 years||Age, Customized||participants|Number|0|0.0||||||
4013934|NCT01190878|3835011|B3|18-30 years||Age, Customized||participants|Number|1|1.0||||||
4013935|NCT01190878|3835012|B2|18-30 years||Age, Customized||participants|Number|0|0.0||||||
4013936|NCT01190878|3835013|B1|18-30 years||Age, Customized||participants|Number|0|0.0||||||
4013937|NCT01190878|3835009|B5|||Age||years|Mean|69.5|69.5|Standard Deviation|9.47|9.47|||
4013938|NCT01190878|3835010|B4|||Age||years|Mean|67.0|67.0|Standard Deviation|9.30|9.3|||
4013939|NCT01190878|3835011|B3|||Age||years|Mean|68.6|68.6|Standard Deviation|10.49|10.49|||
4013940|NCT01190878|3835012|B2|||Age||years|Mean|70.9|70.9|Standard Deviation|9.75|9.75|||
4013941|NCT01190878|3835013|B1|||Age||years|Mean|71.3|71.3|Standard Deviation|7.70|7.7|||
4013942|NCT01190865|3835026|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4013943|NCT01190865|3835026|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4013944|NCT01190865|3835026|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4013945|NCT01190865|3835026|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4013946|NCT01190865|3835026|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4013947|NCT01190865|3835026|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4013948|NCT01190865|3835026|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4013949|NCT01190865|3835026|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4013950|NCT01190865|3835026|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4013951|NCT01190865|3835026|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4013952|NCT01190865|3835026|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4013953|NCT01190865|3835026|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4013954|NCT01190865|3835026|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4013955|NCT01190865|3835026|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4013956|NCT01190865|3835026|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4013957|NCT01190839|3835031|B3||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4013958|NCT01190839|3835032|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4013959|NCT01190839|3835033|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4013960|NCT01190839|3835031|B3||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4013961|NCT01190839|3835032|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4013962|NCT01190839|3835033|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4013963|NCT01190839|3835031|B3|||Age||years|Mean|36.3|36.3|Standard Deviation|12.96|12.96|||
4013964|NCT01190839|3835032|B2|||Age||years|Mean|37.1|37.1|Standard Deviation|13.49|13.49|||
4013965|NCT01190839|3835033|B1|||Age||years|Mean|35.4|35.4|Standard Deviation|12.41|12.41|||
4013966|NCT01190813|3835046|B3|||Anisometropia at Randomization||diopters|Mean|2.7|2.7|Standard Deviation|2.1|2.1|||
4013967|NCT01190813|3835047|B2|||Anisometropia at Randomization||diopters|Mean|3.1|3.1|Standard Deviation|2.0|2.0|||
4013968|NCT01190813|3835048|B1|||Anisometropia at Randomization||diopters|Mean|2.5|2.5|Standard Deviation|2.1|2.1|||
4013969|NCT01190813|3835046|B3|||SE Refractive Error in Fellow Eye at Randomization||diopters|Mean|1.8|1.8|Standard Deviation|1.9|1.9|||
4013970|NCT01190813|3835047|B2|||SE Refractive Error in Fellow Eye at Randomization||diopters|Mean|1.6|1.6|Standard Deviation|1.7|1.7|||
4013971|NCT01190813|3835048|B1|||SE Refractive Error in Fellow Eye at Randomization||diopters|Mean|1.9|1.9|Standard Deviation|2.0|2.0|||
4013972|NCT01190813|3835046|B3|||SE Refractive Error in Amblyopic Eye at Randomization||diopters|Mean|4.2|4.2|Standard Deviation|2.5|2.5|||
4013973|NCT01190813|3835047|B2|||SE Refractive Error in Amblyopic Eye at Randomization||diopters|Mean|4.5|4.5|Standard Deviation|2.3|2.3|||
4013974|NCT01190813|3835048|B1|||SE Refractive Error in Amblyopic Eye at Randomization||diopters|Mean|4.0|4.0|Standard Deviation|2.6|2.6|||
4013975|NCT01190813|3835046|B3|||Intraocular Visual Acuity Difference at Randomization||letters|Mean|34.5|34.5|Standard Deviation|11.7|11.7|||
4013976|NCT01190813|3835047|B2|||Intraocular Visual Acuity Difference at Randomization||letters|Mean|35.6|35.6|Standard Deviation|13.1|13.1|||
4013977|NCT01190813|3835048|B1|||Intraocular Visual Acuity Difference at Randomization||letters|Mean|33.9|33.9|Standard Deviation|10.9|10.9|||
4013978|NCT01190813|3835046|B3|||Visual Acuity in the Fellow Eye at Randomization||letters|Mean|86.9|86.9|Standard Deviation|3.9|3.9|||
4013979|NCT01190813|3835047|B2|||Visual Acuity in the Fellow Eye at Randomization||letters|Mean|87.3|87.3|Standard Deviation|3.5|3.5|||
4013980|NCT01190813|3835048|B1|||Visual Acuity in the Fellow Eye at Randomization||letters|Mean|86.7|86.7|Standard Deviation|4.1|4.1|||
4013981|NCT01190813|3835046|B3|20/12 (93-97 letters)||Visual Acuity in the Fellow Eye at Randomization||participants|Number|8|8.0||||||
4013982|NCT01190813|3835047|B2|20/12 (93-97 letters)||Visual Acuity in the Fellow Eye at Randomization||participants|Number|2|2.0||||||
4013983|NCT01190813|3835048|B1|20/12 (93-97 letters)||Visual Acuity in the Fellow Eye at Randomization||participants|Number|6|6.0||||||
4013984|NCT01190813|3835046|B3|20/16 (88-92 letters)||Visual Acuity in the Fellow Eye at Randomization||participants|Number|57|57.0||||||
4013985|NCT01190813|3835047|B2|20/16 (88-92 letters)||Visual Acuity in the Fellow Eye at Randomization||participants|Number|23|23.0||||||
4013986|NCT01190813|3835048|B1|20/16 (88-92 letters)||Visual Acuity in the Fellow Eye at Randomization||participants|Number|34|34.0||||||
4013987|NCT01190813|3835046|B3|20/20 (83-87 letters)||Visual Acuity in the Fellow Eye at Randomization||participants|Number|55|55.0||||||
4013988|NCT01190813|3835047|B2|20/20 (83-87 letters)||Visual Acuity in the Fellow Eye at Randomization||participants|Number|20|20.0||||||
4013989|NCT01190813|3835048|B1|20/20 (83-87 letters)||Visual Acuity in the Fellow Eye at Randomization||participants|Number|35|35.0||||||
4013990|NCT01190813|3835046|B3|20/25 (78-82 letters)||Visual Acuity in the Fellow Eye at Randomization||participants|Number|19|19.0||||||
4013991|NCT01190813|3835047|B2|20/25 (78-82 letters)||Visual Acuity in the Fellow Eye at Randomization||participants|Number|4|4.0||||||
4013992|NCT01190813|3835048|B1|20/25 (78-82 letters)||Visual Acuity in the Fellow Eye at Randomization||participants|Number|15|15.0||||||
4013993|NCT01190813|3835046|B3|||Visual Acuity in the Amblyopic Eye at Randomization||letters|Mean|52.4|52.4|Standard Deviation|10.5|10.5|||
4013994|NCT01190813|3835047|B2|||Visual Acuity in the Amblyopic Eye at Randomization||letters|Mean|51.7|51.7|Standard Deviation|11.9|11.9|||
4013995|NCT01190813|3835048|B1|||Visual Acuity in the Amblyopic Eye at Randomization||letters|Mean|52.8|52.8|Standard Deviation|9.8|9.8|||
4013996|NCT01190813|3835046|B3|20/50 (63-67 letters)||Visual Acuity in the Amblyopic Eye at Randomization||participants|Number|27|27.0||||||
4013997|NCT01190813|3835047|B2|20/50 (63-67 letters)||Visual Acuity in the Amblyopic Eye at Randomization||participants|Number|13|13.0||||||
4013998|NCT01190813|3835048|B1|20/50 (63-67 letters)||Visual Acuity in the Amblyopic Eye at Randomization||participants|Number|14|14.0||||||
4013999|NCT01190813|3835046|B3|20/63 (58-62 letters)||Visual Acuity in the Amblyopic Eye at Randomization||participants|Number|26|26.0||||||
4014000|NCT01190813|3835047|B2|20/63 (58-62 letters)||Visual Acuity in the Amblyopic Eye at Randomization||participants|Number|6|6.0||||||
4014001|NCT01190813|3835048|B1|20/63 (58-62 letters)||Visual Acuity in the Amblyopic Eye at Randomization||participants|Number|20|20.0||||||
4014002|NCT01190813|3835046|B3|20/80 (53-57 letters)||Visual Acuity in the Amblyopic Eye at Randomization||participants|Number|23|23.0||||||
4014003|NCT01190813|3835047|B2|20/80 (53-57 letters)||Visual Acuity in the Amblyopic Eye at Randomization||participants|Number|8|8.0||||||
4014004|NCT01190813|3835048|B1|20/80 (53-57 letters)||Visual Acuity in the Amblyopic Eye at Randomization||participants|Number|15|15.0||||||
4014005|NCT01190813|3835046|B3|20/100 to <20/200 (38-52 letters)||Visual Acuity in the Amblyopic Eye at Randomization||participants|Number|47|47.0||||||
4014006|NCT01190813|3835047|B2|20/100 to <20/200 (38-52 letters)||Visual Acuity in the Amblyopic Eye at Randomization||participants|Number|13|13.0||||||
4014007|NCT01190813|3835048|B1|20/100 to <20/200 (38-52 letters)||Visual Acuity in the Amblyopic Eye at Randomization||participants|Number|34|34.0||||||
4014008|NCT01190813|3835046|B3|20/200 or worse (<=37 letters)||Visual Acuity in the Amblyopic Eye at Randomization||participants|Number|16|16.0||||||
4014009|NCT01190813|3835047|B2|20/200 or worse (<=37 letters)||Visual Acuity in the Amblyopic Eye at Randomization||participants|Number|9|9.0||||||
4014010|NCT01190813|3835048|B1|20/200 or worse (<=37 letters)||Visual Acuity in the Amblyopic Eye at Randomization||participants|Number|7|7.0||||||
4014011|NCT01190813|3835046|B3|>= 3 hours per day||Patching Duration at Randomization||participants|Number|15|15.0||||||
4014012|NCT01190813|3835047|B2|>= 3 hours per day||Patching Duration at Randomization||participants|Number|6|6.0||||||
4014013|NCT01190813|3835048|B1|>= 3 hours per day||Patching Duration at Randomization||participants|Number|9|9.0||||||
4014014|NCT01190813|3835046|B3|2 hours per day||Patching Duration at Randomization||participants|Number|124|124.0||||||
4014015|NCT01190813|3835047|B2|2 hours per day||Patching Duration at Randomization||participants|Number|43|43.0||||||
4014016|NCT01190813|3835048|B1|2 hours per day||Patching Duration at Randomization||participants|Number|81|81.0||||||
4014017|NCT01190813|3835046|B3|Combined Mechanism||Cause of Amblyopia||participants|Number|76|76.0||||||
4014018|NCT01190813|3835047|B2|Combined Mechanism||Cause of Amblyopia||participants|Number|28|28.0||||||
4014019|NCT01190813|3835048|B1|Combined Mechanism||Cause of Amblyopia||participants|Number|48|48.0||||||
4014020|NCT01190813|3835046|B3|Anisometropia||Cause of Amblyopia||participants|Number|36|36.0||||||
4014021|NCT01190813|3835047|B2|Anisometropia||Cause of Amblyopia||participants|Number|16|16.0||||||
4014022|NCT01190813|3835048|B1|Anisometropia||Cause of Amblyopia||participants|Number|20|20.0||||||
4014023|NCT01190813|3835046|B3|Strabismus||Cause of Amblyopia||participants|Number|27|27.0||||||
4014024|NCT01190813|3835047|B2|Strabismus||Cause of Amblyopia||participants|Number|5|5.0||||||
4014025|NCT01190813|3835048|B1|Strabismus||Cause of Amblyopia||participants|Number|22|22.0||||||
4014026|NCT01190813|3835046|B3|United States||Region of Enrollment||participants|Number|139|139.0||||||
4014027|NCT01190813|3835047|B2|United States||Region of Enrollment||participants|Number|49|49.0||||||
4014028|NCT01190813|3835048|B1|United States||Region of Enrollment||participants|Number|90|90.0||||||
4014029|NCT01190813|3835046|B3|Unknown/Not Reported||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4014030|NCT01190813|3835047|B2|Unknown/Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4014031|NCT01190813|3835048|B1|Unknown/Not Reported||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4014032|NCT01190813|3835046|B3|White||Race/Ethnicity, Customized||participants|Number|121|121.0||||||
4014033|NCT01190813|3835047|B2|White||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4014034|NCT01190813|3835048|B1|White||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
4014035|NCT01190813|3835046|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4014036|NCT01190813|3835047|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4014037|NCT01190813|3835048|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4014038|NCT01190813|3835046|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4014039|NCT01190813|3835047|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4014040|NCT01190813|3835048|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4014041|NCT01190813|3835046|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4014042|NCT01190813|3835047|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4014043|NCT01190813|3835048|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4014044|NCT01190813|3835046|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4014045|NCT01190813|3835047|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4014046|NCT01190813|3835048|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4014047|NCT01190813|3835046|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4014048|NCT01190813|3835047|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4014049|NCT01190813|3835048|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4014050|NCT01190813|3835046|B3|11 to <13 years||Age, Customized||participants|Number|32|32.0||||||
4014051|NCT01190813|3835047|B2|11 to <13 years||Age, Customized||participants|Number|14|14.0||||||
4014052|NCT01190813|3835048|B1|11 to <13 years||Age, Customized||participants|Number|18|18.0||||||
4014053|NCT01190813|3835046|B3|9 to <11 years||Age, Customized||participants|Number|47|47.0||||||
4014054|NCT01190813|3835047|B2|9 to <11 years||Age, Customized||participants|Number|14|14.0||||||
4014055|NCT01190813|3835048|B1|9 to <11 years||Age, Customized||participants|Number|33|33.0||||||
4014056|NCT01190813|3835046|B3|7 to <9 years||Age, Customized||participants|Number|60|60.0||||||
4014057|NCT01190813|3835047|B2|7 to <9 years||Age, Customized||participants|Number|21|21.0||||||
4014058|NCT01190813|3835048|B1|7 to <9 years||Age, Customized||participants|Number|39|39.0||||||
4014059|NCT01190813|3835046|B3|||Age||years|Mean|9.5|9.5|Standard Deviation|1.7|1.7|||
4014060|NCT01190813|3835047|B2|||Age||years|Mean|9.5|9.5|Standard Deviation|1.7|1.7|||
4014061|NCT01190813|3835048|B1|||Age||years|Mean|9.4|9.4|Standard Deviation|1.8|1.8|||
4014062|NCT01190813|3835046|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4014063|NCT01190813|3835047|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4014064|NCT01190813|3835048|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4014065|NCT01190813|3835046|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4014066|NCT01190813|3835047|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4014067|NCT01190813|3835048|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4014068|NCT01190813|3835046|B3||<=18 years|Age||Participants|Count of Participants|139|139.0||||||
4014069|NCT01190813|3835047|B2||<=18 years|Age||Participants|Count of Participants|49|49.0||||||
4014070|NCT01190813|3835048|B1||<=18 years|Age||Participants|Count of Participants|90|90.0||||||
4014071|NCT01190566|3835139|B3|HER2-positive||Immunohistochemical subtype||participants|Number|7|7.0||||||
4014072|NCT01190566|3835140|B2|HER2-positive||Immunohistochemical subtype||participants|Number|6|6.0||||||
4014073|NCT01190566|3835141|B1|HER2-positive||Immunohistochemical subtype||participants|Number|1|1.0||||||
4014074|NCT01190566|3835139|B3|Triple negative||Immunohistochemical subtype||participants|Number|14|14.0||||||
4014075|NCT01190566|3835140|B2|Triple negative||Immunohistochemical subtype||participants|Number|10|10.0||||||
4014076|NCT01190566|3835141|B1|Triple negative||Immunohistochemical subtype||participants|Number|4|4.0||||||
4014077|NCT01190566|3835139|B3|Hormone receptor positive||Immunohistochemical subtype||participants|Number|27|27.0||||||
4014078|NCT01190566|3835140|B2|Hormone receptor positive||Immunohistochemical subtype||participants|Number|26|26.0||||||
4014079|NCT01190566|3835141|B1|Hormone receptor positive||Immunohistochemical subtype||participants|Number|1|1.0||||||
4014080|NCT01190566|3835139|B3|more than 14% (high proliferation)||Ki-67 (Cellular marker for proliferation)||participants|Number|18|18.0||||||
4014081|NCT01190566|3835140|B2|more than 14% (high proliferation)||Ki-67 (Cellular marker for proliferation)||participants|Number|14|14.0||||||
4014082|NCT01190566|3835141|B1|more than 14% (high proliferation)||Ki-67 (Cellular marker for proliferation)||participants|Number|4|4.0||||||
4014083|NCT01190566|3835139|B3|14% or less (low proliferation)||Ki-67 (Cellular marker for proliferation)||participants|Number|30|30.0||||||
4014084|NCT01190566|3835140|B2|14% or less (low proliferation)||Ki-67 (Cellular marker for proliferation)||participants|Number|28|28.0||||||
4014085|NCT01190566|3835141|B1|14% or less (low proliferation)||Ki-67 (Cellular marker for proliferation)||participants|Number|2|2.0||||||
4014086|NCT01190566|3835139|B3|Positive||HER2||participants|Number|11|11.0||||||
4014087|NCT01190566|3835140|B2|Positive||HER2||participants|Number|10|10.0||||||
4014088|NCT01190566|3835141|B1|Positive||HER2||participants|Number|1|1.0||||||
4014089|NCT01190566|3835139|B3|Negative||HER2||participants|Number|37|37.0||||||
4014090|NCT01190566|3835140|B2|Negative||HER2||participants|Number|32|32.0||||||
4014091|NCT01190566|3835141|B1|Negative||HER2||participants|Number|5|5.0||||||
4014092|NCT01190566|3835139|B3|Positive||Progesterone receptor||participants|Number|12|12.0||||||
4014093|NCT01190566|3835140|B2|Positive||Progesterone receptor||participants|Number|11|11.0||||||
4014094|NCT01190566|3835141|B1|Positive||Progesterone receptor||participants|Number|1|1.0||||||
4014095|NCT01190566|3835139|B3|Negative||Progesterone receptor||participants|Number|36|36.0||||||
4014096|NCT01190566|3835140|B2|Negative||Progesterone receptor||participants|Number|31|31.0||||||
4014097|NCT01190566|3835141|B1|Negative||Progesterone receptor||participants|Number|5|5.0||||||
4014098|NCT01190566|3835139|B3|Positive||Estrogen receptor||participants|Number|27|27.0||||||
4014099|NCT01190566|3835140|B2|Positive||Estrogen receptor||participants|Number|26|26.0||||||
4014100|NCT01190566|3835141|B1|Positive||Estrogen receptor||participants|Number|1|1.0||||||
4014101|NCT01190566|3835139|B3|Negative||Estrogen receptor||participants|Number|21|21.0||||||
4014102|NCT01190566|3835140|B2|Negative||Estrogen receptor||participants|Number|16|16.0||||||
4014103|NCT01190566|3835141|B1|Negative||Estrogen receptor||participants|Number|5|5.0||||||
4014104|NCT01190566|3835139|B3|Stage III||Clinical stage (American Joint Committee on Cancer 7th edition)||participants|Number|38|38.0||||||
4014105|NCT01190566|3835140|B2|Stage III||Clinical stage (American Joint Committee on Cancer 7th edition)||participants|Number|34|34.0||||||
4014106|NCT01190566|3835141|B1|Stage III||Clinical stage (American Joint Committee on Cancer 7th edition)||participants|Number|4|4.0||||||
4014107|NCT01190566|3835139|B3|Stage II||Clinical stage (American Joint Committee on Cancer 7th edition)||participants|Number|10|10.0||||||
4014108|NCT01190566|3835140|B2|Stage II||Clinical stage (American Joint Committee on Cancer 7th edition)||participants|Number|8|8.0||||||
4014109|NCT01190566|3835141|B1|Stage II||Clinical stage (American Joint Committee on Cancer 7th edition)||participants|Number|2|2.0||||||
4014110|NCT01190566|3835139|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4014111|NCT01190566|3835140|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4014112|NCT01190566|3835141|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4014113|NCT01190566|3835139|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4014114|NCT01190566|3835140|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4014115|NCT01190566|3835141|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4014116|NCT01190566|3835139|B3|more than 40 years old||Age, Customized||participants|Number|37|37.0||||||
4014117|NCT01190566|3835140|B2|more than 40 years old||Age, Customized||participants|Number|33|33.0||||||
4014118|NCT01190566|3835141|B1|more than 40 years old||Age, Customized||participants|Number|4|4.0||||||
4014119|NCT01190566|3835139|B3|40 years old or less||Age, Customized||participants|Number|11|11.0||||||
4014120|NCT01190566|3835140|B2|40 years old or less||Age, Customized||participants|Number|9|9.0||||||
4014121|NCT01190566|3835141|B1|40 years old or less||Age, Customized||participants|Number|2|2.0||||||
4014122|NCT01190527|3835163|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4014123|NCT01190527|3835163|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4014124|NCT01190527|3835163|B1|||Age||years|Median|63|63.0|Full Range|||45.0|83.0|
4014125|NCT01190514|3835170|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4014126|NCT01190514|3835170|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4014127|NCT01190514|3835170|B1|||Age||years|Mean|37.6|37.6|Standard Deviation|10.6|10.6|||
4014128|NCT01190475|3835203|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
4014129|NCT01190475|3835204|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4014130|NCT01190475|3835205|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4014131|NCT01190475|3835206|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4014132|NCT01190475|3835203|B4|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4014133|NCT01190475|3835204|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4014134|NCT01190475|3835205|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4014135|NCT01190475|3835206|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4014136|NCT01190475|3835203|B4|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4014137|NCT01190475|3835204|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4014138|NCT01190475|3835205|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4014139|NCT01190475|3835206|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4014140|NCT01190475|3835203|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4014141|NCT01190475|3835204|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4014142|NCT01190475|3835205|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4014143|NCT01190475|3835206|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4014144|NCT01190475|3835203|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4014145|NCT01190475|3835204|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4014146|NCT01190475|3835205|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4014147|NCT01190475|3835206|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4014148|NCT01190475|3835203|B4|||Age||years|Mean|29|29.0|Full Range|||21.0|39.0|
4014149|NCT01190475|3835204|B3|||Age||years|Mean|30.5|30.5|Full Range|||30.0|31.0|
4014150|NCT01190475|3835205|B2|||Age||years|Mean|28|28.0|Full Range|||28.0|28.0|
4014151|NCT01190475|3835206|B1|||Age||years|Mean|30|30.0|Full Range|||21.0|39.0|
4014152|NCT01190475|3835203|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4014153|NCT01190475|3835204|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4014154|NCT01190475|3835205|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4014155|NCT01190475|3835206|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4014156|NCT01190475|3835203|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4014157|NCT01190475|3835204|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4014158|NCT01190475|3835205|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4014159|NCT01190475|3835206|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4014160|NCT01190475|3835203|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4014161|NCT01190475|3835204|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4014162|NCT01190475|3835205|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4014163|NCT01190475|3835206|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4014164|NCT01190449|3835216|B3|United States||Region of Enrollment||Participants|Count of Participants|51|51.0||||||
4014165|NCT01190449|3835217|B2|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
4014166|NCT01190449|3835218|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4014167|NCT01190449|3835216|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4014168|NCT01190449|3835217|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4014169|NCT01190449|3835218|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4014170|NCT01190449|3835216|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4014171|NCT01190449|3835217|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4014172|NCT01190449|3835218|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4014173|NCT01190449|3835216|B3|||Age||years|Median|60|60.0|Full Range|||40.0|85.0|
4014174|NCT01190449|3835217|B2|||Age||years|Median|58|58.0|Full Range|||40.0|85.0|
4014175|NCT01190449|3835218|B1|||Age||years|Median|63|63.0|Full Range|||43.0|85.0|
4014176|NCT01190436|3835227|B1||Male|Gender||Participants|Count of Participants|52|52.0||||||
4014177|NCT01190436|3835227|B1||Female|Gender||Participants|Count of Participants|73|73.0||||||
4014178|NCT01190436|3835227|B1|||Age||years|Mean|58.5|58.5|Standard Deviation|12.1|12.1|||
4014179|NCT01190306|3835241|B3|United States||Region of Enrollment||participants|Number|0|0.0||||||
4014180|NCT01190306|3835242|B2|United States||Region of Enrollment||participants|Number|NA|||||||The sponsor terminated the study prior to data analysis for financial reasons.
4014181|NCT01190306|3835243|B1|United States||Region of Enrollment||participants|Number|NA|||||||The sponsor terminated the study prior to data analysis for financial reasons.
4014182|NCT01190306|3835241|B3||Male|Gender||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4014183|NCT01190306|3835242|B2||Male|Gender||Participants|Count of Participants|NA|||||||The sponsor terminated the study prior to data analysis for financial reasons.
4014184|NCT01190306|3835243|B1||Male|Gender||Participants|Count of Participants|NA|||||||The sponsor terminated the study prior to data analysis for financial reasons.
4014185|NCT01190306|3835241|B3||Female|Gender||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4014186|NCT01190306|3835242|B2||Female|Gender||Participants|Count of Participants|NA|||||||The sponsor terminated the study prior to data analysis for financial reasons.
4014187|NCT01190306|3835243|B1||Female|Gender||Participants|Count of Participants|NA|||||||The sponsor terminated the study prior to data analysis for financial reasons.
4014188|NCT01190306|3835241|B3|||Age||years|Mean|NA||Standard Deviation|NA||||The sponsor terminated the study prior to data analysis for financial reasons.
4014189|NCT01190306|3835242|B2|||Age||years|Mean|NA||Standard Deviation|NA||||The sponsor terminated the study prior to data analysis for financial reasons.
4014190|NCT01190306|3835243|B1|||Age||years|Mean|NA||Standard Deviation|NA||||The sponsor terminated the study prior to data analysis for financial reasons.
4014191|NCT01190306|3835241|B3||>=65 years|Age||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4014192|NCT01190306|3835242|B2||>=65 years|Age||Participants|Count of Participants|NA|||||||The sponsor terminated the study prior to data analysis for financial reasons.
4014193|NCT01190306|3835243|B1||>=65 years|Age||Participants|Count of Participants|NA|||||||The sponsor terminated the study prior to data analysis for financial reasons.
4014194|NCT01190306|3835241|B3||Between 18 and 65 years|Age||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4014195|NCT01190306|3835242|B2||Between 18 and 65 years|Age||Participants|Count of Participants|NA|||||||The sponsor terminated the study prior to data analysis for financial reasons.
4014196|NCT01190306|3835243|B1||Between 18 and 65 years|Age||Participants|Count of Participants|NA|||||||The sponsor terminated the study prior to data analysis for financial reasons.
4014197|NCT01190306|3835241|B3||<=18 years|Age||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4014198|NCT01190306|3835242|B2||<=18 years|Age||Participants|Count of Participants|NA|||||||The sponsor terminated the study prior to data analysis for financial reasons.
4014199|NCT01190306|3835243|B1||<=18 years|Age||Participants|Count of Participants|NA|||||||The sponsor terminated the study prior to data analysis for financial reasons.
4014200|NCT01190267|3835250|B3||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4014201|NCT01190267|3835251|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4014202|NCT01190267|3835252|B1||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4014203|NCT01190267|3835250|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4014204|NCT01190267|3835251|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4014205|NCT01190267|3835252|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4014206|NCT01190267|3835250|B3|||Age||years|Mean|15.4|15.4|Standard Deviation|1.6|1.6|||
4014207|NCT01190267|3835251|B2|||Age||years|Mean|18|18.0|Standard Deviation|0|0.0|||
4014208|NCT01190267|3835252|B1|||Age||years|Mean|15.3|15.3|Standard Deviation|1.5|1.5|||
4014271|NCT01190254|3835263|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4014272|NCT01190254|3835264|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4014209|NCT01190254|3835261|B4|||PQ-LES-Q overall score|PQ-LES-Q is a questionnaire to assess quality of life enjoyment and satisfaction in children and adolescents. The participant is asked to rate 15 items reflecting quality of life with respect to the previous week on a scale of 1=very poor to 5=very good. The PQ-LES-Q overall score (Item 15, a global assessment of quality of life) ranged from 1 to 5 with a higher score indicating better quality of life. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|3.1|3.1|Standard Deviation|1.0|1.0|||
4014210|NCT01190254|3835262|B3|||PQ-LES-Q overall score|PQ-LES-Q is a questionnaire to assess quality of life enjoyment and satisfaction in children and adolescents. The participant is asked to rate 15 items reflecting quality of life with respect to the previous week on a scale of 1=very poor to 5=very good. The PQ-LES-Q overall score (Item 15, a global assessment of quality of life) ranged from 1 to 5 with a higher score indicating better quality of life. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|3.0|3.0|Standard Deviation|1.0|1.0|||
4014211|NCT01190254|3835263|B2|||PQ-LES-Q overall score|PQ-LES-Q is a questionnaire to assess quality of life enjoyment and satisfaction in children and adolescents. The participant is asked to rate 15 items reflecting quality of life with respect to the previous week on a scale of 1=very poor to 5=very good. The PQ-LES-Q overall score (Item 15, a global assessment of quality of life) ranged from 1 to 5 with a higher score indicating better quality of life. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|3.1|3.1|Standard Deviation|0.9|0.9|||
4014212|NCT01190254|3835264|B1|||PQ-LES-Q overall score|PQ-LES-Q is a questionnaire to assess quality of life enjoyment and satisfaction in children and adolescents. The participant is asked to rate 15 items reflecting quality of life with respect to the previous week on a scale of 1=very poor to 5=very good. The PQ-LES-Q overall score (Item 15, a global assessment of quality of life) ranged from 1 to 5 with a higher score indicating better quality of life. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|3.1|3.1|Standard Deviation|1.0|1.0|||
4014213|NCT01190254|3835261|B4|||Pediatric Quality of Life Enjoyment and Satisfaction Questionnaire (PQ-LES-Q) total score|PQ-LES-Q is a questionnaire to assess quality of life enjoyment and satisfaction in children and adolescents. The participant is asked to rate 15 items reflecting quality of life with respect to the previous week on a scale of 1=very poor to 5=very good. The PQ-LES-Q total score (sum of Items 1-14) for each participant ranged from 14 to 70 with a higher score indicating better quality of life. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|41.1|41.1|Standard Deviation|10.1|10.1|||
4014214|NCT01190254|3835262|B3|||Pediatric Quality of Life Enjoyment and Satisfaction Questionnaire (PQ-LES-Q) total score|PQ-LES-Q is a questionnaire to assess quality of life enjoyment and satisfaction in children and adolescents. The participant is asked to rate 15 items reflecting quality of life with respect to the previous week on a scale of 1=very poor to 5=very good. The PQ-LES-Q total score (sum of Items 1-14) for each participant ranged from 14 to 70 with a higher score indicating better quality of life. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|40.7|40.7|Standard Deviation|9.5|9.5|||
4014215|NCT01190254|3835263|B2|||Pediatric Quality of Life Enjoyment and Satisfaction Questionnaire (PQ-LES-Q) total score|PQ-LES-Q is a questionnaire to assess quality of life enjoyment and satisfaction in children and adolescents. The participant is asked to rate 15 items reflecting quality of life with respect to the previous week on a scale of 1=very poor to 5=very good. The PQ-LES-Q total score (sum of Items 1-14) for each participant ranged from 14 to 70 with a higher score indicating better quality of life. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|41.2|41.2|Standard Deviation|10.0|10.0|||
4014216|NCT01190254|3835264|B1|||Pediatric Quality of Life Enjoyment and Satisfaction Questionnaire (PQ-LES-Q) total score|PQ-LES-Q is a questionnaire to assess quality of life enjoyment and satisfaction in children and adolescents. The participant is asked to rate 15 items reflecting quality of life with respect to the previous week on a scale of 1=very poor to 5=very good. The PQ-LES-Q total score (sum of Items 1-14) for each participant ranged from 14 to 70 with a higher score indicating better quality of life. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|41.6|41.6|Standard Deviation|10.7|10.7|||
4014217|NCT01190254|3835261|B4|||Children’s Global Assessment Scale (CGAS) score - current functioning|CGAS is a 100-point scale measuring psychological, social, and school functioning in children aged 6-17. Minimum scores ranged from 1-10, representing the need for constant supervision (worse result) to maximum scores of 91-100, representing superior functioning (better result). Summary statistics presented are for efficacy population (FAS) except as noted: N=99 (baseline value not available for 1 FAS participant in this group), 96, 104 and 299 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|42.5|42.5|Standard Deviation|8.7|8.7|||
4014218|NCT01190254|3835262|B3|||Children’s Global Assessment Scale (CGAS) score - current functioning|CGAS is a 100-point scale measuring psychological, social, and school functioning in children aged 6-17. Minimum scores ranged from 1-10, representing the need for constant supervision (worse result) to maximum scores of 91-100, representing superior functioning (better result). Summary statistics presented are for efficacy population (FAS) except as noted: N=99 (baseline value not available for 1 FAS participant in this group), 96, 104 and 299 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|42.9|42.9|Standard Deviation|8.5|8.5|||
4014273|NCT01190254|3835261|B4|||Age||years|Mean|15.3|15.3|Standard Deviation|1.5|1.5|||
4014274|NCT01190254|3835262|B3|||Age||years|Mean|15.4|15.4|Standard Deviation|1.5|1.5|||
4014275|NCT01190254|3835263|B2|||Age||years|Mean|15.2|15.2|Standard Deviation|1.5|1.5|||
4014276|NCT01190254|3835264|B1|||Age||years|Mean|15.4|15.4|Standard Deviation|1.4|1.4|||
4014219|NCT01190254|3835263|B2|||Children’s Global Assessment Scale (CGAS) score - current functioning|CGAS is a 100-point scale measuring psychological, social, and school functioning in children aged 6-17. Minimum scores ranged from 1-10, representing the need for constant supervision (worse result) to maximum scores of 91-100, representing superior functioning (better result). Summary statistics presented are for efficacy population (FAS) except as noted: N=99 (baseline value not available for 1 FAS participant in this group), 96, 104 and 299 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|41.6|41.6|Standard Deviation|9.1|9.1|||
4014220|NCT01190254|3835264|B1|||Children’s Global Assessment Scale (CGAS) score - current functioning|CGAS is a 100-point scale measuring psychological, social, and school functioning in children aged 6-17. Minimum scores ranged from 1-10, representing the need for constant supervision (worse result) to maximum scores of 91-100, representing superior functioning (better result). Summary statistics presented are for efficacy population (FAS) except as noted: N=99 (baseline value not available for 1 FAS participant in this group), 96, 104 and 299 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|43.0|43.0|Standard Deviation|8.4|8.4|||
4014221|NCT01190254|3835261|B4|||PANSS Marder anxiety/depression factor score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder anxiety/depression factor score (calculated from value of 4 identified PANSS items) ranged from 4 to 28 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|9.9|9.9|Standard Deviation|3.1|3.1|||
4014222|NCT01190254|3835262|B3|||PANSS Marder anxiety/depression factor score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder anxiety/depression factor score (calculated from value of 4 identified PANSS items) ranged from 4 to 28 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|10.3|10.3|Standard Deviation|3.1|3.1|||
4014223|NCT01190254|3835263|B2|||PANSS Marder anxiety/depression factor score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder anxiety/depression factor score (calculated from value of 4 identified PANSS items) ranged from 4 to 28 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|9.8|9.8|Standard Deviation|3.1|3.1|||
4014224|NCT01190254|3835264|B1|||PANSS Marder anxiety/depression factor score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder anxiety/depression factor score (calculated from value of 4 identified PANSS items) ranged from 4 to 28 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|9.6|9.6|Standard Deviation|3.1|3.1|||
4014225|NCT01190254|3835261|B4|||PANSS Marder hostility/excitement factor score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder hostility/excitement factor score (calculated from value of 4 identified PANSS items) ranged from 4 to 28 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|12.9|12.9|Standard Deviation|3.8|3.8|||
4014226|NCT01190254|3835262|B3|||PANSS Marder hostility/excitement factor score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder hostility/excitement factor score (calculated from value of 4 identified PANSS items) ranged from 4 to 28 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|13.1|13.1|Standard Deviation|4.3|4.3|||
4014227|NCT01190254|3835263|B2|||PANSS Marder hostility/excitement factor score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder hostility/excitement factor score (calculated from value of 4 identified PANSS items) ranged from 4 to 28 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|12.8|12.8|Standard Deviation|3.6|3.6|||
4014228|NCT01190254|3835264|B1|||PANSS Marder hostility/excitement factor score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder hostility/excitement factor score (calculated from value of 4 identified PANSS items) ranged from 4 to 28 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|12.9|12.9|Standard Deviation|3.5|3.5|||
4014229|NCT01190254|3835261|B4|||PANSS Marder disorganized thoughts factor score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder disorganized thoughts factor score (calculated from value of 7 identified PANSS items) ranged from 7 to 49 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|22.4|22.4|Standard Deviation|3.9|3.9|||
4014277|NCT01190228|3835328|B4|Philippines||Region of Enrollment||Participants|Number|450|450.0||||||
4014278|NCT01190228|3835329|B3|Philippines||Region of Enrollment||Participants|Number|59|59.0||||||
4014230|NCT01190254|3835262|B3|||PANSS Marder disorganized thoughts factor score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder disorganized thoughts factor score (calculated from value of 7 identified PANSS items) ranged from 7 to 49 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|22.5|22.5|Standard Deviation|4.6|4.6|||
4014231|NCT01190254|3835263|B2|||PANSS Marder disorganized thoughts factor score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder disorganized thoughts factor score (calculated from value of 7 identified PANSS items) ranged from 7 to 49 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|22.3|22.3|Standard Deviation|3.4|3.4|||
4014232|NCT01190254|3835264|B1|||PANSS Marder disorganized thoughts factor score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder disorganized thoughts factor score (calculated from value of 7 identified PANSS items) ranged from 7 to 49 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|22.4|22.4|Standard Deviation|3.7|3.7|||
4014233|NCT01190254|3835261|B4|||PANSS Marder negative symptoms factor score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder negative symptoms factor score (calculated from value of 7 identified PANSS items) ranged from 7 to 49 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|23.9|23.9|Standard Deviation|5.4|5.4|||
4014234|NCT01190254|3835262|B3|||PANSS Marder negative symptoms factor score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder negative symptoms factor score (calculated from value of 7 identified PANSS items) ranged from 7 to 49 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|23.8|23.8|Standard Deviation|5.9|5.9|||
4014235|NCT01190254|3835263|B2|||PANSS Marder negative symptoms factor score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder negative symptoms factor score (calculated from value of 7 identified PANSS items) ranged from 7 to 49 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|23.9|23.9|Standard Deviation|5.4|5.4|||
4014236|NCT01190254|3835264|B1|||PANSS Marder negative symptoms factor score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder negative symptoms factor score (calculated from value of 7 identified PANSS items) ranged from 7 to 49 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|24.2|24.2|Standard Deviation|4.8|4.8|||
4014237|NCT01190254|3835261|B4|||PANSS Marder positive symptoms factor score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder positive symptoms factor score (calculated from value of 8 identified PANSS items) ranged from 8 to 56 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|28.7|28.7|Standard Deviation|4.0|4.0|||
4014238|NCT01190254|3835262|B3|||PANSS Marder positive symptoms factor score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder positive symptoms factor score (calculated from value of 8 identified PANSS items) ranged from 8 to 56 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|28.9|28.9|Standard Deviation|4.3|4.3|||
4014239|NCT01190254|3835263|B2|||PANSS Marder positive symptoms factor score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder positive symptoms factor score (calculated from value of 8 identified PANSS items) ranged from 8 to 56 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|28.7|28.7|Standard Deviation|3.6|3.6|||
4014240|NCT01190254|3835264|B1|||PANSS Marder positive symptoms factor score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS Marder positive symptoms factor score (calculated from value of 8 identified PANSS items) ranged from 8 to 56 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|28.4|28.4|Standard Deviation|4.0|4.0|||
4014279|NCT01190228|3835330|B2|Philippines||Region of Enrollment||Participants|Number|46|46.0||||||
4014280|NCT01190228|3835331|B1|Philippines||Region of Enrollment||Participants|Number|345|345.0||||||
4014241|NCT01190254|3835261|B4|||PANSS general psychopathology subscale score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS general psychopathology subscale score (16 PANSS items) ranged from 16 to 112 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|47.4|47.4|Standard Deviation|6.8|6.8|||
4014242|NCT01190254|3835262|B3|||PANSS general psychopathology subscale score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS general psychopathology subscale score (16 PANSS items) ranged from 16 to 112 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|47.9|47.9|Standard Deviation|7.7|7.7|||
4014243|NCT01190254|3835263|B2|||PANSS general psychopathology subscale score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS general psychopathology subscale score (16 PANSS items) ranged from 16 to 112 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|47.2|47.2|Standard Deviation|6.0|6.0|||
4014244|NCT01190254|3835264|B1|||PANSS general psychopathology subscale score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS general psychopathology subscale score (16 PANSS items) ranged from 16 to 112 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|47.1|47.1|Standard Deviation|6.4|6.4|||
4014245|NCT01190254|3835261|B4|||PANSS positive and negative subscale scores combined|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS positive and negative subscale scores combined (14 PANSS items) ranged from 14 to 98 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|50.5|50.5|Standard Deviation|6.3|6.3|||
4014246|NCT01190254|3835262|B3|||PANSS positive and negative subscale scores combined|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS positive and negative subscale scores combined (14 PANSS items) ranged from 14 to 98 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|50.7|50.7|Standard Deviation|7.3|7.3|||
4014247|NCT01190254|3835263|B2|||PANSS positive and negative subscale scores combined|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS positive and negative subscale scores combined (14 PANSS items) ranged from 14 to 98 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|50.2|50.2|Standard Deviation|5.9|5.9|||
4014248|NCT01190254|3835264|B1|||PANSS positive and negative subscale scores combined|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS positive and negative subscale scores combined (14 PANSS items) ranged from 14 to 98 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|50.5|50.5|Standard Deviation|5.7|5.7|||
4014249|NCT01190254|3835261|B4|||PANSS negative subscale score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS negative subscale score (7 PANSS items) ranged from 7 to 49 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|24.8|24.8|Standard Deviation|4.9|4.9|||
4014250|NCT01190254|3835262|B3|||PANSS negative subscale score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS negative subscale score (7 PANSS items) ranged from 7 to 49 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|24.5|24.5|Standard Deviation|5.4|5.4|||
4014251|NCT01190254|3835263|B2|||PANSS negative subscale score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS negative subscale score (7 PANSS items) ranged from 7 to 49 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|24.9|24.9|Standard Deviation|4.8|4.8|||
4014252|NCT01190254|3835264|B1|||PANSS negative subscale score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS negative subscale score (7 PANSS items) ranged from 7 to 49 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|25.0|25.0|Standard Deviation|4.5|4.5|||
4014281|NCT01190228|3835328|B4||Male|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
4014253|NCT01190254|3835261|B4|||PANSS positive subscale score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS positive subscale score (7 PANSS items) ranged from 7 to 49 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|25.7|25.7|Standard Deviation|4.2|4.2|||
4014254|NCT01190254|3835262|B3|||PANSS positive subscale score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS positive subscale score (7 PANSS items) ranged from 7 to 49 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|26.2|26.2|Standard Deviation|4.5|4.5|||
4014255|NCT01190254|3835263|B2|||PANSS positive subscale score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS positive subscale score (7 PANSS items) ranged from 7 to 49 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|25.4|25.4|Standard Deviation|4.2|4.2|||
4014256|NCT01190254|3835264|B1|||PANSS positive subscale score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS positive subscale score (7 PANSS items) ranged from 7 to 49 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|25.5|25.5|Standard Deviation|3.8|3.8|||
4014257|NCT01190254|3835261|B4|||Clinical Global Impression of Severity (CGI-S) score|CGI-S is a 7-point scale for assessing the global severity of the participant’s illness, with ratings from 1=normal, not ill to 7=very severely ill. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|4.6|4.6|Standard Deviation|0.6|0.6|||
4014258|NCT01190254|3835262|B3|||Clinical Global Impression of Severity (CGI-S) score|CGI-S is a 7-point scale for assessing the global severity of the participant’s illness, with ratings from 1=normal, not ill to 7=very severely ill. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|4.7|4.7|Standard Deviation|0.6|0.6|||
4014259|NCT01190254|3835263|B2|||Clinical Global Impression of Severity (CGI-S) score|CGI-S is a 7-point scale for assessing the global severity of the participant’s illness, with ratings from 1=normal, not ill to 7=very severely ill. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|4.6|4.6|Standard Deviation|0.6|0.6|||
4014260|NCT01190254|3835264|B1|||Clinical Global Impression of Severity (CGI-S) score|CGI-S is a 7-point scale for assessing the global severity of the participant’s illness, with ratings from 1=normal, not ill to 7=very severely ill. Summary statistics presented are for efficacy population (FAS): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|4.6|4.6|Standard Deviation|0.6|0.6|||
4014261|NCT01190254|3835261|B4|||Positive and Negative Syndrome Scale (PANSS) total score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS total score (30 items) ranged from 30 to 210 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (Full Analysis Set [FAS]): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|97.9|97.9|Standard Deviation|11.4|11.4|||
4014262|NCT01190254|3835262|B3|||Positive and Negative Syndrome Scale (PANSS) total score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS total score (30 items) ranged from 30 to 210 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (Full Analysis Set [FAS]): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|98.6|98.6|Standard Deviation|13.4|13.4|||
4014263|NCT01190254|3835263|B2|||Positive and Negative Syndrome Scale (PANSS) total score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS total score (30 items) ranged from 30 to 210 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (Full Analysis Set [FAS]): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|97.4|97.4|Standard Deviation|10.2|10.2|||
4014264|NCT01190254|3835264|B1|||Positive and Negative Syndrome Scale (PANSS) total score|The PANSS is a 30-item scale for assessing the symptoms of schizophrenia. For each PANSS item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS total score (30 items) ranged from 30 to 210 with a higher score indicating greater severity of symptoms. Summary statistics presented are for efficacy population (Full Analysis Set [FAS]): N=100, 96, 104 and 300 for Placebo, asenapine 2.5 mg BID, asenapine 5.0 mg BID and Total groups, respectively.|score on a scale|Mean|97.5|97.5|Standard Deviation|10.3|10.3|||
4014265|NCT01190254|3835261|B4||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4014266|NCT01190254|3835262|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4014267|NCT01190254|3835263|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4014268|NCT01190254|3835264|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4014269|NCT01190254|3835261|B4||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4014270|NCT01190254|3835262|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4014282|NCT01190228|3835329|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4014283|NCT01190228|3835330|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4014284|NCT01190228|3835331|B1||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4014285|NCT01190228|3835328|B4||Female|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
4014286|NCT01190228|3835329|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4014287|NCT01190228|3835330|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4014288|NCT01190228|3835331|B1||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4014289|NCT01190228|3835328|B4|||Age||Months|Mean|39.5|39.5|Standard Deviation|1.79|1.79|||
4014290|NCT01190228|3835329|B3|||Age||Months|Mean|39.3|39.3|Standard Deviation|2.09|2.09|||
4014291|NCT01190228|3835330|B2|||Age||Months|Mean|39.3|39.3|Standard Deviation|1.99|1.99|||
4014292|NCT01190228|3835331|B1|||Age||Months|Mean|39.6|39.6|Standard Deviation|1.71|1.71|||
4014293|NCT01190228|3835328|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4014294|NCT01190228|3835329|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4014295|NCT01190228|3835330|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4014296|NCT01190228|3835331|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4014297|NCT01190228|3835328|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4014298|NCT01190228|3835329|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4014299|NCT01190228|3835330|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4014300|NCT01190228|3835331|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4014301|NCT01190228|3835328|B4||<=18 years|Age||Participants|Count of Participants|450|450.0||||||
4014302|NCT01190228|3835329|B3||<=18 years|Age||Participants|Count of Participants|59|59.0||||||
4014303|NCT01190228|3835330|B2||<=18 years|Age||Participants|Count of Participants|46|46.0||||||
4014304|NCT01190228|3835331|B1||<=18 years|Age||Participants|Count of Participants|345|345.0||||||
4014305|NCT01190215|3835354|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4014306|NCT01190215|3835355|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4014307|NCT01190215|3835356|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4014308|NCT01190215|3835354|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4014309|NCT01190215|3835355|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4014310|NCT01190215|3835356|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4014311|NCT01190215|3835354|B3|||Age||Years|Mean|14.7|14.7|Standard Deviation|2.25|2.25|||
4014312|NCT01190215|3835355|B2|||Age||Years|Mean|14.7|14.7|Standard Deviation|2.28|2.28|||
4014313|NCT01190215|3835356|B1|||Age||Years|Mean|14.6|14.6|Standard Deviation|2.22|2.22|||
4014314|NCT01190189|3835425|B1|Geographic Ancestry|Cuban|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4014315|NCT01190189|3835425|B1|Geographic Ancestry|Native Canadian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4014316|NCT01190189|3835425|B1|Geographic Ancestry|White - Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|119|119.0||||||
4014317|NCT01190189|3835425|B1|Geographic Ancestry|White - Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4014318|NCT01190189|3835425|B1|Geographic Ancestry|Asian - Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4014319|NCT01190189|3835425|B1|Geographic Ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4014320|NCT01190189|3835425|B1|Geographic Ancestry|African Heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4014321|NCT01190189|3835425|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4014322|NCT01190189|3835425|B1||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4014323|NCT01190189|3835425|B1|||Age||Years|Mean|47.9|47.9|Standard Deviation|7.2|7.2|||
4014324|NCT01190176|3835432|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4014325|NCT01190176|3835432|B1|African Heritage / African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4014326|NCT01190176|3835432|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4014327|NCT01190176|3835432|B1|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
4014328|NCT01190176|3835432|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4014329|NCT01190176|3835432|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4014330|NCT01190176|3835432|B1|||Age||years|Mean|39.3|39.3|Standard Deviation|6.3|6.3|||
4014331|NCT01190150|3835451|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4014332|NCT01190150|3835452|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4014333|NCT01190150|3835453|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4014334|NCT01190150|3835451|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4014335|NCT01190150|3835452|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4014336|NCT01190150|3835453|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4014337|NCT01190150|3835451|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4014338|NCT01190150|3835452|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4014339|NCT01190150|3835453|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4014340|NCT01190150|3835451|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4014341|NCT01190150|3835452|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4014342|NCT01190150|3835453|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4014343|NCT01190150|3835451|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4014344|NCT01190150|3835452|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4014345|NCT01190150|3835453|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4014346|NCT01190150|3835451|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4014347|NCT01190150|3835452|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4014348|NCT01190150|3835453|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4014349|NCT01190150|3835451|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4014350|NCT01190150|3835452|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4014351|NCT01190150|3835453|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4014352|NCT01190150|3835451|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4014353|NCT01190150|3835452|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4014354|NCT01190150|3835453|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4014355|NCT01190150|3835451|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4014356|NCT01190150|3835452|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4014357|NCT01190150|3835453|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4014358|NCT01190150|3835451|B3|||Age||years|Mean|14.4|14.4|Standard Deviation|1.19|1.19|||
4014359|NCT01190150|3835452|B2|||Age||years|Mean|14.3|14.3|Standard Deviation|1.32|1.32|||
4014360|NCT01190150|3835453|B1|||Age||years|Mean|14.5|14.5|Standard Deviation|1.13|1.13|||
4014361|NCT01190124|3835478|B4||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4014362|NCT01190124|3835479|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4014363|NCT01190124|3835480|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4014364|NCT01190124|3835481|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4014365|NCT01190124|3835478|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4014366|NCT01190124|3835479|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4014367|NCT01190124|3835480|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4014368|NCT01190124|3835481|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4014369|NCT01190124|3835478|B4|||Age||years|Median|45.0|45.0|Full Range|10.9|10.9|25.0|77.0|
4014370|NCT01190124|3835479|B3|||Age||years|Median|52.5|52.5|Full Range|11.6|11.6|27.0|65.0|
4014371|NCT01190124|3835480|B2|||Age||years|Median|45.5|45.5|Full Range|12.7|12.7|25.0|72.0|
4014372|NCT01190124|3835481|B1|||Age||years|Median|44.0|44.0|Full Range|10.2|10.2|30.0|77.0|
4014373|NCT01190098|3835519|B3|United States||Region of Enrollment||participants|Number|52|52.0||||||
4014374|NCT01190098|3835520|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4014375|NCT01190098|3835521|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4014376|NCT01190098|3835519|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4014377|NCT01190098|3835520|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4014378|NCT01190098|3835521|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4014379|NCT01190098|3835519|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4014380|NCT01190098|3835520|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4014381|NCT01190098|3835521|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4014382|NCT01190098|3835519|B3||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4014383|NCT01190098|3835520|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4014384|NCT01190098|3835521|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4014385|NCT01190098|3835519|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4014386|NCT01190098|3835520|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4014387|NCT01190098|3835521|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4014388|NCT01190098|3835519|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4014389|NCT01190098|3835520|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4014390|NCT01190098|3835521|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4014391|NCT01190098|3835519|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4014392|NCT01190098|3835520|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4014393|NCT01190098|3835521|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4014394|NCT01190098|3835519|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4014395|NCT01190098|3835520|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4014396|NCT01190098|3835521|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4014397|NCT01190098|3835519|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4014398|NCT01190098|3835520|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4014399|NCT01190098|3835521|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4014400|NCT01190098|3835519|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4014401|NCT01190098|3835520|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4014402|NCT01190098|3835521|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4014403|NCT01190098|3835519|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4014404|NCT01190098|3835520|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4014405|NCT01190098|3835521|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4014406|NCT01190098|3835519|B3||Male|Gender||Participants|Count of Participants|16|16.0||||||
4014407|NCT01190098|3835520|B2||Male|Gender||Participants|Count of Participants|3|3.0||||||
4014408|NCT01190098|3835521|B1||Male|Gender||Participants|Count of Participants|13|13.0||||||
4014409|NCT01190098|3835519|B3||Female|Gender||Participants|Count of Participants|36|36.0||||||
4014410|NCT01190098|3835520|B2||Female|Gender||Participants|Count of Participants|7|7.0||||||
4014411|NCT01190098|3835521|B1||Female|Gender||Participants|Count of Participants|29|29.0||||||
4014412|NCT01190098|3835519|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4014413|NCT01190098|3835520|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4014414|NCT01190098|3835521|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4014415|NCT01190098|3835519|B3||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4014416|NCT01190098|3835520|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4014417|NCT01190098|3835521|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4014418|NCT01190098|3835519|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4014419|NCT01190098|3835520|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4014420|NCT01190098|3835521|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4014421|NCT01190085|3835542|B4|United States||Region of Enrollment||participants|Number|45|45.0||||||
4014422|NCT01190085|3835543|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4014423|NCT01190085|3835544|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4014424|NCT01190085|3835545|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4014425|NCT01190085|3835542|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4014426|NCT01190085|3835543|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4014427|NCT01190085|3835544|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4014428|NCT01190085|3835545|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4014429|NCT01190085|3835542|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4014430|NCT01190085|3835543|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4014431|NCT01190085|3835544|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4014432|NCT01190085|3835545|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4014433|NCT01190085|3835542|B4|||Age||years|Mean|44.7|44.7|Standard Deviation|9.1|9.1|||
4014434|NCT01190085|3835543|B3|||Age||years|Mean|46.6|46.6|Standard Deviation|9.0|9.0|||
4014435|NCT01190085|3835544|B2|||Age||years|Mean|43.9|43.9|Standard Deviation|8.6|8.6|||
4014436|NCT01190085|3835545|B1|||Age||years|Mean|42.8|42.8|Standard Deviation|9.8|9.8|||
4014437|NCT01190085|3835542|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4014438|NCT01190085|3835543|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4014439|NCT01190085|3835544|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4014440|NCT01190085|3835545|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4014441|NCT01190085|3835542|B4||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4014442|NCT01190085|3835543|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4014443|NCT01190085|3835544|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4014444|NCT01190085|3835545|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4014445|NCT01190085|3835542|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4014446|NCT01190085|3835543|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4014447|NCT01190085|3835544|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4014448|NCT01190085|3835545|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4014449|NCT01190007|3835561|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4014450|NCT01190007|3835561|B1||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4014451|NCT01190007|3835561|B1|||Age||years|Mean|65.0|65.0|Standard Deviation|9.5|9.5|||
4014452|NCT01189890|3835576|B3|||Body Weight|All randomized participants who received at least one dose of study treatment and had a body weight measurement at baseline. Sitagliptin (n=205) and glimepiride (n=203).|kg|Mean|76.0|76.0|Standard Deviation|15.6|15.6|||
4014453|NCT01189890|3835577|B2|||Body Weight|All randomized participants who received at least one dose of study treatment and had a body weight measurement at baseline. Sitagliptin (n=205) and glimepiride (n=203).|kg|Mean|75.4|75.4|Standard Deviation|16.4|16.4|||
4014454|NCT01189890|3835578|B1|||Body Weight|All randomized participants who received at least one dose of study treatment and had a body weight measurement at baseline. Sitagliptin (n=205) and glimepiride (n=203).|kg|Mean|76.9|76.9|Standard Deviation|15.1|15.1|||
4014455|NCT01189890|3835576|B3|||Fasting Plasma Glucose (FPG)|The population included all randomized participants who had a baseline FPG, did not take prohibited concomitant medications, had compliance >85%, and did not receive any incorrect study medication. Sitagliptin (n=194) and glimepiride (n=191).|mg/dL|Mean|169.0|169.0|Standard Deviation|33.3|33.3|||
4014456|NCT01189890|3835577|B2|||Fasting Plasma Glucose (FPG)|The population included all randomized participants who had a baseline FPG, did not take prohibited concomitant medications, had compliance >85%, and did not receive any incorrect study medication. Sitagliptin (n=194) and glimepiride (n=191).|mg/dL|Mean|169.7|169.7|Standard Deviation|35.5|35.5|||
4014457|NCT01189890|3835578|B1|||Fasting Plasma Glucose (FPG)|The population included all randomized participants who had a baseline FPG, did not take prohibited concomitant medications, had compliance >85%, and did not receive any incorrect study medication. Sitagliptin (n=194) and glimepiride (n=191).|mg/dL|Mean|168.4|168.4|Standard Deviation|31.2|31.2|||
4014458|NCT01189890|3835576|B3|||Hemoglobin A1c (HbA1c)|The population included all randomized participants who had a baseline HbA1c, did not take prohibited concomitant medications, had compliance >85%, and did not receive any incorrect study medication. Sitagliptin (n=197) and glimepiride (n=191).|Percentage of HbA1c|Mean|7.78|7.78|Standard Deviation|0.69|0.69|||
4014459|NCT01189890|3835577|B2|||Hemoglobin A1c (HbA1c)|The population included all randomized participants who had a baseline HbA1c, did not take prohibited concomitant medications, had compliance >85%, and did not receive any incorrect study medication. Sitagliptin (n=197) and glimepiride (n=191).|Percentage of HbA1c|Mean|7.78|7.78|Standard Deviation|0.67|0.67|||
4014460|NCT01189890|3835578|B1|||Hemoglobin A1c (HbA1c)|The population included all randomized participants who had a baseline HbA1c, did not take prohibited concomitant medications, had compliance >85%, and did not receive any incorrect study medication. Sitagliptin (n=197) and glimepiride (n=191).|Percentage of HbA1c|Mean|7.78|7.78|Standard Deviation|0.70|0.7|||
4014461|NCT01189890|3835576|B3||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4014462|NCT01189890|3835577|B2||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4014463|NCT01189890|3835578|B1||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4014464|NCT01189890|3835576|B3||Female|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
4014465|NCT01189890|3835577|B2||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4014466|NCT01189890|3835578|B1||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4014467|NCT01189890|3835576|B3|||Age||years|Mean|70.7|70.7|Standard Deviation|4.8|4.8|||
4014468|NCT01189890|3835577|B2|||Age||years|Mean|70.8|70.8|Standard Deviation|4.9|4.9|||
4014469|NCT01189890|3835578|B1|||Age||years|Mean|70.7|70.7|Standard Deviation|4.8|4.8|||
4014470|NCT01189812|3835599|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
4014471|NCT01189812|3835600|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4014472|NCT01189812|3835601|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4014473|NCT01189812|3835599|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4014474|NCT01189812|3835600|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4014475|NCT01189812|3835601|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4014476|NCT01189812|3835599|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4014477|NCT01189812|3835600|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4014478|NCT01189812|3835601|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4014479|NCT01189812|3835599|B3|||Age||years|Mean|41.8|41.8|Standard Deviation|13.8|13.8|||
4014480|NCT01189812|3835600|B2|||Age||years|Mean|45.0|45.0|Standard Deviation|11.6|11.6|||
4014481|NCT01189812|3835601|B1|||Age||years|Mean|38.5|38.5|Standard Deviation|15.2|15.2|||
4014482|NCT01189812|3835599|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4014483|NCT01189812|3835600|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4014484|NCT01189812|3835601|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4014485|NCT01189812|3835599|B3||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
4014486|NCT01189812|3835600|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4014487|NCT01189812|3835601|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4014488|NCT01189812|3835599|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4014489|NCT01189812|3835600|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4014490|NCT01189812|3835601|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4014491|NCT01189760|3835608|B4|Severe||CFL Severity as Assessed by the Investigator|Crow’s Feet Line (CFL) severity as assessed at Baseline by the Investigator using the 4-point Facial Wrinkle Scale (FWS) at maximum smile.|Participants|Number|580|580.0||||||
4014492|NCT01189760|3835609|B3|Severe||CFL Severity as Assessed by the Investigator|Crow’s Feet Line (CFL) severity as assessed at Baseline by the Investigator using the 4-point Facial Wrinkle Scale (FWS) at maximum smile.|Participants|Number|193|193.0||||||
4014493|NCT01189760|3835610|B2|Severe||CFL Severity as Assessed by the Investigator|Crow’s Feet Line (CFL) severity as assessed at Baseline by the Investigator using the 4-point Facial Wrinkle Scale (FWS) at maximum smile.|Participants|Number|191|191.0||||||
4014494|NCT01189760|3835611|B1|Severe||CFL Severity as Assessed by the Investigator|Crow’s Feet Line (CFL) severity as assessed at Baseline by the Investigator using the 4-point Facial Wrinkle Scale (FWS) at maximum smile.|Participants|Number|196|196.0||||||
4014495|NCT01189760|3835608|B4|Moderate||CFL Severity as Assessed by the Investigator|Crow’s Feet Line (CFL) severity as assessed at Baseline by the Investigator using the 4-point Facial Wrinkle Scale (FWS) at maximum smile.|Participants|Number|337|337.0||||||
4014496|NCT01189760|3835609|B3|Moderate||CFL Severity as Assessed by the Investigator|Crow’s Feet Line (CFL) severity as assessed at Baseline by the Investigator using the 4-point Facial Wrinkle Scale (FWS) at maximum smile.|Participants|Number|113|113.0||||||
4014497|NCT01189760|3835610|B2|Moderate||CFL Severity as Assessed by the Investigator|Crow’s Feet Line (CFL) severity as assessed at Baseline by the Investigator using the 4-point Facial Wrinkle Scale (FWS) at maximum smile.|Participants|Number|115|115.0||||||
4014498|NCT01189760|3835611|B1|Moderate||CFL Severity as Assessed by the Investigator|Crow’s Feet Line (CFL) severity as assessed at Baseline by the Investigator using the 4-point Facial Wrinkle Scale (FWS) at maximum smile.|Participants|Number|109|109.0||||||
4014499|NCT01189760|3835608|B4||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4014500|NCT01189760|3835609|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4014501|NCT01189760|3835610|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4014502|NCT01189760|3835611|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4014503|NCT01189760|3835608|B4||Female|Sex: Female, Male||Participants|Count of Participants|803|803.0||||||
4014504|NCT01189760|3835609|B3||Female|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
4014505|NCT01189760|3835610|B2||Female|Sex: Female, Male||Participants|Count of Participants|273|273.0||||||
4014506|NCT01189760|3835611|B1||Female|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
4014507|NCT01189760|3835608|B4|>65 Years||Age, Customized||Participants|Number|43|43.0||||||
4014508|NCT01189760|3835609|B3|>65 Years||Age, Customized||Participants|Number|12|12.0||||||
4014509|NCT01189760|3835610|B2|>65 Years||Age, Customized||Participants|Number|17|17.0||||||
4014510|NCT01189760|3835611|B1|>65 Years||Age, Customized||Participants|Number|14|14.0||||||
4014511|NCT01189760|3835608|B4|45 to 65 Years||Age, Customized||Participants|Number|598|598.0||||||
4014512|NCT01189760|3835609|B3|45 to 65 Years||Age, Customized||Participants|Number|194|194.0||||||
4014513|NCT01189760|3835610|B2|45 to 65 Years||Age, Customized||Participants|Number|200|200.0||||||
4014514|NCT01189760|3835611|B1|45 to 65 Years||Age, Customized||Participants|Number|204|204.0||||||
4014515|NCT01189760|3835608|B4|<45 Years||Age, Customized||Participants|Number|276|276.0||||||
4014516|NCT01189760|3835609|B3|<45 Years||Age, Customized||Participants|Number|100|100.0||||||
4014517|NCT01189760|3835610|B2|<45 Years||Age, Customized||Participants|Number|89|89.0||||||
4014518|NCT01189760|3835611|B1|<45 Years||Age, Customized||Participants|Number|87|87.0||||||
4014519|NCT01189747|3835645|B3|No data available||CFL Severity as Assessed by Investigator|Crow’s Feet Line (CFL) severity as assessed at Baseline by the investigator using the 4-point Facial Wrinkle Scale (FWS) at maximum smile.|Participants|Number|2|2.0||||||
4014520|NCT01189747|3835646|B2|No data available||CFL Severity as Assessed by Investigator|Crow’s Feet Line (CFL) severity as assessed at Baseline by the investigator using the 4-point Facial Wrinkle Scale (FWS) at maximum smile.|Participants|Number|1|1.0||||||
4014521|NCT01189747|3835647|B1|No data available||CFL Severity as Assessed by Investigator|Crow’s Feet Line (CFL) severity as assessed at Baseline by the investigator using the 4-point Facial Wrinkle Scale (FWS) at maximum smile.|Participants|Number|1|1.0||||||
4014522|NCT01189747|3835645|B3|Severe||CFL Severity as Assessed by Investigator|Crow’s Feet Line (CFL) severity as assessed at Baseline by the investigator using the 4-point Facial Wrinkle Scale (FWS) at maximum smile.|Participants|Number|223|223.0||||||
4014523|NCT01189747|3835646|B2|Severe||CFL Severity as Assessed by Investigator|Crow’s Feet Line (CFL) severity as assessed at Baseline by the investigator using the 4-point Facial Wrinkle Scale (FWS) at maximum smile.|Participants|Number|111|111.0||||||
4014524|NCT01189747|3835647|B1|Severe||CFL Severity as Assessed by Investigator|Crow’s Feet Line (CFL) severity as assessed at Baseline by the investigator using the 4-point Facial Wrinkle Scale (FWS) at maximum smile.|Participants|Number|112|112.0||||||
4014525|NCT01189747|3835645|B3|Moderate||CFL Severity as Assessed by Investigator|Crow’s Feet Line (CFL) severity as assessed at Baseline by the investigator using the 4-point Facial Wrinkle Scale (FWS) at maximum smile.|Participants|Number|221|221.0||||||
4014526|NCT01189747|3835646|B2|Moderate||CFL Severity as Assessed by Investigator|Crow’s Feet Line (CFL) severity as assessed at Baseline by the investigator using the 4-point Facial Wrinkle Scale (FWS) at maximum smile.|Participants|Number|112|112.0||||||
4014527|NCT01189747|3835647|B1|Moderate||CFL Severity as Assessed by Investigator|Crow’s Feet Line (CFL) severity as assessed at Baseline by the investigator using the 4-point Facial Wrinkle Scale (FWS) at maximum smile.|Participants|Number|109|109.0||||||
4014528|NCT01189747|3835645|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4014529|NCT01189747|3835646|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4014530|NCT01189747|3835647|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4014531|NCT01189747|3835645|B3||Female|Sex: Female, Male||Participants|Count of Participants|385|385.0||||||
4014532|NCT01189747|3835646|B2||Female|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4014533|NCT01189747|3835647|B1||Female|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4014534|NCT01189747|3835645|B3|> 65 Years||Age, Customized||Participants|Number|10|10.0||||||
4014535|NCT01189747|3835646|B2|> 65 Years||Age, Customized||Participants|Number|5|5.0||||||
4014536|NCT01189747|3835647|B1|> 65 Years||Age, Customized||Participants|Number|5|5.0||||||
4014537|NCT01189747|3835645|B3|45 to 65 Years||Age, Customized||Participants|Number|253|253.0||||||
4014538|NCT01189747|3835646|B2|45 to 65 Years||Age, Customized||Participants|Number|118|118.0||||||
4014539|NCT01189747|3835647|B1|45 to 65 Years||Age, Customized||Participants|Number|135|135.0||||||
4014540|NCT01189747|3835645|B3|< 45 Years||Age, Customized||Participants|Number|183|183.0||9.53|9.53|||
4014541|NCT01189747|3835646|B2|< 45 Years||Age, Customized||Participants|Number|101|101.0||9.70|9.7|||
4014542|NCT01189747|3835647|B1|< 45 Years||Age, Customized||Participants|Number|82|82.0||9.37|9.37|||
4014543|NCT01189617|3835670|B3|Postmenopausal||Female Sub-Typing - Menopausal State||Participants|Number|17|17.0||||||
4014544|NCT01189617|3835671|B2|Postmenopausal||Female Sub-Typing - Menopausal State||Participants|Number|17|17.0||||||
4014596|NCT01189604|3835686|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4014545|NCT01189617|3835672|B1|Postmenopausal||Female Sub-Typing - Menopausal State||Participants|Number|NA|||||||Data for this element is not available for male subjects because they do not experience menopause.
4014546|NCT01189617|3835670|B3|Premenopausal||Female Sub-Typing - Menopausal State||Participants|Number|18|18.0||||||
4014547|NCT01189617|3835671|B2|Premenopausal||Female Sub-Typing - Menopausal State||Participants|Number|18|18.0||||||
4014548|NCT01189617|3835672|B1|Premenopausal||Female Sub-Typing - Menopausal State||Participants|Number|NA|||||||Data for this element is not available for male subjects because they do not experience menopause.
4014549|NCT01189617|3835670|B3|United States||Region of Enrollment||participants|Number|70|70.0||||||
4014550|NCT01189617|3835671|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
4014551|NCT01189617|3835672|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4014552|NCT01189617|3835670|B3|Other [unknown]||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4014553|NCT01189617|3835671|B2|Other [unknown]||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4014554|NCT01189617|3835672|B1|Other [unknown]||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4014555|NCT01189617|3835670|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4014556|NCT01189617|3835671|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4014557|NCT01189617|3835672|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4014558|NCT01189617|3835670|B3|Black or African-American||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4014559|NCT01189617|3835671|B2|Black or African-American||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4014560|NCT01189617|3835672|B1|Black or African-American||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4014561|NCT01189617|3835670|B3|White||Race/Ethnicity, Customized||Participants|Number|46|46.0||||||
4014562|NCT01189617|3835671|B2|White||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
4014563|NCT01189617|3835672|B1|White||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
4014564|NCT01189617|3835670|B3||Male|Gender||Participants|Count of Participants|35|35.0||||||
4014565|NCT01189617|3835671|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
4014566|NCT01189617|3835672|B1||Male|Gender||Participants|Count of Participants|35|35.0||||||
4014567|NCT01189617|3835670|B3||Female|Gender||Participants|Count of Participants|35|35.0||||||
4014568|NCT01189617|3835671|B2||Female|Gender||Participants|Count of Participants|35|35.0||||||
4014569|NCT01189617|3835672|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
4014570|NCT01189617|3835670|B3|||Age||years|Mean|50.25|50.25|Standard Deviation|12.8|12.8|||
4014571|NCT01189617|3835671|B2|||Age||years|Mean|49.3|49.3|Standard Deviation|12.8|12.8|||
4014572|NCT01189617|3835672|B1|||Age||years|Mean|51.2|51.2|Standard Deviation|12.8|12.8|||
4014573|NCT01189604|3835679|B8|Colonoscopy||Procedures|Patients underwent either esophagogastroduodenoscopy (EGD) or colonoscopy.|participants|Number|60|60.0||||||
4014574|NCT01189604|3835680|B7|Colonoscopy||Procedures|Patients underwent either esophagogastroduodenoscopy (EGD) or colonoscopy.|participants|Number|5|5.0||||||
4014575|NCT01189604|3835681|B6|Colonoscopy||Procedures|Patients underwent either esophagogastroduodenoscopy (EGD) or colonoscopy.|participants|Number|5|5.0||||||
4014576|NCT01189604|3835682|B5|Colonoscopy||Procedures|Patients underwent either esophagogastroduodenoscopy (EGD) or colonoscopy.|participants|Number|10|10.0||||||
4014577|NCT01189604|3835683|B4|Colonoscopy||Procedures|Patients underwent either esophagogastroduodenoscopy (EGD) or colonoscopy.|participants|Number|10|10.0||||||
4014578|NCT01189604|3835684|B3|Colonoscopy||Procedures|Patients underwent either esophagogastroduodenoscopy (EGD) or colonoscopy.|participants|Number|10|10.0||||||
4014579|NCT01189604|3835685|B2|Colonoscopy||Procedures|Patients underwent either esophagogastroduodenoscopy (EGD) or colonoscopy.|participants|Number|10|10.0||||||
4014580|NCT01189604|3835686|B1|Colonoscopy||Procedures|Patients underwent either esophagogastroduodenoscopy (EGD) or colonoscopy.|participants|Number|10|10.0||||||
4014581|NCT01189604|3835679|B8|Esophagogastroduodenoscopy (EGD)||Procedures|Patients underwent either esophagogastroduodenoscopy (EGD) or colonoscopy.|participants|Number|60|60.0||||||
4014582|NCT01189604|3835680|B7|Esophagogastroduodenoscopy (EGD)||Procedures|Patients underwent either esophagogastroduodenoscopy (EGD) or colonoscopy.|participants|Number|5|5.0||||||
4014583|NCT01189604|3835681|B6|Esophagogastroduodenoscopy (EGD)||Procedures|Patients underwent either esophagogastroduodenoscopy (EGD) or colonoscopy.|participants|Number|5|5.0||||||
4014584|NCT01189604|3835682|B5|Esophagogastroduodenoscopy (EGD)||Procedures|Patients underwent either esophagogastroduodenoscopy (EGD) or colonoscopy.|participants|Number|10|10.0||||||
4014585|NCT01189604|3835683|B4|Esophagogastroduodenoscopy (EGD)||Procedures|Patients underwent either esophagogastroduodenoscopy (EGD) or colonoscopy.|participants|Number|10|10.0||||||
4014586|NCT01189604|3835684|B3|Esophagogastroduodenoscopy (EGD)||Procedures|Patients underwent either esophagogastroduodenoscopy (EGD) or colonoscopy.|participants|Number|10|10.0||||||
4014587|NCT01189604|3835685|B2|Esophagogastroduodenoscopy (EGD)||Procedures|Patients underwent either esophagogastroduodenoscopy (EGD) or colonoscopy.|participants|Number|10|10.0||||||
4014588|NCT01189604|3835686|B1|Esophagogastroduodenoscopy (EGD)||Procedures|Patients underwent either esophagogastroduodenoscopy (EGD) or colonoscopy.|participants|Number|10|10.0||||||
4014589|NCT01189604|3835679|B8||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4014590|NCT01189604|3835680|B7||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4014591|NCT01189604|3835681|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4014592|NCT01189604|3835682|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4014593|NCT01189604|3835683|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4014594|NCT01189604|3835684|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4014595|NCT01189604|3835685|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4014597|NCT01189604|3835679|B8||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4014598|NCT01189604|3835680|B7||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4014599|NCT01189604|3835681|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4014600|NCT01189604|3835682|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4014601|NCT01189604|3835683|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4014602|NCT01189604|3835684|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4014603|NCT01189604|3835685|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4014604|NCT01189604|3835686|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4014605|NCT01189604|3835679|B8|||Age||years|Mean|53.2|53.2|Standard Deviation|14.5|14.5|||
4014606|NCT01189604|3835680|B7|||Age||years|Mean|51.8|51.8|Standard Deviation|8.5|8.5|||
4014607|NCT01189604|3835681|B6|||Age||years|Mean|49.4|49.4|Standard Deviation|14.2|14.2|||
4014608|NCT01189604|3835682|B5|||Age||years|Mean|56.4|56.4|Standard Deviation|12.7|12.7|||
4014609|NCT01189604|3835683|B4|||Age||years|Mean|52.0|52.0|Standard Deviation|14.9|14.9|||
4014610|NCT01189604|3835684|B3|||Age||years|Mean|56.1|56.1|Standard Deviation|14.4|14.4|||
4014611|NCT01189604|3835685|B2|||Age||years|Mean|51.0|51.0|Standard Deviation|16.4|16.4|||
4014612|NCT01189604|3835686|B1|||Age||years|Mean|53.2|53.2|Standard Deviation|17.3|17.3|||
4014613|NCT01189500|3835736|B1|||Sex/Gender, Customized|Female|participants|Number|30|30.0||||||
4014614|NCT01189500|3835736|B1|≥65 years||Age, Customized||participants|Number|3|3.0||||||
4014615|NCT01189500|3835736|B1|45 to 64 years||Age, Customized||participants|Number|27|27.0||||||
4014616|NCT01189487|3835797|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4014617|NCT01189487|3835797|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4014618|NCT01189487|3835797|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|16.4|16.4|||
4014619|NCT01189461|3835805|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4014620|NCT01189461|3835805|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4014621|NCT01189461|3835805|B1|||Age||years|Mean|65.0|65.0|Standard Deviation|10.6|10.6|||
4014622|NCT01189435|3835812|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4014623|NCT01189435|3835812|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4014624|NCT01189435|3835812|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4014625|NCT01189435|3835812|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4014626|NCT01189435|3835812|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4014627|NCT01189409|3835816|B3|Other||Diagnosis||Participants|Count of Participants|24|24.0||||||
4014628|NCT01189409|3835817|B2|Other||Diagnosis||Participants|Count of Participants|12|12.0||||||
4014629|NCT01189409|3835818|B1|Other||Diagnosis||Participants|Count of Participants|12|12.0||||||
4014630|NCT01189409|3835816|B3|Haematological||Diagnosis||Participants|Count of Participants|8|8.0||||||
4014631|NCT01189409|3835817|B2|Haematological||Diagnosis||Participants|Count of Participants|5|5.0||||||
4014632|NCT01189409|3835818|B1|Haematological||Diagnosis||Participants|Count of Participants|3|3.0||||||
4014633|NCT01189409|3835816|B3|Bladder||Diagnosis||Participants|Count of Participants|1|1.0||||||
4014634|NCT01189409|3835817|B2|Bladder||Diagnosis||Participants|Count of Participants|0|0.0||||||
4014635|NCT01189409|3835818|B1|Bladder||Diagnosis||Participants|Count of Participants|1|1.0||||||
4014636|NCT01189409|3835816|B3|Prostate||Diagnosis||Participants|Count of Participants|6|6.0||||||
4014637|NCT01189409|3835817|B2|Prostate||Diagnosis||Participants|Count of Participants|3|3.0||||||
4014638|NCT01189409|3835818|B1|Prostate||Diagnosis||Participants|Count of Participants|3|3.0||||||
4014639|NCT01189409|3835816|B3|Kidney||Diagnosis||Participants|Count of Participants|1|1.0||||||
4014640|NCT01189409|3835817|B2|Kidney||Diagnosis||Participants|Count of Participants|0|0.0||||||
4014641|NCT01189409|3835818|B1|Kidney||Diagnosis||Participants|Count of Participants|1|1.0||||||
4014642|NCT01189409|3835816|B3|Brain||Diagnosis||Participants|Count of Participants|1|1.0||||||
4014643|NCT01189409|3835817|B2|Brain||Diagnosis||Participants|Count of Participants|0|0.0||||||
4014644|NCT01189409|3835818|B1|Brain||Diagnosis||Participants|Count of Participants|1|1.0||||||
4014645|NCT01189409|3835816|B3|GI||Diagnosis||Participants|Count of Participants|6|6.0||||||
4014646|NCT01189409|3835817|B2|GI||Diagnosis||Participants|Count of Participants|3|3.0||||||
4014647|NCT01189409|3835818|B1|GI||Diagnosis||Participants|Count of Participants|3|3.0||||||
4014648|NCT01189409|3835816|B3|Breast||Diagnosis||Participants|Count of Participants|13|13.0||||||
4014649|NCT01189409|3835817|B2|Breast||Diagnosis||Participants|Count of Participants|4|4.0||||||
4014650|NCT01189409|3835818|B1|Breast||Diagnosis||Participants|Count of Participants|9|9.0||||||
4014651|NCT01189409|3835816|B3|Lung||Diagnosis||Participants|Count of Participants|10|10.0||||||
4014652|NCT01189409|3835817|B2|Lung||Diagnosis||Participants|Count of Participants|6|6.0||||||
4014653|NCT01189409|3835818|B1|Lung||Diagnosis||Participants|Count of Participants|4|4.0||||||
4014654|NCT01189409|3835816|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4014655|NCT01189409|3835816|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4014656|NCT01189409|3835817|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4014657|NCT01189409|3835818|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4014658|NCT01189409|3835816|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4014659|NCT01189409|3835817|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4014660|NCT01189409|3835818|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4014661|NCT01189409|3835816|B3|||Age||years|Mean|66|66.0|Full Range|||26.0|89.0|
4014662|NCT01189409|3835817|B2|||Age||years|Mean|59.2|59.2|Full Range|||38.0|74.0|
4014663|NCT01189409|3835818|B1|||Age||years|Mean|72.8|72.8|Full Range|||26.0|89.0|
4014664|NCT01189409|3835816|B3||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4014665|NCT01189409|3835817|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4014666|NCT01189409|3835818|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4014667|NCT01189409|3835816|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4014668|NCT01189409|3835817|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4014669|NCT01189409|3835818|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4014670|NCT01189409|3835816|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4014671|NCT01189409|3835817|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4014672|NCT01189409|3835818|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4014673|NCT01189370|3835834|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4014674|NCT01189370|3835834|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4014675|NCT01189370|3835834|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4014676|NCT01189370|3835834|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4014677|NCT01189370|3835834|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4014678|NCT01189292|3835843|B3|Benign disease||Histology of specimen||participants|Number|136|136.0||||||
4014679|NCT01189292|3835844|B2|Benign disease||Histology of specimen||participants|Number|67|67.0||||||
4014680|NCT01189292|3835845|B1|Benign disease||Histology of specimen||participants|Number|69|69.0||||||
4014681|NCT01189292|3835843|B3|Follicular thyroid cancer (FTC)||Histology of specimen||participants|Number|6|6.0||||||
4014682|NCT01189292|3835844|B2|Follicular thyroid cancer (FTC)||Histology of specimen||participants|Number|2|2.0||||||
4014683|NCT01189292|3835845|B1|Follicular thyroid cancer (FTC)||Histology of specimen||participants|Number|4|4.0||||||
4014684|NCT01189292|3835843|B3|Papillary thyroid cancer (PTC)||Histology of specimen||participants|Number|10|10.0||||||
4014685|NCT01189292|3835844|B2|Papillary thyroid cancer (PTC)||Histology of specimen||participants|Number|7|7.0||||||
4014686|NCT01189292|3835845|B1|Papillary thyroid cancer (PTC)||Histology of specimen||participants|Number|3|3.0||||||
4014687|NCT01189292|3835843|B3|||Specimen weight||gram|Mean|48.3|48.3|Standard Deviation|49.9|49.9|||
4014688|NCT01189292|3835844|B2|||Specimen weight||gram|Mean|51.2|51.2|Standard Deviation|58.2|58.2|||
4014689|NCT01189292|3835845|B1|||Specimen weight||gram|Mean|45.3|45.3|Standard Deviation|40.1|40.1|||
4014690|NCT01189292|3835843|B3|||Operating time||minutes|Mean|126.8|126.8|Standard Deviation|43.2|43.2|||
4014691|NCT01189292|3835844|B2|||Operating time||minutes|Mean|127.5|127.5|Standard Deviation|45.7|45.7|||
4014692|NCT01189292|3835845|B1|||Operating time||minutes|Mean|126.2|126.2|Standard Deviation|40.9|40.9|||
4014693|NCT01189292|3835843|B3|yes||Lymph node dissection (C1/level VI)||participants|Number|24|24.0||||||
4014694|NCT01189292|3835844|B2|yes||Lymph node dissection (C1/level VI)||participants|Number|11|11.0||||||
4014695|NCT01189292|3835845|B1|yes||Lymph node dissection (C1/level VI)||participants|Number|13|13.0||||||
4014696|NCT01189292|3835843|B3|no||Lymph node dissection (C1/level VI)||participants|Number|128|128.0||||||
4014697|NCT01189292|3835844|B2|no||Lymph node dissection (C1/level VI)||participants|Number|65|65.0||||||
4014698|NCT01189292|3835845|B1|no||Lymph node dissection (C1/level VI)||participants|Number|63|63.0||||||
4014699|NCT01189292|3835843|B3|Total thyroidectomy||Type of surgery||participants|Number|45|45.0||||||
4014700|NCT01189292|3835844|B2|Total thyroidectomy||Type of surgery||participants|Number|25|25.0||||||
4014701|NCT01189292|3835845|B1|Total thyroidectomy||Type of surgery||participants|Number|20|20.0||||||
4014702|NCT01189292|3835843|B3|Near total thyroidectomy||Type of surgery||participants|Number|32|32.0||||||
4014703|NCT01189292|3835844|B2|Near total thyroidectomy||Type of surgery||participants|Number|13|13.0||||||
4014704|NCT01189292|3835845|B1|Near total thyroidectomy||Type of surgery||participants|Number|19|19.0||||||
4014705|NCT01189292|3835843|B3|Hemithyroidectomy||Type of surgery||participants|Number|75|75.0||||||
4014706|NCT01189292|3835844|B2|Hemithyroidectomy||Type of surgery||participants|Number|38|38.0||||||
4014707|NCT01189292|3835845|B1|Hemithyroidectomy||Type of surgery||participants|Number|37|37.0||||||
4014708|NCT01189292|3835843|B3|Goiter, uninodular||Diagnosis||participants|Number|59|59.0||||||
4014709|NCT01189292|3835844|B2|Goiter, uninodular||Diagnosis||participants|Number|31|31.0||||||
4014710|NCT01189292|3835845|B1|Goiter, uninodular||Diagnosis||participants|Number|28|28.0||||||
4014711|NCT01189292|3835843|B3|Goiter, multinodular||Diagnosis||participants|Number|68|68.0||||||
4014712|NCT01189292|3835844|B2|Goiter, multinodular||Diagnosis||participants|Number|33|33.0||||||
4014713|NCT01189292|3835845|B1|Goiter, multinodular||Diagnosis||participants|Number|35|35.0||||||
4014714|NCT01189292|3835843|B3|Graves disease||Diagnosis||participants|Number|25|25.0||||||
4014715|NCT01189292|3835844|B2|Graves disease||Diagnosis||participants|Number|12|12.0||||||
4014716|NCT01189292|3835845|B1|Graves disease||Diagnosis||participants|Number|13|13.0||||||
4014717|NCT01189292|3835843|B3|||Body mass index||kg/m²|Mean|25.1|25.1|Standard Deviation|4.4|4.4|||
4014718|NCT01189292|3835844|B2|||Body mass index||kg/m²|Mean|25.4|25.4|Standard Deviation|4.6|4.6|||
4014719|NCT01189292|3835845|B1|||Body mass index||kg/m²|Mean|24.8|24.8|Standard Deviation|4.1|4.1|||
4014720|NCT01189292|3835843|B3|Switzerland||Region of Enrollment||participants|Number|152|152.0||||||
4014721|NCT01189292|3835844|B2|Switzerland||Region of Enrollment||participants|Number|76|76.0||||||
4014722|NCT01189292|3835845|B1|Switzerland||Region of Enrollment||participants|Number|76|76.0||||||
4014723|NCT01189292|3835843|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4014724|NCT01189292|3835844|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4014725|NCT01189292|3835845|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4014726|NCT01189292|3835843|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4014727|NCT01189292|3835844|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4014728|NCT01189292|3835845|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4014729|NCT01189292|3835843|B3|||Age||years|Mean|49.0|49.0|Standard Deviation|12.7|12.7|||
4014730|NCT01189292|3835844|B2|||Age||years|Mean|48.4|48.4|Standard Deviation|13.4|13.4|||
4014731|NCT01189292|3835845|B1|||Age||years|Mean|49.5|49.5|Standard Deviation|12.0|12.0|||
4014732|NCT01189292|3835843|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4014733|NCT01189292|3835844|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4014734|NCT01189292|3835845|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4014735|NCT01189292|3835843|B3||Between 18 and 65 years|Age||Participants|Count of Participants|137|137.0||||||
4014736|NCT01189292|3835844|B2||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
4014737|NCT01189292|3835845|B1||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4014738|NCT01189292|3835843|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4014739|NCT01189292|3835844|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4014740|NCT01189292|3835845|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4014741|NCT01189279|3835864|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4014742|NCT01189279|3835865|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4014743|NCT01189279|3835866|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4014744|NCT01189279|3835867|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4014745|NCT01189279|3835864|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4014746|NCT01189279|3835865|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4014747|NCT01189279|3835866|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4014748|NCT01189279|3835867|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4014749|NCT01189279|3835864|B4|45 to 64 years||Age, Customized||Participants|Number|25|25.0||||||
4014750|NCT01189279|3835865|B3|45 to 64 years||Age, Customized||Participants|Number|6|6.0||||||
4014751|NCT01189279|3835866|B2|45 to 64 years||Age, Customized||Participants|Number|10|10.0||||||
4014752|NCT01189279|3835867|B1|45 to 64 years||Age, Customized||Participants|Number|9|9.0||||||
4014753|NCT01189279|3835864|B4|<45 years||Age, Customized||Participants|Number|17|17.0||||||
4014754|NCT01189279|3835865|B3|<45 years||Age, Customized||Participants|Number|8|8.0||||||
4014755|NCT01189279|3835866|B2|<45 years||Age, Customized||Participants|Number|4|4.0||||||
4014756|NCT01189279|3835867|B1|<45 years||Age, Customized||Participants|Number|5|5.0||||||
4014757|NCT01189240|3835889|B1|Other||Initial Histological Diagnosis||participants|Number|2|2.0||||||
4014758|NCT01189240|3835889|B1|Glioblastoma||Initial Histological Diagnosis||participants|Number|10|10.0||||||
4014759|NCT01189240|3835889|B1|Resection||Initial Procedure||participants|Number|11|11.0||||||
4014760|NCT01189240|3835889|B1|biopsy||Initial Procedure||participants|Number|1|1.0||||||
4014761|NCT01189240|3835889|B1|3 relapses||Prior Relapses||participants|Number|1|1.0||||||
4014762|NCT01189240|3835889|B1|2 relapes||Prior Relapses||participants|Number|3|3.0||||||
4014763|NCT01189240|3835889|B1|1 relapse||Prior Relapses||participants|Number|8|8.0||||||
4014764|NCT01189240|3835889|B1|||Mini Mental State Examination (MMSE)|"Measure of Cognitive impairment~24-30 No cognitive impairment 18-23 Mild cognitive impairment 0-17 Severe cognitive impairment~Series of questions with a point value for each question which is summed to give a total final score."|units on a scale|Median|29|29.0|Full Range|||21.0|30.0|
4014765|NCT01189240|3835889|B1|60||Karnofsky Performance Status|"100-80: Able to carry on normal activity and to work; No special care needed.~70-50: Unable to work; able to live at home and care for most personal needs; varying amount of assistance needed.~40-10: Unable to care for self; Requires equivalent of institutional or hospital care;diseases may be progressing rapidly.~0: Dead"|participants|Number|1|1.0||||||
4014766|NCT01189240|3835889|B1|70||Karnofsky Performance Status|"100-80: Able to carry on normal activity and to work; No special care needed.~70-50: Unable to work; able to live at home and care for most personal needs; varying amount of assistance needed.~40-10: Unable to care for self; Requires equivalent of institutional or hospital care;diseases may be progressing rapidly.~0: Dead"|participants|Number|0|0.0||||||
4014767|NCT01189240|3835889|B1|80||Karnofsky Performance Status|"100-80: Able to carry on normal activity and to work; No special care needed.~70-50: Unable to work; able to live at home and care for most personal needs; varying amount of assistance needed.~40-10: Unable to care for self; Requires equivalent of institutional or hospital care;diseases may be progressing rapidly.~0: Dead"|participants|Number|5|5.0||||||
4014768|NCT01189240|3835889|B1|90||Karnofsky Performance Status|"100-80: Able to carry on normal activity and to work; No special care needed.~70-50: Unable to work; able to live at home and care for most personal needs; varying amount of assistance needed.~40-10: Unable to care for self; Requires equivalent of institutional or hospital care;diseases may be progressing rapidly.~0: Dead"|participants|Number|6|6.0||||||
4014769|NCT01189240|3835889|B1|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4014770|NCT01189240|3835889|B1|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4014771|NCT01189240|3835889|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4014772|NCT01189240|3835889|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4014773|NCT01189240|3835889|B1|||Age||years|Median|56|56.0|Full Range|||42.0|62.0|
4014774|NCT01189227|3835910|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4014775|NCT01189227|3835911|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4014776|NCT01189227|3835912|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4014777|NCT01189227|3835910|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4014778|NCT01189227|3835911|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4014779|NCT01189227|3835912|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4014780|NCT01189227|3835910|B3|||Age||years|Mean|61|61.0|Standard Deviation|14.4|14.4|||
4014781|NCT01189227|3835911|B2|||Age||years|Mean|55|55.0|Standard Deviation|13.9|13.9|||
4014782|NCT01189227|3835912|B1|||Age||years|Mean|64|64.0|Standard Deviation|14.9|14.9|||
4014783|NCT01189201|3835919|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4014784|NCT01189201|3835919|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4014785|NCT01189201|3835919|B1|||Age||years|Mean|40.3|40.3|Standard Deviation|10.3|10.3|||
4014786|NCT01189136|3835973|B3|||BMI||kg/m2|Mean|28.9|28.9|Standard Deviation|3.3|3.3|||
4014787|NCT01189136|3835974|B2|||BMI||kg/m2|Mean|28.7|28.7|Standard Deviation|3.5|3.5|||
4014788|NCT01189136|3835975|B1|||BMI||kg/m2|Mean|29.0|29.0|Standard Deviation|3.1|3.1|||
4014789|NCT01189136|3835973|B3|||Parity||pregnancies|Mean|2|2.0|Standard Deviation|1|1.0|||
4014790|NCT01189136|3835974|B2|||Parity||pregnancies|Mean|2|2.0|Standard Deviation|1|1.0|||
4014791|NCT01189136|3835975|B1|||Parity||pregnancies|Mean|2|2.0|Standard Deviation|1|1.0|||
4014792|NCT01189136|3835973|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
4014793|NCT01189136|3835974|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
4014794|NCT01189136|3835975|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4014795|NCT01189136|3835973|B3||Female|Gender||Participants|Count of Participants|84|84.0||||||
4014796|NCT01189136|3835974|B2||Female|Gender||Participants|Count of Participants|42|42.0||||||
4014797|NCT01189136|3835975|B1||Female|Gender||Participants|Count of Participants|42|42.0||||||
4014798|NCT01189136|3835973|B3|||Age, Customized||years|Mean|50|50.0|Standard Deviation|9|9.0|||
4014799|NCT01189136|3835974|B2|||Age, Customized||years|Mean|54|54.0|Standard Deviation|11|11.0|||
4014800|NCT01189136|3835975|B1|||Age, Customized||years|Mean|46|46.0|Standard Deviation|8|8.0|||
4014801|NCT01189136|3835973|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4014802|NCT01189136|3835974|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4014803|NCT01189136|3835975|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4014804|NCT01189136|3835973|B3||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4014805|NCT01189136|3835974|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4014806|NCT01189136|3835975|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4014807|NCT01189136|3835973|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4014808|NCT01189136|3835974|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4014809|NCT01189136|3835975|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4014810|NCT01189123|3835988|B3|United States||Region of Enrollment||participants|Number|105|105.0||||||
4014811|NCT01189123|3835989|B2|United States||Region of Enrollment||participants|Number|53|53.0||||||
4014812|NCT01189123|3835990|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
4014813|NCT01189123|3835988|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4014814|NCT01189123|3835989|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4014815|NCT01189123|3835990|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4014816|NCT01189123|3835988|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4014817|NCT01189123|3835989|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4014818|NCT01189123|3835990|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4014819|NCT01189123|3835988|B3||>=65 years|Age||Participants|Count of Participants|105|105.0||||||
4014820|NCT01189123|3835989|B2||>=65 years|Age||Participants|Count of Participants|53|53.0||||||
4014821|NCT01189123|3835990|B1||>=65 years|Age||Participants|Count of Participants|52|52.0||||||
4014822|NCT01189123|3835988|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4014823|NCT01189123|3835989|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4014824|NCT01189123|3835990|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4014825|NCT01189123|3835988|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4014826|NCT01189123|3835989|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4014827|NCT01189123|3835990|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4014828|NCT01189123|3835988|B3|||Age||years|Mean|73|73.0|Inter-Quartile Range|||67.0|77.0|
4014829|NCT01189123|3835989|B2|||Age||years|Mean|72|72.0|Inter-Quartile Range|||67.0|79.0|
4014830|NCT01189123|3835990|B1|||Age||years|Mean|74|74.0|Inter-Quartile Range|||68.0|77.0|
4014831|NCT01189110|3835999|B3|United States||Region of Enrollment||participants|Number|125|125.0||||||
4014832|NCT01189110|3836000|B2|United States||Region of Enrollment||participants|Number|61|61.0||||||
4014833|NCT01189110|3836001|B1|United States||Region of Enrollment||participants|Number|64|64.0||||||
4014834|NCT01189110|3835999|B3||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4014835|NCT01189110|3836000|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4014836|NCT01189110|3836001|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4014837|NCT01189110|3835999|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4014838|NCT01189110|3836000|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4014839|NCT01189110|3836001|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4014840|NCT01189110|3835999|B3|||Age||years|Mean|55.5|55.5|Standard Deviation|9.5|9.5|||
4014841|NCT01189110|3836000|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|10|10.0|||
4014842|NCT01189110|3836001|B1|||Age||years|Mean|55.3|55.3|Standard Deviation|9.1|9.1|||
4014843|NCT01189110|3835999|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4014844|NCT01189110|3836000|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4014845|NCT01189110|3836001|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4014846|NCT01189110|3835999|B3||Between 18 and 65 years|Age||Participants|Count of Participants|125|125.0||||||
4014847|NCT01189110|3836000|B2||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4014848|NCT01189110|3836001|B1||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4014849|NCT01189110|3835999|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4014850|NCT01189110|3836000|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4014851|NCT01189110|3836001|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4014852|NCT01189071|3836008|B3|United States||Region of Enrollment||||0|0.0||||||
4014853|NCT01189071|3836008|B3||Male|Gender||||0|0.0||||||
4014854|NCT01189071|3836008|B3||Female|Gender||||0|0.0||||||
4014855|NCT01189071|3836008|B3||>=65 years|Age||||0|0.0||||||
4014856|NCT01189071|3836008|B3||Between 18 and 65 years|Age||||0|0.0||||||
4014857|NCT01189071|3836008|B3||<=18 years|Age||||0|0.0||||||
4014858|NCT01189032|3836019|B4||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4014859|NCT01189032|3836020|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4014860|NCT01189032|3836021|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4014861|NCT01189032|3836022|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4014862|NCT01189032|3836019|B4||Female|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
4014863|NCT01189032|3836020|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4014864|NCT01189032|3836021|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4014865|NCT01189032|3836022|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4014866|NCT01189032|3836019|B4|||Age||years|Mean|56.6|56.6|Standard Deviation|17.1|17.1|||
4014867|NCT01189032|3836020|B3|||Age||years|Mean|56.4|56.4|Standard Deviation|17.8|17.8|||
4014868|NCT01189032|3836021|B2|||Age||years|Mean|57.9|57.9|Standard Deviation|16.3|16.3|||
4014869|NCT01189032|3836022|B1|||Age||years|Mean|56.1|56.1|Standard Deviation|17.3|17.3|||
4014870|NCT01188967|3836032|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4014871|NCT01188967|3836033|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4014872|NCT01188967|3836034|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4014873|NCT01188967|3836032|B3||Male|Gender||Participants|Count of Participants|11|11.0||||||
4014874|NCT01188967|3836033|B2||Male|Gender||Participants|Count of Participants|6|6.0||||||
4014875|NCT01188967|3836034|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
4014876|NCT01188967|3836032|B3||Female|Gender||Participants|Count of Participants|7|7.0||||||
4014877|NCT01188967|3836033|B2||Female|Gender||Participants|Count of Participants|4|4.0||||||
4014878|NCT01188967|3836034|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
4014879|NCT01188967|3836032|B3|||Age|The study only included participants aged 18-65|years|Mean|47.7|47.7|Standard Deviation|5|5.0|||
4014880|NCT01188967|3836033|B2|||Age|The study only included participants aged 18-65|years|Mean|46.7|46.7|Standard Deviation|5|5.0|||
4014881|NCT01188967|3836034|B1|||Age|The study only included participants aged 18-65|years|Mean|48.7|48.7|Standard Deviation|5|5.0|||
4014882|NCT01188967|3836032|B3||>=65 years|Age|The study only included participants aged 18-65.|Participants|Count of Participants|0|0.0||||||
4014883|NCT01188967|3836033|B2||>=65 years|Age|The study only included participants aged 18-65.|Participants|Count of Participants|0|0.0||||||
4014884|NCT01188967|3836034|B1||>=65 years|Age|The study only included participants aged 18-65.|Participants|Count of Participants|0|0.0||||||
4014885|NCT01188967|3836032|B3||Between 18 and 65 years|Age|The study only included participants aged 18-65.|Participants|Count of Participants|18|18.0||||||
4014886|NCT01188967|3836033|B2||Between 18 and 65 years|Age|The study only included participants aged 18-65.|Participants|Count of Participants|10|10.0||||||
4014887|NCT01188967|3836034|B1||Between 18 and 65 years|Age|The study only included participants aged 18-65.|Participants|Count of Participants|8|8.0||||||
4014888|NCT01188967|3836032|B3||<=18 years|Age|The study only included participants aged 18-65.|Participants|Count of Participants|0|0.0||||||
4014889|NCT01188967|3836033|B2||<=18 years|Age|The study only included participants aged 18-65.|Participants|Count of Participants|0|0.0||||||
4014890|NCT01188967|3836034|B1||<=18 years|Age|The study only included participants aged 18-65.|Participants|Count of Participants|0|0.0||||||
4014891|NCT01188928|3836047|B5|United States||Region of Enrollment||participants|Number|1152|1152.0||||||
4014892|NCT01188928|3836048|B4|United States||Region of Enrollment||participants|Number|95|95.0||||||
4014893|NCT01188928|3836049|B3|United States||Region of Enrollment||participants|Number|96|96.0||||||
4014894|NCT01188928|3836050|B2|United States||Region of Enrollment||participants|Number|479|479.0||||||
4014895|NCT01188928|3836051|B1|United States||Region of Enrollment||participants|Number|482|482.0||||||
4014896|NCT01188928|3836047|B5||Male|Gender||Participants|Count of Participants|690|690.0||||||
4014897|NCT01188928|3836048|B4||Male|Gender||Participants|Count of Participants|60|60.0||||||
4014898|NCT01188928|3836049|B3||Male|Gender||Participants|Count of Participants|60|60.0||||||
4014899|NCT01188928|3836050|B2||Male|Gender||Participants|Count of Participants|286|286.0||||||
4014900|NCT01188928|3836051|B1||Male|Gender||Participants|Count of Participants|284|284.0||||||
4014901|NCT01188928|3836047|B5||Female|Gender||Participants|Count of Participants|462|462.0||||||
4014902|NCT01188928|3836048|B4||Female|Gender||Participants|Count of Participants|35|35.0||||||
4014903|NCT01188928|3836049|B3||Female|Gender||Participants|Count of Participants|36|36.0||||||
4014904|NCT01188928|3836050|B2||Female|Gender||Participants|Count of Participants|193|193.0||||||
4014905|NCT01188928|3836051|B1||Female|Gender||Participants|Count of Participants|198|198.0||||||
4014906|NCT01188928|3836047|B5|||Age||years|Mean|48.6|48.6|Standard Deviation|13.5|13.5|||
4014907|NCT01188928|3836048|B4|||Age||years|Mean|49.4|49.4|Standard Deviation|13.0|13.0|||
4014908|NCT01188928|3836049|B3|||Age||years|Mean|48|48.0|Standard Deviation|13.7|13.7|||
4014909|NCT01188928|3836050|B2|||Age||years|Mean|48.5|48.5|Standard Deviation|13.8|13.8|||
4014910|NCT01188928|3836051|B1|||Age||years|Mean|48.7|48.7|Standard Deviation|13.4|13.4|||
4014911|NCT01188876|3836076|B1||Other|Histology Subtype||Participants|Count of Participants|10|10.0||||||
4014912|NCT01188876|3836076|B1||Carcinosarcoma|Histology Subtype||Participants|Count of Participants|3|3.0||||||
4014913|NCT01188876|3836076|B1||Transitional Cell|Histology Subtype||Participants|Count of Participants|1|1.0||||||
4014914|NCT01188876|3836076|B1||Endometrioid|Histology Subtype||Participants|Count of Participants|6|6.0||||||
4014915|NCT01188876|3836076|B1||Serous|Histology Subtype||Participants|Count of Participants|30|30.0||||||
4014916|NCT01188876|3836076|B1||Other|Primary Site||Participants|Count of Participants|5|5.0||||||
4014917|NCT01188876|3836076|B1||Peritoneal|Primary Site||Participants|Count of Participants|5|5.0||||||
4014918|NCT01188876|3836076|B1||Fallopian Tube|Primary Site||Participants|Count of Participants|6|6.0||||||
4014919|NCT01188876|3836076|B1||Ovary|Primary Site||Participants|Count of Participants|34|34.0||||||
4014920|NCT01188876|3836076|B1||1|ECOG Performance Status|"Eastern Cooperative Oncology Group (ECOG) score~0: Asymptomatic (Fully active, able to carry on all pre-disease activities without restriction)~1: Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. For example, light housework, office work)"|Participants|Count of Participants|16|16.0||||||
4014921|NCT01188876|3836076|B1||0|ECOG Performance Status|"Eastern Cooperative Oncology Group (ECOG) score~0: Asymptomatic (Fully active, able to carry on all pre-disease activities without restriction)~1: Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. For example, light housework, office work)"|Participants|Count of Participants|34|34.0||||||
4014922|NCT01188876|3836076|B1|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
4014923|NCT01188876|3836076|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4014924|NCT01188876|3836076|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4014925|NCT01188876|3836076|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
4014926|NCT01188876|3836076|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4014927|NCT01188876|3836076|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4014928|NCT01188876|3836076|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4014929|NCT01188876|3836076|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4014930|NCT01188876|3836076|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4014931|NCT01188876|3836076|B1|||Age||years|Median|59|59.0|Full Range|||39.0|72.0|
4014932|NCT01188811|3836086|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
4014933|NCT01188811|3836087|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4014934|NCT01188811|3836088|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4014935|NCT01188811|3836086|B3||Male|Gender||Participants|Count of Participants|22|22.0||||||
4014936|NCT01188811|3836087|B2||Male|Gender||Participants|Count of Participants|10|10.0||||||
4014937|NCT01188811|3836088|B1||Male|Gender||Participants|Count of Participants|12|12.0||||||
4014938|NCT01188811|3836086|B3||Female|Gender||Participants|Count of Participants|32|32.0||||||
4014939|NCT01188811|3836087|B2||Female|Gender||Participants|Count of Participants|16|16.0||||||
4014940|NCT01188811|3836088|B1||Female|Gender||Participants|Count of Participants|16|16.0||||||
4014941|NCT01188811|3836086|B3|||Age||years|Mean|58.7|58.7|Standard Deviation|6.4|6.4|||
4014942|NCT01188811|3836087|B2|||Age||years|Mean|59.7|59.7|Standard Deviation|6.1|6.1|||
4014943|NCT01188811|3836088|B1|||Age||years|Mean|57.9|57.9|Standard Deviation|6.7|6.7|||
4014944|NCT01188811|3836086|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4014945|NCT01188811|3836087|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4014946|NCT01188811|3836088|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4014947|NCT01188811|3836086|B3||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4014948|NCT01188811|3836087|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4014949|NCT01188811|3836088|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4014950|NCT01188811|3836086|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4014951|NCT01188811|3836087|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4014952|NCT01188811|3836088|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4014953|NCT01188798|3836099|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4014954|NCT01188798|3836100|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4014955|NCT01188798|3836101|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4014956|NCT01188798|3836099|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4014957|NCT01188798|3836100|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4014958|NCT01188798|3836101|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4014959|NCT01188798|3836099|B3|||Age||years|Mean|12.08|12.08|Standard Deviation|5.32|5.32|||
4014960|NCT01188798|3836100|B2|||Age||years|Mean|12.95|12.95|Standard Deviation|6.65|6.65|||
4014961|NCT01188798|3836101|B1|||Age||years|Mean|10.35|10.35|Standard Deviation|0.07|0.07|||
4014962|NCT01188772|3836110|B5|TT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|18|18.0||||||
4014963|NCT01188772|3836111|B4|TT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|1|1.0||||||
4014964|NCT01188772|3836112|B3|TT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|4|4.0||||||
4014965|NCT01188772|3836113|B2|TT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|10|10.0||||||
4014966|NCT01188772|3836114|B1|TT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|3|3.0||||||
4014967|NCT01188772|3836110|B5|CT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|71|71.0||||||
4014968|NCT01188772|3836111|B4|CT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|17|17.0||||||
4014969|NCT01188772|3836112|B3|CT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|11|11.0||||||
4014970|NCT01188772|3836113|B2|CT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|19|19.0||||||
4014971|NCT01188772|3836114|B1|CT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|24|24.0||||||
4014972|NCT01188772|3836110|B5|CC||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|57|57.0||||||
4014973|NCT01188772|3836111|B4|CC||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|7|7.0||||||
4014974|NCT01188772|3836112|B3|CC||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|11|11.0||||||
4014975|NCT01188772|3836113|B2|CC||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|18|18.0||||||
4014976|NCT01188772|3836114|B1|CC||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|21|21.0||||||
4014977|NCT01188772|3836110|B5|||Alanine Aminotransferase (ALT)||IU/L|Mean|78.7|78.7|Standard Deviation|61.53|61.53|||
4014978|NCT01188772|3836111|B4|||Alanine Aminotransferase (ALT)||IU/L|Mean|74.5|74.5|Standard Deviation|54.81|54.81|||
4014979|NCT01188772|3836112|B3|||Alanine Aminotransferase (ALT)||IU/L|Mean|81.4|81.4|Standard Deviation|49.14|49.14|||
4014980|NCT01188772|3836113|B2|||Alanine Aminotransferase (ALT)||IU/L|Mean|76.1|76.1|Standard Deviation|67.56|67.56|||
4014981|NCT01188772|3836114|B1|||Alanine Aminotransferase (ALT)||IU/L|Mean|81.9|81.9|Standard Deviation|66.07|66.07|||
4014982|NCT01188772|3836110|B5|Cirrhosis||Liver Biopsy Fibrosis Score||participants|Number|0|0.0||||||
4014983|NCT01188772|3836111|B4|Cirrhosis||Liver Biopsy Fibrosis Score||participants|Number|0|0.0||||||
4014984|NCT01188772|3836112|B3|Cirrhosis||Liver Biopsy Fibrosis Score||participants|Number|0|0.0||||||
4014985|NCT01188772|3836113|B2|Cirrhosis||Liver Biopsy Fibrosis Score||participants|Number|0|0.0||||||
4014986|NCT01188772|3836114|B1|Cirrhosis||Liver Biopsy Fibrosis Score||participants|Number|0|0.0||||||
4014987|NCT01188772|3836110|B5|Bridging Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|5|5.0||||||
4014988|NCT01188772|3836111|B4|Bridging Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|0|0.0||||||
4014989|NCT01188772|3836112|B3|Bridging Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|2|2.0||||||
4014990|NCT01188772|3836113|B2|Bridging Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|2|2.0||||||
4014991|NCT01188772|3836114|B1|Bridging Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|1|1.0||||||
4014992|NCT01188772|3836110|B5|Portal Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|112|112.0||||||
4014993|NCT01188772|3836111|B4|Portal Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|18|18.0||||||
4014994|NCT01188772|3836112|B3|Portal Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|21|21.0||||||
4014995|NCT01188772|3836113|B2|Portal Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|38|38.0||||||
4014996|NCT01188772|3836114|B1|Portal Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|35|35.0||||||
4014997|NCT01188772|3836110|B5|None or Minimal Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|29|29.0||||||
4014998|NCT01188772|3836111|B4|None or Minimal Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|7|7.0||||||
4014999|NCT01188772|3836112|B3|None or Minimal Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|3|3.0||||||
4015000|NCT01188772|3836113|B2|None or Minimal Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|7|7.0||||||
4015001|NCT01188772|3836114|B1|None or Minimal Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|12|12.0||||||
4015002|NCT01188772|3836110|B5|||Hepatitis C (HCV) RNA||log10 IU/mL|Mean|6.40|6.4|Standard Deviation|0.760|0.76|||
4015003|NCT01188772|3836111|B4|||Hepatitis C (HCV) RNA||log10 IU/mL|Mean|6.07|6.07|Standard Deviation|0.794|0.794|||
4015004|NCT01188772|3836112|B3|||Hepatitis C (HCV) RNA||log10 IU/mL|Mean|6.50|6.5|Standard Deviation|0.762|0.762|||
4015005|NCT01188772|3836113|B2|||Hepatitis C (HCV) RNA||log10 IU/mL|Mean|6.39|6.39|Standard Deviation|0.827|0.827|||
4015006|NCT01188772|3836114|B1|||Hepatitis C (HCV) RNA||log10 IU/mL|Mean|6.54|6.54|Standard Deviation|0.630|0.63|||
4015007|NCT01188772|3836110|B5|White||Race/Ethnicity, Customized||participants|Number|117|117.0||||||
4015008|NCT01188772|3836111|B4|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4015009|NCT01188772|3836112|B3|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4015010|NCT01188772|3836113|B2|White||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4015011|NCT01188772|3836114|B1|White||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4015012|NCT01188772|3836110|B5|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4015013|NCT01188772|3836111|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4015014|NCT01188772|3836112|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4015015|NCT01188772|3836113|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4015016|NCT01188772|3836114|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4015017|NCT01188772|3836110|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4015018|NCT01188772|3836111|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4015019|NCT01188772|3836112|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4015020|NCT01188772|3836113|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4015021|NCT01188772|3836114|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4015022|NCT01188772|3836110|B5|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4015023|NCT01188772|3836111|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4015024|NCT01188772|3836112|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4015025|NCT01188772|3836113|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4015026|NCT01188772|3836114|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4015027|NCT01188772|3836110|B5|American Indian or Alaska native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4015028|NCT01188772|3836111|B4|American Indian or Alaska native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4015029|NCT01188772|3836112|B3|American Indian or Alaska native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4015030|NCT01188772|3836113|B2|American Indian or Alaska native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4015031|NCT01188772|3836114|B1|American Indian or Alaska native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4015032|NCT01188772|3836110|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4015033|NCT01188772|3836111|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015034|NCT01188772|3836112|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4015035|NCT01188772|3836113|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015036|NCT01188772|3836114|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015037|NCT01188772|3836110|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
4015038|NCT01188772|3836111|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4015039|NCT01188772|3836112|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4015040|NCT01188772|3836113|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4015041|NCT01188772|3836114|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4015042|NCT01188772|3836110|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4015043|NCT01188772|3836111|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4015044|NCT01188772|3836112|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4015045|NCT01188772|3836113|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4015046|NCT01188772|3836114|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4015047|NCT01188772|3836110|B5||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4015048|NCT01188772|3836111|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4015049|NCT01188772|3836112|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4015050|NCT01188772|3836113|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4015051|NCT01188772|3836114|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4015052|NCT01188772|3836110|B5||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4015053|NCT01188772|3836111|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4015054|NCT01188772|3836112|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4015055|NCT01188772|3836113|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4015056|NCT01188772|3836114|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4015057|NCT01188772|3836110|B5|||Age||years|Mean|49.2|49.2|Standard Deviation|10.41|10.41|||
4015058|NCT01188772|3836111|B4|||Age||years|Mean|47.2|47.2|Standard Deviation|11.07|11.07|||
4015059|NCT01188772|3836112|B3|||Age||years|Mean|48.6|48.6|Standard Deviation|9.35|9.35|||
4015060|NCT01188772|3836113|B2|||Age||years|Mean|51.4|51.4|Standard Deviation|9.37|9.37|||
4015061|NCT01188772|3836114|B1|||Age||years|Mean|48.4|48.4|Standard Deviation|11.49|11.49|||
4015062|NCT01188694|3836172|B4|United States||Region of Enrollment||participants|Number|42|42.0||||||
4015063|NCT01188694|3836173|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4015064|NCT01188694|3836174|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4015065|NCT01188694|3836175|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4015066|NCT01188694|3836172|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4015067|NCT01188694|3836173|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4015068|NCT01188694|3836174|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4015069|NCT01188694|3836175|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4015070|NCT01188694|3836172|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4015071|NCT01188694|3836173|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4015072|NCT01188694|3836174|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4015073|NCT01188694|3836175|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4015074|NCT01188694|3836172|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4015075|NCT01188694|3836173|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4015076|NCT01188694|3836174|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4015077|NCT01188694|3836175|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4015078|NCT01188694|3836172|B4||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4015079|NCT01188694|3836173|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4015080|NCT01188694|3836174|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4015081|NCT01188694|3836175|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4015082|NCT01188694|3836172|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4015083|NCT01188694|3836173|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4015084|NCT01188694|3836174|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4015085|NCT01188694|3836175|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4015086|NCT01188681|3836185|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015087|NCT01188681|3836186|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015088|NCT01188681|3836187|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015089|NCT01188681|3836188|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015090|NCT01188681|3836189|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015091|NCT01188681|3836185|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015092|NCT01188681|3836186|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015093|NCT01188681|3836187|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015094|NCT01188681|3836188|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015095|NCT01188681|3836189|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015096|NCT01188681|3836185|B5||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4015097|NCT01188681|3836186|B4||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4015098|NCT01188681|3836187|B3||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4015099|NCT01188681|3836188|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4015100|NCT01188681|3836189|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4015101|NCT01188681|3836185|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4015102|NCT01188681|3836186|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4015103|NCT01188681|3836187|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4015104|NCT01188681|3836188|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4015105|NCT01188681|3836189|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4015106|NCT01188681|3836185|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015107|NCT01188681|3836186|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015108|NCT01188681|3836187|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015109|NCT01188681|3836188|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015110|NCT01188681|3836189|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015111|NCT01188681|3836185|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015112|NCT01188681|3836186|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015113|NCT01188681|3836187|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015114|NCT01188681|3836188|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015115|NCT01188681|3836189|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015116|NCT01188681|3836185|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015117|NCT01188681|3836186|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015118|NCT01188681|3836187|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015119|NCT01188681|3836188|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015120|NCT01188681|3836189|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015121|NCT01188681|3836185|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015122|NCT01188681|3836186|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015123|NCT01188681|3836187|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015124|NCT01188681|3836188|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015125|NCT01188681|3836189|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015126|NCT01188681|3836185|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
4015127|NCT01188681|3836186|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4015128|NCT01188681|3836187|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4015129|NCT01188681|3836188|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4015130|NCT01188681|3836189|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4015131|NCT01188681|3836185|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015132|NCT01188681|3836186|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015133|NCT01188681|3836187|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015134|NCT01188681|3836188|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015135|NCT01188681|3836189|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015136|NCT01188681|3836185|B5||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4015137|NCT01188681|3836186|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4015138|NCT01188681|3836187|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4015139|NCT01188681|3836188|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4015140|NCT01188681|3836189|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4015141|NCT01188681|3836185|B5||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4015142|NCT01188681|3836186|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4015143|NCT01188681|3836187|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4015144|NCT01188681|3836188|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4015145|NCT01188681|3836189|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4015146|NCT01188681|3836185|B5|||Age||years|Mean|62.3|62.3|Standard Deviation|8.4|8.4|||
4015147|NCT01188681|3836186|B4|||Age||years|Mean|62.2|62.2|Standard Deviation|8.1|8.1|||
4015148|NCT01188681|3836187|B3|||Age||years|Mean|64.1|64.1|Standard Deviation|9.4|9.4|||
4015149|NCT01188681|3836188|B2|||Age||years|Mean|67.7|67.7|Standard Deviation|8.9|8.9|||
4015150|NCT01188681|3836189|B1|||Age||years|Mean|66.3|66.3|Standard Deviation|5.8|5.8|||
4015151|NCT01188681|3836185|B5||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4015152|NCT01188681|3836186|B4||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4015153|NCT01188681|3836187|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4015154|NCT01188681|3836188|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4015155|NCT01188681|3836189|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4015156|NCT01188681|3836185|B5||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4015157|NCT01188681|3836186|B4||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4015158|NCT01188681|3836187|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4015159|NCT01188681|3836188|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4015160|NCT01188681|3836189|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4015161|NCT01188681|3836185|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4015162|NCT01188681|3836186|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4015163|NCT01188681|3836187|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4015164|NCT01188681|3836188|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4015165|NCT01188681|3836189|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4015166|NCT01188668|3836206|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4015167|NCT01188668|3836206|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4015168|NCT01188668|3836206|B1|||Age||years|Mean|35.2|35.2|Standard Deviation|6.6|6.6|||
4015169|NCT01188655|3836239|B1|||Spine agility function by Ott test|The Ott index determines the agility of the thoracic spine. Number of participants analyzed for Ott test (n)= 48|cm|Mean|11.8|11.8|Standard Deviation|14.3|14.3|||
4015170|NCT01188655|3836239|B1|||Spine agility function by Schober test|Schober test determines agility of lumbar spine. It measures participant’s ability to flex lower back. Examiner makes mark at fifth lumbar vertebra (L5); places 1 finger 5 cm below and another 10 cm above the mark. Participant is asked to touch toes. Examiner measures increase in distance between 2 fingers. Number of participants analyzed (n)= 58.|cm|Mean|6.3|6.3|Standard Deviation|5.5|5.5|||
4015171|NCT01188655|3836239|B1|||Occiput-to-wall distance|Number of participants analyzed for occiput-to-wall distance (n)= 67|centimeter (cm)|Mean|3.8|3.8|Standard Deviation|6.0|6.0|||
4015172|NCT01188655|3836239|B1|||Percentage of Participants Without Peripheral Arthritis|Number of participants analyzed for Peripheral Arthritis (n)= 87|Percentage of Participants|Number|70.1|70.1||||||
4015173|NCT01188655|3836239|B1|||Percentage of Participants Without Enthesitis|Number of participants analyzed for Enthesitis (n)= 87|Percentage of Participants|Number|57.5|57.5||||||
4015174|NCT01188655|3836239|B1|||Ankylosing Spondylitis Quality of Life Scale (ASQoL) at baseline|ASQoL is a questionnaire consisting of 18 statements, related to mobility, self-care, usual activities, pain/discomfort and anxiety/depression, relevant to the physical and mental conditions of the participant with AS, to assess disease-specific quality of life. Score range: 0 (good)-18 (poor). Number of participants analyzed for ASQoL (n)= 77|Units on a scale|Mean|11.9|11.9|Standard Deviation|3.9|3.9|||
4015175|NCT01188655|3836239|B1|||Duration of morning stiffness at baseline|Duration of morning stiffness is defined as the time elapsed when participant woke up in the morning and was able to resume normal activities without stiffness in minutes. Number of participants analyzed for morning stiffness (n)= 80|minutes|Mean|88.3|88.3|Standard Deviation|67.5|67.5|||
4015176|NCT01188655|3836239|B1|||Physician's Global Assessment Visual Analog Scale at baseline|Physician Global Assessment of Disease Activity was measured on a 0 to 100 mm Visual Analog Scale (VAS), with 0 mm = no disease activity.|mm|Mean|6.6|6.6|Standard Deviation|1.4|1.4|||
4015177|NCT01188655|3836239|B1|||Participant's Global Assessment Visual Analog Scale at baseline|Measured using a 100mm Visual Analog Scale (VAS) ranging from 0=very good to 100=very bad. Number of participants analyzed for Participant’s Global Assessment VAS (n)= 84|Units on a scale|Mean|6.7|6.7|Standard Deviation|2.0|2.0|||
4015178|NCT01188655|3836239|B1|||Bath Ankylosing Spondylitis Functional Index (BASFI) at baseline|BASFI is a validated self assessment tool that determines the degree of functional limitation in AS. Utilizing a VAS of 0-10 (0 = easy, 10 =impossible), participants answered 10 questions assessing their ability in completing normal daily activities or physically demanding activities. Number of participants analyzed for BASFI (n)= 83|Units on a scale|Mean|4.7|4.7|Standard Deviation|2.3|2.3|||
4015179|NCT01188655|3836239|B1|||Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) at baseline|BASDAI is a validated self assessment tool used to determine disease activity in participant with Ankylosing Spondylitis (AS). Utilizing a Visual Analog Scale (VAS) of 0-10 (0=none and 10=very severe) participant's answered 6 questions measuring discomfort, pain and fatigue. Number of participants analyzed for BASDAI (n)= 84|units on a scale|Mean|5.3|5.3|Standard Deviation|1.6|1.6|||
4015180|NCT01188655|3836239|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4015181|NCT01188655|3836239|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4015182|NCT01188655|3836239|B1|||Age||Years|Mean|41.6|41.6|Standard Deviation|11.7|11.7|||
4015183|NCT01188603|3836254|B1|||BMI|Body Mass Index|kg/m^2|Mean|28.25|28.25|Standard Deviation|5.31|5.31|||
4015184|NCT01188603|3836254|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4015185|NCT01188603|3836254|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4015186|NCT01188603|3836254|B1|||Age||Years|Mean|59.6|59.6|Standard Deviation|8.3|8.3|||
4015187|NCT01188577|3836262|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4015188|NCT01188577|3836263|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4015189|NCT01188577|3836264|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4015190|NCT01188577|3836262|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4015191|NCT01188577|3836263|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4015192|NCT01188577|3836264|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4015193|NCT01188577|3836262|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4015194|NCT01188577|3836263|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4015195|NCT01188577|3836264|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4015196|NCT01188577|3836262|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4015197|NCT01188577|3836263|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4015198|NCT01188577|3836264|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4015199|NCT01188577|3836262|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4015200|NCT01188577|3836263|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4015201|NCT01188577|3836264|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4015202|NCT01188577|3836262|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4015203|NCT01188577|3836263|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4015204|NCT01188577|3836264|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4015205|NCT01188577|3836262|B3|||Age||Years|Mean|23.8|23.8|Standard Deviation|3.05|3.05|||
4015206|NCT01188577|3836263|B2|||Age||Years|Mean|24.8|24.8|Standard Deviation|2.93|2.93|||
4015207|NCT01188577|3836264|B1|||Age||Years|Mean|22.8|22.8|Standard Deviation|2.99|2.99|||
4015208|NCT01188564|3836281|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4015209|NCT01188564|3836282|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4015210|NCT01188564|3836283|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4015211|NCT01188564|3836281|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4015212|NCT01188564|3836282|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4015213|NCT01188564|3836283|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4015214|NCT01188564|3836281|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4015215|NCT01188564|3836282|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4015216|NCT01188564|3836283|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4015217|NCT01188564|3836281|B3||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4015218|NCT01188564|3836282|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4015219|NCT01188564|3836283|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4015220|NCT01188564|3836281|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4015221|NCT01188564|3836282|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4015222|NCT01188564|3836283|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4015223|NCT01188551|3836292|B5|United States||Region of Enrollment||participants|Number|100|100.0||||||
4015224|NCT01188551|3836293|B4|United States||Region of Enrollment||participants|Number|25|25.0||||||
4015225|NCT01188551|3836294|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4015226|NCT01188551|3836295|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4015227|NCT01188551|3836296|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4015228|NCT01188551|3836292|B5||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4015229|NCT01188551|3836293|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4015230|NCT01188551|3836294|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4015231|NCT01188551|3836295|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4015232|NCT01188551|3836296|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4015233|NCT01188551|3836292|B5||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4015234|NCT01188551|3836293|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4015235|NCT01188551|3836294|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4015236|NCT01188551|3836295|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4015237|NCT01188551|3836296|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4015238|NCT01188551|3836292|B5|||Age||years|Mean|3|3.0|Standard Deviation|1.59|1.59|||
4015239|NCT01188551|3836293|B4|||Age||years|Mean|2.22|2.22|Standard Deviation|1.16|1.16|||
4015240|NCT01188551|3836294|B3|||Age||years|Mean|2.98|2.98|Standard Deviation|1.87|1.87|||
4015241|NCT01188551|3836295|B2|||Age||years|Mean|3|3.0|Standard Deviation|2.02|2.02|||
4015242|NCT01188551|3836296|B1|||Age||years|Mean|2.14|2.14|Standard Deviation|1.01|1.01|||
4015243|NCT01188551|3836292|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4015244|NCT01188551|3836293|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4015245|NCT01188551|3836294|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4015246|NCT01188551|3836295|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4015247|NCT01188551|3836296|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4015248|NCT01188551|3836292|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4015249|NCT01188551|3836293|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4015250|NCT01188551|3836294|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4015251|NCT01188551|3836295|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4015252|NCT01188551|3836296|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4015253|NCT01188551|3836292|B5||<=18 years|Age||Participants|Count of Participants|100|100.0||||||
4015254|NCT01188551|3836293|B4||<=18 years|Age||Participants|Count of Participants|25|25.0||||||
4015255|NCT01188551|3836294|B3||<=18 years|Age||Participants|Count of Participants|25|25.0||||||
4015256|NCT01188551|3836295|B2||<=18 years|Age||Participants|Count of Participants|25|25.0||||||
4015257|NCT01188551|3836296|B1||<=18 years|Age||Participants|Count of Participants|25|25.0||||||
4015258|NCT01188538|3836313|B3|Poland||Region of Enrollment||participants|Number|40|40.0||||||
4015259|NCT01188538|3836314|B2|Poland||Region of Enrollment||participants|Number|20|20.0||||||
4015260|NCT01188538|3836315|B1|Poland||Region of Enrollment||participants|Number|20|20.0||||||
4015261|NCT01188538|3836313|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4015262|NCT01188538|3836314|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4015263|NCT01188538|3836315|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4015264|NCT01188538|3836313|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4015265|NCT01188538|3836314|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4015266|NCT01188538|3836315|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4015267|NCT01188538|3836313|B3|||Age||years|Mean|22.1|22.1|Standard Deviation|3.8|3.8|||
4015268|NCT01188538|3836314|B2|||Age||years|Mean|21.4|21.4|Standard Deviation|2.9|2.9|||
4015269|NCT01188538|3836315|B1|||Age||years|Mean|22.9|22.9|Standard Deviation|4.5|4.5|||
4015270|NCT01188538|3836313|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4015271|NCT01188538|3836314|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4015272|NCT01188538|3836315|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4015273|NCT01188538|3836313|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4015274|NCT01188538|3836314|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4015275|NCT01188538|3836315|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4015276|NCT01188538|3836313|B3||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4015277|NCT01188538|3836314|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4015278|NCT01188538|3836315|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4015279|NCT01188499|3836324|B6|United States||Region of Enrollment||participants|Number|176|176.0||||||
4015280|NCT01188499|3836325|B5|United States||Region of Enrollment||participants|Number|18|18.0||||||
4015281|NCT01188499|3836326|B4|United States||Region of Enrollment||participants|Number|18|18.0||||||
4015282|NCT01188499|3836327|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
4015283|NCT01188499|3836328|B2|United States||Region of Enrollment||participants|Number|83|83.0||||||
4015284|NCT01188499|3836329|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4015285|NCT01188499|3836324|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4015286|NCT01188499|3836325|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4015287|NCT01188499|3836326|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015288|NCT01188499|3836327|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015289|NCT01188499|3836328|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015290|NCT01188499|3836329|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015291|NCT01188499|3836324|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015292|NCT01188499|3836325|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015293|NCT01188499|3836326|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015294|NCT01188499|3836327|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015295|NCT01188499|3836328|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015296|NCT01188499|3836329|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015297|NCT01188499|3836324|B6||White|Race (NIH/OMB)||Participants|Count of Participants|151|151.0||||||
4015298|NCT01188499|3836325|B5||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4015299|NCT01188499|3836326|B4||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4015300|NCT01188499|3836327|B3||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4015301|NCT01188499|3836328|B2||White|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
4015302|NCT01188499|3836329|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4015303|NCT01188499|3836324|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4015304|NCT01188499|3836325|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4015305|NCT01188499|3836326|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4015306|NCT01188499|3836327|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4015307|NCT01188499|3836328|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4015308|NCT01188499|3836329|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4015309|NCT01188499|3836324|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015310|NCT01188499|3836325|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015311|NCT01188499|3836326|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015312|NCT01188499|3836327|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015313|NCT01188499|3836328|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015314|NCT01188499|3836329|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015315|NCT01188499|3836324|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4015316|NCT01188499|3836325|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4015317|NCT01188499|3836326|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015318|NCT01188499|3836327|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015319|NCT01188499|3836328|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015320|NCT01188499|3836329|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015321|NCT01188499|3836324|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015322|NCT01188499|3836325|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015323|NCT01188499|3836326|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015324|NCT01188499|3836327|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015325|NCT01188499|3836328|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015326|NCT01188499|3836329|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015327|NCT01188499|3836324|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015328|NCT01188499|3836325|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015329|NCT01188499|3836326|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015330|NCT01188499|3836327|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015331|NCT01188499|3836328|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015332|NCT01188499|3836329|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015333|NCT01188499|3836324|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|168|168.0||||||
4015334|NCT01188499|3836325|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4015335|NCT01188499|3836326|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4015336|NCT01188499|3836327|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4015337|NCT01188499|3836328|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
4015338|NCT01188499|3836329|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4015339|NCT01188499|3836324|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4015340|NCT01188499|3836325|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4015341|NCT01188499|3836326|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4015342|NCT01188499|3836327|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4015343|NCT01188499|3836328|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4015344|NCT01188499|3836329|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4015345|NCT01188499|3836324|B6||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4015346|NCT01188499|3836325|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4015347|NCT01188499|3836326|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4015348|NCT01188499|3836327|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4015349|NCT01188499|3836328|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4015350|NCT01188499|3836329|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4015351|NCT01188499|3836324|B6||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4015352|NCT01188499|3836325|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4015353|NCT01188499|3836326|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4015354|NCT01188499|3836327|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4015355|NCT01188499|3836328|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4015356|NCT01188499|3836329|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4015357|NCT01188499|3836324|B6|||Age||years|Mean|59.7|59.7|Standard Deviation|10.82|10.82|||
4015358|NCT01188499|3836325|B5|||Age||years|Mean|56.5|56.5|Standard Deviation|10.44|10.44|||
4015359|NCT01188499|3836326|B4|||Age||years|Mean|56.7|56.7|Standard Deviation|8.55|8.55|||
4015360|NCT01188499|3836327|B3|||Age||years|Mean|60.7|60.7|Standard Deviation|11.16|11.16|||
4015361|NCT01188499|3836328|B2|||Age||years|Mean|59.6|59.6|Standard Deviation|11.58|11.58|||
4015362|NCT01188499|3836329|B1|||Age||years|Mean|63|63.0|Standard Deviation|8.77|8.77|||
4015363|NCT01188460|3836350|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4015364|NCT01188460|3836351|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4015365|NCT01188460|3836352|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4015366|NCT01188460|3836350|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4015367|NCT01188460|3836351|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4015368|NCT01188460|3836352|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4015369|NCT01188460|3836350|B3|||Age||years|Mean|46.09|46.09|Standard Deviation|9.94|9.94|||
4015370|NCT01188460|3836351|B2|||Age||years|Mean|47.96|47.96|Standard Deviation|10.21|10.21|||
4015371|NCT01188460|3836352|B1|||Age||years|Mean|44.29|44.29|Standard Deviation|9.55|9.55|||
4015372|NCT01188447|3836379|B1|Canada||Region of Enrollment||participants|Number|4034|4034.0||||||
4015373|NCT01188447|3836379|B1||Male|Sex: Female, Male||Participants|Count of Participants|1884|1884.0||||||
4015374|NCT01188447|3836379|B1||Female|Sex: Female, Male||Participants|Count of Participants|2150|2150.0||||||
4015375|NCT01188447|3836379|B1|||Age||years|Mean|43|43.0|Full Range|||16.0|99.0|
4015376|NCT01188421|3836387|B4|Caucasian||Race/Ethnicity, Customized||percentage of participants|Number|42.5|42.5||||||
4015377|NCT01188421|3836388|B3|Caucasian||Race/Ethnicity, Customized||percentage of participants|Number|41.6|41.6||||||
4015378|NCT01188421|3836389|B2|Caucasian||Race/Ethnicity, Customized||percentage of participants|Number|47.2|47.2||||||
4015379|NCT01188421|3836390|B1|Caucasian||Race/Ethnicity, Customized||percentage of participants|Number|38.7|38.7||||||
4015380|NCT01188421|3836387|B4||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4015381|NCT01188421|3836388|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4015382|NCT01188421|3836389|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4015383|NCT01188421|3836390|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4015384|NCT01188421|3836387|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4015385|NCT01188421|3836388|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4015386|NCT01188421|3836389|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4015387|NCT01188421|3836390|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4015388|NCT01188421|3836387|B4|||Age||years|Mean|41.2|41.2|Standard Deviation|10.4|10.4|||
4015389|NCT01188421|3836388|B3|||Age||years|Mean|41.5|41.5|Standard Deviation|10.5|10.5|||
4015390|NCT01188421|3836389|B2|||Age||years|Mean|40.9|40.9|Standard Deviation|9.7|9.7|||
4015391|NCT01188421|3836390|B1|||Age||years|Mean|41.1|41.1|Standard Deviation|10.9|10.9|||
4015392|NCT01188369|3836400|B3|Denmark||Region of Enrollment||participants|Number|10|10.0||||||
4015393|NCT01188369|3836401|B2|Denmark||Region of Enrollment||participants|Number|10|10.0||||||
4015394|NCT01188369|3836402|B1|Denmark||Region of Enrollment||participants|Number|10|10.0||||||
4015395|NCT01188369|3836400|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4015396|NCT01188369|3836401|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4015397|NCT01188369|3836402|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4015398|NCT01188369|3836400|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4015399|NCT01188369|3836401|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4015400|NCT01188369|3836402|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4015401|NCT01188369|3836400|B3|||Age||years|Median|74|74.0|Full Range|||69.0|87.0|
4015402|NCT01188369|3836401|B2|||Age||years|Median|73|73.0|Full Range|||73.0|85.0|
4015403|NCT01188369|3836402|B1|||Age||years|Median|76|76.0|Full Range|||69.0|87.0|
4015404|NCT01188343|3836409|B4|Taiwan||Region of Enrollment||Participants|Number|542|542.0||||||
4015405|NCT01188343|3836410|B3|Taiwan||Region of Enrollment||Participants|Number|221|221.0||||||
4015406|NCT01188343|3836411|B2|Taiwan||Region of Enrollment||Participants|Number|219|219.0||||||
4015407|NCT01188343|3836412|B1|Taiwan||Region of Enrollment||Participants|Number|102|102.0||||||
4015408|NCT01188343|3836409|B4||Male|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
4015409|NCT01188343|3836410|B3||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4015410|NCT01188343|3836411|B2||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4015411|NCT01188343|3836412|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4015412|NCT01188343|3836409|B4||Female|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
4015413|NCT01188343|3836410|B3||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4015414|NCT01188343|3836411|B2||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4015415|NCT01188343|3836412|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4015416|NCT01188343|3836409|B4|||Age||Months|Mean|13.1|13.1|Standard Deviation|1.13|1.13|||
4015417|NCT01188343|3836410|B3|||Age||Months|Mean|13.1|13.1|Standard Deviation|1.19|1.19|||
4015418|NCT01188343|3836411|B2|||Age||Months|Mean|13.0|13.0|Standard Deviation|1.08|1.08|||
4015419|NCT01188343|3836412|B1|||Age||Months|Mean|13.1|13.1|Standard Deviation|1.12|1.12|||
4015420|NCT01188343|3836409|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4015421|NCT01188343|3836410|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4015422|NCT01188343|3836411|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4015423|NCT01188343|3836412|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4015424|NCT01188343|3836409|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4015425|NCT01188343|3836410|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4015426|NCT01188343|3836411|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4015427|NCT01188343|3836412|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4015428|NCT01188343|3836409|B4||<=18 years|Age||Participants|Count of Participants|542|542.0||||||
4015429|NCT01188343|3836410|B3||<=18 years|Age||Participants|Count of Participants|221|221.0||||||
4015430|NCT01188343|3836411|B2||<=18 years|Age||Participants|Count of Participants|219|219.0||||||
4015431|NCT01188343|3836412|B1||<=18 years|Age||Participants|Count of Participants|102|102.0||||||
4015432|NCT01188226|3836440|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4015433|NCT01188226|3836440|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4015434|NCT01188226|3836440|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4015435|NCT01188226|3836440|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4015436|NCT01188226|3836440|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4015437|NCT01188226|3836440|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4015438|NCT01188109|3836479|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4015439|NCT01188109|3836479|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015440|NCT01188109|3836479|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015441|NCT01188109|3836479|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4015442|NCT01188109|3836479|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4015443|NCT01188109|3836479|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015444|NCT01188109|3836479|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4015445|NCT01188109|3836479|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015446|NCT01188109|3836479|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4015447|NCT01188109|3836479|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4015448|NCT01188109|3836479|B1|||Age||years|Mean|60.0|60.0|Standard Deviation|9.2|9.2|||
4015449|NCT01187953|3836484|B3|Missing||Donor Type||participants|Number|1|1.0||||||
4015450|NCT01187953|3836485|B2|Missing||Donor Type||participants|Number|1|1.0||||||
4015451|NCT01187953|3836486|B1|Missing||Donor Type||participants|Number|0|0.0||||||
4015452|NCT01187953|3836484|B3|Deceased||Donor Type||participants|Number|278|278.0||||||
4015453|NCT01187953|3836485|B2|Deceased||Donor Type||participants|Number|145|145.0||||||
4015454|NCT01187953|3836486|B1|Deceased||Donor Type||participants|Number|133|133.0||||||
4015455|NCT01187953|3836484|B3|Living||Donor Type||participants|Number|264|264.0||||||
4015456|NCT01187953|3836485|B2|Living||Donor Type||participants|Number|129|129.0||||||
4015457|NCT01187953|3836486|B1|Living||Donor Type||participants|Number|135|135.0||||||
4015458|NCT01187953|3836484|B3|||Time from transplant to first dose||hours|Mean|34.27|34.27|Standard Deviation|9.312|9.312|||
4015459|NCT01187953|3836485|B2|||Time from transplant to first dose||hours|Mean|34.38|34.38|Standard Deviation|9.735|9.735|||
4015460|NCT01187953|3836486|B1|||Time from transplant to first dose||hours|Mean|34.15|34.15|Standard Deviation|8.878|8.878|||
4015461|NCT01187953|3836484|B3|Patients without diabetes at transplant||Diabetes at the time of transplant||participants|Number|437|437.0||||||
4015462|NCT01187953|3836485|B2|Patients without diabetes at transplant||Diabetes at the time of transplant||participants|Number|219|219.0||||||
4015463|NCT01187953|3836486|B1|Patients without diabetes at transplant||Diabetes at the time of transplant||participants|Number|218|218.0||||||
4015464|NCT01187953|3836484|B3|Patients with diabetes at transplant||Diabetes at the time of transplant||participants|Number|106|106.0||||||
4015465|NCT01187953|3836485|B2|Patients with diabetes at transplant||Diabetes at the time of transplant||participants|Number|56|56.0||||||
4015466|NCT01187953|3836486|B1|Patients with diabetes at transplant||Diabetes at the time of transplant||participants|Number|50|50.0||||||
4015467|NCT01187953|3836484|B3|||Body Mass Index||kg/m^2|Mean|26.21|26.21|Standard Deviation|4.822|4.822|||
4015468|NCT01187953|3836485|B2|||Body Mass Index||kg/m^2|Mean|26.68|26.68|Standard Deviation|4.948|4.948|||
4015469|NCT01187953|3836486|B1|||Body Mass Index||kg/m^2|Mean|25.72|25.72|Standard Deviation|4.648|4.648|||
4015470|NCT01187953|3836484|B3|Germany||Region of Enrollment||participants|Number|67|67.0||||||
4015471|NCT01187953|3836485|B2|Germany||Region of Enrollment||participants|Number|35|35.0||||||
4015472|NCT01187953|3836486|B1|Germany||Region of Enrollment||participants|Number|32|32.0||||||
4015473|NCT01187953|3836484|B3|Serbia||Region of Enrollment||participants|Number|11|11.0||||||
4015474|NCT01187953|3836485|B2|Serbia||Region of Enrollment||participants|Number|5|5.0||||||
4015475|NCT01187953|3836486|B1|Serbia||Region of Enrollment||participants|Number|6|6.0||||||
4015476|NCT01187953|3836484|B3|France||Region of Enrollment||participants|Number|73|73.0||||||
4015477|NCT01187953|3836485|B2|France||Region of Enrollment||participants|Number|38|38.0||||||
4015478|NCT01187953|3836486|B1|France||Region of Enrollment||participants|Number|35|35.0||||||
4015479|NCT01187953|3836484|B3|Australia||Region of Enrollment||participants|Number|22|22.0||||||
4015480|NCT01187953|3836485|B2|Australia||Region of Enrollment||participants|Number|11|11.0||||||
4015481|NCT01187953|3836486|B1|Australia||Region of Enrollment||participants|Number|11|11.0||||||
4015482|NCT01187953|3836484|B3|Italy||Region of Enrollment||participants|Number|12|12.0||||||
4015483|NCT01187953|3836485|B2|Italy||Region of Enrollment||participants|Number|6|6.0||||||
4015484|NCT01187953|3836486|B1|Italy||Region of Enrollment||participants|Number|6|6.0||||||
4015485|NCT01187953|3836484|B3|Mexico||Region of Enrollment||participants|Number|56|56.0||||||
4015486|NCT01187953|3836485|B2|Mexico||Region of Enrollment||participants|Number|29|29.0||||||
4015487|NCT01187953|3836486|B1|Mexico||Region of Enrollment||participants|Number|27|27.0||||||
4015488|NCT01187953|3836484|B3|Brazil||Region of Enrollment||participants|Number|58|58.0||||||
4015489|NCT01187953|3836485|B2|Brazil||Region of Enrollment||participants|Number|29|29.0||||||
4015490|NCT01187953|3836486|B1|Brazil||Region of Enrollment||participants|Number|29|29.0||||||
4015491|NCT01187953|3836484|B3|Poland||Region of Enrollment||participants|Number|53|53.0||||||
4015492|NCT01187953|3836485|B2|Poland||Region of Enrollment||participants|Number|26|26.0||||||
4015493|NCT01187953|3836486|B1|Poland||Region of Enrollment||participants|Number|27|27.0||||||
4015494|NCT01187953|3836484|B3|New Zealand||Region of Enrollment||participants|Number|5|5.0||||||
4015495|NCT01187953|3836485|B2|New Zealand||Region of Enrollment||participants|Number|3|3.0||||||
4015496|NCT01187953|3836486|B1|New Zealand||Region of Enrollment||participants|Number|2|2.0||||||
4015497|NCT01187953|3836484|B3|Spain||Region of Enrollment||participants|Number|45|45.0||||||
4015498|NCT01187953|3836485|B2|Spain||Region of Enrollment||participants|Number|21|21.0||||||
4015499|NCT01187953|3836486|B1|Spain||Region of Enrollment||participants|Number|24|24.0||||||
4015500|NCT01187953|3836484|B3|United States||Region of Enrollment||participants|Number|137|137.0||||||
4015501|NCT01187953|3836485|B2|United States||Region of Enrollment||participants|Number|70|70.0||||||
4015502|NCT01187953|3836486|B1|United States||Region of Enrollment||participants|Number|67|67.0||||||
4015503|NCT01187953|3836484|B3|Singapore||Region of Enrollment||participants|Number|2|2.0||||||
4015504|NCT01187953|3836485|B2|Singapore||Region of Enrollment||participants|Number|1|1.0||||||
4015505|NCT01187953|3836486|B1|Singapore||Region of Enrollment||participants|Number|1|1.0||||||
4015506|NCT01187953|3836484|B3|Argentina||Region of Enrollment||participants|Number|2|2.0||||||
4015507|NCT01187953|3836485|B2|Argentina||Region of Enrollment||participants|Number|1|1.0||||||
4015508|NCT01187953|3836486|B1|Argentina||Region of Enrollment||participants|Number|1|1.0||||||
4015509|NCT01187953|3836484|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
4015510|NCT01187953|3836485|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4015511|NCT01187953|3836486|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4015512|NCT01187953|3836484|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015513|NCT01187953|3836485|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015514|NCT01187953|3836486|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015515|NCT01187953|3836484|B3||White|Race (NIH/OMB)||Participants|Count of Participants|417|417.0||||||
4015516|NCT01187953|3836485|B2||White|Race (NIH/OMB)||Participants|Count of Participants|214|214.0||||||
4015517|NCT01187953|3836486|B1||White|Race (NIH/OMB)||Participants|Count of Participants|203|203.0||||||
4015518|NCT01187953|3836484|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4015519|NCT01187953|3836485|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4015520|NCT01187953|3836486|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4015521|NCT01187953|3836484|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4015522|NCT01187953|3836485|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4015523|NCT01187953|3836486|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4015524|NCT01187953|3836484|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4015525|NCT01187953|3836485|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4015526|NCT01187953|3836486|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4015527|NCT01187953|3836484|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4015528|NCT01187953|3836485|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4015529|NCT01187953|3836486|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015530|NCT01187953|3836484|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015531|NCT01187953|3836485|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015532|NCT01187953|3836486|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015533|NCT01187953|3836484|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|390|390.0||||||
4015534|NCT01187953|3836485|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|196|196.0||||||
4015535|NCT01187953|3836486|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|194|194.0||||||
4015536|NCT01187953|3836484|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|153|153.0||||||
4015537|NCT01187953|3836485|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
4015538|NCT01187953|3836486|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4015539|NCT01187953|3836484|B3||Male|Sex: Female, Male||Participants|Count of Participants|355|355.0||||||
4015540|NCT01187953|3836485|B2||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4015541|NCT01187953|3836486|B1||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4015542|NCT01187953|3836484|B3||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4015543|NCT01187953|3836485|B2||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4015544|NCT01187953|3836486|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4015545|NCT01187953|3836484|B3|||Age||years|Mean|45.8|45.8|Standard Deviation|13.82|13.82|||
4015546|NCT01187953|3836485|B2|||Age||years|Mean|46.9|46.9|Standard Deviation|14.26|14.26|||
4015547|NCT01187953|3836486|B1|||Age||years|Mean|44.8|44.8|Standard Deviation|13.29|13.29|||
4015548|NCT01187953|3836484|B3||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
4015549|NCT01187953|3836485|B2||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4015550|NCT01187953|3836486|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4015551|NCT01187953|3836484|B3||Between 18 and 65 years|Age||Participants|Count of Participants|499|499.0||||||
4015552|NCT01187953|3836485|B2||Between 18 and 65 years|Age||Participants|Count of Participants|247|247.0||||||
4015553|NCT01187953|3836486|B1||Between 18 and 65 years|Age||Participants|Count of Participants|252|252.0||||||
4015554|NCT01187953|3836484|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4015555|NCT01187953|3836485|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4015556|NCT01187953|3836486|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4015557|NCT01187914|3836495|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4015558|NCT01187914|3836495|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4015559|NCT01187914|3836495|B1|||Age||years|Mean|65.2|65.2|Standard Deviation|12.3|12.3|||
4015560|NCT01187914|3836495|B1||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4015561|NCT01187914|3836495|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4015562|NCT01187914|3836495|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4015563|NCT01187901|3836499|B3|Attenuated FAP||Familial Adenomatous Polyposis (FAP) Status||participants|Number|28|28.0||||||
4015564|NCT01187901|3836500|B2|Attenuated FAP||Familial Adenomatous Polyposis (FAP) Status||participants|Number|14|14.0||||||
4015565|NCT01187901|3836501|B1|Attenuated FAP||Familial Adenomatous Polyposis (FAP) Status||participants|Number|14|14.0||||||
4015566|NCT01187901|3836499|B3|Classic FAP||Familial Adenomatous Polyposis (FAP) Status||participants|Number|64|64.0||||||
4015567|NCT01187901|3836500|B2|Classic FAP||Familial Adenomatous Polyposis (FAP) Status||participants|Number|32|32.0||||||
4015568|NCT01187901|3836501|B1|Classic FAP||Familial Adenomatous Polyposis (FAP) Status||participants|Number|32|32.0||||||
4015569|NCT01187901|3836499|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4015570|NCT01187901|3836500|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4015571|NCT01187901|3836501|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4015572|NCT01187901|3836499|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4015573|NCT01187901|3836500|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4015574|NCT01187901|3836501|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4015575|NCT01187901|3836499|B3|||Age||years|Mean|41|41.0|Standard Deviation|14|14.0|||
4015576|NCT01187901|3836500|B2|||Age||years|Mean|41|41.0|Standard Deviation|14|14.0|||
4015577|NCT01187901|3836501|B1|||Age||years|Mean|42|42.0|Standard Deviation|14|14.0|||
4015578|NCT01187771|3836518|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
4015579|NCT01187771|3836519|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4015580|NCT01187771|3836520|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4015581|NCT01187771|3836518|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4015582|NCT01187771|3836519|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4015583|NCT01187771|3836520|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4015584|NCT01187771|3836518|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4015585|NCT01187771|3836519|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4015586|NCT01187771|3836520|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4015587|NCT01187771|3836518|B3|||Age||years|Mean|48.8|48.8|Standard Deviation|9.9|9.9|||
4015588|NCT01187771|3836519|B2|||Age||years|Mean|46.3|46.3|Standard Deviation|10.5|10.5|||
4015589|NCT01187771|3836520|B1|||Age||years|Mean|50.7|50.7|Standard Deviation|9.2|9.2|||
4015590|NCT01187771|3836518|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4015591|NCT01187771|3836519|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4015592|NCT01187771|3836520|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4015593|NCT01187771|3836518|B3||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4015594|NCT01187771|3836519|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4015595|NCT01187771|3836520|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4015596|NCT01187771|3836518|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4015597|NCT01187771|3836519|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4015598|NCT01187771|3836520|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4015599|NCT01187550|3836541|B3||Male|Sex: Female, Male|Out of a total of 213 participants, data for baseline measure (gender) was available for only 205 participants who were treated.|Participants|Count of Participants|153|153.0||||||
4015600|NCT01187550|3836542|B2||Male|Sex: Female, Male|Out of a total of 213 participants, data for baseline measure (gender) was available for only 205 participants who were treated.|Participants|Count of Participants|24|24.0||||||
4015601|NCT01187550|3836543|B1||Male|Sex: Female, Male|Out of a total of 213 participants, data for baseline measure (gender) was available for only 205 participants who were treated.|Participants|Count of Participants|129|129.0||||||
4015602|NCT01187550|3836541|B3||Female|Sex: Female, Male|Out of a total of 213 participants, data for baseline measure (gender) was available for only 205 participants who were treated.|Participants|Count of Participants|52|52.0||||||
4015603|NCT01187550|3836542|B2||Female|Sex: Female, Male|Out of a total of 213 participants, data for baseline measure (gender) was available for only 205 participants who were treated.|Participants|Count of Participants|6|6.0||||||
4015604|NCT01187550|3836543|B1||Female|Sex: Female, Male|Out of a total of 213 participants, data for baseline measure (gender) was available for only 205 participants who were treated.|Participants|Count of Participants|46|46.0||||||
4015605|NCT01187550|3836541|B3|||Age|Out of a total of 213 participants, data for baseline measure (age) was available for only 205 participants who were treated.|years|Mean|10.35|10.35|Standard Deviation|3.931|3.931|||
4015606|NCT01187550|3836542|B2|||Age|Out of a total of 213 participants, data for baseline measure (age) was available for only 205 participants who were treated.|years|Mean|9.39|9.39|Standard Deviation|4.349|4.349|||
4015607|NCT01187550|3836543|B1|||Age|Out of a total of 213 participants, data for baseline measure (age) was available for only 205 participants who were treated.|years|Mean|10.52|10.52|Standard Deviation|3.844|3.844|||
4015608|NCT01187511|3836560|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4015609|NCT01187511|3836561|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015610|NCT01187511|3836562|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4015611|NCT01187511|3836560|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015612|NCT01187511|3836561|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015613|NCT01187511|3836562|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015614|NCT01187511|3836560|B3||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4015615|NCT01187511|3836561|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4015616|NCT01187511|3836562|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4015617|NCT01187511|3836560|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4015618|NCT01187511|3836561|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4015619|NCT01187511|3836562|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4015620|NCT01187511|3836560|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015621|NCT01187511|3836561|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015622|NCT01187511|3836562|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015623|NCT01187511|3836560|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015624|NCT01187511|3836561|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015625|NCT01187511|3836562|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015626|NCT01187511|3836560|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015627|NCT01187511|3836561|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015628|NCT01187511|3836562|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015629|NCT01187511|3836560|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015630|NCT01187511|3836561|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015631|NCT01187511|3836562|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015632|NCT01187511|3836560|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4015633|NCT01187511|3836561|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4015634|NCT01187511|3836562|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4015635|NCT01187511|3836560|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4015636|NCT01187511|3836561|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015637|NCT01187511|3836562|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4015638|NCT01187511|3836560|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4015639|NCT01187511|3836561|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4015640|NCT01187511|3836562|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4015641|NCT01187511|3836560|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4015642|NCT01187511|3836561|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4015643|NCT01187511|3836562|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4015644|NCT01187511|3836560|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4015645|NCT01187511|3836561|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4015646|NCT01187511|3836562|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4015647|NCT01187511|3836560|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4015648|NCT01187511|3836561|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4015649|NCT01187511|3836562|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4015650|NCT01187511|3836560|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4015651|NCT01187511|3836561|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4015652|NCT01187511|3836562|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4015653|NCT01187498|3836669|B3|United States||Region of Enrollment||participants|Number|143|143.0||||||
4015654|NCT01187498|3836670|B2|United States||Region of Enrollment||participants|Number|70|70.0||||||
4015655|NCT01187498|3836671|B1|United States||Region of Enrollment||participants|Number|73|73.0||||||
4015656|NCT01187498|3836669|B3||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4015657|NCT01187498|3836670|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4015658|NCT01187498|3836671|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4015659|NCT01187498|3836669|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4015660|NCT01187498|3836670|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4015661|NCT01187498|3836671|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4015662|NCT01187498|3836669|B3|||Age||years|Mean|64.2|64.2|Standard Deviation|9.9|9.9|||
4015663|NCT01187498|3836670|B2|||Age||years|Mean|64.8|64.8|Standard Deviation|9.6|9.6|||
4015664|NCT01187498|3836671|B1|||Age||years|Mean|63.7|63.7|Standard Deviation|10.3|10.3|||
4015665|NCT01187446|3836698|B3||Mycosis fungoides, Stage IIIB|Clinical Stage|"Participants are stratified by MF stage as follows.~Stage IB: ~10 % skin involvement, with up to 1000/mm3 clone+ Sezary cells in blood. No abnormal lymph nodes.~Stage IIA: Up to 10% skin involvement, with up to 1000/mm3 clone+ Sezary cells in blood & clinically abnormal peripheral lymph nodes.~Stage IIB: One or more tumors 1 cm in diameter, with up to 1000/mm3 clone+ Sezary cells in blood & clinically abnormal peripheral lymph nodes.~Stage IIIB: Skin erythema >80 % body surface area, with up to 1000/mm3 clone+ Sezary cells in blood & clinically abnormal peripheral lymph nodes."|Participants|Count of Participants|2|2.0||||||
4015666|NCT01187446|3836699|B2||Mycosis fungoides, Stage IIIB|Clinical Stage|"Participants are stratified by MF stage as follows.~Stage IB: ~10 % skin involvement, with up to 1000/mm3 clone+ Sezary cells in blood. No abnormal lymph nodes.~Stage IIA: Up to 10% skin involvement, with up to 1000/mm3 clone+ Sezary cells in blood & clinically abnormal peripheral lymph nodes.~Stage IIB: One or more tumors 1 cm in diameter, with up to 1000/mm3 clone+ Sezary cells in blood & clinically abnormal peripheral lymph nodes.~Stage IIIB: Skin erythema >80 % body surface area, with up to 1000/mm3 clone+ Sezary cells in blood & clinically abnormal peripheral lymph nodes."|Participants|Count of Participants|1|1.0||||||
4015667|NCT01187446|3836700|B1||Mycosis fungoides, Stage IIIB|Clinical Stage|"Participants are stratified by MF stage as follows.~Stage IB: ~10 % skin involvement, with up to 1000/mm3 clone+ Sezary cells in blood. No abnormal lymph nodes.~Stage IIA: Up to 10% skin involvement, with up to 1000/mm3 clone+ Sezary cells in blood & clinically abnormal peripheral lymph nodes.~Stage IIB: One or more tumors 1 cm in diameter, with up to 1000/mm3 clone+ Sezary cells in blood & clinically abnormal peripheral lymph nodes.~Stage IIIB: Skin erythema >80 % body surface area, with up to 1000/mm3 clone+ Sezary cells in blood & clinically abnormal peripheral lymph nodes."|Participants|Count of Participants|1|1.0||||||
4015668|NCT01187446|3836698|B3||Mycosis fungoides, Stage IIB|Clinical Stage|"Participants are stratified by MF stage as follows.~Stage IB: ~10 % skin involvement, with up to 1000/mm3 clone+ Sezary cells in blood. No abnormal lymph nodes.~Stage IIA: Up to 10% skin involvement, with up to 1000/mm3 clone+ Sezary cells in blood & clinically abnormal peripheral lymph nodes.~Stage IIB: One or more tumors 1 cm in diameter, with up to 1000/mm3 clone+ Sezary cells in blood & clinically abnormal peripheral lymph nodes.~Stage IIIB: Skin erythema >80 % body surface area, with up to 1000/mm3 clone+ Sezary cells in blood & clinically abnormal peripheral lymph nodes."|Participants|Count of Participants|5|5.0||||||
4015669|NCT01187446|3836699|B2||Mycosis fungoides, Stage IIB|Clinical Stage|"Participants are stratified by MF stage as follows.~Stage IB: ~10 % skin involvement, with up to 1000/mm3 clone+ Sezary cells in blood. No abnormal lymph nodes.~Stage IIA: Up to 10% skin involvement, with up to 1000/mm3 clone+ Sezary cells in blood & clinically abnormal peripheral lymph nodes.~Stage IIB: One or more tumors 1 cm in diameter, with up to 1000/mm3 clone+ Sezary cells in blood & clinically abnormal peripheral lymph nodes.~Stage IIIB: Skin erythema >80 % body surface area, with up to 1000/mm3 clone+ Sezary cells in blood & clinically abnormal peripheral lymph nodes."|Participants|Count of Participants|3|3.0||||||
4015670|NCT01187446|3836700|B1||Mycosis fungoides, Stage IIB|Clinical Stage|"Participants are stratified by MF stage as follows.~Stage IB: ~10 % skin involvement, with up to 1000/mm3 clone+ Sezary cells in blood. No abnormal lymph nodes.~Stage IIA: Up to 10% skin involvement, with up to 1000/mm3 clone+ Sezary cells in blood & clinically abnormal peripheral lymph nodes.~Stage IIB: One or more tumors 1 cm in diameter, with up to 1000/mm3 clone+ Sezary cells in blood & clinically abnormal peripheral lymph nodes.~Stage IIIB: Skin erythema >80 % body surface area, with up to 1000/mm3 clone+ Sezary cells in blood & clinically abnormal peripheral lymph nodes."|Participants|Count of Participants|2|2.0||||||
4015702|NCT01187446|3836699|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4015703|NCT01187446|3836700|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4015671|NCT01187446|3836698|B3||Mycosis fungoides, Stage IIA|Clinical Stage|"Participants are stratified by MF stage as follows.~Stage IB: ~10 % skin involvement, with up to 1000/mm3 clone+ Sezary cells in blood. No abnormal lymph nodes.~Stage IIA: Up to 10% skin involvement, with up to 1000/mm3 clone+ Sezary cells in blood & clinically abnormal peripheral lymph nodes.~Stage IIB: One or more tumors 1 cm in diameter, with up to 1000/mm3 clone+ Sezary cells in blood & clinically abnormal peripheral lymph nodes.~Stage IIIB: Skin erythema >80 % body surface area, with up to 1000/mm3 clone+ Sezary cells in blood & clinically abnormal peripheral lymph nodes."|Participants|Count of Participants|4|4.0||||||
4015672|NCT01187446|3836699|B2||Mycosis fungoides, Stage IIA|Clinical Stage|"Participants are stratified by MF stage as follows.~Stage IB: ~10 % skin involvement, with up to 1000/mm3 clone+ Sezary cells in blood. No abnormal lymph nodes.~Stage IIA: Up to 10% skin involvement, with up to 1000/mm3 clone+ Sezary cells in blood & clinically abnormal peripheral lymph nodes.~Stage IIB: One or more tumors 1 cm in diameter, with up to 1000/mm3 clone+ Sezary cells in blood & clinically abnormal peripheral lymph nodes.~Stage IIIB: Skin erythema >80 % body surface area, with up to 1000/mm3 clone+ Sezary cells in blood & clinically abnormal peripheral lymph nodes."|Participants|Count of Participants|2|2.0||||||
4015673|NCT01187446|3836700|B1||Mycosis fungoides, Stage IIA|Clinical Stage|"Participants are stratified by MF stage as follows.~Stage IB: ~10 % skin involvement, with up to 1000/mm3 clone+ Sezary cells in blood. No abnormal lymph nodes.~Stage IIA: Up to 10% skin involvement, with up to 1000/mm3 clone+ Sezary cells in blood & clinically abnormal peripheral lymph nodes.~Stage IIB: One or more tumors 1 cm in diameter, with up to 1000/mm3 clone+ Sezary cells in blood & clinically abnormal peripheral lymph nodes.~Stage IIIB: Skin erythema >80 % body surface area, with up to 1000/mm3 clone+ Sezary cells in blood & clinically abnormal peripheral lymph nodes."|Participants|Count of Participants|2|2.0||||||
4015674|NCT01187446|3836698|B3||Mycosis fungoides, Stage IB|Clinical Stage|"Participants are stratified by MF stage as follows.~Stage IB: ~10 % skin involvement, with up to 1000/mm3 clone+ Sezary cells in blood. No abnormal lymph nodes.~Stage IIA: Up to 10% skin involvement, with up to 1000/mm3 clone+ Sezary cells in blood & clinically abnormal peripheral lymph nodes.~Stage IIB: One or more tumors 1 cm in diameter, with up to 1000/mm3 clone+ Sezary cells in blood & clinically abnormal peripheral lymph nodes.~Stage IIIB: Skin erythema >80 % body surface area, with up to 1000/mm3 clone+ Sezary cells in blood & clinically abnormal peripheral lymph nodes."|Participants|Count of Participants|17|17.0||||||
4015675|NCT01187446|3836699|B2||Mycosis fungoides, Stage IB|Clinical Stage|"Participants are stratified by MF stage as follows.~Stage IB: ~10 % skin involvement, with up to 1000/mm3 clone+ Sezary cells in blood. No abnormal lymph nodes.~Stage IIA: Up to 10% skin involvement, with up to 1000/mm3 clone+ Sezary cells in blood & clinically abnormal peripheral lymph nodes.~Stage IIB: One or more tumors 1 cm in diameter, with up to 1000/mm3 clone+ Sezary cells in blood & clinically abnormal peripheral lymph nodes.~Stage IIIB: Skin erythema >80 % body surface area, with up to 1000/mm3 clone+ Sezary cells in blood & clinically abnormal peripheral lymph nodes."|Participants|Count of Participants|8|8.0||||||
4015676|NCT01187446|3836700|B1||Mycosis fungoides, Stage IB|Clinical Stage|"Participants are stratified by MF stage as follows.~Stage IB: ~10 % skin involvement, with up to 1000/mm3 clone+ Sezary cells in blood. No abnormal lymph nodes.~Stage IIA: Up to 10% skin involvement, with up to 1000/mm3 clone+ Sezary cells in blood & clinically abnormal peripheral lymph nodes.~Stage IIB: One or more tumors 1 cm in diameter, with up to 1000/mm3 clone+ Sezary cells in blood & clinically abnormal peripheral lymph nodes.~Stage IIIB: Skin erythema >80 % body surface area, with up to 1000/mm3 clone+ Sezary cells in blood & clinically abnormal peripheral lymph nodes."|Participants|Count of Participants|9|9.0||||||
4015677|NCT01187446|3836698|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4015678|NCT01187446|3836699|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4015679|NCT01187446|3836700|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4015680|NCT01187446|3836698|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015681|NCT01187446|3836699|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015682|NCT01187446|3836700|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015683|NCT01187446|3836698|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4015684|NCT01187446|3836699|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4015685|NCT01187446|3836700|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4015686|NCT01187446|3836698|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4015687|NCT01187446|3836699|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4015688|NCT01187446|3836700|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4015689|NCT01187446|3836698|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015690|NCT01187446|3836699|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015691|NCT01187446|3836700|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015692|NCT01187446|3836698|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4015693|NCT01187446|3836699|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4015694|NCT01187446|3836700|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015695|NCT01187446|3836698|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015696|NCT01187446|3836699|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015697|NCT01187446|3836700|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015698|NCT01187446|3836698|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4015699|NCT01187446|3836699|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4015700|NCT01187446|3836700|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4015701|NCT01187446|3836698|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4015704|NCT01187446|3836698|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4015705|NCT01187446|3836699|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4015706|NCT01187446|3836700|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4015707|NCT01187446|3836698|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4015708|NCT01187446|3836699|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4015709|NCT01187446|3836700|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4015710|NCT01187446|3836698|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4015711|NCT01187446|3836699|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4015712|NCT01187446|3836700|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4015713|NCT01187446|3836698|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4015714|NCT01187446|3836699|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4015715|NCT01187446|3836700|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4015716|NCT01187446|3836698|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4015717|NCT01187446|3836699|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4015718|NCT01187446|3836700|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4015719|NCT01187446|3836698|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4015720|NCT01187446|3836699|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4015721|NCT01187446|3836700|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4015722|NCT01187433|3836715|B3|Brazil||Region of Enrollment||Participants|Number|150|150.0||||||
4015723|NCT01187433|3836716|B2|Brazil||Region of Enrollment||Participants|Number|50|50.0||||||
4015724|NCT01187433|3836717|B1|Brazil||Region of Enrollment||Participants|Number|100|100.0||||||
4015725|NCT01187433|3836715|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4015726|NCT01187433|3836716|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4015727|NCT01187433|3836717|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4015728|NCT01187433|3836715|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4015729|NCT01187433|3836716|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4015730|NCT01187433|3836717|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4015731|NCT01187433|3836715|B3|Age Continuous||Age||Years|Mean|12.7|12.7|Standard Deviation|2.15|2.15|||
4015732|NCT01187433|3836716|B2|Age Continuous||Age||Years|Mean|12.7|12.7|Standard Deviation|2.2|2.2|||
4015733|NCT01187433|3836717|B1|Age Continuous||Age||Years|Mean|12.7|12.7|Standard Deviation|2.1|2.1|||
4015734|NCT01187433|3836715|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4015735|NCT01187433|3836716|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4015736|NCT01187433|3836717|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4015737|NCT01187433|3836715|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4015738|NCT01187433|3836716|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4015739|NCT01187433|3836717|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4015740|NCT01187433|3836715|B3||<=18 years|Age||Participants|Count of Participants|150|150.0||||||
4015741|NCT01187433|3836716|B2||<=18 years|Age||Participants|Count of Participants|50|50.0||||||
4015742|NCT01187433|3836717|B1||<=18 years|Age||Participants|Count of Participants|100|100.0||||||
4015743|NCT01187407|3836744|B5|Romania||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
4015744|NCT01187407|3836745|B4|Romania||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4015745|NCT01187407|3836746|B3|Romania||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4015746|NCT01187407|3836747|B2|Romania||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4015747|NCT01187407|3836748|B1|Romania||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4015748|NCT01187407|3836744|B5|Hungary||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4015749|NCT01187407|3836745|B4|Hungary||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4015750|NCT01187407|3836746|B3|Hungary||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4015751|NCT01187407|3836747|B2|Hungary||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4015752|NCT01187407|3836748|B1|Hungary||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4015753|NCT01187407|3836744|B5|Japan||Region of Enrollment||Participants|Count of Participants|115|115.0||||||
4015754|NCT01187407|3836745|B4|Japan||Region of Enrollment||Participants|Count of Participants|53|53.0||||||
4015755|NCT01187407|3836746|B3|Japan||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4015756|NCT01187407|3836747|B2|Japan||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4015757|NCT01187407|3836748|B1|Japan||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4015758|NCT01187407|3836744|B5|Croatia||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
4015759|NCT01187407|3836745|B4|Croatia||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
4015760|NCT01187407|3836746|B3|Croatia||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4015761|NCT01187407|3836747|B2|Croatia||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4015762|NCT01187407|3836748|B1|Croatia||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4015763|NCT01187407|3836744|B5|Finland||Region of Enrollment||Participants|Count of Participants|108|108.0||||||
4015764|NCT01187407|3836745|B4|Finland||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
4015765|NCT01187407|3836746|B3|Finland||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
4015766|NCT01187407|3836747|B2|Finland||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4015767|NCT01187407|3836748|B1|Finland||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4015768|NCT01187407|3836744|B5|Slovakia||Region of Enrollment||Participants|Count of Participants|141|141.0||||||
4015769|NCT01187407|3836745|B4|Slovakia||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
4015770|NCT01187407|3836746|B3|Slovakia||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
4015771|NCT01187407|3836747|B2|Slovakia||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
4015772|NCT01187407|3836748|B1|Slovakia||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
4015773|NCT01187407|3836744|B5|Czechia||Region of Enrollment||Participants|Count of Participants|253|253.0||||||
4015774|NCT01187407|3836745|B4|Czechia||Region of Enrollment||Participants|Count of Participants|119|119.0||||||
4015775|NCT01187407|3836746|B3|Czechia||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
4015776|NCT01187407|3836747|B2|Czechia||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
4015777|NCT01187407|3836748|B1|Czechia||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
4015778|NCT01187407|3836744|B5|United States||Region of Enrollment||Participants|Count of Participants|682|682.0||||||
4015779|NCT01187407|3836745|B4|United States||Region of Enrollment||Participants|Count of Participants|377|377.0||||||
4015780|NCT01187407|3836746|B3|United States||Region of Enrollment||Participants|Count of Participants|104|104.0||||||
4015781|NCT01187407|3836747|B2|United States||Region of Enrollment||Participants|Count of Participants|98|98.0||||||
4015782|NCT01187407|3836748|B1|United States||Region of Enrollment||Participants|Count of Participants|103|103.0||||||
4015783|NCT01187407|3836744|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4015784|NCT01187407|3836745|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015785|NCT01187407|3836746|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4015786|NCT01187407|3836747|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015787|NCT01187407|3836748|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015788|NCT01187407|3836744|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4015789|NCT01187407|3836745|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4015790|NCT01187407|3836746|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4015791|NCT01187407|3836747|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4015792|NCT01187407|3836748|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4015793|NCT01187407|3836744|B5||White|Race (NIH/OMB)||Participants|Count of Participants|1123|1123.0||||||
4015794|NCT01187407|3836745|B4||White|Race (NIH/OMB)||Participants|Count of Participants|572|572.0||||||
4015795|NCT01187407|3836746|B3||White|Race (NIH/OMB)||Participants|Count of Participants|186|186.0||||||
4015796|NCT01187407|3836747|B2||White|Race (NIH/OMB)||Participants|Count of Participants|173|173.0||||||
4015797|NCT01187407|3836748|B1||White|Race (NIH/OMB)||Participants|Count of Participants|192|192.0||||||
4015798|NCT01187407|3836744|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
4015799|NCT01187407|3836745|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4015800|NCT01187407|3836746|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4015801|NCT01187407|3836747|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4015802|NCT01187407|3836748|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4015803|NCT01187407|3836744|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015804|NCT01187407|3836745|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015805|NCT01187407|3836746|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015806|NCT01187407|3836747|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015807|NCT01187407|3836748|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015808|NCT01187407|3836744|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|121|121.0||||||
4015809|NCT01187407|3836745|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4015810|NCT01187407|3836746|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4015811|NCT01187407|3836747|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4015812|NCT01187407|3836748|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4015813|NCT01187407|3836744|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4015814|NCT01187407|3836745|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4015815|NCT01187407|3836746|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4015816|NCT01187407|3836747|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4015817|NCT01187407|3836748|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4015818|NCT01187407|3836744|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|203|203.0||||||
4015819|NCT01187407|3836745|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4015820|NCT01187407|3836746|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4015821|NCT01187407|3836747|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4015822|NCT01187407|3836748|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4015823|NCT01187407|3836744|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1104|1104.0||||||
4015824|NCT01187407|3836745|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|562|562.0||||||
4015825|NCT01187407|3836746|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|178|178.0||||||
4015826|NCT01187407|3836747|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|181|181.0||||||
4015827|NCT01187407|3836748|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|183|183.0||||||
4015828|NCT01187407|3836744|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
4015829|NCT01187407|3836745|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4015830|NCT01187407|3836746|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4015831|NCT01187407|3836747|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4015832|NCT01187407|3836748|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4015833|NCT01187407|3836744|B5||Male|Sex: Female, Male||Participants|Count of Participants|467|467.0||||||
4015834|NCT01187407|3836745|B4||Male|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
4015835|NCT01187407|3836746|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4015836|NCT01187407|3836747|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4015837|NCT01187407|3836748|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4015838|NCT01187407|3836744|B5||Female|Sex: Female, Male||Participants|Count of Participants|923|923.0||||||
4015839|NCT01187407|3836745|B4||Female|Sex: Female, Male||Participants|Count of Participants|465|465.0||||||
4015840|NCT01187407|3836746|B3||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4015841|NCT01187407|3836747|B2||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4015842|NCT01187407|3836748|B1||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4015843|NCT01187407|3836744|B5|||Age||years|Mean|46.67|46.67|Standard Deviation|12.35|12.35|||
4015844|NCT01187407|3836745|B4|||Age||years|Mean|46.35|46.35|Standard Deviation|12.42|12.42|||
4015845|NCT01187407|3836746|B3|||Age||years|Mean|47.30|47.3|Standard Deviation|12.10|12.1|||
4015846|NCT01187407|3836747|B2|||Age||years|Mean|47.06|47.06|Standard Deviation|12.76|12.76|||
4015847|NCT01187407|3836748|B1|||Age||years|Mean|46.63|46.63|Standard Deviation|12.00|12.0|||
4015848|NCT01187381|3836822|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4015849|NCT01187381|3836822|B1||Female|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
4015850|NCT01187381|3836822|B1|||Age||years|Mean|51.2600|51.26|Standard Deviation|10.61939|10.61939|||
4015851|NCT01187355|3836832|B3||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4015852|NCT01187355|3836833|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4015853|NCT01187355|3836834|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4015854|NCT01187355|3836832|B3||Female|Sex: Female, Male||Participants|Count of Participants|421|421.0||||||
4015855|NCT01187355|3836833|B2||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4015856|NCT01187355|3836834|B1||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4015857|NCT01187355|3836832|B3|||Age||years|Mean|34.3|34.3|Standard Deviation|11.33|11.33|||
4015858|NCT01187355|3836833|B2|||Age||years|Mean|34.0|34.0|Standard Deviation|11.24|11.24|||
4015859|NCT01187355|3836834|B1|||Age||years|Mean|34.5|34.5|Standard Deviation|11.43|11.43|||
4015860|NCT01187329|3836845|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4015861|NCT01187329|3836846|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4015862|NCT01187329|3836847|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4015863|NCT01187329|3836845|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4015864|NCT01187329|3836846|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4015865|NCT01187329|3836847|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4015866|NCT01187329|3836845|B3|||Age||years|Mean|70|70.0|Standard Deviation|10|10.0|||
4015867|NCT01187329|3836846|B2|||Age||years|Mean|70|70.0|Standard Deviation|11|11.0|||
4015868|NCT01187329|3836847|B1|||Age||years|Mean|70|70.0|Standard Deviation|9|9.0|||
4015869|NCT01187043|3836860|B6|United States||Region of Enrollment||participants|Number|58|58.0||||||
4015870|NCT01187043|3836861|B5|United States||Region of Enrollment||participants|Number|12|12.0||||||
4015871|NCT01187043|3836862|B4|United States||Region of Enrollment||participants|Number|12|12.0||||||
4015872|NCT01187043|3836863|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4015873|NCT01187043|3836864|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4015874|NCT01187043|3836865|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4015875|NCT01187043|3836860|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4015876|NCT01187043|3836861|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4015877|NCT01187043|3836862|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4015878|NCT01187043|3836863|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4015879|NCT01187043|3836864|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4015880|NCT01187043|3836865|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4015881|NCT01187043|3836860|B6||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4015882|NCT01187043|3836861|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4015883|NCT01187043|3836862|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4015884|NCT01187043|3836863|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4015885|NCT01187043|3836864|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4015886|NCT01187043|3836865|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4015887|NCT01187043|3836860|B6|||Age||years|Mean|36.7|36.7|Standard Deviation|7.8|7.8|||
4015888|NCT01187043|3836861|B5|||Age||years|Mean|36.3|36.3|Standard Deviation|7.0|7.0|||
4015889|NCT01187043|3836862|B4|||Age||years|Mean|34.4|34.4|Standard Deviation|8.3|8.3|||
4015890|NCT01187043|3836863|B3|||Age||years|Mean|37.1|37.1|Standard Deviation|8.6|8.6|||
4015891|NCT01187043|3836864|B2|||Age||years|Mean|38.5|38.5|Standard Deviation|7.6|7.6|||
4015892|NCT01187043|3836865|B1|||Age||years|Mean|37.4|37.4|Standard Deviation|7.8|7.8|||
4015893|NCT01187017|3836881|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4015894|NCT01187017|3836881|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4015895|NCT01187017|3836881|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4015896|NCT01187017|3836881|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4015897|NCT01187017|3836881|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4015898|NCT01187017|3836881|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4015899|NCT01187004|3836885|B3|Italy||Region of Enrollment||participants|Number|164|164.0||||||
4015900|NCT01187004|3836886|B2|Italy||Region of Enrollment||participants|Number|144|144.0||||||
4015901|NCT01187004|3836887|B1|Italy||Region of Enrollment||participants|Number|20|20.0||||||
4015902|NCT01187004|3836885|B3||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4015903|NCT01187004|3836886|B2||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4015904|NCT01187004|3836887|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4015905|NCT01187004|3836885|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4015906|NCT01187004|3836886|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4015907|NCT01187004|3836887|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4015908|NCT01187004|3836885|B3|||Age||years|Mean|66|66.0|Standard Deviation|13|13.0|||
4015909|NCT01187004|3836886|B2|||Age||years|Mean|65|65.0|Standard Deviation|14|14.0|||
4015910|NCT01187004|3836887|B1|||Age||years|Mean|69|69.0|Standard Deviation|10|10.0|||
4015911|NCT01187004|3836885|B3||>=65 years|Age||Participants|Count of Participants|100|100.0||||||
4015912|NCT01187004|3836886|B2||>=65 years|Age||Participants|Count of Participants|87|87.0||||||
4015913|NCT01187004|3836887|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4015914|NCT01187004|3836885|B3||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4015915|NCT01187004|3836886|B2||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4015916|NCT01187004|3836887|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4015917|NCT01187004|3836885|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4015918|NCT01187004|3836886|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4015919|NCT01187004|3836887|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4015920|NCT01186939|3836895|B1|Indeterminate||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The scale is 0-3.5 at .5 increments. Scores of 2.5-3.5 represent high risk which corresponds to poorer prognosis. The assessment was performed by the Independent Review Committee.|participants|Number|2|2.0||||||
4015921|NCT01186939|3836895|B1|Not applicable||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The scale is 0-3.5 at .5 increments. Scores of 2.5-3.5 represent high risk which corresponds to poorer prognosis. The assessment was performed by the Independent Review Committee.|participants|Number|2|2.0||||||
4015922|NCT01186939|3836895|B1|High risk (2.5-3.5)||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The scale is 0-3.5 at .5 increments. Scores of 2.5-3.5 represent high risk which corresponds to poorer prognosis. The assessment was performed by the Independent Review Committee.|participants|Number|14|14.0||||||
4015923|NCT01186939|3836895|B1|Intermediate risk level 2 (1.5-2.0)||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The scale is 0-3.5 at .5 increments. Scores of 2.5-3.5 represent high risk which corresponds to poorer prognosis. The assessment was performed by the Independent Review Committee.|participants|Number|21|21.0||||||
4015924|NCT01186939|3836895|B1|Intermediate risk level 1 (0.5-1.0)||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The scale is 0-3.5 at .5 increments. Scores of 2.5-3.5 represent high risk which corresponds to poorer prognosis. The assessment was performed by the Independent Review Committee.|participants|Number|1|1.0||||||
4015978|NCT01186744|3836922|B7|||Age||years|Mean|44.9|44.9|Standard Deviation|13.2|13.2|||
4015925|NCT01186939|3836895|B1|Acute myeloid leukemia||World Health Organization (WHO) Classification|WHO classifications were determined by the Independent Review Committee.|participants|Number|11|11.0||||||
4015926|NCT01186939|3836895|B1|Chronic myelomonocytic leukemia - 2 (CMMoL-2)||World Health Organization (WHO) Classification|WHO classifications were determined by the Independent Review Committee.|participants|Number|2|2.0||||||
4015927|NCT01186939|3836895|B1|Chronic myelomonocytic leukemia - 1 (CMMoL-1)||World Health Organization (WHO) Classification|WHO classifications were determined by the Independent Review Committee.|participants|Number|0|0.0||||||
4015928|NCT01186939|3836895|B1|Refractory anemia with excess blasts - 2||World Health Organization (WHO) Classification|WHO classifications were determined by the Independent Review Committee.|participants|Number|22|22.0||||||
4015929|NCT01186939|3836895|B1|Refractory anemia with excess blasts - 1||World Health Organization (WHO) Classification|WHO classifications were determined by the Independent Review Committee.|participants|Number|5|5.0||||||
4015930|NCT01186939|3836895|B1|Myeloproliferative disease||French-American-British (FAB) Classification|FAB classifications were determined by the Independent Review Committee|participants|Number|1|1.0||||||
4015931|NCT01186939|3836895|B1|Acute myeloid leukemia||French-American-British (FAB) Classification|FAB classifications were determined by the Independent Review Committee|participants|Number|1|1.0||||||
4015932|NCT01186939|3836895|B1|Modified chronic myelomonocytic leukemia||French-American-British (FAB) Classification|FAB classifications were determined by the Independent Review Committee|participants|Number|1|1.0||||||
4015933|NCT01186939|3836895|B1|RAEB in transformation||French-American-British (FAB) Classification|FAB classifications were determined by the Independent Review Committee|participants|Number|10|10.0||||||
4015934|NCT01186939|3836895|B1|Refractory anemia with excess blasts (RAEB)||French-American-British (FAB) Classification|FAB classifications were determined by the Independent Review Committee|participants|Number|27|27.0||||||
4015935|NCT01186939|3836895|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4015936|NCT01186939|3836895|B1||Male|Gender||Participants|Count of Participants|32|32.0||||||
4015937|NCT01186939|3836895|B1||Female|Gender||Participants|Count of Participants|8|8.0||||||
4015938|NCT01186939|3836895|B1|||Age||years|Mean|68.6|68.6|Standard Deviation|8.23|8.23|||
4015939|NCT01186848|3836899|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4015940|NCT01186848|3836899|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4015941|NCT01186848|3836899|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4015942|NCT01186848|3836899|B1|||Age||years|Mean|36|36.0|Standard Deviation|8.2|8.2|||
4015943|NCT01186848|3836899|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4015944|NCT01186848|3836899|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4015945|NCT01186848|3836899|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4015946|NCT01186796|3836905|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4015947|NCT01186796|3836906|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4015948|NCT01186796|3836907|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4015949|NCT01186796|3836905|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4015950|NCT01186796|3836906|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4015951|NCT01186796|3836907|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4015952|NCT01186796|3836905|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4015953|NCT01186796|3836906|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4015954|NCT01186796|3836907|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4015955|NCT01186796|3836905|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4015956|NCT01186796|3836906|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4015957|NCT01186796|3836907|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4015958|NCT01186796|3836905|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4015959|NCT01186796|3836906|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4015960|NCT01186796|3836907|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4015961|NCT01186796|3836905|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4015962|NCT01186796|3836906|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4015963|NCT01186796|3836907|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4015964|NCT01186744|3836922|B7||Male|Sex: Female, Male||Participants|Count of Participants|458|458.0||||||
4015965|NCT01186744|3836923|B6||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4015966|NCT01186744|3836924|B5||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4015967|NCT01186744|3836925|B4||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4015968|NCT01186744|3836926|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4015969|NCT01186744|3836927|B2||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4015970|NCT01186744|3836928|B1||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4015971|NCT01186744|3836922|B7||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4015972|NCT01186744|3836923|B6||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4015973|NCT01186744|3836924|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4015974|NCT01186744|3836925|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4015975|NCT01186744|3836926|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4015976|NCT01186744|3836927|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4015977|NCT01186744|3836928|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4015979|NCT01186744|3836923|B6|||Age||years|Mean|46.1|46.1|Standard Deviation|13.4|13.4|||
4015980|NCT01186744|3836924|B5|||Age||years|Mean|48.5|48.5|Standard Deviation|14.8|14.8|||
4015981|NCT01186744|3836925|B4|||Age||years|Mean|45.2|45.2|Standard Deviation|13.4|13.4|||
4015982|NCT01186744|3836926|B3|||Age||years|Mean|44.3|44.3|Standard Deviation|13.0|13.0|||
4015983|NCT01186744|3836927|B2|||Age||years|Mean|45.6|45.6|Standard Deviation|12.6|12.6|||
4015984|NCT01186744|3836928|B1|||Age||years|Mean|42.8|42.8|Standard Deviation|13.0|13.0|||
4015985|NCT01186705|3837349|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4015986|NCT01186705|3837349|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4015987|NCT01186705|3837349|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4015988|NCT01186705|3837349|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4015989|NCT01186705|3837349|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4015990|NCT01186692|3837353|B1|United States||Region of Enrollment||participants|Number|131|131.0||||||
4015991|NCT01186692|3837353|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4015992|NCT01186692|3837353|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4015993|NCT01186692|3837353|B1|||Age||years|Median|20.1|20.1|Standard Deviation|9.8|9.8|||
4015994|NCT01186562|3837361|B3|United States||Region of Enrollment||participants|Number|83|83.0||||||
4015995|NCT01186562|3837362|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4015996|NCT01186562|3837363|B1|United States||Region of Enrollment||participants|Number|54|54.0||||||
4015997|NCT01186562|3837361|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4015998|NCT01186562|3837362|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4015999|NCT01186562|3837363|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4016000|NCT01186562|3837361|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4016001|NCT01186562|3837362|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4016002|NCT01186562|3837363|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4016003|NCT01186562|3837361|B3|||Age||years|Mean|41|41.0|Standard Deviation|11|11.0|||
4016004|NCT01186562|3837362|B2|||Age||years|Mean|42.6|42.6|Standard Deviation|10.3|10.3|||
4016005|NCT01186562|3837363|B1|||Age||years|Mean|39.0|39.0|Standard Deviation|11|11.0|||
4016006|NCT01186458|3837380|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4016007|NCT01186458|3837380|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016008|NCT01186458|3837380|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016009|NCT01186458|3837380|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4016010|NCT01186458|3837380|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016011|NCT01186458|3837380|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016012|NCT01186458|3837380|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016013|NCT01186458|3837380|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016014|NCT01186458|3837380|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4016015|NCT01186458|3837380|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4016016|NCT01186458|3837380|B1|||Age||years|Mean|59.50|59.5|Standard Deviation|14.01|14.01|||
4016017|NCT01186419|3837387|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4016018|NCT01186419|3837388|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4016019|NCT01186419|3837389|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4016020|NCT01186419|3837387|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4016021|NCT01186419|3837388|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4016022|NCT01186419|3837389|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4016023|NCT01186419|3837387|B3|||Age||years|Mean|28.5|28.5|Standard Deviation|7.77|7.77|||
4016024|NCT01186419|3837388|B2|||Age||years|Mean|28.4|28.4|Standard Deviation|7.11|7.11|||
4016025|NCT01186419|3837389|B1|||Age||years|Mean|28.7|28.7|Standard Deviation|8.60|8.6|||
4016026|NCT01186419|3837387|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4016027|NCT01186419|3837388|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4016028|NCT01186419|3837389|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4016029|NCT01186419|3837387|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4016030|NCT01186419|3837388|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4016031|NCT01186419|3837389|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4016032|NCT01186419|3837387|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4016033|NCT01186419|3837388|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4016034|NCT01186419|3837389|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4016035|NCT01186406|3837397|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4016036|NCT01186406|3837397|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4016037|NCT01186406|3837397|B1|||Age||years|Mean|57.2|57.2|Standard Deviation|10.7|10.7|||
4016038|NCT01186250|3837404|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4016039|NCT01186250|3837405|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4016040|NCT01186250|3837406|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4016041|NCT01186250|3837404|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4016042|NCT01186250|3837405|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4016043|NCT01186250|3837406|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4016044|NCT01186250|3837404|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4016045|NCT01186250|3837405|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4016046|NCT01186250|3837406|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4016047|NCT01186250|3837404|B3|||Age||years|Mean|50.0|50.0|Full Range|||22.0|72.0|
4016048|NCT01186250|3837405|B2|||Age||years|Mean|49.2|49.2|Full Range|||22.0|72.0|
4016049|NCT01186250|3837406|B1|||Age||years|Mean|50.8|50.8|Full Range|||23.0|72.0|
4016050|NCT01186250|3837404|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4016051|NCT01186250|3837405|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4016052|NCT01186250|3837406|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4016053|NCT01186250|3837404|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4016054|NCT01186250|3837405|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4016055|NCT01186250|3837406|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4016056|NCT01186250|3837404|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4016057|NCT01186250|3837405|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4016058|NCT01186250|3837406|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4016059|NCT01185964|3837425|B4|United States||Region of Enrollment||participants|Number|148|148.0||||||
4016060|NCT01185964|3837426|B3|United States||Region of Enrollment||participants|Number|67|67.0||||||
4016061|NCT01185964|3837427|B2|United States||Region of Enrollment||participants|Number|66|66.0||||||
4016062|NCT01185964|3837428|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4016063|NCT01185964|3837425|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016064|NCT01185964|3837426|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016065|NCT01185964|3837427|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016066|NCT01185964|3837428|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016067|NCT01185964|3837425|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4016068|NCT01185964|3837426|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016069|NCT01185964|3837427|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4016070|NCT01185964|3837428|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4016071|NCT01185964|3837425|B4||White|Race (NIH/OMB)||Participants|Count of Participants|127|127.0||||||
4016072|NCT01185964|3837426|B3||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4016073|NCT01185964|3837427|B2||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4016074|NCT01185964|3837428|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4016075|NCT01185964|3837425|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4016076|NCT01185964|3837426|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4016077|NCT01185964|3837427|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4016078|NCT01185964|3837428|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4016079|NCT01185964|3837425|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4016080|NCT01185964|3837426|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016081|NCT01185964|3837427|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4016082|NCT01185964|3837428|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016083|NCT01185964|3837425|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4016084|NCT01185964|3837426|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4016085|NCT01185964|3837427|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4016086|NCT01185964|3837428|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016087|NCT01185964|3837425|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016088|NCT01185964|3837426|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016089|NCT01185964|3837427|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016090|NCT01185964|3837428|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016091|NCT01185964|3837425|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4016092|NCT01185964|3837426|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4016093|NCT01185964|3837427|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016094|NCT01185964|3837428|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016095|NCT01185964|3837425|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
4016096|NCT01185964|3837426|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4016097|NCT01185964|3837427|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4016098|NCT01185964|3837428|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4016099|NCT01185964|3837425|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4016100|NCT01185964|3837426|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4016101|NCT01185964|3837427|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4016102|NCT01185964|3837428|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4016103|NCT01185964|3837425|B4||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4016104|NCT01185964|3837426|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4016105|NCT01185964|3837427|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4016106|NCT01185964|3837428|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4016107|NCT01185964|3837425|B4||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4016108|NCT01185964|3837426|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4016109|NCT01185964|3837427|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4016110|NCT01185964|3837428|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4016111|NCT01185964|3837425|B4|||Age||years|Mean|56.7|56.7|Standard Deviation|10.62|10.62|||
4016112|NCT01185964|3837426|B3|||Age||years|Mean|55.3|55.3|Standard Deviation|12.96|12.96|||
4016113|NCT01185964|3837427|B2|||Age||years|Mean|56.8|56.8|Standard Deviation|12.53|12.53|||
4016114|NCT01185964|3837428|B1|||Age||years|Mean|48.7|48.7|Standard Deviation|13.16|13.16|||
4016115|NCT01185834|3837457|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4016116|NCT01185834|3837457|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4016117|NCT01185834|3837457|B1|||Age||years|Mean|34.1|34.1|Standard Deviation|10.3|10.3|||
4016118|NCT01185821|3837462|B6|||Expanded disability status scale (EDSS)|Disability progression was assessed based on the EDSS scores ranging from 0 (normal) to 10 (death due to MS)|units on a scale|Mean|2.07|2.07|Standard Deviation|1.190|1.19|||
4016119|NCT01185821|3837463|B5|||Expanded disability status scale (EDSS)|Disability progression was assessed based on the EDSS scores ranging from 0 (normal) to 10 (death due to MS)|units on a scale|Mean|2.22|2.22|Standard Deviation|1.258|1.258|||
4016120|NCT01185821|3837464|B4|||Expanded disability status scale (EDSS)|Disability progression was assessed based on the EDSS scores ranging from 0 (normal) to 10 (death due to MS)|units on a scale|Mean|1.88|1.88|Standard Deviation|1.374|1.374|||
4016121|NCT01185821|3837465|B3|||Expanded disability status scale (EDSS)|Disability progression was assessed based on the EDSS scores ranging from 0 (normal) to 10 (death due to MS)|units on a scale|Mean|1.95|1.95|Standard Deviation|1.096|1.096|||
4016122|NCT01185821|3837466|B2|||Expanded disability status scale (EDSS)|Disability progression was assessed based on the EDSS scores ranging from 0 (normal) to 10 (death due to MS)|units on a scale|Mean|2.19|2.19|Standard Deviation|1.278|1.278|||
4016123|NCT01185821|3837467|B1|||Expanded disability status scale (EDSS)|Disability progression was assessed based on the EDSS scores ranging from 0 (normal) to 10 (death due to MS)|units on a scale|Mean|2.03|2.03|Standard Deviation|0.960|0.96|||
4016124|NCT01185821|3837462|B6||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4016125|NCT01185821|3837463|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4016126|NCT01185821|3837464|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4016127|NCT01185821|3837465|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4016128|NCT01185821|3837466|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4016129|NCT01185821|3837467|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4016130|NCT01185821|3837462|B6||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4016131|NCT01185821|3837463|B5||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4016132|NCT01185821|3837464|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4016133|NCT01185821|3837465|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4016134|NCT01185821|3837466|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4016135|NCT01185821|3837467|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4016136|NCT01185821|3837462|B6|||Age||years|Mean|35.7|35.7|Standard Deviation|8.59|8.59|||
4016137|NCT01185821|3837463|B5|||Age||years|Mean|37.2|37.2|Standard Deviation|8.42|8.42|||
4016138|NCT01185821|3837464|B4|||Age||years|Mean|35.2|35.2|Standard Deviation|9.10|9.1|||
4016139|NCT01185821|3837465|B3|||Age||years|Mean|34.0|34.0|Standard Deviation|7.57|7.57|||
4016140|NCT01185821|3837466|B2|||Age||years|Mean|35.1|35.1|Standard Deviation|9.16|9.16|||
4016141|NCT01185821|3837467|B1|||Age||years|Mean|36.8|36.8|Standard Deviation|9.09|9.09|||
4016142|NCT01185782|3837520|B3|4||Previous episodes of Ovarian hyperstimulation syndrome (OHSS)|OHSS is a syndrome which can manifest with enlarged ovaries, advanced ascites with increased vascular permeability, pleural fluid accumulation, hemoconcentration, and increased blood clotting. Episodes of OHSS are presented as values from 0 to 4 where 0 = no episodes to 4 = four episodes.|participants|Number|1|1.0||||||
4016143|NCT01185782|3837521|B2|4||Previous episodes of Ovarian hyperstimulation syndrome (OHSS)|OHSS is a syndrome which can manifest with enlarged ovaries, advanced ascites with increased vascular permeability, pleural fluid accumulation, hemoconcentration, and increased blood clotting. Episodes of OHSS are presented as values from 0 to 4 where 0 = no episodes to 4 = four episodes.|participants|Number|0|0.0||||||
4016144|NCT01185782|3837522|B1|4||Previous episodes of Ovarian hyperstimulation syndrome (OHSS)|OHSS is a syndrome which can manifest with enlarged ovaries, advanced ascites with increased vascular permeability, pleural fluid accumulation, hemoconcentration, and increased blood clotting. Episodes of OHSS are presented as values from 0 to 4 where 0 = no episodes to 4 = four episodes.|participants|Number|1|1.0||||||
4016176|NCT01185600|3837587|B2|||Annexin V+ microparticles|Annexin V+ microparticles are a marker for non-specific cell activation and apoptosis.|counts / uL|Mean|6637|6637.0|Standard Deviation|6518|6518.0|||
4016145|NCT01185782|3837520|B3|3||Previous episodes of Ovarian hyperstimulation syndrome (OHSS)|OHSS is a syndrome which can manifest with enlarged ovaries, advanced ascites with increased vascular permeability, pleural fluid accumulation, hemoconcentration, and increased blood clotting. Episodes of OHSS are presented as values from 0 to 4 where 0 = no episodes to 4 = four episodes.|participants|Number|1|1.0||||||
4016146|NCT01185782|3837521|B2|3||Previous episodes of Ovarian hyperstimulation syndrome (OHSS)|OHSS is a syndrome which can manifest with enlarged ovaries, advanced ascites with increased vascular permeability, pleural fluid accumulation, hemoconcentration, and increased blood clotting. Episodes of OHSS are presented as values from 0 to 4 where 0 = no episodes to 4 = four episodes.|participants|Number|0|0.0||||||
4016147|NCT01185782|3837522|B1|3||Previous episodes of Ovarian hyperstimulation syndrome (OHSS)|OHSS is a syndrome which can manifest with enlarged ovaries, advanced ascites with increased vascular permeability, pleural fluid accumulation, hemoconcentration, and increased blood clotting. Episodes of OHSS are presented as values from 0 to 4 where 0 = no episodes to 4 = four episodes.|participants|Number|1|1.0||||||
4016148|NCT01185782|3837520|B3|2||Previous episodes of Ovarian hyperstimulation syndrome (OHSS)|OHSS is a syndrome which can manifest with enlarged ovaries, advanced ascites with increased vascular permeability, pleural fluid accumulation, hemoconcentration, and increased blood clotting. Episodes of OHSS are presented as values from 0 to 4 where 0 = no episodes to 4 = four episodes.|participants|Number|5|5.0||||||
4016149|NCT01185782|3837521|B2|2||Previous episodes of Ovarian hyperstimulation syndrome (OHSS)|OHSS is a syndrome which can manifest with enlarged ovaries, advanced ascites with increased vascular permeability, pleural fluid accumulation, hemoconcentration, and increased blood clotting. Episodes of OHSS are presented as values from 0 to 4 where 0 = no episodes to 4 = four episodes.|participants|Number|3|3.0||||||
4016150|NCT01185782|3837522|B1|2||Previous episodes of Ovarian hyperstimulation syndrome (OHSS)|OHSS is a syndrome which can manifest with enlarged ovaries, advanced ascites with increased vascular permeability, pleural fluid accumulation, hemoconcentration, and increased blood clotting. Episodes of OHSS are presented as values from 0 to 4 where 0 = no episodes to 4 = four episodes.|participants|Number|2|2.0||||||
4016151|NCT01185782|3837520|B3|1||Previous episodes of Ovarian hyperstimulation syndrome (OHSS)|OHSS is a syndrome which can manifest with enlarged ovaries, advanced ascites with increased vascular permeability, pleural fluid accumulation, hemoconcentration, and increased blood clotting. Episodes of OHSS are presented as values from 0 to 4 where 0 = no episodes to 4 = four episodes.|participants|Number|19|19.0||||||
4016152|NCT01185782|3837521|B2|1||Previous episodes of Ovarian hyperstimulation syndrome (OHSS)|OHSS is a syndrome which can manifest with enlarged ovaries, advanced ascites with increased vascular permeability, pleural fluid accumulation, hemoconcentration, and increased blood clotting. Episodes of OHSS are presented as values from 0 to 4 where 0 = no episodes to 4 = four episodes.|participants|Number|10|10.0||||||
4016153|NCT01185782|3837522|B1|1||Previous episodes of Ovarian hyperstimulation syndrome (OHSS)|OHSS is a syndrome which can manifest with enlarged ovaries, advanced ascites with increased vascular permeability, pleural fluid accumulation, hemoconcentration, and increased blood clotting. Episodes of OHSS are presented as values from 0 to 4 where 0 = no episodes to 4 = four episodes.|participants|Number|9|9.0||||||
4016154|NCT01185782|3837520|B3|0||Previous episodes of Ovarian hyperstimulation syndrome (OHSS)|OHSS is a syndrome which can manifest with enlarged ovaries, advanced ascites with increased vascular permeability, pleural fluid accumulation, hemoconcentration, and increased blood clotting. Episodes of OHSS are presented as values from 0 to 4 where 0 = no episodes to 4 = four episodes.|participants|Number|235|235.0||||||
4016155|NCT01185782|3837521|B2|0||Previous episodes of Ovarian hyperstimulation syndrome (OHSS)|OHSS is a syndrome which can manifest with enlarged ovaries, advanced ascites with increased vascular permeability, pleural fluid accumulation, hemoconcentration, and increased blood clotting. Episodes of OHSS are presented as values from 0 to 4 where 0 = no episodes to 4 = four episodes.|participants|Number|119|119.0||||||
4016156|NCT01185782|3837522|B1|0||Previous episodes of Ovarian hyperstimulation syndrome (OHSS)|OHSS is a syndrome which can manifest with enlarged ovaries, advanced ascites with increased vascular permeability, pleural fluid accumulation, hemoconcentration, and increased blood clotting. Episodes of OHSS are presented as values from 0 to 4 where 0 = no episodes to 4 = four episodes.|participants|Number|116|116.0||||||
4016157|NCT01185782|3837520|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4016158|NCT01185782|3837521|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4016159|NCT01185782|3837522|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4016160|NCT01185782|3837520|B3||Female|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
4016161|NCT01185782|3837521|B2||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4016162|NCT01185782|3837522|B1||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4016163|NCT01185782|3837520|B3|||Age||years|Mean|31.6|31.6|Standard Deviation|3.8|3.8|||
4016164|NCT01185782|3837521|B2|||Age||years|Mean|31.6|31.6|Standard Deviation|3.8|3.8|||
4016165|NCT01185782|3837522|B1|||Age||years|Mean|31.6|31.6|Standard Deviation|3.8|3.8|||
4016166|NCT01185704|3837549|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4016167|NCT01185704|3837550|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4016168|NCT01185704|3837551|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4016169|NCT01185704|3837549|B3||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4016170|NCT01185704|3837550|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4016171|NCT01185704|3837551|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4016172|NCT01185704|3837549|B3|||Age||years|Mean|29.7|29.7|Standard Deviation|3.1|3.1|||
4016173|NCT01185704|3837550|B2|||Age||years|Mean|29.7|29.7|Standard Deviation|3.3|3.3|||
4016174|NCT01185704|3837551|B1|||Age||years|Mean|29.7|29.7|Standard Deviation|2.9|2.9|||
4016175|NCT01185600|3837586|B3|||Annexin V+ microparticles|Annexin V+ microparticles are a marker for non-specific cell activation and apoptosis.|counts / uL|Mean|7697|7697.0|Standard Deviation|8568|8568.0|||
4016225|NCT01185600|3837588|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4016177|NCT01185600|3837588|B1|||Annexin V+ microparticles|Annexin V+ microparticles are a marker for non-specific cell activation and apoptosis.|counts / uL|Mean|9171|9171.0|Standard Deviation|10710|10710.0|||
4016178|NCT01185600|3837586|B3|||CD62E+ endothelial microparticles|CD62E+ endothelial microparticles are a specific marker for endothelial activation and apoptosis.|counts / uL|Mean|296|296.0|Standard Deviation|435|435.0|||
4016179|NCT01185600|3837587|B2|||CD62E+ endothelial microparticles|CD62E+ endothelial microparticles are a specific marker for endothelial activation and apoptosis.|counts / uL|Mean|296|296.0|Standard Deviation|446|446.0|||
4016180|NCT01185600|3837588|B1|||CD62E+ endothelial microparticles|CD62E+ endothelial microparticles are a specific marker for endothelial activation and apoptosis.|counts / uL|Mean|297|297.0|Standard Deviation|430|430.0|||
4016181|NCT01185600|3837586|B3|||CD235a+ red cell microparticles|Cd235a+ red cell microparticles are a specific marker for red cell storage lesions. They may reflect the conditions of transfused RBC in circulation.|counts / uL|Mean|1927|1927.0|Standard Deviation|2029|2029.0|||
4016182|NCT01185600|3837587|B2|||CD235a+ red cell microparticles|Cd235a+ red cell microparticles are a specific marker for red cell storage lesions. They may reflect the conditions of transfused RBC in circulation.|counts / uL|Mean|1862|1862.0|Standard Deviation|1719|1719.0|||
4016183|NCT01185600|3837588|B1|||CD235a+ red cell microparticles|Cd235a+ red cell microparticles are a specific marker for red cell storage lesions. They may reflect the conditions of transfused RBC in circulation.|counts / uL|Mean|2017|2017.0|Standard Deviation|2414|2414.0|||
4016184|NCT01185600|3837586|B3|||CD41+ platelet microparticles|Cd41+ platelet microparticles is a specific biomarker for platelet activation|counts / uL|Mean|12009|12009.0|Standard Deviation|10279|10279.0|||
4016185|NCT01185600|3837587|B2|||CD41+ platelet microparticles|Cd41+ platelet microparticles is a specific biomarker for platelet activation|counts / uL|Mean|12118|12118.0|Standard Deviation|10517|10517.0|||
4016186|NCT01185600|3837588|B1|||CD41+ platelet microparticles|Cd41+ platelet microparticles is a specific biomarker for platelet activation|counts / uL|Mean|11858|11858.0|Standard Deviation|10066|10066.0|||
4016187|NCT01185600|3837586|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
4016188|NCT01185600|3837587|B2|United States||Region of Enrollment||participants|Number|59|59.0||||||
4016189|NCT01185600|3837588|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4016190|NCT01185600|3837586|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016191|NCT01185600|3837587|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016192|NCT01185600|3837588|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016193|NCT01185600|3837586|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016194|NCT01185600|3837587|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016195|NCT01185600|3837588|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016196|NCT01185600|3837586|B3||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4016197|NCT01185600|3837587|B2||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4016198|NCT01185600|3837588|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4016199|NCT01185600|3837586|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4016200|NCT01185600|3837587|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4016201|NCT01185600|3837588|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4016202|NCT01185600|3837586|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016203|NCT01185600|3837587|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016204|NCT01185600|3837588|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016205|NCT01185600|3837586|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4016206|NCT01185600|3837587|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4016207|NCT01185600|3837588|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016208|NCT01185600|3837586|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016209|NCT01185600|3837587|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016210|NCT01185600|3837588|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016211|NCT01185600|3837586|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016212|NCT01185600|3837587|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016213|NCT01185600|3837588|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016214|NCT01185600|3837586|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4016215|NCT01185600|3837587|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4016216|NCT01185600|3837588|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4016217|NCT01185600|3837586|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4016218|NCT01185600|3837587|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4016219|NCT01185600|3837588|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4016220|NCT01185600|3837586|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4016221|NCT01185600|3837587|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4016222|NCT01185600|3837588|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4016223|NCT01185600|3837586|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4016224|NCT01185600|3837587|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4016226|NCT01185600|3837586|B3|||Age||years|Mean|63.0|63.0|Standard Deviation|9.7|9.7|||
4016227|NCT01185600|3837587|B2|||Age||years|Mean|63.9|63.9|Standard Deviation|11.1|11.1|||
4016228|NCT01185600|3837588|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|7.1|7.1|||
4016229|NCT01185600|3837586|B3||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
4016230|NCT01185600|3837587|B2||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4016231|NCT01185600|3837588|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4016232|NCT01185600|3837586|B3||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4016233|NCT01185600|3837587|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4016234|NCT01185600|3837588|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4016235|NCT01185600|3837586|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4016236|NCT01185600|3837587|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4016237|NCT01185600|3837588|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4016238|NCT01185561|3837609|B3|||STAXI Anger Expression Subtest|The STAXI anger expression subtest is a 24-item scale measuring how anger is generally being experienced and expressed. Scores may range from 0 to 72 with higher scores indicating greater anger.|units on a scale|Mean|37.7|37.7|Standard Deviation|13.8|13.8|||
4016239|NCT01185561|3837610|B2|||STAXI Anger Expression Subtest|The STAXI anger expression subtest is a 24-item scale measuring how anger is generally being experienced and expressed. Scores may range from 0 to 72 with higher scores indicating greater anger.|units on a scale|Mean|34.7|34.7|Standard Deviation|13.9|13.9|||
4016240|NCT01185561|3837611|B1|||STAXI Anger Expression Subtest|The STAXI anger expression subtest is a 24-item scale measuring how anger is generally being experienced and expressed. Scores may range from 0 to 72 with higher scores indicating greater anger.|units on a scale|Mean|40.6|40.6|Standard Deviation|13.2|13.2|||
4016241|NCT01185561|3837609|B3|||STAI State Anxiety Subtest|The STAI state anxiety subtest is a 20-item scale measuring state anxiety. Scores may range from 20 to 80 with higher scores indicating greater state anxiety.|units on a scale|Mean|46.8|46.8|Standard Deviation|12.3|12.3|||
4016242|NCT01185561|3837610|B2|||STAI State Anxiety Subtest|The STAI state anxiety subtest is a 20-item scale measuring state anxiety. Scores may range from 20 to 80 with higher scores indicating greater state anxiety.|units on a scale|Mean|47.9|47.9|Standard Deviation|11.9|11.9|||
4016243|NCT01185561|3837611|B1|||STAI State Anxiety Subtest|The STAI state anxiety subtest is a 20-item scale measuring state anxiety. Scores may range from 20 to 80 with higher scores indicating greater state anxiety.|units on a scale|Mean|45.8|45.8|Standard Deviation|12.8|12.8|||
4016244|NCT01185561|3837609|B3|||STAI Trait Anxiety Subtest|The STAI trait anxiety subtest is a 20-item scale measuring state anxiety. Scores may range from 20 to 80 with higher scores indicating greater state anxiety.|units on a scale|Mean|51.0|51.0|Standard Deviation|9.4|9.4|||
4016245|NCT01185561|3837610|B2|||STAI Trait Anxiety Subtest|The STAI trait anxiety subtest is a 20-item scale measuring state anxiety. Scores may range from 20 to 80 with higher scores indicating greater state anxiety.|units on a scale|Mean|50.4|50.4|Standard Deviation|9.2|9.2|||
4016246|NCT01185561|3837611|B1|||STAI Trait Anxiety Subtest|The STAI trait anxiety subtest is a 20-item scale measuring state anxiety. Scores may range from 20 to 80 with higher scores indicating greater state anxiety.|units on a scale|Mean|51.6|51.6|Standard Deviation|9.8|9.8|||
4016247|NCT01185561|3837609|B3|||CES-D|The CES-D is a self-report questionnaire assessing frequency and severity of depression symptoms. Scores may range from 0 to 60, where higher scores indicate worse mood.|units on a scale|Mean|28.3|28.3|Standard Deviation|9.4|9.4|||
4016248|NCT01185561|3837610|B2|||CES-D|The CES-D is a self-report questionnaire assessing frequency and severity of depression symptoms. Scores may range from 0 to 60, where higher scores indicate worse mood.|units on a scale|Mean|28.9|28.9|Standard Deviation|9.5|9.5|||
4016249|NCT01185561|3837611|B1|||CES-D|The CES-D is a self-report questionnaire assessing frequency and severity of depression symptoms. Scores may range from 0 to 60, where higher scores indicate worse mood.|units on a scale|Mean|27.7|27.7|Standard Deviation|9.3|9.3|||
4016250|NCT01185561|3837609|B3|||Years Living with Diabetes||years|Mean|10.3|10.3|Standard Deviation|7.4|7.4|||
4016251|NCT01185561|3837610|B2|||Years Living with Diabetes||years|Mean|10.0|10.0|Standard Deviation|6.5|6.5|||
4016252|NCT01185561|3837611|B1|||Years Living with Diabetes||years|Mean|10.5|10.5|Standard Deviation|8.2|8.2|||
4016253|NCT01185561|3837609|B3|||Weight||pounds (lbs)|Mean|228.0|228.0|Standard Deviation|56.9|56.9|||
4016254|NCT01185561|3837610|B2|||Weight||pounds (lbs)|Mean|226.9|226.9|Standard Deviation|48.7|48.7|||
4016255|NCT01185561|3837611|B1|||Weight||pounds (lbs)|Mean|229.1|229.1|Standard Deviation|64.4|64.4|||
4016256|NCT01185561|3837609|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016257|NCT01185561|3837610|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016258|NCT01185561|3837611|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016259|NCT01185561|3837609|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016260|NCT01185561|3837610|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016261|NCT01185561|3837611|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016262|NCT01185561|3837609|B3||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4016263|NCT01185561|3837610|B2||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4016264|NCT01185561|3837611|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4016265|NCT01185561|3837609|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4016266|NCT01185561|3837610|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4016267|NCT01185561|3837611|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4016268|NCT01185561|3837609|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016269|NCT01185561|3837610|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016270|NCT01185561|3837611|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016271|NCT01185561|3837609|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016272|NCT01185561|3837610|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016273|NCT01185561|3837611|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016274|NCT01185561|3837609|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016275|NCT01185561|3837610|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016276|NCT01185561|3837611|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016277|NCT01185561|3837609|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016278|NCT01185561|3837610|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016279|NCT01185561|3837611|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016280|NCT01185561|3837609|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
4016281|NCT01185561|3837610|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4016282|NCT01185561|3837611|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4016283|NCT01185561|3837609|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4016284|NCT01185561|3837610|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4016285|NCT01185561|3837611|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4016286|NCT01185561|3837609|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4016287|NCT01185561|3837610|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4016288|NCT01185561|3837611|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4016289|NCT01185561|3837609|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4016290|NCT01185561|3837610|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4016291|NCT01185561|3837611|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4016292|NCT01185561|3837609|B3|||Age||years|Mean|54.4|54.4|Standard Deviation|8.6|8.6|||
4016293|NCT01185561|3837610|B2|||Age||years|Mean|54.0|54.0|Standard Deviation|8.4|8.4|||
4016294|NCT01185561|3837611|B1|||Age||years|Mean|54.8|54.8|Standard Deviation|8.8|8.8|||
4016295|NCT01185548|3837624|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4016296|NCT01185548|3837624|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016297|NCT01185548|3837624|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016298|NCT01185548|3837624|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4016299|NCT01185548|3837624|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016300|NCT01185548|3837624|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016301|NCT01185548|3837624|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016302|NCT01185548|3837624|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016303|NCT01185548|3837624|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4016304|NCT01185548|3837624|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4016305|NCT01185548|3837624|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4016306|NCT01185548|3837624|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4016307|NCT01185548|3837624|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4016308|NCT01185522|3837637|B1|Missing||Sex/Gender, Customized||participants|Number|7|7.0||||||
4016309|NCT01185522|3837637|B1|Male||Sex/Gender, Customized||participants|Number|125|125.0||||||
4016310|NCT01185522|3837637|B1|Female||Sex/Gender, Customized||participants|Number|561|561.0||||||
4016311|NCT01185522|3837637|B1|||Age||Year|Mean|55.65|55.65|Standard Deviation|13.09|13.09|||
4016312|NCT01185509|3837661|B3|Unknown||Progesterone Receptor Status at Metastatic Diagnosis||participants|Number|7|7.0||||||
4016313|NCT01185509|3837662|B2|Unknown||Progesterone Receptor Status at Metastatic Diagnosis||participants|Number|7|7.0||||||
4016314|NCT01185509|3837663|B1|Unknown||Progesterone Receptor Status at Metastatic Diagnosis||participants|Number|0|0.0||||||
4016315|NCT01185509|3837661|B3|Negative||Progesterone Receptor Status at Metastatic Diagnosis||participants|Number|16|16.0||||||
4016316|NCT01185509|3837662|B2|Negative||Progesterone Receptor Status at Metastatic Diagnosis||participants|Number|9|9.0||||||
4016317|NCT01185509|3837663|B1|Negative||Progesterone Receptor Status at Metastatic Diagnosis||participants|Number|7|7.0||||||
4016318|NCT01185509|3837661|B3|Positive||Progesterone Receptor Status at Metastatic Diagnosis||participants|Number|8|8.0||||||
4016319|NCT01185509|3837662|B2|Positive||Progesterone Receptor Status at Metastatic Diagnosis||participants|Number|4|4.0||||||
4016320|NCT01185509|3837663|B1|Positive||Progesterone Receptor Status at Metastatic Diagnosis||participants|Number|4|4.0||||||
4016321|NCT01185509|3837661|B3|Unknown||Estrogen Receptor Status at Metastatic Diagnosis||Participants|Count of Participants|7|7.0||||||
4016322|NCT01185509|3837662|B2|Unknown||Estrogen Receptor Status at Metastatic Diagnosis||Participants|Count of Participants|7|7.0||||||
4016323|NCT01185509|3837663|B1|Unknown||Estrogen Receptor Status at Metastatic Diagnosis||Participants|Count of Participants|0|0.0||||||
4016324|NCT01185509|3837661|B3|Negative||Estrogen Receptor Status at Metastatic Diagnosis||Participants|Count of Participants|7|7.0||||||
4016325|NCT01185509|3837662|B2|Negative||Estrogen Receptor Status at Metastatic Diagnosis||Participants|Count of Participants|5|5.0||||||
4016326|NCT01185509|3837663|B1|Negative||Estrogen Receptor Status at Metastatic Diagnosis||Participants|Count of Participants|2|2.0||||||
4016327|NCT01185509|3837661|B3|Positive||Estrogen Receptor Status at Metastatic Diagnosis||Participants|Count of Participants|17|17.0||||||
4016328|NCT01185509|3837662|B2|Positive||Estrogen Receptor Status at Metastatic Diagnosis||Participants|Count of Participants|8|8.0||||||
4016329|NCT01185509|3837663|B1|Positive||Estrogen Receptor Status at Metastatic Diagnosis||Participants|Count of Participants|9|9.0||||||
4016330|NCT01185509|3837661|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4016331|NCT01185509|3837662|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4016332|NCT01185509|3837663|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4016333|NCT01185509|3837661|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4016334|NCT01185509|3837662|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4016335|NCT01185509|3837663|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4016336|NCT01185509|3837661|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4016337|NCT01185509|3837662|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4016338|NCT01185509|3837663|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4016339|NCT01185509|3837661|B3|||Age||years|Median|54|54.0|Full Range|||26.0|78.0|
4016340|NCT01185509|3837662|B2|||Age||years|Median|54|54.0|Full Range|||34.0|66.0|
4016341|NCT01185509|3837663|B1|||Age||years|Median|50|50.0|Full Range|||26.0|78.0|
4016342|NCT01185353|3837674|B6|||Erythrocyte Sedimentation Rate (ESR)|ESR is a laboratory analyte that is an indicator of inflammation. Decreases represent reductions in inflammation.|millimeters/hour (mm/hr)|Mean|38.8|38.8|Standard Deviation|18.39|18.39|||
4016343|NCT01185353|3837675|B5|||Erythrocyte Sedimentation Rate (ESR)|ESR is a laboratory analyte that is an indicator of inflammation. Decreases represent reductions in inflammation.|millimeters/hour (mm/hr)|Mean|39.9|39.9|Standard Deviation|20.94|20.94|||
4016344|NCT01185353|3837676|B4|||Erythrocyte Sedimentation Rate (ESR)|ESR is a laboratory analyte that is an indicator of inflammation. Decreases represent reductions in inflammation.|millimeters/hour (mm/hr)|Mean|43.3|43.3|Standard Deviation|18.17|18.17|||
4016345|NCT01185353|3837677|B3|||Erythrocyte Sedimentation Rate (ESR)|ESR is a laboratory analyte that is an indicator of inflammation. Decreases represent reductions in inflammation.|millimeters/hour (mm/hr)|Mean|35.4|35.4|Standard Deviation|17.16|17.16|||
4016346|NCT01185353|3837678|B2|||Erythrocyte Sedimentation Rate (ESR)|ESR is a laboratory analyte that is an indicator of inflammation. Decreases represent reductions in inflammation.|millimeters/hour (mm/hr)|Mean|36.5|36.5|Standard Deviation|14.62|14.62|||
4016347|NCT01185353|3837679|B1|||Erythrocyte Sedimentation Rate (ESR)|ESR is a laboratory analyte that is an indicator of inflammation. Decreases represent reductions in inflammation.|millimeters/hour (mm/hr)|Mean|38.2|38.2|Standard Deviation|17.57|17.57|||
4016348|NCT01185353|3837674|B6|||High Sensitivity C-Reactive Protein (hsCRP)|HsCRP is a laboratory analyte that is an indicator of inflammation. Decreases in hsCRP represent reductions in inflammation.|milligrams/liter (mg/L)|Mean|12.81|12.81|Standard Deviation|19.402|19.402|||
4016349|NCT01185353|3837675|B5|||High Sensitivity C-Reactive Protein (hsCRP)|HsCRP is a laboratory analyte that is an indicator of inflammation. Decreases in hsCRP represent reductions in inflammation.|milligrams/liter (mg/L)|Mean|14.03|14.03|Standard Deviation|23.527|23.527|||
4016350|NCT01185353|3837676|B4|||High Sensitivity C-Reactive Protein (hsCRP)|HsCRP is a laboratory analyte that is an indicator of inflammation. Decreases in hsCRP represent reductions in inflammation.|milligrams/liter (mg/L)|Mean|14.32|14.32|Standard Deviation|15.602|15.602|||
4016351|NCT01185353|3837677|B3|||High Sensitivity C-Reactive Protein (hsCRP)|HsCRP is a laboratory analyte that is an indicator of inflammation. Decreases in hsCRP represent reductions in inflammation.|milligrams/liter (mg/L)|Mean|11.39|11.39|Standard Deviation|16.941|16.941|||
4016352|NCT01185353|3837678|B2|||High Sensitivity C-Reactive Protein (hsCRP)|HsCRP is a laboratory analyte that is an indicator of inflammation. Decreases in hsCRP represent reductions in inflammation.|milligrams/liter (mg/L)|Mean|12.02|12.02|Standard Deviation|22.111|22.111|||
4016353|NCT01185353|3837679|B1|||High Sensitivity C-Reactive Protein (hsCRP)|HsCRP is a laboratory analyte that is an indicator of inflammation. Decreases in hsCRP represent reductions in inflammation.|milligrams/liter (mg/L)|Mean|11.22|11.22|Standard Deviation|12.410|12.41|||
4016354|NCT01185353|3837674|B6|||Swollen Joint Counts (SJC)|SJC is the number of swollen joints determined for each participant by examination of 66 joints. Joints were classified as either swollen or not swollen. Swelling was defined as palpable fluctuating synovitis of the joint.|number of joints|Mean|15.8|15.8|Standard Deviation|8.13|8.13|||
4016355|NCT01185353|3837675|B5|||Swollen Joint Counts (SJC)|SJC is the number of swollen joints determined for each participant by examination of 66 joints. Joints were classified as either swollen or not swollen. Swelling was defined as palpable fluctuating synovitis of the joint.|number of joints|Mean|15.8|15.8|Standard Deviation|8.64|8.64|||
4016356|NCT01185353|3837676|B4|||Swollen Joint Counts (SJC)|SJC is the number of swollen joints determined for each participant by examination of 66 joints. Joints were classified as either swollen or not swollen. Swelling was defined as palpable fluctuating synovitis of the joint.|number of joints|Mean|16.1|16.1|Standard Deviation|7.92|7.92|||
4016357|NCT01185353|3837677|B3|||Swollen Joint Counts (SJC)|SJC is the number of swollen joints determined for each participant by examination of 66 joints. Joints were classified as either swollen or not swollen. Swelling was defined as palpable fluctuating synovitis of the joint.|number of joints|Mean|14.8|14.8|Standard Deviation|7.54|7.54|||
4016358|NCT01185353|3837678|B2|||Swollen Joint Counts (SJC)|SJC is the number of swollen joints determined for each participant by examination of 66 joints. Joints were classified as either swollen or not swollen. Swelling was defined as palpable fluctuating synovitis of the joint.|number of joints|Mean|17.0|17.0|Standard Deviation|9.32|9.32|||
4016399|NCT01185353|3837677|B3|Poland||Region of Enrollment||participants|Number|6|6.0||||||
4016400|NCT01185353|3837678|B2|Poland||Region of Enrollment||participants|Number|5|5.0||||||
4016359|NCT01185353|3837679|B1|||Swollen Joint Counts (SJC)|SJC is the number of swollen joints determined for each participant by examination of 66 joints. Joints were classified as either swollen or not swollen. Swelling was defined as palpable fluctuating synovitis of the joint.|number of joints|Mean|15.2|15.2|Standard Deviation|6.55|6.55|||
4016360|NCT01185353|3837674|B6|||Tender Joint Counts (TJC)|TJC is the number of tender and painful joints determined for each participant by examination of 68 joints. Joints were assessed by pressure and joint manipulation on physical examination. Participants were asked for pain sensations on these manipulations and watched for spontaneous pain reactions. Any positive response on pressure, movement, or both was translated into a single tender-versus-nontender dichotomy.|number of joints|Mean|22.2|22.2|Standard Deviation|12.38|12.38|||
4016361|NCT01185353|3837675|B5|||Tender Joint Counts (TJC)|TJC is the number of tender and painful joints determined for each participant by examination of 68 joints. Joints were assessed by pressure and joint manipulation on physical examination. Participants were asked for pain sensations on these manipulations and watched for spontaneous pain reactions. Any positive response on pressure, movement, or both was translated into a single tender-versus-nontender dichotomy.|number of joints|Mean|22.2|22.2|Standard Deviation|12.06|12.06|||
4016362|NCT01185353|3837676|B4|||Tender Joint Counts (TJC)|TJC is the number of tender and painful joints determined for each participant by examination of 68 joints. Joints were assessed by pressure and joint manipulation on physical examination. Participants were asked for pain sensations on these manipulations and watched for spontaneous pain reactions. Any positive response on pressure, movement, or both was translated into a single tender-versus-nontender dichotomy.|number of joints|Mean|24.4|24.4|Standard Deviation|13.76|13.76|||
4016363|NCT01185353|3837677|B3|||Tender Joint Counts (TJC)|TJC is the number of tender and painful joints determined for each participant by examination of 68 joints. Joints were assessed by pressure and joint manipulation on physical examination. Participants were asked for pain sensations on these manipulations and watched for spontaneous pain reactions. Any positive response on pressure, movement, or both was translated into a single tender-versus-nontender dichotomy.|number of joints|Mean|19.9|19.9|Standard Deviation|12.71|12.71|||
4016364|NCT01185353|3837678|B2|||Tender Joint Counts (TJC)|TJC is the number of tender and painful joints determined for each participant by examination of 68 joints. Joints were assessed by pressure and joint manipulation on physical examination. Participants were asked for pain sensations on these manipulations and watched for spontaneous pain reactions. Any positive response on pressure, movement, or both was translated into a single tender-versus-nontender dichotomy.|number of joints|Mean|23.0|23.0|Standard Deviation|12.60|12.6|||
4016365|NCT01185353|3837679|B1|||Tender Joint Counts (TJC)|TJC is the number of tender and painful joints determined for each participant by examination of 68 joints. Joints were assessed by pressure and joint manipulation on physical examination. Participants were asked for pain sensations on these manipulations and watched for spontaneous pain reactions. Any positive response on pressure, movement, or both was translated into a single tender-versus-nontender dichotomy.|number of joints|Mean|21.4|21.4|Standard Deviation|10.90|10.9|||
4016366|NCT01185353|3837674|B6|||Duration of Rheumatoid Arthritis||years|Mean|5.62|5.62|Standard Deviation|4.401|4.401|||
4016367|NCT01185353|3837675|B5|||Duration of Rheumatoid Arthritis||years|Mean|5.40|5.4|Standard Deviation|4.283|4.283|||
4016368|NCT01185353|3837676|B4|||Duration of Rheumatoid Arthritis||years|Mean|6.63|6.63|Standard Deviation|5.048|5.048|||
4016369|NCT01185353|3837677|B3|||Duration of Rheumatoid Arthritis||years|Mean|5.28|5.28|Standard Deviation|4.466|4.466|||
4016370|NCT01185353|3837678|B2|||Duration of Rheumatoid Arthritis||years|Mean|5.53|5.53|Standard Deviation|4.377|4.377|||
4016371|NCT01185353|3837679|B1|||Duration of Rheumatoid Arthritis||years|Mean|5.45|5.45|Standard Deviation|3.885|3.885|||
4016372|NCT01185353|3837674|B6|India||Region of Enrollment||participants|Number|43|43.0||||||
4016373|NCT01185353|3837675|B5|India||Region of Enrollment||participants|Number|14|14.0||||||
4016374|NCT01185353|3837676|B4|India||Region of Enrollment||participants|Number|7|7.0||||||
4016375|NCT01185353|3837677|B3|India||Region of Enrollment||participants|Number|7|7.0||||||
4016376|NCT01185353|3837678|B2|India||Region of Enrollment||participants|Number|8|8.0||||||
4016377|NCT01185353|3837679|B1|India||Region of Enrollment||participants|Number|7|7.0||||||
4016378|NCT01185353|3837674|B6|Romania||Region of Enrollment||participants|Number|11|11.0||||||
4016379|NCT01185353|3837675|B5|Romania||Region of Enrollment||participants|Number|3|3.0||||||
4016380|NCT01185353|3837676|B4|Romania||Region of Enrollment||participants|Number|3|3.0||||||
4016381|NCT01185353|3837677|B3|Romania||Region of Enrollment||participants|Number|1|1.0||||||
4016382|NCT01185353|3837678|B2|Romania||Region of Enrollment||participants|Number|2|2.0||||||
4016383|NCT01185353|3837679|B1|Romania||Region of Enrollment||participants|Number|2|2.0||||||
4016384|NCT01185353|3837674|B6|Croatia||Region of Enrollment||participants|Number|7|7.0||||||
4016385|NCT01185353|3837675|B5|Croatia||Region of Enrollment||participants|Number|5|5.0||||||
4016386|NCT01185353|3837676|B4|Croatia||Region of Enrollment||participants|Number|1|1.0||||||
4016387|NCT01185353|3837677|B3|Croatia||Region of Enrollment||participants|Number|0|0.0||||||
4016388|NCT01185353|3837678|B2|Croatia||Region of Enrollment||participants|Number|1|1.0||||||
4016389|NCT01185353|3837679|B1|Croatia||Region of Enrollment||participants|Number|0|0.0||||||
4016390|NCT01185353|3837674|B6|Ukraine||Region of Enrollment||participants|Number|29|29.0||||||
4016391|NCT01185353|3837675|B5|Ukraine||Region of Enrollment||participants|Number|9|9.0||||||
4016392|NCT01185353|3837676|B4|Ukraine||Region of Enrollment||participants|Number|3|3.0||||||
4016393|NCT01185353|3837677|B3|Ukraine||Region of Enrollment||participants|Number|5|5.0||||||
4016394|NCT01185353|3837678|B2|Ukraine||Region of Enrollment||participants|Number|6|6.0||||||
4016395|NCT01185353|3837679|B1|Ukraine||Region of Enrollment||participants|Number|6|6.0||||||
4016396|NCT01185353|3837674|B6|Poland||Region of Enrollment||participants|Number|33|33.0||||||
4016397|NCT01185353|3837675|B5|Poland||Region of Enrollment||participants|Number|11|11.0||||||
4016398|NCT01185353|3837676|B4|Poland||Region of Enrollment||participants|Number|7|7.0||||||
4016401|NCT01185353|3837679|B1|Poland||Region of Enrollment||participants|Number|4|4.0||||||
4016402|NCT01185353|3837674|B6|Mexico||Region of Enrollment||participants|Number|47|47.0||||||
4016403|NCT01185353|3837675|B5|Mexico||Region of Enrollment||participants|Number|16|16.0||||||
4016404|NCT01185353|3837676|B4|Mexico||Region of Enrollment||participants|Number|8|8.0||||||
4016405|NCT01185353|3837677|B3|Mexico||Region of Enrollment||participants|Number|8|8.0||||||
4016406|NCT01185353|3837678|B2|Mexico||Region of Enrollment||participants|Number|8|8.0||||||
4016407|NCT01185353|3837679|B1|Mexico||Region of Enrollment||participants|Number|7|7.0||||||
4016408|NCT01185353|3837674|B6|Czech Republic||Region of Enrollment||participants|Number|23|23.0||||||
4016409|NCT01185353|3837675|B5|Czech Republic||Region of Enrollment||participants|Number|7|7.0||||||
4016410|NCT01185353|3837676|B4|Czech Republic||Region of Enrollment||participants|Number|3|3.0||||||
4016411|NCT01185353|3837677|B3|Czech Republic||Region of Enrollment||participants|Number|6|6.0||||||
4016412|NCT01185353|3837678|B2|Czech Republic||Region of Enrollment||participants|Number|3|3.0||||||
4016413|NCT01185353|3837679|B1|Czech Republic||Region of Enrollment||participants|Number|4|4.0||||||
4016414|NCT01185353|3837674|B6|Hungary||Region of Enrollment||participants|Number|13|13.0||||||
4016415|NCT01185353|3837675|B5|Hungary||Region of Enrollment||participants|Number|2|2.0||||||
4016416|NCT01185353|3837676|B4|Hungary||Region of Enrollment||participants|Number|2|2.0||||||
4016417|NCT01185353|3837677|B3|Hungary||Region of Enrollment||participants|Number|3|3.0||||||
4016418|NCT01185353|3837678|B2|Hungary||Region of Enrollment||participants|Number|3|3.0||||||
4016419|NCT01185353|3837679|B1|Hungary||Region of Enrollment||participants|Number|3|3.0||||||
4016420|NCT01185353|3837674|B6|United States||Region of Enrollment||participants|Number|95|95.0||||||
4016421|NCT01185353|3837675|B5|United States||Region of Enrollment||participants|Number|31|31.0||||||
4016422|NCT01185353|3837676|B4|United States||Region of Enrollment||participants|Number|16|16.0||||||
4016423|NCT01185353|3837677|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4016424|NCT01185353|3837678|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4016425|NCT01185353|3837679|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4016426|NCT01185353|3837674|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016427|NCT01185353|3837675|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016428|NCT01185353|3837676|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016429|NCT01185353|3837677|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016430|NCT01185353|3837678|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016431|NCT01185353|3837679|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016432|NCT01185353|3837674|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016433|NCT01185353|3837675|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016434|NCT01185353|3837676|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016435|NCT01185353|3837677|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016436|NCT01185353|3837678|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016437|NCT01185353|3837679|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016438|NCT01185353|3837674|B6||White|Race (NIH/OMB)||Participants|Count of Participants|224|224.0||||||
4016439|NCT01185353|3837675|B5||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4016440|NCT01185353|3837676|B4||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4016441|NCT01185353|3837677|B3||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4016442|NCT01185353|3837678|B2||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4016443|NCT01185353|3837679|B1||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4016444|NCT01185353|3837674|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4016445|NCT01185353|3837675|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4016446|NCT01185353|3837676|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4016447|NCT01185353|3837677|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4016448|NCT01185353|3837678|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4016449|NCT01185353|3837679|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016450|NCT01185353|3837674|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016451|NCT01185353|3837675|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016452|NCT01185353|3837676|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016453|NCT01185353|3837677|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016454|NCT01185353|3837678|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016455|NCT01185353|3837679|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016456|NCT01185353|3837674|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4016457|NCT01185353|3837675|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4016458|NCT01185353|3837676|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4016459|NCT01185353|3837677|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4016460|NCT01185353|3837678|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4016461|NCT01185353|3837679|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4016462|NCT01185353|3837674|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4016463|NCT01185353|3837675|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4016464|NCT01185353|3837676|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4016465|NCT01185353|3837677|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4016466|NCT01185353|3837678|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4016467|NCT01185353|3837679|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4016468|NCT01185353|3837674|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4016469|NCT01185353|3837675|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4016470|NCT01185353|3837676|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4016471|NCT01185353|3837677|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4016472|NCT01185353|3837678|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4016473|NCT01185353|3837679|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4016474|NCT01185353|3837674|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|227|227.0||||||
4016475|NCT01185353|3837675|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
4016476|NCT01185353|3837676|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4016477|NCT01185353|3837677|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4016478|NCT01185353|3837678|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4016479|NCT01185353|3837679|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4016480|NCT01185353|3837674|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4016481|NCT01185353|3837675|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4016482|NCT01185353|3837676|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4016483|NCT01185353|3837677|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4016484|NCT01185353|3837678|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4016485|NCT01185353|3837679|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4016486|NCT01185353|3837674|B6||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4016487|NCT01185353|3837675|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4016488|NCT01185353|3837676|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4016489|NCT01185353|3837677|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4016490|NCT01185353|3837678|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4016491|NCT01185353|3837679|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4016492|NCT01185353|3837674|B6||Female|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
4016493|NCT01185353|3837675|B5||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4016494|NCT01185353|3837676|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4016495|NCT01185353|3837677|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4016496|NCT01185353|3837678|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4016497|NCT01185353|3837679|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4016498|NCT01185353|3837674|B6|||Age||years|Mean|51.2|51.2|Standard Deviation|11.71|11.71|||
4016499|NCT01185353|3837675|B5|||Age||years|Mean|49.2|49.2|Standard Deviation|12.15|12.15|||
4016500|NCT01185353|3837676|B4|||Age||years|Mean|52.7|52.7|Standard Deviation|10.91|10.91|||
4016501|NCT01185353|3837677|B3|||Age||years|Mean|52.5|52.5|Standard Deviation|10.42|10.42|||
4016502|NCT01185353|3837678|B2|||Age||years|Mean|50.7|50.7|Standard Deviation|13.12|13.12|||
4016503|NCT01185353|3837679|B1|||Age||years|Mean|53.1|53.1|Standard Deviation|11.07|11.07|||
4016504|NCT01185340|3837846|B4|Sweden||Region of Enrollment||Participants|Count of Participants|116|116.0||||||
4016505|NCT01185340|3837847|B3|Sweden||Region of Enrollment||Participants|Count of Participants|77|77.0||||||
4016506|NCT01185340|3837848|B2|Sweden||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4016507|NCT01185340|3837849|B1|Sweden||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
4016508|NCT01185340|3837846|B4|United Kingdom||Region of Enrollment||Participants|Count of Participants|64|64.0||||||
4016509|NCT01185340|3837847|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4016510|NCT01185340|3837848|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4016511|NCT01185340|3837849|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4016512|NCT01185340|3837846|B4|Germany||Region of Enrollment||Participants|Count of Participants|216|216.0||||||
4016513|NCT01185340|3837847|B3|Germany||Region of Enrollment||Participants|Count of Participants|95|95.0||||||
4016514|NCT01185340|3837848|B2|Germany||Region of Enrollment||Participants|Count of Participants|63|63.0||||||
4016515|NCT01185340|3837849|B1|Germany||Region of Enrollment||Participants|Count of Participants|58|58.0||||||
4016516|NCT01185340|3837846|B4|Australia||Region of Enrollment||Participants|Count of Participants|126|126.0||||||
4016517|NCT01185340|3837847|B3|Australia||Region of Enrollment||Participants|Count of Participants|84|84.0||||||
4016518|NCT01185340|3837848|B2|Australia||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4016519|NCT01185340|3837849|B1|Australia||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4016520|NCT01185340|3837846|B4|Austria||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
4016521|NCT01185340|3837847|B3|Austria||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4016522|NCT01185340|3837848|B2|Austria||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4016523|NCT01185340|3837849|B1|Austria||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4016524|NCT01185340|3837846|B4|Belgium||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
4016525|NCT01185340|3837847|B3|Belgium||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4016526|NCT01185340|3837848|B2|Belgium||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4016527|NCT01185340|3837849|B1|Belgium||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4016528|NCT01185340|3837846|B4|United States||Region of Enrollment||Participants|Count of Participants|377|377.0||||||
4016529|NCT01185340|3837847|B3|United States||Region of Enrollment||Participants|Count of Participants|195|195.0||||||
4016530|NCT01185340|3837848|B2|United States||Region of Enrollment||Participants|Count of Participants|89|89.0||||||
4016531|NCT01185340|3837849|B1|United States||Region of Enrollment||Participants|Count of Participants|93|93.0||||||
4016532|NCT01185340|3837846|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4016533|NCT01185340|3837847|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4016534|NCT01185340|3837848|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016535|NCT01185340|3837849|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016536|NCT01185340|3837846|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4016537|NCT01185340|3837847|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4016538|NCT01185340|3837848|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4016539|NCT01185340|3837849|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4016540|NCT01185340|3837846|B4||White|Race (NIH/OMB)||Participants|Count of Participants|849|849.0||||||
4016541|NCT01185340|3837847|B3||White|Race (NIH/OMB)||Participants|Count of Participants|457|457.0||||||
4016542|NCT01185340|3837848|B2||White|Race (NIH/OMB)||Participants|Count of Participants|185|185.0||||||
4016543|NCT01185340|3837849|B1||White|Race (NIH/OMB)||Participants|Count of Participants|207|207.0||||||
4016544|NCT01185340|3837846|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
4016545|NCT01185340|3837847|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4016546|NCT01185340|3837848|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4016547|NCT01185340|3837849|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4016548|NCT01185340|3837846|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016549|NCT01185340|3837847|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016550|NCT01185340|3837848|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016551|NCT01185340|3837849|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016552|NCT01185340|3837846|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4016553|NCT01185340|3837847|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4016554|NCT01185340|3837848|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4016555|NCT01185340|3837849|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4016556|NCT01185340|3837846|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4016557|NCT01185340|3837847|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4016558|NCT01185340|3837848|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016559|NCT01185340|3837849|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016560|NCT01185340|3837846|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|214|214.0||||||
4016561|NCT01185340|3837847|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|118|118.0||||||
4016562|NCT01185340|3837848|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4016563|NCT01185340|3837849|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4016564|NCT01185340|3837846|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|692|692.0||||||
4016565|NCT01185340|3837847|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|370|370.0||||||
4016566|NCT01185340|3837848|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|158|158.0||||||
4016567|NCT01185340|3837849|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|164|164.0||||||
4016568|NCT01185340|3837846|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4016569|NCT01185340|3837847|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4016570|NCT01185340|3837848|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4016571|NCT01185340|3837849|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4016572|NCT01185340|3837846|B4||Male|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
4016573|NCT01185340|3837847|B3||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4016574|NCT01185340|3837848|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4016575|NCT01185340|3837849|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4016576|NCT01185340|3837846|B4||Female|Sex: Female, Male||Participants|Count of Participants|654|654.0||||||
4016577|NCT01185340|3837847|B3||Female|Sex: Female, Male||Participants|Count of Participants|354|354.0||||||
4016578|NCT01185340|3837848|B2||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4016579|NCT01185340|3837849|B1||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4016580|NCT01185340|3837846|B4|||Age||years|Mean|47.84|47.84|Standard Deviation|12.21|12.21|||
4016581|NCT01185340|3837847|B3|||Age||years|Mean|47.39|47.39|Standard Deviation|12.68|12.68|||
4016582|NCT01185340|3837848|B2|||Age||years|Mean|48.44|48.44|Standard Deviation|11.39|11.39|||
4016583|NCT01185340|3837849|B1|||Age||years|Mean|48.29|48.29|Standard Deviation|11.90|11.9|||
4016584|NCT01185301|3837900|B5|||Health Assessment Questionnaire - Disability Index (HAQ-DI)|HAQ-DI consists of 20 questions in 8 domains: dressing/grooming, arising, eating, walking, hygiene, reach, grip, and daily activities. Participants assessed their ability to do each task over the past week as: without any difficulty (0); with some difficulty (1); with much difficulty (2); unable to do (3). Scores on each task were summed and averaged to provide an overall score from 0 to 3, where 0=no disability and 3=very severe, high-dependency disability. Baseline values are presented for 96, 98, 97, 98 participants in the 2.5 mg, 5 mg, 10 mg, and 20 mg treatment groups, respectively.|units on a scale|Mean|1.57|1.57|Standard Deviation|0.670|0.67|||
4016585|NCT01185301|3837901|B4|||Health Assessment Questionnaire - Disability Index (HAQ-DI)|HAQ-DI consists of 20 questions in 8 domains: dressing/grooming, arising, eating, walking, hygiene, reach, grip, and daily activities. Participants assessed their ability to do each task over the past week as: without any difficulty (0); with some difficulty (1); with much difficulty (2); unable to do (3). Scores on each task were summed and averaged to provide an overall score from 0 to 3, where 0=no disability and 3=very severe, high-dependency disability. Baseline values are presented for 96, 98, 97, 98 participants in the 2.5 mg, 5 mg, 10 mg, and 20 mg treatment groups, respectively.|units on a scale|Mean|1.58|1.58|Standard Deviation|0.653|0.653|||
4016586|NCT01185301|3837902|B3|||Health Assessment Questionnaire - Disability Index (HAQ-DI)|HAQ-DI consists of 20 questions in 8 domains: dressing/grooming, arising, eating, walking, hygiene, reach, grip, and daily activities. Participants assessed their ability to do each task over the past week as: without any difficulty (0); with some difficulty (1); with much difficulty (2); unable to do (3). Scores on each task were summed and averaged to provide an overall score from 0 to 3, where 0=no disability and 3=very severe, high-dependency disability. Baseline values are presented for 96, 98, 97, 98 participants in the 2.5 mg, 5 mg, 10 mg, and 20 mg treatment groups, respectively.|units on a scale|Mean|1.62|1.62|Standard Deviation|0.667|0.667|||
4016587|NCT01185301|3837903|B2|||Health Assessment Questionnaire - Disability Index (HAQ-DI)|HAQ-DI consists of 20 questions in 8 domains: dressing/grooming, arising, eating, walking, hygiene, reach, grip, and daily activities. Participants assessed their ability to do each task over the past week as: without any difficulty (0); with some difficulty (1); with much difficulty (2); unable to do (3). Scores on each task were summed and averaged to provide an overall score from 0 to 3, where 0=no disability and 3=very severe, high-dependency disability. Baseline values are presented for 96, 98, 97, 98 participants in the 2.5 mg, 5 mg, 10 mg, and 20 mg treatment groups, respectively.|units on a scale|Mean|1.57|1.57|Standard Deviation|0.624|0.624|||
4016588|NCT01185301|3837904|B1|||Health Assessment Questionnaire - Disability Index (HAQ-DI)|HAQ-DI consists of 20 questions in 8 domains: dressing/grooming, arising, eating, walking, hygiene, reach, grip, and daily activities. Participants assessed their ability to do each task over the past week as: without any difficulty (0); with some difficulty (1); with much difficulty (2); unable to do (3). Scores on each task were summed and averaged to provide an overall score from 0 to 3, where 0=no disability and 3=very severe, high-dependency disability. Baseline values are presented for 96, 98, 97, 98 participants in the 2.5 mg, 5 mg, 10 mg, and 20 mg treatment groups, respectively.|units on a scale|Mean|1.49|1.49|Standard Deviation|0.737|0.737|||
4016589|NCT01185301|3837900|B5|||Modified Total Sharp Score (mTSS)|MTSS is a measure of change in joint health from digitized images of radiographs of hands and feet. Joints were scored for erosions on a scale of 0 (no damage) to 5 (complete collapse) and joint space narrowing on a scale of 0 (no damage) to 4 (ankylosis or complete dislocation). Erosion scores and narrowing scores were added to obtain the mTSS (range = 0 [normal] to 398 [maximal disease]). Baseline values are presented for 96, 98, 98, 95 participants in the 2.5 mg, 5 mg, 10 mg, and 20 mg treatment groups, respectively.|score|Mean|9.92|9.92|Standard Deviation|12.005|12.005|||
4016590|NCT01185301|3837901|B4|||Modified Total Sharp Score (mTSS)|MTSS is a measure of change in joint health from digitized images of radiographs of hands and feet. Joints were scored for erosions on a scale of 0 (no damage) to 5 (complete collapse) and joint space narrowing on a scale of 0 (no damage) to 4 (ankylosis or complete dislocation). Erosion scores and narrowing scores were added to obtain the mTSS (range = 0 [normal] to 398 [maximal disease]). Baseline values are presented for 96, 98, 98, 95 participants in the 2.5 mg, 5 mg, 10 mg, and 20 mg treatment groups, respectively.|score|Mean|10.55|10.55|Standard Deviation|12.852|12.852|||
4016591|NCT01185301|3837902|B3|||Modified Total Sharp Score (mTSS)|MTSS is a measure of change in joint health from digitized images of radiographs of hands and feet. Joints were scored for erosions on a scale of 0 (no damage) to 5 (complete collapse) and joint space narrowing on a scale of 0 (no damage) to 4 (ankylosis or complete dislocation). Erosion scores and narrowing scores were added to obtain the mTSS (range = 0 [normal] to 398 [maximal disease]). Baseline values are presented for 96, 98, 98, 95 participants in the 2.5 mg, 5 mg, 10 mg, and 20 mg treatment groups, respectively.|score|Mean|10.76|10.76|Standard Deviation|13.017|13.017|||
4016623|NCT01185301|3837904|B1|||Age||years|Mean|52.0|52.0|Standard Deviation|13.19|13.19|||
4016624|NCT01185288|3837965|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4016625|NCT01185288|3837966|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4016626|NCT01185288|3837967|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4016592|NCT01185301|3837903|B2|||Modified Total Sharp Score (mTSS)|MTSS is a measure of change in joint health from digitized images of radiographs of hands and feet. Joints were scored for erosions on a scale of 0 (no damage) to 5 (complete collapse) and joint space narrowing on a scale of 0 (no damage) to 4 (ankylosis or complete dislocation). Erosion scores and narrowing scores were added to obtain the mTSS (range = 0 [normal] to 398 [maximal disease]). Baseline values are presented for 96, 98, 98, 95 participants in the 2.5 mg, 5 mg, 10 mg, and 20 mg treatment groups, respectively.|score|Mean|8.60|8.6|Standard Deviation|8.912|8.912|||
4016593|NCT01185301|3837904|B1|||Modified Total Sharp Score (mTSS)|MTSS is a measure of change in joint health from digitized images of radiographs of hands and feet. Joints were scored for erosions on a scale of 0 (no damage) to 5 (complete collapse) and joint space narrowing on a scale of 0 (no damage) to 4 (ankylosis or complete dislocation). Erosion scores and narrowing scores were added to obtain the mTSS (range = 0 [normal] to 398 [maximal disease]). Baseline values are presented for 96, 98, 98, 95 participants in the 2.5 mg, 5 mg, 10 mg, and 20 mg treatment groups, respectively.|score|Mean|9.79|9.79|Standard Deviation|12.849|12.849|||
4016594|NCT01185301|3837900|B5|||28-Joint Disease Activity Score of C-reactive Protein (DAS28[CRP])|The DAS28(CRP) is a validated index of rheumatoid arthritis disease activity. Twenty-eight tender joint counts, 28 swollen joint counts, C-reactive protein, and general health are included in the DAS28 score. Scores on the DAS28 range from 0 to 10. A DAS28 score >5.1 indicates high disease activity, a DAS28 score <3.2 indicates low disease activity, and a DAS28 score <2.6 indicates clinical remission. Baseline values are presented for 96, 98, 95, 97 participants in the 2.5 mg, 5 mg, 10 mg, and 20 mg treatment groups, respectively.|scores on a scale|Mean|6.02|6.02|Standard Deviation|0.970|0.97|||
4016595|NCT01185301|3837901|B4|||28-Joint Disease Activity Score of C-reactive Protein (DAS28[CRP])|The DAS28(CRP) is a validated index of rheumatoid arthritis disease activity. Twenty-eight tender joint counts, 28 swollen joint counts, C-reactive protein, and general health are included in the DAS28 score. Scores on the DAS28 range from 0 to 10. A DAS28 score >5.1 indicates high disease activity, a DAS28 score <3.2 indicates low disease activity, and a DAS28 score <2.6 indicates clinical remission. Baseline values are presented for 96, 98, 95, 97 participants in the 2.5 mg, 5 mg, 10 mg, and 20 mg treatment groups, respectively.|scores on a scale|Mean|5.91|5.91|Standard Deviation|1.014|1.014|||
4016596|NCT01185301|3837902|B3|||28-Joint Disease Activity Score of C-reactive Protein (DAS28[CRP])|The DAS28(CRP) is a validated index of rheumatoid arthritis disease activity. Twenty-eight tender joint counts, 28 swollen joint counts, C-reactive protein, and general health are included in the DAS28 score. Scores on the DAS28 range from 0 to 10. A DAS28 score >5.1 indicates high disease activity, a DAS28 score <3.2 indicates low disease activity, and a DAS28 score <2.6 indicates clinical remission. Baseline values are presented for 96, 98, 95, 97 participants in the 2.5 mg, 5 mg, 10 mg, and 20 mg treatment groups, respectively.|scores on a scale|Mean|5.86|5.86|Standard Deviation|0.971|0.971|||
4016597|NCT01185301|3837903|B2|||28-Joint Disease Activity Score of C-reactive Protein (DAS28[CRP])|The DAS28(CRP) is a validated index of rheumatoid arthritis disease activity. Twenty-eight tender joint counts, 28 swollen joint counts, C-reactive protein, and general health are included in the DAS28 score. Scores on the DAS28 range from 0 to 10. A DAS28 score >5.1 indicates high disease activity, a DAS28 score <3.2 indicates low disease activity, and a DAS28 score <2.6 indicates clinical remission. Baseline values are presented for 96, 98, 95, 97 participants in the 2.5 mg, 5 mg, 10 mg, and 20 mg treatment groups, respectively.|scores on a scale|Mean|6.22|6.22|Standard Deviation|0.943|0.943|||
4016598|NCT01185301|3837904|B1|||28-Joint Disease Activity Score of C-reactive Protein (DAS28[CRP])|The DAS28(CRP) is a validated index of rheumatoid arthritis disease activity. Twenty-eight tender joint counts, 28 swollen joint counts, C-reactive protein, and general health are included in the DAS28 score. Scores on the DAS28 range from 0 to 10. A DAS28 score >5.1 indicates high disease activity, a DAS28 score <3.2 indicates low disease activity, and a DAS28 score <2.6 indicates clinical remission. Baseline values are presented for 96, 98, 95, 97 participants in the 2.5 mg, 5 mg, 10 mg, and 20 mg treatment groups, respectively.|scores on a scale|Mean|6.10|6.1|Standard Deviation|0.921|0.921|||
4016599|NCT01185301|3837900|B5||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4016600|NCT01185301|3837901|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4016601|NCT01185301|3837902|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4016602|NCT01185301|3837903|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4016603|NCT01185301|3837904|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4016604|NCT01185301|3837900|B5||Female|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
4016605|NCT01185301|3837901|B4||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4016606|NCT01185301|3837902|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4016607|NCT01185301|3837903|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4016608|NCT01185301|3837904|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4016609|NCT01185301|3837900|B5|> 65 years||Age, Customized||participants|Number|60|60.0||||||
4016610|NCT01185301|3837901|B4|> 65 years||Age, Customized||participants|Number|21|21.0||||||
4016611|NCT01185301|3837902|B3|> 65 years||Age, Customized||participants|Number|14|14.0||||||
4016612|NCT01185301|3837903|B2|> 65 years||Age, Customized||participants|Number|11|11.0||||||
4016613|NCT01185301|3837904|B1|> 65 years||Age, Customized||participants|Number|14|14.0||||||
4016614|NCT01185301|3837900|B5|< 65 years||Age, Customized||participants|Number|335|335.0||||||
4016615|NCT01185301|3837901|B4|< 65 years||Age, Customized||participants|Number|77|77.0||||||
4016616|NCT01185301|3837902|B3|< 65 years||Age, Customized||participants|Number|85|85.0||||||
4016617|NCT01185301|3837903|B2|< 65 years||Age, Customized||participants|Number|89|89.0||||||
4016618|NCT01185301|3837904|B1|< 65 years||Age, Customized||participants|Number|84|84.0||||||
4016619|NCT01185301|3837900|B5|||Age||years|Mean|51.9|51.9|Standard Deviation|13.46|13.46|||
4016620|NCT01185301|3837901|B4|||Age||years|Mean|53.8|53.8|Standard Deviation|14.41|14.41|||
4016621|NCT01185301|3837902|B3|||Age||years|Mean|52.1|52.1|Standard Deviation|12.94|12.94|||
4016622|NCT01185301|3837903|B2|||Age||years|Mean|49.7|49.7|Standard Deviation|13.14|13.14|||
4016627|NCT01185288|3837965|B3||Female|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
4016628|NCT01185288|3837966|B2||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4016629|NCT01185288|3837967|B1||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4016630|NCT01185288|3837965|B3|||Age||years|Mean|54.8|54.8|Standard Deviation|12.12|12.12|||
4016631|NCT01185288|3837966|B2|||Age||years|Mean|54.5|54.5|Standard Deviation|11.09|11.09|||
4016632|NCT01185288|3837967|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|13.11|13.11|||
4016633|NCT01185249|3837986|B1|||Body Weight|Body weight on admission|kilograms|Mean|85.9|85.9|Standard Deviation|1.80|1.8|||
4016634|NCT01185249|3837986|B1|United States||Region of Enrollment||participants|Number|66|66.0||||||
4016635|NCT01185249|3837986|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4016636|NCT01185249|3837986|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4016637|NCT01185249|3837986|B1|||Age||years|Mean|61|61.0|Standard Deviation|2.06|2.06|||
4016638|NCT01185249|3837986|B1||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4016639|NCT01185249|3837986|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4016640|NCT01185249|3837986|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4016641|NCT01185080|3837991|B4||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4016642|NCT01185080|3837992|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4016643|NCT01185080|3837993|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4016644|NCT01185080|3837994|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4016645|NCT01185080|3837991|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4016646|NCT01185080|3837992|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4016647|NCT01185080|3837993|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4016648|NCT01185080|3837994|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4016649|NCT01185080|3837991|B4|||Age||years|Mean|29.8|29.8|Full Range|||18.0|53.0|
4016650|NCT01185080|3837992|B3|||Age||years|Mean|31.0|31.0|Full Range|||19.0|47.0|
4016651|NCT01185080|3837993|B2|||Age||years|Mean|28.8|28.8|Full Range|||20.0|46.0|
4016652|NCT01185080|3837994|B1|||Age||years|Mean|29.7|29.7|Full Range|||18.0|53.0|
4016653|NCT01185028|3838043|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4016654|NCT01185028|3838043|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4016655|NCT01185028|3838043|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4016656|NCT01185028|3838043|B1|||Age|Mean has been calculated to the third decimal place. Standard Deviation value has been calculated to the thirteenth decimal place|years|Mean|56.375|56.375|Standard Deviation|7.4487834577198|7.4487834577198|||
4016657|NCT01185028|3838043|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4016658|NCT01185028|3838043|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4016659|NCT01185028|3838043|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4016660|NCT01184989|3838048|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4016661|NCT01184989|3838048|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4016662|NCT01184989|3838048|B1|||Age||years|Mean|79.1|79.1|Standard Deviation|6.5|6.5|||
4016663|NCT01184898|3838054|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4016664|NCT01184898|3838054|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4016665|NCT01184898|3838054|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4016666|NCT01184898|3838054|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4016667|NCT01184898|3838054|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4016668|NCT01184898|3838054|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4016669|NCT01184898|3838054|B1|||Age||years|Mean|60.05|60.05|Standard Deviation|11.84|11.84|||
4016670|NCT01184885|3838061|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4016671|NCT01184885|3838061|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4016672|NCT01184885|3838061|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4016673|NCT01184885|3838061|B1|||Age||years|Mean|41.68|41.68|Standard Deviation|18.94|18.94|||
4016674|NCT01184885|3838061|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4016675|NCT01184885|3838061|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4016676|NCT01184885|3838061|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4016677|NCT01184872|3838066|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4016678|NCT01184872|3838067|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4016679|NCT01184872|3838068|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4016680|NCT01184872|3838066|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4016681|NCT01184872|3838067|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4016682|NCT01184872|3838068|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4016683|NCT01184872|3838066|B3|||Age||years|Mean|74.84|74.84|Standard Deviation|6.063|6.063|||
4016684|NCT01184872|3838067|B2|||Age||years|Mean|75.28|75.28|Standard Deviation|5.515|5.515|||
4016685|NCT01184872|3838068|B1|||Age||years|Mean|74.63|74.63|Standard Deviation|6.331|6.331|||
4016686|NCT01184859|3838083|B6|||24-Hour Urine Volume||mL|Mean|1775.93|1775.93|Standard Deviation|423.67|423.67|||
4016687|NCT01184859|3838084|B5|||24-Hour Urine Volume||mL|Mean|1785.65|1785.65|Standard Deviation|404.67|404.67|||
4016688|NCT01184859|3838085|B4|||24-Hour Urine Volume||mL|Mean|1848.32|1848.32|Standard Deviation|497.96|497.96|||
4016689|NCT01184859|3838086|B3|||24-Hour Urine Volume||mL|Mean|1881.67|1881.67|Standard Deviation|399.42|399.42|||
4016690|NCT01184859|3838087|B2|||24-Hour Urine Volume||mL|Mean|1632.17|1632.17|Standard Deviation|454.75|454.75|||
4016691|NCT01184859|3838088|B1|||24-Hour Urine Volume||mL|Mean|1742.32|1742.32|Standard Deviation|344.99|344.99|||
4016692|NCT01184859|3838083|B6|||Nocturnal Urine Volume||mL|Mean|616.64|616.64|Standard Deviation|200.13|200.13|||
4016693|NCT01184859|3838084|B5|||Nocturnal Urine Volume||mL|Mean|631.78|631.78|Standard Deviation|175.02|175.02|||
4016694|NCT01184859|3838085|B4|||Nocturnal Urine Volume||mL|Mean|635.87|635.87|Standard Deviation|211.53|211.53|||
4016695|NCT01184859|3838086|B3|||Nocturnal Urine Volume||mL|Mean|613.06|613.06|Standard Deviation|182.47|182.47|||
4016696|NCT01184859|3838087|B2|||Nocturnal Urine Volume||mL|Mean|568.55|568.55|Standard Deviation|227.40|227.4|||
4016697|NCT01184859|3838088|B1|||Nocturnal Urine Volume||mL|Mean|634.78|634.78|Standard Deviation|210.54|210.54|||
4016698|NCT01184859|3838083|B6|||Number of 24-hour Voids||voids|Mean|10.58|10.58|Standard Deviation|1.83|1.83|||
4016699|NCT01184859|3838084|B5|||Number of 24-hour Voids||voids|Mean|10.60|10.6|Standard Deviation|1.60|1.6|||
4016700|NCT01184859|3838085|B4|||Number of 24-hour Voids||voids|Mean|10.95|10.95|Standard Deviation|2.12|2.12|||
4016701|NCT01184859|3838086|B3|||Number of 24-hour Voids||voids|Mean|11.15|11.15|Standard Deviation|1.79|1.79|||
4016702|NCT01184859|3838087|B2|||Number of 24-hour Voids||voids|Mean|10.41|10.41|Standard Deviation|1.94|1.94|||
4016703|NCT01184859|3838088|B1|||Number of 24-hour Voids||voids|Mean|9.83|9.83|Standard Deviation|1.52|1.52|||
4016704|NCT01184859|3838083|B6|||Number of Daytime Voids||daytime voids|Mean|8.26|8.26|Standard Deviation|1.74|1.74|||
4016705|NCT01184859|3838084|B5|||Number of Daytime Voids||daytime voids|Mean|8.33|8.33|Standard Deviation|1.65|1.65|||
4016706|NCT01184859|3838085|B4|||Number of Daytime Voids||daytime voids|Mean|8.67|8.67|Standard Deviation|1.99|1.99|||
4016707|NCT01184859|3838086|B3|||Number of Daytime Voids||daytime voids|Mean|8.70|8.7|Standard Deviation|1.53|1.53|||
4016708|NCT01184859|3838087|B2|||Number of Daytime Voids||daytime voids|Mean|7.97|7.97|Standard Deviation|1.91|1.91|||
4016709|NCT01184859|3838088|B1|||Number of Daytime Voids||daytime voids|Mean|7.67|7.67|Standard Deviation|1.48|1.48|||
4016710|NCT01184859|3838083|B6|||Number of Nocturnal Voids||nocturnal voids|Mean|2.32|2.32|Standard Deviation|0.42|0.42|||
4016711|NCT01184859|3838084|B5|||Number of Nocturnal Voids||nocturnal voids|Mean|2.26|2.26|Standard Deviation|0.38|0.38|||
4016712|NCT01184859|3838085|B4|||Number of Nocturnal Voids||nocturnal voids|Mean|2.29|2.29|Standard Deviation|0.44|0.44|||
4016713|NCT01184859|3838086|B3|||Number of Nocturnal Voids||nocturnal voids|Mean|2.45|2.45|Standard Deviation|0.45|0.45|||
4016714|NCT01184859|3838087|B2|||Number of Nocturnal Voids||nocturnal voids|Mean|2.43|2.43|Standard Deviation|0.51|0.51|||
4016715|NCT01184859|3838088|B1|||Number of Nocturnal Voids||nocturnal voids|Mean|2.16|2.16|Standard Deviation|0.26|0.26|||
4016716|NCT01184859|3838083|B6||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4016717|NCT01184859|3838084|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4016718|NCT01184859|3838085|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4016719|NCT01184859|3838086|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4016720|NCT01184859|3838087|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4016721|NCT01184859|3838088|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4016722|NCT01184859|3838083|B6||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4016723|NCT01184859|3838084|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4016724|NCT01184859|3838085|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4016725|NCT01184859|3838086|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4016726|NCT01184859|3838087|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4016727|NCT01184859|3838088|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4016728|NCT01184859|3838083|B6|>=65 and <76 years||Age, Customized||participants|Number|61|61.0||||||
4016729|NCT01184859|3838084|B5|>=65 and <76 years||Age, Customized||participants|Number|12|12.0||||||
4016730|NCT01184859|3838085|B4|>=65 and <76 years||Age, Customized||participants|Number|11|11.0||||||
4016731|NCT01184859|3838086|B3|>=65 and <76 years||Age, Customized||participants|Number|12|12.0||||||
4016732|NCT01184859|3838087|B2|>=65 and <76 years||Age, Customized||participants|Number|15|15.0||||||
4016733|NCT01184859|3838088|B1|>=65 and <76 years||Age, Customized||participants|Number|11|11.0||||||
4016734|NCT01184859|3838083|B6|>=55 and <65 years||Age, Customized||participants|Number|52|52.0||||||
4016735|NCT01184859|3838084|B5|>=55 and <65 years||Age, Customized||participants|Number|12|12.0||||||
4016736|NCT01184859|3838085|B4|>=55 and <65 years||Age, Customized||participants|Number|10|10.0||||||
4016737|NCT01184859|3838086|B3|>=55 and <65 years||Age, Customized||participants|Number|10|10.0||||||
4016738|NCT01184859|3838087|B2|>=55 and <65 years||Age, Customized||participants|Number|8|8.0||||||
4016739|NCT01184859|3838088|B1|>=55 and <65 years||Age, Customized||participants|Number|12|12.0||||||
4016740|NCT01184859|3838083|B6|||Age|FAS population is used for the Baseline Measures|years|Mean|65.4|65.4|Standard Deviation|6.1|6.1|||
4016741|NCT01184859|3838084|B5|||Age|FAS population is used for the Baseline Measures|years|Mean|65.3|65.3|Standard Deviation|5.6|5.6|||
4016742|NCT01184859|3838085|B4|||Age|FAS population is used for the Baseline Measures|years|Mean|64.9|64.9|Standard Deviation|7.1|7.1|||
4016743|NCT01184859|3838086|B3|||Age|FAS population is used for the Baseline Measures|years|Mean|65.5|65.5|Standard Deviation|6.0|6.0|||
4016744|NCT01184859|3838087|B2|||Age|FAS population is used for the Baseline Measures|years|Mean|67.0|67.0|Standard Deviation|5.6|5.6|||
4016745|NCT01184859|3838088|B1|||Age|FAS population is used for the Baseline Measures|years|Mean|64.3|64.3|Standard Deviation|6.4|6.4|||
4016746|NCT01184846|3838184|B1|IVIG-untreated subjects||Previous IVIG treatment||participants|Number|15|15.0||||||
4016747|NCT01184846|3838184|B1|IVIG-pretreated subjects||Previous IVIG treatment||participants|Number|13|13.0||||||
4016748|NCT01184846|3838184|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4016749|NCT01184846|3838184|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4016750|NCT01184846|3838184|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|14.34|14.34|||
4016751|NCT01184755|3838202|B4|United States||Region of Enrollment||participants|Number|253|253.0||||||
4016752|NCT01184755|3838203|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
4016753|NCT01184755|3838204|B2|United States||Region of Enrollment||participants|Number|65|65.0||||||
4016754|NCT01184755|3838205|B1|United States||Region of Enrollment||participants|Number|126|126.0||||||
4016755|NCT01184755|3838202|B4||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4016756|NCT01184755|3838203|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4016757|NCT01184755|3838204|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4016758|NCT01184755|3838205|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4016759|NCT01184755|3838202|B4||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4016760|NCT01184755|3838203|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4016761|NCT01184755|3838204|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4016762|NCT01184755|3838205|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4016763|NCT01184755|3838202|B4|||Age||years|Mean|56.74|56.74|Full Range|||23.0|80.0|
4016764|NCT01184755|3838203|B3|||Age||years|Mean|56.34|56.34|Full Range|||27.0|76.0|
4016765|NCT01184755|3838204|B2|||Age||years|Mean|57.58|57.58|Full Range|||34.0|79.0|
4016766|NCT01184755|3838205|B1|||Age||years|Mean|56.65|56.65|Full Range|||23.0|80.0|
4016767|NCT01184755|3838202|B4||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
4016768|NCT01184755|3838203|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4016769|NCT01184755|3838204|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4016770|NCT01184755|3838205|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4016771|NCT01184755|3838202|B4||Between 18 and 65 years|Age||Participants|Count of Participants|203|203.0||||||
4016772|NCT01184755|3838203|B3||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4016773|NCT01184755|3838204|B2||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4016774|NCT01184755|3838205|B1||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
4016775|NCT01184755|3838202|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4016776|NCT01184755|3838203|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4016777|NCT01184755|3838204|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4016778|NCT01184755|3838205|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4016779|NCT01184508|3838215|B3|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|26.4|26.4|Standard Deviation|4.39|4.39|||
4016780|NCT01184508|3838216|B2|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|26.3|26.3|Standard Deviation|5.13|5.13|||
4016781|NCT01184508|3838217|B1|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|26.5|26.5|Standard Deviation|3.65|3.65|||
4016782|NCT01184508|3838215|B3|United States||Region of Enrollment||Participants|Count of Participants|86|86.0||||||
4016783|NCT01184508|3838216|B2|United States||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
4016784|NCT01184508|3838217|B1|United States||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
4016785|NCT01184508|3838215|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|74|74.0||||||
4016786|NCT01184508|3838216|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
4016787|NCT01184508|3838217|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
4016788|NCT01184508|3838215|B3|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4016789|NCT01184508|3838216|B2|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4016790|NCT01184508|3838217|B1|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4016791|NCT01184508|3838215|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4016792|NCT01184508|3838216|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4016793|NCT01184508|3838217|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4016794|NCT01184508|3838215|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4016795|NCT01184508|3838216|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4016796|NCT01184508|3838217|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4016797|NCT01184508|3838215|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4016798|NCT01184508|3838216|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4016799|NCT01184508|3838217|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4016800|NCT01184508|3838215|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4016801|NCT01184508|3838216|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4016802|NCT01184508|3838217|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4016803|NCT01184508|3838215|B3|||Age||years|Mean|42.4|42.4|Standard Deviation|11.10|11.1|||
4016804|NCT01184508|3838216|B2|||Age||years|Mean|41.4|41.4|Standard Deviation|12.17|12.17|||
4016805|NCT01184508|3838217|B1|||Age||years|Mean|43.3|43.3|Standard Deviation|10.09|10.09|||
4016806|NCT01184417|3838243|B3|United States||Region of Enrollment||participants|Number|102|102.0||||||
4016807|NCT01184417|3838244|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
4016808|NCT01184417|3838245|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4016809|NCT01184417|3838243|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4016810|NCT01184417|3838244|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4016811|NCT01184417|3838245|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4016812|NCT01184417|3838243|B3||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4016813|NCT01184417|3838244|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4016814|NCT01184417|3838245|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4016815|NCT01184417|3838243|B3|||Age||years|Mean|47|47.0|Standard Deviation|14|14.0|||
4016816|NCT01184417|3838244|B2|||Age||years|Mean|48|48.0|Standard Deviation|17|17.0|||
4016817|NCT01184417|3838245|B1|||Age||years|Mean|46|46.0|Standard Deviation|12|12.0|||
4016818|NCT01184417|3838243|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4016819|NCT01184417|3838244|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4016820|NCT01184417|3838245|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4016821|NCT01184417|3838243|B3||Between 18 and 65 years|Age||Participants|Count of Participants|102|102.0||||||
4016822|NCT01184417|3838244|B2||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4016823|NCT01184417|3838245|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4016824|NCT01184417|3838243|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4016825|NCT01184417|3838244|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4016826|NCT01184417|3838245|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4016827|NCT01184326|3838266|B1||Lung|Tumor type||Participants|Count of Participants|3|3.0||||||
4016828|NCT01184326|3838266|B1||Bladder|Tumor type||Participants|Count of Participants|19|19.0||||||
4016829|NCT01184326|3838266|B1||Adrenal cortex|Tumor type||Participants|Count of Participants|1|1.0||||||
4016830|NCT01184326|3838266|B1|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4016831|NCT01184326|3838266|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
4016832|NCT01184326|3838266|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4016833|NCT01184326|3838266|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4016834|NCT01184326|3838266|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4016835|NCT01184326|3838266|B1|||Age||years|Median|66|66.0|Inter-Quartile Range|||59.0|72.0|
4016836|NCT01184118|3838274|B1|||BMI||kg/m^2|Mean|26.8|26.8|Standard Deviation|5.3|5.3|||
4016837|NCT01184118|3838274|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4016838|NCT01184118|3838274|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4016839|NCT01184118|3838274|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4016840|NCT01184118|3838274|B1|||Age||years|Mean|25.9|25.9|Standard Deviation|6.3|6.3|||
4016841|NCT01184118|3838274|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4016842|NCT01184118|3838274|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4016843|NCT01184118|3838274|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4016844|NCT01184079|3838280|B3|United States||Region of Enrollment||participants|Number|220|220.0||||||
4016845|NCT01184079|3838281|B2|United States||Region of Enrollment||participants|Number|109|109.0||||||
4016846|NCT01184079|3838282|B1|United States||Region of Enrollment||participants|Number|111|111.0||||||
4016847|NCT01184079|3838280|B3||Male|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
4016848|NCT01184079|3838281|B2||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4016849|NCT01184079|3838282|B1||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4016850|NCT01184079|3838280|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4016851|NCT01184079|3838281|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4016852|NCT01184079|3838282|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4016853|NCT01184079|3838280|B3|||Age||years|Mean|21.3|21.3|Standard Deviation|2.2|2.2|||
4016854|NCT01184079|3838281|B2|||Age||years|Mean|21.4|21.4|Standard Deviation|2.2|2.2|||
4016855|NCT01184079|3838282|B1|||Age||years|Mean|21.3|21.3|Standard Deviation|2.3|2.3|||
4016856|NCT01184079|3838280|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4016857|NCT01184079|3838281|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4016858|NCT01184079|3838282|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4016859|NCT01184079|3838280|B3||Between 18 and 65 years|Age||Participants|Count of Participants|201|201.0||||||
4016860|NCT01184079|3838281|B2||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4016861|NCT01184079|3838282|B1||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
4016862|NCT01184079|3838280|B3||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
4016863|NCT01184079|3838281|B2||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4016864|NCT01184079|3838282|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4016865|NCT01184053|3838293|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4016866|NCT01184053|3838293|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016867|NCT01184053|3838293|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016868|NCT01184053|3838293|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4016869|NCT01184053|3838293|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4016870|NCT01184053|3838293|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016871|NCT01184053|3838293|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016872|NCT01184053|3838293|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016873|NCT01184053|3838293|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016874|NCT01184053|3838293|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4016875|NCT01184053|3838293|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016876|NCT01184053|3838293|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4016877|NCT01184053|3838293|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4016878|NCT01184053|3838293|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4016879|NCT01184053|3838293|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4016880|NCT01184053|3838293|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4016881|NCT01184014|3838300|B3|United States||Region of Enrollment||participants|Number|72|72.0||||||
4016882|NCT01184014|3838301|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4016883|NCT01184014|3838302|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4016884|NCT01184014|3838300|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4016885|NCT01184014|3838301|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4016886|NCT01184014|3838302|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4016887|NCT01184014|3838300|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4016888|NCT01184014|3838301|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4016889|NCT01184014|3838302|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4016890|NCT01184014|3838300|B3|||Age||years|Mean|69.4|69.4|Standard Deviation|33.1|33.1|||
4016891|NCT01184014|3838301|B2|||Age||years|Mean|71.6|71.6|Standard Deviation|44.6|44.6|||
4016892|NCT01184014|3838302|B1|||Age||years|Mean|67.1|67.1|Standard Deviation|14.2|14.2|||
4016893|NCT01184014|3838300|B3||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
4016894|NCT01184014|3838301|B2||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4016895|NCT01184014|3838302|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4016896|NCT01184014|3838300|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4016897|NCT01184014|3838301|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4016898|NCT01184014|3838302|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4016899|NCT01184014|3838300|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4016900|NCT01184014|3838301|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4016901|NCT01184014|3838302|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4016902|NCT01183975|3838309|B1|||Patients treated with SAGB by solicited teams||participants|Number|517|517.0||||||
4016903|NCT01183975|3838309|B1|France||Region of Enrollment||participants|Number|517|517.0||||||
4016904|NCT01183975|3838309|B1|Male||Gender||participants|Number|61|61.0||||||
4016905|NCT01183975|3838309|B1|Female||Gender||participants|Number|455|455.0||||||
4016906|NCT01183975|3838309|B1|||Age||years|Mean|37.5|37.5|Standard Deviation|10.92|10.92|||
4016907|NCT01183858|3838314|B3||Male|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
4016908|NCT01183858|3838315|B2||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4016909|NCT01183858|3838316|B1||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4016910|NCT01183858|3838314|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4016911|NCT01183858|3838315|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4016912|NCT01183858|3838316|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4016913|NCT01183858|3838314|B3|||Age||years|Mean|59.4|59.4|Standard Deviation|9.18|9.18|||
4016914|NCT01183858|3838315|B2|||Age||years|Mean|59.2|59.2|Standard Deviation|9.14|9.14|||
4016915|NCT01183858|3838316|B1|||Age||years|Mean|59.7|59.7|Standard Deviation|9.25|9.25|||
4016916|NCT01183780|3838337|B3|Sweden||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4016917|NCT01183780|3838338|B2|Sweden||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4016918|NCT01183780|3838339|B1|Sweden||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4016919|NCT01183780|3838337|B3|Japan||Region of Enrollment||Participants|Count of Participants|136|136.0||||||
4016920|NCT01183780|3838338|B2|Japan||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
4016921|NCT01183780|3838339|B1|Japan||Region of Enrollment||Participants|Count of Participants|74|74.0||||||
4016922|NCT01183780|3838337|B3|Germany||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
4016923|NCT01183780|3838338|B2|Germany||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4016924|NCT01183780|3838339|B1|Germany||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4016925|NCT01183780|3838337|B3|Romania||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
4016926|NCT01183780|3838338|B2|Romania||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4016927|NCT01183780|3838339|B1|Romania||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4016928|NCT01183780|3838337|B3|Brazil||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4016929|NCT01183780|3838338|B2|Brazil||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4016930|NCT01183780|3838339|B1|Brazil||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4016931|NCT01183780|3838337|B3|Belgium||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
4016932|NCT01183780|3838338|B2|Belgium||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4016933|NCT01183780|3838339|B1|Belgium||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4016934|NCT01183780|3838337|B3|Argentina||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4016935|NCT01183780|3838338|B2|Argentina||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4016936|NCT01183780|3838339|B1|Argentina||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4016937|NCT01183780|3838337|B3|Hungary||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
4016938|NCT01183780|3838338|B2|Hungary||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4016939|NCT01183780|3838339|B1|Hungary||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
4016940|NCT01183780|3838337|B3|Czech Republic||Region of Enrollment||Participants|Count of Participants|77|77.0||||||
4016941|NCT01183780|3838338|B2|Czech Republic||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
4016942|NCT01183780|3838339|B1|Czech Republic||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
4016943|NCT01183780|3838337|B3|Austria||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4016944|NCT01183780|3838338|B2|Austria||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4016945|NCT01183780|3838339|B1|Austria||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4016946|NCT01183780|3838337|B3|Finland||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4016947|NCT01183780|3838338|B2|Finland||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4016948|NCT01183780|3838339|B1|Finland||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4016949|NCT01183780|3838337|B3|Korea, Republic of||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
4016950|NCT01183780|3838338|B2|Korea, Republic of||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4016951|NCT01183780|3838339|B1|Korea, Republic of||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4016952|NCT01183780|3838337|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4016953|NCT01183780|3838338|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4016954|NCT01183780|3838339|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4016955|NCT01183780|3838337|B3|Denmark||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4016956|NCT01183780|3838338|B2|Denmark||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4016957|NCT01183780|3838339|B1|Denmark||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4016958|NCT01183780|3838337|B3|Australia||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
4016959|NCT01183780|3838338|B2|Australia||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4016960|NCT01183780|3838339|B1|Australia||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4016961|NCT01183780|3838337|B3|Puerto Rico||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4016962|NCT01183780|3838338|B2|Puerto Rico||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4016963|NCT01183780|3838339|B1|Puerto Rico||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4016964|NCT01183780|3838337|B3|France||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
4016965|NCT01183780|3838338|B2|France||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4016966|NCT01183780|3838339|B1|France||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4016967|NCT01183780|3838337|B3|India||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4016968|NCT01183780|3838338|B2|India||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4016969|NCT01183780|3838339|B1|India||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4016970|NCT01183780|3838337|B3|Italy||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
4016971|NCT01183780|3838338|B2|Italy||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4016972|NCT01183780|3838339|B1|Italy||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
4016973|NCT01183780|3838337|B3|Israel||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4016974|NCT01183780|3838338|B2|Israel||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4016975|NCT01183780|3838339|B1|Israel||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4016976|NCT01183780|3838337|B3|Spain||Region of Enrollment||Participants|Count of Participants|111|111.0||||||
4016977|NCT01183780|3838338|B2|Spain||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
4016978|NCT01183780|3838339|B1|Spain||Region of Enrollment||Participants|Count of Participants|51|51.0||||||
4016979|NCT01183780|3838337|B3|Greece||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4016980|NCT01183780|3838338|B2|Greece||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4016981|NCT01183780|3838339|B1|Greece||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4016982|NCT01183780|3838337|B3|Taiwan||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4016983|NCT01183780|3838338|B2|Taiwan||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4016984|NCT01183780|3838339|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4016985|NCT01183780|3838337|B3|Portugal||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4016986|NCT01183780|3838338|B2|Portugal||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4016987|NCT01183780|3838339|B1|Portugal||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4016988|NCT01183780|3838337|B3|United States||Region of Enrollment||Participants|Count of Participants|283|283.0||||||
4016989|NCT01183780|3838338|B2|United States||Region of Enrollment||Participants|Count of Participants|142|142.0||||||
4016990|NCT01183780|3838339|B1|United States||Region of Enrollment||Participants|Count of Participants|141|141.0||||||
4016991|NCT01183780|3838337|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4016992|NCT01183780|3838338|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4016993|NCT01183780|3838339|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4016994|NCT01183780|3838337|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4016995|NCT01183780|3838338|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4016996|NCT01183780|3838339|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4016997|NCT01183780|3838337|B3||White|Race (NIH/OMB)||Participants|Count of Participants|815|815.0||||||
4016998|NCT01183780|3838338|B2||White|Race (NIH/OMB)||Participants|Count of Participants|410|410.0||||||
4016999|NCT01183780|3838339|B1||White|Race (NIH/OMB)||Participants|Count of Participants|405|405.0||||||
4017000|NCT01183780|3838337|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4017001|NCT01183780|3838338|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4017002|NCT01183780|3838339|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4017003|NCT01183780|3838337|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4017004|NCT01183780|3838338|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4017005|NCT01183780|3838339|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4017006|NCT01183780|3838337|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|214|214.0||||||
4017007|NCT01183780|3838338|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
4017008|NCT01183780|3838339|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
4017009|NCT01183780|3838337|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4017010|NCT01183780|3838338|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4017011|NCT01183780|3838339|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017012|NCT01183780|3838337|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|526|526.0||||||
4017013|NCT01183780|3838338|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|276|276.0||||||
4017014|NCT01183780|3838339|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|250|250.0||||||
4017015|NCT01183780|3838337|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|469|469.0||||||
4017016|NCT01183780|3838338|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|221|221.0||||||
4017017|NCT01183780|3838339|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|248|248.0||||||
4017018|NCT01183780|3838337|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
4017019|NCT01183780|3838338|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4017020|NCT01183780|3838339|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4017021|NCT01183780|3838337|B3||Male|Sex: Female, Male||Participants|Count of Participants|615|615.0||||||
4017022|NCT01183780|3838338|B2||Male|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
4017023|NCT01183780|3838339|B1||Male|Sex: Female, Male||Participants|Count of Participants|289|289.0||||||
4017024|NCT01183780|3838337|B3||Female|Sex: Female, Male||Participants|Count of Participants|457|457.0||||||
4017025|NCT01183780|3838338|B2||Female|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4017026|NCT01183780|3838339|B1||Female|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
4017027|NCT01183780|3838337|B3|||Age||years|Median|62.0|62.0|Full Range|||21.0|87.0|
4017028|NCT01183780|3838338|B2|||Age||years|Median|62.0|62.0|Full Range|||33.0|87.0|
4017029|NCT01183780|3838339|B1|||Age||years|Median|62.0|62.0|Full Range|||21.0|83.0|
4017030|NCT01183780|3838337|B3||>=65 years|Age||Participants|Count of Participants|427|427.0||||||
4017031|NCT01183780|3838338|B2||>=65 years|Age||Participants|Count of Participants|215|215.0||||||
4017032|NCT01183780|3838339|B1||>=65 years|Age||Participants|Count of Participants|212|212.0||||||
4017033|NCT01183780|3838337|B3||Between 18 and 65 years|Age||Participants|Count of Participants|645|645.0||||||
4017034|NCT01183780|3838338|B2||Between 18 and 65 years|Age||Participants|Count of Participants|321|321.0||||||
4017035|NCT01183780|3838339|B1||Between 18 and 65 years|Age||Participants|Count of Participants|324|324.0||||||
4017036|NCT01183780|3838337|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017037|NCT01183780|3838338|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017038|NCT01183780|3838339|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017208|NCT01183390|3838485|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4017039|NCT01183728|3838357|B1|With 2nd or 3th grade osteoarthritis||Number of Participants with 4th grade osteoarthritis.||participants|Number|7|7.0||||||
4017040|NCT01183728|3838357|B1|With 4th grade osteoarthritis||Number of Participants with 4th grade osteoarthritis.||participants|Number|5|5.0||||||
4017041|NCT01183728|3838357|B1|Without Major Surgical History on Treated Knee||Number of Participants with Major Surgical History on Treated Knee||participants|Number|3|3.0||||||
4017042|NCT01183728|3838357|B1|With Major Surgical History on Treated Knee||Number of Participants with Major Surgical History on Treated Knee||participants|Number|9|9.0||||||
4017043|NCT01183728|3838357|B1|Spain||Region of Enrollment||participants|Number|12|12.0||||||
4017044|NCT01183728|3838357|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4017045|NCT01183728|3838357|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4017046|NCT01183728|3838357|B1|>70 years||Age, Customized||participants|Number|3|3.0||||||
4017047|NCT01183728|3838357|B1|>=18 and <=70 years||Age, Customized||participants|Number|9|9.0||||||
4017048|NCT01183689|3838362|B4||Other|Employment Status||Participants|Count of Participants|57|57.0||||||
4017049|NCT01183689|3838363|B3||Other|Employment Status||Participants|Count of Participants|17|17.0||||||
4017050|NCT01183689|3838364|B2||Other|Employment Status||Participants|Count of Participants|14|14.0||||||
4017051|NCT01183689|3838365|B1||Other|Employment Status||Participants|Count of Participants|26|26.0||||||
4017052|NCT01183689|3838362|B4||Student full time|Employment Status||Participants|Count of Participants|165|165.0||||||
4017053|NCT01183689|3838363|B3||Student full time|Employment Status||Participants|Count of Participants|55|55.0||||||
4017054|NCT01183689|3838364|B2||Student full time|Employment Status||Participants|Count of Participants|61|61.0||||||
4017055|NCT01183689|3838365|B1||Student full time|Employment Status||Participants|Count of Participants|49|49.0||||||
4017056|NCT01183689|3838362|B4||Employed full time|Employment Status||Participants|Count of Participants|377|377.0||||||
4017057|NCT01183689|3838363|B3||Employed full time|Employment Status||Participants|Count of Participants|125|125.0||||||
4017058|NCT01183689|3838364|B2||Employed full time|Employment Status||Participants|Count of Participants|125|125.0||||||
4017059|NCT01183689|3838365|B1||Employed full time|Employment Status||Participants|Count of Participants|127|127.0||||||
4017060|NCT01183689|3838362|B4||College graduate|Education||Participants|Count of Participants|479|479.0||||||
4017061|NCT01183689|3838363|B3||College graduate|Education||Participants|Count of Participants|162|162.0||||||
4017062|NCT01183689|3838364|B2||College graduate|Education||Participants|Count of Participants|154|154.0||||||
4017063|NCT01183689|3838365|B1||College graduate|Education||Participants|Count of Participants|163|163.0||||||
4017064|NCT01183689|3838362|B4||Not college graduate|Education||Participants|Count of Participants|120|120.0||||||
4017065|NCT01183689|3838363|B3||Not college graduate|Education||Participants|Count of Participants|35|35.0||||||
4017066|NCT01183689|3838364|B2||Not college graduate|Education||Participants|Count of Participants|46|46.0||||||
4017067|NCT01183689|3838365|B1||Not college graduate|Education||Participants|Count of Participants|39|39.0||||||
4017068|NCT01183689|3838362|B4|||Weight||kilograms|Mean|71.4|71.4|Standard Deviation|10.7|10.7|||
4017069|NCT01183689|3838363|B3|||Weight||kilograms|Mean|70.8|70.8|Standard Deviation|11.0|11.0|||
4017070|NCT01183689|3838364|B2|||Weight||kilograms|Mean|71.9|71.9|Standard Deviation|11.0|11.0|||
4017071|NCT01183689|3838365|B1|||Weight||kilograms|Mean|71.4|71.4|Standard Deviation|10.2|10.2|||
4017072|NCT01183689|3838362|B4||>=25.0 kg/m2|BMI||Participants|Count of Participants|322|322.0||||||
4017073|NCT01183689|3838363|B3||>=25.0 kg/m2|BMI||Participants|Count of Participants|101|101.0||||||
4017074|NCT01183689|3838364|B2||>=25.0 kg/m2|BMI||Participants|Count of Participants|116|116.0||||||
4017075|NCT01183689|3838365|B1||>=25.0 kg/m2|BMI||Participants|Count of Participants|105|105.0||||||
4017076|NCT01183689|3838362|B4||<25.0 kg/m2|BMI||Participants|Count of Participants|277|277.0||||||
4017077|NCT01183689|3838363|B3||<25.0 kg/m2|BMI||Participants|Count of Participants|96|96.0||||||
4017078|NCT01183689|3838364|B2||<25.0 kg/m2|BMI||Participants|Count of Participants|84|84.0||||||
4017079|NCT01183689|3838365|B1||<25.0 kg/m2|BMI||Participants|Count of Participants|97|97.0||||||
4017080|NCT01183689|3838362|B4|Race/Ethnicity|Multiple/Refused|Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
4017081|NCT01183689|3838363|B3|Race/Ethnicity|Multiple/Refused|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4017082|NCT01183689|3838364|B2|Race/Ethnicity|Multiple/Refused|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4017083|NCT01183689|3838365|B1|Race/Ethnicity|Multiple/Refused|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4017084|NCT01183689|3838362|B4|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
4017085|NCT01183689|3838363|B3|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
4017086|NCT01183689|3838364|B2|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4017087|NCT01183689|3838365|B1|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
4017088|NCT01183689|3838362|B4|Race/Ethnicity|Asian/Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
4017089|NCT01183689|3838363|B3|Race/Ethnicity|Asian/Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4017090|NCT01183689|3838364|B2|Race/Ethnicity|Asian/Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4017091|NCT01183689|3838365|B1|Race/Ethnicity|Asian/Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4017092|NCT01183689|3838362|B4|Race/Ethnicity|Non-Hispanic white|Race/Ethnicity, Customized||Participants|Count of Participants|438|438.0||||||
4017093|NCT01183689|3838363|B3|Race/Ethnicity|Non-Hispanic white|Race/Ethnicity, Customized||Participants|Count of Participants|144|144.0||||||
4017094|NCT01183689|3838364|B2|Race/Ethnicity|Non-Hispanic white|Race/Ethnicity, Customized||Participants|Count of Participants|146|146.0||||||
4017095|NCT01183689|3838365|B1|Race/Ethnicity|Non-Hispanic white|Race/Ethnicity, Customized||Participants|Count of Participants|148|148.0||||||
4017096|NCT01183689|3838362|B4|Race/Ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|66|66.0||||||
4017097|NCT01183689|3838363|B3|Race/Ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
4017098|NCT01183689|3838364|B2|Race/Ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
4017099|NCT01183689|3838365|B1|Race/Ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
4017100|NCT01183689|3838362|B4||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4017101|NCT01183689|3838363|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4017102|NCT01183689|3838364|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4017103|NCT01183689|3838365|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4017104|NCT01183689|3838362|B4||Female|Sex: Female, Male||Participants|Count of Participants|469|469.0||||||
4017105|NCT01183689|3838363|B3||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4017106|NCT01183689|3838364|B2||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4017107|NCT01183689|3838365|B1||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4017108|NCT01183689|3838362|B4|Age|Age : 25-35 years|Age, Customized||Participants|Count of Participants|430|430.0||||||
4017109|NCT01183689|3838363|B3|Age|Age : 25-35 years|Age, Customized||Participants|Count of Participants|141|141.0||||||
4017110|NCT01183689|3838364|B2|Age|Age : 25-35 years|Age, Customized||Participants|Count of Participants|140|140.0||||||
4017111|NCT01183689|3838365|B1|Age|Age : 25-35 years|Age, Customized||Participants|Count of Participants|149|149.0||||||
4017112|NCT01183689|3838362|B4|Age|Age : 18-24 years|Age, Customized||Participants|Count of Participants|169|169.0||||||
4017113|NCT01183689|3838363|B3|Age|Age : 18-24 years|Age, Customized||Participants|Count of Participants|56|56.0||||||
4017114|NCT01183689|3838364|B2|Age|Age : 18-24 years|Age, Customized||Participants|Count of Participants|60|60.0||||||
4017115|NCT01183689|3838365|B1|Age|Age : 18-24 years|Age, Customized||Participants|Count of Participants|53|53.0||||||
4017116|NCT01183650|3838435|B3|Japan||Region of Enrollment||participants|Number|12|12.0||||||
4017117|NCT01183650|3838436|B2|Japan||Region of Enrollment||participants|Number|0|0.0||||||
4017118|NCT01183650|3838437|B1|Japan||Region of Enrollment||participants|Number|12|12.0||||||
4017119|NCT01183650|3838435|B3|Germany||Region of Enrollment||participants|Number|12|12.0||||||
4017120|NCT01183650|3838436|B2|Germany||Region of Enrollment||participants|Number|12|12.0||||||
4017121|NCT01183650|3838437|B1|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4017122|NCT01183650|3838435|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017123|NCT01183650|3838436|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017124|NCT01183650|3838437|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017125|NCT01183650|3838435|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017126|NCT01183650|3838436|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017127|NCT01183650|3838437|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017128|NCT01183650|3838435|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4017129|NCT01183650|3838436|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4017130|NCT01183650|3838437|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017131|NCT01183650|3838435|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017132|NCT01183650|3838436|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017133|NCT01183650|3838437|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017134|NCT01183650|3838435|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017135|NCT01183650|3838436|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017136|NCT01183650|3838437|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017137|NCT01183650|3838435|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4017138|NCT01183650|3838436|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017139|NCT01183650|3838437|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4017140|NCT01183650|3838435|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017141|NCT01183650|3838436|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017142|NCT01183650|3838437|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017143|NCT01183650|3838435|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017144|NCT01183650|3838436|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017145|NCT01183650|3838437|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017146|NCT01183650|3838435|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4017147|NCT01183650|3838436|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4017148|NCT01183650|3838437|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4017149|NCT01183650|3838435|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017150|NCT01183650|3838436|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017151|NCT01183650|3838437|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017152|NCT01183650|3838435|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4017153|NCT01183650|3838436|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4017154|NCT01183650|3838437|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4017155|NCT01183650|3838435|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4017156|NCT01183650|3838436|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4017157|NCT01183650|3838437|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4017158|NCT01183650|3838435|B3|||Age||years|Mean|58.8|58.8|Standard Deviation|8.7|8.7|||
4017159|NCT01183650|3838436|B2|||Age||years|Mean|60.6|60.6|Standard Deviation|7.2|7.2|||
4017160|NCT01183650|3838437|B1|||Age||years|Mean|57.0|57.0|Standard Deviation|9.9|9.9|||
4017161|NCT01183546|3838448|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
4017162|NCT01183546|3838448|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4017163|NCT01183546|3838448|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4017164|NCT01183546|3838448|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4017165|NCT01183546|3838448|B1||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4017166|NCT01183546|3838448|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017167|NCT01183533|3838455|B1|||National Institutes of Health Stroke Scale score, median (range)|"National Institutes of Health Stroke Scale (NIHSS) score is a numerical 0-42 point scale that defines the severity of stroke deficits. It is routinely used in both the clinical assessment of patients as well as a research tool. Zero indicates a normal exam with no stroke deficits; whereas 42 indicates a severely affected individual who is comatose and unable to move their extremities. Unit of measure: units on a scale."|units on a scale|Median|6.5|6.5|Full Range|||2.0|24.0|
4017168|NCT01183533|3838455|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4017169|NCT01183533|3838455|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4017170|NCT01183533|3838455|B1|African American||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4017171|NCT01183533|3838455|B1|Caucasian, Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4017172|NCT01183533|3838455|B1|Caucasian, Non-Hispanic||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4017173|NCT01183533|3838455|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4017174|NCT01183533|3838455|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4017175|NCT01183533|3838455|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|13.2|13.2|||
4017176|NCT01183481|3838461|B1|Canada||Region of Enrollment||participants|Number|19|19.0||||||
4017177|NCT01183481|3838461|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4017178|NCT01183481|3838461|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4017179|NCT01183481|3838461|B1|||Age||years|Mean|68.4|68.4|Standard Deviation|15.48|15.48|||
4017180|NCT01183481|3838461|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4017181|NCT01183481|3838461|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4017182|NCT01183481|3838461|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017183|NCT01183468|3838469|B5|United States||Region of Enrollment||participants|Number|17|17.0||||||
4017184|NCT01183468|3838472|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4017185|NCT01183468|3838473|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4017186|NCT01183468|3838469|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4017187|NCT01183468|3838472|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4017188|NCT01183468|3838473|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4017189|NCT01183468|3838469|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4017190|NCT01183468|3838472|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4017191|NCT01183468|3838473|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4017192|NCT01183468|3838469|B5|||Age||years|Mean|15.4|15.4|Standard Deviation|6.6|6.6|||
4017193|NCT01183468|3838472|B2|||Age||years|Mean|10.7|10.7|Standard Deviation|2.2|2.2|||
4017194|NCT01183468|3838473|B1|||Age||years|Mean|20.6|20.6|Standard Deviation|5.7|5.7|||
4017195|NCT01183468|3838469|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4017196|NCT01183468|3838472|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4017197|NCT01183468|3838473|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4017198|NCT01183468|3838469|B5||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4017199|NCT01183468|3838472|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4017200|NCT01183468|3838473|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4017201|NCT01183468|3838469|B5||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4017202|NCT01183468|3838472|B2||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4017203|NCT01183468|3838473|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4017204|NCT01183390|3838484|B3|Canada||Region of Enrollment||participants|Number|22|22.0||||||
4017205|NCT01183390|3838485|B2|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4017206|NCT01183390|3838486|B1|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4017207|NCT01183390|3838484|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4017209|NCT01183390|3838486|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4017210|NCT01183390|3838484|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4017211|NCT01183390|3838485|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4017212|NCT01183390|3838486|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4017213|NCT01183390|3838484|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4017214|NCT01183390|3838485|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4017215|NCT01183390|3838486|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4017216|NCT01183390|3838484|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4017217|NCT01183390|3838485|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4017218|NCT01183390|3838486|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4017219|NCT01183390|3838484|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4017220|NCT01183390|3838485|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4017221|NCT01183390|3838486|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4017222|NCT01183390|3838484|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4017223|NCT01183390|3838485|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4017224|NCT01183390|3838486|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4017225|NCT01183390|3838484|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017226|NCT01183390|3838485|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017227|NCT01183390|3838486|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017228|NCT01183312|3838495|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4017229|NCT01183312|3838496|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4017230|NCT01183312|3838497|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4017231|NCT01183312|3838495|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4017232|NCT01183312|3838496|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4017233|NCT01183312|3838497|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4017234|NCT01183312|3838495|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4017235|NCT01183312|3838496|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4017236|NCT01183312|3838497|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4017237|NCT01183312|3838495|B3|||Age||years|Mean|37.7|37.7|Standard Deviation|15.6|15.6|||
4017238|NCT01183312|3838496|B2|||Age||years|Mean|41.8|41.8|Standard Deviation|18.1|18.1|||
4017239|NCT01183312|3838497|B1|||Age||years|Mean|33.6|33.6|Standard Deviation|13.3|13.3|||
4017240|NCT01183312|3838495|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4017241|NCT01183312|3838496|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4017242|NCT01183312|3838497|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4017243|NCT01183312|3838495|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4017244|NCT01183312|3838496|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4017245|NCT01183312|3838497|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4017246|NCT01183312|3838495|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017247|NCT01183312|3838496|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017248|NCT01183312|3838497|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017249|NCT01183260|3838518|B3|||BMI (kg/m^2), Continuous||kg/m^2|Mean|30.31|30.31|Standard Deviation|6.44|6.44|||
4017250|NCT01183260|3838519|B2|||BMI (kg/m^2), Continuous||kg/m^2|Mean|30.49|30.49|Standard Deviation|7.56|7.56|||
4017251|NCT01183260|3838520|B1|||BMI (kg/m^2), Continuous||kg/m^2|Mean|30.14|30.14|Standard Deviation|6.07|6.07|||
4017252|NCT01183260|3838518|B3||Right|Operative Side: Left, Right||Participants|Count of Participants|9|9.0||||||
4017253|NCT01183260|3838519|B2||Right|Operative Side: Left, Right||Participants|Count of Participants|4|4.0||||||
4017254|NCT01183260|3838520|B1||Right|Operative Side: Left, Right||Participants|Count of Participants|5|5.0||||||
4017255|NCT01183260|3838518|B3||Left|Operative Side: Left, Right||Participants|Count of Participants|10|10.0||||||
4017256|NCT01183260|3838519|B2||Left|Operative Side: Left, Right||Participants|Count of Participants|5|5.0||||||
4017257|NCT01183260|3838520|B1||Left|Operative Side: Left, Right||Participants|Count of Participants|5|5.0||||||
4017258|NCT01183260|3838518|B3|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4017259|NCT01183260|3838519|B2|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4017260|NCT01183260|3838520|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4017261|NCT01183260|3838518|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4017262|NCT01183260|3838518|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4017263|NCT01183260|3838519|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4017264|NCT01183260|3838520|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4017265|NCT01183260|3838518|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4017266|NCT01183260|3838519|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4017267|NCT01183260|3838520|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4017268|NCT01183260|3838518|B3|||Age||years|Mean|59.79|59.79|Standard Deviation|10.15|10.15|||
4017269|NCT01183260|3838519|B2|||Age||years|Mean|61.11|61.11|Standard Deviation|9.74|9.74|||
4017270|NCT01183260|3838520|B1|||Age||years|Mean|58.60|58.6|Standard Deviation|11.40|11.4|||
4017271|NCT01183234|3838529|B3|United Kingdom||Region of Enrollment||participants|Number|28|28.0||||||
4017272|NCT01183234|3838530|B2|United Kingdom||Region of Enrollment||participants|Number|14|14.0||||||
4017273|NCT01183234|3838531|B1|United Kingdom||Region of Enrollment||participants|Number|14|14.0||||||
4017274|NCT01183234|3838529|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4017275|NCT01183234|3838530|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4017276|NCT01183234|3838531|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4017277|NCT01183234|3838529|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4017278|NCT01183234|3838530|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4017279|NCT01183234|3838531|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4017280|NCT01183234|3838529|B3|18 to 55 years||Age, Customized||participants|Number|28|28.0||||||
4017281|NCT01183234|3838530|B2|18 to 55 years||Age, Customized||participants|Number|14|14.0||||||
4017282|NCT01183234|3838531|B1|18 to 55 years||Age, Customized||participants|Number|14|14.0||||||
4017283|NCT01183234|3838529|B3|||Age, Customized||years|Mean|30.1|30.1|Standard Deviation|9.24|9.24|||
4017284|NCT01183234|3838530|B2|||Age, Customized||years|Mean|29.5|29.5|Standard Deviation|8.61|8.61|||
4017285|NCT01183234|3838531|B1|||Age, Customized||years|Mean|30.8|30.8|Standard Deviation|10.12|10.12|||
4017286|NCT01183169|3838542|B5||Male|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
4017287|NCT01183169|3838543|B4||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4017288|NCT01183169|3838544|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4017289|NCT01183169|3838545|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4017290|NCT01183169|3838546|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4017291|NCT01183169|3838542|B5||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4017292|NCT01183169|3838543|B4||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4017293|NCT01183169|3838544|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4017294|NCT01183169|3838545|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4017295|NCT01183169|3838546|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4017296|NCT01183169|3838542|B5|||Age||years|Mean|50.6|50.6|Standard Deviation|9.86|9.86|||
4017297|NCT01183169|3838543|B4|||Age||years|Mean|51.0|51.0|Standard Deviation|9.68|9.68|||
4017298|NCT01183169|3838544|B3|||Age||years|Mean|50.5|50.5|Standard Deviation|10.50|10.5|||
4017299|NCT01183169|3838545|B2|||Age||years|Mean|50.9|50.9|Standard Deviation|10.11|10.11|||
4017300|NCT01183169|3838546|B1|||Age||years|Mean|50.2|50.2|Standard Deviation|9.24|9.24|||
4017301|NCT01183143|3838624|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4017302|NCT01183143|3838624|B1||Female|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4017303|NCT01183143|3838624|B1|||Age||years|Mean|30.0|30.0|Standard Deviation|3.3|3.3|||
4017304|NCT01183104|3838638|B3|||Insulin/Proinsulin Ratio||ratio|Mean|0.211|0.211|Standard Deviation|0.125|0.125|||
4017305|NCT01183104|3838639|B2|||Insulin/Proinsulin Ratio||ratio|Mean|0.205|0.205|Standard Deviation|0.129|0.129|||
4017306|NCT01183104|3838640|B1|||Insulin/Proinsulin Ratio||ratio|Mean|0.217|0.217|Standard Deviation|0.122|0.122|||
4017307|NCT01183104|3838638|B3|||HOMA-β||percent|Mean|41.1|41.1|Standard Deviation|33.9|33.9|||
4017308|NCT01183104|3838639|B2|||HOMA-β||percent|Mean|38.5|38.5|Standard Deviation|34.0|34.0|||
4017309|NCT01183104|3838640|B1|||HOMA-β||percent|Mean|43.3|43.3|Standard Deviation|33.7|33.7|||
4017310|NCT01183104|3838638|B3|||Body weight||kg|Mean|60.9|60.9|Standard Deviation|9.7|9.7|||
4017311|NCT01183104|3838639|B2|||Body weight||kg|Mean|60.9|60.9|Standard Deviation|9.7|9.7|||
4017312|NCT01183104|3838640|B1|||Body weight||kg|Mean|60.9|60.9|Standard Deviation|9.7|9.7|||
4017313|NCT01183104|3838638|B3|||eGFR||mL/min/1.73m^2|Mean|68.4|68.4|Standard Deviation|17.1|17.1|||
4017314|NCT01183104|3838639|B2|||eGFR||mL/min/1.73m^2|Mean|67.9|67.9|Standard Deviation|17.1|17.1|||
4017315|NCT01183104|3838640|B1|||eGFR||mL/min/1.73m^2|Mean|68.8|68.8|Standard Deviation|17.1|17.1|||
4017316|NCT01183104|3838638|B3|||BMI||kg/m^2|Mean|24.2|24.2|Standard Deviation|3.4|3.4|||
4017317|NCT01183104|3838639|B2|||BMI||kg/m^2|Mean|24.2|24.2|Standard Deviation|3.6|3.6|||
4017318|NCT01183104|3838640|B1|||BMI||kg/m^2|Mean|24.1|24.1|Standard Deviation|3.3|3.3|||
4017319|NCT01183104|3838638|B3|||HbA1c||percent|Mean|7.48|7.48|Standard Deviation|0.67|0.67|||
4017320|NCT01183104|3838639|B2|||HbA1c||percent|Mean|7.49|7.49|Standard Deviation|0.67|0.67|||
4017321|NCT01183104|3838640|B1|||HbA1c||percent|Mean|7.48|7.48|Standard Deviation|0.68|0.68|||
4017322|NCT01183104|3838638|B3|Japan||Region of Enrollment||participants|Number|272|272.0||||||
4017323|NCT01183104|3838639|B2|Japan||Region of Enrollment||participants|Number|129|129.0||||||
4017324|NCT01183104|3838640|B1|Japan||Region of Enrollment||participants|Number|143|143.0||||||
4017325|NCT01183104|3838638|B3||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4017326|NCT01183104|3838639|B2||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4017327|NCT01183104|3838640|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4017328|NCT01183104|3838638|B3||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4017329|NCT01183104|3838639|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4017330|NCT01183104|3838640|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4017331|NCT01183104|3838638|B3|||Age||years|Mean|70.5|70.5|Standard Deviation|5.5|5.5|||
4017332|NCT01183104|3838639|B2|||Age||years|Mean|70.8|70.8|Standard Deviation|5.5|5.5|||
4017333|NCT01183104|3838640|B1|||Age||years|Mean|70.2|70.2|Standard Deviation|5.4|5.4|||
4017334|NCT01183065|3838657|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4017335|NCT01183065|3838657|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4017336|NCT01183065|3838657|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4017337|NCT01183065|3838657|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4017338|NCT01183065|3838657|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017339|NCT01183013|3838661|B8|||Baseline fasting plasma glucose (FPG)||mg/dL|Mean|166.3|166.3|Standard Deviation|39.9|39.9|||
4017340|NCT01183013|3838662|B7|||Baseline fasting plasma glucose (FPG)||mg/dL|Mean|162.3|162.3|Standard Deviation|36.8|36.8|||
4017341|NCT01183013|3838663|B6|||Baseline fasting plasma glucose (FPG)||mg/dL|Mean|168.8|168.8|Standard Deviation|46.8|46.8|||
4017342|NCT01183013|3838664|B5|||Baseline fasting plasma glucose (FPG)||mg/dL|Mean|167.3|167.3|Standard Deviation|39.5|39.5|||
4017343|NCT01183013|3838665|B4|||Baseline fasting plasma glucose (FPG)||mg/dL|Mean|161.4|161.4|Standard Deviation|38.1|38.1|||
4017344|NCT01183013|3838666|B3|||Baseline fasting plasma glucose (FPG)||mg/dL|Mean|167.5|167.5|Standard Deviation|37.9|37.9|||
4017345|NCT01183013|3838667|B2|||Baseline fasting plasma glucose (FPG)||mg/dL|Mean|165.8|165.8|Standard Deviation|40.0|40.0|||
4017346|NCT01183013|3838668|B1|||Baseline fasting plasma glucose (FPG)||mg/dL|Mean|171.3|171.3|Standard Deviation|39.3|39.3|||
4017347|NCT01183013|3838661|B8|||Baseline HbA1c||percent|Mean|8.11|8.11|Standard Deviation|0.91|0.91|||
4017348|NCT01183013|3838662|B7|||Baseline HbA1c||percent|Mean|8.01|8.01|Standard Deviation|0.81|0.81|||
4017349|NCT01183013|3838663|B6|||Baseline HbA1c||percent|Mean|8.17|8.17|Standard Deviation|1.07|1.07|||
4017350|NCT01183013|3838664|B5|||Baseline HbA1c||percent|Mean|8.13|8.13|Standard Deviation|0.94|0.94|||
4017351|NCT01183013|3838665|B4|||Baseline HbA1c||percent|Mean|8.01|8.01|Standard Deviation|0.88|0.88|||
4017352|NCT01183013|3838666|B3|||Baseline HbA1c||percent|Mean|8.12|8.12|Standard Deviation|0.87|0.87|||
4017353|NCT01183013|3838667|B2|||Baseline HbA1c||percent|Mean|7.99|7.99|Standard Deviation|0.85|0.85|||
4017354|NCT01183013|3838668|B1|||Baseline HbA1c||percent|Mean|8.33|8.33|Standard Deviation|0.93|0.93|||
4017355|NCT01183013|3838661|B8||Male|Sex: Female, Male||Participants|Count of Participants|483|483.0||||||
4017356|NCT01183013|3838662|B7||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4017357|NCT01183013|3838663|B6||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4017358|NCT01183013|3838664|B5||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4017359|NCT01183013|3838665|B4||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4017360|NCT01183013|3838666|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4017361|NCT01183013|3838667|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4017362|NCT01183013|3838668|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4017363|NCT01183013|3838661|B8||Female|Sex: Female, Male||Participants|Count of Participants|410|410.0||||||
4017364|NCT01183013|3838662|B7||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4017365|NCT01183013|3838663|B6||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4017366|NCT01183013|3838664|B5||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4017367|NCT01183013|3838665|B4||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4017368|NCT01183013|3838666|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4017369|NCT01183013|3838667|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4017370|NCT01183013|3838668|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4017371|NCT01183013|3838661|B8|||Age||years|Mean|57.1|57.1|Standard Deviation|10.5|10.5|||
4017372|NCT01183013|3838662|B7|||Age||years|Mean|60.1|60.1|Standard Deviation|10.2|10.2|||
4017373|NCT01183013|3838663|B6|||Age||years|Mean|56.4|56.4|Standard Deviation|10.0|10.0|||
4017374|NCT01183013|3838664|B5|||Age||years|Mean|57.1|57.1|Standard Deviation|10.2|10.2|||
4017375|NCT01183013|3838665|B4|||Age||years|Mean|56.3|56.3|Standard Deviation|10.1|10.1|||
4017376|NCT01183013|3838666|B3|||Age||years|Mean|56.5|56.5|Standard Deviation|11.1|11.1|||
4017377|NCT01183013|3838667|B2|||Age||years|Mean|57.2|57.2|Standard Deviation|11.1|11.1|||
4017378|NCT01183013|3838668|B1|||Age||years|Mean|56.4|56.4|Standard Deviation|10.4|10.4|||
4017379|NCT01182805|3838753|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4017380|NCT01182805|3838753|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4017381|NCT01182805|3838753|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4017382|NCT01182805|3838753|B1|||Age||years|Mean|59|59.0|Standard Deviation|10|10.0|||
4017383|NCT01182727|3838762|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4017384|NCT01182727|3838762|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4017385|NCT01182727|3838762|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4017386|NCT01182727|3838762|B1|||Age||years|Mean|46.9|46.9|Standard Deviation|7.4|7.4|||
4017387|NCT01182727|3838762|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4017388|NCT01182727|3838762|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4017389|NCT01182727|3838762|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017390|NCT01182675|3838766|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4017391|NCT01182675|3838768|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4017392|NCT01182675|3838766|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4017393|NCT01182675|3838768|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4017394|NCT01182675|3838766|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4017395|NCT01182675|3838768|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4017396|NCT01182675|3838766|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4017397|NCT01182675|3838768|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4017398|NCT01182675|3838766|B3||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4017399|NCT01182675|3838768|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4017400|NCT01182610|3838785|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4017401|NCT01182610|3838785|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4017402|NCT01182610|3838785|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4017403|NCT01182610|3838785|B1|||Age||years|Mean|73|73.0|Standard Deviation|0|0.0|||
4017404|NCT01182610|3838785|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4017405|NCT01182610|3838785|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4017406|NCT01182610|3838785|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017407|NCT01182493|3838793|B3|||HbA1c||% of glycosylated hemoglobin|Mean|9.0|9.0|Standard Deviation|0.75|0.75|||
4017408|NCT01182493|3838794|B2|||HbA1c||% of glycosylated hemoglobin|Mean|9.0|9.0|Standard Deviation|0.76|0.76|||
4017409|NCT01182493|3838795|B1|||HbA1c||% of glycosylated hemoglobin|Mean|9.0|9.0|Standard Deviation|0.75|0.75|||
4017410|NCT01182493|3838793|B3||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4017411|NCT01182493|3838794|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4017412|NCT01182493|3838795|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4017413|NCT01182493|3838793|B3||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4017414|NCT01182493|3838794|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4017415|NCT01182493|3838795|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4017416|NCT01182493|3838793|B3|||Age||years|Mean|56.0|56.0|Standard Deviation|9.6|9.6|||
4017417|NCT01182493|3838794|B2|||Age||years|Mean|56.4|56.4|Standard Deviation|9.5|9.5|||
4017418|NCT01182493|3838795|B1|||Age||years|Mean|55.5|55.5|Standard Deviation|9.7|9.7|||
4017419|NCT01182493|3838793|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4017420|NCT01182493|3838794|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4017421|NCT01182493|3838795|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4017422|NCT01182493|3838793|B3||Between 18 and 65 years|Age||Participants|Count of Participants|331|331.0||||||
4017423|NCT01182493|3838794|B2||Between 18 and 65 years|Age||Participants|Count of Participants|163|163.0||||||
4017424|NCT01182493|3838795|B1||Between 18 and 65 years|Age||Participants|Count of Participants|168|168.0||||||
4017425|NCT01182493|3838793|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017426|NCT01182493|3838794|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017427|NCT01182493|3838795|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017428|NCT01182480|3838814|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
4017429|NCT01182480|3838814|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4017430|NCT01182480|3838814|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4017431|NCT01182480|3838814|B1|||Age||years|Mean|50.29|50.29|Standard Deviation|11.24|11.24|||
4017432|NCT01182480|3838814|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4017433|NCT01182480|3838814|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4017434|NCT01182480|3838814|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017435|NCT01182441|3838818|B3|||CHADS2 Stroke Risk Score|"The CHADS2 score is used to estimate the risk of stroke in patients with non-rheumatic atrial fibrillation. To calculate the CHADS2 score, one point was assigned each for the presence of Congestive heart failure, history of Hypertension, Age 75 years or older, and Diabetes, and two points assigned for prior Stroke or TIA.~The range for this stroke scale is 0, with an annual stroke risk of 1.9%, to 6, which represents the highest risk of stroke for these patients using this scale and an annual stroke risk of 18.2% (JAMA. 285 (22): 2864–70)."|scores on a scale|Mean|2.6|2.6|Standard Deviation|1.0|1.0|||
4017436|NCT01182441|3838819|B2|||CHADS2 Stroke Risk Score|"The CHADS2 score is used to estimate the risk of stroke in patients with non-rheumatic atrial fibrillation. To calculate the CHADS2 score, one point was assigned each for the presence of Congestive heart failure, history of Hypertension, Age 75 years or older, and Diabetes, and two points assigned for prior Stroke or TIA.~The range for this stroke scale is 0, with an annual stroke risk of 1.9%, to 6, which represents the highest risk of stroke for these patients using this scale and an annual stroke risk of 18.2% (JAMA. 285 (22): 2864–70)."|scores on a scale|Mean|2.6|2.6|Standard Deviation|1.0|1.0|||
4017437|NCT01182441|3838820|B1|||CHADS2 Stroke Risk Score|"The CHADS2 score is used to estimate the risk of stroke in patients with non-rheumatic atrial fibrillation. To calculate the CHADS2 score, one point was assigned each for the presence of Congestive heart failure, history of Hypertension, Age 75 years or older, and Diabetes, and two points assigned for prior Stroke or TIA.~The range for this stroke scale is 0, with an annual stroke risk of 1.9%, to 6, which represents the highest risk of stroke for these patients using this scale and an annual stroke risk of 18.2% (JAMA. 285 (22): 2864–70)."|scores on a scale|Mean|2.6|2.6|Standard Deviation|1.0|1.0|||
4017438|NCT01182441|3838818|B3|United States||Region of Enrollment||participants|Number|407|407.0||||||
4017439|NCT01182441|3838819|B2|United States||Region of Enrollment||participants|Number|138|138.0||||||
4017440|NCT01182441|3838820|B1|United States||Region of Enrollment||participants|Number|269|269.0||||||
4017441|NCT01182441|3838818|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4017442|NCT01182441|3838819|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4017443|NCT01182441|3838820|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4017444|NCT01182441|3838818|B3|Native American Indian/Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4017445|NCT01182441|3838819|B2|Native American Indian/Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4017446|NCT01182441|3838820|B1|Native American Indian/Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4017447|NCT01182441|3838818|B3|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4017448|NCT01182441|3838819|B2|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4017449|NCT01182441|3838820|B1|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4017450|NCT01182441|3838818|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|384|384.0||||||
4017451|NCT01182441|3838819|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|131|131.0||||||
4017452|NCT01182441|3838820|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|253|253.0||||||
4017453|NCT01182441|3838818|B3|Black/Aftrican American||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4017454|NCT01182441|3838819|B2|Black/Aftrican American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4017455|NCT01182441|3838820|B1|Black/Aftrican American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4017456|NCT01182441|3838818|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4017457|NCT01182441|3838819|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4017458|NCT01182441|3838820|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4017459|NCT01182441|3838818|B3||Male|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
4017460|NCT01182441|3838819|B2||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4017461|NCT01182441|3838820|B1||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4017462|NCT01182441|3838818|B3||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4017463|NCT01182441|3838819|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4017464|NCT01182441|3838820|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4017465|NCT01182441|3838818|B3|||Age||years|Mean|74.3|74.3|Standard Deviation|7.4|7.4|||
4017466|NCT01182441|3838819|B2|||Age||years|Mean|74.9|74.9|Standard Deviation|7.2|7.2|||
4017467|NCT01182441|3838820|B1|||Age||years|Mean|74.0|74.0|Standard Deviation|7.4|7.4|||
4017468|NCT01182428|3838830|B3|Norway||Region of Enrollment||participants|Number|12|12.0||||||
4017469|NCT01182428|3838831|B2|Norway||Region of Enrollment||participants|Number|5|5.0||||||
4017470|NCT01182428|3838832|B1|Norway||Region of Enrollment||participants|Number|7|7.0||||||
4017471|NCT01182428|3838830|B3|Netherlands||Region of Enrollment||participants|Number|10|10.0||||||
4017472|NCT01182428|3838831|B2|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
4017473|NCT01182428|3838832|B1|Netherlands||Region of Enrollment||participants|Number|8|8.0||||||
4017474|NCT01182428|3838830|B3|Latvia||Region of Enrollment||participants|Number|27|27.0||||||
4017475|NCT01182428|3838831|B2|Latvia||Region of Enrollment||participants|Number|11|11.0||||||
4017476|NCT01182428|3838832|B1|Latvia||Region of Enrollment||participants|Number|16|16.0||||||
4017477|NCT01182428|3838830|B3|Germany||Region of Enrollment||participants|Number|39|39.0||||||
4017478|NCT01182428|3838831|B2|Germany||Region of Enrollment||participants|Number|13|13.0||||||
4017479|NCT01182428|3838832|B1|Germany||Region of Enrollment||participants|Number|26|26.0||||||
4017480|NCT01182428|3838830|B3|Denmark||Region of Enrollment||participants|Number|21|21.0||||||
4017481|NCT01182428|3838831|B2|Denmark||Region of Enrollment||participants|Number|5|5.0||||||
4017482|NCT01182428|3838832|B1|Denmark||Region of Enrollment||participants|Number|16|16.0||||||
4017483|NCT01182428|3838830|B3|Poland||Region of Enrollment||participants|Number|15|15.0||||||
4017484|NCT01182428|3838831|B2|Poland||Region of Enrollment||participants|Number|3|3.0||||||
4017485|NCT01182428|3838832|B1|Poland||Region of Enrollment||participants|Number|12|12.0||||||
4017486|NCT01182428|3838830|B3|Brazil||Region of Enrollment||participants|Number|6|6.0||||||
4017487|NCT01182428|3838831|B2|Brazil||Region of Enrollment||participants|Number|1|1.0||||||
4017488|NCT01182428|3838832|B1|Brazil||Region of Enrollment||participants|Number|5|5.0||||||
4017489|NCT01182428|3838830|B3|Belgium||Region of Enrollment||participants|Number|10|10.0||||||
4017490|NCT01182428|3838831|B2|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
4017491|NCT01182428|3838832|B1|Belgium||Region of Enrollment||participants|Number|6|6.0||||||
4017492|NCT01182428|3838830|B3|Argentina||Region of Enrollment||participants|Number|17|17.0||||||
4017493|NCT01182428|3838831|B2|Argentina||Region of Enrollment||participants|Number|6|6.0||||||
4017494|NCT01182428|3838832|B1|Argentina||Region of Enrollment||participants|Number|11|11.0||||||
4017495|NCT01182428|3838830|B3|Hungary||Region of Enrollment||participants|Number|53|53.0||||||
4017496|NCT01182428|3838831|B2|Hungary||Region of Enrollment||participants|Number|12|12.0||||||
4017497|NCT01182428|3838832|B1|Hungary||Region of Enrollment||participants|Number|41|41.0||||||
4017498|NCT01182428|3838830|B3|France||Region of Enrollment||participants|Number|41|41.0||||||
4017499|NCT01182428|3838831|B2|France||Region of Enrollment||participants|Number|17|17.0||||||
4017500|NCT01182428|3838832|B1|France||Region of Enrollment||participants|Number|24|24.0||||||
4017501|NCT01182428|3838830|B3|Italy||Region of Enrollment||participants|Number|93|93.0||||||
4017502|NCT01182428|3838831|B2|Italy||Region of Enrollment||participants|Number|31|31.0||||||
4017503|NCT01182428|3838832|B1|Italy||Region of Enrollment||participants|Number|62|62.0||||||
4017504|NCT01182428|3838830|B3|Switzerland||Region of Enrollment||participants|Number|68|68.0||||||
4017505|NCT01182428|3838831|B2|Switzerland||Region of Enrollment||participants|Number|25|25.0||||||
4017506|NCT01182428|3838832|B1|Switzerland||Region of Enrollment||participants|Number|43|43.0||||||
4017507|NCT01182428|3838830|B3|Austria||Region of Enrollment||participants|Number|6|6.0||||||
4017508|NCT01182428|3838831|B2|Austria||Region of Enrollment||participants|Number|3|3.0||||||
4017509|NCT01182428|3838832|B1|Austria||Region of Enrollment||participants|Number|3|3.0||||||
4017510|NCT01182428|3838830|B3|Spain||Region of Enrollment||participants|Number|37|37.0||||||
4017511|NCT01182428|3838831|B2|Spain||Region of Enrollment||participants|Number|13|13.0||||||
4017512|NCT01182428|3838832|B1|Spain||Region of Enrollment||participants|Number|24|24.0||||||
4017513|NCT01182428|3838830|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4017514|NCT01182428|3838831|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4017515|NCT01182428|3838832|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4017516|NCT01182428|3838830|B3||Female|Sex: Female, Male||Participants|Count of Participants|455|455.0||||||
4017517|NCT01182428|3838831|B2||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4017518|NCT01182428|3838832|B1||Female|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
4017519|NCT01182428|3838830|B3|||Age||years|Mean|68.86|68.86|Standard Deviation|10.29|10.29|||
4017520|NCT01182428|3838831|B2|||Age||years|Mean|69.85|69.85|Standard Deviation|10.54|10.54|||
4017521|NCT01182428|3838832|B1|||Age||years|Mean|68.37|68.37|Standard Deviation|10.14|10.14|||
4017522|NCT01182428|3838830|B3||>=65 years|Age||Participants|Count of Participants|308|308.0||||||
4017523|NCT01182428|3838831|B2||>=65 years|Age||Participants|Count of Participants|109|109.0||||||
4017524|NCT01182428|3838832|B1||>=65 years|Age||Participants|Count of Participants|199|199.0||||||
4017525|NCT01182428|3838830|B3||Between 18 and 65 years|Age||Participants|Count of Participants|147|147.0||||||
4017526|NCT01182428|3838831|B2||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4017527|NCT01182428|3838832|B1||Between 18 and 65 years|Age||Participants|Count of Participants|105|105.0||||||
4017528|NCT01182428|3838830|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017529|NCT01182428|3838831|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017530|NCT01182428|3838832|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017531|NCT01182415|3838897|B1|Other Radiation Therapy||Prior Treatment History||Participants|Count of Participants|8|8.0||||||
4017532|NCT01182415|3838897|B1|Whole brain radiation therapy (WBRT)||Prior Treatment History||Participants|Count of Participants|2|2.0||||||
4017533|NCT01182415|3838897|B1|Rituximab (Intravenous)||Prior Treatment History||Participants|Count of Participants|30|30.0||||||
4017534|NCT01182415|3838897|B1|High-Dose Cytarabine||Prior Treatment History||Participants|Count of Participants|3|3.0||||||
4017535|NCT01182415|3838897|B1|High-Dose Intravenous Methotrexate||Prior Treatment History||Participants|Count of Participants|29|29.0||||||
4017536|NCT01182415|3838897|B1|Follicular Non-Hodgkin lymphoma||Histology|CLL: Chronic lymphocytic leukemia SLL: Small lymphocytic lymphoma|Participants|Count of Participants|1|1.0||||||
4017537|NCT01182415|3838897|B1|CLL/ SLL||Histology|CLL: Chronic lymphocytic leukemia SLL: Small lymphocytic lymphoma|Participants|Count of Participants|2|2.0||||||
4017538|NCT01182415|3838897|B1|Diffuse Large B-cell Lymphoma||Histology|CLL: Chronic lymphocytic leukemia SLL: Small lymphocytic lymphoma|Participants|Count of Participants|27|27.0||||||
4017539|NCT01182415|3838897|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4017540|NCT01182415|3838897|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4017541|NCT01182415|3838897|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4017542|NCT01182415|3838897|B1|||Age||years|Median|59|59.0|Full Range|||24.0|74.0|
4017543|NCT01182376|3838904|B3|||Pre-treatment left atrial fibrosis percentage|Percentage of left atrial fibrosis is determined using an MRI image of the acutal fibrotic tissue located on the surface of the left atrium. Proprietary software is used to calculate fibrosis percentage based on the image. Fibrosis percentage can range from 0% to 40%. As a rule, the higher the percentage the worse the cardiovascular outcome of the patient.|percentage|Mean|17.7|17.7|Standard Deviation|.08|0.08|||
4017544|NCT01182376|3838905|B2|||Pre-treatment left atrial fibrosis percentage|Percentage of left atrial fibrosis is determined using an MRI image of the acutal fibrotic tissue located on the surface of the left atrium. Proprietary software is used to calculate fibrosis percentage based on the image. Fibrosis percentage can range from 0% to 40%. As a rule, the higher the percentage the worse the cardiovascular outcome of the patient.|percentage|Mean|15.5|15.5|Standard Deviation|.05|0.05|||
4017545|NCT01182376|3838906|B1|||Pre-treatment left atrial fibrosis percentage|Percentage of left atrial fibrosis is determined using an MRI image of the acutal fibrotic tissue located on the surface of the left atrium. Proprietary software is used to calculate fibrosis percentage based on the image. Fibrosis percentage can range from 0% to 40%. As a rule, the higher the percentage the worse the cardiovascular outcome of the patient.|percentage|Mean|19.9|19.9|Standard Deviation|.10|0.1|||
4017546|NCT01182376|3838904|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4017547|NCT01182376|3838905|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4017548|NCT01182376|3838906|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4017549|NCT01182376|3838904|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4017550|NCT01182376|3838905|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4017551|NCT01182376|3838906|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4017552|NCT01182376|3838904|B3|||Age||years|Mean|68|68.0|Standard Deviation|10|10.0|||
4017553|NCT01182376|3838905|B2|||Age||years|Mean|64|64.0|Standard Deviation|11|11.0|||
4017554|NCT01182376|3838906|B1|||Age||years|Mean|71|71.0|Standard Deviation|8|8.0|||
4017555|NCT01182376|3838904|B3||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4017556|NCT01182376|3838905|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4017557|NCT01182376|3838906|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4017558|NCT01182376|3838904|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4017559|NCT01182376|3838905|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4017560|NCT01182376|3838906|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4017561|NCT01182376|3838904|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017562|NCT01182376|3838905|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017563|NCT01182376|3838906|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017564|NCT01182337|3838913|B3|Korea, Republic of||Region of Enrollment||participants|Number|31|31.0||||||
4017565|NCT01182337|3838914|B2|Korea, Republic of||Region of Enrollment||participants|Number|9|9.0||||||
4017566|NCT01182337|3838915|B1|Korea, Republic of||Region of Enrollment||participants|Number|22|22.0||||||
4017567|NCT01182337|3838913|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4017568|NCT01182337|3838914|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4017569|NCT01182337|3838915|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4017570|NCT01182337|3838913|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4017571|NCT01182337|3838914|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4017572|NCT01182337|3838915|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4017573|NCT01182337|3838913|B3|||Age||years|Mean|41.2|41.2|Standard Deviation|12.74|12.74|||
4017574|NCT01182337|3838914|B2|||Age||years|Mean|40.6|40.6|Standard Deviation|15.63|15.63|||
4017575|NCT01182337|3838915|B1|||Age||years|Mean|41.4|41.4|Standard Deviation|11.78|11.78|||
4017576|NCT01182298|3838934|B1|Puerto Rico||Region of Enrollment||participants|Number|10|10.0||||||
4017577|NCT01182298|3838934|B1|United States||Region of Enrollment||participants|Number|0|0.0||||||
4017578|NCT01182298|3838934|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017579|NCT01182298|3838934|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017580|NCT01182298|3838934|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4017581|NCT01182298|3838934|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4017582|NCT01182298|3838934|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4017583|NCT01182298|3838934|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4017584|NCT01182298|3838934|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4017585|NCT01182298|3838934|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017586|NCT01182285|3838938|B1|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4017587|NCT01182285|3838938|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4017588|NCT01182285|3838938|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017589|NCT01182285|3838938|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4017590|NCT01182285|3838938|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4017591|NCT01182285|3838938|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017592|NCT01182285|3838938|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017593|NCT01182285|3838938|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017594|NCT01182285|3838938|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4017595|NCT01182285|3838938|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4017596|NCT01182285|3838938|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017597|NCT01182285|3838938|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4017598|NCT01182285|3838938|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4017599|NCT01182285|3838938|B1|||Age||years|Mean|61.08|61.08|Standard Deviation|7.63|7.63|||
4017600|NCT01182285|3838938|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4017601|NCT01182285|3838938|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4017602|NCT01182285|3838938|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017603|NCT01182207|3838948|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
4017604|NCT01182207|3838949|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4017605|NCT01182207|3838950|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4017606|NCT01182207|3838948|B3|American Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4017607|NCT01182207|3838949|B2|American Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4017608|NCT01182207|3838950|B1|American Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4017609|NCT01182207|3838948|B3|More than One||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4017610|NCT01182207|3838949|B2|More than One||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4017611|NCT01182207|3838950|B1|More than One||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4017612|NCT01182207|3838948|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4017613|NCT01182207|3838949|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4017614|NCT01182207|3838950|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4017615|NCT01182207|3838948|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4017616|NCT01182207|3838949|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4017617|NCT01182207|3838950|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4017618|NCT01182207|3838948|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4017619|NCT01182207|3838949|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4017620|NCT01182207|3838950|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4017621|NCT01182207|3838948|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4017622|NCT01182207|3838949|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4017623|NCT01182207|3838950|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4017624|NCT01182207|3838948|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4017625|NCT01182207|3838949|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4017626|NCT01182207|3838950|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4017627|NCT01182207|3838948|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4017628|NCT01182207|3838949|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4017629|NCT01182207|3838950|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4017630|NCT01182207|3838948|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017631|NCT01182207|3838949|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017632|NCT01182207|3838950|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017633|NCT01182194|3838967|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4017634|NCT01182194|3838968|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4017635|NCT01182194|3838969|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4017636|NCT01182194|3838967|B3|American Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4017637|NCT01182194|3838968|B2|American Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4017638|NCT01182194|3838969|B1|American Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4017639|NCT01182194|3838967|B3|More than One||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4017640|NCT01182194|3838968|B2|More than One||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4017641|NCT01182194|3838969|B1|More than One||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4017642|NCT01182194|3838967|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4017643|NCT01182194|3838968|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4017644|NCT01182194|3838969|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4017645|NCT01182194|3838967|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4017646|NCT01182194|3838968|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4017647|NCT01182194|3838969|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4017648|NCT01182194|3838967|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4017649|NCT01182194|3838968|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4017650|NCT01182194|3838969|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4017651|NCT01182194|3838967|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4017652|NCT01182194|3838968|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4017653|NCT01182194|3838969|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4017654|NCT01182194|3838967|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4017655|NCT01182194|3838968|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4017656|NCT01182194|3838969|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4017657|NCT01182194|3838967|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017658|NCT01182194|3838968|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017659|NCT01182194|3838969|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017660|NCT01182181|3838986|B3|Canada||Region of Enrollment||participants|Number|22|22.0||||||
4017661|NCT01182181|3838987|B2|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4017662|NCT01182181|3838988|B1|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4017663|NCT01182181|3838986|B3|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4017664|NCT01182181|3838987|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4017665|NCT01182181|3838988|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4017666|NCT01182181|3838986|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4017667|NCT01182181|3838987|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4017668|NCT01182181|3838988|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4017669|NCT01182181|3838986|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4017670|NCT01182181|3838987|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4017671|NCT01182181|3838988|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4017672|NCT01182181|3838986|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4017673|NCT01182181|3838987|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4017674|NCT01182181|3838988|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4017675|NCT01182181|3838986|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4017676|NCT01182181|3838987|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4017677|NCT01182181|3838988|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4017678|NCT01182181|3838986|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4017679|NCT01182181|3838987|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4017680|NCT01182181|3838988|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4017681|NCT01182181|3838986|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017682|NCT01182181|3838987|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017683|NCT01182181|3838988|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017684|NCT01182103|3838997|B3|Taiwan||Region of Enrollment||participants|Number|110|110.0||||||
4017685|NCT01182103|3838998|B2|Taiwan||Region of Enrollment||participants|Number|62|62.0||||||
4017686|NCT01182103|3838999|B1|Taiwan||Region of Enrollment||participants|Number|48|48.0||||||
4017687|NCT01182103|3838997|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4017688|NCT01182103|3838998|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4017689|NCT01182103|3838999|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4017690|NCT01182103|3838997|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4017691|NCT01182103|3838998|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4017692|NCT01182103|3838999|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4017693|NCT01182103|3838997|B3|||Age||years|Mean|35.53|35.53|Standard Deviation|10.81|10.81|||
4017694|NCT01182103|3838998|B2|||Age||years|Mean|30.18|30.18|Standard Deviation|5.6|5.6|||
4017695|NCT01182103|3838999|B1|||Age||years|Mean|42.44|42.44|Standard Deviation|12.09|12.09|||
4017696|NCT01182103|3838997|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4017697|NCT01182103|3838998|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4017698|NCT01182103|3838999|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4017699|NCT01182103|3838997|B3||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
4017700|NCT01182103|3838998|B2||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4017701|NCT01182103|3838999|B1||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4017702|NCT01182103|3838997|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017703|NCT01182103|3838998|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017704|NCT01182103|3838999|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017705|NCT01181986|3839012|B3|No||Lipid-lowering therapy||participants|Number|56|56.0||||||
4017706|NCT01181986|3839013|B2|No||Lipid-lowering therapy||participants|Number|19|19.0||||||
4017707|NCT01181986|3839014|B1|No||Lipid-lowering therapy||participants|Number|37|37.0||||||
4017708|NCT01181986|3839012|B3|Yes||Lipid-lowering therapy||participants|Number|20|20.0||||||
4017709|NCT01181986|3839013|B2|Yes||Lipid-lowering therapy||participants|Number|15|15.0||||||
4017710|NCT01181986|3839014|B1|Yes||Lipid-lowering therapy||participants|Number|5|5.0||||||
4017711|NCT01181986|3839012|B3|No||History of hypertension||participants|Number|27|27.0||||||
4017712|NCT01181986|3839013|B2|No||History of hypertension||participants|Number|18|18.0||||||
4017713|NCT01181986|3839014|B1|No||History of hypertension||participants|Number|9|9.0||||||
4017714|NCT01181986|3839012|B3|Yes||History of hypertension||participants|Number|49|49.0||||||
4017715|NCT01181986|3839013|B2|Yes||History of hypertension||participants|Number|16|16.0||||||
4017716|NCT01181986|3839014|B1|Yes||History of hypertension||participants|Number|33|33.0||||||
4017717|NCT01181986|3839012|B3|||Diastolic BP (mmHg)||mmHg|Mean|79|79.0|Standard Deviation|8|8.0|||
4017718|NCT01181986|3839013|B2|||Diastolic BP (mmHg)||mmHg|Mean|80|80.0|Standard Deviation|8|8.0|||
4017719|NCT01181986|3839014|B1|||Diastolic BP (mmHg)||mmHg|Mean|78|78.0|Standard Deviation|8|8.0|||
4017720|NCT01181986|3839012|B3|||Systolic BP||mmHg|Mean|127|127.0|Standard Deviation|14|14.0|||
4017721|NCT01181986|3839013|B2|||Systolic BP||mmHg|Mean|125|125.0|Standard Deviation|12|12.0|||
4017722|NCT01181986|3839014|B1|||Systolic BP||mmHg|Mean|128|128.0|Standard Deviation|8|8.0|||
4017723|NCT01181986|3839012|B3|||Diabetes duration (years)||years|Median|6|6.0|Inter-Quartile Range|||1.0|9.0|
4017724|NCT01181986|3839013|B2|||Diabetes duration (years)||years|Median|0|0.0|Inter-Quartile Range|||0.0|1.0|
4017725|NCT01181986|3839014|B1|||Diabetes duration (years)||years|Median|6|6.0|Inter-Quartile Range|||1.0|9.0|
4017726|NCT01181986|3839012|B3|||Glycated hemoglobin||%|Mean|6.4|6.4|Standard Deviation|0.8|0.8|||
4017727|NCT01181986|3839013|B2|||Glycated hemoglobin||%|Mean|6.1|6.1|Standard Deviation|0.5|0.5|||
4017728|NCT01181986|3839014|B1|||Glycated hemoglobin||%|Mean|6.6|6.6|Standard Deviation|0.9|0.9|||
4017729|NCT01181986|3839012|B3|||Body mass index||kg/m^2|Mean|33|33.0|Standard Deviation|9|9.0|||
4017730|NCT01181986|3839013|B2|||Body mass index||kg/m^2|Mean|33|33.0|Standard Deviation|12|12.0|||
4017731|NCT01181986|3839014|B1|||Body mass index||kg/m^2|Mean|33|33.0|Standard Deviation|6|6.0|||
4017732|NCT01181986|3839012|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017733|NCT01181986|3839013|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017734|NCT01181986|3839014|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017735|NCT01181986|3839012|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017736|NCT01181986|3839013|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017737|NCT01181986|3839014|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017738|NCT01181986|3839012|B3||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4017739|NCT01181986|3839013|B2||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4017740|NCT01181986|3839014|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4017741|NCT01181986|3839012|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4017742|NCT01181986|3839013|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4017743|NCT01181986|3839014|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4017744|NCT01181986|3839012|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017745|NCT01181986|3839013|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017746|NCT01181986|3839014|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017747|NCT01181986|3839012|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017748|NCT01181986|3839013|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017749|NCT01181986|3839014|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017750|NCT01181986|3839012|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017751|NCT01181986|3839013|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017752|NCT01181986|3839014|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017753|NCT01181986|3839012|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4017754|NCT01181986|3839013|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4017755|NCT01181986|3839014|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4017756|NCT01181986|3839012|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4017757|NCT01181986|3839013|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4017758|NCT01181986|3839014|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4017759|NCT01181986|3839012|B3|||Age||years|Mean|61|61.0|Standard Deviation|6|6.0|||
4017760|NCT01181986|3839013|B2|||Age||years|Mean|60|60.0|Standard Deviation|6|6.0|||
4017761|NCT01181986|3839014|B1|||Age||years|Mean|62|62.0|Standard Deviation|6|6.0|||
4017762|NCT01181947|3839032|B1|||Native aorta diameter||mm|Median|32|32.0|Full Range|||22.0|42.0|
4017763|NCT01181947|3839032|B1|Italy||Region of Enrollment||participants|Number|17|17.0||||||
4017764|NCT01181947|3839032|B1|United Kingdom||Region of Enrollment||participants|Number|21|21.0||||||
4017765|NCT01181947|3839032|B1|Germany||Region of Enrollment||participants|Number|24|24.0||||||
4017766|NCT01181947|3839032|B1|Netherlands||Region of Enrollment||participants|Number|16|16.0||||||
4017767|NCT01181947|3839032|B1|Austria||Region of Enrollment||participants|Number|2|2.0||||||
4017768|NCT01181947|3839032|B1|Turkey||Region of Enrollment||participants|Number|15|15.0||||||
4017769|NCT01181947|3839032|B1|Spain||Region of Enrollment||participants|Number|5|5.0||||||
4017770|NCT01181947|3839032|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4017771|NCT01181947|3839032|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4017772|NCT01181947|3839032|B1|||Age||year|Median|65.0|65.0|Full Range|||25.0|87.0|
4017773|NCT01181947|3839032|B1||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4017774|NCT01181947|3839032|B1||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4017775|NCT01181947|3839032|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017776|NCT01181921|3839037|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4017777|NCT01181921|3839037|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4017778|NCT01181921|3839037|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4017779|NCT01181921|3839037|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4017780|NCT01181921|3839037|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017781|NCT01181895|3839041|B4|White||Race/Ethnicity, Customized||Participants|Number|202|202.0||||||
4017782|NCT01181895|3839042|B3|White||Race/Ethnicity, Customized||Participants|Number|68|68.0||||||
4017783|NCT01181895|3839043|B2|White||Race/Ethnicity, Customized||Participants|Number|66|66.0||||||
4017784|NCT01181895|3839044|B1|White||Race/Ethnicity, Customized||Participants|Number|68|68.0||||||
4017785|NCT01181895|3839041|B4|Japanese/East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4017786|NCT01181895|3839042|B3|Japanese/East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4017787|NCT01181895|3839043|B2|Japanese/East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4017788|NCT01181895|3839044|B1|Japanese/East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4017789|NCT01181895|3839041|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|122|122.0||||||
4017790|NCT01181895|3839042|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|41|41.0||||||
4017791|NCT01181895|3839043|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|44|44.0||||||
4017792|NCT01181895|3839044|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
4017793|NCT01181895|3839041|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4017794|NCT01181895|3839042|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4017795|NCT01181895|3839043|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4017796|NCT01181895|3839044|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4017797|NCT01181895|3839041|B4||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4017798|NCT01181895|3839042|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4017799|NCT01181895|3839043|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4017800|NCT01181895|3839044|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4017801|NCT01181895|3839041|B4||Female|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4017802|NCT01181895|3839042|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4017803|NCT01181895|3839043|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4017804|NCT01181895|3839044|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4017805|NCT01181895|3839041|B4|||Age||Years|Mean|41.3|41.3|Standard Deviation|17.06|17.06|||
4017806|NCT01181895|3839042|B3|||Age||Years|Mean|41.1|41.1|Standard Deviation|16.84|16.84|||
4017807|NCT01181895|3839043|B2|||Age||Years|Mean|41.0|41.0|Standard Deviation|17.81|17.81|||
4017808|NCT01181895|3839044|B1|||Age||Years|Mean|41.7|41.7|Standard Deviation|16.64|16.64|||
4017809|NCT01181804|3839075|B5||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4017810|NCT01181804|3839076|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4017811|NCT01181804|3839077|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4017812|NCT01181804|3839078|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4017813|NCT01181804|3839079|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4017814|NCT01181804|3839075|B5||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4017815|NCT01181804|3839076|B4||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4017816|NCT01181804|3839077|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4017817|NCT01181804|3839078|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4017818|NCT01181804|3839079|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4017819|NCT01181804|3839075|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4017820|NCT01181804|3839076|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4017821|NCT01181804|3839077|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4017822|NCT01181804|3839078|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4017823|NCT01181804|3839079|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4017824|NCT01181804|3839075|B5||Between 18 and 65 years|Age||Participants|Count of Participants|177|177.0||||||
4017825|NCT01181804|3839076|B4||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4017826|NCT01181804|3839077|B3||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4017827|NCT01181804|3839078|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4017828|NCT01181804|3839079|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4017829|NCT01181804|3839075|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017830|NCT01181804|3839076|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017831|NCT01181804|3839077|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017832|NCT01181804|3839078|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017833|NCT01181804|3839079|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017834|NCT01181778|3839104|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4017835|NCT01181778|3839104|B1||Female|Sex: Female, Male||Participants|Count of Participants|1919|1919.0||||||
4017836|NCT01181778|3839104|B1|||Age||years|Mean|26.6|26.6|Standard Deviation|6.3|6.3|||
4017837|NCT01181726|3839110|B3|Canada||Region of Enrollment||participants|Number|40|40.0||||||
4017838|NCT01181726|3839111|B2|Canada||Region of Enrollment||participants|Number|20|20.0||||||
4017839|NCT01181726|3839112|B1|Canada||Region of Enrollment||participants|Number|20|20.0||||||
4017840|NCT01181726|3839110|B3|American Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4017841|NCT01181726|3839111|B2|American Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4017842|NCT01181726|3839112|B1|American Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4017843|NCT01181726|3839110|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4017844|NCT01181726|3839111|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4017845|NCT01181726|3839112|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4017846|NCT01181726|3839110|B3|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4017847|NCT01181726|3839111|B2|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4017848|NCT01181726|3839112|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4017849|NCT01181726|3839110|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4017850|NCT01181726|3839111|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4017851|NCT01181726|3839112|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4017852|NCT01181726|3839110|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4017853|NCT01181726|3839111|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4017854|NCT01181726|3839112|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4017855|NCT01181726|3839110|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4017856|NCT01181726|3839111|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4017857|NCT01181726|3839112|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4017858|NCT01181726|3839110|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4017859|NCT01181726|3839111|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4017860|NCT01181726|3839112|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4017861|NCT01181726|3839110|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4017862|NCT01181726|3839111|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4017863|NCT01181726|3839112|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4017864|NCT01181726|3839110|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4017865|NCT01181726|3839111|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4017866|NCT01181726|3839112|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4017867|NCT01181726|3839110|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017868|NCT01181726|3839111|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017869|NCT01181726|3839112|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017870|NCT01181609|3839159|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4017871|NCT01181609|3839159|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4017872|NCT01181609|3839159|B1|||Age||years|Mean|60.2|60.2|Standard Deviation|11.6|11.6|||
4017873|NCT01181531|3839170|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4017874|NCT01181531|3839171|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4017875|NCT01181531|3839172|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4017876|NCT01181531|3839170|B3|More than one race||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4017877|NCT01181531|3839171|B2|More than one race||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4017878|NCT01181531|3839172|B1|More than one race||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4017879|NCT01181531|3839170|B3|White||Race/Ethnicity, Customized||participants|Number|152|152.0||||||
4017880|NCT01181531|3839171|B2|White||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
4017881|NCT01181531|3839172|B1|White||Race/Ethnicity, Customized||participants|Number|86|86.0||||||
4017882|NCT01181531|3839170|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|136|136.0||||||
4017883|NCT01181531|3839171|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
4017884|NCT01181531|3839172|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
4017885|NCT01181531|3839170|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4017886|NCT01181531|3839171|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4017887|NCT01181531|3839172|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4017888|NCT01181531|3839170|B3|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4017889|NCT01181531|3839171|B2|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4017890|NCT01181531|3839172|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4017891|NCT01181531|3839170|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4017892|NCT01181531|3839171|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4017893|NCT01181531|3839172|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4017894|NCT01181531|3839170|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017895|NCT01181531|3839171|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017896|NCT01181531|3839172|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017897|NCT01181531|3839170|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|233|233.0||||||
4017898|NCT01181531|3839171|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
4017899|NCT01181531|3839172|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
4017900|NCT01181531|3839170|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
4017901|NCT01181531|3839171|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4017902|NCT01181531|3839172|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4017903|NCT01181531|3839170|B3||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4017904|NCT01181531|3839171|B2||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4017905|NCT01181531|3839172|B1||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4017906|NCT01181531|3839170|B3||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4017907|NCT01181531|3839171|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4017908|NCT01181531|3839172|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4017909|NCT01181531|3839170|B3|||Age|All Enrolled subjects|years|Mean|53.9|53.9|Standard Deviation|14.2|14.2|||
4017910|NCT01181531|3839171|B2|||Age|All Enrolled subjects|years|Mean|53.5|53.5|Standard Deviation|14.5|14.5|||
4017911|NCT01181531|3839172|B1|||Age|All Enrolled subjects|years|Mean|54.3|54.3|Standard Deviation|13.9|13.9|||
4017912|NCT01181492|3839183|B4|China||Region of Enrollment||participants|Number|176|176.0||||||
4017913|NCT01181492|3839184|B3|China||Region of Enrollment||participants|Number|7|7.0||||||
4017914|NCT01181492|3839185|B2|China||Region of Enrollment||participants|Number|66|66.0||||||
4017915|NCT01181492|3839186|B1|China||Region of Enrollment||participants|Number|103|103.0||||||
4017916|NCT01181492|3839183|B4||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4017917|NCT01181492|3839184|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4017918|NCT01181492|3839185|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4017919|NCT01181492|3839186|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4017920|NCT01181492|3839183|B4||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4017921|NCT01181492|3839184|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4017922|NCT01181492|3839185|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4017923|NCT01181492|3839186|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4017924|NCT01181492|3839183|B4|||Age||years|Mean|45.9|45.9|Standard Deviation|11.1|11.1|||
4017925|NCT01181492|3839184|B3|||Age||years|Mean|42.3|42.3|Standard Deviation|7.8|7.8|||
4017926|NCT01181492|3839185|B2|||Age||years|Mean|47.1|47.1|Standard Deviation|10.1|10.1|||
4017927|NCT01181492|3839186|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|11.7|11.7|||
4017928|NCT01181492|3839183|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4017929|NCT01181492|3839184|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4017930|NCT01181492|3839185|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4017931|NCT01181492|3839186|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4017932|NCT01181492|3839183|B4||Between 18 and 65 years|Age||Participants|Count of Participants|176|176.0||||||
4017933|NCT01181492|3839184|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4017934|NCT01181492|3839185|B2||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4017935|NCT01181492|3839186|B1||Between 18 and 65 years|Age||Participants|Count of Participants|103|103.0||||||
4017936|NCT01181492|3839183|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017937|NCT01181492|3839184|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017938|NCT01181492|3839185|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017939|NCT01181492|3839186|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4017940|NCT01181479|3839202|B3|United States||Region of Enrollment||participants|Number|1273|1273.0||||||
4017941|NCT01181479|3839203|B2|United States||Region of Enrollment||participants|Number|230|230.0||||||
4017942|NCT01181479|3839204|B1|United States||Region of Enrollment||participants|Number|1043|1043.0||||||
4017943|NCT01181479|3839202|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4017944|NCT01181479|3839203|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4017945|NCT01181479|3839204|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4017946|NCT01181479|3839202|B3||Female|Sex: Female, Male||Participants|Count of Participants|1273|1273.0||||||
4017947|NCT01181479|3839203|B2||Female|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4017948|NCT01181479|3839204|B1||Female|Sex: Female, Male||Participants|Count of Participants|1043|1043.0||||||
4017949|NCT01181479|3839202|B3|||Age||years|Mean|26.46|26.46|Standard Deviation|5.677|5.677|||
4017950|NCT01181479|3839203|B2|||Age||years|Mean|26.86|26.86|Standard Deviation|5.738|5.738|||
4017951|NCT01181479|3839204|B1|||Age||years|Mean|26.38|26.38|Standard Deviation|5.663|5.663|||
4017952|NCT01181479|3839202|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4017953|NCT01181479|3839203|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4017954|NCT01181479|3839204|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4017955|NCT01181479|3839202|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1266|1266.0||||||
4017956|NCT01181479|3839203|B2||Between 18 and 65 years|Age||Participants|Count of Participants|228|228.0||||||
4017957|NCT01181479|3839204|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1038|1038.0||||||
4017958|NCT01181479|3839202|B3||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4017959|NCT01181479|3839203|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4017960|NCT01181479|3839204|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4017961|NCT01181349|3839221|B1||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4017962|NCT01181349|3839221|B1||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4017963|NCT01181349|3839221|B1|||Age||years|Mean|54.3|54.3|Standard Deviation|15.9|15.9|||
4017964|NCT01181323|3839233|B5|United States||Region of Enrollment||participants|Number|497|497.0||||||
4017965|NCT01181323|3839234|B4|United States||Region of Enrollment||participants|Number|125|125.0||||||
4017966|NCT01181323|3839235|B3|United States||Region of Enrollment||participants|Number|124|124.0||||||
4017967|NCT01181323|3839236|B2|United States||Region of Enrollment||participants|Number|124|124.0||||||
4017968|NCT01181323|3839237|B1|United States||Region of Enrollment||participants|Number|124|124.0||||||
4017969|NCT01181323|3839233|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017970|NCT01181323|3839234|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017971|NCT01181323|3839235|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017972|NCT01181323|3839236|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017973|NCT01181323|3839237|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017974|NCT01181323|3839233|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|474|474.0||||||
4017975|NCT01181323|3839234|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
4017976|NCT01181323|3839235|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|114|114.0||||||
4017977|NCT01181323|3839236|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
4017978|NCT01181323|3839237|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|118|118.0||||||
4017979|NCT01181323|3839233|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4017980|NCT01181323|3839234|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4017981|NCT01181323|3839235|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4017982|NCT01181323|3839236|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4017983|NCT01181323|3839237|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4017984|NCT01181323|3839233|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4017985|NCT01181323|3839234|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017986|NCT01181323|3839235|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017987|NCT01181323|3839236|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4017988|NCT01181323|3839237|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4017989|NCT01181323|3839233|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4017990|NCT01181323|3839234|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4017991|NCT01181323|3839235|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4017992|NCT01181323|3839236|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4017993|NCT01181323|3839237|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4017994|NCT01181323|3839233|B5||White|Race (NIH/OMB)||Participants|Count of Participants|384|384.0||||||
4017995|NCT01181323|3839234|B4||White|Race (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
4017996|NCT01181323|3839235|B3||White|Race (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
4017997|NCT01181323|3839236|B2||White|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
4017998|NCT01181323|3839237|B1||White|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
4017999|NCT01181323|3839233|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4018000|NCT01181323|3839234|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4018001|NCT01181323|3839235|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4018002|NCT01181323|3839236|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4018003|NCT01181323|3839237|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4018004|NCT01181323|3839233|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4018005|NCT01181323|3839234|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4018006|NCT01181323|3839235|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018007|NCT01181323|3839236|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4018008|NCT01181323|3839237|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4018009|NCT01181323|3839233|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4018010|NCT01181323|3839234|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4018011|NCT01181323|3839235|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4018012|NCT01181323|3839236|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4018013|NCT01181323|3839237|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4018014|NCT01181323|3839233|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018015|NCT01181323|3839234|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018016|NCT01181323|3839235|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018017|NCT01181323|3839236|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018018|NCT01181323|3839237|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018019|NCT01181323|3839233|B5||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4018020|NCT01181323|3839234|B4||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4018021|NCT01181323|3839235|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4018022|NCT01181323|3839236|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4018023|NCT01181323|3839237|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4018024|NCT01181323|3839233|B5||Female|Sex: Female, Male||Participants|Count of Participants|371|371.0||||||
4018025|NCT01181323|3839234|B4||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4018026|NCT01181323|3839235|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4018027|NCT01181323|3839236|B2||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4018028|NCT01181323|3839237|B1||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4018029|NCT01181323|3839233|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4018030|NCT01181323|3839234|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4018031|NCT01181323|3839235|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4018032|NCT01181323|3839236|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4018033|NCT01181323|3839237|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4018034|NCT01181323|3839233|B5||Between 18 and 65 years|Age||Participants|Count of Participants|248|248.0||||||
4018035|NCT01181323|3839234|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4018036|NCT01181323|3839235|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4018037|NCT01181323|3839236|B2||Between 18 and 65 years|Age||Participants|Count of Participants|124|124.0||||||
4018038|NCT01181323|3839237|B1||Between 18 and 65 years|Age||Participants|Count of Participants|124|124.0||||||
4018039|NCT01181323|3839233|B5||<=18 years|Age||Participants|Count of Participants|249|249.0||||||
4018040|NCT01181323|3839234|B4||<=18 years|Age||Participants|Count of Participants|125|125.0||||||
4018041|NCT01181323|3839235|B3||<=18 years|Age||Participants|Count of Participants|124|124.0||||||
4018042|NCT01181323|3839236|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4018043|NCT01181323|3839237|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4018044|NCT01181271|3839315|B1||Complete Response|Disease status at study entry||Participants|Count of Participants|21|21.0||||||
4018045|NCT01181271|3839315|B1||Partial Response|Disease status at study entry||Participants|Count of Participants|21|21.0||||||
4018046|NCT01181271|3839315|B1||Heavy chain disease|Diagnosis||Participants|Count of Participants|1|1.0||||||
4018047|NCT01181271|3839315|B1||Relapsed/Refractory Hodgkin Lymphoma|Diagnosis||Participants|Count of Participants|1|1.0||||||
4018048|NCT01181271|3839315|B1||Mantle cell Non-Hodgkin Lymphoma|Diagnosis||Participants|Count of Participants|3|3.0||||||
4018049|NCT01181271|3839315|B1||T-cell Non-Hodgkin Lymphoma|Diagnosis||Participants|Count of Participants|4|4.0||||||
4018050|NCT01181271|3839315|B1||Transformed B-cell Non-Hodgkin Lymphoma|Diagnosis||Participants|Count of Participants|8|8.0||||||
4018051|NCT01181271|3839315|B1||Double-Expressing Non-Hodgkin Lymphoma|Diagnosis||Participants|Count of Participants|9|9.0||||||
4018052|NCT01181271|3839315|B1||Relapsed/refractory Non-Hodgkin Lymphoma|Diagnosis||Participants|Count of Participants|6|6.0||||||
4018053|NCT01181271|3839315|B1||Relapsed/refractory Diffuse Large B-cell Lymphoma|Diagnosis||Participants|Count of Participants|10|10.0||||||
4018054|NCT01181271|3839315|B1|||Prior lines of chemotherapy||lines|Median|2|2.0|Full Range|||1.0|6.0|
4018055|NCT01181271|3839315|B1|United States||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
4018056|NCT01181271|3839315|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4018057|NCT01181271|3839315|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4018058|NCT01181271|3839315|B1|||Age||years|Median|56.5|56.5|Full Range|||22.0|69.0|
4018059|NCT01181258|3839330|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4018060|NCT01181258|3839330|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4018061|NCT01181258|3839330|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4018062|NCT01181258|3839330|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4018063|NCT01181258|3839330|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4018064|NCT01181258|3839330|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4018065|NCT01181167|3839337|B3|Japan||Region of Enrollment||participants|Number|503|503.0||||||
4018066|NCT01181167|3839338|B2|Japan||Region of Enrollment||participants|Number|248|248.0||||||
4018067|NCT01181167|3839339|B1|Japan||Region of Enrollment||participants|Number|255|255.0||||||
4018068|NCT01181167|3839337|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018069|NCT01181167|3839338|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018070|NCT01181167|3839339|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018071|NCT01181167|3839337|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018072|NCT01181167|3839338|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018073|NCT01181167|3839339|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018074|NCT01181167|3839337|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018075|NCT01181167|3839338|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018076|NCT01181167|3839339|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018077|NCT01181167|3839337|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018078|NCT01181167|3839338|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018079|NCT01181167|3839339|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018080|NCT01181167|3839337|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018081|NCT01181167|3839338|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018082|NCT01181167|3839339|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018083|NCT01181167|3839337|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|503|503.0||||||
4018084|NCT01181167|3839338|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|248|248.0||||||
4018085|NCT01181167|3839339|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|255|255.0||||||
4018086|NCT01181167|3839337|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018087|NCT01181167|3839338|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018088|NCT01181167|3839339|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018089|NCT01181167|3839337|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4018090|NCT01181167|3839338|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4018091|NCT01181167|3839339|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4018092|NCT01181167|3839337|B3||Female|Sex: Female, Male||Participants|Count of Participants|432|432.0||||||
4018093|NCT01181167|3839338|B2||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4018094|NCT01181167|3839339|B1||Female|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
4018095|NCT01181167|3839337|B3|||Age||years|Mean|62.8|62.8|Standard Deviation|9.65|9.65|||
4018096|NCT01181167|3839338|B2|||Age||years|Mean|62.8|62.8|Standard Deviation|9.72|9.72|||
4018097|NCT01181167|3839339|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|9.61|9.61|||
4018098|NCT01181141|3839348|B3|Japan||Region of Enrollment||participants|Number|88|88.0||||||
4018099|NCT01181141|3839349|B2|Japan||Region of Enrollment||participants|Number|29|29.0||||||
4018100|NCT01181141|3839350|B1|Japan||Region of Enrollment||participants|Number|59|59.0||||||
4018101|NCT01181141|3839348|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018102|NCT01181141|3839349|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018103|NCT01181141|3839350|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018104|NCT01181141|3839348|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018105|NCT01181141|3839349|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018106|NCT01181141|3839350|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018107|NCT01181141|3839348|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018108|NCT01181141|3839349|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018109|NCT01181141|3839350|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018110|NCT01181141|3839348|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018111|NCT01181141|3839349|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018112|NCT01181141|3839350|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018113|NCT01181141|3839348|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018114|NCT01181141|3839349|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018115|NCT01181141|3839350|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018116|NCT01181141|3839348|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
4018117|NCT01181141|3839349|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4018118|NCT01181141|3839350|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4018119|NCT01181141|3839348|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018120|NCT01181141|3839349|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018121|NCT01181141|3839350|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018122|NCT01181141|3839348|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4018123|NCT01181141|3839349|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4018124|NCT01181141|3839350|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4018125|NCT01181141|3839348|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4018126|NCT01181141|3839349|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4018127|NCT01181141|3839350|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4018128|NCT01181141|3839348|B3|||Age||years|Mean|76.3|76.3|Standard Deviation|11.2|11.2|||
4018129|NCT01181141|3839349|B2|||Age||years|Mean|75.6|75.6|Standard Deviation|12.0|12.0|||
4018130|NCT01181141|3839350|B1|||Age||years|Mean|76.5|76.5|Standard Deviation|11.0|11.0|||
4018131|NCT01181128|3839357|B4||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4018132|NCT01181128|3839358|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4018133|NCT01181128|3839359|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4018134|NCT01181128|3839360|B1||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4018135|NCT01181128|3839357|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4018136|NCT01181128|3839358|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4018137|NCT01181128|3839359|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4018138|NCT01181128|3839360|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4018139|NCT01181128|3839357|B4|||Age||years|Median|30.0|30.0|Full Range|||12.0|65.0|
4018140|NCT01181128|3839358|B3|||Age||years|Median|34.0|34.0|Full Range|||13.0|62.0|
4018141|NCT01181128|3839359|B2|||Age||years|Median|31.5|31.5|Full Range|||18.0|59.0|
4018142|NCT01181128|3839360|B1|||Age||years|Median|29.0|29.0|Full Range|||12.0|65.0|
4018143|NCT01181102|3839448|B3|Japan||Region of Enrollment||participants|Number|543|543.0||||||
4018144|NCT01181102|3839449|B2|Japan||Region of Enrollment||participants|Number|270|270.0||||||
4018145|NCT01181102|3839450|B1|Japan||Region of Enrollment||participants|Number|273|273.0||||||
4018146|NCT01181102|3839448|B3|Taiwan||Region of Enrollment||participants|Number|51|51.0||||||
4018147|NCT01181102|3839449|B2|Taiwan||Region of Enrollment||participants|Number|25|25.0||||||
4018148|NCT01181102|3839450|B1|Taiwan||Region of Enrollment||participants|Number|26|26.0||||||
4018149|NCT01181102|3839448|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018150|NCT01181102|3839449|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018151|NCT01181102|3839450|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018152|NCT01181102|3839448|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018153|NCT01181102|3839449|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018154|NCT01181102|3839450|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018155|NCT01181102|3839448|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018156|NCT01181102|3839449|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018157|NCT01181102|3839450|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018158|NCT01181102|3839448|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018159|NCT01181102|3839449|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018160|NCT01181102|3839450|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018161|NCT01181102|3839448|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018162|NCT01181102|3839449|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018163|NCT01181102|3839450|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018164|NCT01181102|3839448|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|594|594.0||||||
4018165|NCT01181102|3839449|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|295|295.0||||||
4018166|NCT01181102|3839450|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|299|299.0||||||
4018167|NCT01181102|3839448|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018168|NCT01181102|3839449|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018169|NCT01181102|3839450|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018170|NCT01181102|3839448|B3||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4018171|NCT01181102|3839449|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4018172|NCT01181102|3839450|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4018173|NCT01181102|3839448|B3||Female|Sex: Female, Male||Participants|Count of Participants|474|474.0||||||
4018174|NCT01181102|3839449|B2||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4018175|NCT01181102|3839450|B1||Female|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4018176|NCT01181102|3839448|B3|||Age||years|Mean|72.4|72.4|Standard Deviation|7.6|7.6|||
4018177|NCT01181102|3839449|B2|||Age||years|Mean|72.1|72.1|Standard Deviation|7.8|7.8|||
4018178|NCT01181102|3839450|B1|||Age||years|Mean|72.6|72.6|Standard Deviation|7.5|7.5|||
4018179|NCT01181050|3839459|B3|||DAS28-CRP (Disease Activity Score based on count of 28 joints and the C-reactive protein)|DAS28-CRP=0.56×sqrt(tender joints [count:1-28])+0.28×sqrt(swollen joints [count:1-28])+0.36×Ln(CRP level+1)+0.014×(patient’s disease assessment on 0-100 mm scale [100=most severe])+0.96. Range: 0.96 to no upper limit. Higher score=more severe disease|scores|Mean|5.4|5.4|Standard Deviation|0.9|0.9|||
4018180|NCT01181050|3839460|B2|||DAS28-CRP (Disease Activity Score based on count of 28 joints and the C-reactive protein)|DAS28-CRP=0.56×sqrt(tender joints [count:1-28])+0.28×sqrt(swollen joints [count:1-28])+0.36×Ln(CRP level+1)+0.014×(patient’s disease assessment on 0-100 mm scale [100=most severe])+0.96. Range: 0.96 to no upper limit. Higher score=more severe disease|scores|Mean|5.4|5.4|Standard Deviation|1.0|1.0|||
4018181|NCT01181050|3839461|B1|||DAS28-CRP (Disease Activity Score based on count of 28 joints and the C-reactive protein)|DAS28-CRP=0.56×sqrt(tender joints [count:1-28])+0.28×sqrt(swollen joints [count:1-28])+0.36×Ln(CRP level+1)+0.014×(patient’s disease assessment on 0-100 mm scale [100=most severe])+0.96. Range: 0.96 to no upper limit. Higher score=more severe disease|scores|Mean|5.4|5.4|Standard Deviation|0.9|0.9|||
4018182|NCT01181050|3839459|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4018183|NCT01181050|3839460|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4018184|NCT01181050|3839461|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4018185|NCT01181050|3839459|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4018186|NCT01181050|3839460|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4018187|NCT01181050|3839461|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4018188|NCT01181050|3839459|B3|||Age||years|Mean|52.4|52.4|Standard Deviation|10.7|10.7|||
4018189|NCT01181050|3839460|B2|||Age||years|Mean|52.0|52.0|Standard Deviation|10.8|10.8|||
4018190|NCT01181050|3839461|B1|||Age||years|Mean|52.6|52.6|Standard Deviation|10.8|10.8|||
4018191|NCT01181011|3839472|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4018192|NCT01181011|3839472|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4018193|NCT01181011|3839472|B1|||Age||Years|Mean|24|24.0|Standard Deviation|2.0|2.0|||
4018194|NCT01180998|3839519|B4|United Kingdom||Region of Enrollment||participants|Number|200|200.0||||||
4018195|NCT01180998|3839520|B3|United Kingdom||Region of Enrollment||participants|Number|61|61.0||||||
4018196|NCT01180998|3839521|B2|United Kingdom||Region of Enrollment||participants|Number|72|72.0||||||
4018197|NCT01180998|3839522|B1|United Kingdom||Region of Enrollment||participants|Number|67|67.0||||||
4018198|NCT01180998|3839519|B4||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4018199|NCT01180998|3839520|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4018200|NCT01180998|3839521|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4018201|NCT01180998|3839522|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4018202|NCT01180998|3839519|B4||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4018203|NCT01180998|3839520|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4018204|NCT01180998|3839521|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4018205|NCT01180998|3839522|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4018206|NCT01180998|3839519|B4|||Age||years|Mean|36.3|36.3|Standard Deviation|11.6|11.6|||
4018207|NCT01180998|3839520|B3|||Age||years|Mean|32.4|32.4|Standard Deviation|12.3|12.3|||
4018208|NCT01180998|3839521|B2|||Age||years|Mean|39.2|39.2|Standard Deviation|10.0|10.0|||
4018209|NCT01180998|3839522|B1|||Age||years|Mean|36.6|36.6|Standard Deviation|11.8|11.8|||
4018210|NCT01180985|3839538|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
4018211|NCT01180985|3839538|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4018212|NCT01180985|3839538|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4018213|NCT01180985|3839538|B1|||Age||years|Mean|28.00|28.0|Standard Deviation|5.82|5.82|||
4018214|NCT01180985|3839538|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4018215|NCT01180985|3839538|B1||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4018216|NCT01180985|3839538|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4018217|NCT01180894|3839556|B3|United States||Region of Enrollment||participants|Number|150|150.0||||||
4018218|NCT01180894|3839557|B2|United States||Region of Enrollment||participants|Number|75|75.0||||||
4018219|NCT01180894|3839558|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
4018220|NCT01180894|3839556|B3||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4018221|NCT01180894|3839557|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4018222|NCT01180894|3839558|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4018223|NCT01180894|3839556|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4018224|NCT01180894|3839557|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4018225|NCT01180894|3839558|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4018226|NCT01180894|3839556|B3|||Age||years|Median|41.0|41.0|Full Range|||18.0|87.0|
4018227|NCT01180894|3839557|B2|||Age||years|Median|40.4|40.4|Full Range|||18.0|87.0|
4018228|NCT01180894|3839558|B1|||Age||years|Median|41.6|41.6|Full Range|||18.0|83.0|
4018229|NCT01180894|3839556|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4018230|NCT01180894|3839557|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4018231|NCT01180894|3839558|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4018232|NCT01180894|3839556|B3||Between 18 and 65 years|Age||Participants|Count of Participants|122|122.0||||||
4018233|NCT01180894|3839557|B2||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4018234|NCT01180894|3839558|B1||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4018235|NCT01180894|3839556|B3||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4018236|NCT01180894|3839557|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4018237|NCT01180894|3839558|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4018238|NCT01180790|3839571|B8||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4018239|NCT01180790|3839572|B7||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4018240|NCT01180790|3839573|B6||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4018241|NCT01180790|3839574|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4018242|NCT01180790|3839575|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4018243|NCT01180790|3839576|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4018244|NCT01180790|3839577|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4018245|NCT01180790|3839578|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4018246|NCT01180790|3839571|B8||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4018247|NCT01180790|3839572|B7||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4018248|NCT01180790|3839573|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4018249|NCT01180790|3839574|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4018250|NCT01180790|3839575|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4018251|NCT01180790|3839576|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4018252|NCT01180790|3839577|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4018253|NCT01180790|3839578|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4018254|NCT01180790|3839571|B8||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4018255|NCT01180790|3839572|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4018256|NCT01180790|3839573|B6||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4018257|NCT01180790|3839574|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4018258|NCT01180790|3839575|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4018259|NCT01180790|3839576|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4018260|NCT01180790|3839577|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4018261|NCT01180790|3839578|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4018262|NCT01180790|3839571|B8||Between 18 and 65 years|Age||Participants|Count of Participants|119|119.0||||||
4018263|NCT01180790|3839572|B7||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4018264|NCT01180790|3839573|B6||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4018265|NCT01180790|3839574|B5||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4018266|NCT01180790|3839575|B4||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4018267|NCT01180790|3839576|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4018268|NCT01180790|3839577|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4018269|NCT01180790|3839578|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4018270|NCT01180790|3839571|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4018271|NCT01180790|3839572|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4018272|NCT01180790|3839573|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4018273|NCT01180790|3839574|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4018274|NCT01180790|3839575|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4018275|NCT01180790|3839576|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4018276|NCT01180790|3839577|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4018277|NCT01180790|3839578|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4018278|NCT01180790|3839571|B8|||Age||years|Mean|48|48.0|Standard Deviation|11|11.0|||
4018279|NCT01180790|3839572|B7|||Age||years|Mean|42|42.0|Standard Deviation|12|12.0|||
4018280|NCT01180790|3839573|B6|||Age||years|Mean|48|48.0|Standard Deviation|12|12.0|||
4018281|NCT01180790|3839574|B5|||Age||years|Mean|45|45.0|Standard Deviation|11|11.0|||
4018282|NCT01180790|3839575|B4|||Age||years|Mean|47|47.0|Standard Deviation|9|9.0|||
4018283|NCT01180790|3839576|B3|||Age||years|Mean|52|52.0|Standard Deviation|13|13.0|||
4018284|NCT01180790|3839577|B2|||Age||years|Mean|51|51.0|Standard Deviation|9|9.0|||
4018285|NCT01180790|3839578|B1|||Age||years|Mean|51|51.0|Standard Deviation|7|7.0|||
4018286|NCT01180777|3839649|B1|United States||Region of Enrollment||participants|Number|95|95.0||||||
4018287|NCT01180777|3839649|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4018288|NCT01180777|3839649|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4018289|NCT01180777|3839649|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4018290|NCT01180777|3839649|B1||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
4018291|NCT01180777|3839649|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4018292|NCT01180660|3839661|B3|||Body Mass Index||Unit of measure (kg/m2)|Median|47|47.0|Inter-Quartile Range|||43.0|53.0|
4018293|NCT01180660|3839662|B2|||Body Mass Index||Unit of measure (kg/m2)|Median|48|48.0|Inter-Quartile Range|||44.0|53.0|
4018294|NCT01180660|3839663|B1|||Body Mass Index||Unit of measure (kg/m2)|Median|47|47.0|Inter-Quartile Range|||42.0|54.0|
4018295|NCT01180660|3839661|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
4018296|NCT01180660|3839662|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4018297|NCT01180660|3839663|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4018298|NCT01180660|3839661|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4018299|NCT01180660|3839662|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4018300|NCT01180660|3839663|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4018301|NCT01180660|3839661|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4018302|NCT01180660|3839662|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4018303|NCT01180660|3839663|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4018304|NCT01180660|3839661|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4018305|NCT01180660|3839662|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4018306|NCT01180660|3839663|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4018307|NCT01180660|3839661|B3||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4018308|NCT01180660|3839662|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4018309|NCT01180660|3839663|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4018310|NCT01180660|3839661|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4018311|NCT01180660|3839662|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4018312|NCT01180660|3839663|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4018313|NCT01180647|3839672|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
4018314|NCT01180647|3839673|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4018315|NCT01180647|3839674|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4018316|NCT01180647|3839672|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4018317|NCT01180647|3839673|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4018318|NCT01180647|3839674|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4018319|NCT01180647|3839672|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4018320|NCT01180647|3839673|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4018321|NCT01180647|3839674|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4018322|NCT01180647|3839672|B3|||Age||years|Mean|44|44.0|Full Range|||26.0|58.0|
4018323|NCT01180647|3839673|B2|||Age||years|Mean|47|47.0|Full Range|||39.0|58.0|
4018324|NCT01180647|3839674|B1|||Age||years|Mean|40|40.0|Full Range|||26.0|52.0|
4018325|NCT01180647|3839672|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4018326|NCT01180647|3839673|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4018327|NCT01180647|3839674|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4018328|NCT01180647|3839672|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4018329|NCT01180647|3839673|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4018330|NCT01180647|3839674|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4018331|NCT01180647|3839672|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4018332|NCT01180647|3839673|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4018333|NCT01180647|3839674|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4018334|NCT01180478|3839691|B3|United Arab Emirates||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4018335|NCT01180478|3839692|B2|United Arab Emirates||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4018336|NCT01180478|3839693|B1|United Arab Emirates||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4018337|NCT01180478|3839691|B3|United States||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
4018338|NCT01180478|3839692|B2|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
4018339|NCT01180478|3839693|B1|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4018340|NCT01180478|3839691|B3|Turkey||Region of Enrollment||Participants|Count of Participants|77|77.0||||||
4018341|NCT01180478|3839692|B2|Turkey||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
4018342|NCT01180478|3839693|B1|Turkey||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
4018343|NCT01180478|3839691|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|79|79.0||||||
4018344|NCT01180478|3839692|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
4018345|NCT01180478|3839693|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
4018346|NCT01180478|3839691|B3|Spain||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4018347|NCT01180478|3839692|B2|Spain||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4018348|NCT01180478|3839693|B1|Spain||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4018349|NCT01180478|3839691|B3|Russia||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4018350|NCT01180478|3839692|B2|Russia||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4018351|NCT01180478|3839693|B1|Russia||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4018352|NCT01180478|3839691|B3|Romania||Region of Enrollment||Participants|Count of Participants|59|59.0||||||
4018353|NCT01180478|3839692|B2|Romania||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4018354|NCT01180478|3839693|B1|Romania||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
4018355|NCT01180478|3839691|B3|Norway||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
4018356|NCT01180478|3839692|B2|Norway||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4018357|NCT01180478|3839693|B1|Norway||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4018358|NCT01180478|3839691|B3|South Korea||Region of Enrollment||Participants|Count of Participants|91|91.0||||||
4018359|NCT01180478|3839692|B2|South Korea||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
4018360|NCT01180478|3839693|B1|South Korea||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
4018361|NCT01180478|3839691|B3|Japan||Region of Enrollment||Participants|Count of Participants|172|172.0||||||
4018362|NCT01180478|3839692|B2|Japan||Region of Enrollment||Participants|Count of Participants|75|75.0||||||
4018363|NCT01180478|3839693|B1|Japan||Region of Enrollment||Participants|Count of Participants|97|97.0||||||
4018364|NCT01180478|3839691|B3|Italy||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4018365|NCT01180478|3839692|B2|Italy||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4018366|NCT01180478|3839693|B1|Italy||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4018367|NCT01180478|3839691|B3|India||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
4018368|NCT01180478|3839692|B2|India||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4018369|NCT01180478|3839693|B1|India||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4018370|NCT01180478|3839691|B3|Hong Kong||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
4018371|NCT01180478|3839692|B2|Hong Kong||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
4018372|NCT01180478|3839693|B1|Hong Kong||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4018373|NCT01180478|3839691|B3|Czechia||Region of Enrollment||Participants|Count of Participants|118|118.0||||||
4018374|NCT01180478|3839692|B2|Czechia||Region of Enrollment||Participants|Count of Participants|67|67.0||||||
4018375|NCT01180478|3839693|B1|Czechia||Region of Enrollment||Participants|Count of Participants|51|51.0||||||
4018376|NCT01180478|3839691|B3|China||Region of Enrollment||Participants|Count of Participants|75|75.0||||||
4018377|NCT01180478|3839692|B2|China||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
4018378|NCT01180478|3839693|B1|China||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
4018379|NCT01180478|3839691|B3|Canada||Region of Enrollment||Participants|Count of Participants|92|92.0||||||
4018380|NCT01180478|3839692|B2|Canada||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
4018381|NCT01180478|3839693|B1|Canada||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
4018382|NCT01180478|3839691|B3|Austria||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4018383|NCT01180478|3839692|B2|Austria||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4018384|NCT01180478|3839693|B1|Austria||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4018385|NCT01180478|3839691|B3||Male|Sex: Female, Male||Participants|Count of Participants|773|773.0||||||
4018386|NCT01180478|3839692|B2||Male|Sex: Female, Male||Participants|Count of Participants|383|383.0||||||
4018387|NCT01180478|3839693|B1||Male|Sex: Female, Male||Participants|Count of Participants|390|390.0||||||
4018388|NCT01180478|3839691|B3||Female|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4018389|NCT01180478|3839692|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4018390|NCT01180478|3839693|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4018391|NCT01180478|3839691|B3|||Age||years|Mean|66.24|66.24|Standard Deviation|12.41|12.41|||
4018392|NCT01180478|3839692|B2|||Age||years|Mean|66.7|66.7|Standard Deviation|12.3|12.3|||
4018393|NCT01180478|3839693|B1|||Age||years|Mean|65.8|65.8|Standard Deviation|12.5|12.5|||
4018394|NCT01180400|3839708|B3|||Montgomery-Asberg Depression Rating Scale (MADRS) total score at randomization|A 10-item scale for the evaluation of depressive symptoms. Each MADRS item is rated on a 0 to 6 scale. The MADRS total score is calculated as the sum of the 10 individual item scores; the total score can range from 0 to 60. Higher MADRS scores indicate higher levels of depressive symptoms.|Scores on a scale|Mean|24.7|24.7|Standard Deviation|4.82|4.82|||
4018395|NCT01180400|3839709|B2|||Montgomery-Asberg Depression Rating Scale (MADRS) total score at randomization|A 10-item scale for the evaluation of depressive symptoms. Each MADRS item is rated on a 0 to 6 scale. The MADRS total score is calculated as the sum of the 10 individual item scores; the total score can range from 0 to 60. Higher MADRS scores indicate higher levels of depressive symptoms.|Scores on a scale|Mean|25.1|25.1|Standard Deviation|4.72|4.72|||
4018396|NCT01180400|3839710|B1|||Montgomery-Asberg Depression Rating Scale (MADRS) total score at randomization|A 10-item scale for the evaluation of depressive symptoms. Each MADRS item is rated on a 0 to 6 scale. The MADRS total score is calculated as the sum of the 10 individual item scores; the total score can range from 0 to 60. Higher MADRS scores indicate higher levels of depressive symptoms.|Scores on a scale|Mean|24.3|24.3|Standard Deviation|4.92|4.92|||
4018397|NCT01180400|3839708|B3|||Hamilton Rating Scale for Depression-17 items (HAMD-17) total score at randomization|A 17-item, clinician-rated scale that assesses depressive symptoms. The HAMD-17 consists of 17 symptoms, each of which is rated from 0 to 2 or 0 to 4, where 0 is none/absent. The HAMD-17 total score is calculated as the sum of the 17 individual symptom scores; the total score can range from 0 to 52. Higher HAMD-17 scores indicate more severe depression.|Scores on a scale|Mean|20.2|20.2|Standard Deviation|3.11|3.11|||
4018398|NCT01180400|3839709|B2|||Hamilton Rating Scale for Depression-17 items (HAMD-17) total score at randomization|A 17-item, clinician-rated scale that assesses depressive symptoms. The HAMD-17 consists of 17 symptoms, each of which is rated from 0 to 2 or 0 to 4, where 0 is none/absent. The HAMD-17 total score is calculated as the sum of the 17 individual symptom scores; the total score can range from 0 to 52. Higher HAMD-17 scores indicate more severe depression.|Scores on a scale|Mean|20.5|20.5|Standard Deviation|3.41|3.41|||
4018399|NCT01180400|3839710|B1|||Hamilton Rating Scale for Depression-17 items (HAMD-17) total score at randomization|A 17-item, clinician-rated scale that assesses depressive symptoms. The HAMD-17 consists of 17 symptoms, each of which is rated from 0 to 2 or 0 to 4, where 0 is none/absent. The HAMD-17 total score is calculated as the sum of the 17 individual symptom scores; the total score can range from 0 to 52. Higher HAMD-17 scores indicate more severe depression.|Scores on a scale|Mean|20.0|20.0|Standard Deviation|2.77|2.77|||
4018400|NCT01180400|3839708|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4018401|NCT01180400|3839709|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4018402|NCT01180400|3839710|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4018403|NCT01180400|3839708|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4018404|NCT01180400|3839709|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4018405|NCT01180400|3839710|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4018406|NCT01180400|3839708|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4018407|NCT01180400|3839709|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4018408|NCT01180400|3839710|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4018409|NCT01180400|3839708|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4018410|NCT01180400|3839709|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4018411|NCT01180400|3839710|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4018412|NCT01180400|3839708|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4018413|NCT01180400|3839709|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4018414|NCT01180400|3839710|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4018415|NCT01180400|3839708|B3|White||Race/Ethnicity, Customized||participants|Number|294|294.0||||||
4018416|NCT01180400|3839709|B2|White||Race/Ethnicity, Customized||participants|Number|148|148.0||||||
4018417|NCT01180400|3839710|B1|White||Race/Ethnicity, Customized||participants|Number|146|146.0||||||
4018418|NCT01180400|3839708|B3||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4018419|NCT01180400|3839709|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4018420|NCT01180400|3839710|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4018421|NCT01180400|3839708|B3||Female|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4018422|NCT01180400|3839709|B2||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4018423|NCT01180400|3839710|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4018424|NCT01180400|3839708|B3|||Age||years|Mean|44.8|44.8|Standard Deviation|11.34|11.34|||
4018425|NCT01180400|3839709|B2|||Age||years|Mean|43.4|43.4|Standard Deviation|11.31|11.31|||
4018426|NCT01180400|3839710|B1|||Age||years|Mean|46.1|46.1|Standard Deviation|11.25|11.25|||
4018427|NCT01180296|3839757|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4018428|NCT01180296|3839758|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4018429|NCT01180296|3839759|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4018430|NCT01180296|3839757|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4018431|NCT01180296|3839758|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4018432|NCT01180296|3839759|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4018433|NCT01180296|3839757|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4018434|NCT01180296|3839758|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4018435|NCT01180296|3839759|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4018436|NCT01180296|3839757|B3|||Age||years|Mean|28|28.0|Standard Deviation|4|4.0|||
4018437|NCT01180296|3839758|B2|||Age||years|Mean|27.2|27.2|Standard Deviation|4.9|4.9|||
4018438|NCT01180296|3839759|B1|||Age||years|Mean|29.3|29.3|Standard Deviation|4.7|4.7|||
4018439|NCT01180296|3839757|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4018440|NCT01180296|3839758|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4018441|NCT01180296|3839759|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4018442|NCT01180296|3839757|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4018443|NCT01180296|3839758|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4018444|NCT01180296|3839759|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4018445|NCT01180296|3839757|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4018446|NCT01180296|3839758|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4018447|NCT01180296|3839759|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4018448|NCT01180244|3839766|B3|United States||Region of Enrollment||participants|Number|77|77.0||||||
4018449|NCT01180244|3839767|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
4018450|NCT01180244|3839768|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4018451|NCT01180244|3839766|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4018452|NCT01180244|3839767|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4018453|NCT01180244|3839768|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4018454|NCT01180244|3839766|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4018455|NCT01180244|3839767|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4018456|NCT01180244|3839768|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4018457|NCT01180244|3839766|B3|||Age||years|Mean|52.7|52.7|Standard Deviation|9.7|9.7|||
4018458|NCT01180244|3839767|B2|||Age||years|Mean|54.0|54.0|Standard Deviation|9.0|9.0|||
4018459|NCT01180244|3839768|B1|||Age||years|Mean|51.3|51.3|Standard Deviation|10.3|10.3|||
4018460|NCT01180127|3839783|B5|United States||Region of Enrollment||participants|Number|41|41.0||||||
4018461|NCT01180127|3839784|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
4018462|NCT01180127|3839785|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4018463|NCT01180127|3839786|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4018464|NCT01180127|3839787|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4018465|NCT01180127|3839783|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4018466|NCT01180127|3839784|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4018467|NCT01180127|3839785|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4018468|NCT01180127|3839786|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4018469|NCT01180127|3839787|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4018470|NCT01180127|3839783|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018471|NCT01180127|3839784|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018472|NCT01180127|3839785|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018473|NCT01180127|3839786|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018474|NCT01180127|3839787|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018475|NCT01180127|3839783|B5||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4018476|NCT01180127|3839784|B4||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4018477|NCT01180127|3839785|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4018478|NCT01180127|3839786|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4018479|NCT01180127|3839787|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4018480|NCT01180127|3839783|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4018481|NCT01180127|3839784|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4018482|NCT01180127|3839785|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4018483|NCT01180127|3839786|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4018484|NCT01180127|3839787|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4018485|NCT01180127|3839783|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018486|NCT01180127|3839784|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018487|NCT01180127|3839785|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018488|NCT01180127|3839786|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018489|NCT01180127|3839787|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018490|NCT01180127|3839783|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4018491|NCT01180127|3839784|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4018492|NCT01180127|3839785|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018493|NCT01180127|3839786|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018494|NCT01180127|3839787|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4018495|NCT01180127|3839783|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018496|NCT01180127|3839784|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018497|NCT01180127|3839785|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018498|NCT01180127|3839786|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018499|NCT01180127|3839787|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018500|NCT01180127|3839783|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018501|NCT01180127|3839784|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018502|NCT01180127|3839785|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018503|NCT01180127|3839786|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018504|NCT01180127|3839787|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018505|NCT01180127|3839783|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4018506|NCT01180127|3839784|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4018507|NCT01180127|3839785|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4018508|NCT01180127|3839786|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4018509|NCT01180127|3839787|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4018510|NCT01180127|3839783|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4018511|NCT01180127|3839784|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4018512|NCT01180127|3839785|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4018513|NCT01180127|3839786|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4018514|NCT01180127|3839787|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4018515|NCT01180127|3839783|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4018516|NCT01180127|3839784|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4018517|NCT01180127|3839785|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4018518|NCT01180127|3839786|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4018519|NCT01180127|3839787|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4018520|NCT01180127|3839783|B5||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4018521|NCT01180127|3839784|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4018522|NCT01180127|3839785|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4018523|NCT01180127|3839786|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4018524|NCT01180127|3839787|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4018525|NCT01180127|3839783|B5|||Age||years|Mean|57.5|57.5|Standard Deviation|4.89|4.89|||
4018526|NCT01180127|3839784|B4|||Age||years|Mean|56.6|56.6|Standard Deviation|3.7|3.7|||
4018527|NCT01180127|3839785|B3|||Age||years|Mean|56.6|56.6|Standard Deviation|5.56|5.56|||
4018528|NCT01180127|3839786|B2|||Age||years|Mean|57.5|57.5|Standard Deviation|5.34|5.34|||
4018529|NCT01180127|3839787|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|4.9|4.9|||
4018530|NCT01180049|3839812|B3||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4018531|NCT01180049|3839813|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4018532|NCT01180049|3839814|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4018533|NCT01180049|3839812|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4018534|NCT01180049|3839813|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4018535|NCT01180049|3839814|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4018536|NCT01180049|3839812|B3|||Age||Years|Mean|66.6|66.6|Standard Deviation|8.44|8.44|||
4018537|NCT01180049|3839813|B2|||Age||Years|Mean|66.3|66.3|Standard Deviation|8.47|8.47|||
4018538|NCT01180049|3839814|B1|||Age||Years|Mean|67|67.0|Standard Deviation|8.49|8.49|||
4018539|NCT01179984|3839835|B1|Germany||Region of Enrollment||participants|Number|76|76.0||||||
4018540|NCT01179984|3839835|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018541|NCT01179984|3839835|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018542|NCT01179984|3839835|B1||White|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
4018543|NCT01179984|3839835|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018544|NCT01179984|3839835|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018545|NCT01179984|3839835|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018546|NCT01179984|3839835|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018547|NCT01179984|3839835|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
4018548|NCT01179984|3839835|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018549|NCT01179984|3839835|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018550|NCT01179984|3839835|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4018551|NCT01179984|3839835|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4018552|NCT01179984|3839835|B1|||Age||Years|Mean|70.1|70.1|Standard Deviation|8.5|8.5|||
4018553|NCT01179984|3839835|B1||>=65 years|Age||Participants|Count of Participants|52|52.0||||||
4018554|NCT01179984|3839835|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4018555|NCT01179984|3839835|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4018556|NCT01179919|3839841|B1|||Body Mass Index||kg/m^2|Median|43.7|43.7|Full Range|||40.0|54.4|
4018557|NCT01179919|3839841|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018558|NCT01179919|3839841|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4018559|NCT01179919|3839841|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4018560|NCT01179919|3839841|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4018561|NCT01179919|3839841|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018562|NCT01179919|3839841|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018563|NCT01179919|3839841|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018564|NCT01179919|3839841|B1||Male|Gender||Participants|Count of Participants|4|4.0||||||
4018565|NCT01179919|3839841|B1||Female|Gender||Participants|Count of Participants|17|17.0||||||
4018566|NCT01179919|3839841|B1|||Age||years|Median|36|36.0|Full Range|||19.0|50.0|
4018567|NCT01179737|3839846|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4018568|NCT01179737|3839847|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4018569|NCT01179737|3839848|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4018570|NCT01179737|3839849|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4018571|NCT01179737|3839850|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4018572|NCT01179737|3839846|B5||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4018573|NCT01179737|3839847|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4018574|NCT01179737|3839848|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4018575|NCT01179737|3839849|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4018576|NCT01179737|3839850|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4018577|NCT01179737|3839846|B5|||Age||Years|Mean|32|32.0|Standard Deviation|11.8|11.8|||
4018578|NCT01179737|3839847|B4|||Age||Years|Mean|33|33.0|Standard Deviation|10.2|10.2|||
4018579|NCT01179737|3839848|B3|||Age||Years|Mean|31|31.0|Standard Deviation|14.6|14.6|||
4018580|NCT01179737|3839849|B2|||Age||Years|Mean|60|60.0|Standard Deviation|6.1|6.1|||
4018581|NCT01179737|3839850|B1|||Age||Years|Mean|52|52.0|Standard Deviation|13.1|13.1|||
4018582|NCT01179672|3839862|B3|||Sheehan Disability Scale (SDS) Total Score|SDS was self-reported and used to assess the effect of the participant's symptoms on their work (Item 1), social life (Item 2), and family life (Item 3). Each item was measured on a 0 (not at all) to 10 (extremely) point scale with higher values indicating greater disruption. SDS Total Score was the sum of the 3 items and ranged from 0 to 30 with higher values indicating greater disruption in the participant's work/social/family life. Scores ≥5 were associated with significant functional impairment.|units on a scale|Mean|10.85|10.85|Standard Deviation|7.45|7.45|||
4018583|NCT01179672|3839863|B2|||Sheehan Disability Scale (SDS) Total Score|SDS was self-reported and used to assess the effect of the participant's symptoms on their work (Item 1), social life (Item 2), and family life (Item 3). Each item was measured on a 0 (not at all) to 10 (extremely) point scale with higher values indicating greater disruption. SDS Total Score was the sum of the 3 items and ranged from 0 to 30 with higher values indicating greater disruption in the participant's work/social/family life. Scores ≥5 were associated with significant functional impairment.|units on a scale|Mean|10.54|10.54|Standard Deviation|7.31|7.31|||
4018584|NCT01179672|3839864|B1|||Sheehan Disability Scale (SDS) Total Score|SDS was self-reported and used to assess the effect of the participant's symptoms on their work (Item 1), social life (Item 2), and family life (Item 3). Each item was measured on a 0 (not at all) to 10 (extremely) point scale with higher values indicating greater disruption. SDS Total Score was the sum of the 3 items and ranged from 0 to 30 with higher values indicating greater disruption in the participant's work/social/family life. Scores ≥5 were associated with significant functional impairment.|units on a scale|Mean|11.16|11.16|Standard Deviation|7.59|7.59|||
4018585|NCT01179672|3839862|B3|||BPI-Interference Average Score|BPI-Interference Score was self-reported scale that measured interference of pain based on the average of the 7 questions assessing the interference of pain for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. The average interference scores ranged from 0 (does not interfere) to 10 (completely interferes).|units on a scale|Mean|4.23|4.23|Standard Deviation|2.30|2.3|||
4018586|NCT01179672|3839863|B2|||BPI-Interference Average Score|BPI-Interference Score was self-reported scale that measured interference of pain based on the average of the 7 questions assessing the interference of pain for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. The average interference scores ranged from 0 (does not interfere) to 10 (completely interferes).|units on a scale|Mean|4.08|4.08|Standard Deviation|2.30|2.3|||
4018610|NCT01179672|3839863|B2|Type II Diabetes||Diabetes Disease Characteristics-Types of Diabetes||participants|Number|199|199.0||||||
4018611|NCT01179672|3839864|B1|Type II Diabetes||Diabetes Disease Characteristics-Types of Diabetes||participants|Number|200|200.0||||||
4018612|NCT01179672|3839862|B3|Type I Diabetes||Diabetes Disease Characteristics-Types of Diabetes||participants|Number|6|6.0||||||
4018587|NCT01179672|3839864|B1|||BPI-Interference Average Score|BPI-Interference Score was self-reported scale that measured interference of pain based on the average of the 7 questions assessing the interference of pain for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. The average interference scores ranged from 0 (does not interfere) to 10 (completely interferes).|units on a scale|Mean|4.38|4.38|Standard Deviation|2.29|2.29|||
4018588|NCT01179672|3839862|B3|||Short Form-McGill Pain Questionnaire (SF-MPQ), Sensory Portion Total Score|SF-MPQ sensory portion was a self-reported instrument consisting of 11 sensory descriptors describing pain, each rated on an intensity scale from 0 (none) to 3 (severe). Total scores ranged from 0 to 33.|units on a scale|Mean|12.02|12.02|Standard Deviation|5.97|5.97|||
4018589|NCT01179672|3839863|B2|||Short Form-McGill Pain Questionnaire (SF-MPQ), Sensory Portion Total Score|SF-MPQ sensory portion was a self-reported instrument consisting of 11 sensory descriptors describing pain, each rated on an intensity scale from 0 (none) to 3 (severe). Total scores ranged from 0 to 33.|units on a scale|Mean|11.81|11.81|Standard Deviation|5.52|5.52|||
4018590|NCT01179672|3839864|B1|||Short Form-McGill Pain Questionnaire (SF-MPQ), Sensory Portion Total Score|SF-MPQ sensory portion was a self-reported instrument consisting of 11 sensory descriptors describing pain, each rated on an intensity scale from 0 (none) to 3 (severe). Total scores ranged from 0 to 33.|units on a scale|Mean|12.24|12.24|Standard Deviation|6.39|6.39|||
4018591|NCT01179672|3839862|B3|||Clinical Global Impression of Severity (CGI-S)|Number of participants analyzed was: Duloxetine treatment =126 and Placebo=136. Data from 9 sites were not included in baseline analysis due to wrong questionnaire used. CSI-S was administered by the investigator in the presence of the participant and measured severity of illness at baseline with scores ranging from 1 (normal, not at all ill) to 7 (among the most extremely ill participants).|units on a scale|Mean|4.71|4.71|Standard Deviation|1.14|1.14|||
4018592|NCT01179672|3839863|B2|||Clinical Global Impression of Severity (CGI-S)|Number of participants analyzed was: Duloxetine treatment =126 and Placebo=136. Data from 9 sites were not included in baseline analysis due to wrong questionnaire used. CSI-S was administered by the investigator in the presence of the participant and measured severity of illness at baseline with scores ranging from 1 (normal, not at all ill) to 7 (among the most extremely ill participants).|units on a scale|Mean|4.66|4.66|Standard Deviation|1.07|1.07|||
4018593|NCT01179672|3839864|B1|||Clinical Global Impression of Severity (CGI-S)|Number of participants analyzed was: Duloxetine treatment =126 and Placebo=136. Data from 9 sites were not included in baseline analysis due to wrong questionnaire used. CSI-S was administered by the investigator in the presence of the participant and measured severity of illness at baseline with scores ranging from 1 (normal, not at all ill) to 7 (among the most extremely ill participants).|units on a scale|Mean|4.76|4.76|Standard Deviation|1.22|1.22|||
4018594|NCT01179672|3839862|B3|||Brief Pain Inventory (BPI)-Severity Average Pain in the Last Week|BPI-Severity Modified Short Form Severity was a self-reported scale that measured the severity of pain. Severity scores ranged from 0 (no pain) to 10 (pain as bad as you could imagine). There were 4 questions assessing the severity for worst pain, least pain, average pain, and the pain right now.|units on a scale|Mean|5.91|5.91|Standard Deviation|1.67|1.67|||
4018595|NCT01179672|3839863|B2|||Brief Pain Inventory (BPI)-Severity Average Pain in the Last Week|BPI-Severity Modified Short Form Severity was a self-reported scale that measured the severity of pain. Severity scores ranged from 0 (no pain) to 10 (pain as bad as you could imagine). There were 4 questions assessing the severity for worst pain, least pain, average pain, and the pain right now.|units on a scale|Mean|5.86|5.86|Standard Deviation|1.64|1.64|||
4018596|NCT01179672|3839864|B1|||Brief Pain Inventory (BPI)-Severity Average Pain in the Last Week|BPI-Severity Modified Short Form Severity was a self-reported scale that measured the severity of pain. Severity scores ranged from 0 (no pain) to 10 (pain as bad as you could imagine). There were 4 questions assessing the severity for worst pain, least pain, average pain, and the pain right now.|units on a scale|Mean|5.97|5.97|Standard Deviation|1.70|1.7|||
4018597|NCT01179672|3839862|B3|||Weekly Mean of 24-Hour Average Pain|Participants measured their pain on an 11-point Likert scale that was completed daily. The scale ranged from 0 (no pain) to 10 (worst possible pain). The participant-recorded average pain due to diabetic neuropathy over the previous 24 hours.|units on a scale|Mean|5.67|5.67|Standard Deviation|1.69|1.69|||
4018598|NCT01179672|3839863|B2|||Weekly Mean of 24-Hour Average Pain|Participants measured their pain on an 11-point Likert scale that was completed daily. The scale ranged from 0 (no pain) to 10 (worst possible pain). The participant-recorded average pain due to diabetic neuropathy over the previous 24 hours.|units on a scale|Mean|5.62|5.62|Standard Deviation|1.66|1.66|||
4018599|NCT01179672|3839864|B1|||Weekly Mean of 24-Hour Average Pain|Participants measured their pain on an 11-point Likert scale that was completed daily. The scale ranged from 0 (no pain) to 10 (worst possible pain). The participant-recorded average pain due to diabetic neuropathy over the previous 24 hours.|units on a scale|Mean|5.72|5.72|Standard Deviation|1.72|1.72|||
4018600|NCT01179672|3839862|B3|Duration of Diabetic Neuropathy Pain||Diabetes Disease Characteristics||years|Mean|2.83|2.83|Standard Deviation|3.24|3.24|||
4018601|NCT01179672|3839863|B2|Duration of Diabetic Neuropathy Pain||Diabetes Disease Characteristics||years|Mean|2.59|2.59|Standard Deviation|2.69|2.69|||
4018602|NCT01179672|3839864|B1|Duration of Diabetic Neuropathy Pain||Diabetes Disease Characteristics||years|Mean|3.06|3.06|Standard Deviation|3.70|3.7|||
4018603|NCT01179672|3839862|B3|Duration of Diabetic Neuropathy||Diabetes Disease Characteristics||years|Mean|3.27|3.27|Standard Deviation|3.55|3.55|||
4018604|NCT01179672|3839863|B2|Duration of Diabetic Neuropathy||Diabetes Disease Characteristics||years|Mean|3.07|3.07|Standard Deviation|3.13|3.13|||
4018605|NCT01179672|3839864|B1|Duration of Diabetic Neuropathy||Diabetes Disease Characteristics||years|Mean|3.47|3.47|Standard Deviation|3.91|3.91|||
4018606|NCT01179672|3839862|B3|Duration of Diabetes||Diabetes Disease Characteristics||years|Mean|11.45|11.45|Standard Deviation|7.14|7.14|||
4018607|NCT01179672|3839863|B2|Duration of Diabetes||Diabetes Disease Characteristics||years|Mean|11.38|11.38|Standard Deviation|7.47|7.47|||
4018608|NCT01179672|3839864|B1|Duration of Diabetes||Diabetes Disease Characteristics||years|Mean|11.53|11.53|Standard Deviation|6.81|6.81|||
4018609|NCT01179672|3839862|B3|Type II Diabetes||Diabetes Disease Characteristics-Types of Diabetes||participants|Number|399|399.0||||||
4018754|NCT01179516|3839918|B4|||Weight||kg|Mean|87.81|87.81|Standard Deviation|23.678|23.678|||
4018613|NCT01179672|3839863|B2|Type I Diabetes||Diabetes Disease Characteristics-Types of Diabetes||participants|Number|3|3.0||||||
4018614|NCT01179672|3839864|B1|Type I Diabetes||Diabetes Disease Characteristics-Types of Diabetes||participants|Number|3|3.0||||||
4018615|NCT01179672|3839862|B3|China||Region of Enrollment||participants|Number|405|405.0||||||
4018616|NCT01179672|3839863|B2|China||Region of Enrollment||participants|Number|202|202.0||||||
4018617|NCT01179672|3839864|B1|China||Region of Enrollment||participants|Number|203|203.0||||||
4018618|NCT01179672|3839862|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018619|NCT01179672|3839863|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018620|NCT01179672|3839864|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018621|NCT01179672|3839862|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018622|NCT01179672|3839863|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018623|NCT01179672|3839864|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018624|NCT01179672|3839862|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018625|NCT01179672|3839863|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018626|NCT01179672|3839864|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018627|NCT01179672|3839862|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018628|NCT01179672|3839863|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018629|NCT01179672|3839864|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018630|NCT01179672|3839862|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018631|NCT01179672|3839863|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018632|NCT01179672|3839864|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018633|NCT01179672|3839862|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|405|405.0||||||
4018634|NCT01179672|3839863|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|202|202.0||||||
4018635|NCT01179672|3839864|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|203|203.0||||||
4018636|NCT01179672|3839862|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018637|NCT01179672|3839863|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018638|NCT01179672|3839864|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018639|NCT01179672|3839862|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018640|NCT01179672|3839863|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018641|NCT01179672|3839864|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018642|NCT01179672|3839862|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|405|405.0||||||
4018643|NCT01179672|3839863|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|202|202.0||||||
4018644|NCT01179672|3839864|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|203|203.0||||||
4018645|NCT01179672|3839862|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018646|NCT01179672|3839863|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018647|NCT01179672|3839864|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018648|NCT01179672|3839862|B3||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4018649|NCT01179672|3839863|B2||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4018650|NCT01179672|3839864|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4018651|NCT01179672|3839862|B3||Female|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4018652|NCT01179672|3839863|B2||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4018653|NCT01179672|3839864|B1||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4018654|NCT01179672|3839862|B3|||Age||years|Mean|61.37|61.37|Standard Deviation|9.52|9.52|||
4018655|NCT01179672|3839863|B2|||Age||years|Mean|61.17|61.17|Standard Deviation|9.42|9.42|||
4018656|NCT01179672|3839864|B1|||Age||years|Mean|61.56|61.56|Standard Deviation|9.65|9.65|||
4018657|NCT01179568|3839891|B5|Others||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4018658|NCT01179568|3839892|B4|Others||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4018659|NCT01179568|3839893|B3|Others||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4018660|NCT01179568|3839894|B2|Others||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4018661|NCT01179568|3839895|B1|Others||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4018662|NCT01179568|3839891|B5|Black||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4018663|NCT01179568|3839892|B4|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4018664|NCT01179568|3839893|B3|Black||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4018665|NCT01179568|3839894|B2|Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4018666|NCT01179568|3839895|B1|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4018667|NCT01179568|3839891|B5|While||Race/Ethnicity, Customized||participants|Number|325|325.0||||||
4018668|NCT01179568|3839892|B4|While||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
4018669|NCT01179568|3839893|B3|While||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
4018670|NCT01179568|3839894|B2|While||Race/Ethnicity, Customized||participants|Number|80|80.0||||||
4018671|NCT01179568|3839895|B1|While||Race/Ethnicity, Customized||participants|Number|85|85.0||||||
4018672|NCT01179568|3839891|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018673|NCT01179568|3839892|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018674|NCT01179568|3839893|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018675|NCT01179568|3839894|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018676|NCT01179568|3839895|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018677|NCT01179568|3839891|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|350|350.0||||||
4018678|NCT01179568|3839892|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
4018679|NCT01179568|3839893|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
4018680|NCT01179568|3839894|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
4018681|NCT01179568|3839895|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
4018682|NCT01179568|3839891|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4018683|NCT01179568|3839892|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4018684|NCT01179568|3839893|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4018685|NCT01179568|3839894|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4018686|NCT01179568|3839895|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4018687|NCT01179568|3839891|B5||Male|Gender||Participants|Count of Participants|87|87.0||||||
4018688|NCT01179568|3839892|B4||Male|Gender||Participants|Count of Participants|17|17.0||||||
4018689|NCT01179568|3839893|B3||Male|Gender||Participants|Count of Participants|21|21.0||||||
4018690|NCT01179568|3839894|B2||Male|Gender||Participants|Count of Participants|30|30.0||||||
4018691|NCT01179568|3839895|B1||Male|Gender||Participants|Count of Participants|19|19.0||||||
4018692|NCT01179568|3839891|B5||Female|Gender||Participants|Count of Participants|308|308.0||||||
4018693|NCT01179568|3839892|B4||Female|Gender||Participants|Count of Participants|79|79.0||||||
4018694|NCT01179568|3839893|B3||Female|Gender||Participants|Count of Participants|78|78.0||||||
4018695|NCT01179568|3839894|B2||Female|Gender||Participants|Count of Participants|69|69.0||||||
4018696|NCT01179568|3839895|B1||Female|Gender||Participants|Count of Participants|82|82.0||||||
4018697|NCT01179568|3839891|B5|||Age||years|Mean|53.0|53.0|Standard Deviation|14.5|14.5|||
4018698|NCT01179568|3839892|B4|||Age||years|Mean|53.5|53.5|Standard Deviation|16.0|16.0|||
4018699|NCT01179568|3839893|B3|||Age||years|Mean|52.1|52.1|Standard Deviation|15.3|15.3|||
4018700|NCT01179568|3839894|B2|||Age||years|Mean|53.9|53.9|Standard Deviation|13.8|13.8|||
4018701|NCT01179568|3839895|B1|||Age||years|Mean|52.4|52.4|Standard Deviation|13.1|13.1|||
4018702|NCT01179516|3839918|B4|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|sores on a scale|Mean|4.7|4.7|Standard Deviation|0.59|0.59|||
4018703|NCT01179516|3839919|B3|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|sores on a scale|Mean|4.6|4.6|Standard Deviation|0.59|0.59|||
4018704|NCT01179516|3839920|B2|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|sores on a scale|Mean|4.7|4.7|Standard Deviation|0.56|0.56|||
4018705|NCT01179516|3839921|B1|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|sores on a scale|Mean|4.7|4.7|Standard Deviation|0.61|0.61|||
4018706|NCT01179516|3839918|B4|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 (absent) to 56 (maximum severity).|scores on a scale|Mean|19.9|19.9|Standard Deviation|5.78|5.78|||
4018707|NCT01179516|3839919|B3|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 (absent) to 56 (maximum severity).|scores on a scale|Mean|19.5|19.5|Standard Deviation|5.42|5.42|||
4018752|NCT01179516|3839920|B2|||Body Mass Index (BMI)||kg/m^2|Mean|31.29|31.29|Standard Deviation|8.063|8.063|||
4018753|NCT01179516|3839921|B1|||Body Mass Index (BMI)||kg/m^2|Mean|31.14|31.14|Standard Deviation|7.533|7.533|||
4018708|NCT01179516|3839920|B2|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 (absent) to 56 (maximum severity).|scores on a scale|Mean|20.1|20.1|Standard Deviation|5.77|5.77|||
4018709|NCT01179516|3839921|B1|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 (absent) to 56 (maximum severity).|scores on a scale|Mean|20.0|20.0|Standard Deviation|6.14|6.14|||
4018710|NCT01179516|3839918|B4|||Montgomery Åsberg Depression Rating Scale (MADRS) Total Score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|33.7|33.7|Standard Deviation|4.37|4.37|||
4018711|NCT01179516|3839919|B3|||Montgomery Åsberg Depression Rating Scale (MADRS) Total Score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|33.7|33.7|Standard Deviation|4.51|4.51|||
4018712|NCT01179516|3839920|B2|||Montgomery Åsberg Depression Rating Scale (MADRS) Total Score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|34.1|34.1|Standard Deviation|4.07|4.07|||
4018713|NCT01179516|3839921|B1|||Montgomery Åsberg Depression Rating Scale (MADRS) Total Score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|33.4|33.4|Standard Deviation|4.53|4.53|||
4018714|NCT01179516|3839918|B4|Daily||Alcohol Consumption||participants|Number|10|10.0||||||
4018715|NCT01179516|3839919|B3|Daily||Alcohol Consumption||participants|Number|4|4.0||||||
4018716|NCT01179516|3839920|B2|Daily||Alcohol Consumption||participants|Number|5|5.0||||||
4018717|NCT01179516|3839921|B1|Daily||Alcohol Consumption||participants|Number|1|1.0||||||
4018718|NCT01179516|3839918|B4|2 to 6 times per week||Alcohol Consumption||participants|Number|60|60.0||||||
4018719|NCT01179516|3839919|B3|2 to 6 times per week||Alcohol Consumption||participants|Number|14|14.0||||||
4018720|NCT01179516|3839920|B2|2 to 6 times per week||Alcohol Consumption||participants|Number|22|22.0||||||
4018721|NCT01179516|3839921|B1|2 to 6 times per week||Alcohol Consumption||participants|Number|24|24.0||||||
4018722|NCT01179516|3839918|B4|Once per week||Alcohol Consumption||participants|Number|67|67.0||||||
4018723|NCT01179516|3839919|B3|Once per week||Alcohol Consumption||participants|Number|21|21.0||||||
4018724|NCT01179516|3839920|B2|Once per week||Alcohol Consumption||participants|Number|20|20.0||||||
4018725|NCT01179516|3839921|B1|Once per week||Alcohol Consumption||participants|Number|26|26.0||||||
4018726|NCT01179516|3839918|B4|Once monthly or less often||Alcohol Consumption||participants|Number|178|178.0||||||
4018727|NCT01179516|3839919|B3|Once monthly or less often||Alcohol Consumption||participants|Number|62|62.0||||||
4018728|NCT01179516|3839920|B2|Once monthly or less often||Alcohol Consumption||participants|Number|56|56.0||||||
4018729|NCT01179516|3839921|B1|Once monthly or less often||Alcohol Consumption||participants|Number|60|60.0||||||
4018730|NCT01179516|3839918|B4|Never||Alcohol Consumption||participants|Number|154|154.0||||||
4018731|NCT01179516|3839919|B3|Never||Alcohol Consumption||participants|Number|51|51.0||||||
4018732|NCT01179516|3839920|B2|Never||Alcohol Consumption||participants|Number|54|54.0||||||
4018733|NCT01179516|3839921|B1|Never||Alcohol Consumption||participants|Number|49|49.0||||||
4018734|NCT01179516|3839918|B4|Ex-smoker||Smoking Classification||participants|Number|100|100.0||||||
4018735|NCT01179516|3839919|B3|Ex-smoker||Smoking Classification||participants|Number|38|38.0||||||
4018736|NCT01179516|3839920|B2|Ex-smoker||Smoking Classification||participants|Number|31|31.0||||||
4018737|NCT01179516|3839921|B1|Ex-smoker||Smoking Classification||participants|Number|31|31.0||||||
4018738|NCT01179516|3839918|B4|Current smoker||Smoking Classification||participants|Number|138|138.0||||||
4018739|NCT01179516|3839919|B3|Current smoker||Smoking Classification||participants|Number|52|52.0||||||
4018740|NCT01179516|3839920|B2|Current smoker||Smoking Classification||participants|Number|40|40.0||||||
4018741|NCT01179516|3839921|B1|Current smoker||Smoking Classification||participants|Number|46|46.0||||||
4018742|NCT01179516|3839918|B4|Never smoked||Smoking Classification||participants|Number|231|231.0||||||
4018743|NCT01179516|3839919|B3|Never smoked||Smoking Classification||participants|Number|62|62.0||||||
4018744|NCT01179516|3839920|B2|Never smoked||Smoking Classification||participants|Number|86|86.0||||||
4018745|NCT01179516|3839921|B1|Never smoked||Smoking Classification||participants|Number|83|83.0||||||
4018746|NCT01179516|3839918|B4|||Waist Circumference||cm|Mean|99.31|99.31|Standard Deviation|17.370|17.37|||
4018747|NCT01179516|3839919|B3|||Waist Circumference||cm|Mean|97.93|97.93|Standard Deviation|17.536|17.536|||
4018748|NCT01179516|3839920|B2|||Waist Circumference||cm|Mean|100.02|100.02|Standard Deviation|16.762|16.762|||
4018749|NCT01179516|3839921|B1|||Waist Circumference||cm|Mean|99.93|99.93|Standard Deviation|17.820|17.82|||
4018750|NCT01179516|3839918|B4|||Body Mass Index (BMI)||kg/m^2|Mean|31.07|31.07|Standard Deviation|7.771|7.771|||
4018751|NCT01179516|3839919|B3|||Body Mass Index (BMI)||kg/m^2|Mean|30.78|30.78|Standard Deviation|7.752|7.752|||
4018755|NCT01179516|3839919|B3|||Weight||kg|Mean|86.49|86.49|Standard Deviation|23.154|23.154|||
4018756|NCT01179516|3839920|B2|||Weight||kg|Mean|87.74|87.74|Standard Deviation|23.914|23.914|||
4018757|NCT01179516|3839921|B1|||Weight||kg|Mean|89.14|89.14|Standard Deviation|24.010|24.01|||
4018758|NCT01179516|3839918|B4|||Height||cm|Mean|167.92|167.92|Standard Deviation|9.920|9.92|||
4018759|NCT01179516|3839919|B3|||Height||cm|Mean|167.52|167.52|Standard Deviation|9.789|9.789|||
4018760|NCT01179516|3839920|B2|||Height||cm|Mean|167.35|167.35|Standard Deviation|9.523|9.523|||
4018761|NCT01179516|3839921|B1|||Height||cm|Mean|168.85|168.85|Standard Deviation|10.407|10.407|||
4018762|NCT01179516|3839918|B4|United States||Region of Enrollment||participants|Number|469|469.0||||||
4018763|NCT01179516|3839919|B3|United States||Region of Enrollment||participants|Number|152|152.0||||||
4018764|NCT01179516|3839920|B2|United States||Region of Enrollment||participants|Number|157|157.0||||||
4018765|NCT01179516|3839921|B1|United States||Region of Enrollment||participants|Number|160|160.0||||||
4018766|NCT01179516|3839918|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4018767|NCT01179516|3839919|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4018768|NCT01179516|3839920|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4018769|NCT01179516|3839921|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4018770|NCT01179516|3839918|B4|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4018771|NCT01179516|3839919|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4018772|NCT01179516|3839920|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4018773|NCT01179516|3839921|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4018774|NCT01179516|3839918|B4|Black||Race/Ethnicity, Customized||participants|Number|112|112.0||||||
4018775|NCT01179516|3839919|B3|Black||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4018776|NCT01179516|3839920|B2|Black||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4018777|NCT01179516|3839921|B1|Black||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4018778|NCT01179516|3839918|B4|Caucasian (White, including Hispanic)||Race/Ethnicity, Customized||participants|Number|348|348.0||||||
4018779|NCT01179516|3839919|B3|Caucasian (White, including Hispanic)||Race/Ethnicity, Customized||participants|Number|109|109.0||||||
4018780|NCT01179516|3839920|B2|Caucasian (White, including Hispanic)||Race/Ethnicity, Customized||participants|Number|115|115.0||||||
4018781|NCT01179516|3839921|B1|Caucasian (White, including Hispanic)||Race/Ethnicity, Customized||participants|Number|124|124.0||||||
4018782|NCT01179516|3839918|B4|Non-Hispanic and non-Latino||Race/Ethnicity, Customized||participants|Number|415|415.0||||||
4018783|NCT01179516|3839919|B3|Non-Hispanic and non-Latino||Race/Ethnicity, Customized||participants|Number|134|134.0||||||
4018784|NCT01179516|3839920|B2|Non-Hispanic and non-Latino||Race/Ethnicity, Customized||participants|Number|141|141.0||||||
4018785|NCT01179516|3839921|B1|Non-Hispanic and non-Latino||Race/Ethnicity, Customized||participants|Number|140|140.0||||||
4018786|NCT01179516|3839918|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
4018787|NCT01179516|3839919|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4018788|NCT01179516|3839920|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4018789|NCT01179516|3839921|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4018790|NCT01179516|3839918|B4||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4018791|NCT01179516|3839919|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4018792|NCT01179516|3839920|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4018793|NCT01179516|3839921|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4018794|NCT01179516|3839918|B4||Female|Sex: Female, Male||Participants|Count of Participants|329|329.0||||||
4018795|NCT01179516|3839919|B3||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4018796|NCT01179516|3839920|B2||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4018797|NCT01179516|3839921|B1||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4018798|NCT01179516|3839918|B4|>55 years||Age, Customized||participants|Number|98|98.0||||||
4018799|NCT01179516|3839919|B3|>55 years||Age, Customized||participants|Number|32|32.0||||||
4018800|NCT01179516|3839920|B2|>55 years||Age, Customized||participants|Number|28|28.0||||||
4018801|NCT01179516|3839921|B1|>55 years||Age, Customized||participants|Number|38|38.0||||||
4018802|NCT01179516|3839918|B4|≤55 years||Age, Customized||participants|Number|371|371.0||||||
4018803|NCT01179516|3839919|B3|≤55 years||Age, Customized||participants|Number|120|120.0||||||
4018804|NCT01179516|3839920|B2|≤55 years||Age, Customized||participants|Number|129|129.0||||||
4018805|NCT01179516|3839921|B1|≤55 years||Age, Customized||participants|Number|122|122.0||||||
4018806|NCT01179516|3839918|B4|||Age||years|Mean|45.1|45.1|Standard Deviation|12.44|12.44|||
4018807|NCT01179516|3839919|B3|||Age||years|Mean|43.8|43.8|Standard Deviation|13.51|13.51|||
4018808|NCT01179516|3839920|B2|||Age||years|Mean|45.2|45.2|Standard Deviation|11.94|11.94|||
4018809|NCT01179516|3839921|B1|||Age||years|Mean|46.2|46.2|Standard Deviation|11.79|11.79|||
4018810|NCT01179490|3839946|B1|||Body surface area||m2|Median|1.470|1.47|Standard Deviation|0.185|0.185|||
4018811|NCT01179490|3839946|B1|||Weight||kg|Median|52.40|52.4|Standard Deviation|10.41|10.41|||
4018812|NCT01179490|3839946|B1|||Height||cm|Mean|151.40|151.4|Standard Deviation|8.53|8.53|||
4018813|NCT01179490|3839946|B1|||Serum β2M in clinical stage||mg/L|Median|5.00|5.0|Standard Deviation|1.48|1.48|||
4018814|NCT01179490|3839946|B1|Yes||Complications of multiple myeloma||Participants|Number|5|5.0||||||
4018815|NCT01179490|3839946|B1|No||Complications of multiple myeloma||Participants|Number|0|0.0||||||
4018816|NCT01179490|3839946|B1|Yes||Associated symptom of the primary disease||Participants|Number|5|5.0||||||
4018817|NCT01179490|3839946|B1|No||Associated symptom of the primary disease||Participants|Number|0|0.0||||||
4018818|NCT01179490|3839946|B1|Yes||Previous history of multiple myeloma||Participants|Number|0|0.0||||||
4018819|NCT01179490|3839946|B1|No||Previous history of multiple myeloma||Participants|Number|5|5.0||||||
4018820|NCT01179490|3839946|B1|Stage III||Clinical stage [International staging system (ISS) category]|"Stage I: Serum β2-microglobulin (β2M) < 3.5 mg/L and serum albumin ≥ 3.5 g/dL)~Stage II: Serum β2M ≥3.5 - < 5.5 mg/L; or serum β2M < 3.5 mg/L and serum albumin < 3.5 g/dL)~Stage III: (Serum β2M ≥ 5.5 mg/L)"|Participants|Number|2|2.0||||||
4018821|NCT01179490|3839946|B1|Stage II||Clinical stage [International staging system (ISS) category]|"Stage I: Serum β2-microglobulin (β2M) < 3.5 mg/L and serum albumin ≥ 3.5 g/dL)~Stage II: Serum β2M ≥3.5 - < 5.5 mg/L; or serum β2M < 3.5 mg/L and serum albumin < 3.5 g/dL)~Stage III: (Serum β2M ≥ 5.5 mg/L)"|Participants|Number|3|3.0||||||
4018822|NCT01179490|3839946|B1|Stage I||Clinical stage [International staging system (ISS) category]|"Stage I: Serum β2-microglobulin (β2M) < 3.5 mg/L and serum albumin ≥ 3.5 g/dL)~Stage II: Serum β2M ≥3.5 - < 5.5 mg/L; or serum β2M < 3.5 mg/L and serum albumin < 3.5 g/dL)~Stage III: (Serum β2M ≥ 5.5 mg/L)"|Participants|Number|0|0.0||||||
4018823|NCT01179490|3839946|B1|3||Performance status (P.S.)|0: Asymptomatic 1: Symptomatic but completely ambulatory 2: Symptomatic, <50% in bed during the day 3: Symptomatic, >50% in bed, but not bedbound|Participants|Number|0|0.0||||||
4018824|NCT01179490|3839946|B1|2||Performance status (P.S.)|0: Asymptomatic 1: Symptomatic but completely ambulatory 2: Symptomatic, <50% in bed during the day 3: Symptomatic, >50% in bed, but not bedbound|Participants|Number|2|2.0||||||
4018825|NCT01179490|3839946|B1|1||Performance status (P.S.)|0: Asymptomatic 1: Symptomatic but completely ambulatory 2: Symptomatic, <50% in bed during the day 3: Symptomatic, >50% in bed, but not bedbound|Participants|Number|0|0.0||||||
4018826|NCT01179490|3839946|B1|0||Performance status (P.S.)|0: Asymptomatic 1: Symptomatic but completely ambulatory 2: Symptomatic, <50% in bed during the day 3: Symptomatic, >50% in bed, but not bedbound|Participants|Number|3|3.0||||||
4018827|NCT01179490|3839946|B1|Other||Reason for not eligible for hematopoietic stem cell transplantation||Participants|Number|0|0.0||||||
4018828|NCT01179490|3839946|B1|Renal dysfunction||Reason for not eligible for hematopoietic stem cell transplantation||Participants|Number|0|0.0||||||
4018829|NCT01179490|3839946|B1|Presence of cardiopulmonary dysfunction||Reason for not eligible for hematopoietic stem cell transplantation||Participants|Number|0|0.0||||||
4018830|NCT01179490|3839946|B1|Age 66 years or older||Reason for not eligible for hematopoietic stem cell transplantation||Participants|Number|5|5.0||||||
4018831|NCT01179490|3839946|B1|Yes||Previous treatment of multiple myeloma||Participants|Number|0|0.0||||||
4018832|NCT01179490|3839946|B1|No||Previous treatment of multiple myeloma||Participants|Number|5|5.0||||||
4018833|NCT01179490|3839946|B1|Yes||Condition with symptoms of Multiple Myeloma|Condition with symptoms of Multiple Myeloma (Development of hyperviscosity syndrome, amyloidosis, Bacterial infection twice or more in a year)|Participants|Number|0|0.0||||||
4018834|NCT01179490|3839946|B1|No||Condition with symptoms of Multiple Myeloma|Condition with symptoms of Multiple Myeloma (Development of hyperviscosity syndrome, amyloidosis, Bacterial infection twice or more in a year)|Participants|Number|5|5.0||||||
4018835|NCT01179490|3839946|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4018836|NCT01179490|3839946|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4018837|NCT01179490|3839946|B1|70-84 years||Age, Customized||Participants|Number|2|2.0||||||
4018838|NCT01179490|3839946|B1|60-69 years||Age, Customized||Participants|Number|3|3.0||||||
4018839|NCT01179490|3839946|B1|50-59 years||Age, Customized||Participants|Number|0|0.0||||||
4018840|NCT01179490|3839946|B1|40-49 years||Age, Customized||Participants|Number|0|0.0||||||
4018841|NCT01179490|3839946|B1|30-39 years||Age, Customized||Participants|Number|0|0.0||||||
4018842|NCT01179490|3839946|B1|20-29 years||Age, Customized||Participants|Number|0|0.0||||||
4018843|NCT01179490|3839946|B1|||Age||Year|Median|69.0|69.0|Standard Deviation|2.3|2.3|||
4018844|NCT01179399|3839967|B1|Spain||Region of Enrollment||participants|Number|12|12.0||||||
4018845|NCT01179399|3839967|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4018846|NCT01179399|3839967|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4018847|NCT01179399|3839967|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4018848|NCT01179399|3839967|B1|||Age||years|Mean|64.9|64.9|Standard Deviation|9.77|9.77|||
4018849|NCT01179399|3839967|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4018850|NCT01179399|3839967|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4018851|NCT01179399|3839967|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4018852|NCT01179347|3839971|B3||Male|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
4018853|NCT01179347|3839972|B2||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4018854|NCT01179347|3839973|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4018855|NCT01179347|3839971|B3||Female|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4018856|NCT01179347|3839972|B2||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4018857|NCT01179347|3839973|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4018858|NCT01179347|3839971|B3|||Age||years|Mean|19.8|19.8|Standard Deviation|12.5|12.5|||
4018859|NCT01179347|3839972|B2|||Age||years|Mean|19.3|19.3|Standard Deviation|12.0|12.0|||
4018860|NCT01179347|3839973|B1|||Age||years|Mean|20.6|20.6|Standard Deviation|13.6|13.6|||
4018861|NCT01179334|3839994|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4018862|NCT01179334|3839995|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4018863|NCT01179334|3839996|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4018864|NCT01179334|3839994|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4018865|NCT01179334|3839995|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4018866|NCT01179334|3839996|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4018867|NCT01179334|3839994|B3|||Age||Years|Mean|59.3|59.3|Standard Deviation|10.3|10.3|||
4018868|NCT01179334|3839995|B2|||Age||Years|Mean|61.3|61.3|Standard Deviation|10.0|10.0|||
4018869|NCT01179334|3839996|B1|||Age||Years|Mean|58.3|58.3|Standard Deviation|10.7|10.7|||
4018870|NCT01179217|3840025|B3||Sickle Beta zero Thalassemia|Diagnosis||Participants|Count of Participants|21|21.0||||||
4018871|NCT01179217|3840026|B2||Sickle Beta zero Thalassemia|Diagnosis||Participants|Count of Participants|7|7.0||||||
4018872|NCT01179217|3840027|B1||Sickle Beta zero Thalassemia|Diagnosis||Participants|Count of Participants|14|14.0||||||
4018873|NCT01179217|3840025|B3||Sickle Beta plus Thalassemia|Diagnosis||Participants|Count of Participants|2|2.0||||||
4018874|NCT01179217|3840026|B2||Sickle Beta plus Thalassemia|Diagnosis||Participants|Count of Participants|0|0.0||||||
4018875|NCT01179217|3840027|B1||Sickle Beta plus Thalassemia|Diagnosis||Participants|Count of Participants|2|2.0||||||
4018876|NCT01179217|3840025|B3||Sickle Cell Anemia|Diagnosis||Participants|Count of Participants|207|207.0||||||
4018877|NCT01179217|3840026|B2||Sickle Cell Anemia|Diagnosis||Participants|Count of Participants|71|71.0||||||
4018878|NCT01179217|3840027|B1||Sickle Cell Anemia|Diagnosis||Participants|Count of Participants|136|136.0||||||
4018879|NCT01179217|3840025|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4018880|NCT01179217|3840026|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4018881|NCT01179217|3840027|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4018882|NCT01179217|3840025|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018883|NCT01179217|3840026|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018884|NCT01179217|3840027|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018885|NCT01179217|3840025|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018886|NCT01179217|3840026|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018887|NCT01179217|3840027|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018888|NCT01179217|3840025|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|217|217.0||||||
4018889|NCT01179217|3840026|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
4018890|NCT01179217|3840027|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
4018891|NCT01179217|3840025|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018892|NCT01179217|3840026|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018893|NCT01179217|3840027|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018894|NCT01179217|3840025|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018895|NCT01179217|3840026|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018896|NCT01179217|3840027|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018897|NCT01179217|3840025|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018898|NCT01179217|3840026|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018899|NCT01179217|3840027|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4018900|NCT01179217|3840025|B3||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4018901|NCT01179217|3840026|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4018902|NCT01179217|3840027|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4018903|NCT01179217|3840025|B3||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4018904|NCT01179217|3840026|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4018905|NCT01179217|3840027|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4018906|NCT01179217|3840025|B3|||Age||years|Mean|22.0|22.0|Standard Deviation|12.33|12.33|||
4018907|NCT01179217|3840026|B2|||Age||years|Mean|21.4|21.4|Standard Deviation|12.42|12.42|||
4018908|NCT01179217|3840027|B1|||Age||years|Mean|22.4|22.4|Standard Deviation|12.32|12.32|||
4018909|NCT01179217|3840025|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4018910|NCT01179217|3840026|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4018911|NCT01179217|3840027|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4018912|NCT01179217|3840025|B3||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
4018913|NCT01179217|3840026|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4018914|NCT01179217|3840027|B1||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
4018915|NCT01179217|3840025|B3||<=18 years|Age||Participants|Count of Participants|118|118.0||||||
4018916|NCT01179217|3840026|B2||<=18 years|Age||Participants|Count of Participants|43|43.0||||||
4018917|NCT01179217|3840027|B1||<=18 years|Age||Participants|Count of Participants|75|75.0||||||
4018918|NCT01179191|3840052|B1|Suspected someone taking Op:no(n=535)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|464|464.0||||||
4019080|NCT01179113|3840070|B2|||Body Mass Index (BMI)||kg/m^2|Mean|26|26.0|Standard Deviation|4|4.0|||
4018919|NCT01179191|3840052|B1|Suspected someone taking Op:yes,all times (n=70)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|3|3.0||||||
4018920|NCT01179191|3840052|B1|Suspected someone taking Op:yes,sometimes (n=70)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|8|8.0||||||
4018921|NCT01179191|3840052|B1|Suspected someone taking Op:yes,few times(n=70)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|29|29.0||||||
4018922|NCT01179191|3840052|B1|Suspected someone taking Op:yes,once(n=70)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|30|30.0||||||
4018923|NCT01179191|3840052|B1|Suspected someone taking Op:yes(n=535)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|71|71.0||||||
4018924|NCT01179191|3840052|B1|Keeps Op hidden or locked:no(n=535)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|162|162.0||||||
4018925|NCT01179191|3840052|B1|Keeps Op hidden or locked:yes(n=535)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|373|373.0||||||
4018926|NCT01179191|3840052|B1|Got Op from someone other than a doctor:no(n=537)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|494|494.0||||||
4018927|NCT01179191|3840052|B1|Got Op from someone other than a doctor:yes(n=537)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|43|43.0||||||
4018928|NCT01179191|3840052|B1|Gave Op to sick/in pain:no(n=526)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|491|491.0||||||
4018929|NCT01179191|3840052|B1|Gave Op to sick/in pain:yes, >10 times(n=35)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|3|3.0||||||
4018930|NCT01179191|3840052|B1|Gave Op to sick/in pain:yes,6-10times(n=35)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|3|3.0||||||
4018931|NCT01179191|3840052|B1|Gave Op to sick/in pain:yes, 2-5times(n=35)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|24|24.0||||||
4019081|NCT01179113|3840071|B1|||Body Mass Index (BMI)||kg/m^2|Mean|26|26.0|Standard Deviation|5|5.0|||
4019082|NCT01179113|3840069|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
4019083|NCT01179113|3840070|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4018932|NCT01179191|3840052|B1|Gave Op to sick/in pain:yes,once(n=35)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|5|5.0||||||
4018933|NCT01179191|3840052|B1|Gave Op to sick/in pain:yes (n=526)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|35|35.0||||||
4018934|NCT01179191|3840052|B1|Rn- more than (>) 1 Dr:other(n=61)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|24|24.0||||||
4018935|NCT01179191|3840052|B1|Rn- more than 1 Dr:Dr didn’t prescribed more(n=61)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|11|11.0||||||
4018936|NCT01179191|3840052|B1|Rn- more than 1 Dr:feel pleasant/high (n=61)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|1|1.0||||||
4018937|NCT01179191|3840052|B1|Rn- more than 1 Dr:afraid to ask for more(n=61)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|12|12.0||||||
4018938|NCT01179191|3840052|B1|Rn- more than 1 Dr: prevent withdrawal(n=61)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|6|6.0||||||
4018939|NCT01179191|3840052|B1|Rn- more than 1 Dr:treat pain better(n=61)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|26|26.0||||||
4018940|NCT01179191|3840052|B1|More than 1 Dr for Op:never(n=529)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|488|488.0||||||
4018941|NCT01179191|3840052|B1|More than 1 Dr for Op:often(n=529)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|3|3.0||||||
4018942|NCT01179191|3840052|B1|More than 1 Dr for Op:sometime(n=529)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|12|12.0||||||
4018943|NCT01179191|3840052|B1|More than 1 doctor (Dr) for Op:once/twice(n=529)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|26|26.0||||||
4018944|NCT01179191|3840052|B1|Rn-Alc when on Op:other(n=170)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|65|65.0||||||
4019084|NCT01179113|3840071|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4019085|NCT01179113|3840069|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4019086|NCT01179113|3840070|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4019087|NCT01179113|3840071|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4018945|NCT01179191|3840052|B1|Rn-Alc when on Op:feel talkative/outgoing(n=170)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|2|2.0||||||
4018946|NCT01179191|3840052|B1|Rn-Alc when on Op:feel less depressed(n=170)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|4|4.0||||||
4018947|NCT01179191|3840052|B1|Rn-Alc when on Op:feel pleasant/high(n=170)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|3|3.0||||||
4018948|NCT01179191|3840052|B1|Rn-Alc when on Op:enjoy occasional drink(n=170||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|91|91.0||||||
4018949|NCT01179191|3840052|B1|Rn-Alc when on Op:sleep better/relax(n=170)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|21|21.0||||||
4018950|NCT01179191|3840052|B1|Rn-Alc when on Op:treat new pain(n=170)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|1|1.0||||||
4018951|NCT01179191|3840052|B1|Rn-Alc when on Op:treat pain better(n=170)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|10|10.0||||||
4018952|NCT01179191|3840052|B1|Alc use when on Op:never(n=534)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|391|391.0||||||
4018953|NCT01179191|3840052|B1|Alc use when on Op:daily(n=534)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|7|7.0||||||
4018954|NCT01179191|3840052|B1|Alc use when on Op:few times a week(n=534)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|19|19.0||||||
4018955|NCT01179191|3840052|B1|Alc use when on Op:few times a month(n=534)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|35|35.0||||||
4018956|NCT01179191|3840052|B1|Alc use when on Op:few times a year(n=534)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|50|50.0||||||
4018957|NCT01179191|3840052|B1|Alcohol(Alc)use when on Op:tried once/twice(n=534)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|32|32.0||||||
4019088|NCT01179113|3840069|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4019089|NCT01179113|3840070|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4019090|NCT01179113|3840071|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4019091|NCT01179113|3840069|B3|||Age||years|Mean|57|57.0|Standard Deviation|14|14.0|||
4018958|NCT01179191|3840052|B1|Rn-snort,smoke,inj:other(n=37)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|28|28.0||||||
4018959|NCT01179191|3840052|B1|Rn-snort,smoke,inj:feel talkative/outgoing(n=37)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|2|2.0||||||
4018960|NCT01179191|3840052|B1|Rn-snort,smoke,inj:feel less depressed (n=37)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|2|2.0||||||
4018961|NCT01179191|3840052|B1|Rn-snort,smoke,inj:feel pleasant/high(n=37)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|2|2.0||||||
4018962|NCT01179191|3840052|B1|Rn-snort,smoke,inj:sleep better/relax(n=37)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|2|2.0||||||
4018963|NCT01179191|3840052|B1|Rn-snort,smoke,inj:treat new pain (n=37)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|1|1.0||||||
4018964|NCT01179191|3840052|B1|Rn-snort,smoke,inj:treat pain better(n=37)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|10|10.0||||||
4018965|NCT01179191|3840052|B1|Snort,smoke,inj Op:never(n=533)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|523|523.0||||||
4018966|NCT01179191|3840052|B1|Snort,smoke,inj Op:daily(n=533)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|1|1.0||||||
4018967|NCT01179191|3840052|B1|Snort,smoke,inj Op:few times a week(n=533)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|0|0.0||||||
4018968|NCT01179191|3840052|B1|Snort,smoke,inj Op:few times a month(n=533)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|2|2.0||||||
4018969|NCT01179191|3840052|B1|Snort,smoke,inj Op: few times a year(n=533)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|0|0.0||||||
4018970|NCT01179191|3840052|B1|Snort,smoke,inject(inj) Op:once/twice(n=533)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|7|7.0||||||
4019092|NCT01179113|3840070|B2|||Age||years|Mean|54|54.0|Standard Deviation|16|16.0|||
4019093|NCT01179113|3840071|B1|||Age||years|Mean|59|59.0|Standard Deviation|11|11.0|||
4019094|NCT01179048|3840082|B3||Male|Sex: Female, Male||Participants|Count of Participants|6003|6003.0||||||
4019095|NCT01179048|3840083|B2||Male|Sex: Female, Male||Participants|Count of Participants|2992|2992.0||||||
4018971|NCT01179191|3840052|B1|Rn for more Op use: other(n=315)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|44|44.0||||||
4018972|NCT01179191|3840052|B1|Rn for more Op use:feel talkative/outgoing(n=315)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|3|3.0||||||
4018973|NCT01179191|3840052|B1|Rn for more Op use:feel less depressed (n=315)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|16|16.0||||||
4018974|NCT01179191|3840052|B1|Rn for more Op use:feel pleasant/high(n=315)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|3|3.0||||||
4018975|NCT01179191|3840052|B1|Rn for more Op use:sleep better/relax(n=315)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|48|48.0||||||
4018976|NCT01179191|3840052|B1|Rn for more Op use:treat new pain(n=315)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|42|42.0||||||
4018977|NCT01179191|3840052|B1|Rn for more Op use:treat pain better(n=315)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|274|274.0||||||
4018978|NCT01179191|3840052|B1|More Op than prescribed:never(n=530)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|212|212.0||||||
4018979|NCT01179191|3840052|B1|More Op than prescribed:daily(n=530)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|23|23.0||||||
4018980|NCT01179191|3840052|B1|More Op than prescribed:few times a week(n=530)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|58|58.0||||||
4018981|NCT01179191|3840052|B1|More Op than prescribed:few times a month(n=530)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|116|116.0||||||
4018982|NCT01179191|3840052|B1|More Op than prescribed:few times a year(n=530)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|46|46.0||||||
4018983|NCT01179191|3840052|B1|More Op than prescribed:tried once/twice(n=530)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|75|75.0||||||
4019096|NCT01179048|3840084|B1||Male|Sex: Female, Male||Participants|Count of Participants|3011|3011.0||||||
4019097|NCT01179048|3840082|B3||Female|Sex: Female, Male||Participants|Count of Participants|3337|3337.0||||||
4019098|NCT01179048|3840083|B2||Female|Sex: Female, Male||Participants|Count of Participants|1680|1680.0||||||
4018984|NCT01179191|3840052|B1|Rn to chew/crush Op:other(n=71)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|29|29.0||||||
4018985|NCT01179191|3840052|B1|Rn to chew/crush Op:feel talkative/outgoing(n=71)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|2|2.0||||||
4018986|NCT01179191|3840052|B1|Rn to chew/crush Op:feel less depressed (n=71)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|6|6.0||||||
4018987|NCT01179191|3840052|B1|Rn to chew/crush Op:feel pleasant/high(n=71)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|3|3.0||||||
4018988|NCT01179191|3840052|B1|Rn to chew/crush Op:help swallow drug(n=71)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|16|16.0||||||
4018989|NCT01179191|3840052|B1|Rn to chew/crush Op:sleep better/relax(n=71)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|14|14.0||||||
4018990|NCT01179191|3840052|B1|Rn to chew/crush Op:treat new pain(n=71)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|4|4.0||||||
4018991|NCT01179191|3840052|B1|Reason(Rn)to chew/crush Op:treat pain better(n=71)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|35|35.0||||||
4018992|NCT01179191|3840052|B1|Chewed/crushed Op:never(n=534)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|476|476.0||||||
4018993|NCT01179191|3840052|B1|Chewed/crushed Op:daily(n=534)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|5|5.0||||||
4018994|NCT01179191|3840052|B1|Chewed/crushed Op:few times a week(n=534)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|7|7.0||||||
4018995|NCT01179191|3840052|B1|Chewed/crushed Op:few times a month(n=534)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|10|10.0||||||
4018996|NCT01179191|3840052|B1|Chewed/crushed Op:few times a year(n=534)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|5|5.0||||||
4019099|NCT01179048|3840084|B1||Female|Sex: Female, Male||Participants|Count of Participants|1657|1657.0||||||
4019100|NCT01179048|3840082|B3|85 years and over||Age, Customized||Participants|Number|42|42.0||||||
4019101|NCT01179048|3840083|B2|85 years and over||Age, Customized||Participants|Number|25|25.0||||||
4018997|NCT01179191|3840052|B1|Chewed/crushed Op:tried once/twice(n=534)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|31|31.0||||||
4018998|NCT01179191|3840052|B1|Worried about hard time to stop Op:10(n=537)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|36|36.0||||||
4018999|NCT01179191|3840052|B1|Worried about hard time to stop Op:9(n=537)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|27|27.0||||||
4019000|NCT01179191|3840052|B1|Worried about hard time to stop Op:8(n=537)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|35|35.0||||||
4019001|NCT01179191|3840052|B1|Worried about hard time to stop Op:7(n=537)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|39|39.0||||||
4019002|NCT01179191|3840052|B1|Worried about hard time to stop Op:6(n=537)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|26|26.0||||||
4019003|NCT01179191|3840052|B1|Worried about hard time to stop Op:5(n=537)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|54|54.0||||||
4019004|NCT01179191|3840052|B1|Worried about hard time to stop Op:4(n=537)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|20|20.0||||||
4019005|NCT01179191|3840052|B1|Worried about hard time to stop Op:3(n=537)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|45|45.0||||||
4019006|NCT01179191|3840052|B1|Worried about hard time to stop Op:2(n=537)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|67|67.0||||||
4019007|NCT01179191|3840052|B1|Worried about hard time to stop Op:1(n=537)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|50|50.0||||||
4019008|NCT01179191|3840052|B1|Worried about hard time to stop Op:0(n=537)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|138|138.0||||||
4019009|NCT01179191|3840052|B1|Worried getting addicted or hooked to Op:10(n=537)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|33|33.0||||||
4019102|NCT01179048|3840084|B1|85 years and over||Age, Customized||Participants|Number|17|17.0||||||
4019103|NCT01179048|3840082|B3|Between 65 to 84 years||Age, Customized||Participants|Number|4287|4287.0||||||
4019104|NCT01179048|3840083|B2|Between 65 to 84 years||Age, Customized||Participants|Number|2148|2148.0||||||
4019010|NCT01179191|3840052|B1|Worried getting addicted or hooked to Op:9(n=537)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|11|11.0||||||
4019011|NCT01179191|3840052|B1|Worried getting addicted or hooked to Op:8(n=537)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|31|31.0||||||
4019012|NCT01179191|3840052|B1|Worried getting addicted or hooked to Op:7(n=537)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|33|33.0||||||
4019013|NCT01179191|3840052|B1|Worried getting addicted or hooked to Op:6(n=537)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|28|28.0||||||
4019014|NCT01179191|3840052|B1|Worried getting addicted or hooked to Op:5(n=537)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|53|53.0||||||
4019015|NCT01179191|3840052|B1|Worried getting addicted or hooked to Op:4(n=537)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|30|30.0||||||
4019016|NCT01179191|3840052|B1|Worried getting addicted or hooked to Op:3(n=537)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|47|47.0||||||
4019017|NCT01179191|3840052|B1|Worried getting addicted or hooked to Op:2(n=537)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|53|53.0||||||
4019018|NCT01179191|3840052|B1|Worried getting addicted or hooked to Op:1(n=537)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|47|47.0||||||
4019019|NCT01179191|3840052|B1|Worried getting addicted or hooked to Op:0(n=537)||Number of Participants Reporting Concerns With Prescription Opioid (Op) Misuse, Abuse or Diversion|Participant experience and concerns with prescription opioids questionnaire consisted of multiple choice questions and numeric rating scale(NRS);range=0(not at all) to 10 (extremely worried);used to assess current concerns, past behaviors related to opioid misuse, abuse, diversion.n=Pa evaluable for given question. Pa may choose more than 1 reason.|Participants|Number|171|171.0||||||
4019020|NCT01179191|3840052|B1|Diversion: High (Ir)/ High (Pa) (n= 5)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|2|2.0||||||
4019021|NCT01179191|3840052|B1|Diversion: High (Ir)/ Mod (Pa) (n= 5)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|0|0.0||||||
4019022|NCT01179191|3840052|B1|Diversion: High (Ir)/ Low (Pa) (n= 5)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|3|3.0||||||
4019105|NCT01179048|3840084|B1|Between 65 to 84 years||Age, Customized||Participants|Number|2139|2139.0||||||
4019106|NCT01179048|3840082|B3|Between 18 and 64 years||Age, Customized||Participants|Number|5011|5011.0||||||
4019107|NCT01179048|3840083|B2|Between 18 and 64 years||Age, Customized||Participants|Number|2499|2499.0||||||
4019023|NCT01179191|3840052|B1|Diversion: Mod (Ir)/ High (Pa) (n= 22)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|1|1.0||||||
4019024|NCT01179191|3840052|B1|Diversion: Mod (Ir)/ Mod (Pa) (n= 22)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|2|2.0||||||
4019025|NCT01179191|3840052|B1|Diversion: Mod (Ir)/ Low (Pa) (n= 22)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|19|19.0||||||
4019026|NCT01179191|3840052|B1|Diversion: Low (Ir)/ High (Pa) (n= 487)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|10|10.0||||||
4019027|NCT01179191|3840052|B1|Diversion: Low (Ir)/ Mod (Pa) (n= 487)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|10|10.0||||||
4019028|NCT01179191|3840052|B1|Diversion: Low (Ir)/ Low (Pa) (n= 487)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|467|467.0||||||
4019029|NCT01179191|3840052|B1|Misuse Total: High(Ir)/ High(Pa) (n= 6)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|1|1.0||||||
4019030|NCT01179191|3840052|B1|Misuse Total: High(Ir)/ Mod(Pa) (n= 6)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|2|2.0||||||
4019031|NCT01179191|3840052|B1|Misuse Total: High(Ir)/ Low(Pa) (n= 6)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|3|3.0||||||
4019032|NCT01179191|3840052|B1|Misuse Total: Mod(Ir)/ High(Pa) (n= 56)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|2|2.0||||||
4019033|NCT01179191|3840052|B1|Misuse Total: Mod(Ir)/ Mod(Pa) (n= 56)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|14|14.0||||||
4019034|NCT01179191|3840052|B1|Misuse Total: Mod(Ir)/ Low(Pa) (n= 56)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|40|40.0||||||
4019035|NCT01179191|3840052|B1|Misuse Total: Low(Ir)/ High(Pa) (n= 295)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|1|1.0||||||
4019108|NCT01179048|3840084|B1|Between 18 and 64 years||Age, Customized||Participants|Number|2512|2512.0||||||
4019109|NCT01179048|3840082|B3|||Age||years|Mean|64.3|64.3|Standard Deviation|7.2|7.2|||
4019110|NCT01179048|3840083|B2|||Age||years|Mean|64.4|64.4|Standard Deviation|7.2|7.2|||
4019111|NCT01179048|3840084|B1|||Age||years|Mean|64.2|64.2|Standard Deviation|7.2|7.2|||
4019036|NCT01179191|3840052|B1|Misuse Total: Low(Ir)/ Mod(Pa) (n= 295)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|49|49.0||||||
4019037|NCT01179191|3840052|B1|Misuse Total: Low(Ir)/ Low(Pa) (n= 295)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|245|245.0||||||
4019038|NCT01179191|3840052|B1|Misuse Pseudoaddiction: High(Ir)/ High(Pa) (n= 5)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|1|1.0||||||
4019039|NCT01179191|3840052|B1|Misuse Pseudoaddiction: High(Ir)/ Mod(Pa) (n= 5)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|1|1.0||||||
4019040|NCT01179191|3840052|B1|Misuse Pseudoaddiction: High(Ir)/ Low(Pa) (n= 5)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|3|3.0||||||
4019041|NCT01179191|3840052|B1|Misuse Pseudoaddiction: Mod(Ir)/ High(Pa) (n= 42)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|1|1.0||||||
4019042|NCT01179191|3840052|B1|Misuse Pseudoaddiction: Mod(Ir)/ Mod(Pa) (n= 42)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|3|3.0||||||
4019043|NCT01179191|3840052|B1|Misuse Pseudoaddiction: Mod(Ir)/ Low(Pa) (n= 42)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|38|38.0||||||
4019044|NCT01179191|3840052|B1|Misuse Pseudoaddiction: Low(Ir)/ High(Pa) (n= 227)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|1|1.0||||||
4019045|NCT01179191|3840052|B1|Misuse Pseudoaddiction: Low(Ir)/ Mod(Pa) (n= 227)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|18|18.0||||||
4019046|NCT01179191|3840052|B1|Misuse Pseudoaddiction: Low(Ir)/ Low(Pa) (n= 227)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|208|208.0||||||
4019047|NCT01179191|3840052|B1|Misuse General: High(Ir)/ High(Pa) (n= 3)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|0|0.0||||||
4019048|NCT01179191|3840052|B1|Misuse General: High(Ir)/ Mod(Pa) (n= 3)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|1|1.0||||||
4019112|NCT01178944|3840101|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4019113|NCT01178944|3840101|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4019114|NCT01178944|3840101|B1|||Age||years|Mean|64.7|64.7|Standard Deviation|9.9|9.9|||
4019049|NCT01179191|3840052|B1|Misuse General: High(Ir)/ Low(Pa) (n= 3)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|2|2.0||||||
4019050|NCT01179191|3840052|B1|Misuse General: Mod(Ir)/ High(Pa) (n= 24)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|0|0.0||||||
4019051|NCT01179191|3840052|B1|Misuse General: Mod(Ir)/ Mod(Pa) (n= 24)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|2|2.0||||||
4019052|NCT01179191|3840052|B1|Misuse General: Mod(Ir)/ Low(Pa) (n= 24)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|22|22.0||||||
4019053|NCT01179191|3840052|B1|Misuse General: Low(Ir)/ High(Pa) (n= 127)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|0|0.0||||||
4019054|NCT01179191|3840052|B1|Misuse General: Low(Ir)/ Mod(Pa) (n= 127)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|9|9.0||||||
4019055|NCT01179191|3840052|B1|Misuse General: Low(Ir)/ Low(Pa) (n= 127)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|118|118.0||||||
4019056|NCT01179191|3840052|B1|Abuse: High(Ir)/ High(Pa) (n= 1)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|0|0.0||||||
4019057|NCT01179191|3840052|B1|Abuse: High(Ir)/ Mod(Pa) (n= 1)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|1|1.0||||||
4019058|NCT01179191|3840052|B1|Abuse: High(Ir)/ Low(Pa) (n= 1)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|0|0.0||||||
4019059|NCT01179191|3840052|B1|Abuse: Mod(Ir)/ High(Pa) (n= 1)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|0|0.0||||||
4019060|NCT01179191|3840052|B1|Abuse: Mod(Ir)/ Mod(Pa) (n= 1)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|0|0.0||||||
4019061|NCT01179191|3840052|B1|Abuse: Mod(Ir)/ Low(Pa) (n= 1)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|1|1.0||||||
4019115|NCT01178853|3840110|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
4019116|NCT01178853|3840111|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4019117|NCT01178853|3840112|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4019118|NCT01178853|3840110|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4019062|NCT01179191|3840052|B1|Abuse: Low(Ir)/ High(Pa) (n= 6)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|0|0.0||||||
4019063|NCT01179191|3840052|B1|Abuse: Low(Ir)/ Moderate (Mod)(Pa) (n= 6)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|0|0.0||||||
4019064|NCT01179191|3840052|B1|Abuse: Low(Ir)/ Low(Pa) (n= 6)||Investigator(Ir) Compared to Participant(Pa)-Derived Risk Level Assessment of Misuse,Abuse,Diversion|Number of participants at Ir-assessed risk level compared to Pa-derived risk level (low,moderate[mod] or high) for opioid misuse,abuse,diversion. An exploratory scoring algorithm applied to results of Participant’s Experience and Concerns Questionnaire to get Pa-derived risk levels. Pa evaluable=683. 'n'=Pa evaluated for each assessed risk level.|Participants|Number|6|6.0||||||
4019065|NCT01179191|3840052|B1|Enjoyment of Life (n = 640)||Brief Pain Inventory (BPI)|BPI:11-item questionnaire,4 questions:pain intensity(worst,least,average,relief),7questions:pain impact on daily functions(general activity,mood,walking ability,normal work,relations with others,sleep,life enjoyment).Each question range=0-10(0%-100% for relief),higher score=more pain/relief/interference.'n'=participants evaluated for each subscale.|Units on a scale|Mean|7.03|7.03|Standard Deviation|2.64|2.64|||
4019066|NCT01179191|3840052|B1|Sleep (n = 642)||Brief Pain Inventory (BPI)|BPI:11-item questionnaire,4 questions:pain intensity(worst,least,average,relief),7questions:pain impact on daily functions(general activity,mood,walking ability,normal work,relations with others,sleep,life enjoyment).Each question range=0-10(0%-100% for relief),higher score=more pain/relief/interference.'n'=participants evaluated for each subscale.|Units on a scale|Mean|6.80|6.8|Standard Deviation|2.74|2.74|||
4019067|NCT01179191|3840052|B1|Relationships with Others (n = 644)||Brief Pain Inventory (BPI)|BPI:11-item questionnaire,4 questions:pain intensity(worst,least,average,relief),7questions:pain impact on daily functions(general activity,mood,walking ability,normal work,relations with others,sleep,life enjoyment).Each question range=0-10(0%-100% for relief),higher score=more pain/relief/interference.'n'=participants evaluated for each subscale.|Units on a scale|Mean|5.41|5.41|Standard Deviation|3.08|3.08|||
4019068|NCT01179191|3840052|B1|Normal Work (n = 637)||Brief Pain Inventory (BPI)|BPI:11-item questionnaire,4 questions:pain intensity(worst,least,average,relief),7questions:pain impact on daily functions(general activity,mood,walking ability,normal work,relations with others,sleep,life enjoyment).Each question range=0-10(0%-100% for relief),higher score=more pain/relief/interference.'n'=participants evaluated for each subscale.|Units on a scale|Mean|7.21|7.21|Standard Deviation|2.48|2.48|||
4019069|NCT01179191|3840052|B1|Walking Ability (n = 641)||Brief Pain Inventory (BPI)|BPI:11-item questionnaire,4 questions:pain intensity(worst,least,average,relief),7questions:pain impact on daily functions(general activity,mood,walking ability,normal work,relations with others,sleep,life enjoyment).Each question range=0-10(0%-100% for relief),higher score=more pain/relief/interference.'n'=participants evaluated for each subscale.|Units on a scale|Mean|6.48|6.48|Standard Deviation|2.78|2.78|||
4019070|NCT01179191|3840052|B1|Mood (n = 642)||Brief Pain Inventory (BPI)|BPI:11-item questionnaire,4 questions:pain intensity(worst,least,average,relief),7questions:pain impact on daily functions(general activity,mood,walking ability,normal work,relations with others,sleep,life enjoyment).Each question range=0-10(0%-100% for relief),higher score=more pain/relief/interference.'n'=participants evaluated for each subscale.|Units on a scale|Mean|6.31|6.31|Standard Deviation|2.73|2.73|||
4019071|NCT01179191|3840052|B1|General Activity (n = 643)||Brief Pain Inventory (BPI)|BPI:11-item questionnaire,4 questions:pain intensity(worst,least,average,relief),7questions:pain impact on daily functions(general activity,mood,walking ability,normal work,relations with others,sleep,life enjoyment).Each question range=0-10(0%-100% for relief),higher score=more pain/relief/interference.'n'=participants evaluated for each subscale.|Units on a scale|Mean|7.01|7.01|Standard Deviation|2.33|2.33|||
4019072|NCT01179191|3840052|B1|Relief (n = 639)||Brief Pain Inventory (BPI)|BPI:11-item questionnaire,4 questions:pain intensity(worst,least,average,relief),7questions:pain impact on daily functions(general activity,mood,walking ability,normal work,relations with others,sleep,life enjoyment).Each question range=0-10(0%-100% for relief),higher score=more pain/relief/interference.'n'=participants evaluated for each subscale.|Units on a scale|Mean|53.36|53.36|Standard Deviation|22.72|22.72|||
4019073|NCT01179191|3840052|B1|Least Pain (n = 642)||Brief Pain Inventory (BPI)|BPI:11-item questionnaire,4 questions:pain intensity(worst,least,average,relief),7questions:pain impact on daily functions(general activity,mood,walking ability,normal work,relations with others,sleep,life enjoyment).Each question range=0-10(0%-100% for relief),higher score=more pain/relief/interference.'n'=participants evaluated for each subscale.|Units on a scale|Mean|4.63|4.63|Standard Deviation|2.27|2.27|||
4019074|NCT01179191|3840052|B1|Worst Pain (n = 636)||Brief Pain Inventory (BPI)|BPI:11-item questionnaire,4 questions:pain intensity(worst,least,average,relief),7questions:pain impact on daily functions(general activity,mood,walking ability,normal work,relations with others,sleep,life enjoyment).Each question range=0-10(0%-100% for relief),higher score=more pain/relief/interference.'n'=participants evaluated for each subscale.|Units on a scale|Mean|7.95|7.95|Standard Deviation|1.64|1.64|||
4019075|NCT01179191|3840052|B1|Average Pain (n = 636)||Brief Pain Inventory (BPI)|BPI:11-item questionnaire,4 questions:pain intensity(worst,least,average,relief),7questions:pain impact on daily functions(general activity,mood,walking ability,normal work,relations with others,sleep,life enjoyment).Each question range=0-10(0%-100% for relief),higher score=more pain/relief/interference.'n'=participants evaluated for each subscale.|Units on a scale|Mean|6.27|6.27|Standard Deviation|1.79|1.79|||
4019076|NCT01179191|3840052|B1||Male|Sex: Female, Male||Participants|Count of Participants|306|306.0||||||
4019077|NCT01179191|3840052|B1||Female|Sex: Female, Male||Participants|Count of Participants|378|378.0||||||
4019078|NCT01179191|3840052|B1|||Age||Years|Mean|51.77|51.77|Standard Deviation|12.34|12.34|||
4019079|NCT01179113|3840069|B3|||Body Mass Index (BMI)||kg/m^2|Mean|26|26.0|Standard Deviation|5|5.0|||
4019119|NCT01178853|3840111|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4019120|NCT01178853|3840112|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4019121|NCT01178853|3840110|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4019122|NCT01178853|3840111|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4019123|NCT01178853|3840112|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4019124|NCT01178853|3840110|B3|||Age||years|Mean|33.3|33.3|Standard Deviation|7.5|7.5|||
4019125|NCT01178853|3840111|B2|||Age||years|Mean|34.1|34.1|Standard Deviation|7.2|7.2|||
4019126|NCT01178853|3840112|B1|||Age||years|Mean|32.4|32.4|Standard Deviation|7.8|7.8|||
4019127|NCT01178853|3840110|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4019128|NCT01178853|3840111|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4019129|NCT01178853|3840112|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4019130|NCT01178853|3840110|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4019131|NCT01178853|3840111|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4019132|NCT01178853|3840112|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4019133|NCT01178853|3840110|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4019134|NCT01178853|3840111|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4019135|NCT01178853|3840112|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4019136|NCT01178827|3840119|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4019137|NCT01178827|3840120|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4019138|NCT01178827|3840121|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4019139|NCT01178827|3840122|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4019140|NCT01178827|3840119|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4019141|NCT01178827|3840120|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4019142|NCT01178827|3840121|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4019143|NCT01178827|3840122|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4019144|NCT01178827|3840119|B4|||Age||Years|Mean|72.0|72.0|Standard Deviation|8.2|8.2|||
4019145|NCT01178827|3840120|B3|||Age||Years|Mean|77.6|77.6|Standard Deviation|12.3|12.3|||
4019146|NCT01178827|3840121|B2|||Age||Years|Mean|68.3|68.3|Standard Deviation|6.1|6.1|||
4019147|NCT01178827|3840122|B1|||Age||Years|Mean|74.4|74.4|Standard Deviation|6.3|6.3|||
4019148|NCT01178762|3840153|B1|Taiwan||Region of Enrollment||participants|Number|42|42.0||||||
4019149|NCT01178762|3840153|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4019150|NCT01178762|3840153|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4019151|NCT01178762|3840153|B1|||Age||years|Mean|41|41.0|Standard Deviation|12|12.0|||
4019152|NCT01178762|3840153|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4019153|NCT01178762|3840153|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4019154|NCT01178762|3840153|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4019155|NCT01178671|3840157|B3|||Clinician Administered PTSD Scale|Measures severity of posttraumatic stress disorder symptoms from 0 (least severe) to 136 (most severe).|units on a scale|Mean|79.6|79.6|Standard Deviation|16.2|16.2|||
4019156|NCT01178671|3840158|B2|||Clinician Administered PTSD Scale|Measures severity of posttraumatic stress disorder symptoms from 0 (least severe) to 136 (most severe).|units on a scale|Mean|81.3|81.3|Standard Deviation|12.2|12.2|||
4019157|NCT01178671|3840159|B1|||Clinician Administered PTSD Scale|Measures severity of posttraumatic stress disorder symptoms from 0 (least severe) to 136 (most severe).|units on a scale|Mean|77.9|77.9|Standard Deviation|19.5|19.5|||
4019158|NCT01178671|3840157|B3|||Pittsburgh Sleep Quality Index Addendum for PTSD|Measure severity of sleep impairment related to posttraumatic stress disorder symptoms on a scale from 0 (least impairment) to 100 (most impairment)|units on a scale|Mean|10.6|10.6|Standard Deviation|5.2|5.2|||
4019159|NCT01178671|3840158|B2|||Pittsburgh Sleep Quality Index Addendum for PTSD|Measure severity of sleep impairment related to posttraumatic stress disorder symptoms on a scale from 0 (least impairment) to 100 (most impairment)|units on a scale|Mean|11.2|11.2|Standard Deviation|5.6|5.6|||
4019160|NCT01178671|3840159|B1|||Pittsburgh Sleep Quality Index Addendum for PTSD|Measure severity of sleep impairment related to posttraumatic stress disorder symptoms on a scale from 0 (least impairment) to 100 (most impairment)|units on a scale|Mean|10.0|10.0|Standard Deviation|4.9|4.9|||
4019161|NCT01178671|3840157|B3|||Pittsburgh Sleep Quality Index Global|Measures severity of sleep impairment from 0 (least impairment) to 21 (most severe).|units on a scale|Mean|12.1|12.1|Standard Deviation|4.1|4.1|||
4019162|NCT01178671|3840158|B2|||Pittsburgh Sleep Quality Index Global|Measures severity of sleep impairment from 0 (least impairment) to 21 (most severe).|units on a scale|Mean|12.8|12.8|Standard Deviation|3.1|3.1|||
4019163|NCT01178671|3840159|B1|||Pittsburgh Sleep Quality Index Global|Measures severity of sleep impairment from 0 (least impairment) to 21 (most severe).|units on a scale|Mean|11.5|11.5|Standard Deviation|4.9|4.9|||
4019164|NCT01178671|3840157|B3|||Medical Outcomes Study Short Form 12 - Mental|Measures level of mental functioning from 0 (worst) to 100 (best).|units on a scale|Mean|30.4|30.4|Standard Deviation|11.7|11.7|||
4019165|NCT01178671|3840158|B2|||Medical Outcomes Study Short Form 12 - Mental|Measures level of mental functioning from 0 (worst) to 100 (best).|units on a scale|Mean|30.4|30.4|Standard Deviation|10.0|10.0|||
4019166|NCT01178671|3840159|B1|||Medical Outcomes Study Short Form 12 - Mental|Measures level of mental functioning from 0 (worst) to 100 (best).|units on a scale|Mean|30.3|30.3|Standard Deviation|13.5|13.5|||
4019237|NCT01178528|3840184|B4|MALE||Sex/Gender, Customized||participants|Number|82|82.0||||||
4019167|NCT01178671|3840157|B3|||Medical Outcomes Study Short Form 12 - Physical|Measures level of physical functioning from 0 (worst) to 100 (best).|units on a scale|Mean|42.7|42.7|Standard Deviation|10.1|10.1|||
4019168|NCT01178671|3840158|B2|||Medical Outcomes Study Short Form 12 - Physical|Measures level of physical functioning from 0 (worst) to 100 (best).|units on a scale|Mean|41.4|41.4|Standard Deviation|10.6|10.6|||
4019169|NCT01178671|3840159|B1|||Medical Outcomes Study Short Form 12 - Physical|Measures level of physical functioning from 0 (worst) to 100 (best).|units on a scale|Mean|43.9|43.9|Standard Deviation|9.8|9.8|||
4019170|NCT01178671|3840157|B3|||Quality of Life Enjoyment and Satisfaction Scale|Measures quality of life from 16 (lowest quality) to 80 (greatest).|units on a scale|Mean|40.2|40.2|Standard Deviation|13.4|13.4|||
4019171|NCT01178671|3840158|B2|||Quality of Life Enjoyment and Satisfaction Scale|Measures quality of life from 16 (lowest quality) to 80 (greatest).|units on a scale|Mean|41.4|41.4|Standard Deviation|13.5|13.5|||
4019172|NCT01178671|3840159|B1|||Quality of Life Enjoyment and Satisfaction Scale|Measures quality of life from 16 (lowest quality) to 80 (greatest).|units on a scale|Mean|39.1|39.1|Standard Deviation|13.6|13.6|||
4019173|NCT01178671|3840157|B3|||Posttraumatic Stress Disorder Checklist|Measures severity of posttraumatic stress disorder symptoms from 17 (mildest) to 85 (most severe).|units on a scale|Mean|59.5|59.5|Standard Deviation|10.8|10.8|||
4019174|NCT01178671|3840158|B2|||Posttraumatic Stress Disorder Checklist|Measures severity of posttraumatic stress disorder symptoms from 17 (mildest) to 85 (most severe).|units on a scale|Mean|60.0|60.0|Standard Deviation|10.5|10.5|||
4019175|NCT01178671|3840159|B1|||Posttraumatic Stress Disorder Checklist|Measures severity of posttraumatic stress disorder symptoms from 17 (mildest) to 85 (most severe).|units on a scale|Mean|58.9|58.9|Standard Deviation|11.0|11.0|||
4019176|NCT01178671|3840157|B3|||Hamilton Rating Scale for Depression|Measures severity of depression on scale from 0 (not depressed) to 50 (most severe).|units on a scale|Mean|20.6|20.6|Standard Deviation|6.0|6.0|||
4019177|NCT01178671|3840158|B2|||Hamilton Rating Scale for Depression|Measures severity of depression on scale from 0 (not depressed) to 50 (most severe).|units on a scale|Mean|20.4|20.4|Standard Deviation|5.9|5.9|||
4019178|NCT01178671|3840159|B1|||Hamilton Rating Scale for Depression|Measures severity of depression on scale from 0 (not depressed) to 50 (most severe).|units on a scale|Mean|20.8|20.8|Standard Deviation|6.2|6.2|||
4019179|NCT01178671|3840157|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4019180|NCT01178671|3840158|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4019181|NCT01178671|3840159|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4019182|NCT01178671|3840157|B3|other||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4019183|NCT01178671|3840158|B2|other||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4019184|NCT01178671|3840159|B1|other||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4019185|NCT01178671|3840157|B3|black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4019186|NCT01178671|3840158|B2|black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4019187|NCT01178671|3840159|B1|black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4019188|NCT01178671|3840157|B3|white||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4019189|NCT01178671|3840158|B2|white||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4019190|NCT01178671|3840159|B1|white||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4019191|NCT01178671|3840157|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4019192|NCT01178671|3840158|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4019193|NCT01178671|3840159|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4019194|NCT01178671|3840157|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4019195|NCT01178671|3840158|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4019196|NCT01178671|3840159|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4019197|NCT01178671|3840157|B3|||Age||years|Mean|40.0|40.0|Standard Deviation|12.5|12.5|||
4019198|NCT01178671|3840158|B2|||Age||years|Mean|42.4|42.4|Standard Deviation|13.3|13.3|||
4019199|NCT01178671|3840159|B1|||Age||years|Mean|37.6|37.6|Standard Deviation|11.7|11.7|||
4019200|NCT01178671|3840157|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4019201|NCT01178671|3840158|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4019202|NCT01178671|3840159|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4019203|NCT01178671|3840157|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4019204|NCT01178671|3840158|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4019205|NCT01178671|3840159|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4019206|NCT01178671|3840157|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4019207|NCT01178671|3840158|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4019208|NCT01178671|3840159|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4019209|NCT01178528|3840184|B4|class III||New York Heart Association (NYHA) class|The NYHA Classification system is a measure of functional status. Class II describes patients with cardiovascular disease (CVD) resulting in slight limitation of physical activity and comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea, or anginal pain. There is objective evidence of minimal CVD. Class III describes patients with CVD resulting in marked limitation of physical activity and comfortable at rest. Less than ordinary physical activity causes fatigue, palpitation, dyspnea, or anginal pain. There is objective evidence of moderately severe CVD.|participants|Number|58|58.0||||||
4019238|NCT01178528|3840185|B3|MALE||Sex/Gender, Customized||participants|Number|28|28.0||||||
4019239|NCT01178528|3840186|B2|MALE||Sex/Gender, Customized||participants|Number|26|26.0||||||
4019240|NCT01178528|3840187|B1|MALE||Sex/Gender, Customized||participants|Number|28|28.0||||||
4019241|NCT01178528|3840184|B4||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4019210|NCT01178528|3840185|B3|class III||New York Heart Association (NYHA) class|The NYHA Classification system is a measure of functional status. Class II describes patients with cardiovascular disease (CVD) resulting in slight limitation of physical activity and comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea, or anginal pain. There is objective evidence of minimal CVD. Class III describes patients with CVD resulting in marked limitation of physical activity and comfortable at rest. Less than ordinary physical activity causes fatigue, palpitation, dyspnea, or anginal pain. There is objective evidence of moderately severe CVD.|participants|Number|21|21.0||||||
4019211|NCT01178528|3840186|B2|class III||New York Heart Association (NYHA) class|The NYHA Classification system is a measure of functional status. Class II describes patients with cardiovascular disease (CVD) resulting in slight limitation of physical activity and comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea, or anginal pain. There is objective evidence of minimal CVD. Class III describes patients with CVD resulting in marked limitation of physical activity and comfortable at rest. Less than ordinary physical activity causes fatigue, palpitation, dyspnea, or anginal pain. There is objective evidence of moderately severe CVD.|participants|Number|16|16.0||||||
4019212|NCT01178528|3840187|B1|class III||New York Heart Association (NYHA) class|The NYHA Classification system is a measure of functional status. Class II describes patients with cardiovascular disease (CVD) resulting in slight limitation of physical activity and comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea, or anginal pain. There is objective evidence of minimal CVD. Class III describes patients with CVD resulting in marked limitation of physical activity and comfortable at rest. Less than ordinary physical activity causes fatigue, palpitation, dyspnea, or anginal pain. There is objective evidence of moderately severe CVD.|participants|Number|21|21.0||||||
4019213|NCT01178528|3840184|B4|class II||New York Heart Association (NYHA) class|The NYHA Classification system is a measure of functional status. Class II describes patients with cardiovascular disease (CVD) resulting in slight limitation of physical activity and comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea, or anginal pain. There is objective evidence of minimal CVD. Class III describes patients with CVD resulting in marked limitation of physical activity and comfortable at rest. Less than ordinary physical activity causes fatigue, palpitation, dyspnea, or anginal pain. There is objective evidence of moderately severe CVD.|participants|Number|63|63.0||||||
4019214|NCT01178528|3840185|B3|class II||New York Heart Association (NYHA) class|The NYHA Classification system is a measure of functional status. Class II describes patients with cardiovascular disease (CVD) resulting in slight limitation of physical activity and comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea, or anginal pain. There is objective evidence of minimal CVD. Class III describes patients with CVD resulting in marked limitation of physical activity and comfortable at rest. Less than ordinary physical activity causes fatigue, palpitation, dyspnea, or anginal pain. There is objective evidence of moderately severe CVD.|participants|Number|21|21.0||||||
4019215|NCT01178528|3840186|B2|class II||New York Heart Association (NYHA) class|The NYHA Classification system is a measure of functional status. Class II describes patients with cardiovascular disease (CVD) resulting in slight limitation of physical activity and comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea, or anginal pain. There is objective evidence of minimal CVD. Class III describes patients with CVD resulting in marked limitation of physical activity and comfortable at rest. Less than ordinary physical activity causes fatigue, palpitation, dyspnea, or anginal pain. There is objective evidence of moderately severe CVD.|participants|Number|22|22.0||||||
4019216|NCT01178528|3840187|B1|class II||New York Heart Association (NYHA) class|The NYHA Classification system is a measure of functional status. Class II describes patients with cardiovascular disease (CVD) resulting in slight limitation of physical activity and comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea, or anginal pain. There is objective evidence of minimal CVD. Class III describes patients with CVD resulting in marked limitation of physical activity and comfortable at rest. Less than ordinary physical activity causes fatigue, palpitation, dyspnea, or anginal pain. There is objective evidence of moderately severe CVD.|participants|Number|20|20.0||||||
4019217|NCT01178528|3840184|B4|||Quality of Life||units on a scale|Mean|4.5|4.5|Standard Deviation|0.7|0.7|||
4019218|NCT01178528|3840185|B3|||Quality of Life||units on a scale|Mean|4.7|4.7|Standard Deviation|0.8|0.8|||
4019219|NCT01178528|3840186|B2|||Quality of Life||units on a scale|Mean|4.6|4.6|Standard Deviation|0.8|0.8|||
4019220|NCT01178528|3840187|B1|||Quality of Life||units on a scale|Mean|4.3|4.3|Standard Deviation|0.5|0.5|||
4019221|NCT01178528|3840184|B4|||Maximal Oxygen Consumption||mL/Kg/min|Mean|12.25|12.25|Standard Deviation|2.4|2.4|||
4019222|NCT01178528|3840185|B3|||Maximal Oxygen Consumption||mL/Kg/min|Mean|12.4|12.4|Standard Deviation|2.5|2.5|||
4019223|NCT01178528|3840186|B2|||Maximal Oxygen Consumption||mL/Kg/min|Mean|12.3|12.3|Standard Deviation|2.6|2.6|||
4019224|NCT01178528|3840187|B1|||Maximal Oxygen Consumption||mL/Kg/min|Mean|12.05|12.05|Standard Deviation|2.1|2.1|||
4019225|NCT01178528|3840184|B4|||Exercise Tolerance Assessed by 6 Minute Walking Test||meters|Mean|361.3|361.3|Standard Deviation|105.3|105.3|||
4019226|NCT01178528|3840185|B3|||Exercise Tolerance Assessed by 6 Minute Walking Test||meters|Mean|358.2|358.2|Standard Deviation|107.6|107.6|||
4019227|NCT01178528|3840186|B2|||Exercise Tolerance Assessed by 6 Minute Walking Test||meters|Mean|379.0|379.0|Standard Deviation|96.3|96.3|||
4019228|NCT01178528|3840187|B1|||Exercise Tolerance Assessed by 6 Minute Walking Test||meters|Mean|346.7|346.7|Standard Deviation|112.0|112.0|||
4019229|NCT01178528|3840184|B4|Italy||Region of Enrollment||participants|Number|121|121.0||||||
4019230|NCT01178528|3840185|B3|Italy||Region of Enrollment||participants|Number|42|42.0||||||
4019231|NCT01178528|3840186|B2|Italy||Region of Enrollment||participants|Number|38|38.0||||||
4019232|NCT01178528|3840187|B1|Italy||Region of Enrollment||participants|Number|41|41.0||||||
4019233|NCT01178528|3840184|B4|FEMALE||Sex/Gender, Customized||participants|Number|39|39.0||||||
4019234|NCT01178528|3840185|B3|FEMALE||Sex/Gender, Customized||participants|Number|14|14.0||||||
4019235|NCT01178528|3840186|B2|FEMALE||Sex/Gender, Customized||participants|Number|12|12.0||||||
4019236|NCT01178528|3840187|B1|FEMALE||Sex/Gender, Customized||participants|Number|13|13.0||||||
4019242|NCT01178528|3840185|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4019243|NCT01178528|3840186|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4019244|NCT01178528|3840187|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4019245|NCT01178528|3840184|B4||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
4019246|NCT01178528|3840185|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4019247|NCT01178528|3840186|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4019248|NCT01178528|3840187|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4019249|NCT01178528|3840184|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4019250|NCT01178528|3840185|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4019251|NCT01178528|3840186|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4019252|NCT01178528|3840187|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4019253|NCT01178385|3840206|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
4019254|NCT01178385|3840207|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4019255|NCT01178385|3840208|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4019256|NCT01178385|3840206|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4019257|NCT01178385|3840207|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4019258|NCT01178385|3840208|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4019259|NCT01178385|3840206|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4019260|NCT01178385|3840207|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4019261|NCT01178385|3840208|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4019262|NCT01178385|3840206|B3|||Age||years|Mean|8.89|8.89|Standard Deviation|1.34|1.34|||
4019263|NCT01178385|3840207|B2|||Age||years|Mean|8.95|8.95|Standard Deviation|1.40|1.4|||
4019264|NCT01178385|3840208|B1|||Age||years|Mean|8.83|8.83|Standard Deviation|1.31|1.31|||
4019265|NCT01178385|3840206|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4019266|NCT01178385|3840207|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4019267|NCT01178385|3840208|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4019268|NCT01178385|3840206|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4019269|NCT01178385|3840207|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4019270|NCT01178385|3840208|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4019271|NCT01178385|3840206|B3||<=18 years|Age||Participants|Count of Participants|45|45.0||||||
4019272|NCT01178385|3840207|B2||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
4019273|NCT01178385|3840208|B1||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
4019274|NCT01178333|3840219|B4|Missing||Admitting service||participants|Number|4|4.0||||||
4019275|NCT01178333|3840220|B3|Missing||Admitting service||participants|Number|1|1.0||||||
4019276|NCT01178333|3840221|B2|Missing||Admitting service||participants|Number|3|3.0||||||
4019277|NCT01178333|3840222|B1|Missing||Admitting service||participants|Number|0|0.0||||||
4019278|NCT01178333|3840219|B4|Medicine||Admitting service||participants|Number|253|253.0||||||
4019279|NCT01178333|3840220|B3|Medicine||Admitting service||participants|Number|56|56.0||||||
4019280|NCT01178333|3840221|B2|Medicine||Admitting service||participants|Number|161|161.0||||||
4019281|NCT01178333|3840222|B1|Medicine||Admitting service||participants|Number|36|36.0||||||
4019282|NCT01178333|3840219|B4|Other surgery||Admitting service||participants|Number|56|56.0||||||
4019283|NCT01178333|3840220|B3|Other surgery||Admitting service||participants|Number|8|8.0||||||
4019284|NCT01178333|3840221|B2|Other surgery||Admitting service||participants|Number|33|33.0||||||
4019285|NCT01178333|3840222|B1|Other surgery||Admitting service||participants|Number|15|15.0||||||
4019286|NCT01178333|3840219|B4|Orthopedic surgery||Admitting service||participants|Number|15|15.0||||||
4019287|NCT01178333|3840220|B3|Orthopedic surgery||Admitting service||participants|Number|4|4.0||||||
4019288|NCT01178333|3840221|B2|Orthopedic surgery||Admitting service||participants|Number|9|9.0||||||
4019289|NCT01178333|3840222|B1|Orthopedic surgery||Admitting service||participants|Number|2|2.0||||||
4019290|NCT01178333|3840219|B4|CV/thoracic surgery||Admitting service||participants|Number|114|114.0||||||
4019291|NCT01178333|3840220|B3|CV/thoracic surgery||Admitting service||participants|Number|18|18.0||||||
4019292|NCT01178333|3840221|B2|CV/thoracic surgery||Admitting service||participants|Number|78|78.0||||||
4019293|NCT01178333|3840222|B1|CV/thoracic surgery||Admitting service||participants|Number|18|18.0||||||
4019294|NCT01178333|3840219|B4|Missing||Heparin-PF4 (platelet factor 4) OD (optical density) test results|The OD in the Heparin-PF4 OD test stands for optical density. The PF4 stands for platelet factor 4. The test looks for antibodies to complexes of heparin combined with platelet factor 4. Higher optical density indicates higher antibody concentration. We could say that generally OD values above 0.4 are considered a positive result, and that the higher the OD, the greater the concentration of antibodies in the patient’s blood.|participants|Number|1|1.0||||||
4019295|NCT01178333|3840220|B3|Missing||Heparin-PF4 (platelet factor 4) OD (optical density) test results|The OD in the Heparin-PF4 OD test stands for optical density. The PF4 stands for platelet factor 4. The test looks for antibodies to complexes of heparin combined with platelet factor 4. Higher optical density indicates higher antibody concentration. We could say that generally OD values above 0.4 are considered a positive result, and that the higher the OD, the greater the concentration of antibodies in the patient’s blood.|participants|Number|0|0.0||||||
4019333|NCT01178333|3840222|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4019334|NCT01178333|3840219|B4|||Age||years|Mean|60|60.0|Standard Deviation|18|18.0|||
4019296|NCT01178333|3840221|B2|Missing||Heparin-PF4 (platelet factor 4) OD (optical density) test results|The OD in the Heparin-PF4 OD test stands for optical density. The PF4 stands for platelet factor 4. The test looks for antibodies to complexes of heparin combined with platelet factor 4. Higher optical density indicates higher antibody concentration. We could say that generally OD values above 0.4 are considered a positive result, and that the higher the OD, the greater the concentration of antibodies in the patient’s blood.|participants|Number|1|1.0||||||
4019297|NCT01178333|3840222|B1|Missing||Heparin-PF4 (platelet factor 4) OD (optical density) test results|The OD in the Heparin-PF4 OD test stands for optical density. The PF4 stands for platelet factor 4. The test looks for antibodies to complexes of heparin combined with platelet factor 4. Higher optical density indicates higher antibody concentration. We could say that generally OD values above 0.4 are considered a positive result, and that the higher the OD, the greater the concentration of antibodies in the patient’s blood.|participants|Number|0|0.0||||||
4019298|NCT01178333|3840219|B4|Greater than or equal to 1.0||Heparin-PF4 (platelet factor 4) OD (optical density) test results|The OD in the Heparin-PF4 OD test stands for optical density. The PF4 stands for platelet factor 4. The test looks for antibodies to complexes of heparin combined with platelet factor 4. Higher optical density indicates higher antibody concentration. We could say that generally OD values above 0.4 are considered a positive result, and that the higher the OD, the greater the concentration of antibodies in the patient’s blood.|participants|Number|183|183.0||||||
4019299|NCT01178333|3840220|B3|Greater than or equal to 1.0||Heparin-PF4 (platelet factor 4) OD (optical density) test results|The OD in the Heparin-PF4 OD test stands for optical density. The PF4 stands for platelet factor 4. The test looks for antibodies to complexes of heparin combined with platelet factor 4. Higher optical density indicates higher antibody concentration. We could say that generally OD values above 0.4 are considered a positive result, and that the higher the OD, the greater the concentration of antibodies in the patient’s blood.|participants|Number|26|26.0||||||
4019300|NCT01178333|3840221|B2|Greater than or equal to 1.0||Heparin-PF4 (platelet factor 4) OD (optical density) test results|The OD in the Heparin-PF4 OD test stands for optical density. The PF4 stands for platelet factor 4. The test looks for antibodies to complexes of heparin combined with platelet factor 4. Higher optical density indicates higher antibody concentration. We could say that generally OD values above 0.4 are considered a positive result, and that the higher the OD, the greater the concentration of antibodies in the patient’s blood.|participants|Number|120|120.0||||||
4019301|NCT01178333|3840222|B1|Greater than or equal to 1.0||Heparin-PF4 (platelet factor 4) OD (optical density) test results|The OD in the Heparin-PF4 OD test stands for optical density. The PF4 stands for platelet factor 4. The test looks for antibodies to complexes of heparin combined with platelet factor 4. Higher optical density indicates higher antibody concentration. We could say that generally OD values above 0.4 are considered a positive result, and that the higher the OD, the greater the concentration of antibodies in the patient’s blood.|participants|Number|37|37.0||||||
4019302|NCT01178333|3840219|B4|Less than 1.0||Heparin-PF4 (platelet factor 4) OD (optical density) test results|The OD in the Heparin-PF4 OD test stands for optical density. The PF4 stands for platelet factor 4. The test looks for antibodies to complexes of heparin combined with platelet factor 4. Higher optical density indicates higher antibody concentration. We could say that generally OD values above 0.4 are considered a positive result, and that the higher the OD, the greater the concentration of antibodies in the patient’s blood.|participants|Number|258|258.0||||||
4019303|NCT01178333|3840220|B3|Less than 1.0||Heparin-PF4 (platelet factor 4) OD (optical density) test results|The OD in the Heparin-PF4 OD test stands for optical density. The PF4 stands for platelet factor 4. The test looks for antibodies to complexes of heparin combined with platelet factor 4. Higher optical density indicates higher antibody concentration. We could say that generally OD values above 0.4 are considered a positive result, and that the higher the OD, the greater the concentration of antibodies in the patient’s blood.|participants|Number|61|61.0||||||
4019304|NCT01178333|3840221|B2|Less than 1.0||Heparin-PF4 (platelet factor 4) OD (optical density) test results|The OD in the Heparin-PF4 OD test stands for optical density. The PF4 stands for platelet factor 4. The test looks for antibodies to complexes of heparin combined with platelet factor 4. Higher optical density indicates higher antibody concentration. We could say that generally OD values above 0.4 are considered a positive result, and that the higher the OD, the greater the concentration of antibodies in the patient’s blood.|participants|Number|163|163.0||||||
4019305|NCT01178333|3840222|B1|Less than 1.0||Heparin-PF4 (platelet factor 4) OD (optical density) test results|The OD in the Heparin-PF4 OD test stands for optical density. The PF4 stands for platelet factor 4. The test looks for antibodies to complexes of heparin combined with platelet factor 4. Higher optical density indicates higher antibody concentration. We could say that generally OD values above 0.4 are considered a positive result, and that the higher the OD, the greater the concentration of antibodies in the patient’s blood.|participants|Number|34|34.0||||||
4019306|NCT01178333|3840219|B4|Non-use of low molecular weight heparin||Heparin exposure this admission before Day 0: use (or non-use) of low molecular weight heparin|Two types of heparins are commonly used as anticoagulants - unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH). Low molecular weight heparin (LMWH) is derived from UFH by depolymerization. Each LMWH product has a specific molecular weight distribution that determines its anticoagulant activity and duration of action.|participants|Number|368|368.0||||||
4019307|NCT01178333|3840220|B3|Non-use of low molecular weight heparin||Heparin exposure this admission before Day 0: use (or non-use) of low molecular weight heparin|Two types of heparins are commonly used as anticoagulants - unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH). Low molecular weight heparin (LMWH) is derived from UFH by depolymerization. Each LMWH product has a specific molecular weight distribution that determines its anticoagulant activity and duration of action.|participants|Number|76|76.0||||||
4019308|NCT01178333|3840221|B2|Non-use of low molecular weight heparin||Heparin exposure this admission before Day 0: use (or non-use) of low molecular weight heparin|Two types of heparins are commonly used as anticoagulants - unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH). Low molecular weight heparin (LMWH) is derived from UFH by depolymerization. Each LMWH product has a specific molecular weight distribution that determines its anticoagulant activity and duration of action.|participants|Number|236|236.0||||||
4019335|NCT01178333|3840220|B3|||Age||years|Mean|60|60.0|Standard Deviation|19|19.0|||
4019336|NCT01178333|3840221|B2|||Age||years|Mean|59|59.0|Standard Deviation|18|18.0|||
4019309|NCT01178333|3840222|B1|Non-use of low molecular weight heparin||Heparin exposure this admission before Day 0: use (or non-use) of low molecular weight heparin|Two types of heparins are commonly used as anticoagulants - unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH). Low molecular weight heparin (LMWH) is derived from UFH by depolymerization. Each LMWH product has a specific molecular weight distribution that determines its anticoagulant activity and duration of action.|participants|Number|56|56.0||||||
4019310|NCT01178333|3840219|B4|Use of low molecular weight heparin||Heparin exposure this admission before Day 0: use (or non-use) of low molecular weight heparin|Two types of heparins are commonly used as anticoagulants - unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH). Low molecular weight heparin (LMWH) is derived from UFH by depolymerization. Each LMWH product has a specific molecular weight distribution that determines its anticoagulant activity and duration of action.|participants|Number|74|74.0||||||
4019311|NCT01178333|3840220|B3|Use of low molecular weight heparin||Heparin exposure this admission before Day 0: use (or non-use) of low molecular weight heparin|Two types of heparins are commonly used as anticoagulants - unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH). Low molecular weight heparin (LMWH) is derived from UFH by depolymerization. Each LMWH product has a specific molecular weight distribution that determines its anticoagulant activity and duration of action.|participants|Number|11|11.0||||||
4019312|NCT01178333|3840221|B2|Use of low molecular weight heparin||Heparin exposure this admission before Day 0: use (or non-use) of low molecular weight heparin|Two types of heparins are commonly used as anticoagulants - unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH). Low molecular weight heparin (LMWH) is derived from UFH by depolymerization. Each LMWH product has a specific molecular weight distribution that determines its anticoagulant activity and duration of action.|participants|Number|48|48.0||||||
4019313|NCT01178333|3840222|B1|Use of low molecular weight heparin||Heparin exposure this admission before Day 0: use (or non-use) of low molecular weight heparin|Two types of heparins are commonly used as anticoagulants - unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH). Low molecular weight heparin (LMWH) is derived from UFH by depolymerization. Each LMWH product has a specific molecular weight distribution that determines its anticoagulant activity and duration of action.|participants|Number|15|15.0||||||
4019314|NCT01178333|3840219|B4|Non-use of unfractionated heparin||Heparin exposure this admission before Day 0: use (or non-use) of unfractionated heparin (UFH)|Two types of heparins are commonly used as anticoagulants - unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH). Unfractionated heparin (UFH) has been used for the prevention and treatment of thrombosis for several decades.|participants|Number|33|33.0||||||
4019315|NCT01178333|3840220|B3|Non-use of unfractionated heparin||Heparin exposure this admission before Day 0: use (or non-use) of unfractionated heparin (UFH)|Two types of heparins are commonly used as anticoagulants - unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH). Unfractionated heparin (UFH) has been used for the prevention and treatment of thrombosis for several decades.|participants|Number|8|8.0||||||
4019316|NCT01178333|3840221|B2|Non-use of unfractionated heparin||Heparin exposure this admission before Day 0: use (or non-use) of unfractionated heparin (UFH)|Two types of heparins are commonly used as anticoagulants - unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH). Unfractionated heparin (UFH) has been used for the prevention and treatment of thrombosis for several decades.|participants|Number|21|21.0||||||
4019317|NCT01178333|3840222|B1|Non-use of unfractionated heparin||Heparin exposure this admission before Day 0: use (or non-use) of unfractionated heparin (UFH)|Two types of heparins are commonly used as anticoagulants - unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH). Unfractionated heparin (UFH) has been used for the prevention and treatment of thrombosis for several decades.|participants|Number|4|4.0||||||
4019318|NCT01178333|3840219|B4|Use of unfractionated heparin||Heparin exposure this admission before Day 0: use (or non-use) of unfractionated heparin (UFH)|Two types of heparins are commonly used as anticoagulants - unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH). Unfractionated heparin (UFH) has been used for the prevention and treatment of thrombosis for several decades.|participants|Number|409|409.0||||||
4019319|NCT01178333|3840220|B3|Use of unfractionated heparin||Heparin exposure this admission before Day 0: use (or non-use) of unfractionated heparin (UFH)|Two types of heparins are commonly used as anticoagulants - unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH). Unfractionated heparin (UFH) has been used for the prevention and treatment of thrombosis for several decades.|participants|Number|79|79.0||||||
4019320|NCT01178333|3840221|B2|Use of unfractionated heparin||Heparin exposure this admission before Day 0: use (or non-use) of unfractionated heparin (UFH)|Two types of heparins are commonly used as anticoagulants - unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH). Unfractionated heparin (UFH) has been used for the prevention and treatment of thrombosis for several decades.|participants|Number|263|263.0||||||
4019321|NCT01178333|3840222|B1|Use of unfractionated heparin||Heparin exposure this admission before Day 0: use (or non-use) of unfractionated heparin (UFH)|Two types of heparins are commonly used as anticoagulants - unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH). Unfractionated heparin (UFH) has been used for the prevention and treatment of thrombosis for several decades.|participants|Number|67|67.0||||||
4019322|NCT01178333|3840219|B4|||Baseline Platelet Count||x 10^9/L|Mean|261|261.0|Standard Deviation|158|158.0|||
4019323|NCT01178333|3840220|B3|||Baseline Platelet Count||x 10^9/L|Mean|215|215.0|Standard Deviation|172|172.0|||
4019324|NCT01178333|3840221|B2|||Baseline Platelet Count||x 10^9/L|Mean|270|270.0|Standard Deviation|149|149.0|||
4019325|NCT01178333|3840222|B1|||Baseline Platelet Count||x 10^9/L|Mean|282|282.0|Standard Deviation|268|268.0|||
4019326|NCT01178333|3840219|B4||Male|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
4019327|NCT01178333|3840220|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4019328|NCT01178333|3840221|B2||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4019329|NCT01178333|3840222|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4019330|NCT01178333|3840219|B4||Female|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4019331|NCT01178333|3840220|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4019332|NCT01178333|3840221|B2||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4019337|NCT01178333|3840222|B1|||Age||years|Mean|62|62.0|Standard Deviation|16|16.0|||
4019338|NCT01178294|3840278|B1|India||Region of Enrollment|Of 16 subjects enrolled in the US, 12 were enrolled under Protocol 301 and 4 were enrolled under the expanded access Protocol 301a.|participants|Number|4|4.0||||||
4019339|NCT01178294|3840278|B1|United Kingdom||Region of Enrollment|Of 16 subjects enrolled in the US, 12 were enrolled under Protocol 301 and 4 were enrolled under the expanded access Protocol 301a.|participants|Number|4|4.0||||||
4019340|NCT01178294|3840278|B1|Canada||Region of Enrollment|Of 16 subjects enrolled in the US, 12 were enrolled under Protocol 301 and 4 were enrolled under the expanded access Protocol 301a.|participants|Number|5|5.0||||||
4019341|NCT01178294|3840278|B1|United States||Region of Enrollment|Of 16 subjects enrolled in the US, 12 were enrolled under Protocol 301 and 4 were enrolled under the expanded access Protocol 301a.|participants|Number|16|16.0||||||
4019342|NCT01178294|3840278|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4019343|NCT01178294|3840278|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4019344|NCT01178294|3840278|B1|||Age||years|Mean|69.8|69.8|Standard Deviation|13.28|13.28|||
4019345|NCT01178281|3840299|B3|No||Disease sub-type: Post-Essential Thrombocythemia Myelofibrosis|Post-Essential Thrombocytemia Myelofibrosis. (pET) include all 4 criteria: 1. Platelet count ≥450 x 10^9/L. 2. Bone marrow biopsy specimen showing proliferation of the megakaryocytic lineage with increased numbers of enlarged, mature megakaryocytes. No increase or left-shift of neutrophil granulopoiesis or erythropoiesis. 3. Not meeting WHO criteria for PV, primary myelofibrosis, BCR-ABL1–positive CML, or myelodysplastic syndrome, or other myeloid neoplasm. 4. Demonstration of JAK2 V617F or other clonal marker, or in the absence of JAK2 V617F, no evidence of reactive thrombocytosis.|participants|Number|218|218.0||||||
4019346|NCT01178281|3840300|B2|No||Disease sub-type: Post-Essential Thrombocythemia Myelofibrosis|Post-Essential Thrombocytemia Myelofibrosis. (pET) include all 4 criteria: 1. Platelet count ≥450 x 10^9/L. 2. Bone marrow biopsy specimen showing proliferation of the megakaryocytic lineage with increased numbers of enlarged, mature megakaryocytes. No increase or left-shift of neutrophil granulopoiesis or erythropoiesis. 3. Not meeting WHO criteria for PV, primary myelofibrosis, BCR-ABL1–positive CML, or myelodysplastic syndrome, or other myeloid neoplasm. 4. Demonstration of JAK2 V617F or other clonal marker, or in the absence of JAK2 V617F, no evidence of reactive thrombocytosis.|participants|Number|73|73.0||||||
4019347|NCT01178281|3840301|B1|No||Disease sub-type: Post-Essential Thrombocythemia Myelofibrosis|Post-Essential Thrombocytemia Myelofibrosis. (pET) include all 4 criteria: 1. Platelet count ≥450 x 10^9/L. 2. Bone marrow biopsy specimen showing proliferation of the megakaryocytic lineage with increased numbers of enlarged, mature megakaryocytes. No increase or left-shift of neutrophil granulopoiesis or erythropoiesis. 3. Not meeting WHO criteria for PV, primary myelofibrosis, BCR-ABL1–positive CML, or myelodysplastic syndrome, or other myeloid neoplasm. 4. Demonstration of JAK2 V617F or other clonal marker, or in the absence of JAK2 V617F, no evidence of reactive thrombocytosis.|participants|Number|145|145.0||||||
4019348|NCT01178281|3840299|B3|Yes||Disease sub-type: Post-Essential Thrombocythemia Myelofibrosis|Post-Essential Thrombocytemia Myelofibrosis. (pET) include all 4 criteria: 1. Platelet count ≥450 x 10^9/L. 2. Bone marrow biopsy specimen showing proliferation of the megakaryocytic lineage with increased numbers of enlarged, mature megakaryocytes. No increase or left-shift of neutrophil granulopoiesis or erythropoiesis. 3. Not meeting WHO criteria for PV, primary myelofibrosis, BCR-ABL1–positive CML, or myelodysplastic syndrome, or other myeloid neoplasm. 4. Demonstration of JAK2 V617F or other clonal marker, or in the absence of JAK2 V617F, no evidence of reactive thrombocytosis.|participants|Number|34|34.0||||||
4019349|NCT01178281|3840300|B2|Yes||Disease sub-type: Post-Essential Thrombocythemia Myelofibrosis|Post-Essential Thrombocytemia Myelofibrosis. (pET) include all 4 criteria: 1. Platelet count ≥450 x 10^9/L. 2. Bone marrow biopsy specimen showing proliferation of the megakaryocytic lineage with increased numbers of enlarged, mature megakaryocytes. No increase or left-shift of neutrophil granulopoiesis or erythropoiesis. 3. Not meeting WHO criteria for PV, primary myelofibrosis, BCR-ABL1–positive CML, or myelodysplastic syndrome, or other myeloid neoplasm. 4. Demonstration of JAK2 V617F or other clonal marker, or in the absence of JAK2 V617F, no evidence of reactive thrombocytosis.|participants|Number|11|11.0||||||
4019350|NCT01178281|3840301|B1|Yes||Disease sub-type: Post-Essential Thrombocythemia Myelofibrosis|Post-Essential Thrombocytemia Myelofibrosis. (pET) include all 4 criteria: 1. Platelet count ≥450 x 10^9/L. 2. Bone marrow biopsy specimen showing proliferation of the megakaryocytic lineage with increased numbers of enlarged, mature megakaryocytes. No increase or left-shift of neutrophil granulopoiesis or erythropoiesis. 3. Not meeting WHO criteria for PV, primary myelofibrosis, BCR-ABL1–positive CML, or myelodysplastic syndrome, or other myeloid neoplasm. 4. Demonstration of JAK2 V617F or other clonal marker, or in the absence of JAK2 V617F, no evidence of reactive thrombocytosis.|participants|Number|23|23.0||||||
4019351|NCT01178281|3840299|B3|No||Disease sub-type: Post-polycythemia Vera Myelofibrosis|The polycythemia Vera (pPV) major and minor critiera: 1. Hemoglobin >18.5 g/dL in men, >16.5 g/dL in women or other evidence of increased red cell volume. 2. Presence of JAK2 V617F or other functionally similar mutation such as JAK2 exon 12 mutation. 3. Bone marrow biopsy showing hypercellularity for age with trilineage growth (panmyelosis) with prominent erythroid, granulocytic, and megakaryocytic proliferation. 4. Serum erythropoietin level below the reference range for normal. 5. Endogenous erythroid colony formation in vitro.|Participants|Number|227|227.0||||||
4019352|NCT01178281|3840300|B2|No||Disease sub-type: Post-polycythemia Vera Myelofibrosis|The polycythemia Vera (pPV) major and minor critiera: 1. Hemoglobin >18.5 g/dL in men, >16.5 g/dL in women or other evidence of increased red cell volume. 2. Presence of JAK2 V617F or other functionally similar mutation such as JAK2 exon 12 mutation. 3. Bone marrow biopsy showing hypercellularity for age with trilineage growth (panmyelosis) with prominent erythroid, granulocytic, and megakaryocytic proliferation. 4. Serum erythropoietin level below the reference range for normal. 5. Endogenous erythroid colony formation in vitro.|Participants|Number|76|76.0||||||
4019353|NCT01178281|3840301|B1|No||Disease sub-type: Post-polycythemia Vera Myelofibrosis|The polycythemia Vera (pPV) major and minor critiera: 1. Hemoglobin >18.5 g/dL in men, >16.5 g/dL in women or other evidence of increased red cell volume. 2. Presence of JAK2 V617F or other functionally similar mutation such as JAK2 exon 12 mutation. 3. Bone marrow biopsy showing hypercellularity for age with trilineage growth (panmyelosis) with prominent erythroid, granulocytic, and megakaryocytic proliferation. 4. Serum erythropoietin level below the reference range for normal. 5. Endogenous erythroid colony formation in vitro.|Participants|Number|151|151.0||||||
4019354|NCT01178281|3840299|B3|Yes||Disease sub-type: Post-polycythemia Vera Myelofibrosis|The polycythemia Vera (pPV) major and minor critiera: 1. Hemoglobin >18.5 g/dL in men, >16.5 g/dL in women or other evidence of increased red cell volume. 2. Presence of JAK2 V617F or other functionally similar mutation such as JAK2 exon 12 mutation. 3. Bone marrow biopsy showing hypercellularity for age with trilineage growth (panmyelosis) with prominent erythroid, granulocytic, and megakaryocytic proliferation. 4. Serum erythropoietin level below the reference range for normal. 5. Endogenous erythroid colony formation in vitro.|Participants|Number|25|25.0||||||
4019355|NCT01178281|3840300|B2|Yes||Disease sub-type: Post-polycythemia Vera Myelofibrosis|The polycythemia Vera (pPV) major and minor critiera: 1. Hemoglobin >18.5 g/dL in men, >16.5 g/dL in women or other evidence of increased red cell volume. 2. Presence of JAK2 V617F or other functionally similar mutation such as JAK2 exon 12 mutation. 3. Bone marrow biopsy showing hypercellularity for age with trilineage growth (panmyelosis) with prominent erythroid, granulocytic, and megakaryocytic proliferation. 4. Serum erythropoietin level below the reference range for normal. 5. Endogenous erythroid colony formation in vitro.|Participants|Number|8|8.0||||||
4019356|NCT01178281|3840301|B1|Yes||Disease sub-type: Post-polycythemia Vera Myelofibrosis|The polycythemia Vera (pPV) major and minor critiera: 1. Hemoglobin >18.5 g/dL in men, >16.5 g/dL in women or other evidence of increased red cell volume. 2. Presence of JAK2 V617F or other functionally similar mutation such as JAK2 exon 12 mutation. 3. Bone marrow biopsy showing hypercellularity for age with trilineage growth (panmyelosis) with prominent erythroid, granulocytic, and megakaryocytic proliferation. 4. Serum erythropoietin level below the reference range for normal. 5. Endogenous erythroid colony formation in vitro.|Participants|Number|17|17.0||||||
4019357|NCT01178281|3840299|B3|No||Disease Sub-type: Primary Myelofibrosis (PMF)|PMF criteria: 1. Presence of megakaryocyte proliferation and atypiaa, accompanied by either reticulin or collagen fibrosis, or, in the absence of significant reticulin fibrosis, the megakaryocyte changes must be accompanied by an increased bone marrow cellularity characterized by granulocytic proliferation and decreased erythropoiesis 2. Not meeting World Health Organization (WHO) criteria for polycythemia vera, BCR-ABL1–positive chronic myelogenous leukemia, myelodysplastic syndrome, or other myeloid disorders. 3. Demonstration of JAK2 V617F or other clonal marker (eg, MPLW515K/L)|Participants|Number|60|60.0||||||
4019358|NCT01178281|3840300|B2|No||Disease Sub-type: Primary Myelofibrosis (PMF)|PMF criteria: 1. Presence of megakaryocyte proliferation and atypiaa, accompanied by either reticulin or collagen fibrosis, or, in the absence of significant reticulin fibrosis, the megakaryocyte changes must be accompanied by an increased bone marrow cellularity characterized by granulocytic proliferation and decreased erythropoiesis 2. Not meeting World Health Organization (WHO) criteria for polycythemia vera, BCR-ABL1–positive chronic myelogenous leukemia, myelodysplastic syndrome, or other myeloid disorders. 3. Demonstration of JAK2 V617F or other clonal marker (eg, MPLW515K/L)|Participants|Number|19|19.0||||||
4019359|NCT01178281|3840301|B1|No||Disease Sub-type: Primary Myelofibrosis (PMF)|PMF criteria: 1. Presence of megakaryocyte proliferation and atypiaa, accompanied by either reticulin or collagen fibrosis, or, in the absence of significant reticulin fibrosis, the megakaryocyte changes must be accompanied by an increased bone marrow cellularity characterized by granulocytic proliferation and decreased erythropoiesis 2. Not meeting World Health Organization (WHO) criteria for polycythemia vera, BCR-ABL1–positive chronic myelogenous leukemia, myelodysplastic syndrome, or other myeloid disorders. 3. Demonstration of JAK2 V617F or other clonal marker (eg, MPLW515K/L)|Participants|Number|41|41.0||||||
4019360|NCT01178281|3840299|B3|Yes||Disease Sub-type: Primary Myelofibrosis (PMF)|PMF criteria: 1. Presence of megakaryocyte proliferation and atypiaa, accompanied by either reticulin or collagen fibrosis, or, in the absence of significant reticulin fibrosis, the megakaryocyte changes must be accompanied by an increased bone marrow cellularity characterized by granulocytic proliferation and decreased erythropoiesis 2. Not meeting World Health Organization (WHO) criteria for polycythemia vera, BCR-ABL1–positive chronic myelogenous leukemia, myelodysplastic syndrome, or other myeloid disorders. 3. Demonstration of JAK2 V617F or other clonal marker (eg, MPLW515K/L)|Participants|Number|192|192.0||||||
4019361|NCT01178281|3840300|B2|Yes||Disease Sub-type: Primary Myelofibrosis (PMF)|PMF criteria: 1. Presence of megakaryocyte proliferation and atypiaa, accompanied by either reticulin or collagen fibrosis, or, in the absence of significant reticulin fibrosis, the megakaryocyte changes must be accompanied by an increased bone marrow cellularity characterized by granulocytic proliferation and decreased erythropoiesis 2. Not meeting World Health Organization (WHO) criteria for polycythemia vera, BCR-ABL1–positive chronic myelogenous leukemia, myelodysplastic syndrome, or other myeloid disorders. 3. Demonstration of JAK2 V617F or other clonal marker (eg, MPLW515K/L)|Participants|Number|65|65.0||||||
4019362|NCT01178281|3840301|B1|Yes||Disease Sub-type: Primary Myelofibrosis (PMF)|PMF criteria: 1. Presence of megakaryocyte proliferation and atypiaa, accompanied by either reticulin or collagen fibrosis, or, in the absence of significant reticulin fibrosis, the megakaryocyte changes must be accompanied by an increased bone marrow cellularity characterized by granulocytic proliferation and decreased erythropoiesis 2. Not meeting World Health Organization (WHO) criteria for polycythemia vera, BCR-ABL1–positive chronic myelogenous leukemia, myelodysplastic syndrome, or other myeloid disorders. 3. Demonstration of JAK2 V617F or other clonal marker (eg, MPLW515K/L)|Participants|Number|127|127.0||||||
4019363|NCT01178281|3840299|B3|||Baseline RBC Transfusion Burden (units/28days)|Defined as the average number of RBC-transfusion-units per 28 days over the 84 days immediately prior to randomization.|units per 28 days|Mean|3.5|3.5|Standard Deviation|1.81|1.81|1.3|13.3|
4019364|NCT01178281|3840300|B2|||Baseline RBC Transfusion Burden (units/28days)|Defined as the average number of RBC-transfusion-units per 28 days over the 84 days immediately prior to randomization.|units per 28 days|Mean|3.5|3.5|Standard Deviation|1.76|1.76|1.3|10.0|
4019365|NCT01178281|3840301|B1|||Baseline RBC Transfusion Burden (units/28days)|Defined as the average number of RBC-transfusion-units per 28 days over the 84 days immediately prior to randomization.|units per 28 days|Mean|3.5|3.5|Standard Deviation|1.84|1.84|1.3|13.3|
4019366|NCT01178281|3840299|B3|4 = (Completely Disabled)||ECOG Performance Status|"ECOG-Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)"|participants|Number|0|0.0||||||
4019367|NCT01178281|3840300|B2|4 = (Completely Disabled)||ECOG Performance Status|"ECOG-Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)"|participants|Number|0|0.0||||||
4019368|NCT01178281|3840301|B1|4 = (Completely Disabled)||ECOG Performance Status|"ECOG-Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)"|participants|Number|0|0.0||||||
4019369|NCT01178281|3840299|B3|3 = (Limited self care)||ECOG Performance Status|"ECOG-Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)"|participants|Number|0|0.0||||||
4019370|NCT01178281|3840300|B2|3 = (Limited self care)||ECOG Performance Status|"ECOG-Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)"|participants|Number|0|0.0||||||
4019371|NCT01178281|3840301|B1|3 = (Limited self care)||ECOG Performance Status|"ECOG-Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)"|participants|Number|0|0.0||||||
4019372|NCT01178281|3840299|B3|2 = (Ambulatory but unable to work)||ECOG Performance Status|"ECOG-Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)"|participants|Number|45|45.0||||||
4019373|NCT01178281|3840300|B2|2 = (Ambulatory but unable to work)||ECOG Performance Status|"ECOG-Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)"|participants|Number|15|15.0||||||
4019374|NCT01178281|3840301|B1|2 = (Ambulatory but unable to work)||ECOG Performance Status|"ECOG-Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)"|participants|Number|30|30.0||||||
4019375|NCT01178281|3840299|B3|1 = (Restrictive but ambulatory)||ECOG Performance Status|"ECOG-Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)"|participants|Number|132|132.0||||||
4019376|NCT01178281|3840300|B2|1 = (Restrictive but ambulatory)||ECOG Performance Status|"ECOG-Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)"|participants|Number|47|47.0||||||
4019377|NCT01178281|3840301|B1|1 = (Restrictive but ambulatory)||ECOG Performance Status|"ECOG-Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)"|participants|Number|85|85.0||||||
4019378|NCT01178281|3840299|B3|0 = (Fully Active)||ECOG Performance Status|"ECOG-Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)"|participants|Number|75|75.0||||||
4019433|NCT01178125|3840558|B1|||Weight|n=2764 (1 participant did not have a value recorded for weight)|kg|Mean|72.4|72.4|Standard Deviation|18.62|18.62|||
4019379|NCT01178281|3840300|B2|0 = (Fully Active)||ECOG Performance Status|"ECOG-Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)"|participants|Number|22|22.0||||||
4019380|NCT01178281|3840301|B1|0 = (Fully Active)||ECOG Performance Status|"ECOG-Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)"|participants|Number|53|53.0||||||
4019381|NCT01178281|3840299|B3||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4019382|NCT01178281|3840300|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4019383|NCT01178281|3840301|B1||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4019384|NCT01178281|3840299|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4019385|NCT01178281|3840300|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4019386|NCT01178281|3840301|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4019387|NCT01178281|3840299|B3|||Age||Years|Mean|68.2|68.2|Standard Deviation|8.64|8.64|||
4019388|NCT01178281|3840300|B2|||Age||Years|Mean|68.6|68.6|Standard Deviation|8.16|8.16|||
4019389|NCT01178281|3840301|B1|||Age||Years|Mean|68.0|68.0|Standard Deviation|8.89|8.89|||
4019390|NCT01178268|3840308|B3|China||Region of Enrollment||participants|Number|488|488.0||||||
4019391|NCT01178268|3840309|B2|China||Region of Enrollment||participants|Number|121|121.0||||||
4019392|NCT01178268|3840310|B1|China||Region of Enrollment||participants|Number|367|367.0||||||
4019393|NCT01178268|3840308|B3|Chinese||Race/Ethnicity, Customized||participants|Number|488|488.0||||||
4019394|NCT01178268|3840309|B2|Chinese||Race/Ethnicity, Customized||participants|Number|121|121.0||||||
4019395|NCT01178268|3840310|B1|Chinese||Race/Ethnicity, Customized||participants|Number|367|367.0||||||
4019396|NCT01178268|3840308|B3||Male|Sex: Female, Male||Participants|Count of Participants|353|353.0||||||
4019397|NCT01178268|3840309|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4019398|NCT01178268|3840310|B1||Male|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
4019399|NCT01178268|3840308|B3||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4019400|NCT01178268|3840309|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4019401|NCT01178268|3840310|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4019402|NCT01178268|3840308|B3|Age < 65 years||Age, Customized||participants|Number|360|360.0||||||
4019403|NCT01178268|3840309|B2|Age < 65 years||Age, Customized||participants|Number|88|88.0||||||
4019404|NCT01178268|3840310|B1|Age < 65 years||Age, Customized||participants|Number|272|272.0||||||
4019405|NCT01178268|3840308|B3|Age ≥ 65 years||Age, Customized||participants|Number|128|128.0||||||
4019406|NCT01178268|3840309|B2|Age ≥ 65 years||Age, Customized||participants|Number|33|33.0||||||
4019407|NCT01178268|3840310|B1|Age ≥ 65 years||Age, Customized||participants|Number|95|95.0||||||
4019408|NCT01178268|3840308|B3|||Age||years|Mean|58.64|58.64|Standard Deviation|10.28|10.28|||
4019409|NCT01178268|3840309|B2|||Age||years|Mean|58.74|58.74|Standard Deviation|9.12|9.12|||
4019410|NCT01178268|3840310|B1|||Age||years|Mean|58.60|58.6|Standard Deviation|10.65|10.65|||
4019411|NCT01178216|3840528|B1|United States||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
4019412|NCT01178216|3840528|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4019413|NCT01178216|3840528|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4019414|NCT01178216|3840528|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4019415|NCT01178216|3840528|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4019416|NCT01178216|3840528|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4019417|NCT01178216|3840528|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4019418|NCT01178216|3840528|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4019419|NCT01178216|3840528|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4019420|NCT01178216|3840528|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4019421|NCT01178216|3840528|B1|||Age||years|Median|48|48.0|Inter-Quartile Range|||23.0|69.0|
4019422|NCT01178216|3840528|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4019423|NCT01178216|3840528|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4019424|NCT01178216|3840528|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4019425|NCT01178138|3840537|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4019426|NCT01178138|3840537|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4019427|NCT01178138|3840537|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
4019428|NCT01178138|3840537|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4019429|NCT01178138|3840537|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4019430|NCT01178138|3840537|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4019431|NCT01178138|3840537|B1|||Age||years|Mean|42.6|42.6|Standard Deviation|9.2|9.2|||
4019432|NCT01178125|3840558|B1|||Body Mass Index (BMI)|n=2763 (2 participants did not have values recorded for BMI)|kg/m^2|Mean|26.9|26.9|Standard Deviation|6.54|6.54|||
4019434|NCT01178125|3840558|B1|Other||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
4019435|NCT01178125|3840558|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|393|393.0||||||
4019436|NCT01178125|3840558|B1|Asian||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
4019437|NCT01178125|3840558|B1|Black||Race/Ethnicity, Customized||participants|Number|428|428.0||||||
4019438|NCT01178125|3840558|B1|White||Race/Ethnicity, Customized||participants|Number|1798|1798.0||||||
4019439|NCT01178125|3840558|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4019440|NCT01178125|3840558|B1||Female|Sex: Female, Male||Participants|Count of Participants|2765|2765.0||||||
4019441|NCT01178125|3840558|B1|||Age||years|Mean|26.7|26.7|Standard Deviation|5.44|5.44|||
4019442|NCT01178099|3840585|B5|United Kingdom||Region of Enrollment||participants|Number|26|26.0||||||
4019443|NCT01178099|3840586|B4|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
4019444|NCT01178099|3840587|B3|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4019445|NCT01178099|3840588|B2|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
4019446|NCT01178099|3840589|B1|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4019447|NCT01178099|3840585|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4019448|NCT01178099|3840586|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4019449|NCT01178099|3840587|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4019450|NCT01178099|3840588|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4019451|NCT01178099|3840589|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4019452|NCT01178099|3840585|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4019453|NCT01178099|3840586|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4019454|NCT01178099|3840587|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4019455|NCT01178099|3840588|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4019456|NCT01178099|3840589|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4019457|NCT01178099|3840585|B5||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4019458|NCT01178099|3840586|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4019459|NCT01178099|3840587|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4019460|NCT01178099|3840588|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4019461|NCT01178099|3840589|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4019462|NCT01178099|3840585|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4019463|NCT01178099|3840586|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4019464|NCT01178099|3840587|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4019465|NCT01178099|3840588|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4019466|NCT01178099|3840589|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4019467|NCT01178099|3840585|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4019468|NCT01178099|3840586|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4019469|NCT01178099|3840587|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4019470|NCT01178099|3840588|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4019471|NCT01178099|3840589|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4019472|NCT01178099|3840585|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4019473|NCT01178099|3840586|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4019474|NCT01178099|3840587|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4019475|NCT01178099|3840588|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4019476|NCT01178099|3840589|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4019477|NCT01178099|3840585|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4019478|NCT01178099|3840586|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4019479|NCT01178099|3840587|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4019480|NCT01178099|3840588|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4019481|NCT01178099|3840589|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4019482|NCT01178099|3840585|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4019483|NCT01178099|3840586|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4019484|NCT01178099|3840587|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4019485|NCT01178099|3840588|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4019486|NCT01178099|3840589|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4019487|NCT01178099|3840585|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4019488|NCT01178099|3840586|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4019489|NCT01178099|3840587|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4019490|NCT01178099|3840588|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4019491|NCT01178099|3840589|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4019492|NCT01178099|3840585|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4019493|NCT01178099|3840586|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4019494|NCT01178099|3840587|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4019495|NCT01178099|3840588|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4019496|NCT01178099|3840589|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4019497|NCT01178099|3840585|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4019498|NCT01178099|3840586|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4019499|NCT01178099|3840587|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4019500|NCT01178099|3840588|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4019501|NCT01178099|3840589|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4019502|NCT01178099|3840585|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4019503|NCT01178099|3840586|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4019504|NCT01178099|3840587|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4019505|NCT01178099|3840588|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4019506|NCT01178099|3840589|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4019507|NCT01178099|3840585|B5|||Age||years|Mean|27.9|27.9|Standard Deviation|7.6|7.6|||
4019508|NCT01178099|3840586|B4|||Age||years|Mean|29.6|29.6|Standard Deviation|6.8|6.8|||
4019509|NCT01178099|3840587|B3|||Age||years|Mean|28.0|28.0|Standard Deviation|14.8|14.8|||
4019510|NCT01178099|3840588|B2|||Age||years|Mean|27.6|27.6|Standard Deviation|6.5|6.5|||
4019511|NCT01178099|3840589|B1|||Age||years|Mean|24.8|24.8|Standard Deviation|3.0|3.0|||
4019512|NCT01178086|3840628|B3||Male|Sex: Female, Male||Participants|Count of Participants|417|417.0||||||
4019513|NCT01178086|3840629|B2||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4019514|NCT01178086|3840630|B1||Male|Sex: Female, Male||Participants|Count of Participants|312|312.0||||||
4019515|NCT01178086|3840628|B3||Female|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
4019516|NCT01178086|3840629|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4019517|NCT01178086|3840630|B1||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4019518|NCT01178086|3840628|B3|||Age||years|Mean|70.5|70.5|Standard Deviation|9.0|9.0|||
4019519|NCT01178086|3840629|B2|||Age||years|Mean|74.2|74.2|Standard Deviation|7.9|7.9|||
4019520|NCT01178086|3840630|B1|||Age||years|Mean|68.9|68.9|Standard Deviation|9.0|9.0|||
4019521|NCT01178073|3840654|B4|Missing||Race/Ethnicity, Customized|Intent-to-Treat Population|Participants|Number|1|1.0||||||
4019522|NCT01178073|3840655|B3|Missing||Race/Ethnicity, Customized|Intent-to-Treat Population|Participants|Number|0|0.0||||||
4019523|NCT01178073|3840656|B2|Missing||Race/Ethnicity, Customized|Intent-to-Treat Population|Participants|Number|1|1.0||||||
4019524|NCT01178073|3840657|B1|Missing||Race/Ethnicity, Customized|Intent-to-Treat Population|Participants|Number|0|0.0||||||
4019525|NCT01178073|3840654|B4|Mixed Race||Race/Ethnicity, Customized|Intent-to-Treat Population|Participants|Number|3|3.0||||||
4019526|NCT01178073|3840655|B3|Mixed Race||Race/Ethnicity, Customized|Intent-to-Treat Population|Participants|Number|0|0.0||||||
4019527|NCT01178073|3840656|B2|Mixed Race||Race/Ethnicity, Customized|Intent-to-Treat Population|Participants|Number|1|1.0||||||
4019528|NCT01178073|3840657|B1|Mixed Race||Race/Ethnicity, Customized|Intent-to-Treat Population|Participants|Number|2|2.0||||||
4019529|NCT01178073|3840654|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|Intent-to-Treat Population|Participants|Number|544|544.0||||||
4019530|NCT01178073|3840655|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|Intent-to-Treat Population|Participants|Number|133|133.0||||||
4019531|NCT01178073|3840656|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|Intent-to-Treat Population|Participants|Number|131|131.0||||||
4019532|NCT01178073|3840657|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|Intent-to-Treat Population|Participants|Number|280|280.0||||||
4019533|NCT01178073|3840654|B4|White - Arabic /North African Heritage||Race/Ethnicity, Customized|Intent-to-Treat Population|Participants|Number|2|2.0||||||
4019534|NCT01178073|3840655|B3|White - Arabic /North African Heritage||Race/Ethnicity, Customized|Intent-to-Treat Population|Participants|Number|0|0.0||||||
4019535|NCT01178073|3840656|B2|White - Arabic /North African Heritage||Race/Ethnicity, Customized|Intent-to-Treat Population|Participants|Number|1|1.0||||||
4019536|NCT01178073|3840657|B1|White - Arabic /North African Heritage||Race/Ethnicity, Customized|Intent-to-Treat Population|Participants|Number|1|1.0||||||
4019537|NCT01178073|3840654|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Intent-to-Treat Population|Participants|Number|3|3.0||||||
4019538|NCT01178073|3840655|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Intent-to-Treat Population|Participants|Number|2|2.0||||||
4019539|NCT01178073|3840656|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Intent-to-Treat Population|Participants|Number|0|0.0||||||
4019540|NCT01178073|3840657|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Intent-to-Treat Population|Participants|Number|1|1.0||||||
4019541|NCT01178073|3840654|B4|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Intent-to-Treat Population|Participants|Number|4|4.0||||||
4019542|NCT01178073|3840655|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Intent-to-Treat Population|Participants|Number|1|1.0||||||
4019543|NCT01178073|3840656|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Intent-to-Treat Population|Participants|Number|2|2.0||||||
4019598|NCT01177943|3840712|B3|Japanese||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4019544|NCT01178073|3840657|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Intent-to-Treat Population|Participants|Number|1|1.0||||||
4019545|NCT01178073|3840654|B4|Asian - Japanese Heritage||Race/Ethnicity, Customized|Intent-to-Treat Population|Participants|Number|4|4.0||||||
4019546|NCT01178073|3840655|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized|Intent-to-Treat Population|Participants|Number|1|1.0||||||
4019547|NCT01178073|3840656|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized|Intent-to-Treat Population|Participants|Number|0|0.0||||||
4019548|NCT01178073|3840657|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized|Intent-to-Treat Population|Participants|Number|3|3.0||||||
4019549|NCT01178073|3840654|B4|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Intent-to-Treat Population|Participants|Number|4|4.0||||||
4019550|NCT01178073|3840655|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Intent-to-Treat Population|Participants|Number|1|1.0||||||
4019551|NCT01178073|3840656|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Intent-to-Treat Population|Participants|Number|2|2.0||||||
4019552|NCT01178073|3840657|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Intent-to-Treat Population|Participants|Number|1|1.0||||||
4019553|NCT01178073|3840654|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized|Intent-to-Treat Population|Participants|Number|2|2.0||||||
4019554|NCT01178073|3840655|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized|Intent-to-Treat Population|Participants|Number|0|0.0||||||
4019555|NCT01178073|3840656|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized|Intent-to-Treat Population|Participants|Number|0|0.0||||||
4019556|NCT01178073|3840657|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized|Intent-to-Treat Population|Participants|Number|2|2.0||||||
4019557|NCT01178073|3840654|B4|African American/African Heritage||Race/Ethnicity, Customized|Intent-to-Treat Population|Participants|Number|38|38.0||||||
4019558|NCT01178073|3840655|B3|African American/African Heritage||Race/Ethnicity, Customized|Intent-to-Treat Population|Participants|Number|13|13.0||||||
4019559|NCT01178073|3840656|B2|African American/African Heritage||Race/Ethnicity, Customized|Intent-to-Treat Population|Participants|Number|14|14.0||||||
4019560|NCT01178073|3840657|B1|African American/African Heritage||Race/Ethnicity, Customized|Intent-to-Treat Population|Participants|Number|11|11.0||||||
4019561|NCT01178073|3840654|B4||Male|Sex: Female, Male|Intent-to-Treat Population|Participants|Count of Participants|144|144.0||||||
4019562|NCT01178073|3840655|B3||Male|Sex: Female, Male|Intent-to-Treat Population|Participants|Count of Participants|30|30.0||||||
4019563|NCT01178073|3840656|B2||Male|Sex: Female, Male|Intent-to-Treat Population|Participants|Count of Participants|35|35.0||||||
4019564|NCT01178073|3840657|B1||Male|Sex: Female, Male|Intent-to-Treat Population|Participants|Count of Participants|79|79.0||||||
4019565|NCT01178073|3840654|B4||Female|Sex: Female, Male|Intent-to-Treat Population|Participants|Count of Participants|461|461.0||||||
4019566|NCT01178073|3840655|B3||Female|Sex: Female, Male|Intent-to-Treat Population|Participants|Count of Participants|121|121.0||||||
4019567|NCT01178073|3840656|B2||Female|Sex: Female, Male|Intent-to-Treat Population|Participants|Count of Participants|117|117.0||||||
4019568|NCT01178073|3840657|B1||Female|Sex: Female, Male|Intent-to-Treat Population|Participants|Count of Participants|223|223.0||||||
4019569|NCT01178073|3840654|B4|||Age|Intent-to-Treat Population|Years|Mean|55.7|55.7|Standard Deviation|14.21|14.21|||
4019570|NCT01178073|3840655|B3|||Age|Intent-to-Treat Population|Years|Mean|55.9|55.9|Standard Deviation|14.75|14.75|||
4019571|NCT01178073|3840656|B2|||Age|Intent-to-Treat Population|Years|Mean|55.2|55.2|Standard Deviation|14.41|14.41|||
4019572|NCT01178073|3840657|B1|||Age|Intent-to-Treat Population|Years|Mean|55.9|55.9|Standard Deviation|13.86|13.86|||
4019573|NCT01177969|3840688|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
4019574|NCT01177969|3840689|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4019575|NCT01177969|3840690|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4019576|NCT01177969|3840688|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4019577|NCT01177969|3840689|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4019578|NCT01177969|3840690|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4019579|NCT01177969|3840688|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4019580|NCT01177969|3840689|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4019581|NCT01177969|3840690|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4019582|NCT01177969|3840688|B3|||Age||years|Mean|12.3|12.3|Standard Deviation|1.14|1.14|||
4019583|NCT01177969|3840689|B2|||Age||years|Mean|12.2|12.2|Standard Deviation|.98|0.98|||
4019584|NCT01177969|3840690|B1|||Age||years|Mean|12.4|12.4|Standard Deviation|1.3|1.3|||
4019585|NCT01177956|3840699|B1|Asian (Korean)||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4019586|NCT01177956|3840699|B1|Asian (Chinese)||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
4019587|NCT01177956|3840699|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4019588|NCT01177956|3840699|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4019589|NCT01177956|3840699|B1|>=65 years||Age, Customized||participants|Number|13|13.0||||||
4019590|NCT01177956|3840699|B1|<65 years||Age, Customized||participants|Number|55|55.0||||||
4019591|NCT01177956|3840699|B1|||Age||years|Mean|55.7|55.7|Standard Deviation|9.5|9.5|||
4019592|NCT01177943|3840712|B3|||weight (kg)||kilograms (kg)|Mean|61.79|61.79|Standard Deviation|6.57|6.57|||
4019593|NCT01177943|3840713|B2|||weight (kg)||kilograms (kg)|Mean|61.28|61.28|Standard Deviation|5.90|5.9|||
4019594|NCT01177943|3840714|B1|||weight (kg)||kilograms (kg)|Mean|62.29|62.29|Standard Deviation|7.29|7.29|||
4019595|NCT01177943|3840712|B3|Japan||Region of Enrollment||participants|Number|42|42.0||||||
4019596|NCT01177943|3840713|B2|Japan||Region of Enrollment||participants|Number|21|21.0||||||
4019597|NCT01177943|3840714|B1|Japan||Region of Enrollment||participants|Number|21|21.0||||||
4019599|NCT01177943|3840713|B2|Japanese||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4019600|NCT01177943|3840714|B1|Japanese||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4019601|NCT01177943|3840712|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4019602|NCT01177943|3840713|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4019603|NCT01177943|3840714|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4019604|NCT01177943|3840712|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4019605|NCT01177943|3840713|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4019606|NCT01177943|3840714|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4019607|NCT01177943|3840712|B3|||Age||years|Mean|23.2|23.2|Standard Deviation|3.7|3.7|||
4019608|NCT01177943|3840713|B2|||Age||years|Mean|23.4|23.4|Standard Deviation|2.9|2.9|||
4019609|NCT01177943|3840714|B1|||Age||years|Mean|23.0|23.0|Standard Deviation|4.4|4.4|||
4019610|NCT01177813|3840723|B6||Male|Sex: Female, Male||Participants|Count of Participants|615|615.0||||||
4019611|NCT01177813|3840724|B5||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4019612|NCT01177813|3840725|B4||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4019613|NCT01177813|3840726|B3||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4019614|NCT01177813|3840727|B2||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4019615|NCT01177813|3840728|B1||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4019616|NCT01177813|3840723|B6||Female|Sex: Female, Male||Participants|Count of Participants|371|371.0||||||
4019617|NCT01177813|3840724|B5||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4019618|NCT01177813|3840725|B4||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4019619|NCT01177813|3840726|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4019620|NCT01177813|3840727|B2||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4019621|NCT01177813|3840728|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4019622|NCT01177813|3840723|B6|||Age|The descriptive statistics for Total refers to the 4 non-open label groups (Placebo, Empagliflozin 10mg and 25 mg, Sitagliptin)|years|Mean|55.0|55.0|Standard Deviation|11.0|11.0|||
4019623|NCT01177813|3840724|B5|||Age|The descriptive statistics for Total refers to the 4 non-open label groups (Placebo, Empagliflozin 10mg and 25 mg, Sitagliptin)|years|Mean|50.2|50.2|Standard Deviation|11.3|11.3|||
4019624|NCT01177813|3840725|B4|||Age|The descriptive statistics for Total refers to the 4 non-open label groups (Placebo, Empagliflozin 10mg and 25 mg, Sitagliptin)|years|Mean|55.1|55.1|Standard Deviation|9.9|9.9|||
4019625|NCT01177813|3840726|B3|||Age|The descriptive statistics for Total refers to the 4 non-open label groups (Placebo, Empagliflozin 10mg and 25 mg, Sitagliptin)|years|Mean|53.8|53.8|Standard Deviation|11.6|11.6|||
4019626|NCT01177813|3840727|B2|||Age|The descriptive statistics for Total refers to the 4 non-open label groups (Placebo, Empagliflozin 10mg and 25 mg, Sitagliptin)|years|Mean|56.2|56.2|Standard Deviation|11.6|11.6|||
4019627|NCT01177813|3840728|B1|||Age|The descriptive statistics for Total refers to the 4 non-open label groups (Placebo, Empagliflozin 10mg and 25 mg, Sitagliptin)|years|Mean|54.9|54.9|Standard Deviation|10.9|10.9|||
4019628|NCT01177800|3840759|B3||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4019629|NCT01177800|3840760|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4019630|NCT01177800|3840761|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4019631|NCT01177800|3840759|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4019632|NCT01177800|3840760|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4019633|NCT01177800|3840761|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4019634|NCT01177800|3840759|B3|||Age||years|Mean|39.7|39.7|Standard Deviation|11.9|11.9|||
4019635|NCT01177800|3840760|B2|||Age||years|Mean|40.1|40.1|Standard Deviation|11.1|11.1|||
4019636|NCT01177800|3840761|B1|||Age||years|Mean|39.4|39.4|Standard Deviation|12.3|12.3|||
4019637|NCT01177735|3840776|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
4019638|NCT01177735|3840776|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4019639|NCT01177735|3840776|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4019640|NCT01177735|3840776|B1||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
4019641|NCT01177735|3840776|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4019642|NCT01177735|3840776|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4019643|NCT01177735|3840776|B1|||Age||years|Mean|64.25|64.25|Standard Deviation|76.161|76.161|||
4019644|NCT01177722|3840780|B5|Costa Rica||Region of Enrollment||Participants|Number|442|442.0||||||
4019645|NCT01177722|3840781|B4|Costa Rica||Region of Enrollment||Participants|Number|112|112.0||||||
4019646|NCT01177722|3840782|B3|Costa Rica||Region of Enrollment||Participants|Number|109|109.0||||||
4019647|NCT01177722|3840783|B2|Costa Rica||Region of Enrollment||Participants|Number|110|110.0||||||
4019648|NCT01177722|3840784|B1|Costa Rica||Region of Enrollment||Participants|Number|111|111.0||||||
4019649|NCT01177722|3840780|B5|Colombia||Region of Enrollment||Participants|Number|933|933.0||||||
4019650|NCT01177722|3840781|B4|Colombia||Region of Enrollment||Participants|Number|233|233.0||||||
4019651|NCT01177722|3840782|B3|Colombia||Region of Enrollment||Participants|Number|233|233.0||||||
4019652|NCT01177722|3840783|B2|Colombia||Region of Enrollment||Participants|Number|234|234.0||||||
4019653|NCT01177722|3840784|B1|Colombia||Region of Enrollment||Participants|Number|233|233.0||||||
4019654|NCT01177722|3840780|B5||Male|Sex: Female, Male||Participants|Count of Participants|741|741.0||||||
4019655|NCT01177722|3840781|B4||Male|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4019656|NCT01177722|3840782|B3||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4019657|NCT01177722|3840783|B2||Male|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4019658|NCT01177722|3840784|B1||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4019659|NCT01177722|3840780|B5||Female|Sex: Female, Male||Participants|Count of Participants|634|634.0||||||
4019660|NCT01177722|3840781|B4||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4019661|NCT01177722|3840782|B3||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4019662|NCT01177722|3840783|B2||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4019663|NCT01177722|3840784|B1||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4019664|NCT01177722|3840780|B5|||Age||Days|Mean|58.7|58.7|Standard Deviation|3.30|3.3|||
4019665|NCT01177722|3840781|B4|||Age||Days|Mean|58.7|58.7|Standard Deviation|3.31|3.31|||
4019666|NCT01177722|3840782|B3|||Age||Days|Mean|58.5|58.5|Standard Deviation|3.16|3.16|||
4019667|NCT01177722|3840783|B2|||Age||Days|Mean|58.7|58.7|Standard Deviation|3.25|3.25|||
4019668|NCT01177722|3840784|B1|||Age||Days|Mean|58.8|58.8|Standard Deviation|3.49|3.49|||
4019669|NCT01177722|3840780|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4019670|NCT01177722|3840781|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4019671|NCT01177722|3840782|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4019672|NCT01177722|3840783|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4019673|NCT01177722|3840784|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4019674|NCT01177722|3840780|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4019675|NCT01177722|3840781|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4019676|NCT01177722|3840782|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4019677|NCT01177722|3840783|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4019678|NCT01177722|3840784|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4019679|NCT01177722|3840780|B5||<=18 years|Age||Participants|Count of Participants|1375|1375.0||||||
4019680|NCT01177722|3840781|B4||<=18 years|Age||Participants|Count of Participants|345|345.0||||||
4019681|NCT01177722|3840782|B3||<=18 years|Age||Participants|Count of Participants|342|342.0||||||
4019682|NCT01177722|3840783|B2||<=18 years|Age||Participants|Count of Participants|344|344.0||||||
4019683|NCT01177722|3840784|B1||<=18 years|Age||Participants|Count of Participants|344|344.0||||||
4019684|NCT01177709|3840813|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4019685|NCT01177709|3840813|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4019686|NCT01177709|3840813|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4019687|NCT01177709|3840813|B1|||Age||years|Mean|38.5|38.5|Standard Deviation|10.2|10.2|||
4019688|NCT01177670|3840819|B1|United States||Region of Enrollment||participants|Number|169|169.0||||||
4019689|NCT01177670|3840819|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4019690|NCT01177670|3840819|B1||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4019691|NCT01177670|3840819|B1|||Age||years|Mean|35.8|35.8|Standard Deviation|5.4|5.4|||
4019692|NCT01177670|3840819|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4019693|NCT01177670|3840819|B1||Between 18 and 65 years|Age||Participants|Count of Participants|169|169.0||||||
4019694|NCT01177670|3840819|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4019695|NCT01177553|3840824|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4019696|NCT01177553|3840825|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4019697|NCT01177553|3840826|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4019698|NCT01177553|3840824|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4019699|NCT01177553|3840825|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4019700|NCT01177553|3840826|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4019701|NCT01177553|3840824|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4019702|NCT01177553|3840825|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4019703|NCT01177553|3840826|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4019704|NCT01177553|3840824|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4019705|NCT01177553|3840825|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4019706|NCT01177553|3840826|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4019707|NCT01177553|3840824|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4019708|NCT01177553|3840825|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4019709|NCT01177553|3840826|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4019710|NCT01177553|3840824|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4019711|NCT01177553|3840825|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4019712|NCT01177553|3840826|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4019713|NCT01177410|3840833|B4|United States||Region of Enrollment||participants|Number|148|148.0||||||
4019714|NCT01177410|3840834|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4019715|NCT01177410|3840835|B2|United States||Region of Enrollment||participants|Number|47|47.0||||||
4019716|NCT01177410|3840836|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4019717|NCT01177410|3840833|B4||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4019718|NCT01177410|3840834|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4019719|NCT01177410|3840835|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4019720|NCT01177410|3840836|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4019721|NCT01177410|3840833|B4||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4019722|NCT01177410|3840834|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4019723|NCT01177410|3840835|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4019724|NCT01177410|3840836|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4019725|NCT01177410|3840833|B4|||Age||years|Mean|43.8|43.8|Standard Deviation|13.73|13.73|||
4019726|NCT01177410|3840834|B3|||Age||years|Mean|44.6|44.6|Standard Deviation|12.04|12.04|||
4019727|NCT01177410|3840835|B2|||Age||years|Mean|44.4|44.4|Standard Deviation|16|16.0|||
4019728|NCT01177410|3840836|B1|||Age||years|Mean|42.5|42.5|Standard Deviation|13.17|13.17|||
4019729|NCT01177410|3840833|B4||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4019730|NCT01177410|3840834|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4019731|NCT01177410|3840835|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4019732|NCT01177410|3840836|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4019733|NCT01177410|3840833|B4||Between 18 and 65 years|Age||Participants|Count of Participants|137|137.0||||||
4019734|NCT01177410|3840834|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4019735|NCT01177410|3840835|B2||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4019736|NCT01177410|3840836|B1||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4019737|NCT01177410|3840833|B4||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4019738|NCT01177410|3840834|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4019739|NCT01177410|3840835|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4019740|NCT01177410|3840836|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4019741|NCT01177384|3840849|B3|||Fasting plasma glucose||mg/dL|Mean|177.4|177.4|Standard Deviation|38.8|38.8|||
4019742|NCT01177384|3840850|B2|||Fasting plasma glucose||mg/dL|Mean|177.5|177.5|Standard Deviation|40.2|40.2|||
4019743|NCT01177384|3840851|B1|||Fasting plasma glucose||mg/dL|Mean|177.3|177.3|Standard Deviation|37.5|37.5|||
4019744|NCT01177384|3840849|B3|||Hemoglobin A1c (A1C)|Percent of glycosylated hemoglobin|Percent|Mean|8.08|8.08|Standard Deviation|0.85|0.85|||
4019745|NCT01177384|3840850|B2|||Hemoglobin A1c (A1C)|Percent of glycosylated hemoglobin|Percent|Mean|8.08|8.08|Standard Deviation|0.90|0.9|||
4019746|NCT01177384|3840851|B1|||Hemoglobin A1c (A1C)|Percent of glycosylated hemoglobin|Percent|Mean|8.09|8.09|Standard Deviation|0.79|0.79|||
4019747|NCT01177384|3840849|B3||Male|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4019748|NCT01177384|3840850|B2||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4019749|NCT01177384|3840851|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4019750|NCT01177384|3840849|B3||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4019751|NCT01177384|3840850|B2||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4019752|NCT01177384|3840851|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4019753|NCT01177384|3840849|B3|||Age||Years|Mean|57.1|57.1|Standard Deviation|9.2|9.2|||
4019754|NCT01177384|3840850|B2|||Age||Years|Mean|57.8|57.8|Standard Deviation|9.5|9.5|||
4019755|NCT01177384|3840851|B1|||Age||Years|Mean|56.5|56.5|Standard Deviation|8.9|8.9|||
4019756|NCT01177293|3840864|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4019757|NCT01177293|3840864|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4019758|NCT01177293|3840864|B1|||Age||years|Mean|25.00|25.0|Standard Deviation|6.36|6.36|||
4019759|NCT01177228|3840879|B5|No||Participants with Significant Medical Conditions in Past 6 Months||participants|Number|9|9.0||||||
4019760|NCT01177228|3840880|B4|No||Participants with Significant Medical Conditions in Past 6 Months||participants|Number|2|2.0||||||
4019761|NCT01177228|3840881|B3|No||Participants with Significant Medical Conditions in Past 6 Months||participants|Number|2|2.0||||||
4019762|NCT01177228|3840882|B2|No||Participants with Significant Medical Conditions in Past 6 Months||participants|Number|1|1.0||||||
4019763|NCT01177228|3840883|B1|No||Participants with Significant Medical Conditions in Past 6 Months||participants|Number|4|4.0||||||
4019764|NCT01177228|3840879|B5|Yes||Participants with Significant Medical Conditions in Past 6 Months||participants|Number|37|37.0||||||
4019765|NCT01177228|3840880|B4|Yes||Participants with Significant Medical Conditions in Past 6 Months||participants|Number|9|9.0||||||
4019766|NCT01177228|3840881|B3|Yes||Participants with Significant Medical Conditions in Past 6 Months||participants|Number|12|12.0||||||
4019767|NCT01177228|3840882|B2|Yes||Participants with Significant Medical Conditions in Past 6 Months||participants|Number|11|11.0||||||
4019768|NCT01177228|3840883|B1|Yes||Participants with Significant Medical Conditions in Past 6 Months||participants|Number|5|5.0||||||
4019769|NCT01177228|3840879|B5|No||Participants with Ongoing Therapy for UC at Enrollment||participants|Number|4|4.0||||||
4019770|NCT01177228|3840880|B4|No||Participants with Ongoing Therapy for UC at Enrollment||participants|Number|2|2.0||||||
4019771|NCT01177228|3840881|B3|No||Participants with Ongoing Therapy for UC at Enrollment||participants|Number|1|1.0||||||
4019772|NCT01177228|3840882|B2|No||Participants with Ongoing Therapy for UC at Enrollment||participants|Number|1|1.0||||||
4019773|NCT01177228|3840883|B1|No||Participants with Ongoing Therapy for UC at Enrollment||participants|Number|0|0.0||||||
4019774|NCT01177228|3840879|B5|Yes||Participants with Ongoing Therapy for UC at Enrollment||participants|Number|42|42.0||||||
4019775|NCT01177228|3840880|B4|Yes||Participants with Ongoing Therapy for UC at Enrollment||participants|Number|9|9.0||||||
4019776|NCT01177228|3840881|B3|Yes||Participants with Ongoing Therapy for UC at Enrollment||participants|Number|13|13.0||||||
4019777|NCT01177228|3840882|B2|Yes||Participants with Ongoing Therapy for UC at Enrollment||participants|Number|11|11.0||||||
4019778|NCT01177228|3840883|B1|Yes||Participants with Ongoing Therapy for UC at Enrollment||participants|Number|9|9.0||||||
4019779|NCT01177228|3840879|B5|No||Participants Hospitalized for UC in Past 12 Months||participants|Number|32|32.0||||||
4019780|NCT01177228|3840880|B4|No||Participants Hospitalized for UC in Past 12 Months||participants|Number|7|7.0||||||
4019781|NCT01177228|3840881|B3|No||Participants Hospitalized for UC in Past 12 Months||participants|Number|12|12.0||||||
4019782|NCT01177228|3840882|B2|No||Participants Hospitalized for UC in Past 12 Months||participants|Number|9|9.0||||||
4019783|NCT01177228|3840883|B1|No||Participants Hospitalized for UC in Past 12 Months||participants|Number|4|4.0||||||
4019784|NCT01177228|3840879|B5|Yes||Participants Hospitalized for UC in Past 12 Months||participants|Number|14|14.0||||||
4019785|NCT01177228|3840880|B4|Yes||Participants Hospitalized for UC in Past 12 Months||participants|Number|4|4.0||||||
4019786|NCT01177228|3840881|B3|Yes||Participants Hospitalized for UC in Past 12 Months||participants|Number|2|2.0||||||
4019787|NCT01177228|3840882|B2|Yes||Participants Hospitalized for UC in Past 12 Months||participants|Number|3|3.0||||||
4019788|NCT01177228|3840883|B1|Yes||Participants Hospitalized for UC in Past 12 Months||participants|Number|5|5.0||||||
4019789|NCT01177228|3840879|B5|No||Participants with Acute Exacerbations in Past 12 Months||participants|Number|3|3.0||||||
4019790|NCT01177228|3840880|B4|No||Participants with Acute Exacerbations in Past 12 Months||participants|Number|2|2.0||||||
4019791|NCT01177228|3840881|B3|No||Participants with Acute Exacerbations in Past 12 Months||participants|Number|1|1.0||||||
4019792|NCT01177228|3840882|B2|No||Participants with Acute Exacerbations in Past 12 Months||participants|Number|0|0.0||||||
4019793|NCT01177228|3840883|B1|No||Participants with Acute Exacerbations in Past 12 Months||participants|Number|0|0.0||||||
4019794|NCT01177228|3840879|B5|Yes||Participants with Acute Exacerbations in Past 12 Months||participants|Number|43|43.0||||||
4019795|NCT01177228|3840880|B4|Yes||Participants with Acute Exacerbations in Past 12 Months||participants|Number|9|9.0||||||
4019796|NCT01177228|3840881|B3|Yes||Participants with Acute Exacerbations in Past 12 Months||participants|Number|13|13.0||||||
4019797|NCT01177228|3840882|B2|Yes||Participants with Acute Exacerbations in Past 12 Months||participants|Number|12|12.0||||||
4019798|NCT01177228|3840883|B1|Yes||Participants with Acute Exacerbations in Past 12 Months||participants|Number|9|9.0||||||
4019799|NCT01177228|3840879|B5|||Time Since Diagnosis||years|Mean|4.76|4.76|Standard Deviation|6.01|6.01|||
4019800|NCT01177228|3840880|B4|||Time Since Diagnosis||years|Mean|5.46|5.46|Standard Deviation|9.72|9.72|||
4019801|NCT01177228|3840881|B3|||Time Since Diagnosis||years|Mean|5.38|5.38|Standard Deviation|4.79|4.79|||
4019802|NCT01177228|3840882|B2|||Time Since Diagnosis||years|Mean|5.26|5.26|Standard Deviation|4.92|4.92|||
4019803|NCT01177228|3840883|B1|||Time Since Diagnosis||years|Mean|2.29|2.29|Standard Deviation|2.43|2.43|||
4019804|NCT01177228|3840879|B5|||Time Since Onset of Symptoms||years|Mean|6.16|6.16|Standard Deviation|6.08|6.08|||
4019805|NCT01177228|3840880|B4|||Time Since Onset of Symptoms||years|Mean|7.03|7.03|Standard Deviation|10.13|10.13|||
4019806|NCT01177228|3840881|B3|||Time Since Onset of Symptoms||years|Mean|6.85|6.85|Standard Deviation|4.31|4.31|||
4019807|NCT01177228|3840882|B2|||Time Since Onset of Symptoms||years|Mean|6.25|6.25|Standard Deviation|5.00|5.0|||
4019808|NCT01177228|3840883|B1|||Time Since Onset of Symptoms||years|Mean|3.92|3.92|Standard Deviation|2.79|2.79|||
4019809|NCT01177228|3840879|B5|||Body Surface Area (BSA)||m²|Mean|1.88|1.88|Standard Deviation|0.25|0.25|||
4019810|NCT01177228|3840880|B4|||Body Surface Area (BSA)||m²|Mean|1.86|1.86|Standard Deviation|0.20|0.2|||
4019811|NCT01177228|3840881|B3|||Body Surface Area (BSA)||m²|Mean|1.92|1.92|Standard Deviation|0.21|0.21|||
4019812|NCT01177228|3840882|B2|||Body Surface Area (BSA)||m²|Mean|1.88|1.88|Standard Deviation|0.30|0.3|||
4019813|NCT01177228|3840883|B1|||Body Surface Area (BSA)||m²|Mean|1.84|1.84|Standard Deviation|0.31|0.31|||
4019814|NCT01177228|3840879|B5|||Body Mass Index (BMI)||kg/m²|Mean|26.64|26.64|Standard Deviation|6.37|6.37|||
4019815|NCT01177228|3840880|B4|||Body Mass Index (BMI)||kg/m²|Mean|25.29|25.29|Standard Deviation|5.07|5.07|||
4019816|NCT01177228|3840881|B3|||Body Mass Index (BMI)||kg/m²|Mean|28.51|28.51|Standard Deviation|6.66|6.66|||
4019817|NCT01177228|3840882|B2|||Body Mass Index (BMI)||kg/m²|Mean|26.03|26.03|Standard Deviation|5.58|5.58|||
4019818|NCT01177228|3840883|B1|||Body Mass Index (BMI)||kg/m²|Mean|26.22|26.22|Standard Deviation|8.46|8.46|||
4019819|NCT01177228|3840879|B5|||Weight||kg|Mean|76.04|76.04|Standard Deviation|18.38|18.38|||
4019820|NCT01177228|3840880|B4|||Weight||kg|Mean|73.46|73.46|Standard Deviation|13.60|13.6|||
4019821|NCT01177228|3840881|B3|||Weight||kg|Mean|79.61|79.61|Standard Deviation|16.65|16.65|||
4019822|NCT01177228|3840882|B2|||Weight||kg|Mean|75.76|75.76|Standard Deviation|20.98|20.98|||
4019823|NCT01177228|3840883|B1|||Weight||kg|Mean|74.01|74.01|Standard Deviation|24.04|24.04|||
4019824|NCT01177228|3840879|B5|||Height||cm|Mean|169.1|169.1|Standard Deviation|9.00|9.0|||
4019825|NCT01177228|3840880|B4|||Height||cm|Mean|170.7|170.7|Standard Deviation|8.15|8.15|||
4019826|NCT01177228|3840881|B3|||Height||cm|Mean|167.9|167.9|Standard Deviation|9.87|9.87|||
4019827|NCT01177228|3840882|B2|||Height||cm|Mean|169.8|169.8|Standard Deviation|10.52|10.52|||
4019828|NCT01177228|3840883|B1|||Height||cm|Mean|168.0|168.0|Standard Deviation|7.33|7.33|||
4019829|NCT01177228|3840879|B5|White, Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4019830|NCT01177228|3840880|B4|White, Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4019831|NCT01177228|3840881|B3|White, Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4019832|NCT01177228|3840882|B2|White, Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4019833|NCT01177228|3840883|B1|White, Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4019834|NCT01177228|3840879|B5||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4019835|NCT01177228|3840880|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4019836|NCT01177228|3840881|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4019837|NCT01177228|3840882|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4019838|NCT01177228|3840883|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4019839|NCT01177228|3840879|B5||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4019840|NCT01177228|3840880|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4019841|NCT01177228|3840881|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4019842|NCT01177228|3840882|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4019843|NCT01177228|3840883|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4019844|NCT01177228|3840879|B5|||Age||years|Mean|41.0|41.0|Standard Deviation|11.46|11.46|||
4019845|NCT01177228|3840880|B4|||Age||years|Mean|44.3|44.3|Standard Deviation|14.99|14.99|||
4019846|NCT01177228|3840881|B3|||Age||years|Mean|44.4|44.4|Standard Deviation|12.37|12.37|||
4019847|NCT01177228|3840882|B2|||Age||years|Mean|39.0|39.0|Standard Deviation|6.06|6.06|||
4019848|NCT01177228|3840883|B1|||Age||years|Mean|34.2|34.2|Standard Deviation|8.11|8.11|||
4019849|NCT01177137|3840924|B4|||Rank of tinnitus as problem|"The question How much of a problem is tinnitus? was scored on a visual analogue scale from 0 (no problem at all) to 10 as much as you can imagine."|units on a scale|Mean|6.3|6.3|Standard Deviation|2.2|2.2|||
4019850|NCT01177137|3840925|B3|||Rank of tinnitus as problem|"The question How much of a problem is tinnitus? was scored on a visual analogue scale from 0 (no problem at all) to 10 as much as you can imagine."|units on a scale|Mean|6.3|6.3|Standard Deviation|2.1|2.1|||
4019851|NCT01177137|3840926|B2|||Rank of tinnitus as problem|"The question How much of a problem is tinnitus? was scored on a visual analogue scale from 0 (no problem at all) to 10 as much as you can imagine."|units on a scale|Mean|6.4|6.4|Standard Deviation|2.2|2.2|||
4019852|NCT01177137|3840927|B1|||Rank of tinnitus as problem|"The question How much of a problem is tinnitus? was scored on a visual analogue scale from 0 (no problem at all) to 10 as much as you can imagine."|units on a scale|Mean|6.2|6.2|Standard Deviation|2.2|2.2|||
4019853|NCT01177137|3840924|B4|Catastrophic subscale||Baseline scores on the Tinnitus Handicap Inventory and sub-scales|"The Tinnitus Handicap Inventory has 25 questions scored as 0, 2, or 4 for no, sometimes, and yes respectively for a total score ranging from 0 to 100, with higher scores indicated more tinnitus distress. Subscales (ranges for scores) are functional (0 to 44), emotional (0 to 36) and catastrophic (0 to 20)."|units on a scale|Mean|8.3|8.3|Standard Deviation|3.7|3.7|||
4019854|NCT01177137|3840925|B3|Catastrophic subscale||Baseline scores on the Tinnitus Handicap Inventory and sub-scales|"The Tinnitus Handicap Inventory has 25 questions scored as 0, 2, or 4 for no, sometimes, and yes respectively for a total score ranging from 0 to 100, with higher scores indicated more tinnitus distress. Subscales (ranges for scores) are functional (0 to 44), emotional (0 to 36) and catastrophic (0 to 20)."|units on a scale|Mean|8.0|8.0|Standard Deviation|3.5|3.5|||
4019855|NCT01177137|3840926|B2|Catastrophic subscale||Baseline scores on the Tinnitus Handicap Inventory and sub-scales|"The Tinnitus Handicap Inventory has 25 questions scored as 0, 2, or 4 for no, sometimes, and yes respectively for a total score ranging from 0 to 100, with higher scores indicated more tinnitus distress. Subscales (ranges for scores) are functional (0 to 44), emotional (0 to 36) and catastrophic (0 to 20)."|units on a scale|Mean|8.7|8.7|Standard Deviation|4.2|4.2|||
4019856|NCT01177137|3840927|B1|Catastrophic subscale||Baseline scores on the Tinnitus Handicap Inventory and sub-scales|"The Tinnitus Handicap Inventory has 25 questions scored as 0, 2, or 4 for no, sometimes, and yes respectively for a total score ranging from 0 to 100, with higher scores indicated more tinnitus distress. Subscales (ranges for scores) are functional (0 to 44), emotional (0 to 36) and catastrophic (0 to 20)."|units on a scale|Mean|8.2|8.2|Standard Deviation|3.4|3.4|||
4019857|NCT01177137|3840924|B4|Emotional subscale||Baseline scores on the Tinnitus Handicap Inventory and sub-scales|"The Tinnitus Handicap Inventory has 25 questions scored as 0, 2, or 4 for no, sometimes, and yes respectively for a total score ranging from 0 to 100, with higher scores indicated more tinnitus distress. Subscales (ranges for scores) are functional (0 to 44), emotional (0 to 36) and catastrophic (0 to 20)."|units on a scale|Mean|11.8|11.8|Standard Deviation|7.5|7.5|||
4019858|NCT01177137|3840925|B3|Emotional subscale||Baseline scores on the Tinnitus Handicap Inventory and sub-scales|"The Tinnitus Handicap Inventory has 25 questions scored as 0, 2, or 4 for no, sometimes, and yes respectively for a total score ranging from 0 to 100, with higher scores indicated more tinnitus distress. Subscales (ranges for scores) are functional (0 to 44), emotional (0 to 36) and catastrophic (0 to 20)."|units on a scale|Mean|11.4|11.4|Standard Deviation|7.1|7.1|||
4019859|NCT01177137|3840926|B2|Emotional subscale||Baseline scores on the Tinnitus Handicap Inventory and sub-scales|"The Tinnitus Handicap Inventory has 25 questions scored as 0, 2, or 4 for no, sometimes, and yes respectively for a total score ranging from 0 to 100, with higher scores indicated more tinnitus distress. Subscales (ranges for scores) are functional (0 to 44), emotional (0 to 36) and catastrophic (0 to 20)."|units on a scale|Mean|12.7|12.7|Standard Deviation|9.0|9.0|||
4019860|NCT01177137|3840927|B1|Emotional subscale||Baseline scores on the Tinnitus Handicap Inventory and sub-scales|"The Tinnitus Handicap Inventory has 25 questions scored as 0, 2, or 4 for no, sometimes, and yes respectively for a total score ranging from 0 to 100, with higher scores indicated more tinnitus distress. Subscales (ranges for scores) are functional (0 to 44), emotional (0 to 36) and catastrophic (0 to 20)."|units on a scale|Mean|11.3|11.3|Standard Deviation|6.2|6.2|||
4019965|NCT01177137|3840924|B4|Unknown/missing||Duration of tinnitus as a problem||Participants|Count of Participants|2|2.0||||||
4019966|NCT01177137|3840925|B3|Unknown/missing||Duration of tinnitus as a problem||Participants|Count of Participants|1|1.0||||||
4019861|NCT01177137|3840924|B4|Functional subscale||Baseline scores on the Tinnitus Handicap Inventory and sub-scales|"The Tinnitus Handicap Inventory has 25 questions scored as 0, 2, or 4 for no, sometimes, and yes respectively for a total score ranging from 0 to 100, with higher scores indicated more tinnitus distress. Subscales (ranges for scores) are functional (0 to 44), emotional (0 to 36) and catastrophic (0 to 20)."|units on a scale|Mean|19.5|19.5|Standard Deviation|8.2|8.2|||
4019862|NCT01177137|3840925|B3|Functional subscale||Baseline scores on the Tinnitus Handicap Inventory and sub-scales|"The Tinnitus Handicap Inventory has 25 questions scored as 0, 2, or 4 for no, sometimes, and yes respectively for a total score ranging from 0 to 100, with higher scores indicated more tinnitus distress. Subscales (ranges for scores) are functional (0 to 44), emotional (0 to 36) and catastrophic (0 to 20)."|units on a scale|Mean|19.3|19.3|Standard Deviation|8.4|8.4|||
4019863|NCT01177137|3840926|B2|Functional subscale||Baseline scores on the Tinnitus Handicap Inventory and sub-scales|"The Tinnitus Handicap Inventory has 25 questions scored as 0, 2, or 4 for no, sometimes, and yes respectively for a total score ranging from 0 to 100, with higher scores indicated more tinnitus distress. Subscales (ranges for scores) are functional (0 to 44), emotional (0 to 36) and catastrophic (0 to 20)."|units on a scale|Mean|20.9|20.9|Standard Deviation|9.5|9.5|||
4019864|NCT01177137|3840927|B1|Functional subscale||Baseline scores on the Tinnitus Handicap Inventory and sub-scales|"The Tinnitus Handicap Inventory has 25 questions scored as 0, 2, or 4 for no, sometimes, and yes respectively for a total score ranging from 0 to 100, with higher scores indicated more tinnitus distress. Subscales (ranges for scores) are functional (0 to 44), emotional (0 to 36) and catastrophic (0 to 20)."|units on a scale|Mean|18.4|18.4|Standard Deviation|6.2|6.2|||
4019865|NCT01177137|3840924|B4|Total||Baseline scores on the Tinnitus Handicap Inventory and sub-scales|"The Tinnitus Handicap Inventory has 25 questions scored as 0, 2, or 4 for no, sometimes, and yes respectively for a total score ranging from 0 to 100, with higher scores indicated more tinnitus distress. Subscales (ranges for scores) are functional (0 to 44), emotional (0 to 36) and catastrophic (0 to 20)."|units on a scale|Mean|39.6|39.6|Standard Deviation|17.1|17.1|||
4019866|NCT01177137|3840925|B3|Total||Baseline scores on the Tinnitus Handicap Inventory and sub-scales|"The Tinnitus Handicap Inventory has 25 questions scored as 0, 2, or 4 for no, sometimes, and yes respectively for a total score ranging from 0 to 100, with higher scores indicated more tinnitus distress. Subscales (ranges for scores) are functional (0 to 44), emotional (0 to 36) and catastrophic (0 to 20)."|units on a scale|Mean|38.6|38.6|Standard Deviation|16.7|16.7|||
4019867|NCT01177137|3840926|B2|Total||Baseline scores on the Tinnitus Handicap Inventory and sub-scales|"The Tinnitus Handicap Inventory has 25 questions scored as 0, 2, or 4 for no, sometimes, and yes respectively for a total score ranging from 0 to 100, with higher scores indicated more tinnitus distress. Subscales (ranges for scores) are functional (0 to 44), emotional (0 to 36) and catastrophic (0 to 20)."|units on a scale|Mean|42.3|42.3|Standard Deviation|20.7|20.7|||
4019868|NCT01177137|3840927|B1|Total||Baseline scores on the Tinnitus Handicap Inventory and sub-scales|"The Tinnitus Handicap Inventory has 25 questions scored as 0, 2, or 4 for no, sometimes, and yes respectively for a total score ranging from 0 to 100, with higher scores indicated more tinnitus distress. Subscales (ranges for scores) are functional (0 to 44), emotional (0 to 36) and catastrophic (0 to 20)."|units on a scale|Mean|37.8|37.8|Standard Deviation|13.0|13.0|||
4019869|NCT01177137|3840924|B4|Sleep disturbance||Baseline scores on Tinnitus Functional Index and sub-scales|The Tinnitus Functional Index (TFI) has 25 questions, scored from 0 to 10. The total score ranges from 0 to 100, with higher scores indicating more tinnitus distress. All sub-scales are normalized to range from 0 to 100 scores. Sub-scales include auditory difficulties, cognitive interference, emotional distress, intrusiveness, reduced sense of control, reduced quality of life, relaxation interference, and sleep disturbance.|units on a scale|Mean|55.5|55.5|Standard Deviation|29.8|29.8|||
4019870|NCT01177137|3840925|B3|Sleep disturbance||Baseline scores on Tinnitus Functional Index and sub-scales|The Tinnitus Functional Index (TFI) has 25 questions, scored from 0 to 10. The total score ranges from 0 to 100, with higher scores indicating more tinnitus distress. All sub-scales are normalized to range from 0 to 100 scores. Sub-scales include auditory difficulties, cognitive interference, emotional distress, intrusiveness, reduced sense of control, reduced quality of life, relaxation interference, and sleep disturbance.|units on a scale|Mean|61.0|61.0|Standard Deviation|30.2|30.2|||
4019871|NCT01177137|3840926|B2|Sleep disturbance||Baseline scores on Tinnitus Functional Index and sub-scales|The Tinnitus Functional Index (TFI) has 25 questions, scored from 0 to 10. The total score ranges from 0 to 100, with higher scores indicating more tinnitus distress. All sub-scales are normalized to range from 0 to 100 scores. Sub-scales include auditory difficulties, cognitive interference, emotional distress, intrusiveness, reduced sense of control, reduced quality of life, relaxation interference, and sleep disturbance.|units on a scale|Mean|50.3|50.3|Standard Deviation|28.1|28.1|||
4019872|NCT01177137|3840927|B1|Sleep disturbance||Baseline scores on Tinnitus Functional Index and sub-scales|The Tinnitus Functional Index (TFI) has 25 questions, scored from 0 to 10. The total score ranges from 0 to 100, with higher scores indicating more tinnitus distress. All sub-scales are normalized to range from 0 to 100 scores. Sub-scales include auditory difficulties, cognitive interference, emotional distress, intrusiveness, reduced sense of control, reduced quality of life, relaxation interference, and sleep disturbance.|units on a scale|Mean|55.4|55.4|Standard Deviation|30.8|30.8|||
4019873|NCT01177137|3840924|B4|Relaxation difficulties||Baseline scores on Tinnitus Functional Index and sub-scales|The Tinnitus Functional Index (TFI) has 25 questions, scored from 0 to 10. The total score ranges from 0 to 100, with higher scores indicating more tinnitus distress. All sub-scales are normalized to range from 0 to 100 scores. Sub-scales include auditory difficulties, cognitive interference, emotional distress, intrusiveness, reduced sense of control, reduced quality of life, relaxation interference, and sleep disturbance.|units on a scale|Mean|64.6|64.6|Standard Deviation|25.1|25.1|||
4019874|NCT01177137|3840925|B3|Relaxation difficulties||Baseline scores on Tinnitus Functional Index and sub-scales|The Tinnitus Functional Index (TFI) has 25 questions, scored from 0 to 10. The total score ranges from 0 to 100, with higher scores indicating more tinnitus distress. All sub-scales are normalized to range from 0 to 100 scores. Sub-scales include auditory difficulties, cognitive interference, emotional distress, intrusiveness, reduced sense of control, reduced quality of life, relaxation interference, and sleep disturbance.|units on a scale|Mean|68.2|68.2|Standard Deviation|24.4|24.4|||
4019875|NCT01177137|3840926|B2|Relaxation difficulties||Baseline scores on Tinnitus Functional Index and sub-scales|The Tinnitus Functional Index (TFI) has 25 questions, scored from 0 to 10. The total score ranges from 0 to 100, with higher scores indicating more tinnitus distress. All sub-scales are normalized to range from 0 to 100 scores. Sub-scales include auditory difficulties, cognitive interference, emotional distress, intrusiveness, reduced sense of control, reduced quality of life, relaxation interference, and sleep disturbance.|units on a scale|Mean|61.9|61.9|Standard Deviation|27.2|27.2|||
4019876|NCT01177137|3840927|B1|Relaxation difficulties||Baseline scores on Tinnitus Functional Index and sub-scales|The Tinnitus Functional Index (TFI) has 25 questions, scored from 0 to 10. The total score ranges from 0 to 100, with higher scores indicating more tinnitus distress. All sub-scales are normalized to range from 0 to 100 scores. Sub-scales include auditory difficulties, cognitive interference, emotional distress, intrusiveness, reduced sense of control, reduced quality of life, relaxation interference, and sleep disturbance.|units on a scale|Mean|63.9|63.9|Standard Deviation|23.6|23.6|||
4019877|NCT01177137|3840924|B4|Reduced quality of life||Baseline scores on Tinnitus Functional Index and sub-scales|The Tinnitus Functional Index (TFI) has 25 questions, scored from 0 to 10. The total score ranges from 0 to 100, with higher scores indicating more tinnitus distress. All sub-scales are normalized to range from 0 to 100 scores. Sub-scales include auditory difficulties, cognitive interference, emotional distress, intrusiveness, reduced sense of control, reduced quality of life, relaxation interference, and sleep disturbance.|units on a scale|Mean|34.2|34.2|Standard Deviation|23.8|23.8|||
4019878|NCT01177137|3840925|B3|Reduced quality of life||Baseline scores on Tinnitus Functional Index and sub-scales|The Tinnitus Functional Index (TFI) has 25 questions, scored from 0 to 10. The total score ranges from 0 to 100, with higher scores indicating more tinnitus distress. All sub-scales are normalized to range from 0 to 100 scores. Sub-scales include auditory difficulties, cognitive interference, emotional distress, intrusiveness, reduced sense of control, reduced quality of life, relaxation interference, and sleep disturbance.|units on a scale|Mean|37.0|37.0|Standard Deviation|25.4|25.4|||
4019879|NCT01177137|3840926|B2|Reduced quality of life||Baseline scores on Tinnitus Functional Index and sub-scales|The Tinnitus Functional Index (TFI) has 25 questions, scored from 0 to 10. The total score ranges from 0 to 100, with higher scores indicating more tinnitus distress. All sub-scales are normalized to range from 0 to 100 scores. Sub-scales include auditory difficulties, cognitive interference, emotional distress, intrusiveness, reduced sense of control, reduced quality of life, relaxation interference, and sleep disturbance.|units on a scale|Mean|35.7|35.7|Standard Deviation|23.1|23.1|||
4019880|NCT01177137|3840927|B1|Reduced quality of life||Baseline scores on Tinnitus Functional Index and sub-scales|The Tinnitus Functional Index (TFI) has 25 questions, scored from 0 to 10. The total score ranges from 0 to 100, with higher scores indicating more tinnitus distress. All sub-scales are normalized to range from 0 to 100 scores. Sub-scales include auditory difficulties, cognitive interference, emotional distress, intrusiveness, reduced sense of control, reduced quality of life, relaxation interference, and sleep disturbance.|units on a scale|Mean|30.1|30.1|Standard Deviation|22.7|22.7|||
4019881|NCT01177137|3840924|B4|Reduced sense of control||Baseline scores on Tinnitus Functional Index and sub-scales|The Tinnitus Functional Index (TFI) has 25 questions, scored from 0 to 10. The total score ranges from 0 to 100, with higher scores indicating more tinnitus distress. All sub-scales are normalized to range from 0 to 100 scores. Sub-scales include auditory difficulties, cognitive interference, emotional distress, intrusiveness, reduced sense of control, reduced quality of life, relaxation interference, and sleep disturbance.|units on a scale|Mean|63.3|63.3|Standard Deviation|19.3|19.3|||
4019882|NCT01177137|3840925|B3|Reduced sense of control||Baseline scores on Tinnitus Functional Index and sub-scales|The Tinnitus Functional Index (TFI) has 25 questions, scored from 0 to 10. The total score ranges from 0 to 100, with higher scores indicating more tinnitus distress. All sub-scales are normalized to range from 0 to 100 scores. Sub-scales include auditory difficulties, cognitive interference, emotional distress, intrusiveness, reduced sense of control, reduced quality of life, relaxation interference, and sleep disturbance.|units on a scale|Mean|67.8|67.8|Standard Deviation|19.5|19.5|||
4019883|NCT01177137|3840926|B2|Reduced sense of control||Baseline scores on Tinnitus Functional Index and sub-scales|The Tinnitus Functional Index (TFI) has 25 questions, scored from 0 to 10. The total score ranges from 0 to 100, with higher scores indicating more tinnitus distress. All sub-scales are normalized to range from 0 to 100 scores. Sub-scales include auditory difficulties, cognitive interference, emotional distress, intrusiveness, reduced sense of control, reduced quality of life, relaxation interference, and sleep disturbance.|units on a scale|Mean|63.7|63.7|Standard Deviation|16.7|16.7|||
4019884|NCT01177137|3840927|B1|Reduced sense of control||Baseline scores on Tinnitus Functional Index and sub-scales|The Tinnitus Functional Index (TFI) has 25 questions, scored from 0 to 10. The total score ranges from 0 to 100, with higher scores indicating more tinnitus distress. All sub-scales are normalized to range from 0 to 100 scores. Sub-scales include auditory difficulties, cognitive interference, emotional distress, intrusiveness, reduced sense of control, reduced quality of life, relaxation interference, and sleep disturbance.|units on a scale|Mean|58.6|58.6|Standard Deviation|20.9|20.9|||
4019885|NCT01177137|3840924|B4|Intrusiveness||Baseline scores on Tinnitus Functional Index and sub-scales|The Tinnitus Functional Index (TFI) has 25 questions, scored from 0 to 10. The total score ranges from 0 to 100, with higher scores indicating more tinnitus distress. All sub-scales are normalized to range from 0 to 100 scores. Sub-scales include auditory difficulties, cognitive interference, emotional distress, intrusiveness, reduced sense of control, reduced quality of life, relaxation interference, and sleep disturbance.|units on a scale|Mean|67.1|67.1|Standard Deviation|19.8|19.8|||
4019886|NCT01177137|3840925|B3|Intrusiveness||Baseline scores on Tinnitus Functional Index and sub-scales|The Tinnitus Functional Index (TFI) has 25 questions, scored from 0 to 10. The total score ranges from 0 to 100, with higher scores indicating more tinnitus distress. All sub-scales are normalized to range from 0 to 100 scores. Sub-scales include auditory difficulties, cognitive interference, emotional distress, intrusiveness, reduced sense of control, reduced quality of life, relaxation interference, and sleep disturbance.|units on a scale|Mean|70.7|70.7|Standard Deviation|17.3|17.3|||
4019967|NCT01177137|3840926|B2|Unknown/missing||Duration of tinnitus as a problem||Participants|Count of Participants|1|1.0||||||
4019968|NCT01177137|3840927|B1|Unknown/missing||Duration of tinnitus as a problem||Participants|Count of Participants|0|0.0||||||
4019887|NCT01177137|3840926|B2|Intrusiveness||Baseline scores on Tinnitus Functional Index and sub-scales|The Tinnitus Functional Index (TFI) has 25 questions, scored from 0 to 10. The total score ranges from 0 to 100, with higher scores indicating more tinnitus distress. All sub-scales are normalized to range from 0 to 100 scores. Sub-scales include auditory difficulties, cognitive interference, emotional distress, intrusiveness, reduced sense of control, reduced quality of life, relaxation interference, and sleep disturbance.|units on a scale|Mean|67.5|67.5|Standard Deviation|18.0|18.0|||
4019888|NCT01177137|3840927|B1|Intrusiveness||Baseline scores on Tinnitus Functional Index and sub-scales|The Tinnitus Functional Index (TFI) has 25 questions, scored from 0 to 10. The total score ranges from 0 to 100, with higher scores indicating more tinnitus distress. All sub-scales are normalized to range from 0 to 100 scores. Sub-scales include auditory difficulties, cognitive interference, emotional distress, intrusiveness, reduced sense of control, reduced quality of life, relaxation interference, and sleep disturbance.|units on a scale|Mean|63.3|63.3|Standard Deviation|23.2|23.2|||
4019889|NCT01177137|3840924|B4|Emotional distress||Baseline scores on Tinnitus Functional Index and sub-scales|The Tinnitus Functional Index (TFI) has 25 questions, scored from 0 to 10. The total score ranges from 0 to 100, with higher scores indicating more tinnitus distress. All sub-scales are normalized to range from 0 to 100 scores. Sub-scales include auditory difficulties, cognitive interference, emotional distress, intrusiveness, reduced sense of control, reduced quality of life, relaxation interference, and sleep disturbance.|units on a scale|Mean|32.6|32.6|Standard Deviation|24.7|24.7|||
4019890|NCT01177137|3840925|B3|Emotional distress||Baseline scores on Tinnitus Functional Index and sub-scales|The Tinnitus Functional Index (TFI) has 25 questions, scored from 0 to 10. The total score ranges from 0 to 100, with higher scores indicating more tinnitus distress. All sub-scales are normalized to range from 0 to 100 scores. Sub-scales include auditory difficulties, cognitive interference, emotional distress, intrusiveness, reduced sense of control, reduced quality of life, relaxation interference, and sleep disturbance.|units on a scale|Mean|34.4|34.4|Standard Deviation|23.6|23.6|||
4019891|NCT01177137|3840926|B2|Emotional distress||Baseline scores on Tinnitus Functional Index and sub-scales|The Tinnitus Functional Index (TFI) has 25 questions, scored from 0 to 10. The total score ranges from 0 to 100, with higher scores indicating more tinnitus distress. All sub-scales are normalized to range from 0 to 100 scores. Sub-scales include auditory difficulties, cognitive interference, emotional distress, intrusiveness, reduced sense of control, reduced quality of life, relaxation interference, and sleep disturbance.|units on a scale|Mean|31.8|31.8|Standard Deviation|26.1|26.1|||
4019892|NCT01177137|3840927|B1|Emotional distress||Baseline scores on Tinnitus Functional Index and sub-scales|The Tinnitus Functional Index (TFI) has 25 questions, scored from 0 to 10. The total score ranges from 0 to 100, with higher scores indicating more tinnitus distress. All sub-scales are normalized to range from 0 to 100 scores. Sub-scales include auditory difficulties, cognitive interference, emotional distress, intrusiveness, reduced sense of control, reduced quality of life, relaxation interference, and sleep disturbance.|units on a scale|Mean|31.6|31.6|Standard Deviation|24.6|24.6|||
4019893|NCT01177137|3840924|B4|Cognitive interference||Baseline scores on Tinnitus Functional Index and sub-scales|The Tinnitus Functional Index (TFI) has 25 questions, scored from 0 to 10. The total score ranges from 0 to 100, with higher scores indicating more tinnitus distress. All sub-scales are normalized to range from 0 to 100 scores. Sub-scales include auditory difficulties, cognitive interference, emotional distress, intrusiveness, reduced sense of control, reduced quality of life, relaxation interference, and sleep disturbance.|units on a scale|Mean|47.2|47.2|Standard Deviation|22.7|22.7|||
4019894|NCT01177137|3840925|B3|Cognitive interference||Baseline scores on Tinnitus Functional Index and sub-scales|The Tinnitus Functional Index (TFI) has 25 questions, scored from 0 to 10. The total score ranges from 0 to 100, with higher scores indicating more tinnitus distress. All sub-scales are normalized to range from 0 to 100 scores. Sub-scales include auditory difficulties, cognitive interference, emotional distress, intrusiveness, reduced sense of control, reduced quality of life, relaxation interference, and sleep disturbance.|units on a scale|Mean|47.8|47.8|Standard Deviation|24.5|24.5|||
4019895|NCT01177137|3840926|B2|Cognitive interference||Baseline scores on Tinnitus Functional Index and sub-scales|The Tinnitus Functional Index (TFI) has 25 questions, scored from 0 to 10. The total score ranges from 0 to 100, with higher scores indicating more tinnitus distress. All sub-scales are normalized to range from 0 to 100 scores. Sub-scales include auditory difficulties, cognitive interference, emotional distress, intrusiveness, reduced sense of control, reduced quality of life, relaxation interference, and sleep disturbance.|units on a scale|Mean|51.0|51.0|Standard Deviation|22.1|22.1|||
4019896|NCT01177137|3840927|B1|Cognitive interference||Baseline scores on Tinnitus Functional Index and sub-scales|The Tinnitus Functional Index (TFI) has 25 questions, scored from 0 to 10. The total score ranges from 0 to 100, with higher scores indicating more tinnitus distress. All sub-scales are normalized to range from 0 to 100 scores. Sub-scales include auditory difficulties, cognitive interference, emotional distress, intrusiveness, reduced sense of control, reduced quality of life, relaxation interference, and sleep disturbance.|units on a scale|Mean|42.7|42.7|Standard Deviation|21.2|21.2|||
4019897|NCT01177137|3840924|B4|Auditory difficulties||Baseline scores on Tinnitus Functional Index and sub-scales|The Tinnitus Functional Index (TFI) has 25 questions, scored from 0 to 10. The total score ranges from 0 to 100, with higher scores indicating more tinnitus distress. All sub-scales are normalized to range from 0 to 100 scores. Sub-scales include auditory difficulties, cognitive interference, emotional distress, intrusiveness, reduced sense of control, reduced quality of life, relaxation interference, and sleep disturbance.|units on a scale|Mean|45.6|45.6|Standard Deviation|25.9|25.9|||
4019898|NCT01177137|3840925|B3|Auditory difficulties||Baseline scores on Tinnitus Functional Index and sub-scales|The Tinnitus Functional Index (TFI) has 25 questions, scored from 0 to 10. The total score ranges from 0 to 100, with higher scores indicating more tinnitus distress. All sub-scales are normalized to range from 0 to 100 scores. Sub-scales include auditory difficulties, cognitive interference, emotional distress, intrusiveness, reduced sense of control, reduced quality of life, relaxation interference, and sleep disturbance.|units on a scale|Mean|46.6|46.6|Standard Deviation|25.7|25.7|||
4019969|NCT01177137|3840924|B4|More than 5 years||Duration of tinnitus as a problem||Participants|Count of Participants|68|68.0||||||
4019970|NCT01177137|3840925|B3|More than 5 years||Duration of tinnitus as a problem||Participants|Count of Participants|22|22.0||||||
4019899|NCT01177137|3840926|B2|Auditory difficulties||Baseline scores on Tinnitus Functional Index and sub-scales|The Tinnitus Functional Index (TFI) has 25 questions, scored from 0 to 10. The total score ranges from 0 to 100, with higher scores indicating more tinnitus distress. All sub-scales are normalized to range from 0 to 100 scores. Sub-scales include auditory difficulties, cognitive interference, emotional distress, intrusiveness, reduced sense of control, reduced quality of life, relaxation interference, and sleep disturbance.|units on a scale|Mean|45.0|45.0|Standard Deviation|27.2|27.2|||
4019900|NCT01177137|3840927|B1|Auditory difficulties||Baseline scores on Tinnitus Functional Index and sub-scales|The Tinnitus Functional Index (TFI) has 25 questions, scored from 0 to 10. The total score ranges from 0 to 100, with higher scores indicating more tinnitus distress. All sub-scales are normalized to range from 0 to 100 scores. Sub-scales include auditory difficulties, cognitive interference, emotional distress, intrusiveness, reduced sense of control, reduced quality of life, relaxation interference, and sleep disturbance.|units on a scale|Mean|45.1|45.1|Standard Deviation|27.2|27.2|||
4019901|NCT01177137|3840924|B4|Total||Baseline scores on Tinnitus Functional Index and sub-scales|The Tinnitus Functional Index (TFI) has 25 questions, scored from 0 to 10. The total score ranges from 0 to 100, with higher scores indicating more tinnitus distress. All sub-scales are normalized to range from 0 to 100 scores. Sub-scales include auditory difficulties, cognitive interference, emotional distress, intrusiveness, reduced sense of control, reduced quality of life, relaxation interference, and sleep disturbance.|units on a scale|Mean|50.6|50.6|Standard Deviation|17.3|17.3|||
4019902|NCT01177137|3840925|B3|Total||Baseline scores on Tinnitus Functional Index and sub-scales|The Tinnitus Functional Index (TFI) has 25 questions, scored from 0 to 10. The total score ranges from 0 to 100, with higher scores indicating more tinnitus distress. All sub-scales are normalized to range from 0 to 100 scores. Sub-scales include auditory difficulties, cognitive interference, emotional distress, intrusiveness, reduced sense of control, reduced quality of life, relaxation interference, and sleep disturbance.|units on a scale|Mean|53.5|53.5|Standard Deviation|17.3|17.3|||
4019903|NCT01177137|3840926|B2|Total||Baseline scores on Tinnitus Functional Index and sub-scales|The Tinnitus Functional Index (TFI) has 25 questions, scored from 0 to 10. The total score ranges from 0 to 100, with higher scores indicating more tinnitus distress. All sub-scales are normalized to range from 0 to 100 scores. Sub-scales include auditory difficulties, cognitive interference, emotional distress, intrusiveness, reduced sense of control, reduced quality of life, relaxation interference, and sleep disturbance.|units on a scale|Mean|50.3|50.3|Standard Deviation|17.1|17.1|||
4019904|NCT01177137|3840927|B1|Total||Baseline scores on Tinnitus Functional Index and sub-scales|The Tinnitus Functional Index (TFI) has 25 questions, scored from 0 to 10. The total score ranges from 0 to 100, with higher scores indicating more tinnitus distress. All sub-scales are normalized to range from 0 to 100 scores. Sub-scales include auditory difficulties, cognitive interference, emotional distress, intrusiveness, reduced sense of control, reduced quality of life, relaxation interference, and sleep disturbance.|units on a scale|Mean|48.1|48.1|Standard Deviation|17.6|17.6|||
4019905|NCT01177137|3840924|B4|Somatic complaint||Baseline scores on the Tinnitus Questionnaire and sub-scales|The Tinnitus Questionnaire has 52 questions, scored as 0, 1, or 2. The total score is the sum of the scores of all questions and ranges from 0 to 102, with higher scores indicating more tinnitus distress. Sub-scales (range of scores) include auditory perceptual difficulties (0 to 14), emotional distress (0 to 38), intrusiveness (0 to 14), sleep disturbance (0 to 8), and somatic complaint (0 to 8).|units on a scale|Mean|4.9|4.9|Standard Deviation|1.7|1.7|||
4019906|NCT01177137|3840925|B3|Somatic complaint||Baseline scores on the Tinnitus Questionnaire and sub-scales|The Tinnitus Questionnaire has 52 questions, scored as 0, 1, or 2. The total score is the sum of the scores of all questions and ranges from 0 to 102, with higher scores indicating more tinnitus distress. Sub-scales (range of scores) include auditory perceptual difficulties (0 to 14), emotional distress (0 to 38), intrusiveness (0 to 14), sleep disturbance (0 to 8), and somatic complaint (0 to 8).|units on a scale|Mean|4.9|4.9|Standard Deviation|1.7|1.7|||
4019907|NCT01177137|3840926|B2|Somatic complaint||Baseline scores on the Tinnitus Questionnaire and sub-scales|The Tinnitus Questionnaire has 52 questions, scored as 0, 1, or 2. The total score is the sum of the scores of all questions and ranges from 0 to 102, with higher scores indicating more tinnitus distress. Sub-scales (range of scores) include auditory perceptual difficulties (0 to 14), emotional distress (0 to 38), intrusiveness (0 to 14), sleep disturbance (0 to 8), and somatic complaint (0 to 8).|units on a scale|Mean|4.5|4.5|Standard Deviation|1.8|1.8|||
4019908|NCT01177137|3840927|B1|Somatic complaint||Baseline scores on the Tinnitus Questionnaire and sub-scales|The Tinnitus Questionnaire has 52 questions, scored as 0, 1, or 2. The total score is the sum of the scores of all questions and ranges from 0 to 102, with higher scores indicating more tinnitus distress. Sub-scales (range of scores) include auditory perceptual difficulties (0 to 14), emotional distress (0 to 38), intrusiveness (0 to 14), sleep disturbance (0 to 8), and somatic complaint (0 to 8).|units on a scale|Mean|5.3|5.3|Standard Deviation|1.6|1.6|||
4019909|NCT01177137|3840924|B4|Sleep disturbance||Baseline scores on the Tinnitus Questionnaire and sub-scales|The Tinnitus Questionnaire has 52 questions, scored as 0, 1, or 2. The total score is the sum of the scores of all questions and ranges from 0 to 102, with higher scores indicating more tinnitus distress. Sub-scales (range of scores) include auditory perceptual difficulties (0 to 14), emotional distress (0 to 38), intrusiveness (0 to 14), sleep disturbance (0 to 8), and somatic complaint (0 to 8).|units on a scale|Mean|4.7|4.7|Standard Deviation|2.3|2.3|||
4019910|NCT01177137|3840925|B3|Sleep disturbance||Baseline scores on the Tinnitus Questionnaire and sub-scales|The Tinnitus Questionnaire has 52 questions, scored as 0, 1, or 2. The total score is the sum of the scores of all questions and ranges from 0 to 102, with higher scores indicating more tinnitus distress. Sub-scales (range of scores) include auditory perceptual difficulties (0 to 14), emotional distress (0 to 38), intrusiveness (0 to 14), sleep disturbance (0 to 8), and somatic complaint (0 to 8).|units on a scale|Mean|4.8|4.8|Standard Deviation|2.4|2.4|||
4019911|NCT01177137|3840926|B2|Sleep disturbance||Baseline scores on the Tinnitus Questionnaire and sub-scales|The Tinnitus Questionnaire has 52 questions, scored as 0, 1, or 2. The total score is the sum of the scores of all questions and ranges from 0 to 102, with higher scores indicating more tinnitus distress. Sub-scales (range of scores) include auditory perceptual difficulties (0 to 14), emotional distress (0 to 38), intrusiveness (0 to 14), sleep disturbance (0 to 8), and somatic complaint (0 to 8).|units on a scale|Mean|4.3|4.3|Standard Deviation|2.2|2.2|||
4019912|NCT01177137|3840927|B1|Sleep disturbance||Baseline scores on the Tinnitus Questionnaire and sub-scales|The Tinnitus Questionnaire has 52 questions, scored as 0, 1, or 2. The total score is the sum of the scores of all questions and ranges from 0 to 102, with higher scores indicating more tinnitus distress. Sub-scales (range of scores) include auditory perceptual difficulties (0 to 14), emotional distress (0 to 38), intrusiveness (0 to 14), sleep disturbance (0 to 8), and somatic complaint (0 to 8).|units on a scale|Mean|4.9|4.9|Standard Deviation|2.3|2.3|||
4019913|NCT01177137|3840924|B4|Intrusiveness||Baseline scores on the Tinnitus Questionnaire and sub-scales|The Tinnitus Questionnaire has 52 questions, scored as 0, 1, or 2. The total score is the sum of the scores of all questions and ranges from 0 to 102, with higher scores indicating more tinnitus distress. Sub-scales (range of scores) include auditory perceptual difficulties (0 to 14), emotional distress (0 to 38), intrusiveness (0 to 14), sleep disturbance (0 to 8), and somatic complaint (0 to 8).|units on a scale|Mean|9.9|9.9|Standard Deviation|2.0|2.0|||
4019914|NCT01177137|3840925|B3|Intrusiveness||Baseline scores on the Tinnitus Questionnaire and sub-scales|The Tinnitus Questionnaire has 52 questions, scored as 0, 1, or 2. The total score is the sum of the scores of all questions and ranges from 0 to 102, with higher scores indicating more tinnitus distress. Sub-scales (range of scores) include auditory perceptual difficulties (0 to 14), emotional distress (0 to 38), intrusiveness (0 to 14), sleep disturbance (0 to 8), and somatic complaint (0 to 8).|units on a scale|Mean|9.8|9.8|Standard Deviation|1.8|1.8|||
4019915|NCT01177137|3840926|B2|Intrusiveness||Baseline scores on the Tinnitus Questionnaire and sub-scales|The Tinnitus Questionnaire has 52 questions, scored as 0, 1, or 2. The total score is the sum of the scores of all questions and ranges from 0 to 102, with higher scores indicating more tinnitus distress. Sub-scales (range of scores) include auditory perceptual difficulties (0 to 14), emotional distress (0 to 38), intrusiveness (0 to 14), sleep disturbance (0 to 8), and somatic complaint (0 to 8).|units on a scale|Mean|9.9|9.9|Standard Deviation|2.1|2.1|||
4019916|NCT01177137|3840927|B1|Intrusiveness||Baseline scores on the Tinnitus Questionnaire and sub-scales|The Tinnitus Questionnaire has 52 questions, scored as 0, 1, or 2. The total score is the sum of the scores of all questions and ranges from 0 to 102, with higher scores indicating more tinnitus distress. Sub-scales (range of scores) include auditory perceptual difficulties (0 to 14), emotional distress (0 to 38), intrusiveness (0 to 14), sleep disturbance (0 to 8), and somatic complaint (0 to 8).|units on a scale|Mean|9.9|9.9|Standard Deviation|2.0|2.0|||
4019917|NCT01177137|3840924|B4|Emotional distress||Baseline scores on the Tinnitus Questionnaire and sub-scales|The Tinnitus Questionnaire has 52 questions, scored as 0, 1, or 2. The total score is the sum of the scores of all questions and ranges from 0 to 102, with higher scores indicating more tinnitus distress. Sub-scales (range of scores) include auditory perceptual difficulties (0 to 14), emotional distress (0 to 38), intrusiveness (0 to 14), sleep disturbance (0 to 8), and somatic complaint (0 to 8).|units on a scale|Mean|16.7|16.7|Standard Deviation|6.1|6.1|||
4019918|NCT01177137|3840925|B3|Emotional distress||Baseline scores on the Tinnitus Questionnaire and sub-scales|The Tinnitus Questionnaire has 52 questions, scored as 0, 1, or 2. The total score is the sum of the scores of all questions and ranges from 0 to 102, with higher scores indicating more tinnitus distress. Sub-scales (range of scores) include auditory perceptual difficulties (0 to 14), emotional distress (0 to 38), intrusiveness (0 to 14), sleep disturbance (0 to 8), and somatic complaint (0 to 8).|units on a scale|Mean|15.8|15.8|Standard Deviation|5.5|5.5|||
4019919|NCT01177137|3840926|B2|Emotional distress||Baseline scores on the Tinnitus Questionnaire and sub-scales|The Tinnitus Questionnaire has 52 questions, scored as 0, 1, or 2. The total score is the sum of the scores of all questions and ranges from 0 to 102, with higher scores indicating more tinnitus distress. Sub-scales (range of scores) include auditory perceptual difficulties (0 to 14), emotional distress (0 to 38), intrusiveness (0 to 14), sleep disturbance (0 to 8), and somatic complaint (0 to 8).|units on a scale|Mean|17.0|17.0|Standard Deviation|6.6|6.6|||
4019920|NCT01177137|3840927|B1|Emotional distress||Baseline scores on the Tinnitus Questionnaire and sub-scales|The Tinnitus Questionnaire has 52 questions, scored as 0, 1, or 2. The total score is the sum of the scores of all questions and ranges from 0 to 102, with higher scores indicating more tinnitus distress. Sub-scales (range of scores) include auditory perceptual difficulties (0 to 14), emotional distress (0 to 38), intrusiveness (0 to 14), sleep disturbance (0 to 8), and somatic complaint (0 to 8).|units on a scale|Mean|17.2|17.2|Standard Deviation|6.2|6.2|||
4019921|NCT01177137|3840924|B4|Auditory perceptual||Baseline scores on the Tinnitus Questionnaire and sub-scales|The Tinnitus Questionnaire has 52 questions, scored as 0, 1, or 2. The total score is the sum of the scores of all questions and ranges from 0 to 102, with higher scores indicating more tinnitus distress. Sub-scales (range of scores) include auditory perceptual difficulties (0 to 14), emotional distress (0 to 38), intrusiveness (0 to 14), sleep disturbance (0 to 8), and somatic complaint (0 to 8).|units on a scale|Mean|7.3|7.3|Standard Deviation|3.1|3.1|||
4019922|NCT01177137|3840925|B3|Auditory perceptual||Baseline scores on the Tinnitus Questionnaire and sub-scales|The Tinnitus Questionnaire has 52 questions, scored as 0, 1, or 2. The total score is the sum of the scores of all questions and ranges from 0 to 102, with higher scores indicating more tinnitus distress. Sub-scales (range of scores) include auditory perceptual difficulties (0 to 14), emotional distress (0 to 38), intrusiveness (0 to 14), sleep disturbance (0 to 8), and somatic complaint (0 to 8).|units on a scale|Mean|7.7|7.7|Standard Deviation|3.7|3.7|||
4019923|NCT01177137|3840926|B2|Auditory perceptual||Baseline scores on the Tinnitus Questionnaire and sub-scales|The Tinnitus Questionnaire has 52 questions, scored as 0, 1, or 2. The total score is the sum of the scores of all questions and ranges from 0 to 102, with higher scores indicating more tinnitus distress. Sub-scales (range of scores) include auditory perceptual difficulties (0 to 14), emotional distress (0 to 38), intrusiveness (0 to 14), sleep disturbance (0 to 8), and somatic complaint (0 to 8).|units on a scale|Mean|7.1|7.1|Standard Deviation|3.0|3.0|||
4019924|NCT01177137|3840927|B1|Auditory perceptual||Baseline scores on the Tinnitus Questionnaire and sub-scales|The Tinnitus Questionnaire has 52 questions, scored as 0, 1, or 2. The total score is the sum of the scores of all questions and ranges from 0 to 102, with higher scores indicating more tinnitus distress. Sub-scales (range of scores) include auditory perceptual difficulties (0 to 14), emotional distress (0 to 38), intrusiveness (0 to 14), sleep disturbance (0 to 8), and somatic complaint (0 to 8).|units on a scale|Mean|7.2|7.2|Standard Deviation|2.8|2.8|||
4019971|NCT01177137|3840926|B2|More than 5 years||Duration of tinnitus as a problem||Participants|Count of Participants|22|22.0||||||
4019925|NCT01177137|3840924|B4|Total||Baseline scores on the Tinnitus Questionnaire and sub-scales|The Tinnitus Questionnaire has 52 questions, scored as 0, 1, or 2. The total score is the sum of the scores of all questions and ranges from 0 to 102, with higher scores indicating more tinnitus distress. Sub-scales (range of scores) include auditory perceptual difficulties (0 to 14), emotional distress (0 to 38), intrusiveness (0 to 14), sleep disturbance (0 to 8), and somatic complaint (0 to 8).|units on a scale|Mean|55.1|55.1|Standard Deviation|11.5|11.5|||
4019926|NCT01177137|3840925|B3|Total||Baseline scores on the Tinnitus Questionnaire and sub-scales|The Tinnitus Questionnaire has 52 questions, scored as 0, 1, or 2. The total score is the sum of the scores of all questions and ranges from 0 to 102, with higher scores indicating more tinnitus distress. Sub-scales (range of scores) include auditory perceptual difficulties (0 to 14), emotional distress (0 to 38), intrusiveness (0 to 14), sleep disturbance (0 to 8), and somatic complaint (0 to 8).|units on a scale|Mean|54.6|54.6|Standard Deviation|11.2|11.2|||
4019927|NCT01177137|3840926|B2|Total||Baseline scores on the Tinnitus Questionnaire and sub-scales|The Tinnitus Questionnaire has 52 questions, scored as 0, 1, or 2. The total score is the sum of the scores of all questions and ranges from 0 to 102, with higher scores indicating more tinnitus distress. Sub-scales (range of scores) include auditory perceptual difficulties (0 to 14), emotional distress (0 to 38), intrusiveness (0 to 14), sleep disturbance (0 to 8), and somatic complaint (0 to 8).|units on a scale|Mean|54.4|54.4|Standard Deviation|11.5|11.5|||
4019928|NCT01177137|3840927|B1|Total||Baseline scores on the Tinnitus Questionnaire and sub-scales|The Tinnitus Questionnaire has 52 questions, scored as 0, 1, or 2. The total score is the sum of the scores of all questions and ranges from 0 to 102, with higher scores indicating more tinnitus distress. Sub-scales (range of scores) include auditory perceptual difficulties (0 to 14), emotional distress (0 to 38), intrusiveness (0 to 14), sleep disturbance (0 to 8), and somatic complaint (0 to 8).|units on a scale|Mean|56.4|56.4|Standard Deviation|11.9|11.9|||
4019929|NCT01177137|3840924|B4|In the head and one or both ears||Tinnitus location||Participants|Count of Participants|38|38.0||||||
4019930|NCT01177137|3840925|B3|In the head and one or both ears||Tinnitus location||Participants|Count of Participants|15|15.0||||||
4019931|NCT01177137|3840926|B2|In the head and one or both ears||Tinnitus location||Participants|Count of Participants|12|12.0||||||
4019932|NCT01177137|3840927|B1|In the head and one or both ears||Tinnitus location||Participants|Count of Participants|11|11.0||||||
4019933|NCT01177137|3840924|B4|In the head||Tinnitus location||Participants|Count of Participants|28|28.0||||||
4019934|NCT01177137|3840925|B3|In the head||Tinnitus location||Participants|Count of Participants|10|10.0||||||
4019935|NCT01177137|3840926|B2|In the head||Tinnitus location||Participants|Count of Participants|11|11.0||||||
4019936|NCT01177137|3840927|B1|In the head||Tinnitus location||Participants|Count of Participants|7|7.0||||||
4019937|NCT01177137|3840924|B4|Both ears||Tinnitus location||Participants|Count of Participants|66|66.0||||||
4019938|NCT01177137|3840925|B3|Both ears||Tinnitus location||Participants|Count of Participants|20|20.0||||||
4019939|NCT01177137|3840926|B2|Both ears||Tinnitus location||Participants|Count of Participants|24|24.0||||||
4019940|NCT01177137|3840927|B1|Both ears||Tinnitus location||Participants|Count of Participants|22|22.0||||||
4019941|NCT01177137|3840924|B4|One ear||Tinnitus location||Participants|Count of Participants|19|19.0||||||
4019942|NCT01177137|3840925|B3|One ear||Tinnitus location||Participants|Count of Participants|4|4.0||||||
4019943|NCT01177137|3840926|B2|One ear||Tinnitus location||Participants|Count of Participants|4|4.0||||||
4019944|NCT01177137|3840927|B1|One ear||Tinnitus location||Participants|Count of Participants|11|11.0||||||
4019945|NCT01177137|3840924|B4|Missing||Tinnitus type of sound||Participants|Count of Participants|1|1.0||||||
4019946|NCT01177137|3840925|B3|Missing||Tinnitus type of sound||Participants|Count of Participants|1|1.0||||||
4019947|NCT01177137|3840926|B2|Missing||Tinnitus type of sound||Participants|Count of Participants|0|0.0||||||
4019948|NCT01177137|3840927|B1|Missing||Tinnitus type of sound||Participants|Count of Participants|0|0.0||||||
4019949|NCT01177137|3840924|B4|Other (clicking, crickets, etc.)||Tinnitus type of sound||Participants|Count of Participants|1|1.0||||||
4019950|NCT01177137|3840925|B3|Other (clicking, crickets, etc.)||Tinnitus type of sound||Participants|Count of Participants|0|0.0||||||
4019951|NCT01177137|3840926|B2|Other (clicking, crickets, etc.)||Tinnitus type of sound||Participants|Count of Participants|1|1.0||||||
4019952|NCT01177137|3840927|B1|Other (clicking, crickets, etc.)||Tinnitus type of sound||Participants|Count of Participants|0|0.0||||||
4019953|NCT01177137|3840924|B4|High frequency (hissing, sizzling, ectc.)||Tinnitus type of sound||Participants|Count of Participants|1|1.0||||||
4019954|NCT01177137|3840925|B3|High frequency (hissing, sizzling, ectc.)||Tinnitus type of sound||Participants|Count of Participants|0|0.0||||||
4019955|NCT01177137|3840926|B2|High frequency (hissing, sizzling, ectc.)||Tinnitus type of sound||Participants|Count of Participants|1|1.0||||||
4019956|NCT01177137|3840927|B1|High frequency (hissing, sizzling, ectc.)||Tinnitus type of sound||Participants|Count of Participants|0|0.0||||||
4019957|NCT01177137|3840924|B4|Low frequency (buzzing, puldating, ocean, etc.||Tinnitus type of sound||Participants|Count of Participants|7|7.0||||||
4019958|NCT01177137|3840925|B3|Low frequency (buzzing, puldating, ocean, etc.||Tinnitus type of sound||Participants|Count of Participants|1|1.0||||||
4019959|NCT01177137|3840926|B2|Low frequency (buzzing, puldating, ocean, etc.||Tinnitus type of sound||Participants|Count of Participants|2|2.0||||||
4019960|NCT01177137|3840927|B1|Low frequency (buzzing, puldating, ocean, etc.||Tinnitus type of sound||Participants|Count of Participants|4|4.0||||||
4019961|NCT01177137|3840924|B4|Tonal (ringing, music, whistling, etc.)||Tinnitus type of sound||Participants|Count of Participants|141|141.0||||||
4019962|NCT01177137|3840925|B3|Tonal (ringing, music, whistling, etc.)||Tinnitus type of sound||Participants|Count of Participants|47|47.0||||||
4019963|NCT01177137|3840926|B2|Tonal (ringing, music, whistling, etc.)||Tinnitus type of sound||Participants|Count of Participants|47|47.0||||||
4019964|NCT01177137|3840927|B1|Tonal (ringing, music, whistling, etc.)||Tinnitus type of sound||Participants|Count of Participants|47|47.0||||||
4020147|NCT01176617|3841095|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4019972|NCT01177137|3840927|B1|More than 5 years||Duration of tinnitus as a problem||Participants|Count of Participants|24|24.0||||||
4019973|NCT01177137|3840924|B4|More than 2 years but less than 5 years||Duration of tinnitus as a problem||Participants|Count of Participants|52|52.0||||||
4019974|NCT01177137|3840925|B3|More than 2 years but less than 5 years||Duration of tinnitus as a problem||Participants|Count of Participants|20|20.0||||||
4019975|NCT01177137|3840926|B2|More than 2 years but less than 5 years||Duration of tinnitus as a problem||Participants|Count of Participants|17|17.0||||||
4019976|NCT01177137|3840927|B1|More than 2 years but less than 5 years||Duration of tinnitus as a problem||Participants|Count of Participants|15|15.0||||||
4019977|NCT01177137|3840924|B4|Less than 2 years||Duration of tinnitus as a problem||Participants|Count of Participants|29|29.0||||||
4019978|NCT01177137|3840925|B3|Less than 2 years||Duration of tinnitus as a problem||Participants|Count of Participants|6|6.0||||||
4019979|NCT01177137|3840926|B2|Less than 2 years||Duration of tinnitus as a problem||Participants|Count of Participants|11|11.0||||||
4019980|NCT01177137|3840927|B1|Less than 2 years||Duration of tinnitus as a problem||Participants|Count of Participants|12|12.0||||||
4019981|NCT01177137|3840924|B4|Never smoked||Smoking status||Participants|Count of Participants|105|105.0||||||
4019982|NCT01177137|3840925|B3|Never smoked||Smoking status||Participants|Count of Participants|36|36.0||||||
4019983|NCT01177137|3840926|B2|Never smoked||Smoking status||Participants|Count of Participants|33|33.0||||||
4019984|NCT01177137|3840927|B1|Never smoked||Smoking status||Participants|Count of Participants|36|36.0||||||
4019985|NCT01177137|3840924|B4|Previous smoker||Smoking status||Participants|Count of Participants|41|41.0||||||
4019986|NCT01177137|3840925|B3|Previous smoker||Smoking status||Participants|Count of Participants|11|11.0||||||
4019987|NCT01177137|3840926|B2|Previous smoker||Smoking status||Participants|Count of Participants|15|15.0||||||
4019988|NCT01177137|3840927|B1|Previous smoker||Smoking status||Participants|Count of Participants|15|15.0||||||
4019989|NCT01177137|3840924|B4|Current smoker||Smoking status||Participants|Count of Participants|5|5.0||||||
4019990|NCT01177137|3840925|B3|Current smoker||Smoking status||Participants|Count of Participants|2|2.0||||||
4019991|NCT01177137|3840926|B2|Current smoker||Smoking status||Participants|Count of Participants|3|3.0||||||
4019992|NCT01177137|3840927|B1|Current smoker||Smoking status||Participants|Count of Participants|0|0.0||||||
4019993|NCT01177137|3840924|B4|Other/unknown||Marital status||Participants|Count of Participants|1|1.0||||||
4019994|NCT01177137|3840925|B3|Other/unknown||Marital status||Participants|Count of Participants|0|0.0||||||
4019995|NCT01177137|3840926|B2|Other/unknown||Marital status||Participants|Count of Participants|0|0.0||||||
4019996|NCT01177137|3840927|B1|Other/unknown||Marital status||Participants|Count of Participants|1|1.0||||||
4019997|NCT01177137|3840924|B4|Widowed||Marital status||Participants|Count of Participants|1|1.0||||||
4019998|NCT01177137|3840925|B3|Widowed||Marital status||Participants|Count of Participants|1|1.0||||||
4019999|NCT01177137|3840926|B2|Widowed||Marital status||Participants|Count of Participants|0|0.0||||||
4020000|NCT01177137|3840927|B1|Widowed||Marital status||Participants|Count of Participants|0|0.0||||||
4020001|NCT01177137|3840924|B4|Divorced/separated||Marital status||Participants|Count of Participants|15|15.0||||||
4020002|NCT01177137|3840925|B3|Divorced/separated||Marital status||Participants|Count of Participants|4|4.0||||||
4020003|NCT01177137|3840926|B2|Divorced/separated||Marital status||Participants|Count of Participants|4|4.0||||||
4020004|NCT01177137|3840927|B1|Divorced/separated||Marital status||Participants|Count of Participants|7|7.0||||||
4020005|NCT01177137|3840924|B4|Single/never married||Marital status||Participants|Count of Participants|13|13.0||||||
4020006|NCT01177137|3840925|B3|Single/never married||Marital status||Participants|Count of Participants|3|3.0||||||
4020007|NCT01177137|3840926|B2|Single/never married||Marital status||Participants|Count of Participants|6|6.0||||||
4020008|NCT01177137|3840927|B1|Single/never married||Marital status||Participants|Count of Participants|4|4.0||||||
4020009|NCT01177137|3840924|B4|Married/living with partner||Marital status||Participants|Count of Participants|121|121.0||||||
4020010|NCT01177137|3840925|B3|Married/living with partner||Marital status||Participants|Count of Participants|41|41.0||||||
4020011|NCT01177137|3840926|B2|Married/living with partner||Marital status||Participants|Count of Participants|41|41.0||||||
4020012|NCT01177137|3840927|B1|Married/living with partner||Marital status||Participants|Count of Participants|39|39.0||||||
4020013|NCT01177137|3840924|B4|Unknown or not reported||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4020014|NCT01177137|3840925|B3|Unknown or not reported||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4020015|NCT01177137|3840926|B2|Unknown or not reported||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4020016|NCT01177137|3840927|B1|Unknown or not reported||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4020017|NCT01177137|3840924|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|126|126.0||||||
4020018|NCT01177137|3840925|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
4020019|NCT01177137|3840926|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
4020020|NCT01177137|3840927|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
4020021|NCT01177137|3840924|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4020022|NCT01177137|3840925|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4020023|NCT01177137|3840926|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4020024|NCT01177137|3840927|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4020025|NCT01177137|3840924|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4020026|NCT01177137|3840925|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4020027|NCT01177137|3840926|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4020028|NCT01177137|3840927|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4020029|NCT01177137|3840924|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4020030|NCT01177137|3840925|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4020031|NCT01177137|3840926|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020032|NCT01177137|3840927|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4020033|NCT01177137|3840924|B4||White|Race (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
4020034|NCT01177137|3840925|B3||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4020035|NCT01177137|3840926|B2||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4020036|NCT01177137|3840927|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4020037|NCT01177137|3840924|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4020038|NCT01177137|3840925|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4020039|NCT01177137|3840926|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4020040|NCT01177137|3840927|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4020041|NCT01177137|3840924|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4020042|NCT01177137|3840925|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020043|NCT01177137|3840926|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4020044|NCT01177137|3840927|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4020045|NCT01177137|3840924|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4020046|NCT01177137|3840925|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4020047|NCT01177137|3840926|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4020048|NCT01177137|3840927|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4020049|NCT01177137|3840924|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020050|NCT01177137|3840925|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020051|NCT01177137|3840926|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020052|NCT01177137|3840927|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020053|NCT01177137|3840924|B4||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4020054|NCT01177137|3840925|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4020055|NCT01177137|3840926|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4020056|NCT01177137|3840927|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4020057|NCT01177137|3840924|B4||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4020058|NCT01177137|3840925|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4020059|NCT01177137|3840926|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4020060|NCT01177137|3840927|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4020061|NCT01177137|3840924|B4|||Age||years|Mean|50.6|50.6|Standard Deviation|11.3|11.3|||
4020062|NCT01177137|3840925|B3|||Age||years|Mean|49.9|49.9|Standard Deviation|10.6|10.6|||
4020063|NCT01177137|3840926|B2|||Age||years|Mean|50.9|50.9|Standard Deviation|11.2|11.2|||
4020064|NCT01177137|3840927|B1|||Age||years|Mean|51.1|51.1|Standard Deviation|12.6|12.6|||
4020065|NCT01177098|3840994|B3||Male|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
4020066|NCT01177098|3840995|B2||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4020067|NCT01177098|3840996|B1||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4020068|NCT01177098|3840994|B3||Female|Sex: Female, Male||Participants|Count of Participants|321|321.0||||||
4020069|NCT01177098|3840995|B2||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4020070|NCT01177098|3840996|B1||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4020071|NCT01177098|3840994|B3|>65 Years||Age, Customized||Participants|Number|269|269.0||||||
4020072|NCT01177098|3840995|B2|>65 Years||Age, Customized||Participants|Number|135|135.0||||||
4020073|NCT01177098|3840996|B1|>65 Years||Age, Customized||Participants|Number|134|134.0||||||
4020074|NCT01177098|3840994|B3|45 to 65 Years||Age, Customized||Participants|Number|267|267.0||||||
4020075|NCT01177098|3840995|B2|45 to 65 Years||Age, Customized||Participants|Number|135|135.0||||||
4020076|NCT01177098|3840996|B1|45 to 65 Years||Age, Customized||Participants|Number|132|132.0||||||
4020077|NCT01177098|3840994|B3|<45 Years||Age, Customized||Participants|Number|25|25.0||10.71|10.71|||
4020078|NCT01177098|3840995|B2|<45 Years||Age, Customized||Participants|Number|13|13.0||10.82|10.82|||
4020079|NCT01177098|3840996|B1|<45 Years||Age, Customized||Participants|Number|12|12.0||10.61|10.61|||
4020080|NCT01177059|3841013|B1|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
4020081|NCT01177059|3841013|B1|Australia||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
4020082|NCT01177059|3841013|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4020083|NCT01177059|3841013|B1|Maori/Polynesian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4020084|NCT01177059|3841013|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4020085|NCT01177059|3841013|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|53|53.0||||||
4020086|NCT01177059|3841013|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4020087|NCT01177059|3841013|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4020088|NCT01177059|3841013|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4020089|NCT01177059|3841013|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4020090|NCT01177059|3841013|B1|||Age||Years|Mean|40.2|40.2|Standard Deviation|5.79|5.79|||
4020091|NCT01177007|3841019|B1|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
4020092|NCT01177007|3841019|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4020093|NCT01177007|3841019|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4020094|NCT01177007|3841019|B1|||Age||years|Mean|59.3|59.3|Full Range|||25.0|79.0|
4020095|NCT01176968|3841031|B3||Male|Sex: Female, Male||Participants|Count of Participants|823|823.0||||||
4020096|NCT01176968|3841032|B2||Male|Sex: Female, Male||Participants|Count of Participants|403|403.0||||||
4020097|NCT01176968|3841033|B1||Male|Sex: Female, Male||Participants|Count of Participants|420|420.0||||||
4020098|NCT01176968|3841031|B3||Female|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4020099|NCT01176968|3841032|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4020100|NCT01176968|3841033|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4020101|NCT01176968|3841031|B3|||Age||Years|Mean|58.2|58.2|Standard Deviation|10.9|10.9|||
4020102|NCT01176968|3841032|B2|||Age||Years|Mean|57.8|57.8|Standard Deviation|11.0|11.0|||
4020103|NCT01176968|3841033|B1|||Age||Years|Mean|58.5|58.5|Standard Deviation|10.8|10.8|||
4020104|NCT01176955|3841066|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4020105|NCT01176955|3841067|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4020106|NCT01176955|3841068|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4020107|NCT01176955|3841066|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4020108|NCT01176955|3841067|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4020109|NCT01176955|3841068|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4020110|NCT01176955|3841066|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4020111|NCT01176955|3841067|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4020112|NCT01176955|3841068|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4020113|NCT01176955|3841066|B3|||Age||years|Mean|15.4|15.4|Standard Deviation|1.85|1.85|||
4020114|NCT01176955|3841067|B2|||Age||years|Mean|15.5|15.5|Standard Deviation|2.22|2.22|||
4020115|NCT01176955|3841068|B1|||Age||years|Mean|15.3|15.3|Standard Deviation|1.49|1.49|||
4020116|NCT01176955|3841066|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4020117|NCT01176955|3841067|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4020118|NCT01176955|3841068|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4020119|NCT01176955|3841066|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4020120|NCT01176955|3841067|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4020121|NCT01176955|3841068|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4020122|NCT01176955|3841066|B3||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
4020123|NCT01176955|3841067|B2||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4020124|NCT01176955|3841068|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4020125|NCT01176877|3841080|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4020126|NCT01176877|3841080|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4020127|NCT01176877|3841080|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4020128|NCT01176877|3841080|B1|||Age||years|Mean|40|40.0|Inter-Quartile Range|||29.0|50.0|
4020129|NCT01176877|3841080|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4020130|NCT01176877|3841080|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4020131|NCT01176877|3841080|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4020132|NCT01176773|3841085|B1|United Kingdom||Region of Enrollment||participants|Number|60|60.0||||||
4020133|NCT01176773|3841085|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4020134|NCT01176773|3841085|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4020135|NCT01176773|3841085|B1|||Age||years|Mean|50.2|50.2|Standard Deviation|12.14|12.14|||
4020136|NCT01176773|3841085|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4020137|NCT01176773|3841085|B1||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4020138|NCT01176773|3841085|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4020139|NCT01176617|3841094|B3|United States||Region of Enrollment||participants|Number|0|0.0||||||
4020140|NCT01176617|3841095|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4020141|NCT01176617|3841096|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4020142|NCT01176617|3841094|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4020143|NCT01176617|3841094|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4020144|NCT01176617|3841095|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4020145|NCT01176617|3841096|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4020146|NCT01176617|3841094|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4020148|NCT01176617|3841096|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4020149|NCT01176617|3841094|B3|||Age||Years|Mean|59.4|59.4|Standard Deviation|11|11.0|||
4020150|NCT01176617|3841095|B2|||Age||Years|Mean|61|61.0|Standard Deviation|9|9.0|||
4020151|NCT01176617|3841096|B1|||Age||Years|Mean|57|57.0|Standard Deviation|12|12.0|||
4020152|NCT01176617|3841094|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4020153|NCT01176617|3841095|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4020154|NCT01176617|3841096|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4020155|NCT01176617|3841094|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4020156|NCT01176617|3841095|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4020157|NCT01176617|3841096|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4020158|NCT01176617|3841094|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4020159|NCT01176617|3841095|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4020160|NCT01176617|3841096|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4020161|NCT01176565|3841107|B3|||Failure to attain systolic blood pressure target for 2 consecutive hours during 2-24 hours|This data parameter is a measure of the success (or lack of success) with which SBP control to the assigned treatment range was consistently maintained during the 24-hour SBP control study period.|Participants|Count of Participants|85|85.0||||||
4020162|NCT01176565|3841108|B2|||Failure to attain systolic blood pressure target for 2 consecutive hours during 2-24 hours|This data parameter is a measure of the success (or lack of success) with which SBP control to the assigned treatment range was consistently maintained during the 24-hour SBP control study period.|Participants|Count of Participants|78|78.0||||||
4020163|NCT01176565|3841109|B1|||Failure to attain systolic blood pressure target for 2 consecutive hours during 2-24 hours|This data parameter is a measure of the success (or lack of success) with which SBP control to the assigned treatment range was consistently maintained during the 24-hour SBP control study period.|Participants|Count of Participants|7|7.0||||||
4020164|NCT01176565|3841107|B3|||Failure to attain systolic blood pressure target within 2 hours|Elevation of systolic blood pressure is common with intracerebral hemorrhage. Recovery of normalized blood pressure may occur quickly for some patients and only after an extended time for others, and more or less medication may be needed. The systolic blood pressure goal is usually achieved incrementally, as antihypertensive medication begins to take effect to control blood pressure. A lower target SBP range may take longer or be more difficult to achieve. The goal in this study was to achieve blood pressure control within 2 hours of randomization for all patients, regardless of treatment arm.|Participants|Count of Participants|65|65.0||||||
4020165|NCT01176565|3841108|B2|||Failure to attain systolic blood pressure target within 2 hours|Elevation of systolic blood pressure is common with intracerebral hemorrhage. Recovery of normalized blood pressure may occur quickly for some patients and only after an extended time for others, and more or less medication may be needed. The systolic blood pressure goal is usually achieved incrementally, as antihypertensive medication begins to take effect to control blood pressure. A lower target SBP range may take longer or be more difficult to achieve. The goal in this study was to achieve blood pressure control within 2 hours of randomization for all patients, regardless of treatment arm.|Participants|Count of Participants|61|61.0||||||
4020166|NCT01176565|3841109|B1|||Failure to attain systolic blood pressure target within 2 hours|Elevation of systolic blood pressure is common with intracerebral hemorrhage. Recovery of normalized blood pressure may occur quickly for some patients and only after an extended time for others, and more or less medication may be needed. The systolic blood pressure goal is usually achieved incrementally, as antihypertensive medication begins to take effect to control blood pressure. A lower target SBP range may take longer or be more difficult to achieve. The goal in this study was to achieve blood pressure control within 2 hours of randomization for all patients, regardless of treatment arm.|Participants|Count of Participants|4|4.0||||||
4020167|NCT01176565|3841107|B3|||Mean minimum systolic blood pressure, during the first 2 hours post randomization||mmHg|Mean|135|135.0|Standard Deviation|16.6|16.6|||
4020168|NCT01176565|3841108|B2|||Mean minimum systolic blood pressure, during the first 2 hours post randomization||mmHg|Mean|128.9|128.9|Standard Deviation|16|16.0|||
4020169|NCT01176565|3841109|B1|||Mean minimum systolic blood pressure, during the first 2 hours post randomization||mmHg|Mean|141.1|141.1|Standard Deviation|14.8|14.8|||
4020170|NCT01176565|3841107|B3|||Symptom onset to nicardipine infusion time|"To qualify, patients had to have SBP greater than 180 mmHg prior to antihypertensive treatment and SBP not below 140 mmHg at the time of randomization. Nicardipine infusion had to be able to start within 4.5 hours of symptom onset. In accordance with recommendations, treatment of significant hypertension in patients presenting with ICH was not delayed for consent and randomization. This measure captures the earliest nicardipine start time but other intravenous antihypertensive medications may have been given before then. Zero nicardipine start rates may not have been recorded in all cases."|minutes|Mean|157|157.0|Standard Deviation|85.2|85.2|||
4020171|NCT01176565|3841108|B2|||Symptom onset to nicardipine infusion time|"To qualify, patients had to have SBP greater than 180 mmHg prior to antihypertensive treatment and SBP not below 140 mmHg at the time of randomization. Nicardipine infusion had to be able to start within 4.5 hours of symptom onset. In accordance with recommendations, treatment of significant hypertension in patients presenting with ICH was not delayed for consent and randomization. This measure captures the earliest nicardipine start time but other intravenous antihypertensive medications may have been given before then. Zero nicardipine start rates may not have been recorded in all cases."|minutes|Mean|149|149.0|Standard Deviation|65|65.0|||
4020172|NCT01176565|3841109|B1|||Symptom onset to nicardipine infusion time|"To qualify, patients had to have SBP greater than 180 mmHg prior to antihypertensive treatment and SBP not below 140 mmHg at the time of randomization. Nicardipine infusion had to be able to start within 4.5 hours of symptom onset. In accordance with recommendations, treatment of significant hypertension in patients presenting with ICH was not delayed for consent and randomization. This measure captures the earliest nicardipine start time but other intravenous antihypertensive medications may have been given before then. Zero nicardipine start rates may not have been recorded in all cases."|minutes|Mean|165.3|165.3|Standard Deviation|101.3|101.3|||
4020173|NCT01176565|3841107|B3|||Symptom onset to randomization time, minutes||minutes|Mean|183.5|183.5|Standard Deviation|57|57.0|||
4020174|NCT01176565|3841108|B2|||Symptom onset to randomization time, minutes||minutes|Mean|182.2|182.2|Standard Deviation|57.2|57.2|||
4020175|NCT01176565|3841109|B1|||Symptom onset to randomization time, minutes||minutes|Mean|184.7|184.7|Standard Deviation|56.7|56.7|||
4020176|NCT01176565|3841107|B3|||Previous use of antihypertensive drugs||Participants|Count of Participants|495|495.0||||||
4020177|NCT01176565|3841108|B2|||Previous use of antihypertensive drugs||Participants|Count of Participants|260|260.0||||||
4020178|NCT01176565|3841109|B1|||Previous use of antihypertensive drugs||Participants|Count of Participants|235|235.0||||||
4020179|NCT01176565|3841107|B3|||History of diabetes mellitus Type 2||Participants|Count of Participants|175|175.0||||||
4020180|NCT01176565|3841108|B2|||History of diabetes mellitus Type 2||Participants|Count of Participants|92|92.0||||||
4020181|NCT01176565|3841109|B1|||History of diabetes mellitus Type 2||Participants|Count of Participants|83|83.0||||||
4020182|NCT01176565|3841107|B3|||History of cardiac dysrhythmias||Participants|Count of Participants|38|38.0||||||
4020183|NCT01176565|3841108|B2|||History of cardiac dysrhythmias||Participants|Count of Participants|17|17.0||||||
4020184|NCT01176565|3841109|B1|||History of cardiac dysrhythmias||Participants|Count of Participants|21|21.0||||||
4020185|NCT01176565|3841107|B3|||History of hyperlipidemia||Participants|Count of Participants|241|241.0||||||
4020186|NCT01176565|3841108|B2|||History of hyperlipidemia||Participants|Count of Participants|122|122.0||||||
4020187|NCT01176565|3841109|B1|||History of hyperlipidemia||Participants|Count of Participants|119|119.0||||||
4020188|NCT01176565|3841107|B3|||History of peripheral vascular disease||Participants|Count of Participants|22|22.0||||||
4020189|NCT01176565|3841108|B2|||History of peripheral vascular disease||Participants|Count of Participants|9|9.0||||||
4020190|NCT01176565|3841109|B1|||History of peripheral vascular disease||Participants|Count of Participants|13|13.0||||||
4020191|NCT01176565|3841107|B3|||History of hypertension||Participants|Count of Participants|793|793.0||||||
4020192|NCT01176565|3841108|B2|||History of hypertension||Participants|Count of Participants|411|411.0||||||
4020193|NCT01176565|3841109|B1|||History of hypertension||Participants|Count of Participants|382|382.0||||||
4020194|NCT01176565|3841107|B3|||History of coronary artery disease||Participants|Count of Participants|44|44.0||||||
4020195|NCT01176565|3841108|B2|||History of coronary artery disease||Participants|Count of Participants|27|27.0||||||
4020196|NCT01176565|3841109|B1|||History of coronary artery disease||Participants|Count of Participants|17|17.0||||||
4020197|NCT01176565|3841107|B3|||Myocardial infarction in the previous 3 months||Participants|Count of Participants|1|1.0||||||
4020198|NCT01176565|3841108|B2|||Myocardial infarction in the previous 3 months||Participants|Count of Participants|1|1.0||||||
4020199|NCT01176565|3841109|B1|||Myocardial infarction in the previous 3 months||Participants|Count of Participants|0|0.0||||||
4020200|NCT01176565|3841107|B3|||History of atrial fibrillation||Participants|Count of Participants|36|36.0||||||
4020201|NCT01176565|3841108|B2|||History of atrial fibrillation||Participants|Count of Participants|20|20.0||||||
4020202|NCT01176565|3841109|B1|||History of atrial fibrillation||Participants|Count of Participants|16|16.0||||||
4020203|NCT01176565|3841107|B3|||History of congestive heart failure||Participants|Count of Participants|37|37.0||||||
4020204|NCT01176565|3841108|B2|||History of congestive heart failure||Participants|Count of Participants|16|16.0||||||
4020205|NCT01176565|3841109|B1|||History of congestive heart failure||Participants|Count of Participants|21|21.0||||||
4020206|NCT01176565|3841107|B3|||Other prior nervous system disorders||Participants|Count of Participants|40|40.0||||||
4020207|NCT01176565|3841108|B2|||Other prior nervous system disorders||Participants|Count of Participants|23|23.0||||||
4020208|NCT01176565|3841109|B1|||Other prior nervous system disorders||Participants|Count of Participants|17|17.0||||||
4020209|NCT01176565|3841107|B3|||Prior stroke/transient ischemic attack||Participants|Count of Participants|164|164.0||||||
4020210|NCT01176565|3841108|B2|||Prior stroke/transient ischemic attack||Participants|Count of Participants|80|80.0||||||
4020211|NCT01176565|3841109|B1|||Prior stroke/transient ischemic attack||Participants|Count of Participants|84|84.0||||||
4020212|NCT01176565|3841107|B3||Cerebellum|Location of Hemorrhage|The primary location of hemorrhage (bleeding) in the brain tissue was recorded as being located in the basal ganglia, thalamus, or a lobar region on either the right or left side of the brain. One patient was included that had a cerebellar hemorrhage, which means that bleeding was in the lower dorsal (back) region of the brain.|Participants|Count of Participants|1|1.0||||||
4020213|NCT01176565|3841108|B2||Cerebellum|Location of Hemorrhage|The primary location of hemorrhage (bleeding) in the brain tissue was recorded as being located in the basal ganglia, thalamus, or a lobar region on either the right or left side of the brain. One patient was included that had a cerebellar hemorrhage, which means that bleeding was in the lower dorsal (back) region of the brain.|Participants|Count of Participants|0|0.0||||||
4020214|NCT01176565|3841109|B1||Cerebellum|Location of Hemorrhage|The primary location of hemorrhage (bleeding) in the brain tissue was recorded as being located in the basal ganglia, thalamus, or a lobar region on either the right or left side of the brain. One patient was included that had a cerebellar hemorrhage, which means that bleeding was in the lower dorsal (back) region of the brain.|Participants|Count of Participants|1|1.0||||||
4020215|NCT01176565|3841107|B3||Cerebral lobe|Location of Hemorrhage|The primary location of hemorrhage (bleeding) in the brain tissue was recorded as being located in the basal ganglia, thalamus, or a lobar region on either the right or left side of the brain. One patient was included that had a cerebellar hemorrhage, which means that bleeding was in the lower dorsal (back) region of the brain.|Participants|Count of Participants|108|108.0||||||
4020216|NCT01176565|3841108|B2||Cerebral lobe|Location of Hemorrhage|The primary location of hemorrhage (bleeding) in the brain tissue was recorded as being located in the basal ganglia, thalamus, or a lobar region on either the right or left side of the brain. One patient was included that had a cerebellar hemorrhage, which means that bleeding was in the lower dorsal (back) region of the brain.|Participants|Count of Participants|48|48.0||||||
4020217|NCT01176565|3841109|B1||Cerebral lobe|Location of Hemorrhage|The primary location of hemorrhage (bleeding) in the brain tissue was recorded as being located in the basal ganglia, thalamus, or a lobar region on either the right or left side of the brain. One patient was included that had a cerebellar hemorrhage, which means that bleeding was in the lower dorsal (back) region of the brain.|Participants|Count of Participants|60|60.0||||||
4020218|NCT01176565|3841107|B3||Basal ganglia|Location of Hemorrhage|The primary location of hemorrhage (bleeding) in the brain tissue was recorded as being located in the basal ganglia, thalamus, or a lobar region on either the right or left side of the brain. One patient was included that had a cerebellar hemorrhage, which means that bleeding was in the lower dorsal (back) region of the brain.|Participants|Count of Participants|506|506.0||||||
4020219|NCT01176565|3841108|B2||Basal ganglia|Location of Hemorrhage|The primary location of hemorrhage (bleeding) in the brain tissue was recorded as being located in the basal ganglia, thalamus, or a lobar region on either the right or left side of the brain. One patient was included that had a cerebellar hemorrhage, which means that bleeding was in the lower dorsal (back) region of the brain.|Participants|Count of Participants|255|255.0||||||
4020220|NCT01176565|3841109|B1||Basal ganglia|Location of Hemorrhage|The primary location of hemorrhage (bleeding) in the brain tissue was recorded as being located in the basal ganglia, thalamus, or a lobar region on either the right or left side of the brain. One patient was included that had a cerebellar hemorrhage, which means that bleeding was in the lower dorsal (back) region of the brain.|Participants|Count of Participants|251|251.0||||||
4020221|NCT01176565|3841107|B3||Thalamus|Location of Hemorrhage|The primary location of hemorrhage (bleeding) in the brain tissue was recorded as being located in the basal ganglia, thalamus, or a lobar region on either the right or left side of the brain. One patient was included that had a cerebellar hemorrhage, which means that bleeding was in the lower dorsal (back) region of the brain.|Participants|Count of Participants|373|373.0||||||
4020222|NCT01176565|3841108|B2||Thalamus|Location of Hemorrhage|The primary location of hemorrhage (bleeding) in the brain tissue was recorded as being located in the basal ganglia, thalamus, or a lobar region on either the right or left side of the brain. One patient was included that had a cerebellar hemorrhage, which means that bleeding was in the lower dorsal (back) region of the brain.|Participants|Count of Participants|193|193.0||||||
4020223|NCT01176565|3841109|B1||Thalamus|Location of Hemorrhage|The primary location of hemorrhage (bleeding) in the brain tissue was recorded as being located in the basal ganglia, thalamus, or a lobar region on either the right or left side of the brain. One patient was included that had a cerebellar hemorrhage, which means that bleeding was in the lower dorsal (back) region of the brain.|Participants|Count of Participants|180|180.0||||||
4020224|NCT01176565|3841107|B3|||Intraventricular Hemorrhage|Intraventricular hemorrhage is bleeding that is present within the ventricles, or internal fluid-filled spaces, within the brain. These spaces are usually filled with cerebrospinal fluid that also circulates around the brain and spinal column, which helps to protect and cushion the delicate brain tissue. In this study, when intraventricular hemorrhage was present it meant that bleeding had extended from another region within the brain tissue to also being present in the brain ventricles. Intraventricular blood is associated with other complications and may indicate a more severe condition.|Participants|Count of Participants|264|264.0||||||
4020225|NCT01176565|3841108|B2|||Intraventricular Hemorrhage|Intraventricular hemorrhage is bleeding that is present within the ventricles, or internal fluid-filled spaces, within the brain. These spaces are usually filled with cerebrospinal fluid that also circulates around the brain and spinal column, which helps to protect and cushion the delicate brain tissue. In this study, when intraventricular hemorrhage was present it meant that bleeding had extended from another region within the brain tissue to also being present in the brain ventricles. Intraventricular blood is associated with other complications and may indicate a more severe condition.|Participants|Count of Participants|122|122.0||||||
4020226|NCT01176565|3841109|B1|||Intraventricular Hemorrhage|Intraventricular hemorrhage is bleeding that is present within the ventricles, or internal fluid-filled spaces, within the brain. These spaces are usually filled with cerebrospinal fluid that also circulates around the brain and spinal column, which helps to protect and cushion the delicate brain tissue. In this study, when intraventricular hemorrhage was present it meant that bleeding had extended from another region within the brain tissue to also being present in the brain ventricles. Intraventricular blood is associated with other complications and may indicate a more severe condition.|Participants|Count of Participants|142|142.0||||||
4020227|NCT01176565|3841107|B3|||Intracerebral hematoma volume greater than 30 cm3|Hematoma volumes are reported in cubic centimeters (cm3), as measured by the central reader. The area of the hematoma on head CT imaging was delineated by image analysis software with the use of density thresholds on each slice, followed by manual correction. The central reader and those performing manual correction were unaware of the patient identities, treatment assignments, clinical findings, and time points of image acquisition. The software provided total volume measurements by summing up volumes (product of area and slice thickness) from all the slices containing the hematoma.|Participants|Count of Participants|96|96.0||||||
4020228|NCT01176565|3841108|B2|||Intracerebral hematoma volume greater than 30 cm3|Hematoma volumes are reported in cubic centimeters (cm3), as measured by the central reader. The area of the hematoma on head CT imaging was delineated by image analysis software with the use of density thresholds on each slice, followed by manual correction. The central reader and those performing manual correction were unaware of the patient identities, treatment assignments, clinical findings, and time points of image acquisition. The software provided total volume measurements by summing up volumes (product of area and slice thickness) from all the slices containing the hematoma.|Participants|Count of Participants|45|45.0||||||
4020229|NCT01176565|3841109|B1|||Intracerebral hematoma volume greater than 30 cm3|Hematoma volumes are reported in cubic centimeters (cm3), as measured by the central reader. The area of the hematoma on head CT imaging was delineated by image analysis software with the use of density thresholds on each slice, followed by manual correction. The central reader and those performing manual correction were unaware of the patient identities, treatment assignments, clinical findings, and time points of image acquisition. The software provided total volume measurements by summing up volumes (product of area and slice thickness) from all the slices containing the hematoma.|Participants|Count of Participants|51|51.0||||||
4020325|NCT01176435|3841143|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020326|NCT01176435|3841144|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020230|NCT01176565|3841107|B3|||Intracerebral Hematoma Volume|Hematoma volumes are reported in cubic centimeters (cm3), as measured by the central reader. The area of the hematoma on head CT imaging was delineated by image analysis software with the use of density thresholds on each slice, followed by manual correction. The central reader and those performing manual correction were unaware of the patient identities, treatment assignments, clinical findings, and time points of image acquisition. The software provided total volume measurements by summing up volumes (product of area and slice thickness) from all the slices containing the hematoma.|cubic centimeters (cm3)|Median|10.3|10.3|Full Range|||0.98|85.2|
4020231|NCT01176565|3841108|B2|||Intracerebral Hematoma Volume|Hematoma volumes are reported in cubic centimeters (cm3), as measured by the central reader. The area of the hematoma on head CT imaging was delineated by image analysis software with the use of density thresholds on each slice, followed by manual correction. The central reader and those performing manual correction were unaware of the patient identities, treatment assignments, clinical findings, and time points of image acquisition. The software provided total volume measurements by summing up volumes (product of area and slice thickness) from all the slices containing the hematoma.|cubic centimeters (cm3)|Median|10.3|10.3|Full Range|||2.3|85.2|
4020232|NCT01176565|3841109|B1|||Intracerebral Hematoma Volume|Hematoma volumes are reported in cubic centimeters (cm3), as measured by the central reader. The area of the hematoma on head CT imaging was delineated by image analysis software with the use of density thresholds on each slice, followed by manual correction. The central reader and those performing manual correction were unaware of the patient identities, treatment assignments, clinical findings, and time points of image acquisition. The software provided total volume measurements by summing up volumes (product of area and slice thickness) from all the slices containing the hematoma.|cubic centimeters (cm3)|Median|10.2|10.2|Full Range|||0.98|79.1|
4020233|NCT01176565|3841107|B3|||Median NIHSS score (range)|The National Institutes of Health Stroke Scale (NIHSS) is a serial measure of neurologic deficit (problems in function). It uses a scale (range 0 - 42) to quantify neurologic deficits in 11 categories. The categories are measured by asking questions that indicate the patient's level of consciousness, then testing horizontal eye movements, visual fields, facial palsy, movement in each limb, sensation, language and speech, and extinction or inattention on one side of the body. A score of 0 indicates normal function without neurologic deficit. Higher scores indicate greater severity of deficit.|units on a scale (NIHSS range 0 - 42)|Median|11|11.0|Full Range|||0.0|40.0|
4020234|NCT01176565|3841108|B2|||Median NIHSS score (range)|The National Institutes of Health Stroke Scale (NIHSS) is a serial measure of neurologic deficit (problems in function). It uses a scale (range 0 - 42) to quantify neurologic deficits in 11 categories. The categories are measured by asking questions that indicate the patient's level of consciousness, then testing horizontal eye movements, visual fields, facial palsy, movement in each limb, sensation, language and speech, and extinction or inattention on one side of the body. A score of 0 indicates normal function without neurologic deficit. Higher scores indicate greater severity of deficit.|units on a scale (NIHSS range 0 - 42)|Median|11|11.0|Full Range|||0.0|40.0|
4020235|NCT01176565|3841109|B1|||Median NIHSS score (range)|The National Institutes of Health Stroke Scale (NIHSS) is a serial measure of neurologic deficit (problems in function). It uses a scale (range 0 - 42) to quantify neurologic deficits in 11 categories. The categories are measured by asking questions that indicate the patient's level of consciousness, then testing horizontal eye movements, visual fields, facial palsy, movement in each limb, sensation, language and speech, and extinction or inattention on one side of the body. A score of 0 indicates normal function without neurologic deficit. Higher scores indicate greater severity of deficit.|units on a scale (NIHSS range 0 - 42)|Median|11|11.0|Full Range|||0.0|40.0|
4020236|NCT01176565|3841107|B3|||Systolic Blood Pressure at presentation in hospital emergency department (ED)|"Blood pressure is reported as the systolic (systolic blood pressure or SBP) reading over the diastolic (or DBP) reading, and is measured in millimeters of mercury (mmHg) on a gauge. SBP is a measure of the force pressing against the blood vessels when the heart contracts to push blood out to the body, and was considered most important for this study. DBP measures lingering pressure within the blood vessels as the heart fills with newly-oxygenated blood from the lungs. Hospitals selected the method that they felt was the most accurate way to report systolic blood pressures for each patient."|mmHg|Mean|200.6|200.6|Standard Deviation|27.0|27.0|||
4020237|NCT01176565|3841108|B2|||Systolic Blood Pressure at presentation in hospital emergency department (ED)|"Blood pressure is reported as the systolic (systolic blood pressure or SBP) reading over the diastolic (or DBP) reading, and is measured in millimeters of mercury (mmHg) on a gauge. SBP is a measure of the force pressing against the blood vessels when the heart contracts to push blood out to the body, and was considered most important for this study. DBP measures lingering pressure within the blood vessels as the heart fills with newly-oxygenated blood from the lungs. Hospitals selected the method that they felt was the most accurate way to report systolic blood pressures for each patient."|mmHg|Mean|200|200.0|Standard Deviation|27.1|27.1|||
4020238|NCT01176565|3841109|B1|||Systolic Blood Pressure at presentation in hospital emergency department (ED)|"Blood pressure is reported as the systolic (systolic blood pressure or SBP) reading over the diastolic (or DBP) reading, and is measured in millimeters of mercury (mmHg) on a gauge. SBP is a measure of the force pressing against the blood vessels when the heart contracts to push blood out to the body, and was considered most important for this study. DBP measures lingering pressure within the blood vessels as the heart fills with newly-oxygenated blood from the lungs. Hospitals selected the method that they felt was the most accurate way to report systolic blood pressures for each patient."|mmHg|Mean|201.1|201.1|Standard Deviation|26.9|26.9|||
4020239|NCT01176565|3841107|B3||ED arrival GCS score = 15|First Glasgow Coma Scale Score assessed upon hospital emergency department (ED) arrival|The Glasgow Coma Scale (GCS) score is a measure of level of consciousness. The scale quantifies response in three components: eye, motor, and verbal. A lower score indicates a reduced response and a higher score indicates a full response. At least one point is given in each category so the scale ranges from 3 to 15. A score of 3 indicates deep unconsciousness; a higher score indicates milder impairment of consciousness. The maximum score of 15 indicates consciousness is not impaired but other neurological symptoms may still be present. Estimated verbal scoring was used for intubated patients.|Participants|Count of Participants|559|559.0||||||
4020327|NCT01176435|3841141|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4020328|NCT01176435|3841142|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4020240|NCT01176565|3841108|B2||ED arrival GCS score = 15|First Glasgow Coma Scale Score assessed upon hospital emergency department (ED) arrival|The Glasgow Coma Scale (GCS) score is a measure of level of consciousness. The scale quantifies response in three components: eye, motor, and verbal. A lower score indicates a reduced response and a higher score indicates a full response. At least one point is given in each category so the scale ranges from 3 to 15. A score of 3 indicates deep unconsciousness; a higher score indicates milder impairment of consciousness. The maximum score of 15 indicates consciousness is not impaired but other neurological symptoms may still be present. Estimated verbal scoring was used for intubated patients.|Participants|Count of Participants|275|275.0||||||
4020241|NCT01176565|3841109|B1||ED arrival GCS score = 15|First Glasgow Coma Scale Score assessed upon hospital emergency department (ED) arrival|The Glasgow Coma Scale (GCS) score is a measure of level of consciousness. The scale quantifies response in three components: eye, motor, and verbal. A lower score indicates a reduced response and a higher score indicates a full response. At least one point is given in each category so the scale ranges from 3 to 15. A score of 3 indicates deep unconsciousness; a higher score indicates milder impairment of consciousness. The maximum score of 15 indicates consciousness is not impaired but other neurological symptoms may still be present. Estimated verbal scoring was used for intubated patients.|Participants|Count of Participants|284|284.0||||||
4020242|NCT01176565|3841107|B3||ED arrival GCS score = 12 - 14|First Glasgow Coma Scale Score assessed upon hospital emergency department (ED) arrival|The Glasgow Coma Scale (GCS) score is a measure of level of consciousness. The scale quantifies response in three components: eye, motor, and verbal. A lower score indicates a reduced response and a higher score indicates a full response. At least one point is given in each category so the scale ranges from 3 to 15. A score of 3 indicates deep unconsciousness; a higher score indicates milder impairment of consciousness. The maximum score of 15 indicates consciousness is not impaired but other neurological symptoms may still be present. Estimated verbal scoring was used for intubated patients.|Participants|Count of Participants|294|294.0||||||
4020243|NCT01176565|3841108|B2||ED arrival GCS score = 12 - 14|First Glasgow Coma Scale Score assessed upon hospital emergency department (ED) arrival|The Glasgow Coma Scale (GCS) score is a measure of level of consciousness. The scale quantifies response in three components: eye, motor, and verbal. A lower score indicates a reduced response and a higher score indicates a full response. At least one point is given in each category so the scale ranges from 3 to 15. A score of 3 indicates deep unconsciousness; a higher score indicates milder impairment of consciousness. The maximum score of 15 indicates consciousness is not impaired but other neurological symptoms may still be present. Estimated verbal scoring was used for intubated patients.|Participants|Count of Participants|152|152.0||||||
4020244|NCT01176565|3841109|B1||ED arrival GCS score = 12 - 14|First Glasgow Coma Scale Score assessed upon hospital emergency department (ED) arrival|The Glasgow Coma Scale (GCS) score is a measure of level of consciousness. The scale quantifies response in three components: eye, motor, and verbal. A lower score indicates a reduced response and a higher score indicates a full response. At least one point is given in each category so the scale ranges from 3 to 15. A score of 3 indicates deep unconsciousness; a higher score indicates milder impairment of consciousness. The maximum score of 15 indicates consciousness is not impaired but other neurological symptoms may still be present. Estimated verbal scoring was used for intubated patients.|Participants|Count of Participants|142|142.0||||||
4020245|NCT01176565|3841107|B3||ED arrival GCS score = 3 - 11|First Glasgow Coma Scale Score assessed upon hospital emergency department (ED) arrival|The Glasgow Coma Scale (GCS) score is a measure of level of consciousness. The scale quantifies response in three components: eye, motor, and verbal. A lower score indicates a reduced response and a higher score indicates a full response. At least one point is given in each category so the scale ranges from 3 to 15. A score of 3 indicates deep unconsciousness; a higher score indicates milder impairment of consciousness. The maximum score of 15 indicates consciousness is not impaired but other neurological symptoms may still be present. Estimated verbal scoring was used for intubated patients.|Participants|Count of Participants|147|147.0||||||
4020246|NCT01176565|3841108|B2||ED arrival GCS score = 3 - 11|First Glasgow Coma Scale Score assessed upon hospital emergency department (ED) arrival|The Glasgow Coma Scale (GCS) score is a measure of level of consciousness. The scale quantifies response in three components: eye, motor, and verbal. A lower score indicates a reduced response and a higher score indicates a full response. At least one point is given in each category so the scale ranges from 3 to 15. A score of 3 indicates deep unconsciousness; a higher score indicates milder impairment of consciousness. The maximum score of 15 indicates consciousness is not impaired but other neurological symptoms may still be present. Estimated verbal scoring was used for intubated patients.|Participants|Count of Participants|73|73.0||||||
4020247|NCT01176565|3841109|B1||ED arrival GCS score = 3 - 11|First Glasgow Coma Scale Score assessed upon hospital emergency department (ED) arrival|The Glasgow Coma Scale (GCS) score is a measure of level of consciousness. The scale quantifies response in three components: eye, motor, and verbal. A lower score indicates a reduced response and a higher score indicates a full response. At least one point is given in each category so the scale ranges from 3 to 15. A score of 3 indicates deep unconsciousness; a higher score indicates milder impairment of consciousness. The maximum score of 15 indicates consciousness is not impaired but other neurological symptoms may still be present. Estimated verbal scoring was used for intubated patients.|Participants|Count of Participants|74|74.0||||||
4020248|NCT01176565|3841107|B3|||Recruited at site in Asia|Defined as patients who were enrolled at a clinical site geographically located within regions including Japan, China, Taiwan, or South Korea. Data from these patients were analyzed separately in addition to being part of the full group and other race/ethnicity analyses to examine for potential population differences surrounding intracerebral hemorrhage (ICH) events and recovery that are regional in nature.|Participants|Count of Participants|537|537.0||||||
4020249|NCT01176565|3841108|B2|||Recruited at site in Asia|Defined as patients who were enrolled at a clinical site geographically located within regions including Japan, China, Taiwan, or South Korea. Data from these patients were analyzed separately in addition to being part of the full group and other race/ethnicity analyses to examine for potential population differences surrounding intracerebral hemorrhage (ICH) events and recovery that are regional in nature.|Participants|Count of Participants|264|264.0||||||
4020329|NCT01176435|3841143|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4020330|NCT01176435|3841144|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4020331|NCT01176435|3841141|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4020250|NCT01176565|3841109|B1|||Recruited at site in Asia|Defined as patients who were enrolled at a clinical site geographically located within regions including Japan, China, Taiwan, or South Korea. Data from these patients were analyzed separately in addition to being part of the full group and other race/ethnicity analyses to examine for potential population differences surrounding intracerebral hemorrhage (ICH) events and recovery that are regional in nature.|Participants|Count of Participants|273|273.0||||||
4020251|NCT01176565|3841107|B3|Race|Other or unknown|Race/Ethnicity, Customized|"Race and ethnicity were recorded according to how a person identified themselves, not according to genetic testing or observation. The number of persons who reported American Indian, Alaska Native, Native Hawaiian of other Pacific Islander, or of having origins within more than one race has been included in the other or unknown category because the number of persons enrolled in the study from each of these categories was too small to provide a meaningful analysis that would examine these groups individually. Asian race included patients enrolled in Asian countries and non-Asian countries."|Participants|Count of Participants|20|20.0||||||
4020252|NCT01176565|3841108|B2|Race|Other or unknown|Race/Ethnicity, Customized|"Race and ethnicity were recorded according to how a person identified themselves, not according to genetic testing or observation. The number of persons who reported American Indian, Alaska Native, Native Hawaiian of other Pacific Islander, or of having origins within more than one race has been included in the other or unknown category because the number of persons enrolled in the study from each of these categories was too small to provide a meaningful analysis that would examine these groups individually. Asian race included patients enrolled in Asian countries and non-Asian countries."|Participants|Count of Participants|8|8.0||||||
4020253|NCT01176565|3841109|B1|Race|Other or unknown|Race/Ethnicity, Customized|"Race and ethnicity were recorded according to how a person identified themselves, not according to genetic testing or observation. The number of persons who reported American Indian, Alaska Native, Native Hawaiian of other Pacific Islander, or of having origins within more than one race has been included in the other or unknown category because the number of persons enrolled in the study from each of these categories was too small to provide a meaningful analysis that would examine these groups individually. Asian race included patients enrolled in Asian countries and non-Asian countries."|Participants|Count of Participants|12|12.0||||||
4020254|NCT01176565|3841107|B3|Race|White|Race/Ethnicity, Customized|"Race and ethnicity were recorded according to how a person identified themselves, not according to genetic testing or observation. The number of persons who reported American Indian, Alaska Native, Native Hawaiian of other Pacific Islander, or of having origins within more than one race has been included in the other or unknown category because the number of persons enrolled in the study from each of these categories was too small to provide a meaningful analysis that would examine these groups individually. Asian race included patients enrolled in Asian countries and non-Asian countries."|Participants|Count of Participants|287|287.0||||||
4020255|NCT01176565|3841108|B2|Race|White|Race/Ethnicity, Customized|"Race and ethnicity were recorded according to how a person identified themselves, not according to genetic testing or observation. The number of persons who reported American Indian, Alaska Native, Native Hawaiian of other Pacific Islander, or of having origins within more than one race has been included in the other or unknown category because the number of persons enrolled in the study from each of these categories was too small to provide a meaningful analysis that would examine these groups individually. Asian race included patients enrolled in Asian countries and non-Asian countries."|Participants|Count of Participants|142|142.0||||||
4020256|NCT01176565|3841109|B1|Race|White|Race/Ethnicity, Customized|"Race and ethnicity were recorded according to how a person identified themselves, not according to genetic testing or observation. The number of persons who reported American Indian, Alaska Native, Native Hawaiian of other Pacific Islander, or of having origins within more than one race has been included in the other or unknown category because the number of persons enrolled in the study from each of these categories was too small to provide a meaningful analysis that would examine these groups individually. Asian race included patients enrolled in Asian countries and non-Asian countries."|Participants|Count of Participants|145|145.0||||||
4020257|NCT01176565|3841107|B3|Race|Black|Race/Ethnicity, Customized|"Race and ethnicity were recorded according to how a person identified themselves, not according to genetic testing or observation. The number of persons who reported American Indian, Alaska Native, Native Hawaiian of other Pacific Islander, or of having origins within more than one race has been included in the other or unknown category because the number of persons enrolled in the study from each of these categories was too small to provide a meaningful analysis that would examine these groups individually. Asian race included patients enrolled in Asian countries and non-Asian countries."|Participants|Count of Participants|131|131.0||||||
4020258|NCT01176565|3841108|B2|Race|Black|Race/Ethnicity, Customized|"Race and ethnicity were recorded according to how a person identified themselves, not according to genetic testing or observation. The number of persons who reported American Indian, Alaska Native, Native Hawaiian of other Pacific Islander, or of having origins within more than one race has been included in the other or unknown category because the number of persons enrolled in the study from each of these categories was too small to provide a meaningful analysis that would examine these groups individually. Asian race included patients enrolled in Asian countries and non-Asian countries."|Participants|Count of Participants|73|73.0||||||
4020259|NCT01176565|3841109|B1|Race|Black|Race/Ethnicity, Customized|"Race and ethnicity were recorded according to how a person identified themselves, not according to genetic testing or observation. The number of persons who reported American Indian, Alaska Native, Native Hawaiian of other Pacific Islander, or of having origins within more than one race has been included in the other or unknown category because the number of persons enrolled in the study from each of these categories was too small to provide a meaningful analysis that would examine these groups individually. Asian race included patients enrolled in Asian countries and non-Asian countries."|Participants|Count of Participants|58|58.0||||||
4020260|NCT01176565|3841107|B3|Race|Asian|Race/Ethnicity, Customized|"Race and ethnicity were recorded according to how a person identified themselves, not according to genetic testing or observation. The number of persons who reported American Indian, Alaska Native, Native Hawaiian of other Pacific Islander, or of having origins within more than one race has been included in the other or unknown category because the number of persons enrolled in the study from each of these categories was too small to provide a meaningful analysis that would examine these groups individually. Asian race included patients enrolled in Asian countries and non-Asian countries."|Participants|Count of Participants|562|562.0||||||
4020261|NCT01176565|3841108|B2|Race|Asian|Race/Ethnicity, Customized|"Race and ethnicity were recorded according to how a person identified themselves, not according to genetic testing or observation. The number of persons who reported American Indian, Alaska Native, Native Hawaiian of other Pacific Islander, or of having origins within more than one race has been included in the other or unknown category because the number of persons enrolled in the study from each of these categories was too small to provide a meaningful analysis that would examine these groups individually. Asian race included patients enrolled in Asian countries and non-Asian countries."|Participants|Count of Participants|277|277.0||||||
4020262|NCT01176565|3841109|B1|Race|Asian|Race/Ethnicity, Customized|"Race and ethnicity were recorded according to how a person identified themselves, not according to genetic testing or observation. The number of persons who reported American Indian, Alaska Native, Native Hawaiian of other Pacific Islander, or of having origins within more than one race has been included in the other or unknown category because the number of persons enrolled in the study from each of these categories was too small to provide a meaningful analysis that would examine these groups individually. Asian race included patients enrolled in Asian countries and non-Asian countries."|Participants|Count of Participants|285|285.0||||||
4020263|NCT01176565|3841107|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)|"Ethnicity describes persons who have (versus have not) self-identified as being of Cuban, Mexican, Puerto Rican, Cuban, South or Central American, or other Spanish culture or origin, regardless of race.~Data are analyzed according to the ethnicity and race of patients included to determine whether there are population differences in health measures or treatment responses that differ. Whether recruitment included an adequate diversity within the affected population is important to understanding the generalizability of results that were obtained and whether further research may be indicated."|Participants|Count of Participants|29|29.0||||||
4020264|NCT01176565|3841108|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)|"Ethnicity describes persons who have (versus have not) self-identified as being of Cuban, Mexican, Puerto Rican, Cuban, South or Central American, or other Spanish culture or origin, regardless of race.~Data are analyzed according to the ethnicity and race of patients included to determine whether there are population differences in health measures or treatment responses that differ. Whether recruitment included an adequate diversity within the affected population is important to understanding the generalizability of results that were obtained and whether further research may be indicated."|Participants|Count of Participants|16|16.0||||||
4020265|NCT01176565|3841109|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|"Ethnicity describes persons who have (versus have not) self-identified as being of Cuban, Mexican, Puerto Rican, Cuban, South or Central American, or other Spanish culture or origin, regardless of race.~Data are analyzed according to the ethnicity and race of patients included to determine whether there are population differences in health measures or treatment responses that differ. Whether recruitment included an adequate diversity within the affected population is important to understanding the generalizability of results that were obtained and whether further research may be indicated."|Participants|Count of Participants|13|13.0||||||
4020266|NCT01176565|3841107|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)|"Ethnicity describes persons who have (versus have not) self-identified as being of Cuban, Mexican, Puerto Rican, Cuban, South or Central American, or other Spanish culture or origin, regardless of race.~Data are analyzed according to the ethnicity and race of patients included to determine whether there are population differences in health measures or treatment responses that differ. Whether recruitment included an adequate diversity within the affected population is important to understanding the generalizability of results that were obtained and whether further research may be indicated."|Participants|Count of Participants|892|892.0||||||
4020267|NCT01176565|3841108|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)|"Ethnicity describes persons who have (versus have not) self-identified as being of Cuban, Mexican, Puerto Rican, Cuban, South or Central American, or other Spanish culture or origin, regardless of race.~Data are analyzed according to the ethnicity and race of patients included to determine whether there are population differences in health measures or treatment responses that differ. Whether recruitment included an adequate diversity within the affected population is important to understanding the generalizability of results that were obtained and whether further research may be indicated."|Participants|Count of Participants|446|446.0||||||
4020268|NCT01176565|3841109|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|"Ethnicity describes persons who have (versus have not) self-identified as being of Cuban, Mexican, Puerto Rican, Cuban, South or Central American, or other Spanish culture or origin, regardless of race.~Data are analyzed according to the ethnicity and race of patients included to determine whether there are population differences in health measures or treatment responses that differ. Whether recruitment included an adequate diversity within the affected population is important to understanding the generalizability of results that were obtained and whether further research may be indicated."|Participants|Count of Participants|446|446.0||||||
4020269|NCT01176565|3841107|B3||Hispanic or Latino|Ethnicity (NIH/OMB)|"Ethnicity describes persons who have (versus have not) self-identified as being of Cuban, Mexican, Puerto Rican, Cuban, South or Central American, or other Spanish culture or origin, regardless of race.~Data are analyzed according to the ethnicity and race of patients included to determine whether there are population differences in health measures or treatment responses that differ. Whether recruitment included an adequate diversity within the affected population is important to understanding the generalizability of results that were obtained and whether further research may be indicated."|Participants|Count of Participants|79|79.0||||||
4020270|NCT01176565|3841108|B2||Hispanic or Latino|Ethnicity (NIH/OMB)|"Ethnicity describes persons who have (versus have not) self-identified as being of Cuban, Mexican, Puerto Rican, Cuban, South or Central American, or other Spanish culture or origin, regardless of race.~Data are analyzed according to the ethnicity and race of patients included to determine whether there are population differences in health measures or treatment responses that differ. Whether recruitment included an adequate diversity within the affected population is important to understanding the generalizability of results that were obtained and whether further research may be indicated."|Participants|Count of Participants|38|38.0||||||
4020332|NCT01176435|3841142|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4020333|NCT01176435|3841143|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4020334|NCT01176435|3841144|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4020335|NCT01176435|3841141|B4|||Age||years|Mean|14.5|14.5|Full Range|||3.5|57.0|
4020336|NCT01176435|3841142|B3|||Age||years|Mean|10.6|10.6|Full Range|||4.0|18.1|
4020271|NCT01176565|3841109|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|"Ethnicity describes persons who have (versus have not) self-identified as being of Cuban, Mexican, Puerto Rican, Cuban, South or Central American, or other Spanish culture or origin, regardless of race.~Data are analyzed according to the ethnicity and race of patients included to determine whether there are population differences in health measures or treatment responses that differ. Whether recruitment included an adequate diversity within the affected population is important to understanding the generalizability of results that were obtained and whether further research may be indicated."|Participants|Count of Participants|41|41.0||||||
4020272|NCT01176565|3841107|B3||Male|Sex: Female, Male||Participants|Count of Participants|620|620.0||||||
4020273|NCT01176565|3841108|B2||Male|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
4020274|NCT01176565|3841109|B1||Male|Sex: Female, Male||Participants|Count of Participants|316|316.0||||||
4020275|NCT01176565|3841107|B3||Female|Sex: Female, Male||Participants|Count of Participants|380|380.0||||||
4020276|NCT01176565|3841108|B2||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4020277|NCT01176565|3841109|B1||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4020278|NCT01176565|3841107|B3|||Age||years|Mean|61.93|61.93|Standard Deviation|13.1|13.1|||
4020279|NCT01176565|3841108|B2|||Age||years|Mean|62|62.0|Standard Deviation|13.1|13.1|||
4020280|NCT01176565|3841109|B1|||Age||years|Mean|61.9|61.9|Standard Deviation|13.1|13.1|||
4020281|NCT01176513|3841128|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4020282|NCT01176513|3841128|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4020283|NCT01176513|3841128|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4020284|NCT01176513|3841128|B1|||Age||years|Mean|61.0|61.0|Standard Deviation|6.98|6.98|||
4020285|NCT01176513|3841128|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4020286|NCT01176513|3841128|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4020287|NCT01176513|3841128|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4020288|NCT01176448|3841133|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4020289|NCT01176448|3841133|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4020290|NCT01176448|3841133|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4020291|NCT01176448|3841133|B1|||Age||years|Mean|54.6|54.6|Standard Deviation|6.5|6.5|||
4020292|NCT01176448|3841133|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4020293|NCT01176448|3841133|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4020294|NCT01176448|3841133|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4020295|NCT01176435|3841141|B4|United States||Region of Enrollment||participants|Number|45|45.0||||||
4020296|NCT01176435|3841142|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4020297|NCT01176435|3841143|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4020298|NCT01176435|3841144|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4020299|NCT01176435|3841141|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020300|NCT01176435|3841142|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020301|NCT01176435|3841143|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020302|NCT01176435|3841144|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020303|NCT01176435|3841141|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020304|NCT01176435|3841142|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020305|NCT01176435|3841143|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020306|NCT01176435|3841144|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020307|NCT01176435|3841141|B4||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4020308|NCT01176435|3841142|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4020309|NCT01176435|3841143|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4020310|NCT01176435|3841144|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4020311|NCT01176435|3841141|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4020312|NCT01176435|3841142|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4020313|NCT01176435|3841143|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4020314|NCT01176435|3841144|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4020315|NCT01176435|3841141|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020316|NCT01176435|3841142|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020317|NCT01176435|3841143|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020318|NCT01176435|3841144|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020319|NCT01176435|3841141|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4020320|NCT01176435|3841142|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4020321|NCT01176435|3841143|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020322|NCT01176435|3841144|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4020323|NCT01176435|3841141|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020324|NCT01176435|3841142|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020337|NCT01176435|3841143|B2|||Age||years|Mean|19.7|19.7|Full Range|||4.0|49.3|
4020338|NCT01176435|3841144|B1|||Age||years|Mean|12.5|12.5|Full Range|||3.5|57.0|
4020339|NCT01176292|3841154|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4020340|NCT01176292|3841155|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4020341|NCT01176292|3841156|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4020342|NCT01176292|3841154|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4020343|NCT01176292|3841155|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4020344|NCT01176292|3841156|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4020345|NCT01176292|3841154|B3|||Age||years|Mean|64|64.0|Standard Deviation|7|7.0|||
4020346|NCT01176292|3841155|B2|||Age||years|Mean|62|62.0|Standard Deviation|7|7.0|||
4020347|NCT01176292|3841156|B1|||Age||years|Mean|65|65.0|Standard Deviation|7|7.0|||
4020348|NCT01176266|3841175|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4020349|NCT01176266|3841175|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4020350|NCT01176266|3841175|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|54|54.0||||||
4020351|NCT01176266|3841175|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4020352|NCT01176266|3841175|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4020353|NCT01176266|3841175|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4020354|NCT01176266|3841175|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4020355|NCT01176266|3841175|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4020356|NCT01176266|3841175|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4020357|NCT01176266|3841175|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4020358|NCT01176266|3841175|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4020359|NCT01176266|3841175|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4020360|NCT01176266|3841175|B1|||Age||weeks|Mean|113.42|113.42|Standard Deviation|108.912|108.912|||
4020361|NCT01176240|3841195|B5|United States||Region of Enrollment||participants|Number|222|222.0||||||
4020362|NCT01176240|3841196|B4|United States||Region of Enrollment||participants|Number|84|84.0||||||
4020363|NCT01176240|3841197|B3|United States||Region of Enrollment||participants|Number|87|87.0||||||
4020364|NCT01176240|3841198|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4020365|NCT01176240|3841199|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4020366|NCT01176240|3841195|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020367|NCT01176240|3841196|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020368|NCT01176240|3841197|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020369|NCT01176240|3841198|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020370|NCT01176240|3841199|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020371|NCT01176240|3841195|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020372|NCT01176240|3841196|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020373|NCT01176240|3841197|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020374|NCT01176240|3841198|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020375|NCT01176240|3841199|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020376|NCT01176240|3841195|B5||White|Race (NIH/OMB)||Participants|Count of Participants|216|216.0||||||
4020377|NCT01176240|3841196|B4||White|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
4020378|NCT01176240|3841197|B3||White|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
4020379|NCT01176240|3841198|B2||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4020380|NCT01176240|3841199|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4020381|NCT01176240|3841195|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4020382|NCT01176240|3841196|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4020383|NCT01176240|3841197|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4020384|NCT01176240|3841198|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4020385|NCT01176240|3841199|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020386|NCT01176240|3841195|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020387|NCT01176240|3841196|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020388|NCT01176240|3841197|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020389|NCT01176240|3841198|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020390|NCT01176240|3841199|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020391|NCT01176240|3841195|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4020392|NCT01176240|3841196|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020393|NCT01176240|3841197|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4020394|NCT01176240|3841198|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020395|NCT01176240|3841199|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020396|NCT01176240|3841195|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020397|NCT01176240|3841196|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020398|NCT01176240|3841197|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020399|NCT01176240|3841198|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020400|NCT01176240|3841199|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020401|NCT01176240|3841195|B5||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4020402|NCT01176240|3841196|B4||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4020403|NCT01176240|3841197|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4020404|NCT01176240|3841198|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4020405|NCT01176240|3841199|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4020406|NCT01176240|3841195|B5||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4020407|NCT01176240|3841196|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4020408|NCT01176240|3841197|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4020409|NCT01176240|3841198|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4020410|NCT01176240|3841199|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4020411|NCT01176240|3841195|B5|||Age||years|Mean|72.4|72.4|Standard Deviation|7.78|7.78|||
4020412|NCT01176240|3841196|B4|||Age||years|Mean|72.2|72.2|Standard Deviation|7.97|7.97|||
4020413|NCT01176240|3841197|B3|||Age||years|Mean|72.5|72.5|Standard Deviation|7.64|7.64|||
4020414|NCT01176240|3841198|B2|||Age||years|Mean|72.9|72.9|Standard Deviation|7.76|7.76|||
4020415|NCT01176240|3841199|B1|||Age||years|Mean|72.2|72.2|Standard Deviation|7.30|7.3|||
4020416|NCT01176058|3841224|B3|Other||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|3|3.0||||||
4020417|NCT01176058|3841225|B2|Other||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|1|1.0||||||
4020418|NCT01176058|3841226|B1|Other||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|2|2.0||||||
4020419|NCT01176058|3841224|B3|Purulence||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|3|3.0||||||
4020420|NCT01176058|3841225|B2|Purulence||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|2|2.0||||||
4020421|NCT01176058|3841226|B1|Purulence||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|1|1.0||||||
4020422|NCT01176058|3841224|B3|Localized erythema||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|1|1.0||||||
4020423|NCT01176058|3841225|B2|Localized erythema||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|0|0.0||||||
4020424|NCT01176058|3841226|B1|Localized erythema||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|1|1.0||||||
4020425|NCT01176058|3841224|B3|Feeling hot||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|8|8.0||||||
4020426|NCT01176058|3841225|B2|Feeling hot||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|4|4.0||||||
4020427|NCT01176058|3841226|B1|Feeling hot||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|4|4.0||||||
4020428|NCT01176058|3841224|B3|Swelling||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|3|3.0||||||
4020429|NCT01176058|3841225|B2|Swelling||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|2|2.0||||||
4020430|NCT01176058|3841226|B1|Swelling||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|1|1.0||||||
4020431|NCT01176058|3841224|B3|Mechanical ventilation||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|2|2.0||||||
4020432|NCT01176058|3841225|B2|Mechanical ventilation||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|1|1.0||||||
4020433|NCT01176058|3841226|B1|Mechanical ventilation||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|1|1.0||||||
4020434|NCT01176058|3841224|B3|Partial pressure of carbon dioxide (PCO2) decrease||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|1|1.0||||||
4020435|NCT01176058|3841225|B2|Partial pressure of carbon dioxide (PCO2) decrease||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|1|1.0||||||
4020475|NCT01176032|3841251|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4020436|NCT01176058|3841226|B1|Partial pressure of carbon dioxide (PCO2) decrease||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|0|0.0||||||
4020437|NCT01176058|3841224|B3|Respiratory rate increased||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|3|3.0||||||
4020438|NCT01176058|3841225|B2|Respiratory rate increased||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|1|1.0||||||
4020439|NCT01176058|3841226|B1|Respiratory rate increased||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|2|2.0||||||
4020440|NCT01176058|3841224|B3|White blood cell morphology abnormal||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|1|1.0||||||
4020441|NCT01176058|3841225|B2|White blood cell morphology abnormal||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|1|1.0||||||
4020442|NCT01176058|3841226|B1|White blood cell morphology abnormal||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|0|0.0||||||
4020443|NCT01176058|3841224|B3|White blood cell count increased||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|4|4.0||||||
4020444|NCT01176058|3841225|B2|White blood cell count increased||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|1|1.0||||||
4020445|NCT01176058|3841226|B1|White blood cell count increased||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|3|3.0||||||
4020446|NCT01176058|3841224|B3|White blood cell count decreased||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|2|2.0||||||
4020447|NCT01176058|3841225|B2|White blood cell count decreased||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|0|0.0||||||
4020448|NCT01176058|3841226|B1|White blood cell count decreased||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|2|2.0||||||
4020449|NCT01176058|3841224|B3|Tachycardia||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|5|5.0||||||
4020450|NCT01176058|3841225|B2|Tachycardia||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|2|2.0||||||
4020451|NCT01176058|3841226|B1|Tachycardia||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|3|3.0||||||
4020452|NCT01176058|3841224|B3|Hypothermia||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|0|0.0||||||
4020453|NCT01176058|3841225|B2|Hypothermia||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|0|0.0||||||
4020454|NCT01176058|3841226|B1|Hypothermia||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|0|0.0||||||
4020455|NCT01176058|3841224|B3|Fever||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|14|14.0||||||
4020456|NCT01176058|3841225|B2|Fever||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|7|7.0||||||
4020457|NCT01176058|3841226|B1|Fever||Presence of Signs and Symptoms of Candidemia|Each participant could have been counted in more than 1 category for the signs and symptoms of Candidemia.|participants|Number|7|7.0||||||
4020458|NCT01176058|3841224|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4020459|NCT01176058|3841225|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4020460|NCT01176058|3841226|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4020461|NCT01176058|3841224|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4020462|NCT01176058|3841225|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4020463|NCT01176058|3841226|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4020464|NCT01176058|3841224|B3|More than 65 years||Age, Customized||participants|Number|6|6.0||||||
4020465|NCT01176058|3841225|B2|More than 65 years||Age, Customized||participants|Number|2|2.0||||||
4020466|NCT01176058|3841226|B1|More than 65 years||Age, Customized||participants|Number|4|4.0||||||
4020467|NCT01176058|3841224|B3|Between 45 and 64 years||Age, Customized||participants|Number|6|6.0||||||
4020468|NCT01176058|3841225|B2|Between 45 and 64 years||Age, Customized||participants|Number|2|2.0||||||
4020469|NCT01176058|3841226|B1|Between 45 and 64 years||Age, Customized||participants|Number|4|4.0||||||
4020470|NCT01176058|3841224|B3|Between 18 and 44 years||Age, Customized||participants|Number|5|5.0||||||
4020471|NCT01176058|3841225|B2|Between 18 and 44 years||Age, Customized||participants|Number|4|4.0||||||
4020472|NCT01176058|3841226|B1|Between 18 and 44 years||Age, Customized||participants|Number|1|1.0||||||
4020473|NCT01176032|3841249|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4020474|NCT01176032|3841250|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4020476|NCT01176032|3841249|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4020477|NCT01176032|3841250|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4020478|NCT01176032|3841251|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4020479|NCT01176032|3841249|B3|||Age||Years|Mean|59.12|59.12|Standard Deviation|9.88|9.88|||
4020480|NCT01176032|3841250|B2|||Age||Years|Mean|58.05|58.05|Standard Deviation|10.34|10.34|||
4020481|NCT01176032|3841251|B1|||Age||Years|Mean|60.34|60.34|Standard Deviation|9.34|9.34|||
4020482|NCT01175902|3841310|B3|||Mean deviation of visual field||decibels|Mean|-3.46|-3.46|Standard Deviation|3.41|3.41|||
4020483|NCT01175902|3841311|B2|||Mean deviation of visual field||decibels|Mean|-2.92|-2.92|Standard Deviation|2.96|2.96|||
4020484|NCT01175902|3841312|B1|||Mean deviation of visual field||decibels|Mean|-4.00|-4.0|Standard Deviation|3.79|3.79|||
4020485|NCT01175902|3841310|B3|||Central corneal thickness||micrometers|Mean|543.48|543.48|Standard Deviation|14.53|14.53|||
4020486|NCT01175902|3841311|B2|||Central corneal thickness||micrometers|Mean|544.23|544.23|Standard Deviation|17.33|17.33|||
4020487|NCT01175902|3841312|B1|||Central corneal thickness||micrometers|Mean|542.73|542.73|Standard Deviation|11.43|11.43|||
4020488|NCT01175902|3841310|B3|||Spherical equivalent|Sperical equvalaent comes from refractive error of the patient and it is calcaulated as the algebraic sum of the value of the sphere and half the cylindrical value.|diopters|Mean|-0.89|-0.89|Standard Deviation|2.34|2.34|||
4020489|NCT01175902|3841311|B2|||Spherical equivalent|Sperical equvalaent comes from refractive error of the patient and it is calcaulated as the algebraic sum of the value of the sphere and half the cylindrical value.|diopters|Mean|-1.04|-1.04|Standard Deviation|2.71|2.71|||
4020490|NCT01175902|3841312|B1|||Spherical equivalent|Sperical equvalaent comes from refractive error of the patient and it is calcaulated as the algebraic sum of the value of the sphere and half the cylindrical value.|diopters|Mean|-0.74|-0.74|Standard Deviation|1.95|1.95|||
4020491|NCT01175902|3841310|B3|Korea, Republic of||Region of Enrollment||participants|Number|44|44.0||||||
4020492|NCT01175902|3841311|B2|Korea, Republic of||Region of Enrollment||participants|Number|22|22.0||||||
4020493|NCT01175902|3841312|B1|Korea, Republic of||Region of Enrollment||participants|Number|22|22.0||||||
4020494|NCT01175902|3841310|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4020495|NCT01175902|3841311|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4020496|NCT01175902|3841312|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4020497|NCT01175902|3841310|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4020498|NCT01175902|3841311|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4020499|NCT01175902|3841312|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4020500|NCT01175902|3841310|B3|||Age||years|Mean|60.20|60.2|Standard Deviation|7.20|7.2|||
4020501|NCT01175902|3841311|B2|||Age||years|Mean|59.68|59.68|Standard Deviation|7.12|7.12|||
4020502|NCT01175902|3841312|B1|||Age||years|Mean|60.72|60.72|Standard Deviation|7.42|7.42|||
4020503|NCT01175850|3841329|B3||Male|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4020504|NCT01175850|3841330|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4020505|NCT01175850|3841331|B1||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4020506|NCT01175850|3841329|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4020507|NCT01175850|3841330|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4020508|NCT01175850|3841331|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4020509|NCT01175850|3841329|B3|||Age||Years|Mean|67.5|67.5|Standard Deviation|9.4|9.4|||
4020510|NCT01175850|3841330|B2|||Age||Years|Mean|68.0|68.0|Standard Deviation|9.2|9.2|||
4020511|NCT01175850|3841331|B1|||Age||Years|Mean|67.5|67.5|Standard Deviation|9.5|9.5|||
4020512|NCT01175824|3841374|B3|Turkey||Region of Enrollment||participants|Number|15|15.0||||||
4020513|NCT01175824|3841375|B2|Turkey||Region of Enrollment||participants|Number|7|7.0||||||
4020514|NCT01175824|3841376|B1|Turkey||Region of Enrollment||participants|Number|8|8.0||||||
4020515|NCT01175824|3841374|B3|Spain||Region of Enrollment||participants|Number|46|46.0||||||
4020516|NCT01175824|3841375|B2|Spain||Region of Enrollment||participants|Number|23|23.0||||||
4020517|NCT01175824|3841376|B1|Spain||Region of Enrollment||participants|Number|23|23.0||||||
4020518|NCT01175824|3841374|B3|Russian Federation||Region of Enrollment||participants|Number|5|5.0||||||
4020519|NCT01175824|3841375|B2|Russian Federation||Region of Enrollment||participants|Number|3|3.0||||||
4020520|NCT01175824|3841376|B1|Russian Federation||Region of Enrollment||participants|Number|2|2.0||||||
4020521|NCT01175824|3841374|B3|Romania||Region of Enrollment||participants|Number|76|76.0||||||
4020522|NCT01175824|3841375|B2|Romania||Region of Enrollment||participants|Number|38|38.0||||||
4020523|NCT01175824|3841376|B1|Romania||Region of Enrollment||participants|Number|38|38.0||||||
4020524|NCT01175824|3841374|B3|Mexico||Region of Enrollment||participants|Number|40|40.0||||||
4020525|NCT01175824|3841375|B2|Mexico||Region of Enrollment||participants|Number|20|20.0||||||
4020526|NCT01175824|3841376|B1|Mexico||Region of Enrollment||participants|Number|20|20.0||||||
4020527|NCT01175824|3841374|B3|Korea, Republic of||Region of Enrollment||participants|Number|51|51.0||||||
4020528|NCT01175824|3841375|B2|Korea, Republic of||Region of Enrollment||participants|Number|26|26.0||||||
4020529|NCT01175824|3841376|B1|Korea, Republic of||Region of Enrollment||participants|Number|25|25.0||||||
4020530|NCT01175824|3841374|B3|India||Region of Enrollment||participants|Number|81|81.0||||||
4020531|NCT01175824|3841375|B2|India||Region of Enrollment||participants|Number|41|41.0||||||
4020532|NCT01175824|3841376|B1|India||Region of Enrollment||participants|Number|40|40.0||||||
4020533|NCT01175824|3841374|B3|Egypt||Region of Enrollment||participants|Number|12|12.0||||||
4020534|NCT01175824|3841375|B2|Egypt||Region of Enrollment||participants|Number|7|7.0||||||
4020535|NCT01175824|3841376|B1|Egypt||Region of Enrollment||participants|Number|5|5.0||||||
4020536|NCT01175824|3841374|B3|China||Region of Enrollment||participants|Number|28|28.0||||||
4020537|NCT01175824|3841375|B2|China||Region of Enrollment||participants|Number|13|13.0||||||
4020538|NCT01175824|3841376|B1|China||Region of Enrollment||participants|Number|15|15.0||||||
4020539|NCT01175824|3841374|B3|Brazil||Region of Enrollment||participants|Number|43|43.0||||||
4020540|NCT01175824|3841375|B2|Brazil||Region of Enrollment||participants|Number|23|23.0||||||
4020541|NCT01175824|3841376|B1|Brazil||Region of Enrollment||participants|Number|20|20.0||||||
4020542|NCT01175824|3841374|B3|Argentina||Region of Enrollment||participants|Number|79|79.0||||||
4020543|NCT01175824|3841375|B2|Argentina||Region of Enrollment||participants|Number|39|39.0||||||
4020544|NCT01175824|3841376|B1|Argentina||Region of Enrollment||participants|Number|40|40.0||||||
4020545|NCT01175824|3841374|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4020546|NCT01175824|3841375|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4020547|NCT01175824|3841376|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4020548|NCT01175824|3841374|B3|More than one race||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4020549|NCT01175824|3841375|B2|More than one race||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4020550|NCT01175824|3841376|B1|More than one race||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4020551|NCT01175824|3841374|B3|White||Race/Ethnicity, Customized||participants|Number|269|269.0||||||
4020552|NCT01175824|3841375|B2|White||Race/Ethnicity, Customized||participants|Number|136|136.0||||||
4020553|NCT01175824|3841376|B1|White||Race/Ethnicity, Customized||participants|Number|133|133.0||||||
4020554|NCT01175824|3841374|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4020555|NCT01175824|3841375|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4020556|NCT01175824|3841376|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4020557|NCT01175824|3841374|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4020558|NCT01175824|3841375|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4020559|NCT01175824|3841376|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4020560|NCT01175824|3841374|B3|Asian||Race/Ethnicity, Customized||participants|Number|160|160.0||||||
4020561|NCT01175824|3841375|B2|Asian||Race/Ethnicity, Customized||participants|Number|80|80.0||||||
4020562|NCT01175824|3841376|B1|Asian||Race/Ethnicity, Customized||participants|Number|80|80.0||||||
4020563|NCT01175824|3841374|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4020564|NCT01175824|3841375|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4020565|NCT01175824|3841376|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4020566|NCT01175824|3841374|B3||Male|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4020567|NCT01175824|3841375|B2||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4020568|NCT01175824|3841376|B1||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4020569|NCT01175824|3841374|B3||Female|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
4020570|NCT01175824|3841375|B2||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4020571|NCT01175824|3841376|B1||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4020572|NCT01175824|3841374|B3|||Age||years|Mean|57.5|57.5|Standard Deviation|9.52|9.52|||
4020573|NCT01175824|3841375|B2|||Age||years|Mean|57.7|57.7|Standard Deviation|9.12|9.12|||
4020574|NCT01175824|3841376|B1|||Age||years|Mean|57.4|57.4|Standard Deviation|9.93|9.93|||
4020575|NCT01175811|3841409|B3|Korea, Republic of||Region of Enrollment||participants|Number|49|49.0||||||
4020576|NCT01175811|3841410|B2|Korea, Republic of||Region of Enrollment||participants|Number|25|25.0||||||
4020577|NCT01175811|3841411|B1|Korea, Republic of||Region of Enrollment||participants|Number|24|24.0||||||
4020578|NCT01175811|3841409|B3|China||Region of Enrollment||participants|Number|315|315.0||||||
4020579|NCT01175811|3841410|B2|China||Region of Enrollment||participants|Number|158|158.0||||||
4020580|NCT01175811|3841411|B1|China||Region of Enrollment||participants|Number|157|157.0||||||
4020581|NCT01175811|3841409|B3|Taiwan||Region of Enrollment||participants|Number|38|38.0||||||
4020582|NCT01175811|3841410|B2|Taiwan||Region of Enrollment||participants|Number|20|20.0||||||
4020583|NCT01175811|3841411|B1|Taiwan||Region of Enrollment||participants|Number|18|18.0||||||
4020584|NCT01175811|3841409|B3|Non-Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4020585|NCT01175811|3841410|B2|Non-Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4020586|NCT01175811|3841411|B1|Non-Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4020587|NCT01175811|3841409|B3|Asian||Race/Ethnicity, Customized||participants|Number|402|402.0||||||
4020588|NCT01175811|3841410|B2|Asian||Race/Ethnicity, Customized||participants|Number|203|203.0||||||
4020589|NCT01175811|3841411|B1|Asian||Race/Ethnicity, Customized||participants|Number|199|199.0||||||
4020590|NCT01175811|3841409|B3||Male|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
4020591|NCT01175811|3841410|B2||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4020592|NCT01175811|3841411|B1||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4020593|NCT01175811|3841409|B3||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4020594|NCT01175811|3841410|B2||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4020595|NCT01175811|3841411|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4020596|NCT01175811|3841409|B3|||Age||years|Mean|58.6|58.6|Standard Deviation|9.17|9.17|||
4020597|NCT01175811|3841410|B2|||Age||years|Mean|58.1|58.1|Standard Deviation|9.05|9.05|||
4020598|NCT01175811|3841411|B1|||Age||years|Mean|59.0|59.0|Standard Deviation|9.29|9.29|||
4020599|NCT01175798|3841436|B3|||25(OH) vitamin D||ng/dL|Median|13.2|13.2|Inter-Quartile Range|||9.5|19.3|
4020600|NCT01175798|3841437|B2|||25(OH) vitamin D||ng/dL|Median|13.4|13.4|Inter-Quartile Range|||9.3|19.7|
4020601|NCT01175798|3841438|B1|||25(OH) vitamin D||ng/dL|Median|13.1|13.1|Inter-Quartile Range|||9.9|18.6|
4020602|NCT01175798|3841436|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4020603|NCT01175798|3841437|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4020604|NCT01175798|3841438|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4020605|NCT01175798|3841436|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4020606|NCT01175798|3841437|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4020607|NCT01175798|3841438|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4020608|NCT01175798|3841436|B3|||Age||years|Mean|59|59.0|Standard Deviation|15|15.0|||
4020609|NCT01175798|3841437|B2|||Age||years|Mean|60.2|60.2|Standard Deviation|14.3|14.3|||
4020610|NCT01175798|3841438|B1|||Age||years|Mean|58.9|58.9|Standard Deviation|14.9|14.9|||
4020611|NCT01175707|3841445|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4020612|NCT01175707|3841446|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4020613|NCT01175707|3841447|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4020614|NCT01175707|3841445|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4020615|NCT01175707|3841446|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4020616|NCT01175707|3841447|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4020617|NCT01175707|3841445|B3|||Age||years|Mean|57.665|57.665|Standard Deviation|16.8765|16.8765|||
4020618|NCT01175707|3841446|B2|||Age||years|Mean|56.78|56.78|Standard Deviation|19.366|19.366|||
4020619|NCT01175707|3841447|B1|||Age||years|Mean|58.55|58.55|Standard Deviation|14.387|14.387|||
4020620|NCT01175668|3841482|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4020621|NCT01175668|3841483|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4020622|NCT01175668|3841484|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4020623|NCT01175668|3841482|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4020624|NCT01175668|3841483|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4020625|NCT01175668|3841484|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4020626|NCT01175668|3841482|B3|||Age||days|Mean|2.05|2.05|Standard Deviation|1.32|1.32|||
4020627|NCT01175668|3841483|B2|||Age||days|Mean|2.26|2.26|Standard Deviation|1.60|1.6|||
4020628|NCT01175668|3841484|B1|||Age||days|Mean|1.8|1.8|Standard Deviation|0.9|0.9|||
4020629|NCT01175590|3841493|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4020630|NCT01175590|3841494|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4020631|NCT01175590|3841495|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4020632|NCT01175590|3841493|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020633|NCT01175590|3841494|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020634|NCT01175590|3841495|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020635|NCT01175590|3841493|B3||White|Race (NIH/OMB)||Participants|Count of Participants|316|316.0||||||
4020636|NCT01175590|3841494|B2||White|Race (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
4020637|NCT01175590|3841495|B1||White|Race (NIH/OMB)||Participants|Count of Participants|213|213.0||||||
4020638|NCT01175590|3841493|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
4020639|NCT01175590|3841494|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4020640|NCT01175590|3841495|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
4020641|NCT01175590|3841493|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4020642|NCT01175590|3841494|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4020643|NCT01175590|3841495|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020644|NCT01175590|3841493|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4020645|NCT01175590|3841494|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4020646|NCT01175590|3841495|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4020647|NCT01175590|3841493|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4020648|NCT01175590|3841494|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4020649|NCT01175590|3841495|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4020650|NCT01175590|3841493|B3||Male|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4020651|NCT01175590|3841494|B2||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4020652|NCT01175590|3841495|B1||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4020653|NCT01175590|3841493|B3||Female|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
4020654|NCT01175590|3841494|B2||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4020655|NCT01175590|3841495|B1||Female|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4020656|NCT01175590|3841493|B3|>=50 years||Age, Customized||participants|Number|130|130.0||||||
4020657|NCT01175590|3841494|B2|>=50 years||Age, Customized||participants|Number|38|38.0||||||
4020658|NCT01175590|3841495|B1|>=50 years||Age, Customized||participants|Number|92|92.0||||||
4020659|NCT01175590|3841493|B3|18 - 49 years||Age, Customized||participants|Number|177|177.0||||||
4020660|NCT01175590|3841494|B2|18 - 49 years||Age, Customized||participants|Number|71|71.0||||||
4020661|NCT01175590|3841495|B1|18 - 49 years||Age, Customized||participants|Number|106|106.0||||||
4020662|NCT01175590|3841493|B3|0-17 years||Age, Customized||participants|Number|211|211.0||||||
4020663|NCT01175590|3841494|B2|0-17 years||Age, Customized||participants|Number|62|62.0||||||
4020664|NCT01175590|3841495|B1|0-17 years||Age, Customized||participants|Number|149|149.0||||||
4020665|NCT01175473|3841528|B3|4.5 h||Obestatin Concentration|Obestatin concentration was determined at 0.5 (8:00 clock time; prior to standardized breakfast), 2.5 and 4.5 hours on Day -1 (time-matched baseline). PD population was evaluable for this baseline characteristic.|nanomole per liter (nmol/L)|Mean|0.25|0.25|Standard Deviation|0.15|0.15|||
4020666|NCT01175473|3841529|B2|4.5 h||Obestatin Concentration|Obestatin concentration was determined at 0.5 (8:00 clock time; prior to standardized breakfast), 2.5 and 4.5 hours on Day -1 (time-matched baseline). PD population was evaluable for this baseline characteristic.|nanomole per liter (nmol/L)|Mean|0.27|0.27|Standard Deviation|0.17|0.17|||
4020667|NCT01175473|3841530|B1|4.5 h||Obestatin Concentration|Obestatin concentration was determined at 0.5 (8:00 clock time; prior to standardized breakfast), 2.5 and 4.5 hours on Day -1 (time-matched baseline). PD population was evaluable for this baseline characteristic.|nanomole per liter (nmol/L)|Mean|0.24|0.24|Standard Deviation|0.12|0.12|||
4020668|NCT01175473|3841528|B3|2.5 h||Obestatin Concentration|Obestatin concentration was determined at 0.5 (8:00 clock time; prior to standardized breakfast), 2.5 and 4.5 hours on Day -1 (time-matched baseline). PD population was evaluable for this baseline characteristic.|nanomole per liter (nmol/L)|Mean|0.24|0.24|Standard Deviation|0.13|0.13|||
4020669|NCT01175473|3841529|B2|2.5 h||Obestatin Concentration|Obestatin concentration was determined at 0.5 (8:00 clock time; prior to standardized breakfast), 2.5 and 4.5 hours on Day -1 (time-matched baseline). PD population was evaluable for this baseline characteristic.|nanomole per liter (nmol/L)|Mean|0.26|0.26|Standard Deviation|0.15|0.15|||
4020670|NCT01175473|3841530|B1|2.5 h||Obestatin Concentration|Obestatin concentration was determined at 0.5 (8:00 clock time; prior to standardized breakfast), 2.5 and 4.5 hours on Day -1 (time-matched baseline). PD population was evaluable for this baseline characteristic.|nanomole per liter (nmol/L)|Mean|0.22|0.22|Standard Deviation|0.11|0.11|||
4020671|NCT01175473|3841528|B3|0.5 h||Obestatin Concentration|Obestatin concentration was determined at 0.5 (8:00 clock time; prior to standardized breakfast), 2.5 and 4.5 hours on Day -1 (time-matched baseline). PD population was evaluable for this baseline characteristic.|nanomole per liter (nmol/L)|Mean|0.26|0.26|Standard Deviation|0.15|0.15|||
4020672|NCT01175473|3841529|B2|0.5 h||Obestatin Concentration|Obestatin concentration was determined at 0.5 (8:00 clock time; prior to standardized breakfast), 2.5 and 4.5 hours on Day -1 (time-matched baseline). PD population was evaluable for this baseline characteristic.|nanomole per liter (nmol/L)|Mean|0.29|0.29|Standard Deviation|0.18|0.18|||
4020673|NCT01175473|3841530|B1|0.5 h||Obestatin Concentration|Obestatin concentration was determined at 0.5 (8:00 clock time; prior to standardized breakfast), 2.5 and 4.5 hours on Day -1 (time-matched baseline). PD population was evaluable for this baseline characteristic.|nanomole per liter (nmol/L)|Mean|0.24|0.24|Standard Deviation|0.12|0.12|||
4020674|NCT01175473|3841528|B3|4.5 h||Peptide YY3-36 (PYY3-36) Concentration|PYY3-36 concentration was determined at 0.5 (8:00 clock time; prior to standardized breakfast), 2.5 and 4.5 hours on Day -1 (time-matched baseline). PD population was evaluable for this baseline characteristic.|picomole per liter (pmol/L)|Mean|21.46|21.46|Standard Deviation|10.68|10.68|||
4020675|NCT01175473|3841529|B2|4.5 h||Peptide YY3-36 (PYY3-36) Concentration|PYY3-36 concentration was determined at 0.5 (8:00 clock time; prior to standardized breakfast), 2.5 and 4.5 hours on Day -1 (time-matched baseline). PD population was evaluable for this baseline characteristic.|picomole per liter (pmol/L)|Mean|20.88|20.88|Standard Deviation|10.66|10.66|||
4020676|NCT01175473|3841530|B1|4.5 h||Peptide YY3-36 (PYY3-36) Concentration|PYY3-36 concentration was determined at 0.5 (8:00 clock time; prior to standardized breakfast), 2.5 and 4.5 hours on Day -1 (time-matched baseline). PD population was evaluable for this baseline characteristic.|picomole per liter (pmol/L)|Mean|21.98|21.98|Standard Deviation|10.74|10.74|||
4020677|NCT01175473|3841528|B3|2.5 h||Peptide YY3-36 (PYY3-36) Concentration|PYY3-36 concentration was determined at 0.5 (8:00 clock time; prior to standardized breakfast), 2.5 and 4.5 hours on Day -1 (time-matched baseline). PD population was evaluable for this baseline characteristic.|picomole per liter (pmol/L)|Mean|21.40|21.4|Standard Deviation|10.62|10.62|||
4020678|NCT01175473|3841529|B2|2.5 h||Peptide YY3-36 (PYY3-36) Concentration|PYY3-36 concentration was determined at 0.5 (8:00 clock time; prior to standardized breakfast), 2.5 and 4.5 hours on Day -1 (time-matched baseline). PD population was evaluable for this baseline characteristic.|picomole per liter (pmol/L)|Mean|21.02|21.02|Standard Deviation|9.19|9.19|||
4020679|NCT01175473|3841530|B1|2.5 h||Peptide YY3-36 (PYY3-36) Concentration|PYY3-36 concentration was determined at 0.5 (8:00 clock time; prior to standardized breakfast), 2.5 and 4.5 hours on Day -1 (time-matched baseline). PD population was evaluable for this baseline characteristic.|picomole per liter (pmol/L)|Mean|21.73|21.73|Standard Deviation|11.83|11.83|||
4020680|NCT01175473|3841528|B3|0.5 h||Peptide YY3-36 (PYY3-36) Concentration|PYY3-36 concentration was determined at 0.5 (8:00 clock time; prior to standardized breakfast), 2.5 and 4.5 hours on Day -1 (time-matched baseline). PD population was evaluable for this baseline characteristic.|picomole per liter (pmol/L)|Mean|17.71|17.71|Standard Deviation|9.35|9.35|||
4020681|NCT01175473|3841529|B2|0.5 h||Peptide YY3-36 (PYY3-36) Concentration|PYY3-36 concentration was determined at 0.5 (8:00 clock time; prior to standardized breakfast), 2.5 and 4.5 hours on Day -1 (time-matched baseline). PD population was evaluable for this baseline characteristic.|picomole per liter (pmol/L)|Mean|17.83|17.83|Standard Deviation|9.29|9.29|||
4020728|NCT01175434|3841555|B3|||Age||years|Mean|7.2|7.2|Standard Deviation|1.8|1.8|||
4020682|NCT01175473|3841530|B1|0.5 h||Peptide YY3-36 (PYY3-36) Concentration|PYY3-36 concentration was determined at 0.5 (8:00 clock time; prior to standardized breakfast), 2.5 and 4.5 hours on Day -1 (time-matched baseline). PD population was evaluable for this baseline characteristic.|picomole per liter (pmol/L)|Mean|17.60|17.6|Standard Deviation|9.46|9.46|||
4020683|NCT01175473|3841528|B3|||Glycosylated Hemoglobin (HbA1c)|HbA1c on Day 1 (pre-dose [hour 0]) was the baseline. Number of patients analyzed = 74 and 68 for Lixisenatide and Liraglutide arms, respectively.|percentage of hemoglobin|Mean|7.30|7.3|Standard Deviation|0.72|0.72|||
4020684|NCT01175473|3841529|B2|||Glycosylated Hemoglobin (HbA1c)|HbA1c on Day 1 (pre-dose [hour 0]) was the baseline. Number of patients analyzed = 74 and 68 for Lixisenatide and Liraglutide arms, respectively.|percentage of hemoglobin|Mean|7.41|7.41|Standard Deviation|0.81|0.81|||
4020685|NCT01175473|3841530|B1|||Glycosylated Hemoglobin (HbA1c)|HbA1c on Day 1 (pre-dose [hour 0]) was the baseline. Number of patients analyzed = 74 and 68 for Lixisenatide and Liraglutide arms, respectively.|percentage of hemoglobin|Mean|7.20|7.2|Standard Deviation|0.63|0.63|||
4020686|NCT01175473|3841528|B3|||Glucagon AUC(0:30-4:30h)|The area under the glucagon concentration time curve (AUC0:30-4:30h) was calculated using the linear trapezoidal rule from time of breakfast start (8:00 clock time; prior to standardized breakfast [time: 0.5 hours]) to 4 hours after breakfast start (time: 4.5 hours) and corrected by subtracting pre-breakfast glucagon concentration (time: 0.5 hours). Glucagon AUC0:30-4:30h on Day -1 was the baseline. PD population was evaluable for this baseline characteristic.|hour*picogram per milliliter (h*pg/mL)|Mean|22.05|22.05|Standard Deviation|69.87|69.87|||
4020687|NCT01175473|3841529|B2|||Glucagon AUC(0:30-4:30h)|The area under the glucagon concentration time curve (AUC0:30-4:30h) was calculated using the linear trapezoidal rule from time of breakfast start (8:00 clock time; prior to standardized breakfast [time: 0.5 hours]) to 4 hours after breakfast start (time: 4.5 hours) and corrected by subtracting pre-breakfast glucagon concentration (time: 0.5 hours). Glucagon AUC0:30-4:30h on Day -1 was the baseline. PD population was evaluable for this baseline characteristic.|hour*picogram per milliliter (h*pg/mL)|Mean|16.47|16.47|Standard Deviation|78.98|78.98|||
4020688|NCT01175473|3841530|B1|||Glucagon AUC(0:30-4:30h)|The area under the glucagon concentration time curve (AUC0:30-4:30h) was calculated using the linear trapezoidal rule from time of breakfast start (8:00 clock time; prior to standardized breakfast [time: 0.5 hours]) to 4 hours after breakfast start (time: 4.5 hours) and corrected by subtracting pre-breakfast glucagon concentration (time: 0.5 hours). Glucagon AUC0:30-4:30h on Day -1 was the baseline. PD population was evaluable for this baseline characteristic.|hour*picogram per milliliter (h*pg/mL)|Mean|27.10|27.1|Standard Deviation|60.54|60.54|||
4020689|NCT01175473|3841528|B3|||C-Peptide AUC(0:30-4:30h)|The area under the C-peptide concentration time curve (AUC0:30-4:30h) was calculated using the linear trapezoidal rule from time of breakfast start (8:00 clock time; prior to standardized breakfast [time: 0.5 hours]) to 4 hours after breakfast start (time: 4.5 hours) and corrected by subtracting pre-breakfast C-peptide concentration (time: 0.5 hours). C-peptide AUC0:30-4:30h on Day -1 was the baseline. PD population was evaluable for this baseline characteristic.|hour*nanogram per milliliter (h*ng/mL)|Mean|10.31|10.31|Standard Deviation|4.65|4.65|||
4020690|NCT01175473|3841529|B2|||C-Peptide AUC(0:30-4:30h)|The area under the C-peptide concentration time curve (AUC0:30-4:30h) was calculated using the linear trapezoidal rule from time of breakfast start (8:00 clock time; prior to standardized breakfast [time: 0.5 hours]) to 4 hours after breakfast start (time: 4.5 hours) and corrected by subtracting pre-breakfast C-peptide concentration (time: 0.5 hours). C-peptide AUC0:30-4:30h on Day -1 was the baseline. PD population was evaluable for this baseline characteristic.|hour*nanogram per milliliter (h*ng/mL)|Mean|9.99|9.99|Standard Deviation|4.89|4.89|||
4020691|NCT01175473|3841530|B1|||C-Peptide AUC(0:30-4:30h)|The area under the C-peptide concentration time curve (AUC0:30-4:30h) was calculated using the linear trapezoidal rule from time of breakfast start (8:00 clock time; prior to standardized breakfast [time: 0.5 hours]) to 4 hours after breakfast start (time: 4.5 hours) and corrected by subtracting pre-breakfast C-peptide concentration (time: 0.5 hours). C-peptide AUC0:30-4:30h on Day -1 was the baseline. PD population was evaluable for this baseline characteristic.|hour*nanogram per milliliter (h*ng/mL)|Mean|10.61|10.61|Standard Deviation|4.44|4.44|||
4020692|NCT01175473|3841528|B3|||Insulin AUC(0:30-4:30h)|The area under the insulin concentration time curve (AUC0:30-4:30h) was calculated using the linear trapezoidal rule from time of breakfast start (8:00 clock time; prior to standardized breakfast [time: 0.5 hours]) to 4 hours after breakfast start (time: 4.5 hours) and corrected by subtracting pre-breakfast insulin concentration (time: 0.5 hours). Insulin AUC0:30-4:30h on Day -1 was the baseline. PD population was evaluable for this baseline characteristic.|hour*micro international unit/milliliter|Mean|96.55|96.55|Standard Deviation|50.50|50.5|||
4020693|NCT01175473|3841529|B2|||Insulin AUC(0:30-4:30h)|The area under the insulin concentration time curve (AUC0:30-4:30h) was calculated using the linear trapezoidal rule from time of breakfast start (8:00 clock time; prior to standardized breakfast [time: 0.5 hours]) to 4 hours after breakfast start (time: 4.5 hours) and corrected by subtracting pre-breakfast insulin concentration (time: 0.5 hours). Insulin AUC0:30-4:30h on Day -1 was the baseline. PD population was evaluable for this baseline characteristic.|hour*micro international unit/milliliter|Mean|93.24|93.24|Standard Deviation|57.30|57.3|||
4020694|NCT01175473|3841530|B1|||Insulin AUC(0:30-4:30h)|The area under the insulin concentration time curve (AUC0:30-4:30h) was calculated using the linear trapezoidal rule from time of breakfast start (8:00 clock time; prior to standardized breakfast [time: 0.5 hours]) to 4 hours after breakfast start (time: 4.5 hours) and corrected by subtracting pre-breakfast insulin concentration (time: 0.5 hours). Insulin AUC0:30-4:30h on Day -1 was the baseline. PD population was evaluable for this baseline characteristic.|hour*micro international unit/milliliter|Mean|99.55|99.55|Standard Deviation|43.61|43.61|||
4020695|NCT01175473|3841528|B3|||Pro-insulin AUC(0:30-4:30h)|The area under the pro-insulin concentration time curve (AUC0:30-4:30h) was calculated using the linear trapezoidal rule from time of breakfast start (8:00 clock time; prior to standardized breakfast [time: 0.5 hours]) to 4 hours after breakfast start (time: 4.5 hours) and corrected by subtracting pre-breakfast pro-insulin concentration (time: 0.5 hours). Pro-insulin AUC0:30-4:30h on Day -1 was the baseline. PD population was evaluable for this baseline characteristic.|hour*micro international unit/milliliter|Mean|6.09|6.09|Standard Deviation|5.86|5.86|||
4020729|NCT01175434|3841556|B2|||Age||years|Mean|6.98|6.98|Standard Deviation|1.8|1.8|||
4020730|NCT01175434|3841557|B1|||Age||years|Mean|7.48|7.48|Standard Deviation|1.7|1.7|||
4020696|NCT01175473|3841529|B2|||Pro-insulin AUC(0:30-4:30h)|The area under the pro-insulin concentration time curve (AUC0:30-4:30h) was calculated using the linear trapezoidal rule from time of breakfast start (8:00 clock time; prior to standardized breakfast [time: 0.5 hours]) to 4 hours after breakfast start (time: 4.5 hours) and corrected by subtracting pre-breakfast pro-insulin concentration (time: 0.5 hours). Pro-insulin AUC0:30-4:30h on Day -1 was the baseline. PD population was evaluable for this baseline characteristic.|hour*micro international unit/milliliter|Mean|6.54|6.54|Standard Deviation|5.40|5.4|||
4020697|NCT01175473|3841530|B1|||Pro-insulin AUC(0:30-4:30h)|The area under the pro-insulin concentration time curve (AUC0:30-4:30h) was calculated using the linear trapezoidal rule from time of breakfast start (8:00 clock time; prior to standardized breakfast [time: 0.5 hours]) to 4 hours after breakfast start (time: 4.5 hours) and corrected by subtracting pre-breakfast pro-insulin concentration (time: 0.5 hours). Pro-insulin AUC0:30-4:30h on Day -1 was the baseline. PD population was evaluable for this baseline characteristic.|hour*micro international unit/milliliter|Mean|5.68|5.68|Standard Deviation|6.25|6.25|||
4020698|NCT01175473|3841528|B3|||Postprandial Plasma Glucose (PPG) Excursion|PPG excursion was determined on Day -1 (baseline) as the maximum change in PPG from time of breakfast start (8:00 clock time; prior to standardized breakfast [time: 0.5 hours]) until 4 hours later subtracted from pre-meal plasma concentration. PD population was evaluable for this baseline characteristic.|milligram per deciliter (mg/dL)|Mean|88.06|88.06|Standard Deviation|32.47|32.47|||
4020699|NCT01175473|3841529|B2|||Postprandial Plasma Glucose (PPG) Excursion|PPG excursion was determined on Day -1 (baseline) as the maximum change in PPG from time of breakfast start (8:00 clock time; prior to standardized breakfast [time: 0.5 hours]) until 4 hours later subtracted from pre-meal plasma concentration. PD population was evaluable for this baseline characteristic.|milligram per deciliter (mg/dL)|Mean|88.06|88.06|Standard Deviation|35.86|35.86|||
4020700|NCT01175473|3841530|B1|||Postprandial Plasma Glucose (PPG) Excursion|PPG excursion was determined on Day -1 (baseline) as the maximum change in PPG from time of breakfast start (8:00 clock time; prior to standardized breakfast [time: 0.5 hours]) until 4 hours later subtracted from pre-meal plasma concentration. PD population was evaluable for this baseline characteristic.|milligram per deciliter (mg/dL)|Mean|88.06|88.06|Standard Deviation|29.31|29.31|||
4020701|NCT01175473|3841528|B3|||Area Under Plasma Glucose Concentration Curve From Time 0.5 Hours to 4.5 Hours (GLU-AUC0:30-4:30h)|The area under the plasma glucose concentration time curve (GLU-AUC0:30-4:30h) was calculated using the linear trapezoidal rule from time of breakfast start (8:00 clock time; prior to standardized breakfast [time: 0.5 hours]) to 4 hours after breakfast start (time: 4.5 hours) and corrected by subtracting pre-breakfast plasma glucose concentration (time: 0.5 hours). GLU-AUC0:30-4:30h on Day -1 was the baseline. PD population was evaluable for this baseline characteristic.|hour*milligram per deciliter (h*mg/dL)|Mean|176.28|176.28|Standard Deviation|92.39|92.39|||
4020702|NCT01175473|3841529|B2|||Area Under Plasma Glucose Concentration Curve From Time 0.5 Hours to 4.5 Hours (GLU-AUC0:30-4:30h)|The area under the plasma glucose concentration time curve (GLU-AUC0:30-4:30h) was calculated using the linear trapezoidal rule from time of breakfast start (8:00 clock time; prior to standardized breakfast [time: 0.5 hours]) to 4 hours after breakfast start (time: 4.5 hours) and corrected by subtracting pre-breakfast plasma glucose concentration (time: 0.5 hours). GLU-AUC0:30-4:30h on Day -1 was the baseline. PD population was evaluable for this baseline characteristic.|hour*milligram per deciliter (h*mg/dL)|Mean|183.86|183.86|Standard Deviation|100.89|100.89|||
4020703|NCT01175473|3841530|B1|||Area Under Plasma Glucose Concentration Curve From Time 0.5 Hours to 4.5 Hours (GLU-AUC0:30-4:30h)|The area under the plasma glucose concentration time curve (GLU-AUC0:30-4:30h) was calculated using the linear trapezoidal rule from time of breakfast start (8:00 clock time; prior to standardized breakfast [time: 0.5 hours]) to 4 hours after breakfast start (time: 4.5 hours) and corrected by subtracting pre-breakfast plasma glucose concentration (time: 0.5 hours). GLU-AUC0:30-4:30h on Day -1 was the baseline. PD population was evaluable for this baseline characteristic.|hour*milligram per deciliter (h*mg/dL)|Mean|169.41|169.41|Standard Deviation|84.03|84.03|||
4020704|NCT01175473|3841528|B3|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4020705|NCT01175473|3841529|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4020706|NCT01175473|3841530|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4020707|NCT01175473|3841528|B3|Caucasian/White||Race/Ethnicity, Customized||participants|Number|147|147.0||||||
4020708|NCT01175473|3841529|B2|Caucasian/White||Race/Ethnicity, Customized||participants|Number|71|71.0||||||
4020709|NCT01175473|3841530|B1|Caucasian/White||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
4020710|NCT01175473|3841528|B3||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4020711|NCT01175473|3841529|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4020712|NCT01175473|3841530|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4020713|NCT01175473|3841528|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4020714|NCT01175473|3841529|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4020715|NCT01175473|3841530|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4020716|NCT01175473|3841528|B3|||Age||years|Mean|60.1|60.1|Standard Deviation|8.0|8.0|||
4020717|NCT01175473|3841529|B2|||Age||years|Mean|59.7|59.7|Standard Deviation|8.5|8.5|||
4020718|NCT01175473|3841530|B1|||Age||years|Mean|60.5|60.5|Standard Deviation|7.5|7.5|||
4020719|NCT01175434|3841555|B3|United States||Region of Enrollment||participants|Number|99|99.0||||||
4020720|NCT01175434|3841556|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
4020721|NCT01175434|3841557|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4020722|NCT01175434|3841555|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4020723|NCT01175434|3841556|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4020724|NCT01175434|3841557|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4020725|NCT01175434|3841555|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4020726|NCT01175434|3841556|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4020727|NCT01175434|3841557|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4020731|NCT01175434|3841555|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4020732|NCT01175434|3841556|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4020733|NCT01175434|3841557|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4020734|NCT01175434|3841555|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4020735|NCT01175434|3841556|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4020736|NCT01175434|3841557|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4020737|NCT01175434|3841555|B3||<=18 years|Age||Participants|Count of Participants|99|99.0||||||
4020738|NCT01175434|3841556|B2||<=18 years|Age||Participants|Count of Participants|51|51.0||||||
4020739|NCT01175434|3841557|B1||<=18 years|Age||Participants|Count of Participants|48|48.0||||||
4020740|NCT01175395|3841564|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4020741|NCT01175395|3841564|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4020742|NCT01175395|3841564|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4020743|NCT01175395|3841564|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4020744|NCT01175395|3841564|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4020745|NCT01175382|3841569|B4|No||Earned Wages Outside Home||participants|Number|118|118.0||||||
4020746|NCT01175382|3841570|B3|No||Earned Wages Outside Home||participants|Number|35|35.0||||||
4020747|NCT01175382|3841571|B2|No||Earned Wages Outside Home||participants|Number|40|40.0||||||
4020748|NCT01175382|3841572|B1|No||Earned Wages Outside Home||participants|Number|43|43.0||||||
4020749|NCT01175382|3841569|B4|Yes||Earned Wages Outside Home||participants|Number|86|86.0||||||
4020750|NCT01175382|3841570|B3|Yes||Earned Wages Outside Home||participants|Number|30|30.0||||||
4020751|NCT01175382|3841571|B2|Yes||Earned Wages Outside Home||participants|Number|28|28.0||||||
4020752|NCT01175382|3841572|B1|Yes||Earned Wages Outside Home||participants|Number|28|28.0||||||
4020753|NCT01175382|3841569|B4|Other||Living Status||participants|Number|19|19.0||||||
4020754|NCT01175382|3841570|B3|Other||Living Status||participants|Number|7|7.0||||||
4020755|NCT01175382|3841571|B2|Other||Living Status||participants|Number|6|6.0||||||
4020756|NCT01175382|3841572|B1|Other||Living Status||participants|Number|6|6.0||||||
4020757|NCT01175382|3841569|B4|With Someone||Living Status||participants|Number|139|139.0||||||
4020758|NCT01175382|3841570|B3|With Someone||Living Status||participants|Number|45|45.0||||||
4020759|NCT01175382|3841571|B2|With Someone||Living Status||participants|Number|43|43.0||||||
4020760|NCT01175382|3841572|B1|With Someone||Living Status||participants|Number|51|51.0||||||
4020761|NCT01175382|3841569|B4|Alone||Living Status||participants|Number|46|46.0||||||
4020762|NCT01175382|3841570|B3|Alone||Living Status||participants|Number|13|13.0||||||
4020763|NCT01175382|3841571|B2|Alone||Living Status||participants|Number|19|19.0||||||
4020764|NCT01175382|3841572|B1|Alone||Living Status||participants|Number|14|14.0||||||
4020765|NCT01175382|3841569|B4|Widowed||Marital Status||participants|Number|7|7.0||||||
4020766|NCT01175382|3841570|B3|Widowed||Marital Status||participants|Number|1|1.0||||||
4020767|NCT01175382|3841571|B2|Widowed||Marital Status||participants|Number|4|4.0||||||
4020768|NCT01175382|3841572|B1|Widowed||Marital Status||participants|Number|2|2.0||||||
4020769|NCT01175382|3841569|B4|Divorced||Marital Status||participants|Number|38|38.0||||||
4020770|NCT01175382|3841570|B3|Divorced||Marital Status||participants|Number|7|7.0||||||
4020771|NCT01175382|3841571|B2|Divorced||Marital Status||participants|Number|15|15.0||||||
4020772|NCT01175382|3841572|B1|Divorced||Marital Status||participants|Number|16|16.0||||||
4020773|NCT01175382|3841569|B4|Married||Marital Status||participants|Number|115|115.0||||||
4020774|NCT01175382|3841570|B3|Married||Marital Status||participants|Number|41|41.0||||||
4020775|NCT01175382|3841571|B2|Married||Marital Status||participants|Number|34|34.0||||||
4020776|NCT01175382|3841572|B1|Married||Marital Status||participants|Number|40|40.0||||||
4020777|NCT01175382|3841569|B4|Single||Marital Status||participants|Number|44|44.0||||||
4020778|NCT01175382|3841570|B3|Single||Marital Status||participants|Number|16|16.0||||||
4020779|NCT01175382|3841571|B2|Single||Marital Status||participants|Number|15|15.0||||||
4020780|NCT01175382|3841572|B1|Single||Marital Status||participants|Number|13|13.0||||||
4020781|NCT01175382|3841569|B4|White||Race/Ethnicity, Customized||participants|Number|133|133.0||||||
4020782|NCT01175382|3841570|B3|White||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4020783|NCT01175382|3841571|B2|White||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4020784|NCT01175382|3841572|B1|White||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
4020785|NCT01175382|3841569|B4|Other||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4020786|NCT01175382|3841570|B3|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4020787|NCT01175382|3841571|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4020788|NCT01175382|3841572|B1|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4020789|NCT01175382|3841569|B4|Black||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
4020790|NCT01175382|3841570|B3|Black||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4020791|NCT01175382|3841571|B2|Black||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4020792|NCT01175382|3841572|B1|Black||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4020793|NCT01175382|3841569|B4||Male|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4020794|NCT01175382|3841570|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4020795|NCT01175382|3841571|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4020796|NCT01175382|3841572|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4020797|NCT01175382|3841569|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4020798|NCT01175382|3841570|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4020799|NCT01175382|3841571|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4020800|NCT01175382|3841572|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4020801|NCT01175382|3841569|B4|||Age||years|Mean|64.1|64.1|Standard Deviation|11.1|11.1|||
4020802|NCT01175382|3841570|B3|||Age||years|Mean|63.2|63.2|Standard Deviation|11.6|11.6|||
4020803|NCT01175382|3841571|B2|||Age||years|Mean|65.5|65.5|Standard Deviation|11.0|11.0|||
4020804|NCT01175382|3841572|B1|||Age||years|Mean|63.6|63.6|Standard Deviation|10.9|10.9|||
4020805|NCT01175369|3841651|B3|United States||Region of Enrollment||participants|Number|530|530.0||||||
4020806|NCT01175369|3841652|B2|United States||Region of Enrollment||participants|Number|265|265.0||||||
4020807|NCT01175369|3841653|B1|United States||Region of Enrollment||participants|Number|265|265.0||||||
4020808|NCT01175369|3841651|B3||Male|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
4020809|NCT01175369|3841652|B2||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4020810|NCT01175369|3841653|B1||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4020811|NCT01175369|3841651|B3||Female|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4020812|NCT01175369|3841652|B2||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4020813|NCT01175369|3841653|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4020814|NCT01175369|3841651|B3|||Age||years|Mean|7.1|7.1|Standard Deviation|1.9|1.9|||
4020815|NCT01175369|3841652|B2|||Age||years|Mean|7.1|7.1|Standard Deviation|2.0|2.0|||
4020816|NCT01175369|3841653|B1|||Age||years|Mean|7.2|7.2|Standard Deviation|1.9|1.9|||
4020817|NCT01175369|3841651|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4020818|NCT01175369|3841652|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4020819|NCT01175369|3841653|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4020820|NCT01175369|3841651|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4020821|NCT01175369|3841652|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4020822|NCT01175369|3841653|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4020823|NCT01175369|3841651|B3||<=18 years|Age||Participants|Count of Participants|530|530.0||||||
4020824|NCT01175369|3841652|B2||<=18 years|Age||Participants|Count of Participants|265|265.0||||||
4020825|NCT01175369|3841653|B1||<=18 years|Age||Participants|Count of Participants|265|265.0||||||
4020826|NCT01175356|3841660|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4020827|NCT01175356|3841660|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020828|NCT01175356|3841660|B1||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4020829|NCT01175356|3841660|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4020830|NCT01175356|3841660|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4020831|NCT01175356|3841660|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4020832|NCT01175356|3841660|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4020833|NCT01175356|3841660|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4020834|NCT01175356|3841660|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4020835|NCT01175356|3841660|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4020836|NCT01175356|3841660|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4020837|NCT01175356|3841660|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4020838|NCT01175356|3841660|B1|||Age||Years|Mean|4.2|4.2|Standard Deviation|2.9|2.9|||
4020839|NCT01175356|3841660|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4020840|NCT01175356|3841660|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4020841|NCT01175356|3841660|B1||<=18 years|Age||Participants|Count of Participants|99|99.0||||||
4020842|NCT01175343|3841666|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4020843|NCT01175343|3841666|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4020844|NCT01175343|3841666|B1|||Age||years|Median|58|58.0|Full Range|||26.0|81.0|
4020845|NCT01175343|3841666|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4020846|NCT01175343|3841666|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4020847|NCT01175343|3841666|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4020848|NCT01175317|3841676|B3|Netherlands||Region of Enrollment||participants|Number|58|58.0||||||
4020849|NCT01175317|3841677|B2|Netherlands||Region of Enrollment||participants|Number|31|31.0||||||
4020850|NCT01175317|3841678|B1|Netherlands||Region of Enrollment||participants|Number|27|27.0||||||
4020851|NCT01175317|3841676|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4020852|NCT01175317|3841677|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4020853|NCT01175317|3841678|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4020854|NCT01175317|3841676|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4020855|NCT01175317|3841677|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4020856|NCT01175317|3841678|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4020857|NCT01175317|3841676|B3|||Age||years|Mean|68.1|68.1|Standard Deviation|10.3|10.3|||
4020858|NCT01175317|3841677|B2|||Age||years|Mean|67.6|67.6|Standard Deviation|10.0|10.0|||
4020859|NCT01175317|3841678|B1|||Age||years|Mean|68.6|68.6|Standard Deviation|10.8|10.8|||
4020860|NCT01175317|3841676|B3||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4020861|NCT01175317|3841677|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4020862|NCT01175317|3841678|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4020863|NCT01175317|3841676|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4020864|NCT01175317|3841677|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4020865|NCT01175317|3841678|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4020866|NCT01175317|3841676|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4020867|NCT01175317|3841677|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4020868|NCT01175317|3841678|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4020869|NCT01175226|3841687|B3|United States||Region of Enrollment||participants|Number|299|299.0||||||
4020870|NCT01175226|3841688|B2|United States||Region of Enrollment||participants|Number|145|145.0||||||
4020871|NCT01175226|3841689|B1|United States||Region of Enrollment||participants|Number|154|154.0||||||
4020872|NCT01175226|3841687|B3||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4020873|NCT01175226|3841688|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4020874|NCT01175226|3841689|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4020875|NCT01175226|3841687|B3||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4020876|NCT01175226|3841688|B2||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4020877|NCT01175226|3841689|B1||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4020878|NCT01175226|3841687|B3|||Age||years|Mean|41.3|41.3|Standard Deviation|14.02|14.02|||
4020879|NCT01175226|3841688|B2|||Age||years|Mean|42.0|42.0|Standard Deviation|13.69|13.69|||
4020880|NCT01175226|3841689|B1|||Age||years|Mean|40.6|40.6|Standard Deviation|14.34|14.34|||
4020881|NCT01175213|3841696|B5|United States||Region of Enrollment||Participants|Number|66|66.0||||||
4020882|NCT01175213|3841697|B4|United States||Region of Enrollment||Participants|Number|8|8.0||||||
4020883|NCT01175213|3841698|B3|United States||Region of Enrollment||Participants|Number|47|47.0||||||
4020884|NCT01175213|3841699|B2|United States||Region of Enrollment||Participants|Number|7|7.0||||||
4020885|NCT01175213|3841700|B1|United States||Region of Enrollment||Participants|Number|4|4.0||||||
4020886|NCT01175213|3841696|B5||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4020887|NCT01175213|3841697|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4020888|NCT01175213|3841698|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4020889|NCT01175213|3841699|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4020890|NCT01175213|3841700|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4020891|NCT01175213|3841696|B5||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4020892|NCT01175213|3841697|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4020893|NCT01175213|3841698|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4020894|NCT01175213|3841699|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4020895|NCT01175213|3841700|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4020896|NCT01175213|3841696|B5|||Age||Years|Median|43.0|43.0|Full Range|||9.0|80.0|
4020897|NCT01175213|3841697|B4|||Age||Years|Median|71.0|71.0|Full Range|||65.0|80.0|
4020898|NCT01175213|3841698|B3|||Age||Years|Median|47.0|47.0|Full Range|||16.0|64.0|
4020899|NCT01175213|3841699|B2|||Age||Years|Median|15.0|15.0|Full Range|||13.0|15.0|
4020900|NCT01175213|3841700|B1|||Age||Years|Median|10.5|10.5|Full Range|||9.0|11.0|
4020901|NCT01175148|3841746|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4020902|NCT01175148|3841747|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4020903|NCT01175148|3841748|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4020904|NCT01175148|3841746|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4020905|NCT01175148|3841747|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4020906|NCT01175148|3841748|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4020907|NCT01175148|3841746|B3|70-80||Age, Customized||participants|Number|3|3.0||||||
4020908|NCT01175148|3841747|B2|70-80||Age, Customized||participants|Number|2|2.0||||||
4020909|NCT01175148|3841748|B1|70-80||Age, Customized||participants|Number|1|1.0||||||
4020910|NCT01175148|3841746|B3|50--69||Age, Customized||participants|Number|36|36.0||||||
4020911|NCT01175148|3841747|B2|50--69||Age, Customized||participants|Number|17|17.0||||||
4020912|NCT01175148|3841748|B1|50--69||Age, Customized||participants|Number|19|19.0||||||
4020913|NCT01175148|3841746|B3|18-49||Age, Customized||participants|Number|21|21.0||||||
4020914|NCT01175148|3841747|B2|18-49||Age, Customized||participants|Number|11|11.0||||||
4020915|NCT01175148|3841748|B1|18-49||Age, Customized||participants|Number|10|10.0||||||
4020916|NCT01175135|3841754|B5||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4020917|NCT01175135|3841755|B4||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4020918|NCT01175135|3841756|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4020919|NCT01175135|3841757|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4020920|NCT01175135|3841758|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4020921|NCT01175135|3841754|B5||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4020922|NCT01175135|3841755|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4020923|NCT01175135|3841756|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4020924|NCT01175135|3841757|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4020925|NCT01175135|3841758|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4020926|NCT01175135|3841754|B5|||Age||years|Mean|41.9|41.9|Standard Deviation|10.8|10.8|||
4020927|NCT01175135|3841755|B4|||Age||years|Mean|41.2|41.2|Standard Deviation|10.9|10.9|||
4020928|NCT01175135|3841756|B3|||Age||years|Mean|41.3|41.3|Standard Deviation|10.9|10.9|||
4020929|NCT01175135|3841757|B2|||Age||years|Mean|41.7|41.7|Standard Deviation|10.5|10.5|||
4020930|NCT01175135|3841758|B1|||Age||years|Mean|43.1|43.1|Standard Deviation|11.2|11.2|||
4020931|NCT01175031|3841843|B1|Complex Sleep Apnea||Diagnosis||participants|Number|13|13.0||||||
4020932|NCT01175031|3841843|B1|Obstructive Sleep apnea||Diagnosis||participants|Number|32|32.0||||||
4020933|NCT01175031|3841843|B1|||Diagnostic Apnea-Hypopnea Index (AHI)||events/hour|Mean|39.3|39.3|Standard Deviation|26.0|26.0|||
4020934|NCT01175031|3841843|B1|||Body mass index||kg/m^2|Mean|53.2|53.2|Standard Deviation|13.9|13.9|||
4020935|NCT01175031|3841843|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4020936|NCT01175031|3841843|B1|Others||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4020937|NCT01175031|3841843|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4020938|NCT01175031|3841843|B1|African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4020939|NCT01175031|3841843|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4020940|NCT01175031|3841843|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4020941|NCT01175031|3841843|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4020942|NCT01175031|3841843|B1|||Age||years|Mean|53.2|53.2|Standard Deviation|13.9|13.9|||
4020943|NCT01175018|3841851|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4020944|NCT01175018|3841852|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4020945|NCT01175018|3841853|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4020946|NCT01175018|3841851|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4020947|NCT01175018|3841852|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4020948|NCT01175018|3841853|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4020949|NCT01175018|3841851|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4020950|NCT01175018|3841852|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4020951|NCT01175018|3841853|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4020952|NCT01175018|3841851|B3|||Age||years|Mean|59|59.0|Standard Deviation|12|12.0|||
4020953|NCT01175018|3841852|B2|||Age||years|Mean|58|58.0|Standard Deviation|12|12.0|||
4020954|NCT01175018|3841853|B1|||Age||years|Mean|59|59.0|Standard Deviation|12|12.0|||
4020955|NCT01175018|3841851|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4020956|NCT01175018|3841852|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4020957|NCT01175018|3841853|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4020958|NCT01175018|3841851|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4020959|NCT01175018|3841852|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4020960|NCT01175018|3841853|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4020961|NCT01175018|3841851|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4020962|NCT01175018|3841852|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4020963|NCT01175018|3841853|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4020964|NCT01175005|3841890|B1|Blood culture positive||Blood culture|Blood culture negative vs positive|participants|Number|14|14.0||||||
4020965|NCT01175005|3841890|B1|Blood culture negative||Blood culture|Blood culture negative vs positive|participants|Number|48|48.0||||||
4020966|NCT01175005|3841890|B1|Non neutropenic||Neutropenic|Number of patients who were neutropenic defined as ANC less than 1500 cells/microliter|participants|Number|35|35.0||||||
4020967|NCT01175005|3841890|B1|neutropenic||Neutropenic|Number of patients who were neutropenic defined as ANC less than 1500 cells/microliter|participants|Number|27|27.0||||||
4020968|NCT01175005|3841890|B1|United States||Region of Enrollment||participants|Number|62|62.0||||||
4020969|NCT01175005|3841890|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4020970|NCT01175005|3841890|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4020971|NCT01175005|3841890|B1|||Age||years|Mean|6|6.0|Standard Deviation|4.8|4.8|||
4020972|NCT01175005|3841890|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4020973|NCT01175005|3841890|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4020974|NCT01175005|3841890|B1||<=18 years|Age||Participants|Count of Participants|62|62.0||||||
4020975|NCT01174784|3841895|B1|United States||Region of Enrollment||participants|Number|88|88.0||||||
4020976|NCT01174784|3841895|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4020977|NCT01174784|3841895|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4020978|NCT01174784|3841895|B1|||Age||years|Mean|69.5|69.5|Standard Deviation|11.1|11.1|||
4020979|NCT01174784|3841895|B1||>=65 years|Age||Participants|Count of Participants|62|62.0||||||
4020980|NCT01174784|3841895|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4020981|NCT01174784|3841895|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4020982|NCT01174576|3841900|B1|Greece||Region of Enrollment||participants|Number|16|16.0||||||
4020983|NCT01174576|3841900|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4020984|NCT01174576|3841900|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4020985|NCT01174576|3841900|B1|||Age||years|Mean|27.8|27.8|Standard Deviation|5.2|5.2|||
4020986|NCT01174576|3841900|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4020987|NCT01174576|3841900|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4020988|NCT01174576|3841900|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4020989|NCT01174563|3841941|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4020990|NCT01174563|3841941|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4020991|NCT01174563|3841941|B1|||Age||years|Mean|69.0|69.0|Standard Deviation|12.3|12.3|||
4020992|NCT01174550|3841947|B3||Male|Sex: Female, Male||Participants|Count of Participants|4733|4733.0||||||
4020993|NCT01174550|3841948|B2||Male|Sex: Female, Male||Participants|Count of Participants|2401|2401.0||||||
4020994|NCT01174550|3841949|B1||Male|Sex: Female, Male||Participants|Count of Participants|2332|2332.0||||||
4020995|NCT01174550|3841947|B3||Female|Sex: Female, Male||Participants|Count of Participants|5270|5270.0||||||
4020996|NCT01174550|3841948|B2||Female|Sex: Female, Male||Participants|Count of Participants|2595|2595.0||||||
4020997|NCT01174550|3841949|B1||Female|Sex: Female, Male||Participants|Count of Participants|2675|2675.0||||||
4020998|NCT01174550|3841947|B3|||Age||years|Mean|60.8|60.8|Standard Deviation|8.3|8.3|||
4020999|NCT01174550|3841948|B2|||Age||years|Mean|60.7|60.7|Standard Deviation|8.3|8.3|||
4021000|NCT01174550|3841949|B1|||Age||years|Mean|60.9|60.9|Standard Deviation|8.3|8.3|||
4021001|NCT01174459|3841978|B1||Male|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4021002|NCT01174459|3841978|B1||Female|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
4021003|NCT01174459|3841978|B1|||Age||years|Mean|61.4|61.4|Standard Deviation|16.8|16.8|||
4021004|NCT01174446|3841983|B1|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
4021005|NCT01174446|3841983|B1|Japan||Region of Enrollment||participants|Number|5|5.0||||||
4021006|NCT01174446|3841983|B1|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4021007|NCT01174446|3841983|B1|Bulgaria||Region of Enrollment||participants|Number|10|10.0||||||
4021008|NCT01174446|3841983|B1|Romania||Region of Enrollment||participants|Number|8|8.0||||||
4021009|NCT01174446|3841983|B1|Poland||Region of Enrollment||participants|Number|12|12.0||||||
4021010|NCT01174446|3841983|B1|Brazil||Region of Enrollment||participants|Number|1|1.0||||||
4021011|NCT01174446|3841983|B1|Argentina||Region of Enrollment||participants|Number|2|2.0||||||
4021012|NCT01174446|3841983|B1|Czech Republic||Region of Enrollment||participants|Number|2|2.0||||||
4021013|NCT01174446|3841983|B1|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4021014|NCT01174446|3841983|B1|Colombia||Region of Enrollment||participants|Number|5|5.0||||||
4021015|NCT01174446|3841983|B1|Russian Federation||Region of Enrollment||participants|Number|12|12.0||||||
4021016|NCT01174446|3841983|B1|Chile||Region of Enrollment||participants|Number|4|4.0||||||
4021017|NCT01174446|3841983|B1|Ukraine||Region of Enrollment||participants|Number|8|8.0||||||
4021018|NCT01174446|3841983|B1|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4021019|NCT01174446|3841983|B1|United States||Region of Enrollment||participants|Number|0|0.0||||||
4021020|NCT01174446|3841983|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4021021|NCT01174446|3841983|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4021022|NCT01174446|3841983|B1|||Age||years|Mean|34.5|34.5|Standard Deviation|12.2|12.2|||
4021023|NCT01174368|3842173|B1|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4021024|NCT01174368|3842173|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4021025|NCT01174368|3842173|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4021026|NCT01174368|3842173|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4021027|NCT01174368|3842173|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4021028|NCT01174368|3842173|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4021029|NCT01174368|3842173|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4021030|NCT01174342|3842179|B1|Israel||Region of Enrollment||participants|Number|30|30.0||||||
4021031|NCT01174342|3842179|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4021032|NCT01174342|3842179|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4021033|NCT01174342|3842179|B1|||Age||years|Mean|31.5|31.5|Standard Deviation|5|5.0|||
4021034|NCT01174342|3842179|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4021035|NCT01174342|3842179|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4021036|NCT01174342|3842179|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4021037|NCT01174264|3842183|B4|United States||Region of Enrollment||participants|Number|63|63.0||||||
4021038|NCT01174264|3842184|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4021039|NCT01174264|3842185|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4021040|NCT01174264|3842186|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4021041|NCT01174264|3842183|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4021042|NCT01174264|3842184|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4021043|NCT01174264|3842185|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4021044|NCT01174264|3842186|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4021045|NCT01174264|3842183|B4|African-American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4021046|NCT01174264|3842184|B3|African-American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4021047|NCT01174264|3842185|B2|African-American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4021048|NCT01174264|3842186|B1|African-American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4021049|NCT01174264|3842183|B4|White||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4021050|NCT01174264|3842184|B3|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4021051|NCT01174264|3842185|B2|White||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4021052|NCT01174264|3842186|B1|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4021053|NCT01174264|3842183|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4021054|NCT01174264|3842184|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4021055|NCT01174264|3842185|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4021056|NCT01174264|3842186|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4021057|NCT01174264|3842183|B4||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4021058|NCT01174264|3842184|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4021059|NCT01174264|3842185|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4021060|NCT01174264|3842186|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4021061|NCT01174264|3842183|B4|||Age||years|Median|61|61.0|Full Range|||24.0|84.0|
4021062|NCT01174264|3842184|B3|||Age||years|Median|64|64.0|Full Range|||46.0|84.0|
4021063|NCT01174264|3842185|B2|||Age||years|Median|57|57.0|Full Range|||24.0|71.0|
4021064|NCT01174264|3842186|B1|||Age||years|Median|53|53.0|Full Range|||34.0|74.0|
4021065|NCT01174238|3842220|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4021066|NCT01174238|3842220|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4021067|NCT01174238|3842220|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4021068|NCT01174238|3842220|B1|||Age||years|Mean|63.8|63.8|Standard Deviation|10.4|10.4|||
4021069|NCT01174186|3842229|B3|||Expert opinion of active disease||participants|Number|30|30.0||||||
4021070|NCT01174186|3842230|B2|||Expert opinion of active disease||participants|Number|15|15.0||||||
4021071|NCT01174186|3842231|B1|||Expert opinion of active disease||participants|Number|15|15.0||||||
4021072|NCT01174186|3842229|B3|||No effect of NSAID||participants|Number|30|30.0||||||
4021073|NCT01174186|3842230|B2|||No effect of NSAID||participants|Number|15|15.0||||||
4021074|NCT01174186|3842231|B1|||No effect of NSAID||participants|Number|15|15.0||||||
4021075|NCT01174186|3842229|B3|||Bath Ankylosing Spondylitis Disease Activity Index >4|Patient answered composite index for describing disease activity. Range from 0-10. Higher scores indicate higher disease activity|participants|Number|30|30.0||||||
4021076|NCT01174186|3842230|B2|||Bath Ankylosing Spondylitis Disease Activity Index >4|Patient answered composite index for describing disease activity. Range from 0-10. Higher scores indicate higher disease activity|participants|Number|15|15.0||||||
4021077|NCT01174186|3842231|B1|||Bath Ankylosing Spondylitis Disease Activity Index >4|Patient answered composite index for describing disease activity. Range from 0-10. Higher scores indicate higher disease activity|participants|Number|15|15.0||||||
4021078|NCT01174186|3842229|B3|Denmark||Region of Enrollment||participants|Number|30|30.0||||||
4021079|NCT01174186|3842230|B2|Denmark||Region of Enrollment||participants|Number|15|15.0||||||
4021080|NCT01174186|3842231|B1|Denmark||Region of Enrollment||participants|Number|15|15.0||||||
4021081|NCT01174186|3842229|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4021082|NCT01174186|3842230|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4021083|NCT01174186|3842231|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4021084|NCT01174186|3842229|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4021085|NCT01174186|3842230|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4021086|NCT01174186|3842231|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4021087|NCT01174186|3842229|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4021088|NCT01174186|3842230|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4021089|NCT01174186|3842231|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4021090|NCT01174186|3842229|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4021091|NCT01174186|3842230|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4021092|NCT01174186|3842231|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4021093|NCT01174186|3842229|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4021094|NCT01174186|3842230|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4021095|NCT01174186|3842231|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4021096|NCT01174173|3842239|B1|||6-minute walk test||meters|Mean|383|383.0|Standard Deviation|60|60.0|||
4021097|NCT01174173|3842239|B1|||Right heart catheterization||Mean pulmonary artery pressure (mm Hg)|Mean|48|48.0|Standard Deviation|14|14.0|||
4021098|NCT01174173|3842239|B1|||Exercise stress echocardiography with strain||Ejection Fraction (%)|Mean|63|63.0|Standard Deviation|5|5.0|||
4021099|NCT01174173|3842239|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4021100|NCT01174173|3842239|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4021101|NCT01174173|3842239|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021102|NCT01174173|3842239|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4021103|NCT01174173|3842239|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4021104|NCT01174173|3842239|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021105|NCT01174173|3842239|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021106|NCT01174173|3842239|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021107|NCT01174173|3842239|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4021108|NCT01174173|3842239|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4021109|NCT01174173|3842239|B1|||Age||years|Mean|48|48.0|Standard Deviation|13|13.0|||
4021110|NCT01174173|3842239|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4021111|NCT01174173|3842239|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4021112|NCT01174173|3842239|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4021113|NCT01174160|3842248|B3|More than 48 hours||Atrial fibrillation (AF) duration||participants|Number|47|47.0||||||
4021114|NCT01174160|3842249|B2|More than 48 hours||Atrial fibrillation (AF) duration||participants|Number|25|25.0||||||
4021115|NCT01174160|3842250|B1|More than 48 hours||Atrial fibrillation (AF) duration||participants|Number|22|22.0||||||
4021116|NCT01174160|3842248|B3|Less than or equal to 48 hours||Atrial fibrillation (AF) duration||participants|Number|64|64.0||||||
4021117|NCT01174160|3842249|B2|Less than or equal to 48 hours||Atrial fibrillation (AF) duration||participants|Number|31|31.0||||||
4021118|NCT01174160|3842250|B1|Less than or equal to 48 hours||Atrial fibrillation (AF) duration||participants|Number|33|33.0||||||
4021119|NCT01174160|3842248|B3|Valvular Heart Disease||Structural Heart Disease|Participants could have been classified in more than one category|participants|Number|5|5.0||||||
4021120|NCT01174160|3842249|B2|Valvular Heart Disease||Structural Heart Disease|Participants could have been classified in more than one category|participants|Number|3|3.0||||||
4021121|NCT01174160|3842250|B1|Valvular Heart Disease||Structural Heart Disease|Participants could have been classified in more than one category|participants|Number|2|2.0||||||
4021122|NCT01174160|3842248|B3|Myocardial Infarction||Structural Heart Disease|Participants could have been classified in more than one category|participants|Number|1|1.0||||||
4021123|NCT01174160|3842249|B2|Myocardial Infarction||Structural Heart Disease|Participants could have been classified in more than one category|participants|Number|0|0.0||||||
4021124|NCT01174160|3842250|B1|Myocardial Infarction||Structural Heart Disease|Participants could have been classified in more than one category|participants|Number|1|1.0||||||
4021125|NCT01174160|3842248|B3|Ischemic Heart Disease||Structural Heart Disease|Participants could have been classified in more than one category|participants|Number|11|11.0||||||
4021126|NCT01174160|3842249|B2|Ischemic Heart Disease||Structural Heart Disease|Participants could have been classified in more than one category|participants|Number|7|7.0||||||
4021127|NCT01174160|3842250|B1|Ischemic Heart Disease||Structural Heart Disease|Participants could have been classified in more than one category|participants|Number|4|4.0||||||
4021128|NCT01174160|3842248|B3|Congestive Heart Failure||Structural Heart Disease|Participants could have been classified in more than one category|participants|Number|8|8.0||||||
4021129|NCT01174160|3842249|B2|Congestive Heart Failure||Structural Heart Disease|Participants could have been classified in more than one category|participants|Number|3|3.0||||||
4021130|NCT01174160|3842250|B1|Congestive Heart Failure||Structural Heart Disease|Participants could have been classified in more than one category|participants|Number|5|5.0||||||
4021131|NCT01174160|3842248|B3|None||Structural Heart Disease|Participants could have been classified in more than one category|participants|Number|87|87.0||||||
4021132|NCT01174160|3842249|B2|None||Structural Heart Disease|Participants could have been classified in more than one category|participants|Number|43|43.0||||||
4021133|NCT01174160|3842250|B1|None||Structural Heart Disease|Participants could have been classified in more than one category|participants|Number|44|44.0||||||
4021134|NCT01174160|3842248|B3|Class III (Marked limitation in activity)||New York Heart Association (NYHA) Classification|NHYA classifies the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity; the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina pain.|participants|Number|2|2.0||||||
4021135|NCT01174160|3842249|B2|Class III (Marked limitation in activity)||New York Heart Association (NYHA) Classification|NHYA classifies the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity; the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina pain.|participants|Number|0|0.0||||||
4021136|NCT01174160|3842250|B1|Class III (Marked limitation in activity)||New York Heart Association (NYHA) Classification|NHYA classifies the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity; the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina pain.|participants|Number|2|2.0||||||
4021137|NCT01174160|3842248|B3|Class II (mild symptoms during normal activity)||New York Heart Association (NYHA) Classification|NHYA classifies the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity; the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina pain.|participants|Number|4|4.0||||||
4021138|NCT01174160|3842249|B2|Class II (mild symptoms during normal activity)||New York Heart Association (NYHA) Classification|NHYA classifies the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity; the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina pain.|participants|Number|2|2.0||||||
4021139|NCT01174160|3842250|B1|Class II (mild symptoms during normal activity)||New York Heart Association (NYHA) Classification|NHYA classifies the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity; the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina pain.|participants|Number|2|2.0||||||
4021184|NCT01174160|3842250|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4021185|NCT01174160|3842248|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4021140|NCT01174160|3842248|B3|Class I (cardiac disease but no symptoms)||New York Heart Association (NYHA) Classification|NHYA classifies the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity; the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina pain.|participants|Number|2|2.0||||||
4021141|NCT01174160|3842249|B2|Class I (cardiac disease but no symptoms)||New York Heart Association (NYHA) Classification|NHYA classifies the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity; the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina pain.|participants|Number|1|1.0||||||
4021142|NCT01174160|3842250|B1|Class I (cardiac disease but no symptoms)||New York Heart Association (NYHA) Classification|NHYA classifies the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity; the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina pain.|participants|Number|1|1.0||||||
4021143|NCT01174160|3842248|B3|None (no heart failure)||New York Heart Association (NYHA) Classification|NHYA classifies the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity; the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina pain.|participants|Number|103|103.0||||||
4021144|NCT01174160|3842249|B2|None (no heart failure)||New York Heart Association (NYHA) Classification|NHYA classifies the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity; the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina pain.|participants|Number|53|53.0||||||
4021145|NCT01174160|3842250|B1|None (no heart failure)||New York Heart Association (NYHA) Classification|NHYA classifies the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity; the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina pain.|participants|Number|50|50.0||||||
4021146|NCT01174160|3842248|B3|Taiwan||Region of Enrollment||participants|Number|20|20.0||||||
4021147|NCT01174160|3842249|B2|Taiwan||Region of Enrollment||participants|Number|7|7.0||||||
4021148|NCT01174160|3842250|B1|Taiwan||Region of Enrollment||participants|Number|13|13.0||||||
4021149|NCT01174160|3842248|B3|India||Region of Enrollment||participants|Number|1|1.0||||||
4021150|NCT01174160|3842249|B2|India||Region of Enrollment||participants|Number|1|1.0||||||
4021151|NCT01174160|3842250|B1|India||Region of Enrollment||participants|Number|0|0.0||||||
4021152|NCT01174160|3842248|B3|Korea, Republic of||Region of Enrollment||participants|Number|90|90.0||||||
4021153|NCT01174160|3842249|B2|Korea, Republic of||Region of Enrollment||participants|Number|48|48.0||||||
4021154|NCT01174160|3842250|B1|Korea, Republic of||Region of Enrollment||participants|Number|42|42.0||||||
4021155|NCT01174160|3842248|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021156|NCT01174160|3842249|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021157|NCT01174160|3842250|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021158|NCT01174160|3842248|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021159|NCT01174160|3842249|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021160|NCT01174160|3842250|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021161|NCT01174160|3842248|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021162|NCT01174160|3842249|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021163|NCT01174160|3842250|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021164|NCT01174160|3842248|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021165|NCT01174160|3842249|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021166|NCT01174160|3842250|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021167|NCT01174160|3842248|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021168|NCT01174160|3842249|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021169|NCT01174160|3842250|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021170|NCT01174160|3842248|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
4021171|NCT01174160|3842249|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4021172|NCT01174160|3842250|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4021173|NCT01174160|3842248|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4021174|NCT01174160|3842249|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4021175|NCT01174160|3842250|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021176|NCT01174160|3842248|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021177|NCT01174160|3842249|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021178|NCT01174160|3842250|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021179|NCT01174160|3842248|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
4021180|NCT01174160|3842249|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4021181|NCT01174160|3842250|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4021182|NCT01174160|3842248|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4021183|NCT01174160|3842249|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021186|NCT01174160|3842249|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4021187|NCT01174160|3842250|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4021188|NCT01174160|3842248|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4021189|NCT01174160|3842249|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4021190|NCT01174160|3842250|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4021191|NCT01174160|3842248|B3|||Age||years|Mean|59.9|59.9|Standard Deviation|12.8|12.8|||
4021192|NCT01174160|3842249|B2|||Age||years|Mean|59.2|59.2|Standard Deviation|12.0|12.0|||
4021193|NCT01174160|3842250|B1|||Age||years|Mean|60.7|60.7|Standard Deviation|13.7|13.7|||
4021194|NCT01174082|3842257|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4021195|NCT01174082|3842258|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4021196|NCT01174082|3842259|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4021197|NCT01174082|3842257|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021198|NCT01174082|3842258|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021199|NCT01174082|3842259|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021200|NCT01174082|3842257|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021201|NCT01174082|3842258|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021202|NCT01174082|3842259|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021203|NCT01174082|3842257|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4021204|NCT01174082|3842258|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4021205|NCT01174082|3842259|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4021206|NCT01174082|3842257|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021207|NCT01174082|3842258|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021208|NCT01174082|3842259|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021209|NCT01174082|3842257|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021210|NCT01174082|3842258|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021211|NCT01174082|3842259|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021212|NCT01174082|3842257|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021213|NCT01174082|3842258|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021214|NCT01174082|3842259|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021215|NCT01174082|3842257|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021216|NCT01174082|3842258|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021217|NCT01174082|3842259|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021218|NCT01174082|3842257|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4021219|NCT01174082|3842258|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4021220|NCT01174082|3842259|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4021221|NCT01174082|3842257|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4021222|NCT01174082|3842258|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4021223|NCT01174082|3842259|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4021224|NCT01174082|3842257|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4021225|NCT01174082|3842258|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4021226|NCT01174082|3842259|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4021227|NCT01174082|3842257|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4021228|NCT01174082|3842258|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4021229|NCT01174082|3842259|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4021230|NCT01174082|3842257|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4021231|NCT01174082|3842258|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4021232|NCT01174082|3842259|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4021233|NCT01174043|3842266|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021234|NCT01174043|3842266|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021235|NCT01174043|3842266|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4021236|NCT01174043|3842266|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021237|NCT01174043|3842266|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021238|NCT01174043|3842266|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021239|NCT01174043|3842266|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021240|NCT01174043|3842266|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021241|NCT01174043|3842266|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4021242|NCT01174043|3842266|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021243|NCT01174043|3842266|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4021244|NCT01174043|3842266|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4021245|NCT01174043|3842266|B1|||Age||years|Mean|76.8|76.8|Standard Deviation|7.04|7.04|||
4021246|NCT01174043|3842266|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4021247|NCT01174043|3842266|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4021248|NCT01174043|3842266|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4021249|NCT01174030|3842272|B6|United States||Region of Enrollment||participants|Number|269|269.0||||||
4021250|NCT01174030|3842273|B5|United States||Region of Enrollment||participants|Number|53|53.0||||||
4021251|NCT01174030|3842274|B4|United States||Region of Enrollment||participants|Number|55|55.0||||||
4021252|NCT01174030|3842275|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
4021253|NCT01174030|3842276|B2|United States||Region of Enrollment||participants|Number|54|54.0||||||
4021254|NCT01174030|3842277|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
4021255|NCT01174030|3842272|B6||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4021256|NCT01174030|3842273|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4021257|NCT01174030|3842274|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4021258|NCT01174030|3842275|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4021259|NCT01174030|3842276|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4021260|NCT01174030|3842277|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4021261|NCT01174030|3842272|B6||Female|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
4021262|NCT01174030|3842273|B5||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4021263|NCT01174030|3842274|B4||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4021264|NCT01174030|3842275|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4021265|NCT01174030|3842276|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4021266|NCT01174030|3842277|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4021267|NCT01174030|3842272|B6|||Age||years|Mean|44.3|44.3|Standard Deviation|12.32|12.32|||
4021268|NCT01174030|3842273|B5|||Age||years|Mean|43.0|43.0|Standard Deviation|12.33|12.33|||
4021269|NCT01174030|3842274|B4|||Age||years|Mean|43.4|43.4|Standard Deviation|12.73|12.73|||
4021270|NCT01174030|3842275|B3|||Age||years|Mean|43.2|43.2|Standard Deviation|12.28|12.28|||
4021271|NCT01174030|3842276|B2|||Age||years|Mean|46.9|46.9|Standard Deviation|12.72|12.72|||
4021272|NCT01174030|3842277|B1|||Age||years|Mean|44.9|44.9|Standard Deviation|11.50|11.5|||
4021273|NCT01174030|3842272|B6||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4021274|NCT01174030|3842273|B5||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4021275|NCT01174030|3842274|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4021276|NCT01174030|3842275|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4021277|NCT01174030|3842276|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4021278|NCT01174030|3842277|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4021279|NCT01174030|3842272|B6||Between 18 and 65 years|Age||Participants|Count of Participants|257|257.0||||||
4021280|NCT01174030|3842273|B5||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4021281|NCT01174030|3842274|B4||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4021282|NCT01174030|3842275|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4021283|NCT01174030|3842276|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4021284|NCT01174030|3842277|B1||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4021285|NCT01174030|3842272|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4021286|NCT01174030|3842273|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4021287|NCT01174030|3842274|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4021288|NCT01174030|3842275|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4021289|NCT01174030|3842276|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4021290|NCT01174030|3842277|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4021291|NCT01174004|3842303|B3|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4021292|NCT01174004|3842304|B2|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4021293|NCT01174004|3842305|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4021294|NCT01174004|3842303|B3|United States||Region of Enrollment||participants|Number|193|193.0||||||
4021295|NCT01174004|3842304|B2|United States||Region of Enrollment||participants|Number|101|101.0||||||
4021296|NCT01174004|3842305|B1|United States||Region of Enrollment||participants|Number|92|92.0||||||
4021297|NCT01174004|3842303|B3||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4021298|NCT01174004|3842304|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4021299|NCT01174004|3842305|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4021300|NCT01174004|3842303|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4021301|NCT01174004|3842304|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4021302|NCT01174004|3842305|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4021303|NCT01174004|3842303|B3|||Age||years|Mean|72.7|72.7|Standard Deviation|7.25|7.25|||
4021304|NCT01174004|3842304|B2|||Age||years|Mean|72.6|72.6|Standard Deviation|6.49|6.49|||
4021305|NCT01174004|3842305|B1|||Age||years|Mean|72.7|72.7|Standard Deviation|8.03|8.03|||
4021306|NCT01174004|3842303|B3||>=65 years|Age|Safety Analysis Set|Participants|Count of Participants|175|175.0||||||
4021307|NCT01174004|3842304|B2||>=65 years|Age|Safety Analysis Set|Participants|Count of Participants|92|92.0||||||
4021308|NCT01174004|3842305|B1||>=65 years|Age|Safety Analysis Set|Participants|Count of Participants|83|83.0||||||
4021309|NCT01174004|3842303|B3||Between 18 and 65 years|Age|Safety Analysis Set|Participants|Count of Participants|23|23.0||||||
4021310|NCT01174004|3842304|B2||Between 18 and 65 years|Age|Safety Analysis Set|Participants|Count of Participants|12|12.0||||||
4021311|NCT01174004|3842305|B1||Between 18 and 65 years|Age|Safety Analysis Set|Participants|Count of Participants|11|11.0||||||
4021312|NCT01174004|3842303|B3||<=18 years|Age|Safety Analysis Set|Participants|Count of Participants|0|0.0||||||
4021313|NCT01174004|3842304|B2||<=18 years|Age|Safety Analysis Set|Participants|Count of Participants|0|0.0||||||
4021314|NCT01174004|3842305|B1||<=18 years|Age|Safety Analysis Set|Participants|Count of Participants|0|0.0||||||
4021315|NCT01173874|3842314|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4021316|NCT01173874|3842315|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4021317|NCT01173874|3842316|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4021318|NCT01173874|3842314|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4021319|NCT01173874|3842315|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4021320|NCT01173874|3842316|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4021321|NCT01173874|3842314|B3|||Age||years|Mean|37.7|37.7|Standard Deviation|10.1|10.1|||
4021322|NCT01173874|3842315|B2|||Age||years|Mean|38.1|38.1|Standard Deviation|10.3|10.3|||
4021323|NCT01173874|3842316|B1|||Age||years|Mean|37.1|37.1|Standard Deviation|9.9|9.9|||
4021324|NCT01173848|3842329|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4021325|NCT01173848|3842330|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4021326|NCT01173848|3842331|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4021327|NCT01173848|3842329|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4021328|NCT01173848|3842330|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4021329|NCT01173848|3842331|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4021330|NCT01173848|3842329|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4021331|NCT01173848|3842330|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4021332|NCT01173848|3842331|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4021333|NCT01173848|3842329|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4021334|NCT01173848|3842330|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4021335|NCT01173848|3842331|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4021336|NCT01173848|3842329|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4021337|NCT01173848|3842330|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4021338|NCT01173848|3842331|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4021339|NCT01173718|3842337|B1|United States||Region of Enrollment||participants|Number|138|138.0||||||
4021340|NCT01173718|3842337|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4021341|NCT01173718|3842337|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4021342|NCT01173718|3842337|B1|||Age||years|Mean|63|63.0|Standard Deviation|13.8|13.8|||
4021343|NCT01173679|3842346|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4021344|NCT01173679|3842346|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4021345|NCT01173679|3842346|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4021346|NCT01173679|3842346|B1|||Age||years|Median|68|68.0|Full Range|||60.0|85.0|
4021347|NCT01173653|3842352|B3|United States||Region of Enrollment||participants|Number|199|199.0||||||
4021348|NCT01173653|3842353|B2|United States||Region of Enrollment||participants|Number|90|90.0||||||
4021349|NCT01173653|3842354|B1|United States||Region of Enrollment||participants|Number|109|109.0||||||
4021350|NCT01173653|3842352|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4021351|NCT01173653|3842353|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4021352|NCT01173653|3842354|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4021353|NCT01173653|3842352|B3||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4021354|NCT01173653|3842353|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4021355|NCT01173653|3842354|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4021356|NCT01173653|3842352|B3|||Age||years|Median|44|44.0|Inter-Quartile Range|33, 50|33.0|32.0|50.0|
4021357|NCT01173653|3842353|B2|||Age||years|Median|44|44.0|Inter-Quartile Range|33, 49|33.0|33.0|49.0|
4021358|NCT01173653|3842354|B1|||Age||years|Median|44|44.0|Inter-Quartile Range|31, 51|31.0|31.0|51.0|
4021359|NCT01173653|3842352|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4021360|NCT01173653|3842353|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4021361|NCT01173653|3842354|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4021362|NCT01173653|3842352|B3||Between 18 and 65 years|Age||Participants|Count of Participants|199|199.0||||||
4021363|NCT01173653|3842353|B2||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
4021364|NCT01173653|3842354|B1||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
4021365|NCT01173653|3842352|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4021366|NCT01173653|3842353|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4021367|NCT01173653|3842354|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4021368|NCT01173601|3842361|B5|Japan||Region of Enrollment||Participants|Count of Participants|261|261.0||||||
4021369|NCT01173601|3842362|B4|Japan||Region of Enrollment||Participants|Count of Participants|117|117.0||||||
4021370|NCT01173601|3842363|B3|Japan||Region of Enrollment||Participants|Count of Participants|53|53.0||||||
4021371|NCT01173601|3842364|B2|Japan||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
4021372|NCT01173601|3842365|B1|Japan||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
4021373|NCT01173601|3842361|B5|Latvia||Region of Enrollment||Participants|Count of Participants|81|81.0||||||
4021374|NCT01173601|3842362|B4|Latvia||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
4021375|NCT01173601|3842363|B3|Latvia||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
4021376|NCT01173601|3842364|B2|Latvia||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4021377|NCT01173601|3842365|B1|Latvia||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4021378|NCT01173601|3842361|B5|South Africa||Region of Enrollment||Participants|Count of Participants|73|73.0||||||
4021379|NCT01173601|3842362|B4|South Africa||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
4021380|NCT01173601|3842363|B3|South Africa||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4021381|NCT01173601|3842364|B2|South Africa||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4021382|NCT01173601|3842365|B1|South Africa||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4021383|NCT01173601|3842361|B5|Russia||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
4021384|NCT01173601|3842362|B4|Russia||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4021385|NCT01173601|3842363|B3|Russia||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4021386|NCT01173601|3842364|B2|Russia||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4021387|NCT01173601|3842365|B1|Russia||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4021388|NCT01173601|3842361|B5|Ukraine||Region of Enrollment||Participants|Count of Participants|127|127.0||||||
4021389|NCT01173601|3842362|B4|Ukraine||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
4021390|NCT01173601|3842363|B3|Ukraine||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
4021391|NCT01173601|3842364|B2|Ukraine||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
4021392|NCT01173601|3842365|B1|Ukraine||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
4021393|NCT01173601|3842361|B5|Poland||Region of Enrollment||Participants|Count of Participants|212|212.0||||||
4021394|NCT01173601|3842362|B4|Poland||Region of Enrollment||Participants|Count of Participants|63|63.0||||||
4021395|NCT01173601|3842363|B3|Poland||Region of Enrollment||Participants|Count of Participants|51|51.0||||||
4021396|NCT01173601|3842364|B2|Poland||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
4021397|NCT01173601|3842365|B1|Poland||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
4021398|NCT01173601|3842361|B5|United States||Region of Enrollment||Participants|Count of Participants|541|541.0||||||
4021399|NCT01173601|3842362|B4|United States||Region of Enrollment||Participants|Count of Participants|318|318.0||||||
4021400|NCT01173601|3842363|B3|United States||Region of Enrollment||Participants|Count of Participants|74|74.0||||||
4021401|NCT01173601|3842364|B2|United States||Region of Enrollment||Participants|Count of Participants|76|76.0||||||
4021402|NCT01173601|3842365|B1|United States||Region of Enrollment||Participants|Count of Participants|73|73.0||||||
4021403|NCT01173601|3842361|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4021404|NCT01173601|3842362|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4021405|NCT01173601|3842363|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4021406|NCT01173601|3842364|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021407|NCT01173601|3842365|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4021408|NCT01173601|3842361|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4021409|NCT01173601|3842362|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4021410|NCT01173601|3842363|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021411|NCT01173601|3842364|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4021412|NCT01173601|3842365|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4021413|NCT01173601|3842361|B5||White|Race (NIH/OMB)||Participants|Count of Participants|927|927.0||||||
4021414|NCT01173601|3842362|B4||White|Race (NIH/OMB)||Participants|Count of Participants|429|429.0||||||
4021415|NCT01173601|3842363|B3||White|Race (NIH/OMB)||Participants|Count of Participants|164|164.0||||||
4021416|NCT01173601|3842364|B2||White|Race (NIH/OMB)||Participants|Count of Participants|170|170.0||||||
4021417|NCT01173601|3842365|B1||White|Race (NIH/OMB)||Participants|Count of Participants|164|164.0||||||
4021418|NCT01173601|3842361|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|112|112.0||||||
4021419|NCT01173601|3842362|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4021420|NCT01173601|3842363|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4021421|NCT01173601|3842364|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4021422|NCT01173601|3842365|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4021423|NCT01173601|3842361|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021424|NCT01173601|3842362|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021425|NCT01173601|3842363|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021426|NCT01173601|3842364|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021427|NCT01173601|3842365|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021428|NCT01173601|3842361|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|269|269.0||||||
4021429|NCT01173601|3842362|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|121|121.0||||||
4021430|NCT01173601|3842363|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4021431|NCT01173601|3842364|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4021432|NCT01173601|3842365|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4021433|NCT01173601|3842361|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4021434|NCT01173601|3842362|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4021435|NCT01173601|3842363|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021436|NCT01173601|3842364|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021437|NCT01173601|3842365|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021438|NCT01173601|3842361|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|216|216.0||||||
4021439|NCT01173601|3842362|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
4021440|NCT01173601|3842363|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4021441|NCT01173601|3842364|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4021442|NCT01173601|3842365|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4021443|NCT01173601|3842361|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1061|1061.0||||||
4021444|NCT01173601|3842362|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|520|520.0||||||
4021445|NCT01173601|3842363|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|188|188.0||||||
4021446|NCT01173601|3842364|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|172|172.0||||||
4021447|NCT01173601|3842365|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|181|181.0||||||
4021448|NCT01173601|3842361|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4021449|NCT01173601|3842362|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4021450|NCT01173601|3842363|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4021451|NCT01173601|3842364|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4021452|NCT01173601|3842365|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4021453|NCT01173601|3842361|B5||Male|Sex: Female, Male||Participants|Count of Participants|428|428.0||||||
4021454|NCT01173601|3842362|B4||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4021455|NCT01173601|3842363|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4021456|NCT01173601|3842364|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4021457|NCT01173601|3842365|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4021458|NCT01173601|3842361|B5||Female|Sex: Female, Male||Participants|Count of Participants|900|900.0||||||
4021459|NCT01173601|3842362|B4||Female|Sex: Female, Male||Participants|Count of Participants|451|451.0||||||
4021460|NCT01173601|3842363|B3||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4021461|NCT01173601|3842364|B2||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4021462|NCT01173601|3842365|B1||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4021463|NCT01173601|3842361|B5|||Age||years|Mean|44.94|44.94|Standard Deviation|11.92|11.92|||
4021464|NCT01173601|3842362|B4|||Age||years|Mean|44.73|44.73|Standard Deviation|11.89|11.89|||
4021465|NCT01173601|3842363|B3|||Age||years|Mean|44.38|44.38|Standard Deviation|10.60|10.6|||
4021466|NCT01173601|3842364|B2|||Age||years|Mean|46.06|46.06|Standard Deviation|12.82|12.82|||
4021467|NCT01173601|3842365|B1|||Age||years|Mean|44.95|44.95|Standard Deviation|12.38|12.38|||
4021468|NCT01173523|3842444|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4021469|NCT01173523|3842445|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4021470|NCT01173523|3842446|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4021471|NCT01173523|3842444|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4021472|NCT01173523|3842445|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4021473|NCT01173523|3842446|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4021474|NCT01173523|3842444|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4021475|NCT01173523|3842445|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4021476|NCT01173523|3842446|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4021477|NCT01173523|3842444|B3|||Age||years|Median|61|61.0|Full Range|||43.0|72.0|
4021478|NCT01173523|3842445|B2|||Age||years|Median|59.5|59.5|Full Range|||43.0|70.0|
4021479|NCT01173523|3842446|B1|||Age||years|Median|62|62.0|Full Range|||44.0|72.0|
4021480|NCT01173471|3842459|B5|Not on intra-ocular pressure medication||Stratification factor||Participants|Number|32|32.0||||||
4021481|NCT01173471|3842460|B4|Not on intra-ocular pressure medication||Stratification factor||Participants|Number|10|10.0||||||
4021541|NCT01173471|3842460|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4021482|NCT01173471|3842461|B3|Not on intra-ocular pressure medication||Stratification factor||Participants|Number|10|10.0||||||
4021483|NCT01173471|3842462|B2|Not on intra-ocular pressure medication||Stratification factor||Participants|Number|6|6.0||||||
4021484|NCT01173471|3842463|B1|Not on intra-ocular pressure medication||Stratification factor||Participants|Number|6|6.0||||||
4021485|NCT01173471|3842459|B5|Add-on to intra-ocular pressure medication||Stratification factor||Participants|Number|18|18.0||||||
4021486|NCT01173471|3842460|B4|Add-on to intra-ocular pressure medication||Stratification factor||Participants|Number|9|9.0||||||
4021487|NCT01173471|3842461|B3|Add-on to intra-ocular pressure medication||Stratification factor||Participants|Number|8|8.0||||||
4021488|NCT01173471|3842462|B2|Add-on to intra-ocular pressure medication||Stratification factor||Participants|Number|1|1.0||||||
4021489|NCT01173471|3842463|B1|Add-on to intra-ocular pressure medication||Stratification factor||Participants|Number|0|0.0||||||
4021490|NCT01173471|3842459|B5|United States||Region of Enrollment||Participants|Number|37|37.0||||||
4021491|NCT01173471|3842460|B4|United States||Region of Enrollment||Participants|Number|19|19.0||||||
4021492|NCT01173471|3842461|B3|United States||Region of Enrollment||Participants|Number|18|18.0||||||
4021493|NCT01173471|3842462|B2|United States||Region of Enrollment||Participants|Number|0|0.0||||||
4021494|NCT01173471|3842463|B1|United States||Region of Enrollment||Participants|Number|0|0.0||||||
4021495|NCT01173471|3842459|B5|Sweden||Region of Enrollment||Participants|Number|7|7.0||||||
4021496|NCT01173471|3842460|B4|Sweden||Region of Enrollment||Participants|Number|0|0.0||||||
4021497|NCT01173471|3842461|B3|Sweden||Region of Enrollment||Participants|Number|0|0.0||||||
4021498|NCT01173471|3842462|B2|Sweden||Region of Enrollment||Participants|Number|3|3.0||||||
4021499|NCT01173471|3842463|B1|Sweden||Region of Enrollment||Participants|Number|4|4.0||||||
4021500|NCT01173471|3842459|B5|United Kingdom||Region of Enrollment||Participants|Number|6|6.0||||||
4021501|NCT01173471|3842460|B4|United Kingdom||Region of Enrollment||Participants|Number|0|0.0||||||
4021502|NCT01173471|3842461|B3|United Kingdom||Region of Enrollment||Participants|Number|0|0.0||||||
4021503|NCT01173471|3842462|B2|United Kingdom||Region of Enrollment||Participants|Number|4|4.0||||||
4021504|NCT01173471|3842463|B1|United Kingdom||Region of Enrollment||Participants|Number|2|2.0||||||
4021505|NCT01173471|3842459|B5|Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4021506|NCT01173471|3842460|B4|Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4021507|NCT01173471|3842461|B3|Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4021508|NCT01173471|3842462|B2|Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4021509|NCT01173471|3842463|B1|Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4021510|NCT01173471|3842459|B5|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4021511|NCT01173471|3842460|B4|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4021512|NCT01173471|3842461|B3|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4021513|NCT01173471|3842462|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4021514|NCT01173471|3842463|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4021515|NCT01173471|3842459|B5|White||Race/Ethnicity, Customized||Participants|Number|39|39.0||||||
4021516|NCT01173471|3842460|B4|White||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4021517|NCT01173471|3842461|B3|White||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4021518|NCT01173471|3842462|B2|White||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4021519|NCT01173471|3842463|B1|White||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4021520|NCT01173471|3842459|B5|Black or African American||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4021521|NCT01173471|3842460|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4021522|NCT01173471|3842461|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4021523|NCT01173471|3842462|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4021524|NCT01173471|3842463|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4021525|NCT01173471|3842459|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4021526|NCT01173471|3842460|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4021527|NCT01173471|3842461|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4021528|NCT01173471|3842462|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4021529|NCT01173471|3842463|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4021530|NCT01173471|3842459|B5|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4021531|NCT01173471|3842460|B4|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4021532|NCT01173471|3842461|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4021533|NCT01173471|3842462|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4021534|NCT01173471|3842463|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4021535|NCT01173471|3842459|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4021536|NCT01173471|3842460|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4021537|NCT01173471|3842461|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4021538|NCT01173471|3842462|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4021539|NCT01173471|3842463|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4021540|NCT01173471|3842459|B5||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4021542|NCT01173471|3842461|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4021543|NCT01173471|3842462|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4021544|NCT01173471|3842463|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4021545|NCT01173471|3842459|B5||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4021546|NCT01173471|3842460|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4021547|NCT01173471|3842461|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4021548|NCT01173471|3842462|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4021549|NCT01173471|3842463|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4021550|NCT01173471|3842459|B5|>=65 years||Age, Customized||Participants|Number|24|24.0||||||
4021551|NCT01173471|3842460|B4|>=65 years||Age, Customized||Participants|Number|12|12.0||||||
4021552|NCT01173471|3842461|B3|>=65 years||Age, Customized||Participants|Number|7|7.0||||||
4021553|NCT01173471|3842462|B2|>=65 years||Age, Customized||Participants|Number|2|2.0||||||
4021554|NCT01173471|3842463|B1|>=65 years||Age, Customized||Participants|Number|3|3.0||||||
4021555|NCT01173471|3842459|B5|>=50-<65 years||Age, Customized||Participants|Number|18|18.0||||||
4021556|NCT01173471|3842460|B4|>=50-<65 years||Age, Customized||Participants|Number|5|5.0||||||
4021557|NCT01173471|3842461|B3|>=50-<65 years||Age, Customized||Participants|Number|6|6.0||||||
4021558|NCT01173471|3842462|B2|>=50-<65 years||Age, Customized||Participants|Number|4|4.0||||||
4021559|NCT01173471|3842463|B1|>=50-<65 years||Age, Customized||Participants|Number|3|3.0||||||
4021560|NCT01173471|3842459|B5|<50 years||Age, Customized||Participants|Number|8|8.0||||||
4021561|NCT01173471|3842460|B4|<50 years||Age, Customized||Participants|Number|2|2.0||||||
4021562|NCT01173471|3842461|B3|<50 years||Age, Customized||Participants|Number|5|5.0||||||
4021563|NCT01173471|3842462|B2|<50 years||Age, Customized||Participants|Number|1|1.0||||||
4021564|NCT01173471|3842463|B1|<50 years||Age, Customized||Participants|Number|0|0.0||||||
4021565|NCT01173471|3842459|B5|||Age||Years|Mean|61|61.0|Standard Deviation|11.9|11.9|||
4021566|NCT01173471|3842460|B4|||Age||Years|Mean|65|65.0|Standard Deviation|10.1|10.1|||
4021567|NCT01173471|3842461|B3|||Age||Years|Mean|57|57.0|Standard Deviation|15.1|15.1|||
4021568|NCT01173471|3842462|B2|||Age||Years|Mean|63|63.0|Standard Deviation|8.7|8.7|||
4021569|NCT01173471|3842463|B1|||Age||Years|Mean|63|63.0|Standard Deviation|6.7|6.7|||
4021570|NCT01173211|3842484|B7|United States||Region of Enrollment||participants|Number|183|183.0||||||
4021571|NCT01173211|3842485|B6|United States||Region of Enrollment||participants|Number|13|13.0||||||
4021572|NCT01173211|3842486|B5|United States||Region of Enrollment||participants|Number|16|16.0||||||
4021573|NCT01173211|3842487|B4|United States||Region of Enrollment||participants|Number|15|15.0||||||
4021574|NCT01173211|3842488|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
4021575|NCT01173211|3842489|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
4021576|NCT01173211|3842490|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4021577|NCT01173211|3842484|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4021578|NCT01173211|3842485|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4021579|NCT01173211|3842486|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4021580|NCT01173211|3842487|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4021581|NCT01173211|3842488|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4021582|NCT01173211|3842489|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4021583|NCT01173211|3842490|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4021584|NCT01173211|3842484|B7||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4021585|NCT01173211|3842485|B6||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4021586|NCT01173211|3842486|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4021587|NCT01173211|3842487|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4021588|NCT01173211|3842488|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4021589|NCT01173211|3842489|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4021590|NCT01173211|3842490|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4021591|NCT01173211|3842484|B7|||Age||years|Mean|30.0|30.0|Standard Deviation|4.9|4.9|||
4021592|NCT01173211|3842485|B6|||Age||years|Mean|29.7|29.7|Standard Deviation|5.2|5.2|||
4021593|NCT01173211|3842486|B5|||Age||years|Mean|29.3|29.3|Standard Deviation|6.7|6.7|||
4021594|NCT01173211|3842487|B4|||Age||years|Mean|27.5|27.5|Standard Deviation|6.5|6.5|||
4021595|NCT01173211|3842488|B3|||Age||years|Mean|30.7|30.7|Standard Deviation|4.8|4.8|||
4021596|NCT01173211|3842489|B2|||Age||years|Mean|29.8|29.8|Standard Deviation|4.1|4.1|||
4021597|NCT01173211|3842490|B1|||Age||years|Mean|30.7|30.7|Standard Deviation|4.4|4.4|||
4021598|NCT01173211|3842484|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4021599|NCT01173211|3842485|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4021600|NCT01173211|3842486|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4021601|NCT01173211|3842487|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4021602|NCT01173211|3842488|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4021603|NCT01173211|3842489|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4021604|NCT01173211|3842490|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4021605|NCT01173211|3842484|B7||Between 18 and 65 years|Age||Participants|Count of Participants|183|183.0||||||
4021606|NCT01173211|3842485|B6||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4021607|NCT01173211|3842486|B5||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4021608|NCT01173211|3842487|B4||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4021609|NCT01173211|3842488|B3||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4021610|NCT01173211|3842489|B2||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4021611|NCT01173211|3842490|B1||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4021612|NCT01173211|3842484|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4021613|NCT01173211|3842485|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4021614|NCT01173211|3842486|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4021615|NCT01173211|3842487|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4021616|NCT01173211|3842488|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4021617|NCT01173211|3842489|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4021618|NCT01173211|3842490|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4021619|NCT01173120|3842596|B1|||Baseline Methotrexate Dose||mg/wk|Mean|17.2|17.2|Standard Deviation|3.8|3.8|||
4021620|NCT01173120|3842596|B1|Negative||Rheumatoid Factor (RF) Status|RF is an autoantibody (antibody directed against an organism's own tissues) most relevant in rheumatoid arthritis. It is an antibody against the Fc portion of Immunoglobulin (Ig)G, which is itself an antibody. RF and IgG join to form immune complexes that contribute to the disease process. A positive value for RF was >20 IU/mL; a negative value for RF was ≤20 IU/mL.|participants|Number|16|16.0||||||
4021621|NCT01173120|3842596|B1|Positive||Rheumatoid Factor (RF) Status|RF is an autoantibody (antibody directed against an organism's own tissues) most relevant in rheumatoid arthritis. It is an antibody against the Fc portion of Immunoglobulin (Ig)G, which is itself an antibody. RF and IgG join to form immune complexes that contribute to the disease process. A positive value for RF was >20 IU/mL; a negative value for RF was ≤20 IU/mL.|participants|Number|46|46.0||||||
4021622|NCT01173120|3842596|B1|||Disease Activity Score (DAS 28)|The DAS28 is a continuous disease measure that is a composite of 4 variables: the 28 tender joint count, the 28 swollen joint count, CRP levels, and participant assessment of disease activity measure on a visual analogue scale. The DAS28 has numeric thresholds that define high disease activity (>5.1), low disease activity (<3.2) and remission (<2.6). A clinically significant response=decrease in DAS28 score of >1.2 from baseline.|units on a scale|Mean|6.0|6.0|Standard Deviation|0.8|0.8|||
4021623|NCT01173120|3842596|B1|||High Sensitivity C-Reactive Protein (hs-CRP) Level|hs-CRP is an acute phase reactant protein that is a clinical marker for rheumatoid arthritis. Levels of hs-CRP can be used to determine the disease activity score.|mg/dL|Mean|1.7|1.7|Standard Deviation|1.2|1.2|||
4021624|NCT01173120|3842596|B1|||Physician Global Assessment|Physician global rheumatoid arthritis assessment core component of the ACR scoring system, where increasing score indicates increasing level of severity as indicated on a 100 mm Visual Analog Scale, with 0 mm representing no pain and 100 mm representing the most pain possible.|units on a scale|Mean|62.0|62.0|Standard Deviation|17.4|17.4|||
4021625|NCT01173120|3842596|B1|||Participant Global Assessment|Participant self-reported global rheumatoid arthritis assessment core component of the ACR scoring system, where increasing score indicates increasing level of severity as indicated on a 100 mm Visual Analog Scale, with 0 mm representing no pain and 100 mm representing the most pain possible.|units on a scale|Mean|61.6|61.6|Standard Deviation|19.7|19.7|||
4021626|NCT01173120|3842596|B1|||Physical Function (Health Assessment Questionnaire Disability Index [HAQ-DI])|The disability section of the full HAQ includes 20 questions that assess physical functions in 8 domains: dressing, arising, eating, walking, hygiene, reach, grip, and other common activities. The questions are evaluated on a 4-point scale: 0=without any difficulty, 1=with some difficulty, 2=with much difficulty, and 3=unable to do. Higher scores=greater dysfunction. A disability index was calculated by summing the worst scores in each domain and dividing by the number of domains answered.|units on a scale|Mean|1.5|1.5|Standard Deviation|0.7|0.7|||
4021627|NCT01173120|3842596|B1|||Participant Pain Assessment|The participant self-reported pain assessment is a core component of the American College of Rheumatology (ACR)scoring system, where increasing score indicates increasing level of severity as indicated on a 100 mm Visual Analog Scale, with 0 mm representing no pain and 100 mm representing the most pain possible.|units on a scale|Mean|64.2|64.2|Standard Deviation|21.5|21.5|||
4021628|NCT01173120|3842596|B1|||Number of Swollen Joints|Swollen joints are an indicator of rheumatoid arthritis. The number of swollen joints in a standard 66 joint count was evaluated. The number of swollen joints ranges from 0 swollen joints to 66, where an increased number of swollen joints indicates increasing level of disease severity.|swollen joints|Mean|20.8|20.8|Standard Deviation|8.2|8.2|||
4021629|NCT01173120|3842596|B1|||Number of Tender Joints|Tender joints are an indicator of rheumatoid arthritis. The number of tender joints in a standard 68 joint count was evaluated. The number of tender joints ranges from 0 to 68, where an increased number of tender joints indicates increasing level of disease severity.|tender joints|Mean|31.6|31.6|Standard Deviation|15.2|15.2|||
4021630|NCT01173120|3842596|B1|>10 years||Duration of Disease-Categorical||participants|Number|17|17.0||||||
4021631|NCT01173120|3842596|B1|>5 - 10 years||Duration of Disease-Categorical||participants|Number|7|7.0||||||
4021632|NCT01173120|3842596|B1|>2 - ≤5 years||Duration of Disease-Categorical||participants|Number|10|10.0||||||
4021633|NCT01173120|3842596|B1|≤ 2 years||Duration of Disease-Categorical||participants|Number|28|28.0||||||
4021634|NCT01173120|3842596|B1|||Mean Duration of Disease||years|Mean|7.4|7.4|Standard Deviation|10.1|10.1|||
4021635|NCT01173120|3842596|B1|||Weight||kg|Mean|86.3|86.3|Standard Deviation|20.1|20.1|||
4021636|NCT01173120|3842596|B1|North America||Region of Enrollment||participants|Number|62|62.0||||||
4021637|NCT01173120|3842596|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4021638|NCT01173120|3842596|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021639|NCT01173120|3842596|B1||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4021640|NCT01173120|3842596|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4021641|NCT01173120|3842596|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021642|NCT01173120|3842596|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021643|NCT01173120|3842596|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4021644|NCT01173120|3842596|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4021645|NCT01173120|3842596|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4021646|NCT01173120|3842596|B1|||Age||years|Mean|54.2|54.2|Standard Deviation|10.1|10.1|||
4021647|NCT01173055|3842612|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4021648|NCT01173055|3842613|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4021649|NCT01173055|3842614|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4021650|NCT01173055|3842612|B3|Female||Sex/Gender, Customized||participants|Number|15|15.0||||||
4021651|NCT01173055|3842613|B2|Female||Sex/Gender, Customized||participants|Number|9|9.0||||||
4021652|NCT01173055|3842614|B1|Female||Sex/Gender, Customized||participants|Number|6|6.0||||||
4021653|NCT01173055|3842612|B3|Fibromyalgia||Age, Customized||years|Mean|40.73|40.73|Standard Deviation|10.187|10.187|||
4021654|NCT01173055|3842613|B2|Fibromyalgia||Age, Customized||years|Mean|36.67|36.67|Standard Deviation|8.64|8.64|||
4021655|NCT01173055|3842614|B1|Fibromyalgia||Age, Customized||years|Mean|46.83|46.83|Standard Deviation|9.83|9.83|||
4021656|NCT01173029|3842631|B3|||Anti-hypertensive treatment|Anti-hypertensive treatment, including regimen, drug and the number of drugs prescribed, was left at discrtion of the physician who carried primary assiatnce.|participants|Number|92|92.0||||||
4021657|NCT01173029|3842632|B2|||Anti-hypertensive treatment|Anti-hypertensive treatment, including regimen, drug and the number of drugs prescribed, was left at discrtion of the physician who carried primary assiatnce.|participants|Number|31|31.0||||||
4021658|NCT01173029|3842633|B1|||Anti-hypertensive treatment|Anti-hypertensive treatment, including regimen, drug and the number of drugs prescribed, was left at discrtion of the physician who carried primary assiatnce.|participants|Number|61|61.0||||||
4021659|NCT01173029|3842631|B3|Angiotensinogen (M235T) MM||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment was carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C)|participants|Number|22|22.0||||||
4021660|NCT01173029|3842632|B2|Angiotensinogen (M235T) MM||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment was carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C)|participants|Number|10|10.0||||||
4021661|NCT01173029|3842633|B1|Angiotensinogen (M235T) MM||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment was carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C)|participants|Number|12|12.0||||||
4021662|NCT01173029|3842631|B3|Angiotensinogen (M235T) MT||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment was carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C)|participants|Number|40|40.0||||||
4021663|NCT01173029|3842632|B2|Angiotensinogen (M235T) MT||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment was carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C)|participants|Number|15|15.0||||||
4021664|NCT01173029|3842633|B1|Angiotensinogen (M235T) MT||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment was carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C)|participants|Number|25|25.0||||||
4021665|NCT01173029|3842631|B3|Angiotensinogen (M235T) TT||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment was carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C)|participants|Number|30|30.0||||||
4021666|NCT01173029|3842632|B2|Angiotensinogen (M235T) TT||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment was carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C)|participants|Number|6|6.0||||||
4021667|NCT01173029|3842633|B1|Angiotensinogen (M235T) TT||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment was carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C)|participants|Number|24|24.0||||||
4021668|NCT01173029|3842631|B3|aldosterone synthase (C344T) TT||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment was carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C).|participants|Number|14|14.0||||||
4021759|NCT01172873|3842846|B3||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4021760|NCT01172873|3842847|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4021669|NCT01173029|3842632|B2|aldosterone synthase (C344T) TT||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment was carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C).|participants|Number|7|7.0||||||
4021670|NCT01173029|3842633|B1|aldosterone synthase (C344T) TT||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment was carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C).|participants|Number|7|7.0||||||
4021671|NCT01173029|3842631|B3|aldosterone synthase (C344T) TC||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment was carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C).|participants|Number|45|45.0||||||
4021672|NCT01173029|3842632|B2|aldosterone synthase (C344T) TC||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment was carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C).|participants|Number|15|15.0||||||
4021673|NCT01173029|3842633|B1|aldosterone synthase (C344T) TC||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment was carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C).|participants|Number|30|30.0||||||
4021674|NCT01173029|3842631|B3|aldosterone synthase (C344T) CC||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment was carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C).|participants|Number|33|33.0||||||
4021675|NCT01173029|3842632|B2|aldosterone synthase (C344T) CC||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment was carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C).|participants|Number|9|9.0||||||
4021676|NCT01173029|3842633|B1|aldosterone synthase (C344T) CC||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment was carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C).|participants|Number|24|24.0||||||
4021677|NCT01173029|3842631|B3|Angiotensin II type 1 receptor (A1166C) CC||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C)|participants|Number|1|1.0||||||
4021678|NCT01173029|3842632|B2|Angiotensin II type 1 receptor (A1166C) CC||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C)|participants|Number|0|0.0||||||
4021679|NCT01173029|3842633|B1|Angiotensin II type 1 receptor (A1166C) CC||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C)|participants|Number|1|1.0||||||
4021680|NCT01173029|3842631|B3|Angiotensin II type 1 receptor (A1166C) AC||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C)|participants|Number|29|29.0||||||
4021681|NCT01173029|3842632|B2|Angiotensin II type 1 receptor (A1166C) AC||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C)|participants|Number|5|5.0||||||
4021682|NCT01173029|3842633|B1|Angiotensin II type 1 receptor (A1166C) AC||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C)|participants|Number|24|24.0||||||
4021683|NCT01173029|3842631|B3|Angiotensin II type 1 receptor (A1166C) AA||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C)|participants|Number|62|62.0||||||
4021684|NCT01173029|3842632|B2|Angiotensin II type 1 receptor (A1166C) AA||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C)|participants|Number|26|26.0||||||
4021761|NCT01172873|3842848|B1||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4021685|NCT01173029|3842633|B1|Angiotensin II type 1 receptor (A1166C) AA||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C)|participants|Number|36|36.0||||||
4021686|NCT01173029|3842631|B3|ACE (I/D) DD||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment was carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C)|participants|Number|31|31.0||||||
4021687|NCT01173029|3842632|B2|ACE (I/D) DD||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment was carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C)|participants|Number|11|11.0||||||
4021688|NCT01173029|3842633|B1|ACE (I/D) DD||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment was carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C)|participants|Number|20|20.0||||||
4021689|NCT01173029|3842631|B3|ACE (I/D) ID||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment was carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C)|participants|Number|42|42.0||||||
4021690|NCT01173029|3842632|B2|ACE (I/D) ID||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment was carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C)|participants|Number|13|13.0||||||
4021691|NCT01173029|3842633|B1|ACE (I/D) ID||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment was carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C)|participants|Number|29|29.0||||||
4021692|NCT01173029|3842631|B3|ACE (I/D) II||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment was carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C)|participants|Number|19|19.0||||||
4021693|NCT01173029|3842632|B2|ACE (I/D) II||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment was carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C)|participants|Number|7|7.0||||||
4021694|NCT01173029|3842633|B1|ACE (I/D) II||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment was carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C)|participants|Number|12|12.0||||||
4021695|NCT01173029|3842631|B3|Renin (G1051A) AA||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment was carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C)|participants|Number|30|30.0||||||
4021696|NCT01173029|3842632|B2|Renin (G1051A) AA||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment was carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C)|participants|Number|15|15.0||||||
4021697|NCT01173029|3842633|B1|Renin (G1051A) AA||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment was carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C)|participants|Number|15|15.0||||||
4021698|NCT01173029|3842631|B3|Renin (G1051A) GA||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment was carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C)|participants|Number|30|30.0||||||
4021699|NCT01173029|3842632|B2|Renin (G1051A) GA||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment was carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C)|participants|Number|6|6.0||||||
4021700|NCT01173029|3842633|B1|Renin (G1051A) GA||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment was carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C)|participants|Number|24|24.0||||||
4021701|NCT01173029|3842631|B3|Renin (G1051A) GG||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment was carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C)|participants|Number|32|32.0||||||
4021702|NCT01173029|3842632|B2|Renin (G1051A) GG||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment was carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C)|participants|Number|10|10.0||||||
4021703|NCT01173029|3842633|B1|Renin (G1051A) GG||Renin-Angiotensin-Aldosterone System Polymorphism|Genetic assessment was carried out using polymerase chain reaction assay amplification. The following single nucleotide polymorphisms were analyzed: renin (G1051A), angiotensinogen (M235T), ACE (I/D), angiotensin II type 1 receptor (A1166C), aldosterone synthase (C344T) and mineralocorticoid receptor (G3514C)|participants|Number|22|22.0||||||
4021704|NCT01173029|3842631|B3|Brazil||Region of Enrollment||participants|Number|92|92.0||||||
4021705|NCT01173029|3842632|B2|Brazil||Region of Enrollment||participants|Number|31|31.0||||||
4021706|NCT01173029|3842633|B1|Brazil||Region of Enrollment||participants|Number|61|61.0||||||
4021707|NCT01173029|3842631|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4021708|NCT01173029|3842632|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4021709|NCT01173029|3842633|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4021710|NCT01173029|3842631|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4021711|NCT01173029|3842632|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4021712|NCT01173029|3842633|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4021713|NCT01173029|3842631|B3|||Age||years|Mean|54.4|54.4|Standard Deviation|9.4|9.4|||
4021714|NCT01173029|3842632|B2|||Age||years|Mean|56.8|56.8|Standard Deviation|9.0|9.0|||
4021715|NCT01173029|3842633|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|9.6|9.6|||
4021716|NCT01173029|3842631|B3||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4021717|NCT01173029|3842632|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4021718|NCT01173029|3842633|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4021719|NCT01173029|3842631|B3||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4021720|NCT01173029|3842632|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4021721|NCT01173029|3842633|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4021722|NCT01173029|3842631|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4021723|NCT01173029|3842632|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4021724|NCT01173029|3842633|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4021725|NCT01172938|3842651|B4|||Duration of psoriatic arthritis||years|Mean|7.53|7.53|Standard Deviation|7.366|7.366|||
4021726|NCT01172938|3842652|B3|||Duration of psoriatic arthritis||years|Mean|8.09|8.09|Standard Deviation|8.092|8.092|||
4021727|NCT01172938|3842653|B2|||Duration of psoriatic arthritis||years|Mean|7.18|7.18|Standard Deviation|6.842|6.842|||
4021728|NCT01172938|3842654|B1|||Duration of psoriatic arthritis||years|Mean|7.31|7.31|Standard Deviation|7.118|7.118|||
4021729|NCT01172938|3842651|B4||Male|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
4021730|NCT01172938|3842652|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4021731|NCT01172938|3842653|B2||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4021732|NCT01172938|3842654|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4021733|NCT01172938|3842651|B4||Female|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
4021734|NCT01172938|3842652|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4021735|NCT01172938|3842653|B2||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4021736|NCT01172938|3842654|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4021737|NCT01172938|3842651|B4|||Age||years|Mean|50.4|50.4|Standard Deviation|11.66|11.66|||
4021738|NCT01172938|3842652|B3|||Age||years|Mean|51.4|51.4|Standard Deviation|11.72|11.72|||
4021739|NCT01172938|3842653|B2|||Age||years|Mean|48.7|48.7|Standard Deviation|10.99|10.99|||
4021740|NCT01172938|3842654|B1|||Age||years|Mean|51.1|51.1|Standard Deviation|12.13|12.13|||
4021741|NCT01172873|3842846|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4021742|NCT01172873|3842847|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4021743|NCT01172873|3842848|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4021744|NCT01172873|3842846|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4021745|NCT01172873|3842847|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4021746|NCT01172873|3842848|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4021747|NCT01172873|3842846|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4021748|NCT01172873|3842847|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4021749|NCT01172873|3842848|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4021750|NCT01172873|3842846|B3|||Age||years|Mean|15.85|15.85|Standard Deviation|1.21|1.21|||
4021751|NCT01172873|3842847|B2|||Age||years|Mean|16.25|16.25|Standard Deviation|.96|0.96|||
4021752|NCT01172873|3842848|B1|||Age||years|Mean|15.67|15.67|Standard Deviation|1.32|1.32|||
4021753|NCT01172873|3842846|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4021754|NCT01172873|3842847|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4021755|NCT01172873|3842848|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4021756|NCT01172873|3842846|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4021757|NCT01172873|3842847|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4021758|NCT01172873|3842848|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4021762|NCT01172847|3842859|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4021763|NCT01172847|3842859|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4021764|NCT01172847|3842859|B1|||Age||years|Mean|33.5|33.5|Standard Deviation|7.34|7.34|||
4021765|NCT01172821|3842884|B5||Male|Sex: Female, Male||Participants|Count of Participants|426|426.0||||||
4021766|NCT01172821|3842885|B4||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4021767|NCT01172821|3842886|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4021768|NCT01172821|3842887|B2||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4021769|NCT01172821|3842888|B1||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4021770|NCT01172821|3842884|B5||Female|Sex: Female, Male||Participants|Count of Participants|604|604.0||||||
4021771|NCT01172821|3842885|B4||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4021772|NCT01172821|3842886|B3||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4021773|NCT01172821|3842887|B2||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4021774|NCT01172821|3842888|B1||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4021775|NCT01172821|3842884|B5|||Age||years|Mean|42.9|42.9|Standard Deviation|12.9|12.9|||
4021776|NCT01172821|3842885|B4|||Age||years|Mean|41.5|41.5|Standard Deviation|13.1|13.1|||
4021777|NCT01172821|3842886|B3|||Age||years|Mean|44.3|44.3|Standard Deviation|12.7|12.7|||
4021778|NCT01172821|3842887|B2|||Age||years|Mean|43.0|43.0|Standard Deviation|12.6|12.6|||
4021779|NCT01172821|3842888|B1|||Age||years|Mean|43.0|43.0|Standard Deviation|13.0|13.0|||
4021780|NCT01172808|3842977|B5||Male|Sex: Female, Male||Participants|Count of Participants|435|435.0||||||
4021781|NCT01172808|3842978|B4||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4021782|NCT01172808|3842979|B3||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4021783|NCT01172808|3842980|B2||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4021784|NCT01172808|3842981|B1||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4021785|NCT01172808|3842977|B5||Female|Sex: Female, Male||Participants|Count of Participants|635|635.0||||||
4021786|NCT01172808|3842978|B4||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4021787|NCT01172808|3842979|B3||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4021788|NCT01172808|3842980|B2||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4021789|NCT01172808|3842981|B1||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4021790|NCT01172808|3842977|B5|||Age||years|Mean|43.3|43.3|Standard Deviation|12.9|12.9|||
4021791|NCT01172808|3842978|B4|||Age||years|Mean|42.6|42.6|Standard Deviation|12.6|12.6|||
4021792|NCT01172808|3842979|B3|||Age||years|Mean|44.4|44.4|Standard Deviation|12.6|12.6|||
4021793|NCT01172808|3842980|B2|||Age||years|Mean|43.7|43.7|Standard Deviation|13.1|13.1|||
4021794|NCT01172808|3842981|B1|||Age||years|Mean|42.5|42.5|Standard Deviation|13.1|13.1|||
4021795|NCT01172639|3843070|B6|||Symptom duration||weeks|Mean|36.2|36.2|Standard Deviation|52.6|52.6|||
4021796|NCT01172639|3843071|B5|||Symptom duration||weeks|Mean|33.1|33.1|Standard Deviation|62.2|62.2|||
4021797|NCT01172639|3843072|B4|||Symptom duration||weeks|Mean|34.4|34.4|Standard Deviation|68.2|68.2|||
4021798|NCT01172639|3843073|B3|||Symptom duration||weeks|Mean|44.3|44.3|Standard Deviation|65.9|65.9|||
4021799|NCT01172639|3843074|B2|||Symptom duration||weeks|Mean|33.2|33.2|Standard Deviation|38.2|38.2|||
4021800|NCT01172639|3843075|B1|||Symptom duration||weeks|Mean|33.8|33.8|Standard Deviation|35.5|35.5|||
4021801|NCT01172639|3843070|B6|never||Smoking status||Participants|Count of Participants|170|170.0||||||
4021802|NCT01172639|3843071|B5|never||Smoking status||Participants|Count of Participants|29|29.0||||||
4021803|NCT01172639|3843072|B4|never||Smoking status||Participants|Count of Participants|22|22.0||||||
4021804|NCT01172639|3843073|B3|never||Smoking status||Participants|Count of Participants|37|37.0||||||
4021805|NCT01172639|3843074|B2|never||Smoking status||Participants|Count of Participants|40|40.0||||||
4021806|NCT01172639|3843075|B1|never||Smoking status||Participants|Count of Participants|42|42.0||||||
4021807|NCT01172639|3843070|B6|past||Smoking status||Participants|Count of Participants|112|112.0||||||
4021808|NCT01172639|3843071|B5|past||Smoking status||Participants|Count of Participants|14|14.0||||||
4021809|NCT01172639|3843072|B4|past||Smoking status||Participants|Count of Participants|11|11.0||||||
4021810|NCT01172639|3843073|B3|past||Smoking status||Participants|Count of Participants|33|33.0||||||
4021811|NCT01172639|3843074|B2|past||Smoking status||Participants|Count of Participants|28|28.0||||||
4021812|NCT01172639|3843075|B1|past||Smoking status||Participants|Count of Participants|26|26.0||||||
4021813|NCT01172639|3843070|B6|current||Smoking status||Participants|Count of Participants|97|97.0||||||
4021814|NCT01172639|3843071|B5|current||Smoking status||Participants|Count of Participants|4|4.0||||||
4021815|NCT01172639|3843072|B4|current||Smoking status||Participants|Count of Participants|10|10.0||||||
4021816|NCT01172639|3843073|B3|current||Smoking status||Participants|Count of Participants|23|23.0||||||
4021817|NCT01172639|3843074|B2|current||Smoking status||Participants|Count of Participants|30|30.0||||||
4021818|NCT01172639|3843075|B1|current||Smoking status||Participants|Count of Participants|30|30.0||||||
4021819|NCT01172639|3843070|B6|North African||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4021820|NCT01172639|3843071|B5|North African||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4021821|NCT01172639|3843072|B4|North African||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4021822|NCT01172639|3843073|B3|North African||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4021823|NCT01172639|3843074|B2|North African||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4021824|NCT01172639|3843075|B1|North African||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4021825|NCT01172639|3843070|B6|Black||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4021826|NCT01172639|3843071|B5|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4021827|NCT01172639|3843072|B4|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4021828|NCT01172639|3843073|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4021829|NCT01172639|3843074|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4021830|NCT01172639|3843075|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4021831|NCT01172639|3843070|B6|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4021832|NCT01172639|3843071|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4021833|NCT01172639|3843072|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4021834|NCT01172639|3843073|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4021835|NCT01172639|3843074|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4021836|NCT01172639|3843075|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4021837|NCT01172639|3843070|B6|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4021838|NCT01172639|3843071|B5|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4021839|NCT01172639|3843072|B4|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4021840|NCT01172639|3843073|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4021841|NCT01172639|3843074|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4021842|NCT01172639|3843075|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4021843|NCT01172639|3843070|B6|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|371|371.0||||||
4021844|NCT01172639|3843071|B5|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
4021845|NCT01172639|3843072|B4|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
4021846|NCT01172639|3843073|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|90|90.0||||||
4021847|NCT01172639|3843074|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|96|96.0||||||
4021848|NCT01172639|3843075|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|95|95.0||||||
4021849|NCT01172639|3843070|B6||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4021850|NCT01172639|3843071|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4021851|NCT01172639|3843072|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4021852|NCT01172639|3843073|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4021853|NCT01172639|3843074|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4021854|NCT01172639|3843075|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4021855|NCT01172639|3843070|B6||Female|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
4021856|NCT01172639|3843071|B5||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4021857|NCT01172639|3843072|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4021858|NCT01172639|3843073|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4021859|NCT01172639|3843074|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4021860|NCT01172639|3843075|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4021861|NCT01172639|3843070|B6|||Age||years|Mean|51.9|51.9|Standard Deviation|12.9|12.9|||
4021862|NCT01172639|3843071|B5|||Age||years|Mean|51.0|51.0|Standard Deviation|14.0|14.0|||
4021863|NCT01172639|3843072|B4|||Age||years|Mean|51.4|51.4|Standard Deviation|14.4|14.4|||
4021864|NCT01172639|3843073|B3|||Age||years|Mean|51.1|51.1|Standard Deviation|12.8|12.8|||
4021865|NCT01172639|3843074|B2|||Age||years|Mean|51.8|51.8|Standard Deviation|13.1|13.1|||
4021866|NCT01172639|3843075|B1|||Age||years|Mean|53.2|53.2|Standard Deviation|11.9|11.9|||
4021867|NCT01172600|3843121|B3|Never smoked||Smoking status||participants|Number|32|32.0||||||
4021868|NCT01172600|3843122|B2|Never smoked||Smoking status||participants|Number|18|18.0||||||
4021869|NCT01172600|3843123|B1|Never smoked||Smoking status||participants|Number|14|14.0||||||
4021870|NCT01172600|3843121|B3|Previously quit||Smoking status||participants|Number|27|27.0||||||
4021871|NCT01172600|3843122|B2|Previously quit||Smoking status||participants|Number|12|12.0||||||
4021872|NCT01172600|3843123|B1|Previously quit||Smoking status||participants|Number|15|15.0||||||
4021873|NCT01172600|3843121|B3|Current Smoker||Smoking status||participants|Number|19|19.0||||||
4021874|NCT01172600|3843122|B2|Current Smoker||Smoking status||participants|Number|9|9.0||||||
4021875|NCT01172600|3843123|B1|Current Smoker||Smoking status||participants|Number|10|10.0||||||
4021876|NCT01172600|3843121|B3|III: A patient with severe systemic disease||American Society of Anesthesiologists physical status||participants|Number|5|5.0||||||
4021877|NCT01172600|3843122|B2|III: A patient with severe systemic disease||American Society of Anesthesiologists physical status||participants|Number|5|5.0||||||
4021878|NCT01172600|3843123|B1|III: A patient with severe systemic disease||American Society of Anesthesiologists physical status||participants|Number|0|0.0||||||
4021879|NCT01172600|3843121|B3|II: A patient with mild systemic disease||American Society of Anesthesiologists physical status||participants|Number|57|57.0||||||
4021880|NCT01172600|3843122|B2|II: A patient with mild systemic disease||American Society of Anesthesiologists physical status||participants|Number|27|27.0||||||
4021881|NCT01172600|3843123|B1|II: A patient with mild systemic disease||American Society of Anesthesiologists physical status||participants|Number|30|30.0||||||
4021882|NCT01172600|3843121|B3|I: A normal healthy patient||American Society of Anesthesiologists physical status||participants|Number|16|16.0||||||
4021883|NCT01172600|3843122|B2|I: A normal healthy patient||American Society of Anesthesiologists physical status||participants|Number|7|7.0||||||
4021884|NCT01172600|3843123|B1|I: A normal healthy patient||American Society of Anesthesiologists physical status||participants|Number|9|9.0||||||
4021885|NCT01172600|3843121|B3|||Body mass index||kg/m2|Median|30|30.0|Inter-Quartile Range|||26.0|34.0|
4021886|NCT01172600|3843122|B2|||Body mass index||kg/m2|Median|28|28.0|Inter-Quartile Range|||25.0|34.0|
4021887|NCT01172600|3843123|B1|||Body mass index||kg/m2|Median|30|30.0|Inter-Quartile Range|||27.0|35.0|
4021888|NCT01172600|3843121|B3|African American||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4021889|NCT01172600|3843122|B2|African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4021890|NCT01172600|3843123|B1|African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4021891|NCT01172600|3843121|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
4021892|NCT01172600|3843122|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4021893|NCT01172600|3843123|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4021894|NCT01172600|3843121|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4021895|NCT01172600|3843122|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4021896|NCT01172600|3843123|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4021897|NCT01172600|3843121|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4021898|NCT01172600|3843122|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4021899|NCT01172600|3843123|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4021900|NCT01172600|3843121|B3|||Age||years|Mean|71|71.0|Standard Deviation|18|18.0|||
4021901|NCT01172600|3843122|B2|||Age||years|Mean|73|73.0|Standard Deviation|16|16.0|||
4021902|NCT01172600|3843123|B1|||Age||years|Mean|70|70.0|Standard Deviation|20|20.0|||
4021903|NCT01172535|3843154|B1|||CD4% at study entry||percentage of total lymphocytes|Median|24.2|24.2|Inter-Quartile Range|||15.8|29.0|
4021904|NCT01172535|3843154|B1|||HIV RNA (copies/mL) at study entry||log copies/mL|Median|5.2|5.2|Inter-Quartile Range|||4.6|5.7|
4021905|NCT01172535|3843154|B1|Thailand||Region of Enrollment||participants|Number|37|37.0||||||
4021906|NCT01172535|3843154|B1|South Africa||Region of Enrollment||participants|Number|23|23.0||||||
4021907|NCT01172535|3843154|B1|Brazil||Region of Enrollment||participants|Number|32|32.0||||||
4021908|NCT01172535|3843154|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4021909|NCT01172535|3843154|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4021910|NCT01172535|3843154|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021911|NCT01172535|3843154|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4021912|NCT01172535|3843154|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4021913|NCT01172535|3843154|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021914|NCT01172535|3843154|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4021915|NCT01172535|3843154|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021916|NCT01172535|3843154|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4021917|NCT01172535|3843154|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4021918|NCT01172535|3843154|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4021919|NCT01172535|3843154|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4021920|NCT01172535|3843154|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4021921|NCT01172535|3843154|B1|||Age||years|Median|2.5|2.5|Inter-Quartile Range|||0.5|6.2|
4021922|NCT01172522|3843169|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4021923|NCT01172522|3843170|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4021924|NCT01172522|3843171|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4021925|NCT01172522|3843169|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4021926|NCT01172522|3843170|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4021927|NCT01172522|3843171|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4021928|NCT01172522|3843169|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4021929|NCT01172522|3843170|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4021930|NCT01172522|3843171|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4021931|NCT01172522|3843169|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4021932|NCT01172522|3843170|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4021933|NCT01172522|3843171|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4021934|NCT01172522|3843169|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4021935|NCT01172522|3843170|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4021936|NCT01172522|3843171|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4021937|NCT01172522|3843169|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4021938|NCT01172522|3843170|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4021939|NCT01172522|3843171|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4021940|NCT01172522|3843169|B3|||Age||years|Mean|30|30.0|Standard Deviation|15|15.0|||
4021941|NCT01172522|3843170|B2|||Age||years|Mean|30|30.0|Standard Deviation|15|15.0|||
4021942|NCT01172522|3843171|B1|||Age||years|Mean|30|30.0|Standard Deviation|15|15.0|||
4021943|NCT01172418|3843177|B3|United States||Region of Enrollment||participants|Number|200|200.0||||||
4021944|NCT01172418|3843178|B2|United States||Region of Enrollment||participants|Number|100|100.0||||||
4021945|NCT01172418|3843179|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
4021946|NCT01172418|3843177|B3||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4021947|NCT01172418|3843178|B2||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4021948|NCT01172418|3843179|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4021949|NCT01172418|3843177|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4021950|NCT01172418|3843178|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4021951|NCT01172418|3843179|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4021952|NCT01172418|3843177|B3||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4021953|NCT01172418|3843178|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4021954|NCT01172418|3843179|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4021955|NCT01172418|3843177|B3||Between 18 and 65 years|Age||Participants|Count of Participants|178|178.0||||||
4021956|NCT01172418|3843178|B2||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
4021957|NCT01172418|3843179|B1||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
4021958|NCT01172418|3843177|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4021959|NCT01172418|3843178|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4021960|NCT01172418|3843179|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4021961|NCT01172418|3843177|B3|||Age||participants|Mean|49.65|49.65|Standard Deviation|12.5|12.5|||
4021962|NCT01172418|3843178|B2|||Age||participants|Mean|49.4|49.4|Standard Deviation|13|13.0|||
4021963|NCT01172418|3843179|B1|||Age||participants|Mean|49.9|49.9|Standard Deviation|12|12.0|||
4021964|NCT01172353|3843194|B3|Brazil||Region of Enrollment||participants|Number|301|301.0||||||
4021965|NCT01172353|3843195|B2|Brazil||Region of Enrollment||participants|Number|151|151.0||||||
4021966|NCT01172353|3843196|B1|Brazil||Region of Enrollment||participants|Number|150|150.0||||||
4021967|NCT01172353|3843194|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021968|NCT01172353|3843195|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021969|NCT01172353|3843196|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021970|NCT01172353|3843194|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021971|NCT01172353|3843195|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021972|NCT01172353|3843196|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021973|NCT01172353|3843194|B3||White|Race (NIH/OMB)||Participants|Count of Participants|280|280.0||||||
4021974|NCT01172353|3843195|B2||White|Race (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
4021975|NCT01172353|3843196|B1||White|Race (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
4021976|NCT01172353|3843194|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4021977|NCT01172353|3843195|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4021978|NCT01172353|3843196|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4021979|NCT01172353|3843194|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021980|NCT01172353|3843195|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021981|NCT01172353|3843196|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021982|NCT01172353|3843194|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021983|NCT01172353|3843195|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021984|NCT01172353|3843196|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021985|NCT01172353|3843194|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021986|NCT01172353|3843195|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021987|NCT01172353|3843196|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4021988|NCT01172353|3843194|B3||Male|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
4021989|NCT01172353|3843195|B2||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4021990|NCT01172353|3843196|B1||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4021991|NCT01172353|3843194|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4021992|NCT01172353|3843195|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4021993|NCT01172353|3843196|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4021994|NCT01172353|3843194|B3|||Age||years|Mean|64.3|64.3|Standard Deviation|12|12.0|||
4021995|NCT01172353|3843195|B2|||Age||years|Mean|64.5|64.5|Standard Deviation|12|12.0|||
4021996|NCT01172353|3843196|B1|||Age||years|Mean|64.1|64.1|Standard Deviation|12|12.0|||
4021997|NCT01172288|3843205|B3|||Age of onset||years|Mean|6.4|6.4|Standard Deviation|1.17|1.17|||
4021998|NCT01172288|3843206|B2|||Age of onset||years|Mean|6.1|6.1|Standard Deviation|2.4|2.4|||
4021999|NCT01172288|3843207|B1|||Age of onset||years|Mean|6.8|6.8|Standard Deviation|1.4|1.4|||
4022000|NCT01172288|3843205|B3||Male|Gender||Participants|Count of Participants|24|24.0||||||
4022001|NCT01172288|3843206|B2||Male|Gender||Participants|Count of Participants|12|12.0||||||
4022002|NCT01172288|3843207|B1||Male|Gender||Participants|Count of Participants|12|12.0||||||
4022003|NCT01172288|3843205|B3||Female|Gender||Participants|Count of Participants|7|7.0||||||
4022004|NCT01172288|3843206|B2||Female|Gender||Participants|Count of Participants|2|2.0||||||
4022005|NCT01172288|3843207|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
4022006|NCT01172288|3843205|B3|||Age||years|Mean|11.9|11.9|Standard Deviation|2.17|2.17|||
4022007|NCT01172288|3843206|B2|||Age||years|Mean|11.5|11.5|Standard Deviation|2.8|2.8|||
4022008|NCT01172288|3843207|B1|||Age||years|Mean|12.4|12.4|Standard Deviation|1.4|1.4|||
4022009|NCT01172197|3843222|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4022010|NCT01172197|3843223|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4022011|NCT01172197|3843224|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4022012|NCT01172197|3843222|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4022013|NCT01172197|3843222|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4022014|NCT01172197|3843223|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4022015|NCT01172197|3843224|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4022016|NCT01172197|3843222|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4022017|NCT01172197|3843223|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4022018|NCT01172197|3843224|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4022019|NCT01172197|3843222|B3|||Age||years|Median|62|62.0|Full Range|||53.0|72.0|
4022020|NCT01172197|3843223|B2|||Age||years|Median|64|64.0|Full Range|||56.0|72.0|
4022021|NCT01172197|3843224|B1|||Age||years|Median|60|60.0|Full Range|||53.0|70.0|
4022022|NCT01172184|3843231|B1|Taiwan||Region of Enrollment||participants|Number|111|111.0||||||
4022023|NCT01172184|3843231|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4022024|NCT01172184|3843231|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4022025|NCT01172184|3843231|B1|||Age||years|Mean|68|68.0|Standard Deviation|18|18.0|||
4022026|NCT01172184|3843231|B1||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
4022027|NCT01172184|3843231|B1||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4022028|NCT01172184|3843231|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022029|NCT01172145|3843237|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4022030|NCT01172145|3843238|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4022031|NCT01172145|3843239|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4022032|NCT01172145|3843237|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4022033|NCT01172145|3843238|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4022034|NCT01172145|3843239|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4022035|NCT01172145|3843237|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4022036|NCT01172145|3843238|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4022037|NCT01172145|3843239|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4022038|NCT01172145|3843237|B3|||Age||years|Mean|77.32|77.32|Standard Deviation|8.07|8.07|||
4022039|NCT01172145|3843238|B2|||Age||years|Mean|75.27|75.27|Standard Deviation|8.34|8.34|||
4022040|NCT01172145|3843239|B1|||Age||years|Mean|79.36|79.36|Standard Deviation|7.62|7.62|||
4022041|NCT01172145|3843237|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4022042|NCT01172145|3843238|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4022043|NCT01172145|3843239|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4022044|NCT01172145|3843237|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4022045|NCT01172145|3843238|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4022046|NCT01172145|3843239|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4022047|NCT01172145|3843237|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022048|NCT01172145|3843238|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022049|NCT01172145|3843239|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022050|NCT01171989|3843260|B4|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|391|391.0||||||
4022051|NCT01171989|3843261|B3|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|121|121.0||||||
4022052|NCT01171989|3843262|B2|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|133|133.0||||||
4022053|NCT01171989|3843263|B1|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|137|137.0||||||
4022054|NCT01171989|3843260|B4||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4022055|NCT01171989|3843261|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4022056|NCT01171989|3843262|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4022057|NCT01171989|3843263|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4022058|NCT01171989|3843260|B4||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4022059|NCT01171989|3843261|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4022060|NCT01171989|3843262|B2||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4022061|NCT01171989|3843263|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4022062|NCT01171989|3843260|B4|||Age||Months|Mean|13.73|13.73|Standard Deviation|0.73|0.73|||
4022063|NCT01171989|3843261|B3|||Age||Months|Mean|13.7|13.7|Standard Deviation|0.76|0.76|||
4022064|NCT01171989|3843262|B2|||Age||Months|Mean|13.8|13.8|Standard Deviation|0.73|0.73|||
4022065|NCT01171989|3843263|B1|||Age||Months|Mean|13.7|13.7|Standard Deviation|0.71|0.71|||
4022066|NCT01171976|3843336|B4||Male|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
4022067|NCT01171976|3843337|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4022068|NCT01171976|3843338|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4022069|NCT01171976|3843339|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4022070|NCT01171976|3843336|B4||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4022071|NCT01171976|3843337|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4022072|NCT01171976|3843338|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4022073|NCT01171976|3843339|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4022074|NCT01171976|3843336|B4|||Age||Years|Mean|63.7|63.7|Standard Deviation|9.53|9.53|||
4022075|NCT01171976|3843337|B3|||Age||Years|Mean|64.5|64.5|Standard Deviation|9.66|9.66|||
4022076|NCT01171976|3843338|B2|||Age||Years|Mean|63.0|63.0|Standard Deviation|9.83|9.83|||
4022077|NCT01171976|3843339|B1|||Age||Years|Mean|63.7|63.7|Standard Deviation|9.07|9.07|||
4022078|NCT01171963|3843376|B3||Male|Sex: Female, Male||Participants|Count of Participants|1702|1702.0||||||
4022079|NCT01171963|3843377|B2||Male|Sex: Female, Male||Participants|Count of Participants|831|831.0||||||
4022080|NCT01171963|3843378|B1||Male|Sex: Female, Male||Participants|Count of Participants|871|871.0||||||
4022081|NCT01171963|3843376|B3||Female|Sex: Female, Male||Participants|Count of Participants|1631|1631.0||||||
4022082|NCT01171963|3843377|B2||Female|Sex: Female, Male||Participants|Count of Participants|836|836.0||||||
4022083|NCT01171963|3843378|B1||Female|Sex: Female, Male||Participants|Count of Participants|795|795.0||||||
4022084|NCT01171963|3843376|B3|||Age||Weeks|Mean|9.6|9.6|Standard Deviation|2.62|2.62|||
4022085|NCT01171963|3843377|B2|||Age||Weeks|Mean|9.7|9.7|Standard Deviation|2.59|2.59|||
4022086|NCT01171963|3843378|B1|||Age||Weeks|Mean|9.5|9.5|Standard Deviation|2.64|2.64|||
4022087|NCT01171924|3843435|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
4022088|NCT01171924|3843436|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4022089|NCT01171924|3843437|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4022090|NCT01171924|3843435|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4022091|NCT01171924|3843436|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4022092|NCT01171924|3843437|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022093|NCT01171924|3843435|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022094|NCT01171924|3843436|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022095|NCT01171924|3843437|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022096|NCT01171924|3843435|B3||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4022097|NCT01171924|3843436|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4022098|NCT01171924|3843437|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4022099|NCT01171924|3843435|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4022100|NCT01171924|3843436|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4022101|NCT01171924|3843437|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4022102|NCT01171924|3843435|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022103|NCT01171924|3843436|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022104|NCT01171924|3843437|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022105|NCT01171924|3843435|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4022106|NCT01171924|3843436|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4022107|NCT01171924|3843437|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4022108|NCT01171924|3843435|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022109|NCT01171924|3843436|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022110|NCT01171924|3843437|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022111|NCT01171924|3843435|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4022112|NCT01171924|3843436|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4022113|NCT01171924|3843437|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022114|NCT01171924|3843435|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4022115|NCT01171924|3843436|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4022116|NCT01171924|3843437|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4022117|NCT01171924|3843435|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4022118|NCT01171924|3843436|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4022238|NCT01171820|3843473|B3|||Age||years|Mean|65.46|65.46|Standard Deviation|9.39|9.39|||
4022119|NCT01171924|3843437|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4022120|NCT01171924|3843435|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4022121|NCT01171924|3843436|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4022122|NCT01171924|3843437|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4022123|NCT01171924|3843435|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4022124|NCT01171924|3843436|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4022125|NCT01171924|3843437|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4022126|NCT01171924|3843435|B3|||Age||years|Median|63.0|63.0|Full Range|||37.0|85.0|
4022127|NCT01171924|3843436|B2|||Age||years|Median|65.0|65.0|Full Range|||37.0|85.0|
4022128|NCT01171924|3843437|B1|||Age||years|Median|61.0|61.0|Full Range|||40.0|78.0|
4022129|NCT01171898|3843444|B5|United States||Region of Enrollment||Participants|Count of Participants|127|127.0||||||
4022130|NCT01171898|3843445|B4|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
4022131|NCT01171898|3843446|B3|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4022132|NCT01171898|3843447|B2|United States||Region of Enrollment||Participants|Count of Participants|51|51.0||||||
4022133|NCT01171898|3843448|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4022134|NCT01171898|3843444|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022135|NCT01171898|3843445|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022136|NCT01171898|3843446|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022137|NCT01171898|3843447|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022138|NCT01171898|3843448|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022139|NCT01171898|3843444|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022140|NCT01171898|3843445|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022141|NCT01171898|3843446|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022142|NCT01171898|3843447|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022143|NCT01171898|3843448|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022144|NCT01171898|3843444|B5||White|Race (NIH/OMB)||Participants|Count of Participants|121|121.0||||||
4022145|NCT01171898|3843445|B4||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4022146|NCT01171898|3843446|B3||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4022147|NCT01171898|3843447|B2||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4022148|NCT01171898|3843448|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4022149|NCT01171898|3843444|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4022150|NCT01171898|3843445|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4022151|NCT01171898|3843446|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022152|NCT01171898|3843447|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4022153|NCT01171898|3843448|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022154|NCT01171898|3843444|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022155|NCT01171898|3843445|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022156|NCT01171898|3843446|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022157|NCT01171898|3843447|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022158|NCT01171898|3843448|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022159|NCT01171898|3843444|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4022160|NCT01171898|3843445|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022161|NCT01171898|3843446|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022162|NCT01171898|3843447|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4022163|NCT01171898|3843448|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022164|NCT01171898|3843444|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022165|NCT01171898|3843445|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022166|NCT01171898|3843446|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022167|NCT01171898|3843447|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022168|NCT01171898|3843448|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022169|NCT01171898|3843444|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022170|NCT01171898|3843445|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022171|NCT01171898|3843446|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022172|NCT01171898|3843447|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022173|NCT01171898|3843448|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022174|NCT01171898|3843444|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
4022175|NCT01171898|3843445|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4022176|NCT01171898|3843446|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4022177|NCT01171898|3843447|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4022178|NCT01171898|3843448|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4022179|NCT01171898|3843444|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4022180|NCT01171898|3843445|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022181|NCT01171898|3843446|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022182|NCT01171898|3843447|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4022183|NCT01171898|3843448|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4022184|NCT01171898|3843444|B5||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4022185|NCT01171898|3843445|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4022186|NCT01171898|3843446|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4022187|NCT01171898|3843447|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4022188|NCT01171898|3843448|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4022189|NCT01171898|3843444|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4022190|NCT01171898|3843445|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4022191|NCT01171898|3843446|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4022192|NCT01171898|3843447|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4022193|NCT01171898|3843448|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4022194|NCT01171898|3843444|B5|||Age||years|Mean|70.2|70.2|Standard Deviation|9.82|9.82|||
4022195|NCT01171898|3843445|B4|||Age||years|Mean|67.4|67.4|Standard Deviation|9.28|9.28|||
4022196|NCT01171898|3843446|B3|||Age||years|Mean|70|70.0|Standard Deviation|11.8|11.8|||
4022197|NCT01171898|3843447|B2|||Age||years|Mean|72.8|72.8|Standard Deviation|8.73|8.73|||
4022198|NCT01171898|3843448|B1|||Age||years|Mean|67.7|67.7|Standard Deviation|9.44|9.44|||
4022199|NCT01171820|3843473|B3|Italy||Region of Enrollment||participants|Number|60|60.0||||||
4022200|NCT01171820|3843474|B2|Italy||Region of Enrollment||participants|Number|43|43.0||||||
4022201|NCT01171820|3843475|B1|Italy||Region of Enrollment||participants|Number|17|17.0||||||
4022202|NCT01171820|3843473|B3|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
4022203|NCT01171820|3843474|B2|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4022204|NCT01171820|3843475|B1|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4022205|NCT01171820|3843473|B3|Germany||Region of Enrollment||participants|Number|36|36.0||||||
4022206|NCT01171820|3843474|B2|Germany||Region of Enrollment||participants|Number|22|22.0||||||
4022207|NCT01171820|3843475|B1|Germany||Region of Enrollment||participants|Number|14|14.0||||||
4022208|NCT01171820|3843473|B3|Netherlands||Region of Enrollment||participants|Number|13|13.0||||||
4022209|NCT01171820|3843474|B2|Netherlands||Region of Enrollment||participants|Number|12|12.0||||||
4022210|NCT01171820|3843475|B1|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4022211|NCT01171820|3843473|B3|Israel||Region of Enrollment||participants|Number|2|2.0||||||
4022212|NCT01171820|3843474|B2|Israel||Region of Enrollment||participants|Number|1|1.0||||||
4022213|NCT01171820|3843475|B1|Israel||Region of Enrollment||participants|Number|1|1.0||||||
4022214|NCT01171820|3843473|B3|Austria||Region of Enrollment||participants|Number|10|10.0||||||
4022215|NCT01171820|3843474|B2|Austria||Region of Enrollment||participants|Number|8|8.0||||||
4022216|NCT01171820|3843475|B1|Austria||Region of Enrollment||participants|Number|2|2.0||||||
4022217|NCT01171820|3843473|B3|Malaysia||Region of Enrollment||participants|Number|14|14.0||||||
4022218|NCT01171820|3843474|B2|Malaysia||Region of Enrollment||participants|Number|13|13.0||||||
4022219|NCT01171820|3843475|B1|Malaysia||Region of Enrollment||participants|Number|1|1.0||||||
4022220|NCT01171820|3843473|B3|Poland||Region of Enrollment||participants|Number|25|25.0||||||
4022221|NCT01171820|3843474|B2|Poland||Region of Enrollment||participants|Number|17|17.0||||||
4022222|NCT01171820|3843475|B1|Poland||Region of Enrollment||participants|Number|8|8.0||||||
4022223|NCT01171820|3843473|B3|Spain||Region of Enrollment||participants|Number|144|144.0||||||
4022224|NCT01171820|3843474|B2|Spain||Region of Enrollment||participants|Number|87|87.0||||||
4022225|NCT01171820|3843475|B1|Spain||Region of Enrollment||participants|Number|57|57.0||||||
4022226|NCT01171820|3843473|B3|Thailand||Region of Enrollment||participants|Number|2|2.0||||||
4022227|NCT01171820|3843474|B2|Thailand||Region of Enrollment||participants|Number|2|2.0||||||
4022228|NCT01171820|3843475|B1|Thailand||Region of Enrollment||participants|Number|0|0.0||||||
4022229|NCT01171820|3843473|B3|France||Region of Enrollment||participants|Number|9|9.0||||||
4022230|NCT01171820|3843474|B2|France||Region of Enrollment||participants|Number|7|7.0||||||
4022231|NCT01171820|3843475|B1|France||Region of Enrollment||participants|Number|2|2.0||||||
4022232|NCT01171820|3843473|B3||Male|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4022233|NCT01171820|3843474|B2||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4022234|NCT01171820|3843475|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4022235|NCT01171820|3843473|B3||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4022236|NCT01171820|3843474|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4022237|NCT01171820|3843475|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4022239|NCT01171820|3843474|B2|||Age||years|Mean|65.32|65.32|Standard Deviation|9.61|9.61|||
4022240|NCT01171820|3843475|B1|||Age||years|Mean|65.75|65.75|Standard Deviation|8.95|8.95|||
4022241|NCT01171820|3843473|B3||>=65 years|Age||Participants|Count of Participants|173|173.0||||||
4022242|NCT01171820|3843474|B2||>=65 years|Age||Participants|Count of Participants|116|116.0||||||
4022243|NCT01171820|3843475|B1||>=65 years|Age||Participants|Count of Participants|57|57.0||||||
4022244|NCT01171820|3843473|B3||Between 18 and 65 years|Age||Participants|Count of Participants|151|151.0||||||
4022245|NCT01171820|3843474|B2||Between 18 and 65 years|Age||Participants|Count of Participants|102|102.0||||||
4022246|NCT01171820|3843475|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4022247|NCT01171820|3843473|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022248|NCT01171820|3843474|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022249|NCT01171820|3843475|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022250|NCT01171794|3843530|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4022251|NCT01171794|3843531|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4022252|NCT01171794|3843532|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4022253|NCT01171794|3843530|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4022254|NCT01171794|3843531|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4022255|NCT01171794|3843532|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4022256|NCT01171794|3843530|B3|||Age||years|Mean|36.6|36.6|Standard Deviation|13.9|13.9|||
4022257|NCT01171794|3843531|B2|||Age||years|Mean|34.2|34.2|Standard Deviation|13.2|13.2|||
4022258|NCT01171794|3843532|B1|||Age||years|Mean|38.4|38.4|Standard Deviation|14.5|14.5|||
4022259|NCT01171794|3843530|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4022260|NCT01171794|3843531|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4022261|NCT01171794|3843532|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4022262|NCT01171794|3843530|B3||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
4022263|NCT01171794|3843531|B2||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4022264|NCT01171794|3843532|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4022265|NCT01171794|3843530|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022266|NCT01171794|3843531|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022267|NCT01171794|3843532|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022268|NCT01171690|3843541|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4022269|NCT01171690|3843542|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4022270|NCT01171690|3843543|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4022271|NCT01171690|3843541|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4022272|NCT01171690|3843542|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4022273|NCT01171690|3843543|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4022274|NCT01171690|3843541|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4022275|NCT01171690|3843542|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4022276|NCT01171690|3843543|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4022277|NCT01171690|3843541|B3|||Age||years|Median|41|41.0|Inter-Quartile Range|||31.0|56.0|
4022278|NCT01171690|3843542|B2|||Age||years|Median|40|40.0|Inter-Quartile Range|||32.0|57.0|
4022279|NCT01171690|3843543|B1|||Age||years|Median|41|41.0|Inter-Quartile Range|||31.0|53.0|
4022280|NCT01171677|3843552|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4022281|NCT01171677|3843553|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4022282|NCT01171677|3843554|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4022283|NCT01171677|3843552|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4022284|NCT01171677|3843553|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4022285|NCT01171677|3843554|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4022286|NCT01171677|3843552|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4022287|NCT01171677|3843553|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4022288|NCT01171677|3843554|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4022289|NCT01171677|3843552|B3|||Age||years|Mean|59|59.0|Standard Deviation|3.6|3.6|||
4022290|NCT01171677|3843553|B2|||Age||years|Mean|59|59.0|Standard Deviation|3.2|3.2|||
4022291|NCT01171677|3843554|B1|||Age||years|Mean|59|59.0|Standard Deviation|4.3|4.3|||
4022292|NCT01171677|3843552|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4022293|NCT01171677|3843553|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4022294|NCT01171677|3843554|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4022295|NCT01171677|3843552|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4022296|NCT01171677|3843553|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4022297|NCT01171677|3843554|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4022298|NCT01171677|3843552|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022299|NCT01171677|3843553|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022300|NCT01171677|3843554|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022359|NCT01171183|3843617|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4022301|NCT01171612|3843587|B1|Not antiplatelet therapy||Antiplatelet Therapy|patients taking previous aspirin, clopidogrel or both|participants|Number|20|20.0||||||
4022302|NCT01171612|3843587|B1|Antiplatelet therapy||Antiplatelet Therapy|patients taking previous aspirin, clopidogrel or both|participants|Number|412|412.0||||||
4022303|NCT01171612|3843587|B1|||Body Mass Index||Kgm^2|Median|27.9|27.9|Full Range|||18.0|50.0|
4022304|NCT01171612|3843587|B1|Spain||Region of Enrollment||participants|Number|432|432.0||||||
4022305|NCT01171612|3843587|B1||Male|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
4022306|NCT01171612|3843587|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4022307|NCT01171612|3843587|B1|>70 years||Age, Customized|age < or = 70 years old age > 70 years old|participants|Number|213|213.0||||||
4022308|NCT01171612|3843587|B1|Between 18 and 70 years||Age, Customized|age < or = 70 years old age > 70 years old|participants|Number|219|219.0||||||
4022309|NCT01171534|3843595|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4022310|NCT01171534|3843596|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4022311|NCT01171534|3843595|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4022312|NCT01171534|3843596|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4022313|NCT01171534|3843595|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4022314|NCT01171534|3843596|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4022315|NCT01171534|3843595|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4022316|NCT01171534|3843596|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4022317|NCT01171534|3843595|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022318|NCT01171534|3843596|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022319|NCT01171521|3843610|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4022320|NCT01171521|3843610|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4022321|NCT01171521|3843610|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4022322|NCT01171521|3843610|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4022323|NCT01171521|3843610|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022324|NCT01171183|3843615|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4022325|NCT01171183|3843616|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4022326|NCT01171183|3843617|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4022327|NCT01171183|3843615|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022328|NCT01171183|3843616|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022329|NCT01171183|3843617|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022330|NCT01171183|3843615|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022331|NCT01171183|3843616|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022332|NCT01171183|3843617|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022333|NCT01171183|3843615|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4022334|NCT01171183|3843616|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4022335|NCT01171183|3843617|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4022336|NCT01171183|3843615|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4022337|NCT01171183|3843616|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4022338|NCT01171183|3843617|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4022339|NCT01171183|3843615|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022340|NCT01171183|3843616|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022341|NCT01171183|3843617|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022342|NCT01171183|3843615|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022343|NCT01171183|3843616|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022344|NCT01171183|3843617|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022345|NCT01171183|3843615|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022346|NCT01171183|3843616|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022347|NCT01171183|3843617|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022348|NCT01171183|3843615|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4022349|NCT01171183|3843616|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4022350|NCT01171183|3843617|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4022351|NCT01171183|3843615|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4022352|NCT01171183|3843616|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4022353|NCT01171183|3843617|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4022354|NCT01171183|3843615|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4022355|NCT01171183|3843616|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4022356|NCT01171183|3843617|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4022357|NCT01171183|3843615|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4022358|NCT01171183|3843616|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4022360|NCT01171183|3843615|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022361|NCT01171183|3843616|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022362|NCT01171183|3843617|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022363|NCT01171118|3843626|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4022364|NCT01171118|3843626|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4022365|NCT01171118|3843626|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4022366|NCT01171118|3843626|B1|||Age||years|Mean|24.7|24.7|Standard Deviation|5.7|5.7|||
4022367|NCT01171118|3843626|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4022368|NCT01171118|3843626|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4022369|NCT01171118|3843626|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022370|NCT01170962|3843636|B4||Male|Sex: Female, Male||Participants|Count of Participants|273|273.0||||||
4022371|NCT01170962|3843637|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4022372|NCT01170962|3843638|B2||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4022373|NCT01170962|3843639|B1||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4022374|NCT01170962|3843636|B4||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4022375|NCT01170962|3843637|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4022376|NCT01170962|3843638|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4022377|NCT01170962|3843639|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4022378|NCT01170962|3843636|B4|>=65 years||Age, Customized||participants|Number|23|23.0||||||
4022379|NCT01170962|3843637|B3|>=65 years||Age, Customized||participants|Number|2|2.0||||||
4022380|NCT01170962|3843638|B2|>=65 years||Age, Customized||participants|Number|10|10.0||||||
4022381|NCT01170962|3843639|B1|>=65 years||Age, Customized||participants|Number|11|11.0||||||
4022382|NCT01170962|3843636|B4|21-65 years||Age, Customized||participants|Number|396|396.0||||||
4022383|NCT01170962|3843637|B3|21-65 years||Age, Customized||participants|Number|15|15.0||||||
4022384|NCT01170962|3843638|B2|21-65 years||Age, Customized||participants|Number|189|189.0||||||
4022385|NCT01170962|3843639|B1|21-65 years||Age, Customized||participants|Number|192|192.0||||||
4022386|NCT01170949|3843685|B3|Germany||Region of Enrollment||participants|Number|76|76.0||||||
4022387|NCT01170949|3843686|B2|Germany||Region of Enrollment||participants|Number|26|26.0||||||
4022388|NCT01170949|3843687|B1|Germany||Region of Enrollment||participants|Number|50|50.0||||||
4022389|NCT01170949|3843685|B3||Male|Gender||Participants|Count of Participants|34|34.0||||||
4022390|NCT01170949|3843686|B2||Male|Gender||Participants|Count of Participants|12|12.0||||||
4022391|NCT01170949|3843687|B1||Male|Gender||Participants|Count of Participants|22|22.0||||||
4022392|NCT01170949|3843685|B3||Female|Gender||Participants|Count of Participants|42|42.0||||||
4022393|NCT01170949|3843686|B2||Female|Gender||Participants|Count of Participants|14|14.0||||||
4022394|NCT01170949|3843687|B1||Female|Gender||Participants|Count of Participants|28|28.0||||||
4022395|NCT01170949|3843685|B3|||Age||years|Mean|44|44.0|Standard Deviation|24.9|24.9|||
4022396|NCT01170949|3843686|B2|||Age||years|Mean|42.6|42.6|Standard Deviation|12.5|12.5|||
4022397|NCT01170949|3843687|B1|||Age||years|Mean|45.0|45.0|Standard Deviation|12.4|12.4|||
4022398|NCT01170949|3843685|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4022399|NCT01170949|3843686|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4022400|NCT01170949|3843687|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4022401|NCT01170949|3843685|B3||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4022402|NCT01170949|3843686|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4022403|NCT01170949|3843687|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4022404|NCT01170949|3843685|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022405|NCT01170949|3843686|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022406|NCT01170949|3843687|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022407|NCT01170884|3843694|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4022408|NCT01170884|3843695|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4022409|NCT01170884|3843696|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4022410|NCT01170884|3843694|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4022411|NCT01170884|3843695|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4022412|NCT01170884|3843696|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4022413|NCT01170884|3843694|B3|||Age||years|Mean|63.3|63.3|Standard Deviation|11.93|11.93|||
4022414|NCT01170884|3843695|B2|||Age||years|Mean|62.6|62.6|Standard Deviation|13.19|13.19|||
4022415|NCT01170884|3843696|B1|||Age||years|Mean|64.0|64.0|Standard Deviation|10.52|10.52|||
4022416|NCT01170754|3843703|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4022417|NCT01170754|3843704|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4022418|NCT01170754|3843705|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4022419|NCT01170754|3843703|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4022420|NCT01170754|3843704|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4022421|NCT01170754|3843705|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4022422|NCT01170754|3843703|B3|||Age||years|Mean|56.4|56.4|Standard Deviation|7.7|7.7|||
4022423|NCT01170754|3843704|B2|||Age||years|Mean|56.7|56.7|Standard Deviation|7.0|7.0|||
4022424|NCT01170754|3843705|B1|||Age||years|Mean|56.3|56.3|Standard Deviation|8.4|8.4|||
4022425|NCT01170754|3843703|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4022426|NCT01170754|3843704|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4022427|NCT01170754|3843705|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4022428|NCT01170754|3843703|B3||Between 18 and 65 years|Age||Participants|Count of Participants|124|124.0||||||
4022429|NCT01170754|3843704|B2||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4022430|NCT01170754|3843705|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4022431|NCT01170754|3843703|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022432|NCT01170754|3843704|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022433|NCT01170754|3843705|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022434|NCT01170663|3843734|B3|Israel||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4022435|NCT01170663|3843735|B2|Israel||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4022436|NCT01170663|3843736|B1|Israel||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4022437|NCT01170663|3843734|B3|Hong Kong||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4022438|NCT01170663|3843735|B2|Hong Kong||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4022439|NCT01170663|3843736|B1|Hong Kong||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4022440|NCT01170663|3843734|B3|Japan||Region of Enrollment||Participants|Count of Participants|140|140.0||||||
4022441|NCT01170663|3843735|B2|Japan||Region of Enrollment||Participants|Count of Participants|72|72.0||||||
4022442|NCT01170663|3843736|B1|Japan||Region of Enrollment||Participants|Count of Participants|68|68.0||||||
4022443|NCT01170663|3843734|B3|Germany||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
4022444|NCT01170663|3843735|B2|Germany||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4022445|NCT01170663|3843736|B1|Germany||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4022446|NCT01170663|3843734|B3|Bulgaria||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4022447|NCT01170663|3843735|B2|Bulgaria||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4022448|NCT01170663|3843736|B1|Bulgaria||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4022449|NCT01170663|3843734|B3|Romania||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4022450|NCT01170663|3843735|B2|Romania||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4022451|NCT01170663|3843736|B1|Romania||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4022452|NCT01170663|3843734|B3|Singapore||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4022453|NCT01170663|3843735|B2|Singapore||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4022454|NCT01170663|3843736|B1|Singapore||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4022455|NCT01170663|3843734|B3|Belgium||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
4022456|NCT01170663|3843735|B2|Belgium||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4022457|NCT01170663|3843736|B1|Belgium||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4022458|NCT01170663|3843734|B3|Brazil||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
4022459|NCT01170663|3843735|B2|Brazil||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4022460|NCT01170663|3843736|B1|Brazil||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4022461|NCT01170663|3843734|B3|Poland||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
4022462|NCT01170663|3843735|B2|Poland||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4022463|NCT01170663|3843736|B1|Poland||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4022464|NCT01170663|3843734|B3|Argentina||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4022465|NCT01170663|3843735|B2|Argentina||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4022466|NCT01170663|3843736|B1|Argentina||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4022467|NCT01170663|3843734|B3|Mexico||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4022468|NCT01170663|3843735|B2|Mexico||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4022469|NCT01170663|3843736|B1|Mexico||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4022470|NCT01170663|3843734|B3|Hungary||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
4022471|NCT01170663|3843735|B2|Hungary||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4022472|NCT01170663|3843736|B1|Hungary||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4022473|NCT01170663|3843734|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4022474|NCT01170663|3843735|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4022475|NCT01170663|3843736|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4022476|NCT01170663|3843734|B3|Austria||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4022477|NCT01170663|3843735|B2|Austria||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4022478|NCT01170663|3843736|B1|Austria||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4022479|NCT01170663|3843734|B3|Lithuania||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4022480|NCT01170663|3843735|B2|Lithuania||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4022481|NCT01170663|3843736|B1|Lithuania||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4022482|NCT01170663|3843734|B3|South Korea||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
4022483|NCT01170663|3843735|B2|South Korea||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4022484|NCT01170663|3843736|B1|South Korea||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4022485|NCT01170663|3843734|B3|Australia||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
4022486|NCT01170663|3843735|B2|Australia||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4022487|NCT01170663|3843736|B1|Australia||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4022488|NCT01170663|3843734|B3|France||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
4022489|NCT01170663|3843735|B2|France||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4022490|NCT01170663|3843736|B1|France||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4022491|NCT01170663|3843734|B3|Italy||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
4022492|NCT01170663|3843735|B2|Italy||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4022493|NCT01170663|3843736|B1|Italy||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4022494|NCT01170663|3843734|B3|Chile||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4022495|NCT01170663|3843735|B2|Chile||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4022496|NCT01170663|3843736|B1|Chile||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4022497|NCT01170663|3843734|B3|Russia||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
4022498|NCT01170663|3843735|B2|Russia||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4022499|NCT01170663|3843736|B1|Russia||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4022500|NCT01170663|3843734|B3|Spain||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
4022501|NCT01170663|3843735|B2|Spain||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4022502|NCT01170663|3843736|B1|Spain||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4022503|NCT01170663|3843734|B3|Taiwan||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4022504|NCT01170663|3843735|B2|Taiwan||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4022505|NCT01170663|3843736|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4022506|NCT01170663|3843734|B3|Estonia||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4022507|NCT01170663|3843735|B2|Estonia||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4022508|NCT01170663|3843736|B1|Estonia||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4022509|NCT01170663|3843734|B3|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
4022510|NCT01170663|3843735|B2|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4022511|NCT01170663|3843736|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4022512|NCT01170663|3843734|B3|Portugal||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4022513|NCT01170663|3843735|B2|Portugal||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4022514|NCT01170663|3843736|B1|Portugal||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4022515|NCT01170663|3843734|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4022516|NCT01170663|3843735|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4022517|NCT01170663|3843736|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4022518|NCT01170663|3843734|B3|More than one race||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4022519|NCT01170663|3843735|B2|More than one race||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4022520|NCT01170663|3843736|B1|More than one race||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4022521|NCT01170663|3843734|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|407|407.0||||||
4022522|NCT01170663|3843735|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|199|199.0||||||
4022523|NCT01170663|3843736|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|208|208.0||||||
4022524|NCT01170663|3843734|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4022525|NCT01170663|3843735|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4022526|NCT01170663|3843736|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4022527|NCT01170663|3843734|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|231|231.0||||||
4022528|NCT01170663|3843735|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|121|121.0||||||
4022529|NCT01170663|3843736|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|110|110.0||||||
4022530|NCT01170663|3843734|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4022531|NCT01170663|3843735|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4022532|NCT01170663|3843736|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4022533|NCT01170663|3843734|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022534|NCT01170663|3843735|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022535|NCT01170663|3843736|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022536|NCT01170663|3843734|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|608|608.0||||||
4022537|NCT01170663|3843735|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|309|309.0||||||
4022538|NCT01170663|3843736|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|299|299.0||||||
4022539|NCT01170663|3843734|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4022540|NCT01170663|3843735|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4022541|NCT01170663|3843736|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4022542|NCT01170663|3843734|B3||Male|Sex: Female, Male||Participants|Count of Participants|472|472.0||||||
4022543|NCT01170663|3843735|B2||Male|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
4022544|NCT01170663|3843736|B1||Male|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4022545|NCT01170663|3843734|B3||Female|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4022546|NCT01170663|3843735|B2||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4022547|NCT01170663|3843736|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4022548|NCT01170663|3843734|B3|||Age||years|Median|61|61.0|Full Range|||24.0|84.0|
4022549|NCT01170663|3843735|B2|||Age||years|Median|61|61.0|Full Range|||24.0|84.0|
4022550|NCT01170663|3843736|B1|||Age||years|Median|61|61.0|Full Range|||25.0|83.0|
4022551|NCT01170663|3843734|B3||>=65 years|Age||Participants|Count of Participants|247|247.0||||||
4022552|NCT01170663|3843735|B2||>=65 years|Age||Participants|Count of Participants|122|122.0||||||
4022553|NCT01170663|3843736|B1||>=65 years|Age||Participants|Count of Participants|125|125.0||||||
4022554|NCT01170663|3843734|B3||Between 18 and 65 years|Age||Participants|Count of Participants|418|418.0||||||
4022555|NCT01170663|3843735|B2||Between 18 and 65 years|Age||Participants|Count of Participants|213|213.0||||||
4022556|NCT01170663|3843736|B1||Between 18 and 65 years|Age||Participants|Count of Participants|205|205.0||||||
4022557|NCT01170663|3843734|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022558|NCT01170663|3843735|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022559|NCT01170663|3843736|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022560|NCT01170598|3843765|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4022561|NCT01170598|3843765|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4022562|NCT01170598|3843765|B1|>=60 years||Age, Customized||years|Number|17|17.0||||||
4022563|NCT01170598|3843765|B1|<60 years||Age, Customized||years|Number|18|18.0||||||
4022564|NCT01170546|3843780|B5|Taiwan||Region of Enrollment||participants|Number|28|28.0||||||
4022565|NCT01170546|3843781|B4|Taiwan||Region of Enrollment||participants|Number|8|8.0||||||
4022566|NCT01170546|3843782|B3|Taiwan||Region of Enrollment||participants|Number|6|6.0||||||
4022567|NCT01170546|3843783|B2|Taiwan||Region of Enrollment||participants|Number|7|7.0||||||
4022568|NCT01170546|3843784|B1|Taiwan||Region of Enrollment||participants|Number|7|7.0||||||
4022569|NCT01170546|3843780|B5||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4022570|NCT01170546|3843781|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4022571|NCT01170546|3843782|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4022572|NCT01170546|3843783|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4022573|NCT01170546|3843784|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4022574|NCT01170546|3843780|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4022575|NCT01170546|3843781|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4022576|NCT01170546|3843782|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4022577|NCT01170546|3843783|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4022578|NCT01170546|3843784|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4022579|NCT01170546|3843780|B5|||Age||years|Mean|20.7|20.7|Standard Deviation|0.62|0.62|||
4022580|NCT01170546|3843781|B4|||Age||years|Mean|21.5|21.5|Standard Deviation|0.78|0.78|||
4022581|NCT01170546|3843782|B3|||Age||years|Mean|20.3|20.3|Standard Deviation|0.8|0.8|||
4022582|NCT01170546|3843783|B2|||Age||years|Mean|20.3|20.3|Standard Deviation|0.49|0.49|||
4022583|NCT01170546|3843784|B1|||Age||years|Mean|20.6|20.6|Standard Deviation|0.42|0.42|||
4022584|NCT01170546|3843780|B5|Between 18 and 25 years||Age||participants|Number|28|28.0||||||
4022585|NCT01170546|3843781|B4|Between 18 and 25 years||Age||participants|Number|8|8.0||||||
4022586|NCT01170546|3843782|B3|Between 18 and 25 years||Age||participants|Number|6|6.0||||||
4022587|NCT01170546|3843783|B2|Between 18 and 25 years||Age||participants|Number|7|7.0||||||
4022588|NCT01170546|3843784|B1|Between 18 and 25 years||Age||participants|Number|7|7.0||||||
4022589|NCT01170533|3843797|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4022590|NCT01170533|3843797|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4022591|NCT01170533|3843797|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4022592|NCT01170533|3843797|B1|Pantoprazole cross-over n=20||Age||years|Mean|33|33.0|Standard Deviation|5|5.0|||
4022593|NCT01170533|3843797|B1|Omeprazole cross-over n=20||Age||years|Mean|34|34.0|Standard Deviation|6|6.0|||
4022594|NCT01170533|3843797|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4022595|NCT01170533|3843797|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4022596|NCT01170533|3843797|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022597|NCT01170390|3843808|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4022598|NCT01170390|3843809|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4022599|NCT01170390|3843810|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4022600|NCT01170390|3843808|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4022601|NCT01170390|3843809|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4022602|NCT01170390|3843810|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4022603|NCT01170390|3843808|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4022604|NCT01170390|3843809|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4022605|NCT01170390|3843810|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4022606|NCT01170390|3843808|B3|||Age||years|Mean|29|29.0|Standard Deviation|4.7|4.7|||
4022607|NCT01170390|3843809|B2|||Age||years|Mean|27|27.0|Standard Deviation|4|4.0|||
4022608|NCT01170390|3843810|B1|||Age||years|Mean|30|30.0|Standard Deviation|4|4.0|||
4022609|NCT01170390|3843808|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4022610|NCT01170390|3843809|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4022611|NCT01170390|3843810|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4022612|NCT01170390|3843808|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4022613|NCT01170390|3843809|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4022614|NCT01170390|3843810|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4022615|NCT01170390|3843808|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022616|NCT01170390|3843809|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022617|NCT01170390|3843810|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022618|NCT01170364|3843826|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4022619|NCT01170364|3843827|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4022620|NCT01170364|3843828|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4022621|NCT01170364|3843826|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4022622|NCT01170364|3843827|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4022623|NCT01170364|3843828|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4022624|NCT01170364|3843826|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4022625|NCT01170364|3843827|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4022626|NCT01170364|3843828|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4022627|NCT01170364|3843826|B3|||Age||years|Mean|36|36.0|Standard Deviation|10|10.0|||
4022628|NCT01170364|3843827|B2|||Age||years|Mean|39|39.0|Standard Deviation|11|11.0|||
4022629|NCT01170364|3843828|B1|||Age||years|Mean|33|33.0|Standard Deviation|6|6.0|||
4022630|NCT01170364|3843826|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4022631|NCT01170364|3843827|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4022632|NCT01170364|3843828|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4022633|NCT01170364|3843826|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4022634|NCT01170364|3843827|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4022635|NCT01170364|3843828|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4022636|NCT01170364|3843826|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022637|NCT01170364|3843827|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022638|NCT01170364|3843828|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022639|NCT01170273|3843835|B3||Male|Gender||Participants|Count of Participants|130|130.0||||||
4022640|NCT01170273|3843836|B2||Male|Gender||Participants|Count of Participants|66|66.0||||||
4022641|NCT01170273|3843837|B1||Male|Gender||Participants|Count of Participants|64|64.0||||||
4022642|NCT01170273|3843835|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
4022643|NCT01170273|3843836|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
4022644|NCT01170273|3843837|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
4022645|NCT01170273|3843835|B3|||Age||years|Mean|72.4|72.4|Standard Deviation|6.8|6.8|||
4022646|NCT01170273|3843836|B2|||Age||years|Mean|71.8|71.8|Standard Deviation|6.3|6.3|||
4022647|NCT01170273|3843837|B1|||Age||years|Mean|73.0|73.0|Standard Deviation|7.3|7.3|||
4022648|NCT01170247|3843844|B3|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4022649|NCT01170247|3843845|B2|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4022650|NCT01170247|3843846|B1|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4022651|NCT01170247|3843844|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022652|NCT01170247|3843845|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022653|NCT01170247|3843846|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022654|NCT01170247|3843844|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022655|NCT01170247|3843845|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022656|NCT01170247|3843846|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022657|NCT01170247|3843844|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4022658|NCT01170247|3843845|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4022659|NCT01170247|3843846|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4022660|NCT01170247|3843844|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022661|NCT01170247|3843845|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022662|NCT01170247|3843846|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022663|NCT01170247|3843844|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022664|NCT01170247|3843845|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022665|NCT01170247|3843846|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022666|NCT01170247|3843844|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022667|NCT01170247|3843845|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022668|NCT01170247|3843846|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022669|NCT01170247|3843844|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022670|NCT01170247|3843845|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022671|NCT01170247|3843846|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022672|NCT01170247|3843844|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4022673|NCT01170247|3843845|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4022674|NCT01170247|3843846|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4022675|NCT01170247|3843844|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4022676|NCT01170247|3843845|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4022677|NCT01170247|3843846|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4022678|NCT01170247|3843844|B3|||Age||years|Mean|3|3.0|Standard Deviation|0|0.0|||
4022679|NCT01170247|3843845|B2|||Age||years|Mean|3|3.0|Standard Deviation|NA||||Standard deviation not calculated for one patient
4022680|NCT01170247|3843846|B1|||Age||years|Mean|3|3.0|Standard Deviation|1|1.0|||
4022681|NCT01170221|3843853|B3||Male|Sex: Female, Male||Participants|Count of Participants|402|402.0||||||
4022682|NCT01170221|3843854|B2||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4022683|NCT01170221|3843855|B1||Male|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4022684|NCT01170221|3843853|B3||Female|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
4022685|NCT01170221|3843854|B2||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4022686|NCT01170221|3843855|B1||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4022687|NCT01170221|3843853|B3|||Age||Years|Mean|43.3|43.3|Standard Deviation|15.0|15.0|||
4022688|NCT01170221|3843854|B2|||Age||Years|Mean|43.1|43.1|Standard Deviation|15.06|15.06|||
4022689|NCT01170221|3843855|B1|||Age||Years|Mean|43.6|43.6|Standard Deviation|14.96|14.96|||
4022690|NCT01170208|3843876|B4|||Weekly Mean Blood Glucose|Week 4 baseline weekly mean blood glucose|mg/dL|Mean|172.4|172.4|Standard Deviation|35.0|35.0|||
4022691|NCT01170208|3843877|B3|||Weekly Mean Blood Glucose|Week 4 baseline weekly mean blood glucose|mg/dL|Mean|190.8|190.8|Standard Deviation|47.0|47.0|||
4022692|NCT01170208|3843878|B2|||Weekly Mean Blood Glucose|Week 4 baseline weekly mean blood glucose|mg/dL|Mean|164.9|164.9|Standard Deviation|37.6|37.6|||
4022693|NCT01170208|3843879|B1|||Weekly Mean Blood Glucose|Week 4 baseline weekly mean blood glucose|mg/dL|Mean|176.9|176.9|Standard Deviation|28.3|28.3|||
4022694|NCT01170208|3843876|B4|United States||Region of Enrollment||participants|Number|46|46.0||||||
4022695|NCT01170208|3843877|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4022696|NCT01170208|3843878|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4022697|NCT01170208|3843879|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4022698|NCT01170208|3843876|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4022699|NCT01170208|3843877|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4022700|NCT01170208|3843878|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4022701|NCT01170208|3843879|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4022702|NCT01170208|3843876|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4022703|NCT01170208|3843877|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4022704|NCT01170208|3843878|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4022705|NCT01170208|3843879|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4022706|NCT01170208|3843876|B4|||Age||years|Mean|52|52.0|Standard Deviation|12|12.0|||
4022707|NCT01170208|3843877|B3|||Age||years|Mean|55|55.0|Standard Deviation|7|7.0|||
4022708|NCT01170208|3843878|B2|||Age||years|Mean|60|60.0|Standard Deviation|7|7.0|||
4022709|NCT01170208|3843879|B1|||Age||years|Mean|44|44.0|Standard Deviation|12|12.0|||
4022710|NCT01170208|3843876|B4||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4022711|NCT01170208|3843877|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4022712|NCT01170208|3843878|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4022713|NCT01170208|3843879|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4022714|NCT01170208|3843876|B4||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4022715|NCT01170208|3843877|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4022716|NCT01170208|3843878|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4022717|NCT01170208|3843879|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4022718|NCT01170208|3843876|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022719|NCT01170208|3843877|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022720|NCT01170208|3843878|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022721|NCT01170208|3843879|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022722|NCT01170117|3843889|B3|||BMI||kg/m2|Mean|16.7|16.7|Standard Deviation|1.20|1.2|||
4022723|NCT01170117|3843890|B2|||BMI||kg/m2|Mean|16.79|16.79|Standard Deviation|1.17|1.17|||
4022724|NCT01170117|3843891|B1|||BMI||kg/m2|Mean|16.69|16.69|Standard Deviation|1.18|1.18|||
4022725|NCT01170117|3843889|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022726|NCT01170117|3843890|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022727|NCT01170117|3843891|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022728|NCT01170117|3843889|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022729|NCT01170117|3843890|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022730|NCT01170117|3843891|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022731|NCT01170117|3843889|B3||White|Race (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
4022732|NCT01170117|3843890|B2||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
4022733|NCT01170117|3843891|B1||White|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
4022734|NCT01170117|3843889|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4022735|NCT01170117|3843890|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4022736|NCT01170117|3843891|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4022737|NCT01170117|3843889|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022738|NCT01170117|3843890|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022739|NCT01170117|3843891|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022740|NCT01170117|3843889|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4022741|NCT01170117|3843890|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4022742|NCT01170117|3843891|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4022743|NCT01170117|3843889|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022744|NCT01170117|3843890|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022745|NCT01170117|3843891|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022746|NCT01170117|3843889|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022747|NCT01170117|3843890|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022748|NCT01170117|3843891|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022749|NCT01170117|3843889|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
4022750|NCT01170117|3843890|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4022751|NCT01170117|3843891|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
4022752|NCT01170117|3843889|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4022753|NCT01170117|3843890|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4022754|NCT01170117|3843891|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4022755|NCT01170117|3843889|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4022756|NCT01170117|3843890|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4022757|NCT01170117|3843891|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4022758|NCT01170117|3843889|B3||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4022759|NCT01170117|3843890|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4022760|NCT01170117|3843891|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4022761|NCT01170117|3843889|B3|||Age||Years|Mean|29.0|29.0|Standard Deviation|10.9|10.9|||
4022762|NCT01170117|3843890|B2|||Age||Years|Mean|28.0|28.0|Standard Deviation|10.8|10.8|||
4022763|NCT01170117|3843891|B1|||Age||Years|Mean|30.0|30.0|Standard Deviation|10.9|10.9|||
4022764|NCT01170091|3843900|B1|Not reported||Sex/Gender, Customized||Participants|Number|6|6.0||||||
4022765|NCT01170091|3843900|B1|Male||Sex/Gender, Customized||Participants|Number|276|276.0||||||
4022766|NCT01170091|3843900|B1|Female||Sex/Gender, Customized||Participants|Number|369|369.0||||||
4022767|NCT01170091|3843900|B1|||Age||Years|Mean|60.9|60.9|Standard Deviation|13.2|13.2|||
4022768|NCT01170039|3843907|B3|United States||Region of Enrollment||participants|Number|76|76.0||||||
4022769|NCT01170039|3843908|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
4022770|NCT01170039|3843909|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4022771|NCT01170039|3843907|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4022772|NCT01170039|3843908|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4022773|NCT01170039|3843909|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4022774|NCT01170039|3843907|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4022775|NCT01170039|3843908|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4022776|NCT01170039|3843909|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4022777|NCT01170039|3843907|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4022778|NCT01170039|3843908|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4022779|NCT01170039|3843909|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4022780|NCT01170039|3843907|B3||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
4022781|NCT01170039|3843908|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4022782|NCT01170039|3843909|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4022783|NCT01170039|3843907|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022784|NCT01170039|3843908|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022785|NCT01170039|3843909|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022786|NCT01169987|3843922|B1||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4022787|NCT01169987|3843922|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4022788|NCT01169987|3843922|B1|||Age||years|Mean|44.9|44.9|Standard Deviation|12.1|12.1|||
4022789|NCT01169779|3843986|B3|No||Number of Patients With Sulfonylurea use at Baseline||participants|Number|216|216.0||||||
4022790|NCT01169779|3843987|B2|No||Number of Patients With Sulfonylurea use at Baseline||participants|Number|114|114.0||||||
4022791|NCT01169779|3843988|B1|No||Number of Patients With Sulfonylurea use at Baseline||participants|Number|102|102.0||||||
4022792|NCT01169779|3843986|B3|Yes||Number of Patients With Sulfonylurea use at Baseline||participants|Number|174|174.0||||||
4022793|NCT01169779|3843987|B2|Yes||Number of Patients With Sulfonylurea use at Baseline||participants|Number|82|82.0||||||
4022794|NCT01169779|3843988|B1|Yes||Number of Patients With Sulfonylurea use at Baseline||participants|Number|92|92.0||||||
4022795|NCT01169779|3843986|B3|||Metformin Daily Dose||milligram (mg) per day|Mean|1366.7|1366.7|Standard Deviation|220.7|220.7|||
4022796|NCT01169779|3843987|B2|||Metformin Daily Dose||milligram (mg) per day|Mean|1369.9|1369.9|Standard Deviation|219.9|219.9|||
4022797|NCT01169779|3843988|B1|||Metformin Daily Dose||milligram (mg) per day|Mean|1363.4|1363.4|Standard Deviation|221.9|221.9|||
4022798|NCT01169779|3843986|B3|||Body Mass Index (BMI)|BMI was calculated by dividing body weight by the height squared.|kilogram per square meter (kg/m^2)|Mean|26.91|26.91|Standard Deviation|3.80|3.8|||
4022799|NCT01169779|3843987|B2|||Body Mass Index (BMI)|BMI was calculated by dividing body weight by the height squared.|kilogram per square meter (kg/m^2)|Mean|26.75|26.75|Standard Deviation|3.86|3.86|||
4022800|NCT01169779|3843988|B1|||Body Mass Index (BMI)|BMI was calculated by dividing body weight by the height squared.|kilogram per square meter (kg/m^2)|Mean|27.08|27.08|Standard Deviation|3.75|3.75|||
4022801|NCT01169779|3843986|B3|||Duration of Diabetes||years|Mean|6.64|6.64|Standard Deviation|4.72|4.72|||
4022802|NCT01169779|3843987|B2|||Duration of Diabetes||years|Mean|6.45|6.45|Standard Deviation|4.64|4.64|||
4022803|NCT01169779|3843988|B1|||Duration of Diabetes||years|Mean|6.84|6.84|Standard Deviation|4.80|4.8|||
4022804|NCT01169779|3843986|B3|||Body Weight||kilogram (kg)|Mean|72.96|72.96|Standard Deviation|13.77|13.77|||
4022805|NCT01169779|3843987|B2|||Body Weight||kilogram (kg)|Mean|73.18|73.18|Standard Deviation|13.93|13.93|||
4022806|NCT01169779|3843988|B1|||Body Weight||kilogram (kg)|Mean|72.74|72.74|Standard Deviation|13.64|13.64|||
4022807|NCT01169779|3843986|B3|||Glucose Excursion|Glucose excursion = 2-hour PPG minus plasma glucose 30 minutes prior to the meal test, before study drug administration. Number of patients analyzed = 130 and 121 for Placebo and Lixisenatide treatment arm, respectively, as meal challenge test was performed at selected sites only.|mmol/L|Mean|7.65|7.65|Standard Deviation|3.20|3.2|||
4022808|NCT01169779|3843987|B2|||Glucose Excursion|Glucose excursion = 2-hour PPG minus plasma glucose 30 minutes prior to the meal test, before study drug administration. Number of patients analyzed = 130 and 121 for Placebo and Lixisenatide treatment arm, respectively, as meal challenge test was performed at selected sites only.|mmol/L|Mean|7.12|7.12|Standard Deviation|3.21|3.21|||
4022809|NCT01169779|3843988|B1|||Glucose Excursion|Glucose excursion = 2-hour PPG minus plasma glucose 30 minutes prior to the meal test, before study drug administration. Number of patients analyzed = 130 and 121 for Placebo and Lixisenatide treatment arm, respectively, as meal challenge test was performed at selected sites only.|mmol/L|Mean|8.14|8.14|Standard Deviation|3.11|3.11|||
4022810|NCT01169779|3843986|B3|||2-Hour Postprandial Plasma Glucose (PPG)|The 2-hour PPG test measured blood glucose 2 hours after eating a standardized meal. Number of patients analyzed = 130 and 121 for Placebo and Lixisenatide treatment arm, respectively, as meal challenge test was performed at selected sites only.|mmol/L|Mean|16.65|16.65|Standard Deviation|3.95|3.95|||
4022811|NCT01169779|3843987|B2|||2-Hour Postprandial Plasma Glucose (PPG)|The 2-hour PPG test measured blood glucose 2 hours after eating a standardized meal. Number of patients analyzed = 130 and 121 for Placebo and Lixisenatide treatment arm, respectively, as meal challenge test was performed at selected sites only.|mmol/L|Mean|16.07|16.07|Standard Deviation|3.77|3.77|||
4022812|NCT01169779|3843988|B1|||2-Hour Postprandial Plasma Glucose (PPG)|The 2-hour PPG test measured blood glucose 2 hours after eating a standardized meal. Number of patients analyzed = 130 and 121 for Placebo and Lixisenatide treatment arm, respectively, as meal challenge test was performed at selected sites only.|mmol/L|Mean|17.19|17.19|Standard Deviation|4.06|4.06|||
4022813|NCT01169779|3843986|B3|||Fasting Plasma Glucose (FPG)||millimole per liter (mmol/L)|Mean|8.79|8.79|Standard Deviation|1.98|1.98|||
4022814|NCT01169779|3843987|B2|||Fasting Plasma Glucose (FPG)||millimole per liter (mmol/L)|Mean|8.84|8.84|Standard Deviation|2.12|2.12|||
4022815|NCT01169779|3843988|B1|||Fasting Plasma Glucose (FPG)||millimole per liter (mmol/L)|Mean|8.74|8.74|Standard Deviation|1.83|1.83|||
4022816|NCT01169779|3843986|B3|||Glycosylated Hemoglobin (HbA1c)||percentage of hemoglobin|Mean|7.90|7.9|Standard Deviation|0.76|0.76|||
4022817|NCT01169779|3843987|B2|||Glycosylated Hemoglobin (HbA1c)||percentage of hemoglobin|Mean|7.95|7.95|Standard Deviation|0.81|0.81|||
4022818|NCT01169779|3843988|B1|||Glycosylated Hemoglobin (HbA1c)||percentage of hemoglobin|Mean|7.85|7.85|Standard Deviation|0.71|0.71|||
4022819|NCT01169779|3843986|B3|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|390|390.0||||||
4022820|NCT01169779|3843987|B2|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|196|196.0||||||
4022821|NCT01169779|3843988|B1|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|194|194.0||||||
4022822|NCT01169779|3843986|B3||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4022823|NCT01169779|3843987|B2||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4022824|NCT01169779|3843988|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4022825|NCT01169779|3843986|B3||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4022826|NCT01169779|3843987|B2||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4022827|NCT01169779|3843988|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4022828|NCT01169779|3843986|B3|||Age||years|Mean|54.8|54.8|Standard Deviation|10.4|10.4|||
4022829|NCT01169779|3843987|B2|||Age||years|Mean|54.5|54.5|Standard Deviation|10.3|10.3|||
4022830|NCT01169779|3843988|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|10.5|10.5|||
4022831|NCT01169753|3844013|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4022832|NCT01169753|3844014|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4022833|NCT01169753|3844013|B3|Male||Gender||participants|Number|0|0.0||||||
4022834|NCT01169753|3844014|B2|Male||Gender||participants|Number|0|0.0||||||
4022835|NCT01169753|3844013|B3|Female||Gender||participants|Number|1|1.0||||||
4022836|NCT01169753|3844014|B2|Female||Gender||participants|Number|1|1.0||||||
4022837|NCT01169753|3844013|B3|>=65 years||Age||participants|Number|0|0.0||||||
4022838|NCT01169753|3844014|B2|>=65 years||Age||participants|Number|0|0.0||||||
4022839|NCT01169753|3844013|B3|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
4022840|NCT01169753|3844014|B2|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
4022841|NCT01169753|3844013|B3|<=18 years||Age||participants|Number|0|0.0||||||
4022842|NCT01169753|3844014|B2|<=18 years||Age||participants|Number|0|0.0||||||
4022843|NCT01169701|3844022|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4022844|NCT01169701|3844023|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4022845|NCT01169701|3844024|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4022846|NCT01169701|3844022|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4022847|NCT01169701|3844023|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4022848|NCT01169701|3844024|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4022849|NCT01169701|3844022|B3|||Age||Years|Mean|48.3|48.3|Standard Deviation|12.5|12.5|||
4022850|NCT01169701|3844023|B2|||Age||Years|Mean|47.4|47.4|Standard Deviation|13.2|13.2|||
4022851|NCT01169701|3844024|B1|||Age||Years|Mean|49.1|49.1|Standard Deviation|12.0|12.0|||
4022852|NCT01169675|3844057|B6||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4022853|NCT01169675|3844058|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4022854|NCT01169675|3844059|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4022855|NCT01169675|3844060|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4022856|NCT01169675|3844061|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4022857|NCT01169675|3844062|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4022858|NCT01169675|3844057|B6||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4022859|NCT01169675|3844058|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4022860|NCT01169675|3844059|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4022861|NCT01169675|3844060|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4022862|NCT01169675|3844061|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4022863|NCT01169675|3844062|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4022864|NCT01169675|3844057|B6|||Age||years|Mean|60.8|60.8|Standard Deviation|10.7|10.7|||
4022865|NCT01169675|3844058|B5|||Age||years|Mean|64.8|64.8|Standard Deviation|7.4|7.4|||
4022866|NCT01169675|3844059|B4|||Age||years|Mean|57.9|57.9|Standard Deviation|10.7|10.7|||
4022867|NCT01169675|3844060|B3|||Age||years|Mean|69.6|69.6|Standard Deviation|10.5|10.5|||
4022868|NCT01169675|3844061|B2|||Age||years|Mean|53.7|53.7|Standard Deviation|16.6|16.6|||
4022869|NCT01169675|3844062|B1|||Age||years|Mean|60.2|60.2|Standard Deviation|9.4|9.4|||
4022870|NCT01169649|3844103|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4022871|NCT01169649|3844103|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4022872|NCT01169649|3844103|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4022873|NCT01169649|3844103|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4022874|NCT01169649|3844103|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022875|NCT01169610|3844107|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4022876|NCT01169610|3844107|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4022877|NCT01169610|3844107|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4022878|NCT01169610|3844107|B1|||Age||years|Mean|35|35.0|Standard Deviation|||||
4022879|NCT01169610|3844107|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4022880|NCT01169610|3844107|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4022881|NCT01169610|3844107|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022882|NCT01169558|3844115|B1||Male|Gender||Participants|Count of Participants|73|73.0||||||
4022883|NCT01169558|3844115|B1||Female|Gender||Participants|Count of Participants|89|89.0||||||
4022884|NCT01169558|3844115|B1|||Age||years|Mean|55.9|55.9|Standard Deviation|13.1|13.1|||
4022885|NCT01169519|3844122|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4022886|NCT01169519|3844122|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4022887|NCT01169519|3844122|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4022888|NCT01169519|3844122|B1|||Age||years|Mean|3.4|3.4|Standard Deviation|2.6|2.6|||
4022889|NCT01169519|3844122|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4022890|NCT01169519|3844122|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4022891|NCT01169519|3844122|B1||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
4022892|NCT01169493|3844134|B7|Male||Gender||participants|Number|16|16.0||||||
4022893|NCT01169493|3844135|B6|Male||Gender||participants|Number|5|5.0||||||
4022894|NCT01169493|3844138|B3|Male||Gender||participants|Number|5|5.0||||||
4022895|NCT01169493|3844139|B2|Male||Gender||participants|Number|4|4.0||||||
4022896|NCT01169493|3844140|B1|Male||Gender||participants|Number|2|2.0||||||
4022897|NCT01169493|3844134|B7|Female||Gender||participants|Number|0|0.0||||||
4022898|NCT01169493|3844135|B6|Female||Gender||participants|Number|0|0.0||||||
4022899|NCT01169493|3844138|B3|Female||Gender||participants|Number|0|0.0||||||
4022900|NCT01169493|3844139|B2|Female||Gender||participants|Number|0|0.0||||||
4022901|NCT01169493|3844140|B1|Female||Gender||participants|Number|0|0.0||||||
4022902|NCT01169493|3844134|B7|>=65 years||Age||participants|Number|13|13.0||||||
4022903|NCT01169493|3844135|B6|>=65 years||Age||participants|Number|3|3.0||||||
4022904|NCT01169493|3844138|B3|>=65 years||Age||participants|Number|5|5.0||||||
4022905|NCT01169493|3844139|B2|>=65 years||Age||participants|Number|3|3.0||||||
4022906|NCT01169493|3844140|B1|>=65 years||Age||participants|Number|2|2.0||||||
4022907|NCT01169493|3844134|B7|Between 18 and 65 years||Age||participants|Number|3|3.0||||||
4022908|NCT01169493|3844135|B6|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
4022909|NCT01169493|3844138|B3|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
4022910|NCT01169493|3844139|B2|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
4022911|NCT01169493|3844140|B1|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
4022912|NCT01169493|3844134|B7|<=18 years||Age||participants|Number|0|0.0||||||
4022913|NCT01169493|3844135|B6|<=18 years||Age||participants|Number|0|0.0||||||
4022914|NCT01169493|3844138|B3|<=18 years||Age||participants|Number|0|0.0||||||
4022915|NCT01169493|3844139|B2|<=18 years||Age||participants|Number|0|0.0||||||
4022916|NCT01169493|3844140|B1|<=18 years||Age||participants|Number|0|0.0||||||
4022917|NCT01169467|3844174|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022918|NCT01169467|3844175|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022919|NCT01169467|3844176|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022920|NCT01169467|3844174|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
4022921|NCT01169467|3844175|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4022922|NCT01169467|3844176|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4022923|NCT01169467|3844174|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4022924|NCT01169467|3844175|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4022925|NCT01169467|3844176|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4022926|NCT01169467|3844174|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022927|NCT01169467|3844175|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022928|NCT01169467|3844176|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022929|NCT01169467|3844174|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022930|NCT01169467|3844175|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022931|NCT01169467|3844176|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022932|NCT01169467|3844174|B3||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4022933|NCT01169467|3844175|B2||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4022934|NCT01169467|3844176|B1||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4022935|NCT01169467|3844174|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4022936|NCT01169467|3844175|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4022937|NCT01169467|3844176|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4022938|NCT01169467|3844174|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022939|NCT01169467|3844175|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022940|NCT01169467|3844176|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022941|NCT01169467|3844174|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022942|NCT01169467|3844175|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022943|NCT01169467|3844176|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4022944|NCT01169467|3844174|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4022945|NCT01169467|3844175|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4022946|NCT01169467|3844176|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4022947|NCT01169467|3844174|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4022948|NCT01169467|3844175|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4022949|NCT01169467|3844176|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4022950|NCT01169467|3844174|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4022951|NCT01169467|3844175|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4022952|NCT01169467|3844176|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4022953|NCT01169467|3844174|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4022954|NCT01169467|3844175|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4022955|NCT01169467|3844176|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4022956|NCT01169467|3844174|B3||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4022957|NCT01169467|3844175|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4022958|NCT01169467|3844176|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4022959|NCT01169467|3844174|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022960|NCT01169467|3844175|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022961|NCT01169467|3844176|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022962|NCT01169350|3844191|B1|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4022963|NCT01169350|3844191|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4022964|NCT01169350|3844191|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4022965|NCT01169350|3844191|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4022966|NCT01169350|3844191|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4022967|NCT01169350|3844191|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4022968|NCT01169350|3844191|B1|||Age||years|Median|61|61.0|Full Range|||45.0|80.0|
4022969|NCT01169311|3844198|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4022970|NCT01169311|3844198|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4022971|NCT01169311|3844198|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4022972|NCT01169311|3844198|B1|||Age||years|Mean|49.2|49.2|Standard Deviation|12.8|12.8|||
4022973|NCT01169103|3844210|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4022974|NCT01169103|3844211|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4022975|NCT01169103|3844212|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4022976|NCT01169103|3844210|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4022977|NCT01169103|3844211|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4022978|NCT01169103|3844212|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4022979|NCT01169103|3844210|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4022980|NCT01169103|3844211|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4022981|NCT01169103|3844212|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4022982|NCT01169103|3844210|B3|||Age||years|Mean|16.6|16.6|Standard Deviation|2.34|2.34|||
4022983|NCT01169103|3844211|B2|||Age||years|Mean|16.9|16.9|Standard Deviation|2.1|2.1|||
4022984|NCT01169103|3844212|B1|||Age||years|Mean|16.2|16.2|Standard Deviation|2.6|2.6|||
4022985|NCT01169103|3844210|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4022986|NCT01169103|3844211|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4022987|NCT01169103|3844212|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4022988|NCT01169103|3844210|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4022989|NCT01169103|3844211|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4022990|NCT01169103|3844212|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4022991|NCT01169103|3844210|B3||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
4022992|NCT01169103|3844211|B2||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4022993|NCT01169103|3844212|B1||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4022994|NCT01169064|3844227|B3|||No use of alcohol during pregnancy||participants|Number|475|475.0||||||
4022995|NCT01169064|3844228|B2|||No use of alcohol during pregnancy||participants|Number|236|236.0||||||
4022996|NCT01169064|3844229|B1|||No use of alcohol during pregnancy||participants|Number|239|239.0||||||
4022997|NCT01169064|3844227|B3|No||Tobacco use during pregnancy||participants|Number|385|385.0||||||
4022998|NCT01169064|3844228|B2|No||Tobacco use during pregnancy||participants|Number|195|195.0||||||
4022999|NCT01169064|3844229|B1|No||Tobacco use during pregnancy||participants|Number|190|190.0||||||
4023000|NCT01169064|3844227|B3|Yes||Tobacco use during pregnancy||participants|Number|90|90.0||||||
4023001|NCT01169064|3844228|B2|Yes||Tobacco use during pregnancy||participants|Number|41|41.0||||||
4023002|NCT01169064|3844229|B1|Yes||Tobacco use during pregnancy||participants|Number|49|49.0||||||
4023003|NCT01169064|3844227|B3|||Average BMI||kg/m^2|Mean|32.4|32.4|Full Range|||28.0|38.1|
4023004|NCT01169064|3844228|B2|||Average BMI||kg/m^2|Mean|32.8|32.8|Full Range|||28.8|38.1|
4023005|NCT01169064|3844229|B1|||Average BMI||kg/m^2|Mean|32.0|32.0|Full Range|||28.0|36.3|
4023006|NCT01169064|3844227|B3|Other||Race/Ethnicity, Customized|Race/Ethnicity was not captured on every patient.|participants|Number|27|27.0||||||
4023007|NCT01169064|3844228|B2|Other||Race/Ethnicity, Customized|Race/Ethnicity was not captured on every patient.|participants|Number|10|10.0||||||
4023008|NCT01169064|3844229|B1|Other||Race/Ethnicity, Customized|Race/Ethnicity was not captured on every patient.|participants|Number|17|17.0||||||
4023122|NCT01168986|3844295|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4023009|NCT01169064|3844227|B3|Hispanic||Race/Ethnicity, Customized|Race/Ethnicity was not captured on every patient.|participants|Number|36|36.0||||||
4023010|NCT01169064|3844228|B2|Hispanic||Race/Ethnicity, Customized|Race/Ethnicity was not captured on every patient.|participants|Number|16|16.0||||||
4023011|NCT01169064|3844229|B1|Hispanic||Race/Ethnicity, Customized|Race/Ethnicity was not captured on every patient.|participants|Number|20|20.0||||||
4023012|NCT01169064|3844227|B3|African American||Race/Ethnicity, Customized|Race/Ethnicity was not captured on every patient.|participants|Number|93|93.0||||||
4023013|NCT01169064|3844228|B2|African American||Race/Ethnicity, Customized|Race/Ethnicity was not captured on every patient.|participants|Number|50|50.0||||||
4023014|NCT01169064|3844229|B1|African American||Race/Ethnicity, Customized|Race/Ethnicity was not captured on every patient.|participants|Number|43|43.0||||||
4023015|NCT01169064|3844227|B3|Caucasian||Race/Ethnicity, Customized|Race/Ethnicity was not captured on every patient.|participants|Number|311|311.0||||||
4023016|NCT01169064|3844228|B2|Caucasian||Race/Ethnicity, Customized|Race/Ethnicity was not captured on every patient.|participants|Number|156|156.0||||||
4023017|NCT01169064|3844229|B1|Caucasian||Race/Ethnicity, Customized|Race/Ethnicity was not captured on every patient.|participants|Number|155|155.0||||||
4023018|NCT01169064|3844227|B3|Women||Sex/Gender, Customized|Women Only|participants|Number|475|475.0||||||
4023019|NCT01169064|3844228|B2|Women||Sex/Gender, Customized|Women Only|participants|Number|236|236.0||||||
4023020|NCT01169064|3844229|B1|Women||Sex/Gender, Customized|Women Only|participants|Number|239|239.0||||||
4023021|NCT01169064|3844227|B3|36-45||Age, Customized|Age not recorded in several patients from both groups.|years|Number|54|54.0||||||
4023022|NCT01169064|3844228|B2|36-45||Age, Customized|Age not recorded in several patients from both groups.|years|Number|30|30.0||||||
4023023|NCT01169064|3844229|B1|36-45||Age, Customized|Age not recorded in several patients from both groups.|years|Number|24|24.0||||||
4023024|NCT01169064|3844227|B3|26-35||Age, Customized|Age not recorded in several patients from both groups.|years|Number|256|256.0||||||
4023025|NCT01169064|3844228|B2|26-35||Age, Customized|Age not recorded in several patients from both groups.|years|Number|113|113.0||||||
4023026|NCT01169064|3844229|B1|26-35||Age, Customized|Age not recorded in several patients from both groups.|years|Number|143|143.0||||||
4023027|NCT01169064|3844227|B3|16-25||Age, Customized|Age not recorded in several patients from both groups.|years|Number|159|159.0||||||
4023028|NCT01169064|3844228|B2|16-25||Age, Customized|Age not recorded in several patients from both groups.|years|Number|88|88.0||||||
4023029|NCT01169064|3844229|B1|16-25||Age, Customized|Age not recorded in several patients from both groups.|years|Number|71|71.0||||||
4023030|NCT01169038|3844240|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4023031|NCT01169038|3844240|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4023032|NCT01169038|3844240|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4023033|NCT01169038|3844240|B1|||Age||years|Mean|54|54.0|Standard Deviation|2|2.0|||
4023034|NCT01169038|3844240|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4023035|NCT01169038|3844240|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4023036|NCT01169038|3844240|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4023037|NCT01168999|3844244|B5|United States||Region of Enrollment||participants|Number|110|110.0||||||
4023038|NCT01168999|3844245|B4|United States||Region of Enrollment||participants|Number|28|28.0||||||
4023039|NCT01168999|3844246|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
4023040|NCT01168999|3844247|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4023041|NCT01168999|3844248|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4023042|NCT01168999|3844244|B5||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4023043|NCT01168999|3844245|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4023044|NCT01168999|3844246|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4023045|NCT01168999|3844247|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4023046|NCT01168999|3844248|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4023047|NCT01168999|3844244|B5||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4023048|NCT01168999|3844245|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4023049|NCT01168999|3844246|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4023050|NCT01168999|3844247|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4023051|NCT01168999|3844248|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4023052|NCT01168999|3844244|B5|||Age||years|Mean|31.68|31.68|Standard Deviation|11.85|11.85|||
4023053|NCT01168999|3844245|B4|||Age||years|Mean|29.85|29.85|Standard Deviation|12.09|12.09|||
4023054|NCT01168999|3844246|B3|||Age||years|Mean|31.56|31.56|Standard Deviation|11.85|11.85|||
4023055|NCT01168999|3844247|B2|||Age||years|Mean|33.22|33.22|Standard Deviation|13.29|13.29|||
4023056|NCT01168999|3844248|B1|||Age||years|Mean|32.07|32.07|Standard Deviation|10.98|10.98|||
4023057|NCT01168999|3844244|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4023058|NCT01168999|3844245|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4023059|NCT01168999|3844246|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4023060|NCT01168999|3844247|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4023061|NCT01168999|3844248|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4023062|NCT01168999|3844244|B5||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
4023063|NCT01168999|3844245|B4||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4023064|NCT01168999|3844246|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4023065|NCT01168999|3844247|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4023066|NCT01168999|3844248|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4023067|NCT01168999|3844244|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4023068|NCT01168999|3844245|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4023069|NCT01168999|3844246|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4023070|NCT01168999|3844247|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4023071|NCT01168999|3844248|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4023072|NCT01168986|3844293|B4|United States||Region of Enrollment||participants|Number|62|62.0||||||
4023073|NCT01168986|3844294|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4023074|NCT01168986|3844295|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4023075|NCT01168986|3844296|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4023076|NCT01168986|3844293|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4023077|NCT01168986|3844294|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4023078|NCT01168986|3844295|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4023079|NCT01168986|3844296|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4023080|NCT01168986|3844293|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023081|NCT01168986|3844294|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023082|NCT01168986|3844295|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023083|NCT01168986|3844296|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023084|NCT01168986|3844293|B4||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4023085|NCT01168986|3844294|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4023086|NCT01168986|3844295|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4023087|NCT01168986|3844296|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4023088|NCT01168986|3844293|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4023089|NCT01168986|3844294|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4023090|NCT01168986|3844295|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4023091|NCT01168986|3844296|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4023092|NCT01168986|3844293|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023093|NCT01168986|3844294|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023094|NCT01168986|3844295|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023095|NCT01168986|3844296|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023096|NCT01168986|3844293|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4023097|NCT01168986|3844294|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4023098|NCT01168986|3844295|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4023099|NCT01168986|3844296|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4023100|NCT01168986|3844293|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4023101|NCT01168986|3844294|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023102|NCT01168986|3844295|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4023103|NCT01168986|3844296|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4023104|NCT01168986|3844293|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4023105|NCT01168986|3844294|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023106|NCT01168986|3844295|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023107|NCT01168986|3844296|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4023108|NCT01168986|3844293|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4023109|NCT01168986|3844294|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4023110|NCT01168986|3844295|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4023111|NCT01168986|3844296|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4023112|NCT01168986|3844293|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4023113|NCT01168986|3844294|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4023114|NCT01168986|3844295|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4023115|NCT01168986|3844296|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4023116|NCT01168986|3844293|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4023117|NCT01168986|3844294|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4023118|NCT01168986|3844295|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4023119|NCT01168986|3844296|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4023120|NCT01168986|3844293|B4||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4023121|NCT01168986|3844294|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4023123|NCT01168986|3844296|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4023124|NCT01168986|3844293|B4|||Age||years|Mean|33.98|33.98|Standard Deviation|12.49|12.49|||
4023125|NCT01168986|3844294|B3|||Age||years|Mean|36.33|36.33|Standard Deviation|14.12|14.12|||
4023126|NCT01168986|3844295|B2|||Age||years|Mean|31.48|31.48|Standard Deviation|10.95|10.95|||
4023127|NCT01168986|3844296|B1|||Age||years|Mean|34.15|34.15|Standard Deviation|12.32|12.32|||
4023128|NCT01168973|3844315|B3|Sweden||Region of Enrollment||participants|Number|17|17.0||||||
4023129|NCT01168973|3844316|B2|Sweden||Region of Enrollment||participants|Number|7|7.0||||||
4023130|NCT01168973|3844317|B1|Sweden||Region of Enrollment||participants|Number|10|10.0||||||
4023131|NCT01168973|3844315|B3|New Zealand||Region of Enrollment||participants|Number|7|7.0||||||
4023132|NCT01168973|3844316|B2|New Zealand||Region of Enrollment||participants|Number|4|4.0||||||
4023133|NCT01168973|3844317|B1|New Zealand||Region of Enrollment||participants|Number|3|3.0||||||
4023134|NCT01168973|3844315|B3|Germany||Region of Enrollment||participants|Number|82|82.0||||||
4023135|NCT01168973|3844316|B2|Germany||Region of Enrollment||participants|Number|42|42.0||||||
4023136|NCT01168973|3844317|B1|Germany||Region of Enrollment||participants|Number|40|40.0||||||
4023137|NCT01168973|3844315|B3|Norway||Region of Enrollment||participants|Number|13|13.0||||||
4023138|NCT01168973|3844316|B2|Norway||Region of Enrollment||participants|Number|3|3.0||||||
4023139|NCT01168973|3844317|B1|Norway||Region of Enrollment||participants|Number|10|10.0||||||
4023140|NCT01168973|3844315|B3|Romania||Region of Enrollment||participants|Number|77|77.0||||||
4023141|NCT01168973|3844316|B2|Romania||Region of Enrollment||participants|Number|36|36.0||||||
4023142|NCT01168973|3844317|B1|Romania||Region of Enrollment||participants|Number|41|41.0||||||
4023143|NCT01168973|3844315|B3|Poland||Region of Enrollment||participants|Number|63|63.0||||||
4023144|NCT01168973|3844316|B2|Poland||Region of Enrollment||participants|Number|33|33.0||||||
4023145|NCT01168973|3844317|B1|Poland||Region of Enrollment||participants|Number|30|30.0||||||
4023146|NCT01168973|3844315|B3|Brazil||Region of Enrollment||participants|Number|7|7.0||||||
4023147|NCT01168973|3844316|B2|Brazil||Region of Enrollment||participants|Number|3|3.0||||||
4023148|NCT01168973|3844317|B1|Brazil||Region of Enrollment||participants|Number|4|4.0||||||
4023149|NCT01168973|3844315|B3|Argentina||Region of Enrollment||participants|Number|33|33.0||||||
4023150|NCT01168973|3844316|B2|Argentina||Region of Enrollment||participants|Number|17|17.0||||||
4023151|NCT01168973|3844317|B1|Argentina||Region of Enrollment||participants|Number|16|16.0||||||
4023152|NCT01168973|3844315|B3|Canada||Region of Enrollment||participants|Number|19|19.0||||||
4023153|NCT01168973|3844316|B2|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4023154|NCT01168973|3844317|B1|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4023155|NCT01168973|3844315|B3|Mexico||Region of Enrollment||participants|Number|31|31.0||||||
4023156|NCT01168973|3844316|B2|Mexico||Region of Enrollment||participants|Number|20|20.0||||||
4023157|NCT01168973|3844317|B1|Mexico||Region of Enrollment||participants|Number|11|11.0||||||
4023158|NCT01168973|3844315|B3|Hungary||Region of Enrollment||participants|Number|13|13.0||||||
4023159|NCT01168973|3844316|B2|Hungary||Region of Enrollment||participants|Number|4|4.0||||||
4023160|NCT01168973|3844317|B1|Hungary||Region of Enrollment||participants|Number|9|9.0||||||
4023161|NCT01168973|3844315|B3|United Kingdom||Region of Enrollment||participants|Number|38|38.0||||||
4023162|NCT01168973|3844316|B2|United Kingdom||Region of Enrollment||participants|Number|19|19.0||||||
4023163|NCT01168973|3844317|B1|United Kingdom||Region of Enrollment||participants|Number|19|19.0||||||
4023164|NCT01168973|3844315|B3|Austria||Region of Enrollment||participants|Number|20|20.0||||||
4023165|NCT01168973|3844316|B2|Austria||Region of Enrollment||participants|Number|9|9.0||||||
4023166|NCT01168973|3844317|B1|Austria||Region of Enrollment||participants|Number|11|11.0||||||
4023167|NCT01168973|3844315|B3|Turkey||Region of Enrollment||participants|Number|45|45.0||||||
4023168|NCT01168973|3844316|B2|Turkey||Region of Enrollment||participants|Number|23|23.0||||||
4023169|NCT01168973|3844317|B1|Turkey||Region of Enrollment||participants|Number|22|22.0||||||
4023170|NCT01168973|3844315|B3|Korea, Republic of||Region of Enrollment||participants|Number|62|62.0||||||
4023171|NCT01168973|3844316|B2|Korea, Republic of||Region of Enrollment||participants|Number|28|28.0||||||
4023172|NCT01168973|3844317|B1|Korea, Republic of||Region of Enrollment||participants|Number|34|34.0||||||
4023173|NCT01168973|3844315|B3|Netherlands||Region of Enrollment||participants|Number|31|31.0||||||
4023174|NCT01168973|3844316|B2|Netherlands||Region of Enrollment||participants|Number|16|16.0||||||
4023175|NCT01168973|3844317|B1|Netherlands||Region of Enrollment||participants|Number|15|15.0||||||
4023176|NCT01168973|3844315|B3|Puerto Rico||Region of Enrollment||participants|Number|3|3.0||||||
4023177|NCT01168973|3844316|B2|Puerto Rico||Region of Enrollment||participants|Number|2|2.0||||||
4023178|NCT01168973|3844317|B1|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
4023179|NCT01168973|3844315|B3|France||Region of Enrollment||participants|Number|45|45.0||||||
4023180|NCT01168973|3844316|B2|France||Region of Enrollment||participants|Number|24|24.0||||||
4023181|NCT01168973|3844317|B1|France||Region of Enrollment||participants|Number|21|21.0||||||
4023182|NCT01168973|3844315|B3|India||Region of Enrollment||participants|Number|55|55.0||||||
4023183|NCT01168973|3844316|B2|India||Region of Enrollment||participants|Number|33|33.0||||||
4023184|NCT01168973|3844317|B1|India||Region of Enrollment||participants|Number|22|22.0||||||
4023185|NCT01168973|3844315|B3|Switzerland||Region of Enrollment||participants|Number|26|26.0||||||
4023186|NCT01168973|3844316|B2|Switzerland||Region of Enrollment||participants|Number|14|14.0||||||
4023187|NCT01168973|3844317|B1|Switzerland||Region of Enrollment||participants|Number|12|12.0||||||
4023188|NCT01168973|3844315|B3|Italy||Region of Enrollment||participants|Number|54|54.0||||||
4023189|NCT01168973|3844316|B2|Italy||Region of Enrollment||participants|Number|28|28.0||||||
4023190|NCT01168973|3844317|B1|Italy||Region of Enrollment||participants|Number|26|26.0||||||
4023191|NCT01168973|3844315|B3|Russian Federation||Region of Enrollment||participants|Number|61|61.0||||||
4023192|NCT01168973|3844316|B2|Russian Federation||Region of Enrollment||participants|Number|33|33.0||||||
4023193|NCT01168973|3844317|B1|Russian Federation||Region of Enrollment||participants|Number|28|28.0||||||
4023194|NCT01168973|3844315|B3|Israel||Region of Enrollment||participants|Number|22|22.0||||||
4023195|NCT01168973|3844316|B2|Israel||Region of Enrollment||participants|Number|8|8.0||||||
4023196|NCT01168973|3844317|B1|Israel||Region of Enrollment||participants|Number|14|14.0||||||
4023197|NCT01168973|3844315|B3|Spain||Region of Enrollment||participants|Number|50|50.0||||||
4023198|NCT01168973|3844316|B2|Spain||Region of Enrollment||participants|Number|23|23.0||||||
4023199|NCT01168973|3844317|B1|Spain||Region of Enrollment||participants|Number|27|27.0||||||
4023200|NCT01168973|3844315|B3|Greece||Region of Enrollment||participants|Number|44|44.0||||||
4023201|NCT01168973|3844316|B2|Greece||Region of Enrollment||participants|Number|19|19.0||||||
4023202|NCT01168973|3844317|B1|Greece||Region of Enrollment||participants|Number|25|25.0||||||
4023203|NCT01168973|3844315|B3|Taiwan||Region of Enrollment||participants|Number|27|27.0||||||
4023204|NCT01168973|3844316|B2|Taiwan||Region of Enrollment||participants|Number|18|18.0||||||
4023205|NCT01168973|3844317|B1|Taiwan||Region of Enrollment||participants|Number|9|9.0||||||
4023206|NCT01168973|3844315|B3|United States||Region of Enrollment||participants|Number|308|308.0||||||
4023207|NCT01168973|3844316|B2|United States||Region of Enrollment||participants|Number|152|152.0||||||
4023208|NCT01168973|3844317|B1|United States||Region of Enrollment||participants|Number|156|156.0||||||
4023209|NCT01168973|3844315|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4023210|NCT01168973|3844316|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023211|NCT01168973|3844317|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4023212|NCT01168973|3844315|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023213|NCT01168973|3844316|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023214|NCT01168973|3844317|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023215|NCT01168973|3844315|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1029|1029.0||||||
4023216|NCT01168973|3844316|B2||White|Race (NIH/OMB)||Participants|Count of Participants|503|503.0||||||
4023217|NCT01168973|3844317|B1||White|Race (NIH/OMB)||Participants|Count of Participants|526|526.0||||||
4023218|NCT01168973|3844315|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4023219|NCT01168973|3844316|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4023220|NCT01168973|3844317|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4023221|NCT01168973|3844315|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4023222|NCT01168973|3844316|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023223|NCT01168973|3844317|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4023224|NCT01168973|3844315|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|160|160.0||||||
4023225|NCT01168973|3844316|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4023226|NCT01168973|3844317|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4023227|NCT01168973|3844315|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4023228|NCT01168973|3844316|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4023229|NCT01168973|3844317|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4023230|NCT01168973|3844315|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|390|390.0||||||
4023231|NCT01168973|3844316|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|192|192.0||||||
4023232|NCT01168973|3844317|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|198|198.0||||||
4023233|NCT01168973|3844315|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|767|767.0||||||
4023234|NCT01168973|3844316|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|380|380.0||||||
4023235|NCT01168973|3844317|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|387|387.0||||||
4023236|NCT01168973|3844315|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4023237|NCT01168973|3844316|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4023238|NCT01168973|3844317|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4023239|NCT01168973|3844315|B3||Male|Sex: Female, Male||Participants|Count of Participants|834|834.0||||||
4023240|NCT01168973|3844316|B2||Male|Sex: Female, Male||Participants|Count of Participants|415|415.0||||||
4023241|NCT01168973|3844317|B1||Male|Sex: Female, Male||Participants|Count of Participants|419|419.0||||||
4023242|NCT01168973|3844315|B3||Female|Sex: Female, Male||Participants|Count of Participants|419|419.0||||||
4023243|NCT01168973|3844316|B2||Female|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4023244|NCT01168973|3844317|B1||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4023245|NCT01168973|3844315|B3||>=65 years|Age||Participants|Count of Participants|455|455.0||||||
4023246|NCT01168973|3844316|B2||>=65 years|Age||Participants|Count of Participants|218|218.0||||||
4023247|NCT01168973|3844317|B1||>=65 years|Age||Participants|Count of Participants|237|237.0||||||
4023248|NCT01168973|3844315|B3||Between 18 and 65 years|Age||Participants|Count of Participants|798|798.0||||||
4023249|NCT01168973|3844316|B2||Between 18 and 65 years|Age||Participants|Count of Participants|407|407.0||||||
4023250|NCT01168973|3844317|B1||Between 18 and 65 years|Age||Participants|Count of Participants|391|391.0||||||
4023251|NCT01168973|3844315|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4023252|NCT01168973|3844316|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4023253|NCT01168973|3844317|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4023254|NCT01168934|3844339|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4023255|NCT01168934|3844339|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4023256|NCT01168934|3844339|B1|||Age||years|Mean|35.7|35.7|Standard Deviation|11.5|11.5|||
4023257|NCT01168908|3844372|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023258|NCT01168908|3844373|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023259|NCT01168908|3844374|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023260|NCT01168908|3844372|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023261|NCT01168908|3844373|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023262|NCT01168908|3844374|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023263|NCT01168908|3844372|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4023264|NCT01168908|3844373|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4023265|NCT01168908|3844374|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4023266|NCT01168908|3844372|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4023267|NCT01168908|3844373|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023268|NCT01168908|3844374|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4023269|NCT01168908|3844372|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023270|NCT01168908|3844373|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023271|NCT01168908|3844374|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023272|NCT01168908|3844372|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4023273|NCT01168908|3844373|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4023274|NCT01168908|3844374|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4023275|NCT01168908|3844372|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023276|NCT01168908|3844373|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023277|NCT01168908|3844374|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023278|NCT01168908|3844372|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4023279|NCT01168908|3844373|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4023280|NCT01168908|3844374|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4023281|NCT01168908|3844372|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4023282|NCT01168908|3844373|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4023283|NCT01168908|3844374|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4023284|NCT01168908|3844372|B3|||Age||years|Mean|24.05|24.05|Standard Deviation|6.6|6.6|||
4023285|NCT01168908|3844373|B2|||Age||years|Mean|22.6|22.6|Standard Deviation|4.4|4.4|||
4023286|NCT01168908|3844374|B1|||Age||years|Mean|25.5|25.5|Standard Deviation|8.2|8.2|||
4023287|NCT01168856|3844389|B3||Male|Sex: Female, Male||Participants|Count of Participants|455|455.0||||||
4023288|NCT01168856|3844390|B2||Male|Sex: Female, Male||Participants|Count of Participants|330|330.0||||||
4023289|NCT01168856|3844391|B1||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4023290|NCT01168856|3844389|B3||Female|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
4023291|NCT01168856|3844390|B2||Female|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4023292|NCT01168856|3844391|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4023293|NCT01168856|3844389|B3|||Age||years|Mean|51.2|51.2|Standard Deviation|10.29|10.29|||
4023294|NCT01168856|3844390|B2|||Age||years|Mean|51.0|51.0|Standard Deviation|10.79|10.79|||
4023295|NCT01168856|3844391|B1|||Age||years|Mean|52.1|52.1|Standard Deviation|8.48|8.48|||
4023296|NCT01168726|3844449|B4|United States||Region of Enrollment||participants|Number|365|365.0||||||
4023297|NCT01168726|3844450|B3|United States||Region of Enrollment||participants|Number|133|133.0||||||
4023298|NCT01168726|3844451|B2|United States||Region of Enrollment||participants|Number|121|121.0||||||
4023299|NCT01168726|3844452|B1|United States||Region of Enrollment||participants|Number|111|111.0||||||
4023300|NCT01168726|3844449|B4||Male|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
4023301|NCT01168726|3844450|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4023302|NCT01168726|3844451|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4023303|NCT01168726|3844452|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4023304|NCT01168726|3844449|B4||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4023305|NCT01168726|3844450|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4023306|NCT01168726|3844451|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4023307|NCT01168726|3844452|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4023308|NCT01168726|3844449|B4|||Age||Years|Mean|20.10|20.1|Standard Deviation|1.35|1.35|||
4023309|NCT01168726|3844450|B3|||Age||Years|Mean|20.20|20.2|Standard Deviation|1.31|1.31|||
4023310|NCT01168726|3844451|B2|||Age||Years|Mean|20.12|20.12|Standard Deviation|1.38|1.38|||
4023311|NCT01168726|3844452|B1|||Age||Years|Mean|19.95|19.95|Standard Deviation|1.36|1.36|||
4023312|NCT01168726|3844449|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4023313|NCT01168726|3844450|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4023314|NCT01168726|3844451|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4023315|NCT01168726|3844452|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4023316|NCT01168726|3844449|B4||Between 18 and 65 years|Age||Participants|Count of Participants|365|365.0||||||
4023317|NCT01168726|3844450|B3||Between 18 and 65 years|Age||Participants|Count of Participants|133|133.0||||||
4023318|NCT01168726|3844451|B2||Between 18 and 65 years|Age||Participants|Count of Participants|121|121.0||||||
4023319|NCT01168726|3844452|B1||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
4023320|NCT01168726|3844449|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4023321|NCT01168726|3844450|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4023322|NCT01168726|3844451|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4023323|NCT01168726|3844452|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4023324|NCT01168687|3844471|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
4023325|NCT01168687|3844472|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4023326|NCT01168687|3844473|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4023327|NCT01168687|3844471|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4023328|NCT01168687|3844472|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4023329|NCT01168687|3844473|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4023330|NCT01168687|3844471|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4023331|NCT01168687|3844472|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4023332|NCT01168687|3844473|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4023333|NCT01168687|3844471|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4023334|NCT01168687|3844472|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4023335|NCT01168687|3844473|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4023336|NCT01168687|3844471|B3||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4023337|NCT01168687|3844472|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4023338|NCT01168687|3844473|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4023339|NCT01168687|3844471|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4023340|NCT01168687|3844472|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4023341|NCT01168687|3844473|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4023342|NCT01168674|3844480|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4023343|NCT01168674|3844480|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4023344|NCT01168674|3844480|B1|||Age||years|Mean|42.6|42.6|Standard Deviation|11.4|11.4|||
4023345|NCT01168596|3844488|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4023346|NCT01168596|3844489|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4023347|NCT01168596|3844490|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4023348|NCT01168596|3844488|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4023349|NCT01168596|3844489|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4023350|NCT01168596|3844490|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4023351|NCT01168596|3844488|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4023352|NCT01168596|3844489|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4023353|NCT01168596|3844490|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4023354|NCT01168596|3844488|B3|||Age||years|Mean|67.1|67.1|Standard Deviation|7|7.0|||
4023355|NCT01168596|3844489|B2|||Age||years|Mean|65.43|65.43|Standard Deviation|6.42|6.42|||
4023356|NCT01168596|3844490|B1|||Age||years|Mean|68.67|68.67|Standard Deviation|7.39|7.39|||
4023357|NCT01168427|3844535|B1|United States||Region of Enrollment||participants|Number|66|66.0||||||
4023358|NCT01168427|3844535|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4023359|NCT01168427|3844535|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4023360|NCT01168427|3844535|B1|||Age||years|Mean|59.9|59.9|Standard Deviation|17.98|17.98|||
4023361|NCT01168427|3844535|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4023362|NCT01168427|3844535|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4023363|NCT01168427|3844535|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4023364|NCT01168401|3844540|B12|Blood Type AB||Blood Type||Participants|Count of Participants|6|6.0||||||
4023365|NCT01168401|3844541|B11|Blood Type AB||Blood Type||Participants|Count of Participants|1|1.0||||||
4023366|NCT01168401|3844542|B10|Blood Type AB||Blood Type||Participants|Count of Participants|0|0.0||||||
4023367|NCT01168401|3844543|B9|Blood Type AB||Blood Type||Participants|Count of Participants|0|0.0||||||
4023368|NCT01168401|3844544|B8|Blood Type AB||Blood Type||Participants|Count of Participants|0|0.0||||||
4023369|NCT01168401|3844545|B7|Blood Type AB||Blood Type||Participants|Count of Participants|1|1.0||||||
4023370|NCT01168401|3844546|B6|Blood Type AB||Blood Type||Participants|Count of Participants|0|0.0||||||
4023371|NCT01168401|3844547|B5|Blood Type AB||Blood Type||Participants|Count of Participants|1|1.0||||||
4023372|NCT01168401|3844548|B4|Blood Type AB||Blood Type||Participants|Count of Participants|0|0.0||||||
4023373|NCT01168401|3844549|B3|Blood Type AB||Blood Type||Participants|Count of Participants|0|0.0||||||
4023374|NCT01168401|3844550|B2|Blood Type AB||Blood Type||Participants|Count of Participants|2|2.0||||||
4023375|NCT01168401|3844551|B1|Blood Type AB||Blood Type||Participants|Count of Participants|1|1.0||||||
4023376|NCT01168401|3844540|B12|Blood Type O||Blood Type||Participants|Count of Participants|53|53.0||||||
4023377|NCT01168401|3844541|B11|Blood Type O||Blood Type||Participants|Count of Participants|3|3.0||||||
4023378|NCT01168401|3844542|B10|Blood Type O||Blood Type||Participants|Count of Participants|5|5.0||||||
4023379|NCT01168401|3844543|B9|Blood Type O||Blood Type||Participants|Count of Participants|5|5.0||||||
4023380|NCT01168401|3844544|B8|Blood Type O||Blood Type||Participants|Count of Participants|7|7.0||||||
4023381|NCT01168401|3844545|B7|Blood Type O||Blood Type||Participants|Count of Participants|3|3.0||||||
4023382|NCT01168401|3844546|B6|Blood Type O||Blood Type||Participants|Count of Participants|5|5.0||||||
4023383|NCT01168401|3844547|B5|Blood Type O||Blood Type||Participants|Count of Participants|5|5.0||||||
4023384|NCT01168401|3844548|B4|Blood Type O||Blood Type||Participants|Count of Participants|5|5.0||||||
4023385|NCT01168401|3844549|B3|Blood Type O||Blood Type||Participants|Count of Participants|5|5.0||||||
4023386|NCT01168401|3844550|B2|Blood Type O||Blood Type||Participants|Count of Participants|4|4.0||||||
4023387|NCT01168401|3844551|B1|Blood Type O||Blood Type||Participants|Count of Participants|6|6.0||||||
4023388|NCT01168401|3844540|B12|Blood Type B||Blood Type||Participants|Count of Participants|11|11.0||||||
4023389|NCT01168401|3844541|B11|Blood Type B||Blood Type||Participants|Count of Participants|2|2.0||||||
4023390|NCT01168401|3844542|B10|Blood Type B||Blood Type||Participants|Count of Participants|2|2.0||||||
4023391|NCT01168401|3844543|B9|Blood Type B||Blood Type||Participants|Count of Participants|2|2.0||||||
4023392|NCT01168401|3844544|B8|Blood Type B||Blood Type||Participants|Count of Participants|0|0.0||||||
4023393|NCT01168401|3844545|B7|Blood Type B||Blood Type||Participants|Count of Participants|0|0.0||||||
4023394|NCT01168401|3844546|B6|Blood Type B||Blood Type||Participants|Count of Participants|2|2.0||||||
4023395|NCT01168401|3844547|B5|Blood Type B||Blood Type||Participants|Count of Participants|1|1.0||||||
4023396|NCT01168401|3844548|B4|Blood Type B||Blood Type||Participants|Count of Participants|1|1.0||||||
4023397|NCT01168401|3844549|B3|Blood Type B||Blood Type||Participants|Count of Participants|0|0.0||||||
4023398|NCT01168401|3844550|B2|Blood Type B||Blood Type||Participants|Count of Participants|1|1.0||||||
4023399|NCT01168401|3844551|B1|Blood Type B||Blood Type||Participants|Count of Participants|0|0.0||||||
4023400|NCT01168401|3844540|B12|Blood Type A||Blood Type||Participants|Count of Participants|32|32.0||||||
4023401|NCT01168401|3844541|B11|Blood Type A||Blood Type||Participants|Count of Participants|2|2.0||||||
4023402|NCT01168401|3844542|B10|Blood Type A||Blood Type||Participants|Count of Participants|1|1.0||||||
4023403|NCT01168401|3844543|B9|Blood Type A||Blood Type||Participants|Count of Participants|2|2.0||||||
4023404|NCT01168401|3844544|B8|Blood Type A||Blood Type||Participants|Count of Participants|3|3.0||||||
4023405|NCT01168401|3844545|B7|Blood Type A||Blood Type||Participants|Count of Participants|6|6.0||||||
4023406|NCT01168401|3844546|B6|Blood Type A||Blood Type||Participants|Count of Participants|2|2.0||||||
4023407|NCT01168401|3844547|B5|Blood Type A||Blood Type||Participants|Count of Participants|2|2.0||||||
4023408|NCT01168401|3844548|B4|Blood Type A||Blood Type||Participants|Count of Participants|3|3.0||||||
4023409|NCT01168401|3844549|B3|Blood Type A||Blood Type||Participants|Count of Participants|5|5.0||||||
4023410|NCT01168401|3844550|B2|Blood Type A||Blood Type||Participants|Count of Participants|3|3.0||||||
4023411|NCT01168401|3844551|B1|Blood Type A||Blood Type||Participants|Count of Participants|3|3.0||||||
4023412|NCT01168401|3844540|B12|Saliva Secretor Status Negative||Saliva Secretor Status||Participants|Count of Participants|23|23.0||||||
4023413|NCT01168401|3844541|B11|Saliva Secretor Status Negative||Saliva Secretor Status||Participants|Count of Participants|3|3.0||||||
4023414|NCT01168401|3844542|B10|Saliva Secretor Status Negative||Saliva Secretor Status||Participants|Count of Participants|1|1.0||||||
4023415|NCT01168401|3844543|B9|Saliva Secretor Status Negative||Saliva Secretor Status||Participants|Count of Participants|2|2.0||||||
4023416|NCT01168401|3844544|B8|Saliva Secretor Status Negative||Saliva Secretor Status||Participants|Count of Participants|2|2.0||||||
4023417|NCT01168401|3844545|B7|Saliva Secretor Status Negative||Saliva Secretor Status||Participants|Count of Participants|2|2.0||||||
4023418|NCT01168401|3844546|B6|Saliva Secretor Status Negative||Saliva Secretor Status||Participants|Count of Participants|3|3.0||||||
4023419|NCT01168401|3844547|B5|Saliva Secretor Status Negative||Saliva Secretor Status||Participants|Count of Participants|1|1.0||||||
4023420|NCT01168401|3844548|B4|Saliva Secretor Status Negative||Saliva Secretor Status||Participants|Count of Participants|0|0.0||||||
4023421|NCT01168401|3844549|B3|Saliva Secretor Status Negative||Saliva Secretor Status||Participants|Count of Participants|4|4.0||||||
4023422|NCT01168401|3844550|B2|Saliva Secretor Status Negative||Saliva Secretor Status||Participants|Count of Participants|2|2.0||||||
4023423|NCT01168401|3844551|B1|Saliva Secretor Status Negative||Saliva Secretor Status||Participants|Count of Participants|3|3.0||||||
4023424|NCT01168401|3844540|B12|Saliva Secretor Status Positive||Saliva Secretor Status||Participants|Count of Participants|79|79.0||||||
4023425|NCT01168401|3844541|B11|Saliva Secretor Status Positive||Saliva Secretor Status||Participants|Count of Participants|5|5.0||||||
4023426|NCT01168401|3844542|B10|Saliva Secretor Status Positive||Saliva Secretor Status||Participants|Count of Participants|7|7.0||||||
4023427|NCT01168401|3844543|B9|Saliva Secretor Status Positive||Saliva Secretor Status||Participants|Count of Participants|7|7.0||||||
4023428|NCT01168401|3844544|B8|Saliva Secretor Status Positive||Saliva Secretor Status||Participants|Count of Participants|8|8.0||||||
4023429|NCT01168401|3844545|B7|Saliva Secretor Status Positive||Saliva Secretor Status||Participants|Count of Participants|8|8.0||||||
4023430|NCT01168401|3844546|B6|Saliva Secretor Status Positive||Saliva Secretor Status||Participants|Count of Participants|6|6.0||||||
4023431|NCT01168401|3844547|B5|Saliva Secretor Status Positive||Saliva Secretor Status||Participants|Count of Participants|8|8.0||||||
4023432|NCT01168401|3844548|B4|Saliva Secretor Status Positive||Saliva Secretor Status||Participants|Count of Participants|9|9.0||||||
4023433|NCT01168401|3844549|B3|Saliva Secretor Status Positive||Saliva Secretor Status||Participants|Count of Participants|6|6.0||||||
4023434|NCT01168401|3844550|B2|Saliva Secretor Status Positive||Saliva Secretor Status||Participants|Count of Participants|8|8.0||||||
4023435|NCT01168401|3844551|B1|Saliva Secretor Status Positive||Saliva Secretor Status||Participants|Count of Participants|7|7.0||||||
4023436|NCT01168401|3844540|B12|Hispanic||Ethnicity||Participants|Count of Participants|5|5.0||||||
4023437|NCT01168401|3844541|B11|Hispanic||Ethnicity||Participants|Count of Participants|0|0.0||||||
4023438|NCT01168401|3844542|B10|Hispanic||Ethnicity||Participants|Count of Participants|2|2.0||||||
4023439|NCT01168401|3844543|B9|Hispanic||Ethnicity||Participants|Count of Participants|0|0.0||||||
4023440|NCT01168401|3844544|B8|Hispanic||Ethnicity||Participants|Count of Participants|0|0.0||||||
4023441|NCT01168401|3844545|B7|Hispanic||Ethnicity||Participants|Count of Participants|1|1.0||||||
4023442|NCT01168401|3844546|B6|Hispanic||Ethnicity||Participants|Count of Participants|0|0.0||||||
4023443|NCT01168401|3844547|B5|Hispanic||Ethnicity||Participants|Count of Participants|0|0.0||||||
4023444|NCT01168401|3844548|B4|Hispanic||Ethnicity||Participants|Count of Participants|0|0.0||||||
4023445|NCT01168401|3844549|B3|Hispanic||Ethnicity||Participants|Count of Participants|0|0.0||||||
4023446|NCT01168401|3844550|B2|Hispanic||Ethnicity||Participants|Count of Participants|0|0.0||||||
4023447|NCT01168401|3844551|B1|Hispanic||Ethnicity||Participants|Count of Participants|2|2.0||||||
4023448|NCT01168401|3844540|B12|Non-Hispanic||Ethnicity||Participants|Count of Participants|97|97.0||||||
4023449|NCT01168401|3844541|B11|Non-Hispanic||Ethnicity||Participants|Count of Participants|8|8.0||||||
4023450|NCT01168401|3844542|B10|Non-Hispanic||Ethnicity||Participants|Count of Participants|6|6.0||||||
4023451|NCT01168401|3844543|B9|Non-Hispanic||Ethnicity||Participants|Count of Participants|9|9.0||||||
4023452|NCT01168401|3844544|B8|Non-Hispanic||Ethnicity||Participants|Count of Participants|10|10.0||||||
4023453|NCT01168401|3844545|B7|Non-Hispanic||Ethnicity||Participants|Count of Participants|9|9.0||||||
4023454|NCT01168401|3844546|B6|Non-Hispanic||Ethnicity||Participants|Count of Participants|9|9.0||||||
4023455|NCT01168401|3844547|B5|Non-Hispanic||Ethnicity||Participants|Count of Participants|9|9.0||||||
4023456|NCT01168401|3844548|B4|Non-Hispanic||Ethnicity||Participants|Count of Participants|9|9.0||||||
4023457|NCT01168401|3844549|B3|Non-Hispanic||Ethnicity||Participants|Count of Participants|10|10.0||||||
4023458|NCT01168401|3844550|B2|Non-Hispanic||Ethnicity||Participants|Count of Participants|10|10.0||||||
4023459|NCT01168401|3844551|B1|Non-Hispanic||Ethnicity||Participants|Count of Participants|8|8.0||||||
4023460|NCT01168401|3844540|B12|More than one race||Race||Participants|Count of Participants|2|2.0||||||
4023461|NCT01168401|3844541|B11|More than one race||Race||Participants|Count of Participants|1|1.0||||||
4023462|NCT01168401|3844542|B10|More than one race||Race||Participants|Count of Participants|0|0.0||||||
4023463|NCT01168401|3844543|B9|More than one race||Race||Participants|Count of Participants|0|0.0||||||
4023464|NCT01168401|3844544|B8|More than one race||Race||Participants|Count of Participants|0|0.0||||||
4023465|NCT01168401|3844545|B7|More than one race||Race||Participants|Count of Participants|0|0.0||||||
4023466|NCT01168401|3844546|B6|More than one race||Race||Participants|Count of Participants|0|0.0||||||
4023467|NCT01168401|3844547|B5|More than one race||Race||Participants|Count of Participants|0|0.0||||||
4023468|NCT01168401|3844548|B4|More than one race||Race||Participants|Count of Participants|0|0.0||||||
4023469|NCT01168401|3844549|B3|More than one race||Race||Participants|Count of Participants|0|0.0||||||
4023470|NCT01168401|3844550|B2|More than one race||Race||Participants|Count of Participants|1|1.0||||||
4023471|NCT01168401|3844551|B1|More than one race||Race||Participants|Count of Participants|0|0.0||||||
4023472|NCT01168401|3844540|B12|White||Race||Participants|Count of Participants|76|76.0||||||
4023473|NCT01168401|3844541|B11|White||Race||Participants|Count of Participants|2|2.0||||||
4023474|NCT01168401|3844542|B10|White||Race||Participants|Count of Participants|3|3.0||||||
4023475|NCT01168401|3844543|B9|White||Race||Participants|Count of Participants|9|9.0||||||
4023476|NCT01168401|3844544|B8|White||Race||Participants|Count of Participants|10|10.0||||||
4023477|NCT01168401|3844545|B7|White||Race||Participants|Count of Participants|9|9.0||||||
4023478|NCT01168401|3844546|B6|White||Race||Participants|Count of Participants|9|9.0||||||
4023479|NCT01168401|3844547|B5|White||Race||Participants|Count of Participants|7|7.0||||||
4023480|NCT01168401|3844548|B4|White||Race||Participants|Count of Participants|6|6.0||||||
4023481|NCT01168401|3844549|B3|White||Race||Participants|Count of Participants|6|6.0||||||
4023482|NCT01168401|3844550|B2|White||Race||Participants|Count of Participants|7|7.0||||||
4023483|NCT01168401|3844551|B1|White||Race||Participants|Count of Participants|8|8.0||||||
4023484|NCT01168401|3844540|B12|Black or African American||Race||Participants|Count of Participants|19|19.0||||||
4023485|NCT01168401|3844541|B11|Black or African American||Race||Participants|Count of Participants|5|5.0||||||
4023486|NCT01168401|3844542|B10|Black or African American||Race||Participants|Count of Participants|5|5.0||||||
4023487|NCT01168401|3844543|B9|Black or African American||Race||Participants|Count of Participants|0|0.0||||||
4023488|NCT01168401|3844544|B8|Black or African American||Race||Participants|Count of Participants|0|0.0||||||
4023489|NCT01168401|3844545|B7|Black or African American||Race||Participants|Count of Participants|0|0.0||||||
4023490|NCT01168401|3844546|B6|Black or African American||Race||Participants|Count of Participants|0|0.0||||||
4023491|NCT01168401|3844547|B5|Black or African American||Race||Participants|Count of Participants|2|2.0||||||
4023492|NCT01168401|3844548|B4|Black or African American||Race||Participants|Count of Participants|1|1.0||||||
4023493|NCT01168401|3844549|B3|Black or African American||Race||Participants|Count of Participants|2|2.0||||||
4023494|NCT01168401|3844550|B2|Black or African American||Race||Participants|Count of Participants|2|2.0||||||
4023495|NCT01168401|3844551|B1|Black or African American||Race||Participants|Count of Participants|2|2.0||||||
4023496|NCT01168401|3844540|B12|Asian||Race||Participants|Count of Participants|4|4.0||||||
4023497|NCT01168401|3844541|B11|Asian||Race||Participants|Count of Participants|0|0.0||||||
4023498|NCT01168401|3844542|B10|Asian||Race||Participants|Count of Participants|0|0.0||||||
4023499|NCT01168401|3844543|B9|Asian||Race||Participants|Count of Participants|0|0.0||||||
4023500|NCT01168401|3844544|B8|Asian||Race||Participants|Count of Participants|0|0.0||||||
4023501|NCT01168401|3844545|B7|Asian||Race||Participants|Count of Participants|0|0.0||||||
4023502|NCT01168401|3844546|B6|Asian||Race||Participants|Count of Participants|0|0.0||||||
4023503|NCT01168401|3844547|B5|Asian||Race||Participants|Count of Participants|0|0.0||||||
4023504|NCT01168401|3844548|B4|Asian||Race||Participants|Count of Participants|2|2.0||||||
4023505|NCT01168401|3844549|B3|Asian||Race||Participants|Count of Participants|2|2.0||||||
4023506|NCT01168401|3844550|B2|Asian||Race||Participants|Count of Participants|0|0.0||||||
4023507|NCT01168401|3844551|B1|Asian||Race||Participants|Count of Participants|0|0.0||||||
4023508|NCT01168401|3844540|B12|American Indian or Alaska Native||Race||Participants|Count of Participants|1|1.0||||||
4023509|NCT01168401|3844541|B11|American Indian or Alaska Native||Race||Participants|Count of Participants|0|0.0||||||
4023510|NCT01168401|3844542|B10|American Indian or Alaska Native||Race||Participants|Count of Participants|0|0.0||||||
4023511|NCT01168401|3844543|B9|American Indian or Alaska Native||Race||Participants|Count of Participants|0|0.0||||||
4023512|NCT01168401|3844544|B8|American Indian or Alaska Native||Race||Participants|Count of Participants|0|0.0||||||
4023513|NCT01168401|3844545|B7|American Indian or Alaska Native||Race||Participants|Count of Participants|1|1.0||||||
4023514|NCT01168401|3844546|B6|American Indian or Alaska Native||Race||Participants|Count of Participants|0|0.0||||||
4023515|NCT01168401|3844547|B5|American Indian or Alaska Native||Race||Participants|Count of Participants|0|0.0||||||
4023516|NCT01168401|3844548|B4|American Indian or Alaska Native||Race||Participants|Count of Participants|0|0.0||||||
4023517|NCT01168401|3844549|B3|American Indian or Alaska Native||Race||Participants|Count of Participants|0|0.0||||||
4023518|NCT01168401|3844550|B2|American Indian or Alaska Native||Race||Participants|Count of Participants|0|0.0||||||
4023519|NCT01168401|3844551|B1|American Indian or Alaska Native||Race||Participants|Count of Participants|0|0.0||||||
4023520|NCT01168401|3844540|B12|United States||Region of Enrollment||participants|Number|102|102.0||||||
4023521|NCT01168401|3844541|B11|United States||Region of Enrollment||participants|Number|8|8.0||||||
4023522|NCT01168401|3844542|B10|United States||Region of Enrollment||participants|Number|8|8.0||||||
4023523|NCT01168401|3844543|B9|United States||Region of Enrollment||participants|Number|9|9.0||||||
4023524|NCT01168401|3844544|B8|United States||Region of Enrollment||participants|Number|10|10.0||||||
4023525|NCT01168401|3844545|B7|United States||Region of Enrollment||participants|Number|10|10.0||||||
4023526|NCT01168401|3844546|B6|United States||Region of Enrollment||participants|Number|9|9.0||||||
4023527|NCT01168401|3844547|B5|United States||Region of Enrollment||participants|Number|9|9.0||||||
4023528|NCT01168401|3844548|B4|United States||Region of Enrollment||participants|Number|9|9.0||||||
4023529|NCT01168401|3844549|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4023530|NCT01168401|3844550|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4023531|NCT01168401|3844551|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4023532|NCT01168401|3844540|B12||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4023533|NCT01168401|3844541|B11||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4023534|NCT01168401|3844542|B10||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4023535|NCT01168401|3844543|B9||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4023536|NCT01168401|3844544|B8||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4023537|NCT01168401|3844545|B7||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4023538|NCT01168401|3844546|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4023539|NCT01168401|3844547|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4023540|NCT01168401|3844548|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4023541|NCT01168401|3844549|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4023542|NCT01168401|3844550|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4023543|NCT01168401|3844551|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4023544|NCT01168401|3844540|B12||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4023545|NCT01168401|3844541|B11||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4023546|NCT01168401|3844542|B10||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4023547|NCT01168401|3844543|B9||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4023548|NCT01168401|3844544|B8||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4023549|NCT01168401|3844545|B7||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4023550|NCT01168401|3844546|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4023551|NCT01168401|3844547|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4023552|NCT01168401|3844548|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4023553|NCT01168401|3844549|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4023554|NCT01168401|3844550|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4023555|NCT01168401|3844551|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4023556|NCT01168401|3844540|B12|>=65 years||Age, Customized||participants|Number|19|19.0||||||
4023557|NCT01168401|3844541|B11|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4023558|NCT01168401|3844542|B10|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4023559|NCT01168401|3844543|B9|>=65 years||Age, Customized||participants|Number|9|9.0||||||
4023560|NCT01168401|3844544|B8|>=65 years||Age, Customized||participants|Number|10|10.0||||||
4023561|NCT01168401|3844545|B7|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4023562|NCT01168401|3844546|B6|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4023563|NCT01168401|3844547|B5|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4023564|NCT01168401|3844548|B4|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4023565|NCT01168401|3844549|B3|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4023566|NCT01168401|3844550|B2|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4023567|NCT01168401|3844551|B1|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4023568|NCT01168401|3844540|B12|Greater than or equal to (>=) 18 and <64 years||Age, Customized||participants|Number|83|83.0||||||
4023569|NCT01168401|3844541|B11|Greater than or equal to (>=) 18 and <64 years||Age, Customized||participants|Number|8|8.0||||||
4023570|NCT01168401|3844542|B10|Greater than or equal to (>=) 18 and <64 years||Age, Customized||participants|Number|8|8.0||||||
4023571|NCT01168401|3844543|B9|Greater than or equal to (>=) 18 and <64 years||Age, Customized||participants|Number|0|0.0||||||
4023572|NCT01168401|3844544|B8|Greater than or equal to (>=) 18 and <64 years||Age, Customized||participants|Number|0|0.0||||||
4023573|NCT01168401|3844545|B7|Greater than or equal to (>=) 18 and <64 years||Age, Customized||participants|Number|10|10.0||||||
4023574|NCT01168401|3844546|B6|Greater than or equal to (>=) 18 and <64 years||Age, Customized||participants|Number|9|9.0||||||
4023575|NCT01168401|3844547|B5|Greater than or equal to (>=) 18 and <64 years||Age, Customized||participants|Number|9|9.0||||||
4023576|NCT01168401|3844548|B4|Greater than or equal to (>=) 18 and <64 years||Age, Customized||participants|Number|9|9.0||||||
4023577|NCT01168401|3844549|B3|Greater than or equal to (>=) 18 and <64 years||Age, Customized||participants|Number|10|10.0||||||
4023578|NCT01168401|3844550|B2|Greater than or equal to (>=) 18 and <64 years||Age, Customized||participants|Number|10|10.0||||||
4023579|NCT01168401|3844551|B1|Greater than or equal to (>=) 18 and <64 years||Age, Customized||participants|Number|10|10.0||||||
4023580|NCT01168349|3844794|B1||Male|Sex: Female, Male||Participants|Count of Participants|451|451.0||||||
4023581|NCT01168349|3844794|B1||Female|Sex: Female, Male||Participants|Count of Participants|528|528.0||||||
4023582|NCT01168349|3844794|B1|||Age||years|Mean|65.4|65.4|Standard Deviation|12.5|12.5|||
4023583|NCT01168232|3844900|B1|Carcinosarcoma, MMT||Histologic Type||participants|Number|6|6.0||||||
4023584|NCT01168232|3844900|B1|Carcinosarcoma-homologous||Histologic Type||participants|Number|11|11.0||||||
4023585|NCT01168232|3844900|B1|Carcinosarcoma-heterologus||Histologic Type||participants|Number|17|17.0||||||
4023586|NCT01168232|3844900|B1|||International Federation of Gynecology and Obstetrics (FIGO) Stage - Recurrent/Persistent||participants|Number|34|34.0||||||
4023587|NCT01168232|3844900|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4023588|NCT01168232|3844900|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4023589|NCT01168232|3844900|B1|80-89 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
4023590|NCT01168232|3844900|B1|70-79 years||Age, Customized||Participants|Count of Participants|12|12.0||||||
4023591|NCT01168232|3844900|B1|60-69 years||Age, Customized||Participants|Count of Participants|13|13.0||||||
4023592|NCT01168232|3844900|B1|50-59 years||Age, Customized||Participants|Count of Participants|7|7.0||||||
4023593|NCT01168232|3844900|B1|40-49 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4023594|NCT01168232|3844900|B1|30-39 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4023595|NCT01168232|3844900|B1|20-29 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4023596|NCT01168232|3844900|B1|||Age||years|Mean|66.9|66.9|Standard Deviation|7.7|7.7|||
4023597|NCT01168219|3844907|B1||Acute Myeloid Leukemia (AML)|Disease type||Participants|Count of Participants|44|44.0||||||
4023598|NCT01168219|3844907|B1||Myelodysplastic Syndrome (MDS)|Disease type||Participants|Count of Participants|24|24.0||||||
4023599|NCT01168219|3844907|B1|United States||Region of Enrollment||Participants|Count of Participants|68|68.0||||||
4023600|NCT01168219|3844907|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4023601|NCT01168219|3844907|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4023602|NCT01168219|3844907|B1||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4023603|NCT01168219|3844907|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4023604|NCT01168219|3844907|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023605|NCT01168219|3844907|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4023606|NCT01168219|3844907|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4023821|NCT01167179|3845115|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4023607|NCT01168219|3844907|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4023608|NCT01168219|3844907|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4023609|NCT01168219|3844907|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4023610|NCT01168219|3844907|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4023611|NCT01168219|3844907|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4023612|NCT01168219|3844907|B1|||Age||years|Median|62.9|62.9|Full Range|||44.8|74.3|
4023613|NCT01168024|3844911|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4023614|NCT01168024|3844912|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4023615|NCT01168024|3844913|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4023616|NCT01168024|3844911|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4023617|NCT01168024|3844912|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4023618|NCT01168024|3844913|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4023619|NCT01168024|3844911|B3|||Age||years|Mean|71|71.0|Standard Deviation|11.1|11.1|||
4023620|NCT01168024|3844912|B2|||Age||years|Mean|82|82.0|Standard Deviation|13.8|13.8|||
4023621|NCT01168024|3844913|B1|||Age||years|Mean|67.2|67.2|Standard Deviation|11.5|11.5|||
4023622|NCT01167907|3844926|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4023623|NCT01167907|3844927|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4023624|NCT01167907|3844928|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4023625|NCT01167907|3844926|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023626|NCT01167907|3844927|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023627|NCT01167907|3844928|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023628|NCT01167907|3844926|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023629|NCT01167907|3844927|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023630|NCT01167907|3844928|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023631|NCT01167907|3844926|B3||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4023632|NCT01167907|3844927|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4023633|NCT01167907|3844928|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4023634|NCT01167907|3844926|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4023635|NCT01167907|3844927|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4023636|NCT01167907|3844928|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4023637|NCT01167907|3844926|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023638|NCT01167907|3844927|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023639|NCT01167907|3844928|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023640|NCT01167907|3844926|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023641|NCT01167907|3844927|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023642|NCT01167907|3844928|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023643|NCT01167907|3844926|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023644|NCT01167907|3844927|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023645|NCT01167907|3844928|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023646|NCT01167907|3844926|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4023647|NCT01167907|3844927|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4023648|NCT01167907|3844928|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4023649|NCT01167907|3844926|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4023650|NCT01167907|3844927|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4023651|NCT01167907|3844928|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4023652|NCT01167907|3844926|B3|||Age||years|Mean|49.8|49.8|Standard Deviation|14.5|14.5|||
4023653|NCT01167907|3844927|B2|||Age||years|Mean|47.9|47.9|Standard Deviation|16.8|16.8|||
4023654|NCT01167907|3844928|B1|||Age||years|Mean|51.6|51.6|Standard Deviation|12.4|12.4|||
4023655|NCT01167881|3844945|B3||Male|Sex: Female, Male||Participants|Count of Participants|853|853.0||||||
4023656|NCT01167881|3844946|B2||Male|Sex: Female, Male||Participants|Count of Participants|421|421.0||||||
4023657|NCT01167881|3844947|B1||Male|Sex: Female, Male||Participants|Count of Participants|432|432.0||||||
4023658|NCT01167881|3844945|B3||Female|Sex: Female, Male||Participants|Count of Participants|692|692.0||||||
4023659|NCT01167881|3844946|B2||Female|Sex: Female, Male||Participants|Count of Participants|359|359.0||||||
4023660|NCT01167881|3844947|B1||Female|Sex: Female, Male||Participants|Count of Participants|333|333.0||||||
4023661|NCT01167881|3844945|B3|||Age||years|Mean|55.9|55.9|Standard Deviation|10.4|10.4|||
4023662|NCT01167881|3844946|B2|||Age||years|Mean|55.7|55.7|Standard Deviation|10.4|10.4|||
4023663|NCT01167881|3844947|B1|||Age||years|Mean|56.2|56.2|Standard Deviation|10.3|10.3|||
4023664|NCT01167829|3844972|B1|||Prostate-specific antigen (PSA)||ng/mL|Mean|0.91|0.91|Standard Deviation|0.56|0.56|||
4023665|NCT01167829|3844972|B1|||Testosterone||ng/dL|Mean|510|510.0|Standard Deviation|13|13.0|||
4023666|NCT01167829|3844972|B1|||Luteinizing hormone (LH)||IU/L|Mean|5.4|5.4|Standard Deviation|4.4|4.4|||
4023667|NCT01167829|3844972|B1|||Follicle-stimulating hormone (FSH)||IU/L|Mean|3.2|3.2|Standard Deviation|1.5|1.5|||
4023668|NCT01167829|3844972|B1|||Body Weight||kg|Mean|79.9|79.9|Standard Deviation|7.5|7.5|||
4023669|NCT01167829|3844972|B1|||Body Mass Index (BMI)||kg/m^2|Mean|24.2|24.2|Standard Deviation|1.5|1.5|||
4023670|NCT01167829|3844972|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4023671|NCT01167829|3844972|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4023672|NCT01167829|3844972|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4023673|NCT01167829|3844972|B1|||Age||years|Median|28.1|28.1|Inter-Quartile Range|||19.0|51.0|
4023674|NCT01167712|3844985|B3|South Korea||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4023675|NCT01167712|3844986|B2|South Korea||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4023676|NCT01167712|3844987|B1|South Korea||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4023677|NCT01167712|3844985|B3|United States||Region of Enrollment||Participants|Count of Participants|690|690.0||||||
4023678|NCT01167712|3844986|B2|United States||Region of Enrollment||Participants|Count of Participants|345|345.0||||||
4023679|NCT01167712|3844987|B1|United States||Region of Enrollment||Participants|Count of Participants|345|345.0||||||
4023680|NCT01167712|3844985|B3|Canada||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4023681|NCT01167712|3844986|B2|Canada||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4023682|NCT01167712|3844987|B1|Canada||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4023683|NCT01167712|3844985|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4023684|NCT01167712|3844986|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4023685|NCT01167712|3844987|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4023686|NCT01167712|3844985|B3||Female|Sex: Female, Male||Participants|Count of Participants|692|692.0||||||
4023687|NCT01167712|3844986|B2||Female|Sex: Female, Male||Participants|Count of Participants|346|346.0||||||
4023688|NCT01167712|3844987|B1||Female|Sex: Female, Male||Participants|Count of Participants|346|346.0||||||
4023689|NCT01167712|3844985|B3||>=65 years|Age||Participants|Count of Participants|261|261.0||||||
4023690|NCT01167712|3844986|B2||>=65 years|Age||Participants|Count of Participants|129|129.0||||||
4023691|NCT01167712|3844987|B1||>=65 years|Age||Participants|Count of Participants|132|132.0||||||
4023692|NCT01167712|3844985|B3||Between 18 and 65 years|Age||Participants|Count of Participants|431|431.0||||||
4023693|NCT01167712|3844986|B2||Between 18 and 65 years|Age||Participants|Count of Participants|217|217.0||||||
4023694|NCT01167712|3844987|B1||Between 18 and 65 years|Age||Participants|Count of Participants|214|214.0||||||
4023695|NCT01167712|3844985|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4023696|NCT01167712|3844986|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4023697|NCT01167712|3844987|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4023698|NCT01167634|3844998|B5||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4023699|NCT01167634|3844999|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4023700|NCT01167634|3845000|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4023701|NCT01167634|3845001|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4023702|NCT01167634|3845002|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4023703|NCT01167634|3844998|B5||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4023704|NCT01167634|3844999|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4023705|NCT01167634|3845000|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4023706|NCT01167634|3845001|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4023707|NCT01167634|3845002|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4023708|NCT01167634|3844998|B5|||Age||years|Mean|43.9|43.9|Standard Deviation|10.0|10.0|||
4023709|NCT01167634|3844999|B4|||Age||years|Mean|43.5|43.5|Standard Deviation|9.6|9.6|||
4023710|NCT01167634|3845000|B3|||Age||years|Mean|42.0|42.0|Standard Deviation|9.6|9.6|||
4023711|NCT01167634|3845001|B2|||Age||years|Mean|44.3|44.3|Standard Deviation|11.5|11.5|||
4023712|NCT01167634|3845002|B1|||Age||years|Mean|45.9|45.9|Standard Deviation|9.0|9.0|||
4023713|NCT01167608|3845015|B1|United States||Region of Enrollment||participants|Number|883|883.0||||||
4023714|NCT01167608|3845015|B1|Male||Gender|This was an anonymous cross-sectional survey. Not all participants provided responses to all survey items. Thus, sample size varies between survey items and does not equal the total number of individuals who enrolled.|participants|Number|380|380.0||||||
4023715|NCT01167608|3845015|B1|Female||Gender|This was an anonymous cross-sectional survey. Not all participants provided responses to all survey items. Thus, sample size varies between survey items and does not equal the total number of individuals who enrolled.|participants|Number|375|375.0||||||
4023716|NCT01167608|3845015|B1|||Age|This was an anonymous cross-sectional survey. Not all participants provided responses to all survey items. Thus, sample size varies between survey items and does not equal the total number of individuals who enrolled.|years|Mean|63.83|63.83|Standard Deviation|10.45|10.45|||
4023717|NCT01167608|3845015|B1|>=65 years||Age|This was an anonymous cross-sectional survey. Not all participants provided responses to all survey items. Thus, sample size varies between survey items and does not equal the total number of individuals who enrolled.|participants|Number|347|347.0||||||
4023718|NCT01167608|3845015|B1|Between 18 and 65 years||Age|This was an anonymous cross-sectional survey. Not all participants provided responses to all survey items. Thus, sample size varies between survey items and does not equal the total number of individuals who enrolled.|participants|Number|408|408.0||||||
4023719|NCT01167608|3845015|B1|<=18 years||Age|This was an anonymous cross-sectional survey. Not all participants provided responses to all survey items. Thus, sample size varies between survey items and does not equal the total number of individuals who enrolled.|participants|Number|0|0.0||||||
4023720|NCT01167582|3845024|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4023721|NCT01167582|3845025|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4023722|NCT01167582|3845026|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4023723|NCT01167582|3845024|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4023724|NCT01167582|3845025|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4023725|NCT01167582|3845026|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4023726|NCT01167582|3845024|B3|||Age||years|Mean|70.8|70.8|Standard Deviation|12.8|12.8|||
4023727|NCT01167582|3845025|B2|||Age||years|Mean|74.3|74.3|Standard Deviation|11.1|11.1|||
4023728|NCT01167582|3845026|B1|||Age||years|Mean|67.3|67.3|Standard Deviation|13.6|13.6|||
4023729|NCT01167504|3845057|B1|United Kingdom||Region of Enrollment||participants|Number|15|15.0||||||
4023730|NCT01167504|3845057|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4023731|NCT01167504|3845057|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4023732|NCT01167504|3845057|B1|||Age||years|Mean|30.5|30.5|Standard Deviation|8.7|8.7|||
4023733|NCT01167504|3845057|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4023734|NCT01167504|3845057|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4023735|NCT01167504|3845057|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4023736|NCT01167452|3845062|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4023737|NCT01167452|3845062|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4023738|NCT01167452|3845062|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4023739|NCT01167452|3845062|B1|||Age||years|Median|37|37.0|Full Range|||18.0|77.0|
4023740|NCT01167452|3845062|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4023741|NCT01167452|3845062|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4023742|NCT01167452|3845062|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4023743|NCT01167426|3845067|B1|||Duration of Multiple Sclerosis Disease||years|Mean|10.167|10.167|Standard Deviation|9.0643|9.0643|||
4023744|NCT01167426|3845067|B1|||Duration of Glatiramer Acetate||years|Mean|4.823|4.823|Standard Deviation|3.5539|3.5539|||
4023745|NCT01167426|3845067|B1|United States||Region of Enrollment||participants|Number|148|148.0||||||
4023746|NCT01167426|3845067|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4023747|NCT01167426|3845067|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4023748|NCT01167426|3845067|B1|White||Race/Ethnicity, Customized||participants|Number|141|141.0||||||
4023749|NCT01167426|3845067|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023750|NCT01167426|3845067|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
4023751|NCT01167426|3845067|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4023752|NCT01167426|3845067|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4023753|NCT01167426|3845067|B1||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4023754|NCT01167426|3845067|B1|||Age||years|Mean|48.1|48.1|Standard Deviation|10.29|10.29|||
4023755|NCT01167426|3845067|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4023756|NCT01167426|3845067|B1||Between 18 and 65 years|Age||Participants|Count of Participants|140|140.0||||||
4023757|NCT01167426|3845067|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4023758|NCT01167257|3845073|B3|None||Prior therapy||participants|Number|4|4.0||||||
4023759|NCT01167257|3845074|B2|None||Prior therapy||participants|Number|2|2.0||||||
4023760|NCT01167257|3845075|B1|None||Prior therapy||participants|Number|2|2.0||||||
4023761|NCT01167257|3845073|B3|Prior therapy taken||Prior therapy||participants|Number|58|58.0||||||
4023762|NCT01167257|3845074|B2|Prior therapy taken||Prior therapy||participants|Number|29|29.0||||||
4023763|NCT01167257|3845075|B1|Prior therapy taken||Prior therapy||participants|Number|29|29.0||||||
4023764|NCT01167257|3845073|B3|None||Background or Prior disease||participants|Number|0|0.0||||||
4023765|NCT01167257|3845074|B2|None||Background or Prior disease||participants|Number|0|0.0||||||
4023766|NCT01167257|3845075|B1|None||Background or Prior disease||participants|Number|0|0.0||||||
4023767|NCT01167257|3845073|B3|Any prior disease||Background or Prior disease||participants|Number|62|62.0||||||
4023768|NCT01167257|3845074|B2|Any prior disease||Background or Prior disease||participants|Number|31|31.0||||||
4023769|NCT01167257|3845075|B1|Any prior disease||Background or Prior disease||participants|Number|31|31.0||||||
4023770|NCT01167257|3845073|B3|Non disease||Associated medical conditions||participants|Number|30|30.0||||||
4023771|NCT01167257|3845074|B2|Non disease||Associated medical conditions||participants|Number|8|8.0||||||
4023772|NCT01167257|3845075|B1|Non disease||Associated medical conditions||participants|Number|22|22.0||||||
4023773|NCT01167257|3845073|B3|Other disease||Associated medical conditions||participants|Number|2|2.0||||||
4023774|NCT01167257|3845074|B2|Other disease||Associated medical conditions||participants|Number|1|1.0||||||
4023775|NCT01167257|3845075|B1|Other disease||Associated medical conditions||participants|Number|1|1.0||||||
4023776|NCT01167257|3845073|B3|Pelvic surgery||Associated medical conditions||participants|Number|1|1.0||||||
4023777|NCT01167257|3845074|B2|Pelvic surgery||Associated medical conditions||participants|Number|1|1.0||||||
4023778|NCT01167257|3845075|B1|Pelvic surgery||Associated medical conditions||participants|Number|0|0.0||||||
4023779|NCT01167257|3845073|B3|Hypertension||Associated medical conditions||participants|Number|17|17.0||||||
4023780|NCT01167257|3845074|B2|Hypertension||Associated medical conditions||participants|Number|12|12.0||||||
4023781|NCT01167257|3845075|B1|Hypertension||Associated medical conditions||participants|Number|5|5.0||||||
4023782|NCT01167257|3845073|B3|Diabetes Mellitus||Associated medical conditions||participants|Number|12|12.0||||||
4023783|NCT01167257|3845074|B2|Diabetes Mellitus||Associated medical conditions||participants|Number|9|9.0||||||
4023784|NCT01167257|3845075|B1|Diabetes Mellitus||Associated medical conditions||participants|Number|3|3.0||||||
4023785|NCT01167257|3845073|B3|Taiwan||Region of Enrollment||participants|Number|62|62.0||||||
4023786|NCT01167257|3845074|B2|Taiwan||Region of Enrollment||participants|Number|31|31.0||||||
4023787|NCT01167257|3845075|B1|Taiwan||Region of Enrollment||participants|Number|31|31.0||||||
4023788|NCT01167257|3845073|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4023789|NCT01167257|3845074|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4023790|NCT01167257|3845075|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4023791|NCT01167257|3845073|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4023792|NCT01167257|3845074|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4023793|NCT01167257|3845075|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4023794|NCT01167257|3845073|B3|||Age||years|Mean|65.12|65.12|Standard Deviation|13.49|13.49|38.0|82.0|
4023795|NCT01167257|3845074|B2|||Age||years|Mean|65.81|65.81|Standard Deviation|14.48|14.48|38.0|73.0|
4023796|NCT01167257|3845075|B1|||Age||years|Mean|64.43|64.43|Standard Deviation|12.49|12.49|48.0|82.0|
4023797|NCT01167192|3845098|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4023798|NCT01167192|3845098|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4023799|NCT01167192|3845098|B1||Female|Gender||Participants|Count of Participants|10|10.0||||||
4023800|NCT01167192|3845098|B1|||Age||years|Median|48|48.0|Full Range|||29.0|73.0|
4023801|NCT01167179|3845113|B3|||Quality of Life|Quality of Life(QoL)was measured with the EORTC QLQ-C30 and QLQ-H&N35.The EORTC QLQ-C30 contains five functioning scales, a global health status/QoL scale, and nine symptom scales. The QLQ-H&N35 contains 18 disease-specific symptom scales. All scores in both the EORTC QLQ-C30 and QLQ-H&N35 were transformed to a 0-100 scale following instructions in the scoring manual, with higher scores representing better quality of life and less disease-specific symptoms.|units on a scale|Mean|72|72.0|Standard Deviation|19|19.0|||
4023802|NCT01167179|3845114|B2|||Quality of Life|Quality of Life(QoL)was measured with the EORTC QLQ-C30 and QLQ-H&N35.The EORTC QLQ-C30 contains five functioning scales, a global health status/QoL scale, and nine symptom scales. The QLQ-H&N35 contains 18 disease-specific symptom scales. All scores in both the EORTC QLQ-C30 and QLQ-H&N35 were transformed to a 0-100 scale following instructions in the scoring manual, with higher scores representing better quality of life and less disease-specific symptoms.|units on a scale|Mean|64|64.0|Standard Deviation|23|23.0|||
4023803|NCT01167179|3845115|B1|||Quality of Life|Quality of Life(QoL)was measured with the EORTC QLQ-C30 and QLQ-H&N35.The EORTC QLQ-C30 contains five functioning scales, a global health status/QoL scale, and nine symptom scales. The QLQ-H&N35 contains 18 disease-specific symptom scales. All scores in both the EORTC QLQ-C30 and QLQ-H&N35 were transformed to a 0-100 scale following instructions in the scoring manual, with higher scores representing better quality of life and less disease-specific symptoms.|units on a scale|Mean|76|76.0|Standard Deviation|17|17.0|||
4023804|NCT01167179|3845113|B3|||Psychosocial adjustment|Psychosocial Adjustment to Illness Scale – Self Report (PAIS-SR), a 46-item self-report measure that assesses changes in seven domains. The Dutch validated questionnaire was used.HRQOL was measured with the European Organisation of Research and Treatment of Cancer Quality of Life Questionnaire with additional Head & Neck Module (EORTC QLQ-C30 and QLQ-H&N35).|units on a scale|Mean|49|49.0|Standard Deviation|12|12.0|||
4023805|NCT01167179|3845114|B2|||Psychosocial adjustment|Psychosocial Adjustment to Illness Scale – Self Report (PAIS-SR), a 46-item self-report measure that assesses changes in seven domains. The Dutch validated questionnaire was used.HRQOL was measured with the European Organisation of Research and Treatment of Cancer Quality of Life Questionnaire with additional Head & Neck Module (EORTC QLQ-C30 and QLQ-H&N35).|units on a scale|Mean|50|50.0|Standard Deviation|11|11.0|||
4023806|NCT01167179|3845115|B1|||Psychosocial adjustment|Psychosocial Adjustment to Illness Scale – Self Report (PAIS-SR), a 46-item self-report measure that assesses changes in seven domains. The Dutch validated questionnaire was used.HRQOL was measured with the European Organisation of Research and Treatment of Cancer Quality of Life Questionnaire with additional Head & Neck Module (EORTC QLQ-C30 and QLQ-H&N35).|units on a scale|Mean|46|46.0|Standard Deviation|12|12.0|||
4023807|NCT01167179|3845113|B3|Netherlands||Region of Enrollment||participants|Number|160|160.0||||||
4023808|NCT01167179|3845114|B2|Netherlands||Region of Enrollment||participants|Number|80|80.0||||||
4023809|NCT01167179|3845115|B1|Netherlands||Region of Enrollment||participants|Number|80|80.0||||||
4023810|NCT01167179|3845113|B3||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4023811|NCT01167179|3845114|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4023812|NCT01167179|3845115|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4023813|NCT01167179|3845113|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4023814|NCT01167179|3845114|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4023815|NCT01167179|3845115|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4023816|NCT01167179|3845113|B3|||Age||years|Mean|58.8|58.8|Standard Deviation|11.8|11.8|||
4023817|NCT01167179|3845114|B2|||Age||years|Mean|59.2|59.2|Standard Deviation|12.3|12.3|||
4023818|NCT01167179|3845115|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|13.0|13.0|||
4023819|NCT01167179|3845113|B3||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4023820|NCT01167179|3845114|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4023822|NCT01167179|3845113|B3||Between 18 and 65 years|Age||Participants|Count of Participants|137|137.0||||||
4023823|NCT01167179|3845114|B2||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
4023824|NCT01167179|3845115|B1||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
4023825|NCT01167179|3845113|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4023826|NCT01167179|3845114|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4023827|NCT01167179|3845115|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4023828|NCT01167153|3845124|B3||Male|Sex: Female, Male||Participants|Count of Participants|270|270.0||||||
4023829|NCT01167153|3845125|B2||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4023830|NCT01167153|3845126|B1||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4023831|NCT01167153|3845124|B3||Female|Sex: Female, Male||Participants|Count of Participants|270|270.0||||||
4023832|NCT01167153|3845125|B2||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4023833|NCT01167153|3845126|B1||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4023834|NCT01167153|3845124|B3|||Age|demographic measures were based on intent to treat (ITT) population. One patient was missing from Nifedipine arm for Age, continuous measurement.|years|Mean|53.5|53.5|Standard Deviation|8.63|8.63|||
4023835|NCT01167153|3845125|B2|||Age|demographic measures were based on intent to treat (ITT) population. One patient was missing from Nifedipine arm for Age, continuous measurement.|years|Mean|53.1|53.1|Standard Deviation|8.72|8.72|||
4023836|NCT01167153|3845126|B1|||Age|demographic measures were based on intent to treat (ITT) population. One patient was missing from Nifedipine arm for Age, continuous measurement.|years|Mean|53.8|53.8|Standard Deviation|8.59|8.59|||
4023837|NCT01167140|3845145|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4023838|NCT01167140|3845145|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4023839|NCT01167140|3845145|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4023840|NCT01167140|3845145|B1|||Age||years|Mean|52|52.0|Standard Deviation|9|9.0|||
4023841|NCT01167140|3845145|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4023842|NCT01167140|3845145|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4023843|NCT01167140|3845145|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4023844|NCT01167023|3845151|B3|Hemoglobin SS (Hb SS) genotype||Sickle-Cell Genotype|The number of participants for this baseline measure differs from the overall number of baseline participants because 1 participant from the 5-mg prasugrel arm did not have sickle cell disease (SCD), but possessed the thalassemia trait.|participants|Number|37|37.0||||||
4023845|NCT01167023|3845152|B2|Hemoglobin SS (Hb SS) genotype||Sickle-Cell Genotype|The number of participants for this baseline measure differs from the overall number of baseline participants because 1 participant from the 5-mg prasugrel arm did not have sickle cell disease (SCD), but possessed the thalassemia trait.|participants|Number|24|24.0||||||
4023846|NCT01167023|3845153|B1|Hemoglobin SS (Hb SS) genotype||Sickle-Cell Genotype|The number of participants for this baseline measure differs from the overall number of baseline participants because 1 participant from the 5-mg prasugrel arm did not have sickle cell disease (SCD), but possessed the thalassemia trait.|participants|Number|13|13.0||||||
4023847|NCT01167023|3845151|B3|Hb SC genotype||Sickle-Cell Genotype|The number of participants for this baseline measure differs from the overall number of baseline participants because 1 participant from the 5-mg prasugrel arm did not have sickle cell disease (SCD), but possessed the thalassemia trait.|participants|Number|15|15.0||||||
4023848|NCT01167023|3845152|B2|Hb SC genotype||Sickle-Cell Genotype|The number of participants for this baseline measure differs from the overall number of baseline participants because 1 participant from the 5-mg prasugrel arm did not have sickle cell disease (SCD), but possessed the thalassemia trait.|participants|Number|10|10.0||||||
4023849|NCT01167023|3845153|B1|Hb SC genotype||Sickle-Cell Genotype|The number of participants for this baseline measure differs from the overall number of baseline participants because 1 participant from the 5-mg prasugrel arm did not have sickle cell disease (SCD), but possessed the thalassemia trait.|participants|Number|5|5.0||||||
4023850|NCT01167023|3845151|B3|Hb S ß0 thalassemia genotype||Sickle-Cell Genotype|The number of participants for this baseline measure differs from the overall number of baseline participants because 1 participant from the 5-mg prasugrel arm did not have sickle cell disease (SCD), but possessed the thalassemia trait.|participants|Number|3|3.0||||||
4023851|NCT01167023|3845152|B2|Hb S ß0 thalassemia genotype||Sickle-Cell Genotype|The number of participants for this baseline measure differs from the overall number of baseline participants because 1 participant from the 5-mg prasugrel arm did not have sickle cell disease (SCD), but possessed the thalassemia trait.|participants|Number|2|2.0||||||
4023852|NCT01167023|3845153|B1|Hb S ß0 thalassemia genotype||Sickle-Cell Genotype|The number of participants for this baseline measure differs from the overall number of baseline participants because 1 participant from the 5-mg prasugrel arm did not have sickle cell disease (SCD), but possessed the thalassemia trait.|participants|Number|1|1.0||||||
4023853|NCT01167023|3845151|B3|Hb S ß+ thalassemia genotype||Sickle-Cell Genotype|The number of participants for this baseline measure differs from the overall number of baseline participants because 1 participant from the 5-mg prasugrel arm did not have sickle cell disease (SCD), but possessed the thalassemia trait.|participants|Number|6|6.0||||||
4023854|NCT01167023|3845152|B2|Hb S ß+ thalassemia genotype||Sickle-Cell Genotype|The number of participants for this baseline measure differs from the overall number of baseline participants because 1 participant from the 5-mg prasugrel arm did not have sickle cell disease (SCD), but possessed the thalassemia trait.|participants|Number|4|4.0||||||
4023855|NCT01167023|3845153|B1|Hb S ß+ thalassemia genotype||Sickle-Cell Genotype|The number of participants for this baseline measure differs from the overall number of baseline participants because 1 participant from the 5-mg prasugrel arm did not have sickle cell disease (SCD), but possessed the thalassemia trait.|participants|Number|2|2.0||||||
4023856|NCT01167023|3845151|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
4023857|NCT01167023|3845152|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4023858|NCT01167023|3845153|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4023859|NCT01167023|3845151|B3|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4023860|NCT01167023|3845152|B2|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4023861|NCT01167023|3845153|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4023862|NCT01167023|3845151|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023863|NCT01167023|3845152|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023864|NCT01167023|3845153|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023865|NCT01167023|3845151|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023866|NCT01167023|3845152|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023867|NCT01167023|3845153|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023868|NCT01167023|3845151|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4023869|NCT01167023|3845152|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4023870|NCT01167023|3845153|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023871|NCT01167023|3845151|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4023872|NCT01167023|3845152|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4023873|NCT01167023|3845153|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4023874|NCT01167023|3845151|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023875|NCT01167023|3845152|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023876|NCT01167023|3845153|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023877|NCT01167023|3845151|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023878|NCT01167023|3845152|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023879|NCT01167023|3845153|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023880|NCT01167023|3845151|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023881|NCT01167023|3845152|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023882|NCT01167023|3845153|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023883|NCT01167023|3845151|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023884|NCT01167023|3845152|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023885|NCT01167023|3845153|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023886|NCT01167023|3845151|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4023887|NCT01167023|3845152|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4023888|NCT01167023|3845153|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4023889|NCT01167023|3845151|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4023890|NCT01167023|3845152|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4023891|NCT01167023|3845153|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023892|NCT01167023|3845151|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4023893|NCT01167023|3845152|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4023894|NCT01167023|3845153|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4023895|NCT01167023|3845151|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4023896|NCT01167023|3845152|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4023897|NCT01167023|3845153|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4023898|NCT01167023|3845151|B3|||Age||years|Mean|32.42|32.42|Standard Deviation|8.42|8.42|||
4023899|NCT01167023|3845152|B2|||Age||years|Mean|32.88|32.88|Standard Deviation|8.60|8.6|||
4023900|NCT01167023|3845153|B1|||Age||years|Mean|31.52|31.52|Standard Deviation|8.20|8.2|||
4023901|NCT01166997|3845173|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4023902|NCT01166997|3845174|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4023903|NCT01166997|3845175|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4023904|NCT01166997|3845173|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4023905|NCT01166997|3845174|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4023906|NCT01166997|3845175|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4023907|NCT01166997|3845173|B3|||Age||years|Mean|63.1|63.1|Standard Deviation|14.3|14.3|||
4023908|NCT01166997|3845174|B2|||Age||years|Mean|64.1|64.1|Standard Deviation|15.2|15.2|||
4023909|NCT01166997|3845175|B1|||Age||years|Mean|62.0|62.0|Standard Deviation|13.4|13.4|||
4023910|NCT01166971|3845184|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4023911|NCT01166971|3845185|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4023912|NCT01166971|3845186|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4023913|NCT01166971|3845184|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4023914|NCT01166971|3845185|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4023915|NCT01166971|3845186|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4023916|NCT01166971|3845184|B3||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
4023917|NCT01166971|3845185|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4023918|NCT01166971|3845186|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4023919|NCT01166971|3845184|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4023920|NCT01166971|3845185|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4023921|NCT01166971|3845186|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4023922|NCT01166971|3845184|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4023923|NCT01166971|3845185|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4023924|NCT01166971|3845186|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4023925|NCT01166958|3845193|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4023926|NCT01166958|3845194|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4023927|NCT01166958|3845195|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4023928|NCT01166958|3845193|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4023929|NCT01166958|3845194|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4023930|NCT01166958|3845195|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4023931|NCT01166958|3845193|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4023932|NCT01166958|3845194|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4023933|NCT01166958|3845195|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4023934|NCT01166958|3845193|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4023935|NCT01166958|3845194|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4023936|NCT01166958|3845195|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4023937|NCT01166958|3845193|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4023938|NCT01166958|3845194|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4023939|NCT01166958|3845195|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4023940|NCT01166958|3845193|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4023941|NCT01166958|3845194|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4023942|NCT01166958|3845195|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4023943|NCT01166958|3845193|B3|||Age||years|Mean|67.0|67.0|Full Range|||56.0|83.1|
4023944|NCT01166958|3845194|B2|||Age||years|Mean|66.2|66.2|Full Range|||56.0|78.8|
4023945|NCT01166958|3845195|B1|||Age||years|Mean|67.7|67.7|Full Range|||61.2|83.1|
4023946|NCT01166763|3845210|B1|||Gail Risk 5-year Probability of Cancer Development|Gail model is an algorithm to calculate a predicted probability of developing breast cancer within the next 5 years.|percent probability|Mean|1.6|1.6|Standard Deviation|1.2|1.2|||
4023947|NCT01166763|3845210|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023948|NCT01166763|3845210|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4023949|NCT01166763|3845210|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4023950|NCT01166763|3845210|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023951|NCT01166763|3845210|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023952|NCT01166763|3845210|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4023953|NCT01166763|3845210|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4023954|NCT01166763|3845210|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023955|NCT01166763|3845210|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023956|NCT01166763|3845210|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4023957|NCT01166763|3845210|B1|Female||Sex/Gender, Customized||participants|Number|30|30.0||||||
4023958|NCT01166763|3845210|B1|||Age||years|Mean|41.4|41.4|Standard Deviation|4.9|4.9|||
4023959|NCT01166750|3845216|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4023960|NCT01166750|3845217|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4023961|NCT01166750|3845218|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4023962|NCT01166750|3845216|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4023963|NCT01166750|3845217|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4023964|NCT01166750|3845218|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4023965|NCT01166750|3845216|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4023966|NCT01166750|3845217|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4023967|NCT01166750|3845218|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4023968|NCT01166750|3845216|B3|||Age||years|Mean|10.5|10.5|Standard Deviation|1.4|1.4|||
4023969|NCT01166750|3845217|B2|||Age||years|Mean|10.6|10.6|Standard Deviation|1.6|1.6|||
4023970|NCT01166750|3845218|B1|||Age||years|Mean|10.3|10.3|Standard Deviation|1.2|1.2|||
4023971|NCT01166750|3845216|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4023972|NCT01166750|3845217|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4023973|NCT01166750|3845218|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4023974|NCT01166750|3845216|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4023975|NCT01166750|3845217|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4023976|NCT01166750|3845218|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4023977|NCT01166750|3845216|B3||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
4023978|NCT01166750|3845217|B2||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4023979|NCT01166750|3845218|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4023980|NCT01166724|3845225|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4023981|NCT01166724|3845225|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4023982|NCT01166724|3845226|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4023983|NCT01166724|3845227|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4023984|NCT01166724|3845225|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4023985|NCT01166724|3845226|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4023986|NCT01166724|3845227|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4023987|NCT01166724|3845225|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4023988|NCT01166724|3845226|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4023989|NCT01166724|3845227|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4023990|NCT01166724|3845225|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4023991|NCT01166724|3845226|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4023992|NCT01166724|3845227|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4023993|NCT01166724|3845225|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4023994|NCT01166724|3845226|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4023995|NCT01166724|3845227|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4023996|NCT01166659|3845236|B1|Spain||Region of Enrollment||participants|Number|3|3.0||||||
4023997|NCT01166659|3845236|B1|Germany||Region of Enrollment||participants|Number|33|33.0||||||
4023998|NCT01166659|3845236|B1|Bulgaria||Region of Enrollment||participants|Number|8|8.0||||||
4023999|NCT01166659|3845236|B1|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4024000|NCT01166659|3845236|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4024001|NCT01166659|3845236|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4024002|NCT01166659|3845236|B1|||Age||years|Mean|68|68.0|Standard Deviation|10.96|10.96|||
4024003|NCT01166646|3845243|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024004|NCT01166646|3845244|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024005|NCT01166646|3845245|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024006|NCT01166646|3845243|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4024007|NCT01166646|3845244|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024008|NCT01166646|3845245|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4024009|NCT01166646|3845243|B3||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4024010|NCT01166646|3845244|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4024011|NCT01166646|3845245|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4024012|NCT01166646|3845243|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4024013|NCT01166646|3845244|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4024014|NCT01166646|3845245|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4024015|NCT01166646|3845243|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4024016|NCT01166646|3845244|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024017|NCT01166646|3845245|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4024018|NCT01166646|3845243|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4024019|NCT01166646|3845244|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4024020|NCT01166646|3845245|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024021|NCT01166646|3845243|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024022|NCT01166646|3845244|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024023|NCT01166646|3845245|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024024|NCT01166646|3845243|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024025|NCT01166646|3845244|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024026|NCT01166646|3845245|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024027|NCT01166646|3845243|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4024028|NCT01166646|3845244|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4024029|NCT01166646|3845245|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4024030|NCT01166646|3845243|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4024031|NCT01166646|3845244|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4024032|NCT01166646|3845245|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4024033|NCT01166646|3845243|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4024034|NCT01166646|3845244|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4024035|NCT01166646|3845245|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4024036|NCT01166646|3845243|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4024037|NCT01166646|3845244|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4024038|NCT01166646|3845245|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4024039|NCT01166646|3845243|B3|||Age||years|Mean|48.5|48.5|Standard Deviation|11.00|11.0|||
4024040|NCT01166646|3845244|B2|||Age||years|Mean|47.7|47.7|Standard Deviation|12.57|12.57|||
4024041|NCT01166646|3845245|B1|||Age||years|Mean|49.5|49.5|Standard Deviation|9.28|9.28|||
4024042|NCT01166568|3845262|B4|||DCNVA 20/40 or Better (at baseline)||Participants|Count of Participants|1|1.0||||||
4024043|NCT01166568|3845263|B3|||DCNVA 20/40 or Better (at baseline)||Participants|Count of Participants|0|0.0||||||
4024044|NCT01166568|3845264|B2|||DCNVA 20/40 or Better (at baseline)||Participants|Count of Participants|0|0.0||||||
4024045|NCT01166568|3845265|B1|||DCNVA 20/40 or Better (at baseline)||Participants|Count of Participants|1|1.0||||||
4024046|NCT01166568|3845262|B4|United States||Region of Enrollment||Participants|Count of Participants|337|337.0||||||
4024047|NCT01166568|3845263|B3|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4024048|NCT01166568|3845264|B2|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
4024049|NCT01166568|3845265|B1|United States||Region of Enrollment||Participants|Count of Participants|288|288.0||||||
4024050|NCT01166568|3845262|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4024051|NCT01166568|3845263|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4024052|NCT01166568|3845264|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4024053|NCT01166568|3845265|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4024054|NCT01166568|3845262|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024055|NCT01166568|3845263|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024056|NCT01166568|3845264|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024057|NCT01166568|3845265|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024058|NCT01166568|3845262|B4||White|Race (NIH/OMB)||Participants|Count of Participants|299|299.0||||||
4024059|NCT01166568|3845263|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4024060|NCT01166568|3845264|B2||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4024061|NCT01166568|3845265|B1||White|Race (NIH/OMB)||Participants|Count of Participants|258|258.0||||||
4024062|NCT01166568|3845262|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4024063|NCT01166568|3845263|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024064|NCT01166568|3845264|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024065|NCT01166568|3845265|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4024066|NCT01166568|3845262|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024067|NCT01166568|3845263|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024068|NCT01166568|3845264|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024069|NCT01166568|3845265|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024070|NCT01166568|3845262|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4024071|NCT01166568|3845263|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024072|NCT01166568|3845264|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024073|NCT01166568|3845265|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4024074|NCT01166568|3845262|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4024075|NCT01166568|3845263|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024076|NCT01166568|3845264|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024077|NCT01166568|3845265|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4024078|NCT01166568|3845262|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024079|NCT01166568|3845263|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024080|NCT01166568|3845264|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024081|NCT01166568|3845265|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024082|NCT01166568|3845262|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|297|297.0||||||
4024083|NCT01166568|3845263|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4024084|NCT01166568|3845264|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4024085|NCT01166568|3845265|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|256|256.0||||||
4024086|NCT01166568|3845262|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4024087|NCT01166568|3845263|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4024088|NCT01166568|3845264|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4024089|NCT01166568|3845265|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4024090|NCT01166568|3845262|B4||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4024091|NCT01166568|3845263|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4024092|NCT01166568|3845264|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4024093|NCT01166568|3845265|B1||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4024094|NCT01166568|3845262|B4||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4024095|NCT01166568|3845263|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4024096|NCT01166568|3845264|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4024097|NCT01166568|3845265|B1||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4024098|NCT01166568|3845262|B4|||Age||Years|Mean|54.93|54.93|Standard Deviation|2.88|2.88|||
4024099|NCT01166568|3845263|B3|||Age||Years|Mean|55.03|55.03|Standard Deviation|2.66|2.66|||
4024100|NCT01166568|3845264|B2|||Age||Years|Mean|54.62|54.62|Standard Deviation|2.96|2.96|||
4024101|NCT01166568|3845265|B1|||Age||Years|Mean|54.92|54.92|Standard Deviation|2.90|2.9|||
4024102|NCT01166438|3845278|B3|||No prior anticholinergic therapy||Participants|Count of Participants|102|102.0||||||
4024103|NCT01166438|3845279|B2|||No prior anticholinergic therapy||Participants|Count of Participants|54|54.0||||||
4024104|NCT01166438|3845280|B1|||No prior anticholinergic therapy||Participants|Count of Participants|48|48.0||||||
4024105|NCT01166438|3845278|B3|Not sure||Menopausal status||Participants|Count of Participants|16|16.0||||||
4024106|NCT01166438|3845279|B2|Not sure||Menopausal status||Participants|Count of Participants|12|12.0||||||
4024107|NCT01166438|3845280|B1|Not sure||Menopausal status||Participants|Count of Participants|4|4.0||||||
4024108|NCT01166438|3845278|B3|Postmenopausal||Menopausal status||Participants|Count of Participants|194|194.0||||||
4024109|NCT01166438|3845279|B2|Postmenopausal||Menopausal status||Participants|Count of Participants|92|92.0||||||
4024110|NCT01166438|3845280|B1|Postmenopausal||Menopausal status||Participants|Count of Participants|102|102.0||||||
4024111|NCT01166438|3845278|B3|Premenopausal||Menopausal status||Participants|Count of Participants|37|37.0||||||
4024112|NCT01166438|3845279|B2|Premenopausal||Menopausal status||Participants|Count of Participants|22|22.0||||||
4024113|NCT01166438|3845280|B1|Premenopausal||Menopausal status||Participants|Count of Participants|15|15.0||||||
4024114|NCT01166438|3845278|B3|Not reported||Smoking status||Participants|Count of Participants|1|1.0||||||
4024115|NCT01166438|3845279|B2|Not reported||Smoking status||Participants|Count of Participants|0|0.0||||||
4024116|NCT01166438|3845280|B1|Not reported||Smoking status||Participants|Count of Participants|1|1.0||||||
4024117|NCT01166438|3845278|B3|Current smoker||Smoking status||Participants|Count of Participants|27|27.0||||||
4024118|NCT01166438|3845279|B2|Current smoker||Smoking status||Participants|Count of Participants|12|12.0||||||
4024119|NCT01166438|3845280|B1|Current smoker||Smoking status||Participants|Count of Participants|15|15.0||||||
4024120|NCT01166438|3845278|B3|Previous smoker||Smoking status||Participants|Count of Participants|79|79.0||||||
4024121|NCT01166438|3845279|B2|Previous smoker||Smoking status||Participants|Count of Participants|40|40.0||||||
4024122|NCT01166438|3845280|B1|Previous smoker||Smoking status||Participants|Count of Participants|39|39.0||||||
4024123|NCT01166438|3845278|B3|Never smoked||Smoking status||Participants|Count of Participants|140|140.0||||||
4024124|NCT01166438|3845279|B2|Never smoked||Smoking status||Participants|Count of Participants|74|74.0||||||
4024125|NCT01166438|3845280|B1|Never smoked||Smoking status||Participants|Count of Participants|66|66.0||||||
4024126|NCT01166438|3845278|B3|Not reported||Type of health insurance||Participants|Count of Participants|1|1.0||||||
4024127|NCT01166438|3845279|B2|Not reported||Type of health insurance||Participants|Count of Participants|0|0.0||||||
4024128|NCT01166438|3845280|B1|Not reported||Type of health insurance||Participants|Count of Participants|1|1.0||||||
4024129|NCT01166438|3845278|B3|Combination of several types||Type of health insurance||Participants|Count of Participants|37|37.0||||||
4024130|NCT01166438|3845279|B2|Combination of several types||Type of health insurance||Participants|Count of Participants|16|16.0||||||
4024131|NCT01166438|3845280|B1|Combination of several types||Type of health insurance||Participants|Count of Participants|21|21.0||||||
4024132|NCT01166438|3845278|B3|Other only||Type of health insurance||Participants|Count of Participants|62|62.0||||||
4024133|NCT01166438|3845279|B2|Other only||Type of health insurance||Participants|Count of Participants|34|34.0||||||
4024134|NCT01166438|3845280|B1|Other only||Type of health insurance||Participants|Count of Participants|28|28.0||||||
4024135|NCT01166438|3845278|B3|Medicare or Medicaid only||Type of health insurance||Participants|Count of Participants|26|26.0||||||
4024136|NCT01166438|3845279|B2|Medicare or Medicaid only||Type of health insurance||Participants|Count of Participants|16|16.0||||||
4024137|NCT01166438|3845280|B1|Medicare or Medicaid only||Type of health insurance||Participants|Count of Participants|10|10.0||||||
4024138|NCT01166438|3845278|B3|Private only||Type of health insurance||Participants|Count of Participants|121|121.0||||||
4024139|NCT01166438|3845279|B2|Private only||Type of health insurance||Participants|Count of Participants|60|60.0||||||
4024140|NCT01166438|3845280|B1|Private only||Type of health insurance||Participants|Count of Participants|61|61.0||||||
4024141|NCT01166438|3845278|B3|||Educational level at least some college||Participants|Count of Participants|176|176.0||||||
4024142|NCT01166438|3845279|B2|||Educational level at least some college||Participants|Count of Participants|90|90.0||||||
4024143|NCT01166438|3845280|B1|||Educational level at least some college||Participants|Count of Participants|86|86.0||||||
4024144|NCT01166438|3845278|B3|Not reported||Marital Status||Participants|Count of Participants|8|8.0||||||
4024145|NCT01166438|3845279|B2|Not reported||Marital Status||Participants|Count of Participants|4|4.0||||||
4024146|NCT01166438|3845280|B1|Not reported||Marital Status||Participants|Count of Participants|4|4.0||||||
4024147|NCT01166438|3845278|B3|Other||Marital Status||Participants|Count of Participants|1|1.0||||||
4024148|NCT01166438|3845279|B2|Other||Marital Status||Participants|Count of Participants|1|1.0||||||
4024149|NCT01166438|3845280|B1|Other||Marital Status||Participants|Count of Participants|0|0.0||||||
4024150|NCT01166438|3845278|B3|Single, never married||Marital Status||Participants|Count of Participants|31|31.0||||||
4024151|NCT01166438|3845279|B2|Single, never married||Marital Status||Participants|Count of Participants|16|16.0||||||
4024152|NCT01166438|3845280|B1|Single, never married||Marital Status||Participants|Count of Participants|15|15.0||||||
4024153|NCT01166438|3845278|B3|Divorced, separated, or widowed||Marital Status||Participants|Count of Participants|92|92.0||||||
4024154|NCT01166438|3845279|B2|Divorced, separated, or widowed||Marital Status||Participants|Count of Participants|48|48.0||||||
4024155|NCT01166438|3845280|B1|Divorced, separated, or widowed||Marital Status||Participants|Count of Participants|44|44.0||||||
4024156|NCT01166438|3845278|B3|Married or living as married||Marital Status||Participants|Count of Participants|115|115.0||||||
4024157|NCT01166438|3845279|B2|Married or living as married||Marital Status||Participants|Count of Participants|57|57.0||||||
4024158|NCT01166438|3845280|B1|Married or living as married||Marital Status||Participants|Count of Participants|58|58.0||||||
4024159|NCT01166438|3845278|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4024160|NCT01166438|3845279|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4024161|NCT01166438|3845280|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4024162|NCT01166438|3845278|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024163|NCT01166438|3845279|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024164|NCT01166438|3845280|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024165|NCT01166438|3845278|B3||White|Race (NIH/OMB)||Participants|Count of Participants|194|194.0||||||
4024166|NCT01166438|3845279|B2||White|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
4024167|NCT01166438|3845280|B1||White|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4024168|NCT01166438|3845278|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4024169|NCT01166438|3845279|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4024170|NCT01166438|3845280|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4024171|NCT01166438|3845278|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4024172|NCT01166438|3845279|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024173|NCT01166438|3845280|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4024174|NCT01166438|3845278|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024175|NCT01166438|3845279|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024176|NCT01166438|3845280|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024177|NCT01166438|3845278|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4024178|NCT01166438|3845279|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4024179|NCT01166438|3845280|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4024180|NCT01166438|3845278|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024181|NCT01166438|3845279|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024182|NCT01166438|3845280|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024183|NCT01166438|3845278|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|203|203.0||||||
4024184|NCT01166438|3845279|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
4024185|NCT01166438|3845280|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
4024186|NCT01166438|3845278|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4024187|NCT01166438|3845279|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4024188|NCT01166438|3845280|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4024189|NCT01166438|3845278|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4024190|NCT01166438|3845279|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4024191|NCT01166438|3845280|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4024192|NCT01166438|3845278|B3||Female|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
4024193|NCT01166438|3845279|B2||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4024194|NCT01166438|3845280|B1||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4024195|NCT01166438|3845278|B3|||Age||Years|Mean|57.9|57.9|Standard Deviation|11.3|11.3|||
4024196|NCT01166438|3845279|B2|||Age||Years|Mean|56.7|56.7|Standard Deviation|11.6|11.6|||
4024197|NCT01166438|3845280|B1|||Age||Years|Mean|59.3|59.3|Standard Deviation|10.8|10.8|||
4024198|NCT01166347|3845295|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4024199|NCT01166347|3845296|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4024200|NCT01166347|3845297|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4024201|NCT01166347|3845295|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|343|343.0||||||
4024202|NCT01166347|3845296|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|115|115.0||||||
4024203|NCT01166347|3845297|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|228|228.0||||||
4024262|NCT01166139|3845398|B1|||Methotrexate||Participants|Count of Participants|2|2.0||||||
4024204|NCT01166347|3845295|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4024205|NCT01166347|3845296|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4024206|NCT01166347|3845297|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4024207|NCT01166347|3845295|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|98|98.0||||||
4024208|NCT01166347|3845296|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
4024209|NCT01166347|3845297|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|66|66.0||||||
4024210|NCT01166347|3845295|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4024211|NCT01166347|3845296|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4024212|NCT01166347|3845297|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4024213|NCT01166347|3845295|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4024214|NCT01166347|3845296|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4024215|NCT01166347|3845297|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4024216|NCT01166347|3845295|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024217|NCT01166347|3845296|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024218|NCT01166347|3845297|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024219|NCT01166347|3845295|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|430|430.0||||||
4024220|NCT01166347|3845296|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|142|142.0||||||
4024221|NCT01166347|3845297|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|288|288.0||||||
4024222|NCT01166347|3845295|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4024223|NCT01166347|3845296|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4024224|NCT01166347|3845297|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4024225|NCT01166347|3845295|B3||Male|Sex: Female, Male||Participants|Count of Participants|349|349.0||||||
4024226|NCT01166347|3845296|B2||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4024227|NCT01166347|3845297|B1||Male|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
4024228|NCT01166347|3845295|B3||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4024229|NCT01166347|3845296|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4024230|NCT01166347|3845297|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4024231|NCT01166347|3845295|B3|||Age||years|Mean|64.7|64.7|Standard Deviation|11.20|11.2|||
4024232|NCT01166347|3845296|B2|||Age||years|Mean|66.2|66.2|Standard Deviation|10.23|10.23|||
4024233|NCT01166347|3845297|B1|||Age||years|Mean|63.9|63.9|Standard Deviation|11.60|11.6|||
4024234|NCT01166282|3845328|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4024235|NCT01166282|3845329|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4024236|NCT01166282|3845330|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4024237|NCT01166282|3845328|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4024238|NCT01166282|3845329|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4024239|NCT01166282|3845330|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4024240|NCT01166282|3845328|B3|||Age||years|Mean|12.9|12.9|Standard Deviation|2.92|2.92|||
4024241|NCT01166282|3845329|B2|||Age||years|Mean|13.4|13.4|Standard Deviation|2.86|2.86|||
4024242|NCT01166282|3845330|B1|||Age||years|Mean|11.9|11.9|Standard Deviation|2.85|2.85|||
4024243|NCT01166230|3845354|B3||Male|Sex: Female, Male||Participants|Count of Participants|435|435.0||||||
4024244|NCT01166230|3845355|B2||Male|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4024245|NCT01166230|3845356|B1||Male|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4024246|NCT01166230|3845354|B3||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4024247|NCT01166230|3845355|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4024248|NCT01166230|3845356|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4024249|NCT01166230|3845354|B3|||Age||years|Mean|68.8|68.8|Standard Deviation|10.76|10.76|||
4024250|NCT01166230|3845355|B2|||Age||years|Mean|68|68.0|Standard Deviation|10.79|10.79|||
4024251|NCT01166230|3845356|B1|||Age||years|Mean|69.6|69.6|Standard Deviation|10.68|10.68|||
4024252|NCT01166178|3845369|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4024253|NCT01166178|3845370|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4024254|NCT01166178|3845371|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4024255|NCT01166178|3845369|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4024256|NCT01166178|3845370|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4024257|NCT01166178|3845371|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4024258|NCT01166178|3845369|B3|||Age||years|Mean|59.0|59.0|Standard Deviation|8.1|8.1|||
4024259|NCT01166178|3845370|B2|||Age||years|Mean|56.0|56.0|Standard Deviation|8.2|8.2|||
4024260|NCT01166178|3845371|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|8.0|8.0|||
4024261|NCT01166139|3845398|B1|||No immunosuppression||Participants|Count of Participants|8|8.0||||||
4024263|NCT01166139|3845398|B1|||Previous treatment, n (%)||Participants|Count of Participants|0|0.0||||||
4024264|NCT01166139|3845398|B1|||Tendon friction rubs, n (%)||Participants|Count of Participants|4|4.0||||||
4024265|NCT01166139|3845398|B1|||Mean change in MRSS in 1 month prior to baseline|The Modified Rodnan Skin Score (MRSS) measures dermal skin thickness through the examination of 17 body areas: fingers, hands, forearms, arms, feet, legs, and thighs (in pairs), and face, chest, and abdomen. The skin score is 0 for uninvolved skin through 3 for severe thickening (hidebound skin). The total skin score is the sum of the skin scores of the individual areas. The minimum score is 0 and the maximum score is 51. A higher score indicates greater severity of disease. The mean change in MRSS represents the average change in total skin score in 1 month before baseline.|units on a scale|Mean|2.9|2.9|Standard Deviation|3.4|3.4|||
4024266|NCT01166139|3845398|B1|||Modified Rodnan Skin Score (MRSS) at baseline|The Modified Rodnan Skin Score (MRSS) measures dermal skin thickness through the examination of 17 body areas: fingers, hands, forearms, arms, feet, legs, and thighs (in pairs), and face, chest, and abdomen. In each of these areas, the skin score is evaluated by manual palpation. The skin score is 0 for uninvolved skin, 1 for mild thickening, 2 for moderate thickening, and 3 for severe thickening (hidebound skin). The total skin score is the sum of the skin scores of the individual areas. The minimum score is 0 and the maximum score is 51. A higher score indicates greater severity of disease.|units on a scale|Mean|30.1|30.1|Standard Deviation|8.2|8.2|||
4024267|NCT01166139|3845398|B1|||RNA polymerase III-positive, n (%)||Participants|Count of Participants|5|5.0||||||
4024268|NCT01166139|3845398|B1|||Anti-Scl 70-positive, n (%)||Participants|Count of Participants|3|3.0||||||
4024269|NCT01166139|3845398|B1|||ANA-positive, n (%)||Participants|Count of Participants|9|9.0||||||
4024270|NCT01166139|3845398|B1|||Disease Duration, median (range)||years|Median|0.7|0.7|Full Range|||0.5|1.7|
4024271|NCT01166139|3845398|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4024272|NCT01166139|3845398|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024273|NCT01166139|3845398|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4024274|NCT01166139|3845398|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4024275|NCT01166139|3845398|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024276|NCT01166139|3845398|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024277|NCT01166139|3845398|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024278|NCT01166139|3845398|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4024279|NCT01166139|3845398|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4024280|NCT01166139|3845398|B1|||Age||years|Median|46|46.0|Full Range|||18.0|69.0|
4024281|NCT01166139|3845398|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4024282|NCT01166139|3845398|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4024283|NCT01166139|3845398|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4024284|NCT01166126|3845404|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4024285|NCT01166126|3845404|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4024286|NCT01166126|3845404|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4024287|NCT01166126|3845404|B1|||Age||years|Mean|52.5|52.5|Full Range|||39.0|69.0|
4024288|NCT01166126|3845404|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4024289|NCT01166126|3845404|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4024290|NCT01166126|3845404|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4024291|NCT01165996|3845411|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4024292|NCT01165996|3845411|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4024293|NCT01165996|3845411|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4024294|NCT01165996|3845411|B1|80-89 years||Age, Customized||participants|Number|6|6.0||||||
4024295|NCT01165996|3845411|B1|70-79 years||Age, Customized||participants|Number|9|9.0||||||
4024296|NCT01165996|3845411|B1|60-69 years||Age, Customized||participants|Number|8|8.0||||||
4024297|NCT01165996|3845411|B1|50-59 years||Age, Customized||participants|Number|1|1.0||||||
4024298|NCT01165996|3845411|B1|40-49 years||Age, Customized||participants|Number|1|1.0||||||
4024299|NCT01165983|3845417|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
4024300|NCT01165983|3845418|B2|United States||Region of Enrollment||participants|Number|49|49.0||||||
4024301|NCT01165983|3845419|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4024302|NCT01165983|3845417|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4024303|NCT01165983|3845418|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4024304|NCT01165983|3845419|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4024305|NCT01165983|3845417|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4024306|NCT01165983|3845418|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4024307|NCT01165983|3845419|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4024308|NCT01165983|3845417|B3|||Age||years|Mean|54|54.0|Standard Deviation|11|11.0|||
4024309|NCT01165983|3845418|B2|||Age||years|Mean|54|54.0|Standard Deviation|11|11.0|||
4024310|NCT01165983|3845419|B1|||Age||years|Mean|54|54.0|Standard Deviation|11|11.0|||
4024311|NCT01165840|3845464|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4024312|NCT01165840|3845464|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4024313|NCT01165840|3845464|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4024314|NCT01165840|3845464|B1|||Age||years|Mean|38.2|38.2|Standard Deviation|13.7|13.7|||
4024315|NCT01165840|3845464|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4024316|NCT01165840|3845464|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4024317|NCT01165840|3845464|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4024318|NCT01165775|3845468|B1|||Gestational age at enrollment||weeks|Mean|29.29|29.29|Full Range|||25.14|34.0|
4024319|NCT01165775|3845468|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4024320|NCT01165775|3845468|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024321|NCT01165775|3845468|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4024322|NCT01165775|3845468|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4024323|NCT01165775|3845468|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4024324|NCT01165775|3845468|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024325|NCT01165775|3845468|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4024326|NCT01165775|3845468|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024327|NCT01165775|3845468|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024328|NCT01165775|3845468|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4024329|NCT01165775|3845468|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4024330|NCT01165775|3845468|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4024331|NCT01165775|3845468|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4024332|NCT01165775|3845468|B1|||Age||years|Mean|30|30.0|Standard Deviation|5|5.0|||
4024333|NCT01165684|3845476|B3|||Fasting plasma glucose (FPG)||mmol/L|Mean|6.9|6.9|Standard Deviation|1.8|1.8|||
4024334|NCT01165684|3845477|B2|||Fasting plasma glucose (FPG)||mmol/L|Mean|6.9|6.9|Standard Deviation|1.6|1.6|||
4024335|NCT01165684|3845478|B1|||Fasting plasma glucose (FPG)||mmol/L|Mean|7.0|7.0|Standard Deviation|1.9|1.9|||
4024336|NCT01165684|3845476|B3|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|7.9|7.9|Standard Deviation|0.6|0.6|||
4024337|NCT01165684|3845477|B2|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|7.9|7.9|Standard Deviation|0.6|0.6|||
4024338|NCT01165684|3845478|B1|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|7.9|7.9|Standard Deviation|0.6|0.6|||
4024339|NCT01165684|3845476|B3|||Body Mass Index (BMI)||kg/m^2|Mean|31.1|31.1|Standard Deviation|4.7|4.7|||
4024340|NCT01165684|3845477|B2|||Body Mass Index (BMI)||kg/m^2|Mean|30.7|30.7|Standard Deviation|4.6|4.6|||
4024341|NCT01165684|3845478|B1|||Body Mass Index (BMI)||kg/m^2|Mean|31.5|31.5|Standard Deviation|4.8|4.8|||
4024342|NCT01165684|3845476|B3|||Body weight||kg|Mean|87.5|87.5|Standard Deviation|17.1|17.1|||
4024343|NCT01165684|3845477|B2|||Body weight||kg|Mean|86.1|86.1|Standard Deviation|15.2|15.2|||
4024344|NCT01165684|3845478|B1|||Body weight||kg|Mean|88.9|88.9|Standard Deviation|18.7|18.7|||
4024345|NCT01165684|3845476|B3||Male|Gender||Participants|Count of Participants|203|203.0||||||
4024346|NCT01165684|3845477|B2||Male|Gender||Participants|Count of Participants|99|99.0||||||
4024347|NCT01165684|3845478|B1||Male|Gender||Participants|Count of Participants|104|104.0||||||
4024348|NCT01165684|3845476|B3||Female|Gender||Participants|Count of Participants|198|198.0||||||
4024349|NCT01165684|3845477|B2||Female|Gender||Participants|Count of Participants|101|101.0||||||
4024350|NCT01165684|3845478|B1||Female|Gender||Participants|Count of Participants|97|97.0||||||
4024351|NCT01165684|3845476|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|9.3|9.3|||
4024352|NCT01165684|3845477|B2|||Age||years|Mean|59.6|59.6|Standard Deviation|9.5|9.5|||
4024353|NCT01165684|3845478|B1|||Age||years|Mean|60.0|60.0|Standard Deviation|9.1|9.1|||
4024354|NCT01165554|3845513|B1|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
4024355|NCT01165554|3845513|B1|United States||Region of Enrollment||participants|Number|168|168.0||||||
4024356|NCT01165554|3845513|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4024357|NCT01165554|3845513|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4024358|NCT01165554|3845513|B1|||Age||years|Mean|79.9|79.9|Standard Deviation|9.6|9.6|||
4024359|NCT01165554|3845513|B1||>=65 years|Age||Participants|Count of Participants|165|165.0||||||
4024360|NCT01165554|3845513|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4024361|NCT01165554|3845513|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4024362|NCT01165541|3845520|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4024363|NCT01165541|3845520|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4024364|NCT01165541|3845520|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4024365|NCT01165541|3845520|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4024366|NCT01165541|3845520|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4024367|NCT01165541|3845520|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4024368|NCT01165541|3845520|B1|||Age||years|Mean|48.1|48.1|Standard Deviation|10.1|10.1|||
4024369|NCT01165450|3845526|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4024370|NCT01165450|3845526|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4024371|NCT01165450|3845526|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4024372|NCT01165450|3845526|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4024373|NCT01165450|3845526|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4024374|NCT01165450|3845526|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4024375|NCT01165424|3845536|B1|Japan||Region of Enrollment||Participants|Number|80|80.0||||||
4024376|NCT01165424|3845536|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4024377|NCT01165424|3845536|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4024378|NCT01165424|3845536|B1|||Age||years|Mean|9.2|9.2|Standard Deviation|3.4|3.4|||
4024379|NCT01165320|3845541|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4024380|NCT01165320|3845542|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4024381|NCT01165320|3845543|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4024382|NCT01165320|3845541|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4024383|NCT01165320|3845542|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4024384|NCT01165320|3845543|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4024385|NCT01165320|3845541|B3|>=12 years and <18 years||Age, Customized||Participants|Number|8|8.0||||||
4024386|NCT01165320|3845542|B2|>=12 years and <18 years||Age, Customized||Participants|Number|4|4.0||||||
4024387|NCT01165320|3845543|B1|>=12 years and <18 years||Age, Customized||Participants|Number|4|4.0||||||
4024388|NCT01165320|3845541|B3|>=2 years and <12 years||Age, Customized||Participants|Number|11|11.0||||||
4024389|NCT01165320|3845542|B2|>=2 years and <12 years||Age, Customized||Participants|Number|3|3.0||||||
4024390|NCT01165320|3845543|B1|>=2 years and <12 years||Age, Customized||Participants|Number|8|8.0||||||
4024391|NCT01165320|3845541|B3|>=3 months and <2 years||Age, Customized||Participants|Number|1|1.0||||||
4024392|NCT01165320|3845542|B2|>=3 months and <2 years||Age, Customized||Participants|Number|1|1.0||||||
4024393|NCT01165320|3845543|B1|>=3 months and <2 years||Age, Customized||Participants|Number|0|0.0||||||
4024394|NCT01165320|3845541|B3|||Age||Years|Mean|9.8|9.8|Standard Deviation|5.0|5.0|||
4024395|NCT01165320|3845542|B2|||Age||Years|Mean|9.8|9.8|Standard Deviation|5.2|5.2|||
4024396|NCT01165320|3845543|B1|||Age||Years|Mean|9.8|9.8|Standard Deviation|5.2|5.2|||
4024397|NCT01165307|3845553|B3|United States||Region of Enrollment||participants|Number|67|67.0||||||
4024398|NCT01165307|3845554|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
4024399|NCT01165307|3845555|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4024400|NCT01165307|3845553|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4024401|NCT01165307|3845554|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4024402|NCT01165307|3845555|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4024403|NCT01165307|3845553|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4024404|NCT01165307|3845554|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4024405|NCT01165307|3845555|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4024406|NCT01165307|3845553|B3|||Age||years|Mean|42.3|42.3|Standard Deviation|5.8|5.8|||
4024407|NCT01165307|3845554|B2|||Age||years|Mean|41.9|41.9|Standard Deviation|6.0|6.0|||
4024408|NCT01165307|3845555|B1|||Age||years|Mean|42.8|42.8|Standard Deviation|5.5|5.5|||
4024409|NCT01165281|3845584|B3|>=65 years||Age Customized||Participants|Number|184|184.0||||||
4024410|NCT01165281|3845585|B2|>=65 years||Age Customized||Participants|Number|93|93.0||||||
4024411|NCT01165281|3845586|B1|>=65 years||Age Customized||Participants|Number|91|91.0||||||
4024412|NCT01165281|3845584|B3|<65 years||Age Customized||Participants|Number|156|156.0||||||
4024413|NCT01165281|3845585|B2|<65 years||Age Customized||Participants|Number|79|79.0||||||
4024414|NCT01165281|3845586|B1|<65 years||Age Customized||Participants|Number|77|77.0||||||
4024415|NCT01165281|3845584|B3|Korea||Region of Enrollment||participants|Number|119|119.0||||||
4024416|NCT01165281|3845585|B2|Korea||Region of Enrollment||participants|Number|62|62.0||||||
4024417|NCT01165281|3845586|B1|Korea||Region of Enrollment||participants|Number|57|57.0||||||
4024418|NCT01165281|3845584|B3|Japan||Region of Enrollment||participants|Number|221|221.0||||||
4024419|NCT01165281|3845585|B2|Japan||Region of Enrollment||participants|Number|110|110.0||||||
4024420|NCT01165281|3845586|B1|Japan||Region of Enrollment||participants|Number|111|111.0||||||
4024421|NCT01165281|3845584|B3||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4024422|NCT01165281|3845585|B2||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4024423|NCT01165281|3845586|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4024424|NCT01165281|3845584|B3||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4024425|NCT01165281|3845585|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4024426|NCT01165281|3845586|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4024427|NCT01165281|3845584|B3|||Age||years|Mean|65.2|65.2|Standard Deviation|11.3|11.3|||
4024428|NCT01165281|3845585|B2|||Age||years|Mean|64.9|64.9|Standard Deviation|11.41|11.41|||
4024429|NCT01165281|3845586|B1|||Age||years|Mean|65.5|65.5|Standard Deviation|11.21|11.21|||
4024430|NCT01165242|3845605|B4|Geographic ancestry|Other (Mix of races, e.g. African/White)|Race/Ethnicity, Customized||Participants|Count of Participants|62|62.0||||||
4024431|NCT01165242|3845606|B3|Geographic ancestry|Other (Mix of races, e.g. African/White)|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4024432|NCT01165242|3845607|B2|Geographic ancestry|Other (Mix of races, e.g. African/White)|Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
4024433|NCT01165242|3845608|B1|Geographic ancestry|Other (Mix of races, e.g. African/White)|Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
4024434|NCT01165242|3845605|B4|Geographic ancestry|White - Caucasian/ European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|754|754.0||||||
4024435|NCT01165242|3845606|B3|Geographic ancestry|White - Caucasian/ European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|257|257.0||||||
4024436|NCT01165242|3845607|B2|Geographic ancestry|White - Caucasian/ European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|249|249.0||||||
4024437|NCT01165242|3845608|B1|Geographic ancestry|White - Caucasian/ European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|248|248.0||||||
4024438|NCT01165242|3845605|B4|Geographic ancestry|White - Arabic/ North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4024439|NCT01165242|3845606|B3|Geographic ancestry|White - Arabic/ North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4024440|NCT01165242|3845607|B2|Geographic ancestry|White - Arabic/ North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4024441|NCT01165242|3845608|B1|Geographic ancestry|White - Arabic/ North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4024442|NCT01165242|3845605|B4|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4024443|NCT01165242|3845606|B3|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4024444|NCT01165242|3845607|B2|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4024445|NCT01165242|3845608|B1|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4024446|NCT01165242|3845605|B4|Geographic ancestry|Asian - Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4024447|NCT01165242|3845606|B3|Geographic ancestry|Asian - Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4024448|NCT01165242|3845607|B2|Geographic ancestry|Asian - Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4024449|NCT01165242|3845608|B1|Geographic ancestry|Asian - Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4024450|NCT01165242|3845605|B4|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4024451|NCT01165242|3845606|B3|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4024452|NCT01165242|3845607|B2|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4024453|NCT01165242|3845608|B1|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4024454|NCT01165242|3845605|B4|Geographic ancestry|Asian-Central/ South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
4024455|NCT01165242|3845606|B3|Geographic ancestry|Asian-Central/ South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4024456|NCT01165242|3845607|B2|Geographic ancestry|Asian-Central/ South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4024457|NCT01165242|3845608|B1|Geographic ancestry|Asian-Central/ South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4024458|NCT01165242|3845605|B4|Geographic ancestry|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4024459|NCT01165242|3845606|B3|Geographic ancestry|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4024460|NCT01165242|3845607|B2|Geographic ancestry|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4024461|NCT01165242|3845608|B1|Geographic ancestry|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4024462|NCT01165242|3845605|B4|Geographic ancestry|African Heritage/ African American|Race/Ethnicity, Customized||Participants|Count of Participants|107|107.0||||||
4024463|NCT01165242|3845606|B3|Geographic ancestry|African Heritage/ African American|Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
4024464|NCT01165242|3845607|B2|Geographic ancestry|African Heritage/ African American|Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
4024465|NCT01165242|3845608|B1|Geographic ancestry|African Heritage/ African American|Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
4024466|NCT01165242|3845605|B4||Male|Sex: Female, Male||Participants|Count of Participants|491|491.0||||||
4024467|NCT01165242|3845606|B3||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4024468|NCT01165242|3845607|B2||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4024469|NCT01165242|3845608|B1||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4024470|NCT01165242|3845605|B4||Female|Sex: Female, Male||Participants|Count of Participants|520|520.0||||||
4024471|NCT01165242|3845606|B3||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4024472|NCT01165242|3845607|B2||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4024473|NCT01165242|3845608|B1||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4024474|NCT01165242|3845605|B4|||Age||Years|Mean|16.30|16.3|Standard Deviation|5.09|5.09|||
4024475|NCT01165242|3845606|B3|||Age||Years|Mean|16.2|16.2|Standard Deviation|4.97|4.97|||
4024476|NCT01165242|3845607|B2|||Age||Years|Mean|16.3|16.3|Standard Deviation|5.16|5.16|||
4024477|NCT01165242|3845608|B1|||Age||Years|Mean|16.4|16.4|Standard Deviation|5.16|5.16|||
4024478|NCT01165229|3845642|B3|Geographic ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|610|610.0||||||
4024479|NCT01165229|3845643|B2|Geographic ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|306|306.0||||||
4024480|NCT01165229|3845644|B1|Geographic ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|304|304.0||||||
4024481|NCT01165229|3845642|B3|Geographic ancestry|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|10608|10608.0||||||
4024482|NCT01165229|3845643|B2|Geographic ancestry|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|5301|5301.0||||||
4024483|NCT01165229|3845644|B1|Geographic ancestry|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|5307|5307.0||||||
4024484|NCT01165229|3845642|B3|Geographic ancestry|White - Arabic / North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|87|87.0||||||
4024485|NCT01165229|3845643|B2|Geographic ancestry|White - Arabic / North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
4024486|NCT01165229|3845644|B1|Geographic ancestry|White - Arabic / North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
4024487|NCT01165229|3845642|B3|Geographic ancestry|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4024488|NCT01165229|3845643|B2|Geographic ancestry|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4024489|NCT01165229|3845644|B1|Geographic ancestry|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4024490|NCT01165229|3845642|B3|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4024491|NCT01165229|3845643|B2|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4024492|NCT01165229|3845644|B1|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4024493|NCT01165229|3845642|B3|Geographic ancestry|Asian - Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|598|598.0||||||
4024494|NCT01165229|3845643|B2|Geographic ancestry|Asian - Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|300|300.0||||||
4024495|NCT01165229|3845644|B1|Geographic ancestry|Asian - Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|298|298.0||||||
4024496|NCT01165229|3845642|B3|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1815|1815.0||||||
4024497|NCT01165229|3845643|B2|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|908|908.0||||||
4024498|NCT01165229|3845644|B1|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|907|907.0||||||
4024499|NCT01165229|3845642|B3|Geographic ancestry|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4024500|NCT01165229|3845643|B2|Geographic ancestry|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4024501|NCT01165229|3845644|B1|Geographic ancestry|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4024502|NCT01165229|3845642|B3|Geographic ancestry|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4024503|NCT01165229|3845643|B2|Geographic ancestry|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4024504|NCT01165229|3845644|B1|Geographic ancestry|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4024505|NCT01165229|3845642|B3|Geographic ancestry|African Heritage / African American|Race/Ethnicity, Customized||Participants|Count of Participants|146|146.0||||||
4024506|NCT01165229|3845643|B2|Geographic ancestry|African Heritage / African American|Race/Ethnicity, Customized||Participants|Count of Participants|67|67.0||||||
4024507|NCT01165229|3845644|B1|Geographic ancestry|African Heritage / African American|Race/Ethnicity, Customized||Participants|Count of Participants|79|79.0||||||
4024508|NCT01165229|3845642|B3||Male|Sex: Female, Male||Participants|Count of Participants|6275|6275.0||||||
4024509|NCT01165229|3845643|B2||Male|Sex: Female, Male||Participants|Count of Participants|3114|3114.0||||||
4024510|NCT01165229|3845644|B1||Male|Sex: Female, Male||Participants|Count of Participants|3161|3161.0||||||
4024511|NCT01165229|3845642|B3||Female|Sex: Female, Male||Participants|Count of Participants|7625|7625.0||||||
4024512|NCT01165229|3845643|B2||Female|Sex: Female, Male||Participants|Count of Participants|3836|3836.0||||||
4024513|NCT01165229|3845644|B1||Female|Sex: Female, Male||Participants|Count of Participants|3789|3789.0||||||
4024514|NCT01165229|3845642|B3|||Age||Years|Mean|75.6|75.6|Standard Deviation|4.7|4.7|||
4024515|NCT01165229|3845643|B2|||Age||Years|Mean|75.6|75.6|Standard Deviation|4.7|4.7|||
4024516|NCT01165229|3845644|B1|||Age||Years|Mean|75.6|75.6|Standard Deviation|4.7|4.7|||
4024517|NCT01165216|3845771|B3|Not reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4024518|NCT01165216|3845772|B2|Not reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4024519|NCT01165216|3845773|B1|Not reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4024520|NCT01165216|3845771|B3|Japanese||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4024521|NCT01165216|3845772|B2|Japanese||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4024522|NCT01165216|3845773|B1|Japanese||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4024523|NCT01165216|3845771|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4024524|NCT01165216|3845772|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4024525|NCT01165216|3845773|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4024526|NCT01165216|3845771|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4024527|NCT01165216|3845772|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4024528|NCT01165216|3845773|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4024529|NCT01165216|3845771|B3|65 years and older||Age, Customized||Participants|Number|4|4.0||||||
4024530|NCT01165216|3845772|B2|65 years and older||Age, Customized||Participants|Number|3|3.0||||||
4024531|NCT01165216|3845773|B1|65 years and older||Age, Customized||Participants|Number|1|1.0||||||
4024532|NCT01165216|3845771|B3|Younger than 65 years||Age, Customized||Participants|Number|11|11.0||||||
4024533|NCT01165216|3845772|B2|Younger than 65 years||Age, Customized||Participants|Number|4|4.0||||||
4024534|NCT01165216|3845773|B1|Younger than 65 years||Age, Customized||Participants|Number|7|7.0||||||
4024535|NCT01165216|3845771|B3|||Age||Years|Mean|57.3|57.3|Standard Deviation|11.26|11.26|||
4024536|NCT01165216|3845772|B2|||Age||Years|Mean|58.9|58.9|Standard Deviation|10.25|10.25|||
4024537|NCT01165216|3845773|B1|||Age||Years|Mean|56.0|56.0|Standard Deviation|12.62|12.62|||
4024538|NCT01165203|3845794|B3|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4024539|NCT01165203|3845795|B2|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4024540|NCT01165203|3845796|B1|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4024541|NCT01165203|3845794|B3|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|108|108.0||||||
4024542|NCT01165203|3845795|B2|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
4024543|NCT01165203|3845796|B1|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|66|66.0||||||
4024544|NCT01165203|3845794|B3|Asian-Japanese heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4024545|NCT01165203|3845795|B2|Asian-Japanese heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4024546|NCT01165203|3845796|B1|Asian-Japanese heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4024547|NCT01165203|3845794|B3|Asian-East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4024548|NCT01165203|3845795|B2|Asian-East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4024549|NCT01165203|3845796|B1|Asian-East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4024550|NCT01165203|3845794|B3|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4024551|NCT01165203|3845795|B2|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4024552|NCT01165203|3845796|B1|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4024553|NCT01165203|3845794|B3||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4024554|NCT01165203|3845795|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4024555|NCT01165203|3845796|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4024556|NCT01165203|3845794|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4024557|NCT01165203|3845795|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4024558|NCT01165203|3845796|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4024559|NCT01165203|3845794|B3|||Age||Years|Mean|46.0|46.0|Standard Deviation|10.93|10.93|||
4024560|NCT01165203|3845795|B2|||Age||Years|Mean|45.1|45.1|Standard Deviation|11.36|11.36|||
4024561|NCT01165203|3845796|B1|||Age||Years|Mean|46.6|46.6|Standard Deviation|10.68|10.68|||
4024562|NCT01165177|3845885|B3||Male|Sex: Female, Male||Participants|Count of Participants|5985|5985.0||||||
4024563|NCT01165177|3845886|B2||Male|Sex: Female, Male||Participants|Count of Participants|2999|2999.0||||||
4024564|NCT01165177|3845887|B1||Male|Sex: Female, Male||Participants|Count of Participants|2986|2986.0||||||
4024565|NCT01165177|3845885|B3||Female|Sex: Female, Male||Participants|Count of Participants|9420|9420.0||||||
4024566|NCT01165177|3845886|B2||Female|Sex: Female, Male||Participants|Count of Participants|4711|4711.0||||||
4024567|NCT01165177|3845887|B1||Female|Sex: Female, Male||Participants|Count of Participants|4709|4709.0||||||
4024568|NCT01165177|3845885|B3|>= 70 YOA||Age, Customized||Participants|Number|3631|3631.0||||||
4024569|NCT01165177|3845886|B2|>= 70 YOA||Age, Customized||Participants|Number|1823|1823.0||||||
4024570|NCT01165177|3845887|B1|>= 70 YOA||Age, Customized||Participants|Number|1808|1808.0||||||
4024571|NCT01165177|3845885|B3|60 - 69 YOA||Age, Customized||Participants|Number|4488|4488.0||||||
4024572|NCT01165177|3845886|B2|60 - 69 YOA||Age, Customized||Participants|Number|2245|2245.0||||||
4024573|NCT01165177|3845887|B1|60 - 69 YOA||Age, Customized||Participants|Number|2243|2243.0||||||
4024574|NCT01165177|3845885|B3|50 - 59 YOA||Age, Customized||Participants|Number|7286|7286.0||||||
4024575|NCT01165177|3845886|B2|50 - 59 YOA||Age, Customized||Participants|Number|3642|3642.0||||||
4024576|NCT01165177|3845887|B1|50 - 59 YOA||Age, Customized||Participants|Number|3644|3644.0||||||
4024577|NCT01165177|3845885|B3|||Age||Years|Mean|62.35|62.35|Standard Deviation|9.0|9.0|||
4024578|NCT01165177|3845886|B2|||Age||Years|Mean|62.3|62.3|Standard Deviation|9.0|9.0|||
4024579|NCT01165177|3845887|B1|||Age||Years|Mean|62.4|62.4|Standard Deviation|9.0|9.0|||
4024580|NCT01165138|3846010|B4|Mixed Race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4024581|NCT01165138|3846011|B3|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4024582|NCT01165138|3846012|B2|Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4024583|NCT01165138|3846013|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4024584|NCT01165138|3846010|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|511|511.0||||||
4024585|NCT01165138|3846011|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|172|172.0||||||
4024586|NCT01165138|3846012|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|170|170.0||||||
4024587|NCT01165138|3846013|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|169|169.0||||||
4024588|NCT01165138|3846010|B4|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4024589|NCT01165138|3846011|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4024590|NCT01165138|3846012|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4024591|NCT01165138|3846013|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4024592|NCT01165138|3846010|B4|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4024593|NCT01165138|3846011|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4024594|NCT01165138|3846012|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4024595|NCT01165138|3846013|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4024596|NCT01165138|3846010|B4|Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
4024597|NCT01165138|3846011|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4024598|NCT01165138|3846012|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4024599|NCT01165138|3846013|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4024600|NCT01165138|3846010|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4024601|NCT01165138|3846011|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4024602|NCT01165138|3846012|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4024603|NCT01165138|3846013|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4024604|NCT01165138|3846010|B4|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4024605|NCT01165138|3846011|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4024606|NCT01165138|3846012|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4024607|NCT01165138|3846013|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4024608|NCT01165138|3846010|B4||Male|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
4024609|NCT01165138|3846011|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4024610|NCT01165138|3846012|B2||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4024611|NCT01165138|3846013|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4024612|NCT01165138|3846010|B4||Female|Sex: Female, Male||Participants|Count of Participants|353|353.0||||||
4024613|NCT01165138|3846011|B3||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4024614|NCT01165138|3846012|B2||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4024615|NCT01165138|3846013|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4024616|NCT01165138|3846010|B4|||Age||Years|Mean|39.7|39.7|Standard Deviation|16.56|16.56|||
4024617|NCT01165138|3846011|B3|||Age||Years|Mean|40.7|40.7|Standard Deviation|16.38|16.38|||
4024618|NCT01165138|3846012|B2|||Age||Years|Mean|40.4|40.4|Standard Deviation|16.78|16.78|||
4024619|NCT01165138|3846013|B1|||Age||Years|Mean|38.1|38.1|Standard Deviation|16.49|16.49|||
4024620|NCT01165112|3846075|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4024621|NCT01165112|3846075|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024622|NCT01165112|3846075|B1||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4024623|NCT01165112|3846075|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4024624|NCT01165112|3846075|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4024625|NCT01165112|3846075|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4024626|NCT01165112|3846075|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024627|NCT01165112|3846075|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4024628|NCT01165112|3846075|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4024629|NCT01165112|3846075|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4024630|NCT01165112|3846075|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4024631|NCT01165112|3846075|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4024632|NCT01165112|3846075|B1|||Age||years|Median|56|56.0|Full Range|||23.0|69.0|
4024633|NCT01165047|3846082|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4024634|NCT01165047|3846082|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4024635|NCT01165047|3846082|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024636|NCT01165047|3846082|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4024637|NCT01165047|3846082|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4024638|NCT01165047|3846082|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024639|NCT01165047|3846082|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4024640|NCT01165047|3846082|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024641|NCT01165047|3846082|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4024642|NCT01165047|3846082|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4024643|NCT01165047|3846082|B1|equal or greater than 18||Age, Customized|>= 18 years|participants|Number|10|10.0||||||
4024644|NCT01165021|3846086|B1|Never Used Tobacco||Tobacco Consumption Status||participants|Number|3|3.0||||||
4024645|NCT01165021|3846086|B1|Former Tobacco User||Tobacco Consumption Status||participants|Number|12|12.0||||||
4024646|NCT01165021|3846086|B1|Current Tobacco User||Tobacco Consumption Status||participants|Number|4|4.0||||||
4024647|NCT01165021|3846086|B1|T3N2M0||Tumor-Node-Metastasis (TNM) Stage of Disease|Tumor size: T1=surrounded by lung or visceral pleura with no evidence of invasion more proximal than lobar bronchus; T1a ≤2 centimeters (cm) at greatest dimension (GD); T1b >2 cm, ≤3 cm at GD; T2=involves main bronchus, ≥2 cm distal to carina; invades visceral pleura, associated with atelectasis or obstructive pneumonitis extends to hilar but not entire lung; T2a >3 cm, ≤5 cm at GD; T2b >5 cm, ≤7 cm at GD; T3= >7 cm or 1 that invades the thoracic cavity. Nodal status (N): N2 =Metastasis in ipsilateral mediastinal and/or subcarinal lymph nodes. Distant metastasis (M): M0 =No distant metastasis.|participants|Number|8|8.0||||||
4024648|NCT01165021|3846086|B1|T2bN2M0||Tumor-Node-Metastasis (TNM) Stage of Disease|Tumor size: T1=surrounded by lung or visceral pleura with no evidence of invasion more proximal than lobar bronchus; T1a ≤2 centimeters (cm) at greatest dimension (GD); T1b >2 cm, ≤3 cm at GD; T2=involves main bronchus, ≥2 cm distal to carina; invades visceral pleura, associated with atelectasis or obstructive pneumonitis extends to hilar but not entire lung; T2a >3 cm, ≤5 cm at GD; T2b >5 cm, ≤7 cm at GD; T3= >7 cm or 1 that invades the thoracic cavity. Nodal status (N): N2 =Metastasis in ipsilateral mediastinal and/or subcarinal lymph nodes. Distant metastasis (M): M0 =No distant metastasis.|participants|Number|3|3.0||||||
4024649|NCT01165021|3846086|B1|T2aN2M0||Tumor-Node-Metastasis (TNM) Stage of Disease|Tumor size: T1=surrounded by lung or visceral pleura with no evidence of invasion more proximal than lobar bronchus; T1a ≤2 centimeters (cm) at greatest dimension (GD); T1b >2 cm, ≤3 cm at GD; T2=involves main bronchus, ≥2 cm distal to carina; invades visceral pleura, associated with atelectasis or obstructive pneumonitis extends to hilar but not entire lung; T2a >3 cm, ≤5 cm at GD; T2b >5 cm, ≤7 cm at GD; T3= >7 cm or 1 that invades the thoracic cavity. Nodal status (N): N2 =Metastasis in ipsilateral mediastinal and/or subcarinal lymph nodes. Distant metastasis (M): M0 =No distant metastasis.|participants|Number|3|3.0||||||
4024650|NCT01165021|3846086|B1|T1bN2M0||Tumor-Node-Metastasis (TNM) Stage of Disease|Tumor size: T1=surrounded by lung or visceral pleura with no evidence of invasion more proximal than lobar bronchus; T1a ≤2 centimeters (cm) at greatest dimension (GD); T1b >2 cm, ≤3 cm at GD; T2=involves main bronchus, ≥2 cm distal to carina; invades visceral pleura, associated with atelectasis or obstructive pneumonitis extends to hilar but not entire lung; T2a >3 cm, ≤5 cm at GD; T2b >5 cm, ≤7 cm at GD; T3= >7 cm or 1 that invades the thoracic cavity. Nodal status (N): N2 =Metastasis in ipsilateral mediastinal and/or subcarinal lymph nodes. Distant metastasis (M): M0 =No distant metastasis.|participants|Number|2|2.0||||||
4024651|NCT01165021|3846086|B1|T1aN2M0||Tumor-Node-Metastasis (TNM) Stage of Disease|Tumor size: T1=surrounded by lung or visceral pleura with no evidence of invasion more proximal than lobar bronchus; T1a ≤2 centimeters (cm) at greatest dimension (GD); T1b >2 cm, ≤3 cm at GD; T2=involves main bronchus, ≥2 cm distal to carina; invades visceral pleura, associated with atelectasis or obstructive pneumonitis extends to hilar but not entire lung; T2a >3 cm, ≤5 cm at GD; T2b >5 cm, ≤7 cm at GD; T3= >7 cm or 1 that invades the thoracic cavity. Nodal status (N): N2 =Metastasis in ipsilateral mediastinal and/or subcarinal lymph nodes. Distant metastasis (M): M0 =No distant metastasis.|participants|Number|3|3.0||||||
4024652|NCT01165021|3846086|B1|Carcinoma, Non-Small Cell, Lung||Initial Pathological Diagnosis|Initial cancer diagnosis confirmed by tissue biopsy.|participants|Number|1|1.0||||||
4024653|NCT01165021|3846086|B1|Carcinoma, Large Cell, Lung||Initial Pathological Diagnosis|Initial cancer diagnosis confirmed by tissue biopsy.|participants|Number|1|1.0||||||
4024654|NCT01165021|3846086|B1|Adenocarcinoma, Lung||Initial Pathological Diagnosis|Initial cancer diagnosis confirmed by tissue biopsy.|participants|Number|17|17.0||||||
4024655|NCT01165021|3846086|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG classifies participants according to their functional impairment. Scores range from 0 (fully active) to 5 (death). 0 (fully active, able to carry on all pre-disease performance without restriction) and 1 (restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature).|participants|Number|4|4.0||||||
4024656|NCT01165021|3846086|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG classifies participants according to their functional impairment. Scores range from 0 (fully active) to 5 (death). 0 (fully active, able to carry on all pre-disease performance without restriction) and 1 (restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature).|participants|Number|15|15.0||||||
4024657|NCT01165021|3846086|B1|Italy||Region of Enrollment||participants|Number|19|19.0||||||
4024658|NCT01165021|3846086|B1|White||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4024659|NCT01165021|3846086|B1||Male|Gender||Participants|Count of Participants|13|13.0||||||
4024660|NCT01165021|3846086|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
4024661|NCT01165021|3846086|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|9.32|9.32|||
4024662|NCT01164891|3846094|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4024663|NCT01164891|3846094|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4024664|NCT01164891|3846094|B1|||Age||years|Mean|55.7|55.7|Standard Deviation|12.09|12.09|||
4024665|NCT01164865|3846112|B3|United States||Region of Enrollment||participants|Number|78|78.0||||||
4024666|NCT01164865|3846113|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
4024667|NCT01164865|3846114|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4024668|NCT01164865|3846112|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4024669|NCT01164865|3846113|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4024670|NCT01164865|3846114|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4024671|NCT01164865|3846112|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4024672|NCT01164865|3846113|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4024673|NCT01164865|3846114|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4024674|NCT01164865|3846112|B3|||Age||years|Mean|39.3|39.3|Standard Deviation|11.16|11.16|||
4024675|NCT01164865|3846113|B2|||Age||years|Mean|41.5|41.5|Standard Deviation|9.59|9.59|||
4024676|NCT01164865|3846114|B1|||Age||years|Mean|37.1|37.1|Standard Deviation|12.27|12.27|||
4024677|NCT01164722|3846123|B3|United States||Region of Enrollment||participants|Number|120|120.0||||||
4024678|NCT01164722|3846124|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
4024679|NCT01164722|3846125|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4024680|NCT01164722|3846123|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024681|NCT01164722|3846124|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024682|NCT01164722|3846125|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024683|NCT01164722|3846123|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4024684|NCT01164722|3846124|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024685|NCT01164722|3846125|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4024686|NCT01164722|3846123|B3||White|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
4024687|NCT01164722|3846124|B2||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4024688|NCT01164722|3846125|B1||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4024689|NCT01164722|3846123|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4024690|NCT01164722|3846124|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4024691|NCT01164722|3846125|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4024692|NCT01164722|3846123|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4024693|NCT01164722|3846124|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4024694|NCT01164722|3846125|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024695|NCT01164722|3846123|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4024696|NCT01164722|3846124|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024697|NCT01164722|3846125|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4024698|NCT01164722|3846123|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4024699|NCT01164722|3846124|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024700|NCT01164722|3846125|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4024701|NCT01164722|3846123|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4024702|NCT01164722|3846124|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024703|NCT01164722|3846125|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4024704|NCT01164722|3846123|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
4024705|NCT01164722|3846124|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4024706|NCT01164722|3846125|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4024707|NCT01164722|3846123|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4024708|NCT01164722|3846124|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4024709|NCT01164722|3846125|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4024710|NCT01164722|3846123|B3||Male|Gender||Participants|Count of Participants|112|112.0||||||
4024711|NCT01164722|3846124|B2||Male|Gender||Participants|Count of Participants|54|54.0||||||
4024712|NCT01164722|3846125|B1||Male|Gender||Participants|Count of Participants|58|58.0||||||
4024713|NCT01164722|3846123|B3||Female|Gender||Participants|Count of Participants|8|8.0||||||
4024714|NCT01164722|3846124|B2||Female|Gender||Participants|Count of Participants|6|6.0||||||
4024715|NCT01164722|3846125|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
4024716|NCT01164722|3846123|B3|||Age||years|Mean|49.8|49.8|Standard Deviation|9.3|9.3|||
4024717|NCT01164722|3846124|B2|||Age||years|Mean|49.0|49.0|Standard Deviation|9.6|9.6|||
4024718|NCT01164722|3846125|B1|||Age||years|Mean|50.0|50.0|Standard Deviation|9.0|9.0|||
4024719|NCT01164644|3846140|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4024720|NCT01164644|3846141|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4024721|NCT01164644|3846142|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4024722|NCT01164644|3846140|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4024723|NCT01164644|3846141|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4024724|NCT01164644|3846142|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4024725|NCT01164644|3846140|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4024726|NCT01164644|3846141|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4024727|NCT01164644|3846142|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4024728|NCT01164644|3846140|B3|||Age||years|Mean|33.65|33.65|Standard Deviation|13.05|13.05|||
4024729|NCT01164644|3846141|B2|||Age||years|Mean|32.71|32.71|Standard Deviation|13.34|13.34|||
4024730|NCT01164644|3846142|B1|||Age||years|Mean|34.75|34.75|Standard Deviation|13.06|13.06|||
4024731|NCT01164644|3846140|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4024732|NCT01164644|3846141|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4024733|NCT01164644|3846142|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4024734|NCT01164644|3846140|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4024735|NCT01164644|3846141|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4024736|NCT01164644|3846142|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4024737|NCT01164644|3846140|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4024738|NCT01164644|3846141|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4024739|NCT01164644|3846142|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4024740|NCT01164579|3846153|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4024741|NCT01164579|3846154|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4024742|NCT01164579|3846155|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4024743|NCT01164579|3846156|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4024744|NCT01164579|3846153|B4||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4024745|NCT01164579|3846154|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4024746|NCT01164579|3846155|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4024747|NCT01164579|3846156|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4024748|NCT01164579|3846153|B4|||Age||years|Mean|48.8|48.8|Standard Deviation|12.2|12.2|||
4024749|NCT01164579|3846154|B3|||Age||years|Mean|47.8|47.8|Standard Deviation|11.6|11.6|||
4024750|NCT01164579|3846155|B2|||Age||years|Mean|50.8|50.8|Standard Deviation|12.8|12.8|||
4024751|NCT01164579|3846156|B1|||Age||years|Mean|47.8|47.8|Standard Deviation|12.3|12.3|||
4024752|NCT01164501|3846235|B4||Male|Sex: Female, Male||Participants|Count of Participants|430|430.0||||||
4024753|NCT01164501|3846236|B3||Male|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4024754|NCT01164501|3846237|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4024755|NCT01164501|3846238|B1||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4024756|NCT01164501|3846235|B4||Female|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
4024757|NCT01164501|3846236|B3||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4024758|NCT01164501|3846237|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4024759|NCT01164501|3846238|B1||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4024760|NCT01164501|3846235|B4|||Age||years|Mean|63.9|63.9|Standard Deviation|8.8|8.8|||
4024761|NCT01164501|3846236|B3|||Age||years|Mean|63.9|63.9|Standard Deviation|9.0|9.0|||
4024762|NCT01164501|3846237|B2|||Age||years|Mean|63.2|63.2|Standard Deviation|8.5|8.5|||
4024763|NCT01164501|3846238|B1|||Age||years|Mean|64.1|64.1|Standard Deviation|8.7|8.7|||
4024764|NCT01164475|3846255|B3|Greater than or equal to 10 cells/mcL||Number of Patients With Peripheral-Blood (PB) Cluster of Differentiation 34+ (CD34+) Cell Count|Baseline for this characteristic was “pre G-CSF dose on Day 4”|participants|Number|20|20.0||||||
4024765|NCT01164475|3846256|B2|Greater than or equal to 10 cells/mcL||Number of Patients With Peripheral-Blood (PB) Cluster of Differentiation 34+ (CD34+) Cell Count|Baseline for this characteristic was “pre G-CSF dose on Day 4”|participants|Number|10|10.0||||||
4024766|NCT01164475|3846257|B1|Greater than or equal to 10 cells/mcL||Number of Patients With Peripheral-Blood (PB) Cluster of Differentiation 34+ (CD34+) Cell Count|Baseline for this characteristic was “pre G-CSF dose on Day 4”|participants|Number|10|10.0||||||
4024767|NCT01164475|3846255|B3|Less than 10 cells per microliter (mcL)||Number of Patients With Peripheral-Blood (PB) Cluster of Differentiation 34+ (CD34+) Cell Count|Baseline for this characteristic was “pre G-CSF dose on Day 4”|participants|Number|41|41.0||||||
4024768|NCT01164475|3846256|B2|Less than 10 cells per microliter (mcL)||Number of Patients With Peripheral-Blood (PB) Cluster of Differentiation 34+ (CD34+) Cell Count|Baseline for this characteristic was “pre G-CSF dose on Day 4”|participants|Number|21|21.0||||||
4024769|NCT01164475|3846257|B1|Less than 10 cells per microliter (mcL)||Number of Patients With Peripheral-Blood (PB) Cluster of Differentiation 34+ (CD34+) Cell Count|Baseline for this characteristic was “pre G-CSF dose on Day 4”|participants|Number|20|20.0||||||
4024770|NCT01164475|3846255|B3|Ethnicity: Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
4024771|NCT01164475|3846256|B2|Ethnicity: Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4024772|NCT01164475|3846257|B1|Ethnicity: Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4024773|NCT01164475|3846255|B3|Ethnicity: Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4024774|NCT01164475|3846256|B2|Ethnicity: Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4024775|NCT01164475|3846257|B1|Ethnicity: Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4024776|NCT01164475|3846255|B3|Race: White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4024777|NCT01164475|3846256|B2|Race: White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4024778|NCT01164475|3846257|B1|Race: White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4024779|NCT01164475|3846255|B3|Race: Asian||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
4024780|NCT01164475|3846256|B2|Race: Asian||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4024781|NCT01164475|3846257|B1|Race: Asian||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4024782|NCT01164475|3846255|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4024783|NCT01164475|3846256|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4024784|NCT01164475|3846257|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4024785|NCT01164475|3846255|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4024786|NCT01164475|3846256|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4024787|NCT01164475|3846257|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4024788|NCT01164475|3846255|B3|||Age||years|Mean|47.00|47.0|Standard Deviation|13.41|13.41|||
4024789|NCT01164475|3846256|B2|||Age||years|Mean|47.84|47.84|Standard Deviation|13.59|13.59|||
4024790|NCT01164475|3846257|B1|||Age||years|Mean|46.13|46.13|Standard Deviation|13.40|13.4|||
4024791|NCT01164137|3846282|B3|Canada||Region of Enrollment||participants|Number|156|156.0||||||
4024792|NCT01164137|3846283|B2|Canada||Region of Enrollment||participants|Number|76|76.0||||||
4024793|NCT01164137|3846284|B1|Canada||Region of Enrollment||participants|Number|80|80.0||||||
4024794|NCT01164137|3846282|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4024795|NCT01164137|3846283|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4024796|NCT01164137|3846284|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4024797|NCT01164137|3846282|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4024798|NCT01164137|3846283|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4024799|NCT01164137|3846284|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4024800|NCT01164137|3846282|B3|||Age||years|Mean|70.48|70.48|Standard Deviation|14.12|14.12|||
4024801|NCT01164137|3846283|B2|||Age||years|Mean|72.59|72.59|Standard Deviation|13.27|13.27|||
4024802|NCT01164137|3846284|B1|||Age||years|Mean|68.40|68.4|Standard Deviation|14.70|14.7|||
4024803|NCT01164137|3846282|B3||>=65 years|Age||Participants|Count of Participants|106|106.0||||||
4024804|NCT01164137|3846283|B2||>=65 years|Age||Participants|Count of Participants|60|60.0||||||
4024805|NCT01164137|3846284|B1||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
4024806|NCT01164137|3846282|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4024807|NCT01164137|3846283|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4024808|NCT01164137|3846284|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4024809|NCT01164137|3846282|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4024810|NCT01164137|3846283|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4024811|NCT01164137|3846284|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4024812|NCT01164098|3846299|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4024813|NCT01164098|3846300|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024814|NCT01164098|3846301|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4024815|NCT01164098|3846299|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024816|NCT01164098|3846300|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024817|NCT01164098|3846301|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024818|NCT01164098|3846299|B3||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4024819|NCT01164098|3846300|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4024820|NCT01164098|3846301|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4024821|NCT01164098|3846299|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4024822|NCT01164098|3846300|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4024823|NCT01164098|3846301|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4024824|NCT01164098|3846299|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024825|NCT01164098|3846300|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024826|NCT01164098|3846301|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024827|NCT01164098|3846299|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024828|NCT01164098|3846300|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024829|NCT01164098|3846301|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024830|NCT01164098|3846299|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024831|NCT01164098|3846300|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024832|NCT01164098|3846301|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024833|NCT01164098|3846299|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024834|NCT01164098|3846300|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024835|NCT01164098|3846301|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024836|NCT01164098|3846299|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4024837|NCT01164098|3846300|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4024838|NCT01164098|3846301|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4024839|NCT01164098|3846299|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4024840|NCT01164098|3846300|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4024841|NCT01164098|3846301|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4024842|NCT01164098|3846299|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4024843|NCT01164098|3846300|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4024844|NCT01164098|3846301|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4024845|NCT01164098|3846299|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4024846|NCT01164098|3846300|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4024847|NCT01164098|3846301|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4024848|NCT01164098|3846299|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4024849|NCT01164098|3846300|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4024850|NCT01164098|3846301|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4024851|NCT01164098|3846299|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4024852|NCT01164098|3846300|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4024853|NCT01164098|3846301|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4024854|NCT01164098|3846299|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4024855|NCT01164098|3846300|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4024856|NCT01164098|3846301|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4024857|NCT01164007|3846312|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4024858|NCT01164007|3846312|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4024859|NCT01164007|3846312|B1|||Age||years|Mean|54.16|54.16|Standard Deviation|13.11|13.11|||
4024860|NCT01163955|3846326|B3|United States||Region of Enrollment||participants|Number|56|56.0||||||
4024861|NCT01163955|3846327|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4024862|NCT01163955|3846328|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4024863|NCT01163955|3846326|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4024864|NCT01163955|3846327|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4024865|NCT01163955|3846328|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4024866|NCT01163955|3846326|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4024867|NCT01163955|3846327|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4024868|NCT01163955|3846328|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4024869|NCT01163955|3846326|B3|||Age||years|Mean|8.8|8.8|Standard Deviation|2.5|2.5|||
4024870|NCT01163955|3846327|B2|||Age||years|Mean|8.8|8.8|Standard Deviation|2.5|2.5|||
4024871|NCT01163955|3846328|B1|||Age||years|Mean|8.7|8.7|Standard Deviation|2.5|2.5|||
4024872|NCT01163955|3846326|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4024873|NCT01163955|3846327|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4024874|NCT01163955|3846328|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4024875|NCT01163955|3846326|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4024876|NCT01163955|3846327|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4024877|NCT01163955|3846328|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4024878|NCT01163955|3846326|B3||<=18 years|Age||Participants|Count of Participants|56|56.0||||||
4024879|NCT01163955|3846327|B2||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4024880|NCT01163955|3846328|B1||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
4024881|NCT01163916|3846335|B4|Russian Federation||Region of Enrollment||participants|Number|252|252.0||||||
4024882|NCT01163916|3846336|B3|Russian Federation||Region of Enrollment||participants|Number|91|91.0||||||
4024883|NCT01163916|3846337|B2|Russian Federation||Region of Enrollment||participants|Number|35|35.0||||||
4024884|NCT01163916|3846338|B1|Russian Federation||Region of Enrollment||participants|Number|126|126.0||||||
4024885|NCT01163916|3846335|B4||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4024886|NCT01163916|3846336|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4024887|NCT01163916|3846337|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4024888|NCT01163916|3846338|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4024889|NCT01163916|3846335|B4||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4024890|NCT01163916|3846336|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4024891|NCT01163916|3846337|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4024892|NCT01163916|3846338|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4024893|NCT01163916|3846335|B4|||Age||years|Mean|42.5|42.5|Standard Deviation|13.4|13.4|||
4024894|NCT01163916|3846336|B3|||Age||years|Mean|36.2|36.2|Standard Deviation|10.6|10.6|||
4024895|NCT01163916|3846337|B2|||Age||years|Mean|42.4|42.4|Standard Deviation|12.6|12.6|||
4024896|NCT01163916|3846338|B1|||Age||years|Mean|47.0|47.0|Standard Deviation|13.7|13.7|||
4024897|NCT01163851|3846376|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4024898|NCT01163851|3846377|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4024899|NCT01163851|3846378|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4024900|NCT01163851|3846376|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4024901|NCT01163851|3846377|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4024902|NCT01163851|3846378|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4024903|NCT01163851|3846376|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4024904|NCT01163851|3846377|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4024905|NCT01163851|3846378|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4024906|NCT01163851|3846376|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4024907|NCT01163851|3846377|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4024908|NCT01163851|3846378|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4024909|NCT01163851|3846376|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4024910|NCT01163851|3846377|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4024911|NCT01163851|3846378|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4024912|NCT01163760|3846457|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4024913|NCT01163760|3846457|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4024914|NCT01163760|3846457|B1|||Age||years|Mean|25.0|25.0|Standard Deviation|4.8|4.8|||
4024915|NCT01163747|3846472|B3|United States||Region of Enrollment||participants|Number|81|81.0||||||
4024916|NCT01163747|3846473|B2|United States||Region of Enrollment||participants|Number|54|54.0||||||
4024917|NCT01163747|3846474|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4024918|NCT01163747|3846472|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4024919|NCT01163747|3846473|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4024920|NCT01163747|3846474|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4024921|NCT01163747|3846472|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4024922|NCT01163747|3846473|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4024923|NCT01163747|3846474|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4024924|NCT01163747|3846472|B3|||Age|Demographic data are provided for the per protocol population.|years|Mean|51.2|51.2|Standard Deviation|9.04|9.04|||
4024925|NCT01163747|3846473|B2|||Age|Demographic data are provided for the per protocol population.|years|Mean|51.1|51.1|Standard Deviation|8.90|8.9|||
4024926|NCT01163747|3846474|B1|||Age|Demographic data are provided for the per protocol population.|years|Mean|51.4|51.4|Standard Deviation|9.47|9.47|||
4024927|NCT01163721|3846493|B3|||Fasting Serum Glucose|Fasting serum glucose was measured following an overnight fast.|mg/dL|Mean|163.4|163.4|Standard Deviation|48.60|48.6|||
4024928|NCT01163721|3846494|B2|||Fasting Serum Glucose|Fasting serum glucose was measured following an overnight fast.|mg/dL|Mean|172.7|172.7|Standard Deviation|52.20|52.2|||
4024929|NCT01163721|3846495|B1|||Fasting Serum Glucose|Fasting serum glucose was measured following an overnight fast.|mg/dL|Mean|153.7|153.7|Standard Deviation|43.05|43.05|||
4024930|NCT01163721|3846493|B3|||2-hour Postprandial Glucose|2-hour postprandial serum glucose was defined as the average of serum glucose measurement at 120 minutes and 125 minutes following a meal.|mg/dL|Mean|262.5|262.5|Standard Deviation|74.57|74.57|||
4024931|NCT01163721|3846494|B2|||2-hour Postprandial Glucose|2-hour postprandial serum glucose was defined as the average of serum glucose measurement at 120 minutes and 125 minutes following a meal.|mg/dL|Mean|271.5|271.5|Standard Deviation|87.67|87.67|||
4024932|NCT01163721|3846495|B1|||2-hour Postprandial Glucose|2-hour postprandial serum glucose was defined as the average of serum glucose measurement at 120 minutes and 125 minutes following a meal.|mg/dL|Mean|253.1|253.1|Standard Deviation|57.37|57.37|||
4024933|NCT01163721|3846493|B3|||Glycosylated hemoglobin (HbA1c)||percent HbA1c in blood|Mean|8.46|8.46|Standard Deviation|1.117|1.117|||
4024934|NCT01163721|3846494|B2|||Glycosylated hemoglobin (HbA1c)||percent HbA1c in blood|Mean|8.51|8.51|Standard Deviation|1.163|1.163|||
4024935|NCT01163721|3846495|B1|||Glycosylated hemoglobin (HbA1c)||percent HbA1c in blood|Mean|8.41|8.41|Standard Deviation|1.078|1.078|||
4024936|NCT01163721|3846493|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4024937|NCT01163721|3846494|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4024938|NCT01163721|3846495|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4024939|NCT01163721|3846493|B3|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4024940|NCT01163721|3846494|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4024941|NCT01163721|3846495|B1|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4024942|NCT01163721|3846493|B3|White||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
4024943|NCT01163721|3846494|B2|White||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4024944|NCT01163721|3846495|B1|White||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4024945|NCT01163721|3846493|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024946|NCT01163721|3846494|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024947|NCT01163721|3846495|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4024948|NCT01163721|3846493|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4024949|NCT01163721|3846494|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4024950|NCT01163721|3846495|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4024951|NCT01163721|3846493|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4024952|NCT01163721|3846494|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4024953|NCT01163721|3846495|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4024954|NCT01163721|3846493|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4024955|NCT01163721|3846494|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4024956|NCT01163721|3846495|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4024957|NCT01163721|3846493|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4024958|NCT01163721|3846494|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4024959|NCT01163721|3846495|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4024960|NCT01163721|3846493|B3|||Age||years|Mean|58|58.0|Standard Deviation|9.5|9.5|||
4024961|NCT01163721|3846494|B2|||Age||years|Mean|58|58.0|Standard Deviation|9.1|9.1|||
4024962|NCT01163721|3846495|B1|||Age||years|Mean|58|58.0|Standard Deviation|10.1|10.1|||
4024963|NCT01163656|3846506|B3|United States||Region of Enrollment||participants|Number|66|66.0||||||
4024964|NCT01163656|3846507|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4024965|NCT01163656|3846508|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4024966|NCT01163656|3846506|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4024967|NCT01163656|3846507|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4024968|NCT01163656|3846508|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4024969|NCT01163656|3846506|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4024970|NCT01163656|3846507|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4024971|NCT01163656|3846508|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4024972|NCT01163656|3846506|B3|||Age||years|Mean|0.459|0.459|Standard Deviation|0.279|0.279|||
4024973|NCT01163656|3846507|B2|||Age||years|Mean|0.492|0.492|Standard Deviation|0.283|0.283|||
4024974|NCT01163656|3846508|B1|||Age||years|Mean|0.425|0.425|Standard Deviation|0.275|0.275|||
4024975|NCT01163656|3846506|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4024976|NCT01163656|3846507|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4024977|NCT01163656|3846508|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4024978|NCT01163656|3846506|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4024979|NCT01163656|3846507|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4024980|NCT01163656|3846508|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4024981|NCT01163656|3846506|B3||<=18 years|Age||Participants|Count of Participants|66|66.0||||||
4024982|NCT01163656|3846507|B2||<=18 years|Age||Participants|Count of Participants|33|33.0||||||
4024983|NCT01163656|3846508|B1||<=18 years|Age||Participants|Count of Participants|33|33.0||||||
4024984|NCT01163617|3846515|B1|United States||Region of Enrollment||participants|Number|85|85.0||||||
4024985|NCT01163617|3846515|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4024986|NCT01163617|3846515|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4024987|NCT01163617|3846515|B1|>=65 years||Age, Customized||participants|Number|23|23.0||||||
4024988|NCT01163617|3846515|B1|<65 years||Age, Customized||participants|Number|62|62.0||||||
4024989|NCT01163604|3846542|B3|China||Region of Enrollment||participants|Number|114|114.0||||||
4024990|NCT01163604|3846543|B2|China||Region of Enrollment||participants|Number|56|56.0||||||
4024991|NCT01163604|3846544|B1|China||Region of Enrollment||participants|Number|58|58.0||||||
4024992|NCT01163604|3846542|B3||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4024993|NCT01163604|3846543|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4024994|NCT01163604|3846544|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4024995|NCT01163604|3846542|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4024996|NCT01163604|3846543|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4024997|NCT01163604|3846544|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4024998|NCT01163604|3846542|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4024999|NCT01163604|3846543|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4025000|NCT01163604|3846544|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4025001|NCT01163604|3846542|B3||Between 18 and 65 years|Age||Participants|Count of Participants|114|114.0||||||
4025002|NCT01163604|3846543|B2||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4025003|NCT01163604|3846544|B1||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4025004|NCT01163604|3846542|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4025005|NCT01163604|3846543|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4025006|NCT01163604|3846544|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4025007|NCT01163604|3846542|B3|||Age||years|Mean|28.10|28.1|Standard Deviation|11.64|11.64|||
4025008|NCT01163604|3846543|B2|||Age||years|Mean|28.14|28.14|Standard Deviation|11.46|11.46|||
4025009|NCT01163604|3846544|B1|||Age||years|Mean|28.07|28.07|Standard Deviation|11.87|11.87|||
4025010|NCT01163474|3846551|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4025011|NCT01163474|3846551|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4025012|NCT01163474|3846551|B1|African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4025013|NCT01163474|3846551|B1|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4025014|NCT01163474|3846551|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4025015|NCT01163474|3846551|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4025016|NCT01163474|3846551|B1|||Age||years|Mean|64|64.0|Standard Deviation|8.3|8.3|||
4025017|NCT01163461|3846557|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4025018|NCT01163461|3846557|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4025019|NCT01163461|3846557|B1|||Age||years|Mean|56|56.0|Standard Deviation|15|15.0|||
4025020|NCT01163318|3846562|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4025021|NCT01163318|3846562|B1||Female|Sex: Female, Male||Participants|Count of Participants|416|416.0||||||
4025022|NCT01163318|3846562|B1|||Age||Years|Mean|59.5|59.5|Standard Deviation|13.4|13.4|||
4025023|NCT01163292|3846569|B3|Female||Matrix Metalloprotease (MMP-3)|Matrix metalloprotease level in serum|ng/mL|Mean|87.94|87.94|Standard Deviation|152.09|152.09|||
4025024|NCT01163292|3846570|B2|Female||Matrix Metalloprotease (MMP-3)|Matrix metalloprotease level in serum|ng/mL|Mean|88.88|88.88|Standard Deviation|182.09|182.09|||
4025025|NCT01163292|3846571|B1|Female||Matrix Metalloprotease (MMP-3)|Matrix metalloprotease level in serum|ng/mL|Mean|86.94|86.94|Standard Deviation|113.09|113.09|||
4025026|NCT01163292|3846569|B3|Male||Matrix Metalloprotease (MMP-3)|Matrix metalloprotease level in serum|ng/mL|Mean|130.50|130.5|Standard Deviation|125.92|125.92|||
4025027|NCT01163292|3846570|B2|Male||Matrix Metalloprotease (MMP-3)|Matrix metalloprotease level in serum|ng/mL|Mean|113.70|113.7|Standard Deviation|135.15|135.15|||
4025028|NCT01163292|3846571|B1|Male||Matrix Metalloprotease (MMP-3)|Matrix metalloprotease level in serum|ng/mL|Mean|149.95|149.95|Standard Deviation|114.81|114.81|||
4025029|NCT01163292|3846569|B3|||Modified Total Sharp Score (mTSS)|Modified Total Sharp Score (mTSS) is a method of assessing radiographs, used in evaluation of inhibition of joint destruction of disease. Digitized X-rays of hands and feet were obtained, then scored in a blinded manner: for erosion (0 [no damage] to 5 [complete collapse or total destruction of joint]) and for joint space narrowing (0 [no damage] to 4 [complete luxation of joint]). Sum of scores was given as total mTSS (0 [normal] to 380 [maximal disease]).|units on a scale|Mean|16.05|16.05|Standard Deviation|22.20|22.2|||
4025030|NCT01163292|3846570|B2|||Modified Total Sharp Score (mTSS)|Modified Total Sharp Score (mTSS) is a method of assessing radiographs, used in evaluation of inhibition of joint destruction of disease. Digitized X-rays of hands and feet were obtained, then scored in a blinded manner: for erosion (0 [no damage] to 5 [complete collapse or total destruction of joint]) and for joint space narrowing (0 [no damage] to 4 [complete luxation of joint]). Sum of scores was given as total mTSS (0 [normal] to 380 [maximal disease]).|units on a scale|Mean|16.47|16.47|Standard Deviation|22.30|22.3|||
4025031|NCT01163292|3846571|B1|||Modified Total Sharp Score (mTSS)|Modified Total Sharp Score (mTSS) is a method of assessing radiographs, used in evaluation of inhibition of joint destruction of disease. Digitized X-rays of hands and feet were obtained, then scored in a blinded manner: for erosion (0 [no damage] to 5 [complete collapse or total destruction of joint]) and for joint space narrowing (0 [no damage] to 4 [complete luxation of joint]). Sum of scores was given as total mTSS (0 [normal] to 380 [maximal disease]).|units on a scale|Mean|15.61|15.61|Standard Deviation|22.19|22.19|||
4025032|NCT01163292|3846569|B3|||Disease Activity Score|The Disease Activity Score (DAS28) is a combined index used to measure disease activity in patients with rheumatoid arthritis. Calculation of the DAS28 score used the tender joint count (28 joints), swollen joint count (28 joints), patient’s global assessment of disease activity, and the erythrocyte sedimentation rate (ESR). DAS 28 (ESR) scores range from 0 (no disease activity) to 9 (maximal disease activity).|units on a scale|Mean|2.81|2.81|Standard Deviation|1.11|1.11|||
4025033|NCT01163292|3846570|B2|||Disease Activity Score|The Disease Activity Score (DAS28) is a combined index used to measure disease activity in patients with rheumatoid arthritis. Calculation of the DAS28 score used the tender joint count (28 joints), swollen joint count (28 joints), patient’s global assessment of disease activity, and the erythrocyte sedimentation rate (ESR). DAS 28 (ESR) scores range from 0 (no disease activity) to 9 (maximal disease activity).|units on a scale|Mean|2.74|2.74|Standard Deviation|1.11|1.11|||
4025034|NCT01163292|3846571|B1|||Disease Activity Score|The Disease Activity Score (DAS28) is a combined index used to measure disease activity in patients with rheumatoid arthritis. Calculation of the DAS28 score used the tender joint count (28 joints), swollen joint count (28 joints), patient’s global assessment of disease activity, and the erythrocyte sedimentation rate (ESR). DAS 28 (ESR) scores range from 0 (no disease activity) to 9 (maximal disease activity).|units on a scale|Mean|2.89|2.89|Standard Deviation|1.10|1.1|||
4025035|NCT01163292|3846569|B3|||Health Assessment Questionnaire Disability Index (HAQ-DI)|Participants assessed their ability to perform the following tasks: 1) dress/groom; 2) arise; 3) eat; 4) walk; 5) reach; 6) grip; 7) maintain hygiene; and 8) maintain daily activity. Participants assessed their ability to do these tasks over the past week by marking their response on a questionnaire. Possible responses/scores included the following: without any difficulty (0); with some difficulty (1); with much difficulty (2); and unable to do (3).|units on a scale|Mean|0.27|0.27|Standard Deviation|0.34|0.34|||
4025036|NCT01163292|3846570|B2|||Health Assessment Questionnaire Disability Index (HAQ-DI)|Participants assessed their ability to perform the following tasks: 1) dress/groom; 2) arise; 3) eat; 4) walk; 5) reach; 6) grip; 7) maintain hygiene; and 8) maintain daily activity. Participants assessed their ability to do these tasks over the past week by marking their response on a questionnaire. Possible responses/scores included the following: without any difficulty (0); with some difficulty (1); with much difficulty (2); and unable to do (3).|units on a scale|Mean|0.25|0.25|Standard Deviation|0.33|0.33|||
4025037|NCT01163292|3846571|B1|||Health Assessment Questionnaire Disability Index (HAQ-DI)|Participants assessed their ability to perform the following tasks: 1) dress/groom; 2) arise; 3) eat; 4) walk; 5) reach; 6) grip; 7) maintain hygiene; and 8) maintain daily activity. Participants assessed their ability to do these tasks over the past week by marking their response on a questionnaire. Possible responses/scores included the following: without any difficulty (0); with some difficulty (1); with much difficulty (2); and unable to do (3).|units on a scale|Mean|0.29|0.29|Standard Deviation|0.34|0.34|||
4025038|NCT01163292|3846569|B3|Negative||Rheumatoid Factor||participants|Number|89|89.0||||||
4025039|NCT01163292|3846570|B2|Negative||Rheumatoid Factor||participants|Number|43|43.0||||||
4025040|NCT01163292|3846571|B1|Negative||Rheumatoid Factor||participants|Number|46|46.0||||||
4025041|NCT01163292|3846569|B3|Positive||Rheumatoid Factor||participants|Number|131|131.0||||||
4025042|NCT01163292|3846570|B2|Positive||Rheumatoid Factor||participants|Number|71|71.0||||||
4025043|NCT01163292|3846571|B1|Positive||Rheumatoid Factor||participants|Number|60|60.0||||||
4025044|NCT01163292|3846569|B3|No||Concomitant Glucocorticoid Use||participants|Number|157|157.0||||||
4025045|NCT01163292|3846570|B2|No||Concomitant Glucocorticoid Use||participants|Number|84|84.0||||||
4025046|NCT01163292|3846571|B1|No||Concomitant Glucocorticoid Use||participants|Number|73|73.0||||||
4025047|NCT01163292|3846569|B3|Yes||Concomitant Glucocorticoid Use||participants|Number|63|63.0||||||
4025048|NCT01163292|3846570|B2|Yes||Concomitant Glucocorticoid Use||participants|Number|30|30.0||||||
4025049|NCT01163292|3846571|B1|Yes||Concomitant Glucocorticoid Use||participants|Number|33|33.0||||||
4025050|NCT01163292|3846569|B3|No||Prior Disease Modifying Anti-Rheumatic Drug (except methotrexate)||participants|Number|111|111.0||||||
4025051|NCT01163292|3846570|B2|No||Prior Disease Modifying Anti-Rheumatic Drug (except methotrexate)||participants|Number|63|63.0||||||
4025052|NCT01163292|3846571|B1|No||Prior Disease Modifying Anti-Rheumatic Drug (except methotrexate)||participants|Number|48|48.0||||||
4025053|NCT01163292|3846569|B3|Yes||Prior Disease Modifying Anti-Rheumatic Drug (except methotrexate)||participants|Number|109|109.0||||||
4025054|NCT01163292|3846570|B2|Yes||Prior Disease Modifying Anti-Rheumatic Drug (except methotrexate)||participants|Number|51|51.0||||||
4025055|NCT01163292|3846571|B1|Yes||Prior Disease Modifying Anti-Rheumatic Drug (except methotrexate)||participants|Number|58|58.0||||||
4025056|NCT01163292|3846569|B3|||Rheumatoid arthritis duration||years|Mean|1.303|1.303|Standard Deviation|0.433|0.433|||
4025057|NCT01163292|3846570|B2|||Rheumatoid arthritis duration||years|Mean|1.316|1.316|Standard Deviation|0.438|0.438|||
4025058|NCT01163292|3846571|B1|||Rheumatoid arthritis duration||years|Mean|1.290|1.29|Standard Deviation|0.428|0.428|||
4025059|NCT01163292|3846569|B3|||Body weight||kg|Mean|56.53|56.53|Standard Deviation|10.16|10.16|||
4025060|NCT01163292|3846570|B2|||Body weight||kg|Mean|57.53|57.53|Standard Deviation|11.08|11.08|||
4025061|NCT01163292|3846571|B1|||Body weight||kg|Mean|55.46|55.46|Standard Deviation|8.99|8.99|||
4025062|NCT01163292|3846569|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4025063|NCT01163292|3846570|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4025064|NCT01163292|3846571|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4025065|NCT01163292|3846569|B3||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4025066|NCT01163292|3846570|B2||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4025067|NCT01163292|3846571|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4025068|NCT01163292|3846569|B3|||Age||years|Mean|55.3|55.3|Standard Deviation|12.6|12.6|||
4025069|NCT01163292|3846570|B2|||Age||years|Mean|54.7|54.7|Standard Deviation|12.3|12.3|||
4025070|NCT01163292|3846571|B1|||Age||years|Mean|56.0|56.0|Standard Deviation|13.0|13.0|||
4025071|NCT01163279|3846586|B3|Canada||Region of Enrollment||participants|Number|19|19.0||||||
4025072|NCT01163279|3846587|B2|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4025073|NCT01163279|3846588|B1|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4025074|NCT01163279|3846586|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4025075|NCT01163279|3846587|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4025076|NCT01163279|3846588|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4025077|NCT01163279|3846586|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4025078|NCT01163279|3846587|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4025079|NCT01163279|3846588|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4025080|NCT01163279|3846586|B3|||Age||years|Mean|73.94|73.94|Standard Deviation|7.18|7.18|||
4025081|NCT01163279|3846587|B2|||Age||years|Mean|73.67|73.67|Standard Deviation|5.43|5.43|||
4025082|NCT01163279|3846588|B1|||Age||years|Mean|74.10|74.1|Standard Deviation|8.77|8.77|||
4025083|NCT01163279|3846586|B3||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4025084|NCT01163279|3846587|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4025085|NCT01163279|3846588|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4025086|NCT01163279|3846586|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4025087|NCT01163279|3846587|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4025088|NCT01163279|3846588|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4025089|NCT01163279|3846586|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4025090|NCT01163279|3846587|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4025091|NCT01163279|3846588|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4025092|NCT01163266|3846615|B4|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|scores on a scale|Mean|4.5|4.5|Standard Deviation|0.55|0.55|||
4025093|NCT01163266|3846616|B3|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|scores on a scale|Mean|4.5|4.5|Standard Deviation|0.54|0.54|||
4025094|NCT01163266|3846617|B2|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|scores on a scale|Mean|4.5|4.5|Standard Deviation|0.55|0.55|||
4025095|NCT01163266|3846618|B1|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|scores on a scale|Mean|4.5|4.5|Standard Deviation|0.55|0.55|||
4025096|NCT01163266|3846615|B4|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 (absent) to 56 (maximum severity).|scores on a scale|Mean|18.4|18.4|Standard Deviation|5.44|5.44|||
4025097|NCT01163266|3846616|B3|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 (absent) to 56 (maximum severity).|scores on a scale|Mean|18.9|18.9|Standard Deviation|5.64|5.64|||
4025098|NCT01163266|3846617|B2|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 (absent) to 56 (maximum severity).|scores on a scale|Mean|18.5|18.5|Standard Deviation|5.25|5.25|||
4025099|NCT01163266|3846618|B1|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 (absent) to 56 (maximum severity).|scores on a scale|Mean|17.8|17.8|Standard Deviation|5.41|5.41|||
4025100|NCT01163266|3846615|B4|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|32.2|32.2|Standard Deviation|4.27|4.27|||
4025101|NCT01163266|3846616|B3|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|32.4|32.4|Standard Deviation|4.30|4.3|||
4025102|NCT01163266|3846617|B2|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|32.3|32.3|Standard Deviation|4.52|4.52|||
4025103|NCT01163266|3846618|B1|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|32.0|32.0|Standard Deviation|3.99|3.99|||
4025104|NCT01163266|3846615|B4|Daily||Alcohol Consumption||participants|Number|6|6.0||||||
4025105|NCT01163266|3846616|B3|Daily||Alcohol Consumption||participants|Number|0|0.0||||||
4025106|NCT01163266|3846617|B2|Daily||Alcohol Consumption||participants|Number|3|3.0||||||
4025107|NCT01163266|3846618|B1|Daily||Alcohol Consumption||participants|Number|3|3.0||||||
4025108|NCT01163266|3846615|B4|2-to-6 times per week||Alcohol Consumption||participants|Number|50|50.0||||||
4025109|NCT01163266|3846616|B3|2-to-6 times per week||Alcohol Consumption||participants|Number|14|14.0||||||
4025110|NCT01163266|3846617|B2|2-to-6 times per week||Alcohol Consumption||participants|Number|21|21.0||||||
4025111|NCT01163266|3846618|B1|2-to-6 times per week||Alcohol Consumption||participants|Number|15|15.0||||||
4025112|NCT01163266|3846615|B4|Once per week||Alcohol Consumption||participants|Number|62|62.0||||||
4025113|NCT01163266|3846616|B3|Once per week||Alcohol Consumption||participants|Number|19|19.0||||||
4025114|NCT01163266|3846617|B2|Once per week||Alcohol Consumption||participants|Number|21|21.0||||||
4025115|NCT01163266|3846618|B1|Once per week||Alcohol Consumption||participants|Number|22|22.0||||||
4025116|NCT01163266|3846615|B4|Once monthly or less often||Alcohol Consumption||participants|Number|175|175.0||||||
4025117|NCT01163266|3846616|B3|Once monthly or less often||Alcohol Consumption||participants|Number|65|65.0||||||
4025118|NCT01163266|3846617|B2|Once monthly or less often||Alcohol Consumption||participants|Number|47|47.0||||||
4025119|NCT01163266|3846618|B1|Once monthly or less often||Alcohol Consumption||participants|Number|63|63.0||||||
4025120|NCT01163266|3846615|B4|Never||Alcohol Consumption||participants|Number|169|169.0||||||
4025121|NCT01163266|3846616|B3|Never||Alcohol Consumption||participants|Number|52|52.0||||||
4025122|NCT01163266|3846617|B2|Never||Alcohol Consumption||participants|Number|63|63.0||||||
4025123|NCT01163266|3846618|B1|Never||Alcohol Consumption||participants|Number|54|54.0||||||
4025124|NCT01163266|3846615|B4|Ex-smoker||Smoking Classification||participants|Number|95|95.0||||||
4025125|NCT01163266|3846616|B3|Ex-smoker||Smoking Classification||participants|Number|28|28.0||||||
4025126|NCT01163266|3846617|B2|Ex-smoker||Smoking Classification||participants|Number|27|27.0||||||
4025127|NCT01163266|3846618|B1|Ex-smoker||Smoking Classification||participants|Number|40|40.0||||||
4025128|NCT01163266|3846615|B4|Current smoker||Smoking Classification||participants|Number|143|143.0||||||
4025129|NCT01163266|3846616|B3|Current smoker||Smoking Classification||participants|Number|45|45.0||||||
4025130|NCT01163266|3846617|B2|Current smoker||Smoking Classification||participants|Number|46|46.0||||||
4025131|NCT01163266|3846618|B1|Current smoker||Smoking Classification||participants|Number|52|52.0||||||
4025132|NCT01163266|3846615|B4|Never smoked||Smoking Classification||participants|Number|224|224.0||||||
4025133|NCT01163266|3846616|B3|Never smoked||Smoking Classification||participants|Number|77|77.0||||||
4025134|NCT01163266|3846617|B2|Never smoked||Smoking Classification||participants|Number|82|82.0||||||
4025135|NCT01163266|3846618|B1|Never smoked||Smoking Classification||participants|Number|65|65.0||||||
4025136|NCT01163266|3846615|B4|||Waist Circumference||cm|Mean|98.93|98.93|Standard Deviation|17.426|17.426|||
4025137|NCT01163266|3846616|B3|||Waist Circumference||cm|Mean|96.76|96.76|Standard Deviation|16.434|16.434|||
4025138|NCT01163266|3846617|B2|||Waist Circumference||cm|Mean|99.76|99.76|Standard Deviation|16.996|16.996|||
4025139|NCT01163266|3846618|B1|||Waist Circumference||cm|Mean|100.20|100.2|Standard Deviation|18.640|18.64|||
4025140|NCT01163266|3846615|B4|||Body Mass Index (BMI)||kg/m^2|Mean|31.36|31.36|Standard Deviation|7.622|7.622|||
4025141|NCT01163266|3846616|B3|||Body Mass Index (BMI)||kg/m^2|Mean|30.84|30.84|Standard Deviation|7.836|7.836|||
4025142|NCT01163266|3846617|B2|||Body Mass Index (BMI)||kg/m^2|Mean|31.92|31.92|Standard Deviation|7.779|7.779|||
4025143|NCT01163266|3846618|B1|||Body Mass Index (BMI)||kg/m^2|Mean|31.31|31.31|Standard Deviation|7.262|7.262|||
4025144|NCT01163266|3846615|B4|||Weight||kg|Mean|88.13|88.13|Standard Deviation|23.277|23.277|||
4025145|NCT01163266|3846616|B3|||Weight||kg|Mean|87.08|87.08|Standard Deviation|23.582|23.582|||
4025146|NCT01163266|3846617|B2|||Weight||kg|Mean|89.00|89.0|Standard Deviation|23.076|23.076|||
4025147|NCT01163266|3846618|B1|||Weight||kg|Mean|88.28|88.28|Standard Deviation|23.290|23.29|||
4025148|NCT01163266|3846615|B4|||Height||cm|Mean|167.41|167.41|Standard Deviation|9.210|9.21|||
4025149|NCT01163266|3846616|B3|||Height||cm|Mean|167.92|167.92|Standard Deviation|9.194|9.194|||
4025150|NCT01163266|3846617|B2|||Height||cm|Mean|166.86|166.86|Standard Deviation|9.199|9.199|||
4025151|NCT01163266|3846618|B1|||Height||cm|Mean|167.46|167.46|Standard Deviation|9.265|9.265|||
4025152|NCT01163266|3846615|B4|United States||Region of Enrollment||participants|Number|462|462.0||||||
4025153|NCT01163266|3846616|B3|United States||Region of Enrollment||participants|Number|150|150.0||||||
4025154|NCT01163266|3846617|B2|United States||Region of Enrollment||participants|Number|155|155.0||||||
4025155|NCT01163266|3846618|B1|United States||Region of Enrollment||participants|Number|157|157.0||||||
4025156|NCT01163266|3846615|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4025157|NCT01163266|3846616|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4025158|NCT01163266|3846617|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4025159|NCT01163266|3846618|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4025160|NCT01163266|3846615|B4|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4025161|NCT01163266|3846616|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4025162|NCT01163266|3846617|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4025163|NCT01163266|3846618|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4025164|NCT01163266|3846615|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4025165|NCT01163266|3846616|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4025166|NCT01163266|3846617|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4025167|NCT01163266|3846618|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4025168|NCT01163266|3846615|B4|Black||Race/Ethnicity, Customized||participants|Number|129|129.0||||||
4025169|NCT01163266|3846616|B3|Black||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4025170|NCT01163266|3846617|B2|Black||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4025171|NCT01163266|3846618|B1|Black||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4025172|NCT01163266|3846615|B4|Caucasian (White, including Hispanic)||Race/Ethnicity, Customized||participants|Number|323|323.0||||||
4025173|NCT01163266|3846616|B3|Caucasian (White, including Hispanic)||Race/Ethnicity, Customized||participants|Number|97|97.0||||||
4025174|NCT01163266|3846617|B2|Caucasian (White, including Hispanic)||Race/Ethnicity, Customized||participants|Number|106|106.0||||||
4025175|NCT01163266|3846618|B1|Caucasian (White, including Hispanic)||Race/Ethnicity, Customized||participants|Number|120|120.0||||||
4025176|NCT01163266|3846615|B4|Non-Hispanic and non-Latino||Race/Ethnicity, Customized||participants|Number|425|425.0||||||
4025177|NCT01163266|3846616|B3|Non-Hispanic and non-Latino||Race/Ethnicity, Customized||participants|Number|140|140.0||||||
4025178|NCT01163266|3846617|B2|Non-Hispanic and non-Latino||Race/Ethnicity, Customized||participants|Number|145|145.0||||||
4025179|NCT01163266|3846618|B1|Non-Hispanic and non-Latino||Race/Ethnicity, Customized||participants|Number|140|140.0||||||
4025180|NCT01163266|3846615|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4025181|NCT01163266|3846616|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4025182|NCT01163266|3846617|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4025183|NCT01163266|3846618|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4025184|NCT01163266|3846615|B4||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4025185|NCT01163266|3846616|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4025186|NCT01163266|3846617|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4025187|NCT01163266|3846618|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4025188|NCT01163266|3846615|B4||Female|Sex: Female, Male||Participants|Count of Participants|335|335.0||||||
4025189|NCT01163266|3846616|B3||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4025190|NCT01163266|3846617|B2||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4025191|NCT01163266|3846618|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4025192|NCT01163266|3846615|B4|>55 years||Age, Customized||participants|Number|75|75.0||||||
4025193|NCT01163266|3846616|B3|>55 years||Age, Customized||participants|Number|26|26.0||||||
4025194|NCT01163266|3846617|B2|>55 years||Age, Customized||participants|Number|22|22.0||||||
4025195|NCT01163266|3846618|B1|>55 years||Age, Customized||participants|Number|27|27.0||||||
4025196|NCT01163266|3846615|B4|≤55 years||Age, Customized||participants|Number|387|387.0||||||
4025197|NCT01163266|3846616|B3|≤55 years||Age, Customized||participants|Number|124|124.0||||||
4025198|NCT01163266|3846617|B2|≤55 years||Age, Customized||participants|Number|133|133.0||||||
4025199|NCT01163266|3846618|B1|≤55 years||Age, Customized||participants|Number|130|130.0||||||
4025200|NCT01163266|3846615|B4|||Age||years|Mean|42.8|42.8|Standard Deviation|12.23|12.23|||
4025201|NCT01163266|3846616|B3|||Age||years|Mean|43.1|43.1|Standard Deviation|13.09|13.09|||
4025202|NCT01163266|3846617|B2|||Age||years|Mean|43.1|43.1|Standard Deviation|12.04|12.04|||
4025203|NCT01163266|3846618|B1|||Age||years|Mean|42.3|42.3|Standard Deviation|11.61|11.61|||
4025204|NCT01163253|3846643|B3||Male|Sex: Female, Male||Participants|Count of Participants|2024|2024.0||||||
4025205|NCT01163253|3846644|B2||Male|Sex: Female, Male||Participants|Count of Participants|383|383.0||||||
4025206|NCT01163253|3846645|B1||Male|Sex: Female, Male||Participants|Count of Participants|1641|1641.0||||||
4025207|NCT01163253|3846643|B3||Female|Sex: Female, Male||Participants|Count of Participants|843|843.0||||||
4025208|NCT01163253|3846644|B2||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4025209|NCT01163253|3846645|B1||Female|Sex: Female, Male||Participants|Count of Participants|640|640.0||||||
4025210|NCT01163253|3846643|B3|||Age||years|Mean|45.6|45.6|Standard Deviation|12.6|12.6|||
4025211|NCT01163253|3846644|B2|||Age||years|Mean|47.0|47.0|Standard Deviation|13.0|13.0|||
4025212|NCT01163253|3846645|B1|||Age||years|Mean|45.3|45.3|Standard Deviation|12.5|12.5|||
4025213|NCT01163214|3846806|B3|United States||Region of Enrollment||participants|Number|160|160.0||||||
4025214|NCT01163214|3846807|B2|United States||Region of Enrollment||participants|Number|81|81.0||||||
4025215|NCT01163214|3846808|B1|United States||Region of Enrollment||participants|Number|79|79.0||||||
4025216|NCT01163214|3846806|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4025217|NCT01163214|3846807|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4025218|NCT01163214|3846808|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4025219|NCT01163214|3846806|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4025220|NCT01163214|3846807|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4025221|NCT01163214|3846808|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4025222|NCT01163214|3846806|B3|||Age||years|Mean|67.7|67.7|Standard Deviation|7.6|7.6|||
4025223|NCT01163214|3846807|B2|||Age||years|Mean|67.7|67.7|Standard Deviation|7.2|7.2|||
4025224|NCT01163214|3846808|B1|||Age||years|Mean|67.8|67.8|Standard Deviation|7.9|7.9|||
4025225|NCT01163162|3846825|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4025226|NCT01163162|3846825|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4025227|NCT01163162|3846825|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4025228|NCT01163162|3846825|B1|||Age||years|Mean|69.6|69.6|Standard Deviation|9.8|9.8|||
4025229|NCT01163149|3846831|B4||Adult (≥ 18 years)|Hypophosphatasia (HPP) Phenotype||Participants|Count of Participants|1|1.0||||||
4025230|NCT01163149|3846832|B3||Adult (≥ 18 years)|Hypophosphatasia (HPP) Phenotype||Participants|Count of Participants|0|0.0||||||
4025231|NCT01163149|3846833|B2||Adult (≥ 18 years)|Hypophosphatasia (HPP) Phenotype||Participants|Count of Participants|0|0.0||||||
4025232|NCT01163149|3846834|B1||Adult (≥ 18 years)|Hypophosphatasia (HPP) Phenotype||Participants|Count of Participants|1|1.0||||||
4025233|NCT01163149|3846831|B4||Juvenile (≥ 6 months to < 18 years)|Hypophosphatasia (HPP) Phenotype||Participants|Count of Participants|14|14.0||||||
4025234|NCT01163149|3846832|B3||Juvenile (≥ 6 months to < 18 years)|Hypophosphatasia (HPP) Phenotype||Participants|Count of Participants|5|5.0||||||
4025235|NCT01163149|3846833|B2||Juvenile (≥ 6 months to < 18 years)|Hypophosphatasia (HPP) Phenotype||Participants|Count of Participants|4|4.0||||||
4025236|NCT01163149|3846834|B1||Juvenile (≥ 6 months to < 18 years)|Hypophosphatasia (HPP) Phenotype||Participants|Count of Participants|5|5.0||||||
4025237|NCT01163149|3846831|B4||Infantile (<6 months)|Hypophosphatasia (HPP) Phenotype||Participants|Count of Participants|4|4.0||||||
4025238|NCT01163149|3846832|B3||Infantile (<6 months)|Hypophosphatasia (HPP) Phenotype||Participants|Count of Participants|1|1.0||||||
4025239|NCT01163149|3846833|B2||Infantile (<6 months)|Hypophosphatasia (HPP) Phenotype||Participants|Count of Participants|2|2.0||||||
4025240|NCT01163149|3846834|B1||Infantile (<6 months)|Hypophosphatasia (HPP) Phenotype||Participants|Count of Participants|1|1.0||||||
4025241|NCT01163149|3846831|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4025242|NCT01163149|3846832|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4025243|NCT01163149|3846833|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025244|NCT01163149|3846834|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025245|NCT01163149|3846831|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025246|NCT01163149|3846832|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025247|NCT01163149|3846833|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025248|NCT01163149|3846834|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025249|NCT01163149|3846831|B4||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4025250|NCT01163149|3846832|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4025251|NCT01163149|3846833|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4025252|NCT01163149|3846834|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4025253|NCT01163149|3846831|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025254|NCT01163149|3846832|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025255|NCT01163149|3846833|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025256|NCT01163149|3846834|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025257|NCT01163149|3846831|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025258|NCT01163149|3846832|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025259|NCT01163149|3846833|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025260|NCT01163149|3846834|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025261|NCT01163149|3846831|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025262|NCT01163149|3846832|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025263|NCT01163149|3846833|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025264|NCT01163149|3846834|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025265|NCT01163149|3846831|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025266|NCT01163149|3846832|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025267|NCT01163149|3846833|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025268|NCT01163149|3846834|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025269|NCT01163149|3846831|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025270|NCT01163149|3846832|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025271|NCT01163149|3846833|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025272|NCT01163149|3846834|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025273|NCT01163149|3846831|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4025274|NCT01163149|3846832|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4025275|NCT01163149|3846833|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4025276|NCT01163149|3846834|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4025277|NCT01163149|3846831|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025278|NCT01163149|3846832|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025279|NCT01163149|3846833|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025280|NCT01163149|3846834|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025281|NCT01163149|3846831|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4025282|NCT01163149|3846832|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4025283|NCT01163149|3846833|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4025284|NCT01163149|3846834|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4025285|NCT01163149|3846831|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4025286|NCT01163149|3846832|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4025287|NCT01163149|3846833|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4025288|NCT01163149|3846834|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4025289|NCT01163149|3846831|B4|Age Group|Adult (≥ 18 years)|Age, Customized||Participants|Count of Participants|13|13.0||||||
4025290|NCT01163149|3846832|B3|Age Group|Adult (≥ 18 years)|Age, Customized||Participants|Count of Participants|3|3.0||||||
4025291|NCT01163149|3846833|B2|Age Group|Adult (≥ 18 years)|Age, Customized||Participants|Count of Participants|5|5.0||||||
4025292|NCT01163149|3846834|B1|Age Group|Adult (≥ 18 years)|Age, Customized||Participants|Count of Participants|5|5.0||||||
4025293|NCT01163149|3846831|B4|Age Group|Adolescent (12-17 years)|Age, Customized||Participants|Count of Participants|6|6.0||||||
4025294|NCT01163149|3846832|B3|Age Group|Adolescent (12-17 years)|Age, Customized||Participants|Count of Participants|3|3.0||||||
4025295|NCT01163149|3846833|B2|Age Group|Adolescent (12-17 years)|Age, Customized||Participants|Count of Participants|1|1.0||||||
4025296|NCT01163149|3846834|B1|Age Group|Adolescent (12-17 years)|Age, Customized||Participants|Count of Participants|2|2.0||||||
4025297|NCT01163149|3846831|B4|Age at Onset of Symptoms||Age, Customized||years|Median|2.0|2.0|Full Range|||0.0|36.0|
4025298|NCT01163149|3846832|B3|Age at Onset of Symptoms||Age, Customized||years|Median|0.88|0.88|Full Range|||0.2|4.0|
4025299|NCT01163149|3846833|B2|Age at Onset of Symptoms||Age, Customized||years|Median|2.0|2.0|Full Range|||0.0|3.0|
4025300|NCT01163149|3846834|B1|Age at Onset of Symptoms||Age, Customized||years|Median|2.0|2.0|Full Range|||0.2|36.0|
4025301|NCT01163149|3846831|B4|||Age||years|Median|53.0|53.0|Full Range|||13.0|66.0|
4025302|NCT01163149|3846832|B3|||Age||years|Median|21.0|21.0|Full Range|||13.0|58.0|
4025303|NCT01163149|3846833|B2|||Age||years|Median|55.0|55.0|Full Range|||15.0|57.0|
4025304|NCT01163149|3846834|B1|||Age||years|Median|45.0|45.0|Full Range|||14.0|66.0|
4025305|NCT01163097|3846878|B4|||Body Mass Index||kg/m2|Mean|25.62|25.62|Standard Deviation|2.5|2.5|||
4025306|NCT01163097|3846879|B3|||Body Mass Index||kg/m2|Mean|25.98|25.98|Standard Deviation|3.185|3.185|||
4025307|NCT01163097|3846880|B2|||Body Mass Index||kg/m2|Mean|26.08|26.08|Standard Deviation|2.111|2.111|||
4025308|NCT01163097|3846881|B1|||Body Mass Index||kg/m2|Mean|24.95|24.95|Standard Deviation|2.144|2.144|||
4025309|NCT01163097|3846878|B4|United States||Region of Enrollment||participants|Number|39|39.0||||||
4025310|NCT01163097|3846879|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4025311|NCT01163097|3846880|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4025312|NCT01163097|3846881|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4025313|NCT01163097|3846878|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025314|NCT01163097|3846879|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025315|NCT01163097|3846880|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025316|NCT01163097|3846881|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025317|NCT01163097|3846878|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025318|NCT01163097|3846879|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025319|NCT01163097|3846880|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025320|NCT01163097|3846881|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025321|NCT01163097|3846878|B4||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4025322|NCT01163097|3846879|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4025323|NCT01163097|3846880|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4025324|NCT01163097|3846881|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4025325|NCT01163097|3846878|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4025326|NCT01163097|3846879|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4025327|NCT01163097|3846880|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4025328|NCT01163097|3846881|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4025329|NCT01163097|3846878|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025330|NCT01163097|3846879|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025331|NCT01163097|3846880|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025332|NCT01163097|3846881|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025333|NCT01163097|3846878|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025334|NCT01163097|3846879|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025335|NCT01163097|3846880|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025336|NCT01163097|3846881|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025337|NCT01163097|3846878|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025338|NCT01163097|3846879|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025339|NCT01163097|3846880|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025340|NCT01163097|3846881|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025341|NCT01163097|3846878|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025342|NCT01163097|3846879|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025343|NCT01163097|3846880|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025344|NCT01163097|3846881|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025345|NCT01163097|3846878|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4025346|NCT01163097|3846879|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4025347|NCT01163097|3846880|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4025348|NCT01163097|3846881|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4025349|NCT01163097|3846878|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4025350|NCT01163097|3846879|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025351|NCT01163097|3846880|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025352|NCT01163097|3846881|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4025353|NCT01163097|3846878|B4||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4025354|NCT01163097|3846879|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4025355|NCT01163097|3846880|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4025356|NCT01163097|3846881|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4025357|NCT01163097|3846878|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4025358|NCT01163097|3846879|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4025359|NCT01163097|3846880|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4025360|NCT01163097|3846881|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4025361|NCT01163097|3846878|B4|||Age||years|Mean|28.1|28.1|Standard Deviation|7|7.0|||
4025362|NCT01163097|3846879|B3|||Age||years|Mean|22.8|22.8|Standard Deviation|3.62|3.62|||
4025363|NCT01163097|3846880|B2|||Age||years|Mean|32.9|32.9|Standard Deviation|7.82|7.82|||
4025364|NCT01163097|3846881|B1|||Age||years|Mean|25.9|25.9|Standard Deviation|5.29|5.29|||
4025365|NCT01163097|3846878|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4025366|NCT01163097|3846879|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4025367|NCT01163097|3846880|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4025368|NCT01163097|3846881|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4025369|NCT01163097|3846878|B4||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4025370|NCT01163097|3846879|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4025371|NCT01163097|3846880|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4025372|NCT01163097|3846881|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4025373|NCT01163097|3846878|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4025374|NCT01163097|3846879|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4025375|NCT01163097|3846880|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4025376|NCT01163097|3846881|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4025377|NCT01163032|3846933|B4||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4025378|NCT01163032|3846934|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4025379|NCT01163032|3846935|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4025380|NCT01163032|3846936|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4025381|NCT01163032|3846933|B4||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4025382|NCT01163032|3846934|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4025383|NCT01163032|3846935|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4025384|NCT01163032|3846936|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4025385|NCT01163032|3846933|B4|Rand to OLE (Male)||Sex/Gender, Customized|N = 2 (tasimelteon randomized then went to OLE) and 1 (placebo randomized then went to OLE)|participants|Number|3|3.0||||||
4025386|NCT01163032|3846934|B3|Rand to OLE (Male)||Sex/Gender, Customized|N = 2 (tasimelteon randomized then went to OLE) and 1 (placebo randomized then went to OLE)|participants|Number|0|0.0||||||
4025387|NCT01163032|3846935|B2|Rand to OLE (Male)||Sex/Gender, Customized|N = 2 (tasimelteon randomized then went to OLE) and 1 (placebo randomized then went to OLE)|participants|Number|1|1.0||||||
4025388|NCT01163032|3846936|B1|Rand to OLE (Male)||Sex/Gender, Customized|N = 2 (tasimelteon randomized then went to OLE) and 1 (placebo randomized then went to OLE)|participants|Number|2|2.0||||||
4025389|NCT01163032|3846933|B4|Rand to OLE (Female)||Sex/Gender, Customized|N = 2 (tasimelteon randomized then went to OLE) and 1 (placebo randomized then went to OLE)|participants|Number|0|0.0||||||
4025390|NCT01163032|3846934|B3|Rand to OLE (Female)||Sex/Gender, Customized|N = 2 (tasimelteon randomized then went to OLE) and 1 (placebo randomized then went to OLE)|participants|Number|0|0.0||||||
4025391|NCT01163032|3846935|B2|Rand to OLE (Female)||Sex/Gender, Customized|N = 2 (tasimelteon randomized then went to OLE) and 1 (placebo randomized then went to OLE)|participants|Number|0|0.0||||||
4025392|NCT01163032|3846936|B1|Rand to OLE (Female)||Sex/Gender, Customized|N = 2 (tasimelteon randomized then went to OLE) and 1 (placebo randomized then went to OLE)|participants|Number|0|0.0||||||
4025393|NCT01163032|3846933|B4|Rand to OLE||Age, Customized|N = 2 (tasimelteon randomized then went to OLE) and 1 (placebo randomized then went to OLE)|years|Mean|46.00|46.0|Standard Deviation|8.00|8.0|||
4025394|NCT01163032|3846934|B3|Rand to OLE||Age, Customized|N = 2 (tasimelteon randomized then went to OLE) and 1 (placebo randomized then went to OLE)|years|Mean|NA||Standard Deviation|NA||||
4025395|NCT01163032|3846935|B2|Rand to OLE||Age, Customized|N = 2 (tasimelteon randomized then went to OLE) and 1 (placebo randomized then went to OLE)|years|Mean|54.00|54.0|Standard Deviation|NA||||N = 1; Cannot be calculated
4025396|NCT01163032|3846936|B1|Rand to OLE||Age, Customized|N = 2 (tasimelteon randomized then went to OLE) and 1 (placebo randomized then went to OLE)|years|Mean|42.00|42.0|Standard Deviation|5.66|5.66|||
4025397|NCT01163032|3846933|B4|||Age||years|Mean|50.6|50.6|Standard Deviation|12.91|12.91|||
4025398|NCT01163032|3846934|B3|||Age||years|Mean|50.37|50.37|Standard Deviation|13.17|13.17|||
4025399|NCT01163032|3846935|B2|||Age||years|Mean|50.7|50.7|Standard Deviation|13.15|13.15|||
4025400|NCT01163032|3846936|B1|||Age||years|Mean|50.8|50.8|Standard Deviation|12.63|12.63|||
4025401|NCT01162863|3846968|B4|||Baseline Colon Motility Index|natural log [(sum of pressure amplitudes times the number of contractions) + 1]|units on a scale|Mean|16.43|16.43|Standard Deviation|1.83|1.83|||
4025402|NCT01162863|3846969|B3|||Baseline Colon Motility Index|natural log [(sum of pressure amplitudes times the number of contractions) + 1]|units on a scale|Mean|16.17|16.17|Standard Deviation|1.79|1.79|||
4025403|NCT01162863|3846970|B2|||Baseline Colon Motility Index|natural log [(sum of pressure amplitudes times the number of contractions) + 1]|units on a scale|Mean|16.9|16.9|Standard Deviation|2.14|2.14|||
4025404|NCT01162863|3846971|B1|||Baseline Colon Motility Index|natural log [(sum of pressure amplitudes times the number of contractions) + 1]|units on a scale|Mean|16.26|16.26|Standard Deviation|1.57|1.57|||
4025405|NCT01162863|3846968|B4|||Baseline Small Bowel Motility Index|natural log [(sum of pressure amplitudes times the number of contractions) + 1] , resulting in a sort of units on a naturally derived scale|units on a scale|Mean|12.86|12.86|Standard Deviation|1.93|1.93|||
4025406|NCT01162863|3846969|B3|||Baseline Small Bowel Motility Index|natural log [(sum of pressure amplitudes times the number of contractions) + 1] , resulting in a sort of units on a naturally derived scale|units on a scale|Mean|12.65|12.65|Standard Deviation|2.26|2.26|||
4025407|NCT01162863|3846970|B2|||Baseline Small Bowel Motility Index|natural log [(sum of pressure amplitudes times the number of contractions) + 1] , resulting in a sort of units on a naturally derived scale|units on a scale|Mean|12.80|12.8|Standard Deviation|1.86|1.86|||
4025408|NCT01162863|3846971|B1|||Baseline Small Bowel Motility Index|natural log [(sum of pressure amplitudes times the number of contractions) + 1] , resulting in a sort of units on a naturally derived scale|units on a scale|Mean|13.14|13.14|Standard Deviation|1.66|1.66|||
4025409|NCT01162863|3846968|B4|||Baseline Colon pH||units on pH scale|Mean|6.50|6.5|Standard Deviation|0.51|0.51|||
4025410|NCT01162863|3846969|B3|||Baseline Colon pH||units on pH scale|Mean|6.47|6.47|Standard Deviation|0.48|0.48|||
4025411|NCT01162863|3846970|B2|||Baseline Colon pH||units on pH scale|Mean|6.75|6.75|Standard Deviation|0.34|0.34|||
4025412|NCT01162863|3846971|B1|||Baseline Colon pH||units on pH scale|Mean|6.56|6.56|Standard Deviation|0.55|0.55|||
4025413|NCT01162863|3846968|B4|||Baseline Small Bowel pH||units on pH scale|Mean|6.78|6.78|Standard Deviation|0.33|0.33|||
4025414|NCT01162863|3846969|B3|||Baseline Small Bowel pH||units on pH scale|Mean|6.77|6.77|Standard Deviation|0.39|0.39|||
4025415|NCT01162863|3846970|B2|||Baseline Small Bowel pH||units on pH scale|Mean|6.75|6.75|Standard Deviation|0.34|0.34|||
4025416|NCT01162863|3846971|B1|||Baseline Small Bowel pH||units on pH scale|Mean|6.82|6.82|Standard Deviation|0.28|0.28|||
4025417|NCT01162863|3846968|B4|||Baseline Whole Gut Transit Time||hours|Mean|47.0|47.0|Standard Deviation|24.97|24.97|||
4025418|NCT01162863|3846969|B3|||Baseline Whole Gut Transit Time||hours|Mean|47.0|47.0|Standard Deviation|30.0|30.0|||
4025419|NCT01162863|3846970|B2|||Baseline Whole Gut Transit Time||hours|Mean|51.81|51.81|Standard Deviation|26.78|26.78|||
4025420|NCT01162863|3846971|B1|||Baseline Whole Gut Transit Time||hours|Mean|41.47|41.47|Standard Deviation|16.26|16.26|||
4025421|NCT01162863|3846968|B4|||Baseline Colon Transit Time||hours|Mean|38.15|38.15|Standard Deviation|25.31|25.31|||
4025422|NCT01162863|3846969|B3|||Baseline Colon Transit Time||hours|Mean|37.12|37.12|Standard Deviation|30.04|30.04|||
4025423|NCT01162863|3846970|B2|||Baseline Colon Transit Time||hours|Mean|44.61|44.61|Standard Deviation|27.18|27.18|||
4025424|NCT01162863|3846971|B1|||Baseline Colon Transit Time||hours|Mean|32.18|32.18|Standard Deviation|16.46|16.46|||
4025425|NCT01162863|3846968|B4|||Baseline Small Bowel Transit time||hours|Mean|4.63|4.63|Standard Deviation|1.75|1.75|||
4025426|NCT01162863|3846969|B3|||Baseline Small Bowel Transit time||hours|Mean|4.81|4.81|Standard Deviation|2.13|2.13|||
4025427|NCT01162863|3846970|B2|||Baseline Small Bowel Transit time||hours|Mean|4.01|4.01|Standard Deviation|1.02|1.02|||
4025428|NCT01162863|3846971|B1|||Baseline Small Bowel Transit time||hours|Mean|4.84|4.84|Standard Deviation|1.69|1.69|||
4025429|NCT01162863|3846968|B4|||Baseline gastric emptying time||hours|Mean|4.01|4.01|Standard Deviation|3.74|3.74|||
4025430|NCT01162863|3846969|B3|||Baseline gastric emptying time||hours|Mean|4.67|4.67|Standard Deviation|3.47|3.47|||
4025431|NCT01162863|3846970|B2|||Baseline gastric emptying time||hours|Mean|3.18|3.18|Standard Deviation|0.95|0.95|||
4025432|NCT01162863|3846971|B1|||Baseline gastric emptying time||hours|Mean|4.25|4.25|Standard Deviation|5.52|5.52|||
4025433|NCT01162863|3846968|B4|United States||Region of Enrollment||participants|Number|50|50.0||||||
4025434|NCT01162863|3846969|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4025435|NCT01162863|3846970|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4025436|NCT01162863|3846971|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4025437|NCT01162863|3846968|B4||Male|Gender||Participants|Count of Participants|6|6.0||||||
4025438|NCT01162863|3846969|B3||Male|Gender||Participants|Count of Participants|4|4.0||||||
4025439|NCT01162863|3846970|B2||Male|Gender||Participants|Count of Participants|1|1.0||||||
4025440|NCT01162863|3846971|B1||Male|Gender||Participants|Count of Participants|1|1.0||||||
4025441|NCT01162863|3846968|B4||Female|Gender||Participants|Count of Participants|44|44.0||||||
4025442|NCT01162863|3846969|B3||Female|Gender||Participants|Count of Participants|13|13.0||||||
4025443|NCT01162863|3846970|B2||Female|Gender||Participants|Count of Participants|15|15.0||||||
4025444|NCT01162863|3846971|B1||Female|Gender||Participants|Count of Participants|16|16.0||||||
4025445|NCT01162863|3846968|B4|mean age||Age, Customized||years|Mean|41.2|41.2|Standard Deviation|17.2|17.2|||
4025446|NCT01162863|3846969|B3|mean age||Age, Customized||years|Mean|37.2|37.2|Standard Deviation|15.8|15.8|||
4025447|NCT01162863|3846970|B2|mean age||Age, Customized||years|Mean|46.5|46.5|Standard Deviation|18.7|18.7|||
4025448|NCT01162863|3846971|B1|mean age||Age, Customized||years|Mean|39.9|39.9|Standard Deviation|16.1|16.1|||
4025449|NCT01162733|3846987|B3|United States||Region of Enrollment||participants|Number|99|99.0||||||
4025450|NCT01162733|3846988|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
4025451|NCT01162733|3846989|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
4025452|NCT01162733|3846987|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4025453|NCT01162733|3846988|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4025454|NCT01162733|3846989|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4025455|NCT01162733|3846987|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4025456|NCT01162733|3846988|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4025457|NCT01162733|3846989|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4025458|NCT01162733|3846987|B3|Greater than 18 years of age||Age, Customized||participants|Number|99|99.0||||||
4025459|NCT01162733|3846988|B2|Greater than 18 years of age||Age, Customized||participants|Number|50|50.0||||||
4025460|NCT01162733|3846989|B1|Greater than 18 years of age||Age, Customized||participants|Number|49|49.0||||||
4025461|NCT01162499|3846998|B1|Between 3-4 years||Age at Post-Prandial Hypoglycemia Diagnosis||participants|Number|3|3.0||||||
4025462|NCT01162499|3846998|B1|Between 2-3 years||Age at Post-Prandial Hypoglycemia Diagnosis||participants|Number|1|1.0||||||
4025463|NCT01162499|3846998|B1|Between 1-2 years||Age at Post-Prandial Hypoglycemia Diagnosis||participants|Number|1|1.0||||||
4025464|NCT01162499|3846998|B1|Less than 1 year||Age at Post-Prandial Hypoglycemia Diagnosis||participants|Number|1|1.0||||||
4025465|NCT01162499|3846998|B1|Frequent||Post-Prandial Hypoglycemia Treatment Frequency||participants|Number|3|3.0||||||
4025466|NCT01162499|3846998|B1|Intermittent||Post-Prandial Hypoglycemia Treatment Frequency||participants|Number|3|3.0||||||
4025467|NCT01162499|3846998|B1|Feeding||Post-Prandial Hypoglycemia Treatment|Subjects with feeding manipulations had feedings which were modified to decrease volume and slow the rate of delivery.|participants|Number|2|2.0||||||
4025468|NCT01162499|3846998|B1|Acarbose||Post-Prandial Hypoglycemia Treatment|Subjects with feeding manipulations had feedings which were modified to decrease volume and slow the rate of delivery.|participants|Number|4|4.0||||||
4025469|NCT01162499|3846998|B1|Gastrostomy Only||Feeding Regimen||participants|Number|1|1.0||||||
4025470|NCT01162499|3846998|B1|Both Oral & Gastrostomy||Feeding Regimen||participants|Number|3|3.0||||||
4025471|NCT01162499|3846998|B1|Oral Only||Feeding Regimen||participants|Number|2|2.0||||||
4025472|NCT01162499|3846998|B1|Gastric pull-through||Previous Surgery||participants|Number|1|1.0||||||
4025473|NCT01162499|3846998|B1|Nissen fundoplication||Previous Surgery||participants|Number|5|5.0||||||
4025474|NCT01162499|3846998|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4025475|NCT01162499|3846998|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025476|NCT01162499|3846998|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025477|NCT01162499|3846998|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4025478|NCT01162499|3846998|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025479|NCT01162499|3846998|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025480|NCT01162499|3846998|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025481|NCT01162499|3846998|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025482|NCT01162499|3846998|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4025483|NCT01162499|3846998|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4025484|NCT01162499|3846998|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4025485|NCT01162499|3846998|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4025486|NCT01162499|3846998|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4025487|NCT01162473|3847019|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4025488|NCT01162473|3847020|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4025489|NCT01162473|3847021|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4025490|NCT01162473|3847019|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4025491|NCT01162473|3847020|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4025492|NCT01162473|3847021|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4025493|NCT01162473|3847019|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4025494|NCT01162473|3847020|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4025495|NCT01162473|3847021|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4025496|NCT01162473|3847019|B3|||Age||years|Mean|8.68|8.68|Full Range|||6.0|13.0|
4025497|NCT01162473|3847020|B2|||Age||years|Mean|8.88|8.88|Full Range|||6.0|13.0|
4025498|NCT01162473|3847021|B1|||Age||years|Mean|8.25|8.25|Full Range|||6.0|12.0|
4025499|NCT01162473|3847019|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4025500|NCT01162473|3847020|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4025501|NCT01162473|3847021|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4025502|NCT01162473|3847019|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4025503|NCT01162473|3847020|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4025504|NCT01162473|3847021|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4025505|NCT01162473|3847019|B3||<=18 years|Age||Participants|Count of Participants|25|25.0||||||
4025506|NCT01162473|3847020|B2||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
4025507|NCT01162473|3847021|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4025508|NCT01162421|3847028|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4025509|NCT01162421|3847029|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4025510|NCT01162421|3847030|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4025511|NCT01162421|3847028|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4025512|NCT01162421|3847029|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4025513|NCT01162421|3847030|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4025514|NCT01162421|3847028|B3|>/= 65 years||Age, Customized||participants|Number|10|10.0||||||
4025515|NCT01162421|3847029|B2|>/= 65 years||Age, Customized||participants|Number|5|5.0||||||
4025516|NCT01162421|3847030|B1|>/= 65 years||Age, Customized||participants|Number|5|5.0||||||
4025517|NCT01162421|3847028|B3|< 65 years||Age, Customized||participants|Number|64|64.0||||||
4025518|NCT01162421|3847029|B2|< 65 years||Age, Customized||participants|Number|34|34.0||||||
4025519|NCT01162421|3847030|B1|< 65 years||Age, Customized||participants|Number|30|30.0||||||
4025520|NCT01162421|3847028|B3|||Age||years|Mean|52.8|52.8|Standard Deviation|11.01|11.01|||
4025521|NCT01162421|3847029|B2|||Age||years|Mean|51.9|51.9|Standard Deviation|11.55|11.55|||
4025522|NCT01162421|3847030|B1|||Age||years|Mean|53.8|53.8|Standard Deviation|10.46|10.46|||
4025523|NCT01162343|3847109|B1|||Admitted to the hospital||Participants|Count of Participants|294|294.0||||||
4025524|NCT01162343|3847109|B1|||Acute Physiology Score|Measured by APACHE II, a severity-of-disease classification system Higher values represent higher severity of illness (sicker). APACHE II score ranges from 0 to 71|points on a scale|Median|2|2.0|Inter-Quartile Range|||1.0|4.0|
4025525|NCT01162343|3847109|B1|||Charlson Comorbidity Index|Total range for the Charlson Comorbidity Index is 0 to 33. Higher values represent higher comorbidity burden.|points on a scale|Median|2|2.0|Inter-Quartile Range|||1.0|4.0|
4025526|NCT01162343|3847109|B1|||Dementia documented in medical record||Participants|Count of Participants|24|24.0||||||
4025527|NCT01162343|3847109|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|349|349.0||||||
4025528|NCT01162343|3847109|B1|Race|Non-white|Race/Ethnicity, Customized||Participants|Count of Participants|57|57.0||||||
4025529|NCT01162343|3847109|B1||Male|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4025530|NCT01162343|3847109|B1||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4025531|NCT01162343|3847109|B1|||Age||years|Median|73.5|73.5|Inter-Quartile Range|||69.0|80.0|
4025532|NCT01162317|3847113|B3|||Pittsburgh Sleep Quality Index (PSQI)|In scoring the PSQI, seven component scores are derived, each scored 0 (no difficulty) to 3 (severe difficulty). The component scores are summed to produce a global score (range 0 to 21). Higher scores indicate worse sleep quality. Only global PSQI scores were used for this study.|units on a scale|Mean|14.26|14.26|Standard Deviation|3.20|3.2|||
4025533|NCT01162317|3847114|B2|||Pittsburgh Sleep Quality Index (PSQI)|In scoring the PSQI, seven component scores are derived, each scored 0 (no difficulty) to 3 (severe difficulty). The component scores are summed to produce a global score (range 0 to 21). Higher scores indicate worse sleep quality. Only global PSQI scores were used for this study.|units on a scale|Mean|14.17|14.17|Standard Deviation|3.41|3.41|||
4025534|NCT01162317|3847115|B1|||Pittsburgh Sleep Quality Index (PSQI)|In scoring the PSQI, seven component scores are derived, each scored 0 (no difficulty) to 3 (severe difficulty). The component scores are summed to produce a global score (range 0 to 21). Higher scores indicate worse sleep quality. Only global PSQI scores were used for this study.|units on a scale|Mean|14.33|14.33|Standard Deviation|3.10|3.1|||
4025535|NCT01162317|3847113|B3|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
4025536|NCT01162317|3847114|B2|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4025537|NCT01162317|3847115|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4025538|NCT01162317|3847113|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4025539|NCT01162317|3847114|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4025540|NCT01162317|3847115|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4025541|NCT01162317|3847113|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4025542|NCT01162317|3847114|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4025543|NCT01162317|3847115|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4025544|NCT01162317|3847113|B3|||Age||years|Mean|39.8|39.8|Standard Deviation|10|10.0|||
4025545|NCT01162317|3847114|B2|||Age||years|Mean|39.6|39.6|Standard Deviation|9.7|9.7|||
4025546|NCT01162317|3847115|B1|||Age||years|Mean|40|40.0|Standard Deviation|10.3|10.3|||
4025547|NCT01162317|3847113|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4025548|NCT01162317|3847114|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4025549|NCT01162317|3847115|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4025550|NCT01162317|3847113|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4025551|NCT01162317|3847114|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4025552|NCT01162317|3847115|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4025553|NCT01162317|3847113|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4025554|NCT01162317|3847114|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4025555|NCT01162317|3847115|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4025556|NCT01162304|3847124|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4025557|NCT01162304|3847124|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4025558|NCT01162304|3847124|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025559|NCT01162304|3847124|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4025560|NCT01162304|3847124|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4025561|NCT01162304|3847124|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025562|NCT01162304|3847124|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025563|NCT01162304|3847124|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025564|NCT01162304|3847124|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4025565|NCT01162304|3847124|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4025566|NCT01162304|3847124|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025567|NCT01162304|3847124|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4025568|NCT01162304|3847124|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4025569|NCT01162304|3847124|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4025570|NCT01162304|3847124|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4025571|NCT01162304|3847124|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4025572|NCT01162135|3847138|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4025573|NCT01162135|3847138|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025574|NCT01162135|3847138|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4025575|NCT01162135|3847138|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4025576|NCT01162135|3847138|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4025577|NCT01162135|3847138|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025578|NCT01162135|3847138|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4025579|NCT01162135|3847138|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4025580|NCT01162135|3847138|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025581|NCT01162135|3847138|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025582|NCT01162135|3847138|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025583|NCT01162135|3847138|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4025584|NCT01162135|3847138|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4025585|NCT01162135|3847138|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4025586|NCT01162135|3847138|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4025587|NCT01162135|3847138|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4025588|NCT01162135|3847138|B1|||Age||years|Mean|67.5|67.5|Standard Deviation|9.5|9.5|||
4025589|NCT01162122|3847142|B3||Male|Sex: Female, Male||Participants|Count of Participants|2468|2468.0||||||
4025590|NCT01162122|3847143|B2||Male|Sex: Female, Male||Participants|Count of Participants|1195|1195.0||||||
4025591|NCT01162122|3847144|B1||Male|Sex: Female, Male||Participants|Count of Participants|1273|1273.0||||||
4025592|NCT01162122|3847142|B3||Female|Sex: Female, Male||Participants|Count of Participants|4614|4614.0||||||
4025593|NCT01162122|3847143|B2||Female|Sex: Female, Male||Participants|Count of Participants|2342|2342.0||||||
4025594|NCT01162122|3847144|B1||Female|Sex: Female, Male||Participants|Count of Participants|2272|2272.0||||||
4025595|NCT01162122|3847142|B3|||Age||years|Mean|71.9|71.9|Standard Deviation|5.3|5.3|||
4025596|NCT01162122|3847143|B2|||Age||years|Mean|71.8|71.8|Standard Deviation|5.3|5.3|||
4025597|NCT01162122|3847144|B1|||Age||years|Mean|72.0|72.0|Standard Deviation|5.3|5.3|||
4025598|NCT01162096|3847202|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4025599|NCT01162096|3847202|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4025600|NCT01162096|3847202|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4025601|NCT01162096|3847202|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025602|NCT01162096|3847202|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025603|NCT01162096|3847202|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025604|NCT01162096|3847202|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4025605|NCT01162096|3847202|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4025606|NCT01162096|3847202|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025607|NCT01162096|3847202|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4025608|NCT01162096|3847202|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025609|NCT01162096|3847202|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4025610|NCT01162096|3847202|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4025611|NCT01162096|3847202|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4025612|NCT01162096|3847202|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4025613|NCT01162096|3847202|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4025614|NCT01162096|3847202|B1|||Age||years|Mean|59.23|59.23|Standard Deviation|15.57|15.57|||
4025615|NCT01161862|3847208|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4025616|NCT01161862|3847209|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4025617|NCT01161862|3847210|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4025618|NCT01161862|3847208|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4025619|NCT01161862|3847209|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4025620|NCT01161862|3847210|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4025621|NCT01161862|3847208|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4025622|NCT01161862|3847209|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4025623|NCT01161862|3847210|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4025624|NCT01161862|3847208|B3|||Age||years|Mean|30|30.0|Standard Deviation|18|18.0|||
4025625|NCT01161862|3847209|B2|||Age||years|Mean|30.5|30.5|Standard Deviation|19.0|19.0|||
4025626|NCT01161862|3847210|B1|||Age||years|Mean|30|30.0|Standard Deviation|17.7|17.7|||
4025627|NCT01161862|3847208|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4025628|NCT01161862|3847209|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4025629|NCT01161862|3847210|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4025630|NCT01161862|3847208|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4025631|NCT01161862|3847209|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4025632|NCT01161862|3847210|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4025633|NCT01161862|3847208|B3||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4025634|NCT01161862|3847209|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4025635|NCT01161862|3847210|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4025636|NCT01161771|3847231|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4025637|NCT01161771|3847231|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4025638|NCT01161771|3847231|B1|||Age||years|Median|68.29|68.29|Full Range|||51.64|83.84|
4025639|NCT01161628|3847240|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4025640|NCT01161628|3847240|B1|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4025641|NCT01161628|3847240|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4025642|NCT01161628|3847240|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4025643|NCT01161628|3847240|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4025644|NCT01161628|3847240|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4025645|NCT01161628|3847240|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4025646|NCT01161563|3847252|B3|United States||Region of Enrollment||participants|Number|118|118.0||||||
4025647|NCT01161563|3847253|B2|United States||Region of Enrollment||participants|Number|63|63.0||||||
4025648|NCT01161563|3847254|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4025649|NCT01161563|3847252|B3||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4025650|NCT01161563|3847253|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4025651|NCT01161563|3847254|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4025652|NCT01161563|3847252|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4025653|NCT01161563|3847253|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4025654|NCT01161563|3847254|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4025655|NCT01161563|3847252|B3|||Age||years|Mean|74|74.0|Standard Deviation|9.7|9.7|||
4025656|NCT01161563|3847253|B2|||Age||years|Mean|73.2|73.2|Standard Deviation|9.6|9.6|||
4025657|NCT01161563|3847254|B1|||Age||years|Mean|75.0|75.0|Standard Deviation|9.6|9.6|||
4025658|NCT01161563|3847252|B3||>=65 years|Age||Participants|Count of Participants|89|89.0||||||
4025659|NCT01161563|3847253|B2||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
4025660|NCT01161563|3847254|B1||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
4025661|NCT01161563|3847252|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4025662|NCT01161563|3847253|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4025663|NCT01161563|3847254|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4025664|NCT01161563|3847252|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4025665|NCT01161563|3847253|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4025666|NCT01161563|3847254|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4025667|NCT01161537|3847263|B1|Part B (n = 9)||Body Mass Index (BMI)|BMI = (Weight [in kg]) divided by (Height [in meters])^2. Data was planned to be reported separately for Part A and Part B of the study. Here “n” signifies subjects who were evaluable for specified part of the study.|kilogram per square meter (kg/m^2)|Mean|22.96|22.96|Standard Deviation|4.066|4.066|||
4025668|NCT01161537|3847263|B1|Part A (n = 8)||Body Mass Index (BMI)|BMI = (Weight [in kg]) divided by (Height [in meters])^2. Data was planned to be reported separately for Part A and Part B of the study. Here “n” signifies subjects who were evaluable for specified part of the study.|kilogram per square meter (kg/m^2)|Mean|23.44|23.44|Standard Deviation|3.570|3.57|||
4025669|NCT01161537|3847263|B1|Part B (n = 9)||Height|Data was planned to be reported separately for Part A and Part B of the study. Here “n” signifies subjects who were evaluable for specified part of the study.|centimeter (cm)|Mean|169.9|169.9|Standard Deviation|11.82|11.82|||
4025670|NCT01161537|3847263|B1|Part A (n = 8)||Height|Data was planned to be reported separately for Part A and Part B of the study. Here “n” signifies subjects who were evaluable for specified part of the study.|centimeter (cm)|Mean|167.5|167.5|Standard Deviation|9.66|9.66|||
4025671|NCT01161537|3847263|B1|Part B (n = 9)||Body Weight|Data was planned to be reported separately for Part A and Part B of the study. Here “n” signifies subjects who were evaluable for specified part of the study.|kilogram (kg)|Mean|66.53|66.53|Standard Deviation|13.693|13.693|||
4025672|NCT01161537|3847263|B1|Part A (n = 8)||Body Weight|Data was planned to be reported separately for Part A and Part B of the study. Here “n” signifies subjects who were evaluable for specified part of the study.|kilogram (kg)|Mean|66.31|66.31|Standard Deviation|14.393|14.393|||
4025673|NCT01161537|3847263|B1|Part B: >=90% (n = 9)||Percent Predicted Forced Expiratory Volume in 1 Second (FEV1)|FEV1 is the volume of air that can forcibly be blown out in one second, after full inspiration. Predicted FEV1 (for age, gender, and height) was calculated using the Knudson method. Number of subjects in each percent predicted FEV1 category (less than [<] 70%, greater than or equal to [>=] 70%-<90%, and >=90%) are reported. Data was planned to be reported separately for Part A and Part B of the study. Here “n” signifies subjects who were evaluable for specified part of the study. Subjects may be reported in more than one category.|participants|Number|2|2.0||||||
4025674|NCT01161537|3847263|B1|Part B: >=70%-<90% (n = 9)||Percent Predicted Forced Expiratory Volume in 1 Second (FEV1)|FEV1 is the volume of air that can forcibly be blown out in one second, after full inspiration. Predicted FEV1 (for age, gender, and height) was calculated using the Knudson method. Number of subjects in each percent predicted FEV1 category (less than [<] 70%, greater than or equal to [>=] 70%-<90%, and >=90%) are reported. Data was planned to be reported separately for Part A and Part B of the study. Here “n” signifies subjects who were evaluable for specified part of the study. Subjects may be reported in more than one category.|participants|Number|1|1.0||||||
4025675|NCT01161537|3847263|B1|Part B: <70% (n = 9)||Percent Predicted Forced Expiratory Volume in 1 Second (FEV1)|FEV1 is the volume of air that can forcibly be blown out in one second, after full inspiration. Predicted FEV1 (for age, gender, and height) was calculated using the Knudson method. Number of subjects in each percent predicted FEV1 category (less than [<] 70%, greater than or equal to [>=] 70%-<90%, and >=90%) are reported. Data was planned to be reported separately for Part A and Part B of the study. Here “n” signifies subjects who were evaluable for specified part of the study. Subjects may be reported in more than one category.|participants|Number|6|6.0||||||
4025705|NCT01161472|3847306|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4025676|NCT01161537|3847263|B1|Part A: >=90% (n = 8)||Percent Predicted Forced Expiratory Volume in 1 Second (FEV1)|FEV1 is the volume of air that can forcibly be blown out in one second, after full inspiration. Predicted FEV1 (for age, gender, and height) was calculated using the Knudson method. Number of subjects in each percent predicted FEV1 category (less than [<] 70%, greater than or equal to [>=] 70%-<90%, and >=90%) are reported. Data was planned to be reported separately for Part A and Part B of the study. Here “n” signifies subjects who were evaluable for specified part of the study. Subjects may be reported in more than one category.|participants|Number|5|5.0||||||
4025677|NCT01161537|3847263|B1|Part A: >=70%-<90% (n = 8)||Percent Predicted Forced Expiratory Volume in 1 Second (FEV1)|FEV1 is the volume of air that can forcibly be blown out in one second, after full inspiration. Predicted FEV1 (for age, gender, and height) was calculated using the Knudson method. Number of subjects in each percent predicted FEV1 category (less than [<] 70%, greater than or equal to [>=] 70%-<90%, and >=90%) are reported. Data was planned to be reported separately for Part A and Part B of the study. Here “n” signifies subjects who were evaluable for specified part of the study. Subjects may be reported in more than one category.|participants|Number|1|1.0||||||
4025678|NCT01161537|3847263|B1|Part A: <70% (n = 8)||Percent Predicted Forced Expiratory Volume in 1 Second (FEV1)|FEV1 is the volume of air that can forcibly be blown out in one second, after full inspiration. Predicted FEV1 (for age, gender, and height) was calculated using the Knudson method. Number of subjects in each percent predicted FEV1 category (less than [<] 70%, greater than or equal to [>=] 70%-<90%, and >=90%) are reported. Data was planned to be reported separately for Part A and Part B of the study. Here “n” signifies subjects who were evaluable for specified part of the study. Subjects may be reported in more than one category.|participants|Number|2|2.0||||||
4025679|NCT01161537|3847263|B1|Part B, Ethnicity: Not Hispanic or Latino (n = 9)||Race/Ethnicity, Customized|Data was planned to be reported separately for Part A and Part B of the study. Here “n” signifies subjects who were evaluable for specified part of the study. Subject may be counted in more than one category.|participants|Number|9|9.0||||||
4025680|NCT01161537|3847263|B1|Part B, Race: White (n = 9)||Race/Ethnicity, Customized|Data was planned to be reported separately for Part A and Part B of the study. Here “n” signifies subjects who were evaluable for specified part of the study. Subject may be counted in more than one category.|participants|Number|9|9.0||||||
4025681|NCT01161537|3847263|B1|Part A, Ethnicity: Not Hispanic or Latino (n = 8)||Race/Ethnicity, Customized|Data was planned to be reported separately for Part A and Part B of the study. Here “n” signifies subjects who were evaluable for specified part of the study. Subject may be counted in more than one category.|participants|Number|8|8.0||||||
4025682|NCT01161537|3847263|B1|Part A, Race: Black or African American (n = 8)||Race/Ethnicity, Customized|Data was planned to be reported separately for Part A and Part B of the study. Here “n” signifies subjects who were evaluable for specified part of the study. Subject may be counted in more than one category.|participants|Number|1|1.0||||||
4025683|NCT01161537|3847263|B1|Part A, Race: White (n = 8)||Race/Ethnicity, Customized|Data was planned to be reported separately for Part A and Part B of the study. Here “n” signifies subjects who were evaluable for specified part of the study. Subject may be counted in more than one category.|participants|Number|7|7.0||||||
4025684|NCT01161537|3847263|B1|Part B: Male (n = 9)||Sex/Gender, Customized|Data was planned to be reported separately for Part A and Part B of the study. Here “n” signifies subjects who were evaluable for specified part of the study. Subjects may be counted in more than one category.|participants|Number|6|6.0||||||
4025685|NCT01161537|3847263|B1|Part B: Female (n = 9)||Sex/Gender, Customized|Data was planned to be reported separately for Part A and Part B of the study. Here “n” signifies subjects who were evaluable for specified part of the study. Subjects may be counted in more than one category.|participants|Number|3|3.0||||||
4025686|NCT01161537|3847263|B1|Part A: Male (n = 8)||Sex/Gender, Customized|Data was planned to be reported separately for Part A and Part B of the study. Here “n” signifies subjects who were evaluable for specified part of the study. Subjects may be counted in more than one category.|participants|Number|4|4.0||||||
4025687|NCT01161537|3847263|B1|Part A: Female (n = 8)||Sex/Gender, Customized|Data was planned to be reported separately for Part A and Part B of the study. Here “n” signifies subjects who were evaluable for specified part of the study. Subjects may be counted in more than one category.|participants|Number|4|4.0||||||
4025688|NCT01161537|3847263|B1|Part B (n = 9)||Age|Data was planned to be reported separately for Part A and Part B of the study. Here “n” signifies participants who were evaluable for specified part of the study.|years|Mean|24.4|24.4|Standard Deviation|10.3|10.3|||
4025689|NCT01161537|3847263|B1|Part A (n = 8)||Age|Data was planned to be reported separately for Part A and Part B of the study. Here “n” signifies participants who were evaluable for specified part of the study.|years|Mean|18.9|18.9|Standard Deviation|4.64|4.64|||
4025690|NCT01161498|3847279|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4025691|NCT01161498|3847280|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4025692|NCT01161498|3847281|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4025693|NCT01161498|3847279|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4025694|NCT01161498|3847280|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4025695|NCT01161498|3847281|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4025696|NCT01161498|3847279|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4025697|NCT01161498|3847280|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4025698|NCT01161498|3847281|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4025699|NCT01161498|3847279|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4025700|NCT01161498|3847280|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4025701|NCT01161498|3847281|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4025702|NCT01161498|3847279|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4025703|NCT01161498|3847280|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4025704|NCT01161498|3847281|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4025706|NCT01161472|3847306|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4025707|NCT01161472|3847306|B1|||Age||Years|Mean|72.2|72.2|Standard Deviation|5.2|5.2|||
4025708|NCT01161446|3847363|B3||No|Diagnosis of bacterial sexually transmitted infection at enrollment visit||Participants|Count of Participants|202|202.0||||||
4025709|NCT01161446|3847364|B2||No|Diagnosis of bacterial sexually transmitted infection at enrollment visit||Participants|Count of Participants|95|95.0||||||
4025710|NCT01161446|3847365|B1||No|Diagnosis of bacterial sexually transmitted infection at enrollment visit||Participants|Count of Participants|107|107.0||||||
4025711|NCT01161446|3847363|B3||Yes|Diagnosis of bacterial sexually transmitted infection at enrollment visit||Participants|Count of Participants|28|28.0||||||
4025712|NCT01161446|3847364|B2||Yes|Diagnosis of bacterial sexually transmitted infection at enrollment visit||Participants|Count of Participants|19|19.0||||||
4025713|NCT01161446|3847365|B1||Yes|Diagnosis of bacterial sexually transmitted infection at enrollment visit||Participants|Count of Participants|9|9.0||||||
4025714|NCT01161446|3847363|B3||No|Inhaled nitrite use in last 3 months||Participants|Count of Participants|156|156.0||||||
4025715|NCT01161446|3847364|B2||No|Inhaled nitrite use in last 3 months||Participants|Count of Participants|79|79.0||||||
4025716|NCT01161446|3847365|B1||No|Inhaled nitrite use in last 3 months||Participants|Count of Participants|77|77.0||||||
4025717|NCT01161446|3847363|B3||Yes|Inhaled nitrite use in last 3 months||Participants|Count of Participants|74|74.0||||||
4025718|NCT01161446|3847364|B2||Yes|Inhaled nitrite use in last 3 months||Participants|Count of Participants|35|35.0||||||
4025719|NCT01161446|3847365|B1||Yes|Inhaled nitrite use in last 3 months||Participants|Count of Participants|39|39.0||||||
4025720|NCT01161446|3847363|B3||Unknown or not reported|Methamphetamine use in last 3 months||Participants|Count of Participants|2|2.0||||||
4025721|NCT01161446|3847364|B2||Unknown or not reported|Methamphetamine use in last 3 months||Participants|Count of Participants|1|1.0||||||
4025722|NCT01161446|3847365|B1||Unknown or not reported|Methamphetamine use in last 3 months||Participants|Count of Participants|1|1.0||||||
4025723|NCT01161446|3847363|B3||No|Methamphetamine use in last 3 months||Participants|Count of Participants|206|206.0||||||
4025724|NCT01161446|3847364|B2||No|Methamphetamine use in last 3 months||Participants|Count of Participants|103|103.0||||||
4025725|NCT01161446|3847365|B1||No|Methamphetamine use in last 3 months||Participants|Count of Participants|103|103.0||||||
4025726|NCT01161446|3847363|B3||Yes|Methamphetamine use in last 3 months||Participants|Count of Participants|22|22.0||||||
4025727|NCT01161446|3847364|B2||Yes|Methamphetamine use in last 3 months||Participants|Count of Participants|10|10.0||||||
4025728|NCT01161446|3847365|B1||Yes|Methamphetamine use in last 3 months||Participants|Count of Participants|12|12.0||||||
4025729|NCT01161446|3847363|B3||Unknown or not reported|Any condomless anal intercourse with an HIV-discordant partner in last 3 months||Participants|Count of Participants|15|15.0||||||
4025730|NCT01161446|3847364|B2||Unknown or not reported|Any condomless anal intercourse with an HIV-discordant partner in last 3 months||Participants|Count of Participants|6|6.0||||||
4025731|NCT01161446|3847365|B1||Unknown or not reported|Any condomless anal intercourse with an HIV-discordant partner in last 3 months||Participants|Count of Participants|9|9.0||||||
4025732|NCT01161446|3847363|B3||No|Any condomless anal intercourse with an HIV-discordant partner in last 3 months||Participants|Count of Participants|144|144.0||||||
4025733|NCT01161446|3847364|B2||No|Any condomless anal intercourse with an HIV-discordant partner in last 3 months||Participants|Count of Participants|74|74.0||||||
4025734|NCT01161446|3847365|B1||No|Any condomless anal intercourse with an HIV-discordant partner in last 3 months||Participants|Count of Participants|70|70.0||||||
4025735|NCT01161446|3847363|B3||Yes|Any condomless anal intercourse with an HIV-discordant partner in last 3 months||Participants|Count of Participants|71|71.0||||||
4025736|NCT01161446|3847364|B2||Yes|Any condomless anal intercourse with an HIV-discordant partner in last 3 months||Participants|Count of Participants|34|34.0||||||
4025737|NCT01161446|3847365|B1||Yes|Any condomless anal intercourse with an HIV-discordant partner in last 3 months||Participants|Count of Participants|37|37.0||||||
4025738|NCT01161446|3847363|B3|||Number of male condomless anal intercourse partners in last 3 months||partners|Median|1|1.0|Inter-Quartile Range|||1.0|3.0|
4025739|NCT01161446|3847364|B2|||Number of male condomless anal intercourse partners in last 3 months||partners|Median|1|1.0|Inter-Quartile Range|||1.0|3.0|
4025740|NCT01161446|3847365|B1|||Number of male condomless anal intercourse partners in last 3 months||partners|Median|1|1.0|Inter-Quartile Range|||0.5|2.0|
4025741|NCT01161446|3847363|B3|||Number of male sex partners in last 3 months||partners|Median|5|5.0|Inter-Quartile Range|||3.0|10.0|
4025742|NCT01161446|3847364|B2|||Number of male sex partners in last 3 months||partners|Median|5.5|5.5|Inter-Quartile Range|||3.0|10.0|
4025743|NCT01161446|3847365|B1|||Number of male sex partners in last 3 months||partners|Median|5|5.0|Inter-Quartile Range|||3.0|10.0|
4025744|NCT01161446|3847363|B3||Unknown or not reported|Gender of sex partners in last 3 months||Participants|Count of Participants|1|1.0||||||
4025745|NCT01161446|3847364|B2||Unknown or not reported|Gender of sex partners in last 3 months||Participants|Count of Participants|1|1.0||||||
4025746|NCT01161446|3847365|B1||Unknown or not reported|Gender of sex partners in last 3 months||Participants|Count of Participants|0|0.0||||||
4025747|NCT01161446|3847363|B3||Both men and women|Gender of sex partners in last 3 months||Participants|Count of Participants|14|14.0||||||
4025748|NCT01161446|3847364|B2||Both men and women|Gender of sex partners in last 3 months||Participants|Count of Participants|6|6.0||||||
4025749|NCT01161446|3847365|B1||Both men and women|Gender of sex partners in last 3 months||Participants|Count of Participants|8|8.0||||||
4025750|NCT01161446|3847363|B3||Women|Gender of sex partners in last 3 months||Participants|Count of Participants|1|1.0||||||
4025751|NCT01161446|3847364|B2||Women|Gender of sex partners in last 3 months||Participants|Count of Participants|0|0.0||||||
4025752|NCT01161446|3847365|B1||Women|Gender of sex partners in last 3 months||Participants|Count of Participants|1|1.0||||||
4025923|NCT01161225|3847416|B2|||Age||years|Mean|14.97|14.97|Standard Deviation|1.29|1.29|||
4025753|NCT01161446|3847363|B3||Men|Gender of sex partners in last 3 months||Participants|Count of Participants|214|214.0||||||
4025754|NCT01161446|3847364|B2||Men|Gender of sex partners in last 3 months||Participants|Count of Participants|107|107.0||||||
4025755|NCT01161446|3847365|B1||Men|Gender of sex partners in last 3 months||Participants|Count of Participants|107|107.0||||||
4025756|NCT01161446|3847363|B3||Unknown or not reported|Ever used a home HIV test||Participants|Count of Participants|1|1.0||||||
4025757|NCT01161446|3847364|B2||Unknown or not reported|Ever used a home HIV test||Participants|Count of Participants|0|0.0||||||
4025758|NCT01161446|3847365|B1||Unknown or not reported|Ever used a home HIV test||Participants|Count of Participants|1|1.0||||||
4025759|NCT01161446|3847363|B3||No|Ever used a home HIV test||Participants|Count of Participants|217|217.0||||||
4025760|NCT01161446|3847364|B2||No|Ever used a home HIV test||Participants|Count of Participants|104|104.0||||||
4025761|NCT01161446|3847365|B1||No|Ever used a home HIV test||Participants|Count of Participants|113|113.0||||||
4025762|NCT01161446|3847363|B3||Yes|Ever used a home HIV test||Participants|Count of Participants|12|12.0||||||
4025763|NCT01161446|3847364|B2||Yes|Ever used a home HIV test||Participants|Count of Participants|10|10.0||||||
4025764|NCT01161446|3847365|B1||Yes|Ever used a home HIV test||Participants|Count of Participants|2|2.0||||||
4025765|NCT01161446|3847363|B3||Unknown or not reported|Currently tests for HIV on regular basis||Participants|Count of Participants|2|2.0||||||
4025766|NCT01161446|3847364|B2||Unknown or not reported|Currently tests for HIV on regular basis||Participants|Count of Participants|2|2.0||||||
4025767|NCT01161446|3847365|B1||Unknown or not reported|Currently tests for HIV on regular basis||Participants|Count of Participants|0|0.0||||||
4025768|NCT01161446|3847363|B3||No|Currently tests for HIV on regular basis||Participants|Count of Participants|89|89.0||||||
4025769|NCT01161446|3847364|B2||No|Currently tests for HIV on regular basis||Participants|Count of Participants|39|39.0||||||
4025770|NCT01161446|3847365|B1||No|Currently tests for HIV on regular basis||Participants|Count of Participants|50|50.0||||||
4025771|NCT01161446|3847363|B3||Yes|Currently tests for HIV on regular basis||Participants|Count of Participants|139|139.0||||||
4025772|NCT01161446|3847364|B2||Yes|Currently tests for HIV on regular basis||Participants|Count of Participants|73|73.0||||||
4025773|NCT01161446|3847365|B1||Yes|Currently tests for HIV on regular basis||Participants|Count of Participants|66|66.0||||||
4025774|NCT01161446|3847363|B3|||Number of HIV tests in last year||HIV tests|Median|2|2.0|Inter-Quartile Range|||1.0|4.0|
4025775|NCT01161446|3847364|B2|||Number of HIV tests in last year||HIV tests|Median|2.5|2.5|Inter-Quartile Range|||1.0|4.0|
4025776|NCT01161446|3847365|B1|||Number of HIV tests in last year||HIV tests|Median|2|2.0|Inter-Quartile Range|||1.0|3.0|
4025777|NCT01161446|3847363|B3||Unknown or not reported|Living Situation||Participants|Count of Participants|2|2.0||||||
4025778|NCT01161446|3847364|B2||Unknown or not reported|Living Situation||Participants|Count of Participants|1|1.0||||||
4025779|NCT01161446|3847365|B1||Unknown or not reported|Living Situation||Participants|Count of Participants|1|1.0||||||
4025780|NCT01161446|3847363|B3||No regular place to stay, couch surfing, homeless|Living Situation||Participants|Count of Participants|13|13.0||||||
4025781|NCT01161446|3847364|B2||No regular place to stay, couch surfing, homeless|Living Situation||Participants|Count of Participants|5|5.0||||||
4025782|NCT01161446|3847365|B1||No regular place to stay, couch surfing, homeless|Living Situation||Participants|Count of Participants|8|8.0||||||
4025783|NCT01161446|3847363|B3||In school or university dormitories|Living Situation||Participants|Count of Participants|1|1.0||||||
4025784|NCT01161446|3847364|B2||In school or university dormitories|Living Situation||Participants|Count of Participants|0|0.0||||||
4025785|NCT01161446|3847365|B1||In school or university dormitories|Living Situation||Participants|Count of Participants|1|1.0||||||
4025786|NCT01161446|3847363|B3||With parents, guardians, or other relatives|Living Situation||Participants|Count of Participants|16|16.0||||||
4025787|NCT01161446|3847364|B2||With parents, guardians, or other relatives|Living Situation||Participants|Count of Participants|12|12.0||||||
4025788|NCT01161446|3847365|B1||With parents, guardians, or other relatives|Living Situation||Participants|Count of Participants|4|4.0||||||
4025789|NCT01161446|3847363|B3||With friends or roommates|Living Situation||Participants|Count of Participants|77|77.0||||||
4025790|NCT01161446|3847364|B2||With friends or roommates|Living Situation||Participants|Count of Participants|31|31.0||||||
4025791|NCT01161446|3847365|B1||With friends or roommates|Living Situation||Participants|Count of Participants|46|46.0||||||
4025792|NCT01161446|3847363|B3||With a sex partner, lover, or spouse|Living Situation||Participants|Count of Participants|34|34.0||||||
4025793|NCT01161446|3847364|B2||With a sex partner, lover, or spouse|Living Situation||Participants|Count of Participants|18|18.0||||||
4025794|NCT01161446|3847365|B1||With a sex partner, lover, or spouse|Living Situation||Participants|Count of Participants|16|16.0||||||
4025795|NCT01161446|3847363|B3||Alone in a house or apartment|Living Situation||Participants|Count of Participants|87|87.0||||||
4025796|NCT01161446|3847364|B2||Alone in a house or apartment|Living Situation||Participants|Count of Participants|47|47.0||||||
4025797|NCT01161446|3847365|B1||Alone in a house or apartment|Living Situation||Participants|Count of Participants|40|40.0||||||
4025798|NCT01161446|3847363|B3||Unknown or not reported|Education||Participants|Count of Participants|4|4.0||||||
4025799|NCT01161446|3847364|B2||Unknown or not reported|Education||Participants|Count of Participants|3|3.0||||||
4025800|NCT01161446|3847365|B1||Unknown or not reported|Education||Participants|Count of Participants|1|1.0||||||
4025801|NCT01161446|3847363|B3||Bachelor's degree or more|Education||Participants|Count of Participants|122|122.0||||||
4025802|NCT01161446|3847364|B2||Bachelor's degree or more|Education||Participants|Count of Participants|65|65.0||||||
4025803|NCT01161446|3847365|B1||Bachelor's degree or more|Education||Participants|Count of Participants|57|57.0||||||
4025804|NCT01161446|3847363|B3||Some college, Associate's, or technical training|Education||Participants|Count of Participants|76|76.0||||||
4025805|NCT01161446|3847364|B2||Some college, Associate's, or technical training|Education||Participants|Count of Participants|32|32.0||||||
4025806|NCT01161446|3847365|B1||Some college, Associate's, or technical training|Education||Participants|Count of Participants|44|44.0||||||
4025807|NCT01161446|3847363|B3||High school or less|Education||Participants|Count of Participants|28|28.0||||||
4025808|NCT01161446|3847364|B2||High school or less|Education||Participants|Count of Participants|14|14.0||||||
4025809|NCT01161446|3847365|B1||High school or less|Education||Participants|Count of Participants|14|14.0||||||
4025810|NCT01161446|3847363|B3|United States||Region of Enrollment||participants|Number|230|230.0||||||
4025811|NCT01161446|3847364|B2|United States||Region of Enrollment||participants|Number|114|114.0||||||
4025812|NCT01161446|3847365|B1|United States||Region of Enrollment||participants|Number|116|116.0||||||
4025813|NCT01161446|3847363|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4025814|NCT01161446|3847364|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4025815|NCT01161446|3847365|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4025816|NCT01161446|3847363|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4025817|NCT01161446|3847364|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4025818|NCT01161446|3847365|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4025819|NCT01161446|3847363|B3||White|Race (NIH/OMB)||Participants|Count of Participants|169|169.0||||||
4025820|NCT01161446|3847364|B2||White|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
4025821|NCT01161446|3847365|B1||White|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4025822|NCT01161446|3847363|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4025823|NCT01161446|3847364|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4025824|NCT01161446|3847365|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4025825|NCT01161446|3847363|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025826|NCT01161446|3847364|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025827|NCT01161446|3847365|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025828|NCT01161446|3847363|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4025829|NCT01161446|3847364|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4025830|NCT01161446|3847365|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4025831|NCT01161446|3847363|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025832|NCT01161446|3847364|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025833|NCT01161446|3847365|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025834|NCT01161446|3847363|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4025835|NCT01161446|3847364|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4025836|NCT01161446|3847365|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4025837|NCT01161446|3847363|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|192|192.0||||||
4025838|NCT01161446|3847364|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
4025839|NCT01161446|3847365|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
4025840|NCT01161446|3847363|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4025841|NCT01161446|3847364|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4025842|NCT01161446|3847365|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4025843|NCT01161446|3847363|B3||Male|Sex: Female, Male|Sex at birth|Participants|Count of Participants|230|230.0||||||
4025844|NCT01161446|3847364|B2||Male|Sex: Female, Male|Sex at birth|Participants|Count of Participants|114|114.0||||||
4025845|NCT01161446|3847365|B1||Male|Sex: Female, Male|Sex at birth|Participants|Count of Participants|116|116.0||||||
4025846|NCT01161446|3847363|B3||Female|Sex: Female, Male|Sex at birth|Participants|Count of Participants|0|0.0||||||
4025847|NCT01161446|3847364|B2||Female|Sex: Female, Male|Sex at birth|Participants|Count of Participants|0|0.0||||||
4025848|NCT01161446|3847365|B1||Female|Sex: Female, Male|Sex at birth|Participants|Count of Participants|0|0.0||||||
4025849|NCT01161446|3847363|B3|||Age||years|Median|36|36.0|Inter-Quartile Range|||28.0|46.0|
4025850|NCT01161446|3847364|B2|||Age||years|Median|37.5|37.5|Inter-Quartile Range|||29.0|47.0|
4025851|NCT01161446|3847365|B1|||Age||years|Median|35.5|35.5|Inter-Quartile Range|||27.0|45.5|
4025852|NCT01161420|3847378|B1|Germany||Region of Enrollment||participants|Number|11|11.0||||||
4025853|NCT01161420|3847378|B1|Netherlands||Region of Enrollment||participants|Number|22|22.0||||||
4025854|NCT01161420|3847378|B1|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
4025855|NCT01161420|3847378|B1|United States||Region of Enrollment||participants|Number|87|87.0||||||
4025856|NCT01161420|3847378|B1|France||Region of Enrollment||participants|Number|2|2.0||||||
4025857|NCT01161420|3847378|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
4025858|NCT01161420|3847378|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4025859|NCT01161420|3847378|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4025860|NCT01161420|3847378|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4025861|NCT01161420|3847378|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025862|NCT01161420|3847378|B1||White|Race (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
4025863|NCT01161420|3847378|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025864|NCT01161420|3847378|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025865|NCT01161420|3847378|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4025866|NCT01161420|3847378|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4025867|NCT01161420|3847378|B1||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4025868|NCT01161420|3847378|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4025869|NCT01161420|3847378|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4025870|NCT01161420|3847378|B1||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
4025871|NCT01161420|3847378|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4025872|NCT01161420|3847378|B1|||Age||years|Mean|54.5|54.5|Standard Deviation|10.2|10.2|||
4025873|NCT01161407|3847390|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4025874|NCT01161407|3847391|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4025875|NCT01161407|3847392|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4025876|NCT01161407|3847390|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4025877|NCT01161407|3847391|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4025878|NCT01161407|3847392|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4025879|NCT01161407|3847390|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4025880|NCT01161407|3847391|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4025881|NCT01161407|3847392|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4025882|NCT01161407|3847390|B3|||Age||years|Mean|57.4|57.4|Standard Deviation|7.5|7.5|||
4025883|NCT01161407|3847391|B2|||Age||years|Mean|60.8|60.8|Standard Deviation|5.3|5.3|||
4025884|NCT01161407|3847392|B1|||Age||years|Mean|54.0|54.0|Standard Deviation|8.1|8.1|||
4025885|NCT01161407|3847390|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4025886|NCT01161407|3847391|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4025887|NCT01161407|3847392|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4025888|NCT01161407|3847390|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4025889|NCT01161407|3847391|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4025890|NCT01161407|3847392|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4025891|NCT01161407|3847390|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4025892|NCT01161407|3847391|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4025893|NCT01161407|3847392|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4025894|NCT01161329|3847403|B3|||Months since stroke||months|Median|13|13.0|Inter-Quartile Range|||12.0|16.0|
4025895|NCT01161329|3847404|B2|||Months since stroke||months|Median|13|13.0|Inter-Quartile Range|||12.0|16.0|
4025896|NCT01161329|3847405|B1|||Months since stroke||months|Median|13|13.0|Inter-Quartile Range|||12.0|14.0|
4025897|NCT01161329|3847403|B3|Sweden||Region of Enrollment||participants|Number|67|67.0||||||
4025898|NCT01161329|3847404|B2|Sweden||Region of Enrollment||participants|Number|34|34.0||||||
4025899|NCT01161329|3847405|B1|Sweden||Region of Enrollment||participants|Number|33|33.0||||||
4025900|NCT01161329|3847403|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4025901|NCT01161329|3847404|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4025902|NCT01161329|3847405|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4025903|NCT01161329|3847403|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4025904|NCT01161329|3847404|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4025905|NCT01161329|3847405|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4025906|NCT01161329|3847403|B3|||Age||years|Mean|73.1|73.1|Standard Deviation|5.4|5.4|||
4025907|NCT01161329|3847404|B2|||Age||years|Mean|72.6|72.6|Standard Deviation|5.5|5.5|||
4025908|NCT01161329|3847405|B1|||Age||years|Mean|73.7|73.7|Standard Deviation|5.3|5.3|||
4025909|NCT01161225|3847414|B4|United States||Region of Enrollment||participants|Number|126|126.0||||||
4025910|NCT01161225|3847415|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4025911|NCT01161225|3847416|B2|United States||Region of Enrollment||participants|Number|53|53.0||||||
4025912|NCT01161225|3847417|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
4025913|NCT01161225|3847414|B4||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4025914|NCT01161225|3847415|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4025915|NCT01161225|3847416|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4025916|NCT01161225|3847417|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4025917|NCT01161225|3847414|B4||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4025918|NCT01161225|3847415|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4025919|NCT01161225|3847416|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4025920|NCT01161225|3847417|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4025921|NCT01161225|3847414|B4|||Age||years|Mean|15.50|15.5|Standard Deviation|1.71|1.71|||
4025922|NCT01161225|3847415|B3|||Age||years|Mean|18.28|18.28|Standard Deviation|1.90|1.9|||
4025924|NCT01161225|3847417|B1|||Age||years|Mean|15.31|15.31|Standard Deviation|1.36|1.36|||
4025925|NCT01161173|3847448|B1||Male|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
4025926|NCT01161173|3847448|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4025927|NCT01161173|3847448|B1|||Age||years|Median|65|65.0|Full Range|||36.0|86.0|
4025928|NCT01161160|3847457|B4|Asian-South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|207|207.0||||||
4025929|NCT01161160|3847458|B3|Asian-South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|57|57.0||||||
4025930|NCT01161160|3847459|B2|Asian-South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|74|74.0||||||
4025931|NCT01161160|3847460|B1|Asian-South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|76|76.0||||||
4025932|NCT01161160|3847457|B4|Asian-East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4025933|NCT01161160|3847458|B3|Asian-East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4025934|NCT01161160|3847459|B2|Asian-East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4025935|NCT01161160|3847460|B1|Asian-East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4025936|NCT01161160|3847457|B4|Asian-Central/South Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4025937|NCT01161160|3847458|B3|Asian-Central/South Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4025938|NCT01161160|3847459|B2|Asian-Central/South Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4025939|NCT01161160|3847460|B1|Asian-Central/South Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4025940|NCT01161160|3847457|B4||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4025941|NCT01161160|3847458|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4025942|NCT01161160|3847459|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4025943|NCT01161160|3847460|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4025944|NCT01161160|3847457|B4||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4025945|NCT01161160|3847458|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4025946|NCT01161160|3847459|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4025947|NCT01161160|3847460|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4025948|NCT01161160|3847457|B4|||Age||Years|Mean|6|6.0|Standard Deviation|2.01|2.01|||
4025949|NCT01161160|3847458|B3|||Age||Years|Mean|6|6.0|Standard Deviation|2|2.0|||
4025950|NCT01161160|3847459|B2|||Age||Years|Mean|6|6.0|Standard Deviation|2.02|2.02|||
4025951|NCT01161160|3847460|B1|||Age||Years|Mean|6|6.0|Standard Deviation|2.03|2.03|||
4025952|NCT01161121|3847533|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4025953|NCT01161121|3847533|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4025954|NCT01161121|3847533|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4025955|NCT01161121|3847533|B1|||Age||years|Mean|59|59.0|Standard Deviation|10|10.0|||
4025956|NCT01161121|3847533|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4025957|NCT01161121|3847533|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4025958|NCT01161121|3847533|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4025959|NCT01160848|3847543|B3|Visonac left on skin for 24 hours, area 2||Fluoresence intensity|"In the study arm 3 Areas Per Patient, 3 Hours, participants were only treated with Alcohol wipe and Visonac without occlusion, Saline wipe and Visonac with occlusion, Saline wipe and Visonac without occlusion.~In the study arm 3 Areas Per Patient, 24 Hours participants were only treated with Visonac left on skin for 1 hour, Visonac left on skin for 24 hours, area 1, Visonac left on skin for 24 hours, area 2."|Fluoresence intensity unit|Mean|10.6|10.6|Full Range|||4.0|21.0|
4025960|NCT01160848|3847544|B2|Visonac left on skin for 24 hours, area 2||Fluoresence intensity|"In the study arm 3 Areas Per Patient, 3 Hours, participants were only treated with Alcohol wipe and Visonac without occlusion, Saline wipe and Visonac with occlusion, Saline wipe and Visonac without occlusion.~In the study arm 3 Areas Per Patient, 24 Hours participants were only treated with Visonac left on skin for 1 hour, Visonac left on skin for 24 hours, area 1, Visonac left on skin for 24 hours, area 2."|Fluoresence intensity unit|Mean|10.6|10.6|Full Range|||4.0|21.0|
4025961|NCT01160848|3847545|B1|Visonac left on skin for 24 hours, area 2||Fluoresence intensity|"In the study arm 3 Areas Per Patient, 3 Hours, participants were only treated with Alcohol wipe and Visonac without occlusion, Saline wipe and Visonac with occlusion, Saline wipe and Visonac without occlusion.~In the study arm 3 Areas Per Patient, 24 Hours participants were only treated with Visonac left on skin for 1 hour, Visonac left on skin for 24 hours, area 1, Visonac left on skin for 24 hours, area 2."|Fluoresence intensity unit|Mean|NA||Full Range|||0.0|0.0|Participants in this study arm were not provided this treatment, please see Baseline Measure Description.
4025962|NCT01160848|3847543|B3|Visonac left on skin for 24 hours, area 1||Fluoresence intensity|"In the study arm 3 Areas Per Patient, 3 Hours, participants were only treated with Alcohol wipe and Visonac without occlusion, Saline wipe and Visonac with occlusion, Saline wipe and Visonac without occlusion.~In the study arm 3 Areas Per Patient, 24 Hours participants were only treated with Visonac left on skin for 1 hour, Visonac left on skin for 24 hours, area 1, Visonac left on skin for 24 hours, area 2."|Fluoresence intensity unit|Mean|10.5|10.5|Full Range|||4.0|19.5|
4025963|NCT01160848|3847544|B2|Visonac left on skin for 24 hours, area 1||Fluoresence intensity|"In the study arm 3 Areas Per Patient, 3 Hours, participants were only treated with Alcohol wipe and Visonac without occlusion, Saline wipe and Visonac with occlusion, Saline wipe and Visonac without occlusion.~In the study arm 3 Areas Per Patient, 24 Hours participants were only treated with Visonac left on skin for 1 hour, Visonac left on skin for 24 hours, area 1, Visonac left on skin for 24 hours, area 2."|Fluoresence intensity unit|Mean|10.5|10.5|Full Range|||4.0|19.5|
4025964|NCT01160848|3847545|B1|Visonac left on skin for 24 hours, area 1||Fluoresence intensity|"In the study arm 3 Areas Per Patient, 3 Hours, participants were only treated with Alcohol wipe and Visonac without occlusion, Saline wipe and Visonac with occlusion, Saline wipe and Visonac without occlusion.~In the study arm 3 Areas Per Patient, 24 Hours participants were only treated with Visonac left on skin for 1 hour, Visonac left on skin for 24 hours, area 1, Visonac left on skin for 24 hours, area 2."|Fluoresence intensity unit|Mean|NA||Full Range|||0.0|0.0|Participants in this study arm were not provided this treatment, please see Baseline Measure Description.
4025965|NCT01160848|3847543|B3|Visonac left on skin for 1 hour||Fluoresence intensity|"In the study arm 3 Areas Per Patient, 3 Hours, participants were only treated with Alcohol wipe and Visonac without occlusion, Saline wipe and Visonac with occlusion, Saline wipe and Visonac without occlusion.~In the study arm 3 Areas Per Patient, 24 Hours participants were only treated with Visonac left on skin for 1 hour, Visonac left on skin for 24 hours, area 1, Visonac left on skin for 24 hours, area 2."|Fluoresence intensity unit|Mean|9.3|9.3|Full Range|||3.0|20.5|
4025966|NCT01160848|3847544|B2|Visonac left on skin for 1 hour||Fluoresence intensity|"In the study arm 3 Areas Per Patient, 3 Hours, participants were only treated with Alcohol wipe and Visonac without occlusion, Saline wipe and Visonac with occlusion, Saline wipe and Visonac without occlusion.~In the study arm 3 Areas Per Patient, 24 Hours participants were only treated with Visonac left on skin for 1 hour, Visonac left on skin for 24 hours, area 1, Visonac left on skin for 24 hours, area 2."|Fluoresence intensity unit|Mean|9.3|9.3|Full Range|||3.0|20.5|
4025967|NCT01160848|3847545|B1|Visonac left on skin for 1 hour||Fluoresence intensity|"In the study arm 3 Areas Per Patient, 3 Hours, participants were only treated with Alcohol wipe and Visonac without occlusion, Saline wipe and Visonac with occlusion, Saline wipe and Visonac without occlusion.~In the study arm 3 Areas Per Patient, 24 Hours participants were only treated with Visonac left on skin for 1 hour, Visonac left on skin for 24 hours, area 1, Visonac left on skin for 24 hours, area 2."|Fluoresence intensity unit|Mean|NA||Full Range|||0.0|0.0|Participants in this study arm were not provided this treatment, please see Baseline Measure Description.
4025968|NCT01160848|3847543|B3|Saline wipe and Visonac without occlusion||Fluoresence intensity|"In the study arm 3 Areas Per Patient, 3 Hours, participants were only treated with Alcohol wipe and Visonac without occlusion, Saline wipe and Visonac with occlusion, Saline wipe and Visonac without occlusion.~In the study arm 3 Areas Per Patient, 24 Hours participants were only treated with Visonac left on skin for 1 hour, Visonac left on skin for 24 hours, area 1, Visonac left on skin for 24 hours, area 2."|Fluoresence intensity unit|Mean|10.8|10.8|Full Range|||5.0|17.0|
4025969|NCT01160848|3847544|B2|Saline wipe and Visonac without occlusion||Fluoresence intensity|"In the study arm 3 Areas Per Patient, 3 Hours, participants were only treated with Alcohol wipe and Visonac without occlusion, Saline wipe and Visonac with occlusion, Saline wipe and Visonac without occlusion.~In the study arm 3 Areas Per Patient, 24 Hours participants were only treated with Visonac left on skin for 1 hour, Visonac left on skin for 24 hours, area 1, Visonac left on skin for 24 hours, area 2."|Fluoresence intensity unit|Mean|NA||Full Range|||0.0|0.0|Participants in this study arm were not provided this treatment, please see Baseline Measure Description.
4025970|NCT01160848|3847545|B1|Saline wipe and Visonac without occlusion||Fluoresence intensity|"In the study arm 3 Areas Per Patient, 3 Hours, participants were only treated with Alcohol wipe and Visonac without occlusion, Saline wipe and Visonac with occlusion, Saline wipe and Visonac without occlusion.~In the study arm 3 Areas Per Patient, 24 Hours participants were only treated with Visonac left on skin for 1 hour, Visonac left on skin for 24 hours, area 1, Visonac left on skin for 24 hours, area 2."|Fluoresence intensity unit|Mean|10.8|10.8|Full Range|||5.0|17.0|
4025971|NCT01160848|3847543|B3|Saline wipe and Visonac with occlusion||Fluoresence intensity|"In the study arm 3 Areas Per Patient, 3 Hours, participants were only treated with Alcohol wipe and Visonac without occlusion, Saline wipe and Visonac with occlusion, Saline wipe and Visonac without occlusion.~In the study arm 3 Areas Per Patient, 24 Hours participants were only treated with Visonac left on skin for 1 hour, Visonac left on skin for 24 hours, area 1, Visonac left on skin for 24 hours, area 2."|Fluoresence intensity unit|Mean|11.2|11.2|Full Range|||5.0|28.0|
4025972|NCT01160848|3847544|B2|Saline wipe and Visonac with occlusion||Fluoresence intensity|"In the study arm 3 Areas Per Patient, 3 Hours, participants were only treated with Alcohol wipe and Visonac without occlusion, Saline wipe and Visonac with occlusion, Saline wipe and Visonac without occlusion.~In the study arm 3 Areas Per Patient, 24 Hours participants were only treated with Visonac left on skin for 1 hour, Visonac left on skin for 24 hours, area 1, Visonac left on skin for 24 hours, area 2."|Fluoresence intensity unit|Mean|NA||Full Range|||0.0|0.0|Participants in this study arm were not provided this treatment, please see Baseline Measure Description.
4025973|NCT01160848|3847545|B1|Saline wipe and Visonac with occlusion||Fluoresence intensity|"In the study arm 3 Areas Per Patient, 3 Hours, participants were only treated with Alcohol wipe and Visonac without occlusion, Saline wipe and Visonac with occlusion, Saline wipe and Visonac without occlusion.~In the study arm 3 Areas Per Patient, 24 Hours participants were only treated with Visonac left on skin for 1 hour, Visonac left on skin for 24 hours, area 1, Visonac left on skin for 24 hours, area 2."|Fluoresence intensity unit|Mean|11.2|11.2|Full Range|||5.0|28.0|
4025974|NCT01160848|3847543|B3|Alcohol wipe and Visonac without occlusion||Fluoresence intensity|"In the study arm 3 Areas Per Patient, 3 Hours, participants were only treated with Alcohol wipe and Visonac without occlusion, Saline wipe and Visonac with occlusion, Saline wipe and Visonac without occlusion.~In the study arm 3 Areas Per Patient, 24 Hours participants were only treated with Visonac left on skin for 1 hour, Visonac left on skin for 24 hours, area 1, Visonac left on skin for 24 hours, area 2."|Fluoresence intensity unit|Mean|10.5|10.5|Full Range|||4.0|17.5|
4025975|NCT01160848|3847544|B2|Alcohol wipe and Visonac without occlusion||Fluoresence intensity|"In the study arm 3 Areas Per Patient, 3 Hours, participants were only treated with Alcohol wipe and Visonac without occlusion, Saline wipe and Visonac with occlusion, Saline wipe and Visonac without occlusion.~In the study arm 3 Areas Per Patient, 24 Hours participants were only treated with Visonac left on skin for 1 hour, Visonac left on skin for 24 hours, area 1, Visonac left on skin for 24 hours, area 2."|Fluoresence intensity unit|Mean|NA||Full Range|||0.0|0.0|Participants in this study arm were not provided this treatment, please see Baseline Measure Description.
4026033|NCT01160744|3847682|B2|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4025976|NCT01160848|3847545|B1|Alcohol wipe and Visonac without occlusion||Fluoresence intensity|"In the study arm 3 Areas Per Patient, 3 Hours, participants were only treated with Alcohol wipe and Visonac without occlusion, Saline wipe and Visonac with occlusion, Saline wipe and Visonac without occlusion.~In the study arm 3 Areas Per Patient, 24 Hours participants were only treated with Visonac left on skin for 1 hour, Visonac left on skin for 24 hours, area 1, Visonac left on skin for 24 hours, area 2."|Fluoresence intensity unit|Mean|10.5|10.5|Full Range|5.0|5.0|4.0|17.5|
4025977|NCT01160848|3847543|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4025978|NCT01160848|3847544|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4025979|NCT01160848|3847545|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4025980|NCT01160848|3847543|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4025981|NCT01160848|3847544|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4025982|NCT01160848|3847545|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4025983|NCT01160848|3847543|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4025984|NCT01160848|3847544|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4025985|NCT01160848|3847545|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4025986|NCT01160848|3847543|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4025987|NCT01160848|3847544|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4025988|NCT01160848|3847545|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4025989|NCT01160848|3847543|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4025990|NCT01160848|3847544|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4025991|NCT01160848|3847545|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4025992|NCT01160848|3847543|B3||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4025993|NCT01160848|3847544|B2||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4025994|NCT01160848|3847545|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4025995|NCT01160822|3847568|B8||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4025996|NCT01160822|3847569|B7||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4025997|NCT01160822|3847570|B6||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4025998|NCT01160822|3847571|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4025999|NCT01160822|3847572|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4026000|NCT01160822|3847573|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4026001|NCT01160822|3847574|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4026002|NCT01160822|3847575|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4026003|NCT01160822|3847568|B8||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4026004|NCT01160822|3847569|B7||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4026005|NCT01160822|3847570|B6||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4026006|NCT01160822|3847571|B5||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4026007|NCT01160822|3847572|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4026008|NCT01160822|3847573|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4026009|NCT01160822|3847574|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4026010|NCT01160822|3847575|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4026011|NCT01160822|3847568|B8|||Age, Customized||years|Mean|61.3|61.3|Standard Deviation|8.89|8.89|||
4026012|NCT01160822|3847569|B7|||Age, Customized||years|Mean|62.2|62.2|Standard Deviation|8.10|8.1|||
4026013|NCT01160822|3847570|B6|||Age, Customized||years|Mean|60.3|60.3|Standard Deviation|9.71|9.71|||
4026014|NCT01160822|3847571|B5|||Age, Customized||years|Mean|61.4|61.4|Standard Deviation|8.96|8.96|||
4026015|NCT01160822|3847572|B4|||Age, Customized||years|Mean|NA||Standard Deviation|NA||||Age demographic data for Study Part B.
4026016|NCT01160822|3847573|B3|||Age, Customized||years|Mean|NA||Standard Deviation|NA||||Age demographic data for Study Part B.
4026017|NCT01160822|3847574|B2|||Age, Customized||years|Mean|NA||Standard Deviation|NA||||Age demographic data for Study Part B.
4026018|NCT01160822|3847575|B1|||Age, Customized||years|Mean|NA||Standard Deviation|NA||||Age demographic data for Study Part B.
4026019|NCT01160822|3847568|B8|||Age||years|Mean|60.5|60.5|Standard Deviation|10.07|10.07|||
4026020|NCT01160822|3847569|B7|||Age||years|Mean|NA||Standard Deviation|NA||||Age demographic data for Study Part A.
4026021|NCT01160822|3847570|B6|||Age||years|Mean|NA||Standard Deviation|NA||||Age demographic data for Study Part A.
4026022|NCT01160822|3847571|B5|||Age||years|Mean|NA||Standard Deviation|NA||||Age demographic data for Study Part A.
4026023|NCT01160822|3847572|B4|||Age||years|Mean|57.8|57.8|Standard Deviation|7.76|7.76|||
4026024|NCT01160822|3847573|B3|||Age||years|Mean|64.2|64.2|Standard Deviation|10.68|10.68|||
4026025|NCT01160822|3847574|B2|||Age||years|Mean|61.0|61.0|Standard Deviation|9.63|9.63|||
4026026|NCT01160822|3847575|B1|||Age||years|Mean|58.3|58.3|Standard Deviation|12.79|12.79|||
4026027|NCT01160770|3847670|B1||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4026028|NCT01160770|3847670|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4026029|NCT01160770|3847670|B1|||Age||years|Mean|11.3|11.3|Standard Deviation|7.80|7.8|||
4026030|NCT01160744|3847679|B5|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4026031|NCT01160744|3847680|B4|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4026032|NCT01160744|3847681|B3|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4026034|NCT01160744|3847683|B1|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4026035|NCT01160744|3847679|B5|Germany||Region of Enrollment||participants|Number|22|22.0||||||
4026036|NCT01160744|3847680|B4|Germany||Region of Enrollment||participants|Number|8|8.0||||||
4026037|NCT01160744|3847681|B3|Germany||Region of Enrollment||participants|Number|14|14.0||||||
4026038|NCT01160744|3847682|B2|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4026039|NCT01160744|3847683|B1|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4026040|NCT01160744|3847679|B5|Poland||Region of Enrollment||participants|Number|16|16.0||||||
4026041|NCT01160744|3847680|B4|Poland||Region of Enrollment||participants|Number|12|12.0||||||
4026042|NCT01160744|3847681|B3|Poland||Region of Enrollment||participants|Number|4|4.0||||||
4026043|NCT01160744|3847682|B2|Poland||Region of Enrollment||participants|Number|0|0.0||||||
4026044|NCT01160744|3847683|B1|Poland||Region of Enrollment||participants|Number|0|0.0||||||
4026045|NCT01160744|3847679|B5|Belgium||Region of Enrollment||participants|Number|9|9.0||||||
4026046|NCT01160744|3847680|B4|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
4026047|NCT01160744|3847681|B3|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
4026048|NCT01160744|3847682|B2|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
4026049|NCT01160744|3847683|B1|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
4026050|NCT01160744|3847679|B5|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4026051|NCT01160744|3847680|B4|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4026052|NCT01160744|3847681|B3|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4026053|NCT01160744|3847682|B2|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4026054|NCT01160744|3847683|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4026055|NCT01160744|3847679|B5|United States||Region of Enrollment||participants|Number|223|223.0||||||
4026056|NCT01160744|3847680|B4|United States||Region of Enrollment||participants|Number|41|41.0||||||
4026057|NCT01160744|3847681|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4026058|NCT01160744|3847682|B2|United States||Region of Enrollment||participants|Number|69|69.0||||||
4026059|NCT01160744|3847683|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
4026060|NCT01160744|3847679|B5|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4026061|NCT01160744|3847680|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4026062|NCT01160744|3847681|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4026063|NCT01160744|3847682|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4026064|NCT01160744|3847683|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4026065|NCT01160744|3847679|B5|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4026066|NCT01160744|3847680|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4026067|NCT01160744|3847681|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4026068|NCT01160744|3847682|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4026069|NCT01160744|3847683|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4026070|NCT01160744|3847679|B5|Black||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4026071|NCT01160744|3847680|B4|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4026072|NCT01160744|3847681|B3|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4026073|NCT01160744|3847682|B2|Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4026074|NCT01160744|3847683|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4026075|NCT01160744|3847679|B5|White||Race/Ethnicity, Customized||participants|Number|257|257.0||||||
4026076|NCT01160744|3847680|B4|White||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
4026077|NCT01160744|3847681|B3|White||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
4026078|NCT01160744|3847682|B2|White||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
4026079|NCT01160744|3847683|B1|White||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
4026080|NCT01160744|3847679|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026081|NCT01160744|3847680|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026082|NCT01160744|3847681|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026083|NCT01160744|3847682|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026084|NCT01160744|3847683|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026085|NCT01160744|3847679|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|274|274.0||||||
4026086|NCT01160744|3847680|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
4026087|NCT01160744|3847681|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4026088|NCT01160744|3847682|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4026089|NCT01160744|3847683|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4026090|NCT01160744|3847679|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4026091|NCT01160744|3847680|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026092|NCT01160744|3847681|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4026093|NCT01160744|3847682|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4026094|NCT01160744|3847683|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4026095|NCT01160744|3847679|B5||Male|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4026096|NCT01160744|3847680|B4||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4026097|NCT01160744|3847681|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4026098|NCT01160744|3847682|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4026099|NCT01160744|3847683|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4026100|NCT01160744|3847679|B5||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4026101|NCT01160744|3847680|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4026102|NCT01160744|3847681|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4026103|NCT01160744|3847682|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4026104|NCT01160744|3847683|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4026105|NCT01160744|3847679|B5|Missing Data||Age, Customized||participants|Number|2|2.0||||||
4026106|NCT01160744|3847680|B4|Missing Data||Age, Customized||participants|Number|0|0.0||||||
4026107|NCT01160744|3847681|B3|Missing Data||Age, Customized||participants|Number|2|2.0||||||
4026108|NCT01160744|3847682|B2|Missing Data||Age, Customized||participants|Number|0|0.0||||||
4026109|NCT01160744|3847683|B1|Missing Data||Age, Customized||participants|Number|0|0.0||||||
4026110|NCT01160744|3847679|B5|>=65 years||Age, Customized||participants|Number|143|143.0||||||
4026111|NCT01160744|3847680|B4|>=65 years||Age, Customized||participants|Number|37|37.0||||||
4026112|NCT01160744|3847681|B3|>=65 years||Age, Customized||participants|Number|40|40.0||||||
4026113|NCT01160744|3847682|B2|>=65 years||Age, Customized||participants|Number|32|32.0||||||
4026114|NCT01160744|3847683|B1|>=65 years||Age, Customized||participants|Number|34|34.0||||||
4026115|NCT01160744|3847679|B5|Between 18 and 65 years||Age, Customized||participants|Number|135|135.0||||||
4026116|NCT01160744|3847680|B4|Between 18 and 65 years||Age, Customized||participants|Number|34|34.0||||||
4026117|NCT01160744|3847681|B3|Between 18 and 65 years||Age, Customized||participants|Number|27|27.0||||||
4026118|NCT01160744|3847682|B2|Between 18 and 65 years||Age, Customized||participants|Number|37|37.0||||||
4026119|NCT01160744|3847683|B1|Between 18 and 65 years||Age, Customized||participants|Number|37|37.0||||||
4026120|NCT01160744|3847679|B5|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4026121|NCT01160744|3847680|B4|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4026122|NCT01160744|3847681|B3|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4026123|NCT01160744|3847682|B2|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4026124|NCT01160744|3847683|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4026125|NCT01160640|3847720|B3|United States||Region of Enrollment||participants|Number|233|233.0||||||
4026126|NCT01160640|3847721|B2|United States||Region of Enrollment||participants|Number|116|116.0||||||
4026127|NCT01160640|3847722|B1|United States||Region of Enrollment||participants|Number|117|117.0||||||
4026128|NCT01160640|3847720|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4026129|NCT01160640|3847721|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4026130|NCT01160640|3847722|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4026131|NCT01160640|3847720|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4026132|NCT01160640|3847721|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4026133|NCT01160640|3847722|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4026134|NCT01160640|3847720|B3||White|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4026135|NCT01160640|3847721|B2||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4026136|NCT01160640|3847722|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4026137|NCT01160640|3847720|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
4026138|NCT01160640|3847721|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4026139|NCT01160640|3847722|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
4026140|NCT01160640|3847720|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4026141|NCT01160640|3847721|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026142|NCT01160640|3847722|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4026143|NCT01160640|3847720|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026144|NCT01160640|3847721|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026145|NCT01160640|3847722|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026146|NCT01160640|3847720|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4026147|NCT01160640|3847721|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4026148|NCT01160640|3847722|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026149|NCT01160640|3847720|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026150|NCT01160640|3847721|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026151|NCT01160640|3847722|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026152|NCT01160640|3847720|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|211|211.0||||||
4026153|NCT01160640|3847721|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
4026154|NCT01160640|3847722|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
4026155|NCT01160640|3847720|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4026156|NCT01160640|3847721|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4026157|NCT01160640|3847722|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4026158|NCT01160640|3847720|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4026159|NCT01160640|3847721|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4026160|NCT01160640|3847722|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4026161|NCT01160640|3847720|B3||Female|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
4026162|NCT01160640|3847721|B2||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4026163|NCT01160640|3847722|B1||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4026164|NCT01160640|3847720|B3|||Age||years|Mean|24.0|24.0|Standard Deviation|4.8|4.8|||
4026165|NCT01160640|3847721|B2|||Age||years|Mean|24.7|24.7|Standard Deviation|5.1|5.1|||
4026166|NCT01160640|3847722|B1|||Age||years|Mean|23.2|23.2|Standard Deviation|4.3|4.3|||
4026167|NCT01160614|3847737|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026168|NCT01160614|3847738|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026169|NCT01160614|3847739|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026170|NCT01160614|3847737|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026171|NCT01160614|3847738|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026172|NCT01160614|3847739|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026173|NCT01160614|3847737|B3||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4026174|NCT01160614|3847738|B2||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4026175|NCT01160614|3847739|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4026176|NCT01160614|3847737|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4026177|NCT01160614|3847738|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4026178|NCT01160614|3847739|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4026179|NCT01160614|3847737|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026180|NCT01160614|3847738|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026181|NCT01160614|3847739|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026182|NCT01160614|3847737|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026183|NCT01160614|3847738|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026184|NCT01160614|3847739|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026185|NCT01160614|3847737|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4026186|NCT01160614|3847738|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4026187|NCT01160614|3847739|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026188|NCT01160614|3847737|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4026189|NCT01160614|3847738|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4026190|NCT01160614|3847739|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4026191|NCT01160614|3847737|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4026192|NCT01160614|3847738|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4026193|NCT01160614|3847739|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4026194|NCT01160614|3847737|B3|||Age||Years|Mean|13.5|13.5|Standard Deviation|2.0|2.0|||
4026195|NCT01160614|3847738|B2|||Age||Years|Mean|14.1|14.1|Standard Deviation|1.6|1.6|||
4026196|NCT01160614|3847739|B1|||Age||Years|Mean|10.6|10.6|Standard Deviation|0.9|0.9|||
4026197|NCT01160484|3847788|B1|PLD+btz+dex and len+ glucocorticoids||Total Number of prior lines of treatment||number of treatments|Number|10|10.0||||||
4026198|NCT01160484|3847788|B1|PLD+btz+dexamethasone (dex)||Total Number of prior lines of treatment||number of treatments|Number|17|17.0||||||
4026199|NCT01160484|3847788|B1|Other||Total Number of prior lines of treatment||number of treatments|Number|11|11.0||||||
4026200|NCT01160484|3847788|B1|Transplant (autologous)||Total Number of prior lines of treatment||number of treatments|Number|5|5.0||||||
4026201|NCT01160484|3847788|B1|HDAC inhibitors (panobinostat/romidepsin)||Total Number of prior lines of treatment||number of treatments|Number|7|7.0||||||
4026202|NCT01160484|3847788|B1|Glucocorticoids||Total Number of prior lines of treatment||number of treatments|Number|35|35.0||||||
4026203|NCT01160484|3847788|B1|Lenalidomide (LEN)||Total Number of prior lines of treatment||number of treatments|Number|19|19.0||||||
4026204|NCT01160484|3847788|B1|Thalidomide||Total Number of prior lines of treatment||number of treatments|Number|15|15.0||||||
4026205|NCT01160484|3847788|B1|PLD or Doxorubucin||Total Number of prior lines of treatment||number of treatments|Number|15|15.0||||||
4026206|NCT01160484|3847788|B1|Alkylating agents||Total Number of prior lines of treatment||number of treatments|Number|20|20.0||||||
4026207|NCT01160484|3847788|B1|Bortezomib (BTZ)||Total Number of prior lines of treatment||number of treatments|Number|33|33.0||||||
4026208|NCT01160484|3847788|B1|||Prior treatments||number of treatments|Mean|3|3.0|Full Range|||1.0|17.0|
4026209|NCT01160484|3847788|B1|||Serum creatinine||mg/dL|Median|1.0|1.0|Full Range|||0.6|3.4|
4026210|NCT01160484|3847788|B1|||Urine-M protein||mg/dL|Median|261.1|261.1|Full Range|||0.0|7162.0|
4026211|NCT01160484|3847788|B1|||Serum M-protein||g/dL|Median|2.05|2.05|Full Range|||0.0|7.0|
4026212|NCT01160484|3847788|B1|III (B2M >5.5)||International Staging System (ISS); stage (N)||participants|Number|10|10.0||||||
4026213|NCT01160484|3847788|B1|II (B2M 3.5 +albumin < 3.5; or B2M 3.5–5.5)||International Staging System (ISS); stage (N)||participants|Number|14|14.0||||||
4026214|NCT01160484|3847788|B1|I (beta 2 microglobulin(B2M )<3.5 +Albumin ≥3.5)||International Staging System (ISS); stage (N)||participants|Number|16|16.0||||||
4026215|NCT01160484|3847788|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4026216|NCT01160484|3847788|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4026217|NCT01160484|3847788|B1|||Age||years|Median|71|71.0|Full Range|||34.0|86.0|
4026218|NCT01160484|3847788|B1||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4026219|NCT01160484|3847788|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4026220|NCT01160484|3847788|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4026221|NCT01160458|3847798|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4026222|NCT01160458|3847798|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026223|NCT01160458|3847798|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026224|NCT01160458|3847798|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4026225|NCT01160458|3847798|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4026226|NCT01160458|3847798|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4026227|NCT01160458|3847798|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026228|NCT01160458|3847798|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026229|NCT01160458|3847798|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026230|NCT01160458|3847798|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4026231|NCT01160458|3847798|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4026232|NCT01160458|3847798|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4026233|NCT01160458|3847798|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4026234|NCT01160458|3847798|B1|||Age||years|Mean|63.28|63.28|Standard Deviation|13.28|13.28|||
4026235|NCT01160458|3847798|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4026236|NCT01160458|3847798|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4026237|NCT01160458|3847798|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4026238|NCT01160445|3847806|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4026239|NCT01160445|3847807|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4026240|NCT01160445|3847808|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4026241|NCT01160445|3847806|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026242|NCT01160445|3847807|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026243|NCT01160445|3847808|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026244|NCT01160445|3847806|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026245|NCT01160445|3847807|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026246|NCT01160445|3847808|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026247|NCT01160445|3847806|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4026248|NCT01160445|3847807|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4026249|NCT01160445|3847808|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4026250|NCT01160445|3847806|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026251|NCT01160445|3847807|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026252|NCT01160445|3847808|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026253|NCT01160445|3847806|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026254|NCT01160445|3847807|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026255|NCT01160445|3847808|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026256|NCT01160445|3847806|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026257|NCT01160445|3847807|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026258|NCT01160445|3847808|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026259|NCT01160445|3847806|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026260|NCT01160445|3847807|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026261|NCT01160445|3847808|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026262|NCT01160445|3847806|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026263|NCT01160445|3847807|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026264|NCT01160445|3847808|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026265|NCT01160445|3847806|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4026266|NCT01160445|3847807|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4026267|NCT01160445|3847808|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4026268|NCT01160445|3847806|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026269|NCT01160445|3847807|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026270|NCT01160445|3847808|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026271|NCT01160445|3847806|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4026272|NCT01160445|3847807|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4026273|NCT01160445|3847808|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4026274|NCT01160445|3847806|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4026275|NCT01160445|3847807|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4026276|NCT01160445|3847808|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4026277|NCT01160445|3847806|B3|||Age||years|Mean|50.7|50.7|Standard Deviation|12.8|12.8|||
4026278|NCT01160445|3847807|B2|||Age||years|Mean|61.0|61.0|Standard Deviation|5.7|5.7|||
4026279|NCT01160445|3847808|B1|||Age||years|Mean|47.7|47.7|Standard Deviation|12.9|12.9|||
4026280|NCT01160445|3847806|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4026281|NCT01160445|3847807|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4026282|NCT01160445|3847808|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4026283|NCT01160445|3847806|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4026284|NCT01160445|3847807|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4026285|NCT01160445|3847808|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4026286|NCT01160445|3847806|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4026287|NCT01160445|3847807|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4026288|NCT01160445|3847808|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4026289|NCT01160380|3847817|B3|||Fatigue (baseline)-International Classification of Diseases version 10 (ICD-10)|ICD-10 Criteria (Range: 0-14) A1-A11 Fatigue Criteria B. Clinically significant distress or impaired functioning C. Symptoms are a consequence of cancer or cancer therapy D. Symptoms are a consequence of comorbid psychiatric disorders|units on a scale|Median|9|9.0|Full Range|||6.0|12.0|
4026290|NCT01160380|3847818|B2|||Fatigue (baseline)-International Classification of Diseases version 10 (ICD-10)|ICD-10 Criteria (Range: 0-14) A1-A11 Fatigue Criteria B. Clinically significant distress or impaired functioning C. Symptoms are a consequence of cancer or cancer therapy D. Symptoms are a consequence of comorbid psychiatric disorders|units on a scale|Median|9|9.0|Full Range|||6.0|12.0|
4026291|NCT01160380|3847819|B1|||Fatigue (baseline)-International Classification of Diseases version 10 (ICD-10)|ICD-10 Criteria (Range: 0-14) A1-A11 Fatigue Criteria B. Clinically significant distress or impaired functioning C. Symptoms are a consequence of cancer or cancer therapy D. Symptoms are a consequence of comorbid psychiatric disorders|units on a scale|Median|9|9.0|Full Range|||6.0|12.0|
4026292|NCT01160380|3847817|B3|||Fatigue (baseline)-Brief Fatigue Inventory (BFI)|BFI scale: 9 items; range=0-90 (0-10 per item) Mild = 1-3 Moderate = 4-7 Severe = 8-10|units on a scale|Median|60|60.0|Full Range|||36.0|83.0|
4026293|NCT01160380|3847818|B2|||Fatigue (baseline)-Brief Fatigue Inventory (BFI)|BFI scale: 9 items; range=0-90 (0-10 per item) Mild = 1-3 Moderate = 4-7 Severe = 8-10|units on a scale|Median|60.5|60.5|Full Range|||36.0|79.0|
4026294|NCT01160380|3847819|B1|||Fatigue (baseline)-Brief Fatigue Inventory (BFI)|BFI scale: 9 items; range=0-90 (0-10 per item) Mild = 1-3 Moderate = 4-7 Severe = 8-10|units on a scale|Median|59|59.0|Full Range|||39.0|83.0|
4026295|NCT01160380|3847817|B3|2||ECOG (Eastern Cooperative Oncology Group)|"Grade ECOG Performance status~0 Fully active, performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~Capable of only limited self-care, confined to bed or chair more than 50% of waking hours~Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair~Dead"|paarticipants|Number|3|3.0||||||
4026296|NCT01160380|3847818|B2|2||ECOG (Eastern Cooperative Oncology Group)|"Grade ECOG Performance status~0 Fully active, performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~Capable of only limited self-care, confined to bed or chair more than 50% of waking hours~Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair~Dead"|paarticipants|Number|1|1.0||||||
4026297|NCT01160380|3847819|B1|2||ECOG (Eastern Cooperative Oncology Group)|"Grade ECOG Performance status~0 Fully active, performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~Capable of only limited self-care, confined to bed or chair more than 50% of waking hours~Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair~Dead"|paarticipants|Number|2|2.0||||||
4026298|NCT01160380|3847817|B3|1||ECOG (Eastern Cooperative Oncology Group)|"Grade ECOG Performance status~0 Fully active, performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~Capable of only limited self-care, confined to bed or chair more than 50% of waking hours~Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair~Dead"|paarticipants|Number|35|35.0||||||
4026299|NCT01160380|3847818|B2|1||ECOG (Eastern Cooperative Oncology Group)|"Grade ECOG Performance status~0 Fully active, performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~Capable of only limited self-care, confined to bed or chair more than 50% of waking hours~Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair~Dead"|paarticipants|Number|17|17.0||||||
4026345|NCT01160198|3847868|B2|India||Region of Enrollment||Participants|Number|91|91.0||||||
4026300|NCT01160380|3847819|B1|1||ECOG (Eastern Cooperative Oncology Group)|"Grade ECOG Performance status~0 Fully active, performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~Capable of only limited self-care, confined to bed or chair more than 50% of waking hours~Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair~Dead"|paarticipants|Number|18|18.0||||||
4026301|NCT01160380|3847817|B3|0||ECOG (Eastern Cooperative Oncology Group)|"Grade ECOG Performance status~0 Fully active, performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~Capable of only limited self-care, confined to bed or chair more than 50% of waking hours~Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair~Dead"|paarticipants|Number|12|12.0||||||
4026302|NCT01160380|3847818|B2|0||ECOG (Eastern Cooperative Oncology Group)|"Grade ECOG Performance status~0 Fully active, performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~Capable of only limited self-care, confined to bed or chair more than 50% of waking hours~Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair~Dead"|paarticipants|Number|7|7.0||||||
4026303|NCT01160380|3847819|B1|0||ECOG (Eastern Cooperative Oncology Group)|"Grade ECOG Performance status~0 Fully active, performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~Capable of only limited self-care, confined to bed or chair more than 50% of waking hours~Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair~Dead"|paarticipants|Number|5|5.0||||||
4026304|NCT01160380|3847817|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4026305|NCT01160380|3847818|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4026306|NCT01160380|3847819|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4026307|NCT01160380|3847817|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026308|NCT01160380|3847818|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026309|NCT01160380|3847819|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026310|NCT01160380|3847817|B3||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4026311|NCT01160380|3847818|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4026312|NCT01160380|3847819|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4026313|NCT01160380|3847817|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4026314|NCT01160380|3847818|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4026315|NCT01160380|3847819|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4026316|NCT01160380|3847817|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026317|NCT01160380|3847818|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026318|NCT01160380|3847819|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026319|NCT01160380|3847817|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4026320|NCT01160380|3847818|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4026321|NCT01160380|3847819|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026322|NCT01160380|3847817|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026323|NCT01160380|3847818|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026324|NCT01160380|3847819|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026325|NCT01160380|3847817|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4026326|NCT01160380|3847818|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4026327|NCT01160380|3847819|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4026328|NCT01160380|3847817|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4026329|NCT01160380|3847818|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4026330|NCT01160380|3847819|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4026331|NCT01160380|3847817|B3|||Age||years|Mean|65|65.0|Standard Deviation|2.1|2.1|||
4026332|NCT01160380|3847818|B2|||Age||years|Mean|67|67.0|Standard Deviation|2.3|2.3|||
4026333|NCT01160380|3847819|B1|||Age||years|Mean|63|63.0|Standard Deviation|1.8|1.8|||
4026334|NCT01160237|3847838|B4|Male||Gender||subjects|Number|2|2.0||||||
4026335|NCT01160237|3847840|B2|Male||Gender||subjects|Number|1|1.0||||||
4026336|NCT01160237|3847841|B1|Male||Gender||subjects|Number|1|1.0||||||
4026337|NCT01160237|3847838|B4|Female||Gender||subjects|Number|5|5.0||||||
4026338|NCT01160237|3847840|B2|Female||Gender||subjects|Number|2|2.0||||||
4026339|NCT01160237|3847841|B1|Female||Gender||subjects|Number|3|3.0||||||
4026340|NCT01160237|3847838|B4|||Age||years|Mean|58.7|58.7|Standard Deviation|13.16|13.16|||
4026341|NCT01160237|3847840|B2|||Age||years|Mean|55.3|55.3|Standard Deviation|18.80|18.8|||
4026342|NCT01160237|3847841|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|9.50|9.5|||
4026343|NCT01160198|3847866|B4|India||Region of Enrollment||Participants|Number|270|270.0||||||
4026344|NCT01160198|3847867|B3|India||Region of Enrollment||Participants|Number|90|90.0||||||
4026346|NCT01160198|3847869|B1|India||Region of Enrollment||Participants|Number|89|89.0||||||
4026347|NCT01160198|3847866|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4026348|NCT01160198|3847867|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4026349|NCT01160198|3847868|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4026350|NCT01160198|3847869|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4026351|NCT01160198|3847866|B4||Female|Sex: Female, Male||Participants|Count of Participants|270|270.0||||||
4026352|NCT01160198|3847867|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4026353|NCT01160198|3847868|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4026354|NCT01160198|3847869|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4026355|NCT01160198|3847866|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4026356|NCT01160198|3847867|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4026357|NCT01160198|3847868|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4026358|NCT01160198|3847869|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4026359|NCT01160198|3847866|B4||Between 18 and 65 years|Age||Participants|Count of Participants|270|270.0||||||
4026360|NCT01160198|3847867|B3||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
4026361|NCT01160198|3847868|B2||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
4026362|NCT01160198|3847869|B1||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
4026363|NCT01160198|3847866|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4026364|NCT01160198|3847867|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4026365|NCT01160198|3847868|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4026366|NCT01160198|3847869|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4026367|NCT01159938|3847890|B4|Finland||Region of Enrollment||participants|Number|71|71.0||||||
4026368|NCT01159938|3847891|B3|Finland||Region of Enrollment||participants|Number|24|24.0||||||
4026369|NCT01159938|3847892|B2|Finland||Region of Enrollment||participants|Number|22|22.0||||||
4026370|NCT01159938|3847893|B1|Finland||Region of Enrollment||participants|Number|25|25.0||||||
4026371|NCT01159938|3847890|B4|White||Race/Ethnicity, Customized||participants|Number|71|71.0||||||
4026372|NCT01159938|3847891|B3|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4026373|NCT01159938|3847892|B2|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4026374|NCT01159938|3847893|B1|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4026375|NCT01159938|3847890|B4||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4026376|NCT01159938|3847891|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4026377|NCT01159938|3847892|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4026378|NCT01159938|3847893|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4026379|NCT01159938|3847890|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4026380|NCT01159938|3847891|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4026381|NCT01159938|3847892|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4026382|NCT01159938|3847893|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4026383|NCT01159938|3847890|B4|||Age||years|Mean|61.2|61.2|Standard Deviation|5.9|5.9|||
4026384|NCT01159938|3847891|B3|||Age||years|Mean|63.7|63.7|Standard Deviation|5.2|5.2|||
4026385|NCT01159938|3847892|B2|||Age||years|Mean|61.2|61.2|Standard Deviation|4.9|4.9|||
4026386|NCT01159938|3847893|B1|||Age||years|Mean|58.8|58.8|Standard Deviation|6.6|6.6|||
4026387|NCT01159912|3847957|B4|Missing||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4026388|NCT01159912|3847958|B3|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4026389|NCT01159912|3847959|B2|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4026390|NCT01159912|3847960|B1|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4026391|NCT01159912|3847957|B4|American Indian or Alaska Native & White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4026392|NCT01159912|3847958|B3|American Indian or Alaska Native & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4026393|NCT01159912|3847959|B2|American Indian or Alaska Native & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4026394|NCT01159912|3847960|B1|American Indian or Alaska Native & White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4026395|NCT01159912|3847957|B4|White||Race/Ethnicity, Customized||participants|Number|270|270.0||||||
4026396|NCT01159912|3847958|B3|White||Race/Ethnicity, Customized||participants|Number|92|92.0||||||
4026397|NCT01159912|3847959|B2|White||Race/Ethnicity, Customized||participants|Number|90|90.0||||||
4026398|NCT01159912|3847960|B1|White||Race/Ethnicity, Customized||participants|Number|88|88.0||||||
4026399|NCT01159912|3847957|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4026400|NCT01159912|3847958|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4026401|NCT01159912|3847959|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4026402|NCT01159912|3847960|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4026403|NCT01159912|3847957|B4|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4026404|NCT01159912|3847958|B3|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4026405|NCT01159912|3847959|B2|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4026406|NCT01159912|3847960|B1|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4026407|NCT01159912|3847957|B4|Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4026408|NCT01159912|3847958|B3|Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4026409|NCT01159912|3847959|B2|Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4026410|NCT01159912|3847960|B1|Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4026411|NCT01159912|3847957|B4|African American/African Heritage (HER)||Race/Ethnicity, Customized||participants|Number|64|64.0||||||
4026412|NCT01159912|3847958|B3|African American/African Heritage (HER)||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4026413|NCT01159912|3847959|B2|African American/African Heritage (HER)||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4026414|NCT01159912|3847960|B1|African American/African Heritage (HER)||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4026415|NCT01159912|3847957|B4||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4026416|NCT01159912|3847958|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4026417|NCT01159912|3847959|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4026418|NCT01159912|3847960|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4026419|NCT01159912|3847957|B4||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4026420|NCT01159912|3847958|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4026421|NCT01159912|3847959|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4026422|NCT01159912|3847960|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4026423|NCT01159912|3847957|B4|||Age||Years|Mean|40.6|40.6|Standard Deviation|16.48|16.48|||
4026424|NCT01159912|3847958|B3|||Age||Years|Mean|41.4|41.4|Standard Deviation|15.64|15.64|||
4026425|NCT01159912|3847959|B2|||Age||Years|Mean|40.1|40.1|Standard Deviation|16.17|16.17|||
4026426|NCT01159912|3847960|B1|||Age||Years|Mean|40.3|40.3|Standard Deviation|17.68|17.68|||
4026427|NCT01159769|3847985|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4026428|NCT01159769|3847985|B1||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4026429|NCT01159769|3847985|B1|||Age||years|Mean|55.03|55.03|Standard Deviation|18.58|18.58|||
4026430|NCT01159769|3847985|B1||>=65 years|Age||Participants|Count of Participants|81|81.0||||||
4026431|NCT01159769|3847985|B1||Between 18 and 65 years|Age||Participants|Count of Participants|127|127.0||||||
4026432|NCT01159769|3847985|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4026433|NCT01159743|3847990|B3|No||Previous acquired immunodeficiency syndrome (AIDS) diagnosis|Data available for 237 and 108 patients in each treatment group respectively, 345 total patients.|participants|Number|272|272.0||||||
4026434|NCT01159743|3847991|B2|No||Previous acquired immunodeficiency syndrome (AIDS) diagnosis|Data available for 237 and 108 patients in each treatment group respectively, 345 total patients.|participants|Number|74|74.0||||||
4026435|NCT01159743|3847992|B1|No||Previous acquired immunodeficiency syndrome (AIDS) diagnosis|Data available for 237 and 108 patients in each treatment group respectively, 345 total patients.|participants|Number|198|198.0||||||
4026436|NCT01159743|3847990|B3|Yes||Previous acquired immunodeficiency syndrome (AIDS) diagnosis|Data available for 237 and 108 patients in each treatment group respectively, 345 total patients.|participants|Number|73|73.0||||||
4026437|NCT01159743|3847991|B2|Yes||Previous acquired immunodeficiency syndrome (AIDS) diagnosis|Data available for 237 and 108 patients in each treatment group respectively, 345 total patients.|participants|Number|34|34.0||||||
4026438|NCT01159743|3847992|B1|Yes||Previous acquired immunodeficiency syndrome (AIDS) diagnosis|Data available for 237 and 108 patients in each treatment group respectively, 345 total patients.|participants|Number|39|39.0||||||
4026439|NCT01159743|3847990|B3|||CD4+ T-cell count nadir|Data available for 231 and 107 patients in each treatment group respectively, 338 total patients.|cells/µL|Mean|202.00|202.0|Standard Deviation|134.39|134.39|||
4026440|NCT01159743|3847991|B2|||CD4+ T-cell count nadir|Data available for 231 and 107 patients in each treatment group respectively, 338 total patients.|cells/µL|Mean|169.94|169.94|Standard Deviation|153.84|153.84|||
4026441|NCT01159743|3847992|B1|||CD4+ T-cell count nadir|Data available for 231 and 107 patients in each treatment group respectively, 338 total patients.|cells/µL|Mean|216.85|216.85|Standard Deviation|121.88|121.88|||
4026442|NCT01159743|3847990|B3|||Cluster of differentiation 4 (CD4)+ T-cell count|Data available for 236 and 108 patients in each treatment group respectively, 344 total patients.|cells/µL|Mean|587.82|587.82|Standard Deviation|250.31|250.31|||
4026443|NCT01159743|3847991|B2|||Cluster of differentiation 4 (CD4)+ T-cell count|Data available for 236 and 108 patients in each treatment group respectively, 344 total patients.|cells/µL|Mean|592.75|592.75|Standard Deviation|258.77|258.77|||
4026444|NCT01159743|3847992|B1|||Cluster of differentiation 4 (CD4)+ T-cell count|Data available for 236 and 108 patients in each treatment group respectively, 344 total patients.|cells/µL|Mean|585.56|585.56|Standard Deviation|246.87|246.87|||
4026445|NCT01159743|3847990|B3|||Undetectable HIV-1 RNA (< 50 copies/mL)|Data available for 236 and 109 patients in each treatment group respectively, 345 total patients.|participants|Number|345|345.0||||||
4026446|NCT01159743|3847991|B2|||Undetectable HIV-1 RNA (< 50 copies/mL)|Data available for 236 and 109 patients in each treatment group respectively, 345 total patients.|participants|Number|109|109.0||||||
4026447|NCT01159743|3847992|B1|||Undetectable HIV-1 RNA (< 50 copies/mL)|Data available for 236 and 109 patients in each treatment group respectively, 345 total patients.|participants|Number|236|236.0||||||
4026448|NCT01159743|3847990|B3|More than 4 years||Time on current antiretroviral regimen||participants|Number|136|136.0||||||
4026449|NCT01159743|3847991|B2|More than 4 years||Time on current antiretroviral regimen||participants|Number|50|50.0||||||
4026450|NCT01159743|3847992|B1|More than 4 years||Time on current antiretroviral regimen||participants|Number|86|86.0||||||
4026510|NCT01159600|3848048|B4||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4026451|NCT01159743|3847990|B3|3 - 4 years||Time on current antiretroviral regimen||participants|Number|108|108.0||||||
4026452|NCT01159743|3847991|B2|3 - 4 years||Time on current antiretroviral regimen||participants|Number|32|32.0||||||
4026453|NCT01159743|3847992|B1|3 - 4 years||Time on current antiretroviral regimen||participants|Number|76|76.0||||||
4026454|NCT01159743|3847990|B3|2 - 3 years||Time on current antiretroviral regimen||participants|Number|102|102.0||||||
4026455|NCT01159743|3847991|B2|2 - 3 years||Time on current antiretroviral regimen||participants|Number|27|27.0||||||
4026456|NCT01159743|3847992|B1|2 - 3 years||Time on current antiretroviral regimen||participants|Number|75|75.0||||||
4026457|NCT01159743|3847990|B3|HCV negative||Hepatitis C Virus (HCV) Co-infection||participants|Number|272|272.0||||||
4026458|NCT01159743|3847991|B2|HCV negative||Hepatitis C Virus (HCV) Co-infection||participants|Number|76|76.0||||||
4026459|NCT01159743|3847992|B1|HCV negative||Hepatitis C Virus (HCV) Co-infection||participants|Number|196|196.0||||||
4026460|NCT01159743|3847990|B3|HCV positive||Hepatitis C Virus (HCV) Co-infection||participants|Number|74|74.0||||||
4026461|NCT01159743|3847991|B2|HCV positive||Hepatitis C Virus (HCV) Co-infection||participants|Number|33|33.0||||||
4026462|NCT01159743|3847992|B1|HCV positive||Hepatitis C Virus (HCV) Co-infection||participants|Number|41|41.0||||||
4026463|NCT01159743|3847990|B3|Spain||Region of Enrollment||participants|Number|346|346.0||||||
4026464|NCT01159743|3847991|B2|Spain||Region of Enrollment||participants|Number|109|109.0||||||
4026465|NCT01159743|3847992|B1|Spain||Region of Enrollment||participants|Number|237|237.0||||||
4026466|NCT01159743|3847990|B3||Male|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
4026467|NCT01159743|3847991|B2||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4026468|NCT01159743|3847992|B1||Male|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4026469|NCT01159743|3847990|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4026470|NCT01159743|3847991|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4026471|NCT01159743|3847992|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4026472|NCT01159743|3847990|B3|||Age|Data available for 235 and 109 patients in each treatment group respectively, 344 total patients.|years|Mean|42.8|42.8|Standard Deviation|9.69|9.69|||
4026473|NCT01159743|3847991|B2|||Age|Data available for 235 and 109 patients in each treatment group respectively, 344 total patients.|years|Mean|44.3|44.3|Standard Deviation|9.46|9.46|||
4026474|NCT01159743|3847992|B1|||Age|Data available for 235 and 109 patients in each treatment group respectively, 344 total patients.|years|Mean|42.2|42.2|Standard Deviation|9.74|9.74|||
4026475|NCT01159691|3848005|B1|||Height||centimeter (cm)|Mean|171.1|171.1|Standard Deviation|9.6|9.6|||
4026476|NCT01159691|3848005|B1|||Weight||kilogram (kg)|Mean|78.1|78.1|Standard Deviation|12.9|12.9|||
4026477|NCT01159691|3848005|B1|Germany||Region of Enrollment||participants|Number|76|76.0||||||
4026478|NCT01159691|3848005|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4026479|NCT01159691|3848005|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4026480|NCT01159691|3848005|B1|||Age||years|Mean|70.3|70.3|Standard Deviation|9.8|9.8|||
4026481|NCT01159691|3848005|B1||>=65 years|Age||Participants|Count of Participants|62|62.0||||||
4026482|NCT01159691|3848005|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4026483|NCT01159691|3848005|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4026484|NCT01159665|3848012|B7||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4026485|NCT01159665|3848013|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4026486|NCT01159665|3848014|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4026487|NCT01159665|3848015|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4026488|NCT01159665|3848016|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4026489|NCT01159665|3848017|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4026490|NCT01159665|3848018|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4026491|NCT01159665|3848012|B7||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4026492|NCT01159665|3848013|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4026493|NCT01159665|3848014|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4026494|NCT01159665|3848015|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4026495|NCT01159665|3848016|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4026496|NCT01159665|3848017|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4026497|NCT01159665|3848018|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4026498|NCT01159665|3848012|B7|||Age||years|Mean|66.0|66.0|Standard Deviation|10.5|10.5|||
4026499|NCT01159665|3848013|B6|||Age||years|Mean|69.8|69.8|Standard Deviation|7.80|7.8|||
4026500|NCT01159665|3848014|B5|||Age||years|Mean|59.3|59.3|Standard Deviation|11.87|11.87|||
4026501|NCT01159665|3848015|B4|||Age||years|Mean|62.5|62.5|Standard Deviation|8.66|8.66|||
4026502|NCT01159665|3848016|B3|||Age||years|Mean|63.8|63.8|Standard Deviation|9.38|9.38|||
4026503|NCT01159665|3848017|B2|||Age||years|Mean|65.6|65.6|Standard Deviation|13.50|13.5|||
4026504|NCT01159665|3848018|B1|||Age||years|Mean|71.3|71.3|Standard Deviation|8.56|8.56|||
4026505|NCT01159600|3848043|B9||Male|Sex: Female, Male||Participants|Count of Participants|795|795.0||||||
4026506|NCT01159600|3848044|B8||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4026507|NCT01159600|3848045|B7||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4026508|NCT01159600|3848046|B6||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4026509|NCT01159600|3848047|B5||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4026511|NCT01159600|3848049|B3||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4026512|NCT01159600|3848050|B2||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4026513|NCT01159600|3848051|B1||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4026514|NCT01159600|3848043|B9||Female|Sex: Female, Male||Participants|Count of Participants|678|678.0||||||
4026515|NCT01159600|3848044|B8||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4026516|NCT01159600|3848045|B7||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4026517|NCT01159600|3848046|B6||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4026518|NCT01159600|3848047|B5||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4026519|NCT01159600|3848048|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4026520|NCT01159600|3848049|B3||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4026521|NCT01159600|3848050|B2||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4026522|NCT01159600|3848051|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4026523|NCT01159600|3848043|B9|||Age||years|Mean|55.9|55.9|Standard Deviation|9.9|9.9|||
4026524|NCT01159600|3848044|B8|||Age||years|Mean|53.4|53.4|Standard Deviation|10.5|10.5|||
4026525|NCT01159600|3848045|B7|||Age||years|Mean|57.4|57.4|Standard Deviation|9.3|9.3|||
4026526|NCT01159600|3848046|B6|||Age||years|Mean|57.0|57.0|Standard Deviation|9.2|9.2|||
4026527|NCT01159600|3848047|B5|||Age||years|Mean|56.9|56.9|Standard Deviation|9.2|9.2|||
4026528|NCT01159600|3848048|B4|||Age||years|Mean|49.8|49.8|Standard Deviation|11.5|11.5|||
4026529|NCT01159600|3848049|B3|||Age||years|Mean|55.6|55.6|Standard Deviation|10.2|10.2|||
4026530|NCT01159600|3848050|B2|||Age||years|Mean|55.5|55.5|Standard Deviation|9.9|9.9|||
4026531|NCT01159600|3848051|B1|||Age||years|Mean|56.0|56.0|Standard Deviation|9.7|9.7|||
4026532|NCT01159574|3848100|B1|||lactage dehydrogenase at baseline (U/L)||u/l|Median|170.5|170.5|Full Range|||79.0|1353.0|
4026533|NCT01159574|3848100|B1|||Beta-2 microglobulin at baseline (in mg/L)||mg/L|Median|35|35.0|Full Range|||1.2|40.4|
4026534|NCT01159574|3848100|B1|||Range of Prior Therapies||years|Median|5|5.0|Full Range|||3.0|15.0|
4026535|NCT01159574|3848100|B1|||Hemoglobin||g/dL|Median|10.4|10.4|Full Range|||6.4|14.6|
4026536|NCT01159574|3848100|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4026537|NCT01159574|3848100|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026538|NCT01159574|3848100|B1||White|Race (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
4026539|NCT01159574|3848100|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4026540|NCT01159574|3848100|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026541|NCT01159574|3848100|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4026542|NCT01159574|3848100|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026543|NCT01159574|3848100|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4026544|NCT01159574|3848100|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|112|112.0||||||
4026545|NCT01159574|3848100|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4026546|NCT01159574|3848100|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4026547|NCT01159574|3848100|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4026548|NCT01159574|3848100|B1|||Age||years|Median|63|63.0|Full Range|||42.0|87.0|
4026549|NCT01159535|3848106|B4|United States||Region of Enrollment||participants|Number|286|286.0||||||
4026550|NCT01159535|3848107|B3|United States||Region of Enrollment||participants|Number|95|95.0||||||
4026551|NCT01159535|3848108|B2|United States||Region of Enrollment||participants|Number|88|88.0||||||
4026552|NCT01159535|3848109|B1|United States||Region of Enrollment||participants|Number|103|103.0||||||
4026553|NCT01159535|3848106|B4||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4026554|NCT01159535|3848107|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4026555|NCT01159535|3848108|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4026556|NCT01159535|3848109|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4026557|NCT01159535|3848106|B4||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4026558|NCT01159535|3848107|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4026559|NCT01159535|3848108|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4026560|NCT01159535|3848109|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4026561|NCT01159535|3848106|B4|||Age||years|Mean|38.5|38.5|Standard Deviation|10.9|10.9|||
4026562|NCT01159535|3848107|B3|||Age||years|Mean|37.2|37.2|Standard Deviation|10.8|10.8|||
4026563|NCT01159535|3848108|B2|||Age||years|Mean|38.9|38.9|Standard Deviation|10.9|10.9|||
4026564|NCT01159535|3848109|B1|||Age||years|Mean|39.1|39.1|Standard Deviation|10.9|10.9|||
4026565|NCT01159535|3848106|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4026566|NCT01159535|3848107|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4026567|NCT01159535|3848108|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4026568|NCT01159535|3848109|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4026569|NCT01159535|3848106|B4||Between 18 and 65 years|Age||Participants|Count of Participants|286|286.0||||||
4026570|NCT01159535|3848107|B3||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
4026571|NCT01159535|3848108|B2||Between 18 and 65 years|Age||Participants|Count of Participants|88|88.0||||||
4026572|NCT01159535|3848109|B1||Between 18 and 65 years|Age||Participants|Count of Participants|103|103.0||||||
4026573|NCT01159535|3848106|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4026574|NCT01159535|3848107|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4026575|NCT01159535|3848108|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4026576|NCT01159535|3848109|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4026577|NCT01159431|3848119|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4026578|NCT01159431|3848120|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4026579|NCT01159431|3848121|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4026580|NCT01159431|3848119|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4026581|NCT01159431|3848120|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4026582|NCT01159431|3848121|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4026583|NCT01159431|3848119|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4026584|NCT01159431|3848120|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4026585|NCT01159431|3848121|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4026586|NCT01159431|3848119|B3|||Age||years|Mean|33.44|33.44|Standard Deviation|10.58|10.58|||
4026587|NCT01159431|3848120|B2|||Age||years|Mean|34.2|34.2|Standard Deviation|10.81|10.81|||
4026588|NCT01159431|3848121|B1|||Age||years|Mean|33.1|33.1|Standard Deviation|10.57|10.57|||
4026589|NCT01159431|3848119|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4026590|NCT01159431|3848120|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4026591|NCT01159431|3848121|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4026592|NCT01159431|3848119|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4026593|NCT01159431|3848120|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4026594|NCT01159431|3848121|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4026595|NCT01159431|3848119|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4026596|NCT01159431|3848120|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4026597|NCT01159431|3848121|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4026598|NCT01159262|3848138|B4|United States||Region of Enrollment||participants|Number|36|36.0||||||
4026599|NCT01159262|3848139|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4026600|NCT01159262|3848140|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4026601|NCT01159262|3848141|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4026602|NCT01159262|3848138|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4026603|NCT01159262|3848139|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4026604|NCT01159262|3848140|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4026605|NCT01159262|3848141|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4026606|NCT01159262|3848138|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4026607|NCT01159262|3848139|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026608|NCT01159262|3848140|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026609|NCT01159262|3848141|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4026610|NCT01159262|3848138|B4||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4026611|NCT01159262|3848139|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4026612|NCT01159262|3848140|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4026613|NCT01159262|3848141|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4026614|NCT01159262|3848138|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4026615|NCT01159262|3848139|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026616|NCT01159262|3848140|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4026617|NCT01159262|3848141|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026618|NCT01159262|3848138|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026619|NCT01159262|3848139|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026620|NCT01159262|3848140|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026621|NCT01159262|3848141|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026622|NCT01159262|3848138|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026623|NCT01159262|3848139|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026624|NCT01159262|3848140|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026625|NCT01159262|3848141|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026626|NCT01159262|3848138|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026627|NCT01159262|3848139|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026628|NCT01159262|3848140|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026629|NCT01159262|3848141|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026630|NCT01159262|3848138|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4026631|NCT01159262|3848139|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4026632|NCT01159262|3848140|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4026633|NCT01159262|3848141|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4026634|NCT01159262|3848138|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4026635|NCT01159262|3848139|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4026636|NCT01159262|3848140|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4026637|NCT01159262|3848141|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4026638|NCT01159262|3848138|B4|>= 36 weeks to <= 44 weeks gestational age||Age, Customized||Participants|Number|24|24.0||||||
4026639|NCT01159262|3848139|B3|>= 36 weeks to <= 44 weeks gestational age||Age, Customized||Participants|Number|8|8.0||||||
4026640|NCT01159262|3848140|B2|>= 36 weeks to <= 44 weeks gestational age||Age, Customized||Participants|Number|8|8.0||||||
4026641|NCT01159262|3848141|B1|>= 36 weeks to <= 44 weeks gestational age||Age, Customized||Participants|Number|8|8.0||||||
4026642|NCT01159262|3848138|B4|= 28 weeks to < 36 weeks gestational age||Age, Customized||Participants|Number|12|12.0||||||
4026643|NCT01159262|3848139|B3|= 28 weeks to < 36 weeks gestational age||Age, Customized||Participants|Number|0|0.0||||||
4026644|NCT01159262|3848140|B2|= 28 weeks to < 36 weeks gestational age||Age, Customized||Participants|Number|6|6.0||||||
4026645|NCT01159262|3848141|B1|= 28 weeks to < 36 weeks gestational age||Age, Customized||Participants|Number|6|6.0||||||
4026646|NCT01159262|3848138|B4|||Age||weeks|Mean|1.558|1.558|Standard Deviation|1.5382|1.5382|||
4026647|NCT01159262|3848139|B3|||Age||weeks|Mean|2.225|2.225|Standard Deviation|1.5779|1.5779|||
4026648|NCT01159262|3848140|B2|||Age||weeks|Mean|1.098|1.098|Standard Deviation|1.0849|1.0849|||
4026649|NCT01159262|3848141|B1|||Age||weeks|Mean|1.637|1.637|Standard Deviation|1.8290|1.829|||
4026650|NCT01159262|3848138|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4026651|NCT01159262|3848139|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4026652|NCT01159262|3848140|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4026653|NCT01159262|3848141|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4026654|NCT01159262|3848138|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4026655|NCT01159262|3848139|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4026656|NCT01159262|3848140|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4026657|NCT01159262|3848141|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4026658|NCT01159262|3848138|B4||<=18 years|Age||Participants|Count of Participants|36|36.0||||||
4026659|NCT01159262|3848139|B3||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4026660|NCT01159262|3848140|B2||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4026661|NCT01159262|3848141|B1||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4026662|NCT01159171|3848175|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4026663|NCT01159171|3848175|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4026664|NCT01159171|3848175|B1|||Age||years|Mean|59.08|59.08|Standard Deviation|9.62|9.62|||
4026665|NCT01159054|3848190|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4026666|NCT01159054|3848190|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4026667|NCT01159054|3848190|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4026668|NCT01159054|3848190|B1|||Age||years|Mean|58.9|58.9|Full Range|||25.0|89.0|
4026669|NCT01159054|3848190|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4026670|NCT01159054|3848190|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4026671|NCT01159054|3848190|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4026672|NCT01158976|3848202|B3|United States||Region of Enrollment||participants|Number|64|64.0||||||
4026673|NCT01158976|3848203|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4026674|NCT01158976|3848204|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4026675|NCT01158976|3848202|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026676|NCT01158976|3848203|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026677|NCT01158976|3848204|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026678|NCT01158976|3848202|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026679|NCT01158976|3848203|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026680|NCT01158976|3848204|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026681|NCT01158976|3848202|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026682|NCT01158976|3848203|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026683|NCT01158976|3848204|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026684|NCT01158976|3848202|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4026685|NCT01158976|3848203|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4026686|NCT01158976|3848204|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4026687|NCT01158976|3848202|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026688|NCT01158976|3848203|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026689|NCT01158976|3848204|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026690|NCT01158976|3848202|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026691|NCT01158976|3848203|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026692|NCT01158976|3848204|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026693|NCT01158976|3848202|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026694|NCT01158976|3848203|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026695|NCT01158976|3848204|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026696|NCT01158976|3848202|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4026697|NCT01158976|3848203|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4026698|NCT01158976|3848204|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4026699|NCT01158976|3848202|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4026700|NCT01158976|3848203|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4026701|NCT01158976|3848204|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4026702|NCT01158976|3848202|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4026703|NCT01158976|3848203|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4026704|NCT01158976|3848204|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4026705|NCT01158976|3848202|B3||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4026706|NCT01158976|3848203|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4026707|NCT01158976|3848204|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4026708|NCT01158976|3848202|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4026709|NCT01158976|3848203|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4026710|NCT01158976|3848204|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4026711|NCT01158924|3848247|B3|Australia||Region of Enrollment||participants|Number|40|40.0||||||
4026712|NCT01158924|3848248|B2|Australia||Region of Enrollment||participants|Number|26|26.0||||||
4026713|NCT01158924|3848249|B1|Australia||Region of Enrollment||participants|Number|14|14.0||||||
4026714|NCT01158924|3848247|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4026715|NCT01158924|3848248|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4026716|NCT01158924|3848249|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4026717|NCT01158924|3848247|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4026718|NCT01158924|3848248|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4026719|NCT01158924|3848249|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4026720|NCT01158924|3848247|B3|||Age||years|Mean|46.9|46.9|Standard Deviation|10.59|10.59|||
4026721|NCT01158924|3848248|B2|||Age||years|Mean|48.3|48.3|Standard Deviation|10.37|10.37|||
4026722|NCT01158924|3848249|B1|||Age||years|Mean|44.2|44.2|Standard Deviation|10.85|10.85|||
4026723|NCT01158820|3848264|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4026724|NCT01158820|3848265|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4026725|NCT01158820|3848266|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4026726|NCT01158820|3848264|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4026727|NCT01158820|3848265|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4026728|NCT01158820|3848266|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4026729|NCT01158820|3848264|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4026730|NCT01158820|3848265|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4026731|NCT01158820|3848266|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4026732|NCT01158820|3848264|B3|||Age||years|Mean|59.88|59.88|Standard Deviation|15.86|15.86|||
4026733|NCT01158820|3848265|B2|||Age||years|Mean|61.2|61.2|Standard Deviation|14.9|14.9|||
4026734|NCT01158820|3848266|B1|||Age||years|Mean|59.4|59.4|Standard Deviation|13.2|13.2|||
4026735|NCT01158820|3848264|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4026736|NCT01158820|3848265|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4026737|NCT01158820|3848266|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4026738|NCT01158820|3848264|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4026739|NCT01158820|3848265|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4026740|NCT01158820|3848266|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4026741|NCT01158820|3848264|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4026742|NCT01158820|3848265|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4026743|NCT01158820|3848266|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4026744|NCT01158716|3848287|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4026745|NCT01158716|3848288|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4026746|NCT01158716|3848289|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4026747|NCT01158716|3848287|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4026748|NCT01158716|3848288|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4026749|NCT01158716|3848289|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4026750|NCT01158716|3848287|B3|||Age||years|Mean|60.5|60.5|Standard Deviation|10.6|10.6|||
4026751|NCT01158716|3848288|B2|||Age||years|Mean|60.2|60.2|Standard Deviation|10.9|10.9|||
4026752|NCT01158716|3848289|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|10.4|10.4|||
4026753|NCT01158703|3848296|B3|||Diastolic Blood Pressure||mmHg|Mean|67.8|67.8|Standard Deviation|8.5|8.5|||
4026754|NCT01158703|3848297|B2|||Diastolic Blood Pressure||mmHg|Mean|65.1|65.1|Standard Deviation|7.3|7.3|||
4026755|NCT01158703|3848298|B1|||Diastolic Blood Pressure||mmHg|Mean|69.5|69.5|Standard Deviation|9.1|9.1|||
4026756|NCT01158703|3848296|B3|||Systolic Blood Pressure||mmHg|Mean|116.8|116.8|Standard Deviation|11.6|11.6|||
4026757|NCT01158703|3848297|B2|||Systolic Blood Pressure||mmHg|Mean|115.4|115.4|Standard Deviation|12.34|12.34|||
4026758|NCT01158703|3848298|B1|||Systolic Blood Pressure||mmHg|Mean|117.8|117.8|Standard Deviation|10.7|10.7|||
4026759|NCT01158703|3848296|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4026760|NCT01158703|3848297|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4026761|NCT01158703|3848298|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4026762|NCT01158703|3848296|B3||Male|Sex: Female, Male|Gender distribution among groups|Participants|Count of Participants|18|18.0||||||
4026763|NCT01158703|3848297|B2||Male|Sex: Female, Male|Gender distribution among groups|Participants|Count of Participants|7|7.0||||||
4026764|NCT01158703|3848298|B1||Male|Sex: Female, Male|Gender distribution among groups|Participants|Count of Participants|11|11.0||||||
4026765|NCT01158703|3848296|B3||Female|Sex: Female, Male|Gender distribution among groups|Participants|Count of Participants|2|2.0||||||
4026766|NCT01158703|3848297|B2||Female|Sex: Female, Male|Gender distribution among groups|Participants|Count of Participants|1|1.0||||||
4026767|NCT01158703|3848298|B1||Female|Sex: Female, Male|Gender distribution among groups|Participants|Count of Participants|1|1.0||||||
4026768|NCT01158703|3848296|B3|||Age||years|Mean|66.4|66.4|Standard Deviation|9.9|9.9|||
4026769|NCT01158703|3848297|B2|||Age||years|Mean|64.8|64.8|Standard Deviation|10.2|10.2|||
4026770|NCT01158703|3848298|B1|||Age||years|Mean|67.4|67.4|Standard Deviation|9.7|9.7|||
4026771|NCT01158573|3848315|B5|||BMI||kg/m^2|Mean|30.8|30.8|Standard Deviation|9.2|9.2|||
4026772|NCT01158573|3848316|B4|||BMI||kg/m^2|Mean|37.7|37.7|Standard Deviation|5.4|5.4|||
4026773|NCT01158573|3848317|B3|||BMI||kg/m^2|Mean|22.8|22.8|Standard Deviation|1.7|1.7|||
4026774|NCT01158573|3848318|B2|||BMI||kg/m^2|Mean|22.9|22.9|Standard Deviation|1.7|1.7|||
4026775|NCT01158573|3848319|B1|||BMI||kg/m^2|Mean|38.9|38.9|Standard Deviation|6.1|6.1|||
4026776|NCT01158573|3848315|B5||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4026777|NCT01158573|3848316|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4026778|NCT01158573|3848317|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4026779|NCT01158573|3848318|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4026780|NCT01158573|3848319|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4026781|NCT01158573|3848315|B5||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4026782|NCT01158573|3848316|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4026783|NCT01158573|3848317|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4026784|NCT01158573|3848318|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4026785|NCT01158573|3848319|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4026786|NCT01158573|3848315|B5|||Age||years|Mean|37.0|37.0|Standard Deviation|13.6|13.6|||
4026787|NCT01158573|3848316|B4|||Age||years|Mean|42.7|42.7|Standard Deviation|13.6|13.6|||
4026788|NCT01158573|3848317|B3|||Age||years|Mean|29.9|29.9|Standard Deviation|9.8|9.8|||
4026789|NCT01158573|3848318|B2|||Age||years|Mean|31.5|31.5|Standard Deviation|11.6|11.6|||
4026790|NCT01158573|3848319|B1|||Age||years|Mean|44.0|44.0|Standard Deviation|10.3|10.3|||
4026791|NCT01158534|3848344|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4026792|NCT01158534|3848344|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4026793|NCT01158534|3848344|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4026794|NCT01158534|3848344|B1|||Age||years|Mean|62.9|62.9|Standard Deviation|9.6|9.6|||
4026795|NCT01158521|3848352|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4026796|NCT01158521|3848352|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4026797|NCT01158521|3848352|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4026798|NCT01158521|3848352|B1|||Age||years|Median|64|64.0|Inter-Quartile Range|||37.0|80.0|
4026799|NCT01158378|3848361|B3|United States||Region of Enrollment||participants|Number|242|242.0||||||
4026800|NCT01158378|3848362|B2|United States||Region of Enrollment||participants|Number|122|122.0||||||
4026801|NCT01158378|3848363|B1|United States||Region of Enrollment||participants|Number|120|120.0||||||
4026802|NCT01158378|3848361|B3||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4026803|NCT01158378|3848362|B2||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4026804|NCT01158378|3848363|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4026805|NCT01158378|3848361|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4026806|NCT01158378|3848362|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4026807|NCT01158378|3848363|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4026808|NCT01158378|3848361|B3|||Age, Customized||years|Mean|50.4|50.4|Standard Deviation|15.1|15.1|||
4026809|NCT01158378|3848362|B2|||Age, Customized||years|Mean|49.6|49.6|Standard Deviation|15.1|15.1|||
4026810|NCT01158378|3848363|B1|||Age, Customized||years|Mean|51.1|51.1|Standard Deviation|14.0|14.0|||
4026811|NCT01158261|3848376|B1|Current smoker||History of Smoking||participants|Number|56|56.0||||||
4026812|NCT01158261|3848376|B1|Ex-smoker||History of Smoking||participants|Number|136|136.0||||||
4026813|NCT01158261|3848376|B1|Never smoked||History of Smoking||participants|Number|108|108.0||||||
4026814|NCT01158261|3848376|B1|Morbidly obese||BMI (grouped)||participants|Number|24|24.0||||||
4026815|NCT01158261|3848376|B1|Obese||BMI (grouped)||participants|Number|108|108.0||||||
4026816|NCT01158261|3848376|B1|Overweight||BMI (grouped)||participants|Number|79|79.0||||||
4026817|NCT01158261|3848376|B1|Normal||BMI (grouped)||participants|Number|84|84.0||||||
4026818|NCT01158261|3848376|B1|Underweight||BMI (grouped)||participants|Number|5|5.0||||||
4026819|NCT01158261|3848376|B1|United States||Region of Enrollment||participants|Number|300|300.0||||||
4026820|NCT01158261|3848376|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026821|NCT01158261|3848376|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4026822|NCT01158261|3848376|B1||White|Race (NIH/OMB)||Participants|Count of Participants|185|185.0||||||
4026823|NCT01158261|3848376|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
4026824|NCT01158261|3848376|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4026825|NCT01158261|3848376|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4026826|NCT01158261|3848376|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026827|NCT01158261|3848376|B1||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4026828|NCT01158261|3848376|B1||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4026829|NCT01158261|3848376|B1|||Age|The study population has a mean age of 62.2 years (std 13.9). The median is reported in the table below.|years|Median|64|64.0|Full Range|||19.0|91.0|
4026830|NCT01158261|3848376|B1||>=65 years|Age||Participants|Count of Participants|149|149.0||||||
4026831|NCT01158261|3848376|B1||Between 18 and 65 years|Age||Participants|Count of Participants|151|151.0||||||
4026832|NCT01158261|3848376|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4026833|NCT01158222|3848380|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4026834|NCT01158222|3848380|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4026835|NCT01158222|3848380|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026836|NCT01158222|3848380|B1||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4026837|NCT01158222|3848380|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4026838|NCT01158222|3848380|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026839|NCT01158222|3848380|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026840|NCT01158222|3848380|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026841|NCT01158222|3848380|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4026842|NCT01158222|3848380|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4026843|NCT01158222|3848380|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026844|NCT01158222|3848380|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4026845|NCT01158222|3848380|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4026846|NCT01158222|3848380|B1|80-89||Age, Customized||Participants|Count of Participants|1|1.0||||||
4026847|NCT01158222|3848380|B1|70-79||Age, Customized||Participants|Count of Participants|6|6.0||||||
4026848|NCT01158222|3848380|B1|60-69||Age, Customized||Participants|Count of Participants|18|18.0||||||
4026849|NCT01158222|3848380|B1|50-59||Age, Customized||Participants|Count of Participants|9|9.0||||||
4026850|NCT01158222|3848380|B1|40-49||Age, Customized||Participants|Count of Participants|3|3.0||||||
4026851|NCT01158118|3848386|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
4026852|NCT01158118|3848387|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4026853|NCT01158118|3848388|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4026854|NCT01158118|3848386|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4026855|NCT01158118|3848387|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4026856|NCT01158118|3848388|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4026857|NCT01158118|3848386|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4026858|NCT01158118|3848387|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4026859|NCT01158118|3848388|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4026860|NCT01158118|3848386|B3|||Age||years|Median|56|56.0|Full Range|||21.0|65.0|
4026861|NCT01158118|3848387|B2|||Age||years|Median|57|57.0|Full Range|||32.0|64.0|
4026862|NCT01158118|3848388|B1|||Age||years|Median|53|53.0|Full Range|||21.0|65.0|
4026863|NCT01157845|3848405|B1|Other||Chronic Liver Disease Etiology||participants|Number|11|11.0||||||
4026864|NCT01157845|3848405|B1|Fatty LIver||Chronic Liver Disease Etiology||participants|Number|19|19.0||||||
4026865|NCT01157845|3848405|B1|Hepatitis C||Chronic Liver Disease Etiology||participants|Number|75|75.0||||||
4026866|NCT01157845|3848405|B1|Hepatitis B||Chronic Liver Disease Etiology||participants|Number|5|5.0||||||
4026867|NCT01157845|3848405|B1|Cryptogenic cirrhosis||Chronic Liver Disease Etiology||participants|Number|17|17.0||||||
4026868|NCT01157845|3848405|B1|Cholestatic||Chronic Liver Disease Etiology||participants|Number|16|16.0||||||
4026869|NCT01157845|3848405|B1|Alcoholic Liver Disease||Chronic Liver Disease Etiology||participants|Number|22|22.0||||||
4026870|NCT01157845|3848405|B1|Israel||Region of Enrollment||participants|Number|66|66.0||||||
4026871|NCT01157845|3848405|B1|United States||Region of Enrollment||participants|Number|99|99.0||||||
4026872|NCT01157845|3848405|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026873|NCT01157845|3848405|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|163|163.0||||||
4026874|NCT01157845|3848405|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4026875|NCT01157845|3848405|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4026876|NCT01157845|3848405|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4026877|NCT01157845|3848405|B1|||Age||years|Mean|55.7|55.7|Standard Deviation|10.43|10.43|||
4026878|NCT01157533|3848410|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4026879|NCT01157533|3848410|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4026880|NCT01157533|3848410|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4026881|NCT01157533|3848410|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4026882|NCT01157533|3848410|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4026883|NCT01157533|3848410|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4026884|NCT01157429|3848414|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4026885|NCT01157429|3848415|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4026886|NCT01157429|3848416|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4026887|NCT01157429|3848414|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4026888|NCT01157429|3848415|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4026889|NCT01157429|3848416|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4026890|NCT01157429|3848414|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4026891|NCT01157429|3848415|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4026892|NCT01157429|3848416|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4026893|NCT01157429|3848414|B3|||Age||years|Mean|15.8|15.8|Standard Deviation|1.6|1.6|||
4026894|NCT01157429|3848415|B2|||Age||years|Mean|15.9|15.9|Standard Deviation|1.7|1.7|||
4026895|NCT01157429|3848416|B1|||Age||years|Mean|15.7|15.7|Standard Deviation|1.6|1.6|||
4026896|NCT01157416|3848423|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
4026897|NCT01157416|3848424|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4026898|NCT01157416|3848425|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4026899|NCT01157416|3848423|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4026900|NCT01157416|3848424|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4026901|NCT01157416|3848425|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4026902|NCT01157416|3848423|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4026903|NCT01157416|3848424|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4026904|NCT01157416|3848425|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4026905|NCT01157416|3848423|B3|||Age||years|Mean|10.1|10.1|Standard Deviation|1.9|1.9|||
4026906|NCT01157416|3848424|B2|||Age||years|Mean|10.2|10.2|Standard Deviation|1.9|1.9|||
4026907|NCT01157416|3848425|B1|||Age||years|Mean|10.1|10.1|Standard Deviation|1.8|1.8|||
4026908|NCT01157377|3848432|B8||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4026909|NCT01157377|3848433|B7||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4026910|NCT01157377|3848434|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4026911|NCT01157377|3848435|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4026912|NCT01157377|3848436|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4026913|NCT01157377|3848437|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4026914|NCT01157377|3848438|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4026915|NCT01157377|3848439|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4026916|NCT01157377|3848432|B8||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4026917|NCT01157377|3848433|B7||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4026918|NCT01157377|3848434|B6||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4026919|NCT01157377|3848435|B5||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4026920|NCT01157377|3848436|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4026921|NCT01157377|3848437|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4026922|NCT01157377|3848438|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4026923|NCT01157377|3848439|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4026924|NCT01157377|3848432|B8|>=65 years||Age, Customized||Participants|Number|59|59.0||||||
4026925|NCT01157377|3848433|B7|>=65 years||Age, Customized||Participants|Number|12|12.0||||||
4026926|NCT01157377|3848434|B6|>=65 years||Age, Customized||Participants|Number|9|9.0||||||
4026927|NCT01157377|3848435|B5|>=65 years||Age, Customized||Participants|Number|7|7.0||||||
4026928|NCT01157377|3848436|B4|>=65 years||Age, Customized||Participants|Number|6|6.0||||||
4026929|NCT01157377|3848437|B3|>=65 years||Age, Customized||Participants|Number|12|12.0||||||
4026930|NCT01157377|3848438|B2|>=65 years||Age, Customized||Participants|Number|7|7.0||||||
4026931|NCT01157377|3848439|B1|>=65 years||Age, Customized||Participants|Number|6|6.0||||||
4026932|NCT01157377|3848432|B8|40-64 years||Age, Customized||Participants|Number|93|93.0||||||
4026933|NCT01157377|3848433|B7|40-64 years||Age, Customized||Participants|Number|16|16.0||||||
4026934|NCT01157377|3848434|B6|40-64 years||Age, Customized||Participants|Number|10|10.0||||||
4026935|NCT01157377|3848435|B5|40-64 years||Age, Customized||Participants|Number|13|13.0||||||
4026936|NCT01157377|3848436|B4|40-64 years||Age, Customized||Participants|Number|9|9.0||||||
4026937|NCT01157377|3848437|B3|40-64 years||Age, Customized||Participants|Number|14|14.0||||||
4026938|NCT01157377|3848438|B2|40-64 years||Age, Customized||Participants|Number|15|15.0||||||
4026939|NCT01157377|3848439|B1|40-64 years||Age, Customized||Participants|Number|16|16.0||||||
4026940|NCT01157377|3848432|B8|< 40 years||Age, Customized||Participants|Number|4|4.0||||||
4026941|NCT01157377|3848433|B7|< 40 years||Age, Customized||Participants|Number|1|1.0||||||
4026942|NCT01157377|3848434|B6|< 40 years||Age, Customized||Participants|Number|0|0.0||||||
4026943|NCT01157377|3848435|B5|< 40 years||Age, Customized||Participants|Number|0|0.0||||||
4026944|NCT01157377|3848436|B4|< 40 years||Age, Customized||Participants|Number|0|0.0||||||
4026945|NCT01157377|3848437|B3|< 40 years||Age, Customized||Participants|Number|1|1.0||||||
4026946|NCT01157377|3848438|B2|< 40 years||Age, Customized||Participants|Number|1|1.0||||||
4026947|NCT01157377|3848439|B1|< 40 years||Age, Customized||Participants|Number|1|1.0||||||
4026948|NCT01157351|3848461|B3|||Baseline Clinical Global Impression - Severity (CGI-S) Total Score|The CGI-S rating scale was a 7-point global assessment of symptom severity with scores determined by clinician as follows: 1=Not ill, 2=Very Mild, 3= Mild, 4= Moderate, 5= Marked, 6= Severe, and 7= Extremely Severe. The higher the score the worse the illness.|Units on a scale|Mean|3.8|3.8|Standard Deviation|0.75|0.75|||
4026949|NCT01157351|3848462|B2|||Baseline Clinical Global Impression - Severity (CGI-S) Total Score|The CGI-S rating scale was a 7-point global assessment of symptom severity with scores determined by clinician as follows: 1=Not ill, 2=Very Mild, 3= Mild, 4= Moderate, 5= Marked, 6= Severe, and 7= Extremely Severe. The higher the score the worse the illness.|Units on a scale|Mean|3.9|3.9|Standard Deviation|0.70|0.7|||
4026950|NCT01157351|3848463|B1|||Baseline Clinical Global Impression - Severity (CGI-S) Total Score|The CGI-S rating scale was a 7-point global assessment of symptom severity with scores determined by clinician as follows: 1=Not ill, 2=Very Mild, 3= Mild, 4= Moderate, 5= Marked, 6= Severe, and 7= Extremely Severe. The higher the score the worse the illness.|Units on a scale|Mean|3.8|3.8|Standard Deviation|0.80|0.8|||
4026951|NCT01157351|3848461|B3|||Baseline Personal and Social Performance (PSP) Total Score|The PSP score assesses degree of difficulty within 4 domains of behavior using 6-point Likert scale(0=absent to 5=very severe).The domain ratings were then transformed to PSP total score ranging from 1 to 100. Higher PSP total scores=better functioning.|Units on a scale|Mean|54.9|54.9|Standard Deviation|12.76|12.76|||
4026952|NCT01157351|3848462|B2|||Baseline Personal and Social Performance (PSP) Total Score|The PSP score assesses degree of difficulty within 4 domains of behavior using 6-point Likert scale(0=absent to 5=very severe).The domain ratings were then transformed to PSP total score ranging from 1 to 100. Higher PSP total scores=better functioning.|Units on a scale|Mean|55.0|55.0|Standard Deviation|12.73|12.73|||
4026953|NCT01157351|3848463|B1|||Baseline Personal and Social Performance (PSP) Total Score|The PSP score assesses degree of difficulty within 4 domains of behavior using 6-point Likert scale(0=absent to 5=very severe).The domain ratings were then transformed to PSP total score ranging from 1 to 100. Higher PSP total scores=better functioning.|Units on a scale|Mean|54.8|54.8|Standard Deviation|12.83|12.83|||
4026954|NCT01157351|3848461|B3||Male|Sex: Female, Male||Participants|Count of Participants|383|383.0||||||
4026955|NCT01157351|3848462|B2||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4026956|NCT01157351|3848463|B1||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4026957|NCT01157351|3848461|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4026958|NCT01157351|3848462|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4026959|NCT01157351|3848463|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4026960|NCT01157351|3848461|B3|||Age||years|Mean|38.1|38.1|Standard Deviation|10.47|10.47|||
4026961|NCT01157351|3848462|B2|||Age||years|Mean|38.6|38.6|Standard Deviation|10.36|10.36|||
4026962|NCT01157351|3848463|B1|||Age||years|Mean|37.7|37.7|Standard Deviation|10.57|10.57|||
4026963|NCT01157234|3848480|B3|||Number of Antihypertensive Drug Classes Being Used|Full analysis included all participants who signed informed consent and received at least one dose of study drug|Antihypertensive Drug Classes|Mean|1.90|1.9|Standard Deviation|0.89|0.89|||
4026964|NCT01157234|3848481|B2|||Number of Antihypertensive Drug Classes Being Used|Full analysis included all participants who signed informed consent and received at least one dose of study drug|Antihypertensive Drug Classes|Mean|1.80|1.8|Standard Deviation|0.68|0.68|||
4026965|NCT01157234|3848482|B1|||Number of Antihypertensive Drug Classes Being Used|Full analysis included all participants who signed informed consent and received at least one dose of study drug|Antihypertensive Drug Classes|Mean|2.00|2.0|Standard Deviation|0.84|0.84|||
4026966|NCT01157234|3848480|B3|||Mean Arterial Blood Pressure|Full analysis included all participants who signed informed consent and received at least one dose of study drug|millimeter, mercury|Mean|100.83|100.83|Standard Deviation|9.36|9.36|||
4026967|NCT01157234|3848481|B2|||Mean Arterial Blood Pressure|Full analysis included all participants who signed informed consent and received at least one dose of study drug|millimeter, mercury|Mean|101.47|101.47|Standard Deviation|10.76|10.76|||
4026968|NCT01157234|3848482|B1|||Mean Arterial Blood Pressure|Full analysis included all participants who signed informed consent and received at least one dose of study drug|millimeter, mercury|Mean|100.20|100.2|Standard Deviation|8.06|8.06|||
4026969|NCT01157234|3848480|B3|||Diastolic Blood Pressure|Full analysis included all participants who signed informed consent and received at least one dose of study drug|millimeter, mercury|Mean|85.20|85.2|Standard Deviation|8.53|8.53|||
4026970|NCT01157234|3848481|B2|||Diastolic Blood Pressure|Full analysis included all participants who signed informed consent and received at least one dose of study drug|millimeter, mercury|Mean|86.33|86.33|Standard Deviation|8.62|8.62|||
4026971|NCT01157234|3848482|B1|||Diastolic Blood Pressure|Full analysis included all participants who signed informed consent and received at least one dose of study drug|millimeter, mercury|Mean|84.07|84.07|Standard Deviation|8.59|8.59|||
4026972|NCT01157234|3848480|B3|||Systolic Blood Pressure|Full analysis included all participants who signed informed consent and received at least one dose of study drug.|millimeter, mercury|Mean|132.13|132.13|Standard Deviation|16.73|16.73|||
4026973|NCT01157234|3848481|B2|||Systolic Blood Pressure|Full analysis included all participants who signed informed consent and received at least one dose of study drug.|millimeter, mercury|Mean|131.33|131.33|Standard Deviation|18.14|18.14|||
4026974|NCT01157234|3848482|B1|||Systolic Blood Pressure|Full analysis included all participants who signed informed consent and received at least one dose of study drug.|millimeter, mercury|Mean|132.93|132.93|Standard Deviation|15.79|15.79|||
4026975|NCT01157234|3848480|B3|||Estimated Glomerular Filtration Rate|"Estimated glomerular filtration rate is calculated according to the modification of diet in renal disease equation using age, gender and race in calculating kidney function.~Full analysis included all participants who signed informed consent and received at least one dose of study drug"|milliliter/minute|Mean|53.80|53.8|Standard Deviation|13.67|13.67|||
4026976|NCT01157234|3848481|B2|||Estimated Glomerular Filtration Rate|"Estimated glomerular filtration rate is calculated according to the modification of diet in renal disease equation using age, gender and race in calculating kidney function.~Full analysis included all participants who signed informed consent and received at least one dose of study drug"|milliliter/minute|Mean|54.47|54.47|Standard Deviation|14.65|14.65|||
4026977|NCT01157234|3848482|B1|||Estimated Glomerular Filtration Rate|"Estimated glomerular filtration rate is calculated according to the modification of diet in renal disease equation using age, gender and race in calculating kidney function.~Full analysis included all participants who signed informed consent and received at least one dose of study drug"|milliliter/minute|Mean|53.13|53.13|Standard Deviation|14.15|14.15|||
4026978|NCT01157234|3848480|B3|||Plasma Nitric Oxide|Full analysis included all participants who signed informed consent and received at least one dose of study drug.|nmol/l|Mean|50.53|50.53|Standard Deviation|17.99|17.99|||
4026979|NCT01157234|3848481|B2|||Plasma Nitric Oxide|Full analysis included all participants who signed informed consent and received at least one dose of study drug.|nmol/l|Mean|48.23|48.23|Standard Deviation|15.37|15.37|||
4026980|NCT01157234|3848482|B1|||Plasma Nitric Oxide|Full analysis included all participants who signed informed consent and received at least one dose of study drug.|nmol/l|Mean|52.93|52.93|Standard Deviation|21.09|21.09|||
4026981|NCT01157234|3848480|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4026982|NCT01157234|3848481|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4026983|NCT01157234|3848482|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4026984|NCT01157234|3848480|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026985|NCT01157234|3848481|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026986|NCT01157234|3848482|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026987|NCT01157234|3848480|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026988|NCT01157234|3848481|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026989|NCT01157234|3848482|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026990|NCT01157234|3848480|B3||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4026991|NCT01157234|3848481|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4026992|NCT01157234|3848482|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4026993|NCT01157234|3848480|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4026994|NCT01157234|3848481|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4026995|NCT01157234|3848482|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4026996|NCT01157234|3848480|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026997|NCT01157234|3848481|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026998|NCT01157234|3848482|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4026999|NCT01157234|3848480|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4027000|NCT01157234|3848481|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4027001|NCT01157234|3848482|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4027002|NCT01157234|3848480|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4027003|NCT01157234|3848481|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4027004|NCT01157234|3848482|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4027005|NCT01157234|3848480|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4027006|NCT01157234|3848481|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4027007|NCT01157234|3848482|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4027008|NCT01157234|3848480|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4027009|NCT01157234|3848481|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4027010|NCT01157234|3848482|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4027011|NCT01157234|3848480|B3|||Age||years|Mean|49.7|49.7|Standard Deviation|14.8|14.8|||
4027012|NCT01157234|3848481|B2|||Age||years|Mean|46.4|46.4|Standard Deviation|13.8|13.8|||
4027013|NCT01157234|3848482|B1|||Age||years|Mean|53|53.0|Standard Deviation|15.9|15.9|||
4027014|NCT01157182|3848513|B3|Canada||Region of Enrollment||participants|Number|36|36.0||||||
4027015|NCT01157182|3848514|B2|Canada||Region of Enrollment||participants|Number|18|18.0||||||
4027016|NCT01157182|3848515|B1|Canada||Region of Enrollment||participants|Number|18|18.0||||||
4027017|NCT01157182|3848513|B3|American Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4027018|NCT01157182|3848514|B2|American Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4027019|NCT01157182|3848515|B1|American Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4027020|NCT01157182|3848513|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4027021|NCT01157182|3848514|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4027022|NCT01157182|3848515|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4027023|NCT01157182|3848513|B3|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4027024|NCT01157182|3848514|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4027025|NCT01157182|3848515|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4027026|NCT01157182|3848513|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4027027|NCT01157182|3848514|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4027028|NCT01157182|3848515|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4027029|NCT01157182|3848513|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4027030|NCT01157182|3848514|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4027031|NCT01157182|3848515|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4027032|NCT01157182|3848513|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4027033|NCT01157182|3848514|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4027034|NCT01157182|3848515|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4027035|NCT01157182|3848513|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4027036|NCT01157182|3848514|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4027037|NCT01157182|3848515|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4027038|NCT01157182|3848513|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4027039|NCT01157182|3848514|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4027040|NCT01157182|3848515|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4027041|NCT01157182|3848513|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4027042|NCT01157182|3848514|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4027043|NCT01157182|3848515|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4027044|NCT01157182|3848513|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4027045|NCT01157182|3848514|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4027046|NCT01157182|3848515|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4027047|NCT01157169|3848562|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4027048|NCT01157169|3848563|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4027049|NCT01157169|3848564|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4027050|NCT01157169|3848562|B3|American Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4027051|NCT01157169|3848563|B2|American Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4027052|NCT01157169|3848564|B1|American Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4027053|NCT01157169|3848562|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4027054|NCT01157169|3848563|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4027055|NCT01157169|3848564|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4027056|NCT01157169|3848562|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4027057|NCT01157169|3848563|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4027058|NCT01157169|3848564|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4027059|NCT01157169|3848562|B3|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4027060|NCT01157169|3848563|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4027061|NCT01157169|3848564|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4027062|NCT01157169|3848562|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4027063|NCT01157169|3848563|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4027064|NCT01157169|3848564|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4027065|NCT01157169|3848562|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4027066|NCT01157169|3848563|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4027067|NCT01157169|3848564|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4027068|NCT01157169|3848562|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4027069|NCT01157169|3848563|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4027070|NCT01157169|3848564|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4027071|NCT01157169|3848562|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4027072|NCT01157169|3848563|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4027073|NCT01157169|3848564|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4027074|NCT01157169|3848562|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4027075|NCT01157169|3848563|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4027076|NCT01157169|3848564|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4027077|NCT01157169|3848562|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4027078|NCT01157169|3848563|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4027079|NCT01157169|3848564|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4027080|NCT01157117|3848581|B4|||Age at Initial Milk Allergic Reaction|Age in years at the participant's first milk allergic reaction. Note: These data were only available for 14 of the 28 Omalizumab/Milk OIT participants, 19 of the 29 Placebo for Omalizumab/Milk OIT participants, and 14 of the 20 Untreated Control participants.|years|Mean|0.7|0.7|Standard Deviation|1.1|1.1|||
4027081|NCT01157117|3848582|B3|||Age at Initial Milk Allergic Reaction|Age in years at the participant's first milk allergic reaction. Note: These data were only available for 14 of the 28 Omalizumab/Milk OIT participants, 19 of the 29 Placebo for Omalizumab/Milk OIT participants, and 14 of the 20 Untreated Control participants.|years|Mean|0.9|0.9|Standard Deviation|0.8|0.8|||
4027082|NCT01157117|3848583|B2|||Age at Initial Milk Allergic Reaction|Age in years at the participant's first milk allergic reaction. Note: These data were only available for 14 of the 28 Omalizumab/Milk OIT participants, 19 of the 29 Placebo for Omalizumab/Milk OIT participants, and 14 of the 20 Untreated Control participants.|years|Mean|0.5|0.5|Standard Deviation|0.5|0.5|||
4027083|NCT01157117|3848584|B1|||Age at Initial Milk Allergic Reaction|Age in years at the participant's first milk allergic reaction. Note: These data were only available for 14 of the 28 Omalizumab/Milk OIT participants, 19 of the 29 Placebo for Omalizumab/Milk OIT participants, and 14 of the 20 Untreated Control participants.|years|Mean|0.9|0.9|Standard Deviation|1.8|1.8|||
4027084|NCT01157117|3848581|B4|||Milk Skin Prick Test Score|This score is calculated by subtracting the size of the saline wheal (in mm) from the size of the milk wheal (in mm) observed for a skin prick test. Individuals with a milk skin prick test score of < 3 mm are considered to have a negative result.|mm|Mean|8.9|8.9|Standard Deviation|3.2|3.2|||
4027085|NCT01157117|3848582|B3|||Milk Skin Prick Test Score|This score is calculated by subtracting the size of the saline wheal (in mm) from the size of the milk wheal (in mm) observed for a skin prick test. Individuals with a milk skin prick test score of < 3 mm are considered to have a negative result.|mm|Mean|NA||Standard Deviation|NA||||Data were not collected for this group.
4027086|NCT01157117|3848583|B2|||Milk Skin Prick Test Score|This score is calculated by subtracting the size of the saline wheal (in mm) from the size of the milk wheal (in mm) observed for a skin prick test. Individuals with a milk skin prick test score of < 3 mm are considered to have a negative result.|mm|Mean|9.0|9.0|Standard Deviation|3.2|3.2|||
4027087|NCT01157117|3848584|B1|||Milk Skin Prick Test Score|This score is calculated by subtracting the size of the saline wheal (in mm) from the size of the milk wheal (in mm) observed for a skin prick test. Individuals with a milk skin prick test score of < 3 mm are considered to have a negative result.|mm|Mean|8.9|8.9|Standard Deviation|3.3|3.3|||
4027088|NCT01157117|3848581|B4|||Milk IgE|Amount of serum milk-specific immunoglobulin E (IgE). Individuals with a milk IgE of <0.35 kUA/L (allergen-equivalent kilounits per liter) are considered not to be sensitized to milk.|kUA/L|Mean|59.6|59.6|Standard Deviation|54.9|54.9|||
4027089|NCT01157117|3848582|B3|||Milk IgE|Amount of serum milk-specific immunoglobulin E (IgE). Individuals with a milk IgE of <0.35 kUA/L (allergen-equivalent kilounits per liter) are considered not to be sensitized to milk.|kUA/L|Mean|72.4|72.4|Standard Deviation|63.9|63.9|||
4027090|NCT01157117|3848583|B2|||Milk IgE|Amount of serum milk-specific immunoglobulin E (IgE). Individuals with a milk IgE of <0.35 kUA/L (allergen-equivalent kilounits per liter) are considered not to be sensitized to milk.|kUA/L|Mean|57.9|57.9|Standard Deviation|55.5|55.5|||
4027091|NCT01157117|3848584|B1|||Milk IgE|Amount of serum milk-specific immunoglobulin E (IgE). Individuals with a milk IgE of <0.35 kUA/L (allergen-equivalent kilounits per liter) are considered not to be sensitized to milk.|kUA/L|Mean|52.2|52.2|Standard Deviation|47.4|47.4|||
4027092|NCT01157117|3848581|B4|||Total IgE|Total amount of serum immunoglobulin E (IgE).|kU/L|Mean|735.2|735.2|Standard Deviation|670.3|670.3|||
4027093|NCT01157117|3848582|B3|||Total IgE|Total amount of serum immunoglobulin E (IgE).|kU/L|Mean|878.8|878.8|Standard Deviation|824.3|824.3|||
4027094|NCT01157117|3848583|B2|||Total IgE|Total amount of serum immunoglobulin E (IgE).|kU/L|Mean|686.6|686.6|Standard Deviation|565.7|565.7|||
4027095|NCT01157117|3848584|B1|||Total IgE|Total amount of serum immunoglobulin E (IgE).|kU/L|Mean|683.1|683.1|Standard Deviation|658.9|658.9|||
4027096|NCT01157117|3848581|B4|||Atopic Dermatitis Total Score|The Atopic Dermatitis Total Score is scored on a 10 point scale of 0 to 9 where a higher score indicates increasing severity of atopic dermatitis. This score is a combination of three scores that range from 0 to 3 in the following areas: body surface area score, disease course, and disease intensity. Note: These data were only available for 12 of the 20 Untreated Control participants.|Scores on a scale|Mean|0.5|0.5|Standard Deviation|1.5|1.5|||
4027097|NCT01157117|3848582|B3|||Atopic Dermatitis Total Score|The Atopic Dermatitis Total Score is scored on a 10 point scale of 0 to 9 where a higher score indicates increasing severity of atopic dermatitis. This score is a combination of three scores that range from 0 to 3 in the following areas: body surface area score, disease course, and disease intensity. Note: These data were only available for 12 of the 20 Untreated Control participants.|Scores on a scale|Mean|1.0|1.0|Standard Deviation|2.3|2.3|||
4027098|NCT01157117|3848583|B2|||Atopic Dermatitis Total Score|The Atopic Dermatitis Total Score is scored on a 10 point scale of 0 to 9 where a higher score indicates increasing severity of atopic dermatitis. This score is a combination of three scores that range from 0 to 3 in the following areas: body surface area score, disease course, and disease intensity. Note: These data were only available for 12 of the 20 Untreated Control participants.|Scores on a scale|Mean|0.5|0.5|Standard Deviation|1.5|1.5|||
4027099|NCT01157117|3848584|B1|||Atopic Dermatitis Total Score|The Atopic Dermatitis Total Score is scored on a 10 point scale of 0 to 9 where a higher score indicates increasing severity of atopic dermatitis. This score is a combination of three scores that range from 0 to 3 in the following areas: body surface area score, disease course, and disease intensity. Note: These data were only available for 12 of the 20 Untreated Control participants.|Scores on a scale|Mean|0.3|0.3|Standard Deviation|0.9|0.9|||
4027100|NCT01157117|3848581|B4|||Age||years|Mean|11.8|11.8|Standard Deviation|4.5|4.5|||
4027101|NCT01157117|3848582|B3|||Age||years|Mean|11.3|11.3|Standard Deviation|2.9|2.9|||
4027102|NCT01157117|3848583|B2|||Age||years|Mean|11.5|11.5|Standard Deviation|5.6|5.6|||
4027103|NCT01157117|3848584|B1|||Age||years|Mean|12.6|12.6|Standard Deviation|4.1|4.1|||
4027104|NCT01157117|3848581|B4|United States||Region of Enrollment||participants|Number|77|77.0||||||
4027105|NCT01157117|3848582|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4027106|NCT01157117|3848583|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4027107|NCT01157117|3848584|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4027108|NCT01157117|3848581|B4|White||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
4027109|NCT01157117|3848582|B3|White||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4027110|NCT01157117|3848583|B2|White||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4027111|NCT01157117|3848584|B1|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4027112|NCT01157117|3848581|B4|Black/African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4027113|NCT01157117|3848582|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4027114|NCT01157117|3848583|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4027115|NCT01157117|3848584|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4027116|NCT01157117|3848581|B4|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4027117|NCT01157117|3848582|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4027118|NCT01157117|3848583|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4027119|NCT01157117|3848584|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4027120|NCT01157117|3848581|B4|Non-Hispanic or non-Latino origin||Race/Ethnicity, Customized||participants|Number|75|75.0||||||
4027121|NCT01157117|3848582|B3|Non-Hispanic or non-Latino origin||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4027122|NCT01157117|3848583|B2|Non-Hispanic or non-Latino origin||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4027123|NCT01157117|3848584|B1|Non-Hispanic or non-Latino origin||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4027124|NCT01157117|3848581|B4|Hispanic or Latino origin||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4027125|NCT01157117|3848582|B3|Hispanic or Latino origin||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4027126|NCT01157117|3848583|B2|Hispanic or Latino origin||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4027127|NCT01157117|3848584|B1|Hispanic or Latino origin||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4027128|NCT01157117|3848581|B4||Male|Gender||Participants|Count of Participants|55|55.0||||||
4027129|NCT01157117|3848582|B3||Male|Gender||Participants|Count of Participants|15|15.0||||||
4027130|NCT01157117|3848583|B2||Male|Gender||Participants|Count of Participants|20|20.0||||||
4027131|NCT01157117|3848584|B1||Male|Gender||Participants|Count of Participants|20|20.0||||||
4027132|NCT01157117|3848581|B4||Female|Gender||Participants|Count of Participants|22|22.0||||||
4027133|NCT01157117|3848582|B3||Female|Gender||Participants|Count of Participants|5|5.0||||||
4027134|NCT01157117|3848583|B2||Female|Gender||Participants|Count of Participants|9|9.0||||||
4027135|NCT01157117|3848584|B1||Female|Gender||Participants|Count of Participants|8|8.0||||||
4027136|NCT01157117|3848581|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4027137|NCT01157117|3848582|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4027138|NCT01157117|3848583|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4027139|NCT01157117|3848584|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4027140|NCT01157117|3848581|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4027141|NCT01157117|3848582|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4027142|NCT01157117|3848583|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4027143|NCT01157117|3848584|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4027144|NCT01157117|3848581|B4||<=18 years|Age||Participants|Count of Participants|73|73.0||||||
4027145|NCT01157117|3848582|B3||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
4027146|NCT01157117|3848583|B2||<=18 years|Age||Participants|Count of Participants|27|27.0||||||
4027147|NCT01157117|3848584|B1||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
4027148|NCT01157078|3848625|B3|||Montgomery-Asberg Depression Rating Scale (MADRS) total score at randomization|A 10-item scale for the evaluation of depressive symptoms. Each MADRS item is rated on a 0 to 6 scale. The MADRS total score is calculated as the sum of the 10 individual item scores; the total score can range from 0 to 60. Higher MADRS scores indicate higher levels of depressive symptoms.|Scores on a scale|Mean|27.0|27.0|Standard Deviation|5.61|5.61|||
4027149|NCT01157078|3848626|B2|||Montgomery-Asberg Depression Rating Scale (MADRS) total score at randomization|A 10-item scale for the evaluation of depressive symptoms. Each MADRS item is rated on a 0 to 6 scale. The MADRS total score is calculated as the sum of the 10 individual item scores; the total score can range from 0 to 60. Higher MADRS scores indicate higher levels of depressive symptoms.|Scores on a scale|Mean|26.6|26.6|Standard Deviation|5.63|5.63|||
4027150|NCT01157078|3848627|B1|||Montgomery-Asberg Depression Rating Scale (MADRS) total score at randomization|A 10-item scale for the evaluation of depressive symptoms. Each MADRS item is rated on a 0 to 6 scale. The MADRS total score is calculated as the sum of the 10 individual item scores; the total score can range from 0 to 60. Higher MADRS scores indicate higher levels of depressive symptoms.|Scores on a scale|Mean|27.4|27.4|Standard Deviation|5.58|5.58|||
4027151|NCT01157078|3848625|B3|||Hamilton Rating Scale for Depression-17 items (HAMD-17) total score at randomization|A 17-item, clinician-rated scale that assesses depressive symptoms. The HAMD-17 consists of 17 symptoms, each of which is rated from 0 to 2 or 0 to 4, where 0 is none/absent. The HAMD-17 total score is calculated as the sum of the 17 individual symptom scores; the total score can range from 0 to 52. Higher HAMD-17 scores indicate more severe depression.|Scores on a scale|Mean|21.5|21.5|Standard Deviation|3.98|3.98|||
4027206|NCT01156987|3848688|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4027207|NCT01156987|3848689|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4027152|NCT01157078|3848626|B2|||Hamilton Rating Scale for Depression-17 items (HAMD-17) total score at randomization|A 17-item, clinician-rated scale that assesses depressive symptoms. The HAMD-17 consists of 17 symptoms, each of which is rated from 0 to 2 or 0 to 4, where 0 is none/absent. The HAMD-17 total score is calculated as the sum of the 17 individual symptom scores; the total score can range from 0 to 52. Higher HAMD-17 scores indicate more severe depression.|Scores on a scale|Mean|21.1|21.1|Standard Deviation|3.81|3.81|||
4027153|NCT01157078|3848627|B1|||Hamilton Rating Scale for Depression-17 items (HAMD-17) total score at randomization|A 17-item, clinician-rated scale that assesses depressive symptoms. The HAMD-17 consists of 17 symptoms, each of which is rated from 0 to 2 or 0 to 4, where 0 is none/absent. The HAMD-17 total score is calculated as the sum of the 17 individual symptom scores; the total score can range from 0 to 52. Higher HAMD-17 scores indicate more severe depression.|Scores on a scale|Mean|22.0|22.0|Standard Deviation|4.13|4.13|||
4027154|NCT01157078|3848625|B3|Other||Race/Ethnicity, Customized|Race|participants|Number|4|4.0||||||
4027155|NCT01157078|3848626|B2|Other||Race/Ethnicity, Customized|Race|participants|Number|3|3.0||||||
4027156|NCT01157078|3848627|B1|Other||Race/Ethnicity, Customized|Race|participants|Number|1|1.0||||||
4027157|NCT01157078|3848625|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|Race|participants|Number|1|1.0||||||
4027158|NCT01157078|3848626|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|Race|participants|Number|1|1.0||||||
4027159|NCT01157078|3848627|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Race|participants|Number|0|0.0||||||
4027160|NCT01157078|3848625|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|Race|participants|Number|0|0.0||||||
4027161|NCT01157078|3848626|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|Race|participants|Number|0|0.0||||||
4027162|NCT01157078|3848627|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|Race|participants|Number|0|0.0||||||
4027163|NCT01157078|3848625|B3|Asian||Race/Ethnicity, Customized|Race|participants|Number|85|85.0||||||
4027164|NCT01157078|3848626|B2|Asian||Race/Ethnicity, Customized|Race|participants|Number|37|37.0||||||
4027165|NCT01157078|3848627|B1|Asian||Race/Ethnicity, Customized|Race|participants|Number|48|48.0||||||
4027166|NCT01157078|3848625|B3|Black or African American||Race/Ethnicity, Customized|Race|participants|Number|30|30.0||||||
4027167|NCT01157078|3848626|B2|Black or African American||Race/Ethnicity, Customized|Race|participants|Number|19|19.0||||||
4027168|NCT01157078|3848627|B1|Black or African American||Race/Ethnicity, Customized|Race|participants|Number|11|11.0||||||
4027169|NCT01157078|3848625|B3|White||Race/Ethnicity, Customized|Race|participants|Number|199|199.0||||||
4027170|NCT01157078|3848626|B2|White||Race/Ethnicity, Customized|Race|participants|Number|100|100.0||||||
4027171|NCT01157078|3848627|B1|White||Race/Ethnicity, Customized|Race|participants|Number|99|99.0||||||
4027172|NCT01157078|3848625|B3||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4027173|NCT01157078|3848626|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4027174|NCT01157078|3848627|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4027175|NCT01157078|3848625|B3||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4027176|NCT01157078|3848626|B2||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4027177|NCT01157078|3848627|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4027178|NCT01157078|3848625|B3|||Age||years|Mean|40.4|40.4|Standard Deviation|11.45|11.45|||
4027179|NCT01157078|3848626|B2|||Age||years|Mean|41.0|41.0|Standard Deviation|11.53|11.53|||
4027180|NCT01157078|3848627|B1|||Age||years|Mean|39.7|39.7|Standard Deviation|11.37|11.37|||
4027181|NCT01157065|3848676|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
4027182|NCT01157065|3848677|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4027183|NCT01157065|3848678|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4027184|NCT01157065|3848676|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4027185|NCT01157065|3848677|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4027186|NCT01157065|3848678|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4027187|NCT01157065|3848676|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4027188|NCT01157065|3848677|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4027189|NCT01157065|3848678|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4027190|NCT01157065|3848676|B3|≥65 years||Age, Customized||participants|Number|46|46.0||||||
4027191|NCT01157065|3848677|B2|≥65 years||Age, Customized||participants|Number|11|11.0||||||
4027192|NCT01157065|3848678|B1|≥65 years||Age, Customized||participants|Number|35|35.0||||||
4027193|NCT01157065|3848676|B3|18 to 64 years||Age, Customized||participants|Number|3|3.0||||||
4027194|NCT01157065|3848677|B2|18 to 64 years||Age, Customized||participants|Number|0|0.0||||||
4027195|NCT01157065|3848678|B1|18 to 64 years||Age, Customized||participants|Number|3|3.0||||||
4027196|NCT01156987|3848687|B3|||Lesion measurements||participants|Number|31|31.0||||||
4027197|NCT01156987|3848688|B2|||Lesion measurements||participants|Number|23|23.0||||||
4027198|NCT01156987|3848689|B1|||Lesion measurements||participants|Number|8|8.0||||||
4027199|NCT01156987|3848687|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4027200|NCT01156987|3848688|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4027201|NCT01156987|3848689|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4027202|NCT01156987|3848687|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4027203|NCT01156987|3848688|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4027204|NCT01156987|3848689|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4027205|NCT01156987|3848687|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4027208|NCT01156987|3848687|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4027209|NCT01156987|3848688|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4027210|NCT01156987|3848689|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4027211|NCT01156987|3848687|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4027212|NCT01156987|3848688|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4027213|NCT01156987|3848689|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4027214|NCT01156844|3848696|B5||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4027215|NCT01156844|3848697|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4027216|NCT01156844|3848698|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4027217|NCT01156844|3848699|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4027218|NCT01156844|3848700|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4027219|NCT01156844|3848696|B5||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4027220|NCT01156844|3848697|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4027221|NCT01156844|3848698|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4027222|NCT01156844|3848699|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4027223|NCT01156844|3848700|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4027224|NCT01156844|3848696|B5|||Age|Baseline measures used the Safety Set that included all participants who received at least one dose of study drug.|years|Mean|40.3|40.3|Standard Deviation|12.7|12.7|||
4027225|NCT01156844|3848697|B4|||Age|Baseline measures used the Safety Set that included all participants who received at least one dose of study drug.|years|Mean|40.8|40.8|Standard Deviation|12.7|12.7|||
4027226|NCT01156844|3848698|B3|||Age|Baseline measures used the Safety Set that included all participants who received at least one dose of study drug.|years|Mean|42.0|42.0|Standard Deviation|12.2|12.2|||
4027227|NCT01156844|3848699|B2|||Age|Baseline measures used the Safety Set that included all participants who received at least one dose of study drug.|years|Mean|41.1|41.1|Standard Deviation|14.7|14.7|||
4027228|NCT01156844|3848700|B1|||Age|Baseline measures used the Safety Set that included all participants who received at least one dose of study drug.|years|Mean|37.4|37.4|Standard Deviation|11.0|11.0|||
4027229|NCT01156792|3848722|B1|Missing||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4027230|NCT01156792|3848722|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4027231|NCT01156792|3848722|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|115|115.0||||||
4027232|NCT01156792|3848722|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4027233|NCT01156792|3848722|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4027234|NCT01156792|3848722|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|42|42.0||||||
4027235|NCT01156792|3848722|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4027236|NCT01156792|3848722|B1||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4027237|NCT01156792|3848722|B1|||Age||Years|Mean|36.8|36.8|Standard Deviation|14.43|14.43|||
4027238|NCT01156701|3848787|B1||Male|Sex: Female, Male||Participants|Count of Participants|87543|87543.0||||||
4027239|NCT01156701|3848787|B1||Female|Sex: Female, Male||Participants|Count of Participants|84162|84162.0||||||
4027240|NCT01156701|3848787|B1|>=65 years||Age, Customized|Number of participants in the indicated age category|Participants|Number|1276|1276.0||||||
4027241|NCT01156701|3848787|B1|45-64 years||Age, Customized|Number of participants in the indicated age category|Participants|Number|37119|37119.0||||||
4027242|NCT01156701|3848787|B1|15-44 years||Age, Customized|Number of participants in the indicated age category|Participants|Number|85640|85640.0||||||
4027243|NCT01156701|3848787|B1|5-14 years||Age, Customized|Number of participants in the indicated age category|Participants|Number|47670|47670.0||||||
4027244|NCT01156675|3848824|B4|||Height (inches)||inches|Mean|67.1|67.1|Standard Deviation|3.84|3.84|||
4027245|NCT01156675|3848825|B3|||Height (inches)||inches|Mean|66.0|66.0|Standard Deviation|11.31|11.31|||
4027246|NCT01156675|3848826|B2|||Height (inches)||inches|Mean|67.2|67.2|Standard Deviation|3.94|3.94|||
4027247|NCT01156675|3848827|B1|||Height (inches)||inches|Mean|67.0|67.0|Standard Deviation|3.62|3.62|||
4027248|NCT01156675|3848824|B4|||Weight (lbs)||lbs|Mean|187.5|187.5|Standard Deviation|36.45|36.45|||
4027249|NCT01156675|3848825|B3|||Weight (lbs)||lbs|Mean|195.0|195.0|Standard Deviation|77.78|77.78|||
4027250|NCT01156675|3848826|B2|||Weight (lbs)||lbs|Mean|193.2|193.2|Standard Deviation|37.75|37.75|||
4027251|NCT01156675|3848827|B1|||Weight (lbs)||lbs|Mean|181.8|181.8|Standard Deviation|33.87|33.87|||
4027252|NCT01156675|3848824|B4|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4027253|NCT01156675|3848825|B3|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4027254|NCT01156675|3848826|B2|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4027255|NCT01156675|3848827|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4027256|NCT01156675|3848824|B4|Race|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4027257|NCT01156675|3848825|B3|Race|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4027258|NCT01156675|3848826|B2|Race|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4027259|NCT01156675|3848827|B1|Race|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4027260|NCT01156675|3848824|B4|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4027261|NCT01156675|3848825|B3|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4027262|NCT01156675|3848826|B2|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4027263|NCT01156675|3848827|B1|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4027264|NCT01156675|3848824|B4|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4027265|NCT01156675|3848825|B3|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4027266|NCT01156675|3848826|B2|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4027267|NCT01156675|3848827|B1|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4027268|NCT01156675|3848824|B4|Race|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|202|202.0||||||
4027269|NCT01156675|3848825|B3|Race|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4027270|NCT01156675|3848826|B2|Race|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|102|102.0||||||
4027271|NCT01156675|3848827|B1|Race|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|98|98.0||||||
4027272|NCT01156675|3848824|B4||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4027273|NCT01156675|3848825|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4027274|NCT01156675|3848826|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4027275|NCT01156675|3848827|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4027276|NCT01156675|3848824|B4||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4027277|NCT01156675|3848825|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4027278|NCT01156675|3848826|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4027279|NCT01156675|3848827|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4027280|NCT01156675|3848824|B4|||Age||years|Mean|67.8|67.8|Standard Deviation|8.87|8.87|||
4027281|NCT01156675|3848825|B3|||Age||years|Mean|71.5|71.5|Standard Deviation|4.95|4.95|||
4027282|NCT01156675|3848826|B2|||Age||years|Mean|67.3|67.3|Standard Deviation|8.88|8.88|||
4027283|NCT01156675|3848827|B1|||Age||years|Mean|68.2|68.2|Standard Deviation|8.93|8.93|||
4027284|NCT01156597|3848861|B3|||High Density Lipoprotein||mg/dl|Mean|46.7|46.7|Standard Deviation|9.8|9.8|||
4027285|NCT01156597|3848862|B2|||High Density Lipoprotein||mg/dl|Mean|48.0|48.0|Standard Deviation|8.4|8.4|||
4027286|NCT01156597|3848863|B1|||High Density Lipoprotein||mg/dl|Mean|45.3|45.3|Standard Deviation|11.2|11.2|||
4027287|NCT01156597|3848861|B3|||Hemoglobin A1C||%|Mean|7.5|7.5|Standard Deviation|1.2|1.2|||
4027288|NCT01156597|3848862|B2|||Hemoglobin A1C||%|Mean|7.8|7.8|Standard Deviation|1.3|1.3|||
4027289|NCT01156597|3848863|B1|||Hemoglobin A1C||%|Mean|7.2|7.2|Standard Deviation|1.3|1.3|||
4027290|NCT01156597|3848861|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4027291|NCT01156597|3848862|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4027292|NCT01156597|3848863|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4027293|NCT01156597|3848861|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4027294|NCT01156597|3848862|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4027295|NCT01156597|3848863|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4027296|NCT01156597|3848861|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4027297|NCT01156597|3848862|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4027298|NCT01156597|3848863|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4027299|NCT01156597|3848861|B3|||Age||years|Mean|58.3|58.3|Standard Deviation|5.9|5.9|||
4027300|NCT01156597|3848862|B2|||Age||years|Mean|58.2|58.2|Standard Deviation|8.2|8.2|||
4027301|NCT01156597|3848863|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|5.9|5.9|||
4027302|NCT01156571|3848874|B3|Thailand||Region of Enrollment||participants|Number|302|302.0||||||
4027303|NCT01156571|3848875|B2|Thailand||Region of Enrollment||participants|Number|151|151.0||||||
4027304|NCT01156571|3848876|B1|Thailand||Region of Enrollment||participants|Number|151|151.0||||||
4027305|NCT01156571|3848874|B3|Russian Federation||Region of Enrollment||participants|Number|582|582.0||||||
4027306|NCT01156571|3848875|B2|Russian Federation||Region of Enrollment||participants|Number|286|286.0||||||
4027307|NCT01156571|3848876|B1|Russian Federation||Region of Enrollment||participants|Number|296|296.0||||||
4027308|NCT01156571|3848874|B3|Poland||Region of Enrollment||participants|Number|702|702.0||||||
4027309|NCT01156571|3848875|B2|Poland||Region of Enrollment||participants|Number|350|350.0||||||
4027310|NCT01156571|3848876|B1|Poland||Region of Enrollment||participants|Number|352|352.0||||||
4027311|NCT01156571|3848874|B3|New Zealand||Region of Enrollment||participants|Number|45|45.0||||||
4027312|NCT01156571|3848875|B2|New Zealand||Region of Enrollment||participants|Number|23|23.0||||||
4027313|NCT01156571|3848876|B1|New Zealand||Region of Enrollment||participants|Number|22|22.0||||||
4027314|NCT01156571|3848874|B3|Italy||Region of Enrollment||participants|Number|621|621.0||||||
4027315|NCT01156571|3848875|B2|Italy||Region of Enrollment||participants|Number|310|310.0||||||
4027316|NCT01156571|3848876|B1|Italy||Region of Enrollment||participants|Number|311|311.0||||||
4027317|NCT01156571|3848874|B3|Germany||Region of Enrollment||participants|Number|494|494.0||||||
4027318|NCT01156571|3848875|B2|Germany||Region of Enrollment||participants|Number|251|251.0||||||
4027319|NCT01156571|3848876|B1|Germany||Region of Enrollment||participants|Number|243|243.0||||||
4027320|NCT01156571|3848874|B3|Georgia||Region of Enrollment||participants|Number|1485|1485.0||||||
4027321|NCT01156571|3848875|B2|Georgia||Region of Enrollment||participants|Number|741|741.0||||||
4027322|NCT01156571|3848876|B1|Georgia||Region of Enrollment||participants|Number|744|744.0||||||
4027323|NCT01156571|3848874|B3|Czech Republic||Region of Enrollment||participants|Number|1630|1630.0||||||
4027324|NCT01156571|3848875|B2|Czech Republic||Region of Enrollment||participants|Number|816|816.0||||||
4027325|NCT01156571|3848876|B1|Czech Republic||Region of Enrollment||participants|Number|814|814.0||||||
4027326|NCT01156571|3848874|B3|Bulgaria||Region of Enrollment||participants|Number|336|336.0||||||
4027327|NCT01156571|3848875|B2|Bulgaria||Region of Enrollment||participants|Number|167|167.0||||||
4027328|NCT01156571|3848876|B1|Bulgaria||Region of Enrollment||participants|Number|169|169.0||||||
4027329|NCT01156571|3848874|B3|Brazil||Region of Enrollment||participants|Number|158|158.0||||||
4027330|NCT01156571|3848875|B2|Brazil||Region of Enrollment||participants|Number|80|80.0||||||
4027331|NCT01156571|3848876|B1|Brazil||Region of Enrollment||participants|Number|78|78.0||||||
4027332|NCT01156571|3848874|B3|Austria||Region of Enrollment||participants|Number|602|602.0||||||
4027333|NCT01156571|3848875|B2|Austria||Region of Enrollment||participants|Number|300|300.0||||||
4027334|NCT01156571|3848876|B1|Austria||Region of Enrollment||participants|Number|302|302.0||||||
4027335|NCT01156571|3848874|B3|United States||Region of Enrollment||participants|Number|4188|4188.0||||||
4027336|NCT01156571|3848875|B2|United States||Region of Enrollment||participants|Number|2089|2089.0||||||
4027337|NCT01156571|3848876|B1|United States||Region of Enrollment||participants|Number|2099|2099.0||||||
4027338|NCT01156571|3848874|B3||Male|Sex: Female, Male||Participants|Count of Participants|8024|8024.0||||||
4027339|NCT01156571|3848875|B2||Male|Sex: Female, Male||Participants|Count of Participants|4042|4042.0||||||
4027340|NCT01156571|3848876|B1||Male|Sex: Female, Male||Participants|Count of Participants|3982|3982.0||||||
4027341|NCT01156571|3848874|B3||Female|Sex: Female, Male||Participants|Count of Participants|3121|3121.0||||||
4027342|NCT01156571|3848875|B2||Female|Sex: Female, Male||Participants|Count of Participants|1522|1522.0||||||
4027343|NCT01156571|3848876|B1||Female|Sex: Female, Male||Participants|Count of Participants|1599|1599.0||||||
4027344|NCT01156571|3848874|B3|||Age||years|Mean|63.9|63.9|Standard Deviation|11.0|11.0|||
4027345|NCT01156571|3848875|B2|||Age||years|Mean|63.8|63.8|Standard Deviation|11.0|11.0|||
4027346|NCT01156571|3848876|B1|||Age||years|Mean|64.0|64.0|Standard Deviation|11.0|11.0|||
4027347|NCT01156571|3848874|B3||>=65 years|Age||Participants|Count of Participants|5351|5351.0||||||
4027348|NCT01156571|3848875|B2||>=65 years|Age||Participants|Count of Participants|2662|2662.0||||||
4027349|NCT01156571|3848876|B1||>=65 years|Age||Participants|Count of Participants|2689|2689.0||||||
4027350|NCT01156571|3848874|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5794|5794.0||||||
4027351|NCT01156571|3848875|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2902|2902.0||||||
4027352|NCT01156571|3848876|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2892|2892.0||||||
4027353|NCT01156571|3848874|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4027354|NCT01156571|3848875|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4027355|NCT01156571|3848876|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4027356|NCT01156532|3848887|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4027357|NCT01156532|3848887|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4027358|NCT01156532|3848887|B1|||Age||years|Mean|51|51.0|Standard Deviation|11|11.0|||
4027359|NCT01156480|3848897|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4027360|NCT01156480|3848898|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4027361|NCT01156480|3848897|B3|Male||Gender||participants|Number|0|0.0||||||
4027362|NCT01156480|3848898|B2|Male||Gender||participants|Number|0|0.0||||||
4027363|NCT01156480|3848897|B3|Female||Gender||participants|Number|1|1.0||||||
4027364|NCT01156480|3848898|B2|Female||Gender||participants|Number|1|1.0||||||
4027365|NCT01156480|3848897|B3|>=65 years||Age||participants|Number|0|0.0||||||
4027366|NCT01156480|3848898|B2|>=65 years||Age||participants|Number|0|0.0||||||
4027367|NCT01156480|3848897|B3|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
4027368|NCT01156480|3848898|B2|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
4027369|NCT01156480|3848897|B3|<=18 years||Age||participants|Number|1|1.0||||||
4027370|NCT01156480|3848898|B2|<=18 years||Age||participants|Number|1|1.0||||||
4027371|NCT01156376|3848908|B4|USA||Region of Enrollment||participants|Number|80|80.0||||||
4027372|NCT01156376|3848909|B3|USA||Region of Enrollment||participants|Number|27|27.0||||||
4027373|NCT01156376|3848910|B2|USA||Region of Enrollment||participants|Number|26|26.0||||||
4027374|NCT01156376|3848911|B1|USA||Region of Enrollment||participants|Number|27|27.0||||||
4027375|NCT01156376|3848908|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4027376|NCT01156376|3848909|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4027377|NCT01156376|3848910|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4027378|NCT01156376|3848911|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4027379|NCT01156376|3848908|B4||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4027380|NCT01156376|3848909|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4027381|NCT01156376|3848910|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4027382|NCT01156376|3848911|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4027383|NCT01156376|3848908|B4|||Age||years|Mean|45.8|45.8|Standard Deviation|15.47|15.47|||
4027384|NCT01156376|3848909|B3|||Age||years|Mean|51.0|51.0|Standard Deviation|15.03|15.03|||
4027385|NCT01156376|3848910|B2|||Age||years|Mean|37.6|37.6|Standard Deviation|14.29|14.29|||
4027386|NCT01156376|3848911|B1|||Age||years|Mean|48.4|48.4|Standard Deviation|14.24|14.24|||
4027387|NCT01156363|3849134|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4027388|NCT01156363|3849134|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4027389|NCT01156363|3849134|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|13.3|13.3|||
4027390|NCT01156311|3849154|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4027391|NCT01156311|3849155|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4027392|NCT01156311|3849156|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4027393|NCT01156311|3849154|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4027394|NCT01156311|3849155|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4027395|NCT01156311|3849156|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4027396|NCT01156311|3849154|B3|50 to 55 years||Age, Customized||participants|Number|13|13.0||||||
4027397|NCT01156311|3849155|B2|50 to 55 years||Age, Customized||participants|Number|7|7.0||||||
4027398|NCT01156311|3849156|B1|50 to 55 years||Age, Customized||participants|Number|6|6.0||||||
4027399|NCT01156311|3849154|B3|40 to 49 years||Age, Customized||participants|Number|42|42.0||||||
4027400|NCT01156311|3849155|B2|40 to 49 years||Age, Customized||participants|Number|15|15.0||||||
4027401|NCT01156311|3849156|B1|40 to 49 years||Age, Customized||participants|Number|27|27.0||||||
4027402|NCT01156311|3849154|B3|30 to 39 years||Age, Customized||participants|Number|40|40.0||||||
4027403|NCT01156311|3849155|B2|30 to 39 years||Age, Customized||participants|Number|22|22.0||||||
4027404|NCT01156311|3849156|B1|30 to 39 years||Age, Customized||participants|Number|18|18.0||||||
4027405|NCT01156311|3849154|B3|20 to 29 years||Age, Customized||participants|Number|8|8.0||||||
4027406|NCT01156311|3849155|B2|20 to 29 years||Age, Customized||participants|Number|3|3.0||||||
4027407|NCT01156311|3849156|B1|20 to 29 years||Age, Customized||participants|Number|5|5.0||||||
4027408|NCT01156311|3849154|B3|18 to 19 years||Age, Customized||participants|Number|1|1.0||||||
4027409|NCT01156311|3849155|B2|18 to 19 years||Age, Customized||participants|Number|0|0.0||||||
4027410|NCT01156311|3849156|B1|18 to 19 years||Age, Customized||participants|Number|1|1.0||||||
4027411|NCT01156311|3849154|B3|||Age||years|Mean|40.1|40.1|Standard Deviation|7.96|7.96|||
4027412|NCT01156311|3849155|B2|||Age||years|Mean|40.7|40.7|Standard Deviation|8.44|8.44|||
4027413|NCT01156311|3849156|B1|||Age||years|Mean|39.5|39.5|Standard Deviation|7.58|7.58|||
4027414|NCT01156142|3849181|B3|United States||Region of Enrollment||participants|Number|140|140.0||||||
4027415|NCT01156142|3849182|B2|United States||Region of Enrollment||participants|Number|71|71.0||||||
4027416|NCT01156142|3849183|B1|United States||Region of Enrollment||participants|Number|69|69.0||||||
4027417|NCT01156142|3849181|B3||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4027418|NCT01156142|3849182|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4027419|NCT01156142|3849183|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4027420|NCT01156142|3849181|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4027421|NCT01156142|3849182|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4027422|NCT01156142|3849183|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4027423|NCT01156142|3849181|B3|||Age||years|Mean|61|61.0|Full Range|||37.0|93.0|
4027424|NCT01156142|3849182|B2|||Age||years|Mean|60|60.0|Full Range|||37.0|86.0|
4027425|NCT01156142|3849183|B1|||Age||years|Mean|62|62.0|Full Range|||39.0|93.0|
4027426|NCT01156116|3849200|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
4027427|NCT01156116|3849201|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4027428|NCT01156116|3849202|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4027429|NCT01156116|3849200|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4027430|NCT01156116|3849201|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4027431|NCT01156116|3849202|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4027432|NCT01156116|3849200|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4027433|NCT01156116|3849201|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4027434|NCT01156116|3849202|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4027435|NCT01156116|3849200|B3|||Age||years|Mean|54.3|54.3|Standard Deviation|6.9|6.9|||
4027436|NCT01156116|3849201|B2|||Age||years|Mean|55.2|55.2|Standard Deviation|8.4|8.4|||
4027437|NCT01156116|3849202|B1|||Age||years|Mean|53.8|53.8|Standard Deviation|6.2|6.2|||
4027438|NCT01156051|3849215|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
4027439|NCT01156051|3849216|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4027440|NCT01156051|3849217|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4027441|NCT01156051|3849215|B3|African-American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4027442|NCT01156051|3849216|B2|African-American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4027443|NCT01156051|3849217|B1|African-American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4027444|NCT01156051|3849215|B3|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4027445|NCT01156051|3849216|B2|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4027446|NCT01156051|3849217|B1|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4027447|NCT01156051|3849215|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4027448|NCT01156051|3849216|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4027449|NCT01156051|3849217|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4027450|NCT01156051|3849215|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4027451|NCT01156051|3849216|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4027452|NCT01156051|3849217|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4027453|NCT01156051|3849215|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4027454|NCT01156051|3849216|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4027455|NCT01156051|3849217|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4027456|NCT01156051|3849215|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4027457|NCT01156051|3849216|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4027458|NCT01156051|3849217|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4027459|NCT01156051|3849215|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4027460|NCT01156051|3849216|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4027461|NCT01156051|3849217|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4027462|NCT01156051|3849215|B3|||Age||years|Mean|8.9|8.9|Standard Deviation|1.9|1.9|||
4027463|NCT01156051|3849216|B2|||Age||years|Mean|8.8|8.8|Standard Deviation|1.9|1.9|||
4027464|NCT01156051|3849217|B1|||Age||years|Mean|9.1|9.1|Standard Deviation|1.8|1.8|||
4027465|NCT01156012|3849230|B3|Tunisia||Region of Enrollment||participants|Number|91|91.0||||||
4027466|NCT01156012|3849231|B2|Tunisia||Region of Enrollment||participants|Number|44|44.0||||||
4027467|NCT01156012|3849232|B1|Tunisia||Region of Enrollment||participants|Number|47|47.0||||||
4027468|NCT01156012|3849230|B3|Portugal||Region of Enrollment||participants|Number|30|30.0||||||
4027469|NCT01156012|3849231|B2|Portugal||Region of Enrollment||participants|Number|15|15.0||||||
4027470|NCT01156012|3849232|B1|Portugal||Region of Enrollment||participants|Number|15|15.0||||||
4027471|NCT01156012|3849230|B3|Spain||Region of Enrollment||participants|Number|15|15.0||||||
4027472|NCT01156012|3849231|B2|Spain||Region of Enrollment||participants|Number|7|7.0||||||
4027473|NCT01156012|3849232|B1|Spain||Region of Enrollment||participants|Number|8|8.0||||||
4027474|NCT01156012|3849230|B3|Italy||Region of Enrollment||participants|Number|47|47.0||||||
4027475|NCT01156012|3849231|B2|Italy||Region of Enrollment||participants|Number|22|22.0||||||
4027476|NCT01156012|3849232|B1|Italy||Region of Enrollment||participants|Number|25|25.0||||||
4027477|NCT01156012|3849230|B3|Belgium||Region of Enrollment||participants|Number|22|22.0||||||
4027478|NCT01156012|3849231|B2|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
4027479|NCT01156012|3849232|B1|Belgium||Region of Enrollment||participants|Number|14|14.0||||||
4027480|NCT01156012|3849230|B3|France||Region of Enrollment||participants|Number|197|197.0||||||
4027481|NCT01156012|3849231|B2|France||Region of Enrollment||participants|Number|93|93.0||||||
4027482|NCT01156012|3849232|B1|France||Region of Enrollment||participants|Number|104|104.0||||||
4027483|NCT01156012|3849230|B3||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4027484|NCT01156012|3849231|B2||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4027485|NCT01156012|3849232|B1||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4027486|NCT01156012|3849230|B3||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4027487|NCT01156012|3849231|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4027488|NCT01156012|3849232|B1||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4027489|NCT01156012|3849230|B3|||Age||years|Mean|64.7|64.7|Standard Deviation|11.5|11.5|||
4027490|NCT01156012|3849231|B2|||Age||years|Mean|65.7|65.7|Standard Deviation|11.7|11.7|||
4027491|NCT01156012|3849232|B1|||Age||years|Mean|63.9|63.9|Standard Deviation|11.4|11.4|||
4027492|NCT01155999|3849239|B3|Tunisia||Region of Enrollment||participants|Number|93|93.0||||||
4027493|NCT01155999|3849240|B2|Tunisia||Region of Enrollment||participants|Number|46|46.0||||||
4027494|NCT01155999|3849241|B1|Tunisia||Region of Enrollment||participants|Number|47|47.0||||||
4027495|NCT01155999|3849239|B3|Algeria||Region of Enrollment||participants|Number|35|35.0||||||
4027496|NCT01155999|3849240|B2|Algeria||Region of Enrollment||participants|Number|17|17.0||||||
4027497|NCT01155999|3849241|B1|Algeria||Region of Enrollment||participants|Number|18|18.0||||||
4027498|NCT01155999|3849239|B3|Romania||Region of Enrollment||participants|Number|57|57.0||||||
4027499|NCT01155999|3849240|B2|Romania||Region of Enrollment||participants|Number|28|28.0||||||
4027500|NCT01155999|3849241|B1|Romania||Region of Enrollment||participants|Number|29|29.0||||||
4027501|NCT01155999|3849239|B3|Portugal||Region of Enrollment||participants|Number|6|6.0||||||
4027502|NCT01155999|3849240|B2|Portugal||Region of Enrollment||participants|Number|4|4.0||||||
4027503|NCT01155999|3849241|B1|Portugal||Region of Enrollment||participants|Number|2|2.0||||||
4027504|NCT01155999|3849239|B3|Poland||Region of Enrollment||participants|Number|36|36.0||||||
4027505|NCT01155999|3849240|B2|Poland||Region of Enrollment||participants|Number|17|17.0||||||
4027506|NCT01155999|3849241|B1|Poland||Region of Enrollment||participants|Number|19|19.0||||||
4027507|NCT01155999|3849239|B3|Italy||Region of Enrollment||participants|Number|4|4.0||||||
4027508|NCT01155999|3849240|B2|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4027509|NCT01155999|3849241|B1|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4027510|NCT01155999|3849239|B3|Germany||Region of Enrollment||participants|Number|25|25.0||||||
4027511|NCT01155999|3849240|B2|Germany||Region of Enrollment||participants|Number|11|11.0||||||
4027512|NCT01155999|3849241|B1|Germany||Region of Enrollment||participants|Number|14|14.0||||||
4027513|NCT01155999|3849239|B3|France||Region of Enrollment||participants|Number|26|26.0||||||
4027514|NCT01155999|3849240|B2|France||Region of Enrollment||participants|Number|11|11.0||||||
4027515|NCT01155999|3849241|B1|France||Region of Enrollment||participants|Number|15|15.0||||||
4027516|NCT01155999|3849239|B3||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4027517|NCT01155999|3849240|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4027518|NCT01155999|3849241|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4027519|NCT01155999|3849239|B3||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4027520|NCT01155999|3849240|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4027521|NCT01155999|3849241|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4027522|NCT01155999|3849239|B3|||Age||years|Mean|3.28|3.28|Standard Deviation|3.79|3.79|||
4027523|NCT01155999|3849240|B2|||Age||years|Mean|3.52|3.52|Standard Deviation|4.17|4.17|||
4027524|NCT01155999|3849241|B1|||Age||years|Mean|3.06|3.06|Standard Deviation|3.40|3.4|||
4027525|NCT01155869|3849248|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4027526|NCT01155869|3849249|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4027527|NCT01155869|3849250|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4027528|NCT01155869|3849248|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4027529|NCT01155869|3849249|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4027530|NCT01155869|3849250|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4027531|NCT01155869|3849248|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4027532|NCT01155869|3849249|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4027533|NCT01155869|3849250|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4027534|NCT01155869|3849248|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4027535|NCT01155869|3849249|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4027536|NCT01155869|3849250|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4027537|NCT01155869|3849248|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4027538|NCT01155869|3849249|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4027539|NCT01155869|3849250|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4027540|NCT01155869|3849248|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4027541|NCT01155869|3849249|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4027542|NCT01155869|3849250|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4027543|NCT01155830|3849259|B4|United States||Region of Enrollment||participants|Number|21|21.0||||||
4027544|NCT01155830|3849260|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4027545|NCT01155830|3849259|B4|Male||Gender||participants|Number|13|13.0||||||
4027546|NCT01155830|3849260|B3|Male||Gender||participants|Number|13|13.0||||||
4027547|NCT01155830|3849259|B4|Female||Gender||participants|Number|8|8.0||||||
4027548|NCT01155830|3849260|B3|Female||Gender||participants|Number|8|8.0||||||
4027549|NCT01155830|3849259|B4|||Age||Days|Mean|1|1.0|Standard Deviation|1|1.0|||
4027550|NCT01155830|3849260|B3|||Age||Days|Mean|1|1.0|Standard Deviation|1|1.0|||
4027551|NCT01155830|3849259|B4|>=65 years||Age||participants|Number|0|0.0||||||
4027552|NCT01155830|3849260|B3|>=65 years||Age||participants|Number|0|0.0||||||
4027553|NCT01155830|3849259|B4|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
4027554|NCT01155830|3849260|B3|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
4027555|NCT01155830|3849259|B4|<=18 years||Age||participants|Number|21|21.0||||||
4027556|NCT01155830|3849260|B3|<=18 years||Age||participants|Number|21|21.0||||||
4027557|NCT01155778|3849275|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4027558|NCT01155778|3849276|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4027559|NCT01155778|3849277|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4027560|NCT01155778|3849278|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4027561|NCT01155778|3849275|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4027562|NCT01155778|3849276|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4027563|NCT01155778|3849277|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4027564|NCT01155778|3849278|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4027565|NCT01155778|3849275|B4|||Age||years|Mean|9.618|9.618|Standard Deviation|7.2941|7.2941|||
4027566|NCT01155778|3849276|B3|||Age||years|Mean|10.64|10.64|Standard Deviation|8.7|8.7|||
4027567|NCT01155778|3849277|B2|||Age||years|Mean|9.07|9.07|Standard Deviation|9.8|9.8|||
4027568|NCT01155778|3849278|B1|||Age||years|Mean|9.15|9.15|Standard Deviation|4.7|4.7|||
4027569|NCT01155726|3849360|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4027570|NCT01155726|3849360|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4027571|NCT01155726|3849360|B1|||Age||years|Mean|25|25.0|Standard Deviation|9|9.0|||
4027572|NCT01155661|3849385|B1|Spain||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4027573|NCT01155661|3849385|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4027574|NCT01155661|3849385|B1|Lithuania||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
4027575|NCT01155661|3849385|B1|Chile||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
4027576|NCT01155661|3849385|B1|Brazil||Region of Enrollment||Participants|Count of Participants|82|82.0||||||
4027577|NCT01155661|3849385|B1|Mexico||Region of Enrollment||Participants|Count of Participants|110|110.0||||||
4027578|NCT01155661|3849385|B1|United States||Region of Enrollment||Participants|Count of Participants|300|300.0||||||
4027579|NCT01155661|3849385|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4027580|NCT01155661|3849385|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4027581|NCT01155661|3849385|B1||White|Race (NIH/OMB)||Participants|Count of Participants|521|521.0||||||
4027582|NCT01155661|3849385|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4027583|NCT01155661|3849385|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4027584|NCT01155661|3849385|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4027585|NCT01155661|3849385|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4027586|NCT01155661|3849385|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4027587|NCT01155661|3849385|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|320|320.0||||||
4027588|NCT01155661|3849385|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|214|214.0||||||
4027589|NCT01155661|3849385|B1||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4027590|NCT01155661|3849385|B1||Female|Sex: Female, Male||Participants|Count of Participants|455|455.0||||||
4027591|NCT01155661|3849385|B1|||Age||years|Mean|47.54|47.54|Standard Deviation|12.97|12.97|||
4027592|NCT01155570|3849411|B1|||Disease Activity Score 28-4, C-reactive Protein (DAS28-4 [CRP])|DAS28-4 (CRP) is calculated using the number of tender and swollen joints (out of 28 counted), C-reactive protein (CRP) level, and the patient's global assessment of disease activity via the visual analog scale (VAS). The calculated range of DAS28-4 is 0.49 to 9.07. A DAS28-4 score less than 2.6 indicates clinical remission, DAS28-4 2.6 to 3.2 indicates low disease activity, DAS28-4 3.2 to less than 5.1 indicates moderate disease activity, and DAS28-4 of 5.1 or greater indicates high disease activity. DAS28-4 (CRP) was assessed at baseline in 131 participants with psoriatic arthritis.|units on a scale|Mean|3.5|3.5|Standard Deviation|1.3|1.3|||
4027593|NCT01155570|3849411|B1|||Disease Activity Score 28-4, Erythrocyte Sedimentation Rate (DAS28-4 [ESR])|DAS28-4 (ESR) is calculated using the number of tender and swollen joints (out of 28 counted), erythrocyte sedimentation rate (ESR), and the patient's global assessment of disease activity via the visual analog scale (VAS). The calculated range of DAS28-4 is 0.49 to 9.07. A DAS28-4 score less than 2.6 indicates clinical remission, DAS28-4 2.6 to 3.2 indicates low disease activity, DAS28-4 3.2 to less than 5.1 indicates moderate disease activity, and DAS28-4 of 5.1 or greater indicates high disease activity. DAS28-4 (ESR) was assessed at baseline in 94 participants with psoriatic arthritis.|units on a scale|Mean|4.4|4.4|Standard Deviation|1.7|1.7|||
4027594|NCT01155570|3849411|B1|||Pain Visual Analog Scale (VAS)|Participants assessed their pain due to psoriatic arthritis in the last week, on a a single-line Visual Analogue Scale (VAS) from 0 (no pain) to 100 (pain as bad as it could be). VAS was assessed at baseline in 153 participants.|units on a scale|Mean|49.5|49.5|Standard Deviation|30.7|30.7|||
4027595|NCT01155570|3849411|B1|||Dermatology Life Quality Index (DLQI)|Dermatology Life Quality Index (DLQI) score is a participant-reported outcome consisting of a set of 10 questions regarding the degree to which the participant's skin has affected certain behaviors and quality of life over the last week. Responses to each question are: very much (score of 3), a lot, a little, or not at all (score of 0). The DLQI score ranges from 0 (best) to 30 (worst); the higher the score, the more quality of life is impaired. DLQI was assessed at baseline in 280 participants.|units on a scale|Mean|8.43|8.43|Standard Deviation|6.77|6.77|||
4027596|NCT01155570|3849411|B1|||Psoriasis Area and Severity Index (PASI)|Psoriasis Area and Severity Index (PASI) is a composite score based on the degree of effect on body surface area of psoriasis and the extension of erythema (reddening), induration (plaque thickness), desquamation (scaling) of the lesions, and area affected as observed on the day of examination. The score ranges from 0 (no psoriasis) to 72 (very severe psoriasis). PASI was assessed at baseline in 625 participants.|units on a scale|Mean|15.7|15.7|Standard Deviation|12.2|12.2|||
4027597|NCT01155570|3849411|B1|||Physician's Global Assessment (PGA)|The Physician's Global Assessment (PGA) is a 6-point scale used to measure the severity of disease at the time of the physician's evaluation of the participant. The degree of overall lesion severity was evaluated using the following categories: 0 (Clear); 1 (Minimal); 2 (Mild); 3 (Moderate); 4 (Severe); 5 (Very Severe). PGA was assessed at baseline in 644 participants.|units on a scale|Mean|2.7|2.7|Standard Deviation|5.7|5.7|||
4027598|NCT01155570|3849411|B1||Male|Sex: Female, Male||Participants|Count of Participants|558|558.0||||||
4027599|NCT01155570|3849411|B1||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4027600|NCT01155570|3849411|B1|||Age||years|Mean|50.7|50.7|Standard Deviation|13.4|13.4|||
4027601|NCT01155531|3849441|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4027602|NCT01155531|3849442|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4027603|NCT01155531|3849443|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4027604|NCT01155531|3849444|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4027605|NCT01155531|3849445|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4027606|NCT01155531|3849441|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4027607|NCT01155531|3849442|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4027608|NCT01155531|3849443|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4027609|NCT01155531|3849444|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4027610|NCT01155531|3849445|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4027611|NCT01155531|3849441|B5||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4027612|NCT01155531|3849442|B4||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4027613|NCT01155531|3849443|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4027614|NCT01155531|3849444|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4027615|NCT01155531|3849445|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4027616|NCT01155531|3849441|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4027617|NCT01155531|3849442|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4027618|NCT01155531|3849443|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4027619|NCT01155531|3849444|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4027620|NCT01155531|3849445|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4027621|NCT01155531|3849441|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4027622|NCT01155531|3849442|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4027623|NCT01155531|3849443|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4027624|NCT01155531|3849444|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4027625|NCT01155531|3849445|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4027626|NCT01155531|3849441|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4027627|NCT01155531|3849442|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4027628|NCT01155531|3849443|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4027629|NCT01155531|3849444|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4027630|NCT01155531|3849445|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4027631|NCT01155531|3849441|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4027632|NCT01155531|3849442|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4027633|NCT01155531|3849443|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4027634|NCT01155531|3849444|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4027635|NCT01155531|3849445|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4027636|NCT01155531|3849441|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4027637|NCT01155531|3849442|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4027638|NCT01155531|3849443|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4027639|NCT01155531|3849444|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4027640|NCT01155531|3849445|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4027641|NCT01155531|3849441|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4027642|NCT01155531|3849442|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4027643|NCT01155531|3849443|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4027644|NCT01155531|3849444|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4027645|NCT01155531|3849445|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4027646|NCT01155531|3849441|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4027647|NCT01155531|3849442|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4027648|NCT01155531|3849443|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4027649|NCT01155531|3849444|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4027650|NCT01155531|3849445|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4027651|NCT01155531|3849441|B5||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4027652|NCT01155531|3849442|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4027653|NCT01155531|3849443|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4027654|NCT01155531|3849444|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4027655|NCT01155531|3849445|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4027656|NCT01155531|3849441|B5||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4027657|NCT01155531|3849442|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4027658|NCT01155531|3849443|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4027659|NCT01155531|3849444|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4027660|NCT01155531|3849445|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4027661|NCT01155531|3849441|B5|||Age||years|Mean|33.4|33.4|Full Range|||21.0|45.0|
4027662|NCT01155531|3849442|B4|||Age||years|Mean|34.3|34.3|Full Range|||22.0|45.0|
4027663|NCT01155531|3849443|B3|||Age||years|Mean|33.5|33.5|Full Range|||22.0|44.0|
4027664|NCT01155531|3849444|B2|||Age||years|Mean|35.2|35.2|Full Range|||21.0|45.0|
4027665|NCT01155531|3849445|B1|||Age||years|Mean|30.7|30.7|Full Range|||22.0|42.0|
4027666|NCT01155479|3849466|B6||Male|Sex: Female, Male||Participants|Count of Participants|597|597.0||||||
4027667|NCT01155479|3849467|B5||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4027668|NCT01155479|3849468|B4||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4027669|NCT01155479|3849469|B3||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4027670|NCT01155479|3849470|B2||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4027671|NCT01155479|3849471|B1||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4027672|NCT01155479|3849466|B6||Female|Sex: Female, Male||Participants|Count of Participants|425|425.0||||||
4027673|NCT01155479|3849467|B5||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4027674|NCT01155479|3849468|B4||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4027675|NCT01155479|3849469|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4027676|NCT01155479|3849470|B2||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4027677|NCT01155479|3849471|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4027678|NCT01155479|3849466|B6|||Age||Years|Mean|63.1|63.1|Standard Deviation|10.4|10.4|||
4027679|NCT01155479|3849467|B5|||Age||Years|Mean|62.9|62.9|Standard Deviation|10.2|10.2|||
4027680|NCT01155479|3849468|B4|||Age||Years|Mean|63.3|63.3|Standard Deviation|10.0|10.0|||
4027681|NCT01155479|3849469|B3|||Age||Years|Mean|63.8|63.8|Standard Deviation|11.1|11.1|||
4027682|NCT01155479|3849470|B2|||Age||Years|Mean|62.3|62.3|Standard Deviation|10.2|10.2|||
4027683|NCT01155479|3849471|B1|||Age||Years|Mean|63.0|63.0|Standard Deviation|10.5|10.5|||
4027684|NCT01155466|3849522|B6||Male|Sex: Female, Male||Participants|Count of Participants|446|446.0||||||
4027685|NCT01155466|3849523|B5||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4027686|NCT01155466|3849524|B4||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4027687|NCT01155466|3849525|B3||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4027688|NCT01155466|3849526|B2||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4027689|NCT01155466|3849527|B1||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4027690|NCT01155466|3849522|B6||Female|Sex: Female, Male||Participants|Count of Participants|332|332.0||||||
4027691|NCT01155466|3849523|B5||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4027692|NCT01155466|3849524|B4||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4027693|NCT01155466|3849525|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4027694|NCT01155466|3849526|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4027695|NCT01155466|3849527|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4027696|NCT01155466|3849522|B6|||Age||Years|Mean|62.9|62.9|Standard Deviation|8.7|8.7|||
4027697|NCT01155466|3849523|B5|||Age||Years|Mean|63.8|63.8|Standard Deviation|9.0|9.0|||
4027698|NCT01155466|3849524|B4|||Age||Years|Mean|63.0|63.0|Standard Deviation|8.4|8.4|||
4027699|NCT01155466|3849525|B3|||Age||Years|Mean|63.6|63.6|Standard Deviation|8.4|8.4|||
4027700|NCT01155466|3849526|B2|||Age||Years|Mean|62.6|62.6|Standard Deviation|8.5|8.5|||
4027701|NCT01155466|3849527|B1|||Age||Years|Mean|61.7|61.7|Standard Deviation|9.2|9.2|||
4027702|NCT01155388|3849583|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4027703|NCT01155388|3849584|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4027704|NCT01155388|3849585|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4027705|NCT01155388|3849583|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4027706|NCT01155388|3849584|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4027707|NCT01155388|3849585|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4027708|NCT01155388|3849583|B3|||Age||years|Mean|14.6|14.6|Standard Deviation|2.93|2.93|||
4027709|NCT01155388|3849584|B2|||Age||years|Mean|13.8|13.8|Standard Deviation|4.52|4.52|||
4027710|NCT01155388|3849585|B1|||Age||years|Mean|15.2|15.2|Standard Deviation|1.65|1.65|||
4027711|NCT01155388|3849583|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4027712|NCT01155388|3849584|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4027713|NCT01155388|3849585|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4027714|NCT01155388|3849583|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4027715|NCT01155388|3849584|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4027716|NCT01155388|3849585|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4027717|NCT01155388|3849583|B3||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4027718|NCT01155388|3849584|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4027719|NCT01155388|3849585|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4027720|NCT01155375|3849594|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4027721|NCT01155375|3849595|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4027722|NCT01155375|3849596|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4027723|NCT01155375|3849594|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4027724|NCT01155375|3849595|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4027725|NCT01155375|3849596|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4027726|NCT01155375|3849594|B3|||Age||years|Mean|14.6|14.6|Standard Deviation|2.93|2.93|||
4027727|NCT01155375|3849595|B2|||Age||years|Mean|13.8|13.8|Standard Deviation|4.52|4.52|||
4027728|NCT01155375|3849596|B1|||Age||years|Mean|15.2|15.2|Standard Deviation|1.65|1.65|||
4027729|NCT01155375|3849594|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4027730|NCT01155375|3849595|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4027731|NCT01155375|3849596|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4027732|NCT01155375|3849594|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4027733|NCT01155375|3849595|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4027734|NCT01155375|3849596|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4027735|NCT01155375|3849594|B3||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4027736|NCT01155375|3849595|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4027737|NCT01155375|3849596|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4027738|NCT01155336|3849605|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4027739|NCT01155336|3849606|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4027740|NCT01155336|3849605|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4027741|NCT01155336|3849606|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4027742|NCT01155336|3849605|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4027743|NCT01155336|3849606|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4027744|NCT01155336|3849605|B3|||Age||years|Mean|60.25|60.25|Standard Deviation|10|10.0|||
4027745|NCT01155336|3849606|B2|||Age||years|Mean|60.25|60.25|Standard Deviation|10|10.0|||
4027746|NCT01155336|3849605|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4027747|NCT01155336|3849606|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4027748|NCT01155336|3849605|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4027749|NCT01155336|3849606|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4027750|NCT01155336|3849605|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4027751|NCT01155336|3849606|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4027752|NCT01155323|3849616|B1|Singapore||Region of Enrollment||participants|Number|113|113.0||||||
4027753|NCT01155323|3849616|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4027754|NCT01155323|3849616|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4027755|NCT01155323|3849616|B1|||Age||years|Mean|25.3|25.3|Standard Deviation|4.4|4.4|||
4027756|NCT01155284|3849633|B3|||IDA-HbA1c (%)||%|Mean|8.83|8.83|Standard Deviation|1.49|1.49|||
4027757|NCT01155284|3849634|B2|||IDA-HbA1c (%)||%|Mean|8.68|8.68|Standard Deviation|1.43|1.43|||
4027758|NCT01155284|3849635|B1|||IDA-HbA1c (%)||%|Mean|8.9|8.9|Standard Deviation|1.53|1.53|||
4027759|NCT01155284|3849633|B3|||HbA1c (%)||%|Mean|7.18|7.18|Standard Deviation|1.09|1.09|||
4027760|NCT01155284|3849634|B2|||HbA1c (%)||%|Mean|7.15|7.15|Standard Deviation|1.13|1.13|||
4027761|NCT01155284|3849635|B1|||HbA1c (%)||%|Mean|7.19|7.19|Standard Deviation|1.09|1.09|||
4027762|NCT01155284|3849633|B3|||Glucose (mmol/L)|time weighed mean during mixed meal test|mmol/L|Mean|10.56|10.56|Standard Deviation|3.35|3.35|||
4027763|NCT01155284|3849634|B2|||Glucose (mmol/L)|time weighed mean during mixed meal test|mmol/L|Mean|10.47|10.47|Standard Deviation|3.43|3.43|||
4027764|NCT01155284|3849635|B1|||Glucose (mmol/L)|time weighed mean during mixed meal test|mmol/L|Mean|10.61|10.61|Standard Deviation|3.35|3.35|||
4027765|NCT01155284|3849633|B3|||2 -hour C-peptide Area Under Curve Result in Response to Standardized Mixed Meal Tolerance Test|C-peptide reflects how much insulin pancreatic beta cells are making. The MMTT measures how much insulin can be made. Blood samples for C-peptide were collected at baseline, 15, 30, 60, 90 and 120 minutes post-meal. Results are presented as the time weighted average concentration. To maintain consistency with prior reports, this has been labeled as “AUC,” although it may be more accurate to describe this as an AUC mean (pmol/L), [true AUC (pmol*min/L) / 120 minutes]. Larger numbers are better, reflecting preservation of insulin production.|pmol/L|Mean|686|686.0|Standard Deviation|413|413.0|||
4027766|NCT01155284|3849634|B2|||2 -hour C-peptide Area Under Curve Result in Response to Standardized Mixed Meal Tolerance Test|C-peptide reflects how much insulin pancreatic beta cells are making. The MMTT measures how much insulin can be made. Blood samples for C-peptide were collected at baseline, 15, 30, 60, 90 and 120 minutes post-meal. Results are presented as the time weighted average concentration. To maintain consistency with prior reports, this has been labeled as “AUC,” although it may be more accurate to describe this as an AUC mean (pmol/L), [true AUC (pmol*min/L) / 120 minutes]. Larger numbers are better, reflecting preservation of insulin production.|pmol/L|Mean|747|747.0|Standard Deviation|468|468.0|||
4027767|NCT01155284|3849635|B1|||2 -hour C-peptide Area Under Curve Result in Response to Standardized Mixed Meal Tolerance Test|C-peptide reflects how much insulin pancreatic beta cells are making. The MMTT measures how much insulin can be made. Blood samples for C-peptide were collected at baseline, 15, 30, 60, 90 and 120 minutes post-meal. Results are presented as the time weighted average concentration. To maintain consistency with prior reports, this has been labeled as “AUC,” although it may be more accurate to describe this as an AUC mean (pmol/L), [true AUC (pmol*min/L) / 120 minutes]. Larger numbers are better, reflecting preservation of insulin production.|pmol/L|Mean|656|656.0|Standard Deviation|385|385.0|||
4027768|NCT01155284|3849633|B3|||Insulin use (units/kg per day)||units/kg per day|Mean|0.41|0.41|Standard Deviation|0.20|0.2|||
4027769|NCT01155284|3849634|B2|||Insulin use (units/kg per day)||units/kg per day|Mean|0.38|0.38|Standard Deviation|0.17|0.17|||
4027770|NCT01155284|3849635|B1|||Insulin use (units/kg per day)||units/kg per day|Mean|0.43|0.43|Standard Deviation|0.22|0.22|||
4027771|NCT01155284|3849633|B3|||HLA DR Allele - Both DR3 and DR4||participants|Number|20|20.0||||||
4027772|NCT01155284|3849634|B2|||HLA DR Allele - Both DR3 and DR4||participants|Number|6|6.0||||||
4027773|NCT01155284|3849635|B1|||HLA DR Allele - Both DR3 and DR4||participants|Number|14|14.0||||||
4027774|NCT01155284|3849633|B3|||HLA DR4 Allele only||participants|Number|25|25.0||||||
4027775|NCT01155284|3849634|B2|||HLA DR4 Allele only||participants|Number|6|6.0||||||
4027776|NCT01155284|3849635|B1|||HLA DR4 Allele only||participants|Number|19|19.0||||||
4027777|NCT01155284|3849633|B3|||HLA DR Allele - DR3 only||participants|Number|18|18.0||||||
4027778|NCT01155284|3849634|B2|||HLA DR Allele - DR3 only||participants|Number|7|7.0||||||
4027779|NCT01155284|3849635|B1|||HLA DR Allele - DR3 only||participants|Number|11|11.0||||||
4027780|NCT01155284|3849633|B3|||HLA DR Allele - Neither DR3 nor DR4||participants|Number|5|5.0||||||
4027781|NCT01155284|3849634|B2|||HLA DR Allele - Neither DR3 nor DR4||participants|Number|3|3.0||||||
4027782|NCT01155284|3849635|B1|||HLA DR Allele - Neither DR3 nor DR4||participants|Number|2|2.0||||||
4027783|NCT01155284|3849633|B3|||GAD antibody positive||participants|Number|64|64.0||||||
4027784|NCT01155284|3849634|B2|||GAD antibody positive||participants|Number|22|22.0||||||
4027785|NCT01155284|3849635|B1|||GAD antibody positive||participants|Number|42|42.0||||||
4027786|NCT01155284|3849633|B3|||Days Post diagnosis||Days|Mean|103.4|103.4|Standard Deviation|51.7|51.7|||
4027787|NCT01155284|3849634|B2|||Days Post diagnosis||Days|Mean|104.7|104.7|Standard Deviation|52.8|52.8|||
4027788|NCT01155284|3849635|B1|||Days Post diagnosis||Days|Mean|102.8|102.8|Standard Deviation|51.8|51.8|||
4027789|NCT01155284|3849633|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4027790|NCT01155284|3849634|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4027791|NCT01155284|3849635|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4027792|NCT01155284|3849633|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4027793|NCT01155284|3849634|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4027794|NCT01155284|3849635|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4027795|NCT01155284|3849633|B3|Age (years)||Age, Customized||years|Mean|16.2|16.2|Standard Deviation|5.8|5.8|||
4027796|NCT01155284|3849634|B2|Age (years)||Age, Customized||years|Mean|17.6|17.6|Standard Deviation|6.9|6.9|||
4027797|NCT01155284|3849635|B1|Age (years)||Age, Customized||years|Mean|15.5|15.5|Standard Deviation|5.1|5.1|||
4027798|NCT01155219|3849644|B3|France||Region of Enrollment||participants|Number|150|150.0||||||
4027799|NCT01155219|3849645|B2|France||Region of Enrollment||participants|Number|73|73.0||||||
4027800|NCT01155219|3849646|B1|France||Region of Enrollment||participants|Number|77|77.0||||||
4027801|NCT01155219|3849644|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4027802|NCT01155219|3849645|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4027803|NCT01155219|3849646|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4027804|NCT01155219|3849644|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4027805|NCT01155219|3849645|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4027806|NCT01155219|3849646|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4027807|NCT01155219|3849644|B3|||Age||years|Mean|65.41|65.41|Standard Deviation|11.68|11.68|||
4027808|NCT01155219|3849645|B2|||Age||years|Mean|64.86|64.86|Standard Deviation|11.62|11.62|||
4027809|NCT01155219|3849646|B1|||Age||years|Mean|65.94|65.94|Standard Deviation|11.79|11.79|||
4027810|NCT01155193|3849653|B5|||Immunoprophylaxis with Palivizumab Started in Hospital||Participants|Count of Participants|5604|5604.0||||||
4027811|NCT01155193|3849654|B4|||Immunoprophylaxis with Palivizumab Started in Hospital||Participants|Count of Participants|3127|3127.0||||||
4027812|NCT01155193|3849655|B3|||Immunoprophylaxis with Palivizumab Started in Hospital||Participants|Count of Participants|313|313.0||||||
4027813|NCT01155193|3849656|B2|||Immunoprophylaxis with Palivizumab Started in Hospital||Participants|Count of Participants|519|519.0||||||
4027814|NCT01155193|3849657|B1|||Immunoprophylaxis with Palivizumab Started in Hospital||Participants|Count of Participants|1645|1645.0||||||
4027815|NCT01155193|3849653|B5|Breast feeding ≤ 2 months||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4027816|NCT01155193|3849654|B4|Breast feeding ≤ 2 months||Risk Factors for RSV Complications||Participants|Count of Participants|5794|5794.0||||||
4027817|NCT01155193|3849655|B3|Breast feeding ≤ 2 months||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||This risk factor was not assessed during this period
4027818|NCT01155193|3849656|B2|Breast feeding ≤ 2 months||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||This risk factor was not assessed during this period
4027819|NCT01155193|3849657|B1|Breast feeding ≤ 2 months||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||This risk factor was not assessed during this period
4027820|NCT01155193|3849653|B5|Exposition to air pollution||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4027821|NCT01155193|3849654|B4|Exposition to air pollution||Risk Factors for RSV Complications||Participants|Count of Participants|1710|1710.0||||||
4027822|NCT01155193|3849655|B3|Exposition to air pollution||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||This risk factor was not assessed during this period
4027823|NCT01155193|3849656|B2|Exposition to air pollution||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||This risk factor was not assessed during this period
4027824|NCT01155193|3849657|B1|Exposition to air pollution||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||This risk factor was not assessed during this period
4027825|NCT01155193|3849653|B5|Crowded living conditions||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4027826|NCT01155193|3849654|B4|Crowded living conditions||Risk Factors for RSV Complications||Participants|Count of Participants|2592|2592.0||||||
4027827|NCT01155193|3849655|B3|Crowded living conditions||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||This risk factor was not assessed during this period
4027828|NCT01155193|3849656|B2|Crowded living conditions||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||This risk factor was not assessed during this period
4027829|NCT01155193|3849657|B1|Crowded living conditions||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||This risk factor was not assessed during this period
4027830|NCT01155193|3849653|B5|Low social status||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4027831|NCT01155193|3849654|B4|Low social status||Risk Factors for RSV Complications||Participants|Count of Participants|2258|2258.0||||||
4027832|NCT01155193|3849655|B3|Low social status||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||This risk factor was not assessed during this period
4027917|NCT01155193|3849655|B3|Multiple births||Risk Factors for RSV Complications||Participants|Count of Participants|632|632.0||||||
4027833|NCT01155193|3849656|B2|Low social status||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||This risk factor was not assessed during this period
4027834|NCT01155193|3849657|B1|Low social status||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||This risk factor was not assessed during this period
4027835|NCT01155193|3849653|B5|Serious neurological disease||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4027836|NCT01155193|3849654|B4|Serious neurological disease||Risk Factors for RSV Complications||Participants|Count of Participants|428|428.0||||||
4027837|NCT01155193|3849655|B3|Serious neurological disease||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||This risk factor was not assessed during this period
4027838|NCT01155193|3849656|B2|Serious neurological disease||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||This risk factor was not assessed during this period
4027839|NCT01155193|3849657|B1|Serious neurological disease||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||This risk factor was not assessed during this period
4027840|NCT01155193|3849653|B5|Down syndrome (Trisomy 21)||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4027841|NCT01155193|3849654|B4|Down syndrome (Trisomy 21)||Risk Factors for RSV Complications||Participants|Count of Participants|249|249.0||||||
4027842|NCT01155193|3849655|B3|Down syndrome (Trisomy 21)||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||This risk factor was not assessed during this period
4027843|NCT01155193|3849656|B2|Down syndrome (Trisomy 21)||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||This risk factor was not assessed during this period
4027844|NCT01155193|3849657|B1|Down syndrome (Trisomy 21)||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||This risk factor was not assessed during this period
4027845|NCT01155193|3849653|B5|Neuromuscular impairment||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4027846|NCT01155193|3849654|B4|Neuromuscular impairment||Risk Factors for RSV Complications||Participants|Count of Participants|786|786.0||||||
4027847|NCT01155193|3849655|B3|Neuromuscular impairment||Risk Factors for RSV Complications||Participants|Count of Participants|120|120.0||||||
4027848|NCT01155193|3849656|B2|Neuromuscular impairment||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||This risk factor was not assessed during this period
4027849|NCT01155193|3849657|B1|Neuromuscular impairment||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||This risk factor was not assessed during this period
4027850|NCT01155193|3849653|B5|Treatment with oxygen at home||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4027851|NCT01155193|3849654|B4|Treatment with oxygen at home||Risk Factors for RSV Complications||Participants|Count of Participants|763|763.0||||||
4027852|NCT01155193|3849655|B3|Treatment with oxygen at home||Risk Factors for RSV Complications||Participants|Count of Participants|133|133.0||||||
4027853|NCT01155193|3849656|B2|Treatment with oxygen at home||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||This risk factor was not assessed during this period
4027854|NCT01155193|3849657|B1|Treatment with oxygen at home||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||This risk factor was not assessed during this period
4027855|NCT01155193|3849653|B5|Chronic lung disease therapy||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4027856|NCT01155193|3849654|B4|Chronic lung disease therapy||Risk Factors for RSV Complications||Participants|Count of Participants|1803|1803.0||||||
4027857|NCT01155193|3849655|B3|Chronic lung disease therapy||Risk Factors for RSV Complications||Participants|Count of Participants|281|281.0||||||
4027858|NCT01155193|3849656|B2|Chronic lung disease therapy||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||This risk factor was not assessed during this period
4027859|NCT01155193|3849657|B1|Chronic lung disease therapy||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||This risk factor was not assessed during this period
4027860|NCT01155193|3849653|B5|Cyanotic heart defect||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4027861|NCT01155193|3849654|B4|Cyanotic heart defect||Risk Factors for RSV Complications||Participants|Count of Participants|784|784.0||||||
4027862|NCT01155193|3849655|B3|Cyanotic heart defect||Risk Factors for RSV Complications||Participants|Count of Participants|123|123.0||||||
4027863|NCT01155193|3849656|B2|Cyanotic heart defect||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||This risk factor was not assessed during this period
4027864|NCT01155193|3849657|B1|Cyanotic heart defect||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||This risk factor was not assessed during this period
4027865|NCT01155193|3849653|B5|Family history of atopy||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4027866|NCT01155193|3849654|B4|Family history of atopy||Risk Factors for RSV Complications||Participants|Count of Participants|2039|2039.0||||||
4027867|NCT01155193|3849655|B3|Family history of atopy||Risk Factors for RSV Complications||Participants|Count of Participants|346|346.0||||||
4027868|NCT01155193|3849656|B2|Family history of atopy||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||This risk factor was not assessed during this period
4027869|NCT01155193|3849657|B1|Family history of atopy||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||This risk factor was not assessed during this period
4027870|NCT01155193|3849653|B5|Family history of allergic eczema||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4027871|NCT01155193|3849654|B4|Family history of allergic eczema||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||This risk factor was not assessed during this period
4027872|NCT01155193|3849655|B3|Family history of allergic eczema||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||This risk factor was not assessed during this period
4027873|NCT01155193|3849656|B2|Family history of allergic eczema||Risk Factors for RSV Complications||Participants|Count of Participants|245|245.0||||||
4027874|NCT01155193|3849657|B1|Family history of allergic eczema||Risk Factors for RSV Complications||Participants|Count of Participants|713|713.0||||||
4027875|NCT01155193|3849653|B5|Family history of allergic rhinitis||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4027876|NCT01155193|3849654|B4|Family history of allergic rhinitis||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||This risk factor was not assessed during this period
4027877|NCT01155193|3849655|B3|Family history of allergic rhinitis||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||This risk factor was not assessed during this period
4027878|NCT01155193|3849656|B2|Family history of allergic rhinitis||Risk Factors for RSV Complications||Participants|Count of Participants|450|450.0||||||
4027879|NCT01155193|3849657|B1|Family history of allergic rhinitis||Risk Factors for RSV Complications||Participants|Count of Participants|1234|1234.0||||||
4027880|NCT01155193|3849653|B5|Family history of asthma||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4027881|NCT01155193|3849654|B4|Family history of asthma||Risk Factors for RSV Complications||Participants|Count of Participants|1128|1128.0||||||
4027882|NCT01155193|3849655|B3|Family history of asthma||Risk Factors for RSV Complications||Participants|Count of Participants|NA|||||||This risk factor was not assessed during this period
4027883|NCT01155193|3849656|B2|Family history of asthma||Risk Factors for RSV Complications||Participants|Count of Participants|304|304.0||||||
4027884|NCT01155193|3849657|B1|Family history of asthma||Risk Factors for RSV Complications||Participants|Count of Participants|823|823.0||||||
4027885|NCT01155193|3849653|B5|Other children (< 12 years) in household||Risk Factors for RSV Complications||Participants|Count of Participants|12136|12136.0||||||
4027886|NCT01155193|3849654|B4|Other children (< 12 years) in household||Risk Factors for RSV Complications||Participants|Count of Participants|4899|4899.0||||||
4027887|NCT01155193|3849655|B3|Other children (< 12 years) in household||Risk Factors for RSV Complications||Participants|Count of Participants|1115|1115.0||||||
4027888|NCT01155193|3849656|B2|Other children (< 12 years) in household||Risk Factors for RSV Complications||Participants|Count of Participants|1682|1682.0||||||
4027889|NCT01155193|3849657|B1|Other children (< 12 years) in household||Risk Factors for RSV Complications||Participants|Count of Participants|4440|4440.0||||||
4027890|NCT01155193|3849653|B5|Attending daycare||Risk Factors for RSV Complications||Participants|Count of Participants|784|784.0||||||
4027891|NCT01155193|3849654|B4|Attending daycare||Risk Factors for RSV Complications||Participants|Count of Participants|361|361.0||||||
4027892|NCT01155193|3849655|B3|Attending daycare||Risk Factors for RSV Complications||Participants|Count of Participants|74|74.0||||||
4027893|NCT01155193|3849656|B2|Attending daycare||Risk Factors for RSV Complications||Participants|Count of Participants|109|109.0||||||
4027894|NCT01155193|3849657|B1|Attending daycare||Risk Factors for RSV Complications||Participants|Count of Participants|240|240.0||||||
4027895|NCT01155193|3849653|B5|Immunodeficiency||Risk Factors for RSV Complications||Participants|Count of Participants|798|798.0||||||
4027896|NCT01155193|3849654|B4|Immunodeficiency||Risk Factors for RSV Complications||Participants|Count of Participants|171|171.0||||||
4027897|NCT01155193|3849655|B3|Immunodeficiency||Risk Factors for RSV Complications||Participants|Count of Participants|30|30.0||||||
4027898|NCT01155193|3849656|B2|Immunodeficiency||Risk Factors for RSV Complications||Participants|Count of Participants|167|167.0||||||
4027899|NCT01155193|3849657|B1|Immunodeficiency||Risk Factors for RSV Complications||Participants|Count of Participants|430|430.0||||||
4027900|NCT01155193|3849653|B5|Chronic lung disease||Risk Factors for RSV Complications||Participants|Count of Participants|8439|8439.0||||||
4027901|NCT01155193|3849654|B4|Chronic lung disease||Risk Factors for RSV Complications||Participants|Count of Participants|2346|2346.0||||||
4027902|NCT01155193|3849655|B3|Chronic lung disease||Risk Factors for RSV Complications||Participants|Count of Participants|584|584.0||||||
4027903|NCT01155193|3849656|B2|Chronic lung disease||Risk Factors for RSV Complications||Participants|Count of Participants|1330|1330.0||||||
4027904|NCT01155193|3849657|B1|Chronic lung disease||Risk Factors for RSV Complications||Participants|Count of Participants|4179|4179.0||||||
4027905|NCT01155193|3849653|B5|Smoking in the family||Risk Factors for RSV Complications||Participants|Count of Participants|4341|4341.0||||||
4027906|NCT01155193|3849654|B4|Smoking in the family||Risk Factors for RSV Complications||Participants|Count of Participants|2037|2037.0||||||
4027907|NCT01155193|3849655|B3|Smoking in the family||Risk Factors for RSV Complications||Participants|Count of Participants|400|400.0||||||
4027908|NCT01155193|3849656|B2|Smoking in the family||Risk Factors for RSV Complications||Participants|Count of Participants|482|482.0||||||
4027909|NCT01155193|3849657|B1|Smoking in the family||Risk Factors for RSV Complications||Participants|Count of Participants|1422|1422.0||||||
4027910|NCT01155193|3849653|B5|Congenital heart disease||Risk Factors for RSV Complications||Participants|Count of Participants|8281|8281.0||||||
4027911|NCT01155193|3849654|B4|Congenital heart disease||Risk Factors for RSV Complications||Participants|Count of Participants|3430|3430.0||||||
4027912|NCT01155193|3849655|B3|Congenital heart disease||Risk Factors for RSV Complications||Participants|Count of Participants|567|567.0||||||
4027913|NCT01155193|3849656|B2|Congenital heart disease||Risk Factors for RSV Complications||Participants|Count of Participants|1283|1283.0||||||
4027914|NCT01155193|3849657|B1|Congenital heart disease||Risk Factors for RSV Complications||Participants|Count of Participants|3001|3001.0||||||
4027915|NCT01155193|3849653|B5|Multiple births||Risk Factors for RSV Complications||Participants|Count of Participants|7954|7954.0||||||
4027916|NCT01155193|3849654|B4|Multiple births||Risk Factors for RSV Complications||Participants|Count of Participants|3793|3793.0||||||
4027918|NCT01155193|3849656|B2|Multiple births||Risk Factors for RSV Complications||Participants|Count of Participants|922|922.0||||||
4027919|NCT01155193|3849657|B1|Multiple births||Risk Factors for RSV Complications||Participants|Count of Participants|2607|2607.0||||||
4027920|NCT01155193|3849653|B5|Premature birth (≤ 35 weeks GA)||Risk Factors for RSV Complications||Participants|Count of Participants|24036|24036.0||||||
4027921|NCT01155193|3849654|B4|Premature birth (≤ 35 weeks GA)||Risk Factors for RSV Complications||Participants|Count of Participants|10784|10784.0||||||
4027922|NCT01155193|3849655|B3|Premature birth (≤ 35 weeks GA)||Risk Factors for RSV Complications||Participants|Count of Participants|1873|1873.0||||||
4027923|NCT01155193|3849656|B2|Premature birth (≤ 35 weeks GA)||Risk Factors for RSV Complications||Participants|Count of Participants|2912|2912.0||||||
4027924|NCT01155193|3849657|B1|Premature birth (≤ 35 weeks GA)||Risk Factors for RSV Complications||Participants|Count of Participants|8467|8467.0||||||
4027925|NCT01155193|3849653|B5|Premature birth (< 29 weeks GA)||Risk Factors for RSV Complications||Participants|Count of Participants|8963|8963.0||||||
4027926|NCT01155193|3849654|B4|Premature birth (< 29 weeks GA)||Risk Factors for RSV Complications||Participants|Count of Participants|3514|3514.0||||||
4027927|NCT01155193|3849655|B3|Premature birth (< 29 weeks GA)||Risk Factors for RSV Complications||Participants|Count of Participants|694|694.0||||||
4027928|NCT01155193|3849656|B2|Premature birth (< 29 weeks GA)||Risk Factors for RSV Complications||Participants|Count of Participants|1173|1173.0||||||
4027929|NCT01155193|3849657|B1|Premature birth (< 29 weeks GA)||Risk Factors for RSV Complications||Participants|Count of Participants|3582|3582.0||||||
4027930|NCT01155193|3849653|B5|Registry 09/10 – 15/16||Age at Start of Immunoprophylaxis||months|Mean|4.3|4.3|Standard Deviation|3.6|3.6|||
4027931|NCT01155193|3849654|B4|Registry 09/10 – 15/16||Age at Start of Immunoprophylaxis||months|Mean|4.3|4.3|Standard Deviation|3.6|3.6|||
4027932|NCT01155193|3849653|B5|Registry 08/09||Age at Start of Immunoprophylaxis||months|Mean|5.9|5.9|Standard Deviation|4.9|4.9|||
4027933|NCT01155193|3849655|B3|Registry 08/09||Age at Start of Immunoprophylaxis||months|Mean|5.9|5.9|Standard Deviation|4.9|4.9|||
4027934|NCT01155193|3849653|B5|Registry 07/08||Age at Start of Immunoprophylaxis||months|Mean|5.0|5.0|Standard Deviation|4.0|4.0|||
4027935|NCT01155193|3849656|B2|Registry 07/08||Age at Start of Immunoprophylaxis||months|Mean|5.0|5.0|Standard Deviation|4.0|4.0|||
4027936|NCT01155193|3849653|B5|Registry 02/03 – 06/07||Age at Start of Immunoprophylaxis||months|Mean|5.2|5.2|Standard Deviation|4.0|4.0|||
4027937|NCT01155193|3849657|B1|Registry 02/03 – 06/07||Age at Start of Immunoprophylaxis||months|Mean|5.2|5.2|Standard Deviation|4.0|4.0|||
4027938|NCT01155193|3849653|B5||Missing|Birth Weight||Participants|Count of Participants|323|323.0||||||
4027939|NCT01155193|3849654|B4||Missing|Birth Weight||Participants|Count of Participants|0|0.0||||||
4027940|NCT01155193|3849655|B3||Missing|Birth Weight||Participants|Count of Participants|0|0.0||||||
4027941|NCT01155193|3849656|B2||Missing|Birth Weight||Participants|Count of Participants|85|85.0||||||
4027942|NCT01155193|3849657|B1||Missing|Birth Weight||Participants|Count of Participants|238|238.0||||||
4027943|NCT01155193|3849653|B5||≥ 2000 g|Birth Weight||Participants|Count of Participants|8411|8411.0||||||
4027944|NCT01155193|3849654|B4||≥ 2000 g|Birth Weight||Participants|Count of Participants|4130|4130.0||||||
4027945|NCT01155193|3849655|B3||≥ 2000 g|Birth Weight||Participants|Count of Participants|691|691.0||||||
4027946|NCT01155193|3849656|B2||≥ 2000 g|Birth Weight||Participants|Count of Participants|995|995.0||||||
4027947|NCT01155193|3849657|B1||≥ 2000 g|Birth Weight||Participants|Count of Participants|2595|2595.0||||||
4027948|NCT01155193|3849653|B5||1500 – 1999 g|Birth Weight||Participants|Count of Participants|5461|5461.0||||||
4027949|NCT01155193|3849654|B4||1500 – 1999 g|Birth Weight||Participants|Count of Participants|2590|2590.0||||||
4027950|NCT01155193|3849655|B3||1500 – 1999 g|Birth Weight||Participants|Count of Participants|424|424.0||||||
4027951|NCT01155193|3849656|B2||1500 – 1999 g|Birth Weight||Participants|Count of Participants|659|659.0||||||
4027952|NCT01155193|3849657|B1||1500 – 1999 g|Birth Weight||Participants|Count of Participants|1788|1788.0||||||
4027953|NCT01155193|3849653|B5||1000 – 1499 g|Birth Weight||Participants|Count of Participants|7348|7348.0||||||
4027954|NCT01155193|3849654|B4||1000 – 1499 g|Birth Weight||Participants|Count of Participants|3063|3063.0||||||
4027955|NCT01155193|3849655|B3||1000 – 1499 g|Birth Weight||Participants|Count of Participants|538|538.0||||||
4027956|NCT01155193|3849656|B2||1000 – 1499 g|Birth Weight||Participants|Count of Participants|965|965.0||||||
4027957|NCT01155193|3849657|B1||1000 – 1499 g|Birth Weight||Participants|Count of Participants|2782|2782.0||||||
4027958|NCT01155193|3849653|B5||< 1000 g|Birth Weight||Participants|Count of Participants|7925|7925.0||||||
4027959|NCT01155193|3849654|B4||< 1000 g|Birth Weight||Participants|Count of Participants|2946|2946.0||||||
4027960|NCT01155193|3849655|B3||< 1000 g|Birth Weight||Participants|Count of Participants|595|595.0||||||
4027961|NCT01155193|3849656|B2||< 1000 g|Birth Weight||Participants|Count of Participants|1101|1101.0||||||
4027962|NCT01155193|3849657|B1||< 1000 g|Birth Weight||Participants|Count of Participants|3283|3283.0||||||
4027963|NCT01155193|3849653|B5||Missing|Sex/Gender, Customized||Participants|Count of Participants|95|95.0||||||
4027964|NCT01155193|3849654|B4||Missing|Sex/Gender, Customized||Participants|Count of Participants|9|9.0||||||
4027965|NCT01155193|3849655|B3||Missing|Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
4027966|NCT01155193|3849656|B2||Missing|Sex/Gender, Customized||Participants|Count of Participants|17|17.0||||||
4027967|NCT01155193|3849657|B1||Missing|Sex/Gender, Customized||Participants|Count of Participants|69|69.0||||||
4027968|NCT01155193|3849653|B5||Male|Sex/Gender, Customized||Participants|Count of Participants|16009|16009.0||||||
4027969|NCT01155193|3849654|B4||Male|Sex/Gender, Customized||Participants|Count of Participants|7013|7013.0||||||
4027970|NCT01155193|3849655|B3||Male|Sex/Gender, Customized||Participants|Count of Participants|1229|1229.0||||||
4027971|NCT01155193|3849656|B2||Male|Sex/Gender, Customized||Participants|Count of Participants|2051|2051.0||||||
4027972|NCT01155193|3849657|B1||Male|Sex/Gender, Customized||Participants|Count of Participants|5716|5716.0||||||
4027973|NCT01155193|3849653|B5||Female|Sex/Gender, Customized||Participants|Count of Participants|13364|13364.0||||||
4027974|NCT01155193|3849654|B4||Female|Sex/Gender, Customized||Participants|Count of Participants|5707|5707.0||||||
4027975|NCT01155193|3849655|B3||Female|Sex/Gender, Customized||Participants|Count of Participants|1019|1019.0||||||
4027976|NCT01155193|3849656|B2||Female|Sex/Gender, Customized||Participants|Count of Participants|1737|1737.0||||||
4027977|NCT01155193|3849657|B1||Female|Sex/Gender, Customized||Participants|Count of Participants|4901|4901.0||||||
4027978|NCT01155193|3849653|B5||Missing|Age, Customized|Gestational age at birth is reported|Participants|Count of Participants|2467|2467.0||||||
4027979|NCT01155193|3849654|B4||Missing|Age, Customized|Gestational age at birth is reported|Participants|Count of Participants|0|0.0||||||
4027980|NCT01155193|3849655|B3||Missing|Age, Customized|Gestational age at birth is reported|Participants|Count of Participants|0|0.0||||||
4027981|NCT01155193|3849656|B2||Missing|Age, Customized|Gestational age at birth is reported|Participants|Count of Participants|729|729.0||||||
4027982|NCT01155193|3849657|B1||Missing|Age, Customized|Gestational age at birth is reported|Participants|Count of Participants|1738|1738.0||||||
4027983|NCT01155193|3849653|B5||> 35 weeks|Age, Customized|Gestational age at birth is reported|Participants|Count of Participants|2965|2965.0||||||
4027984|NCT01155193|3849654|B4||> 35 weeks|Age, Customized|Gestational age at birth is reported|Participants|Count of Participants|1945|1945.0||||||
4027985|NCT01155193|3849655|B3||> 35 weeks|Age, Customized|Gestational age at birth is reported|Participants|Count of Participants|375|375.0||||||
4027986|NCT01155193|3849656|B2||> 35 weeks|Age, Customized|Gestational age at birth is reported|Participants|Count of Participants|164|164.0||||||
4027987|NCT01155193|3849657|B1||> 35 weeks|Age, Customized|Gestational age at birth is reported|Participants|Count of Participants|481|481.0||||||
4027988|NCT01155193|3849653|B5||33 to ≤ 35 weeks|Age, Customized|Gestational age at birth is reported|Participants|Count of Participants|5789|5789.0||||||
4027989|NCT01155193|3849654|B4||33 to ≤ 35 weeks|Age, Customized|Gestational age at birth is reported|Participants|Count of Participants|3237|3237.0||||||
4027990|NCT01155193|3849655|B3||33 to ≤ 35 weeks|Age, Customized|Gestational age at birth is reported|Participants|Count of Participants|474|474.0||||||
4027991|NCT01155193|3849656|B2||33 to ≤ 35 weeks|Age, Customized|Gestational age at birth is reported|Participants|Count of Participants|578|578.0||||||
4027992|NCT01155193|3849657|B1||33 to ≤ 35 weeks|Age, Customized|Gestational age at birth is reported|Participants|Count of Participants|1500|1500.0||||||
4027993|NCT01155193|3849653|B5||29 to < 33 weeks|Age, Customized|Gestational age at birth is reported|Participants|Count of Participants|9284|9284.0||||||
4027994|NCT01155193|3849654|B4||29 to < 33 weeks|Age, Customized|Gestational age at birth is reported|Participants|Count of Participants|4033|4033.0||||||
4027995|NCT01155193|3849655|B3||29 to < 33 weeks|Age, Customized|Gestational age at birth is reported|Participants|Count of Participants|705|705.0||||||
4027996|NCT01155193|3849656|B2||29 to < 33 weeks|Age, Customized|Gestational age at birth is reported|Participants|Count of Participants|1161|1161.0||||||
4027997|NCT01155193|3849657|B1||29 to < 33 weeks|Age, Customized|Gestational age at birth is reported|Participants|Count of Participants|3385|3385.0||||||
4027998|NCT01155193|3849653|B5||< 29 weeks|Age, Customized|Gestational age at birth is reported|Participants|Count of Participants|8963|8963.0||||||
4027999|NCT01155193|3849654|B4||< 29 weeks|Age, Customized|Gestational age at birth is reported|Participants|Count of Participants|3514|3514.0||||||
4028000|NCT01155193|3849655|B3||< 29 weeks|Age, Customized|Gestational age at birth is reported|Participants|Count of Participants|694|694.0||||||
4028001|NCT01155193|3849656|B2||< 29 weeks|Age, Customized|Gestational age at birth is reported|Participants|Count of Participants|1173|1173.0||||||
4028002|NCT01155193|3849657|B1||< 29 weeks|Age, Customized|Gestational age at birth is reported|Participants|Count of Participants|3582|3582.0||||||
4028003|NCT01155180|3849685|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4028004|NCT01155180|3849686|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4028005|NCT01155180|3849687|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4028006|NCT01155180|3849685|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4028007|NCT01155180|3849686|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4028008|NCT01155180|3849687|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4028009|NCT01155180|3849685|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4028010|NCT01155180|3849686|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4028011|NCT01155180|3849687|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4028012|NCT01155180|3849685|B3|years||Age, Customized||years|Mean|45|45.0|Full Range|||23.0|67.0|
4028013|NCT01155180|3849686|B2|years||Age, Customized||years|Mean|45.5|45.5|Full Range|||24.0|67.0|
4028014|NCT01155180|3849687|B1|years||Age, Customized||years|Mean|32|32.0|Full Range|||23.0|41.0|
4028015|NCT01155167|3849694|B3|United States||Region of Enrollment||participants|Number|83|83.0||||||
4028016|NCT01155167|3849695|B2|United States||Region of Enrollment||participants|Number|43|43.0||||||
4028017|NCT01155167|3849696|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4028018|NCT01155167|3849694|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4028019|NCT01155167|3849695|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4028020|NCT01155167|3849696|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4028021|NCT01155167|3849694|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4028022|NCT01155167|3849695|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4028023|NCT01155167|3849696|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4028024|NCT01155167|3849694|B3|||Age||years|Mean|61.2|61.2|Standard Deviation|12.7|12.7|||
4028025|NCT01155167|3849695|B2|||Age||years|Mean|63.4|63.4|Standard Deviation|12.6|12.6|||
4028026|NCT01155167|3849696|B1|||Age||years|Mean|59|59.0|Standard Deviation|12.8|12.8|||
4028027|NCT01155167|3849694|B3||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
4028028|NCT01155167|3849695|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4028029|NCT01155167|3849696|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4028030|NCT01155167|3849694|B3||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4028031|NCT01155167|3849695|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4028032|NCT01155167|3849696|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4028033|NCT01155167|3849694|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4028034|NCT01155167|3849695|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4028035|NCT01155167|3849696|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4028036|NCT01155154|3849707|B4|United States||Region of Enrollment||participants|Number|73|73.0||||||
4028037|NCT01155154|3849708|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4028038|NCT01155154|3849709|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4028039|NCT01155154|3849710|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4028040|NCT01155154|3849707|B4||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4028041|NCT01155154|3849708|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4028042|NCT01155154|3849709|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4028043|NCT01155154|3849710|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4028044|NCT01155154|3849707|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4028045|NCT01155154|3849708|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4028046|NCT01155154|3849709|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4028047|NCT01155154|3849710|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4028048|NCT01155154|3849707|B4||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4028049|NCT01155154|3849708|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4028050|NCT01155154|3849709|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4028051|NCT01155154|3849710|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4028052|NCT01155154|3849707|B4||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4028053|NCT01155154|3849708|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4028054|NCT01155154|3849709|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4028055|NCT01155154|3849710|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4028056|NCT01155154|3849707|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4028057|NCT01155154|3849708|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4028058|NCT01155154|3849709|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4028059|NCT01155154|3849710|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4028060|NCT01155154|3849707|B4|||Age||years|Median|41|41.0|Inter-Quartile Range|||29.0|55.5|
4028061|NCT01155154|3849708|B3|||Age||years|Median|40|40.0|Inter-Quartile Range|||29.0|52.0|
4028062|NCT01155154|3849709|B2|||Age||years|Median|42|42.0|Inter-Quartile Range|||32.0|58.0|
4028063|NCT01155154|3849710|B1|||Age||years|Median|39|39.0|Inter-Quartile Range|||26.0|56.0|
4028064|NCT01155141|3849720|B1|||eGFR||mL/min/1.73m^2|Median|56|56.0|Standard Deviation|34.8|34.8|||
4028065|NCT01155141|3849720|B1|||Total cholesterol||mg/dL|Median|236|236.0|Standard Deviation|99.5|99.5|||
4028066|NCT01155141|3849720|B1|||Diastolic blood pressure||mm Hg|Median|82|82.0|Standard Deviation|9.8|9.8|||
4028067|NCT01155141|3849720|B1|||Systolic blood pressure||mm Hg|Median|128|128.0|Standard Deviation|15.9|15.9|||
4028068|NCT01155141|3849720|B1|||Weight||kg|Median|87.3|87.3|Standard Deviation|24.3|24.3|||
4028069|NCT01155141|3849720|B1|||Glucose||mg/dL|Median|95|95.0|Standard Deviation|8.4|8.4|||
4028070|NCT01155141|3849720|B1|||Protein/creatinine ratio||unitless|Median|3.1|3.1|Standard Deviation|2.3|2.3|||
4028071|NCT01155141|3849720|B1|||Serum Creatinine||mg/dL|Median|1.4|1.4|Standard Deviation|0.9|0.9|||
4028072|NCT01155141|3849720|B1|||24 hour proteinuria||g/day|Median|3.6|3.6|Standard Deviation|5.7|5.7|||
4028073|NCT01155141|3849720|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4028074|NCT01155141|3849720|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4028075|NCT01155141|3849720|B1|||Age||years|Median|40|40.0|Standard Deviation|15.1|15.1|||
4028076|NCT01155063|3849732|B1|Hypertension||Concomitant morbidities in the past|Participants who had a concomitant morbidity in the past; participants with more than one concomitant co-morbidity were counted for each of the co-morbidity classes applicable.|Participants|Number|2|2.0||||||
4028077|NCT01155063|3849732|B1|Reproductive tract disorder||Concomitant morbidities in the past|Participants who had a concomitant morbidity in the past; participants with more than one concomitant co-morbidity were counted for each of the co-morbidity classes applicable.|Participants|Number|19|19.0||||||
4028078|NCT01155063|3849732|B1|Rectal cancer||Concomitant morbidities in the past|Participants who had a concomitant morbidity in the past; participants with more than one concomitant co-morbidity were counted for each of the co-morbidity classes applicable.|Participants|Number|1|1.0||||||
4028079|NCT01155063|3849732|B1|Neoplasm malignant||Concomitant morbidities in the past|Participants who had a concomitant morbidity in the past; participants with more than one concomitant co-morbidity were counted for each of the co-morbidity classes applicable.|Participants|Number|1|1.0||||||
4028121|NCT01155024|3849742|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4028080|NCT01155063|3849732|B1|Rheumatic fever||Concomitant morbidities in the past|Participants who had a concomitant morbidity in the past; participants with more than one concomitant co-morbidity were counted for each of the co-morbidity classes applicable.|Participants|Number|1|1.0||||||
4028081|NCT01155063|3849732|B1|Lipid metabolism disorder||Concomitant morbidities in the past|Participants who had a concomitant morbidity in the past; participants with more than one concomitant co-morbidity were counted for each of the co-morbidity classes applicable.|Participants|Number|1|1.0||||||
4028082|NCT01155063|3849732|B1|Drug hypersensitivity||Concomitant morbidities in the past|Participants who had a concomitant morbidity in the past; participants with more than one concomitant co-morbidity were counted for each of the co-morbidity classes applicable.|Participants|Number|1|1.0||||||
4028083|NCT01155063|3849732|B1|Cholecystitis||Concomitant morbidities in the past|Participants who had a concomitant morbidity in the past; participants with more than one concomitant co-morbidity were counted for each of the co-morbidity classes applicable.|Participants|Number|1|1.0||||||
4028084|NCT01155063|3849732|B1|Thyroid disorder||Concomitant morbidities in the past|Participants who had a concomitant morbidity in the past; participants with more than one concomitant co-morbidity were counted for each of the co-morbidity classes applicable.|Participants|Number|1|1.0||||||
4028085|NCT01155063|3849732|B1|Myocardial infarction||Concomitant morbidities in the past|Participants who had a concomitant morbidity in the past; participants with more than one concomitant co-morbidity were counted for each of the co-morbidity classes applicable.|Participants|Number|2|2.0||||||
4028086|NCT01155063|3849732|B1|||Number of participants on radiotherapy|Number of participants who received radiotherapy as measured in radiations per centigray (Rads/cGy).|Participants|Number|NA|||||||Data for this pre-specified outcome measure was collected and reported in individual participant listings but not statistically summarized for analysis.
4028087|NCT01155063|3849732|B1|||Number of participants on chemotherapy|Number of participants who received chemotherapy. Chemotherapeutic drugs included cyclophosphamide, doxorubicin, 5-fluorouracil, paclitaxel, epirubicin, fluorouracil.|Participants|Number|NA|||||||Data for this pre-specified outcome measure was collected and reported in individual participant listings but not statistically summarized for analysis.
4028088|NCT01155063|3849732|B1|Unknown||Histopathological Grade|The grade of a cancer depends on what the cells look like and the growth-rate. Lower grade indicates a slower-growing cancer and a higher grade indicates a faster-growing one. Grade 1 (resemble normal cells, not growing rapidly), grade 2 (grow faster than normal cells), grade 3 and 4 (abnormal cells, grow and spread aggressively).|Participants|Number|25|25.0||||||
4028089|NCT01155063|3849732|B1|Grade 4||Histopathological Grade|The grade of a cancer depends on what the cells look like and the growth-rate. Lower grade indicates a slower-growing cancer and a higher grade indicates a faster-growing one. Grade 1 (resemble normal cells, not growing rapidly), grade 2 (grow faster than normal cells), grade 3 and 4 (abnormal cells, grow and spread aggressively).|Participants|Number|0|0.0||||||
4028090|NCT01155063|3849732|B1|Grade 3||Histopathological Grade|The grade of a cancer depends on what the cells look like and the growth-rate. Lower grade indicates a slower-growing cancer and a higher grade indicates a faster-growing one. Grade 1 (resemble normal cells, not growing rapidly), grade 2 (grow faster than normal cells), grade 3 and 4 (abnormal cells, grow and spread aggressively).|Participants|Number|5|5.0||||||
4028091|NCT01155063|3849732|B1|Grade 2||Histopathological Grade|The grade of a cancer depends on what the cells look like and the growth-rate. Lower grade indicates a slower-growing cancer and a higher grade indicates a faster-growing one. Grade 1 (resemble normal cells, not growing rapidly), grade 2 (grow faster than normal cells), grade 3 and 4 (abnormal cells, grow and spread aggressively).|Participants|Number|43|43.0||||||
4028092|NCT01155063|3849732|B1|Grade 1||Histopathological Grade|The grade of a cancer depends on what the cells look like and the growth-rate. Lower grade indicates a slower-growing cancer and a higher grade indicates a faster-growing one. Grade 1 (resemble normal cells, not growing rapidly), grade 2 (grow faster than normal cells), grade 3 and 4 (abnormal cells, grow and spread aggressively).|Participants|Number|16|16.0||||||
4028093|NCT01155063|3849732|B1|Stage IIIC||Tumor Node Metastasis (TNM) Stage|TNM was based on size of tumor, if cancer cells had spread to nearby lymph nodes (LN), or distant (to other parts of the body) metastasis had occurred. Stages included: stage 0(no evidence of cancer cells), stage 1(T1N0M0), stage IIA(T0N1M0, T1N1M0, T2N0M0), stage IIB(T2N1M0, T3N0M0), stage IIIA(T0N2M0, T1N2M0, T2N3M0, T3N1orN2M0), stage IIIC(any TN3M0), stage IV(anyT anyNM1), where T0=early form of tumor, T1= <2 centimeter(cm), T2=2-5 cm, T3= >2 cm, T4=large sized tumor, N0=not spread to LN, N1=spread to 1 to 3,N2=spread to 4 to 9,N3=spread >10 axillary LN, M0=no metastasis, M1= Metastasis.|Participants|Number|2|2.0||||||
4028094|NCT01155063|3849732|B1|Stage IIIA||Tumor Node Metastasis (TNM) Stage|TNM was based on size of tumor, if cancer cells had spread to nearby lymph nodes (LN), or distant (to other parts of the body) metastasis had occurred. Stages included: stage 0(no evidence of cancer cells), stage 1(T1N0M0), stage IIA(T0N1M0, T1N1M0, T2N0M0), stage IIB(T2N1M0, T3N0M0), stage IIIA(T0N2M0, T1N2M0, T2N3M0, T3N1orN2M0), stage IIIC(any TN3M0), stage IV(anyT anyNM1), where T0=early form of tumor, T1= <2 centimeter(cm), T2=2-5 cm, T3= >2 cm, T4=large sized tumor, N0=not spread to LN, N1=spread to 1 to 3,N2=spread to 4 to 9,N3=spread >10 axillary LN, M0=no metastasis, M1= Metastasis.|Participants|Number|4|4.0||||||
4028095|NCT01155063|3849732|B1|Stage IV||Tumor Node Metastasis (TNM) Stage|TNM was based on size of tumor, if cancer cells had spread to nearby lymph nodes (LN), or distant (to other parts of the body) metastasis had occurred. Stages included: stage 0(no evidence of cancer cells), stage 1(T1N0M0), stage IIA(T0N1M0, T1N1M0, T2N0M0), stage IIB(T2N1M0, T3N0M0), stage IIIA(T0N2M0, T1N2M0, T2N3M0, T3N1orN2M0), stage IIIC(any TN3M0), stage IV(anyT anyNM1), where T0=early form of tumor, T1= <2 centimeter(cm), T2=2-5 cm, T3= >2 cm, T4=large sized tumor, N0=not spread to LN, N1=spread to 1 to 3,N2=spread to 4 to 9,N3=spread >10 axillary LN, M0=no metastasis, M1= Metastasis.|Participants|Number|0|0.0||||||
4028096|NCT01155063|3849732|B1|Stage IIIB||Tumor Node Metastasis (TNM) Stage|TNM was based on size of tumor, if cancer cells had spread to nearby lymph nodes (LN), or distant (to other parts of the body) metastasis had occurred. Stages included: stage 0(no evidence of cancer cells), stage 1(T1N0M0), stage IIA(T0N1M0, T1N1M0, T2N0M0), stage IIB(T2N1M0, T3N0M0), stage IIIA(T0N2M0, T1N2M0, T2N3M0, T3N1orN2M0), stage IIIC(any TN3M0), stage IV(anyT anyNM1), where T0=early form of tumor, T1= <2 centimeter(cm), T2=2-5 cm, T3= >2 cm, T4=large sized tumor, N0=not spread to LN, N1=spread to 1 to 3,N2=spread to 4 to 9,N3=spread >10 axillary LN, M0=no metastasis, M1= Metastasis.|Participants|Number|8|8.0||||||
4028097|NCT01155063|3849732|B1|Stage IIB||Tumor Node Metastasis (TNM) Stage|TNM was based on size of tumor, if cancer cells had spread to nearby lymph nodes (LN), or distant (to other parts of the body) metastasis had occurred. Stages included: stage 0(no evidence of cancer cells), stage 1(T1N0M0), stage IIA(T0N1M0, T1N1M0, T2N0M0), stage IIB(T2N1M0, T3N0M0), stage IIIA(T0N2M0, T1N2M0, T2N3M0, T3N1orN2M0), stage IIIC(any TN3M0), stage IV(anyT anyNM1), where T0=early form of tumor, T1= <2 centimeter(cm), T2=2-5 cm, T3= >2 cm, T4=large sized tumor, N0=not spread to LN, N1=spread to 1 to 3,N2=spread to 4 to 9,N3=spread >10 axillary LN, M0=no metastasis, M1= Metastasis.|Participants|Number|13|13.0||||||
4028098|NCT01155063|3849732|B1|Stage IIA||Tumor Node Metastasis (TNM) Stage|TNM was based on size of tumor, if cancer cells had spread to nearby lymph nodes (LN), or distant (to other parts of the body) metastasis had occurred. Stages included: stage 0(no evidence of cancer cells), stage 1(T1N0M0), stage IIA(T0N1M0, T1N1M0, T2N0M0), stage IIB(T2N1M0, T3N0M0), stage IIIA(T0N2M0, T1N2M0, T2N3M0, T3N1orN2M0), stage IIIC(any TN3M0), stage IV(anyT anyNM1), where T0=early form of tumor, T1= <2 centimeter(cm), T2=2-5 cm, T3= >2 cm, T4=large sized tumor, N0=not spread to LN, N1=spread to 1 to 3,N2=spread to 4 to 9,N3=spread >10 axillary LN, M0=no metastasis, M1= Metastasis.|Participants|Number|42|42.0||||||
4028099|NCT01155063|3849732|B1|Stage I||Tumor Node Metastasis (TNM) Stage|TNM was based on size of tumor, if cancer cells had spread to nearby lymph nodes (LN), or distant (to other parts of the body) metastasis had occurred. Stages included: stage 0(no evidence of cancer cells), stage 1(T1N0M0), stage IIA(T0N1M0, T1N1M0, T2N0M0), stage IIB(T2N1M0, T3N0M0), stage IIIA(T0N2M0, T1N2M0, T2N3M0, T3N1orN2M0), stage IIIC(any TN3M0), stage IV(anyT anyNM1), where T0=early form of tumor, T1= <2 centimeter(cm), T2=2-5 cm, T3= >2 cm, T4=large sized tumor, N0=not spread to LN, N1=spread to 1 to 3,N2=spread to 4 to 9,N3=spread >10 axillary LN, M0=no metastasis, M1= Metastasis.|Participants|Number|20|20.0||||||
4028100|NCT01155063|3849732|B1|||Lymph Node Status||Participants|Number|NA|||||||Data for this pre-specified outcome measure was collected and reported in individual participant listings but not statistically summarized for analysis.
4028101|NCT01155063|3849732|B1|Progesterone receptor: Unknown||Hormone Receptor Status|Number of participants with positive or negative estrogen and progesterone receptors.|Participants|Number|1|1.0||||||
4028102|NCT01155063|3849732|B1|Progesterone receptor: Negative||Hormone Receptor Status|Number of participants with positive or negative estrogen and progesterone receptors.|Participants|Number|4|4.0||||||
4028103|NCT01155063|3849732|B1|Progesterone receptor: Positive||Hormone Receptor Status|Number of participants with positive or negative estrogen and progesterone receptors.|Participants|Number|84|84.0||||||
4028104|NCT01155063|3849732|B1|Estrogen receptor: Unknown||Hormone Receptor Status|Number of participants with positive or negative estrogen and progesterone receptors.|Participants|Number|1|1.0||||||
4028105|NCT01155063|3849732|B1|Estrogen receptor: Negative||Hormone Receptor Status|Number of participants with positive or negative estrogen and progesterone receptors.|Participants|Number|1|1.0||||||
4028106|NCT01155063|3849732|B1|Estrogen receptor: Positive||Hormone Receptor Status|Number of participants with positive or negative estrogen and progesterone receptors.|Participants|Number|87|87.0||||||
4028107|NCT01155063|3849732|B1|||Type of Surgery|Number of participants who had undergone different type of surgeries which included mammectomy, radical resection, radical mastectomy, mastectomy, mammectomy with lymphadenectomy, ovariectomy, mammectomy with lymph node dissection, mastectomy type madden of mammary gland.|Participants|Number|NA|||||||Data for this pre-specified outcome measure was collected and reported in individual participant listings but not statistically summarized for analysis.
4028108|NCT01155063|3849732|B1|Other||Type of Tumor|Number of participants with different types of tumor such as; ductal carcinoma, lobular carcinoma, invasive ductal carcinoma, invasive lobular carcinoma, papillary carcinoma, medullary carcinoma, mucinous (colloid) carcinoma and others.|Participants|Number|1|1.0||||||
4028109|NCT01155063|3849732|B1|Mucinous (colloid) carcinoma||Type of Tumor|Number of participants with different types of tumor such as; ductal carcinoma, lobular carcinoma, invasive ductal carcinoma, invasive lobular carcinoma, papillary carcinoma, medullary carcinoma, mucinous (colloid) carcinoma and others.|Participants|Number|2|2.0||||||
4028110|NCT01155063|3849732|B1|Medullary carcinoma||Type of Tumor|Number of participants with different types of tumor such as; ductal carcinoma, lobular carcinoma, invasive ductal carcinoma, invasive lobular carcinoma, papillary carcinoma, medullary carcinoma, mucinous (colloid) carcinoma and others.|Participants|Number|5|5.0||||||
4028111|NCT01155063|3849732|B1|Papillary carcinoma||Type of Tumor|Number of participants with different types of tumor such as; ductal carcinoma, lobular carcinoma, invasive ductal carcinoma, invasive lobular carcinoma, papillary carcinoma, medullary carcinoma, mucinous (colloid) carcinoma and others.|Participants|Number|0|0.0||||||
4028112|NCT01155063|3849732|B1|Invasive lobular carcinoma||Type of Tumor|Number of participants with different types of tumor such as; ductal carcinoma, lobular carcinoma, invasive ductal carcinoma, invasive lobular carcinoma, papillary carcinoma, medullary carcinoma, mucinous (colloid) carcinoma and others.|Participants|Number|20|20.0||||||
4028113|NCT01155063|3849732|B1|Invasive ductal carcinoma||Type of Tumor|Number of participants with different types of tumor such as; ductal carcinoma, lobular carcinoma, invasive ductal carcinoma, invasive lobular carcinoma, papillary carcinoma, medullary carcinoma, mucinous (colloid) carcinoma and others.|Participants|Number|50|50.0||||||
4028114|NCT01155063|3849732|B1|Lobular carcinoma||Type of Tumor|Number of participants with different types of tumor such as; ductal carcinoma, lobular carcinoma, invasive ductal carcinoma, invasive lobular carcinoma, papillary carcinoma, medullary carcinoma, mucinous (colloid) carcinoma and others.|Participants|Number|6|6.0||||||
4028115|NCT01155063|3849732|B1|Ductal carcinoma||Type of Tumor|Number of participants with different types of tumor such as; ductal carcinoma, lobular carcinoma, invasive ductal carcinoma, invasive lobular carcinoma, papillary carcinoma, medullary carcinoma, mucinous (colloid) carcinoma and others.|Participants|Number|5|5.0||||||
4028116|NCT01155063|3849732|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4028117|NCT01155063|3849732|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4028118|NCT01155063|3849732|B1|||Age||Years|Mean|59.2|59.2|Standard Deviation|7.3|7.3|||
4028119|NCT01155024|3849742|B1|||Number of years participant has worn a Prosthesis|Total number of years the participant has worn a lower limb prosthesis|years|Mean|13.4|13.4|Standard Deviation|9.9|9.9|||
4028120|NCT01155024|3849742|B1|||Weight||kg|Mean|106|106.0|Standard Deviation|24.7|24.7|||
4028122|NCT01155024|3849742|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4028123|NCT01155024|3849742|B1|||Age||years|Mean|53.2|53.2|Standard Deviation|11.9|11.9|||
4028124|NCT01155024|3849742|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4028125|NCT01155024|3849742|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4028126|NCT01155024|3849742|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4028127|NCT01155011|3849751|B3|||Marital Status|Married|Participants|Count of Participants|126|126.0||||||
4028128|NCT01155011|3849752|B2|||Marital Status|Married|Participants|Count of Participants|81|81.0||||||
4028129|NCT01155011|3849753|B1|||Marital Status|Married|Participants|Count of Participants|45|45.0||||||
4028130|NCT01155011|3849751|B3|||Education|College education and above|participants|Number|199|199.0||||||
4028131|NCT01155011|3849752|B2|||Education|College education and above|participants|Number|108|108.0||||||
4028132|NCT01155011|3849753|B1|||Education|College education and above|participants|Number|91|91.0||||||
4028133|NCT01155011|3849751|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4028134|NCT01155011|3849752|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4028135|NCT01155011|3849753|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028136|NCT01155011|3849751|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4028137|NCT01155011|3849752|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028138|NCT01155011|3849753|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4028139|NCT01155011|3849751|B3||White|Race (NIH/OMB)||Participants|Count of Participants|282|282.0||||||
4028140|NCT01155011|3849752|B2||White|Race (NIH/OMB)||Participants|Count of Participants|150|150.0||||||
4028141|NCT01155011|3849753|B1||White|Race (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
4028142|NCT01155011|3849751|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4028143|NCT01155011|3849752|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028144|NCT01155011|3849753|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4028145|NCT01155011|3849751|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028146|NCT01155011|3849752|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028147|NCT01155011|3849753|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028148|NCT01155011|3849751|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4028149|NCT01155011|3849752|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4028150|NCT01155011|3849753|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4028151|NCT01155011|3849751|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4028152|NCT01155011|3849752|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4028153|NCT01155011|3849753|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4028154|NCT01155011|3849751|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4028155|NCT01155011|3849752|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4028156|NCT01155011|3849753|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4028157|NCT01155011|3849751|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|299|299.0||||||
4028158|NCT01155011|3849752|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|151|151.0||||||
4028159|NCT01155011|3849753|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|148|148.0||||||
4028160|NCT01155011|3849751|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4028161|NCT01155011|3849752|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4028162|NCT01155011|3849753|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4028163|NCT01155011|3849751|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4028164|NCT01155011|3849752|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4028165|NCT01155011|3849753|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4028166|NCT01155011|3849751|B3||Female|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4028167|NCT01155011|3849752|B2||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4028168|NCT01155011|3849753|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4028169|NCT01155011|3849751|B3|||Age||years|Mean|83.6|83.6|Standard Deviation|6.4|6.4|||
4028170|NCT01155011|3849752|B2|||Age||years|Mean|81.9|81.9|Standard Deviation|5.9|5.9|||
4028171|NCT01155011|3849753|B1|||Age||years|Mean|85.3|85.3|Standard Deviation|6.5|6.5|||
4028172|NCT01154985|3849764|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028173|NCT01154985|3849765|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028174|NCT01154985|3849766|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028175|NCT01154985|3849767|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028176|NCT01154985|3849764|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028177|NCT01154985|3849765|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028178|NCT01154985|3849766|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028179|NCT01154985|3849767|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028180|NCT01154985|3849764|B4||White|Race (NIH/OMB)||Participants|Count of Participants|220|220.0||||||
4028181|NCT01154985|3849765|B3||White|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4028182|NCT01154985|3849766|B2||White|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
4028183|NCT01154985|3849767|B1||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4028184|NCT01154985|3849764|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4028185|NCT01154985|3849765|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4028186|NCT01154985|3849766|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4028187|NCT01154985|3849767|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4028188|NCT01154985|3849764|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4028189|NCT01154985|3849765|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4028190|NCT01154985|3849766|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028191|NCT01154985|3849767|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4028192|NCT01154985|3849764|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4028193|NCT01154985|3849765|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4028194|NCT01154985|3849766|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4028195|NCT01154985|3849767|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4028196|NCT01154985|3849764|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4028197|NCT01154985|3849765|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4028198|NCT01154985|3849766|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4028199|NCT01154985|3849767|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028200|NCT01154985|3849764|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028201|NCT01154985|3849765|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028202|NCT01154985|3849766|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028203|NCT01154985|3849767|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028204|NCT01154985|3849764|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|198|198.0||||||
4028205|NCT01154985|3849765|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
4028206|NCT01154985|3849766|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4028207|NCT01154985|3849767|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4028208|NCT01154985|3849764|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4028209|NCT01154985|3849765|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4028210|NCT01154985|3849766|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4028211|NCT01154985|3849767|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4028212|NCT01154985|3849764|B4||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4028213|NCT01154985|3849765|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4028214|NCT01154985|3849766|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4028215|NCT01154985|3849767|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4028216|NCT01154985|3849764|B4||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4028217|NCT01154985|3849765|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4028218|NCT01154985|3849766|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4028219|NCT01154985|3849767|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4028220|NCT01154985|3849764|B4|||Age||years|Mean|48.6|48.6|Standard Deviation|12.02|12.02|||
4028221|NCT01154985|3849765|B3|||Age||years|Mean|47.8|47.8|Standard Deviation|11.14|11.14|||
4028222|NCT01154985|3849766|B2|||Age||years|Mean|47.8|47.8|Standard Deviation|12.48|12.48|||
4028223|NCT01154985|3849767|B1|||Age||years|Mean|50.5|50.5|Standard Deviation|12.45|12.45|||
4028224|NCT01154985|3849764|B4||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4028225|NCT01154985|3849765|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4028226|NCT01154985|3849766|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4028227|NCT01154985|3849767|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4028228|NCT01154985|3849764|B4||Between 18 and 65 years|Age||Participants|Count of Participants|221|221.0||||||
4028229|NCT01154985|3849765|B3||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4028230|NCT01154985|3849766|B2||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
4028231|NCT01154985|3849767|B1||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
4028232|NCT01154985|3849764|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4028233|NCT01154985|3849765|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4028234|NCT01154985|3849766|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4028235|NCT01154985|3849767|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4028327|NCT01154816|3849783|B13||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028236|NCT01154816|3849783|B13|United Kingdom||Region of Enrollment|Region unknown for 1 patient in the Recurrent Wilms Tumor and Other Childhood Kidney Tumors arm.|participants|Number|2|2.0||||||
4028237|NCT01154816|3849784|B12|United Kingdom||Region of Enrollment|Region unknown for 1 patient in the Recurrent Wilms Tumor and Other Childhood Kidney Tumors arm.|participants|Number|0|0.0||||||
4028238|NCT01154816|3849785|B11|United Kingdom||Region of Enrollment|Region unknown for 1 patient in the Recurrent Wilms Tumor and Other Childhood Kidney Tumors arm.|participants|Number|0|0.0||||||
4028239|NCT01154816|3849786|B10|United Kingdom||Region of Enrollment|Region unknown for 1 patient in the Recurrent Wilms Tumor and Other Childhood Kidney Tumors arm.|participants|Number|0|0.0||||||
4028240|NCT01154816|3849787|B9|United Kingdom||Region of Enrollment|Region unknown for 1 patient in the Recurrent Wilms Tumor and Other Childhood Kidney Tumors arm.|participants|Number|0|0.0||||||
4028241|NCT01154816|3849788|B8|United Kingdom||Region of Enrollment|Region unknown for 1 patient in the Recurrent Wilms Tumor and Other Childhood Kidney Tumors arm.|participants|Number|0|0.0||||||
4028242|NCT01154816|3849789|B7|United Kingdom||Region of Enrollment|Region unknown for 1 patient in the Recurrent Wilms Tumor and Other Childhood Kidney Tumors arm.|participants|Number|0|0.0||||||
4028243|NCT01154816|3849790|B6|United Kingdom||Region of Enrollment|Region unknown for 1 patient in the Recurrent Wilms Tumor and Other Childhood Kidney Tumors arm.|participants|Number|0|0.0||||||
4028244|NCT01154816|3849791|B5|United Kingdom||Region of Enrollment|Region unknown for 1 patient in the Recurrent Wilms Tumor and Other Childhood Kidney Tumors arm.|participants|Number|0|0.0||||||
4028245|NCT01154816|3849792|B4|United Kingdom||Region of Enrollment|Region unknown for 1 patient in the Recurrent Wilms Tumor and Other Childhood Kidney Tumors arm.|participants|Number|0|0.0||||||
4028246|NCT01154816|3849793|B3|United Kingdom||Region of Enrollment|Region unknown for 1 patient in the Recurrent Wilms Tumor and Other Childhood Kidney Tumors arm.|participants|Number|0|0.0||||||
4028247|NCT01154816|3849794|B2|United Kingdom||Region of Enrollment|Region unknown for 1 patient in the Recurrent Wilms Tumor and Other Childhood Kidney Tumors arm.|participants|Number|1|1.0||||||
4028248|NCT01154816|3849795|B1|United Kingdom||Region of Enrollment|Region unknown for 1 patient in the Recurrent Wilms Tumor and Other Childhood Kidney Tumors arm.|participants|Number|1|1.0||||||
4028249|NCT01154816|3849783|B13|United States||Region of Enrollment|Region unknown for 1 patient in the Recurrent Wilms Tumor and Other Childhood Kidney Tumors arm.|participants|Number|107|107.0||||||
4028250|NCT01154816|3849784|B12|United States||Region of Enrollment|Region unknown for 1 patient in the Recurrent Wilms Tumor and Other Childhood Kidney Tumors arm.|participants|Number|4|4.0||||||
4028251|NCT01154816|3849785|B11|United States||Region of Enrollment|Region unknown for 1 patient in the Recurrent Wilms Tumor and Other Childhood Kidney Tumors arm.|participants|Number|10|10.0||||||
4028252|NCT01154816|3849786|B10|United States||Region of Enrollment|Region unknown for 1 patient in the Recurrent Wilms Tumor and Other Childhood Kidney Tumors arm.|participants|Number|10|10.0||||||
4028253|NCT01154816|3849787|B9|United States||Region of Enrollment|Region unknown for 1 patient in the Recurrent Wilms Tumor and Other Childhood Kidney Tumors arm.|participants|Number|8|8.0||||||
4028254|NCT01154816|3849788|B8|United States||Region of Enrollment|Region unknown for 1 patient in the Recurrent Wilms Tumor and Other Childhood Kidney Tumors arm.|participants|Number|6|6.0||||||
4028255|NCT01154816|3849789|B7|United States||Region of Enrollment|Region unknown for 1 patient in the Recurrent Wilms Tumor and Other Childhood Kidney Tumors arm.|participants|Number|5|5.0||||||
4028256|NCT01154816|3849790|B6|United States||Region of Enrollment|Region unknown for 1 patient in the Recurrent Wilms Tumor and Other Childhood Kidney Tumors arm.|participants|Number|8|8.0||||||
4028257|NCT01154816|3849791|B5|United States||Region of Enrollment|Region unknown for 1 patient in the Recurrent Wilms Tumor and Other Childhood Kidney Tumors arm.|participants|Number|10|10.0||||||
4028258|NCT01154816|3849792|B4|United States||Region of Enrollment|Region unknown for 1 patient in the Recurrent Wilms Tumor and Other Childhood Kidney Tumors arm.|participants|Number|10|10.0||||||
4028259|NCT01154816|3849793|B3|United States||Region of Enrollment|Region unknown for 1 patient in the Recurrent Wilms Tumor and Other Childhood Kidney Tumors arm.|participants|Number|9|9.0||||||
4028260|NCT01154816|3849794|B2|United States||Region of Enrollment|Region unknown for 1 patient in the Recurrent Wilms Tumor and Other Childhood Kidney Tumors arm.|participants|Number|9|9.0||||||
4028261|NCT01154816|3849795|B1|United States||Region of Enrollment|Region unknown for 1 patient in the Recurrent Wilms Tumor and Other Childhood Kidney Tumors arm.|participants|Number|18|18.0||||||
4028262|NCT01154816|3849783|B13|Canada||Region of Enrollment|Region unknown for 1 patient in the Recurrent Wilms Tumor and Other Childhood Kidney Tumors arm.|participants|Number|8|8.0||||||
4028263|NCT01154816|3849784|B12|Canada||Region of Enrollment|Region unknown for 1 patient in the Recurrent Wilms Tumor and Other Childhood Kidney Tumors arm.|participants|Number|0|0.0||||||
4028264|NCT01154816|3849785|B11|Canada||Region of Enrollment|Region unknown for 1 patient in the Recurrent Wilms Tumor and Other Childhood Kidney Tumors arm.|participants|Number|1|1.0||||||
4028265|NCT01154816|3849786|B10|Canada||Region of Enrollment|Region unknown for 1 patient in the Recurrent Wilms Tumor and Other Childhood Kidney Tumors arm.|participants|Number|0|0.0||||||
4028266|NCT01154816|3849787|B9|Canada||Region of Enrollment|Region unknown for 1 patient in the Recurrent Wilms Tumor and Other Childhood Kidney Tumors arm.|participants|Number|1|1.0||||||
4028267|NCT01154816|3849788|B8|Canada||Region of Enrollment|Region unknown for 1 patient in the Recurrent Wilms Tumor and Other Childhood Kidney Tumors arm.|participants|Number|1|1.0||||||
4028268|NCT01154816|3849789|B7|Canada||Region of Enrollment|Region unknown for 1 patient in the Recurrent Wilms Tumor and Other Childhood Kidney Tumors arm.|participants|Number|1|1.0||||||
4028269|NCT01154816|3849790|B6|Canada||Region of Enrollment|Region unknown for 1 patient in the Recurrent Wilms Tumor and Other Childhood Kidney Tumors arm.|participants|Number|0|0.0||||||
4028270|NCT01154816|3849791|B5|Canada||Region of Enrollment|Region unknown for 1 patient in the Recurrent Wilms Tumor and Other Childhood Kidney Tumors arm.|participants|Number|0|0.0||||||
4028271|NCT01154816|3849792|B4|Canada||Region of Enrollment|Region unknown for 1 patient in the Recurrent Wilms Tumor and Other Childhood Kidney Tumors arm.|participants|Number|0|0.0||||||
4028272|NCT01154816|3849793|B3|Canada||Region of Enrollment|Region unknown for 1 patient in the Recurrent Wilms Tumor and Other Childhood Kidney Tumors arm.|participants|Number|1|1.0||||||
4028273|NCT01154816|3849794|B2|Canada||Region of Enrollment|Region unknown for 1 patient in the Recurrent Wilms Tumor and Other Childhood Kidney Tumors arm.|participants|Number|2|2.0||||||
4028274|NCT01154816|3849795|B1|Canada||Region of Enrollment|Region unknown for 1 patient in the Recurrent Wilms Tumor and Other Childhood Kidney Tumors arm.|participants|Number|1|1.0||||||
4028275|NCT01154816|3849783|B13||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4028276|NCT01154816|3849784|B12||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4028277|NCT01154816|3849785|B11||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4028278|NCT01154816|3849786|B10||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4028279|NCT01154816|3849787|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4028280|NCT01154816|3849788|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4028281|NCT01154816|3849789|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4028282|NCT01154816|3849790|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4028283|NCT01154816|3849791|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4028284|NCT01154816|3849792|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4028285|NCT01154816|3849793|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4028286|NCT01154816|3849794|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4028287|NCT01154816|3849795|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4028288|NCT01154816|3849783|B13||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028289|NCT01154816|3849784|B12||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028290|NCT01154816|3849785|B11||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028291|NCT01154816|3849786|B10||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028292|NCT01154816|3849787|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028293|NCT01154816|3849788|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028294|NCT01154816|3849789|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028295|NCT01154816|3849790|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028296|NCT01154816|3849791|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028297|NCT01154816|3849792|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028298|NCT01154816|3849793|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028299|NCT01154816|3849794|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028300|NCT01154816|3849795|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028301|NCT01154816|3849783|B13||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
4028302|NCT01154816|3849784|B12||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4028303|NCT01154816|3849785|B11||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4028304|NCT01154816|3849786|B10||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4028305|NCT01154816|3849787|B9||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4028306|NCT01154816|3849788|B8||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4028307|NCT01154816|3849789|B7||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4028308|NCT01154816|3849790|B6||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4028309|NCT01154816|3849791|B5||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4028310|NCT01154816|3849792|B4||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4028311|NCT01154816|3849793|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4028312|NCT01154816|3849794|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4028313|NCT01154816|3849795|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4028314|NCT01154816|3849783|B13||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4028315|NCT01154816|3849784|B12||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028316|NCT01154816|3849785|B11||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4028317|NCT01154816|3849786|B10||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4028318|NCT01154816|3849787|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4028319|NCT01154816|3849788|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028320|NCT01154816|3849789|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4028321|NCT01154816|3849790|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4028322|NCT01154816|3849791|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028323|NCT01154816|3849792|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4028324|NCT01154816|3849793|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4028325|NCT01154816|3849794|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4028326|NCT01154816|3849795|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4028328|NCT01154816|3849784|B12||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028329|NCT01154816|3849785|B11||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028330|NCT01154816|3849786|B10||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028331|NCT01154816|3849787|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028332|NCT01154816|3849788|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028333|NCT01154816|3849789|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028334|NCT01154816|3849790|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028335|NCT01154816|3849791|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028336|NCT01154816|3849792|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028337|NCT01154816|3849793|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028338|NCT01154816|3849794|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028339|NCT01154816|3849795|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028340|NCT01154816|3849783|B13||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028341|NCT01154816|3849784|B12||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028342|NCT01154816|3849785|B11||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028343|NCT01154816|3849786|B10||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028344|NCT01154816|3849787|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028345|NCT01154816|3849788|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028346|NCT01154816|3849789|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028347|NCT01154816|3849790|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028348|NCT01154816|3849791|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028349|NCT01154816|3849792|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028350|NCT01154816|3849793|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028351|NCT01154816|3849794|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028352|NCT01154816|3849795|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028353|NCT01154816|3849783|B13||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028354|NCT01154816|3849784|B12||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028355|NCT01154816|3849785|B11||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028356|NCT01154816|3849786|B10||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028357|NCT01154816|3849787|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028358|NCT01154816|3849788|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028359|NCT01154816|3849789|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028360|NCT01154816|3849790|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028361|NCT01154816|3849791|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028362|NCT01154816|3849792|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028363|NCT01154816|3849793|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028364|NCT01154816|3849794|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028365|NCT01154816|3849795|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028366|NCT01154816|3849783|B13||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4028367|NCT01154816|3849784|B12||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028368|NCT01154816|3849785|B11||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4028369|NCT01154816|3849786|B10||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028370|NCT01154816|3849787|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4028371|NCT01154816|3849788|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4028372|NCT01154816|3849789|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028373|NCT01154816|3849790|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4028374|NCT01154816|3849791|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4028375|NCT01154816|3849792|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028376|NCT01154816|3849793|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4028377|NCT01154816|3849794|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4028378|NCT01154816|3849795|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4028379|NCT01154816|3849783|B13||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
4028380|NCT01154816|3849784|B12||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4028381|NCT01154816|3849785|B11||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4028382|NCT01154816|3849786|B10||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4028383|NCT01154816|3849787|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4028384|NCT01154816|3849788|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4028385|NCT01154816|3849789|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4028386|NCT01154816|3849790|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4028387|NCT01154816|3849791|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4028388|NCT01154816|3849792|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4028389|NCT01154816|3849793|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4028390|NCT01154816|3849794|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4028391|NCT01154816|3849795|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4028392|NCT01154816|3849783|B13||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4028393|NCT01154816|3849784|B12||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4028394|NCT01154816|3849785|B11||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4028395|NCT01154816|3849786|B10||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4028396|NCT01154816|3849787|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4028397|NCT01154816|3849788|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4028398|NCT01154816|3849789|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4028399|NCT01154816|3849790|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4028400|NCT01154816|3849791|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4028401|NCT01154816|3849792|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4028402|NCT01154816|3849793|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4028403|NCT01154816|3849794|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4028404|NCT01154816|3849795|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4028405|NCT01154816|3849783|B13||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4028406|NCT01154816|3849784|B12||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4028407|NCT01154816|3849785|B11||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4028408|NCT01154816|3849786|B10||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4028409|NCT01154816|3849787|B9||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4028410|NCT01154816|3849788|B8||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4028411|NCT01154816|3849789|B7||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4028412|NCT01154816|3849790|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4028413|NCT01154816|3849791|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4028414|NCT01154816|3849792|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4028415|NCT01154816|3849793|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4028416|NCT01154816|3849794|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4028417|NCT01154816|3849795|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4028418|NCT01154816|3849783|B13||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4028419|NCT01154816|3849784|B12||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4028420|NCT01154816|3849785|B11||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4028421|NCT01154816|3849786|B10||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4028422|NCT01154816|3849787|B9||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4028423|NCT01154816|3849788|B8||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4028424|NCT01154816|3849789|B7||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4028425|NCT01154816|3849790|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4028426|NCT01154816|3849791|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4028427|NCT01154816|3849792|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4028428|NCT01154816|3849793|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4028429|NCT01154816|3849794|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4028430|NCT01154816|3849795|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4028431|NCT01154816|3849783|B13|||Age||Years|Median|11|11.0|Full Range|||2.0|21.0|
4028432|NCT01154816|3849784|B12|||Age||Years|Median|5|5.0|Full Range|||2.0|7.0|
4028433|NCT01154816|3849785|B11|||Age||Years|Median|10|10.0|Full Range|||3.0|15.0|
4028434|NCT01154816|3849786|B10|||Age||Years|Median|13|13.0|Full Range|||7.0|19.0|
4028435|NCT01154816|3849787|B9|||Age||Years|Median|10|10.0|Full Range|||3.0|18.0|
4028436|NCT01154816|3849788|B8|||Age||Years|Median|11|11.0|Full Range|||3.0|19.0|
4028437|NCT01154816|3849789|B7|||Age||Years|Median|5|5.0|Full Range|||3.0|14.0|
4028438|NCT01154816|3849790|B6|||Age||Years|Median|16|16.0|Full Range|||13.0|21.0|
4028439|NCT01154816|3849791|B5|||Age||Years|Median|14|14.0|Full Range|||6.0|20.0|
4028440|NCT01154816|3849792|B4|||Age||Years|Median|17|17.0|Full Range|||12.0|21.0|
4028441|NCT01154816|3849793|B3|||Age||Years|Median|12|12.0|Full Range|||4.0|21.0|
4028442|NCT01154816|3849794|B2|||Age||Years|Median|8|8.0|Full Range|||5.0|17.0|
4028443|NCT01154816|3849795|B1|||Age||Years|Median|8|8.0|Full Range|||3.0|20.0|
4028444|NCT01154751|3849839|B1|||Occlusion|Core laboratory reported|participants|Number|50|50.0||||||
4028445|NCT01154751|3849839|B1|Femoropopliteal conjunction (n=3)||Percent diameter stenosis|Percent diameter stenosis is site reported.|percentage diameter stenosis|Mean|96.67|96.67|Standard Deviation|5.77|5.77|||
4028446|NCT01154751|3849839|B1|Popliteal (n=23)||Percent diameter stenosis|Percent diameter stenosis is site reported.|percentage diameter stenosis|Mean|93.83|93.83|Standard Deviation|7.91|7.91|||
4028447|NCT01154751|3849839|B1|Superficial femoral (n=87)||Percent diameter stenosis|Percent diameter stenosis is site reported.|percentage diameter stenosis|Mean|93.07|93.07|Standard Deviation|8.78|8.78|||
4028448|NCT01154751|3849839|B1|Femoropopliteal conjunction (n=3)||Lesion length|Lesion length is site reported|Centimeters|Mean|18.67|18.67|Standard Deviation|2.31|2.31|||
4028449|NCT01154751|3849839|B1|Popliteal (n=22)||Lesion length|Lesion length is site reported|Centimeters|Mean|7.77|7.77|Standard Deviation|5.00|5.0|||
4028450|NCT01154751|3849839|B1|Superficial femoral (n=86)||Lesion length|Lesion length is site reported|Centimeters|Mean|16.40|16.4|Standard Deviation|28.93|28.93|||
4028451|NCT01154751|3849839|B1|Germany||Region of Enrollment||participants|Number|109|109.0||||||
4028452|NCT01154751|3849839|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4028453|NCT01154751|3849839|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4028454|NCT01154751|3849839|B1|||Age||Years|Mean|71|71.0|Standard Deviation|8.8|8.8|||
4028455|NCT01154699|3849862|B3|||CPAP Usage||minutes|Mean|264|264.0|Standard Deviation|96|96.0|||
4028456|NCT01154699|3849863|B2|||CPAP Usage||minutes|Mean|264|264.0|Standard Deviation|96|96.0|||
4028457|NCT01154699|3849862|B3|||CPAP Pressure||cm of water|Mean|11.6|11.6|Standard Deviation|3.4|3.4|||
4028458|NCT01154699|3849863|B2|||CPAP Pressure||cm of water|Mean|11.6|11.6|Standard Deviation|3.4|3.4|||
4028459|NCT01154699|3849862|B3|||AHI (events/hour)||events per hour|Mean|11.6|11.6|Standard Deviation|3.4|3.4|||
4028460|NCT01154699|3849863|B2|||AHI (events/hour)||events per hour|Mean|40.0|40.0|Standard Deviation|30.1|30.1|||
4028461|NCT01154699|3849864|B1|||AHI (events/hour)||events per hour|Mean|2.5|2.5|Standard Deviation|2.3|2.3|||
4028462|NCT01154699|3849862|B3|||PC20 (mg/mL)||mg/mL|Geometric Mean|1.6|1.6|Standard Deviation|0.3|0.3|||
4028463|NCT01154699|3849863|B2|||PC20 (mg/mL)||mg/mL|Geometric Mean|1.8|1.8|Standard Deviation|1.4|1.4|||
4028464|NCT01154699|3849864|B1|||PC20 (mg/mL)||mg/mL|Geometric Mean|1.5|1.5|Standard Deviation|0.5|0.5|||
4028465|NCT01154699|3849862|B3|||FEV1/FVC||ratio|Mean|0.75|0.75|Standard Deviation|.07|0.07|||
4028466|NCT01154699|3849863|B2|||FEV1/FVC||ratio|Mean|0.75|0.75|Standard Deviation|.06|0.06|||
4028467|NCT01154699|3849864|B1|||FEV1/FVC||ratio|Mean|0.75|0.75|Standard Deviation|0.09|0.09|||
4028468|NCT01154699|3849862|B3|||FEV1% predicted||%|Mean|89.9|89.9|Standard Deviation|20.7|20.7|||
4028469|NCT01154699|3849863|B2|||FEV1% predicted||%|Mean|89.4|89.4|Standard Deviation|21.0|21.0|||
4028470|NCT01154699|3849864|B1|||FEV1% predicted||%|Mean|90.2|90.2|Standard Deviation|21.3|21.3|||
4028471|NCT01154699|3849862|B3|||Body Mass Index (kg/m2)||kg/m2|Mean|32.7|32.7|Standard Deviation|7.2|7.2|||
4028472|NCT01154699|3849863|B2|||Body Mass Index (kg/m2)||kg/m2|Mean|36.4|36.4|Standard Deviation|5.2|5.2|||
4028473|NCT01154699|3849864|B1|||Body Mass Index (kg/m2)||kg/m2|Mean|30.5|30.5|Standard Deviation|7.4|7.4|||
4028474|NCT01154699|3849862|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4028475|NCT01154699|3849863|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4028476|NCT01154699|3849864|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4028477|NCT01154699|3849862|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4028478|NCT01154699|3849863|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4028479|NCT01154699|3849864|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4028480|NCT01154699|3849862|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4028481|NCT01154699|3849863|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4028482|NCT01154699|3849864|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4028483|NCT01154699|3849862|B3|||Age||years|Mean|43.8|43.8|Standard Deviation|14.4|14.4|||
4028484|NCT01154699|3849863|B2|||Age||years|Mean|44.75|44.75|Standard Deviation|10.5|10.5|||
4028485|NCT01154699|3849864|B1|||Age||years|Mean|43.2|43.2|Standard Deviation|16.7|16.7|||
4028486|NCT01154673|3849881|B3|Canada||Region of Enrollment||participants|Number|32|32.0||||||
4028487|NCT01154673|3849882|B2|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4028488|NCT01154673|3849883|B1|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4028489|NCT01154673|3849881|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4028490|NCT01154673|3849882|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4028491|NCT01154673|3849883|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4028492|NCT01154673|3849881|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4028493|NCT01154673|3849882|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4028494|NCT01154673|3849883|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4028495|NCT01154673|3849881|B3|||Age||years|Mean|32|32.0|Full Range|||22.0|59.0|
4028496|NCT01154673|3849882|B2|||Age||years|Mean|30|30.0|Full Range|||23.0|49.0|
4028497|NCT01154673|3849883|B1|||Age||years|Mean|34|34.0|Full Range|||22.0|59.0|
4028498|NCT01154673|3849881|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4028499|NCT01154673|3849882|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4028500|NCT01154673|3849883|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4028501|NCT01154673|3849881|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4028502|NCT01154673|3849882|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4028503|NCT01154673|3849883|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4028504|NCT01154673|3849881|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4028505|NCT01154673|3849882|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4028506|NCT01154673|3849883|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4028507|NCT01154634|3849890|B5||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4028508|NCT01154634|3849891|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4028509|NCT01154634|3849892|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4028510|NCT01154634|3849893|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4028511|NCT01154634|3849894|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4028512|NCT01154634|3849890|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4028513|NCT01154634|3849891|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4028514|NCT01154634|3849892|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4028515|NCT01154634|3849893|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4028516|NCT01154634|3849894|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4028517|NCT01154634|3849890|B5|Age (years)||Age||years|Mean|26.95|26.95|Standard Deviation|6.3|6.3|||
4028518|NCT01154634|3849891|B4|Age (years)||Age||years|Mean|23|23.0|Standard Deviation|4.2|4.2|||
4028519|NCT01154634|3849892|B3|Age (years)||Age||years|Mean|28.8|28.8|Standard Deviation|5.9|5.9|||
4028520|NCT01154634|3849893|B2|Age (years)||Age||years|Mean|25|25.0|Standard Deviation|4.5|4.5|||
4028521|NCT01154634|3849894|B1|Age (years)||Age||years|Mean|31|31.0|Standard Deviation|9.6|9.6|||
4028522|NCT01154452|3849935|B5|United States||Region of Enrollment||participants|Number|78|78.0||||||
4028523|NCT01154452|3849936|B4|United States||Region of Enrollment||participants|Number|33|33.0||||||
4028524|NCT01154452|3849937|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
4028525|NCT01154452|3849938|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4028526|NCT01154452|3849939|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4028527|NCT01154452|3849935|B5||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4028528|NCT01154452|3849936|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4028529|NCT01154452|3849937|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4028530|NCT01154452|3849938|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4028531|NCT01154452|3849939|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4028532|NCT01154452|3849935|B5||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4028533|NCT01154452|3849936|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4028534|NCT01154452|3849937|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4028535|NCT01154452|3849938|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4028536|NCT01154452|3849939|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4028537|NCT01154452|3849935|B5||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4028538|NCT01154452|3849936|B4||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4028539|NCT01154452|3849937|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4028540|NCT01154452|3849938|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4028541|NCT01154452|3849939|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4028542|NCT01154452|3849935|B5||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4028543|NCT01154452|3849936|B4||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4028544|NCT01154452|3849937|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4028545|NCT01154452|3849938|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4028546|NCT01154452|3849939|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4028547|NCT01154452|3849935|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4028548|NCT01154452|3849936|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4028549|NCT01154452|3849937|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4028550|NCT01154452|3849938|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4028551|NCT01154452|3849939|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4028552|NCT01154335|3849955|B4|United States||Region of Enrollment||participants|Number|18|18.0||||||
4028553|NCT01154335|3849956|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4028554|NCT01154335|3849957|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4028555|NCT01154335|3849958|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4028556|NCT01154335|3849955|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4028557|NCT01154335|3849956|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4028558|NCT01154335|3849957|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4028559|NCT01154335|3849958|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4028560|NCT01154335|3849955|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4028561|NCT01154335|3849956|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4028562|NCT01154335|3849957|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4028563|NCT01154335|3849958|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4028564|NCT01154335|3849955|B4|||Age||years|Median|55|55.0|Full Range|||44.0|76.0|
4028565|NCT01154335|3849956|B3|||Age||years|Median|70|70.0|Full Range|||44.0|76.0|
4028566|NCT01154335|3849957|B2|||Age||years|Median|54|54.0|Full Range|||51.0|76.0|
4028567|NCT01154335|3849958|B1|||Age||years|Median|55|55.0|Full Range|||47.0|73.0|
4028568|NCT01154322|3849967|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4028569|NCT01154322|3849967|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4028570|NCT01154322|3849967|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4028571|NCT01154322|3849967|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4028572|NCT01154322|3849967|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4028573|NCT01154322|3849967|B1||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4028574|NCT01154296|3849972|B3|||# of unprotected partners|Note that standard errors (not standard deviations) are presented below with the least squares means.|unprotected partners|Least Squares Mean|2.1|2.1|Standard Deviation|0.04069|0.04069|||
4028575|NCT01154296|3849973|B2|||# of unprotected partners|Note that standard errors (not standard deviations) are presented below with the least squares means.|unprotected partners|Least Squares Mean|2.1|2.1|Standard Deviation|0.05696|0.05696|||
4028576|NCT01154296|3849974|B1|||# of unprotected partners|Note that standard errors (not standard deviations) are presented below with the least squares means.|unprotected partners|Least Squares Mean|2.1|2.1|Standard Deviation|0.05812|0.05812|||
4028577|NCT01154296|3849972|B3|||# of partners|Note that standard errors (not standard deviations) are presented below with the least squares means.|partners|Least Squares Mean|4.6|4.6|Standard Deviation|0.08047|0.08047|||
4028578|NCT01154296|3849973|B2|||# of partners|Note that standard errors (not standard deviations) are presented below with the least squares means.|partners|Least Squares Mean|4.6|4.6|Standard Deviation|0.1135|0.1135|||
4028579|NCT01154296|3849974|B1|||# of partners|Note that standard errors (not standard deviations) are presented below with the least squares means.|partners|Least Squares Mean|4.7|4.7|Standard Deviation|0.1141|0.1141|||
4028580|NCT01154296|3849972|B3|||# of unprotected sex acts|Note that standard errors (not standard deviations) are presented below with the least squares means.|unprotected sex acts|Least Squares Mean|23.3|23.3|Standard Deviation|0.6594|0.6594|||
4028581|NCT01154296|3849973|B2|||# of unprotected sex acts|Note that standard errors (not standard deviations) are presented below with the least squares means.|unprotected sex acts|Least Squares Mean|22.6|22.6|Standard Deviation|0.9068|0.9068|||
4028582|NCT01154296|3849974|B1|||# of unprotected sex acts|Note that standard errors (not standard deviations) are presented below with the least squares means.|unprotected sex acts|Least Squares Mean|23.9|23.9|Standard Deviation|0.9578|0.9578|||
4028583|NCT01154296|3849972|B3|||# of sex acts|Note that standard errors (not standard deviations) are presented below with the least squares means.|sex acts|Least Squares Mean|34.0|34.0|Standard Deviation|0.751|0.751|||
4028584|NCT01154296|3849973|B2|||# of sex acts|Note that standard errors (not standard deviations) are presented below with the least squares means.|sex acts|Least Squares Mean|33.4|33.4|Standard Deviation|1.0431|1.0431|||
4028585|NCT01154296|3849974|B1|||# of sex acts|Note that standard errors (not standard deviations) are presented below with the least squares means.|sex acts|Least Squares Mean|34.6|34.6|Standard Deviation|1.0809|1.0809|||
4028586|NCT01154296|3849972|B3|||HIV, #||participants|Number|53|53.0||||||
4028587|NCT01154296|3849973|B2|||HIV, #||participants|Number|24|24.0||||||
4028588|NCT01154296|3849974|B1|||HIV, #||participants|Number|29|29.0||||||
4028589|NCT01154296|3849972|B3|||HSV-2, #||participants|Number|1551|1551.0||||||
4028590|NCT01154296|3849973|B2|||HSV-2, #||participants|Number|793|793.0||||||
4028591|NCT01154296|3849974|B1|||HSV-2, #||participants|Number|758|758.0||||||
4028592|NCT01154296|3849972|B3|||Syphilis, #||participants|Number|63|63.0||||||
4028593|NCT01154296|3849973|B2|||Syphilis, #||participants|Number|35|35.0||||||
4028594|NCT01154296|3849974|B1|||Syphilis, #||participants|Number|28|28.0||||||
4028595|NCT01154296|3849972|B3|||Trichomoniasis, #||participants|Number|245|245.0||||||
4028596|NCT01154296|3849973|B2|||Trichomoniasis, #||participants|Number|119|119.0||||||
4028597|NCT01154296|3849974|B1|||Trichomoniasis, #||participants|Number|126|126.0||||||
4028598|NCT01154296|3849972|B3|||Chlamydia, #||participants|Number|492|492.0||||||
4028599|NCT01154296|3849973|B2|||Chlamydia, #||participants|Number|254|254.0||||||
4028600|NCT01154296|3849974|B1|||Chlamydia, #||participants|Number|238|238.0||||||
4028601|NCT01154296|3849972|B3|||Gonorrhea, #||participants|Number|282|282.0||||||
4028602|NCT01154296|3849973|B2|||Gonorrhea, #||participants|Number|145|145.0||||||
4028603|NCT01154296|3849974|B1|||Gonorrhea, #||participants|Number|137|137.0||||||
4028604|NCT01154296|3849972|B3|||Any STI excluding trichomoniasis, #||participants|Number|2086|2086.0||||||
4028605|NCT01154296|3849973|B2|||Any STI excluding trichomoniasis, #||participants|Number|1070|1070.0||||||
4028606|NCT01154296|3849974|B1|||Any STI excluding trichomoniasis, #||participants|Number|1016|1016.0||||||
4028607|NCT01154296|3849972|B3|||Any STI, #||participants|Number|2141|2141.0||||||
4028608|NCT01154296|3849973|B2|||Any STI, #||participants|Number|1092|1092.0||||||
4028609|NCT01154296|3849974|B1|||Any STI, #||participants|Number|1049|1049.0||||||
4028610|NCT01154296|3849972|B3|||Men who have sex with men (MSM), #|Men were classified as MSM if, at study intake, they reported any previous anal or oral sex with males or if on the baseline sexual risk behavior questions they reported having anal or oral sexwith another male at any time during the study. All men who did not meet the definition of MSM were classified as men who have sex with women.|participants|Number|1400|1400.0||||||
4028611|NCT01154296|3849973|B2|||Men who have sex with men (MSM), #|Men were classified as MSM if, at study intake, they reported any previous anal or oral sex with males or if on the baseline sexual risk behavior questions they reported having anal or oral sexwith another male at any time during the study. All men who did not meet the definition of MSM were classified as men who have sex with women.|participants|Number|711|711.0||||||
4028612|NCT01154296|3849974|B1|||Men who have sex with men (MSM), #|Men were classified as MSM if, at study intake, they reported any previous anal or oral sex with males or if on the baseline sexual risk behavior questions they reported having anal or oral sexwith another male at any time during the study. All men who did not meet the definition of MSM were classified as men who have sex with women.|participants|Number|689|689.0||||||
4028613|NCT01154296|3849972|B3|United States||Region of Enrollment||participants|Number|5012|5012.0||||||
4028614|NCT01154296|3849973|B2|United States||Region of Enrollment||participants|Number|2507|2507.0||||||
4028615|NCT01154296|3849974|B1|United States||Region of Enrollment||participants|Number|2505|2505.0||||||
4028616|NCT01154296|3849972|B3|Other||Race/Ethnicity, Customized||participants|Number|555|555.0||||||
4028617|NCT01154296|3849973|B2|Other||Race/Ethnicity, Customized||participants|Number|275|275.0||||||
4028618|NCT01154296|3849974|B1|Other||Race/Ethnicity, Customized||participants|Number|280|280.0||||||
4028619|NCT01154296|3849972|B3|White||Race/Ethnicity, Customized||participants|Number|1592|1592.0||||||
4028620|NCT01154296|3849973|B2|White||Race/Ethnicity, Customized||participants|Number|794|794.0||||||
4028621|NCT01154296|3849974|B1|White||Race/Ethnicity, Customized||participants|Number|798|798.0||||||
4028622|NCT01154296|3849972|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|767|767.0||||||
4028623|NCT01154296|3849973|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|385|385.0||||||
4028624|NCT01154296|3849974|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|382|382.0||||||
4028625|NCT01154296|3849972|B3|Black||Race/Ethnicity, Customized||participants|Number|2098|2098.0||||||
4028626|NCT01154296|3849973|B2|Black||Race/Ethnicity, Customized||participants|Number|1053|1053.0||||||
4028627|NCT01154296|3849974|B1|Black||Race/Ethnicity, Customized||participants|Number|1045|1045.0||||||
4028628|NCT01154296|3849972|B3|Female sex||Sex/Gender, Customized||participants|Number|1704|1704.0||||||
4028629|NCT01154296|3849973|B2|Female sex||Sex/Gender, Customized||participants|Number|854|854.0||||||
4028630|NCT01154296|3849974|B1|Female sex||Sex/Gender, Customized||participants|Number|850|850.0||||||
4028631|NCT01154296|3849972|B3|Male sex||Sex/Gender, Customized||participants|Number|3308|3308.0||||||
4028632|NCT01154296|3849973|B2|Male sex||Sex/Gender, Customized||participants|Number|1653|1653.0||||||
4028633|NCT01154296|3849974|B1|Male sex||Sex/Gender, Customized||participants|Number|1655|1655.0||||||
4028634|NCT01154296|3849972|B3|>=25 years||Age, Customized||participants|Number|1580|1580.0||||||
4028635|NCT01154296|3849973|B2|>=25 years||Age, Customized||participants|Number|780|780.0||||||
4028636|NCT01154296|3849974|B1|>=25 years||Age, Customized||participants|Number|800|800.0||||||
4028637|NCT01154296|3849972|B3|<25 years||Age, Customized||participants|Number|3432|3432.0||||||
4028638|NCT01154296|3849973|B2|<25 years||Age, Customized||participants|Number|1727|1727.0||||||
4028639|NCT01154296|3849974|B1|<25 years||Age, Customized||participants|Number|1705|1705.0||||||
4028640|NCT01154283|3849991|B3||Male|Gender||Participants|Count of Participants|15|15.0||||||
4028641|NCT01154283|3849992|B2||Male|Gender||Participants|Count of Participants|7|7.0||||||
4028642|NCT01154283|3849993|B1||Male|Gender||Participants|Count of Participants|8|8.0||||||
4028643|NCT01154283|3849991|B3||Female|Gender||Participants|Count of Participants|13|13.0||||||
4028644|NCT01154283|3849992|B2||Female|Gender||Participants|Count of Participants|7|7.0||||||
4028645|NCT01154283|3849993|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
4028646|NCT01154283|3849991|B3|||Age||years|Mean|60|60.0|Full Range|||37.0|78.0|
4028647|NCT01154283|3849992|B2|||Age||years|Mean|59|59.0|Full Range|||37.0|75.0|
4028648|NCT01154283|3849993|B1|||Age||years|Mean|62|62.0|Full Range|||48.0|78.0|
4028649|NCT01154231|3850006|B1|No||Hemophilic Arthropathy||Participants|Number|179|179.0||||||
4028650|NCT01154231|3850006|B1|Yes||Hemophilic Arthropathy||Participants|Number|133|133.0||||||
4028651|NCT01154231|3850006|B1|No||History of Inhibitor||Participants|Number|306|306.0||||||
4028652|NCT01154231|3850006|B1|Yes||History of Inhibitor||Participants|Number|6|6.0||||||
4028653|NCT01154231|3850006|B1|Unknown||Number of Bleeding in the Past 1 Year||Participants|Number|37|37.0||||||
4028654|NCT01154231|3850006|B1|≥50 Times||Number of Bleeding in the Past 1 Year||Participants|Number|8|8.0||||||
4028655|NCT01154231|3850006|B1|≥10 to ˂50 Times||Number of Bleeding in the Past 1 Year||Participants|Number|73|73.0||||||
4028656|NCT01154231|3850006|B1|˂10 Times||Number of Bleeding in the Past 1 Year||Participants|Number|194|194.0||||||
4028657|NCT01154231|3850006|B1|Unknown||Severity|The severity of heamophilia B was defined as follows; severe, blood coagulation factor IX activity less than 1%; moderate, 1% to 5%; mild, more than 1%.|Participans|Number|15|15.0||||||
4028658|NCT01154231|3850006|B1|Mild||Severity|The severity of heamophilia B was defined as follows; severe, blood coagulation factor IX activity less than 1%; moderate, 1% to 5%; mild, more than 1%.|Participans|Number|43|43.0||||||
4028659|NCT01154231|3850006|B1|Moderate||Severity|The severity of heamophilia B was defined as follows; severe, blood coagulation factor IX activity less than 1%; moderate, 1% to 5%; mild, more than 1%.|Participans|Number|98|98.0||||||
4028660|NCT01154231|3850006|B1|Severe||Severity|The severity of heamophilia B was defined as follows; severe, blood coagulation factor IX activity less than 1%; moderate, 1% to 5%; mild, more than 1%.|Participans|Number|156|156.0||||||
4028661|NCT01154231|3850006|B1|Others||Previously Treated History|PTPs refer to previously treated patients. PUPs refer to previously untreated patients.|Participants|Number|3|3.0||||||
4028662|NCT01154231|3850006|B1|PUPs||Previously Treated History|PTPs refer to previously treated patients. PUPs refer to previously untreated patients.|Participants|Number|28|28.0||||||
4028663|NCT01154231|3850006|B1|PTPs||Previously Treated History|PTPs refer to previously treated patients. PUPs refer to previously untreated patients.|Participants|Number|281|281.0||||||
4028664|NCT01154231|3850006|B1||Male|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
4028665|NCT01154231|3850006|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4028666|NCT01154231|3850006|B1|Unknown||Age, Customized||Participants|Number|1|1.0||||||
4028667|NCT01154231|3850006|B1|≥65 years||Age, Customized||Participants|Number|8|8.0||||||
4028668|NCT01154231|3850006|B1|≥15 years <65 years||Age, Customized||Participants|Number|179|179.0||||||
4028669|NCT01154231|3850006|B1|<15 years||Age, Customized||Participants|Number|124|124.0||||||
4028670|NCT01154218|3850012|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4028671|NCT01154218|3850012|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4028672|NCT01154218|3850012|B1|||Age||years|Mean|38.9|38.9|Standard Deviation|8.1|8.1|||
4028673|NCT01154166|3850065|B3|Oriental||Race/Ethnicity, Customized|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all randomized participants who received at least one dose of study medication and for whom at least one post-baseline efficacy assessment was available.|participants|Number|344|344.0||||||
4028674|NCT01154166|3850066|B2|Oriental||Race/Ethnicity, Customized|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all randomized participants who received at least one dose of study medication and for whom at least one post-baseline efficacy assessment was available.|participants|Number|175|175.0||||||
4028675|NCT01154166|3850067|B1|Oriental||Race/Ethnicity, Customized|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all randomized participants who received at least one dose of study medication and for whom at least one post-baseline efficacy assessment was available.|participants|Number|169|169.0||||||
4028676|NCT01154166|3850065|B3||Male|Sex: Female, Male|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all randomized participants who received at least one dose of study medication and for whom at least one post-baseline efficacy assessment was available.|Participants|Count of Participants|220|220.0||||||
4028677|NCT01154166|3850066|B2||Male|Sex: Female, Male|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all randomized participants who received at least one dose of study medication and for whom at least one post-baseline efficacy assessment was available.|Participants|Count of Participants|116|116.0||||||
4028678|NCT01154166|3850067|B1||Male|Sex: Female, Male|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all randomized participants who received at least one dose of study medication and for whom at least one post-baseline efficacy assessment was available.|Participants|Count of Participants|104|104.0||||||
4028679|NCT01154166|3850065|B3||Female|Sex: Female, Male|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all randomized participants who received at least one dose of study medication and for whom at least one post-baseline efficacy assessment was available.|Participants|Count of Participants|124|124.0||||||
4028680|NCT01154166|3850066|B2||Female|Sex: Female, Male|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all randomized participants who received at least one dose of study medication and for whom at least one post-baseline efficacy assessment was available.|Participants|Count of Participants|59|59.0||||||
4028681|NCT01154166|3850067|B1||Female|Sex: Female, Male|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all randomized participants who received at least one dose of study medication and for whom at least one post-baseline efficacy assessment was available.|Participants|Count of Participants|65|65.0||||||
4028682|NCT01154166|3850065|B3|||Age|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all randomized participants who received at least one dose of study medication and for whom at least one post-baseline efficacy assessment was available.|Years|Mean|63.9|63.9|Standard Deviation|9.75|9.75|||
4028683|NCT01154166|3850066|B2|||Age|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all randomized participants who received at least one dose of study medication and for whom at least one post-baseline efficacy assessment was available.|Years|Mean|64.1|64.1|Standard Deviation|8.99|8.99|||
4028684|NCT01154166|3850067|B1|||Age|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all randomized participants who received at least one dose of study medication and for whom at least one post-baseline efficacy assessment was available.|Years|Mean|63.6|63.6|Standard Deviation|10.50|10.5|||
4028685|NCT01154153|3850098|B3|||Time from the first Allergic Rhinitis symptom to Visit 1|For participants with both PAR and SAR, it is the longest time. A missing month of the first symptom start date was imputed as December and a missing day was imputed as the last date of the month.|Years|Mean|4.80|4.8|Standard Deviation|2.59|2.59|||
4028686|NCT01154153|3850099|B2|||Time from the first Allergic Rhinitis symptom to Visit 1|For participants with both PAR and SAR, it is the longest time. A missing month of the first symptom start date was imputed as December and a missing day was imputed as the last date of the month.|Years|Mean|4.79|4.79|Standard Deviation|2.48|2.48|||
4028687|NCT01154153|3850100|B1|||Time from the first Allergic Rhinitis symptom to Visit 1|For participants with both PAR and SAR, it is the longest time. A missing month of the first symptom start date was imputed as December and a missing day was imputed as the last date of the month.|Years|Mean|4.82|4.82|Standard Deviation|2.70|2.7|||
4028688|NCT01154153|3850098|B3|Both PAR and SAR||Primary Allergic Rhinitis (AR) diagnosis|Participants diagnosed with perennial allergic rhinitis (PAR); and seasonal allergic rhinitis (SAR).|Participants|Number|109|109.0||||||
4028689|NCT01154153|3850099|B2|Both PAR and SAR||Primary Allergic Rhinitis (AR) diagnosis|Participants diagnosed with perennial allergic rhinitis (PAR); and seasonal allergic rhinitis (SAR).|Participants|Number|54|54.0||||||
4028690|NCT01154153|3850100|B1|Both PAR and SAR||Primary Allergic Rhinitis (AR) diagnosis|Participants diagnosed with perennial allergic rhinitis (PAR); and seasonal allergic rhinitis (SAR).|Participants|Number|55|55.0||||||
4028691|NCT01154153|3850098|B3|SAR only||Primary Allergic Rhinitis (AR) diagnosis|Participants diagnosed with perennial allergic rhinitis (PAR); and seasonal allergic rhinitis (SAR).|Participants|Number|8|8.0||||||
4028692|NCT01154153|3850099|B2|SAR only||Primary Allergic Rhinitis (AR) diagnosis|Participants diagnosed with perennial allergic rhinitis (PAR); and seasonal allergic rhinitis (SAR).|Participants|Number|3|3.0||||||
4028693|NCT01154153|3850100|B1|SAR only||Primary Allergic Rhinitis (AR) diagnosis|Participants diagnosed with perennial allergic rhinitis (PAR); and seasonal allergic rhinitis (SAR).|Participants|Number|5|5.0||||||
4028694|NCT01154153|3850098|B3|PAR only||Primary Allergic Rhinitis (AR) diagnosis|Participants diagnosed with perennial allergic rhinitis (PAR); and seasonal allergic rhinitis (SAR).|Participants|Number|23|23.0||||||
4028695|NCT01154153|3850099|B2|PAR only||Primary Allergic Rhinitis (AR) diagnosis|Participants diagnosed with perennial allergic rhinitis (PAR); and seasonal allergic rhinitis (SAR).|Participants|Number|12|12.0||||||
4028696|NCT01154153|3850100|B1|PAR only||Primary Allergic Rhinitis (AR) diagnosis|Participants diagnosed with perennial allergic rhinitis (PAR); and seasonal allergic rhinitis (SAR).|Participants|Number|11|11.0||||||
4028697|NCT01154153|3850098|B3|Stage 5||Tanner Classification|Tanner classification distinguishes stages of puberty. Each stage represents the extent of breast, genitalia and pubic hair growth. Tanner Stage I represents the pre-adolescent stage where breast, genitalia and pubic hair growth are of the same size and shape as in early childhood and in Tanner Stage 5 breasts and genitalia are of adult shape and size, and pubic hair is adult in quantity (mature stage). Stages 2, 3 and 4 are intermediate stages.|Participants|Number|0|0.0||||||
4028698|NCT01154153|3850099|B2|Stage 5||Tanner Classification|Tanner classification distinguishes stages of puberty. Each stage represents the extent of breast, genitalia and pubic hair growth. Tanner Stage I represents the pre-adolescent stage where breast, genitalia and pubic hair growth are of the same size and shape as in early childhood and in Tanner Stage 5 breasts and genitalia are of adult shape and size, and pubic hair is adult in quantity (mature stage). Stages 2, 3 and 4 are intermediate stages.|Participants|Number|0|0.0||||||
4028699|NCT01154153|3850100|B1|Stage 5||Tanner Classification|Tanner classification distinguishes stages of puberty. Each stage represents the extent of breast, genitalia and pubic hair growth. Tanner Stage I represents the pre-adolescent stage where breast, genitalia and pubic hair growth are of the same size and shape as in early childhood and in Tanner Stage 5 breasts and genitalia are of adult shape and size, and pubic hair is adult in quantity (mature stage). Stages 2, 3 and 4 are intermediate stages.|Participants|Number|0|0.0||||||
4028700|NCT01154153|3850098|B3|Stage 4||Tanner Classification|Tanner classification distinguishes stages of puberty. Each stage represents the extent of breast, genitalia and pubic hair growth. Tanner Stage I represents the pre-adolescent stage where breast, genitalia and pubic hair growth are of the same size and shape as in early childhood and in Tanner Stage 5 breasts and genitalia are of adult shape and size, and pubic hair is adult in quantity (mature stage). Stages 2, 3 and 4 are intermediate stages.|Participants|Number|0|0.0||||||
4028701|NCT01154153|3850099|B2|Stage 4||Tanner Classification|Tanner classification distinguishes stages of puberty. Each stage represents the extent of breast, genitalia and pubic hair growth. Tanner Stage I represents the pre-adolescent stage where breast, genitalia and pubic hair growth are of the same size and shape as in early childhood and in Tanner Stage 5 breasts and genitalia are of adult shape and size, and pubic hair is adult in quantity (mature stage). Stages 2, 3 and 4 are intermediate stages.|Participants|Number|0|0.0||||||
4028702|NCT01154153|3850100|B1|Stage 4||Tanner Classification|Tanner classification distinguishes stages of puberty. Each stage represents the extent of breast, genitalia and pubic hair growth. Tanner Stage I represents the pre-adolescent stage where breast, genitalia and pubic hair growth are of the same size and shape as in early childhood and in Tanner Stage 5 breasts and genitalia are of adult shape and size, and pubic hair is adult in quantity (mature stage). Stages 2, 3 and 4 are intermediate stages.|Participants|Number|0|0.0||||||
4028703|NCT01154153|3850098|B3|Stage 3||Tanner Classification|Tanner classification distinguishes stages of puberty. Each stage represents the extent of breast, genitalia and pubic hair growth. Tanner Stage I represents the pre-adolescent stage where breast, genitalia and pubic hair growth are of the same size and shape as in early childhood and in Tanner Stage 5 breasts and genitalia are of adult shape and size, and pubic hair is adult in quantity (mature stage). Stages 2, 3 and 4 are intermediate stages.|Participants|Number|4|4.0||||||
4028704|NCT01154153|3850099|B2|Stage 3||Tanner Classification|Tanner classification distinguishes stages of puberty. Each stage represents the extent of breast, genitalia and pubic hair growth. Tanner Stage I represents the pre-adolescent stage where breast, genitalia and pubic hair growth are of the same size and shape as in early childhood and in Tanner Stage 5 breasts and genitalia are of adult shape and size, and pubic hair is adult in quantity (mature stage). Stages 2, 3 and 4 are intermediate stages.|Participants|Number|0|0.0||||||
4028705|NCT01154153|3850100|B1|Stage 3||Tanner Classification|Tanner classification distinguishes stages of puberty. Each stage represents the extent of breast, genitalia and pubic hair growth. Tanner Stage I represents the pre-adolescent stage where breast, genitalia and pubic hair growth are of the same size and shape as in early childhood and in Tanner Stage 5 breasts and genitalia are of adult shape and size, and pubic hair is adult in quantity (mature stage). Stages 2, 3 and 4 are intermediate stages.|Participants|Number|4|4.0||||||
4028706|NCT01154153|3850098|B3|Stage 2||Tanner Classification|Tanner classification distinguishes stages of puberty. Each stage represents the extent of breast, genitalia and pubic hair growth. Tanner Stage I represents the pre-adolescent stage where breast, genitalia and pubic hair growth are of the same size and shape as in early childhood and in Tanner Stage 5 breasts and genitalia are of adult shape and size, and pubic hair is adult in quantity (mature stage). Stages 2, 3 and 4 are intermediate stages.|Participants|Number|21|21.0||||||
4028707|NCT01154153|3850099|B2|Stage 2||Tanner Classification|Tanner classification distinguishes stages of puberty. Each stage represents the extent of breast, genitalia and pubic hair growth. Tanner Stage I represents the pre-adolescent stage where breast, genitalia and pubic hair growth are of the same size and shape as in early childhood and in Tanner Stage 5 breasts and genitalia are of adult shape and size, and pubic hair is adult in quantity (mature stage). Stages 2, 3 and 4 are intermediate stages.|Participants|Number|9|9.0||||||
4028708|NCT01154153|3850100|B1|Stage 2||Tanner Classification|Tanner classification distinguishes stages of puberty. Each stage represents the extent of breast, genitalia and pubic hair growth. Tanner Stage I represents the pre-adolescent stage where breast, genitalia and pubic hair growth are of the same size and shape as in early childhood and in Tanner Stage 5 breasts and genitalia are of adult shape and size, and pubic hair is adult in quantity (mature stage). Stages 2, 3 and 4 are intermediate stages.|Participants|Number|12|12.0||||||
4028760|NCT01154127|3850171|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4028761|NCT01154127|3850172|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4028762|NCT01154127|3850173|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4028763|NCT01154127|3850171|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4028709|NCT01154153|3850098|B3|Stage 1||Tanner Classification|Tanner classification distinguishes stages of puberty. Each stage represents the extent of breast, genitalia and pubic hair growth. Tanner Stage I represents the pre-adolescent stage where breast, genitalia and pubic hair growth are of the same size and shape as in early childhood and in Tanner Stage 5 breasts and genitalia are of adult shape and size, and pubic hair is adult in quantity (mature stage). Stages 2, 3 and 4 are intermediate stages.|Participants|Number|115|115.0||||||
4028710|NCT01154153|3850099|B2|Stage 1||Tanner Classification|Tanner classification distinguishes stages of puberty. Each stage represents the extent of breast, genitalia and pubic hair growth. Tanner Stage I represents the pre-adolescent stage where breast, genitalia and pubic hair growth are of the same size and shape as in early childhood and in Tanner Stage 5 breasts and genitalia are of adult shape and size, and pubic hair is adult in quantity (mature stage). Stages 2, 3 and 4 are intermediate stages.|Participants|Number|60|60.0||||||
4028711|NCT01154153|3850100|B1|Stage 1||Tanner Classification|Tanner classification distinguishes stages of puberty. Each stage represents the extent of breast, genitalia and pubic hair growth. Tanner Stage I represents the pre-adolescent stage where breast, genitalia and pubic hair growth are of the same size and shape as in early childhood and in Tanner Stage 5 breasts and genitalia are of adult shape and size, and pubic hair is adult in quantity (mature stage). Stages 2, 3 and 4 are intermediate stages.|Participants|Number|55|55.0||||||
4028712|NCT01154153|3850098|B3|United States||Region of Enrollment||participants|Number|140|140.0||||||
4028713|NCT01154153|3850099|B2|United States||Region of Enrollment||participants|Number|69|69.0||||||
4028714|NCT01154153|3850100|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
4028715|NCT01154153|3850098|B3|Others||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4028716|NCT01154153|3850099|B2|Others||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4028717|NCT01154153|3850100|B1|Others||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4028718|NCT01154153|3850098|B3|White||Race/Ethnicity, Customized||participants|Number|85|85.0||||||
4028719|NCT01154153|3850099|B2|White||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4028720|NCT01154153|3850100|B1|White||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4028721|NCT01154153|3850098|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4028722|NCT01154153|3850099|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4028723|NCT01154153|3850100|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4028724|NCT01154153|3850098|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4028725|NCT01154153|3850099|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4028726|NCT01154153|3850100|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4028727|NCT01154153|3850098|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4028728|NCT01154153|3850099|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4028729|NCT01154153|3850100|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4028730|NCT01154153|3850098|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4028731|NCT01154153|3850099|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4028732|NCT01154153|3850100|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4028733|NCT01154153|3850098|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4028734|NCT01154153|3850099|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4028735|NCT01154153|3850100|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4028736|NCT01154153|3850098|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4028737|NCT01154153|3850099|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4028738|NCT01154153|3850100|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4028739|NCT01154153|3850098|B3|>=6 to < 12 years||Age, Customized||participants|Number|98|98.0||||||
4028740|NCT01154153|3850099|B2|>=6 to < 12 years||Age, Customized||participants|Number|48|48.0||||||
4028741|NCT01154153|3850100|B1|>=6 to < 12 years||Age, Customized||participants|Number|50|50.0||||||
4028742|NCT01154153|3850098|B3|>=4 to < 6 years||Age, Customized||participants|Number|31|31.0||||||
4028743|NCT01154153|3850099|B2|>=4 to < 6 years||Age, Customized||participants|Number|16|16.0||||||
4028744|NCT01154153|3850100|B1|>=4 to < 6 years||Age, Customized||participants|Number|15|15.0||||||
4028745|NCT01154153|3850098|B3|>=2 to < 4 years||Age, Customized||participants|Number|11|11.0||||||
4028746|NCT01154153|3850099|B2|>=2 to < 4 years||Age, Customized||participants|Number|5|5.0||||||
4028747|NCT01154153|3850100|B1|>=2 to < 4 years||Age, Customized||participants|Number|6|6.0||||||
4028748|NCT01154153|3850098|B3|||Age||years|Mean|7.2|7.2|Standard Deviation|2.6|2.6|||
4028749|NCT01154153|3850099|B2|||Age||years|Mean|7.1|7.1|Standard Deviation|2.5|2.5|||
4028750|NCT01154153|3850100|B1|||Age||years|Mean|7.3|7.3|Standard Deviation|2.7|2.7|||
4028751|NCT01154140|3850117|B3||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4028752|NCT01154140|3850118|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4028753|NCT01154140|3850119|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4028754|NCT01154140|3850117|B3||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4028755|NCT01154140|3850118|B2||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4028756|NCT01154140|3850119|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4028757|NCT01154140|3850117|B3|||Age||years|Mean|51.92|51.92|Standard Deviation|12.6|12.6|||
4028758|NCT01154140|3850118|B2|||Age||years|Mean|52.89|52.89|Standard Deviation|13.1|13.1|||
4028759|NCT01154140|3850119|B1|||Age||years|Mean|50.94|50.94|Standard Deviation|11.9|11.9|||
4028764|NCT01154127|3850172|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4028765|NCT01154127|3850173|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4028766|NCT01154127|3850171|B3|||Age||years|Mean|60.5|60.5|Standard Deviation|8.64|8.64|||
4028767|NCT01154127|3850172|B2|||Age||years|Mean|59.7|59.7|Standard Deviation|8.78|8.78|||
4028768|NCT01154127|3850173|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|8.50|8.5|||
4028769|NCT01154101|3850196|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4028770|NCT01154101|3850197|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028771|NCT01154101|3850198|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028772|NCT01154101|3850199|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4028773|NCT01154101|3850200|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028774|NCT01154101|3850201|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028775|NCT01154101|3850196|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028776|NCT01154101|3850197|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028777|NCT01154101|3850198|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028778|NCT01154101|3850199|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028779|NCT01154101|3850200|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028780|NCT01154101|3850201|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028781|NCT01154101|3850196|B6||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4028782|NCT01154101|3850197|B5||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4028783|NCT01154101|3850198|B4||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4028784|NCT01154101|3850199|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4028785|NCT01154101|3850200|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4028786|NCT01154101|3850201|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4028787|NCT01154101|3850196|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4028788|NCT01154101|3850197|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028789|NCT01154101|3850198|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4028790|NCT01154101|3850199|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028791|NCT01154101|3850200|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4028792|NCT01154101|3850201|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4028793|NCT01154101|3850196|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028794|NCT01154101|3850197|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028795|NCT01154101|3850198|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028796|NCT01154101|3850199|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028797|NCT01154101|3850200|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028798|NCT01154101|3850201|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028799|NCT01154101|3850196|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4028800|NCT01154101|3850197|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028801|NCT01154101|3850198|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028802|NCT01154101|3850199|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4028803|NCT01154101|3850200|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028804|NCT01154101|3850201|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028805|NCT01154101|3850196|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028806|NCT01154101|3850197|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028807|NCT01154101|3850198|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028808|NCT01154101|3850199|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028809|NCT01154101|3850200|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028810|NCT01154101|3850201|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4028811|NCT01154101|3850196|B6||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4028812|NCT01154101|3850197|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4028813|NCT01154101|3850198|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4028814|NCT01154101|3850199|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4028815|NCT01154101|3850200|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4028816|NCT01154101|3850201|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4028817|NCT01154101|3850196|B6||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4028818|NCT01154101|3850197|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4028819|NCT01154101|3850198|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4028820|NCT01154101|3850199|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4028821|NCT01154101|3850200|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4028822|NCT01154101|3850201|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4028823|NCT01154101|3850196|B6|||Age||Years|Mean|46.4|46.4|Standard Deviation|14.63|14.63|||
4028824|NCT01154101|3850198|B4|||Age||Years|Mean|44.6|44.6|Standard Deviation|13.58|13.58|||
4028825|NCT01154101|3850199|B3|||Age||Years|Mean|49.3|49.3|Standard Deviation|14.41|14.41|||
4028826|NCT01154101|3850200|B2|||Age||Years|Mean|40.6|40.6|Standard Deviation|16.05|16.05|||
4028827|NCT01154101|3850201|B1|||Age||Years|Mean|51.4|51.4|Standard Deviation|14.88|14.88|||
4028828|NCT01154088|3850257|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|302|302.0||||||
4028829|NCT01154088|3850258|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|100|100.0||||||
4028830|NCT01154088|3850259|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|102|102.0||||||
4028831|NCT01154088|3850260|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|100|100.0||||||
4028832|NCT01154088|3850257|B4|White - Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
4028833|NCT01154088|3850258|B3|White - Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4028834|NCT01154088|3850259|B2|White - Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4028835|NCT01154088|3850260|B1|White - Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4028836|NCT01154088|3850257|B4|White - Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4028837|NCT01154088|3850258|B3|White - Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4028838|NCT01154088|3850259|B2|White - Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4028839|NCT01154088|3850260|B1|White - Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4028840|NCT01154088|3850257|B4|Asian - South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|774|774.0||||||
4028841|NCT01154088|3850258|B3|Asian - South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|257|257.0||||||
4028842|NCT01154088|3850259|B2|Asian - South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|259|259.0||||||
4028843|NCT01154088|3850260|B1|Asian - South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|258|258.0||||||
4028844|NCT01154088|3850257|B4|Asian - Japanese heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4028845|NCT01154088|3850258|B3|Asian - Japanese heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4028846|NCT01154088|3850259|B2|Asian - Japanese heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4028847|NCT01154088|3850260|B1|Asian - Japanese heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4028848|NCT01154088|3850257|B4|Asian - East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4028849|NCT01154088|3850258|B3|Asian - East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4028850|NCT01154088|3850259|B2|Asian - East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4028851|NCT01154088|3850260|B1|Asian - East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4028852|NCT01154088|3850257|B4|Asian - Central/South Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4028853|NCT01154088|3850258|B3|Asian - Central/South Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4028854|NCT01154088|3850259|B2|Asian - Central/South Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4028855|NCT01154088|3850260|B1|Asian - Central/South Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4028856|NCT01154088|3850257|B4|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
4028857|NCT01154088|3850258|B3|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4028858|NCT01154088|3850259|B2|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4028859|NCT01154088|3850260|B1|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
4028860|NCT01154088|3850257|B4||Male|Sex: Female, Male||Participants|Count of Participants|544|544.0||||||
4028861|NCT01154088|3850258|B3||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4028862|NCT01154088|3850259|B2||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4028863|NCT01154088|3850260|B1||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4028864|NCT01154088|3850257|B4||Female|Sex: Female, Male||Participants|Count of Participants|626|626.0||||||
4028865|NCT01154088|3850258|B3||Female|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4028866|NCT01154088|3850259|B2||Female|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
4028867|NCT01154088|3850260|B1||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4028868|NCT01154088|3850257|B4|||Age||Years|Mean|20.77|20.77|Standard Deviation|2.06|2.06|||
4028869|NCT01154088|3850258|B3|||Age||Years|Mean|20.6|20.6|Standard Deviation|1.94|1.94|||
4028870|NCT01154088|3850259|B2|||Age||Years|Mean|20.9|20.9|Standard Deviation|2.10|2.1|||
4028871|NCT01154088|3850260|B1|||Age||Years|Mean|20.8|20.8|Standard Deviation|2.14|2.14|||
4028872|NCT01154036|3850299|B4||Male|Sex: Female, Male||Participants|Count of Participants|734|734.0||||||
4028873|NCT01154036|3850300|B3||Male|Sex: Female, Male||Participants|Count of Participants|455|455.0||||||
4028874|NCT01154036|3850301|B2||Male|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4028875|NCT01154036|3850302|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4028876|NCT01154036|3850299|B4||Female|Sex: Female, Male||Participants|Count of Participants|813|813.0||||||
4028877|NCT01154036|3850300|B3||Female|Sex: Female, Male||Participants|Count of Participants|489|489.0||||||
4028878|NCT01154036|3850301|B2||Female|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
4028879|NCT01154036|3850302|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4028880|NCT01154036|3850299|B4|≥65 years||Age, Customized||Participants|Number|508|508.0||||||
4028881|NCT01154036|3850300|B3|≥65 years||Age, Customized||Participants|Number|310|310.0||||||
4028882|NCT01154036|3850301|B2|≥65 years||Age, Customized||Participants|Number|159|159.0||||||
4028883|NCT01154036|3850302|B1|≥65 years||Age, Customized||Participants|Number|39|39.0||||||
4028884|NCT01154036|3850299|B4|60 to 64 years||Age, Customized||Participants|Number|297|297.0||||||
4028885|NCT01154036|3850300|B3|60 to 64 years||Age, Customized||Participants|Number|183|183.0||||||
4028886|NCT01154036|3850301|B2|60 to 64 years||Age, Customized||Participants|Number|87|87.0||||||
4028887|NCT01154036|3850302|B1|60 to 64 years||Age, Customized||Participants|Number|27|27.0||||||
4028888|NCT01154036|3850299|B4|50 to 59 years||Age, Customized||Participants|Number|531|531.0||||||
4028889|NCT01154036|3850300|B3|50 to 59 years||Age, Customized||Participants|Number|324|324.0||||||
4028890|NCT01154036|3850301|B2|50 to 59 years||Age, Customized||Participants|Number|170|170.0||||||
4028891|NCT01154036|3850302|B1|50 to 59 years||Age, Customized||Participants|Number|37|37.0||||||
4028892|NCT01154036|3850299|B4|40 to 49 years||Age, Customized||Participants|Number|165|165.0||||||
4028893|NCT01154036|3850300|B3|40 to 49 years||Age, Customized||Participants|Number|99|99.0||||||
4028894|NCT01154036|3850301|B2|40 to 49 years||Age, Customized||Participants|Number|50|50.0||||||
4028895|NCT01154036|3850302|B1|40 to 49 years||Age, Customized||Participants|Number|16|16.0||||||
4028896|NCT01154036|3850299|B4|30 to 39 years||Age, Customized||Participants|Number|39|39.0||||||
4028897|NCT01154036|3850300|B3|30 to 39 years||Age, Customized||Participants|Number|25|25.0||||||
4028898|NCT01154036|3850301|B2|30 to 39 years||Age, Customized||Participants|Number|13|13.0||||||
4028899|NCT01154036|3850302|B1|30 to 39 years||Age, Customized||Participants|Number|1|1.0||||||
4028900|NCT01154036|3850299|B4|20 to 29 years||Age, Customized||Participants|Number|6|6.0||||||
4028901|NCT01154036|3850300|B3|20 to 29 years||Age, Customized||Participants|Number|2|2.0||||||
4028902|NCT01154036|3850301|B2|20 to 29 years||Age, Customized||Participants|Number|4|4.0||||||
4028903|NCT01154036|3850302|B1|20 to 29 years||Age, Customized||Participants|Number|0|0.0||||||
4028904|NCT01154036|3850299|B4|<20 years||Age, Customized||Participants|Number|1|1.0||||||
4028905|NCT01154036|3850300|B3|<20 years||Age, Customized||Participants|Number|1|1.0||||||
4028906|NCT01154036|3850301|B2|<20 years||Age, Customized||Participants|Number|0|0.0||||||
4028907|NCT01154036|3850302|B1|<20 years||Age, Customized||Participants|Number|0|0.0||||||
4028908|NCT01154010|3850431|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4028909|NCT01154010|3850432|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4028910|NCT01154010|3850433|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4028911|NCT01154010|3850431|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4028912|NCT01154010|3850432|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4028913|NCT01154010|3850433|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4028914|NCT01154010|3850431|B3|||Age||years|Mean|41.275|41.275|Standard Deviation|13.576|13.576|||
4028915|NCT01154010|3850432|B2|||Age||years|Mean|40.22|40.22|Standard Deviation|14.228|14.228|||
4028916|NCT01154010|3850433|B1|||Age||years|Mean|42.33|42.33|Standard Deviation|12.808|12.808|||
4028917|NCT01153984|3850440|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4028918|NCT01153984|3850440|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4028919|NCT01153984|3850440|B1|||Age||Years|Mean|55.52|55.52|Standard Deviation|11.59|11.59|||
4028920|NCT01153971|3850451|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4028921|NCT01153971|3850451|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4028922|NCT01153971|3850451|B1|||Age||years|Mean|57.3|57.3|Standard Deviation|8.2|8.2|||
4028923|NCT01153958|3850472|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4028924|NCT01153958|3850473|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4028925|NCT01153958|3850474|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4028926|NCT01153958|3850472|B3||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4028927|NCT01153958|3850473|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4028928|NCT01153958|3850474|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4028929|NCT01153958|3850472|B3|||Age||years|Mean|31.41|31.41|Standard Deviation|7.95|7.95|||
4028930|NCT01153958|3850473|B2|||Age||years|Mean|30.72|30.72|Standard Deviation|7.06|7.06|||
4028931|NCT01153958|3850474|B1|||Age||years|Mean|32.11|32.11|Standard Deviation|8.78|8.78|||
4028932|NCT01153893|3850491|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4028933|NCT01153893|3850492|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4028934|NCT01153893|3850493|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4028935|NCT01153893|3850491|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4028936|NCT01153893|3850492|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4028937|NCT01153893|3850493|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4028938|NCT01153893|3850491|B3|||Age||Months|Mean|16.55|16.55|Standard Deviation|0.955|0.955|||
4028939|NCT01153893|3850492|B2|||Age||Months|Mean|16.4|16.4|Standard Deviation|0.91|0.91|||
4028940|NCT01153893|3850493|B1|||Age||Months|Mean|16.7|16.7|Standard Deviation|1.00|1.0|||
4028941|NCT01153841|3850518|B3||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4028942|NCT01153841|3850519|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4028943|NCT01153841|3850520|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4028944|NCT01153841|3850518|B3||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4028945|NCT01153841|3850519|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4028946|NCT01153841|3850520|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4028947|NCT01153841|3850518|B3|||Age||Weeks|Mean|8.77|8.77|Standard Deviation|1.20|1.2|||
4028948|NCT01153841|3850519|B2|||Age||Weeks|Mean|8.7|8.7|Standard Deviation|1.11|1.11|||
4028949|NCT01153841|3850520|B1|||Age||Weeks|Mean|8.8|8.8|Standard Deviation|1.24|1.24|||
4028950|NCT01153815|3850535|B3|Chinese||Race/Ethnicity, Customized||Participants|Number|170|170.0||||||
4028951|NCT01153815|3850536|B2|Chinese||Race/Ethnicity, Customized||Participants|Number|87|87.0||||||
4028952|NCT01153815|3850537|B1|Chinese||Race/Ethnicity, Customized||Participants|Number|83|83.0||||||
4028953|NCT01153815|3850535|B3||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4028954|NCT01153815|3850536|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4028955|NCT01153815|3850537|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4028956|NCT01153815|3850535|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4028957|NCT01153815|3850536|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4028958|NCT01153815|3850537|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4028959|NCT01153815|3850535|B3|||Age||Years|Mean|55.8|55.8|Standard Deviation|11.44|11.44|||
4028960|NCT01153815|3850536|B2|||Age||Years|Mean|55.4|55.4|Standard Deviation|10.69|10.69|||
4028961|NCT01153815|3850537|B1|||Age||Years|Mean|56.3|56.3|Standard Deviation|12.23|12.23|||
4028962|NCT01153763|3850560|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4028963|NCT01153763|3850560|B1|White||Race/Ethnicity, Customized||participants|Number|91|91.0||||||
4028964|NCT01153763|3850560|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4028965|NCT01153763|3850560|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4028966|NCT01153763|3850560|B1|||Age||Years|Mean|54.8|54.8|Standard Deviation|14.44|14.44|||
4028967|NCT01153724|3850576|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4028968|NCT01153724|3850576|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4028969|NCT01153724|3850576|B1|||Age||years|Mean|32.0|32.0|Standard Deviation|9.0|9.0|||
4028970|NCT01153711|3850596|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4028971|NCT01153711|3850596|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4028972|NCT01153711|3850596|B1|||Age||years|Mean|38.5|38.5|Standard Deviation|7.2|7.2|||
4028973|NCT01153698|3850616|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4028974|NCT01153698|3850616|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4028975|NCT01153698|3850616|B1|||Age||Years|Mean|60.9|60.9|Standard Deviation|9.2|9.2|||
4028976|NCT01153685|3850630|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4028977|NCT01153685|3850631|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4028978|NCT01153685|3850632|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4028979|NCT01153685|3850630|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4028980|NCT01153685|3850631|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4028981|NCT01153685|3850632|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4028982|NCT01153685|3850630|B3|||Age||Years|Mean|50.7|50.7|Standard Deviation|9.23|9.23|||
4028983|NCT01153685|3850631|B2|||Age||Years|Mean|66.6|66.6|Standard Deviation|4.73|4.73|||
4028984|NCT01153685|3850632|B1|||Age||Years|Mean|34.8|34.8|Standard Deviation|13.72|13.72|||
4028985|NCT01153672|3850657|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4028986|NCT01153672|3850657|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4028987|NCT01153672|3850657|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4028988|NCT01153672|3850657|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4028989|NCT01153672|3850657|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4028990|NCT01153633|3850665|B3|||Duration of leg ulceration||months|Median|54|54.0|Full Range|||3.0|384.0|
4028991|NCT01153633|3850666|B2|||Duration of leg ulceration||months|Median|84|84.0|Full Range|||3.0|84.0|
4028992|NCT01153633|3850667|B1|||Duration of leg ulceration||months|Median|36|36.0|Full Range|||5.0|360.0|
4028993|NCT01153633|3850665|B3|United Kingdom||Region of Enrollment||participants|Number|34|34.0||||||
4028994|NCT01153633|3850666|B2|United Kingdom||Region of Enrollment||participants|Number|17|17.0||||||
4028995|NCT01153633|3850667|B1|United Kingdom||Region of Enrollment||participants|Number|17|17.0||||||
4028996|NCT01153633|3850665|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4028997|NCT01153633|3850666|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4028998|NCT01153633|3850667|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4028999|NCT01153633|3850665|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4029000|NCT01153633|3850666|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4029001|NCT01153633|3850667|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4029002|NCT01153633|3850665|B3|||Age||years|Mean|71.6|71.6|Standard Deviation|10.1|10.1|||
4029003|NCT01153633|3850666|B2|||Age||years|Mean|73.1|73.1|Standard Deviation|10.7|10.7|||
4029004|NCT01153633|3850667|B1|||Age||years|Mean|71.1|71.1|Standard Deviation|9.6|9.6|||
4029005|NCT01153620|3850684|B3|Switzerland||Region of Enrollment||participants|Number|61|61.0||||||
4029006|NCT01153620|3850685|B2|Switzerland||Region of Enrollment||participants|Number|31|31.0||||||
4029007|NCT01153620|3850686|B1|Switzerland||Region of Enrollment||participants|Number|30|30.0||||||
4029008|NCT01153620|3850684|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4029009|NCT01153620|3850685|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4029010|NCT01153620|3850686|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4029011|NCT01153620|3850684|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4029012|NCT01153620|3850685|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4029013|NCT01153620|3850686|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4029014|NCT01153620|3850684|B3|||Age||years|Mean|47.66|47.66|Standard Deviation|23.553|23.553|||
4029015|NCT01153620|3850685|B2|||Age||years|Mean|47.68|47.68|Standard Deviation|23.019|23.019|||
4029016|NCT01153620|3850686|B1|||Age||years|Mean|47.63|47.63|Standard Deviation|24.487|24.487|||
4029017|NCT01153620|3850684|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4029018|NCT01153620|3850685|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4029019|NCT01153620|3850686|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4029020|NCT01153620|3850684|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4029021|NCT01153620|3850685|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4029022|NCT01153620|3850686|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4029023|NCT01153620|3850684|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4029024|NCT01153620|3850685|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4029025|NCT01153620|3850686|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4029026|NCT01153581|3850693|B1|United States||Region of Enrollment||participants|Number|109|109.0||||||
4029027|NCT01153581|3850693|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4029028|NCT01153581|3850693|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4029029|NCT01153581|3850693|B1||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4029030|NCT01153581|3850693|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4029031|NCT01153581|3850693|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029032|NCT01153581|3850693|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4029033|NCT01153581|3850693|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029034|NCT01153581|3850693|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4029035|NCT01153581|3850693|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4029036|NCT01153581|3850693|B1|||Age||years|Mean|22|22.0|Standard Deviation|1|1.0|||
4029037|NCT01153581|3850693|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4029038|NCT01153581|3850693|B1||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
4029039|NCT01153581|3850693|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4029040|NCT01153503|3850703|B4|United States||Region of Enrollment||participants|Number|74|74.0||||||
4029041|NCT01153503|3850704|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4029042|NCT01153503|3850705|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4029043|NCT01153503|3850706|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4029044|NCT01153503|3850703|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4029045|NCT01153503|3850704|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4029046|NCT01153503|3850705|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4029047|NCT01153503|3850706|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4029048|NCT01153503|3850703|B4||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4029049|NCT01153503|3850704|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4029050|NCT01153503|3850705|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4029051|NCT01153503|3850706|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4029052|NCT01153503|3850703|B4|||Age||years|Mean|43.1|43.1|Standard Deviation|5.8|5.8|||
4029053|NCT01153503|3850704|B3|||Age||years|Mean|43.1|43.1|Standard Deviation|5.6|5.6|||
4029054|NCT01153503|3850705|B2|||Age||years|Mean|43.8|43.8|Standard Deviation|6.5|6.5|||
4029055|NCT01153503|3850706|B1|||Age||years|Mean|42.4|42.4|Standard Deviation|5.4|5.4|||
4029056|NCT01153425|3850716|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029057|NCT01153425|3850717|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029058|NCT01153425|3850718|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029059|NCT01153425|3850716|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4029060|NCT01153425|3850717|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4029061|NCT01153425|3850718|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4029062|NCT01153425|3850716|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4029063|NCT01153425|3850717|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4029064|NCT01153425|3850718|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4029065|NCT01153425|3850716|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029066|NCT01153425|3850717|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029067|NCT01153425|3850718|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029068|NCT01153425|3850716|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029069|NCT01153425|3850717|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029070|NCT01153425|3850718|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029071|NCT01153425|3850716|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029072|NCT01153425|3850717|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029073|NCT01153425|3850718|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029074|NCT01153425|3850716|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029075|NCT01153425|3850717|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029076|NCT01153425|3850718|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029077|NCT01153425|3850716|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029078|NCT01153425|3850717|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029079|NCT01153425|3850718|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029080|NCT01153425|3850716|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4029081|NCT01153425|3850717|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4029082|NCT01153425|3850718|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4029083|NCT01153425|3850716|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029084|NCT01153425|3850717|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029085|NCT01153425|3850718|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029086|NCT01153425|3850716|B3||Male|Sex: Female, Male|Post menopausal females|Participants|Count of Participants|0|0.0||||||
4029087|NCT01153425|3850717|B2||Male|Sex: Female, Male|Post menopausal females|Participants|Count of Participants|0|0.0||||||
4029088|NCT01153425|3850718|B1||Male|Sex: Female, Male|Post menopausal females|Participants|Count of Participants|0|0.0||||||
4029089|NCT01153425|3850716|B3||Female|Sex: Female, Male|Post menopausal females|Participants|Count of Participants|33|33.0||||||
4029090|NCT01153425|3850717|B2||Female|Sex: Female, Male|Post menopausal females|Participants|Count of Participants|17|17.0||||||
4029091|NCT01153425|3850718|B1||Female|Sex: Female, Male|Post menopausal females|Participants|Count of Participants|16|16.0||||||
4029092|NCT01153425|3850716|B3|||Age||years|Mean|67.94|67.94|Full Range|||58.0|84.0|
4029093|NCT01153425|3850717|B2|||Age||years|Mean|66.22|66.22|Full Range|||58.0|84.0|
4029094|NCT01153425|3850718|B1|||Age||years|Mean|69.55|69.55|Full Range|||58.0|84.0|
4029095|NCT01153347|3850727|B5|||Montgomery-Asberg Depression Rating Scale (MADRS) total score at randomization|A 10-item scale for the evaluation of depressive symptoms. Each MADRS item is rated on a 0 to 6 scale. The MADRS total score is calculated as the sum of the 10 individual item scores; the total score can range from 0 to 60. Higher MADRS scores indicate higher levels of depressive symptoms.|Scores on a scale|Mean|26.75|26.75|Standard Deviation|6.261|6.261|||
4029096|NCT01153347|3850728|B4|||Montgomery-Asberg Depression Rating Scale (MADRS) total score at randomization|A 10-item scale for the evaluation of depressive symptoms. Each MADRS item is rated on a 0 to 6 scale. The MADRS total score is calculated as the sum of the 10 individual item scores; the total score can range from 0 to 60. Higher MADRS scores indicate higher levels of depressive symptoms.|Scores on a scale|Mean|26.70|26.7|Standard Deviation|6.809|6.809|||
4029097|NCT01153347|3850729|B3|||Montgomery-Asberg Depression Rating Scale (MADRS) total score at randomization|A 10-item scale for the evaluation of depressive symptoms. Each MADRS item is rated on a 0 to 6 scale. The MADRS total score is calculated as the sum of the 10 individual item scores; the total score can range from 0 to 60. Higher MADRS scores indicate higher levels of depressive symptoms.|Scores on a scale|Mean|27.06|27.06|Standard Deviation|5.854|5.854|||
4029098|NCT01153347|3850730|B2|||Montgomery-Asberg Depression Rating Scale (MADRS) total score at randomization|A 10-item scale for the evaluation of depressive symptoms. Each MADRS item is rated on a 0 to 6 scale. The MADRS total score is calculated as the sum of the 10 individual item scores; the total score can range from 0 to 60. Higher MADRS scores indicate higher levels of depressive symptoms.|Scores on a scale|Mean|26.37|26.37|Standard Deviation|6.036|6.036|||
4029099|NCT01153347|3850731|B1|||Montgomery-Asberg Depression Rating Scale (MADRS) total score at randomization|A 10-item scale for the evaluation of depressive symptoms. Each MADRS item is rated on a 0 to 6 scale. The MADRS total score is calculated as the sum of the 10 individual item scores; the total score can range from 0 to 60. Higher MADRS scores indicate higher levels of depressive symptoms.|Scores on a scale|Mean|26.86|26.86|Standard Deviation|6.331|6.331|||
4029100|NCT01153347|3850727|B5|||Hamilton Rating Scale for Depression-17 items (HAMD-17) total score at randomization|A 17-item, clinician-rated scale that assesses depressive symptoms. The HAMD-17 consists of 17 symptoms, each of which is rated from 0 to 2 or 0 to 4, where 0 is none/absent. The HAMD-17 total score is calculated as the sum of the 17 individual symptom scores; the total score can range from 0 to 52. Higher HAMD-17 scores indicate more severe depression.|Scores on a scale|Mean|22.0|22.0|Standard Deviation|3.97|3.97|||
4029147|NCT01153347|3850729|B3|||Age||years|Mean|42.1|42.1|Standard Deviation|11.35|11.35|||
4029101|NCT01153347|3850728|B4|||Hamilton Rating Scale for Depression-17 items (HAMD-17) total score at randomization|A 17-item, clinician-rated scale that assesses depressive symptoms. The HAMD-17 consists of 17 symptoms, each of which is rated from 0 to 2 or 0 to 4, where 0 is none/absent. The HAMD-17 total score is calculated as the sum of the 17 individual symptom scores; the total score can range from 0 to 52. Higher HAMD-17 scores indicate more severe depression.|Scores on a scale|Mean|22.1|22.1|Standard Deviation|4.08|4.08|||
4029102|NCT01153347|3850729|B3|||Hamilton Rating Scale for Depression-17 items (HAMD-17) total score at randomization|A 17-item, clinician-rated scale that assesses depressive symptoms. The HAMD-17 consists of 17 symptoms, each of which is rated from 0 to 2 or 0 to 4, where 0 is none/absent. The HAMD-17 total score is calculated as the sum of the 17 individual symptom scores; the total score can range from 0 to 52. Higher HAMD-17 scores indicate more severe depression.|Scores on a scale|Mean|22.0|22.0|Standard Deviation|4.07|4.07|||
4029103|NCT01153347|3850730|B2|||Hamilton Rating Scale for Depression-17 items (HAMD-17) total score at randomization|A 17-item, clinician-rated scale that assesses depressive symptoms. The HAMD-17 consists of 17 symptoms, each of which is rated from 0 to 2 or 0 to 4, where 0 is none/absent. The HAMD-17 total score is calculated as the sum of the 17 individual symptom scores; the total score can range from 0 to 52. Higher HAMD-17 scores indicate more severe depression.|Scores on a scale|Mean|21.5|21.5|Standard Deviation|3.74|3.74|||
4029104|NCT01153347|3850731|B1|||Hamilton Rating Scale for Depression-17 items (HAMD-17) total score at randomization|A 17-item, clinician-rated scale that assesses depressive symptoms. The HAMD-17 consists of 17 symptoms, each of which is rated from 0 to 2 or 0 to 4, where 0 is none/absent. The HAMD-17 total score is calculated as the sum of the 17 individual symptom scores; the total score can range from 0 to 52. Higher HAMD-17 scores indicate more severe depression.|Scores on a scale|Mean|22.3|22.3|Standard Deviation|3.98|3.98|||
4029105|NCT01153347|3850727|B5|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4029106|NCT01153347|3850728|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4029107|NCT01153347|3850729|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4029108|NCT01153347|3850730|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4029109|NCT01153347|3850731|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4029110|NCT01153347|3850727|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4029111|NCT01153347|3850728|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4029112|NCT01153347|3850729|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4029113|NCT01153347|3850730|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4029114|NCT01153347|3850731|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4029115|NCT01153347|3850727|B5|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4029116|NCT01153347|3850728|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4029117|NCT01153347|3850729|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4029118|NCT01153347|3850730|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4029119|NCT01153347|3850731|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4029120|NCT01153347|3850727|B5|Asian||Race/Ethnicity, Customized||participants|Number|167|167.0||||||
4029121|NCT01153347|3850728|B4|Asian||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4029122|NCT01153347|3850729|B3|Asian||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4029123|NCT01153347|3850730|B2|Asian||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4029124|NCT01153347|3850731|B1|Asian||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
4029125|NCT01153347|3850727|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|84|84.0||||||
4029126|NCT01153347|3850728|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4029127|NCT01153347|3850729|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4029128|NCT01153347|3850730|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4029129|NCT01153347|3850731|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4029130|NCT01153347|3850727|B5|White||Race/Ethnicity, Customized||participants|Number|381|381.0||||||
4029131|NCT01153347|3850728|B4|White||Race/Ethnicity, Customized||participants|Number|103|103.0||||||
4029132|NCT01153347|3850729|B3|White||Race/Ethnicity, Customized||participants|Number|91|91.0||||||
4029133|NCT01153347|3850730|B2|White||Race/Ethnicity, Customized||participants|Number|100|100.0||||||
4029134|NCT01153347|3850731|B1|White||Race/Ethnicity, Customized||participants|Number|87|87.0||||||
4029135|NCT01153347|3850727|B5||Male|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
4029136|NCT01153347|3850728|B4||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4029137|NCT01153347|3850729|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4029138|NCT01153347|3850730|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4029139|NCT01153347|3850731|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4029140|NCT01153347|3850727|B5||Female|Sex: Female, Male||Participants|Count of Participants|365|365.0||||||
4029141|NCT01153347|3850728|B4||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4029142|NCT01153347|3850729|B3||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4029143|NCT01153347|3850730|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4029144|NCT01153347|3850731|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4029145|NCT01153347|3850727|B5|||Age||years|Mean|42.0|42.0|Standard Deviation|11.72|11.72|||
4029146|NCT01153347|3850728|B4|||Age||years|Mean|43.2|43.2|Standard Deviation|11.92|11.92|||
4029148|NCT01153347|3850730|B2|||Age||years|Mean|42.1|42.1|Standard Deviation|11.77|11.77|||
4029149|NCT01153347|3850731|B1|||Age||years|Mean|40.6|40.6|Standard Deviation|11.78|11.78|||
4029150|NCT01153321|3850832|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4029151|NCT01153321|3850833|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4029152|NCT01153321|3850834|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4029153|NCT01153321|3850832|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4029154|NCT01153321|3850833|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4029155|NCT01153321|3850834|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4029156|NCT01153321|3850832|B3|||Age||Years|Mean|53|53.0|Standard Deviation|7.9|7.9|||
4029157|NCT01153321|3850833|B2|||Age||Years|Mean|54.1|54.1|Standard Deviation|8.1|8.1|||
4029158|NCT01153321|3850834|B1|||Age||Years|Mean|51.8|51.8|Standard Deviation|7.6|7.6|||
4029159|NCT01153269|3850947|B1|||Duration of HIV infection|How long participants had been diagnosed with HIV infection at Baseline. Based on 32 participants.|years|Mean|9.7|9.7|Standard Deviation|7.4|7.4|||
4029160|NCT01153269|3850947|B1|Chronic hepatitis C||Hepatitis Co-infection|The number of participants with hepatitis B or hepatitis C co-infection.|participants|Number|24|24.0||||||
4029161|NCT01153269|3850947|B1|Chronic hepatitis B||Hepatitis Co-infection|The number of participants with hepatitis B or hepatitis C co-infection.|participants|Number|9|9.0||||||
4029162|NCT01153269|3850947|B1|Germany||Region of Enrollment||participants|Number|33|33.0||||||
4029163|NCT01153269|3850947|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4029164|NCT01153269|3850947|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4029165|NCT01153269|3850947|B1|||Age||years|Mean|42.4|42.4|Standard Deviation|7.1|7.1|||
4029166|NCT01153009|3851006|B5|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|scores on a scale|Mean|4.5|4.5|Standard Deviation|0.58|0.58|||
4029167|NCT01153009|3851007|B4|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|scores on a scale|Mean|4.5|4.5|Standard Deviation|0.60|0.6|||
4029168|NCT01153009|3851008|B3|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|scores on a scale|Mean|4.5|4.5|Standard Deviation|0.60|0.6|||
4029169|NCT01153009|3851009|B2|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|scores on a scale|Mean|4.5|4.5|Standard Deviation|0.55|0.55|||
4029170|NCT01153009|3851010|B1|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|scores on a scale|Mean|4.6|4.6|Standard Deviation|0.58|0.58|||
4029171|NCT01153009|3851006|B5|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 (absent) to 56 (maximum severity).|scores on a scale|Mean|17.7|17.7|Standard Deviation|5.42|5.42|||
4029172|NCT01153009|3851007|B4|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 (absent) to 56 (maximum severity).|scores on a scale|Mean|18.4|18.4|Standard Deviation|5.81|5.81|||
4029173|NCT01153009|3851008|B3|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 (absent) to 56 (maximum severity).|scores on a scale|Mean|17.8|17.8|Standard Deviation|5.42|5.42|||
4029174|NCT01153009|3851009|B2|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 (absent) to 56 (maximum severity).|scores on a scale|Mean|17.5|17.5|Standard Deviation|5.28|5.28|||
4029175|NCT01153009|3851010|B1|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 (absent) to 56 (maximum severity).|scores on a scale|Mean|17.0|17.0|Standard Deviation|5.12|5.12|||
4029176|NCT01153009|3851006|B5|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|32.1|32.1|Standard Deviation|4.27|4.27|||
4029177|NCT01153009|3851007|B4|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|32.9|32.9|Standard Deviation|4.39|4.39|||
4029178|NCT01153009|3851008|B3|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|32.0|32.0|Standard Deviation|4.36|4.36|||
4029179|NCT01153009|3851009|B2|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|31.9|31.9|Standard Deviation|4.08|4.08|||
4029180|NCT01153009|3851010|B1|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|31.6|31.6|Standard Deviation|4.18|4.18|||
4029181|NCT01153009|3851006|B5|Daily||Alcohol consumption||participants|Number|7|7.0||||||
4029182|NCT01153009|3851007|B4|Daily||Alcohol consumption||participants|Number|0|0.0||||||
4029183|NCT01153009|3851008|B3|Daily||Alcohol consumption||participants|Number|3|3.0||||||
4029184|NCT01153009|3851009|B2|Daily||Alcohol consumption||participants|Number|2|2.0||||||
4029185|NCT01153009|3851010|B1|Daily||Alcohol consumption||participants|Number|2|2.0||||||
4029186|NCT01153009|3851006|B5|2 to 6 times per week||Alcohol consumption||participants|Number|70|70.0||||||
4029187|NCT01153009|3851007|B4|2 to 6 times per week||Alcohol consumption||participants|Number|14|14.0||||||
4029188|NCT01153009|3851008|B3|2 to 6 times per week||Alcohol consumption||participants|Number|21|21.0||||||
4029189|NCT01153009|3851009|B2|2 to 6 times per week||Alcohol consumption||participants|Number|19|19.0||||||
4029190|NCT01153009|3851010|B1|2 to 6 times per week||Alcohol consumption||participants|Number|16|16.0||||||
4029191|NCT01153009|3851006|B5|Once per week||Alcohol consumption||participants|Number|88|88.0||||||
4029192|NCT01153009|3851007|B4|Once per week||Alcohol consumption||participants|Number|17|17.0||||||
4029193|NCT01153009|3851008|B3|Once per week||Alcohol consumption||participants|Number|24|24.0||||||
4029194|NCT01153009|3851009|B2|Once per week||Alcohol consumption||participants|Number|23|23.0||||||
4029195|NCT01153009|3851010|B1|Once per week||Alcohol consumption||participants|Number|24|24.0||||||
4029196|NCT01153009|3851006|B5|Once monthly or less often||Alcohol consumption||participants|Number|212|212.0||||||
4029197|NCT01153009|3851007|B4|Once monthly or less often||Alcohol consumption||participants|Number|54|54.0||||||
4029198|NCT01153009|3851008|B3|Once monthly or less often||Alcohol consumption||participants|Number|45|45.0||||||
4029199|NCT01153009|3851009|B2|Once monthly or less often||Alcohol consumption||participants|Number|55|55.0||||||
4029200|NCT01153009|3851010|B1|Once monthly or less often||Alcohol consumption||participants|Number|58|58.0||||||
4029201|NCT01153009|3851006|B5|Never||Alcohol consumption||participants|Number|237|237.0||||||
4029202|NCT01153009|3851007|B4|Never||Alcohol consumption||participants|Number|67|67.0||||||
4029203|NCT01153009|3851008|B3|Never||Alcohol consumption||participants|Number|61|61.0||||||
4029204|NCT01153009|3851009|B2|Never||Alcohol consumption||participants|Number|48|48.0||||||
4029205|NCT01153009|3851010|B1|Never||Alcohol consumption||participants|Number|61|61.0||||||
4029206|NCT01153009|3851006|B5|Ex-smoker||Smoking classification||participants|Number|141|141.0||||||
4029207|NCT01153009|3851007|B4|Ex-smoker||Smoking classification||participants|Number|38|38.0||||||
4029208|NCT01153009|3851008|B3|Ex-smoker||Smoking classification||participants|Number|40|40.0||||||
4029209|NCT01153009|3851009|B2|Ex-smoker||Smoking classification||participants|Number|30|30.0||||||
4029210|NCT01153009|3851010|B1|Ex-smoker||Smoking classification||participants|Number|33|33.0||||||
4029211|NCT01153009|3851006|B5|Current smoker||Smoking classification||participants|Number|164|164.0||||||
4029212|NCT01153009|3851007|B4|Current smoker||Smoking classification||participants|Number|39|39.0||||||
4029213|NCT01153009|3851008|B3|Current smoker||Smoking classification||participants|Number|41|41.0||||||
4029214|NCT01153009|3851009|B2|Current smoker||Smoking classification||participants|Number|38|38.0||||||
4029215|NCT01153009|3851010|B1|Current smoker||Smoking classification||participants|Number|46|46.0||||||
4029216|NCT01153009|3851006|B5|Never smoked||Smoking classification||participants|Number|309|309.0||||||
4029217|NCT01153009|3851007|B4|Never smoked||Smoking classification||participants|Number|75|75.0||||||
4029218|NCT01153009|3851008|B3|Never smoked||Smoking classification||participants|Number|73|73.0||||||
4029219|NCT01153009|3851009|B2|Never smoked||Smoking classification||participants|Number|79|79.0||||||
4029220|NCT01153009|3851010|B1|Never smoked||Smoking classification||participants|Number|82|82.0||||||
4029221|NCT01153009|3851006|B5|||Waist circumference||cm|Mean|97.47|97.47|Standard Deviation|17.678|17.678|||
4029222|NCT01153009|3851007|B4|||Waist circumference||cm|Mean|97.73|97.73|Standard Deviation|17.971|17.971|||
4029223|NCT01153009|3851008|B3|||Waist circumference||cm|Mean|96.47|96.47|Standard Deviation|18.301|18.301|||
4029224|NCT01153009|3851009|B2|||Waist circumference||cm|Mean|96.86|96.86|Standard Deviation|16.116|16.116|||
4029225|NCT01153009|3851010|B1|||Waist circumference||cm|Mean|98.73|98.73|Standard Deviation|18.232|18.232|||
4029226|NCT01153009|3851006|B5|||Body Mass Index (BMI)||kg/m^2|Mean|31.20|31.2|Standard Deviation|7.855|7.855|||
4029227|NCT01153009|3851007|B4|||Body Mass Index (BMI)||kg/m^2|Mean|31.49|31.49|Standard Deviation|8.448|8.448|||
4029228|NCT01153009|3851008|B3|||Body Mass Index (BMI)||kg/m^2|Mean|30.92|30.92|Standard Deviation|7.633|7.633|||
4029229|NCT01153009|3851009|B2|||Body Mass Index (BMI)||kg/m^2|Mean|31.26|31.26|Standard Deviation|7.476|7.476|||
4029230|NCT01153009|3851010|B1|||Body Mass Index (BMI)||kg/m^2|Mean|31.13|31.13|Standard Deviation|7.882|7.882|||
4029231|NCT01153009|3851006|B5|||Weight||kg|Mean|87.67|87.67|Standard Deviation|23.574|23.574|||
4029232|NCT01153009|3851007|B4|||Weight||kg|Mean|87.16|87.16|Standard Deviation|24.196|24.196|||
4029233|NCT01153009|3851008|B3|||Weight||kg|Mean|87.44|87.44|Standard Deviation|23.806|23.806|||
4029234|NCT01153009|3851009|B2|||Weight||kg|Mean|87.42|87.42|Standard Deviation|21.431|21.431|||
4029235|NCT01153009|3851010|B1|||Weight||kg|Mean|88.61|88.61|Standard Deviation|24.786|24.786|||
4029236|NCT01153009|3851006|B5|||Height||cm|Mean|167.55|167.55|Standard Deviation|9.395|9.395|||
4029237|NCT01153009|3851007|B4|||Height||cm|Mean|166.40|166.4|Standard Deviation|9.851|9.851|||
4029238|NCT01153009|3851008|B3|||Height||cm|Mean|168.03|168.03|Standard Deviation|9.530|9.53|||
4029239|NCT01153009|3851009|B2|||Height||cm|Mean|167.23|167.23|Standard Deviation|8.254|8.254|||
4029240|NCT01153009|3851010|B1|||Height||cm|Mean|168.46|168.46|Standard Deviation|9.757|9.757|||
4029241|NCT01153009|3851006|B5|United States||Region of Enrollment||participants|Number|614|614.0||||||
4029242|NCT01153009|3851007|B4|United States||Region of Enrollment||participants|Number|152|152.0||||||
4029243|NCT01153009|3851008|B3|United States||Region of Enrollment||participants|Number|154|154.0||||||
4029244|NCT01153009|3851009|B2|United States||Region of Enrollment||participants|Number|147|147.0||||||
4029245|NCT01153009|3851010|B1|United States||Region of Enrollment||participants|Number|161|161.0||||||
4029246|NCT01153009|3851006|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4029247|NCT01153009|3851007|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4029248|NCT01153009|3851008|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4029249|NCT01153009|3851009|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4029250|NCT01153009|3851010|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4029251|NCT01153009|3851006|B5|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4029252|NCT01153009|3851007|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4029253|NCT01153009|3851008|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4029254|NCT01153009|3851009|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4029255|NCT01153009|3851010|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4029256|NCT01153009|3851006|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4029257|NCT01153009|3851007|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4029258|NCT01153009|3851008|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4029259|NCT01153009|3851009|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4029260|NCT01153009|3851010|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4029261|NCT01153009|3851006|B5|Black||Race/Ethnicity, Customized||participants|Number|136|136.0||||||
4029262|NCT01153009|3851007|B4|Black||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4029263|NCT01153009|3851008|B3|Black||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4029264|NCT01153009|3851009|B2|Black||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4029265|NCT01153009|3851010|B1|Black||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4029266|NCT01153009|3851006|B5|Caucasian (or White, including Hispanic)||Race/Ethnicity, Customized||participants|Number|470|470.0||||||
4029267|NCT01153009|3851007|B4|Caucasian (or White, including Hispanic)||Race/Ethnicity, Customized||participants|Number|119|119.0||||||
4029268|NCT01153009|3851008|B3|Caucasian (or White, including Hispanic)||Race/Ethnicity, Customized||participants|Number|115|115.0||||||
4029269|NCT01153009|3851009|B2|Caucasian (or White, including Hispanic)||Race/Ethnicity, Customized||participants|Number|114|114.0||||||
4029270|NCT01153009|3851010|B1|Caucasian (or White, including Hispanic)||Race/Ethnicity, Customized||participants|Number|122|122.0||||||
4029271|NCT01153009|3851006|B5|Non-Hispanic and non-Latino||Race/Ethnicity, Customized||participants|Number|535|535.0||||||
4029272|NCT01153009|3851007|B4|Non-Hispanic and non-Latino||Race/Ethnicity, Customized||participants|Number|129|129.0||||||
4029273|NCT01153009|3851008|B3|Non-Hispanic and non-Latino||Race/Ethnicity, Customized||participants|Number|136|136.0||||||
4029274|NCT01153009|3851009|B2|Non-Hispanic and non-Latino||Race/Ethnicity, Customized||participants|Number|127|127.0||||||
4029275|NCT01153009|3851010|B1|Non-Hispanic and non-Latino||Race/Ethnicity, Customized||participants|Number|143|143.0||||||
4029276|NCT01153009|3851006|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
4029277|NCT01153009|3851007|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4029278|NCT01153009|3851008|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4029279|NCT01153009|3851009|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4029280|NCT01153009|3851010|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4029281|NCT01153009|3851006|B5||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4029282|NCT01153009|3851007|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4029283|NCT01153009|3851008|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4029284|NCT01153009|3851009|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4029285|NCT01153009|3851010|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4029286|NCT01153009|3851006|B5||Female|Sex: Female, Male||Participants|Count of Participants|453|453.0||||||
4029287|NCT01153009|3851007|B4||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4029288|NCT01153009|3851008|B3||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4029289|NCT01153009|3851009|B2||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4029290|NCT01153009|3851010|B1||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4029291|NCT01153009|3851006|B5|>55 years||Age, Customized||participants|Number|93|93.0||||||
4029292|NCT01153009|3851007|B4|>55 years||Age, Customized||participants|Number|26|26.0||||||
4029293|NCT01153009|3851008|B3|>55 years||Age, Customized||participants|Number|22|22.0||||||
4029294|NCT01153009|3851009|B2|>55 years||Age, Customized||participants|Number|22|22.0||||||
4029295|NCT01153009|3851010|B1|>55 years||Age, Customized||participants|Number|23|23.0||||||
4029296|NCT01153009|3851006|B5|≤55 years||Age, Customized||participants|Number|521|521.0||||||
4029297|NCT01153009|3851007|B4|≤55 years||Age, Customized||participants|Number|126|126.0||||||
4029298|NCT01153009|3851008|B3|≤55 years||Age, Customized||participants|Number|132|132.0||||||
4029299|NCT01153009|3851009|B2|≤55 years||Age, Customized||participants|Number|125|125.0||||||
4029300|NCT01153009|3851010|B1|≤55 years||Age, Customized||participants|Number|138|138.0||||||
4029301|NCT01153009|3851006|B5|||Age||years|Mean|42.9|42.9|Standard Deviation|12.35|12.35|||
4029302|NCT01153009|3851007|B4|||Age||years|Mean|43.4|43.4|Standard Deviation|12.24|12.24|||
4029303|NCT01153009|3851008|B3|||Age||years|Mean|42.8|42.8|Standard Deviation|12.40|12.4|||
4029304|NCT01153009|3851009|B2|||Age||years|Mean|43.1|43.1|Standard Deviation|12.28|12.28|||
4029305|NCT01153009|3851010|B1|||Age||years|Mean|42.4|42.4|Standard Deviation|12.55|12.55|||
4029306|NCT01152996|3851043|B1|||Clinical Global Impression - Severity scale (CGI-S) score|"The CGI-S assesses the clinician’s impression of the subject’s current state of mental illness and consists of one question for the investigator: Considering your total clinical experience with this particular population, how mentally ill is the patient at this time? which is rated on a seven-point scale (1=normal, not ill at all; 2=borderline mentally ill; 3=mildly ill; 4=moderately ill; 5=markedly ill; 6=severely ill). Higher scores indicate greater severity of illness."|scores on a scale|Mean|3.3|3.3|Standard Deviation|1.21|1.21|||
4029307|NCT01152996|3851043|B1|||Hamilton Anxiety Scale (HAM-A) total score|HAM-A is a 14 item rating scale to quantify anxiety symptomatology severity (i.e., anxious mood, tension, fear, insomnia, etc.) rated on a 5-point scale from 0 (not present) to 4 (severe) with a total score range from 0 to 56. Higher scores indicate greater severity of symptoms.|scores on a scale|Mean|11.6|11.6|Standard Deviation|6.65|6.65|||
4029308|NCT01152996|3851043|B1|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|MADRS is a 10-item clinician rated scale to measure overall severity of depressive symptoms (i.e., apparent sadness, reported sadness, inner tension, etc.) rated on a 7-point Likert scale from 0 (normal) to 6 (most abnormal) with a total score range from 0 to 60. Higher scores indicate greater severity of symptoms.|scores on a scale|Mean|20.0|20.0|Standard Deviation|10.70|10.7|||
4029309|NCT01152996|3851043|B1|||Height||cm|Mean|167.44|167.44|Standard Deviation|9.456|9.456|||
4029310|NCT01152996|3851043|B1|||Body Mass Index (BMI)||kg/m^2|Mean|31.60|31.6|Standard Deviation|8.061|8.061|||
4029311|NCT01152996|3851043|B1|||Weight||kg)|Mean|88.77|88.77|Standard Deviation|24.160|24.16|||
4029312|NCT01152996|3851043|B1|Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||participants|Number|971|971.0||||||
4029313|NCT01152996|3851043|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|104|104.0||||||
4029314|NCT01152996|3851043|B1|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4029315|NCT01152996|3851043|B1|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4029316|NCT01152996|3851043|B1|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4029317|NCT01152996|3851043|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|249|249.0||||||
4029318|NCT01152996|3851043|B1|Caucasian (or White, including Hispanic)||Race/Ethnicity, Customized||participants|Number|813|813.0||||||
4029319|NCT01152996|3851043|B1||Male|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
4029320|NCT01152996|3851043|B1||Female|Sex: Female, Male||Participants|Count of Participants|790|790.0||||||
4029321|NCT01152996|3851043|B1|||Age||years|Mean|44.5|44.5|Standard Deviation|12.05|12.05|||
4029322|NCT01152814|3851056|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4029323|NCT01152814|3851056|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4029324|NCT01152814|3851056|B1|||Age||Years|Mean|73.3|73.3|Standard Deviation|5.1|5.1|||
4029325|NCT01152788|3851063|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4029326|NCT01152788|3851064|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4029327|NCT01152788|3851065|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4029328|NCT01152788|3851063|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4029329|NCT01152788|3851064|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4029330|NCT01152788|3851065|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4029331|NCT01152788|3851063|B3|||Age||years|Median|62|62.0|Full Range|||29.0|94.0|
4029332|NCT01152788|3851064|B2|||Age||years|Median|65|65.0|Full Range|||31.0|81.0|
4029333|NCT01152788|3851065|B1|||Age||years|Median|60|60.0|Full Range|||29.0|94.0|
4029334|NCT01152697|3851078|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4029335|NCT01152697|3851078|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4029336|NCT01152697|3851078|B1|||Age||years|Mean|41.77|41.77|Standard Deviation|8.59|8.59|||
4029337|NCT01152580|3851101|B3|||Body Mass Index (BMI)||kg/m^2|Mean|24.6|24.6|Standard Deviation|4.0|4.0|||
4029338|NCT01152580|3851102|B2|||Body Mass Index (BMI)||kg/m^2|Mean|25.7|25.7|Standard Deviation|3.7|3.7|||
4029339|NCT01152580|3851103|B1|||Body Mass Index (BMI)||kg/m^2|Mean|21.7|21.7|Standard Deviation|3.5|3.5|||
4029340|NCT01152580|3851101|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4029341|NCT01152580|3851102|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4029342|NCT01152580|3851103|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4029343|NCT01152580|3851101|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029344|NCT01152580|3851102|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029345|NCT01152580|3851103|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029346|NCT01152580|3851101|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4029347|NCT01152580|3851102|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4029348|NCT01152580|3851103|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4029349|NCT01152580|3851101|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029350|NCT01152580|3851102|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029351|NCT01152580|3851103|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029352|NCT01152580|3851101|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4029353|NCT01152580|3851102|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4029354|NCT01152580|3851103|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4029355|NCT01152580|3851101|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4029356|NCT01152580|3851102|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4029357|NCT01152580|3851103|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4029358|NCT01152580|3851101|B3|||Age||years|Mean|49.5|49.5|Standard Deviation|3.0|3.0|||
4029359|NCT01152580|3851102|B2|||Age||years|Mean|50.3|50.3|Standard Deviation|3|3.0|||
4029360|NCT01152580|3851103|B1|||Age||years|Mean|47.5|47.5|Standard Deviation|2.0|2.0|||
4029361|NCT01152580|3851101|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4029362|NCT01152580|3851102|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4029363|NCT01152580|3851103|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4029364|NCT01152580|3851101|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4029365|NCT01152580|3851102|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4029366|NCT01152580|3851103|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4029367|NCT01152580|3851101|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4029368|NCT01152580|3851102|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4029369|NCT01152580|3851103|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4029370|NCT01152554|3851124|B3|||Montgomery-Asberg Depression Rating Scale (MADRS) total score at randomization|A 10-item scale for the evaluation of depressive symptoms. Each MADRS item is rated on a 0 to 6 scale. The MADRS total score is calculated as the sum of the 10 individual item scores; the total score can range from 0 to 60. Higher MADRS scores indicate higher levels of depressive symptoms.|Scores on a scale|Mean|23.4|23.4|Standard Deviation|6.21|6.21|||
4029371|NCT01152554|3851125|B2|||Montgomery-Asberg Depression Rating Scale (MADRS) total score at randomization|A 10-item scale for the evaluation of depressive symptoms. Each MADRS item is rated on a 0 to 6 scale. The MADRS total score is calculated as the sum of the 10 individual item scores; the total score can range from 0 to 60. Higher MADRS scores indicate higher levels of depressive symptoms.|Scores on a scale|Mean|23.4|23.4|Standard Deviation|5.85|5.85|||
4029372|NCT01152554|3851126|B1|||Montgomery-Asberg Depression Rating Scale (MADRS) total score at randomization|A 10-item scale for the evaluation of depressive symptoms. Each MADRS item is rated on a 0 to 6 scale. The MADRS total score is calculated as the sum of the 10 individual item scores; the total score can range from 0 to 60. Higher MADRS scores indicate higher levels of depressive symptoms.|Scores on a scale|Mean|23.5|23.5|Standard Deviation|6.34|6.34|||
4029373|NCT01152554|3851124|B3|||Hamilton Rating Scale for Depression-17 items (HAMD-17) total score at randomization|A 17-item, clinician-rated scale that assesses depressive symptoms. The HAMD-17 consists of 17 symptoms, each of which is rated from 0 to 2 or 0 to 4, where 0 is none/absent. The HAMD-17 total score is calculated as the sum of the 17 individual symptom scores; the total score can range from 0 to 52. Higher HAMD-17 scores indicate more severe depression.|Scores on a scale|Mean|18.5|18.5|Standard Deviation|4.52|4.52|||
4029374|NCT01152554|3851125|B2|||Hamilton Rating Scale for Depression-17 items (HAMD-17) total score at randomization|A 17-item, clinician-rated scale that assesses depressive symptoms. The HAMD-17 consists of 17 symptoms, each of which is rated from 0 to 2 or 0 to 4, where 0 is none/absent. The HAMD-17 total score is calculated as the sum of the 17 individual symptom scores; the total score can range from 0 to 52. Higher HAMD-17 scores indicate more severe depression.|Scores on a scale|Mean|18.6|18.6|Standard Deviation|4.61|4.61|||
4029433|NCT01152359|3851288|B3|United States||Region of Enrollment||participants|Number|207|207.0||||||
4029434|NCT01152359|3851289|B2|United States||Region of Enrollment||participants|Number|102|102.0||||||
4029375|NCT01152554|3851126|B1|||Hamilton Rating Scale for Depression-17 items (HAMD-17) total score at randomization|A 17-item, clinician-rated scale that assesses depressive symptoms. The HAMD-17 consists of 17 symptoms, each of which is rated from 0 to 2 or 0 to 4, where 0 is none/absent. The HAMD-17 total score is calculated as the sum of the 17 individual symptom scores; the total score can range from 0 to 52. Higher HAMD-17 scores indicate more severe depression.|Scores on a scale|Mean|18.4|18.4|Standard Deviation|4.49|4.49|||
4029376|NCT01152554|3851124|B3|Other||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4029377|NCT01152554|3851125|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4029378|NCT01152554|3851126|B1|Other||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4029379|NCT01152554|3851124|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4029380|NCT01152554|3851125|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4029381|NCT01152554|3851126|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4029382|NCT01152554|3851124|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4029383|NCT01152554|3851125|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4029384|NCT01152554|3851126|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4029385|NCT01152554|3851124|B3|Asian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4029386|NCT01152554|3851125|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4029387|NCT01152554|3851126|B1|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4029388|NCT01152554|3851124|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|165|165.0||||||
4029389|NCT01152554|3851125|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4029390|NCT01152554|3851126|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|121|121.0||||||
4029391|NCT01152554|3851124|B3|White||Race/Ethnicity, Customized||participants|Number|616|616.0||||||
4029392|NCT01152554|3851125|B2|White||Race/Ethnicity, Customized||participants|Number|149|149.0||||||
4029393|NCT01152554|3851126|B1|White||Race/Ethnicity, Customized||participants|Number|467|467.0||||||
4029394|NCT01152554|3851124|B3||Male|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
4029395|NCT01152554|3851125|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4029396|NCT01152554|3851126|B1||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4029397|NCT01152554|3851124|B3||Female|Sex: Female, Male||Participants|Count of Participants|566|566.0||||||
4029398|NCT01152554|3851125|B2||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4029399|NCT01152554|3851126|B1||Female|Sex: Female, Male||Participants|Count of Participants|418|418.0||||||
4029400|NCT01152554|3851124|B3|||Age||years|Mean|43.1|43.1|Standard Deviation|11.69|11.69|||
4029401|NCT01152554|3851125|B2|||Age||years|Mean|42.8|42.8|Standard Deviation|11.75|11.75|||
4029402|NCT01152554|3851126|B1|||Age||years|Mean|43.2|43.2|Standard Deviation|11.68|11.68|||
4029403|NCT01152450|3851149|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4029404|NCT01152450|3851149|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4029405|NCT01152450|3851149|B1|||Age||Years|Mean|44.3|44.3|Standard Deviation|13.2|13.2|||
4029406|NCT01152437|3851222|B4||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4029407|NCT01152437|3851223|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4029408|NCT01152437|3851224|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4029409|NCT01152437|3851225|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4029410|NCT01152437|3851222|B4||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4029411|NCT01152437|3851223|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4029412|NCT01152437|3851224|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4029413|NCT01152437|3851225|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4029414|NCT01152437|3851222|B4|||Age||years|Mean|61.4|61.4|Standard Deviation|10.8|10.8|||
4029415|NCT01152437|3851223|B3|||Age||years|Mean|60.0|60.0|Standard Deviation|11.9|11.9|||
4029416|NCT01152437|3851224|B2|||Age||years|Mean|62.6|62.6|Standard Deviation|7.7|7.7|||
4029417|NCT01152437|3851225|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|10.4|10.4|||
4029418|NCT01152385|3851243|B5||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4029419|NCT01152385|3851244|B4||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4029420|NCT01152385|3851245|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4029421|NCT01152385|3851246|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4029422|NCT01152385|3851247|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4029423|NCT01152385|3851243|B5||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4029424|NCT01152385|3851244|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4029425|NCT01152385|3851245|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4029426|NCT01152385|3851246|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4029427|NCT01152385|3851247|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4029428|NCT01152385|3851243|B5|||Age||Years|Mean|56|56.0|Standard Deviation|9|9.0|||
4029429|NCT01152385|3851244|B4|||Age||Years|Mean|57|57.0|Standard Deviation|9|9.0|||
4029430|NCT01152385|3851245|B3|||Age||Years|Mean|55|55.0|Standard Deviation|10|10.0|||
4029431|NCT01152385|3851246|B2|||Age||Years|Mean|55|55.0|Standard Deviation|9|9.0|||
4029432|NCT01152385|3851247|B1|||Age||Years|Mean|57|57.0|Standard Deviation|9|9.0|||
4029435|NCT01152359|3851290|B1|United States||Region of Enrollment||participants|Number|105|105.0||||||
4029436|NCT01152359|3851288|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4029437|NCT01152359|3851289|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4029438|NCT01152359|3851290|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4029439|NCT01152359|3851288|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029440|NCT01152359|3851289|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029441|NCT01152359|3851290|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029442|NCT01152359|3851288|B3||White|Race (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
4029443|NCT01152359|3851289|B2||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4029444|NCT01152359|3851290|B1||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4029445|NCT01152359|3851288|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
4029446|NCT01152359|3851289|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4029447|NCT01152359|3851290|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4029448|NCT01152359|3851288|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029449|NCT01152359|3851289|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029450|NCT01152359|3851290|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029451|NCT01152359|3851288|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029452|NCT01152359|3851289|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029453|NCT01152359|3851290|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029454|NCT01152359|3851288|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029455|NCT01152359|3851289|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029456|NCT01152359|3851290|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029457|NCT01152359|3851288|B3||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4029458|NCT01152359|3851289|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4029459|NCT01152359|3851290|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4029460|NCT01152359|3851288|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4029461|NCT01152359|3851289|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4029462|NCT01152359|3851290|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4029463|NCT01152359|3851288|B3|||Age||years|Mean|55|55.0|Standard Deviation|11|11.0|||
4029464|NCT01152359|3851289|B2|||Age||years|Mean|55|55.0|Standard Deviation|10|10.0|||
4029465|NCT01152359|3851290|B1|||Age||years|Mean|54|54.0|Standard Deviation|11|11.0|||
4029466|NCT01152307|3851297|B3|United States||Region of Enrollment||participants|Number|405|405.0||||||
4029467|NCT01152307|3851298|B2|United States||Region of Enrollment||participants|Number|214|214.0||||||
4029468|NCT01152307|3851299|B1|United States||Region of Enrollment||participants|Number|191|191.0||||||
4029469|NCT01152307|3851297|B3||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4029470|NCT01152307|3851298|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4029471|NCT01152307|3851299|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4029472|NCT01152307|3851297|B3||Female|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
4029473|NCT01152307|3851298|B2||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4029474|NCT01152307|3851299|B1||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4029475|NCT01152307|3851297|B3|||Age||years|Mean|42|42.0|Standard Deviation|15.4|15.4|||
4029476|NCT01152307|3851298|B2|||Age||years|Mean|43.5|43.5|Standard Deviation|16.8|16.8|||
4029477|NCT01152307|3851299|B1|||Age||years|Mean|39.5|39.5|Standard Deviation|13.4|13.4|||
4029478|NCT01152307|3851297|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4029479|NCT01152307|3851298|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4029480|NCT01152307|3851299|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4029481|NCT01152307|3851297|B3||Between 18 and 65 years|Age||Participants|Count of Participants|395|395.0||||||
4029482|NCT01152307|3851298|B2||Between 18 and 65 years|Age||Participants|Count of Participants|209|209.0||||||
4029483|NCT01152307|3851299|B1||Between 18 and 65 years|Age||Participants|Count of Participants|186|186.0||||||
4029484|NCT01152307|3851297|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4029485|NCT01152307|3851298|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4029486|NCT01152307|3851299|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4029487|NCT01152294|3851306|B3|United States||Region of Enrollment||participants|Number|401|401.0||||||
4029488|NCT01152294|3851307|B2|United States||Region of Enrollment||participants|Number|188|188.0||||||
4029489|NCT01152294|3851308|B1|United States||Region of Enrollment||participants|Number|213|213.0||||||
4029490|NCT01152294|3851306|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4029491|NCT01152294|3851307|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4029492|NCT01152294|3851308|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4029493|NCT01152294|3851306|B3||Female|Sex: Female, Male||Participants|Count of Participants|401|401.0||||||
4029494|NCT01152294|3851307|B2||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4029495|NCT01152294|3851308|B1||Female|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
4029496|NCT01152294|3851306|B3|||Age||years|Mean|51|51.0|Standard Deviation|5.3|5.3|||
4029497|NCT01152294|3851307|B2|||Age||years|Mean|51|51.0|Standard Deviation|5.5|5.5|||
4029498|NCT01152294|3851308|B1|||Age||years|Mean|51|51.0|Standard Deviation|5.1|5.1|||
4029499|NCT01152294|3851306|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4029500|NCT01152294|3851307|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4029501|NCT01152294|3851308|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4029502|NCT01152294|3851306|B3||Between 18 and 65 years|Age||Participants|Count of Participants|398|398.0||||||
4029503|NCT01152294|3851307|B2||Between 18 and 65 years|Age||Participants|Count of Participants|186|186.0||||||
4029504|NCT01152294|3851308|B1||Between 18 and 65 years|Age||Participants|Count of Participants|212|212.0||||||
4029505|NCT01152294|3851306|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4029506|NCT01152294|3851307|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4029507|NCT01152294|3851308|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4029508|NCT01152190|3851315|B3|||Prostate Specific Antigen||nanograms per milliliter (ng/mL)|Mean|2.0|2.0|Standard Deviation|1.81|1.81|||
4029509|NCT01152190|3851316|B2|||Prostate Specific Antigen||nanograms per milliliter (ng/mL)|Mean|2.1|2.1|Standard Deviation|1.93|1.93|||
4029510|NCT01152190|3851317|B1|||Prostate Specific Antigen||nanograms per milliliter (ng/mL)|Mean|1.9|1.9|Standard Deviation|1.70|1.7|||
4029511|NCT01152190|3851315|B3|||Postvoid Residual Volume|Postvoid residual volume of urine measured by ultrasound.|milliliters (mL)|Mean|53.6|53.6|Standard Deviation|52.56|52.56|||
4029512|NCT01152190|3851316|B2|||Postvoid Residual Volume|Postvoid residual volume of urine measured by ultrasound.|milliliters (mL)|Mean|47.8|47.8|Standard Deviation|44.47|44.47|||
4029513|NCT01152190|3851317|B1|||Postvoid Residual Volume|Postvoid residual volume of urine measured by ultrasound.|milliliters (mL)|Mean|59.0|59.0|Standard Deviation|59.11|59.11|||
4029514|NCT01152190|3851315|B3|||Urinary Peak Flow Rate (Qmax)|Qmax was measured in mL/sec using a standard, calibrated flowmeter. Only randomized participants with a valid uroflowmetry assessment at baseline were summarized (Placebo N=48 and Tadalafil N=45).|milliliters per second (mL/sec)|Mean|10.0|10.0|Standard Deviation|2.65|2.65|||
4029515|NCT01152190|3851316|B2|||Urinary Peak Flow Rate (Qmax)|Qmax was measured in mL/sec using a standard, calibrated flowmeter. Only randomized participants with a valid uroflowmetry assessment at baseline were summarized (Placebo N=48 and Tadalafil N=45).|milliliters per second (mL/sec)|Mean|10.4|10.4|Standard Deviation|2.78|2.78|||
4029516|NCT01152190|3851317|B1|||Urinary Peak Flow Rate (Qmax)|Qmax was measured in mL/sec using a standard, calibrated flowmeter. Only randomized participants with a valid uroflowmetry assessment at baseline were summarized (Placebo N=48 and Tadalafil N=45).|milliliters per second (mL/sec)|Mean|9.6|9.6|Standard Deviation|2.50|2.5|||
4029517|NCT01152190|3851315|B3|Severe||Baseline Lower Urinary Tract Symptoms (LUTS) Severity|LUTS was reported as moderate [International Prostate Symptom Score (IPSS) Total Score <20] or severe (IPSS Total Score ≥20). The IPSS Total Score was the sum of Questions 1 through 7 in the IPSS questionnaire. Each question was scored from 0 (none/no symptoms) to 5 (frequent symptoms) for an IPSS Total Score ranging from 0 to 35 points; higher numerical scores from the IPSS questionnaire represented a greater severity of symptoms.|participants|Number|55|55.0||||||
4029518|NCT01152190|3851316|B2|Severe||Baseline Lower Urinary Tract Symptoms (LUTS) Severity|LUTS was reported as moderate [International Prostate Symptom Score (IPSS) Total Score <20] or severe (IPSS Total Score ≥20). The IPSS Total Score was the sum of Questions 1 through 7 in the IPSS questionnaire. Each question was scored from 0 (none/no symptoms) to 5 (frequent symptoms) for an IPSS Total Score ranging from 0 to 35 points; higher numerical scores from the IPSS questionnaire represented a greater severity of symptoms.|participants|Number|27|27.0||||||
4029519|NCT01152190|3851317|B1|Severe||Baseline Lower Urinary Tract Symptoms (LUTS) Severity|LUTS was reported as moderate [International Prostate Symptom Score (IPSS) Total Score <20] or severe (IPSS Total Score ≥20). The IPSS Total Score was the sum of Questions 1 through 7 in the IPSS questionnaire. Each question was scored from 0 (none/no symptoms) to 5 (frequent symptoms) for an IPSS Total Score ranging from 0 to 35 points; higher numerical scores from the IPSS questionnaire represented a greater severity of symptoms.|participants|Number|28|28.0||||||
4029520|NCT01152190|3851315|B3|Moderate||Baseline Lower Urinary Tract Symptoms (LUTS) Severity|LUTS was reported as moderate [International Prostate Symptom Score (IPSS) Total Score <20] or severe (IPSS Total Score ≥20). The IPSS Total Score was the sum of Questions 1 through 7 in the IPSS questionnaire. Each question was scored from 0 (none/no symptoms) to 5 (frequent symptoms) for an IPSS Total Score ranging from 0 to 35 points; higher numerical scores from the IPSS questionnaire represented a greater severity of symptoms.|participants|Number|42|42.0||||||
4029521|NCT01152190|3851316|B2|Moderate||Baseline Lower Urinary Tract Symptoms (LUTS) Severity|LUTS was reported as moderate [International Prostate Symptom Score (IPSS) Total Score <20] or severe (IPSS Total Score ≥20). The IPSS Total Score was the sum of Questions 1 through 7 in the IPSS questionnaire. Each question was scored from 0 (none/no symptoms) to 5 (frequent symptoms) for an IPSS Total Score ranging from 0 to 35 points; higher numerical scores from the IPSS questionnaire represented a greater severity of symptoms.|participants|Number|20|20.0||||||
4029522|NCT01152190|3851317|B1|Moderate||Baseline Lower Urinary Tract Symptoms (LUTS) Severity|LUTS was reported as moderate [International Prostate Symptom Score (IPSS) Total Score <20] or severe (IPSS Total Score ≥20). The IPSS Total Score was the sum of Questions 1 through 7 in the IPSS questionnaire. Each question was scored from 0 (none/no symptoms) to 5 (frequent symptoms) for an IPSS Total Score ranging from 0 to 35 points; higher numerical scores from the IPSS questionnaire represented a greater severity of symptoms.|participants|Number|22|22.0||||||
4029523|NCT01152190|3851315|B3|||Sitting Systolic Blood Pressure||millimeters of mercury (mm Hg)|Mean|131.4|131.4|Standard Deviation|12.82|12.82|||
4029524|NCT01152190|3851316|B2|||Sitting Systolic Blood Pressure||millimeters of mercury (mm Hg)|Mean|131.7|131.7|Standard Deviation|11.96|11.96|||
4029525|NCT01152190|3851317|B1|||Sitting Systolic Blood Pressure||millimeters of mercury (mm Hg)|Mean|131.0|131.0|Standard Deviation|13.69|13.69|||
4029563|NCT01152190|3851316|B2|Italy||Region of Enrollment||participants|Number|14|14.0||||||
4029526|NCT01152190|3851315|B3|||Sitting Diastolic Blood Pressure||millimeters of mercury (mm Hg)|Mean|81.7|81.7|Standard Deviation|7.83|7.83|||
4029527|NCT01152190|3851316|B2|||Sitting Diastolic Blood Pressure||millimeters of mercury (mm Hg)|Mean|81.5|81.5|Standard Deviation|6.85|6.85|||
4029528|NCT01152190|3851317|B1|||Sitting Diastolic Blood Pressure||millimeters of mercury (mm Hg)|Mean|81.8|81.8|Standard Deviation|8.73|8.73|||
4029529|NCT01152190|3851315|B3|||Body Mass Index|Body mass index was an estimate of body fat based on body weight divided by height squared.|kilograms per meter-squared (kg/m^2)|Mean|26.9|26.9|Standard Deviation|3.25|3.25|||
4029530|NCT01152190|3851316|B2|||Body Mass Index|Body mass index was an estimate of body fat based on body weight divided by height squared.|kilograms per meter-squared (kg/m^2)|Mean|26.4|26.4|Standard Deviation|3.28|3.28|||
4029531|NCT01152190|3851317|B1|||Body Mass Index|Body mass index was an estimate of body fat based on body weight divided by height squared.|kilograms per meter-squared (kg/m^2)|Mean|27.4|27.4|Standard Deviation|3.19|3.19|||
4029532|NCT01152190|3851315|B3|≥1 year||ED Duration|Participant-reported ED duration (<1 year or ≥1 year). ED was defined as a consistent change in the quality of an erection adversely affecting the participant's satisfaction with sexual intercourse. Only randomized participants with ED at baseline, who had a baseline ED duration assessment, were summarized (Placebo N=32 and Tadalafil N=29).|participants|Number|56|56.0||||||
4029533|NCT01152190|3851316|B2|≥1 year||ED Duration|Participant-reported ED duration (<1 year or ≥1 year). ED was defined as a consistent change in the quality of an erection adversely affecting the participant's satisfaction with sexual intercourse. Only randomized participants with ED at baseline, who had a baseline ED duration assessment, were summarized (Placebo N=32 and Tadalafil N=29).|participants|Number|28|28.0||||||
4029534|NCT01152190|3851317|B1|≥1 year||ED Duration|Participant-reported ED duration (<1 year or ≥1 year). ED was defined as a consistent change in the quality of an erection adversely affecting the participant's satisfaction with sexual intercourse. Only randomized participants with ED at baseline, who had a baseline ED duration assessment, were summarized (Placebo N=32 and Tadalafil N=29).|participants|Number|28|28.0||||||
4029535|NCT01152190|3851315|B3|<1 year||ED Duration|Participant-reported ED duration (<1 year or ≥1 year). ED was defined as a consistent change in the quality of an erection adversely affecting the participant's satisfaction with sexual intercourse. Only randomized participants with ED at baseline, who had a baseline ED duration assessment, were summarized (Placebo N=32 and Tadalafil N=29).|participants|Number|5|5.0||||||
4029536|NCT01152190|3851316|B2|<1 year||ED Duration|Participant-reported ED duration (<1 year or ≥1 year). ED was defined as a consistent change in the quality of an erection adversely affecting the participant's satisfaction with sexual intercourse. Only randomized participants with ED at baseline, who had a baseline ED duration assessment, were summarized (Placebo N=32 and Tadalafil N=29).|participants|Number|1|1.0||||||
4029537|NCT01152190|3851317|B1|<1 year||ED Duration|Participant-reported ED duration (<1 year or ≥1 year). ED was defined as a consistent change in the quality of an erection adversely affecting the participant's satisfaction with sexual intercourse. Only randomized participants with ED at baseline, who had a baseline ED duration assessment, were summarized (Placebo N=32 and Tadalafil N=29).|participants|Number|4|4.0||||||
4029538|NCT01152190|3851315|B3|Severe||ED Severity|Investigator-reported severity of a participant's ED at baseline. ED was defined as a consistent change in the quality of an erection adversely affecting the participant's satisfaction with sexual intercourse. The severity (mild, moderate, or severe) of ED was based on the investigator's opinion. Only randomized participants with ED at baseline were summarized (Placebo N=33 and Tadalafil N=29).|participants|Number|11|11.0||||||
4029539|NCT01152190|3851316|B2|Severe||ED Severity|Investigator-reported severity of a participant's ED at baseline. ED was defined as a consistent change in the quality of an erection adversely affecting the participant's satisfaction with sexual intercourse. The severity (mild, moderate, or severe) of ED was based on the investigator's opinion. Only randomized participants with ED at baseline were summarized (Placebo N=33 and Tadalafil N=29).|participants|Number|5|5.0||||||
4029540|NCT01152190|3851317|B1|Severe||ED Severity|Investigator-reported severity of a participant's ED at baseline. ED was defined as a consistent change in the quality of an erection adversely affecting the participant's satisfaction with sexual intercourse. The severity (mild, moderate, or severe) of ED was based on the investigator's opinion. Only randomized participants with ED at baseline were summarized (Placebo N=33 and Tadalafil N=29).|participants|Number|6|6.0||||||
4029541|NCT01152190|3851315|B3|Moderate||ED Severity|Investigator-reported severity of a participant's ED at baseline. ED was defined as a consistent change in the quality of an erection adversely affecting the participant's satisfaction with sexual intercourse. The severity (mild, moderate, or severe) of ED was based on the investigator's opinion. Only randomized participants with ED at baseline were summarized (Placebo N=33 and Tadalafil N=29).|participants|Number|31|31.0||||||
4029542|NCT01152190|3851316|B2|Moderate||ED Severity|Investigator-reported severity of a participant's ED at baseline. ED was defined as a consistent change in the quality of an erection adversely affecting the participant's satisfaction with sexual intercourse. The severity (mild, moderate, or severe) of ED was based on the investigator's opinion. Only randomized participants with ED at baseline were summarized (Placebo N=33 and Tadalafil N=29).|participants|Number|15|15.0||||||
4029543|NCT01152190|3851317|B1|Moderate||ED Severity|Investigator-reported severity of a participant's ED at baseline. ED was defined as a consistent change in the quality of an erection adversely affecting the participant's satisfaction with sexual intercourse. The severity (mild, moderate, or severe) of ED was based on the investigator's opinion. Only randomized participants with ED at baseline were summarized (Placebo N=33 and Tadalafil N=29).|participants|Number|16|16.0||||||
4029544|NCT01152190|3851315|B3|Mild||ED Severity|Investigator-reported severity of a participant's ED at baseline. ED was defined as a consistent change in the quality of an erection adversely affecting the participant's satisfaction with sexual intercourse. The severity (mild, moderate, or severe) of ED was based on the investigator's opinion. Only randomized participants with ED at baseline were summarized (Placebo N=33 and Tadalafil N=29).|participants|Number|20|20.0||||||
4029564|NCT01152190|3851317|B1|Italy||Region of Enrollment||participants|Number|15|15.0||||||
4029565|NCT01152190|3851315|B3|Belgium||Region of Enrollment||participants|Number|9|9.0||||||
4029566|NCT01152190|3851316|B2|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
4029545|NCT01152190|3851316|B2|Mild||ED Severity|Investigator-reported severity of a participant's ED at baseline. ED was defined as a consistent change in the quality of an erection adversely affecting the participant's satisfaction with sexual intercourse. The severity (mild, moderate, or severe) of ED was based on the investigator's opinion. Only randomized participants with ED at baseline were summarized (Placebo N=33 and Tadalafil N=29).|participants|Number|9|9.0||||||
4029546|NCT01152190|3851317|B1|Mild||ED Severity|Investigator-reported severity of a participant's ED at baseline. ED was defined as a consistent change in the quality of an erection adversely affecting the participant's satisfaction with sexual intercourse. The severity (mild, moderate, or severe) of ED was based on the investigator's opinion. Only randomized participants with ED at baseline were summarized (Placebo N=33 and Tadalafil N=29).|participants|Number|11|11.0||||||
4029547|NCT01152190|3851315|B3|Unknown||Erectile Dysfunction (ED) Etiology|Investigator-reported etiology of a participant's ED at baseline. ED was defined as a consistent change in the quality of an erection adversely affecting the participant's satisfaction with sexual intercourse. ED etiology (psychogenic, organic, mixed, or unknown) was based on the investigator's opinion. Only randomized participants with ED at baseline were summarized (Placebo N=33 and Tadalafil N=29).|participants|Number|4|4.0||||||
4029548|NCT01152190|3851316|B2|Unknown||Erectile Dysfunction (ED) Etiology|Investigator-reported etiology of a participant's ED at baseline. ED was defined as a consistent change in the quality of an erection adversely affecting the participant's satisfaction with sexual intercourse. ED etiology (psychogenic, organic, mixed, or unknown) was based on the investigator's opinion. Only randomized participants with ED at baseline were summarized (Placebo N=33 and Tadalafil N=29).|participants|Number|2|2.0||||||
4029549|NCT01152190|3851317|B1|Unknown||Erectile Dysfunction (ED) Etiology|Investigator-reported etiology of a participant's ED at baseline. ED was defined as a consistent change in the quality of an erection adversely affecting the participant's satisfaction with sexual intercourse. ED etiology (psychogenic, organic, mixed, or unknown) was based on the investigator's opinion. Only randomized participants with ED at baseline were summarized (Placebo N=33 and Tadalafil N=29).|participants|Number|2|2.0||||||
4029550|NCT01152190|3851315|B3|Mixed||Erectile Dysfunction (ED) Etiology|Investigator-reported etiology of a participant's ED at baseline. ED was defined as a consistent change in the quality of an erection adversely affecting the participant's satisfaction with sexual intercourse. ED etiology (psychogenic, organic, mixed, or unknown) was based on the investigator's opinion. Only randomized participants with ED at baseline were summarized (Placebo N=33 and Tadalafil N=29).|participants|Number|25|25.0||||||
4029551|NCT01152190|3851316|B2|Mixed||Erectile Dysfunction (ED) Etiology|Investigator-reported etiology of a participant's ED at baseline. ED was defined as a consistent change in the quality of an erection adversely affecting the participant's satisfaction with sexual intercourse. ED etiology (psychogenic, organic, mixed, or unknown) was based on the investigator's opinion. Only randomized participants with ED at baseline were summarized (Placebo N=33 and Tadalafil N=29).|participants|Number|12|12.0||||||
4029552|NCT01152190|3851317|B1|Mixed||Erectile Dysfunction (ED) Etiology|Investigator-reported etiology of a participant's ED at baseline. ED was defined as a consistent change in the quality of an erection adversely affecting the participant's satisfaction with sexual intercourse. ED etiology (psychogenic, organic, mixed, or unknown) was based on the investigator's opinion. Only randomized participants with ED at baseline were summarized (Placebo N=33 and Tadalafil N=29).|participants|Number|13|13.0||||||
4029553|NCT01152190|3851315|B3|Organic||Erectile Dysfunction (ED) Etiology|Investigator-reported etiology of a participant's ED at baseline. ED was defined as a consistent change in the quality of an erection adversely affecting the participant's satisfaction with sexual intercourse. ED etiology (psychogenic, organic, mixed, or unknown) was based on the investigator's opinion. Only randomized participants with ED at baseline were summarized (Placebo N=33 and Tadalafil N=29).|participants|Number|33|33.0||||||
4029554|NCT01152190|3851316|B2|Organic||Erectile Dysfunction (ED) Etiology|Investigator-reported etiology of a participant's ED at baseline. ED was defined as a consistent change in the quality of an erection adversely affecting the participant's satisfaction with sexual intercourse. ED etiology (psychogenic, organic, mixed, or unknown) was based on the investigator's opinion. Only randomized participants with ED at baseline were summarized (Placebo N=33 and Tadalafil N=29).|participants|Number|15|15.0||||||
4029555|NCT01152190|3851317|B1|Organic||Erectile Dysfunction (ED) Etiology|Investigator-reported etiology of a participant's ED at baseline. ED was defined as a consistent change in the quality of an erection adversely affecting the participant's satisfaction with sexual intercourse. ED etiology (psychogenic, organic, mixed, or unknown) was based on the investigator's opinion. Only randomized participants with ED at baseline were summarized (Placebo N=33 and Tadalafil N=29).|participants|Number|18|18.0||||||
4029556|NCT01152190|3851315|B3|Psychogenic||Erectile Dysfunction (ED) Etiology|Investigator-reported etiology of a participant's ED at baseline. ED was defined as a consistent change in the quality of an erection adversely affecting the participant's satisfaction with sexual intercourse. ED etiology (psychogenic, organic, mixed, or unknown) was based on the investigator's opinion. Only randomized participants with ED at baseline were summarized (Placebo N=33 and Tadalafil N=29).|participants|Number|0|0.0||||||
4029557|NCT01152190|3851316|B2|Psychogenic||Erectile Dysfunction (ED) Etiology|Investigator-reported etiology of a participant's ED at baseline. ED was defined as a consistent change in the quality of an erection adversely affecting the participant's satisfaction with sexual intercourse. ED etiology (psychogenic, organic, mixed, or unknown) was based on the investigator's opinion. Only randomized participants with ED at baseline were summarized (Placebo N=33 and Tadalafil N=29).|participants|Number|0|0.0||||||
4029558|NCT01152190|3851317|B1|Psychogenic||Erectile Dysfunction (ED) Etiology|Investigator-reported etiology of a participant's ED at baseline. ED was defined as a consistent change in the quality of an erection adversely affecting the participant's satisfaction with sexual intercourse. ED etiology (psychogenic, organic, mixed, or unknown) was based on the investigator's opinion. Only randomized participants with ED at baseline were summarized (Placebo N=33 and Tadalafil N=29).|participants|Number|0|0.0||||||
4029559|NCT01152190|3851315|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
4029560|NCT01152190|3851316|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4029561|NCT01152190|3851317|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4029562|NCT01152190|3851315|B3|Italy||Region of Enrollment||participants|Number|29|29.0||||||
4029567|NCT01152190|3851317|B1|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
4029568|NCT01152190|3851315|B3|Austria||Region of Enrollment||participants|Number|13|13.0||||||
4029569|NCT01152190|3851316|B2|Austria||Region of Enrollment||participants|Number|7|7.0||||||
4029570|NCT01152190|3851317|B1|Austria||Region of Enrollment||participants|Number|6|6.0||||||
4029571|NCT01152190|3851315|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029572|NCT01152190|3851316|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029573|NCT01152190|3851317|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029574|NCT01152190|3851315|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029575|NCT01152190|3851316|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029576|NCT01152190|3851317|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029577|NCT01152190|3851315|B3||White|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
4029578|NCT01152190|3851316|B2||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4029579|NCT01152190|3851317|B1||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4029580|NCT01152190|3851315|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4029581|NCT01152190|3851316|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4029582|NCT01152190|3851317|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4029583|NCT01152190|3851315|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029584|NCT01152190|3851316|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029585|NCT01152190|3851317|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029586|NCT01152190|3851315|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4029587|NCT01152190|3851316|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4029588|NCT01152190|3851317|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4029589|NCT01152190|3851315|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029590|NCT01152190|3851316|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029591|NCT01152190|3851317|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029592|NCT01152190|3851315|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029593|NCT01152190|3851316|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029594|NCT01152190|3851317|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029595|NCT01152190|3851315|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
4029596|NCT01152190|3851316|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4029597|NCT01152190|3851317|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4029598|NCT01152190|3851315|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4029599|NCT01152190|3851316|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4029600|NCT01152190|3851317|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029601|NCT01152190|3851315|B3||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4029602|NCT01152190|3851316|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4029603|NCT01152190|3851317|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4029604|NCT01152190|3851315|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4029605|NCT01152190|3851316|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4029606|NCT01152190|3851317|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4029607|NCT01152190|3851315|B3|||Age||years|Mean|60.2|60.2|Standard Deviation|7.83|7.83|||
4029608|NCT01152190|3851316|B2|||Age||years|Mean|60.0|60.0|Standard Deviation|7.53|7.53|||
4029609|NCT01152190|3851317|B1|||Age||years|Mean|60.3|60.3|Standard Deviation|8.18|8.18|||
4029610|NCT01152112|3851330|B3|United States||Region of Enrollment||participants|Number|74|74.0||||||
4029611|NCT01152112|3851331|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
4029612|NCT01152112|3851332|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4029613|NCT01152112|3851330|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4029614|NCT01152112|3851331|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4029615|NCT01152112|3851332|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4029616|NCT01152112|3851330|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4029617|NCT01152112|3851331|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4029618|NCT01152112|3851332|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4029619|NCT01152112|3851330|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4029620|NCT01152112|3851331|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4029621|NCT01152112|3851332|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4029622|NCT01152112|3851330|B3||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
4029623|NCT01152112|3851331|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4029624|NCT01152112|3851332|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4029625|NCT01152112|3851330|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4029626|NCT01152112|3851331|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4029627|NCT01152112|3851332|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4029628|NCT01151904|3851339|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4029629|NCT01151904|3851339|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4029630|NCT01151904|3851339|B1|>65 years||Age, Customized||Participants|Number|10|10.0||||||
4029631|NCT01151904|3851339|B1|Between 45 and 65 years||Age, Customized||Participants|Number|7|7.0||||||
4029632|NCT01151904|3851339|B1|<45 years||Age, Customized||Participants|Number|0|0.0||||||
4029633|NCT01151852|3851345|B3|Korea, Republic of||Region of Enrollment||participants|Number|81|81.0||||||
4029634|NCT01151852|3851346|B2|Korea, Republic of||Region of Enrollment||participants|Number|40|40.0||||||
4029635|NCT01151852|3851347|B1|Korea, Republic of||Region of Enrollment||participants|Number|41|41.0||||||
4029636|NCT01151852|3851345|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4029637|NCT01151852|3851346|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4029638|NCT01151852|3851347|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4029639|NCT01151852|3851345|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4029640|NCT01151852|3851346|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4029641|NCT01151852|3851347|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4029642|NCT01151852|3851345|B3|||Age||years|Mean|58.7|58.7|Standard Deviation|10.5|10.5|||
4029643|NCT01151852|3851346|B2|||Age||years|Mean|59.6|59.6|Standard Deviation|10.6|10.6|||
4029644|NCT01151852|3851347|B1|||Age||years|Mean|57.9|57.9|Standard Deviation|10.4|10.4|||
4029645|NCT01151852|3851345|B3||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4029646|NCT01151852|3851346|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4029647|NCT01151852|3851347|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4029648|NCT01151852|3851345|B3||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4029649|NCT01151852|3851346|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4029650|NCT01151852|3851347|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4029651|NCT01151852|3851345|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4029652|NCT01151852|3851346|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4029653|NCT01151852|3851347|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4029654|NCT01151761|3851364|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4029655|NCT01151761|3851364|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4029656|NCT01151761|3851364|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4029657|NCT01151761|3851364|B1|||Age||years|Mean|64.5|64.5|Standard Deviation|9.19|9.19|||
4029658|NCT01151761|3851364|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4029659|NCT01151761|3851364|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4029660|NCT01151761|3851364|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4029661|NCT01151579|3851375|B3|United States||Region of Enrollment||participants|Number|89|89.0||||||
4029662|NCT01151579|3851376|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
4029663|NCT01151579|3851377|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
4029664|NCT01151579|3851375|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4029665|NCT01151579|3851376|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4029666|NCT01151579|3851377|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4029667|NCT01151579|3851375|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4029668|NCT01151579|3851376|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4029669|NCT01151579|3851377|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4029670|NCT01151579|3851375|B3|||Age||years|Mean|67.3|67.3|Standard Deviation|13.4|13.4|||
4029671|NCT01151579|3851376|B2|||Age||years|Mean|67.5|67.5|Standard Deviation|13.7|13.7|||
4029672|NCT01151579|3851377|B1|||Age||years|Mean|67.3|67.3|Standard Deviation|13.1|13.1|||
4029673|NCT01151579|3851375|B3||>=65 years|Age||Participants|Count of Participants|62|62.0||||||
4029674|NCT01151579|3851376|B2||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4029675|NCT01151579|3851377|B1||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
4029676|NCT01151579|3851375|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4029677|NCT01151579|3851376|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4029678|NCT01151579|3851377|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4029679|NCT01151579|3851375|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4029680|NCT01151579|3851376|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4029681|NCT01151579|3851377|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4029682|NCT01151553|3851388|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4029683|NCT01151553|3851388|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4029684|NCT01151553|3851388|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4029685|NCT01151553|3851388|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|10.9|10.9|||
4029686|NCT01151553|3851388|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4029687|NCT01151553|3851388|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4029688|NCT01151553|3851388|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4029689|NCT01151449|3851392|B1|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4029690|NCT01151449|3851392|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4029691|NCT01151449|3851392|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4029692|NCT01151449|3851392|B1|||Age||years|Median|51|51.0|Full Range|||41.0|64.0|
4029693|NCT01151449|3851392|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4029694|NCT01151449|3851392|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4029695|NCT01151449|3851392|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4029696|NCT01151436|3851400|B1|Germany||Region of Enrollment||participants|Number|30|30.0||||||
4029697|NCT01151436|3851400|B1|France||Region of Enrollment||participants|Number|47|47.0||||||
4029698|NCT01151436|3851400|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4029699|NCT01151436|3851400|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4029700|NCT01151436|3851400|B1|||Age||years|Mean|54.5|54.5|Standard Deviation|8.2|8.2|||
4029701|NCT01151436|3851400|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4029702|NCT01151436|3851400|B1||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4029703|NCT01151436|3851400|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4029704|NCT01151410|3851430|B3||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4029705|NCT01151410|3851431|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4029706|NCT01151410|3851432|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4029707|NCT01151410|3851430|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4029708|NCT01151410|3851431|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4029709|NCT01151410|3851432|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4029710|NCT01151410|3851430|B3|Adolescents 12 – 17 years||Age, Customized||participants|Number|107|107.0||||||
4029711|NCT01151410|3851431|B2|Adolescents 12 – 17 years||Age, Customized||participants|Number|53|53.0||||||
4029712|NCT01151410|3851432|B1|Adolescents 12 – 17 years||Age, Customized||participants|Number|54|54.0||||||
4029713|NCT01151410|3851430|B3|Children 6 – 11 years||Age, Customized||participants|Number|101|101.0||||||
4029714|NCT01151410|3851431|B2|Children 6 – 11 years||Age, Customized||participants|Number|51|51.0||||||
4029715|NCT01151410|3851432|B1|Children 6 – 11 years||Age, Customized||participants|Number|50|50.0||||||
4029716|NCT01151410|3851430|B3|||Age||years|Mean|11.8|11.8|Standard Deviation|3.39|3.39|||
4029717|NCT01151410|3851431|B2|||Age||years|Mean|11.9|11.9|Standard Deviation|3.40|3.4|||
4029718|NCT01151410|3851432|B1|||Age||years|Mean|11.7|11.7|Standard Deviation|3.40|3.4|||
4029719|NCT01151371|3851443|B4|United States||Region of Enrollment||participants|Number|452|452.0||||||
4029720|NCT01151371|3851444|B3|United States||Region of Enrollment||participants|Number|153|153.0||||||
4029721|NCT01151371|3851445|B2|United States||Region of Enrollment||participants|Number|150|150.0||||||
4029722|NCT01151371|3851446|B1|United States||Region of Enrollment||participants|Number|149|149.0||||||
4029723|NCT01151371|3851443|B4||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4029724|NCT01151371|3851444|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4029725|NCT01151371|3851445|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4029726|NCT01151371|3851446|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4029727|NCT01151371|3851443|B4||Female|Sex: Female, Male||Participants|Count of Participants|328|328.0||||||
4029728|NCT01151371|3851444|B3||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4029729|NCT01151371|3851445|B2||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4029730|NCT01151371|3851446|B1||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4029731|NCT01151371|3851443|B4|||Age||years|Mean|27.8|27.8|Standard Deviation|6.2|6.2|||
4029732|NCT01151371|3851444|B3|||Age||years|Mean|28|28.0|Standard Deviation|6.2|6.2|||
4029733|NCT01151371|3851445|B2|||Age||years|Mean|27.6|27.6|Standard Deviation|6.0|6.0|||
4029734|NCT01151371|3851446|B1|||Age||years|Mean|27.9|27.9|Standard Deviation|6.4|6.4|||
4029735|NCT01151345|3851477|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4029736|NCT01151345|3851477|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4029737|NCT01151345|3851477|B1|||Age||Years|Mean|33.0|33.0|Standard Deviation|10.0|10.0|||
4029738|NCT01151280|3851492|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4029739|NCT01151280|3851492|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4029740|NCT01151280|3851492|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4029741|NCT01151280|3851492|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|5.52|5.52|||
4029742|NCT01151280|3851492|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4029743|NCT01151280|3851492|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4029744|NCT01151280|3851492|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4029745|NCT01151215|3851502|B4|Metastatic disease||Study Stratification: Disease Classification|Study was stratified by locally advanced / metastatic disease|Participants|Number|276|276.0||||||
4029746|NCT01151215|3851503|B3|Metastatic disease||Study Stratification: Disease Classification|Study was stratified by locally advanced / metastatic disease|Participants|Number|93|93.0||||||
4029747|NCT01151215|3851504|B2|Metastatic disease||Study Stratification: Disease Classification|Study was stratified by locally advanced / metastatic disease|Participants|Number|91|91.0||||||
4029748|NCT01151215|3851505|B1|Metastatic disease||Study Stratification: Disease Classification|Study was stratified by locally advanced / metastatic disease|Participants|Number|92|92.0||||||
4029749|NCT01151215|3851502|B4|Locally advanced||Study Stratification: Disease Classification|Study was stratified by locally advanced / metastatic disease|Participants|Number|83|83.0||||||
4029750|NCT01151215|3851503|B3|Locally advanced||Study Stratification: Disease Classification|Study was stratified by locally advanced / metastatic disease|Participants|Number|28|28.0||||||
4029751|NCT01151215|3851504|B2|Locally advanced||Study Stratification: Disease Classification|Study was stratified by locally advanced / metastatic disease|Participants|Number|27|27.0||||||
4029752|NCT01151215|3851505|B1|Locally advanced||Study Stratification: Disease Classification|Study was stratified by locally advanced / metastatic disease|Participants|Number|28|28.0||||||
4029753|NCT01151215|3851502|B4|Race: Other||Race/Ethnicity, Customized||Participants|Number|67|67.0||||||
4029754|NCT01151215|3851503|B3|Race: Other||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4029755|NCT01151215|3851504|B2|Race: Other||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4029756|NCT01151215|3851505|B1|Race: Other||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
4029757|NCT01151215|3851502|B4|Race: White||Race/Ethnicity, Customized||Participants|Number|166|166.0||||||
4029758|NCT01151215|3851503|B3|Race: White||Race/Ethnicity, Customized||Participants|Number|60|60.0||||||
4029759|NCT01151215|3851504|B2|Race: White||Race/Ethnicity, Customized||Participants|Number|56|56.0||||||
4029760|NCT01151215|3851505|B1|Race: White||Race/Ethnicity, Customized||Participants|Number|50|50.0||||||
4029761|NCT01151215|3851502|B4|Race: Black or African American||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4029762|NCT01151215|3851503|B3|Race: Black or African American||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4029763|NCT01151215|3851504|B2|Race: Black or African American||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4029764|NCT01151215|3851505|B1|Race: Black or African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4029765|NCT01151215|3851502|B4|Race: Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4029766|NCT01151215|3851503|B3|Race: Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4029767|NCT01151215|3851504|B2|Race: Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4029768|NCT01151215|3851505|B1|Race: Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4029769|NCT01151215|3851502|B4|Race: Asian||Race/Ethnicity, Customized||Participants|Number|108|108.0||||||
4029770|NCT01151215|3851503|B3|Race: Asian||Race/Ethnicity, Customized||Participants|Number|36|36.0||||||
4029771|NCT01151215|3851504|B2|Race: Asian||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
4029772|NCT01151215|3851505|B1|Race: Asian||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
4029773|NCT01151215|3851502|B4|Race: American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4029774|NCT01151215|3851503|B3|Race: American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4029775|NCT01151215|3851504|B2|Race: American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4029776|NCT01151215|3851505|B1|Race: American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4029777|NCT01151215|3851502|B4|Ethnicity: Not applicable||Race/Ethnicity, Customized||Participants|Number|49|49.0||||||
4029778|NCT01151215|3851503|B3|Ethnicity: Not applicable||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4029779|NCT01151215|3851504|B2|Ethnicity: Not applicable||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4029780|NCT01151215|3851505|B1|Ethnicity: Not applicable||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4029781|NCT01151215|3851502|B4|Ethnicity: Other||Race/Ethnicity, Customized||Participants|Number|46|46.0||||||
4029782|NCT01151215|3851503|B3|Ethnicity: Other||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4029783|NCT01151215|3851504|B2|Ethnicity: Other||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4029784|NCT01151215|3851505|B1|Ethnicity: Other||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4029785|NCT01151215|3851502|B4|Ethnicity: Japanese||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4029786|NCT01151215|3851503|B3|Ethnicity: Japanese||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4029787|NCT01151215|3851504|B2|Ethnicity: Japanese||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4029788|NCT01151215|3851505|B1|Ethnicity: Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4029789|NCT01151215|3851502|B4|Ethnicity: Chinese||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4029790|NCT01151215|3851503|B3|Ethnicity: Chinese||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4029791|NCT01151215|3851504|B2|Ethnicity: Chinese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4029792|NCT01151215|3851505|B1|Ethnicity: Chinese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4029793|NCT01151215|3851502|B4|Ethnicity: Asian (other than Chinese/Japanese)||Race/Ethnicity, Customized||Participants|Number|98|98.0||||||
4029794|NCT01151215|3851503|B3|Ethnicity: Asian (other than Chinese/Japanese)||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
4029795|NCT01151215|3851504|B2|Ethnicity: Asian (other than Chinese/Japanese)||Race/Ethnicity, Customized||Participants|Number|31|31.0||||||
4029796|NCT01151215|3851505|B1|Ethnicity: Asian (other than Chinese/Japanese)||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
4029797|NCT01151215|3851502|B4|Ethnicity: African||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4029798|NCT01151215|3851503|B3|Ethnicity: African||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4029799|NCT01151215|3851504|B2|Ethnicity: African||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4029800|NCT01151215|3851505|B1|Ethnicity: African||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4029801|NCT01151215|3851502|B4|Ethnicity: Native American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4029802|NCT01151215|3851503|B3|Ethnicity: Native American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4029803|NCT01151215|3851504|B2|Ethnicity: Native American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4029804|NCT01151215|3851505|B1|Ethnicity: Native American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4029805|NCT01151215|3851502|B4|Ethnicity: Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|149|149.0||||||
4029806|NCT01151215|3851503|B3|Ethnicity: Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|45|45.0||||||
4029807|NCT01151215|3851504|B2|Ethnicity: Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|53|53.0||||||
4029808|NCT01151215|3851505|B1|Ethnicity: Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|51|51.0||||||
4029809|NCT01151215|3851502|B4|||Sex/Gender, Customized|Female only|Participants|Number|359|359.0||||||
4029810|NCT01151215|3851503|B3|||Sex/Gender, Customized|Female only|Participants|Number|121|121.0||||||
4029811|NCT01151215|3851504|B2|||Sex/Gender, Customized|Female only|Participants|Number|118|118.0||||||
4029812|NCT01151215|3851505|B1|||Sex/Gender, Customized|Female only|Participants|Number|120|120.0||||||
4029813|NCT01151215|3851502|B4|||Age||Years|Mean|61.0|61.0|Standard Deviation|10.73|10.73|||
4029814|NCT01151215|3851503|B3|||Age||Years|Mean|60.5|60.5|Standard Deviation|10.29|10.29|||
4029815|NCT01151215|3851504|B2|||Age||Years|Mean|62.0|62.0|Standard Deviation|11.23|11.23|||
4029816|NCT01151215|3851505|B1|||Age||Years|Mean|60.4|60.4|Standard Deviation|10.69|10.69|||
4029817|NCT01151189|3851518|B3|South Africa||Region of Enrollment||participants|Number|292|292.0||||||
4029818|NCT01151189|3851519|B2|South Africa||Region of Enrollment||participants|Number|146|146.0||||||
4029819|NCT01151189|3851520|B1|South Africa||Region of Enrollment||participants|Number|146|146.0||||||
4029820|NCT01151189|3851518|B3|Senegal||Region of Enrollment||participants|Number|357|357.0||||||
4029821|NCT01151189|3851519|B2|Senegal||Region of Enrollment||participants|Number|178|178.0||||||
4029822|NCT01151189|3851520|B1|Senegal||Region of Enrollment||participants|Number|179|179.0||||||
4029823|NCT01151189|3851518|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4029824|NCT01151189|3851519|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4029825|NCT01151189|3851520|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4029826|NCT01151189|3851518|B3|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4029827|NCT01151189|3851519|B2|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4029828|NCT01151189|3851520|B1|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4029829|NCT01151189|3851518|B3|Coloured||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4029830|NCT01151189|3851519|B2|Coloured||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4029831|NCT01151189|3851520|B1|Coloured||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4029832|NCT01151189|3851518|B3|Black||Race/Ethnicity, Customized||participants|Number|606|606.0||||||
4029833|NCT01151189|3851519|B2|Black||Race/Ethnicity, Customized||participants|Number|302|302.0||||||
4029834|NCT01151189|3851520|B1|Black||Race/Ethnicity, Customized||participants|Number|304|304.0||||||
4029835|NCT01151189|3851518|B3||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4029836|NCT01151189|3851519|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4029837|NCT01151189|3851520|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4029838|NCT01151189|3851518|B3||Female|Sex: Female, Male||Participants|Count of Participants|520|520.0||||||
4029839|NCT01151189|3851519|B2||Female|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
4029840|NCT01151189|3851520|B1||Female|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
4029841|NCT01151189|3851518|B3|||Age||years|Mean|37.7|37.7|Standard Deviation|6.65|6.65|||
4029842|NCT01151189|3851519|B2|||Age||years|Mean|37.7|37.7|Standard Deviation|6.69|6.69|||
4029843|NCT01151189|3851520|B1|||Age||years|Mean|37.8|37.8|Standard Deviation|6.61|6.61|||
4029844|NCT01151137|3851543|B3|NYHA Class III||New York Heart Association [NYHA] class|"NYHA classification is a functional classification that places the patient in one of 4 categories, based on how much he/she is limited during physical activity:~Class I: no limitation of activities; the patient suffers no symptoms from ordinary activities.~Class II: slight, mild limitation of activity; the patient is comfortable with rest or with mild exertion.~Class III: marked limitation of activity; the patient is comfortable only at rest.~Class IV: complete rest, confined to bed or chair; any physical activity brings on discomfort and symptoms occur at rest."|participants|Number|265|265.0||||||
4029845|NCT01151137|3851544|B2|NYHA Class III||New York Heart Association [NYHA] class|"NYHA classification is a functional classification that places the patient in one of 4 categories, based on how much he/she is limited during physical activity:~Class I: no limitation of activities; the patient suffers no symptoms from ordinary activities.~Class II: slight, mild limitation of activity; the patient is comfortable with rest or with mild exertion.~Class III: marked limitation of activity; the patient is comfortable only at rest.~Class IV: complete rest, confined to bed or chair; any physical activity brings on discomfort and symptoms occur at rest."|participants|Number|141|141.0||||||
4029846|NCT01151137|3851545|B1|NYHA Class III||New York Heart Association [NYHA] class|"NYHA classification is a functional classification that places the patient in one of 4 categories, based on how much he/she is limited during physical activity:~Class I: no limitation of activities; the patient suffers no symptoms from ordinary activities.~Class II: slight, mild limitation of activity; the patient is comfortable with rest or with mild exertion.~Class III: marked limitation of activity; the patient is comfortable only at rest.~Class IV: complete rest, confined to bed or chair; any physical activity brings on discomfort and symptoms occur at rest."|participants|Number|124|124.0||||||
4029942|NCT01151046|3851586|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029943|NCT01151046|3851584|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029847|NCT01151137|3851543|B3|NYHA Class II||New York Heart Association [NYHA] class|"NYHA classification is a functional classification that places the patient in one of 4 categories, based on how much he/she is limited during physical activity:~Class I: no limitation of activities; the patient suffers no symptoms from ordinary activities.~Class II: slight, mild limitation of activity; the patient is comfortable with rest or with mild exertion.~Class III: marked limitation of activity; the patient is comfortable only at rest.~Class IV: complete rest, confined to bed or chair; any physical activity brings on discomfort and symptoms occur at rest."|participants|Number|1481|1481.0||||||
4029848|NCT01151137|3851544|B2|NYHA Class II||New York Heart Association [NYHA] class|"NYHA classification is a functional classification that places the patient in one of 4 categories, based on how much he/she is limited during physical activity:~Class I: no limitation of activities; the patient suffers no symptoms from ordinary activities.~Class II: slight, mild limitation of activity; the patient is comfortable with rest or with mild exertion.~Class III: marked limitation of activity; the patient is comfortable only at rest.~Class IV: complete rest, confined to bed or chair; any physical activity brings on discomfort and symptoms occur at rest."|participants|Number|732|732.0||||||
4029849|NCT01151137|3851545|B1|NYHA Class II||New York Heart Association [NYHA] class|"NYHA classification is a functional classification that places the patient in one of 4 categories, based on how much he/she is limited during physical activity:~Class I: no limitation of activities; the patient suffers no symptoms from ordinary activities.~Class II: slight, mild limitation of activity; the patient is comfortable with rest or with mild exertion.~Class III: marked limitation of activity; the patient is comfortable only at rest.~Class IV: complete rest, confined to bed or chair; any physical activity brings on discomfort and symptoms occur at rest."|participants|Number|749|749.0||||||
4029850|NCT01151137|3851543|B3|NYHA Class I||New York Heart Association [NYHA] class|"NYHA classification is a functional classification that places the patient in one of 4 categories, based on how much he/she is limited during physical activity:~Class I: no limitation of activities; the patient suffers no symptoms from ordinary activities.~Class II: slight, mild limitation of activity; the patient is comfortable with rest or with mild exertion.~Class III: marked limitation of activity; the patient is comfortable only at rest.~Class IV: complete rest, confined to bed or chair; any physical activity brings on discomfort and symptoms occur at rest."|participants|Number|443|443.0||||||
4029851|NCT01151137|3851544|B2|NYHA Class I||New York Heart Association [NYHA] class|"NYHA classification is a functional classification that places the patient in one of 4 categories, based on how much he/she is limited during physical activity:~Class I: no limitation of activities; the patient suffers no symptoms from ordinary activities.~Class II: slight, mild limitation of activity; the patient is comfortable with rest or with mild exertion.~Class III: marked limitation of activity; the patient is comfortable only at rest.~Class IV: complete rest, confined to bed or chair; any physical activity brings on discomfort and symptoms occur at rest."|participants|Number|234|234.0||||||
4029852|NCT01151137|3851545|B1|NYHA Class I||New York Heart Association [NYHA] class|"NYHA classification is a functional classification that places the patient in one of 4 categories, based on how much he/she is limited during physical activity:~Class I: no limitation of activities; the patient suffers no symptoms from ordinary activities.~Class II: slight, mild limitation of activity; the patient is comfortable with rest or with mild exertion.~Class III: marked limitation of activity; the patient is comfortable only at rest.~Class IV: complete rest, confined to bed or chair; any physical activity brings on discomfort and symptoms occur at rest."|participants|Number|209|209.0||||||
4029853|NCT01151137|3851543|B3|No congestive heart failure [CHF]||New York Heart Association [NYHA] class|"NYHA classification is a functional classification that places the patient in one of 4 categories, based on how much he/she is limited during physical activity:~Class I: no limitation of activities; the patient suffers no symptoms from ordinary activities.~Class II: slight, mild limitation of activity; the patient is comfortable with rest or with mild exertion.~Class III: marked limitation of activity; the patient is comfortable only at rest.~Class IV: complete rest, confined to bed or chair; any physical activity brings on discomfort and symptoms occur at rest."|participants|Number|1047|1047.0||||||
4029854|NCT01151137|3851544|B2|No congestive heart failure [CHF]||New York Heart Association [NYHA] class|"NYHA classification is a functional classification that places the patient in one of 4 categories, based on how much he/she is limited during physical activity:~Class I: no limitation of activities; the patient suffers no symptoms from ordinary activities.~Class II: slight, mild limitation of activity; the patient is comfortable with rest or with mild exertion.~Class III: marked limitation of activity; the patient is comfortable only at rest.~Class IV: complete rest, confined to bed or chair; any physical activity brings on discomfort and symptoms occur at rest."|participants|Number|512|512.0||||||
4029855|NCT01151137|3851545|B1|No congestive heart failure [CHF]||New York Heart Association [NYHA] class|"NYHA classification is a functional classification that places the patient in one of 4 categories, based on how much he/she is limited during physical activity:~Class I: no limitation of activities; the patient suffers no symptoms from ordinary activities.~Class II: slight, mild limitation of activity; the patient is comfortable with rest or with mild exertion.~Class III: marked limitation of activity; the patient is comfortable only at rest.~Class IV: complete rest, confined to bed or chair; any physical activity brings on discomfort and symptoms occur at rest."|participants|Number|535|535.0||||||
4029856|NCT01151137|3851543|B3|Unavailable||CHADS2 Score|"CHADS2 is a risk-prediction score ranging from 0 to 6 used estimate Stroke Risk in Atrial Fibrillation patients.~CHADS2 score is obtained by adding together the points that correspond to the conditions that are present:~C: Congestive Heart Failure history: 1 point~H: Hypertension history: 1 point~A: Age ≥75 years: 1 point~D: Diabetes Mellitus history: 1 point~S: Stroke symptoms previously or Transient Ischemic Attack [TIA]: 2 points"|participants|Number|2|2.0||||||
4029857|NCT01151137|3851544|B2|Unavailable||CHADS2 Score|"CHADS2 is a risk-prediction score ranging from 0 to 6 used estimate Stroke Risk in Atrial Fibrillation patients.~CHADS2 score is obtained by adding together the points that correspond to the conditions that are present:~C: Congestive Heart Failure history: 1 point~H: Hypertension history: 1 point~A: Age ≥75 years: 1 point~D: Diabetes Mellitus history: 1 point~S: Stroke symptoms previously or Transient Ischemic Attack [TIA]: 2 points"|participants|Number|1|1.0||||||
4029944|NCT01151046|3851585|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029945|NCT01151046|3851586|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029946|NCT01151046|3851584|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
4029858|NCT01151137|3851545|B1|Unavailable||CHADS2 Score|"CHADS2 is a risk-prediction score ranging from 0 to 6 used estimate Stroke Risk in Atrial Fibrillation patients.~CHADS2 score is obtained by adding together the points that correspond to the conditions that are present:~C: Congestive Heart Failure history: 1 point~H: Hypertension history: 1 point~A: Age ≥75 years: 1 point~D: Diabetes Mellitus history: 1 point~S: Stroke symptoms previously or Transient Ischemic Attack [TIA]: 2 points"|participants|Number|1|1.0||||||
4029859|NCT01151137|3851543|B3|≥ 2||CHADS2 Score|"CHADS2 is a risk-prediction score ranging from 0 to 6 used estimate Stroke Risk in Atrial Fibrillation patients.~CHADS2 score is obtained by adding together the points that correspond to the conditions that are present:~C: Congestive Heart Failure history: 1 point~H: Hypertension history: 1 point~A: Age ≥75 years: 1 point~D: Diabetes Mellitus history: 1 point~S: Stroke symptoms previously or Transient Ischemic Attack [TIA]: 2 points"|participants|Number|2871|2871.0||||||
4029860|NCT01151137|3851544|B2|≥ 2||CHADS2 Score|"CHADS2 is a risk-prediction score ranging from 0 to 6 used estimate Stroke Risk in Atrial Fibrillation patients.~CHADS2 score is obtained by adding together the points that correspond to the conditions that are present:~C: Congestive Heart Failure history: 1 point~H: Hypertension history: 1 point~A: Age ≥75 years: 1 point~D: Diabetes Mellitus history: 1 point~S: Stroke symptoms previously or Transient Ischemic Attack [TIA]: 2 points"|participants|Number|1427|1427.0||||||
4029861|NCT01151137|3851545|B1|≥ 2||CHADS2 Score|"CHADS2 is a risk-prediction score ranging from 0 to 6 used estimate Stroke Risk in Atrial Fibrillation patients.~CHADS2 score is obtained by adding together the points that correspond to the conditions that are present:~C: Congestive Heart Failure history: 1 point~H: Hypertension history: 1 point~A: Age ≥75 years: 1 point~D: Diabetes Mellitus history: 1 point~S: Stroke symptoms previously or Transient Ischemic Attack [TIA]: 2 points"|participants|Number|1444|1444.0||||||
4029862|NCT01151137|3851543|B3|< 2||CHADS2 Score|"CHADS2 is a risk-prediction score ranging from 0 to 6 used estimate Stroke Risk in Atrial Fibrillation patients.~CHADS2 score is obtained by adding together the points that correspond to the conditions that are present:~C: Congestive Heart Failure history: 1 point~H: Hypertension history: 1 point~A: Age ≥75 years: 1 point~D: Diabetes Mellitus history: 1 point~S: Stroke symptoms previously or Transient Ischemic Attack [TIA]: 2 points"|participants|Number|363|363.0||||||
4029863|NCT01151137|3851544|B2|< 2||CHADS2 Score|"CHADS2 is a risk-prediction score ranging from 0 to 6 used estimate Stroke Risk in Atrial Fibrillation patients.~CHADS2 score is obtained by adding together the points that correspond to the conditions that are present:~C: Congestive Heart Failure history: 1 point~H: Hypertension history: 1 point~A: Age ≥75 years: 1 point~D: Diabetes Mellitus history: 1 point~S: Stroke symptoms previously or Transient Ischemic Attack [TIA]: 2 points"|participants|Number|191|191.0||||||
4029864|NCT01151137|3851545|B1|< 2||CHADS2 Score|"CHADS2 is a risk-prediction score ranging from 0 to 6 used estimate Stroke Risk in Atrial Fibrillation patients.~CHADS2 score is obtained by adding together the points that correspond to the conditions that are present:~C: Congestive Heart Failure history: 1 point~H: Hypertension history: 1 point~A: Age ≥75 years: 1 point~D: Diabetes Mellitus history: 1 point~S: Stroke symptoms previously or Transient Ischemic Attack [TIA]: 2 points"|participants|Number|172|172.0||||||
4029865|NCT01151137|3851543|B3|Unknown||Permanent atrial fibrillation [AF] history||participants|Number|5|5.0||||||
4029866|NCT01151137|3851544|B2|Unknown||Permanent atrial fibrillation [AF] history||participants|Number|2|2.0||||||
4029867|NCT01151137|3851545|B1|Unknown||Permanent atrial fibrillation [AF] history||participants|Number|3|3.0||||||
4029868|NCT01151137|3851543|B3|> 2 years||Permanent atrial fibrillation [AF] history||participants|Number|2243|2243.0||||||
4029869|NCT01151137|3851544|B2|> 2 years||Permanent atrial fibrillation [AF] history||participants|Number|1119|1119.0||||||
4029870|NCT01151137|3851545|B1|> 2 years||Permanent atrial fibrillation [AF] history||participants|Number|1124|1124.0||||||
4029871|NCT01151137|3851543|B3|6 months to 2 years||Permanent atrial fibrillation [AF] history||participants|Number|988|988.0||||||
4029872|NCT01151137|3851544|B2|6 months to 2 years||Permanent atrial fibrillation [AF] history||participants|Number|498|498.0||||||
4029873|NCT01151137|3851545|B1|6 months to 2 years||Permanent atrial fibrillation [AF] history||participants|Number|490|490.0||||||
4029874|NCT01151137|3851543|B3|Rest of the word||Region of Enrollment|"Regions were defined as follows:~North America: Canada, United States~South America: Argentina, Brazil, Chile, Mexico~Western Europe: Austria, Belgium, Denmark, Finland, France, Germany, Greece, Italy, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom~Eastern Europe: Bulgaria, Czech Republic, Hungary, Poland, Romania, Russian Federation, Slovakia, Ukraine Asia: Hong Kong, Republic of Korea, Malaysia, Singapore, Taiwan Rest of the World: Australia, Israel, New zealand, South Africa"|participants|Number|209|209.0||||||
4029875|NCT01151137|3851544|B2|Rest of the word||Region of Enrollment|"Regions were defined as follows:~North America: Canada, United States~South America: Argentina, Brazil, Chile, Mexico~Western Europe: Austria, Belgium, Denmark, Finland, France, Germany, Greece, Italy, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom~Eastern Europe: Bulgaria, Czech Republic, Hungary, Poland, Romania, Russian Federation, Slovakia, Ukraine Asia: Hong Kong, Republic of Korea, Malaysia, Singapore, Taiwan Rest of the World: Australia, Israel, New zealand, South Africa"|participants|Number|107|107.0||||||
4029876|NCT01151137|3851545|B1|Rest of the word||Region of Enrollment|"Regions were defined as follows:~North America: Canada, United States~South America: Argentina, Brazil, Chile, Mexico~Western Europe: Austria, Belgium, Denmark, Finland, France, Germany, Greece, Italy, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom~Eastern Europe: Bulgaria, Czech Republic, Hungary, Poland, Romania, Russian Federation, Slovakia, Ukraine Asia: Hong Kong, Republic of Korea, Malaysia, Singapore, Taiwan Rest of the World: Australia, Israel, New zealand, South Africa"|participants|Number|102|102.0||||||
4029877|NCT01151137|3851543|B3|Asia||Region of Enrollment|"Regions were defined as follows:~North America: Canada, United States~South America: Argentina, Brazil, Chile, Mexico~Western Europe: Austria, Belgium, Denmark, Finland, France, Germany, Greece, Italy, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom~Eastern Europe: Bulgaria, Czech Republic, Hungary, Poland, Romania, Russian Federation, Slovakia, Ukraine Asia: Hong Kong, Republic of Korea, Malaysia, Singapore, Taiwan Rest of the World: Australia, Israel, New zealand, South Africa"|participants|Number|100|100.0||||||
4029947|NCT01151046|3851585|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4029948|NCT01151046|3851586|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4029878|NCT01151137|3851544|B2|Asia||Region of Enrollment|"Regions were defined as follows:~North America: Canada, United States~South America: Argentina, Brazil, Chile, Mexico~Western Europe: Austria, Belgium, Denmark, Finland, France, Germany, Greece, Italy, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom~Eastern Europe: Bulgaria, Czech Republic, Hungary, Poland, Romania, Russian Federation, Slovakia, Ukraine Asia: Hong Kong, Republic of Korea, Malaysia, Singapore, Taiwan Rest of the World: Australia, Israel, New zealand, South Africa"|participants|Number|47|47.0||||||
4029879|NCT01151137|3851545|B1|Asia||Region of Enrollment|"Regions were defined as follows:~North America: Canada, United States~South America: Argentina, Brazil, Chile, Mexico~Western Europe: Austria, Belgium, Denmark, Finland, France, Germany, Greece, Italy, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom~Eastern Europe: Bulgaria, Czech Republic, Hungary, Poland, Romania, Russian Federation, Slovakia, Ukraine Asia: Hong Kong, Republic of Korea, Malaysia, Singapore, Taiwan Rest of the World: Australia, Israel, New zealand, South Africa"|participants|Number|53|53.0||||||
4029880|NCT01151137|3851543|B3|Eastern Europe||Region of Enrollment|"Regions were defined as follows:~North America: Canada, United States~South America: Argentina, Brazil, Chile, Mexico~Western Europe: Austria, Belgium, Denmark, Finland, France, Germany, Greece, Italy, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom~Eastern Europe: Bulgaria, Czech Republic, Hungary, Poland, Romania, Russian Federation, Slovakia, Ukraine Asia: Hong Kong, Republic of Korea, Malaysia, Singapore, Taiwan Rest of the World: Australia, Israel, New zealand, South Africa"|participants|Number|983|983.0||||||
4029881|NCT01151137|3851544|B2|Eastern Europe||Region of Enrollment|"Regions were defined as follows:~North America: Canada, United States~South America: Argentina, Brazil, Chile, Mexico~Western Europe: Austria, Belgium, Denmark, Finland, France, Germany, Greece, Italy, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom~Eastern Europe: Bulgaria, Czech Republic, Hungary, Poland, Romania, Russian Federation, Slovakia, Ukraine Asia: Hong Kong, Republic of Korea, Malaysia, Singapore, Taiwan Rest of the World: Australia, Israel, New zealand, South Africa"|participants|Number|488|488.0||||||
4029882|NCT01151137|3851545|B1|Eastern Europe||Region of Enrollment|"Regions were defined as follows:~North America: Canada, United States~South America: Argentina, Brazil, Chile, Mexico~Western Europe: Austria, Belgium, Denmark, Finland, France, Germany, Greece, Italy, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom~Eastern Europe: Bulgaria, Czech Republic, Hungary, Poland, Romania, Russian Federation, Slovakia, Ukraine Asia: Hong Kong, Republic of Korea, Malaysia, Singapore, Taiwan Rest of the World: Australia, Israel, New zealand, South Africa"|participants|Number|495|495.0||||||
4029883|NCT01151137|3851543|B3|Western Europe||Region of Enrollment|"Regions were defined as follows:~North America: Canada, United States~South America: Argentina, Brazil, Chile, Mexico~Western Europe: Austria, Belgium, Denmark, Finland, France, Germany, Greece, Italy, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom~Eastern Europe: Bulgaria, Czech Republic, Hungary, Poland, Romania, Russian Federation, Slovakia, Ukraine Asia: Hong Kong, Republic of Korea, Malaysia, Singapore, Taiwan Rest of the World: Australia, Israel, New zealand, South Africa"|participants|Number|934|934.0||||||
4029884|NCT01151137|3851544|B2|Western Europe||Region of Enrollment|"Regions were defined as follows:~North America: Canada, United States~South America: Argentina, Brazil, Chile, Mexico~Western Europe: Austria, Belgium, Denmark, Finland, France, Germany, Greece, Italy, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom~Eastern Europe: Bulgaria, Czech Republic, Hungary, Poland, Romania, Russian Federation, Slovakia, Ukraine Asia: Hong Kong, Republic of Korea, Malaysia, Singapore, Taiwan Rest of the World: Australia, Israel, New zealand, South Africa"|participants|Number|475|475.0||||||
4029885|NCT01151137|3851545|B1|Western Europe||Region of Enrollment|"Regions were defined as follows:~North America: Canada, United States~South America: Argentina, Brazil, Chile, Mexico~Western Europe: Austria, Belgium, Denmark, Finland, France, Germany, Greece, Italy, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom~Eastern Europe: Bulgaria, Czech Republic, Hungary, Poland, Romania, Russian Federation, Slovakia, Ukraine Asia: Hong Kong, Republic of Korea, Malaysia, Singapore, Taiwan Rest of the World: Australia, Israel, New zealand, South Africa"|participants|Number|459|459.0||||||
4029886|NCT01151137|3851543|B3|South America||Region of Enrollment|"Regions were defined as follows:~North America: Canada, United States~South America: Argentina, Brazil, Chile, Mexico~Western Europe: Austria, Belgium, Denmark, Finland, France, Germany, Greece, Italy, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom~Eastern Europe: Bulgaria, Czech Republic, Hungary, Poland, Romania, Russian Federation, Slovakia, Ukraine Asia: Hong Kong, Republic of Korea, Malaysia, Singapore, Taiwan Rest of the World: Australia, Israel, New zealand, South Africa"|participants|Number|463|463.0||||||
4029887|NCT01151137|3851544|B2|South America||Region of Enrollment|"Regions were defined as follows:~North America: Canada, United States~South America: Argentina, Brazil, Chile, Mexico~Western Europe: Austria, Belgium, Denmark, Finland, France, Germany, Greece, Italy, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom~Eastern Europe: Bulgaria, Czech Republic, Hungary, Poland, Romania, Russian Federation, Slovakia, Ukraine Asia: Hong Kong, Republic of Korea, Malaysia, Singapore, Taiwan Rest of the World: Australia, Israel, New zealand, South Africa"|participants|Number|236|236.0||||||
4029888|NCT01151137|3851545|B1|South America||Region of Enrollment|"Regions were defined as follows:~North America: Canada, United States~South America: Argentina, Brazil, Chile, Mexico~Western Europe: Austria, Belgium, Denmark, Finland, France, Germany, Greece, Italy, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom~Eastern Europe: Bulgaria, Czech Republic, Hungary, Poland, Romania, Russian Federation, Slovakia, Ukraine Asia: Hong Kong, Republic of Korea, Malaysia, Singapore, Taiwan Rest of the World: Australia, Israel, New zealand, South Africa"|participants|Number|227|227.0||||||
4029889|NCT01151137|3851543|B3|North America||Region of Enrollment|"Regions were defined as follows:~North America: Canada, United States~South America: Argentina, Brazil, Chile, Mexico~Western Europe: Austria, Belgium, Denmark, Finland, France, Germany, Greece, Italy, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom~Eastern Europe: Bulgaria, Czech Republic, Hungary, Poland, Romania, Russian Federation, Slovakia, Ukraine Asia: Hong Kong, Republic of Korea, Malaysia, Singapore, Taiwan Rest of the World: Australia, Israel, New zealand, South Africa"|participants|Number|547|547.0||||||
4029949|NCT01151046|3851584|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4029950|NCT01151046|3851585|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4029951|NCT01151046|3851586|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4029890|NCT01151137|3851544|B2|North America||Region of Enrollment|"Regions were defined as follows:~North America: Canada, United States~South America: Argentina, Brazil, Chile, Mexico~Western Europe: Austria, Belgium, Denmark, Finland, France, Germany, Greece, Italy, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom~Eastern Europe: Bulgaria, Czech Republic, Hungary, Poland, Romania, Russian Federation, Slovakia, Ukraine Asia: Hong Kong, Republic of Korea, Malaysia, Singapore, Taiwan Rest of the World: Australia, Israel, New zealand, South Africa"|participants|Number|266|266.0||||||
4029891|NCT01151137|3851545|B1|North America||Region of Enrollment|"Regions were defined as follows:~North America: Canada, United States~South America: Argentina, Brazil, Chile, Mexico~Western Europe: Austria, Belgium, Denmark, Finland, France, Germany, Greece, Italy, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom~Eastern Europe: Bulgaria, Czech Republic, Hungary, Poland, Romania, Russian Federation, Slovakia, Ukraine Asia: Hong Kong, Republic of Korea, Malaysia, Singapore, Taiwan Rest of the World: Australia, Israel, New zealand, South Africa"|participants|Number|281|281.0||||||
4029892|NCT01151137|3851543|B3||Male|Sex: Female, Male||Participants|Count of Participants|2091|2091.0||||||
4029893|NCT01151137|3851544|B2||Male|Sex: Female, Male||Participants|Count of Participants|1051|1051.0||||||
4029894|NCT01151137|3851545|B1||Male|Sex: Female, Male||Participants|Count of Participants|1040|1040.0||||||
4029895|NCT01151137|3851543|B3||Female|Sex: Female, Male||Participants|Count of Participants|1145|1145.0||||||
4029896|NCT01151137|3851544|B2||Female|Sex: Female, Male||Participants|Count of Participants|568|568.0||||||
4029897|NCT01151137|3851545|B1||Female|Sex: Female, Male||Participants|Count of Participants|577|577.0||||||
4029898|NCT01151137|3851543|B3|||Age||years|Mean|75.0|75.0|Standard Deviation|5.9|5.9|||
4029899|NCT01151137|3851544|B2|||Age||years|Mean|75.0|75.0|Standard Deviation|5.9|5.9|||
4029900|NCT01151137|3851545|B1|||Age||years|Mean|75.0|75.0|Standard Deviation|5.9|5.9|||
4029901|NCT01151098|3851564|B1|United Kingdom||Region of Enrollment||participants|Number|86|86.0||||||
4029902|NCT01151098|3851564|B1|United States||Region of Enrollment||participants|Number|103|103.0||||||
4029903|NCT01151098|3851564|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4029904|NCT01151098|3851564|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4029905|NCT01151098|3851564|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|12.84|12.84|||
4029906|NCT01151085|3851568|B1||Male|Sex: Female, Male||Participants|Count of Participants|611|611.0||||||
4029907|NCT01151085|3851568|B1||Female|Sex: Female, Male||Participants|Count of Participants|335|335.0||||||
4029908|NCT01151085|3851568|B1|>=65 years||Age, Customized||participants|Number|446|446.0||||||
4029909|NCT01151085|3851568|B1|<65 years||Age, Customized||participants|Number|500|500.0||||||
4029910|NCT01151046|3851584|B3|Metastatic||Progression Setting (Adjuvant, Metastatic)||participants|Number|71|71.0||||||
4029911|NCT01151046|3851585|B2|Metastatic||Progression Setting (Adjuvant, Metastatic)||participants|Number|37|37.0||||||
4029912|NCT01151046|3851586|B1|Metastatic||Progression Setting (Adjuvant, Metastatic)||participants|Number|34|34.0||||||
4029913|NCT01151046|3851584|B3|Adjuvant||Progression Setting (Adjuvant, Metastatic)||participants|Number|44|44.0||||||
4029914|NCT01151046|3851585|B2|Adjuvant||Progression Setting (Adjuvant, Metastatic)||participants|Number|22|22.0||||||
4029915|NCT01151046|3851586|B1|Adjuvant||Progression Setting (Adjuvant, Metastatic)||participants|Number|22|22.0||||||
4029916|NCT01151046|3851584|B3|Bone-Only (No)||Bone-Only Disease (Y/N)||participants|Number|86|86.0||||||
4029917|NCT01151046|3851585|B2|Bone-Only (No)||Bone-Only Disease (Y/N)||participants|Number|42|42.0||||||
4029918|NCT01151046|3851586|B1|Bone-Only (No)||Bone-Only Disease (Y/N)||participants|Number|44|44.0||||||
4029919|NCT01151046|3851584|B3|Bone-Only (Yes)||Bone-Only Disease (Y/N)||participants|Number|29|29.0||||||
4029920|NCT01151046|3851585|B2|Bone-Only (Yes)||Bone-Only Disease (Y/N)||participants|Number|17|17.0||||||
4029921|NCT01151046|3851586|B1|Bone-Only (Yes)||Bone-Only Disease (Y/N)||participants|Number|12|12.0||||||
4029922|NCT01151046|3851584|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029923|NCT01151046|3851585|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029924|NCT01151046|3851586|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029925|NCT01151046|3851584|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029926|NCT01151046|3851585|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029927|NCT01151046|3851586|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029928|NCT01151046|3851584|B3||White|Race (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
4029929|NCT01151046|3851585|B2||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4029930|NCT01151046|3851586|B1||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4029931|NCT01151046|3851584|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4029932|NCT01151046|3851585|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029933|NCT01151046|3851586|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4029934|NCT01151046|3851584|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4029935|NCT01151046|3851585|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4029936|NCT01151046|3851586|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029937|NCT01151046|3851584|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029938|NCT01151046|3851585|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029939|NCT01151046|3851586|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029940|NCT01151046|3851584|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029941|NCT01151046|3851585|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4029952|NCT01151046|3851584|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4029953|NCT01151046|3851585|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4029954|NCT01151046|3851586|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4029955|NCT01151046|3851584|B3||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4029956|NCT01151046|3851585|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4029957|NCT01151046|3851586|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4029958|NCT01151046|3851584|B3|||Age||years|Mean|61.6|61.6|Standard Deviation|9.81|9.81|||
4029959|NCT01151046|3851585|B2|||Age||years|Mean|60.5|60.5|Standard Deviation|9.13|9.13|||
4029960|NCT01151046|3851586|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|10.43|10.43|||
4029961|NCT01151046|3851584|B3||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
4029962|NCT01151046|3851585|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4029963|NCT01151046|3851586|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4029964|NCT01151046|3851584|B3||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
4029965|NCT01151046|3851585|B2||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4029966|NCT01151046|3851586|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4029967|NCT01151046|3851584|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4029968|NCT01151046|3851585|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4029969|NCT01151046|3851586|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4029970|NCT01151020|3851599|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4029971|NCT01151020|3851599|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4029972|NCT01151020|3851599|B1|||Age||years|Mean|72.2|72.2|Standard Deviation|9.8|9.8|||
4029973|NCT01150981|3851604|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
4029974|NCT01150981|3851605|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4029975|NCT01150981|3851606|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4029976|NCT01150981|3851604|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4029977|NCT01150981|3851605|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4029978|NCT01150981|3851606|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4029979|NCT01150981|3851604|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4029980|NCT01150981|3851605|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4029981|NCT01150981|3851606|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4029982|NCT01150981|3851604|B3|||Age||years|Mean|40.09|40.09|Standard Deviation|10.43|10.43|||
4029983|NCT01150981|3851605|B2|||Age||years|Mean|40.2|40.2|Standard Deviation|10.23|10.23|||
4029984|NCT01150981|3851606|B1|||Age||years|Mean|39.25|39.25|Standard Deviation|2.42|2.42|||
4029985|NCT01150981|3851604|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4029986|NCT01150981|3851605|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4029987|NCT01150981|3851606|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4029988|NCT01150981|3851604|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4029989|NCT01150981|3851605|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4029990|NCT01150981|3851606|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4029991|NCT01150981|3851604|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4029992|NCT01150981|3851605|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4029993|NCT01150981|3851606|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4029994|NCT01150903|3851615|B3||Male|Sex: Female, Male||Participants|Count of Participants|98832|98832.0||||||
4029995|NCT01150903|3851616|B2||Male|Sex: Female, Male||Participants|Count of Participants|74124|74124.0||||||
4029996|NCT01150903|3851617|B1||Male|Sex: Female, Male||Participants|Count of Participants|24708|24708.0||||||
4029997|NCT01150903|3851615|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4029998|NCT01150903|3851616|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4029999|NCT01150903|3851617|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4030000|NCT01150903|3851615|B3|||Age||Years|Median|59.0|59.0|Full Range|||18.0|91.0|
4030001|NCT01150903|3851616|B2|||Age||Years|Median|59.0|59.0|Full Range|||18.0|91.0|
4030002|NCT01150903|3851617|B1|||Age||Years|Median|59.0|59.0|Full Range|||18.0|91.0|
4030003|NCT01150903|3851615|B3|||Age||Years|Mean|57.63|57.63|Standard Deviation|11.59|11.59|||
4030004|NCT01150903|3851616|B2|||Age||Years|Mean|57.63|57.63|Standard Deviation|11.59|11.59|||
4030005|NCT01150903|3851617|B1|||Age||Years|Mean|57.63|57.63|Standard Deviation|11.59|11.59|||
4030006|NCT01150760|3851632|B3|Other||Surgeon type|The type of surgeon that performed the patient's bowel resection during their hospitalization|Participants|Number|718|718.0||||||
4030007|NCT01150760|3851633|B2|Other||Surgeon type|The type of surgeon that performed the patient's bowel resection during their hospitalization|Participants|Number|359|359.0||||||
4030008|NCT01150760|3851634|B1|Other||Surgeon type|The type of surgeon that performed the patient's bowel resection during their hospitalization|Participants|Number|359|359.0||||||
4030009|NCT01150760|3851632|B3|Colorectal surgeon||Surgeon type|The type of surgeon that performed the patient's bowel resection during their hospitalization|Participants|Number|2714|2714.0||||||
4030010|NCT01150760|3851633|B2|Colorectal surgeon||Surgeon type|The type of surgeon that performed the patient's bowel resection during their hospitalization|Participants|Number|1357|1357.0||||||
4030114|NCT01150409|3851714|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4030011|NCT01150760|3851634|B1|Colorectal surgeon||Surgeon type|The type of surgeon that performed the patient's bowel resection during their hospitalization|Participants|Number|1357|1357.0||||||
4030012|NCT01150760|3851632|B3|General surgeon||Surgeon type|The type of surgeon that performed the patient's bowel resection during their hospitalization|Participants|Number|3618|3618.0||||||
4030013|NCT01150760|3851633|B2|General surgeon||Surgeon type|The type of surgeon that performed the patient's bowel resection during their hospitalization|Participants|Number|1809|1809.0||||||
4030014|NCT01150760|3851634|B1|General surgeon||Surgeon type|The type of surgeon that performed the patient's bowel resection during their hospitalization|Participants|Number|1809|1809.0||||||
4030015|NCT01150760|3851632|B3|Laparoscopic or open ostomy takedown, bypass,other||Procedure type|Category of bowel resection that patients underwent during their hospitalization|Participants|Number|644|644.0||||||
4030016|NCT01150760|3851633|B2|Laparoscopic or open ostomy takedown, bypass,other||Procedure type|Category of bowel resection that patients underwent during their hospitalization|Participants|Number|322|322.0||||||
4030017|NCT01150760|3851634|B1|Laparoscopic or open ostomy takedown, bypass,other||Procedure type|Category of bowel resection that patients underwent during their hospitalization|Participants|Number|322|322.0||||||
4030018|NCT01150760|3851632|B3|Laparoscopic or open small bowel resection||Procedure type|Category of bowel resection that patients underwent during their hospitalization|Participants|Number|362|362.0||||||
4030019|NCT01150760|3851633|B2|Laparoscopic or open small bowel resection||Procedure type|Category of bowel resection that patients underwent during their hospitalization|Participants|Number|181|181.0||||||
4030020|NCT01150760|3851634|B1|Laparoscopic or open small bowel resection||Procedure type|Category of bowel resection that patients underwent during their hospitalization|Participants|Number|181|181.0||||||
4030021|NCT01150760|3851632|B3|Laparoscopic or open colon or rectal resection||Procedure type|Category of bowel resection that patients underwent during their hospitalization|Participants|Number|848|848.0||||||
4030022|NCT01150760|3851633|B2|Laparoscopic or open colon or rectal resection||Procedure type|Category of bowel resection that patients underwent during their hospitalization|Participants|Number|424|424.0||||||
4030023|NCT01150760|3851634|B1|Laparoscopic or open colon or rectal resection||Procedure type|Category of bowel resection that patients underwent during their hospitalization|Participants|Number|424|424.0||||||
4030024|NCT01150760|3851632|B3|Open colon or rectal resection||Procedure type|Category of bowel resection that patients underwent during their hospitalization|Participants|Number|2342|2342.0||||||
4030025|NCT01150760|3851633|B2|Open colon or rectal resection||Procedure type|Category of bowel resection that patients underwent during their hospitalization|Participants|Number|1171|1171.0||||||
4030026|NCT01150760|3851634|B1|Open colon or rectal resection||Procedure type|Category of bowel resection that patients underwent during their hospitalization|Participants|Number|1171|1171.0||||||
4030027|NCT01150760|3851632|B3|Laparoscopic colon or rectal resection||Procedure type|Category of bowel resection that patients underwent during their hospitalization|Participants|Number|2854|2854.0||||||
4030028|NCT01150760|3851633|B2|Laparoscopic colon or rectal resection||Procedure type|Category of bowel resection that patients underwent during their hospitalization|Participants|Number|1427|1427.0||||||
4030029|NCT01150760|3851634|B1|Laparoscopic colon or rectal resection||Procedure type|Category of bowel resection that patients underwent during their hospitalization|Participants|Number|1427|1427.0||||||
4030030|NCT01150760|3851632|B3|Other||Race/Ethnicity, Customized||Participants|Number|1133|1133.0||||||
4030031|NCT01150760|3851633|B2|Other||Race/Ethnicity, Customized||Participants|Number|614|614.0||||||
4030032|NCT01150760|3851634|B1|Other||Race/Ethnicity, Customized||Participants|Number|519|519.0||||||
4030033|NCT01150760|3851632|B3|White||Race/Ethnicity, Customized||Participants|Number|5218|5218.0||||||
4030034|NCT01150760|3851633|B2|White||Race/Ethnicity, Customized||Participants|Number|2543|2543.0||||||
4030035|NCT01150760|3851634|B1|White||Race/Ethnicity, Customized||Participants|Number|2675|2675.0||||||
4030036|NCT01150760|3851632|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|699|699.0||||||
4030037|NCT01150760|3851633|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|368|368.0||||||
4030038|NCT01150760|3851634|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|331|331.0||||||
4030039|NCT01150760|3851632|B3||Male|Sex: Female, Male||Participants|Count of Participants|3331|3331.0||||||
4030040|NCT01150760|3851633|B2||Male|Sex: Female, Male||Participants|Count of Participants|1653|1653.0||||||
4030041|NCT01150760|3851634|B1||Male|Sex: Female, Male||Participants|Count of Participants|1678|1678.0||||||
4030042|NCT01150760|3851632|B3||Female|Sex: Female, Male||Participants|Count of Participants|3719|3719.0||||||
4030043|NCT01150760|3851633|B2||Female|Sex: Female, Male||Participants|Count of Participants|1872|1872.0||||||
4030044|NCT01150760|3851634|B1||Female|Sex: Female, Male||Participants|Count of Participants|1847|1847.0||||||
4030045|NCT01150760|3851632|B3|||Age||years|Mean|61.9|61.9|Standard Deviation|14.4|14.4|||
4030046|NCT01150760|3851633|B2|||Age||years|Mean|61.8|61.8|Standard Deviation|14.7|14.7|||
4030047|NCT01150760|3851634|B1|||Age||years|Mean|61.9|61.9|Standard Deviation|14.1|14.1|||
4030048|NCT01150500|3851667|B1|Japan||Region of Enrollment||participants|Number|65|65.0||||||
4030049|NCT01150500|3851667|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4030050|NCT01150500|3851667|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4030051|NCT01150500|3851667|B1|||Age||years|Mean|69.4|69.4|Standard Deviation|9.5|9.5|||
4030052|NCT01150500|3851667|B1||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4030053|NCT01150500|3851667|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4030054|NCT01150500|3851667|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4030055|NCT01150474|3851676|B3|||Preoperative Pain|Pain was recorded on a validated numeric pain scale (1-10), with 0 = no pain and 10 = worst pain imaginable. Not all participants completed the pain scale, therefore the populations analyzed were Belladonna and Morphine Suppository Arm (N=39), Placebo Suppository Arm (N=45).|units on a scale|Mean|0.3|0.3|Standard Deviation|1.07|1.07|||
4030056|NCT01150474|3851677|B2|||Preoperative Pain|Pain was recorded on a validated numeric pain scale (1-10), with 0 = no pain and 10 = worst pain imaginable. Not all participants completed the pain scale, therefore the populations analyzed were Belladonna and Morphine Suppository Arm (N=39), Placebo Suppository Arm (N=45).|units on a scale|Mean|0.24|0.24|Standard Deviation|0.91|0.91|||
4030057|NCT01150474|3851678|B1|||Preoperative Pain|Pain was recorded on a validated numeric pain scale (1-10), with 0 = no pain and 10 = worst pain imaginable. Not all participants completed the pain scale, therefore the populations analyzed were Belladonna and Morphine Suppository Arm (N=39), Placebo Suppository Arm (N=45).|units on a scale|Mean|0.44|0.44|Standard Deviation|1.25|1.25|||
4030058|NCT01150474|3851676|B3|||Estimated Blood Loss||mL|Mean|161|161.0|Standard Deviation|186|186.0|||
4030059|NCT01150474|3851677|B2|||Estimated Blood Loss||mL|Mean|150|150.0|Standard Deviation|110|110.0|||
4030060|NCT01150474|3851678|B1|||Estimated Blood Loss||mL|Mean|180|180.0|Standard Deviation|250|250.0|||
4030061|NCT01150474|3851676|B3|||Procedure time||minutes|Mean|97|97.0|Standard Deviation|37|37.0|||
4030062|NCT01150474|3851677|B2|||Procedure time||minutes|Mean|96|96.0|Standard Deviation|38|38.0|||
4030063|NCT01150474|3851678|B1|||Procedure time||minutes|Mean|98|98.0|Standard Deviation|37|37.0|||
4030064|NCT01150474|3851676|B3|No Prolapse||Pelvic Organ Prolapse||participants|Number|44|44.0||||||
4030065|NCT01150474|3851677|B2|No Prolapse||Pelvic Organ Prolapse||participants|Number|24|24.0||||||
4030066|NCT01150474|3851678|B1|No Prolapse||Pelvic Organ Prolapse||participants|Number|20|20.0||||||
4030067|NCT01150474|3851676|B3|Prolapse||Pelvic Organ Prolapse||participants|Number|46|46.0||||||
4030068|NCT01150474|3851677|B2|Prolapse||Pelvic Organ Prolapse||participants|Number|25|25.0||||||
4030069|NCT01150474|3851678|B1|Prolapse||Pelvic Organ Prolapse||participants|Number|21|21.0||||||
4030070|NCT01150474|3851676|B3|United States||Region of Enrollment||participants|Number|90|90.0||||||
4030071|NCT01150474|3851677|B2|United States||Region of Enrollment||participants|Number|49|49.0||||||
4030072|NCT01150474|3851678|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4030073|NCT01150474|3851676|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4030074|NCT01150474|3851677|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4030075|NCT01150474|3851678|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4030076|NCT01150474|3851676|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4030077|NCT01150474|3851677|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4030078|NCT01150474|3851678|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4030079|NCT01150474|3851676|B3|||Age||years|Mean|55|55.0|Standard Deviation|12.5|12.5|||
4030080|NCT01150474|3851677|B2|||Age||years|Mean|55|55.0|Standard Deviation|13|13.0|||
4030081|NCT01150474|3851678|B1|||Age||years|Mean|56|56.0|Standard Deviation|12|12.0|||
4030082|NCT01150461|3851701|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4030083|NCT01150461|3851702|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4030084|NCT01150461|3851703|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4030085|NCT01150461|3851701|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4030086|NCT01150461|3851702|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4030087|NCT01150461|3851703|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4030088|NCT01150461|3851701|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4030089|NCT01150461|3851702|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4030090|NCT01150461|3851703|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4030091|NCT01150461|3851701|B3|||Age||years|Mean|51|51.0|Standard Deviation|13|13.0|||
4030092|NCT01150461|3851702|B2|||Age||years|Mean|54|54.0|Standard Deviation|11|11.0|||
4030093|NCT01150461|3851703|B1|||Age||years|Mean|49|49.0|Standard Deviation|14|14.0|||
4030094|NCT01150461|3851701|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4030095|NCT01150461|3851702|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4030096|NCT01150461|3851703|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4030097|NCT01150461|3851701|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4030098|NCT01150461|3851702|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4030099|NCT01150461|3851703|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4030100|NCT01150461|3851701|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4030101|NCT01150461|3851702|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4030102|NCT01150461|3851703|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4030103|NCT01150409|3851712|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4030104|NCT01150409|3851714|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4030105|NCT01150409|3851712|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4030106|NCT01150409|3851714|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4030107|NCT01150409|3851712|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4030108|NCT01150409|3851714|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4030109|NCT01150409|3851712|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4030110|NCT01150409|3851714|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4030111|NCT01150409|3851712|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4030112|NCT01150409|3851714|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4030113|NCT01150409|3851712|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4030115|NCT01150357|3851721|B4||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4030116|NCT01150357|3851722|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4030117|NCT01150357|3851723|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4030118|NCT01150357|3851724|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4030119|NCT01150357|3851721|B4||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4030120|NCT01150357|3851722|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4030121|NCT01150357|3851723|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4030122|NCT01150357|3851724|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4030123|NCT01150357|3851721|B4|Adolescents 12 – 17 years||Age, Customized||participants|Number|139|139.0||||||
4030124|NCT01150357|3851722|B3|Adolescents 12 – 17 years||Age, Customized||participants|Number|54|54.0||||||
4030125|NCT01150357|3851723|B2|Adolescents 12 – 17 years||Age, Customized||participants|Number|26|26.0||||||
4030126|NCT01150357|3851724|B1|Adolescents 12 – 17 years||Age, Customized||participants|Number|59|59.0||||||
4030127|NCT01150357|3851721|B4|Children 6 – 11 years||Age, Customized||participants|Number|128|128.0||||||
4030128|NCT01150357|3851722|B3|Children 6 – 11 years||Age, Customized||participants|Number|51|51.0||||||
4030129|NCT01150357|3851723|B2|Children 6 – 11 years||Age, Customized||participants|Number|28|28.0||||||
4030130|NCT01150357|3851724|B1|Children 6 – 11 years||Age, Customized||participants|Number|49|49.0||||||
4030131|NCT01150357|3851721|B4|||Age||years|Mean|11.8|11.8|Standard Deviation|3.36|3.36|||
4030132|NCT01150357|3851722|B3|||Age||years|Mean|11.8|11.8|Standard Deviation|3.5|3.5|||
4030133|NCT01150357|3851723|B2|||Age||years|Mean|11.6|11.6|Standard Deviation|3.29|3.29|||
4030134|NCT01150357|3851724|B1|||Age||years|Mean|11.9|11.9|Standard Deviation|3.27|3.27|||
4030135|NCT01150123|3851788|B19||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4030136|NCT01150123|3851789|B18||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4030137|NCT01150123|3851790|B17||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4030138|NCT01150123|3851791|B16||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4030139|NCT01150123|3851792|B15||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4030140|NCT01150123|3851793|B14||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4030141|NCT01150123|3851794|B13||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4030142|NCT01150123|3851795|B12||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4030143|NCT01150123|3851796|B11||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4030144|NCT01150123|3851797|B10||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4030145|NCT01150123|3851798|B9||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4030146|NCT01150123|3851799|B8||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4030147|NCT01150123|3851800|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4030148|NCT01150123|3851801|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4030149|NCT01150123|3851802|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4030150|NCT01150123|3851803|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4030151|NCT01150123|3851804|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4030152|NCT01150123|3851805|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4030153|NCT01150123|3851806|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4030154|NCT01150123|3851788|B19||Female|Sex: Female, Male||Participants|Count of Participants|678|678.0||||||
4030155|NCT01150123|3851789|B18||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4030156|NCT01150123|3851790|B17||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4030157|NCT01150123|3851791|B16||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4030158|NCT01150123|3851792|B15||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4030159|NCT01150123|3851793|B14||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4030160|NCT01150123|3851794|B13||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4030161|NCT01150123|3851795|B12||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4030162|NCT01150123|3851796|B11||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4030163|NCT01150123|3851797|B10||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4030164|NCT01150123|3851798|B9||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4030165|NCT01150123|3851799|B8||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4030166|NCT01150123|3851800|B7||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4030167|NCT01150123|3851801|B6||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4030168|NCT01150123|3851802|B5||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4030169|NCT01150123|3851803|B4||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4030170|NCT01150123|3851804|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4030171|NCT01150123|3851805|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4030172|NCT01150123|3851806|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4030173|NCT01150123|3851788|B19|||Age||years|Mean|24.3|24.3|Standard Deviation|5.5|5.5|||
4030174|NCT01150123|3851789|B18|||Age||years|Mean|23.5|23.5|Standard Deviation|5.3|5.3|||
4030175|NCT01150123|3851790|B17|||Age||years|Mean|22.9|22.9|Standard Deviation|5.8|5.8|||
4030176|NCT01150123|3851791|B16|||Age||years|Mean|22.7|22.7|Standard Deviation|4.0|4.0|||
4030177|NCT01150123|3851792|B15|||Age||years|Mean|24.9|24.9|Standard Deviation|5.9|5.9|||
4030178|NCT01150123|3851793|B14|||Age||years|Mean|23.6|23.6|Standard Deviation|5.0|5.0|||
4030179|NCT01150123|3851794|B13|||Age||years|Mean|24.7|24.7|Standard Deviation|6.1|6.1|||
4030180|NCT01150123|3851795|B12|||Age||years|Mean|23.5|23.5|Standard Deviation|5.2|5.2|||
4030181|NCT01150123|3851796|B11|||Age||years|Mean|23.5|23.5|Standard Deviation|5.7|5.7|||
4030182|NCT01150123|3851797|B10|||Age||years|Mean|23.4|23.4|Standard Deviation|4.1|4.1|||
4030183|NCT01150123|3851798|B9|||Age||years|Mean|23.5|23.5|Standard Deviation|3.2|3.2|||
4030184|NCT01150123|3851799|B8|||Age||years|Mean|24.3|24.3|Standard Deviation|6.0|6.0|||
4030185|NCT01150123|3851800|B7|||Age||years|Mean|25.1|25.1|Standard Deviation|6.3|6.3|||
4030186|NCT01150123|3851801|B6|||Age||years|Mean|25.1|25.1|Standard Deviation|5.3|5.3|||
4030187|NCT01150123|3851802|B5|||Age||years|Mean|26.5|26.5|Standard Deviation|6.2|6.2|||
4030188|NCT01150123|3851803|B4|||Age||years|Mean|24.1|24.1|Standard Deviation|4.6|4.6|||
4030189|NCT01150123|3851804|B3|||Age||years|Mean|25.5|25.5|Standard Deviation|5.0|5.0|||
4030190|NCT01150123|3851805|B2|||Age||years|Mean|26.2|26.2|Standard Deviation|7.2|7.2|||
4030191|NCT01150123|3851806|B1|||Age||years|Mean|24.3|24.3|Standard Deviation|5.5|5.5|||
4030192|NCT01150097|3851996|B4||Male|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4030193|NCT01150097|3851997|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4030194|NCT01150097|3851998|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4030195|NCT01150097|3851999|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4030196|NCT01150097|3851996|B4||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4030197|NCT01150097|3851997|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4030198|NCT01150097|3851998|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4030199|NCT01150097|3851999|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4030200|NCT01150097|3851996|B4|||Age||Years|Mean|54.5|54.5|Standard Deviation|9.25|9.25|||
4030201|NCT01150097|3851997|B3|||Age||Years|Mean|55.2|55.2|Standard Deviation|8.10|8.1|||
4030202|NCT01150097|3851998|B2|||Age||Years|Mean|54.9|54.9|Standard Deviation|10.07|10.07|||
4030203|NCT01150097|3851999|B1|||Age||Years|Mean|53.5|53.5|Standard Deviation|9.57|9.57|||
4030204|NCT01149876|3852024|B5|||Baseline Hyperpigmentation Score||units on a scale|Mean|3.4|3.4|Standard Deviation|1|1.0|||
4030205|NCT01149876|3852025|B4|||Baseline Hyperpigmentation Score||units on a scale|Mean|3.28|3.28|Standard Deviation|1.07|1.07|||
4030206|NCT01149876|3852026|B3|||Baseline Hyperpigmentation Score||units on a scale|Mean|3.3|3.3|Standard Deviation|1.17|1.17|||
4030207|NCT01149876|3852027|B2|||Baseline Hyperpigmentation Score||units on a scale|Mean|3.35|3.35|Standard Deviation|.93|0.93|||
4030208|NCT01149876|3852028|B1|||Baseline Hyperpigmentation Score||units on a scale|Mean|3.7|3.7|Standard Deviation|1.03|1.03|||
4030209|NCT01149876|3852024|B5|United States||Region of Enrollment||participants|Number|80|80.0||||||
4030210|NCT01149876|3852025|B4|United States||Region of Enrollment||participants|Number|18|18.0||||||
4030211|NCT01149876|3852026|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4030212|NCT01149876|3852027|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4030213|NCT01149876|3852028|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4030214|NCT01149876|3852024|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4030215|NCT01149876|3852025|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4030216|NCT01149876|3852026|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4030217|NCT01149876|3852027|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4030218|NCT01149876|3852028|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4030219|NCT01149876|3852024|B5||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4030220|NCT01149876|3852025|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4030221|NCT01149876|3852026|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4030222|NCT01149876|3852027|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4030223|NCT01149876|3852028|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4030224|NCT01149876|3852024|B5|||Age||years|Mean|46.5|46.5|Standard Deviation|7.6|7.6|||
4030225|NCT01149876|3852025|B4|||Age||years|Mean|49.6|49.6|Standard Deviation|5.5|5.5|||
4030226|NCT01149876|3852026|B3|||Age||years|Mean|42.3|42.3|Standard Deviation|8.7|8.7|||
4030227|NCT01149876|3852027|B2|||Age||years|Mean|46.9|46.9|Standard Deviation|8.3|8.3|||
4030228|NCT01149876|3852028|B1|||Age||years|Mean|47.4|47.4|Standard Deviation|6.3|6.3|||
4030229|NCT01149863|3852045|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4030230|NCT01149863|3852045|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4030231|NCT01149863|3852045|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4030232|NCT01149863|3852045|B1|||Age, Customized||Years|Median|59|59.0|Full Range|||40.0|70.0|
4030233|NCT01149785|3852050|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4030234|NCT01149785|3852050|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4030235|NCT01149785|3852050|B1|||Age||years|Mean|36.5|36.5|Standard Deviation|7.6|7.6|||
4030236|NCT01149772|3852083|B3|||Kansas City Cardiomyopathy Questionnaire (KCCQ)|The KCCQ measures the health status of patients with congestive heart failure. The overall score is a mean score scaled from 0 - 100; where 0 represents most severe/limited functioning.|units on a scale|Mean|36.97|36.97|Standard Deviation|16.81|16.81|||
4030237|NCT01149772|3852084|B2|||Kansas City Cardiomyopathy Questionnaire (KCCQ)|The KCCQ measures the health status of patients with congestive heart failure. The overall score is a mean score scaled from 0 - 100; where 0 represents most severe/limited functioning.|units on a scale|Mean|37.03|37.03|Standard Deviation|19.36|19.36|||
4030238|NCT01149772|3852085|B1|||Kansas City Cardiomyopathy Questionnaire (KCCQ)|The KCCQ measures the health status of patients with congestive heart failure. The overall score is a mean score scaled from 0 - 100; where 0 represents most severe/limited functioning.|units on a scale|Mean|36.93|36.93|Standard Deviation|14.94|14.94|||
4030239|NCT01149772|3852083|B3|||Chronic Respiratory Questionnaire_Fatigue|The CRQ measures the quality of life of patients with a chronic respiratory disease. This subscale measures the amount of fatigue patients experience with the condition. The CRQ is a mean score and ranges from 1 - 7, where a higher score = better health.|units on a scale|Mean|2.55|2.55|Standard Deviation|.93|0.93|||
4030240|NCT01149772|3852084|B2|||Chronic Respiratory Questionnaire_Fatigue|The CRQ measures the quality of life of patients with a chronic respiratory disease. This subscale measures the amount of fatigue patients experience with the condition. The CRQ is a mean score and ranges from 1 - 7, where a higher score = better health.|units on a scale|Mean|2.43|2.43|Standard Deviation|.97|0.97|||
4030241|NCT01149772|3852085|B1|||Chronic Respiratory Questionnaire_Fatigue|The CRQ measures the quality of life of patients with a chronic respiratory disease. This subscale measures the amount of fatigue patients experience with the condition. The CRQ is a mean score and ranges from 1 - 7, where a higher score = better health.|units on a scale|Mean|2.63|2.63|Standard Deviation|.90|0.9|||
4030242|NCT01149772|3852083|B3|||Chronic Respiratory Questionnaire_Dyspnea|The CRQ measures the quality of life of patients with a chronic respiratory disease. The subscale Dyspnea looks at how much shortness of breath a patient experiences. The CRQ is a mean score and ranges from 1 - 7, where a higher score = better health.|units on a scale|Mean|2.99|2.99|Standard Deviation|.98|0.98|||
4030243|NCT01149772|3852084|B2|||Chronic Respiratory Questionnaire_Dyspnea|The CRQ measures the quality of life of patients with a chronic respiratory disease. The subscale Dyspnea looks at how much shortness of breath a patient experiences. The CRQ is a mean score and ranges from 1 - 7, where a higher score = better health.|units on a scale|Mean|2.90|2.9|Standard Deviation|1.03|1.03|||
4030244|NCT01149772|3852085|B1|||Chronic Respiratory Questionnaire_Dyspnea|The CRQ measures the quality of life of patients with a chronic respiratory disease. The subscale Dyspnea looks at how much shortness of breath a patient experiences. The CRQ is a mean score and ranges from 1 - 7, where a higher score = better health.|units on a scale|Mean|3.05|3.05|Standard Deviation|.95|0.95|||
4030245|NCT01149772|3852083|B3|||Chronic Respiratory Questionnaire_Mastery|The CRQ measures the quality of life of patients with a chronic respiratory disease. The subscale Mastery looks at the patients perceived control over the condition. The CRQ is a mean score and ranges from 1 - 7, where a higher score = better health.|units on a scale|Mean|3.57|3.57|Standard Deviation|1.08|1.08|||
4030246|NCT01149772|3852084|B2|||Chronic Respiratory Questionnaire_Mastery|The CRQ measures the quality of life of patients with a chronic respiratory disease. The subscale Mastery looks at the patients perceived control over the condition. The CRQ is a mean score and ranges from 1 - 7, where a higher score = better health.|units on a scale|Mean|3.48|3.48|Standard Deviation|1.16|1.16|||
4030247|NCT01149772|3852085|B1|||Chronic Respiratory Questionnaire_Mastery|The CRQ measures the quality of life of patients with a chronic respiratory disease. The subscale Mastery looks at the patients perceived control over the condition. The CRQ is a mean score and ranges from 1 - 7, where a higher score = better health.|units on a scale|Mean|3.63|3.63|Standard Deviation|1.03|1.03|||
4030248|NCT01149772|3852083|B3|||Beck Anxiety Inventory (BAI)|The BAI measures an individual's level of anxiety. The measure is summed and ranges from 0 - 63 (individual item score range 0 - 3 per 21 items); where higher scores = worse symptoms.|units on a scale|Mean|22.0|22.0|Standard Deviation|9.6|9.6|||
4030249|NCT01149772|3852084|B2|||Beck Anxiety Inventory (BAI)|The BAI measures an individual's level of anxiety. The measure is summed and ranges from 0 - 63 (individual item score range 0 - 3 per 21 items); where higher scores = worse symptoms.|units on a scale|Mean|22.9|22.9|Standard Deviation|10.7|10.7|||
4030250|NCT01149772|3852085|B1|||Beck Anxiety Inventory (BAI)|The BAI measures an individual's level of anxiety. The measure is summed and ranges from 0 - 63 (individual item score range 0 - 3 per 21 items); where higher scores = worse symptoms.|units on a scale|Mean|21.4|21.4|Standard Deviation|8.9|8.9|||
4030251|NCT01149772|3852083|B3|||Patient Health Questionnaire (PHQ9)|The PHQ9 measures an individual's level of depression. The measure is summed and ranges from 0 - 27 (individual item score range 0 - 3 per 9 items); where higher scores = worse symptoms.|units on a scale|Mean|14.2|14.2|Standard Deviation|4.8|4.8|||
4030252|NCT01149772|3852084|B2|||Patient Health Questionnaire (PHQ9)|The PHQ9 measures an individual's level of depression. The measure is summed and ranges from 0 - 27 (individual item score range 0 - 3 per 9 items); where higher scores = worse symptoms.|units on a scale|Mean|14.9|14.9|Standard Deviation|5.0|5.0|||
4030253|NCT01149772|3852085|B1|||Patient Health Questionnaire (PHQ9)|The PHQ9 measures an individual's level of depression. The measure is summed and ranges from 0 - 27 (individual item score range 0 - 3 per 9 items); where higher scores = worse symptoms.|units on a scale|Mean|13.8|13.8|Standard Deviation|4.6|4.6|||
4030254|NCT01149772|3852083|B3|United States||Region of Enrollment||participants|Number|302|302.0||||||
4030255|NCT01149772|3852084|B2|United States||Region of Enrollment||participants|Number|122|122.0||||||
4030256|NCT01149772|3852085|B1|United States||Region of Enrollment||participants|Number|180|180.0||||||
4030257|NCT01149772|3852083|B3||Male|Sex: Female, Male||Participants|Count of Participants|284|284.0||||||
4030258|NCT01149772|3852084|B2||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4030259|NCT01149772|3852085|B1||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4030260|NCT01149772|3852083|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4030261|NCT01149772|3852084|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4030262|NCT01149772|3852085|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4030263|NCT01149772|3852083|B3|||Age||years|Mean|65.5|65.5|Standard Deviation|8.6|8.6|||
4030264|NCT01149772|3852084|B2|||Age||years|Mean|66.5|66.5|Standard Deviation|8.3|8.3|||
4030265|NCT01149772|3852085|B1|||Age||years|Mean|64.9|64.9|Standard Deviation|8.8|8.8|||
4030266|NCT01149759|3852102|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4030267|NCT01149759|3852102|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4030268|NCT01149759|3852102|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4030269|NCT01149759|3852102|B1|||Age||years|Mean|38|38.0|Standard Deviation|2|2.0|||
4030270|NCT01149759|3852102|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4030271|NCT01149759|3852102|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4030272|NCT01149759|3852102|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4030273|NCT01149733|3852107|B3|Canada||Region of Enrollment||participants|Number|32|32.0||||||
4030274|NCT01149733|3852108|B2|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4030275|NCT01149733|3852109|B1|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4030276|NCT01149733|3852107|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4030277|NCT01149733|3852108|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4030278|NCT01149733|3852109|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4030279|NCT01149733|3852107|B3|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4030280|NCT01149733|3852108|B2|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4030281|NCT01149733|3852109|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4030282|NCT01149733|3852107|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4030283|NCT01149733|3852108|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4030284|NCT01149733|3852109|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4030285|NCT01149733|3852107|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4030286|NCT01149733|3852108|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4030287|NCT01149733|3852109|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4030288|NCT01149733|3852107|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4030289|NCT01149733|3852108|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4030290|NCT01149733|3852109|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4030291|NCT01149733|3852107|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4030292|NCT01149733|3852108|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4030293|NCT01149733|3852109|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4030294|NCT01149733|3852107|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4030295|NCT01149733|3852108|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4030296|NCT01149733|3852109|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4030297|NCT01149733|3852107|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4030298|NCT01149733|3852108|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4030299|NCT01149733|3852109|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4030300|NCT01149655|3852120|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4030301|NCT01149655|3852121|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4030302|NCT01149655|3852122|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4030303|NCT01149655|3852120|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4030304|NCT01149655|3852121|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4030305|NCT01149655|3852122|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4030306|NCT01149655|3852120|B3|Female||Age||Years|Mean|15.3|15.3|Standard Deviation|1.1|1.1|||
4030307|NCT01149655|3852121|B2|Female||Age||Years|Mean|15.3|15.3|Standard Deviation|1.0|1.0|||
4030308|NCT01149655|3852122|B1|Female||Age||Years|Mean|15.4|15.4|Standard Deviation|1.1|1.1|||
4030309|NCT01149655|3852120|B3|Male||Age||Years|Mean|15.4|15.4|Standard Deviation|1.2|1.2|||
4030310|NCT01149655|3852121|B2|Male||Age||Years|Mean|15.6|15.6|Standard Deviation|1.1|1.1|||
4030311|NCT01149655|3852122|B1|Male||Age||Years|Mean|15.3|15.3|Standard Deviation|1.3|1.3|||
4030312|NCT01149616|3852153|B3|United States||Region of Enrollment||participants|Number|82|82.0||||||
4030313|NCT01149616|3852154|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
4030314|NCT01149616|3852155|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4030315|NCT01149616|3852153|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4030316|NCT01149616|3852153|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4030317|NCT01149616|3852154|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4030318|NCT01149616|3852155|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4030319|NCT01149616|3852153|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4030320|NCT01149616|3852154|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4030321|NCT01149616|3852155|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4030322|NCT01149616|3852153|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4030323|NCT01149616|3852154|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4030324|NCT01149616|3852155|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4030325|NCT01149616|3852153|B3||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
4030326|NCT01149616|3852154|B2||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4030327|NCT01149616|3852155|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4030328|NCT01149616|3852153|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4030329|NCT01149616|3852154|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4030330|NCT01149616|3852155|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4030331|NCT01149538|3852166|B3||Male|Gender||Participants|Count of Participants|22|22.0||||||
4030332|NCT01149538|3852167|B2||Male|Gender||Participants|Count of Participants|10|10.0||||||
4030333|NCT01149538|3852168|B1||Male|Gender||Participants|Count of Participants|12|12.0||||||
4030334|NCT01149538|3852166|B3||Female|Gender||Participants|Count of Participants|38|38.0||||||
4030335|NCT01149538|3852167|B2||Female|Gender||Participants|Count of Participants|19|19.0||||||
4030336|NCT01149538|3852168|B1||Female|Gender||Participants|Count of Participants|19|19.0||||||
4030337|NCT01149538|3852166|B3|||Age||years|Mean|3.855|3.855|Standard Deviation|.78|0.78|||
4030338|NCT01149538|3852167|B2|||Age||years|Mean|3.92|3.92|Standard Deviation|.76|0.76|||
4030339|NCT01149538|3852168|B1|||Age||years|Mean|3.79|3.79|Standard Deviation|.80|0.8|||
4030340|NCT01149512|3852183|B1|||initial BMI||kg/m^2|Mean|44.2|44.2|Standard Deviation|7|7.0|||
4030341|NCT01149512|3852183|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4030342|NCT01149512|3852183|B1||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4030343|NCT01149512|3852183|B1|||Age||years|Mean|42.8|42.8|Standard Deviation|10.4|10.4|||
4030344|NCT01149486|3852188|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4030345|NCT01149486|3852189|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4030346|NCT01149486|3852190|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4030347|NCT01149486|3852188|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4030348|NCT01149486|3852189|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4030349|NCT01149486|3852190|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4030350|NCT01149486|3852188|B3|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4030351|NCT01149486|3852189|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4030352|NCT01149486|3852190|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4030353|NCT01149486|3852188|B3|American Indian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4030354|NCT01149486|3852189|B2|American Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4030355|NCT01149486|3852190|B1|American Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4030356|NCT01149486|3852188|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4030357|NCT01149486|3852189|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4030358|NCT01149486|3852190|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4030359|NCT01149486|3852188|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4030360|NCT01149486|3852189|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4030361|NCT01149486|3852190|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4030362|NCT01149486|3852188|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4030363|NCT01149486|3852189|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4030364|NCT01149486|3852190|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4030365|NCT01149486|3852188|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4030366|NCT01149486|3852189|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4030367|NCT01149486|3852190|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4030368|NCT01149486|3852188|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4030369|NCT01149486|3852189|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4030370|NCT01149486|3852190|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4030371|NCT01149473|3852213|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
4030372|NCT01149473|3852214|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4030373|NCT01149473|3852215|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4030374|NCT01149473|3852213|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4030375|NCT01149473|3852214|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4030376|NCT01149473|3852215|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4030377|NCT01149473|3852213|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|71|71.0||||||
4030378|NCT01149473|3852214|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4030379|NCT01149473|3852215|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4030380|NCT01149473|3852213|B3|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4030381|NCT01149473|3852214|B2|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4030382|NCT01149473|3852215|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4030383|NCT01149473|3852213|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4030384|NCT01149473|3852214|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4030385|NCT01149473|3852215|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4030386|NCT01149473|3852213|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4030387|NCT01149473|3852214|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4030388|NCT01149473|3852215|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4030389|NCT01149473|3852213|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4030390|NCT01149473|3852214|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4030391|NCT01149473|3852215|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4030392|NCT01149473|3852213|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4030393|NCT01149473|3852214|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4030394|NCT01149473|3852215|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4030395|NCT01149473|3852213|B3||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
4030396|NCT01149473|3852214|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4030397|NCT01149473|3852215|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4030398|NCT01149473|3852213|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4030399|NCT01149473|3852214|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4030400|NCT01149473|3852215|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4030401|NCT01149460|3852232|B3|Canada||Region of Enrollment||participants|Number|36|36.0||||||
4030402|NCT01149460|3852233|B2|Canada||Region of Enrollment||participants|Number|18|18.0||||||
4030403|NCT01149460|3852234|B1|Canada||Region of Enrollment||participants|Number|18|18.0||||||
4030404|NCT01149460|3852232|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|36|36.0||||||
4030405|NCT01149460|3852233|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4030406|NCT01149460|3852234|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4030407|NCT01149460|3852232|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4030408|NCT01149460|3852233|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4030409|NCT01149460|3852234|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4030410|NCT01149460|3852232|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4030411|NCT01149460|3852233|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4030412|NCT01149460|3852234|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4030413|NCT01149460|3852232|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4030414|NCT01149460|3852233|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4030415|NCT01149460|3852234|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4030416|NCT01149460|3852232|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4030417|NCT01149460|3852233|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4030418|NCT01149460|3852234|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4030419|NCT01149460|3852232|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4030420|NCT01149460|3852233|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4030421|NCT01149460|3852234|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4030422|NCT01149434|3852251|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4030423|NCT01149434|3852252|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4030424|NCT01149434|3852253|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4030425|NCT01149434|3852251|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4030426|NCT01149434|3852252|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4030427|NCT01149434|3852253|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4030428|NCT01149434|3852251|B3|||Age||years|Mean|60|60.0|Full Range|||35.0|80.0|
4030429|NCT01149434|3852252|B2|||Age||years|Mean|60|60.0|Full Range|||35.0|79.0|
4030430|NCT01149434|3852253|B1|||Age||years|Mean|72|72.0|Full Range|||65.0|80.0|
4030431|NCT01149421|3852265|B4|Mean Seated Heart Rate (Clinic)||Mean Heart Rate (HR)|Clinic heart rate (HR) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|beats per minute (bpm)|Mean|74.37|74.37|Standard Deviation|10.25|10.25|||
4030432|NCT01149421|3852266|B3|Mean Seated Heart Rate (Clinic)||Mean Heart Rate (HR)|Clinic heart rate (HR) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|beats per minute (bpm)|Mean|74.90|74.9|Standard Deviation|10.56|10.56|||
4030433|NCT01149421|3852267|B2|Mean Seated Heart Rate (Clinic)||Mean Heart Rate (HR)|Clinic heart rate (HR) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|beats per minute (bpm)|Mean|73.71|73.71|Standard Deviation|9.31|9.31|||
4030434|NCT01149421|3852268|B1|Mean Seated Heart Rate (Clinic)||Mean Heart Rate (HR)|Clinic heart rate (HR) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|beats per minute (bpm)|Mean|74.50|74.5|Standard Deviation|10.81|10.81|||
4030435|NCT01149421|3852265|B4|Mean Nighttime Heart Rate||Mean Heart Rate (HR)|Clinic heart rate (HR) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|beats per minute (bpm)|Mean|72.10|72.1|Standard Deviation|10.36|10.36|||
4030531|NCT01149421|3852265|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4030532|NCT01149421|3852266|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4030436|NCT01149421|3852266|B3|Mean Nighttime Heart Rate||Mean Heart Rate (HR)|Clinic heart rate (HR) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|beats per minute (bpm)|Mean|72.20|72.2|Standard Deviation|10.35|10.35|||
4030437|NCT01149421|3852267|B2|Mean Nighttime Heart Rate||Mean Heart Rate (HR)|Clinic heart rate (HR) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|beats per minute (bpm)|Mean|71.33|71.33|Standard Deviation|9.94|9.94|||
4030438|NCT01149421|3852268|B1|Mean Nighttime Heart Rate||Mean Heart Rate (HR)|Clinic heart rate (HR) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|beats per minute (bpm)|Mean|72.78|72.78|Standard Deviation|10.76|10.76|||
4030439|NCT01149421|3852265|B4|Mean Daytime Heart Rate||Mean Heart Rate (HR)|Clinic heart rate (HR) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|beats per minute (bpm)|Mean|82.47|82.47|Standard Deviation|10.92|10.92|||
4030440|NCT01149421|3852266|B3|Mean Daytime Heart Rate||Mean Heart Rate (HR)|Clinic heart rate (HR) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|beats per minute (bpm)|Mean|82.96|82.96|Standard Deviation|10.69|10.69|||
4030441|NCT01149421|3852267|B2|Mean Daytime Heart Rate||Mean Heart Rate (HR)|Clinic heart rate (HR) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|beats per minute (bpm)|Mean|81.99|81.99|Standard Deviation|10.45|10.45|||
4030442|NCT01149421|3852268|B1|Mean Daytime Heart Rate||Mean Heart Rate (HR)|Clinic heart rate (HR) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|beats per minute (bpm)|Mean|82.47|82.47|Standard Deviation|11.61|11.61|||
4030443|NCT01149421|3852265|B4|Mean 24-Hour Heart Rate||Mean Heart Rate (HR)|Clinic heart rate (HR) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|beats per minute (bpm)|Mean|79.59|79.59|Standard Deviation|10.18|10.18|||
4030444|NCT01149421|3852266|B3|Mean 24-Hour Heart Rate||Mean Heart Rate (HR)|Clinic heart rate (HR) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|beats per minute (bpm)|Mean|79.91|79.91|Standard Deviation|9.97|9.97|||
4030445|NCT01149421|3852267|B2|Mean 24-Hour Heart Rate||Mean Heart Rate (HR)|Clinic heart rate (HR) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|beats per minute (bpm)|Mean|79.01|79.01|Standard Deviation|9.75|9.75|||
4030446|NCT01149421|3852268|B1|Mean 24-Hour Heart Rate||Mean Heart Rate (HR)|Clinic heart rate (HR) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|beats per minute (bpm)|Mean|79.86|79.86|Standard Deviation|10.83|10.83|||
4030447|NCT01149421|3852265|B4|Mean Seated Diastolic Blood Pressure (Clinic)||Mean Diastolic Blood Pressure (DBP)|Clinic diastolic blood pressure (DBP) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|millimeters of mercury (mmHg)|Mean|75.97|75.97|Standard Deviation|8.87|8.87|||
4030448|NCT01149421|3852266|B3|Mean Seated Diastolic Blood Pressure (Clinic)||Mean Diastolic Blood Pressure (DBP)|Clinic diastolic blood pressure (DBP) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|millimeters of mercury (mmHg)|Mean|76.14|76.14|Standard Deviation|9.19|9.19|||
4030449|NCT01149421|3852267|B2|Mean Seated Diastolic Blood Pressure (Clinic)||Mean Diastolic Blood Pressure (DBP)|Clinic diastolic blood pressure (DBP) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|millimeters of mercury (mmHg)|Mean|75.81|75.81|Standard Deviation|8.84|8.84|||
4030533|NCT01149421|3852267|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4030534|NCT01149421|3852268|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4030535|NCT01149421|3852265|B4||White|Race (NIH/OMB)||Participants|Count of Participants|608|608.0||||||
4030536|NCT01149421|3852266|B3||White|Race (NIH/OMB)||Participants|Count of Participants|203|203.0||||||
4030450|NCT01149421|3852268|B1|Mean Seated Diastolic Blood Pressure (Clinic)||Mean Diastolic Blood Pressure (DBP)|Clinic diastolic blood pressure (DBP) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|millimeters of mercury (mmHg)|Mean|75.95|75.95|Standard Deviation|8.61|8.61|||
4030451|NCT01149421|3852265|B4|Mean Nighttime Diastolic Blood Pressure||Mean Diastolic Blood Pressure (DBP)|Clinic diastolic blood pressure (DBP) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|millimeters of mercury (mmHg)|Mean|68.65|68.65|Standard Deviation|9.29|9.29|||
4030452|NCT01149421|3852266|B3|Mean Nighttime Diastolic Blood Pressure||Mean Diastolic Blood Pressure (DBP)|Clinic diastolic blood pressure (DBP) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|millimeters of mercury (mmHg)|Mean|68.21|68.21|Standard Deviation|8.70|8.7|||
4030453|NCT01149421|3852267|B2|Mean Nighttime Diastolic Blood Pressure||Mean Diastolic Blood Pressure (DBP)|Clinic diastolic blood pressure (DBP) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|millimeters of mercury (mmHg)|Mean|68.92|68.92|Standard Deviation|9.47|9.47|||
4030454|NCT01149421|3852268|B1|Mean Nighttime Diastolic Blood Pressure||Mean Diastolic Blood Pressure (DBP)|Clinic diastolic blood pressure (DBP) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|millimeters of mercury (mmHg)|Mean|68.83|68.83|Standard Deviation|9.70|9.7|||
4030455|NCT01149421|3852265|B4|Mean Daytime Diastolic Blood Pressure||Mean Diastolic Blood Pressure (DBP)|Clinic diastolic blood pressure (DBP) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|millimeters of mercury (mmHg)|Mean|78.99|78.99|Standard Deviation|8.61|8.61|||
4030456|NCT01149421|3852266|B3|Mean Daytime Diastolic Blood Pressure||Mean Diastolic Blood Pressure (DBP)|Clinic diastolic blood pressure (DBP) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|millimeters of mercury (mmHg)|Mean|78.68|78.68|Standard Deviation|8.27|8.27|||
4030457|NCT01149421|3852267|B2|Mean Daytime Diastolic Blood Pressure||Mean Diastolic Blood Pressure (DBP)|Clinic diastolic blood pressure (DBP) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|millimeters of mercury (mmHg)|Mean|79.35|79.35|Standard Deviation|8.81|8.81|||
4030458|NCT01149421|3852268|B1|Mean Daytime Diastolic Blood Pressure||Mean Diastolic Blood Pressure (DBP)|Clinic diastolic blood pressure (DBP) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|millimeters of mercury (mmHg)|Mean|78.93|78.93|Standard Deviation|8.77|8.77|||
4030459|NCT01149421|3852265|B4|Mean 24-hour Diastolic Blood Pressure||Mean Diastolic Blood Pressure (DBP)|Clinic diastolic blood pressure (DBP) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|millimeters of mercury (mmHg)|Mean|76.30|76.3|Standard Deviation|8.18|8.18|||
4030460|NCT01149421|3852266|B3|Mean 24-hour Diastolic Blood Pressure||Mean Diastolic Blood Pressure (DBP)|Clinic diastolic blood pressure (DBP) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|millimeters of mercury (mmHg)|Mean|75.96|75.96|Standard Deviation|7.79|7.79|||
4030461|NCT01149421|3852267|B2|Mean 24-hour Diastolic Blood Pressure||Mean Diastolic Blood Pressure (DBP)|Clinic diastolic blood pressure (DBP) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|millimeters of mercury (mmHg)|Mean|76.64|76.64|Standard Deviation|8.38|8.38|||
4030462|NCT01149421|3852268|B1|Mean 24-hour Diastolic Blood Pressure||Mean Diastolic Blood Pressure (DBP)|Clinic diastolic blood pressure (DBP) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|millimeters of mercury (mmHg)|Mean|76.29|76.29|Standard Deviation|8.39|8.39|||
4030463|NCT01149421|3852265|B4|Mean Seated Systolic Blood Pressure (Clinic)||Mean Systolic Blood Pressure (SBP)|Clinic systolic blood pressure (SBP) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|millimeters of mercury (mmHg)|Mean|126.98|126.98|Standard Deviation|12.96|12.96|||
4030464|NCT01149421|3852266|B3|Mean Seated Systolic Blood Pressure (Clinic)||Mean Systolic Blood Pressure (SBP)|Clinic systolic blood pressure (SBP) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|millimeters of mercury (mmHg)|Mean|126.81|126.81|Standard Deviation|13.67|13.67|||
4030465|NCT01149421|3852267|B2|Mean Seated Systolic Blood Pressure (Clinic)||Mean Systolic Blood Pressure (SBP)|Clinic systolic blood pressure (SBP) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|millimeters of mercury (mmHg)|Mean|127.42|127.42|Standard Deviation|12.79|12.79|||
4030466|NCT01149421|3852268|B1|Mean Seated Systolic Blood Pressure (Clinic)||Mean Systolic Blood Pressure (SBP)|Clinic systolic blood pressure (SBP) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|millimeters of mercury (mmHg)|Mean|126.71|126.71|Standard Deviation|12.44|12.44|||
4030467|NCT01149421|3852265|B4|Mean Nighttime Systolic Blood Pressure||Mean Systolic Blood Pressure (SBP)|Clinic systolic blood pressure (SBP) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|millimeters of mercury (mmHg)|Mean|121.90|121.9|Standard Deviation|14.02|14.02|||
4030468|NCT01149421|3852266|B3|Mean Nighttime Systolic Blood Pressure||Mean Systolic Blood Pressure (SBP)|Clinic systolic blood pressure (SBP) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|millimeters of mercury (mmHg)|Mean|121.92|121.92|Standard Deviation|12.82|12.82|||
4030469|NCT01149421|3852267|B2|Mean Nighttime Systolic Blood Pressure||Mean Systolic Blood Pressure (SBP)|Clinic systolic blood pressure (SBP) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|millimeters of mercury (mmHg)|Mean|122.10|122.1|Standard Deviation|14.83|14.83|||
4030470|NCT01149421|3852268|B1|Mean Nighttime Systolic Blood Pressure||Mean Systolic Blood Pressure (SBP)|Clinic systolic blood pressure (SBP) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|millimeters of mercury (mmHg)|Mean|121.68|121.68|Standard Deviation|14.39|14.39|||
4030471|NCT01149421|3852265|B4|Mean Daytime Systolic Blood Pressure||Mean Systolic Blood Pressure (SBP)|Clinic systolic blood pressure (SBP) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|millimeters of mercury (mmHg)|Mean|134.48|134.48|Standard Deviation|12.48|12.48|||
4030472|NCT01149421|3852266|B3|Mean Daytime Systolic Blood Pressure||Mean Systolic Blood Pressure (SBP)|Clinic systolic blood pressure (SBP) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|millimeters of mercury (mmHg)|Mean|134.15|134.15|Standard Deviation|11.70|11.7|||
4030473|NCT01149421|3852267|B2|Mean Daytime Systolic Blood Pressure||Mean Systolic Blood Pressure (SBP)|Clinic systolic blood pressure (SBP) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|millimeters of mercury (mmHg)|Mean|135.37|135.37|Standard Deviation|13.36|13.36|||
4030474|NCT01149421|3852268|B1|Mean Daytime Systolic Blood Pressure||Mean Systolic Blood Pressure (SBP)|Clinic systolic blood pressure (SBP) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|millimeters of mercury (mmHg)|Mean|133.92|133.92|Standard Deviation|12.30|12.3|||
4030475|NCT01149421|3852265|B4|Mean 24-hour Systolic Blood Pressure||Mean Systolic Blood Pressure (SBP)|Clinic systolic blood pressure (SBP) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|millimeters of mercury (mmHg)|Mean|131.36|131.36|Standard Deviation|12.13|12.13|||
4030476|NCT01149421|3852266|B3|Mean 24-hour Systolic Blood Pressure||Mean Systolic Blood Pressure (SBP)|Clinic systolic blood pressure (SBP) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|millimeters of mercury (mmHg)|Mean|131.13|131.13|Standard Deviation|11.23|11.23|||
4030477|NCT01149421|3852267|B2|Mean 24-hour Systolic Blood Pressure||Mean Systolic Blood Pressure (SBP)|Clinic systolic blood pressure (SBP) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|millimeters of mercury (mmHg)|Mean|132.08|132.08|Standard Deviation|12.97|12.97|||
4030478|NCT01149421|3852268|B1|Mean 24-hour Systolic Blood Pressure||Mean Systolic Blood Pressure (SBP)|Clinic systolic blood pressure (SBP) measurements were taken in triplicate after the participant was seated for 5 minutes using an automated digital professional blood pressure monitor. The mean of the last 2 clinic readings at screening determined study eligibility; the mean of 3 readings at baseline and all post-baseline visits was used for analyses.|millimeters of mercury (mmHg)|Mean|130.85|130.85|Standard Deviation|12.14|12.14|||
4030479|NCT01149421|3852265|B4|||Duration of Diabetes||years|Mean|8.34|8.34|Standard Deviation|5.86|5.86|||
4030480|NCT01149421|3852266|B3|||Duration of Diabetes||years|Mean|8.40|8.4|Standard Deviation|5.76|5.76|||
4030481|NCT01149421|3852267|B2|||Duration of Diabetes||years|Mean|8.99|8.99|Standard Deviation|6.39|6.39|||
4030482|NCT01149421|3852268|B1|||Duration of Diabetes||years|Mean|7.61|7.61|Standard Deviation|5.30|5.3|||
4030483|NCT01149421|3852265|B4|||Body Weight||kilogram (kg)|Mean|91.58|91.58|Standard Deviation|19.60|19.6|||
4030484|NCT01149421|3852266|B3|||Body Weight||kilogram (kg)|Mean|93.90|93.9|Standard Deviation|21.26|21.26|||
4030485|NCT01149421|3852267|B2|||Body Weight||kilogram (kg)|Mean|90.45|90.45|Standard Deviation|18.74|18.74|||
4030486|NCT01149421|3852268|B1|||Body Weight||kilogram (kg)|Mean|90.42|90.42|Standard Deviation|18.58|18.58|||
4030487|NCT01149421|3852265|B4|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|7.93|7.93|Standard Deviation|0.76|0.76|||
4030488|NCT01149421|3852266|B3|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|7.94|7.94|Standard Deviation|0.78|0.78|||
4030489|NCT01149421|3852267|B2|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|7.91|7.91|Standard Deviation|0.73|0.73|||
4030490|NCT01149421|3852268|B1|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|7.93|7.93|Standard Deviation|0.76|0.76|||
4030491|NCT01149421|3852265|B4|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters (kg/m^2)|Mean|32.96|32.96|Standard Deviation|6.02|6.02|||
4030492|NCT01149421|3852266|B3|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters (kg/m^2)|Mean|33.53|33.53|Standard Deviation|6.49|6.49|||
4030493|NCT01149421|3852267|B2|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters (kg/m^2)|Mean|32.55|32.55|Standard Deviation|5.86|5.86|||
4030494|NCT01149421|3852268|B1|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters (kg/m^2)|Mean|32.80|32.8|Standard Deviation|5.66|5.66|||
4030495|NCT01149421|3852265|B4|India||Region of Enrollment||participants|Number|43|43.0||||||
4030496|NCT01149421|3852266|B3|India||Region of Enrollment||participants|Number|14|14.0||||||
4030497|NCT01149421|3852267|B2|India||Region of Enrollment||participants|Number|14|14.0||||||
4030498|NCT01149421|3852268|B1|India||Region of Enrollment||participants|Number|15|15.0||||||
4030499|NCT01149421|3852265|B4|Denmark||Region of Enrollment||participants|Number|28|28.0||||||
4030500|NCT01149421|3852266|B3|Denmark||Region of Enrollment||participants|Number|8|8.0||||||
4030501|NCT01149421|3852267|B2|Denmark||Region of Enrollment||participants|Number|11|11.0||||||
4030502|NCT01149421|3852268|B1|Denmark||Region of Enrollment||participants|Number|9|9.0||||||
4030503|NCT01149421|3852265|B4|Brazil||Region of Enrollment||participants|Number|21|21.0||||||
4030504|NCT01149421|3852266|B3|Brazil||Region of Enrollment||participants|Number|7|7.0||||||
4030505|NCT01149421|3852267|B2|Brazil||Region of Enrollment||participants|Number|6|6.0||||||
4030506|NCT01149421|3852268|B1|Brazil||Region of Enrollment||participants|Number|8|8.0||||||
4030507|NCT01149421|3852265|B4|Argentina||Region of Enrollment||participants|Number|82|82.0||||||
4030508|NCT01149421|3852266|B3|Argentina||Region of Enrollment||participants|Number|25|25.0||||||
4030509|NCT01149421|3852267|B2|Argentina||Region of Enrollment||participants|Number|28|28.0||||||
4030510|NCT01149421|3852268|B1|Argentina||Region of Enrollment||participants|Number|29|29.0||||||
4030511|NCT01149421|3852265|B4|Canada||Region of Enrollment||participants|Number|96|96.0||||||
4030512|NCT01149421|3852266|B3|Canada||Region of Enrollment||participants|Number|30|30.0||||||
4030513|NCT01149421|3852267|B2|Canada||Region of Enrollment||participants|Number|32|32.0||||||
4030514|NCT01149421|3852268|B1|Canada||Region of Enrollment||participants|Number|34|34.0||||||
4030515|NCT01149421|3852265|B4|Puerto Rico||Region of Enrollment||participants|Number|40|40.0||||||
4030516|NCT01149421|3852266|B3|Puerto Rico||Region of Enrollment||participants|Number|14|14.0||||||
4030517|NCT01149421|3852267|B2|Puerto Rico||Region of Enrollment||participants|Number|14|14.0||||||
4030518|NCT01149421|3852268|B1|Puerto Rico||Region of Enrollment||participants|Number|12|12.0||||||
4030519|NCT01149421|3852265|B4|Czech Republic||Region of Enrollment||participants|Number|37|37.0||||||
4030520|NCT01149421|3852266|B3|Czech Republic||Region of Enrollment||participants|Number|13|13.0||||||
4030521|NCT01149421|3852267|B2|Czech Republic||Region of Enrollment||participants|Number|12|12.0||||||
4030522|NCT01149421|3852268|B1|Czech Republic||Region of Enrollment||participants|Number|12|12.0||||||
4030523|NCT01149421|3852265|B4|United States||Region of Enrollment||participants|Number|408|408.0||||||
4030524|NCT01149421|3852266|B3|United States||Region of Enrollment||participants|Number|139|139.0||||||
4030525|NCT01149421|3852267|B2|United States||Region of Enrollment||participants|Number|137|137.0||||||
4030526|NCT01149421|3852268|B1|United States||Region of Enrollment||participants|Number|132|132.0||||||
4030527|NCT01149421|3852265|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4030528|NCT01149421|3852266|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4030529|NCT01149421|3852267|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4030530|NCT01149421|3852268|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4030537|NCT01149421|3852267|B2||White|Race (NIH/OMB)||Participants|Count of Participants|204|204.0||||||
4030538|NCT01149421|3852268|B1||White|Race (NIH/OMB)||Participants|Count of Participants|201|201.0||||||
4030539|NCT01149421|3852265|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4030540|NCT01149421|3852266|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4030541|NCT01149421|3852267|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4030542|NCT01149421|3852268|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4030543|NCT01149421|3852265|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4030544|NCT01149421|3852266|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4030545|NCT01149421|3852267|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4030546|NCT01149421|3852268|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4030547|NCT01149421|3852265|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
4030548|NCT01149421|3852266|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4030549|NCT01149421|3852267|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4030550|NCT01149421|3852268|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4030551|NCT01149421|3852265|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4030552|NCT01149421|3852266|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4030553|NCT01149421|3852267|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4030554|NCT01149421|3852268|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4030555|NCT01149421|3852265|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4030556|NCT01149421|3852266|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4030557|NCT01149421|3852267|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4030558|NCT01149421|3852268|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4030559|NCT01149421|3852265|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|468|468.0||||||
4030560|NCT01149421|3852266|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|159|159.0||||||
4030561|NCT01149421|3852267|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|153|153.0||||||
4030562|NCT01149421|3852268|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|156|156.0||||||
4030563|NCT01149421|3852265|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|287|287.0||||||
4030564|NCT01149421|3852266|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
4030565|NCT01149421|3852267|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
4030566|NCT01149421|3852268|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
4030567|NCT01149421|3852265|B4||Male|Sex: Female, Male||Participants|Count of Participants|392|392.0||||||
4030568|NCT01149421|3852266|B3||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4030569|NCT01149421|3852267|B2||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4030570|NCT01149421|3852268|B1||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4030571|NCT01149421|3852265|B4||Female|Sex: Female, Male||Participants|Count of Participants|363|363.0||||||
4030572|NCT01149421|3852266|B3||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4030573|NCT01149421|3852267|B2||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4030574|NCT01149421|3852268|B1||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4030575|NCT01149421|3852265|B4|||Age||years|Mean|56.48|56.48|Standard Deviation|10.27|10.27|||
4030576|NCT01149421|3852266|B3|||Age||years|Mean|56.43|56.43|Standard Deviation|10.50|10.5|||
4030577|NCT01149421|3852267|B2|||Age||years|Mean|57.05|57.05|Standard Deviation|10.17|10.17|||
4030578|NCT01149421|3852268|B1|||Age||years|Mean|55.96|55.96|Standard Deviation|10.14|10.14|||
4030579|NCT01149343|3852349|B5|Geographic Ancestry|Unspecified|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4030580|NCT01149343|3852350|B4|Geographic Ancestry|Unspecified|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4030581|NCT01149343|3852351|B3|Geographic Ancestry|Unspecified|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4030582|NCT01149343|3852352|B2|Geographic Ancestry|Unspecified|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4030583|NCT01149343|3852353|B1|Geographic Ancestry|Unspecified|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4030584|NCT01149343|3852349|B5|Geographic Ancestry|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|104|104.0||||||
4030585|NCT01149343|3852350|B4|Geographic Ancestry|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
4030586|NCT01149343|3852351|B3|Geographic Ancestry|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
4030587|NCT01149343|3852352|B2|Geographic Ancestry|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
4030588|NCT01149343|3852353|B1|Geographic Ancestry|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
4030589|NCT01149343|3852349|B5||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4030590|NCT01149343|3852350|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4030591|NCT01149343|3852351|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4030592|NCT01149343|3852352|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4030593|NCT01149343|3852353|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4030594|NCT01149343|3852349|B5||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4030595|NCT01149343|3852350|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4030596|NCT01149343|3852351|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4030597|NCT01149343|3852352|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4030598|NCT01149343|3852353|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4030599|NCT01149343|3852349|B5|||Age||Years|Mean|60.4|60.4|Standard Deviation|16.2|16.2|||
4030600|NCT01149343|3852350|B4|||Age||Years|Mean|60.7|60.7|Standard Deviation|18.1|18.1|||
4030601|NCT01149343|3852351|B3|||Age||Years|Mean|59.5|59.5|Standard Deviation|15.2|15.2|||
4030602|NCT01149343|3852352|B2|||Age||Years|Mean|60.8|60.8|Standard Deviation|15.5|15.5|||
4030603|NCT01149343|3852353|B1|||Age||Years|Mean|60.3|60.3|Standard Deviation|14.9|14.9|||
4030604|NCT01149148|3852439|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4030605|NCT01149148|3852440|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4030606|NCT01149148|3852441|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4030607|NCT01149148|3852439|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4030608|NCT01149148|3852440|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4030609|NCT01149148|3852441|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4030610|NCT01149148|3852439|B3|||Age||years|Mean|61.44|61.44|Standard Deviation|10.3846|10.3846|||
4030611|NCT01149148|3852440|B2|||Age||years|Mean|62.30769|62.30769|Standard Deviation|11.52088|11.52088|||
4030612|NCT01149148|3852441|B1|||Age||years|Mean|60.5|60.5|Standard Deviation|9.414689|9.414689|||
4030613|NCT01149148|3852439|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4030614|NCT01149148|3852440|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4030615|NCT01149148|3852441|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4030616|NCT01149148|3852439|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4030617|NCT01149148|3852440|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4030618|NCT01149148|3852441|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4030619|NCT01149148|3852439|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4030620|NCT01149148|3852440|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4030621|NCT01149148|3852441|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4030622|NCT01149057|3852450|B1||Male|Gender||Participants|Count of Participants|24|24.0||||||
4030623|NCT01149057|3852450|B1||Female|Gender||Participants|Count of Participants|121|121.0||||||
4030624|NCT01149057|3852450|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|13.4|13.4|||
4030625|NCT01148979|3852475|B3|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
4030626|NCT01148979|3852476|B2|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4030627|NCT01148979|3852477|B1|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4030628|NCT01148979|3852475|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4030629|NCT01148979|3852476|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4030630|NCT01148979|3852477|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4030631|NCT01148979|3852475|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4030632|NCT01148979|3852476|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4030633|NCT01148979|3852477|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4030634|NCT01148979|3852475|B3|||Age||years|Mean|50.6|50.6|Standard Deviation|11.0|11.0|||
4030635|NCT01148979|3852476|B2|||Age||years|Mean|48.9|48.9|Standard Deviation|11.4|11.4|||
4030636|NCT01148979|3852477|B1|||Age||years|Mean|52.8|52.8|Standard Deviation|10.6|10.6|||
4030637|NCT01148862|3852484|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4030638|NCT01148862|3852484|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4030639|NCT01148862|3852484|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4030640|NCT01148862|3852484|B1|||Age||years|Mean|34.3|34.3|Standard Deviation|12.4|12.4|||
4030641|NCT01148862|3852484|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4030642|NCT01148862|3852484|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4030643|NCT01148862|3852484|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4030644|NCT01148836|3852493|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4030645|NCT01148836|3852494|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4030646|NCT01148836|3852495|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4030647|NCT01148836|3852493|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4030648|NCT01148836|3852494|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4030649|NCT01148836|3852495|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4030650|NCT01148836|3852493|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4030651|NCT01148836|3852494|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4030652|NCT01148836|3852495|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4030653|NCT01148836|3852493|B3|||Age||years|Mean|41.5|41.5|Standard Deviation|3|3.0|||
4030654|NCT01148836|3852494|B2|||Age||years|Mean|41|41.0|Standard Deviation|3|3.0|||
4030655|NCT01148836|3852495|B1|||Age||years|Mean|42|42.0|Standard Deviation|5|5.0|||
4030656|NCT01148836|3852493|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4030657|NCT01148836|3852494|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4030658|NCT01148836|3852495|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4030659|NCT01148836|3852493|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4030660|NCT01148836|3852494|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4030661|NCT01148836|3852495|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4030662|NCT01148836|3852493|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4030663|NCT01148836|3852494|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4030664|NCT01148836|3852495|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4030665|NCT01148771|3852515|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4030666|NCT01148771|3852516|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4030667|NCT01148771|3852517|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4030668|NCT01148771|3852515|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4030669|NCT01148771|3852516|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4030670|NCT01148771|3852517|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4030671|NCT01148771|3852515|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4030672|NCT01148771|3852516|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4030673|NCT01148771|3852517|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4030674|NCT01148771|3852515|B3|||Age||years|Mean|32.4|32.4|Standard Deviation|13.9|13.9|||
4030675|NCT01148771|3852516|B2|||Age||years|Mean|32.4|32.4|Standard Deviation|13.9|13.9|||
4030676|NCT01148771|3852517|B1|||Age||years|Mean|32.4|32.4|Standard Deviation|13.9|13.9|||
4030677|NCT01148771|3852515|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4030678|NCT01148771|3852516|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4030679|NCT01148771|3852517|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4030680|NCT01148771|3852515|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4030681|NCT01148771|3852516|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4030682|NCT01148771|3852517|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4030683|NCT01148771|3852515|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4030684|NCT01148771|3852516|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4030685|NCT01148771|3852517|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4030686|NCT01148745|3852530|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4030687|NCT01148745|3852530|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4030688|NCT01148745|3852530|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4030689|NCT01148745|3852530|B1|||Age||years|Mean|60|60.0|Standard Deviation|14|14.0|||
4030690|NCT01148745|3852530|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4030691|NCT01148745|3852530|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4030692|NCT01148745|3852530|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4030693|NCT01148693|3852536|B3|Iran, Islamic Republic of||Region of Enrollment||participants|Number|137|137.0||||||
4030694|NCT01148693|3852537|B2|Iran, Islamic Republic of||Region of Enrollment||participants|Number|67|67.0||||||
4030695|NCT01148693|3852538|B1|Iran, Islamic Republic of||Region of Enrollment||participants|Number|70|70.0||||||
4030696|NCT01148693|3852536|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4030697|NCT01148693|3852537|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4030698|NCT01148693|3852538|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4030699|NCT01148693|3852536|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4030700|NCT01148693|3852537|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4030701|NCT01148693|3852538|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4030702|NCT01148693|3852536|B3|||Age||years|Mean|64.62|64.62|Standard Deviation|14.533|14.533|||
4030703|NCT01148693|3852537|B2|||Age||years|Mean|66.74|66.74|Standard Deviation|14.145|14.145|||
4030704|NCT01148693|3852538|B1|||Age||years|Mean|62.59|62.59|Standard Deviation|15.082|15.082|||
4030705|NCT01148693|3852536|B3||>=65 years|Age||Participants|Count of Participants|58|58.0||||||
4030706|NCT01148693|3852537|B2||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4030707|NCT01148693|3852538|B1||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4030708|NCT01148693|3852536|B3||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
4030709|NCT01148693|3852537|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4030710|NCT01148693|3852538|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4030711|NCT01148693|3852536|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4030712|NCT01148693|3852537|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4030713|NCT01148693|3852538|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4030714|NCT01148563|3852545|B3|United States||Region of Enrollment||participants|Number|136|136.0||||||
4030715|NCT01148563|3852546|B2|United States||Region of Enrollment||participants|Number|67|67.0||||||
4030716|NCT01148563|3852547|B1|United States||Region of Enrollment||participants|Number|69|69.0||||||
4030717|NCT01148563|3852545|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4030718|NCT01148563|3852546|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4030719|NCT01148563|3852547|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4030720|NCT01148563|3852545|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4030721|NCT01148563|3852546|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4030722|NCT01148563|3852547|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4030723|NCT01148563|3852545|B3|||Age||years|Mean|57.139706|57.139706|Standard Deviation|9.6633502|9.6633502|||
4030724|NCT01148563|3852546|B2|||Age||years|Mean|56.641791|56.641791|Standard Deviation|10.08855|10.08855|||
4030725|NCT01148563|3852547|B1|||Age||years|Mean|57.623188|57.623188|Standard Deviation|9.2801202|9.2801202|||
4030726|NCT01148563|3852545|B3||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4030727|NCT01148563|3852546|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4030728|NCT01148563|3852547|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4030729|NCT01148563|3852545|B3||Between 18 and 65 years|Age||Participants|Count of Participants|106|106.0||||||
4030730|NCT01148563|3852546|B2||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4030731|NCT01148563|3852547|B1||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4030732|NCT01148563|3852545|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4030733|NCT01148563|3852546|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4030734|NCT01148563|3852547|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4030735|NCT01148537|3852556|B4||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4030736|NCT01148537|3852557|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4030737|NCT01148537|3852558|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4030738|NCT01148537|3852559|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4030739|NCT01148537|3852556|B4||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4030740|NCT01148537|3852557|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4030741|NCT01148537|3852558|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4030742|NCT01148537|3852559|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4030743|NCT01148537|3852556|B4|||Age||years|Mean|31.2|31.2|Standard Deviation|10.1|10.1|||
4030744|NCT01148537|3852557|B3|||Age||years|Mean|28.8|28.8|Standard Deviation|9.69|9.69|||
4030745|NCT01148537|3852558|B2|||Age||years|Mean|34.1|34.1|Standard Deviation|10.7|10.7|||
4030746|NCT01148537|3852559|B1|||Age||years|Mean|30.8|30.8|Standard Deviation|9.46|9.46|||
4030747|NCT01148524|3852582|B10||Male|Sex: Female, Male||Participants|Count of Participants|355|355.0||||||
4030748|NCT01148524|3852583|B9||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4030749|NCT01148524|3852584|B8||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4030750|NCT01148524|3852585|B7||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4030751|NCT01148524|3852586|B6||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4030752|NCT01148524|3852587|B5||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4030753|NCT01148524|3852588|B4||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4030754|NCT01148524|3852589|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4030755|NCT01148524|3852590|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4030756|NCT01148524|3852591|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4030757|NCT01148524|3852582|B10||Female|Sex: Female, Male||Participants|Count of Participants|462|462.0||||||
4030758|NCT01148524|3852583|B9||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4030759|NCT01148524|3852584|B8||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4030760|NCT01148524|3852585|B7||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4030761|NCT01148524|3852586|B6||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4030762|NCT01148524|3852587|B5||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4030763|NCT01148524|3852588|B4||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4030764|NCT01148524|3852589|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4030765|NCT01148524|3852590|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4030766|NCT01148524|3852591|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4030767|NCT01148524|3852582|B10|||Age||Years|Mean|15.9|15.9|Standard Deviation|1.9|1.9|||
4030768|NCT01148524|3852583|B9|||Age||Years|Mean|15.6|15.6|Standard Deviation|1.7|1.7|||
4030769|NCT01148524|3852584|B8|||Age||Years|Mean|16.0|16.0|Standard Deviation|1.9|1.9|||
4030770|NCT01148524|3852585|B7|||Age||Years|Mean|15.9|15.9|Standard Deviation|1.9|1.9|||
4030771|NCT01148524|3852586|B6|||Age||Years|Mean|15.9|15.9|Standard Deviation|1.8|1.8|||
4030772|NCT01148524|3852587|B5|||Age||Years|Mean|15.6|15.6|Standard Deviation|1.9|1.9|||
4030773|NCT01148524|3852588|B4|||Age||Years|Mean|16.1|16.1|Standard Deviation|1.9|1.9|||
4030774|NCT01148524|3852589|B3|||Age||Years|Mean|16.2|16.2|Standard Deviation|2.1|2.1|||
4030775|NCT01148524|3852590|B2|||Age||Years|Mean|16.0|16.0|Standard Deviation|2.0|2.0|||
4030776|NCT01148524|3852591|B1|||Age||Years|Mean|16.2|16.2|Standard Deviation|1.9|1.9|||
4030777|NCT01148511|3852645|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4030778|NCT01148511|3852646|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4030779|NCT01148511|3852647|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4030780|NCT01148511|3852645|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4030781|NCT01148511|3852646|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4030782|NCT01148511|3852647|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4030783|NCT01148511|3852645|B3|||Age||years|Mean|70.9|70.9|Standard Deviation|8.6|8.6|||
4030784|NCT01148511|3852646|B2|||Age||years|Mean|71.1|71.1|Standard Deviation|8.4|8.4|||
4030785|NCT01148511|3852647|B1|||Age||years|Mean|70.8|70.8|Standard Deviation|8.8|8.8|||
4030786|NCT01148420|3852668|B1|||Hemoglobin baseline||g/dL|Mean|10.9|10.9|Standard Deviation|1.58|1.58|||
4030787|NCT01148420|3852668|B1|||BMI||kg/m^2|Mean|34.9|34.9|Standard Deviation|8.09|8.09|||
4030788|NCT01148420|3852668|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4030789|NCT01148420|3852668|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4030790|NCT01148420|3852668|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4030791|NCT01148420|3852668|B1|||Age||years|Mean|40.7|40.7|Standard Deviation|9.35|9.35|||
4030792|NCT01148420|3852668|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4030793|NCT01148420|3852668|B1||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4030794|NCT01148420|3852668|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4030795|NCT01148056|3852674|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4030796|NCT01148056|3852674|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4030797|NCT01148056|3852674|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4030798|NCT01148056|3852674|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4030799|NCT01148056|3852674|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4030800|NCT01148056|3852674|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4030801|NCT01148056|3852674|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4030802|NCT01148056|3852674|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4030803|NCT01148056|3852674|B1||Male|Gender||Participants|Count of Participants|2|2.0||||||
4030804|NCT01148056|3852674|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
4030805|NCT01148056|3852674|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4030806|NCT01148056|3852674|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4030807|NCT01148056|3852674|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4030808|NCT01148017|3852683|B5|United States||Region of Enrollment||participants|Number|433|433.0||||||
4030809|NCT01148017|3852684|B4|United States||Region of Enrollment||participants|Number|45|45.0||||||
4030810|NCT01148017|3852685|B3|United States||Region of Enrollment||participants|Number|53|53.0||||||
4030811|NCT01148017|3852686|B2|United States||Region of Enrollment||participants|Number|121|121.0||||||
4030812|NCT01148017|3852687|B1|United States||Region of Enrollment||participants|Number|214|214.0||||||
4030813|NCT01148017|3852683|B5||Male|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
4030814|NCT01148017|3852684|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4030815|NCT01148017|3852685|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4030816|NCT01148017|3852686|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4030817|NCT01148017|3852687|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4030818|NCT01148017|3852683|B5||Female|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4030819|NCT01148017|3852684|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4030820|NCT01148017|3852685|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4030821|NCT01148017|3852686|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4030822|NCT01148017|3852687|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4030823|NCT01148017|3852683|B5|60 months enrollment (N=136, 89, 45, 270)||Age||Months|Mean|59.7|59.7|Standard Deviation|2.2|2.2|||
4030824|NCT01148017|3852684|B4|60 months enrollment (N=136, 89, 45, 270)||Age||Months|Mean|60|60.0|Standard Deviation|1.7|1.7|||
4030825|NCT01148017|3852685|B3|60 months enrollment (N=136, 89, 45, 270)||Age||Months|Mean|NA||Standard Deviation|NA||||Subjects in this group were enrolled at 40 months of age.
4030826|NCT01148017|3852686|B2|60 months enrollment (N=136, 89, 45, 270)||Age||Months|Mean|59.6|59.6|Standard Deviation|2.4|2.4|||
4030827|NCT01148017|3852687|B1|60 months enrollment (N=136, 89, 45, 270)||Age||Months|Mean|59.7|59.7|Standard Deviation|2.2|2.2|||
4030828|NCT01148017|3852683|B5|40 months enrollment (N=210, 119, 53, 382)||Age||Months|Mean|39.2|39.2|Standard Deviation|1.8|1.8|||
4030829|NCT01148017|3852684|B4|40 months enrollment (N=210, 119, 53, 382)||Age||Months|Mean|NA||Standard Deviation|NA||||Subjects in this group were enrolled at 60 months of age.
4030830|NCT01148017|3852685|B3|40 months enrollment (N=210, 119, 53, 382)||Age||Months|Mean|38.7|38.7|Standard Deviation|1.8|1.8|||
4030831|NCT01148017|3852686|B2|40 months enrollment (N=210, 119, 53, 382)||Age||Months|Mean|39.3|39.3|Standard Deviation|1.7|1.7|||
4030832|NCT01148017|3852687|B1|40 months enrollment (N=210, 119, 53, 382)||Age||Months|Mean|39.2|39.2|Standard Deviation|1.8|1.8|||
4030833|NCT01147926|3852727|B3|UNITED KINGDOM||Region of Enrollment||Participants|Number|24|24.0||||||
4030834|NCT01147926|3852728|B2|UNITED KINGDOM||Region of Enrollment||Participants|Number|14|14.0||||||
4030835|NCT01147926|3852729|B1|UNITED KINGDOM||Region of Enrollment||Participants|Number|10|10.0||||||
4030836|NCT01147926|3852727|B3|ROMANIA||Region of Enrollment||Participants|Number|113|113.0||||||
4030837|NCT01147926|3852728|B2|ROMANIA||Region of Enrollment||Participants|Number|56|56.0||||||
4030838|NCT01147926|3852729|B1|ROMANIA||Region of Enrollment||Participants|Number|57|57.0||||||
4030839|NCT01147926|3852727|B3|POLAND||Region of Enrollment||Participants|Number|54|54.0||||||
4030840|NCT01147926|3852728|B2|POLAND||Region of Enrollment||Participants|Number|26|26.0||||||
4030841|NCT01147926|3852729|B1|POLAND||Region of Enrollment||Participants|Number|28|28.0||||||
4030842|NCT01147926|3852727|B3|NETHERLANDS||Region of Enrollment||Participants|Number|10|10.0||||||
4030843|NCT01147926|3852728|B2|NETHERLANDS||Region of Enrollment||Participants|Number|5|5.0||||||
4030844|NCT01147926|3852729|B1|NETHERLANDS||Region of Enrollment||Participants|Number|5|5.0||||||
4030845|NCT01147926|3852727|B3|GERMANY||Region of Enrollment||Participants|Number|21|21.0||||||
4030846|NCT01147926|3852728|B2|GERMANY||Region of Enrollment||Participants|Number|10|10.0||||||
4030847|NCT01147926|3852729|B1|GERMANY||Region of Enrollment||Participants|Number|11|11.0||||||
4030848|NCT01147926|3852727|B3|FRANCE||Region of Enrollment||Participants|Number|41|41.0||||||
4030849|NCT01147926|3852728|B2|FRANCE||Region of Enrollment||Participants|Number|21|21.0||||||
4030850|NCT01147926|3852729|B1|FRANCE||Region of Enrollment||Participants|Number|20|20.0||||||
4030851|NCT01147926|3852727|B3|DENMARK||Region of Enrollment||Participants|Number|40|40.0||||||
4030852|NCT01147926|3852728|B2|DENMARK||Region of Enrollment||Participants|Number|19|19.0||||||
4030853|NCT01147926|3852729|B1|DENMARK||Region of Enrollment||Participants|Number|21|21.0||||||
4030854|NCT01147926|3852727|B3|CZECH REPUBLIC||Region of Enrollment||Participants|Number|29|29.0||||||
4030855|NCT01147926|3852728|B2|CZECH REPUBLIC||Region of Enrollment||Participants|Number|14|14.0||||||
4030856|NCT01147926|3852729|B1|CZECH REPUBLIC||Region of Enrollment||Participants|Number|15|15.0||||||
4030857|NCT01147926|3852727|B3|BULGARIA||Region of Enrollment||Participants|Number|18|18.0||||||
4030858|NCT01147926|3852728|B2|BULGARIA||Region of Enrollment||Participants|Number|9|9.0||||||
4030859|NCT01147926|3852729|B1|BULGARIA||Region of Enrollment||Participants|Number|9|9.0||||||
4030860|NCT01147926|3852727|B3|BELGIUM||Region of Enrollment||Participants|Number|20|20.0||||||
4030861|NCT01147926|3852728|B2|BELGIUM||Region of Enrollment||Participants|Number|10|10.0||||||
4030862|NCT01147926|3852729|B1|BELGIUM||Region of Enrollment||Participants|Number|10|10.0||||||
4030863|NCT01147926|3852727|B3||Male|Sex: Female, Male||Participants|Count of Participants|370|370.0||||||
4030864|NCT01147926|3852728|B2||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4030865|NCT01147926|3852729|B1||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4030866|NCT01147926|3852727|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4030867|NCT01147926|3852728|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4030868|NCT01147926|3852729|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4030869|NCT01147926|3852727|B3|75 years and above||Age, Customized||Participants|Number|69|69.0||||||
4030870|NCT01147926|3852728|B2|75 years and above||Age, Customized||Participants|Number|37|37.0||||||
4030871|NCT01147926|3852729|B1|75 years and above||Age, Customized||Participants|Number|32|32.0||||||
4030872|NCT01147926|3852727|B3|Between 65 and 75 years||Age, Customized||Participants|Number|82|82.0||||||
4030873|NCT01147926|3852728|B2|Between 65 and 75 years||Age, Customized||Participants|Number|43|43.0||||||
4030874|NCT01147926|3852729|B1|Between 65 and 75 years||Age, Customized||Participants|Number|39|39.0||||||
4030875|NCT01147926|3852727|B3|Less than 65 years||Age, Customized||Participants|Number|219|219.0||||||
4030876|NCT01147926|3852728|B2|Less than 65 years||Age, Customized||Participants|Number|104|104.0||||||
4030877|NCT01147926|3852729|B1|Less than 65 years||Age, Customized||Participants|Number|115|115.0||||||
4030878|NCT01147926|3852727|B3|||Age||Years|Mean|58.5|58.5|Standard Deviation|16.91|16.91|||
4030879|NCT01147926|3852728|B2|||Age||Years|Mean|58.4|58.4|Standard Deviation|17.57|17.57|||
4030880|NCT01147926|3852729|B1|||Age||Years|Mean|58.5|58.5|Standard Deviation|16.28|16.28|||
4030881|NCT01147900|3852762|B4||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4030882|NCT01147900|3852763|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4030883|NCT01147900|3852764|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4030884|NCT01147900|3852765|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4030885|NCT01147900|3852762|B4||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4030886|NCT01147900|3852763|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4030887|NCT01147900|3852764|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4030888|NCT01147900|3852765|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4030889|NCT01147900|3852762|B4||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4030890|NCT01147900|3852763|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4030891|NCT01147900|3852764|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4030892|NCT01147900|3852765|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4030893|NCT01147900|3852762|B4||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4030894|NCT01147900|3852763|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4030895|NCT01147900|3852764|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4030896|NCT01147900|3852765|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4030897|NCT01147900|3852762|B4|||Age||Years|Mean|23.4|23.4|Standard Deviation|1.19|1.19|||
4030898|NCT01147900|3852763|B3|||Age||Years|Mean|23.3|23.3|Standard Deviation|1.17|1.17|||
4030899|NCT01147900|3852764|B2|||Age||Years|Mean|23.4|23.4|Standard Deviation|1.21|1.21|||
4030900|NCT01147900|3852765|B1|||Age||Years|Mean|23.5|23.5|Standard Deviation|1.44|1.44|||
4030901|NCT01147900|3852762|B4|||Age||Years|Mean|22.3|22.3|Standard Deviation|1.18|1.18|||
4030902|NCT01147900|3852763|B3|||Age||Years|Mean|22.3|22.3|Standard Deviation|1.17|1.17|||
4030903|NCT01147900|3852764|B2|||Age||Years|Mean|22.3|22.3|Standard Deviation|1.20|1.2|||
4030904|NCT01147900|3852765|B1|||Age||Years|Mean|22.4|22.4|Standard Deviation|1.46|1.46|||
4030905|NCT01147874|3852826|B1||Male|Sex: Female, Male||Participants|Count of Participants|609|609.0||||||
4030906|NCT01147874|3852826|B1||Female|Sex: Female, Male||Participants|Count of Participants|404|404.0||||||
4030907|NCT01147874|3852826|B1|||Age||Years|Mean|49.90|49.9|Standard Deviation|13.82|13.82|||
4030908|NCT01147848|3852832|B3|Mixed Race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4030909|NCT01147848|3852833|B2|Mixed Race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4030910|NCT01147848|3852834|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4030911|NCT01147848|3852832|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|473|473.0||||||
4030912|NCT01147848|3852833|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|232|232.0||||||
4030913|NCT01147848|3852834|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|241|241.0||||||
4030914|NCT01147848|3852832|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4030915|NCT01147848|3852833|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4030916|NCT01147848|3852834|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4030917|NCT01147848|3852832|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4030918|NCT01147848|3852833|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4030919|NCT01147848|3852834|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4030920|NCT01147848|3852832|B3|Asian - Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4030921|NCT01147848|3852833|B2|Asian - Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4030922|NCT01147848|3852834|B1|Asian - Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4030923|NCT01147848|3852832|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|160|160.0||||||
4030924|NCT01147848|3852833|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
4030925|NCT01147848|3852834|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
4030926|NCT01147848|3852832|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4030927|NCT01147848|3852833|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4030928|NCT01147848|3852834|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4030929|NCT01147848|3852832|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|86|86.0||||||
4030930|NCT01147848|3852833|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4030931|NCT01147848|3852834|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4030932|NCT01147848|3852832|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4030933|NCT01147848|3852833|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4030934|NCT01147848|3852834|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4030935|NCT01147848|3852832|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
4030936|NCT01147848|3852833|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4030937|NCT01147848|3852834|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4030938|NCT01147848|3852832|B3||Male|Gender||Participants|Count of Participants|317|317.0||||||
4030939|NCT01147848|3852833|B2||Male|Gender||Participants|Count of Participants|158|158.0||||||
4030940|NCT01147848|3852834|B1||Male|Gender||Participants|Count of Participants|159|159.0||||||
4030941|NCT01147848|3852832|B3||Female|Gender||Participants|Count of Participants|489|489.0||||||
4030942|NCT01147848|3852833|B2||Female|Gender||Participants|Count of Participants|245|245.0||||||
4030943|NCT01147848|3852834|B1||Female|Gender||Participants|Count of Participants|244|244.0||||||
4030944|NCT01147848|3852832|B3|||Age||Years|Mean|42.8|42.8|Standard Deviation|16.41|16.41|||
4030945|NCT01147848|3852833|B2|||Age||Years|Mean|41.9|41.9|Standard Deviation|16.90|16.9|||
4030946|NCT01147848|3852834|B1|||Age||Years|Mean|43.8|43.8|Standard Deviation|15.86|15.86|||
4030947|NCT01147822|3852866|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4030948|NCT01147822|3852867|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4030949|NCT01147822|3852868|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4030950|NCT01147822|3852866|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|60|60.0||||||
4030951|NCT01147822|3852867|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|31|31.0||||||
4030952|NCT01147822|3852868|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
4030953|NCT01147822|3852866|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|298|298.0||||||
4030954|NCT01147822|3852867|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|144|144.0||||||
4030955|NCT01147822|3852868|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|154|154.0||||||
4030956|NCT01147822|3852866|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4030957|NCT01147822|3852867|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4030958|NCT01147822|3852868|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4030959|NCT01147822|3852866|B3||Male|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
4030960|NCT01147822|3852867|B2||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4030961|NCT01147822|3852868|B1||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4030962|NCT01147822|3852866|B3||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4030963|NCT01147822|3852867|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4030964|NCT01147822|3852868|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4030965|NCT01147822|3852866|B3|||Age||Years|Mean|57.6|57.6|Standard Deviation|11.34|11.34|||
4030966|NCT01147822|3852867|B2|||Age||Years|Mean|57.6|57.6|Standard Deviation|11.19|11.19|||
4030967|NCT01147822|3852868|B1|||Age||Years|Mean|57.7|57.7|Standard Deviation|11.51|11.51|||
4030968|NCT01147809|3852883|B7|Japanese/East Asian Heritage/South East Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4030969|NCT01147809|3852884|B6|Japanese/East Asian Heritage/South East Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4030970|NCT01147809|3852885|B5|Japanese/East Asian Heritage/South East Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4030971|NCT01147809|3852886|B4|Japanese/East Asian Heritage/South East Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4030972|NCT01147809|3852887|B3|Japanese/East Asian Heritage/South East Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4030973|NCT01147809|3852888|B2|Japanese/East Asian Heritage/South East Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4030974|NCT01147809|3852889|B1|Japanese/East Asian Heritage/South East Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4030975|NCT01147809|3852883|B7|Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4030976|NCT01147809|3852884|B6|Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4030977|NCT01147809|3852885|B5|Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4030978|NCT01147809|3852886|B4|Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4030979|NCT01147809|3852887|B3|Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4030980|NCT01147809|3852888|B2|Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4030981|NCT01147809|3852889|B1|Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4030982|NCT01147809|3852883|B7|White||Race/Ethnicity, Customized||Participants|Number|95|95.0||||||
4030983|NCT01147809|3852884|B6|White||Race/Ethnicity, Customized||Participants|Number|52|52.0||||||
4030984|NCT01147809|3852885|B5|White||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4030985|NCT01147809|3852886|B4|White||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4030986|NCT01147809|3852887|B3|White||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4030987|NCT01147809|3852888|B2|White||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4030988|NCT01147809|3852889|B1|White||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4030989|NCT01147809|3852883|B7|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4030990|NCT01147809|3852884|B6|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4030991|NCT01147809|3852885|B5|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4030992|NCT01147809|3852886|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4030993|NCT01147809|3852887|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4030994|NCT01147809|3852888|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4030995|NCT01147809|3852889|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4030996|NCT01147809|3852883|B7||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4030997|NCT01147809|3852884|B6||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4030998|NCT01147809|3852885|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4030999|NCT01147809|3852886|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4031000|NCT01147809|3852887|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4031001|NCT01147809|3852888|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4031002|NCT01147809|3852889|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4031003|NCT01147809|3852883|B7||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4031004|NCT01147809|3852884|B6||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4031005|NCT01147809|3852885|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4031006|NCT01147809|3852886|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4031007|NCT01147809|3852887|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4031008|NCT01147809|3852888|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4031009|NCT01147809|3852889|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4031010|NCT01147809|3852883|B7|||Age||Years|Mean|64.1|64.1|Standard Deviation|10.56|10.56|||
4031011|NCT01147809|3852884|B6|||Age||Years|Mean|66.3|66.3|Standard Deviation|8.98|8.98|||
4031012|NCT01147809|3852885|B5|||Age||Years|Mean|64.4|64.4|Standard Deviation|9.96|9.96|||
4031013|NCT01147809|3852886|B4|||Age||Years|Mean|65.6|65.6|Standard Deviation|8.41|8.41|||
4031014|NCT01147809|3852887|B3|||Age||Years|Mean|61.8|61.8|Standard Deviation|22.82|22.82|||
4031015|NCT01147809|3852888|B2|||Age||Years|Mean|53.8|53.8|Standard Deviation|11.27|11.27|||
4031016|NCT01147809|3852889|B1|||Age||Years|Mean|53.3|53.3|Standard Deviation|3.79|3.79|||
4031017|NCT01147744|3853008|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031018|NCT01147744|3853009|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031019|NCT01147744|3853010|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031020|NCT01147744|3853011|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031021|NCT01147744|3853012|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031022|NCT01147744|3853013|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031023|NCT01147744|3853014|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031024|NCT01147744|3853015|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031025|NCT01147744|3853008|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031026|NCT01147744|3853009|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031027|NCT01147744|3853010|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031028|NCT01147744|3853011|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031029|NCT01147744|3853012|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031030|NCT01147744|3853013|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031031|NCT01147744|3853014|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031032|NCT01147744|3853015|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031033|NCT01147744|3853008|B8||White|Race (NIH/OMB)||Participants|Count of Participants|549|549.0||||||
4031034|NCT01147744|3853009|B7||White|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
4031035|NCT01147744|3853010|B6||White|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
4031036|NCT01147744|3853011|B5||White|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
4031037|NCT01147744|3853012|B4||White|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
4031038|NCT01147744|3853013|B3||White|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
4031039|NCT01147744|3853014|B2||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4031040|NCT01147744|3853015|B1||White|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
4031041|NCT01147744|3853008|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4031042|NCT01147744|3853009|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4031043|NCT01147744|3853010|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4031044|NCT01147744|3853011|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4031045|NCT01147744|3853012|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4031046|NCT01147744|3853013|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4031047|NCT01147744|3853014|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4031048|NCT01147744|3853015|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4031049|NCT01147744|3853008|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031050|NCT01147744|3853009|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031051|NCT01147744|3853010|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031052|NCT01147744|3853011|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031053|NCT01147744|3853012|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031054|NCT01147744|3853013|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031055|NCT01147744|3853014|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031056|NCT01147744|3853015|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031057|NCT01147744|3853008|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
4031058|NCT01147744|3853009|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4031059|NCT01147744|3853010|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4031060|NCT01147744|3853011|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4031061|NCT01147744|3853012|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4031062|NCT01147744|3853013|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4031063|NCT01147744|3853014|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4031064|NCT01147744|3853015|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4031065|NCT01147744|3853008|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4031066|NCT01147744|3853009|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031067|NCT01147744|3853010|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4031068|NCT01147744|3853011|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4031069|NCT01147744|3853012|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4031070|NCT01147744|3853013|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031071|NCT01147744|3853014|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031072|NCT01147744|3853015|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031073|NCT01147744|3853008|B8||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4031074|NCT01147744|3853009|B7||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4031075|NCT01147744|3853010|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4031076|NCT01147744|3853011|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4031077|NCT01147744|3853012|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4031078|NCT01147744|3853013|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4031079|NCT01147744|3853014|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4031080|NCT01147744|3853015|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4031081|NCT01147744|3853008|B8||Female|Sex: Female, Male||Participants|Count of Participants|644|644.0||||||
4031082|NCT01147744|3853009|B7||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4031083|NCT01147744|3853010|B6||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4031084|NCT01147744|3853011|B5||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4031085|NCT01147744|3853012|B4||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4031086|NCT01147744|3853013|B3||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4031087|NCT01147744|3853014|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4031088|NCT01147744|3853015|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4031089|NCT01147744|3853008|B8|||Age||Years|Mean|42.2|42.2|Standard Deviation|15.25|15.25|||
4031090|NCT01147744|3853009|B7|||Age||Years|Mean|44.3|44.3|Standard Deviation|14.97|14.97|||
4031091|NCT01147744|3853010|B6|||Age||Years|Mean|41.5|41.5|Standard Deviation|15.16|15.16|||
4031092|NCT01147744|3853011|B5|||Age||Years|Mean|42.2|42.2|Standard Deviation|14.15|14.15|||
4031093|NCT01147744|3853012|B4|||Age||Years|Mean|42.2|42.2|Standard Deviation|14.63|14.63|||
4031094|NCT01147744|3853013|B3|||Age||Years|Mean|43.1|43.1|Standard Deviation|16.17|16.17|||
4031095|NCT01147744|3853014|B2|||Age||Years|Mean|40|40.0|Standard Deviation|15.56|15.56|||
4031096|NCT01147744|3853015|B1|||Age||Years|Mean|42.3|42.3|Standard Deviation|16.13|16.13|||
4031097|NCT01147653|3853114|B3||Hypotonic Quadriplegia|Type of Cerebral Palsy||Participants|Count of Participants|4|4.0||||||
4031098|NCT01147653|3853115|B2||Hypotonic Quadriplegia|Type of Cerebral Palsy||Participants|Count of Participants|3|3.0||||||
4031099|NCT01147653|3853116|B1||Hypotonic Quadriplegia|Type of Cerebral Palsy||Participants|Count of Participants|1|1.0||||||
4031100|NCT01147653|3853114|B3||Spastic Quadriplegia|Type of Cerebral Palsy||Participants|Count of Participants|17|17.0||||||
4031101|NCT01147653|3853115|B2||Spastic Quadriplegia|Type of Cerebral Palsy||Participants|Count of Participants|7|7.0||||||
4031102|NCT01147653|3853116|B1||Spastic Quadriplegia|Type of Cerebral Palsy||Participants|Count of Participants|10|10.0||||||
4031103|NCT01147653|3853114|B3||Spastic Hemiplegia|Type of Cerebral Palsy||Participants|Count of Participants|30|30.0||||||
4031104|NCT01147653|3853115|B2||Spastic Hemiplegia|Type of Cerebral Palsy||Participants|Count of Participants|15|15.0||||||
4031105|NCT01147653|3853116|B1||Spastic Hemiplegia|Type of Cerebral Palsy||Participants|Count of Participants|15|15.0||||||
4031106|NCT01147653|3853114|B3||Spastic Diplegia|Type of Cerebral Palsy||Participants|Count of Participants|12|12.0||||||
4031107|NCT01147653|3853115|B2||Spastic Diplegia|Type of Cerebral Palsy||Participants|Count of Participants|6|6.0||||||
4031108|NCT01147653|3853116|B1||Spastic Diplegia|Type of Cerebral Palsy||Participants|Count of Participants|6|6.0||||||
4031109|NCT01147653|3853114|B3||Level IV|GMFCS Level|The Gross Motor Function Classification System (GMFCS) classifies gross motor function of children with cerebral palsy into Levels I (least disabled) to V (most disabled). For example, children at Level I are able to walk at home, in school, and in the community and can climb stairs without a railing. At Level II children may walk with assistance and can climb stairs using a railing. At Level III children walk with handheld assistive devices for short distances but use a wheelchair for long distance mobility. Mobility at Levels IV and V require physical assistance or powered devices.|Participants|Count of Participants|14|14.0||||||
4031110|NCT01147653|3853115|B2||Level IV|GMFCS Level|The Gross Motor Function Classification System (GMFCS) classifies gross motor function of children with cerebral palsy into Levels I (least disabled) to V (most disabled). For example, children at Level I are able to walk at home, in school, and in the community and can climb stairs without a railing. At Level II children may walk with assistance and can climb stairs using a railing. At Level III children walk with handheld assistive devices for short distances but use a wheelchair for long distance mobility. Mobility at Levels IV and V require physical assistance or powered devices.|Participants|Count of Participants|6|6.0||||||
4031111|NCT01147653|3853116|B1||Level IV|GMFCS Level|The Gross Motor Function Classification System (GMFCS) classifies gross motor function of children with cerebral palsy into Levels I (least disabled) to V (most disabled). For example, children at Level I are able to walk at home, in school, and in the community and can climb stairs without a railing. At Level II children may walk with assistance and can climb stairs using a railing. At Level III children walk with handheld assistive devices for short distances but use a wheelchair for long distance mobility. Mobility at Levels IV and V require physical assistance or powered devices.|Participants|Count of Participants|8|8.0||||||
4031132|NCT01147653|3853116|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4031133|NCT01147653|3853114|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031134|NCT01147653|3853115|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031112|NCT01147653|3853114|B3||Level III|GMFCS Level|The Gross Motor Function Classification System (GMFCS) classifies gross motor function of children with cerebral palsy into Levels I (least disabled) to V (most disabled). For example, children at Level I are able to walk at home, in school, and in the community and can climb stairs without a railing. At Level II children may walk with assistance and can climb stairs using a railing. At Level III children walk with handheld assistive devices for short distances but use a wheelchair for long distance mobility. Mobility at Levels IV and V require physical assistance or powered devices.|Participants|Count of Participants|8|8.0||||||
4031113|NCT01147653|3853115|B2||Level III|GMFCS Level|The Gross Motor Function Classification System (GMFCS) classifies gross motor function of children with cerebral palsy into Levels I (least disabled) to V (most disabled). For example, children at Level I are able to walk at home, in school, and in the community and can climb stairs without a railing. At Level II children may walk with assistance and can climb stairs using a railing. At Level III children walk with handheld assistive devices for short distances but use a wheelchair for long distance mobility. Mobility at Levels IV and V require physical assistance or powered devices.|Participants|Count of Participants|4|4.0||||||
4031114|NCT01147653|3853116|B1||Level III|GMFCS Level|The Gross Motor Function Classification System (GMFCS) classifies gross motor function of children with cerebral palsy into Levels I (least disabled) to V (most disabled). For example, children at Level I are able to walk at home, in school, and in the community and can climb stairs without a railing. At Level II children may walk with assistance and can climb stairs using a railing. At Level III children walk with handheld assistive devices for short distances but use a wheelchair for long distance mobility. Mobility at Levels IV and V require physical assistance or powered devices.|Participants|Count of Participants|4|4.0||||||
4031115|NCT01147653|3853114|B3||Level II|GMFCS Level|The Gross Motor Function Classification System (GMFCS) classifies gross motor function of children with cerebral palsy into Levels I (least disabled) to V (most disabled). For example, children at Level I are able to walk at home, in school, and in the community and can climb stairs without a railing. At Level II children may walk with assistance and can climb stairs using a railing. At Level III children walk with handheld assistive devices for short distances but use a wheelchair for long distance mobility. Mobility at Levels IV and V require physical assistance or powered devices.|Participants|Count of Participants|24|24.0||||||
4031116|NCT01147653|3853115|B2||Level II|GMFCS Level|The Gross Motor Function Classification System (GMFCS) classifies gross motor function of children with cerebral palsy into Levels I (least disabled) to V (most disabled). For example, children at Level I are able to walk at home, in school, and in the community and can climb stairs without a railing. At Level II children may walk with assistance and can climb stairs using a railing. At Level III children walk with handheld assistive devices for short distances but use a wheelchair for long distance mobility. Mobility at Levels IV and V require physical assistance or powered devices.|Participants|Count of Participants|15|15.0||||||
4031117|NCT01147653|3853116|B1||Level II|GMFCS Level|The Gross Motor Function Classification System (GMFCS) classifies gross motor function of children with cerebral palsy into Levels I (least disabled) to V (most disabled). For example, children at Level I are able to walk at home, in school, and in the community and can climb stairs without a railing. At Level II children may walk with assistance and can climb stairs using a railing. At Level III children walk with handheld assistive devices for short distances but use a wheelchair for long distance mobility. Mobility at Levels IV and V require physical assistance or powered devices.|Participants|Count of Participants|9|9.0||||||
4031118|NCT01147653|3853114|B3||Level I|GMFCS Level|The Gross Motor Function Classification System (GMFCS) classifies gross motor function of children with cerebral palsy into Levels I (least disabled) to V (most disabled). For example, children at Level I are able to walk at home, in school, and in the community and can climb stairs without a railing. At Level II children may walk with assistance and can climb stairs using a railing. At Level III children walk with handheld assistive devices for short distances but use a wheelchair for long distance mobility. Mobility at Levels IV and V require physical assistance or powered devices.|Participants|Count of Participants|17|17.0||||||
4031119|NCT01147653|3853115|B2||Level I|GMFCS Level|The Gross Motor Function Classification System (GMFCS) classifies gross motor function of children with cerebral palsy into Levels I (least disabled) to V (most disabled). For example, children at Level I are able to walk at home, in school, and in the community and can climb stairs without a railing. At Level II children may walk with assistance and can climb stairs using a railing. At Level III children walk with handheld assistive devices for short distances but use a wheelchair for long distance mobility. Mobility at Levels IV and V require physical assistance or powered devices.|Participants|Count of Participants|6|6.0||||||
4031120|NCT01147653|3853116|B1||Level I|GMFCS Level|The Gross Motor Function Classification System (GMFCS) classifies gross motor function of children with cerebral palsy into Levels I (least disabled) to V (most disabled). For example, children at Level I are able to walk at home, in school, and in the community and can climb stairs without a railing. At Level II children may walk with assistance and can climb stairs using a railing. At Level III children walk with handheld assistive devices for short distances but use a wheelchair for long distance mobility. Mobility at Levels IV and V require physical assistance or powered devices.|Participants|Count of Participants|11|11.0||||||
4031121|NCT01147653|3853114|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031122|NCT01147653|3853115|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031123|NCT01147653|3853116|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031124|NCT01147653|3853114|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031125|NCT01147653|3853115|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031126|NCT01147653|3853116|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031127|NCT01147653|3853114|B3||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4031128|NCT01147653|3853115|B2||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4031129|NCT01147653|3853116|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4031130|NCT01147653|3853114|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4031131|NCT01147653|3853115|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031135|NCT01147653|3853116|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031136|NCT01147653|3853114|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4031137|NCT01147653|3853115|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4031138|NCT01147653|3853116|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4031139|NCT01147653|3853114|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031140|NCT01147653|3853115|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031141|NCT01147653|3853116|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031142|NCT01147653|3853114|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031143|NCT01147653|3853115|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031144|NCT01147653|3853116|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031145|NCT01147653|3853114|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4031146|NCT01147653|3853115|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4031147|NCT01147653|3853116|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4031148|NCT01147653|3853114|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4031149|NCT01147653|3853115|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4031150|NCT01147653|3853116|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4031151|NCT01147653|3853114|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4031152|NCT01147653|3853115|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4031153|NCT01147653|3853116|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4031154|NCT01147653|3853114|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4031155|NCT01147653|3853115|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4031156|NCT01147653|3853116|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4031157|NCT01147653|3853114|B3|||Age||Years|Median|2.3|2.3|Full Range|||1.1|7.0|
4031158|NCT01147653|3853115|B2|||Age||Years|Median|2.3|2.3|Full Range|||1.1|7.0|
4031159|NCT01147653|3853116|B1|||Age||Years|Median|2.1|2.1|Full Range|||1.1|6.2|
4031160|NCT01147640|3853176|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4031161|NCT01147640|3853177|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4031162|NCT01147640|3853178|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4031163|NCT01147640|3853176|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4031164|NCT01147640|3853177|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4031165|NCT01147640|3853178|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4031166|NCT01147640|3853176|B3|||Age||years|Mean|47.8|47.8|Standard Deviation|18.64|18.64|||
4031167|NCT01147640|3853177|B2|||Age||years|Mean|46.4|46.4|Standard Deviation|18.48|18.48|||
4031168|NCT01147640|3853178|B1|||Age||years|Mean|48.5|48.5|Standard Deviation|18.79|18.79|||
4031169|NCT01147627|3853187|B4|China||Region of Enrollment||participants|Number|416|416.0||||||
4031170|NCT01147627|3853188|B3|China||Region of Enrollment||participants|Number|136|136.0||||||
4031171|NCT01147627|3853189|B2|China||Region of Enrollment||participants|Number|138|138.0||||||
4031172|NCT01147627|3853190|B1|China||Region of Enrollment||participants|Number|142|142.0||||||
4031173|NCT01147627|3853187|B4||Male|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
4031174|NCT01147627|3853188|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4031175|NCT01147627|3853189|B2||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4031176|NCT01147627|3853190|B1||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4031177|NCT01147627|3853187|B4||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4031178|NCT01147627|3853188|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4031179|NCT01147627|3853189|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4031180|NCT01147627|3853190|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4031181|NCT01147627|3853187|B4|||Age||years|Mean|50.31|50.31|Standard Deviation|9.40|9.4|||
4031182|NCT01147627|3853188|B3|||Age||years|Mean|49.66|49.66|Standard Deviation|8.86|8.86|||
4031183|NCT01147627|3853189|B2|||Age||years|Mean|51.39|51.39|Standard Deviation|9.65|9.65|||
4031184|NCT01147627|3853190|B1|||Age||years|Mean|49.89|49.89|Standard Deviation|9.64|9.64|||
4031185|NCT01147627|3853187|B4||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4031186|NCT01147627|3853188|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4031187|NCT01147627|3853189|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4031188|NCT01147627|3853190|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4031189|NCT01147627|3853187|B4||Between 18 and 65 years|Age||Participants|Count of Participants|389|389.0||||||
4031190|NCT01147627|3853188|B3||Between 18 and 65 years|Age||Participants|Count of Participants|129|129.0||||||
4031191|NCT01147627|3853189|B2||Between 18 and 65 years|Age||Participants|Count of Participants|128|128.0||||||
4031192|NCT01147627|3853190|B1||Between 18 and 65 years|Age||Participants|Count of Participants|132|132.0||||||
4031193|NCT01147627|3853187|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031194|NCT01147627|3853188|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031195|NCT01147627|3853189|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031196|NCT01147627|3853190|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031197|NCT01147601|3853200|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4031198|NCT01147601|3853201|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4031199|NCT01147601|3853202|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4031200|NCT01147601|3853200|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031201|NCT01147601|3853201|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031202|NCT01147601|3853202|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031203|NCT01147601|3853200|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031204|NCT01147601|3853201|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031205|NCT01147601|3853202|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031206|NCT01147601|3853200|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4031207|NCT01147601|3853201|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4031208|NCT01147601|3853202|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4031209|NCT01147601|3853200|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031210|NCT01147601|3853201|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031211|NCT01147601|3853202|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031212|NCT01147601|3853200|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031213|NCT01147601|3853201|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031214|NCT01147601|3853202|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031215|NCT01147601|3853200|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031216|NCT01147601|3853201|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031217|NCT01147601|3853202|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031218|NCT01147601|3853200|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031219|NCT01147601|3853201|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031220|NCT01147601|3853202|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031221|NCT01147601|3853200|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031222|NCT01147601|3853201|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031223|NCT01147601|3853202|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031224|NCT01147601|3853200|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4031225|NCT01147601|3853201|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4031226|NCT01147601|3853202|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4031227|NCT01147601|3853200|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031228|NCT01147601|3853201|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031229|NCT01147601|3853202|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031230|NCT01147601|3853200|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4031231|NCT01147601|3853201|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4031232|NCT01147601|3853202|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4031233|NCT01147601|3853200|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4031234|NCT01147601|3853201|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4031235|NCT01147601|3853202|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4031236|NCT01147601|3853200|B3|||Age||days|Mean|123.2|123.2|Full Range|||41.0|217.0|
4031237|NCT01147601|3853201|B2|||Age||days|Mean|178|178.0|Full Range|||178.0|178.0|
4031238|NCT01147601|3853202|B1|||Age||days|Mean|93.5|93.5|Full Range|||41.0|217.0|
4031239|NCT01147497|3853209|B3|United States||Region of Enrollment||participants|Number|73|73.0||||||
4031240|NCT01147497|3853210|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
4031241|NCT01147497|3853211|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4031242|NCT01147497|3853209|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4031243|NCT01147497|3853210|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4031244|NCT01147497|3853211|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4031245|NCT01147497|3853209|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4031246|NCT01147497|3853210|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4031247|NCT01147497|3853211|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4031248|NCT01147497|3853209|B3|||Age||years|Mean|25.775|25.775|Standard Deviation|.554|0.554|||
4031249|NCT01147497|3853210|B2|||Age||years|Mean|25.5|25.5|Standard Deviation|.554|0.554|||
4031250|NCT01147497|3853211|B1|||Age||years|Mean|26.05|26.05|Standard Deviation|.554|0.554|||
4031251|NCT01147497|3853209|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4031252|NCT01147497|3853210|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4031253|NCT01147497|3853211|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4031254|NCT01147497|3853209|B3||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4031255|NCT01147497|3853210|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4031256|NCT01147497|3853211|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4031257|NCT01147497|3853209|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031258|NCT01147497|3853210|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031259|NCT01147497|3853211|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031260|NCT01147471|3853230|B3|Antero-lateral||Side & position of flail||participants|Number|5|5.0||||||
4031261|NCT01147471|3853231|B2|Antero-lateral||Side & position of flail||participants|Number|2|2.0||||||
4031262|NCT01147471|3853232|B1|Antero-lateral||Side & position of flail||participants|Number|3|3.0||||||
4031263|NCT01147471|3853230|B3|Postero-lateral||Side & position of flail||participants|Number|19|19.0||||||
4031264|NCT01147471|3853231|B2|Postero-lateral||Side & position of flail||participants|Number|9|9.0||||||
4031265|NCT01147471|3853232|B1|Postero-lateral||Side & position of flail||participants|Number|10|10.0||||||
4031266|NCT01147471|3853230|B3|left side flail||Side & position of flail||participants|Number|10|10.0||||||
4031267|NCT01147471|3853231|B2|left side flail||Side & position of flail||participants|Number|4|4.0||||||
4031268|NCT01147471|3853232|B1|left side flail||Side & position of flail||participants|Number|6|6.0||||||
4031269|NCT01147471|3853230|B3|right side flail||Side & position of flail||participants|Number|14|14.0||||||
4031270|NCT01147471|3853231|B2|right side flail||Side & position of flail||participants|Number|7|7.0||||||
4031271|NCT01147471|3853232|B1|right side flail||Side & position of flail||participants|Number|7|7.0||||||
4031272|NCT01147471|3853230|B3|Pedestrian struck||Mechanism of injury||participants|Number|4|4.0||||||
4031273|NCT01147471|3853231|B2|Pedestrian struck||Mechanism of injury||participants|Number|1|1.0||||||
4031274|NCT01147471|3853232|B1|Pedestrian struck||Mechanism of injury||participants|Number|3|3.0||||||
4031275|NCT01147471|3853230|B3|Motor vehicle crash||Mechanism of injury||participants|Number|12|12.0||||||
4031276|NCT01147471|3853231|B2|Motor vehicle crash||Mechanism of injury||participants|Number|5|5.0||||||
4031277|NCT01147471|3853232|B1|Motor vehicle crash||Mechanism of injury||participants|Number|7|7.0||||||
4031278|NCT01147471|3853230|B3|Motor cycle crash||Mechanism of injury||participants|Number|7|7.0||||||
4031279|NCT01147471|3853231|B2|Motor cycle crash||Mechanism of injury||participants|Number|5|5.0||||||
4031280|NCT01147471|3853232|B1|Motor cycle crash||Mechanism of injury||participants|Number|2|2.0||||||
4031281|NCT01147471|3853230|B3|Fall from height||Mechanism of injury||participants|Number|1|1.0||||||
4031282|NCT01147471|3853231|B2|Fall from height||Mechanism of injury||participants|Number|0|0.0||||||
4031283|NCT01147471|3853232|B1|Fall from height||Mechanism of injury||participants|Number|1|1.0||||||
4031284|NCT01147471|3853230|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4031285|NCT01147471|3853231|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4031286|NCT01147471|3853232|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4031287|NCT01147471|3853230|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4031288|NCT01147471|3853231|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4031289|NCT01147471|3853232|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4031290|NCT01147471|3853230|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031291|NCT01147471|3853231|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031292|NCT01147471|3853232|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031293|NCT01147471|3853230|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4031294|NCT01147471|3853231|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4031295|NCT01147471|3853232|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4031296|NCT01147471|3853230|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4031297|NCT01147471|3853231|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4031298|NCT01147471|3853232|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4031299|NCT01147471|3853230|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031300|NCT01147471|3853231|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031301|NCT01147471|3853232|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031302|NCT01147471|3853230|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031303|NCT01147471|3853231|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031304|NCT01147471|3853232|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031305|NCT01147471|3853230|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031306|NCT01147471|3853231|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031307|NCT01147471|3853232|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031308|NCT01147471|3853230|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4031309|NCT01147471|3853231|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4031310|NCT01147471|3853232|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4031311|NCT01147471|3853230|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4031312|NCT01147471|3853231|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4031429|NCT01147406|3853301|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4031313|NCT01147471|3853232|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4031314|NCT01147471|3853230|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4031315|NCT01147471|3853231|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4031316|NCT01147471|3853232|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4031317|NCT01147471|3853230|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4031318|NCT01147471|3853231|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4031319|NCT01147471|3853232|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4031320|NCT01147471|3853230|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4031321|NCT01147471|3853231|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4031322|NCT01147471|3853232|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4031323|NCT01147471|3853230|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4031324|NCT01147471|3853231|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4031325|NCT01147471|3853232|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4031326|NCT01147471|3853230|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4031327|NCT01147471|3853231|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4031328|NCT01147471|3853232|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4031329|NCT01147471|3853230|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031330|NCT01147471|3853231|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031331|NCT01147471|3853232|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031332|NCT01147458|3853247|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4031333|NCT01147458|3853247|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4031334|NCT01147458|3853247|B1|||Age||Years|Mean|59.4|59.4|Standard Deviation|8.7|8.7|||
4031335|NCT01147406|3853298|B7|United States||Region of Enrollment||participants|Number|41|41.0||||||
4031336|NCT01147406|3853299|B6|United States||Region of Enrollment||participants|Number|10|10.0||||||
4031337|NCT01147406|3853300|B5|United States||Region of Enrollment||participants|Number|6|6.0||||||
4031338|NCT01147406|3853301|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
4031339|NCT01147406|3853302|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4031340|NCT01147406|3853303|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4031341|NCT01147406|3853304|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4031342|NCT01147406|3853298|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031343|NCT01147406|3853299|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031344|NCT01147406|3853300|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031345|NCT01147406|3853301|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031346|NCT01147406|3853302|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031347|NCT01147406|3853303|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031348|NCT01147406|3853304|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031349|NCT01147406|3853298|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4031350|NCT01147406|3853299|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4031351|NCT01147406|3853300|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4031352|NCT01147406|3853301|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4031353|NCT01147406|3853302|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4031354|NCT01147406|3853303|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4031355|NCT01147406|3853304|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4031356|NCT01147406|3853298|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4031357|NCT01147406|3853299|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4031358|NCT01147406|3853300|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031359|NCT01147406|3853301|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4031360|NCT01147406|3853302|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031361|NCT01147406|3853303|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031362|NCT01147406|3853304|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031363|NCT01147406|3853298|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031364|NCT01147406|3853299|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031365|NCT01147406|3853300|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031366|NCT01147406|3853301|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031367|NCT01147406|3853302|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031368|NCT01147406|3853303|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031369|NCT01147406|3853304|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031370|NCT01147406|3853298|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031371|NCT01147406|3853299|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031372|NCT01147406|3853300|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031373|NCT01147406|3853301|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031374|NCT01147406|3853302|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031375|NCT01147406|3853303|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031376|NCT01147406|3853304|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031377|NCT01147406|3853298|B7||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4031378|NCT01147406|3853299|B6||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4031379|NCT01147406|3853300|B5||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4031380|NCT01147406|3853301|B4||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4031381|NCT01147406|3853302|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031382|NCT01147406|3853303|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4031383|NCT01147406|3853304|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4031384|NCT01147406|3853298|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4031385|NCT01147406|3853299|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4031386|NCT01147406|3853300|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4031387|NCT01147406|3853301|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4031388|NCT01147406|3853302|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4031389|NCT01147406|3853303|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4031390|NCT01147406|3853304|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4031391|NCT01147406|3853298|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031392|NCT01147406|3853299|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031393|NCT01147406|3853300|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031394|NCT01147406|3853301|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031395|NCT01147406|3853302|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031396|NCT01147406|3853303|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031397|NCT01147406|3853304|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031398|NCT01147406|3853298|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031399|NCT01147406|3853299|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031400|NCT01147406|3853300|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031401|NCT01147406|3853301|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031402|NCT01147406|3853302|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031403|NCT01147406|3853303|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031404|NCT01147406|3853304|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031405|NCT01147406|3853298|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031406|NCT01147406|3853299|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031407|NCT01147406|3853300|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031408|NCT01147406|3853301|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031409|NCT01147406|3853302|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031410|NCT01147406|3853303|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031411|NCT01147406|3853304|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031412|NCT01147406|3853298|B7||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4031413|NCT01147406|3853299|B6||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4031414|NCT01147406|3853300|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4031415|NCT01147406|3853301|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4031416|NCT01147406|3853302|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4031417|NCT01147406|3853303|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4031418|NCT01147406|3853304|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4031419|NCT01147406|3853298|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4031420|NCT01147406|3853299|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4031421|NCT01147406|3853300|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4031422|NCT01147406|3853301|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4031423|NCT01147406|3853302|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4031424|NCT01147406|3853303|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4031425|NCT01147406|3853304|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4031426|NCT01147406|3853298|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4031427|NCT01147406|3853299|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4031428|NCT01147406|3853300|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4031430|NCT01147406|3853302|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4031431|NCT01147406|3853303|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4031432|NCT01147406|3853304|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4031433|NCT01147406|3853298|B7||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4031434|NCT01147406|3853299|B6||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4031435|NCT01147406|3853300|B5||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4031436|NCT01147406|3853301|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4031437|NCT01147406|3853302|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4031438|NCT01147406|3853303|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4031439|NCT01147406|3853304|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4031440|NCT01147406|3853298|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031441|NCT01147406|3853299|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031442|NCT01147406|3853300|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031443|NCT01147406|3853301|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031444|NCT01147406|3853302|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031445|NCT01147406|3853303|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031446|NCT01147406|3853304|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031447|NCT01147393|3853329|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4031448|NCT01147393|3853329|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4031449|NCT01147393|3853329|B1|Patients by Age|70-79 Years of Age|Age, Customized||Participants|Count of Participants|1|1.0||||||
4031450|NCT01147393|3853329|B1|Patients by Age|60-69 Years of Age|Age, Customized||Participants|Count of Participants|3|3.0||||||
4031451|NCT01147380|3853337|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4031452|NCT01147380|3853338|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4031453|NCT01147380|3853339|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4031454|NCT01147380|3853337|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4031455|NCT01147380|3853338|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4031456|NCT01147380|3853339|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4031457|NCT01147380|3853337|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4031458|NCT01147380|3853338|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4031459|NCT01147380|3853339|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4031460|NCT01147380|3853337|B3|||Age||years|Mean|56.9|56.9|Full Range|||20.0|68.0|
4031461|NCT01147380|3853338|B2|||Age||years|Mean|55.6|55.6|Full Range|||20.0|68.0|
4031462|NCT01147380|3853339|B1|||Age||years|Mean|59.5|59.5|Full Range|||52.0|66.0|
4031463|NCT01147380|3853337|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4031464|NCT01147380|3853338|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4031465|NCT01147380|3853339|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4031466|NCT01147380|3853337|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4031467|NCT01147380|3853338|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4031468|NCT01147380|3853339|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4031469|NCT01147380|3853337|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031470|NCT01147380|3853338|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031471|NCT01147380|3853339|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031472|NCT01147341|3853348|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
4031473|NCT01147341|3853349|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4031474|NCT01147341|3853350|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4031475|NCT01147341|3853348|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4031476|NCT01147341|3853349|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4031477|NCT01147341|3853350|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4031478|NCT01147341|3853348|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4031479|NCT01147341|3853349|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4031480|NCT01147341|3853350|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4031481|NCT01147341|3853348|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4031482|NCT01147341|3853349|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4031483|NCT01147341|3853350|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4031484|NCT01147341|3853348|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4031485|NCT01147341|3853349|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4031486|NCT01147341|3853350|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4031487|NCT01147341|3853348|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031488|NCT01147341|3853349|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031489|NCT01147341|3853350|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031490|NCT01147302|3853379|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4031491|NCT01147302|3853380|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4031492|NCT01147302|3853381|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4031493|NCT01147302|3853379|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4031494|NCT01147302|3853380|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4031495|NCT01147302|3853381|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4031496|NCT01147302|3853379|B3|65 to 75 years||Age, Customized||participants|Number|3|3.0||||||
4031497|NCT01147302|3853380|B2|65 to 75 years||Age, Customized||participants|Number|1|1.0||||||
4031498|NCT01147302|3853381|B1|65 to 75 years||Age, Customized||participants|Number|2|2.0||||||
4031499|NCT01147302|3853379|B3|45 to 64 years||Age, Customized||participants|Number|8|8.0||||||
4031500|NCT01147302|3853380|B2|45 to 64 years||Age, Customized||participants|Number|4|4.0||||||
4031501|NCT01147302|3853381|B1|45 to 64 years||Age, Customized||participants|Number|4|4.0||||||
4031502|NCT01147302|3853379|B3|18 to 44 years||Age, Customized||participants|Number|7|7.0||||||
4031503|NCT01147302|3853380|B2|18 to 44 years||Age, Customized||participants|Number|4|4.0||||||
4031504|NCT01147302|3853381|B1|18 to 44 years||Age, Customized||participants|Number|3|3.0||||||
4031505|NCT01147302|3853379|B3|||Age||years|Mean|48.7|48.7|Standard Deviation|12.4|12.4|||
4031506|NCT01147302|3853380|B2|||Age||years|Mean|48.6|48.6|Standard Deviation|12.5|12.5|||
4031507|NCT01147302|3853381|B1|||Age||years|Mean|48.8|48.8|Standard Deviation|13.0|13.0|||
4031508|NCT01147250|3853412|B3|||Duration of Diabetes|N=3034, 3031|years|Mean|9.29|9.29|Standard Deviation|8.25|8.25|||
4031509|NCT01147250|3853413|B2|||Duration of Diabetes|N=3034, 3031|years|Mean|9.2|9.2|Standard Deviation|8.19|8.19|||
4031510|NCT01147250|3853414|B1|||Duration of Diabetes|N=3034, 3031|years|Mean|9.38|9.38|Standard Deviation|8.32|8.32|||
4031511|NCT01147250|3853412|B3|||Glycosylated Hemoglobin (HbA1c)|N=3033, 3034|Percentage of HbA1c|Mean|7.68|7.68|Standard Deviation|1.30|1.3|||
4031512|NCT01147250|3853413|B2|||Glycosylated Hemoglobin (HbA1c)|N=3033, 3034|Percentage of HbA1c|Mean|7.72|7.72|Standard Deviation|1.32|1.32|||
4031513|NCT01147250|3853414|B1|||Glycosylated Hemoglobin (HbA1c)|N=3033, 3034|Percentage of HbA1c|Mean|7.64|7.64|Standard Deviation|1.28|1.28|||
4031514|NCT01147250|3853412|B3|||Body Weight|N=3032, 3033|kg|Mean|84.85|84.85|Standard Deviation|19.43|19.43|||
4031515|NCT01147250|3853413|B2|||Body Weight|N=3032, 3033|kg|Mean|84.64|84.64|Standard Deviation|19.21|19.21|||
4031516|NCT01147250|3853414|B1|||Body Weight|N=3032, 3033|kg|Mean|85.06|85.06|Standard Deviation|19.64|19.64|||
4031517|NCT01147250|3853412|B3|||Body Mass Index (BMI)|N=3032, 3033|kg/m^2|Mean|30.16|30.16|Standard Deviation|5.69|5.69|||
4031518|NCT01147250|3853413|B2|||Body Mass Index (BMI)|N=3032, 3033|kg/m^2|Mean|30.12|30.12|Standard Deviation|5.6|5.6|||
4031519|NCT01147250|3853414|B1|||Body Mass Index (BMI)|N=3032, 3033|kg/m^2|Mean|30.2|30.2|Standard Deviation|5.79|5.79|||
4031520|NCT01147250|3853412|B3|Not qualifying ACS event||Qualifying Acute Coronary Syndrome (ACS) event||participants|Number|3|3.0||||||
4031521|NCT01147250|3853413|B2|Not qualifying ACS event||Qualifying Acute Coronary Syndrome (ACS) event||participants|Number|1|1.0||||||
4031522|NCT01147250|3853414|B1|Not qualifying ACS event||Qualifying Acute Coronary Syndrome (ACS) event||participants|Number|2|2.0||||||
4031523|NCT01147250|3853412|B3|Unclassified||Qualifying Acute Coronary Syndrome (ACS) event||participants|Number|9|9.0||||||
4031524|NCT01147250|3853413|B2|Unclassified||Qualifying Acute Coronary Syndrome (ACS) event||participants|Number|5|5.0||||||
4031525|NCT01147250|3853414|B1|Unclassified||Qualifying Acute Coronary Syndrome (ACS) event||participants|Number|4|4.0||||||
4031526|NCT01147250|3853412|B3|Unstable angina||Qualifying Acute Coronary Syndrome (ACS) event||participants|Number|1042|1042.0||||||
4031527|NCT01147250|3853413|B2|Unstable angina||Qualifying Acute Coronary Syndrome (ACS) event||participants|Number|514|514.0||||||
4031528|NCT01147250|3853414|B1|Unstable angina||Qualifying Acute Coronary Syndrome (ACS) event||participants|Number|528|528.0||||||
4031529|NCT01147250|3853412|B3|Non ST-segment elevation MI||Qualifying Acute Coronary Syndrome (ACS) event||participants|Number|2348|2348.0||||||
4031530|NCT01147250|3853413|B2|Non ST-segment elevation MI||Qualifying Acute Coronary Syndrome (ACS) event||participants|Number|1165|1165.0||||||
4031531|NCT01147250|3853414|B1|Non ST-segment elevation MI||Qualifying Acute Coronary Syndrome (ACS) event||participants|Number|1183|1183.0||||||
4031532|NCT01147250|3853412|B3|ST-segment elevation myocardial infarction (MI)||Qualifying Acute Coronary Syndrome (ACS) event||participants|Number|2666|2666.0||||||
4031533|NCT01147250|3853413|B2|ST-segment elevation myocardial infarction (MI)||Qualifying Acute Coronary Syndrome (ACS) event||participants|Number|1349|1349.0||||||
4031534|NCT01147250|3853414|B1|ST-segment elevation myocardial infarction (MI)||Qualifying Acute Coronary Syndrome (ACS) event||participants|Number|1317|1317.0||||||
4031535|NCT01147250|3853412|B3|Not Hispanic||Ethnicity||participants|Number|4300|4300.0||||||
4031536|NCT01147250|3853413|B2|Not Hispanic||Ethnicity||participants|Number|2169|2169.0||||||
4031537|NCT01147250|3853414|B1|Not Hispanic||Ethnicity||participants|Number|2131|2131.0||||||
4031538|NCT01147250|3853412|B3|Hispanic||Ethnicity||participants|Number|1768|1768.0||||||
4031539|NCT01147250|3853413|B2|Hispanic||Ethnicity||participants|Number|865|865.0||||||
4031540|NCT01147250|3853414|B1|Hispanic||Ethnicity||participants|Number|903|903.0||||||
4031541|NCT01147250|3853412|B3|Other||Race||participants|Number|500|500.0||||||
4031542|NCT01147250|3853413|B2|Other||Race||participants|Number|254|254.0||||||
4031543|NCT01147250|3853414|B1|Other||Race||participants|Number|246|246.0||||||
4031544|NCT01147250|3853412|B3|Asian/Oriental||Race||participants|Number|771|771.0||||||
4031545|NCT01147250|3853413|B2|Asian/Oriental||Race||participants|Number|404|404.0||||||
4031546|NCT01147250|3853414|B1|Asian/Oriental||Race||participants|Number|367|367.0||||||
4031547|NCT01147250|3853412|B3|Black||Race||participants|Number|221|221.0||||||
4031548|NCT01147250|3853413|B2|Black||Race||participants|Number|118|118.0||||||
4031549|NCT01147250|3853414|B1|Black||Race||participants|Number|103|103.0||||||
4031550|NCT01147250|3853412|B3|Caucasian/White||Race||participants|Number|4576|4576.0||||||
4031551|NCT01147250|3853413|B2|Caucasian/White||Race||participants|Number|2258|2258.0||||||
4031552|NCT01147250|3853414|B1|Caucasian/White||Race||participants|Number|2318|2318.0||||||
4031553|NCT01147250|3853412|B3||Male|Gender||Participants|Count of Participants|4207|4207.0||||||
4031554|NCT01147250|3853413|B2||Male|Gender||Participants|Count of Participants|2111|2111.0||||||
4031555|NCT01147250|3853414|B1||Male|Gender||Participants|Count of Participants|2096|2096.0||||||
4031556|NCT01147250|3853412|B3||Female|Gender||Participants|Count of Participants|1861|1861.0||||||
4031557|NCT01147250|3853413|B2||Female|Gender||Participants|Count of Participants|923|923.0||||||
4031558|NCT01147250|3853414|B1||Female|Gender||Participants|Count of Participants|938|938.0||||||
4031559|NCT01147250|3853412|B3|||Age||years|Mean|60.3|60.3|Standard Deviation|9.7|9.7|||
4031560|NCT01147250|3853413|B2|||Age||years|Mean|59.9|59.9|Standard Deviation|9.7|9.7|||
4031561|NCT01147250|3853414|B1|||Age||years|Mean|60.6|60.6|Standard Deviation|9.6|9.6|||
4031562|NCT01147172|3853427|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4031563|NCT01147172|3853427|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4031564|NCT01147172|3853427|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031565|NCT01147172|3853427|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4031566|NCT01147172|3853427|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4031567|NCT01147172|3853427|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4031568|NCT01147172|3853427|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4031569|NCT01147172|3853427|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4031570|NCT01147172|3853427|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4031571|NCT01147172|3853427|B1|||Age||years|Mean|50.1|50.1|Standard Deviation|10.4|10.4|||
4031572|NCT01147068|3853438|B8||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4031573|NCT01147068|3853439|B7||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4031574|NCT01147068|3853440|B6||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4031575|NCT01147068|3853441|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4031576|NCT01147068|3853442|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4031577|NCT01147068|3853443|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4031578|NCT01147068|3853444|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4031579|NCT01147068|3853445|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4031580|NCT01147068|3853438|B8||Female|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
4031581|NCT01147068|3853439|B7||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4031582|NCT01147068|3853440|B6||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4031583|NCT01147068|3853441|B5||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4031584|NCT01147068|3853442|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4031585|NCT01147068|3853443|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4031586|NCT01147068|3853444|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4031587|NCT01147068|3853445|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4031588|NCT01147068|3853438|B8|||Age|The median was measured based on the total population of each arm.|years|Median|32.2|32.2|Full Range|||18.0|49.0|
4031589|NCT01147068|3853439|B7|||Age|The median was measured based on the total population of each arm.|years|Median|33.0|33.0|Full Range|||19.0|49.0|
4031590|NCT01147068|3853440|B6|||Age|The median was measured based on the total population of each arm.|years|Median|27.0|27.0|Full Range|||19.0|48.0|
4031591|NCT01147068|3853441|B5|||Age|The median was measured based on the total population of each arm.|years|Median|33.5|33.5|Full Range|||18.0|49.0|
4031592|NCT01147068|3853442|B4|||Age|The median was measured based on the total population of each arm.|years|Median|31.0|31.0|Full Range|||18.0|49.0|
4031593|NCT01147068|3853443|B3|||Age|The median was measured based on the total population of each arm.|years|Median|32.0|32.0|Full Range|||18.0|49.0|
4031594|NCT01147068|3853444|B2|||Age|The median was measured based on the total population of each arm.|years|Median|30.0|30.0|Full Range|||18.0|48.0|
4031595|NCT01147068|3853445|B1|||Age|The median was measured based on the total population of each arm.|years|Median|32.0|32.0|Full Range|||18.0|49.0|
4031596|NCT01147055|3853481|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4031597|NCT01147055|3853481|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4031598|NCT01147055|3853481|B1|||Age||years|Mean|38.9|38.9|Standard Deviation|8.5|8.5|||
4031599|NCT01147042|3853514|B3|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4031600|NCT01147042|3853515|B2|United States||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4031601|NCT01147042|3853516|B1|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4031602|NCT01147042|3853514|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4031603|NCT01147042|3853515|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4031604|NCT01147042|3853516|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4031605|NCT01147042|3853514|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4031606|NCT01147042|3853515|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4031607|NCT01147042|3853516|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4031608|NCT01147042|3853514|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4031609|NCT01147042|3853515|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4031610|NCT01147042|3853516|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4031611|NCT01147042|3853514|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4031612|NCT01147042|3853515|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4031613|NCT01147042|3853516|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4031614|NCT01147042|3853514|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4031615|NCT01147042|3853515|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031616|NCT01147042|3853516|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4031617|NCT01146951|3853522|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4031618|NCT01146951|3853523|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4031619|NCT01146951|3853524|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4031620|NCT01146951|3853522|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4031621|NCT01146951|3853523|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4031622|NCT01146951|3853524|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4031623|NCT01146951|3853522|B3|||Age||years|Mean|14.9|14.9|Standard Deviation|6.6|6.6|||
4031624|NCT01146951|3853523|B2|||Age||years|Mean|13.9|13.9|Standard Deviation|6.1|6.1|||
4031625|NCT01146951|3853524|B1|||Age||years|Mean|16.0|16.0|Standard Deviation|7.1|7.1|||
4031626|NCT01146912|3853539|B8|United States||Region of Enrollment||participants|Number|15862|15862.0||||||
4031627|NCT01146912|3853540|B7|United States||Region of Enrollment||participants|Number|1820|1820.0||||||
4031628|NCT01146912|3853541|B6|United States||Region of Enrollment||participants|Number|1821|1821.0||||||
4031629|NCT01146912|3853542|B5|United States||Region of Enrollment||participants|Number|1821|1821.0||||||
4031630|NCT01146912|3853543|B4|United States||Region of Enrollment||participants|Number|594|594.0||||||
4031631|NCT01146912|3853544|B3|United States||Region of Enrollment||participants|Number|593|593.0||||||
4031632|NCT01146912|3853545|B2|United States||Region of Enrollment||participants|Number|4606|4606.0||||||
4031633|NCT01146912|3853546|B1|United States||Region of Enrollment||participants|Number|4607|4607.0||||||
4031634|NCT01146912|3853539|B8||Male|Sex: Female, Male||Participants|Count of Participants|7351|7351.0||||||
4031635|NCT01146912|3853540|B7||Male|Sex: Female, Male||Participants|Count of Participants|958|958.0||||||
4031636|NCT01146912|3853541|B6||Male|Sex: Female, Male||Participants|Count of Participants|895|895.0||||||
4031637|NCT01146912|3853542|B5||Male|Sex: Female, Male||Participants|Count of Participants|952|952.0||||||
4031638|NCT01146912|3853543|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4031639|NCT01146912|3853544|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4031640|NCT01146912|3853545|B2||Male|Sex: Female, Male||Participants|Count of Participants|2274|2274.0||||||
4031641|NCT01146912|3853546|B1||Male|Sex: Female, Male||Participants|Count of Participants|2272|2272.0||||||
4031642|NCT01146912|3853539|B8||Female|Sex: Female, Male||Participants|Count of Participants|8511|8511.0||||||
4031643|NCT01146912|3853540|B7||Female|Sex: Female, Male||Participants|Count of Participants|862|862.0||||||
4031644|NCT01146912|3853541|B6||Female|Sex: Female, Male||Participants|Count of Participants|926|926.0||||||
4031645|NCT01146912|3853542|B5||Female|Sex: Female, Male||Participants|Count of Participants|869|869.0||||||
4031646|NCT01146912|3853543|B4||Female|Sex: Female, Male||Participants|Count of Participants|594|594.0||||||
4031647|NCT01146912|3853544|B3||Female|Sex: Female, Male||Participants|Count of Participants|593|593.0||||||
4031648|NCT01146912|3853545|B2||Female|Sex: Female, Male||Participants|Count of Participants|2332|2332.0||||||
4031649|NCT01146912|3853546|B1||Female|Sex: Female, Male||Participants|Count of Participants|2335|2335.0||||||
4031650|NCT01146912|3853539|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4031651|NCT01146912|3853540|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4031652|NCT01146912|3853541|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4031653|NCT01146912|3853542|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4031654|NCT01146912|3853543|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4031655|NCT01146912|3853544|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4031656|NCT01146912|3853545|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4031657|NCT01146912|3853546|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4031658|NCT01146912|3853539|B8||Between 18 and 65 years|Age||Participants|Count of Participants|1187|1187.0||||||
4031659|NCT01146912|3853540|B7||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4031660|NCT01146912|3853541|B6||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4031661|NCT01146912|3853542|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4031662|NCT01146912|3853543|B4||Between 18 and 65 years|Age||Participants|Count of Participants|594|594.0||||||
4031663|NCT01146912|3853544|B3||Between 18 and 65 years|Age||Participants|Count of Participants|593|593.0||||||
4031664|NCT01146912|3853545|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4031665|NCT01146912|3853546|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4031666|NCT01146912|3853539|B8||<=18 years|Age||Participants|Count of Participants|14675|14675.0||||||
4031667|NCT01146912|3853540|B7||<=18 years|Age||Participants|Count of Participants|1820|1820.0||||||
4031668|NCT01146912|3853541|B6||<=18 years|Age||Participants|Count of Participants|1821|1821.0||||||
4031669|NCT01146912|3853542|B5||<=18 years|Age||Participants|Count of Participants|1821|1821.0||||||
4031670|NCT01146912|3853543|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031671|NCT01146912|3853544|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031672|NCT01146912|3853545|B2||<=18 years|Age||Participants|Count of Participants|4606|4606.0||||||
4031673|NCT01146912|3853546|B1||<=18 years|Age||Participants|Count of Participants|4607|4607.0||||||
4031674|NCT01146873|3853573|B3||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4031675|NCT01146873|3853574|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4031676|NCT01146873|3853575|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4031677|NCT01146873|3853573|B3||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4031678|NCT01146873|3853574|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4031679|NCT01146873|3853575|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4031680|NCT01146873|3853573|B3|||Age||years|Mean|4.27|4.27|Standard Deviation|0.9|0.9|||
4031681|NCT01146873|3853574|B2|||Age||years|Mean|4.28|4.28|Standard Deviation|0.9|0.9|||
4031682|NCT01146873|3853575|B1|||Age||years|Mean|4.26|4.26|Standard Deviation|1.0|1.0|||
4031683|NCT01146860|3853590|B3|Germany||Region of Enrollment||participants|Number|386|386.0||||||
4031684|NCT01146860|3853591|B2|Germany||Region of Enrollment||participants|Number|192|192.0||||||
4031685|NCT01146860|3853592|B1|Germany||Region of Enrollment||participants|Number|194|194.0||||||
4031686|NCT01146860|3853590|B3||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4031687|NCT01146860|3853591|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4031688|NCT01146860|3853592|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4031689|NCT01146860|3853590|B3||Female|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
4031690|NCT01146860|3853591|B2||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4031691|NCT01146860|3853592|B1||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4031692|NCT01146860|3853590|B3|||Age||years|Mean|40.7|40.7|Standard Deviation|14.9|14.9|||
4031693|NCT01146860|3853591|B2|||Age||years|Mean|40.4|40.4|Standard Deviation|14.3|14.3|||
4031694|NCT01146860|3853592|B1|||Age||years|Mean|41.0|41.0|Standard Deviation|15.4|15.4|||
4031695|NCT01146860|3853590|B3||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4031696|NCT01146860|3853591|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4031697|NCT01146860|3853592|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4031698|NCT01146860|3853590|B3||Between 18 and 65 years|Age||Participants|Count of Participants|356|356.0||||||
4031699|NCT01146860|3853591|B2||Between 18 and 65 years|Age||Participants|Count of Participants|182|182.0||||||
4031700|NCT01146860|3853592|B1||Between 18 and 65 years|Age||Participants|Count of Participants|174|174.0||||||
4031701|NCT01146860|3853590|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031702|NCT01146860|3853591|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031703|NCT01146860|3853592|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031704|NCT01146808|3853607|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4031705|NCT01146808|3853607|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4031706|NCT01146808|3853607|B1|||Age||years|Mean|54|54.0|Standard Deviation|11|11.0|||
4031707|NCT01146782|3853613|B1|United States||Region of Enrollment||participants|Number|146|146.0||||||
4031708|NCT01146782|3853613|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4031709|NCT01146782|3853613|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4031710|NCT01146782|3853613|B1|||Age||years|Mean|53.2|53.2|Standard Deviation|10.6|10.6|||
4031711|NCT01146782|3853613|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4031712|NCT01146782|3853613|B1||Between 18 and 65 years|Age||Participants|Count of Participants|130|130.0||||||
4031713|NCT01146782|3853613|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031714|NCT01146665|3853620|B3|None||Report of using other substances prior to ED visit||Participants|Count of Participants|33|33.0||||||
4031715|NCT01146665|3853621|B2|None||Report of using other substances prior to ED visit||Participants|Count of Participants|19|19.0||||||
4031716|NCT01146665|3853622|B1|None||Report of using other substances prior to ED visit||Participants|Count of Participants|14|14.0||||||
4031717|NCT01146665|3853620|B3|Over the counter medication||Report of using other substances prior to ED visit||Participants|Count of Participants|1|1.0||||||
4031718|NCT01146665|3853621|B2|Over the counter medication||Report of using other substances prior to ED visit||Participants|Count of Participants|1|1.0||||||
4031719|NCT01146665|3853622|B1|Over the counter medication||Report of using other substances prior to ED visit||Participants|Count of Participants|0|0.0||||||
4031720|NCT01146665|3853620|B3|Marijuana and ecstasy||Report of using other substances prior to ED visit||Participants|Count of Participants|1|1.0||||||
4031721|NCT01146665|3853621|B2|Marijuana and ecstasy||Report of using other substances prior to ED visit||Participants|Count of Participants|0|0.0||||||
4031722|NCT01146665|3853622|B1|Marijuana and ecstasy||Report of using other substances prior to ED visit||Participants|Count of Participants|1|1.0||||||
4031723|NCT01146665|3853620|B3|Marijuana||Report of using other substances prior to ED visit||Participants|Count of Participants|9|9.0||||||
4031724|NCT01146665|3853621|B2|Marijuana||Report of using other substances prior to ED visit||Participants|Count of Participants|6|6.0||||||
4031725|NCT01146665|3853622|B1|Marijuana||Report of using other substances prior to ED visit||Participants|Count of Participants|3|3.0||||||
4031764|NCT01146613|3853654|B2|||Penn Alcohol Craving Scale Score|PACS Scale Range (0-30) - A higher value score equals more craving.|score|Mean|16.7|16.7|Standard Deviation|6.8|6.8|||
4031765|NCT01146613|3853655|B1|||Penn Alcohol Craving Scale Score|PACS Scale Range (0-30) - A higher value score equals more craving.|score|Mean|17.7|17.7|Standard Deviation|6.2|6.2|||
4031726|NCT01146665|3853620|B3|||Met AUDIT-C cut-score of 3 for harmful and hazardous drinking|AUDIT-C (Alcohol Use Disorders Identification Test Consumption subscale): 1 item regarding frequency of alcohol consumption, 1 item regarding the amount of alcohol consumption, and 1 item regarding the frequency of binge drinking. Scores are summed and range from 0 to 12 with higher scores reflecting more consumption. A cut-score of 3 is recommended for identifying youth with harmful and hazardous drinking.|Participants|Count of Participants|39|39.0||||||
4031727|NCT01146665|3853621|B2|||Met AUDIT-C cut-score of 3 for harmful and hazardous drinking|AUDIT-C (Alcohol Use Disorders Identification Test Consumption subscale): 1 item regarding frequency of alcohol consumption, 1 item regarding the amount of alcohol consumption, and 1 item regarding the frequency of binge drinking. Scores are summed and range from 0 to 12 with higher scores reflecting more consumption. A cut-score of 3 is recommended for identifying youth with harmful and hazardous drinking.|Participants|Count of Participants|24|24.0||||||
4031728|NCT01146665|3853622|B1|||Met AUDIT-C cut-score of 3 for harmful and hazardous drinking|AUDIT-C (Alcohol Use Disorders Identification Test Consumption subscale): 1 item regarding frequency of alcohol consumption, 1 item regarding the amount of alcohol consumption, and 1 item regarding the frequency of binge drinking. Scores are summed and range from 0 to 12 with higher scores reflecting more consumption. A cut-score of 3 is recommended for identifying youth with harmful and hazardous drinking.|Participants|Count of Participants|15|15.0||||||
4031729|NCT01146665|3853620|B3|Canada||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
4031730|NCT01146665|3853621|B2|Canada||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
4031731|NCT01146665|3853622|B1|Canada||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4031732|NCT01146665|3853620|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4031733|NCT01146665|3853620|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4031734|NCT01146665|3853621|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4031735|NCT01146665|3853622|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4031736|NCT01146665|3853620|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4031737|NCT01146665|3853621|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4031738|NCT01146665|3853622|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4031739|NCT01146665|3853620|B3|17 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
4031740|NCT01146665|3853621|B2|17 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4031741|NCT01146665|3853622|B1|17 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
4031742|NCT01146665|3853620|B3|16 years||Age, Customized||Participants|Count of Participants|12|12.0||||||
4031743|NCT01146665|3853621|B2|16 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
4031744|NCT01146665|3853622|B1|16 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
4031745|NCT01146665|3853620|B3|15 years||Age, Customized||Participants|Count of Participants|16|16.0||||||
4031746|NCT01146665|3853621|B2|15 years||Age, Customized||Participants|Count of Participants|9|9.0||||||
4031747|NCT01146665|3853622|B1|15 years||Age, Customized||Participants|Count of Participants|7|7.0||||||
4031748|NCT01146665|3853620|B3|14 years||Age, Customized||Participants|Count of Participants|12|12.0||||||
4031749|NCT01146665|3853621|B2|14 years||Age, Customized||Participants|Count of Participants|9|9.0||||||
4031750|NCT01146665|3853622|B1|14 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
4031751|NCT01146665|3853620|B3|13 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
4031752|NCT01146665|3853621|B2|13 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
4031753|NCT01146665|3853622|B1|13 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
4031754|NCT01146613|3853653|B3|||Gamma-glutamyl transpeptidase (GGT)||IU/L|Mean|71.9|71.9|Standard Deviation|113.3|113.3|||
4031755|NCT01146613|3853654|B2|||Gamma-glutamyl transpeptidase (GGT)||IU/L|Mean|70.1|70.1|Standard Deviation|103.1|103.1|||
4031756|NCT01146613|3853655|B1|||Gamma-glutamyl transpeptidase (GGT)||IU/L|Mean|72.9|72.9|Standard Deviation|123.5|123.5|||
4031757|NCT01146613|3853653|B3|||Age of onset of regular drinking|One question asking at what age regular drinking began.|years|Mean|19|19.0|Standard Deviation|5.8|5.8|||
4031758|NCT01146613|3853654|B2|||Age of onset of regular drinking|One question asking at what age regular drinking began.|years|Mean|19.3|19.3|Standard Deviation|5.5|5.5|||
4031759|NCT01146613|3853655|B1|||Age of onset of regular drinking|One question asking at what age regular drinking began.|years|Mean|18.7|18.7|Standard Deviation|6.1|6.1|||
4031760|NCT01146613|3853653|B3|||Alcohol-related consequences score - ImBIBE|ImBIBe - 15 questions (0-60) - Lower score is better The Impact of Beverage Intake on Behavior (ImBIBe) is a 15-item questionnaire in which the subject responds on a 5-point scale to questions on the consequences of alcohol use. This scale was adapted from the Drinker Inventory of Consequences questionnaire based on FDA recommendations on patient reported outcomes (Miller & Tonigen-1995).|score|Mean|17|17.0|Standard Deviation|9.7|9.7|||
4031761|NCT01146613|3853654|B2|||Alcohol-related consequences score - ImBIBE|ImBIBe - 15 questions (0-60) - Lower score is better The Impact of Beverage Intake on Behavior (ImBIBe) is a 15-item questionnaire in which the subject responds on a 5-point scale to questions on the consequences of alcohol use. This scale was adapted from the Drinker Inventory of Consequences questionnaire based on FDA recommendations on patient reported outcomes (Miller & Tonigen-1995).|score|Mean|16.3|16.3|Standard Deviation|9.7|9.7|||
4031762|NCT01146613|3853655|B1|||Alcohol-related consequences score - ImBIBE|ImBIBe - 15 questions (0-60) - Lower score is better The Impact of Beverage Intake on Behavior (ImBIBe) is a 15-item questionnaire in which the subject responds on a 5-point scale to questions on the consequences of alcohol use. This scale was adapted from the Drinker Inventory of Consequences questionnaire based on FDA recommendations on patient reported outcomes (Miller & Tonigen-1995).|score|Mean|17.8|17.8|Standard Deviation|9.8|9.8|||
4031763|NCT01146613|3853653|B3|||Penn Alcohol Craving Scale Score|PACS Scale Range (0-30) - A higher value score equals more craving.|score|Mean|17.2|17.2|Standard Deviation|6.5|6.5|||
4031766|NCT01146613|3853653|B3|||Percent heavy drinking days||percent heavy drinking days|Mean|87.7|87.7|Standard Deviation|16.1|16.1|||
4031767|NCT01146613|3853654|B2|||Percent heavy drinking days||percent heavy drinking days|Mean|87.2|87.2|Standard Deviation|16.4|16.4|||
4031768|NCT01146613|3853655|B1|||Percent heavy drinking days||percent heavy drinking days|Mean|88.1|88.1|Standard Deviation|15.8|15.8|||
4031769|NCT01146613|3853653|B3|||Percent days abstinent||percent days abstinent|Mean|7.8|7.8|Standard Deviation|13|13.0|||
4031770|NCT01146613|3853654|B2|||Percent days abstinent||percent days abstinent|Mean|7.9|7.9|Standard Deviation|13.6|13.6|||
4031771|NCT01146613|3853655|B1|||Percent days abstinent||percent days abstinent|Mean|7.7|7.7|Standard Deviation|12.5|12.5|||
4031772|NCT01146613|3853653|B3|||Drinks per drinking day||drinks per drinking day|Mean|14.4|14.4|Standard Deviation|9.3|9.3|||
4031773|NCT01146613|3853654|B2|||Drinks per drinking day||drinks per drinking day|Mean|13.6|13.6|Standard Deviation|9|9.0|||
4031774|NCT01146613|3853655|B1|||Drinks per drinking day||drinks per drinking day|Mean|15.3|15.3|Standard Deviation|9.6|9.6|||
4031775|NCT01146613|3853653|B3|||Drinks per day||drinks per day|Mean|13|13.0|Standard Deviation|9|9.0|||
4031776|NCT01146613|3853654|B2|||Drinks per day||drinks per day|Mean|12.5|12.5|Standard Deviation|9|9.0|||
4031777|NCT01146613|3853655|B1|||Drinks per day||drinks per day|Mean|14|14.0|Standard Deviation|9.3|9.3|||
4031778|NCT01146613|3853653|B3|United States||Region of Enrollment||participants|Number|198|198.0||||||
4031779|NCT01146613|3853654|B2|United States||Region of Enrollment||participants|Number|101|101.0||||||
4031780|NCT01146613|3853655|B1|United States||Region of Enrollment||participants|Number|97|97.0||||||
4031781|NCT01146613|3853653|B3||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4031782|NCT01146613|3853654|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4031783|NCT01146613|3853655|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4031784|NCT01146613|3853653|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4031785|NCT01146613|3853654|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4031786|NCT01146613|3853655|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4031787|NCT01146613|3853653|B3|||Age||years|Mean|45.5|45.5|Standard Deviation|11.6|11.6|||
4031788|NCT01146613|3853654|B2|||Age||years|Mean|45|45.0|Standard Deviation|12.3|12.3|||
4031789|NCT01146613|3853655|B1|||Age||years|Mean|46|46.0|Standard Deviation|11|11.0|||
4031790|NCT01146600|3853662|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4031791|NCT01146600|3853663|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4031792|NCT01146600|3853664|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4031793|NCT01146600|3853662|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4031794|NCT01146600|3853663|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4031795|NCT01146600|3853664|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4031796|NCT01146600|3853662|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4031797|NCT01146600|3853663|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4031798|NCT01146600|3853664|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4031799|NCT01146600|3853662|B3|||Age||years|Mean|34.2|34.2|Standard Deviation|13.6|13.6|||
4031800|NCT01146600|3853663|B2|||Age||years|Mean|34.7|34.7|Standard Deviation|14.5|14.5|||
4031801|NCT01146600|3853664|B1|||Age||years|Mean|33.8|33.8|Standard Deviation|13.4|13.4|||
4031802|NCT01146600|3853662|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4031803|NCT01146600|3853663|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4031804|NCT01146600|3853664|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4031805|NCT01146600|3853662|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4031806|NCT01146600|3853663|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4031807|NCT01146600|3853664|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4031808|NCT01146600|3853662|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031809|NCT01146600|3853663|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031810|NCT01146600|3853664|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031811|NCT01146457|3853690|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4031812|NCT01146457|3853691|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4031813|NCT01146457|3853692|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4031814|NCT01146457|3853693|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4031815|NCT01146457|3853694|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4031816|NCT01146457|3853695|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4031817|NCT01146457|3853690|B6||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4031818|NCT01146457|3853691|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4031819|NCT01146457|3853692|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4031820|NCT01146457|3853693|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4031821|NCT01146457|3853694|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4031822|NCT01146457|3853695|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4031823|NCT01146457|3853690|B6|||Age||Years|Mean|32.3|32.3|Standard Deviation|5.7|5.7|||
4031824|NCT01146457|3853691|B5|||Age||Years|Mean|32.4|32.4|Standard Deviation|5.7|5.7|||
4031825|NCT01146457|3853692|B4|||Age||Years|Mean|32.5|32.5|Standard Deviation|5.5|5.5|||
4031826|NCT01146457|3853693|B3|||Age||Years|Mean|31.3|31.3|Standard Deviation|6.6|6.6|||
4031827|NCT01146457|3853694|B2|||Age||Years|Mean|31.5|31.5|Standard Deviation|5.3|5.3|||
4031828|NCT01146457|3853695|B1|||Age||Years|Mean|34.3|34.3|Standard Deviation|5.3|5.3|||
4031829|NCT01146418|3853711|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4031830|NCT01146418|3853712|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4031831|NCT01146418|3853713|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4031832|NCT01146418|3853711|B3||Female|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
4031833|NCT01146418|3853712|B2||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4031834|NCT01146418|3853713|B1||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4031835|NCT01146418|3853711|B3|||Age||Years|Mean|38.4|38.4|Standard Deviation|2.2|2.2|||
4031836|NCT01146418|3853712|B2|||Age||Years|Mean|38.3|38.3|Standard Deviation|2.2|2.2|||
4031837|NCT01146418|3853713|B1|||Age||Years|Mean|38.5|38.5|Standard Deviation|2.1|2.1|||
4031838|NCT01146379|3853728|B5|||Time since stroke||months|Median|12.5|12.5|Full Range|||6.0|221.0|
4031839|NCT01146379|3853729|B4|||Time since stroke||months|Median|11.5|11.5|Full Range|||6.0|144.0|
4031840|NCT01146379|3853730|B3|||Time since stroke||months|Median|13|13.0|Full Range|||6.0|54.0|
4031841|NCT01146379|3853731|B2|||Time since stroke||months|Median|13|13.0|Full Range|||6.0|221.0|
4031842|NCT01146379|3853732|B1|||Time since stroke||months|Median|12|12.0|Full Range|||6.0|180.0|
4031843|NCT01146379|3853728|B5||Left|Affected side||Participants|Count of Participants|38|38.0||||||
4031844|NCT01146379|3853729|B4||Left|Affected side||Participants|Count of Participants|7|7.0||||||
4031845|NCT01146379|3853730|B3||Left|Affected side||Participants|Count of Participants|11|11.0||||||
4031846|NCT01146379|3853731|B2||Left|Affected side||Participants|Count of Participants|11|11.0||||||
4031847|NCT01146379|3853732|B1||Left|Affected side||Participants|Count of Participants|9|9.0||||||
4031848|NCT01146379|3853728|B5||Right|Affected side||Participants|Count of Participants|44|44.0||||||
4031849|NCT01146379|3853729|B4||Right|Affected side||Participants|Count of Participants|13|13.0||||||
4031850|NCT01146379|3853730|B3||Right|Affected side||Participants|Count of Participants|10|10.0||||||
4031851|NCT01146379|3853731|B2||Right|Affected side||Participants|Count of Participants|10|10.0||||||
4031852|NCT01146379|3853732|B1||Right|Affected side||Participants|Count of Participants|11|11.0||||||
4031853|NCT01146379|3853728|B5||Left|Dominant side||Participants|Count of Participants|11|11.0||||||
4031854|NCT01146379|3853729|B4||Left|Dominant side||Participants|Count of Participants|2|2.0||||||
4031855|NCT01146379|3853730|B3||Left|Dominant side||Participants|Count of Participants|2|2.0||||||
4031856|NCT01146379|3853731|B2||Left|Dominant side||Participants|Count of Participants|5|5.0||||||
4031857|NCT01146379|3853732|B1||Left|Dominant side||Participants|Count of Participants|2|2.0||||||
4031858|NCT01146379|3853728|B5||Right|Dominant side||Participants|Count of Participants|71|71.0||||||
4031859|NCT01146379|3853729|B4||Right|Dominant side||Participants|Count of Participants|18|18.0||||||
4031860|NCT01146379|3853730|B3||Right|Dominant side||Participants|Count of Participants|19|19.0||||||
4031861|NCT01146379|3853731|B2||Right|Dominant side||Participants|Count of Participants|16|16.0||||||
4031862|NCT01146379|3853732|B1||Right|Dominant side||Participants|Count of Participants|18|18.0||||||
4031863|NCT01146379|3853728|B5|United States||Region of Enrollment||participants|Number|82|82.0||||||
4031864|NCT01146379|3853729|B4|United States||Region of Enrollment||participants|Number|20|20.0||||||
4031865|NCT01146379|3853730|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4031866|NCT01146379|3853731|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4031867|NCT01146379|3853732|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4031868|NCT01146379|3853728|B5|Race|Non-caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
4031869|NCT01146379|3853729|B4|Race|Non-caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4031870|NCT01146379|3853730|B3|Race|Non-caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4031871|NCT01146379|3853731|B2|Race|Non-caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4031872|NCT01146379|3853732|B1|Race|Non-caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4031873|NCT01146379|3853728|B5|Race|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
4031874|NCT01146379|3853729|B4|Race|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4031875|NCT01146379|3853730|B3|Race|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4031876|NCT01146379|3853731|B2|Race|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4031877|NCT01146379|3853732|B1|Race|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4031878|NCT01146379|3853728|B5||Male|Gender||Participants|Count of Participants|52|52.0||||||
4031879|NCT01146379|3853729|B4||Male|Gender||Participants|Count of Participants|12|12.0||||||
4031880|NCT01146379|3853730|B3||Male|Gender||Participants|Count of Participants|11|11.0||||||
4031881|NCT01146379|3853731|B2||Male|Gender||Participants|Count of Participants|16|16.0||||||
4031882|NCT01146379|3853732|B1||Male|Gender||Participants|Count of Participants|13|13.0||||||
4031883|NCT01146379|3853728|B5||Female|Gender||Participants|Count of Participants|30|30.0||||||
4031884|NCT01146379|3853729|B4||Female|Gender||Participants|Count of Participants|8|8.0||||||
4031885|NCT01146379|3853730|B3||Female|Gender||Participants|Count of Participants|10|10.0||||||
4031886|NCT01146379|3853731|B2||Female|Gender||Participants|Count of Participants|5|5.0||||||
4031887|NCT01146379|3853732|B1||Female|Gender||Participants|Count of Participants|7|7.0||||||
4031888|NCT01146379|3853728|B5|||Age||years|Mean|60.7|60.7|Standard Deviation|10.8|10.8|||
4031889|NCT01146379|3853729|B4|||Age||years|Mean|60.9|60.9|Standard Deviation|13.4|13.4|||
4031890|NCT01146379|3853730|B3|||Age||years|Mean|60.0|60.0|Standard Deviation|8.3|8.3|||
4031891|NCT01146379|3853731|B2|||Age||years|Mean|62.1|62.1|Standard Deviation|8.6|8.6|||
4031892|NCT01146379|3853732|B1|||Age||years|Mean|59.9|59.9|Standard Deviation|12.8|12.8|||
4031893|NCT01146288|3853745|B3|male||Sex/Gender, Customized||participants|Number|12|12.0||||||
4031894|NCT01146288|3853746|B2|male||Sex/Gender, Customized||participants|Number|5|5.0||||||
4031895|NCT01146288|3853747|B1|male||Sex/Gender, Customized||participants|Number|7|7.0||||||
4031896|NCT01146288|3853745|B3|||Age||years|Median|36|36.0|Standard Deviation|8|8.0|||
4031897|NCT01146288|3853746|B2|||Age||years|Median|36|36.0|Standard Deviation|7.1|7.1|||
4031898|NCT01146288|3853747|B1|||Age||years|Median|37|37.0|Standard Deviation|6.6|6.6|||
4031899|NCT01146288|3853745|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4031900|NCT01146288|3853746|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4031901|NCT01146288|3853747|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4031902|NCT01146288|3853745|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4031903|NCT01146288|3853746|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4031904|NCT01146288|3853747|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4031905|NCT01146288|3853745|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031906|NCT01146288|3853746|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031907|NCT01146288|3853747|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031908|NCT01146275|3853757|B1|Sweden||Region of Enrollment||participants|Number|6|6.0||||||
4031909|NCT01146275|3853757|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4031910|NCT01146275|3853757|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4031911|NCT01146275|3853757|B1|||Age||years|Mean|31|31.0|Standard Deviation|4.3|4.3|||
4031912|NCT01146275|3853757|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4031913|NCT01146275|3853757|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4031914|NCT01146275|3853757|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031915|NCT01146054|3853762|B1|Stanford University||Treating Institutions||Participants|Count of Participants|14|14.0||||||
4031916|NCT01146054|3853762|B1|Memorial Sloan-Kettering Cancer Center||Treating Institutions||Participants|Count of Participants|3|3.0||||||
4031917|NCT01146054|3853762|B1|Johns Hopkins University||Treating Institutions||Participants|Count of Participants|32|32.0||||||
4031918|NCT01146054|3853762|B1|ECOG 1||Eastern Cooperative Oncology Group performance status (ECOG PS)|"Performance status assessed by the physician prior to treatment. ECOG 0= Asymptomatic (Fully active, able to carry on all predisease activities without restriction)~ECOG 1 = Symptomatic but completely ambulatory ECOG 2 = Symptomatic, <50% in bed during the day ECOG 3 = Symptomatic, >50% in bed, but not bedbound ECOG 4 = Bedbound, Completely disabled. Cannot carry on any self-care. ECOG 5 = Death"|Participants|Count of Participants|28|28.0||||||
4031919|NCT01146054|3853762|B1|ECOG 0||Eastern Cooperative Oncology Group performance status (ECOG PS)|"Performance status assessed by the physician prior to treatment. ECOG 0= Asymptomatic (Fully active, able to carry on all predisease activities without restriction)~ECOG 1 = Symptomatic but completely ambulatory ECOG 2 = Symptomatic, <50% in bed during the day ECOG 3 = Symptomatic, >50% in bed, but not bedbound ECOG 4 = Bedbound, Completely disabled. Cannot carry on any self-care. ECOG 5 = Death"|Participants|Count of Participants|21|21.0||||||
4031920|NCT01146054|3853762|B1|CA 19-9 >= 90 U/mL||Baseline Cancer Antigen 19-9 (CA19-9)|Tumor marker from blood draw during routine labs.|Participants|Count of Participants|27|27.0||||||
4031921|NCT01146054|3853762|B1|CA 19-9 < 90 U/mL||Baseline Cancer Antigen 19-9 (CA19-9)|Tumor marker from blood draw during routine labs.|Participants|Count of Participants|18|18.0||||||
4031922|NCT01146054|3853762|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
4031923|NCT01146054|3853762|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4031924|NCT01146054|3853762|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4031925|NCT01146054|3853762|B1|||Age||Years|Median|67|67.0|Full Range|||35.0|87.0|
4031926|NCT01146054|3853762|B1||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
4031927|NCT01146054|3853762|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4031928|NCT01146054|3853762|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031929|NCT01145898|3853770|B3|United States||Region of Enrollment||participants|Number|56|56.0||||||
4031930|NCT01145898|3853771|B2|United States||Region of Enrollment||participants|Number|44|44.0||||||
4031931|NCT01145898|3853772|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4031932|NCT01145898|3853770|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4031933|NCT01145898|3853771|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4031934|NCT01145898|3853772|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4031935|NCT01145898|3853770|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4031936|NCT01145898|3853771|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4031937|NCT01145898|3853772|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4031938|NCT01145898|3853770|B3|||Age||years|Mean|64.82|64.82|Standard Deviation|8.38|8.38|||
4031939|NCT01145898|3853771|B2|||Age||years|Mean|65.25|65.25|Standard Deviation|8.78|8.78|||
4031940|NCT01145898|3853772|B1|||Age||years|Mean|63.23|63.23|Standard Deviation|6.78|6.78|||
4031941|NCT01145898|3853770|B3||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4031942|NCT01145898|3853771|B2||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4031943|NCT01145898|3853772|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4031944|NCT01145898|3853770|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4031945|NCT01145898|3853771|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4031946|NCT01145898|3853772|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4031947|NCT01145898|3853770|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031948|NCT01145898|3853771|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031949|NCT01145898|3853772|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031950|NCT01145755|3853804|B4||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4031951|NCT01145755|3853805|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4031952|NCT01145755|3853806|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4031953|NCT01145755|3853807|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4031954|NCT01145755|3853804|B4||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4031955|NCT01145755|3853805|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4031956|NCT01145755|3853806|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4031957|NCT01145755|3853807|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4031958|NCT01145755|3853804|B4|||Age||Years|Mean|40.1|40.1|Full Range|||19.0|60.0|
4031959|NCT01145755|3853805|B3|||Age||Years|Mean|38.4|38.4|Full Range|||20.0|61.0|
4031960|NCT01145755|3853806|B2|||Age||Years|Mean|39.9|39.9|Full Range|||19.0|60.0|
4031961|NCT01145755|3853807|B1|||Age||Years|Mean|42.2|42.2|Full Range|||21.0|60.0|
4031962|NCT01145638|3853823|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4031963|NCT01145638|3853824|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4031964|NCT01145638|3853825|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4031965|NCT01145638|3853823|B3|Sweden||Region of Enrollment||participants|Number|8|8.0||||||
4031966|NCT01145638|3853824|B2|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
4031967|NCT01145638|3853825|B1|Sweden||Region of Enrollment||participants|Number|5|5.0||||||
4031968|NCT01145638|3853823|B3|Russian Federation||Region of Enrollment||participants|Number|47|47.0||||||
4031969|NCT01145638|3853824|B2|Russian Federation||Region of Enrollment||participants|Number|18|18.0||||||
4031970|NCT01145638|3853825|B1|Russian Federation||Region of Enrollment||participants|Number|29|29.0||||||
4031971|NCT01145638|3853823|B3|Poland||Region of Enrollment||participants|Number|56|56.0||||||
4031972|NCT01145638|3853824|B2|Poland||Region of Enrollment||participants|Number|16|16.0||||||
4031973|NCT01145638|3853825|B1|Poland||Region of Enrollment||participants|Number|40|40.0||||||
4031974|NCT01145638|3853823|B3|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4031975|NCT01145638|3853824|B2|Spain||Region of Enrollment||participants|Number|0|0.0||||||
4031976|NCT01145638|3853825|B1|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4031977|NCT01145638|3853823|B3|Denmark||Region of Enrollment||participants|Number|4|4.0||||||
4031978|NCT01145638|3853824|B2|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
4031979|NCT01145638|3853825|B1|Denmark||Region of Enrollment||participants|Number|3|3.0||||||
4031980|NCT01145638|3853823|B3|Germany||Region of Enrollment||participants|Number|10|10.0||||||
4031981|NCT01145638|3853824|B2|Germany||Region of Enrollment||participants|Number|3|3.0||||||
4031982|NCT01145638|3853825|B1|Germany||Region of Enrollment||participants|Number|7|7.0||||||
4031983|NCT01145638|3853823|B3|India||Region of Enrollment||participants|Number|205|205.0||||||
4031984|NCT01145638|3853824|B2|India||Region of Enrollment||participants|Number|72|72.0||||||
4031985|NCT01145638|3853825|B1|India||Region of Enrollment||participants|Number|133|133.0||||||
4031986|NCT01145638|3853823|B3||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4031987|NCT01145638|3853824|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4031988|NCT01145638|3853825|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4031989|NCT01145638|3853823|B3||Female|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
4031990|NCT01145638|3853824|B2||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4031991|NCT01145638|3853825|B1||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4031992|NCT01145638|3853823|B3||>=65 years|Age||Participants|Count of Participants|62|62.0||||||
4031993|NCT01145638|3853824|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4031994|NCT01145638|3853825|B1||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
4031995|NCT01145638|3853823|B3||Between 18 and 65 years|Age||Participants|Count of Participants|288|288.0||||||
4031996|NCT01145638|3853824|B2||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
4031997|NCT01145638|3853825|B1||Between 18 and 65 years|Age||Participants|Count of Participants|187|187.0||||||
4031998|NCT01145638|3853823|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4031999|NCT01145638|3853824|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4032000|NCT01145638|3853825|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4032001|NCT01145625|3853834|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4032002|NCT01145625|3853835|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4032003|NCT01145625|3853836|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4032004|NCT01145625|3853834|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032005|NCT01145625|3853835|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032006|NCT01145625|3853836|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032007|NCT01145625|3853834|B3||White|Race (NIH/OMB)||Participants|Count of Participants|290|290.0||||||
4032008|NCT01145625|3853835|B2||White|Race (NIH/OMB)||Participants|Count of Participants|141|141.0||||||
4032009|NCT01145625|3853836|B1||White|Race (NIH/OMB)||Participants|Count of Participants|149|149.0||||||
4032010|NCT01145625|3853834|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4032011|NCT01145625|3853835|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4032012|NCT01145625|3853836|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4032013|NCT01145625|3853834|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4032014|NCT01145625|3853835|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4032015|NCT01145625|3853836|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032016|NCT01145625|3853834|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4032017|NCT01145625|3853835|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4032018|NCT01145625|3853836|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4032019|NCT01145625|3853834|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4032020|NCT01145625|3853835|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4032021|NCT01145625|3853836|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032022|NCT01145625|3853834|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4032023|NCT01145625|3853835|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4032024|NCT01145625|3853836|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4032025|NCT01145625|3853834|B3||Female|Sex: Female, Male||Participants|Count of Participants|322|322.0||||||
4032026|NCT01145625|3853835|B2||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4032027|NCT01145625|3853836|B1||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4032028|NCT01145625|3853834|B3||>=65 years|Age||Participants|Count of Participants|57|57.0||||||
4032029|NCT01145625|3853835|B2||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4032030|NCT01145625|3853836|B1||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4032031|NCT01145625|3853834|B3||Between 18 and 65 years|Age||Participants|Count of Participants|263|263.0||||||
4032032|NCT01145625|3853835|B2||Between 18 and 65 years|Age||Participants|Count of Participants|129|129.0||||||
4032033|NCT01145625|3853836|B1||Between 18 and 65 years|Age||Participants|Count of Participants|134|134.0||||||
4032034|NCT01145625|3853834|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4032035|NCT01145625|3853835|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4032036|NCT01145625|3853836|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4032037|NCT01145560|3853847|B4||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4032038|NCT01145560|3853848|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4032039|NCT01145560|3853849|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4032040|NCT01145560|3853850|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4032041|NCT01145560|3853847|B4||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4032042|NCT01145560|3853848|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4032043|NCT01145560|3853849|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4032044|NCT01145560|3853850|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4032045|NCT01145560|3853847|B4|||Age||years|Mean|65.0|65.0|Standard Deviation|15.21|15.21|||
4032046|NCT01145560|3853848|B3|||Age||years|Mean|64.1|64.1|Standard Deviation|15.25|15.25|||
4032047|NCT01145560|3853849|B2|||Age||years|Mean|66.6|66.6|Standard Deviation|14.61|14.61|||
4032048|NCT01145560|3853850|B1|||Age||years|Mean|64.4|64.4|Standard Deviation|15.76|15.76|||
4032049|NCT01145547|3853869|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4032050|NCT01145547|3853869|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4032051|NCT01145547|3853869|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4032052|NCT01145547|3853869|B1|||Age||years|Mean|45|45.0|Standard Deviation|4.5|4.5|||
4032053|NCT01145547|3853869|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4032054|NCT01145547|3853869|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4032055|NCT01145547|3853869|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4032056|NCT01145508|3853876|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4032057|NCT01145508|3853877|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4032058|NCT01145508|3853878|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4032059|NCT01145508|3853876|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4032060|NCT01145508|3853877|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4032061|NCT01145508|3853878|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4032062|NCT01145508|3853876|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4032063|NCT01145508|3853877|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4032064|NCT01145508|3853878|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4032065|NCT01145508|3853876|B3|||Age||years|Median|64|64.0|Full Range|||56.0|73.0|
4032066|NCT01145508|3853877|B2|||Age||years|Median|65|65.0|Full Range|||65.0|73.0|
4032067|NCT01145508|3853878|B1|||Age||years|Median|63|63.0|Full Range|||56.0|72.0|
4032068|NCT01145495|3853885|B1|Not reported||Follicular Lymphoma International Prognostic Index (FLIPI)|"Follicular Lymphoma International Prognostic Index (FLIPI) (abstracted from Solal-Céligny et al., Blood, 2004. 104(5): p. 1258-1265)~Factors (1 point for each variable present):~Age > 60y~Ann Arbor Stage III-IV (range I-IV, with III and IV indicating highest risk)~Hemoglobin level < 12 g/dL~Lactate dehydrogenase (LDH) level > upper limit of normal (ULN)~>= 4 nodal sites of disease~Risk category (factors):~Low risk (0 or 1)~Intermediate risk (2)~High risk (> 3)"|participants|Number|2|2.0||||||
4032069|NCT01145495|3853885|B1|2||Follicular Lymphoma International Prognostic Index (FLIPI)|"Follicular Lymphoma International Prognostic Index (FLIPI) (abstracted from Solal-Céligny et al., Blood, 2004. 104(5): p. 1258-1265)~Factors (1 point for each variable present):~Age > 60y~Ann Arbor Stage III-IV (range I-IV, with III and IV indicating highest risk)~Hemoglobin level < 12 g/dL~Lactate dehydrogenase (LDH) level > upper limit of normal (ULN)~>= 4 nodal sites of disease~Risk category (factors):~Low risk (0 or 1)~Intermediate risk (2)~High risk (> 3)"|participants|Number|42|42.0||||||
4032070|NCT01145495|3853885|B1|0-1||Follicular Lymphoma International Prognostic Index (FLIPI)|"Follicular Lymphoma International Prognostic Index (FLIPI) (abstracted from Solal-Céligny et al., Blood, 2004. 104(5): p. 1258-1265)~Factors (1 point for each variable present):~Age > 60y~Ann Arbor Stage III-IV (range I-IV, with III and IV indicating highest risk)~Hemoglobin level < 12 g/dL~Lactate dehydrogenase (LDH) level > upper limit of normal (ULN)~>= 4 nodal sites of disease~Risk category (factors):~Low risk (0 or 1)~Intermediate risk (2)~High risk (> 3)"|participants|Number|19|19.0||||||
4032071|NCT01145495|3853885|B1|United States||Region of Enrollment||participants|Number|63|63.0||||||
4032072|NCT01145495|3853885|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4032073|NCT01145495|3853885|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4032074|NCT01145495|3853885|B1|||Age||years|Median|53|53.0|Full Range|||32.0|79.0|
4032075|NCT01145482|3853889|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4032076|NCT01145482|3853890|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4032077|NCT01145482|3853891|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4032078|NCT01145482|3853889|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4032079|NCT01145482|3853890|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4032080|NCT01145482|3853891|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4032081|NCT01145482|3853889|B3|||Age||years|Mean|74.09|74.09|Standard Deviation|6.54|6.54|||
4032082|NCT01145482|3853890|B2|||Age||years|Mean|74.33|74.33|Standard Deviation|5.92|5.92|||
4032083|NCT01145482|3853891|B1|||Age||years|Mean|73.8|73.8|Standard Deviation|8.58|8.58|||
4032084|NCT01145417|3853900|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4032085|NCT01145417|3853901|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4032086|NCT01145417|3853902|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4032087|NCT01145417|3853900|B3||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4032088|NCT01145417|3853901|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4032089|NCT01145417|3853902|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4032090|NCT01145417|3853900|B3|||Age||years|Mean|42.9|42.9|Standard Deviation|8.4|8.4|||
4032091|NCT01145417|3853901|B2|||Age||years|Mean|43.5|43.5|Standard Deviation|7.9|7.9|||
4032092|NCT01145417|3853902|B1|||Age||years|Mean|42.4|42.4|Standard Deviation|8.8|8.8|||
4032093|NCT01145391|3853925|B3|United States||Region of Enrollment||participants|Number|591|591.0||||||
4032094|NCT01145391|3853926|B2|United States||Region of Enrollment||participants|Number|298|298.0||||||
4032095|NCT01145391|3853927|B1|United States||Region of Enrollment||participants|Number|293|293.0||||||
4032096|NCT01145391|3853925|B3||Male|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
4032097|NCT01145391|3853926|B2||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4032098|NCT01145391|3853927|B1||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4032099|NCT01145391|3853925|B3||Female|Sex: Female, Male||Participants|Count of Participants|323|323.0||||||
4032100|NCT01145391|3853926|B2||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4032101|NCT01145391|3853927|B1||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4032102|NCT01145391|3853925|B3|Age, 65-79 years||Age||years|Mean|69.7|69.7|Standard Deviation|3.8|3.8|||
4032103|NCT01145391|3853926|B2|Age, 65-79 years||Age||years|Mean|69.6|69.6|Standard Deviation|3.7|3.7|||
4032104|NCT01145391|3853927|B1|Age, 65-79 years||Age||years|Mean|69.8|69.8|Standard Deviation|3.9|3.9|||
4032105|NCT01145391|3853925|B3|Age, 55-64 years||Age||years|Mean|59.2|59.2|Standard Deviation|2.8|2.8|||
4032106|NCT01145391|3853926|B2|Age, 55-64 years||Age||years|Mean|59.6|59.6|Standard Deviation|2.6|2.6|||
4032107|NCT01145391|3853927|B1|Age, 55-64 years||Age||years|Mean|58.9|58.9|Standard Deviation|3.0|3.0|||
4032108|NCT01145391|3853925|B3|Age, 45-54 years||Age||years|Mean|49.8|49.8|Standard Deviation|2.8|2.8|||
4032109|NCT01145391|3853926|B2|Age, 45-54 years||Age||years|Mean|49.9|49.9|Standard Deviation|2.9|2.9|||
4032110|NCT01145391|3853927|B1|Age, 45-54 years||Age||years|Mean|49.7|49.7|Standard Deviation|2.8|2.8|||
4032111|NCT01145391|3853925|B3|Age, <45 years||Age||years|Mean|35.1|35.1|Standard Deviation|5.8|5.8|||
4032112|NCT01145391|3853926|B2|Age, <45 years||Age||years|Mean|35.5|35.5|Standard Deviation|5.3|5.3|||
4032113|NCT01145391|3853927|B1|Age, <45 years||Age||years|Mean|34.6|34.6|Standard Deviation|6.4|6.4|||
4032114|NCT01145352|3853936|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4032115|NCT01145352|3853936|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4032116|NCT01145352|3853936|B1|>=30 years||Age, Customized||participants|Number|0|0.0||||||
4032117|NCT01145352|3853936|B1|>= 20 to < 30 years||Age, Customized||participants|Number|10|10.0||||||
4032118|NCT01145352|3853936|B1|>= 15 to < 20 years||Age, Customized||participants|Number|30|30.0||||||
4032119|NCT01145352|3853936|B1|>= 10 to < 15 years||Age, Customized||participants|Number|37|37.0||||||
4032120|NCT01145352|3853936|B1|>= 5 to < 10 years||Age, Customized||participants|Number|24|24.0||||||
4032121|NCT01145352|3853936|B1|<5 years||Age, Customized||participants|Number|1|1.0||||||
4032122|NCT01145066|3853944|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4032123|NCT01145066|3853945|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4032124|NCT01145066|3853946|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4032125|NCT01145066|3853947|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4032126|NCT01145066|3853944|B4||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4032127|NCT01145066|3853945|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4032128|NCT01145066|3853946|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4032129|NCT01145066|3853947|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4032130|NCT01145066|3853944|B4|||Age||years|Mean|57.96|57.96|Standard Deviation|8.8|8.8|||
4032131|NCT01145066|3853945|B3|||Age||years|Mean|59.9|59.9|Standard Deviation|9.8|9.8|||
4032132|NCT01145066|3853946|B2|||Age||years|Mean|56.2|56.2|Standard Deviation|8.7|8.7|||
4032133|NCT01145066|3853947|B1|||Age||years|Mean|57.4|57.4|Standard Deviation|7.8|7.8|||
4032134|NCT01145053|3854017|B1||Male|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
4032135|NCT01145053|3854017|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4032136|NCT01145053|3854017|B1|||Age||years|Mean|73.6|73.6|Standard Deviation|9.0|9.0|||
4032137|NCT01145001|3854027|B5|United States||Region of Enrollment||participants|Number|154|154.0||||||
4032138|NCT01145001|3854028|B4|United States||Region of Enrollment||participants|Number|37|37.0||||||
4032139|NCT01145001|3854029|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
4032140|NCT01145001|3854030|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4032141|NCT01145001|3854031|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4032142|NCT01145001|3854027|B5||Male|Gender||Participants|Count of Participants|95|95.0||||||
4032143|NCT01145001|3854028|B4||Male|Gender||Participants|Count of Participants|20|20.0||||||
4032144|NCT01145001|3854029|B3||Male|Gender||Participants|Count of Participants|27|27.0||||||
4032145|NCT01145001|3854030|B2||Male|Gender||Participants|Count of Participants|23|23.0||||||
4032146|NCT01145001|3854031|B1||Male|Gender||Participants|Count of Participants|25|25.0||||||
4032147|NCT01145001|3854027|B5||Female|Gender||Participants|Count of Participants|59|59.0||||||
4032148|NCT01145001|3854028|B4||Female|Gender||Participants|Count of Participants|17|17.0||||||
4032149|NCT01145001|3854029|B3||Female|Gender||Participants|Count of Participants|17|17.0||||||
4032150|NCT01145001|3854030|B2||Female|Gender||Participants|Count of Participants|14|14.0||||||
4032151|NCT01145001|3854031|B1||Female|Gender||Participants|Count of Participants|11|11.0||||||
4032152|NCT01145001|3854027|B5|||Age||years|Mean|16.53|16.53|Standard Deviation|1.161|1.161|||
4032153|NCT01145001|3854028|B4|||Age||years|Mean|16.30|16.3|Standard Deviation|1.151|1.151|||
4032154|NCT01145001|3854029|B3|||Age||years|Mean|16.66|16.66|Standard Deviation|1.01|1.01|||
4032155|NCT01145001|3854030|B2|||Age||years|Mean|16.62|16.62|Standard Deviation|1.233|1.233|||
4032156|NCT01145001|3854031|B1|||Age||years|Mean|16.53|16.53|Standard Deviation|1.276|1.276|||
4032157|NCT01145001|3854027|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4032158|NCT01145001|3854028|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4032159|NCT01145001|3854029|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4032160|NCT01145001|3854030|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4032161|NCT01145001|3854031|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4032162|NCT01145001|3854027|B5||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4032163|NCT01145001|3854028|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4032164|NCT01145001|3854029|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4032165|NCT01145001|3854030|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4032166|NCT01145001|3854031|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4032167|NCT01145001|3854027|B5||<=18 years|Age||Participants|Count of Participants|149|149.0||||||
4032168|NCT01145001|3854028|B4||<=18 years|Age||Participants|Count of Participants|37|37.0||||||
4032169|NCT01145001|3854029|B3||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
4032170|NCT01145001|3854030|B2||<=18 years|Age||Participants|Count of Participants|36|36.0||||||
4032171|NCT01145001|3854031|B1||<=18 years|Age||Participants|Count of Participants|34|34.0||||||
4032172|NCT01144949|3854048|B3||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4032173|NCT01144949|3854049|B2||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4032174|NCT01144949|3854050|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4032175|NCT01144949|3854048|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4032176|NCT01144949|3854049|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4032177|NCT01144949|3854050|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4032178|NCT01144949|3854048|B3|||Age||years|Mean|47.0|47.0|Standard Deviation|13.9|13.9|||
4032179|NCT01144949|3854049|B2|||Age||years|Mean|46.7|46.7|Standard Deviation|15.2|15.2|||
4032180|NCT01144949|3854050|B1|||Age||years|Mean|47.4|47.4|Standard Deviation|12.5|12.5|||
4032181|NCT01144715|3854067|B3|United States||Region of Enrollment||participants|Number|99|99.0||||||
4032182|NCT01144715|3854068|B2|United States||Region of Enrollment||participants|Number|48|48.0||||||
4032183|NCT01144715|3854069|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4032184|NCT01144715|3854067|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4032185|NCT01144715|3854068|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032186|NCT01144715|3854069|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4032187|NCT01144715|3854067|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4032188|NCT01144715|3854068|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4032189|NCT01144715|3854069|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4032190|NCT01144715|3854067|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4032191|NCT01144715|3854068|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032192|NCT01144715|3854069|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4032193|NCT01144715|3854067|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4032194|NCT01144715|3854068|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032195|NCT01144715|3854069|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4032196|NCT01144715|3854067|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032197|NCT01144715|3854068|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032198|NCT01144715|3854069|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032199|NCT01144715|3854067|B3||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4032200|NCT01144715|3854068|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4032201|NCT01144715|3854069|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4032202|NCT01144715|3854067|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4032203|NCT01144715|3854068|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4032204|NCT01144715|3854069|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4032205|NCT01144715|3854067|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032206|NCT01144715|3854068|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032207|NCT01144715|3854069|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032208|NCT01144715|3854067|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4032209|NCT01144715|3854068|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4032210|NCT01144715|3854069|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032211|NCT01144715|3854067|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032212|NCT01144715|3854068|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032213|NCT01144715|3854069|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032214|NCT01144715|3854067|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4032215|NCT01144715|3854068|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4032216|NCT01144715|3854069|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4032217|NCT01144715|3854067|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4032218|NCT01144715|3854068|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4032219|NCT01144715|3854069|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4032220|NCT01144715|3854067|B3||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4032221|NCT01144715|3854068|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4032222|NCT01144715|3854069|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4032223|NCT01144715|3854067|B3||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
4032224|NCT01144715|3854068|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4032225|NCT01144715|3854069|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4032226|NCT01144715|3854067|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4032227|NCT01144715|3854068|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4032228|NCT01144715|3854069|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4032229|NCT01144715|3854067|B3|||Age||years|Mean|57.5|57.5|Standard Deviation|13.3|13.3|||
4032230|NCT01144715|3854068|B2|||Age||years|Mean|59.1|59.1|Standard Deviation|14.1|14.1|||
4032231|NCT01144715|3854069|B1|||Age||years|Mean|54.7|54.7|Standard Deviation|12.2|12.2|||
4032232|NCT01144624|3854082|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4032233|NCT01144624|3854083|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4032234|NCT01144624|3854084|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4032235|NCT01144624|3854085|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4032236|NCT01144624|3854082|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4032237|NCT01144624|3854083|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4032238|NCT01144624|3854084|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4032239|NCT01144624|3854085|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4032240|NCT01144624|3854082|B4|||Age||years|Mean|75.4|75.4|Standard Deviation|12.78|12.78|||
4032241|NCT01144624|3854083|B3|||Age||years|Mean|77.7|77.7|Standard Deviation|17.64|17.64|||
4032242|NCT01144624|3854084|B2|||Age||years|Mean|77.6|77.6|Standard Deviation|10.45|10.45|||
4032243|NCT01144624|3854085|B1|||Age||years|Mean|71.3|71.3|Standard Deviation|10.89|10.89|||
4032244|NCT01144598|3854101|B1||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4032245|NCT01144598|3854101|B1||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4032246|NCT01144598|3854101|B1|Over 60 years||Age, Customized||participants|Number|12|12.0||||||
4032247|NCT01144598|3854101|B1|51 to 60 years||Age, Customized||participants|Number|53|53.0||||||
4032248|NCT01144598|3854101|B1|41 to 50 years||Age, Customized||participants|Number|120|120.0||||||
4032249|NCT01144598|3854101|B1|30 to 40 years||Age, Customized||participants|Number|122|122.0||||||
4032250|NCT01144598|3854101|B1|Less than 30 years||Age, Customized||participants|Number|49|49.0||||||
4032251|NCT01144455|3854119|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4032252|NCT01144455|3854120|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4032253|NCT01144455|3854121|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4032254|NCT01144455|3854122|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032255|NCT01144455|3854119|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032256|NCT01144455|3854120|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032257|NCT01144455|3854121|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032258|NCT01144455|3854122|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032259|NCT01144455|3854119|B4||White|Race (NIH/OMB)||Participants|Count of Participants|193|193.0||||||
4032260|NCT01144455|3854120|B3||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4032261|NCT01144455|3854121|B2||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4032262|NCT01144455|3854122|B1||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4032263|NCT01144455|3854119|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4032264|NCT01144455|3854120|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4032265|NCT01144455|3854121|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4032266|NCT01144455|3854122|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4032267|NCT01144455|3854119|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032268|NCT01144455|3854120|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032269|NCT01144455|3854121|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032270|NCT01144455|3854122|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032271|NCT01144455|3854119|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4032272|NCT01144455|3854120|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4032273|NCT01144455|3854121|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032274|NCT01144455|3854122|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4032275|NCT01144455|3854119|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032276|NCT01144455|3854120|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032277|NCT01144455|3854121|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032278|NCT01144455|3854122|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032279|NCT01144455|3854119|B4||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4032280|NCT01144455|3854120|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4032281|NCT01144455|3854121|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4032282|NCT01144455|3854122|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4032283|NCT01144455|3854119|B4||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4032284|NCT01144455|3854120|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4032285|NCT01144455|3854121|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4032286|NCT01144455|3854122|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4032287|NCT01144455|3854119|B4||>=65 years|Age||Participants|Count of Participants|107|107.0||||||
4032288|NCT01144455|3854120|B3||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4032289|NCT01144455|3854121|B2||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4032290|NCT01144455|3854122|B1||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
4032291|NCT01144455|3854119|B4||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
4032292|NCT01144455|3854120|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4032293|NCT01144455|3854121|B2||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4032294|NCT01144455|3854122|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4032295|NCT01144455|3854119|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4032296|NCT01144455|3854120|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4032297|NCT01144455|3854121|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4032298|NCT01144455|3854122|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4032299|NCT01144442|3854132|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4032300|NCT01144442|3854132|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4032301|NCT01144442|3854132|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4032302|NCT01144442|3854132|B1|||Age, Customized||years|Median|56|56.0|Full Range|16.7|16.7|47.0|66.0|
4032303|NCT01144442|3854132|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4032304|NCT01144442|3854132|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4032305|NCT01144442|3854132|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4032306|NCT01144416|3854137|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4032307|NCT01144416|3854138|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4032308|NCT01144416|3854139|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4032309|NCT01144416|3854137|B3||Female|Sex: Female, Male||Participants|Count of Participants|1390|1390.0||||||
4032310|NCT01144416|3854138|B2||Female|Sex: Female, Male||Participants|Count of Participants|696|696.0||||||
4032311|NCT01144416|3854139|B1||Female|Sex: Female, Male||Participants|Count of Participants|694|694.0||||||
4032312|NCT01144416|3854137|B3|||Age||years|Mean|38.0|38.0|Standard Deviation|2.2|2.2|||
4032313|NCT01144416|3854138|B2|||Age||years|Mean|38.0|38.0|Standard Deviation|2.2|2.2|||
4032314|NCT01144416|3854139|B1|||Age||years|Mean|38.0|38.0|Standard Deviation|2.2|2.2|||
4032315|NCT01144403|3854156|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4032316|NCT01144403|3854156|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4032317|NCT01144403|3854156|B1|||Age||years|Mean|60.50|60.5|Standard Deviation|7.964|7.964|||
4032318|NCT01144377|3854163|B6|||Total Hip Bone Mineral Density (Baseline)||grams/square centimeter|Mean|0.75|0.75|Standard Deviation|0.12|0.12|||
4032319|NCT01144377|3854164|B5|||Total Hip Bone Mineral Density (Baseline)||grams/square centimeter|Mean|0.73|0.73|Standard Deviation|0.14|0.14|||
4032320|NCT01144377|3854165|B4|||Total Hip Bone Mineral Density (Baseline)||grams/square centimeter|Mean|0.73|0.73|Standard Deviation|0.11|0.11|||
4032321|NCT01144377|3854166|B3|||Total Hip Bone Mineral Density (Baseline)||grams/square centimeter|Mean|0.77|0.77|Standard Deviation|0.10|0.1|||
4032322|NCT01144377|3854167|B2|||Total Hip Bone Mineral Density (Baseline)||grams/square centimeter|Mean|0.75|0.75|Standard Deviation|0.13|0.13|||
4032323|NCT01144377|3854168|B1|||Total Hip Bone Mineral Density (Baseline)||grams/square centimeter|Mean|0.75|0.75|Standard Deviation|0.11|0.11|||
4032324|NCT01144377|3854163|B6|||Femoral Neck Bone Mineral Density (Baseline)||g/cm^2|Mean|0.66|0.66|Standard Deviation|0.14|0.14|||
4032325|NCT01144377|3854164|B5|||Femoral Neck Bone Mineral Density (Baseline)||g/cm^2|Mean|0.66|0.66|Standard Deviation|0.17|0.17|||
4032326|NCT01144377|3854165|B4|||Femoral Neck Bone Mineral Density (Baseline)||g/cm^2|Mean|0.63|0.63|Standard Deviation|0.11|0.11|||
4032327|NCT01144377|3854166|B3|||Femoral Neck Bone Mineral Density (Baseline)||g/cm^2|Mean|0.69|0.69|Standard Deviation|0.11|0.11|||
4032328|NCT01144377|3854167|B2|||Femoral Neck Bone Mineral Density (Baseline)||g/cm^2|Mean|0.66|0.66|Standard Deviation|0.15|0.15|||
4032329|NCT01144377|3854168|B1|||Femoral Neck Bone Mineral Density (Baseline)||g/cm^2|Mean|0.66|0.66|Standard Deviation|0.15|0.15|||
4032330|NCT01144377|3854163|B6|||Lumbar Spine Bone Mineral Density (Baseline)||grams/square centimeter (g/cm^2)|Mean|0.78|0.78|Standard Deviation|0.09|0.09|||
4032331|NCT01144377|3854164|B5|||Lumbar Spine Bone Mineral Density (Baseline)||grams/square centimeter (g/cm^2)|Mean|0.78|0.78|Standard Deviation|0.09|0.09|||
4032332|NCT01144377|3854165|B4|||Lumbar Spine Bone Mineral Density (Baseline)||grams/square centimeter (g/cm^2)|Mean|0.77|0.77|Standard Deviation|0.09|0.09|||
4032333|NCT01144377|3854166|B3|||Lumbar Spine Bone Mineral Density (Baseline)||grams/square centimeter (g/cm^2)|Mean|0.80|0.8|Standard Deviation|0.09|0.09|||
4032334|NCT01144377|3854167|B2|||Lumbar Spine Bone Mineral Density (Baseline)||grams/square centimeter (g/cm^2)|Mean|0.78|0.78|Standard Deviation|0.07|0.07|||
4032335|NCT01144377|3854168|B1|||Lumbar Spine Bone Mineral Density (Baseline)||grams/square centimeter (g/cm^2)|Mean|0.78|0.78|Standard Deviation|0.09|0.09|||
4032336|NCT01144377|3854163|B6|Japan||Region of Enrollment||Participants|Count of Participants|65|65.0||||||
4032337|NCT01144377|3854164|B5|Japan||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4032338|NCT01144377|3854165|B4|Japan||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4032339|NCT01144377|3854166|B3|Japan||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4032340|NCT01144377|3854167|B2|Japan||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4032341|NCT01144377|3854168|B1|Japan||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4032342|NCT01144377|3854163|B6|Denmark||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4032343|NCT01144377|3854164|B5|Denmark||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4032344|NCT01144377|3854165|B4|Denmark||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4032345|NCT01144377|3854166|B3|Denmark||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4032346|NCT01144377|3854167|B2|Denmark||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4032347|NCT01144377|3854168|B1|Denmark||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4032348|NCT01144377|3854163|B6|Lithuania||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4032349|NCT01144377|3854164|B5|Lithuania||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4032350|NCT01144377|3854165|B4|Lithuania||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4032351|NCT01144377|3854166|B3|Lithuania||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4032352|NCT01144377|3854167|B2|Lithuania||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4032353|NCT01144377|3854168|B1|Lithuania||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4032354|NCT01144377|3854163|B6|Estonia||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4032355|NCT01144377|3854164|B5|Estonia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4032356|NCT01144377|3854165|B4|Estonia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4032357|NCT01144377|3854166|B3|Estonia||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4032358|NCT01144377|3854167|B2|Estonia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4032359|NCT01144377|3854168|B1|Estonia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4032360|NCT01144377|3854163|B6|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
4032361|NCT01144377|3854164|B5|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4032362|NCT01144377|3854165|B4|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4032363|NCT01144377|3854166|B3|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4032364|NCT01144377|3854167|B2|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4032365|NCT01144377|3854168|B1|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4032366|NCT01144377|3854163|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032367|NCT01144377|3854164|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032368|NCT01144377|3854165|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032369|NCT01144377|3854166|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032370|NCT01144377|3854167|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032371|NCT01144377|3854168|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032372|NCT01144377|3854163|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032373|NCT01144377|3854164|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032374|NCT01144377|3854165|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032375|NCT01144377|3854166|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032376|NCT01144377|3854167|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032377|NCT01144377|3854168|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032378|NCT01144377|3854163|B6||White|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
4032379|NCT01144377|3854164|B5||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4032380|NCT01144377|3854165|B4||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4032381|NCT01144377|3854166|B3||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4032382|NCT01144377|3854167|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4032383|NCT01144377|3854168|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4032384|NCT01144377|3854163|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4032385|NCT01144377|3854164|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4032386|NCT01144377|3854165|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032387|NCT01144377|3854166|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032388|NCT01144377|3854167|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032389|NCT01144377|3854168|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032390|NCT01144377|3854163|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032391|NCT01144377|3854164|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032392|NCT01144377|3854165|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032393|NCT01144377|3854166|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032394|NCT01144377|3854167|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032395|NCT01144377|3854168|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032396|NCT01144377|3854163|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4032397|NCT01144377|3854164|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4032398|NCT01144377|3854165|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4032399|NCT01144377|3854166|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4032400|NCT01144377|3854167|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4032401|NCT01144377|3854168|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4032402|NCT01144377|3854163|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032403|NCT01144377|3854164|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032404|NCT01144377|3854165|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032405|NCT01144377|3854166|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032406|NCT01144377|3854167|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032407|NCT01144377|3854168|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032408|NCT01144377|3854163|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4032409|NCT01144377|3854164|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4032410|NCT01144377|3854165|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032411|NCT01144377|3854166|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4032412|NCT01144377|3854167|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4032413|NCT01144377|3854168|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4032414|NCT01144377|3854163|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
4032415|NCT01144377|3854164|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4032416|NCT01144377|3854165|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4032417|NCT01144377|3854166|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4032418|NCT01144377|3854167|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4032419|NCT01144377|3854168|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4032420|NCT01144377|3854163|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4032421|NCT01144377|3854164|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4032422|NCT01144377|3854165|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4032423|NCT01144377|3854166|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4032424|NCT01144377|3854167|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4032425|NCT01144377|3854168|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4032426|NCT01144377|3854163|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4032427|NCT01144377|3854164|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4032428|NCT01144377|3854165|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4032429|NCT01144377|3854166|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4032430|NCT01144377|3854167|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4032431|NCT01144377|3854168|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4032432|NCT01144377|3854163|B6||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4032433|NCT01144377|3854164|B5||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4032434|NCT01144377|3854165|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4032435|NCT01144377|3854166|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4032436|NCT01144377|3854167|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4032437|NCT01144377|3854168|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4032438|NCT01144377|3854163|B6|||Age||years|Mean|65.22|65.22|Standard Deviation|8.38|8.38|||
4032439|NCT01144377|3854164|B5|||Age||years|Mean|65.17|65.17|Standard Deviation|8.91|8.91|||
4032440|NCT01144377|3854165|B4|||Age||years|Mean|63.56|63.56|Standard Deviation|8.02|8.02|||
4032441|NCT01144377|3854166|B3|||Age||years|Mean|66.12|66.12|Standard Deviation|7.68|7.68|||
4032442|NCT01144377|3854167|B2|||Age||years|Mean|64.17|64.17|Standard Deviation|8.20|8.2|||
4032443|NCT01144377|3854168|B1|||Age||years|Mean|66.78|66.78|Standard Deviation|8.98|8.98|||
4032444|NCT01144364|3854219|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4032445|NCT01144364|3854220|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4032446|NCT01144364|3854221|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4032447|NCT01144364|3854219|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4032448|NCT01144364|3854220|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4032449|NCT01144364|3854221|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4032450|NCT01144364|3854219|B3|||Age||years|Median|66|66.0|Inter-Quartile Range|||63.0|69.0|
4032451|NCT01144364|3854220|B2|||Age||years|Median|65|65.0|Inter-Quartile Range|||62.0|69.0|
4032452|NCT01144364|3854221|B1|||Age||years|Median|66|66.0|Inter-Quartile Range|||64.0|70.0|
4032453|NCT01144338|3854247|B3||No|Prior CV Event|Patient had prior cardiovascular event or not at randomization|Participants|Count of Participants|3970|3970.0||||||
4032454|NCT01144338|3854248|B2||No|Prior CV Event|Patient had prior cardiovascular event or not at randomization|Participants|Count of Participants|1962|1962.0||||||
4032455|NCT01144338|3854249|B1||No|Prior CV Event|Patient had prior cardiovascular event or not at randomization|Participants|Count of Participants|2008|2008.0||||||
4032456|NCT01144338|3854247|B3||Yes|Prior CV Event|Patient had prior cardiovascular event or not at randomization|Participants|Count of Participants|10782|10782.0||||||
4032457|NCT01144338|3854248|B2||Yes|Prior CV Event|Patient had prior cardiovascular event or not at randomization|Participants|Count of Participants|5394|5394.0||||||
4032458|NCT01144338|3854249|B1||Yes|Prior CV Event|Patient had prior cardiovascular event or not at randomization|Participants|Count of Participants|5388|5388.0||||||
4032459|NCT01144338|3854247|B3|Global|NORTH AMERICA|Region of Enrollment||Participants|Count of Participants|3708|3708.0||||||
4032516|NCT01144286|3854296|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4032460|NCT01144338|3854248|B2|Global|NORTH AMERICA|Region of Enrollment||Participants|Count of Participants|1834|1834.0||||||
4032461|NCT01144338|3854249|B1|Global|NORTH AMERICA|Region of Enrollment||Participants|Count of Participants|1874|1874.0||||||
4032462|NCT01144338|3854247|B3|Global|LATIN AMERICA|Region of Enrollment||Participants|Count of Participants|2727|2727.0||||||
4032463|NCT01144338|3854248|B2|Global|LATIN AMERICA|Region of Enrollment||Participants|Count of Participants|1364|1364.0||||||
4032464|NCT01144338|3854249|B1|Global|LATIN AMERICA|Region of Enrollment||Participants|Count of Participants|1363|1363.0||||||
4032465|NCT01144338|3854247|B3|Global|EUROPE|Region of Enrollment||Participants|Count of Participants|6788|6788.0||||||
4032466|NCT01144338|3854248|B2|Global|EUROPE|Region of Enrollment||Participants|Count of Participants|3389|3389.0||||||
4032467|NCT01144338|3854249|B1|Global|EUROPE|Region of Enrollment||Participants|Count of Participants|3399|3399.0||||||
4032468|NCT01144338|3854247|B3|Global|ASIA PACIFIC|Region of Enrollment||Participants|Count of Participants|1529|1529.0||||||
4032469|NCT01144338|3854248|B2|Global|ASIA PACIFIC|Region of Enrollment||Participants|Count of Participants|769|769.0||||||
4032470|NCT01144338|3854249|B1|Global|ASIA PACIFIC|Region of Enrollment||Participants|Count of Participants|760|760.0||||||
4032471|NCT01144338|3854247|B3||MISSING|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4032472|NCT01144338|3854248|B2||MISSING|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4032473|NCT01144338|3854249|B1||MISSING|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4032474|NCT01144338|3854247|B3||HISPANIC|Race/Ethnicity, Customized||Participants|Count of Participants|1134|1134.0||||||
4032475|NCT01144338|3854248|B2||HISPANIC|Race/Ethnicity, Customized||Participants|Count of Participants|577|577.0||||||
4032476|NCT01144338|3854249|B1||HISPANIC|Race/Ethnicity, Customized||Participants|Count of Participants|557|557.0||||||
4032477|NCT01144338|3854247|B3||NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER|Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
4032478|NCT01144338|3854248|B2||NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
4032479|NCT01144338|3854249|B1||NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4032480|NCT01144338|3854247|B3||INDIAN (AMERICAN ) OR ALASKA NATIVE|Race/Ethnicity, Customized||Participants|Count of Participants|73|73.0||||||
4032481|NCT01144338|3854248|B2||INDIAN (AMERICAN ) OR ALASKA NATIVE|Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
4032482|NCT01144338|3854249|B1||INDIAN (AMERICAN ) OR ALASKA NATIVE|Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
4032483|NCT01144338|3854247|B3||ASIAN|Race/Ethnicity, Customized||Participants|Count of Participants|1452|1452.0||||||
4032484|NCT01144338|3854248|B2||ASIAN|Race/Ethnicity, Customized||Participants|Count of Participants|725|725.0||||||
4032485|NCT01144338|3854249|B1||ASIAN|Race/Ethnicity, Customized||Participants|Count of Participants|727|727.0||||||
4032486|NCT01144338|3854247|B3||BLACK OR AFRICAN AMERICAN|Race/Ethnicity, Customized||Participants|Count of Participants|878|878.0||||||
4032487|NCT01144338|3854248|B2||BLACK OR AFRICAN AMERICAN|Race/Ethnicity, Customized||Participants|Count of Participants|442|442.0||||||
4032488|NCT01144338|3854249|B1||BLACK OR AFRICAN AMERICAN|Race/Ethnicity, Customized||Participants|Count of Participants|436|436.0||||||
4032489|NCT01144338|3854247|B3||WHITE|Race/Ethnicity, Customized||Participants|Count of Participants|11175|11175.0||||||
4032490|NCT01144338|3854248|B2||WHITE|Race/Ethnicity, Customized||Participants|Count of Participants|5554|5554.0||||||
4032491|NCT01144338|3854249|B1||WHITE|Race/Ethnicity, Customized||Participants|Count of Participants|5621|5621.0||||||
4032492|NCT01144338|3854247|B3||Male|Sex: Female, Male||Participants|Count of Participants|9149|9149.0||||||
4032493|NCT01144338|3854248|B2||Male|Sex: Female, Male||Participants|Count of Participants|4562|4562.0||||||
4032494|NCT01144338|3854249|B1||Male|Sex: Female, Male||Participants|Count of Participants|4587|4587.0||||||
4032495|NCT01144338|3854247|B3||Female|Sex: Female, Male||Participants|Count of Participants|5603|5603.0||||||
4032496|NCT01144338|3854248|B2||Female|Sex: Female, Male||Participants|Count of Participants|2794|2794.0||||||
4032497|NCT01144338|3854249|B1||Female|Sex: Female, Male||Participants|Count of Participants|2809|2809.0||||||
4032498|NCT01144338|3854247|B3|||Age|Age at enrollment|Years|Mean|61.9|61.9|Standard Deviation|9.4|9.4|||
4032499|NCT01144338|3854248|B2|||Age|Age at enrollment|Years|Mean|61.8|61.8|Standard Deviation|9.4|9.4|||
4032500|NCT01144338|3854249|B1|||Age|Age at enrollment|Years|Mean|61.9|61.9|Standard Deviation|9.4|9.4|||
4032501|NCT01144299|3854270|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4032502|NCT01144299|3854271|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4032503|NCT01144299|3854272|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4032504|NCT01144299|3854270|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4032505|NCT01144299|3854271|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4032506|NCT01144299|3854272|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4032507|NCT01144299|3854270|B3|||Age||Years|Mean|52.1|52.1|Standard Deviation|18.83|18.83|||
4032508|NCT01144299|3854271|B2|||Age||Years|Mean|68.6|68.6|Standard Deviation|5.08|5.08|||
4032509|NCT01144299|3854272|B1|||Age||Years|Mean|37.1|37.1|Standard Deviation|13.10|13.1|||
4032510|NCT01144286|3854295|B5|Europe||Region of Enrollment||participants|Number|229|229.0||||||
4032511|NCT01144286|3854296|B4|Europe||Region of Enrollment||participants|Number|56|56.0||||||
4032512|NCT01144286|3854297|B3|Europe||Region of Enrollment||participants|Number|58|58.0||||||
4032513|NCT01144286|3854298|B2|Europe||Region of Enrollment||participants|Number|58|58.0||||||
4032514|NCT01144286|3854299|B1|Europe||Region of Enrollment||participants|Number|57|57.0||||||
4032515|NCT01144286|3854295|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4032517|NCT01144286|3854297|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4032518|NCT01144286|3854298|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4032519|NCT01144286|3854299|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4032520|NCT01144286|3854295|B5||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4032521|NCT01144286|3854296|B4||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4032522|NCT01144286|3854297|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4032523|NCT01144286|3854298|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4032524|NCT01144286|3854299|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4032525|NCT01144286|3854295|B5|||Age||years|Mean|31.1|31.1|Standard Deviation|8.13|8.13|||
4032526|NCT01144286|3854296|B4|||Age||years|Mean|31.8|31.8|Standard Deviation|8.53|8.53|||
4032527|NCT01144286|3854297|B3|||Age||years|Mean|29.7|29.7|Standard Deviation|7.58|7.58|||
4032528|NCT01144286|3854298|B2|||Age||years|Mean|32.8|32.8|Standard Deviation|8.47|8.47|||
4032529|NCT01144286|3854299|B1|||Age||years|Mean|30.1|30.1|Standard Deviation|7.74|7.74|||
4032530|NCT01144286|3854295|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4032531|NCT01144286|3854296|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4032532|NCT01144286|3854297|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4032533|NCT01144286|3854298|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4032534|NCT01144286|3854299|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4032535|NCT01144286|3854295|B5||Between 18 and 65 years|Age||Participants|Count of Participants|229|229.0||||||
4032536|NCT01144286|3854296|B4||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4032537|NCT01144286|3854297|B3||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4032538|NCT01144286|3854298|B2||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4032539|NCT01144286|3854299|B1||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4032540|NCT01144286|3854295|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4032541|NCT01144286|3854296|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4032542|NCT01144286|3854297|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4032543|NCT01144286|3854298|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4032544|NCT01144286|3854299|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4032545|NCT01144182|3854316|B3|||Length of hospital stay||days|Median|6|6.0|Inter-Quartile Range|||3.0|9.0|
4032546|NCT01144182|3854317|B2|||Length of hospital stay||days|Median|6|6.0|Inter-Quartile Range|||4.0|9.0|
4032547|NCT01144182|3854318|B1|||Length of hospital stay||days|Median|6|6.0|Inter-Quartile Range|||3.0|9.0|
4032548|NCT01144182|3854316|B3|||Number of heart failure medications||number of heart failure medications|Median|3|3.0|Inter-Quartile Range|||2.0|3.0|
4032549|NCT01144182|3854317|B2|||Number of heart failure medications||number of heart failure medications|Median|3|3.0|Inter-Quartile Range|||2.0|3.0|
4032550|NCT01144182|3854318|B1|||Number of heart failure medications||number of heart failure medications|Median|3|3.0|Inter-Quartile Range|||2.0|3.0|
4032551|NCT01144182|3854316|B3|||BNP|B-type natriuretic peptide|pg/mL|Median|696.0|696.0|Inter-Quartile Range|||413.0|1580.0|
4032552|NCT01144182|3854317|B2|||BNP|B-type natriuretic peptide|pg/mL|Median|739.0|739.0|Inter-Quartile Range|||383.0|1702.0|
4032553|NCT01144182|3854318|B1|||BNP|B-type natriuretic peptide|pg/mL|Median|645.0|645.0|Inter-Quartile Range|||433.0|1512.5|
4032554|NCT01144182|3854316|B3|Brooklyn||Campus||participants|Number|41|41.0||||||
4032555|NCT01144182|3854317|B2|Brooklyn||Campus||participants|Number|23|23.0||||||
4032556|NCT01144182|3854318|B1|Brooklyn||Campus||participants|Number|18|18.0||||||
4032557|NCT01144182|3854316|B3|Manhattan||Campus||participants|Number|95|95.0||||||
4032558|NCT01144182|3854317|B2|Manhattan||Campus||participants|Number|45|45.0||||||
4032559|NCT01144182|3854318|B1|Manhattan||Campus||participants|Number|50|50.0||||||
4032560|NCT01144182|3854316|B3|Not employed||Employment status||participants|Number|126|126.0||||||
4032561|NCT01144182|3854317|B2|Not employed||Employment status||participants|Number|64|64.0||||||
4032562|NCT01144182|3854318|B1|Not employed||Employment status||participants|Number|62|62.0||||||
4032563|NCT01144182|3854316|B3|Employed||Employment status||participants|Number|10|10.0||||||
4032564|NCT01144182|3854317|B2|Employed||Employment status||participants|Number|4|4.0||||||
4032565|NCT01144182|3854318|B1|Employed||Employment status||participants|Number|6|6.0||||||
4032566|NCT01144182|3854316|B3|Some college or higher||Education||participants|Number|70|70.0||||||
4032567|NCT01144182|3854317|B2|Some college or higher||Education||participants|Number|36|36.0||||||
4032568|NCT01144182|3854318|B1|Some college or higher||Education||participants|Number|34|34.0||||||
4032569|NCT01144182|3854316|B3|High school graduate or below||Education||participants|Number|66|66.0||||||
4032570|NCT01144182|3854317|B2|High school graduate or below||Education||participants|Number|32|32.0||||||
4032571|NCT01144182|3854318|B1|High school graduate or below||Education||participants|Number|34|34.0||||||
4032572|NCT01144182|3854316|B3|Not Married||Marital Status||participants|Number|103|103.0||||||
4032573|NCT01144182|3854317|B2|Not Married||Marital Status||participants|Number|50|50.0||||||
4032574|NCT01144182|3854318|B1|Not Married||Marital Status||participants|Number|53|53.0||||||
4032575|NCT01144182|3854316|B3|Married||Marital Status||participants|Number|33|33.0||||||
4032576|NCT01144182|3854317|B2|Married||Marital Status||participants|Number|18|18.0||||||
4032577|NCT01144182|3854318|B1|Married||Marital Status||participants|Number|15|15.0||||||
4032578|NCT01144182|3854316|B3|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4032579|NCT01144182|3854317|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4032580|NCT01144182|3854318|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4032581|NCT01144182|3854316|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4032582|NCT01144182|3854317|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4032583|NCT01144182|3854318|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4032584|NCT01144182|3854316|B3|Black (non-Hispanic)||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4032585|NCT01144182|3854317|B2|Black (non-Hispanic)||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4032586|NCT01144182|3854318|B1|Black (non-Hispanic)||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4032587|NCT01144182|3854316|B3|White (non-Hispanic)||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
4032588|NCT01144182|3854317|B2|White (non-Hispanic)||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4032589|NCT01144182|3854318|B1|White (non-Hispanic)||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4032590|NCT01144182|3854316|B3||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4032591|NCT01144182|3854317|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4032592|NCT01144182|3854318|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4032593|NCT01144182|3854316|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4032594|NCT01144182|3854317|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4032595|NCT01144182|3854318|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4032596|NCT01144182|3854316|B3|||Age||years|Median|74.8|74.8|Inter-Quartile Range|||63.8|84.0|
4032597|NCT01144182|3854317|B2|||Age||years|Median|74.8|74.8|Inter-Quartile Range|||64.7|84.6|
4032598|NCT01144182|3854318|B1|||Age||years|Median|75.3|75.3|Inter-Quartile Range|||61.4|83.5|
4032599|NCT01144143|3854349|B4|United States||Region of Enrollment||participants|Number|16|16.0||||||
4032600|NCT01144143|3854350|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4032601|NCT01144143|3854351|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4032602|NCT01144143|3854352|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4032603|NCT01144143|3854349|B4|Unknown or Not Reported||Race/Ethnicity, Customized||Number|Number|0|0.0||||||
4032604|NCT01144143|3854350|B3|Unknown or Not Reported||Race/Ethnicity, Customized||Number|Number|0|0.0||||||
4032605|NCT01144143|3854351|B2|Unknown or Not Reported||Race/Ethnicity, Customized||Number|Number|0|0.0||||||
4032606|NCT01144143|3854352|B1|Unknown or Not Reported||Race/Ethnicity, Customized||Number|Number|0|0.0||||||
4032607|NCT01144143|3854349|B4|More than one race||Race/Ethnicity, Customized||Number|Number|0|0.0||||||
4032608|NCT01144143|3854350|B3|More than one race||Race/Ethnicity, Customized||Number|Number|0|0.0||||||
4032609|NCT01144143|3854351|B2|More than one race||Race/Ethnicity, Customized||Number|Number|0|0.0||||||
4032610|NCT01144143|3854352|B1|More than one race||Race/Ethnicity, Customized||Number|Number|0|0.0||||||
4032611|NCT01144143|3854349|B4|White||Race/Ethnicity, Customized||Number|Number|11|11.0||||||
4032612|NCT01144143|3854350|B3|White||Race/Ethnicity, Customized||Number|Number|3|3.0||||||
4032613|NCT01144143|3854351|B2|White||Race/Ethnicity, Customized||Number|Number|3|3.0||||||
4032614|NCT01144143|3854352|B1|White||Race/Ethnicity, Customized||Number|Number|5|5.0||||||
4032615|NCT01144143|3854349|B4|Black or African American||Race/Ethnicity, Customized||Number|Number|5|5.0||||||
4032616|NCT01144143|3854350|B3|Black or African American||Race/Ethnicity, Customized||Number|Number|1|1.0||||||
4032617|NCT01144143|3854351|B2|Black or African American||Race/Ethnicity, Customized||Number|Number|1|1.0||||||
4032618|NCT01144143|3854352|B1|Black or African American||Race/Ethnicity, Customized||Number|Number|3|3.0||||||
4032619|NCT01144143|3854349|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Number|Number|0|0.0||||||
4032620|NCT01144143|3854350|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Number|Number|0|0.0||||||
4032621|NCT01144143|3854351|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Number|Number|0|0.0||||||
4032622|NCT01144143|3854352|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Number|Number|0|0.0||||||
4032623|NCT01144143|3854349|B4|Asian||Race/Ethnicity, Customized||Number|Number|0|0.0||||||
4032624|NCT01144143|3854350|B3|Asian||Race/Ethnicity, Customized||Number|Number|0|0.0||||||
4032625|NCT01144143|3854351|B2|Asian||Race/Ethnicity, Customized||Number|Number|0|0.0||||||
4032626|NCT01144143|3854352|B1|Asian||Race/Ethnicity, Customized||Number|Number|0|0.0||||||
4032627|NCT01144143|3854349|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Number|Number|0|0.0||||||
4032628|NCT01144143|3854350|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Number|Number|0|0.0||||||
4032629|NCT01144143|3854351|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Number|Number|0|0.0||||||
4032630|NCT01144143|3854352|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Number|Number|0|0.0||||||
4032631|NCT01144143|3854349|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4032632|NCT01144143|3854350|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4032633|NCT01144143|3854351|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4032634|NCT01144143|3854352|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4032635|NCT01144143|3854349|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4032636|NCT01144143|3854350|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4032637|NCT01144143|3854351|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4032638|NCT01144143|3854352|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4032639|NCT01144143|3854349|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4032640|NCT01144143|3854350|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4032641|NCT01144143|3854351|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4032642|NCT01144143|3854352|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4032643|NCT01144143|3854349|B4||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4032644|NCT01144143|3854350|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4032645|NCT01144143|3854351|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4032646|NCT01144143|3854352|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4032647|NCT01144143|3854349|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4032648|NCT01144143|3854350|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4032649|NCT01144143|3854351|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4032650|NCT01144143|3854352|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4032651|NCT01144052|3854377|B3|Switzerland||Region of Enrollment||participants|Number|19|19.0||||||
4032652|NCT01144052|3854378|B2|Switzerland||Region of Enrollment||participants|Number|9|9.0||||||
4032653|NCT01144052|3854379|B1|Switzerland||Region of Enrollment||participants|Number|10|10.0||||||
4032654|NCT01144052|3854377|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4032655|NCT01144052|3854378|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4032656|NCT01144052|3854379|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4032657|NCT01144052|3854377|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4032658|NCT01144052|3854378|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4032659|NCT01144052|3854379|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4032660|NCT01144052|3854377|B3|||Age||years|Mean|41|41.0|Standard Deviation|12.05|12.05|||
4032661|NCT01144052|3854378|B2|||Age||years|Mean|39|39.0|Standard Deviation|13.26|13.26|||
4032662|NCT01144052|3854379|B1|||Age||years|Mean|43|43.0|Standard Deviation|10.83|10.83|||
4032663|NCT01144052|3854377|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4032664|NCT01144052|3854378|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4032665|NCT01144052|3854379|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4032666|NCT01144052|3854377|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4032667|NCT01144052|3854378|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4032668|NCT01144052|3854379|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4032669|NCT01144052|3854377|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4032670|NCT01144052|3854378|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4032671|NCT01144052|3854379|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4032672|NCT01144026|3854400|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4032673|NCT01144026|3854401|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4032674|NCT01144026|3854402|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4032675|NCT01144026|3854400|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4032676|NCT01144026|3854401|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4032677|NCT01144026|3854402|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4032678|NCT01144026|3854400|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4032679|NCT01144026|3854401|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4032680|NCT01144026|3854402|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4032681|NCT01144026|3854400|B3|||Age||years|Mean|38.4|38.4|Standard Deviation|7.64|7.64|||
4032682|NCT01144026|3854401|B2|||Age||years|Mean|36.4|36.4|Standard Deviation|4.56|4.56|||
4032683|NCT01144026|3854402|B1|||Age||years|Mean|38.4|38.4|Standard Deviation|8.51|8.51|||
4032684|NCT01144026|3854400|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4032685|NCT01144026|3854401|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4032686|NCT01144026|3854402|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4032687|NCT01144026|3854400|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4032688|NCT01144026|3854401|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4032689|NCT01144026|3854402|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4032690|NCT01144026|3854400|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4032691|NCT01144026|3854401|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4032692|NCT01144026|3854402|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4032693|NCT01143896|3854409|B3|Don't Know/Refused||Taking antidepressant meds at baseline|Do you have a current prescription for any anti-depressant medications, such as prozac or lexapro?|participants|Number|4|4.0||||||
4032694|NCT01143896|3854410|B2|Don't Know/Refused||Taking antidepressant meds at baseline|Do you have a current prescription for any anti-depressant medications, such as prozac or lexapro?|participants|Number|1|1.0||||||
4032695|NCT01143896|3854411|B1|Don't Know/Refused||Taking antidepressant meds at baseline|Do you have a current prescription for any anti-depressant medications, such as prozac or lexapro?|participants|Number|3|3.0||||||
4032696|NCT01143896|3854409|B3|No||Taking antidepressant meds at baseline|Do you have a current prescription for any anti-depressant medications, such as prozac or lexapro?|participants|Number|150|150.0||||||
4032697|NCT01143896|3854410|B2|No||Taking antidepressant meds at baseline|Do you have a current prescription for any anti-depressant medications, such as prozac or lexapro?|participants|Number|79|79.0||||||
4032698|NCT01143896|3854411|B1|No||Taking antidepressant meds at baseline|Do you have a current prescription for any anti-depressant medications, such as prozac or lexapro?|participants|Number|71|71.0||||||
4032699|NCT01143896|3854409|B3|Yes||Taking antidepressant meds at baseline|Do you have a current prescription for any anti-depressant medications, such as prozac or lexapro?|participants|Number|138|138.0||||||
4032700|NCT01143896|3854410|B2|Yes||Taking antidepressant meds at baseline|Do you have a current prescription for any anti-depressant medications, such as prozac or lexapro?|participants|Number|67|67.0||||||
4032701|NCT01143896|3854411|B1|Yes||Taking antidepressant meds at baseline|Do you have a current prescription for any anti-depressant medications, such as prozac or lexapro?|participants|Number|71|71.0||||||
4032702|NCT01143896|3854409|B3|Don't Know/Refused||History of Mood Disorders|In the last 6 months, did you receive care for personal or emotional problems, feeling down, worried or anxious, or alcohol or drug problem?|participants|Number|2|2.0||||||
4032703|NCT01143896|3854410|B2|Don't Know/Refused||History of Mood Disorders|In the last 6 months, did you receive care for personal or emotional problems, feeling down, worried or anxious, or alcohol or drug problem?|participants|Number|2|2.0||||||
4032704|NCT01143896|3854411|B1|Don't Know/Refused||History of Mood Disorders|In the last 6 months, did you receive care for personal or emotional problems, feeling down, worried or anxious, or alcohol or drug problem?|participants|Number|0|0.0||||||
4032705|NCT01143896|3854409|B3|No||History of Mood Disorders|In the last 6 months, did you receive care for personal or emotional problems, feeling down, worried or anxious, or alcohol or drug problem?|participants|Number|158|158.0||||||
4032706|NCT01143896|3854410|B2|No||History of Mood Disorders|In the last 6 months, did you receive care for personal or emotional problems, feeling down, worried or anxious, or alcohol or drug problem?|participants|Number|78|78.0||||||
4032707|NCT01143896|3854411|B1|No||History of Mood Disorders|In the last 6 months, did you receive care for personal or emotional problems, feeling down, worried or anxious, or alcohol or drug problem?|participants|Number|80|80.0||||||
4032708|NCT01143896|3854409|B3|Yes||History of Mood Disorders|In the last 6 months, did you receive care for personal or emotional problems, feeling down, worried or anxious, or alcohol or drug problem?|participants|Number|132|132.0||||||
4032709|NCT01143896|3854410|B2|Yes||History of Mood Disorders|In the last 6 months, did you receive care for personal or emotional problems, feeling down, worried or anxious, or alcohol or drug problem?|participants|Number|67|67.0||||||
4032710|NCT01143896|3854411|B1|Yes||History of Mood Disorders|In the last 6 months, did you receive care for personal or emotional problems, feeling down, worried or anxious, or alcohol or drug problem?|participants|Number|65|65.0||||||
4032711|NCT01143896|3854409|B3|Don't Know/Refused||Annual Income||participants|Number|91|91.0||||||
4032712|NCT01143896|3854410|B2|Don't Know/Refused||Annual Income||participants|Number|49|49.0||||||
4032713|NCT01143896|3854411|B1|Don't Know/Refused||Annual Income||participants|Number|42|42.0||||||
4032714|NCT01143896|3854409|B3|Over $20,000||Annual Income||participants|Number|84|84.0||||||
4032715|NCT01143896|3854410|B2|Over $20,000||Annual Income||participants|Number|41|41.0||||||
4032716|NCT01143896|3854411|B1|Over $20,000||Annual Income||participants|Number|43|43.0||||||
4032717|NCT01143896|3854409|B3|Less than $20,000||Annual Income||participants|Number|117|117.0||||||
4032718|NCT01143896|3854410|B2|Less than $20,000||Annual Income||participants|Number|57|57.0||||||
4032719|NCT01143896|3854411|B1|Less than $20,000||Annual Income||participants|Number|60|60.0||||||
4032720|NCT01143896|3854409|B3|Other (divorced, widowed, separated, no response)||Marital Status||participants|Number|149|149.0||||||
4032721|NCT01143896|3854410|B2|Other (divorced, widowed, separated, no response)||Marital Status||participants|Number|63|63.0||||||
4032722|NCT01143896|3854411|B1|Other (divorced, widowed, separated, no response)||Marital Status||participants|Number|86|86.0||||||
4032723|NCT01143896|3854409|B3|Married||Marital Status||participants|Number|30|30.0||||||
4032724|NCT01143896|3854410|B2|Married||Marital Status||participants|Number|16|16.0||||||
4032725|NCT01143896|3854411|B1|Married||Marital Status||participants|Number|14|14.0||||||
4032726|NCT01143896|3854409|B3|Single, Never Married||Marital Status||participants|Number|113|113.0||||||
4032727|NCT01143896|3854410|B2|Single, Never Married||Marital Status||participants|Number|68|68.0||||||
4032728|NCT01143896|3854411|B1|Single, Never Married||Marital Status||participants|Number|45|45.0||||||
4032729|NCT01143896|3854409|B3|United States||Region of Enrollment||participants|Number|292|292.0||||||
4032730|NCT01143896|3854410|B2|United States||Region of Enrollment||participants|Number|147|147.0||||||
4032731|NCT01143896|3854411|B1|United States||Region of Enrollment||participants|Number|145|145.0||||||
4032732|NCT01143896|3854409|B3|Other||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4032733|NCT01143896|3854410|B2|Other||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4032734|NCT01143896|3854411|B1|Other||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4032735|NCT01143896|3854409|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|163|163.0||||||
4032736|NCT01143896|3854410|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|91|91.0||||||
4032737|NCT01143896|3854411|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
4032738|NCT01143896|3854409|B3|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|100|100.0||||||
4032739|NCT01143896|3854410|B2|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4032740|NCT01143896|3854411|B1|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
4032741|NCT01143896|3854409|B3||Male|Sex: Female, Male||Participants|Count of Participants|280|280.0||||||
4032742|NCT01143896|3854410|B2||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4032743|NCT01143896|3854411|B1||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4032744|NCT01143896|3854409|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4032745|NCT01143896|3854410|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4032746|NCT01143896|3854411|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4032747|NCT01143896|3854409|B3|||Age||years|Mean|59|59.0|Standard Deviation|5.5|5.5|||
4032748|NCT01143896|3854410|B2|||Age||years|Mean|59|59.0|Standard Deviation|5.2|5.2|||
4032749|NCT01143896|3854411|B1|||Age||years|Mean|59|59.0|Standard Deviation|5.8|5.8|||
4032750|NCT01143883|3854428|B3|United States||Region of Enrollment||participants|Number|110|110.0||||||
4032751|NCT01143883|3854429|B2|United States||Region of Enrollment||participants|Number|55|55.0||||||
4032752|NCT01143883|3854430|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4032753|NCT01143883|3854428|B3|Male||Gender||participants|Number|54|54.0||||||
4032754|NCT01143883|3854429|B2|Male||Gender||participants|Number|26|26.0||||||
4032755|NCT01143883|3854430|B1|Male||Gender||participants|Number|28|28.0||||||
4032756|NCT01143883|3854428|B3|Female||Gender||participants|Number|55|55.0||||||
4032757|NCT01143883|3854429|B2|Female||Gender||participants|Number|28|28.0||||||
4032758|NCT01143883|3854430|B1|Female||Gender||participants|Number|27|27.0||||||
4032759|NCT01143883|3854428|B3|||Age||years|Mean|60|60.0|Standard Deviation|13.7|13.7|||
4032760|NCT01143883|3854429|B2|||Age||years|Mean|58|58.0|Standard Deviation|11.1|11.1|||
4032761|NCT01143883|3854430|B1|||Age||years|Mean|62|62.0|Standard Deviation|15.6|15.6|||
4032762|NCT01143883|3854428|B3||>=65 years|Age||Participants|Count of Participants|58|58.0||||||
4032763|NCT01143883|3854429|B2||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4032764|NCT01143883|3854430|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4032765|NCT01143883|3854428|B3||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4032766|NCT01143883|3854429|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4032767|NCT01143883|3854430|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4032768|NCT01143883|3854428|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4032769|NCT01143883|3854429|B2||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4032770|NCT01143883|3854430|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4032771|NCT01143870|3854437|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4032772|NCT01143870|3854438|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4032773|NCT01143870|3854439|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4032774|NCT01143870|3854440|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4032775|NCT01143870|3854437|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032776|NCT01143870|3854438|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032777|NCT01143870|3854439|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032778|NCT01143870|3854440|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032779|NCT01143870|3854437|B4||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4032780|NCT01143870|3854438|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4032781|NCT01143870|3854439|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4032782|NCT01143870|3854440|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4032783|NCT01143870|3854437|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
4032784|NCT01143870|3854438|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4032785|NCT01143870|3854439|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4032786|NCT01143870|3854440|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4032787|NCT01143870|3854437|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032788|NCT01143870|3854438|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032789|NCT01143870|3854439|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032790|NCT01143870|3854440|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032791|NCT01143870|3854437|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032792|NCT01143870|3854438|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032793|NCT01143870|3854439|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032794|NCT01143870|3854440|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032795|NCT01143870|3854437|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032796|NCT01143870|3854438|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032797|NCT01143870|3854439|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032798|NCT01143870|3854440|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032799|NCT01143870|3854437|B4||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4032800|NCT01143870|3854438|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4032801|NCT01143870|3854439|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4032802|NCT01143870|3854440|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4032803|NCT01143870|3854437|B4||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4032804|NCT01143870|3854438|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4032805|NCT01143870|3854439|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4032806|NCT01143870|3854440|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4032807|NCT01143870|3854437|B4|||Age||years|Mean|56.4|56.4|Standard Deviation|1.9|1.9|||
4032808|NCT01143870|3854438|B3|||Age||years|Mean|55|55.0|Standard Deviation|3.5|3.5|||
4032809|NCT01143870|3854439|B2|||Age||years|Mean|57.8|57.8|Standard Deviation|3.1|3.1|||
4032810|NCT01143870|3854440|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|3.3|3.3|||
4032811|NCT01143818|3854450|B1|United Arab Emirates||Region of Enrollment||Participants|Number|10|10.0||||||
4032812|NCT01143818|3854450|B1|Romania||Region of Enrollment||Participants|Number|54|54.0||||||
4032813|NCT01143818|3854450|B1|Saudi Arabia||Region of Enrollment||Participants|Number|68|68.0||||||
4032814|NCT01143818|3854450|B1|Slovenia||Region of Enrollment||Participants|Number|87|87.0||||||
4032815|NCT01143818|3854450|B1|Germany||Region of Enrollment||Participants|Number|91|91.0||||||
4032816|NCT01143818|3854450|B1|Croatia||Region of Enrollment||Participants|Number|134|134.0||||||
4032817|NCT01143818|3854450|B1|Russian Federation||Region of Enrollment||Participants|Number|267|267.0||||||
4032818|NCT01143818|3854450|B1|Canada||Region of Enrollment||Participants|Number|338|338.0||||||
4032819|NCT01143818|3854450|B1||Male|Sex: Female, Male||Participants|Count of Participants|1049|1049.0||||||
4032820|NCT01143818|3854450|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4032821|NCT01143818|3854450|B1|||Age||years|Mean|53|53.0|Standard Deviation|12|12.0|||
4032822|NCT01143792|3854457|B4|United States||Region of Enrollment||participants|Number|270|270.0||||||
4032823|NCT01143792|3854458|B3|United States||Region of Enrollment||participants|Number|91|91.0||||||
4032824|NCT01143792|3854459|B2|United States||Region of Enrollment||participants|Number|86|86.0||||||
4032825|NCT01143792|3854460|B1|United States||Region of Enrollment||participants|Number|93|93.0||||||
4032826|NCT01143792|3854457|B4||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4032827|NCT01143792|3854458|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4032828|NCT01143792|3854459|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4032829|NCT01143792|3854460|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4032830|NCT01143792|3854457|B4||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4032831|NCT01143792|3854458|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4032832|NCT01143792|3854459|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4032833|NCT01143792|3854460|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4032834|NCT01143792|3854457|B4|||Age||years|Mean|18.7|18.7|Standard Deviation|1.3|1.3|||
4032835|NCT01143792|3854458|B3|||Age||years|Mean|18.84|18.84|Standard Deviation|1.11|1.11|||
4032836|NCT01143792|3854459|B2|||Age||years|Mean|18.69|18.69|Standard Deviation|1.32|1.32|||
4032837|NCT01143792|3854460|B1|||Age||years|Mean|18.70|18.7|Standard Deviation|1.34|1.34|||
4032838|NCT01143792|3854457|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4032839|NCT01143792|3854458|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4032840|NCT01143792|3854459|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4032841|NCT01143792|3854460|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4032842|NCT01143792|3854457|B4||Between 18 and 65 years|Age||Participants|Count of Participants|227|227.0||||||
4032843|NCT01143792|3854458|B3||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
4032844|NCT01143792|3854459|B2||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4032845|NCT01143792|3854460|B1||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
4032846|NCT01143792|3854457|B4||<=18 years|Age||Participants|Count of Participants|43|43.0||||||
4032847|NCT01143792|3854458|B3||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4032848|NCT01143792|3854459|B2||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4032849|NCT01143792|3854460|B1||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
4032850|NCT01143766|3854494|B3|United States||Region of Enrollment||participants|Number|56|56.0||||||
4032851|NCT01143766|3854495|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
4032852|NCT01143766|3854496|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4032853|NCT01143766|3854494|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4032854|NCT01143766|3854495|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4032855|NCT01143766|3854496|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4032856|NCT01143766|3854494|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4032857|NCT01143766|3854495|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4032858|NCT01143766|3854496|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4032859|NCT01143766|3854494|B3|||Age||years|Mean|48.6|48.6|Standard Deviation|14.5|14.5|||
4032860|NCT01143766|3854495|B2|||Age||years|Mean|48.1|48.1|Standard Deviation|12.8|12.8|||
4032861|NCT01143766|3854496|B1|||Age||years|Mean|49.1|49.1|Standard Deviation|16.6|16.6|||
4032862|NCT01143766|3854494|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4032863|NCT01143766|3854495|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4032864|NCT01143766|3854496|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4032865|NCT01143766|3854494|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4032866|NCT01143766|3854495|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4032867|NCT01143766|3854496|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4032868|NCT01143766|3854494|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4032869|NCT01143766|3854495|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4032870|NCT01143766|3854496|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4032871|NCT01143727|3854511|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4032872|NCT01143727|3854512|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4032873|NCT01143727|3854513|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4032874|NCT01143727|3854511|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4032875|NCT01143727|3854512|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4032876|NCT01143727|3854513|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4032877|NCT01143727|3854511|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4032878|NCT01143727|3854512|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4032879|NCT01143727|3854513|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4032880|NCT01143727|3854511|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|16.1|16.1|||
4032881|NCT01143727|3854512|B2|||Age||years|Mean|58.0|58.0|Standard Deviation|17.8|17.8|||
4032882|NCT01143727|3854513|B1|||Age||years|Mean|61.4|61.4|Standard Deviation|15.3|15.3|||
4032883|NCT01143727|3854511|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4032884|NCT01143727|3854512|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4032885|NCT01143727|3854513|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4032886|NCT01143727|3854511|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4032887|NCT01143727|3854512|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4032888|NCT01143727|3854513|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4032889|NCT01143727|3854511|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4032890|NCT01143727|3854512|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4032891|NCT01143727|3854513|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4032892|NCT01143714|3854522|B3|United States||Region of Enrollment||participants|Number|57|57.0||||||
4032893|NCT01143714|3854523|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4032894|NCT01143714|3854524|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4032895|NCT01143714|3854522|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4032896|NCT01143714|3854523|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4032897|NCT01143714|3854524|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4032898|NCT01143714|3854522|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4032899|NCT01143714|3854523|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4032900|NCT01143714|3854524|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4032901|NCT01143714|3854522|B3|||Age||years|Mean|59.9|59.9|Standard Deviation|10.9|10.9|||
4032902|NCT01143714|3854523|B2|||Age||years|Mean|59.9|59.9|Standard Deviation|12.4|12.4|||
4032903|NCT01143714|3854524|B1|||Age||years|Mean|60.0|60.0|Standard Deviation|9.4|9.4|||
4032904|NCT01143714|3854522|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4032905|NCT01143714|3854523|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4032906|NCT01143714|3854524|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4032907|NCT01143714|3854522|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4032908|NCT01143714|3854523|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4032909|NCT01143714|3854524|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4032910|NCT01143714|3854522|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4032911|NCT01143714|3854523|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4032912|NCT01143714|3854524|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4032913|NCT01143701|3854533|B3|United States||Region of Enrollment||participants|Number|577|577.0||||||
4032914|NCT01143701|3854534|B2|United States||Region of Enrollment||participants|Number|319|319.0||||||
4032915|NCT01143701|3854535|B1|United States||Region of Enrollment||participants|Number|258|258.0||||||
4032916|NCT01143701|3854533|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032917|NCT01143701|3854534|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032918|NCT01143701|3854535|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032919|NCT01143701|3854533|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
4032920|NCT01143701|3854534|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4032921|NCT01143701|3854535|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4032922|NCT01143701|3854533|B3||White|Race (NIH/OMB)||Participants|Count of Participants|378|378.0||||||
4032923|NCT01143701|3854534|B2||White|Race (NIH/OMB)||Participants|Count of Participants|191|191.0||||||
4032924|NCT01143701|3854535|B1||White|Race (NIH/OMB)||Participants|Count of Participants|187|187.0||||||
4032925|NCT01143701|3854533|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
4032926|NCT01143701|3854534|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4032927|NCT01143701|3854535|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4032928|NCT01143701|3854533|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032929|NCT01143701|3854534|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032930|NCT01143701|3854535|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032931|NCT01143701|3854533|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4032932|NCT01143701|3854534|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4032933|NCT01143701|3854535|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4032934|NCT01143701|3854533|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4032935|NCT01143701|3854534|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4032936|NCT01143701|3854535|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032937|NCT01143701|3854533|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032938|NCT01143701|3854534|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032939|NCT01143701|3854535|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032940|NCT01143701|3854533|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|564|564.0||||||
4032941|NCT01143701|3854534|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|312|312.0||||||
4032942|NCT01143701|3854535|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|252|252.0||||||
4032943|NCT01143701|3854533|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4032944|NCT01143701|3854534|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4032945|NCT01143701|3854535|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4032946|NCT01143701|3854533|B3||Male|Sex: Female, Male||Participants|Count of Participants|407|407.0||||||
4032947|NCT01143701|3854534|B2||Male|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
4032948|NCT01143701|3854535|B1||Male|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4032949|NCT01143701|3854533|B3||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4032950|NCT01143701|3854534|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4032951|NCT01143701|3854535|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4032952|NCT01143701|3854533|B3|||Age||Years|Mean|7.8|7.8|Standard Deviation|1.4|1.4|||
4032953|NCT01143701|3854534|B2|||Age||Years|Mean|7.8|7.8|Standard Deviation|1.4|1.4|||
4032954|NCT01143701|3854535|B1|||Age||Years|Mean|7.9|7.9|Standard Deviation|1.5|1.5|||
4032955|NCT01143688|3854544|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4032956|NCT01143688|3854544|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032957|NCT01143688|3854544|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4032958|NCT01143688|3854544|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4032959|NCT01143688|3854544|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032960|NCT01143688|3854544|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032961|NCT01143688|3854544|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4032962|NCT01143688|3854544|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4032963|NCT01143688|3854544|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4032964|NCT01143688|3854544|B1|||Age||years|Mean|41.5|41.5|Standard Deviation|17|17.0|||
4032965|NCT01143649|3854558|B6||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4032966|NCT01143649|3854559|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4032967|NCT01143649|3854560|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4032968|NCT01143649|3854561|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4032969|NCT01143649|3854562|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4032970|NCT01143649|3854563|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4032971|NCT01143649|3854558|B6||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4032972|NCT01143649|3854559|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4032973|NCT01143649|3854560|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4032974|NCT01143649|3854561|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4032975|NCT01143649|3854562|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4032976|NCT01143649|3854563|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4032977|NCT01143649|3854558|B6|||Age||years|Mean|35.75|35.75|Standard Deviation|11.69|11.69|||
4032978|NCT01143649|3854559|B5|||Age||years|Mean|35.83|35.83|Standard Deviation|18.65|18.65|||
4032979|NCT01143649|3854560|B4|||Age||years|Mean|20.4|20.4|Standard Deviation|1.7|1.7|||
4032980|NCT01143649|3854561|B3|||Age||years|Mean|20.4|20.4|Standard Deviation|1.7|1.7|||
4032981|NCT01143649|3854562|B2|||Age||years|Mean|50.8|50.8|Standard Deviation|14.9|14.9|||
4032982|NCT01143649|3854563|B1|||Age||years|Mean|42.5|42.5|Standard Deviation|12.8|12.8|||
4032983|NCT01143649|3854558|B6||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4032984|NCT01143649|3854559|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4032985|NCT01143649|3854560|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4032986|NCT01143649|3854561|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4032987|NCT01143649|3854562|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4032988|NCT01143649|3854563|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4032989|NCT01143649|3854558|B6||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4032990|NCT01143649|3854559|B5||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4032991|NCT01143649|3854560|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4032992|NCT01143649|3854561|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4032993|NCT01143649|3854562|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4032994|NCT01143649|3854563|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4032995|NCT01143649|3854558|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4032996|NCT01143649|3854559|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4032997|NCT01143649|3854560|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4032998|NCT01143649|3854561|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4032999|NCT01143649|3854562|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4033000|NCT01143649|3854563|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4033001|NCT01143636|3854582|B4|United States||Region of Enrollment||participants|Number|26|26.0||||||
4033002|NCT01143636|3854583|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4033003|NCT01143636|3854584|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4033004|NCT01143636|3854585|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4033005|NCT01143636|3854582|B4|Male||Sex/Gender, Customized||participants|Number|8|8.0||||||
4033006|NCT01143636|3854583|B3|Male||Sex/Gender, Customized||participants|Number|6|6.0||||||
4033007|NCT01143636|3854584|B2|Male||Sex/Gender, Customized||participants|Number|1|1.0||||||
4033008|NCT01143636|3854585|B1|Male||Sex/Gender, Customized||participants|Number|1|1.0||||||
4033009|NCT01143636|3854582|B4|Female||Sex/Gender, Customized||participants|Number|18|18.0||||||
4033010|NCT01143636|3854583|B3|Female||Sex/Gender, Customized||participants|Number|9|9.0||||||
4033011|NCT01143636|3854584|B2|Female||Sex/Gender, Customized||participants|Number|4|4.0||||||
4033012|NCT01143636|3854585|B1|Female||Sex/Gender, Customized||participants|Number|5|5.0||||||
4033013|NCT01143636|3854582|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4033014|NCT01143636|3854583|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4033015|NCT01143636|3854584|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4033016|NCT01143636|3854585|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4033017|NCT01143636|3854582|B4||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4033018|NCT01143636|3854583|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4033019|NCT01143636|3854584|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4033020|NCT01143636|3854585|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4033021|NCT01143636|3854582|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4033022|NCT01143636|3854583|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4033023|NCT01143636|3854584|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4033024|NCT01143636|3854585|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4033025|NCT01143610|3854616|B3|Brazil||Region of Enrollment||participants|Number|15|15.0||||||
4033026|NCT01143610|3854617|B2|Brazil||Region of Enrollment||participants|Number|8|8.0||||||
4033027|NCT01143610|3854618|B1|Brazil||Region of Enrollment||participants|Number|7|7.0||||||
4033028|NCT01143610|3854616|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4033029|NCT01143610|3854617|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4033030|NCT01143610|3854618|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4033031|NCT01143610|3854616|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4033032|NCT01143610|3854617|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4033033|NCT01143610|3854618|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4033034|NCT01143610|3854616|B3|||Age||years|Mean|41.26|41.26|Standard Deviation|3.39|3.39|||
4033035|NCT01143610|3854617|B2|||Age||years|Mean|41.5|41.5|Standard Deviation|2.67|2.67|||
4033036|NCT01143610|3854618|B1|||Age||years|Mean|41|41.0|Standard Deviation|4.24|4.24|||
4033037|NCT01143610|3854616|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4033038|NCT01143610|3854617|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4033039|NCT01143610|3854618|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4033040|NCT01143610|3854616|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4033041|NCT01143610|3854617|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4033042|NCT01143610|3854618|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4033043|NCT01143610|3854616|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4033044|NCT01143610|3854617|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4033045|NCT01143610|3854618|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4033046|NCT01143402|3854627|B4||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4033047|NCT01143402|3854628|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4033048|NCT01143402|3854629|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4033049|NCT01143402|3854630|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4033050|NCT01143402|3854627|B4||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4033051|NCT01143402|3854628|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4033052|NCT01143402|3854629|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4033053|NCT01143402|3854630|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4033054|NCT01143402|3854627|B4|||Age||years|Median|62|62.0|Full Range|||32.0|86.0|
4033055|NCT01143402|3854628|B3|||Age||years|Median|63|63.0|Full Range|||42.0|81.0|
4033056|NCT01143402|3854629|B2|||Age||years|Median|62|62.0|Full Range|||32.0|86.0|
4033057|NCT01143402|3854630|B1|||Age||years|Median|62|62.0|Full Range|||34.0|86.0|
4033058|NCT01143389|3854641|B3||Ectasia after refractive surgery|Keratoconus/ectasia classification|Patients with keratoconus were classified as mild, moderate, or severe based upon tomography imaging of the shape of the anterior corneal surface. The imaging device reports the keratometry (curvature) in the steep meridian and the orthogonal flat meridian. The keratoconus was classified as mild if the flat keratometry was less than 51 diopters. Keratoconus was classified as moderate if the flat keratometry was between 51 and 56 diopters or astigmatism exceeded 8 diopters. Keratoconus was classified as severe if the flat keratometry exceeded 56 diopters.|Participants|Count of Participants|104|104.0||||||
4033059|NCT01143389|3854642|B2||Ectasia after refractive surgery|Keratoconus/ectasia classification|Patients with keratoconus were classified as mild, moderate, or severe based upon tomography imaging of the shape of the anterior corneal surface. The imaging device reports the keratometry (curvature) in the steep meridian and the orthogonal flat meridian. The keratoconus was classified as mild if the flat keratometry was less than 51 diopters. Keratoconus was classified as moderate if the flat keratometry was between 51 and 56 diopters or astigmatism exceeded 8 diopters. Keratoconus was classified as severe if the flat keratometry exceeded 56 diopters.|Participants|Count of Participants|54|54.0||||||
4033060|NCT01143389|3854643|B1||Ectasia after refractive surgery|Keratoconus/ectasia classification|Patients with keratoconus were classified as mild, moderate, or severe based upon tomography imaging of the shape of the anterior corneal surface. The imaging device reports the keratometry (curvature) in the steep meridian and the orthogonal flat meridian. The keratoconus was classified as mild if the flat keratometry was less than 51 diopters. Keratoconus was classified as moderate if the flat keratometry was between 51 and 56 diopters or astigmatism exceeded 8 diopters. Keratoconus was classified as severe if the flat keratometry exceeded 56 diopters.|Participants|Count of Participants|50|50.0||||||
4033061|NCT01143389|3854641|B3||Keratoconus severe (flat K >56D by tomography)|Keratoconus/ectasia classification|Patients with keratoconus were classified as mild, moderate, or severe based upon tomography imaging of the shape of the anterior corneal surface. The imaging device reports the keratometry (curvature) in the steep meridian and the orthogonal flat meridian. The keratoconus was classified as mild if the flat keratometry was less than 51 diopters. Keratoconus was classified as moderate if the flat keratometry was between 51 and 56 diopters or astigmatism exceeded 8 diopters. Keratoconus was classified as severe if the flat keratometry exceeded 56 diopters.|Participants|Count of Participants|41|41.0||||||
4033062|NCT01143389|3854642|B2||Keratoconus severe (flat K >56D by tomography)|Keratoconus/ectasia classification|Patients with keratoconus were classified as mild, moderate, or severe based upon tomography imaging of the shape of the anterior corneal surface. The imaging device reports the keratometry (curvature) in the steep meridian and the orthogonal flat meridian. The keratoconus was classified as mild if the flat keratometry was less than 51 diopters. Keratoconus was classified as moderate if the flat keratometry was between 51 and 56 diopters or astigmatism exceeded 8 diopters. Keratoconus was classified as severe if the flat keratometry exceeded 56 diopters.|Participants|Count of Participants|21|21.0||||||
4033063|NCT01143389|3854643|B1||Keratoconus severe (flat K >56D by tomography)|Keratoconus/ectasia classification|Patients with keratoconus were classified as mild, moderate, or severe based upon tomography imaging of the shape of the anterior corneal surface. The imaging device reports the keratometry (curvature) in the steep meridian and the orthogonal flat meridian. The keratoconus was classified as mild if the flat keratometry was less than 51 diopters. Keratoconus was classified as moderate if the flat keratometry was between 51 and 56 diopters or astigmatism exceeded 8 diopters. Keratoconus was classified as severe if the flat keratometry exceeded 56 diopters.|Participants|Count of Participants|20|20.0||||||
4033064|NCT01143389|3854641|B3||Keratoconus moderate|Keratoconus/ectasia classification|Patients with keratoconus were classified as mild, moderate, or severe based upon tomography imaging of the shape of the anterior corneal surface. The imaging device reports the keratometry (curvature) in the steep meridian and the orthogonal flat meridian. The keratoconus was classified as mild if the flat keratometry was less than 51 diopters. Keratoconus was classified as moderate if the flat keratometry was between 51 and 56 diopters or astigmatism exceeded 8 diopters. Keratoconus was classified as severe if the flat keratometry exceeded 56 diopters.|Participants|Count of Participants|86|86.0||||||
4033065|NCT01143389|3854642|B2||Keratoconus moderate|Keratoconus/ectasia classification|Patients with keratoconus were classified as mild, moderate, or severe based upon tomography imaging of the shape of the anterior corneal surface. The imaging device reports the keratometry (curvature) in the steep meridian and the orthogonal flat meridian. The keratoconus was classified as mild if the flat keratometry was less than 51 diopters. Keratoconus was classified as moderate if the flat keratometry was between 51 and 56 diopters or astigmatism exceeded 8 diopters. Keratoconus was classified as severe if the flat keratometry exceeded 56 diopters.|Participants|Count of Participants|43|43.0||||||
4033066|NCT01143389|3854643|B1||Keratoconus moderate|Keratoconus/ectasia classification|Patients with keratoconus were classified as mild, moderate, or severe based upon tomography imaging of the shape of the anterior corneal surface. The imaging device reports the keratometry (curvature) in the steep meridian and the orthogonal flat meridian. The keratoconus was classified as mild if the flat keratometry was less than 51 diopters. Keratoconus was classified as moderate if the flat keratometry was between 51 and 56 diopters or astigmatism exceeded 8 diopters. Keratoconus was classified as severe if the flat keratometry exceeded 56 diopters.|Participants|Count of Participants|43|43.0||||||
4033067|NCT01143389|3854641|B3||Keratoconus mild (flat K <51D and astigmatism <8D)|Keratoconus/ectasia classification|Patients with keratoconus were classified as mild, moderate, or severe based upon tomography imaging of the shape of the anterior corneal surface. The imaging device reports the keratometry (curvature) in the steep meridian and the orthogonal flat meridian. The keratoconus was classified as mild if the flat keratometry was less than 51 diopters. Keratoconus was classified as moderate if the flat keratometry was between 51 and 56 diopters or astigmatism exceeded 8 diopters. Keratoconus was classified as severe if the flat keratometry exceeded 56 diopters.|Participants|Count of Participants|279|279.0||||||
4033119|NCT01143337|3854657|B2|40 - 50 years||Age, Customized||participants|Number|7|7.0||||||
4033120|NCT01143337|3854658|B1|40 - 50 years||Age, Customized||participants|Number|9|9.0||||||
4033068|NCT01143389|3854642|B2||Keratoconus mild (flat K <51D and astigmatism <8D)|Keratoconus/ectasia classification|Patients with keratoconus were classified as mild, moderate, or severe based upon tomography imaging of the shape of the anterior corneal surface. The imaging device reports the keratometry (curvature) in the steep meridian and the orthogonal flat meridian. The keratoconus was classified as mild if the flat keratometry was less than 51 diopters. Keratoconus was classified as moderate if the flat keratometry was between 51 and 56 diopters or astigmatism exceeded 8 diopters. Keratoconus was classified as severe if the flat keratometry exceeded 56 diopters.|Participants|Count of Participants|139|139.0||||||
4033069|NCT01143389|3854643|B1||Keratoconus mild (flat K <51D and astigmatism <8D)|Keratoconus/ectasia classification|Patients with keratoconus were classified as mild, moderate, or severe based upon tomography imaging of the shape of the anterior corneal surface. The imaging device reports the keratometry (curvature) in the steep meridian and the orthogonal flat meridian. The keratoconus was classified as mild if the flat keratometry was less than 51 diopters. Keratoconus was classified as moderate if the flat keratometry was between 51 and 56 diopters or astigmatism exceeded 8 diopters. Keratoconus was classified as severe if the flat keratometry exceeded 56 diopters.|Participants|Count of Participants|140|140.0||||||
4033070|NCT01143389|3854641|B3|United States||Region of Enrollment||participants|Number|510|510.0||||||
4033071|NCT01143389|3854642|B2|United States||Region of Enrollment||participants|Number|257|257.0||||||
4033072|NCT01143389|3854643|B1|United States||Region of Enrollment||participants|Number|253|253.0||||||
4033073|NCT01143389|3854641|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033074|NCT01143389|3854642|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033075|NCT01143389|3854643|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033076|NCT01143389|3854641|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033077|NCT01143389|3854642|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033078|NCT01143389|3854643|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033079|NCT01143389|3854641|B3||White|Race (NIH/OMB)||Participants|Count of Participants|435|435.0||||||
4033080|NCT01143389|3854642|B2||White|Race (NIH/OMB)||Participants|Count of Participants|220|220.0||||||
4033081|NCT01143389|3854643|B1||White|Race (NIH/OMB)||Participants|Count of Participants|215|215.0||||||
4033082|NCT01143389|3854641|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4033083|NCT01143389|3854642|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4033084|NCT01143389|3854643|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4033085|NCT01143389|3854641|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033086|NCT01143389|3854642|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033087|NCT01143389|3854643|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033088|NCT01143389|3854641|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4033089|NCT01143389|3854642|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4033090|NCT01143389|3854643|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4033091|NCT01143389|3854641|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033092|NCT01143389|3854642|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033093|NCT01143389|3854643|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033094|NCT01143389|3854641|B3||Male|Sex: Female, Male||Participants|Count of Participants|387|387.0||||||
4033095|NCT01143389|3854642|B2||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4033096|NCT01143389|3854643|B1||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4033097|NCT01143389|3854641|B3||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4033098|NCT01143389|3854642|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4033099|NCT01143389|3854643|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4033100|NCT01143389|3854641|B3|||Age||years|Mean|32|32.0|Standard Deviation|13|13.0|||
4033101|NCT01143389|3854642|B2|||Age||years|Mean|32|32.0|Standard Deviation|13|13.0|||
4033102|NCT01143389|3854643|B1|||Age||years|Mean|32|32.0|Standard Deviation|12|12.0|||
4033103|NCT01143337|3854656|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4033104|NCT01143337|3854657|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4033105|NCT01143337|3854658|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4033106|NCT01143337|3854656|B3||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4033107|NCT01143337|3854657|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4033108|NCT01143337|3854658|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4033109|NCT01143337|3854656|B3|≧ 70 years||Age, Customized||participants|Number|11|11.0||||||
4033110|NCT01143337|3854657|B2|≧ 70 years||Age, Customized||participants|Number|7|7.0||||||
4033111|NCT01143337|3854658|B1|≧ 70 years||Age, Customized||participants|Number|4|4.0||||||
4033112|NCT01143337|3854656|B3|60 - 70 years||Age, Customized||participants|Number|27|27.0||||||
4033113|NCT01143337|3854657|B2|60 - 70 years||Age, Customized||participants|Number|12|12.0||||||
4033114|NCT01143337|3854658|B1|60 - 70 years||Age, Customized||participants|Number|15|15.0||||||
4033115|NCT01143337|3854656|B3|50 - 60 years||Age, Customized||participants|Number|26|26.0||||||
4033116|NCT01143337|3854657|B2|50 - 60 years||Age, Customized||participants|Number|13|13.0||||||
4033117|NCT01143337|3854658|B1|50 - 60 years||Age, Customized||participants|Number|13|13.0||||||
4033118|NCT01143337|3854656|B3|40 - 50 years||Age, Customized||participants|Number|16|16.0||||||
4033121|NCT01143337|3854656|B3|< 40 years||Age, Customized||participants|Number|13|13.0||||||
4033122|NCT01143337|3854657|B2|< 40 years||Age, Customized||participants|Number|8|8.0||||||
4033123|NCT01143337|3854658|B1|< 40 years||Age, Customized||participants|Number|5|5.0||||||
4033124|NCT01143324|3854674|B1|Netherlands||Region of Enrollment|In total, 255 patients were enrolled, from which 3 patients were not submitted to a minimally invasive MAST fusion and therefore 252 patients were treated and analyzed.|Participants|Number|16|16.0||||||
4033125|NCT01143324|3854674|B1|Germany||Region of Enrollment|In total, 255 patients were enrolled, from which 3 patients were not submitted to a minimally invasive MAST fusion and therefore 252 patients were treated and analyzed.|Participants|Number|81|81.0||||||
4033126|NCT01143324|3854674|B1|Kuwait||Region of Enrollment|In total, 255 patients were enrolled, from which 3 patients were not submitted to a minimally invasive MAST fusion and therefore 252 patients were treated and analyzed.|Participants|Number|0|0.0||||||
4033127|NCT01143324|3854674|B1|Poland||Region of Enrollment|In total, 255 patients were enrolled, from which 3 patients were not submitted to a minimally invasive MAST fusion and therefore 252 patients were treated and analyzed.|Participants|Number|4|4.0||||||
4033128|NCT01143324|3854674|B1|Belgium||Region of Enrollment|In total, 255 patients were enrolled, from which 3 patients were not submitted to a minimally invasive MAST fusion and therefore 252 patients were treated and analyzed.|Participants|Number|15|15.0||||||
4033129|NCT01143324|3854674|B1|Canada||Region of Enrollment|In total, 255 patients were enrolled, from which 3 patients were not submitted to a minimally invasive MAST fusion and therefore 252 patients were treated and analyzed.|Participants|Number|14|14.0||||||
4033130|NCT01143324|3854674|B1|Czech Republic||Region of Enrollment|In total, 255 patients were enrolled, from which 3 patients were not submitted to a minimally invasive MAST fusion and therefore 252 patients were treated and analyzed.|Participants|Number|40|40.0||||||
4033131|NCT01143324|3854674|B1|United Kingdom||Region of Enrollment|In total, 255 patients were enrolled, from which 3 patients were not submitted to a minimally invasive MAST fusion and therefore 252 patients were treated and analyzed.|Participants|Number|11|11.0||||||
4033132|NCT01143324|3854674|B1|Italy||Region of Enrollment|In total, 255 patients were enrolled, from which 3 patients were not submitted to a minimally invasive MAST fusion and therefore 252 patients were treated and analyzed.|Participants|Number|16|16.0||||||
4033133|NCT01143324|3854674|B1|Israel||Region of Enrollment|In total, 255 patients were enrolled, from which 3 patients were not submitted to a minimally invasive MAST fusion and therefore 252 patients were treated and analyzed.|Participants|Number|8|8.0||||||
4033134|NCT01143324|3854674|B1|Austria||Region of Enrollment|In total, 255 patients were enrolled, from which 3 patients were not submitted to a minimally invasive MAST fusion and therefore 252 patients were treated and analyzed.|Participants|Number|25|25.0||||||
4033135|NCT01143324|3854674|B1|Spain||Region of Enrollment|In total, 255 patients were enrolled, from which 3 patients were not submitted to a minimally invasive MAST fusion and therefore 252 patients were treated and analyzed.|Participants|Number|4|4.0||||||
4033136|NCT01143324|3854674|B1|Greece||Region of Enrollment|In total, 255 patients were enrolled, from which 3 patients were not submitted to a minimally invasive MAST fusion and therefore 252 patients were treated and analyzed.|Participants|Number|1|1.0||||||
4033137|NCT01143324|3854674|B1|Slovakia||Region of Enrollment|In total, 255 patients were enrolled, from which 3 patients were not submitted to a minimally invasive MAST fusion and therefore 252 patients were treated and analyzed.|Participants|Number|7|7.0||||||
4033138|NCT01143324|3854674|B1|Portugal||Region of Enrollment|In total, 255 patients were enrolled, from which 3 patients were not submitted to a minimally invasive MAST fusion and therefore 252 patients were treated and analyzed.|Participants|Number|10|10.0||||||
4033139|NCT01143324|3854674|B1||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4033140|NCT01143324|3854674|B1||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4033141|NCT01143324|3854674|B1|||Age||years|Mean|53.8|53.8|Standard Deviation|11.8|11.8|||
4033142|NCT01143272|3854690|B3|||Leukocyte count||10^9 cells/L|Mean|10.8|10.8|Standard Deviation|5.7|5.7|||
4033143|NCT01143272|3854691|B2|||Leukocyte count||10^9 cells/L|Mean|11.4|11.4|Standard Deviation|6.7|6.7|||
4033144|NCT01143272|3854692|B1|||Leukocyte count||10^9 cells/L|Mean|10.3|10.3|Standard Deviation|4.6|4.6|||
4033145|NCT01143272|3854690|B3|||C-reactive protein (CRP)||mg/L|Mean|71.6|71.6|Standard Deviation|93.9|93.9|||
4033146|NCT01143272|3854691|B2|||C-reactive protein (CRP)||mg/L|Mean|72.2|72.2|Standard Deviation|98.9|98.9|||
4033147|NCT01143272|3854692|B1|||C-reactive protein (CRP)||mg/L|Mean|71.0|71.0|Standard Deviation|89.3|89.3|||
4033148|NCT01143272|3854690|B3|||Body mass index||kg/m^2|Mean|28.1|28.1|Standard Deviation|5.4|5.4|||
4033149|NCT01143272|3854691|B2|||Body mass index||kg/m^2|Mean|28.1|28.1|Standard Deviation|5.6|5.6|||
4033150|NCT01143272|3854692|B1|||Body mass index||kg/m^2|Mean|28.1|28.1|Standard Deviation|5.2|5.2|||
4033151|NCT01143272|3854690|B3|||Body weight||kg|Mean|83.0|83.0|Standard Deviation|17.5|17.5|||
4033152|NCT01143272|3854691|B2|||Body weight||kg|Mean|83.0|83.0|Standard Deviation|18.1|18.1|||
4033153|NCT01143272|3854692|B1|||Body weight||kg|Mean|83.1|83.1|Standard Deviation|17.0|17.0|||
4033154|NCT01143272|3854690|B3|||Body height||cm|Mean|171.7|171.7|Standard Deviation|9.7|9.7|||
4033155|NCT01143272|3854691|B2|||Body height||cm|Mean|171.7|171.7|Standard Deviation|10.0|10.0|||
4033156|NCT01143272|3854692|B1|||Body height||cm|Mean|171.8|171.8|Standard Deviation|9.4|9.4|||
4033157|NCT01143272|3854690|B3|Germany||Region of Enrollment||participants|Number|477|477.0||||||
4033158|NCT01143272|3854691|B2|Germany||Region of Enrollment||participants|Number|231|231.0||||||
4033159|NCT01143272|3854692|B1|Germany||Region of Enrollment||participants|Number|246|246.0||||||
4033160|NCT01143272|3854690|B3||Male|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
4033161|NCT01143272|3854691|B2||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4033162|NCT01143272|3854692|B1||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4033163|NCT01143272|3854690|B3||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4033164|NCT01143272|3854691|B2||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4033165|NCT01143272|3854692|B1||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4033166|NCT01143272|3854690|B3|||Age||years|Mean|58.4|58.4|Standard Deviation|17.2|17.2|||
4033167|NCT01143272|3854691|B2|||Age||years|Mean|56.5|56.5|Standard Deviation|17.8|17.8|||
4033168|NCT01143272|3854692|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|16.5|16.5|||
4033169|NCT01143259|3854711|B3|||Total Cases Using An Open Approach|This only includes those surgical cases that were used in the analysis of the study which had surgery with an open approach versus laparoscopic.|Cases|Number|68|68.0||||||
4033170|NCT01143259|3854712|B2|||Total Cases Using An Open Approach|This only includes those surgical cases that were used in the analysis of the study which had surgery with an open approach versus laparoscopic.|Cases|Number|25|25.0||||||
4033171|NCT01143259|3854713|B1|||Total Cases Using An Open Approach|This only includes those surgical cases that were used in the analysis of the study which had surgery with an open approach versus laparoscopic.|Cases|Number|43|43.0||||||
4033172|NCT01143259|3854711|B3|||Mean BMI||Kg/M^2|Median|28|28.0|Full Range|||16.0|60.0|
4033173|NCT01143259|3854712|B2|||Mean BMI||Kg/M^2|Median|29|29.0|Full Range|||19.0|51.0|
4033174|NCT01143259|3854713|B1|||Mean BMI||Kg/M^2|Median|28|28.0|Full Range|||16.0|60.0|
4033175|NCT01143259|3854711|B3|United States||Region of Enrollment||participants|Number|274|274.0||||||
4033176|NCT01143259|3854712|B2|United States||Region of Enrollment||participants|Number|138|138.0||||||
4033177|NCT01143259|3854713|B1|United States||Region of Enrollment||participants|Number|136|136.0||||||
4033178|NCT01143259|3854711|B3||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4033179|NCT01143259|3854712|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4033180|NCT01143259|3854713|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4033181|NCT01143259|3854711|B3||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4033182|NCT01143259|3854712|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4033183|NCT01143259|3854713|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4033184|NCT01143259|3854711|B3|Age||Age, Customized||years|Mean|61|61.0|Full Range|||18.0|89.0|
4033185|NCT01143259|3854712|B2|Age||Age, Customized||years|Mean|61|61.0|Full Range|||18.0|87.0|
4033186|NCT01143259|3854713|B1|Age||Age, Customized||years|Mean|61|61.0|Full Range|||20.0|89.0|
4033187|NCT01143207|3854722|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4033188|NCT01143207|3854722|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4033189|NCT01143207|3854722|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4033190|NCT01143207|3854722|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4033191|NCT01143207|3854722|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4033192|NCT01143207|3854722|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4033193|NCT01143142|3854731|B3|United States||Region of Enrollment||participants|Number|70|70.0||||||
4033194|NCT01143142|3854732|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
4033195|NCT01143142|3854733|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4033196|NCT01143142|3854731|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4033197|NCT01143142|3854732|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4033198|NCT01143142|3854733|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4033199|NCT01143142|3854731|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033200|NCT01143142|3854732|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033201|NCT01143142|3854733|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033202|NCT01143142|3854731|B3||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4033203|NCT01143142|3854732|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4033204|NCT01143142|3854733|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4033205|NCT01143142|3854731|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4033206|NCT01143142|3854732|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4033207|NCT01143142|3854733|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4033208|NCT01143142|3854731|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033209|NCT01143142|3854732|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033210|NCT01143142|3854733|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033211|NCT01143142|3854731|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4033212|NCT01143142|3854732|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4033213|NCT01143142|3854733|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033214|NCT01143142|3854731|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033215|NCT01143142|3854732|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033216|NCT01143142|3854733|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033217|NCT01143142|3854731|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4033218|NCT01143142|3854732|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4033219|NCT01143142|3854733|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4033220|NCT01143142|3854731|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4033221|NCT01143142|3854732|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4033222|NCT01143142|3854733|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4033223|NCT01143142|3854731|B3|||Age||years|Mean|40|40.0|Full Range|||32.0|60.0|
4033224|NCT01143142|3854732|B2|||Age||years|Mean|40|40.0|Full Range|||32.0|60.0|
4033225|NCT01143142|3854733|B1|||Age||years|Mean|40|40.0|Full Range|||38.0|55.0|
4033226|NCT01143090|3854742|B1|United States||Region of Enrollment|One enrolled subject did not receive any study medication and was excluded from this summary.|participants|Number|148|148.0||||||
4033227|NCT01143090|3854742|B1||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4033228|NCT01143090|3854742|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4033229|NCT01143090|3854742|B1|||Age||years|Mean|42.8|42.8|Standard Deviation|11.1|11.1|||
4033230|NCT01143090|3854742|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4033231|NCT01143090|3854742|B1||Between 18 and 65 years|Age||Participants|Count of Participants|146|146.0||||||
4033232|NCT01143090|3854742|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4033233|NCT01143077|3854746|B4|United States||Region of Enrollment|244 patients were randomized, 240 received study medication.|participants|Number|240|240.0||||||
4033234|NCT01143077|3854747|B3|United States||Region of Enrollment|244 patients were randomized, 240 received study medication.|participants|Number|81|81.0||||||
4033235|NCT01143077|3854748|B2|United States||Region of Enrollment|244 patients were randomized, 240 received study medication.|participants|Number|87|87.0||||||
4033236|NCT01143077|3854749|B1|United States||Region of Enrollment|244 patients were randomized, 240 received study medication.|participants|Number|72|72.0||||||
4033237|NCT01143077|3854746|B4||Male|Sex: Female, Male|244 patients were randomized, 240 received study medication.|Participants|Count of Participants|156|156.0||||||
4033238|NCT01143077|3854747|B3||Male|Sex: Female, Male|244 patients were randomized, 240 received study medication.|Participants|Count of Participants|59|59.0||||||
4033239|NCT01143077|3854748|B2||Male|Sex: Female, Male|244 patients were randomized, 240 received study medication.|Participants|Count of Participants|50|50.0||||||
4033240|NCT01143077|3854749|B1||Male|Sex: Female, Male|244 patients were randomized, 240 received study medication.|Participants|Count of Participants|47|47.0||||||
4033241|NCT01143077|3854746|B4||Female|Sex: Female, Male|244 patients were randomized, 240 received study medication.|Participants|Count of Participants|84|84.0||||||
4033242|NCT01143077|3854747|B3||Female|Sex: Female, Male|244 patients were randomized, 240 received study medication.|Participants|Count of Participants|22|22.0||||||
4033243|NCT01143077|3854748|B2||Female|Sex: Female, Male|244 patients were randomized, 240 received study medication.|Participants|Count of Participants|37|37.0||||||
4033244|NCT01143077|3854749|B1||Female|Sex: Female, Male|244 patients were randomized, 240 received study medication.|Participants|Count of Participants|25|25.0||||||
4033245|NCT01143077|3854746|B4|||Age|244 patients were randomized, 240 received study medication.|years|Mean|43.9|43.9|Standard Deviation|10.9|10.9|||
4033246|NCT01143077|3854747|B3|||Age|244 patients were randomized, 240 received study medication.|years|Mean|44.4|44.4|Standard Deviation|10.0|10.0|||
4033247|NCT01143077|3854748|B2|||Age|244 patients were randomized, 240 received study medication.|years|Mean|44.0|44.0|Standard Deviation|11.5|11.5|||
4033248|NCT01143077|3854749|B1|||Age|244 patients were randomized, 240 received study medication.|years|Mean|43.2|43.2|Standard Deviation|11.3|11.3|||
4033249|NCT01143077|3854746|B4||>=65 years|Age|244 patients were randomized, 240 received study medication.|Participants|Count of Participants|1|1.0||||||
4033250|NCT01143077|3854747|B3||>=65 years|Age|244 patients were randomized, 240 received study medication.|Participants|Count of Participants|0|0.0||||||
4033251|NCT01143077|3854748|B2||>=65 years|Age|244 patients were randomized, 240 received study medication.|Participants|Count of Participants|1|1.0||||||
4033252|NCT01143077|3854749|B1||>=65 years|Age|244 patients were randomized, 240 received study medication.|Participants|Count of Participants|0|0.0||||||
4033253|NCT01143077|3854746|B4||Between 18 and 65 years|Age|244 patients were randomized, 240 received study medication.|Participants|Count of Participants|237|237.0||||||
4033254|NCT01143077|3854747|B3||Between 18 and 65 years|Age|244 patients were randomized, 240 received study medication.|Participants|Count of Participants|81|81.0||||||
4033255|NCT01143077|3854748|B2||Between 18 and 65 years|Age|244 patients were randomized, 240 received study medication.|Participants|Count of Participants|85|85.0||||||
4033256|NCT01143077|3854749|B1||Between 18 and 65 years|Age|244 patients were randomized, 240 received study medication.|Participants|Count of Participants|71|71.0||||||
4033257|NCT01143077|3854746|B4||<=18 years|Age|244 patients were randomized, 240 received study medication.|Participants|Count of Participants|2|2.0||||||
4033258|NCT01143077|3854747|B3||<=18 years|Age|244 patients were randomized, 240 received study medication.|Participants|Count of Participants|0|0.0||||||
4033259|NCT01143077|3854748|B2||<=18 years|Age|244 patients were randomized, 240 received study medication.|Participants|Count of Participants|1|1.0||||||
4033260|NCT01143077|3854749|B1||<=18 years|Age|244 patients were randomized, 240 received study medication.|Participants|Count of Participants|1|1.0||||||
4033261|NCT01143051|3854762|B7|United States||Region of Enrollment||participants|Number|24|24.0||||||
4033262|NCT01143051|3854763|B6|United States||Region of Enrollment||participants|Number|4|4.0||||||
4033263|NCT01143051|3854764|B5|United States||Region of Enrollment||participants|Number|4|4.0||||||
4033264|NCT01143051|3854765|B4|United States||Region of Enrollment||participants|Number|4|4.0||||||
4033265|NCT01143051|3854766|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4033266|NCT01143051|3854767|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4033267|NCT01143051|3854768|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4033268|NCT01143051|3854762|B7||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4033269|NCT01143051|3854763|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4033270|NCT01143051|3854764|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4033271|NCT01143051|3854765|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4033272|NCT01143051|3854766|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4033273|NCT01143051|3854767|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4033274|NCT01143051|3854768|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4033275|NCT01143051|3854762|B7||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4033276|NCT01143051|3854763|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4033277|NCT01143051|3854764|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4033278|NCT01143051|3854765|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4033279|NCT01143051|3854766|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4033280|NCT01143051|3854767|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4033281|NCT01143051|3854768|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4033282|NCT01143051|3854762|B7|||Age||years|Mean|23.7|23.7|Standard Deviation|3.01|3.01|||
4033283|NCT01143051|3854763|B6|||Age||years|Mean|22.0|22.0|Standard Deviation|3.56|3.56|||
4033284|NCT01143051|3854764|B5|||Age||years|Mean|25.3|25.3|Standard Deviation|0.50|0.5|||
4033285|NCT01143051|3854765|B4|||Age||years|Mean|21.8|21.8|Standard Deviation|1.71|1.71|||
4033286|NCT01143051|3854766|B3|||Age||years|Mean|24.0|24.0|Standard Deviation|3.37|3.37|||
4033287|NCT01143051|3854767|B2|||Age||years|Mean|25.3|25.3|Standard Deviation|4.27|4.27|||
4033288|NCT01143051|3854768|B1|||Age||years|Mean|24.0|24.0|Standard Deviation|2.94|2.94|||
4033289|NCT01143051|3854762|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4033290|NCT01143051|3854763|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4033291|NCT01143051|3854764|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4033292|NCT01143051|3854765|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4033293|NCT01143051|3854766|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4033294|NCT01143051|3854767|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4033295|NCT01143051|3854768|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4033296|NCT01143051|3854762|B7||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4033297|NCT01143051|3854763|B6||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4033298|NCT01143051|3854764|B5||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4033299|NCT01143051|3854765|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4033300|NCT01143051|3854766|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4033301|NCT01143051|3854767|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4033302|NCT01143051|3854768|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4033303|NCT01143051|3854762|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4033304|NCT01143051|3854763|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4033305|NCT01143051|3854764|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4033306|NCT01143051|3854765|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4033307|NCT01143051|3854766|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4033308|NCT01143051|3854767|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4033309|NCT01143051|3854768|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4033310|NCT01143038|3854822|B1|||Platelet Count at Screening||x 10^9/L|Mean|19.78|19.78|Standard Deviation|15.80|15.8|||
4033311|NCT01143038|3854822|B1|||Time since ITP diagnosis||months|Median|2.2|2.2|Full Range|||0.1|6.6|
4033312|NCT01143038|3854822|B1|Not Hispanic/Latino||Ethnicity||participants|Number|69|69.0||||||
4033313|NCT01143038|3854822|B1|Hispanic/Latino||Ethnicity||participants|Number|6|6.0||||||
4033314|NCT01143038|3854822|B1|Unknown||Race||participants|Number|1|1.0||||||
4033315|NCT01143038|3854822|B1|Other||Race||participants|Number|0|0.0||||||
4033316|NCT01143038|3854822|B1|White||Race||participants|Number|72|72.0||||||
4033317|NCT01143038|3854822|B1|Native Hawaiian or Other Pacific Islander||Race||participants|Number|0|0.0||||||
4033318|NCT01143038|3854822|B1|Black (or African American)||Race||participants|Number|1|1.0||||||
4033319|NCT01143038|3854822|B1|Asian||Race||participants|Number|1|1.0||||||
4033320|NCT01143038|3854822|B1|American Indian or Alaska Native||Race||participants|Number|0|0.0||||||
4033321|NCT01143038|3854822|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4033322|NCT01143038|3854822|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4033323|NCT01143038|3854822|B1|||Age||years|Mean|44.5|44.5|Standard Deviation|18.7|18.7|||
4033324|NCT01142908|3854830|B3|United States||Region of Enrollment||participants|Number|428|428.0||||||
4033325|NCT01142908|3854831|B2|United States||Region of Enrollment||participants|Number|213|213.0||||||
4033326|NCT01142908|3854832|B1|United States||Region of Enrollment||participants|Number|215|215.0||||||
4033327|NCT01142908|3854830|B3|Refused/Missing||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4033328|NCT01142908|3854831|B2|Refused/Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4033329|NCT01142908|3854832|B1|Refused/Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4033330|NCT01142908|3854830|B3|Other||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4033331|NCT01142908|3854831|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4033332|NCT01142908|3854832|B1|Other||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4033333|NCT01142908|3854830|B3|Black||Race/Ethnicity, Customized||participants|Number|213|213.0||||||
4033334|NCT01142908|3854831|B2|Black||Race/Ethnicity, Customized||participants|Number|102|102.0||||||
4033335|NCT01142908|3854832|B1|Black||Race/Ethnicity, Customized||participants|Number|111|111.0||||||
4033336|NCT01142908|3854830|B3|White||Race/Ethnicity, Customized||participants|Number|199|199.0||||||
4033337|NCT01142908|3854831|B2|White||Race/Ethnicity, Customized||participants|Number|106|106.0||||||
4033338|NCT01142908|3854832|B1|White||Race/Ethnicity, Customized||participants|Number|93|93.0||||||
4033339|NCT01142908|3854830|B3||Male|Sex: Female, Male||Participants|Count of Participants|363|363.0||||||
4033340|NCT01142908|3854831|B2||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4033341|NCT01142908|3854832|B1||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4033342|NCT01142908|3854830|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4033343|NCT01142908|3854831|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4033344|NCT01142908|3854832|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4033345|NCT01142908|3854830|B3|||Age||years|Mean|61.2|61.2|Standard Deviation|8.7|8.7|||
4033346|NCT01142908|3854831|B2|||Age||years|Mean|61.5|61.5|Standard Deviation|8.9|8.9|||
4033347|NCT01142908|3854832|B1|||Age||years|Mean|60.9|60.9|Standard Deviation|8.4|8.4|||
4033348|NCT01142726|3854879|B4|||Swollen joint count||Joints|Mean|16.5|16.5|Standard Deviation|12.35|12.35|||
4033349|NCT01142726|3854880|B3|||Swollen joint count||Joints|Mean|15.7|15.7|Standard Deviation|11.78|11.78|||
4033350|NCT01142726|3854881|B2|||Swollen joint count||Joints|Mean|17.2|17.2|Standard Deviation|12.88|12.88|||
4033351|NCT01142726|3854882|B1|||Swollen joint count||Joints|Mean|16.5|16.5|Standard Deviation|12.43|12.43|||
4033352|NCT01142726|3854879|B4|||Tender joint count||Joints|Mean|23.3|23.3|Standard Deviation|14.77|14.77|||
4033353|NCT01142726|3854880|B3|||Tender joint count||Joints|Mean|21.7|21.7|Standard Deviation|14.00|14.0|||
4033354|NCT01142726|3854881|B2|||Tender joint count||Joints|Mean|23.9|23.9|Standard Deviation|14.47|14.47|||
4033355|NCT01142726|3854882|B1|||Tender joint count||Joints|Mean|24.3|24.3|Standard Deviation|15.74|15.74|||
4033356|NCT01142726|3854879|B4|Negative||Rheumatoid factor status||Participants|Number|17|17.0||||||
4033357|NCT01142726|3854880|B3|Negative||Rheumatoid factor status||Participants|Number|6|6.0||||||
4033358|NCT01142726|3854881|B2|Negative||Rheumatoid factor status||Participants|Number|5|5.0||||||
4033359|NCT01142726|3854882|B1|Negative||Rheumatoid factor status||Participants|Number|6|6.0||||||
4033360|NCT01142726|3854879|B4|Positive||Rheumatoid factor status||Participants|Number|334|334.0||||||
4033361|NCT01142726|3854880|B3|Positive||Rheumatoid factor status||Participants|Number|110|110.0||||||
4033362|NCT01142726|3854881|B2|Positive||Rheumatoid factor status||Participants|Number|111|111.0||||||
4033363|NCT01142726|3854882|B1|Positive||Rheumatoid factor status||Participants|Number|113|113.0||||||
4033364|NCT01142726|3854879|B4|||Health Assessment Questionnaire Disability Index (HAQ-DI) score|The HAQ-DI assesses patients' functional ability by rating their abilities over the previous week. It includes at least 2 questions from each of 8 categories: dressing and grooming, hygiene, arising, reach, eating, grip, walking, and common daily activities. Patients rate difficulty performing specific tasks: 0=without difficulty, 1=with some difficulty, 2=with much difficulty, and 3=unable to do. The sum of the categories score (the highest scored item in the category) is divided by the number of categories answered, yielding a score from 0-3.|Units on a scale|Mean|1.419|1.419|Standard Deviation|0.6609|0.6609|||
4033365|NCT01142726|3854880|B3|||Health Assessment Questionnaire Disability Index (HAQ-DI) score|The HAQ-DI assesses patients' functional ability by rating their abilities over the previous week. It includes at least 2 questions from each of 8 categories: dressing and grooming, hygiene, arising, reach, eating, grip, walking, and common daily activities. Patients rate difficulty performing specific tasks: 0=without difficulty, 1=with some difficulty, 2=with much difficulty, and 3=unable to do. The sum of the categories score (the highest scored item in the category) is divided by the number of categories answered, yielding a score from 0-3.|Units on a scale|Mean|1.383|1.383|Standard Deviation|0.6493|0.6493|||
4033366|NCT01142726|3854881|B2|||Health Assessment Questionnaire Disability Index (HAQ-DI) score|The HAQ-DI assesses patients' functional ability by rating their abilities over the previous week. It includes at least 2 questions from each of 8 categories: dressing and grooming, hygiene, arising, reach, eating, grip, walking, and common daily activities. Patients rate difficulty performing specific tasks: 0=without difficulty, 1=with some difficulty, 2=with much difficulty, and 3=unable to do. The sum of the categories score (the highest scored item in the category) is divided by the number of categories answered, yielding a score from 0-3.|Units on a scale|Mean|1.419|1.419|Standard Deviation|0.6587|0.6587|||
4033367|NCT01142726|3854882|B1|||Health Assessment Questionnaire Disability Index (HAQ-DI) score|The HAQ-DI assesses patients' functional ability by rating their abilities over the previous week. It includes at least 2 questions from each of 8 categories: dressing and grooming, hygiene, arising, reach, eating, grip, walking, and common daily activities. Patients rate difficulty performing specific tasks: 0=without difficulty, 1=with some difficulty, 2=with much difficulty, and 3=unable to do. The sum of the categories score (the highest scored item in the category) is divided by the number of categories answered, yielding a score from 0-3.|Units on a scale|Mean|1.452|1.452|Standard Deviation|0.6778|0.6778|||
4033368|NCT01142726|3854879|B4|||Disease Activity Score 28 based on C-reactive protein (DAS28-CRP)|The DAS28-CRP is a measure of disease activity in rheumatoid arthritis (RA) and assesses the 28 joints RA commonly affects; the score includes the number of tender and swollen joints (out of 28), CRP level (a measure of inflammation in the blood), and the patient’s global assessment of health (ranging from very good to very bad). These measures are then fed into a complex mathematical formula to produce the overall DAS (a score greater than 5.1 implies active disease; less than 3.2, well controlled disease; and less than 2.6, remission.)|Units on a scale|Mean|5.435|5.435|Standard Deviation|1.2465|1.2465|||
4033415|NCT01142661|3854947|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4033416|NCT01142661|3854947|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4033369|NCT01142726|3854880|B3|||Disease Activity Score 28 based on C-reactive protein (DAS28-CRP)|The DAS28-CRP is a measure of disease activity in rheumatoid arthritis (RA) and assesses the 28 joints RA commonly affects; the score includes the number of tender and swollen joints (out of 28), CRP level (a measure of inflammation in the blood), and the patient’s global assessment of health (ranging from very good to very bad). These measures are then fed into a complex mathematical formula to produce the overall DAS (a score greater than 5.1 implies active disease; less than 3.2, well controlled disease; and less than 2.6, remission.)|Units on a scale|Mean|5.315|5.315|Standard Deviation|1.3330|1.333|||
4033370|NCT01142726|3854881|B2|||Disease Activity Score 28 based on C-reactive protein (DAS28-CRP)|The DAS28-CRP is a measure of disease activity in rheumatoid arthritis (RA) and assesses the 28 joints RA commonly affects; the score includes the number of tender and swollen joints (out of 28), CRP level (a measure of inflammation in the blood), and the patient’s global assessment of health (ranging from very good to very bad). These measures are then fed into a complex mathematical formula to produce the overall DAS (a score greater than 5.1 implies active disease; less than 3.2, well controlled disease; and less than 2.6, remission.)|Units on a scale|Mean|5.463|5.463|Standard Deviation|1.1493|1.1493|||
4033371|NCT01142726|3854882|B1|||Disease Activity Score 28 based on C-reactive protein (DAS28-CRP)|The DAS28-CRP is a measure of disease activity in rheumatoid arthritis (RA) and assesses the 28 joints RA commonly affects; the score includes the number of tender and swollen joints (out of 28), CRP level (a measure of inflammation in the blood), and the patient’s global assessment of health (ranging from very good to very bad). These measures are then fed into a complex mathematical formula to produce the overall DAS (a score greater than 5.1 implies active disease; less than 3.2, well controlled disease; and less than 2.6, remission.)|Units on a scale|Mean|5.528|5.528|Standard Deviation|1.2501|1.2501|||
4033372|NCT01142726|3854879|B4|||Duration of rheumatoid arthritis||Years|Mean|0.56|0.56|Standard Deviation|0.504|0.504|||
4033373|NCT01142726|3854880|B3|||Duration of rheumatoid arthritis||Years|Mean|0.50|0.5|Standard Deviation|0.488|0.488|||
4033374|NCT01142726|3854881|B2|||Duration of rheumatoid arthritis||Years|Mean|0.59|0.59|Standard Deviation|0.522|0.522|||
4033375|NCT01142726|3854882|B1|||Duration of rheumatoid arthritis||Years|Mean|0.58|0.58|Standard Deviation|0.500|0.5|||
4033376|NCT01142726|3854879|B4|Other||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4033377|NCT01142726|3854880|B3|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4033378|NCT01142726|3854881|B2|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4033379|NCT01142726|3854882|B1|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4033380|NCT01142726|3854879|B4|American Indian/Alaska native||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4033381|NCT01142726|3854880|B3|American Indian/Alaska native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4033382|NCT01142726|3854881|B2|American Indian/Alaska native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4033383|NCT01142726|3854882|B1|American Indian/Alaska native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4033384|NCT01142726|3854879|B4|Black/African American||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4033385|NCT01142726|3854880|B3|Black/African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4033386|NCT01142726|3854881|B2|Black/African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4033387|NCT01142726|3854882|B1|Black/African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4033388|NCT01142726|3854879|B4|Asian||Race/Ethnicity, Customized||Participants|Number|36|36.0||||||
4033389|NCT01142726|3854880|B3|Asian||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4033390|NCT01142726|3854881|B2|Asian||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4033391|NCT01142726|3854882|B1|Asian||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4033392|NCT01142726|3854879|B4|White||Race/Ethnicity, Customized||Participants|Number|297|297.0||||||
4033393|NCT01142726|3854880|B3|White||Race/Ethnicity, Customized||Participants|Number|102|102.0||||||
4033394|NCT01142726|3854881|B2|White||Race/Ethnicity, Customized||Participants|Number|95|95.0||||||
4033395|NCT01142726|3854882|B1|White||Race/Ethnicity, Customized||Participants|Number|100|100.0||||||
4033396|NCT01142726|3854879|B4||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4033397|NCT01142726|3854880|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4033398|NCT01142726|3854881|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4033399|NCT01142726|3854882|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4033400|NCT01142726|3854879|B4||Female|Sex: Female, Male||Participants|Count of Participants|273|273.0||||||
4033401|NCT01142726|3854880|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4033402|NCT01142726|3854881|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4033403|NCT01142726|3854882|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4033404|NCT01142726|3854879|B4|||Age||Years|Mean|47.0|47.0|Standard Deviation|12.57|12.57|||
4033405|NCT01142726|3854880|B3|||Age||Years|Mean|49.1|49.1|Standard Deviation|12.36|12.36|||
4033406|NCT01142726|3854881|B2|||Age||Years|Mean|45.4|45.4|Standard Deviation|11.92|11.92|||
4033407|NCT01142726|3854882|B1|||Age||Years|Mean|46.4|46.4|Standard Deviation|13.20|13.2|||
4033408|NCT01142661|3854947|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033409|NCT01142661|3854947|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033410|NCT01142661|3854947|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4033411|NCT01142661|3854947|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033412|NCT01142661|3854947|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033413|NCT01142661|3854947|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033414|NCT01142661|3854947|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033417|NCT01142661|3854947|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|11.58|11.58|||
4033418|NCT01142596|3854952|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4033419|NCT01142596|3854953|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4033420|NCT01142596|3854954|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4033421|NCT01142596|3854952|B3||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4033422|NCT01142596|3854953|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4033423|NCT01142596|3854954|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4033424|NCT01142596|3854952|B3|||Age||years|Mean|41.97|41.97|Standard Deviation|11.86|11.86|||
4033425|NCT01142596|3854953|B2|||Age||years|Mean|41.82|41.82|Standard Deviation|11.44|11.44|||
4033426|NCT01142596|3854954|B1|||Age||years|Mean|42.50|42.5|Standard Deviation|13.39|13.39|||
4033427|NCT01142466|3855005|B3|||Expanded Disability Status Scale (EDSS)|EDSS assesses disability in 8 functional systems. An overall score ranging from 0 (normal) to 10 (death due to MS) was calculated. One participant of the safety population discontinued the study after 25 days due to an adverse event (AE) without providing any baseline data and hence was not included in this analysis.|Units on Scale|Mean|4.2|4.2|Standard Deviation|1.2|1.2|||
4033428|NCT01142466|3855006|B2|||Expanded Disability Status Scale (EDSS)|EDSS assesses disability in 8 functional systems. An overall score ranging from 0 (normal) to 10 (death due to MS) was calculated. One participant of the safety population discontinued the study after 25 days due to an adverse event (AE) without providing any baseline data and hence was not included in this analysis.|Units on Scale|Mean|4.3|4.3|Standard Deviation|1.0|1.0|||
4033429|NCT01142466|3855007|B1|||Expanded Disability Status Scale (EDSS)|EDSS assesses disability in 8 functional systems. An overall score ranging from 0 (normal) to 10 (death due to MS) was calculated. One participant of the safety population discontinued the study after 25 days due to an adverse event (AE) without providing any baseline data and hence was not included in this analysis.|Units on Scale|Mean|4.1|4.1|Standard Deviation|1.4|1.4|||
4033430|NCT01142466|3855005|B3||Male|Sex: Female, Male|One participant of the safety population discontinued the study after 25 days due to an adverse event (AE) without providing any baseline data and hence was not included in this analysis.|Participants|Count of Participants|9|9.0||||||
4033431|NCT01142466|3855006|B2||Male|Sex: Female, Male|One participant of the safety population discontinued the study after 25 days due to an adverse event (AE) without providing any baseline data and hence was not included in this analysis.|Participants|Count of Participants|6|6.0||||||
4033432|NCT01142466|3855007|B1||Male|Sex: Female, Male|One participant of the safety population discontinued the study after 25 days due to an adverse event (AE) without providing any baseline data and hence was not included in this analysis.|Participants|Count of Participants|3|3.0||||||
4033433|NCT01142466|3855005|B3||Female|Sex: Female, Male|One participant of the safety population discontinued the study after 25 days due to an adverse event (AE) without providing any baseline data and hence was not included in this analysis.|Participants|Count of Participants|20|20.0||||||
4033434|NCT01142466|3855006|B2||Female|Sex: Female, Male|One participant of the safety population discontinued the study after 25 days due to an adverse event (AE) without providing any baseline data and hence was not included in this analysis.|Participants|Count of Participants|9|9.0||||||
4033435|NCT01142466|3855007|B1||Female|Sex: Female, Male|One participant of the safety population discontinued the study after 25 days due to an adverse event (AE) without providing any baseline data and hence was not included in this analysis.|Participants|Count of Participants|11|11.0||||||
4033436|NCT01142466|3855005|B3|||Age|One participant of the safety population discontinued the study after 25 days due to an adverse event (AE) without providing any baseline data and hence was not included in this analysis.|years|Mean|44.1|44.1|Standard Deviation|6.6|6.6|||
4033437|NCT01142466|3855006|B2|||Age|One participant of the safety population discontinued the study after 25 days due to an adverse event (AE) without providing any baseline data and hence was not included in this analysis.|years|Mean|44.3|44.3|Standard Deviation|6.5|6.5|||
4033438|NCT01142466|3855007|B1|||Age|One participant of the safety population discontinued the study after 25 days due to an adverse event (AE) without providing any baseline data and hence was not included in this analysis.|years|Mean|43.8|43.8|Standard Deviation|7.0|7.0|||
4033439|NCT01142388|3855026|B3|United States||Region of Enrollment||participants|Number|87|87.0||||||
4033440|NCT01142388|3855027|B2|United States||Region of Enrollment||participants|Number|44|44.0||||||
4033441|NCT01142388|3855028|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4033442|NCT01142388|3855026|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4033443|NCT01142388|3855027|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4033444|NCT01142388|3855028|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4033445|NCT01142388|3855026|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4033446|NCT01142388|3855027|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4033447|NCT01142388|3855028|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4033448|NCT01142388|3855026|B3|||Age||years|Median|62|62.0|Full Range|||40.0|89.0|
4033449|NCT01142388|3855027|B2|||Age||years|Median|62|62.0|Full Range|||40.0|82.0|
4033450|NCT01142388|3855028|B1|||Age||years|Median|63|63.0|Full Range|||40.0|89.0|
4033451|NCT01142336|3855039|B3|||CSF ptau level||pg/ml|Mean|29|29.0|Standard Deviation|12|12.0|||
4033452|NCT01142336|3855040|B2|||CSF ptau level||pg/ml|Mean|27|27.0|Standard Deviation|10|10.0|||
4033453|NCT01142336|3855041|B1|||CSF ptau level||pg/ml|Mean|31|31.0|Standard Deviation|15|15.0|||
4033454|NCT01142336|3855039|B3|||CSF total tau level||pg/ml|Mean|41|41.0|Standard Deviation|16|16.0|||
4033455|NCT01142336|3855040|B2|||CSF total tau level||pg/ml|Mean|38|38.0|Standard Deviation|16|16.0|||
4033456|NCT01142336|3855041|B1|||CSF total tau level||pg/ml|Mean|43|43.0|Standard Deviation|17|17.0|||
4033457|NCT01142336|3855039|B3|||CSF Aβ42 level||pg/ml|Mean|517|517.0|Standard Deviation|113|113.0|||
4033458|NCT01142336|3855040|B2|||CSF Aβ42 level||pg/ml|Mean|520|520.0|Standard Deviation|114|114.0|||
4033459|NCT01142336|3855041|B1|||CSF Aβ42 level||pg/ml|Mean|515|515.0|Standard Deviation|113|113.0|||
4033460|NCT01142336|3855039|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
4033461|NCT01142336|3855040|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4033462|NCT01142336|3855041|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4033463|NCT01142336|3855039|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4033464|NCT01142336|3855040|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4033465|NCT01142336|3855041|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4033466|NCT01142336|3855039|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4033467|NCT01142336|3855040|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4033468|NCT01142336|3855041|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4033469|NCT01142336|3855039|B3|||Age||years|Mean|55.9|55.9|Standard Deviation|4.7|4.7|||
4033470|NCT01142336|3855040|B2|||Age||years|Mean|55.7|55.7|Standard Deviation|4.5|4.5|||
4033471|NCT01142336|3855041|B1|||Age||years|Mean|56.1|56.1|Standard Deviation|4.9|4.9|||
4033472|NCT01142323|3855052|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4033473|NCT01142323|3855052|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4033474|NCT01142323|3855052|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4033475|NCT01142323|3855052|B1|||Age||years|Mean|43.7|43.7|Standard Deviation|8|8.0|||
4033476|NCT01142323|3855052|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4033477|NCT01142323|3855052|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4033478|NCT01142323|3855052|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4033479|NCT01142310|3855058|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033480|NCT01142310|3855059|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033481|NCT01142310|3855060|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033482|NCT01142310|3855058|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4033483|NCT01142310|3855059|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4033484|NCT01142310|3855060|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033485|NCT01142310|3855058|B3||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4033486|NCT01142310|3855059|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4033487|NCT01142310|3855060|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4033488|NCT01142310|3855058|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4033489|NCT01142310|3855059|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4033490|NCT01142310|3855060|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4033491|NCT01142310|3855058|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033492|NCT01142310|3855059|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033493|NCT01142310|3855060|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033494|NCT01142310|3855058|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033495|NCT01142310|3855059|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033496|NCT01142310|3855060|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033497|NCT01142310|3855058|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033498|NCT01142310|3855059|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033499|NCT01142310|3855060|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033500|NCT01142310|3855058|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4033501|NCT01142310|3855059|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4033502|NCT01142310|3855060|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033503|NCT01142310|3855058|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4033504|NCT01142310|3855059|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4033505|NCT01142310|3855060|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4033506|NCT01142310|3855058|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4033507|NCT01142310|3855059|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4033508|NCT01142310|3855060|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4033509|NCT01142310|3855058|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4033510|NCT01142310|3855059|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4033511|NCT01142310|3855060|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4033512|NCT01142310|3855058|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4033513|NCT01142310|3855059|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4033514|NCT01142310|3855060|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4033515|NCT01142310|3855058|B3|||Age||years|Mean|44.315|44.315|Standard Deviation|10.968|10.968|||
4033516|NCT01142310|3855059|B2|||Age||years|Mean|46.286|46.286|Standard Deviation|9.974|9.974|||
4033517|NCT01142310|3855060|B1|||Age||years|Mean|42.192|42.192|Standard Deviation|11.771|11.771|||
4033518|NCT01142297|3855067|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4033519|NCT01142297|3855067|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4033520|NCT01142297|3855067|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4033521|NCT01142297|3855067|B1|||Age||years|Mean|57.3|57.3|Standard Deviation|9.5|9.5|||
4033522|NCT01142297|3855067|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4033523|NCT01142297|3855067|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4033524|NCT01142297|3855067|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4033525|NCT01142193|3855074|B3||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4033526|NCT01142193|3855075|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4033527|NCT01142193|3855076|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4033528|NCT01142193|3855074|B3||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4033529|NCT01142193|3855075|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4033530|NCT01142193|3855076|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4033531|NCT01142193|3855074|B3|||Age||Years|Mean|37.6|37.6|Standard Deviation|11.02|11.02|||
4033532|NCT01142193|3855075|B2|||Age||Years|Mean|37.6|37.6|Standard Deviation|11.11|11.11|||
4033533|NCT01142193|3855076|B1|||Age||Years|Mean|37.6|37.6|Standard Deviation|10.97|10.97|||
4033534|NCT01142128|3855101|B5|United States||Region of Enrollment||participants|Number|8|8.0||||||
4033535|NCT01142128|3855103|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4033536|NCT01142128|3855104|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4033537|NCT01142128|3855105|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4033538|NCT01142128|3855101|B5|Male||Gender||participants|Number|4|4.0||||||
4033539|NCT01142128|3855103|B3|Male||Gender||participants|Number|1|1.0||||||
4033540|NCT01142128|3855104|B2|Male||Gender||participants|Number|1|1.0||||||
4033541|NCT01142128|3855105|B1|Male||Gender||participants|Number|2|2.0||||||
4033542|NCT01142128|3855101|B5|Female||Gender||participants|Number|4|4.0||||||
4033543|NCT01142128|3855103|B3|Female||Gender||participants|Number|1|1.0||||||
4033544|NCT01142128|3855104|B2|Female||Gender||participants|Number|2|2.0||||||
4033545|NCT01142128|3855105|B1|Female||Gender||participants|Number|1|1.0||||||
4033546|NCT01142128|3855101|B5|>=65 years||Age||participants|Number|1|1.0||||||
4033547|NCT01142128|3855103|B3|>=65 years||Age||participants|Number|0|0.0||||||
4033548|NCT01142128|3855104|B2|>=65 years||Age||participants|Number|1|1.0||||||
4033549|NCT01142128|3855105|B1|>=65 years||Age||participants|Number|0|0.0||||||
4033550|NCT01142128|3855101|B5|Between 18 and 65 years||Age||participants|Number|7|7.0||||||
4033551|NCT01142128|3855103|B3|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
4033552|NCT01142128|3855104|B2|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
4033553|NCT01142128|3855105|B1|Between 18 and 65 years||Age||participants|Number|3|3.0||||||
4033554|NCT01142128|3855101|B5|<=18 years||Age||participants|Number|0|0.0||||||
4033555|NCT01142128|3855103|B3|<=18 years||Age||participants|Number|0|0.0||||||
4033556|NCT01142128|3855104|B2|<=18 years||Age||participants|Number|0|0.0||||||
4033557|NCT01142128|3855105|B1|<=18 years||Age||participants|Number|0|0.0||||||
4033558|NCT01142115|3855115|B1|Denmark||Region of Enrollment||participants|Number|41|41.0||||||
4033559|NCT01142115|3855115|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4033560|NCT01142115|3855115|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4033561|NCT01142115|3855115|B1|||Age||years|Mean|25.9|25.9|Standard Deviation|8.4|8.4|||
4033562|NCT01142115|3855115|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4033563|NCT01142115|3855115|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4033564|NCT01142115|3855115|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4033565|NCT01142089|3855131|B3|No||Baseline Pathogen Identified||Participants|Count of Participants|83|83.0||||||
4033566|NCT01142089|3855132|B2|No||Baseline Pathogen Identified||Participants|Count of Participants|66|66.0||||||
4033567|NCT01142089|3855133|B1|No||Baseline Pathogen Identified||Participants|Count of Participants|17|17.0||||||
4033568|NCT01142089|3855131|B3|Yes||Baseline Pathogen Identified||Participants|Count of Participants|181|181.0||||||
4033569|NCT01142089|3855132|B2|Yes||Baseline Pathogen Identified||Participants|Count of Participants|133|133.0||||||
4033570|NCT01142089|3855133|B1|Yes||Baseline Pathogen Identified||Participants|Count of Participants|48|48.0||||||
4033571|NCT01142089|3855131|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4033572|NCT01142089|3855132|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4033573|NCT01142089|3855133|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4033574|NCT01142089|3855131|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033575|NCT01142089|3855132|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033576|NCT01142089|3855133|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033577|NCT01142089|3855131|B3||White|Race (NIH/OMB)||Participants|Count of Participants|231|231.0||||||
4033578|NCT01142089|3855132|B2||White|Race (NIH/OMB)||Participants|Count of Participants|175|175.0||||||
4033579|NCT01142089|3855133|B1||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4033580|NCT01142089|3855131|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4033581|NCT01142089|3855132|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4033582|NCT01142089|3855133|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4033583|NCT01142089|3855131|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033584|NCT01142089|3855132|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033585|NCT01142089|3855133|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033586|NCT01142089|3855131|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4033587|NCT01142089|3855132|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4033588|NCT01142089|3855133|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4033589|NCT01142089|3855131|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033590|NCT01142089|3855132|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033591|NCT01142089|3855133|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033592|NCT01142089|3855131|B3||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4033593|NCT01142089|3855132|B2||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4033594|NCT01142089|3855133|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4033595|NCT01142089|3855131|B3||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4033596|NCT01142089|3855132|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4033597|NCT01142089|3855133|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4033598|NCT01142089|3855131|B3|||Age||years|Mean|28.3|28.3|Standard Deviation|11.74|11.74|||
4033599|NCT01142089|3855132|B2|||Age||years|Mean|28|28.0|Standard Deviation|11.43|11.43|||
4033600|NCT01142089|3855133|B1|||Age||years|Mean|28.9|28.9|Standard Deviation|12.72|12.72|||
4033601|NCT01141725|3855142|B1|ECOG 2||ECOG|"ECOG performance status~grade 0: fully active, able to carry on all pre-disease performance without restriction~grade 1 : restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~grade 2 : ambulatory and capable of all selfcare but unable to carry out any work activities, up and about more than 50% of waking hours"|Participants|Count of Participants|4|4.0||||||
4033602|NCT01141725|3855142|B1|ECOG 1||ECOG|"ECOG performance status~grade 0: fully active, able to carry on all pre-disease performance without restriction~grade 1 : restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~grade 2 : ambulatory and capable of all selfcare but unable to carry out any work activities, up and about more than 50% of waking hours"|Participants|Count of Participants|35|35.0||||||
4033603|NCT01141725|3855142|B1|ECOG 0||ECOG|"ECOG performance status~grade 0: fully active, able to carry on all pre-disease performance without restriction~grade 1 : restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~grade 2 : ambulatory and capable of all selfcare but unable to carry out any work activities, up and about more than 50% of waking hours"|Participants|Count of Participants|0|0.0||||||
4033604|NCT01141725|3855142|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4033605|NCT01141725|3855142|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4033606|NCT01141725|3855142|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4033607|NCT01141725|3855142|B1|||Age||years|Median|73|73.0|Full Range|||56.0|82.0|
4033608|NCT01141712|3855156|B1|Relapsed or Progressive Disease||Disease Status||participants|Number|1|1.0||||||
4033609|NCT01141712|3855156|B1|Partial Remission||Disease Status||participants|Number|9|9.0||||||
4033610|NCT01141712|3855156|B1|Complete Remission||Disease Status||participants|Number|30|30.0||||||
4033611|NCT01141712|3855156|B1|Burkitt's Lymphoma||Participant Diagnosis||participants|Number|7|7.0||||||
4033612|NCT01141712|3855156|B1|Plasmablastic Lymphoma||Participant Diagnosis||participants|Number|2|2.0||||||
4033613|NCT01141712|3855156|B1|Diffuse Large B-cell Lymphoma||Participant Diagnosis||participants|Number|16|16.0||||||
4033614|NCT01141712|3855156|B1|Hodgkin's Lymphoma||Participant Diagnosis||participants|Number|15|15.0||||||
4033615|NCT01141712|3855156|B1|70||Karnofsky Performance Score|Measure Description: Assesses patient self-perceived global quality of life and functioning on a scale of 0 - 100; where 100 equals normal quality of life with no evidence of disease, 90 equals ability to carry on normal activity with minor signs/symptoms of disease, 80 equals normal activity with effort and some signs/symptoms of disease, and 70 equals ability to care for self but unable to carry on normal activity or to do active work.|participants|Number|2|2.0||||||
4033616|NCT01141712|3855156|B1|80||Karnofsky Performance Score|Measure Description: Assesses patient self-perceived global quality of life and functioning on a scale of 0 - 100; where 100 equals normal quality of life with no evidence of disease, 90 equals ability to carry on normal activity with minor signs/symptoms of disease, 80 equals normal activity with effort and some signs/symptoms of disease, and 70 equals ability to care for self but unable to carry on normal activity or to do active work.|participants|Number|7|7.0||||||
4033617|NCT01141712|3855156|B1|90||Karnofsky Performance Score|Measure Description: Assesses patient self-perceived global quality of life and functioning on a scale of 0 - 100; where 100 equals normal quality of life with no evidence of disease, 90 equals ability to carry on normal activity with minor signs/symptoms of disease, 80 equals normal activity with effort and some signs/symptoms of disease, and 70 equals ability to care for self but unable to carry on normal activity or to do active work.|participants|Number|20|20.0||||||
4033719|NCT01141608|3855201|B1|||Age||years|Mean|38.5|38.5|Standard Deviation|10|10.0|||
4033720|NCT01141608|3855199|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4033721|NCT01141608|3855200|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4033618|NCT01141712|3855156|B1|100||Karnofsky Performance Score|Measure Description: Assesses patient self-perceived global quality of life and functioning on a scale of 0 - 100; where 100 equals normal quality of life with no evidence of disease, 90 equals ability to carry on normal activity with minor signs/symptoms of disease, 80 equals normal activity with effort and some signs/symptoms of disease, and 70 equals ability to care for self but unable to carry on normal activity or to do active work.|participants|Number|11|11.0||||||
4033619|NCT01141712|3855156|B1|Unknown||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4033620|NCT01141712|3855156|B1|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4033621|NCT01141712|3855156|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4033622|NCT01141712|3855156|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4033623|NCT01141712|3855156|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4033624|NCT01141712|3855156|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4033625|NCT01141712|3855156|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4033626|NCT01141712|3855156|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4033627|NCT01141712|3855156|B1|||Age||years|Median|46.9|46.9|Full Range|||22.5|62.2|
4033628|NCT01141660|3855175|B3|United States||Region of Enrollment||participants|Number|131|131.0||||||
4033629|NCT01141660|3855176|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
4033630|NCT01141660|3855177|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
4033631|NCT01141660|3855175|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4033632|NCT01141660|3855176|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4033633|NCT01141660|3855177|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4033634|NCT01141660|3855175|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4033635|NCT01141660|3855176|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4033636|NCT01141660|3855177|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4033637|NCT01141660|3855175|B3|||Age||years|Mean|5.6|5.6|Standard Deviation|2.4|2.4|||
4033638|NCT01141660|3855176|B2|||Age||years|Mean|5.69|5.69|Standard Deviation|2.3|2.3|||
4033639|NCT01141660|3855177|B1|||Age||years|Mean|5.5|5.5|Standard Deviation|2.5|2.5|||
4033640|NCT01141660|3855175|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4033641|NCT01141660|3855176|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4033642|NCT01141660|3855177|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4033643|NCT01141660|3855175|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4033644|NCT01141660|3855176|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4033645|NCT01141660|3855177|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4033646|NCT01141660|3855175|B3||<=18 years|Age||Participants|Count of Participants|131|131.0||||||
4033647|NCT01141660|3855176|B2||<=18 years|Age||Participants|Count of Participants|60|60.0||||||
4033648|NCT01141660|3855177|B1||<=18 years|Age||Participants|Count of Participants|71|71.0||||||
4033649|NCT01141647|3855186|B1|Physical Component Scale||Quality of Life VR-36|The VR-36 is used to measure health related quality of life. Assesses 8 domains (general health, physical functioning, role limitations, pain, energy-fatigue, social functioning and mental health). The 36 items have a 5-point ordinal response and result in providing two scores, physical component score (PCS) and mental component score (MCS). Items are summed with a range of 0-100. The PCS and MCS are standardized using a T-score and normed to a U.S. population (1990 population) score of 50 and standard deviation of 10.Higher scores means better outcome.|T-score|Mean|27.2|27.2|Standard Deviation|8.6|8.6|||
4033650|NCT01141647|3855186|B1|Mental Component Scale||Quality of Life VR-36|The VR-36 is used to measure health related quality of life. Assesses 8 domains (general health, physical functioning, role limitations, pain, energy-fatigue, social functioning and mental health). The 36 items have a 5-point ordinal response and result in providing two scores, physical component score (PCS) and mental component score (MCS). Items are summed with a range of 0-100. The PCS and MCS are standardized using a T-score and normed to a U.S. population (1990 population) score of 50 and standard deviation of 10.Higher scores means better outcome.|T-score|Mean|56.5|56.5|Standard Deviation|12.4|12.4|||
4033651|NCT01141647|3855186|B1|Economic Self Sufficiency||Measures of Handicap (CHART)|The CHART is a tool assessing an individuals level of handicap with six subscales. It consists of 32 items which assess six dimensions (cognitive independence, physical independence, mobility, occupation, social integration, and economic self-sufficiency). The scores for each subscale range from 0-100, with a score of 100 indicates no handicap in a given dimension.|units on a scale|Mean|57.9|57.9|Standard Deviation|42.1|42.1|||
4033652|NCT01141647|3855186|B1|Cognitive||Measures of Handicap (CHART)|The CHART is a tool assessing an individuals level of handicap with six subscales. It consists of 32 items which assess six dimensions (cognitive independence, physical independence, mobility, occupation, social integration, and economic self-sufficiency). The scores for each subscale range from 0-100, with a score of 100 indicates no handicap in a given dimension.|units on a scale|Mean|90.7|90.7|Standard Deviation|16.2|16.2|||
4033653|NCT01141647|3855186|B1|Physical||Measures of Handicap (CHART)|The CHART is a tool assessing an individuals level of handicap with six subscales. It consists of 32 items which assess six dimensions (cognitive independence, physical independence, mobility, occupation, social integration, and economic self-sufficiency). The scores for each subscale range from 0-100, with a score of 100 indicates no handicap in a given dimension.|units on a scale|Mean|85.4|85.4|Standard Deviation|20.9|20.9|||
4033654|NCT01141647|3855186|B1|Mobility||Measures of Handicap (CHART)|The CHART is a tool assessing an individuals level of handicap with six subscales. It consists of 32 items which assess six dimensions (cognitive independence, physical independence, mobility, occupation, social integration, and economic self-sufficiency). The scores for each subscale range from 0-100, with a score of 100 indicates no handicap in a given dimension.|units on a scale|Mean|76.8|76.8|Standard Deviation|23.9|23.9|||
4033655|NCT01141647|3855186|B1|Occupation||Measures of Handicap (CHART)|The CHART is a tool assessing an individuals level of handicap with six subscales. It consists of 32 items which assess six dimensions (cognitive independence, physical independence, mobility, occupation, social integration, and economic self-sufficiency). The scores for each subscale range from 0-100, with a score of 100 indicates no handicap in a given dimension.|units on a scale|Mean|47.6|47.6|Standard Deviation|33.9|33.9|||
4033656|NCT01141647|3855186|B1|Social Integration||Measures of Handicap (CHART)|The CHART is a tool assessing an individuals level of handicap with six subscales. It consists of 32 items which assess six dimensions (cognitive independence, physical independence, mobility, occupation, social integration, and economic self-sufficiency). The scores for each subscale range from 0-100, with a score of 100 indicates no handicap in a given dimension.|units on a scale|Mean|88.6|88.6|Standard Deviation|14.5|14.5|||
4033657|NCT01141647|3855186|B1|Missing/Other||Neither Social Security Income/Social Security Disability Insurance Recipient||participants|Number|13|13.0||||||
4033658|NCT01141647|3855186|B1|N/A||Neither Social Security Income/Social Security Disability Insurance Recipient||participants|Number|2|2.0||||||
4033659|NCT01141647|3855186|B1|One or more||Neither Social Security Income/Social Security Disability Insurance Recipient||participants|Number|798|798.0||||||
4033660|NCT01141647|3855186|B1|Neither||Neither Social Security Income/Social Security Disability Insurance Recipient||participants|Number|234|234.0||||||
4033661|NCT01141647|3855186|B1|||Monthly Social Security Disability Insurance Benefits||Dollar|Mean|1215|1215.0|Standard Deviation|556.2|556.2|||
4033662|NCT01141647|3855186|B1|||Monthly Social Security Income Benefits||Dollars|Mean|994|994.0|Standard Deviation|485.2|485.2|||
4033663|NCT01141647|3855186|B1|||Monthly Non-Service-connected pension||Dollars|Mean|1078|1078.0|Standard Deviation|795.4|795.4|||
4033664|NCT01141647|3855186|B1|Missing/Other||Non-Service-connected pension||participants|Number|39|39.0||||||
4033665|NCT01141647|3855186|B1|N/A||Non-Service-connected pension||participants|Number|378|378.0||||||
4033666|NCT01141647|3855186|B1|No||Non-Service-connected pension||participants|Number|498|498.0||||||
4033667|NCT01141647|3855186|B1|Yes||Non-Service-connected pension||participants|Number|132|132.0||||||
4033668|NCT01141647|3855186|B1|Missing||Military Service-connected 100%||participants|Number|69|69.0||||||
4033669|NCT01141647|3855186|B1|N/A||Military Service-connected 100%||participants|Number|379|379.0||||||
4033670|NCT01141647|3855186|B1|No||Military Service-connected 100%||participants|Number|258|258.0||||||
4033671|NCT01141647|3855186|B1|Yes||Military Service-connected 100%||participants|Number|341|341.0||||||
4033672|NCT01141647|3855186|B1|Missing/Other||Military Service-connected benefits for SCI|Service connected disability compensation is a monetary benefit paid to Veterans who are determined by VA to be disabled by an injury or illness that was incurred or aggravated during active military service. The level of benefit is indicated as a percentages in intervals of 10 starting at 0. Ratings of 10% or higher are monetarily compensated. To be Spinal Cord Injury service connected 100% is the highest level of compensation for a SCI that was incurred or aggravated during active military service.|participants|Number|35|35.0||||||
4033673|NCT01141647|3855186|B1|N/A||Military Service-connected benefits for SCI|Service connected disability compensation is a monetary benefit paid to Veterans who are determined by VA to be disabled by an injury or illness that was incurred or aggravated during active military service. The level of benefit is indicated as a percentages in intervals of 10 starting at 0. Ratings of 10% or higher are monetarily compensated. To be Spinal Cord Injury service connected 100% is the highest level of compensation for a SCI that was incurred or aggravated during active military service.|participants|Number|444|444.0||||||
4033674|NCT01141647|3855186|B1|No||Military Service-connected benefits for SCI|Service connected disability compensation is a monetary benefit paid to Veterans who are determined by VA to be disabled by an injury or illness that was incurred or aggravated during active military service. The level of benefit is indicated as a percentages in intervals of 10 starting at 0. Ratings of 10% or higher are monetarily compensated. To be Spinal Cord Injury service connected 100% is the highest level of compensation for a SCI that was incurred or aggravated during active military service.|participants|Number|237|237.0||||||
4033675|NCT01141647|3855186|B1|Yes||Military Service-connected benefits for SCI|Service connected disability compensation is a monetary benefit paid to Veterans who are determined by VA to be disabled by an injury or illness that was incurred or aggravated during active military service. The level of benefit is indicated as a percentages in intervals of 10 starting at 0. Ratings of 10% or higher are monetarily compensated. To be Spinal Cord Injury service connected 100% is the highest level of compensation for a SCI that was incurred or aggravated during active military service.|participants|Number|331|331.0||||||
4033676|NCT01141647|3855186|B1|Missing/Other||VA Benefits Recipient||participants|Number|21|21.0||||||
4033677|NCT01141647|3855186|B1|N/A||VA Benefits Recipient||participants|Number|2|2.0||||||
4033678|NCT01141647|3855186|B1|No||VA Benefits Recipient||participants|Number|369|369.0||||||
4033679|NCT01141647|3855186|B1|Yes||VA Benefits Recipient||participants|Number|655|655.0||||||
4033680|NCT01141647|3855186|B1|||Education Years||years|Mean|13.8|13.8|Standard Deviation|2.4|2.4|||
4033681|NCT01141647|3855186|B1|Refused/NA||Marital Status||participants|Number|3|3.0||||||
4033682|NCT01141647|3855186|B1|Other||Marital Status||participants|Number|305|305.0||||||
4033683|NCT01141647|3855186|B1|Divorced||Marital Status||participants|Number|366|366.0||||||
4033684|NCT01141647|3855186|B1|Married||Marital Status||participants|Number|373|373.0||||||
4033685|NCT01141647|3855186|B1|Missing||AIS and neurological Level|"High Tetraplegia, AIS, A, B, C: high cervical injury with upper and lower extremities motor and/or sensory impairment.~Low Tetraplegia, AIS, A, B, C low cervical injury with upper and lower extremities motor and/or sensory impairment.~Paraplegia, AIS, A, B,C: an injury to the thoracic or lumbar area of the spinal cord resulting in motor and/or sensory impairment of the lower extremities.~Tetraplegia or Paraplegia AIS D/E: cervical, thoracic or lumbar injury with the least amount of motor and/or sensory impairment."|participants|Number|13|13.0||||||
4033722|NCT01141608|3855201|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4033723|NCT01141608|3855199|B3||Between 18 and 65 years|Age||Participants|Count of Participants|302|302.0||||||
4033724|NCT01141608|3855200|B2||Between 18 and 65 years|Age||Participants|Count of Participants|150|150.0||||||
4033686|NCT01141647|3855186|B1|AIS D/E||AIS and neurological Level|"High Tetraplegia, AIS, A, B, C: high cervical injury with upper and lower extremities motor and/or sensory impairment.~Low Tetraplegia, AIS, A, B, C low cervical injury with upper and lower extremities motor and/or sensory impairment.~Paraplegia, AIS, A, B,C: an injury to the thoracic or lumbar area of the spinal cord resulting in motor and/or sensory impairment of the lower extremities.~Tetraplegia or Paraplegia AIS D/E: cervical, thoracic or lumbar injury with the least amount of motor and/or sensory impairment."|participants|Number|372|372.0||||||
4033687|NCT01141647|3855186|B1|Paraplegia, AIS A,B,C||AIS and neurological Level|"High Tetraplegia, AIS, A, B, C: high cervical injury with upper and lower extremities motor and/or sensory impairment.~Low Tetraplegia, AIS, A, B, C low cervical injury with upper and lower extremities motor and/or sensory impairment.~Paraplegia, AIS, A, B,C: an injury to the thoracic or lumbar area of the spinal cord resulting in motor and/or sensory impairment of the lower extremities.~Tetraplegia or Paraplegia AIS D/E: cervical, thoracic or lumbar injury with the least amount of motor and/or sensory impairment."|participants|Number|371|371.0||||||
4033688|NCT01141647|3855186|B1|Low Tetraplegia, AIS A,B,C||AIS and neurological Level|"High Tetraplegia, AIS, A, B, C: high cervical injury with upper and lower extremities motor and/or sensory impairment.~Low Tetraplegia, AIS, A, B, C low cervical injury with upper and lower extremities motor and/or sensory impairment.~Paraplegia, AIS, A, B,C: an injury to the thoracic or lumbar area of the spinal cord resulting in motor and/or sensory impairment of the lower extremities.~Tetraplegia or Paraplegia AIS D/E: cervical, thoracic or lumbar injury with the least amount of motor and/or sensory impairment."|participants|Number|200|200.0||||||
4033689|NCT01141647|3855186|B1|High Tetraplegia, AIS, A, B, C||AIS and neurological Level|"High Tetraplegia, AIS, A, B, C: high cervical injury with upper and lower extremities motor and/or sensory impairment.~Low Tetraplegia, AIS, A, B, C low cervical injury with upper and lower extremities motor and/or sensory impairment.~Paraplegia, AIS, A, B,C: an injury to the thoracic or lumbar area of the spinal cord resulting in motor and/or sensory impairment of the lower extremities.~Tetraplegia or Paraplegia AIS D/E: cervical, thoracic or lumbar injury with the least amount of motor and/or sensory impairment."|participants|Number|91|91.0||||||
4033690|NCT01141647|3855186|B1|Missing||ASIA Impairment Scale (AIS)|ASIA Impairment is used to describe an individual's functional level impairment due to spinal cord injury. Ranging from level A indicating greatest impairment to level E all functioning having returned.|participants|Number|12|12.0||||||
4033691|NCT01141647|3855186|B1|E||ASIA Impairment Scale (AIS)|ASIA Impairment is used to describe an individual's functional level impairment due to spinal cord injury. Ranging from level A indicating greatest impairment to level E all functioning having returned.|participants|Number|7|7.0||||||
4033692|NCT01141647|3855186|B1|D||ASIA Impairment Scale (AIS)|ASIA Impairment is used to describe an individual's functional level impairment due to spinal cord injury. Ranging from level A indicating greatest impairment to level E all functioning having returned.|participants|Number|366|366.0||||||
4033693|NCT01141647|3855186|B1|C||ASIA Impairment Scale (AIS)|ASIA Impairment is used to describe an individual's functional level impairment due to spinal cord injury. Ranging from level A indicating greatest impairment to level E all functioning having returned.|participants|Number|133|133.0||||||
4033694|NCT01141647|3855186|B1|B||ASIA Impairment Scale (AIS)|ASIA Impairment is used to describe an individual's functional level impairment due to spinal cord injury. Ranging from level A indicating greatest impairment to level E all functioning having returned.|participants|Number|121|121.0||||||
4033695|NCT01141647|3855186|B1|A||ASIA Impairment Scale (AIS)|ASIA Impairment is used to describe an individual's functional level impairment due to spinal cord injury. Ranging from level A indicating greatest impairment to level E all functioning having returned.|participants|Number|408|408.0||||||
4033696|NCT01141647|3855186|B1|||Functional Independence Measure|This measure contains 18 items composed of 13 motor-related tasks and 5 cognitive-related tasks. Each task is rated on a 7-point ordinal (1=total assistance (or complete dependence) to 7=complete independence). The range of scores is 18 to 126, with the lower score indicating greater dependence.|units on a scale|Mean|71.5|71.5|Standard Deviation|27.2|27.2|||
4033697|NCT01141647|3855186|B1|Other/Unknown||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
4033698|NCT01141647|3855186|B1|Native American||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4033699|NCT01141647|3855186|B1|Asian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4033700|NCT01141647|3855186|B1|African American||Race/Ethnicity, Customized||participants|Number|306|306.0||||||
4033701|NCT01141647|3855186|B1|Caucasion||Race/Ethnicity, Customized||participants|Number|653|653.0||||||
4033702|NCT01141647|3855186|B1||Male|Sex: Female, Male||Participants|Count of Participants|1002|1002.0||||||
4033703|NCT01141647|3855186|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4033704|NCT01141647|3855186|B1|||Age||years|Mean|53.3|53.3|Standard Deviation|10.1|10.1|||
4033705|NCT01141647|3855186|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4033706|NCT01141647|3855186|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1047|1047.0||||||
4033707|NCT01141647|3855186|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4033708|NCT01141608|3855199|B3|United States||Region of Enrollment||Participants|Count of Participants|302|302.0||||||
4033709|NCT01141608|3855200|B2|United States||Region of Enrollment||Participants|Count of Participants|150|150.0||||||
4033710|NCT01141608|3855201|B1|United States||Region of Enrollment||Participants|Count of Participants|152|152.0||||||
4033711|NCT01141608|3855199|B3||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4033712|NCT01141608|3855200|B2||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4033713|NCT01141608|3855201|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4033714|NCT01141608|3855199|B3||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4033715|NCT01141608|3855200|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4033716|NCT01141608|3855201|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4033717|NCT01141608|3855199|B3|||Age||years|Mean|39|39.0|Standard Deviation|10.5|10.5|||
4033718|NCT01141608|3855200|B2|||Age||years|Mean|39.5|39.5|Standard Deviation|11|11.0|||
4033725|NCT01141608|3855201|B1||Between 18 and 65 years|Age||Participants|Count of Participants|152|152.0||||||
4033726|NCT01141608|3855199|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4033727|NCT01141608|3855200|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4033728|NCT01141608|3855201|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4033729|NCT01141595|3855208|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4033730|NCT01141595|3855208|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4033731|NCT01141595|3855208|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4033732|NCT01141595|3855208|B1|||Age||years|Mean|5.0|5.0|Standard Deviation|1.2|1.2|||
4033733|NCT01141595|3855208|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4033734|NCT01141595|3855208|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4033735|NCT01141595|3855208|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4033736|NCT01141569|3855212|B1|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4033737|NCT01141569|3855212|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4033738|NCT01141569|3855212|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4033739|NCT01141569|3855212|B1|||Age||years|Median|60|60.0|Full Range|||49.0|70.0|
4033740|NCT01141569|3855212|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4033741|NCT01141569|3855212|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4033742|NCT01141569|3855212|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4033743|NCT01141491|3855221|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4033744|NCT01141491|3855222|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4033745|NCT01141491|3855223|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033746|NCT01141491|3855221|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033747|NCT01141491|3855222|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033748|NCT01141491|3855223|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033749|NCT01141491|3855221|B3||White|Race (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
4033750|NCT01141491|3855222|B2||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4033751|NCT01141491|3855223|B1||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4033752|NCT01141491|3855221|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4033753|NCT01141491|3855222|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4033754|NCT01141491|3855223|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4033755|NCT01141491|3855221|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033756|NCT01141491|3855222|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033757|NCT01141491|3855223|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033758|NCT01141491|3855221|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4033759|NCT01141491|3855222|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4033760|NCT01141491|3855223|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4033761|NCT01141491|3855221|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4033762|NCT01141491|3855222|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033763|NCT01141491|3855223|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4033764|NCT01141491|3855221|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4033765|NCT01141491|3855222|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4033766|NCT01141491|3855223|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4033767|NCT01141491|3855221|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4033768|NCT01141491|3855222|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4033769|NCT01141491|3855223|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4033770|NCT01141491|3855221|B3||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4033771|NCT01141491|3855222|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4033772|NCT01141491|3855223|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4033773|NCT01141491|3855221|B3||Between 18 and 65 years|Age||Participants|Count of Participants|108|108.0||||||
4033774|NCT01141491|3855222|B2||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4033775|NCT01141491|3855223|B1||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4033776|NCT01141491|3855221|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4033777|NCT01141491|3855222|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4033778|NCT01141491|3855223|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4033779|NCT01141374|3855230|B4|||score stress|The List of Symptoms of Stress is an evaluation questionnaire which consists of a list of 60 psycho-physiological and psychosocial stress, in which the subject must associate to each symptom of the four answers: never (0), rarely (1 ), often (2) or always (3). The scores are added together and the answers provide the level of stress the individual.In this questionnaire to score from 0 to 11 is void, 12 to 29 (low level), 30 to 59 (medium level), 60 to 120 (high level) and above 120, very high level. Participants below 29 points were excluded.|scores on a scale|Mean|61.48|61.48|Standard Deviation|20.17|20.17|||
4033933|NCT01140880|3855321|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4033780|NCT01141374|3855231|B3|||score stress|The List of Symptoms of Stress is an evaluation questionnaire which consists of a list of 60 psycho-physiological and psychosocial stress, in which the subject must associate to each symptom of the four answers: never (0), rarely (1 ), often (2) or always (3). The scores are added together and the answers provide the level of stress the individual.In this questionnaire to score from 0 to 11 is void, 12 to 29 (low level), 30 to 59 (medium level), 60 to 120 (high level) and above 120, very high level. Participants below 29 points were excluded.|scores on a scale|Mean|54.36|54.36|Standard Deviation|15.90|15.9|||
4033781|NCT01141374|3855232|B2|||score stress|The List of Symptoms of Stress is an evaluation questionnaire which consists of a list of 60 psycho-physiological and psychosocial stress, in which the subject must associate to each symptom of the four answers: never (0), rarely (1 ), often (2) or always (3). The scores are added together and the answers provide the level of stress the individual.In this questionnaire to score from 0 to 11 is void, 12 to 29 (low level), 30 to 59 (medium level), 60 to 120 (high level) and above 120, very high level. Participants below 29 points were excluded.|scores on a scale|Mean|66.82|66.82|Standard Deviation|18.56|18.56|||
4033782|NCT01141374|3855233|B1|||score stress|The List of Symptoms of Stress is an evaluation questionnaire which consists of a list of 60 psycho-physiological and psychosocial stress, in which the subject must associate to each symptom of the four answers: never (0), rarely (1 ), often (2) or always (3). The scores are added together and the answers provide the level of stress the individual.In this questionnaire to score from 0 to 11 is void, 12 to 29 (low level), 30 to 59 (medium level), 60 to 120 (high level) and above 120, very high level. Participants below 29 points were excluded.|scores on a scale|Mean|63.27|63.27|Standard Deviation|26.05|26.05|||
4033783|NCT01141374|3855230|B4|Brazil||Region of Enrollment||participants|Number|75|75.0||||||
4033784|NCT01141374|3855231|B3|Brazil||Region of Enrollment||participants|Number|22|22.0||||||
4033785|NCT01141374|3855232|B2|Brazil||Region of Enrollment||participants|Number|27|27.0||||||
4033786|NCT01141374|3855233|B1|Brazil||Region of Enrollment||participants|Number|26|26.0||||||
4033787|NCT01141374|3855230|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4033788|NCT01141374|3855231|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4033789|NCT01141374|3855232|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4033790|NCT01141374|3855233|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4033791|NCT01141374|3855230|B4||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4033792|NCT01141374|3855231|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4033793|NCT01141374|3855232|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4033794|NCT01141374|3855233|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4033795|NCT01141374|3855230|B4|||Age||years|Mean|42.06|42.06|Standard Deviation|9.27|9.27|||
4033796|NCT01141374|3855231|B3|||Age||years|Mean|39.25|39.25|Standard Deviation|13.17|13.17|||
4033797|NCT01141374|3855232|B2|||Age||years|Mean|41.37|41.37|Standard Deviation|8.23|8.23|||
4033798|NCT01141374|3855233|B1|||Age||years|Mean|45.57|45.57|Standard Deviation|6.40|6.4|||
4033799|NCT01141374|3855230|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4033800|NCT01141374|3855231|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4033801|NCT01141374|3855232|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4033802|NCT01141374|3855233|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4033803|NCT01141374|3855230|B4||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4033804|NCT01141374|3855231|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4033805|NCT01141374|3855232|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4033806|NCT01141374|3855233|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4033807|NCT01141374|3855230|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4033808|NCT01141374|3855231|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4033809|NCT01141374|3855232|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4033810|NCT01141374|3855233|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4033811|NCT01141283|3855246|B1||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4033812|NCT01141283|3855246|B1||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4033813|NCT01141283|3855246|B1|||Age||years|Mean|60.4|60.4|Standard Deviation|9.28|9.28|||
4033814|NCT01141205|3855250|B3|Guinea-Bissau||Region of Enrollment||participants|Number|23|23.0||||||
4033815|NCT01141205|3855251|B2|Guinea-Bissau||Region of Enrollment||participants|Number|5|5.0||||||
4033816|NCT01141205|3855252|B1|Guinea-Bissau||Region of Enrollment||participants|Number|18|18.0||||||
4033817|NCT01141205|3855250|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4033818|NCT01141205|3855251|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4033819|NCT01141205|3855252|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4033820|NCT01141205|3855250|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4033821|NCT01141205|3855251|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4033822|NCT01141205|3855252|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4033823|NCT01141205|3855250|B3|||Age||years|Mean|32|32.0|Standard Deviation|2|2.0|||
4033824|NCT01141205|3855251|B2|||Age||years|Mean|29|29.0|Standard Deviation|2|2.0|||
4033825|NCT01141205|3855252|B1|||Age||years|Mean|34|34.0|Standard Deviation|2|2.0|||
4033826|NCT01141205|3855250|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4033827|NCT01141205|3855251|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4033828|NCT01141205|3855252|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4033829|NCT01141205|3855250|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4033830|NCT01141205|3855251|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4033831|NCT01141205|3855252|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4033832|NCT01141205|3855250|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4033833|NCT01141205|3855251|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4033834|NCT01141205|3855252|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4033835|NCT01141049|3855265|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033836|NCT01141049|3855266|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033837|NCT01141049|3855267|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033838|NCT01141049|3855265|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4033839|NCT01141049|3855266|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4033840|NCT01141049|3855267|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4033841|NCT01141049|3855265|B3||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4033842|NCT01141049|3855266|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4033843|NCT01141049|3855267|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4033844|NCT01141049|3855265|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4033845|NCT01141049|3855266|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4033846|NCT01141049|3855267|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4033847|NCT01141049|3855265|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033848|NCT01141049|3855266|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033849|NCT01141049|3855267|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033850|NCT01141049|3855265|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033851|NCT01141049|3855266|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033852|NCT01141049|3855267|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033853|NCT01141049|3855265|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033854|NCT01141049|3855266|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033855|NCT01141049|3855267|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033856|NCT01141049|3855265|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033857|NCT01141049|3855266|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033858|NCT01141049|3855267|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033859|NCT01141049|3855265|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4033860|NCT01141049|3855266|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4033861|NCT01141049|3855267|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4033862|NCT01141049|3855265|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4033863|NCT01141049|3855266|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4033864|NCT01141049|3855267|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4033865|NCT01141049|3855265|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4033866|NCT01141049|3855266|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4033867|NCT01141049|3855267|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4033868|NCT01141049|3855265|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4033869|NCT01141049|3855266|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4033870|NCT01141049|3855267|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4033871|NCT01141049|3855265|B3|||Age||years|Mean|48.1|48.1|Standard Deviation|9.1|9.1|||
4033872|NCT01141049|3855266|B2|||Age||years|Mean|49.8|49.8|Standard Deviation|8.7|8.7|||
4033873|NCT01141049|3855267|B1|||Age||years|Mean|46.2|46.2|Standard Deviation|9.5|9.5|||
4033874|NCT01140906|3855276|B5|||SDS total baseline score|The Sheehan Disability Scale (SDS) comprises self-rated items designed to measure impairment. The patient rates the extent to which his or her (1) work, (2) social life or leisure activities and (3) home life or family responsibilities are impaired on a 10-point visual analogue scales, on which 0 = normal functioning and 10 = severe functional impairment. The three items may be summed into a single dimensional measure of global functional impairment that ranges from 0 (unimpaired) to 30 (highly impaired). The higher the score, the more severe.|units on a scale|Mean|20.4|20.4|Standard Deviation|5.2|5.2|||
4033875|NCT01140906|3855277|B4|||SDS total baseline score|The Sheehan Disability Scale (SDS) comprises self-rated items designed to measure impairment. The patient rates the extent to which his or her (1) work, (2) social life or leisure activities and (3) home life or family responsibilities are impaired on a 10-point visual analogue scales, on which 0 = normal functioning and 10 = severe functional impairment. The three items may be summed into a single dimensional measure of global functional impairment that ranges from 0 (unimpaired) to 30 (highly impaired). The higher the score, the more severe.|units on a scale|Mean|20.5|20.5|Standard Deviation|4.4|4.4|||
4033926|NCT01140880|3855323|B1|African American/black||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4033927|NCT01140880|3855321|B3|Caucasian/white||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
4033928|NCT01140880|3855322|B2|Caucasian/white||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4033876|NCT01140906|3855278|B3|||SDS total baseline score|The Sheehan Disability Scale (SDS) comprises self-rated items designed to measure impairment. The patient rates the extent to which his or her (1) work, (2) social life or leisure activities and (3) home life or family responsibilities are impaired on a 10-point visual analogue scales, on which 0 = normal functioning and 10 = severe functional impairment. The three items may be summed into a single dimensional measure of global functional impairment that ranges from 0 (unimpaired) to 30 (highly impaired). The higher the score, the more severe.|units on a scale|Mean|20.7|20.7|Standard Deviation|4.8|4.8|||
4033877|NCT01140906|3855279|B2|||SDS total baseline score|The Sheehan Disability Scale (SDS) comprises self-rated items designed to measure impairment. The patient rates the extent to which his or her (1) work, (2) social life or leisure activities and (3) home life or family responsibilities are impaired on a 10-point visual analogue scales, on which 0 = normal functioning and 10 = severe functional impairment. The three items may be summed into a single dimensional measure of global functional impairment that ranges from 0 (unimpaired) to 30 (highly impaired). The higher the score, the more severe.|units on a scale|Mean|20.6|20.6|Standard Deviation|5.3|5.3|||
4033878|NCT01140906|3855280|B1|||SDS total baseline score|The Sheehan Disability Scale (SDS) comprises self-rated items designed to measure impairment. The patient rates the extent to which his or her (1) work, (2) social life or leisure activities and (3) home life or family responsibilities are impaired on a 10-point visual analogue scales, on which 0 = normal functioning and 10 = severe functional impairment. The three items may be summed into a single dimensional measure of global functional impairment that ranges from 0 (unimpaired) to 30 (highly impaired). The higher the score, the more severe.|units on a scale|Mean|19.8|19.8|Standard Deviation|6.0|6.0|||
4033879|NCT01140906|3855276|B5|||HAM-A baseline total score|The Hamilton Anxiety Rating Scale (HAM-A) consists of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behaviour at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic, and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total score from 0 to 56. The higher the score, the more severe.|units on a scale|Mean|20.8|20.8|Standard Deviation|6.7|6.7|||
4033880|NCT01140906|3855277|B4|||HAM-A baseline total score|The Hamilton Anxiety Rating Scale (HAM-A) consists of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behaviour at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic, and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total score from 0 to 56. The higher the score, the more severe.|units on a scale|Mean|20.5|20.5|Standard Deviation|6.7|6.7|||
4033881|NCT01140906|3855278|B3|||HAM-A baseline total score|The Hamilton Anxiety Rating Scale (HAM-A) consists of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behaviour at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic, and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total score from 0 to 56. The higher the score, the more severe.|units on a scale|Mean|20.4|20.4|Standard Deviation|6.9|6.9|||
4033882|NCT01140906|3855279|B2|||HAM-A baseline total score|The Hamilton Anxiety Rating Scale (HAM-A) consists of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behaviour at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic, and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total score from 0 to 56. The higher the score, the more severe.|units on a scale|Mean|21.3|21.3|Standard Deviation|6.8|6.8|||
4033883|NCT01140906|3855280|B1|||HAM-A baseline total score|The Hamilton Anxiety Rating Scale (HAM-A) consists of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behaviour at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic, and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total score from 0 to 56. The higher the score, the more severe.|units on a scale|Mean|20.8|20.8|Standard Deviation|6.6|6.6|||
4033884|NCT01140906|3855276|B5|||CGI-S baseline severity score|The Clinical Global Impression – Severity of Illness (CGI-S) is a 7-point scale rated from 1 (normal, not at all ill) to 7 (among the most extremely ill patients). The investigator should use his/her total clinical experience with this patient population to judge how mentally ill the patient is at the time of rating.|units on a scale|Mean|4.8|4.8|Standard Deviation|0.7|0.7|||
4033885|NCT01140906|3855277|B4|||CGI-S baseline severity score|The Clinical Global Impression – Severity of Illness (CGI-S) is a 7-point scale rated from 1 (normal, not at all ill) to 7 (among the most extremely ill patients). The investigator should use his/her total clinical experience with this patient population to judge how mentally ill the patient is at the time of rating.|units on a scale|Mean|4.8|4.8|Standard Deviation|0.7|0.7|||
4033886|NCT01140906|3855278|B3|||CGI-S baseline severity score|The Clinical Global Impression – Severity of Illness (CGI-S) is a 7-point scale rated from 1 (normal, not at all ill) to 7 (among the most extremely ill patients). The investigator should use his/her total clinical experience with this patient population to judge how mentally ill the patient is at the time of rating.|units on a scale|Mean|4.8|4.8|Standard Deviation|0.7|0.7|||
4033887|NCT01140906|3855279|B2|||CGI-S baseline severity score|The Clinical Global Impression – Severity of Illness (CGI-S) is a 7-point scale rated from 1 (normal, not at all ill) to 7 (among the most extremely ill patients). The investigator should use his/her total clinical experience with this patient population to judge how mentally ill the patient is at the time of rating.|units on a scale|Mean|4.9|4.9|Standard Deviation|0.6|0.6|||
4033888|NCT01140906|3855280|B1|||CGI-S baseline severity score|The Clinical Global Impression – Severity of Illness (CGI-S) is a 7-point scale rated from 1 (normal, not at all ill) to 7 (among the most extremely ill patients). The investigator should use his/her total clinical experience with this patient population to judge how mentally ill the patient is at the time of rating.|units on a scale|Mean|4.9|4.9|Standard Deviation|0.7|0.7|||
4033929|NCT01140880|3855323|B1|Caucasian/white||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4033930|NCT01140880|3855321|B3||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4033931|NCT01140880|3855322|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4033932|NCT01140880|3855323|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4033889|NCT01140906|3855276|B5|||MADRS baseline total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 (no symptom) to 6 (severe symptom). The 10 items represent the core symptoms of depressive illness. The rating should be based on a clinical interview with the patient, moving from broadly phrased questions about symptoms to more detailed ones, which allow a precise rating of severity, covering the last 7 days. 9 of the items are based on patient report, and 1 is based on the rater's observation of the patients. Total score from 0 to 60. The higher the score, the more severe.|units on a scale|Mean|31.4|31.4|Standard Deviation|3.5|3.5|||
4033890|NCT01140906|3855277|B4|||MADRS baseline total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 (no symptom) to 6 (severe symptom). The 10 items represent the core symptoms of depressive illness. The rating should be based on a clinical interview with the patient, moving from broadly phrased questions about symptoms to more detailed ones, which allow a precise rating of severity, covering the last 7 days. 9 of the items are based on patient report, and 1 is based on the rater's observation of the patients. Total score from 0 to 60. The higher the score, the more severe.|units on a scale|Mean|31.2|31.2|Standard Deviation|3.5|3.5|||
4033891|NCT01140906|3855278|B3|||MADRS baseline total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 (no symptom) to 6 (severe symptom). The 10 items represent the core symptoms of depressive illness. The rating should be based on a clinical interview with the patient, moving from broadly phrased questions about symptoms to more detailed ones, which allow a precise rating of severity, covering the last 7 days. 9 of the items are based on patient report, and 1 is based on the rater's observation of the patients. Total score from 0 to 60. The higher the score, the more severe.|units on a scale|Mean|31.2|31.2|Standard Deviation|3.4|3.4|||
4033892|NCT01140906|3855279|B2|||MADRS baseline total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 (no symptom) to 6 (severe symptom). The 10 items represent the core symptoms of depressive illness. The rating should be based on a clinical interview with the patient, moving from broadly phrased questions about symptoms to more detailed ones, which allow a precise rating of severity, covering the last 7 days. 9 of the items are based on patient report, and 1 is based on the rater's observation of the patients. Total score from 0 to 60. The higher the score, the more severe.|units on a scale|Mean|31.8|31.8|Standard Deviation|3.4|3.4|||
4033893|NCT01140906|3855280|B1|||MADRS baseline total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 (no symptom) to 6 (severe symptom). The 10 items represent the core symptoms of depressive illness. The rating should be based on a clinical interview with the patient, moving from broadly phrased questions about symptoms to more detailed ones, which allow a precise rating of severity, covering the last 7 days. 9 of the items are based on patient report, and 1 is based on the rater's observation of the patients. Total score from 0 to 60. The higher the score, the more severe.|units on a scale|Mean|31.5|31.5|Standard Deviation|3.6|3.6|||
4033894|NCT01140906|3855276|B5||Male|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4033895|NCT01140906|3855277|B4||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4033896|NCT01140906|3855278|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4033897|NCT01140906|3855279|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4033898|NCT01140906|3855280|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4033899|NCT01140906|3855276|B5||Female|Sex: Female, Male||Participants|Count of Participants|400|400.0||||||
4033900|NCT01140906|3855277|B4||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4033901|NCT01140906|3855278|B3||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4033902|NCT01140906|3855279|B2||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4033903|NCT01140906|3855280|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4033904|NCT01140906|3855276|B5|||Age||years|Mean|46.7|46.7|Standard Deviation|13.7|13.7|||
4033905|NCT01140906|3855277|B4|||Age||years|Mean|45.6|45.6|Standard Deviation|13.6|13.6|||
4033906|NCT01140906|3855278|B3|||Age||years|Mean|46.2|46.2|Standard Deviation|13.4|13.4|||
4033907|NCT01140906|3855279|B2|||Age||years|Mean|47.0|47.0|Standard Deviation|14.6|14.6|||
4033908|NCT01140906|3855280|B1|||Age||years|Mean|48.1|48.1|Standard Deviation|13.1|13.1|||
4033909|NCT01140880|3855321|B3|United States||Region of Enrollment||participants|Number|140|140.0||||||
4033910|NCT01140880|3855322|B2|United States||Region of Enrollment||participants|Number|70|70.0||||||
4033911|NCT01140880|3855323|B1|United States||Region of Enrollment||participants|Number|70|70.0||||||
4033912|NCT01140880|3855321|B3|Multiracial/Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4033913|NCT01140880|3855322|B2|Multiracial/Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4033914|NCT01140880|3855323|B1|Multiracial/Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4033915|NCT01140880|3855321|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4033916|NCT01140880|3855322|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4033917|NCT01140880|3855323|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4033918|NCT01140880|3855321|B3|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4033919|NCT01140880|3855322|B2|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4033920|NCT01140880|3855323|B1|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4033921|NCT01140880|3855321|B3|Native American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4033922|NCT01140880|3855322|B2|Native American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4033923|NCT01140880|3855323|B1|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4033924|NCT01140880|3855321|B3|African American/black||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
4033925|NCT01140880|3855322|B2|African American/black||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4033934|NCT01140880|3855322|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4033935|NCT01140880|3855323|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4033936|NCT01140880|3855321|B3|||Age||years|Mean|36.8|36.8|Standard Deviation|11.1|11.1|||
4033937|NCT01140880|3855322|B2|||Age||years|Mean|37.9|37.9|Standard Deviation|11.8|11.8|||
4033938|NCT01140880|3855323|B1|||Age||years|Mean|35.8|35.8|Standard Deviation|10.3|10.3|||
4033939|NCT01140867|3855336|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033940|NCT01140867|3855336|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033941|NCT01140867|3855336|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033942|NCT01140867|3855336|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033943|NCT01140867|3855336|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033944|NCT01140867|3855336|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|121|121.0||||||
4033945|NCT01140867|3855336|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033946|NCT01140867|3855336|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4033947|NCT01140867|3855336|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4033948|NCT01140867|3855336|B1|||Age||years|Mean|37.70|37.7|Standard Deviation|11.19|11.19|||
4033949|NCT01140815|3855343|B3|||Knee Score||units on a scale|Mean|51.3|51.3|Full Range|||15.0|90.0|
4033950|NCT01140815|3855344|B2|||Knee Score||units on a scale|Mean|52.7|52.7|Full Range|||20.0|90.0|
4033951|NCT01140815|3855345|B1|||Knee Score||units on a scale|Mean|50|50.0|Full Range|||15.0|78.0|
4033952|NCT01140815|3855343|B3|||Body Mass Index||lbs/square inches|Mean|29.2|29.2|Full Range|||23.0|35.0|
4033953|NCT01140815|3855344|B2|||Body Mass Index||lbs/square inches|Mean|28.8|28.8|Full Range|||23.0|34.0|
4033954|NCT01140815|3855345|B1|||Body Mass Index||lbs/square inches|Mean|30|30.0|Full Range|||25.0|35.0|
4033955|NCT01140815|3855343|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4033956|NCT01140815|3855344|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4033957|NCT01140815|3855345|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4033958|NCT01140815|3855343|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4033959|NCT01140815|3855344|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4033960|NCT01140815|3855345|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4033961|NCT01140815|3855343|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4033962|NCT01140815|3855344|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4033963|NCT01140815|3855345|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4033964|NCT01140815|3855343|B3|||Age||years|Mean|59.3|59.3|Full Range|||45.0|65.0|
4033965|NCT01140815|3855344|B2|||Age||years|Mean|60.3|60.3|Full Range|||53.0|65.0|
4033966|NCT01140815|3855345|B1|||Age||years|Mean|58.3|58.3|Full Range|||45.0|65.0|
4033967|NCT01140646|3855376|B1|No||Breast Cancer History||Participants|Number|25|25.0||||||
4033968|NCT01140646|3855376|B1|Yes||Breast Cancer History||Participants|Number|18|18.0||||||
4033969|NCT01140646|3855376|B1|>=9 months||Duration of Flash Symptoms (months)||Participants|Number|38|38.0||||||
4033970|NCT01140646|3855376|B1|<9 months||Duration of Flash Symptoms (months)||Participants|Number|5|5.0||||||
4033971|NCT01140646|3855376|B1|>=10||Average Hot Flashes per Day||Participants|Number|19|19.0||||||
4033972|NCT01140646|3855376|B1|4-9||Average Hot Flashes per Day||Participants|Number|21|21.0||||||
4033973|NCT01140646|3855376|B1|2-3||Average Hot Flashes per Day||Participants|Number|3|3.0||||||
4033974|NCT01140646|3855376|B1|No||Aromatase Inhibitor Therapy||Participants|Number|38|38.0||||||
4033975|NCT01140646|3855376|B1|Yes||Aromatase Inhibitor Therapy||Participants|Number|5|5.0||||||
4033976|NCT01140646|3855376|B1|No||Raloxifene Therapy||Participants|Number|43|43.0||||||
4033977|NCT01140646|3855376|B1|Yes||Raloxifene Therapy||Participants|Number|0|0.0||||||
4033978|NCT01140646|3855376|B1|No||Tamoxifen Therapy||Participants|Number|35|35.0||||||
4033979|NCT01140646|3855376|B1|Yes||Tamoxifen Therapy||Participants|Number|8|8.0||||||
4033980|NCT01140646|3855376|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4033981|NCT01140646|3855376|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4033982|NCT01140646|3855376|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4033983|NCT01140646|3855376|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|6.5|6.5|||
4033984|NCT01140503|3855380|B1|||Dermatology Life Quality Index (DLQI)|This is a validated instrument that estimates the impact of skin disease on the quality of life. score ranges from 0-30, with a higher score representing a greater adverse impact on quality of life.|units on a scale|Median|9|9.0|Standard Deviation|3.89|3.89|||
4033985|NCT01140503|3855380|B1|||Patient Pruritis Scale (VAS)|This is a patient-reported estimate of itching. The patient fills out a visual analog scale (0-10cm) to estimate the severity of itching. A higher score is more severe itch.|units on a scale|Median|2.9|2.9|Standard Deviation|2.40|2.4|||
4033986|NCT01140503|3855380|B1|||Manual Muscle Testing (MMT-8) score|This is a validated measure of muscle strength. Scale goes from 0-150. 150 is perfect strength.|units on a scale|Median|147|147.0|Standard Deviation|4.21|4.21|||
4033987|NCT01140503|3855380|B1|||CDASI Activity Score|This is a validated instrument (Cutaneous Dermatomyositis Activity and Severity Index) quantifying dermatomyositis skin disease activity by assigning severity points on redness, scale, and ulceration to specific body sites typically involved by dermatomyositis. Possible scores for the CDASI-a range from 0 to 100, with higher numbers represent higher severity of skin disease. Scores above 15 are considered to have moderate-to-severe activity. A clinically meaningful improvement in this scale is 4.|units on a scale|Median|31|31.0|Standard Deviation|6.8|6.8|||
4033988|NCT01140503|3855380|B1|||Physician Global Assessment of Skin Activity (Likert)|This is a 5 point scale (0=clear; 1=mild; 2=moderate; 3=severe; 4=very severe) in which the physician estimates the severity of the dermatomyositis skin disease activity|units on a scale|Median|2|2.0|Standard Deviation|0|0.0|||
4033989|NCT01140503|3855380|B1|||Physician Global Assessment of Skin Activity (VAS)|This is a visual analog scale (0-10cm) in which the physician estimates the global activity of the dermatomyositis skin disease. The score ranges from 0 to 10, with higher scores representing higher disease severity|units on a scale|Median|3.8|3.8|Standard Deviation|0.98|0.98|||
4033990|NCT01140503|3855380|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033991|NCT01140503|3855380|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033992|NCT01140503|3855380|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4033993|NCT01140503|3855380|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033994|NCT01140503|3855380|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033995|NCT01140503|3855380|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033996|NCT01140503|3855380|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4033997|NCT01140503|3855380|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4033998|NCT01140503|3855380|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4033999|NCT01140503|3855380|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4034000|NCT01140503|3855380|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4034001|NCT01140503|3855380|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4034002|NCT01140477|3855386|B3||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4034003|NCT01140477|3855387|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4034004|NCT01140477|3855388|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4034005|NCT01140477|3855386|B3||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4034006|NCT01140477|3855387|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4034007|NCT01140477|3855388|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4034008|NCT01140477|3855386|B3|||Age||years|Mean|70.0|70.0|Full Range|||47.0|89.0|
4034009|NCT01140477|3855387|B2|||Age||years|Mean|69.8|69.8|Full Range|9.2|9.2|47.0|89.0|
4034010|NCT01140477|3855388|B1|||Age||years|Mean|70.1|70.1|Full Range|9.0|9.0|48.0|89.0|
4034011|NCT01140360|3855398|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4034012|NCT01140360|3855398|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4034013|NCT01140360|3855398|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4034014|NCT01140360|3855398|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4034015|NCT01140360|3855398|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4034016|NCT01140360|3855398|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4034017|NCT01140360|3855398|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4034018|NCT01140360|3855398|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4034019|NCT01140360|3855398|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4034020|NCT01140360|3855398|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4034021|NCT01140360|3855398|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4034022|NCT01140360|3855398|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4034023|NCT01140360|3855398|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4034024|NCT01140360|3855398|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4034025|NCT01140360|3855398|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4034026|NCT01140360|3855398|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4034027|NCT01140347|3855402|B3|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
4034028|NCT01140347|3855403|B2|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
4034029|NCT01140347|3855404|B1|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
4034030|NCT01140347|3855402|B3|Japan||Region of Enrollment||participants|Number|93|93.0||||||
4034031|NCT01140347|3855403|B2|Japan||Region of Enrollment||participants|Number|48|48.0||||||
4034032|NCT01140347|3855404|B1|Japan||Region of Enrollment||participants|Number|45|45.0||||||
4034033|NCT01140347|3855402|B3|Norway||Region of Enrollment||participants|Number|2|2.0||||||
4034034|NCT01140347|3855403|B2|Norway||Region of Enrollment||participants|Number|1|1.0||||||
4034035|NCT01140347|3855404|B1|Norway||Region of Enrollment||participants|Number|1|1.0||||||
4034036|NCT01140347|3855402|B3|Germany||Region of Enrollment||participants|Number|40|40.0||||||
4034037|NCT01140347|3855403|B2|Germany||Region of Enrollment||participants|Number|21|21.0||||||
4034038|NCT01140347|3855404|B1|Germany||Region of Enrollment||participants|Number|19|19.0||||||
4034039|NCT01140347|3855402|B3|Bulgaria||Region of Enrollment||participants|Number|6|6.0||||||
4034040|NCT01140347|3855403|B2|Bulgaria||Region of Enrollment||participants|Number|4|4.0||||||
4034041|NCT01140347|3855404|B1|Bulgaria||Region of Enrollment||participants|Number|2|2.0||||||
4034042|NCT01140347|3855402|B3|Romania||Region of Enrollment||participants|Number|7|7.0||||||
4034043|NCT01140347|3855403|B2|Romania||Region of Enrollment||participants|Number|4|4.0||||||
4034044|NCT01140347|3855404|B1|Romania||Region of Enrollment||participants|Number|3|3.0||||||
4034045|NCT01140347|3855402|B3|Brazil||Region of Enrollment||participants|Number|27|27.0||||||
4034046|NCT01140347|3855403|B2|Brazil||Region of Enrollment||participants|Number|12|12.0||||||
4034047|NCT01140347|3855404|B1|Brazil||Region of Enrollment||participants|Number|15|15.0||||||
4034048|NCT01140347|3855402|B3|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
4034049|NCT01140347|3855403|B2|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
4034050|NCT01140347|3855404|B1|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
4034051|NCT01140347|3855402|B3|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4034052|NCT01140347|3855403|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4034053|NCT01140347|3855404|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4034054|NCT01140347|3855402|B3|Hungary||Region of Enrollment||participants|Number|1|1.0||||||
4034055|NCT01140347|3855403|B2|Hungary||Region of Enrollment||participants|Number|0|0.0||||||
4034056|NCT01140347|3855404|B1|Hungary||Region of Enrollment||participants|Number|1|1.0||||||
4034057|NCT01140347|3855402|B3|Czech Republic||Region of Enrollment||participants|Number|20|20.0||||||
4034058|NCT01140347|3855403|B2|Czech Republic||Region of Enrollment||participants|Number|9|9.0||||||
4034059|NCT01140347|3855404|B1|Czech Republic||Region of Enrollment||participants|Number|11|11.0||||||
4034060|NCT01140347|3855402|B3|Austria||Region of Enrollment||participants|Number|8|8.0||||||
4034061|NCT01140347|3855403|B2|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4034062|NCT01140347|3855404|B1|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4034063|NCT01140347|3855402|B3|Finland||Region of Enrollment||participants|Number|3|3.0||||||
4034064|NCT01140347|3855403|B2|Finland||Region of Enrollment||participants|Number|3|3.0||||||
4034065|NCT01140347|3855404|B1|Finland||Region of Enrollment||participants|Number|0|0.0||||||
4034066|NCT01140347|3855402|B3|Korea, Republic of||Region of Enrollment||participants|Number|70|70.0||||||
4034067|NCT01140347|3855403|B2|Korea, Republic of||Region of Enrollment||participants|Number|42|42.0||||||
4034068|NCT01140347|3855404|B1|Korea, Republic of||Region of Enrollment||participants|Number|28|28.0||||||
4034069|NCT01140347|3855402|B3|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
4034070|NCT01140347|3855403|B2|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4034071|NCT01140347|3855404|B1|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
4034072|NCT01140347|3855402|B3|Australia||Region of Enrollment||participants|Number|11|11.0||||||
4034073|NCT01140347|3855403|B2|Australia||Region of Enrollment||participants|Number|8|8.0||||||
4034074|NCT01140347|3855404|B1|Australia||Region of Enrollment||participants|Number|3|3.0||||||
4034075|NCT01140347|3855402|B3|France||Region of Enrollment||participants|Number|59|59.0||||||
4034076|NCT01140347|3855403|B2|France||Region of Enrollment||participants|Number|27|27.0||||||
4034077|NCT01140347|3855404|B1|France||Region of Enrollment||participants|Number|32|32.0||||||
4034078|NCT01140347|3855402|B3|Italy||Region of Enrollment||participants|Number|51|51.0||||||
4034079|NCT01140347|3855403|B2|Italy||Region of Enrollment||participants|Number|18|18.0||||||
4034080|NCT01140347|3855404|B1|Italy||Region of Enrollment||participants|Number|33|33.0||||||
4034081|NCT01140347|3855402|B3|Switzerland||Region of Enrollment||participants|Number|2|2.0||||||
4034082|NCT01140347|3855403|B2|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4034083|NCT01140347|3855404|B1|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4034084|NCT01140347|3855402|B3|Israel||Region of Enrollment||participants|Number|2|2.0||||||
4034085|NCT01140347|3855403|B2|Israel||Region of Enrollment||participants|Number|1|1.0||||||
4034086|NCT01140347|3855404|B1|Israel||Region of Enrollment||participants|Number|1|1.0||||||
4034087|NCT01140347|3855402|B3|Thailand||Region of Enrollment||participants|Number|6|6.0||||||
4034088|NCT01140347|3855403|B2|Thailand||Region of Enrollment||participants|Number|1|1.0||||||
4034089|NCT01140347|3855404|B1|Thailand||Region of Enrollment||participants|Number|5|5.0||||||
4034090|NCT01140347|3855402|B3|Spain||Region of Enrollment||participants|Number|21|21.0||||||
4034091|NCT01140347|3855403|B2|Spain||Region of Enrollment||participants|Number|12|12.0||||||
4034092|NCT01140347|3855404|B1|Spain||Region of Enrollment||participants|Number|9|9.0||||||
4034093|NCT01140347|3855402|B3|Hong Kong||Region of Enrollment||participants|Number|24|24.0||||||
4034094|NCT01140347|3855403|B2|Hong Kong||Region of Enrollment||participants|Number|10|10.0||||||
4034095|NCT01140347|3855404|B1|Hong Kong||Region of Enrollment||participants|Number|14|14.0||||||
4034096|NCT01140347|3855402|B3|Taiwan||Region of Enrollment||participants|Number|58|58.0||||||
4034097|NCT01140347|3855403|B2|Taiwan||Region of Enrollment||participants|Number|25|25.0||||||
4034098|NCT01140347|3855404|B1|Taiwan||Region of Enrollment||participants|Number|33|33.0||||||
4034099|NCT01140347|3855402|B3|Philippines||Region of Enrollment||participants|Number|1|1.0||||||
4034100|NCT01140347|3855403|B2|Philippines||Region of Enrollment||participants|Number|0|0.0||||||
4034101|NCT01140347|3855404|B1|Philippines||Region of Enrollment||participants|Number|1|1.0||||||
4034102|NCT01140347|3855402|B3|Portugal||Region of Enrollment||participants|Number|2|2.0||||||
4034103|NCT01140347|3855403|B2|Portugal||Region of Enrollment||participants|Number|2|2.0||||||
4034104|NCT01140347|3855404|B1|Portugal||Region of Enrollment||participants|Number|0|0.0||||||
4034105|NCT01140347|3855402|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
4034106|NCT01140347|3855403|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4034107|NCT01140347|3855404|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4034108|NCT01140347|3855402|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4034109|NCT01140347|3855403|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4034110|NCT01140347|3855404|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4034111|NCT01140347|3855402|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4034112|NCT01140347|3855403|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4034113|NCT01140347|3855404|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4034114|NCT01140347|3855402|B3||White|Race (NIH/OMB)||Participants|Count of Participants|276|276.0||||||
4034115|NCT01140347|3855403|B2||White|Race (NIH/OMB)||Participants|Count of Participants|137|137.0||||||
4034116|NCT01140347|3855404|B1||White|Race (NIH/OMB)||Participants|Count of Participants|139|139.0||||||
4034117|NCT01140347|3855402|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4034118|NCT01140347|3855403|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4034119|NCT01140347|3855404|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4034120|NCT01140347|3855402|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4034121|NCT01140347|3855403|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4034122|NCT01140347|3855404|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4034123|NCT01140347|3855402|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|266|266.0||||||
4034124|NCT01140347|3855403|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|135|135.0||||||
4034125|NCT01140347|3855404|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
4034126|NCT01140347|3855402|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4034127|NCT01140347|3855403|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4034128|NCT01140347|3855404|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4034129|NCT01140347|3855402|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4034130|NCT01140347|3855403|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4034131|NCT01140347|3855404|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4034132|NCT01140347|3855402|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|513|513.0||||||
4034133|NCT01140347|3855403|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|260|260.0||||||
4034134|NCT01140347|3855404|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|253|253.0||||||
4034135|NCT01140347|3855402|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4034136|NCT01140347|3855403|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4034137|NCT01140347|3855404|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4034138|NCT01140347|3855402|B3||Male|Sex: Female, Male||Participants|Count of Participants|478|478.0||||||
4034139|NCT01140347|3855403|B2||Male|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
4034140|NCT01140347|3855404|B1||Male|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
4034141|NCT01140347|3855402|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4034142|NCT01140347|3855403|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4034143|NCT01140347|3855404|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4034144|NCT01140347|3855402|B3|≥65 years||Age, Customized||participants|Number|253|253.0||||||
4034145|NCT01140347|3855403|B2|≥65 years||Age, Customized||participants|Number|120|120.0||||||
4034146|NCT01140347|3855404|B1|≥65 years||Age, Customized||participants|Number|133|133.0||||||
4034147|NCT01140347|3855402|B3|<65 years||Age, Customized||participants|Number|312|312.0||||||
4034148|NCT01140347|3855403|B2|<65 years||Age, Customized||participants|Number|162|162.0||||||
4034149|NCT01140347|3855404|B1|<65 years||Age, Customized||participants|Number|150|150.0||||||
4034150|NCT01140347|3855402|B3|||Age||years|Mean|62.7|62.7|Standard Deviation|11.33|11.33|||
4034151|NCT01140347|3855403|B2|||Age||years|Mean|62.5|62.5|Standard Deviation|11.10|11.1|||
4034152|NCT01140347|3855404|B1|||Age||years|Mean|62.9|62.9|Standard Deviation|11.56|11.56|||
4034153|NCT01140295|3855428|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
4034154|NCT01140295|3855429|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4034155|NCT01140295|3855430|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4034156|NCT01140295|3855428|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4034157|NCT01140295|3855429|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4034158|NCT01140295|3855430|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4034159|NCT01140295|3855428|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4034160|NCT01140295|3855429|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4034161|NCT01140295|3855430|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4034162|NCT01140295|3855428|B3|||Age||years|Mean|14.5|14.5|Standard Deviation|5|5.0|||
4034163|NCT01140295|3855429|B2|||Age||years|Mean|15|15.0|Standard Deviation|1.2|1.2|||
4034164|NCT01140295|3855430|B1|||Age||years|Mean|12|12.0|Standard Deviation|1.3|1.3|||
4034165|NCT01140295|3855428|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4034166|NCT01140295|3855429|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4034167|NCT01140295|3855430|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4034168|NCT01140295|3855428|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4034169|NCT01140295|3855429|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4034170|NCT01140295|3855430|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4034171|NCT01140295|3855428|B3||<=18 years|Age||Participants|Count of Participants|33|33.0||||||
4034172|NCT01140295|3855429|B2||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4034173|NCT01140295|3855430|B1||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
4034174|NCT01140191|3855439|B1|||Number of Lesions||Lesions|Number|1|1.0||||||
4034175|NCT01140191|3855439|B1|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4034176|NCT01140191|3855439|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4034177|NCT01140191|3855439|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4034178|NCT01140191|3855439|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4034179|NCT01140191|3855439|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4034180|NCT01140191|3855439|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4034181|NCT01140061|3855448|B11||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4034182|NCT01140061|3855449|B10||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4034183|NCT01140061|3855450|B9||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4034184|NCT01140061|3855451|B8||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4034185|NCT01140061|3855452|B7||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4034186|NCT01140061|3855453|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4034187|NCT01140061|3855454|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4034188|NCT01140061|3855455|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4034189|NCT01140061|3855456|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4034190|NCT01140061|3855457|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4034191|NCT01140061|3855458|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4034192|NCT01140061|3855448|B11||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4034193|NCT01140061|3855449|B10||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4034194|NCT01140061|3855450|B9||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4034195|NCT01140061|3855451|B8||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4034196|NCT01140061|3855452|B7||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4034197|NCT01140061|3855453|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4034198|NCT01140061|3855454|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4034199|NCT01140061|3855455|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4034200|NCT01140061|3855456|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4034201|NCT01140061|3855457|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4034202|NCT01140061|3855458|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4034203|NCT01140061|3855448|B11|||Age||Years|Mean|39.67|39.67|Full Range|11.49|11.49|18.0|62.0|
4034204|NCT01140061|3855449|B10|||Age||Years|Mean|40.00|40.0|Full Range|15.56|15.56|29.0|51.0|
4034205|NCT01140061|3855450|B9|||Age||Years|Mean|42.86|42.86|Full Range|11.33|11.33|23.0|54.0|
4034206|NCT01140061|3855451|B8|||Age||Years|Mean|35.50|35.5|Full Range|2.12|2.12|34.0|37.0|
4034207|NCT01140061|3855452|B7|||Age||Years|Mean|30.33|30.33|Full Range|6.77|6.77|21.0|38.0|
4034208|NCT01140061|3855453|B6|||Age||Years|Mean|34.00|34.0|Full Range|7.07|7.07|29.0|39.0|
4034209|NCT01140061|3855454|B5|||Age||Years|Mean|45.67|45.67|Full Range|12.79|12.79|28.0|62.0|
4034210|NCT01140061|3855455|B4|||Age||Years|Mean|45.50|45.5|Full Range|14.85|14.85|35.0|56.0|
4034211|NCT01140061|3855456|B3|||Age||Years|Mean|40.00|40.0|Full Range|11.78|11.78|26.0|60.0|
4034212|NCT01140061|3855457|B2|||Age||Years|Mean|30.50|30.5|Full Range|17.68|17.68|18.0|43.0|
4034213|NCT01140061|3855458|B1|||Age||Years|Mean|42.71|42.71|Full Range|12.19|12.19|23.0|53.0|
4034214|NCT01140048|3855494|B1||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4034215|NCT01140048|3855494|B1||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4034216|NCT01140048|3855494|B1|||Age||months|Mean|45.7|45.7|Standard Deviation|10.0|10.0|||
4034217|NCT01139879|3855509|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4034218|NCT01139879|3855509|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4034219|NCT01139879|3855509|B1|||Age||years|Mean|64.9|64.9|Standard Deviation|21.5|21.5|||
4034220|NCT01139814|3855515|B1|United Kingdom||Region of Enrollment||participants|Number|29|29.0||||||
4034221|NCT01139814|3855515|B1|United States||Region of Enrollment||participants|Number|152|152.0||||||
4034222|NCT01139814|3855515|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4034223|NCT01139814|3855515|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4034224|NCT01139814|3855515|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|16.4|16.4|||
4034225|NCT01139801|3855520|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4034226|NCT01139801|3855521|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4034227|NCT01139801|3855522|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4034228|NCT01139801|3855520|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4034229|NCT01139801|3855521|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4034230|NCT01139801|3855522|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4034231|NCT01139801|3855520|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4034232|NCT01139801|3855521|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4034233|NCT01139801|3855522|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4034234|NCT01139801|3855520|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4034235|NCT01139801|3855521|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4034236|NCT01139801|3855522|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4034237|NCT01139801|3855520|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4034238|NCT01139801|3855521|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4034239|NCT01139801|3855522|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4034240|NCT01139775|3855531|B4|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death) as follows: 0 - Fully Active; 1 - Ambulatory, Restricted Strenuous Activity; 2 - Ambulatory, No Work Activities; 3 - Partially Confined to Bed, Limited Self Care; 4 - Completely Disabled; and 5 - Dead.|Participants|Count of Participants|1|1.0||||||
4034241|NCT01139775|3855532|B3|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death) as follows: 0 - Fully Active; 1 - Ambulatory, Restricted Strenuous Activity; 2 - Ambulatory, No Work Activities; 3 - Partially Confined to Bed, Limited Self Care; 4 - Completely Disabled; and 5 - Dead.|Participants|Count of Participants|1|1.0||||||
4034242|NCT01139775|3855533|B2|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death) as follows: 0 - Fully Active; 1 - Ambulatory, Restricted Strenuous Activity; 2 - Ambulatory, No Work Activities; 3 - Partially Confined to Bed, Limited Self Care; 4 - Completely Disabled; and 5 - Dead.|Participants|Count of Participants|0|0.0||||||
4034243|NCT01139775|3855534|B1|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death) as follows: 0 - Fully Active; 1 - Ambulatory, Restricted Strenuous Activity; 2 - Ambulatory, No Work Activities; 3 - Partially Confined to Bed, Limited Self Care; 4 - Completely Disabled; and 5 - Dead.|Participants|Count of Participants|0|0.0||||||
4034244|NCT01139775|3855531|B4|ECOG Status 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death) as follows: 0 - Fully Active; 1 - Ambulatory, Restricted Strenuous Activity; 2 - Ambulatory, No Work Activities; 3 - Partially Confined to Bed, Limited Self Care; 4 - Completely Disabled; and 5 - Dead.|Participants|Count of Participants|48|48.0||||||
4034245|NCT01139775|3855532|B3|ECOG Status 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death) as follows: 0 - Fully Active; 1 - Ambulatory, Restricted Strenuous Activity; 2 - Ambulatory, No Work Activities; 3 - Partially Confined to Bed, Limited Self Care; 4 - Completely Disabled; and 5 - Dead.|Participants|Count of Participants|15|15.0||||||
4034246|NCT01139775|3855533|B2|ECOG Status 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death) as follows: 0 - Fully Active; 1 - Ambulatory, Restricted Strenuous Activity; 2 - Ambulatory, No Work Activities; 3 - Partially Confined to Bed, Limited Self Care; 4 - Completely Disabled; and 5 - Dead.|Participants|Count of Participants|30|30.0||||||
4034247|NCT01139775|3855534|B1|ECOG Status 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death) as follows: 0 - Fully Active; 1 - Ambulatory, Restricted Strenuous Activity; 2 - Ambulatory, No Work Activities; 3 - Partially Confined to Bed, Limited Self Care; 4 - Completely Disabled; and 5 - Dead.|Participants|Count of Participants|3|3.0||||||
4034248|NCT01139775|3855531|B4|ECOG Status 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death) as follows: 0 - Fully Active; 1 - Ambulatory, Restricted Strenuous Activity; 2 - Ambulatory, No Work Activities; 3 - Partially Confined to Bed, Limited Self Care; 4 - Completely Disabled; and 5 - Dead.|Participants|Count of Participants|27|27.0||||||
4034249|NCT01139775|3855532|B3|ECOG Status 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death) as follows: 0 - Fully Active; 1 - Ambulatory, Restricted Strenuous Activity; 2 - Ambulatory, No Work Activities; 3 - Partially Confined to Bed, Limited Self Care; 4 - Completely Disabled; and 5 - Dead.|Participants|Count of Participants|7|7.0||||||
4034250|NCT01139775|3855533|B2|ECOG Status 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death) as follows: 0 - Fully Active; 1 - Ambulatory, Restricted Strenuous Activity; 2 - Ambulatory, No Work Activities; 3 - Partially Confined to Bed, Limited Self Care; 4 - Completely Disabled; and 5 - Dead.|Participants|Count of Participants|9|9.0||||||
4034251|NCT01139775|3855534|B1|ECOG Status 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death) as follows: 0 - Fully Active; 1 - Ambulatory, Restricted Strenuous Activity; 2 - Ambulatory, No Work Activities; 3 - Partially Confined to Bed, Limited Self Care; 4 - Completely Disabled; and 5 - Dead.|Participants|Count of Participants|11|11.0||||||
4034252|NCT01139775|3855531|B4|Pleuritis Carcinomatosa||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4034253|NCT01139775|3855532|B3|Pleuritis Carcinomatosa||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4034254|NCT01139775|3855533|B2|Pleuritis Carcinomatosa||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4034255|NCT01139775|3855534|B1|Pleuritis Carcinomatosa||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4034256|NCT01139775|3855531|B4|Mesothelioma, Malignum||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4034257|NCT01139775|3855532|B3|Mesothelioma, Malignum||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4034258|NCT01139775|3855533|B2|Mesothelioma, Malignum||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4034259|NCT01139775|3855534|B1|Mesothelioma, Malignum||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4034260|NCT01139775|3855531|B4|Carcinoma, Pancreas||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4034261|NCT01139775|3855532|B3|Carcinoma, Pancreas||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4034262|NCT01139775|3855533|B2|Carcinoma, Pancreas||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4034263|NCT01139775|3855534|B1|Carcinoma, Pancreas||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4034264|NCT01139775|3855531|B4|Carcinoma, Non-small Cell, Poorly Diff, Lung||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4034265|NCT01139775|3855532|B3|Carcinoma, Non-small Cell, Poorly Diff, Lung||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4034266|NCT01139775|3855533|B2|Carcinoma, Non-small Cell, Poorly Diff, Lung||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4034267|NCT01139775|3855534|B1|Carcinoma, Non-small Cell, Poorly Diff, Lung||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4034268|NCT01139775|3855531|B4|Carcinoma, Lung||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4034269|NCT01139775|3855532|B3|Carcinoma, Lung||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4034270|NCT01139775|3855533|B2|Carcinoma, Lung||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4034271|NCT01139775|3855534|B1|Carcinoma, Lung||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4034272|NCT01139775|3855531|B4|Carcinoma, Large Cell, Lung||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4034273|NCT01139775|3855532|B3|Carcinoma, Large Cell, Lung||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4034274|NCT01139775|3855533|B2|Carcinoma, Large Cell, Lung||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4034275|NCT01139775|3855534|B1|Carcinoma, Large Cell, Lung||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4034276|NCT01139775|3855531|B4|Carcinoma, Breast||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4034277|NCT01139775|3855532|B3|Carcinoma, Breast||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4034278|NCT01139775|3855533|B2|Carcinoma, Breast||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4034279|NCT01139775|3855534|B1|Carcinoma, Breast||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4034280|NCT01139775|3855531|B4|Carcinoma, Ampulla of Vater||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4034281|NCT01139775|3855532|B3|Carcinoma, Ampulla of Vater||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4034282|NCT01139775|3855533|B2|Carcinoma, Ampulla of Vater||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4034283|NCT01139775|3855534|B1|Carcinoma, Ampulla of Vater||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4034284|NCT01139775|3855531|B4|Adenocarcinoma, Moderately Diff., Lung||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4034285|NCT01139775|3855532|B3|Adenocarcinoma, Moderately Diff., Lung||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4034286|NCT01139775|3855533|B2|Adenocarcinoma, Moderately Diff., Lung||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4034287|NCT01139775|3855534|B1|Adenocarcinoma, Moderately Diff., Lung||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4034288|NCT01139775|3855531|B4|Adenocarcinoma, Lung||Initial Pathological Diagnosis||Participants|Count of Participants|65|65.0||||||
4034289|NCT01139775|3855532|B3|Adenocarcinoma, Lung||Initial Pathological Diagnosis||Participants|Count of Participants|19|19.0||||||
4034290|NCT01139775|3855533|B2|Adenocarcinoma, Lung||Initial Pathological Diagnosis||Participants|Count of Participants|38|38.0||||||
4034291|NCT01139775|3855534|B1|Adenocarcinoma, Lung||Initial Pathological Diagnosis||Participants|Count of Participants|8|8.0||||||
4034292|NCT01139775|3855531|B4|Adenocarcinoma, Colon||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4034293|NCT01139775|3855532|B3|Adenocarcinoma, Colon||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4034294|NCT01139775|3855533|B2|Adenocarcinoma, Colon||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4034295|NCT01139775|3855534|B1|Adenocarcinoma, Colon||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4034296|NCT01139775|3855531|B4|Adenocarcinoma, Bronchiolalveolar||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4034297|NCT01139775|3855532|B3|Adenocarcinoma, Bronchiolalveolar||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4034298|NCT01139775|3855533|B2|Adenocarcinoma, Bronchiolalveolar||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4034299|NCT01139775|3855534|B1|Adenocarcinoma, Bronchiolalveolar||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4034300|NCT01139775|3855531|B4|Germany||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
4034301|NCT01139775|3855532|B3|Germany||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4034302|NCT01139775|3855533|B2|Germany||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4034303|NCT01139775|3855534|B1|Germany||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4034304|NCT01139775|3855531|B4|Spain||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
4034305|NCT01139775|3855532|B3|Spain||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4034306|NCT01139775|3855533|B2|Spain||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
4034307|NCT01139775|3855534|B1|Spain||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4034308|NCT01139775|3855531|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|76|76.0||||||
4034309|NCT01139775|3855532|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
4034310|NCT01139775|3855533|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
4034311|NCT01139775|3855534|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4034312|NCT01139775|3855531|B4||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4034313|NCT01139775|3855532|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4034314|NCT01139775|3855533|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4034315|NCT01139775|3855534|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4034316|NCT01139775|3855531|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4034317|NCT01139775|3855532|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4034318|NCT01139775|3855533|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4034319|NCT01139775|3855534|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4034320|NCT01139775|3855531|B4|||Age||years|Mean|57.4|57.4|Standard Deviation|10.1|10.1|||
4034321|NCT01139775|3855532|B3|||Age||years|Mean|56.4|56.4|Standard Deviation|9.8|9.8|||
4034322|NCT01139775|3855533|B2|||Age||years|Mean|57.9|57.9|Standard Deviation|10.1|10.1|||
4034323|NCT01139775|3855534|B1|||Age||years|Mean|57.9|57.9|Standard Deviation|11.4|11.4|||
4034324|NCT01139762|3855566|B3|||Body Mass Index (BMI)||kilograms/square meter (kg/m²)|Mean|28.3|28.3|Standard Deviation|3.90|3.9|||
4034325|NCT01139762|3855567|B2|||Body Mass Index (BMI)||kilograms/square meter (kg/m²)|Mean|28.3|28.3|Standard Deviation|3.80|3.8|||
4034326|NCT01139762|3855568|B1|||Body Mass Index (BMI)||kilograms/square meter (kg/m²)|Mean|28.3|28.3|Standard Deviation|4.00|4.0|||
4034327|NCT01139762|3855566|B3|||Weight||kilograms (kg)|Mean|85.4|85.4|Standard Deviation|14.15|14.15|||
4034328|NCT01139762|3855567|B2|||Weight||kilograms (kg)|Mean|85.6|85.6|Standard Deviation|14.16|14.16|||
4034329|NCT01139762|3855568|B1|||Weight||kilograms (kg)|Mean|85.3|85.3|Standard Deviation|14.16|14.16|||
4034330|NCT01139762|3855566|B3|||Height||centimeters (cm)|Mean|173.7|173.7|Standard Deviation|7.77|7.77|||
4034331|NCT01139762|3855567|B2|||Height||centimeters (cm)|Mean|173.8|173.8|Standard Deviation|7.65|7.65|||
4034332|NCT01139762|3855568|B1|||Height||centimeters (cm)|Mean|173.5|173.5|Standard Deviation|7.90|7.9|||
4034333|NCT01139762|3855566|B3|Not Applicable||Sexual activity with female partner||participants|Number|1|1.0||||||
4034334|NCT01139762|3855567|B2|Not Applicable||Sexual activity with female partner||participants|Number|1|1.0||||||
4034335|NCT01139762|3855568|B1|Not Applicable||Sexual activity with female partner||participants|Number|0|0.0||||||
4034336|NCT01139762|3855566|B3|No||Sexual activity with female partner||participants|Number|84|84.0||||||
4034337|NCT01139762|3855567|B2|No||Sexual activity with female partner||participants|Number|44|44.0||||||
4034338|NCT01139762|3855568|B1|No||Sexual activity with female partner||participants|Number|40|40.0||||||
4034339|NCT01139762|3855566|B3|Yes||Sexual activity with female partner||participants|Number|610|610.0||||||
4034340|NCT01139762|3855567|B2|Yes||Sexual activity with female partner||participants|Number|305|305.0||||||
4034341|NCT01139762|3855568|B1|Yes||Sexual activity with female partner||participants|Number|305|305.0||||||
4034342|NCT01139762|3855566|B3|No||Erectile Dysfunction||participants|Number|245|245.0||||||
4034343|NCT01139762|3855567|B2|No||Erectile Dysfunction||participants|Number|127|127.0||||||
4034344|NCT01139762|3855568|B1|No||Erectile Dysfunction||participants|Number|118|118.0||||||
4034345|NCT01139762|3855566|B3|Yes||Erectile Dysfunction||participants|Number|450|450.0||||||
4034346|NCT01139762|3855567|B2|Yes||Erectile Dysfunction||participants|Number|223|223.0||||||
4034347|NCT01139762|3855568|B1|Yes||Erectile Dysfunction||participants|Number|227|227.0||||||
4034348|NCT01139762|3855566|B3|||Prostate Specific Antigen (PSA)|One participant from Tadalafil and 3 participants from placebo group had missing data and are not included in the calculation of mean and standard deviation.|nanograms/milliliter (ng/mL)|Mean|2.4|2.4|Standard Deviation|2.04|2.04|||
4034349|NCT01139762|3855567|B2|||Prostate Specific Antigen (PSA)|One participant from Tadalafil and 3 participants from placebo group had missing data and are not included in the calculation of mean and standard deviation.|nanograms/milliliter (ng/mL)|Mean|2.5|2.5|Standard Deviation|2.06|2.06|||
4034350|NCT01139762|3855568|B1|||Prostate Specific Antigen (PSA)|One participant from Tadalafil and 3 participants from placebo group had missing data and are not included in the calculation of mean and standard deviation.|nanograms/milliliter (ng/mL)|Mean|2.3|2.3|Standard Deviation|2.02|2.02|||
4034351|NCT01139762|3855566|B3|||Prostate Volume||milliliters (mL)|Mean|49.4|49.4|Standard Deviation|20.35|20.35|||
4034352|NCT01139762|3855567|B2|||Prostate Volume||milliliters (mL)|Mean|50.6|50.6|Standard Deviation|21.17|21.17|||
4034353|NCT01139762|3855568|B1|||Prostate Volume||milliliters (mL)|Mean|48.2|48.2|Standard Deviation|19.43|19.43|||
4034354|NCT01139762|3855566|B3|||Postvoid residual volume (PVR)|Two participants from placebo group had missing data and are not included in the calculation of mean and standard deviation.|milliliters (mL)|Mean|64.1|64.1|Standard Deviation|60.10|60.1|||
4034355|NCT01139762|3855567|B2|||Postvoid residual volume (PVR)|Two participants from placebo group had missing data and are not included in the calculation of mean and standard deviation.|milliliters (mL)|Mean|62.6|62.6|Standard Deviation|59.57|59.57|||
4034385|NCT01139762|3855567|B2|Belgium||Region of Enrollment||participants|Number|16|16.0||||||
4034356|NCT01139762|3855568|B1|||Postvoid residual volume (PVR)|Two participants from placebo group had missing data and are not included in the calculation of mean and standard deviation.|milliliters (mL)|Mean|65.5|65.5|Standard Deviation|60.69|60.69|||
4034357|NCT01139762|3855566|B3|>15 mL/sec||Peak urine flow rate|Peak urine flow rate is expressed as milliliters/second (mL/sec).|participants|Number|2|2.0||||||
4034358|NCT01139762|3855567|B2|>15 mL/sec||Peak urine flow rate|Peak urine flow rate is expressed as milliliters/second (mL/sec).|participants|Number|1|1.0||||||
4034359|NCT01139762|3855568|B1|>15 mL/sec||Peak urine flow rate|Peak urine flow rate is expressed as milliliters/second (mL/sec).|participants|Number|1|1.0||||||
4034360|NCT01139762|3855566|B3|10-15 mL/sec||Peak urine flow rate|Peak urine flow rate is expressed as milliliters/second (mL/sec).|participants|Number|370|370.0||||||
4034361|NCT01139762|3855567|B2|10-15 mL/sec||Peak urine flow rate|Peak urine flow rate is expressed as milliliters/second (mL/sec).|participants|Number|180|180.0||||||
4034362|NCT01139762|3855568|B1|10-15 mL/sec||Peak urine flow rate|Peak urine flow rate is expressed as milliliters/second (mL/sec).|participants|Number|190|190.0||||||
4034363|NCT01139762|3855566|B3|<10 milliliters/second (mL/sec)||Peak urine flow rate|Peak urine flow rate is expressed as milliliters/second (mL/sec).|participants|Number|323|323.0||||||
4034364|NCT01139762|3855567|B2|<10 milliliters/second (mL/sec)||Peak urine flow rate|Peak urine flow rate is expressed as milliliters/second (mL/sec).|participants|Number|169|169.0||||||
4034365|NCT01139762|3855568|B1|<10 milliliters/second (mL/sec)||Peak urine flow rate|Peak urine flow rate is expressed as milliliters/second (mL/sec).|participants|Number|154|154.0||||||
4034366|NCT01139762|3855566|B3|Unknown||Lower urinary tract symptoms (LUTS) severity|The International Prostate Symptom Score (IPSS) is a rating scale for severity of lower urinary tract symptoms (LUTS). The IPSS has a 7-component questionnaire. Each question is scored on a scale from 0 (none/no symptoms) to 5 (frequent symptoms), for a total score range of 0 to 35. Higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|2|2.0||||||
4034367|NCT01139762|3855567|B2|Unknown||Lower urinary tract symptoms (LUTS) severity|The International Prostate Symptom Score (IPSS) is a rating scale for severity of lower urinary tract symptoms (LUTS). The IPSS has a 7-component questionnaire. Each question is scored on a scale from 0 (none/no symptoms) to 5 (frequent symptoms), for a total score range of 0 to 35. Higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|1|1.0||||||
4034368|NCT01139762|3855568|B1|Unknown||Lower urinary tract symptoms (LUTS) severity|The International Prostate Symptom Score (IPSS) is a rating scale for severity of lower urinary tract symptoms (LUTS). The IPSS has a 7-component questionnaire. Each question is scored on a scale from 0 (none/no symptoms) to 5 (frequent symptoms), for a total score range of 0 to 35. Higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|1|1.0||||||
4034369|NCT01139762|3855566|B3|Severe (IPSS≥20)||Lower urinary tract symptoms (LUTS) severity|The International Prostate Symptom Score (IPSS) is a rating scale for severity of lower urinary tract symptoms (LUTS). The IPSS has a 7-component questionnaire. Each question is scored on a scale from 0 (none/no symptoms) to 5 (frequent symptoms), for a total score range of 0 to 35. Higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|220|220.0||||||
4034370|NCT01139762|3855567|B2|Severe (IPSS≥20)||Lower urinary tract symptoms (LUTS) severity|The International Prostate Symptom Score (IPSS) is a rating scale for severity of lower urinary tract symptoms (LUTS). The IPSS has a 7-component questionnaire. Each question is scored on a scale from 0 (none/no symptoms) to 5 (frequent symptoms), for a total score range of 0 to 35. Higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|114|114.0||||||
4034371|NCT01139762|3855568|B1|Severe (IPSS≥20)||Lower urinary tract symptoms (LUTS) severity|The International Prostate Symptom Score (IPSS) is a rating scale for severity of lower urinary tract symptoms (LUTS). The IPSS has a 7-component questionnaire. Each question is scored on a scale from 0 (none/no symptoms) to 5 (frequent symptoms), for a total score range of 0 to 35. Higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|106|106.0||||||
4034372|NCT01139762|3855566|B3|Moderate (IPSS<20)||Lower urinary tract symptoms (LUTS) severity|The International Prostate Symptom Score (IPSS) is a rating scale for severity of lower urinary tract symptoms (LUTS). The IPSS has a 7-component questionnaire. Each question is scored on a scale from 0 (none/no symptoms) to 5 (frequent symptoms), for a total score range of 0 to 35. Higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|473|473.0||||||
4034373|NCT01139762|3855567|B2|Moderate (IPSS<20)||Lower urinary tract symptoms (LUTS) severity|The International Prostate Symptom Score (IPSS) is a rating scale for severity of lower urinary tract symptoms (LUTS). The IPSS has a 7-component questionnaire. Each question is scored on a scale from 0 (none/no symptoms) to 5 (frequent symptoms), for a total score range of 0 to 35. Higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|235|235.0||||||
4034374|NCT01139762|3855568|B1|Moderate (IPSS<20)||Lower urinary tract symptoms (LUTS) severity|The International Prostate Symptom Score (IPSS) is a rating scale for severity of lower urinary tract symptoms (LUTS). The IPSS has a 7-component questionnaire. Each question is scored on a scale from 0 (none/no symptoms) to 5 (frequent symptoms), for a total score range of 0 to 35. Higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|238|238.0||||||
4034375|NCT01139762|3855566|B3|Germany||Region of Enrollment||participants|Number|52|52.0||||||
4034376|NCT01139762|3855567|B2|Germany||Region of Enrollment||participants|Number|28|28.0||||||
4034377|NCT01139762|3855568|B1|Germany||Region of Enrollment||participants|Number|24|24.0||||||
4034378|NCT01139762|3855566|B3|Brazil||Region of Enrollment||participants|Number|25|25.0||||||
4034379|NCT01139762|3855567|B2|Brazil||Region of Enrollment||participants|Number|13|13.0||||||
4034380|NCT01139762|3855568|B1|Brazil||Region of Enrollment||participants|Number|12|12.0||||||
4034381|NCT01139762|3855566|B3|Poland||Region of Enrollment||participants|Number|71|71.0||||||
4034382|NCT01139762|3855567|B2|Poland||Region of Enrollment||participants|Number|39|39.0||||||
4034383|NCT01139762|3855568|B1|Poland||Region of Enrollment||participants|Number|32|32.0||||||
4034384|NCT01139762|3855566|B3|Belgium||Region of Enrollment||participants|Number|23|23.0||||||
4034386|NCT01139762|3855568|B1|Belgium||Region of Enrollment||participants|Number|7|7.0||||||
4034387|NCT01139762|3855566|B3|Argentina||Region of Enrollment||participants|Number|87|87.0||||||
4034388|NCT01139762|3855567|B2|Argentina||Region of Enrollment||participants|Number|41|41.0||||||
4034389|NCT01139762|3855568|B1|Argentina||Region of Enrollment||participants|Number|46|46.0||||||
4034390|NCT01139762|3855566|B3|Canada||Region of Enrollment||participants|Number|58|58.0||||||
4034391|NCT01139762|3855567|B2|Canada||Region of Enrollment||participants|Number|28|28.0||||||
4034392|NCT01139762|3855568|B1|Canada||Region of Enrollment||participants|Number|30|30.0||||||
4034393|NCT01139762|3855566|B3|Mexico||Region of Enrollment||participants|Number|70|70.0||||||
4034394|NCT01139762|3855567|B2|Mexico||Region of Enrollment||participants|Number|37|37.0||||||
4034395|NCT01139762|3855568|B1|Mexico||Region of Enrollment||participants|Number|33|33.0||||||
4034396|NCT01139762|3855566|B3|France||Region of Enrollment||participants|Number|30|30.0||||||
4034397|NCT01139762|3855567|B2|France||Region of Enrollment||participants|Number|9|9.0||||||
4034398|NCT01139762|3855568|B1|France||Region of Enrollment||participants|Number|21|21.0||||||
4034399|NCT01139762|3855566|B3|Italy||Region of Enrollment||participants|Number|46|46.0||||||
4034400|NCT01139762|3855567|B2|Italy||Region of Enrollment||participants|Number|25|25.0||||||
4034401|NCT01139762|3855568|B1|Italy||Region of Enrollment||participants|Number|21|21.0||||||
4034402|NCT01139762|3855566|B3|Russian Federation||Region of Enrollment||participants|Number|69|69.0||||||
4034403|NCT01139762|3855567|B2|Russian Federation||Region of Enrollment||participants|Number|37|37.0||||||
4034404|NCT01139762|3855568|B1|Russian Federation||Region of Enrollment||participants|Number|32|32.0||||||
4034405|NCT01139762|3855566|B3|Turkey||Region of Enrollment||participants|Number|45|45.0||||||
4034406|NCT01139762|3855567|B2|Turkey||Region of Enrollment||participants|Number|19|19.0||||||
4034407|NCT01139762|3855568|B1|Turkey||Region of Enrollment||participants|Number|26|26.0||||||
4034408|NCT01139762|3855566|B3|Greece||Region of Enrollment||participants|Number|30|30.0||||||
4034409|NCT01139762|3855567|B2|Greece||Region of Enrollment||participants|Number|12|12.0||||||
4034410|NCT01139762|3855568|B1|Greece||Region of Enrollment||participants|Number|18|18.0||||||
4034411|NCT01139762|3855566|B3|United States||Region of Enrollment||participants|Number|89|89.0||||||
4034412|NCT01139762|3855567|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
4034413|NCT01139762|3855568|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4034414|NCT01139762|3855566|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4034415|NCT01139762|3855567|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4034416|NCT01139762|3855568|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4034417|NCT01139762|3855566|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4034418|NCT01139762|3855567|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4034419|NCT01139762|3855568|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4034420|NCT01139762|3855566|B3||White|Race (NIH/OMB)||Participants|Count of Participants|594|594.0||||||
4034421|NCT01139762|3855567|B2||White|Race (NIH/OMB)||Participants|Count of Participants|296|296.0||||||
4034422|NCT01139762|3855568|B1||White|Race (NIH/OMB)||Participants|Count of Participants|298|298.0||||||
4034423|NCT01139762|3855566|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4034424|NCT01139762|3855567|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4034425|NCT01139762|3855568|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4034426|NCT01139762|3855566|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4034427|NCT01139762|3855567|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4034428|NCT01139762|3855568|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4034429|NCT01139762|3855566|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4034430|NCT01139762|3855567|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4034431|NCT01139762|3855568|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4034432|NCT01139762|3855566|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4034433|NCT01139762|3855567|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4034434|NCT01139762|3855568|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4034435|NCT01139762|3855566|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)|Information was not collected for participants outside of United States.|Participants|Count of Participants|606|606.0||||||
4034436|NCT01139762|3855567|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)|Information was not collected for participants outside of United States.|Participants|Count of Participants|304|304.0||||||
4034437|NCT01139762|3855568|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|Information was not collected for participants outside of United States.|Participants|Count of Participants|302|302.0||||||
4034438|NCT01139762|3855566|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Information was not collected for participants outside of United States.|Participants|Count of Participants|80|80.0||||||
4034439|NCT01139762|3855567|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Information was not collected for participants outside of United States.|Participants|Count of Participants|41|41.0||||||
4034440|NCT01139762|3855568|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Information was not collected for participants outside of United States.|Participants|Count of Participants|39|39.0||||||
4034441|NCT01139762|3855566|B3||Hispanic or Latino|Ethnicity (NIH/OMB)|Information was not collected for participants outside of United States.|Participants|Count of Participants|9|9.0||||||
4034442|NCT01139762|3855567|B2||Hispanic or Latino|Ethnicity (NIH/OMB)|Information was not collected for participants outside of United States.|Participants|Count of Participants|5|5.0||||||
4034443|NCT01139762|3855568|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|Information was not collected for participants outside of United States.|Participants|Count of Participants|4|4.0||||||
4034444|NCT01139762|3855566|B3||Male|Sex: Female, Male||Participants|Count of Participants|695|695.0||||||
4034445|NCT01139762|3855567|B2||Male|Sex: Female, Male||Participants|Count of Participants|350|350.0||||||
4034446|NCT01139762|3855568|B1||Male|Sex: Female, Male||Participants|Count of Participants|345|345.0||||||
4034447|NCT01139762|3855566|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4034448|NCT01139762|3855567|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4034449|NCT01139762|3855568|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4034450|NCT01139762|3855566|B3|||Age||years|Mean|63.7|63.7|Standard Deviation|7.68|7.68|||
4034451|NCT01139762|3855567|B2|||Age||years|Mean|63.6|63.6|Standard Deviation|7.85|7.85|||
4034452|NCT01139762|3855568|B1|||Age||years|Mean|63.8|63.8|Standard Deviation|7.50|7.5|||
4034453|NCT01139658|3855603|B3|Epidural||Type of anesthesia||participants|Number|1|1.0||||||
4034454|NCT01139658|3855604|B2|Epidural||Type of anesthesia||participants|Number|1|1.0||||||
4034455|NCT01139658|3855605|B1|Epidural||Type of anesthesia||participants|Number|0|0.0||||||
4034456|NCT01139658|3855603|B3|Spinal||Type of anesthesia||participants|Number|468|468.0||||||
4034457|NCT01139658|3855604|B2|Spinal||Type of anesthesia||participants|Number|187|187.0||||||
4034458|NCT01139658|3855605|B1|Spinal||Type of anesthesia||participants|Number|281|281.0||||||
4034459|NCT01139658|3855603|B3|General||Type of anesthesia||participants|Number|1205|1205.0||||||
4034460|NCT01139658|3855604|B2|General||Type of anesthesia||participants|Number|742|742.0||||||
4034461|NCT01139658|3855605|B1|General||Type of anesthesia||participants|Number|463|463.0||||||
4034462|NCT01139658|3855603|B3|||Duration of the surgery||minutes|Mean|74.9|74.9|Standard Deviation|28.1|28.1|||
4034463|NCT01139658|3855604|B2|||Duration of the surgery||minutes|Mean|70.1|70.1|Standard Deviation|28.6|28.6|||
4034464|NCT01139658|3855605|B1|||Duration of the surgery||minutes|Mean|80.8|80.8|Standard Deviation|27.5|27.5|||
4034465|NCT01139658|3855603|B3|Other||Indication for the surgery||participants|Number|11|11.0||||||
4034466|NCT01139658|3855604|B2|Other||Indication for the surgery||participants|Number|9|9.0||||||
4034467|NCT01139658|3855605|B1|Other||Indication for the surgery||participants|Number|2|2.0||||||
4034468|NCT01139658|3855603|B3|Inflammatory arthritis||Indication for the surgery||participants|Number|16|16.0||||||
4034469|NCT01139658|3855604|B2|Inflammatory arthritis||Indication for the surgery||participants|Number|10|10.0||||||
4034470|NCT01139658|3855605|B1|Inflammatory arthritis||Indication for the surgery||participants|Number|6|6.0||||||
4034471|NCT01139658|3855603|B3|Post-trauma||Indication for the surgery||participants|Number|25|25.0||||||
4034472|NCT01139658|3855604|B2|Post-trauma||Indication for the surgery||participants|Number|19|19.0||||||
4034473|NCT01139658|3855605|B1|Post-trauma||Indication for the surgery||participants|Number|6|6.0||||||
4034474|NCT01139658|3855603|B3|Osteonecrosis||Indication for the surgery||participants|Number|37|37.0||||||
4034475|NCT01139658|3855604|B2|Osteonecrosis||Indication for the surgery||participants|Number|30|30.0||||||
4034476|NCT01139658|3855605|B1|Osteonecrosis||Indication for the surgery||participants|Number|7|7.0||||||
4034477|NCT01139658|3855603|B3|Repair of existing prothesis||Indication for the surgery||participants|Number|66|66.0||||||
4034478|NCT01139658|3855604|B2|Repair of existing prothesis||Indication for the surgery||participants|Number|42|42.0||||||
4034479|NCT01139658|3855605|B1|Repair of existing prothesis||Indication for the surgery||participants|Number|24|24.0||||||
4034480|NCT01139658|3855603|B3|Osteoarthritis||Indication for the surgery||participants|Number|1519|1519.0||||||
4034481|NCT01139658|3855604|B2|Osteoarthritis||Indication for the surgery||participants|Number|818|818.0||||||
4034482|NCT01139658|3855605|B1|Osteoarthritis||Indication for the surgery||participants|Number|701|701.0||||||
4034483|NCT01139658|3855603|B3|||Type of orthopedic surgery||participants|Number|1675|1675.0||||||
4034484|NCT01139658|3855604|B2|||Type of orthopedic surgery||participants|Number|929|929.0||||||
4034485|NCT01139658|3855605|B1|||Type of orthopedic surgery||participants|Number|746|746.0||||||
4034486|NCT01139658|3855603|B3|Verapamil||Current treatment||participants|Number|7|7.0||||||
4034487|NCT01139658|3855604|B2|Verapamil||Current treatment||participants|Number|3|3.0||||||
4034488|NCT01139658|3855605|B1|Verapamil||Current treatment||participants|Number|4|4.0||||||
4034489|NCT01139658|3855603|B3|Hydroquinidin||Current treatment||participants|Number|0|0.0||||||
4034490|NCT01139658|3855604|B2|Hydroquinidin||Current treatment||participants|Number|0|0.0||||||
4034491|NCT01139658|3855605|B1|Hydroquinidin||Current treatment||participants|Number|0|0.0||||||
4034492|NCT01139658|3855603|B3|Amiodarone||Current treatment||participants|Number|14|14.0||||||
4034493|NCT01139658|3855604|B2|Amiodarone||Current treatment||participants|Number|7|7.0||||||
4034494|NCT01139658|3855605|B1|Amiodarone||Current treatment||participants|Number|7|7.0||||||
4034495|NCT01139658|3855603|B3|Clopidogrel||Current treatment||participants|Number|8|8.0||||||
4034496|NCT01139658|3855604|B2|Clopidogrel||Current treatment||participants|Number|3|3.0||||||
4034497|NCT01139658|3855605|B1|Clopidogrel||Current treatment||participants|Number|5|5.0||||||
4034498|NCT01139658|3855603|B3|Aspirin||Current treatment||participants|Number|101|101.0||||||
4034499|NCT01139658|3855604|B2|Aspirin||Current treatment||participants|Number|45|45.0||||||
4034500|NCT01139658|3855605|B1|Aspirin||Current treatment||participants|Number|56|56.0||||||
4034501|NCT01139658|3855603|B3|NSAID||Current treatment||participants|Number|217|217.0||||||
4034502|NCT01139658|3855604|B2|NSAID||Current treatment||participants|Number|125|125.0||||||
4034503|NCT01139658|3855605|B1|NSAID||Current treatment||participants|Number|92|92.0||||||
4034504|NCT01139658|3855603|B3|Verapimil||Previous treatment||participants|Number|7|7.0||||||
4034505|NCT01139658|3855604|B2|Verapimil||Previous treatment||participants|Number|3|3.0||||||
4034506|NCT01139658|3855605|B1|Verapimil||Previous treatment||participants|Number|4|4.0||||||
4034507|NCT01139658|3855603|B3|Hydroquindin||Previous treatment||participants|Number|0|0.0||||||
4034508|NCT01139658|3855604|B2|Hydroquindin||Previous treatment||participants|Number|0|0.0||||||
4034509|NCT01139658|3855605|B1|Hydroquindin||Previous treatment||participants|Number|0|0.0||||||
4034510|NCT01139658|3855603|B3|Amiodarone||Previous treatment||participants|Number|14|14.0||||||
4034511|NCT01139658|3855604|B2|Amiodarone||Previous treatment||participants|Number|7|7.0||||||
4034512|NCT01139658|3855605|B1|Amiodarone||Previous treatment||participants|Number|7|7.0||||||
4034513|NCT01139658|3855603|B3|Clopidogrel||Previous treatment||participants|Number|27|27.0||||||
4034514|NCT01139658|3855604|B2|Clopidogrel||Previous treatment||participants|Number|15|15.0||||||
4034515|NCT01139658|3855605|B1|Clopidogrel||Previous treatment||participants|Number|12|12.0||||||
4034516|NCT01139658|3855603|B3|Aspirin||Previous treatment||participants|Number|162|162.0||||||
4034517|NCT01139658|3855604|B2|Aspirin||Previous treatment||participants|Number|79|79.0||||||
4034518|NCT01139658|3855605|B1|Aspirin||Previous treatment||participants|Number|83|83.0||||||
4034519|NCT01139658|3855603|B3|NSAID||Previous treatment||participants|Number|911|911.0||||||
4034520|NCT01139658|3855604|B2|NSAID||Previous treatment||participants|Number|509|509.0||||||
4034521|NCT01139658|3855605|B1|NSAID||Previous treatment||participants|Number|402|402.0||||||
4034522|NCT01139658|3855603|B3|||Participants with at least one concomitant disease||participants|Number|379|379.0||||||
4034523|NCT01139658|3855604|B2|||Participants with at least one concomitant disease||participants|Number|203|203.0||||||
4034524|NCT01139658|3855605|B1|||Participants with at least one concomitant disease||participants|Number|176|176.0||||||
4034525|NCT01139658|3855603|B3|||Participants with at least one cardiovascular risk factor||participants|Number|1129|1129.0||||||
4034526|NCT01139658|3855604|B2|||Participants with at least one cardiovascular risk factor||participants|Number|586|586.0||||||
4034527|NCT01139658|3855605|B1|||Participants with at least one cardiovascular risk factor||participants|Number|543|543.0||||||
4034528|NCT01139658|3855603|B3|||Participants with at least one thromboembolic risk factor||participants|Number|296|296.0||||||
4034529|NCT01139658|3855604|B2|||Participants with at least one thromboembolic risk factor||participants|Number|145|145.0||||||
4034530|NCT01139658|3855605|B1|||Participants with at least one thromboembolic risk factor||participants|Number|151|151.0||||||
4034531|NCT01139658|3855603|B3|||Participants with a Alanine Aminotransferase (ALT) of >2x normal upper limit||participants|Number|69|69.0||||||
4034532|NCT01139658|3855604|B2|||Participants with a Alanine Aminotransferase (ALT) of >2x normal upper limit||participants|Number|40|40.0||||||
4034533|NCT01139658|3855605|B1|||Participants with a Alanine Aminotransferase (ALT) of >2x normal upper limit||participants|Number|29|29.0||||||
4034534|NCT01139658|3855603|B3|||Height||cm|Mean|165.8|165.8|Standard Deviation|9.1|9.1|||
4034535|NCT01139658|3855604|B2|||Height||cm|Mean|166.8|166.8|Standard Deviation|9.1|9.1|||
4034536|NCT01139658|3855605|B1|||Height||cm|Mean|164.6|164.6|Standard Deviation|9.1|9.1|||
4034537|NCT01139658|3855603|B3|||Weight||kilogramm|Mean|76.8|76.8|Standard Deviation|15.9|15.9|||
4034538|NCT01139658|3855604|B2|||Weight||kilogramm|Mean|74.5|74.5|Standard Deviation|15.6|15.6|||
4034539|NCT01139658|3855605|B1|||Weight||kilogramm|Mean|79.6|79.6|Standard Deviation|16.3|16.3|||
4034540|NCT01139658|3855603|B3|||Creatinine clearance||mL/min|Mean|85.7|85.7|Standard Deviation|30.9|30.9|||
4034541|NCT01139658|3855604|B2|||Creatinine clearance||mL/min|Mean|85.1|85.1|Standard Deviation|31.9|31.9|||
4034542|NCT01139658|3855605|B1|||Creatinine clearance||mL/min|Mean|86.4|86.4|Standard Deviation|29.6|29.6|||
4034543|NCT01139658|3855603|B3||Male|Sex: Female, Male||Participants|Count of Participants|684|684.0||||||
4034544|NCT01139658|3855604|B2||Male|Sex: Female, Male||Participants|Count of Participants|435|435.0||||||
4034545|NCT01139658|3855605|B1||Male|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
4034546|NCT01139658|3855603|B3||Female|Sex: Female, Male||Participants|Count of Participants|991|991.0||||||
4034547|NCT01139658|3855604|B2||Female|Sex: Female, Male||Participants|Count of Participants|494|494.0||||||
4034548|NCT01139658|3855605|B1||Female|Sex: Female, Male||Participants|Count of Participants|497|497.0||||||
4034549|NCT01139658|3855603|B3|||Age||years|Mean|68.69|68.69|Standard Deviation|10.78|10.78|||
4034550|NCT01139658|3855604|B2|||Age||years|Mean|67.8|67.8|Standard Deviation|11.7|11.7|||
4034551|NCT01139658|3855605|B1|||Age||years|Mean|69.8|69.8|Standard Deviation|9.5|9.5|||
4034552|NCT01139580|3855642|B3|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4034553|NCT01139580|3855643|B2|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4034554|NCT01139580|3855644|B1|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4034555|NCT01139580|3855642|B3|White||Race/Ethnicity, Customized||participants|Number|316|316.0||||||
4034556|NCT01139580|3855643|B2|White||Race/Ethnicity, Customized||participants|Number|160|160.0||||||
4034557|NCT01139580|3855644|B1|White||Race/Ethnicity, Customized||participants|Number|156|156.0||||||
4034558|NCT01139580|3855642|B3|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4034559|NCT01139580|3855643|B2|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4034560|NCT01139580|3855644|B1|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4034561|NCT01139580|3855642|B3|Multiracial||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4034562|NCT01139580|3855643|B2|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4034563|NCT01139580|3855644|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4034564|NCT01139580|3855642|B3|Black||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4034565|NCT01139580|3855643|B2|Black||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4034566|NCT01139580|3855644|B1|Black||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4034567|NCT01139580|3855642|B3|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4034568|NCT01139580|3855643|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4034569|NCT01139580|3855644|B1|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4034570|NCT01139580|3855642|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4034571|NCT01139580|3855643|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4034572|NCT01139580|3855644|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4034573|NCT01139580|3855642|B3||Male|Gender||Participants|Count of Participants|218|218.0||||||
4034574|NCT01139580|3855643|B2||Male|Gender||Participants|Count of Participants|106|106.0||||||
4034575|NCT01139580|3855644|B1||Male|Gender||Participants|Count of Participants|112|112.0||||||
4034576|NCT01139580|3855642|B3||Female|Gender||Participants|Count of Participants|145|145.0||||||
4034577|NCT01139580|3855643|B2||Female|Gender||Participants|Count of Participants|76|76.0||||||
4034578|NCT01139580|3855644|B1||Female|Gender||Participants|Count of Participants|69|69.0||||||
4034579|NCT01139580|3855642|B3|||Age||Years|Mean|45.2|45.2|Standard Deviation|15.4|15.4|||
4034580|NCT01139580|3855643|B2|||Age||Years|Mean|44.4|44.4|Standard Deviation|15.5|15.5|||
4034581|NCT01139580|3855644|B1|||Age||Years|Mean|45.9|45.9|Standard Deviation|15.3|15.3|||
4034582|NCT01139515|3855661|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4034583|NCT01139515|3855661|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4034584|NCT01139515|3855661|B1|||Age||Years|Mean|24.8|24.8|Standard Deviation|2.9|2.9|||
4034585|NCT01139450|3855690|B4|Central America||Region of Enrollment||participants|Number|65|65.0||||||
4034586|NCT01139450|3855691|B3|Central America||Region of Enrollment||participants|Number|21|21.0||||||
4034587|NCT01139450|3855692|B2|Central America||Region of Enrollment||participants|Number|22|22.0||||||
4034588|NCT01139450|3855693|B1|Central America||Region of Enrollment||participants|Number|22|22.0||||||
4034589|NCT01139450|3855690|B4|United States||Region of Enrollment||participants|Number|834|834.0||||||
4034590|NCT01139450|3855691|B3|United States||Region of Enrollment||participants|Number|279|279.0||||||
4034591|NCT01139450|3855692|B2|United States||Region of Enrollment||participants|Number|275|275.0||||||
4034592|NCT01139450|3855693|B1|United States||Region of Enrollment||participants|Number|280|280.0||||||
4034593|NCT01139450|3855690|B4||Male|Sex: Female, Male||Participants|Count of Participants|333|333.0||||||
4034594|NCT01139450|3855691|B3||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4034595|NCT01139450|3855692|B2||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4034596|NCT01139450|3855693|B1||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4034597|NCT01139450|3855690|B4||Female|Sex: Female, Male||Participants|Count of Participants|566|566.0||||||
4034598|NCT01139450|3855691|B3||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4034599|NCT01139450|3855692|B2||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4034600|NCT01139450|3855693|B1||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4034601|NCT01139450|3855690|B4|Age, Years||Age, Customized||years|Mean|28.0|28.0|Standard Deviation|18.14|18.14|||
4034602|NCT01139450|3855691|B3|Age, Years||Age, Customized||years|Mean|27.6|27.6|Standard Deviation|17.34|17.34|||
4034603|NCT01139450|3855692|B2|Age, Years||Age, Customized||years|Mean|28.8|28.8|Standard Deviation|18.99|18.99|||
4034604|NCT01139450|3855693|B1|Age, Years||Age, Customized||years|Mean|27.74|27.74|Standard Deviation|18.11|18.11|||
4034605|NCT01139411|3855703|B3|||Communication 2: Observed parent-adolescent communication quality|Observed parent-adolescent communication quality was measured using the Dyadic Observed Communication Scale (DOCS) used to code communication between adolescent and caregiver during a video-taped observational coding session. The DOCS is coded on a scale of 0 -10, with higher scores reflecting higher quality of communication, as observed by an independent rater.|units on a scale|Mean|5.7|5.7|Standard Deviation|1.9|1.9|||
4034606|NCT01139411|3855704|B2|||Communication 2: Observed parent-adolescent communication quality|Observed parent-adolescent communication quality was measured using the Dyadic Observed Communication Scale (DOCS) used to code communication between adolescent and caregiver during a video-taped observational coding session. The DOCS is coded on a scale of 0 -10, with higher scores reflecting higher quality of communication, as observed by an independent rater.|units on a scale|Mean|5.8|5.8|Standard Deviation|1.9|1.9|||
4034607|NCT01139411|3855705|B1|||Communication 2: Observed parent-adolescent communication quality|Observed parent-adolescent communication quality was measured using the Dyadic Observed Communication Scale (DOCS) used to code communication between adolescent and caregiver during a video-taped observational coding session. The DOCS is coded on a scale of 0 -10, with higher scores reflecting higher quality of communication, as observed by an independent rater.|units on a scale|Mean|5.5|5.5|Standard Deviation|2.1|2.1|||
4034608|NCT01139411|3855703|B3|||Communication 1: Negative weight-related comments|Negative maternal weight-related commentary was assessed using the Negative maternal weight-related commentary subscale of the Family Experiences Related to Food Questionnaire (FERF-Q)), an adolescent-report measure of parent behavior pertaining to weight control. The Negative maternal weight-related commentary subscale of the FERF-Q has a scale range of 1 - 5, with higher scores corresponding to greater negative maternal weight-related commentary, as perceived and reported by the adolescent.|units on a scale|Mean|2.79|2.79|Standard Deviation|0.70|0.7|||
4034624|NCT01139411|3855704|B2|||Body Mass Index (kg/m^2)||kilograms/meters squared (kg/m2)|Mean|31.17|31.17|Standard Deviation|3.01|3.01|||
4034609|NCT01139411|3855704|B2|||Communication 1: Negative weight-related comments|Negative maternal weight-related commentary was assessed using the Negative maternal weight-related commentary subscale of the Family Experiences Related to Food Questionnaire (FERF-Q)), an adolescent-report measure of parent behavior pertaining to weight control. The Negative maternal weight-related commentary subscale of the FERF-Q has a scale range of 1 - 5, with higher scores corresponding to greater negative maternal weight-related commentary, as perceived and reported by the adolescent.|units on a scale|Mean|2.85|2.85|Standard Deviation|0.64|0.64|||
4034610|NCT01139411|3855705|B1|||Communication 1: Negative weight-related comments|Negative maternal weight-related commentary was assessed using the Negative maternal weight-related commentary subscale of the Family Experiences Related to Food Questionnaire (FERF-Q)), an adolescent-report measure of parent behavior pertaining to weight control. The Negative maternal weight-related commentary subscale of the FERF-Q has a scale range of 1 - 5, with higher scores corresponding to greater negative maternal weight-related commentary, as perceived and reported by the adolescent.|units on a scale|Mean|2.73|2.73|Standard Deviation|0.73|0.73|||
4034611|NCT01139411|3855703|B3|||Parent modeling 4: Weight and Body Concerns|Parent modeling of concern about weight/body was assessed using the Parent Modeling of Weight and Body Concerns subscale of the Family Experiences Related to Food Questionnaire (FERF-Q)), an adolescent-report measure of parent behavior pertaining to weight control. The Weight and Body Concerns subscale of the FERF-Q has a scale range of 1 - 5, with greater scores corresponding to greater parent weight and body concerns, as perceived and reported by the adolescent.|units on a scale|Mean|2.83|2.83|Standard Deviation|0.84|0.84|||
4034612|NCT01139411|3855704|B2|||Parent modeling 4: Weight and Body Concerns|Parent modeling of concern about weight/body was assessed using the Parent Modeling of Weight and Body Concerns subscale of the Family Experiences Related to Food Questionnaire (FERF-Q)), an adolescent-report measure of parent behavior pertaining to weight control. The Weight and Body Concerns subscale of the FERF-Q has a scale range of 1 - 5, with greater scores corresponding to greater parent weight and body concerns, as perceived and reported by the adolescent.|units on a scale|Mean|2.90|2.9|Standard Deviation|0.89|0.89|||
4034613|NCT01139411|3855705|B1|||Parent modeling 4: Weight and Body Concerns|Parent modeling of concern about weight/body was assessed using the Parent Modeling of Weight and Body Concerns subscale of the Family Experiences Related to Food Questionnaire (FERF-Q)), an adolescent-report measure of parent behavior pertaining to weight control. The Weight and Body Concerns subscale of the FERF-Q has a scale range of 1 - 5, with greater scores corresponding to greater parent weight and body concerns, as perceived and reported by the adolescent.|units on a scale|Mean|2.75|2.75|Standard Deviation|0.80|0.8|||
4034614|NCT01139411|3855703|B3|||Parent modeling 3: Physical Activity (WCSS)|). Parent modeling of Physical Activity was assessed using the Physical Activity subscale of the Weight Control Strategies Scale (WCSS), a parent-report measure of his/her own healthy weight control practices. The Physical Activity subscale of the WCSS has a scale range of 0-4, with higher scores corresponding to greater physical activity.|units on a scale|Mean|1.30|1.3|Standard Deviation|1.18|1.18|||
4034615|NCT01139411|3855704|B2|||Parent modeling 3: Physical Activity (WCSS)|). Parent modeling of Physical Activity was assessed using the Physical Activity subscale of the Weight Control Strategies Scale (WCSS), a parent-report measure of his/her own healthy weight control practices. The Physical Activity subscale of the WCSS has a scale range of 0-4, with higher scores corresponding to greater physical activity.|units on a scale|Mean|0.90|0.9|Standard Deviation|1.05|1.05|||
4034616|NCT01139411|3855705|B1|||Parent modeling 3: Physical Activity (WCSS)|). Parent modeling of Physical Activity was assessed using the Physical Activity subscale of the Weight Control Strategies Scale (WCSS), a parent-report measure of his/her own healthy weight control practices. The Physical Activity subscale of the WCSS has a scale range of 0-4, with higher scores corresponding to greater physical activity.|units on a scale|Mean|1.75|1.75|Standard Deviation|1.17|1.17|||
4034617|NCT01139411|3855703|B3|||Parent modeling 2: Self-monitoring (WCSS)|Parent modeling of self-monitoring behavior was assessed using the Self Monitoring subscale of the Weight Control Strategies Scale (WCSS), a parent-report measure of his/her own healthy weight control practices. The Self Monitoring subscale of the WCSS has a scale range of 0 - 4, with higher scores corresponding to more self-monitoring behavior.|units on a scale|Mean|0.67|0.67|Standard Deviation|0.75|0.75|||
4034618|NCT01139411|3855704|B2|||Parent modeling 2: Self-monitoring (WCSS)|Parent modeling of self-monitoring behavior was assessed using the Self Monitoring subscale of the Weight Control Strategies Scale (WCSS), a parent-report measure of his/her own healthy weight control practices. The Self Monitoring subscale of the WCSS has a scale range of 0 - 4, with higher scores corresponding to more self-monitoring behavior.|units on a scale|Mean|0.55|0.55|Standard Deviation|0.70|0.7|||
4034619|NCT01139411|3855705|B1|||Parent modeling 2: Self-monitoring (WCSS)|Parent modeling of self-monitoring behavior was assessed using the Self Monitoring subscale of the Weight Control Strategies Scale (WCSS), a parent-report measure of his/her own healthy weight control practices. The Self Monitoring subscale of the WCSS has a scale range of 0 - 4, with higher scores corresponding to more self-monitoring behavior.|units on a scale|Mean|.81|0.81|Standard Deviation|0.80|0.8|||
4034620|NCT01139411|3855703|B3|||Parent modeling 1: Dietary Choices (WCSS)|Parent modeling of dietary choices was assessed using the Diet Choices subscale of the Weight Control Strategies Scale (WCSS), a parent-report measure of his/her own healthy weight control practices. The Dietary choices subscale of the WCSS has a scale range of 0 - 4, with higher scores corresponding to healthier diet choices.|units on a scale|Mean|2.50|2.5|Standard Deviation|0.98|0.98|||
4034621|NCT01139411|3855704|B2|||Parent modeling 1: Dietary Choices (WCSS)|Parent modeling of dietary choices was assessed using the Diet Choices subscale of the Weight Control Strategies Scale (WCSS), a parent-report measure of his/her own healthy weight control practices. The Dietary choices subscale of the WCSS has a scale range of 0 - 4, with higher scores corresponding to healthier diet choices.|units on a scale|Mean|2.32|2.32|Standard Deviation|1.13|1.13|||
4034622|NCT01139411|3855705|B1|||Parent modeling 1: Dietary Choices (WCSS)|Parent modeling of dietary choices was assessed using the Diet Choices subscale of the Weight Control Strategies Scale (WCSS), a parent-report measure of his/her own healthy weight control practices. The Dietary choices subscale of the WCSS has a scale range of 0 - 4, with higher scores corresponding to healthier diet choices.|units on a scale|Mean|2.70|2.7|Standard Deviation|0.76|0.76|||
4034623|NCT01139411|3855703|B3|||Body Mass Index (kg/m^2)||kilograms/meters squared (kg/m2)|Mean|32.16|32.16|Standard Deviation|3.64|3.64|||
4034625|NCT01139411|3855705|B1|||Body Mass Index (kg/m^2)||kilograms/meters squared (kg/m2)|Mean|33.25|33.25|Standard Deviation|4.02|4.02|||
4034626|NCT01139411|3855703|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
4034627|NCT01139411|3855704|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4034628|NCT01139411|3855705|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4034629|NCT01139411|3855703|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4034630|NCT01139411|3855704|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4034631|NCT01139411|3855705|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4034632|NCT01139411|3855703|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4034633|NCT01139411|3855704|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4034634|NCT01139411|3855705|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4034635|NCT01139411|3855703|B3|||Age||years|Mean|15.10|15.1|Standard Deviation|1.33|1.33|||
4034636|NCT01139411|3855704|B2|||Age||years|Mean|15.00|15.0|Standard Deviation|1.30|1.3|||
4034637|NCT01139411|3855705|B1|||Age||years|Mean|15.21|15.21|Standard Deviation|1.40|1.4|||
4034638|NCT01139411|3855703|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4034639|NCT01139411|3855704|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4034640|NCT01139411|3855705|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4034641|NCT01139411|3855703|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4034642|NCT01139411|3855704|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4034643|NCT01139411|3855705|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4034644|NCT01139411|3855703|B3||<=18 years|Age||Participants|Count of Participants|49|49.0||||||
4034645|NCT01139411|3855704|B2||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
4034646|NCT01139411|3855705|B1||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
4034647|NCT01139190|3855735|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4034648|NCT01139190|3855736|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4034649|NCT01139190|3855737|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4034650|NCT01139190|3855735|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4034651|NCT01139190|3855736|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4034652|NCT01139190|3855737|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4034653|NCT01139190|3855735|B3|||Age||years|Mean|56.1|56.1|Standard Deviation|5.29|5.29|||
4034654|NCT01139190|3855736|B2|||Age||years|Mean|55.6|55.6|Standard Deviation|4.56|4.56|||
4034655|NCT01139190|3855737|B1|||Age||years|Mean|56.7|56.7|Standard Deviation|5.97|5.97|||
4034656|NCT01139164|3855744|B4|United States||Region of Enrollment||participants|Number|78|78.0||||||
4034657|NCT01139164|3855745|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4034658|NCT01139164|3855746|B2|United States||Region of Enrollment||participants|Number|67|67.0||||||
4034659|NCT01139164|3855747|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4034660|NCT01139164|3855744|B4||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4034661|NCT01139164|3855745|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4034662|NCT01139164|3855746|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4034663|NCT01139164|3855747|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4034664|NCT01139164|3855744|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4034665|NCT01139164|3855745|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4034666|NCT01139164|3855746|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4034667|NCT01139164|3855747|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4034668|NCT01139164|3855744|B4||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4034669|NCT01139164|3855745|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4034670|NCT01139164|3855746|B2||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4034671|NCT01139164|3855747|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4034672|NCT01139164|3855744|B4||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4034673|NCT01139164|3855745|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4034674|NCT01139164|3855746|B2||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4034675|NCT01139164|3855747|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4034676|NCT01139164|3855744|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4034677|NCT01139164|3855745|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4034678|NCT01139164|3855746|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4034679|NCT01139164|3855747|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4034680|NCT01139125|3855763|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4034681|NCT01139125|3855763|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4034682|NCT01139125|3855763|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4034683|NCT01139125|3855763|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4034684|NCT01139125|3855763|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4034685|NCT01139125|3855763|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4034686|NCT01139125|3855763|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4034687|NCT01139125|3855763|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4034688|NCT01139125|3855763|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4034689|NCT01139125|3855763|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4034690|NCT01139125|3855763|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4034691|NCT01139125|3855763|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4034692|NCT01139125|3855763|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4034693|NCT01139047|3855767|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4034694|NCT01139047|3855767|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4034695|NCT01139047|3855767|B1|||Age||years|Mean|42.4|42.4|Standard Deviation|15.07|15.07|||
4034696|NCT01139021|3855776|B7|Finland||Region of Enrollment||Number of Subjects|Number|163|163.0||||||
4034697|NCT01139021|3855777|B6|Finland||Region of Enrollment||Number of Subjects|Number|1|1.0||||||
4034698|NCT01139021|3855778|B5|Finland||Region of Enrollment||Number of Subjects|Number|50|50.0||||||
4034699|NCT01139021|3855779|B4|Finland||Region of Enrollment||Number of Subjects|Number|5|5.0||||||
4034700|NCT01139021|3855780|B3|Finland||Region of Enrollment||Number of Subjects|Number|20|20.0||||||
4034701|NCT01139021|3855781|B2|Finland||Region of Enrollment||Number of Subjects|Number|40|40.0||||||
4034702|NCT01139021|3855782|B1|Finland||Region of Enrollment||Number of Subjects|Number|47|47.0||||||
4034703|NCT01139021|3855776|B7|Czech Republic||Region of Enrollment||Number of Subjects|Number|345|345.0||||||
4034704|NCT01139021|3855777|B6|Czech Republic||Region of Enrollment||Number of Subjects|Number|0|0.0||||||
4034705|NCT01139021|3855778|B5|Czech Republic||Region of Enrollment||Number of Subjects|Number|66|66.0||||||
4034706|NCT01139021|3855779|B4|Czech Republic||Region of Enrollment||Number of Subjects|Number|14|14.0||||||
4034707|NCT01139021|3855780|B3|Czech Republic||Region of Enrollment||Number of Subjects|Number|47|47.0||||||
4034708|NCT01139021|3855781|B2|Czech Republic||Region of Enrollment||Number of Subjects|Number|113|113.0||||||
4034709|NCT01139021|3855782|B1|Czech Republic||Region of Enrollment||Number of Subjects|Number|105|105.0||||||
4034710|NCT01139021|3855776|B7||Male|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
4034711|NCT01139021|3855777|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4034712|NCT01139021|3855778|B5||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4034713|NCT01139021|3855779|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4034714|NCT01139021|3855780|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4034715|NCT01139021|3855781|B2||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4034716|NCT01139021|3855782|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4034717|NCT01139021|3855776|B7||Female|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
4034718|NCT01139021|3855777|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4034719|NCT01139021|3855778|B5||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4034720|NCT01139021|3855779|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4034721|NCT01139021|3855780|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4034722|NCT01139021|3855781|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4034723|NCT01139021|3855782|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4034724|NCT01139021|3855776|B7|||Age||months|Mean|25.4|25.4|Standard Deviation|1.3|1.3|||
4034725|NCT01139021|3855777|B6|||Age||months|Mean|26|26.0|Standard Deviation|0|0.0|||
4034726|NCT01139021|3855778|B5|||Age||months|Mean|24.7|24.7|Standard Deviation|1.4|1.4|||
4034727|NCT01139021|3855779|B4|||Age||months|Mean|26.6|26.6|Standard Deviation|1.2|1.2|||
4034728|NCT01139021|3855780|B3|||Age||months|Mean|27.3|27.3|Standard Deviation|0.9|0.9|||
4034729|NCT01139021|3855781|B2|||Age||months|Mean|25.3|25.3|Standard Deviation|0.9|0.9|||
4034730|NCT01139021|3855782|B1|||Age||months|Mean|25|25.0|Standard Deviation|1.0|1.0|||
4034731|NCT01139008|3855823|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4034732|NCT01139008|3855823|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4034733|NCT01139008|3855823|B1|||Age||years|Mean|45|45.0|Standard Deviation|15.16|15.16|||
4034734|NCT01138995|3855832|B3|United States||Region of Enrollment||participants|Number|197|197.0||||||
4034735|NCT01138995|3855833|B2|United States||Region of Enrollment||participants|Number|99|99.0||||||
4034736|NCT01138995|3855834|B1|United States||Region of Enrollment||participants|Number|98|98.0||||||
4034737|NCT01138995|3855832|B3||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4034738|NCT01138995|3855833|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4034739|NCT01138995|3855834|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4034740|NCT01138995|3855832|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4034741|NCT01138995|3855833|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4034742|NCT01138995|3855834|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4034743|NCT01138995|3855832|B3|||Age||years|Mean|61.1|61.1|Standard Deviation|11.6|11.6|||
4034744|NCT01138995|3855833|B2|||Age||years|Mean|60.7|60.7|Standard Deviation|12.2|12.2|||
4034745|NCT01138995|3855834|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|10.9|10.9|||
4034746|NCT01138969|3855845|B3|Taiwan||Region of Enrollment||participants|Number|165|165.0||||||
4034747|NCT01138969|3855846|B2|Taiwan||Region of Enrollment||participants|Number|82|82.0||||||
4034748|NCT01138969|3855847|B1|Taiwan||Region of Enrollment||participants|Number|83|83.0||||||
4034749|NCT01138969|3855845|B3||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4034750|NCT01138969|3855846|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4034751|NCT01138969|3855847|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4034752|NCT01138969|3855845|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4034753|NCT01138969|3855846|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4034754|NCT01138969|3855847|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4034755|NCT01138969|3855845|B3|||Age||years|Mean|72.0|72.0|Standard Deviation|11.4|11.4|||
4034756|NCT01138969|3855846|B2|||Age||years|Mean|73.3|73.3|Standard Deviation|10.7|10.7|||
4034757|NCT01138969|3855847|B1|||Age||years|Mean|70.6|70.6|Standard Deviation|11.5|11.5|||
4034758|NCT01138969|3855845|B3||>=65 years|Age||Participants|Count of Participants|119|119.0||||||
4034759|NCT01138969|3855846|B2||>=65 years|Age||Participants|Count of Participants|61|61.0||||||
4034760|NCT01138969|3855847|B1||>=65 years|Age||Participants|Count of Participants|58|58.0||||||
4034761|NCT01138969|3855845|B3||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4034762|NCT01138969|3855846|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4034763|NCT01138969|3855847|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4034764|NCT01138969|3855845|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4034765|NCT01138969|3855846|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4034766|NCT01138969|3855847|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4034767|NCT01138826|3855856|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4034768|NCT01138826|3855856|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4034769|NCT01138826|3855856|B1|||Age||years|Mean|27.22|27.22|Standard Deviation|7.22|7.22|||
4034770|NCT01138735|3855881|B3|Canada||Region of Enrollment||participants|Number|26|26.0||||||
4034771|NCT01138735|3855882|B2|Canada||Region of Enrollment||participants|Number|14|14.0||||||
4034772|NCT01138735|3855883|B1|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4034773|NCT01138735|3855881|B3|United States||Region of Enrollment||participants|Number|259|259.0||||||
4034774|NCT01138735|3855882|B2|United States||Region of Enrollment||participants|Number|129|129.0||||||
4034775|NCT01138735|3855883|B1|United States||Region of Enrollment||participants|Number|130|130.0||||||
4034776|NCT01138735|3855881|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4034777|NCT01138735|3855882|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4034778|NCT01138735|3855883|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4034779|NCT01138735|3855881|B3||Female|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
4034780|NCT01138735|3855882|B2||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4034781|NCT01138735|3855883|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4034782|NCT01138735|3855881|B3|||Age||years|Mean|10.4|10.4|Standard Deviation|0.72|0.72|||
4034783|NCT01138735|3855882|B2|||Age||years|Mean|10.4|10.4|Standard Deviation|0.68|0.68|||
4034784|NCT01138735|3855883|B1|||Age||years|Mean|10.3|10.3|Standard Deviation|0.76|0.76|||
4034785|NCT01138735|3855881|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4034786|NCT01138735|3855882|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4034787|NCT01138735|3855883|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4034788|NCT01138735|3855881|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4034789|NCT01138735|3855882|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4034790|NCT01138735|3855883|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4034791|NCT01138735|3855881|B3||<=18 years|Age||Participants|Count of Participants|285|285.0||||||
4034792|NCT01138735|3855882|B2||<=18 years|Age||Participants|Count of Participants|143|143.0||||||
4034793|NCT01138735|3855883|B1||<=18 years|Age||Participants|Count of Participants|142|142.0||||||
4034794|NCT01138657|3855896|B3|||Duration of Uveitis||months|Mean|49.90|49.9|Standard Deviation|71.660|71.66|||
4034795|NCT01138657|3855897|B2|||Duration of Uveitis||months|Mean|41.18|41.18|Standard Deviation|53.530|53.53|||
4034796|NCT01138657|3855898|B1|||Duration of Uveitis||months|Mean|58.56|58.56|Standard Deviation|85.308|85.308|||
4034797|NCT01138657|3855896|B3|Both||Eye Affected||participants|Number|217|217.0||||||
4034798|NCT01138657|3855897|B2|Both||Eye Affected||participants|Number|106|106.0||||||
4034799|NCT01138657|3855898|B1|Both||Eye Affected||participants|Number|111|111.0||||||
4034800|NCT01138657|3855896|B3|Right||Eye Affected||participants|Number|11|11.0||||||
4034801|NCT01138657|3855897|B2|Right||Eye Affected||participants|Number|7|7.0||||||
4034802|NCT01138657|3855898|B1|Right||Eye Affected||participants|Number|4|4.0||||||
4034803|NCT01138657|3855896|B3|Left||Eye Affected||participants|Number|11|11.0||||||
4034804|NCT01138657|3855897|B2|Left||Eye Affected||participants|Number|6|6.0||||||
4034805|NCT01138657|3855898|B1|Left||Eye Affected||participants|Number|5|5.0||||||
4034806|NCT01138657|3855896|B3|Other||Diagnosis||participants|Number|23|23.0||||||
4034807|NCT01138657|3855897|B2|Other||Diagnosis||participants|Number|9|9.0||||||
4034808|NCT01138657|3855898|B1|Other||Diagnosis||participants|Number|14|14.0||||||
4034809|NCT01138657|3855896|B3|Behcet's||Diagnosis||participants|Number|18|18.0||||||
4034810|NCT01138657|3855897|B2|Behcet's||Diagnosis||participants|Number|14|14.0||||||
4034811|NCT01138657|3855898|B1|Behcet's||Diagnosis||participants|Number|4|4.0||||||
4034812|NCT01138657|3855896|B3|Sarcoid||Diagnosis||participants|Number|24|24.0||||||
4034813|NCT01138657|3855897|B2|Sarcoid||Diagnosis||participants|Number|12|12.0||||||
4034814|NCT01138657|3855898|B1|Sarcoid||Diagnosis||participants|Number|12|12.0||||||
4034815|NCT01138657|3855896|B3|Vogt Koyanagi Harada||Diagnosis||participants|Number|26|26.0||||||
4034816|NCT01138657|3855897|B2|Vogt Koyanagi Harada||Diagnosis||participants|Number|12|12.0||||||
4034817|NCT01138657|3855898|B1|Vogt Koyanagi Harada||Diagnosis||participants|Number|14|14.0||||||
4034818|NCT01138657|3855896|B3|Multifocal Choroiditis And Panuveitis||Diagnosis||participants|Number|13|13.0||||||
4034819|NCT01138657|3855897|B2|Multifocal Choroiditis And Panuveitis||Diagnosis||participants|Number|8|8.0||||||
4034820|NCT01138657|3855898|B1|Multifocal Choroiditis And Panuveitis||Diagnosis||participants|Number|5|5.0||||||
4034821|NCT01138657|3855896|B3|Birdshot Choroidopathy||Diagnosis||participants|Number|45|45.0||||||
4034822|NCT01138657|3855897|B2|Birdshot Choroidopathy||Diagnosis||participants|Number|24|24.0||||||
4034823|NCT01138657|3855898|B1|Birdshot Choroidopathy||Diagnosis||participants|Number|21|21.0||||||
4034824|NCT01138657|3855896|B3|Idiopathic||Diagnosis||participants|Number|90|90.0||||||
4034825|NCT01138657|3855897|B2|Idiopathic||Diagnosis||participants|Number|40|40.0||||||
4034826|NCT01138657|3855898|B1|Idiopathic||Diagnosis||participants|Number|50|50.0||||||
4034827|NCT01138657|3855896|B3|Panuveitis||Type of Uveitis||participants|Number|114|114.0||||||
4034828|NCT01138657|3855897|B2|Panuveitis||Type of Uveitis||participants|Number|56|56.0||||||
4034829|NCT01138657|3855898|B1|Panuveitis||Type of Uveitis||participants|Number|58|58.0||||||
4034830|NCT01138657|3855896|B3|Posterior||Type of Uveitis||participants|Number|76|76.0||||||
4034831|NCT01138657|3855897|B2|Posterior||Type of Uveitis||participants|Number|38|38.0||||||
4034832|NCT01138657|3855898|B1|Posterior||Type of Uveitis||participants|Number|38|38.0||||||
4034833|NCT01138657|3855896|B3|Intermediate||Type of Uveitis||participants|Number|49|49.0||||||
4034834|NCT01138657|3855897|B2|Intermediate||Type of Uveitis||participants|Number|25|25.0||||||
4034835|NCT01138657|3855898|B1|Intermediate||Type of Uveitis||participants|Number|24|24.0||||||
4034836|NCT01138657|3855896|B3|Multi Race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4034837|NCT01138657|3855897|B2|Multi Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4034838|NCT01138657|3855898|B1|Multi Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4034839|NCT01138657|3855896|B3|Other||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4034840|NCT01138657|3855897|B2|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4034841|NCT01138657|3855898|B1|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4034842|NCT01138657|3855896|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4034843|NCT01138657|3855897|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4034844|NCT01138657|3855898|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4034845|NCT01138657|3855896|B3|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4034846|NCT01138657|3855897|B2|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4034847|NCT01138657|3855898|B1|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4034848|NCT01138657|3855896|B3|Asian||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4034849|NCT01138657|3855897|B2|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4034850|NCT01138657|3855898|B1|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4034851|NCT01138657|3855896|B3|Black||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4034852|NCT01138657|3855897|B2|Black||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4034853|NCT01138657|3855898|B1|Black||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4034854|NCT01138657|3855896|B3|White||Race/Ethnicity, Customized||participants|Number|180|180.0||||||
4034855|NCT01138657|3855897|B2|White||Race/Ethnicity, Customized||participants|Number|89|89.0||||||
4034856|NCT01138657|3855898|B1|White||Race/Ethnicity, Customized||participants|Number|91|91.0||||||
4034857|NCT01138657|3855896|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4034858|NCT01138657|3855897|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4034859|NCT01138657|3855898|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4034860|NCT01138657|3855896|B3||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4034861|NCT01138657|3855897|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4034862|NCT01138657|3855898|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4034863|NCT01138657|3855896|B3|≥ 65 years||Age, Customized||participants|Number|26|26.0||||||
4034864|NCT01138657|3855897|B2|≥ 65 years||Age, Customized||participants|Number|16|16.0||||||
4034865|NCT01138657|3855898|B1|≥ 65 years||Age, Customized||participants|Number|10|10.0||||||
4034866|NCT01138657|3855896|B3|40 - 64 years||Age, Customized||participants|Number|110|110.0||||||
4034867|NCT01138657|3855897|B2|40 - 64 years||Age, Customized||participants|Number|56|56.0||||||
4034868|NCT01138657|3855898|B1|40 - 64 years||Age, Customized||participants|Number|54|54.0||||||
4034869|NCT01138657|3855896|B3|< 40 years||Age, Customized||participants|Number|103|103.0||||||
4034870|NCT01138657|3855897|B2|< 40 years||Age, Customized||participants|Number|47|47.0||||||
4034871|NCT01138657|3855898|B1|< 40 years||Age, Customized||participants|Number|56|56.0||||||
4034872|NCT01138657|3855896|B3|||Age||years|Mean|43.33|43.33|Standard Deviation|14.872|14.872|||
4034873|NCT01138657|3855897|B2|||Age||years|Mean|43.46|43.46|Standard Deviation|15.458|15.458|||
4034874|NCT01138657|3855898|B1|||Age||years|Mean|43.19|43.19|Standard Deviation|14.331|14.331|||
4034875|NCT01138514|3855943|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|333|333.0||||||
4034876|NCT01138514|3855944|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|109|109.0||||||
4034877|NCT01138514|3855945|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|114|114.0||||||
4034878|NCT01138514|3855946|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
4034879|NCT01138514|3855943|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4034880|NCT01138514|3855944|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4034881|NCT01138514|3855945|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4034882|NCT01138514|3855946|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4034883|NCT01138514|3855943|B4||White|Race (NIH/OMB)||Participants|Count of Participants|914|914.0||||||
4034884|NCT01138514|3855944|B3||White|Race (NIH/OMB)||Participants|Count of Participants|296|296.0||||||
4034885|NCT01138514|3855945|B2||White|Race (NIH/OMB)||Participants|Count of Participants|310|310.0||||||
4034886|NCT01138514|3855946|B1||White|Race (NIH/OMB)||Participants|Count of Participants|308|308.0||||||
4034887|NCT01138514|3855943|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|268|268.0||||||
4034888|NCT01138514|3855944|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
4034889|NCT01138514|3855945|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
4034890|NCT01138514|3855946|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4034891|NCT01138514|3855943|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4034892|NCT01138514|3855944|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4034893|NCT01138514|3855945|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4034894|NCT01138514|3855946|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4034895|NCT01138514|3855943|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4034896|NCT01138514|3855944|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4034897|NCT01138514|3855945|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4034898|NCT01138514|3855946|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4034899|NCT01138514|3855943|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4034900|NCT01138514|3855944|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4034901|NCT01138514|3855945|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4034902|NCT01138514|3855946|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4034903|NCT01138514|3855943|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4034904|NCT01138514|3855944|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4034905|NCT01138514|3855945|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4034906|NCT01138514|3855946|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4034907|NCT01138514|3855943|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|783|783.0||||||
4034908|NCT01138514|3855944|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|266|266.0||||||
4034909|NCT01138514|3855945|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|248|248.0||||||
4034910|NCT01138514|3855946|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|269|269.0||||||
4034911|NCT01138514|3855943|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|772|772.0||||||
4034912|NCT01138514|3855944|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|251|251.0||||||
4034913|NCT01138514|3855945|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|268|268.0||||||
4034914|NCT01138514|3855946|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|253|253.0||||||
4034915|NCT01138514|3855943|B4||Male|Sex: Female, Male||Participants|Count of Participants|710|710.0||||||
4034916|NCT01138514|3855944|B3||Male|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
4034917|NCT01138514|3855945|B2||Male|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
4034918|NCT01138514|3855946|B1||Male|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
4034919|NCT01138514|3855943|B4||Female|Sex: Female, Male||Participants|Count of Participants|845|845.0||||||
4034920|NCT01138514|3855944|B3||Female|Sex: Female, Male||Participants|Count of Participants|279|279.0||||||
4034921|NCT01138514|3855945|B2||Female|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
4034922|NCT01138514|3855946|B1||Female|Sex: Female, Male||Participants|Count of Participants|284|284.0||||||
4034923|NCT01138514|3855943|B4|||Age||years|Mean|20.4|20.4|Standard Deviation|7.7|7.7|||
4034924|NCT01138514|3855944|B3|||Age||years|Mean|20.7|20.7|Standard Deviation|8.1|8.1|||
4034925|NCT01138514|3855945|B2|||Age||years|Mean|20.1|20.1|Standard Deviation|7.4|7.4|||
4034926|NCT01138514|3855946|B1|||Age||years|Mean|20.2|20.2|Standard Deviation|7.6|7.6|||
4034927|NCT01138501|3855962|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4034928|NCT01138501|3855962|B1|Turkey||Region of Enrollment||participants|Number|7|7.0||||||
4034929|NCT01138501|3855962|B1|Taiwan||Region of Enrollment||participants|Number|1|1.0||||||
4034930|NCT01138501|3855962|B1|Russia||Region of Enrollment||participants|Number|8|8.0||||||
4034931|NCT01138501|3855962|B1|Poland||Region of Enrollment||participants|Number|5|5.0||||||
4034932|NCT01138501|3855962|B1|Malaysia||Region of Enrollment||participants|Number|5|5.0||||||
4034933|NCT01138501|3855962|B1|Macedonia, The Former Yugoslav Republic of||Region of Enrollment||participants|Number|5|5.0||||||
4034934|NCT01138501|3855962|B1|Lithuania||Region of Enrollment||participants|Number|4|4.0||||||
4034935|NCT01138501|3855962|B1|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4034936|NCT01138501|3855962|B1|Serbia||Region of Enrollment||participants|Number|5|5.0||||||
4034937|NCT01138501|3855962|B1|Brazil||Region of Enrollment||participants|Number|9|9.0||||||
4034938|NCT01138501|3855962|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4034939|NCT01138501|3855962|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4034940|NCT01138501|3855962|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4034941|NCT01138501|3855962|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4034942|NCT01138501|3855962|B1|||Age||years|Mean|6.08|6.08|Standard Deviation|2.91|2.91|||
4034943|NCT01138475|3855967|B4|||bone specific alkaline phosphatase||U/L|Mean|18|18.0|Standard Deviation|8.2|8.2|||
4034944|NCT01138475|3855968|B3|||bone specific alkaline phosphatase||U/L|Mean|19|19.0|Standard Deviation|10|10.0|||
4034945|NCT01138475|3855969|B2|||bone specific alkaline phosphatase||U/L|Mean|19|19.0|Standard Deviation|8.1|8.1|||
4034946|NCT01138475|3855970|B1|||bone specific alkaline phosphatase||U/L|Mean|15|15.0|Standard Deviation|5|5.0|||
4034947|NCT01138475|3855967|B4|||Urine N-telopeptide cross linked||nmol|Mean|73|73.0|Standard Deviation|40|40.0|||
4034948|NCT01138475|3855968|B3|||Urine N-telopeptide cross linked||nmol|Mean|82|82.0|Standard Deviation|55|55.0|||
4034949|NCT01138475|3855969|B2|||Urine N-telopeptide cross linked||nmol|Mean|73|73.0|Standard Deviation|30|30.0|||
4034950|NCT01138475|3855970|B1|||Urine N-telopeptide cross linked||nmol|Mean|64|64.0|Standard Deviation|26|26.0|||
4034951|NCT01138475|3855967|B4|||osteocalcin||ng/mL|Mean|39|39.0|Standard Deviation|19|19.0|||
4034952|NCT01138475|3855968|B3|||osteocalcin||ng/mL|Mean|40|40.0|Standard Deviation|20|20.0|||
4034953|NCT01138475|3855969|B2|||osteocalcin||ng/mL|Mean|36|36.0|Standard Deviation|17|17.0|||
4034954|NCT01138475|3855970|B1|||osteocalcin||ng/mL|Mean|39|39.0|Standard Deviation|19|19.0|||
4034955|NCT01138475|3855967|B4|||24 hour urine calcium||mmol|Mean|109|109.0|Standard Deviation|105|105.0|||
4034956|NCT01138475|3855968|B3|||24 hour urine calcium||mmol|Mean|131|131.0|Standard Deviation|91|91.0|||
4034957|NCT01138475|3855969|B2|||24 hour urine calcium||mmol|Mean|106|106.0|Standard Deviation|139|139.0|||
4034958|NCT01138475|3855970|B1|||24 hour urine calcium||mmol|Mean|89|89.0|Standard Deviation|81|81.0|||
4034959|NCT01138475|3855967|B4|||serum phosphorous||mg/dL|Mean|3.7|3.7|Standard Deviation|0.5|0.5|||
4034960|NCT01138475|3855968|B3|||serum phosphorous||mg/dL|Mean|3.7|3.7|Standard Deviation|0.5|0.5|||
4034961|NCT01138475|3855969|B2|||serum phosphorous||mg/dL|Mean|3.7|3.7|Standard Deviation|0.5|0.5|||
4034962|NCT01138475|3855970|B1|||serum phosphorous||mg/dL|Mean|3.9|3.9|Standard Deviation|0.6|0.6|||
4034963|NCT01138475|3855967|B4|||25 OH vitamin D||ng/dL|Mean|30|30.0|Standard Deviation|12|12.0|||
4034964|NCT01138475|3855968|B3|||25 OH vitamin D||ng/dL|Mean|30|30.0|Standard Deviation|7|7.0|||
4034965|NCT01138475|3855969|B2|||25 OH vitamin D||ng/dL|Mean|32|32.0|Standard Deviation|13|13.0|||
4034966|NCT01138475|3855970|B1|||25 OH vitamin D||ng/dL|Mean|30|30.0|Standard Deviation|16|16.0|||
4034967|NCT01138475|3855967|B4|||serum calcium||mg/dL|Mean|9.3|9.3|Standard Deviation|0.3|0.3|||
4034968|NCT01138475|3855968|B3|||serum calcium||mg/dL|Mean|9.4|9.4|Standard Deviation|0.4|0.4|||
4034969|NCT01138475|3855969|B2|||serum calcium||mg/dL|Mean|9.3|9.3|Standard Deviation|0.3|0.3|||
4034970|NCT01138475|3855970|B1|||serum calcium||mg/dL|Mean|9.4|9.4|Standard Deviation|0.3|0.3|||
4034971|NCT01138475|3855967|B4|||alkaline phosphatase||u/L|Mean|95|95.0|Standard Deviation|27|27.0|||
4034972|NCT01138475|3855968|B3|||alkaline phosphatase||u/L|Mean|101|101.0|Standard Deviation|32|32.0|||
4034973|NCT01138475|3855969|B2|||alkaline phosphatase||u/L|Mean|97|97.0|Standard Deviation|29|29.0|||
4034974|NCT01138475|3855970|B1|||alkaline phosphatase||u/L|Mean|87|87.0|Standard Deviation|19|19.0|||
4034975|NCT01138475|3855967|B4|||PTH||ng/mL|Mean|96|96.0|Standard Deviation|24|24.0|||
4034976|NCT01138475|3855968|B3|||PTH||ng/mL|Mean|101|101.0|Standard Deviation|25|25.0|||
4034977|NCT01138475|3855969|B2|||PTH||ng/mL|Mean|90|90.0|Standard Deviation|15|15.0|||
4034978|NCT01138475|3855970|B1|||PTH||ng/mL|Mean|96|96.0|Standard Deviation|27|27.0|||
4034979|NCT01138475|3855967|B4|United States||Region of Enrollment||participants|Number|49|49.0||||||
4034980|NCT01138475|3855968|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4034981|NCT01138475|3855969|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4034982|NCT01138475|3855970|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4034983|NCT01138475|3855967|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4034984|NCT01138475|3855968|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4034985|NCT01138475|3855969|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4034986|NCT01138475|3855970|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4034987|NCT01138475|3855967|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4034988|NCT01138475|3855968|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4034989|NCT01138475|3855969|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4034990|NCT01138475|3855970|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4034991|NCT01138475|3855967|B4|||Age||years|Mean|53.8|53.8|Standard Deviation|9.9|9.9|||
4034992|NCT01138475|3855968|B3|||Age||years|Mean|51|51.0|Standard Deviation|11|11.0|||
4034993|NCT01138475|3855969|B2|||Age||years|Mean|55|55.0|Standard Deviation|10|10.0|||
4034994|NCT01138475|3855970|B1|||Age||years|Mean|55|55.0|Standard Deviation|9|9.0|||
4034995|NCT01138475|3855967|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4034996|NCT01138475|3855968|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4034997|NCT01138475|3855969|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4034998|NCT01138475|3855970|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4034999|NCT01138475|3855967|B4||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4035000|NCT01138475|3855968|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4035001|NCT01138475|3855969|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4035002|NCT01138475|3855970|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4035003|NCT01138475|3855967|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4035004|NCT01138475|3855968|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4035005|NCT01138475|3855969|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4035006|NCT01138475|3855970|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4035007|NCT01138150|3856004|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035008|NCT01138150|3856005|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035009|NCT01138150|3856006|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035010|NCT01138150|3856004|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035011|NCT01138150|3856005|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035012|NCT01138150|3856006|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035013|NCT01138150|3856004|B3||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4035014|NCT01138150|3856005|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4035015|NCT01138150|3856006|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4035016|NCT01138150|3856004|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4035017|NCT01138150|3856005|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4035018|NCT01138150|3856006|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4035019|NCT01138150|3856004|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035020|NCT01138150|3856005|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035021|NCT01138150|3856006|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035022|NCT01138150|3856004|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4035023|NCT01138150|3856005|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4035024|NCT01138150|3856006|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4035025|NCT01138150|3856004|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035026|NCT01138150|3856005|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035027|NCT01138150|3856006|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035028|NCT01138150|3856004|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4035029|NCT01138150|3856005|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4035030|NCT01138150|3856006|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4035031|NCT01138150|3856004|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4035032|NCT01138150|3856005|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4035033|NCT01138150|3856006|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4035034|NCT01138150|3856004|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4035035|NCT01138150|3856005|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4035036|NCT01138150|3856006|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4035037|NCT01138150|3856004|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4035038|NCT01138150|3856005|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4035039|NCT01138150|3856006|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4035040|NCT01138150|3856004|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4035041|NCT01138150|3856005|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4035042|NCT01138150|3856006|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4035043|NCT01138124|3856059|B5|Neuropathic Pain||Number of participants with the indicated medical conditions/drug use in Renal Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed. Drug use up to the index date according to British National Formulary codes was analyzed.|participants|Number|4446|4446.0||||||
4035044|NCT01138124|3856060|B4|Neuropathic Pain||Number of participants with the indicated medical conditions/drug use in Renal Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed. Drug use up to the index date according to British National Formulary codes was analyzed.|participants|Number|4018|4018.0||||||
4035045|NCT01138124|3856061|B3|Neuropathic Pain||Number of participants with the indicated medical conditions/drug use in Renal Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed. Drug use up to the index date according to British National Formulary codes was analyzed.|participants|Number|428|428.0||||||
4035046|NCT01138124|3856062|B2|Neuropathic Pain||Number of participants with the indicated medical conditions/drug use in Renal Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed. Drug use up to the index date according to British National Formulary codes was analyzed.|participants|Number|0|0.0||||||
4035101|NCT01138124|3856062|B2|Ex-smoker||Number of participants with the indicated smoking status||participants|Number|6626|6626.0||||||
4035047|NCT01138124|3856063|B1|Neuropathic Pain||Number of participants with the indicated medical conditions/drug use in Renal Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed. Drug use up to the index date according to British National Formulary codes was analyzed.|participants|Number|0|0.0||||||
4035048|NCT01138124|3856059|B5|Epilepsy||Number of participants with the indicated medical conditions/drug use in Renal Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed. Drug use up to the index date according to British National Formulary codes was analyzed.|participants|Number|336|336.0||||||
4035049|NCT01138124|3856060|B4|Epilepsy||Number of participants with the indicated medical conditions/drug use in Renal Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed. Drug use up to the index date according to British National Formulary codes was analyzed.|participants|Number|303|303.0||||||
4035050|NCT01138124|3856061|B3|Epilepsy||Number of participants with the indicated medical conditions/drug use in Renal Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed. Drug use up to the index date according to British National Formulary codes was analyzed.|participants|Number|33|33.0||||||
4035051|NCT01138124|3856062|B2|Epilepsy||Number of participants with the indicated medical conditions/drug use in Renal Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed. Drug use up to the index date according to British National Formulary codes was analyzed.|participants|Number|0|0.0||||||
4035052|NCT01138124|3856063|B1|Epilepsy||Number of participants with the indicated medical conditions/drug use in Renal Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed. Drug use up to the index date according to British National Formulary codes was analyzed.|participants|Number|0|0.0||||||
4035053|NCT01138124|3856059|B5|Diabetes||Number of participants with the indicated medical conditions/drug use in Renal Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed. Drug use up to the index date according to British National Formulary codes was analyzed.|participants|Number|1838|1838.0||||||
4035054|NCT01138124|3856060|B4|Diabetes||Number of participants with the indicated medical conditions/drug use in Renal Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed. Drug use up to the index date according to British National Formulary codes was analyzed.|participants|Number|1598|1598.0||||||
4035055|NCT01138124|3856061|B3|Diabetes||Number of participants with the indicated medical conditions/drug use in Renal Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed. Drug use up to the index date according to British National Formulary codes was analyzed.|participants|Number|240|240.0||||||
4035056|NCT01138124|3856062|B2|Diabetes||Number of participants with the indicated medical conditions/drug use in Renal Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed. Drug use up to the index date according to British National Formulary codes was analyzed.|participants|Number|0|0.0||||||
4035057|NCT01138124|3856063|B1|Diabetes||Number of participants with the indicated medical conditions/drug use in Renal Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed. Drug use up to the index date according to British National Formulary codes was analyzed.|participants|Number|0|0.0||||||
4035058|NCT01138124|3856059|B5|Diuretic use||Number of participants with the indicated medical conditions/drug use in Renal Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed. Drug use up to the index date according to British National Formulary codes was analyzed.|participants|Number|7271|7271.0||||||
4035059|NCT01138124|3856060|B4|Diuretic use||Number of participants with the indicated medical conditions/drug use in Renal Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed. Drug use up to the index date according to British National Formulary codes was analyzed.|participants|Number|6396|6396.0||||||
4035060|NCT01138124|3856061|B3|Diuretic use||Number of participants with the indicated medical conditions/drug use in Renal Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed. Drug use up to the index date according to British National Formulary codes was analyzed.|participants|Number|875|875.0||||||
4035061|NCT01138124|3856062|B2|Diuretic use||Number of participants with the indicated medical conditions/drug use in Renal Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed. Drug use up to the index date according to British National Formulary codes was analyzed.|participants|Number|0|0.0||||||
4035062|NCT01138124|3856063|B1|Diuretic use||Number of participants with the indicated medical conditions/drug use in Renal Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed. Drug use up to the index date according to British National Formulary codes was analyzed.|participants|Number|0|0.0||||||
4035063|NCT01138124|3856059|B5|Hypertension||Number of participants with the indicated medical conditions/drug use in Renal Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed. Drug use up to the index date according to British National Formulary codes was analyzed.|participants|Number|10272|10272.0||||||
4035064|NCT01138124|3856060|B4|Hypertension||Number of participants with the indicated medical conditions/drug use in Renal Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed. Drug use up to the index date according to British National Formulary codes was analyzed.|participants|Number|9113|9113.0||||||
4035065|NCT01138124|3856061|B3|Hypertension||Number of participants with the indicated medical conditions/drug use in Renal Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed. Drug use up to the index date according to British National Formulary codes was analyzed.|participants|Number|1159|1159.0||||||
4035066|NCT01138124|3856062|B2|Hypertension||Number of participants with the indicated medical conditions/drug use in Renal Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed. Drug use up to the index date according to British National Formulary codes was analyzed.|participants|Number|0|0.0||||||
4035067|NCT01138124|3856063|B1|Hypertension||Number of participants with the indicated medical conditions/drug use in Renal Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed. Drug use up to the index date according to British National Formulary codes was analyzed.|participants|Number|0|0.0||||||
4035102|NCT01138124|3856063|B1|Ex-smoker||Number of participants with the indicated smoking status||participants|Number|768|768.0||||||
4035232|NCT01138046|3856142|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4035068|NCT01138124|3856059|B5|Chronic Pancreatitis (>=2 years prior to ID)||Number of participants with the indicated medical conditions in Pancreatic Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed.|participants|Number|30|30.0||||||
4035069|NCT01138124|3856060|B4|Chronic Pancreatitis (>=2 years prior to ID)||Number of participants with the indicated medical conditions in Pancreatic Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed.|participants|Number|0|0.0||||||
4035070|NCT01138124|3856061|B3|Chronic Pancreatitis (>=2 years prior to ID)||Number of participants with the indicated medical conditions in Pancreatic Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed.|participants|Number|0|0.0||||||
4035071|NCT01138124|3856062|B2|Chronic Pancreatitis (>=2 years prior to ID)||Number of participants with the indicated medical conditions in Pancreatic Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed.|participants|Number|17|17.0||||||
4035072|NCT01138124|3856063|B1|Chronic Pancreatitis (>=2 years prior to ID)||Number of participants with the indicated medical conditions in Pancreatic Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed.|participants|Number|13|13.0||||||
4035073|NCT01138124|3856059|B5|Neuropathic Pain||Number of participants with the indicated medical conditions in Pancreatic Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed.|participants|Number|7353|7353.0||||||
4035074|NCT01138124|3856060|B4|Neuropathic Pain||Number of participants with the indicated medical conditions in Pancreatic Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed.|participants|Number|0|0.0||||||
4035075|NCT01138124|3856061|B3|Neuropathic Pain||Number of participants with the indicated medical conditions in Pancreatic Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed.|participants|Number|0|0.0||||||
4035076|NCT01138124|3856062|B2|Neuropathic Pain||Number of participants with the indicated medical conditions in Pancreatic Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed.|participants|Number|6616|6616.0||||||
4035077|NCT01138124|3856063|B1|Neuropathic Pain||Number of participants with the indicated medical conditions in Pancreatic Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed.|participants|Number|737|737.0||||||
4035078|NCT01138124|3856059|B5|Epilepsy||Number of participants with the indicated medical conditions in Pancreatic Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed.|participants|Number|511|511.0||||||
4035079|NCT01138124|3856060|B4|Epilepsy||Number of participants with the indicated medical conditions in Pancreatic Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed.|participants|Number|0|0.0||||||
4035080|NCT01138124|3856061|B3|Epilepsy||Number of participants with the indicated medical conditions in Pancreatic Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed.|participants|Number|0|0.0||||||
4035081|NCT01138124|3856062|B2|Epilepsy||Number of participants with the indicated medical conditions in Pancreatic Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed.|participants|Number|458|458.0||||||
4035082|NCT01138124|3856063|B1|Epilepsy||Number of participants with the indicated medical conditions in Pancreatic Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed.|participants|Number|53|53.0||||||
4035083|NCT01138124|3856059|B5|Diabetes (>=2 years prior to index date [ID])||Number of participants with the indicated medical conditions in Pancreatic Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed.|participants|Number|2500|2500.0||||||
4035084|NCT01138124|3856060|B4|Diabetes (>=2 years prior to index date [ID])||Number of participants with the indicated medical conditions in Pancreatic Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed.|participants|Number|0|0.0||||||
4035085|NCT01138124|3856061|B3|Diabetes (>=2 years prior to index date [ID])||Number of participants with the indicated medical conditions in Pancreatic Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed.|participants|Number|0|0.0||||||
4035086|NCT01138124|3856062|B2|Diabetes (>=2 years prior to index date [ID])||Number of participants with the indicated medical conditions in Pancreatic Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed.|participants|Number|2137|2137.0||||||
4035087|NCT01138124|3856063|B1|Diabetes (>=2 years prior to index date [ID])||Number of participants with the indicated medical conditions in Pancreatic Cancer Cases/Controls|Medical conditions up to the index date by READ/OXMIS codes were analyzed.|participants|Number|363|363.0||||||
4035088|NCT01138124|3856059|B5|Status Unknown||Number of participants with the indicated smoking status||participants|Number|5454|5454.0||||||
4035089|NCT01138124|3856060|B4|Status Unknown||Number of participants with the indicated smoking status||participants|Number|1781|1781.0||||||
4035090|NCT01138124|3856061|B3|Status Unknown||Number of participants with the indicated smoking status||participants|Number|114|114.0||||||
4035091|NCT01138124|3856062|B2|Status Unknown||Number of participants with the indicated smoking status||participants|Number|3294|3294.0||||||
4035092|NCT01138124|3856063|B1|Status Unknown||Number of participants with the indicated smoking status||participants|Number|265|265.0||||||
4035093|NCT01138124|3856059|B5|Never Smoked||Number of participants with the indicated smoking status||participants|Number|26622|26622.0||||||
4035094|NCT01138124|3856060|B4|Never Smoked||Number of participants with the indicated smoking status||participants|Number|9121|9121.0||||||
4035095|NCT01138124|3856061|B3|Never Smoked||Number of participants with the indicated smoking status||participants|Number|867|867.0||||||
4035096|NCT01138124|3856062|B2|Never Smoked||Number of participants with the indicated smoking status||participants|Number|15249|15249.0||||||
4035097|NCT01138124|3856063|B1|Never Smoked||Number of participants with the indicated smoking status||participants|Number|1385|1385.0||||||
4035098|NCT01138124|3856059|B5|Ex-smoker||Number of participants with the indicated smoking status||participants|Number|12507|12507.0||||||
4035099|NCT01138124|3856060|B4|Ex-smoker||Number of participants with the indicated smoking status||participants|Number|4589|4589.0||||||
4035100|NCT01138124|3856061|B3|Ex-smoker||Number of participants with the indicated smoking status||participants|Number|524|524.0||||||
4035103|NCT01138124|3856059|B5|Current Smoker||Number of participants with the indicated smoking status||participants|Number|9619|9619.0||||||
4035104|NCT01138124|3856060|B4|Current Smoker||Number of participants with the indicated smoking status||participants|Number|3555|3555.0||||||
4035105|NCT01138124|3856061|B3|Current Smoker||Number of participants with the indicated smoking status||participants|Number|476|476.0||||||
4035106|NCT01138124|3856062|B2|Current Smoker||Number of participants with the indicated smoking status||participants|Number|4857|4857.0||||||
4035107|NCT01138124|3856063|B1|Current Smoker||Number of participants with the indicated smoking status||participants|Number|731|731.0||||||
4035108|NCT01138124|3856059|B5|Missing||Number of participants with the indicated body mass index (BMI)|BMI is calculated as weight in kilograms (between one and three years prior to the index date, closest to 1 year prior to index date) divided by height in meters (one year or longer prior to index date) squared (m^2).|participants|Number|34475|34475.0||||||
4035109|NCT01138124|3856060|B4|Missing||Number of participants with the indicated body mass index (BMI)|BMI is calculated as weight in kilograms (between one and three years prior to the index date, closest to 1 year prior to index date) divided by height in meters (one year or longer prior to index date) squared (m^2).|participants|Number|11989|11989.0||||||
4035110|NCT01138124|3856061|B3|Missing||Number of participants with the indicated body mass index (BMI)|BMI is calculated as weight in kilograms (between one and three years prior to the index date, closest to 1 year prior to index date) divided by height in meters (one year or longer prior to index date) squared (m^2).|participants|Number|1150|1150.0||||||
4035111|NCT01138124|3856062|B2|Missing||Number of participants with the indicated body mass index (BMI)|BMI is calculated as weight in kilograms (between one and three years prior to the index date, closest to 1 year prior to index date) divided by height in meters (one year or longer prior to index date) squared (m^2).|participants|Number|19419|19419.0||||||
4035112|NCT01138124|3856063|B1|Missing||Number of participants with the indicated body mass index (BMI)|BMI is calculated as weight in kilograms (between one and three years prior to the index date, closest to 1 year prior to index date) divided by height in meters (one year or longer prior to index date) squared (m^2).|participants|Number|1917|1917.0||||||
4035113|NCT01138124|3856059|B5|>=30 kg/m^2||Number of participants with the indicated body mass index (BMI)|BMI is calculated as weight in kilograms (between one and three years prior to the index date, closest to 1 year prior to index date) divided by height in meters (one year or longer prior to index date) squared (m^2).|participants|Number|4790|4790.0||||||
4035114|NCT01138124|3856060|B4|>=30 kg/m^2||Number of participants with the indicated body mass index (BMI)|BMI is calculated as weight in kilograms (between one and three years prior to the index date, closest to 1 year prior to index date) divided by height in meters (one year or longer prior to index date) squared (m^2).|participants|Number|1773|1773.0||||||
4035115|NCT01138124|3856061|B3|>=30 kg/m^2||Number of participants with the indicated body mass index (BMI)|BMI is calculated as weight in kilograms (between one and three years prior to the index date, closest to 1 year prior to index date) divided by height in meters (one year or longer prior to index date) squared (m^2).|participants|Number|250|250.0||||||
4035116|NCT01138124|3856062|B2|>=30 kg/m^2||Number of participants with the indicated body mass index (BMI)|BMI is calculated as weight in kilograms (between one and three years prior to the index date, closest to 1 year prior to index date) divided by height in meters (one year or longer prior to index date) squared (m^2).|participants|Number|2476|2476.0||||||
4035117|NCT01138124|3856063|B1|>=30 kg/m^2||Number of participants with the indicated body mass index (BMI)|BMI is calculated as weight in kilograms (between one and three years prior to the index date, closest to 1 year prior to index date) divided by height in meters (one year or longer prior to index date) squared (m^2).|participants|Number|291|291.0||||||
4035118|NCT01138124|3856059|B5|25 to 29.99 kg/m^2||Number of participants with the indicated body mass index (BMI)|BMI is calculated as weight in kilograms (between one and three years prior to the index date, closest to 1 year prior to index date) divided by height in meters (one year or longer prior to index date) squared (m^2).|participants|Number|7971|7971.0||||||
4035119|NCT01138124|3856060|B4|25 to 29.99 kg/m^2||Number of participants with the indicated body mass index (BMI)|BMI is calculated as weight in kilograms (between one and three years prior to the index date, closest to 1 year prior to index date) divided by height in meters (one year or longer prior to index date) squared (m^2).|participants|Number|2938|2938.0||||||
4035120|NCT01138124|3856061|B3|25 to 29.99 kg/m^2||Number of participants with the indicated body mass index (BMI)|BMI is calculated as weight in kilograms (between one and three years prior to the index date, closest to 1 year prior to index date) divided by height in meters (one year or longer prior to index date) squared (m^2).|participants|Number|326|326.0||||||
4035121|NCT01138124|3856062|B2|25 to 29.99 kg/m^2||Number of participants with the indicated body mass index (BMI)|BMI is calculated as weight in kilograms (between one and three years prior to the index date, closest to 1 year prior to index date) divided by height in meters (one year or longer prior to index date) squared (m^2).|participants|Number|4250|4250.0||||||
4035122|NCT01138124|3856063|B1|25 to 29.99 kg/m^2||Number of participants with the indicated body mass index (BMI)|BMI is calculated as weight in kilograms (between one and three years prior to the index date, closest to 1 year prior to index date) divided by height in meters (one year or longer prior to index date) squared (m^2).|participants|Number|457|457.0||||||
4035123|NCT01138124|3856059|B5|18.5 to 24.99 kg/m^2||Number of participants with the indicated body mass index (BMI)|BMI is calculated as weight in kilograms (between one and three years prior to the index date, closest to 1 year prior to index date) divided by height in meters (one year or longer prior to index date) squared (m^2).|participants|Number|6610|6610.0||||||
4035124|NCT01138124|3856060|B4|18.5 to 24.99 kg/m^2||Number of participants with the indicated body mass index (BMI)|BMI is calculated as weight in kilograms (between one and three years prior to the index date, closest to 1 year prior to index date) divided by height in meters (one year or longer prior to index date) squared (m^2).|participants|Number|2236|2236.0||||||
4035125|NCT01138124|3856061|B3|18.5 to 24.99 kg/m^2||Number of participants with the indicated body mass index (BMI)|BMI is calculated as weight in kilograms (between one and three years prior to the index date, closest to 1 year prior to index date) divided by height in meters (one year or longer prior to index date) squared (m^2).|participants|Number|237|237.0||||||
4035181|NCT01138124|3856062|B2||Female|Sex: Female, Male||Participants|Count of Participants|15316|15316.0||||||
4035126|NCT01138124|3856062|B2|18.5 to 24.99 kg/m^2||Number of participants with the indicated body mass index (BMI)|BMI is calculated as weight in kilograms (between one and three years prior to the index date, closest to 1 year prior to index date) divided by height in meters (one year or longer prior to index date) squared (m^2).|participants|Number|3678|3678.0||||||
4035127|NCT01138124|3856063|B1|18.5 to 24.99 kg/m^2||Number of participants with the indicated body mass index (BMI)|BMI is calculated as weight in kilograms (between one and three years prior to the index date, closest to 1 year prior to index date) divided by height in meters (one year or longer prior to index date) squared (m^2).|participants|Number|459|459.0||||||
4035128|NCT01138124|3856059|B5|<18.5 kg/m^2||Number of participants with the indicated body mass index (BMI)|BMI is calculated as weight in kilograms (between one and three years prior to the index date, closest to 1 year prior to index date) divided by height in meters (one year or longer prior to index date) squared (m^2).|participants|Number|356|356.0||||||
4035129|NCT01138124|3856060|B4|<18.5 kg/m^2||Number of participants with the indicated body mass index (BMI)|BMI is calculated as weight in kilograms (between one and three years prior to the index date, closest to 1 year prior to index date) divided by height in meters (one year or longer prior to index date) squared (m^2).|participants|Number|110|110.0||||||
4035130|NCT01138124|3856061|B3|<18.5 kg/m^2||Number of participants with the indicated body mass index (BMI)|BMI is calculated as weight in kilograms (between one and three years prior to the index date, closest to 1 year prior to index date) divided by height in meters (one year or longer prior to index date) squared (m^2).|participants|Number|18|18.0||||||
4035131|NCT01138124|3856062|B2|<18.5 kg/m^2||Number of participants with the indicated body mass index (BMI)|BMI is calculated as weight in kilograms (between one and three years prior to the index date, closest to 1 year prior to index date) divided by height in meters (one year or longer prior to index date) squared (m^2).|participants|Number|203|203.0||||||
4035132|NCT01138124|3856063|B1|<18.5 kg/m^2||Number of participants with the indicated body mass index (BMI)|BMI is calculated as weight in kilograms (between one and three years prior to the index date, closest to 1 year prior to index date) divided by height in meters (one year or longer prior to index date) squared (m^2).|participants|Number|25|25.0||||||
4035133|NCT01138124|3856059|B5|>=8 years||Number of participants with the indicated duration of follow-up from GPRD study cohort entry to ID|Entry into the GPRD study cohort began Jan 1, 1993, or at the time of GPRD registration if after Jan 1, 1993. Subjects were required to have at least 2 years of follow-up prior to the index date (ID).|participants|Number|33052|33052.0||||||
4035134|NCT01138124|3856060|B4|>=8 years||Number of participants with the indicated duration of follow-up from GPRD study cohort entry to ID|Entry into the GPRD study cohort began Jan 1, 1993, or at the time of GPRD registration if after Jan 1, 1993. Subjects were required to have at least 2 years of follow-up prior to the index date (ID).|participants|Number|11933|11933.0||||||
4035135|NCT01138124|3856061|B3|>=8 years||Number of participants with the indicated duration of follow-up from GPRD study cohort entry to ID|Entry into the GPRD study cohort began Jan 1, 1993, or at the time of GPRD registration if after Jan 1, 1993. Subjects were required to have at least 2 years of follow-up prior to the index date (ID).|participants|Number|1223|1223.0||||||
4035136|NCT01138124|3856062|B2|>=8 years||Number of participants with the indicated duration of follow-up from GPRD study cohort entry to ID|Entry into the GPRD study cohort began Jan 1, 1993, or at the time of GPRD registration if after Jan 1, 1993. Subjects were required to have at least 2 years of follow-up prior to the index date (ID).|participants|Number|18036|18036.0||||||
4035137|NCT01138124|3856063|B1|>=8 years||Number of participants with the indicated duration of follow-up from GPRD study cohort entry to ID|Entry into the GPRD study cohort began Jan 1, 1993, or at the time of GPRD registration if after Jan 1, 1993. Subjects were required to have at least 2 years of follow-up prior to the index date (ID).|participants|Number|1860|1860.0||||||
4035138|NCT01138124|3856059|B5|6-7 years||Number of participants with the indicated duration of follow-up from GPRD study cohort entry to ID|Entry into the GPRD study cohort began Jan 1, 1993, or at the time of GPRD registration if after Jan 1, 1993. Subjects were required to have at least 2 years of follow-up prior to the index date (ID).|participants|Number|7244|7244.0||||||
4035139|NCT01138124|3856060|B4|6-7 years||Number of participants with the indicated duration of follow-up from GPRD study cohort entry to ID|Entry into the GPRD study cohort began Jan 1, 1993, or at the time of GPRD registration if after Jan 1, 1993. Subjects were required to have at least 2 years of follow-up prior to the index date (ID).|participants|Number|2338|2338.0||||||
4035140|NCT01138124|3856061|B3|6-7 years||Number of participants with the indicated duration of follow-up from GPRD study cohort entry to ID|Entry into the GPRD study cohort began Jan 1, 1993, or at the time of GPRD registration if after Jan 1, 1993. Subjects were required to have at least 2 years of follow-up prior to the index date (ID).|participants|Number|246|246.0||||||
4035141|NCT01138124|3856062|B2|6-7 years||Number of participants with the indicated duration of follow-up from GPRD study cohort entry to ID|Entry into the GPRD study cohort began Jan 1, 1993, or at the time of GPRD registration if after Jan 1, 1993. Subjects were required to have at least 2 years of follow-up prior to the index date (ID).|participants|Number|4213|4213.0||||||
4035142|NCT01138124|3856063|B1|6-7 years||Number of participants with the indicated duration of follow-up from GPRD study cohort entry to ID|Entry into the GPRD study cohort began Jan 1, 1993, or at the time of GPRD registration if after Jan 1, 1993. Subjects were required to have at least 2 years of follow-up prior to the index date (ID).|participants|Number|447|447.0||||||
4035143|NCT01138124|3856059|B5|4-5 years||Number of participants with the indicated duration of follow-up from GPRD study cohort entry to ID|Entry into the GPRD study cohort began Jan 1, 1993, or at the time of GPRD registration if after Jan 1, 1993. Subjects were required to have at least 2 years of follow-up prior to the index date (ID).|participants|Number|6400|6400.0||||||
4035144|NCT01138124|3856060|B4|4-5 years||Number of participants with the indicated duration of follow-up from GPRD study cohort entry to ID|Entry into the GPRD study cohort began Jan 1, 1993, or at the time of GPRD registration if after Jan 1, 1993. Subjects were required to have at least 2 years of follow-up prior to the index date (ID).|participants|Number|2122|2122.0||||||
4035145|NCT01138124|3856061|B3|4-5 years||Number of participants with the indicated duration of follow-up from GPRD study cohort entry to ID|Entry into the GPRD study cohort began Jan 1, 1993, or at the time of GPRD registration if after Jan 1, 1993. Subjects were required to have at least 2 years of follow-up prior to the index date (ID).|participants|Number|226|226.0||||||
4035146|NCT01138124|3856062|B2|4-5 years||Number of participants with the indicated duration of follow-up from GPRD study cohort entry to ID|Entry into the GPRD study cohort began Jan 1, 1993, or at the time of GPRD registration if after Jan 1, 1993. Subjects were required to have at least 2 years of follow-up prior to the index date (ID).|participants|Number|3656|3656.0||||||
4035147|NCT01138124|3856063|B1|4-5 years||Number of participants with the indicated duration of follow-up from GPRD study cohort entry to ID|Entry into the GPRD study cohort began Jan 1, 1993, or at the time of GPRD registration if after Jan 1, 1993. Subjects were required to have at least 2 years of follow-up prior to the index date (ID).|participants|Number|396|396.0||||||
4035148|NCT01138124|3856059|B5|2-3 years||Number of participants with the indicated duration of follow-up from GPRD study cohort entry to ID|Entry into the GPRD study cohort began Jan 1, 1993, or at the time of GPRD registration if after Jan 1, 1993. Subjects were required to have at least 2 years of follow-up prior to the index date (ID).|participants|Number|7506|7506.0||||||
4035149|NCT01138124|3856060|B4|2-3 years||Number of participants with the indicated duration of follow-up from GPRD study cohort entry to ID|Entry into the GPRD study cohort began Jan 1, 1993, or at the time of GPRD registration if after Jan 1, 1993. Subjects were required to have at least 2 years of follow-up prior to the index date (ID).|participants|Number|2653|2653.0||||||
4035150|NCT01138124|3856061|B3|2-3 years||Number of participants with the indicated duration of follow-up from GPRD study cohort entry to ID|Entry into the GPRD study cohort began Jan 1, 1993, or at the time of GPRD registration if after Jan 1, 1993. Subjects were required to have at least 2 years of follow-up prior to the index date (ID).|participants|Number|286|286.0||||||
4035151|NCT01138124|3856062|B2|2-3 years||Number of participants with the indicated duration of follow-up from GPRD study cohort entry to ID|Entry into the GPRD study cohort began Jan 1, 1993, or at the time of GPRD registration if after Jan 1, 1993. Subjects were required to have at least 2 years of follow-up prior to the index date (ID).|participants|Number|4121|4121.0||||||
4035152|NCT01138124|3856063|B1|2-3 years||Number of participants with the indicated duration of follow-up from GPRD study cohort entry to ID|Entry into the GPRD study cohort began Jan 1, 1993, or at the time of GPRD registration if after Jan 1, 1993. Subjects were required to have at least 2 years of follow-up prior to the index date (ID).|participants|Number|446|446.0||||||
4035153|NCT01138124|3856059|B5|>=8 years||Number of participants with the indicated duration of follow-up from GPRD registration to index date||participants|Number|44748|44748.0||||||
4035154|NCT01138124|3856060|B4|>=8 years||Number of participants with the indicated duration of follow-up from GPRD registration to index date||participants|Number|15550|15550.0||||||
4035155|NCT01138124|3856061|B3|>=8 years||Number of participants with the indicated duration of follow-up from GPRD registration to index date||participants|Number|1594|1594.0||||||
4035156|NCT01138124|3856062|B2|>=8 years||Number of participants with the indicated duration of follow-up from GPRD registration to index date||participants|Number|25050|25050.0||||||
4035157|NCT01138124|3856063|B1|>=8 years||Number of participants with the indicated duration of follow-up from GPRD registration to index date||participants|Number|2554|2554.0||||||
4035158|NCT01138124|3856059|B5|6-7 years||Number of participants with the indicated duration of follow-up from GPRD registration to index date||participants|Number|3665|3665.0||||||
4035159|NCT01138124|3856060|B4|6-7 years||Number of participants with the indicated duration of follow-up from GPRD registration to index date||participants|Number|1280|1280.0||||||
4035160|NCT01138124|3856061|B3|6-7 years||Number of participants with the indicated duration of follow-up from GPRD registration to index date||participants|Number|141|141.0||||||
4035161|NCT01138124|3856062|B2|6-7 years||Number of participants with the indicated duration of follow-up from GPRD registration to index date||participants|Number|2007|2007.0||||||
4035162|NCT01138124|3856063|B1|6-7 years||Number of participants with the indicated duration of follow-up from GPRD registration to index date||participants|Number|237|237.0||||||
4035163|NCT01138124|3856059|B5|4-5 years||Number of participants with the indicated duration of follow-up from GPRD registration to index date||participants|Number|2946|2946.0||||||
4035164|NCT01138124|3856060|B4|4-5 years||Number of participants with the indicated duration of follow-up from GPRD registration to index date||participants|Number|1135|1135.0||||||
4035165|NCT01138124|3856061|B3|4-5 years||Number of participants with the indicated duration of follow-up from GPRD registration to index date||participants|Number|117|117.0||||||
4035166|NCT01138124|3856062|B2|4-5 years||Number of participants with the indicated duration of follow-up from GPRD registration to index date||participants|Number|1509|1509.0||||||
4035167|NCT01138124|3856063|B1|4-5 years||Number of participants with the indicated duration of follow-up from GPRD registration to index date||participants|Number|185|185.0||||||
4035168|NCT01138124|3856059|B5|2-3 years||Number of participants with the indicated duration of follow-up from GPRD registration to index date||participants|Number|2843|2843.0||||||
4035169|NCT01138124|3856060|B4|2-3 years||Number of participants with the indicated duration of follow-up from GPRD registration to index date||participants|Number|1081|1081.0||||||
4035170|NCT01138124|3856061|B3|2-3 years||Number of participants with the indicated duration of follow-up from GPRD registration to index date||participants|Number|129|129.0||||||
4035171|NCT01138124|3856062|B2|2-3 years||Number of participants with the indicated duration of follow-up from GPRD registration to index date||participants|Number|1460|1460.0||||||
4035172|NCT01138124|3856063|B1|2-3 years||Number of participants with the indicated duration of follow-up from GPRD registration to index date||participants|Number|173|173.0||||||
4035173|NCT01138124|3856059|B5||Male|Sex: Female, Male||Participants|Count of Participants|29251|29251.0||||||
4035174|NCT01138124|3856060|B4||Male|Sex: Female, Male||Participants|Count of Participants|11773|11773.0||||||
4035175|NCT01138124|3856061|B3||Male|Sex: Female, Male||Participants|Count of Participants|1222|1222.0||||||
4035176|NCT01138124|3856062|B2||Male|Sex: Female, Male||Participants|Count of Participants|14710|14710.0||||||
4035177|NCT01138124|3856063|B1||Male|Sex: Female, Male||Participants|Count of Participants|1546|1546.0||||||
4035178|NCT01138124|3856059|B5||Female|Sex: Female, Male||Participants|Count of Participants|24951|24951.0||||||
4035179|NCT01138124|3856060|B4||Female|Sex: Female, Male||Participants|Count of Participants|7273|7273.0||||||
4035180|NCT01138124|3856061|B3||Female|Sex: Female, Male||Participants|Count of Participants|759|759.0||||||
4035182|NCT01138124|3856063|B1||Female|Sex: Female, Male||Participants|Count of Participants|1603|1603.0||||||
4035183|NCT01138124|3856059|B5|>=80 years||Age, Customized|Number of participants with the indicated age at index date.|Participants|Number|12243|12243.0||||||
4035184|NCT01138124|3856060|B4|>=80 years||Age, Customized|Number of participants with the indicated age at index date.|Participants|Number|3031|3031.0||||||
4035185|NCT01138124|3856061|B3|>=80 years||Age, Customized|Number of participants with the indicated age at index date.|Participants|Number|327|327.0||||||
4035186|NCT01138124|3856062|B2|>=80 years||Age, Customized|Number of participants with the indicated age at index date.|Participants|Number|7988|7988.0||||||
4035187|NCT01138124|3856063|B1|>=80 years||Age, Customized|Number of participants with the indicated age at index date.|Participants|Number|897|897.0||||||
4035188|NCT01138124|3856059|B5|70-79 years||Age, Customized|Number of participants with the indicated age at index date.|Participants|Number|17323|17323.0||||||
4035189|NCT01138124|3856060|B4|70-79 years||Age, Customized|Number of participants with the indicated age at index date.|Participants|Number|5604|5604.0||||||
4035190|NCT01138124|3856061|B3|70-79 years||Age, Customized|Number of participants with the indicated age at index date.|Participants|Number|594|594.0||||||
4035191|NCT01138124|3856062|B2|70-79 years||Age, Customized|Number of participants with the indicated age at index date.|Participants|Number|10092|10092.0||||||
4035192|NCT01138124|3856063|B1|70-79 years||Age, Customized|Number of participants with the indicated age at index date.|Participants|Number|1033|1033.0||||||
4035193|NCT01138124|3856059|B5|60-69 years||Age, Customized|Number of participants with the indicated age at index date.|Participants|Number|13709|13709.0||||||
4035194|NCT01138124|3856060|B4|60-69 years||Age, Customized|Number of participants with the indicated age at index date.|Participants|Number|5199|5199.0||||||
4035195|NCT01138124|3856061|B3|60-69 years||Age, Customized|Number of participants with the indicated age at index date.|Participants|Number|528|528.0||||||
4035196|NCT01138124|3856062|B2|60-69 years||Age, Customized|Number of participants with the indicated age at index date.|Participants|Number|7234|7234.0||||||
4035197|NCT01138124|3856063|B1|60-69 years||Age, Customized|Number of participants with the indicated age at index date.|Participants|Number|748|748.0||||||
4035198|NCT01138124|3856059|B5|50-59 years||Age, Customized|Number of participants with the indicated age at index date.|Participants|Number|7756|7756.0||||||
4035199|NCT01138124|3856060|B4|50-59 years||Age, Customized|Number of participants with the indicated age at index date.|Participants|Number|3418|3418.0||||||
4035200|NCT01138124|3856061|B3|50-59 years||Age, Customized|Number of participants with the indicated age at index date.|Participants|Number|355|355.0||||||
4035201|NCT01138124|3856062|B2|50-59 years||Age, Customized|Number of participants with the indicated age at index date.|Participants|Number|3616|3616.0||||||
4035202|NCT01138124|3856063|B1|50-59 years||Age, Customized|Number of participants with the indicated age at index date.|Participants|Number|367|367.0||||||
4035203|NCT01138124|3856059|B5|40-49 years||Age, Customized|Number of participants with the indicated age at index date.|Participants|Number|2465|2465.0||||||
4035204|NCT01138124|3856060|B4|40-49 years||Age, Customized|Number of participants with the indicated age at index date.|Participants|Number|1348|1348.0||||||
4035205|NCT01138124|3856061|B3|40-49 years||Age, Customized|Number of participants with the indicated age at index date.|Participants|Number|134|134.0||||||
4035206|NCT01138124|3856062|B2|40-49 years||Age, Customized|Number of participants with the indicated age at index date.|Participants|Number|897|897.0||||||
4035207|NCT01138124|3856063|B1|40-49 years||Age, Customized|Number of participants with the indicated age at index date.|Participants|Number|86|86.0||||||
4035208|NCT01138124|3856059|B5|<40 years||Age, Customized|Number of participants with the indicated age at index date.|Participants|Number|706|706.0||||||
4035209|NCT01138124|3856060|B4|<40 years||Age, Customized|Number of participants with the indicated age at index date.|Participants|Number|446|446.0||||||
4035210|NCT01138124|3856061|B3|<40 years||Age, Customized|Number of participants with the indicated age at index date.|Participants|Number|43|43.0||||||
4035211|NCT01138124|3856062|B2|<40 years||Age, Customized|Number of participants with the indicated age at index date.|Participants|Number|199|199.0||||||
4035212|NCT01138124|3856063|B1|<40 years||Age, Customized|Number of participants with the indicated age at index date.|Participants|Number|18|18.0||||||
4035213|NCT01138111|3856088|B1|Australia||Region of Enrollment||participants|Number|45|45.0||||||
4035214|NCT01138111|3856088|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4035215|NCT01138111|3856088|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4035216|NCT01138111|3856088|B1|||Age||years|Mean|72.7|72.7|Standard Deviation|6.5|6.5|||
4035217|NCT01138111|3856088|B1||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4035218|NCT01138111|3856088|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4035219|NCT01138111|3856088|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4035220|NCT01138098|3856117|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4035221|NCT01138098|3856117|B3||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4035222|NCT01138098|3856118|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4035223|NCT01138098|3856119|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4035224|NCT01138098|3856117|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4035225|NCT01138098|3856118|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4035226|NCT01138098|3856119|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4035227|NCT01138098|3856117|B3|||Age||Years|Mean|11.3|11.3|Standard Deviation|0.47|0.47|||
4035228|NCT01138098|3856118|B2|||Age||Years|Mean|11.3|11.3|Standard Deviation|0.47|0.47|||
4035229|NCT01138098|3856119|B1|||Age||Years|Mean|11.3|11.3|Standard Deviation|0.46|0.46|||
4035230|NCT01138046|3856142|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4035231|NCT01138046|3856142|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4035233|NCT01138046|3856142|B1|||Age||Years|Mean|58.1|58.1|Standard Deviation|7.76|7.76|||
4035234|NCT01138007|3856159|B4|Asian – Mixed Race||Race/Ethnicity, Customized|Baseline data were collected in members of the FAS, consisting of all participants who took at least one dose of investigational product and provided at least one efficacy observation at a Treatment Phase visit (i.e., Week 1 or later).|participants|Number|1|1.0||||||
4035235|NCT01138007|3856160|B3|Asian – Mixed Race||Race/Ethnicity, Customized|Baseline data were collected in members of the FAS, consisting of all participants who took at least one dose of investigational product and provided at least one efficacy observation at a Treatment Phase visit (i.e., Week 1 or later).|participants|Number|1|1.0||||||
4035236|NCT01138007|3856161|B2|Asian – Mixed Race||Race/Ethnicity, Customized|Baseline data were collected in members of the FAS, consisting of all participants who took at least one dose of investigational product and provided at least one efficacy observation at a Treatment Phase visit (i.e., Week 1 or later).|participants|Number|0|0.0||||||
4035237|NCT01138007|3856162|B1|Asian – Mixed Race||Race/Ethnicity, Customized|Baseline data were collected in members of the FAS, consisting of all participants who took at least one dose of investigational product and provided at least one efficacy observation at a Treatment Phase visit (i.e., Week 1 or later).|participants|Number|0|0.0||||||
4035238|NCT01138007|3856159|B4|Asian – East Asian Heritage||Race/Ethnicity, Customized|Baseline data were collected in members of the FAS, consisting of all participants who took at least one dose of investigational product and provided at least one efficacy observation at a Treatment Phase visit (i.e., Week 1 or later).|participants|Number|113|113.0||||||
4035239|NCT01138007|3856160|B3|Asian – East Asian Heritage||Race/Ethnicity, Customized|Baseline data were collected in members of the FAS, consisting of all participants who took at least one dose of investigational product and provided at least one efficacy observation at a Treatment Phase visit (i.e., Week 1 or later).|participants|Number|40|40.0||||||
4035240|NCT01138007|3856161|B2|Asian – East Asian Heritage||Race/Ethnicity, Customized|Baseline data were collected in members of the FAS, consisting of all participants who took at least one dose of investigational product and provided at least one efficacy observation at a Treatment Phase visit (i.e., Week 1 or later).|participants|Number|36|36.0||||||
4035241|NCT01138007|3856162|B1|Asian – East Asian Heritage||Race/Ethnicity, Customized|Baseline data were collected in members of the FAS, consisting of all participants who took at least one dose of investigational product and provided at least one efficacy observation at a Treatment Phase visit (i.e., Week 1 or later).|participants|Number|37|37.0||||||
4035242|NCT01138007|3856159|B4|Asian – Japanese Heritage||Race/Ethnicity, Customized|Baseline data were collected in members of the FAS, consisting of all participants who took at least one dose of investigational product and provided at least one efficacy observation at a Treatment Phase visit (i.e., Week 1 or later).|participants|Number|450|450.0||||||
4035243|NCT01138007|3856160|B3|Asian – Japanese Heritage||Race/Ethnicity, Customized|Baseline data were collected in members of the FAS, consisting of all participants who took at least one dose of investigational product and provided at least one efficacy observation at a Treatment Phase visit (i.e., Week 1 or later).|participants|Number|147|147.0||||||
4035244|NCT01138007|3856161|B2|Asian – Japanese Heritage||Race/Ethnicity, Customized|Baseline data were collected in members of the FAS, consisting of all participants who took at least one dose of investigational product and provided at least one efficacy observation at a Treatment Phase visit (i.e., Week 1 or later).|participants|Number|154|154.0||||||
4035245|NCT01138007|3856162|B1|Asian – Japanese Heritage||Race/Ethnicity, Customized|Baseline data were collected in members of the FAS, consisting of all participants who took at least one dose of investigational product and provided at least one efficacy observation at a Treatment Phase visit (i.e., Week 1 or later).|participants|Number|149|149.0||||||
4035246|NCT01138007|3856159|B4||Male|Sex: Female, Male|Baseline data were collected in members of the FAS, consisting of all participants who took at least one dose of investigational product and provided at least one efficacy observation at a Treatment Phase visit (i.e., Week 1 or later).|Participants|Count of Participants|260|260.0||||||
4035247|NCT01138007|3856160|B3||Male|Sex: Female, Male|Baseline data were collected in members of the FAS, consisting of all participants who took at least one dose of investigational product and provided at least one efficacy observation at a Treatment Phase visit (i.e., Week 1 or later).|Participants|Count of Participants|83|83.0||||||
4035248|NCT01138007|3856161|B2||Male|Sex: Female, Male|Baseline data were collected in members of the FAS, consisting of all participants who took at least one dose of investigational product and provided at least one efficacy observation at a Treatment Phase visit (i.e., Week 1 or later).|Participants|Count of Participants|92|92.0||||||
4035249|NCT01138007|3856162|B1||Male|Sex: Female, Male|Baseline data were collected in members of the FAS, consisting of all participants who took at least one dose of investigational product and provided at least one efficacy observation at a Treatment Phase visit (i.e., Week 1 or later).|Participants|Count of Participants|85|85.0||||||
4035250|NCT01138007|3856159|B4||Female|Sex: Female, Male|Baseline data were collected in members of the FAS, consisting of all participants who took at least one dose of investigational product and provided at least one efficacy observation at a Treatment Phase visit (i.e., Week 1 or later).|Participants|Count of Participants|304|304.0||||||
4035251|NCT01138007|3856160|B3||Female|Sex: Female, Male|Baseline data were collected in members of the FAS, consisting of all participants who took at least one dose of investigational product and provided at least one efficacy observation at a Treatment Phase visit (i.e., Week 1 or later).|Participants|Count of Participants|105|105.0||||||
4035252|NCT01138007|3856161|B2||Female|Sex: Female, Male|Baseline data were collected in members of the FAS, consisting of all participants who took at least one dose of investigational product and provided at least one efficacy observation at a Treatment Phase visit (i.e., Week 1 or later).|Participants|Count of Participants|98|98.0||||||
4035253|NCT01138007|3856162|B1||Female|Sex: Female, Male|Baseline data were collected in members of the FAS, consisting of all participants who took at least one dose of investigational product and provided at least one efficacy observation at a Treatment Phase visit (i.e., Week 1 or later).|Participants|Count of Participants|101|101.0||||||
4035254|NCT01138007|3856159|B4|||Age|Baseline data were collected in members of the Full Analysis Set (FAS), consisting of all participants who took at least one dose of investigational product and provided at least one efficacy observation at a Treatment Phase visit (i.e., Week 1 or later).|Years|Mean|37.1|37.1|Standard Deviation|10.83|10.83|||
4035255|NCT01138007|3856160|B3|||Age|Baseline data were collected in members of the Full Analysis Set (FAS), consisting of all participants who took at least one dose of investigational product and provided at least one efficacy observation at a Treatment Phase visit (i.e., Week 1 or later).|Years|Mean|37.5|37.5|Standard Deviation|10.96|10.96|||
4035256|NCT01138007|3856161|B2|||Age|Baseline data were collected in members of the Full Analysis Set (FAS), consisting of all participants who took at least one dose of investigational product and provided at least one efficacy observation at a Treatment Phase visit (i.e., Week 1 or later).|Years|Mean|36.0|36.0|Standard Deviation|10.42|10.42|||
4035257|NCT01138007|3856162|B1|||Age|Baseline data were collected in members of the Full Analysis Set (FAS), consisting of all participants who took at least one dose of investigational product and provided at least one efficacy observation at a Treatment Phase visit (i.e., Week 1 or later).|Years|Mean|37.9|37.9|Standard Deviation|11.09|11.09|||
4035258|NCT01137890|3856196|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4035259|NCT01137890|3856197|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4035260|NCT01137890|3856198|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4035261|NCT01137890|3856196|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4035262|NCT01137890|3856197|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4035263|NCT01137890|3856198|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4035264|NCT01137890|3856196|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4035265|NCT01137890|3856197|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4035266|NCT01137890|3856198|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4035267|NCT01137890|3856196|B3|||Age||years|Mean|38.7|38.7|Standard Deviation|5|5.0|||
4035268|NCT01137890|3856197|B2|||Age||years|Mean|38.2|38.2|Standard Deviation|4.1|4.1|||
4035269|NCT01137890|3856198|B1|||Age||years|Mean|38.9|38.9|Standard Deviation|5.6|5.6|||
4035270|NCT01137890|3856196|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4035271|NCT01137890|3856197|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4035272|NCT01137890|3856198|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4035273|NCT01137890|3856196|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4035274|NCT01137890|3856197|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4035275|NCT01137890|3856198|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4035276|NCT01137890|3856196|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4035277|NCT01137890|3856197|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4035278|NCT01137890|3856198|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4035279|NCT01137812|3856269|B3|UNITED STATES||Region Treated||participants|Number|243|243.0||||||
4035280|NCT01137812|3856270|B2|UNITED STATES||Region Treated||participants|Number|121|121.0||||||
4035281|NCT01137812|3856271|B1|UNITED STATES||Region Treated||participants|Number|122|122.0||||||
4035282|NCT01137812|3856269|B3|UKRAINE||Region Treated||participants|Number|46|46.0||||||
4035283|NCT01137812|3856270|B2|UKRAINE||Region Treated||participants|Number|19|19.0||||||
4035284|NCT01137812|3856271|B1|UKRAINE||Region Treated||participants|Number|27|27.0||||||
4035285|NCT01137812|3856269|B3|SOUTH KOREA||Region Treated||participants|Number|19|19.0||||||
4035286|NCT01137812|3856270|B2|SOUTH KOREA||Region Treated||participants|Number|12|12.0||||||
4035287|NCT01137812|3856271|B1|SOUTH KOREA||Region Treated||participants|Number|7|7.0||||||
4035288|NCT01137812|3856269|B3|SINGAPORE||Region Treated||participants|Number|4|4.0||||||
4035289|NCT01137812|3856270|B2|SINGAPORE||Region Treated||participants|Number|2|2.0||||||
4035290|NCT01137812|3856271|B1|SINGAPORE||Region Treated||participants|Number|2|2.0||||||
4035291|NCT01137812|3856269|B3|POLAND||Region Treated||participants|Number|45|45.0||||||
4035292|NCT01137812|3856270|B2|POLAND||Region Treated||participants|Number|25|25.0||||||
4035293|NCT01137812|3856271|B1|POLAND||Region Treated||participants|Number|20|20.0||||||
4035294|NCT01137812|3856269|B3|NEW ZEALAND||Region Treated||participants|Number|24|24.0||||||
4035295|NCT01137812|3856270|B2|NEW ZEALAND||Region Treated||participants|Number|13|13.0||||||
4035296|NCT01137812|3856271|B1|NEW ZEALAND||Region Treated||participants|Number|11|11.0||||||
4035297|NCT01137812|3856269|B3|NETHERLANDS||Region Treated||participants|Number|3|3.0||||||
4035298|NCT01137812|3856270|B2|NETHERLANDS||Region Treated||participants|Number|1|1.0||||||
4035299|NCT01137812|3856271|B1|NETHERLANDS||Region Treated||participants|Number|2|2.0||||||
4035300|NCT01137812|3856269|B3|MALAYSIA||Region Treated||participants|Number|24|24.0||||||
4035301|NCT01137812|3856270|B2|MALAYSIA||Region Treated||participants|Number|14|14.0||||||
4035302|NCT01137812|3856271|B1|MALAYSIA||Region Treated||participants|Number|10|10.0||||||
4035303|NCT01137812|3856269|B3|ISRAEL||Region Treated||participants|Number|10|10.0||||||
4035304|NCT01137812|3856270|B2|ISRAEL||Region Treated||participants|Number|3|3.0||||||
4035305|NCT01137812|3856271|B1|ISRAEL||Region Treated||participants|Number|7|7.0||||||
4035306|NCT01137812|3856269|B3|INDIA||Region Treated||participants|Number|56|56.0||||||
4035307|NCT01137812|3856270|B2|INDIA||Region Treated||participants|Number|23|23.0||||||
4035308|NCT01137812|3856271|B1|INDIA||Region Treated||participants|Number|33|33.0||||||
4035309|NCT01137812|3856269|B3|GERMANY||Region Treated||participants|Number|10|10.0||||||
4035310|NCT01137812|3856270|B2|GERMANY||Region Treated||participants|Number|5|5.0||||||
4035311|NCT01137812|3856271|B1|GERMANY||Region Treated||participants|Number|5|5.0||||||
4035312|NCT01137812|3856269|B3|FRANCE||Region Treated||participants|Number|11|11.0||||||
4035313|NCT01137812|3856270|B2|FRANCE||Region Treated||participants|Number|6|6.0||||||
4035314|NCT01137812|3856271|B1|FRANCE||Region Treated||participants|Number|5|5.0||||||
4035315|NCT01137812|3856269|B3|DENMARK||Region Treated||participants|Number|7|7.0||||||
4035316|NCT01137812|3856270|B2|DENMARK||Region Treated||participants|Number|5|5.0||||||
4035317|NCT01137812|3856271|B1|DENMARK||Region Treated||participants|Number|2|2.0||||||
4035318|NCT01137812|3856269|B3|CANADA||Region Treated||participants|Number|86|86.0||||||
4035319|NCT01137812|3856270|B2|CANADA||Region Treated||participants|Number|45|45.0||||||
4035320|NCT01137812|3856271|B1|CANADA||Region Treated||participants|Number|41|41.0||||||
4035321|NCT01137812|3856269|B3|BRAZIL||Region Treated||participants|Number|156|156.0||||||
4035322|NCT01137812|3856270|B2|BRAZIL||Region Treated||participants|Number|80|80.0||||||
4035323|NCT01137812|3856271|B1|BRAZIL||Region Treated||participants|Number|76|76.0||||||
4035324|NCT01137812|3856269|B3|BELGIUM||Region Treated||participants|Number|5|5.0||||||
4035325|NCT01137812|3856270|B2|BELGIUM||Region Treated||participants|Number|2|2.0||||||
4035326|NCT01137812|3856271|B1|BELGIUM||Region Treated||participants|Number|3|3.0||||||
4035327|NCT01137812|3856269|B3|AUSTRIA||Region Treated||participants|Number|6|6.0||||||
4035328|NCT01137812|3856270|B2|AUSTRIA||Region Treated||participants|Number|2|2.0||||||
4035329|NCT01137812|3856271|B1|AUSTRIA||Region Treated||participants|Number|4|4.0||||||
4035330|NCT01137812|3856269|B3||Male|Sex: Female, Male||Participants|Count of Participants|422|422.0||||||
4035331|NCT01137812|3856270|B2||Male|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
4035332|NCT01137812|3856271|B1||Male|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4035333|NCT01137812|3856269|B3||Female|Sex: Female, Male||Participants|Count of Participants|333|333.0||||||
4035334|NCT01137812|3856270|B2||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4035335|NCT01137812|3856271|B1||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4035336|NCT01137812|3856269|B3|||Age||years|Mean|56.5|56.5|Standard Deviation|9.47|9.47|||
4035337|NCT01137812|3856270|B2|||Age||years|Mean|56.6|56.6|Standard Deviation|9.33|9.33|||
4035338|NCT01137812|3856271|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|9.62|9.62|||
4035339|NCT01137812|3856269|B3||>=65 years|Age||Participants|Count of Participants|144|144.0||||||
4035340|NCT01137812|3856270|B2||>=65 years|Age||Participants|Count of Participants|71|71.0||||||
4035341|NCT01137812|3856271|B1||>=65 years|Age||Participants|Count of Participants|73|73.0||||||
4035342|NCT01137812|3856269|B3||Between 18 and 65 years|Age||Participants|Count of Participants|611|611.0||||||
4035343|NCT01137812|3856270|B2||Between 18 and 65 years|Age||Participants|Count of Participants|307|307.0||||||
4035344|NCT01137812|3856271|B1||Between 18 and 65 years|Age||Participants|Count of Participants|304|304.0||||||
4035345|NCT01137812|3856269|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4035346|NCT01137812|3856270|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4035347|NCT01137812|3856271|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4035348|NCT01137786|3856290|B3|Italy||Region of Enrollment||participants|Number|9|9.0||||||
4035349|NCT01137786|3856291|B2|Italy||Region of Enrollment||participants|Number|5|5.0||||||
4035350|NCT01137786|3856292|B1|Italy||Region of Enrollment||participants|Number|4|4.0||||||
4035351|NCT01137786|3856290|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
4035352|NCT01137786|3856291|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4035353|NCT01137786|3856292|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4035354|NCT01137786|3856290|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4035355|NCT01137786|3856291|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4035356|NCT01137786|3856292|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4035357|NCT01137786|3856290|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4035358|NCT01137786|3856291|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4035359|NCT01137786|3856292|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4035360|NCT01137786|3856290|B3|||Age||years|Mean|62.7|62.7|Standard Deviation|11.66|11.66|||
4035361|NCT01137786|3856291|B2|||Age||years|Mean|63.4|63.4|Standard Deviation|12.82|12.82|||
4035362|NCT01137786|3856292|B1|||Age||years|Mean|62.0|62.0|Standard Deviation|10.65|10.65|||
4035363|NCT01137786|3856290|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4035364|NCT01137786|3856291|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4035365|NCT01137786|3856292|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4035366|NCT01137786|3856290|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4035367|NCT01137786|3856291|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4035368|NCT01137786|3856292|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4035369|NCT01137786|3856290|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4035370|NCT01137786|3856291|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4035371|NCT01137786|3856292|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4035372|NCT01137773|3856301|B3|United States||Region of Enrollment||Participants|Count of Participants|56|56.0||||||
4035373|NCT01137773|3856302|B2|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4035374|NCT01137773|3856303|B1|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
4035375|NCT01137773|3856301|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4035376|NCT01137773|3856302|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4035377|NCT01137773|3856303|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4035378|NCT01137773|3856301|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4035379|NCT01137773|3856302|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4035380|NCT01137773|3856303|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4035381|NCT01137773|3856301|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4035382|NCT01137773|3856302|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4035383|NCT01137773|3856303|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4035384|NCT01137773|3856301|B3||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4035385|NCT01137773|3856302|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4035386|NCT01137773|3856303|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4035387|NCT01137773|3856301|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4035388|NCT01137773|3856302|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4035389|NCT01137773|3856303|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4035390|NCT01137682|3856312|B4|Asian||Race/Ethnicity, Customized|CORE Period|Participants|Number|4|4.0||||||
4035391|NCT01137682|3856313|B3|Asian||Race/Ethnicity, Customized|CORE Period|Participants|Number|0|0.0||||||
4035392|NCT01137682|3856314|B2|Asian||Race/Ethnicity, Customized|CORE Period|Participants|Number|1|1.0||||||
4035393|NCT01137682|3856315|B1|Asian||Race/Ethnicity, Customized|CORE Period|Participants|Number|3|3.0||||||
4035394|NCT01137682|3856312|B4|Native American||Race/Ethnicity, Customized|CORE Period|Participants|Number|4|4.0||||||
4035395|NCT01137682|3856313|B3|Native American||Race/Ethnicity, Customized|CORE Period|Participants|Number|1|1.0||||||
4035396|NCT01137682|3856314|B2|Native American||Race/Ethnicity, Customized|CORE Period|Participants|Number|1|1.0||||||
4035397|NCT01137682|3856315|B1|Native American||Race/Ethnicity, Customized|CORE Period|Participants|Number|2|2.0||||||
4035398|NCT01137682|3856312|B4|Other||Race/Ethnicity, Customized|CORE Period|Participants|Number|14|14.0||||||
4035399|NCT01137682|3856313|B3|Other||Race/Ethnicity, Customized|CORE Period|Participants|Number|7|7.0||||||
4035400|NCT01137682|3856314|B2|Other||Race/Ethnicity, Customized|CORE Period|Participants|Number|3|3.0||||||
4035401|NCT01137682|3856315|B1|Other||Race/Ethnicity, Customized|CORE Period|Participants|Number|4|4.0||||||
4035402|NCT01137682|3856312|B4|Black||Race/Ethnicity, Customized|CORE Period|Participants|Number|15|15.0||||||
4035403|NCT01137682|3856313|B3|Black||Race/Ethnicity, Customized|CORE Period|Participants|Number|4|4.0||||||
4035404|NCT01137682|3856314|B2|Black||Race/Ethnicity, Customized|CORE Period|Participants|Number|8|8.0||||||
4035405|NCT01137682|3856315|B1|Black||Race/Ethnicity, Customized|CORE Period|Participants|Number|3|3.0||||||
4035406|NCT01137682|3856312|B4|Caucasian||Race/Ethnicity, Customized|CORE Period|Participants|Number|161|161.0||||||
4035407|NCT01137682|3856313|B3|Caucasian||Race/Ethnicity, Customized|CORE Period|Participants|Number|56|56.0||||||
4035408|NCT01137682|3856314|B2|Caucasian||Race/Ethnicity, Customized|CORE Period|Participants|Number|52|52.0||||||
4035409|NCT01137682|3856315|B1|Caucasian||Race/Ethnicity, Customized|CORE Period|Participants|Number|53|53.0||||||
4035410|NCT01137682|3856312|B4||Male|Sex: Female, Male|CORE Period|Participants|Count of Participants|87|87.0||||||
4035411|NCT01137682|3856313|B3||Male|Sex: Female, Male|CORE Period|Participants|Count of Participants|30|30.0||||||
4035412|NCT01137682|3856314|B2||Male|Sex: Female, Male|CORE Period|Participants|Count of Participants|30|30.0||||||
4035413|NCT01137682|3856315|B1||Male|Sex: Female, Male|CORE Period|Participants|Count of Participants|27|27.0||||||
4035414|NCT01137682|3856312|B4||Female|Sex: Female, Male|CORE Period|Participants|Count of Participants|111|111.0||||||
4035415|NCT01137682|3856313|B3||Female|Sex: Female, Male|CORE Period|Participants|Count of Participants|38|38.0||||||
4035416|NCT01137682|3856314|B2||Female|Sex: Female, Male|CORE Period|Participants|Count of Participants|35|35.0||||||
4035417|NCT01137682|3856315|B1||Female|Sex: Female, Male|CORE Period|Participants|Count of Participants|38|38.0||||||
4035418|NCT01137682|3856312|B4|≥ 65 Years||Age, Customized|CORE Period|Participants|Number|16|16.0||||||
4035419|NCT01137682|3856313|B3|≥ 65 Years||Age, Customized|CORE Period|Participants|Number|5|5.0||||||
4035420|NCT01137682|3856314|B2|≥ 65 Years||Age, Customized|CORE Period|Participants|Number|8|8.0||||||
4035421|NCT01137682|3856315|B1|≥ 65 Years||Age, Customized|CORE Period|Participants|Number|3|3.0||||||
4035422|NCT01137682|3856312|B4|<65 Years||Age, Customized|CORE Period|Participants|Number|182|182.0||||||
4035423|NCT01137682|3856313|B3|<65 Years||Age, Customized|CORE Period|Participants|Number|63|63.0||||||
4035424|NCT01137682|3856314|B2|<65 Years||Age, Customized|CORE Period|Participants|Number|57|57.0||||||
4035425|NCT01137682|3856315|B1|<65 Years||Age, Customized|CORE Period|Participants|Number|62|62.0||||||
4035426|NCT01137604|3856363|B5|Grade 4||World Health Organization Grading for Gliomas||Participants|Number|112|112.0||||||
4035427|NCT01137604|3856364|B4|Grade 4||World Health Organization Grading for Gliomas||Participants|Number|32|32.0||||||
4035428|NCT01137604|3856365|B3|Grade 4||World Health Organization Grading for Gliomas||Participants|Number|0|0.0||||||
4035429|NCT01137604|3856366|B2|Grade 4||World Health Organization Grading for Gliomas||Participants|Number|42|42.0||||||
4035430|NCT01137604|3856367|B1|Grade 4||World Health Organization Grading for Gliomas||Participants|Number|38|38.0||||||
4035431|NCT01137604|3856363|B5|Grade 3||World Health Organization Grading for Gliomas||Participants|Number|39|39.0||||||
4035432|NCT01137604|3856364|B4|Grade 3||World Health Organization Grading for Gliomas||Participants|Number|0|0.0||||||
4035433|NCT01137604|3856365|B3|Grade 3||World Health Organization Grading for Gliomas||Participants|Number|39|39.0||||||
4035434|NCT01137604|3856366|B2|Grade 3||World Health Organization Grading for Gliomas||Participants|Number|0|0.0||||||
4035435|NCT01137604|3856367|B1|Grade 3||World Health Organization Grading for Gliomas||Participants|Number|0|0.0||||||
4035436|NCT01137604|3856363|B5||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4035437|NCT01137604|3856364|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4035438|NCT01137604|3856365|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4035439|NCT01137604|3856366|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4035440|NCT01137604|3856367|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4035441|NCT01137604|3856363|B5||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4035442|NCT01137604|3856364|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4035443|NCT01137604|3856365|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4035444|NCT01137604|3856366|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4035445|NCT01137604|3856367|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4035446|NCT01137604|3856363|B5|||Age||Years|Mean|52.6|52.6|Standard Deviation|11.74|11.74|||
4035447|NCT01137604|3856364|B4|||Age||Years|Mean|53.0|53.0|Standard Deviation|11.15|11.15|||
4035448|NCT01137604|3856365|B3|||Age||Years|Mean|49.2|49.2|Standard Deviation|11.35|11.35|||
4035449|NCT01137604|3856366|B2|||Age||Years|Mean|55.5|55.5|Standard Deviation|11.96|11.96|||
4035450|NCT01137604|3856367|B1|||Age||Years|Mean|55.1|55.1|Standard Deviation|10.61|10.61|||
4035451|NCT01137578|3856404|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4035452|NCT01137578|3856404|B1|American Indian or Alaska native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4035453|NCT01137578|3856404|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4035454|NCT01137578|3856404|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4035455|NCT01137578|3856404|B1|White||Race/Ethnicity, Customized||participants|Number|117|117.0||||||
4035456|NCT01137578|3856404|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4035457|NCT01137578|3856404|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4035458|NCT01137578|3856404|B1|Between 12 years and <18 years||Age, Customized||participants|Number|63|63.0||||||
4035459|NCT01137578|3856404|B1|Between 2 years and <12 years||Age, Customized||participants|Number|64|64.0||||||
4035460|NCT01137578|3856404|B1|Less than (<) 2 years||Age, Customized||participants|Number|7|7.0||||||
4035461|NCT01137578|3856404|B1|||Age||years|Mean|9.9|9.9|Standard Deviation|4.89|4.89|||
4035462|NCT01137539|3856446|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4035463|NCT01137539|3856446|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4035464|NCT01137539|3856446|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
4035465|NCT01137539|3856446|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4035466|NCT01137539|3856446|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4035467|NCT01137539|3856446|B1|||Age||years|Median|46.7|46.7|Standard Deviation|8.8|8.8|||
4035468|NCT01137539|3856446|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4035469|NCT01137539|3856446|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4035470|NCT01137539|3856446|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4035471|NCT01137474|3856451|B5|30 kg/m^2 and greater||Body Mass Index||Participants|Number|488|488.0||||||
4035472|NCT01137474|3856452|B4|30 kg/m^2 and greater||Body Mass Index||Participants|Number|173|173.0||||||
4035473|NCT01137474|3856453|B3|30 kg/m^2 and greater||Body Mass Index||Participants|Number|84|84.0||||||
4035474|NCT01137474|3856454|B2|30 kg/m^2 and greater||Body Mass Index||Participants|Number|79|79.0||||||
4035475|NCT01137474|3856455|B1|30 kg/m^2 and greater||Body Mass Index||Participants|Number|152|152.0||||||
4035476|NCT01137474|3856451|B5|25 kg/m^2 to 30 kg/m^2||Body Mass Index||Participants|Number|356|356.0||||||
4035477|NCT01137474|3856452|B4|25 kg/m^2 to 30 kg/m^2||Body Mass Index||Participants|Number|95|95.0||||||
4035478|NCT01137474|3856453|B3|25 kg/m^2 to 30 kg/m^2||Body Mass Index||Participants|Number|63|63.0||||||
4035479|NCT01137474|3856454|B2|25 kg/m^2 to 30 kg/m^2||Body Mass Index||Participants|Number|67|67.0||||||
4035480|NCT01137474|3856455|B1|25 kg/m^2 to 30 kg/m^2||Body Mass Index||Participants|Number|131|131.0||||||
4035481|NCT01137474|3856451|B5|Less than 25 kg/m^2||Body Mass Index||Participants|Number|100|100.0||||||
4035482|NCT01137474|3856452|B4|Less than 25 kg/m^2||Body Mass Index||Participants|Number|34|34.0||||||
4035483|NCT01137474|3856453|B3|Less than 25 kg/m^2||Body Mass Index||Participants|Number|18|18.0||||||
4035484|NCT01137474|3856454|B2|Less than 25 kg/m^2||Body Mass Index||Participants|Number|20|20.0||||||
4035485|NCT01137474|3856455|B1|Less than 25 kg/m^2||Body Mass Index||Participants|Number|28|28.0||||||
4035486|NCT01137474|3856451|B5|Other||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4035487|NCT01137474|3856452|B4|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4035488|NCT01137474|3856453|B3|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4035489|NCT01137474|3856454|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4035490|NCT01137474|3856455|B1|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4035491|NCT01137474|3856451|B5|Asian||Race/Ethnicity, Customized||Participants|Number|201|201.0||||||
4035492|NCT01137474|3856452|B4|Asian||Race/Ethnicity, Customized||Participants|Number|49|49.0||||||
4035493|NCT01137474|3856453|B3|Asian||Race/Ethnicity, Customized||Participants|Number|49|49.0||||||
4035494|NCT01137474|3856454|B2|Asian||Race/Ethnicity, Customized||Participants|Number|49|49.0||||||
4035495|NCT01137474|3856455|B1|Asian||Race/Ethnicity, Customized||Participants|Number|54|54.0||||||
4035496|NCT01137474|3856451|B5|Black or African American||Race/Ethnicity, Customized||Participants|Number|45|45.0||||||
4035497|NCT01137474|3856452|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4035498|NCT01137474|3856453|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4035499|NCT01137474|3856454|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4035500|NCT01137474|3856455|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4035501|NCT01137474|3856451|B5|White||Race/Ethnicity, Customized||Participants|Number|693|693.0||||||
4035502|NCT01137474|3856452|B4|White||Race/Ethnicity, Customized||Participants|Number|239|239.0||||||
4035503|NCT01137474|3856453|B3|White||Race/Ethnicity, Customized||Participants|Number|108|108.0||||||
4035504|NCT01137474|3856454|B2|White||Race/Ethnicity, Customized||Participants|Number|105|105.0||||||
4035505|NCT01137474|3856455|B1|White||Race/Ethnicity, Customized||Participants|Number|241|241.0||||||
4035506|NCT01137474|3856451|B5||Male|Gender||Participants|Count of Participants|529|529.0||||||
4035507|NCT01137474|3856452|B4||Male|Gender||Participants|Count of Participants|179|179.0||||||
4035508|NCT01137474|3856453|B3||Male|Gender||Participants|Count of Participants|89|89.0||||||
4035509|NCT01137474|3856454|B2||Male|Gender||Participants|Count of Participants|90|90.0||||||
4035510|NCT01137474|3856455|B1||Male|Gender||Participants|Count of Participants|171|171.0||||||
4035511|NCT01137474|3856451|B5||Female|Gender||Participants|Count of Participants|415|415.0||||||
4035512|NCT01137474|3856452|B4||Female|Gender||Participants|Count of Participants|123|123.0||||||
4035513|NCT01137474|3856453|B3||Female|Gender||Participants|Count of Participants|76|76.0||||||
4035514|NCT01137474|3856454|B2||Female|Gender||Participants|Count of Participants|76|76.0||||||
4035515|NCT01137474|3856455|B1||Female|Gender||Participants|Count of Participants|140|140.0||||||
4035516|NCT01137474|3856451|B5|75 years and older||Age, Customized||Participants|Number|8|8.0||||||
4035517|NCT01137474|3856452|B4|75 years and older||Age, Customized||Participants|Number|0|0.0||||||
4035518|NCT01137474|3856453|B3|75 years and older||Age, Customized||Participants|Number|2|2.0||||||
4035519|NCT01137474|3856454|B2|75 years and older||Age, Customized||Participants|Number|0|0.0||||||
4035520|NCT01137474|3856455|B1|75 years and older||Age, Customized||Participants|Number|6|6.0||||||
4035521|NCT01137474|3856451|B5|65 years and older to younger than 75 years||Age, Customized||Participants|Number|134|134.0||||||
4035522|NCT01137474|3856452|B4|65 years and older to younger than 75 years||Age, Customized||Participants|Number|42|42.0||||||
4035523|NCT01137474|3856453|B3|65 years and older to younger than 75 years||Age, Customized||Participants|Number|21|21.0||||||
4035524|NCT01137474|3856454|B2|65 years and older to younger than 75 years||Age, Customized||Participants|Number|25|25.0||||||
4035525|NCT01137474|3856455|B1|65 years and older to younger than 75 years||Age, Customized||Participants|Number|46|46.0||||||
4035526|NCT01137474|3856451|B5|Younger than 65 years||Age, Customized||Participants|Number|802|802.0||||||
4035527|NCT01137474|3856452|B4|Younger than 65 years||Age, Customized||Participants|Number|260|260.0||||||
4035528|NCT01137474|3856453|B3|Younger than 65 years||Age, Customized||Participants|Number|142|142.0||||||
4035529|NCT01137474|3856454|B2|Younger than 65 years||Age, Customized||Participants|Number|141|141.0||||||
4035530|NCT01137474|3856455|B1|Younger than 65 years||Age, Customized||Participants|Number|259|259.0||||||
4035531|NCT01137435|3856476|B1|Korea, Republic of||Region of Enrollment||Participants|Number|659|659.0||||||
4035532|NCT01137435|3856476|B1||Male|Gender||Participants|Count of Participants|205|205.0||||||
4035533|NCT01137435|3856476|B1||Female|Gender||Participants|Count of Participants|454|454.0||||||
4035534|NCT01137435|3856476|B1|||Age||Years|Mean|24.38|24.38|Standard Deviation|13.51|13.51|||
4035535|NCT01137435|3856476|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4035536|NCT01137435|3856476|B1||Between 18 and 65 years|Age||Participants|Count of Participants|384|384.0||||||
4035537|NCT01137435|3856476|B1||<=18 years|Age||Participants|Count of Participants|275|275.0||||||
4035538|NCT01137396|3856483|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4035539|NCT01137396|3856484|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4035540|NCT01137396|3856485|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4035541|NCT01137396|3856483|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4035542|NCT01137396|3856484|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4035543|NCT01137396|3856485|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4035544|NCT01137396|3856483|B3|||Age||years|Mean|43|43.0|Standard Deviation|7|7.0|||
4035545|NCT01137396|3856484|B2|||Age||years|Mean|44|44.0|Standard Deviation|7|7.0|||
4035546|NCT01137396|3856485|B1|||Age||years|Mean|42|42.0|Standard Deviation|7|7.0|||
4035547|NCT01137370|3856494|B3|Korea, Republic of||Region of Enrollment||participants|Number|203|203.0||||||
4035548|NCT01137370|3856495|B2|Korea, Republic of||Region of Enrollment||participants|Number|87|87.0||||||
4035549|NCT01137370|3856496|B1|Korea, Republic of||Region of Enrollment||participants|Number|116|116.0||||||
4035550|NCT01137370|3856494|B3||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4035551|NCT01137370|3856495|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4035552|NCT01137370|3856496|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4035553|NCT01137370|3856494|B3||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4035554|NCT01137370|3856495|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4035555|NCT01137370|3856496|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4035556|NCT01137370|3856494|B3|||Age||years|Mean|51.7|51.7|Standard Deviation|16.96|16.96|||
4035557|NCT01137370|3856495|B2|||Age||years|Mean|50.9|50.9|Standard Deviation|15.20|15.2|||
4035558|NCT01137370|3856496|B1|||Age||years|Mean|52.2|52.2|Standard Deviation|18.20|18.2|||
4035559|NCT01137370|3856494|B3||>=65 years|Age||Participants|Count of Participants|54|54.0||||||
4035560|NCT01137370|3856495|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4035561|NCT01137370|3856496|B1||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
4035562|NCT01137370|3856494|B3||Between 18 and 65 years|Age||Participants|Count of Participants|147|147.0||||||
4035563|NCT01137370|3856495|B2||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
4035564|NCT01137370|3856496|B1||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
4035565|NCT01137370|3856494|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4035566|NCT01137370|3856495|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4035567|NCT01137370|3856496|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4035568|NCT01137292|3856503|B1|Other Invasive Mycosis||Number of Participants with Risk Factors of Invasive Fungal Infections||participants|Number|5|5.0||||||
4035569|NCT01137292|3856503|B1|Mucositisis||Number of Participants with Risk Factors of Invasive Fungal Infections||participants|Number|38|38.0||||||
4035570|NCT01137292|3856503|B1|Steroid Treatment||Number of Participants with Risk Factors of Invasive Fungal Infections||participants|Number|74|74.0||||||
4035571|NCT01137292|3856503|B1|Previous Antibiotic Treatment||Number of Participants with Risk Factors of Invasive Fungal Infections||participants|Number|120|120.0||||||
4035572|NCT01137292|3856503|B1|Organ Transplant||Number of Participants with Risk Factors of Invasive Fungal Infections||participants|Number|3|3.0||||||
4035573|NCT01137292|3856503|B1|Diabetes Mellitus||Number of Participants with Risk Factors of Invasive Fungal Infections||participants|Number|10|10.0||||||
4035574|NCT01137292|3856503|B1|Allogenic Bone Marrow Transplant||Number of Participants with Risk Factors of Invasive Fungal Infections||participants|Number|13|13.0||||||
4035575|NCT01137292|3856503|B1|Cytomegalovirus Infection||Number of Participants with Risk Factors of Invasive Fungal Infections||participants|Number|13|13.0||||||
4035576|NCT01137292|3856503|B1|Total Parental Nutrition||Number of Participants with Risk Factors of Invasive Fungal Infections||participants|Number|35|35.0||||||
4035577|NCT01137292|3856503|B1|Primary/Secondary Immunodeficiency||Number of Participants with Risk Factors of Invasive Fungal Infections||participants|Number|101|101.0||||||
4035578|NCT01137292|3856503|B1|Antifungal Prophylaxis||Number of Participants with Risk Factors of Invasive Fungal Infections||participants|Number|114|114.0||||||
4035579|NCT01137292|3856503|B1|Hemodialysis||Number of Participants with Risk Factors of Invasive Fungal Infections||participants|Number|5|5.0||||||
4035580|NCT01137292|3856503|B1|Ventilation (Intubation)||Number of Participants with Risk Factors of Invasive Fungal Infections||participants|Number|32|32.0||||||
4035581|NCT01137292|3856503|B1|Central Venous Catether||Number of Participants with Risk Factors of Invasive Fungal Infections||participants|Number|110|110.0||||||
4035582|NCT01137292|3856503|B1|Undergone Surgery||Number of Participants with Risk Factors of Invasive Fungal Infections||participants|Number|23|23.0||||||
4035583|NCT01137292|3856503|B1|Chemotherapy||Number of Participants with Risk Factors of Invasive Fungal Infections||participants|Number|122|122.0||||||
4035584|NCT01137292|3856503|B1|Malignant Tumour||Number of Participants with Risk Factors of Invasive Fungal Infections||participants|Number|110|110.0||||||
4035585|NCT01137292|3856503|B1|Graft-Versus-Host Disease||Number of Participants with Risk Factors of Invasive Fungal Infections||participants|Number|7|7.0||||||
4035586|NCT01137292|3856503|B1|Immunosuppressive Treatment||Number of Participants with Risk Factors of Invasive Fungal Infections||participants|Number|42|42.0||||||
4035587|NCT01137292|3856503|B1|Antibiotic Prophylaxis||Number of Participants with Risk Factors of Invasive Fungal Infections||participants|Number|81|81.0||||||
4035588|NCT01137292|3856503|B1|Polytrauma||Number of Participants with Risk Factors of Invasive Fungal Infections||participants|Number|13|13.0||||||
4035589|NCT01137292|3856503|B1|Autologic Bone Marrow Transplant||Number of Participants with Risk Factors of Invasive Fungal Infections||participants|Number|11|11.0||||||
4035590|NCT01137292|3856503|B1|Neuropenia||Number of Participants with Risk Factors of Invasive Fungal Infections||participants|Number|104|104.0||||||
4035591|NCT01137292|3856503|B1|Radiotherapy||Number of Participants with Risk Factors of Invasive Fungal Infections||participants|Number|8|8.0||||||
4035592|NCT01137292|3856503|B1|Biopsy||Number of Participants Having Certain Methods of Diagnosis of Invasive Aspergillosis||participants|Number|2|2.0||||||
4035593|NCT01137292|3856503|B1|Bronchoalveolar Lavage (BAL)||Number of Participants Having Certain Methods of Diagnosis of Invasive Aspergillosis||participants|Number|23|23.0||||||
4035594|NCT01137292|3856503|B1|Blood Culture||Number of Participants Having Certain Methods of Diagnosis of Invasive Aspergillosis||participants|Number|8|8.0||||||
4035595|NCT01137292|3856503|B1|Polymerase Chain Reaction (PCR)||Number of Participants Having Certain Methods of Diagnosis of Invasive Aspergillosis||participants|Number|5|5.0||||||
4035596|NCT01137292|3856503|B1|Galactomannan||Number of Participants Having Certain Methods of Diagnosis of Invasive Aspergillosis||participants|Number|55|55.0||||||
4035597|NCT01137292|3856503|B1|Hi-Resolution Computed Tomography||Number of Participants Having Certain Methods of Diagnosis of Invasive Aspergillosis||participants|Number|91|91.0||||||
4035598|NCT01137292|3856503|B1||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4035599|NCT01137292|3856503|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4035600|NCT01137292|3856503|B1|> = 65 years||Age, Customized||participants|Number|26|26.0||||||
4035601|NCT01137292|3856503|B1|45 to 64 years||Age, Customized||participants|Number|80|80.0||||||
4035602|NCT01137292|3856503|B1|19 to 44 years||Age, Customized||participants|Number|52|52.0||||||
4035603|NCT01137292|3856503|B1|2 to 18 years||Age, Customized||participants|Number|16|16.0||||||
4035604|NCT01137292|3856503|B1|< 2 years||Age, Customized||participants|Number|3|3.0||||||
4035605|NCT01137071|3856510|B1|Brazil||Region of Enrollment|The clinical trial was performed only in Brazil|participants|Number|29|29.0||||||
4035606|NCT01137071|3856510|B1|Other||Race/Ethnicity, Customized|Race/Ethnicity/Color was recorded at screening|participants|Number|0|0.0||||||
4035607|NCT01137071|3856510|B1|Brown||Race/Ethnicity, Customized|Race/Ethnicity/Color was recorded at screening|participants|Number|4|4.0||||||
4035608|NCT01137071|3856510|B1|Yellow||Race/Ethnicity, Customized|Race/Ethnicity/Color was recorded at screening|participants|Number|0|0.0||||||
4035609|NCT01137071|3856510|B1|Black||Race/Ethnicity, Customized|Race/Ethnicity/Color was recorded at screening|participants|Number|1|1.0||||||
4035610|NCT01137071|3856510|B1|White||Race/Ethnicity, Customized|Race/Ethnicity/Color was recorded at screening|participants|Number|24|24.0||||||
4035611|NCT01137071|3856510|B1||Male|Gender|"# of Female patients is due to the inclusion criteria number #02: Female patients of ≥18 years of age"|Participants|Count of Participants|0|0.0||||||
4035612|NCT01137071|3856510|B1||Female|Gender|"# of Female patients is due to the inclusion criteria number #02: Female patients of ≥18 years of age"|Participants|Count of Participants|29|29.0||||||
4035613|NCT01137071|3856510|B1|||Age||Years|Mean|55.69|55.69|Full Range|||29.0|67.0|
4035614|NCT01137032|3856571|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4035615|NCT01137032|3856571|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4035616|NCT01137032|3856571|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4035617|NCT01137032|3856571|B1|||Age||years|Mean|48.3|48.3|Full Range|||23.0|82.0|
4035618|NCT01137032|3856571|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4035619|NCT01137032|3856571|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4035620|NCT01137032|3856571|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4035621|NCT01136967|3856577|B3|Unresectable Stage IV||AJCC Melanoma Tumor, Node, Metastasis (TNM) Stage at Study Entry||Participants|Number|170|170.0||||||
4035622|NCT01136967|3856578|B2|Unresectable Stage IV||AJCC Melanoma Tumor, Node, Metastasis (TNM) Stage at Study Entry||Participants|Number|82|82.0||||||
4035623|NCT01136967|3856579|B1|Unresectable Stage IV||AJCC Melanoma Tumor, Node, Metastasis (TNM) Stage at Study Entry||Participants|Number|88|88.0||||||
4035624|NCT01136967|3856577|B3|Unresectable Stage III||AJCC Melanoma Tumor, Node, Metastasis (TNM) Stage at Study Entry||Participants|Number|12|12.0||||||
4035625|NCT01136967|3856578|B2|Unresectable Stage III||AJCC Melanoma Tumor, Node, Metastasis (TNM) Stage at Study Entry||Participants|Number|7|7.0||||||
4035626|NCT01136967|3856579|B1|Unresectable Stage III||AJCC Melanoma Tumor, Node, Metastasis (TNM) Stage at Study Entry||Participants|Number|5|5.0||||||
4035627|NCT01136967|3856577|B3||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4035628|NCT01136967|3856578|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4035629|NCT01136967|3856579|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4035630|NCT01136967|3856577|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4035631|NCT01136967|3856578|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4035632|NCT01136967|3856579|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4035633|NCT01136967|3856577|B3|||Age||Years|Mean|58.8|58.8|Standard Deviation|13.47|13.47|||
4035634|NCT01136967|3856578|B2|||Age||Years|Mean|55.0|55.0|Standard Deviation|14.18|14.18|||
4035635|NCT01136967|3856579|B1|||Age||Years|Mean|62.5|62.5|Standard Deviation|11.71|11.71|||
4035636|NCT01136954|3856596|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4035637|NCT01136954|3856597|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4035638|NCT01136954|3856598|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4035639|NCT01136954|3856596|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4035640|NCT01136954|3856597|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4035641|NCT01136954|3856598|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4035642|NCT01136954|3856596|B3|12-18 Years||Age, Customized||Participants|Number|77|77.0||||||
4035643|NCT01136954|3856597|B2|12-18 Years||Age, Customized||Participants|Number|39|39.0||||||
4035644|NCT01136954|3856598|B1|12-18 Years||Age, Customized||Participants|Number|38|38.0||||||
4035645|NCT01136954|3856596|B3|6-11 Years||Age, Customized||Participants|Number|67|67.0||||||
4035646|NCT01136954|3856597|B2|6-11 Years||Age, Customized||Participants|Number|33|33.0||||||
4035647|NCT01136954|3856598|B1|6-11 Years||Age, Customized||Participants|Number|34|34.0||||||
4035648|NCT01136915|3856611|B3|China||Region of Enrollment||participants|Number|11|11.0||||||
4035649|NCT01136915|3856612|B2|China||Region of Enrollment||participants|Number|6|6.0||||||
4035650|NCT01136915|3856613|B1|China||Region of Enrollment||participants|Number|5|5.0||||||
4035651|NCT01136915|3856611|B3|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4035652|NCT01136915|3856612|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4035653|NCT01136915|3856613|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4035654|NCT01136915|3856611|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4035655|NCT01136915|3856612|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4035656|NCT01136915|3856613|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4035657|NCT01136915|3856611|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4035658|NCT01136915|3856612|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4035659|NCT01136915|3856613|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4035660|NCT01136915|3856611|B3|||Age||years|Mean|68.7|68.7|Standard Deviation|11.3|11.3|||
4035661|NCT01136915|3856612|B2|||Age||years|Mean|67.7|67.7|Standard Deviation|14.2|14.2|||
4035662|NCT01136915|3856613|B1|||Age||years|Mean|69.5|69.5|Standard Deviation|9.1|9.1|||
4035663|NCT01136915|3856611|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4035664|NCT01136915|3856612|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4035665|NCT01136915|3856613|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4035666|NCT01136915|3856611|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4035667|NCT01136915|3856612|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4035668|NCT01136915|3856613|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4035669|NCT01136915|3856611|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4035670|NCT01136915|3856612|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4035671|NCT01136915|3856613|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4035672|NCT01136876|3856622|B3|Canada||Region of Enrollment||participants|Number|19|19.0||||||
4035673|NCT01136876|3856623|B2|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4035674|NCT01136876|3856624|B1|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4035675|NCT01136876|3856622|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
4035676|NCT01136876|3856623|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4035677|NCT01136876|3856624|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4035678|NCT01136876|3856622|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4035679|NCT01136876|3856623|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4035680|NCT01136876|3856624|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4035681|NCT01136876|3856622|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4035682|NCT01136876|3856623|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4035683|NCT01136876|3856624|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4035684|NCT01136876|3856622|B3|||Age||years|Mean|72.2|72.2|Standard Deviation|8.8|8.8|||
4035685|NCT01136876|3856623|B2|||Age||years|Mean|73.3|73.3|Standard Deviation|10.0|10.0|||
4035686|NCT01136876|3856624|B1|||Age||years|Mean|71.1|71.1|Standard Deviation|7.4|7.4|||
4035687|NCT01136876|3856622|B3||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
4035688|NCT01136876|3856623|B2||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4035689|NCT01136876|3856624|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4035690|NCT01136876|3856622|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4035691|NCT01136876|3856623|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4035692|NCT01136876|3856624|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4035693|NCT01136876|3856622|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4035694|NCT01136876|3856623|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4035695|NCT01136876|3856624|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4035696|NCT01136798|3856633|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4035697|NCT01136798|3856634|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4035698|NCT01136798|3856635|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4035699|NCT01136798|3856633|B3|Non-Hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4035700|NCT01136798|3856634|B2|Non-Hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4035701|NCT01136798|3856635|B1|Non-Hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4035702|NCT01136798|3856633|B3|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4035703|NCT01136798|3856634|B2|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4035704|NCT01136798|3856635|B1|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4035705|NCT01136798|3856633|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4035706|NCT01136798|3856634|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4035707|NCT01136798|3856635|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4035708|NCT01136798|3856633|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4035709|NCT01136798|3856634|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4035710|NCT01136798|3856635|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4035711|NCT01136798|3856633|B3|||Age||years|Mean|56.2|56.2|Standard Deviation|8.6|8.6|||
4035712|NCT01136798|3856634|B2|||Age||years|Mean|52.8|52.8|Standard Deviation|8.6|8.6|||
4035713|NCT01136798|3856635|B1|||Age||years|Mean|59|59.0|Standard Deviation|7.6|7.6|||
4035714|NCT01136785|3856652|B3|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4035715|NCT01136785|3856653|B2|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4035716|NCT01136785|3856654|B1|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4035717|NCT01136785|3856652|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035718|NCT01136785|3856653|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035719|NCT01136785|3856654|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035720|NCT01136785|3856652|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4035721|NCT01136785|3856653|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035722|NCT01136785|3856654|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4035723|NCT01136785|3856652|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4035724|NCT01136785|3856653|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4035725|NCT01136785|3856654|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4035726|NCT01136785|3856652|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4035727|NCT01136785|3856653|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4035728|NCT01136785|3856654|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4035729|NCT01136785|3856652|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4035730|NCT01136785|3856653|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035731|NCT01136785|3856654|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4035732|NCT01136785|3856652|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035733|NCT01136785|3856653|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035734|NCT01136785|3856654|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035735|NCT01136785|3856652|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035736|NCT01136785|3856653|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035737|NCT01136785|3856654|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035738|NCT01136785|3856652|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4035739|NCT01136785|3856653|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4035740|NCT01136785|3856654|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4035741|NCT01136785|3856652|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4035742|NCT01136785|3856653|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4035743|NCT01136785|3856654|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4035744|NCT01136785|3856652|B3|||Age||years|Mean|55.0|55.0|Standard Deviation|9.6|9.6|||
4035745|NCT01136785|3856653|B2|||Age||years|Mean|52.3|52.3|Standard Deviation|3.1|3.1|||
4035746|NCT01136785|3856654|B1|||Age||years|Mean|56.2|56.2|Standard Deviation|11.4|11.4|||
4035747|NCT01136772|3856668|B3||Male|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4035748|NCT01136772|3856669|B2||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4035749|NCT01136772|3856670|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4035750|NCT01136772|3856668|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4035751|NCT01136772|3856669|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4035752|NCT01136772|3856670|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4035753|NCT01136772|3856668|B3|||Age||years|Mean|44|44.0|Standard Deviation|12.4|12.4|||
4035754|NCT01136772|3856669|B2|||Age||years|Mean|45|45.0|Standard Deviation|12.3|12.3|||
4035755|NCT01136772|3856670|B1|||Age||years|Mean|43|43.0|Standard Deviation|12.6|12.6|||
4035756|NCT01136746|3856679|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4035757|NCT01136746|3856680|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4035758|NCT01136746|3856681|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4035759|NCT01136746|3856679|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035760|NCT01136746|3856680|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035761|NCT01136746|3856681|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035762|NCT01136746|3856679|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035763|NCT01136746|3856680|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035764|NCT01136746|3856681|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035765|NCT01136746|3856679|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4035766|NCT01136746|3856680|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4035767|NCT01136746|3856681|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4035768|NCT01136746|3856679|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4035769|NCT01136746|3856680|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4035770|NCT01136746|3856681|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4035771|NCT01136746|3856679|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035772|NCT01136746|3856680|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035773|NCT01136746|3856681|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035774|NCT01136746|3856679|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035775|NCT01136746|3856680|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035776|NCT01136746|3856681|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035777|NCT01136746|3856679|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035778|NCT01136746|3856680|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035779|NCT01136746|3856681|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035780|NCT01136746|3856679|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035781|NCT01136746|3856680|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035782|NCT01136746|3856681|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035783|NCT01136746|3856679|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4035784|NCT01136746|3856680|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4035785|NCT01136746|3856681|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4035786|NCT01136746|3856679|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4035787|NCT01136746|3856680|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035788|NCT01136746|3856681|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4035789|NCT01136746|3856679|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4035790|NCT01136746|3856680|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4035791|NCT01136746|3856681|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4035792|NCT01136746|3856679|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4035793|NCT01136746|3856680|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4035794|NCT01136746|3856681|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4035795|NCT01136746|3856679|B3|||Age||years|Mean|56.4|56.4|Standard Deviation|14.1|14.1|||
4035796|NCT01136746|3856680|B2|||Age||years|Mean|51.4|51.4|Standard Deviation|8.5|8.5|||
4035797|NCT01136746|3856681|B1|||Age||years|Mean|60.2|60.2|Standard Deviation|16.8|16.8|||
4035798|NCT01136655|3856742|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4035799|NCT01136655|3856742|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035800|NCT01136655|3856742|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4035801|NCT01136655|3856742|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4035802|NCT01136655|3856742|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035803|NCT01136655|3856742|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035804|NCT01136655|3856742|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035805|NCT01136655|3856742|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4035806|NCT01136655|3856742|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4035807|NCT01136655|3856742|B1|>=8 to < 12 years||Age, Customized||participants|Number|43|43.0||||||
4035808|NCT01136655|3856742|B1|>=6 to <8 years||Age, Customized||participants|Number|11|11.0||||||
4035809|NCT01136655|3856742|B1|||Age||years|Mean|9.2|9.2|Standard Deviation|1.79|1.79|||
4035810|NCT01136486|3856768|B1|United States||Region of Enrollment||participants|Number|56|56.0||||||
4035811|NCT01136486|3856768|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4035812|NCT01136486|3856768|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4035813|NCT01136486|3856768|B1|caucasian||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4035814|NCT01136486|3856768|B1|African america||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4035815|NCT01136486|3856768|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4035816|NCT01136486|3856768|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4035817|NCT01136486|3856768|B1|||Age||years|Mean|43|43.0|Standard Deviation|7|7.0|||
4035818|NCT01136486|3856768|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4035819|NCT01136486|3856768|B1||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4035820|NCT01136486|3856768|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4035821|NCT01136408|3856772|B4||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4035822|NCT01136408|3856773|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4035823|NCT01136408|3856774|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4035824|NCT01136408|3856775|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4035825|NCT01136408|3856772|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4035826|NCT01136408|3856773|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4035827|NCT01136408|3856774|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4035828|NCT01136408|3856775|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4035829|NCT01136408|3856772|B4|||Age||years|Mean|68.4|68.4|Standard Deviation|8.6|8.6|||
4035830|NCT01136408|3856773|B3|||Age||years|Mean|67.4|67.4|Standard Deviation|8.8|8.8|||
4035831|NCT01136408|3856774|B2|||Age||years|Mean|68.3|68.3|Standard Deviation|9.1|9.1|||
4035832|NCT01136408|3856775|B1|||Age||years|Mean|69.9|69.9|Standard Deviation|7.5|7.5|||
4035833|NCT01136382|3856832|B3|||Forced expiratory volume in 1 second (FEV1)||liters|Mean|1.70|1.7|Standard Deviation|0.401|0.401|||
4035834|NCT01136382|3856833|B2|||Forced expiratory volume in 1 second (FEV1)||liters|Mean|1.69|1.69|Standard Deviation|0.388|0.388|||
4035835|NCT01136382|3856834|B1|||Forced expiratory volume in 1 second (FEV1)||liters|Mean|1.70|1.7|Standard Deviation|0.416|0.416|||
4035836|NCT01136382|3856832|B3|Other||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4035837|NCT01136382|3856833|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4035838|NCT01136382|3856834|B1|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4035839|NCT01136382|3856832|B3|Not Applicable||Race/Ethnicity, Customized||participants|Number|254|254.0||||||
4035840|NCT01136382|3856833|B2|Not Applicable||Race/Ethnicity, Customized||participants|Number|126|126.0||||||
4035841|NCT01136382|3856834|B1|Not Applicable||Race/Ethnicity, Customized||participants|Number|128|128.0||||||
4035842|NCT01136382|3856832|B3|Asian (other than Chinese and Japanese)||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4035843|NCT01136382|3856833|B2|Asian (other than Chinese and Japanese)||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4035844|NCT01136382|3856834|B1|Asian (other than Chinese and Japanese)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4035845|NCT01136382|3856832|B3|African American||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4035846|NCT01136382|3856833|B2|African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4035847|NCT01136382|3856834|B1|African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4035848|NCT01136382|3856832|B3|Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4035849|NCT01136382|3856833|B2|Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4035850|NCT01136382|3856834|B1|Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4035851|NCT01136382|3856832|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4035852|NCT01136382|3856833|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4035853|NCT01136382|3856834|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4035854|NCT01136382|3856832|B3||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4035855|NCT01136382|3856833|B2||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4035856|NCT01136382|3856834|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4035857|NCT01136382|3856832|B3||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4035858|NCT01136382|3856833|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4035859|NCT01136382|3856834|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4035860|NCT01136382|3856832|B3|8 to- <12 years||Age, Customized||participants|Number|238|238.0||||||
4035861|NCT01136382|3856833|B2|8 to- <12 years||Age, Customized||participants|Number|119|119.0||||||
4035862|NCT01136382|3856834|B1|8 to- <12 years||Age, Customized||participants|Number|119|119.0||||||
4035863|NCT01136382|3856832|B3|6 to <8 years||Age, Customized||participants|Number|66|66.0||||||
4035864|NCT01136382|3856833|B2|6 to <8 years||Age, Customized||participants|Number|33|33.0||||||
4035865|NCT01136382|3856834|B1|6 to <8 years||Age, Customized||participants|Number|33|33.0||||||
4035866|NCT01136382|3856832|B3|||Age||years|Mean|9.0|9.0|Standard Deviation|1.62|1.62|||
4035867|NCT01136382|3856833|B2|||Age||years|Mean|9.0|9.0|Standard Deviation|1.63|1.63|||
4035868|NCT01136382|3856834|B1|||Age||years|Mean|9.0|9.0|Standard Deviation|1.62|1.62|||
4035869|NCT01136356|3856861|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4035870|NCT01136356|3856861|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035871|NCT01136356|3856861|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035872|NCT01136356|3856861|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4035873|NCT01136356|3856861|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4035874|NCT01136356|3856861|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035875|NCT01136356|3856861|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035876|NCT01136356|3856861|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035877|NCT01136356|3856861|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4035878|NCT01136356|3856861|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4035879|NCT01136356|3856861|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4035880|NCT01136356|3856861|B1||Male|Gender||Participants|Count of Participants|12|12.0||||||
4035881|NCT01136356|3856861|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
4035882|NCT01136356|3856861|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4035883|NCT01136356|3856861|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4035884|NCT01136356|3856861|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4035885|NCT01136291|3856871|B3|Brazil||Region of Enrollment||participants|Number|82|82.0||||||
4035886|NCT01136291|3856872|B2|Brazil||Region of Enrollment||participants|Number|42|42.0||||||
4035887|NCT01136291|3856873|B1|Brazil||Region of Enrollment||participants|Number|40|40.0||||||
4035888|NCT01136291|3856871|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4035889|NCT01136291|3856872|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4035890|NCT01136291|3856873|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4035891|NCT01136291|3856871|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4035892|NCT01136291|3856872|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4035893|NCT01136291|3856873|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4035894|NCT01136291|3856871|B3|||Age||years|Mean|30.1|30.1|Standard Deviation|6.2|6.2|||
4035895|NCT01136291|3856872|B2|||Age||years|Mean|30.9|30.9|Standard Deviation|5.9|5.9|||
4035896|NCT01136291|3856873|B1|||Age||years|Mean|29.7|29.7|Standard Deviation|6.8|6.8|||
4035897|NCT01136226|3856884|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4035898|NCT01136226|3856884|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4035899|NCT01136226|3856884|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4035900|NCT01136226|3856884|B1|||Age||years|Mean|70.8|70.8|Standard Deviation|6.4|6.4|||
4035901|NCT01136226|3856884|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4035902|NCT01136226|3856884|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4035903|NCT01136226|3856884|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4035904|NCT01136174|3856889|B5||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4035905|NCT01136174|3856890|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4035906|NCT01136174|3856891|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4035907|NCT01136174|3856892|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4035908|NCT01136174|3856893|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4035909|NCT01136174|3856889|B5||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4035910|NCT01136174|3856890|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4035911|NCT01136174|3856891|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4035912|NCT01136174|3856892|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4035913|NCT01136174|3856893|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4035914|NCT01136174|3856889|B5|||Age||years|Mean|65.2|65.2|Standard Deviation|8.2|8.2|||
4035915|NCT01136174|3856890|B4|||Age||years|Mean|64.7|64.7|Standard Deviation|8.5|8.5|||
4035916|NCT01136174|3856891|B3|||Age||years|Mean|67.5|67.5|Standard Deviation|7.4|7.4|||
4035917|NCT01136174|3856892|B2|||Age||years|Mean|66.7|66.7|Standard Deviation|2.9|2.9|||
4035918|NCT01136174|3856893|B1|||Age||years|Mean|64.1|64.1|Standard Deviation|10.3|10.3|||
4035919|NCT01135992|3856976|B1|||Body weight at baseline||kg|Mean|99.3|99.3|Standard Deviation|20.4|20.4|||
4035920|NCT01135992|3856976|B1|||Fasting plasma glucose (FPG) at baseline||mmol/L|Mean|7.0|7.0|Standard Deviation|2.2|2.2|||
4035921|NCT01135992|3856976|B1|||HbA1c (glycosylated haemoglobin) at baseline||percentage of glycosylated haemoglobin|Mean|7.5|7.5|Standard Deviation|1.1|1.1|||
4035922|NCT01135992|3856976|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4035923|NCT01135992|3856976|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4035924|NCT01135992|3856976|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|10.2|10.2|||
4035925|NCT01135914|3856985|B4||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4035926|NCT01135914|3856986|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4035927|NCT01135914|3856987|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4035928|NCT01135914|3856988|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4035929|NCT01135914|3856985|B4||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4035930|NCT01135914|3856986|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4035931|NCT01135914|3856987|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4035932|NCT01135914|3856988|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4035933|NCT01135914|3856985|B4|||Age||years|Mean|61.7|61.7|Standard Deviation|9.83|9.83|||
4035934|NCT01135914|3856986|B3|||Age||years|Mean|62.8|62.8|Standard Deviation|9.44|9.44|||
4035935|NCT01135914|3856987|B2|||Age||years|Mean|61.5|61.5|Standard Deviation|9.86|9.86|||
4035936|NCT01135914|3856988|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|10.21|10.21|||
4035937|NCT01135524|3857019|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4035938|NCT01135524|3857019|B1||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4035939|NCT01135524|3857019|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|9.83|9.83|||
4035940|NCT01135511|3857023|B10||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4035941|NCT01135511|3857024|B9||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4035942|NCT01135511|3857025|B8||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4035943|NCT01135511|3857026|B7||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4035944|NCT01135511|3857027|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4035945|NCT01135511|3857028|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4035946|NCT01135511|3857029|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4035947|NCT01135511|3857030|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4035948|NCT01135511|3857031|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4035949|NCT01135511|3857032|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4035950|NCT01135511|3857023|B10||Female|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
4035951|NCT01135511|3857024|B9||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4035952|NCT01135511|3857025|B8||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4035953|NCT01135511|3857026|B7||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4035954|NCT01135511|3857027|B6||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4035955|NCT01135511|3857028|B5||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4035956|NCT01135511|3857029|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4035957|NCT01135511|3857030|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4035958|NCT01135511|3857031|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4035959|NCT01135511|3857032|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4035960|NCT01135511|3857023|B10|>=65 years||Age, Customized||participants|Number|95|95.0||||||
4035961|NCT01135511|3857024|B9|>=65 years||Age, Customized||participants|Number|8|8.0||||||
4035962|NCT01135511|3857025|B8|>=65 years||Age, Customized||participants|Number|1|1.0||||||
4035963|NCT01135511|3857026|B7|>=65 years||Age, Customized||participants|Number|3|3.0||||||
4035964|NCT01135511|3857027|B6|>=65 years||Age, Customized||participants|Number|6|6.0||||||
4035965|NCT01135511|3857028|B5|>=65 years||Age, Customized||participants|Number|14|14.0||||||
4035966|NCT01135511|3857029|B4|>=65 years||Age, Customized||participants|Number|13|13.0||||||
4035967|NCT01135511|3857030|B3|>=65 years||Age, Customized||participants|Number|18|18.0||||||
4035968|NCT01135511|3857031|B2|>=65 years||Age, Customized||participants|Number|14|14.0||||||
4035969|NCT01135511|3857032|B1|>=65 years||Age, Customized||participants|Number|18|18.0||||||
4035970|NCT01135511|3857023|B10|Between 45 and 64 years||Age, Customized||participants|Number|106|106.0||||||
4035971|NCT01135511|3857024|B9|Between 45 and 64 years||Age, Customized||participants|Number|10|10.0||||||
4035972|NCT01135511|3857025|B8|Between 45 and 64 years||Age, Customized||participants|Number|13|13.0||||||
4035973|NCT01135511|3857026|B7|Between 45 and 64 years||Age, Customized||participants|Number|8|8.0||||||
4035974|NCT01135511|3857027|B6|Between 45 and 64 years||Age, Customized||participants|Number|10|10.0||||||
4035975|NCT01135511|3857028|B5|Between 45 and 64 years||Age, Customized||participants|Number|14|14.0||||||
4035976|NCT01135511|3857029|B4|Between 45 and 64 years||Age, Customized||participants|Number|16|16.0||||||
4035977|NCT01135511|3857030|B3|Between 45 and 64 years||Age, Customized||participants|Number|12|12.0||||||
4035978|NCT01135511|3857031|B2|Between 45 and 64 years||Age, Customized||participants|Number|14|14.0||||||
4035979|NCT01135511|3857032|B1|Between 45 and 64 years||Age, Customized||participants|Number|9|9.0||||||
4035980|NCT01135511|3857023|B10|Between 18 and 44 years||Age, Customized||participants|Number|84|84.0||||||
4035981|NCT01135511|3857024|B9|Between 18 and 44 years||Age, Customized||participants|Number|3|3.0||||||
4035982|NCT01135511|3857025|B8|Between 18 and 44 years||Age, Customized||participants|Number|7|7.0||||||
4035983|NCT01135511|3857026|B7|Between 18 and 44 years||Age, Customized||participants|Number|8|8.0||||||
4035984|NCT01135511|3857027|B6|Between 18 and 44 years||Age, Customized||participants|Number|5|5.0||||||
4035985|NCT01135511|3857028|B5|Between 18 and 44 years||Age, Customized||participants|Number|11|11.0||||||
4035986|NCT01135511|3857029|B4|Between 18 and 44 years||Age, Customized||participants|Number|11|11.0||||||
4035987|NCT01135511|3857030|B3|Between 18 and 44 years||Age, Customized||participants|Number|11|11.0||||||
4035988|NCT01135511|3857031|B2|Between 18 and 44 years||Age, Customized||participants|Number|14|14.0||||||
4035989|NCT01135511|3857032|B1|Between 18 and 44 years||Age, Customized||participants|Number|14|14.0||||||
4035990|NCT01135498|3857322|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4035991|NCT01135498|3857322|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4035992|NCT01135498|3857322|B1|||Age||years|Mean|59.23|59.23|Standard Deviation|8.18|8.18|||
4035993|NCT01135420|3857331|B3|United States||Region of Enrollment||participants|Number|406|406.0||||||
4035994|NCT01135420|3857332|B2|United States||Region of Enrollment||participants|Number|207|207.0||||||
4035995|NCT01135420|3857333|B1|United States||Region of Enrollment||participants|Number|199|199.0||||||
4035996|NCT01135420|3857331|B3||Male|Gender||Participants|Count of Participants|372|372.0||||||
4035997|NCT01135420|3857332|B2||Male|Gender||Participants|Count of Participants|189|189.0||||||
4035998|NCT01135420|3857333|B1||Male|Gender||Participants|Count of Participants|183|183.0||||||
4035999|NCT01135420|3857331|B3||Female|Gender||Participants|Count of Participants|34|34.0||||||
4036000|NCT01135420|3857332|B2||Female|Gender||Participants|Count of Participants|18|18.0||||||
4036001|NCT01135420|3857333|B1||Female|Gender||Participants|Count of Participants|16|16.0||||||
4036002|NCT01135420|3857331|B3|||Age||Years|Mean|45|45.0|Standard Deviation|13|13.0|||
4036003|NCT01135420|3857332|B2|||Age||Years|Mean|45|45.0|Standard Deviation|13|13.0|||
4036004|NCT01135420|3857333|B1|||Age||Years|Mean|45|45.0|Standard Deviation|13|13.0|||
4036005|NCT01135381|3857340|B5|United States||Region of Enrollment||participants|Number|478|478.0||||||
4036006|NCT01135381|3857341|B4|United States||Region of Enrollment||participants|Number|67|67.0||||||
4036007|NCT01135381|3857342|B3|United States||Region of Enrollment||participants|Number|65|65.0||||||
4036008|NCT01135381|3857343|B2|United States||Region of Enrollment||participants|Number|178|178.0||||||
4036009|NCT01135381|3857344|B1|United States||Region of Enrollment||participants|Number|168|168.0||||||
4036010|NCT01135381|3857340|B5||Male|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4036011|NCT01135381|3857341|B4||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4036012|NCT01135381|3857342|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4036013|NCT01135381|3857343|B2||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4036014|NCT01135381|3857344|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4036015|NCT01135381|3857340|B5||Female|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
4036016|NCT01135381|3857341|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4036017|NCT01135381|3857342|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4036018|NCT01135381|3857343|B2||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4036019|NCT01135381|3857344|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4036020|NCT01135381|3857340|B5|||Age||years|Mean|63|63.0|Standard Deviation|12.4|12.4|||
4036021|NCT01135381|3857341|B4|||Age||years|Mean|61|61.0|Standard Deviation|14.0|14.0|||
4036022|NCT01135381|3857342|B3|||Age||years|Mean|62|62.0|Standard Deviation|13.4|13.4|||
4036023|NCT01135381|3857343|B2|||Age||years|Mean|63|63.0|Standard Deviation|13.4|13.4|||
4036024|NCT01135381|3857344|B1|||Age||years|Mean|62|62.0|Standard Deviation|12.5|12.5|||
4036025|NCT01135381|3857340|B5||>=65 years|Age||Participants|Count of Participants|224|224.0||||||
4036026|NCT01135381|3857341|B4||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4036027|NCT01135381|3857342|B3||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4036028|NCT01135381|3857343|B2||>=65 years|Age||Participants|Count of Participants|89|89.0||||||
4036029|NCT01135381|3857344|B1||>=65 years|Age||Participants|Count of Participants|74|74.0||||||
4036030|NCT01135381|3857340|B5||Between 18 and 65 years|Age||Participants|Count of Participants|254|254.0||||||
4036031|NCT01135381|3857341|B4||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4036032|NCT01135381|3857342|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4036033|NCT01135381|3857343|B2||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
4036034|NCT01135381|3857344|B1||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
4036035|NCT01135381|3857340|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4036036|NCT01135381|3857341|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4036037|NCT01135381|3857342|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4036038|NCT01135381|3857343|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4036039|NCT01135381|3857344|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4036040|NCT01135368|3857365|B1|Recurrence||Diagnosis of Reflux Disease||participants|Number|356|356.0||||||
4036041|NCT01135368|3857365|B1|First diagnosis||Diagnosis of Reflux Disease||participants|Number|150|150.0||||||
4036042|NCT01135368|3857365|B1|||Body Mass Index (BMI)||kg/cm^2|Mean|28.09|28.09|Standard Deviation|4.15|4.15|||
4036043|NCT01135368|3857365|B1|||Weight||kg|Mean|82.2|82.2|Standard Deviation|13.7|13.7|||
4036044|NCT01135368|3857365|B1|||Height||cm|Mean|171.1|171.1|Standard Deviation|9.3|9.3|||
4036045|NCT01135368|3857365|B1|Oriental||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4036046|NCT01135368|3857365|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4036047|NCT01135368|3857365|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|502|502.0||||||
4036048|NCT01135368|3857365|B1||Male|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
4036049|NCT01135368|3857365|B1||Female|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4036050|NCT01135368|3857365|B1|||Age||years|Mean|53.5|53.5|Standard Deviation|12.1|12.1|||
4036051|NCT01135329|3857481|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4036052|NCT01135329|3857481|B1|Male||Sex/Gender, Customized||participants|Number|9|9.0||||||
4036053|NCT01135329|3857481|B1|Female||Sex/Gender, Customized||participants|Number|6|6.0||||||
4036054|NCT01135329|3857481|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4036055|NCT01135329|3857481|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4036056|NCT01135329|3857481|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4036057|NCT01135329|3857481|B1|||Age||years|Mean|49|49.0|Full Range|||3.0|73.0|
4036058|NCT01135186|3857492|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4036059|NCT01135186|3857492|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4036060|NCT01135186|3857492|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4036061|NCT01135186|3857492|B1|||Age||years|Mean|42.56|42.56|Standard Deviation|15.03|15.03|||
4036062|NCT01135186|3857492|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4036063|NCT01135186|3857492|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4036064|NCT01135186|3857492|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4036065|NCT01135134|3857499|B3||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4036066|NCT01135134|3857500|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4036067|NCT01135134|3857501|B1||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4036068|NCT01135134|3857499|B3||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4036069|NCT01135134|3857500|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4036070|NCT01135134|3857501|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4036071|NCT01135134|3857499|B3|Between 12 and 15 years||Age, Customized||Participants|Number|113|113.0||||||
4036072|NCT01135134|3857500|B2|Between 12 and 15 years||Age, Customized||Participants|Number|39|39.0||||||
4036073|NCT01135134|3857501|B1|Between 12 and 15 years||Age, Customized||Participants|Number|74|74.0||||||
4036074|NCT01135134|3857499|B3|Between 5 and 11 years||Age, Customized||Participants|Number|220|220.0||||||
4036075|NCT01135134|3857500|B2|Between 5 and 11 years||Age, Customized||Participants|Number|74|74.0||||||
4036076|NCT01135134|3857501|B1|Between 5 and 11 years||Age, Customized||Participants|Number|146|146.0||||||
4036077|NCT01135069|3857510|B4|United States||Region of Enrollment||participants|Number|480|480.0||||||
4036078|NCT01135069|3857511|B3|United States||Region of Enrollment||participants|Number|66|66.0||||||
4036079|NCT01135069|3857512|B2|United States||Region of Enrollment||participants|Number|209|209.0||||||
4036080|NCT01135069|3857513|B1|United States||Region of Enrollment||participants|Number|205|205.0||||||
4036081|NCT01135069|3857510|B4||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4036082|NCT01135069|3857511|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4036083|NCT01135069|3857512|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4036084|NCT01135069|3857513|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4036085|NCT01135069|3857510|B4||Female|Sex: Female, Male||Participants|Count of Participants|342|342.0||||||
4036086|NCT01135069|3857511|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4036087|NCT01135069|3857512|B2||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4036088|NCT01135069|3857513|B1||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4036089|NCT01135069|3857510|B4|||Age||years|Mean|21|21.0|Standard Deviation|7.5|7.5|||
4036090|NCT01135069|3857511|B3|||Age||years|Mean|19|19.0|Standard Deviation|6.7|6.7|||
4036091|NCT01135069|3857512|B2|||Age||years|Mean|21|21.0|Standard Deviation|8.1|8.1|||
4036092|NCT01135069|3857513|B1|||Age||years|Mean|21|21.0|Standard Deviation|7.4|7.4|||
4036093|NCT01135069|3857510|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4036094|NCT01135069|3857511|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4036095|NCT01135069|3857512|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4036096|NCT01135069|3857513|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4036097|NCT01135069|3857510|B4||Between 18 and 65 years|Age||Participants|Count of Participants|247|247.0||||||
4036098|NCT01135069|3857511|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4036099|NCT01135069|3857512|B2||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
4036100|NCT01135069|3857513|B1||Between 18 and 65 years|Age||Participants|Count of Participants|105|105.0||||||
4036101|NCT01135069|3857510|B4||<=18 years|Age||Participants|Count of Participants|233|233.0||||||
4036102|NCT01135069|3857511|B3||<=18 years|Age||Participants|Count of Participants|33|33.0||||||
4036103|NCT01135069|3857512|B2||<=18 years|Age||Participants|Count of Participants|100|100.0||||||
4036104|NCT01135069|3857513|B1||<=18 years|Age||Participants|Count of Participants|100|100.0||||||
4036105|NCT01135017|3857523|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4036106|NCT01135017|3857524|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4036107|NCT01135017|3857525|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4036108|NCT01135017|3857523|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4036109|NCT01135017|3857524|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4036110|NCT01135017|3857525|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4036111|NCT01135017|3857523|B3|||Age||years|Mean|75.9|75.9|Standard Deviation|9.1|9.1|||
4036112|NCT01135017|3857524|B2|||Age||years|Mean|77.3|77.3|Standard Deviation|8.6|8.6|||
4036113|NCT01135017|3857525|B1|||Age||years|Mean|74.5|74.5|Standard Deviation|9.5|9.5|||
4036114|NCT01134952|3857542|B1|||Triglyceride||mmol/L|Mean|1.7|1.7|Standard Deviation|0.5|0.5|||
4036115|NCT01134952|3857542|B1|||Fasting cholesterol||mmol/L|Mean|4.9|4.9|Standard Deviation|1.4|1.4|||
4036116|NCT01134952|3857542|B1|||Platelet count||10^9/L|Mean|165.3|165.3|Standard Deviation|58.3|58.3|||
4036117|NCT01134952|3857542|B1|||Hemoglobin||g/L|Mean|145.1|145.1|Standard Deviation|13.2|13.2|||
4036118|NCT01134952|3857542|B1|||Alanine aminotransferase||U/ml|Mean|86.3|86.3|Standard Deviation|56.1|56.1|||
4036119|NCT01134952|3857542|B1|||Alkaline phosphatase||U/L|Mean|94.5|94.5|Standard Deviation|40.2|40.2|||
4036120|NCT01134952|3857542|B1|||Bilirubin||umol/L|Mean|8.8|8.8|Standard Deviation|3.2|3.2|||
4036121|NCT01134952|3857542|B1|||Tacrolimus trough level||ng/ml|Mean|5.5|5.5|Standard Deviation|1.9|1.9|||
4036122|NCT01134952|3857542|B1|||Hepatitis C viral load||10^7 HCV IU/mL|Mean|2.8|2.8|Standard Deviation|2.6|2.6|||
4036123|NCT01134952|3857542|B1|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4036124|NCT01134952|3857542|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4036125|NCT01134952|3857542|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4036126|NCT01134952|3857542|B1|||Age||years|Mean|53|53.0|Standard Deviation|7|7.0|||
4036127|NCT01134939|3857556|B9||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4036128|NCT01134939|3857557|B8||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4036129|NCT01134939|3857558|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4036130|NCT01134939|3857559|B6||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4036131|NCT01134939|3857560|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4036132|NCT01134939|3857561|B4||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4036133|NCT01134939|3857562|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4036134|NCT01134939|3857563|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4036135|NCT01134939|3857564|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4036136|NCT01134939|3857556|B9||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4036137|NCT01134939|3857557|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4036138|NCT01134939|3857558|B7||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4036139|NCT01134939|3857559|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4036140|NCT01134939|3857560|B5||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4036141|NCT01134939|3857561|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4036142|NCT01134939|3857562|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4036143|NCT01134939|3857563|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4036144|NCT01134939|3857564|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4036145|NCT01134939|3857556|B9|||Age||years|Mean|39.7|39.7|Standard Deviation|9.6|9.6|||
4036146|NCT01134939|3857557|B8|||Age||years|Mean|50.0|50.0|Standard Deviation|||||
4036147|NCT01134939|3857558|B7|||Age||years|Mean|38.9|38.9|Standard Deviation|8.9|8.9|||
4036148|NCT01134939|3857559|B6|||Age||years|Mean|43.2|43.2|Standard Deviation|10.7|10.7|||
4036149|NCT01134939|3857560|B5|||Age||years|Mean|36.3|36.3|Standard Deviation|8.0|8.0|||
4036150|NCT01134939|3857561|B4|||Age||years|Mean|44.2|44.2|Standard Deviation|8.1|8.1|||
4036151|NCT01134939|3857562|B3|||Age||years|Mean|39.2|39.2|Standard Deviation|9.1|9.1|||
4036152|NCT01134939|3857563|B2|||Age||years|Mean|39.2|39.2|Standard Deviation|11.2|11.2|||
4036153|NCT01134939|3857564|B1|||Age||years|Mean|38.1|38.1|Standard Deviation|9.7|9.7|||
4036154|NCT01134900|3857681|B3|United States||Region of Enrollment||participants|Number|396|396.0||||||
4036155|NCT01134900|3857682|B2|United States||Region of Enrollment||participants|Number|196|196.0||||||
4036156|NCT01134900|3857683|B1|United States||Region of Enrollment||participants|Number|200|200.0||||||
4036157|NCT01134900|3857681|B3||Male|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
4036158|NCT01134900|3857682|B2||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4036159|NCT01134900|3857683|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4036160|NCT01134900|3857681|B3||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4036161|NCT01134900|3857682|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4036162|NCT01134900|3857683|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4036163|NCT01134900|3857681|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|16.3|16.3|||
4036164|NCT01134900|3857682|B2|||Age||years|Mean|58.3|58.3|Standard Deviation|15.7|15.7|||
4036165|NCT01134900|3857683|B1|||Age||years|Mean|60.7|60.7|Standard Deviation|16.8|16.8|||
4036166|NCT01134900|3857681|B3||>=65 years|Age||Participants|Count of Participants|165|165.0||||||
4036167|NCT01134900|3857682|B2||>=65 years|Age||Participants|Count of Participants|76|76.0||||||
4036168|NCT01134900|3857683|B1||>=65 years|Age||Participants|Count of Participants|89|89.0||||||
4036169|NCT01134900|3857681|B3||Between 18 and 65 years|Age||Participants|Count of Participants|231|231.0||||||
4036170|NCT01134900|3857682|B2||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
4036171|NCT01134900|3857683|B1||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
4036172|NCT01134900|3857681|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4036173|NCT01134900|3857682|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4036174|NCT01134900|3857683|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4036175|NCT01134887|3857692|B5|United States||Region of Enrollment||participants|Number|30|30.0||||||
4036176|NCT01134887|3857693|B4|United States||Region of Enrollment||participants|Number|5|5.0||||||
4036177|NCT01134887|3857694|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4036178|NCT01134887|3857695|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4036179|NCT01134887|3857696|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4036180|NCT01134887|3857692|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4036181|NCT01134887|3857693|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4036182|NCT01134887|3857694|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4036183|NCT01134887|3857695|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4036184|NCT01134887|3857696|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4036185|NCT01134887|3857692|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036186|NCT01134887|3857693|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036187|NCT01134887|3857694|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036188|NCT01134887|3857695|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036189|NCT01134887|3857696|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036190|NCT01134887|3857692|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036191|NCT01134887|3857693|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036192|NCT01134887|3857694|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036193|NCT01134887|3857695|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036194|NCT01134887|3857696|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036195|NCT01134887|3857692|B5||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4036196|NCT01134887|3857693|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4036197|NCT01134887|3857694|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4036198|NCT01134887|3857695|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4036199|NCT01134887|3857696|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4036200|NCT01134887|3857692|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4036201|NCT01134887|3857693|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4036202|NCT01134887|3857694|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4036203|NCT01134887|3857695|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4036204|NCT01134887|3857696|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4036205|NCT01134887|3857692|B5||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4036206|NCT01134887|3857693|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4036207|NCT01134887|3857694|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4036208|NCT01134887|3857695|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4036209|NCT01134887|3857696|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4036210|NCT01134887|3857692|B5||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4036211|NCT01134887|3857693|B4||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4036212|NCT01134887|3857694|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4036213|NCT01134887|3857695|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4036214|NCT01134887|3857696|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4036215|NCT01134887|3857692|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4036216|NCT01134887|3857693|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4036217|NCT01134887|3857694|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4036218|NCT01134887|3857695|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4036219|NCT01134887|3857696|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4036220|NCT01134783|3857707|B3|United States||Region of Enrollment||participants|Number|441|441.0||||||
4036221|NCT01134783|3857708|B2|United States||Region of Enrollment||participants|Number|224|224.0||||||
4036222|NCT01134783|3857709|B1|United States||Region of Enrollment||participants|Number|217|217.0||||||
4036223|NCT01134783|3857707|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036224|NCT01134783|3857708|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036225|NCT01134783|3857709|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036226|NCT01134783|3857707|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4036227|NCT01134783|3857708|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4036228|NCT01134783|3857709|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4036229|NCT01134783|3857707|B3||White|Race (NIH/OMB)||Participants|Count of Participants|320|320.0||||||
4036230|NCT01134783|3857708|B2||White|Race (NIH/OMB)||Participants|Count of Participants|171|171.0||||||
4036231|NCT01134783|3857709|B1||White|Race (NIH/OMB)||Participants|Count of Participants|149|149.0||||||
4036232|NCT01134783|3857707|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4036233|NCT01134783|3857708|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4036234|NCT01134783|3857709|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4036235|NCT01134783|3857707|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4036236|NCT01134783|3857708|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036237|NCT01134783|3857709|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4036238|NCT01134783|3857707|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4036239|NCT01134783|3857708|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4036240|NCT01134783|3857709|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4036241|NCT01134783|3857707|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4036242|NCT01134783|3857708|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4036243|NCT01134783|3857709|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4036244|NCT01134783|3857707|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036245|NCT01134783|3857708|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036246|NCT01134783|3857709|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036247|NCT01134783|3857707|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|408|408.0||||||
4036248|NCT01134783|3857708|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|207|207.0||||||
4036249|NCT01134783|3857709|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|201|201.0||||||
4036250|NCT01134783|3857707|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4036251|NCT01134783|3857708|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4036252|NCT01134783|3857709|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4036253|NCT01134783|3857707|B3||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4036254|NCT01134783|3857708|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4036255|NCT01134783|3857709|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4036256|NCT01134783|3857707|B3||Female|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
4036257|NCT01134783|3857708|B2||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4036258|NCT01134783|3857709|B1||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4036259|NCT01134783|3857707|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4036260|NCT01134783|3857708|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4036261|NCT01134783|3857709|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4036262|NCT01134783|3857707|B3||Between 18 and 65 years|Age||Participants|Count of Participants|441|441.0||||||
4036263|NCT01134783|3857708|B2||Between 18 and 65 years|Age||Participants|Count of Participants|224|224.0||||||
4036264|NCT01134783|3857709|B1||Between 18 and 65 years|Age||Participants|Count of Participants|217|217.0||||||
4036265|NCT01134783|3857707|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4036266|NCT01134783|3857708|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4036267|NCT01134783|3857709|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4036268|NCT01134731|3857726|B4|United States||Region of Enrollment||participants|Number|54|54.0||||||
4036269|NCT01134731|3857727|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4036270|NCT01134731|3857728|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4036271|NCT01134731|3857729|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4036272|NCT01134731|3857726|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4036273|NCT01134731|3857727|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4036274|NCT01134731|3857728|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4036275|NCT01134731|3857729|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4036276|NCT01134731|3857726|B4||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4036277|NCT01134731|3857727|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4036278|NCT01134731|3857728|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4036279|NCT01134731|3857729|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4036280|NCT01134731|3857726|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4036281|NCT01134731|3857727|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4036282|NCT01134731|3857728|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4036283|NCT01134731|3857729|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4036284|NCT01134731|3857726|B4||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4036285|NCT01134731|3857727|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4036286|NCT01134731|3857728|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4036287|NCT01134731|3857729|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4036288|NCT01134731|3857726|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4036289|NCT01134731|3857727|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4036290|NCT01134731|3857728|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4036291|NCT01134731|3857729|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4036292|NCT01134705|3857742|B3|United States||Region of Enrollment||participants|Number|466|466.0||||||
4036293|NCT01134705|3857743|B2|United States||Region of Enrollment||participants|Number|234|234.0||||||
4036294|NCT01134705|3857744|B1|United States||Region of Enrollment||participants|Number|232|232.0||||||
4036295|NCT01134705|3857742|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|410|410.0||||||
4036296|NCT01134705|3857743|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|204|204.0||||||
4036297|NCT01134705|3857744|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|206|206.0||||||
4036298|NCT01134705|3857742|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
4036299|NCT01134705|3857743|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4036300|NCT01134705|3857744|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4036301|NCT01134705|3857742|B3|Other||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|7|7.0||||||
4036302|NCT01134705|3857743|B2|Other||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|6|6.0||||||
4036303|NCT01134705|3857744|B1|Other||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|1|1.0||||||
4036304|NCT01134705|3857742|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|3|3.0||||||
4036305|NCT01134705|3857743|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|2|2.0||||||
4036306|NCT01134705|3857744|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|1|1.0||||||
4036307|NCT01134705|3857742|B3|Asian||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|11|11.0||||||
4036308|NCT01134705|3857743|B2|Asian||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|5|5.0||||||
4036309|NCT01134705|3857744|B1|Asian||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|6|6.0||||||
4036310|NCT01134705|3857742|B3|Black or African American||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|80|80.0||||||
4036311|NCT01134705|3857743|B2|Black or African American||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|40|40.0||||||
4036312|NCT01134705|3857744|B1|Black or African American||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|40|40.0||||||
4036313|NCT01134705|3857742|B3|White||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|371|371.0||||||
4036314|NCT01134705|3857743|B2|White||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|185|185.0||||||
4036315|NCT01134705|3857744|B1|White||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|186|186.0||||||
4036316|NCT01134705|3857742|B3||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4036317|NCT01134705|3857743|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4036318|NCT01134705|3857744|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4036319|NCT01134705|3857742|B3||Female|Sex: Female, Male||Participants|Count of Participants|319|319.0||||||
4036320|NCT01134705|3857743|B2||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4036321|NCT01134705|3857744|B1||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4036322|NCT01134705|3857742|B3|||Age|Demographic data are provided for the Intent to Treat population.|years|Mean|37.0|37.0|Standard Deviation|14.1|14.1|||
4036323|NCT01134705|3857743|B2|||Age|Demographic data are provided for the Intent to Treat population.|years|Mean|37.2|37.2|Standard Deviation|13.7|13.7|||
4036324|NCT01134705|3857744|B1|||Age|Demographic data are provided for the Intent to Treat population.|years|Mean|36.8|36.8|Standard Deviation|14.5|14.5|||
4036325|NCT01134627|3857755|B3||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4036326|NCT01134627|3857756|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4036327|NCT01134627|3857757|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4036328|NCT01134627|3857755|B3||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4036329|NCT01134627|3857756|B2||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4036330|NCT01134627|3857757|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4036331|NCT01134627|3857755|B3|||Age||years|Mean|37.0|37.0|Standard Deviation|8.7|8.7|||
4036332|NCT01134627|3857756|B2|||Age||years|Mean|37.7|37.7|Standard Deviation|8.6|8.6|||
4036333|NCT01134627|3857757|B1|||Age||years|Mean|36.2|36.2|Standard Deviation|8.8|8.8|||
4036334|NCT01134614|3857786|B3|United States||Region of Enrollment||participants|Number|245|245.0||||||
4036335|NCT01134614|3857787|B2|United States||Region of Enrollment||participants|Number|122|122.0||||||
4036336|NCT01134614|3857788|B1|United States||Region of Enrollment||participants|Number|123|123.0||||||
4036337|NCT01134614|3857786|B3||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4036338|NCT01134614|3857787|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4036339|NCT01134614|3857788|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4036340|NCT01134614|3857786|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4036341|NCT01134614|3857787|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4036342|NCT01134614|3857788|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4036343|NCT01134614|3857786|B3|||Age||years|Median|63|63.0|Full Range|||21.0|89.0|
4036344|NCT01134614|3857787|B2|||Age||years|Median|64|64.0|Full Range|||21.0|89.0|
4036345|NCT01134614|3857788|B1|||Age||years|Median|61|61.0|Full Range|||25.0|86.0|
4036346|NCT01134562|3857799|B6||Non-Hispanic or Latino|Ethnicity||Participants|Count of Participants|28|28.0||||||
4036347|NCT01134562|3857800|B5||Non-Hispanic or Latino|Ethnicity||Participants|Count of Participants|8|8.0||||||
4036348|NCT01134562|3857801|B4||Non-Hispanic or Latino|Ethnicity||Participants|Count of Participants|8|8.0||||||
4036349|NCT01134562|3857802|B3||Non-Hispanic or Latino|Ethnicity||Participants|Count of Participants|4|4.0||||||
4036350|NCT01134562|3857803|B2||Non-Hispanic or Latino|Ethnicity||Participants|Count of Participants|4|4.0||||||
4036351|NCT01134562|3857804|B1||Non-Hispanic or Latino|Ethnicity||Participants|Count of Participants|4|4.0||||||
4036352|NCT01134562|3857799|B6||Hispanic or Latino|Ethnicity||Participants|Count of Participants|0|0.0||||||
4036353|NCT01134562|3857800|B5||Hispanic or Latino|Ethnicity||Participants|Count of Participants|0|0.0||||||
4036354|NCT01134562|3857801|B4||Hispanic or Latino|Ethnicity||Participants|Count of Participants|0|0.0||||||
4036355|NCT01134562|3857802|B3||Hispanic or Latino|Ethnicity||Participants|Count of Participants|0|0.0||||||
4036356|NCT01134562|3857803|B2||Hispanic or Latino|Ethnicity||Participants|Count of Participants|0|0.0||||||
4036357|NCT01134562|3857804|B1||Hispanic or Latino|Ethnicity||Participants|Count of Participants|0|0.0||||||
4036358|NCT01134562|3857799|B6||Asian|Race||Participants|Count of Participants|1|1.0||||||
4036359|NCT01134562|3857800|B5||Asian|Race||Participants|Count of Participants|0|0.0||||||
4036360|NCT01134562|3857801|B4||Asian|Race||Participants|Count of Participants|0|0.0||||||
4036361|NCT01134562|3857802|B3||Asian|Race||Participants|Count of Participants|0|0.0||||||
4036362|NCT01134562|3857803|B2||Asian|Race||Participants|Count of Participants|0|0.0||||||
4036363|NCT01134562|3857804|B1||Asian|Race||Participants|Count of Participants|1|1.0||||||
4036364|NCT01134562|3857799|B6||African American|Race||Participants|Count of Participants|24|24.0||||||
4036365|NCT01134562|3857800|B5||African American|Race||Participants|Count of Participants|7|7.0||||||
4036366|NCT01134562|3857801|B4||African American|Race||Participants|Count of Participants|8|8.0||||||
4036367|NCT01134562|3857802|B3||African American|Race||Participants|Count of Participants|3|3.0||||||
4036368|NCT01134562|3857803|B2||African American|Race||Participants|Count of Participants|4|4.0||||||
4036369|NCT01134562|3857804|B1||African American|Race||Participants|Count of Participants|2|2.0||||||
4036370|NCT01134562|3857799|B6||White|Race||Participants|Count of Participants|3|3.0||||||
4036371|NCT01134562|3857800|B5||White|Race||Participants|Count of Participants|1|1.0||||||
4036372|NCT01134562|3857801|B4||White|Race||Participants|Count of Participants|0|0.0||||||
4036373|NCT01134562|3857802|B3||White|Race||Participants|Count of Participants|1|1.0||||||
4036374|NCT01134562|3857803|B2||White|Race||Participants|Count of Participants|0|0.0||||||
4036375|NCT01134562|3857804|B1||White|Race||Participants|Count of Participants|1|1.0||||||
4036376|NCT01134562|3857799|B6||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4036377|NCT01134562|3857800|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4036378|NCT01134562|3857801|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4036379|NCT01134562|3857802|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4036380|NCT01134562|3857803|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4036381|NCT01134562|3857804|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4036382|NCT01134562|3857799|B6||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4036383|NCT01134562|3857800|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4036384|NCT01134562|3857801|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4036385|NCT01134562|3857802|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4036386|NCT01134562|3857803|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4036387|NCT01134562|3857804|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4036388|NCT01134562|3857799|B6|||Age||years|Mean|52.4|52.4|Standard Deviation|13.6|13.6|||
4036389|NCT01134562|3857800|B5|||Age||years|Mean|47.5|47.5|Standard Deviation|10.9|10.9|||
4036390|NCT01134562|3857801|B4|||Age||years|Mean|52.9|52.9|Standard Deviation|14.6|14.6|||
4036391|NCT01134562|3857802|B3|||Age||years|Mean|52.8|52.8|Standard Deviation|21.2|21.2|||
4036392|NCT01134562|3857803|B2|||Age||years|Mean|59.0|59.0|Standard Deviation|14.5|14.5|||
4036393|NCT01134562|3857804|B1|||Age||years|Mean|54.3|54.3|Standard Deviation|10.4|10.4|||
4036394|NCT01134549|3857872|B6||Not Hispanic or Latino|Ethnicity||Participants|Count of Participants|31|31.0||||||
4036395|NCT01134549|3857873|B5||Not Hispanic or Latino|Ethnicity||Participants|Count of Participants|6|6.0||||||
4036396|NCT01134549|3857874|B4||Not Hispanic or Latino|Ethnicity||Participants|Count of Participants|6|6.0||||||
4036397|NCT01134549|3857875|B3||Not Hispanic or Latino|Ethnicity||Participants|Count of Participants|5|5.0||||||
4036398|NCT01134549|3857876|B2||Not Hispanic or Latino|Ethnicity||Participants|Count of Participants|6|6.0||||||
4036399|NCT01134549|3857877|B1||Not Hispanic or Latino|Ethnicity||Participants|Count of Participants|8|8.0||||||
4036400|NCT01134549|3857872|B6||Hispanic or Latino|Ethnicity||Participants|Count of Participants|1|1.0||||||
4036401|NCT01134549|3857873|B5||Hispanic or Latino|Ethnicity||Participants|Count of Participants|0|0.0||||||
4036402|NCT01134549|3857874|B4||Hispanic or Latino|Ethnicity||Participants|Count of Participants|0|0.0||||||
4036403|NCT01134549|3857875|B3||Hispanic or Latino|Ethnicity||Participants|Count of Participants|1|1.0||||||
4036404|NCT01134549|3857876|B2||Hispanic or Latino|Ethnicity||Participants|Count of Participants|0|0.0||||||
4036405|NCT01134549|3857877|B1||Hispanic or Latino|Ethnicity||Participants|Count of Participants|0|0.0||||||
4036406|NCT01134549|3857872|B6||Other|Race||Participants|Count of Participants|1|1.0||||||
4036407|NCT01134549|3857873|B5||Other|Race||Participants|Count of Participants|0|0.0||||||
4036408|NCT01134549|3857874|B4||Other|Race||Participants|Count of Participants|1|1.0||||||
4036409|NCT01134549|3857875|B3||Other|Race||Participants|Count of Participants|0|0.0||||||
4036410|NCT01134549|3857876|B2||Other|Race||Participants|Count of Participants|0|0.0||||||
4036411|NCT01134549|3857877|B1||Other|Race||Participants|Count of Participants|0|0.0||||||
4036412|NCT01134549|3857872|B6||Asian|Race||Participants|Count of Participants|8|8.0||||||
4036413|NCT01134549|3857873|B5||Asian|Race||Participants|Count of Participants|2|2.0||||||
4036414|NCT01134549|3857874|B4||Asian|Race||Participants|Count of Participants|2|2.0||||||
4036415|NCT01134549|3857875|B3||Asian|Race||Participants|Count of Participants|0|0.0||||||
4036416|NCT01134549|3857876|B2||Asian|Race||Participants|Count of Participants|2|2.0||||||
4036417|NCT01134549|3857877|B1||Asian|Race||Participants|Count of Participants|2|2.0||||||
4036418|NCT01134549|3857872|B6||White|Race||Participants|Count of Participants|23|23.0||||||
4036419|NCT01134549|3857873|B5||White|Race||Participants|Count of Participants|4|4.0||||||
4036420|NCT01134549|3857874|B4||White|Race||Participants|Count of Participants|3|3.0||||||
4036421|NCT01134549|3857875|B3||White|Race||Participants|Count of Participants|6|6.0||||||
4036422|NCT01134549|3857876|B2||White|Race||Participants|Count of Participants|4|4.0||||||
4036423|NCT01134549|3857877|B1||White|Race||Participants|Count of Participants|6|6.0||||||
4036424|NCT01134549|3857872|B6||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4036425|NCT01134549|3857873|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4036426|NCT01134549|3857874|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4036427|NCT01134549|3857875|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4036428|NCT01134549|3857876|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4036429|NCT01134549|3857877|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4036430|NCT01134549|3857872|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4036431|NCT01134549|3857873|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4036432|NCT01134549|3857874|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4036433|NCT01134549|3857875|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4036434|NCT01134549|3857876|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4036435|NCT01134549|3857877|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4036436|NCT01134549|3857872|B6|||Age||years|Mean|25.3|25.3|Standard Deviation|5.7|5.7|||
4036437|NCT01134549|3857873|B5|||Age||years|Mean|26.0|26.0|Standard Deviation|6.2|6.2|||
4036438|NCT01134549|3857874|B4|||Age||years|Mean|24.2|24.2|Standard Deviation|4.4|4.4|||
4036439|NCT01134549|3857875|B3|||Age||years|Mean|26.8|26.8|Standard Deviation|4.9|4.9|||
4036440|NCT01134549|3857876|B2|||Age||years|Mean|27.8|27.8|Standard Deviation|8.9|8.9|||
4036441|NCT01134549|3857877|B1|||Age||years|Mean|22.4|22.4|Standard Deviation|3.5|3.5|||
4036442|NCT01134510|3857965|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4036443|NCT01134510|3857966|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4036444|NCT01134510|3857967|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4036445|NCT01134510|3857965|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4036446|NCT01134510|3857966|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4036447|NCT01134510|3857967|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4036448|NCT01134510|3857965|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4036449|NCT01134510|3857966|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4036450|NCT01134510|3857967|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4036451|NCT01134510|3857965|B3|||Age||years|Mean|47|47.0|Standard Deviation|15.5|15.5|||
4036452|NCT01134510|3857966|B2|||Age||years|Mean|47|47.0|Standard Deviation|16|16.0|||
4036453|NCT01134510|3857967|B1|||Age||years|Mean|46|46.0|Standard Deviation|14|14.0|||
4036454|NCT01134510|3857965|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4036455|NCT01134510|3857966|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4036456|NCT01134510|3857967|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4036457|NCT01134510|3857965|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4036458|NCT01134510|3857966|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4036459|NCT01134510|3857967|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4036460|NCT01134510|3857965|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4036461|NCT01134510|3857966|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4036462|NCT01134510|3857967|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4036463|NCT01134393|3857980|B1|||Diastolic Blood Pressure (DBP) at time of baseline||mmHg|Mean|91.8|91.8|Standard Deviation|8.8|8.8|||
4036464|NCT01134393|3857980|B1|||Systolic Blood Pressure (SBP) at time of baseline||mmHg|Mean|151.4|151.4|Standard Deviation|10.2|10.2|||
4036465|NCT01134393|3857980|B1||Male|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
4036466|NCT01134393|3857980|B1||Female|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4036467|NCT01134393|3857980|B1|||Age||Years|Mean|58.0|58.0|Standard Deviation|11.5|11.5|||
4036468|NCT01134328|3857994|B5|United States||Region of Enrollment||participants|Number|83|83.0||||||
4036469|NCT01134328|3857995|B4|United States||Region of Enrollment||participants|Number|21|21.0||||||
4036470|NCT01134328|3857996|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4036471|NCT01134328|3857997|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4036472|NCT01134328|3857998|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4036473|NCT01134328|3857994|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4036474|NCT01134328|3857995|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036475|NCT01134328|3857996|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4036476|NCT01134328|3857997|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4036477|NCT01134328|3857998|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4036478|NCT01134328|3857994|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036479|NCT01134328|3857995|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036480|NCT01134328|3857996|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036481|NCT01134328|3857997|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036482|NCT01134328|3857998|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036483|NCT01134328|3857994|B5||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4036484|NCT01134328|3857995|B4||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4036485|NCT01134328|3857996|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4036486|NCT01134328|3857997|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4036487|NCT01134328|3857998|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4036488|NCT01134328|3857994|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4036489|NCT01134328|3857995|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4036490|NCT01134328|3857996|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036491|NCT01134328|3857997|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036492|NCT01134328|3857998|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4036493|NCT01134328|3857994|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4036494|NCT01134328|3857995|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036495|NCT01134328|3857996|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4036496|NCT01134328|3857997|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036497|NCT01134328|3857998|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036498|NCT01134328|3857994|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4036499|NCT01134328|3857995|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4036500|NCT01134328|3857996|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4036501|NCT01134328|3857997|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4036502|NCT01134328|3857998|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4036503|NCT01134328|3857994|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4036504|NCT01134328|3857995|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036505|NCT01134328|3857996|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4036506|NCT01134328|3857997|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036507|NCT01134328|3857998|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036508|NCT01134328|3857994|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036509|NCT01134328|3857995|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036510|NCT01134328|3857996|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036511|NCT01134328|3857997|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036512|NCT01134328|3857998|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036513|NCT01134328|3857994|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4036514|NCT01134328|3857995|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4036515|NCT01134328|3857996|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4036516|NCT01134328|3857997|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4036517|NCT01134328|3857998|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4036518|NCT01134328|3857994|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4036519|NCT01134328|3857995|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4036520|NCT01134328|3857996|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4036521|NCT01134328|3857997|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4036522|NCT01134328|3857998|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4036523|NCT01134328|3857994|B5||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4036524|NCT01134328|3857995|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4036525|NCT01134328|3857996|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4036526|NCT01134328|3857997|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4036527|NCT01134328|3857998|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4036528|NCT01134328|3857994|B5||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4036529|NCT01134328|3857995|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4036530|NCT01134328|3857996|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4036531|NCT01134328|3857997|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4036532|NCT01134328|3857998|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4036533|NCT01134328|3857994|B5|||Age||years|Mean|37.8|37.8|Standard Deviation|13.78|13.78|||
4036534|NCT01134328|3857995|B4|||Age||years|Mean|38.3|38.3|Standard Deviation|16.16|16.16|||
4036535|NCT01134328|3857996|B3|||Age||years|Mean|40.2|40.2|Standard Deviation|12.23|12.23|||
4036536|NCT01134328|3857997|B2|||Age||years|Mean|35.1|35.1|Standard Deviation|14.32|14.32|||
4036537|NCT01134328|3857998|B1|||Age||years|Mean|37.7|37.7|Standard Deviation|12.56|12.56|||
4036538|NCT01134315|3858099|B3|United States||Region of Enrollment||participants|Number|61|61.0||||||
4036539|NCT01134315|3858100|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4036540|NCT01134315|3858101|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4036541|NCT01134315|3858099|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4036542|NCT01134315|3858100|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4036543|NCT01134315|3858101|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4036544|NCT01134315|3858099|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4036545|NCT01134315|3858100|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4036546|NCT01134315|3858101|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4036547|NCT01134315|3858099|B3|>=8 years||Age, Customized||participants|Number|37|37.0||||||
4036548|NCT01134315|3858100|B2|>=8 years||Age, Customized||participants|Number|21|21.0||||||
4036549|NCT01134315|3858101|B1|>=8 years||Age, Customized||participants|Number|16|16.0||||||
4036550|NCT01134315|3858099|B3|<8 years||Age, Customized||participants|Number|24|24.0||||||
4036551|NCT01134315|3858100|B2|<8 years||Age, Customized||participants|Number|19|19.0||||||
4036552|NCT01134315|3858101|B1|<8 years||Age, Customized||participants|Number|5|5.0||||||
4036553|NCT01134276|3858122|B3|Korea, Republic of||Region of Enrollment||participants|Number|211|211.0||||||
4036554|NCT01134276|3858123|B2|Korea, Republic of||Region of Enrollment||participants|Number|107|107.0||||||
4036555|NCT01134276|3858124|B1|Korea, Republic of||Region of Enrollment||participants|Number|104|104.0||||||
4036556|NCT01134276|3858122|B3||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4036557|NCT01134276|3858123|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4036558|NCT01134276|3858124|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4036559|NCT01134276|3858122|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4036560|NCT01134276|3858123|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4036561|NCT01134276|3858124|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4036562|NCT01134276|3858122|B3|||Age||years|Mean|64.8|64.8|Standard Deviation|8.9|8.9|||
4036563|NCT01134276|3858123|B2|||Age||years|Mean|63.5|63.5|Standard Deviation|9.0|9.0|||
4036564|NCT01134276|3858124|B1|||Age||years|Mean|66.3|66.3|Standard Deviation|8.6|8.6|||
4036565|NCT01134198|3858135|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4036566|NCT01134198|3858136|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4036567|NCT01134198|3858137|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4036568|NCT01134198|3858135|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036569|NCT01134198|3858136|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036570|NCT01134198|3858137|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036571|NCT01134198|3858135|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4036572|NCT01134198|3858136|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4036573|NCT01134198|3858137|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4036574|NCT01134198|3858135|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4036575|NCT01134198|3858136|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4036576|NCT01134198|3858137|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4036577|NCT01134198|3858135|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036578|NCT01134198|3858136|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036579|NCT01134198|3858137|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036580|NCT01134198|3858135|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036581|NCT01134198|3858136|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036582|NCT01134198|3858137|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036583|NCT01134198|3858135|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036584|NCT01134198|3858136|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036585|NCT01134198|3858137|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036586|NCT01134198|3858135|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036587|NCT01134198|3858136|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036588|NCT01134198|3858137|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036589|NCT01134198|3858135|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4036590|NCT01134198|3858136|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4036591|NCT01134198|3858137|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4036592|NCT01134198|3858135|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4036593|NCT01134198|3858136|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4036594|NCT01134198|3858137|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4036595|NCT01134198|3858135|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4036596|NCT01134198|3858136|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4036597|NCT01134198|3858137|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4036598|NCT01134198|3858135|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4036599|NCT01134198|3858136|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4036600|NCT01134198|3858137|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4036601|NCT01134198|3858135|B3|||Age||years|Mean|46|46.0|Standard Deviation|8.3|8.3|||
4036602|NCT01134198|3858136|B2|||Age||years|Mean|46|46.0|Standard Deviation|8.3|8.3|||
4036603|NCT01134198|3858137|B1|||Age||years|Mean|46|46.0|Standard Deviation|8.3|8.3|||
4036604|NCT01134107|3858144|B3|Germany||Region of Enrollment||participants|Number|34|34.0||||||
4036605|NCT01134107|3858145|B2|Germany||Region of Enrollment||participants|Number|15|15.0||||||
4036606|NCT01134107|3858146|B1|Germany||Region of Enrollment||participants|Number|19|19.0||||||
4036607|NCT01134107|3858144|B3|Hungary||Region of Enrollment||participants|Number|70|70.0||||||
4036608|NCT01134107|3858145|B2|Hungary||Region of Enrollment||participants|Number|37|37.0||||||
4036609|NCT01134107|3858146|B1|Hungary||Region of Enrollment||participants|Number|33|33.0||||||
4036610|NCT01134107|3858144|B3|France||Region of Enrollment||participants|Number|29|29.0||||||
4036611|NCT01134107|3858145|B2|France||Region of Enrollment||participants|Number|14|14.0||||||
4036612|NCT01134107|3858146|B1|France||Region of Enrollment||participants|Number|15|15.0||||||
4036613|NCT01134107|3858144|B3|White||Race/Ethnicity, Customized||participants|Number|133|133.0||||||
4036614|NCT01134107|3858145|B2|White||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
4036615|NCT01134107|3858146|B1|White||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
4036616|NCT01134107|3858144|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4036617|NCT01134107|3858145|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4036618|NCT01134107|3858146|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4036619|NCT01134107|3858144|B3||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4036620|NCT01134107|3858145|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4036621|NCT01134107|3858146|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4036622|NCT01134107|3858144|B3|||Age||years|Mean|42.70|42.7|Standard Deviation|12.56|12.56|||
4036623|NCT01134107|3858145|B2|||Age||years|Mean|44.73|44.73|Standard Deviation|12.96|12.96|||
4036624|NCT01134107|3858146|B1|||Age||years|Mean|40.71|40.71|Standard Deviation|11.91|11.91|||
4036625|NCT01134081|3858179|B1|United States||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
4036626|NCT01134081|3858179|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4036627|NCT01134081|3858179|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4036628|NCT01134081|3858179|B1|||Age||years|Mean|47.1|47.1|Standard Deviation|13.1|13.1|||
4036629|NCT01134055|3858187|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036630|NCT01134055|3858188|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036631|NCT01134055|3858189|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036688|NCT01134055|3858190|B5||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4036632|NCT01134055|3858190|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036633|NCT01134055|3858191|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036634|NCT01134055|3858192|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036635|NCT01134055|3858193|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036636|NCT01134055|3858194|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036637|NCT01134055|3858187|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036638|NCT01134055|3858188|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036639|NCT01134055|3858189|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036640|NCT01134055|3858190|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036641|NCT01134055|3858191|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036642|NCT01134055|3858192|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036643|NCT01134055|3858193|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036644|NCT01134055|3858194|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036645|NCT01134055|3858187|B8||White|Race (NIH/OMB)||Participants|Count of Participants|474|474.0||||||
4036646|NCT01134055|3858188|B7||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4036647|NCT01134055|3858189|B6||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4036648|NCT01134055|3858190|B5||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4036649|NCT01134055|3858191|B4||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4036650|NCT01134055|3858192|B3||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
4036651|NCT01134055|3858193|B2||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4036652|NCT01134055|3858194|B1||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4036653|NCT01134055|3858187|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4036654|NCT01134055|3858188|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036655|NCT01134055|3858189|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036656|NCT01134055|3858190|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036657|NCT01134055|3858191|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036658|NCT01134055|3858192|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036659|NCT01134055|3858193|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4036660|NCT01134055|3858194|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036661|NCT01134055|3858187|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036662|NCT01134055|3858188|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036663|NCT01134055|3858189|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036664|NCT01134055|3858190|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036665|NCT01134055|3858191|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036666|NCT01134055|3858192|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036667|NCT01134055|3858193|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036668|NCT01134055|3858194|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036669|NCT01134055|3858187|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4036670|NCT01134055|3858188|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4036671|NCT01134055|3858189|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4036672|NCT01134055|3858190|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4036673|NCT01134055|3858191|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4036674|NCT01134055|3858192|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4036675|NCT01134055|3858193|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4036676|NCT01134055|3858194|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4036677|NCT01134055|3858187|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036678|NCT01134055|3858188|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036679|NCT01134055|3858189|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036680|NCT01134055|3858190|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036681|NCT01134055|3858191|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036682|NCT01134055|3858192|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036683|NCT01134055|3858193|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036684|NCT01134055|3858194|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036685|NCT01134055|3858187|B8||Male|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4036686|NCT01134055|3858188|B7||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4036687|NCT01134055|3858189|B6||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4036689|NCT01134055|3858191|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4036690|NCT01134055|3858192|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4036691|NCT01134055|3858193|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4036692|NCT01134055|3858194|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4036693|NCT01134055|3858187|B8||Female|Sex: Female, Male||Participants|Count of Participants|296|296.0||||||
4036694|NCT01134055|3858188|B7||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4036695|NCT01134055|3858189|B6||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4036696|NCT01134055|3858190|B5||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4036697|NCT01134055|3858191|B4||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4036698|NCT01134055|3858192|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4036699|NCT01134055|3858193|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4036700|NCT01134055|3858194|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4036701|NCT01134055|3858187|B8|||Age||Years|Mean|75.3|75.3|Standard Deviation|8.23|8.23|||
4036702|NCT01134055|3858188|B7|||Age||Years|Mean|74.9|74.9|Standard Deviation|7.27|7.27|||
4036703|NCT01134055|3858189|B6|||Age||Years|Mean|76.2|76.2|Standard Deviation|8.00|8.0|||
4036704|NCT01134055|3858190|B5|||Age||Years|Mean|75.6|75.6|Standard Deviation|8.71|8.71|||
4036705|NCT01134055|3858191|B4|||Age||Years|Mean|75.4|75.4|Standard Deviation|8.42|8.42|||
4036706|NCT01134055|3858192|B3|||Age||Years|Mean|75.1|75.1|Standard Deviation|8.19|8.19|||
4036707|NCT01134055|3858193|B2|||Age||Years|Mean|74.4|74.4|Standard Deviation|7.60|7.6|||
4036708|NCT01134055|3858194|B1|||Age||Years|Mean|75.6|75.6|Standard Deviation|9.42|9.42|||
4036709|NCT01134042|3858331|B4|African American/African Heritage and White||Race/Ethnicity, Customized|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized to treatment who received at least one dose of study medication. Randomized participants were assumed to have received study medication unless definitive evidence to the contrary existed.|participants|Number|2|2.0||||||
4036710|NCT01134042|3858332|B3|African American/African Heritage and White||Race/Ethnicity, Customized|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized to treatment who received at least one dose of study medication. Randomized participants were assumed to have received study medication unless definitive evidence to the contrary existed.|participants|Number|0|0.0||||||
4036711|NCT01134042|3858333|B2|African American/African Heritage and White||Race/Ethnicity, Customized|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized to treatment who received at least one dose of study medication. Randomized participants were assumed to have received study medication unless definitive evidence to the contrary existed.|participants|Number|1|1.0||||||
4036712|NCT01134042|3858334|B1|African American/African Heritage and White||Race/Ethnicity, Customized|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized to treatment who received at least one dose of study medication. Randomized participants were assumed to have received study medication unless definitive evidence to the contrary existed.|participants|Number|1|1.0||||||
4036713|NCT01134042|3858331|B4|White||Race/Ethnicity, Customized|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized to treatment who received at least one dose of study medication. Randomized participants were assumed to have received study medication unless definitive evidence to the contrary existed.|participants|Number|492|492.0||||||
4036714|NCT01134042|3858332|B3|White||Race/Ethnicity, Customized|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized to treatment who received at least one dose of study medication. Randomized participants were assumed to have received study medication unless definitive evidence to the contrary existed.|participants|Number|162|162.0||||||
4036715|NCT01134042|3858333|B2|White||Race/Ethnicity, Customized|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized to treatment who received at least one dose of study medication. Randomized participants were assumed to have received study medication unless definitive evidence to the contrary existed.|participants|Number|165|165.0||||||
4036716|NCT01134042|3858334|B1|White||Race/Ethnicity, Customized|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized to treatment who received at least one dose of study medication. Randomized participants were assumed to have received study medication unless definitive evidence to the contrary existed.|participants|Number|165|165.0||||||
4036717|NCT01134042|3858331|B4|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized to treatment who received at least one dose of study medication. Randomized participants were assumed to have received study medication unless definitive evidence to the contrary existed.|participants|Number|40|40.0||||||
4036718|NCT01134042|3858332|B3|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized to treatment who received at least one dose of study medication. Randomized participants were assumed to have received study medication unless definitive evidence to the contrary existed.|participants|Number|13|13.0||||||
4036719|NCT01134042|3858333|B2|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized to treatment who received at least one dose of study medication. Randomized participants were assumed to have received study medication unless definitive evidence to the contrary existed.|participants|Number|15|15.0||||||
4036789|NCT01133847|3858443|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4036790|NCT01133847|3858440|B4||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4036791|NCT01133847|3858441|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4036720|NCT01134042|3858334|B1|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized to treatment who received at least one dose of study medication. Randomized participants were assumed to have received study medication unless definitive evidence to the contrary existed.|participants|Number|12|12.0||||||
4036721|NCT01134042|3858331|B4|American Indian or Alaska Native||Race/Ethnicity, Customized|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized to treatment who received at least one dose of study medication. Randomized participants were assumed to have received study medication unless definitive evidence to the contrary existed.|participants|Number|1|1.0||||||
4036722|NCT01134042|3858332|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized to treatment who received at least one dose of study medication. Randomized participants were assumed to have received study medication unless definitive evidence to the contrary existed.|participants|Number|1|1.0||||||
4036723|NCT01134042|3858333|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized to treatment who received at least one dose of study medication. Randomized participants were assumed to have received study medication unless definitive evidence to the contrary existed.|participants|Number|0|0.0||||||
4036724|NCT01134042|3858334|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized to treatment who received at least one dose of study medication. Randomized participants were assumed to have received study medication unless definitive evidence to the contrary existed.|participants|Number|0|0.0||||||
4036725|NCT01134042|3858331|B4|African American/African Heritage (HER)||Race/Ethnicity, Customized|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized to treatment who received at least one dose of study medication. Randomized participants were assumed to have received study medication unless definitive evidence to the contrary existed.|participants|Number|51|51.0||||||
4036726|NCT01134042|3858332|B3|African American/African Heritage (HER)||Race/Ethnicity, Customized|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized to treatment who received at least one dose of study medication. Randomized participants were assumed to have received study medication unless definitive evidence to the contrary existed.|participants|Number|19|19.0||||||
4036727|NCT01134042|3858333|B2|African American/African Heritage (HER)||Race/Ethnicity, Customized|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized to treatment who received at least one dose of study medication. Randomized participants were assumed to have received study medication unless definitive evidence to the contrary existed.|participants|Number|16|16.0||||||
4036728|NCT01134042|3858334|B1|African American/African Heritage (HER)||Race/Ethnicity, Customized|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized to treatment who received at least one dose of study medication. Randomized participants were assumed to have received study medication unless definitive evidence to the contrary existed.|participants|Number|16|16.0||||||
4036729|NCT01134042|3858331|B4||Male|Gender|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized to treatment who received at least one dose of study medication. Randomized participants were assumed to have received study medication unless definitive evidence to the contrary existed.|Participants|Count of Participants|241|241.0||||||
4036730|NCT01134042|3858332|B3||Male|Gender|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized to treatment who received at least one dose of study medication. Randomized participants were assumed to have received study medication unless definitive evidence to the contrary existed.|Participants|Count of Participants|79|79.0||||||
4036731|NCT01134042|3858333|B2||Male|Gender|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized to treatment who received at least one dose of study medication. Randomized participants were assumed to have received study medication unless definitive evidence to the contrary existed.|Participants|Count of Participants|81|81.0||||||
4036732|NCT01134042|3858334|B1||Male|Gender|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized to treatment who received at least one dose of study medication. Randomized participants were assumed to have received study medication unless definitive evidence to the contrary existed.|Participants|Count of Participants|81|81.0||||||
4036733|NCT01134042|3858331|B4||Female|Gender|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized to treatment who received at least one dose of study medication. Randomized participants were assumed to have received study medication unless definitive evidence to the contrary existed.|Participants|Count of Participants|345|345.0||||||
4036734|NCT01134042|3858332|B3||Female|Gender|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized to treatment who received at least one dose of study medication. Randomized participants were assumed to have received study medication unless definitive evidence to the contrary existed.|Participants|Count of Participants|116|116.0||||||
4036735|NCT01134042|3858333|B2||Female|Gender|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized to treatment who received at least one dose of study medication. Randomized participants were assumed to have received study medication unless definitive evidence to the contrary existed.|Participants|Count of Participants|116|116.0||||||
4036736|NCT01134042|3858334|B1||Female|Gender|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized to treatment who received at least one dose of study medication. Randomized participants were assumed to have received study medication unless definitive evidence to the contrary existed.|Participants|Count of Participants|113|113.0||||||
4036792|NCT01133847|3858442|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4036793|NCT01133847|3858443|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4036737|NCT01134042|3858331|B4|||Age|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized to treatment who received at least one dose of study medication. Randomized participants were assumed to have received study medication unless definitive evidence to the contrary existed.|Years|Mean|46.2|46.2|Standard Deviation|14.51|14.51|||
4036738|NCT01134042|3858332|B3|||Age|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized to treatment who received at least one dose of study medication. Randomized participants were assumed to have received study medication unless definitive evidence to the contrary existed.|Years|Mean|47.3|47.3|Standard Deviation|14.06|14.06|||
4036739|NCT01134042|3858333|B2|||Age|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized to treatment who received at least one dose of study medication. Randomized participants were assumed to have received study medication unless definitive evidence to the contrary existed.|Years|Mean|46.6|46.6|Standard Deviation|15.05|15.05|||
4036740|NCT01134042|3858334|B1|||Age|Baseline data were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized to treatment who received at least one dose of study medication. Randomized participants were assumed to have received study medication unless definitive evidence to the contrary existed.|Years|Mean|44.6|44.6|Standard Deviation|14.33|14.33|||
4036741|NCT01134016|3858374|B1|||BMI||kg/m^2|Mean|25.214|25.214|Full Range|||21.15|32.97|
4036742|NCT01134016|3858374|B1|||Weight||Kg|Mean|64.57|64.57|Full Range|||45.7|79.2|
4036743|NCT01134016|3858374|B1|||Height||cm|Mean|159.76|159.76|Full Range|||143.0|172.0|
4036744|NCT01134016|3858374|B1|Taiwan||Region of Enrollment||participants|Number|13|13.0||||||
4036745|NCT01134016|3858374|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036746|NCT01134016|3858374|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036747|NCT01134016|3858374|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036748|NCT01134016|3858374|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036749|NCT01134016|3858374|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036750|NCT01134016|3858374|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4036751|NCT01134016|3858374|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4036752|NCT01134016|3858374|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4036753|NCT01134016|3858374|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4036754|NCT01134016|3858374|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4036755|NCT01134016|3858374|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4036756|NCT01134016|3858374|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4036757|NCT01133977|3858407|B6|Female||Sex/Gender, Customized||participants|Number|40|40.0||||||
4036758|NCT01133977|3858408|B5|Female||Sex/Gender, Customized||participants|Number|16|16.0||||||
4036759|NCT01133977|3858409|B4|Female||Sex/Gender, Customized||participants|Number|17|17.0||||||
4036760|NCT01133977|3858410|B3|Female||Sex/Gender, Customized||participants|Number|2|2.0||||||
4036761|NCT01133977|3858411|B2|Female||Sex/Gender, Customized||participants|Number|5|5.0||||||
4036762|NCT01133977|3858412|B1|Female||Sex/Gender, Customized||participants|Number|0|0.0||||||
4036763|NCT01133977|3858407|B6|Male||Sex/Gender, Customized||participants|Number|57|57.0||||||
4036764|NCT01133977|3858408|B5|Male||Sex/Gender, Customized||participants|Number|23|23.0||||||
4036765|NCT01133977|3858409|B4|Male||Sex/Gender, Customized||participants|Number|25|25.0||||||
4036766|NCT01133977|3858410|B3|Male||Sex/Gender, Customized||participants|Number|4|4.0||||||
4036767|NCT01133977|3858411|B2|Male||Sex/Gender, Customized||participants|Number|2|2.0||||||
4036768|NCT01133977|3858412|B1|Male||Sex/Gender, Customized||participants|Number|3|3.0||||||
4036769|NCT01133977|3858407|B6|18 years and older||Age, Customized||Participants|Number|97|97.0||||||
4036770|NCT01133977|3858408|B5|18 years and older||Age, Customized||Participants|Number|39|39.0||||||
4036771|NCT01133977|3858409|B4|18 years and older||Age, Customized||Participants|Number|42|42.0||||||
4036772|NCT01133977|3858410|B3|18 years and older||Age, Customized||Participants|Number|6|6.0||||||
4036773|NCT01133977|3858411|B2|18 years and older||Age, Customized||Participants|Number|7|7.0||||||
4036774|NCT01133977|3858412|B1|18 years and older||Age, Customized||Participants|Number|3|3.0||||||
4036775|NCT01133860|3858433|B1|Italy||Region of Enrollment||participants|Number|12|12.0||||||
4036776|NCT01133860|3858433|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4036777|NCT01133860|3858433|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4036778|NCT01133860|3858433|B1|||Age||years|Mean|35.0|35.0|Standard Deviation|14.3|14.3|||
4036779|NCT01133860|3858433|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4036780|NCT01133860|3858433|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4036781|NCT01133860|3858433|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4036782|NCT01133847|3858440|B4|United States||Region of Enrollment||participants|Number|216|216.0||||||
4036783|NCT01133847|3858441|B3|United States||Region of Enrollment||participants|Number|66|66.0||||||
4036784|NCT01133847|3858442|B2|United States||Region of Enrollment||participants|Number|73|73.0||||||
4036785|NCT01133847|3858443|B1|United States||Region of Enrollment||participants|Number|77|77.0||||||
4036786|NCT01133847|3858440|B4||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4036787|NCT01133847|3858441|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4036788|NCT01133847|3858442|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4036794|NCT01133847|3858440|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4036795|NCT01133847|3858441|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4036796|NCT01133847|3858442|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4036797|NCT01133847|3858443|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4036798|NCT01133847|3858440|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4036799|NCT01133847|3858441|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4036800|NCT01133847|3858442|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4036801|NCT01133847|3858443|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4036802|NCT01133847|3858440|B4||<=18 years|Age||Participants|Count of Participants|216|216.0||||||
4036803|NCT01133847|3858441|B3||<=18 years|Age||Participants|Count of Participants|66|66.0||||||
4036804|NCT01133847|3858442|B2||<=18 years|Age||Participants|Count of Participants|73|73.0||||||
4036805|NCT01133847|3858443|B1||<=18 years|Age||Participants|Count of Participants|77|77.0||||||
4036806|NCT01133821|3858483|B3|United States||Region of Enrollment||Participants|Count of Participants|92|92.0||||||
4036807|NCT01133821|3858484|B2|United States||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
4036808|NCT01133821|3858485|B1|United States||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
4036809|NCT01133821|3858483|B3|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4036810|NCT01133821|3858484|B2|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4036811|NCT01133821|3858485|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4036812|NCT01133821|3858483|B3|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
4036813|NCT01133821|3858484|B2|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4036814|NCT01133821|3858485|B1|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4036815|NCT01133821|3858483|B3|Race|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|66|66.0||||||
4036816|NCT01133821|3858484|B2|Race|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
4036817|NCT01133821|3858485|B1|Race|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
4036818|NCT01133821|3858483|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4036819|NCT01133821|3858484|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4036820|NCT01133821|3858485|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4036821|NCT01133821|3858483|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4036822|NCT01133821|3858484|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4036823|NCT01133821|3858485|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4036824|NCT01133821|3858483|B3|||Age||years|Mean|32.4|32.4|Standard Deviation|10.8|10.8|||
4036825|NCT01133821|3858484|B2|||Age||years|Mean|30.9|30.9|Standard Deviation|10.3|10.3|||
4036826|NCT01133821|3858485|B1|||Age||years|Mean|33.9|33.9|Standard Deviation|11.2|11.2|||
4036827|NCT01133756|3858494|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4036828|NCT01133756|3858495|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4036829|NCT01133756|3858496|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4036830|NCT01133756|3858497|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4036831|NCT01133756|3858494|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4036832|NCT01133756|3858495|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4036833|NCT01133756|3858496|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4036834|NCT01133756|3858497|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4036835|NCT01133756|3858494|B4||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4036836|NCT01133756|3858495|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4036837|NCT01133756|3858496|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4036838|NCT01133756|3858497|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4036839|NCT01133756|3858494|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4036840|NCT01133756|3858495|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4036841|NCT01133756|3858496|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4036842|NCT01133756|3858497|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4036843|NCT01133756|3858494|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4036844|NCT01133756|3858495|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4036845|NCT01133756|3858496|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4036846|NCT01133756|3858497|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4036847|NCT01133704|3858513|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4036848|NCT01133704|3858514|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4036849|NCT01133704|3858515|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4036850|NCT01133704|3858513|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4036851|NCT01133704|3858514|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4036852|NCT01133704|3858515|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4036853|NCT01133704|3858513|B3|||Age||years|Mean|69.9|69.9|Standard Deviation|8.1|8.1|||
4036854|NCT01133704|3858514|B2|||Age||years|Mean|70.6|70.6|Standard Deviation|7.8|7.8|||
4036855|NCT01133704|3858515|B1|||Age||years|Mean|69.6|69.6|Standard Deviation|8.2|8.2|||
4036856|NCT01133665|3858524|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4036857|NCT01133665|3858524|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4036858|NCT01133665|3858524|B1|||Age||years|Median|59|59.0|Full Range|||42.0|82.0|
4036859|NCT01133626|3858582|B4|||Body Mass Index||kg/m^2|Mean|27.6|27.6|Standard Deviation|7.2|7.2|||
4036860|NCT01133626|3858583|B3|||Body Mass Index||kg/m^2|Mean|28.4|28.4|Standard Deviation|7.9|7.9|||
4036861|NCT01133626|3858584|B2|||Body Mass Index||kg/m^2|Mean|27.0|27.0|Standard Deviation|6.2|6.2|||
4036862|NCT01133626|3858585|B1|||Body Mass Index||kg/m^2|Mean|27.9|27.9|Standard Deviation|7.9|7.9|||
4036863|NCT01133626|3858582|B4|Unknown or Not Reported||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|1|1.0||||||
4036864|NCT01133626|3858583|B3|Unknown or Not Reported||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|0|0.0||||||
4036865|NCT01133626|3858584|B2|Unknown or Not Reported||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|1|1.0||||||
4036866|NCT01133626|3858585|B1|Unknown or Not Reported||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|0|0.0||||||
4036867|NCT01133626|3858582|B4|White||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|87|87.0||||||
4036868|NCT01133626|3858583|B3|White||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|7|7.0||||||
4036869|NCT01133626|3858584|B2|White||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|38|38.0||||||
4036870|NCT01133626|3858585|B1|White||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|42|42.0||||||
4036871|NCT01133626|3858582|B4|Black or African American||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|10|10.0||||||
4036872|NCT01133626|3858583|B3|Black or African American||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|1|1.0||||||
4036873|NCT01133626|3858584|B2|Black or African American||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|2|2.0||||||
4036874|NCT01133626|3858585|B1|Black or African American||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|7|7.0||||||
4036875|NCT01133626|3858582|B4|Asian||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|1|1.0||||||
4036876|NCT01133626|3858583|B3|Asian||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|0|0.0||||||
4036877|NCT01133626|3858584|B2|Asian||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|0|0.0||||||
4036878|NCT01133626|3858585|B1|Asian||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|1|1.0||||||
4036879|NCT01133626|3858582|B4|American Indian or Alaska Native||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|1|1.0||||||
4036880|NCT01133626|3858583|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|1|1.0||||||
4036881|NCT01133626|3858584|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|0|0.0||||||
4036882|NCT01133626|3858585|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|0|0.0||||||
4036883|NCT01133626|3858582|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
4036884|NCT01133626|3858583|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4036885|NCT01133626|3858584|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4036886|NCT01133626|3858585|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4036887|NCT01133626|3858582|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4036888|NCT01133626|3858583|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4036889|NCT01133626|3858584|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4036890|NCT01133626|3858585|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4036891|NCT01133626|3858582|B4||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4036892|NCT01133626|3858583|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4036893|NCT01133626|3858584|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4036894|NCT01133626|3858585|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4036895|NCT01133626|3858582|B4||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4036896|NCT01133626|3858583|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4036897|NCT01133626|3858584|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4036898|NCT01133626|3858585|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4036899|NCT01133626|3858582|B4|||Age|Demographic data are provided for the Per Protocol population.|years|Mean|27.4|27.4|Standard Deviation|10.4|10.4|||
4036900|NCT01133626|3858583|B3|||Age|Demographic data are provided for the Per Protocol population.|years|Mean|26.2|26.2|Standard Deviation|11.9|11.9|||
4036901|NCT01133626|3858584|B2|||Age|Demographic data are provided for the Per Protocol population.|years|Mean|26.6|26.6|Standard Deviation|10.6|10.6|||
4036902|NCT01133626|3858585|B1|||Age|Demographic data are provided for the Per Protocol population.|years|Mean|28.3|28.3|Standard Deviation|10.0|10.0|||
4036903|NCT01133522|3858595|B11|||Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Concentration||ng/mL|Mean|432.0|432.0|Standard Deviation|133.6|133.6|||
4036904|NCT01133522|3858596|B10|||Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Concentration||ng/mL|Mean|396.0|396.0|Standard Deviation|86.4|86.4|||
4036905|NCT01133522|3858597|B9|||Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Concentration||ng/mL|Mean|478.5|478.5|Standard Deviation|94.0|94.0|||
4036906|NCT01133522|3858598|B8|||Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Concentration||ng/mL|Mean|486.6|486.6|Standard Deviation|214.0|214.0|||
4036907|NCT01133522|3858599|B7|||Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Concentration||ng/mL|Mean|382.5|382.5|Standard Deviation|82.7|82.7|||
4036908|NCT01133522|3858600|B6|||Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Concentration||ng/mL|Mean|459.0|459.0|Standard Deviation|163.4|163.4|||
4036909|NCT01133522|3858601|B5|||Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Concentration||ng/mL|Mean|373.7|373.7|Standard Deviation|96.0|96.0|||
4036910|NCT01133522|3858602|B4|||Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Concentration||ng/mL|Mean|384.8|384.8|Standard Deviation|88.0|88.0|||
4036911|NCT01133522|3858603|B3|||Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Concentration||ng/mL|Mean|399.8|399.8|Standard Deviation|116.7|116.7|||
4036912|NCT01133522|3858604|B2|||Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Concentration||ng/mL|Mean|491.2|491.2|Standard Deviation|157.9|157.9|||
4036913|NCT01133522|3858605|B1|||Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Concentration||ng/mL|Mean|429.0|429.0|Standard Deviation|93.1|93.1|||
4036914|NCT01133522|3858595|B11|||Low-Density Lipoprotein Cholesterol (LDL-C) Concentration||mg/dL|Mean|114.1|114.1|Standard Deviation|27.8|27.8|||
4036915|NCT01133522|3858596|B10|||Low-Density Lipoprotein Cholesterol (LDL-C) Concentration||mg/dL|Mean|134.5|134.5|Standard Deviation|31.1|31.1|||
4036916|NCT01133522|3858597|B9|||Low-Density Lipoprotein Cholesterol (LDL-C) Concentration||mg/dL|Mean|168.5|168.5|Standard Deviation|57.3|57.3|||
4036917|NCT01133522|3858598|B8|||Low-Density Lipoprotein Cholesterol (LDL-C) Concentration||mg/dL|Mean|100.2|100.2|Standard Deviation|25.5|25.5|||
4036918|NCT01133522|3858599|B7|||Low-Density Lipoprotein Cholesterol (LDL-C) Concentration||mg/dL|Mean|99.0|99.0|Standard Deviation|31.1|31.1|||
4036919|NCT01133522|3858600|B6|||Low-Density Lipoprotein Cholesterol (LDL-C) Concentration||mg/dL|Mean|120.3|120.3|Standard Deviation|33.0|33.0|||
4036920|NCT01133522|3858601|B5|||Low-Density Lipoprotein Cholesterol (LDL-C) Concentration||mg/dL|Mean|105.8|105.8|Standard Deviation|17.0|17.0|||
4036921|NCT01133522|3858602|B4|||Low-Density Lipoprotein Cholesterol (LDL-C) Concentration||mg/dL|Mean|113.7|113.7|Standard Deviation|14.5|14.5|||
4036922|NCT01133522|3858603|B3|||Low-Density Lipoprotein Cholesterol (LDL-C) Concentration||mg/dL|Mean|106.5|106.5|Standard Deviation|29.4|29.4|||
4036923|NCT01133522|3858604|B2|||Low-Density Lipoprotein Cholesterol (LDL-C) Concentration||mg/dL|Mean|126.7|126.7|Standard Deviation|22.1|22.1|||
4036924|NCT01133522|3858605|B1|||Low-Density Lipoprotein Cholesterol (LDL-C) Concentration||mg/dL|Mean|108.9|108.9|Standard Deviation|21.9|21.9|||
4036925|NCT01133522|3858595|B11|Aborigine||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036926|NCT01133522|3858596|B10|Aborigine||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036927|NCT01133522|3858597|B9|Aborigine||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036928|NCT01133522|3858598|B8|Aborigine||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036929|NCT01133522|3858599|B7|Aborigine||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036930|NCT01133522|3858600|B6|Aborigine||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036931|NCT01133522|3858601|B5|Aborigine||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036932|NCT01133522|3858602|B4|Aborigine||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036933|NCT01133522|3858603|B3|Aborigine||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036934|NCT01133522|3858604|B2|Aborigine||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036935|NCT01133522|3858605|B1|Aborigine||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036936|NCT01133522|3858595|B11|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036937|NCT01133522|3858596|B10|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036938|NCT01133522|3858597|B9|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036939|NCT01133522|3858598|B8|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036940|NCT01133522|3858599|B7|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036941|NCT01133522|3858600|B6|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036942|NCT01133522|3858601|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036943|NCT01133522|3858602|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036944|NCT01133522|3858603|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036945|NCT01133522|3858604|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036946|NCT01133522|3858605|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036947|NCT01133522|3858595|B11|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036948|NCT01133522|3858596|B10|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036949|NCT01133522|3858597|B9|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036950|NCT01133522|3858598|B8|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036951|NCT01133522|3858599|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036952|NCT01133522|3858600|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036953|NCT01133522|3858601|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036954|NCT01133522|3858602|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036955|NCT01133522|3858603|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036956|NCT01133522|3858604|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036957|NCT01133522|3858605|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036958|NCT01133522|3858595|B11|Japanese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036959|NCT01133522|3858596|B10|Japanese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036960|NCT01133522|3858597|B9|Japanese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036961|NCT01133522|3858598|B8|Japanese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036962|NCT01133522|3858599|B7|Japanese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036963|NCT01133522|3858600|B6|Japanese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036964|NCT01133522|3858601|B5|Japanese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036965|NCT01133522|3858602|B4|Japanese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036966|NCT01133522|3858603|B3|Japanese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036967|NCT01133522|3858604|B2|Japanese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036968|NCT01133522|3858605|B1|Japanese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036969|NCT01133522|3858595|B11|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4036970|NCT01133522|3858596|B10|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036971|NCT01133522|3858597|B9|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036972|NCT01133522|3858598|B8|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036973|NCT01133522|3858599|B7|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036974|NCT01133522|3858600|B6|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036975|NCT01133522|3858601|B5|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036976|NCT01133522|3858602|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4036977|NCT01133522|3858603|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036978|NCT01133522|3858604|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036979|NCT01133522|3858605|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036980|NCT01133522|3858595|B11|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4036981|NCT01133522|3858596|B10|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036982|NCT01133522|3858597|B9|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036983|NCT01133522|3858598|B8|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4036984|NCT01133522|3858599|B7|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036985|NCT01133522|3858600|B6|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4036986|NCT01133522|3858601|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036987|NCT01133522|3858602|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4036988|NCT01133522|3858603|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036989|NCT01133522|3858604|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036990|NCT01133522|3858605|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4036991|NCT01133522|3858595|B11|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4036992|NCT01133522|3858596|B10|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4036993|NCT01133522|3858597|B9|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036994|NCT01133522|3858598|B8|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036995|NCT01133522|3858599|B7|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036996|NCT01133522|3858600|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036997|NCT01133522|3858601|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036998|NCT01133522|3858602|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4036999|NCT01133522|3858603|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4037000|NCT01133522|3858604|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4037001|NCT01133522|3858605|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4037002|NCT01133522|3858595|B11|White or Caucasian||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4037003|NCT01133522|3858596|B10|White or Caucasian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4037004|NCT01133522|3858597|B9|White or Caucasian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4037005|NCT01133522|3858598|B8|White or Caucasian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4037006|NCT01133522|3858599|B7|White or Caucasian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4037007|NCT01133522|3858600|B6|White or Caucasian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4037008|NCT01133522|3858601|B5|White or Caucasian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4037009|NCT01133522|3858602|B4|White or Caucasian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4037010|NCT01133522|3858603|B3|White or Caucasian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4037011|NCT01133522|3858604|B2|White or Caucasian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4037012|NCT01133522|3858605|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4037013|NCT01133522|3858595|B11||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4037014|NCT01133522|3858596|B10||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4037015|NCT01133522|3858597|B9||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4037016|NCT01133522|3858598|B8||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4037017|NCT01133522|3858599|B7||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4037018|NCT01133522|3858600|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4037019|NCT01133522|3858601|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4037020|NCT01133522|3858602|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4037021|NCT01133522|3858603|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4037022|NCT01133522|3858604|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4037023|NCT01133522|3858605|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4037024|NCT01133522|3858595|B11||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4037025|NCT01133522|3858596|B10||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4037026|NCT01133522|3858597|B9||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4037027|NCT01133522|3858598|B8||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4037028|NCT01133522|3858599|B7||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4037029|NCT01133522|3858600|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4037030|NCT01133522|3858601|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4037031|NCT01133522|3858602|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4037032|NCT01133522|3858603|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4037033|NCT01133522|3858604|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4037034|NCT01133522|3858605|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4037035|NCT01133522|3858595|B11|||Age||years|Mean|56.9|56.9|Standard Deviation|8.4|8.4|||
4037036|NCT01133522|3858596|B10|||Age||years|Mean|45.0|45.0|Standard Deviation|15.1|15.1|||
4037037|NCT01133522|3858597|B9|||Age||years|Mean|54.5|54.5|Standard Deviation|10.6|10.6|||
4037038|NCT01133522|3858598|B8|||Age||years|Mean|58.2|58.2|Standard Deviation|7.6|7.6|||
4037039|NCT01133522|3858599|B7|||Age||years|Mean|62.0|62.0|Standard Deviation|1.4|1.4|||
4037040|NCT01133522|3858600|B6|||Age||years|Mean|53.8|53.8|Standard Deviation|4.9|4.9|||
4037041|NCT01133522|3858601|B5|||Age||years|Mean|56.3|56.3|Standard Deviation|8.6|8.6|||
4037042|NCT01133522|3858602|B4|||Age||years|Mean|56.2|56.2|Standard Deviation|7.3|7.3|||
4037043|NCT01133522|3858603|B3|||Age||years|Mean|63.7|63.7|Standard Deviation|6.3|6.3|||
4037044|NCT01133522|3858604|B2|||Age||years|Mean|61.3|61.3|Standard Deviation|4.0|4.0|||
4037045|NCT01133522|3858605|B1|||Age||years|Mean|55.8|55.8|Standard Deviation|7.5|7.5|||
4037046|NCT01133418|3858680|B3|United States||Region of Enrollment||participants|Number|72|72.0||||||
4037047|NCT01133418|3858681|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
4037048|NCT01133418|3858682|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4037049|NCT01133418|3858680|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4037050|NCT01133418|3858681|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4037051|NCT01133418|3858682|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4037052|NCT01133418|3858680|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037053|NCT01133418|3858681|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037054|NCT01133418|3858682|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037055|NCT01133418|3858680|B3||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4037056|NCT01133418|3858681|B2||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4037057|NCT01133418|3858682|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4037058|NCT01133418|3858680|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4037059|NCT01133418|3858681|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4037060|NCT01133418|3858682|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4037061|NCT01133418|3858680|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4037062|NCT01133418|3858681|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4037063|NCT01133418|3858682|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037064|NCT01133418|3858680|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4037065|NCT01133418|3858681|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4037066|NCT01133418|3858682|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037067|NCT01133418|3858680|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037068|NCT01133418|3858681|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037069|NCT01133418|3858682|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037070|NCT01133418|3858680|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4037071|NCT01133418|3858681|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4037072|NCT01133418|3858682|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4037073|NCT01133418|3858680|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4037074|NCT01133418|3858681|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4037075|NCT01133418|3858682|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4037076|NCT01133418|3858680|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4037077|NCT01133418|3858681|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4037078|NCT01133418|3858682|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037079|NCT01133418|3858680|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4037080|NCT01133418|3858681|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4037081|NCT01133418|3858682|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4037082|NCT01133418|3858680|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4037083|NCT01133418|3858681|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4037084|NCT01133418|3858682|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4037085|NCT01133418|3858680|B3|||Age||years|Mean|8.98|8.98|Standard Deviation|1.70|1.7|||
4037086|NCT01133418|3858681|B2|||Age||years|Mean|9.19|9.19|Standard Deviation|1.84|1.84|||
4037087|NCT01133418|3858682|B1|||Age||years|Mean|8.71|8.71|Standard Deviation|1.53|1.53|||
4037088|NCT01133418|3858680|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4037089|NCT01133418|3858681|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4037090|NCT01133418|3858682|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4037091|NCT01133418|3858680|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4037092|NCT01133418|3858681|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4037093|NCT01133418|3858682|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4037094|NCT01133418|3858680|B3||<=18 years|Age||Participants|Count of Participants|72|72.0||||||
4037095|NCT01133418|3858681|B2||<=18 years|Age||Participants|Count of Participants|38|38.0||||||
4037096|NCT01133418|3858682|B1||<=18 years|Age||Participants|Count of Participants|34|34.0||||||
4037097|NCT01133392|3858695|B3|Singapore||Region of Enrollment||participants|Number|38|38.0||||||
4037098|NCT01133392|3858696|B2|Singapore||Region of Enrollment||participants|Number|18|18.0||||||
4037099|NCT01133392|3858697|B1|Singapore||Region of Enrollment||participants|Number|20|20.0||||||
4037100|NCT01133392|3858695|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4037101|NCT01133392|3858696|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4037102|NCT01133392|3858697|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4037103|NCT01133392|3858695|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4037104|NCT01133392|3858696|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4037105|NCT01133392|3858697|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4037106|NCT01133392|3858695|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4037107|NCT01133392|3858696|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4037108|NCT01133392|3858697|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4037109|NCT01133392|3858695|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4037110|NCT01133392|3858696|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4037111|NCT01133392|3858697|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4037112|NCT01133392|3858695|B3|||Age||years|Mean|32.4|32.4|Standard Deviation|7.1|7.1|||
4037113|NCT01133392|3858696|B2|||Age||years|Mean|34.6|34.6|Standard Deviation|6.4|6.4|||
4037114|NCT01133392|3858697|B1|||Age||years|Mean|30.4|30.4|Standard Deviation|7.2|7.2|||
4037115|NCT01133379|3858712|B4|USA||Region of Enrollment||participants|Number|174|174.0||||||
4037116|NCT01133379|3858713|B3|USA||Region of Enrollment||participants|Number|58|58.0||||||
4037117|NCT01133379|3858714|B2|USA||Region of Enrollment||participants|Number|58|58.0||||||
4037118|NCT01133379|3858715|B1|USA||Region of Enrollment||participants|Number|58|58.0||||||
4037119|NCT01133379|3858712|B4||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4037120|NCT01133379|3858713|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4037121|NCT01133379|3858714|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4037122|NCT01133379|3858715|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4037123|NCT01133379|3858712|B4||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4037124|NCT01133379|3858713|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4037125|NCT01133379|3858714|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4037126|NCT01133379|3858715|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4037127|NCT01133379|3858712|B4|||Age||years|Mean|35.0|35.0|Standard Deviation|11.41|11.41|||
4037128|NCT01133379|3858713|B3|||Age||years|Mean|35.8|35.8|Standard Deviation|11.98|11.98|||
4037129|NCT01133379|3858714|B2|||Age||years|Mean|33.9|33.9|Standard Deviation|10.98|10.98|||
4037130|NCT01133379|3858715|B1|||Age||years|Mean|35.2|35.2|Standard Deviation|11.36|11.36|||
4037131|NCT01133288|3858770|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4037132|NCT01133288|3858770|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4037133|NCT01133288|3858770|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4037134|NCT01133288|3858770|B1|||Age||years|Mean|31.3|31.3|Standard Deviation|6.57|6.57|||
4037135|NCT01133288|3858770|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4037136|NCT01133288|3858770|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4037137|NCT01133288|3858770|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4037138|NCT01133275|3858775|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4037139|NCT01133275|3858775|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4037140|NCT01133275|3858775|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4037141|NCT01133275|3858775|B1|||Age||years|Mean|68.64|68.64|Full Range|||22.0|88.0|
4037142|NCT01133275|3858775|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4037143|NCT01133275|3858775|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4037144|NCT01133275|3858775|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4037145|NCT01133171|3858780|B4|United States||Region of Enrollment||participants|Number|74|74.0||||||
4037146|NCT01133171|3858781|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4037147|NCT01133171|3858782|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4037148|NCT01133171|3858783|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4037149|NCT01133171|3858780|B4||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4037150|NCT01133171|3858781|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4037151|NCT01133171|3858782|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4037152|NCT01133171|3858783|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4037153|NCT01133171|3858780|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4037154|NCT01133171|3858781|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4037155|NCT01133171|3858782|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4037156|NCT01133171|3858783|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4037157|NCT01133171|3858780|B4|||Age||years|Mean|60|60.0|Standard Deviation|10|10.0|||
4037158|NCT01133171|3858781|B3|||Age||years|Mean|62.8|62.8|Standard Deviation|10.5|10.5|||
4037159|NCT01133171|3858782|B2|||Age||years|Mean|61.9|61.9|Standard Deviation|12.5|12.5|||
4037160|NCT01133171|3858783|B1|||Age||years|Mean|56.3|56.3|Standard Deviation|9.2|9.2|||
4037161|NCT01133158|3858795|B1|Spain||Region of Enrollment||participants|Number|60|60.0||||||
4037162|NCT01133158|3858795|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4037163|NCT01133158|3858795|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4037164|NCT01133158|3858795|B1|||Age||years|Median|62|62.0|Full Range|||32.0|76.0|
4037165|NCT01133158|3858795|B1||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4037166|NCT01133158|3858795|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4037167|NCT01133158|3858795|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4037168|NCT01133067|3858801|B1|Small Cell Carcinoma||Histology||participants|Number|30|30.0||||||
4037169|NCT01133067|3858801|B1|Other NSCLC||Histology||participants|Number|23|23.0||||||
4037170|NCT01133067|3858801|B1|Squamous Carcinoma||Histology||participants|Number|67|67.0||||||
4037171|NCT01133067|3858801|B1|Adenocarcinoma||Histology||participants|Number|80|80.0||||||
4037172|NCT01133067|3858801|B1|Stage IV||Stage|AJCC 7th edition Stage Group|participants|Number|3|3.0||||||
4037173|NCT01133067|3858801|B1|Stage III||Stage|AJCC 7th edition Stage Group|participants|Number|152|152.0||||||
4037174|NCT01133067|3858801|B1|Stage II||Stage|AJCC 7th edition Stage Group|participants|Number|25|25.0||||||
4037175|NCT01133067|3858801|B1|Stage I||Stage|AJCC 7th edition Stage Group|participants|Number|20|20.0||||||
4037176|NCT01133067|3858801|B1|India||Region of Enrollment||participants|Number|200|200.0||||||
4037177|NCT01133067|3858801|B1||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4037178|NCT01133067|3858801|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4037179|NCT01133067|3858801|B1|||Age||years|Median|56|56.0|Inter-Quartile Range|||50.0|63.0|
4037180|NCT01132846|3858806|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4037181|NCT01132846|3858807|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037182|NCT01132846|3858808|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4037183|NCT01132846|3858809|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037184|NCT01132846|3858806|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|344|344.0||||||
4037185|NCT01132846|3858807|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|116|116.0||||||
4037186|NCT01132846|3858808|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|112|112.0||||||
4037187|NCT01132846|3858809|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|116|116.0||||||
4037188|NCT01132846|3858806|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4037189|NCT01132846|3858807|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4037190|NCT01132846|3858808|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4037191|NCT01132846|3858809|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4037192|NCT01132846|3858806|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4037193|NCT01132846|3858807|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037194|NCT01132846|3858808|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4037195|NCT01132846|3858809|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037196|NCT01132846|3858806|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4037197|NCT01132846|3858807|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037198|NCT01132846|3858808|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4037199|NCT01132846|3858809|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4037200|NCT01132846|3858806|B4||White|Race (NIH/OMB)||Participants|Count of Participants|272|272.0||||||
4037201|NCT01132846|3858807|B3||White|Race (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
4037202|NCT01132846|3858808|B2||White|Race (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
4037203|NCT01132846|3858809|B1||White|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4037204|NCT01132846|3858806|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4037205|NCT01132846|3858807|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4037206|NCT01132846|3858808|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4037207|NCT01132846|3858809|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4037208|NCT01132846|3858806|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037209|NCT01132846|3858807|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037210|NCT01132846|3858808|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037211|NCT01132846|3858809|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037212|NCT01132846|3858806|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4037213|NCT01132846|3858807|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4037214|NCT01132846|3858808|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4037215|NCT01132846|3858809|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4037216|NCT01132846|3858806|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4037217|NCT01132846|3858807|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4037218|NCT01132846|3858808|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4037219|NCT01132846|3858809|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4037220|NCT01132846|3858806|B4||Male|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
4037221|NCT01132846|3858807|B3||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4037222|NCT01132846|3858808|B2||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4037223|NCT01132846|3858809|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4037224|NCT01132846|3858806|B4||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4037225|NCT01132846|3858807|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4037226|NCT01132846|3858808|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4037227|NCT01132846|3858809|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4037228|NCT01132846|3858806|B4|||Age||years|Mean|69.6|69.6|Standard Deviation|12.3|12.3|||
4037229|NCT01132846|3858807|B3|||Age||years|Mean|68.3|68.3|Standard Deviation|13.0|13.0|||
4037230|NCT01132846|3858808|B2|||Age||years|Mean|69.3|69.3|Standard Deviation|12.6|12.6|||
4037231|NCT01132846|3858809|B1|||Age||years|Mean|71.0|71.0|Standard Deviation|11.1|11.1|||
4037232|NCT01132820|3858861|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4037233|NCT01132820|3858861|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4037234|NCT01132820|3858861|B1|80-89 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
4037235|NCT01132820|3858861|B1|70-79 years||Age, Customized||Participants|Count of Participants|12|12.0||||||
4037236|NCT01132820|3858861|B1|60-69 years||Age, Customized||Participants|Count of Participants|20|20.0||||||
4037237|NCT01132820|3858861|B1|50-59 years||Age, Customized||Participants|Count of Participants|10|10.0||||||
4037238|NCT01132820|3858861|B1|40-49 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
4037239|NCT01132820|3858861|B1|30-39 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4037240|NCT01132820|3858861|B1|20-29 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4037241|NCT01132820|3858861|B1|||Age||years|Mean|64.9|64.9|Standard Deviation|9.5|9.5|||
4037242|NCT01132690|3858870|B3|Non Jewish||Religion||participants|Number|9|9.0||||||
4037243|NCT01132690|3858871|B2|Non Jewish||Religion||participants|Number|3|3.0||||||
4037244|NCT01132690|3858872|B1|Non Jewish||Religion||participants|Number|6|6.0||||||
4037245|NCT01132690|3858870|B3|Jewish - Non-Ashkenazi||Religion||participants|Number|0|0.0||||||
4037246|NCT01132690|3858871|B2|Jewish - Non-Ashkenazi||Religion||participants|Number|0|0.0||||||
4037247|NCT01132690|3858872|B1|Jewish - Non-Ashkenazi||Religion||participants|Number|0|0.0||||||
4037248|NCT01132690|3858870|B3|Jewish - Ashkenazi||Religion||participants|Number|2|2.0||||||
4037249|NCT01132690|3858871|B2|Jewish - Ashkenazi||Religion||participants|Number|2|2.0||||||
4037250|NCT01132690|3858872|B1|Jewish - Ashkenazi||Religion||participants|Number|0|0.0||||||
4037251|NCT01132690|3858870|B3|Israel||Region of Enrollment||participants|Number|4|4.0||||||
4037252|NCT01132690|3858871|B2|Israel||Region of Enrollment||participants|Number|2|2.0||||||
4037253|NCT01132690|3858872|B1|Israel||Region of Enrollment||participants|Number|2|2.0||||||
4037254|NCT01132690|3858870|B3|South Africa||Region of Enrollment||participants|Number|3|3.0||||||
4037255|NCT01132690|3858871|B2|South Africa||Region of Enrollment||participants|Number|2|2.0||||||
4037256|NCT01132690|3858872|B1|South Africa||Region of Enrollment||participants|Number|1|1.0||||||
4037257|NCT01132690|3858870|B3|Paraguay||Region of Enrollment||participants|Number|4|4.0||||||
4037258|NCT01132690|3858871|B2|Paraguay||Region of Enrollment||participants|Number|1|1.0||||||
4037259|NCT01132690|3858872|B1|Paraguay||Region of Enrollment||participants|Number|3|3.0||||||
4037260|NCT01132690|3858870|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037261|NCT01132690|3858871|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037262|NCT01132690|3858872|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037263|NCT01132690|3858870|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4037264|NCT01132690|3858871|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4037265|NCT01132690|3858872|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4037266|NCT01132690|3858870|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4037267|NCT01132690|3858871|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4037268|NCT01132690|3858872|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4037269|NCT01132690|3858870|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4037270|NCT01132690|3858871|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4037271|NCT01132690|3858872|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037272|NCT01132690|3858870|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037273|NCT01132690|3858871|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037274|NCT01132690|3858872|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037275|NCT01132690|3858870|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4037276|NCT01132690|3858871|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4037277|NCT01132690|3858872|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4037278|NCT01132690|3858870|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037279|NCT01132690|3858871|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037280|NCT01132690|3858872|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037281|NCT01132690|3858870|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037282|NCT01132690|3858871|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037283|NCT01132690|3858872|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037284|NCT01132690|3858870|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037285|NCT01132690|3858871|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037286|NCT01132690|3858872|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037287|NCT01132690|3858870|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037288|NCT01132690|3858871|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037289|NCT01132690|3858872|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037290|NCT01132690|3858870|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4037291|NCT01132690|3858871|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4037292|NCT01132690|3858872|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4037293|NCT01132690|3858870|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4037294|NCT01132690|3858871|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4037295|NCT01132690|3858872|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4037296|NCT01132690|3858870|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4037297|NCT01132690|3858871|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4037298|NCT01132690|3858872|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4037299|NCT01132690|3858870|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4037300|NCT01132690|3858871|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4037301|NCT01132690|3858872|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4037302|NCT01132690|3858870|B3||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4037303|NCT01132690|3858871|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4037304|NCT01132690|3858872|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4037305|NCT01132690|3858870|B3|||Age||years|Mean|8.2|8.2|Standard Deviation|3.8|3.8|||
4037306|NCT01132690|3858871|B2|||Age||years|Mean|6.6|6.6|Standard Deviation|3.1|3.1|||
4037307|NCT01132690|3858872|B1|||Age||years|Mean|9.5|9.5|Standard Deviation|4.0|4.0|||
4037308|NCT01132664|3858889|B6|Sterile - of child bearing age||Female: Child bearing potential||Participants|Number|5|5.0||||||
4037309|NCT01132664|3858890|B5|Sterile - of child bearing age||Female: Child bearing potential||Participants|Number|1|1.0||||||
4037310|NCT01132664|3858891|B4|Sterile - of child bearing age||Female: Child bearing potential||Participants|Number|0|0.0||||||
4037311|NCT01132664|3858892|B3|Sterile - of child bearing age||Female: Child bearing potential||Participants|Number|3|3.0||||||
4037312|NCT01132664|3858893|B2|Sterile - of child bearing age||Female: Child bearing potential||Participants|Number|1|1.0||||||
4037313|NCT01132664|3858894|B1|Sterile - of child bearing age||Female: Child bearing potential||Participants|Number|0|0.0||||||
4037314|NCT01132664|3858889|B6|Post-menopausal||Female: Child bearing potential||Participants|Number|48|48.0||||||
4037315|NCT01132664|3858890|B5|Post-menopausal||Female: Child bearing potential||Participants|Number|4|4.0||||||
4037316|NCT01132664|3858891|B4|Post-menopausal||Female: Child bearing potential||Participants|Number|2|2.0||||||
4037317|NCT01132664|3858892|B3|Post-menopausal||Female: Child bearing potential||Participants|Number|31|31.0||||||
4037318|NCT01132664|3858893|B2|Post-menopausal||Female: Child bearing potential||Participants|Number|8|8.0||||||
4037319|NCT01132664|3858894|B1|Post-menopausal||Female: Child bearing potential||Participants|Number|3|3.0||||||
4037320|NCT01132664|3858889|B6|Premenarche||Female: Child bearing potential||Participants|Number|0|0.0||||||
4037321|NCT01132664|3858890|B5|Premenarche||Female: Child bearing potential||Participants|Number|0|0.0||||||
4037322|NCT01132664|3858891|B4|Premenarche||Female: Child bearing potential||Participants|Number|0|0.0||||||
4037323|NCT01132664|3858892|B3|Premenarche||Female: Child bearing potential||Participants|Number|0|0.0||||||
4037324|NCT01132664|3858893|B2|Premenarche||Female: Child bearing potential||Participants|Number|0|0.0||||||
4037325|NCT01132664|3858894|B1|Premenarche||Female: Child bearing potential||Participants|Number|0|0.0||||||
4037326|NCT01132664|3858889|B6|Able to bear children||Female: Child bearing potential||Participants|Number|15|15.0||||||
4037327|NCT01132664|3858890|B5|Able to bear children||Female: Child bearing potential||Participants|Number|1|1.0||||||
4037328|NCT01132664|3858891|B4|Able to bear children||Female: Child bearing potential||Participants|Number|1|1.0||||||
4037329|NCT01132664|3858892|B3|Able to bear children||Female: Child bearing potential||Participants|Number|8|8.0||||||
4037330|NCT01132664|3858893|B2|Able to bear children||Female: Child bearing potential||Participants|Number|3|3.0||||||
4037331|NCT01132664|3858894|B1|Able to bear children||Female: Child bearing potential||Participants|Number|2|2.0||||||
4037332|NCT01132664|3858889|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4037333|NCT01132664|3858890|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4037334|NCT01132664|3858891|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4037335|NCT01132664|3858892|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4037336|NCT01132664|3858893|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4037337|NCT01132664|3858894|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4037338|NCT01132664|3858889|B6||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4037339|NCT01132664|3858890|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4037340|NCT01132664|3858891|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4037341|NCT01132664|3858892|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4037342|NCT01132664|3858893|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4037343|NCT01132664|3858894|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4037344|NCT01132664|3858889|B6|>=65 years||Age, Customized||Participants|Number|8|8.0||||||
4037345|NCT01132664|3858890|B5|>=65 years||Age, Customized||Participants|Number|0|0.0||||||
4037346|NCT01132664|3858891|B4|>=65 years||Age, Customized||Participants|Number|0|0.0||||||
4037347|NCT01132664|3858892|B3|>=65 years||Age, Customized||Participants|Number|7|7.0||||||
4037348|NCT01132664|3858893|B2|>=65 years||Age, Customized||Participants|Number|1|1.0||||||
4037349|NCT01132664|3858894|B1|>=65 years||Age, Customized||Participants|Number|0|0.0||||||
4037350|NCT01132664|3858889|B6|<65 years||Age, Customized||Participants|Number|60|60.0||||||
4037351|NCT01132664|3858890|B5|<65 years||Age, Customized||Participants|Number|6|6.0||||||
4037352|NCT01132664|3858891|B4|<65 years||Age, Customized||Participants|Number|3|3.0||||||
4037353|NCT01132664|3858892|B3|<65 years||Age, Customized||Participants|Number|35|35.0||||||
4037354|NCT01132664|3858893|B2|<65 years||Age, Customized||Participants|Number|11|11.0||||||
4037355|NCT01132664|3858894|B1|<65 years||Age, Customized||Participants|Number|5|5.0||||||
4037356|NCT01132651|3858930|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4037357|NCT01132651|3858931|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4037358|NCT01132651|3858932|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4037359|NCT01132651|3858930|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4037360|NCT01132651|3858931|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4037361|NCT01132651|3858932|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4037362|NCT01132651|3858930|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4037363|NCT01132651|3858931|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4037364|NCT01132651|3858932|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4037365|NCT01132651|3858930|B3|||Age||years|Mean|34.4|34.4|Standard Deviation|12.2|12.2|||
4037366|NCT01132651|3858931|B2|||Age||years|Mean|34|34.0|Standard Deviation|13.5|13.5|||
4037367|NCT01132651|3858932|B1|||Age||years|Mean|35|35.0|Standard Deviation|10.3|10.3|||
4037368|NCT01132651|3858930|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4037369|NCT01132651|3858931|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4037370|NCT01132651|3858932|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4037371|NCT01132651|3858930|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4037372|NCT01132651|3858931|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4037373|NCT01132651|3858932|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4037374|NCT01132651|3858930|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4037375|NCT01132651|3858931|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4037376|NCT01132651|3858932|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4037377|NCT01132612|3858941|B4||Male|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4037378|NCT01132612|3858942|B3||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4037379|NCT01132612|3858943|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4037380|NCT01132612|3858944|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4037381|NCT01132612|3858941|B4||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4037382|NCT01132612|3858942|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4037383|NCT01132612|3858943|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4037384|NCT01132612|3858944|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4037385|NCT01132612|3858941|B4|||Age||Years|Mean|43.9|43.9|Standard Deviation|12.27|12.27|||
4037386|NCT01132612|3858942|B3|||Age||Years|Mean|45.0|45.0|Standard Deviation|11.78|11.78|||
4037387|NCT01132612|3858943|B2|||Age||Years|Mean|39.9|39.9|Standard Deviation|12.12|12.12|||
4037388|NCT01132612|3858944|B1|||Age||Years|Mean|43.0|43.0|Standard Deviation|13.71|13.71|||
4037389|NCT01132547|3858960|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4037390|NCT01132547|3858961|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4037391|NCT01132547|3858962|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4037392|NCT01132547|3858960|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4037393|NCT01132547|3858961|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4037394|NCT01132547|3858962|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4037395|NCT01132547|3858960|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4037396|NCT01132547|3858961|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4037397|NCT01132547|3858962|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4037398|NCT01132547|3858960|B3|||Age||years|Mean|11.2|11.2|Standard Deviation|5.1|5.1|||
4037399|NCT01132547|3858961|B2|||Age||years|Mean|12.0|12.0|Standard Deviation|4.7|4.7|||
4037400|NCT01132547|3858962|B1|||Age||years|Mean|10.2|10.2|Standard Deviation|5.7|5.7|||
4037401|NCT01132508|3858973|B1|Missing||Orthopaedic Trauma Association (OTA) fracture type|OTA = orthopaedic trauma association B2 = partial articular fracture classified as pure depression B3 = partial articular fracture classified as split depression C3 = complete articular fracture classified as multifragmentary|participants|Number|1|1.0||||||
4037402|NCT01132508|3858973|B1|C3||Orthopaedic Trauma Association (OTA) fracture type|OTA = orthopaedic trauma association B2 = partial articular fracture classified as pure depression B3 = partial articular fracture classified as split depression C3 = complete articular fracture classified as multifragmentary|participants|Number|8|8.0||||||
4037403|NCT01132508|3858973|B1|B3||Orthopaedic Trauma Association (OTA) fracture type|OTA = orthopaedic trauma association B2 = partial articular fracture classified as pure depression B3 = partial articular fracture classified as split depression C3 = complete articular fracture classified as multifragmentary|participants|Number|19|19.0||||||
4037404|NCT01132508|3858973|B1|B2||Orthopaedic Trauma Association (OTA) fracture type|OTA = orthopaedic trauma association B2 = partial articular fracture classified as pure depression B3 = partial articular fracture classified as split depression C3 = complete articular fracture classified as multifragmentary|participants|Number|5|5.0||||||
4037405|NCT01132508|3858973|B1|Sports||Mechanism of injury|Patients may had an injury in more than one category.|participants|Number|6|6.0||||||
4037406|NCT01132508|3858973|B1|High impact trauma||Mechanism of injury|Patients may had an injury in more than one category.|participants|Number|7|7.0||||||
4037407|NCT01132508|3858973|B1|Low impact trauma||Mechanism of injury|Patients may had an injury in more than one category.|participants|Number|29|29.0||||||
4037408|NCT01132508|3858973|B1|Left knee||Injury characteristics: side of fracture||participants|Number|24|24.0||||||
4037409|NCT01132508|3858973|B1|Right knee||Injury characteristics: side of fracture||participants|Number|9|9.0||||||
4037410|NCT01132508|3858973|B1|Missing||Smoking status||participants|Number|1|1.0||||||
4037411|NCT01132508|3858973|B1|Current||Smoking status||participants|Number|10|10.0||||||
4037412|NCT01132508|3858973|B1|Former||Smoking status||participants|Number|11|11.0||||||
4037413|NCT01132508|3858973|B1|Never||Smoking status||participants|Number|11|11.0||||||
4037414|NCT01132508|3858973|B1|Missing||Health status||participants|Number|1|1.0||||||
4037415|NCT01132508|3858973|B1|Poor||Health status||participants|Number|0|0.0||||||
4037416|NCT01132508|3858973|B1|Fair||Health status||participants|Number|9|9.0||||||
4037417|NCT01132508|3858973|B1|Good||Health status||participants|Number|18|18.0||||||
4037418|NCT01132508|3858973|B1|Excellent||Health status||participants|Number|5|5.0||||||
4037419|NCT01132508|3858973|B1|Other||Occupation||participants|Number|9|9.0||||||
4037420|NCT01132508|3858973|B1|Heavy industrial or heavy industrial labor||Occupation||participants|Number|0|0.0||||||
4037421|NCT01132508|3858973|B1|Moderate industrial or moderate physical labor||Occupation||participants|Number|6|6.0||||||
4037422|NCT01132508|3858973|B1|Light industrial or light industrial labor||Occupation||participants|Number|3|3.0||||||
4037423|NCT01132508|3858973|B1|Office worker||Occupation||participants|Number|1|1.0||||||
4037424|NCT01132508|3858973|B1|Home worker||Occupation||participants|Number|2|2.0||||||
4037425|NCT01132508|3858973|B1|Student||Occupation||participants|Number|0|0.0||||||
4037426|NCT01132508|3858973|B1|Retired||Occupation||participants|Number|12|12.0||||||
4037427|NCT01132508|3858973|B1|Missing||Exercise per week||participants|Number|2|2.0||||||
4037428|NCT01132508|3858973|B1|5 or more times per week||Exercise per week||participants|Number|9|9.0||||||
4037429|NCT01132508|3858973|B1|3-4 times per week||Exercise per week||participants|Number|9|9.0||||||
4037430|NCT01132508|3858973|B1|1-2 times per week||Exercise per week||participants|Number|9|9.0||||||
4037431|NCT01132508|3858973|B1|Never||Exercise per week||participants|Number|4|4.0||||||
4037432|NCT01132508|3858973|B1|||BMI (n=32)||kg/m2|Mean|26.3|26.3|Standard Deviation|5.78|5.78|||
4037433|NCT01132508|3858973|B1|||Weight (n=32)||kilogram|Mean|75.5|75.5|Standard Deviation|18.33|18.33|||
4037434|NCT01132508|3858973|B1|||Height (n=32)||centimeter|Mean|169.5|169.5|Standard Deviation|9.85|9.85|||
4037435|NCT01132508|3858973|B1|China||Region of Enrollment||participants|Number|1|1.0||||||
4037436|NCT01132508|3858973|B1|Norway||Region of Enrollment||participants|Number|16|16.0||||||
4037437|NCT01132508|3858973|B1|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
4037438|NCT01132508|3858973|B1|Australia||Region of Enrollment||participants|Number|10|10.0||||||
4037439|NCT01132508|3858973|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4037440|NCT01132508|3858973|B1|Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4037441|NCT01132508|3858973|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4037442|NCT01132508|3858973|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4037443|NCT01132508|3858973|B1|White||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4037444|NCT01132508|3858973|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4037445|NCT01132508|3858973|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4037446|NCT01132508|3858973|B1|||Age||Years|Mean|56.6|56.6|Standard Deviation|15.37|15.37|||
4037447|NCT01132495|3859029|B5||Male|Gender||Participants|Count of Participants|884|884.0||||||
4037448|NCT01132495|3859030|B4||Male|Gender||Participants|Count of Participants|79|79.0||||||
4037449|NCT01132495|3859031|B3||Male|Gender||Participants|Count of Participants|113|113.0||||||
4037450|NCT01132495|3859032|B2||Male|Gender||Participants|Count of Participants|338|338.0||||||
4037451|NCT01132495|3859033|B1||Male|Gender||Participants|Count of Participants|354|354.0||||||
4037452|NCT01132495|3859029|B5||Female|Gender||Participants|Count of Participants|286|286.0||||||
4037453|NCT01132495|3859030|B4||Female|Gender||Participants|Count of Participants|37|37.0||||||
4037454|NCT01132495|3859031|B3||Female|Gender||Participants|Count of Participants|53|53.0||||||
4037455|NCT01132495|3859032|B2||Female|Gender||Participants|Count of Participants|103|103.0||||||
4037456|NCT01132495|3859033|B1||Female|Gender||Participants|Count of Participants|93|93.0||||||
4037457|NCT01132495|3859029|B5|||Age||years|Mean|63.7|63.7|Standard Deviation|9.4|9.4|||
4037458|NCT01132495|3859030|B4|||Age||years|Mean|64.4|64.4|Standard Deviation|8.8|8.8|||
4037459|NCT01132495|3859031|B3|||Age||years|Mean|63.6|63.6|Standard Deviation|9.8|9.8|||
4037460|NCT01132495|3859032|B2|||Age||years|Mean|63.9|63.9|Standard Deviation|9.6|9.6|||
4037461|NCT01132495|3859033|B1|||Age||years|Mean|63.5|63.5|Standard Deviation|9.3|9.3|||
4037462|NCT01132378|3859044|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4037463|NCT01132378|3859044|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4037464|NCT01132378|3859044|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4037465|NCT01132378|3859044|B1|||Age||years|Mean|65.13|65.13|Standard Deviation|6.49|6.49|||
4037466|NCT01132378|3859044|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4037467|NCT01132378|3859044|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4037468|NCT01132378|3859044|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4037469|NCT01132326|3859049|B1|Missing||Primary Clinical Diagnosis||participants|Number|2|2.0||||||
4037470|NCT01132326|3859049|B1|Other||Primary Clinical Diagnosis||participants|Number|7|7.0||||||
4037471|NCT01132326|3859049|B1|Non-Diabetic Autonomic Neuropathy||Primary Clinical Diagnosis||participants|Number|8|8.0||||||
4037472|NCT01132326|3859049|B1|Dopamine Beta-Hydroxylase Deficiency||Primary Clinical Diagnosis||participants|Number|0|0.0||||||
4037473|NCT01132326|3859049|B1|Pure Autonomic Failure||Primary Clinical Diagnosis||participants|Number|68|68.0||||||
4037474|NCT01132326|3859049|B1|Multiple System Atrophy||Primary Clinical Diagnosis||participants|Number|33|33.0||||||
4037475|NCT01132326|3859049|B1|Parkinson's Disease||Primary Clinical Diagnosis||participants|Number|232|232.0||||||
4037476|NCT01132326|3859049|B1|Europe||Region of Enrollment||participants|Number|87|87.0||||||
4037477|NCT01132326|3859049|B1|United States||Region of Enrollment||participants|Number|263|263.0||||||
4037478|NCT01132326|3859049|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037479|NCT01132326|3859049|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037480|NCT01132326|3859049|B1||White|Race (NIH/OMB)||Participants|Count of Participants|344|344.0||||||
4037481|NCT01132326|3859049|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4037482|NCT01132326|3859049|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037483|NCT01132326|3859049|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4037484|NCT01132326|3859049|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037485|NCT01132326|3859049|B1||Male|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4037486|NCT01132326|3859049|B1||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4037487|NCT01132326|3859049|B1|||Age||years|Mean|65.9|65.9|Standard Deviation|15.16|15.16|||
4037488|NCT01132313|3859053|B13||Male|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
4037489|NCT01132313|3859054|B12||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4037490|NCT01132313|3859055|B11||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4037491|NCT01132313|3859056|B10||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4037492|NCT01132313|3859057|B9||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4037493|NCT01132313|3859058|B8||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4037494|NCT01132313|3859059|B7||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4037495|NCT01132313|3859060|B6||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4037496|NCT01132313|3859061|B5||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4037497|NCT01132313|3859062|B4||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4037498|NCT01132313|3859063|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4037499|NCT01132313|3859064|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4037500|NCT01132313|3859065|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4037501|NCT01132313|3859053|B13||Female|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
4037502|NCT01132313|3859054|B12||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4037503|NCT01132313|3859055|B11||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4037504|NCT01132313|3859056|B10||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4037505|NCT01132313|3859057|B9||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4037506|NCT01132313|3859058|B8||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4037507|NCT01132313|3859059|B7||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4037508|NCT01132313|3859060|B6||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4037509|NCT01132313|3859061|B5||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4037510|NCT01132313|3859062|B4||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4037511|NCT01132313|3859063|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4037512|NCT01132313|3859064|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4037513|NCT01132313|3859065|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4037514|NCT01132313|3859053|B13|||Age||Years|Mean|48.1|48.1|Standard Deviation|11.4|11.4|||
4037515|NCT01132313|3859054|B12|||Age||Years|Mean|52.5|52.5|Standard Deviation|4.9|4.9|||
4037516|NCT01132313|3859055|B11|||Age||Years|Mean|59.0|59.0|Standard Deviation|NA||||Not calculable due to only one patient in treatment group
4037517|NCT01132313|3859056|B10|||Age||Years|Mean|46.5|46.5|Standard Deviation|12.5|12.5|||
4037518|NCT01132313|3859057|B9|||Age||Years|Mean|47.2|47.2|Standard Deviation|13.4|13.4|||
4037519|NCT01132313|3859058|B8|||Age||Years|Mean|48.9|48.9|Standard Deviation|11.8|11.8|||
4037520|NCT01132313|3859059|B7|||Age||Years|Mean|45.3|45.3|Standard Deviation|13.0|13.0|||
4037521|NCT01132313|3859060|B6|||Age||Years|Mean|47.9|47.9|Standard Deviation|11.1|11.1|||
4037522|NCT01132313|3859061|B5|||Age||Years|Mean|48.9|48.9|Standard Deviation|10.7|10.7|||
4037523|NCT01132313|3859062|B4|||Age||Years|Mean|47.3|47.3|Standard Deviation|11.2|11.2|||
4037524|NCT01132313|3859063|B3|||Age||Years|Mean|48.6|48.6|Standard Deviation|11.3|11.3|||
4037525|NCT01132313|3859064|B2|||Age||Years|Mean|50.8|50.8|Standard Deviation|11.5|11.5|||
4037526|NCT01132313|3859065|B1|||Age||Years|Mean|50.8|50.8|Standard Deviation|10.0|10.0|||
4037527|NCT01132144|3859131|B3|Brazil||Region of Enrollment||participants|Number|158|158.0||||||
4037528|NCT01132144|3859132|B2|Brazil||Region of Enrollment||participants|Number|79|79.0||||||
4037529|NCT01132144|3859133|B1|Brazil||Region of Enrollment||participants|Number|79|79.0||||||
4037530|NCT01132144|3859131|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4037531|NCT01132144|3859132|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4037532|NCT01132144|3859133|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4037533|NCT01132144|3859131|B3||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4037534|NCT01132144|3859132|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4037535|NCT01132144|3859133|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4037536|NCT01132144|3859131|B3|||Age||years|Mean|32.2|32.2|Standard Deviation|3.2|3.2|||
4037537|NCT01132144|3859132|B2|||Age||years|Mean|32.1|32.1|Standard Deviation|3.1|3.1|||
4037538|NCT01132144|3859133|B1|||Age||years|Mean|32.4|32.4|Standard Deviation|3.2|3.2|||
4037539|NCT01132144|3859131|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4037540|NCT01132144|3859132|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4037541|NCT01132144|3859133|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4037542|NCT01132144|3859131|B3||Between 18 and 65 years|Age||Participants|Count of Participants|158|158.0||||||
4037543|NCT01132144|3859132|B2||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
4037544|NCT01132144|3859133|B1||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
4037545|NCT01132144|3859131|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4037546|NCT01132144|3859132|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4037547|NCT01132144|3859133|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4037548|NCT01132118|3859154|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4037549|NCT01132118|3859155|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4037550|NCT01132118|3859156|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4037551|NCT01132118|3859154|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4037552|NCT01132118|3859155|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4037553|NCT01132118|3859156|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4037554|NCT01132118|3859154|B3|||Age||years|Mean|56.5|56.5|Standard Deviation|11|11.0|||
4037555|NCT01132118|3859155|B2|||Age||years|Mean|57|57.0|Standard Deviation|14|14.0|||
4037556|NCT01132118|3859156|B1|||Age||years|Mean|56|56.0|Standard Deviation|14|14.0|||
4037557|NCT01131884|3859175|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4037558|NCT01131884|3859177|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4037559|NCT01131884|3859175|B3|Male||Gender||participants|Number|1|1.0||||||
4037560|NCT01131884|3859177|B1|Male||Gender||participants|Number|1|1.0||||||
4037561|NCT01131884|3859175|B3|Female||Gender||participants|Number|0|0.0||||||
4037562|NCT01131884|3859177|B1|Female||Gender||participants|Number|0|0.0||||||
4037563|NCT01131884|3859175|B3|||Age||years|Mean|58|58.0|Standard Deviation|0|0.0|||
4037564|NCT01131884|3859177|B1|||Age||years|Mean|58|58.0|Standard Deviation|0|0.0|||
4037565|NCT01131884|3859175|B3|>=65 years||Age||participants|Number|0|0.0||||||
4037566|NCT01131884|3859177|B1|>=65 years||Age||participants|Number|0|0.0||||||
4037567|NCT01131884|3859175|B3|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
4037568|NCT01131884|3859177|B1|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
4037569|NCT01131884|3859175|B3|<=18 years||Age||participants|Number|0|0.0||||||
4037570|NCT01131884|3859177|B1|<=18 years||Age||participants|Number|0|0.0||||||
4037571|NCT01131676|3859184|B4||Male|Sex: Female, Male||Participants|Count of Participants|5016|5016.0||||||
4037572|NCT01131676|3859185|B3||Male|Sex: Female, Male||Participants|Count of Participants|1683|1683.0||||||
4037573|NCT01131676|3859186|B2||Male|Sex: Female, Male||Participants|Count of Participants|1653|1653.0||||||
4037574|NCT01131676|3859187|B1||Male|Sex: Female, Male||Participants|Count of Participants|1680|1680.0||||||
4037575|NCT01131676|3859184|B4||Female|Sex: Female, Male||Participants|Count of Participants|2004|2004.0||||||
4037576|NCT01131676|3859185|B3||Female|Sex: Female, Male||Participants|Count of Participants|659|659.0||||||
4037577|NCT01131676|3859186|B2||Female|Sex: Female, Male||Participants|Count of Participants|692|692.0||||||
4037578|NCT01131676|3859187|B1||Female|Sex: Female, Male||Participants|Count of Participants|653|653.0||||||
4037579|NCT01131676|3859184|B4|||Age||years|Mean|63.1|63.1|Standard Deviation|8.6|8.6|||
4037580|NCT01131676|3859185|B3|||Age||years|Mean|63.2|63.2|Standard Deviation|8.6|8.6|||
4037581|NCT01131676|3859186|B2|||Age||years|Mean|63.0|63.0|Standard Deviation|8.6|8.6|||
4037582|NCT01131676|3859187|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|8.8|8.8|||
4037583|NCT01131585|3859222|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4037584|NCT01131585|3859223|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4037585|NCT01131585|3859224|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4037586|NCT01131585|3859222|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4037587|NCT01131585|3859223|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4037588|NCT01131585|3859224|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4037589|NCT01131585|3859222|B3|>=18 years||Age||years|Mean|63.5|63.5|Standard Deviation|9.7|9.7|||
4037590|NCT01131585|3859223|B2|>=18 years||Age||years|Mean|63.5|63.5|Standard Deviation|10.5|10.5|||
4037591|NCT01131585|3859224|B1|>=18 years||Age||years|Mean|63.5|63.5|Standard Deviation|9.3|9.3|||
4037592|NCT01131520|3859231|B3|United States||Region of Enrollment||Participants|Count of Participants|359|359.0||||||
4037593|NCT01131520|3859232|B2|United States||Region of Enrollment||Participants|Count of Participants|179|179.0||||||
4037594|NCT01131520|3859233|B1|United States||Region of Enrollment||Participants|Count of Participants|180|180.0||||||
4037595|NCT01131520|3859231|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037596|NCT01131520|3859232|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037597|NCT01131520|3859233|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037598|NCT01131520|3859231|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4037599|NCT01131520|3859232|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4037600|NCT01131520|3859233|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4037601|NCT01131520|3859231|B3||White|Race (NIH/OMB)||Participants|Count of Participants|323|323.0||||||
4037602|NCT01131520|3859232|B2||White|Race (NIH/OMB)||Participants|Count of Participants|161|161.0||||||
4037603|NCT01131520|3859233|B1||White|Race (NIH/OMB)||Participants|Count of Participants|162|162.0||||||
4037604|NCT01131520|3859231|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4037605|NCT01131520|3859232|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4037606|NCT01131520|3859233|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4037607|NCT01131520|3859231|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4037608|NCT01131520|3859232|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4037609|NCT01131520|3859233|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4037610|NCT01131520|3859231|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037611|NCT01131520|3859232|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037612|NCT01131520|3859233|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037613|NCT01131520|3859231|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4037614|NCT01131520|3859232|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4037615|NCT01131520|3859233|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4037616|NCT01131520|3859231|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037617|NCT01131520|3859232|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037618|NCT01131520|3859233|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037619|NCT01131520|3859231|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|191|191.0||||||
4037620|NCT01131520|3859232|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
4037621|NCT01131520|3859233|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
4037622|NCT01131520|3859231|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|168|168.0||||||
4037623|NCT01131520|3859232|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
4037624|NCT01131520|3859233|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
4037625|NCT01131520|3859231|B3||Male|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4037626|NCT01131520|3859232|B2||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4037627|NCT01131520|3859233|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4037628|NCT01131520|3859231|B3||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4037629|NCT01131520|3859232|B2||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4037630|NCT01131520|3859233|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4037631|NCT01131520|3859231|B3|||Age||years|Mean|36.1|36.1|Standard Deviation|14.6|14.6|||
4037632|NCT01131520|3859232|B2|||Age||years|Mean|35.7|35.7|Standard Deviation|14.6|14.6|||
4037633|NCT01131520|3859233|B1|||Age||years|Mean|36.5|36.5|Standard Deviation|14.7|14.7|||
4037634|NCT01131507|3859256|B1|||Length|Number of participants evaluable for this baseline characteristic = 14|centimeter|Median|68.5|68.5|Full Range|5.98|5.98|59.0|79.0|
4037635|NCT01131507|3859256|B1|||Weight||kilogram|Median|7.80|7.8|Full Range|1.296|1.296|6.0|10.6|
4037636|NCT01131507|3859256|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4037637|NCT01131507|3859256|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4037638|NCT01131507|3859256|B1|||Age||months|Median|9.0|9.0|Full Range|3.27|3.27|3.0|14.0|
4037639|NCT01131494|3859261|B1|Brazil||Region of Enrollment||participants|Number|17|17.0||||||
4037640|NCT01131494|3859261|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4037641|NCT01131494|3859261|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4037642|NCT01131494|3859261|B1|||Age||years|Mean|60.12|60.12|Standard Deviation|12.34|12.34|||
4037643|NCT01131494|3859261|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4037644|NCT01131494|3859261|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4037645|NCT01131494|3859261|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4037646|NCT01131455|3859268|B4|Male||Gender||participants|Number|3|3.0||||||
4037647|NCT01131455|3859270|B2|Male||Gender||participants|Number|0|0.0||||||
4037648|NCT01131455|3859271|B1|Male||Gender||participants|Number|3|3.0||||||
4037649|NCT01131455|3859268|B4|Female||Gender||participants|Number|7|7.0||||||
4037650|NCT01131455|3859270|B2|Female||Gender||participants|Number|4|4.0||||||
4037651|NCT01131455|3859271|B1|Female||Gender||participants|Number|3|3.0||||||
4037652|NCT01131455|3859268|B4|>=65 years||Age||participants|Number|4|4.0||||||
4037653|NCT01131455|3859270|B2|>=65 years||Age||participants|Number|0|0.0||||||
4037654|NCT01131455|3859271|B1|>=65 years||Age||participants|Number|4|4.0||||||
4037655|NCT01131455|3859268|B4|Between 18 and 65 years||Age||participants|Number|6|6.0||||||
4037656|NCT01131455|3859270|B2|Between 18 and 65 years||Age||participants|Number|4|4.0||||||
4037657|NCT01131455|3859271|B1|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
4037658|NCT01131455|3859268|B4|<=18 years||Age||participants|Number|0|0.0||||||
4037659|NCT01131455|3859270|B2|<=18 years||Age||participants|Number|0|0.0||||||
4037660|NCT01131455|3859271|B1|<=18 years||Age||participants|Number|0|0.0||||||
4037661|NCT01131312|3859281|B4|United States||Region of Enrollment||Participants|Count of Participants|5060|5060.0||||||
4037662|NCT01131312|3859282|B3|United States||Region of Enrollment||Participants|Count of Participants|1836|1836.0||||||
4037663|NCT01131312|3859283|B2|United States||Region of Enrollment||Participants|Count of Participants|1385|1385.0||||||
4037664|NCT01131312|3859284|B1|United States||Region of Enrollment||Participants|Count of Participants|1839|1839.0||||||
4037665|NCT01131312|3859281|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4037666|NCT01131312|3859282|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4037667|NCT01131312|3859283|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4037668|NCT01131312|3859284|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4037669|NCT01131312|3859281|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037670|NCT01131312|3859282|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037671|NCT01131312|3859283|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037672|NCT01131312|3859284|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037673|NCT01131312|3859281|B4||White|Race (NIH/OMB)||Participants|Count of Participants|3191|3191.0||||||
4037674|NCT01131312|3859282|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1146|1146.0||||||
4037675|NCT01131312|3859283|B2||White|Race (NIH/OMB)||Participants|Count of Participants|865|865.0||||||
4037676|NCT01131312|3859284|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1180|1180.0||||||
4037677|NCT01131312|3859281|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1555|1555.0||||||
4037678|NCT01131312|3859282|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|569|569.0||||||
4037679|NCT01131312|3859283|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|427|427.0||||||
4037680|NCT01131312|3859284|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|559|559.0||||||
4037681|NCT01131312|3859281|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037682|NCT01131312|3859282|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037683|NCT01131312|3859283|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037684|NCT01131312|3859284|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037685|NCT01131312|3859281|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|170|170.0||||||
4037686|NCT01131312|3859282|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4037687|NCT01131312|3859283|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4037688|NCT01131312|3859284|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4037689|NCT01131312|3859281|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
4037690|NCT01131312|3859282|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4037691|NCT01131312|3859283|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4037692|NCT01131312|3859284|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4037693|NCT01131312|3859281|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4037694|NCT01131312|3859282|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4037695|NCT01131312|3859283|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4037696|NCT01131312|3859284|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4037697|NCT01131312|3859281|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4822|4822.0||||||
4037698|NCT01131312|3859282|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1751|1751.0||||||
4037699|NCT01131312|3859283|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1317|1317.0||||||
4037700|NCT01131312|3859284|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1754|1754.0||||||
4037701|NCT01131312|3859281|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|230|230.0||||||
4037702|NCT01131312|3859282|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
4037703|NCT01131312|3859283|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4037704|NCT01131312|3859284|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
4037705|NCT01131312|3859281|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4037706|NCT01131312|3859282|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4037707|NCT01131312|3859283|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4037708|NCT01131312|3859284|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4037709|NCT01131312|3859281|B4||Female|Sex: Female, Male||Participants|Count of Participants|5060|5060.0||||||
4037710|NCT01131312|3859282|B3||Female|Sex: Female, Male||Participants|Count of Participants|1836|1836.0||||||
4037711|NCT01131312|3859283|B2||Female|Sex: Female, Male||Participants|Count of Participants|1385|1385.0||||||
4037712|NCT01131312|3859284|B1||Female|Sex: Female, Male||Participants|Count of Participants|1839|1839.0||||||
4037713|NCT01131312|3859281|B4|||Age||years|Mean|27.52|27.52|Standard Deviation|9.05|9.05|||
4037714|NCT01131312|3859282|B3|||Age||years|Mean|27.24|27.24|Standard Deviation|8.90|8.9|||
4037715|NCT01131312|3859283|B2|||Age||years|Mean|28.28|28.28|Standard Deviation|9.62|9.62|||
4037716|NCT01131312|3859284|B1|||Age||years|Mean|27.22|27.22|Standard Deviation|8.73|8.73|||
4037717|NCT01131312|3859281|B4||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4037718|NCT01131312|3859282|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4037719|NCT01131312|3859283|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4037720|NCT01131312|3859284|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4037721|NCT01131312|3859281|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4771|4771.0||||||
4037722|NCT01131312|3859282|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1729|1729.0||||||
4037723|NCT01131312|3859283|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1313|1313.0||||||
4037724|NCT01131312|3859284|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1729|1729.0||||||
4037725|NCT01131312|3859281|B4||<=18 years|Age||Participants|Count of Participants|265|265.0||||||
4037726|NCT01131312|3859282|B3||<=18 years|Age||Participants|Count of Participants|99|99.0||||||
4037727|NCT01131312|3859283|B2||<=18 years|Age||Participants|Count of Participants|63|63.0||||||
4037728|NCT01131312|3859284|B1||<=18 years|Age||Participants|Count of Participants|103|103.0||||||
4037729|NCT01131299|3859297|B1|United States||Region of Enrollment||participants|Number|103|103.0||||||
4037730|NCT01131299|3859297|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4037731|NCT01131299|3859297|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4037732|NCT01131299|3859297|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4037733|NCT01131299|3859297|B1||Between 18 and 65 years|Age||Participants|Count of Participants|99|99.0||||||
4037734|NCT01131299|3859297|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4037735|NCT01131182|3859309|B3||Male|Sex: Female, Male||Participants|Count of Participants|524|524.0||||||
4037736|NCT01131182|3859310|B2||Male|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
4037737|NCT01131182|3859311|B1||Male|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
4037738|NCT01131182|3859309|B3||Female|Sex: Female, Male||Participants|Count of Participants|497|497.0||||||
4037739|NCT01131182|3859310|B2||Female|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
4037740|NCT01131182|3859311|B1||Female|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
4037741|NCT01131182|3859309|B3|||Age||years|Mean|55|55.0|Standard Deviation|11|11.0|||
4037742|NCT01131182|3859310|B2|||Age||years|Mean|55|55.0|Standard Deviation|10|10.0|||
4037743|NCT01131182|3859311|B1|||Age||years|Mean|55|55.0|Standard Deviation|11|11.0|||
4037744|NCT01131130|3859320|B1|United States||Region of Enrollment||participants|Number|117|117.0||||||
4037745|NCT01131130|3859320|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4037746|NCT01131130|3859320|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4037747|NCT01131130|3859320|B1|||Age||years|Mean|31.3|31.3|Standard Deviation|8.5|8.5|||
4037748|NCT01131104|3859333|B1|||Adjudicated NAION Participants within the 30-Day Analysis Set||Participants|Count of Participants|24|24.0||||||
4037749|NCT01131104|3859333|B1|United States||Region of Enrollment||Participants|Count of Participants|279|279.0||||||
4037750|NCT01131104|3859333|B1||Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4037751|NCT01131104|3859333|B1||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|265|265.0||||||
4037752|NCT01131104|3859333|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4037753|NCT01131104|3859333|B1|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4037754|NCT01131104|3859333|B1|More than one race||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4037755|NCT01131104|3859333|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|267|267.0||||||
4037756|NCT01131104|3859333|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4037757|NCT01131104|3859333|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4037758|NCT01131104|3859333|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4037759|NCT01131104|3859333|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4037760|NCT01131104|3859333|B1|Male||Sex/Gender, Customized||Participants|Count of Participants|279|279.0||||||
4037761|NCT01131104|3859333|B1|Female||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
4037762|NCT01131104|3859333|B1|||Age, Customized||years|Mean|61.5|61.5|Standard Deviation|10.70|10.7|||
4037763|NCT01131078|3859337|B4||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4037764|NCT01131078|3859338|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4037765|NCT01131078|3859339|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4037766|NCT01131078|3859340|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4037767|NCT01131078|3859337|B4||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4037768|NCT01131078|3859338|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4037769|NCT01131078|3859339|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4037770|NCT01131078|3859340|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4037771|NCT01131078|3859337|B4|||Age||years|Mean|61.36|61.36|Standard Deviation|9.86|9.86|||
4037772|NCT01131078|3859338|B3|||Age||years|Mean|61.01|61.01|Standard Deviation|10.10|10.1|||
4037773|NCT01131078|3859339|B2|||Age||years|Mean|61.46|61.46|Standard Deviation|10.22|10.22|||
4037774|NCT01131078|3859340|B1|||Age||years|Mean|61.60|61.6|Standard Deviation|9.35|9.35|||
4037775|NCT01131065|3859398|B1|Has fulminant HBV||Hepatitis history||participants|Number|0|0.0||||||
4037776|NCT01131065|3859398|B1|Has chronic HBV||Hepatitis history||participants|Number|15|15.0||||||
4037777|NCT01131065|3859398|B1|||Weight||kilogram|Mean|73.73|73.73|Standard Deviation|12.05|12.05|||
4037778|NCT01131065|3859398|B1|||Height||centimeters|Mean|170.33|170.33|Standard Deviation|8.08|8.08|||
4037779|NCT01131065|3859398|B1|||Alcohol consumption - abstemious||participants|Number|15|15.0||||||
4037780|NCT01131065|3859398|B1|Italy||Region of Enrollment||participants|Number|15|15.0||||||
4037781|NCT01131065|3859398|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037782|NCT01131065|3859398|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037783|NCT01131065|3859398|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4037784|NCT01131065|3859398|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037785|NCT01131065|3859398|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037786|NCT01131065|3859398|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037787|NCT01131065|3859398|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037788|NCT01131065|3859398|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4037789|NCT01131065|3859398|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4037790|NCT01131065|3859398|B1||>=65 years|Age|18 to 70 years of age (inclusive)|Participants|Count of Participants|0|0.0||||||
4037791|NCT01131065|3859398|B1||Between 18 and 65 years|Age|18 to 70 years of age (inclusive)|Participants|Count of Participants|15|15.0||||||
4037792|NCT01131065|3859398|B1||<=18 years|Age|18 to 70 years of age (inclusive)|Participants|Count of Participants|0|0.0||||||
4037793|NCT01131052|3859404|B3|United States||Region of Enrollment||participants|Number|150|150.0||||||
4037794|NCT01131052|3859405|B2|United States||Region of Enrollment||participants|Number|75|75.0||||||
4037795|NCT01131052|3859406|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
4037796|NCT01131052|3859404|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4037797|NCT01131052|3859405|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4037798|NCT01131052|3859406|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4037799|NCT01131052|3859404|B3||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4037800|NCT01131052|3859405|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4037801|NCT01131052|3859406|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4037802|NCT01131052|3859404|B3||>=65 years|Age||Participants|Count of Participants|145|145.0||||||
4037803|NCT01131052|3859405|B2||>=65 years|Age||Participants|Count of Participants|72|72.0||||||
4037804|NCT01131052|3859406|B1||>=65 years|Age||Participants|Count of Participants|73|73.0||||||
4037805|NCT01131052|3859404|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4037806|NCT01131052|3859405|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4037807|NCT01131052|3859406|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4037808|NCT01131052|3859404|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4037809|NCT01131052|3859405|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4037810|NCT01131052|3859406|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4037811|NCT01130974|3859427|B3|Asian Decent||Race/Ethnicity, Customized||participants|Number|200|200.0||||||
4037812|NCT01130974|3859428|B2|Asian Decent||Race/Ethnicity, Customized||participants|Number|100|100.0||||||
4037813|NCT01130974|3859429|B1|Asian Decent||Race/Ethnicity, Customized||participants|Number|100|100.0||||||
4037814|NCT01130974|3859427|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4037815|NCT01130974|3859428|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4037816|NCT01130974|3859429|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4037817|NCT01130974|3859427|B3||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4037818|NCT01130974|3859428|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4037819|NCT01130974|3859429|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4037820|NCT01130974|3859427|B3|Between 18 and 62 years||Age, Customized||participants|Number|200|200.0||||||
4037821|NCT01130974|3859428|B2|Between 18 and 62 years||Age, Customized||participants|Number|100|100.0||||||
4037822|NCT01130974|3859429|B1|Between 18 and 62 years||Age, Customized||participants|Number|100|100.0||||||
4037823|NCT01130896|3859450|B1|United States||Region of Enrollment||participants|Number|1509|1509.0||||||
4037824|NCT01130896|3859450|B1||Male|Sex: Female, Male||Participants|Count of Participants|961|961.0||||||
4037825|NCT01130896|3859450|B1||Female|Sex: Female, Male||Participants|Count of Participants|548|548.0||||||
4037826|NCT01130896|3859450|B1|||Age||years|Mean|69.3|69.3|Full Range|||57.7|78.1|
4037827|NCT01130883|3859456|B1|Czech Republic||Region of Enrollment||participants|Number|3130|3130.0||||||
4037828|NCT01130883|3859456|B1|||Sex/Gender, Customized|Gender was not reported in this study.|Participants|Number|3130|3130.0||||||
4037829|NCT01130883|3859456|B1|90 years of age and older||Age, Customized||participants|Number|7|7.0||||||
4037830|NCT01130883|3859456|B1|80 to 89 years of age||Age, Customized||participants|Number|92|92.0||||||
4037831|NCT01130883|3859456|B1|70 to 79 years of age||Age, Customized||participants|Number|305|305.0||||||
4037832|NCT01130883|3859456|B1|60 to 69 years of age||Age, Customized||participants|Number|630|630.0||||||
4037833|NCT01130883|3859456|B1|50 to 59 years of age||Age, Customized||participants|Number|680|680.0||||||
4037834|NCT01130883|3859456|B1|40 to 49 years of age||Age, Customized||participants|Number|589|589.0||||||
4037835|NCT01130883|3859456|B1|30 to 39 years of age||Age, Customized||participants|Number|544|544.0||||||
4037836|NCT01130883|3859456|B1|18 to 29 years of age||Age, Customized||participants|Number|281|281.0||||||
4037837|NCT01130883|3859456|B1|less than 18 years of age||Age, Customized||participants|Number|2|2.0||||||
4037838|NCT01130844|3859470|B4|Poland||Region of Enrollment||participants|Number|41|41.0||||||
4037839|NCT01130844|3859471|B3|Poland||Region of Enrollment||participants|Number|8|8.0||||||
4037840|NCT01130844|3859472|B2|Poland||Region of Enrollment||participants|Number|17|17.0||||||
4037841|NCT01130844|3859473|B1|Poland||Region of Enrollment||participants|Number|16|16.0||||||
4037842|NCT01130844|3859470|B4|Slovakia||Region of Enrollment||participants|Number|3|3.0||||||
4037843|NCT01130844|3859471|B3|Slovakia||Region of Enrollment||participants|Number|0|0.0||||||
4037844|NCT01130844|3859472|B2|Slovakia||Region of Enrollment||participants|Number|1|1.0||||||
4037845|NCT01130844|3859473|B1|Slovakia||Region of Enrollment||participants|Number|2|2.0||||||
4037846|NCT01130844|3859470|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
4037847|NCT01130844|3859471|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4037848|NCT01130844|3859472|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4037849|NCT01130844|3859473|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4037850|NCT01130844|3859470|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4037851|NCT01130844|3859471|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4037852|NCT01130844|3859472|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4037853|NCT01130844|3859473|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4037854|NCT01130844|3859470|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4037855|NCT01130844|3859471|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4037856|NCT01130844|3859472|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4037857|NCT01130844|3859473|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4037858|NCT01130844|3859470|B4|5 to 17 years, inclusive||Age, Customized||participants|Number|52|52.0||||||
4037859|NCT01130844|3859471|B3|5 to 17 years, inclusive||Age, Customized||participants|Number|9|9.0||||||
4037860|NCT01130844|3859472|B2|5 to 17 years, inclusive||Age, Customized||participants|Number|22|22.0||||||
4037861|NCT01130844|3859473|B1|5 to 17 years, inclusive||Age, Customized||participants|Number|21|21.0||||||
4037862|NCT01130844|3859470|B4|||Age||years|Mean|13.3|13.3|Standard Deviation|3.06|3.06|||
4037863|NCT01130844|3859471|B3|||Age||years|Mean|10.6|10.6|Standard Deviation|3.28|3.28|||
4037864|NCT01130844|3859472|B2|||Age||years|Mean|13.9|13.9|Standard Deviation|2.59|2.59|||
4037865|NCT01130844|3859473|B1|||Age||years|Mean|14.0|14.0|Standard Deviation|2.88|2.88|||
4037866|NCT01130831|3859513|B1|Germany||Region of Enrollment|All screened subjects|participants|Number|66|66.0||||||
4037867|NCT01130831|3859513|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4037868|NCT01130831|3859513|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4037869|NCT01130831|3859513|B1|>=18 years||Age, Customized||participants|Number|61|61.0||||||
4037870|NCT01130831|3859513|B1|||Age||years|Mean|66.0|66.0|Standard Deviation|12.5|12.5|||
4037871|NCT01130740|3859539|B3|||Patient Health Questionnaire 8 (PHQ-8)|8-item validated, self-report measure of depressive symptoms.|units on a scale|Mean|6.8|6.8|Standard Deviation|5.36|5.36|||
4037872|NCT01130740|3859540|B2|||Patient Health Questionnaire 8 (PHQ-8)|8-item validated, self-report measure of depressive symptoms.|units on a scale|Mean|7.2|7.2|Standard Deviation|5.57|5.57|||
4037873|NCT01130740|3859541|B1|||Patient Health Questionnaire 8 (PHQ-8)|8-item validated, self-report measure of depressive symptoms.|units on a scale|Mean|6.4|6.4|Standard Deviation|5.13|5.13|||
4037874|NCT01130740|3859539|B3|||Short Performance Physical Test|Objective functional tests, including an 8-foot timed walk, chair stands, and a series of three balance tests.|units on a scale|Mean|8.0|8.0|Standard Deviation|2.6|2.6|||
4037875|NCT01130740|3859540|B2|||Short Performance Physical Test|Objective functional tests, including an 8-foot timed walk, chair stands, and a series of three balance tests.|units on a scale|Mean|8.0|8.0|Standard Deviation|2.63|2.63|||
4037876|NCT01130740|3859541|B1|||Short Performance Physical Test|Objective functional tests, including an 8-foot timed walk, chair stands, and a series of three balance tests.|units on a scale|Mean|8.1|8.1|Standard Deviation|2.48|2.48|||
4037877|NCT01130740|3859539|B3|||Western Ontario and McMasters Universities Osteoarthritis Index (WOMAC)|The WOMAC includes 24 items, each measured on a Likert Scale of 0-4, with a range of 0-96 and higher scores indicating worse symptoms. There are 3 subscales that make up the total scale:pain (5 items), stiffness (2 items) and function (17 items).|units on a scale|Mean|48.4|48.4|Standard Deviation|17.5|17.5|||
4037878|NCT01130740|3859540|B2|||Western Ontario and McMasters Universities Osteoarthritis Index (WOMAC)|The WOMAC includes 24 items, each measured on a Likert Scale of 0-4, with a range of 0-96 and higher scores indicating worse symptoms. There are 3 subscales that make up the total scale:pain (5 items), stiffness (2 items) and function (17 items).|units on a scale|Mean|48.9|48.9|Standard Deviation|17.6|17.6|||
4037879|NCT01130740|3859541|B1|||Western Ontario and McMasters Universities Osteoarthritis Index (WOMAC)|The WOMAC includes 24 items, each measured on a Likert Scale of 0-4, with a range of 0-96 and higher scores indicating worse symptoms. There are 3 subscales that make up the total scale:pain (5 items), stiffness (2 items) and function (17 items).|units on a scale|Mean|47.8|47.8|Standard Deviation|17.4|17.4|||
4037880|NCT01130740|3859539|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4037881|NCT01130740|3859540|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4037882|NCT01130740|3859541|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4037883|NCT01130740|3859539|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4037884|NCT01130740|3859540|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4037885|NCT01130740|3859541|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4037886|NCT01130740|3859539|B3||White|Race (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
4037887|NCT01130740|3859540|B2||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4037888|NCT01130740|3859541|B1||White|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
4037889|NCT01130740|3859539|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
4037890|NCT01130740|3859540|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
4037891|NCT01130740|3859541|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4037892|NCT01130740|3859539|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037893|NCT01130740|3859540|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037894|NCT01130740|3859541|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037895|NCT01130740|3859539|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037896|NCT01130740|3859540|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037897|NCT01130740|3859541|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037898|NCT01130740|3859539|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4037899|NCT01130740|3859540|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4037900|NCT01130740|3859541|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4037901|NCT01130740|3859539|B3||Male|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
4037902|NCT01130740|3859540|B2||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4037903|NCT01130740|3859541|B1||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4037904|NCT01130740|3859539|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4037905|NCT01130740|3859540|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4037906|NCT01130740|3859541|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4037907|NCT01130740|3859539|B3|||Age||years|Mean|61.1|61.1|Standard Deviation|9.2|9.2|||
4037908|NCT01130740|3859540|B2|||Age||years|Mean|60.4|60.4|Standard Deviation|9.4|9.4|||
4037909|NCT01130740|3859541|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|9.0|9.0|||
4037910|NCT01130597|3859552|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4037911|NCT01130597|3859552|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4037912|NCT01130597|3859552|B1|||Age||years|Mean|70.8|70.8|Full Range|||53.0|86.0|
4037913|NCT01130597|3859552|B1||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
4037914|NCT01130597|3859552|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4037915|NCT01130597|3859552|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4037916|NCT01130532|3859574|B4|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
4037917|NCT01130532|3859575|B3|Puerto Rico||Region of Enrollment||participants|Number|0|0.0||||||
4037918|NCT01130532|3859576|B2|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
4037919|NCT01130532|3859577|B1|Puerto Rico||Region of Enrollment||participants|Number|0|0.0||||||
4037920|NCT01130532|3859574|B4|Canada||Region of Enrollment||participants|Number|37|37.0||||||
4037921|NCT01130532|3859575|B3|Canada||Region of Enrollment||participants|Number|18|18.0||||||
4037922|NCT01130532|3859576|B2|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4037923|NCT01130532|3859577|B1|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4037924|NCT01130532|3859574|B4|United States||Region of Enrollment||participants|Number|585|585.0||||||
4037925|NCT01130532|3859575|B3|United States||Region of Enrollment||participants|Number|191|191.0||||||
4037926|NCT01130532|3859576|B2|United States||Region of Enrollment||participants|Number|195|195.0||||||
4037927|NCT01130532|3859577|B1|United States||Region of Enrollment||participants|Number|199|199.0||||||
4037928|NCT01130532|3859574|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4037929|NCT01130532|3859575|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037930|NCT01130532|3859576|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4037931|NCT01130532|3859577|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037932|NCT01130532|3859574|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4037933|NCT01130532|3859575|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4037934|NCT01130532|3859576|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4037935|NCT01130532|3859577|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4037936|NCT01130532|3859574|B4||White|Race (NIH/OMB)||Participants|Count of Participants|517|517.0||||||
4037937|NCT01130532|3859575|B3||White|Race (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
4037938|NCT01130532|3859576|B2||White|Race (NIH/OMB)||Participants|Count of Participants|177|177.0||||||
4037939|NCT01130532|3859577|B1||White|Race (NIH/OMB)||Participants|Count of Participants|173|173.0||||||
4037940|NCT01130532|3859574|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
4037941|NCT01130532|3859575|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4037942|NCT01130532|3859576|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4037943|NCT01130532|3859577|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4037944|NCT01130532|3859574|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4037945|NCT01130532|3859575|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4037946|NCT01130532|3859576|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037947|NCT01130532|3859577|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037948|NCT01130532|3859574|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4037949|NCT01130532|3859575|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4037950|NCT01130532|3859576|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4037951|NCT01130532|3859577|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4037952|NCT01130532|3859574|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4037953|NCT01130532|3859575|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037954|NCT01130532|3859576|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4037955|NCT01130532|3859577|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037956|NCT01130532|3859574|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037957|NCT01130532|3859575|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037958|NCT01130532|3859576|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037959|NCT01130532|3859577|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037960|NCT01130532|3859574|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|596|596.0||||||
4037961|NCT01130532|3859575|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|200|200.0||||||
4037962|NCT01130532|3859576|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|197|197.0||||||
4037963|NCT01130532|3859577|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|199|199.0||||||
4037964|NCT01130532|3859574|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4037965|NCT01130532|3859575|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4037966|NCT01130532|3859576|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4037967|NCT01130532|3859577|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4037968|NCT01130532|3859574|B4||Male|Sex: Female, Male||Participants|Count of Participants|623|623.0||||||
4037969|NCT01130532|3859575|B3||Male|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4037970|NCT01130532|3859576|B2||Male|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4037971|NCT01130532|3859577|B1||Male|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4037972|NCT01130532|3859574|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4037973|NCT01130532|3859575|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4037974|NCT01130532|3859576|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4037975|NCT01130532|3859577|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4037976|NCT01130532|3859574|B4|||Age||years|Mean|57.6|57.6|Standard Deviation|10.39|10.39|||
4037977|NCT01130532|3859575|B3|||Age||years|Mean|57.6|57.6|Standard Deviation|10.17|10.17|||
4037978|NCT01130532|3859576|B2|||Age||years|Mean|58.1|58.1|Standard Deviation|10.36|10.36|||
4037979|NCT01130532|3859577|B1|||Age||years|Mean|57.3|57.3|Standard Deviation|10.68|10.68|||
4037980|NCT01130493|3859625|B1|Germany||Region of Enrollment||participants|Number|21|21.0||||||
4037981|NCT01130493|3859625|B1|Italy||Region of Enrollment||participants|Number|26|26.0||||||
4037982|NCT01130493|3859625|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4037983|NCT01130493|3859625|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4037984|NCT01130493|3859625|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037985|NCT01130493|3859625|B1||White|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
4037986|NCT01130493|3859625|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037987|NCT01130493|3859625|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037988|NCT01130493|3859625|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037989|NCT01130493|3859625|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4037990|NCT01130493|3859625|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4037991|NCT01130493|3859625|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
4037992|NCT01130493|3859625|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4037993|NCT01130493|3859625|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4037994|NCT01130493|3859625|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4037995|NCT01130493|3859625|B1|||Age||years|Mean|64.1|64.1|Standard Deviation|9.34|9.34|||
4037996|NCT01130493|3859625|B1||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
4037997|NCT01130493|3859625|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4037998|NCT01130493|3859625|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4037999|NCT01130337|3859644|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4038000|NCT01130337|3859644|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4038001|NCT01130337|3859644|B1|||Age||years|Mean|63.44|63.44|Standard Deviation|10.42|10.42|||
4038002|NCT01130168|3859651|B1||Male|Sex: Female, Male|Gender data were not reported for 5 participants who were excluded from analysis.|Participants|Count of Participants|22|22.0||||||
4038003|NCT01130168|3859651|B1||Female|Sex: Female, Male|Gender data were not reported for 5 participants who were excluded from analysis.|Participants|Count of Participants|11|11.0||||||
4038004|NCT01130168|3859651|B1|||Age|Age data were not reported for 5 participants who were excluded from analysis.|years|Mean|49|49.0|Standard Deviation|7.05|7.05|||
4038005|NCT01130103|3859691|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
4038006|NCT01130103|3859692|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4038007|NCT01130103|3859693|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4038008|NCT01130103|3859691|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4038009|NCT01130103|3859692|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4038010|NCT01130103|3859693|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4038011|NCT01130103|3859691|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4038012|NCT01130103|3859692|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4038013|NCT01130103|3859693|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4038014|NCT01130103|3859691|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4038015|NCT01130103|3859692|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4038016|NCT01130103|3859693|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4038017|NCT01130103|3859691|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4038018|NCT01130103|3859692|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4038019|NCT01130103|3859693|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4038020|NCT01130103|3859691|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038021|NCT01130103|3859692|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038022|NCT01130103|3859693|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038023|NCT01130051|3859708|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4038024|NCT01130051|3859708|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4038025|NCT01130051|3859708|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038026|NCT01130051|3859708|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4038027|NCT01130051|3859708|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4038028|NCT01130051|3859708|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038029|NCT01130051|3859708|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038030|NCT01130051|3859708|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038031|NCT01130051|3859708|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038032|NCT01130051|3859708|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4038033|NCT01130051|3859708|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4038034|NCT01130051|3859708|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4038035|NCT01130051|3859708|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4038036|NCT01130051|3859708|B1|||Age||years|Mean|37.812|37.812|Standard Deviation|13.332|13.332|||
4038037|NCT01130051|3859708|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4038038|NCT01130051|3859708|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4038039|NCT01130051|3859708|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038040|NCT01129960|3859719|B5|Other||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4038041|NCT01129960|3859720|B4|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4038042|NCT01129960|3859721|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4038043|NCT01129960|3859722|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4038044|NCT01129960|3859723|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4038045|NCT01129960|3859719|B5|Asian||Race/Ethnicity, Customized||participants|Number|103|103.0||||||
4038046|NCT01129960|3859720|B4|Asian||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4038047|NCT01129960|3859721|B3|Asian||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4038048|NCT01129960|3859722|B2|Asian||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4038049|NCT01129960|3859723|B1|Asian||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4038050|NCT01129960|3859719|B5|Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4038051|NCT01129960|3859720|B4|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4038052|NCT01129960|3859721|B3|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4038053|NCT01129960|3859722|B2|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4038054|NCT01129960|3859723|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4038055|NCT01129960|3859719|B5|White||Race/Ethnicity, Customized||participants|Number|210|210.0||||||
4038056|NCT01129960|3859720|B4|White||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
4038057|NCT01129960|3859721|B3|White||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
4038058|NCT01129960|3859722|B2|White||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
4038059|NCT01129960|3859723|B1|White||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
4038060|NCT01129960|3859719|B5||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4038061|NCT01129960|3859720|B4||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4038062|NCT01129960|3859721|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4038063|NCT01129960|3859722|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4038064|NCT01129960|3859723|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4038065|NCT01129960|3859719|B5||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4038066|NCT01129960|3859720|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4038067|NCT01129960|3859721|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4038068|NCT01129960|3859722|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4038069|NCT01129960|3859723|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4038070|NCT01129960|3859719|B5|||Age||years|Mean|58.5|58.5|Standard Deviation|11.51|11.51|||
4038071|NCT01129960|3859720|B4|||Age||years|Mean|59.5|59.5|Standard Deviation|10.25|10.25|||
4038072|NCT01129960|3859721|B3|||Age||years|Mean|58.0|58.0|Standard Deviation|13.33|13.33|||
4038073|NCT01129960|3859722|B2|||Age||years|Mean|59.0|59.0|Standard Deviation|11.38|11.38|||
4038074|NCT01129960|3859723|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|10.93|10.93|||
4038075|NCT01129921|3859736|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4038076|NCT01129921|3859737|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4038077|NCT01129921|3859738|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4038078|NCT01129921|3859736|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4038079|NCT01129921|3859737|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4038080|NCT01129921|3859738|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4038081|NCT01129921|3859736|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4038082|NCT01129921|3859737|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4038083|NCT01129921|3859738|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4038084|NCT01129921|3859736|B3|||Age||years|Mean|66.6|66.6|Standard Deviation|11.5|11.5|||
4038085|NCT01129921|3859737|B2|||Age||years|Mean|67|67.0|Standard Deviation|12.5|12.5|||
4038086|NCT01129921|3859738|B1|||Age||years|Mean|66.3|66.3|Standard Deviation|10.8|10.8|||
4038087|NCT01129921|3859736|B3||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4038088|NCT01129921|3859737|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4038089|NCT01129921|3859738|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4038090|NCT01129921|3859736|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4038091|NCT01129921|3859737|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4038092|NCT01129921|3859738|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4038093|NCT01129921|3859736|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038094|NCT01129921|3859737|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038095|NCT01129921|3859738|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038096|NCT01129778|3859749|B1|||Mean RDQ heartburn score|The RDQ is a 12 item survey that asks the patient to rate the frequency and severity of GERD symptoms. Each item is scored from 0 to 5 where a score of 0 is equivalent to an asymptomatic state and 5 indicates the worst severity of GERD symptoms. The total RDQ is a sum of all 12 items, and can range from 0 to 60.|units on a scale|Mean|10|10.0|Standard Deviation|6|6.0|||
4038097|NCT01129778|3859749|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4038098|NCT01129778|3859749|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4038099|NCT01129778|3859749|B1|||Age||years|Mean|61|61.0|Standard Deviation|10|10.0|||
4038100|NCT01129765|3859754|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4038101|NCT01129765|3859754|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4038102|NCT01129765|3859754|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4038103|NCT01129765|3859754|B1|||Age||years|Mean|0.75|0.75|Standard Deviation|0.25|0.25|||
4038104|NCT01129765|3859754|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4038105|NCT01129765|3859754|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4038106|NCT01129765|3859754|B1||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4038107|NCT01129622|3859763|B1|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4038108|NCT01129622|3859763|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4038109|NCT01129622|3859763|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4038110|NCT01129622|3859763|B1|||Age||years|Mean|60|60.0|Standard Deviation|11|11.0|||
4038111|NCT01129622|3859763|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4038112|NCT01129622|3859763|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4038113|NCT01129622|3859763|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038114|NCT01129583|3859768|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4038115|NCT01129583|3859769|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4038116|NCT01129583|3859770|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4038117|NCT01129583|3859768|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4038118|NCT01129583|3859769|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4038119|NCT01129583|3859770|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4038120|NCT01129583|3859768|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4038121|NCT01129583|3859769|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4038122|NCT01129583|3859770|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4038123|NCT01129583|3859768|B3|||Age||years|Mean|49|49.0|Standard Deviation|17|17.0|||
4038124|NCT01129583|3859769|B2|||Age||years|Mean|45|45.0|Standard Deviation|21|21.0|||
4038125|NCT01129583|3859770|B1|||Age||years|Mean|52|52.0|Standard Deviation|13|13.0|||
4038126|NCT01129583|3859768|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4038127|NCT01129583|3859769|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4038128|NCT01129583|3859770|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4038129|NCT01129583|3859768|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4038130|NCT01129583|3859769|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4038131|NCT01129583|3859770|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4038132|NCT01129583|3859768|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038133|NCT01129583|3859769|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038134|NCT01129583|3859770|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038135|NCT01129557|3859781|B4|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4038136|NCT01129557|3859782|B3|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4038137|NCT01129557|3859783|B2|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4038138|NCT01129557|3859784|B1|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4038139|NCT01129557|3859781|B4|More than one race||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4038140|NCT01129557|3859782|B3|More than one race||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4038141|NCT01129557|3859783|B2|More than one race||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4038142|NCT01129557|3859784|B1|More than one race||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4038143|NCT01129557|3859781|B4|White||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
4038144|NCT01129557|3859782|B3|White||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4038145|NCT01129557|3859783|B2|White||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4038146|NCT01129557|3859784|B1|White||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4038147|NCT01129557|3859781|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4038148|NCT01129557|3859782|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4038149|NCT01129557|3859783|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4038150|NCT01129557|3859784|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4038151|NCT01129557|3859781|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4038152|NCT01129557|3859782|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4038153|NCT01129557|3859783|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4038154|NCT01129557|3859784|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4038155|NCT01129557|3859781|B4|Asian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4038156|NCT01129557|3859782|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4038157|NCT01129557|3859783|B2|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4038158|NCT01129557|3859784|B1|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4038159|NCT01129557|3859781|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4038160|NCT01129557|3859782|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4038161|NCT01129557|3859783|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4038162|NCT01129557|3859784|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4038163|NCT01129557|3859781|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4038164|NCT01129557|3859782|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4038165|NCT01129557|3859783|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4038166|NCT01129557|3859784|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4038167|NCT01129557|3859781|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4038168|NCT01129557|3859782|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4038169|NCT01129557|3859783|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4038170|NCT01129557|3859784|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4038171|NCT01129557|3859781|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4038172|NCT01129557|3859782|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4038173|NCT01129557|3859783|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4038174|NCT01129557|3859784|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4038175|NCT01129557|3859781|B4||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4038176|NCT01129557|3859782|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4038177|NCT01129557|3859783|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4038178|NCT01129557|3859784|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4038179|NCT01129557|3859781|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038180|NCT01129557|3859782|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038181|NCT01129557|3859783|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038182|NCT01129557|3859784|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038183|NCT01129531|3859854|B4||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4038184|NCT01129531|3859855|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4038185|NCT01129531|3859856|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4038186|NCT01129531|3859857|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4038187|NCT01129531|3859854|B4||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4038188|NCT01129531|3859855|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4038189|NCT01129531|3859856|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4038190|NCT01129531|3859857|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4038191|NCT01129531|3859854|B4|≥ 75 Years||Age, Customized||Participants|Number|71|71.0||||||
4038192|NCT01129531|3859855|B3|≥ 75 Years||Age, Customized||Participants|Number|29|29.0||||||
4038193|NCT01129531|3859856|B2|≥ 75 Years||Age, Customized||Participants|Number|20|20.0||||||
4038194|NCT01129531|3859857|B1|≥ 75 Years||Age, Customized||Participants|Number|22|22.0||||||
4038195|NCT01129531|3859854|B4|65 to < 75 Years||Age, Customized||Participants|Number|132|132.0||||||
4038196|NCT01129531|3859855|B3|65 to < 75 Years||Age, Customized||Participants|Number|57|57.0||||||
4038197|NCT01129531|3859856|B2|65 to < 75 Years||Age, Customized||Participants|Number|33|33.0||||||
4038198|NCT01129531|3859857|B1|65 to < 75 Years||Age, Customized||Participants|Number|42|42.0||||||
4038199|NCT01129531|3859854|B4|40 to < 65 Years||Age, Customized||Participants|Number|85|85.0||||||
4038200|NCT01129531|3859855|B3|40 to < 65 Years||Age, Customized||Participants|Number|38|38.0||||||
4038201|NCT01129531|3859856|B2|40 to < 65 Years||Age, Customized||Participants|Number|29|29.0||||||
4038202|NCT01129531|3859857|B1|40 to < 65 Years||Age, Customized||Participants|Number|18|18.0||||||
4038203|NCT01129531|3859854|B4|18 to < 40 Years||Age, Customized||Participants|Number|6|6.0||||||
4038204|NCT01129531|3859855|B3|18 to < 40 Years||Age, Customized||Participants|Number|2|2.0||||||
4038205|NCT01129531|3859856|B2|18 to < 40 Years||Age, Customized||Participants|Number|2|2.0||||||
4038206|NCT01129531|3859857|B1|18 to < 40 Years||Age, Customized||Participants|Number|2|2.0||||||
4038207|NCT01129336|3859879|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4038208|NCT01129336|3859880|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4038209|NCT01129336|3859881|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4038210|NCT01129336|3859879|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4038211|NCT01129336|3859880|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4038212|NCT01129336|3859881|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4038213|NCT01129336|3859879|B3|||Age||Years|Mean|57.43|57.43|Standard Deviation|13.965|13.965|||
4038214|NCT01129336|3859880|B2|||Age||Years|Mean|59.47|59.47|Standard Deviation|14.535|14.535|||
4038215|NCT01129336|3859881|B1|||Age||Years|Mean|53.48|53.48|Standard Deviation|12.293|12.293|||
4038216|NCT01129284|3859894|B4|Preserved function: eGFR>60 ml/min/1.73m2||Renal Function||Participants|Number|2|2.0||||||
4038217|NCT01129284|3859895|B3|Preserved function: eGFR>60 ml/min/1.73m2||Renal Function||Participants|Number|2|2.0||||||
4038218|NCT01129284|3859896|B2|Preserved function: eGFR>60 ml/min/1.73m2||Renal Function||Participants|Number|0|0.0||||||
4038219|NCT01129284|3859897|B1|Preserved function: eGFR>60 ml/min/1.73m2||Renal Function||Participants|Number|0|0.0||||||
4038220|NCT01129284|3859894|B4|Preserved function: sCr range 0.6-1.2 mg/dl||Renal Function||Participants|Number|5|5.0||||||
4038221|NCT01129284|3859895|B3|Preserved function: sCr range 0.6-1.2 mg/dl||Renal Function||Participants|Number|0|0.0||||||
4038222|NCT01129284|3859896|B2|Preserved function: sCr range 0.6-1.2 mg/dl||Renal Function||Participants|Number|5|5.0||||||
4038223|NCT01129284|3859897|B1|Preserved function: sCr range 0.6-1.2 mg/dl||Renal Function||Participants|Number|0|0.0||||||
4038224|NCT01129284|3859894|B4|Impaired function: sCr range 1.6-2.9 mg/dl||Renal Function||Participants|Number|8|8.0||||||
4038225|NCT01129284|3859895|B3|Impaired function: sCr range 1.6-2.9 mg/dl||Renal Function||Participants|Number|3|3.0||||||
4038226|NCT01129284|3859896|B2|Impaired function: sCr range 1.6-2.9 mg/dl||Renal Function||Participants|Number|0|0.0||||||
4038227|NCT01129284|3859897|B1|Impaired function: sCr range 1.6-2.9 mg/dl||Renal Function||Participants|Number|5|5.0||||||
4038228|NCT01129284|3859894|B4|none||Previous Immunosuppressive therapy||participants|Number|2|2.0||||||
4038229|NCT01129284|3859895|B3|none||Previous Immunosuppressive therapy||participants|Number|2|2.0||||||
4038230|NCT01129284|3859896|B2|none||Previous Immunosuppressive therapy||participants|Number|0|0.0||||||
4038231|NCT01129284|3859897|B1|none||Previous Immunosuppressive therapy||participants|Number|0|0.0||||||
4038232|NCT01129284|3859894|B4|MMF, tacrolimus, cyclosporine, rituximab||Previous Immunosuppressive therapy||participants|Number|1|1.0||||||
4038233|NCT01129284|3859895|B3|MMF, tacrolimus, cyclosporine, rituximab||Previous Immunosuppressive therapy||participants|Number|0|0.0||||||
4038234|NCT01129284|3859896|B2|MMF, tacrolimus, cyclosporine, rituximab||Previous Immunosuppressive therapy||participants|Number|0|0.0||||||
4038235|NCT01129284|3859897|B1|MMF, tacrolimus, cyclosporine, rituximab||Previous Immunosuppressive therapy||participants|Number|1|1.0||||||
4038236|NCT01129284|3859894|B4|MMF, cyclophosphamide||Previous Immunosuppressive therapy||participants|Number|1|1.0||||||
4038237|NCT01129284|3859895|B3|MMF, cyclophosphamide||Previous Immunosuppressive therapy||participants|Number|0|0.0||||||
4038238|NCT01129284|3859896|B2|MMF, cyclophosphamide||Previous Immunosuppressive therapy||participants|Number|0|0.0||||||
4038239|NCT01129284|3859897|B1|MMF, cyclophosphamide||Previous Immunosuppressive therapy||participants|Number|1|1.0||||||
4038240|NCT01129284|3859894|B4|cyclosporine, MMF||Previous Immunosuppressive therapy||participants|Number|1|1.0||||||
4038241|NCT01129284|3859895|B3|cyclosporine, MMF||Previous Immunosuppressive therapy||participants|Number|0|0.0||||||
4038242|NCT01129284|3859896|B2|cyclosporine, MMF||Previous Immunosuppressive therapy||participants|Number|0|0.0||||||
4038243|NCT01129284|3859897|B1|cyclosporine, MMF||Previous Immunosuppressive therapy||participants|Number|1|1.0||||||
4038244|NCT01129284|3859894|B4|steroids, tacrolimus, cyclosporine, MMF||Previous Immunosuppressive therapy||participants|Number|1|1.0||||||
4038245|NCT01129284|3859895|B3|steroids, tacrolimus, cyclosporine, MMF||Previous Immunosuppressive therapy||participants|Number|0|0.0||||||
4038246|NCT01129284|3859896|B2|steroids, tacrolimus, cyclosporine, MMF||Previous Immunosuppressive therapy||participants|Number|1|1.0||||||
4038247|NCT01129284|3859897|B1|steroids, tacrolimus, cyclosporine, MMF||Previous Immunosuppressive therapy||participants|Number|0|0.0||||||
4038248|NCT01129284|3859894|B4|steroids, tacrolimus||Previous Immunosuppressive therapy||participants|Number|1|1.0||||||
4038249|NCT01129284|3859895|B3|steroids, tacrolimus||Previous Immunosuppressive therapy||participants|Number|0|0.0||||||
4038250|NCT01129284|3859896|B2|steroids, tacrolimus||Previous Immunosuppressive therapy||participants|Number|1|1.0||||||
4038251|NCT01129284|3859897|B1|steroids, tacrolimus||Previous Immunosuppressive therapy||participants|Number|0|0.0||||||
4038252|NCT01129284|3859894|B4|steroids, MMF, cyclophosphamide||Previous Immunosuppressive therapy||participants|Number|1|1.0||||||
4038253|NCT01129284|3859895|B3|steroids, MMF, cyclophosphamide||Previous Immunosuppressive therapy||participants|Number|0|0.0||||||
4038254|NCT01129284|3859896|B2|steroids, MMF, cyclophosphamide||Previous Immunosuppressive therapy||participants|Number|0|0.0||||||
4038255|NCT01129284|3859897|B1|steroids, MMF, cyclophosphamide||Previous Immunosuppressive therapy||participants|Number|1|1.0||||||
4038256|NCT01129284|3859894|B4|steroids, MMF||Previous Immunosuppressive therapy||participants|Number|1|1.0||||||
4038257|NCT01129284|3859895|B3|steroids, MMF||Previous Immunosuppressive therapy||participants|Number|1|1.0||||||
4038258|NCT01129284|3859896|B2|steroids, MMF||Previous Immunosuppressive therapy||participants|Number|0|0.0||||||
4038259|NCT01129284|3859897|B1|steroids, MMF||Previous Immunosuppressive therapy||participants|Number|0|0.0||||||
4038260|NCT01129284|3859894|B4|steroids, cyclosporine, tacrolimus||Previous Immunosuppressive therapy||participants|Number|2|2.0||||||
4038261|NCT01129284|3859895|B3|steroids, cyclosporine, tacrolimus||Previous Immunosuppressive therapy||participants|Number|0|0.0||||||
4038262|NCT01129284|3859896|B2|steroids, cyclosporine, tacrolimus||Previous Immunosuppressive therapy||participants|Number|1|1.0||||||
4038263|NCT01129284|3859897|B1|steroids, cyclosporine, tacrolimus||Previous Immunosuppressive therapy||participants|Number|1|1.0||||||
4038264|NCT01129284|3859894|B4|steroids, cyclosporine, MMF||Previous Immunosuppressive therapy||participants|Number|1|1.0||||||
4038265|NCT01129284|3859895|B3|steroids, cyclosporine, MMF||Previous Immunosuppressive therapy||participants|Number|0|0.0||||||
4038266|NCT01129284|3859896|B2|steroids, cyclosporine, MMF||Previous Immunosuppressive therapy||participants|Number|1|1.0||||||
4038267|NCT01129284|3859897|B1|steroids, cyclosporine, MMF||Previous Immunosuppressive therapy||participants|Number|0|0.0||||||
4038268|NCT01129284|3859894|B4|steroids, cyclosporine||Previous Immunosuppressive therapy||participants|Number|1|1.0||||||
4038269|NCT01129284|3859895|B3|steroids, cyclosporine||Previous Immunosuppressive therapy||participants|Number|0|0.0||||||
4038270|NCT01129284|3859896|B2|steroids, cyclosporine||Previous Immunosuppressive therapy||participants|Number|1|1.0||||||
4038271|NCT01129284|3859897|B1|steroids, cyclosporine||Previous Immunosuppressive therapy||participants|Number|0|0.0||||||
4038272|NCT01129284|3859894|B4|steroids||Previous Immunosuppressive therapy||participants|Number|2|2.0||||||
4038273|NCT01129284|3859895|B3|steroids||Previous Immunosuppressive therapy||participants|Number|2|2.0||||||
4038274|NCT01129284|3859896|B2|steroids||Previous Immunosuppressive therapy||participants|Number|0|0.0||||||
4038275|NCT01129284|3859897|B1|steroids||Previous Immunosuppressive therapy||participants|Number|0|0.0||||||
4038276|NCT01129284|3859894|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4038277|NCT01129284|3859895|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4038278|NCT01129284|3859896|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4038279|NCT01129284|3859897|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4038280|NCT01129284|3859894|B4|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4038281|NCT01129284|3859895|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4038282|NCT01129284|3859896|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4038283|NCT01129284|3859897|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4038284|NCT01129284|3859894|B4|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4038285|NCT01129284|3859895|B3|African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4038286|NCT01129284|3859896|B2|African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4038287|NCT01129284|3859897|B1|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4038288|NCT01129284|3859894|B4|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4038289|NCT01129284|3859895|B3|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4038290|NCT01129284|3859896|B2|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4038291|NCT01129284|3859897|B1|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4038292|NCT01129284|3859894|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4038293|NCT01129284|3859895|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4038294|NCT01129284|3859896|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4038295|NCT01129284|3859897|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4038296|NCT01129284|3859894|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4038297|NCT01129284|3859895|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4038298|NCT01129284|3859896|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4038299|NCT01129284|3859897|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4038300|NCT01129284|3859894|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4038301|NCT01129284|3859895|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4038302|NCT01129284|3859896|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4038303|NCT01129284|3859897|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4038304|NCT01129284|3859894|B4||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4038305|NCT01129284|3859895|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4038306|NCT01129284|3859896|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4038307|NCT01129284|3859897|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4038308|NCT01129284|3859894|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038309|NCT01129284|3859895|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038310|NCT01129284|3859896|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038311|NCT01129284|3859897|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038312|NCT01129245|3859910|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4038313|NCT01129245|3859911|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4038314|NCT01129245|3859912|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4038315|NCT01129245|3859910|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4038316|NCT01129245|3859911|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4038317|NCT01129245|3859912|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4038318|NCT01129245|3859910|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4038319|NCT01129245|3859911|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4038320|NCT01129245|3859912|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4038321|NCT01129245|3859910|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4038322|NCT01129245|3859911|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4038323|NCT01129245|3859912|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4038324|NCT01129245|3859910|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4038325|NCT01129245|3859911|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4038326|NCT01129245|3859912|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4038327|NCT01129245|3859910|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038328|NCT01129245|3859911|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038329|NCT01129245|3859912|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038330|NCT01129245|3859910|B3|||Age||years|Mean|27.8|27.8|Full Range|||18.0|35.0|
4038331|NCT01129245|3859911|B2|||Age||years|Mean|28.8|28.8|Full Range|||18.0|35.0|
4038332|NCT01129245|3859912|B1|||Age||years|Mean|27.3|27.3|Full Range|||18.0|35.0|
4038333|NCT01129206|3859919|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4038334|NCT01129206|3859919|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4038335|NCT01129206|3859919|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4038336|NCT01129206|3859919|B1|||Age||years|Median|63.5|63.5|Full Range|||55.0|73.0|
4038337|NCT01129141|3859927|B3|United States||Region of Enrollment||Participants|Count of Participants|205|205.0||||||
4038338|NCT01129141|3859928|B2|United States||Region of Enrollment||Participants|Count of Participants|104|104.0||||||
4038339|NCT01129141|3859929|B1|United States||Region of Enrollment||Participants|Count of Participants|101|101.0||||||
4038340|NCT01129141|3859927|B3||Male|Gender||Participants|Count of Participants|175|175.0||||||
4038341|NCT01129141|3859928|B2||Male|Gender||Participants|Count of Participants|88|88.0||||||
4038342|NCT01129141|3859929|B1||Male|Gender||Participants|Count of Participants|87|87.0||||||
4038343|NCT01129141|3859927|B3||Female|Gender||Participants|Count of Participants|30|30.0||||||
4038344|NCT01129141|3859928|B2||Female|Gender||Participants|Count of Participants|16|16.0||||||
4038345|NCT01129141|3859929|B1||Female|Gender||Participants|Count of Participants|14|14.0||||||
4038346|NCT01129141|3859927|B3|||Age||years|Mean|59.07|59.07|Standard Deviation|10.49|10.49|||
4038347|NCT01129141|3859928|B2|||Age||years|Mean|57.92|57.92|Standard Deviation|10.71|10.71|||
4038348|NCT01129141|3859929|B1|||Age||years|Mean|60.24|60.24|Standard Deviation|10.18|10.18|||
4038349|NCT01129141|3859927|B3||>=65 years|Age||Participants|Count of Participants|67|67.0||||||
4038350|NCT01129141|3859928|B2||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4038351|NCT01129141|3859929|B1||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4038352|NCT01129141|3859927|B3||Between 18 and 65 years|Age||Participants|Count of Participants|138|138.0||||||
4038353|NCT01129141|3859928|B2||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4038354|NCT01129141|3859929|B1||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4038355|NCT01129141|3859927|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038356|NCT01129141|3859928|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038357|NCT01129141|3859929|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038358|NCT01129128|3859936|B4|United States||Region of Enrollment||participants|Number|67|67.0||||||
4038359|NCT01129128|3859937|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4038360|NCT01129128|3859938|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4038361|NCT01129128|3859939|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4038362|NCT01129128|3859936|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4038363|NCT01129128|3859937|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4038364|NCT01129128|3859938|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4038365|NCT01129128|3859939|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4038366|NCT01129128|3859936|B4||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4038367|NCT01129128|3859937|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4038368|NCT01129128|3859938|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4038369|NCT01129128|3859939|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4038370|NCT01129128|3859936|B4|||Age||years|Mean|32.4|32.4|Standard Deviation|13.1|13.1|||
4038371|NCT01129128|3859937|B3|||Age||years|Mean|28.2|28.2|Standard Deviation|8.0|8.0|||
4038372|NCT01129128|3859938|B2|||Age||years|Mean|35.1|35.1|Standard Deviation|13.5|13.5|||
4038373|NCT01129128|3859939|B1|||Age||years|Mean|34.1|34.1|Standard Deviation|10.6|10.6|||
4038374|NCT01129128|3859936|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4038375|NCT01129128|3859937|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4038376|NCT01129128|3859938|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4038377|NCT01129128|3859939|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4038378|NCT01129128|3859936|B4||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
4038379|NCT01129128|3859937|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4038380|NCT01129128|3859938|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4038381|NCT01129128|3859939|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4038382|NCT01129128|3859936|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038383|NCT01129128|3859937|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038384|NCT01129128|3859938|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038385|NCT01129128|3859939|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038386|NCT01129115|3859961|B5||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4038387|NCT01129115|3859962|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4038388|NCT01129115|3859963|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4038389|NCT01129115|3859964|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4038390|NCT01129115|3859965|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4038391|NCT01129115|3859961|B5||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4038392|NCT01129115|3859962|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4038393|NCT01129115|3859963|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4038394|NCT01129115|3859964|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4038395|NCT01129115|3859965|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4038396|NCT01129115|3859961|B5|||Age||years|Mean|72.9|72.9|Standard Deviation|5.6|5.6|||
4038397|NCT01129115|3859962|B4|||Age||years|Mean|73.2|73.2|Standard Deviation|5.3|5.3|||
4038398|NCT01129115|3859963|B3|||Age||years|Mean|72.5|72.5|Standard Deviation|5.7|5.7|||
4038399|NCT01129115|3859964|B2|||Age||years|Mean|73.5|73.5|Standard Deviation|5.9|5.9|||
4038400|NCT01129115|3859965|B1|||Age||years|Mean|72.5|72.5|Standard Deviation|5.8|5.8|||
4038401|NCT01129102|3860002|B4|||Visual analogue scale (VAS) for primary dysmenorrhea|VAS stands for Visual Analogue Scale of pain. The scale was rated as a graphic rating scale. as a 100mm baseline from 0:No pain to 100:Worst possible pain.|units on a scale|Mean|NA||Standard Deviation|NA||||Data unavailable for IKH-01 group
4038402|NCT01129102|3860003|B3|||Visual analogue scale (VAS) for primary dysmenorrhea|VAS stands for Visual Analogue Scale of pain. The scale was rated as a graphic rating scale. as a 100mm baseline from 0:No pain to 100:Worst possible pain.|units on a scale|Mean|48.6|48.6|Standard Deviation|20.15|20.15|||
4038403|NCT01129102|3860004|B2|||Visual analogue scale (VAS) for primary dysmenorrhea|VAS stands for Visual Analogue Scale of pain. The scale was rated as a graphic rating scale. as a 100mm baseline from 0:No pain to 100:Worst possible pain.|units on a scale|Mean|NA||Standard Deviation|NA||||IKH-01 was not allocated for primary dysmenorrhea in this study. Therefore, VAS for primary dysmenorrhea is not available for IKH-01 group.
4038404|NCT01129102|3860005|B1|||Visual analogue scale (VAS) for primary dysmenorrhea|VAS stands for Visual Analogue Scale of pain. The scale was rated as a graphic rating scale. as a 100mm baseline from 0:No pain to 100:Worst possible pain.|units on a scale|Mean|51.8|51.8|Standard Deviation|20.57|20.57|||
4038405|NCT01129102|3860002|B4|Secondary dysmenorrhea||Total dysmenorrhea score|"The detail of dysmenorrhea score that was used in this study is the following. These subscales summed for a total dysmenorrhea score (minimum 0 to maximum 6). Pain score None 0 : None Mild 1 : There are some troubles for work Moderate 2 : Needing to rest in bed and/or affecting work Severe 3 : Morre than 1 day in bed and not possible to work~Drug score (during a menstrual period) None 0 : None Mild 1 : taking analgesics for 1 days Moderate 2 : taking analgesics for 2 days Severe 3 : taking analgesics more than 3 days"|units on a scale|Mean|4.1|4.1|Standard Deviation|0.96|0.96|||
4038406|NCT01129102|3860003|B3|Secondary dysmenorrhea||Total dysmenorrhea score|"The detail of dysmenorrhea score that was used in this study is the following. These subscales summed for a total dysmenorrhea score (minimum 0 to maximum 6). Pain score None 0 : None Mild 1 : There are some troubles for work Moderate 2 : Needing to rest in bed and/or affecting work Severe 3 : Morre than 1 day in bed and not possible to work~Drug score (during a menstrual period) None 0 : None Mild 1 : taking analgesics for 1 days Moderate 2 : taking analgesics for 2 days Severe 3 : taking analgesics more than 3 days"|units on a scale|Mean|4.1|4.1|Standard Deviation|0.99|0.99|||
4038407|NCT01129102|3860004|B2|Secondary dysmenorrhea||Total dysmenorrhea score|"The detail of dysmenorrhea score that was used in this study is the following. These subscales summed for a total dysmenorrhea score (minimum 0 to maximum 6). Pain score None 0 : None Mild 1 : There are some troubles for work Moderate 2 : Needing to rest in bed and/or affecting work Severe 3 : Morre than 1 day in bed and not possible to work~Drug score (during a menstrual period) None 0 : None Mild 1 : taking analgesics for 1 days Moderate 2 : taking analgesics for 2 days Severe 3 : taking analgesics more than 3 days"|units on a scale|Mean|4.0|4.0|Standard Deviation|0.87|0.87|||
4038408|NCT01129102|3860005|B1|Secondary dysmenorrhea||Total dysmenorrhea score|"The detail of dysmenorrhea score that was used in this study is the following. These subscales summed for a total dysmenorrhea score (minimum 0 to maximum 6). Pain score None 0 : None Mild 1 : There are some troubles for work Moderate 2 : Needing to rest in bed and/or affecting work Severe 3 : Morre than 1 day in bed and not possible to work~Drug score (during a menstrual period) None 0 : None Mild 1 : taking analgesics for 1 days Moderate 2 : taking analgesics for 2 days Severe 3 : taking analgesics more than 3 days"|units on a scale|Mean|4.3|4.3|Standard Deviation|1.05|1.05|||
4038409|NCT01129102|3860002|B4|Primary dysmenorrhea||Total dysmenorrhea score|"The detail of dysmenorrhea score that was used in this study is the following. These subscales summed for a total dysmenorrhea score (minimum 0 to maximum 6). Pain score None 0 : None Mild 1 : There are some troubles for work Moderate 2 : Needing to rest in bed and/or affecting work Severe 3 : Morre than 1 day in bed and not possible to work~Drug score (during a menstrual period) None 0 : None Mild 1 : taking analgesics for 1 days Moderate 2 : taking analgesics for 2 days Severe 3 : taking analgesics more than 3 days"|units on a scale|Mean|NA||Standard Deviation|NA||||Data unavailable for IKH-01 group
4038440|NCT01129102|3860005|B1|||Age||years|Mean|32.4|32.4|Standard Deviation|7.29|7.29|||
4038441|NCT01129011|3860016|B3||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4038442|NCT01129011|3860017|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4038443|NCT01129011|3860018|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4038410|NCT01129102|3860003|B3|Primary dysmenorrhea||Total dysmenorrhea score|"The detail of dysmenorrhea score that was used in this study is the following. These subscales summed for a total dysmenorrhea score (minimum 0 to maximum 6). Pain score None 0 : None Mild 1 : There are some troubles for work Moderate 2 : Needing to rest in bed and/or affecting work Severe 3 : Morre than 1 day in bed and not possible to work~Drug score (during a menstrual period) None 0 : None Mild 1 : taking analgesics for 1 days Moderate 2 : taking analgesics for 2 days Severe 3 : taking analgesics more than 3 days"|units on a scale|Mean|4.3|4.3|Standard Deviation|0.90|0.9|||
4038411|NCT01129102|3860004|B2|Primary dysmenorrhea||Total dysmenorrhea score|"The detail of dysmenorrhea score that was used in this study is the following. These subscales summed for a total dysmenorrhea score (minimum 0 to maximum 6). Pain score None 0 : None Mild 1 : There are some troubles for work Moderate 2 : Needing to rest in bed and/or affecting work Severe 3 : Morre than 1 day in bed and not possible to work~Drug score (during a menstrual period) None 0 : None Mild 1 : taking analgesics for 1 days Moderate 2 : taking analgesics for 2 days Severe 3 : taking analgesics more than 3 days"|units on a scale|Mean|NA||Standard Deviation|NA||||IKH-01 was not allocated for primary dysmenorrhea in this study.
4038412|NCT01129102|3860005|B1|Primary dysmenorrhea||Total dysmenorrhea score|"The detail of dysmenorrhea score that was used in this study is the following. These subscales summed for a total dysmenorrhea score (minimum 0 to maximum 6). Pain score None 0 : None Mild 1 : There are some troubles for work Moderate 2 : Needing to rest in bed and/or affecting work Severe 3 : Morre than 1 day in bed and not possible to work~Drug score (during a menstrual period) None 0 : None Mild 1 : taking analgesics for 1 days Moderate 2 : taking analgesics for 2 days Severe 3 : taking analgesics more than 3 days"|units on a scale|Mean|3.9|3.9|Standard Deviation|0.92|0.92|||
4038413|NCT01129102|3860002|B4|Total dysmenorrhea||Total dysmenorrhea score|"The detail of dysmenorrhea score that was used in this study is the following. These subscales summed for a total dysmenorrhea score (minimum 0 to maximum 6). Pain score None 0 : None Mild 1 : There are some troubles for work Moderate 2 : Needing to rest in bed and/or affecting work Severe 3 : Morre than 1 day in bed and not possible to work~Drug score (during a menstrual period) None 0 : None Mild 1 : taking analgesics for 1 days Moderate 2 : taking analgesics for 2 days Severe 3 : taking analgesics more than 3 days"|units on a scale|Mean|NA||Standard Deviation|NA||||Data unavailable for IKH-01 group
4038414|NCT01129102|3860003|B3|Total dysmenorrhea||Total dysmenorrhea score|"The detail of dysmenorrhea score that was used in this study is the following. These subscales summed for a total dysmenorrhea score (minimum 0 to maximum 6). Pain score None 0 : None Mild 1 : There are some troubles for work Moderate 2 : Needing to rest in bed and/or affecting work Severe 3 : Morre than 1 day in bed and not possible to work~Drug score (during a menstrual period) None 0 : None Mild 1 : taking analgesics for 1 days Moderate 2 : taking analgesics for 2 days Severe 3 : taking analgesics more than 3 days"|units on a scale|Mean|4.2|4.2|Standard Deviation|0.95|0.95|||
4038415|NCT01129102|3860004|B2|Total dysmenorrhea||Total dysmenorrhea score|"The detail of dysmenorrhea score that was used in this study is the following. These subscales summed for a total dysmenorrhea score (minimum 0 to maximum 6). Pain score None 0 : None Mild 1 : There are some troubles for work Moderate 2 : Needing to rest in bed and/or affecting work Severe 3 : Morre than 1 day in bed and not possible to work~Drug score (during a menstrual period) None 0 : None Mild 1 : taking analgesics for 1 days Moderate 2 : taking analgesics for 2 days Severe 3 : taking analgesics more than 3 days"|units on a scale|Mean|NA||Standard Deviation|NA||||IKH-01 was not allocated for primary dysmenorrhea in this study. Therefore, total dysmenorrhea score is not available for IKH-01 group.
4038416|NCT01129102|3860005|B1|Total dysmenorrhea||Total dysmenorrhea score|"The detail of dysmenorrhea score that was used in this study is the following. These subscales summed for a total dysmenorrhea score (minimum 0 to maximum 6). Pain score None 0 : None Mild 1 : There are some troubles for work Moderate 2 : Needing to rest in bed and/or affecting work Severe 3 : Morre than 1 day in bed and not possible to work~Drug score (during a menstrual period) None 0 : None Mild 1 : taking analgesics for 1 days Moderate 2 : taking analgesics for 2 days Severe 3 : taking analgesics more than 3 days"|units on a scale|Mean|4.1|4.1|Standard Deviation|1.00|1.0|||
4038417|NCT01129102|3860002|B4|Secondary dysmenorrhea||Diagnostic categories||participants|Number|123|123.0||||||
4038418|NCT01129102|3860003|B3|Secondary dysmenorrhea||Diagnostic categories||participants|Number|26|26.0||||||
4038419|NCT01129102|3860004|B2|Secondary dysmenorrhea||Diagnostic categories||participants|Number|47|47.0||||||
4038420|NCT01129102|3860005|B1|Secondary dysmenorrhea||Diagnostic categories||participants|Number|50|50.0||||||
4038421|NCT01129102|3860002|B4|Primary dysmenorrhea||Diagnostic categories||participants|Number|83|83.0||||||
4038422|NCT01129102|3860003|B3|Primary dysmenorrhea||Diagnostic categories||participants|Number|28|28.0||||||
4038423|NCT01129102|3860004|B2|Primary dysmenorrhea||Diagnostic categories||participants|Number|0|0.0||||||
4038424|NCT01129102|3860005|B1|Primary dysmenorrhea||Diagnostic categories||participants|Number|55|55.0||||||
4038425|NCT01129102|3860002|B4|Female||Sex/Gender, Customized||participants|Number|206|206.0||||||
4038426|NCT01129102|3860003|B3|Female||Sex/Gender, Customized||participants|Number|54|54.0||||||
4038427|NCT01129102|3860004|B2|Female||Sex/Gender, Customized||participants|Number|47|47.0||||||
4038428|NCT01129102|3860005|B1|Female||Sex/Gender, Customized||participants|Number|105|105.0||||||
4038429|NCT01129102|3860002|B4|30 year of age and older||Age, Customized||participants|Number|125|125.0||||||
4038430|NCT01129102|3860003|B3|30 year of age and older||Age, Customized||participants|Number|25|25.0||||||
4038431|NCT01129102|3860004|B2|30 year of age and older||Age, Customized||participants|Number|34|34.0||||||
4038432|NCT01129102|3860005|B1|30 year of age and older||Age, Customized||participants|Number|66|66.0||||||
4038433|NCT01129102|3860002|B4|Under 30 years of age||Age, Customized||participants|Number|81|81.0||||||
4038434|NCT01129102|3860003|B3|Under 30 years of age||Age, Customized||participants|Number|29|29.0||||||
4038435|NCT01129102|3860004|B2|Under 30 years of age||Age, Customized||participants|Number|13|13.0||||||
4038436|NCT01129102|3860005|B1|Under 30 years of age||Age, Customized||participants|Number|39|39.0||||||
4038437|NCT01129102|3860002|B4|||Age||years|Mean|32.3|32.3|Standard Deviation|7.21|7.21|||
4038438|NCT01129102|3860003|B3|||Age||years|Mean|30.4|30.4|Standard Deviation|7.41|7.41|||
4038439|NCT01129102|3860004|B2|||Age||years|Mean|34.0|34.0|Standard Deviation|6.93|6.93|||
4038444|NCT01129011|3860016|B3||Female|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
4038445|NCT01129011|3860017|B2||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4038446|NCT01129011|3860018|B1||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4038447|NCT01129011|3860016|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|8.2|8.2|||
4038448|NCT01129011|3860017|B2|||Age||years|Mean|59.4|59.4|Standard Deviation|8.3|8.3|||
4038449|NCT01129011|3860018|B1|||Age||years|Mean|59.6|59.6|Standard Deviation|8.2|8.2|||
4038450|NCT01128972|3860041|B1|United States||Region of Enrollment||Participants|Number|36|36.0||||||
4038451|NCT01128972|3860041|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4038452|NCT01128972|3860041|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4038453|NCT01128972|3860041|B1|||Age||Years|Mean|37.0|37.0|Standard Deviation|12.90|12.9|||
4038454|NCT01128959|3860074|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038455|NCT01128959|3860074|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4038456|NCT01128959|3860074|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4038457|NCT01128959|3860074|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4038458|NCT01128959|3860074|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038459|NCT01128959|3860074|B1||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4038460|NCT01128959|3860074|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4038461|NCT01128959|3860074|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038462|NCT01128959|3860074|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4038463|NCT01128959|3860074|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4038464|NCT01128959|3860074|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4038465|NCT01128959|3860074|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4038466|NCT01128959|3860074|B1|||Age||years|Mean|40.7|40.7|Standard Deviation|11.2|11.2|||
4038467|NCT01128946|3860080|B1|United States||Region of Enrollment||Participants|Number|83|83.0||||||
4038468|NCT01128946|3860080|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4038469|NCT01128946|3860080|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4038470|NCT01128946|3860080|B1|||Age||Years|Mean|64.0|64.0|Standard Deviation|8.73|8.73|||
4038471|NCT01128894|3860099|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|561|561.0||||||
4038472|NCT01128894|3860100|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|285|285.0||||||
4038473|NCT01128894|3860101|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|276|276.0||||||
4038474|NCT01128894|3860099|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4038475|NCT01128894|3860100|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4038476|NCT01128894|3860101|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4038477|NCT01128894|3860099|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4038478|NCT01128894|3860100|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4038479|NCT01128894|3860101|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4038480|NCT01128894|3860099|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|36|36.0||||||
4038481|NCT01128894|3860100|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4038482|NCT01128894|3860101|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4038483|NCT01128894|3860099|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4038484|NCT01128894|3860100|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4038485|NCT01128894|3860101|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4038486|NCT01128894|3860099|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|44|44.0||||||
4038487|NCT01128894|3860100|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4038488|NCT01128894|3860101|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|26|26.0||||||
4038489|NCT01128894|3860099|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4038490|NCT01128894|3860100|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4038491|NCT01128894|3860101|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4038492|NCT01128894|3860099|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|67|67.0||||||
4038493|NCT01128894|3860100|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
4038494|NCT01128894|3860101|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
4038495|NCT01128894|3860099|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|76|76.0||||||
4038496|NCT01128894|3860100|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
4038497|NCT01128894|3860101|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|47|47.0||||||
4038498|NCT01128894|3860099|B3||Male|Gender||Participants|Count of Participants|409|409.0||||||
4038499|NCT01128894|3860100|B2||Male|Gender||Participants|Count of Participants|218|218.0||||||
4038500|NCT01128894|3860101|B1||Male|Gender||Participants|Count of Participants|191|191.0||||||
4038501|NCT01128894|3860099|B3||Female|Gender||Participants|Count of Participants|403|403.0||||||
4038502|NCT01128894|3860100|B2||Female|Gender||Participants|Count of Participants|190|190.0||||||
4038503|NCT01128894|3860101|B1||Female|Gender||Participants|Count of Participants|213|213.0||||||
4038504|NCT01128894|3860099|B3|||Age||Years|Mean|55.6|55.6|Standard Deviation|10.03|10.03|||
4038505|NCT01128894|3860100|B2|||Age||Years|Mean|55.8|55.8|Standard Deviation|9.95|9.95|||
4038506|NCT01128894|3860101|B1|||Age||Years|Mean|55.4|55.4|Standard Deviation|10.11|10.11|||
4038507|NCT01128842|3860120|B1|Japanese||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4038508|NCT01128842|3860120|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4038509|NCT01128842|3860120|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4038510|NCT01128842|3860120|B1|||Age||years|Mean|52.43|52.43|Standard Deviation|11.27|11.27|||
4038511|NCT01128842|3860120|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4038512|NCT01128842|3860120|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4038513|NCT01128842|3860120|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038514|NCT01128829|3860130|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4038515|NCT01128829|3860130|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4038516|NCT01128829|3860130|B1|||Age||years|Mean|35.1|35.1|Standard Deviation|4.1|4.1|||
4038517|NCT01128738|3860135|B3|Asian-Japanese Heritage||Race/Ethnicity, Customized||participants|Number|152|152.0||||||
4038518|NCT01128738|3860136|B2|Asian-Japanese Heritage||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
4038519|NCT01128738|3860137|B1|Asian-Japanese Heritage||Race/Ethnicity, Customized||participants|Number|78|78.0||||||
4038520|NCT01128738|3860135|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4038521|NCT01128738|3860136|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4038522|NCT01128738|3860137|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4038523|NCT01128738|3860135|B3||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4038524|NCT01128738|3860136|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4038525|NCT01128738|3860137|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4038526|NCT01128738|3860135|B3|||Age||Years|Mean|35.5|35.5|Standard Deviation|10.87|10.87|||
4038527|NCT01128738|3860136|B2|||Age||Years|Mean|34.7|34.7|Standard Deviation|11.69|11.69|||
4038528|NCT01128738|3860137|B1|||Age||Years|Mean|36.2|36.2|Standard Deviation|10.05|10.05|||
4038529|NCT01128621|3860261|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038530|NCT01128621|3860262|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038531|NCT01128621|3860263|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038532|NCT01128621|3860261|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038533|NCT01128621|3860262|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038534|NCT01128621|3860263|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038535|NCT01128621|3860261|B3||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4038536|NCT01128621|3860262|B2||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4038537|NCT01128621|3860263|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4038538|NCT01128621|3860261|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4038539|NCT01128621|3860262|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4038540|NCT01128621|3860263|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4038541|NCT01128621|3860261|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038542|NCT01128621|3860262|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038543|NCT01128621|3860263|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038544|NCT01128621|3860261|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038545|NCT01128621|3860262|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038546|NCT01128621|3860263|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038547|NCT01128621|3860261|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038548|NCT01128621|3860262|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038549|NCT01128621|3860263|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038550|NCT01128621|3860261|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4038551|NCT01128621|3860262|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4038552|NCT01128621|3860263|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4038553|NCT01128621|3860261|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4038554|NCT01128621|3860262|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4038555|NCT01128621|3860263|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4038556|NCT01128621|3860261|B3|36 to 65 Years||Age, Customized||Participants|Count of Participants|73|73.0||||||
4038557|NCT01128621|3860262|B2|36 to 65 Years||Age, Customized||Participants|Count of Participants|67|67.0||||||
4038558|NCT01128621|3860263|B1|36 to 65 Years||Age, Customized||Participants|Count of Participants|6|6.0||||||
4038559|NCT01128595|3860385|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4038560|NCT01128595|3860385|B1|East Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4038561|NCT01128595|3860385|B1|White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4038562|NCT01128595|3860385|B1||Male|Gender||Participants|Count of Participants|19|19.0||||||
4038563|NCT01128595|3860385|B1||Female|Gender||Participants|Count of Participants|8|8.0||||||
4038564|NCT01128595|3860385|B1|||Age||Years|Mean|30.8|30.8|Standard Deviation|7.46|7.46|||
4038565|NCT01128569|3860418|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4038566|NCT01128569|3860418|B1|Asian – South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4038567|NCT01128569|3860418|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4038568|NCT01128569|3860418|B1|White – White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
4038569|NCT01128569|3860418|B1||Male|Gender||Participants|Count of Participants|34|34.0||||||
4038570|NCT01128569|3860418|B1||Female|Gender||Participants|Count of Participants|18|18.0||||||
4038571|NCT01128569|3860418|B1|||Age||Years|Mean|35.4|35.4|Standard Deviation|8.63|8.63|||
4038572|NCT01128543|3860440|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4038573|NCT01128543|3860440|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4038574|NCT01128543|3860440|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4038575|NCT01128543|3860440|B1|||Age||Years|Mean|54|54.0|Standard Deviation|13.2|13.2|||
4038576|NCT01128426|3860446|B1||Male|Sex: Female, Male||Participants|Count of Participants|27628|27628.0||||||
4038577|NCT01128426|3860446|B1||Female|Sex: Female, Male||Participants|Count of Participants|26274|26274.0||||||
4038578|NCT01128426|3860446|B1|||Age||days|Median|63|63.0|Full Range|||34.0|179.0|
4038579|NCT01128413|3860464|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4038580|NCT01128413|3860465|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4038581|NCT01128413|3860466|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4038582|NCT01128413|3860464|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4038583|NCT01128413|3860465|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4038584|NCT01128413|3860466|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4038585|NCT01128413|3860464|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4038586|NCT01128413|3860465|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4038587|NCT01128413|3860466|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4038588|NCT01128413|3860464|B3|||Age||years|Median|57|57.0|Inter-Quartile Range|||51.0|65.0|
4038589|NCT01128413|3860465|B2|||Age||years|Median|59|59.0|Inter-Quartile Range|||54.0|65.0|
4038590|NCT01128413|3860466|B1|||Age||years|Median|56|56.0|Inter-Quartile Range|||47.0|66.0|
4038591|NCT01128413|3860464|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4038592|NCT01128413|3860465|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4038593|NCT01128413|3860466|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4038594|NCT01128413|3860464|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4038595|NCT01128413|3860465|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4038596|NCT01128413|3860466|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4038597|NCT01128413|3860464|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038598|NCT01128413|3860465|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038599|NCT01128413|3860466|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038600|NCT01128400|3860473|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4038601|NCT01128400|3860474|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4038602|NCT01128400|3860475|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4038603|NCT01128400|3860476|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4038604|NCT01128400|3860473|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4038605|NCT01128400|3860474|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4038606|NCT01128400|3860475|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4038607|NCT01128400|3860476|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4038608|NCT01128400|3860473|B4|||Age||years|Mean|39.1|39.1|Standard Deviation|8.8|8.8|||
4038609|NCT01128400|3860474|B3|||Age||years|Mean|39.6|39.6|Standard Deviation|6.4|6.4|||
4038610|NCT01128400|3860475|B2|||Age||years|Mean|39.1|39.1|Standard Deviation|7.0|7.0|||
4038611|NCT01128400|3860476|B1|||Age||years|Mean|38.7|38.7|Standard Deviation|14.0|14.0|||
4038612|NCT01128387|3860489|B3|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4038613|NCT01128387|3860490|B2|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4038614|NCT01128387|3860491|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4038615|NCT01128387|3860489|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038616|NCT01128387|3860490|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038617|NCT01128387|3860491|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038618|NCT01128387|3860489|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038619|NCT01128387|3860490|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038620|NCT01128387|3860491|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038621|NCT01128387|3860489|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4038622|NCT01128387|3860490|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4038623|NCT01128387|3860491|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4038624|NCT01128387|3860489|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038625|NCT01128387|3860490|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038626|NCT01128387|3860491|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038627|NCT01128387|3860489|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038628|NCT01128387|3860490|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038629|NCT01128387|3860491|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038630|NCT01128387|3860489|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038631|NCT01128387|3860490|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038632|NCT01128387|3860491|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038633|NCT01128387|3860489|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038634|NCT01128387|3860490|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038635|NCT01128387|3860491|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038636|NCT01128387|3860489|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038637|NCT01128387|3860490|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038638|NCT01128387|3860491|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038639|NCT01128387|3860489|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4038640|NCT01128387|3860490|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4038641|NCT01128387|3860491|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4038642|NCT01128387|3860489|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038643|NCT01128387|3860490|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038644|NCT01128387|3860491|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038645|NCT01128387|3860489|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4038646|NCT01128387|3860490|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4038647|NCT01128387|3860491|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4038648|NCT01128387|3860489|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4038649|NCT01128387|3860490|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4038650|NCT01128387|3860491|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4038651|NCT01128387|3860489|B3|||Age||years|Mean|61.5|61.5|Full Range|||51.0|69.0|
4038652|NCT01128387|3860490|B2|||Age||years|Mean|62.6|62.6|Full Range|||53.0|69.0|
4038653|NCT01128387|3860491|B1|||Age||years|Mean|60.3|60.3|Full Range|||51.0|69.0|
4038654|NCT01128387|3860489|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4038655|NCT01128387|3860490|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4038656|NCT01128387|3860491|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4038657|NCT01128387|3860489|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4038658|NCT01128387|3860490|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4038659|NCT01128387|3860491|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4038660|NCT01128387|3860489|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038661|NCT01128387|3860490|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038662|NCT01128387|3860491|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038663|NCT01128361|3860500|B3|||Clinical Dementia Rating Sum of Boxes|The Clinical Dementia Rating (CDR) is a scale used to characterize six domains of cognitive and functional performance applicable to Alzheimer disease and related dementias: Memory, Orientation, Judgment & Problem Solving, Community Affairs, Home & Hobbies, and Personal Care. The sum of each domain (CDR Sum of Boxes) is used as a measure of dementia severity from 0 (no impairment) to 18 (severe impairment).|units on a scale|Mean|3.54|3.54|Standard Deviation|1.81|1.81|||
4038664|NCT01128361|3860501|B2|||Clinical Dementia Rating Sum of Boxes|The Clinical Dementia Rating (CDR) is a scale used to characterize six domains of cognitive and functional performance applicable to Alzheimer disease and related dementias: Memory, Orientation, Judgment & Problem Solving, Community Affairs, Home & Hobbies, and Personal Care. The sum of each domain (CDR Sum of Boxes) is used as a measure of dementia severity from 0 (no impairment) to 18 (severe impairment).|units on a scale|Mean|3.55|3.55|Standard Deviation|1.60|1.6|||
4038665|NCT01128361|3860502|B1|||Clinical Dementia Rating Sum of Boxes|The Clinical Dementia Rating (CDR) is a scale used to characterize six domains of cognitive and functional performance applicable to Alzheimer disease and related dementias: Memory, Orientation, Judgment & Problem Solving, Community Affairs, Home & Hobbies, and Personal Care. The sum of each domain (CDR Sum of Boxes) is used as a measure of dementia severity from 0 (no impairment) to 18 (severe impairment).|units on a scale|Mean|3.54|3.54|Standard Deviation|1.99|1.99|||
4038666|NCT01128361|3860500|B3|United States||Region of Enrollment||participants|Number|76|76.0||||||
4038667|NCT01128361|3860501|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4038668|NCT01128361|3860502|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4038669|NCT01128361|3860500|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4038670|NCT01128361|3860501|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4038671|NCT01128361|3860502|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4038672|NCT01128361|3860500|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4038673|NCT01128361|3860501|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4038674|NCT01128361|3860502|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4038675|NCT01128361|3860500|B3|||Age||years|Mean|72.9|72.9|Standard Deviation|7.7|7.7|||
4038676|NCT01128361|3860501|B2|||Age||years|Mean|71.4|71.4|Standard Deviation|8.4|8.4|||
4038677|NCT01128361|3860502|B1|||Age||years|Mean|74.4|74.4|Standard Deviation|6.7|6.7|||
4038678|NCT01128361|3860500|B3||>=65 years|Age||Participants|Count of Participants|76|76.0||||||
4038679|NCT01128361|3860501|B2||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
4038680|NCT01128361|3860502|B1||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4038681|NCT01128361|3860500|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4038682|NCT01128361|3860501|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4038683|NCT01128361|3860502|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4038684|NCT01128361|3860500|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038685|NCT01128361|3860501|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038686|NCT01128361|3860502|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038687|NCT01128296|3860515|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4038688|NCT01128296|3860515|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4038689|NCT01128296|3860515|B1|||Age||years|Mean|64|64.0|Standard Deviation|10|10.0|||
4038690|NCT01128270|3860538|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4038691|NCT01128270|3860538|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4038692|NCT01128270|3860538|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4038693|NCT01128270|3860538|B1|||Age||years|Mean|28.0|28.0|Standard Deviation|7.9|7.9|||
4038694|NCT01128270|3860538|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4038695|NCT01128270|3860538|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4038696|NCT01128270|3860538|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038697|NCT01128244|3860551|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4038698|NCT01128244|3860551|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038699|NCT01128244|3860551|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038700|NCT01128244|3860551|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4038701|NCT01128244|3860551|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4038702|NCT01128244|3860551|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038703|NCT01128244|3860551|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038704|NCT01128244|3860551|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038705|NCT01128244|3860551|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038706|NCT01128244|3860551|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4038707|NCT01128244|3860551|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4038708|NCT01128244|3860551|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4038709|NCT01128244|3860551|B1||Female|Gender||Participants|Count of Participants|13|13.0||||||
4038710|NCT01128244|3860551|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4038711|NCT01128244|3860551|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4038712|NCT01128244|3860551|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038713|NCT01128192|3860559|B3|||Weight (kg)||kg|Mean|75.08|75.08|Standard Deviation|8.26|8.26|||
4038714|NCT01128192|3860560|B2|||Weight (kg)||kg|Mean|74.49|74.49|Standard Deviation|8.41|8.41|||
4038715|NCT01128192|3860561|B1|||Weight (kg)||kg|Mean|75.67|75.67|Standard Deviation|8.11|8.11|||
4038716|NCT01128192|3860559|B3|||Body Mass Index BMI (kg/m2)||kg/m2|Mean|23.49|23.49|Standard Deviation|1.85|1.85|||
4038717|NCT01128192|3860560|B2|||Body Mass Index BMI (kg/m2)||kg/m2|Mean|23.68|23.68|Standard Deviation|2.04|2.04|||
4038718|NCT01128192|3860561|B1|||Body Mass Index BMI (kg/m2)||kg/m2|Mean|23.30|23.3|Standard Deviation|1.61|1.61|||
4038719|NCT01128192|3860559|B3||Male|Sex: Female, Male|Nondiabetic males, aged 18-50 years with body mass index (BMI) ≤ 25. Subjects were not to have any family history of diabetes and no diagnosis of impaired glucose tolerance or gallstone disease.|Participants|Count of Participants|38|38.0||||||
4038720|NCT01128192|3860560|B2||Male|Sex: Female, Male|Nondiabetic males, aged 18-50 years with body mass index (BMI) ≤ 25. Subjects were not to have any family history of diabetes and no diagnosis of impaired glucose tolerance or gallstone disease.|Participants|Count of Participants|19|19.0||||||
4038721|NCT01128192|3860561|B1||Male|Sex: Female, Male|Nondiabetic males, aged 18-50 years with body mass index (BMI) ≤ 25. Subjects were not to have any family history of diabetes and no diagnosis of impaired glucose tolerance or gallstone disease.|Participants|Count of Participants|19|19.0||||||
4038722|NCT01128192|3860559|B3||Female|Sex: Female, Male|Nondiabetic males, aged 18-50 years with body mass index (BMI) ≤ 25. Subjects were not to have any family history of diabetes and no diagnosis of impaired glucose tolerance or gallstone disease.|Participants|Count of Participants|0|0.0||||||
4038782|NCT01128153|3860611|B3|White||Race/Ethnicity, Customized||Participants|Number|116|116.0||||||
4038783|NCT01128153|3860612|B2|White||Race/Ethnicity, Customized||Participants|Number|57|57.0||||||
4038723|NCT01128192|3860560|B2||Female|Sex: Female, Male|Nondiabetic males, aged 18-50 years with body mass index (BMI) ≤ 25. Subjects were not to have any family history of diabetes and no diagnosis of impaired glucose tolerance or gallstone disease.|Participants|Count of Participants|0|0.0||||||
4038724|NCT01128192|3860561|B1||Female|Sex: Female, Male|Nondiabetic males, aged 18-50 years with body mass index (BMI) ≤ 25. Subjects were not to have any family history of diabetes and no diagnosis of impaired glucose tolerance or gallstone disease.|Participants|Count of Participants|0|0.0||||||
4038725|NCT01128192|3860559|B3|||Age||years|Mean|24.45|24.45|Standard Deviation|5.4|5.4|||
4038726|NCT01128192|3860560|B2|||Age||years|Mean|24.6|24.6|Standard Deviation|6.1|6.1|||
4038727|NCT01128192|3860561|B1|||Age||years|Mean|24.3|24.3|Standard Deviation|4.6|4.6|||
4038728|NCT01128179|3860590|B3|France||Region of Enrollment||participants|Number|35|35.0||||||
4038729|NCT01128179|3860591|B2|France||Region of Enrollment||participants|Number|12|12.0||||||
4038730|NCT01128179|3860592|B1|France||Region of Enrollment||participants|Number|23|23.0||||||
4038731|NCT01128179|3860590|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4038732|NCT01128179|3860591|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4038733|NCT01128179|3860592|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4038734|NCT01128179|3860590|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4038735|NCT01128179|3860591|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4038736|NCT01128179|3860592|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4038737|NCT01128179|3860590|B3|>=18 years||Age, Customized||participants|Number|35|35.0||||||
4038738|NCT01128179|3860591|B2|>=18 years||Age, Customized||participants|Number|12|12.0||||||
4038739|NCT01128179|3860592|B1|>=18 years||Age, Customized||participants|Number|23|23.0||||||
4038740|NCT01128179|3860590|B3|||Age||years|Mean|67.2|67.2|Standard Deviation|13.6|13.6|||
4038741|NCT01128179|3860591|B2|||Age||years|Mean|69.4|69.4|Standard Deviation|13.2|13.2|||
4038742|NCT01128179|3860592|B1|||Age||years|Mean|66.0|66.0|Standard Deviation|13.9|13.9|||
4038743|NCT01128153|3860611|B3|||Fasting Plasma Glucose||mmol/L|Mean|8.82|8.82|Standard Deviation|2.393|2.393|||
4038744|NCT01128153|3860612|B2|||Fasting Plasma Glucose||mmol/L|Mean|8.63|8.63|Standard Deviation|2.130|2.13|||
4038745|NCT01128153|3860613|B1|||Fasting Plasma Glucose||mmol/L|Mean|9.00|9.0|Standard Deviation|2.626|2.626|||
4038746|NCT01128153|3860611|B3|||Fasting Plasma Glucose||mg/dL|Mean|158.84|158.84|Standard Deviation|43.125|43.125|||
4038747|NCT01128153|3860612|B2|||Fasting Plasma Glucose||mg/dL|Mean|155.45|155.45|Standard Deviation|38.37|38.37|||
4038748|NCT01128153|3860613|B1|||Fasting Plasma Glucose||mg/dL|Mean|162.24|162.24|Standard Deviation|47.322|47.322|||
4038749|NCT01128153|3860611|B3|||2-hour Postprandial glucose||mmol/L|Mean|14.84|14.84|Standard Deviation|4.064|4.064|||
4038750|NCT01128153|3860612|B2|||2-hour Postprandial glucose||mmol/L|Mean|14.74|14.74|Standard Deviation|3.869|3.869|||
4038751|NCT01128153|3860613|B1|||2-hour Postprandial glucose||mmol/L|Mean|14.94|14.94|Standard Deviation|4.263|4.263|||
4038752|NCT01128153|3860611|B3|||2-hour Postprandial Glucose||mg/dL|Mean|267.39|267.39|Standard Deviation|73.220|73.22|||
4038753|NCT01128153|3860612|B2|||2-hour Postprandial Glucose||mg/dL|Mean|265.6|265.6|Standard Deviation|69.713|69.713|||
4038754|NCT01128153|3860613|B1|||2-hour Postprandial Glucose||mg/dL|Mean|269.18|269.18|Standard Deviation|76.814|76.814|||
4038755|NCT01128153|3860611|B3|||HbA1c||%|Mean|8.28|8.28|Standard Deviation|0.848|0.848|||
4038756|NCT01128153|3860612|B2|||HbA1c||%|Mean|8.19|8.19|Standard Deviation|0.832|0.832|||
4038757|NCT01128153|3860613|B1|||HbA1c||%|Mean|8.38|8.38|Standard Deviation|0.856|0.856|||
4038758|NCT01128153|3860611|B3|||BMI||kg/m2|Mean|29.2|29.2|Standard Deviation|5.09|5.09|||
4038759|NCT01128153|3860612|B2|||BMI||kg/m2|Mean|29.1|29.1|Standard Deviation|4.93|4.93|||
4038760|NCT01128153|3860613|B1|||BMI||kg/m2|Mean|29.4|29.4|Standard Deviation|5.26|5.26|||
4038761|NCT01128153|3860611|B3|United Kingdom||Region of Enrollment||Participants|Number|51|51.0||||||
4038762|NCT01128153|3860612|B2|United Kingdom||Region of Enrollment||Participants|Number|25|25.0||||||
4038763|NCT01128153|3860613|B1|United Kingdom||Region of Enrollment||Participants|Number|26|26.0||||||
4038764|NCT01128153|3860611|B3|Thailand||Region of Enrollment||Participants|Number|18|18.0||||||
4038765|NCT01128153|3860612|B2|Thailand||Region of Enrollment||Participants|Number|10|10.0||||||
4038766|NCT01128153|3860613|B1|Thailand||Region of Enrollment||Participants|Number|8|8.0||||||
4038767|NCT01128153|3860611|B3|Korea, Republic of||Region of Enrollment||Participants|Number|49|49.0||||||
4038768|NCT01128153|3860612|B2|Korea, Republic of||Region of Enrollment||Participants|Number|24|24.0||||||
4038769|NCT01128153|3860613|B1|Korea, Republic of||Region of Enrollment||Participants|Number|25|25.0||||||
4038770|NCT01128153|3860611|B3|India||Region of Enrollment||Participants|Number|69|69.0||||||
4038771|NCT01128153|3860612|B2|India||Region of Enrollment||Participants|Number|34|34.0||||||
4038772|NCT01128153|3860613|B1|India||Region of Enrollment||Participants|Number|35|35.0||||||
4038773|NCT01128153|3860611|B3|Canada||Region of Enrollment||Participants|Number|20|20.0||||||
4038774|NCT01128153|3860612|B2|Canada||Region of Enrollment||Participants|Number|10|10.0||||||
4038775|NCT01128153|3860613|B1|Canada||Region of Enrollment||Participants|Number|10|10.0||||||
4038776|NCT01128153|3860611|B3|Australia||Region of Enrollment||Participants|Number|50|50.0||||||
4038777|NCT01128153|3860612|B2|Australia||Region of Enrollment||Participants|Number|25|25.0||||||
4038778|NCT01128153|3860613|B1|Australia||Region of Enrollment||Participants|Number|25|25.0||||||
4038779|NCT01128153|3860611|B3|Asian||Race/Ethnicity, Customized||Participants|Number|141|141.0||||||
4038780|NCT01128153|3860612|B2|Asian||Race/Ethnicity, Customized||Participants|Number|71|71.0||||||
4038781|NCT01128153|3860613|B1|Asian||Race/Ethnicity, Customized||Participants|Number|70|70.0||||||
4038784|NCT01128153|3860613|B1|White||Race/Ethnicity, Customized||Participants|Number|59|59.0||||||
4038785|NCT01128153|3860611|B3||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4038786|NCT01128153|3860612|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4038787|NCT01128153|3860613|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4038788|NCT01128153|3860611|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4038789|NCT01128153|3860612|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4038790|NCT01128153|3860613|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4038791|NCT01128153|3860611|B3|||Age||years|Mean|57.0|57.0|Standard Deviation|10.54|10.54|||
4038792|NCT01128153|3860612|B2|||Age||years|Mean|56.8|56.8|Standard Deviation|11.49|11.49|||
4038793|NCT01128153|3860613|B1|||Age||years|Mean|57.2|57.2|Standard Deviation|9.55|9.55|||
4038794|NCT01128114|3860630|B1|Korea, Republic of||Region of Enrollment||participants|Number|32|32.0||||||
4038795|NCT01128114|3860630|B1|Female||Sex/Gender, Customized||participants|Number|18|18.0||||||
4038796|NCT01128114|3860630|B1|Male||Sex/Gender, Customized||participants|Number|10|10.0||||||
4038797|NCT01128114|3860630|B1|Unknown||Sex/Gender, Customized||participants|Number|4|4.0||||||
4038798|NCT01128114|3860630|B1|Unknown||Age, Customized||participants|Number|5|5.0||||||
4038799|NCT01128114|3860630|B1|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4038800|NCT01128114|3860630|B1|Between 18 and 65 years||Age, Customized||participants|Number|27|27.0||||||
4038801|NCT01128114|3860630|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4038802|NCT01128049|3860634|B4|United States||Region of Enrollment||participants|Number|15|15.0||||||
4038803|NCT01128049|3860635|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4038804|NCT01128049|3860636|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4038805|NCT01128049|3860637|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4038806|NCT01128049|3860634|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4038807|NCT01128049|3860635|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4038808|NCT01128049|3860636|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4038809|NCT01128049|3860637|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4038810|NCT01128049|3860634|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4038811|NCT01128049|3860635|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4038812|NCT01128049|3860636|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4038813|NCT01128049|3860637|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4038814|NCT01128049|3860634|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4038815|NCT01128049|3860635|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4038816|NCT01128049|3860636|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4038817|NCT01128049|3860637|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4038818|NCT01128049|3860634|B4||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4038819|NCT01128049|3860635|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4038820|NCT01128049|3860636|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4038821|NCT01128049|3860637|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4038822|NCT01128049|3860634|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038823|NCT01128049|3860635|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038824|NCT01128049|3860636|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038825|NCT01128049|3860637|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038826|NCT01127763|3860647|B1|||Number of prior chemotherapy regimens||chemotherapy regimens|Median|1|1.0|Full Range|||0.0|3.0|
4038827|NCT01127763|3860647|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4038828|NCT01127763|3860647|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4038829|NCT01127763|3860647|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4038830|NCT01127763|3860647|B1|||Age||years|Median|58|58.0|Full Range|||32.0|80.0|
4038831|NCT01127763|3860647|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4038832|NCT01127763|3860647|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4038833|NCT01127763|3860647|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038834|NCT01127737|3860656|B3|United States||Region of Enrollment||participants|Number|75|75.0||||||
4038835|NCT01127737|3860657|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
4038836|NCT01127737|3860658|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4038837|NCT01127737|3860656|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4038838|NCT01127737|3860657|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4038839|NCT01127737|3860658|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4038840|NCT01127737|3860656|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4038841|NCT01127737|3860657|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4038842|NCT01127737|3860658|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4038843|NCT01127737|3860656|B3|||Age||years|Median|60|60.0|Full Range|||25.0|79.0|
4038844|NCT01127737|3860657|B2|||Age||years|Median|61|61.0|Full Range|||32.0|76.0|
4038845|NCT01127737|3860658|B1|||Age||years|Median|58|58.0|Full Range|||25.0|74.0|
4038846|NCT01127659|3860665|B7|United States||Region of Enrollment||participants|Number|137|137.0||||||
4038847|NCT01127659|3860666|B6|United States||Region of Enrollment||participants|Number|21|21.0||||||
4038848|NCT01127659|3860667|B5|United States||Region of Enrollment||participants|Number|50|50.0||||||
4038849|NCT01127659|3860668|B4|United States||Region of Enrollment||participants|Number|22|22.0||||||
4038850|NCT01127659|3860669|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4038851|NCT01127659|3860670|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4038852|NCT01127659|3860671|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4038853|NCT01127659|3860665|B7||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4038854|NCT01127659|3860666|B6||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4038855|NCT01127659|3860667|B5||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4038856|NCT01127659|3860668|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4038857|NCT01127659|3860669|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4038858|NCT01127659|3860670|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4038859|NCT01127659|3860671|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4038860|NCT01127659|3860665|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4038861|NCT01127659|3860666|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4038862|NCT01127659|3860667|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4038863|NCT01127659|3860668|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4038864|NCT01127659|3860669|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4038865|NCT01127659|3860670|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4038866|NCT01127659|3860671|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4038867|NCT01127659|3860665|B7|||Age||years|Mean|52|52.0|Standard Deviation|8|8.0|||
4038868|NCT01127659|3860666|B6|||Age||years|Mean|50|50.0|Standard Deviation|8|8.0|||
4038869|NCT01127659|3860667|B5|||Age||years|Mean|52|52.0|Standard Deviation|9|9.0|||
4038870|NCT01127659|3860668|B4|||Age||years|Mean|54|54.0|Standard Deviation|9|9.0|||
4038871|NCT01127659|3860669|B3|||Age||years|Mean|53|53.0|Standard Deviation|7|7.0|||
4038872|NCT01127659|3860670|B2|||Age||years|Mean|46|46.0|Standard Deviation|9|9.0|||
4038873|NCT01127659|3860671|B1|||Age||years|Mean|54|54.0|Standard Deviation|7|7.0|||
4038874|NCT01127659|3860665|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4038875|NCT01127659|3860666|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4038876|NCT01127659|3860667|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4038877|NCT01127659|3860668|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4038878|NCT01127659|3860669|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4038879|NCT01127659|3860670|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4038880|NCT01127659|3860671|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4038881|NCT01127659|3860665|B7||Between 18 and 65 years|Age||Participants|Count of Participants|137|137.0||||||
4038882|NCT01127659|3860666|B6||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4038883|NCT01127659|3860667|B5||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4038884|NCT01127659|3860668|B4||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4038885|NCT01127659|3860669|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4038886|NCT01127659|3860670|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4038887|NCT01127659|3860671|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4038888|NCT01127659|3860665|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038889|NCT01127659|3860666|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038890|NCT01127659|3860667|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038891|NCT01127659|3860668|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038892|NCT01127659|3860669|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038893|NCT01127659|3860670|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038894|NCT01127659|3860671|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4038895|NCT01127646|3860690|B3|Missing||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype: Lifetime Episode|Lifetime episode refers to the most severe episode in the past.|participants|Number|1|1.0||||||
4038896|NCT01127646|3860691|B2|Missing||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype: Lifetime Episode|Lifetime episode refers to the most severe episode in the past.|participants|Number|0|0.0||||||
4038897|NCT01127646|3860692|B1|Missing||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype: Lifetime Episode|Lifetime episode refers to the most severe episode in the past.|participants|Number|1|1.0||||||
4038898|NCT01127646|3860690|B3|Subtype not present||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype: Lifetime Episode|Lifetime episode refers to the most severe episode in the past.|participants|Number|1|1.0||||||
4038899|NCT01127646|3860691|B2|Subtype not present||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype: Lifetime Episode|Lifetime episode refers to the most severe episode in the past.|participants|Number|0|0.0||||||
4038900|NCT01127646|3860692|B1|Subtype not present||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype: Lifetime Episode|Lifetime episode refers to the most severe episode in the past.|participants|Number|1|1.0||||||
4038901|NCT01127646|3860690|B3|Inattentive||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype: Lifetime Episode|Lifetime episode refers to the most severe episode in the past.|participants|Number|5|5.0||||||
4038902|NCT01127646|3860691|B2|Inattentive||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype: Lifetime Episode|Lifetime episode refers to the most severe episode in the past.|participants|Number|0|0.0||||||
4038903|NCT01127646|3860692|B1|Inattentive||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype: Lifetime Episode|Lifetime episode refers to the most severe episode in the past.|participants|Number|5|5.0||||||
4038904|NCT01127646|3860690|B3|Hyperactive/Impulsive||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype: Lifetime Episode|Lifetime episode refers to the most severe episode in the past.|participants|Number|1|1.0||||||
4038905|NCT01127646|3860691|B2|Hyperactive/Impulsive||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype: Lifetime Episode|Lifetime episode refers to the most severe episode in the past.|participants|Number|1|1.0||||||
4038906|NCT01127646|3860692|B1|Hyperactive/Impulsive||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype: Lifetime Episode|Lifetime episode refers to the most severe episode in the past.|participants|Number|0|0.0||||||
4038907|NCT01127646|3860690|B3|Combined||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype: Lifetime Episode|Lifetime episode refers to the most severe episode in the past.|participants|Number|15|15.0||||||
4038908|NCT01127646|3860691|B2|Combined||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype: Lifetime Episode|Lifetime episode refers to the most severe episode in the past.|participants|Number|7|7.0||||||
4038909|NCT01127646|3860692|B1|Combined||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype: Lifetime Episode|Lifetime episode refers to the most severe episode in the past.|participants|Number|8|8.0||||||
4038910|NCT01127646|3860690|B3|Missing||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype: Current Episode||participants|Number|1|1.0||||||
4038911|NCT01127646|3860691|B2|Missing||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype: Current Episode||participants|Number|0|0.0||||||
4038912|NCT01127646|3860692|B1|Missing||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype: Current Episode||participants|Number|1|1.0||||||
4038913|NCT01127646|3860690|B3|Subtype not present||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype: Current Episode||participants|Number|9|9.0||||||
4038914|NCT01127646|3860691|B2|Subtype not present||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype: Current Episode||participants|Number|3|3.0||||||
4038915|NCT01127646|3860692|B1|Subtype not present||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype: Current Episode||participants|Number|6|6.0||||||
4038916|NCT01127646|3860690|B3|Inattentive||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype: Current Episode||participants|Number|1|1.0||||||
4038917|NCT01127646|3860691|B2|Inattentive||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype: Current Episode||participants|Number|0|0.0||||||
4038918|NCT01127646|3860692|B1|Inattentive||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype: Current Episode||participants|Number|1|1.0||||||
4038919|NCT01127646|3860690|B3|Hyperactive/Impulsive||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype: Current Episode||participants|Number|1|1.0||||||
4038920|NCT01127646|3860691|B2|Hyperactive/Impulsive||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype: Current Episode||participants|Number|1|1.0||||||
4038921|NCT01127646|3860692|B1|Hyperactive/Impulsive||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype: Current Episode||participants|Number|0|0.0||||||
4038922|NCT01127646|3860690|B3|Combined||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype: Current Episode||participants|Number|11|11.0||||||
4038923|NCT01127646|3860691|B2|Combined||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype: Current Episode||participants|Number|4|4.0||||||
4038924|NCT01127646|3860692|B1|Combined||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype: Current Episode||participants|Number|7|7.0||||||
4038925|NCT01127646|3860690|B3|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
4038926|NCT01127646|3860691|B2|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
4038927|NCT01127646|3860692|B1|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
4038928|NCT01127646|3860690|B3|Spain||Region of Enrollment||participants|Number|20|20.0||||||
4038929|NCT01127646|3860691|B2|Spain||Region of Enrollment||participants|Number|8|8.0||||||
4038930|NCT01127646|3860692|B1|Spain||Region of Enrollment||participants|Number|12|12.0||||||
4038931|NCT01127646|3860690|B3|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4038932|NCT01127646|3860691|B2|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4038933|NCT01127646|3860692|B1|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4038934|NCT01127646|3860690|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038935|NCT01127646|3860691|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038936|NCT01127646|3860692|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038937|NCT01127646|3860690|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038938|NCT01127646|3860691|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038939|NCT01127646|3860692|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038940|NCT01127646|3860690|B3||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4038941|NCT01127646|3860691|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4038942|NCT01127646|3860692|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4038943|NCT01127646|3860690|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038944|NCT01127646|3860691|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038945|NCT01127646|3860692|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038946|NCT01127646|3860690|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038947|NCT01127646|3860691|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038948|NCT01127646|3860692|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038949|NCT01127646|3860690|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038950|NCT01127646|3860691|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038951|NCT01127646|3860692|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038952|NCT01127646|3860690|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4038953|NCT01127646|3860691|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4038954|NCT01127646|3860692|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4038955|NCT01127646|3860690|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4038956|NCT01127646|3860691|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4038957|NCT01127646|3860692|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4038958|NCT01127646|3860690|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4038959|NCT01127646|3860691|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4038960|NCT01127646|3860692|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4038961|NCT01127646|3860690|B3|||Age||years|Mean|10.8|10.8|Standard Deviation|2.64|2.64|||
4038962|NCT01127646|3860691|B2|||Age||years|Mean|10.9|10.9|Standard Deviation|2.80|2.8|||
4038963|NCT01127646|3860692|B1|||Age||years|Mean|10.8|10.8|Standard Deviation|2.65|2.65|||
4038964|NCT01127633|3860725|B3|Germany||Region of Enrollment||Participants|Count of Participants|79|79.0||||||
4038965|NCT01127633|3860726|B2|Germany||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
4038966|NCT01127633|3860727|B1|Germany||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
4038967|NCT01127633|3860725|B3|France||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
4038968|NCT01127633|3860726|B2|France||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4038969|NCT01127633|3860727|B1|France||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4038970|NCT01127633|3860725|B3|Australia||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
4038971|NCT01127633|3860726|B2|Australia||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4038972|NCT01127633|3860727|B1|Australia||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4038973|NCT01127633|3860725|B3|Italy||Region of Enrollment||Participants|Count of Participants|86|86.0||||||
4038974|NCT01127633|3860726|B2|Italy||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
4038975|NCT01127633|3860727|B1|Italy||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
4038976|NCT01127633|3860725|B3|Brazil||Region of Enrollment||Participants|Count of Participants|72|72.0||||||
4038977|NCT01127633|3860726|B2|Brazil||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
4038978|NCT01127633|3860727|B1|Brazil||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
4038979|NCT01127633|3860725|B3|Poland||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
4038980|NCT01127633|3860726|B2|Poland||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4038981|NCT01127633|3860727|B1|Poland||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4038982|NCT01127633|3860725|B3|Taiwan||Region of Enrollment||Participants|Count of Participants|49|49.0||||||
4038983|NCT01127633|3860726|B2|Taiwan||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4038984|NCT01127633|3860727|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
4038985|NCT01127633|3860725|B3|Sweden||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
4038986|NCT01127633|3860726|B2|Sweden||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4038987|NCT01127633|3860727|B1|Sweden||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
4038988|NCT01127633|3860725|B3|South Korea||Region of Enrollment||Participants|Count of Participants|65|65.0||||||
4038989|NCT01127633|3860726|B2|South Korea||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
4038990|NCT01127633|3860727|B1|South Korea||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
4038991|NCT01127633|3860725|B3|Canada||Region of Enrollment||Participants|Count of Participants|78|78.0||||||
4038992|NCT01127633|3860726|B2|Canada||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
4038993|NCT01127633|3860727|B1|Canada||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
4038994|NCT01127633|3860725|B3|Russia||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
4038995|NCT01127633|3860726|B2|Russia||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4038996|NCT01127633|3860727|B1|Russia||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4038997|NCT01127633|3860725|B3|Spain||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
4038998|NCT01127633|3860726|B2|Spain||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4038999|NCT01127633|3860727|B1|Spain||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4039000|NCT01127633|3860725|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
4039001|NCT01127633|3860726|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4039002|NCT01127633|3860727|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
4039003|NCT01127633|3860725|B3|Japan||Region of Enrollment||Participants|Count of Participants|156|156.0||||||
4039004|NCT01127633|3860726|B2|Japan||Region of Enrollment||Participants|Count of Participants|87|87.0||||||
4039005|NCT01127633|3860727|B1|Japan||Region of Enrollment||Participants|Count of Participants|69|69.0||||||
4039006|NCT01127633|3860725|B3|United States||Region of Enrollment||Participants|Count of Participants|507|507.0||||||
4039007|NCT01127633|3860726|B2|United States||Region of Enrollment||Participants|Count of Participants|243|243.0||||||
4039008|NCT01127633|3860727|B1|United States||Region of Enrollment||Participants|Count of Participants|264|264.0||||||
4039009|NCT01127633|3860725|B3|Argentina||Region of Enrollment||Participants|Count of Participants|81|81.0||||||
4039010|NCT01127633|3860726|B2|Argentina||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
4039011|NCT01127633|3860727|B1|Argentina||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
4039012|NCT01127633|3860725|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039013|NCT01127633|3860726|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039014|NCT01127633|3860727|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039015|NCT01127633|3860725|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4039016|NCT01127633|3860726|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4039017|NCT01127633|3860727|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4039018|NCT01127633|3860725|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1137|1137.0||||||
4039019|NCT01127633|3860726|B2||White|Race (NIH/OMB)||Participants|Count of Participants|566|566.0||||||
4039020|NCT01127633|3860727|B1||White|Race (NIH/OMB)||Participants|Count of Participants|571|571.0||||||
4039021|NCT01127633|3860725|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4039022|NCT01127633|3860726|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4039023|NCT01127633|3860727|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4039024|NCT01127633|3860725|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039025|NCT01127633|3860726|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039026|NCT01127633|3860727|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039027|NCT01127633|3860725|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|286|286.0||||||
4039028|NCT01127633|3860726|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|149|149.0||||||
4039029|NCT01127633|3860727|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|137|137.0||||||
4039030|NCT01127633|3860725|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039031|NCT01127633|3860726|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039032|NCT01127633|3860727|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039033|NCT01127633|3860725|B3||Male|Sex: Female, Male||Participants|Count of Participants|636|636.0||||||
4039034|NCT01127633|3860726|B2||Male|Sex: Female, Male||Participants|Count of Participants|319|319.0||||||
4039035|NCT01127633|3860727|B1||Male|Sex: Female, Male||Participants|Count of Participants|317|317.0||||||
4039036|NCT01127633|3860725|B3||Female|Sex: Female, Male||Participants|Count of Participants|821|821.0||||||
4039037|NCT01127633|3860726|B2||Female|Sex: Female, Male||Participants|Count of Participants|415|415.0||||||
4039038|NCT01127633|3860727|B1||Female|Sex: Female, Male||Participants|Count of Participants|406|406.0||||||
4039039|NCT01127633|3860725|B3|||Age||Years|Mean|73.03|73.03|Standard Deviation|7.883|7.883|||
4039040|NCT01127633|3860726|B2|||Age||Years|Mean|72.96|72.96|Standard Deviation|7.766|7.766|||
4039041|NCT01127633|3860727|B1|||Age||Years|Mean|73.10|73.1|Standard Deviation|8.004|8.004|||
4039042|NCT01127607|3860758|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
4039043|NCT01127607|3860759|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4039044|NCT01127607|3860760|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4039045|NCT01127607|3860758|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4039046|NCT01127607|3860759|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4039047|NCT01127607|3860760|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4039048|NCT01127607|3860758|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4039049|NCT01127607|3860759|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4039050|NCT01127607|3860760|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4039051|NCT01127607|3860758|B3|||Age||years|Mean|41.04|41.04|Standard Deviation|5.20|5.2|||
4039052|NCT01127607|3860759|B2|||Age||years|Mean|40.69|40.69|Standard Deviation|6.06|6.06|||
4039053|NCT01127607|3860760|B1|||Age||years|Mean|41.38|41.38|Standard Deviation|4.41|4.41|||
4039054|NCT01127607|3860758|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4039055|NCT01127607|3860759|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4039056|NCT01127607|3860760|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4039057|NCT01127607|3860758|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4039058|NCT01127607|3860759|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4039059|NCT01127607|3860760|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4039060|NCT01127607|3860758|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4039061|NCT01127607|3860759|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4039062|NCT01127607|3860760|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4039063|NCT01127581|3860832|B3|United States||Region of Enrollment||participants|Number|1358|1358.0||||||
4039064|NCT01127581|3860833|B2|United States||Region of Enrollment||participants|Number|680|680.0||||||
4039065|NCT01127581|3860834|B1|United States||Region of Enrollment||participants|Number|678|678.0||||||
4039066|NCT01127581|3860832|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4039067|NCT01127581|3860833|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4039068|NCT01127581|3860834|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4039069|NCT01127581|3860832|B3||Female|Sex: Female, Male||Participants|Count of Participants|1358|1358.0||||||
4039070|NCT01127581|3860833|B2||Female|Sex: Female, Male||Participants|Count of Participants|680|680.0||||||
4039071|NCT01127581|3860834|B1||Female|Sex: Female, Male||Participants|Count of Participants|678|678.0||||||
4039072|NCT01127581|3860832|B3|||Age||years|Mean|26.0|26.0|Standard Deviation|5.96|5.96|||
4039073|NCT01127581|3860833|B2|||Age||years|Mean|25.9|25.9|Standard Deviation|5.95|5.95|||
4039074|NCT01127581|3860834|B1|||Age||years|Mean|26.2|26.2|Standard Deviation|5.99|5.99|||
4039075|NCT01127581|3860832|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4039076|NCT01127581|3860833|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4039077|NCT01127581|3860834|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4039078|NCT01127581|3860832|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1358|1358.0||||||
4039079|NCT01127581|3860833|B2||Between 18 and 65 years|Age||Participants|Count of Participants|680|680.0||||||
4039080|NCT01127581|3860834|B1||Between 18 and 65 years|Age||Participants|Count of Participants|678|678.0||||||
4039081|NCT01127581|3860832|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4039082|NCT01127581|3860833|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4039083|NCT01127581|3860834|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4039084|NCT01127503|3860861|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4039085|NCT01127503|3860862|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4039086|NCT01127503|3860863|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4039087|NCT01127503|3860861|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4039088|NCT01127503|3860862|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4039089|NCT01127503|3860863|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4039090|NCT01127503|3860861|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4039091|NCT01127503|3860862|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4039092|NCT01127503|3860863|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4039093|NCT01127503|3860861|B3|32||Age, Customized||participants|Number|1|1.0||||||
4039094|NCT01127503|3860862|B2|32||Age, Customized||participants|Number|1|1.0||||||
4039095|NCT01127503|3860863|B1|32||Age, Customized||participants|Number|0|0.0||||||
4039096|NCT01127503|3860861|B3|22||Age, Customized||participants|Number|1|1.0||||||
4039097|NCT01127503|3860862|B2|22||Age, Customized||participants|Number|0|0.0||||||
4039098|NCT01127503|3860863|B1|22||Age, Customized||participants|Number|1|1.0||||||
4039099|NCT01127438|3860870|B7|Other||Race/Ethnicity, Customized|Safety Analysis Set.|Participants|Number|1|1.0||||||
4039100|NCT01127438|3860871|B6|Other||Race/Ethnicity, Customized|Safety Analysis Set.|Participants|Number|0|0.0||||||
4039101|NCT01127438|3860872|B5|Other||Race/Ethnicity, Customized|Safety Analysis Set.|Participants|Number|0|0.0||||||
4039102|NCT01127438|3860873|B4|Other||Race/Ethnicity, Customized|Safety Analysis Set.|Participants|Number|0|0.0||||||
4039103|NCT01127438|3860874|B3|Other||Race/Ethnicity, Customized|Safety Analysis Set.|Participants|Number|0|0.0||||||
4039104|NCT01127438|3860875|B2|Other||Race/Ethnicity, Customized|Safety Analysis Set.|Participants|Number|0|0.0||||||
4039105|NCT01127438|3860876|B1|Other||Race/Ethnicity, Customized|Safety Analysis Set.|Participants|Number|1|1.0||||||
4039106|NCT01127438|3860870|B7|American Indian or Alaska Native||Race/Ethnicity, Customized|Safety Analysis Set.|Participants|Number|1|1.0||||||
4039107|NCT01127438|3860871|B6|American Indian or Alaska Native||Race/Ethnicity, Customized|Safety Analysis Set.|Participants|Number|0|0.0||||||
4039108|NCT01127438|3860872|B5|American Indian or Alaska Native||Race/Ethnicity, Customized|Safety Analysis Set.|Participants|Number|0|0.0||||||
4039109|NCT01127438|3860873|B4|American Indian or Alaska Native||Race/Ethnicity, Customized|Safety Analysis Set.|Participants|Number|0|0.0||||||
4039110|NCT01127438|3860874|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|Safety Analysis Set.|Participants|Number|1|1.0||||||
4039111|NCT01127438|3860875|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|Safety Analysis Set.|Participants|Number|0|0.0||||||
4039112|NCT01127438|3860876|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Safety Analysis Set.|Participants|Number|0|0.0||||||
4039113|NCT01127438|3860870|B7|Asian||Race/Ethnicity, Customized|Safety Analysis Set.|Participants|Number|13|13.0||||||
4039114|NCT01127438|3860871|B6|Asian||Race/Ethnicity, Customized|Safety Analysis Set.|Participants|Number|0|0.0||||||
4039115|NCT01127438|3860872|B5|Asian||Race/Ethnicity, Customized|Safety Analysis Set.|Participants|Number|1|1.0||||||
4039116|NCT01127438|3860873|B4|Asian||Race/Ethnicity, Customized|Safety Analysis Set.|Participants|Number|3|3.0||||||
4039117|NCT01127438|3860874|B3|Asian||Race/Ethnicity, Customized|Safety Analysis Set.|Participants|Number|4|4.0||||||
4039118|NCT01127438|3860875|B2|Asian||Race/Ethnicity, Customized|Safety Analysis Set.|Participants|Number|2|2.0||||||
4039119|NCT01127438|3860876|B1|Asian||Race/Ethnicity, Customized|Safety Analysis Set.|Participants|Number|3|3.0||||||
4039120|NCT01127438|3860870|B7|Black or African American||Race/Ethnicity, Customized|Safety Analysis Set.|Participants|Number|11|11.0||||||
4039121|NCT01127438|3860871|B6|Black or African American||Race/Ethnicity, Customized|Safety Analysis Set.|Participants|Number|0|0.0||||||
4039122|NCT01127438|3860872|B5|Black or African American||Race/Ethnicity, Customized|Safety Analysis Set.|Participants|Number|5|5.0||||||
4039123|NCT01127438|3860873|B4|Black or African American||Race/Ethnicity, Customized|Safety Analysis Set.|Participants|Number|1|1.0||||||
4039124|NCT01127438|3860874|B3|Black or African American||Race/Ethnicity, Customized|Safety Analysis Set.|Participants|Number|2|2.0||||||
4039125|NCT01127438|3860875|B2|Black or African American||Race/Ethnicity, Customized|Safety Analysis Set.|Participants|Number|2|2.0||||||
4039126|NCT01127438|3860876|B1|Black or African American||Race/Ethnicity, Customized|Safety Analysis Set.|Participants|Number|1|1.0||||||
4039127|NCT01127438|3860870|B7|White||Race/Ethnicity, Customized|Safety Analysis Set.|Participants|Number|127|127.0||||||
4039128|NCT01127438|3860871|B6|White||Race/Ethnicity, Customized|Safety Analysis Set.|Participants|Number|25|25.0||||||
4039129|NCT01127438|3860872|B5|White||Race/Ethnicity, Customized|Safety Analysis Set.|Participants|Number|22|22.0||||||
4039130|NCT01127438|3860873|B4|White||Race/Ethnicity, Customized|Safety Analysis Set.|Participants|Number|20|20.0||||||
4039131|NCT01127438|3860874|B3|White||Race/Ethnicity, Customized|Safety Analysis Set.|Participants|Number|19|19.0||||||
4039132|NCT01127438|3860875|B2|White||Race/Ethnicity, Customized|Safety Analysis Set.|Participants|Number|21|21.0||||||
4039133|NCT01127438|3860876|B1|White||Race/Ethnicity, Customized|Safety Analysis Set.|Participants|Number|20|20.0||||||
4039134|NCT01127438|3860870|B7||Male|Sex: Female, Male|Safety Analysis Set: All subjects who received atleast one dose of study medication and had atleast one postdose safety assessment.|Participants|Count of Participants|38|38.0||||||
4039135|NCT01127438|3860871|B6||Male|Sex: Female, Male|Safety Analysis Set: All subjects who received atleast one dose of study medication and had atleast one postdose safety assessment.|Participants|Count of Participants|16|16.0||||||
4039136|NCT01127438|3860872|B5||Male|Sex: Female, Male|Safety Analysis Set: All subjects who received atleast one dose of study medication and had atleast one postdose safety assessment.|Participants|Count of Participants|15|15.0||||||
4039137|NCT01127438|3860873|B4||Male|Sex: Female, Male|Safety Analysis Set: All subjects who received atleast one dose of study medication and had atleast one postdose safety assessment.|Participants|Count of Participants|3|3.0||||||
4039138|NCT01127438|3860874|B3||Male|Sex: Female, Male|Safety Analysis Set: All subjects who received atleast one dose of study medication and had atleast one postdose safety assessment.|Participants|Count of Participants|3|3.0||||||
4039139|NCT01127438|3860875|B2||Male|Sex: Female, Male|Safety Analysis Set: All subjects who received atleast one dose of study medication and had atleast one postdose safety assessment.|Participants|Count of Participants|1|1.0||||||
4039140|NCT01127438|3860876|B1||Male|Sex: Female, Male|Safety Analysis Set: All subjects who received atleast one dose of study medication and had atleast one postdose safety assessment.|Participants|Count of Participants|0|0.0||||||
4039141|NCT01127438|3860870|B7||Female|Sex: Female, Male|Safety Analysis Set: All subjects who received atleast one dose of study medication and had atleast one postdose safety assessment.|Participants|Count of Participants|115|115.0||||||
4039142|NCT01127438|3860871|B6||Female|Sex: Female, Male|Safety Analysis Set: All subjects who received atleast one dose of study medication and had atleast one postdose safety assessment.|Participants|Count of Participants|9|9.0||||||
4039143|NCT01127438|3860872|B5||Female|Sex: Female, Male|Safety Analysis Set: All subjects who received atleast one dose of study medication and had atleast one postdose safety assessment.|Participants|Count of Participants|13|13.0||||||
4039144|NCT01127438|3860873|B4||Female|Sex: Female, Male|Safety Analysis Set: All subjects who received atleast one dose of study medication and had atleast one postdose safety assessment.|Participants|Count of Participants|21|21.0||||||
4039145|NCT01127438|3860874|B3||Female|Sex: Female, Male|Safety Analysis Set: All subjects who received atleast one dose of study medication and had atleast one postdose safety assessment.|Participants|Count of Participants|23|23.0||||||
4039146|NCT01127438|3860875|B2||Female|Sex: Female, Male|Safety Analysis Set: All subjects who received atleast one dose of study medication and had atleast one postdose safety assessment.|Participants|Count of Participants|24|24.0||||||
4039147|NCT01127438|3860876|B1||Female|Sex: Female, Male|Safety Analysis Set: All subjects who received atleast one dose of study medication and had atleast one postdose safety assessment.|Participants|Count of Participants|25|25.0||||||
4039148|NCT01127438|3860870|B7|>=65 Years||Age, Customized|Safety Analysis Set.|Participants|Number|76|76.0||||||
4039149|NCT01127438|3860871|B6|>=65 Years||Age, Customized|Safety Analysis Set.|Participants|Number|20|20.0||||||
4039150|NCT01127438|3860872|B5|>=65 Years||Age, Customized|Safety Analysis Set.|Participants|Number|20|20.0||||||
4039151|NCT01127438|3860873|B4|>=65 Years||Age, Customized|Safety Analysis Set.|Participants|Number|16|16.0||||||
4039152|NCT01127438|3860874|B3|>=65 Years||Age, Customized|Safety Analysis Set.|Participants|Number|20|20.0||||||
4039153|NCT01127438|3860875|B2|>=65 Years||Age, Customized|Safety Analysis Set.|Participants|Number|0|0.0||||||
4039154|NCT01127438|3860876|B1|>=65 Years||Age, Customized|Safety Analysis Set.|Participants|Number|0|0.0||||||
4039155|NCT01127438|3860870|B7|<65 Years||Age, Customized|Safety Analysis Set.|Participants|Number|77|77.0||||||
4039156|NCT01127438|3860871|B6|<65 Years||Age, Customized|Safety Analysis Set.|Participants|Number|5|5.0||||||
4039157|NCT01127438|3860872|B5|<65 Years||Age, Customized|Safety Analysis Set.|Participants|Number|8|8.0||||||
4039158|NCT01127438|3860873|B4|<65 Years||Age, Customized|Safety Analysis Set.|Participants|Number|8|8.0||||||
4039159|NCT01127438|3860874|B3|<65 Years||Age, Customized|Safety Analysis Set.|Participants|Number|6|6.0||||||
4039160|NCT01127438|3860875|B2|<65 Years||Age, Customized|Safety Analysis Set.|Participants|Number|25|25.0||||||
4039161|NCT01127438|3860876|B1|<65 Years||Age, Customized|Safety Analysis Set.|Participants|Number|25|25.0||||||
4039162|NCT01127321|3860903|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4039163|NCT01127321|3860904|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4039164|NCT01127321|3860905|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4039165|NCT01127321|3860906|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4039166|NCT01127321|3860907|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4039167|NCT01127321|3860908|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4039168|NCT01127321|3860903|B6||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4039169|NCT01127321|3860904|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4039170|NCT01127321|3860905|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4039171|NCT01127321|3860906|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4039172|NCT01127321|3860907|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4039173|NCT01127321|3860908|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4039174|NCT01127321|3860903|B6|||Age||years|Mean|38.4|38.4|Standard Deviation|16.1|16.1|||
4039175|NCT01127321|3860904|B5|||Age||years|Mean|39.6|39.6|Standard Deviation|13.8|13.8|||
4039176|NCT01127321|3860905|B4|||Age||years|Mean|35.6|35.6|Standard Deviation|22.2|22.2|||
4039177|NCT01127321|3860906|B3|||Age||years|Mean|41.0|41.0|Standard Deviation|NA||||Standard deviation was not available as there was only 1 participant analyzed for this group.
4039178|NCT01127321|3860907|B2|||Age||years|Mean|49.0|49.0|Standard Deviation|NA||||Standard deviation was not available as there was only 1 participant analyzed for this group.
4039179|NCT01127321|3860908|B1|||Age||years|Mean|38.3|38.3|Standard Deviation|10.6|10.6|||
4039180|NCT01127256|3860934|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039181|NCT01127256|3860935|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039182|NCT01127256|3860936|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039183|NCT01127256|3860934|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039184|NCT01127256|3860935|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039185|NCT01127256|3860936|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039186|NCT01127256|3860934|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039187|NCT01127256|3860935|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039188|NCT01127256|3860936|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039189|NCT01127256|3860934|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039190|NCT01127256|3860935|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039191|NCT01127256|3860936|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039192|NCT01127256|3860934|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039193|NCT01127256|3860935|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039194|NCT01127256|3860936|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039195|NCT01127256|3860934|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|200|200.0||||||
4039196|NCT01127256|3860935|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
4039197|NCT01127256|3860936|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4039198|NCT01127256|3860934|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039199|NCT01127256|3860935|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039200|NCT01127256|3860936|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039201|NCT01127256|3860934|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4039202|NCT01127256|3860935|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4039203|NCT01127256|3860936|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4039204|NCT01127256|3860934|B3||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4039205|NCT01127256|3860935|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4039206|NCT01127256|3860936|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4039207|NCT01127256|3860934|B3|||Age||years|Mean|37.7|37.7|Standard Deviation|15.6|15.6|||
4039208|NCT01127256|3860935|B2|||Age||years|Mean|35.7|35.7|Standard Deviation|15.1|15.1|||
4039209|NCT01127256|3860936|B1|||Age||years|Mean|39.8|39.8|Standard Deviation|15.9|15.9|||
4039210|NCT01127165|3860947|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039211|NCT01127165|3860948|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039212|NCT01127165|3860949|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039213|NCT01127165|3860947|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039214|NCT01127165|3860948|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039215|NCT01127165|3860949|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039216|NCT01127165|3860947|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039217|NCT01127165|3860948|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039218|NCT01127165|3860949|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039219|NCT01127165|3860947|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039220|NCT01127165|3860948|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039221|NCT01127165|3860949|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039222|NCT01127165|3860947|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039223|NCT01127165|3860948|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039224|NCT01127165|3860949|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039225|NCT01127165|3860947|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
4039226|NCT01127165|3860948|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4039227|NCT01127165|3860949|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4039228|NCT01127165|3860947|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039229|NCT01127165|3860948|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039230|NCT01127165|3860949|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039231|NCT01127165|3860947|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4039232|NCT01127165|3860948|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4039233|NCT01127165|3860949|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4039234|NCT01127165|3860947|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4039235|NCT01127165|3860948|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4039236|NCT01127165|3860949|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4039237|NCT01127165|3860947|B3|||Age||years|Mean|8.1|8.1|Standard Deviation|3.0|3.0|||
4039238|NCT01127165|3860948|B2|||Age||years|Mean|7.8|7.8|Standard Deviation|3.0|3.0|||
4039239|NCT01127165|3860949|B1|||Age||years|Mean|8.3|8.3|Standard Deviation|3.0|3.0|||
4039240|NCT01127139|3860962|B1||Male|Sex: Female, Male||Participants|Count of Participants|1885|1885.0||||||
4039241|NCT01127139|3860962|B1||Female|Sex: Female, Male||Participants|Count of Participants|1943|1943.0||||||
4039242|NCT01127139|3860962|B1|Age not reported||Age, Customized||Participants|Number|3828|3828.0||||||
4039243|NCT01127087|3860977|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4039244|NCT01127087|3860978|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4039245|NCT01127087|3860979|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4039246|NCT01127087|3860977|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4039247|NCT01127087|3860978|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4039248|NCT01127087|3860979|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4039249|NCT01127087|3860977|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4039250|NCT01127087|3860978|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4039251|NCT01127087|3860979|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4039252|NCT01127087|3860977|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4039253|NCT01127087|3860978|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4039254|NCT01127087|3860979|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4039255|NCT01127087|3860977|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4039256|NCT01127087|3860978|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4039257|NCT01127087|3860979|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4039258|NCT01127087|3860977|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4039259|NCT01127087|3860978|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4039260|NCT01127087|3860979|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4039261|NCT01126957|3860988|B1|Male and Female||Sex/Gender, Customized||Participants|Count of Participants|107|107.0||||||
4039262|NCT01126957|3860988|B1|Age >1 year||Age, Customized||Participants|Count of Participants|107|107.0||||||
4039263|NCT01126801|3860993|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4039264|NCT01126801|3860994|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4039265|NCT01126801|3860995|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4039266|NCT01126801|3860993|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4039267|NCT01126801|3860994|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4039268|NCT01126801|3860995|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4039269|NCT01126801|3860993|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4039270|NCT01126801|3860994|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4039271|NCT01126801|3860995|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4039272|NCT01126801|3860993|B3|||Age||years|Mean|52.5|52.5|Standard Deviation|3.5|3.5|||
4039273|NCT01126801|3860994|B2|||Age||years|Mean|55|55.0|Standard Deviation|0|0.0|||
4039274|NCT01126801|3860995|B1|||Age||years|Mean|50|50.0|Standard Deviation|0|0.0|||
4039275|NCT01126723|3861004|B3|Nonfrail||Frailty Index||participants|Number|7|7.0||||||
4039276|NCT01126723|3861005|B2|Nonfrail||Frailty Index||participants|Number|2|2.0||||||
4039277|NCT01126723|3861006|B1|Nonfrail||Frailty Index||participants|Number|5|5.0||||||
4039278|NCT01126723|3861004|B3|Prefrail||Frailty Index||participants|Number|43|43.0||||||
4039279|NCT01126723|3861005|B2|Prefrail||Frailty Index||participants|Number|23|23.0||||||
4039280|NCT01126723|3861006|B1|Prefrail||Frailty Index||participants|Number|20|20.0||||||
4039281|NCT01126723|3861004|B3|Frail||Frailty Index||participants|Number|16|16.0||||||
4039282|NCT01126723|3861005|B2|Frail||Frailty Index||participants|Number|6|6.0||||||
4039283|NCT01126723|3861006|B1|Frail||Frailty Index||participants|Number|10|10.0||||||
4039284|NCT01126723|3861004|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4039285|NCT01126723|3861005|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4039286|NCT01126723|3861006|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4039287|NCT01126723|3861004|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4039288|NCT01126723|3861005|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4039289|NCT01126723|3861006|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4039290|NCT01126723|3861004|B3|||Age||years|Mean|87|87.0|Standard Deviation|6|6.0|||
4039291|NCT01126723|3861005|B2|||Age||years|Mean|86|86.0|Standard Deviation|6|6.0|||
4039292|NCT01126723|3861006|B1|||Age||years|Mean|87|87.0|Standard Deviation|5|5.0|||
4039293|NCT01126671|3861013|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
4039294|NCT01126671|3861014|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4039295|NCT01126671|3861015|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4039296|NCT01126671|3861013|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4039297|NCT01126671|3861014|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4039298|NCT01126671|3861015|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4039299|NCT01126671|3861013|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4039300|NCT01126671|3861014|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4039301|NCT01126671|3861015|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4039302|NCT01126671|3861013|B3|||Age||years|Mean|16.1|16.1|Standard Deviation|2.2|2.2|||
4039303|NCT01126671|3861014|B2|||Age||years|Mean|16.1|16.1|Standard Deviation|2.2|2.2|||
4039304|NCT01126671|3861015|B1|||Age||years|Mean|16.1|16.1|Standard Deviation|2.2|2.2|||
4039305|NCT01126671|3861013|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4039306|NCT01126671|3861014|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4039307|NCT01126671|3861015|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4039308|NCT01126671|3861013|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4039309|NCT01126671|3861014|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4039310|NCT01126671|3861015|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4039311|NCT01126671|3861013|B3||<=18 years|Age||Participants|Count of Participants|50|50.0||||||
4039312|NCT01126671|3861014|B2||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
4039313|NCT01126671|3861015|B1||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
4039314|NCT01126619|3861028|B1|||Duration of Psoriasis|Data available for 102 participants.|years|Mean|15.7|15.7|Standard Deviation|9.2|9.2|||
4039315|NCT01126619|3861028|B1|||Dermatology Life Quality Index (DLQI) Score|DLQI is a questionnaire to evaluate dermatology patients for their quality of life for the following subsets of parameters: symptoms and feelings, daily activities, leisure activities, work or school activities, personal relationships and treatment related feelings. Questions related with these parameters are summed up and the range of the total score is 0 to 30. A score of 21 to 30 means an extremely large effect on patient’s life whereas 0-1 means that the disease has no effect at all.|scores on a scale|Mean|15.1|15.1|Standard Deviation|7.3|7.3|||
4039316|NCT01126619|3861028|B1|||Psoriasis Area and Severity Index (PASI) Score|Psoriasis Area and Severity Index (PASI) score is based on assessment of erythema (reddening), induration (plaque thickness), desquamation (scaling), and area affected as observed on the day of examination. The score ranges from 0 (best outcome) to 72 (worst outcome).|scores on a scale|Mean|20.8|20.8|Standard Deviation|11.2|11.2|||
4039317|NCT01126619|3861028|B1|||Body Mass Index (BMI)|Data available for 101 participants.|kg/m^2|Mean|29.3|29.3|Standard Deviation|14.9|14.9|||
4039318|NCT01126619|3861028|B1|||Height|Data available for 101 participants.|cm|Mean|166.9|166.9|Standard Deviation|13.5|13.5|||
4039319|NCT01126619|3861028|B1|||Weight|Data available for 102 participants.|kg|Mean|78.5|78.5|Standard Deviation|16.0|16.0|||
4039320|NCT01126619|3861028|B1|Turkey||Region of Enrollment||participants|Number|103|103.0||||||
4039321|NCT01126619|3861028|B1|Male||Gender|Data available for 102 participants.|participants|Number|62|62.0||||||
4039322|NCT01126619|3861028|B1|Female||Gender|Data available for 102 participants.|participants|Number|40|40.0||||||
4039323|NCT01126619|3861028|B1|||Age|Data available for 102 participants.|years|Mean|44.9|44.9|Standard Deviation|13.9|13.9|||
4039324|NCT01126593|3861040|B4|United States||Region of Enrollment||participants|Number|88|88.0||||||
4039325|NCT01126593|3861041|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4039326|NCT01126593|3861042|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4039327|NCT01126593|3861043|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4039328|NCT01126593|3861040|B4||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4039329|NCT01126593|3861041|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4039330|NCT01126593|3861042|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4039331|NCT01126593|3861043|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4039332|NCT01126593|3861040|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4039333|NCT01126593|3861041|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4039334|NCT01126593|3861042|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4039335|NCT01126593|3861043|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4039336|NCT01126593|3861040|B4|||Age||years|Mean|57|57.0|Standard Deviation|0.8|0.8|||
4039337|NCT01126593|3861041|B3|||Age||years|Mean|56|56.0|Standard Deviation|0.8|0.8|||
4039338|NCT01126593|3861042|B2|||Age||years|Mean|58|58.0|Standard Deviation|0.6|0.6|||
4039339|NCT01126593|3861043|B1|||Age||years|Mean|56|56.0|Standard Deviation|0.9|0.9|||
4039340|NCT01126580|3861053|B4|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|7.60|7.6|Standard Deviation|0.87|0.87|||
4039341|NCT01126580|3861054|B3|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|7.60|7.6|Standard Deviation|0.82|0.82|||
4039342|NCT01126580|3861055|B2|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|7.58|7.58|Standard Deviation|0.87|0.87|||
4039343|NCT01126580|3861056|B1|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|7.63|7.63|Standard Deviation|0.92|0.92|||
4039344|NCT01126580|3861053|B4|||Duration of Diabetes||years|Mean|2.63|2.63|Standard Deviation|1.83|1.83|||
4039345|NCT01126580|3861054|B3|||Duration of Diabetes||years|Mean|2.63|2.63|Standard Deviation|1.77|1.77|||
4039346|NCT01126580|3861055|B2|||Duration of Diabetes||years|Mean|2.60|2.6|Standard Deviation|2.17|2.17|||
4039347|NCT01126580|3861056|B1|||Duration of Diabetes||years|Mean|2.65|2.65|Standard Deviation|1.50|1.5|||
4039348|NCT01126580|3861053|B4|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|33.26|33.26|Standard Deviation|5.53|5.53|||
4039349|NCT01126580|3861054|B3|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|33.05|33.05|Standard Deviation|5.06|5.06|||
4039350|NCT01126580|3861055|B2|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|33.08|33.08|Standard Deviation|5.84|5.84|||
4039351|NCT01126580|3861056|B1|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|33.66|33.66|Standard Deviation|5.65|5.65|||
4039352|NCT01126580|3861053|B4|||Body Weight||kilograms (kg)|Mean|92.28|92.28|Standard Deviation|18.87|18.87|||
4039353|NCT01126580|3861054|B3|||Body Weight||kilograms (kg)|Mean|92.40|92.4|Standard Deviation|19.23|19.23|||
4039354|NCT01126580|3861055|B2|||Body Weight||kilograms (kg)|Mean|91.79|91.79|Standard Deviation|18.67|18.67|||
4039355|NCT01126580|3861056|B1|||Body Weight||kilograms (kg)|Mean|92.67|92.67|Standard Deviation|18.79|18.79|||
4039356|NCT01126580|3861053|B4|Korea, Republic of||Region of Enrollment||participants|Number|12|12.0||||||
4039357|NCT01126580|3861054|B3|Korea, Republic of||Region of Enrollment||participants|Number|5|5.0||||||
4039358|NCT01126580|3861055|B2|Korea, Republic of||Region of Enrollment||participants|Number|4|4.0||||||
4039359|NCT01126580|3861056|B1|Korea, Republic of||Region of Enrollment||participants|Number|3|3.0||||||
4039360|NCT01126580|3861053|B4|Germany||Region of Enrollment||participants|Number|64|64.0||||||
4039361|NCT01126580|3861054|B3|Germany||Region of Enrollment||participants|Number|21|21.0||||||
4039362|NCT01126580|3861055|B2|Germany||Region of Enrollment||participants|Number|21|21.0||||||
4039363|NCT01126580|3861056|B1|Germany||Region of Enrollment||participants|Number|22|22.0||||||
4039364|NCT01126580|3861053|B4|South Africa||Region of Enrollment||participants|Number|35|35.0||||||
4039365|NCT01126580|3861054|B3|South Africa||Region of Enrollment||participants|Number|12|12.0||||||
4039366|NCT01126580|3861055|B2|South Africa||Region of Enrollment||participants|Number|11|11.0||||||
4039367|NCT01126580|3861056|B1|South Africa||Region of Enrollment||participants|Number|12|12.0||||||
4039368|NCT01126580|3861053|B4|Romania||Region of Enrollment||participants|Number|40|40.0||||||
4039369|NCT01126580|3861054|B3|Romania||Region of Enrollment||participants|Number|13|13.0||||||
4039370|NCT01126580|3861055|B2|Romania||Region of Enrollment||participants|Number|13|13.0||||||
4039371|NCT01126580|3861056|B1|Romania||Region of Enrollment||participants|Number|14|14.0||||||
4039372|NCT01126580|3861053|B4|Croatia||Region of Enrollment||participants|Number|11|11.0||||||
4039373|NCT01126580|3861054|B3|Croatia||Region of Enrollment||participants|Number|4|4.0||||||
4039374|NCT01126580|3861055|B2|Croatia||Region of Enrollment||participants|Number|4|4.0||||||
4039375|NCT01126580|3861056|B1|Croatia||Region of Enrollment||participants|Number|3|3.0||||||
4039376|NCT01126580|3861053|B4|Brazil||Region of Enrollment||participants|Number|7|7.0||||||
4039377|NCT01126580|3861054|B3|Brazil||Region of Enrollment||participants|Number|3|3.0||||||
4039378|NCT01126580|3861055|B2|Brazil||Region of Enrollment||participants|Number|2|2.0||||||
4039379|NCT01126580|3861056|B1|Brazil||Region of Enrollment||participants|Number|2|2.0||||||
4039380|NCT01126580|3861053|B4|Poland||Region of Enrollment||participants|Number|18|18.0||||||
4039381|NCT01126580|3861054|B3|Poland||Region of Enrollment||participants|Number|5|5.0||||||
4039382|NCT01126580|3861055|B2|Poland||Region of Enrollment||participants|Number|6|6.0||||||
4039383|NCT01126580|3861056|B1|Poland||Region of Enrollment||participants|Number|7|7.0||||||
4039384|NCT01126580|3861053|B4|Argentina||Region of Enrollment||participants|Number|80|80.0||||||
4039385|NCT01126580|3861054|B3|Argentina||Region of Enrollment||participants|Number|26|26.0||||||
4039386|NCT01126580|3861055|B2|Argentina||Region of Enrollment||participants|Number|27|27.0||||||
4039387|NCT01126580|3861056|B1|Argentina||Region of Enrollment||participants|Number|27|27.0||||||
4039388|NCT01126580|3861053|B4|Puerto Rico||Region of Enrollment||participants|Number|39|39.0||||||
4039389|NCT01126580|3861054|B3|Puerto Rico||Region of Enrollment||participants|Number|15|15.0||||||
4039390|NCT01126580|3861055|B2|Puerto Rico||Region of Enrollment||participants|Number|10|10.0||||||
4039391|NCT01126580|3861056|B1|Puerto Rico||Region of Enrollment||participants|Number|14|14.0||||||
4039392|NCT01126580|3861053|B4|Canada||Region of Enrollment||participants|Number|30|30.0||||||
4039393|NCT01126580|3861054|B3|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4039394|NCT01126580|3861055|B2|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4039395|NCT01126580|3861056|B1|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4039396|NCT01126580|3861053|B4|Mexico||Region of Enrollment||participants|Number|72|72.0||||||
4039397|NCT01126580|3861054|B3|Mexico||Region of Enrollment||participants|Number|23|23.0||||||
4039398|NCT01126580|3861055|B2|Mexico||Region of Enrollment||participants|Number|25|25.0||||||
4039399|NCT01126580|3861056|B1|Mexico||Region of Enrollment||participants|Number|24|24.0||||||
4039400|NCT01126580|3861053|B4|Czech Republic||Region of Enrollment||participants|Number|27|27.0||||||
4039401|NCT01126580|3861054|B3|Czech Republic||Region of Enrollment||participants|Number|8|8.0||||||
4039402|NCT01126580|3861055|B2|Czech Republic||Region of Enrollment||participants|Number|9|9.0||||||
4039403|NCT01126580|3861056|B1|Czech Republic||Region of Enrollment||participants|Number|10|10.0||||||
4039404|NCT01126580|3861053|B4|France||Region of Enrollment||participants|Number|37|37.0||||||
4039405|NCT01126580|3861054|B3|France||Region of Enrollment||participants|Number|13|13.0||||||
4039406|NCT01126580|3861055|B2|France||Region of Enrollment||participants|Number|12|12.0||||||
4039407|NCT01126580|3861056|B1|France||Region of Enrollment||participants|Number|12|12.0||||||
4039408|NCT01126580|3861053|B4|India||Region of Enrollment||participants|Number|29|29.0||||||
4039409|NCT01126580|3861054|B3|India||Region of Enrollment||participants|Number|9|9.0||||||
4039410|NCT01126580|3861055|B2|India||Region of Enrollment||participants|Number|11|11.0||||||
4039411|NCT01126580|3861056|B1|India||Region of Enrollment||participants|Number|9|9.0||||||
4039412|NCT01126580|3861053|B4|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4039413|NCT01126580|3861054|B3|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4039414|NCT01126580|3861055|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4039415|NCT01126580|3861056|B1|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4039416|NCT01126580|3861053|B4|Spain||Region of Enrollment||participants|Number|35|35.0||||||
4039417|NCT01126580|3861054|B3|Spain||Region of Enrollment||participants|Number|12|12.0||||||
4039418|NCT01126580|3861055|B2|Spain||Region of Enrollment||participants|Number|11|11.0||||||
4039419|NCT01126580|3861056|B1|Spain||Region of Enrollment||participants|Number|12|12.0||||||
4039420|NCT01126580|3861053|B4|Finland||Region of Enrollment||participants|Number|12|12.0||||||
4039421|NCT01126580|3861054|B3|Finland||Region of Enrollment||participants|Number|4|4.0||||||
4039422|NCT01126580|3861055|B2|Finland||Region of Enrollment||participants|Number|5|5.0||||||
4039423|NCT01126580|3861056|B1|Finland||Region of Enrollment||participants|Number|3|3.0||||||
4039424|NCT01126580|3861053|B4|Slovakia||Region of Enrollment||participants|Number|26|26.0||||||
4039425|NCT01126580|3861054|B3|Slovakia||Region of Enrollment||participants|Number|9|9.0||||||
4039426|NCT01126580|3861055|B2|Slovakia||Region of Enrollment||participants|Number|9|9.0||||||
4039427|NCT01126580|3861056|B1|Slovakia||Region of Enrollment||participants|Number|8|8.0||||||
4039428|NCT01126580|3861053|B4|United States||Region of Enrollment||participants|Number|231|231.0||||||
4039429|NCT01126580|3861054|B3|United States||Region of Enrollment||participants|Number|74|74.0||||||
4039430|NCT01126580|3861055|B2|United States||Region of Enrollment||participants|Number|80|80.0||||||
4039431|NCT01126580|3861056|B1|United States||Region of Enrollment||participants|Number|77|77.0||||||
4039432|NCT01126580|3861053|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039433|NCT01126580|3861054|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039434|NCT01126580|3861055|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039435|NCT01126580|3861056|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039436|NCT01126580|3861053|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4039437|NCT01126580|3861054|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4039438|NCT01126580|3861055|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4039439|NCT01126580|3861056|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4039440|NCT01126580|3861053|B4||White|Race (NIH/OMB)||Participants|Count of Participants|600|600.0||||||
4039441|NCT01126580|3861054|B3||White|Race (NIH/OMB)||Participants|Count of Participants|201|201.0||||||
4039442|NCT01126580|3861055|B2||White|Race (NIH/OMB)||Participants|Count of Participants|198|198.0||||||
4039443|NCT01126580|3861056|B1||White|Race (NIH/OMB)||Participants|Count of Participants|201|201.0||||||
4039444|NCT01126580|3861053|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4039445|NCT01126580|3861054|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4039446|NCT01126580|3861055|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4039447|NCT01126580|3861056|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4039448|NCT01126580|3861053|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4039449|NCT01126580|3861054|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4039450|NCT01126580|3861055|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039451|NCT01126580|3861056|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039452|NCT01126580|3861053|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4039453|NCT01126580|3861054|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4039454|NCT01126580|3861055|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4039455|NCT01126580|3861056|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4039456|NCT01126580|3861053|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
4039457|NCT01126580|3861054|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4039458|NCT01126580|3861055|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4039459|NCT01126580|3861056|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4039460|NCT01126580|3861053|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039461|NCT01126580|3861054|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039462|NCT01126580|3861055|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039463|NCT01126580|3861056|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039464|NCT01126580|3861053|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|535|535.0||||||
4039465|NCT01126580|3861054|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|173|173.0||||||
4039466|NCT01126580|3861055|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|183|183.0||||||
4039467|NCT01126580|3861056|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|179|179.0||||||
4039468|NCT01126580|3861053|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|272|272.0||||||
4039469|NCT01126580|3861054|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
4039470|NCT01126580|3861055|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
4039471|NCT01126580|3861056|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4039472|NCT01126580|3861053|B4||Male|Sex: Female, Male||Participants|Count of Participants|353|353.0||||||
4039473|NCT01126580|3861054|B3||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4039474|NCT01126580|3861055|B2||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4039475|NCT01126580|3861056|B1||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4039476|NCT01126580|3861053|B4||Female|Sex: Female, Male||Participants|Count of Participants|454|454.0||||||
4039477|NCT01126580|3861054|B3||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4039478|NCT01126580|3861055|B2||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4039479|NCT01126580|3861056|B1||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4039480|NCT01126580|3861053|B4|||Age||years|Mean|55.56|55.56|Standard Deviation|10.38|10.38|||
4039481|NCT01126580|3861054|B3|||Age||years|Mean|55.26|55.26|Standard Deviation|10.10|10.1|||
4039482|NCT01126580|3861055|B2|||Age||years|Mean|55.90|55.9|Standard Deviation|10.68|10.68|||
4039483|NCT01126580|3861056|B1|||Age||years|Mean|55.51|55.51|Standard Deviation|10.38|10.38|||
4039484|NCT01126541|3861150|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4039485|NCT01126541|3861151|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4039486|NCT01126541|3861152|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4039487|NCT01126541|3861153|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4039488|NCT01126541|3861150|B4||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4039489|NCT01126541|3861151|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4039490|NCT01126541|3861152|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4039491|NCT01126541|3861153|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4039492|NCT01126541|3861150|B4|||Age||years|Mean|56.0|56.0|Standard Deviation|11.0|11.0|||
4039493|NCT01126541|3861151|B3|||Age||years|Mean|56.1|56.1|Standard Deviation|11.2|11.2|||
4039494|NCT01126541|3861152|B2|||Age||years|Mean|57.2|57.2|Standard Deviation|10.4|10.4|||
4039495|NCT01126541|3861153|B1|||Age||years|Mean|54.5|54.5|Standard Deviation|11.5|11.5|||
4039496|NCT01126437|3861236|B4||Male|Sex: Female, Male||Participants|Count of Participants|12237|12237.0||||||
4039497|NCT01126437|3861237|B3||Male|Sex: Female, Male||Participants|Count of Participants|4035|4035.0||||||
4039498|NCT01126437|3861238|B2||Male|Sex: Female, Male||Participants|Count of Participants|4134|4134.0||||||
4039499|NCT01126437|3861239|B1||Male|Sex: Female, Male||Participants|Count of Participants|4068|4068.0||||||
4039500|NCT01126437|3861236|B4||Female|Sex: Female, Male||Participants|Count of Participants|4879|4879.0||||||
4039501|NCT01126437|3861237|B3||Female|Sex: Female, Male||Participants|Count of Participants|1652|1652.0||||||
4039502|NCT01126437|3861238|B2||Female|Sex: Female, Male||Participants|Count of Participants|1571|1571.0||||||
4039503|NCT01126437|3861239|B1||Female|Sex: Female, Male||Participants|Count of Participants|1656|1656.0||||||
4039504|NCT01126437|3861236|B4|||Age||years|Mean|65.0|65.0|Standard Deviation|9.1|9.1|||
4039505|NCT01126437|3861237|B3|||Age||years|Mean|65.0|65.0|Standard Deviation|9.0|9.0|||
4039506|NCT01126437|3861238|B2|||Age||years|Mean|64.9|64.9|Standard Deviation|9.1|9.1|||
4039507|NCT01126437|3861239|B1|||Age||years|Mean|65.1|65.1|Standard Deviation|9.1|9.1|||
4039508|NCT01126424|3861273|B7|||Total Geriatric Depression Scale (GDS) Score|The short-form geriatric depression scale (GDS) was developed as a basic screening measure for depression in older adults. It is a 15-point questionnaire in which the patient is required to answer ‘yes’ or ‘no’. The GDS responses were translated into a binary scale on which “1” was indicative of depression and “0” was not; the total score ranges from 0 to 15. A score of > 5 points is considered suggestive of depression. Scores of > 10 points are almost always indicative of depression.|scores on a scale|Mean|1.2|1.2|Standard Deviation|1.11|1.11|||
4039509|NCT01126424|3861274|B6|||Total Geriatric Depression Scale (GDS) Score|The short-form geriatric depression scale (GDS) was developed as a basic screening measure for depression in older adults. It is a 15-point questionnaire in which the patient is required to answer ‘yes’ or ‘no’. The GDS responses were translated into a binary scale on which “1” was indicative of depression and “0” was not; the total score ranges from 0 to 15. A score of > 5 points is considered suggestive of depression. Scores of > 10 points are almost always indicative of depression.|scores on a scale|Mean|1.8|1.8|Standard Deviation|1.26|1.26|||
4039510|NCT01126424|3861275|B5|||Total Geriatric Depression Scale (GDS) Score|The short-form geriatric depression scale (GDS) was developed as a basic screening measure for depression in older adults. It is a 15-point questionnaire in which the patient is required to answer ‘yes’ or ‘no’. The GDS responses were translated into a binary scale on which “1” was indicative of depression and “0” was not; the total score ranges from 0 to 15. A score of > 5 points is considered suggestive of depression. Scores of > 10 points are almost always indicative of depression.|scores on a scale|Mean|1.3|1.3|Standard Deviation|0.96|0.96|||
4039511|NCT01126424|3861276|B4|||Total Geriatric Depression Scale (GDS) Score|The short-form geriatric depression scale (GDS) was developed as a basic screening measure for depression in older adults. It is a 15-point questionnaire in which the patient is required to answer ‘yes’ or ‘no’. The GDS responses were translated into a binary scale on which “1” was indicative of depression and “0” was not; the total score ranges from 0 to 15. A score of > 5 points is considered suggestive of depression. Scores of > 10 points are almost always indicative of depression.|scores on a scale|Mean|1.0|1.0|Standard Deviation|0.63|0.63|||
4039512|NCT01126424|3861277|B3|||Total Geriatric Depression Scale (GDS) Score|The short-form geriatric depression scale (GDS) was developed as a basic screening measure for depression in older adults. It is a 15-point questionnaire in which the patient is required to answer ‘yes’ or ‘no’. The GDS responses were translated into a binary scale on which “1” was indicative of depression and “0” was not; the total score ranges from 0 to 15. A score of > 5 points is considered suggestive of depression. Scores of > 10 points are almost always indicative of depression.|scores on a scale|Mean|1.4|1.4|Standard Deviation|1.67|1.67|||
4039513|NCT01126424|3861278|B2|||Total Geriatric Depression Scale (GDS) Score|The short-form geriatric depression scale (GDS) was developed as a basic screening measure for depression in older adults. It is a 15-point questionnaire in which the patient is required to answer ‘yes’ or ‘no’. The GDS responses were translated into a binary scale on which “1” was indicative of depression and “0” was not; the total score ranges from 0 to 15. A score of > 5 points is considered suggestive of depression. Scores of > 10 points are almost always indicative of depression.|scores on a scale|Mean|1.0|1.0|Standard Deviation|0.82|0.82|||
4039514|NCT01126424|3861279|B1|||Total Geriatric Depression Scale (GDS) Score|The short-form geriatric depression scale (GDS) was developed as a basic screening measure for depression in older adults. It is a 15-point questionnaire in which the patient is required to answer ‘yes’ or ‘no’. The GDS responses were translated into a binary scale on which “1” was indicative of depression and “0” was not; the total score ranges from 0 to 15. A score of > 5 points is considered suggestive of depression. Scores of > 10 points are almost always indicative of depression.|scores on a scale|Mean|1.0|1.0|Standard Deviation|1.73|1.73|||
4039515|NCT01126424|3861273|B7|||Total Mini-Mental State Examination (MMSE) Score|The mini-mental state examination (MMSE) provides measures of orientation, registration (immediate memory), short-term memory (but not long-term memory) and language functioning. The investigator reads a series of questions aloud clearly and slowly to the patient and scores each incorrect answer with “0” and each correct answer with “1”, for a maximum score of 30.|scores on a scale|Mean|27.5|27.5|Standard Deviation|1.39|1.39|||
4039516|NCT01126424|3861274|B6|||Total Mini-Mental State Examination (MMSE) Score|The mini-mental state examination (MMSE) provides measures of orientation, registration (immediate memory), short-term memory (but not long-term memory) and language functioning. The investigator reads a series of questions aloud clearly and slowly to the patient and scores each incorrect answer with “0” and each correct answer with “1”, for a maximum score of 30.|scores on a scale|Mean|27.3|27.3|Standard Deviation|2.06|2.06|||
4039517|NCT01126424|3861275|B5|||Total Mini-Mental State Examination (MMSE) Score|The mini-mental state examination (MMSE) provides measures of orientation, registration (immediate memory), short-term memory (but not long-term memory) and language functioning. The investigator reads a series of questions aloud clearly and slowly to the patient and scores each incorrect answer with “0” and each correct answer with “1”, for a maximum score of 30.|scores on a scale|Mean|26.5|26.5|Standard Deviation|1.00|1.0|||
4039518|NCT01126424|3861276|B4|||Total Mini-Mental State Examination (MMSE) Score|The mini-mental state examination (MMSE) provides measures of orientation, registration (immediate memory), short-term memory (but not long-term memory) and language functioning. The investigator reads a series of questions aloud clearly and slowly to the patient and scores each incorrect answer with “0” and each correct answer with “1”, for a maximum score of 30.|scores on a scale|Mean|27.3|27.3|Standard Deviation|1.75|1.75|||
4039519|NCT01126424|3861277|B3|||Total Mini-Mental State Examination (MMSE) Score|The mini-mental state examination (MMSE) provides measures of orientation, registration (immediate memory), short-term memory (but not long-term memory) and language functioning. The investigator reads a series of questions aloud clearly and slowly to the patient and scores each incorrect answer with “0” and each correct answer with “1”, for a maximum score of 30.|scores on a scale|Mean|28.0|28.0|Standard Deviation|1.00|1.0|||
4039520|NCT01126424|3861278|B2|||Total Mini-Mental State Examination (MMSE) Score|The mini-mental state examination (MMSE) provides measures of orientation, registration (immediate memory), short-term memory (but not long-term memory) and language functioning. The investigator reads a series of questions aloud clearly and slowly to the patient and scores each incorrect answer with “0” and each correct answer with “1”, for a maximum score of 30.|scores on a scale|Mean|28.3|28.3|Standard Deviation|1.26|1.26|||
4039521|NCT01126424|3861279|B1|||Total Mini-Mental State Examination (MMSE) Score|The mini-mental state examination (MMSE) provides measures of orientation, registration (immediate memory), short-term memory (but not long-term memory) and language functioning. The investigator reads a series of questions aloud clearly and slowly to the patient and scores each incorrect answer with “0” and each correct answer with “1”, for a maximum score of 30.|scores on a scale|Mean|27.7|27.7|Standard Deviation|0.58|0.58|||
4039522|NCT01126424|3861273|B7|No||Stockholm criteria for mild cognitive impairment|"The Stockholm criteria for identification of mild cognitive impairment are:~Cognitive complaints from patients or families~Reporting of decline in cognitive functioning relative to previous abilities during the past year by patient or informant~Cognitive disorders as evidenced by clinical evaluation (impairment in memory or in another cognitive domain)~Absence of major repercussions on daily life (the patient may report difficulties in day-to-day activities)~Absence of dementia"|participants|Number|0|0.0||||||
4039523|NCT01126424|3861274|B6|No||Stockholm criteria for mild cognitive impairment|"The Stockholm criteria for identification of mild cognitive impairment are:~Cognitive complaints from patients or families~Reporting of decline in cognitive functioning relative to previous abilities during the past year by patient or informant~Cognitive disorders as evidenced by clinical evaluation (impairment in memory or in another cognitive domain)~Absence of major repercussions on daily life (the patient may report difficulties in day-to-day activities)~Absence of dementia"|participants|Number|0|0.0||||||
4039540|NCT01126424|3861277|B3|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4039541|NCT01126424|3861278|B2|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4039524|NCT01126424|3861275|B5|No||Stockholm criteria for mild cognitive impairment|"The Stockholm criteria for identification of mild cognitive impairment are:~Cognitive complaints from patients or families~Reporting of decline in cognitive functioning relative to previous abilities during the past year by patient or informant~Cognitive disorders as evidenced by clinical evaluation (impairment in memory or in another cognitive domain)~Absence of major repercussions on daily life (the patient may report difficulties in day-to-day activities)~Absence of dementia"|participants|Number|0|0.0||||||
4039525|NCT01126424|3861276|B4|No||Stockholm criteria for mild cognitive impairment|"The Stockholm criteria for identification of mild cognitive impairment are:~Cognitive complaints from patients or families~Reporting of decline in cognitive functioning relative to previous abilities during the past year by patient or informant~Cognitive disorders as evidenced by clinical evaluation (impairment in memory or in another cognitive domain)~Absence of major repercussions on daily life (the patient may report difficulties in day-to-day activities)~Absence of dementia"|participants|Number|0|0.0||||||
4039526|NCT01126424|3861277|B3|No||Stockholm criteria for mild cognitive impairment|"The Stockholm criteria for identification of mild cognitive impairment are:~Cognitive complaints from patients or families~Reporting of decline in cognitive functioning relative to previous abilities during the past year by patient or informant~Cognitive disorders as evidenced by clinical evaluation (impairment in memory or in another cognitive domain)~Absence of major repercussions on daily life (the patient may report difficulties in day-to-day activities)~Absence of dementia"|participants|Number|0|0.0||||||
4039527|NCT01126424|3861278|B2|No||Stockholm criteria for mild cognitive impairment|"The Stockholm criteria for identification of mild cognitive impairment are:~Cognitive complaints from patients or families~Reporting of decline in cognitive functioning relative to previous abilities during the past year by patient or informant~Cognitive disorders as evidenced by clinical evaluation (impairment in memory or in another cognitive domain)~Absence of major repercussions on daily life (the patient may report difficulties in day-to-day activities)~Absence of dementia"|participants|Number|0|0.0||||||
4039528|NCT01126424|3861279|B1|No||Stockholm criteria for mild cognitive impairment|"The Stockholm criteria for identification of mild cognitive impairment are:~Cognitive complaints from patients or families~Reporting of decline in cognitive functioning relative to previous abilities during the past year by patient or informant~Cognitive disorders as evidenced by clinical evaluation (impairment in memory or in another cognitive domain)~Absence of major repercussions on daily life (the patient may report difficulties in day-to-day activities)~Absence of dementia"|participants|Number|0|0.0||||||
4039529|NCT01126424|3861273|B7|Yes||Stockholm criteria for mild cognitive impairment|"The Stockholm criteria for identification of mild cognitive impairment are:~Cognitive complaints from patients or families~Reporting of decline in cognitive functioning relative to previous abilities during the past year by patient or informant~Cognitive disorders as evidenced by clinical evaluation (impairment in memory or in another cognitive domain)~Absence of major repercussions on daily life (the patient may report difficulties in day-to-day activities)~Absence of dementia"|participants|Number|26|26.0||||||
4039530|NCT01126424|3861274|B6|Yes||Stockholm criteria for mild cognitive impairment|"The Stockholm criteria for identification of mild cognitive impairment are:~Cognitive complaints from patients or families~Reporting of decline in cognitive functioning relative to previous abilities during the past year by patient or informant~Cognitive disorders as evidenced by clinical evaluation (impairment in memory or in another cognitive domain)~Absence of major repercussions on daily life (the patient may report difficulties in day-to-day activities)~Absence of dementia"|participants|Number|4|4.0||||||
4039531|NCT01126424|3861275|B5|Yes||Stockholm criteria for mild cognitive impairment|"The Stockholm criteria for identification of mild cognitive impairment are:~Cognitive complaints from patients or families~Reporting of decline in cognitive functioning relative to previous abilities during the past year by patient or informant~Cognitive disorders as evidenced by clinical evaluation (impairment in memory or in another cognitive domain)~Absence of major repercussions on daily life (the patient may report difficulties in day-to-day activities)~Absence of dementia"|participants|Number|4|4.0||||||
4039532|NCT01126424|3861276|B4|Yes||Stockholm criteria for mild cognitive impairment|"The Stockholm criteria for identification of mild cognitive impairment are:~Cognitive complaints from patients or families~Reporting of decline in cognitive functioning relative to previous abilities during the past year by patient or informant~Cognitive disorders as evidenced by clinical evaluation (impairment in memory or in another cognitive domain)~Absence of major repercussions on daily life (the patient may report difficulties in day-to-day activities)~Absence of dementia"|participants|Number|6|6.0||||||
4039533|NCT01126424|3861277|B3|Yes||Stockholm criteria for mild cognitive impairment|"The Stockholm criteria for identification of mild cognitive impairment are:~Cognitive complaints from patients or families~Reporting of decline in cognitive functioning relative to previous abilities during the past year by patient or informant~Cognitive disorders as evidenced by clinical evaluation (impairment in memory or in another cognitive domain)~Absence of major repercussions on daily life (the patient may report difficulties in day-to-day activities)~Absence of dementia"|participants|Number|5|5.0||||||
4039534|NCT01126424|3861278|B2|Yes||Stockholm criteria for mild cognitive impairment|"The Stockholm criteria for identification of mild cognitive impairment are:~Cognitive complaints from patients or families~Reporting of decline in cognitive functioning relative to previous abilities during the past year by patient or informant~Cognitive disorders as evidenced by clinical evaluation (impairment in memory or in another cognitive domain)~Absence of major repercussions on daily life (the patient may report difficulties in day-to-day activities)~Absence of dementia"|participants|Number|4|4.0||||||
4039535|NCT01126424|3861279|B1|Yes||Stockholm criteria for mild cognitive impairment|"The Stockholm criteria for identification of mild cognitive impairment are:~Cognitive complaints from patients or families~Reporting of decline in cognitive functioning relative to previous abilities during the past year by patient or informant~Cognitive disorders as evidenced by clinical evaluation (impairment in memory or in another cognitive domain)~Absence of major repercussions on daily life (the patient may report difficulties in day-to-day activities)~Absence of dementia"|participants|Number|3|3.0||||||
4039536|NCT01126424|3861273|B7|White||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4039537|NCT01126424|3861274|B6|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4039538|NCT01126424|3861275|B5|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4039539|NCT01126424|3861276|B4|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4039542|NCT01126424|3861279|B1|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4039543|NCT01126424|3861273|B7||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4039544|NCT01126424|3861274|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4039545|NCT01126424|3861275|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4039546|NCT01126424|3861276|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4039547|NCT01126424|3861277|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4039548|NCT01126424|3861278|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4039549|NCT01126424|3861279|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4039550|NCT01126424|3861273|B7||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4039551|NCT01126424|3861274|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4039552|NCT01126424|3861275|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4039553|NCT01126424|3861276|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4039554|NCT01126424|3861277|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4039555|NCT01126424|3861278|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4039556|NCT01126424|3861279|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4039557|NCT01126424|3861273|B7|||Age||years|Mean|78.8|78.8|Standard Deviation|3.2|3.2|||
4039558|NCT01126424|3861274|B6|||Age||years|Mean|79.0|79.0|Standard Deviation|4.1|4.1|||
4039559|NCT01126424|3861275|B5|||Age||years|Mean|79.3|79.3|Standard Deviation|2.9|2.9|||
4039560|NCT01126424|3861276|B4|||Age||years|Mean|76.7|76.7|Standard Deviation|2.0|2.0|||
4039561|NCT01126424|3861277|B3|||Age||years|Mean|80.2|80.2|Standard Deviation|4.4|4.4|||
4039562|NCT01126424|3861278|B2|||Age||years|Mean|78.8|78.8|Standard Deviation|2.5|2.5|||
4039563|NCT01126424|3861279|B1|||Age||years|Mean|79.7|79.7|Standard Deviation|3.8|3.8|||
4039564|NCT01126359|3861307|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4039565|NCT01126359|3861307|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4039566|NCT01126359|3861307|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4039567|NCT01126359|3861307|B1|||Age||years|Mean|38|38.0|Standard Deviation|15|15.0|||
4039568|NCT01126359|3861307|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4039569|NCT01126359|3861307|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4039570|NCT01126359|3861307|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4039571|NCT01126268|3861320|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4039572|NCT01126268|3861320|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4039573|NCT01126268|3861320|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4039574|NCT01126268|3861320|B1|||Age||years|Mean|18.5|18.5|Standard Deviation|25.66|25.66|||
4039575|NCT01126268|3861320|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4039576|NCT01126268|3861320|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4039577|NCT01126268|3861320|B1||<=18 years|Age||Participants|Count of Participants|28|28.0||||||
4039578|NCT01126099|3861342|B3|||Brief Psychiatric Rating Scale|The Brief Psychiatric Rating Scale measures 18 psychiatric symptom domains. The scale ranges from 18 to 126, where 18 indicates no psychiatric symptoms.|units on a scale|Mean|44.9|44.9|Standard Deviation|9.1|9.1|||
4039579|NCT01126099|3861343|B2|||Brief Psychiatric Rating Scale|The Brief Psychiatric Rating Scale measures 18 psychiatric symptom domains. The scale ranges from 18 to 126, where 18 indicates no psychiatric symptoms.|units on a scale|Mean|44.2|44.2|Standard Deviation|9.5|9.5|||
4039580|NCT01126099|3861344|B1|||Brief Psychiatric Rating Scale|The Brief Psychiatric Rating Scale measures 18 psychiatric symptom domains. The scale ranges from 18 to 126, where 18 indicates no psychiatric symptoms.|units on a scale|Mean|45.4|45.4|Standard Deviation|9.1|9.1|||
4039581|NCT01126099|3861342|B3|||Total Neuropsychiatric Inventory score|The Neuropsychiatric Inventory is a scale that quantifies behavioral and psychiatric symptoms in patients with dementia. The scale ranges from 0 to 144, with 0 being no symptoms.|units on a scale|Mean|42.4|42.4|Standard Deviation|17.1|17.1|||
4039582|NCT01126099|3861343|B2|||Total Neuropsychiatric Inventory score|The Neuropsychiatric Inventory is a scale that quantifies behavioral and psychiatric symptoms in patients with dementia. The scale ranges from 0 to 144, with 0 being no symptoms.|units on a scale|Mean|40.9|40.9|Standard Deviation|18.9|18.9|||
4039583|NCT01126099|3861344|B1|||Total Neuropsychiatric Inventory score|The Neuropsychiatric Inventory is a scale that quantifies behavioral and psychiatric symptoms in patients with dementia. The scale ranges from 0 to 144, with 0 being no symptoms.|units on a scale|Mean|43.5|43.5|Standard Deviation|16.2|16.2|||
4039584|NCT01126099|3861342|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4039585|NCT01126099|3861343|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4039586|NCT01126099|3861344|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4039587|NCT01126099|3861342|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4039588|NCT01126099|3861343|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4039589|NCT01126099|3861344|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4039590|NCT01126099|3861342|B3|||Age||years|Mean|80.7|80.7|Standard Deviation|9.5|9.5|||
4039591|NCT01126099|3861343|B2|||Age||years|Mean|78.7|78.7|Standard Deviation|8.2|8.2|||
4039592|NCT01126099|3861344|B1|||Age||years|Mean|82.4|82.4|Standard Deviation|10.5|10.5|||
4039593|NCT01126060|3861357|B3|Korea, Republic of||Region of Enrollment||participants|Number|80|80.0||||||
4039594|NCT01126060|3861358|B2|Korea, Republic of||Region of Enrollment||participants|Number|40|40.0||||||
4039595|NCT01126060|3861359|B1|Korea, Republic of||Region of Enrollment||participants|Number|40|40.0||||||
4039596|NCT01126060|3861357|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4039597|NCT01126060|3861358|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4039598|NCT01126060|3861359|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4039599|NCT01126060|3861357|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4039600|NCT01126060|3861358|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4039601|NCT01126060|3861359|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4039602|NCT01126060|3861357|B3|||Age||years|Mean|49.3|49.3|Standard Deviation|10.3|10.3|||
4039603|NCT01126060|3861358|B2|||Age||years|Mean|50.8|50.8|Standard Deviation|10.8|10.8|||
4039604|NCT01126060|3861359|B1|||Age||years|Mean|47.8|47.8|Standard Deviation|9.6|9.6|||
4039605|NCT01126060|3861357|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4039606|NCT01126060|3861358|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4039607|NCT01126060|3861359|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4039608|NCT01126060|3861357|B3||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4039609|NCT01126060|3861358|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4039610|NCT01126060|3861359|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4039611|NCT01126060|3861357|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4039612|NCT01126060|3861358|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4039613|NCT01126060|3861359|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4039614|NCT01125930|3861366|B3|United States||Region of Enrollment||participants|Number|68|68.0||||||
4039615|NCT01125930|3861367|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
4039616|NCT01125930|3861368|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4039617|NCT01125930|3861366|B3|Middle Eastern||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4039618|NCT01125930|3861367|B2|Middle Eastern||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4039619|NCT01125930|3861368|B1|Middle Eastern||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4039620|NCT01125930|3861366|B3|Caucasian, non-European descent||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4039621|NCT01125930|3861367|B2|Caucasian, non-European descent||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4039622|NCT01125930|3861368|B1|Caucasian, non-European descent||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4039623|NCT01125930|3861366|B3|Caucasian, European descent||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
4039624|NCT01125930|3861367|B2|Caucasian, European descent||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4039625|NCT01125930|3861368|B1|Caucasian, European descent||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4039626|NCT01125930|3861366|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4039627|NCT01125930|3861367|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4039628|NCT01125930|3861368|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4039629|NCT01125930|3861366|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4039630|NCT01125930|3861367|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4039631|NCT01125930|3861368|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4039632|NCT01125930|3861366|B3|||Age||years|Mean|55.74|55.74|Standard Deviation|11.39|11.39|||
4039633|NCT01125930|3861367|B2|||Age||years|Mean|56.09|56.09|Standard Deviation|11.58|11.58|||
4039634|NCT01125930|3861368|B1|||Age||years|Mean|55.00|55.0|Standard Deviation|11.24|11.24|||
4039635|NCT01125917|3861523|B1||Male|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4039636|NCT01125917|3861523|B1||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4039637|NCT01125917|3861523|B1|||Age||years|Mean|51.2|51.2|Standard Deviation|12.47|12.47|||
4039638|NCT01125813|3861527|B1|United Kingdom||Region of Enrollment||participants|Number|15|15.0||||||
4039639|NCT01125813|3861527|B1|Germany||Region of Enrollment||participants|Number|8|8.0||||||
4039640|NCT01125813|3861527|B1|Bulgaria||Region of Enrollment||participants|Number|8|8.0||||||
4039641|NCT01125813|3861527|B1|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4039642|NCT01125813|3861527|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4039643|NCT01125813|3861527|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4039644|NCT01125813|3861527|B1|||Age||years|Mean|37.3|37.3|Standard Deviation|13.6|13.6|||
4039645|NCT01125813|3861527|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4039646|NCT01125813|3861527|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4039647|NCT01125813|3861527|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4039648|NCT01125800|3861532|B6||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4039649|NCT01125800|3861533|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4039650|NCT01125800|3861534|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4039651|NCT01125800|3861535|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4039652|NCT01125800|3861536|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4039653|NCT01125800|3861537|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4039654|NCT01125800|3861532|B6||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4039655|NCT01125800|3861533|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4039656|NCT01125800|3861534|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4039657|NCT01125800|3861535|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4039658|NCT01125800|3861536|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4039659|NCT01125800|3861537|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4039660|NCT01125800|3861532|B6|18-65 years||Age, Customized||participants|Number|16|16.0||||||
4039661|NCT01125800|3861533|B5|18-65 years||Age, Customized||participants|Number|16|16.0||||||
4039662|NCT01125800|3861534|B4|18-65 years||Age, Customized||participants|Number|0|0.0||||||
4039663|NCT01125800|3861535|B3|18-65 years||Age, Customized||participants|Number|0|0.0||||||
4039664|NCT01125800|3861536|B2|18-65 years||Age, Customized||participants|Number|0|0.0||||||
4039665|NCT01125800|3861537|B1|18-65 years||Age, Customized||participants|Number|0|0.0||||||
4039666|NCT01125800|3861532|B6|>10 years to 17 years||Age, Customized||participants|Number|37|37.0||||||
4039667|NCT01125800|3861533|B5|>10 years to 17 years||Age, Customized||participants|Number|0|0.0||||||
4039668|NCT01125800|3861534|B4|>10 years to 17 years||Age, Customized||participants|Number|11|11.0||||||
4039669|NCT01125800|3861535|B3|>10 years to 17 years||Age, Customized||participants|Number|6|6.0||||||
4039670|NCT01125800|3861536|B2|>10 years to 17 years||Age, Customized||participants|Number|13|13.0||||||
4039671|NCT01125800|3861537|B1|>10 years to 17 years||Age, Customized||participants|Number|7|7.0||||||
4039672|NCT01125800|3861532|B6|≤ 10 years||Age, Customized||participants|Number|23|23.0||||||
4039673|NCT01125800|3861533|B5|≤ 10 years||Age, Customized||participants|Number|0|0.0||||||
4039674|NCT01125800|3861534|B4|≤ 10 years||Age, Customized||participants|Number|11|11.0||||||
4039675|NCT01125800|3861535|B3|≤ 10 years||Age, Customized||participants|Number|5|5.0||||||
4039676|NCT01125800|3861536|B2|≤ 10 years||Age, Customized||participants|Number|3|3.0||||||
4039677|NCT01125800|3861537|B1|≤ 10 years||Age, Customized||participants|Number|4|4.0||||||
4039678|NCT01125774|3861578|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4039679|NCT01125774|3861579|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4039680|NCT01125774|3861580|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4039681|NCT01125774|3861578|B3||Female|Sex: Female, Male||Participants|Count of Participants|4548|4548.0||||||
4039682|NCT01125774|3861579|B2||Female|Sex: Female, Male||Participants|Count of Participants|1508|1508.0||||||
4039683|NCT01125774|3861580|B1||Female|Sex: Female, Male||Participants|Count of Participants|3040|3040.0||||||
4039684|NCT01125774|3861578|B3|||Age|Due to missing data, N=3039 and 4547 for Telcagepant 140 mg and Total groups, respectively.|Years|Mean|36.0|36.0|Standard Deviation|8.6|8.6|||
4039685|NCT01125774|3861579|B2|||Age|Due to missing data, N=3039 and 4547 for Telcagepant 140 mg and Total groups, respectively.|Years|Mean|35.8|35.8|Standard Deviation|8.7|8.7|||
4039686|NCT01125774|3861580|B1|||Age|Due to missing data, N=3039 and 4547 for Telcagepant 140 mg and Total groups, respectively.|Years|Mean|36.1|36.1|Standard Deviation|8.6|8.6|||
4039687|NCT01125748|3861605|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4039688|NCT01125748|3861606|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4039689|NCT01125748|3861607|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4039690|NCT01125748|3861605|B3||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4039691|NCT01125748|3861606|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4039692|NCT01125748|3861607|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4039693|NCT01125748|3861605|B3|||Age||years|Mean|51.50|51.5|Standard Deviation|12.48|12.48|||
4039694|NCT01125748|3861606|B2|||Age||years|Mean|51.86|51.86|Standard Deviation|13.25|13.25|||
4039695|NCT01125748|3861607|B1|||Age||years|Mean|51.14|51.14|Standard Deviation|11.73|11.73|||
4039696|NCT01125722|3861616|B3|Sweden||Region of Enrollment||participants|Number|13|13.0||||||
4039697|NCT01125722|3861617|B2|Sweden||Region of Enrollment||participants|Number|6|6.0||||||
4039698|NCT01125722|3861618|B1|Sweden||Region of Enrollment||participants|Number|7|7.0||||||
4039699|NCT01125722|3861616|B3|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
4039700|NCT01125722|3861617|B2|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4039701|NCT01125722|3861618|B1|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4039702|NCT01125722|3861616|B3|United States||Region of Enrollment||participants|Number|53|53.0||||||
4039703|NCT01125722|3861617|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4039704|NCT01125722|3861618|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4039705|NCT01125722|3861616|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4039706|NCT01125722|3861617|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4039707|NCT01125722|3861618|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4039708|NCT01125722|3861616|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4039709|NCT01125722|3861617|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4039710|NCT01125722|3861618|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4039711|NCT01125722|3861616|B3|||Age||years|Mean|60.8|60.8|Standard Deviation|12.7|12.7|||
4039712|NCT01125722|3861617|B2|||Age||years|Mean|62.1|62.1|Standard Deviation|14.6|14.6|||
4039713|NCT01125722|3861618|B1|||Age||years|Mean|59.6|59.6|Standard Deviation|10.6|10.6|||
4039714|NCT01125722|3861616|B3||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4039715|NCT01125722|3861617|B2||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4039716|NCT01125722|3861618|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4039717|NCT01125722|3861616|B3||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4039718|NCT01125722|3861617|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4039719|NCT01125722|3861618|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4039720|NCT01125722|3861616|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4039721|NCT01125722|3861617|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4039722|NCT01125722|3861618|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4039723|NCT01125605|3861633|B1|without previous treatment of inclusion diagnosis||Previous treatment of inclusion diagnosis|Within the range of the observational study, it was ascertained whether the inclusion diagnosis had been treated previously.|participants|Number|80|80.0||||||
4039724|NCT01125605|3861633|B1|with previous treatment of inclusion diagnosis||Previous treatment of inclusion diagnosis|Within the range of the observational study, it was ascertained whether the inclusion diagnosis had been treated previously.|participants|Number|245|245.0||||||
4039725|NCT01125605|3861633|B1|missing data||State of inclusion diagnosis|"The duration of complaints was divided into two groups to the extent this was possible:~Acute disease (duration of symptoms ≤2 months)~Subchronic and/or chronic disease (duration of symptoms >2 months)"|participants|Number|119|119.0||||||
4039726|NCT01125605|3861633|B1|subchronic/chronic (> 2 months)||State of inclusion diagnosis|"The duration of complaints was divided into two groups to the extent this was possible:~Acute disease (duration of symptoms ≤2 months)~Subchronic and/or chronic disease (duration of symptoms >2 months)"|participants|Number|163|163.0||||||
4039727|NCT01125605|3861633|B1|acute (<= 2 months)||State of inclusion diagnosis|"The duration of complaints was divided into two groups to the extent this was possible:~Acute disease (duration of symptoms ≤2 months)~Subchronic and/or chronic disease (duration of symptoms >2 months)"|participants|Number|43|43.0||||||
4039728|NCT01125605|3861633|B1|||Duration of disease years||years|Mean|2.0|2.0|Standard Deviation|3.8|3.8|||
4039729|NCT01125605|3861633|B1|without concomitant medication||Concomitant medication||participants|Number|149|149.0||||||
4039730|NCT01125605|3861633|B1|with concomitant medication||Concomitant medication||participants|Number|176|176.0||||||
4039731|NCT01125605|3861633|B1||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4039732|NCT01125605|3861633|B1||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4039733|NCT01125605|3861633|B1||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
4039734|NCT01125605|3861633|B1||Between 18 and 65 years|Age||Participants|Count of Participants|212|212.0||||||
4039735|NCT01125605|3861633|B1||<=18 years|Age||Participants|Count of Participants|72|72.0||||||
4039736|NCT01125566|3861664|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4039737|NCT01125566|3861665|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4039738|NCT01125566|3861666|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4039739|NCT01125566|3861664|B3||Female|Sex: Female, Male||Participants|Count of Participants|500|500.0||||||
4039740|NCT01125566|3861665|B2||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4039741|NCT01125566|3861666|B1||Female|Sex: Female, Male||Participants|Count of Participants|332|332.0||||||
4039742|NCT01125566|3861664|B3|||Age||years|Mean|52.2|52.2|Standard Deviation|11.6|11.6|||
4039743|NCT01125566|3861665|B2|||Age||years|Mean|53.1|53.1|Standard Deviation|12.3|12.3|||
4039744|NCT01125566|3861666|B1|||Age||years|Mean|51.8|51.8|Standard Deviation|11.3|11.3|||
4039745|NCT01125514|3861681|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4039746|NCT01125514|3861681|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4039747|NCT01125514|3861681|B1|||Age||years|Mean|59.6|59.6|Standard Deviation|11.90|11.9|||
4039748|NCT01125202|3861753|B3||Other|Etiology of ESRD|Etiology of ESRD|Participants|Count of Participants|19|19.0||||||
4039749|NCT01125202|3861754|B2||Other|Etiology of ESRD|Etiology of ESRD|Participants|Count of Participants|10|10.0||||||
4039750|NCT01125202|3861755|B1||Other|Etiology of ESRD|Etiology of ESRD|Participants|Count of Participants|9|9.0||||||
4039751|NCT01125202|3861753|B3||Neoplasms/tumors|Etiology of ESRD|Etiology of ESRD|Participants|Count of Participants|13|13.0||||||
4039752|NCT01125202|3861754|B2||Neoplasms/tumors|Etiology of ESRD|Etiology of ESRD|Participants|Count of Participants|4|4.0||||||
4039753|NCT01125202|3861755|B1||Neoplasms/tumors|Etiology of ESRD|Etiology of ESRD|Participants|Count of Participants|9|9.0||||||
4039754|NCT01125202|3861753|B3||Polycystic disease|Etiology of ESRD|Etiology of ESRD|Participants|Count of Participants|6|6.0||||||
4039755|NCT01125202|3861754|B2||Polycystic disease|Etiology of ESRD|Etiology of ESRD|Participants|Count of Participants|1|1.0||||||
4039756|NCT01125202|3861755|B1||Polycystic disease|Etiology of ESRD|Etiology of ESRD|Participants|Count of Participants|5|5.0||||||
4039757|NCT01125202|3861753|B3||Glomerular disease|Etiology of ESRD|Etiology of ESRD|Participants|Count of Participants|20|20.0||||||
4039758|NCT01125202|3861754|B2||Glomerular disease|Etiology of ESRD|Etiology of ESRD|Participants|Count of Participants|6|6.0||||||
4039759|NCT01125202|3861755|B1||Glomerular disease|Etiology of ESRD|Etiology of ESRD|Participants|Count of Participants|14|14.0||||||
4039760|NCT01125202|3861753|B3||Hypertension|Etiology of ESRD|Etiology of ESRD|Participants|Count of Participants|49|49.0||||||
4039761|NCT01125202|3861754|B2||Hypertension|Etiology of ESRD|Etiology of ESRD|Participants|Count of Participants|30|30.0||||||
4039762|NCT01125202|3861755|B1||Hypertension|Etiology of ESRD|Etiology of ESRD|Participants|Count of Participants|19|19.0||||||
4039763|NCT01125202|3861753|B3||Diabetes|Etiology of ESRD|Etiology of ESRD|Participants|Count of Participants|71|71.0||||||
4039764|NCT01125202|3861754|B2||Diabetes|Etiology of ESRD|Etiology of ESRD|Participants|Count of Participants|34|34.0||||||
4039765|NCT01125202|3861755|B1||Diabetes|Etiology of ESRD|Etiology of ESRD|Participants|Count of Participants|37|37.0||||||
4039766|NCT01125202|3861753|B3|United States||Region of Enrollment||participants|Number|178|178.0||||||
4039767|NCT01125202|3861754|B2|United States||Region of Enrollment||participants|Number|85|85.0||||||
4039768|NCT01125202|3861755|B1|United States||Region of Enrollment||participants|Number|93|93.0||||||
4039769|NCT01125202|3861753|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4039770|NCT01125202|3861754|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4039771|NCT01125202|3861755|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4039772|NCT01125202|3861753|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039773|NCT01125202|3861754|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039774|NCT01125202|3861755|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039775|NCT01125202|3861753|B3||White|Race (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
4039776|NCT01125202|3861754|B2||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4039777|NCT01125202|3861755|B1||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4039778|NCT01125202|3861753|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4039779|NCT01125202|3861754|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4039780|NCT01125202|3861755|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4039781|NCT01125202|3861753|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039782|NCT01125202|3861754|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039783|NCT01125202|3861755|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039784|NCT01125202|3861753|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039785|NCT01125202|3861754|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039786|NCT01125202|3861755|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039787|NCT01125202|3861753|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039788|NCT01125202|3861754|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039789|NCT01125202|3861755|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039790|NCT01125202|3861753|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039791|NCT01125202|3861754|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039792|NCT01125202|3861755|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039793|NCT01125202|3861753|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|174|174.0||||||
4039794|NCT01125202|3861754|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
4039795|NCT01125202|3861755|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
4039796|NCT01125202|3861753|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4039797|NCT01125202|3861754|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4039798|NCT01125202|3861755|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4039799|NCT01125202|3861753|B3||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4039800|NCT01125202|3861754|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4039801|NCT01125202|3861755|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4039802|NCT01125202|3861753|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4039803|NCT01125202|3861754|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4039804|NCT01125202|3861755|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4039805|NCT01125202|3861753|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|13.5|13.5|||
4039806|NCT01125202|3861754|B2|||Age||years|Mean|60.8|60.8|Standard Deviation|13.4|13.4|||
4039807|NCT01125202|3861755|B1|||Age||years|Mean|59.1|59.1|Standard Deviation|13.5|13.5|||
4039808|NCT01125189|3861778|B4|Missing||IL-28B Genotype||participants|Number|23|23.0||||||
4039809|NCT01125189|3861779|B3|Missing||IL-28B Genotype||participants|Number|6|6.0||||||
4039810|NCT01125189|3861780|B2|Missing||IL-28B Genotype||participants|Number|10|10.0||||||
4039811|NCT01125189|3861781|B1|Missing||IL-28B Genotype||participants|Number|7|7.0||||||
4039812|NCT01125189|3861778|B4|TT genotype||IL-28B Genotype||participants|Number|46|46.0||||||
4039813|NCT01125189|3861779|B3|TT genotype||IL-28B Genotype||participants|Number|11|11.0||||||
4039814|NCT01125189|3861780|B2|TT genotype||IL-28B Genotype||participants|Number|18|18.0||||||
4039815|NCT01125189|3861781|B1|TT genotype||IL-28B Genotype||participants|Number|17|17.0||||||
4039816|NCT01125189|3861778|B4|CT genotype||IL-28B Genotype||participants|Number|206|206.0||||||
4039817|NCT01125189|3861779|B3|CT genotype||IL-28B Genotype||participants|Number|38|38.0||||||
4039818|NCT01125189|3861780|B2|CT genotype||IL-28B Genotype||participants|Number|86|86.0||||||
4039819|NCT01125189|3861781|B1|CT genotype||IL-28B Genotype||participants|Number|82|82.0||||||
4039820|NCT01125189|3861778|B4|CC genotype||IL-28B Genotype||participants|Number|120|120.0||||||
4039821|NCT01125189|3861779|B3|CC genotype||IL-28B Genotype||participants|Number|23|23.0||||||
4039822|NCT01125189|3861780|B2|CC genotype||IL-28B Genotype||participants|Number|44|44.0||||||
4039823|NCT01125189|3861781|B1|CC genotype||IL-28B Genotype||participants|Number|53|53.0||||||
4039824|NCT01125189|3861778|B4|≥800,000 IU/mL||Hepatitis C Virus RNA Distribution||participants|Number|317|317.0||||||
4039825|NCT01125189|3861779|B3|≥800,000 IU/mL||Hepatitis C Virus RNA Distribution||participants|Number|61|61.0||||||
4039826|NCT01125189|3861780|B2|≥800,000 IU/mL||Hepatitis C Virus RNA Distribution||participants|Number|123|123.0||||||
4039827|NCT01125189|3861781|B1|≥800,000 IU/mL||Hepatitis C Virus RNA Distribution||participants|Number|133|133.0||||||
4039828|NCT01125189|3861778|B4|<800,000 IU/mL||Hepatitis C Virus RNA Distribution||participants|Number|78|78.0||||||
4039829|NCT01125189|3861779|B3|<800,000 IU/mL||Hepatitis C Virus RNA Distribution||participants|Number|17|17.0||||||
4039830|NCT01125189|3861780|B2|<800,000 IU/mL||Hepatitis C Virus RNA Distribution||participants|Number|35|35.0||||||
4039831|NCT01125189|3861781|B1|<800,000 IU/mL||Hepatitis C Virus RNA Distribution||participants|Number|26|26.0||||||
4039832|NCT01125189|3861778|B4||Male|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
4039833|NCT01125189|3861779|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4039834|NCT01125189|3861780|B2||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4039835|NCT01125189|3861781|B1||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4039836|NCT01125189|3861778|B4||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4039837|NCT01125189|3861779|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4039838|NCT01125189|3861780|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4039839|NCT01125189|3861781|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4039840|NCT01125189|3861778|B4|≥65 years||Age, Customized||participants|Number|10|10.0||||||
4039841|NCT01125189|3861779|B3|≥65 years||Age, Customized||participants|Number|1|1.0||||||
4039842|NCT01125189|3861780|B2|≥65 years||Age, Customized||participants|Number|4|4.0||||||
4039843|NCT01125189|3861781|B1|≥65 years||Age, Customized||participants|Number|5|5.0||||||
4039844|NCT01125189|3861778|B4|<65 years||Age, Customized||participants|Number|385|385.0||||||
4039845|NCT01125189|3861779|B3|<65 years||Age, Customized||participants|Number|77|77.0||||||
4039846|NCT01125189|3861780|B2|<65 years||Age, Customized||participants|Number|154|154.0||||||
4039847|NCT01125189|3861781|B1|<65 years||Age, Customized||participants|Number|154|154.0||||||
4039848|NCT01125098|3861809|B3|Italy||Region of Enrollment||participants|Number|181|181.0||||||
4039849|NCT01125098|3861810|B2|Italy||Region of Enrollment||participants|Number|90|90.0||||||
4039850|NCT01125098|3861811|B1|Italy||Region of Enrollment||participants|Number|91|91.0||||||
4039851|NCT01125098|3861809|B3||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4039852|NCT01125098|3861810|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4039853|NCT01125098|3861811|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4039854|NCT01125098|3861809|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4039855|NCT01125098|3861810|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4039856|NCT01125098|3861811|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4039857|NCT01125098|3861809|B3|||Age|Age, median (IQR)|years|Median|73|73.0|Inter-Quartile Range|||66.5|78.0|
4039858|NCT01125098|3861810|B2|||Age|Age, median (IQR)|years|Median|72.5|72.5|Inter-Quartile Range|||65.0|78.0|
4039859|NCT01125098|3861811|B1|||Age|Age, median (IQR)|years|Median|73.5|73.5|Inter-Quartile Range|||68.5|78.0|
4039860|NCT01124955|3861818|B3|Brazil||Region of Enrollment||participants|Number|80|80.0||||||
4039861|NCT01124955|3861819|B2|Brazil||Region of Enrollment||participants|Number|40|40.0||||||
4039862|NCT01124955|3861820|B1|Brazil||Region of Enrollment||participants|Number|40|40.0||||||
4039863|NCT01124955|3861818|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4039864|NCT01124955|3861819|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4039865|NCT01124955|3861820|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4039866|NCT01124955|3861818|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4039867|NCT01124955|3861819|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4039868|NCT01124955|3861820|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4039869|NCT01124955|3861818|B3|||Age||years|Mean|45.4|45.4|Standard Deviation|10.3|10.3|||
4039870|NCT01124955|3861819|B2|||Age||years|Mean|43.9|43.9|Standard Deviation|10.9|10.9|||
4039871|NCT01124955|3861820|B1|||Age||years|Mean|47|47.0|Standard Deviation|9.8|9.8|||
4039872|NCT01124955|3861818|B3||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4039873|NCT01124955|3861819|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4039874|NCT01124955|3861820|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4039875|NCT01124916|3861835|B3||Yes|Prior Hysterectomy||Participants|Count of Participants|33|33.0||||||
4039876|NCT01124916|3861836|B2||Yes|Prior Hysterectomy||Participants|Count of Participants|14|14.0||||||
4039877|NCT01124916|3861837|B1||Yes|Prior Hysterectomy||Participants|Count of Participants|19|19.0||||||
4039878|NCT01124916|3861835|B3||No|Prior Hysterectomy||Participants|Count of Participants|45|45.0||||||
4039879|NCT01124916|3861836|B2||No|Prior Hysterectomy||Participants|Count of Participants|26|26.0||||||
4039880|NCT01124916|3861837|B1||No|Prior Hysterectomy||Participants|Count of Participants|19|19.0||||||
4039881|NCT01124916|3861835|B3||Yes|Previous surgery for pelvic organ prolapse||Participants|Count of Participants|16|16.0||||||
4039882|NCT01124916|3861836|B2||Yes|Previous surgery for pelvic organ prolapse||Participants|Count of Participants|8|8.0||||||
4039883|NCT01124916|3861837|B1||Yes|Previous surgery for pelvic organ prolapse||Participants|Count of Participants|8|8.0||||||
4039884|NCT01124916|3861835|B3||No|Previous surgery for pelvic organ prolapse||Participants|Count of Participants|62|62.0||||||
4039885|NCT01124916|3861836|B2||No|Previous surgery for pelvic organ prolapse||Participants|Count of Participants|32|32.0||||||
4039886|NCT01124916|3861837|B1||No|Previous surgery for pelvic organ prolapse||Participants|Count of Participants|30|30.0||||||
4039887|NCT01124916|3861835|B3||Yes|Previous surgery for urinary incontinence||Participants|Count of Participants|12|12.0||||||
4039888|NCT01124916|3861836|B2||Yes|Previous surgery for urinary incontinence||Participants|Count of Participants|5|5.0||||||
4039889|NCT01124916|3861837|B1||Yes|Previous surgery for urinary incontinence||Participants|Count of Participants|7|7.0||||||
4039890|NCT01124916|3861835|B3||No|Previous surgery for urinary incontinence||Participants|Count of Participants|66|66.0||||||
4039891|NCT01124916|3861836|B2||No|Previous surgery for urinary incontinence||Participants|Count of Participants|35|35.0||||||
4039892|NCT01124916|3861837|B1||No|Previous surgery for urinary incontinence||Participants|Count of Participants|31|31.0||||||
4039893|NCT01124916|3861835|B3||Yes|Concomitant estrogen therapy||Participants|Count of Participants|17|17.0||||||
4039894|NCT01124916|3861836|B2||Yes|Concomitant estrogen therapy||Participants|Count of Participants|6|6.0||||||
4039895|NCT01124916|3861837|B1||Yes|Concomitant estrogen therapy||Participants|Count of Participants|11|11.0||||||
4039896|NCT01124916|3861835|B3||No|Concomitant estrogen therapy||Participants|Count of Participants|61|61.0||||||
4039897|NCT01124916|3861836|B2||No|Concomitant estrogen therapy||Participants|Count of Participants|34|34.0||||||
4039898|NCT01124916|3861837|B1||No|Concomitant estrogen therapy||Participants|Count of Participants|27|27.0||||||
4039899|NCT01124916|3861835|B3||Yes|Postmenopausal||Participants|Count of Participants|58|58.0||||||
4039900|NCT01124916|3861836|B2||Yes|Postmenopausal||Participants|Count of Participants|29|29.0||||||
4039901|NCT01124916|3861837|B1||Yes|Postmenopausal||Participants|Count of Participants|29|29.0||||||
4039902|NCT01124916|3861835|B3||No|Postmenopausal||Participants|Count of Participants|20|20.0||||||
4039903|NCT01124916|3861836|B2||No|Postmenopausal||Participants|Count of Participants|11|11.0||||||
4039904|NCT01124916|3861837|B1||No|Postmenopausal||Participants|Count of Participants|9|9.0||||||
4039905|NCT01124916|3861835|B3||Yes|History of Stomach Ulcer||Participants|Count of Participants|17|17.0||||||
4039906|NCT01124916|3861836|B2||Yes|History of Stomach Ulcer||Participants|Count of Participants|10|10.0||||||
4039907|NCT01124916|3861837|B1||Yes|History of Stomach Ulcer||Participants|Count of Participants|7|7.0||||||
4039908|NCT01124916|3861835|B3||No|History of Stomach Ulcer||Participants|Count of Participants|61|61.0||||||
4039909|NCT01124916|3861836|B2||No|History of Stomach Ulcer||Participants|Count of Participants|30|30.0||||||
4039910|NCT01124916|3861837|B1||No|History of Stomach Ulcer||Participants|Count of Participants|31|31.0||||||
4039911|NCT01124916|3861835|B3||Yes|History of Cancer||Participants|Count of Participants|14|14.0||||||
4039912|NCT01124916|3861836|B2||Yes|History of Cancer||Participants|Count of Participants|8|8.0||||||
4039913|NCT01124916|3861837|B1||Yes|History of Cancer||Participants|Count of Participants|6|6.0||||||
4039914|NCT01124916|3861835|B3||No|History of Cancer||Participants|Count of Participants|64|64.0||||||
4039915|NCT01124916|3861836|B2||No|History of Cancer||Participants|Count of Participants|32|32.0||||||
4039916|NCT01124916|3861837|B1||No|History of Cancer||Participants|Count of Participants|32|32.0||||||
4039917|NCT01124916|3861835|B3||Yes|History of Stroke||Participants|Count of Participants|2|2.0||||||
4039918|NCT01124916|3861836|B2||Yes|History of Stroke||Participants|Count of Participants|0|0.0||||||
4039919|NCT01124916|3861837|B1||Yes|History of Stroke||Participants|Count of Participants|2|2.0||||||
4039920|NCT01124916|3861835|B3||No|History of Stroke||Participants|Count of Participants|76|76.0||||||
4039921|NCT01124916|3861836|B2||No|History of Stroke||Participants|Count of Participants|40|40.0||||||
4039922|NCT01124916|3861837|B1||No|History of Stroke||Participants|Count of Participants|36|36.0||||||
4039923|NCT01124916|3861835|B3||Yes|History of Heart Attack||Participants|Count of Participants|6|6.0||||||
4039924|NCT01124916|3861836|B2||Yes|History of Heart Attack||Participants|Count of Participants|5|5.0||||||
4039925|NCT01124916|3861837|B1||Yes|History of Heart Attack||Participants|Count of Participants|1|1.0||||||
4039926|NCT01124916|3861835|B3||No|History of Heart Attack||Participants|Count of Participants|72|72.0||||||
4039927|NCT01124916|3861836|B2||No|History of Heart Attack||Participants|Count of Participants|35|35.0||||||
4039928|NCT01124916|3861837|B1||No|History of Heart Attack||Participants|Count of Participants|37|37.0||||||
4039929|NCT01124916|3861835|B3||Yes|Comorbid Diabetes||Participants|Count of Participants|9|9.0||||||
4039930|NCT01124916|3861836|B2||Yes|Comorbid Diabetes||Participants|Count of Participants|6|6.0||||||
4039931|NCT01124916|3861837|B1||Yes|Comorbid Diabetes||Participants|Count of Participants|3|3.0||||||
4039932|NCT01124916|3861835|B3||No|Comorbid Diabetes||Participants|Count of Participants|69|69.0||||||
4039933|NCT01124916|3861836|B2||No|Comorbid Diabetes||Participants|Count of Participants|34|34.0||||||
4039934|NCT01124916|3861837|B1||No|Comorbid Diabetes||Participants|Count of Participants|35|35.0||||||
4039935|NCT01124916|3861835|B3||Unknown|Net household income||Participants|Count of Participants|4|4.0||||||
4039936|NCT01124916|3861836|B2||Unknown|Net household income||Participants|Count of Participants|3|3.0||||||
4039937|NCT01124916|3861837|B1||Unknown|Net household income||Participants|Count of Participants|1|1.0||||||
4039938|NCT01124916|3861835|B3||More than $75,000|Net household income||Participants|Count of Participants|23|23.0||||||
4039939|NCT01124916|3861836|B2||More than $75,000|Net household income||Participants|Count of Participants|15|15.0||||||
4039940|NCT01124916|3861837|B1||More than $75,000|Net household income||Participants|Count of Participants|8|8.0||||||
4039941|NCT01124916|3861835|B3||$50,000 to $75,000|Net household income||Participants|Count of Participants|22|22.0||||||
4039942|NCT01124916|3861836|B2||$50,000 to $75,000|Net household income||Participants|Count of Participants|11|11.0||||||
4039943|NCT01124916|3861837|B1||$50,000 to $75,000|Net household income||Participants|Count of Participants|11|11.0||||||
4039944|NCT01124916|3861835|B3||Less than $50,000|Net household income||Participants|Count of Participants|29|29.0||||||
4039945|NCT01124916|3861836|B2||Less than $50,000|Net household income||Participants|Count of Participants|11|11.0||||||
4039946|NCT01124916|3861837|B1||Less than $50,000|Net household income||Participants|Count of Participants|18|18.0||||||
4039947|NCT01124916|3861835|B3||More than 12 years|Years of Education||Participants|Count of Participants|50|50.0||||||
4039948|NCT01124916|3861836|B2||More than 12 years|Years of Education||Participants|Count of Participants|26|26.0||||||
4039949|NCT01124916|3861837|B1||More than 12 years|Years of Education||Participants|Count of Participants|24|24.0||||||
4039950|NCT01124916|3861835|B3||12 or fewer years|Years of Education||Participants|Count of Participants|28|28.0||||||
4039951|NCT01124916|3861836|B2||12 or fewer years|Years of Education||Participants|Count of Participants|14|14.0||||||
4039952|NCT01124916|3861837|B1||12 or fewer years|Years of Education||Participants|Count of Participants|14|14.0||||||
4039953|NCT01124916|3861835|B3|||Parity||Count of pregnancies|Mean|2.7|2.7|Standard Deviation|1.2|1.2|||
4039954|NCT01124916|3861836|B2|||Parity||Count of pregnancies|Mean|2.6|2.6|Standard Deviation|1.1|1.1|||
4039955|NCT01124916|3861837|B1|||Parity||Count of pregnancies|Mean|2.7|2.7|Standard Deviation|1.3|1.3|||
4039956|NCT01124916|3861835|B3|||Body Mass Index (BMI)||kg/m^2|Mean|27.7|27.7|Standard Deviation|5.7|5.7|||
4039957|NCT01124916|3861836|B2|||Body Mass Index (BMI)||kg/m^2|Mean|28.2|28.2|Standard Deviation|6.6|6.6|||
4039958|NCT01124916|3861837|B1|||Body Mass Index (BMI)||kg/m^2|Mean|27|27.0|Standard Deviation|4.7|4.7|||
4039959|NCT01124916|3861835|B3||Los Angeles, California|City and state where the study activities took place||Participants|Count of Participants|22|22.0||||||
4039960|NCT01124916|3861836|B2||Los Angeles, California|City and state where the study activities took place||Participants|Count of Participants|12|12.0||||||
4039961|NCT01124916|3861837|B1||Los Angeles, California|City and state where the study activities took place||Participants|Count of Participants|10|10.0||||||
4039962|NCT01124916|3861835|B3||Maywood, Illinois|City and state where the study activities took place||Participants|Count of Participants|56|56.0||||||
4039963|NCT01124916|3861836|B2||Maywood, Illinois|City and state where the study activities took place||Participants|Count of Participants|28|28.0||||||
4039964|NCT01124916|3861837|B1||Maywood, Illinois|City and state where the study activities took place||Participants|Count of Participants|28|28.0||||||
4039965|NCT01124916|3861835|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039966|NCT01124916|3861836|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039967|NCT01124916|3861837|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039968|NCT01124916|3861835|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039969|NCT01124916|3861836|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039970|NCT01124916|3861837|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039971|NCT01124916|3861835|B3||White|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
4039972|NCT01124916|3861836|B2||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4039973|NCT01124916|3861837|B1||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4039974|NCT01124916|3861835|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4039975|NCT01124916|3861836|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4039976|NCT01124916|3861837|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4039977|NCT01124916|3861835|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039978|NCT01124916|3861836|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039979|NCT01124916|3861837|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039980|NCT01124916|3861835|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039981|NCT01124916|3861836|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039982|NCT01124916|3861837|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039983|NCT01124916|3861835|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039984|NCT01124916|3861836|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039985|NCT01124916|3861837|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039986|NCT01124916|3861835|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039987|NCT01124916|3861836|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039988|NCT01124916|3861837|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4039989|NCT01124916|3861835|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4039990|NCT01124916|3861836|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4039991|NCT01124916|3861837|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4039992|NCT01124916|3861835|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4039993|NCT01124916|3861836|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4039994|NCT01124916|3861837|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4039995|NCT01124916|3861835|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
4039996|NCT01124916|3861836|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
4039997|NCT01124916|3861837|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4039998|NCT01124916|3861835|B3||Female|Gender||Participants|Count of Participants|78|78.0||||||
4039999|NCT01124916|3861836|B2||Female|Gender||Participants|Count of Participants|40|40.0||||||
4040000|NCT01124916|3861837|B1||Female|Gender||Participants|Count of Participants|38|38.0||||||
4040001|NCT01124916|3861835|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|9.9|9.9|||
4040002|NCT01124916|3861836|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|10.5|10.5|||
4040003|NCT01124916|3861837|B1|||Age||years|Mean|60.6|60.6|Standard Deviation|9.2|9.2|||
4040004|NCT01124864|3861846|B7|||Time since smoking cessation||months|Mean|152.4|152.4|Standard Deviation|142.22|142.22|||
4040005|NCT01124864|3861847|B6|||Time since smoking cessation||months|Mean|NA||Standard Deviation|NA||||No patients were analyzed in this group.
4040006|NCT01124864|3861848|B5|||Time since smoking cessation||months|Mean|340.4|340.4|Standard Deviation|179.18|179.18|||
4040007|NCT01124864|3861849|B4|||Time since smoking cessation||months|Mean|NA||Standard Deviation|NA||||No patients were analyzed in this group.
4040008|NCT01124864|3861850|B3|||Time since smoking cessation||months|Mean|180.3|180.3|Standard Deviation|120.88|120.88|||
4040009|NCT01124864|3861851|B2|||Time since smoking cessation||months|Mean|176.6|176.6|Standard Deviation|15.04|15.04|||
4040010|NCT01124864|3861852|B1|||Time since smoking cessation||months|Mean|59.0|59.0|Standard Deviation|80.65|80.65|||
4040011|NCT01124864|3861846|B7|Never smoked||Smoking status||Participants|Number|71|71.0||||||
4040012|NCT01124864|3861847|B6|Never smoked||Smoking status||Participants|Number|2|2.0||||||
4040013|NCT01124864|3861848|B5|Never smoked||Smoking status||Participants|Number|14|14.0||||||
4040014|NCT01124864|3861849|B4|Never smoked||Smoking status||Participants|Number|15|15.0||||||
4040015|NCT01124864|3861850|B3|Never smoked||Smoking status||Participants|Number|14|14.0||||||
4040016|NCT01124864|3861851|B2|Never smoked||Smoking status||Participants|Number|22|22.0||||||
4040017|NCT01124864|3861852|B1|Never smoked||Smoking status||Participants|Number|4|4.0||||||
4040018|NCT01124864|3861846|B7|Ex-smoker||Smoking status||Participants|Number|72|72.0||||||
4040019|NCT01124864|3861847|B6|Ex-smoker||Smoking status||Participants|Number|0|0.0||||||
4040020|NCT01124864|3861848|B5|Ex-smoker||Smoking status||Participants|Number|16|16.0||||||
4040021|NCT01124864|3861849|B4|Ex-smoker||Smoking status||Participants|Number|5|5.0||||||
4040022|NCT01124864|3861850|B3|Ex-smoker||Smoking status||Participants|Number|18|18.0||||||
4040023|NCT01124864|3861851|B2|Ex-smoker||Smoking status||Participants|Number|12|12.0||||||
4040024|NCT01124864|3861852|B1|Ex-smoker||Smoking status||Participants|Number|21|21.0||||||
4040025|NCT01124864|3861846|B7|Current smoker||Smoking status||Participants|Number|10|10.0||||||
4040026|NCT01124864|3861847|B6|Current smoker||Smoking status||Participants|Number|1|1.0||||||
4040027|NCT01124864|3861848|B5|Current smoker||Smoking status||Participants|Number|1|1.0||||||
4040028|NCT01124864|3861849|B4|Current smoker||Smoking status||Participants|Number|2|2.0||||||
4040029|NCT01124864|3861850|B3|Current smoker||Smoking status||Participants|Number|2|2.0||||||
4040030|NCT01124864|3861851|B2|Current smoker||Smoking status||Participants|Number|1|1.0||||||
4040031|NCT01124864|3861852|B1|Current smoker||Smoking status||Participants|Number|3|3.0||||||
4040032|NCT01124864|3861846|B7|Who Performance status: 2||WHO Performance status|"Who Performance status:~0: Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g. light housework, office work~Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours"|Participants|Number|8|8.0||||||
4040033|NCT01124864|3861847|B6|Who Performance status: 2||WHO Performance status|"Who Performance status:~0: Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g. light housework, office work~Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours"|Participants|Number|0|0.0||||||
4040034|NCT01124864|3861848|B5|Who Performance status: 2||WHO Performance status|"Who Performance status:~0: Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g. light housework, office work~Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours"|Participants|Number|0|0.0||||||
4040035|NCT01124864|3861849|B4|Who Performance status: 2||WHO Performance status|"Who Performance status:~0: Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g. light housework, office work~Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours"|Participants|Number|2|2.0||||||
4040036|NCT01124864|3861850|B3|Who Performance status: 2||WHO Performance status|"Who Performance status:~0: Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g. light housework, office work~Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours"|Participants|Number|3|3.0||||||
4040037|NCT01124864|3861851|B2|Who Performance status: 2||WHO Performance status|"Who Performance status:~0: Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g. light housework, office work~Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours"|Participants|Number|3|3.0||||||
4040038|NCT01124864|3861852|B1|Who Performance status: 2||WHO Performance status|"Who Performance status:~0: Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g. light housework, office work~Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours"|Participants|Number|0|0.0||||||
4040120|NCT01124864|3861850|B3|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4040039|NCT01124864|3861846|B7|Who Performance status: 1||WHO Performance status|"Who Performance status:~0: Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g. light housework, office work~Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours"|Participants|Number|91|91.0||||||
4040040|NCT01124864|3861847|B6|Who Performance status: 1||WHO Performance status|"Who Performance status:~0: Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g. light housework, office work~Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours"|Participants|Number|2|2.0||||||
4040041|NCT01124864|3861848|B5|Who Performance status: 1||WHO Performance status|"Who Performance status:~0: Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g. light housework, office work~Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours"|Participants|Number|20|20.0||||||
4040042|NCT01124864|3861849|B4|Who Performance status: 1||WHO Performance status|"Who Performance status:~0: Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g. light housework, office work~Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours"|Participants|Number|11|11.0||||||
4040043|NCT01124864|3861850|B3|Who Performance status: 1||WHO Performance status|"Who Performance status:~0: Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g. light housework, office work~Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours"|Participants|Number|21|21.0||||||
4040044|NCT01124864|3861851|B2|Who Performance status: 1||WHO Performance status|"Who Performance status:~0: Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g. light housework, office work~Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours"|Participants|Number|19|19.0||||||
4040045|NCT01124864|3861852|B1|Who Performance status: 1||WHO Performance status|"Who Performance status:~0: Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g. light housework, office work~Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours"|Participants|Number|18|18.0||||||
4040046|NCT01124864|3861846|B7|Who Performance status: 0||WHO Performance status|"Who Performance status:~0: Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g. light housework, office work~Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours"|Participants|Number|54|54.0||||||
4040047|NCT01124864|3861847|B6|Who Performance status: 0||WHO Performance status|"Who Performance status:~0: Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g. light housework, office work~Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours"|Participants|Number|1|1.0||||||
4040048|NCT01124864|3861848|B5|Who Performance status: 0||WHO Performance status|"Who Performance status:~0: Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g. light housework, office work~Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours"|Participants|Number|11|11.0||||||
4040049|NCT01124864|3861849|B4|Who Performance status: 0||WHO Performance status|"Who Performance status:~0: Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g. light housework, office work~Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours"|Participants|Number|9|9.0||||||
4040050|NCT01124864|3861850|B3|Who Performance status: 0||WHO Performance status|"Who Performance status:~0: Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g. light housework, office work~Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours"|Participants|Number|10|10.0||||||
4040051|NCT01124864|3861851|B2|Who Performance status: 0||WHO Performance status|"Who Performance status:~0: Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g. light housework, office work~Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours"|Participants|Number|13|13.0||||||
4040052|NCT01124864|3861852|B1|Who Performance status: 0||WHO Performance status|"Who Performance status:~0: Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g. light housework, office work~Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours"|Participants|Number|10|10.0||||||
4040053|NCT01124864|3861846|B7|||Percentage of LVEF (left ventricular ejection fraction)||Percentage of LVEF|Mean|66.2|66.2|Standard Deviation|8.51|8.51|||
4040054|NCT01124864|3861847|B6|||Percentage of LVEF (left ventricular ejection fraction)||Percentage of LVEF|Mean|69.0|69.0|Standard Deviation|10.54|10.54|||
4040055|NCT01124864|3861848|B5|||Percentage of LVEF (left ventricular ejection fraction)||Percentage of LVEF|Mean|65.4|65.4|Standard Deviation|7.64|7.64|||
4040121|NCT01124864|3861851|B2|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4040056|NCT01124864|3861849|B4|||Percentage of LVEF (left ventricular ejection fraction)||Percentage of LVEF|Mean|69.5|69.5|Standard Deviation|8.68|8.68|||
4040057|NCT01124864|3861850|B3|||Percentage of LVEF (left ventricular ejection fraction)||Percentage of LVEF|Mean|66.2|66.2|Standard Deviation|9.27|9.27|||
4040058|NCT01124864|3861851|B2|||Percentage of LVEF (left ventricular ejection fraction)||Percentage of LVEF|Mean|66.9|66.9|Standard Deviation|7.63|7.63|||
4040059|NCT01124864|3861852|B1|||Percentage of LVEF (left ventricular ejection fraction)||Percentage of LVEF|Mean|63.2|63.2|Standard Deviation|8.92|8.92|||
4040060|NCT01124864|3861846|B7|||Body surface area||m^2|Mean|1.8|1.8|Standard Deviation|0.21|0.21|||
4040061|NCT01124864|3861847|B6|||Body surface area||m^2|Mean|1.9|1.9|Standard Deviation|0.27|0.27|||
4040062|NCT01124864|3861848|B5|||Body surface area||m^2|Mean|1.8|1.8|Standard Deviation|0.18|0.18|||
4040063|NCT01124864|3861849|B4|||Body surface area||m^2|Mean|1.7|1.7|Standard Deviation|0.20|0.2|||
4040064|NCT01124864|3861850|B3|||Body surface area||m^2|Mean|1.8|1.8|Standard Deviation|0.21|0.21|||
4040065|NCT01124864|3861851|B2|||Body surface area||m^2|Mean|1.7|1.7|Standard Deviation|0.18|0.18|||
4040066|NCT01124864|3861852|B1|||Body surface area||m^2|Mean|1.9|1.9|Standard Deviation|0.23|0.23|||
4040067|NCT01124864|3861846|B7|>= 75 kg||Weight category||Participants|Number|37|37.0||||||
4040068|NCT01124864|3861847|B6|>= 75 kg||Weight category||Participants|Number|1|1.0||||||
4040069|NCT01124864|3861848|B5|>= 75 kg||Weight category||Participants|Number|7|7.0||||||
4040070|NCT01124864|3861849|B4|>= 75 kg||Weight category||Participants|Number|3|3.0||||||
4040071|NCT01124864|3861850|B3|>= 75 kg||Weight category||Participants|Number|9|9.0||||||
4040072|NCT01124864|3861851|B2|>= 75 kg||Weight category||Participants|Number|6|6.0||||||
4040073|NCT01124864|3861852|B1|>= 75 kg||Weight category||Participants|Number|11|11.0||||||
4040074|NCT01124864|3861846|B7|55 - <75 kg||Weight category||Participants|Number|84|84.0||||||
4040075|NCT01124864|3861847|B6|55 - <75 kg||Weight category||Participants|Number|2|2.0||||||
4040076|NCT01124864|3861848|B5|55 - <75 kg||Weight category||Participants|Number|20|20.0||||||
4040077|NCT01124864|3861849|B4|55 - <75 kg||Weight category||Participants|Number|9|9.0||||||
4040078|NCT01124864|3861850|B3|55 - <75 kg||Weight category||Participants|Number|21|21.0||||||
4040079|NCT01124864|3861851|B2|55 - <75 kg||Weight category||Participants|Number|19|19.0||||||
4040080|NCT01124864|3861852|B1|55 - <75 kg||Weight category||Participants|Number|13|13.0||||||
4040081|NCT01124864|3861846|B7|< 55 kg||Weight category||Participants|Number|32|32.0||||||
4040082|NCT01124864|3861847|B6|< 55 kg||Weight category||Participants|Number|0|0.0||||||
4040083|NCT01124864|3861848|B5|< 55 kg||Weight category||Participants|Number|4|4.0||||||
4040084|NCT01124864|3861849|B4|< 55 kg||Weight category||Participants|Number|10|10.0||||||
4040085|NCT01124864|3861850|B3|< 55 kg||Weight category||Participants|Number|4|4.0||||||
4040086|NCT01124864|3861851|B2|< 55 kg||Weight category||Participants|Number|10|10.0||||||
4040087|NCT01124864|3861852|B1|< 55 kg||Weight category||Participants|Number|4|4.0||||||
4040088|NCT01124864|3861846|B7|||Weight||kg|Mean|67.3|67.3|Standard Deviation|13.70|13.7|||
4040089|NCT01124864|3861847|B6|||Weight||kg|Mean|76.6|76.6|Standard Deviation|15.75|15.75|||
4040090|NCT01124864|3861848|B5|||Weight||kg|Mean|67.1|67.1|Standard Deviation|11.02|11.02|||
4040091|NCT01124864|3861849|B4|||Weight||kg|Mean|60.5|60.5|Standard Deviation|12.30|12.3|||
4040092|NCT01124864|3861850|B3|||Weight||kg|Mean|68.4|68.4|Standard Deviation|13.49|13.49|||
4040093|NCT01124864|3861851|B2|||Weight||kg|Mean|64.0|64.0|Standard Deviation|12.05|12.05|||
4040094|NCT01124864|3861852|B1|||Weight||kg|Mean|74.5|74.5|Standard Deviation|16.22|16.22|||
4040095|NCT01124864|3861846|B7|||Height||cm|Mean|165.7|165.7|Standard Deviation|9.49|9.49|||
4040096|NCT01124864|3861847|B6|||Height||cm|Mean|173.0|173.0|Standard Deviation|14.73|14.73|||
4040097|NCT01124864|3861848|B5|||Height||cm|Mean|163.9|163.9|Standard Deviation|8.93|8.93|||
4040098|NCT01124864|3861849|B4|||Height||cm|Mean|164.9|164.9|Standard Deviation|9.80|9.8|||
4040099|NCT01124864|3861850|B3|||Height||cm|Mean|165.8|165.8|Standard Deviation|10.32|10.32|||
4040100|NCT01124864|3861851|B2|||Height||cm|Mean|163.0|163.0|Standard Deviation|6.63|6.63|||
4040101|NCT01124864|3861852|B1|||Height||cm|Mean|170.5|170.5|Standard Deviation|9.94|9.94|||
4040102|NCT01124864|3861846|B7|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4040103|NCT01124864|3861847|B6|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4040104|NCT01124864|3861848|B5|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4040105|NCT01124864|3861849|B4|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4040106|NCT01124864|3861850|B3|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4040107|NCT01124864|3861851|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4040108|NCT01124864|3861852|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4040109|NCT01124864|3861846|B7|Asian||Race/Ethnicity, Customized||Participants|Number|41|41.0||||||
4040110|NCT01124864|3861847|B6|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4040111|NCT01124864|3861848|B5|Asian||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4040112|NCT01124864|3861849|B4|Asian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4040113|NCT01124864|3861850|B3|Asian||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4040114|NCT01124864|3861851|B2|Asian||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4040115|NCT01124864|3861852|B1|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4040116|NCT01124864|3861846|B7|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4040117|NCT01124864|3861847|B6|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4040118|NCT01124864|3861848|B5|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4040119|NCT01124864|3861849|B4|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4040122|NCT01124864|3861852|B1|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4040123|NCT01124864|3861846|B7|Caucasian||Race/Ethnicity, Customized||Participants|Number|107|107.0||||||
4040124|NCT01124864|3861847|B6|Caucasian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4040125|NCT01124864|3861848|B5|Caucasian||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4040126|NCT01124864|3861849|B4|Caucasian||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4040127|NCT01124864|3861850|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
4040128|NCT01124864|3861851|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
4040129|NCT01124864|3861852|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
4040130|NCT01124864|3861846|B7||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4040131|NCT01124864|3861847|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4040132|NCT01124864|3861848|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4040133|NCT01124864|3861849|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4040134|NCT01124864|3861850|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4040135|NCT01124864|3861851|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4040136|NCT01124864|3861852|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4040137|NCT01124864|3861846|B7||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4040138|NCT01124864|3861847|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4040139|NCT01124864|3861848|B5||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4040140|NCT01124864|3861849|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4040141|NCT01124864|3861850|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4040142|NCT01124864|3861851|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4040143|NCT01124864|3861852|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4040144|NCT01124864|3861846|B7|>= 65 years||Age, Customized||Participants|Number|45|45.0||||||
4040145|NCT01124864|3861847|B6|>= 65 years||Age, Customized||Participants|Number|2|2.0||||||
4040146|NCT01124864|3861848|B5|>= 65 years||Age, Customized||Participants|Number|6|6.0||||||
4040147|NCT01124864|3861849|B4|>= 65 years||Age, Customized||Participants|Number|4|4.0||||||
4040148|NCT01124864|3861850|B3|>= 65 years||Age, Customized||Participants|Number|11|11.0||||||
4040149|NCT01124864|3861851|B2|>= 65 years||Age, Customized||Participants|Number|14|14.0||||||
4040150|NCT01124864|3861852|B1|>= 65 years||Age, Customized||Participants|Number|8|8.0||||||
4040151|NCT01124864|3861846|B7|< 65 years||Age, Customized||Participants|Number|108|108.0||||||
4040152|NCT01124864|3861847|B6|< 65 years||Age, Customized||Participants|Number|1|1.0||||||
4040153|NCT01124864|3861848|B5|< 65 years||Age, Customized||Participants|Number|25|25.0||||||
4040154|NCT01124864|3861849|B4|< 65 years||Age, Customized||Participants|Number|18|18.0||||||
4040155|NCT01124864|3861850|B3|< 65 years||Age, Customized||Participants|Number|23|23.0||||||
4040156|NCT01124864|3861851|B2|< 65 years||Age, Customized||Participants|Number|21|21.0||||||
4040157|NCT01124864|3861852|B1|< 65 years||Age, Customized||Participants|Number|20|20.0||||||
4040158|NCT01124838|3861889|B3|||Duration of Uveitis||months|Mean|58.85|58.85|Standard Deviation|63.185|63.185|||
4040159|NCT01124838|3861890|B2|||Duration of Uveitis||months|Mean|58.35|58.35|Standard Deviation|61.834|61.834|||
4040160|NCT01124838|3861891|B1|||Duration of Uveitis||months|Mean|59.36|59.36|Standard Deviation|64.753|64.753|||
4040161|NCT01124838|3861889|B3|No||History of Infectious Uveitis||participants|Number|261|261.0||||||
4040162|NCT01124838|3861890|B2|No||History of Infectious Uveitis||participants|Number|131|131.0||||||
4040163|NCT01124838|3861891|B1|No||History of Infectious Uveitis||participants|Number|130|130.0||||||
4040164|NCT01124838|3861889|B3|Yes||History of Infectious Uveitis||participants|Number|0|0.0||||||
4040165|NCT01124838|3861890|B2|Yes||History of Infectious Uveitis||participants|Number|0|0.0||||||
4040166|NCT01124838|3861891|B1|Yes||History of Infectious Uveitis||participants|Number|0|0.0||||||
4040167|NCT01124838|3861889|B3|Both||Eye Affected||participants|Number|248|248.0||||||
4040168|NCT01124838|3861890|B2|Both||Eye Affected||participants|Number|126|126.0||||||
4040169|NCT01124838|3861891|B1|Both||Eye Affected||participants|Number|122|122.0||||||
4040170|NCT01124838|3861889|B3|Right||Eye Affected||participants|Number|7|7.0||||||
4040171|NCT01124838|3861890|B2|Right||Eye Affected||participants|Number|2|2.0||||||
4040172|NCT01124838|3861891|B1|Right||Eye Affected||participants|Number|5|5.0||||||
4040173|NCT01124838|3861889|B3|Left||Eye Affected||participants|Number|6|6.0||||||
4040174|NCT01124838|3861890|B2|Left||Eye Affected||participants|Number|3|3.0||||||
4040175|NCT01124838|3861891|B1|Left||Eye Affected||participants|Number|3|3.0||||||
4040176|NCT01124838|3861889|B3|Other||Diagnosis||participants|Number|22|22.0||||||
4040177|NCT01124838|3861890|B2|Other||Diagnosis||participants|Number|12|12.0||||||
4040178|NCT01124838|3861891|B1|Other||Diagnosis||participants|Number|10|10.0||||||
4040179|NCT01124838|3861889|B3|Behcet's||Diagnosis||participants|Number|17|17.0||||||
4040180|NCT01124838|3861890|B2|Behcet's||Diagnosis||participants|Number|10|10.0||||||
4040181|NCT01124838|3861891|B1|Behcet's||Diagnosis||participants|Number|7|7.0||||||
4040182|NCT01124838|3861889|B3|Sarcoid||Diagnosis||participants|Number|42|42.0||||||
4040183|NCT01124838|3861890|B2|Sarcoid||Diagnosis||participants|Number|22|22.0||||||
4040184|NCT01124838|3861891|B1|Sarcoid||Diagnosis||participants|Number|20|20.0||||||
4040185|NCT01124838|3861889|B3|Vogt Koyanagi Harada||Diagnosis||participants|Number|64|64.0||||||
4040186|NCT01124838|3861890|B2|Vogt Koyanagi Harada||Diagnosis||participants|Number|34|34.0||||||
4040187|NCT01124838|3861891|B1|Vogt Koyanagi Harada||Diagnosis||participants|Number|30|30.0||||||
4040188|NCT01124838|3861889|B3|Multifocal Choroiditis and Panuveitis||Diagnosis||participants|Number|7|7.0||||||
4040189|NCT01124838|3861890|B2|Multifocal Choroiditis and Panuveitis||Diagnosis||participants|Number|5|5.0||||||
4040190|NCT01124838|3861891|B1|Multifocal Choroiditis and Panuveitis||Diagnosis||participants|Number|2|2.0||||||
4040191|NCT01124838|3861889|B3|Birdshot Choroidopathy||Diagnosis||participants|Number|31|31.0||||||
4040192|NCT01124838|3861890|B2|Birdshot Choroidopathy||Diagnosis||participants|Number|15|15.0||||||
4040193|NCT01124838|3861891|B1|Birdshot Choroidopathy||Diagnosis||participants|Number|16|16.0||||||
4040194|NCT01124838|3861889|B3|Idiopathic||Diagnosis||participants|Number|78|78.0||||||
4040195|NCT01124838|3861890|B2|Idiopathic||Diagnosis||participants|Number|33|33.0||||||
4040196|NCT01124838|3861891|B1|Idiopathic||Diagnosis||participants|Number|45|45.0||||||
4040197|NCT01124838|3861889|B3|Intermediate/Posterior||Type of Uveitis||participants|Number|3|3.0||||||
4040198|NCT01124838|3861890|B2|Intermediate/Posterior||Type of Uveitis||participants|Number|2|2.0||||||
4040199|NCT01124838|3861891|B1|Intermediate/Posterior||Type of Uveitis||participants|Number|1|1.0||||||
4040200|NCT01124838|3861889|B3|Panuveitis||Type of Uveitis||participants|Number|134|134.0||||||
4040201|NCT01124838|3861890|B2|Panuveitis||Type of Uveitis||participants|Number|71|71.0||||||
4040202|NCT01124838|3861891|B1|Panuveitis||Type of Uveitis||participants|Number|63|63.0||||||
4040203|NCT01124838|3861889|B3|Posterior||Type of Uveitis||participants|Number|77|77.0||||||
4040204|NCT01124838|3861890|B2|Posterior||Type of Uveitis||participants|Number|41|41.0||||||
4040205|NCT01124838|3861891|B1|Posterior||Type of Uveitis||participants|Number|36|36.0||||||
4040206|NCT01124838|3861889|B3|Intermediate||Type of Uveitis||participants|Number|47|47.0||||||
4040207|NCT01124838|3861890|B2|Intermediate||Type of Uveitis||participants|Number|17|17.0||||||
4040208|NCT01124838|3861891|B1|Intermediate||Type of Uveitis||participants|Number|30|30.0||||||
4040209|NCT01124838|3861889|B3|Multi-Race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4040210|NCT01124838|3861890|B2|Multi-Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4040211|NCT01124838|3861891|B1|Multi-Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4040212|NCT01124838|3861889|B3|Other||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4040213|NCT01124838|3861890|B2|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4040214|NCT01124838|3861891|B1|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4040215|NCT01124838|3861889|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4040216|NCT01124838|3861890|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4040217|NCT01124838|3861891|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4040218|NCT01124838|3861889|B3|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4040219|NCT01124838|3861890|B2|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4040220|NCT01124838|3861891|B1|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4040221|NCT01124838|3861889|B3|Asian||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4040222|NCT01124838|3861890|B2|Asian||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4040223|NCT01124838|3861891|B1|Asian||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4040224|NCT01124838|3861889|B3|Black||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4040225|NCT01124838|3861890|B2|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4040226|NCT01124838|3861891|B1|Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4040227|NCT01124838|3861889|B3|White||Race/Ethnicity, Customized||participants|Number|192|192.0||||||
4040228|NCT01124838|3861890|B2|White||Race/Ethnicity, Customized||participants|Number|96|96.0||||||
4040229|NCT01124838|3861891|B1|White||Race/Ethnicity, Customized||participants|Number|96|96.0||||||
4040230|NCT01124838|3861889|B3||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4040231|NCT01124838|3861890|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4040232|NCT01124838|3861891|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4040233|NCT01124838|3861889|B3||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4040234|NCT01124838|3861890|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4040235|NCT01124838|3861891|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4040236|NCT01124838|3861889|B3|≥ 65 years||Age, Customized||participants|Number|15|15.0||||||
4040237|NCT01124838|3861890|B2|≥ 65 years||Age, Customized||participants|Number|6|6.0||||||
4040238|NCT01124838|3861891|B1|≥ 65 years||Age, Customized||participants|Number|9|9.0||||||
4040239|NCT01124838|3861889|B3|< 65 years||Age, Customized||participants|Number|246|246.0||||||
4040240|NCT01124838|3861890|B2|< 65 years||Age, Customized||participants|Number|125|125.0||||||
4040241|NCT01124838|3861891|B1|< 65 years||Age, Customized||participants|Number|121|121.0||||||
4040242|NCT01124838|3861889|B3|||Age||years|Mean|43.20|43.2|Standard Deviation|13.360|13.36|||
4040243|NCT01124838|3861890|B2|||Age||years|Mean|43.18|43.18|Standard Deviation|12.719|12.719|||
4040244|NCT01124838|3861891|B1|||Age||years|Mean|43.22|43.22|Standard Deviation|14.026|14.026|||
4040245|NCT01124786|3861936|B3|Sweden||Region of Enrollment||participants|Number|8|8.0||||||
4040246|NCT01124786|3861937|B2|Sweden||Region of Enrollment||participants|Number|7|7.0||||||
4040247|NCT01124786|3861938|B1|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
4040248|NCT01124786|3861936|B3|Norway||Region of Enrollment||participants|Number|5|5.0||||||
4040249|NCT01124786|3861937|B2|Norway||Region of Enrollment||participants|Number|3|3.0||||||
4040250|NCT01124786|3861938|B1|Norway||Region of Enrollment||participants|Number|2|2.0||||||
4040251|NCT01124786|3861936|B3|Germany||Region of Enrollment||participants|Number|31|31.0||||||
4040252|NCT01124786|3861937|B2|Germany||Region of Enrollment||participants|Number|17|17.0||||||
4040253|NCT01124786|3861938|B1|Germany||Region of Enrollment||participants|Number|14|14.0||||||
4040254|NCT01124786|3861936|B3|Australia||Region of Enrollment||participants|Number|9|9.0||||||
4040255|NCT01124786|3861937|B2|Australia||Region of Enrollment||participants|Number|5|5.0||||||
4040256|NCT01124786|3861938|B1|Australia||Region of Enrollment||participants|Number|4|4.0||||||
4040257|NCT01124786|3861936|B3|Belgium||Region of Enrollment||participants|Number|10|10.0||||||
4040258|NCT01124786|3861937|B2|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
4040259|NCT01124786|3861938|B1|Belgium||Region of Enrollment||participants|Number|6|6.0||||||
4040260|NCT01124786|3861936|B3|Brazil||Region of Enrollment||participants|Number|10|10.0||||||
4040261|NCT01124786|3861937|B2|Brazil||Region of Enrollment||participants|Number|3|3.0||||||
4040262|NCT01124786|3861938|B1|Brazil||Region of Enrollment||participants|Number|7|7.0||||||
4040263|NCT01124786|3861936|B3|Argentina||Region of Enrollment||participants|Number|8|8.0||||||
4040264|NCT01124786|3861937|B2|Argentina||Region of Enrollment||participants|Number|6|6.0||||||
4040265|NCT01124786|3861938|B1|Argentina||Region of Enrollment||participants|Number|2|2.0||||||
4040266|NCT01124786|3861936|B3|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4040267|NCT01124786|3861937|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4040268|NCT01124786|3861938|B1|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4040269|NCT01124786|3861936|B3|France||Region of Enrollment||participants|Number|29|29.0||||||
4040270|NCT01124786|3861937|B2|France||Region of Enrollment||participants|Number|10|10.0||||||
4040271|NCT01124786|3861938|B1|France||Region of Enrollment||participants|Number|19|19.0||||||
4040272|NCT01124786|3861936|B3|United Kingdom||Region of Enrollment||participants|Number|21|21.0||||||
4040273|NCT01124786|3861937|B2|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
4040274|NCT01124786|3861938|B1|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
4040275|NCT01124786|3861936|B3|Italy||Region of Enrollment||participants|Number|17|17.0||||||
4040276|NCT01124786|3861937|B2|Italy||Region of Enrollment||participants|Number|9|9.0||||||
4040277|NCT01124786|3861938|B1|Italy||Region of Enrollment||participants|Number|8|8.0||||||
4040278|NCT01124786|3861936|B3|Russian Federation||Region of Enrollment||participants|Number|85|85.0||||||
4040279|NCT01124786|3861937|B2|Russian Federation||Region of Enrollment||participants|Number|40|40.0||||||
4040280|NCT01124786|3861938|B1|Russian Federation||Region of Enrollment||participants|Number|45|45.0||||||
4040281|NCT01124786|3861936|B3|Ukraine||Region of Enrollment||participants|Number|87|87.0||||||
4040282|NCT01124786|3861937|B2|Ukraine||Region of Enrollment||participants|Number|47|47.0||||||
4040283|NCT01124786|3861938|B1|Ukraine||Region of Enrollment||participants|Number|40|40.0||||||
4040284|NCT01124786|3861936|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4040285|NCT01124786|3861937|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4040286|NCT01124786|3861938|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4040287|NCT01124786|3861936|B3||Male|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
4040288|NCT01124786|3861937|B2||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4040289|NCT01124786|3861938|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4040290|NCT01124786|3861936|B3||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4040291|NCT01124786|3861937|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4040292|NCT01124786|3861938|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4040293|NCT01124786|3861936|B3|||Age||years|Mean|61.5|61.5|Standard Deviation|10.47|10.47|||
4040294|NCT01124786|3861937|B2|||Age||years|Mean|60.5|60.5|Standard Deviation|11.19|11.19|||
4040295|NCT01124786|3861938|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|9.62|9.62|||
4040296|NCT01124786|3861936|B3||>=65 years|Age||Participants|Count of Participants|148|148.0||||||
4040297|NCT01124786|3861937|B2||>=65 years|Age||Participants|Count of Participants|69|69.0||||||
4040298|NCT01124786|3861938|B1||>=65 years|Age||Participants|Count of Participants|79|79.0||||||
4040299|NCT01124786|3861936|B3||Between 18 and 65 years|Age||Participants|Count of Participants|219|219.0||||||
4040300|NCT01124786|3861937|B2||Between 18 and 65 years|Age||Participants|Count of Participants|116|116.0||||||
4040301|NCT01124786|3861938|B1||Between 18 and 65 years|Age||Participants|Count of Participants|103|103.0||||||
4040302|NCT01124786|3861936|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4040303|NCT01124786|3861937|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4040304|NCT01124786|3861938|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4040305|NCT01124643|3861959|B1|||Albumin-to-Creatinine (A/Cr) Ratio|Number of participants analyzed for this baseline characteristic was 33|Ratio|Mean|284.1|284.1|Standard Deviation|712.90|712.9|||
4040306|NCT01124643|3861959|B1|||Estimated Glomerular Filtration Rate (eGFR)||(mL/min/1.73m^2)|Mean|77.60|77.6|Standard Deviation|26.12|26.12|||
4040307|NCT01124643|3861959|B1|||Plasma Gb3 (globotriaosylceramide)||nanomoles per milliliter (nmol/mL)|Mean|4.35|4.35|Standard Deviation|2.51|2.51|||
4040346|NCT01124448|3862044|B3|||Total milk bacterial count (initial)||log10 CFU/mL|Mean|3.63|3.63|Standard Deviation|0.39|0.39|||
4040347|NCT01124448|3862045|B2|||Total milk bacterial count (initial)||log10 CFU/mL|Mean|3.19|3.19|Standard Deviation|0.59|0.59|||
4040348|NCT01124448|3862046|B1|||Total milk bacterial count (initial)||log10 CFU/mL|Mean|4.08|4.08|Standard Deviation|0.20|0.2|||
4040308|NCT01124643|3861959|B1|Class IV (Severe)||New York Heart Association (NYHA) Functional Class|Class I = No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea Class II = Slight limitation of physical activity. Comfortable at rest, but ordinary physical activity results in fatigue, palpitation, or dyspnea Class III = Marked limitation of physical activity. Comfortable at rest, but less than ordinary activity causes fatigue, palpitation, or dyspnea Class IV = Unable to carry out any physical activity without discomfort. Symptoms of cardiac insufficiency at rest. If any physical activity is undertaken, discomfort is increased|participants|Number|0|0.0||||||
4040309|NCT01124643|3861959|B1|Class III (Moderate)||New York Heart Association (NYHA) Functional Class|Class I = No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea Class II = Slight limitation of physical activity. Comfortable at rest, but ordinary physical activity results in fatigue, palpitation, or dyspnea Class III = Marked limitation of physical activity. Comfortable at rest, but less than ordinary activity causes fatigue, palpitation, or dyspnea Class IV = Unable to carry out any physical activity without discomfort. Symptoms of cardiac insufficiency at rest. If any physical activity is undertaken, discomfort is increased|participants|Number|1|1.0||||||
4040310|NCT01124643|3861959|B1|Class II (Mild)||New York Heart Association (NYHA) Functional Class|Class I = No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea Class II = Slight limitation of physical activity. Comfortable at rest, but ordinary physical activity results in fatigue, palpitation, or dyspnea Class III = Marked limitation of physical activity. Comfortable at rest, but less than ordinary activity causes fatigue, palpitation, or dyspnea Class IV = Unable to carry out any physical activity without discomfort. Symptoms of cardiac insufficiency at rest. If any physical activity is undertaken, discomfort is increased|participants|Number|13|13.0||||||
4040311|NCT01124643|3861959|B1|Class I (Very Mild)||New York Heart Association (NYHA) Functional Class|Class I = No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea Class II = Slight limitation of physical activity. Comfortable at rest, but ordinary physical activity results in fatigue, palpitation, or dyspnea Class III = Marked limitation of physical activity. Comfortable at rest, but less than ordinary activity causes fatigue, palpitation, or dyspnea Class IV = Unable to carry out any physical activity without discomfort. Symptoms of cardiac insufficiency at rest. If any physical activity is undertaken, discomfort is increased|participants|Number|21|21.0||||||
4040312|NCT01124643|3861959|B1|||Minnesota Living with Heart Failure Questionnaire (MLHF-Q) Summary Score|The MLHF-Q contains 21 questions with answers ranging from 0 (no) to 5 (very much). The final score ( 0 to 105) is the sum of the points for the 21 questions. A higher score indicates a worse quality of life.|units on a scale|Mean|26.5|26.5|Standard Deviation|26.95|26.95|||
4040313|NCT01124643|3861959|B1|||Distance Walked in 6-Minute Walk Test (6MWT)|Number of participants analyzed for this baseline characteristic was 34|meters|Mean|515.5|515.5|Standard Deviation|144.13|144.13|||
4040314|NCT01124643|3861959|B1|||Maximal Oxygen Consumption (VO2max)|Number of participants analyzed for this baseline characteristic was 32|milliliter/minute/kilogram (mL/min/kg)|Mean|20.2|20.2|Standard Deviation|6.73|6.73|||
4040315|NCT01124643|3861959|B1|||Left Ventricular Mass Indexed to Height (LVMI)|Number of participants analyzed for this baseline characteristic was 33|gram per meter to the power 2.7(g/m^2.7)|Mean|81.18|81.18|Standard Deviation|32.13|32.13|||
4040316|NCT01124643|3861959|B1|UNITED STATES||Region of Enrollment||Participants|Number|3|3.0||||||
4040317|NCT01124643|3861959|B1|UNITED KINGDOM||Region of Enrollment||Participants|Number|3|3.0||||||
4040318|NCT01124643|3861959|B1|SLOVENIA||Region of Enrollment||Participants|Number|4|4.0||||||
4040319|NCT01124643|3861959|B1|POLAND||Region of Enrollment||Participants|Number|13|13.0||||||
4040320|NCT01124643|3861959|B1|FINLAND||Region of Enrollment||Participants|Number|5|5.0||||||
4040321|NCT01124643|3861959|B1|CZECH REPUBLIC||Region of Enrollment||Participants|Number|5|5.0||||||
4040322|NCT01124643|3861959|B1|AUSTRALIA||Region of Enrollment||Participants|Number|2|2.0||||||
4040323|NCT01124643|3861959|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4040324|NCT01124643|3861959|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4040325|NCT01124643|3861959|B1|Between 18 and 65 years||Age, Customized|Age at time of consent|Participants|Number|32|32.0||||||
4040326|NCT01124643|3861959|B1|>=65 years||Age, Customized|Age at time of consent|Participants|Number|3|3.0||||||
4040327|NCT01124643|3861959|B1|||Age||Years|Mean|52.3|52.3|Standard Deviation|9.86|9.86|||
4040328|NCT01124617|3861971|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4040329|NCT01124617|3861972|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4040330|NCT01124617|3861973|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4040331|NCT01124617|3861971|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4040332|NCT01124617|3861972|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4040333|NCT01124617|3861973|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4040334|NCT01124617|3861971|B3|||Age||Years|Mean|65.9|65.9|Standard Deviation|12.61|12.61|||
4040335|NCT01124617|3861972|B2|||Age||Years|Mean|68.6|68.6|Standard Deviation|11.60|11.6|||
4040336|NCT01124617|3861973|B1|||Age||Years|Mean|64.6|64.6|Standard Deviation|12.98|12.98|||
4040337|NCT01124604|3862004|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4040338|NCT01124604|3862005|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4040339|NCT01124604|3862006|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4040340|NCT01124604|3862004|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4040341|NCT01124604|3862005|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4040342|NCT01124604|3862006|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4040343|NCT01124604|3862004|B3|||Age||Years|Mean|65.1|65.1|Standard Deviation|15.03|15.03|||
4040344|NCT01124604|3862005|B2|||Age||Years|Mean|68.1|68.1|Standard Deviation|13.73|13.73|||
4040345|NCT01124604|3862006|B1|||Age||Years|Mean|63.6|63.6|Standard Deviation|15.54|15.54|||
4040349|NCT01124448|3862044|B3|Spain||Region of Enrollment||participants|Number|40|40.0||||||
4040350|NCT01124448|3862045|B2|Spain||Region of Enrollment||participants|Number|15|15.0||||||
4040351|NCT01124448|3862046|B1|Spain||Region of Enrollment||participants|Number|25|25.0||||||
4040352|NCT01124448|3862044|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4040353|NCT01124448|3862045|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4040354|NCT01124448|3862046|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4040355|NCT01124448|3862044|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4040356|NCT01124448|3862045|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4040357|NCT01124448|3862046|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4040358|NCT01124448|3862044|B3|||Age||years|Mean|28.6|28.6|Standard Deviation|7.7|7.7|||
4040359|NCT01124448|3862045|B2|||Age||years|Mean|29.0|29.0|Standard Deviation|7.8|7.8|||
4040360|NCT01124448|3862046|B1|||Age||years|Mean|28.2|28.2|Standard Deviation|7.7|7.7|||
4040361|NCT01124422|3862053|B3|American Indian or Alaska Native and White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4040362|NCT01124422|3862054|B2|American Indian or Alaska Native and White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4040363|NCT01124422|3862055|B1|American Indian or Alaska Native and White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4040364|NCT01124422|3862053|B3|White||Race/Ethnicity, Customized||participants|Number|236|236.0||||||
4040365|NCT01124422|3862054|B2|White||Race/Ethnicity, Customized||participants|Number|110|110.0||||||
4040366|NCT01124422|3862055|B1|White||Race/Ethnicity, Customized||participants|Number|126|126.0||||||
4040367|NCT01124422|3862053|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4040368|NCT01124422|3862054|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4040369|NCT01124422|3862055|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4040370|NCT01124422|3862053|B3|Japanese/East Asian Heritage/South East Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4040371|NCT01124422|3862054|B2|Japanese/East Asian Heritage/South East Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4040372|NCT01124422|3862055|B1|Japanese/East Asian Heritage/South East Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4040373|NCT01124422|3862053|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4040374|NCT01124422|3862054|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4040375|NCT01124422|3862055|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4040376|NCT01124422|3862053|B3||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4040377|NCT01124422|3862054|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4040378|NCT01124422|3862055|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4040379|NCT01124422|3862053|B3||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4040380|NCT01124422|3862054|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4040381|NCT01124422|3862055|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4040382|NCT01124422|3862053|B3|||Age||Years|Mean|62.7|62.7|Standard Deviation|9.41|9.41|||
4040383|NCT01124422|3862054|B2|||Age||Years|Mean|62.5|62.5|Standard Deviation|8.94|8.94|||
4040384|NCT01124422|3862055|B1|||Age||Years|Mean|62.9|62.9|Standard Deviation|9.85|9.85|||
4040385|NCT01124370|3862099|B1|No||Concomitant implantable device delivering therapy||participants|Number|28|28.0||||||
4040386|NCT01124370|3862099|B1|Yes||Concomitant implantable device delivering therapy||participants|Number|29|29.0||||||
4040387|NCT01124370|3862099|B1|No||Atrial Fibrillation||participants|Number|41|41.0||||||
4040388|NCT01124370|3862099|B1|Yes||Atrial Fibrillation||participants|Number|16|16.0||||||
4040389|NCT01124370|3862099|B1|No||Hyperlipidemia||participants|Number|37|37.0||||||
4040390|NCT01124370|3862099|B1|Yes||Hyperlipidemia||participants|Number|20|20.0||||||
4040391|NCT01124370|3862099|B1|No||Hypertension||participants|Number|16|16.0||||||
4040392|NCT01124370|3862099|B1|Yes||Hypertension||participants|Number|41|41.0||||||
4040393|NCT01124370|3862099|B1|No||Coronary Artery Disease||participants|Number|22|22.0||||||
4040394|NCT01124370|3862099|B1|Yes||Coronary Artery Disease||participants|Number|35|35.0||||||
4040395|NCT01124370|3862099|B1|||Ejection Fraction|Available for N=54 participants.|percent|Mean|29.6|29.6|Standard Deviation|10.8|10.8|||
4040396|NCT01124370|3862099|B1|No||Heart failure||participants|Number|11|11.0||||||
4040397|NCT01124370|3862099|B1|Yes||Heart failure||participants|Number|46|46.0||||||
4040398|NCT01124370|3862099|B1|Class IV||New York Heart Association (NYHA) Functional Class|"NYHA Class definitions:~Class I: No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea Class II:Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea Class III: Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~Class IV: Unable to carry on any physical activity without discomfort. Symptoms of HF at rest. If any physical activity is undertaken, discomfort increases."|participants|Number|1|1.0||||||
4040399|NCT01124370|3862099|B1|Class III||New York Heart Association (NYHA) Functional Class|"NYHA Class definitions:~Class I: No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea Class II:Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea Class III: Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~Class IV: Unable to carry on any physical activity without discomfort. Symptoms of HF at rest. If any physical activity is undertaken, discomfort increases."|participants|Number|13|13.0||||||
4040400|NCT01124370|3862099|B1|Class II||New York Heart Association (NYHA) Functional Class|"NYHA Class definitions:~Class I: No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea Class II:Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea Class III: Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~Class IV: Unable to carry on any physical activity without discomfort. Symptoms of HF at rest. If any physical activity is undertaken, discomfort increases."|participants|Number|28|28.0||||||
4040401|NCT01124370|3862099|B1|Class I||New York Heart Association (NYHA) Functional Class|"NYHA Class definitions:~Class I: No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea Class II:Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea Class III: Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~Class IV: Unable to carry on any physical activity without discomfort. Symptoms of HF at rest. If any physical activity is undertaken, discomfort increases."|participants|Number|4|4.0||||||
4040402|NCT01124370|3862099|B1|Not applicable||New York Heart Association (NYHA) Functional Class|"NYHA Class definitions:~Class I: No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea Class II:Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea Class III: Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~Class IV: Unable to carry on any physical activity without discomfort. Symptoms of HF at rest. If any physical activity is undertaken, discomfort increases."|participants|Number|11|11.0||||||
4040403|NCT01124370|3862099|B1|||Six minute hall walk|N=55 subjects completed this assessment at baseline.|meters|Mean|377.8|377.8|Standard Deviation|144.5|144.5|||
4040404|NCT01124370|3862099|B1|||Minnesota Living with Heart Failure Questionnaire (MNLHF)|This questionnaire was for the N=46 patients diagnosed with heart failure. Scores can range from 0-105, with lower scores indicating better quality of life.|units on a scale|Mean|41.4|41.4|Standard Deviation|18.9|18.9|||
4040405|NCT01124370|3862099|B1|||Epworth Sleepiness Scale (ESS)|The ESS is an assessment to measure a subject’s general level of daytime sleepiness. Scores can range from 0-24, with higher scores indicating higher level of daytime sleepiness.|units on a scale|Mean|8.6|8.6|Standard Deviation|4.4|4.4|||
4040406|NCT01124370|3862099|B1|||Apnea-Hypopnea Index (AHI)|"The number of apneas and hypopneas per hour of sleep. An apnea is defined by 3 characteristics:~There is a drop in the peak thermal sensor excursion or alternate nasal air pressure transducer (inspiratory effort) by > 90% of baseline~The duration of the event lasts at least 10 seconds~At least 90% of the event’s duration meets the amplitude reduction criteria for apnea~Hypopnea defined as 30% reduction in airflow (or alternative hypopnea sensor) for ≥10 seconds over at least 90% of the event’s duration that is associated with a >4% fall in oxygen saturation from baseline"|events/hour|Mean|49.1|49.1|Standard Deviation|15.0|15.0|||
4040407|NCT01124370|3862099|B1|Italy||Region of Enrollment||participants|Number|3|3.0||||||
4040408|NCT01124370|3862099|B1|Germany||Region of Enrollment||participants|Number|18|18.0||||||
4040409|NCT01124370|3862099|B1|Poland||Region of Enrollment||participants|Number|17|17.0||||||
4040410|NCT01124370|3862099|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4040411|NCT01124370|3862099|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4040412|NCT01124370|3862099|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4040413|NCT01124370|3862099|B1|||Age||years|Mean|66.3|66.3|Standard Deviation|9.4|9.4|||
4040414|NCT01124305|3862109|B3|United States||Region of Enrollment||participants|Number|70|70.0||||||
4040415|NCT01124305|3862110|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
4040416|NCT01124305|3862111|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4040417|NCT01124305|3862109|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4040418|NCT01124305|3862110|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4040419|NCT01124305|3862111|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4040420|NCT01124305|3862109|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4040421|NCT01124305|3862110|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4040422|NCT01124305|3862111|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4040423|NCT01124305|3862109|B3|||Age||years|Mean|70.1|70.1|Standard Deviation|10.0|10.0|||
4040424|NCT01124305|3862110|B2|||Age||years|Mean|69.2|69.2|Standard Deviation|8.5|8.5|||
4040425|NCT01124305|3862111|B1|||Age||years|Mean|71.3|71.3|Standard Deviation|12.1|12.1|||
4040426|NCT01124305|3862109|B3||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4040427|NCT01124305|3862110|B2||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4040428|NCT01124305|3862111|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4040429|NCT01124305|3862109|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4040430|NCT01124305|3862110|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4040431|NCT01124305|3862111|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4040432|NCT01124305|3862109|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4040433|NCT01124305|3862110|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4040434|NCT01124305|3862111|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4040435|NCT01124292|3862124|B4|United States||Region of Enrollment||participants|Number|34|34.0||||||
4040436|NCT01124292|3862125|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4040437|NCT01124292|3862126|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4040438|NCT01124292|3862127|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4040439|NCT01124292|3862124|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4040440|NCT01124292|3862125|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4040441|NCT01124292|3862126|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4040442|NCT01124292|3862127|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4040443|NCT01124292|3862124|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4040444|NCT01124292|3862125|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4040445|NCT01124292|3862126|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4040446|NCT01124292|3862127|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4040447|NCT01124292|3862124|B4|||Age||years|Mean|27.61|27.61|Standard Deviation|9.72|9.72|||
4040448|NCT01124292|3862125|B3|||Age||years|Mean|38.30|38.3|Standard Deviation|10.25|10.25|||
4040449|NCT01124292|3862126|B2|||Age||years|Mean|22.56|22.56|Standard Deviation|4.00|4.0|||
4040450|NCT01124292|3862127|B1|||Age||years|Mean|23.12|23.12|Standard Deviation|4.85|4.85|||
4040451|NCT01124292|3862124|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4040452|NCT01124292|3862125|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4040453|NCT01124292|3862126|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4040454|NCT01124292|3862127|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4040455|NCT01124292|3862124|B4||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4040456|NCT01124292|3862125|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4040457|NCT01124292|3862126|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4040458|NCT01124292|3862127|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4040459|NCT01124292|3862124|B4||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4040460|NCT01124292|3862125|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4040461|NCT01124292|3862126|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4040462|NCT01124292|3862127|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4040463|NCT01124188|3862185|B3|United States||Region of Enrollment||Participants|Count of Participants|139|139.0||||||
4040464|NCT01124188|3862186|B2|United States||Region of Enrollment||Participants|Count of Participants|71|71.0||||||
4040465|NCT01124188|3862187|B1|United States||Region of Enrollment||Participants|Count of Participants|68|68.0||||||
4040466|NCT01124188|3862185|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4040467|NCT01124188|3862186|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4040468|NCT01124188|3862187|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4040469|NCT01124188|3862185|B3||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4040470|NCT01124188|3862186|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4040471|NCT01124188|3862187|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4040472|NCT01124188|3862185|B3|||Age||years|Mean|70.34|70.34|Standard Deviation|8.32|8.32|||
4040473|NCT01124188|3862186|B2|||Age||years|Mean|69.90|69.9|Standard Deviation|8.73|8.73|||
4040474|NCT01124188|3862187|B1|||Age||years|Mean|70.81|70.81|Standard Deviation|7.90|7.9|||
4040475|NCT01124188|3862185|B3||>=65 years|Age||Participants|Count of Participants|89|89.0||||||
4040476|NCT01124188|3862186|B2||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4040477|NCT01124188|3862187|B1||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
4040478|NCT01124188|3862185|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4040479|NCT01124188|3862186|B2||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4040480|NCT01124188|3862187|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4040481|NCT01124188|3862185|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4040482|NCT01124188|3862186|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4040483|NCT01124188|3862187|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4040484|NCT01124175|3862198|B3|Canada||Region of Enrollment||participants|Number|80|80.0||||||
4040485|NCT01124175|3862199|B2|Canada||Region of Enrollment||participants|Number|40|40.0||||||
4040486|NCT01124175|3862200|B1|Canada||Region of Enrollment||participants|Number|40|40.0||||||
4040487|NCT01124175|3862198|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4040488|NCT01124175|3862199|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4040489|NCT01124175|3862200|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4040490|NCT01124175|3862198|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|71|71.0||||||
4040491|NCT01124175|3862199|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4040492|NCT01124175|3862200|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4040493|NCT01124175|3862198|B3|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4040494|NCT01124175|3862199|B2|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4040495|NCT01124175|3862200|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4040496|NCT01124175|3862198|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4040497|NCT01124175|3862199|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4040498|NCT01124175|3862200|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4040499|NCT01124175|3862198|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4040500|NCT01124175|3862199|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4040501|NCT01124175|3862200|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4040502|NCT01124175|3862198|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4040503|NCT01124175|3862199|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4040504|NCT01124175|3862200|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4040505|NCT01124175|3862198|B3||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4040506|NCT01124175|3862199|B2||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4040507|NCT01124175|3862200|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4040508|NCT01124175|3862198|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4040509|NCT01124175|3862199|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4040510|NCT01124175|3862200|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4040511|NCT01124162|3862217|B3|Canada||Region of Enrollment||participants|Number|80|80.0||||||
4040512|NCT01124162|3862218|B2|Canada||Region of Enrollment||participants|Number|40|40.0||||||
4040513|NCT01124162|3862219|B1|Canada||Region of Enrollment||participants|Number|40|40.0||||||
4040514|NCT01124162|3862217|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4040515|NCT01124162|3862218|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4040516|NCT01124162|3862219|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4040517|NCT01124162|3862217|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
4040518|NCT01124162|3862218|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4040519|NCT01124162|3862219|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4040520|NCT01124162|3862217|B3|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4040521|NCT01124162|3862218|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4040522|NCT01124162|3862219|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4040523|NCT01124162|3862217|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4040524|NCT01124162|3862218|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4040525|NCT01124162|3862219|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4040526|NCT01124162|3862217|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4040527|NCT01124162|3862218|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4040528|NCT01124162|3862219|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4040529|NCT01124162|3862217|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4040530|NCT01124162|3862218|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4040531|NCT01124162|3862219|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4040532|NCT01124162|3862217|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4040533|NCT01124162|3862218|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4040534|NCT01124162|3862219|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4040535|NCT01124162|3862217|B3||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4040536|NCT01124162|3862218|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4040537|NCT01124162|3862219|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4040538|NCT01124162|3862217|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4040539|NCT01124162|3862218|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4040540|NCT01124162|3862219|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4040541|NCT01124149|3862236|B1|UNITED STATES||Region of Enrollment|All enrolled subjects (n=722).|Participants|Number|96|96.0||||||
4040542|NCT01124149|3862236|B1|UNITED KINGDOM||Region of Enrollment|All enrolled subjects (n=722).|Participants|Number|3|3.0||||||
4040543|NCT01124149|3862236|B1|SPAIN||Region of Enrollment|All enrolled subjects (n=722).|Participants|Number|3|3.0||||||
4040544|NCT01124149|3862236|B1|SOUTH AFRICA||Region of Enrollment|All enrolled subjects (n=722).|Participants|Number|21|21.0||||||
4040545|NCT01124149|3862236|B1|ROMANIA||Region of Enrollment|All enrolled subjects (n=722).|Participants|Number|41|41.0||||||
4040546|NCT01124149|3862236|B1|POLAND||Region of Enrollment|All enrolled subjects (n=722).|Participants|Number|52|52.0||||||
4040547|NCT01124149|3862236|B1|IRELAND||Region of Enrollment|All enrolled subjects (n=722).|Participants|Number|9|9.0||||||
4040548|NCT01124149|3862236|B1|INDIA||Region of Enrollment|All enrolled subjects (n=722).|Participants|Number|200|200.0||||||
4040549|NCT01124149|3862236|B1|HUNGARY||Region of Enrollment|All enrolled subjects (n=722).|Participants|Number|30|30.0||||||
4040550|NCT01124149|3862236|B1|FRANCE||Region of Enrollment|All enrolled subjects (n=722).|Participants|Number|2|2.0||||||
4040551|NCT01124149|3862236|B1|CZECH REPUBLIC||Region of Enrollment|All enrolled subjects (n=722).|Participants|Number|130|130.0||||||
4040552|NCT01124149|3862236|B1|COLOMBIA||Region of Enrollment|All enrolled subjects (n=722).|Participants|Number|74|74.0||||||
4040553|NCT01124149|3862236|B1|CANADA||Region of Enrollment|All enrolled subjects (n=722).|Participants|Number|39|39.0||||||
4040554|NCT01124149|3862236|B1|BELGIUM||Region of Enrollment|All enrolled subjects (n=722).|Participants|Number|22|22.0||||||
4040555|NCT01124149|3862236|B1||Male|Sex: Female, Male||Participants|Count of Participants|409|409.0||||||
4040556|NCT01124149|3862236|B1||Female|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
4040557|NCT01124149|3862236|B1|Between 18 and 65 years||Age, Customized||Participants|Number|656|656.0||||||
4040558|NCT01124149|3862236|B1|<=18 years||Age, Customized||Participants|Number|10|10.0||||||
4040559|NCT01124149|3862236|B1|>=65 years||Age, Customized||Participants|Number|51|51.0||||||
4040560|NCT01124149|3862236|B1|||Age||Years|Mean|42.9|42.9|Standard Deviation|13.97|13.97|||
4040561|NCT01124097|3862252|B5||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4040562|NCT01124097|3862253|B4||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4040563|NCT01124097|3862254|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4040564|NCT01124097|3862255|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4040565|NCT01124097|3862256|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4040566|NCT01124097|3862252|B5||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4040567|NCT01124097|3862253|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4040568|NCT01124097|3862254|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4040569|NCT01124097|3862255|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4040570|NCT01124097|3862256|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4040571|NCT01124097|3862252|B5|||Age||years|Mean|64.9|64.9|Standard Deviation|15.27|15.27|||
4040572|NCT01124097|3862253|B4|||Age||years|Mean|65.4|65.4|Standard Deviation|14.43|14.43|||
4040573|NCT01124097|3862254|B3|||Age||years|Mean|65.9|65.9|Standard Deviation|15.6|15.6|||
4040574|NCT01124097|3862255|B2|||Age||years|Mean|65.4|65.4|Standard Deviation|14.47|14.47|||
4040575|NCT01124097|3862256|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|16.71|16.71|||
4040576|NCT01124045|3862269|B3|United States||Region of Enrollment||participants|Number|79|79.0||||||
4040577|NCT01124045|3862270|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4040578|NCT01124045|3862271|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4040579|NCT01124045|3862269|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4040580|NCT01124045|3862270|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4040581|NCT01124045|3862271|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4040582|NCT01124045|3862269|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4040583|NCT01124045|3862270|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4040584|NCT01124045|3862271|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4040585|NCT01124045|3862269|B3|Children: 2 to 3 years||Age, Customized||participants|Number|19|19.0||||||
4040586|NCT01124045|3862270|B2|Children: 2 to 3 years||Age, Customized||participants|Number|11|11.0||||||
4040587|NCT01124045|3862271|B1|Children: 2 to 3 years||Age, Customized||participants|Number|8|8.0||||||
4040588|NCT01124045|3862269|B3|Infants and Toddlers: 28 days to 23 months||Age, Customized||participants|Number|54|54.0||||||
4040589|NCT01124045|3862270|B2|Infants and Toddlers: 28 days to 23 months||Age, Customized||participants|Number|26|26.0||||||
4040590|NCT01124045|3862271|B1|Infants and Toddlers: 28 days to 23 months||Age, Customized||participants|Number|28|28.0||||||
4040591|NCT01124045|3862269|B3|Newborns: 0 to 27 days||Age, Customized||participants|Number|6|6.0||||||
4040592|NCT01124045|3862270|B2|Newborns: 0 to 27 days||Age, Customized||participants|Number|3|3.0||||||
4040593|NCT01124045|3862271|B1|Newborns: 0 to 27 days||Age, Customized||participants|Number|3|3.0||||||
4040594|NCT01124006|3862302|B4|United States||Region of Enrollment||participants|Number|24|24.0||||||
4040595|NCT01124006|3862303|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4040596|NCT01124006|3862304|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4040597|NCT01124006|3862305|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4040598|NCT01124006|3862302|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4040599|NCT01124006|3862303|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4040600|NCT01124006|3862304|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4040601|NCT01124006|3862305|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4040602|NCT01124006|3862302|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4040603|NCT01124006|3862303|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4040604|NCT01124006|3862304|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4040605|NCT01124006|3862305|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4040606|NCT01124006|3862302|B4|||Age||years|Mean|42.2|42.2|Standard Deviation|8.40|8.4|||
4040607|NCT01124006|3862303|B3|||Age||years|Mean|42.4|42.4|Standard Deviation|6.38|6.38|||
4040608|NCT01124006|3862304|B2|||Age||years|Mean|44.7|44.7|Standard Deviation|7.86|7.86|||
4040609|NCT01124006|3862305|B1|||Age||years|Mean|39.7|39.7|Standard Deviation|9.56|9.56|||
4040610|NCT01123980|3862333|B3|No||Diabetic complications at baseline||participants|Number|374|374.0||||||
4040611|NCT01123980|3862334|B2|No||Diabetic complications at baseline||participants|Number|185|185.0||||||
4040612|NCT01123980|3862335|B1|No||Diabetic complications at baseline||participants|Number|189|189.0||||||
4040613|NCT01123980|3862333|B3|Yes||Diabetic complications at baseline||participants|Number|147|147.0||||||
4040614|NCT01123980|3862334|B2|Yes||Diabetic complications at baseline||participants|Number|75|75.0||||||
4040615|NCT01123980|3862335|B1|Yes||Diabetic complications at baseline||participants|Number|72|72.0||||||
4040616|NCT01123980|3862333|B3|||Duration of diabetes|Number of years since diagnosis|years|Mean|9.35|9.35|Standard Deviation|6.88|6.88|||
4040617|NCT01123980|3862334|B2|||Duration of diabetes|Number of years since diagnosis|years|Mean|9.47|9.47|Standard Deviation|6.61|6.61|||
4040618|NCT01123980|3862335|B1|||Duration of diabetes|Number of years since diagnosis|years|Mean|9.23|9.23|Standard Deviation|7.15|7.15|||
4040619|NCT01123980|3862333|B3|||HbA1c (glycosylated haemoglobin) at randomisation||percentage of glycosylated haemoglobin|Mean|8.15|8.15|Standard Deviation|0.87|0.87|||
4040620|NCT01123980|3862334|B2|||HbA1c (glycosylated haemoglobin) at randomisation||percentage of glycosylated haemoglobin|Mean|8.14|8.14|Standard Deviation|0.86|0.86|||
4040621|NCT01123980|3862335|B1|||HbA1c (glycosylated haemoglobin) at randomisation||percentage of glycosylated haemoglobin|Mean|8.7|8.7|Standard Deviation|0.88|0.88|||
4040622|NCT01123980|3862333|B3|||Body Mass Index (BMI)||kg/m^2|Mean|25.65|25.65|Standard Deviation|3.41|3.41|||
4040623|NCT01123980|3862334|B2|||Body Mass Index (BMI)||kg/m^2|Mean|25.76|25.76|Standard Deviation|3.44|3.44|||
4040624|NCT01123980|3862335|B1|||Body Mass Index (BMI)||kg/m^2|Mean|25.53|25.53|Standard Deviation|3.39|3.39|||
4040625|NCT01123980|3862333|B3|||Weight||kg|Mean|70.3|70.3|Standard Deviation|12.1|12.1|||
4040626|NCT01123980|3862334|B2|||Weight||kg|Mean|70.6|70.6|Standard Deviation|12.5|12.5|||
4040627|NCT01123980|3862335|B1|||Weight||kg|Mean|70.0|70.0|Standard Deviation|11.6|11.6|||
4040628|NCT01123980|3862333|B3|||Height||cm|Mean|165.3|165.3|Standard Deviation|8.4|8.4|||
4040629|NCT01123980|3862334|B2|||Height||cm|Mean|165.2|165.2|Standard Deviation|8.2|8.2|||
4040630|NCT01123980|3862335|B1|||Height||cm|Mean|165.3|165.3|Standard Deviation|8.6|8.6|||
4040631|NCT01123980|3862333|B3|Japan||Region of Enrollment||participants|Number|99|99.0||||||
4040632|NCT01123980|3862334|B2|Japan||Region of Enrollment||participants|Number|48|48.0||||||
4040633|NCT01123980|3862335|B1|Japan||Region of Enrollment||participants|Number|51|51.0||||||
4040634|NCT01123980|3862333|B3|China||Region of Enrollment||participants|Number|422|422.0||||||
4040635|NCT01123980|3862334|B2|China||Region of Enrollment||participants|Number|212|212.0||||||
4040636|NCT01123980|3862335|B1|China||Region of Enrollment||participants|Number|210|210.0||||||
4040637|NCT01123980|3862333|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040638|NCT01123980|3862334|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040639|NCT01123980|3862335|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040640|NCT01123980|3862333|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040641|NCT01123980|3862334|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040642|NCT01123980|3862335|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040643|NCT01123980|3862333|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040644|NCT01123980|3862334|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040645|NCT01123980|3862335|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040646|NCT01123980|3862333|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040647|NCT01123980|3862334|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040648|NCT01123980|3862335|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040649|NCT01123980|3862333|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040650|NCT01123980|3862334|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040651|NCT01123980|3862335|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040652|NCT01123980|3862333|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|521|521.0||||||
4040653|NCT01123980|3862334|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|260|260.0||||||
4040654|NCT01123980|3862335|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|261|261.0||||||
4040655|NCT01123980|3862333|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040656|NCT01123980|3862334|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040657|NCT01123980|3862335|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040658|NCT01123980|3862333|B3||Male|Gender||Participants|Count of Participants|288|288.0||||||
4040659|NCT01123980|3862334|B2||Male|Gender||Participants|Count of Participants|141|141.0||||||
4040660|NCT01123980|3862335|B1||Male|Gender||Participants|Count of Participants|147|147.0||||||
4040661|NCT01123980|3862333|B3||Female|Gender||Participants|Count of Participants|233|233.0||||||
4040662|NCT01123980|3862334|B2||Female|Gender||Participants|Count of Participants|119|119.0||||||
4040663|NCT01123980|3862335|B1||Female|Gender||Participants|Count of Participants|114|114.0||||||
4040664|NCT01123980|3862333|B3|||Age||years|Mean|56.3|56.3|Standard Deviation|9.6|9.6|||
4040665|NCT01123980|3862334|B2|||Age||years|Mean|56.1|56.1|Standard Deviation|9.9|9.9|||
4040666|NCT01123980|3862335|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|9.4|9.4|||
4040667|NCT01123941|3862354|B3|Belgium||Region of Enrollment||participants|Number|50|50.0||||||
4040668|NCT01123941|3862355|B2|Belgium||Region of Enrollment||participants|Number|25|25.0||||||
4040669|NCT01123941|3862356|B1|Belgium||Region of Enrollment||participants|Number|25|25.0||||||
4040670|NCT01123941|3862354|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4040671|NCT01123941|3862355|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4040672|NCT01123941|3862356|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4040673|NCT01123941|3862354|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4040674|NCT01123941|3862355|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4040675|NCT01123941|3862356|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4040676|NCT01123941|3862354|B3|||Age||years|Mean|22.9|22.9|Standard Deviation|3.7|3.7|||
4040677|NCT01123941|3862355|B2|||Age||years|Mean|23.9|23.9|Standard Deviation|4.6|4.6|||
4040678|NCT01123941|3862356|B1|||Age||years|Mean|21.9|21.9|Standard Deviation|2.0|2.0|||
4040679|NCT01123941|3862354|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4040680|NCT01123941|3862355|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4040681|NCT01123941|3862356|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4040682|NCT01123941|3862354|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4040683|NCT01123941|3862355|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4040684|NCT01123941|3862356|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4040685|NCT01123941|3862354|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4040686|NCT01123941|3862355|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4040687|NCT01123941|3862356|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4040688|NCT01123928|3862369|B3|China||Region of Enrollment||participants|Number|434|434.0||||||
4040689|NCT01123928|3862370|B2|China||Region of Enrollment||participants|Number|222|222.0||||||
4040690|NCT01123928|3862371|B1|China||Region of Enrollment||participants|Number|212|212.0||||||
4040691|NCT01123928|3862369|B3||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4040692|NCT01123928|3862370|B2||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4040693|NCT01123928|3862371|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4040694|NCT01123928|3862369|B3||Female|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
4040695|NCT01123928|3862370|B2||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4040696|NCT01123928|3862371|B1||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4040697|NCT01123928|3862369|B3|||Age||years|Mean|74.5|74.5|Standard Deviation|8.4|8.4|||
4040698|NCT01123928|3862370|B2|||Age||years|Mean|75.5|75.5|Standard Deviation|8.0|8.0|||
4040699|NCT01123928|3862371|B1|||Age||years|Mean|73.4|73.4|Standard Deviation|8.7|8.7|||
4040700|NCT01123928|3862369|B3||>=65 years|Age||Participants|Count of Participants|386|386.0||||||
4040701|NCT01123928|3862370|B2||>=65 years|Age||Participants|Count of Participants|203|203.0||||||
4040702|NCT01123928|3862371|B1||>=65 years|Age||Participants|Count of Participants|183|183.0||||||
4040703|NCT01123928|3862369|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4040704|NCT01123928|3862370|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4040705|NCT01123928|3862371|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4040706|NCT01123928|3862369|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4040707|NCT01123928|3862370|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4040708|NCT01123928|3862371|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4040709|NCT01123889|3862390|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4040710|NCT01123889|3862391|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4040711|NCT01123889|3862392|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4040712|NCT01123889|3862390|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4040713|NCT01123889|3862391|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4040714|NCT01123889|3862392|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4040715|NCT01123889|3862390|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4040716|NCT01123889|3862391|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4040717|NCT01123889|3862392|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4040718|NCT01123889|3862390|B3|||Age||years|Mean|59.25|59.25|Standard Deviation|11.54|11.54|||
4040719|NCT01123889|3862391|B2|||Age||years|Mean|59.3|59.3|Standard Deviation|14.7|14.7|||
4040720|NCT01123889|3862392|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|6.4|6.4|||
4040721|NCT01123889|3862390|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4040722|NCT01123889|3862391|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4040723|NCT01123889|3862392|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4040724|NCT01123889|3862390|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4040725|NCT01123889|3862391|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4040726|NCT01123889|3862392|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4040727|NCT01123889|3862390|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4040728|NCT01123889|3862391|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4040729|NCT01123889|3862392|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4040730|NCT01123850|3862403|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4040731|NCT01123850|3862403|B1||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Study was terminated for slow enrollment. Data was not analysed.
4040732|NCT01123850|3862403|B1||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Study was terminated for slow enrollment. Data was not analysed.
4040733|NCT01123850|3862403|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4040734|NCT01123850|3862403|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4040735|NCT01123850|3862403|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4040736|NCT01123642|3862408|B1||Male|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4040737|NCT01123642|3862408|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4040738|NCT01123642|3862408|B1|||Age||years|Mean|38.81|38.81|Standard Deviation|9.81|9.81|||
4040739|NCT01123512|3862415|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4040740|NCT01123512|3862416|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4040741|NCT01123512|3862417|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4040742|NCT01123512|3862415|B3||Female|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4040743|NCT01123512|3862416|B2||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4040744|NCT01123512|3862417|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4040745|NCT01123512|3862415|B3|||Age||years|Mean|75.57|75.57|Standard Deviation|9.22|9.22|||
4040746|NCT01123512|3862416|B2|||Age||years|Mean|75.09|75.09|Standard Deviation|9.62|9.62|||
4040747|NCT01123512|3862417|B1|||Age||years|Mean|76.03|76.03|Standard Deviation|8.82|8.82|||
4040748|NCT01123395|3862424|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4040749|NCT01123395|3862424|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4040750|NCT01123395|3862424|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040751|NCT01123395|3862424|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4040752|NCT01123395|3862424|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4040753|NCT01123395|3862424|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040754|NCT01123395|3862424|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4040755|NCT01123395|3862424|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040756|NCT01123395|3862424|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040757|NCT01123395|3862424|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4040758|NCT01123395|3862424|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4040759|NCT01123395|3862424|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4040760|NCT01123395|3862424|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4040761|NCT01123395|3862424|B1|||Age||years|Mean|32.44|32.44|Standard Deviation|11.30|11.3|||
4040762|NCT01123395|3862424|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4040763|NCT01123395|3862424|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4040764|NCT01123395|3862424|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4040765|NCT01123382|3862435|B3|||Time Since Stroke||years|Median|2.1|2.1|Inter-Quartile Range|||0.9|4.6|
4040766|NCT01123382|3862436|B2|||Time Since Stroke||years|Median|2.3|2.3|Inter-Quartile Range|||0.8|4.8|
4040767|NCT01123382|3862437|B1|||Time Since Stroke||years|Median|2.1|2.1|Inter-Quartile Range|||0.9|4.0|
4040768|NCT01123382|3862435|B3|||Shoulder pain > 18 mos||Participants|Count of Participants|15|15.0||||||
4040769|NCT01123382|3862436|B2|||Shoulder pain > 18 mos||Participants|Count of Participants|7|7.0||||||
4040770|NCT01123382|3862437|B1|||Shoulder pain > 18 mos||Participants|Count of Participants|8|8.0||||||
4040771|NCT01123382|3862435|B3|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4040772|NCT01123382|3862436|B2|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4040773|NCT01123382|3862437|B1|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4040774|NCT01123382|3862435|B3||Hispanic/Latino|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4040775|NCT01123382|3862436|B2||Hispanic/Latino|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4040776|NCT01123382|3862437|B1||Hispanic/Latino|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4040777|NCT01123382|3862435|B3||African American|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4040778|NCT01123382|3862436|B2||African American|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4040779|NCT01123382|3862437|B1||African American|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4040780|NCT01123382|3862435|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4040781|NCT01123382|3862436|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4040782|NCT01123382|3862437|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4040783|NCT01123382|3862435|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4040784|NCT01123382|3862436|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4040785|NCT01123382|3862437|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4040786|NCT01123382|3862435|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4040787|NCT01123382|3862436|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4040788|NCT01123382|3862437|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4040789|NCT01123382|3862435|B3|||Age||years|Median|55.0|55.0|Inter-Quartile Range|||50.0|65.0|
4040790|NCT01123382|3862436|B2|||Age||years|Median|55.5|55.5|Inter-Quartile Range|||50.0|62.5|
4040791|NCT01123382|3862437|B1|||Age||years|Median|54.0|54.0|Inter-Quartile Range|||50.5|68.0|
4040792|NCT01123356|3862460|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040793|NCT01123356|3862460|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040794|NCT01123356|3862460|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4040795|NCT01123356|3862460|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4040796|NCT01123356|3862460|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040797|NCT01123356|3862460|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040798|NCT01123356|3862460|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040799|NCT01123356|3862460|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040800|NCT01123356|3862460|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4040801|NCT01123356|3862460|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4040802|NCT01123356|3862460|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4040803|NCT01123356|3862460|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4040804|NCT01123356|3862460|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4040805|NCT01123356|3862460|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4040806|NCT01123356|3862460|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4040807|NCT01123200|3862468|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4040808|NCT01123200|3862468|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4040809|NCT01123200|3862468|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4040810|NCT01123200|3862468|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4040811|NCT01123200|3862468|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4040812|NCT01123200|3862468|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4040813|NCT01123161|3862473|B3|||Baseline temperature||degrees (C)|Mean|36.5|36.5|Standard Deviation|0.48|0.48|||
4040814|NCT01123161|3862474|B2|||Baseline temperature||degrees (C)|Mean|36.6|36.6|Standard Deviation|0.46|0.46|||
4040815|NCT01123161|3862475|B1|||Baseline temperature||degrees (C)|Mean|36.4|36.4|Standard Deviation|0.50|0.5|||
4040816|NCT01123161|3862473|B3|||Baseline NIHSS|The NIHSS measures neurological deficit. Scores range from 0 (best) to 42 (worst). Between 0 and 42 higher scores reflect progressively worse neurological deficit.|points|Mean|14.3|14.3|Standard Deviation|4.8|4.8|||
4040817|NCT01123161|3862474|B2|||Baseline NIHSS|The NIHSS measures neurological deficit. Scores range from 0 (best) to 42 (worst). Between 0 and 42 higher scores reflect progressively worse neurological deficit.|points|Mean|14.1|14.1|Standard Deviation|4.8|4.8|||
4040818|NCT01123161|3862475|B1|||Baseline NIHSS|The NIHSS measures neurological deficit. Scores range from 0 (best) to 42 (worst). Between 0 and 42 higher scores reflect progressively worse neurological deficit.|points|Mean|14.5|14.5|Standard Deviation|4.9|4.9|||
4040819|NCT01123161|3862473|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4040820|NCT01123161|3862474|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4040821|NCT01123161|3862475|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4040822|NCT01123161|3862473|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4040823|NCT01123161|3862474|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4040824|NCT01123161|3862475|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4040825|NCT01123161|3862473|B3|||Age||years|Mean|66.4|66.4|Standard Deviation|10.7|10.7|||
4040826|NCT01123161|3862474|B2|||Age||years|Mean|65.5|65.5|Standard Deviation|10.3|10.3|||
4040827|NCT01123161|3862475|B1|||Age||years|Mean|67.5|67.5|Standard Deviation|11.1|11.1|||
4040828|NCT01123148|3862494|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4040829|NCT01123148|3862494|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4040830|NCT01123148|3862494|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4040831|NCT01123148|3862494|B1|||Age||years|Mean|40.5|40.5|Full Range|||19.0|63.0|
4040832|NCT01123148|3862494|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4040833|NCT01123148|3862494|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4040834|NCT01123148|3862494|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4040835|NCT01123083|3862498|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040836|NCT01123083|3862499|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040837|NCT01123083|3862500|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040838|NCT01123083|3862498|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4040839|NCT01123083|3862499|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4040840|NCT01123083|3862500|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4040841|NCT01123083|3862498|B3||White|Race (NIH/OMB)||Participants|Count of Participants|165|165.0||||||
4040842|NCT01123083|3862499|B2||White|Race (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
4040843|NCT01123083|3862500|B1||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4040844|NCT01123083|3862498|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4040845|NCT01123083|3862499|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4040846|NCT01123083|3862500|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4040847|NCT01123083|3862498|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040848|NCT01123083|3862499|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040849|NCT01123083|3862500|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040850|NCT01123083|3862498|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4040851|NCT01123083|3862499|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4040852|NCT01123083|3862500|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4040853|NCT01123083|3862498|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4040854|NCT01123083|3862499|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4040855|NCT01123083|3862500|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4040856|NCT01123083|3862498|B3||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4040857|NCT01123083|3862499|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4040858|NCT01123083|3862500|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4040859|NCT01123083|3862498|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4040860|NCT01123083|3862499|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4040861|NCT01123083|3862500|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4040862|NCT01123083|3862498|B3|||Age||Years|Mean|23.2|23.2|Standard Deviation|8.29|8.29|||
4040863|NCT01123083|3862499|B2|||Age||Years|Mean|23.6|23.6|Standard Deviation|8.34|8.34|||
4040864|NCT01123083|3862500|B1|||Age||Years|Mean|22.5|22.5|Standard Deviation|8.22|8.22|||
4040865|NCT01122927|3862525|B1||Male|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4040866|NCT01122927|3862525|B1||Female|Sex: Female, Male||Participants|Count of Participants|316|316.0||||||
4040867|NCT01122927|3862525|B1|||Age||Years|Mean|15.2|15.2|Standard Deviation|1.6|1.6|||
4040868|NCT01122901|3862557|B3|No||Debulking|surgical procedure to remove brain tumor|Participants|Count of Participants|11|11.0||||||
4040869|NCT01122901|3862558|B2|No||Debulking|surgical procedure to remove brain tumor|Participants|Count of Participants|1|1.0||||||
4040870|NCT01122901|3862559|B1|No||Debulking|surgical procedure to remove brain tumor|Participants|Count of Participants|10|10.0||||||
4040871|NCT01122901|3862557|B3|Yes||Debulking|surgical procedure to remove brain tumor|Participants|Count of Participants|36|36.0||||||
4040872|NCT01122901|3862558|B2|Yes||Debulking|surgical procedure to remove brain tumor|Participants|Count of Participants|6|6.0||||||
4040873|NCT01122901|3862559|B1|Yes||Debulking|surgical procedure to remove brain tumor|Participants|Count of Participants|30|30.0||||||
4040874|NCT01122901|3862557|B3|||Karnofsky Performance Status Scale|Higher score better 100 normal no complaints/disease 90 capable normal activity few symptoms/disease 80 normal activity, some difficulty some symptoms/signs 70 caring for self not capable normal activity/work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care/help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures/treatment 10 moribund rapidly progressive fatal disease processes 0 death|units on a scale|Median|80|80.0|Full Range|||60.0|100.0|
4040875|NCT01122901|3862558|B2|||Karnofsky Performance Status Scale|Higher score better 100 normal no complaints/disease 90 capable normal activity few symptoms/disease 80 normal activity, some difficulty some symptoms/signs 70 caring for self not capable normal activity/work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care/help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures/treatment 10 moribund rapidly progressive fatal disease processes 0 death|units on a scale|Median|80|80.0|Full Range|||60.0|100.0|
4040876|NCT01122901|3862559|B1|||Karnofsky Performance Status Scale|Higher score better 100 normal no complaints/disease 90 capable normal activity few symptoms/disease 80 normal activity, some difficulty some symptoms/signs 70 caring for self not capable normal activity/work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care/help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures/treatment 10 moribund rapidly progressive fatal disease processes 0 death|units on a scale|Median|80|80.0|Full Range|||60.0|100.0|
4040877|NCT01122901|3862557|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4040878|NCT01122901|3862558|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4040879|NCT01122901|3862559|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4040880|NCT01122901|3862557|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4040881|NCT01122901|3862558|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4040882|NCT01122901|3862559|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4040883|NCT01122901|3862557|B3|||Age||years|Median|57|57.0|Full Range|||35.0|77.0|
4040884|NCT01122901|3862558|B2|||Age||years|Median|56|56.0|Full Range|||43.0|77.0|
4040885|NCT01122901|3862559|B1|||Age||years|Median|58|58.0|Full Range|||35.0|75.0|
4040886|NCT01122862|3862578|B1|||Mean Plaque Index Score|Plaque scores were assessed using Turesky Modification of the Quigley Hein Index and categorized as 0: No plaque;1: Slight flecks of plaque at the cervical margin of the tooth;2: A thin continuous band of plaque (1 millimeter [mm] or smaller) at the cervical margin of the tooth;3: A band of plaque wider than 1 mm but covering less than 1/3 of the crown of the tooth;4: Plaque covering at least 1/3 but less than 2/3 of the crown of the tooth;5: Plaque covering 2/3 or more of the crown of the tooth. Plaque Index was calculated by taking average of scores over all tooth sites for a participant.|Score on a scale|Mean|3.01|3.01|Standard Deviation|0.34|0.34|||
4040887|NCT01122862|3862578|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4040888|NCT01122862|3862578|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4040889|NCT01122862|3862578|B1|||Age||Years|Mean|41.9|41.9|Standard Deviation|14.62|14.62|||
4040890|NCT01122849|3862598|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040891|NCT01122849|3862599|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040892|NCT01122849|3862600|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040893|NCT01122849|3862601|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040894|NCT01122849|3862598|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040895|NCT01122849|3862599|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040896|NCT01122849|3862600|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040897|NCT01122849|3862601|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040898|NCT01122849|3862598|B4||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4040899|NCT01122849|3862599|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4040900|NCT01122849|3862600|B2||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4040901|NCT01122849|3862601|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4040902|NCT01122849|3862598|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040903|NCT01122849|3862599|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040904|NCT01122849|3862600|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040905|NCT01122849|3862601|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040906|NCT01122849|3862598|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040907|NCT01122849|3862599|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040908|NCT01122849|3862600|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040909|NCT01122849|3862601|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040910|NCT01122849|3862598|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040911|NCT01122849|3862599|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040912|NCT01122849|3862600|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040913|NCT01122849|3862601|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040914|NCT01122849|3862598|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040915|NCT01122849|3862599|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040916|NCT01122849|3862600|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040917|NCT01122849|3862601|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4040918|NCT01122849|3862598|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4040919|NCT01122849|3862599|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4040920|NCT01122849|3862600|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4040921|NCT01122849|3862601|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4040922|NCT01122849|3862598|B4||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4040923|NCT01122849|3862599|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4040924|NCT01122849|3862600|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4040925|NCT01122849|3862601|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4040926|NCT01122849|3862598|B4|Years||Age, Customized||Years|Mean|44.4|44.4|Standard Deviation|11.29|11.29|||
4040927|NCT01122849|3862599|B3|Years||Age, Customized||Years|Mean|42.5|42.5|Standard Deviation|13.97|13.97|||
4040928|NCT01122849|3862600|B2|Years||Age, Customized||Years|Mean|44.5|44.5|Standard Deviation|9.59|9.59|||
4040929|NCT01122849|3862601|B1|Years||Age, Customized||Years|Mean|46.1|46.1|Standard Deviation|10.17|10.17|||
4040930|NCT01122680|3862686|B1|||Forced expiratory volume in 1s (FEV1)||Litre|Mean|2.742|2.742|Standard Deviation|0.697|0.697|||
4040931|NCT01122680|3862686|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4040932|NCT01122680|3862686|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4040933|NCT01122680|3862686|B1|||Age||Years|Mean|14.0|14.0|Standard Deviation|1.5|1.5|||
4040934|NCT01122576|3862751|B4|United States||Region of Enrollment||participants|Number|78|78.0||||||
4040935|NCT01122576|3862752|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4040936|NCT01122576|3862753|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4040937|NCT01122576|3862754|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4040938|NCT01122576|3862751|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4040939|NCT01122576|3862752|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4040940|NCT01122576|3862753|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4040941|NCT01122576|3862754|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4040942|NCT01122576|3862751|B4||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4040943|NCT01122576|3862752|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4040944|NCT01122576|3862753|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4040945|NCT01122576|3862754|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4040946|NCT01122576|3862751|B4|≥ 80||Age, Customized||participants|Number|1|1.0||||||
4040947|NCT01122576|3862752|B3|≥ 80||Age, Customized||participants|Number|1|1.0||||||
4040948|NCT01122576|3862753|B2|≥ 80||Age, Customized||participants|Number|0|0.0||||||
4040949|NCT01122576|3862754|B1|≥ 80||Age, Customized||participants|Number|0|0.0||||||
4040950|NCT01122576|3862751|B4|70-79 years||Age, Customized||participants|Number|15|15.0||||||
4040951|NCT01122576|3862752|B3|70-79 years||Age, Customized||participants|Number|4|4.0||||||
4040952|NCT01122576|3862753|B2|70-79 years||Age, Customized||participants|Number|8|8.0||||||
4040953|NCT01122576|3862754|B1|70-79 years||Age, Customized||participants|Number|3|3.0||||||
4040954|NCT01122576|3862751|B4|60-69 years||Age, Customized||participants|Number|37|37.0||||||
4040955|NCT01122576|3862752|B3|60-69 years||Age, Customized||participants|Number|12|12.0||||||
4040956|NCT01122576|3862753|B2|60-69 years||Age, Customized||participants|Number|12|12.0||||||
4040957|NCT01122576|3862754|B1|60-69 years||Age, Customized||participants|Number|13|13.0||||||
4040958|NCT01122576|3862751|B4|50-59 years||Age, Customized||participants|Number|23|23.0||||||
4040959|NCT01122576|3862752|B3|50-59 years||Age, Customized||participants|Number|8|8.0||||||
4040960|NCT01122576|3862753|B2|50-59 years||Age, Customized||participants|Number|5|5.0||||||
4040961|NCT01122576|3862754|B1|50-59 years||Age, Customized||participants|Number|10|10.0||||||
4040962|NCT01122576|3862751|B4|40 - 49 years||Age, Customized||participants|Number|2|2.0||||||
4040963|NCT01122576|3862752|B3|40 - 49 years||Age, Customized||participants|Number|1|1.0||||||
4040964|NCT01122576|3862753|B2|40 - 49 years||Age, Customized||participants|Number|1|1.0||||||
4040965|NCT01122576|3862754|B1|40 - 49 years||Age, Customized||participants|Number|0|0.0||||||
4040966|NCT01122576|3862751|B4|<40 years||Age, Customized||participants|Number|0|0.0||||||
4040967|NCT01122576|3862752|B3|<40 years||Age, Customized||participants|Number|0|0.0||||||
4040968|NCT01122576|3862753|B2|<40 years||Age, Customized||participants|Number|0|0.0||||||
4040969|NCT01122576|3862754|B1|<40 years||Age, Customized||participants|Number|0|0.0||||||
4040970|NCT01122511|3862893|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4040971|NCT01122511|3862894|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4040972|NCT01122511|3862895|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4040973|NCT01122511|3862893|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4040974|NCT01122511|3862894|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4040975|NCT01122511|3862895|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4040976|NCT01122511|3862893|B3|>=80 years||Age, Customized||Participants|Number|3|3.0||||||
4040977|NCT01122511|3862894|B2|>=80 years||Age, Customized||Participants|Number|2|2.0||||||
4040978|NCT01122511|3862895|B1|>=80 years||Age, Customized||Participants|Number|1|1.0||||||
4040979|NCT01122511|3862893|B3|Between 50 and 80 years||Age, Customized||Participants|Number|1|1.0||||||
4040980|NCT01122511|3862894|B2|Between 50 and 80 years||Age, Customized||Participants|Number|0|0.0||||||
4040981|NCT01122511|3862895|B1|Between 50 and 80 years||Age, Customized||Participants|Number|1|1.0||||||
4040982|NCT01122394|3862908|B3|Refused||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4040983|NCT01122394|3862909|B2|Refused||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4040984|NCT01122394|3862910|B1|Refused||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4040985|NCT01122394|3862908|B3|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4040986|NCT01122394|3862909|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4040987|NCT01122394|3862910|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4040988|NCT01122394|3862908|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4040989|NCT01122394|3862909|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4040990|NCT01122394|3862910|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4040991|NCT01122394|3862908|B3|Black/African American (non-Hispanic)||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
4040992|NCT01122394|3862909|B2|Black/African American (non-Hispanic)||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4040993|NCT01122394|3862910|B1|Black/African American (non-Hispanic)||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4040994|NCT01122394|3862908|B3|White (non-Hispanic)||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
4040995|NCT01122394|3862909|B2|White (non-Hispanic)||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4040996|NCT01122394|3862910|B1|White (non-Hispanic)||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4040997|NCT01122394|3862908|B3||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4040998|NCT01122394|3862909|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4040999|NCT01122394|3862910|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4041000|NCT01122394|3862908|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4041001|NCT01122394|3862909|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4041002|NCT01122394|3862910|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4041003|NCT01122394|3862908|B3|||Age||years|Mean|67.62|67.62|Standard Deviation|10.13|10.13|||
4041004|NCT01122394|3862909|B2|||Age||years|Mean|68.73|68.73|Standard Deviation|10.30|10.3|||
4041005|NCT01122394|3862910|B1|||Age||years|Mean|66.38|66.38|Standard Deviation|9.86|9.86|||
4041006|NCT01122381|3862925|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4041007|NCT01122381|3862926|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4041008|NCT01122381|3862927|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4041009|NCT01122381|3862925|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041010|NCT01122381|3862926|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041011|NCT01122381|3862927|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041012|NCT01122381|3862925|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041013|NCT01122381|3862926|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041014|NCT01122381|3862927|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041015|NCT01122381|3862925|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4041016|NCT01122381|3862926|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4041017|NCT01122381|3862927|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4041078|NCT01122264|3862934|B4|France||Region of Enrollment||participants|Number|301|301.0||||||
4041018|NCT01122381|3862925|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041019|NCT01122381|3862926|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041020|NCT01122381|3862927|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041021|NCT01122381|3862925|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041022|NCT01122381|3862926|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041023|NCT01122381|3862927|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041024|NCT01122381|3862925|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041025|NCT01122381|3862926|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041026|NCT01122381|3862927|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041027|NCT01122381|3862925|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041028|NCT01122381|3862926|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041029|NCT01122381|3862927|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041030|NCT01122381|3862925|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041031|NCT01122381|3862926|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041032|NCT01122381|3862927|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041033|NCT01122381|3862925|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4041034|NCT01122381|3862926|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4041035|NCT01122381|3862927|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4041036|NCT01122381|3862925|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041037|NCT01122381|3862926|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041038|NCT01122381|3862927|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041039|NCT01122381|3862925|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4041040|NCT01122381|3862926|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4041041|NCT01122381|3862927|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4041042|NCT01122381|3862925|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4041043|NCT01122381|3862926|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4041044|NCT01122381|3862927|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4041045|NCT01122381|3862925|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4041046|NCT01122381|3862926|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4041047|NCT01122381|3862927|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4041048|NCT01122381|3862925|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4041049|NCT01122381|3862926|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4041050|NCT01122381|3862927|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4041051|NCT01122381|3862925|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4041052|NCT01122381|3862926|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4041053|NCT01122381|3862927|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4041054|NCT01122264|3862934|B4|United Kingdom||Region of Enrollment||participants|Number|29|29.0||||||
4041055|NCT01122264|3862935|B3|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
4041056|NCT01122264|3862936|B2|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
4041057|NCT01122264|3862937|B1|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
4041058|NCT01122264|3862934|B4|Germany||Region of Enrollment||participants|Number|137|137.0||||||
4041059|NCT01122264|3862935|B3|Germany||Region of Enrollment||participants|Number|47|47.0||||||
4041060|NCT01122264|3862936|B2|Germany||Region of Enrollment||participants|Number|45|45.0||||||
4041061|NCT01122264|3862937|B1|Germany||Region of Enrollment||participants|Number|45|45.0||||||
4041062|NCT01122264|3862934|B4|Romania||Region of Enrollment||participants|Number|63|63.0||||||
4041063|NCT01122264|3862935|B3|Romania||Region of Enrollment||participants|Number|21|21.0||||||
4041064|NCT01122264|3862936|B2|Romania||Region of Enrollment||participants|Number|22|22.0||||||
4041065|NCT01122264|3862937|B1|Romania||Region of Enrollment||participants|Number|20|20.0||||||
4041066|NCT01122264|3862934|B4|Spain||Region of Enrollment||participants|Number|149|149.0||||||
4041067|NCT01122264|3862935|B3|Spain||Region of Enrollment||participants|Number|52|52.0||||||
4041068|NCT01122264|3862936|B2|Spain||Region of Enrollment||participants|Number|49|49.0||||||
4041069|NCT01122264|3862937|B1|Spain||Region of Enrollment||participants|Number|48|48.0||||||
4041070|NCT01122264|3862934|B4|Poland||Region of Enrollment||participants|Number|47|47.0||||||
4041071|NCT01122264|3862935|B3|Poland||Region of Enrollment||participants|Number|16|16.0||||||
4041072|NCT01122264|3862936|B2|Poland||Region of Enrollment||participants|Number|16|16.0||||||
4041073|NCT01122264|3862937|B1|Poland||Region of Enrollment||participants|Number|15|15.0||||||
4041074|NCT01122264|3862934|B4|Greece||Region of Enrollment||participants|Number|26|26.0||||||
4041075|NCT01122264|3862935|B3|Greece||Region of Enrollment||participants|Number|9|9.0||||||
4041076|NCT01122264|3862936|B2|Greece||Region of Enrollment||participants|Number|8|8.0||||||
4041077|NCT01122264|3862937|B1|Greece||Region of Enrollment||participants|Number|9|9.0||||||
4041079|NCT01122264|3862935|B3|France||Region of Enrollment||participants|Number|100|100.0||||||
4041080|NCT01122264|3862936|B2|France||Region of Enrollment||participants|Number|102|102.0||||||
4041081|NCT01122264|3862937|B1|France||Region of Enrollment||participants|Number|99|99.0||||||
4041082|NCT01122264|3862934|B4|Portugal||Region of Enrollment||participants|Number|18|18.0||||||
4041083|NCT01122264|3862935|B3|Portugal||Region of Enrollment||participants|Number|7|7.0||||||
4041084|NCT01122264|3862936|B2|Portugal||Region of Enrollment||participants|Number|5|5.0||||||
4041085|NCT01122264|3862937|B1|Portugal||Region of Enrollment||participants|Number|6|6.0||||||
4041086|NCT01122264|3862934|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4041087|NCT01122264|3862935|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4041088|NCT01122264|3862936|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4041089|NCT01122264|3862937|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4041090|NCT01122264|3862934|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4041091|NCT01122264|3862935|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4041092|NCT01122264|3862936|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041093|NCT01122264|3862937|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041094|NCT01122264|3862934|B4||White|Race (NIH/OMB)||Participants|Count of Participants|753|753.0||||||
4041095|NCT01122264|3862935|B3||White|Race (NIH/OMB)||Participants|Count of Participants|254|254.0||||||
4041096|NCT01122264|3862936|B2||White|Race (NIH/OMB)||Participants|Count of Participants|251|251.0||||||
4041097|NCT01122264|3862937|B1||White|Race (NIH/OMB)||Participants|Count of Participants|248|248.0||||||
4041098|NCT01122264|3862934|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4041099|NCT01122264|3862935|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4041100|NCT01122264|3862936|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4041101|NCT01122264|3862937|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4041102|NCT01122264|3862934|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041103|NCT01122264|3862935|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041104|NCT01122264|3862936|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041105|NCT01122264|3862937|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041106|NCT01122264|3862934|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041107|NCT01122264|3862935|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041108|NCT01122264|3862936|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041109|NCT01122264|3862937|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041110|NCT01122264|3862934|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041111|NCT01122264|3862935|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041112|NCT01122264|3862936|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041113|NCT01122264|3862937|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041114|NCT01122264|3862934|B4||Male|Sex: Female, Male||Participants|Count of Participants|770|770.0||||||
4041115|NCT01122264|3862935|B3||Male|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
4041116|NCT01122264|3862936|B2||Male|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
4041117|NCT01122264|3862937|B1||Male|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
4041118|NCT01122264|3862934|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4041119|NCT01122264|3862935|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4041120|NCT01122264|3862936|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4041121|NCT01122264|3862937|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4041122|NCT01122264|3862934|B4|||Age||years|Mean|53.0|53.0|Standard Deviation|11.66|11.66|||
4041123|NCT01122264|3862935|B3|||Age||years|Mean|53.0|53.0|Standard Deviation|11.76|11.76|||
4041124|NCT01122264|3862936|B2|||Age||years|Mean|52.9|52.9|Standard Deviation|11.69|11.69|||
4041125|NCT01122264|3862937|B1|||Age||years|Mean|53.2|53.2|Standard Deviation|11.57|11.57|||
4041126|NCT01122238|3862996|B17|United States||Region of Enrollment||participants|Number|517|517.0||||||
4041127|NCT01122238|3862997|B16|United States||Region of Enrollment||participants|Number|31|31.0||||||
4041128|NCT01122238|3862998|B15|United States||Region of Enrollment||participants|Number|28|28.0||||||
4041129|NCT01122238|3862999|B14|United States||Region of Enrollment||participants|Number|32|32.0||||||
4041130|NCT01122238|3863000|B13|United States||Region of Enrollment||participants|Number|30|30.0||||||
4041131|NCT01122238|3863001|B12|United States||Region of Enrollment||participants|Number|33|33.0||||||
4041132|NCT01122238|3863002|B11|United States||Region of Enrollment||participants|Number|32|32.0||||||
4041133|NCT01122238|3863003|B10|United States||Region of Enrollment||participants|Number|34|34.0||||||
4041134|NCT01122238|3863004|B9|United States||Region of Enrollment||participants|Number|32|32.0||||||
4041135|NCT01122238|3863005|B8|United States||Region of Enrollment||participants|Number|32|32.0||||||
4041136|NCT01122238|3863006|B7|United States||Region of Enrollment||participants|Number|35|35.0||||||
4041137|NCT01122238|3863007|B6|United States||Region of Enrollment||participants|Number|32|32.0||||||
4041138|NCT01122238|3863008|B5|United States||Region of Enrollment||participants|Number|33|33.0||||||
4041139|NCT01122238|3863009|B4|United States||Region of Enrollment||participants|Number|33|33.0||||||
4041140|NCT01122238|3863010|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
4041141|NCT01122238|3863011|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4041142|NCT01122238|3863012|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4041143|NCT01122238|3862996|B17||Male|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4041144|NCT01122238|3862997|B16||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4041145|NCT01122238|3862998|B15||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4041146|NCT01122238|3862999|B14||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4041147|NCT01122238|3863000|B13||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4041148|NCT01122238|3863001|B12||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4041149|NCT01122238|3863002|B11||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4041150|NCT01122238|3863003|B10||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4041151|NCT01122238|3863004|B9||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4041152|NCT01122238|3863005|B8||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4041153|NCT01122238|3863006|B7||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4041154|NCT01122238|3863007|B6||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4041155|NCT01122238|3863008|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4041156|NCT01122238|3863009|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4041157|NCT01122238|3863010|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4041158|NCT01122238|3863011|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4041159|NCT01122238|3863012|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4041160|NCT01122238|3862996|B17||Female|Sex: Female, Male||Participants|Count of Participants|328|328.0||||||
4041161|NCT01122238|3862997|B16||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4041162|NCT01122238|3862998|B15||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4041163|NCT01122238|3862999|B14||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4041164|NCT01122238|3863000|B13||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4041165|NCT01122238|3863001|B12||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4041166|NCT01122238|3863002|B11||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4041167|NCT01122238|3863003|B10||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4041168|NCT01122238|3863004|B9||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4041169|NCT01122238|3863005|B8||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4041170|NCT01122238|3863006|B7||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4041171|NCT01122238|3863007|B6||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4041172|NCT01122238|3863008|B5||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4041173|NCT01122238|3863009|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4041174|NCT01122238|3863010|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4041175|NCT01122238|3863011|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4041176|NCT01122238|3863012|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4041177|NCT01122238|3862996|B17|||Age||years|Mean|47.05|47.05|Standard Deviation|14.33|14.33|||
4041178|NCT01122238|3862997|B16|||Age||years|Mean|46.84|46.84|Standard Deviation|15.18|15.18|||
4041179|NCT01122238|3862998|B15|||Age||years|Mean|51.93|51.93|Standard Deviation|12.82|12.82|||
4041180|NCT01122238|3862999|B14|||Age||years|Mean|47.06|47.06|Standard Deviation|14.98|14.98|||
4041181|NCT01122238|3863000|B13|||Age||years|Mean|46.87|46.87|Standard Deviation|14.71|14.71|||
4041182|NCT01122238|3863001|B12|||Age||years|Mean|47.30|47.3|Standard Deviation|13.90|13.9|||
4041183|NCT01122238|3863002|B11|||Age||years|Mean|45.41|45.41|Standard Deviation|14.89|14.89|||
4041184|NCT01122238|3863003|B10|||Age||years|Mean|49.53|49.53|Standard Deviation|13.77|13.77|||
4041185|NCT01122238|3863004|B9|||Age||years|Mean|41.63|41.63|Standard Deviation|15.40|15.4|||
4041186|NCT01122238|3863005|B8|||Age||years|Mean|47.91|47.91|Standard Deviation|14.19|14.19|||
4041187|NCT01122238|3863006|B7|||Age||years|Mean|44.89|44.89|Standard Deviation|14.57|14.57|||
4041188|NCT01122238|3863007|B6|||Age||years|Mean|48.47|48.47|Standard Deviation|14.50|14.5|||
4041189|NCT01122238|3863008|B5|||Age||years|Mean|47.00|47.0|Standard Deviation|14.03|14.03|||
4041190|NCT01122238|3863009|B4|||Age||years|Mean|48.91|48.91|Standard Deviation|13.22|13.22|||
4041191|NCT01122238|3863010|B3|||Age||years|Mean|49.18|49.18|Standard Deviation|14.89|14.89|||
4041192|NCT01122238|3863011|B2|||Age||years|Mean|46.00|46.0|Standard Deviation|14.05|14.05|||
4041193|NCT01122238|3863012|B1|||Age||years|Mean|44.37|44.37|Standard Deviation|13.28|13.28|||
4041194|NCT01122238|3862996|B17||>=65 years|Age||Participants|Count of Participants|59|59.0||||||
4041195|NCT01122238|3862997|B16||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4041196|NCT01122238|3862998|B15||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4041197|NCT01122238|3862999|B14||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4041198|NCT01122238|3863000|B13||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4041199|NCT01122238|3863001|B12||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4041200|NCT01122238|3863002|B11||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4041201|NCT01122238|3863003|B10||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4041202|NCT01122238|3863004|B9||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4041203|NCT01122238|3863005|B8||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4041204|NCT01122238|3863006|B7||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4041205|NCT01122238|3863007|B6||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4041206|NCT01122238|3863008|B5||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4041207|NCT01122238|3863009|B4||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4041208|NCT01122238|3863010|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4041209|NCT01122238|3863011|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4041210|NCT01122238|3863012|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4041211|NCT01122238|3862996|B17||Between 18 and 65 years|Age||Participants|Count of Participants|452|452.0||||||
4041212|NCT01122238|3862997|B16||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4041213|NCT01122238|3862998|B15||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4041214|NCT01122238|3862999|B14||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4041215|NCT01122238|3863000|B13||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4041216|NCT01122238|3863001|B12||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4041217|NCT01122238|3863002|B11||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4041218|NCT01122238|3863003|B10||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4041219|NCT01122238|3863004|B9||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4041220|NCT01122238|3863005|B8||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4041221|NCT01122238|3863006|B7||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4041222|NCT01122238|3863007|B6||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4041223|NCT01122238|3863008|B5||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4041224|NCT01122238|3863009|B4||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4041225|NCT01122238|3863010|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4041226|NCT01122238|3863011|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4041227|NCT01122238|3863012|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4041228|NCT01122238|3862996|B17||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4041229|NCT01122238|3862997|B16||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4041230|NCT01122238|3862998|B15||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4041231|NCT01122238|3862999|B14||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4041232|NCT01122238|3863000|B13||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4041233|NCT01122238|3863001|B12||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4041234|NCT01122238|3863002|B11||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4041235|NCT01122238|3863003|B10||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4041236|NCT01122238|3863004|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4041237|NCT01122238|3863005|B8||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4041238|NCT01122238|3863006|B7||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4041239|NCT01122238|3863007|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4041240|NCT01122238|3863008|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4041241|NCT01122238|3863009|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4041242|NCT01122238|3863010|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4041243|NCT01122238|3863011|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4041244|NCT01122238|3863012|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4041245|NCT01122173|3863049|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4041246|NCT01122173|3863049|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041247|NCT01122173|3863049|B1||White|Race (NIH/OMB)||Participants|Count of Participants|137|137.0||||||
4041248|NCT01122173|3863049|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041249|NCT01122173|3863049|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041250|NCT01122173|3863049|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041251|NCT01122173|3863049|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041252|NCT01122173|3863049|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4041253|NCT01122173|3863049|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4041254|NCT01122173|3863049|B1|||Age||years|Mean|60.2|60.2|Standard Deviation|11.2|11.2|||
4041255|NCT01122160|3863056|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4041256|NCT01122160|3863056|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4041257|NCT01122160|3863056|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4041258|NCT01122160|3863056|B1|||Age||years|Mean|35|35.0|Standard Deviation|13.8|13.8|||
4041259|NCT01122160|3863056|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4041260|NCT01122160|3863056|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4041261|NCT01122160|3863056|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4041262|NCT01122108|3863063|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4041263|NCT01122108|3863063|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4041264|NCT01122108|3863063|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4041265|NCT01122108|3863063|B1|||Age||years|Mean|49.98|49.98|Standard Deviation|1.61|1.61|||
4041266|NCT01122108|3863063|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4041267|NCT01122108|3863063|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4041268|NCT01122108|3863063|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4041269|NCT01122030|3863073|B8|White||Race/Ethnicity, Customized||Participants|Count of Participants|70|70.0||||||
4041270|NCT01122030|3863074|B7|White||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4041271|NCT01122030|3863075|B6|White||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4041272|NCT01122030|3863076|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4041273|NCT01122030|3863077|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4041274|NCT01122030|3863078|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4041275|NCT01122030|3863079|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4041276|NCT01122030|3863080|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
4041277|NCT01122030|3863073|B8|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4041278|NCT01122030|3863074|B7|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4041279|NCT01122030|3863075|B6|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4041280|NCT01122030|3863076|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4041281|NCT01122030|3863077|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4041282|NCT01122030|3863078|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4041283|NCT01122030|3863079|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4041284|NCT01122030|3863080|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4041285|NCT01122030|3863073|B8|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4041286|NCT01122030|3863074|B7|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4041287|NCT01122030|3863075|B6|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4041288|NCT01122030|3863076|B5|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4041289|NCT01122030|3863077|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4041290|NCT01122030|3863078|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4041291|NCT01122030|3863079|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4041292|NCT01122030|3863080|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4041293|NCT01122030|3863073|B8|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4041294|NCT01122030|3863074|B7|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4041295|NCT01122030|3863075|B6|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4041296|NCT01122030|3863076|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4041297|NCT01122030|3863077|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4041298|NCT01122030|3863078|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4041299|NCT01122030|3863079|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4041300|NCT01122030|3863080|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4041301|NCT01122030|3863073|B8|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4041302|NCT01122030|3863074|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4041303|NCT01122030|3863075|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4041304|NCT01122030|3863076|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4041305|NCT01122030|3863077|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4041306|NCT01122030|3863078|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4041307|NCT01122030|3863079|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4041308|NCT01122030|3863080|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4041309|NCT01122030|3863073|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041310|NCT01122030|3863074|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041311|NCT01122030|3863075|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041312|NCT01122030|3863076|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041313|NCT01122030|3863077|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041314|NCT01122030|3863078|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041315|NCT01122030|3863079|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041316|NCT01122030|3863080|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041317|NCT01122030|3863073|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4041318|NCT01122030|3863074|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4041319|NCT01122030|3863075|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4041320|NCT01122030|3863076|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4041321|NCT01122030|3863077|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4041322|NCT01122030|3863078|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4041323|NCT01122030|3863079|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4041324|NCT01122030|3863080|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4041325|NCT01122030|3863073|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4041326|NCT01122030|3863074|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041327|NCT01122030|3863075|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041328|NCT01122030|3863076|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4041329|NCT01122030|3863077|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041330|NCT01122030|3863078|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4041331|NCT01122030|3863079|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4041332|NCT01122030|3863080|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4041333|NCT01122030|3863073|B8||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4041334|NCT01122030|3863074|B7||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4041335|NCT01122030|3863075|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4041336|NCT01122030|3863076|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4041337|NCT01122030|3863077|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4041338|NCT01122030|3863078|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4041339|NCT01122030|3863079|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4041340|NCT01122030|3863080|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4041341|NCT01122030|3863073|B8||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4041342|NCT01122030|3863074|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4041343|NCT01122030|3863075|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4041344|NCT01122030|3863076|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4041345|NCT01122030|3863077|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4041346|NCT01122030|3863078|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4041347|NCT01122030|3863079|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4041348|NCT01122030|3863080|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4041349|NCT01122030|3863073|B8|||Age||years|Mean|43.3|43.3|Standard Deviation|10.30|10.3|||
4041350|NCT01122030|3863074|B7|||Age||years|Mean|44.8|44.8|Standard Deviation|9.09|9.09|||
4041351|NCT01122030|3863075|B6|||Age||years|Mean|36.6|36.6|Standard Deviation|10.19|10.19|||
4041352|NCT01122030|3863076|B5|||Age||years|Mean|39.7|39.7|Standard Deviation|10.64|10.64|||
4041353|NCT01122030|3863077|B4|||Age||years|Mean|45.6|45.6|Standard Deviation|6.02|6.02|||
4041354|NCT01122030|3863078|B3|||Age||years|Mean|45.2|45.2|Standard Deviation|13.13|13.13|||
4041355|NCT01122030|3863079|B2|||Age||years|Mean|41.4|41.4|Standard Deviation|12.99|12.99|||
4041356|NCT01122030|3863080|B1|||Age||years|Mean|46.7|46.7|Standard Deviation|8.55|8.55|||
4041357|NCT01121991|3863272|B1|>20 cigarettes per day||Smoking|Consumption of cigarettes is inclusive of cigarillos and cigars.|participants|Number|1|1.0||||||
4041358|NCT01121991|3863272|B1|6-20 cigarettes per day||Smoking|Consumption of cigarettes is inclusive of cigarillos and cigars.|participants|Number|1|1.0||||||
4041359|NCT01121991|3863272|B1|0 cigarettes per day||Smoking|Consumption of cigarettes is inclusive of cigarillos and cigars.|participants|Number|50|50.0||||||
4041360|NCT01121991|3863272|B1|Canada||Region of Enrollment||participants|Number|52|52.0||||||
4041361|NCT01121991|3863272|B1|Aboriginal||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4041362|NCT01121991|3863272|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4041363|NCT01121991|3863272|B1|White||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4041364|NCT01121991|3863272|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4041365|NCT01121991|3863272|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4041366|NCT01121991|3863272|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4041367|NCT01121991|3863272|B1|>=35 years||Age, Customized||participants|Number|30|30.0||||||
4041368|NCT01121991|3863272|B1|<35 years||Age, Customized||participants|Number|22|22.0||||||
4041369|NCT01121991|3863272|B1|||Age||years|Mean|34.6|34.6|Standard Deviation|3.6|3.6|||
4041370|NCT01121939|3863283|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4041371|NCT01121939|3863283|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4041372|NCT01121939|3863283|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4041373|NCT01121939|3863283|B1|||Age||years|Median|62|62.0|Full Range|||33.0|88.0|
4041374|NCT01121926|3863297|B1|South Africa||Region of Enrollment||participants|Number|30|30.0||||||
4041375|NCT01121926|3863297|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4041376|NCT01121926|3863297|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4041377|NCT01121926|3863297|B1|||Age||years|Mean|25.7|25.7|Standard Deviation|8.4|8.4|||
4041378|NCT01121926|3863297|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4041379|NCT01121926|3863297|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4041380|NCT01121926|3863297|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4041381|NCT01121913|3863316|B1|South Africa||Region of Enrollment||participants|Number|24|24.0||||||
4041382|NCT01121913|3863316|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4041383|NCT01121913|3863316|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4041384|NCT01121913|3863316|B1|||Age||years|Mean|24.9|24.9|Standard Deviation|7.3|7.3|||
4041385|NCT01121913|3863316|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4041386|NCT01121913|3863316|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4041387|NCT01121913|3863316|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4041388|NCT01121900|3863349|B1|South Africa||Region of Enrollment||participants|Number|26|26.0||||||
4041389|NCT01121900|3863349|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4041390|NCT01121900|3863349|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4041391|NCT01121900|3863349|B1|||Age||years|Mean|25.2|25.2|Standard Deviation|10.88|10.88|||
4041392|NCT01121900|3863349|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4041393|NCT01121900|3863349|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4041394|NCT01121900|3863349|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4041395|NCT01121757|3863368|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4041396|NCT01121757|3863369|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4041397|NCT01121757|3863370|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4041398|NCT01121757|3863368|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041399|NCT01121757|3863369|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041400|NCT01121757|3863370|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041401|NCT01121757|3863368|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041402|NCT01121757|3863369|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041403|NCT01121757|3863370|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041404|NCT01121757|3863368|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4041405|NCT01121757|3863369|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4041406|NCT01121757|3863370|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4041407|NCT01121757|3863368|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041408|NCT01121757|3863369|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041409|NCT01121757|3863370|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041410|NCT01121757|3863368|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041411|NCT01121757|3863369|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041412|NCT01121757|3863370|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041413|NCT01121757|3863368|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041414|NCT01121757|3863369|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041415|NCT01121757|3863370|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041416|NCT01121757|3863368|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041417|NCT01121757|3863369|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041418|NCT01121757|3863370|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041419|NCT01121757|3863368|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041420|NCT01121757|3863369|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041421|NCT01121757|3863370|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041422|NCT01121757|3863368|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4041423|NCT01121757|3863369|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4041424|NCT01121757|3863370|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4041425|NCT01121757|3863368|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041426|NCT01121757|3863369|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041427|NCT01121757|3863370|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041428|NCT01121757|3863368|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4041429|NCT01121757|3863369|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4041430|NCT01121757|3863370|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4041431|NCT01121757|3863368|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4041432|NCT01121757|3863369|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4041433|NCT01121757|3863370|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4041434|NCT01121757|3863368|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4041435|NCT01121757|3863369|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4041436|NCT01121757|3863370|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4041437|NCT01121757|3863368|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4041438|NCT01121757|3863369|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4041439|NCT01121757|3863370|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4041440|NCT01121757|3863368|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4041441|NCT01121757|3863369|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4041442|NCT01121757|3863370|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4041443|NCT01121666|3863385|B3|||AMH less than 24 pmol/L|Number of patients of each group who had a lower AMH level than 24 pmol/L. The cut-off level was defined on the basis of the evaluated level published previously.|Number of participants|Number|153|153.0||||||
4041444|NCT01121666|3863386|B2|||AMH less than 24 pmol/L|Number of patients of each group who had a lower AMH level than 24 pmol/L. The cut-off level was defined on the basis of the evaluated level published previously.|Number of participants|Number|47|47.0||||||
4041445|NCT01121666|3863387|B1|||AMH less than 24 pmol/L|Number of patients of each group who had a lower AMH level than 24 pmol/L. The cut-off level was defined on the basis of the evaluated level published previously.|Number of participants|Number|106|106.0||||||
4041446|NCT01121666|3863385|B3|||GnRH-agonist duration||days|Mean|23.1|23.1|Full Range|||11.0|46.0|
4041447|NCT01121666|3863386|B2|||GnRH-agonist duration||days|Mean|22.7|22.7|Full Range|||12.0|46.0|
4041448|NCT01121666|3863387|B1|||GnRH-agonist duration||days|Mean|23.5|23.5|Full Range|||11.0|44.0|
4041449|NCT01121666|3863385|B3|||Body Mass Index||kilogramm/ square meter|Mean|22.6|22.6|Full Range|||18.0|30.3|
4041450|NCT01121666|3863386|B2|||Body Mass Index||kilogramm/ square meter|Mean|22.4|22.4|Full Range|||18.2|28.7|
4041451|NCT01121666|3863387|B1|||Body Mass Index||kilogramm/ square meter|Mean|22.7|22.7|Full Range|||18.0|30.3|
4041452|NCT01121666|3863385|B3|||Antral follicle count||Antral follicle count|Mean|15.2|15.2|Full Range|||10.0|24.0|
4041453|NCT01121666|3863386|B2|||Antral follicle count||Antral follicle count|Mean|15.3|15.3|Full Range|||10.0|24.0|
4041454|NCT01121666|3863387|B1|||Antral follicle count||Antral follicle count|Mean|15.1|15.1|Full Range|||10.0|24.0|
4041455|NCT01121666|3863385|B3|||FSH baseline concentration|The FSH concentration was measured at baseline in IU/L.|(IU/L)|Mean|6.9|6.9|Full Range|||2.5|17.1|
4041456|NCT01121666|3863386|B2|||FSH baseline concentration|The FSH concentration was measured at baseline in IU/L.|(IU/L)|Mean|6.9|6.9|Full Range|||2.8|10.0|
4041457|NCT01121666|3863387|B1|||FSH baseline concentration|The FSH concentration was measured at baseline in IU/L.|(IU/L)|Mean|6.9|6.9|Full Range|||2.5|17.1|
4041458|NCT01121666|3863385|B3|Switzerland||Region of Enrollment||participants|Number|11|11.0||||||
4041459|NCT01121666|3863386|B2|Switzerland||Region of Enrollment||participants|Number|3|3.0||||||
4041460|NCT01121666|3863387|B1|Switzerland||Region of Enrollment||participants|Number|8|8.0||||||
4041461|NCT01121666|3863385|B3|United Kingdom||Region of Enrollment||participants|Number|31|31.0||||||
4041462|NCT01121666|3863386|B2|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
4041463|NCT01121666|3863387|B1|United Kingdom||Region of Enrollment||participants|Number|21|21.0||||||
4041464|NCT01121666|3863385|B3|Germany||Region of Enrollment||participants|Number|35|35.0||||||
4041465|NCT01121666|3863386|B2|Germany||Region of Enrollment||participants|Number|11|11.0||||||
4041466|NCT01121666|3863387|B1|Germany||Region of Enrollment||participants|Number|24|24.0||||||
4041467|NCT01121666|3863385|B3|Spain||Region of Enrollment||participants|Number|52|52.0||||||
4041468|NCT01121666|3863386|B2|Spain||Region of Enrollment||participants|Number|19|19.0||||||
4041469|NCT01121666|3863387|B1|Spain||Region of Enrollment||participants|Number|33|33.0||||||
4041470|NCT01121666|3863385|B3|Denmark||Region of Enrollment||participants|Number|112|112.0||||||
4041471|NCT01121666|3863386|B2|Denmark||Region of Enrollment||participants|Number|37|37.0||||||
4041472|NCT01121666|3863387|B1|Denmark||Region of Enrollment||participants|Number|75|75.0||||||
4041473|NCT01121666|3863385|B3|Austria||Region of Enrollment||participants|Number|131|131.0||||||
4041474|NCT01121666|3863386|B2|Austria||Region of Enrollment||participants|Number|43|43.0||||||
4041475|NCT01121666|3863387|B1|Austria||Region of Enrollment||participants|Number|88|88.0||||||
4041476|NCT01121666|3863385|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4041477|NCT01121666|3863386|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4041478|NCT01121666|3863387|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4041479|NCT01121666|3863385|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041480|NCT01121666|3863386|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041481|NCT01121666|3863387|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041482|NCT01121666|3863385|B3||White|Race (NIH/OMB)||Participants|Count of Participants|346|346.0||||||
4041483|NCT01121666|3863386|B2||White|Race (NIH/OMB)||Participants|Count of Participants|117|117.0||||||
4041484|NCT01121666|3863387|B1||White|Race (NIH/OMB)||Participants|Count of Participants|229|229.0||||||
4041485|NCT01121666|3863385|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4041486|NCT01121666|3863386|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4041487|NCT01121666|3863387|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4041488|NCT01121666|3863385|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041489|NCT01121666|3863386|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041490|NCT01121666|3863387|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041491|NCT01121666|3863385|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4041492|NCT01121666|3863386|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4041493|NCT01121666|3863387|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4041494|NCT01121666|3863385|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041495|NCT01121666|3863386|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041496|NCT01121666|3863387|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041497|NCT01121666|3863385|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4041498|NCT01121666|3863386|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4041499|NCT01121666|3863387|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4041500|NCT01121666|3863385|B3||Female|Sex: Female, Male||Participants|Count of Participants|372|372.0||||||
4041501|NCT01121666|3863386|B2||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4041502|NCT01121666|3863387|B1||Female|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
4041503|NCT01121666|3863385|B3|||Age||years|Mean|31.95|31.95|Standard Deviation|3.90|3.9|||
4041504|NCT01121666|3863386|B2|||Age||years|Mean|32.1|32.1|Standard Deviation|3.76|3.76|||
4041505|NCT01121666|3863387|B1|||Age||years|Mean|31.8|31.8|Standard Deviation|4.02|4.02|||
4041506|NCT01121575|3863438|B7||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4041507|NCT01121575|3863439|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4041508|NCT01121575|3863440|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4041509|NCT01121575|3863441|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4041510|NCT01121575|3863442|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4041511|NCT01121575|3863443|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4041512|NCT01121575|3863444|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4041513|NCT01121575|3863438|B7||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4041514|NCT01121575|3863439|B6||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4041515|NCT01121575|3863440|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4041516|NCT01121575|3863441|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4041517|NCT01121575|3863442|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4041518|NCT01121575|3863443|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4041519|NCT01121575|3863444|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4041520|NCT01121575|3863438|B7|||Age||Years|Mean|59.1|59.1|Standard Deviation|11.05|11.05|||
4041521|NCT01121575|3863439|B6|||Age||Years|Mean|59.6|59.6|Standard Deviation|11.74|11.74|||
4041522|NCT01121575|3863440|B5|||Age||Years|Mean|61.8|61.8|Standard Deviation|10.83|10.83|||
4041523|NCT01121575|3863441|B4|||Age||Years|Mean|62.2|62.2|Standard Deviation|13.61|13.61|||
4041524|NCT01121575|3863442|B3|||Age||Years|Mean|54.7|54.7|Standard Deviation|11.34|11.34|||
4041525|NCT01121575|3863443|B2|||Age||Years|Mean|61.7|61.7|Standard Deviation|7.53|7.53|||
4041526|NCT01121575|3863444|B1|||Age||Years|Mean|53.6|53.6|Standard Deviation|9.87|9.87|||
4041527|NCT01121562|3863573|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4041528|NCT01121562|3863573|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4041529|NCT01121562|3863573|B1|||Age||years|Mean|54.1|54.1|Standard Deviation|13.0|13.0|||
4041530|NCT01121549|3863582|B1|||Number of Participants With Prior Radiation Therapy|A total 271 participants were evaluable for this measure.|participants|Number|239|239.0||||||
4041531|NCT01121549|3863582|B1|||Number of Participants With Prior Chemotherapy||participants|Number|0|0.0||||||
4041532|NCT01121549|3863582|B1|Missing/No Response||Number of Participants With Histopathological Grade|The grade of a cancer depends on what the cells look like and the growth-rate. Lower grade indicates a slower-growing cancer and a higher grade indicates a faster-growing one. Grade 1 (resemble normal cells, not growing rapidly), Grade 2 (grow faster than normal cells), Grade 3 and 4 (abnormal cells, grow and spread aggressively).|participants|Number|3|3.0||||||
4041533|NCT01121549|3863582|B1|Unknown||Number of Participants With Histopathological Grade|The grade of a cancer depends on what the cells look like and the growth-rate. Lower grade indicates a slower-growing cancer and a higher grade indicates a faster-growing one. Grade 1 (resemble normal cells, not growing rapidly), Grade 2 (grow faster than normal cells), Grade 3 and 4 (abnormal cells, grow and spread aggressively).|participants|Number|70|70.0||||||
4041534|NCT01121549|3863582|B1|Grade 3||Number of Participants With Histopathological Grade|The grade of a cancer depends on what the cells look like and the growth-rate. Lower grade indicates a slower-growing cancer and a higher grade indicates a faster-growing one. Grade 1 (resemble normal cells, not growing rapidly), Grade 2 (grow faster than normal cells), Grade 3 and 4 (abnormal cells, grow and spread aggressively).|participants|Number|65|65.0||||||
4041535|NCT01121549|3863582|B1|Grade 2||Number of Participants With Histopathological Grade|The grade of a cancer depends on what the cells look like and the growth-rate. Lower grade indicates a slower-growing cancer and a higher grade indicates a faster-growing one. Grade 1 (resemble normal cells, not growing rapidly), Grade 2 (grow faster than normal cells), Grade 3 and 4 (abnormal cells, grow and spread aggressively).|participants|Number|178|178.0||||||
4041536|NCT01121549|3863582|B1|Grade 1||Number of Participants With Histopathological Grade|The grade of a cancer depends on what the cells look like and the growth-rate. Lower grade indicates a slower-growing cancer and a higher grade indicates a faster-growing one. Grade 1 (resemble normal cells, not growing rapidly), Grade 2 (grow faster than normal cells), Grade 3 and 4 (abnormal cells, grow and spread aggressively).|participants|Number|62|62.0||||||
4041537|NCT01121549|3863582|B1|Missing/No Response||Number of Participants With Tumor Node Metastasis (TNM) Stage|TNM was based on size of tumor, if cancer cells had spread to nearby lymph nodes (LN), or distant (to other parts of the body) metastasis had occurred. Stages included: stage 0(no evidence of cancer cells), stage 1(T1N0M0), stage IIA(T0N1M0, T1N1M0, T2N0M0), stage IIB(T2N1M0, T3N0M0), stage IIIA(T0N2M0, T1N2M0, T2N3M0, T3N1orN2M0), stage IIIC(any TN3M0), stage IV(anyT anyNM1), where T0=early form of tumor, T1= <2 centimeter(cm), T2=2-5 cm, T3= >2 cm, T4=large sized tumor, N0=not spread to LN, N1=spread to 1 to 3, N2=spread to 4 to 9, N3=spread >10 axillary LN, M0=no metastasis, M1= Metastasis.|participants|Number|6|6.0||||||
4041538|NCT01121549|3863582|B1|Other||Number of Participants With Tumor Node Metastasis (TNM) Stage|TNM was based on size of tumor, if cancer cells had spread to nearby lymph nodes (LN), or distant (to other parts of the body) metastasis had occurred. Stages included: stage 0(no evidence of cancer cells), stage 1(T1N0M0), stage IIA(T0N1M0, T1N1M0, T2N0M0), stage IIB(T2N1M0, T3N0M0), stage IIIA(T0N2M0, T1N2M0, T2N3M0, T3N1orN2M0), stage IIIC(any TN3M0), stage IV(anyT anyNM1), where T0=early form of tumor, T1= <2 centimeter(cm), T2=2-5 cm, T3= >2 cm, T4=large sized tumor, N0=not spread to LN, N1=spread to 1 to 3, N2=spread to 4 to 9, N3=spread >10 axillary LN, M0=no metastasis, M1= Metastasis.|participants|Number|2|2.0||||||
4041539|NCT01121549|3863582|B1|Stage IIIC||Number of Participants With Tumor Node Metastasis (TNM) Stage|TNM was based on size of tumor, if cancer cells had spread to nearby lymph nodes (LN), or distant (to other parts of the body) metastasis had occurred. Stages included: stage 0(no evidence of cancer cells), stage 1(T1N0M0), stage IIA(T0N1M0, T1N1M0, T2N0M0), stage IIB(T2N1M0, T3N0M0), stage IIIA(T0N2M0, T1N2M0, T2N3M0, T3N1orN2M0), stage IIIC(any TN3M0), stage IV(anyT anyNM1), where T0=early form of tumor, T1= <2 centimeter(cm), T2=2-5 cm, T3= >2 cm, T4=large sized tumor, N0=not spread to LN, N1=spread to 1 to 3, N2=spread to 4 to 9, N3=spread >10 axillary LN, M0=no metastasis, M1= Metastasis.|participants|Number|2|2.0||||||
4041540|NCT01121549|3863582|B1|Stage IIIB||Number of Participants With Tumor Node Metastasis (TNM) Stage|TNM was based on size of tumor, if cancer cells had spread to nearby lymph nodes (LN), or distant (to other parts of the body) metastasis had occurred. Stages included: stage 0(no evidence of cancer cells), stage 1(T1N0M0), stage IIA(T0N1M0, T1N1M0, T2N0M0), stage IIB(T2N1M0, T3N0M0), stage IIIA(T0N2M0, T1N2M0, T2N3M0, T3N1orN2M0), stage IIIC(any TN3M0), stage IV(anyT anyNM1), where T0=early form of tumor, T1= <2 centimeter(cm), T2=2-5 cm, T3= >2 cm, T4=large sized tumor, N0=not spread to LN, N1=spread to 1 to 3, N2=spread to 4 to 9, N3=spread >10 axillary LN, M0=no metastasis, M1= Metastasis.|participants|Number|16|16.0||||||
4041541|NCT01121549|3863582|B1|Stage IIIA||Number of Participants With Tumor Node Metastasis (TNM) Stage|TNM was based on size of tumor, if cancer cells had spread to nearby lymph nodes (LN), or distant (to other parts of the body) metastasis had occurred. Stages included: stage 0(no evidence of cancer cells), stage 1(T1N0M0), stage IIA(T0N1M0, T1N1M0, T2N0M0), stage IIB(T2N1M0, T3N0M0), stage IIIA(T0N2M0, T1N2M0, T2N3M0, T3N1orN2M0), stage IIIC(any TN3M0), stage IV(anyT anyNM1), where T0=early form of tumor, T1= <2 centimeter(cm), T2=2-5 cm, T3= >2 cm, T4=large sized tumor, N0=not spread to LN, N1=spread to 1 to 3, N2=spread to 4 to 9, N3=spread >10 axillary LN, M0=no metastasis, M1= Metastasis.|participants|Number|67|67.0||||||
4041542|NCT01121549|3863582|B1|Stage IIB||Number of Participants With Tumor Node Metastasis (TNM) Stage|TNM was based on size of tumor, if cancer cells had spread to nearby lymph nodes (LN), or distant (to other parts of the body) metastasis had occurred. Stages included: stage 0(no evidence of cancer cells), stage 1(T1N0M0), stage IIA(T0N1M0, T1N1M0, T2N0M0), stage IIB(T2N1M0, T3N0M0), stage IIIA(T0N2M0, T1N2M0, T2N3M0, T3N1orN2M0), stage IIIC(any TN3M0), stage IV(anyT anyNM1), where T0=early form of tumor, T1= <2 centimeter(cm), T2=2-5 cm, T3= >2 cm, T4=large sized tumor, N0=not spread to LN, N1=spread to 1 to 3, N2=spread to 4 to 9, N3=spread >10 axillary LN, M0=no metastasis, M1= Metastasis.|participants|Number|92|92.0||||||
4041543|NCT01121549|3863582|B1|Stage IIA||Number of Participants With Tumor Node Metastasis (TNM) Stage|TNM was based on size of tumor, if cancer cells had spread to nearby lymph nodes (LN), or distant (to other parts of the body) metastasis had occurred. Stages included: stage 0(no evidence of cancer cells), stage 1(T1N0M0), stage IIA(T0N1M0, T1N1M0, T2N0M0), stage IIB(T2N1M0, T3N0M0), stage IIIA(T0N2M0, T1N2M0, T2N3M0, T3N1orN2M0), stage IIIC(any TN3M0), stage IV(anyT anyNM1), where T0=early form of tumor, T1= <2 centimeter(cm), T2=2-5 cm, T3= >2 cm, T4=large sized tumor, N0=not spread to LN, N1=spread to 1 to 3, N2=spread to 4 to 9, N3=spread >10 axillary LN, M0=no metastasis, M1= Metastasis.|participants|Number|129|129.0||||||
4041544|NCT01121549|3863582|B1|Stage I||Number of Participants With Tumor Node Metastasis (TNM) Stage|TNM was based on size of tumor, if cancer cells had spread to nearby lymph nodes (LN), or distant (to other parts of the body) metastasis had occurred. Stages included: stage 0(no evidence of cancer cells), stage 1(T1N0M0), stage IIA(T0N1M0, T1N1M0, T2N0M0), stage IIB(T2N1M0, T3N0M0), stage IIIA(T0N2M0, T1N2M0, T2N3M0, T3N1orN2M0), stage IIIC(any TN3M0), stage IV(anyT anyNM1), where T0=early form of tumor, T1= <2 centimeter(cm), T2=2-5 cm, T3= >2 cm, T4=large sized tumor, N0=not spread to LN, N1=spread to 1 to 3, N2=spread to 4 to 9, N3=spread >10 axillary LN, M0=no metastasis, M1= Metastasis.|participants|Number|64|64.0||||||
4041545|NCT01121549|3863582|B1|||Number of Participants With Lymph Node Involvement||participants|Number|NA|||||||Data for this measure could not be analyzed because case report forms did not provide data for accurate assessment of lymph node involvement.
4041546|NCT01121549|3863582|B1|||Number of Participants With Estrogen Receptor Positive|Participants whose tumor was estrogen receptor positive are reported.|participants|Number|378|378.0||||||
4041547|NCT01121549|3863582|B1|Splenectomy||Number of Participants With Type of Surgery|Number of participants who had undergone different type of surgeries which included appendicectomy, breast lump removal, cataract operation, cholecystectomy, hysterectomy, intervertebral disc operation, malignant tumor excision, salpingo-oophorectomy bilateral, and splenectomy.|participants|Number|1|1.0||||||
4041548|NCT01121549|3863582|B1|Salpingo-oophorectomy bilateral||Number of Participants With Type of Surgery|Number of participants who had undergone different type of surgeries which included appendicectomy, breast lump removal, cataract operation, cholecystectomy, hysterectomy, intervertebral disc operation, malignant tumor excision, salpingo-oophorectomy bilateral, and splenectomy.|participants|Number|1|1.0||||||
4041549|NCT01121549|3863582|B1|Malignant tumor excision||Number of Participants With Type of Surgery|Number of participants who had undergone different type of surgeries which included appendicectomy, breast lump removal, cataract operation, cholecystectomy, hysterectomy, intervertebral disc operation, malignant tumor excision, salpingo-oophorectomy bilateral, and splenectomy.|participants|Number|1|1.0||||||
4041661|NCT01121263|3863729|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4041550|NCT01121549|3863582|B1|Intervertebral disc operation||Number of Participants With Type of Surgery|Number of participants who had undergone different type of surgeries which included appendicectomy, breast lump removal, cataract operation, cholecystectomy, hysterectomy, intervertebral disc operation, malignant tumor excision, salpingo-oophorectomy bilateral, and splenectomy.|participants|Number|1|1.0||||||
4041551|NCT01121549|3863582|B1|Hysterectomy||Number of Participants With Type of Surgery|Number of participants who had undergone different type of surgeries which included appendicectomy, breast lump removal, cataract operation, cholecystectomy, hysterectomy, intervertebral disc operation, malignant tumor excision, salpingo-oophorectomy bilateral, and splenectomy.|participants|Number|3|3.0||||||
4041552|NCT01121549|3863582|B1|Cholecystectomy||Number of Participants With Type of Surgery|Number of participants who had undergone different type of surgeries which included appendicectomy, breast lump removal, cataract operation, cholecystectomy, hysterectomy, intervertebral disc operation, malignant tumor excision, salpingo-oophorectomy bilateral, and splenectomy.|participants|Number|17|17.0||||||
4041553|NCT01121549|3863582|B1|Cataract operation||Number of Participants With Type of Surgery|Number of participants who had undergone different type of surgeries which included appendicectomy, breast lump removal, cataract operation, cholecystectomy, hysterectomy, intervertebral disc operation, malignant tumor excision, salpingo-oophorectomy bilateral, and splenectomy.|participants|Number|1|1.0||||||
4041554|NCT01121549|3863582|B1|Breast lump removal||Number of Participants With Type of Surgery|Number of participants who had undergone different type of surgeries which included appendicectomy, breast lump removal, cataract operation, cholecystectomy, hysterectomy, intervertebral disc operation, malignant tumor excision, salpingo-oophorectomy bilateral, and splenectomy.|participants|Number|1|1.0||||||
4041555|NCT01121549|3863582|B1|Appendicectomy||Number of Participants With Type of Surgery|Number of participants who had undergone different type of surgeries which included appendicectomy, breast lump removal, cataract operation, cholecystectomy, hysterectomy, intervertebral disc operation, malignant tumor excision, salpingo-oophorectomy bilateral, and splenectomy.|participants|Number|6|6.0||||||
4041556|NCT01121549|3863582|B1|Missing/No Response||Number of Participants With Type of Tumor|Number of participants with different types of tumor such as; ductal carcinoma, lobular carcinoma, invasive ductal carcinoma, invasive lobular carcinoma, papillary carcinoma, medullary carcinoma, mucinous (colloid) carcinoma and others.|participants|Number|16|16.0||||||
4041557|NCT01121549|3863582|B1|Other||Number of Participants With Type of Tumor|Number of participants with different types of tumor such as; ductal carcinoma, lobular carcinoma, invasive ductal carcinoma, invasive lobular carcinoma, papillary carcinoma, medullary carcinoma, mucinous (colloid) carcinoma and others.|participants|Number|24|24.0||||||
4041558|NCT01121549|3863582|B1|Mucinous (Colloid) Carcinoma||Number of Participants With Type of Tumor|Number of participants with different types of tumor such as; ductal carcinoma, lobular carcinoma, invasive ductal carcinoma, invasive lobular carcinoma, papillary carcinoma, medullary carcinoma, mucinous (colloid) carcinoma and others.|participants|Number|5|5.0||||||
4041559|NCT01121549|3863582|B1|Medullary Carcinoma||Number of Participants With Type of Tumor|Number of participants with different types of tumor such as; ductal carcinoma, lobular carcinoma, invasive ductal carcinoma, invasive lobular carcinoma, papillary carcinoma, medullary carcinoma, mucinous (colloid) carcinoma and others.|participants|Number|1|1.0||||||
4041560|NCT01121549|3863582|B1|Papillary Carcinoma||Number of Participants With Type of Tumor|Number of participants with different types of tumor such as; ductal carcinoma, lobular carcinoma, invasive ductal carcinoma, invasive lobular carcinoma, papillary carcinoma, medullary carcinoma, mucinous (colloid) carcinoma and others.|participants|Number|2|2.0||||||
4041561|NCT01121549|3863582|B1|Invasive Lobular Carcinoma||Number of Participants With Type of Tumor|Number of participants with different types of tumor such as; ductal carcinoma, lobular carcinoma, invasive ductal carcinoma, invasive lobular carcinoma, papillary carcinoma, medullary carcinoma, mucinous (colloid) carcinoma and others.|participants|Number|22|22.0||||||
4041562|NCT01121549|3863582|B1|Invasive Ductal Carcinoma||Number of Participants With Type of Tumor|Number of participants with different types of tumor such as; ductal carcinoma, lobular carcinoma, invasive ductal carcinoma, invasive lobular carcinoma, papillary carcinoma, medullary carcinoma, mucinous (colloid) carcinoma and others.|participants|Number|246|246.0||||||
4041563|NCT01121549|3863582|B1|Lobular Carcinoma||Number of Participants With Type of Tumor|Number of participants with different types of tumor such as; ductal carcinoma, lobular carcinoma, invasive ductal carcinoma, invasive lobular carcinoma, papillary carcinoma, medullary carcinoma, mucinous (colloid) carcinoma and others.|participants|Number|4|4.0||||||
4041564|NCT01121549|3863582|B1|Ductal Carcinoma||Number of Participants With Type of Tumor|Number of participants with different types of tumor such as; ductal carcinoma, lobular carcinoma, invasive ductal carcinoma, invasive lobular carcinoma, papillary carcinoma, medullary carcinoma, mucinous (colloid) carcinoma and others.|participants|Number|58|58.0||||||
4041565|NCT01121549|3863582|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4041566|NCT01121549|3863582|B1||Female|Sex: Female, Male||Participants|Count of Participants|378|378.0||||||
4041567|NCT01121549|3863582|B1|||Age||years|Mean|58.3|58.3|Standard Deviation|9.6|9.6|||
4041568|NCT01121536|3863593|B1|||Body Mass Index||kg/m^2|Mean|29.4|29.4|Standard Deviation|6.43|6.43|||
4041569|NCT01121536|3863593|B1|||Height||cm|Mean|168.8|168.8|Standard Deviation|9.54|9.54|||
4041570|NCT01121536|3863593|B1|||Weight||kg|Mean|83.7|83.7|Standard Deviation|19.75|19.75|||
4041571|NCT01121536|3863593|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4041572|NCT01121536|3863593|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041573|NCT01121536|3863593|B1||White|Race (NIH/OMB)||Participants|Count of Participants|709|709.0||||||
4041574|NCT01121536|3863593|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|118|118.0||||||
4041575|NCT01121536|3863593|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4041576|NCT01121536|3863593|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4041577|NCT01121536|3863593|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4041578|NCT01121536|3863593|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4041579|NCT01121536|3863593|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|752|752.0||||||
4041580|NCT01121536|3863593|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
4041581|NCT01121536|3863593|B1||Male|Sex: Female, Male||Participants|Count of Participants|342|342.0||||||
4041582|NCT01121536|3863593|B1||Female|Sex: Female, Male||Participants|Count of Participants|525|525.0||||||
4041583|NCT01121536|3863593|B1|||Age||years|Mean|44.2|44.2|Standard Deviation|10.96|10.96|||
4041584|NCT01121484|3863612|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4041585|NCT01121484|3863613|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4041586|NCT01121484|3863614|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4041587|NCT01121484|3863612|B3||Female|Sex: Female, Male||Participants|Count of Participants|434|434.0||||||
4041588|NCT01121484|3863613|B2||Female|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
4041589|NCT01121484|3863614|B1||Female|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
4041590|NCT01121484|3863612|B3|||Age||Years|Mean|53.0|53.0|Standard Deviation|6.71|6.71|||
4041591|NCT01121484|3863613|B2|||Age||Years|Mean|52.8|52.8|Standard Deviation|6.58|6.58|||
4041592|NCT01121484|3863614|B1|||Age||Years|Mean|53.1|53.1|Standard Deviation|6.85|6.85|||
4041593|NCT01121406|3863631|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4041594|NCT01121406|3863632|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4041595|NCT01121406|3863633|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4041596|NCT01121406|3863631|B3||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4041597|NCT01121406|3863632|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4041598|NCT01121406|3863633|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4041599|NCT01121406|3863631|B3|||Age||years|Mean|61.1|61.1|Standard Deviation|9.53|9.53|||
4041600|NCT01121406|3863632|B2|||Age||years|Mean|60.9|60.9|Standard Deviation|9.26|9.26|||
4041601|NCT01121406|3863633|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|9.88|9.88|||
4041602|NCT01121393|3863682|B3||ECOG PS 1 (baseline)|Eastern Cooperative Oncology Group (ECOG) performance status (PS)|ECOG PS measured on 6 point scale to assess participant's performance status. 0=Fully active, able to carry on all pre-disease activities without restriction; 1=Restricted in physically strenuous activity, but ambulatory and able to carry out light or sedentary work; 2=Ambulatory (>50 percent of waking hours), capable of all selfcare, unable to carry out any work activities; 3=Capable of only limited self care, confined to bed or chair more then 50 percent of waking hours; 4=Completely disabled, cannot carry on any selfcare, totally confined to bed or chair; 5=Dead|Participants|Count of Participants|275|275.0||||||
4041603|NCT01121393|3863683|B2||ECOG PS 1 (baseline)|Eastern Cooperative Oncology Group (ECOG) performance status (PS)|ECOG PS measured on 6 point scale to assess participant's performance status. 0=Fully active, able to carry on all pre-disease activities without restriction; 1=Restricted in physically strenuous activity, but ambulatory and able to carry out light or sedentary work; 2=Ambulatory (>50 percent of waking hours), capable of all selfcare, unable to carry out any work activities; 3=Capable of only limited self care, confined to bed or chair more then 50 percent of waking hours; 4=Completely disabled, cannot carry on any selfcare, totally confined to bed or chair; 5=Dead|Participants|Count of Participants|81|81.0||||||
4041604|NCT01121393|3863684|B1||ECOG PS 1 (baseline)|Eastern Cooperative Oncology Group (ECOG) performance status (PS)|ECOG PS measured on 6 point scale to assess participant's performance status. 0=Fully active, able to carry on all pre-disease activities without restriction; 1=Restricted in physically strenuous activity, but ambulatory and able to carry out light or sedentary work; 2=Ambulatory (>50 percent of waking hours), capable of all selfcare, unable to carry out any work activities; 3=Capable of only limited self care, confined to bed or chair more then 50 percent of waking hours; 4=Completely disabled, cannot carry on any selfcare, totally confined to bed or chair; 5=Dead|Participants|Count of Participants|194|194.0||||||
4041605|NCT01121393|3863682|B3||ECOG PS 0 (baseline)|Eastern Cooperative Oncology Group (ECOG) performance status (PS)|ECOG PS measured on 6 point scale to assess participant's performance status. 0=Fully active, able to carry on all pre-disease activities without restriction; 1=Restricted in physically strenuous activity, but ambulatory and able to carry out light or sedentary work; 2=Ambulatory (>50 percent of waking hours), capable of all selfcare, unable to carry out any work activities; 3=Capable of only limited self care, confined to bed or chair more then 50 percent of waking hours; 4=Completely disabled, cannot carry on any selfcare, totally confined to bed or chair; 5=Dead|Participants|Count of Participants|89|89.0||||||
4041606|NCT01121393|3863683|B2||ECOG PS 0 (baseline)|Eastern Cooperative Oncology Group (ECOG) performance status (PS)|ECOG PS measured on 6 point scale to assess participant's performance status. 0=Fully active, able to carry on all pre-disease activities without restriction; 1=Restricted in physically strenuous activity, but ambulatory and able to carry out light or sedentary work; 2=Ambulatory (>50 percent of waking hours), capable of all selfcare, unable to carry out any work activities; 3=Capable of only limited self care, confined to bed or chair more then 50 percent of waking hours; 4=Completely disabled, cannot carry on any selfcare, totally confined to bed or chair; 5=Dead|Participants|Count of Participants|41|41.0||||||
4041607|NCT01121393|3863684|B1||ECOG PS 0 (baseline)|Eastern Cooperative Oncology Group (ECOG) performance status (PS)|ECOG PS measured on 6 point scale to assess participant's performance status. 0=Fully active, able to carry on all pre-disease activities without restriction; 1=Restricted in physically strenuous activity, but ambulatory and able to carry out light or sedentary work; 2=Ambulatory (>50 percent of waking hours), capable of all selfcare, unable to carry out any work activities; 3=Capable of only limited self care, confined to bed or chair more then 50 percent of waking hours; 4=Completely disabled, cannot carry on any selfcare, totally confined to bed or chair; 5=Dead|Participants|Count of Participants|48|48.0||||||
4041608|NCT01121393|3863682|B3||Other|Epidermal growth factor receptor (EGFR)|EGFR mutation group (L858R / Deletion Exon 19 / other) was a stratification factor.|Participants|Count of Participants|40|40.0||||||
4041609|NCT01121393|3863683|B2||Other|Epidermal growth factor receptor (EGFR)|EGFR mutation group (L858R / Deletion Exon 19 / other) was a stratification factor.|Participants|Count of Participants|14|14.0||||||
4041610|NCT01121393|3863684|B1||Other|Epidermal growth factor receptor (EGFR)|EGFR mutation group (L858R / Deletion Exon 19 / other) was a stratification factor.|Participants|Count of Participants|26|26.0||||||
4041611|NCT01121393|3863682|B3||Deletion Exon 19 (alone)|Epidermal growth factor receptor (EGFR)|EGFR mutation group (L858R / Deletion Exon 19 / other) was a stratification factor.|Participants|Count of Participants|186|186.0||||||
4041612|NCT01121393|3863683|B2||Deletion Exon 19 (alone)|Epidermal growth factor receptor (EGFR)|EGFR mutation group (L858R / Deletion Exon 19 / other) was a stratification factor.|Participants|Count of Participants|62|62.0||||||
4041613|NCT01121393|3863684|B1||Deletion Exon 19 (alone)|Epidermal growth factor receptor (EGFR)|EGFR mutation group (L858R / Deletion Exon 19 / other) was a stratification factor.|Participants|Count of Participants|124|124.0||||||
4041614|NCT01121393|3863682|B3||L858R (L858R alone and L858R + Deletion Exon 19)|Epidermal growth factor receptor (EGFR)|EGFR mutation group (L858R / Deletion Exon 19 / other) was a stratification factor.|Participants|Count of Participants|138|138.0||||||
4041615|NCT01121393|3863683|B2||L858R (L858R alone and L858R + Deletion Exon 19)|Epidermal growth factor receptor (EGFR)|EGFR mutation group (L858R / Deletion Exon 19 / other) was a stratification factor.|Participants|Count of Participants|46|46.0||||||
4041616|NCT01121393|3863684|B1||L858R (L858R alone and L858R + Deletion Exon 19)|Epidermal growth factor receptor (EGFR)|EGFR mutation group (L858R / Deletion Exon 19 / other) was a stratification factor.|Participants|Count of Participants|92|92.0||||||
4041617|NCT01121393|3863682|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4041618|NCT01121393|3863682|B3||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4041619|NCT01121393|3863683|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4041620|NCT01121393|3863684|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4041621|NCT01121393|3863682|B3||Female|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
4041622|NCT01121393|3863683|B2||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4041623|NCT01121393|3863684|B1||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4041624|NCT01121393|3863682|B3|||Age||Years|Mean|56.4|56.4|Standard Deviation|10.9|10.9|||
4041625|NCT01121393|3863683|B2|||Age||Years|Mean|55.6|55.6|Standard Deviation|10.1|10.1|||
4041626|NCT01121393|3863684|B1|||Age||Years|Mean|56.7|56.7|Standard Deviation|11.2|11.2|||
4041627|NCT01121263|3863728|B3|United States||Region of Enrollment||participants|Number|298|298.0||||||
4041628|NCT01121263|3863729|B2|United States||Region of Enrollment||participants|Number|98|98.0||||||
4041629|NCT01121263|3863730|B1|United States||Region of Enrollment||participants|Number|200|200.0||||||
4041630|NCT01121263|3863728|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4041631|NCT01121263|3863729|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4041632|NCT01121263|3863730|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4041633|NCT01121263|3863728|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041634|NCT01121263|3863729|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041635|NCT01121263|3863730|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041636|NCT01121263|3863728|B3||White|Race (NIH/OMB)||Participants|Count of Participants|244|244.0||||||
4041637|NCT01121263|3863729|B2||White|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
4041638|NCT01121263|3863730|B1||White|Race (NIH/OMB)||Participants|Count of Participants|161|161.0||||||
4041639|NCT01121263|3863728|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4041640|NCT01121263|3863729|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4041641|NCT01121263|3863730|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4041642|NCT01121263|3863728|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4041643|NCT01121263|3863729|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041644|NCT01121263|3863730|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4041645|NCT01121263|3863728|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4041646|NCT01121263|3863729|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4041647|NCT01121263|3863730|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4041648|NCT01121263|3863728|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041649|NCT01121263|3863729|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041650|NCT01121263|3863730|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041651|NCT01121263|3863728|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4041652|NCT01121263|3863729|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4041653|NCT01121263|3863730|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4041654|NCT01121263|3863728|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|266|266.0||||||
4041655|NCT01121263|3863729|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
4041656|NCT01121263|3863730|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|183|183.0||||||
4041657|NCT01121263|3863728|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4041658|NCT01121263|3863729|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4041659|NCT01121263|3863730|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4041660|NCT01121263|3863728|B3||Male|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4041662|NCT01121263|3863730|B1||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4041663|NCT01121263|3863728|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4041664|NCT01121263|3863729|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4041665|NCT01121263|3863730|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4041666|NCT01121263|3863728|B3|Age||Age||years|Mean|64.24|64.24|Standard Deviation|11.46|11.46|||
4041667|NCT01121263|3863729|B2|Age||Age||years|Mean|63.91|63.91|Standard Deviation|10.82|10.82|||
4041668|NCT01121263|3863730|B1|Age||Age||years|Mean|64.41|64.41|Standard Deviation|11.78|11.78|||
4041669|NCT01121250|3863739|B4|United States||Region of Enrollment||Participants|Count of Participants|227|227.0||||||
4041670|NCT01121250|3863740|B3|United States||Region of Enrollment||Participants|Count of Participants|75|75.0||||||
4041671|NCT01121250|3863741|B2|United States||Region of Enrollment||Participants|Count of Participants|76|76.0||||||
4041672|NCT01121250|3863742|B1|United States||Region of Enrollment||Participants|Count of Participants|76|76.0||||||
4041673|NCT01121250|3863739|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4041674|NCT01121250|3863740|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4041675|NCT01121250|3863741|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4041676|NCT01121250|3863742|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4041677|NCT01121250|3863739|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041678|NCT01121250|3863740|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041679|NCT01121250|3863741|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041680|NCT01121250|3863742|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041681|NCT01121250|3863739|B4||White|Race (NIH/OMB)||Participants|Count of Participants|180|180.0||||||
4041682|NCT01121250|3863740|B3||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4041683|NCT01121250|3863741|B2||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4041684|NCT01121250|3863742|B1||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4041685|NCT01121250|3863739|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4041686|NCT01121250|3863740|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4041687|NCT01121250|3863741|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4041688|NCT01121250|3863742|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4041689|NCT01121250|3863739|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041690|NCT01121250|3863740|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041691|NCT01121250|3863741|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041692|NCT01121250|3863742|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041693|NCT01121250|3863739|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4041694|NCT01121250|3863740|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4041695|NCT01121250|3863741|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4041696|NCT01121250|3863742|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041697|NCT01121250|3863739|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4041698|NCT01121250|3863740|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4041699|NCT01121250|3863741|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041700|NCT01121250|3863742|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4041701|NCT01121250|3863739|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041702|NCT01121250|3863740|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041703|NCT01121250|3863741|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041704|NCT01121250|3863742|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041705|NCT01121250|3863739|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|200|200.0||||||
4041706|NCT01121250|3863740|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4041707|NCT01121250|3863741|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
4041708|NCT01121250|3863742|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4041709|NCT01121250|3863739|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4041710|NCT01121250|3863740|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4041711|NCT01121250|3863741|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4041712|NCT01121250|3863742|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4041713|NCT01121250|3863739|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4041714|NCT01121250|3863740|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4041715|NCT01121250|3863741|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4041716|NCT01121250|3863742|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4041717|NCT01121250|3863739|B4||Female|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
4041718|NCT01121250|3863740|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4041719|NCT01121250|3863741|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4041720|NCT01121250|3863742|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4041721|NCT01121250|3863739|B4|||Age||years|Mean|36.5|36.5|Standard Deviation|8.6|8.6|||
4041722|NCT01121250|3863740|B3|||Age||years|Mean|35.1|35.1|Standard Deviation|8.7|8.7|||
4041723|NCT01121250|3863741|B2|||Age||years|Mean|38.0|38.0|Standard Deviation|8.3|8.3|||
4041724|NCT01121250|3863742|B1|||Age||years|Mean|36.4|36.4|Standard Deviation|8.6|8.6|||
4041725|NCT01121224|3863758|B3|United States||Region of Enrollment||Participants|Count of Participants|597|597.0||||||
4041726|NCT01121224|3863759|B2|United States||Region of Enrollment||Participants|Count of Participants|292|292.0||||||
4041727|NCT01121224|3863760|B1|United States||Region of Enrollment||Participants|Count of Participants|305|305.0||||||
4041728|NCT01121224|3863758|B3||Not Answered|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4041729|NCT01121224|3863759|B2||Not Answered|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4041730|NCT01121224|3863760|B1||Not Answered|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4041731|NCT01121224|3863758|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
4041732|NCT01121224|3863759|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4041733|NCT01121224|3863760|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4041734|NCT01121224|3863758|B3||Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|49|49.0||||||
4041735|NCT01121224|3863759|B2||Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4041736|NCT01121224|3863760|B1||Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
4041737|NCT01121224|3863758|B3||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|517|517.0||||||
4041738|NCT01121224|3863759|B2||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|263|263.0||||||
4041739|NCT01121224|3863760|B1||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|254|254.0||||||
4041740|NCT01121224|3863758|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4041741|NCT01121224|3863759|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4041742|NCT01121224|3863760|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4041743|NCT01121224|3863758|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|556|556.0||||||
4041744|NCT01121224|3863759|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|270|270.0||||||
4041745|NCT01121224|3863760|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|286|286.0||||||
4041746|NCT01121224|3863758|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4041747|NCT01121224|3863759|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4041748|NCT01121224|3863760|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4041749|NCT01121224|3863758|B3||Male|Sex: Female, Male||Participants|Count of Participants|595|595.0||||||
4041750|NCT01121224|3863759|B2||Male|Sex: Female, Male||Participants|Count of Participants|290|290.0||||||
4041751|NCT01121224|3863760|B1||Male|Sex: Female, Male||Participants|Count of Participants|305|305.0||||||
4041752|NCT01121224|3863758|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4041753|NCT01121224|3863759|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4041754|NCT01121224|3863760|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4041755|NCT01121224|3863758|B3|||Age||years|Mean|68.6|68.6|Standard Deviation|7.6|7.6|||
4041756|NCT01121224|3863759|B2|||Age||years|Mean|69.0|69.0|Standard Deviation|7.4|7.4|||
4041757|NCT01121224|3863760|B1|||Age||years|Mean|68.2|68.2|Standard Deviation|7.7|7.7|||
4041758|NCT01121211|3863783|B3|United States||Region of Enrollment||Participants|Count of Participants|90|90.0||||||
4041759|NCT01121211|3863784|B2|United States||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
4041760|NCT01121211|3863785|B1|United States||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
4041761|NCT01121211|3863783|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4041762|NCT01121211|3863784|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4041763|NCT01121211|3863785|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4041764|NCT01121211|3863783|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4041765|NCT01121211|3863784|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4041766|NCT01121211|3863785|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4041767|NCT01121211|3863783|B3|||Age||years|Mean|27|27.0|Standard Deviation|7|7.0|||
4041768|NCT01121211|3863784|B2|||Age||years|Mean|27|27.0|Standard Deviation|7|7.0|||
4041769|NCT01121211|3863785|B1|||Age||years|Mean|28|28.0|Standard Deviation|7|7.0|||
4041770|NCT01121211|3863783|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4041771|NCT01121211|3863784|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4041772|NCT01121211|3863785|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4041773|NCT01121211|3863783|B3||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
4041774|NCT01121211|3863784|B2||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4041775|NCT01121211|3863785|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4041776|NCT01121211|3863783|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4041777|NCT01121211|3863784|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4041778|NCT01121211|3863785|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4041779|NCT01121185|3863794|B3|||Serum HCV RNA concentration||log10 IU/mL|Median|6.03|6.03|Full Range|||4.47|7.19|
4041780|NCT01121185|3863795|B2|||Serum HCV RNA concentration||log10 IU/mL|Median|5.59|5.59|Full Range|||5.12|6.58|
4041781|NCT01121185|3863796|B1|||Serum HCV RNA concentration||log10 IU/mL|Median|6.07|6.07|Full Range|||4.47|7.19|
4041782|NCT01121185|3863794|B3|||Hepatocellular carcinoma||participants|Number|6|6.0||||||
4041783|NCT01121185|3863795|B2|||Hepatocellular carcinoma||participants|Number|2|2.0||||||
4041784|NCT01121185|3863796|B1|||Hepatocellular carcinoma||participants|Number|4|4.0||||||
4041785|NCT01121185|3863794|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4041786|NCT01121185|3863795|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041787|NCT01121185|3863796|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4041788|NCT01121185|3863794|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041789|NCT01121185|3863795|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041790|NCT01121185|3863796|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041791|NCT01121185|3863794|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4041792|NCT01121185|3863795|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4041793|NCT01121185|3863796|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4041794|NCT01121185|3863794|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4041795|NCT01121185|3863795|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041796|NCT01121185|3863796|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4041797|NCT01121185|3863794|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041798|NCT01121185|3863795|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041799|NCT01121185|3863796|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041800|NCT01121185|3863794|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041801|NCT01121185|3863795|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041802|NCT01121185|3863796|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041803|NCT01121185|3863794|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041804|NCT01121185|3863795|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041805|NCT01121185|3863796|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041806|NCT01121185|3863794|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041807|NCT01121185|3863795|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041808|NCT01121185|3863796|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4041809|NCT01121185|3863794|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4041810|NCT01121185|3863795|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4041811|NCT01121185|3863796|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4041812|NCT01121185|3863794|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4041813|NCT01121185|3863795|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4041814|NCT01121185|3863796|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4041815|NCT01121185|3863794|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4041816|NCT01121185|3863795|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4041817|NCT01121185|3863796|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4041818|NCT01121185|3863794|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4041819|NCT01121185|3863795|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4041820|NCT01121185|3863796|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4041821|NCT01121185|3863794|B3|||Age||years|Mean|59.2|59.2|Full Range|||53.5|66.6|
4041822|NCT01121185|3863795|B2|||Age||years|Mean|57.2|57.2|Full Range|||53.5|60.3|
4041823|NCT01121185|3863796|B1|||Age||years|Mean|60.9|60.9|Full Range|||55.9|66.6|
4041824|NCT01121172|3863819|B3|Greece||Region of Enrollment||participants|Number|180|180.0||||||
4041825|NCT01121172|3863820|B2|Greece||Region of Enrollment||participants|Number|90|90.0||||||
4041826|NCT01121172|3863821|B1|Greece||Region of Enrollment||participants|Number|90|90.0||||||
4041827|NCT01121172|3863819|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4041828|NCT01121172|3863820|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4041829|NCT01121172|3863821|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4041830|NCT01121172|3863819|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4041831|NCT01121172|3863820|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4041832|NCT01121172|3863821|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4041833|NCT01121172|3863819|B3|||Age||years|Median|11.6|11.6|Full Range|||2.6|17.8|
4041834|NCT01121172|3863820|B2|||Age||years|Median|11.7|11.7|Full Range|||3.3|17.8|
4041835|NCT01121172|3863821|B1|||Age||years|Median|11.6|11.6|Full Range|||2.6|16.5|
4041836|NCT01121146|3863829|B3|United States||Region of Enrollment||participants|Number|230|230.0||||||
4041837|NCT01121146|3863830|B2|United States||Region of Enrollment||participants|Number|114|114.0||||||
4041838|NCT01121146|3863831|B1|United States||Region of Enrollment||participants|Number|116|116.0||||||
4041839|NCT01121146|3863829|B3||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4041840|NCT01121146|3863830|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4041841|NCT01121146|3863831|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4041842|NCT01121146|3863829|B3||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4041843|NCT01121146|3863830|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4041844|NCT01121146|3863831|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4041845|NCT01121146|3863829|B3|||Age||years|Mean|62.3|62.3|Standard Deviation|10.8|10.8|||
4041846|NCT01121146|3863830|B2|||Age||years|Mean|62.0|62.0|Standard Deviation|11.1|11.1|||
4041847|NCT01121146|3863831|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|10.6|10.6|||
4041848|NCT01120990|3863846|B1|Greece||Region of Enrollment||participants|Number|51|51.0||||||
4041849|NCT01120990|3863846|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4041850|NCT01120990|3863846|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4041851|NCT01120990|3863846|B1|||Age||years|Mean|50.4|50.4|Standard Deviation|16.3|16.3|||
4041852|NCT01120990|3863846|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4041853|NCT01120990|3863846|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4041854|NCT01120990|3863846|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4041855|NCT01120899|3863853|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4041856|NCT01120899|3863853|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4041857|NCT01120899|3863853|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4041858|NCT01120899|3863853|B1|||Age||years|Mean|63.8|63.8|Standard Deviation|9.5|9.5|||
4041859|NCT01120899|3863853|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4041860|NCT01120899|3863853|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4041861|NCT01120899|3863853|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4041862|NCT01120834|3863873|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4041863|NCT01120834|3863873|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4041864|NCT01120834|3863873|B1|||Age||years|Median|66.5|66.5|Full Range|||27.0|83.0|
4041865|NCT01120808|3863877|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4041866|NCT01120808|3863877|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4041867|NCT01120808|3863877|B1|||Age||years|Mean|40|40.0|Standard Deviation|9.4|9.4|||
4041868|NCT01120782|3863881|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4041869|NCT01120782|3863881|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4041870|NCT01120782|3863881|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4041871|NCT01120782|3863881|B1|||Age||years|Mean|29.2|29.2|Standard Deviation|5.10|5.1|||
4041872|NCT01120717|3863885|B3||Male|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
4041873|NCT01120717|3863886|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4041874|NCT01120717|3863887|B1||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4041875|NCT01120717|3863885|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4041876|NCT01120717|3863886|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4041877|NCT01120717|3863887|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4041878|NCT01120717|3863885|B3|||Age||years|Mean|62.6|62.6|Standard Deviation|8.58|8.58|||
4041879|NCT01120717|3863886|B2|||Age||years|Mean|62.9|62.9|Standard Deviation|8.14|8.14|||
4041880|NCT01120717|3863887|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|8.81|8.81|||
4041881|NCT01120704|3863904|B33|United States||Region of Enrollment||participants|Number|544|544.0||||||
4041882|NCT01120704|3863905|B32|United States||Region of Enrollment||participants|Number|18|18.0||||||
4041883|NCT01120704|3863906|B31|United States||Region of Enrollment||participants|Number|14|14.0||||||
4041884|NCT01120704|3863907|B30|United States||Region of Enrollment||participants|Number|15|15.0||||||
4041885|NCT01120704|3863908|B29|United States||Region of Enrollment||participants|Number|19|19.0||||||
4041886|NCT01120704|3863909|B28|United States||Region of Enrollment||participants|Number|18|18.0||||||
4041887|NCT01120704|3863910|B27|United States||Region of Enrollment||participants|Number|18|18.0||||||
4041888|NCT01120704|3863911|B26|United States||Region of Enrollment||participants|Number|14|14.0||||||
4041889|NCT01120704|3863912|B25|United States||Region of Enrollment||participants|Number|18|18.0||||||
4041890|NCT01120704|3863913|B24|United States||Region of Enrollment||participants|Number|16|16.0||||||
4041891|NCT01120704|3863914|B23|United States||Region of Enrollment||participants|Number|21|21.0||||||
4041892|NCT01120704|3863915|B22|United States||Region of Enrollment||participants|Number|16|16.0||||||
4041893|NCT01120704|3863916|B21|United States||Region of Enrollment||participants|Number|17|17.0||||||
4041894|NCT01120704|3863917|B20|United States||Region of Enrollment||participants|Number|18|18.0||||||
4041895|NCT01120704|3863918|B19|United States||Region of Enrollment||participants|Number|17|17.0||||||
4041896|NCT01120704|3863919|B18|United States||Region of Enrollment||participants|Number|16|16.0||||||
4041897|NCT01120704|3863920|B17|United States||Region of Enrollment||participants|Number|14|14.0||||||
4041898|NCT01120704|3863921|B16|United States||Region of Enrollment||participants|Number|18|18.0||||||
4041899|NCT01120704|3863922|B15|United States||Region of Enrollment||participants|Number|18|18.0||||||
4041900|NCT01120704|3863923|B14|United States||Region of Enrollment||participants|Number|19|19.0||||||
4041901|NCT01120704|3863924|B13|United States||Region of Enrollment||participants|Number|17|17.0||||||
4041902|NCT01120704|3863925|B12|United States||Region of Enrollment||participants|Number|16|16.0||||||
4041903|NCT01120704|3863926|B11|United States||Region of Enrollment||participants|Number|17|17.0||||||
4041904|NCT01120704|3863927|B10|United States||Region of Enrollment||participants|Number|20|20.0||||||
4041905|NCT01120704|3863928|B9|United States||Region of Enrollment||participants|Number|22|22.0||||||
4041906|NCT01120704|3863929|B8|United States||Region of Enrollment||participants|Number|15|15.0||||||
4041907|NCT01120704|3863930|B7|United States||Region of Enrollment||participants|Number|15|15.0||||||
4041908|NCT01120704|3863931|B6|United States||Region of Enrollment||participants|Number|19|19.0||||||
4041909|NCT01120704|3863932|B5|United States||Region of Enrollment||participants|Number|16|16.0||||||
4041910|NCT01120704|3863933|B4|United States||Region of Enrollment||participants|Number|19|19.0||||||
4041911|NCT01120704|3863934|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4041912|NCT01120704|3863935|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4041913|NCT01120704|3863936|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4041914|NCT01120704|3863904|B33||Male|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4041915|NCT01120704|3863905|B32||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4041916|NCT01120704|3863906|B31||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4041917|NCT01120704|3863907|B30||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4041918|NCT01120704|3863908|B29||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4041919|NCT01120704|3863909|B28||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4041920|NCT01120704|3863910|B27||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4041921|NCT01120704|3863911|B26||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4041922|NCT01120704|3863912|B25||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4041923|NCT01120704|3863913|B24||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4041924|NCT01120704|3863914|B23||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4041925|NCT01120704|3863915|B22||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4041926|NCT01120704|3863916|B21||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4041927|NCT01120704|3863917|B20||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4041928|NCT01120704|3863918|B19||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4041929|NCT01120704|3863919|B18||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4041930|NCT01120704|3863920|B17||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4041931|NCT01120704|3863921|B16||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4041932|NCT01120704|3863922|B15||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4041933|NCT01120704|3863923|B14||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4041934|NCT01120704|3863924|B13||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4041935|NCT01120704|3863925|B12||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4041936|NCT01120704|3863926|B11||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4041937|NCT01120704|3863927|B10||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4041938|NCT01120704|3863928|B9||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4041939|NCT01120704|3863929|B8||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4041940|NCT01120704|3863930|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4041941|NCT01120704|3863931|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4041942|NCT01120704|3863932|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4041943|NCT01120704|3863933|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4041944|NCT01120704|3863934|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4041945|NCT01120704|3863935|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4041946|NCT01120704|3863936|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4041947|NCT01120704|3863904|B33||Female|Sex: Female, Male||Participants|Count of Participants|321|321.0||||||
4041948|NCT01120704|3863905|B32||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4041949|NCT01120704|3863906|B31||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4041950|NCT01120704|3863907|B30||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4041951|NCT01120704|3863908|B29||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4041952|NCT01120704|3863909|B28||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4041953|NCT01120704|3863910|B27||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4041954|NCT01120704|3863911|B26||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4041955|NCT01120704|3863912|B25||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4041956|NCT01120704|3863913|B24||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4041957|NCT01120704|3863914|B23||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4041958|NCT01120704|3863915|B22||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4041959|NCT01120704|3863916|B21||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4041960|NCT01120704|3863917|B20||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4041961|NCT01120704|3863918|B19||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4041962|NCT01120704|3863919|B18||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4041963|NCT01120704|3863920|B17||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4041964|NCT01120704|3863921|B16||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4041965|NCT01120704|3863922|B15||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4041966|NCT01120704|3863923|B14||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4041967|NCT01120704|3863924|B13||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4041968|NCT01120704|3863925|B12||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4041969|NCT01120704|3863926|B11||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4041970|NCT01120704|3863927|B10||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4041971|NCT01120704|3863928|B9||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4041972|NCT01120704|3863929|B8||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4041973|NCT01120704|3863930|B7||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4041974|NCT01120704|3863931|B6||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4041975|NCT01120704|3863932|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4041976|NCT01120704|3863933|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4041977|NCT01120704|3863934|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4041978|NCT01120704|3863935|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4041979|NCT01120704|3863936|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4041980|NCT01120704|3863904|B33|||Age||years|Mean|46.12|46.12|Standard Deviation|12.76|12.76|||
4041981|NCT01120704|3863905|B32|||Age||years|Mean|46.78|46.78|Standard Deviation|13.12|13.12|||
4041982|NCT01120704|3863906|B31|||Age||years|Mean|47.21|47.21|Standard Deviation|16.61|16.61|||
4041983|NCT01120704|3863907|B30|||Age||years|Mean|45.33|45.33|Standard Deviation|12.69|12.69|||
4041984|NCT01120704|3863908|B29|||Age||years|Mean|39.53|39.53|Standard Deviation|12.25|12.25|||
4041985|NCT01120704|3863909|B28|||Age||years|Mean|45.72|45.72|Standard Deviation|10.60|10.6|||
4041986|NCT01120704|3863910|B27|||Age||years|Mean|42.67|42.67|Standard Deviation|14.20|14.2|||
4041987|NCT01120704|3863911|B26|||Age||years|Mean|41.50|41.5|Standard Deviation|10.71|10.71|||
4041988|NCT01120704|3863912|B25|||Age||years|Mean|45.50|45.5|Standard Deviation|12.71|12.71|||
4041989|NCT01120704|3863913|B24|||Age||years|Mean|39.19|39.19|Standard Deviation|11.64|11.64|||
4041990|NCT01120704|3863914|B23|||Age||years|Mean|48.76|48.76|Standard Deviation|14.45|14.45|||
4041991|NCT01120704|3863915|B22|||Age||years|Mean|51.81|51.81|Standard Deviation|13.97|13.97|||
4041992|NCT01120704|3863916|B21|||Age||years|Mean|47.35|47.35|Standard Deviation|12.80|12.8|||
4041993|NCT01120704|3863917|B20|||Age||years|Mean|45.72|45.72|Standard Deviation|12.91|12.91|||
4041994|NCT01120704|3863918|B19|||Age||years|Mean|42.53|42.53|Standard Deviation|12.86|12.86|||
4041995|NCT01120704|3863919|B18|||Age||years|Mean|47.00|47.0|Standard Deviation|13.11|13.11|||
4041996|NCT01120704|3863920|B17|||Age||years|Mean|49.07|49.07|Standard Deviation|16.28|16.28|||
4041997|NCT01120704|3863921|B16|||Age||years|Mean|50.39|50.39|Standard Deviation|12.56|12.56|||
4041998|NCT01120704|3863922|B15|||Age||years|Mean|49.33|49.33|Standard Deviation|17.49|17.49|||
4041999|NCT01120704|3863923|B14|||Age||years|Mean|44.58|44.58|Standard Deviation|13.68|13.68|||
4042000|NCT01120704|3863924|B13|||Age||years|Mean|46.41|46.41|Standard Deviation|9.56|9.56|||
4042001|NCT01120704|3863925|B12|||Age||years|Mean|46.69|46.69|Standard Deviation|11.44|11.44|||
4042002|NCT01120704|3863926|B11|||Age||years|Mean|44.29|44.29|Standard Deviation|10.71|10.71|||
4042003|NCT01120704|3863927|B10|||Age||years|Mean|46.50|46.5|Standard Deviation|11.04|11.04|||
4042004|NCT01120704|3863928|B9|||Age||years|Mean|51.55|51.55|Standard Deviation|13.51|13.51|||
4042005|NCT01120704|3863929|B8|||Age||years|Mean|43.53|43.53|Standard Deviation|8.32|8.32|||
4042006|NCT01120704|3863930|B7|||Age||years|Mean|47.33|47.33|Standard Deviation|9.83|9.83|||
4042007|NCT01120704|3863931|B6|||Age||years|Mean|48.89|48.89|Standard Deviation|9.72|9.72|||
4042008|NCT01120704|3863932|B5|||Age||years|Mean|48.81|48.81|Standard Deviation|14.61|14.61|||
4042009|NCT01120704|3863933|B4|||Age||years|Mean|49.42|49.42|Standard Deviation|14.25|14.25|||
4042010|NCT01120704|3863934|B3|||Age||years|Mean|39.86|39.86|Standard Deviation|10.54|10.54|||
4042011|NCT01120704|3863935|B2|||Age||years|Mean|43.82|43.82|Standard Deviation|9.87|9.87|||
4042012|NCT01120704|3863936|B1|||Age||years|Mean|45.08|45.08|Standard Deviation|12.37|12.37|||
4042013|NCT01120704|3863904|B33||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
4042014|NCT01120704|3863905|B32||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4042015|NCT01120704|3863906|B31||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4042016|NCT01120704|3863907|B30||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4042017|NCT01120704|3863908|B29||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4042018|NCT01120704|3863909|B28||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4042019|NCT01120704|3863910|B27||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4042020|NCT01120704|3863911|B26||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4042021|NCT01120704|3863912|B25||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4042022|NCT01120704|3863913|B24||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4042023|NCT01120704|3863914|B23||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4042024|NCT01120704|3863915|B22||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4042025|NCT01120704|3863916|B21||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4042026|NCT01120704|3863917|B20||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4042027|NCT01120704|3863918|B19||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4042028|NCT01120704|3863919|B18||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4042029|NCT01120704|3863920|B17||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4042030|NCT01120704|3863921|B16||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4042031|NCT01120704|3863922|B15||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4042032|NCT01120704|3863923|B14||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4042033|NCT01120704|3863924|B13||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4042034|NCT01120704|3863925|B12||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4042035|NCT01120704|3863926|B11||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4042036|NCT01120704|3863927|B10||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4042037|NCT01120704|3863928|B9||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4042038|NCT01120704|3863929|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4042039|NCT01120704|3863930|B7||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4042040|NCT01120704|3863931|B6||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4042041|NCT01120704|3863932|B5||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4042042|NCT01120704|3863933|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4042043|NCT01120704|3863934|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4042044|NCT01120704|3863935|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4042045|NCT01120704|3863936|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4042046|NCT01120704|3863904|B33||Between 18 and 65 years|Age||Participants|Count of Participants|493|493.0||||||
4042047|NCT01120704|3863905|B32||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4042048|NCT01120704|3863906|B31||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4042049|NCT01120704|3863907|B30||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4042050|NCT01120704|3863908|B29||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4042051|NCT01120704|3863909|B28||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4042052|NCT01120704|3863910|B27||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4042053|NCT01120704|3863911|B26||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4042054|NCT01120704|3863912|B25||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4042055|NCT01120704|3863913|B24||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4042056|NCT01120704|3863914|B23||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4042057|NCT01120704|3863915|B22||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4042058|NCT01120704|3863916|B21||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4042059|NCT01120704|3863917|B20||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4042060|NCT01120704|3863918|B19||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4042061|NCT01120704|3863919|B18||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4042062|NCT01120704|3863920|B17||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4042063|NCT01120704|3863921|B16||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4042064|NCT01120704|3863922|B15||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4042065|NCT01120704|3863923|B14||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4042066|NCT01120704|3863924|B13||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4042067|NCT01120704|3863925|B12||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4042068|NCT01120704|3863926|B11||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4042069|NCT01120704|3863927|B10||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4042070|NCT01120704|3863928|B9||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4042071|NCT01120704|3863929|B8||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4042072|NCT01120704|3863930|B7||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4042073|NCT01120704|3863931|B6||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4042074|NCT01120704|3863932|B5||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4042075|NCT01120704|3863933|B4||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4042076|NCT01120704|3863934|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4042077|NCT01120704|3863935|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4042078|NCT01120704|3863936|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4042079|NCT01120704|3863904|B33||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4042080|NCT01120704|3863905|B32||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042081|NCT01120704|3863906|B31||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042082|NCT01120704|3863907|B30||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042083|NCT01120704|3863908|B29||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042084|NCT01120704|3863909|B28||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042085|NCT01120704|3863910|B27||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4042086|NCT01120704|3863911|B26||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042087|NCT01120704|3863912|B25||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042088|NCT01120704|3863913|B24||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042089|NCT01120704|3863914|B23||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042090|NCT01120704|3863915|B22||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042091|NCT01120704|3863916|B21||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042092|NCT01120704|3863917|B20||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042093|NCT01120704|3863918|B19||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042094|NCT01120704|3863919|B18||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042095|NCT01120704|3863920|B17||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4042096|NCT01120704|3863921|B16||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042097|NCT01120704|3863922|B15||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042098|NCT01120704|3863923|B14||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042099|NCT01120704|3863924|B13||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042100|NCT01120704|3863925|B12||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042101|NCT01120704|3863926|B11||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042102|NCT01120704|3863927|B10||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042103|NCT01120704|3863928|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042104|NCT01120704|3863929|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042105|NCT01120704|3863930|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042106|NCT01120704|3863931|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042107|NCT01120704|3863932|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042108|NCT01120704|3863933|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042109|NCT01120704|3863934|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042110|NCT01120704|3863935|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042111|NCT01120704|3863936|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042112|NCT01120691|3863991|B4||Male|Sex: Female, Male||Participants|Count of Participants|1651|1651.0||||||
4042113|NCT01120691|3863992|B3||Male|Sex: Female, Male||Participants|Count of Participants|553|553.0||||||
4042114|NCT01120691|3863993|B2||Male|Sex: Female, Male||Participants|Count of Participants|542|542.0||||||
4042115|NCT01120691|3863994|B1||Male|Sex: Female, Male||Participants|Count of Participants|556|556.0||||||
4042116|NCT01120691|3863991|B4||Female|Sex: Female, Male||Participants|Count of Participants|555|555.0||||||
4042117|NCT01120691|3863992|B3||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4042118|NCT01120691|3863993|B2||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4042119|NCT01120691|3863994|B1||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4042120|NCT01120691|3863991|B4|||Age||years|Mean|63.3|63.3|Standard Deviation|7.95|7.95|||
4042121|NCT01120691|3863992|B3|||Age||years|Mean|63.6|63.6|Standard Deviation|7.79|7.79|||
4042122|NCT01120691|3863993|B2|||Age||years|Mean|63.1|63.1|Standard Deviation|7.98|7.98|||
4042123|NCT01120691|3863994|B1|||Age||years|Mean|63.1|63.1|Standard Deviation|8.07|8.07|||
4042124|NCT01120626|3864038|B3|||Aberrant Behavior Checklist (ABC)|The Aberrant Behavior Checklist is a 58-item symptom checklist for assessing problem behaviors. The ABC was rated by each participant's parent. Each item is rated on a four-point Likert scale ranging from 0 (not at all a problem) to 3 (the problem is severe in degree). The ABC Total score (range 0-174) is the sum of all individual item scores. Higher score indicates more maladaptive behaviors/worse outcome.|units on a scale|Mean|21.26|21.26|Standard Deviation|19.50|19.5|||
4042125|NCT01120626|3864039|B2|||Aberrant Behavior Checklist (ABC)|The Aberrant Behavior Checklist is a 58-item symptom checklist for assessing problem behaviors. The ABC was rated by each participant's parent. Each item is rated on a four-point Likert scale ranging from 0 (not at all a problem) to 3 (the problem is severe in degree). The ABC Total score (range 0-174) is the sum of all individual item scores. Higher score indicates more maladaptive behaviors/worse outcome.|units on a scale|Mean|30.77|30.77|Standard Deviation|25.54|25.54|||
4042126|NCT01120626|3864040|B1|||Aberrant Behavior Checklist (ABC)|The Aberrant Behavior Checklist is a 58-item symptom checklist for assessing problem behaviors. The ABC was rated by each participant's parent. Each item is rated on a four-point Likert scale ranging from 0 (not at all a problem) to 3 (the problem is severe in degree). The ABC Total score (range 0-174) is the sum of all individual item scores. Higher score indicates more maladaptive behaviors/worse outcome.|units on a scale|Mean|19.70|19.7|Standard Deviation|15.34|15.34|||
4042127|NCT01120626|3864038|B3|CNT Performance Rule 3||Contingency Naming Test (CNT) Performance Score|Baseline Contingency Naming Test (CNT) performance score on Rule 2 (naming shapes) and on Rule 3 (If the inside shape matches the outside shape, name the color, otherwise, name the outside shape). Performance score is the number of correct responses per minute, calculated by dividing the number of correct responses by the time taken to complete the 27 items, and multiplying by 60.|correct responses per minute|Mean|18.21|18.21|Standard Deviation|13.71|13.71|||
4042128|NCT01120626|3864039|B2|CNT Performance Rule 3||Contingency Naming Test (CNT) Performance Score|Baseline Contingency Naming Test (CNT) performance score on Rule 2 (naming shapes) and on Rule 3 (If the inside shape matches the outside shape, name the color, otherwise, name the outside shape). Performance score is the number of correct responses per minute, calculated by dividing the number of correct responses by the time taken to complete the 27 items, and multiplying by 60.|correct responses per minute|Mean|13.77|13.77|Standard Deviation|13.44|13.44|||
4042174|NCT01120405|3864078|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4042129|NCT01120626|3864040|B1|CNT Performance Rule 3||Contingency Naming Test (CNT) Performance Score|Baseline Contingency Naming Test (CNT) performance score on Rule 2 (naming shapes) and on Rule 3 (If the inside shape matches the outside shape, name the color, otherwise, name the outside shape). Performance score is the number of correct responses per minute, calculated by dividing the number of correct responses by the time taken to complete the 27 items, and multiplying by 60.|correct responses per minute|Mean|23.08|23.08|Standard Deviation|12.56|12.56|||
4042130|NCT01120626|3864038|B3|CNT Performance Rule 2||Contingency Naming Test (CNT) Performance Score|Baseline Contingency Naming Test (CNT) performance score on Rule 2 (naming shapes) and on Rule 3 (If the inside shape matches the outside shape, name the color, otherwise, name the outside shape). Performance score is the number of correct responses per minute, calculated by dividing the number of correct responses by the time taken to complete the 27 items, and multiplying by 60.|correct responses per minute|Mean|45.37|45.37|Standard Deviation|23.83|23.83|||
4042131|NCT01120626|3864039|B2|CNT Performance Rule 2||Contingency Naming Test (CNT) Performance Score|Baseline Contingency Naming Test (CNT) performance score on Rule 2 (naming shapes) and on Rule 3 (If the inside shape matches the outside shape, name the color, otherwise, name the outside shape). Performance score is the number of correct responses per minute, calculated by dividing the number of correct responses by the time taken to complete the 27 items, and multiplying by 60.|correct responses per minute|Mean|38.77|38.77|Standard Deviation|26.49|26.49|||
4042132|NCT01120626|3864040|B1|CNT Performance Rule 2||Contingency Naming Test (CNT) Performance Score|Baseline Contingency Naming Test (CNT) performance score on Rule 2 (naming shapes) and on Rule 3 (If the inside shape matches the outside shape, name the color, otherwise, name the outside shape). Performance score is the number of correct responses per minute, calculated by dividing the number of correct responses by the time taken to complete the 27 items, and multiplying by 60.|correct responses per minute|Mean|52.63|52.63|Standard Deviation|18.54|18.54|||
4042133|NCT01120626|3864038|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4042134|NCT01120626|3864039|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4042135|NCT01120626|3864040|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4042136|NCT01120626|3864038|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4042137|NCT01120626|3864039|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4042138|NCT01120626|3864040|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4042139|NCT01120626|3864038|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4042140|NCT01120626|3864039|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4042141|NCT01120626|3864040|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4042142|NCT01120626|3864038|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4042143|NCT01120626|3864039|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4042144|NCT01120626|3864040|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4042145|NCT01120626|3864038|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4042146|NCT01120626|3864039|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4042147|NCT01120626|3864040|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4042148|NCT01120626|3864038|B3||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
4042149|NCT01120626|3864039|B2||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4042150|NCT01120626|3864040|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4042151|NCT01120600|3864049|B3||Male|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
4042152|NCT01120600|3864050|B2||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4042153|NCT01120600|3864051|B1||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4042154|NCT01120600|3864049|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4042155|NCT01120600|3864050|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4042156|NCT01120600|3864051|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4042157|NCT01120600|3864049|B3|||Age||years|Mean|68.8|68.8|Standard Deviation|7.9|7.9|||
4042158|NCT01120600|3864050|B2|||Age||years|Mean|68.7|68.7|Standard Deviation|7.7|7.7|||
4042159|NCT01120600|3864051|B1|||Age||years|Mean|68.9|68.9|Standard Deviation|8.2|8.2|||
4042160|NCT01120405|3864076|B3|≤ 99th percentile||Participants with Baseline Cardiac Troponin (Central Laboratory)||participants|Number|538|538.0||||||
4042161|NCT01120405|3864077|B2|≤ 99th percentile||Participants with Baseline Cardiac Troponin (Central Laboratory)||participants|Number|269|269.0||||||
4042162|NCT01120405|3864078|B1|≤ 99th percentile||Participants with Baseline Cardiac Troponin (Central Laboratory)||participants|Number|269|269.0||||||
4042163|NCT01120405|3864076|B3|> 99th percentile||Participants with Baseline Cardiac Troponin (Central Laboratory)||participants|Number|52|52.0||||||
4042164|NCT01120405|3864077|B2|> 99th percentile||Participants with Baseline Cardiac Troponin (Central Laboratory)||participants|Number|26|26.0||||||
4042165|NCT01120405|3864078|B1|> 99th percentile||Participants with Baseline Cardiac Troponin (Central Laboratory)||participants|Number|26|26.0||||||
4042166|NCT01120405|3864076|B3|France||Region of Enrollment||participants|Number|590|590.0||||||
4042167|NCT01120405|3864077|B2|France||Region of Enrollment||participants|Number|295|295.0||||||
4042168|NCT01120405|3864078|B1|France||Region of Enrollment||participants|Number|295|295.0||||||
4042169|NCT01120405|3864076|B3||Male|Sex: Female, Male||Participants|Count of Participants|481|481.0||||||
4042170|NCT01120405|3864077|B2||Male|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
4042171|NCT01120405|3864078|B1||Male|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
4042172|NCT01120405|3864076|B3||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4042173|NCT01120405|3864077|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4042175|NCT01120405|3864076|B3|||Age||years|Mean|70.9|70.9|Standard Deviation|10.2|10.2|||
4042176|NCT01120405|3864077|B2|||Age||years|Mean|71.2|71.2|Standard Deviation|10.2|10.2|||
4042177|NCT01120405|3864078|B1|||Age||years|Mean|70.6|70.6|Standard Deviation|10.3|10.3|||
4042178|NCT01120379|3864107|B1|United States||Region of Enrollment||participants|Number|5020|5020.0||||||
4042179|NCT01120379|3864107|B1||Male|Sex: Female, Male||Participants|Count of Participants|3456|3456.0||||||
4042180|NCT01120379|3864107|B1||Female|Sex: Female, Male||Participants|Count of Participants|1564|1564.0||||||
4042181|NCT01120379|3864107|B1|||Age||years|Mean|64.75|64.75|Standard Deviation|11.07|11.07|||
4042182|NCT01120379|3864107|B1||>=65 years|Age||Participants|Count of Participants|2495|2495.0||||||
4042183|NCT01120379|3864107|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2525|2525.0||||||
4042184|NCT01120379|3864107|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042185|NCT01120275|3864143|B1|Yes||Elevated Lactate Dehydrogenase (LDH)||participants|Number|13|13.0||||||
4042186|NCT01120275|3864143|B1|No||Elevated Lactate Dehydrogenase (LDH)||participants|Number|19|19.0||||||
4042187|NCT01120275|3864143|B1|Other visceral||Site(s) of Metastases|Distant metastatic involvement is defined as the presence of one or more metastases beyond the regional lymph node drainage.|participants|Number|9|9.0||||||
4042188|NCT01120275|3864143|B1|Other non-visceral||Site(s) of Metastases|Distant metastatic involvement is defined as the presence of one or more metastases beyond the regional lymph node drainage.|participants|Number|1|1.0||||||
4042189|NCT01120275|3864143|B1|Lung||Site(s) of Metastases|Distant metastatic involvement is defined as the presence of one or more metastases beyond the regional lymph node drainage.|participants|Number|17|17.0||||||
4042190|NCT01120275|3864143|B1|Lymph node, skin, soft tissue||Site(s) of Metastases|Distant metastatic involvement is defined as the presence of one or more metastases beyond the regional lymph node drainage.|participants|Number|17|17.0||||||
4042191|NCT01120275|3864143|B1|Liver||Site(s) of Metastases|Distant metastatic involvement is defined as the presence of one or more metastases beyond the regional lymph node drainage.|participants|Number|12|12.0||||||
4042192|NCT01120275|3864143|B1|Bone||Site(s) of Metastases|Distant metastatic involvement is defined as the presence of one or more metastases beyond the regional lymph node drainage.|participants|Number|8|8.0||||||
4042193|NCT01120275|3864143|B1|Unknown primary||Primary Type||participants|Number|10|10.0||||||
4042194|NCT01120275|3864143|B1|Cutaneous||Primary Type||participants|Number|22|22.0||||||
4042195|NCT01120275|3864143|B1|1||Performance Status|Patients were graded according to the Zubrod Performance Status Scale. Performance Status is 0 if patient is fully active, able to carry on all pre-disease performance without restriction. Performance Status is 1 if patient is restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.|participants|Number|8|8.0||||||
4042196|NCT01120275|3864143|B1|0||Performance Status|Patients were graded according to the Zubrod Performance Status Scale. Performance Status is 0 if patient is fully active, able to carry on all pre-disease performance without restriction. Performance Status is 1 if patient is restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.|participants|Number|24|24.0||||||
4042197|NCT01120275|3864143|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4042198|NCT01120275|3864143|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4042199|NCT01120275|3864143|B1|||Age||years|Median|60.9|60.9|Full Range|||32.8|85.9|
4042200|NCT01120236|3864150|B3|||Early Induction Androgen Deprivation|Prior remote AD was allowed only if received in the neoadjuvant, concurrent, and/or adjuvant settings and > 2 years had elapsed since completion of therapy.|participants|Number|124|124.0||||||
4042201|NCT01120236|3864151|B2|||Early Induction Androgen Deprivation|Prior remote AD was allowed only if received in the neoadjuvant, concurrent, and/or adjuvant settings and > 2 years had elapsed since completion of therapy.|participants|Number|65|65.0||||||
4042202|NCT01120236|3864152|B1|||Early Induction Androgen Deprivation|Prior remote AD was allowed only if received in the neoadjuvant, concurrent, and/or adjuvant settings and > 2 years had elapsed since completion of therapy.|participants|Number|59|59.0||||||
4042203|NCT01120236|3864150|B3|||Bone Pain||participants|Number|63|63.0||||||
4042204|NCT01120236|3864151|B2|||Bone Pain||participants|Number|35|35.0||||||
4042205|NCT01120236|3864152|B1|||Bone Pain||participants|Number|28|28.0||||||
4042206|NCT01120236|3864150|B3|Visceral||Site of Metastasis||participants|Number|31|31.0||||||
4042207|NCT01120236|3864151|B2|Visceral||Site of Metastasis||participants|Number|16|16.0||||||
4042208|NCT01120236|3864152|B1|Visceral||Site of Metastasis||participants|Number|15|15.0||||||
4042209|NCT01120236|3864150|B3|Lymph Node and Bone||Site of Metastasis||participants|Number|36|36.0||||||
4042210|NCT01120236|3864151|B2|Lymph Node and Bone||Site of Metastasis||participants|Number|17|17.0||||||
4042211|NCT01120236|3864152|B1|Lymph Node and Bone||Site of Metastasis||participants|Number|19|19.0||||||
4042212|NCT01120236|3864150|B3|Bone Only||Site of Metastasis||participants|Number|119|119.0||||||
4042213|NCT01120236|3864151|B2|Bone Only||Site of Metastasis||participants|Number|63|63.0||||||
4042214|NCT01120236|3864152|B1|Bone Only||Site of Metastasis||participants|Number|56|56.0||||||
4042215|NCT01120236|3864150|B3|Lymph Node Only||Site of Metastasis||participants|Number|24|24.0||||||
4042216|NCT01120236|3864151|B2|Lymph Node Only||Site of Metastasis||participants|Number|9|9.0||||||
4042217|NCT01120236|3864152|B1|Lymph Node Only||Site of Metastasis||participants|Number|15|15.0||||||
4042218|NCT01120236|3864150|B3|2||Zubrod Performance Score|"Scale 0 (best) to 2 (worst)~0 = Fully active, able to carry on all pre-disease performance without restriction.~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~= Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours."|participants|Number|4|4.0||||||
4042262|NCT01120236|3864152|B1|United States||Region of Enrollment||participants|Number|105|105.0||||||
4042219|NCT01120236|3864151|B2|2||Zubrod Performance Score|"Scale 0 (best) to 2 (worst)~0 = Fully active, able to carry on all pre-disease performance without restriction.~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~= Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours."|participants|Number|2|2.0||||||
4042220|NCT01120236|3864152|B1|2||Zubrod Performance Score|"Scale 0 (best) to 2 (worst)~0 = Fully active, able to carry on all pre-disease performance without restriction.~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~= Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours."|participants|Number|2|2.0||||||
4042221|NCT01120236|3864150|B3|1||Zubrod Performance Score|"Scale 0 (best) to 2 (worst)~0 = Fully active, able to carry on all pre-disease performance without restriction.~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~= Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours."|participants|Number|79|79.0||||||
4042222|NCT01120236|3864151|B2|1||Zubrod Performance Score|"Scale 0 (best) to 2 (worst)~0 = Fully active, able to carry on all pre-disease performance without restriction.~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~= Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours."|participants|Number|38|38.0||||||
4042223|NCT01120236|3864152|B1|1||Zubrod Performance Score|"Scale 0 (best) to 2 (worst)~0 = Fully active, able to carry on all pre-disease performance without restriction.~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~= Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours."|participants|Number|41|41.0||||||
4042224|NCT01120236|3864150|B3|0||Zubrod Performance Score|"Scale 0 (best) to 2 (worst)~0 = Fully active, able to carry on all pre-disease performance without restriction.~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~= Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours."|participants|Number|127|127.0||||||
4042225|NCT01120236|3864151|B2|0||Zubrod Performance Score|"Scale 0 (best) to 2 (worst)~0 = Fully active, able to carry on all pre-disease performance without restriction.~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~= Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours."|participants|Number|65|65.0||||||
4042226|NCT01120236|3864152|B1|0||Zubrod Performance Score|"Scale 0 (best) to 2 (worst)~0 = Fully active, able to carry on all pre-disease performance without restriction.~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~= Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours."|participants|Number|62|62.0||||||
4042227|NCT01120236|3864150|B3|Unknown||Gleason Score|This is a 2 to 10 grading system for prostate carcinoma devised by Dr. Donald Gleason in 1977 as a method for predicting the behavior of prostate cancer. Tumors with a low Gleason score are less likely to show aggressive behavior and therefore are less likely to have spread outside of the gland to lymph nodes. To obtain a Gleason score, the dominant tumor pattern is added to the second most prevalent pattern to obtain a number between 2 and 10. If a tumor has patterns 3 and 2, the score would be 5. If the tumor has only one pattern, then the single pattern is added to itself (e.g. 3+3=6).|participants|Number|11|11.0||||||
4042228|NCT01120236|3864151|B2|Unknown||Gleason Score|This is a 2 to 10 grading system for prostate carcinoma devised by Dr. Donald Gleason in 1977 as a method for predicting the behavior of prostate cancer. Tumors with a low Gleason score are less likely to show aggressive behavior and therefore are less likely to have spread outside of the gland to lymph nodes. To obtain a Gleason score, the dominant tumor pattern is added to the second most prevalent pattern to obtain a number between 2 and 10. If a tumor has patterns 3 and 2, the score would be 5. If the tumor has only one pattern, then the single pattern is added to itself (e.g. 3+3=6).|participants|Number|6|6.0||||||
4042229|NCT01120236|3864152|B1|Unknown||Gleason Score|This is a 2 to 10 grading system for prostate carcinoma devised by Dr. Donald Gleason in 1977 as a method for predicting the behavior of prostate cancer. Tumors with a low Gleason score are less likely to show aggressive behavior and therefore are less likely to have spread outside of the gland to lymph nodes. To obtain a Gleason score, the dominant tumor pattern is added to the second most prevalent pattern to obtain a number between 2 and 10. If a tumor has patterns 3 and 2, the score would be 5. If the tumor has only one pattern, then the single pattern is added to itself (e.g. 3+3=6).|participants|Number|5|5.0||||||
4042230|NCT01120236|3864150|B3|>=7||Gleason Score|This is a 2 to 10 grading system for prostate carcinoma devised by Dr. Donald Gleason in 1977 as a method for predicting the behavior of prostate cancer. Tumors with a low Gleason score are less likely to show aggressive behavior and therefore are less likely to have spread outside of the gland to lymph nodes. To obtain a Gleason score, the dominant tumor pattern is added to the second most prevalent pattern to obtain a number between 2 and 10. If a tumor has patterns 3 and 2, the score would be 5. If the tumor has only one pattern, then the single pattern is added to itself (e.g. 3+3=6).|participants|Number|145|145.0||||||
4042231|NCT01120236|3864151|B2|>=7||Gleason Score|This is a 2 to 10 grading system for prostate carcinoma devised by Dr. Donald Gleason in 1977 as a method for predicting the behavior of prostate cancer. Tumors with a low Gleason score are less likely to show aggressive behavior and therefore are less likely to have spread outside of the gland to lymph nodes. To obtain a Gleason score, the dominant tumor pattern is added to the second most prevalent pattern to obtain a number between 2 and 10. If a tumor has patterns 3 and 2, the score would be 5. If the tumor has only one pattern, then the single pattern is added to itself (e.g. 3+3=6).|participants|Number|82|82.0||||||
4042263|NCT01120236|3864150|B3|Other||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4042264|NCT01120236|3864151|B2|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4042265|NCT01120236|3864152|B1|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4042232|NCT01120236|3864152|B1|>=7||Gleason Score|This is a 2 to 10 grading system for prostate carcinoma devised by Dr. Donald Gleason in 1977 as a method for predicting the behavior of prostate cancer. Tumors with a low Gleason score are less likely to show aggressive behavior and therefore are less likely to have spread outside of the gland to lymph nodes. To obtain a Gleason score, the dominant tumor pattern is added to the second most prevalent pattern to obtain a number between 2 and 10. If a tumor has patterns 3 and 2, the score would be 5. If the tumor has only one pattern, then the single pattern is added to itself (e.g. 3+3=6).|participants|Number|63|63.0||||||
4042233|NCT01120236|3864150|B3|7||Gleason Score|This is a 2 to 10 grading system for prostate carcinoma devised by Dr. Donald Gleason in 1977 as a method for predicting the behavior of prostate cancer. Tumors with a low Gleason score are less likely to show aggressive behavior and therefore are less likely to have spread outside of the gland to lymph nodes. To obtain a Gleason score, the dominant tumor pattern is added to the second most prevalent pattern to obtain a number between 2 and 10. If a tumor has patterns 3 and 2, the score would be 5. If the tumor has only one pattern, then the single pattern is added to itself (e.g. 3+3=6).|participants|Number|40|40.0||||||
4042234|NCT01120236|3864151|B2|7||Gleason Score|This is a 2 to 10 grading system for prostate carcinoma devised by Dr. Donald Gleason in 1977 as a method for predicting the behavior of prostate cancer. Tumors with a low Gleason score are less likely to show aggressive behavior and therefore are less likely to have spread outside of the gland to lymph nodes. To obtain a Gleason score, the dominant tumor pattern is added to the second most prevalent pattern to obtain a number between 2 and 10. If a tumor has patterns 3 and 2, the score would be 5. If the tumor has only one pattern, then the single pattern is added to itself (e.g. 3+3=6).|participants|Number|11|11.0||||||
4042235|NCT01120236|3864152|B1|7||Gleason Score|This is a 2 to 10 grading system for prostate carcinoma devised by Dr. Donald Gleason in 1977 as a method for predicting the behavior of prostate cancer. Tumors with a low Gleason score are less likely to show aggressive behavior and therefore are less likely to have spread outside of the gland to lymph nodes. To obtain a Gleason score, the dominant tumor pattern is added to the second most prevalent pattern to obtain a number between 2 and 10. If a tumor has patterns 3 and 2, the score would be 5. If the tumor has only one pattern, then the single pattern is added to itself (e.g. 3+3=6).|participants|Number|29|29.0||||||
4042236|NCT01120236|3864150|B3|<7||Gleason Score|This is a 2 to 10 grading system for prostate carcinoma devised by Dr. Donald Gleason in 1977 as a method for predicting the behavior of prostate cancer. Tumors with a low Gleason score are less likely to show aggressive behavior and therefore are less likely to have spread outside of the gland to lymph nodes. To obtain a Gleason score, the dominant tumor pattern is added to the second most prevalent pattern to obtain a number between 2 and 10. If a tumor has patterns 3 and 2, the score would be 5. If the tumor has only one pattern, then the single pattern is added to itself (e.g. 3+3=6).|participants|Number|14|14.0||||||
4042237|NCT01120236|3864151|B2|<7||Gleason Score|This is a 2 to 10 grading system for prostate carcinoma devised by Dr. Donald Gleason in 1977 as a method for predicting the behavior of prostate cancer. Tumors with a low Gleason score are less likely to show aggressive behavior and therefore are less likely to have spread outside of the gland to lymph nodes. To obtain a Gleason score, the dominant tumor pattern is added to the second most prevalent pattern to obtain a number between 2 and 10. If a tumor has patterns 3 and 2, the score would be 5. If the tumor has only one pattern, then the single pattern is added to itself (e.g. 3+3=6).|participants|Number|6|6.0||||||
4042238|NCT01120236|3864152|B1|<7||Gleason Score|This is a 2 to 10 grading system for prostate carcinoma devised by Dr. Donald Gleason in 1977 as a method for predicting the behavior of prostate cancer. Tumors with a low Gleason score are less likely to show aggressive behavior and therefore are less likely to have spread outside of the gland to lymph nodes. To obtain a Gleason score, the dominant tumor pattern is added to the second most prevalent pattern to obtain a number between 2 and 10. If a tumor has patterns 3 and 2, the score would be 5. If the tumor has only one pattern, then the single pattern is added to itself (e.g. 3+3=6).|participants|Number|8|8.0||||||
4042239|NCT01120236|3864150|B3|Unknown||Body Mass Index (BMI)||participants|Number|6|6.0||||||
4042240|NCT01120236|3864151|B2|Unknown||Body Mass Index (BMI)||participants|Number|2|2.0||||||
4042241|NCT01120236|3864152|B1|Unknown||Body Mass Index (BMI)||participants|Number|4|4.0||||||
4042242|NCT01120236|3864150|B3|>= 30 (obese)||Body Mass Index (BMI)||participants|Number|76|76.0||||||
4042243|NCT01120236|3864151|B2|>= 30 (obese)||Body Mass Index (BMI)||participants|Number|33|33.0||||||
4042244|NCT01120236|3864152|B1|>= 30 (obese)||Body Mass Index (BMI)||participants|Number|43|43.0||||||
4042245|NCT01120236|3864150|B3|25 to 29.9 (overweight)||Body Mass Index (BMI)||participants|Number|75|75.0||||||
4042246|NCT01120236|3864151|B2|25 to 29.9 (overweight)||Body Mass Index (BMI)||participants|Number|39|39.0||||||
4042247|NCT01120236|3864152|B1|25 to 29.9 (overweight)||Body Mass Index (BMI)||participants|Number|36|36.0||||||
4042248|NCT01120236|3864150|B3|18.5 to 24.9 (normal weight)||Body Mass Index (BMI)||participants|Number|50|50.0||||||
4042249|NCT01120236|3864151|B2|18.5 to 24.9 (normal weight)||Body Mass Index (BMI)||participants|Number|29|29.0||||||
4042250|NCT01120236|3864152|B1|18.5 to 24.9 (normal weight)||Body Mass Index (BMI)||participants|Number|21|21.0||||||
4042251|NCT01120236|3864150|B3|<18.5 (underweight)||Body Mass Index (BMI)||participants|Number|3|3.0||||||
4042252|NCT01120236|3864151|B2|<18.5 (underweight)||Body Mass Index (BMI)||participants|Number|2|2.0||||||
4042253|NCT01120236|3864152|B1|<18.5 (underweight)||Body Mass Index (BMI)||participants|Number|1|1.0||||||
4042254|NCT01120236|3864150|B3|||Weight||kg|Median|88|88.0|Inter-Quartile Range|||77.0|100.0|
4042255|NCT01120236|3864151|B2|||Weight||kg|Median|86|86.0|Inter-Quartile Range|||77.0|98.0|
4042256|NCT01120236|3864152|B1|||Weight||kg|Median|90|90.0|Inter-Quartile Range|||79.0|101.0|
4042257|NCT01120236|3864150|B3|||Prostate-Specific Antigen (PSA)||ng/mL|Median|34|34.0|Inter-Quartile Range|||11.0|133.0|
4042258|NCT01120236|3864151|B2|||Prostate-Specific Antigen (PSA)||ng/mL|Median|37|37.0|Inter-Quartile Range|||10.0|200.0|
4042259|NCT01120236|3864152|B1|||Prostate-Specific Antigen (PSA)||ng/mL|Median|31|31.0|Inter-Quartile Range|||12.0|74.0|
4042260|NCT01120236|3864150|B3|United States||Region of Enrollment||participants|Number|210|210.0||||||
4042261|NCT01120236|3864151|B2|United States||Region of Enrollment||participants|Number|105|105.0||||||
4042266|NCT01120236|3864150|B3|White||Race/Ethnicity, Customized||participants|Number|182|182.0||||||
4042267|NCT01120236|3864151|B2|White||Race/Ethnicity, Customized||participants|Number|88|88.0||||||
4042268|NCT01120236|3864152|B1|White||Race/Ethnicity, Customized||participants|Number|94|94.0||||||
4042269|NCT01120236|3864150|B3|Black||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4042270|NCT01120236|3864151|B2|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4042271|NCT01120236|3864152|B1|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4042272|NCT01120236|3864150|B3||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4042273|NCT01120236|3864151|B2||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4042274|NCT01120236|3864152|B1||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4042275|NCT01120236|3864150|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4042276|NCT01120236|3864151|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4042277|NCT01120236|3864152|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4042278|NCT01120236|3864150|B3|||Age||years|Median|66|66.0|Inter-Quartile Range|||59.0|73.0|
4042279|NCT01120236|3864151|B2|||Age||years|Median|66|66.0|Inter-Quartile Range|||58.0|73.0|
4042280|NCT01120236|3864152|B1|||Age||years|Median|65|65.0|Inter-Quartile Range|||60.0|72.0|
4042281|NCT01120223|3864180|B1|United Kingdom||Region of Enrollment||participants|Number|19|19.0||||||
4042282|NCT01120223|3864180|B1|Canada||Region of Enrollment||participants|Number|37|37.0||||||
4042283|NCT01120223|3864180|B1|France||Region of Enrollment||participants|Number|22|22.0||||||
4042284|NCT01120223|3864180|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4042285|NCT01120223|3864180|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4042286|NCT01120223|3864180|B1|||Age||years|Mean|14.6|14.6|Standard Deviation|1.7|1.7|||
4042287|NCT01120223|3864180|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4042288|NCT01120223|3864180|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4042289|NCT01120223|3864180|B1||<=18 years|Age||Participants|Count of Participants|78|78.0||||||
4042290|NCT01120210|3864208|B3|>=65 years||AgeCategorical||participants|Number|16|16.0||||||
4042291|NCT01120210|3864209|B2|>=65 years||AgeCategorical||participants|Number|11|11.0||||||
4042292|NCT01120210|3864210|B1|>=65 years||AgeCategorical||participants|Number|5|5.0||||||
4042293|NCT01120210|3864208|B3|50 - 64 years||AgeCategorical||participants|Number|30|30.0||||||
4042294|NCT01120210|3864209|B2|50 - 64 years||AgeCategorical||participants|Number|23|23.0||||||
4042295|NCT01120210|3864210|B1|50 - 64 years||AgeCategorical||participants|Number|7|7.0||||||
4042296|NCT01120210|3864208|B3|21 - 50 years||AgeCategorical||participants|Number|16|16.0||||||
4042297|NCT01120210|3864209|B2|21 - 50 years||AgeCategorical||participants|Number|12|12.0||||||
4042298|NCT01120210|3864210|B1|21 - 50 years||AgeCategorical||participants|Number|4|4.0||||||
4042299|NCT01120210|3864208|B3|11 - 20 years||AgeCategorical||participants|Number|0|0.0||||||
4042300|NCT01120210|3864209|B2|11 - 20 years||AgeCategorical||participants|Number|0|0.0||||||
4042301|NCT01120210|3864210|B1|11 - 20 years||AgeCategorical||participants|Number|0|0.0||||||
4042302|NCT01120210|3864208|B3|<=10 years||AgeCategorical||participants|Number|0|0.0||||||
4042303|NCT01120210|3864209|B2|<=10 years||AgeCategorical||participants|Number|0|0.0||||||
4042304|NCT01120210|3864210|B1|<=10 years||AgeCategorical||participants|Number|0|0.0||||||
4042305|NCT01120210|3864208|B3|Romania||Region of Enrollment||participants|Number|17|17.0||||||
4042306|NCT01120210|3864209|B2|Romania||Region of Enrollment||participants|Number|12|12.0||||||
4042307|NCT01120210|3864210|B1|Romania||Region of Enrollment||participants|Number|5|5.0||||||
4042308|NCT01120210|3864208|B3|Poland||Region of Enrollment||participants|Number|25|25.0||||||
4042309|NCT01120210|3864209|B2|Poland||Region of Enrollment||participants|Number|21|21.0||||||
4042310|NCT01120210|3864210|B1|Poland||Region of Enrollment||participants|Number|4|4.0||||||
4042311|NCT01120210|3864208|B3|Italy||Region of Enrollment||participants|Number|9|9.0||||||
4042312|NCT01120210|3864209|B2|Italy||Region of Enrollment||participants|Number|7|7.0||||||
4042313|NCT01120210|3864210|B1|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4042314|NCT01120210|3864208|B3|Germany||Region of Enrollment||participants|Number|7|7.0||||||
4042315|NCT01120210|3864209|B2|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4042316|NCT01120210|3864210|B1|Germany||Region of Enrollment||participants|Number|5|5.0||||||
4042317|NCT01120210|3864208|B3|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
4042318|NCT01120210|3864209|B2|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
4042319|NCT01120210|3864210|B1|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
4042320|NCT01120210|3864208|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4042321|NCT01120210|3864209|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4042322|NCT01120210|3864210|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4042323|NCT01120210|3864208|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4042324|NCT01120210|3864209|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4042325|NCT01120210|3864210|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4042326|NCT01120210|3864208|B3|||Age||years|Mean|56.8|56.8|Standard Deviation|12.25|12.25|||
4042327|NCT01120210|3864209|B2|||Age||years|Mean|56.6|56.6|Standard Deviation|12.91|12.91|||
4042328|NCT01120210|3864210|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|10.46|10.46|||
4042329|NCT01120210|3864208|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4042330|NCT01120210|3864209|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4042331|NCT01120210|3864210|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4042332|NCT01120210|3864208|B3||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4042333|NCT01120210|3864209|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4042334|NCT01120210|3864210|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4042335|NCT01120210|3864208|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042336|NCT01120210|3864209|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042337|NCT01120210|3864210|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042338|NCT01120197|3864241|B3|Norway||Region of Enrollment||participants|Number|89|89.0||||||
4042339|NCT01120197|3864242|B2|Norway||Region of Enrollment||participants|Number|42|42.0||||||
4042340|NCT01120197|3864243|B1|Norway||Region of Enrollment||participants|Number|47|47.0||||||
4042341|NCT01120197|3864241|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4042342|NCT01120197|3864242|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4042343|NCT01120197|3864243|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4042344|NCT01120197|3864241|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4042345|NCT01120197|3864242|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4042346|NCT01120197|3864243|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4042347|NCT01120197|3864241|B3|||Age||years|Mean|71.4|71.4|Standard Deviation|5.7|5.7|||
4042348|NCT01120197|3864242|B2|||Age||years|Mean|72|72.0|Standard Deviation|5.8|5.8|||
4042349|NCT01120197|3864243|B1|||Age||years|Mean|70.8|70.8|Standard Deviation|5.9|5.9|||
4042350|NCT01120197|3864241|B3||>=65 years|Age||Participants|Count of Participants|89|89.0||||||
4042351|NCT01120197|3864242|B2||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
4042352|NCT01120197|3864243|B1||>=65 years|Age||Participants|Count of Participants|47|47.0||||||
4042353|NCT01120197|3864241|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4042354|NCT01120197|3864242|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4042355|NCT01120197|3864243|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4042356|NCT01120197|3864241|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042357|NCT01120197|3864242|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042358|NCT01120197|3864243|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042359|NCT01120184|3864258|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4042360|NCT01120184|3864259|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4042361|NCT01120184|3864260|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4042362|NCT01120184|3864261|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4042363|NCT01120184|3864258|B4||Female|Sex: Female, Male||Participants|Count of Participants|1088|1088.0||||||
4042364|NCT01120184|3864259|B3||Female|Sex: Female, Male||Participants|Count of Participants|361|361.0||||||
4042365|NCT01120184|3864260|B2||Female|Sex: Female, Male||Participants|Count of Participants|365|365.0||||||
4042366|NCT01120184|3864261|B1||Female|Sex: Female, Male||Participants|Count of Participants|362|362.0||||||
4042367|NCT01120184|3864258|B4|||Age||years|Mean|53.0|53.0|Standard Deviation|11.6|11.6|||
4042368|NCT01120184|3864259|B3|||Age||years|Mean|52.2|52.2|Standard Deviation|12.0|12.0|||
4042369|NCT01120184|3864260|B2|||Age||years|Mean|52.6|52.6|Standard Deviation|11.4|11.4|||
4042370|NCT01120184|3864261|B1|||Age||years|Mean|54.2|54.2|Standard Deviation|11.3|11.3|||
4042371|NCT01120093|3864385|B1|Germany||Region of Enrollment||participants|Number|76|76.0||||||
4042372|NCT01120093|3864385|B1|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
4042373|NCT01120093|3864385|B1||Male|Gender||Participants|Count of Participants|59|59.0||||||
4042374|NCT01120093|3864385|B1||Female|Gender||Participants|Count of Participants|20|20.0||||||
4042375|NCT01120093|3864385|B1|||Age||years|Mean|61.1|61.1|Standard Deviation|8.5|8.5|||
4042376|NCT01120093|3864385|B1||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4042377|NCT01120093|3864385|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4042378|NCT01120093|3864385|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042379|NCT01120067|3864416|B3|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4042380|NCT01120067|3864417|B2|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4042381|NCT01120067|3864418|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4042382|NCT01120067|3864416|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4042383|NCT01120067|3864417|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4042384|NCT01120067|3864418|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4042385|NCT01120067|3864416|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4042386|NCT01120067|3864417|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4042387|NCT01120067|3864418|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4042388|NCT01120067|3864416|B3|White/Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
4042389|NCT01120067|3864417|B2|White/Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4042390|NCT01120067|3864418|B1|White/Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4042391|NCT01120067|3864416|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4042392|NCT01120067|3864417|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4042393|NCT01120067|3864418|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4042394|NCT01120067|3864416|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4042395|NCT01120067|3864417|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4042396|NCT01120067|3864418|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4042397|NCT01120067|3864416|B3|||Age||years|Mean|49.79|49.79|Standard Deviation|10.274|10.274|||
4042398|NCT01120067|3864417|B2|||Age||years|Mean|52.09|52.09|Standard Deviation|10.64|10.64|||
4042399|NCT01120067|3864418|B1|||Age||years|Mean|47.75|47.75|Standard Deviation|10.39|10.39|||
4042400|NCT01119963|3864425|B3||29w0d-30w6d|Gestational Age Stratum at randomization (wks)||Participants|Count of Participants|42|42.0||||||
4042401|NCT01119963|3864426|B2||29w0d-30w6d|Gestational Age Stratum at randomization (wks)||Participants|Count of Participants|23|23.0||||||
4042402|NCT01119963|3864427|B1||29w0d-30w6d|Gestational Age Stratum at randomization (wks)||Participants|Count of Participants|19|19.0||||||
4042403|NCT01119963|3864425|B3||26w0d - 28w6d|Gestational Age Stratum at randomization (wks)||Participants|Count of Participants|51|51.0||||||
4042404|NCT01119963|3864426|B2||26w0d - 28w6d|Gestational Age Stratum at randomization (wks)||Participants|Count of Participants|27|27.0||||||
4042405|NCT01119963|3864427|B1||26w0d - 28w6d|Gestational Age Stratum at randomization (wks)||Participants|Count of Participants|24|24.0||||||
4042406|NCT01119963|3864425|B3||23w0d-25w6d|Gestational Age Stratum at randomization (wks)||Participants|Count of Participants|59|59.0||||||
4042407|NCT01119963|3864426|B2||23w0d-25w6d|Gestational Age Stratum at randomization (wks)||Participants|Count of Participants|28|28.0||||||
4042408|NCT01119963|3864427|B1||23w0d-25w6d|Gestational Age Stratum at randomization (wks)||Participants|Count of Participants|31|31.0||||||
4042409|NCT01119963|3864425|B3|||Gestational Age at time of randomization (wks)||weeks|Mean|26.9|26.9|Standard Deviation|2.5|2.5|||
4042410|NCT01119963|3864426|B2|||Gestational Age at time of randomization (wks)||weeks|Mean|27.1|27.1|Standard Deviation|2.4|2.4|||
4042411|NCT01119963|3864427|B1|||Gestational Age at time of randomization (wks)||weeks|Mean|26.7|26.7|Standard Deviation|2.5|2.5|||
4042412|NCT01119963|3864425|B3|||Gestational Age at Membrane Rupture||weeks|Mean|26.2|26.2|Standard Deviation|3.0|3.0|||
4042413|NCT01119963|3864426|B2|||Gestational Age at Membrane Rupture||weeks|Mean|26.6|26.6|Standard Deviation|2.9|2.9|||
4042414|NCT01119963|3864427|B1|||Gestational Age at Membrane Rupture||weeks|Mean|25.9|25.9|Standard Deviation|3.0|3.0|||
4042415|NCT01119963|3864425|B3|||Illicit Drug Use||Participants|Count of Participants|21|21.0||||||
4042416|NCT01119963|3864426|B2|||Illicit Drug Use||Participants|Count of Participants|14|14.0||||||
4042417|NCT01119963|3864427|B1|||Illicit Drug Use||Participants|Count of Participants|7|7.0||||||
4042418|NCT01119963|3864425|B3|||Tobacco Use||Participants|Count of Participants|9|9.0||||||
4042419|NCT01119963|3864426|B2|||Tobacco Use||Participants|Count of Participants|5|5.0||||||
4042420|NCT01119963|3864427|B1|||Tobacco Use||Participants|Count of Participants|4|4.0||||||
4042421|NCT01119963|3864425|B3||Not Reported|Education||Participants|Count of Participants|38|38.0||||||
4042422|NCT01119963|3864426|B2||Not Reported|Education||Participants|Count of Participants|20|20.0||||||
4042423|NCT01119963|3864427|B1||Not Reported|Education||Participants|Count of Participants|18|18.0||||||
4042424|NCT01119963|3864425|B3||College Graduate|Education||Participants|Count of Participants|32|32.0||||||
4042425|NCT01119963|3864426|B2||College Graduate|Education||Participants|Count of Participants|15|15.0||||||
4042426|NCT01119963|3864427|B1||College Graduate|Education||Participants|Count of Participants|17|17.0||||||
4042427|NCT01119963|3864425|B3||Some College|Education||Participants|Count of Participants|37|37.0||||||
4042428|NCT01119963|3864426|B2||Some College|Education||Participants|Count of Participants|15|15.0||||||
4042429|NCT01119963|3864427|B1||Some College|Education||Participants|Count of Participants|22|22.0||||||
4042430|NCT01119963|3864425|B3||HS Graduate or equivalent|Education||Participants|Count of Participants|29|29.0||||||
4042431|NCT01119963|3864426|B2||HS Graduate or equivalent|Education||Participants|Count of Participants|18|18.0||||||
4042432|NCT01119963|3864427|B1||HS Graduate or equivalent|Education||Participants|Count of Participants|11|11.0||||||
4042433|NCT01119963|3864425|B3||< HS graduate|Education||Participants|Count of Participants|16|16.0||||||
4042434|NCT01119963|3864426|B2||< HS graduate|Education||Participants|Count of Participants|10|10.0||||||
4042435|NCT01119963|3864427|B1||< HS graduate|Education||Participants|Count of Participants|6|6.0||||||
4042436|NCT01119963|3864425|B3||Other (Unknown)|Marital Status||Participants|Count of Participants|2|2.0||||||
4042437|NCT01119963|3864426|B2||Other (Unknown)|Marital Status||Participants|Count of Participants|2|2.0||||||
4042438|NCT01119963|3864427|B1||Other (Unknown)|Marital Status||Participants|Count of Participants|0|0.0||||||
4042439|NCT01119963|3864425|B3||Divorced/Separated|Marital Status||Participants|Count of Participants|3|3.0||||||
4042440|NCT01119963|3864426|B2||Divorced/Separated|Marital Status||Participants|Count of Participants|0|0.0||||||
4042441|NCT01119963|3864427|B1||Divorced/Separated|Marital Status||Participants|Count of Participants|3|3.0||||||
4042442|NCT01119963|3864425|B3||Single/Widowed|Marital Status||Participants|Count of Participants|57|57.0||||||
4042443|NCT01119963|3864426|B2||Single/Widowed|Marital Status||Participants|Count of Participants|30|30.0||||||
4042444|NCT01119963|3864427|B1||Single/Widowed|Marital Status||Participants|Count of Participants|27|27.0||||||
4042445|NCT01119963|3864425|B3||Married/Living with partner|Marital Status||Participants|Count of Participants|90|90.0||||||
4042446|NCT01119963|3864426|B2||Married/Living with partner|Marital Status||Participants|Count of Participants|46|46.0||||||
4042447|NCT01119963|3864427|B1||Married/Living with partner|Marital Status||Participants|Count of Participants|44|44.0||||||
4042448|NCT01119963|3864425|B3|United States||Region of Enrollment||Participants|Count of Participants|152|152.0||||||
4042449|NCT01119963|3864426|B2|United States||Region of Enrollment||Participants|Count of Participants|78|78.0||||||
4042450|NCT01119963|3864427|B1|United States||Region of Enrollment||Participants|Count of Participants|74|74.0||||||
4042451|NCT01119963|3864425|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042452|NCT01119963|3864426|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042453|NCT01119963|3864427|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042454|NCT01119963|3864425|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4042455|NCT01119963|3864426|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4042456|NCT01119963|3864427|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042457|NCT01119963|3864425|B3||White|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
4042458|NCT01119963|3864426|B2||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4042459|NCT01119963|3864427|B1||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4042460|NCT01119963|3864425|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4042461|NCT01119963|3864426|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4042462|NCT01119963|3864427|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4042463|NCT01119963|3864425|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4042464|NCT01119963|3864426|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042465|NCT01119963|3864427|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4042466|NCT01119963|3864425|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4042467|NCT01119963|3864426|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4042468|NCT01119963|3864427|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4042469|NCT01119963|3864425|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4042470|NCT01119963|3864426|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4042471|NCT01119963|3864427|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4042472|NCT01119963|3864425|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4042473|NCT01119963|3864426|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4042474|NCT01119963|3864427|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042475|NCT01119963|3864425|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|114|114.0||||||
4042476|NCT01119963|3864426|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4042477|NCT01119963|3864427|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4042478|NCT01119963|3864425|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4042479|NCT01119963|3864426|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4042480|NCT01119963|3864427|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4042481|NCT01119963|3864425|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4042482|NCT01119963|3864426|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4042483|NCT01119963|3864427|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4042484|NCT01119963|3864425|B3||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4042485|NCT01119963|3864426|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4042486|NCT01119963|3864427|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4042487|NCT01119963|3864425|B3|||Age||years|Mean|29.7|29.7|Standard Deviation|5.8|5.8|||
4042488|NCT01119963|3864426|B2|||Age||years|Mean|29.5|29.5|Standard Deviation|5.7|5.7|||
4042489|NCT01119963|3864427|B1|||Age||years|Mean|29.9|29.9|Standard Deviation|5.8|5.8|||
4042490|NCT01119950|3864438|B1||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4042491|NCT01119950|3864438|B1||Female|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4042492|NCT01119950|3864438|B1|||Age||Years|Mean|61.2|61.2|Standard Deviation|7.91|7.91|||
4042493|NCT01119937|3864683|B3||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4042494|NCT01119937|3864684|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4042495|NCT01119937|3864685|B1||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4042496|NCT01119937|3864683|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4042497|NCT01119937|3864684|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4042498|NCT01119937|3864685|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4042499|NCT01119937|3864683|B3|||Age||years|Mean|68.7|68.7|Standard Deviation|7.32|7.32|||
4042500|NCT01119937|3864684|B2|||Age||years|Mean|69.4|69.4|Standard Deviation|7.48|7.48|||
4042501|NCT01119937|3864685|B1|||Age||years|Mean|68.4|68.4|Standard Deviation|7.29|7.29|||
4042502|NCT01119859|3864712|B3||Male|Sex: Female, Male|"Baseline Characteristics were analyzed for the intent-to-treat (ITT) population which included all randomized patients who received at least 1 dose of tocilizumab or adalimumab and had at least 1 efficacy assessment.~One randomized patient in the adalimumab treatment group did not receive treatment and was not included in any of the data analyses, including demographics."|Participants|Count of Participants|63|63.0||||||
4042503|NCT01119859|3864713|B2||Male|Sex: Female, Male|"Baseline Characteristics were analyzed for the intent-to-treat (ITT) population which included all randomized patients who received at least 1 dose of tocilizumab or adalimumab and had at least 1 efficacy assessment.~One randomized patient in the adalimumab treatment group did not receive treatment and was not included in any of the data analyses, including demographics."|Participants|Count of Participants|29|29.0||||||
4042504|NCT01119859|3864714|B1||Male|Sex: Female, Male|"Baseline Characteristics were analyzed for the intent-to-treat (ITT) population which included all randomized patients who received at least 1 dose of tocilizumab or adalimumab and had at least 1 efficacy assessment.~One randomized patient in the adalimumab treatment group did not receive treatment and was not included in any of the data analyses, including demographics."|Participants|Count of Participants|34|34.0||||||
4042505|NCT01119859|3864712|B3||Female|Sex: Female, Male|"Baseline Characteristics were analyzed for the intent-to-treat (ITT) population which included all randomized patients who received at least 1 dose of tocilizumab or adalimumab and had at least 1 efficacy assessment.~One randomized patient in the adalimumab treatment group did not receive treatment and was not included in any of the data analyses, including demographics."|Participants|Count of Participants|262|262.0||||||
4042506|NCT01119859|3864713|B2||Female|Sex: Female, Male|"Baseline Characteristics were analyzed for the intent-to-treat (ITT) population which included all randomized patients who received at least 1 dose of tocilizumab or adalimumab and had at least 1 efficacy assessment.~One randomized patient in the adalimumab treatment group did not receive treatment and was not included in any of the data analyses, including demographics."|Participants|Count of Participants|133|133.0||||||
4042507|NCT01119859|3864714|B1||Female|Sex: Female, Male|"Baseline Characteristics were analyzed for the intent-to-treat (ITT) population which included all randomized patients who received at least 1 dose of tocilizumab or adalimumab and had at least 1 efficacy assessment.~One randomized patient in the adalimumab treatment group did not receive treatment and was not included in any of the data analyses, including demographics."|Participants|Count of Participants|129|129.0||||||
4042508|NCT01119859|3864712|B3|||Age|"Baseline Characteristics were analyzed for the intent-to-treat (ITT) population which included all randomized patients who received at least 1 dose of tocilizumab or adalimumab and had at least 1 efficacy assessment.~One randomized patient in the adalimumab treatment group did not receive treatment and was not included in any of the data analyses, including demographics."|years|Mean|53.9|53.9|Standard Deviation|12.67|12.67|||
4042509|NCT01119859|3864713|B2|||Age|"Baseline Characteristics were analyzed for the intent-to-treat (ITT) population which included all randomized patients who received at least 1 dose of tocilizumab or adalimumab and had at least 1 efficacy assessment.~One randomized patient in the adalimumab treatment group did not receive treatment and was not included in any of the data analyses, including demographics."|years|Mean|53.3|53.3|Standard Deviation|12.43|12.43|||
4042510|NCT01119859|3864714|B1|||Age|"Baseline Characteristics were analyzed for the intent-to-treat (ITT) population which included all randomized patients who received at least 1 dose of tocilizumab or adalimumab and had at least 1 efficacy assessment.~One randomized patient in the adalimumab treatment group did not receive treatment and was not included in any of the data analyses, including demographics."|years|Mean|54.4|54.4|Standard Deviation|12.95|12.95|||
4042511|NCT01119846|3864731|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042512|NCT01119846|3864732|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042513|NCT01119846|3864733|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042514|NCT01119846|3864734|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042515|NCT01119846|3864731|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042516|NCT01119846|3864732|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042517|NCT01119846|3864733|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042518|NCT01119846|3864734|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042519|NCT01119846|3864731|B4||White|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4042520|NCT01119846|3864732|B3||White|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4042521|NCT01119846|3864733|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4042522|NCT01119846|3864734|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4042523|NCT01119846|3864731|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4042524|NCT01119846|3864732|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4042525|NCT01119846|3864733|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4042526|NCT01119846|3864734|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4042527|NCT01119846|3864731|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042528|NCT01119846|3864732|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042529|NCT01119846|3864733|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042530|NCT01119846|3864734|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042531|NCT01119846|3864731|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4042532|NCT01119846|3864732|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4042533|NCT01119846|3864733|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042534|NCT01119846|3864734|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042535|NCT01119846|3864731|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4042536|NCT01119846|3864732|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4042537|NCT01119846|3864733|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042538|NCT01119846|3864734|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042539|NCT01119846|3864731|B4||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4042540|NCT01119846|3864732|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4042541|NCT01119846|3864733|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4042542|NCT01119846|3864734|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4042543|NCT01119846|3864731|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4042544|NCT01119846|3864732|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4042545|NCT01119846|3864733|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4042546|NCT01119846|3864734|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4042547|NCT01119846|3864731|B4|18-60 Years||Age, Customized||Participants|Count of Participants|100|100.0||||||
4042548|NCT01119846|3864732|B3|18-60 Years||Age, Customized||Participants|Count of Participants|83|83.0||||||
4042549|NCT01119846|3864733|B2|18-60 Years||Age, Customized||Participants|Count of Participants|4|4.0||||||
4042550|NCT01119846|3864734|B1|18-60 Years||Age, Customized||Participants|Count of Participants|13|13.0||||||
4042551|NCT01119794|3864944|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4042552|NCT01119794|3864944|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4042553|NCT01119794|3864944|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4042554|NCT01119794|3864944|B1|||Age||years|Mean|68|68.0|Full Range|||55.0|85.0|
4042555|NCT01119794|3864944|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4042556|NCT01119794|3864944|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4042557|NCT01119794|3864944|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042558|NCT01119768|3864948|B3|China||Region of Enrollment||participants|Number|305|305.0||||||
4042559|NCT01119768|3864949|B2|China||Region of Enrollment||participants|Number|151|151.0||||||
4042560|NCT01119768|3864950|B1|China||Region of Enrollment||participants|Number|154|154.0||||||
4042561|NCT01119768|3864948|B3||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4042562|NCT01119768|3864949|B2||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4042563|NCT01119768|3864950|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4042564|NCT01119768|3864948|B3||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4042565|NCT01119768|3864949|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4042566|NCT01119768|3864950|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4042567|NCT01119768|3864948|B3|||Age||years|Mean|45.4|45.4|Standard Deviation|12.91|12.91|||
4042568|NCT01119768|3864949|B2|||Age||years|Mean|44.9|44.9|Standard Deviation|13.12|13.12|||
4042569|NCT01119768|3864950|B1|||Age||years|Mean|45.9|45.9|Standard Deviation|12.72|12.72|||
4042570|NCT01119768|3864948|B3||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4042571|NCT01119768|3864949|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4042572|NCT01119768|3864950|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4042573|NCT01119768|3864948|B3||Between 18 and 65 years|Age||Participants|Count of Participants|283|283.0||||||
4042574|NCT01119768|3864949|B2||Between 18 and 65 years|Age||Participants|Count of Participants|140|140.0||||||
4042575|NCT01119768|3864950|B1||Between 18 and 65 years|Age||Participants|Count of Participants|143|143.0||||||
4042576|NCT01119768|3864948|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042577|NCT01119768|3864949|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042578|NCT01119768|3864950|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042579|NCT01119755|3864973|B1|Greece||Region of Enrollment||participants|Number|80|80.0||||||
4042580|NCT01119755|3864973|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4042581|NCT01119755|3864973|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4042582|NCT01119755|3864973|B1|||Age||years|Mean|64|64.0|Standard Deviation|8.8|8.8|||
4042583|NCT01119755|3864973|B1||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
4042584|NCT01119755|3864973|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4042585|NCT01119755|3864973|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042586|NCT01119716|3864984|B1||Male|Sex: Female, Male||Participants|Count of Participants|2916|2916.0||||||
4042587|NCT01119716|3864984|B1||Female|Sex: Female, Male||Participants|Count of Participants|1742|1742.0||||||
4042588|NCT01119716|3864984|B1|||Age||years|Mean|63.5|63.5|Standard Deviation|12.5|12.5|||
4042589|NCT01119703|3865005|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4042590|NCT01119703|3865006|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4042591|NCT01119703|3865007|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4042592|NCT01119703|3865005|B3||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4042593|NCT01119703|3865006|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4042594|NCT01119703|3865007|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4042595|NCT01119703|3865005|B3|||Age||Years|Mean|63.9|63.9|Standard Deviation|14.3|14.3|||
4042596|NCT01119703|3865006|B2|||Age||Years|Mean|70.2|70.2|Standard Deviation|4.1|4.1|||
4042597|NCT01119703|3865007|B1|||Age||Years|Mean|33.9|33.9|Standard Deviation|3.6|3.6|||
4042598|NCT01119625|3865020|B3||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4042599|NCT01119625|3865021|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4042600|NCT01119625|3865022|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4042601|NCT01119625|3865020|B3||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4042602|NCT01119625|3865021|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4042603|NCT01119625|3865022|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4042604|NCT01119625|3865020|B3|||Age||Months|Mean|18.9|18.9|Standard Deviation|0.86|0.86|||
4042605|NCT01119625|3865021|B2|||Age||Months|Mean|18.9|18.9|Standard Deviation|0.87|0.87|||
4042606|NCT01119625|3865022|B1|||Age||Months|Mean|18.8|18.8|Standard Deviation|0.84|0.84|||
4042607|NCT01119443|3865063|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4042608|NCT01119443|3865064|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4042609|NCT01119443|3865065|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4042610|NCT01119443|3865063|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4042611|NCT01119443|3865064|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4042612|NCT01119443|3865065|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4042613|NCT01119443|3865063|B3|||Age||years|Mean|29.1|29.1|Standard Deviation|5.0|5.0|||
4042614|NCT01119443|3865064|B2|||Age||years|Mean|29.1|29.1|Standard Deviation|5.4|5.4|||
4042615|NCT01119443|3865065|B1|||Age||years|Mean|29.2|29.2|Standard Deviation|4.8|4.8|||
4042616|NCT01119287|3865103|B7|Canada||Region of Enrollment||participants|Number|170|170.0||||||
4042617|NCT01119287|3865104|B6|Canada||Region of Enrollment||participants|Number|32|32.0||||||
4042618|NCT01119287|3865105|B5|Canada||Region of Enrollment||participants|Number|31|31.0||||||
4042619|NCT01119287|3865106|B4|Canada||Region of Enrollment||participants|Number|31|31.0||||||
4042620|NCT01119287|3865107|B3|Canada||Region of Enrollment||participants|Number|26|26.0||||||
4042621|NCT01119287|3865108|B2|Canada||Region of Enrollment||participants|Number|24|24.0||||||
4042622|NCT01119287|3865109|B1|Canada||Region of Enrollment||participants|Number|26|26.0||||||
4042623|NCT01119287|3865103|B7||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4042624|NCT01119287|3865104|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4042625|NCT01119287|3865105|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4042626|NCT01119287|3865106|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4042627|NCT01119287|3865107|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4042628|NCT01119287|3865108|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4042629|NCT01119287|3865109|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4042630|NCT01119287|3865103|B7||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4042631|NCT01119287|3865104|B6||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4042632|NCT01119287|3865105|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4042633|NCT01119287|3865106|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4042634|NCT01119287|3865107|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4042635|NCT01119287|3865108|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4042636|NCT01119287|3865109|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4042637|NCT01119287|3865103|B7|||Age||years|Mean|35.91|35.91|Standard Deviation|10.62|10.62|||
4042638|NCT01119287|3865104|B6|||Age||years|Mean|35.9|35.9|Standard Deviation|8.4|8.4|||
4042639|NCT01119287|3865105|B5|||Age||years|Mean|32.9|32.9|Standard Deviation|9.3|9.3|||
4042640|NCT01119287|3865106|B4|||Age||years|Mean|34.5|34.5|Standard Deviation|11.6|11.6|||
4042641|NCT01119287|3865107|B3|||Age||years|Mean|40.0|40.0|Standard Deviation|10.0|10.0|||
4042642|NCT01119287|3865108|B2|||Age||years|Mean|39.2|39.2|Standard Deviation|13.8|13.8|||
4042643|NCT01119287|3865109|B1|||Age||years|Mean|34.0|34.0|Standard Deviation|9.6|9.6|||
4042644|NCT01119248|3865127|B1|||Body Surface Area (BSA)||m²|Mean|0.68|0.68|Full Range|||0.29|1.4|
4042645|NCT01119248|3865127|B1|United States||Region of Enrollment||participants|Number|120|120.0||||||
4042646|NCT01119248|3865127|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4042647|NCT01119248|3865127|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4042648|NCT01119248|3865127|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4042649|NCT01119248|3865127|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4042650|NCT01119248|3865127|B1||<=18 years|Age||Participants|Count of Participants|120|120.0||||||
4042651|NCT01119222|3865133|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4042652|NCT01119222|3865133|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4042653|NCT01119222|3865133|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4042654|NCT01119222|3865133|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4042655|NCT01119222|3865133|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042656|NCT01119131|3865174|B4|||Falls Self-Report||Falls|Mean|3.75|3.75|Standard Deviation|11.6|11.6|||
4042657|NCT01119131|3865175|B3|||Falls Self-Report||Falls|Mean|3.05|3.05|Standard Deviation|7.26|7.26|||
4042658|NCT01119131|3865176|B2|||Falls Self-Report||Falls|Mean|3.79|3.79|Standard Deviation|14.85|14.85|||
4042659|NCT01119131|3865177|B1|||Falls Self-Report||Falls|Mean|5.86|5.86|Standard Deviation|14.18|14.18|||
4042726|NCT01118988|3865228|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042727|NCT01118988|3865229|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042728|NCT01118988|3865226|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4042660|NCT01119131|3865174|B4|||MoCA|The MoCA is a short cognitive screening test designed to assist health care professionals for the detection of mild cognitive impairment. The MoCA assesses cognitive function across a variety of domains, such as visuospatial /executive functioning, naming (animals), memory, attention, language, abstraction, delayed recall, and orientation. The MoCA is scored on a 0 to 30 scale, with lower numbers indicating more cognitive impairment. A point is added to the MoCA if the subject's education high school or less (12 years or less education).|units on a scale|Mean|24.78|24.78|Standard Deviation|2.93|2.93|||
4042661|NCT01119131|3865175|B3|||MoCA|The MoCA is a short cognitive screening test designed to assist health care professionals for the detection of mild cognitive impairment. The MoCA assesses cognitive function across a variety of domains, such as visuospatial /executive functioning, naming (animals), memory, attention, language, abstraction, delayed recall, and orientation. The MoCA is scored on a 0 to 30 scale, with lower numbers indicating more cognitive impairment. A point is added to the MoCA if the subject's education high school or less (12 years or less education).|units on a scale|Mean|24.86|24.86|Standard Deviation|3.00|3.0|||
4042662|NCT01119131|3865176|B2|||MoCA|The MoCA is a short cognitive screening test designed to assist health care professionals for the detection of mild cognitive impairment. The MoCA assesses cognitive function across a variety of domains, such as visuospatial /executive functioning, naming (animals), memory, attention, language, abstraction, delayed recall, and orientation. The MoCA is scored on a 0 to 30 scale, with lower numbers indicating more cognitive impairment. A point is added to the MoCA if the subject's education high school or less (12 years or less education).|units on a scale|Mean|24.07|24.07|Standard Deviation|2.91|2.91|||
4042663|NCT01119131|3865177|B1|||MoCA|The MoCA is a short cognitive screening test designed to assist health care professionals for the detection of mild cognitive impairment. The MoCA assesses cognitive function across a variety of domains, such as visuospatial /executive functioning, naming (animals), memory, attention, language, abstraction, delayed recall, and orientation. The MoCA is scored on a 0 to 30 scale, with lower numbers indicating more cognitive impairment. A point is added to the MoCA if the subject's education high school or less (12 years or less education).|units on a scale|Mean|26.67|26.67|Standard Deviation|1.94|1.94|||
4042664|NCT01119131|3865174|B4|||Baseline Vitamin D||ng/ml|Mean|27.59|27.59|Standard Deviation|7.78|7.78|||
4042665|NCT01119131|3865175|B3|||Baseline Vitamin D||ng/ml|Mean|29.43|29.43|Standard Deviation|6.46|6.46|||
4042666|NCT01119131|3865176|B2|||Baseline Vitamin D||ng/ml|Mean|30.21|30.21|Standard Deviation|5.32|5.32|||
4042667|NCT01119131|3865177|B1|||Baseline Vitamin D||ng/ml|Mean|14.7|14.7|Standard Deviation|3.86|3.86|||
4042668|NCT01119131|3865174|B4|||UPDRS|This is the motor subsection of the UPDRS and is a commonly used tool to rate the symptoms of Parkinson‘s disease. Each item is rated from 0 (normal) to 4 (Can barely perform the task) several motor areas including speech, facial expression, tremor, rigidity, hand movements, agility, posture, and gait. Total score ranges from 0 to 108 with higher values on this scale represent a more severe stage of the disease.|units on a scale|Mean|23.93|23.93|Standard Deviation|10.25|10.25|||
4042669|NCT01119131|3865175|B3|||UPDRS|This is the motor subsection of the UPDRS and is a commonly used tool to rate the symptoms of Parkinson‘s disease. Each item is rated from 0 (normal) to 4 (Can barely perform the task) several motor areas including speech, facial expression, tremor, rigidity, hand movements, agility, posture, and gait. Total score ranges from 0 to 108 with higher values on this scale represent a more severe stage of the disease.|units on a scale|Mean|25.3|25.3|Standard Deviation|11.5|11.5|||
4042670|NCT01119131|3865176|B2|||UPDRS|This is the motor subsection of the UPDRS and is a commonly used tool to rate the symptoms of Parkinson‘s disease. Each item is rated from 0 (normal) to 4 (Can barely perform the task) several motor areas including speech, facial expression, tremor, rigidity, hand movements, agility, posture, and gait. Total score ranges from 0 to 108 with higher values on this scale represent a more severe stage of the disease.|units on a scale|Mean|22.36|22.36|Standard Deviation|8.56|8.56|||
4042671|NCT01119131|3865177|B1|||UPDRS|This is the motor subsection of the UPDRS and is a commonly used tool to rate the symptoms of Parkinson‘s disease. Each item is rated from 0 (normal) to 4 (Can barely perform the task) several motor areas including speech, facial expression, tremor, rigidity, hand movements, agility, posture, and gait. Total score ranges from 0 to 108 with higher values on this scale represent a more severe stage of the disease.|units on a scale|Mean|24.20|24.2|Standard Deviation|11.06|11.06|||
4042672|NCT01119131|3865174|B4|||Hoehn & Yahr|This is an objective staging scale for rating the clinical functioning of Parkinson’s disease patients, combining functional deficits (disability) and objective signs (impairment). This staging scale is commonly used in both research settings and clinical practice. The Hoehn & Yahr is an ordinal scale ranging from 0 (no signs of disease) to 5 (wheelchair bound/bedridden). The modified version of the scale includes increments of 0.5. The HY has shown good inter-rater reliability and, although it is used worldwide, the clinimetric validity has not been established.|units on a scale|Mean|2.45|2.45|Standard Deviation|0.44|0.44|||
4042673|NCT01119131|3865175|B3|||Hoehn & Yahr|This is an objective staging scale for rating the clinical functioning of Parkinson’s disease patients, combining functional deficits (disability) and objective signs (impairment). This staging scale is commonly used in both research settings and clinical practice. The Hoehn & Yahr is an ordinal scale ranging from 0 (no signs of disease) to 5 (wheelchair bound/bedridden). The modified version of the scale includes increments of 0.5. The HY has shown good inter-rater reliability and, although it is used worldwide, the clinimetric validity has not been established.|units on a scale|Mean|2.46|2.46|Standard Deviation|0.47|0.47|||
4042674|NCT01119131|3865176|B2|||Hoehn & Yahr|This is an objective staging scale for rating the clinical functioning of Parkinson’s disease patients, combining functional deficits (disability) and objective signs (impairment). This staging scale is commonly used in both research settings and clinical practice. The Hoehn & Yahr is an ordinal scale ranging from 0 (no signs of disease) to 5 (wheelchair bound/bedridden). The modified version of the scale includes increments of 0.5. The HY has shown good inter-rater reliability and, although it is used worldwide, the clinimetric validity has not been established.|units on a scale|Mean|2.48|2.48|Standard Deviation|0.46|0.46|||
4042729|NCT01118988|3865227|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4042730|NCT01118988|3865228|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042731|NCT01118988|3865229|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042675|NCT01119131|3865177|B1|||Hoehn & Yahr|This is an objective staging scale for rating the clinical functioning of Parkinson’s disease patients, combining functional deficits (disability) and objective signs (impairment). This staging scale is commonly used in both research settings and clinical practice. The Hoehn & Yahr is an ordinal scale ranging from 0 (no signs of disease) to 5 (wheelchair bound/bedridden). The modified version of the scale includes increments of 0.5. The HY has shown good inter-rater reliability and, although it is used worldwide, the clinimetric validity has not been established.|units on a scale|Mean|2.35|2.35|Standard Deviation|0.34|0.34|||
4042676|NCT01119131|3865174|B4|United States||Region of Enrollment||participants|Number|68|68.0||||||
4042677|NCT01119131|3865175|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4042678|NCT01119131|3865176|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4042679|NCT01119131|3865177|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4042680|NCT01119131|3865174|B4||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4042681|NCT01119131|3865175|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4042682|NCT01119131|3865176|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4042683|NCT01119131|3865177|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4042684|NCT01119131|3865174|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4042685|NCT01119131|3865175|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4042686|NCT01119131|3865176|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4042687|NCT01119131|3865177|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4042688|NCT01119131|3865174|B4|||Age||years|Mean|67.2|67.2|Standard Deviation|8.3|8.3|||
4042689|NCT01119131|3865175|B3|||Age||years|Mean|68.8|68.8|Standard Deviation|8.1|8.1|||
4042690|NCT01119131|3865176|B2|||Age||years|Mean|64.5|64.5|Standard Deviation|8.0|8.0|||
4042691|NCT01119131|3865177|B1|||Age||years|Mean|70.1|70.1|Standard Deviation|8.0|8.0|||
4042692|NCT01119118|3865208|B1|Prior Antiandrogen Therapy (no prior chemo)||Prior Therapy||Participants|Number|1|1.0||||||
4042693|NCT01119118|3865208|B1|Prior Antiandrogen and Cytotoxic Chemotherapy||Prior Therapy||Participants|Number|5|5.0||||||
4042694|NCT01119118|3865208|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4042695|NCT01119118|3865208|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4042696|NCT01119118|3865208|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4042697|NCT01119118|3865208|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4042698|NCT01119118|3865208|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4042699|NCT01119118|3865208|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042700|NCT01119040|3865216|B1|||number of days to assure leak-proof gastrocutaneous tract|Following initial placement of a PEG tube, a variable number of days is required to assure a leak-proof gastrocutaneous tract formed between the adherent stomach serosa and the parietal peritoneum of the anterior wall. In well-nourished, healthy individuals free of wound-healing impairment, a robust gastrotomy track is typically formed within 2 to 4 weeks. For PEG tubes dislodged in the first two weeks post-operatively, the risk of an incompletely formed gastrocutaneous fistula track prompts concern for intra-abdominal leakage from gastrotomy.|Days|Number|1|1.0||||||
4042701|NCT01119040|3865216|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4042702|NCT01119040|3865216|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4042703|NCT01119040|3865216|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4042704|NCT01119040|3865216|B1|Over the age of 18 yrs||Age, Customized||Participants|Number|1|1.0||||||
4042705|NCT01119001|3865220|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4042706|NCT01119001|3865220|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4042707|NCT01119001|3865220|B1|||Age||years|Mean|62|62.0|Full Range|||45.0|78.0|
4042708|NCT01118988|3865226|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4042709|NCT01118988|3865227|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042710|NCT01118988|3865228|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4042711|NCT01118988|3865229|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4042712|NCT01118988|3865226|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4042713|NCT01118988|3865227|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4042714|NCT01118988|3865228|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042715|NCT01118988|3865229|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042716|NCT01118988|3865226|B4||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4042717|NCT01118988|3865227|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4042718|NCT01118988|3865228|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4042719|NCT01118988|3865229|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4042720|NCT01118988|3865226|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4042721|NCT01118988|3865227|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042722|NCT01118988|3865228|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042723|NCT01118988|3865229|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4042724|NCT01118988|3865226|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042725|NCT01118988|3865227|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042732|NCT01118988|3865226|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042733|NCT01118988|3865227|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042734|NCT01118988|3865228|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042735|NCT01118988|3865229|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042736|NCT01118988|3865226|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4042737|NCT01118988|3865227|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042738|NCT01118988|3865228|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4042739|NCT01118988|3865229|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4042740|NCT01118988|3865226|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4042741|NCT01118988|3865227|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4042742|NCT01118988|3865228|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4042743|NCT01118988|3865229|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4042744|NCT01118988|3865226|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4042745|NCT01118988|3865227|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4042746|NCT01118988|3865228|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042747|NCT01118988|3865229|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4042748|NCT01118988|3865226|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4042749|NCT01118988|3865227|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4042750|NCT01118988|3865228|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4042751|NCT01118988|3865229|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4042752|NCT01118988|3865226|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4042753|NCT01118988|3865227|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4042754|NCT01118988|3865228|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4042755|NCT01118988|3865229|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4042756|NCT01118988|3865226|B4|||Age||Years|Mean|15.80|15.8|Standard Deviation|1.62|1.62|||
4042757|NCT01118988|3865227|B3|||Age||Years|Mean|16.88|16.88|Standard Deviation|1.49|1.49|||
4042758|NCT01118988|3865228|B2|||Age||Years|Mean|15.35|15.35|Standard Deviation|0.31|0.31|||
4042759|NCT01118988|3865229|B1|||Age||Years|Mean|15.44|15.44|Standard Deviation|1.71|1.71|||
4042760|NCT01118975|3865262|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4042761|NCT01118975|3865263|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4042762|NCT01118975|3865264|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4042763|NCT01118975|3865262|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4042764|NCT01118975|3865263|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4042765|NCT01118975|3865264|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4042766|NCT01118975|3865262|B3|||Age, Customized||years|Median|52|52.0|Full Range|||25.0|66.0|
4042767|NCT01118975|3865263|B2|||Age, Customized||years|Median|51|51.0|Full Range|||42.0|66.0|
4042768|NCT01118975|3865264|B1|||Age, Customized||years|Median|52|52.0|Full Range|||25.0|66.0|
4042769|NCT01118962|3865271|B1|||Height||Centimeters|Mean|167.88|167.88|Standard Deviation|8.25|8.25|||
4042770|NCT01118962|3865271|B1|||Weight||Kilograms|Mean|77.66|77.66|Standard Deviation|17.58|17.58|||
4042771|NCT01118962|3865271|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4042772|NCT01118962|3865271|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4042773|NCT01118962|3865271|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4042774|NCT01118962|3865271|B1|||Age||years|Mean|30.3|30.3|Standard Deviation|10.7|10.7|||
4042775|NCT01118962|3865271|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4042776|NCT01118962|3865271|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4042777|NCT01118962|3865271|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4042778|NCT01118949|3865276|B1|||Weight||kilogram (kg)|Mean|77.90|77.9|Standard Deviation|19.80|19.8|||
4042779|NCT01118949|3865276|B1|||Height||centimeter (cm)|Mean|168.08|168.08|Standard Deviation|9.32|9.32|||
4042780|NCT01118949|3865276|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4042781|NCT01118949|3865276|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4042782|NCT01118949|3865276|B1|||Age||years|Mean|29.7|29.7|Standard Deviation|10.1|10.1|||
4042783|NCT01118949|3865276|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4042784|NCT01118949|3865276|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4042785|NCT01118949|3865276|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4042786|NCT01118845|3865285|B1|||Body Surface Area（BSA）||m^2|Mean|1.537|1.537|Standard Deviation|0.184|0.184|||
4042787|NCT01118845|3865285|B1|||Weight||kg|Mean|57.64|57.64|Standard Deviation|12.85|12.85|||
4042788|NCT01118845|3865285|B1|||Height||cm|Mean|158.25|158.25|Standard Deviation|8.59|8.59|||
4042789|NCT01118845|3865285|B1|Unknown||International Prognostic Index risk category||Percentage of Participants|Number|0.0|0.0||||||
4042790|NCT01118845|3865285|B1|High-Intermediate (score≥3)||International Prognostic Index risk category||Percentage of Participants|Number|30.5|30.5||||||
4042791|NCT01118845|3865285|B1|Low-Intermediate (score<3)||International Prognostic Index risk category||Percentage of Participants|Number|69.5|69.5||||||
4042792|NCT01118845|3865285|B1|Unknown||International Prognostic Index risk category|"The criteria for International Prognostic Index risk category are as below:~Low (score=0-1): 5-year survival of 73%. Low (score=2): 5-year survival of 51%. High-intermediate (score=3): 5-year survival of 43%. High (score=4-5): 5-year survival of 26%"|Percentage of Participants|Number|0.0|0.0||||||
4042793|NCT01118845|3865285|B1|High(score=4-5)||International Prognostic Index risk category|"The criteria for International Prognostic Index risk category are as below:~Low (score=0-1): 5-year survival of 73%. Low (score=2): 5-year survival of 51%. High-intermediate (score=3): 5-year survival of 43%. High (score=4-5): 5-year survival of 26%"|Percentage of Participants|Number|6.8|6.8||||||
4042794|NCT01118845|3865285|B1|High-Intermediate (score=3)||International Prognostic Index risk category|"The criteria for International Prognostic Index risk category are as below:~Low (score=0-1): 5-year survival of 73%. Low (score=2): 5-year survival of 51%. High-intermediate (score=3): 5-year survival of 43%. High (score=4-5): 5-year survival of 26%"|Percentage of Participants|Number|23.6|23.6||||||
4042795|NCT01118845|3865285|B1|Low-Intermediate (score=2)||International Prognostic Index risk category|"The criteria for International Prognostic Index risk category are as below:~Low (score=0-1): 5-year survival of 73%. Low (score=2): 5-year survival of 51%. High-intermediate (score=3): 5-year survival of 43%. High (score=4-5): 5-year survival of 26%"|Percentage of Participants|Number|35.6|35.6||||||
4042796|NCT01118845|3865285|B1|Low (score=0-1)||International Prognostic Index risk category|"The criteria for International Prognostic Index risk category are as below:~Low (score=0-1): 5-year survival of 73%. Low (score=2): 5-year survival of 51%. High-intermediate (score=3): 5-year survival of 43%. High (score=4-5): 5-year survival of 26%"|Percentage of Participants|Number|33.9|33.9||||||
4042797|NCT01118845|3865285|B1|Unknown||Time from prior treatment|Time from the initiation of prior treatment to the initiation of the study drug in subjects with 1 regimen of prior treatment (64.4% of all the subjects).|Percentage of Participants|Number|0.0|0.0||||||
4042798|NCT01118845|3865285|B1|≥12 months||Time from prior treatment|Time from the initiation of prior treatment to the initiation of the study drug in subjects with 1 regimen of prior treatment (64.4% of all the subjects).|Percentage of Participants|Number|49.2|49.2||||||
4042799|NCT01118845|3865285|B1|<12 months||Time from prior treatment|Time from the initiation of prior treatment to the initiation of the study drug in subjects with 1 regimen of prior treatment (64.4% of all the subjects).|Percentage of Participants|Number|15.3|15.3||||||
4042800|NCT01118845|3865285|B1|Unknown||Response to prior treatment||Percentage of Participants|Number|0.0|0.0||||||
4042801|NCT01118845|3865285|B1|Non-Responder||Response to prior treatment||Percentage of Participants|Number|0.0|0.0||||||
4042802|NCT01118845|3865285|B1|Responder||Response to prior treatment||Percentage of Participants|Number|100.0|100.0||||||
4042803|NCT01118845|3865285|B1|Unknown||Bone marrow involvement||Percentage of Participants|Number|1.7|1.7||||||
4042804|NCT01118845|3865285|B1|Indeterminate||Bone marrow involvement||Percentage of Participants|Number|0.0|0.0||||||
4042805|NCT01118845|3865285|B1|Negative||Bone marrow involvement||Percentage of Participants|Number|94.9|94.9||||||
4042806|NCT01118845|3865285|B1|Positive||Bone marrow involvement||Percentage of Participants|Number|3.4|3.4||||||
4042807|NCT01118845|3865285|B1|≥4 extranodular sites||Site of disease||Percentage of Participants|Number|6.8|6.8||||||
4042808|NCT01118845|3865285|B1|<2 extranodular sites||Site of disease||Percentage of Participants|Number|93.2|93.2||||||
4042809|NCT01118845|3865285|B1|≥4 nodular sites||Site of disease||Percentage of Participants|Number|52.5|52.5||||||
4042810|NCT01118845|3865285|B1|<4 nodular sites||Site of disease||Percentage of Participants|Number|47.5|47.5||||||
4042811|NCT01118845|3865285|B1|≥240 IU/L||LDH||Percentage of Participants|Number|61.0|61.0||||||
4042812|NCT01118845|3865285|B1|<240 IU/L||LDH||Percentage of Participants|Number|39.0|39.0||||||
4042813|NCT01118845|3865285|B1|Elevated||lactate dehydrogenase (LDH)|The normal ranges vary among institutions.|Percentage of Participants|Number|55.9|55.9||||||
4042814|NCT01118845|3865285|B1|Within normal range||lactate dehydrogenase (LDH)|The normal ranges vary among institutions.|Percentage of Participants|Number|44.1|44.1||||||
4042815|NCT01118845|3865285|B1|≥7 cm||Tumor diameter||Percentage of Participants|Number|13.6|13.6||||||
4042816|NCT01118845|3865285|B1|<7 cm||Tumor diameter||Percentage of Participants|Number|86.4|86.4||||||
4042817|NCT01118845|3865285|B1|≥5 cm||Tumor diameter||Percentage of Participants|Number|28.8|28.8||||||
4042818|NCT01118845|3865285|B1|<5 cm||Tumor diameter||Percentage of Participants|Number|71.2|71.2||||||
4042819|NCT01118845|3865285|B1|1||P.S.(performance status)[the Eastern Cooperative Oncology Group (ECOG) criteria]|"P.S.(ECOG) criteria are as below:~0: Fully active, able to carry on all pre-disease performance without restriction. 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work. 2: Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours. 3: Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|Percentage of Participants|Number|33.9|33.9||||||
4042820|NCT01118845|3865285|B1|0||P.S.(performance status)[the Eastern Cooperative Oncology Group (ECOG) criteria]|"P.S.(ECOG) criteria are as below:~0: Fully active, able to carry on all pre-disease performance without restriction. 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work. 2: Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours. 3: Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair"|Percentage of Participants|Number|66.1|66.1||||||
4042821|NCT01118845|3865285|B1|3||Number of regimens||Percentage of participants|Number|13.6|13.6||||||
4042822|NCT01118845|3865285|B1|2||Number of regimens||Percentage of participants|Number|22.0|22.0||||||
4042823|NCT01118845|3865285|B1|1||Number of regimens||Percentage of participants|Number|64.4|64.4||||||
4042824|NCT01118845|3865285|B1|Yes||Prior treatment for DLBCL||Percentage of participants|Number|100.0|100.0||||||
4042825|NCT01118845|3865285|B1|No||Prior treatment for DLBCL||Percentage of participants|Number|0.0|0.0||||||
4042826|NCT01118845|3865285|B1|Yes||Prior medication/therapy for DLBCL (Transplant)||Percentage of participants|Number|13.6|13.6||||||
4042827|NCT01118845|3865285|B1|No||Prior medication/therapy for DLBCL (Transplant)||Percentage of participants|Number|86.4|86.4||||||
4042828|NCT01118845|3865285|B1|Yes||Prior medication/therapy for DLBCL||Percentage of participants|Number|91.5|91.5||||||
4042829|NCT01118845|3865285|B1|No||Prior medication/therapy for DLBCL||Percentage of participants|Number|8.5|8.5||||||
4042830|NCT01118845|3865285|B1|Yes||Complications of DLBCL||Percentage of participants|Number|93.2|93.2||||||
4042831|NCT01118845|3865285|B1|No||Complications of DLBCL||Percentage of participants|Number|6.8|6.8||||||
4042832|NCT01118845|3865285|B1|Yes||Medical history of diffuse large B-cell lymphoma (DLBCL)||Percentage of participants|Number|59.3|59.3||||||
4042833|NCT01118845|3865285|B1|No||Medical history of diffuse large B-cell lymphoma (DLBCL)||Percentage of participants|Number|40.7|40.7||||||
4042834|NCT01118845|3865285|B1|Unknown||Systemic symptoms (B symptoms) (Ann Arbor staging)||Percentage of participants|Number|0.0|0.0||||||
4042835|NCT01118845|3865285|B1|Symptomatic||Systemic symptoms (B symptoms) (Ann Arbor staging)||Percentage of participants|Number|13.6|13.6||||||
4042836|NCT01118845|3865285|B1|Asymptomatic||Systemic symptoms (B symptoms) (Ann Arbor staging)||Percentage of participants|Number|86.4|86.4||||||
4042837|NCT01118845|3865285|B1|Unknown||Clinical Stage (Ann Arbor staging)|"The criteria for Clinical Stage (Ann Arbor staging) are as below:~I: involvement of a single nodal region. II: involvement of 2 or more lymph node regions on the same side of the diaphragm. III: involvement of lymph node regions on both sides of the diaphragm. IV: disseminated involvement of 1 or more extra-lymphatic sites with or without associated lymph node involvement~E: if accompanied by localized involvement of a extra-lymphatic organ or site. S: if accompanied by involvement of the spleen. SE: if both S and E"|Percentage of participants|Number|0.0|0.0||||||
4042838|NCT01118845|3865285|B1|Stage IV||Clinical Stage (Ann Arbor staging)|"The criteria for Clinical Stage (Ann Arbor staging) are as below:~I: involvement of a single nodal region. II: involvement of 2 or more lymph node regions on the same side of the diaphragm. III: involvement of lymph node regions on both sides of the diaphragm. IV: disseminated involvement of 1 or more extra-lymphatic sites with or without associated lymph node involvement~E: if accompanied by localized involvement of a extra-lymphatic organ or site. S: if accompanied by involvement of the spleen. SE: if both S and E"|Percentage of participants|Number|25.4|25.4||||||
4042839|NCT01118845|3865285|B1|Stage III-SE||Clinical Stage (Ann Arbor staging)|"The criteria for Clinical Stage (Ann Arbor staging) are as below:~I: involvement of a single nodal region. II: involvement of 2 or more lymph node regions on the same side of the diaphragm. III: involvement of lymph node regions on both sides of the diaphragm. IV: disseminated involvement of 1 or more extra-lymphatic sites with or without associated lymph node involvement~E: if accompanied by localized involvement of a extra-lymphatic organ or site. S: if accompanied by involvement of the spleen. SE: if both S and E"|Percentage of participants|Number|0.0|0.0||||||
4042840|NCT01118845|3865285|B1|Stage III-E||Clinical Stage (Ann Arbor staging)|"The criteria for Clinical Stage (Ann Arbor staging) are as below:~I: involvement of a single nodal region. II: involvement of 2 or more lymph node regions on the same side of the diaphragm. III: involvement of lymph node regions on both sides of the diaphragm. IV: disseminated involvement of 1 or more extra-lymphatic sites with or without associated lymph node involvement~E: if accompanied by localized involvement of a extra-lymphatic organ or site. S: if accompanied by involvement of the spleen. SE: if both S and E"|Percentage of participants|Number|3.4|3.4||||||
4042841|NCT01118845|3865285|B1|Stage III-S||Clinical Stage (Ann Arbor staging)|"The criteria for Clinical Stage (Ann Arbor staging) are as below:~I: involvement of a single nodal region. II: involvement of 2 or more lymph node regions on the same side of the diaphragm. III: involvement of lymph node regions on both sides of the diaphragm. IV: disseminated involvement of 1 or more extra-lymphatic sites with or without associated lymph node involvement~E: if accompanied by localized involvement of a extra-lymphatic organ or site. S: if accompanied by involvement of the spleen. SE: if both S and E"|Percentage of participants|Number|6.8|6.8||||||
4042842|NCT01118845|3865285|B1|Stage III||Clinical Stage (Ann Arbor staging)|"The criteria for Clinical Stage (Ann Arbor staging) are as below:~I: involvement of a single nodal region. II: involvement of 2 or more lymph node regions on the same side of the diaphragm. III: involvement of lymph node regions on both sides of the diaphragm. IV: disseminated involvement of 1 or more extra-lymphatic sites with or without associated lymph node involvement~E: if accompanied by localized involvement of a extra-lymphatic organ or site. S: if accompanied by involvement of the spleen. SE: if both S and E"|Percentage of participants|Number|25.4|25.4||||||
4042843|NCT01118845|3865285|B1|Stage II-E||Clinical Stage (Ann Arbor staging)|"The criteria for Clinical Stage (Ann Arbor staging) are as below:~I: involvement of a single nodal region. II: involvement of 2 or more lymph node regions on the same side of the diaphragm. III: involvement of lymph node regions on both sides of the diaphragm. IV: disseminated involvement of 1 or more extra-lymphatic sites with or without associated lymph node involvement~E: if accompanied by localized involvement of a extra-lymphatic organ or site. S: if accompanied by involvement of the spleen. SE: if both S and E"|Percentage of participants|Number|3.4|3.4||||||
4042844|NCT01118845|3865285|B1|Stage II||Clinical Stage (Ann Arbor staging)|"The criteria for Clinical Stage (Ann Arbor staging) are as below:~I: involvement of a single nodal region. II: involvement of 2 or more lymph node regions on the same side of the diaphragm. III: involvement of lymph node regions on both sides of the diaphragm. IV: disseminated involvement of 1 or more extra-lymphatic sites with or without associated lymph node involvement~E: if accompanied by localized involvement of a extra-lymphatic organ or site. S: if accompanied by involvement of the spleen. SE: if both S and E"|Percentage of participants|Number|27.1|27.1||||||
4042845|NCT01118845|3865285|B1|Stage I-E||Clinical Stage (Ann Arbor staging)|"The criteria for Clinical Stage (Ann Arbor staging) are as below:~I: involvement of a single nodal region. II: involvement of 2 or more lymph node regions on the same side of the diaphragm. III: involvement of lymph node regions on both sides of the diaphragm. IV: disseminated involvement of 1 or more extra-lymphatic sites with or without associated lymph node involvement~E: if accompanied by localized involvement of a extra-lymphatic organ or site. S: if accompanied by involvement of the spleen. SE: if both S and E"|Percentage of participants|Number|3.4|3.4||||||
4042846|NCT01118845|3865285|B1|Stage I||Clinical Stage (Ann Arbor staging)|"The criteria for Clinical Stage (Ann Arbor staging) are as below:~I: involvement of a single nodal region. II: involvement of 2 or more lymph node regions on the same side of the diaphragm. III: involvement of lymph node regions on both sides of the diaphragm. IV: disseminated involvement of 1 or more extra-lymphatic sites with or without associated lymph node involvement~E: if accompanied by localized involvement of a extra-lymphatic organ or site. S: if accompanied by involvement of the spleen. SE: if both S and E"|Percentage of participants|Number|5.1|5.1||||||
4042847|NCT01118845|3865285|B1|||Diagnosis of Relapsed/Refractory Diffuse Large B-Cell Lymphoma||percentage of participants|Number|100.0|100.0||||||
4042848|NCT01118845|3865285|B1|Female||Sex/Gender, Customized||percentage of participants|Number|57.6|57.6||||||
4042849|NCT01118845|3865285|B1|Male||Sex/Gender, Customized||percentage of participants|Number|42.4|42.4||||||
4042850|NCT01118845|3865285|B1|≥65 years||Age, Customized||Percentage of participants|Number|62.7|62.7||||||
4042851|NCT01118845|3865285|B1|<65 years||Age, Customized||Percentage of participants|Number|37.3|37.3||||||
4042852|NCT01118845|3865285|B1|70-75 years||Age, Customized||Percentage of participants|Number|33.9|33.9||||||
4042853|NCT01118845|3865285|B1|60-69 years||Age, Customized||Percentage of participants|Number|39.0|39.0||||||
4042854|NCT01118845|3865285|B1|50-59 years||Age, Customized||Percentage of participants|Number|16.9|16.9||||||
4042855|NCT01118845|3865285|B1|40-49 years||Age, Customized||Percentage of participants|Number|8.5|8.5||||||
4042856|NCT01118845|3865285|B1|30-39 years||Age, Customized||Percentage of participants|Number|1.7|1.7||||||
4042857|NCT01118845|3865285|B1|20-29 years||Age, Customized||Percentage of participants|Number|0.0|0.0||||||
4042858|NCT01118845|3865285|B1|||Age||Year|Mean|64.2|64.2|Standard Deviation|9.2|9.2|||
4042859|NCT01118780|3865304|B3|||Years Since Onset of Generalized Anxiety Disorder (GAD)|GAD was defined as excessive anxiety and worry, present more days than not, for at least 6 months, in accordance with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition-Text Revised (DSM-IV TR). The excessive anxiety and worry must have been difficult to control and must have caused significant distress or impairment in normal functioning.|years|Mean|12.32|12.32|Standard Deviation|15.52|15.52|||
4042860|NCT01118780|3865305|B2|||Years Since Onset of Generalized Anxiety Disorder (GAD)|GAD was defined as excessive anxiety and worry, present more days than not, for at least 6 months, in accordance with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition-Text Revised (DSM-IV TR). The excessive anxiety and worry must have been difficult to control and must have caused significant distress or impairment in normal functioning.|years|Mean|11.83|11.83|Standard Deviation|14.55|14.55|||
4042861|NCT01118780|3865306|B1|||Years Since Onset of Generalized Anxiety Disorder (GAD)|GAD was defined as excessive anxiety and worry, present more days than not, for at least 6 months, in accordance with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition-Text Revised (DSM-IV TR). The excessive anxiety and worry must have been difficult to control and must have caused significant distress or impairment in normal functioning.|years|Mean|12.78|12.78|Standard Deviation|16.40|16.4|||
4042862|NCT01118780|3865304|B3|||Hamilton Anxiety Rating Scale (HAMA) Total Score|The Structured Interview Guide for the Hamilton Anxiety Rating Scale (SIGH-A) was used to collect HAMA data. The HAMA Total Score consisted of 14 items that assessed the severity of anxiety. Each item was scored using a 5-point scale (0=not present to 4=very severe). The HAMA Total Score could have ranged from 0 to 56 and higher scores indicated a greater degree of symptom severity.|units on a scale|Mean|24.49|24.49|Standard Deviation|6.74|6.74|||
4042863|NCT01118780|3865305|B2|||Hamilton Anxiety Rating Scale (HAMA) Total Score|The Structured Interview Guide for the Hamilton Anxiety Rating Scale (SIGH-A) was used to collect HAMA data. The HAMA Total Score consisted of 14 items that assessed the severity of anxiety. Each item was scored using a 5-point scale (0=not present to 4=very severe). The HAMA Total Score could have ranged from 0 to 56 and higher scores indicated a greater degree of symptom severity.|units on a scale|Mean|24.36|24.36|Standard Deviation|7.11|7.11|||
4042864|NCT01118780|3865306|B1|||Hamilton Anxiety Rating Scale (HAMA) Total Score|The Structured Interview Guide for the Hamilton Anxiety Rating Scale (SIGH-A) was used to collect HAMA data. The HAMA Total Score consisted of 14 items that assessed the severity of anxiety. Each item was scored using a 5-point scale (0=not present to 4=very severe). The HAMA Total Score could have ranged from 0 to 56 and higher scores indicated a greater degree of symptom severity.|units on a scale|Mean|24.62|24.62|Standard Deviation|6.40|6.4|||
4042865|NCT01118780|3865304|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4042866|NCT01118780|3865305|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4042867|NCT01118780|3865306|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4042868|NCT01118780|3865304|B3|United Kingdom||Region of Enrollment||participants|Number|17|17.0||||||
4042869|NCT01118780|3865305|B2|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
4042870|NCT01118780|3865306|B1|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
4042871|NCT01118780|3865304|B3|Spain||Region of Enrollment||participants|Number|18|18.0||||||
4042872|NCT01118780|3865305|B2|Spain||Region of Enrollment||participants|Number|9|9.0||||||
4042873|NCT01118780|3865306|B1|Spain||Region of Enrollment||participants|Number|9|9.0||||||
4042874|NCT01118780|3865304|B3|Puerto Rico||Region of Enrollment||participants|Number|12|12.0||||||
4042875|NCT01118780|3865305|B2|Puerto Rico||Region of Enrollment||participants|Number|5|5.0||||||
4042876|NCT01118780|3865306|B1|Puerto Rico||Region of Enrollment||participants|Number|7|7.0||||||
4042877|NCT01118780|3865304|B3|Poland||Region of Enrollment||participants|Number|56|56.0||||||
4042878|NCT01118780|3865305|B2|Poland||Region of Enrollment||participants|Number|29|29.0||||||
4042879|NCT01118780|3865306|B1|Poland||Region of Enrollment||participants|Number|27|27.0||||||
4042880|NCT01118780|3865304|B3|Mexico||Region of Enrollment||participants|Number|42|42.0||||||
4042881|NCT01118780|3865305|B2|Mexico||Region of Enrollment||participants|Number|21|21.0||||||
4042882|NCT01118780|3865306|B1|Mexico||Region of Enrollment||participants|Number|21|21.0||||||
4042883|NCT01118780|3865304|B3|Germany||Region of Enrollment||participants|Number|40|40.0||||||
4042884|NCT01118780|3865305|B2|Germany||Region of Enrollment||participants|Number|20|20.0||||||
4042885|NCT01118780|3865306|B1|Germany||Region of Enrollment||participants|Number|20|20.0||||||
4042886|NCT01118780|3865304|B3|Canada||Region of Enrollment||participants|Number|18|18.0||||||
4042887|NCT01118780|3865305|B2|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4042888|NCT01118780|3865306|B1|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4042889|NCT01118780|3865304|B3|Austria||Region of Enrollment||participants|Number|23|23.0||||||
4042890|NCT01118780|3865305|B2|Austria||Region of Enrollment||participants|Number|10|10.0||||||
4042891|NCT01118780|3865306|B1|Austria||Region of Enrollment||participants|Number|13|13.0||||||
4042892|NCT01118780|3865304|B3|Argentina||Region of Enrollment||participants|Number|29|29.0||||||
4042893|NCT01118780|3865305|B2|Argentina||Region of Enrollment||participants|Number|12|12.0||||||
4042894|NCT01118780|3865306|B1|Argentina||Region of Enrollment||participants|Number|17|17.0||||||
4042895|NCT01118780|3865304|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4042896|NCT01118780|3865305|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4042897|NCT01118780|3865306|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042898|NCT01118780|3865304|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042899|NCT01118780|3865305|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042900|NCT01118780|3865306|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042901|NCT01118780|3865304|B3||White|Race (NIH/OMB)||Participants|Count of Participants|249|249.0||||||
4042902|NCT01118780|3865305|B2||White|Race (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
4042903|NCT01118780|3865306|B1||White|Race (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
4042904|NCT01118780|3865304|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4042905|NCT01118780|3865305|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042906|NCT01118780|3865306|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4042907|NCT01118780|3865304|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042908|NCT01118780|3865305|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042909|NCT01118780|3865306|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042910|NCT01118780|3865304|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042911|NCT01118780|3865305|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042912|NCT01118780|3865306|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042913|NCT01118780|3865304|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4042914|NCT01118780|3865305|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4042915|NCT01118780|3865306|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4042916|NCT01118780|3865304|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042917|NCT01118780|3865305|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042918|NCT01118780|3865306|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042919|NCT01118780|3865304|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|189|189.0||||||
4042920|NCT01118780|3865305|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
4042921|NCT01118780|3865306|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4042922|NCT01118780|3865304|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
4042923|NCT01118780|3865305|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4042924|NCT01118780|3865306|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4042925|NCT01118780|3865304|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4042926|NCT01118780|3865305|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4042927|NCT01118780|3865306|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4042928|NCT01118780|3865304|B3||Female|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
4042929|NCT01118780|3865305|B2||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4042930|NCT01118780|3865306|B1||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4042931|NCT01118780|3865304|B3|||Age||years|Mean|71.56|71.56|Standard Deviation|5.22|5.22|||
4042932|NCT01118780|3865305|B2|||Age||years|Mean|71.70|71.7|Standard Deviation|5.04|5.04|||
4042933|NCT01118780|3865306|B1|||Age||years|Mean|71.43|71.43|Standard Deviation|5.39|5.39|||
4042934|NCT01118741|3865354|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4042935|NCT01118741|3865355|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4042936|NCT01118741|3865356|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4042937|NCT01118741|3865354|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4042938|NCT01118741|3865355|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4042939|NCT01118741|3865356|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4042940|NCT01118741|3865354|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4042941|NCT01118741|3865355|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4042942|NCT01118741|3865356|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4042943|NCT01118741|3865354|B3|||Age||years|Mean|64.5|64.5|Standard Deviation|5.6|5.6|||
4042944|NCT01118741|3865355|B2|||Age||years|Mean|62.6|62.6|Standard Deviation|3.4|3.4|||
4042945|NCT01118741|3865356|B1|||Age||years|Mean|66.6|66.6|Standard Deviation|7.0|7.0|||
4042946|NCT01118741|3865354|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4042947|NCT01118741|3865355|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4042948|NCT01118741|3865356|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4042949|NCT01118741|3865354|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4042950|NCT01118741|3865355|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4042951|NCT01118741|3865356|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4042952|NCT01118741|3865354|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042953|NCT01118741|3865355|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042954|NCT01118741|3865356|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4042955|NCT01118728|3865365|B1||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4042956|NCT01118728|3865365|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4042957|NCT01118728|3865365|B1|||Age||Years|Mean|41.6|41.6|Standard Deviation|11.3|11.3|||
4042958|NCT01118663|3865370|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4042959|NCT01118663|3865371|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4042960|NCT01118663|3865372|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4042961|NCT01118663|3865370|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4042962|NCT01118663|3865371|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4042963|NCT01118663|3865372|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042964|NCT01118663|3865370|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4042965|NCT01118663|3865371|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042966|NCT01118663|3865372|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4042967|NCT01118663|3865370|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4042968|NCT01118663|3865371|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4042969|NCT01118663|3865372|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4042970|NCT01118663|3865370|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042971|NCT01118663|3865371|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042972|NCT01118663|3865372|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042973|NCT01118663|3865370|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042974|NCT01118663|3865371|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042975|NCT01118663|3865372|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042976|NCT01118663|3865370|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042977|NCT01118663|3865371|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042978|NCT01118663|3865372|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042979|NCT01118663|3865370|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042980|NCT01118663|3865371|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042981|NCT01118663|3865372|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042982|NCT01118663|3865370|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042983|NCT01118663|3865371|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042984|NCT01118663|3865372|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4042985|NCT01118663|3865370|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4042986|NCT01118663|3865371|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4042987|NCT01118663|3865372|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4042988|NCT01118663|3865370|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4042989|NCT01118663|3865371|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4042990|NCT01118663|3865372|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4042991|NCT01118663|3865370|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4042992|NCT01118663|3865371|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4042993|NCT01118663|3865372|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4042994|NCT01118663|3865370|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4042995|NCT01118663|3865371|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4042996|NCT01118663|3865372|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4042997|NCT01118663|3865370|B3|≥ 60 years||Age, Customized||participants|Number|2|2.0||||||
4042998|NCT01118663|3865371|B2|≥ 60 years||Age, Customized||participants|Number|2|2.0||||||
4042999|NCT01118663|3865372|B1|≥ 60 years||Age, Customized||participants|Number|0|0.0||||||
4043000|NCT01118663|3865370|B3|19-59 years||Age, Customized||participants|Number|14|14.0||||||
4043001|NCT01118663|3865371|B2|19-59 years||Age, Customized||participants|Number|8|8.0||||||
4043002|NCT01118663|3865372|B1|19-59 years||Age, Customized||participants|Number|6|6.0||||||
4043003|NCT01118663|3865370|B3|≤ 18 years||Age, Customized||participants|Number|1|1.0||||||
4043004|NCT01118663|3865371|B2|≤ 18 years||Age, Customized||participants|Number|0|0.0||||||
4043005|NCT01118663|3865372|B1|≤ 18 years||Age, Customized||participants|Number|1|1.0||||||
4043006|NCT01118624|3865387|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4043007|NCT01118624|3865387|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043008|NCT01118624|3865387|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4043009|NCT01118624|3865387|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043010|NCT01118624|3865387|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043011|NCT01118624|3865387|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043012|NCT01118624|3865387|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043013|NCT01118624|3865387|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4043014|NCT01118624|3865387|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4043015|NCT01118624|3865387|B1|||Age||years|Mean|56.4|56.4|Standard Deviation|11.8|11.8|||
4043016|NCT01118455|3865394|B3|||Age at Epilepsy Onset (years)||years|Mean|2.6|2.6|Standard Deviation|2.8|2.8|||
4043017|NCT01118455|3865395|B2|||Age at Epilepsy Onset (years)||years|Mean|2.7|2.7|Standard Deviation|2.9|2.9|||
4043018|NCT01118455|3865396|B1|||Age at Epilepsy Onset (years)||years|Mean|2.4|2.4|Standard Deviation|2.7|2.7|||
4043019|NCT01118455|3865394|B3|||Number of Failed Medications||Number of failed medications|Median|6.0|6.0|Full Range|2.3|2.3|2.0|11.0|
4043020|NCT01118455|3865395|B2|||Number of Failed Medications||Number of failed medications|Median|6.0|6.0|Full Range|2.4|2.4|2.0|11.0|
4043021|NCT01118455|3865396|B1|||Number of Failed Medications||Number of failed medications|Median|6.0|6.0|Full Range|2.2|2.2|3.0|11.0|
4043022|NCT01118455|3865394|B3||Male|Sex: Female, Male|Treatment Group; VNS (n=65), AED (n=69), Total (n=134)|Participants|Count of Participants|76|76.0||||||
4043023|NCT01118455|3865395|B2||Male|Sex: Female, Male|Treatment Group; VNS (n=65), AED (n=69), Total (n=134)|Participants|Count of Participants|43|43.0||||||
4043024|NCT01118455|3865396|B1||Male|Sex: Female, Male|Treatment Group; VNS (n=65), AED (n=69), Total (n=134)|Participants|Count of Participants|33|33.0||||||
4043025|NCT01118455|3865394|B3||Female|Sex: Female, Male|Treatment Group; VNS (n=65), AED (n=69), Total (n=134)|Participants|Count of Participants|58|58.0||||||
4043026|NCT01118455|3865395|B2||Female|Sex: Female, Male|Treatment Group; VNS (n=65), AED (n=69), Total (n=134)|Participants|Count of Participants|26|26.0||||||
4043027|NCT01118455|3865396|B1||Female|Sex: Female, Male|Treatment Group; VNS (n=65), AED (n=69), Total (n=134)|Participants|Count of Participants|32|32.0||||||
4043028|NCT01118455|3865394|B3|||Age|Age at Enrollment (Years)|years|Mean|10.7|10.7|Standard Deviation|3.4|3.4|||
4043029|NCT01118455|3865395|B2|||Age|Age at Enrollment (Years)|years|Mean|10.8|10.8|Standard Deviation|3.4|3.4|||
4043030|NCT01118455|3865396|B1|||Age|Age at Enrollment (Years)|years|Mean|10.7|10.7|Standard Deviation|3.5|3.5|||
4043031|NCT01118377|3865425|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4043032|NCT01118377|3865425|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4043033|NCT01118377|3865425|B1|||Age||years|Mean|7.5|7.5|Standard Deviation|3.69|3.69|||
4043034|NCT01118325|3865431|B4|Non-Japanese||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4043035|NCT01118325|3865432|B3|Non-Japanese||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4043036|NCT01118325|3865433|B2|Non-Japanese||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4043037|NCT01118325|3865434|B1|Non-Japanese||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4043038|NCT01118325|3865431|B4|Japanese||Race/Ethnicity, Customized||Participants|Number|117|117.0||||||
4043039|NCT01118325|3865432|B3|Japanese||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
4043040|NCT01118325|3865433|B2|Japanese||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
4043041|NCT01118325|3865434|B1|Japanese||Race/Ethnicity, Customized||Participants|Number|42|42.0||||||
4043042|NCT01118325|3865431|B4||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4043043|NCT01118325|3865432|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4043044|NCT01118325|3865433|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4043045|NCT01118325|3865434|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4043046|NCT01118325|3865431|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4043047|NCT01118325|3865432|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4043048|NCT01118325|3865433|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4043049|NCT01118325|3865434|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4043050|NCT01118325|3865431|B4|||Age||Years|Mean|63|63.0|Standard Deviation|10|10.0|||
4043051|NCT01118325|3865432|B3|||Age||Years|Mean|64|64.0|Standard Deviation|10|10.0|||
4043052|NCT01118325|3865433|B2|||Age||Years|Mean|64|64.0|Standard Deviation|9|9.0|||
4043053|NCT01118325|3865434|B1|||Age||Years|Mean|63|63.0|Standard Deviation|11|11.0|||
4043054|NCT01118312|3865480|B3||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4043055|NCT01118312|3865481|B2||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4043056|NCT01118312|3865482|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4043057|NCT01118312|3865480|B3||Female|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4043058|NCT01118312|3865481|B2||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4043059|NCT01118312|3865482|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4043060|NCT01118312|3865480|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4043061|NCT01118312|3865481|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4043062|NCT01118312|3865482|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4043063|NCT01118312|3865480|B3||Between 18 and 65 years|Age||Participants|Count of Participants|237|237.0||||||
4043064|NCT01118312|3865481|B2||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
4043065|NCT01118312|3865482|B1||Between 18 and 65 years|Age||Participants|Count of Participants|117|117.0||||||
4043066|NCT01118312|3865480|B3||<=18 years|Age||Participants|Count of Participants|151|151.0||||||
4043067|NCT01118312|3865481|B2||<=18 years|Age||Participants|Count of Participants|79|79.0||||||
4043068|NCT01118312|3865482|B1||<=18 years|Age||Participants|Count of Participants|72|72.0||||||
4043069|NCT01118273|3865491|B7|Severe pain||Baseline Categorical Pain Rating Scale||Participants|Number|67|67.0||||||
4043070|NCT01118273|3865492|B6|Severe pain||Baseline Categorical Pain Rating Scale||Participants|Number|13|13.0||||||
4043071|NCT01118273|3865493|B5|Severe pain||Baseline Categorical Pain Rating Scale||Participants|Number|6|6.0||||||
4043072|NCT01118273|3865494|B4|Severe pain||Baseline Categorical Pain Rating Scale||Participants|Number|10|10.0||||||
4043073|NCT01118273|3865495|B3|Severe pain||Baseline Categorical Pain Rating Scale||Participants|Number|13|13.0||||||
4043074|NCT01118273|3865496|B2|Severe pain||Baseline Categorical Pain Rating Scale||Participants|Number|13|13.0||||||
4043075|NCT01118273|3865497|B1|Severe pain||Baseline Categorical Pain Rating Scale||Participants|Number|12|12.0||||||
4043076|NCT01118273|3865491|B7|Moderate pain||Baseline Categorical Pain Rating Scale||Participants|Number|95|95.0||||||
4043077|NCT01118273|3865492|B6|Moderate pain||Baseline Categorical Pain Rating Scale||Participants|Number|14|14.0||||||
4043078|NCT01118273|3865493|B5|Moderate pain||Baseline Categorical Pain Rating Scale||Participants|Number|21|21.0||||||
4043079|NCT01118273|3865494|B4|Moderate pain||Baseline Categorical Pain Rating Scale||Participants|Number|17|17.0||||||
4043080|NCT01118273|3865495|B3|Moderate pain||Baseline Categorical Pain Rating Scale||Participants|Number|14|14.0||||||
4043081|NCT01118273|3865496|B2|Moderate pain||Baseline Categorical Pain Rating Scale||Participants|Number|14|14.0||||||
4043082|NCT01118273|3865497|B1|Moderate pain||Baseline Categorical Pain Rating Scale||Participants|Number|15|15.0||||||
4043083|NCT01118273|3865491|B7|Mild pain||Baseline Categorical Pain Rating Scale||Participants|Number|0|0.0||||||
4043084|NCT01118273|3865492|B6|Mild pain||Baseline Categorical Pain Rating Scale||Participants|Number|0|0.0||||||
4043085|NCT01118273|3865493|B5|Mild pain||Baseline Categorical Pain Rating Scale||Participants|Number|0|0.0||||||
4043086|NCT01118273|3865494|B4|Mild pain||Baseline Categorical Pain Rating Scale||Participants|Number|0|0.0||||||
4043087|NCT01118273|3865495|B3|Mild pain||Baseline Categorical Pain Rating Scale||Participants|Number|0|0.0||||||
4043088|NCT01118273|3865496|B2|Mild pain||Baseline Categorical Pain Rating Scale||Participants|Number|0|0.0||||||
4043089|NCT01118273|3865497|B1|Mild pain||Baseline Categorical Pain Rating Scale||Participants|Number|0|0.0||||||
4043090|NCT01118273|3865491|B7|No pain||Baseline Categorical Pain Rating Scale||Participants|Number|0|0.0||||||
4043091|NCT01118273|3865492|B6|No pain||Baseline Categorical Pain Rating Scale||Participants|Number|0|0.0||||||
4043092|NCT01118273|3865493|B5|No pain||Baseline Categorical Pain Rating Scale||Participants|Number|0|0.0||||||
4043093|NCT01118273|3865494|B4|No pain||Baseline Categorical Pain Rating Scale||Participants|Number|0|0.0||||||
4043094|NCT01118273|3865495|B3|No pain||Baseline Categorical Pain Rating Scale||Participants|Number|0|0.0||||||
4043095|NCT01118273|3865496|B2|No pain||Baseline Categorical Pain Rating Scale||Participants|Number|0|0.0||||||
4043096|NCT01118273|3865497|B1|No pain||Baseline Categorical Pain Rating Scale||Participants|Number|0|0.0||||||
4043097|NCT01118273|3865491|B7||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4043098|NCT01118273|3865492|B6||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4043099|NCT01118273|3865493|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4043100|NCT01118273|3865494|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4043101|NCT01118273|3865495|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4043102|NCT01118273|3865496|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4043103|NCT01118273|3865497|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4043104|NCT01118273|3865491|B7||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4043105|NCT01118273|3865492|B6||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4043106|NCT01118273|3865493|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4043107|NCT01118273|3865494|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4043108|NCT01118273|3865495|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4043109|NCT01118273|3865496|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4043110|NCT01118273|3865497|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4043111|NCT01118273|3865491|B7|||Age||years|Mean|19|19.0|Standard Deviation|2.6|2.6|||
4043112|NCT01118273|3865492|B6|||Age||years|Mean|20|20.0|Standard Deviation|2.6|2.6|||
4043113|NCT01118273|3865493|B5|||Age||years|Mean|19|19.0|Standard Deviation|2.5|2.5|||
4043114|NCT01118273|3865494|B4|||Age||years|Mean|19|19.0|Standard Deviation|3.0|3.0|||
4043115|NCT01118273|3865495|B3|||Age||years|Mean|19|19.0|Standard Deviation|2.0|2.0|||
4043116|NCT01118273|3865496|B2|||Age||years|Mean|20|20.0|Standard Deviation|2.8|2.8|||
4043117|NCT01118273|3865497|B1|||Age||years|Mean|19|19.0|Standard Deviation|2.8|2.8|||
4043118|NCT01118221|3865666|B3|South America||Region of Enrollment||participants|Number|1|1.0||||||
4043119|NCT01118221|3865667|B2|South America||Region of Enrollment||participants|Number|1|1.0||||||
4043120|NCT01118221|3865668|B1|South America||Region of Enrollment||participants|Number|0|0.0||||||
4043121|NCT01118221|3865666|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4043122|NCT01118221|3865667|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4043123|NCT01118221|3865668|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4043124|NCT01118221|3865666|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043125|NCT01118221|3865667|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043126|NCT01118221|3865668|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043127|NCT01118221|3865666|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043128|NCT01118221|3865667|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043129|NCT01118221|3865668|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043130|NCT01118221|3865666|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4043131|NCT01118221|3865667|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4043132|NCT01118221|3865668|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4043133|NCT01118221|3865666|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4043134|NCT01118221|3865667|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043135|NCT01118221|3865668|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4043136|NCT01118221|3865666|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043137|NCT01118221|3865667|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043138|NCT01118221|3865668|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043139|NCT01118221|3865666|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043140|NCT01118221|3865667|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043141|NCT01118221|3865668|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043142|NCT01118221|3865666|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043143|NCT01118221|3865667|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043144|NCT01118221|3865668|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043145|NCT01118221|3865666|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043146|NCT01118221|3865667|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043147|NCT01118221|3865668|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043148|NCT01118221|3865666|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4043149|NCT01118221|3865667|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4043150|NCT01118221|3865668|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4043151|NCT01118221|3865666|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4043152|NCT01118221|3865667|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4043153|NCT01118221|3865668|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4043154|NCT01118221|3865666|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4043155|NCT01118221|3865667|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4043156|NCT01118221|3865668|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4043157|NCT01118221|3865666|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4043158|NCT01118221|3865667|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4043159|NCT01118221|3865668|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4043160|NCT01118221|3865666|B3|||Age||years|Mean|69|69.0|Standard Deviation|6|6.0|||
4043161|NCT01118221|3865667|B2|||Age||years|Mean|66|66.0|Standard Deviation|7|7.0|||
4043162|NCT01118221|3865668|B1|||Age||years|Mean|71|71.0|Standard Deviation|6|6.0|||
4043163|NCT01118143|3865679|B3|Adequate health literacy||health literacy level||paticipants|Number|33|33.0||||||
4043164|NCT01118143|3865680|B2|Adequate health literacy||health literacy level||paticipants|Number|20|20.0||||||
4043165|NCT01118143|3865681|B1|Adequate health literacy||health literacy level||paticipants|Number|13|13.0||||||
4043166|NCT01118143|3865679|B3|Marginal health literacy||health literacy level||paticipants|Number|61|61.0||||||
4043167|NCT01118143|3865680|B2|Marginal health literacy||health literacy level||paticipants|Number|25|25.0||||||
4043168|NCT01118143|3865681|B1|Marginal health literacy||health literacy level||paticipants|Number|36|36.0||||||
4043169|NCT01118143|3865679|B3|Inadequate health literacy||health literacy level||paticipants|Number|39|39.0||||||
4043170|NCT01118143|3865680|B2|Inadequate health literacy||health literacy level||paticipants|Number|24|24.0||||||
4043171|NCT01118143|3865681|B1|Inadequate health literacy||health literacy level||paticipants|Number|15|15.0||||||
4043172|NCT01118143|3865679|B3|Norway||Region of Enrollment||participants|Number|133|133.0||||||
4043173|NCT01118143|3865680|B2|Norway||Region of Enrollment||participants|Number|69|69.0||||||
4043174|NCT01118143|3865681|B1|Norway||Region of Enrollment||participants|Number|64|64.0||||||
4043175|NCT01118143|3865679|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4043176|NCT01118143|3865680|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4043177|NCT01118143|3865681|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4043178|NCT01118143|3865679|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4043179|NCT01118143|3865680|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4043180|NCT01118143|3865681|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4043181|NCT01118143|3865679|B3|||Age||years|Mean|47.9|47.9|Standard Deviation|14.73|14.73|||
4043182|NCT01118143|3865680|B2|||Age||years|Mean|46.4|46.4|Standard Deviation|14.23|14.23|||
4043183|NCT01118143|3865681|B1|||Age||years|Mean|49.7|49.7|Standard Deviation|15.19|15.19|||
4043184|NCT01118143|3865679|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4043185|NCT01118143|3865680|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4043186|NCT01118143|3865681|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4043187|NCT01118143|3865679|B3||Between 18 and 65 years|Age||Participants|Count of Participants|117|117.0||||||
4043188|NCT01118143|3865680|B2||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4043189|NCT01118143|3865681|B1||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4043190|NCT01118143|3865679|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043191|NCT01118143|3865680|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043192|NCT01118143|3865681|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043193|NCT01118117|3865690|B3|Korea, Republic of||Region of Enrollment||participants|Number|1|1.0||||||
4043194|NCT01118117|3865691|B2|Korea, Republic of||Region of Enrollment||participants|Number|0|0.0||||||
4043195|NCT01118117|3865692|B1|Korea, Republic of||Region of Enrollment||participants|Number|1|1.0||||||
4043196|NCT01118117|3865690|B3|Taiwan||Region of Enrollment||participants|Number|9|9.0||||||
4043197|NCT01118117|3865691|B2|Taiwan||Region of Enrollment||participants|Number|0|0.0||||||
4043198|NCT01118117|3865692|B1|Taiwan||Region of Enrollment||participants|Number|9|9.0||||||
4043199|NCT01118117|3865690|B3|Japan||Region of Enrollment||participants|Number|50|50.0||||||
4043200|NCT01118117|3865691|B2|Japan||Region of Enrollment||participants|Number|0|0.0||||||
4043201|NCT01118117|3865692|B1|Japan||Region of Enrollment||participants|Number|50|50.0||||||
4043202|NCT01118117|3865690|B3|United States||Region of Enrollment||participants|Number|216|216.0||||||
4043203|NCT01118117|3865691|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4043204|NCT01118117|3865692|B1|United States||Region of Enrollment||participants|Number|201|201.0||||||
4043205|NCT01118117|3865690|B3||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4043206|NCT01118117|3865691|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4043207|NCT01118117|3865692|B1||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4043208|NCT01118117|3865690|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4043209|NCT01118117|3865691|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4043210|NCT01118117|3865692|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4043211|NCT01118117|3865690|B3|||Age||years|Mean|NA||Standard Deviation|NA||||Combined analysis of pivotal cohort and LL sub-study cohort was not completed
4043212|NCT01118117|3865691|B2|||Age||years|Mean|70.7|70.7|Standard Deviation|10.9|10.9|||
4043213|NCT01118117|3865692|B1|||Age||years|Mean|69.3|69.3|Standard Deviation|10|10.0|||
4043214|NCT01118091|3865712|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4043215|NCT01118091|3865713|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4043216|NCT01118091|3865714|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4043217|NCT01118091|3865712|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043218|NCT01118091|3865713|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043219|NCT01118091|3865714|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043220|NCT01118091|3865712|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043221|NCT01118091|3865713|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043222|NCT01118091|3865714|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043223|NCT01118091|3865712|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4043224|NCT01118091|3865713|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4043225|NCT01118091|3865714|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4043226|NCT01118091|3865712|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043227|NCT01118091|3865713|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043228|NCT01118091|3865714|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043229|NCT01118091|3865712|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043230|NCT01118091|3865713|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043231|NCT01118091|3865714|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043232|NCT01118091|3865712|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043233|NCT01118091|3865713|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043234|NCT01118091|3865714|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043235|NCT01118091|3865712|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043236|NCT01118091|3865713|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043237|NCT01118091|3865714|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043238|NCT01118091|3865712|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043239|NCT01118091|3865713|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043240|NCT01118091|3865714|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043241|NCT01118091|3865712|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4043242|NCT01118091|3865713|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4043243|NCT01118091|3865714|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4043244|NCT01118091|3865712|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043245|NCT01118091|3865713|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043246|NCT01118091|3865714|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043247|NCT01118091|3865712|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4043248|NCT01118091|3865713|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4043249|NCT01118091|3865714|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4043250|NCT01118091|3865712|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4043251|NCT01118091|3865713|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4043252|NCT01118091|3865714|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4043253|NCT01118091|3865712|B3|||Age||years|Mean|49.15|49.15|Standard Deviation|8.85|8.85|||
4043254|NCT01118091|3865713|B2|||Age||years|Mean|53.6|53.6|Standard Deviation|9.5|9.5|||
4043255|NCT01118091|3865714|B1|||Age||years|Mean|44.7|44.7|Standard Deviation|8.2|8.2|||
4043256|NCT01118091|3865712|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4043257|NCT01118091|3865713|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4043258|NCT01118091|3865714|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4043259|NCT01118091|3865712|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4043260|NCT01118091|3865713|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4043261|NCT01118091|3865714|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4043262|NCT01118091|3865712|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043263|NCT01118091|3865713|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043264|NCT01118091|3865714|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043265|NCT01118052|3865725|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4043266|NCT01118052|3865725|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4043267|NCT01118052|3865725|B1|70 - 79 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
4043268|NCT01118052|3865725|B1|60 - 69 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
4043269|NCT01118052|3865725|B1|50 - 59 years||Age, Customized||Participants|Count of Participants|12|12.0||||||
4043270|NCT01118052|3865725|B1|40 - 49 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
4043271|NCT01118052|3865725|B1|< 40 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4043272|NCT01118013|3865738|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4043273|NCT01118013|3865738|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043274|NCT01118013|3865738|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043275|NCT01118013|3865738|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4043276|NCT01118013|3865738|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043277|NCT01118013|3865738|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043278|NCT01118013|3865738|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043279|NCT01118013|3865738|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043280|NCT01118013|3865738|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4043281|NCT01118013|3865738|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4043282|NCT01118013|3865738|B1|||Age||years|Median|67|67.0|Full Range|||58.0|71.0|
4043283|NCT01117987|3865746|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4043284|NCT01117987|3865747|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4043285|NCT01117987|3865748|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4043286|NCT01117987|3865746|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4043287|NCT01117987|3865747|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4043288|NCT01117987|3865748|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4043289|NCT01117987|3865746|B3|||Age||Years|Mean|47.4|47.4|Standard Deviation|14.42|14.42|||
4043290|NCT01117987|3865747|B2|||Age||Years|Mean|45.7|45.7|Standard Deviation|13.31|13.31|||
4043291|NCT01117987|3865748|B1|||Age||Years|Mean|49.3|49.3|Standard Deviation|15.52|15.52|||
4043292|NCT01117948|3865759|B3|Germany||Region of Enrollment||participants|Number|22|22.0||||||
4043293|NCT01117948|3865760|B2|Germany||Region of Enrollment||participants|Number|11|11.0||||||
4043294|NCT01117948|3865761|B1|Germany||Region of Enrollment||participants|Number|11|11.0||||||
4043295|NCT01117948|3865759|B3|Slovakia||Region of Enrollment||participants|Number|49|49.0||||||
4043296|NCT01117948|3865760|B2|Slovakia||Region of Enrollment||participants|Number|21|21.0||||||
4043297|NCT01117948|3865761|B1|Slovakia||Region of Enrollment||participants|Number|28|28.0||||||
4043298|NCT01117948|3865759|B3|Czech Republic||Region of Enrollment||participants|Number|78|78.0||||||
4043299|NCT01117948|3865760|B2|Czech Republic||Region of Enrollment||participants|Number|41|41.0||||||
4043300|NCT01117948|3865761|B1|Czech Republic||Region of Enrollment||participants|Number|37|37.0||||||
4043301|NCT01117948|3865759|B3|Austria||Region of Enrollment||participants|Number|70|70.0||||||
4043302|NCT01117948|3865760|B2|Austria||Region of Enrollment||participants|Number|35|35.0||||||
4043303|NCT01117948|3865761|B1|Austria||Region of Enrollment||participants|Number|35|35.0||||||
4043304|NCT01117948|3865759|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4043305|NCT01117948|3865760|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4043306|NCT01117948|3865761|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4043307|NCT01117948|3865759|B3||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4043308|NCT01117948|3865760|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4043309|NCT01117948|3865761|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4043310|NCT01117948|3865759|B3|||Age||years|Mean|74.1|74.1|Standard Deviation|7.45|7.45|||
4043311|NCT01117948|3865760|B2|||Age||years|Mean|73.6|73.6|Standard Deviation|8.11|8.11|||
4043312|NCT01117948|3865761|B1|||Age||years|Mean|74.5|74.5|Standard Deviation|6.75|6.75|||
4043313|NCT01117948|3865759|B3||>=65 years|Age||Participants|Count of Participants|190|190.0||||||
4043314|NCT01117948|3865760|B2||>=65 years|Age||Participants|Count of Participants|89|89.0||||||
4043315|NCT01117948|3865761|B1||>=65 years|Age||Participants|Count of Participants|101|101.0||||||
4043316|NCT01117948|3865759|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4043317|NCT01117948|3865760|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4043318|NCT01117948|3865761|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4043319|NCT01117948|3865759|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043320|NCT01117948|3865760|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043321|NCT01117948|3865761|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043322|NCT01117870|3865768|B3|Canada||Region of Enrollment||participants|Number|31|31.0||||||
4043323|NCT01117870|3865769|B2|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4043324|NCT01117870|3865770|B1|Canada||Region of Enrollment||participants|Number|15|15.0||||||
4043325|NCT01117870|3865768|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4043326|NCT01117870|3865769|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4043327|NCT01117870|3865770|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4043328|NCT01117870|3865768|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4043329|NCT01117870|3865769|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4043330|NCT01117870|3865770|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4043331|NCT01117870|3865768|B3|||Age||years|Mean|59.5|59.5|Full Range|||34.0|85.0|
4043332|NCT01117870|3865769|B2|||Age||years|Mean|63.8|63.8|Full Range|||48.0|85.0|
4043333|NCT01117870|3865770|B1|||Age||years|Mean|57.8|57.8|Full Range|||34.0|83.0|
4043334|NCT01117870|3865768|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4043335|NCT01117870|3865769|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4043336|NCT01117870|3865770|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4043337|NCT01117870|3865768|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4043338|NCT01117870|3865769|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4043339|NCT01117870|3865770|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4043340|NCT01117870|3865768|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043341|NCT01117870|3865769|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043342|NCT01117870|3865770|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043343|NCT01117857|3865785|B1|No||Past hormone therapy use||participants|Number|18|18.0||||||
4043344|NCT01117857|3865785|B1|Yes||Past hormone therapy use||participants|Number|1|1.0||||||
4043345|NCT01117857|3865785|B1|Surgically Postmenopausal||Menopause Status||participants|Number|1|1.0||||||
4043346|NCT01117857|3865785|B1|Naturally Postmenopausal||Menopause Status||participants|Number|7|7.0||||||
4043347|NCT01117857|3865785|B1|Perimenopausal||Menopause Status||participants|Number|11|11.0||||||
4043348|NCT01117857|3865785|B1|Retired||Employment Status||participants|Number|2|2.0||||||
4043349|NCT01117857|3865785|B1|Volunteer||Employment Status||participants|Number|1|1.0||||||
4043350|NCT01117857|3865785|B1|Student||Employment Status||participants|Number|1|1.0||||||
4043351|NCT01117857|3865785|B1|Unemployed/disabled||Employment Status||participants|Number|7|7.0||||||
4043352|NCT01117857|3865785|B1|Homemaker||Employment Status||participants|Number|4|4.0||||||
4043353|NCT01117857|3865785|B1|Full- or part-time work||Employment Status||participants|Number|4|4.0||||||
4043354|NCT01117857|3865785|B1|Bachelor's degree||Education||participants|Number|4|4.0||||||
4043355|NCT01117857|3865785|B1|Some college||Education||participants|Number|9|9.0||||||
4043356|NCT01117857|3865785|B1|High school diploma or GED||Education||participants|Number|5|5.0||||||
4043357|NCT01117857|3865785|B1|Less than high school degree||Education||participants|Number|1|1.0||||||
4043358|NCT01117857|3865785|B1|Decline to answer||Marital Status||participants|Number|3|3.0||||||
4043359|NCT01117857|3865785|B1|Never married/single||Marital Status||participants|Number|8|8.0||||||
4043360|NCT01117857|3865785|B1|Separated/divorced/widowed||Marital Status||participants|Number|5|5.0||||||
4043361|NCT01117857|3865785|B1|Married||Marital Status||participants|Number|3|3.0||||||
4043362|NCT01117857|3865785|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4043363|NCT01117857|3865785|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4043364|NCT01117857|3865785|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4043365|NCT01117857|3865785|B1|||Age||years|Mean|52.1|52.1|Standard Deviation|5.4|5.4|||
4043366|NCT01117766|3865793|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4043367|NCT01117766|3865793|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4043368|NCT01117766|3865793|B1|>=65 years||Age, Customized||participants|Number|10|10.0||||||
4043369|NCT01117766|3865793|B1|45 to 64 years||Age, Customized||participants|Number|12|12.0||||||
4043370|NCT01117766|3865793|B1|18 to 44 years||Age, Customized||participants|Number|9|9.0||||||
4043371|NCT01117727|3865818|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4043372|NCT01117727|3865818|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4043373|NCT01117727|3865818|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4043374|NCT01117727|3865818|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4043375|NCT01117727|3865818|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043376|NCT01117623|3865823|B9||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4043377|NCT01117623|3865824|B8||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4043378|NCT01117623|3865825|B7||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4043379|NCT01117623|3865826|B6||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4043380|NCT01117623|3865827|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4043381|NCT01117623|3865828|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4043382|NCT01117623|3865829|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4043383|NCT01117623|3865830|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4043384|NCT01117623|3865831|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4043385|NCT01117623|3865823|B9||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4043386|NCT01117623|3865824|B8||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4043387|NCT01117623|3865825|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4043388|NCT01117623|3865826|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4043389|NCT01117623|3865827|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4043390|NCT01117623|3865828|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4043391|NCT01117623|3865829|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4043392|NCT01117623|3865830|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4043393|NCT01117623|3865831|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4043394|NCT01117623|3865823|B9|||Age||Years|Mean|59.6|59.6|Standard Deviation|11.8|11.8|||
4043395|NCT01117623|3865824|B8|||Age||Years|Mean|62.4|62.4|Standard Deviation|12.2|12.2|||
4043396|NCT01117623|3865825|B7|||Age||Years|Mean|56.7|56.7|Standard Deviation|13.1|13.1|||
4043397|NCT01117623|3865826|B6|||Age||Years|Mean|56.6|56.6|Standard Deviation|13.2|13.2|||
4043398|NCT01117623|3865827|B5|||Age||Years|Mean|55.7|55.7|Standard Deviation|13.7|13.7|||
4043399|NCT01117623|3865828|B4|||Age||Years|Mean|59.2|59.2|Standard Deviation|10.7|10.7|||
4043400|NCT01117623|3865829|B3|||Age||Years|Mean|61.9|61.9|Standard Deviation|8.8|8.8|||
4043401|NCT01117623|3865830|B2|||Age||Years|Mean|55.3|55.3|Standard Deviation|13.1|13.1|||
4043402|NCT01117623|3865831|B1|||Age||Years|Mean|63.3|63.3|Standard Deviation|8.1|8.1|||
4043403|NCT01117480|3865990|B1|||Rheumatoid Arthritis Disease Activity Index (RADAI)|"The RADAI is a questionnaire used for measuring disease activity. The index consists of 6 questions: (1) global disease activity in the last 6 months, (2) disease activity in terms of current swollen and tender joints, (3) arthritis pain, (4) the current status of health, (5) duration of morning stiffness and (6) tender joints to be rated in a joint list. The RADAI total score is the sum of individual items divided by 5 (range 0-10).~A total of 13 participants had RADAI information missing/ unavailable at baseline. These participants were excluded from the efficacy analysis."|units on a scale|Mean|5.4|5.4|Standard Deviation|2.1|2.1|||
4043404|NCT01117480|3865990|B1|||Health Assessment Questionnaire (HAQ)|"HAQ-DI is a participant-reported questionnaire referring to eight domains: dressing/grooming, arising, eating, walking, hygiene, reach, grip, and daily activities. Participants assessed their ability to do each task over the past week using the following response categories: without any difficulty (0); with some difficulty (1); with much difficulty (2); and unable to do (3); which were summed and averaged to provide an overall score ranging from 0 to 3.~A total of 13 participants had HAQ information missing/ unavailable at baseline. These participants were excluded from the efficacy analysis."|units on a scale|Mean|1.39|1.39|Standard Deviation|0.72|0.72|||
4043405|NCT01117480|3865990|B1|||Disease Activity Score 28 (DAS-28)|"The DAS28 is a validated index of rheumatoid arthritis disease activity. Twenty-eight tender joint counts, 28 swollen joint counts, erythrocyte sedimentation rate (ESR), and the Subject's Global Assessment of Disease Activity (subject rates disease activity using a likert scale from 0 [low activity] to 10 [high activity]) are included in the DAS28 score. Scores on the DAS28 range from 0 to 10.~A total of 64 participants had DAS-28 information missing/ unavailable at baseline. These participants were excluded from the efficacy analysis."|units on a scale|Mean|5.14|5.14|Standard Deviation|1.60|1.6|||
4043406|NCT01117480|3865990|B1|||Disease duration||years|Mean|10.0|10.0|Standard Deviation|9.8|9.8|||
4043407|NCT01117480|3865990|B1||Male|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
4043408|NCT01117480|3865990|B1||Female|Sex: Female, Male||Participants|Count of Participants|751|751.0||||||
4043409|NCT01117480|3865990|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|12.8|12.8|||
4043410|NCT01117454|3865996|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4043411|NCT01117454|3865997|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4043412|NCT01117454|3865998|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4043413|NCT01117454|3865996|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4043414|NCT01117454|3865997|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4043415|NCT01117454|3865998|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4043416|NCT01117454|3865996|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4043417|NCT01117454|3865997|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4043418|NCT01117454|3865998|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4043419|NCT01117454|3865996|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4043420|NCT01117454|3865997|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4043421|NCT01117454|3865998|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4043422|NCT01117454|3865996|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4043423|NCT01117454|3865997|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4043424|NCT01117454|3865998|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4043425|NCT01117454|3865996|B3||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4043426|NCT01117454|3865997|B2||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4043427|NCT01117454|3865998|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4043428|NCT01117428|3866005|B7|||Disease duration||years|Mean|NA||Standard Deviation|NA||||Total disease duration cannot be calculated because it is defined by cohort, not the total study population.
4043429|NCT01117428|3866006|B6|||Disease duration||years|Mean|3.8|3.8|Standard Deviation|2.3|2.3|||
4043430|NCT01117428|3866007|B5|||Disease duration||years|Mean|4.0|4.0|Standard Deviation|2.9|2.9|||
4043431|NCT01117428|3866008|B4|||Disease duration||years|Mean|2.8|2.8|Standard Deviation|1.0|1.0|||
4043432|NCT01117428|3866009|B3|||Disease duration||years|Mean|4.1|4.1|Standard Deviation|2.7|2.7|||
4043433|NCT01117428|3866010|B2|||Disease duration||years|Mean|3.6|3.6|Standard Deviation|1.6|1.6|||
4043434|NCT01117428|3866011|B1|||Disease duration||years|Mean|4.2|4.2|Standard Deviation|2.7|2.7|||
4043435|NCT01117428|3866005|B7|Spain||Region of Enrollment||participants|Number|91|91.0||||||
4043436|NCT01117428|3866006|B6|Spain||Region of Enrollment||participants|Number|17|17.0||||||
4043437|NCT01117428|3866007|B5|Spain||Region of Enrollment||participants|Number|17|17.0||||||
4043438|NCT01117428|3866008|B4|Spain||Region of Enrollment||participants|Number|12|12.0||||||
4043439|NCT01117428|3866009|B3|Spain||Region of Enrollment||participants|Number|12|12.0||||||
4043440|NCT01117428|3866010|B2|Spain||Region of Enrollment||participants|Number|24|24.0||||||
4043441|NCT01117428|3866011|B1|Spain||Region of Enrollment||participants|Number|9|9.0||||||
4043442|NCT01117428|3866005|B7|United States||Region of Enrollment||participants|Number|11|11.0||||||
4043443|NCT01117428|3866006|B6|United States||Region of Enrollment||participants|Number|0|0.0||||||
4043444|NCT01117428|3866007|B5|United States||Region of Enrollment||participants|Number|0|0.0||||||
4043445|NCT01117428|3866008|B4|United States||Region of Enrollment||participants|Number|0|0.0||||||
4043446|NCT01117428|3866009|B3|United States||Region of Enrollment||participants|Number|0|0.0||||||
4043447|NCT01117428|3866010|B2|United States||Region of Enrollment||participants|Number|0|0.0||||||
4043448|NCT01117428|3866011|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4043449|NCT01117428|3866005|B7|Belgium||Region of Enrollment||participants|Number|9|9.0||||||
4043450|NCT01117428|3866006|B6|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
4043451|NCT01117428|3866007|B5|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
4043452|NCT01117428|3866008|B4|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
4043453|NCT01117428|3866009|B3|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4043454|NCT01117428|3866010|B2|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
4043455|NCT01117428|3866011|B1|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
4043456|NCT01117428|3866005|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043457|NCT01117428|3866006|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043458|NCT01117428|3866007|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043459|NCT01117428|3866008|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043460|NCT01117428|3866009|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043461|NCT01117428|3866010|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043462|NCT01117428|3866011|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043463|NCT01117428|3866005|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
4043464|NCT01117428|3866006|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4043465|NCT01117428|3866007|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4043466|NCT01117428|3866008|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4043467|NCT01117428|3866009|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4043468|NCT01117428|3866010|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4043469|NCT01117428|3866011|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4043470|NCT01117428|3866005|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4043471|NCT01117428|3866006|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043472|NCT01117428|3866007|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4043473|NCT01117428|3866008|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043474|NCT01117428|3866009|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043475|NCT01117428|3866010|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4043476|NCT01117428|3866011|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4043477|NCT01117428|3866005|B7||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4043478|NCT01117428|3866006|B6||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4043479|NCT01117428|3866007|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4043480|NCT01117428|3866008|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4043481|NCT01117428|3866009|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4043482|NCT01117428|3866010|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4043483|NCT01117428|3866011|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4043484|NCT01117428|3866005|B7||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4043485|NCT01117428|3866006|B6||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4043486|NCT01117428|3866007|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4043487|NCT01117428|3866008|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4043488|NCT01117428|3866009|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4043489|NCT01117428|3866010|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4043490|NCT01117428|3866011|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4043491|NCT01117428|3866005|B7||>=65 years|Age||Participants|Count of Participants|54|54.0||||||
4043492|NCT01117428|3866006|B6||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4043493|NCT01117428|3866007|B5||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4043494|NCT01117428|3866008|B4||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4043495|NCT01117428|3866009|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4043496|NCT01117428|3866010|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4043497|NCT01117428|3866011|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4043498|NCT01117428|3866005|B7||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4043499|NCT01117428|3866006|B6||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4043500|NCT01117428|3866007|B5||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4043501|NCT01117428|3866008|B4||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4043502|NCT01117428|3866009|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4043503|NCT01117428|3866010|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4043504|NCT01117428|3866011|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4043505|NCT01117428|3866005|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043506|NCT01117428|3866006|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043507|NCT01117428|3866007|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043508|NCT01117428|3866008|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043509|NCT01117428|3866009|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043510|NCT01117428|3866010|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043511|NCT01117428|3866011|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043512|NCT01117350|3866048|B3|||Glycosylated Hemoglobin A1c (HbA1c) at week -2||percent|Mean|9.07|9.07|Standard Deviation|1.09|1.09|||
4043513|NCT01117350|3866049|B2|||Glycosylated Hemoglobin A1c (HbA1c) at week -2||percent|Mean|9.11|9.11|Standard Deviation|1.09|1.09|||
4043514|NCT01117350|3866050|B1|||Glycosylated Hemoglobin A1c (HbA1c) at week -2||percent|Mean|9.04|9.04|Standard Deviation|1.10|1.1|||
4043515|NCT01117350|3866048|B3|No||At least one diabetic late complication|Diabetic late complications: myocardial infarction, angina pectoris, coronary artery disease, heart failure, stroke, transient ischemic attack, peripheral vascular disease, diabetic neuropathy, diabetic nephropathy, diabetic retinopathy|participants|Number|509|509.0||||||
4043516|NCT01117350|3866049|B2|No||At least one diabetic late complication|Diabetic late complications: myocardial infarction, angina pectoris, coronary artery disease, heart failure, stroke, transient ischemic attack, peripheral vascular disease, diabetic neuropathy, diabetic nephropathy, diabetic retinopathy|participants|Number|247|247.0||||||
4043517|NCT01117350|3866050|B1|No||At least one diabetic late complication|Diabetic late complications: myocardial infarction, angina pectoris, coronary artery disease, heart failure, stroke, transient ischemic attack, peripheral vascular disease, diabetic neuropathy, diabetic nephropathy, diabetic retinopathy|participants|Number|262|262.0||||||
4043518|NCT01117350|3866048|B3|Yes||At least one diabetic late complication|Diabetic late complications: myocardial infarction, angina pectoris, coronary artery disease, heart failure, stroke, transient ischemic attack, peripheral vascular disease, diabetic neuropathy, diabetic nephropathy, diabetic retinopathy|participants|Number|435|435.0||||||
4043519|NCT01117350|3866049|B2|Yes||At least one diabetic late complication|Diabetic late complications: myocardial infarction, angina pectoris, coronary artery disease, heart failure, stroke, transient ischemic attack, peripheral vascular disease, diabetic neuropathy, diabetic nephropathy, diabetic retinopathy|participants|Number|223|223.0||||||
4043688|NCT01116986|3866199|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4043520|NCT01117350|3866050|B1|Yes||At least one diabetic late complication|Diabetic late complications: myocardial infarction, angina pectoris, coronary artery disease, heart failure, stroke, transient ischemic attack, peripheral vascular disease, diabetic neuropathy, diabetic nephropathy, diabetic retinopathy|participants|Number|212|212.0||||||
4043521|NCT01117350|3866048|B3|||Duration of Type 2 diabetes||years|Median|8.49|8.49|Inter-Quartile Range|||4.94|12.17|
4043522|NCT01117350|3866049|B2|||Duration of Type 2 diabetes||years|Median|8.41|8.41|Inter-Quartile Range|||4.8|11.69|
4043523|NCT01117350|3866050|B1|||Duration of Type 2 diabetes||years|Median|8.54|8.54|Inter-Quartile Range|||5.2|12.38|
4043524|NCT01117350|3866048|B3|||Body Mass Index (BMI) at week -2||kg/m²|Mean|31.88|31.88|Standard Deviation|4.18|4.18|||
4043525|NCT01117350|3866049|B2|||Body Mass Index (BMI) at week -2||kg/m²|Mean|31.75|31.75|Standard Deviation|4.12|4.12|||
4043526|NCT01117350|3866050|B1|||Body Mass Index (BMI) at week -2||kg/m²|Mean|32.00|32.0|Standard Deviation|4.24|4.24|||
4043527|NCT01117350|3866048|B3||Male|Sex: Female, Male||Participants|Count of Participants|513|513.0||||||
4043528|NCT01117350|3866049|B2||Male|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
4043529|NCT01117350|3866050|B1||Male|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
4043530|NCT01117350|3866048|B3||Female|Sex: Female, Male||Participants|Count of Participants|431|431.0||||||
4043531|NCT01117350|3866049|B2||Female|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4043532|NCT01117350|3866050|B1||Female|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
4043533|NCT01117350|3866048|B3|||Age||years|Mean|57.25|57.25|Standard Deviation|8.81|8.81|||
4043534|NCT01117350|3866049|B2|||Age||years|Mean|57.44|57.44|Standard Deviation|8.85|8.85|||
4043535|NCT01117350|3866050|B1|||Age||years|Mean|57.07|57.07|Standard Deviation|8.78|8.78|||
4043536|NCT01117337|3866081|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4043537|NCT01117337|3866082|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4043538|NCT01117337|3866083|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4043539|NCT01117337|3866081|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4043540|NCT01117337|3866082|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4043541|NCT01117337|3866083|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4043542|NCT01117337|3866081|B3|||Age||years|Mean|49.6|49.6|Standard Deviation|15.1|15.1|||
4043543|NCT01117337|3866082|B2|||Age||years|Mean|51.9|51.9|Standard Deviation|16.8|16.8|||
4043544|NCT01117337|3866083|B1|||Age||years|Mean|47.2|47.2|Standard Deviation|12.9|12.9|||
4043545|NCT01117311|3866094|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4043546|NCT01117311|3866094|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4043547|NCT01117311|3866094|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4043548|NCT01117311|3866094|B1|||Age||years|Mean|53.1|53.1|Standard Deviation|4.8|4.8|||
4043549|NCT01117311|3866094|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4043550|NCT01117311|3866094|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4043551|NCT01117311|3866094|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043552|NCT01117181|3866103|B3|Canada||Region of Enrollment||participants|Number|19|19.0||||||
4043553|NCT01117181|3866104|B2|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4043554|NCT01117181|3866105|B1|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4043555|NCT01117181|3866103|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
4043556|NCT01117181|3866104|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4043557|NCT01117181|3866105|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4043558|NCT01117181|3866103|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4043559|NCT01117181|3866104|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4043560|NCT01117181|3866105|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4043561|NCT01117181|3866103|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4043562|NCT01117181|3866104|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4043563|NCT01117181|3866105|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4043564|NCT01117181|3866103|B3|||Age||years|Mean|76|76.0|Standard Deviation|8|8.0|||
4043565|NCT01117181|3866104|B2|||Age||years|Mean|75|75.0|Standard Deviation|9|9.0|||
4043566|NCT01117181|3866105|B1|||Age||years|Mean|78|78.0|Standard Deviation|8|8.0|||
4043567|NCT01117181|3866103|B3||>=65 years|Age||Participants|Count of Participants|54|54.0||||||
4043568|NCT01117181|3866104|B2||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4043569|NCT01117181|3866105|B1||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4043570|NCT01117181|3866103|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4043571|NCT01117181|3866104|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4043572|NCT01117181|3866105|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4043573|NCT01117181|3866103|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043574|NCT01117181|3866104|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043575|NCT01117181|3866105|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043576|NCT01117090|3866126|B1|Other||Infusion system spasticity treatment sub-indication|The primary treatment indication for all subjects was severe spasticity. This measure describes the treatment sub-indication for each subject.|participants|Number|6|6.0||||||
4043626|NCT01117051|3866137|B3|Belgium||Region of Enrollment|All randomized subjects (n = 174)|participants|Number|17|17.0||||||
4043577|NCT01117090|3866126|B1|Spinal cord injury||Infusion system spasticity treatment sub-indication|The primary treatment indication for all subjects was severe spasticity. This measure describes the treatment sub-indication for each subject.|participants|Number|2|2.0||||||
4043578|NCT01117090|3866126|B1|Brain injury||Infusion system spasticity treatment sub-indication|The primary treatment indication for all subjects was severe spasticity. This measure describes the treatment sub-indication for each subject.|participants|Number|3|3.0||||||
4043579|NCT01117090|3866126|B1|Stroke||Infusion system spasticity treatment sub-indication|The primary treatment indication for all subjects was severe spasticity. This measure describes the treatment sub-indication for each subject.|participants|Number|3|3.0||||||
4043580|NCT01117090|3866126|B1|Multiple sclerosis||Infusion system spasticity treatment sub-indication|The primary treatment indication for all subjects was severe spasticity. This measure describes the treatment sub-indication for each subject.|participants|Number|8|8.0||||||
4043581|NCT01117090|3866126|B1|Cerebral palsy||Infusion system spasticity treatment sub-indication|The primary treatment indication for all subjects was severe spasticity. This measure describes the treatment sub-indication for each subject.|participants|Number|25|25.0||||||
4043582|NCT01117090|3866126|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
4043583|NCT01117090|3866126|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043584|NCT01117090|3866126|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043585|NCT01117090|3866126|B1||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4043586|NCT01117090|3866126|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4043587|NCT01117090|3866126|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043588|NCT01117090|3866126|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043589|NCT01117090|3866126|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043590|NCT01117090|3866126|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043591|NCT01117090|3866126|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4043592|NCT01117090|3866126|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4043593|NCT01117090|3866126|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4043594|NCT01117090|3866126|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4043595|NCT01117090|3866126|B1|||Age||years|Mean|37.8|37.8|Standard Deviation|16.7|16.7|||
4043596|NCT01117090|3866126|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4043597|NCT01117090|3866126|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4043598|NCT01117090|3866126|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4043599|NCT01117051|3866137|B3|Romania||Region of Enrollment|All randomized subjects (n = 174)|participants|Number|11|11.0||||||
4043600|NCT01117051|3866138|B2|Romania||Region of Enrollment|All randomized subjects (n = 174)|participants|Number|6|6.0||||||
4043601|NCT01117051|3866139|B1|Romania||Region of Enrollment|All randomized subjects (n = 174)|participants|Number|5|5.0||||||
4043602|NCT01117051|3866137|B3|Poland||Region of Enrollment|All randomized subjects (n = 174)|participants|Number|11|11.0||||||
4043603|NCT01117051|3866138|B2|Poland||Region of Enrollment|All randomized subjects (n = 174)|participants|Number|5|5.0||||||
4043604|NCT01117051|3866139|B1|Poland||Region of Enrollment|All randomized subjects (n = 174)|participants|Number|6|6.0||||||
4043605|NCT01117051|3866137|B3|Netherlands||Region of Enrollment|All randomized subjects (n = 174)|participants|Number|1|1.0||||||
4043606|NCT01117051|3866138|B2|Netherlands||Region of Enrollment|All randomized subjects (n = 174)|participants|Number|1|1.0||||||
4043607|NCT01117051|3866139|B1|Netherlands||Region of Enrollment|All randomized subjects (n = 174)|participants|Number|0|0.0||||||
4043608|NCT01117051|3866137|B3|Hungary||Region of Enrollment|All randomized subjects (n = 174)|participants|Number|3|3.0||||||
4043609|NCT01117051|3866138|B2|Hungary||Region of Enrollment|All randomized subjects (n = 174)|participants|Number|1|1.0||||||
4043610|NCT01117051|3866139|B1|Hungary||Region of Enrollment|All randomized subjects (n = 174)|participants|Number|2|2.0||||||
4043611|NCT01117051|3866137|B3|United Kingdom||Region of Enrollment|All randomized subjects (n = 174)|participants|Number|27|27.0||||||
4043612|NCT01117051|3866138|B2|United Kingdom||Region of Enrollment|All randomized subjects (n = 174)|participants|Number|14|14.0||||||
4043613|NCT01117051|3866139|B1|United Kingdom||Region of Enrollment|All randomized subjects (n = 174)|participants|Number|13|13.0||||||
4043614|NCT01117051|3866137|B3|France||Region of Enrollment|All randomized subjects (n = 174)|participants|Number|4|4.0||||||
4043615|NCT01117051|3866138|B2|France||Region of Enrollment|All randomized subjects (n = 174)|participants|Number|2|2.0||||||
4043616|NCT01117051|3866139|B1|France||Region of Enrollment|All randomized subjects (n = 174)|participants|Number|2|2.0||||||
4043617|NCT01117051|3866137|B3|Germany||Region of Enrollment|All randomized subjects (n = 174)|participants|Number|13|13.0||||||
4043618|NCT01117051|3866138|B2|Germany||Region of Enrollment|All randomized subjects (n = 174)|participants|Number|7|7.0||||||
4043619|NCT01117051|3866139|B1|Germany||Region of Enrollment|All randomized subjects (n = 174)|participants|Number|6|6.0||||||
4043620|NCT01117051|3866137|B3|Czech Republic||Region of Enrollment|All randomized subjects (n = 174)|participants|Number|78|78.0||||||
4043621|NCT01117051|3866138|B2|Czech Republic||Region of Enrollment|All randomized subjects (n = 174)|participants|Number|38|38.0||||||
4043622|NCT01117051|3866139|B1|Czech Republic||Region of Enrollment|All randomized subjects (n = 174)|participants|Number|40|40.0||||||
4043623|NCT01117051|3866137|B3|Bulgaria||Region of Enrollment|All randomized subjects (n = 174)|participants|Number|9|9.0||||||
4043624|NCT01117051|3866138|B2|Bulgaria||Region of Enrollment|All randomized subjects (n = 174)|participants|Number|5|5.0||||||
4043625|NCT01117051|3866139|B1|Bulgaria||Region of Enrollment|All randomized subjects (n = 174)|participants|Number|4|4.0||||||
4043627|NCT01117051|3866138|B2|Belgium||Region of Enrollment|All randomized subjects (n = 174)|participants|Number|9|9.0||||||
4043628|NCT01117051|3866139|B1|Belgium||Region of Enrollment|All randomized subjects (n = 174)|participants|Number|8|8.0||||||
4043629|NCT01117051|3866137|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4043630|NCT01117051|3866138|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4043631|NCT01117051|3866139|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4043632|NCT01117051|3866137|B3||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4043633|NCT01117051|3866138|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4043634|NCT01117051|3866139|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4043635|NCT01117051|3866137|B3|>=75 years||Age, Customized||participants|Number|19|19.0||||||
4043636|NCT01117051|3866138|B2|>=75 years||Age, Customized||participants|Number|9|9.0||||||
4043637|NCT01117051|3866139|B1|>=75 years||Age, Customized||participants|Number|10|10.0||||||
4043638|NCT01117051|3866137|B3|Between >=65 and <75 years||Age, Customized||participants|Number|22|22.0||||||
4043639|NCT01117051|3866138|B2|Between >=65 and <75 years||Age, Customized||participants|Number|11|11.0||||||
4043640|NCT01117051|3866139|B1|Between >=65 and <75 years||Age, Customized||participants|Number|11|11.0||||||
4043641|NCT01117051|3866137|B3|Between >=18 and <65 years||Age, Customized||participants|Number|128|128.0||||||
4043642|NCT01117051|3866138|B2|Between >=18 and <65 years||Age, Customized||participants|Number|66|66.0||||||
4043643|NCT01117051|3866139|B1|Between >=18 and <65 years||Age, Customized||participants|Number|62|62.0||||||
4043644|NCT01117051|3866137|B3|||Age||years|Mean|56.7|56.7|Standard Deviation|11.92|11.92|||
4043645|NCT01117051|3866138|B2|||Age||years|Mean|55.7|55.7|Standard Deviation|12.15|12.15|||
4043646|NCT01117051|3866139|B1|||Age||years|Mean|57.7|57.7|Standard Deviation|11.67|11.67|||
4043647|NCT01117012|3866148|B3||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4043648|NCT01117012|3866149|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4043649|NCT01117012|3866150|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4043650|NCT01117012|3866148|B3||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4043651|NCT01117012|3866149|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4043652|NCT01117012|3866150|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4043653|NCT01117012|3866148|B3|||Age||years|Mean|22.6|22.6|Standard Deviation|11.26|11.26|||
4043654|NCT01117012|3866149|B2|||Age||years|Mean|23.2|23.2|Standard Deviation|11.55|11.55|||
4043655|NCT01117012|3866150|B1|||Age||years|Mean|22.0|22.0|Standard Deviation|10.94|10.94|||
4043656|NCT01116986|3866167|B33|United States||Region of Enrollment||participants|Number|637|637.0||||||
4043657|NCT01116986|3866168|B32|United States||Region of Enrollment||participants|Number|17|17.0||||||
4043658|NCT01116986|3866169|B31|United States||Region of Enrollment||participants|Number|17|17.0||||||
4043659|NCT01116986|3866170|B30|United States||Region of Enrollment||participants|Number|17|17.0||||||
4043660|NCT01116986|3866171|B29|United States||Region of Enrollment||participants|Number|17|17.0||||||
4043661|NCT01116986|3866172|B28|United States||Region of Enrollment||participants|Number|19|19.0||||||
4043662|NCT01116986|3866173|B27|United States||Region of Enrollment||participants|Number|18|18.0||||||
4043663|NCT01116986|3866174|B26|United States||Region of Enrollment||participants|Number|19|19.0||||||
4043664|NCT01116986|3866175|B25|United States||Region of Enrollment||participants|Number|18|18.0||||||
4043665|NCT01116986|3866176|B24|United States||Region of Enrollment||participants|Number|21|21.0||||||
4043666|NCT01116986|3866177|B23|United States||Region of Enrollment||participants|Number|23|23.0||||||
4043667|NCT01116986|3866178|B22|United States||Region of Enrollment||participants|Number|20|20.0||||||
4043668|NCT01116986|3866179|B21|United States||Region of Enrollment||participants|Number|24|24.0||||||
4043669|NCT01116986|3866180|B20|United States||Region of Enrollment||participants|Number|15|15.0||||||
4043670|NCT01116986|3866181|B19|United States||Region of Enrollment||participants|Number|23|23.0||||||
4043671|NCT01116986|3866182|B18|United States||Region of Enrollment||participants|Number|24|24.0||||||
4043672|NCT01116986|3866183|B17|United States||Region of Enrollment||participants|Number|16|16.0||||||
4043673|NCT01116986|3866184|B16|United States||Region of Enrollment||participants|Number|21|21.0||||||
4043674|NCT01116986|3866185|B15|United States||Region of Enrollment||participants|Number|17|17.0||||||
4043675|NCT01116986|3866186|B14|United States||Region of Enrollment||participants|Number|19|19.0||||||
4043676|NCT01116986|3866187|B13|United States||Region of Enrollment||participants|Number|17|17.0||||||
4043677|NCT01116986|3866188|B12|United States||Region of Enrollment||participants|Number|20|20.0||||||
4043678|NCT01116986|3866189|B11|United States||Region of Enrollment||participants|Number|19|19.0||||||
4043679|NCT01116986|3866190|B10|United States||Region of Enrollment||participants|Number|23|23.0||||||
4043680|NCT01116986|3866191|B9|United States||Region of Enrollment||participants|Number|20|20.0||||||
4043681|NCT01116986|3866192|B8|United States||Region of Enrollment||participants|Number|22|22.0||||||
4043682|NCT01116986|3866193|B7|United States||Region of Enrollment||participants|Number|22|22.0||||||
4043683|NCT01116986|3866194|B6|United States||Region of Enrollment||participants|Number|22|22.0||||||
4043684|NCT01116986|3866195|B5|United States||Region of Enrollment||participants|Number|24|24.0||||||
4043685|NCT01116986|3866196|B4|United States||Region of Enrollment||participants|Number|22|22.0||||||
4043686|NCT01116986|3866197|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4043687|NCT01116986|3866198|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4043689|NCT01116986|3866167|B33||Male|Sex: Female, Male||Participants|Count of Participants|289|289.0||||||
4043690|NCT01116986|3866168|B32||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4043691|NCT01116986|3866169|B31||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4043692|NCT01116986|3866170|B30||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4043693|NCT01116986|3866171|B29||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4043694|NCT01116986|3866172|B28||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4043695|NCT01116986|3866173|B27||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4043696|NCT01116986|3866174|B26||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4043697|NCT01116986|3866175|B25||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4043698|NCT01116986|3866176|B24||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4043699|NCT01116986|3866177|B23||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4043700|NCT01116986|3866178|B22||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4043701|NCT01116986|3866179|B21||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4043702|NCT01116986|3866180|B20||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4043703|NCT01116986|3866181|B19||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4043704|NCT01116986|3866182|B18||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4043705|NCT01116986|3866183|B17||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4043706|NCT01116986|3866184|B16||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4043707|NCT01116986|3866185|B15||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4043708|NCT01116986|3866186|B14||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4043709|NCT01116986|3866187|B13||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4043710|NCT01116986|3866188|B12||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4043711|NCT01116986|3866189|B11||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4043712|NCT01116986|3866190|B10||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4043713|NCT01116986|3866191|B9||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4043714|NCT01116986|3866192|B8||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4043715|NCT01116986|3866193|B7||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4043716|NCT01116986|3866194|B6||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4043717|NCT01116986|3866195|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4043718|NCT01116986|3866196|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4043719|NCT01116986|3866197|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4043720|NCT01116986|3866198|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4043721|NCT01116986|3866199|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4043722|NCT01116986|3866167|B33||Female|Sex: Female, Male||Participants|Count of Participants|348|348.0||||||
4043723|NCT01116986|3866168|B32||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4043724|NCT01116986|3866169|B31||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4043725|NCT01116986|3866170|B30||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4043726|NCT01116986|3866171|B29||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4043727|NCT01116986|3866172|B28||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4043728|NCT01116986|3866173|B27||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4043729|NCT01116986|3866174|B26||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4043730|NCT01116986|3866175|B25||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4043731|NCT01116986|3866176|B24||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4043732|NCT01116986|3866177|B23||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4043733|NCT01116986|3866178|B22||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4043734|NCT01116986|3866179|B21||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4043735|NCT01116986|3866180|B20||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4043736|NCT01116986|3866181|B19||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4043737|NCT01116986|3866182|B18||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4043738|NCT01116986|3866183|B17||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4043739|NCT01116986|3866184|B16||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4043740|NCT01116986|3866185|B15||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4043741|NCT01116986|3866186|B14||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4043742|NCT01116986|3866187|B13||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4043743|NCT01116986|3866188|B12||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4043744|NCT01116986|3866189|B11||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4043745|NCT01116986|3866190|B10||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4043746|NCT01116986|3866191|B9||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4043747|NCT01116986|3866192|B8||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4043748|NCT01116986|3866193|B7||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4043749|NCT01116986|3866194|B6||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4043750|NCT01116986|3866195|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4043751|NCT01116986|3866196|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4043752|NCT01116986|3866197|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4043753|NCT01116986|3866198|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4043754|NCT01116986|3866199|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4043755|NCT01116986|3866167|B33|||Age||years|Mean|45.73|45.73|Standard Deviation|12.05|12.05|||
4043756|NCT01116986|3866168|B32|||Age||years|Mean|40.65|40.65|Standard Deviation|11.25|11.25|||
4043757|NCT01116986|3866169|B31|||Age||years|Mean|51.18|51.18|Standard Deviation|10.00|10.0|||
4043758|NCT01116986|3866170|B30|||Age||years|Mean|48.29|48.29|Standard Deviation|13.96|13.96|||
4043759|NCT01116986|3866171|B29|||Age||years|Mean|41.82|41.82|Standard Deviation|15.02|15.02|||
4043760|NCT01116986|3866172|B28|||Age||years|Mean|48.37|48.37|Standard Deviation|12.95|12.95|||
4043761|NCT01116986|3866173|B27|||Age||years|Mean|54.56|54.56|Standard Deviation|11.59|11.59|||
4043762|NCT01116986|3866174|B26|||Age||years|Mean|46.32|46.32|Standard Deviation|12.87|12.87|||
4043763|NCT01116986|3866175|B25|||Age||years|Mean|45.00|45.0|Standard Deviation|11.78|11.78|||
4043764|NCT01116986|3866176|B24|||Age||years|Mean|45.33|45.33|Standard Deviation|9.98|9.98|||
4043765|NCT01116986|3866177|B23|||Age||years|Mean|44.17|44.17|Standard Deviation|12.51|12.51|||
4043766|NCT01116986|3866178|B22|||Age||years|Mean|46.30|46.3|Standard Deviation|12.09|12.09|||
4043767|NCT01116986|3866179|B21|||Age||years|Mean|47.38|47.38|Standard Deviation|9.57|9.57|||
4043768|NCT01116986|3866180|B20|||Age||years|Mean|45.20|45.2|Standard Deviation|14.56|14.56|||
4043769|NCT01116986|3866181|B19|||Age||years|Mean|43.83|43.83|Standard Deviation|13.66|13.66|||
4043770|NCT01116986|3866182|B18|||Age||years|Mean|45.83|45.83|Standard Deviation|11.45|11.45|||
4043771|NCT01116986|3866183|B17|||Age||years|Mean|47.13|47.13|Standard Deviation|10.68|10.68|||
4043772|NCT01116986|3866184|B16|||Age||years|Mean|50.05|50.05|Standard Deviation|8.87|8.87|||
4043773|NCT01116986|3866185|B15|||Age||years|Mean|44.94|44.94|Standard Deviation|10.97|10.97|||
4043774|NCT01116986|3866186|B14|||Age||years|Mean|42.63|42.63|Standard Deviation|9.75|9.75|||
4043775|NCT01116986|3866187|B13|||Age||years|Mean|42.53|42.53|Standard Deviation|12.58|12.58|||
4043776|NCT01116986|3866188|B12|||Age||years|Mean|45.10|45.1|Standard Deviation|12.23|12.23|||
4043777|NCT01116986|3866189|B11|||Age||years|Mean|46.26|46.26|Standard Deviation|11.84|11.84|||
4043778|NCT01116986|3866190|B10|||Age||years|Mean|47.43|47.43|Standard Deviation|10.75|10.75|||
4043779|NCT01116986|3866191|B9|||Age||years|Mean|43.00|43.0|Standard Deviation|14.18|14.18|||
4043780|NCT01116986|3866192|B8|||Age||years|Mean|39.73|39.73|Standard Deviation|13.58|13.58|||
4043781|NCT01116986|3866193|B7|||Age||years|Mean|46.86|46.86|Standard Deviation|11.67|11.67|||
4043782|NCT01116986|3866194|B6|||Age||years|Mean|41.50|41.5|Standard Deviation|12.50|12.5|||
4043783|NCT01116986|3866195|B5|||Age||years|Mean|50.0|50.0|Standard Deviation|12.03|12.03|||
4043784|NCT01116986|3866196|B4|||Age||years|Mean|43.91|43.91|Standard Deviation|13.19|13.19|||
4043785|NCT01116986|3866197|B3|||Age||years|Mean|44.28|44.28|Standard Deviation|10.88|10.88|||
4043786|NCT01116986|3866198|B2|||Age||years|Mean|44.79|44.79|Standard Deviation|11.67|11.67|||
4043787|NCT01116986|3866199|B1|||Age||years|Mean|48.54|48.54|Standard Deviation|9.90|9.9|||
4043788|NCT01116986|3866167|B33||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4043789|NCT01116986|3866168|B32||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4043790|NCT01116986|3866169|B31||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4043791|NCT01116986|3866170|B30||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4043792|NCT01116986|3866171|B29||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4043793|NCT01116986|3866172|B28||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4043794|NCT01116986|3866173|B27||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4043795|NCT01116986|3866174|B26||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4043796|NCT01116986|3866175|B25||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4043797|NCT01116986|3866176|B24||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4043798|NCT01116986|3866177|B23||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4043799|NCT01116986|3866178|B22||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4043800|NCT01116986|3866179|B21||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4043801|NCT01116986|3866180|B20||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4043802|NCT01116986|3866181|B19||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4043803|NCT01116986|3866182|B18||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4043804|NCT01116986|3866183|B17||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4043805|NCT01116986|3866184|B16||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4043806|NCT01116986|3866185|B15||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4043807|NCT01116986|3866186|B14||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4043808|NCT01116986|3866187|B13||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4043809|NCT01116986|3866188|B12||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4043810|NCT01116986|3866189|B11||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4043811|NCT01116986|3866190|B10||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4043812|NCT01116986|3866191|B9||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4043813|NCT01116986|3866192|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4043814|NCT01116986|3866193|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4043815|NCT01116986|3866194|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4043816|NCT01116986|3866195|B5||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4043817|NCT01116986|3866196|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4043818|NCT01116986|3866197|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4043819|NCT01116986|3866198|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4043820|NCT01116986|3866199|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4043821|NCT01116986|3866167|B33||Between 18 and 65 years|Age||Participants|Count of Participants|607|607.0||||||
4043822|NCT01116986|3866168|B32||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4043823|NCT01116986|3866169|B31||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4043824|NCT01116986|3866170|B30||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4043825|NCT01116986|3866171|B29||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4043826|NCT01116986|3866172|B28||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4043827|NCT01116986|3866173|B27||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4043828|NCT01116986|3866174|B26||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4043829|NCT01116986|3866175|B25||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4043830|NCT01116986|3866176|B24||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4043831|NCT01116986|3866177|B23||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4043832|NCT01116986|3866178|B22||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4043833|NCT01116986|3866179|B21||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4043834|NCT01116986|3866180|B20||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4043835|NCT01116986|3866181|B19||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4043836|NCT01116986|3866182|B18||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4043837|NCT01116986|3866183|B17||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4043838|NCT01116986|3866184|B16||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4043839|NCT01116986|3866185|B15||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4043840|NCT01116986|3866186|B14||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4043841|NCT01116986|3866187|B13||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4043842|NCT01116986|3866188|B12||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4043843|NCT01116986|3866189|B11||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4043844|NCT01116986|3866190|B10||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4043845|NCT01116986|3866191|B9||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4043846|NCT01116986|3866192|B8||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4043847|NCT01116986|3866193|B7||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4043848|NCT01116986|3866194|B6||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4043849|NCT01116986|3866195|B5||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4043850|NCT01116986|3866196|B4||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4043851|NCT01116986|3866197|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4043852|NCT01116986|3866198|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4043853|NCT01116986|3866199|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4043854|NCT01116986|3866167|B33||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4043855|NCT01116986|3866168|B32||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043856|NCT01116986|3866169|B31||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043857|NCT01116986|3866170|B30||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043858|NCT01116986|3866171|B29||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043859|NCT01116986|3866172|B28||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043860|NCT01116986|3866173|B27||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043861|NCT01116986|3866174|B26||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043862|NCT01116986|3866175|B25||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043863|NCT01116986|3866176|B24||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043864|NCT01116986|3866177|B23||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043865|NCT01116986|3866178|B22||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043866|NCT01116986|3866179|B21||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043867|NCT01116986|3866180|B20||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043868|NCT01116986|3866181|B19||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043869|NCT01116986|3866182|B18||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043870|NCT01116986|3866183|B17||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043871|NCT01116986|3866184|B16||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043872|NCT01116986|3866185|B15||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043873|NCT01116986|3866186|B14||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043874|NCT01116986|3866187|B13||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043875|NCT01116986|3866188|B12||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043876|NCT01116986|3866189|B11||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4043877|NCT01116986|3866190|B10||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043878|NCT01116986|3866191|B9||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4043879|NCT01116986|3866192|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043880|NCT01116986|3866193|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043881|NCT01116986|3866194|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043882|NCT01116986|3866195|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043883|NCT01116986|3866196|B4||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4043884|NCT01116986|3866197|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043885|NCT01116986|3866198|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043886|NCT01116986|3866199|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043887|NCT01116934|3866262|B3|Germany||Region of Enrollment||participants|Number|17|17.0||||||
4043888|NCT01116934|3866263|B2|Germany||Region of Enrollment||participants|Number|9|9.0||||||
4043889|NCT01116934|3866264|B1|Germany||Region of Enrollment||participants|Number|8|8.0||||||
4043890|NCT01116934|3866262|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4043891|NCT01116934|3866263|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4043892|NCT01116934|3866264|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4043893|NCT01116934|3866262|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4043894|NCT01116934|3866263|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4043895|NCT01116934|3866264|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4043896|NCT01116934|3866262|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4043897|NCT01116934|3866263|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4043898|NCT01116934|3866264|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4043899|NCT01116934|3866262|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4043900|NCT01116934|3866263|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4043901|NCT01116934|3866264|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4043902|NCT01116934|3866262|B3||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4043903|NCT01116934|3866263|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043904|NCT01116934|3866264|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4043905|NCT01116921|3866271|B3|United States||Region of Enrollment||participants|Number|103|103.0||||||
4043906|NCT01116921|3866272|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
4043907|NCT01116921|3866273|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
4043908|NCT01116921|3866271|B3||Male|Gender||Participants|Count of Participants|65|65.0||||||
4043909|NCT01116921|3866272|B2||Male|Gender||Participants|Count of Participants|30|30.0||||||
4043910|NCT01116921|3866273|B1||Male|Gender||Participants|Count of Participants|35|35.0||||||
4043911|NCT01116921|3866271|B3||Female|Gender||Participants|Count of Participants|38|38.0||||||
4043912|NCT01116921|3866272|B2||Female|Gender||Participants|Count of Participants|20|20.0||||||
4043913|NCT01116921|3866273|B1||Female|Gender||Participants|Count of Participants|18|18.0||||||
4043914|NCT01116921|3866271|B3|||Age|Gestational age|weeks|Mean|32.71|32.71|Standard Deviation|1.86|1.86|||
4043915|NCT01116921|3866272|B2|||Age|Gestational age|weeks|Mean|32.71|32.71|Standard Deviation|1.86|1.86|||
4043916|NCT01116921|3866273|B1|||Age|Gestational age|weeks|Mean|32.86|32.86|Standard Deviation|1.86|1.86|||
4043917|NCT01116921|3866271|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4043918|NCT01116921|3866272|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4043919|NCT01116921|3866273|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4043920|NCT01116921|3866271|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4043921|NCT01116921|3866272|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4043922|NCT01116921|3866273|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4043923|NCT01116921|3866271|B3||<=18 years|Age||Participants|Count of Participants|103|103.0||||||
4043924|NCT01116921|3866272|B2||<=18 years|Age||Participants|Count of Participants|50|50.0||||||
4043925|NCT01116921|3866273|B1||<=18 years|Age||Participants|Count of Participants|53|53.0||||||
4043926|NCT01116895|3866290|B5|France||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
4043927|NCT01116895|3866291|B4|France||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4043928|NCT01116895|3866292|B3|France||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4043929|NCT01116895|3866293|B2|France||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4043930|NCT01116895|3866294|B1|France||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4043931|NCT01116895|3866290|B5|Canada||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4043932|NCT01116895|3866291|B4|Canada||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4043933|NCT01116895|3866292|B3|Canada||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4043934|NCT01116895|3866293|B2|Canada||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4043935|NCT01116895|3866294|B1|Canada||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4043936|NCT01116895|3866290|B5||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4043937|NCT01116895|3866291|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4043938|NCT01116895|3866292|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4043939|NCT01116895|3866293|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4043940|NCT01116895|3866294|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4043941|NCT01116895|3866290|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4043942|NCT01116895|3866291|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4043943|NCT01116895|3866292|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4043944|NCT01116895|3866293|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4043945|NCT01116895|3866294|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4043946|NCT01116895|3866290|B5|||Age||years|Mean|46.0|46.0|Standard Deviation|12.5|12.5|||
4043947|NCT01116895|3866291|B4|||Age||years|Mean|44.9|44.9|Standard Deviation|12.0|12.0|||
4043948|NCT01116895|3866292|B3|||Age||years|Mean|42.4|42.4|Standard Deviation|13.6|13.6|||
4043949|NCT01116895|3866293|B2|||Age||years|Mean|49.8|49.8|Standard Deviation|14.1|14.1|||
4043950|NCT01116895|3866294|B1|||Age||years|Mean|47.5|47.5|Standard Deviation|9.3|9.3|||
4043951|NCT01116882|3866323|B3|Other||Race/Ethnicity, Customized||participants|Number|101|101.0||||||
4043952|NCT01116882|3866324|B2|Other||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4043953|NCT01116882|3866325|B1|Other||Race/Ethnicity, Customized||participants|Number|80|80.0||||||
4043954|NCT01116882|3866323|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|152|152.0||||||
4043955|NCT01116882|3866324|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4043956|NCT01116882|3866325|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|117|117.0||||||
4043957|NCT01116882|3866323|B3|Black||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
4043958|NCT01116882|3866324|B2|Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4043959|NCT01116882|3866325|B1|Black||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4043960|NCT01116882|3866323|B3|White||Race/Ethnicity, Customized||participants|Number|3378|3378.0||||||
4043961|NCT01116882|3866324|B2|White||Race/Ethnicity, Customized||participants|Number|852|852.0||||||
4043962|NCT01116882|3866325|B1|White||Race/Ethnicity, Customized||participants|Number|2526|2526.0||||||
4043963|NCT01116882|3866323|B3|Male||Sex/Gender, Customized||participants|Number|2500|2500.0||||||
4043964|NCT01116882|3866324|B2|Male||Sex/Gender, Customized||participants|Number|609|609.0||||||
4043965|NCT01116882|3866325|B1|Male||Sex/Gender, Customized||participants|Number|1891|1891.0||||||
4043966|NCT01116882|3866323|B3|Female||Sex/Gender, Customized||participants|Number|1191|1191.0||||||
4043967|NCT01116882|3866324|B2|Female||Sex/Gender, Customized||participants|Number|308|308.0||||||
4043968|NCT01116882|3866325|B1|Female||Sex/Gender, Customized||participants|Number|883|883.0||||||
4043969|NCT01116882|3866323|B3|||Age||years|Mean|64.57|64.57|Standard Deviation|11.83|11.83|||
4043970|NCT01116882|3866324|B2|||Age||years|Mean|64.16|64.16|Standard Deviation|11.81|11.81|||
4043971|NCT01116882|3866325|B1|||Age||years|Mean|64.71|64.71|Standard Deviation|11.84|11.84|||
4043972|NCT01116687|3866364|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4043973|NCT01116687|3866364|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4043974|NCT01116687|3866364|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4043975|NCT01116687|3866364|B1|||Age, Customized||years|Median|60|60.0|Full Range|||42.0|81.0|
4043976|NCT01116687|3866364|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4043977|NCT01116687|3866364|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4043978|NCT01116687|3866364|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043979|NCT01116466|3866371|B1|Germany||Region of Enrollment||participants|Number|5|5.0||||||
4043980|NCT01116466|3866371|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4043981|NCT01116466|3866371|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4043982|NCT01116466|3866371|B1|||Age||years|Mean|47.2|47.2|Standard Deviation|11.9|11.9|||
4043983|NCT01116466|3866371|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4043984|NCT01116466|3866371|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4043985|NCT01116466|3866371|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4043986|NCT01116427|3866379|B3|||Baseline T2 Lesion Volume|Total volume of all T2 lesions detected during an MRI scan. Baseline MRI evaluations were obtained at Visit -1 (Wk -1). A T2 lesion is defined as an abnormal, hyperintense white-matter area visible on T2 weighted images. A higher score indicates more severe multiple sclerosis.|cm^3|Mean|7.7|7.7|Standard Deviation|8.5|8.5|||
4043987|NCT01116427|3866380|B2|||Baseline T2 Lesion Volume|Total volume of all T2 lesions detected during an MRI scan. Baseline MRI evaluations were obtained at Visit -1 (Wk -1). A T2 lesion is defined as an abnormal, hyperintense white-matter area visible on T2 weighted images. A higher score indicates more severe multiple sclerosis.|cm^3|Mean|9.6|9.6|Standard Deviation|9.0|9.0|||
4043988|NCT01116427|3866381|B1|||Baseline T2 Lesion Volume|Total volume of all T2 lesions detected during an MRI scan. Baseline MRI evaluations were obtained at Visit -1 (Wk -1). A T2 lesion is defined as an abnormal, hyperintense white-matter area visible on T2 weighted images. A higher score indicates more severe multiple sclerosis.|cm^3|Mean|6.7|6.7|Standard Deviation|8.1|8.1|||
4043989|NCT01116427|3866379|B3|||Baseline Gd-enhanced Lesions|Number of gadolinium (Gd)-enhancing lesions detected during an MRI scan. Baseline MRI evaluations were obtained at Visit -1 (Wk -1). Gd-enhancing lesions are measured on T1 weighted images after injection of 0.1 mM/kg of gadolinium pentate. A higher score indicates more severe multiple sclerosis.|Lesions|Mean|1.7|1.7|Standard Deviation|6.3|6.3|||
4044022|NCT01116427|3866379|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044083|NCT01116102|3866431|B6|||Age||years|Mean|39.7|39.7|Full Range|||37.0|42.4|
4043990|NCT01116427|3866380|B2|||Baseline Gd-enhanced Lesions|Number of gadolinium (Gd)-enhancing lesions detected during an MRI scan. Baseline MRI evaluations were obtained at Visit -1 (Wk -1). Gd-enhancing lesions are measured on T1 weighted images after injection of 0.1 mM/kg of gadolinium pentate. A higher score indicates more severe multiple sclerosis.|Lesions|Mean|3.8|3.8|Standard Deviation|10.7|10.7|||
4043991|NCT01116427|3866381|B1|||Baseline Gd-enhanced Lesions|Number of gadolinium (Gd)-enhancing lesions detected during an MRI scan. Baseline MRI evaluations were obtained at Visit -1 (Wk -1). Gd-enhancing lesions are measured on T1 weighted images after injection of 0.1 mM/kg of gadolinium pentate. A higher score indicates more severe multiple sclerosis.|Lesions|Mean|0.7|0.7|Standard Deviation|1.4|1.4|||
4043992|NCT01116427|3866379|B3|||Baseline Multiple Sclerosis Functional Composite (MSFC) Score|Baseline MSFC score was the most recent score on or before Randomization. The three component measures of the MSFC include the 1) Time 25-foot Walk (a measure of lower extremity function), 2) 9-hole Peg Test (a measure of upper extremity function), and 3) Paced Auditory Serial Addition Test (a measure of cognitive function). Scores from all three components are combined then are converted into a Z-score for analyses, with a range from -1 to 1. A positive score indicates less severity of multiple sclerosis while negative scores indicate more severe multiple sclerosis symptoms.|Scores on a scale|Mean|0.00|0.0|Standard Deviation|0.72|0.72|||
4043993|NCT01116427|3866380|B2|||Baseline Multiple Sclerosis Functional Composite (MSFC) Score|Baseline MSFC score was the most recent score on or before Randomization. The three component measures of the MSFC include the 1) Time 25-foot Walk (a measure of lower extremity function), 2) 9-hole Peg Test (a measure of upper extremity function), and 3) Paced Auditory Serial Addition Test (a measure of cognitive function). Scores from all three components are combined then are converted into a Z-score for analyses, with a range from -1 to 1. A positive score indicates less severity of multiple sclerosis while negative scores indicate more severe multiple sclerosis symptoms.|Scores on a scale|Mean|0.03|0.03|Standard Deviation|0.81|0.81|||
4043994|NCT01116427|3866381|B1|||Baseline Multiple Sclerosis Functional Composite (MSFC) Score|Baseline MSFC score was the most recent score on or before Randomization. The three component measures of the MSFC include the 1) Time 25-foot Walk (a measure of lower extremity function), 2) 9-hole Peg Test (a measure of upper extremity function), and 3) Paced Auditory Serial Addition Test (a measure of cognitive function). Scores from all three components are combined then are converted into a Z-score for analyses, with a range from -1 to 1. A positive score indicates less severity of multiple sclerosis while negative scores indicate more severe multiple sclerosis symptoms.|Scores on a scale|Mean|-0.01|-0.01|Standard Deviation|0.68|0.68|||
4043995|NCT01116427|3866379|B3|||Baseline Expanded Disability Status Scale (EDSS) Score|Baseline EDSS score was the lowest score observed at either visit -2 (Wk -5) or visit -1 (Wk -1). The EDSS is an assessment for severity of multiple sclerosis. The EDSS an ordinal clinical rating scale ranging from 0 (normal neurological examination) to 10 (death due to multiple sclerosis) in half-point increments.|units on a scale|Mean|2.1|2.1|Standard Deviation|1.3|1.3|||
4043996|NCT01116427|3866380|B2|||Baseline Expanded Disability Status Scale (EDSS) Score|Baseline EDSS score was the lowest score observed at either visit -2 (Wk -5) or visit -1 (Wk -1). The EDSS is an assessment for severity of multiple sclerosis. The EDSS an ordinal clinical rating scale ranging from 0 (normal neurological examination) to 10 (death due to multiple sclerosis) in half-point increments.|units on a scale|Mean|2.4|2.4|Standard Deviation|1.2|1.2|||
4043997|NCT01116427|3866381|B1|||Baseline Expanded Disability Status Scale (EDSS) Score|Baseline EDSS score was the lowest score observed at either visit -2 (Wk -5) or visit -1 (Wk -1). The EDSS is an assessment for severity of multiple sclerosis. The EDSS an ordinal clinical rating scale ranging from 0 (normal neurological examination) to 10 (death due to multiple sclerosis) in half-point increments.|units on a scale|Mean|2.0|2.0|Standard Deviation|1.3|1.3|||
4043998|NCT01116427|3866379|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4043999|NCT01116427|3866380|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4044000|NCT01116427|3866381|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4044001|NCT01116427|3866379|B3|Canada||Region of Enrollment||participants|Number|60|60.0||||||
4044002|NCT01116427|3866380|B2|Canada||Region of Enrollment||participants|Number|19|19.0||||||
4044003|NCT01116427|3866381|B1|Canada||Region of Enrollment||participants|Number|41|41.0||||||
4044004|NCT01116427|3866379|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4044005|NCT01116427|3866380|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044006|NCT01116427|3866381|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4044007|NCT01116427|3866379|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4044008|NCT01116427|3866380|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044009|NCT01116427|3866381|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4044010|NCT01116427|3866379|B3||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4044011|NCT01116427|3866380|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4044012|NCT01116427|3866381|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4044013|NCT01116427|3866379|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4044014|NCT01116427|3866380|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4044015|NCT01116427|3866381|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4044016|NCT01116427|3866379|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044017|NCT01116427|3866380|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044018|NCT01116427|3866381|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044019|NCT01116427|3866379|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044020|NCT01116427|3866380|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044021|NCT01116427|3866381|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044023|NCT01116427|3866380|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044024|NCT01116427|3866381|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044025|NCT01116427|3866379|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4044026|NCT01116427|3866380|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044027|NCT01116427|3866381|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4044028|NCT01116427|3866379|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4044029|NCT01116427|3866380|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4044030|NCT01116427|3866381|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4044031|NCT01116427|3866379|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4044032|NCT01116427|3866380|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4044033|NCT01116427|3866381|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4044034|NCT01116427|3866379|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4044035|NCT01116427|3866380|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4044036|NCT01116427|3866381|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4044037|NCT01116427|3866379|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4044038|NCT01116427|3866380|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4044039|NCT01116427|3866381|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4044040|NCT01116427|3866379|B3|||Age||years|Mean|41.2|41.2|Standard Deviation|10.1|10.1|||
4044041|NCT01116427|3866380|B2|||Age||years|Mean|42.7|42.7|Standard Deviation|11.0|11.0|||
4044042|NCT01116427|3866381|B1|||Age||years|Mean|40.5|40.5|Standard Deviation|9.7|9.7|||
4044043|NCT01116401|3866418|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4044044|NCT01116401|3866418|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4044045|NCT01116401|3866418|B1|||Age||years|Mean|27.3|27.3|Standard Deviation|7.2|7.2|||
4044046|NCT01116232|3866423|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4044047|NCT01116232|3866423|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4044048|NCT01116232|3866423|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4044049|NCT01116232|3866423|B1|||Age||years|Mean|50|50.0|Standard Deviation|2.82|2.82|||
4044050|NCT01116232|3866423|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4044051|NCT01116232|3866423|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4044052|NCT01116232|3866423|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044053|NCT01116102|3866428|B9|United States||Region of Enrollment||participants|Number|20|20.0||||||
4044054|NCT01116102|3866429|B8|United States||Region of Enrollment||participants|Number|3|3.0||||||
4044055|NCT01116102|3866430|B7|United States||Region of Enrollment||participants|Number|2|2.0||||||
4044056|NCT01116102|3866431|B6|United States||Region of Enrollment||participants|Number|2|2.0||||||
4044057|NCT01116102|3866432|B5|United States||Region of Enrollment||participants|Number|2|2.0||||||
4044058|NCT01116102|3866433|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
4044059|NCT01116102|3866434|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4044060|NCT01116102|3866435|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4044061|NCT01116102|3866436|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4044062|NCT01116102|3866428|B9||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4044063|NCT01116102|3866429|B8||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4044064|NCT01116102|3866430|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4044065|NCT01116102|3866431|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4044066|NCT01116102|3866432|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4044067|NCT01116102|3866433|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4044068|NCT01116102|3866434|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4044069|NCT01116102|3866435|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4044070|NCT01116102|3866436|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4044071|NCT01116102|3866428|B9||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4044072|NCT01116102|3866429|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4044073|NCT01116102|3866430|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4044074|NCT01116102|3866431|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4044075|NCT01116102|3866432|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4044076|NCT01116102|3866433|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4044077|NCT01116102|3866434|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4044078|NCT01116102|3866435|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4044079|NCT01116102|3866436|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4044080|NCT01116102|3866428|B9|||Age||years|Mean|33.3|33.3|Full Range|||19.9|58.3|
4044081|NCT01116102|3866429|B8|||Age||years|Mean|20.9|20.9|Full Range|||19.9|21.9|
4044082|NCT01116102|3866430|B7|||Age||years|Mean|28.2|28.2|Full Range|||24.1|32.3|
4044084|NCT01116102|3866432|B5|||Age||years|Mean|35.4|35.4|Full Range|||20.3|50.5|
4044085|NCT01116102|3866433|B4|||Age||years|Mean|29.3|29.3|Full Range|||19.9|46.4|
4044086|NCT01116102|3866434|B3|||Age||years|Mean|39.6|39.6|Full Range|||21.4|50.0|
4044087|NCT01116102|3866435|B2|||Age||years|Mean|32.6|32.6|Full Range|||25.4|36.7|
4044088|NCT01116102|3866436|B1|||Age||years|Mean|45.9|45.9|Full Range|||33.5|58.3|
4044089|NCT01116102|3866428|B9||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4044090|NCT01116102|3866429|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4044091|NCT01116102|3866430|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4044092|NCT01116102|3866431|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4044093|NCT01116102|3866432|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4044094|NCT01116102|3866433|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4044095|NCT01116102|3866434|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4044096|NCT01116102|3866435|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4044097|NCT01116102|3866436|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4044098|NCT01116102|3866428|B9||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4044099|NCT01116102|3866429|B8||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4044100|NCT01116102|3866430|B7||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4044101|NCT01116102|3866431|B6||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4044102|NCT01116102|3866432|B5||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4044103|NCT01116102|3866433|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4044104|NCT01116102|3866434|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4044105|NCT01116102|3866435|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4044106|NCT01116102|3866436|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4044107|NCT01116102|3866428|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044108|NCT01116102|3866429|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044109|NCT01116102|3866430|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044110|NCT01116102|3866431|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044111|NCT01116102|3866432|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044112|NCT01116102|3866433|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044113|NCT01116102|3866434|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044114|NCT01116102|3866435|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044115|NCT01116102|3866436|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044116|NCT01116037|3866485|B1|United States||Region of Enrollment|Recruiting sites included 4 in the US (n=9) and 1 in Canada (n=17)|Participants|Count of Participants|9|9.0||||||
4044117|NCT01116037|3866485|B1|Canada||Region of Enrollment|Recruiting sites included 4 in the US (n=9) and 1 in Canada (n=17)|Participants|Count of Participants|17|17.0||||||
4044118|NCT01116037|3866485|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4044119|NCT01116037|3866485|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4044120|NCT01116037|3866485|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|7.4|7.4|||
4044121|NCT01116024|3866490|B1|Germany||Region of Enrollment||participants|Number|67|67.0||||||
4044122|NCT01116024|3866490|B1|Switzerland||Region of Enrollment||participants|Number|38|38.0||||||
4044123|NCT01116024|3866490|B1|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4044124|NCT01116024|3866490|B1|Poland||Region of Enrollment||participants|Number|31|31.0||||||
4044125|NCT01116024|3866490|B1|Austria||Region of Enrollment||participants|Number|6|6.0||||||
4044126|NCT01116024|3866490|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4044127|NCT01116024|3866490|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4044128|NCT01116024|3866490|B1|||Age||years|Mean|76.0|76.0|Standard Deviation|5.6|5.6|||
4044129|NCT01115998|3866529|B3|United States||Region of Enrollment||participants|Number|34.0|34.0||||||
4044130|NCT01115998|3866530|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4044131|NCT01115998|3866531|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4044132|NCT01115998|3866529|B3||Male|Gender||Participants|Count of Participants|15|15.0||||||
4044133|NCT01115998|3866530|B2||Male|Gender||Participants|Count of Participants|7|7.0||||||
4044134|NCT01115998|3866531|B1||Male|Gender||Participants|Count of Participants|8|8.0||||||
4044135|NCT01115998|3866529|B3||Female|Gender||Participants|Count of Participants|19|19.0||||||
4044136|NCT01115998|3866530|B2||Female|Gender||Participants|Count of Participants|10|10.0||||||
4044137|NCT01115998|3866531|B1||Female|Gender||Participants|Count of Participants|9|9.0||||||
4044138|NCT01115998|3866529|B3|||Age||years|Mean|1.82|1.82|Standard Deviation|.43|0.43|||
4044139|NCT01115998|3866530|B2|||Age||years|Mean|1.85|1.85|Standard Deviation|.41|0.41|||
4044140|NCT01115998|3866531|B1|||Age||years|Mean|1.78|1.78|Standard Deviation|.45|0.45|||
4044141|NCT01115998|3866529|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4044142|NCT01115998|3866530|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4044143|NCT01115998|3866531|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4044144|NCT01115998|3866529|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4044145|NCT01115998|3866530|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4044146|NCT01115998|3866531|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4044147|NCT01115998|3866529|B3||<=18 years|Age||Participants|Count of Participants|34|34.0||||||
4044148|NCT01115998|3866530|B2||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
4044149|NCT01115998|3866531|B1||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
4044150|NCT01115933|3866542|B1|Japan||Region of Enrollment||participants|Number|64|64.0||||||
4044151|NCT01115933|3866542|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4044152|NCT01115933|3866542|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4044153|NCT01115933|3866542|B1|||Age||years|Mean|69.63|69.63|Standard Deviation|7.65|7.65|||
4044154|NCT01115933|3866542|B1||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
4044155|NCT01115933|3866542|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4044156|NCT01115933|3866542|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044157|NCT01115855|3866637|B3||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4044158|NCT01115855|3866638|B2||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4044159|NCT01115855|3866639|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4044160|NCT01115855|3866637|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4044161|NCT01115855|3866638|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4044162|NCT01115855|3866639|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4044163|NCT01115855|3866637|B3|||Age||years|Mean|68.7|68.7|Standard Deviation|8.2|8.2|||
4044164|NCT01115855|3866638|B2|||Age||years|Mean|68.4|68.4|Standard Deviation|7.7|7.7|||
4044165|NCT01115855|3866639|B1|||Age||years|Mean|69.0|69.0|Standard Deviation|8.7|8.7|||
4044166|NCT01115738|3866688|B4|ST-elevation Myocardial Infarction||Qualifying Acute Coronary Syndrome (ACS) Event||participants|Number|31|31.0||||||
4044167|NCT01115738|3866689|B3|ST-elevation Myocardial Infarction||Qualifying Acute Coronary Syndrome (ACS) Event||participants|Number|7|7.0||||||
4044168|NCT01115738|3866690|B2|ST-elevation Myocardial Infarction||Qualifying Acute Coronary Syndrome (ACS) Event||participants|Number|13|13.0||||||
4044169|NCT01115738|3866691|B1|ST-elevation Myocardial Infarction||Qualifying Acute Coronary Syndrome (ACS) Event||participants|Number|11|11.0||||||
4044170|NCT01115738|3866688|B4|Non-ST-elevation Myocardial Infarction||Qualifying Acute Coronary Syndrome (ACS) Event||participants|Number|59|59.0||||||
4044171|NCT01115738|3866689|B3|Non-ST-elevation Myocardial Infarction||Qualifying Acute Coronary Syndrome (ACS) Event||participants|Number|21|21.0||||||
4044172|NCT01115738|3866690|B2|Non-ST-elevation Myocardial Infarction||Qualifying Acute Coronary Syndrome (ACS) Event||participants|Number|18|18.0||||||
4044173|NCT01115738|3866691|B1|Non-ST-elevation Myocardial Infarction||Qualifying Acute Coronary Syndrome (ACS) Event||participants|Number|20|20.0||||||
4044174|NCT01115738|3866688|B4|Unstable Angina||Qualifying Acute Coronary Syndrome (ACS) Event||participants|Number|59|59.0||||||
4044175|NCT01115738|3866689|B3|Unstable Angina||Qualifying Acute Coronary Syndrome (ACS) Event||participants|Number|22|22.0||||||
4044176|NCT01115738|3866690|B2|Unstable Angina||Qualifying Acute Coronary Syndrome (ACS) Event||participants|Number|16|16.0||||||
4044177|NCT01115738|3866691|B1|Unstable Angina||Qualifying Acute Coronary Syndrome (ACS) Event||participants|Number|21|21.0||||||
4044178|NCT01115738|3866688|B4|United States||Region of Enrollment||participants|Number|22|22.0||||||
4044179|NCT01115738|3866689|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4044180|NCT01115738|3866690|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4044181|NCT01115738|3866691|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4044182|NCT01115738|3866688|B4|Turkey||Region of Enrollment||participants|Number|16|16.0||||||
4044183|NCT01115738|3866689|B3|Turkey||Region of Enrollment||participants|Number|7|7.0||||||
4044184|NCT01115738|3866690|B2|Turkey||Region of Enrollment||participants|Number|2|2.0||||||
4044185|NCT01115738|3866691|B1|Turkey||Region of Enrollment||participants|Number|7|7.0||||||
4044186|NCT01115738|3866688|B4|Mexico||Region of Enrollment||participants|Number|19|19.0||||||
4044187|NCT01115738|3866689|B3|Mexico||Region of Enrollment||participants|Number|5|5.0||||||
4044188|NCT01115738|3866690|B2|Mexico||Region of Enrollment||participants|Number|6|6.0||||||
4044189|NCT01115738|3866691|B1|Mexico||Region of Enrollment||participants|Number|8|8.0||||||
4044190|NCT01115738|3866688|B4|Canada||Region of Enrollment||participants|Number|29|29.0||||||
4044191|NCT01115738|3866689|B3|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4044192|NCT01115738|3866690|B2|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4044193|NCT01115738|3866691|B1|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4044194|NCT01115738|3866688|B4|Australia||Region of Enrollment||participants|Number|6|6.0||||||
4044195|NCT01115738|3866689|B3|Australia||Region of Enrollment||participants|Number|2|2.0||||||
4044196|NCT01115738|3866690|B2|Australia||Region of Enrollment||participants|Number|3|3.0||||||
4044197|NCT01115738|3866691|B1|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4044198|NCT01115738|3866688|B4|Brazil||Region of Enrollment||participants|Number|17|17.0||||||
4044199|NCT01115738|3866689|B3|Brazil||Region of Enrollment||participants|Number|6|6.0||||||
4044200|NCT01115738|3866690|B2|Brazil||Region of Enrollment||participants|Number|5|5.0||||||
4044201|NCT01115738|3866691|B1|Brazil||Region of Enrollment||participants|Number|6|6.0||||||
4044202|NCT01115738|3866688|B4|Argentina||Region of Enrollment||participants|Number|10|10.0||||||
4044203|NCT01115738|3866689|B3|Argentina||Region of Enrollment||participants|Number|4|4.0||||||
4044204|NCT01115738|3866690|B2|Argentina||Region of Enrollment||participants|Number|4|4.0||||||
4044205|NCT01115738|3866691|B1|Argentina||Region of Enrollment||participants|Number|2|2.0||||||
4044206|NCT01115738|3866688|B4|India||Region of Enrollment||participants|Number|30|30.0||||||
4044207|NCT01115738|3866689|B3|India||Region of Enrollment||participants|Number|9|9.0||||||
4044208|NCT01115738|3866690|B2|India||Region of Enrollment||participants|Number|11|11.0||||||
4044209|NCT01115738|3866691|B1|India||Region of Enrollment||participants|Number|10|10.0||||||
4044210|NCT01115738|3866688|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044211|NCT01115738|3866689|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044212|NCT01115738|3866690|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044213|NCT01115738|3866691|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044214|NCT01115738|3866688|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044215|NCT01115738|3866689|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044216|NCT01115738|3866690|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044217|NCT01115738|3866691|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044218|NCT01115738|3866688|B4||White|Race (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
4044219|NCT01115738|3866689|B3||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4044220|NCT01115738|3866690|B2||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4044221|NCT01115738|3866691|B1||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4044222|NCT01115738|3866688|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4044223|NCT01115738|3866689|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4044224|NCT01115738|3866690|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4044225|NCT01115738|3866691|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4044226|NCT01115738|3866688|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4044227|NCT01115738|3866689|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044228|NCT01115738|3866690|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4044229|NCT01115738|3866691|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4044230|NCT01115738|3866688|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4044231|NCT01115738|3866689|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4044232|NCT01115738|3866690|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4044233|NCT01115738|3866691|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4044234|NCT01115738|3866688|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044235|NCT01115738|3866689|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044236|NCT01115738|3866690|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044237|NCT01115738|3866691|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044238|NCT01115738|3866688|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4044239|NCT01115738|3866689|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4044240|NCT01115738|3866690|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4044241|NCT01115738|3866691|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4044242|NCT01115738|3866688|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
4044243|NCT01115738|3866689|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4044244|NCT01115738|3866690|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4044245|NCT01115738|3866691|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4044246|NCT01115738|3866688|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4044247|NCT01115738|3866689|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4044248|NCT01115738|3866690|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4044249|NCT01115738|3866691|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4044250|NCT01115738|3866688|B4||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4044251|NCT01115738|3866689|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4044252|NCT01115738|3866690|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4044253|NCT01115738|3866691|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4044254|NCT01115738|3866688|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4044255|NCT01115738|3866689|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4044256|NCT01115738|3866690|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4044257|NCT01115738|3866691|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4044258|NCT01115738|3866688|B4|||Age||years|Mean|58.1|58.1|Standard Deviation|8.86|8.86|||
4044259|NCT01115738|3866689|B3|||Age||years|Mean|58.7|58.7|Standard Deviation|8.07|8.07|||
4044260|NCT01115738|3866690|B2|||Age||years|Mean|57.5|57.5|Standard Deviation|9.12|9.12|||
4044261|NCT01115738|3866691|B1|||Age||years|Mean|58.1|58.1|Standard Deviation|9.47|9.47|||
4044262|NCT01115699|3866727|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4044263|NCT01115699|3866727|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4044264|NCT01115699|3866727|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4044265|NCT01115699|3866727|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4044266|NCT01115699|3866727|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4044267|NCT01115699|3866727|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044268|NCT01115673|3866732|B4|United States||Region of Enrollment||participants|Number|540|540.0||||||
4044269|NCT01115673|3866733|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4044270|NCT01115673|3866734|B2|United States||Region of Enrollment||participants|Number|241|241.0||||||
4044271|NCT01115673|3866735|B1|United States||Region of Enrollment||participants|Number|239|239.0||||||
4044272|NCT01115673|3866732|B4||Male|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
4044273|NCT01115673|3866733|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4044274|NCT01115673|3866734|B2||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4044275|NCT01115673|3866735|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4044276|NCT01115673|3866732|B4||Female|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
4044277|NCT01115673|3866733|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4044278|NCT01115673|3866734|B2||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4044279|NCT01115673|3866735|B1||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4044280|NCT01115673|3866732|B4|||Age||years|Mean|18.4|18.4|Standard Deviation|2.09|2.09|||
4044281|NCT01115673|3866733|B3|||Age||years|Mean|18.1|18.1|Standard Deviation|2.02|2.02|||
4044282|NCT01115673|3866734|B2|||Age||years|Mean|18.3|18.3|Standard Deviation|1.96|1.96|||
4044283|NCT01115673|3866735|B1|||Age||years|Mean|18.5|18.5|Standard Deviation|2.24|2.24|||
4044284|NCT01115660|3866871|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4044285|NCT01115660|3866872|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4044286|NCT01115660|3866873|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4044287|NCT01115660|3866871|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4044288|NCT01115660|3866872|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044289|NCT01115660|3866873|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4044290|NCT01115660|3866871|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044291|NCT01115660|3866872|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044292|NCT01115660|3866873|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044293|NCT01115660|3866871|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4044294|NCT01115660|3866872|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4044295|NCT01115660|3866873|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4044296|NCT01115660|3866871|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4044297|NCT01115660|3866872|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4044298|NCT01115660|3866873|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4044299|NCT01115660|3866871|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044300|NCT01115660|3866872|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044301|NCT01115660|3866873|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044302|NCT01115660|3866871|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044303|NCT01115660|3866872|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044304|NCT01115660|3866873|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044305|NCT01115660|3866871|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044306|NCT01115660|3866872|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044307|NCT01115660|3866873|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044308|NCT01115660|3866871|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4044309|NCT01115660|3866872|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4044310|NCT01115660|3866873|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4044311|NCT01115660|3866871|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4044312|NCT01115660|3866872|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4044313|NCT01115660|3866873|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4044314|NCT01115660|3866871|B3|Median Age||Age||years|Median|61|61.0|Inter-Quartile Range|8|8.0|52.0|69.0|
4044315|NCT01115660|3866872|B2|Median Age||Age||years|Median|59|59.0|Inter-Quartile Range|10|10.0|47.0|67.0|
4044316|NCT01115660|3866873|B1|Median Age||Age||years|Median|61|61.0|Inter-Quartile Range|7|7.0|55.0|70.0|
4044317|NCT01115582|3866882|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4044318|NCT01115582|3866882|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4044319|NCT01115582|3866882|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4044320|NCT01115582|3866882|B1|||Age||years|Mean|7.8|7.8|Standard Deviation|4.6|4.6|||
4044321|NCT01115569|3866891|B1|United States||Region of Enrollment||participants|Number|638|638.0||||||
4044322|NCT01115569|3866891|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044323|NCT01115569|3866891|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4044324|NCT01115569|3866891|B1||White|Race (NIH/OMB)||Participants|Count of Participants|518|518.0||||||
4044325|NCT01115569|3866891|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
4044326|NCT01115569|3866891|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044327|NCT01115569|3866891|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4044328|NCT01115569|3866891|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4044329|NCT01115569|3866891|B1||Male|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
4044330|NCT01115569|3866891|B1||Female|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
4044331|NCT01115569|3866891|B1||>=65 years|Age||Participants|Count of Participants|66|66.0||||||
4044332|NCT01115569|3866891|B1||Between 18 and 65 years|Age||Participants|Count of Participants|572|572.0||||||
4044333|NCT01115569|3866891|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044334|NCT01115556|3866897|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4044335|NCT01115556|3866898|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4044336|NCT01115556|3866899|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4044337|NCT01115556|3866897|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4044338|NCT01115556|3866898|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4044339|NCT01115556|3866899|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4044340|NCT01115556|3866897|B3|||Age, Customized||years|Mean|82.0|82.0|Standard Deviation|5.8|5.8|||
4044341|NCT01115556|3866898|B2|||Age, Customized||years|Mean|88.0|88.0|Standard Deviation|0.0|0.0|||
4044342|NCT01115556|3866899|B1|||Age, Customized||years|Mean|80.1|80.1|Standard Deviation|5.4|5.4|||
4044343|NCT01115517|3866908|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4044344|NCT01115517|3866909|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4044345|NCT01115517|3866910|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4044346|NCT01115517|3866908|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4044347|NCT01115517|3866909|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4044348|NCT01115517|3866910|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4044349|NCT01115517|3866908|B3|||Age||years|Mean|49.3|49.3|Standard Deviation|11.7|11.7|||
4044350|NCT01115517|3866909|B2|||Age||years|Mean|43.9|43.9|Standard Deviation|9.4|9.4|||
4044351|NCT01115517|3866910|B1|||Age||years|Mean|55.6|55.6|Standard Deviation|11|11.0|||
4044352|NCT01115491|3866921|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4044353|NCT01115491|3866921|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4044354|NCT01115491|3866921|B1|||Age||years|Mean|56.19|56.19|Standard Deviation|10.58|10.58|||
4044355|NCT01115452|3866930|B1|United States||Region of Enrollment||Participants|Number|32|32.0||||||
4044356|NCT01115452|3866930|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4044357|NCT01115452|3866930|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4044358|NCT01115452|3866930|B1|||Age||Years|Mean|36.5|36.5|Standard Deviation|11.63|11.63|||
4044359|NCT01115166|3866993|B1|Sweden||Region of Enrollment||participants|Number|10|10.0||||||
4044360|NCT01115166|3866993|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4044361|NCT01115166|3866993|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4044362|NCT01115166|3866993|B1|||Age||years|Mean|71.1|71.1|Standard Deviation|11.6|11.6|||
4044363|NCT01115166|3866993|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4044364|NCT01115166|3866993|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4044365|NCT01115166|3866993|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044366|NCT01115101|3866999|B3|Germany||Region of Enrollment||participants|Number|239|239.0||||||
4044367|NCT01115101|3867000|B2|Germany||Region of Enrollment||participants|Number|126|126.0||||||
4044368|NCT01115101|3867001|B1|Germany||Region of Enrollment||participants|Number|113|113.0||||||
4044369|NCT01115101|3866999|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
4044370|NCT01115101|3867000|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
4044371|NCT01115101|3867001|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4044372|NCT01115101|3866999|B3||Female|Gender||Participants|Count of Participants|239|239.0||||||
4044373|NCT01115101|3867000|B2||Female|Gender||Participants|Count of Participants|126|126.0||||||
4044374|NCT01115101|3867001|B1||Female|Gender||Participants|Count of Participants|113|113.0||||||
4044375|NCT01115101|3866999|B3|||Age||years|Mean|29.2|29.2|Standard Deviation|5.5|5.5|||
4044376|NCT01115101|3867000|B2|||Age||years|Mean|29.8|29.8|Standard Deviation|5.1|5.1|||
4044377|NCT01115101|3867001|B1|||Age||years|Mean|28.5|28.5|Standard Deviation|5.9|5.9|||
4044378|NCT01115101|3866999|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4044379|NCT01115101|3867000|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4044380|NCT01115101|3867001|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4044381|NCT01115101|3866999|B3||Between 18 and 65 years|Age||Participants|Count of Participants|239|239.0||||||
4044382|NCT01115101|3867000|B2||Between 18 and 65 years|Age||Participants|Count of Participants|126|126.0||||||
4044383|NCT01115101|3867001|B1||Between 18 and 65 years|Age||Participants|Count of Participants|113|113.0||||||
4044384|NCT01115101|3866999|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044385|NCT01115101|3867000|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044386|NCT01115101|3867001|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044387|NCT01114997|3867008|B4|United States||Region of Enrollment|California, United States|participants|Number|32|32.0||||||
4044388|NCT01114997|3867009|B3|United States||Region of Enrollment|California, United States|participants|Number|11|11.0||||||
4044389|NCT01114997|3867010|B2|United States||Region of Enrollment|California, United States|participants|Number|10|10.0||||||
4044390|NCT01114997|3867011|B1|United States||Region of Enrollment|California, United States|participants|Number|11|11.0||||||
4044391|NCT01114997|3867008|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4044392|NCT01114997|3867009|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4044393|NCT01114997|3867010|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4044394|NCT01114997|3867011|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4044395|NCT01114997|3867008|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4044396|NCT01114997|3867009|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4044397|NCT01114997|3867010|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4044398|NCT01114997|3867011|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4044399|NCT01114997|3867008|B4|||Age||years|Mean|41|41.0|Standard Deviation|9|9.0|||
4044400|NCT01114997|3867009|B3|||Age||years|Mean|38|38.0|Standard Deviation|10|10.0|||
4044401|NCT01114997|3867010|B2|||Age||years|Mean|44|44.0|Standard Deviation|3|3.0|||
4044402|NCT01114997|3867011|B1|||Age||years|Mean|42|42.0|Standard Deviation|8|8.0|||
4044403|NCT01114945|3867039|B5|||Body Mass Index (BMI)||kg/m^2|Mean|42|42.0|Standard Deviation|6|6.0|||
4044404|NCT01114945|3867040|B4|||Body Mass Index (BMI)||kg/m^2|Mean|41|41.0|Standard Deviation|6|6.0|||
4044405|NCT01114945|3867041|B3|||Body Mass Index (BMI)||kg/m^2|Mean|43|43.0|Standard Deviation|5|5.0|||
4044406|NCT01114945|3867042|B2|||Body Mass Index (BMI)||kg/m^2|Mean|43|43.0|Standard Deviation|8|8.0|||
4044407|NCT01114945|3867043|B1|||Body Mass Index (BMI)||kg/m^2|Mean|42|42.0|Standard Deviation|5|5.0|||
4044408|NCT01114945|3867039|B5||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4044409|NCT01114945|3867040|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4044410|NCT01114945|3867041|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4044411|NCT01114945|3867042|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4044412|NCT01114945|3867043|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4044413|NCT01114945|3867039|B5||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4044414|NCT01114945|3867040|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4044415|NCT01114945|3867041|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4044416|NCT01114945|3867042|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4044417|NCT01114945|3867043|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4044418|NCT01114945|3867039|B5|||Age||Years|Mean|45|45.0|Standard Deviation|12|12.0|||
4044419|NCT01114945|3867040|B4|||Age||Years|Mean|45|45.0|Standard Deviation|12|12.0|||
4044420|NCT01114945|3867041|B3|||Age||Years|Mean|45|45.0|Standard Deviation|12|12.0|||
4044421|NCT01114945|3867042|B2|||Age||Years|Mean|44|44.0|Standard Deviation|12|12.0|||
4044422|NCT01114945|3867043|B1|||Age||Years|Mean|46|46.0|Standard Deviation|12|12.0|||
4044423|NCT01114893|3867068|B6||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4044424|NCT01114893|3867069|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4044425|NCT01114893|3867070|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4044426|NCT01114893|3867071|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4044427|NCT01114893|3867072|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4044428|NCT01114893|3867073|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4044429|NCT01114893|3867068|B6||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4044430|NCT01114893|3867069|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4044431|NCT01114893|3867070|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4044432|NCT01114893|3867071|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4044433|NCT01114893|3867072|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4044434|NCT01114893|3867073|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4044435|NCT01114893|3867068|B6||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
4044436|NCT01114893|3867069|B5||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4044437|NCT01114893|3867070|B4||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4044438|NCT01114893|3867071|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4044439|NCT01114893|3867072|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4044440|NCT01114893|3867073|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4044441|NCT01114893|3867068|B6||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4044442|NCT01114893|3867069|B5||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4044443|NCT01114893|3867070|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4044444|NCT01114893|3867071|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4044445|NCT01114893|3867072|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4044446|NCT01114893|3867073|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4044447|NCT01114893|3867068|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044448|NCT01114893|3867069|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044449|NCT01114893|3867070|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044450|NCT01114893|3867071|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044451|NCT01114893|3867072|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044452|NCT01114893|3867073|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044453|NCT01114880|3867094|B3|China||Region of Enrollment||participants|Number|344|344.0||||||
4044454|NCT01114880|3867095|B2|China||Region of Enrollment||participants|Number|115|115.0||||||
4044455|NCT01114880|3867096|B1|China||Region of Enrollment||participants|Number|229|229.0||||||
4044456|NCT01114880|3867094|B3||Male|Sex: Female, Male||Participants|Count of Participants|280|280.0||||||
4044457|NCT01114880|3867095|B2||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4044458|NCT01114880|3867096|B1||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4044459|NCT01114880|3867094|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4044460|NCT01114880|3867095|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4044461|NCT01114880|3867096|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4044462|NCT01114880|3867094|B3|||Age||years|Mean|29.9|29.9|Standard Deviation|8.33|8.33|||
4044463|NCT01114880|3867095|B2|||Age||years|Mean|29.6|29.6|Standard Deviation|7.49|7.49|||
4044464|NCT01114880|3867096|B1|||Age||years|Mean|30.1|30.1|Standard Deviation|8.73|8.73|||
4044465|NCT01114828|3867147|B3|Japan||Region of Enrollment||participants|Number|40|40.0||||||
4044466|NCT01114828|3867148|B2|Japan||Region of Enrollment||participants|Number|21|21.0||||||
4044467|NCT01114828|3867149|B1|Japan||Region of Enrollment||participants|Number|19|19.0||||||
4044468|NCT01114828|3867147|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4044469|NCT01114828|3867148|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4044470|NCT01114828|3867149|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4044471|NCT01114828|3867147|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4044472|NCT01114828|3867148|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4044473|NCT01114828|3867149|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4044474|NCT01114828|3867147|B3||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4044475|NCT01114828|3867148|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4044476|NCT01114828|3867149|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4044477|NCT01114828|3867147|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4044478|NCT01114828|3867148|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4044479|NCT01114828|3867149|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4044480|NCT01114828|3867147|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044481|NCT01114828|3867148|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044482|NCT01114828|3867149|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044483|NCT01114828|3867147|B3|||Age||years|Mean|65.7|65.7|Standard Deviation|9.9|9.9|||
4044484|NCT01114828|3867148|B2|||Age||years|Mean|64.2|64.2|Standard Deviation|10.4|10.4|||
4044485|NCT01114828|3867149|B1|||Age||years|Mean|67.3|67.3|Standard Deviation|9.3|9.3|||
4044486|NCT01114737|3867158|B3|United States||Region of Enrollment||participants|Number|137|137.0||||||
4044487|NCT01114737|3867159|B2|United States||Region of Enrollment||participants|Number|67|67.0||||||
4044488|NCT01114737|3867160|B1|United States||Region of Enrollment||participants|Number|70|70.0||||||
4044489|NCT01114737|3867158|B3|Canada||Region of Enrollment||participants|Number|69|69.0||||||
4044490|NCT01114737|3867159|B2|Canada||Region of Enrollment||participants|Number|31|31.0||||||
4044491|NCT01114737|3867160|B1|Canada||Region of Enrollment||participants|Number|38|38.0||||||
4044492|NCT01114737|3867158|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4044493|NCT01114737|3867159|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4044494|NCT01114737|3867160|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4044495|NCT01114737|3867158|B3|White||Race/Ethnicity, Customized||participants|Number|198|198.0||||||
4044496|NCT01114737|3867159|B2|White||Race/Ethnicity, Customized||participants|Number|96|96.0||||||
4044497|NCT01114737|3867160|B1|White||Race/Ethnicity, Customized||participants|Number|102|102.0||||||
4044498|NCT01114737|3867158|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4044499|NCT01114737|3867159|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4044500|NCT01114737|3867160|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4044501|NCT01114737|3867158|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4044502|NCT01114737|3867159|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4044503|NCT01114737|3867160|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4044504|NCT01114737|3867158|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4044505|NCT01114737|3867159|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4044506|NCT01114737|3867160|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4044507|NCT01114737|3867158|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4044508|NCT01114737|3867159|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4044509|NCT01114737|3867160|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4044510|NCT01114737|3867158|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044511|NCT01114737|3867159|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044512|NCT01114737|3867160|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044513|NCT01114737|3867158|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|198|198.0||||||
4044514|NCT01114737|3867159|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
4044515|NCT01114737|3867160|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
4044516|NCT01114737|3867158|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4044517|NCT01114737|3867159|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4044518|NCT01114737|3867160|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4044519|NCT01114737|3867158|B3||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4044520|NCT01114737|3867159|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4044521|NCT01114737|3867160|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4044522|NCT01114737|3867158|B3||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4044523|NCT01114737|3867159|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4044524|NCT01114737|3867160|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4044525|NCT01114737|3867158|B3|>=18 years||Age, Customized||participants|Number|120|120.0||||||
4044526|NCT01114737|3867159|B2|>=18 years||Age, Customized||participants|Number|55|55.0||||||
4044527|NCT01114737|3867160|B1|>=18 years||Age, Customized||participants|Number|65|65.0||||||
4044528|NCT01114737|3867158|B3|<18 years||Age, Customized||participants|Number|86|86.0||||||
4044529|NCT01114737|3867159|B2|<18 years||Age, Customized||participants|Number|43|43.0||||||
4044530|NCT01114737|3867160|B1|<18 years||Age, Customized||participants|Number|43|43.0||||||
4044531|NCT01114737|3867158|B3|||Age||years|Mean|23.1|23.1|Standard Deviation|11.54|11.54|||
4044532|NCT01114737|3867159|B2|||Age||years|Mean|23.6|23.6|Standard Deviation|12.69|12.69|||
4044533|NCT01114737|3867160|B1|||Age||years|Mean|22.5|22.5|Standard Deviation|10.42|10.42|||
4044534|NCT01114724|3867209|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4044535|NCT01114724|3867209|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4044536|NCT01114724|3867209|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4044537|NCT01114724|3867209|B1|||Age||years|Mean|57.2|57.2|Standard Deviation|12.9|12.9|||
4044538|NCT01114724|3867209|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4044539|NCT01114724|3867209|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4044540|NCT01114724|3867209|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4044541|NCT01114672|3867227|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4044542|NCT01114672|3867228|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4044543|NCT01114672|3867229|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4044544|NCT01114672|3867227|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4044545|NCT01114672|3867228|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4044546|NCT01114672|3867229|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4044547|NCT01114672|3867227|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4044548|NCT01114672|3867228|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4044549|NCT01114672|3867229|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4044550|NCT01114672|3867227|B3|||Age||years|Mean|66.2|66.2|Standard Deviation|15.6|15.6|||
4044551|NCT01114672|3867228|B2|||Age||years|Mean|66.2|66.2|Standard Deviation|13.7|13.7|||
4044552|NCT01114672|3867229|B1|||Age||years|Mean|66.1|66.1|Standard Deviation|14.7|14.7|||
4044553|NCT01114672|3867227|B3||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4044554|NCT01114672|3867228|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4044555|NCT01114672|3867229|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4044556|NCT01114672|3867227|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4044557|NCT01114672|3867228|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4044558|NCT01114672|3867229|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4044559|NCT01114672|3867227|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044560|NCT01114672|3867228|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044561|NCT01114672|3867229|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044562|NCT01114646|3867236|B3|United States||Region of Enrollment||participants|Number|130|130.0||||||
4044563|NCT01114646|3867237|B2|United States||Region of Enrollment||participants|Number|64|64.0||||||
4044564|NCT01114646|3867238|B1|United States||Region of Enrollment||participants|Number|66|66.0||||||
4044565|NCT01114646|3867236|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4044566|NCT01114646|3867237|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4044567|NCT01114646|3867238|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4044568|NCT01114646|3867236|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4044569|NCT01114646|3867237|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4044570|NCT01114646|3867238|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4044571|NCT01114646|3867236|B3|||Age||years|Mean|82.3|82.3|Standard Deviation|8.3|8.3|||
4044572|NCT01114646|3867237|B2|||Age||years|Mean|82.8|82.8|Standard Deviation|7.6|7.6|||
4044573|NCT01114646|3867238|B1|||Age||years|Mean|81.8|81.8|Standard Deviation|9.0|9.0|||
4044574|NCT01114646|3867236|B3||>=65 years|Age||Participants|Count of Participants|130|130.0||||||
4044575|NCT01114646|3867237|B2||>=65 years|Age||Participants|Count of Participants|64|64.0||||||
4044576|NCT01114646|3867238|B1||>=65 years|Age||Participants|Count of Participants|66|66.0||||||
4044577|NCT01114646|3867236|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4044578|NCT01114646|3867237|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4044579|NCT01114646|3867238|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4044580|NCT01114646|3867236|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044581|NCT01114646|3867237|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044582|NCT01114646|3867238|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044583|NCT01114620|3867245|B1|Asian - Japanese heritage||Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
4044584|NCT01114620|3867245|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4044585|NCT01114620|3867245|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4044586|NCT01114620|3867245|B1|||Age||Years|Mean|69.8|69.8|Standard Deviation|4.17|4.17|||
4044587|NCT01114581|3867276|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
4044588|NCT01114581|3867277|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4044589|NCT01114581|3867278|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4044590|NCT01114581|3867276|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4044591|NCT01114581|3867277|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4044592|NCT01114581|3867278|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4044593|NCT01114581|3867276|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4044594|NCT01114581|3867277|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4044595|NCT01114581|3867278|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4044596|NCT01114581|3867276|B3|||Age||years|Mean|27.9|27.9|Standard Deviation|9.56|9.56|||
4044597|NCT01114581|3867277|B2|||Age||years|Mean|30.0|30.0|Standard Deviation|11.94|11.94|||
4044598|NCT01114581|3867278|B1|||Age||years|Mean|25.8|25.8|Standard Deviation|6.0|6.0|||
4044599|NCT01114581|3867276|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4044600|NCT01114581|3867277|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4044601|NCT01114581|3867278|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4044602|NCT01114581|3867276|B3||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4044603|NCT01114581|3867277|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4044604|NCT01114581|3867278|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4044605|NCT01114581|3867276|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044606|NCT01114581|3867277|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044607|NCT01114581|3867278|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044608|NCT01114529|3867289|B4|Other||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
4044609|NCT01114529|3867290|B3|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||5.6|5.6|||
4044610|NCT01114529|3867291|B2|Other||Race/Ethnicity, Customized||participants|Number|11|11.0||4.8|4.8|||
4044611|NCT01114529|3867292|B1|Other||Race/Ethnicity, Customized||participants|Number|36|36.0||10.2|10.2|||
4044612|NCT01114529|3867289|B4|Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4044613|NCT01114529|3867290|B3|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||0.8|0.8|||
4044614|NCT01114529|3867291|B2|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||0.4|0.4|||
4044615|NCT01114529|3867292|B1|Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||0|0.0|||
4044616|NCT01114529|3867289|B4|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4044617|NCT01114529|3867290|B3|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||0.0|0.0|||
4044618|NCT01114529|3867291|B2|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||0.0|0.0|||
4044619|NCT01114529|3867292|B1|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||0.3|0.3|||
4044620|NCT01114529|3867289|B4|Asian||Race/Ethnicity, Customized||participants|Number|127|127.0||||||
4044621|NCT01114529|3867290|B3|Asian||Race/Ethnicity, Customized||participants|Number|20|20.0||16.0|16.0|||
4044622|NCT01114529|3867291|B2|Asian||Race/Ethnicity, Customized||participants|Number|41|41.0||17.7|17.7|||
4044623|NCT01114529|3867292|B1|Asian||Race/Ethnicity, Customized||participants|Number|66|66.0||18.7|18.7|||
4044624|NCT01114529|3867289|B4|Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4044625|NCT01114529|3867290|B3|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||0|0.0|||
4044626|NCT01114529|3867291|B2|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||2.2|2.2|||
4044627|NCT01114529|3867292|B1|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||1.1|1.1|||
4044628|NCT01114529|3867289|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|516|516.0||||||
4044629|NCT01114529|3867290|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|97|97.0||77.6|77.6|||
4044630|NCT01114529|3867291|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|173|173.0||74.9|74.9|||
4044631|NCT01114529|3867292|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|246|246.0||69.7|69.7|||
4044632|NCT01114529|3867289|B4||Male|Sex: Female, Male||Participants|Count of Participants|494|494.0||||||
4044633|NCT01114529|3867290|B3||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4044634|NCT01114529|3867291|B2||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4044635|NCT01114529|3867292|B1||Male|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
4044636|NCT01114529|3867289|B4||Female|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
4044637|NCT01114529|3867290|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4044638|NCT01114529|3867291|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4044639|NCT01114529|3867292|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4044640|NCT01114529|3867289|B4|||Age|Kidney transplant Recipients age in years|years|Mean|46.2|46.2|Standard Deviation|14.8|14.8|||
4044641|NCT01114529|3867290|B3|||Age|Kidney transplant Recipients age in years|years|Mean|45.4|45.4|Standard Deviation|15.6|15.6|||
4044642|NCT01114529|3867291|B2|||Age|Kidney transplant Recipients age in years|years|Mean|47.3|47.3|Standard Deviation|14.5|14.5|||
4044643|NCT01114529|3867292|B1|||Age|Kidney transplant Recipients age in years|years|Mean|46.0|46.0|Standard Deviation|14.4|14.4|||
4044644|NCT01114516|3867311|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4044645|NCT01114516|3867312|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4044646|NCT01114516|3867313|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4044647|NCT01114516|3867311|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4044648|NCT01114516|3867312|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4044649|NCT01114516|3867313|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4044650|NCT01114516|3867311|B3|||Age||years|Mean|30.3|30.3|Standard Deviation|6.0|6.0|||
4044651|NCT01114516|3867312|B2|||Age||years|Mean|31.9|31.9|Standard Deviation|6.5|6.5|||
4044652|NCT01114516|3867313|B1|||Age||years|Mean|28.7|28.7|Standard Deviation|4.9|4.9|||
4044653|NCT01114503|3867328|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044654|NCT01114503|3867328|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044655|NCT01114503|3867328|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4044656|NCT01114503|3867328|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044657|NCT01114503|3867328|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044658|NCT01114503|3867328|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044659|NCT01114503|3867328|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044660|NCT01114503|3867328|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4044661|NCT01114503|3867328|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4044662|NCT01114503|3867328|B1|||Age||Years|Mean|53.5|53.5|Full Range|||53.0|54.0|
4044663|NCT01114438|3867349|B1|||Baseline glucose||mmol/L|Mean|9.5|9.5|Standard Deviation|2.95|2.95|||
4044664|NCT01114438|3867349|B1|||Baseline HbA1c||%|Mean|8.5|8.5|Standard Deviation|0.85|0.85|||
4044665|NCT01114438|3867349|B1|||Duration of Diabetes||years|Mean|4.6|4.6|Standard Deviation|2.79|2.79|||
4044666|NCT01114438|3867349|B1|||BMI||kg/m2|Mean|40.0|40.0|Standard Deviation|5.79|5.79|||
4044667|NCT01114438|3867349|B1|||Weight (kg)||kg|Mean|115|115.0|Standard Deviation|21.02|21.02|||
4044668|NCT01114438|3867349|B1|United Kingdom||Region of Enrollment||participants|Number|45|45.0||||||
4044669|NCT01114438|3867349|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4044670|NCT01114438|3867349|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044671|NCT01114438|3867349|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044672|NCT01114438|3867349|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044673|NCT01114438|3867349|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044674|NCT01114438|3867349|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044675|NCT01114438|3867349|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044676|NCT01114438|3867349|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4044677|NCT01114438|3867349|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044678|NCT01114438|3867349|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044679|NCT01114438|3867349|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4044680|NCT01114438|3867349|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4044681|NCT01114438|3867349|B1|||Age||years|Mean|49.9|49.9|Standard Deviation|7.97|7.97|||
4044682|NCT01114438|3867349|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4044683|NCT01114438|3867349|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4044684|NCT01114438|3867349|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044685|NCT01114373|3867359|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4044686|NCT01114373|3867359|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4044687|NCT01114373|3867359|B1|||Age||years|Mean|48.9|48.9|Standard Deviation|9.9|9.9|||
4044688|NCT01114373|3867359|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4044689|NCT01114373|3867359|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4044690|NCT01114373|3867359|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044691|NCT01114360|3867392|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4044692|NCT01114360|3867392|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4044693|NCT01114360|3867392|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4044694|NCT01114360|3867392|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4044695|NCT01114360|3867392|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044696|NCT01114334|3867429|B3|United States||Region of Enrollment||participants|Number|168|168.0||||||
4044697|NCT01114334|3867430|B2|United States||Region of Enrollment||participants|Number|80|80.0||||||
4044698|NCT01114334|3867431|B1|United States||Region of Enrollment||participants|Number|88|88.0||||||
4044699|NCT01114334|3867429|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4044700|NCT01114334|3867430|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4044701|NCT01114334|3867431|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4044702|NCT01114334|3867429|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4044703|NCT01114334|3867430|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4044704|NCT01114334|3867431|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4044705|NCT01114334|3867429|B3||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4044706|NCT01114334|3867430|B2||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4044707|NCT01114334|3867431|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4044708|NCT01114334|3867429|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4044709|NCT01114334|3867430|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4044710|NCT01114334|3867431|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4044711|NCT01114334|3867429|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044712|NCT01114334|3867430|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044713|NCT01114334|3867431|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044714|NCT01114334|3867429|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044715|NCT01114334|3867430|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044716|NCT01114334|3867431|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044717|NCT01114334|3867429|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4044718|NCT01114334|3867430|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4044719|NCT01114334|3867431|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4044720|NCT01114334|3867429|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044721|NCT01114334|3867430|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044722|NCT01114334|3867431|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044723|NCT01114334|3867429|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|109|109.0||||||
4044724|NCT01114334|3867430|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4044725|NCT01114334|3867431|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4044726|NCT01114334|3867429|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4044727|NCT01114334|3867430|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4044728|NCT01114334|3867431|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4044729|NCT01114334|3867429|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4044730|NCT01114334|3867430|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4044731|NCT01114334|3867431|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4044732|NCT01114334|3867429|B3||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4044733|NCT01114334|3867430|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4044734|NCT01114334|3867431|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4044735|NCT01114334|3867429|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4044736|NCT01114334|3867430|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4044737|NCT01114334|3867431|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4044738|NCT01114334|3867429|B3||Between 18 and 65 years|Age||Participants|Count of Participants|157|157.0||||||
4044739|NCT01114334|3867430|B2||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4044740|NCT01114334|3867431|B1||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
4044741|NCT01114334|3867429|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044742|NCT01114334|3867430|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044743|NCT01114334|3867431|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044744|NCT01114217|3867442|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4044745|NCT01114217|3867443|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4044746|NCT01114217|3867444|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4044747|NCT01114217|3867442|B3||Female|Sex: Female, Male||Participants|Count of Participants|573|573.0||||||
4044748|NCT01114217|3867443|B2||Female|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
4044749|NCT01114217|3867444|B1||Female|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
4044750|NCT01114217|3867442|B3|||Age||years|Mean|44.9|44.9|Standard Deviation|13.33|13.33|||
4044751|NCT01114217|3867443|B2|||Age||years|Mean|43.8|43.8|Standard Deviation|13.26|13.26|||
4044752|NCT01114217|3867444|B1|||Age||years|Mean|46.0|46.0|Standard Deviation|13.33|13.33|||
4044753|NCT01114204|3867455|B3||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4044754|NCT01114204|3867456|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4044755|NCT01114204|3867457|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4044756|NCT01114204|3867455|B3||Female|Sex: Female, Male||Participants|Count of Participants|502|502.0||||||
4044757|NCT01114204|3867456|B2||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4044758|NCT01114204|3867457|B1||Female|Sex: Female, Male||Participants|Count of Participants|342|342.0||||||
4044759|NCT01114204|3867455|B3|||Age||years|Mean|48.2|48.2|Standard Deviation|14.81|14.81|||
4044760|NCT01114204|3867456|B2|||Age||years|Mean|48.9|48.9|Standard Deviation|14.66|14.66|||
4044761|NCT01114204|3867457|B1|||Age||years|Mean|48.0|48.0|Standard Deviation|14.89|14.89|||
4044762|NCT01114139|3867474|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4044763|NCT01114139|3867475|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4044764|NCT01114139|3867476|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4044765|NCT01114139|3867474|B3||Female|Sex: Female, Male||Participants|Count of Participants|720|720.0||||||
4044766|NCT01114139|3867475|B2||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4044767|NCT01114139|3867476|B1||Female|Sex: Female, Male||Participants|Count of Participants|542|542.0||||||
4044768|NCT01114139|3867474|B3|||Age||years|Mean|45.1|45.1|Standard Deviation|13.76|13.76|||
4044769|NCT01114139|3867475|B2|||Age||years|Mean|46.0|46.0|Standard Deviation|13.58|13.58|||
4044770|NCT01114139|3867476|B1|||Age||years|Mean|44.8|44.8|Standard Deviation|13.82|13.82|||
4044771|NCT01113931|3867493|B3|United States||Region of Enrollment||participants|Number|495|495.0||||||
4044772|NCT01113931|3867494|B2|United States||Region of Enrollment||participants|Number|248|248.0||||||
4044773|NCT01113931|3867495|B1|United States||Region of Enrollment||participants|Number|247|247.0||||||
4044774|NCT01113931|3867493|B3|Unknown or Not Reported||Race (NIH/OMB)|mITT Population|Participants|Number|0|0.0||||||
4044775|NCT01113931|3867494|B2|Unknown or Not Reported||Race (NIH/OMB)|mITT Population|Participants|Number|0|0.0||||||
4044776|NCT01113931|3867495|B1|Unknown or Not Reported||Race (NIH/OMB)|mITT Population|Participants|Number|0|0.0||||||
4044777|NCT01113931|3867493|B3|More than one race||Race (NIH/OMB)|mITT Population|Participants|Number|20|20.0||||||
4044778|NCT01113931|3867494|B2|More than one race||Race (NIH/OMB)|mITT Population|Participants|Number|10|10.0||||||
4044779|NCT01113931|3867495|B1|More than one race||Race (NIH/OMB)|mITT Population|Participants|Number|10|10.0||||||
4044780|NCT01113931|3867493|B3|White||Race (NIH/OMB)|mITT Population|Participants|Number|134|134.0||||||
4044781|NCT01113931|3867494|B2|White||Race (NIH/OMB)|mITT Population|Participants|Number|73|73.0||||||
4044782|NCT01113931|3867495|B1|White||Race (NIH/OMB)|mITT Population|Participants|Number|61|61.0||||||
4044783|NCT01113931|3867493|B3|Black or African American||Race (NIH/OMB)|mITT Population|Participants|Number|213|213.0||||||
4044784|NCT01113931|3867494|B2|Black or African American||Race (NIH/OMB)|mITT Population|Participants|Number|104|104.0||||||
4044785|NCT01113931|3867495|B1|Black or African American||Race (NIH/OMB)|mITT Population|Participants|Number|109|109.0||||||
4044786|NCT01113931|3867493|B3|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|mITT Population|Participants|Number|4|4.0||||||
4044787|NCT01113931|3867494|B2|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|mITT Population|Participants|Number|1|1.0||||||
4044788|NCT01113931|3867495|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|mITT Population|Participants|Number|3|3.0||||||
4044789|NCT01113931|3867493|B3|Asian||Race (NIH/OMB)|mITT Population|Participants|Number|4|4.0||||||
4044790|NCT01113931|3867494|B2|Asian||Race (NIH/OMB)|mITT Population|Participants|Number|1|1.0||||||
4044791|NCT01113931|3867495|B1|Asian||Race (NIH/OMB)|mITT Population|Participants|Number|3|3.0||||||
4044792|NCT01113931|3867493|B3|American Indian or Alaska Native||Race (NIH/OMB)|mITT Population|Participants|Number|3|3.0||||||
4044793|NCT01113931|3867494|B2|American Indian or Alaska Native||Race (NIH/OMB)|mITT Population|Participants|Number|1|1.0||||||
4044794|NCT01113931|3867495|B1|American Indian or Alaska Native||Race (NIH/OMB)|mITT Population|Participants|Number|2|2.0||||||
4044795|NCT01113931|3867493|B3|Unknown or Not Reported||Ethnicity (NIH/OMB)|mITT Population|Participants|Number|0|0.0||||||
4044796|NCT01113931|3867494|B2|Unknown or Not Reported||Ethnicity (NIH/OMB)|mITT Population|Participants|Number|0|0.0||||||
4044797|NCT01113931|3867495|B1|Unknown or Not Reported||Ethnicity (NIH/OMB)|mITT Population|Participants|Number|0|0.0||||||
4044798|NCT01113931|3867493|B3|Not Hispanic or Latino||Ethnicity (NIH/OMB)|mITT Population|Participants|Number|301|301.0||||||
4044799|NCT01113931|3867494|B2|Not Hispanic or Latino||Ethnicity (NIH/OMB)|mITT Population|Participants|Number|146|146.0||||||
4044800|NCT01113931|3867495|B1|Not Hispanic or Latino||Ethnicity (NIH/OMB)|mITT Population|Participants|Number|155|155.0||||||
4044801|NCT01113931|3867493|B3|Hispanic or Latino||Ethnicity (NIH/OMB)|mITT Population|Participants|Number|77|77.0||||||
4044802|NCT01113931|3867494|B2|Hispanic or Latino||Ethnicity (NIH/OMB)|mITT Population|Participants|Number|44|44.0||||||
4044803|NCT01113931|3867495|B1|Hispanic or Latino||Ethnicity (NIH/OMB)|mITT Population|Participants|Number|33|33.0||||||
4044804|NCT01113931|3867493|B3|Male||Gender|mITT Population|participants|Number|145|145.0||||||
4044805|NCT01113931|3867494|B2|Male||Gender|mITT Population|participants|Number|72|72.0||||||
4044806|NCT01113931|3867495|B1|Male||Gender|mITT Population|participants|Number|73|73.0||||||
4044807|NCT01113931|3867493|B3|Female||Gender|mITT Population|participants|Number|233|233.0||||||
4044808|NCT01113931|3867494|B2|Female||Gender|mITT Population|participants|Number|118|118.0||||||
4044809|NCT01113931|3867495|B1|Female||Gender|mITT Population|participants|Number|115|115.0||||||
4044810|NCT01113931|3867493|B3|>40 years||Age, Customized|mITT Population|participants|Number|5|5.0||||||
4044811|NCT01113931|3867494|B2|>40 years||Age, Customized|mITT Population|participants|Number|2|2.0||||||
4044812|NCT01113931|3867495|B1|>40 years||Age, Customized|mITT Population|participants|Number|3|3.0||||||
4044813|NCT01113931|3867493|B3|Between 30 and 40 years||Age, Customized|mITT Population|participants|Number|40|40.0||||||
4044814|NCT01113931|3867494|B2|Between 30 and 40 years||Age, Customized|mITT Population|participants|Number|18|18.0||||||
4044815|NCT01113931|3867495|B1|Between 30 and 40 years||Age, Customized|mITT Population|participants|Number|22|22.0||||||
4044816|NCT01113931|3867493|B3|<30 years||Age, Customized|mITT Population|participants|Number|333|333.0||||||
4044817|NCT01113931|3867494|B2|<30 years||Age, Customized|mITT Population|participants|Number|170|170.0||||||
4044818|NCT01113931|3867495|B1|<30 years||Age, Customized|mITT Population|participants|Number|163|163.0||||||
4044819|NCT01113931|3867493|B3|||Age|mITT Population|years|Mean|24.0|24.0|Standard Deviation|4.9|4.9|||
4044820|NCT01113931|3867494|B2|||Age|mITT Population|years|Mean|23.9|23.9|Standard Deviation|4.9|4.9|||
4044821|NCT01113931|3867495|B1|||Age|mITT Population|years|Mean|24.1|24.1|Standard Deviation|4.9|4.9|||
4044822|NCT01113801|3867508|B5|||Estimated Glomerular Filtration Rate (eGFR)||milliliter/minute/1.73 meter squared|Mean|35.464|35.464|Standard Deviation|11.8539|11.8539|||
4044823|NCT01113801|3867509|B4|||Estimated Glomerular Filtration Rate (eGFR)||milliliter/minute/1.73 meter squared|Mean|35.945|35.945|Standard Deviation|12.0852|12.0852|||
4044824|NCT01113801|3867510|B3|||Estimated Glomerular Filtration Rate (eGFR)||milliliter/minute/1.73 meter squared|Mean|36.358|36.358|Standard Deviation|12.5154|12.5154|||
4044825|NCT01113801|3867511|B2|||Estimated Glomerular Filtration Rate (eGFR)||milliliter/minute/1.73 meter squared|Mean|35.705|35.705|Standard Deviation|11.7226|11.7226|||
4044826|NCT01113801|3867512|B1|||Estimated Glomerular Filtration Rate (eGFR)||milliliter/minute/1.73 meter squared|Mean|33.835|33.835|Standard Deviation|11.0568|11.0568|||
4044827|NCT01113801|3867508|B5|||Urine Protein/Creatinine Ratio||gram/gram|Mean|3.262|3.262|Standard Deviation|2.5148|2.5148|||
4044828|NCT01113801|3867509|B4|||Urine Protein/Creatinine Ratio||gram/gram|Mean|3.354|3.354|Standard Deviation|2.5457|2.5457|||
4044829|NCT01113801|3867510|B3|||Urine Protein/Creatinine Ratio||gram/gram|Mean|3.301|3.301|Standard Deviation|2.4510|2.451|||
4044830|NCT01113801|3867511|B2|||Urine Protein/Creatinine Ratio||gram/gram|Mean|3.266|3.266|Standard Deviation|2.5723|2.5723|||
4044831|NCT01113801|3867512|B1|||Urine Protein/Creatinine Ratio||gram/gram|Mean|3.123|3.123|Standard Deviation|2.5180|2.518|||
4044832|NCT01113801|3867508|B5|||Serum Creatinine||milligram/deciliter (mg/dl)|Mean|2.140|2.14|Standard Deviation|0.6141|0.6141|||
4044833|NCT01113801|3867509|B4|||Serum Creatinine||milligram/deciliter (mg/dl)|Mean|2.132|2.132|Standard Deviation|0.6289|0.6289|||
4044834|NCT01113801|3867510|B3|||Serum Creatinine||milligram/deciliter (mg/dl)|Mean|2.091|2.091|Standard Deviation|0.6538|0.6538|||
4044835|NCT01113801|3867511|B2|||Serum Creatinine||milligram/deciliter (mg/dl)|Mean|2.127|2.127|Standard Deviation|0.5824|0.5824|||
4044836|NCT01113801|3867512|B1|||Serum Creatinine||milligram/deciliter (mg/dl)|Mean|2.209|2.209|Standard Deviation|0.5917|0.5917|||
4044837|NCT01113801|3867508|B5|Israel||Region of Enrollment||Participants|Count of Participants|82|82.0||||||
4044838|NCT01113801|3867509|B4|Israel||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4044839|NCT01113801|3867510|B3|Israel||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
4044840|NCT01113801|3867511|B2|Israel||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
4044841|NCT01113801|3867512|B1|Israel||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4044842|NCT01113801|3867508|B5|Australia||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
4044843|NCT01113801|3867509|B4|Australia||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4044844|NCT01113801|3867510|B3|Australia||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4044845|NCT01113801|3867511|B2|Australia||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4044846|NCT01113801|3867512|B1|Australia||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4044847|NCT01113801|3867508|B5|Puerto Rico||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4044848|NCT01113801|3867509|B4|Puerto Rico||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4044849|NCT01113801|3867510|B3|Puerto Rico||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4044850|NCT01113801|3867511|B2|Puerto Rico||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4044851|NCT01113801|3867512|B1|Puerto Rico||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4044852|NCT01113801|3867508|B5|Hungary||Region of Enrollment||Participants|Count of Participants|57|57.0||||||
4044853|NCT01113801|3867509|B4|Hungary||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4044854|NCT01113801|3867510|B3|Hungary||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4044855|NCT01113801|3867511|B2|Hungary||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4044856|NCT01113801|3867512|B1|Hungary||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4044857|NCT01113801|3867508|B5|Czechia||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
4044858|NCT01113801|3867509|B4|Czechia||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4044859|NCT01113801|3867510|B3|Czechia||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4044860|NCT01113801|3867511|B2|Czechia||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4044978|NCT01113710|3867567|B1|||Age||years|Mean|65.6|65.6|Standard Deviation|12.6|12.6|||
4044861|NCT01113801|3867512|B1|Czechia||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4044862|NCT01113801|3867508|B5|United States||Region of Enrollment||Participants|Count of Participants|146|146.0||||||
4044863|NCT01113801|3867509|B4|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
4044864|NCT01113801|3867510|B3|United States||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
4044865|NCT01113801|3867511|B2|United States||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
4044866|NCT01113801|3867512|B1|United States||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
4044867|NCT01113801|3867508|B5|France||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
4044868|NCT01113801|3867509|B4|France||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4044869|NCT01113801|3867510|B3|France||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4044870|NCT01113801|3867511|B2|France||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4044871|NCT01113801|3867512|B1|France||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4044872|NCT01113801|3867508|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4044873|NCT01113801|3867509|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4044874|NCT01113801|3867510|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4044875|NCT01113801|3867511|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4044876|NCT01113801|3867512|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4044877|NCT01113801|3867508|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4044878|NCT01113801|3867509|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044879|NCT01113801|3867510|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4044880|NCT01113801|3867511|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044881|NCT01113801|3867512|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4044882|NCT01113801|3867508|B5||White|Race (NIH/OMB)||Participants|Count of Participants|347|347.0||||||
4044883|NCT01113801|3867509|B4||White|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4044884|NCT01113801|3867510|B3||White|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
4044885|NCT01113801|3867511|B2||White|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4044886|NCT01113801|3867512|B1||White|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
4044887|NCT01113801|3867508|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4044888|NCT01113801|3867509|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4044889|NCT01113801|3867510|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4044890|NCT01113801|3867511|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4044891|NCT01113801|3867512|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4044892|NCT01113801|3867508|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4044893|NCT01113801|3867509|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044894|NCT01113801|3867510|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4044895|NCT01113801|3867511|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044896|NCT01113801|3867512|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4044897|NCT01113801|3867508|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4044898|NCT01113801|3867509|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4044899|NCT01113801|3867510|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4044900|NCT01113801|3867511|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4044901|NCT01113801|3867512|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044902|NCT01113801|3867508|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044903|NCT01113801|3867509|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044904|NCT01113801|3867510|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044905|NCT01113801|3867511|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044906|NCT01113801|3867512|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4044907|NCT01113801|3867508|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|160|160.0||||||
4044908|NCT01113801|3867509|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4044909|NCT01113801|3867510|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4044910|NCT01113801|3867511|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4044911|NCT01113801|3867512|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4044912|NCT01113801|3867508|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|211|211.0||||||
4044913|NCT01113801|3867509|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4044914|NCT01113801|3867510|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4044915|NCT01113801|3867511|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4044916|NCT01113801|3867512|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4044917|NCT01113801|3867508|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4044918|NCT01113801|3867509|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4044919|NCT01113801|3867510|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4044920|NCT01113801|3867511|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4044921|NCT01113801|3867512|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4044922|NCT01113801|3867508|B5||Male|Sex: Female, Male||Participants|Count of Participants|320|320.0||||||
4044923|NCT01113801|3867509|B4||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4044924|NCT01113801|3867510|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4044925|NCT01113801|3867511|B2||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4044926|NCT01113801|3867512|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4044927|NCT01113801|3867508|B5||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4044928|NCT01113801|3867509|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4044929|NCT01113801|3867510|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4044930|NCT01113801|3867511|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4044931|NCT01113801|3867512|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4044932|NCT01113801|3867508|B5|||Age||years|Mean|62.2|62.2|Standard Deviation|10.16|10.16|||
4044933|NCT01113801|3867509|B4|||Age||years|Mean|62.9|62.9|Standard Deviation|10.86|10.86|||
4044934|NCT01113801|3867510|B3|||Age||years|Mean|60.5|60.5|Standard Deviation|9.05|9.05|||
4044935|NCT01113801|3867511|B2|||Age||years|Mean|62.8|62.8|Standard Deviation|9.20|9.2|||
4044936|NCT01113801|3867512|B1|||Age||years|Mean|62.7|62.7|Standard Deviation|11.31|11.31|||
4044937|NCT01113749|3867541|B3|United States||Region of Enrollment||participants|Number|256|256.0||||||
4044938|NCT01113749|3867542|B2|United States||Region of Enrollment||participants|Number|129|129.0||||||
4044939|NCT01113749|3867543|B1|United States||Region of Enrollment||participants|Number|127|127.0||||||
4044940|NCT01113749|3867541|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4044941|NCT01113749|3867542|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4044942|NCT01113749|3867543|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4044943|NCT01113749|3867541|B3||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4044944|NCT01113749|3867542|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4044945|NCT01113749|3867543|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4044946|NCT01113749|3867541|B3|||Age||years|Mean|85.2|85.2|Standard Deviation|2.1|2.1|||
4044947|NCT01113749|3867542|B2|||Age||years|Mean|85.3|85.3|Standard Deviation|2.3|2.3|||
4044948|NCT01113749|3867543|B1|||Age||years|Mean|85.2|85.2|Standard Deviation|2.1|2.1|||
4044949|NCT01113749|3867541|B3||>=65 years|Age||Participants|Count of Participants|256|256.0||||||
4044950|NCT01113749|3867542|B2||>=65 years|Age||Participants|Count of Participants|129|129.0||||||
4044951|NCT01113749|3867543|B1||>=65 years|Age||Participants|Count of Participants|127|127.0||||||
4044952|NCT01113749|3867541|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4044953|NCT01113749|3867542|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4044954|NCT01113749|3867543|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4044955|NCT01113749|3867541|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044956|NCT01113749|3867542|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044957|NCT01113749|3867543|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4044958|NCT01113723|3867554|B3|United States||Region of Enrollment||participants|Number|140|140.0||||||
4044959|NCT01113723|3867555|B2|United States||Region of Enrollment||participants|Number|70|70.0||||||
4044960|NCT01113723|3867556|B1|United States||Region of Enrollment||participants|Number|70|70.0||||||
4044961|NCT01113723|3867554|B3||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4044962|NCT01113723|3867555|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4044963|NCT01113723|3867556|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4044964|NCT01113723|3867554|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4044965|NCT01113723|3867555|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4044966|NCT01113723|3867556|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4044967|NCT01113723|3867554|B3|||Age||years|Mean|53|53.0|Standard Deviation|12|12.0|||
4044968|NCT01113723|3867555|B2|||Age||years|Mean|50|50.0|Standard Deviation|12|12.0|||
4044969|NCT01113723|3867556|B1|||Age||years|Mean|55|55.0|Standard Deviation|12|12.0|||
4044970|NCT01113710|3867567|B1|Germany||Region of Enrollment||participants|Number|687|687.0||||||
4044971|NCT01113710|3867567|B1|Missing||Sex/Gender, Customized||Participants|Number|5|5.0||||||
4044972|NCT01113710|3867567|B1|Male||Sex/Gender, Customized||Participants|Number|188|188.0||||||
4044973|NCT01113710|3867567|B1|Female||Sex/Gender, Customized||Participants|Number|494|494.0||||||
4044974|NCT01113710|3867567|B1|Missing||Age, Customized||Participants|Number|1|1.0||||||
4044975|NCT01113710|3867567|B1|>=65 years||Age, Customized||Participants|Number|408|408.0||||||
4044976|NCT01113710|3867567|B1|Between 18 and 65 years||Age, Customized||Participants|Number|278|278.0||||||
4044977|NCT01113710|3867567|B1|<=18 years||Age, Customized||Participants|Number|0|0.0||||||
4044979|NCT01113632|3867576|B3|United States||Region of Enrollment||participants|Number|77|77.0||||||
4044980|NCT01113632|3867577|B2|United States||Region of Enrollment||participants|Number|44|44.0||||||
4044981|NCT01113632|3867578|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4044982|NCT01113632|3867576|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4044983|NCT01113632|3867577|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4044984|NCT01113632|3867578|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4044985|NCT01113632|3867576|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4044986|NCT01113632|3867577|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4044987|NCT01113632|3867578|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4044988|NCT01113632|3867576|B3|||Age||years|Median|72|72.0|Full Range|||47.0|93.0|
4044989|NCT01113632|3867577|B2|||Age||years|Median|69|69.0|Full Range|||47.0|88.0|
4044990|NCT01113632|3867578|B1|||Age||years|Median|75|75.0|Full Range|||50.0|93.0|
4044991|NCT01113580|3867593|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4044992|NCT01113580|3867594|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4044993|NCT01113580|3867595|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4044994|NCT01113580|3867593|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4044995|NCT01113580|3867594|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4044996|NCT01113580|3867595|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4044997|NCT01113580|3867593|B3|>= 60 years||Age, Customized||participants|Number|60|60.0||||||
4044998|NCT01113580|3867594|B2|>= 60 years||Age, Customized||participants|Number|60|60.0||||||
4044999|NCT01113580|3867595|B1|>= 60 years||Age, Customized||participants|Number|0|0.0||||||
4045000|NCT01113580|3867593|B3|18 to 59 years||Age, Customized||participants|Number|60|60.0||||||
4045001|NCT01113580|3867594|B2|18 to 59 years||Age, Customized||participants|Number|0|0.0||||||
4045002|NCT01113580|3867595|B1|18 to 59 years||Age, Customized||participants|Number|60|60.0||||||
4045003|NCT01113580|3867593|B3|< 18 years||Age, Customized||participants|Number|0|0.0||||||
4045004|NCT01113580|3867594|B2|< 18 years||Age, Customized||participants|Number|0|0.0||||||
4045005|NCT01113580|3867595|B1|< 18 years||Age, Customized||participants|Number|0|0.0||||||
4045006|NCT01113541|3867610|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4045007|NCT01113541|3867610|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4045008|NCT01113541|3867610|B1|||Age||years|Mean|46.5|46.5|Standard Deviation|10.7|10.7|||
4045009|NCT01113463|3867643|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4045010|NCT01113463|3867643|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4045011|NCT01113463|3867643|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4045012|NCT01113463|3867643|B1|||Age||years|Median|61|61.0|Full Range|||31.0|77.0|
4045013|NCT01113398|3867648|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4045014|NCT01113398|3867648|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4045015|NCT01113398|3867648|B1|||Age||years|Mean|53.6|53.6|Standard Deviation|11.1|11.1|||
4045016|NCT01113385|3867655|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4045017|NCT01113385|3867655|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4045018|NCT01113385|3867655|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4045019|NCT01113385|3867655|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4045020|NCT01113385|3867655|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4045021|NCT01113385|3867655|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4045022|NCT01113385|3867655|B1|||Age||years|Mean|7.7|7.7|Standard Deviation|4|4.0|||
4045023|NCT01113008|3867660|B3||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4045024|NCT01113008|3867661|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4045025|NCT01113008|3867662|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4045026|NCT01113008|3867660|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4045027|NCT01113008|3867661|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4045028|NCT01113008|3867662|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4045029|NCT01113008|3867660|B3|||Age||years|Mean|64.6|64.6|Standard Deviation|9.7|9.7|||
4045030|NCT01113008|3867661|B2|||Age||years|Mean|64.4|64.4|Standard Deviation|9.3|9.3|||
4045031|NCT01113008|3867662|B1|||Age||years|Mean|64.8|64.8|Standard Deviation|10.1|10.1|||
4045032|NCT01112917|3867673|B1|United States||Region of Enrollment||participants|Number|149|149.0||||||
4045033|NCT01112917|3867673|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4045034|NCT01112917|3867673|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045035|NCT01112917|3867673|B1||White|Race (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
4045036|NCT01112917|3867673|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4045037|NCT01112917|3867673|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045038|NCT01112917|3867673|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4045039|NCT01112917|3867673|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045040|NCT01112917|3867673|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045041|NCT01112917|3867673|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|145|145.0||||||
4045042|NCT01112917|3867673|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4045043|NCT01112917|3867673|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4045044|NCT01112917|3867673|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4045045|NCT01112917|3867673|B1|||Age||years|Mean|62.7|62.7|Standard Deviation|13|13.0|||
4045046|NCT01112865|3867679|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4045047|NCT01112865|3867679|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4045048|NCT01112865|3867679|B1|≥65 years||Age, Customized||participants|Number|2|2.0||||||
4045049|NCT01112865|3867679|B1|Between 45 and 64 years||Age, Customized||participants|Number|22|22.0||||||
4045050|NCT01112865|3867679|B1|Between 18 and 44 years||Age, Customized||participants|Number|18|18.0||||||
4045051|NCT01112865|3867679|B1|Between 8 and 17 years||Age, Customized||participants|Number|50|50.0||||||
4045052|NCT01112865|3867679|B1|≤7 years||Age, Customized||participants|Number|28|28.0||||||
4045053|NCT01112735|3867690|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045054|NCT01112735|3867691|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045055|NCT01112735|3867692|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045056|NCT01112735|3867690|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045057|NCT01112735|3867691|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045058|NCT01112735|3867692|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045059|NCT01112735|3867690|B3||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4045060|NCT01112735|3867691|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4045061|NCT01112735|3867692|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4045062|NCT01112735|3867690|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4045063|NCT01112735|3867691|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045064|NCT01112735|3867692|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4045065|NCT01112735|3867690|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045066|NCT01112735|3867691|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045067|NCT01112735|3867692|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045068|NCT01112735|3867690|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4045069|NCT01112735|3867691|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045070|NCT01112735|3867692|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4045071|NCT01112735|3867690|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045072|NCT01112735|3867691|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045073|NCT01112735|3867692|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045074|NCT01112735|3867690|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045075|NCT01112735|3867691|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045076|NCT01112735|3867692|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045077|NCT01112735|3867690|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4045078|NCT01112735|3867691|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4045079|NCT01112735|3867692|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4045080|NCT01112735|3867690|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4045081|NCT01112735|3867691|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4045082|NCT01112735|3867692|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4045083|NCT01112735|3867690|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4045084|NCT01112735|3867691|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4045085|NCT01112735|3867692|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4045086|NCT01112735|3867690|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4045087|NCT01112735|3867691|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4045088|NCT01112735|3867692|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4045089|NCT01112735|3867690|B3|||Age||Years|Mean|43.25|43.25|Standard Deviation|9.38|9.38|||
4045090|NCT01112735|3867691|B2|||Age||Years|Mean|45.60|45.6|Standard Deviation|10.32|10.32|||
4045091|NCT01112735|3867692|B1|||Age||Years|Mean|40.90|40.9|Standard Deviation|7.89|7.89|||
4045092|NCT01112696|3867717|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
4045093|NCT01112696|3867717|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4045094|NCT01112696|3867717|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4045095|NCT01112696|3867717|B1|||Age||years|Mean|42.2|42.2|Standard Deviation|15|15.0|||
4045096|NCT01112696|3867717|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4045097|NCT01112696|3867717|B1||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
4045098|NCT01112696|3867717|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4045099|NCT01112683|3867722|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
4045100|NCT01112683|3867723|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4045101|NCT01112683|3867724|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4045102|NCT01112683|3867722|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4045103|NCT01112683|3867723|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4045104|NCT01112683|3867724|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4045105|NCT01112683|3867722|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4045106|NCT01112683|3867723|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4045107|NCT01112683|3867724|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4045108|NCT01112683|3867722|B3|||Age||years|Mean|22.93|22.93|Standard Deviation|3.76|3.76|||
4045109|NCT01112683|3867723|B2|||Age||years|Mean|22.60|22.6|Standard Deviation|4.01|4.01|||
4045110|NCT01112683|3867724|B1|||Age||years|Mean|23.27|23.27|Standard Deviation|3.52|3.52|||
4045111|NCT01112683|3867722|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4045112|NCT01112683|3867723|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4045113|NCT01112683|3867724|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4045114|NCT01112683|3867722|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4045115|NCT01112683|3867723|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4045116|NCT01112683|3867724|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4045117|NCT01112683|3867722|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4045118|NCT01112683|3867723|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4045119|NCT01112683|3867724|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4045120|NCT01112670|3867735|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4045121|NCT01112670|3867735|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4045122|NCT01112670|3867735|B1|||Age||years|Mean|33|33.0|Standard Deviation|10|10.0|||
4045123|NCT01112670|3867735|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4045124|NCT01112670|3867735|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4045125|NCT01112670|3867735|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4045126|NCT01112579|3867776|B3|Germany||Region of Enrollment||Randomized participants|Number|1|1.0||||||
4045127|NCT01112579|3867777|B2|Germany||Region of Enrollment||Randomized participants|Number|0|0.0||||||
4045128|NCT01112579|3867778|B1|Germany||Region of Enrollment||Randomized participants|Number|1|1.0||||||
4045129|NCT01112579|3867776|B3|South Africa||Region of Enrollment||Randomized participants|Number|2|2.0||||||
4045130|NCT01112579|3867777|B2|South Africa||Region of Enrollment||Randomized participants|Number|1|1.0||||||
4045131|NCT01112579|3867778|B1|South Africa||Region of Enrollment||Randomized participants|Number|1|1.0||||||
4045132|NCT01112579|3867776|B3|Italy||Region of Enrollment||Randomized participants|Number|3|3.0||||||
4045133|NCT01112579|3867777|B2|Italy||Region of Enrollment||Randomized participants|Number|0|0.0||||||
4045134|NCT01112579|3867778|B1|Italy||Region of Enrollment||Randomized participants|Number|3|3.0||||||
4045135|NCT01112579|3867776|B3|United States||Region of Enrollment||Randomized participants|Number|12|12.0||||||
4045136|NCT01112579|3867777|B2|United States||Region of Enrollment||Randomized participants|Number|3|3.0||||||
4045137|NCT01112579|3867778|B1|United States||Region of Enrollment||Randomized participants|Number|9|9.0||||||
4045138|NCT01112579|3867776|B3|Sweden||Region of Enrollment||Randomized participants|Number|9|9.0||||||
4045139|NCT01112579|3867777|B2|Sweden||Region of Enrollment||Randomized participants|Number|5|5.0||||||
4045140|NCT01112579|3867778|B1|Sweden||Region of Enrollment||Randomized participants|Number|4|4.0||||||
4045141|NCT01112579|3867776|B3|Netherlands||Region of Enrollment||Randomized participants|Number|14|14.0||||||
4045142|NCT01112579|3867777|B2|Netherlands||Region of Enrollment||Randomized participants|Number|5|5.0||||||
4045143|NCT01112579|3867778|B1|Netherlands||Region of Enrollment||Randomized participants|Number|9|9.0||||||
4045144|NCT01112579|3867776|B3|Czech Republic||Region of Enrollment||Randomized participants|Number|22|22.0||||||
4045145|NCT01112579|3867777|B2|Czech Republic||Region of Enrollment||Randomized participants|Number|10|10.0||||||
4045146|NCT01112579|3867778|B1|Czech Republic||Region of Enrollment||Randomized participants|Number|12|12.0||||||
4045147|NCT01112579|3867776|B3|Canada||Region of Enrollment||Randomized participants|Number|3|3.0||||||
4045148|NCT01112579|3867777|B2|Canada||Region of Enrollment||Randomized participants|Number|0|0.0||||||
4045149|NCT01112579|3867778|B1|Canada||Region of Enrollment||Randomized participants|Number|3|3.0||||||
4045150|NCT01112579|3867776|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4045151|NCT01112579|3867777|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4045152|NCT01112579|3867778|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4045153|NCT01112579|3867776|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4045154|NCT01112579|3867777|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4045155|NCT01112579|3867778|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4045156|NCT01112579|3867776|B3|||Age||years|Mean|61|61.0|Standard Deviation|12|12.0|||
4045157|NCT01112579|3867777|B2|||Age||years|Mean|66|66.0|Standard Deviation|11|11.0|||
4045158|NCT01112579|3867778|B1|||Age||years|Mean|58|58.0|Standard Deviation|11|11.0|||
4045159|NCT01112514|3867789|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4045160|NCT01112514|3867789|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4045161|NCT01112514|3867789|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4045162|NCT01112514|3867789|B1|||Age||years|Mean|57|57.0|Standard Deviation|9.82|9.82|||
4045163|NCT01112514|3867789|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4045164|NCT01112514|3867789|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4045165|NCT01112514|3867789|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4045166|NCT01112358|3867793|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4045167|NCT01112358|3867794|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4045168|NCT01112358|3867795|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4045169|NCT01112358|3867793|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4045170|NCT01112358|3867794|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4045171|NCT01112358|3867795|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4045172|NCT01112358|3867793|B3|||Age||Years|Mean|34.65|34.65|Standard Deviation|2.1|2.1|||
4045173|NCT01112358|3867794|B2|||Age||Years|Mean|34.4|34.4|Standard Deviation|2.0|2.0|||
4045174|NCT01112358|3867795|B1|||Age||Years|Mean|34.9|34.9|Standard Deviation|2.2|2.2|||
4045175|NCT01112267|3867832|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4045176|NCT01112267|3867833|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4045177|NCT01112267|3867834|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4045178|NCT01112267|3867832|B3||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4045179|NCT01112267|3867833|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4045180|NCT01112267|3867834|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4045181|NCT01112267|3867832|B3|||Age||Years|Mean|60.16|60.16|Standard Deviation|10.29|10.29|||
4045182|NCT01112267|3867833|B2|||Age||Years|Mean|60.39|60.39|Standard Deviation|9.87|9.87|||
4045183|NCT01112267|3867834|B1|||Age||Years|Mean|59.93|59.93|Standard Deviation|10.72|10.72|||
4045184|NCT01112241|3867853|B1|Italy||Region of Enrollment||participants|Number|17|17.0||||||
4045185|NCT01112241|3867853|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4045186|NCT01112241|3867853|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4045187|NCT01112241|3867853|B1|||Age||years|Mean|48|48.0|Standard Deviation|12|12.0|||
4045188|NCT01112241|3867853|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4045189|NCT01112241|3867853|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4045190|NCT01112241|3867853|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4045191|NCT01112059|3867866|B3|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
4045192|NCT01112059|3867867|B2|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4045193|NCT01112059|3867868|B1|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4045194|NCT01112059|3867866|B3||Male|Gender||Participants|Count of Participants|25|25.0||||||
4045195|NCT01112059|3867867|B2||Male|Gender||Participants|Count of Participants|12|12.0||||||
4045196|NCT01112059|3867868|B1||Male|Gender||Participants|Count of Participants|13|13.0||||||
4045197|NCT01112059|3867866|B3||Female|Gender||Participants|Count of Participants|14|14.0||||||
4045198|NCT01112059|3867867|B2||Female|Gender||Participants|Count of Participants|8|8.0||||||
4045199|NCT01112059|3867868|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
4045200|NCT01112059|3867866|B3|||Age||years|Mean|28.2|28.2|Standard Deviation|9.1|9.1|||
4045201|NCT01112059|3867867|B2|||Age||years|Mean|29.1|29.1|Standard Deviation|8.9|8.9|||
4045202|NCT01112059|3867868|B1|||Age||years|Mean|27.3|27.3|Standard Deviation|9.4|9.4|||
4045203|NCT01112059|3867866|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4045204|NCT01112059|3867867|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4045205|NCT01112059|3867868|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4045206|NCT01112059|3867866|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4045207|NCT01112059|3867867|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4045208|NCT01112059|3867868|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4045209|NCT01112059|3867866|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4045210|NCT01112059|3867867|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4045211|NCT01112059|3867868|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4045212|NCT01111851|3867881|B3|Belgium||Region of Enrollment||participants|Number|16|16.0||||||
4045213|NCT01111851|3867882|B2|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
4045214|NCT01111851|3867883|B1|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
4045215|NCT01111851|3867881|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4045216|NCT01111851|3867882|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4045217|NCT01111851|3867883|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4045218|NCT01111851|3867881|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4045219|NCT01111851|3867882|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4045220|NCT01111851|3867883|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4045221|NCT01111851|3867881|B3|> = 55 years||Age, Customized||Participants|Number|0|0.0||||||
4045222|NCT01111851|3867882|B2|> = 55 years||Age, Customized||Participants|Number|0|0.0||||||
4045223|NCT01111851|3867883|B1|> = 55 years||Age, Customized||Participants|Number|0|0.0||||||
4045224|NCT01111851|3867881|B3|Between 18 and 55 years||Age, Customized||Participants|Number|16|16.0||||||
4045225|NCT01111851|3867882|B2|Between 18 and 55 years||Age, Customized||Participants|Number|8|8.0||||||
4045226|NCT01111851|3867883|B1|Between 18 and 55 years||Age, Customized||Participants|Number|8|8.0||||||
4045227|NCT01111851|3867881|B3|< = 18 years||Age, Customized||Participants|Number|0|0.0||||||
4045228|NCT01111851|3867882|B2|< = 18 years||Age, Customized||Participants|Number|0|0.0||||||
4045229|NCT01111851|3867883|B1|< = 18 years||Age, Customized||Participants|Number|0|0.0||||||
4045230|NCT01111838|3867896|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4045231|NCT01111838|3867896|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4045232|NCT01111838|3867896|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4045233|NCT01111838|3867896|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4045234|NCT01111838|3867896|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4045235|NCT01111825|3867900|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4045236|NCT01111825|3867901|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4045237|NCT01111825|3867902|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4045238|NCT01111825|3867903|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4045239|NCT01111825|3867904|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4045240|NCT01111825|3867900|B5||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4045241|NCT01111825|3867901|B4||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4045242|NCT01111825|3867902|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4045243|NCT01111825|3867903|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4045244|NCT01111825|3867904|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4045245|NCT01111825|3867900|B5|||Age||years|Mean|52.3|52.3|Standard Deviation|10.1|10.1|||
4045246|NCT01111825|3867901|B4|||Age||years|Mean|53.2|53.2|Standard Deviation|11.0|11.0|||
4045247|NCT01111825|3867902|B3|||Age||years|Mean|52.0|52.0|Standard Deviation|8.3|8.3|||
4045248|NCT01111825|3867903|B2|||Age||years|Mean|53.5|53.5|Standard Deviation|13.0|13.0|||
4045249|NCT01111825|3867904|B1|||Age||years|Mean|47.5|47.5|Standard Deviation|10.4|10.4|||
4045250|NCT01111825|3867900|B5||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4045251|NCT01111825|3867901|B4||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4045252|NCT01111825|3867902|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4045253|NCT01111825|3867903|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4045254|NCT01111825|3867904|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4045255|NCT01111825|3867900|B5||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
4045256|NCT01111825|3867901|B4||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4045257|NCT01111825|3867902|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4045258|NCT01111825|3867903|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4045259|NCT01111825|3867904|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4045260|NCT01111825|3867900|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4045261|NCT01111825|3867901|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4045262|NCT01111825|3867902|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4045263|NCT01111825|3867903|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4045264|NCT01111825|3867904|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4045265|NCT01111526|3867926|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4045266|NCT01111526|3867926|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4045267|NCT01111526|3867926|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4045268|NCT01111526|3867926|B1|||Age||years|Mean|55|55.0|Full Range|||34.0|76.0|
4045269|NCT01111526|3867926|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4045270|NCT01111526|3867926|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4045271|NCT01111526|3867926|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4045272|NCT01111461|3867940|B1|Taxol [Paclitaxel] w/Carboplatin||Prior Platinum-based Chemotherapy Regimen|Participants could have received more than one prior platinum based chemotherapy regimen.|Participants|Number|10|10.0||||||
4045273|NCT01111461|3867940|B1|Cisplatin w/Doxorubicin||Prior Platinum-based Chemotherapy Regimen|Participants could have received more than one prior platinum based chemotherapy regimen.|Participants|Number|4|4.0||||||
4045274|NCT01111461|3867940|B1|Cisplatin||Prior Platinum-based Chemotherapy Regimen|Participants could have received more than one prior platinum based chemotherapy regimen.|Participants|Number|47|47.0||||||
4045275|NCT01111461|3867940|B1|Carboplatin||Prior Platinum-based Chemotherapy Regimen|Participants could have received more than one prior platinum based chemotherapy regimen.|Participants|Number|80|80.0||||||
4045276|NCT01111461|3867940|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4045277|NCT01111461|3867940|B1||Female|Gender||Participants|Count of Participants|133|133.0||||||
4045278|NCT01111461|3867940|B1|||Age||years|Mean|62.7|62.7|Standard Deviation|8.75|8.75|||
4045279|NCT01111370|3867953|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4045280|NCT01111370|3867953|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4045281|NCT01111370|3867953|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4045282|NCT01111370|3867953|B1|||Age||years|Mean|44|44.0|Standard Deviation|13|13.0|||
4045283|NCT01111370|3867953|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4045284|NCT01111370|3867953|B1||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4045285|NCT01111370|3867953|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4045286|NCT01111331|3867957|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4045287|NCT01111331|3867957|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4045288|NCT01111331|3867957|B1|||Age||years|Mean|34.8|34.8|Standard Deviation|7.0|7.0|||
4045289|NCT01111318|3868036|B5||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4045290|NCT01111318|3868037|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4045291|NCT01111318|3868038|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4045292|NCT01111318|3868039|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4045293|NCT01111318|3868040|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4045294|NCT01111318|3868036|B5||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4045295|NCT01111318|3868037|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4045296|NCT01111318|3868038|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4045297|NCT01111318|3868039|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4045298|NCT01111318|3868040|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4045299|NCT01111318|3868036|B5|||Age||years|Mean|53.9|53.9|Standard Deviation|8.6|8.6|||
4045300|NCT01111318|3868037|B4|||Age||years|Mean|53.9|53.9|Standard Deviation|9.6|9.6|||
4045301|NCT01111318|3868038|B3|||Age||years|Mean|51.0|51.0|Standard Deviation|8.5|8.5|||
4045302|NCT01111318|3868039|B2|||Age||years|Mean|57.0|57.0|Standard Deviation|6.9|6.9|||
4045303|NCT01111318|3868040|B1|||Age||years|Mean|53.8|53.8|Standard Deviation|9.2|9.2|||
4045304|NCT01111305|3868105|B3|||Absolute eosinophil count||cells/microliter|Geometric Mean|980|980.0|Full Range|||530.0|3130.0|
4045305|NCT01111305|3868106|B2|||Absolute eosinophil count||cells/microliter|Geometric Mean|710|710.0|Full Range|||560.0|1590.0|
4045306|NCT01111305|3868107|B1|||Absolute eosinophil count||cells/microliter|Geometric Mean|1350|1350.0|Full Range|||530.0|3130.0|
4045307|NCT01111305|3868105|B3|||Loa loa microfilarial level||mf/mL|Geometric Mean|275|275.0|Full Range|||0.0|2120.0|
4045308|NCT01111305|3868106|B2|||Loa loa microfilarial level||mf/mL|Geometric Mean|357|357.0|Full Range|||178.0|810.0|
4045309|NCT01111305|3868107|B1|||Loa loa microfilarial level||mf/mL|Geometric Mean|212|212.0|Full Range|||0.0|2120.0|
4045310|NCT01111305|3868105|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4045311|NCT01111305|3868106|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4045312|NCT01111305|3868107|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4045313|NCT01111305|3868105|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045314|NCT01111305|3868106|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045315|NCT01111305|3868107|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045316|NCT01111305|3868105|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045317|NCT01111305|3868106|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045318|NCT01111305|3868107|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045319|NCT01111305|3868105|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045320|NCT01111305|3868106|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045321|NCT01111305|3868107|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045322|NCT01111305|3868105|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4045323|NCT01111305|3868106|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4045324|NCT01111305|3868107|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4045325|NCT01111305|3868105|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045326|NCT01111305|3868106|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045327|NCT01111305|3868107|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045328|NCT01111305|3868105|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045329|NCT01111305|3868106|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045330|NCT01111305|3868107|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045331|NCT01111305|3868105|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045332|NCT01111305|3868106|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045333|NCT01111305|3868107|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045334|NCT01111305|3868105|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4045335|NCT01111305|3868106|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4045336|NCT01111305|3868107|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4045337|NCT01111305|3868105|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4045338|NCT01111305|3868106|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4045339|NCT01111305|3868107|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4045340|NCT01111305|3868105|B3|||Age||years|Median|31.5|31.5|Full Range|||20.0|55.0|
4045341|NCT01111305|3868106|B2|||Age||years|Median|29|29.0|Full Range|||20.0|55.0|
4045342|NCT01111305|3868107|B1|||Age||years|Median|36|36.0|Full Range|||22.0|44.0|
4045343|NCT01111292|3868118|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4045344|NCT01111292|3868119|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4045345|NCT01111292|3868120|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4045346|NCT01111292|3868118|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045347|NCT01111292|3868119|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045348|NCT01111292|3868120|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045349|NCT01111292|3868118|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045350|NCT01111292|3868119|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045351|NCT01111292|3868120|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045352|NCT01111292|3868118|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4045353|NCT01111292|3868119|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4045354|NCT01111292|3868120|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4045355|NCT01111292|3868118|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045356|NCT01111292|3868119|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045357|NCT01111292|3868120|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045358|NCT01111292|3868118|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045359|NCT01111292|3868119|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045360|NCT01111292|3868120|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045361|NCT01111292|3868118|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045362|NCT01111292|3868119|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045363|NCT01111292|3868120|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045364|NCT01111292|3868118|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045365|NCT01111292|3868119|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045366|NCT01111292|3868120|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045367|NCT01111292|3868118|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045368|NCT01111292|3868119|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045369|NCT01111292|3868120|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045370|NCT01111292|3868118|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4045371|NCT01111292|3868119|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4045372|NCT01111292|3868120|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4045373|NCT01111292|3868118|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045374|NCT01111292|3868119|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045375|NCT01111292|3868120|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045376|NCT01111292|3868118|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4045377|NCT01111292|3868119|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4045378|NCT01111292|3868120|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4045379|NCT01111292|3868118|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4045380|NCT01111292|3868119|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4045381|NCT01111292|3868120|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4045382|NCT01111292|3868118|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4045383|NCT01111292|3868119|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4045384|NCT01111292|3868120|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4045385|NCT01111292|3868118|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4045386|NCT01111292|3868119|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4045387|NCT01111292|3868120|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4045388|NCT01111292|3868118|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4045389|NCT01111292|3868119|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4045390|NCT01111292|3868120|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4045391|NCT01111240|3868127|B1|Male||Gender|NOTE: gender data were not available for all safety participants|participants|Number|2297|2297.0||||||
4045392|NCT01111240|3868127|B1|Female||Gender|NOTE: gender data were not available for all safety participants|participants|Number|2282|2282.0||||||
4045393|NCT01111240|3868127|B1|||Age||years|Mean|49.4|49.4|Standard Deviation|11.8|11.8|||
4045394|NCT01111162|3868149|B1|||Percentage of Participants at Baseline with HAI assay titers ≥ 1:40||percentage of participants|Number|25|25.0||||||
4045395|NCT01111162|3868149|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045396|NCT01111162|3868149|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045397|NCT01111162|3868149|B1||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4045398|NCT01111162|3868149|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
4045399|NCT01111162|3868149|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045400|NCT01111162|3868149|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4045401|NCT01111162|3868149|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045402|NCT01111162|3868149|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045403|NCT01111162|3868149|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
4045404|NCT01111162|3868149|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4045405|NCT01111162|3868149|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4045406|NCT01111162|3868149|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4045407|NCT01111162|3868149|B1|||Age||years|Median|46|46.0|Inter-Quartile Range|||40.0|53.0|
4045408|NCT01111149|3868154|B4|United States||Region of Enrollment||participants|Number|24|24.0||||||
4045409|NCT01111149|3868155|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4045410|NCT01111149|3868156|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4045411|NCT01111149|3868157|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4045412|NCT01111149|3868154|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045413|NCT01111149|3868155|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045414|NCT01111149|3868156|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045415|NCT01111149|3868157|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045416|NCT01111149|3868154|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4045417|NCT01111149|3868155|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4045418|NCT01111149|3868156|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4045419|NCT01111149|3868157|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4045420|NCT01111149|3868154|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045421|NCT01111149|3868155|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045422|NCT01111149|3868156|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045423|NCT01111149|3868157|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045424|NCT01111149|3868154|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045425|NCT01111149|3868155|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045426|NCT01111149|3868156|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045427|NCT01111149|3868157|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045428|NCT01111149|3868154|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045429|NCT01111149|3868155|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045430|NCT01111149|3868156|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045431|NCT01111149|3868157|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045432|NCT01111149|3868154|B4||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4045433|NCT01111149|3868155|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4045434|NCT01111149|3868156|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4045435|NCT01111149|3868157|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4045436|NCT01111149|3868154|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4045437|NCT01111149|3868155|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4045438|NCT01111149|3868156|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4045439|NCT01111149|3868157|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4045440|NCT01111149|3868154|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045441|NCT01111149|3868155|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045442|NCT01111149|3868156|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045443|NCT01111149|3868157|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045444|NCT01111149|3868154|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045445|NCT01111149|3868155|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045446|NCT01111149|3868156|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045447|NCT01111149|3868157|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045448|NCT01111149|3868154|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4045449|NCT01111149|3868155|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4045450|NCT01111149|3868156|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045451|NCT01111149|3868157|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045452|NCT01111149|3868154|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4045453|NCT01111149|3868155|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4045454|NCT01111149|3868156|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4045455|NCT01111149|3868157|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4045456|NCT01111149|3868154|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4045457|NCT01111149|3868155|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4045458|NCT01111149|3868156|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4045459|NCT01111149|3868157|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4045460|NCT01111149|3868154|B4|||Age||years|Mean|41.46|41.46|Standard Deviation|11.63|11.63|||
4045461|NCT01111149|3868155|B3|||Age||years|Mean|43|43.0|Standard Deviation|8.44|8.44|||
4045462|NCT01111149|3868156|B2|||Age||years|Mean|40.4|40.4|Standard Deviation|15.9|15.9|||
4045463|NCT01111149|3868157|B1|||Age||years|Mean|41.4|41.4|Standard Deviation|9.8|9.8|||
4045464|NCT01111123|3868233|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4045465|NCT01111123|3868234|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4045466|NCT01111123|3868235|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4045467|NCT01111123|3868233|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4045468|NCT01111123|3868234|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4045469|NCT01111123|3868235|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4045470|NCT01111123|3868233|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4045471|NCT01111123|3868234|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4045472|NCT01111123|3868235|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4045473|NCT01111123|3868233|B3||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4045474|NCT01111123|3868234|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4045475|NCT01111123|3868235|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4045476|NCT01111123|3868233|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4045477|NCT01111123|3868234|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4045478|NCT01111123|3868235|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4045479|NCT01111110|3868244|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4045480|NCT01111110|3868245|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4045481|NCT01111110|3868246|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4045482|NCT01111110|3868244|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4045483|NCT01111110|3868245|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4045484|NCT01111110|3868246|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4045485|NCT01111110|3868244|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4045486|NCT01111110|3868245|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4045487|NCT01111110|3868246|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4045488|NCT01111110|3868244|B3|||Age||years|Mean|24.4|24.4|Standard Deviation|7.2|7.2|||
4045489|NCT01111110|3868245|B2|||Age||years|Mean|21.5|21.5|Standard Deviation|2.8|2.8|||
4045490|NCT01111110|3868246|B1|||Age||years|Mean|28.3|28.3|Standard Deviation|11.1|11.1|||
4045491|NCT01111110|3868244|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4045492|NCT01111110|3868245|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4045493|NCT01111110|3868246|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4045494|NCT01111110|3868244|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4045495|NCT01111110|3868245|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4045496|NCT01111110|3868246|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4045497|NCT01111110|3868244|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4045498|NCT01111110|3868245|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4045499|NCT01111110|3868246|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4045500|NCT01110967|3868257|B1|Venezuela||Region of Enrollment||participants|Number|30|30.0||||||
4045501|NCT01110967|3868257|B1|Slovakia||Region of Enrollment||participants|Number|8|8.0||||||
4045502|NCT01110967|3868257|B1|Czech Republic||Region of Enrollment||participants|Number|2|2.0||||||
4045503|NCT01110967|3868257|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4045504|NCT01110967|3868257|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4045505|NCT01110967|3868257|B1|||Age||years|Mean|41|41.0|Standard Deviation|11.5|11.5|||
4045506|NCT01110915|3868268|B3|Middle East||Region of Enrollment||participants|Number|15|15.0||||||
4045507|NCT01110915|3868269|B2|Middle East||Region of Enrollment||participants|Number|5|5.0||||||
4045508|NCT01110915|3868270|B1|Middle East||Region of Enrollment||participants|Number|10|10.0||||||
4045509|NCT01110915|3868268|B3|Europe||Region of Enrollment||participants|Number|168|168.0||||||
4045510|NCT01110915|3868269|B2|Europe||Region of Enrollment||participants|Number|56|56.0||||||
4045511|NCT01110915|3868270|B1|Europe||Region of Enrollment||participants|Number|112|112.0||||||
4045512|NCT01110915|3868268|B3|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4045513|NCT01110915|3868269|B2|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4045514|NCT01110915|3868270|B1|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4045515|NCT01110915|3868268|B3|Australia||Region of Enrollment||participants|Number|20|20.0||||||
4045516|NCT01110915|3868269|B2|Australia||Region of Enrollment||participants|Number|5|5.0||||||
4045517|NCT01110915|3868270|B1|Australia||Region of Enrollment||participants|Number|15|15.0||||||
4045518|NCT01110915|3868268|B3|United States||Region of Enrollment||participants|Number|52|52.0||||||
4045519|NCT01110915|3868269|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4045520|NCT01110915|3868270|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4045521|NCT01110915|3868268|B3||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4045522|NCT01110915|3868269|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4045523|NCT01110915|3868270|B1||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4045524|NCT01110915|3868268|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4045525|NCT01110915|3868269|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4045526|NCT01110915|3868270|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4045527|NCT01110915|3868268|B3|||Age||years|Mean|68.3|68.3|Standard Deviation|12.2|12.2|||
4045528|NCT01110915|3868269|B2|||Age||years|Mean|68.7|68.7|Standard Deviation|10.8|10.8|||
4045529|NCT01110915|3868270|B1|||Age||years|Mean|68.1|68.1|Standard Deviation|12.8|12.8|||
4045530|NCT01110915|3868268|B3||>=65 years|Age||Participants|Count of Participants|180|180.0||||||
4045531|NCT01110915|3868269|B2||>=65 years|Age||Participants|Count of Participants|62|62.0||||||
4045532|NCT01110915|3868270|B1||>=65 years|Age||Participants|Count of Participants|118|118.0||||||
4045533|NCT01110915|3868268|B3||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
4045534|NCT01110915|3868269|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4045535|NCT01110915|3868270|B1||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4045536|NCT01110915|3868268|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4045537|NCT01110915|3868269|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4045538|NCT01110915|3868270|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4045539|NCT01110707|3868286|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4045540|NCT01110707|3868287|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4045541|NCT01110707|3868288|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4045542|NCT01110707|3868286|B3||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4045543|NCT01110707|3868287|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4045544|NCT01110707|3868288|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4045545|NCT01110707|3868286|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4045546|NCT01110707|3868287|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4045547|NCT01110707|3868288|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4045548|NCT01110707|3868286|B3||Between 18 and 65 years|Age||Participants|Count of Participants|131|131.0||||||
4045549|NCT01110707|3868287|B2||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
4045550|NCT01110707|3868288|B1||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4045551|NCT01110707|3868286|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4045552|NCT01110707|3868287|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4045553|NCT01110707|3868288|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4045554|NCT01110499|3868311|B9||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4045555|NCT01110499|3868312|B8||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4045556|NCT01110499|3868313|B7||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4045557|NCT01110499|3868314|B6||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4045558|NCT01110499|3868315|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4045559|NCT01110499|3868316|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4045560|NCT01110499|3868317|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4045561|NCT01110499|3868318|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4045562|NCT01110499|3868319|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4045563|NCT01110499|3868311|B9||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4045564|NCT01110499|3868312|B8||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4045565|NCT01110499|3868313|B7||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4045566|NCT01110499|3868314|B6||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4045567|NCT01110499|3868315|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4045568|NCT01110499|3868316|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4045569|NCT01110499|3868317|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4045570|NCT01110499|3868318|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4045571|NCT01110499|3868319|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4045572|NCT01110499|3868311|B9|>65 years||Age, Customized||Participants|Number|77|77.0||||||
4045573|NCT01110499|3868312|B8|>65 years||Age, Customized||Participants|Number|16|16.0||||||
4045574|NCT01110499|3868313|B7|>65 years||Age, Customized||Participants|Number|21|21.0||||||
4045575|NCT01110499|3868314|B6|>65 years||Age, Customized||Participants|Number|7|7.0||||||
4045576|NCT01110499|3868315|B5|>65 years||Age, Customized||Participants|Number|8|8.0||||||
4045577|NCT01110499|3868316|B4|>65 years||Age, Customized||Participants|Number|5|5.0||||||
4045578|NCT01110499|3868317|B3|>65 years||Age, Customized||Participants|Number|7|7.0||||||
4045579|NCT01110499|3868318|B2|>65 years||Age, Customized||Participants|Number|10|10.0||||||
4045580|NCT01110499|3868319|B1|>65 years||Age, Customized||Participants|Number|3|3.0||||||
4045581|NCT01110499|3868311|B9|45 to 65 years||Age, Customized||Participants|Number|82|82.0||||||
4045582|NCT01110499|3868312|B8|45 to 65 years||Age, Customized||Participants|Number|23|23.0||||||
4045583|NCT01110499|3868313|B7|45 to 65 years||Age, Customized||Participants|Number|18|18.0||||||
4045584|NCT01110499|3868314|B6|45 to 65 years||Age, Customized||Participants|Number|7|7.0||||||
4045585|NCT01110499|3868315|B5|45 to 65 years||Age, Customized||Participants|Number|6|6.0||||||
4045586|NCT01110499|3868316|B4|45 to 65 years||Age, Customized||Participants|Number|8|8.0||||||
4045587|NCT01110499|3868317|B3|45 to 65 years||Age, Customized||Participants|Number|6|6.0||||||
4045588|NCT01110499|3868318|B2|45 to 65 years||Age, Customized||Participants|Number|3|3.0||||||
4045589|NCT01110499|3868319|B1|45 to 65 years||Age, Customized||Participants|Number|11|11.0||||||
4045590|NCT01110499|3868311|B9|<45 years||Age, Customized||Participants|Number|4|4.0||||||
4045591|NCT01110499|3868312|B8|<45 years||Age, Customized||Participants|Number|1|1.0||||||
4045592|NCT01110499|3868313|B7|<45 years||Age, Customized||Participants|Number|0|0.0||||||
4045593|NCT01110499|3868314|B6|<45 years||Age, Customized||Participants|Number|0|0.0||||||
4045594|NCT01110499|3868315|B5|<45 years||Age, Customized||Participants|Number|0|0.0||||||
4045595|NCT01110499|3868316|B4|<45 years||Age, Customized||Participants|Number|1|1.0||||||
4045596|NCT01110499|3868317|B3|<45 years||Age, Customized||Participants|Number|1|1.0||||||
4045597|NCT01110499|3868318|B2|<45 years||Age, Customized||Participants|Number|1|1.0||||||
4045598|NCT01110499|3868319|B1|<45 years||Age, Customized||Participants|Number|0|0.0||||||
4045599|NCT01110421|3868346|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4045600|NCT01110421|3868347|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4045601|NCT01110421|3868348|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4045602|NCT01110421|3868346|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4045603|NCT01110421|3868347|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4045604|NCT01110421|3868348|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4045605|NCT01110421|3868346|B3|12 to <18 years||Age, Customized||participants|Number|0|0.0||||||
4045606|NCT01110421|3868347|B2|12 to <18 years||Age, Customized||participants|Number|0|0.0||||||
4045607|NCT01110421|3868348|B1|12 to <18 years||Age, Customized||participants|Number|0|0.0||||||
4045608|NCT01110421|3868346|B3|6 to <12 years||Age, Customized||participants|Number|2|2.0||||||
4045609|NCT01110421|3868347|B2|6 to <12 years||Age, Customized||participants|Number|0|0.0||||||
4045610|NCT01110421|3868348|B1|6 to <12 years||Age, Customized||participants|Number|2|2.0||||||
4045611|NCT01110421|3868346|B3|2 to <6 years||Age, Customized||participants|Number|5|5.0||||||
4045612|NCT01110421|3868347|B2|2 to <6 years||Age, Customized||participants|Number|2|2.0||||||
4045613|NCT01110421|3868348|B1|2 to <6 years||Age, Customized||participants|Number|3|3.0||||||
4045614|NCT01110421|3868346|B3|3 months to <2 years||Age, Customized||participants|Number|0|0.0||||||
4045615|NCT01110421|3868347|B2|3 months to <2 years||Age, Customized||participants|Number|0|0.0||||||
4045616|NCT01110421|3868348|B1|3 months to <2 years||Age, Customized||participants|Number|0|0.0||||||
4045617|NCT01110421|3868346|B3|||Age||years|Mean|5|5.0|Standard Deviation|2.08|2.08|||
4045618|NCT01110421|3868347|B2|||Age||years|Mean|4.5|4.5|Standard Deviation|0.71|0.71|||
4045619|NCT01110421|3868348|B1|||Age||years|Mean|5.2|5.2|Standard Deviation|2.49|2.49|||
4045620|NCT01110421|3868346|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4045621|NCT01110421|3868347|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4045622|NCT01110421|3868348|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4045623|NCT01110421|3868346|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4045624|NCT01110421|3868347|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4045625|NCT01110421|3868348|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4045626|NCT01110421|3868346|B3||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4045627|NCT01110421|3868347|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4045628|NCT01110421|3868348|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4045629|NCT01110408|3868367|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4045630|NCT01110408|3868368|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4045631|NCT01110408|3868369|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4045632|NCT01110408|3868367|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4045633|NCT01110408|3868368|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4045634|NCT01110408|3868369|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4045635|NCT01110408|3868367|B3|12 to <18 years||Age, Customized||participants|Number|5|5.0||||||
4045636|NCT01110408|3868368|B2|12 to <18 years||Age, Customized||participants|Number|1|1.0||||||
4045637|NCT01110408|3868369|B1|12 to <18 years||Age, Customized||participants|Number|4|4.0||||||
4045638|NCT01110408|3868367|B3|6 to <12 years||Age, Customized||participants|Number|10|10.0||||||
4045639|NCT01110408|3868368|B2|6 to <12 years||Age, Customized||participants|Number|3|3.0||||||
4045640|NCT01110408|3868369|B1|6 to <12 years||Age, Customized||participants|Number|7|7.0||||||
4045641|NCT01110408|3868367|B3|2 to <6 years||Age, Customized||participants|Number|10|10.0||||||
4045642|NCT01110408|3868368|B2|2 to <6 years||Age, Customized||participants|Number|2|2.0||||||
4045643|NCT01110408|3868369|B1|2 to <6 years||Age, Customized||participants|Number|8|8.0||||||
4045644|NCT01110408|3868367|B3|3 months to <2 years||Age, Customized||participants|Number|16|16.0||||||
4045645|NCT01110408|3868368|B2|3 months to <2 years||Age, Customized||participants|Number|4|4.0||||||
4045646|NCT01110408|3868369|B1|3 months to <2 years||Age, Customized||participants|Number|12|12.0||||||
4045647|NCT01110408|3868367|B3|||Age||years|Mean|4.6|4.6|Standard Deviation|4.88|4.88|||
4045648|NCT01110408|3868368|B2|||Age||years|Mean|4.3|4.3|Standard Deviation|4.16|4.16|||
4045649|NCT01110408|3868369|B1|||Age||years|Mean|4.7|4.7|Standard Deviation|5.15|5.15|||
4045650|NCT01110408|3868367|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4045651|NCT01110408|3868368|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4045652|NCT01110408|3868369|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4045653|NCT01110408|3868367|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4045654|NCT01110408|3868368|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4045655|NCT01110408|3868369|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4045656|NCT01110408|3868367|B3||<=18 years|Age||Participants|Count of Participants|41|41.0||||||
4045657|NCT01110408|3868368|B2||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4045658|NCT01110408|3868369|B1||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
4045659|NCT01110382|3868388|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4045660|NCT01110382|3868389|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4045661|NCT01110382|3868390|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4045662|NCT01110382|3868388|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4045663|NCT01110382|3868389|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4045664|NCT01110382|3868390|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4045665|NCT01110382|3868388|B3|12 to <18 years||Age, Customized||participants|Number|11|11.0||||||
4045666|NCT01110382|3868389|B2|12 to <18 years||Age, Customized||participants|Number|3|3.0||||||
4045667|NCT01110382|3868390|B1|12 to <18 years||Age, Customized||participants|Number|8|8.0||||||
4045668|NCT01110382|3868388|B3|6 to <12 years||Age, Customized||participants|Number|22|22.0||||||
4045669|NCT01110382|3868389|B2|6 to <12 years||Age, Customized||participants|Number|4|4.0||||||
4045670|NCT01110382|3868390|B1|6 to <12 years||Age, Customized||participants|Number|18|18.0||||||
4045671|NCT01110382|3868388|B3|2 to <6 years||Age, Customized||participants|Number|8|8.0||||||
4045672|NCT01110382|3868389|B2|2 to <6 years||Age, Customized||participants|Number|3|3.0||||||
4045673|NCT01110382|3868390|B1|2 to <6 years||Age, Customized||participants|Number|5|5.0||||||
4045674|NCT01110382|3868388|B3|3 months to <2 years||Age, Customized||participants|Number|0|0.0||||||
4045675|NCT01110382|3868389|B2|3 months to <2 years||Age, Customized||participants|Number|0|0.0||||||
4045676|NCT01110382|3868390|B1|3 months to <2 years||Age, Customized||participants|Number|0|0.0||||||
4045677|NCT01110382|3868388|B3|||Age||years|Mean|8.7|8.7|Standard Deviation|3.66|3.66|||
4045678|NCT01110382|3868389|B2|||Age||years|Mean|9.3|9.3|Standard Deviation|4.52|4.52|||
4045679|NCT01110382|3868390|B1|||Age||years|Mean|8.5|8.5|Standard Deviation|3.40|3.4|||
4045680|NCT01110382|3868388|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4045681|NCT01110382|3868389|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4045682|NCT01110382|3868390|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4045683|NCT01110382|3868388|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4045684|NCT01110382|3868389|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4045685|NCT01110382|3868390|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4045686|NCT01110382|3868388|B3||<=18 years|Age||Participants|Count of Participants|41|41.0||||||
4045687|NCT01110382|3868389|B2||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4045688|NCT01110382|3868390|B1||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
4045689|NCT01110330|3868409|B4|||Baseline BMI||kg/m2|Mean|28.1|28.1|Standard Deviation|5.11|5.11|||
4045690|NCT01110330|3868410|B3|||Baseline BMI||kg/m2|Mean|28.3|28.3|Standard Deviation|5.09|5.09|||
4045691|NCT01110330|3868411|B2|||Baseline BMI||kg/m2|Mean|27.9|27.9|Standard Deviation|4.76|4.76|||
4045692|NCT01110330|3868412|B1|||Baseline BMI||kg/m2|Mean|28.1|28.1|Standard Deviation|5.81|5.81|||
4045693|NCT01110330|3868409|B4||Male|Sex: Female, Male||Participants|Count of Participants|422|422.0||||||
4045694|NCT01110330|3868410|B3||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4045695|NCT01110330|3868411|B2||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4045696|NCT01110330|3868412|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4045697|NCT01110330|3868409|B4||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4045698|NCT01110330|3868410|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4045699|NCT01110330|3868411|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4045700|NCT01110330|3868412|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4045701|NCT01110330|3868409|B4|||Age||years|Mean|45|45.0|Standard Deviation|14.42|14.42|||
4045702|NCT01110330|3868410|B3|||Age||years|Mean|45.9|45.9|Standard Deviation|14.62|14.62|||
4045703|NCT01110330|3868411|B2|||Age||years|Mean|45|45.0|Standard Deviation|13.94|13.94|||
4045704|NCT01110330|3868412|B1|||Age||years|Mean|43.2|43.2|Standard Deviation|14.89|14.89|||
4045705|NCT01110330|3868409|B4||>=65 years|Age||Participants|Count of Participants|55|55.0||||||
4045706|NCT01110330|3868410|B3||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4045707|NCT01110330|3868411|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4045708|NCT01110330|3868412|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4045709|NCT01110330|3868409|B4||Between 18 and 65 years|Age||Participants|Count of Participants|525|525.0||||||
4045710|NCT01110330|3868410|B3||Between 18 and 65 years|Age||Participants|Count of Participants|209|209.0||||||
4045711|NCT01110330|3868411|B2||Between 18 and 65 years|Age||Participants|Count of Participants|207|207.0||||||
4045712|NCT01110330|3868412|B1||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
4045713|NCT01110330|3868409|B4||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4045714|NCT01110330|3868410|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4045715|NCT01110330|3868411|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4045716|NCT01110330|3868412|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4045717|NCT01110252|3868425|B1|Brazil||Region of Enrollment||participants|Number|4|4.0||||||
4045718|NCT01110252|3868425|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4045719|NCT01110252|3868425|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4045720|NCT01110252|3868425|B1|||Age||years|Mean|65.75|65.75|Standard Deviation|1|1.0|||
4045721|NCT01110252|3868425|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4045722|NCT01110252|3868425|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4045723|NCT01110252|3868425|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4045724|NCT01110239|3868438|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4045725|NCT01110239|3868439|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4045726|NCT01110239|3868440|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4045727|NCT01110239|3868441|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4045728|NCT01110239|3868442|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4045729|NCT01110239|3868438|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4045730|NCT01110239|3868439|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4045731|NCT01110239|3868440|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4045732|NCT01110239|3868441|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4045733|NCT01110239|3868442|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4045734|NCT01110239|3868438|B5|||Age||years|Mean|52|52.0|Standard Deviation|12|12.0|||
4045735|NCT01110239|3868439|B4|||Age||years|Mean|62|62.0|Standard Deviation|10|10.0|||
4045736|NCT01110239|3868440|B3|||Age||years|Mean|47|47.0|Standard Deviation|12|12.0|||
4045737|NCT01110239|3868441|B2|||Age||years|Mean|53|53.0|Standard Deviation|14|14.0|||
4045738|NCT01110239|3868442|B1|||Age||years|Mean|49|49.0|Standard Deviation|9|9.0|||
4045739|NCT01110200|3868459|B3|American Indian or Alaska Native & White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4045740|NCT01110200|3868460|B2|American Indian or Alaska Native & White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4045741|NCT01110200|3868461|B1|American Indian or Alaska Native & White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4045742|NCT01110200|3868459|B3|AA/AH & American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4045743|NCT01110200|3868460|B2|AA/AH & American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4045744|NCT01110200|3868461|B1|AA/AH & American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4045745|NCT01110200|3868459|B3|White||Race/Ethnicity, Customized||Participants|Number|584|584.0||||||
4045746|NCT01110200|3868460|B2|White||Race/Ethnicity, Customized||Participants|Number|300|300.0||||||
4045747|NCT01110200|3868461|B1|White||Race/Ethnicity, Customized||Participants|Number|284|284.0||||||
4045748|NCT01110200|3868459|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4045749|NCT01110200|3868460|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4045750|NCT01110200|3868461|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4045751|NCT01110200|3868459|B3|Asian-Japanese/South East and East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4045752|NCT01110200|3868460|B2|Asian-Japanese/South East and East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4045753|NCT01110200|3868461|B1|Asian-Japanese/South East and East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4045754|NCT01110200|3868459|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4045755|NCT01110200|3868460|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4045756|NCT01110200|3868461|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4045757|NCT01110200|3868459|B3|African American/African Heritage (AA/AH)||Race/Ethnicity, Customized||Participants|Number|48|48.0||||||
4045758|NCT01110200|3868460|B2|African American/African Heritage (AA/AH)||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4045759|NCT01110200|3868461|B1|African American/African Heritage (AA/AH)||Race/Ethnicity, Customized||Participants|Number|26|26.0||||||
4045760|NCT01110200|3868459|B3||Male|Sex: Female, Male||Participants|Count of Participants|348|348.0||||||
4045761|NCT01110200|3868460|B2||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4045762|NCT01110200|3868461|B1||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4045763|NCT01110200|3868459|B3||Female|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
4045764|NCT01110200|3868460|B2||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4045765|NCT01110200|3868461|B1||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4045766|NCT01110200|3868459|B3|||Age||Years|Mean|62.9|62.9|Standard Deviation|9.22|9.22|||
4045767|NCT01110200|3868460|B2|||Age||Years|Mean|62.7|62.7|Standard Deviation|9.30|9.3|||
4045768|NCT01110200|3868461|B1|||Age||Years|Mean|63.1|63.1|Standard Deviation|9.15|9.15|||
4045769|NCT01110187|3868476|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4045770|NCT01110187|3868477|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4045771|NCT01110187|3868478|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4045772|NCT01110187|3868476|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4045773|NCT01110187|3868477|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4045774|NCT01110187|3868478|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4045775|NCT01110187|3868476|B3|||Age||years|Median|56|56.0|Full Range|||23.0|66.0|
4045776|NCT01110187|3868477|B2|||Age||years|Median|55.5|55.5|Full Range|||23.0|61.0|
4045777|NCT01110187|3868478|B1|||Age||years|Median|57|57.0|Full Range|||38.0|66.0|
4045778|NCT01110135|3868487|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4045779|NCT01110135|3868487|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4045780|NCT01110135|3868487|B1|||Age||years|Median|61|61.0|Full Range|||46.0|70.0|
4045781|NCT01110005|3868491|B3||Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4045782|NCT01110005|3868492|B2||Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4045783|NCT01110005|3868493|B1||Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4045784|NCT01110005|3868491|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
4045785|NCT01110005|3868492|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
4045786|NCT01110005|3868493|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
4045787|NCT01110005|3868491|B3||African American|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
4045788|NCT01110005|3868492|B2||African American|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4045789|NCT01110005|3868493|B1||African American|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4045790|NCT01110005|3868491|B3||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|256|256.0||||||
4045791|NCT01110005|3868492|B2||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|127|127.0||||||
4045792|NCT01110005|3868493|B1||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|129|129.0||||||
4045793|NCT01110005|3868491|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4045794|NCT01110005|3868492|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045795|NCT01110005|3868493|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4045796|NCT01110005|3868491|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|275|275.0||||||
4045797|NCT01110005|3868492|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
4045798|NCT01110005|3868493|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
4045799|NCT01110005|3868491|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4045800|NCT01110005|3868492|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4045801|NCT01110005|3868493|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4045802|NCT01110005|3868491|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4045803|NCT01110005|3868492|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4045804|NCT01110005|3868493|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4045805|NCT01110005|3868491|B3||Female|Sex: Female, Male||Participants|Count of Participants|309|309.0||||||
4045806|NCT01110005|3868492|B2||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4045807|NCT01110005|3868493|B1||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4045808|NCT01110005|3868491|B3|||Age||years|Mean|26.8|26.8|Standard Deviation|4.9|4.9|||
4045809|NCT01110005|3868492|B2|||Age||years|Mean|26.8|26.8|Standard Deviation|4.9|4.9|||
4045810|NCT01110005|3868493|B1|||Age||years|Mean|26.7|26.7|Standard Deviation|4.9|4.9|||
4045811|NCT01109992|3868504|B3|United States||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
4045812|NCT01109992|3868505|B2|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4045813|NCT01109992|3868506|B1|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4045814|NCT01109992|3868504|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4045815|NCT01109992|3868505|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4045816|NCT01109992|3868506|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045817|NCT01109992|3868504|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045818|NCT01109992|3868505|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045819|NCT01109992|3868506|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045820|NCT01109992|3868504|B3||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4045821|NCT01109992|3868505|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4045822|NCT01109992|3868506|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4045823|NCT01109992|3868504|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4045824|NCT01109992|3868505|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4045825|NCT01109992|3868506|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4045826|NCT01109992|3868504|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045827|NCT01109992|3868505|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045828|NCT01109992|3868506|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045829|NCT01109992|3868504|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4045830|NCT01109992|3868505|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4045831|NCT01109992|3868506|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045832|NCT01109992|3868504|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045833|NCT01109992|3868505|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045834|NCT01109992|3868506|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045835|NCT01109992|3868504|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4045836|NCT01109992|3868505|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4045837|NCT01109992|3868506|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4045838|NCT01109992|3868504|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4045839|NCT01109992|3868505|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4045840|NCT01109992|3868506|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4045841|NCT01109992|3868504|B3|||Age||years|Mean|57|57.0|Standard Deviation|15|15.0|||
4045842|NCT01109992|3868505|B2|||Age||years|Mean|54|54.0|Standard Deviation|15|15.0|||
4045843|NCT01109992|3868506|B1|||Age||years|Mean|66|66.0|Standard Deviation|11|11.0|||
4045844|NCT01109979|3868519|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045845|NCT01109979|3868520|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045846|NCT01109979|3868521|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045847|NCT01109979|3868519|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045848|NCT01109979|3868520|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045849|NCT01109979|3868521|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045850|NCT01109979|3868519|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4045851|NCT01109979|3868520|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4045852|NCT01109979|3868521|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4045853|NCT01109979|3868519|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4045854|NCT01109979|3868520|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4045855|NCT01109979|3868521|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4045856|NCT01109979|3868519|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045857|NCT01109979|3868520|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045858|NCT01109979|3868521|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045859|NCT01109979|3868519|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4045860|NCT01109979|3868520|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4045861|NCT01109979|3868521|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045862|NCT01109979|3868519|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045863|NCT01109979|3868520|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045864|NCT01109979|3868521|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045865|NCT01109979|3868519|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045866|NCT01109979|3868520|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045867|NCT01109979|3868521|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045868|NCT01109979|3868519|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4045869|NCT01109979|3868520|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4045870|NCT01109979|3868521|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4045871|NCT01109979|3868519|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045872|NCT01109979|3868520|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045873|NCT01109979|3868521|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045874|NCT01109979|3868519|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4045875|NCT01109979|3868520|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4045876|NCT01109979|3868521|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4045877|NCT01109979|3868519|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4045878|NCT01109979|3868520|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4045879|NCT01109979|3868521|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4045880|NCT01109979|3868519|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4045881|NCT01109979|3868520|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4045882|NCT01109979|3868521|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4045883|NCT01109979|3868519|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4045943|NCT01109602|3868586|B1|not ischemic||type of stroke||participants|Number|8|8.0||||||
4045884|NCT01109979|3868520|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4045885|NCT01109979|3868521|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4045886|NCT01109979|3868519|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4045887|NCT01109979|3868520|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4045888|NCT01109979|3868521|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4045889|NCT01109849|3868528|B3|||zBMI||Z score|Mean|0.424|0.424|Standard Deviation|0.85|0.85|||
4045890|NCT01109849|3868529|B2|||zBMI||Z score|Mean|0.384|0.384|Standard Deviation|0.837|0.837|||
4045891|NCT01109849|3868530|B1|||zBMI||Z score|Mean|0.581|0.581|Standard Deviation|0.825|0.825|||
4045892|NCT01109849|3868528|B3|||zWeight||Z score|Mean|0.314|0.314|Standard Deviation|0.90|0.9|||
4045893|NCT01109849|3868529|B2|||zWeight||Z score|Mean|.277|0.277|Standard Deviation|.912|0.912|||
4045894|NCT01109849|3868530|B1|||zWeight||Z score|Mean|.350|0.35|Standard Deviation|.918|0.918|||
4045895|NCT01109849|3868528|B3|||zHeight||Z score|Mean|0.07|0.07|Standard Deviation|0.99|0.99|||
4045896|NCT01109849|3868529|B2|||zHeight||Z score|Mean|0.09|0.09|Standard Deviation|0.99|0.99|||
4045897|NCT01109849|3868530|B1|||zHeight||Z score|Mean|0.01|0.01|Standard Deviation|1.00|1.0|||
4045898|NCT01109849|3868528|B3|United States||Region of Enrollment||participants|Number|230|230.0||||||
4045899|NCT01109849|3868529|B2|United States||Region of Enrollment||participants|Number|180|180.0||||||
4045900|NCT01109849|3868530|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4045901|NCT01109849|3868528|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045902|NCT01109849|3868529|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045903|NCT01109849|3868530|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045904|NCT01109849|3868528|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4045905|NCT01109849|3868529|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4045906|NCT01109849|3868530|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045907|NCT01109849|3868528|B3||White|Race (NIH/OMB)||Participants|Count of Participants|202|202.0||||||
4045908|NCT01109849|3868529|B2||White|Race (NIH/OMB)||Participants|Count of Participants|157|157.0||||||
4045909|NCT01109849|3868530|B1||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4045910|NCT01109849|3868528|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4045911|NCT01109849|3868529|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4045912|NCT01109849|3868530|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4045913|NCT01109849|3868528|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4045914|NCT01109849|3868529|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4045915|NCT01109849|3868530|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045916|NCT01109849|3868528|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4045917|NCT01109849|3868529|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4045918|NCT01109849|3868530|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045919|NCT01109849|3868528|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4045920|NCT01109849|3868529|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4045921|NCT01109849|3868530|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045922|NCT01109849|3868528|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045923|NCT01109849|3868529|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045924|NCT01109849|3868530|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045925|NCT01109849|3868528|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4045926|NCT01109849|3868529|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4045927|NCT01109849|3868530|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4045928|NCT01109849|3868528|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|169|169.0||||||
4045929|NCT01109849|3868529|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
4045930|NCT01109849|3868530|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4045931|NCT01109849|3868528|B3||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4045932|NCT01109849|3868529|B2||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4045933|NCT01109849|3868530|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4045934|NCT01109849|3868528|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4045935|NCT01109849|3868529|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4045936|NCT01109849|3868530|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4045937|NCT01109849|3868528|B3|||Age||years|Mean|8.23|8.23|Standard Deviation|1.96|1.96|||
4045938|NCT01109849|3868529|B2|||Age||years|Mean|8.15|8.15|Standard Deviation|1.86|1.86|||
4045939|NCT01109849|3868530|B1|||Age||years|Mean|8.54|8.54|Standard Deviation|2.28|2.28|||
4045940|NCT01109602|3868583|B4|not ischemic||type of stroke||participants|Number|16|16.0||||||
4045941|NCT01109602|3868584|B3|not ischemic||type of stroke||participants|Number|5|5.0||||||
4045942|NCT01109602|3868585|B2|not ischemic||type of stroke||participants|Number|3|3.0||||||
4045944|NCT01109602|3868583|B4|ischemic||type of stroke||participants|Number|31|31.0||||||
4045945|NCT01109602|3868584|B3|ischemic||type of stroke||participants|Number|5|5.0||||||
4045946|NCT01109602|3868585|B2|ischemic||type of stroke||participants|Number|20|20.0||||||
4045947|NCT01109602|3868586|B1|ischemic||type of stroke||participants|Number|6|6.0||||||
4045948|NCT01109602|3868583|B4|||months since stroke||months|Mean|51|51.0|Standard Deviation|40.4|40.4|||
4045949|NCT01109602|3868584|B3|||months since stroke||months|Mean|36.4|36.4|Standard Deviation|23.6|23.6|||
4045950|NCT01109602|3868585|B2|||months since stroke||months|Mean|59.13|59.13|Standard Deviation|43.81|43.81|||
4045951|NCT01109602|3868586|B1|||months since stroke||months|Mean|49.25|49.25|Standard Deviation|44.55|44.55|||
4045952|NCT01109602|3868583|B4|United States||Region of Enrollment||participants|Number|47|47.0||||||
4045953|NCT01109602|3868584|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4045954|NCT01109602|3868585|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4045955|NCT01109602|3868586|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4045956|NCT01109602|3868583|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4045957|NCT01109602|3868584|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045958|NCT01109602|3868585|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4045959|NCT01109602|3868586|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045960|NCT01109602|3868583|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045961|NCT01109602|3868584|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045962|NCT01109602|3868585|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045963|NCT01109602|3868586|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045964|NCT01109602|3868583|B4||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4045965|NCT01109602|3868584|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4045966|NCT01109602|3868585|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4045967|NCT01109602|3868586|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4045968|NCT01109602|3868583|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4045969|NCT01109602|3868584|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4045970|NCT01109602|3868585|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4045971|NCT01109602|3868586|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4045972|NCT01109602|3868583|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4045973|NCT01109602|3868584|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045974|NCT01109602|3868585|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045975|NCT01109602|3868586|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4045976|NCT01109602|3868583|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045977|NCT01109602|3868584|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045978|NCT01109602|3868585|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045979|NCT01109602|3868586|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045980|NCT01109602|3868583|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045981|NCT01109602|3868584|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045982|NCT01109602|3868585|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045983|NCT01109602|3868586|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4045984|NCT01109602|3868583|B4||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4045985|NCT01109602|3868584|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4045986|NCT01109602|3868585|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4045987|NCT01109602|3868586|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4045988|NCT01109602|3868583|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4045989|NCT01109602|3868584|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4045990|NCT01109602|3868585|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4045991|NCT01109602|3868586|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4045992|NCT01109602|3868583|B4|||Age||years|Mean|64.1|64.1|Standard Deviation|8.8|8.8|||
4045993|NCT01109602|3868584|B3|||Age||years|Mean|60.2|60.2|Standard Deviation|8.9|8.9|||
4045994|NCT01109602|3868585|B2|||Age||years|Mean|62.35|62.35|Standard Deviation|8.526|8.526|||
4045995|NCT01109602|3868586|B1|||Age||years|Mean|68.33|68.33|Standard Deviation|8.117|8.117|||
4045996|NCT01109576|3868599|B1|||Profiles of Mood States Total Score|The Profile of Mood States contains 65 self-reported items in 6 subscales (Tension, Depression, Anger, Vigor, Fatigue, and Confusion). Items are rated using a 5-point Likert Scale (scale: 0=not at all, 1=a little, 2=moderately, 3=quite a bit, 4=extremely). Total mood disturbance is calculated by subtracting the Vigor subscale score from the sum of the Tension, Depression, Anger, Fatigue, and Confusion subscale scores. Total scores can range from -32 to 200, with higher score indicating more mood disturbance.|units on a scale|Mean|16|16.0|Standard Deviation|26.2|26.2|||
4045997|NCT01109576|3868599|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4045998|NCT01109576|3868599|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4045999|NCT01109576|3868599|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4046000|NCT01109576|3868599|B1|||Age||years|Mean|85|85.0|Standard Deviation|7.9|7.9|||
4046001|NCT01109576|3868599|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4046002|NCT01109576|3868599|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4046003|NCT01109576|3868599|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4046004|NCT01109524|3868603|B1|2||ECOG PS at baseline|ECOG PS = Eastern Cooperative Oncology Group Performance Status. Baseline is defined as values obtained during the screening period, prior to treatment with study drug. Inclusion criteria included those participants with values of 0, 1 or 2. ECOG=performance questionnaire with a scale of 6 units (0 to 5) with the higher numbers reflecting a worse outcome: 0=fully active, carry on performance without restriction; 1=restricted in physically strenuous activity but ambulatory, 2= ambulatory and capable of self care; 3=capable of limited self care, confined to bed; 4=completely disabled; 5=dead.|Participants|Number|5|5.0||||||
4046005|NCT01109524|3868603|B1|1||ECOG PS at baseline|ECOG PS = Eastern Cooperative Oncology Group Performance Status. Baseline is defined as values obtained during the screening period, prior to treatment with study drug. Inclusion criteria included those participants with values of 0, 1 or 2. ECOG=performance questionnaire with a scale of 6 units (0 to 5) with the higher numbers reflecting a worse outcome: 0=fully active, carry on performance without restriction; 1=restricted in physically strenuous activity but ambulatory, 2= ambulatory and capable of self care; 3=capable of limited self care, confined to bed; 4=completely disabled; 5=dead.|Participants|Number|38|38.0||||||
4046006|NCT01109524|3868603|B1|0||ECOG PS at baseline|ECOG PS = Eastern Cooperative Oncology Group Performance Status. Baseline is defined as values obtained during the screening period, prior to treatment with study drug. Inclusion criteria included those participants with values of 0, 1 or 2. ECOG=performance questionnaire with a scale of 6 units (0 to 5) with the higher numbers reflecting a worse outcome: 0=fully active, carry on performance without restriction; 1=restricted in physically strenuous activity but ambulatory, 2= ambulatory and capable of self care; 3=capable of limited self care, confined to bed; 4=completely disabled; 5=dead.|Participants|Number|17|17.0||||||
4046007|NCT01109524|3868603|B1|Canada||Region of Enrollment||participants|Number|30|30.0||||||
4046008|NCT01109524|3868603|B1|Puerto Rico||Region of Enrollment||participants|Number|7|7.0||||||
4046009|NCT01109524|3868603|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4046010|NCT01109524|3868603|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4046011|NCT01109524|3868603|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4046012|NCT01109524|3868603|B1|||Age||years|Mean|63.8|63.8|Standard Deviation|10.3|10.3|||
4046013|NCT01109524|3868603|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4046014|NCT01109524|3868603|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4046015|NCT01109524|3868603|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4046016|NCT01109381|3868613|B1|Singapore||Region of Enrollment||participants|Number|33|33.0||||||
4046017|NCT01109381|3868613|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4046018|NCT01109381|3868613|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4046019|NCT01109381|3868613|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4046020|NCT01109381|3868613|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4046021|NCT01109381|3868613|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4046022|NCT01109316|3868619|B7|United States||Region of Enrollment||participants|Number|132|132.0||||||
4046023|NCT01109316|3868620|B6|United States||Region of Enrollment||participants|Number|22|22.0||||||
4046024|NCT01109316|3868621|B5|United States||Region of Enrollment||participants|Number|22|22.0||||||
4046025|NCT01109316|3868622|B4|United States||Region of Enrollment||participants|Number|22|22.0||||||
4046026|NCT01109316|3868623|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4046027|NCT01109316|3868624|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4046028|NCT01109316|3868625|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4046029|NCT01109316|3868619|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046030|NCT01109316|3868620|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046031|NCT01109316|3868621|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046032|NCT01109316|3868622|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046033|NCT01109316|3868623|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046034|NCT01109316|3868624|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046035|NCT01109316|3868625|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046036|NCT01109316|3868619|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4046037|NCT01109316|3868620|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4046038|NCT01109316|3868621|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046039|NCT01109316|3868622|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4046040|NCT01109316|3868623|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046041|NCT01109316|3868624|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046042|NCT01109316|3868625|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046043|NCT01109316|3868619|B7||White|Race (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
4046044|NCT01109316|3868620|B6||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4046045|NCT01109316|3868621|B5||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4046046|NCT01109316|3868622|B4||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4046047|NCT01109316|3868623|B3||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4046048|NCT01109316|3868624|B2||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4046049|NCT01109316|3868625|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4046050|NCT01109316|3868619|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4046051|NCT01109316|3868620|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046052|NCT01109316|3868621|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046053|NCT01109316|3868622|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046054|NCT01109316|3868623|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046055|NCT01109316|3868624|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4046056|NCT01109316|3868625|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046057|NCT01109316|3868619|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046058|NCT01109316|3868620|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046059|NCT01109316|3868621|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046060|NCT01109316|3868622|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046061|NCT01109316|3868623|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046062|NCT01109316|3868624|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046063|NCT01109316|3868625|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046064|NCT01109316|3868619|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046065|NCT01109316|3868620|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046066|NCT01109316|3868621|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046067|NCT01109316|3868622|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046068|NCT01109316|3868623|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046069|NCT01109316|3868624|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046070|NCT01109316|3868625|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046071|NCT01109316|3868619|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046072|NCT01109316|3868620|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046073|NCT01109316|3868621|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046074|NCT01109316|3868622|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046075|NCT01109316|3868623|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046076|NCT01109316|3868624|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046077|NCT01109316|3868625|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046078|NCT01109316|3868619|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046079|NCT01109316|3868620|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046080|NCT01109316|3868621|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046081|NCT01109316|3868622|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046082|NCT01109316|3868623|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046083|NCT01109316|3868624|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046084|NCT01109316|3868625|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046085|NCT01109316|3868619|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
4046086|NCT01109316|3868620|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4046087|NCT01109316|3868621|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4046088|NCT01109316|3868622|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4046089|NCT01109316|3868623|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4046090|NCT01109316|3868624|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4046091|NCT01109316|3868625|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4046092|NCT01109316|3868619|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4046093|NCT01109316|3868620|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4046094|NCT01109316|3868621|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4046095|NCT01109316|3868622|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046096|NCT01109316|3868623|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4046097|NCT01109316|3868624|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4046098|NCT01109316|3868625|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4046099|NCT01109316|3868619|B7||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4046100|NCT01109316|3868620|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4046101|NCT01109316|3868621|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4046102|NCT01109316|3868622|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4046103|NCT01109316|3868623|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4046104|NCT01109316|3868624|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4046105|NCT01109316|3868625|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4046106|NCT01109316|3868619|B7||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4046107|NCT01109316|3868620|B6||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4046108|NCT01109316|3868621|B5||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4046109|NCT01109316|3868622|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4046110|NCT01109316|3868623|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4046111|NCT01109316|3868624|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4046112|NCT01109316|3868625|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4046113|NCT01109316|3868619|B7|||Age||years|Mean|41.4|41.4|Standard Deviation|16.7|16.7|||
4046114|NCT01109316|3868620|B6|||Age||years|Mean|38.3|38.3|Standard Deviation|14.9|14.9|||
4046115|NCT01109316|3868621|B5|||Age||years|Mean|41.2|41.2|Standard Deviation|14.2|14.2|||
4046116|NCT01109316|3868622|B4|||Age||years|Mean|47.2|47.2|Standard Deviation|18.8|18.8|||
4046117|NCT01109316|3868623|B3|||Age||years|Mean|42.6|42.6|Standard Deviation|17.4|17.4|||
4046118|NCT01109316|3868624|B2|||Age||years|Mean|36.6|36.6|Standard Deviation|14.1|14.1|||
4046119|NCT01109316|3868625|B1|||Age||years|Mean|42.3|42.3|Standard Deviation|19.6|19.6|||
4046120|NCT01109173|3868671|B5||Male|Sex: Female, Male||Participants|Count of Participants|866|866.0||||||
4046121|NCT01109173|3868672|B4||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4046122|NCT01109173|3868673|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4046123|NCT01109173|3868674|B2||Male|Sex: Female, Male||Participants|Count of Participants|355|355.0||||||
4046124|NCT01109173|3868675|B1||Male|Sex: Female, Male||Participants|Count of Participants|342|342.0||||||
4046125|NCT01109173|3868671|B5||Female|Sex: Female, Male||Participants|Count of Participants|1156|1156.0||||||
4046126|NCT01109173|3868672|B4||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4046127|NCT01109173|3868673|B3||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4046128|NCT01109173|3868674|B2||Female|Sex: Female, Male||Participants|Count of Participants|458|458.0||||||
4046129|NCT01109173|3868675|B1||Female|Sex: Female, Male||Participants|Count of Participants|465|465.0||||||
4046130|NCT01109173|3868671|B5|||Age||years|Mean|68.9|68.9|Standard Deviation|9.22|9.22|||
4046131|NCT01109173|3868672|B4|||Age||years|Mean|68.9|68.9|Standard Deviation|9.37|9.37|||
4046132|NCT01109173|3868673|B3|||Age||years|Mean|69.8|69.8|Standard Deviation|9.31|9.31|||
4046133|NCT01109173|3868674|B2|||Age||years|Mean|68.8|68.8|Standard Deviation|9.31|9.31|||
4046134|NCT01109173|3868675|B1|||Age||years|Mean|68.7|68.7|Standard Deviation|9.08|9.08|||
4046135|NCT01109147|3868692|B4|France||Region of Enrollment||participants|Number|67|67.0||||||
4046136|NCT01109147|3868693|B3|France||Region of Enrollment||participants|Number|36|36.0||||||
4046137|NCT01109147|3868694|B2|France||Region of Enrollment||participants|Number|14|14.0||||||
4046138|NCT01109147|3868695|B1|France||Region of Enrollment||participants|Number|17|17.0||||||
4046139|NCT01109147|3868692|B4||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4046140|NCT01109147|3868693|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4046141|NCT01109147|3868694|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4046142|NCT01109147|3868695|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4046143|NCT01109147|3868692|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4046144|NCT01109147|3868693|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4046145|NCT01109147|3868694|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4046146|NCT01109147|3868695|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4046147|NCT01109147|3868692|B4|||Age||years|Mean|33.1|33.1|Standard Deviation|8.5|8.5|||
4046148|NCT01109147|3868693|B3|||Age||years|Mean|32.9|32.9|Standard Deviation|7.8|7.8|||
4046149|NCT01109147|3868694|B2|||Age||years|Mean|31.6|31.6|Standard Deviation|9.2|9.2|||
4046150|NCT01109147|3868695|B1|||Age||years|Mean|34.6|34.6|Standard Deviation|9.6|9.6|||
4046151|NCT01109147|3868692|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4046152|NCT01109147|3868693|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4046153|NCT01109147|3868694|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4046154|NCT01109147|3868695|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4046155|NCT01109147|3868692|B4||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
4046156|NCT01109147|3868693|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4046157|NCT01109147|3868694|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4046158|NCT01109147|3868695|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4046159|NCT01109147|3868692|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4046160|NCT01109147|3868693|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4046161|NCT01109147|3868694|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4046162|NCT01109147|3868695|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4046163|NCT01109108|3868705|B3|PCV13 Immune|No|Pneumococcal risk factors||Participants|Count of Participants|1627|1627.0||||||
4046164|NCT01109108|3868706|B2|PCV13 Immune|No|Pneumococcal risk factors||Participants|Count of Participants|832|832.0||||||
4046165|NCT01109108|3868707|B1|PCV13 Immune|No|Pneumococcal risk factors||Participants|Count of Participants|795|795.0||||||
4046166|NCT01109108|3868705|B3|PCV13 Immune|Yes|Pneumococcal risk factors||Participants|Count of Participants|7163|7163.0||||||
4046167|NCT01109108|3868706|B2|PCV13 Immune|Yes|Pneumococcal risk factors||Participants|Count of Participants|3923|3923.0||||||
4046168|NCT01109108|3868707|B1|PCV13 Immune|Yes|Pneumococcal risk factors||Participants|Count of Participants|3240|3240.0||||||
4046169|NCT01109108|3868705|B3|Current daycare attendance|No|Pneumococcal risk factors||Participants|Count of Participants|4686|4686.0||||||
4046170|NCT01109108|3868706|B2|Current daycare attendance|No|Pneumococcal risk factors||Participants|Count of Participants|1868|1868.0||||||
4046171|NCT01109108|3868707|B1|Current daycare attendance|No|Pneumococcal risk factors||Participants|Count of Participants|2818|2818.0||||||
4046172|NCT01109108|3868705|B3|Current daycare attendance|Yes|Pneumococcal risk factors||Participants|Count of Participants|4104|4104.0||||||
4046173|NCT01109108|3868706|B2|Current daycare attendance|Yes|Pneumococcal risk factors||Participants|Count of Participants|2887|2887.0||||||
4046174|NCT01109108|3868707|B1|Current daycare attendance|Yes|Pneumococcal risk factors||Participants|Count of Participants|1217|1217.0||||||
4046175|NCT01109108|3868705|B3|Ever Breastfed|No|Pneumococcal risk factors||Participants|Count of Participants|1884|1884.0||||||
4046176|NCT01109108|3868706|B2|Ever Breastfed|No|Pneumococcal risk factors||Participants|Count of Participants|1071|1071.0||||||
4046177|NCT01109108|3868707|B1|Ever Breastfed|No|Pneumococcal risk factors||Participants|Count of Participants|813|813.0||||||
4046178|NCT01109108|3868705|B3|Ever Breastfed|Yes|Pneumococcal risk factors||Participants|Count of Participants|6906|6906.0||||||
4046179|NCT01109108|3868706|B2|Ever Breastfed|Yes|Pneumococcal risk factors||Participants|Count of Participants|3684|3684.0||||||
4046180|NCT01109108|3868707|B1|Ever Breastfed|Yes|Pneumococcal risk factors||Participants|Count of Participants|3222|3222.0||||||
4046181|NCT01109108|3868705|B3|Recent antibiotic use (last 14 days)|No|Pneumococcal risk factors||Participants|Count of Participants|7804|7804.0||||||
4046182|NCT01109108|3868706|B2|Recent antibiotic use (last 14 days)|No|Pneumococcal risk factors||Participants|Count of Participants|4304|4304.0||||||
4046183|NCT01109108|3868707|B1|Recent antibiotic use (last 14 days)|No|Pneumococcal risk factors||Participants|Count of Participants|3500|3500.0||||||
4046184|NCT01109108|3868705|B3|Recent antibiotic use (last 14 days)|Yes|Pneumococcal risk factors||Participants|Count of Participants|986|986.0||||||
4046185|NCT01109108|3868706|B2|Recent antibiotic use (last 14 days)|Yes|Pneumococcal risk factors||Participants|Count of Participants|451|451.0||||||
4046186|NCT01109108|3868707|B1|Recent antibiotic use (last 14 days)|Yes|Pneumococcal risk factors||Participants|Count of Participants|535|535.0||||||
4046187|NCT01109108|3868705|B3|Current RTI (Respiratory tract infection)|No|Pneumococcal risk factors||Participants|Count of Participants|4843|4843.0||||||
4046188|NCT01109108|3868706|B2|Current RTI (Respiratory tract infection)|No|Pneumococcal risk factors||Participants|Count of Participants|2647|2647.0||||||
4046189|NCT01109108|3868707|B1|Current RTI (Respiratory tract infection)|No|Pneumococcal risk factors||Participants|Count of Participants|2196|2196.0||||||
4046190|NCT01109108|3868705|B3|Current RTI (Respiratory tract infection)|Yes|Pneumococcal risk factors||Participants|Count of Participants|3947|3947.0||||||
4046191|NCT01109108|3868706|B2|Current RTI (Respiratory tract infection)|Yes|Pneumococcal risk factors||Participants|Count of Participants|2108|2108.0||||||
4046192|NCT01109108|3868707|B1|Current RTI (Respiratory tract infection)|Yes|Pneumococcal risk factors||Participants|Count of Participants|1839|1839.0||||||
4046193|NCT01109108|3868705|B3|United States||Region of Enrollment||participants|Number|8790|8790.0||||||
4046194|NCT01109108|3868706|B2|United States||Region of Enrollment||participants|Number|4755|4755.0||||||
4046195|NCT01109108|3868707|B1|United States||Region of Enrollment||participants|Number|4035|4035.0||||||
4046196|NCT01109108|3868705|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4046197|NCT01109108|3868706|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046198|NCT01109108|3868707|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4046199|NCT01109108|3868705|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1567|1567.0||||||
4046200|NCT01109108|3868706|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|828|828.0||||||
4046201|NCT01109108|3868707|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|739|739.0||||||
4046202|NCT01109108|3868705|B3||White|Race (NIH/OMB)||Participants|Count of Participants|796|796.0||||||
4046203|NCT01109108|3868706|B2||White|Race (NIH/OMB)||Participants|Count of Participants|351|351.0||||||
4046204|NCT01109108|3868707|B1||White|Race (NIH/OMB)||Participants|Count of Participants|445|445.0||||||
4046205|NCT01109108|3868705|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6164|6164.0||||||
4046206|NCT01109108|3868706|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3445|3445.0||||||
4046207|NCT01109108|3868707|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2719|2719.0||||||
4046208|NCT01109108|3868705|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4046209|NCT01109108|3868706|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4046210|NCT01109108|3868707|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046211|NCT01109108|3868705|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|247|247.0||||||
4046212|NCT01109108|3868706|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
4046213|NCT01109108|3868707|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
4046214|NCT01109108|3868705|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4046476|NCT01108523|3868864|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4046215|NCT01109108|3868706|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4046216|NCT01109108|3868707|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4046217|NCT01109108|3868705|B3||Male|Sex: Female, Male||Participants|Count of Participants|4453|4453.0||||||
4046218|NCT01109108|3868706|B2||Male|Sex: Female, Male||Participants|Count of Participants|2353|2353.0||||||
4046219|NCT01109108|3868707|B1||Male|Sex: Female, Male||Participants|Count of Participants|2100|2100.0||||||
4046220|NCT01109108|3868705|B3||Female|Sex: Female, Male||Participants|Count of Participants|4337|4337.0||||||
4046221|NCT01109108|3868706|B2||Female|Sex: Female, Male||Participants|Count of Participants|2402|2402.0||||||
4046222|NCT01109108|3868707|B1||Female|Sex: Female, Male||Participants|Count of Participants|1935|1935.0||||||
4046223|NCT01109108|3868705|B3|||Age||months|Mean|27.2|27.2|Standard Deviation|16.3|16.3|||
4046224|NCT01109108|3868706|B2|||Age||months|Mean|40.0|40.0|Standard Deviation|10.3|10.3|||
4046225|NCT01109108|3868707|B1|||Age||months|Mean|12.1|12.1|Standard Deviation|5.7|5.7|||
4046226|NCT01109108|3868705|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4046227|NCT01109108|3868706|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4046228|NCT01109108|3868707|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4046229|NCT01109108|3868705|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4046230|NCT01109108|3868706|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4046231|NCT01109108|3868707|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4046232|NCT01109108|3868705|B3||<=18 years|Age||Participants|Count of Participants|8790|8790.0||||||
4046233|NCT01109108|3868706|B2||<=18 years|Age||Participants|Count of Participants|4755|4755.0||||||
4046234|NCT01109108|3868707|B1||<=18 years|Age||Participants|Count of Participants|4035|4035.0||||||
4046235|NCT01109056|3868714|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4046236|NCT01109056|3868715|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4046237|NCT01109056|3868716|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4046238|NCT01109056|3868714|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4046239|NCT01109056|3868715|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4046240|NCT01109056|3868716|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4046241|NCT01109056|3868714|B3|>65 years||Age, Customized||Participants|Number|15|15.0||||||
4046242|NCT01109056|3868715|B2|>65 years||Age, Customized||Participants|Number|7|7.0||||||
4046243|NCT01109056|3868716|B1|>65 years||Age, Customized||Participants|Number|8|8.0||||||
4046244|NCT01109056|3868714|B3|Between 45 and 65 years||Age, Customized||Participants|Number|72|72.0||||||
4046245|NCT01109056|3868715|B2|Between 45 and 65 years||Age, Customized||Participants|Number|36|36.0||||||
4046246|NCT01109056|3868716|B1|Between 45 and 65 years||Age, Customized||Participants|Number|36|36.0||||||
4046247|NCT01109056|3868714|B3|<45 years||Age, Customized||Participants|Number|28|28.0||||||
4046248|NCT01109056|3868715|B2|<45 years||Age, Customized||Participants|Number|15|15.0||||||
4046249|NCT01109056|3868716|B1|<45 years||Age, Customized||Participants|Number|13|13.0||||||
4046250|NCT01109004|3868727|B4||Not Evaluable|Disease Status at Enrollment||Participants|Count of Participants|7|7.0||||||
4046251|NCT01109004|3868728|B3||Not Evaluable|Disease Status at Enrollment||Participants|Count of Participants|3|3.0||||||
4046252|NCT01109004|3868729|B2||Not Evaluable|Disease Status at Enrollment||Participants|Count of Participants|3|3.0||||||
4046253|NCT01109004|3868730|B1||Not Evaluable|Disease Status at Enrollment||Participants|Count of Participants|1|1.0||||||
4046254|NCT01109004|3868727|B4||Progression|Disease Status at Enrollment||Participants|Count of Participants|9|9.0||||||
4046255|NCT01109004|3868728|B3||Progression|Disease Status at Enrollment||Participants|Count of Participants|3|3.0||||||
4046256|NCT01109004|3868729|B2||Progression|Disease Status at Enrollment||Participants|Count of Participants|2|2.0||||||
4046257|NCT01109004|3868730|B1||Progression|Disease Status at Enrollment||Participants|Count of Participants|4|4.0||||||
4046258|NCT01109004|3868727|B4||Stable Disease|Disease Status at Enrollment||Participants|Count of Participants|49|49.0||||||
4046259|NCT01109004|3868728|B3||Stable Disease|Disease Status at Enrollment||Participants|Count of Participants|14|14.0||||||
4046260|NCT01109004|3868729|B2||Stable Disease|Disease Status at Enrollment||Participants|Count of Participants|21|21.0||||||
4046261|NCT01109004|3868730|B1||Stable Disease|Disease Status at Enrollment||Participants|Count of Participants|14|14.0||||||
4046262|NCT01109004|3868727|B4||Partial Response|Disease Status at Enrollment||Participants|Count of Participants|337|337.0||||||
4046263|NCT01109004|3868728|B3||Partial Response|Disease Status at Enrollment||Participants|Count of Participants|123|123.0||||||
4046264|NCT01109004|3868729|B2||Partial Response|Disease Status at Enrollment||Participants|Count of Participants|108|108.0||||||
4046265|NCT01109004|3868730|B1||Partial Response|Disease Status at Enrollment||Participants|Count of Participants|106|106.0||||||
4046266|NCT01109004|3868727|B4||Very Good Partial Response|Disease Status at Enrollment||Participants|Count of Participants|148|148.0||||||
4046267|NCT01109004|3868728|B3||Very Good Partial Response|Disease Status at Enrollment||Participants|Count of Participants|43|43.0||||||
4046268|NCT01109004|3868729|B2||Very Good Partial Response|Disease Status at Enrollment||Participants|Count of Participants|53|53.0||||||
4046269|NCT01109004|3868730|B1||Very Good Partial Response|Disease Status at Enrollment||Participants|Count of Participants|52|52.0||||||
4046270|NCT01109004|3868727|B4||Near Complete Response|Disease Status at Enrollment||Participants|Count of Participants|73|73.0||||||
4046271|NCT01109004|3868728|B3||Near Complete Response|Disease Status at Enrollment||Participants|Count of Participants|24|24.0||||||
4046272|NCT01109004|3868729|B2||Near Complete Response|Disease Status at Enrollment||Participants|Count of Participants|22|22.0||||||
4046273|NCT01109004|3868730|B1||Near Complete Response|Disease Status at Enrollment||Participants|Count of Participants|27|27.0||||||
4046274|NCT01109004|3868727|B4||Complete Response|Disease Status at Enrollment||Participants|Count of Participants|65|65.0||||||
4046275|NCT01109004|3868728|B3||Complete Response|Disease Status at Enrollment||Participants|Count of Participants|24|24.0||||||
4046276|NCT01109004|3868729|B2||Complete Response|Disease Status at Enrollment||Participants|Count of Participants|19|19.0||||||
4046277|NCT01109004|3868730|B1||Complete Response|Disease Status at Enrollment||Participants|Count of Participants|22|22.0||||||
4046278|NCT01109004|3868727|B4||Stringent Complete Response|Disease Status at Enrollment||Participants|Count of Participants|70|70.0||||||
4046279|NCT01109004|3868728|B3||Stringent Complete Response|Disease Status at Enrollment||Participants|Count of Participants|23|23.0||||||
4046280|NCT01109004|3868729|B2||Stringent Complete Response|Disease Status at Enrollment||Participants|Count of Participants|26|26.0||||||
4046281|NCT01109004|3868730|B1||Stringent Complete Response|Disease Status at Enrollment||Participants|Count of Participants|21|21.0||||||
4046282|NCT01109004|3868727|B4||Unknown|Number of Lines of Therapy|Lines of therapy is defined as the number of different regimens received prior to study entry.|Participants|Count of Participants|5|5.0||||||
4046283|NCT01109004|3868728|B3||Unknown|Number of Lines of Therapy|Lines of therapy is defined as the number of different regimens received prior to study entry.|Participants|Count of Participants|0|0.0||||||
4046284|NCT01109004|3868729|B2||Unknown|Number of Lines of Therapy|Lines of therapy is defined as the number of different regimens received prior to study entry.|Participants|Count of Participants|4|4.0||||||
4046285|NCT01109004|3868730|B1||Unknown|Number of Lines of Therapy|Lines of therapy is defined as the number of different regimens received prior to study entry.|Participants|Count of Participants|1|1.0||||||
4046286|NCT01109004|3868727|B4||3|Number of Lines of Therapy|Lines of therapy is defined as the number of different regimens received prior to study entry.|Participants|Count of Participants|8|8.0||||||
4046287|NCT01109004|3868728|B3||3|Number of Lines of Therapy|Lines of therapy is defined as the number of different regimens received prior to study entry.|Participants|Count of Participants|2|2.0||||||
4046288|NCT01109004|3868729|B2||3|Number of Lines of Therapy|Lines of therapy is defined as the number of different regimens received prior to study entry.|Participants|Count of Participants|1|1.0||||||
4046289|NCT01109004|3868730|B1||3|Number of Lines of Therapy|Lines of therapy is defined as the number of different regimens received prior to study entry.|Participants|Count of Participants|5|5.0||||||
4046290|NCT01109004|3868727|B4||2|Number of Lines of Therapy|Lines of therapy is defined as the number of different regimens received prior to study entry.|Participants|Count of Participants|104|104.0||||||
4046291|NCT01109004|3868728|B3||2|Number of Lines of Therapy|Lines of therapy is defined as the number of different regimens received prior to study entry.|Participants|Count of Participants|37|37.0||||||
4046292|NCT01109004|3868729|B2||2|Number of Lines of Therapy|Lines of therapy is defined as the number of different regimens received prior to study entry.|Participants|Count of Participants|36|36.0||||||
4046293|NCT01109004|3868730|B1||2|Number of Lines of Therapy|Lines of therapy is defined as the number of different regimens received prior to study entry.|Participants|Count of Participants|31|31.0||||||
4046294|NCT01109004|3868727|B4||1|Number of Lines of Therapy|Lines of therapy is defined as the number of different regimens received prior to study entry.|Participants|Count of Participants|641|641.0||||||
4046295|NCT01109004|3868728|B3||1|Number of Lines of Therapy|Lines of therapy is defined as the number of different regimens received prior to study entry.|Participants|Count of Participants|218|218.0||||||
4046296|NCT01109004|3868729|B2||1|Number of Lines of Therapy|Lines of therapy is defined as the number of different regimens received prior to study entry.|Participants|Count of Participants|213|213.0||||||
4046297|NCT01109004|3868730|B1||1|Number of Lines of Therapy|Lines of therapy is defined as the number of different regimens received prior to study entry.|Participants|Count of Participants|210|210.0||||||
4046298|NCT01109004|3868727|B4|||Time from Initial Therapy to Enrollment||months|Median|5|5.0|Full Range|||2.0|14.0|
4046299|NCT01109004|3868728|B3|||Time from Initial Therapy to Enrollment||months|Median|5|5.0|Full Range|||2.0|12.0|
4046300|NCT01109004|3868729|B2|||Time from Initial Therapy to Enrollment||months|Median|5|5.0|Full Range|||2.0|12.0|
4046301|NCT01109004|3868730|B1|||Time from Initial Therapy to Enrollment||months|Median|5|5.0|Full Range|||2.0|14.0|
4046302|NCT01109004|3868727|B4||Unknown|Initial Therapy|Initial therapy administered for the treatment of multiple myeloma|Participants|Count of Participants|5|5.0||||||
4046303|NCT01109004|3868728|B3||Unknown|Initial Therapy|Initial therapy administered for the treatment of multiple myeloma|Participants|Count of Participants|0|0.0||||||
4046304|NCT01109004|3868729|B2||Unknown|Initial Therapy|Initial therapy administered for the treatment of multiple myeloma|Participants|Count of Participants|4|4.0||||||
4046305|NCT01109004|3868730|B1||Unknown|Initial Therapy|Initial therapy administered for the treatment of multiple myeloma|Participants|Count of Participants|1|1.0||||||
4046306|NCT01109004|3868727|B4||Other|Initial Therapy|Initial therapy administered for the treatment of multiple myeloma|Participants|Count of Participants|58|58.0||||||
4046307|NCT01109004|3868728|B3||Other|Initial Therapy|Initial therapy administered for the treatment of multiple myeloma|Participants|Count of Participants|20|20.0||||||
4046308|NCT01109004|3868729|B2||Other|Initial Therapy|Initial therapy administered for the treatment of multiple myeloma|Participants|Count of Participants|19|19.0||||||
4046309|NCT01109004|3868730|B1||Other|Initial Therapy|Initial therapy administered for the treatment of multiple myeloma|Participants|Count of Participants|19|19.0||||||
4046310|NCT01109004|3868727|B4||Bortezomib/Dexamethasone|Initial Therapy|Initial therapy administered for the treatment of multiple myeloma|Participants|Count of Participants|93|93.0||||||
4046311|NCT01109004|3868728|B3||Bortezomib/Dexamethasone|Initial Therapy|Initial therapy administered for the treatment of multiple myeloma|Participants|Count of Participants|32|32.0||||||
4046312|NCT01109004|3868729|B2||Bortezomib/Dexamethasone|Initial Therapy|Initial therapy administered for the treatment of multiple myeloma|Participants|Count of Participants|32|32.0||||||
4046477|NCT01108523|3868864|B1|||Age||years|Mean|74.9|74.9|Standard Deviation|15.6|15.6|||
4046313|NCT01109004|3868730|B1||Bortezomib/Dexamethasone|Initial Therapy|Initial therapy administered for the treatment of multiple myeloma|Participants|Count of Participants|29|29.0||||||
4046314|NCT01109004|3868727|B4||Lenalidomide/Dexamethasone|Initial Therapy|Initial therapy administered for the treatment of multiple myeloma|Participants|Count of Participants|74|74.0||||||
4046315|NCT01109004|3868728|B3||Lenalidomide/Dexamethasone|Initial Therapy|Initial therapy administered for the treatment of multiple myeloma|Participants|Count of Participants|22|22.0||||||
4046316|NCT01109004|3868729|B2||Lenalidomide/Dexamethasone|Initial Therapy|Initial therapy administered for the treatment of multiple myeloma|Participants|Count of Participants|28|28.0||||||
4046317|NCT01109004|3868730|B1||Lenalidomide/Dexamethasone|Initial Therapy|Initial therapy administered for the treatment of multiple myeloma|Participants|Count of Participants|24|24.0||||||
4046318|NCT01109004|3868727|B4||Bortezomib/Cyclophosphamide/Dexamethasone|Initial Therapy|Initial therapy administered for the treatment of multiple myeloma|Participants|Count of Participants|108|108.0||||||
4046319|NCT01109004|3868728|B3||Bortezomib/Cyclophosphamide/Dexamethasone|Initial Therapy|Initial therapy administered for the treatment of multiple myeloma|Participants|Count of Participants|40|40.0||||||
4046320|NCT01109004|3868729|B2||Bortezomib/Cyclophosphamide/Dexamethasone|Initial Therapy|Initial therapy administered for the treatment of multiple myeloma|Participants|Count of Participants|35|35.0||||||
4046321|NCT01109004|3868730|B1||Bortezomib/Cyclophosphamide/Dexamethasone|Initial Therapy|Initial therapy administered for the treatment of multiple myeloma|Participants|Count of Participants|33|33.0||||||
4046322|NCT01109004|3868727|B4||Bortezomib/Lenalidomide/Dexamethasone|Initial Therapy|Initial therapy administered for the treatment of multiple myeloma|Participants|Count of Participants|420|420.0||||||
4046323|NCT01109004|3868728|B3||Bortezomib/Lenalidomide/Dexamethasone|Initial Therapy|Initial therapy administered for the treatment of multiple myeloma|Participants|Count of Participants|143|143.0||||||
4046324|NCT01109004|3868729|B2||Bortezomib/Lenalidomide/Dexamethasone|Initial Therapy|Initial therapy administered for the treatment of multiple myeloma|Participants|Count of Participants|136|136.0||||||
4046325|NCT01109004|3868730|B1||Bortezomib/Lenalidomide/Dexamethasone|Initial Therapy|Initial therapy administered for the treatment of multiple myeloma|Participants|Count of Participants|141|141.0||||||
4046326|NCT01109004|3868727|B4||High|Disease Risk|Participants on this study will be stratified for the purposes of statistical analysis into high-risk and standard risk-groups. High-risk multiple myeloma is defined by the presence of high beta-2 microglobulin (> 5.5mg/L) or the presence of cytogenetic abnormalities including t(4;14), t(14;20), t(14;16), deletion (17p) detected by FISH or standard cytogenetics, deletion 13 detected by standard cytogenetics only or aneuploidy. Participants without cytogenetic analysis available and beta-2 microglobulin ≤ 5.5mg/L or with deletion 13 detected by FISH will be classified as standard-risk disease.|Participants|Count of Participants|223|223.0||||||
4046327|NCT01109004|3868728|B3||High|Disease Risk|Participants on this study will be stratified for the purposes of statistical analysis into high-risk and standard risk-groups. High-risk multiple myeloma is defined by the presence of high beta-2 microglobulin (> 5.5mg/L) or the presence of cytogenetic abnormalities including t(4;14), t(14;20), t(14;16), deletion (17p) detected by FISH or standard cytogenetics, deletion 13 detected by standard cytogenetics only or aneuploidy. Participants without cytogenetic analysis available and beta-2 microglobulin ≤ 5.5mg/L or with deletion 13 detected by FISH will be classified as standard-risk disease.|Participants|Count of Participants|75|75.0||||||
4046328|NCT01109004|3868729|B2||High|Disease Risk|Participants on this study will be stratified for the purposes of statistical analysis into high-risk and standard risk-groups. High-risk multiple myeloma is defined by the presence of high beta-2 microglobulin (> 5.5mg/L) or the presence of cytogenetic abnormalities including t(4;14), t(14;20), t(14;16), deletion (17p) detected by FISH or standard cytogenetics, deletion 13 detected by standard cytogenetics only or aneuploidy. Participants without cytogenetic analysis available and beta-2 microglobulin ≤ 5.5mg/L or with deletion 13 detected by FISH will be classified as standard-risk disease.|Participants|Count of Participants|76|76.0||||||
4046329|NCT01109004|3868730|B1||High|Disease Risk|Participants on this study will be stratified for the purposes of statistical analysis into high-risk and standard risk-groups. High-risk multiple myeloma is defined by the presence of high beta-2 microglobulin (> 5.5mg/L) or the presence of cytogenetic abnormalities including t(4;14), t(14;20), t(14;16), deletion (17p) detected by FISH or standard cytogenetics, deletion 13 detected by standard cytogenetics only or aneuploidy. Participants without cytogenetic analysis available and beta-2 microglobulin ≤ 5.5mg/L or with deletion 13 detected by FISH will be classified as standard-risk disease.|Participants|Count of Participants|72|72.0||||||
4046330|NCT01109004|3868727|B4||Standard|Disease Risk|Participants on this study will be stratified for the purposes of statistical analysis into high-risk and standard risk-groups. High-risk multiple myeloma is defined by the presence of high beta-2 microglobulin (> 5.5mg/L) or the presence of cytogenetic abnormalities including t(4;14), t(14;20), t(14;16), deletion (17p) detected by FISH or standard cytogenetics, deletion 13 detected by standard cytogenetics only or aneuploidy. Participants without cytogenetic analysis available and beta-2 microglobulin ≤ 5.5mg/L or with deletion 13 detected by FISH will be classified as standard-risk disease.|Participants|Count of Participants|535|535.0||||||
4046331|NCT01109004|3868728|B3||Standard|Disease Risk|Participants on this study will be stratified for the purposes of statistical analysis into high-risk and standard risk-groups. High-risk multiple myeloma is defined by the presence of high beta-2 microglobulin (> 5.5mg/L) or the presence of cytogenetic abnormalities including t(4;14), t(14;20), t(14;16), deletion (17p) detected by FISH or standard cytogenetics, deletion 13 detected by standard cytogenetics only or aneuploidy. Participants without cytogenetic analysis available and beta-2 microglobulin ≤ 5.5mg/L or with deletion 13 detected by FISH will be classified as standard-risk disease.|Participants|Count of Participants|182|182.0||||||
4046332|NCT01109004|3868729|B2||Standard|Disease Risk|Participants on this study will be stratified for the purposes of statistical analysis into high-risk and standard risk-groups. High-risk multiple myeloma is defined by the presence of high beta-2 microglobulin (> 5.5mg/L) or the presence of cytogenetic abnormalities including t(4;14), t(14;20), t(14;16), deletion (17p) detected by FISH or standard cytogenetics, deletion 13 detected by standard cytogenetics only or aneuploidy. Participants without cytogenetic analysis available and beta-2 microglobulin ≤ 5.5mg/L or with deletion 13 detected by FISH will be classified as standard-risk disease.|Participants|Count of Participants|178|178.0||||||
4046333|NCT01109004|3868730|B1||Standard|Disease Risk|Participants on this study will be stratified for the purposes of statistical analysis into high-risk and standard risk-groups. High-risk multiple myeloma is defined by the presence of high beta-2 microglobulin (> 5.5mg/L) or the presence of cytogenetic abnormalities including t(4;14), t(14;20), t(14;16), deletion (17p) detected by FISH or standard cytogenetics, deletion 13 detected by standard cytogenetics only or aneuploidy. Participants without cytogenetic analysis available and beta-2 microglobulin ≤ 5.5mg/L or with deletion 13 detected by FISH will be classified as standard-risk disease.|Participants|Count of Participants|175|175.0||||||
4046334|NCT01109004|3868727|B4||Less Than 90|Karnofsky Performance Score (KPS)|"KPS describes patient-perceived global quality of life and functioning on a scale of 0-100.~100: No evidence of disease; 90: Normal activity. Minor signs or symptoms of disease; 80: Normal activity with effort. Some signs or symptoms of disease; 70: Cares for self. Unable to continue normal activity; 60: Needs occasional assistance, but cares for most personal needs; 50: Needs considerable assistance and medical care; 40: Disabled. Needs special care and assistance; 30: Severely disabled. Hospital admission indicated; 20: Very sick. Active supportive therapy needed; 10: Moribund; 0: Dead"|Participants|Count of Participants|235|235.0||||||
4046335|NCT01109004|3868728|B3||Less Than 90|Karnofsky Performance Score (KPS)|"KPS describes patient-perceived global quality of life and functioning on a scale of 0-100.~100: No evidence of disease; 90: Normal activity. Minor signs or symptoms of disease; 80: Normal activity with effort. Some signs or symptoms of disease; 70: Cares for self. Unable to continue normal activity; 60: Needs occasional assistance, but cares for most personal needs; 50: Needs considerable assistance and medical care; 40: Disabled. Needs special care and assistance; 30: Severely disabled. Hospital admission indicated; 20: Very sick. Active supportive therapy needed; 10: Moribund; 0: Dead"|Participants|Count of Participants|85|85.0||||||
4046336|NCT01109004|3868729|B2||Less Than 90|Karnofsky Performance Score (KPS)|"KPS describes patient-perceived global quality of life and functioning on a scale of 0-100.~100: No evidence of disease; 90: Normal activity. Minor signs or symptoms of disease; 80: Normal activity with effort. Some signs or symptoms of disease; 70: Cares for self. Unable to continue normal activity; 60: Needs occasional assistance, but cares for most personal needs; 50: Needs considerable assistance and medical care; 40: Disabled. Needs special care and assistance; 30: Severely disabled. Hospital admission indicated; 20: Very sick. Active supportive therapy needed; 10: Moribund; 0: Dead"|Participants|Count of Participants|85|85.0||||||
4046337|NCT01109004|3868730|B1||Less Than 90|Karnofsky Performance Score (KPS)|"KPS describes patient-perceived global quality of life and functioning on a scale of 0-100.~100: No evidence of disease; 90: Normal activity. Minor signs or symptoms of disease; 80: Normal activity with effort. Some signs or symptoms of disease; 70: Cares for self. Unable to continue normal activity; 60: Needs occasional assistance, but cares for most personal needs; 50: Needs considerable assistance and medical care; 40: Disabled. Needs special care and assistance; 30: Severely disabled. Hospital admission indicated; 20: Very sick. Active supportive therapy needed; 10: Moribund; 0: Dead"|Participants|Count of Participants|65|65.0||||||
4046338|NCT01109004|3868727|B4||90 or Greater|Karnofsky Performance Score (KPS)|"KPS describes patient-perceived global quality of life and functioning on a scale of 0-100.~100: No evidence of disease; 90: Normal activity. Minor signs or symptoms of disease; 80: Normal activity with effort. Some signs or symptoms of disease; 70: Cares for self. Unable to continue normal activity; 60: Needs occasional assistance, but cares for most personal needs; 50: Needs considerable assistance and medical care; 40: Disabled. Needs special care and assistance; 30: Severely disabled. Hospital admission indicated; 20: Very sick. Active supportive therapy needed; 10: Moribund; 0: Dead"|Participants|Count of Participants|523|523.0||||||
4046339|NCT01109004|3868728|B3||90 or Greater|Karnofsky Performance Score (KPS)|"KPS describes patient-perceived global quality of life and functioning on a scale of 0-100.~100: No evidence of disease; 90: Normal activity. Minor signs or symptoms of disease; 80: Normal activity with effort. Some signs or symptoms of disease; 70: Cares for self. Unable to continue normal activity; 60: Needs occasional assistance, but cares for most personal needs; 50: Needs considerable assistance and medical care; 40: Disabled. Needs special care and assistance; 30: Severely disabled. Hospital admission indicated; 20: Very sick. Active supportive therapy needed; 10: Moribund; 0: Dead"|Participants|Count of Participants|172|172.0||||||
4046340|NCT01109004|3868729|B2||90 or Greater|Karnofsky Performance Score (KPS)|"KPS describes patient-perceived global quality of life and functioning on a scale of 0-100.~100: No evidence of disease; 90: Normal activity. Minor signs or symptoms of disease; 80: Normal activity with effort. Some signs or symptoms of disease; 70: Cares for self. Unable to continue normal activity; 60: Needs occasional assistance, but cares for most personal needs; 50: Needs considerable assistance and medical care; 40: Disabled. Needs special care and assistance; 30: Severely disabled. Hospital admission indicated; 20: Very sick. Active supportive therapy needed; 10: Moribund; 0: Dead"|Participants|Count of Participants|169|169.0||||||
4046341|NCT01109004|3868730|B1||90 or Greater|Karnofsky Performance Score (KPS)|"KPS describes patient-perceived global quality of life and functioning on a scale of 0-100.~100: No evidence of disease; 90: Normal activity. Minor signs or symptoms of disease; 80: Normal activity with effort. Some signs or symptoms of disease; 70: Cares for self. Unable to continue normal activity; 60: Needs occasional assistance, but cares for most personal needs; 50: Needs considerable assistance and medical care; 40: Disabled. Needs special care and assistance; 30: Severely disabled. Hospital admission indicated; 20: Very sick. Active supportive therapy needed; 10: Moribund; 0: Dead"|Participants|Count of Participants|182|182.0||||||
4046342|NCT01109004|3868727|B4||Multiple/Other/Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|57|57.0||||||
4046343|NCT01109004|3868728|B3||Multiple/Other/Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
4046344|NCT01109004|3868729|B2||Multiple/Other/Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
4046345|NCT01109004|3868730|B1||Multiple/Other/Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
4046346|NCT01109004|3868727|B4||African American|Race/Ethnicity, Customized||Participants|Count of Participants|130|130.0||||||
4046347|NCT01109004|3868728|B3||African American|Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
4046348|NCT01109004|3868729|B2||African American|Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
4046349|NCT01109004|3868730|B1||African American|Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
4046478|NCT01108523|3868864|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4046350|NCT01109004|3868727|B4||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|571|571.0||||||
4046351|NCT01109004|3868728|B3||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|201|201.0||||||
4046352|NCT01109004|3868729|B2||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|192|192.0||||||
4046353|NCT01109004|3868730|B1||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|178|178.0||||||
4046354|NCT01109004|3868727|B4||Male|Sex: Female, Male||Participants|Count of Participants|454|454.0||||||
4046355|NCT01109004|3868728|B3||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4046356|NCT01109004|3868729|B2||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4046357|NCT01109004|3868730|B1||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4046358|NCT01109004|3868727|B4||Female|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
4046359|NCT01109004|3868728|B3||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4046360|NCT01109004|3868729|B2||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4046361|NCT01109004|3868730|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4046362|NCT01109004|3868727|B4|||Age||years|Median|56|56.0|Full Range|||20.0|70.0|
4046363|NCT01109004|3868728|B3|||Age||years|Median|56|56.0|Full Range|||30.0|70.0|
4046364|NCT01109004|3868729|B2|||Age||years|Median|57|57.0|Full Range|||20.0|70.0|
4046365|NCT01109004|3868730|B1|||Age||years|Median|56|56.0|Full Range|||28.0|70.0|
4046366|NCT01108835|3868767|B3|Hong Kong||Region of Enrollment|All subjects are recruited from Hong Kong.|participants|Number|180|180.0||||||
4046367|NCT01108835|3868768|B2|Hong Kong||Region of Enrollment|All subjects are recruited from Hong Kong.|participants|Number|90|90.0||||||
4046368|NCT01108835|3868769|B1|Hong Kong||Region of Enrollment|All subjects are recruited from Hong Kong.|participants|Number|90|90.0||||||
4046369|NCT01108835|3868767|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046370|NCT01108835|3868768|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046371|NCT01108835|3868769|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046372|NCT01108835|3868767|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|180|180.0||||||
4046373|NCT01108835|3868768|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4046374|NCT01108835|3868769|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4046375|NCT01108835|3868767|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046376|NCT01108835|3868768|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046377|NCT01108835|3868769|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046378|NCT01108835|3868767|B3||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4046379|NCT01108835|3868768|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4046380|NCT01108835|3868769|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4046381|NCT01108835|3868767|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4046382|NCT01108835|3868768|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4046383|NCT01108835|3868769|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4046384|NCT01108835|3868767|B3|Age (years)||Age, Customized||years|Mean|74.7|74.7|Standard Deviation|8.2|8.2|||
4046385|NCT01108835|3868768|B2|Age (years)||Age, Customized||years|Mean|74.6|74.6|Standard Deviation|8.6|8.6|||
4046386|NCT01108835|3868769|B1|Age (years)||Age, Customized||years|Mean|74.9|74.9|Standard Deviation|7.9|7.9|||
4046387|NCT01108809|3868784|B1|Other||Additional antihypertensive treatment at baseline|Participants may have taken more than one antihypertensive treatment, so the percentages will not add to 100 percent.|Percentage of participants|Number|15.5|15.5||||||
4046388|NCT01108809|3868784|B1|Beta Blockers||Additional antihypertensive treatment at baseline|Participants may have taken more than one antihypertensive treatment, so the percentages will not add to 100 percent.|Percentage of participants|Number|61.9|61.9||||||
4046389|NCT01108809|3868784|B1|Calcium Channel Blockers||Additional antihypertensive treatment at baseline|Participants may have taken more than one antihypertensive treatment, so the percentages will not add to 100 percent.|Percentage of participants|Number|35.1|35.1||||||
4046390|NCT01108809|3868784|B1|Diuretics||Additional antihypertensive treatment at baseline|Participants may have taken more than one antihypertensive treatment, so the percentages will not add to 100 percent.|Percentage of participants|Number|58.6|58.6||||||
4046391|NCT01108809|3868784|B1|ACE inhibitors||Additional antihypertensive treatment at baseline|Participants may have taken more than one antihypertensive treatment, so the percentages will not add to 100 percent.|Percentage of participants|Number|53.1|53.1||||||
4046392|NCT01108809|3868784|B1|||Heart Rate|Data on heart rate available for 281 patients|beats/minute|Mean|79|79.0|Standard Deviation|11.5|11.5|||
4046393|NCT01108809|3868784|B1|||Diastolic Blood Pressure (mean)||mmHg|Mean|97|97.0|Standard Deviation|10.4|10.4|||
4046394|NCT01108809|3868784|B1|||Systolic Blood Pressure (mean)||mmHg|Mean|171|171.0|Standard Deviation|16.2|16.2|||
4046395|NCT01108809|3868784|B1||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4046396|NCT01108809|3868784|B1||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4046397|NCT01108809|3868784|B1|||Age|Data on age available for 294 patients|years|Mean|61.9|61.9|Standard Deviation|9.8|9.8|||
4046398|NCT01108796|3868797|B5|Male, Micardis®/MicardisPlus®||Sex/Gender, Customized|Patients were enrolled into two groups, receiving treatment with Micardis or MicardisPlus and in addition with Tool or No Tool. The system summarizes the number of patients automatically. The total number is always 1841.|Participants|Number|771|771.0||||||
4046479|NCT01108523|3868864|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4046399|NCT01108796|3868798|B4|Male, Micardis®/MicardisPlus®||Sex/Gender, Customized|Patients were enrolled into two groups, receiving treatment with Micardis or MicardisPlus and in addition with Tool or No Tool. The system summarizes the number of patients automatically. The total number is always 1841.|Participants|Number|0|0.0||||||
4046400|NCT01108796|3868799|B3|Male, Micardis®/MicardisPlus®||Sex/Gender, Customized|Patients were enrolled into two groups, receiving treatment with Micardis or MicardisPlus and in addition with Tool or No Tool. The system summarizes the number of patients automatically. The total number is always 1841.|Participants|Number|0|0.0||||||
4046401|NCT01108796|3868800|B2|Male, Micardis®/MicardisPlus®||Sex/Gender, Customized|Patients were enrolled into two groups, receiving treatment with Micardis or MicardisPlus and in addition with Tool or No Tool. The system summarizes the number of patients automatically. The total number is always 1841.|Participants|Number|443|443.0||||||
4046402|NCT01108796|3868801|B1|Male, Micardis®/MicardisPlus®||Sex/Gender, Customized|Patients were enrolled into two groups, receiving treatment with Micardis or MicardisPlus and in addition with Tool or No Tool. The system summarizes the number of patients automatically. The total number is always 1841.|Participants|Number|328|328.0||||||
4046403|NCT01108796|3868797|B5|Female, Micardis®/MicardisPlus®||Sex/Gender, Customized|Patients were enrolled into two groups, receiving treatment with Micardis or MicardisPlus and in addition with Tool or No Tool. The system summarizes the number of patients automatically. The total number is always 1841.|Participants|Number|1069|1069.0||||||
4046404|NCT01108796|3868798|B4|Female, Micardis®/MicardisPlus®||Sex/Gender, Customized|Patients were enrolled into two groups, receiving treatment with Micardis or MicardisPlus and in addition with Tool or No Tool. The system summarizes the number of patients automatically. The total number is always 1841.|Participants|Number|0|0.0||||||
4046405|NCT01108796|3868799|B3|Female, Micardis®/MicardisPlus®||Sex/Gender, Customized|Patients were enrolled into two groups, receiving treatment with Micardis or MicardisPlus and in addition with Tool or No Tool. The system summarizes the number of patients automatically. The total number is always 1841.|Participants|Number|0|0.0||||||
4046406|NCT01108796|3868800|B2|Female, Micardis®/MicardisPlus®||Sex/Gender, Customized|Patients were enrolled into two groups, receiving treatment with Micardis or MicardisPlus and in addition with Tool or No Tool. The system summarizes the number of patients automatically. The total number is always 1841.|Participants|Number|624|624.0||||||
4046407|NCT01108796|3868801|B1|Female, Micardis®/MicardisPlus®||Sex/Gender, Customized|Patients were enrolled into two groups, receiving treatment with Micardis or MicardisPlus and in addition with Tool or No Tool. The system summarizes the number of patients automatically. The total number is always 1841.|Participants|Number|445|445.0||||||
4046408|NCT01108796|3868797|B5|Male, Tool/No Tool||Sex/Gender, Customized|Patients were enrolled into two groups, receiving treatment with Micardis or MicardisPlus and in addition with Tool or No Tool. The system summarizes the number of patients automatically. The total number is always 1841.|Participants|Number|771|771.0||||||
4046409|NCT01108796|3868798|B4|Male, Tool/No Tool||Sex/Gender, Customized|Patients were enrolled into two groups, receiving treatment with Micardis or MicardisPlus and in addition with Tool or No Tool. The system summarizes the number of patients automatically. The total number is always 1841.|Participants|Number|264|264.0||||||
4046410|NCT01108796|3868799|B3|Male, Tool/No Tool||Sex/Gender, Customized|Patients were enrolled into two groups, receiving treatment with Micardis or MicardisPlus and in addition with Tool or No Tool. The system summarizes the number of patients automatically. The total number is always 1841.|Participants|Number|507|507.0||||||
4046411|NCT01108796|3868800|B2|Male, Tool/No Tool||Sex/Gender, Customized|Patients were enrolled into two groups, receiving treatment with Micardis or MicardisPlus and in addition with Tool or No Tool. The system summarizes the number of patients automatically. The total number is always 1841.|Participants|Number|0|0.0||||||
4046412|NCT01108796|3868801|B1|Male, Tool/No Tool||Sex/Gender, Customized|Patients were enrolled into two groups, receiving treatment with Micardis or MicardisPlus and in addition with Tool or No Tool. The system summarizes the number of patients automatically. The total number is always 1841.|Participants|Number|0|0.0||||||
4046413|NCT01108796|3868797|B5|Female, Tool/No Tool||Sex/Gender, Customized|Patients were enrolled into two groups, receiving treatment with Micardis or MicardisPlus and in addition with Tool or No Tool. The system summarizes the number of patients automatically. The total number is always 1841.|Participants|Number|1069|1069.0||||||
4046414|NCT01108796|3868798|B4|Female, Tool/No Tool||Sex/Gender, Customized|Patients were enrolled into two groups, receiving treatment with Micardis or MicardisPlus and in addition with Tool or No Tool. The system summarizes the number of patients automatically. The total number is always 1841.|Participants|Number|390|390.0||||||
4046415|NCT01108796|3868799|B3|Female, Tool/No Tool||Sex/Gender, Customized|Patients were enrolled into two groups, receiving treatment with Micardis or MicardisPlus and in addition with Tool or No Tool. The system summarizes the number of patients automatically. The total number is always 1841.|Participants|Number|679|679.0||||||
4046416|NCT01108796|3868800|B2|Female, Tool/No Tool||Sex/Gender, Customized|Patients were enrolled into two groups, receiving treatment with Micardis or MicardisPlus and in addition with Tool or No Tool. The system summarizes the number of patients automatically. The total number is always 1841.|Participants|Number|0|0.0||||||
4046417|NCT01108796|3868801|B1|Female, Tool/No Tool||Sex/Gender, Customized|Patients were enrolled into two groups, receiving treatment with Micardis or MicardisPlus and in addition with Tool or No Tool. The system summarizes the number of patients automatically. The total number is always 1841.|Participants|Number|0|0.0||||||
4046418|NCT01108796|3868797|B5|||Age|Patients were enrolled into two groups, receiving treatment with Micardis or MicardisPlus and in addition with Tool or No Tool. The system summarizes the number of patients automatically. The total number is always 1841.|Years|Mean|61.43|61.43|Standard Deviation|10.43|10.43|||
4046419|NCT01108796|3868798|B4|||Age|Patients were enrolled into two groups, receiving treatment with Micardis or MicardisPlus and in addition with Tool or No Tool. The system summarizes the number of patients automatically. The total number is always 1841.|Years|Mean|61.94|61.94|Standard Deviation|11.01|11.01|||
4046420|NCT01108796|3868799|B3|||Age|Patients were enrolled into two groups, receiving treatment with Micardis or MicardisPlus and in addition with Tool or No Tool. The system summarizes the number of patients automatically. The total number is always 1841.|Years|Mean|61.14|61.14|Standard Deviation|10.09|10.09|||
4046421|NCT01108796|3868800|B2|||Age|Patients were enrolled into two groups, receiving treatment with Micardis or MicardisPlus and in addition with Tool or No Tool. The system summarizes the number of patients automatically. The total number is always 1841.|Years|Mean|NA||Standard Deviation|NA||||Mean and Standard Deviation numbers of patients' age per Micardis®/Micardis Plus® arms not available in the statistical analysis report
4046422|NCT01108796|3868801|B1|||Age|Patients were enrolled into two groups, receiving treatment with Micardis or MicardisPlus and in addition with Tool or No Tool. The system summarizes the number of patients automatically. The total number is always 1841.|Years|Mean|NA||Standard Deviation|NA||||Mean and Standard Deviation numbers of patients' age per Micardis®/Micardis Plus® arms not available in the statistical analysis report
4046423|NCT01108757|3868834|B3|||Body mass index|Body mass index (BMI) measured as kg/m^2|kg/m^2|Mean|26.5|26.5|Standard Deviation|3.5|3.5|||
4046424|NCT01108757|3868835|B2|||Body mass index|Body mass index (BMI) measured as kg/m^2|kg/m^2|Mean|27.2|27.2|Standard Deviation|4.3|4.3|||
4046425|NCT01108757|3868836|B1|||Body mass index|Body mass index (BMI) measured as kg/m^2|kg/m^2|Mean|25.8|25.8|Standard Deviation|2.7|2.7|||
4046426|NCT01108757|3868834|B3|United States||Region of Enrollment||participants|Number|52|52.0||||||
4046427|NCT01108757|3868835|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4046428|NCT01108757|3868836|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4046429|NCT01108757|3868834|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4046430|NCT01108757|3868835|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4046431|NCT01108757|3868836|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4046432|NCT01108757|3868834|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4046433|NCT01108757|3868835|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4046434|NCT01108757|3868836|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4046435|NCT01108757|3868834|B3|Mean Age||Age, Customized||years|Mean|59|59.0|Standard Deviation|12.9|12.9|||
4046436|NCT01108757|3868835|B2|Mean Age||Age, Customized||years|Mean|58|58.0|Standard Deviation|13.0|13.0|||
4046437|NCT01108757|3868836|B1|Mean Age||Age, Customized||years|Mean|60|60.0|Standard Deviation|12.9|12.9|||
4046438|NCT01108731|3868843|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4046439|NCT01108731|3868844|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4046440|NCT01108731|3868845|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4046441|NCT01108731|3868843|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4046442|NCT01108731|3868844|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4046443|NCT01108731|3868845|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4046444|NCT01108731|3868843|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4046445|NCT01108731|3868844|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4046446|NCT01108731|3868845|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4046447|NCT01108731|3868843|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4046448|NCT01108731|3868844|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4046449|NCT01108731|3868845|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4046450|NCT01108731|3868843|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4046451|NCT01108731|3868844|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4046452|NCT01108731|3868845|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4046453|NCT01108731|3868843|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4046454|NCT01108731|3868844|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4046455|NCT01108731|3868845|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4046456|NCT01108731|3868843|B3|||Age|Age on intake, continuous|years|Mean|47|47.0|Standard Deviation|4|4.0|||
4046457|NCT01108731|3868844|B2|||Age|Age on intake, continuous|years|Mean|47|47.0|Standard Deviation|5|5.0|||
4046458|NCT01108731|3868845|B1|||Age|Age on intake, continuous|years|Mean|48|48.0|Standard Deviation|4|4.0|||
4046459|NCT01108718|3868856|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4046460|NCT01108718|3868857|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4046461|NCT01108718|3868858|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4046462|NCT01108718|3868856|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4046463|NCT01108718|3868857|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4046464|NCT01108718|3868858|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4046465|NCT01108718|3868856|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4046466|NCT01108718|3868857|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4046467|NCT01108718|3868858|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4046468|NCT01108718|3868856|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4046469|NCT01108718|3868857|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4046470|NCT01108718|3868858|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4046471|NCT01108718|3868856|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4046472|NCT01108718|3868857|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4046473|NCT01108718|3868858|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4046474|NCT01108523|3868864|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4046475|NCT01108523|3868864|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4046480|NCT01108523|3868864|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4046481|NCT01108510|3868869|B3|Indeterminate||Hepatitis C Antibody Status||participants|Number|1|1.0||||||
4046482|NCT01108510|3868870|B2|Indeterminate||Hepatitis C Antibody Status||participants|Number|1|1.0||||||
4046483|NCT01108510|3868871|B1|Indeterminate||Hepatitis C Antibody Status||participants|Number|0|0.0||||||
4046484|NCT01108510|3868869|B3|Negative||Hepatitis C Antibody Status||participants|Number|654|654.0||||||
4046485|NCT01108510|3868870|B2|Negative||Hepatitis C Antibody Status||participants|Number|331|331.0||||||
4046486|NCT01108510|3868871|B1|Negative||Hepatitis C Antibody Status||participants|Number|323|323.0||||||
4046487|NCT01108510|3868869|B3|Positive||Hepatitis C Antibody Status||participants|Number|37|37.0||||||
4046488|NCT01108510|3868870|B2|Positive||Hepatitis C Antibody Status||participants|Number|16|16.0||||||
4046489|NCT01108510|3868871|B1|Positive||Hepatitis C Antibody Status||participants|Number|21|21.0||||||
4046490|NCT01108510|3868869|B3|Negative||Hepatitis B Surface Antigen Status||participants|Number|667|667.0||||||
4046491|NCT01108510|3868870|B2|Negative||Hepatitis B Surface Antigen Status||participants|Number|339|339.0||||||
4046492|NCT01108510|3868871|B1|Negative||Hepatitis B Surface Antigen Status||participants|Number|328|328.0||||||
4046493|NCT01108510|3868869|B3|Positive||Hepatitis B Surface Antigen Status||participants|Number|25|25.0||||||
4046494|NCT01108510|3868870|B2|Positive||Hepatitis B Surface Antigen Status||participants|Number|9|9.0||||||
4046495|NCT01108510|3868871|B1|Positive||Hepatitis B Surface Antigen Status||participants|Number|16|16.0||||||
4046496|NCT01108510|3868869|B3|AIDS||HIV Disease Status||participants|Number|52|52.0||||||
4046497|NCT01108510|3868870|B2|AIDS||HIV Disease Status||participants|Number|24|24.0||||||
4046498|NCT01108510|3868871|B1|AIDS||HIV Disease Status||participants|Number|28|28.0||||||
4046499|NCT01108510|3868869|B3|Symptomatic HIV Infections||HIV Disease Status||participants|Number|63|63.0||||||
4046500|NCT01108510|3868870|B2|Symptomatic HIV Infections||HIV Disease Status||participants|Number|32|32.0||||||
4046501|NCT01108510|3868871|B1|Symptomatic HIV Infections||HIV Disease Status||participants|Number|31|31.0||||||
4046502|NCT01108510|3868869|B3|Asymptomatic||HIV Disease Status||participants|Number|577|577.0||||||
4046503|NCT01108510|3868870|B2|Asymptomatic||HIV Disease Status||participants|Number|292|292.0||||||
4046504|NCT01108510|3868871|B1|Asymptomatic||HIV Disease Status||participants|Number|285|285.0||||||
4046505|NCT01108510|3868869|B3|> 500 cells/μL||CD4 Cell Count Category||participants|Number|95|95.0||||||
4046506|NCT01108510|3868870|B2|> 500 cells/μL||CD4 Cell Count Category||participants|Number|48|48.0||||||
4046507|NCT01108510|3868871|B1|> 500 cells/μL||CD4 Cell Count Category||participants|Number|47|47.0||||||
4046508|NCT01108510|3868869|B3|351 to ≤ 500 cells/μL||CD4 Cell Count Category||participants|Number|240|240.0||||||
4046509|NCT01108510|3868870|B2|351 to ≤ 500 cells/μL||CD4 Cell Count Category||participants|Number|117|117.0||||||
4046510|NCT01108510|3868871|B1|351 to ≤ 500 cells/μL||CD4 Cell Count Category||participants|Number|123|123.0||||||
4046511|NCT01108510|3868869|B3|201 to ≤ 350 cells/μL||CD4 Cell Count Category||participants|Number|240|240.0||||||
4046512|NCT01108510|3868870|B2|201 to ≤ 350 cells/μL||CD4 Cell Count Category||participants|Number|126|126.0||||||
4046513|NCT01108510|3868871|B1|201 to ≤ 350 cells/μL||CD4 Cell Count Category||participants|Number|114|114.0||||||
4046514|NCT01108510|3868869|B3|51 to ≤ 200 cells/μL||CD4 Cell Count Category||participants|Number|94|94.0||||||
4046515|NCT01108510|3868870|B2|51 to ≤ 200 cells/μL||CD4 Cell Count Category||participants|Number|45|45.0||||||
4046516|NCT01108510|3868871|B1|51 to ≤ 200 cells/μL||CD4 Cell Count Category||participants|Number|49|49.0||||||
4046517|NCT01108510|3868869|B3|≤ 50 cells/μL||CD4 Cell Count Category||participants|Number|23|23.0||||||
4046518|NCT01108510|3868870|B2|≤ 50 cells/μL||CD4 Cell Count Category||participants|Number|12|12.0||||||
4046519|NCT01108510|3868871|B1|≤ 50 cells/μL||CD4 Cell Count Category||participants|Number|11|11.0||3.2|3.2|||
4046520|NCT01108510|3868869|B3|||Cluster of differentiation (CD4) Cell Count||cells/µL|Mean|352|352.0|Standard Deviation|172.9|172.9|||
4046521|NCT01108510|3868870|B2|||Cluster of differentiation (CD4) Cell Count||cells/µL|Mean|351|351.0|Standard Deviation|175.5|175.5|||
4046522|NCT01108510|3868871|B1|||Cluster of differentiation (CD4) Cell Count||cells/µL|Mean|353|353.0|Standard Deviation|170.5|170.5|||
4046523|NCT01108510|3868869|B3|> 100,000 copies/mL||HIV-1 RNA Category||participants|Number|275|275.0||||||
4046524|NCT01108510|3868870|B2|> 100,000 copies/mL||HIV-1 RNA Category||participants|Number|143|143.0||||||
4046525|NCT01108510|3868871|B1|> 100,000 copies/mL||HIV-1 RNA Category||participants|Number|132|132.0||||||
4046526|NCT01108510|3868869|B3|≤ 100,000 copies/mL||HIV-1 RNA Category||participants|Number|417|417.0||||||
4046527|NCT01108510|3868870|B2|≤ 100,000 copies/mL||HIV-1 RNA Category||participants|Number|205|205.0||||||
4046528|NCT01108510|3868871|B1|≤ 100,000 copies/mL||HIV-1 RNA Category||participants|Number|212|212.0||||||
4046529|NCT01108510|3868869|B3|||HIV-1 RNA||log10 copies/mL|Mean|4.83|4.83|Standard Deviation|0.589|0.589|||
4046530|NCT01108510|3868870|B2|||HIV-1 RNA||log10 copies/mL|Mean|4.84|4.84|Standard Deviation|0.594|0.594|||
4046531|NCT01108510|3868871|B1|||HIV-1 RNA||log10 copies/mL|Mean|4.81|4.81|Standard Deviation|0.585|0.585|||
4046532|NCT01108510|3868869|B3|United States||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|248|248.0||||||
4046533|NCT01108510|3868870|B2|United States||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|114|114.0||||||
4046534|NCT01108510|3868871|B1|United States||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|134|134.0||||||
4046535|NCT01108510|3868869|B3|United Kingdom||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|32|32.0||||||
4046626|NCT01108458|3868892|B1||Male|Gender||Participants|Count of Participants|1|1.0||||||
4046536|NCT01108510|3868870|B2|United Kingdom||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|18|18.0||||||
4046537|NCT01108510|3868871|B1|United Kingdom||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|14|14.0||||||
4046538|NCT01108510|3868869|B3|Thailand||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|66|66.0||||||
4046539|NCT01108510|3868870|B2|Thailand||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|31|31.0||||||
4046540|NCT01108510|3868871|B1|Thailand||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|35|35.0||||||
4046541|NCT01108510|3868869|B3|Switzerland||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|15|15.0||||||
4046542|NCT01108510|3868870|B2|Switzerland||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|12|12.0||||||
4046543|NCT01108510|3868871|B1|Switzerland||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|3|3.0||||||
4046544|NCT01108510|3868869|B3|Spain||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|7|7.0||||||
4046545|NCT01108510|3868870|B2|Spain||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|4|4.0||||||
4046546|NCT01108510|3868871|B1|Spain||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|3|3.0||||||
4046547|NCT01108510|3868869|B3|Portugal||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|14|14.0||||||
4046548|NCT01108510|3868870|B2|Portugal||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|5|5.0||||||
4046549|NCT01108510|3868871|B1|Portugal||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|9|9.0||||||
4046550|NCT01108510|3868869|B3|Netherlands||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|1|1.0||||||
4046551|NCT01108510|3868870|B2|Netherlands||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|1|1.0||||||
4046552|NCT01108510|3868871|B1|Netherlands||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|0|0.0||||||
4046553|NCT01108510|3868869|B3|Mexico||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|35|35.0||||||
4046554|NCT01108510|3868870|B2|Mexico||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|17|17.0||||||
4046555|NCT01108510|3868871|B1|Mexico||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|18|18.0||||||
4046556|NCT01108510|3868869|B3|Italy||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|21|21.0||||||
4046557|NCT01108510|3868870|B2|Italy||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|15|15.0||||||
4046558|NCT01108510|3868871|B1|Italy||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|6|6.0||||||
4046559|NCT01108510|3868869|B3|Germany||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|38|38.0||||||
4046560|NCT01108510|3868870|B2|Germany||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|21|21.0||||||
4046561|NCT01108510|3868871|B1|Germany||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|17|17.0||||||
4046562|NCT01108510|3868869|B3|France||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|31|31.0||||||
4046563|NCT01108510|3868870|B2|France||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|19|19.0||||||
4046564|NCT01108510|3868871|B1|France||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|12|12.0||||||
4046565|NCT01108510|3868869|B3|Dominican Republic||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|58|58.0||||||
4046566|NCT01108510|3868870|B2|Dominican Republic||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|31|31.0||||||
4046567|NCT01108510|3868871|B1|Dominican Republic||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|27|27.0||||||
4046568|NCT01108510|3868869|B3|Denmark||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|2|2.0||||||
4046569|NCT01108510|3868870|B2|Denmark||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|2|2.0||||||
4046570|NCT01108510|3868871|B1|Denmark||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|0|0.0||||||
4046571|NCT01108510|3868869|B3|Canada||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|44|44.0||||||
4046572|NCT01108510|3868870|B2|Canada||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|18|18.0||||||
4046573|NCT01108510|3868871|B1|Canada||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|26|26.0||||||
4046574|NCT01108510|3868869|B3|Brazil||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|35|35.0||||||
4046575|NCT01108510|3868870|B2|Brazil||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|17|17.0||||||
4046576|NCT01108510|3868871|B1|Brazil||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|18|18.0||||||
4046577|NCT01108510|3868869|B3|Belgium||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|18|18.0||||||
4046578|NCT01108510|3868870|B2|Belgium||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|11|11.0||||||
4046579|NCT01108510|3868871|B1|Belgium||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|7|7.0||||||
4046580|NCT01108510|3868869|B3|Austria||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|18|18.0||||||
4046581|NCT01108510|3868870|B2|Austria||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|5|5.0||||||
4046582|NCT01108510|3868871|B1|Austria||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|13|13.0||||||
4046583|NCT01108510|3868869|B3|Australia||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|15|15.0||||||
4046584|NCT01108510|3868870|B2|Australia||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|8|8.0||||||
4046585|NCT01108510|3868871|B1|Australia||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (n = 349 per group)|participants|Number|7|7.0||||||
4046586|NCT01108510|3868869|B3|Other||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
4046587|NCT01108510|3868870|B2|Other||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4046588|NCT01108510|3868871|B1|Other||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4046589|NCT01108510|3868869|B3|Not Permitted||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4046590|NCT01108510|3868870|B2|Not Permitted||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4046591|NCT01108510|3868871|B1|Not Permitted||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4046592|NCT01108510|3868869|B3|White||Race/Ethnicity, Customized||participants|Number|413|413.0||||||
4046593|NCT01108510|3868870|B2|White||Race/Ethnicity, Customized||participants|Number|215|215.0||||||
4046594|NCT01108510|3868871|B1|White||Race/Ethnicity, Customized||participants|Number|198|198.0||||||
4046595|NCT01108510|3868869|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4046596|NCT01108510|3868870|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4046597|NCT01108510|3868871|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4046598|NCT01108510|3868869|B3|Black or African Heritage||Race/Ethnicity, Customized||participants|Number|128|128.0||||||
4046599|NCT01108510|3868870|B2|Black or African Heritage||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
4046600|NCT01108510|3868871|B1|Black or African Heritage||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
4046601|NCT01108510|3868869|B3|Asian||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
4046602|NCT01108510|3868870|B2|Asian||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4046603|NCT01108510|3868871|B1|Asian||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4046604|NCT01108510|3868869|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4046605|NCT01108510|3868870|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4046606|NCT01108510|3868871|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4046607|NCT01108510|3868869|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4046608|NCT01108510|3868870|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4046609|NCT01108510|3868871|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4046610|NCT01108510|3868869|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|498|498.0||||||
4046611|NCT01108510|3868870|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|253|253.0||||||
4046612|NCT01108510|3868871|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|245|245.0||||||
4046613|NCT01108510|3868869|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|189|189.0||||||
4046614|NCT01108510|3868870|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
4046615|NCT01108510|3868871|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
4046616|NCT01108510|3868869|B3||Male|Sex: Female, Male||Participants|Count of Participants|574|574.0||||||
4046617|NCT01108510|3868870|B2||Male|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
4046618|NCT01108510|3868871|B1||Male|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
4046619|NCT01108510|3868869|B3||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4046620|NCT01108510|3868870|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4046621|NCT01108510|3868871|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4046622|NCT01108510|3868869|B3|||Age||years|Mean|37|37.0|Standard Deviation|9.7|9.7|||
4046623|NCT01108510|3868870|B2|||Age||years|Mean|38|38.0|Standard Deviation|9.6|9.6|||
4046624|NCT01108510|3868871|B1|||Age||years|Mean|37|37.0|Standard Deviation|9.8|9.8|||
4046625|NCT01108458|3868892|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4046627|NCT01108458|3868892|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
4046628|NCT01108458|3868892|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4046629|NCT01108458|3868892|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4046630|NCT01108458|3868892|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4046631|NCT01108445|3868901|B3||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4046632|NCT01108445|3868902|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4046633|NCT01108445|3868903|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4046634|NCT01108445|3868901|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4046635|NCT01108445|3868902|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4046636|NCT01108445|3868903|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4046637|NCT01108445|3868901|B3|||Age||years|Mean|61.4|61.4|Standard Deviation|13.53|13.53|||
4046638|NCT01108445|3868902|B2|||Age||years|Mean|60.9|60.9|Standard Deviation|15.3|15.3|||
4046639|NCT01108445|3868903|B1|||Age||years|Mean|61.9|61.9|Standard Deviation|11.85|11.85|||
4046640|NCT01108406|3868938|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4046641|NCT01108406|3868938|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4046642|NCT01108406|3868938|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4046643|NCT01108406|3868938|B1|||Age||years|Mean|44.41|44.41|Standard Deviation|11.54|11.54|||
4046644|NCT01108406|3868938|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4046645|NCT01108406|3868938|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4046646|NCT01108406|3868938|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4046647|NCT01108341|3868944|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4046648|NCT01108341|3868944|B1|White||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4046649|NCT01108341|3868944|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4046650|NCT01108341|3868944|B1|Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4046651|NCT01108341|3868944|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4046652|NCT01108341|3868944|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4046653|NCT01108341|3868944|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4046654|NCT01108341|3868944|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4046655|NCT01108341|3868944|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4046656|NCT01108341|3868944|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4046657|NCT01108341|3868944|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4046658|NCT01108341|3868944|B1|>=65 years||Age, Customized||participants|Number|18|18.0||||||
4046659|NCT01108341|3868944|B1|<65 years||Age, Customized||participants|Number|31|31.0||||||
4046660|NCT01108341|3868944|B1|||Age||years|Mean|59.1|59.1|Standard Deviation|10.77|10.77|||
4046661|NCT01108263|3868949|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4046662|NCT01108263|3868950|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4046663|NCT01108263|3868951|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4046664|NCT01108263|3868949|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4046665|NCT01108263|3868950|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4046666|NCT01108263|3868951|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4046667|NCT01108263|3868949|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4046668|NCT01108263|3868950|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4046669|NCT01108263|3868951|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4046670|NCT01108263|3868949|B3|||Age||years|Mean|50|50.0|Standard Deviation|5.24404|5.24404|||
4046671|NCT01108263|3868950|B2|||Age||years|Mean|47|47.0|Standard Deviation|4.58258|4.58258|||
4046672|NCT01108263|3868951|B1|||Age||years|Mean|54.5|54.5|Standard Deviation|0.70711|0.70711|||
4046673|NCT01108263|3868949|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4046674|NCT01108263|3868950|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4046675|NCT01108263|3868951|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4046676|NCT01108263|3868949|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4046677|NCT01108263|3868950|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4046678|NCT01108263|3868951|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4046679|NCT01108263|3868949|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4046680|NCT01108263|3868950|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4046681|NCT01108263|3868951|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4046682|NCT01108237|3868960|B3|United States||Region of Enrollment||participants|Number|148|148.0||||||
4046683|NCT01108237|3868961|B2|United States||Region of Enrollment||participants|Number|84|84.0||||||
4046684|NCT01108237|3868962|B1|United States||Region of Enrollment||participants|Number|64|64.0||||||
4046685|NCT01108237|3868960|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4046686|NCT01108237|3868961|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4046687|NCT01108237|3868962|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4046688|NCT01108237|3868960|B3||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4046689|NCT01108237|3868961|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4046690|NCT01108237|3868962|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4046691|NCT01108237|3868960|B3|||Age||years|Mean|65.3|65.3|Standard Deviation|8.0|8.0|||
4046692|NCT01108237|3868961|B2|||Age||years|Mean|64.3|64.3|Standard Deviation|7.6|7.6|||
4046693|NCT01108237|3868962|B1|||Age||years|Mean|66.5|66.5|Standard Deviation|8.4|8.4|||
4046694|NCT01108185|3868969|B1|Mild community-acquired bronchopneumonia||Diagnosis|The diagnosis of each participant at Baseline.|Participants|Number|183|183.0||||||
4046695|NCT01108185|3868969|B1|Acute exacerbation of chronic bronchitis||Diagnosis|The diagnosis of each participant at Baseline.|Participants|Number|281|281.0||||||
4046696|NCT01108185|3868969|B1|Acute tracheitis||Diagnosis|The diagnosis of each participant at Baseline.|Participants|Number|870|870.0||||||
4046697|NCT01108185|3868969|B1|Acute bronchitis||Diagnosis|The diagnosis of each participant at Baseline.|Participants|Number|921|921.0||||||
4046698|NCT01108185|3868969|B1|Acute tracheobronchitis||Diagnosis|The diagnosis of each participant at Baseline.|Participants|Number|926|926.0||||||
4046699|NCT01108185|3868969|B1|Slovakia||Region of Enrollment||participants|Number|3181|3181.0||||||
4046700|NCT01108185|3868969|B1||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Gender not collected in this study
4046701|NCT01108185|3868969|B1||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Gender not collected in this study
4046702|NCT01108185|3868969|B1|Age not reported||Age, Customized||participants|Number|11|11.0||||||
4046703|NCT01108185|3868969|B1|80 years or older||Age, Customized||participants|Number|50|50.0||||||
4046704|NCT01108185|3868969|B1|70 to 79 years||Age, Customized||participants|Number|130|130.0||||||
4046705|NCT01108185|3868969|B1|60 to 69 years||Age, Customized||participants|Number|331|331.0||||||
4046706|NCT01108185|3868969|B1|50 to 59 years||Age, Customized||participants|Number|538|538.0||||||
4046707|NCT01108185|3868969|B1|40 to 49 years||Age, Customized||participants|Number|787|787.0||||||
4046708|NCT01108185|3868969|B1|30 to 39 years||Age, Customized||participants|Number|873|873.0||||||
4046709|NCT01108185|3868969|B1|20 to 29 years||Age, Customized||participants|Number|411|411.0||||||
4046710|NCT01108185|3868969|B1|Less than 20 years||Age, Customized||participants|Number|50|50.0||||||
4046711|NCT01108094|3868982|B5|> 1 Tumor Lesion at Baseline||Number of Tumor Lesions at Baseline||Participants|Count of Participants|9|9.0||||||
4046712|NCT01108094|3868983|B4|> 1 Tumor Lesion at Baseline||Number of Tumor Lesions at Baseline||Participants|Count of Participants|1|1.0||||||
4046713|NCT01108094|3868984|B3|> 1 Tumor Lesion at Baseline||Number of Tumor Lesions at Baseline||Participants|Count of Participants|4|4.0||||||
4046714|NCT01108094|3868985|B2|> 1 Tumor Lesion at Baseline||Number of Tumor Lesions at Baseline||Participants|Count of Participants|0|0.0||||||
4046715|NCT01108094|3868986|B1|> 1 Tumor Lesion at Baseline||Number of Tumor Lesions at Baseline||Participants|Count of Participants|4|4.0||||||
4046716|NCT01108094|3868982|B5|1 Tumor Lesion at Baseline||Number of Tumor Lesions at Baseline||Participants|Count of Participants|21|21.0||||||
4046717|NCT01108094|3868983|B4|1 Tumor Lesion at Baseline||Number of Tumor Lesions at Baseline||Participants|Count of Participants|10|10.0||||||
4046718|NCT01108094|3868984|B3|1 Tumor Lesion at Baseline||Number of Tumor Lesions at Baseline||Participants|Count of Participants|0|0.0||||||
4046719|NCT01108094|3868985|B2|1 Tumor Lesion at Baseline||Number of Tumor Lesions at Baseline||Participants|Count of Participants|3|3.0||||||
4046720|NCT01108094|3868986|B1|1 Tumor Lesion at Baseline||Number of Tumor Lesions at Baseline||Participants|Count of Participants|8|8.0||||||
4046721|NCT01108094|3868982|B5|Chile||Region of Enrollment||participants|Number|4|4.0||||||
4046722|NCT01108094|3868983|B4|Chile||Region of Enrollment||participants|Number|0|0.0||||||
4046723|NCT01108094|3868984|B3|Chile||Region of Enrollment||participants|Number|4|4.0||||||
4046724|NCT01108094|3868985|B2|Chile||Region of Enrollment||participants|Number|0|0.0||||||
4046725|NCT01108094|3868986|B1|Chile||Region of Enrollment||participants|Number|0|0.0||||||
4046726|NCT01108094|3868982|B5|United States||Region of Enrollment||participants|Number|25|25.0||||||
4046727|NCT01108094|3868983|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
4046728|NCT01108094|3868984|B3|United States||Region of Enrollment||participants|Number|0|0.0||||||
4046729|NCT01108094|3868985|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4046730|NCT01108094|3868986|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4046731|NCT01108094|3868982|B5||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4046732|NCT01108094|3868983|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4046733|NCT01108094|3868984|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4046734|NCT01108094|3868985|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4046735|NCT01108094|3868986|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4046736|NCT01108094|3868982|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4046737|NCT01108094|3868983|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4046738|NCT01108094|3868984|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4046739|NCT01108094|3868985|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4046740|NCT01108094|3868986|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4046741|NCT01108094|3868982|B5|||Age||years|Mean|65.35|65.35|Full Range|||44.0|85.0|
4046742|NCT01108094|3868983|B4|||Age||years|Mean|68.5|68.5|Full Range|||53.0|81.0|
4046743|NCT01108094|3868984|B3|||Age||years|Mean|61.7|61.7|Full Range|||51.0|78.0|
4046744|NCT01108094|3868985|B2|||Age||years|Mean|57.7|57.7|Full Range|||55.0|62.0|
4046745|NCT01108094|3868986|B1|||Age||years|Mean|62.2|62.2|Full Range|||44.0|85.0|
4046746|NCT01108081|3869010|B5||Male|Gender||Participants|Count of Participants|164|164.0||||||
4046747|NCT01108081|3869011|B4||Male|Gender||Participants|Count of Participants|40|40.0||||||
4046748|NCT01108081|3869012|B3||Male|Gender||Participants|Count of Participants|38|38.0||||||
4046749|NCT01108081|3869013|B2||Male|Gender||Participants|Count of Participants|42|42.0||||||
4046750|NCT01108081|3869014|B1||Male|Gender||Participants|Count of Participants|44|44.0||||||
4046751|NCT01108081|3869010|B5||Female|Gender||Participants|Count of Participants|5|5.0||||||
4046752|NCT01108081|3869011|B4||Female|Gender||Participants|Count of Participants|3|3.0||||||
4046753|NCT01108081|3869012|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
4046754|NCT01108081|3869013|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
4046755|NCT01108081|3869014|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
4046756|NCT01108081|3869010|B5|||Age||years|Mean|59.5|59.5|Standard Deviation|9.8|9.8|||
4046757|NCT01108081|3869011|B4|||Age||years|Mean|56.3|56.3|Standard Deviation|10.0|10.0|||
4046758|NCT01108081|3869012|B3|||Age||years|Mean|59.1|59.1|Standard Deviation|11.0|11.0|||
4046759|NCT01108081|3869013|B2|||Age||years|Mean|60.5|60.5|Standard Deviation|8.7|8.7|||
4046760|NCT01108081|3869014|B1|||Age||years|Mean|61.8|61.8|Standard Deviation|9.0|9.0|||
4046761|NCT01108068|3869031|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4046762|NCT01108068|3869032|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4046763|NCT01108068|3869033|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4046764|NCT01108068|3869031|B3|Causasian||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
4046765|NCT01108068|3869032|B2|Causasian||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
4046766|NCT01108068|3869033|B1|Causasian||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4046767|NCT01108068|3869031|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4046768|NCT01108068|3869032|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4046769|NCT01108068|3869033|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4046770|NCT01108068|3869031|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4046771|NCT01108068|3869032|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4046772|NCT01108068|3869033|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4046773|NCT01108068|3869031|B3|||Age||years|Mean|18.8|18.8|Standard Deviation|14.1|14.1|||
4046774|NCT01108068|3869032|B2|||Age||years|Mean|21.8|21.8|Standard Deviation|16.5|16.5|||
4046775|NCT01108068|3869033|B1|||Age||years|Mean|13.4|13.4|Standard Deviation|2.5|2.5|||
4046776|NCT01108068|3869031|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4046777|NCT01108068|3869032|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4046778|NCT01108068|3869033|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4046779|NCT01108068|3869031|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4046780|NCT01108068|3869032|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4046781|NCT01108068|3869033|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4046782|NCT01108068|3869031|B3||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4046783|NCT01108068|3869032|B2||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4046784|NCT01108068|3869033|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4046785|NCT01108055|3869041|B1|3||Bellmunt Score||Participants|Count of Participants|0|0.0||||||
4046786|NCT01108055|3869041|B1|2||Bellmunt Score||Participants|Count of Participants|11|11.0||||||
4046787|NCT01108055|3869041|B1|1||Bellmunt Score||Participants|Count of Participants|14|14.0||||||
4046788|NCT01108055|3869041|B1|0||Bellmunt Score||Participants|Count of Participants|7|7.0||||||
4046789|NCT01108055|3869041|B1|> 3 months||Time from last chemotherapy||Participants|Count of Participants|17|17.0||||||
4046790|NCT01108055|3869041|B1|< 3 months||Time from last chemotherapy||Participants|Count of Participants|15|15.0||||||
4046791|NCT01108055|3869041|B1||2|Number of prior chemotherapies||Participants|Count of Participants|19|19.0||||||
4046792|NCT01108055|3869041|B1||1|Number of prior chemotherapies||Participants|Count of Participants|13|13.0||||||
4046793|NCT01108055|3869041|B1||Ureter|Sites of Primary Tumor||Participants|Count of Participants|6|6.0||||||
4046794|NCT01108055|3869041|B1||Renal Pelvis|Sites of Primary Tumor||Participants|Count of Participants|11|11.0||||||
4046795|NCT01108055|3869041|B1||Bladder|Sites of Primary Tumor||Participants|Count of Participants|15|15.0||||||
4046796|NCT01108055|3869041|B1|||Prior Treatment Cycles|A full treatment cycle is defined as 28 days.|Cycles|Median|4|4.0|Full Range|||1.0|14.0|
4046797|NCT01108055|3869041|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4046798|NCT01108055|3869041|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046799|NCT01108055|3869041|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4046800|NCT01108055|3869041|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4046801|NCT01108055|3869041|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046802|NCT01108055|3869041|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4046803|NCT01108055|3869041|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046804|NCT01108055|3869041|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4046805|NCT01108055|3869041|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4046806|NCT01108055|3869041|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4046807|NCT01108055|3869041|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4046808|NCT01108055|3869041|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4046809|NCT01108055|3869041|B1|||Age||years|Mean|67|67.0|Full Range|||29.0|89.0|
4046810|NCT01108003|3869049|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4046811|NCT01108003|3869050|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4046812|NCT01108003|3869051|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4046813|NCT01108003|3869049|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4046814|NCT01108003|3869050|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4046815|NCT01108003|3869051|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4046816|NCT01108003|3869049|B3|||Age||years|Mean|74|74.0|Standard Deviation|4.7|4.7|||
4046817|NCT01108003|3869050|B2|||Age||years|Mean|73|73.0|Standard Deviation|4.9|4.9|||
4046818|NCT01108003|3869051|B1|||Age||years|Mean|74|74.0|Standard Deviation|5.3|5.3|||
4046819|NCT01108003|3869049|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4046820|NCT01108003|3869050|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4046821|NCT01108003|3869051|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4046822|NCT01108003|3869049|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4046823|NCT01108003|3869050|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4046824|NCT01108003|3869051|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4046825|NCT01108003|3869049|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4046826|NCT01108003|3869050|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4046827|NCT01108003|3869051|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4046828|NCT01107964|3869060|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4046829|NCT01107964|3869061|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4046830|NCT01107964|3869062|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4046831|NCT01107964|3869060|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4046832|NCT01107964|3869061|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4046833|NCT01107964|3869062|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4046834|NCT01107964|3869060|B3|||Age||years|Median|58|58.0|Inter-Quartile Range|||49.5|67.5|
4046835|NCT01107964|3869061|B2|||Age||years|Median|60|60.0|Inter-Quartile Range|||55.0|67.0|
4046836|NCT01107964|3869062|B1|||Age||years|Median|54|54.0|Inter-Quartile Range|||44.5|65.0|
4046837|NCT01107925|3869075|B5|Tobacco Use No||Tobacco Use Status||participants|Number|48|48.0||||||
4046838|NCT01107925|3869076|B4|Tobacco Use No||Tobacco Use Status||participants|Number|13|13.0||||||
4046839|NCT01107925|3869077|B3|Tobacco Use No||Tobacco Use Status||participants|Number|16|16.0||||||
4046840|NCT01107925|3869078|B2|Tobacco Use No||Tobacco Use Status||participants|Number|9|9.0||||||
4046841|NCT01107925|3869079|B1|Tobacco Use No||Tobacco Use Status||participants|Number|10|10.0||||||
4046842|NCT01107925|3869075|B5|Tobacco Use Yes||Tobacco Use Status||participants|Number|24|24.0||||||
4046843|NCT01107925|3869076|B4|Tobacco Use Yes||Tobacco Use Status||participants|Number|4|4.0||||||
4046844|NCT01107925|3869077|B3|Tobacco Use Yes||Tobacco Use Status||participants|Number|5|5.0||||||
4046845|NCT01107925|3869078|B2|Tobacco Use Yes||Tobacco Use Status||participants|Number|8|8.0||||||
4046846|NCT01107925|3869079|B1|Tobacco Use Yes||Tobacco Use Status||participants|Number|7|7.0||||||
4046847|NCT01107925|3869075|B5|||Weight||kilograms (kg)|Mean|71.33|71.33|Standard Deviation|17.980|17.98|||
4046848|NCT01107925|3869076|B4|||Weight||kilograms (kg)|Mean|85.96|85.96|Standard Deviation|11.898|11.898|||
4046849|NCT01107925|3869077|B3|||Weight||kilograms (kg)|Mean|83.60|83.6|Standard Deviation|17.146|17.146|||
4046850|NCT01107925|3869078|B2|||Weight||kilograms (kg)|Mean|56.78|56.78|Standard Deviation|2.619|2.619|||
4046851|NCT01107925|3869079|B1|||Weight||kilograms (kg)|Mean|56.06|56.06|Standard Deviation|4.575|4.575|||
4046852|NCT01107925|3869075|B5|Sweden||Region of Enrollment||participants|Number|23|23.0||||||
4046853|NCT01107925|3869076|B4|Sweden||Region of Enrollment||participants|Number|4|4.0||||||
4046854|NCT01107925|3869077|B3|Sweden||Region of Enrollment||participants|Number|6|6.0||||||
4046855|NCT01107925|3869078|B2|Sweden||Region of Enrollment||participants|Number|7|7.0||||||
4046856|NCT01107925|3869079|B1|Sweden||Region of Enrollment||participants|Number|6|6.0||||||
4046857|NCT01107925|3869075|B5|Netherlands||Region of Enrollment||participants|Number|27|27.0||||||
4046858|NCT01107925|3869076|B4|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
4046859|NCT01107925|3869077|B3|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
4046860|NCT01107925|3869078|B2|Netherlands||Region of Enrollment||participants|Number|8|8.0||||||
4046861|NCT01107925|3869079|B1|Netherlands||Region of Enrollment||participants|Number|9|9.0||||||
4046862|NCT01107925|3869075|B5|Ireland||Region of Enrollment||participants|Number|18|18.0||||||
4046863|NCT01107925|3869076|B4|Ireland||Region of Enrollment||participants|Number|6|6.0||||||
4046864|NCT01107925|3869077|B3|Ireland||Region of Enrollment||participants|Number|8|8.0||||||
4046865|NCT01107925|3869078|B2|Ireland||Region of Enrollment||participants|Number|2|2.0||||||
4046866|NCT01107925|3869079|B1|Ireland||Region of Enrollment||participants|Number|2|2.0||||||
4046867|NCT01107925|3869075|B5|United States||Region of Enrollment||participants|Number|4|4.0||||||
4046868|NCT01107925|3869076|B4|United States||Region of Enrollment||participants|Number|2|2.0||||||
4046869|NCT01107925|3869077|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4046870|NCT01107925|3869078|B2|United States||Region of Enrollment||participants|Number|0|0.0||||||
4046871|NCT01107925|3869079|B1|United States||Region of Enrollment||participants|Number|0|0.0||||||
4046872|NCT01107925|3869075|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046873|NCT01107925|3869076|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046874|NCT01107925|3869077|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046875|NCT01107925|3869078|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046876|NCT01107925|3869079|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046877|NCT01107925|3869075|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046878|NCT01107925|3869076|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046879|NCT01107925|3869077|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046880|NCT01107925|3869078|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046881|NCT01107925|3869079|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046882|NCT01107925|3869075|B5||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4046883|NCT01107925|3869076|B4||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4046884|NCT01107925|3869077|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4046885|NCT01107925|3869078|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4046886|NCT01107925|3869079|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4046887|NCT01107925|3869075|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4046888|NCT01107925|3869076|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4046889|NCT01107925|3869077|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4046890|NCT01107925|3869078|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046891|NCT01107925|3869079|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046892|NCT01107925|3869075|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046893|NCT01107925|3869076|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046894|NCT01107925|3869077|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046895|NCT01107925|3869078|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046896|NCT01107925|3869079|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046897|NCT01107925|3869075|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4046898|NCT01107925|3869076|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046899|NCT01107925|3869077|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046900|NCT01107925|3869078|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4046901|NCT01107925|3869079|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046902|NCT01107925|3869075|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046903|NCT01107925|3869076|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046904|NCT01107925|3869077|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046905|NCT01107925|3869078|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046906|NCT01107925|3869079|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046907|NCT01107925|3869075|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4046908|NCT01107925|3869076|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4046909|NCT01107925|3869077|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4046910|NCT01107925|3869078|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4046911|NCT01107925|3869079|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4046912|NCT01107925|3869075|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4046913|NCT01107925|3869076|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4046914|NCT01107925|3869077|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4046915|NCT01107925|3869078|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4046916|NCT01107925|3869079|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4046917|NCT01107925|3869075|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046918|NCT01107925|3869076|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046919|NCT01107925|3869077|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046920|NCT01107925|3869078|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046921|NCT01107925|3869079|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046922|NCT01107925|3869075|B5||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4046923|NCT01107925|3869076|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4046924|NCT01107925|3869077|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4046925|NCT01107925|3869078|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4046926|NCT01107925|3869079|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4046927|NCT01107925|3869075|B5||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4046928|NCT01107925|3869076|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4046929|NCT01107925|3869077|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4046930|NCT01107925|3869078|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4046931|NCT01107925|3869079|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4046932|NCT01107925|3869075|B5|||Age||years|Mean|62.6|62.6|Standard Deviation|8.15|8.15|||
4046933|NCT01107925|3869076|B4|||Age||years|Mean|64.6|64.6|Standard Deviation|6.91|6.91|||
4046934|NCT01107925|3869077|B3|||Age||years|Mean|61.4|61.4|Standard Deviation|9.57|9.57|||
4046935|NCT01107925|3869078|B2|||Age||years|Mean|63.2|63.2|Standard Deviation|7.65|7.65|||
4046936|NCT01107925|3869079|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|8.07|8.07|||
4046937|NCT01107912|3869118|B5|No||Tobacco Use Status at Baseline||participants|Number|126|126.0||||||
4046938|NCT01107912|3869119|B4|No||Tobacco Use Status at Baseline||participants|Number|29|29.0||||||
4046939|NCT01107912|3869120|B3|No||Tobacco Use Status at Baseline||participants|Number|29|29.0||||||
4046940|NCT01107912|3869121|B2|No||Tobacco Use Status at Baseline||participants|Number|36|36.0||||||
4046941|NCT01107912|3869122|B1|No||Tobacco Use Status at Baseline||participants|Number|32|32.0||||||
4046942|NCT01107912|3869118|B5|Yes||Tobacco Use Status at Baseline||participants|Number|29|29.0||||||
4046943|NCT01107912|3869119|B4|Yes||Tobacco Use Status at Baseline||participants|Number|11|11.0||||||
4046944|NCT01107912|3869120|B3|Yes||Tobacco Use Status at Baseline||participants|Number|13|13.0||||||
4046945|NCT01107912|3869121|B2|Yes||Tobacco Use Status at Baseline||participants|Number|1|1.0||||||
4046946|NCT01107912|3869122|B1|Yes||Tobacco Use Status at Baseline||participants|Number|4|4.0||||||
4046947|NCT01107912|3869118|B5|||Weight||kilograms (kg)|Mean|89.45|89.45|Standard Deviation|16.01|16.01|||
4046948|NCT01107912|3869119|B4|||Weight||kilograms (kg)|Mean|93.36|93.36|Standard Deviation|17.32|17.32|||
4046949|NCT01107912|3869120|B3|||Weight||kilograms (kg)|Mean|92.85|92.85|Standard Deviation|20.01|20.01|||
4046950|NCT01107912|3869121|B2|||Weight||kilograms (kg)|Mean|82.30|82.3|Standard Deviation|10.74|10.74|||
4046951|NCT01107912|3869122|B1|||Weight||kilograms (kg)|Mean|88.49|88.49|Standard Deviation|10.92|10.92|||
4046952|NCT01107912|3869118|B5|Sweden||Region of Enrollment||participants|Number|87|87.0||||||
4046953|NCT01107912|3869119|B4|Sweden||Region of Enrollment||participants|Number|19|19.0||||||
4046954|NCT01107912|3869120|B3|Sweden||Region of Enrollment||participants|Number|23|23.0||||||
4046955|NCT01107912|3869121|B2|Sweden||Region of Enrollment||participants|Number|23|23.0||||||
4046956|NCT01107912|3869122|B1|Sweden||Region of Enrollment||participants|Number|22|22.0||||||
4046957|NCT01107912|3869118|B5|Netherlands||Region of Enrollment||participants|Number|10|10.0||||||
4046958|NCT01107912|3869119|B4|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4046959|NCT01107912|3869120|B3|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
4046960|NCT01107912|3869121|B2|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
4046961|NCT01107912|3869122|B1|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
4046962|NCT01107912|3869118|B5|Ireland||Region of Enrollment||participants|Number|19|19.0||||||
4046963|NCT01107912|3869119|B4|Ireland||Region of Enrollment||participants|Number|6|6.0||||||
4046964|NCT01107912|3869120|B3|Ireland||Region of Enrollment||participants|Number|7|7.0||||||
4046965|NCT01107912|3869121|B2|Ireland||Region of Enrollment||participants|Number|3|3.0||||||
4046966|NCT01107912|3869122|B1|Ireland||Region of Enrollment||participants|Number|3|3.0||||||
4046967|NCT01107912|3869118|B5|United States||Region of Enrollment||participants|Number|39|39.0||||||
4046968|NCT01107912|3869119|B4|United States||Region of Enrollment||participants|Number|14|14.0||||||
4046969|NCT01107912|3869120|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4046970|NCT01107912|3869121|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4046971|NCT01107912|3869122|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4046972|NCT01107912|3869118|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046973|NCT01107912|3869119|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046974|NCT01107912|3869120|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046975|NCT01107912|3869121|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046976|NCT01107912|3869122|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046977|NCT01107912|3869118|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4046978|NCT01107912|3869119|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4046979|NCT01107912|3869120|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4046980|NCT01107912|3869121|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046981|NCT01107912|3869122|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046982|NCT01107912|3869118|B5||White|Race (NIH/OMB)||Participants|Count of Participants|141|141.0||||||
4046983|NCT01107912|3869119|B4||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4046984|NCT01107912|3869120|B3||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4046985|NCT01107912|3869121|B2||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4046986|NCT01107912|3869122|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4046987|NCT01107912|3869118|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4046988|NCT01107912|3869119|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4046989|NCT01107912|3869120|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4046990|NCT01107912|3869121|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4046991|NCT01107912|3869122|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4046992|NCT01107912|3869118|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046993|NCT01107912|3869119|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046994|NCT01107912|3869120|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046995|NCT01107912|3869121|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046996|NCT01107912|3869122|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046997|NCT01107912|3869118|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046998|NCT01107912|3869119|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4046999|NCT01107912|3869120|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047000|NCT01107912|3869121|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047001|NCT01107912|3869122|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047002|NCT01107912|3869118|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047003|NCT01107912|3869119|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047004|NCT01107912|3869120|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047005|NCT01107912|3869121|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047006|NCT01107912|3869122|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047007|NCT01107912|3869118|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|116|116.0||||||
4047008|NCT01107912|3869119|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4047009|NCT01107912|3869120|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4047010|NCT01107912|3869121|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4047011|NCT01107912|3869122|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4047012|NCT01107912|3869118|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4047013|NCT01107912|3869119|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4047014|NCT01107912|3869120|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4047015|NCT01107912|3869121|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4047016|NCT01107912|3869122|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4047017|NCT01107912|3869118|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4047018|NCT01107912|3869119|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047019|NCT01107912|3869120|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4047020|NCT01107912|3869121|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047021|NCT01107912|3869122|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047022|NCT01107912|3869118|B5||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4047023|NCT01107912|3869119|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4047024|NCT01107912|3869120|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4047025|NCT01107912|3869121|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4047026|NCT01107912|3869122|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4047027|NCT01107912|3869118|B5||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4047028|NCT01107912|3869119|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4047029|NCT01107912|3869120|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4047030|NCT01107912|3869121|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4047031|NCT01107912|3869122|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4047032|NCT01107912|3869118|B5|||Age||years|Mean|66.94|66.94|Standard Deviation|12.08|12.08|||
4047033|NCT01107912|3869119|B4|||Age||years|Mean|55.46|55.46|Standard Deviation|5.53|5.53|||
4047034|NCT01107912|3869120|B3|||Age||years|Mean|57.11|57.11|Standard Deviation|4.75|4.75|||
4047035|NCT01107912|3869121|B2|||Age||years|Mean|78.74|78.74|Standard Deviation|3.12|3.12|||
4047036|NCT01107912|3869122|B1|||Age||years|Mean|79.02|79.02|Standard Deviation|2.87|2.87|||
4047037|NCT01107899|3869161|B4|Germany||Region of Enrollment||participants|Number|29|29.0||||||
4047038|NCT01107899|3869162|B3|Germany||Region of Enrollment||participants|Number|9|9.0||||||
4047039|NCT01107899|3869163|B2|Germany||Region of Enrollment||participants|Number|10|10.0||||||
4047040|NCT01107899|3869164|B1|Germany||Region of Enrollment||participants|Number|10|10.0||||||
4047041|NCT01107899|3869161|B4|White||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4047042|NCT01107899|3869162|B3|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4047043|NCT01107899|3869163|B2|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4047044|NCT01107899|3869164|B1|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4047045|NCT01107899|3869161|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4047046|NCT01107899|3869162|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4047047|NCT01107899|3869163|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4047048|NCT01107899|3869164|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4047049|NCT01107899|3869161|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4047050|NCT01107899|3869162|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4047051|NCT01107899|3869163|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4047052|NCT01107899|3869164|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4047053|NCT01107899|3869161|B4|||Age||years|Mean|64.8|64.8|Standard Deviation|8.44|8.44|||
4047054|NCT01107899|3869162|B3|||Age||years|Mean|61.5|61.5|Standard Deviation|10.01|10.01|||
4047055|NCT01107899|3869163|B2|||Age||years|Mean|65.6|65.6|Standard Deviation|6.56|6.56|||
4047056|NCT01107899|3869164|B1|||Age||years|Mean|66.9|66.9|Standard Deviation|8.54|8.54|||
4047057|NCT01107886|3869210|B3|Severe impairment||Renal Functione Categor: Normal or Mild impairment/Moderate impairment/Severe impairment|Renal function categories Normal function – Mild impairment defined as: eGFR >50 mL/min; Moderate impairment defined as: eGFR 30 to 50 mL/min; Severe impairment defined as: eGFR eGFR <30 mL/min.|Participants|Number|336|336.0||||||
4047058|NCT01107886|3869211|B2|Severe impairment||Renal Functione Categor: Normal or Mild impairment/Moderate impairment/Severe impairment|Renal function categories Normal function – Mild impairment defined as: eGFR >50 mL/min; Moderate impairment defined as: eGFR 30 to 50 mL/min; Severe impairment defined as: eGFR eGFR <30 mL/min.|Participants|Number|164|164.0||||||
4047059|NCT01107886|3869212|B1|Severe impairment||Renal Functione Categor: Normal or Mild impairment/Moderate impairment/Severe impairment|Renal function categories Normal function – Mild impairment defined as: eGFR >50 mL/min; Moderate impairment defined as: eGFR 30 to 50 mL/min; Severe impairment defined as: eGFR eGFR <30 mL/min.|Participants|Number|172|172.0||||||
4047060|NCT01107886|3869210|B3|Moderate impairment||Renal Functione Categor: Normal or Mild impairment/Moderate impairment/Severe impairment|Renal function categories Normal function – Mild impairment defined as: eGFR >50 mL/min; Moderate impairment defined as: eGFR 30 to 50 mL/min; Severe impairment defined as: eGFR eGFR <30 mL/min.|Participants|Number|2240|2240.0||||||
4047061|NCT01107886|3869211|B2|Moderate impairment||Renal Functione Categor: Normal or Mild impairment/Moderate impairment/Severe impairment|Renal function categories Normal function – Mild impairment defined as: eGFR >50 mL/min; Moderate impairment defined as: eGFR 30 to 50 mL/min; Severe impairment defined as: eGFR eGFR <30 mL/min.|Participants|Number|1118|1118.0||||||
4047062|NCT01107886|3869212|B1|Moderate impairment||Renal Functione Categor: Normal or Mild impairment/Moderate impairment/Severe impairment|Renal function categories Normal function – Mild impairment defined as: eGFR >50 mL/min; Moderate impairment defined as: eGFR 30 to 50 mL/min; Severe impairment defined as: eGFR eGFR <30 mL/min.|Participants|Number|1122|1122.0||||||
4047063|NCT01107886|3869210|B3|Normal or Mild impairment||Renal Functione Categor: Normal or Mild impairment/Moderate impairment/Severe impairment|Renal function categories Normal function – Mild impairment defined as: eGFR >50 mL/min; Moderate impairment defined as: eGFR 30 to 50 mL/min; Severe impairment defined as: eGFR eGFR <30 mL/min.|Participants|Number|13916|13916.0||||||
4047064|NCT01107886|3869211|B2|Normal or Mild impairment||Renal Functione Categor: Normal or Mild impairment/Moderate impairment/Severe impairment|Renal function categories Normal function – Mild impairment defined as: eGFR >50 mL/min; Moderate impairment defined as: eGFR 30 to 50 mL/min; Severe impairment defined as: eGFR eGFR <30 mL/min.|Participants|Number|6930|6930.0||||||
4047065|NCT01107886|3869212|B1|Normal or Mild impairment||Renal Functione Categor: Normal or Mild impairment/Moderate impairment/Severe impairment|Renal function categories Normal function – Mild impairment defined as: eGFR >50 mL/min; Moderate impairment defined as: eGFR 30 to 50 mL/min; Severe impairment defined as: eGFR eGFR <30 mL/min.|Participants|Number|6986|6986.0||||||
4047066|NCT01107886|3869210|B3|MRF||Cardiovascular Risk Category: Cardiovascular disease/Multiple risk factors (CVD/MRF)|CVD subjects were defined as subjects with history of established CV disease. MRF subjects were defined as subjects with MRF for vascular disease without established CV disease.|Participants|Number|3533|3533.0||||||
4047067|NCT01107886|3869211|B2|MRF||Cardiovascular Risk Category: Cardiovascular disease/Multiple risk factors (CVD/MRF)|CVD subjects were defined as subjects with history of established CV disease. MRF subjects were defined as subjects with MRF for vascular disease without established CV disease.|Participants|Number|1747|1747.0||||||
4047068|NCT01107886|3869212|B1|MRF||Cardiovascular Risk Category: Cardiovascular disease/Multiple risk factors (CVD/MRF)|CVD subjects were defined as subjects with history of established CV disease. MRF subjects were defined as subjects with MRF for vascular disease without established CV disease.|Participants|Number|1786|1786.0||||||
4047069|NCT01107886|3869210|B3|CVD||Cardiovascular Risk Category: Cardiovascular disease/Multiple risk factors (CVD/MRF)|CVD subjects were defined as subjects with history of established CV disease. MRF subjects were defined as subjects with MRF for vascular disease without established CV disease.|Participants|Number|12959|12959.0||||||
4047070|NCT01107886|3869211|B2|CVD||Cardiovascular Risk Category: Cardiovascular disease/Multiple risk factors (CVD/MRF)|CVD subjects were defined as subjects with history of established CV disease. MRF subjects were defined as subjects with MRF for vascular disease without established CV disease.|Participants|Number|6465|6465.0||||||
4047071|NCT01107886|3869212|B1|CVD||Cardiovascular Risk Category: Cardiovascular disease/Multiple risk factors (CVD/MRF)|CVD subjects were defined as subjects with history of established CV disease. MRF subjects were defined as subjects with MRF for vascular disease without established CV disease.|Participants|Number|6494|6494.0||||||
4047072|NCT01107886|3869210|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
4047073|NCT01107886|3869211|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4047074|NCT01107886|3869212|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4047075|NCT01107886|3869210|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1526|1526.0||||||
4047192|NCT01107730|3869328|B4|||Age||years|Median|66|66.0|Full Range|||41.0|87.0|
4047076|NCT01107886|3869211|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|758|758.0||||||
4047077|NCT01107886|3869212|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|768|768.0||||||
4047078|NCT01107886|3869210|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12407|12407.0||||||
4047079|NCT01107886|3869211|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6166|6166.0||||||
4047080|NCT01107886|3869212|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6241|6241.0||||||
4047081|NCT01107886|3869210|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|568|568.0||||||
4047082|NCT01107886|3869211|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|290|290.0||||||
4047083|NCT01107886|3869212|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|278|278.0||||||
4047084|NCT01107886|3869210|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4047085|NCT01107886|3869211|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4047086|NCT01107886|3869212|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4047087|NCT01107886|3869210|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1780|1780.0||||||
4047088|NCT01107886|3869211|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|884|884.0||||||
4047089|NCT01107886|3869212|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|896|896.0||||||
4047090|NCT01107886|3869210|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4047091|NCT01107886|3869211|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4047092|NCT01107886|3869212|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4047093|NCT01107886|3869210|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047094|NCT01107886|3869211|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047095|NCT01107886|3869212|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047096|NCT01107886|3869210|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12951|12951.0||||||
4047097|NCT01107886|3869211|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6449|6449.0||||||
4047098|NCT01107886|3869212|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6502|6502.0||||||
4047099|NCT01107886|3869210|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3541|3541.0||||||
4047100|NCT01107886|3869211|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1763|1763.0||||||
4047101|NCT01107886|3869212|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1778|1778.0||||||
4047102|NCT01107886|3869210|B3||Male|Sex: Female, Male||Participants|Count of Participants|11037|11037.0||||||
4047103|NCT01107886|3869211|B2||Male|Sex: Female, Male||Participants|Count of Participants|5525|5525.0||||||
4047104|NCT01107886|3869212|B1||Male|Sex: Female, Male||Participants|Count of Participants|5512|5512.0||||||
4047105|NCT01107886|3869210|B3||Female|Sex: Female, Male||Participants|Count of Participants|5455|5455.0||||||
4047106|NCT01107886|3869211|B2||Female|Sex: Female, Male||Participants|Count of Participants|2687|2687.0||||||
4047107|NCT01107886|3869212|B1||Female|Sex: Female, Male||Participants|Count of Participants|2768|2768.0||||||
4047108|NCT01107886|3869210|B3|||Age||Years|Mean|65.0|65.0|Standard Deviation|8.55|8.55|||
4047109|NCT01107886|3869211|B2|||Age||Years|Mean|65.0|65.0|Standard Deviation|8.58|8.58|||
4047110|NCT01107886|3869212|B1|||Age||Years|Mean|65.1|65.1|Standard Deviation|8.52|8.52|||
4047111|NCT01107834|3869223|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4047112|NCT01107834|3869224|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4047113|NCT01107834|3869225|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4047114|NCT01107834|3869223|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047115|NCT01107834|3869224|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047116|NCT01107834|3869225|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047117|NCT01107834|3869223|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4047118|NCT01107834|3869224|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4047119|NCT01107834|3869225|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4047120|NCT01107834|3869223|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4047121|NCT01107834|3869224|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4047122|NCT01107834|3869225|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4047123|NCT01107834|3869223|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4047124|NCT01107834|3869224|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4047125|NCT01107834|3869225|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4047126|NCT01107834|3869223|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047127|NCT01107834|3869224|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047128|NCT01107834|3869225|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047129|NCT01107834|3869223|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047130|NCT01107834|3869224|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047131|NCT01107834|3869225|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047132|NCT01107834|3869223|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047133|NCT01107834|3869224|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047134|NCT01107834|3869225|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047135|NCT01107834|3869223|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4047136|NCT01107834|3869224|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4047137|NCT01107834|3869225|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4047138|NCT01107834|3869223|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4047139|NCT01107834|3869224|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4047140|NCT01107834|3869225|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4047141|NCT01107834|3869223|B3|||Age||years|Mean|8|8.0|Standard Deviation|2|2.0|||
4047142|NCT01107834|3869224|B2|||Age||years|Mean|8|8.0|Standard Deviation|3|3.0|||
4047143|NCT01107834|3869225|B1|||Age||years|Mean|8|8.0|Standard Deviation|2|2.0|||
4047144|NCT01107743|3869242|B1|Familial hypercholesterolemia||Type of Disease||participants|Number|14|14.0||||||
4047145|NCT01107743|3869242|B1|Hypercholesterolemia||Type of Disease||participants|Number|1227|1227.0||||||
4047146|NCT01107743|3869242|B1|Angina pectoris||Type of Disease||participants|Number|183|183.0||||||
4047147|NCT01107743|3869242|B1|Hypertension||Type of Disease||participants|Number|1237|1237.0||||||
4047148|NCT01107743|3869242|B1||Male|Sex: Female, Male||Participants|Count of Participants|458|458.0||||||
4047149|NCT01107743|3869242|B1||Female|Sex: Female, Male||Participants|Count of Participants|787|787.0||||||
4047150|NCT01107743|3869242|B1|＞=65 years||Age, Customized||participants|Number|868|868.0||||||
4047151|NCT01107743|3869242|B1|＜65 years||Age, Customized||participants|Number|377|377.0||||||
4047152|NCT01107730|3869328|B4|Greece||Region of Enrollment||participants|Number|33|33.0||||||
4047153|NCT01107730|3869329|B3|Greece||Region of Enrollment||participants|Number|11|11.0||||||
4047154|NCT01107730|3869330|B2|Greece||Region of Enrollment||participants|Number|11|11.0||||||
4047155|NCT01107730|3869331|B1|Greece||Region of Enrollment||participants|Number|11|11.0||||||
4047156|NCT01107730|3869328|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047157|NCT01107730|3869329|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047158|NCT01107730|3869330|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047159|NCT01107730|3869331|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047160|NCT01107730|3869328|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047161|NCT01107730|3869329|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047162|NCT01107730|3869330|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047163|NCT01107730|3869331|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047164|NCT01107730|3869328|B4||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4047165|NCT01107730|3869329|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4047166|NCT01107730|3869330|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4047167|NCT01107730|3869331|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4047168|NCT01107730|3869328|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047169|NCT01107730|3869329|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047170|NCT01107730|3869330|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047171|NCT01107730|3869331|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047172|NCT01107730|3869328|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047173|NCT01107730|3869329|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047174|NCT01107730|3869330|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047175|NCT01107730|3869331|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047176|NCT01107730|3869328|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047177|NCT01107730|3869329|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047178|NCT01107730|3869330|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047179|NCT01107730|3869331|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047180|NCT01107730|3869328|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047181|NCT01107730|3869329|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047182|NCT01107730|3869330|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047183|NCT01107730|3869331|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047184|NCT01107730|3869328|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4047185|NCT01107730|3869329|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4047186|NCT01107730|3869330|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4047187|NCT01107730|3869331|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4047188|NCT01107730|3869328|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4047189|NCT01107730|3869329|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4047190|NCT01107730|3869330|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4047191|NCT01107730|3869331|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4047193|NCT01107730|3869329|B3|||Age||years|Median|65|65.0|Full Range|||44.0|87.0|
4047194|NCT01107730|3869330|B2|||Age||years|Median|64|64.0|Full Range|||41.0|79.0|
4047195|NCT01107730|3869331|B1|||Age||years|Median|75|75.0|Full Range|||42.0|85.0|
4047196|NCT01107730|3869328|B4||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4047197|NCT01107730|3869329|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4047198|NCT01107730|3869330|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4047199|NCT01107730|3869331|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4047200|NCT01107730|3869328|B4||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4047201|NCT01107730|3869329|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4047202|NCT01107730|3869330|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4047203|NCT01107730|3869331|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4047204|NCT01107730|3869328|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4047205|NCT01107730|3869329|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4047206|NCT01107730|3869330|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4047207|NCT01107730|3869331|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4047208|NCT01107535|3869341|B1|Gestational age >28 weeks and <32 weeks||Gestational age|Gestational age of participants.|participants|Number|60|60.0||||||
4047209|NCT01107535|3869341|B1|Gestational age less than 28 weeks||Gestational age|Gestational age of participants.|participants|Number|22|22.0||||||
4047210|NCT01107535|3869341|B1|Peru||Region of Enrollment||participants|Number|82|82.0||||||
4047211|NCT01107535|3869341|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4047212|NCT01107535|3869341|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4047213|NCT01107535|3869341|B1|||Age|The mean age of participants at the first injection of study drug.|days|Mean|68|68.0|Standard Deviation|63|63.0|||
4047214|NCT01107457|3869349|B6|||Baseline in Psoriasis Area and Severity Index (PASI)|PASI combines the extent of body surface involvement in 4 anatomical regions (head, trunk, arms, and legs). For each region the percent area of skin involved was estimated from 0 (0%) to 6 (90%-100%) and severity was estimated by clinical signs of erythema, induration and scaling with a scores range from 0 (none) to 4 (very severe). Final PASI calculated as: sum of severity parameters for each region * area score * weighing factor (head [0.1], upper limbs [0.2], trunk [0.3], lower limbs [0.4]).Overall scores range from 0 (no psoriasis) to 72(the most severe disease).|units on a scale|Mean|17.83|17.83|Standard Deviation|5.85|5.85|||
4047215|NCT01107457|3869350|B5|||Baseline in Psoriasis Area and Severity Index (PASI)|PASI combines the extent of body surface involvement in 4 anatomical regions (head, trunk, arms, and legs). For each region the percent area of skin involved was estimated from 0 (0%) to 6 (90%-100%) and severity was estimated by clinical signs of erythema, induration and scaling with a scores range from 0 (none) to 4 (very severe). Final PASI calculated as: sum of severity parameters for each region * area score * weighing factor (head [0.1], upper limbs [0.2], trunk [0.3], lower limbs [0.4]).Overall scores range from 0 (no psoriasis) to 72(the most severe disease).|units on a scale|Mean|17.70|17.7|Standard Deviation|6.21|6.21|||
4047216|NCT01107457|3869351|B4|||Baseline in Psoriasis Area and Severity Index (PASI)|PASI combines the extent of body surface involvement in 4 anatomical regions (head, trunk, arms, and legs). For each region the percent area of skin involved was estimated from 0 (0%) to 6 (90%-100%) and severity was estimated by clinical signs of erythema, induration and scaling with a scores range from 0 (none) to 4 (very severe). Final PASI calculated as: sum of severity parameters for each region * area score * weighing factor (head [0.1], upper limbs [0.2], trunk [0.3], lower limbs [0.4]).Overall scores range from 0 (no psoriasis) to 72(the most severe disease).|units on a scale|Mean|17.20|17.2|Standard Deviation|4.26|4.26|||
4047217|NCT01107457|3869352|B3|||Baseline in Psoriasis Area and Severity Index (PASI)|PASI combines the extent of body surface involvement in 4 anatomical regions (head, trunk, arms, and legs). For each region the percent area of skin involved was estimated from 0 (0%) to 6 (90%-100%) and severity was estimated by clinical signs of erythema, induration and scaling with a scores range from 0 (none) to 4 (very severe). Final PASI calculated as: sum of severity parameters for each region * area score * weighing factor (head [0.1], upper limbs [0.2], trunk [0.3], lower limbs [0.4]).Overall scores range from 0 (no psoriasis) to 72(the most severe disease).|units on a scale|Mean|18.55|18.55|Standard Deviation|4.94|4.94|||
4047218|NCT01107457|3869353|B2|||Baseline in Psoriasis Area and Severity Index (PASI)|PASI combines the extent of body surface involvement in 4 anatomical regions (head, trunk, arms, and legs). For each region the percent area of skin involved was estimated from 0 (0%) to 6 (90%-100%) and severity was estimated by clinical signs of erythema, induration and scaling with a scores range from 0 (none) to 4 (very severe). Final PASI calculated as: sum of severity parameters for each region * area score * weighing factor (head [0.1], upper limbs [0.2], trunk [0.3], lower limbs [0.4]).Overall scores range from 0 (no psoriasis) to 72(the most severe disease).|units on a scale|Mean|19.18|19.18|Standard Deviation|7.96|7.96|||
4047219|NCT01107457|3869354|B1|||Baseline in Psoriasis Area and Severity Index (PASI)|PASI combines the extent of body surface involvement in 4 anatomical regions (head, trunk, arms, and legs). For each region the percent area of skin involved was estimated from 0 (0%) to 6 (90%-100%) and severity was estimated by clinical signs of erythema, induration and scaling with a scores range from 0 (none) to 4 (very severe). Final PASI calculated as: sum of severity parameters for each region * area score * weighing factor (head [0.1], upper limbs [0.2], trunk [0.3], lower limbs [0.4]).Overall scores range from 0 (no psoriasis) to 72(the most severe disease).|units on a scale|Mean|16.45|16.45|Standard Deviation|5.26|5.26|||
4047220|NCT01107457|3869349|B6|Denmark||Region of Enrollment||participants|Number|3|3.0||||||
4047221|NCT01107457|3869350|B5|Denmark||Region of Enrollment||participants|Number|0|0.0||||||
4047222|NCT01107457|3869351|B4|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
4047223|NCT01107457|3869352|B3|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
4047224|NCT01107457|3869353|B2|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
4047225|NCT01107457|3869354|B1|Denmark||Region of Enrollment||participants|Number|0|0.0||||||
4047226|NCT01107457|3869349|B6|United States||Region of Enrollment||participants|Number|139|139.0||||||
4047227|NCT01107457|3869350|B5|United States||Region of Enrollment||participants|Number|28|28.0||||||
4047228|NCT01107457|3869351|B4|United States||Region of Enrollment||participants|Number|28|28.0||||||
4047229|NCT01107457|3869352|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
4047230|NCT01107457|3869353|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4047231|NCT01107457|3869354|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4047232|NCT01107457|3869349|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047233|NCT01107457|3869350|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047234|NCT01107457|3869351|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047235|NCT01107457|3869352|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047236|NCT01107457|3869353|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047237|NCT01107457|3869354|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047238|NCT01107457|3869349|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047239|NCT01107457|3869350|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047240|NCT01107457|3869351|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047241|NCT01107457|3869352|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047242|NCT01107457|3869353|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047243|NCT01107457|3869354|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047244|NCT01107457|3869349|B6||White|Race (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
4047245|NCT01107457|3869350|B5||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4047246|NCT01107457|3869351|B4||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4047247|NCT01107457|3869352|B3||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4047248|NCT01107457|3869353|B2||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4047249|NCT01107457|3869354|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4047250|NCT01107457|3869349|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4047251|NCT01107457|3869350|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4047252|NCT01107457|3869351|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4047253|NCT01107457|3869352|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4047254|NCT01107457|3869353|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047255|NCT01107457|3869354|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4047256|NCT01107457|3869349|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047257|NCT01107457|3869350|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047258|NCT01107457|3869351|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047259|NCT01107457|3869352|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047260|NCT01107457|3869353|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047261|NCT01107457|3869354|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047262|NCT01107457|3869349|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4047263|NCT01107457|3869350|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4047264|NCT01107457|3869351|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4047265|NCT01107457|3869352|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047266|NCT01107457|3869353|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4047267|NCT01107457|3869354|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047268|NCT01107457|3869349|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4047269|NCT01107457|3869350|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047270|NCT01107457|3869351|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4047271|NCT01107457|3869352|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4047272|NCT01107457|3869353|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047273|NCT01107457|3869354|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047274|NCT01107457|3869349|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047275|NCT01107457|3869350|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047276|NCT01107457|3869351|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047277|NCT01107457|3869352|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047278|NCT01107457|3869353|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047279|NCT01107457|3869354|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047280|NCT01107457|3869349|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|117|117.0||||||
4047281|NCT01107457|3869350|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4047282|NCT01107457|3869351|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4047283|NCT01107457|3869352|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4047284|NCT01107457|3869353|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4047285|NCT01107457|3869354|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4047286|NCT01107457|3869349|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4047287|NCT01107457|3869350|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4047288|NCT01107457|3869351|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4047289|NCT01107457|3869352|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4047290|NCT01107457|3869353|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4047291|NCT01107457|3869354|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4047292|NCT01107457|3869349|B6||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4047293|NCT01107457|3869350|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4047294|NCT01107457|3869351|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4047295|NCT01107457|3869352|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4047296|NCT01107457|3869353|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4047297|NCT01107457|3869354|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4047298|NCT01107457|3869349|B6||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4047299|NCT01107457|3869350|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4047300|NCT01107457|3869351|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4047301|NCT01107457|3869352|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4047302|NCT01107457|3869353|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4047303|NCT01107457|3869354|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4047304|NCT01107457|3869349|B6|||Age||years|Mean|46.19|46.19|Standard Deviation|12.71|12.71|||
4047305|NCT01107457|3869350|B5|||Age||years|Mean|45.97|45.97|Standard Deviation|13.00|13.0|||
4047306|NCT01107457|3869351|B4|||Age||years|Mean|46.37|46.37|Standard Deviation|12.50|12.5|||
4047307|NCT01107457|3869352|B3|||Age||years|Mean|45.93|45.93|Standard Deviation|14.53|14.53|||
4047308|NCT01107457|3869353|B2|||Age||years|Mean|47.65|47.65|Standard Deviation|11.20|11.2|||
4047309|NCT01107457|3869354|B1|||Age||years|Mean|45|45.0|Standard Deviation|12.76|12.76|||
4047310|NCT01107418|3869485|B5||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4047311|NCT01107418|3869486|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4047312|NCT01107418|3869487|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4047313|NCT01107418|3869488|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4047314|NCT01107418|3869489|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4047315|NCT01107418|3869485|B5||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4047316|NCT01107418|3869486|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4047317|NCT01107418|3869487|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4047318|NCT01107418|3869488|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4047319|NCT01107418|3869489|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4047320|NCT01107418|3869485|B5|||Age||years|Mean|50.8|50.8|Standard Deviation|12.14|12.14|||
4047321|NCT01107418|3869486|B4|||Age||years|Mean|50.5|50.5|Standard Deviation|11.91|11.91|||
4047322|NCT01107418|3869487|B3|||Age||years|Mean|54.3|54.3|Standard Deviation|10.70|10.7|||
4047323|NCT01107418|3869488|B2|||Age||years|Mean|46.3|46.3|Standard Deviation|10.58|10.58|||
4047324|NCT01107418|3869489|B1|||Age||years|Mean|52.0|52.0|Standard Deviation|15.06|15.06|||
4047325|NCT01107405|3869557|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047326|NCT01107405|3869558|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047327|NCT01107405|3869559|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047328|NCT01107405|3869560|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047329|NCT01107405|3869561|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047330|NCT01107405|3869562|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047331|NCT01107405|3869557|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
4047332|NCT01107405|3869558|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4047333|NCT01107405|3869559|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4047334|NCT01107405|3869560|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4047335|NCT01107405|3869561|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4047336|NCT01107405|3869562|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4047337|NCT01107405|3869557|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4047338|NCT01107405|3869558|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047339|NCT01107405|3869559|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4047340|NCT01107405|3869560|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047341|NCT01107405|3869561|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047342|NCT01107405|3869562|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4047343|NCT01107405|3869557|B6||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4047344|NCT01107405|3869558|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4047345|NCT01107405|3869559|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4047346|NCT01107405|3869560|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4047347|NCT01107405|3869561|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4047348|NCT01107405|3869562|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4047349|NCT01107405|3869557|B6||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4047350|NCT01107405|3869558|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4047351|NCT01107405|3869559|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4047352|NCT01107405|3869560|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4047353|NCT01107405|3869561|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4047354|NCT01107405|3869562|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4047355|NCT01107405|3869557|B6|>=65 years||Age, Customized||participants|Number|2|2.0||||||
4047356|NCT01107405|3869558|B5|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4047357|NCT01107405|3869559|B4|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4047358|NCT01107405|3869560|B3|>=65 years||Age, Customized||participants|Number|1|1.0||||||
4047359|NCT01107405|3869561|B2|>=65 years||Age, Customized||participants|Number|1|1.0||||||
4047360|NCT01107405|3869562|B1|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4047361|NCT01107405|3869557|B6|20 - 64 years||Age, Customized||participants|Number|91|91.0||||||
4047362|NCT01107405|3869558|B5|20 - 64 years||Age, Customized||participants|Number|18|18.0||||||
4047363|NCT01107405|3869559|B4|20 - 64 years||Age, Customized||participants|Number|19|19.0||||||
4047364|NCT01107405|3869560|B3|20 - 64 years||Age, Customized||participants|Number|18|18.0||||||
4047365|NCT01107405|3869561|B2|20 - 64 years||Age, Customized||participants|Number|18|18.0||||||
4047366|NCT01107405|3869562|B1|20 - 64 years||Age, Customized||participants|Number|18|18.0||||||
4047367|NCT01107405|3869557|B6|<=19 years||Age, Customized||participants|Number|8|8.0||||||
4047368|NCT01107405|3869558|B5|<=19 years||Age, Customized||participants|Number|2|2.0||||||
4047369|NCT01107405|3869559|B4|<=19 years||Age, Customized||participants|Number|1|1.0||||||
4047370|NCT01107405|3869560|B3|<=19 years||Age, Customized||participants|Number|1|1.0||||||
4047371|NCT01107405|3869561|B2|<=19 years||Age, Customized||participants|Number|1|1.0||||||
4047372|NCT01107405|3869562|B1|<=19 years||Age, Customized||participants|Number|3|3.0||||||
4047373|NCT01107392|3869603|B3||Male|Sex: Female, Male||Participants|Count of Participants|315|315.0||||||
4047374|NCT01107392|3869604|B2||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4047375|NCT01107392|3869605|B1||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4047376|NCT01107392|3869603|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4047377|NCT01107392|3869604|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4047378|NCT01107392|3869605|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4047379|NCT01107392|3869603|B3|> 65 Years||Age, Customized||Participants|Number|147|147.0||||||
4047380|NCT01107392|3869604|B2|> 65 Years||Age, Customized||Participants|Number|78|78.0||||||
4047381|NCT01107392|3869605|B1|> 65 Years||Age, Customized||Participants|Number|69|69.0||||||
4047382|NCT01107392|3869603|B3|≤ 65 Years||Age, Customized||Participants|Number|168|168.0||||||
4047383|NCT01107392|3869604|B2|≤ 65 Years||Age, Customized||Participants|Number|79|79.0||8.12|8.12|||
4047384|NCT01107392|3869605|B1|≤ 65 Years||Age, Customized||Participants|Number|89|89.0||8.19|8.19|||
4047385|NCT01107379|3869618|B1|United States||Region of Enrollment||participants|Number|203|203.0||||||
4047386|NCT01107379|3869618|B1|Other (not specified)||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4047387|NCT01107379|3869618|B1|North American Indian or Inuit||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4047388|NCT01107379|3869618|B1|Native Hawaiian / Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4047389|NCT01107379|3869618|B1|Black or African||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4047390|NCT01107379|3869618|B1|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4047391|NCT01107379|3869618|B1|White/Caucasian||Race/Ethnicity, Customized||participants|Number|145|145.0||||||
4047392|NCT01107379|3869618|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4047393|NCT01107379|3869618|B1||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4047394|NCT01107379|3869618|B1||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4047395|NCT01107379|3869618|B1|||Age||years|Mean|48.6|48.6|Standard Deviation|15.4|15.4|||
4047396|NCT01107353|3869627|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4047397|NCT01107353|3869628|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4047398|NCT01107353|3869629|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4047399|NCT01107353|3869627|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4047400|NCT01107353|3869628|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047401|NCT01107353|3869629|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4047402|NCT01107353|3869627|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047403|NCT01107353|3869628|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047404|NCT01107353|3869629|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047405|NCT01107353|3869627|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4047406|NCT01107353|3869628|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4047407|NCT01107353|3869629|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047408|NCT01107353|3869627|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4047409|NCT01107353|3869628|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4047410|NCT01107353|3869629|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4047411|NCT01107353|3869627|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047412|NCT01107353|3869628|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047413|NCT01107353|3869629|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047414|NCT01107353|3869627|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047415|NCT01107353|3869628|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047416|NCT01107353|3869629|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047417|NCT01107353|3869627|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047418|NCT01107353|3869628|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047419|NCT01107353|3869629|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047420|NCT01107353|3869627|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4047421|NCT01107353|3869628|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4047422|NCT01107353|3869629|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4047423|NCT01107353|3869627|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4047424|NCT01107353|3869628|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4047425|NCT01107353|3869629|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4047426|NCT01107353|3869627|B3|||Age||years|Mean|28.41|28.41|Standard Deviation|7.65|7.65|||
4047427|NCT01107353|3869628|B2|||Age||years|Mean|28.41|28.41|Standard Deviation|7.65|7.65|||
4047428|NCT01107353|3869629|B1|||Age||years|Mean|28.41|28.41|Standard Deviation|7.65|7.65|||
4047429|NCT01107197|3869636|B3|Italy||Region of Enrollment||participants|Number|157|157.0||||||
4047430|NCT01107197|3869637|B2|Italy||Region of Enrollment||participants|Number|79|79.0||||||
4047431|NCT01107197|3869638|B1|Italy||Region of Enrollment||participants|Number|78|78.0||||||
4047432|NCT01107197|3869636|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4047433|NCT01107197|3869637|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4047434|NCT01107197|3869638|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4047435|NCT01107197|3869636|B3||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4047436|NCT01107197|3869637|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4047437|NCT01107197|3869638|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4047438|NCT01107197|3869636|B3|||Age||years|Mean|80.9|80.9|Standard Deviation|11.3|11.3|||
4047439|NCT01107197|3869637|B2|||Age||years|Mean|81.2|81.2|Standard Deviation|11.3|11.3|||
4047440|NCT01107197|3869638|B1|||Age||years|Mean|80.6|80.6|Standard Deviation|11.4|11.4|||
4047441|NCT01107197|3869636|B3||>=65 years|Age||Participants|Count of Participants|148|148.0||||||
4047442|NCT01107197|3869637|B2||>=65 years|Age||Participants|Count of Participants|75|75.0||||||
4047443|NCT01107197|3869638|B1||>=65 years|Age||Participants|Count of Participants|73|73.0||||||
4047444|NCT01107197|3869636|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4047445|NCT01107197|3869637|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4047446|NCT01107197|3869638|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4047447|NCT01107197|3869636|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4047448|NCT01107197|3869637|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4047449|NCT01107197|3869638|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4047450|NCT01107015|3869657|B5|||HbA1c||percentage of HbA1c|Mean|9.4|9.4|Standard Deviation|2.0|2.0|||
4047451|NCT01107015|3869658|B4|||HbA1c||percentage of HbA1c|Mean|9.9|9.9|Standard Deviation|2.1|2.1|||
4047452|NCT01107015|3869659|B3|||HbA1c||percentage of HbA1c|Mean|9.0|9.0|Standard Deviation|1.8|1.8|||
4047453|NCT01107015|3869660|B2|||HbA1c||percentage of HbA1c|Mean|9.3|9.3|Standard Deviation|1.8|1.8|||
4047454|NCT01107015|3869661|B1|||HbA1c||percentage of HbA1c|Mean|9.2|9.2|Standard Deviation|1.7|1.7|||
4047455|NCT01107015|3869657|B5|United States||Region of Enrollment||Participants|Count of Participants|163|163.0||||||
4047456|NCT01107015|3869658|B4|United States||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
4047457|NCT01107015|3869659|B3|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4047458|NCT01107015|3869660|B2|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4047459|NCT01107015|3869661|B1|United States||Region of Enrollment||Participants|Count of Participants|56|56.0||||||
4047460|NCT01107015|3869657|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047520|NCT01107015|3869657|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4047461|NCT01107015|3869658|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047462|NCT01107015|3869659|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047463|NCT01107015|3869660|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047464|NCT01107015|3869661|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047465|NCT01107015|3869657|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4047466|NCT01107015|3869658|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4047467|NCT01107015|3869659|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4047468|NCT01107015|3869660|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4047469|NCT01107015|3869661|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4047470|NCT01107015|3869657|B5||White|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4047471|NCT01107015|3869658|B4||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4047472|NCT01107015|3869659|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4047473|NCT01107015|3869660|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4047474|NCT01107015|3869661|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4047475|NCT01107015|3869657|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4047476|NCT01107015|3869658|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4047477|NCT01107015|3869659|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4047478|NCT01107015|3869660|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4047479|NCT01107015|3869661|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4047480|NCT01107015|3869657|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047481|NCT01107015|3869658|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047482|NCT01107015|3869659|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047483|NCT01107015|3869660|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047484|NCT01107015|3869661|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047485|NCT01107015|3869657|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047486|NCT01107015|3869658|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047487|NCT01107015|3869659|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047488|NCT01107015|3869660|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047489|NCT01107015|3869661|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047490|NCT01107015|3869657|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047491|NCT01107015|3869658|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047492|NCT01107015|3869659|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047493|NCT01107015|3869660|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047494|NCT01107015|3869661|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047495|NCT01107015|3869657|B5||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4047496|NCT01107015|3869658|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4047497|NCT01107015|3869659|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4047498|NCT01107015|3869660|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4047499|NCT01107015|3869661|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4047500|NCT01107015|3869657|B5||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4047501|NCT01107015|3869658|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4047502|NCT01107015|3869659|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4047503|NCT01107015|3869660|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4047504|NCT01107015|3869661|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4047505|NCT01107015|3869657|B5|||Age||years|Mean|52.8|52.8|Standard Deviation|8.2|8.2|||
4047506|NCT01107015|3869658|B4|||Age||years|Mean|52.0|52.0|Standard Deviation|8.0|8.0|||
4047507|NCT01107015|3869659|B3|||Age||years|Mean|53.7|53.7|Standard Deviation|8.2|8.2|||
4047508|NCT01107015|3869660|B2|||Age||years|Mean|52.8|52.8|Standard Deviation|8.0|8.0|||
4047509|NCT01107015|3869661|B1|||Age||years|Mean|53.2|53.2|Standard Deviation|8.4|8.4|||
4047510|NCT01107015|3869657|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4047511|NCT01107015|3869658|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4047512|NCT01107015|3869659|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4047513|NCT01107015|3869660|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4047514|NCT01107015|3869661|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4047515|NCT01107015|3869657|B5||Between 18 and 65 years|Age||Participants|Count of Participants|163|163.0||||||
4047516|NCT01107015|3869658|B4||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4047517|NCT01107015|3869659|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4047518|NCT01107015|3869660|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4047519|NCT01107015|3869661|B1||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4047521|NCT01107015|3869658|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4047522|NCT01107015|3869659|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4047523|NCT01107015|3869660|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4047524|NCT01107015|3869661|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4047525|NCT01106976|3869674|B1|United States||Region of Enrollment||participants|Number|67|67.0||||||
4047526|NCT01106976|3869674|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4047527|NCT01106976|3869674|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4047528|NCT01106976|3869674|B1|||Age||years|Mean|66.7|66.7|Standard Deviation|7.3|7.3|||
4047529|NCT01106976|3869674|B1||>=65 years|Age||Participants|Count of Participants|53|53.0||||||
4047530|NCT01106976|3869674|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4047531|NCT01106976|3869674|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4047532|NCT01106950|3869678|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4047533|NCT01106950|3869678|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4047534|NCT01106950|3869678|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4047535|NCT01106950|3869678|B1|||Age||years|Mean|44|44.0|Standard Deviation|23.4|23.4|||
4047536|NCT01106950|3869678|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4047537|NCT01106950|3869678|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4047538|NCT01106950|3869678|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4047539|NCT01106911|3869688|B1|United States||Region of Enrollment||participants|Number|1080|1080.0||||||
4047540|NCT01106911|3869688|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4047541|NCT01106911|3869688|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047542|NCT01106911|3869688|B1||White|Race (NIH/OMB)||Participants|Count of Participants|751|751.0||||||
4047543|NCT01106911|3869688|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|278|278.0||||||
4047544|NCT01106911|3869688|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047545|NCT01106911|3869688|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4047546|NCT01106911|3869688|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047547|NCT01106911|3869688|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4047548|NCT01106911|3869688|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1054|1054.0||||||
4047549|NCT01106911|3869688|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4047550|NCT01106911|3869688|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4047551|NCT01106911|3869688|B1||Female|Sex: Female, Male||Participants|Count of Participants|1080|1080.0||||||
4047552|NCT01106911|3869688|B1|||Age||years|Mean|42.03|42.03|Standard Deviation|3.75|3.75|||
4047553|NCT01106898|3869692|B1|United States||Region of Enrollment||Participants|Count of Participants|112|112.0||||||
4047554|NCT01106898|3869692|B1||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4047555|NCT01106898|3869692|B1||Black, not of hispanic origin|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4047556|NCT01106898|3869692|B1||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|107|107.0||||||
4047557|NCT01106898|3869692|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4047558|NCT01106898|3869692|B1||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4047559|NCT01106898|3869692|B1|||Age||years|Mean|57|57.0|Full Range|||34.0|80.0|
4047560|NCT01106859|3869696|B1|||Body Mass Index (BMI)||kilograms/meter^2|Mean|23.2|23.2|Standard Deviation|2.4|2.4|||
4047561|NCT01106859|3869696|B1|Female||Weight||kilograms|Mean|65|65.0|Standard Deviation|8|8.0|||
4047562|NCT01106859|3869696|B1|Male||Weight||kilograms|Mean|79|79.0|Standard Deviation|8|8.0|||
4047563|NCT01106859|3869696|B1|||Height||centimeters|Mean|176|176.0|Standard Deviation|9|9.0|||
4047564|NCT01106859|3869696|B1|Netherlands||Region of Enrollment||participants|Number|40|40.0||||||
4047565|NCT01106859|3869696|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4047566|NCT01106859|3869696|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4047567|NCT01106859|3869696|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4047568|NCT01106859|3869696|B1|White||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4047569|NCT01106859|3869696|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047570|NCT01106859|3869696|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4047571|NCT01106859|3869696|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047572|NCT01106859|3869696|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4047573|NCT01106859|3869696|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4047574|NCT01106859|3869696|B1|||Age||years|Mean|37|37.0|Standard Deviation|15|15.0|||
4047575|NCT01106846|3869735|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4047576|NCT01106846|3869736|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4047577|NCT01106846|3869737|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4047578|NCT01106846|3869735|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4047579|NCT01106846|3869736|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4047580|NCT01106846|3869737|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4047581|NCT01106846|3869735|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4047582|NCT01106846|3869736|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4047583|NCT01106846|3869737|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4047584|NCT01106846|3869735|B3|||Age||years|Mean|44.28|44.28|Standard Deviation|4.43|4.43|||
4047585|NCT01106846|3869736|B2|||Age||years|Mean|43.12|43.12|Standard Deviation|6.19|6.19|||
4047586|NCT01106846|3869737|B1|||Age||years|Mean|45.08|45.08|Standard Deviation|3.88|3.88|||
4047587|NCT01106846|3869735|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4047588|NCT01106846|3869736|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4047589|NCT01106846|3869737|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4047590|NCT01106846|3869735|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4047591|NCT01106846|3869736|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4047592|NCT01106846|3869737|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4047593|NCT01106846|3869735|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4047594|NCT01106846|3869736|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4047595|NCT01106846|3869737|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4047596|NCT01106833|3869744|B3||Unknown Donor Gender|Donor/Recipient Gender Matching||Participants|Count of Participants|2|2.0||||||
4047597|NCT01106833|3869745|B2||Unknown Donor Gender|Donor/Recipient Gender Matching||Participants|Count of Participants|0|0.0||||||
4047598|NCT01106833|3869746|B1||Unknown Donor Gender|Donor/Recipient Gender Matching||Participants|Count of Participants|2|2.0||||||
4047599|NCT01106833|3869744|B3||Male Donor, Male Recipient|Donor/Recipient Gender Matching||Participants|Count of Participants|44|44.0||||||
4047600|NCT01106833|3869745|B2||Male Donor, Male Recipient|Donor/Recipient Gender Matching||Participants|Count of Participants|27|27.0||||||
4047601|NCT01106833|3869746|B1||Male Donor, Male Recipient|Donor/Recipient Gender Matching||Participants|Count of Participants|17|17.0||||||
4047602|NCT01106833|3869744|B3||Male Donor, Female Recipient|Donor/Recipient Gender Matching||Participants|Count of Participants|31|31.0||||||
4047603|NCT01106833|3869745|B2||Male Donor, Female Recipient|Donor/Recipient Gender Matching||Participants|Count of Participants|10|10.0||||||
4047604|NCT01106833|3869746|B1||Male Donor, Female Recipient|Donor/Recipient Gender Matching||Participants|Count of Participants|21|21.0||||||
4047605|NCT01106833|3869744|B3||Female Donor, Male Recipient|Donor/Recipient Gender Matching||Participants|Count of Participants|37|37.0||||||
4047606|NCT01106833|3869745|B2||Female Donor, Male Recipient|Donor/Recipient Gender Matching||Participants|Count of Participants|21|21.0||||||
4047607|NCT01106833|3869746|B1||Female Donor, Male Recipient|Donor/Recipient Gender Matching||Participants|Count of Participants|16|16.0||||||
4047608|NCT01106833|3869744|B3||Female Donor, Female Recipient|Donor/Recipient Gender Matching||Participants|Count of Participants|24|24.0||||||
4047609|NCT01106833|3869745|B2||Female Donor, Female Recipient|Donor/Recipient Gender Matching||Participants|Count of Participants|14|14.0||||||
4047610|NCT01106833|3869746|B1||Female Donor, Female Recipient|Donor/Recipient Gender Matching||Participants|Count of Participants|10|10.0||||||
4047611|NCT01106833|3869744|B3||Unknown|Donor Gender||Participants|Count of Participants|2|2.0||||||
4047612|NCT01106833|3869745|B2||Unknown|Donor Gender||Participants|Count of Participants|0|0.0||||||
4047613|NCT01106833|3869746|B1||Unknown|Donor Gender||Participants|Count of Participants|2|2.0||||||
4047614|NCT01106833|3869744|B3||Male|Donor Gender||Participants|Count of Participants|75|75.0||||||
4047615|NCT01106833|3869745|B2||Male|Donor Gender||Participants|Count of Participants|37|37.0||||||
4047616|NCT01106833|3869746|B1||Male|Donor Gender||Participants|Count of Participants|38|38.0||||||
4047617|NCT01106833|3869744|B3||Female|Donor Gender||Participants|Count of Participants|61|61.0||||||
4047618|NCT01106833|3869745|B2||Female|Donor Gender||Participants|Count of Participants|35|35.0||||||
4047619|NCT01106833|3869746|B1||Female|Donor Gender||Participants|Count of Participants|26|26.0||||||
4047620|NCT01106833|3869744|B3|||Donor Age||years|Mean|41.3|41.3|Standard Deviation|14.0|14.0|||
4047621|NCT01106833|3869745|B2|||Donor Age||years|Mean|38.5|38.5|Standard Deviation|12.9|12.9|||
4047622|NCT01106833|3869746|B1|||Donor Age||years|Mean|44.4|44.4|Standard Deviation|15.2|15.2|||
4047623|NCT01106833|3869744|B3||Non-myeloablative or Reduced Intensity|Conditioning Regimen Intensity||Participants|Count of Participants|62|62.0||||||
4047624|NCT01106833|3869745|B2||Non-myeloablative or Reduced Intensity|Conditioning Regimen Intensity||Participants|Count of Participants|25|25.0||||||
4047625|NCT01106833|3869746|B1||Non-myeloablative or Reduced Intensity|Conditioning Regimen Intensity||Participants|Count of Participants|37|37.0||||||
4047626|NCT01106833|3869744|B3||Myeloablative|Conditioning Regimen Intensity||Participants|Count of Participants|76|76.0||||||
4047627|NCT01106833|3869745|B2||Myeloablative|Conditioning Regimen Intensity||Participants|Count of Participants|47|47.0||||||
4047628|NCT01106833|3869746|B1||Myeloablative|Conditioning Regimen Intensity||Participants|Count of Participants|29|29.0||||||
4047629|NCT01106833|3869744|B3||Unrelated|Donor Type||Participants|Count of Participants|67|67.0||||||
4047630|NCT01106833|3869745|B2||Unrelated|Donor Type||Participants|Count of Participants|40|40.0||||||
4047631|NCT01106833|3869746|B1||Unrelated|Donor Type||Participants|Count of Participants|27|27.0||||||
4047632|NCT01106833|3869744|B3||Related|Donor Type||Participants|Count of Participants|67|67.0||||||
4047633|NCT01106833|3869745|B2||Related|Donor Type||Participants|Count of Participants|29|29.0||||||
4047634|NCT01106833|3869746|B1||Related|Donor Type||Participants|Count of Participants|38|38.0||||||
4047635|NCT01106833|3869744|B3||Double Cord Blood|Graft Type||Participants|Count of Participants|3|3.0||||||
4047636|NCT01106833|3869745|B2||Double Cord Blood|Graft Type||Participants|Count of Participants|3|3.0||||||
4047637|NCT01106833|3869746|B1||Double Cord Blood|Graft Type||Participants|Count of Participants|0|0.0||||||
4047638|NCT01106833|3869744|B3||Single Cord Blood|Graft Type||Participants|Count of Participants|1|1.0||||||
4047639|NCT01106833|3869745|B2||Single Cord Blood|Graft Type||Participants|Count of Participants|0|0.0||||||
4047640|NCT01106833|3869746|B1||Single Cord Blood|Graft Type||Participants|Count of Participants|1|1.0||||||
4047641|NCT01106833|3869744|B3||Peripheral Blood Stem Cells|Graft Type||Participants|Count of Participants|124|124.0||||||
4047642|NCT01106833|3869745|B2||Peripheral Blood Stem Cells|Graft Type||Participants|Count of Participants|64|64.0||||||
4047643|NCT01106833|3869746|B1||Peripheral Blood Stem Cells|Graft Type||Participants|Count of Participants|60|60.0||||||
4047644|NCT01106833|3869744|B3||Bone Marrow|Graft Type||Participants|Count of Participants|10|10.0||||||
4047645|NCT01106833|3869745|B2||Bone Marrow|Graft Type||Participants|Count of Participants|5|5.0||||||
4047646|NCT01106833|3869746|B1||Bone Marrow|Graft Type||Participants|Count of Participants|5|5.0||||||
4047647|NCT01106833|3869744|B3||Other|Primary Disease||Participants|Count of Participants|8|8.0||||||
4047648|NCT01106833|3869745|B2||Other|Primary Disease||Participants|Count of Participants|1|1.0||||||
4047649|NCT01106833|3869746|B1||Other|Primary Disease||Participants|Count of Participants|7|7.0||||||
4047650|NCT01106833|3869744|B3||Lymphoma|Primary Disease||Participants|Count of Participants|22|22.0||||||
4047651|NCT01106833|3869745|B2||Lymphoma|Primary Disease||Participants|Count of Participants|5|5.0||||||
4047652|NCT01106833|3869746|B1||Lymphoma|Primary Disease||Participants|Count of Participants|17|17.0||||||
4047653|NCT01106833|3869744|B3||MDS / MPS|Primary Disease||Participants|Count of Participants|21|21.0||||||
4047654|NCT01106833|3869745|B2||MDS / MPS|Primary Disease||Participants|Count of Participants|12|12.0||||||
4047655|NCT01106833|3869746|B1||MDS / MPS|Primary Disease||Participants|Count of Participants|9|9.0||||||
4047656|NCT01106833|3869744|B3||Chronic Leukemia|Primary Disease||Participants|Count of Participants|15|15.0||||||
4047657|NCT01106833|3869745|B2||Chronic Leukemia|Primary Disease||Participants|Count of Participants|7|7.0||||||
4047658|NCT01106833|3869746|B1||Chronic Leukemia|Primary Disease||Participants|Count of Participants|8|8.0||||||
4047659|NCT01106833|3869744|B3||Acute Leukemia|Primary Disease||Participants|Count of Participants|72|72.0||||||
4047660|NCT01106833|3869745|B2||Acute Leukemia|Primary Disease||Participants|Count of Participants|47|47.0||||||
4047661|NCT01106833|3869746|B1||Acute Leukemia|Primary Disease||Participants|Count of Participants|25|25.0||||||
4047662|NCT01106833|3869744|B3||Unknown / Not Answered|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4047663|NCT01106833|3869745|B2||Unknown / Not Answered|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4047664|NCT01106833|3869746|B1||Unknown / Not Answered|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4047665|NCT01106833|3869744|B3||Non-white|Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
4047666|NCT01106833|3869745|B2||Non-white|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4047667|NCT01106833|3869746|B1||Non-white|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4047668|NCT01106833|3869744|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|111|111.0||||||
4047669|NCT01106833|3869745|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|54|54.0||||||
4047670|NCT01106833|3869746|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|57|57.0||||||
4047671|NCT01106833|3869744|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4047672|NCT01106833|3869745|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4047673|NCT01106833|3869746|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4047674|NCT01106833|3869744|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
4047675|NCT01106833|3869745|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4047676|NCT01106833|3869746|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4047677|NCT01106833|3869744|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4047678|NCT01106833|3869745|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4047679|NCT01106833|3869746|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4047680|NCT01106833|3869744|B3||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4047681|NCT01106833|3869745|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4047682|NCT01106833|3869746|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4047683|NCT01106833|3869744|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4047684|NCT01106833|3869745|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4047685|NCT01106833|3869746|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4047686|NCT01106833|3869744|B3||Over 60|Age, Customized|Age in years|Participants|Count of Participants|35|35.0||||||
4047687|NCT01106833|3869745|B2||Over 60|Age, Customized|Age in years|Participants|Count of Participants|19|19.0||||||
4047688|NCT01106833|3869746|B1||Over 60|Age, Customized|Age in years|Participants|Count of Participants|16|16.0||||||
4047689|NCT01106833|3869744|B3||41 - 60|Age, Customized|Age in years|Participants|Count of Participants|66|66.0||||||
4047690|NCT01106833|3869745|B2||41 - 60|Age, Customized|Age in years|Participants|Count of Participants|30|30.0||||||
4047691|NCT01106833|3869746|B1||41 - 60|Age, Customized|Age in years|Participants|Count of Participants|36|36.0||||||
4047692|NCT01106833|3869744|B3||20 - 40|Age, Customized|Age in years|Participants|Count of Participants|30|30.0||||||
4047693|NCT01106833|3869745|B2||20 - 40|Age, Customized|Age in years|Participants|Count of Participants|18|18.0||||||
4047694|NCT01106833|3869746|B1||20 - 40|Age, Customized|Age in years|Participants|Count of Participants|12|12.0||||||
4047695|NCT01106833|3869744|B3||Less Than 20|Age, Customized|Age in years|Participants|Count of Participants|7|7.0||||||
4047696|NCT01106833|3869745|B2||Less Than 20|Age, Customized|Age in years|Participants|Count of Participants|5|5.0||||||
4047697|NCT01106833|3869746|B1||Less Than 20|Age, Customized|Age in years|Participants|Count of Participants|2|2.0||||||
4047698|NCT01106833|3869744|B3|||Age||years|Mean|49.1|49.1|Standard Deviation|15.2|15.2|||
4047699|NCT01106833|3869745|B2|||Age||years|Mean|47.4|47.4|Standard Deviation|16.1|16.1|||
4047700|NCT01106833|3869746|B1|||Age||years|Mean|50.9|50.9|Standard Deviation|14.2|14.2|||
4047701|NCT01106690|3869785|B4|UNITED STATES||Region of Enrollment||participants|Number|154|154.0||||||
4047702|NCT01106690|3869786|B3|UNITED STATES||Region of Enrollment||participants|Number|56|56.0||||||
4047703|NCT01106690|3869787|B2|UNITED STATES||Region of Enrollment||participants|Number|55|55.0||||||
4047704|NCT01106690|3869788|B1|UNITED STATES||Region of Enrollment||participants|Number|43|43.0||||||
4047705|NCT01106690|3869785|B4|UNITED KINGDOM||Region of Enrollment||participants|Number|8|8.0||||||
4047706|NCT01106690|3869786|B3|UNITED KINGDOM||Region of Enrollment||participants|Number|3|3.0||||||
4047707|NCT01106690|3869787|B2|UNITED KINGDOM||Region of Enrollment||participants|Number|2|2.0||||||
4047708|NCT01106690|3869788|B1|UNITED KINGDOM||Region of Enrollment||participants|Number|3|3.0||||||
4047709|NCT01106690|3869785|B4|THAILAND||Region of Enrollment||participants|Number|17|17.0||||||
4047710|NCT01106690|3869786|B3|THAILAND||Region of Enrollment||participants|Number|4|4.0||||||
4047711|NCT01106690|3869787|B2|THAILAND||Region of Enrollment||participants|Number|8|8.0||||||
4047712|NCT01106690|3869788|B1|THAILAND||Region of Enrollment||participants|Number|5|5.0||||||
4047713|NCT01106690|3869785|B4|SPAIN||Region of Enrollment||participants|Number|15|15.0||||||
4047714|NCT01106690|3869786|B3|SPAIN||Region of Enrollment||participants|Number|2|2.0||||||
4047715|NCT01106690|3869787|B2|SPAIN||Region of Enrollment||participants|Number|5|5.0||||||
4047716|NCT01106690|3869788|B1|SPAIN||Region of Enrollment||participants|Number|8|8.0||||||
4047717|NCT01106690|3869785|B4|MEXICO||Region of Enrollment||participants|Number|21|21.0||||||
4047718|NCT01106690|3869786|B3|MEXICO||Region of Enrollment||participants|Number|11|11.0||||||
4047719|NCT01106690|3869787|B2|MEXICO||Region of Enrollment||participants|Number|3|3.0||||||
4047720|NCT01106690|3869788|B1|MEXICO||Region of Enrollment||participants|Number|7|7.0||||||
4047721|NCT01106690|3869785|B4|INDIA||Region of Enrollment||participants|Number|25|25.0||||||
4047722|NCT01106690|3869786|B3|INDIA||Region of Enrollment||participants|Number|5|5.0||||||
4047723|NCT01106690|3869787|B2|INDIA||Region of Enrollment||participants|Number|10|10.0||||||
4047724|NCT01106690|3869788|B1|INDIA||Region of Enrollment||participants|Number|10|10.0||||||
4047725|NCT01106690|3869785|B4|GREECE||Region of Enrollment||participants|Number|1|1.0||||||
4047726|NCT01106690|3869786|B3|GREECE||Region of Enrollment||participants|Number|1|1.0||||||
4047727|NCT01106690|3869787|B2|GREECE||Region of Enrollment||participants|Number|0|0.0||||||
4047728|NCT01106690|3869788|B1|GREECE||Region of Enrollment||participants|Number|0|0.0||||||
4047729|NCT01106690|3869785|B4|GERMANY||Region of Enrollment||participants|Number|19|19.0||||||
4047730|NCT01106690|3869786|B3|GERMANY||Region of Enrollment||participants|Number|7|7.0||||||
4047731|NCT01106690|3869787|B2|GERMANY||Region of Enrollment||participants|Number|5|5.0||||||
4047732|NCT01106690|3869788|B1|GERMANY||Region of Enrollment||participants|Number|7|7.0||||||
4047733|NCT01106690|3869785|B4|FRANCE||Region of Enrollment||participants|Number|2|2.0||||||
4047734|NCT01106690|3869786|B3|FRANCE||Region of Enrollment||participants|Number|1|1.0||||||
4047735|NCT01106690|3869787|B2|FRANCE||Region of Enrollment||participants|Number|0|0.0||||||
4047736|NCT01106690|3869788|B1|FRANCE||Region of Enrollment||participants|Number|1|1.0||||||
4047737|NCT01106690|3869785|B4|FINLAND||Region of Enrollment||participants|Number|13|13.0||||||
4047738|NCT01106690|3869786|B3|FINLAND||Region of Enrollment||participants|Number|3|3.0||||||
4047739|NCT01106690|3869787|B2|FINLAND||Region of Enrollment||participants|Number|3|3.0||||||
4047740|NCT01106690|3869788|B1|FINLAND||Region of Enrollment||participants|Number|7|7.0||||||
4047741|NCT01106690|3869785|B4|CANADA||Region of Enrollment||participants|Number|67|67.0||||||
4047742|NCT01106690|3869786|B3|CANADA||Region of Enrollment||participants|Number|21|21.0||||||
4047743|NCT01106690|3869787|B2|CANADA||Region of Enrollment||participants|Number|22|22.0||||||
4047744|NCT01106690|3869788|B1|CANADA||Region of Enrollment||participants|Number|24|24.0||||||
4047745|NCT01106690|3869785|B4||Male|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4047746|NCT01106690|3869786|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4047747|NCT01106690|3869787|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4047748|NCT01106690|3869788|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4047749|NCT01106690|3869785|B4||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4047750|NCT01106690|3869786|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4047751|NCT01106690|3869787|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4047752|NCT01106690|3869788|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4047753|NCT01106690|3869785|B4|||Age||years|Mean|57.4|57.4|Standard Deviation|10.03|10.03|||
4047754|NCT01106690|3869786|B3|||Age||years|Mean|57|57.0|Standard Deviation|10.19|10.19|||
4047755|NCT01106690|3869787|B2|||Age||years|Mean|56.7|56.7|Standard Deviation|10.36|10.36|||
4047756|NCT01106690|3869788|B1|||Age||years|Mean|58.3|58.3|Standard Deviation|9.56|9.56|||
4047757|NCT01106690|3869785|B4||>=65 years|Age||Participants|Count of Participants|93|93.0||||||
4047758|NCT01106690|3869786|B3||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4047759|NCT01106690|3869787|B2||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4047760|NCT01106690|3869788|B1||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4047761|NCT01106690|3869785|B4||Between 18 and 65 years|Age||Participants|Count of Participants|249|249.0||||||
4047762|NCT01106690|3869786|B3||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
4047763|NCT01106690|3869787|B2||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
4047764|NCT01106690|3869788|B1||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
4047765|NCT01106690|3869785|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4047766|NCT01106690|3869786|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4047767|NCT01106690|3869787|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4047768|NCT01106690|3869788|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4047769|NCT01106677|3869822|B5|UNITED STATES||Region Enroll||participants|Number|385|385.0||||||
4047770|NCT01106677|3869823|B4|UNITED STATES||Region Enroll||participants|Number|121|121.0||||||
4047771|NCT01106677|3869824|B3|UNITED STATES||Region Enroll||participants|Number|103|103.0||||||
4047772|NCT01106677|3869825|B2|UNITED STATES||Region Enroll||participants|Number|111|111.0||||||
4047773|NCT01106677|3869826|B1|UNITED STATES||Region Enroll||participants|Number|50|50.0||||||
4047774|NCT01106677|3869822|B5|UKRAINE||Region Enroll||participants|Number|91|91.0||||||
4047775|NCT01106677|3869823|B4|UKRAINE||Region Enroll||participants|Number|30|30.0||||||
4047776|NCT01106677|3869824|B3|UKRAINE||Region Enroll||participants|Number|29|29.0||||||
4047777|NCT01106677|3869825|B2|UKRAINE||Region Enroll||participants|Number|24|24.0||||||
4047778|NCT01106677|3869826|B1|UKRAINE||Region Enroll||participants|Number|8|8.0||||||
4047779|NCT01106677|3869822|B5|TURKEY||Region Enroll||participants|Number|26|26.0||||||
4047780|NCT01106677|3869823|B4|TURKEY||Region Enroll||participants|Number|9|9.0||||||
4047781|NCT01106677|3869824|B3|TURKEY||Region Enroll||participants|Number|11|11.0||||||
4047782|NCT01106677|3869825|B2|TURKEY||Region Enroll||participants|Number|5|5.0||||||
4047783|NCT01106677|3869826|B1|TURKEY||Region Enroll||participants|Number|1|1.0||||||
4047784|NCT01106677|3869822|B5|THAILAND||Region Enroll||participants|Number|32|32.0||||||
4047785|NCT01106677|3869823|B4|THAILAND||Region Enroll||participants|Number|8|8.0||||||
4047786|NCT01106677|3869824|B3|THAILAND||Region Enroll||participants|Number|11|11.0||||||
4047787|NCT01106677|3869825|B2|THAILAND||Region Enroll||participants|Number|9|9.0||||||
4047788|NCT01106677|3869826|B1|THAILAND||Region Enroll||participants|Number|4|4.0||||||
4047789|NCT01106677|3869822|B5|SWEDEN||Region Enroll||participants|Number|12|12.0||||||
4047790|NCT01106677|3869823|B4|SWEDEN||Region Enroll||participants|Number|4|4.0||||||
4047791|NCT01106677|3869824|B3|SWEDEN||Region Enroll||participants|Number|2|2.0||||||
4047792|NCT01106677|3869825|B2|SWEDEN||Region Enroll||participants|Number|3|3.0||||||
4047793|NCT01106677|3869826|B1|SWEDEN||Region Enroll||participants|Number|3|3.0||||||
4047794|NCT01106677|3869822|B5|SLOVAKIA||Region Enroll||participants|Number|66|66.0||||||
4047795|NCT01106677|3869823|B4|SLOVAKIA||Region Enroll||participants|Number|17|17.0||||||
4047796|NCT01106677|3869824|B3|SLOVAKIA||Region Enroll||participants|Number|21|21.0||||||
4047797|NCT01106677|3869825|B2|SLOVAKIA||Region Enroll||participants|Number|16|16.0||||||
4047798|NCT01106677|3869826|B1|SLOVAKIA||Region Enroll||participants|Number|12|12.0||||||
4047799|NCT01106677|3869822|B5|SINGAPORE||Region Enroll||participants|Number|14|14.0||||||
4047800|NCT01106677|3869823|B4|SINGAPORE||Region Enroll||participants|Number|3|3.0||||||
4047801|NCT01106677|3869824|B3|SINGAPORE||Region Enroll||participants|Number|3|3.0||||||
4047802|NCT01106677|3869825|B2|SINGAPORE||Region Enroll||participants|Number|5|5.0||||||
4047803|NCT01106677|3869826|B1|SINGAPORE||Region Enroll||participants|Number|3|3.0||||||
4047804|NCT01106677|3869822|B5|RUSSIAN FEDERATION||Region Enroll||participants|Number|99|99.0||||||
4047805|NCT01106677|3869823|B4|RUSSIAN FEDERATION||Region Enroll||participants|Number|22|22.0||||||
4047806|NCT01106677|3869824|B3|RUSSIAN FEDERATION||Region Enroll||participants|Number|28|28.0||||||
4047807|NCT01106677|3869825|B2|RUSSIAN FEDERATION||Region Enroll||participants|Number|34|34.0||||||
4047808|NCT01106677|3869826|B1|RUSSIAN FEDERATION||Region Enroll||participants|Number|15|15.0||||||
4047809|NCT01106677|3869822|B5|PORTUGAL||Region Enroll||participants|Number|4|4.0||||||
4047810|NCT01106677|3869823|B4|PORTUGAL||Region Enroll||participants|Number|2|2.0||||||
4047811|NCT01106677|3869824|B3|PORTUGAL||Region Enroll||participants|Number|0|0.0||||||
4047812|NCT01106677|3869825|B2|PORTUGAL||Region Enroll||participants|Number|1|1.0||||||
4047813|NCT01106677|3869826|B1|PORTUGAL||Region Enroll||participants|Number|1|1.0||||||
4047814|NCT01106677|3869822|B5|POLAND||Region Enroll||participants|Number|43|43.0||||||
4047815|NCT01106677|3869823|B4|POLAND||Region Enroll||participants|Number|10|10.0||||||
4047816|NCT01106677|3869824|B3|POLAND||Region Enroll||participants|Number|14|14.0||||||
4047817|NCT01106677|3869825|B2|POLAND||Region Enroll||participants|Number|18|18.0||||||
4047818|NCT01106677|3869826|B1|POLAND||Region Enroll||participants|Number|1|1.0||||||
4047819|NCT01106677|3869822|B5|PERU||Region Enroll||participants|Number|119|119.0||||||
4047820|NCT01106677|3869823|B4|PERU||Region Enroll||participants|Number|37|37.0||||||
4047821|NCT01106677|3869824|B3|PERU||Region Enroll||participants|Number|30|30.0||||||
4047822|NCT01106677|3869825|B2|PERU||Region Enroll||participants|Number|36|36.0||||||
4047823|NCT01106677|3869826|B1|PERU||Region Enroll||participants|Number|16|16.0||||||
4047824|NCT01106677|3869822|B5|MEXICO||Region Enroll||participants|Number|76|76.0||||||
4047825|NCT01106677|3869823|B4|MEXICO||Region Enroll||participants|Number|18|18.0||||||
4047826|NCT01106677|3869824|B3|MEXICO||Region Enroll||participants|Number|26|26.0||||||
4047827|NCT01106677|3869825|B2|MEXICO||Region Enroll||participants|Number|20|20.0||||||
4047828|NCT01106677|3869826|B1|MEXICO||Region Enroll||participants|Number|12|12.0||||||
4047829|NCT01106677|3869822|B5|MALAYSIA||Region Enroll||participants|Number|34|34.0||||||
4047830|NCT01106677|3869823|B4|MALAYSIA||Region Enroll||participants|Number|7|7.0||||||
4047831|NCT01106677|3869824|B3|MALAYSIA||Region Enroll||participants|Number|11|11.0||||||
4047832|NCT01106677|3869825|B2|MALAYSIA||Region Enroll||participants|Number|7|7.0||||||
4047833|NCT01106677|3869826|B1|MALAYSIA||Region Enroll||participants|Number|9|9.0||||||
4047834|NCT01106677|3869822|B5|LATVIA||Region Enroll||participants|Number|26|26.0||||||
4047835|NCT01106677|3869823|B4|LATVIA||Region Enroll||participants|Number|10|10.0||||||
4047836|NCT01106677|3869824|B3|LATVIA||Region Enroll||participants|Number|6|6.0||||||
4047837|NCT01106677|3869825|B2|LATVIA||Region Enroll||participants|Number|7|7.0||||||
4047838|NCT01106677|3869826|B1|LATVIA||Region Enroll||participants|Number|3|3.0||||||
4047839|NCT01106677|3869822|B5|ITALY||Region Enroll||participants|Number|9|9.0||||||
4047840|NCT01106677|3869823|B4|ITALY||Region Enroll||participants|Number|1|1.0||||||
4047841|NCT01106677|3869824|B3|ITALY||Region Enroll||participants|Number|3|3.0||||||
4047842|NCT01106677|3869825|B2|ITALY||Region Enroll||participants|Number|3|3.0||||||
4047843|NCT01106677|3869826|B1|ITALY||Region Enroll||participants|Number|2|2.0||||||
4047844|NCT01106677|3869822|B5|INDIA||Region Enroll||participants|Number|94|94.0||||||
4047845|NCT01106677|3869823|B4|INDIA||Region Enroll||participants|Number|22|22.0||||||
4047846|NCT01106677|3869824|B3|INDIA||Region Enroll||participants|Number|31|31.0||||||
4047847|NCT01106677|3869825|B2|INDIA||Region Enroll||participants|Number|28|28.0||||||
4047848|NCT01106677|3869826|B1|INDIA||Region Enroll||participants|Number|13|13.0||||||
4047849|NCT01106677|3869822|B5|GREECE||Region Enroll||participants|Number|9|9.0||||||
4047850|NCT01106677|3869823|B4|GREECE||Region Enroll||participants|Number|4|4.0||||||
4047851|NCT01106677|3869824|B3|GREECE||Region Enroll||participants|Number|3|3.0||||||
4047852|NCT01106677|3869825|B2|GREECE||Region Enroll||participants|Number|1|1.0||||||
4047853|NCT01106677|3869826|B1|GREECE||Region Enroll||participants|Number|1|1.0||||||
4047854|NCT01106677|3869822|B5|ESTONIA||Region Enroll||participants|Number|20|20.0||||||
4047855|NCT01106677|3869823|B4|ESTONIA||Region Enroll||participants|Number|5|5.0||||||
4047856|NCT01106677|3869824|B3|ESTONIA||Region Enroll||participants|Number|3|3.0||||||
4047857|NCT01106677|3869825|B2|ESTONIA||Region Enroll||participants|Number|6|6.0||||||
4047858|NCT01106677|3869826|B1|ESTONIA||Region Enroll||participants|Number|6|6.0||||||
4047859|NCT01106677|3869822|B5|CZECH REPUBLIC||Region Enroll||participants|Number|30|30.0||||||
4047860|NCT01106677|3869823|B4|CZECH REPUBLIC||Region Enroll||participants|Number|7|7.0||||||
4047861|NCT01106677|3869824|B3|CZECH REPUBLIC||Region Enroll||participants|Number|8|8.0||||||
4047862|NCT01106677|3869825|B2|CZECH REPUBLIC||Region Enroll||participants|Number|8|8.0||||||
4047863|NCT01106677|3869826|B1|CZECH REPUBLIC||Region Enroll||participants|Number|7|7.0||||||
4047864|NCT01106677|3869822|B5|COLOMBIA||Region Enroll||participants|Number|42|42.0||||||
4047865|NCT01106677|3869823|B4|COLOMBIA||Region Enroll||participants|Number|15|15.0||||||
4047866|NCT01106677|3869824|B3|COLOMBIA||Region Enroll||participants|Number|8|8.0||||||
4047867|NCT01106677|3869825|B2|COLOMBIA||Region Enroll||participants|Number|15|15.0||||||
4047868|NCT01106677|3869826|B1|COLOMBIA||Region Enroll||participants|Number|4|4.0||||||
4047869|NCT01106677|3869822|B5|BULGARIA||Region Enroll||participants|Number|10|10.0||||||
4047870|NCT01106677|3869823|B4|BULGARIA||Region Enroll||participants|Number|3|3.0||||||
4047871|NCT01106677|3869824|B3|BULGARIA||Region Enroll||participants|Number|1|1.0||||||
4047872|NCT01106677|3869825|B2|BULGARIA||Region Enroll||participants|Number|2|2.0||||||
4047873|NCT01106677|3869826|B1|BULGARIA||Region Enroll||participants|Number|4|4.0||||||
4047874|NCT01106677|3869822|B5|ARGENTINA||Region Enroll||participants|Number|43|43.0||||||
4047875|NCT01106677|3869823|B4|ARGENTINA||Region Enroll||participants|Number|11|11.0||||||
4047876|NCT01106677|3869824|B3|ARGENTINA||Region Enroll||participants|Number|15|15.0||||||
4047877|NCT01106677|3869825|B2|ARGENTINA||Region Enroll||participants|Number|9|9.0||||||
4047878|NCT01106677|3869826|B1|ARGENTINA||Region Enroll||participants|Number|8|8.0||||||
4047879|NCT01106677|3869822|B5||Male|Sex: Female, Male||Participants|Count of Participants|605|605.0||||||
4047880|NCT01106677|3869823|B4||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4047881|NCT01106677|3869824|B3||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4047882|NCT01106677|3869825|B2||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4047883|NCT01106677|3869826|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4047884|NCT01106677|3869822|B5||Female|Sex: Female, Male||Participants|Count of Participants|679|679.0||||||
4047885|NCT01106677|3869823|B4||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4047886|NCT01106677|3869824|B3||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4047887|NCT01106677|3869825|B2||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4047888|NCT01106677|3869826|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4047889|NCT01106677|3869822|B5|||Age||years|Mean|55.4|55.4|Standard Deviation|9.42|9.42|||
4047890|NCT01106677|3869823|B4|||Age||years|Mean|55.5|55.5|Standard Deviation|9.55|9.55|||
4047891|NCT01106677|3869824|B3|||Age||years|Mean|55.3|55.3|Standard Deviation|9.19|9.19|||
4047892|NCT01106677|3869825|B2|||Age||years|Mean|55.5|55.5|Standard Deviation|9.38|9.38|||
4047893|NCT01106677|3869826|B1|||Age||years|Mean|55.3|55.3|Standard Deviation|9.76|9.76|||
4047894|NCT01106677|3869822|B5||>=65 years|Age||Participants|Count of Participants|206|206.0||||||
4047895|NCT01106677|3869823|B4||>=65 years|Age||Participants|Count of Participants|57|57.0||||||
4047896|NCT01106677|3869824|B3||>=65 years|Age||Participants|Count of Participants|58|58.0||||||
4047897|NCT01106677|3869825|B2||>=65 years|Age||Participants|Count of Participants|54|54.0||||||
4047898|NCT01106677|3869826|B1||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
4047899|NCT01106677|3869822|B5||Between 18 and 65 years|Age||Participants|Count of Participants|1078|1078.0||||||
4047900|NCT01106677|3869823|B4||Between 18 and 65 years|Age||Participants|Count of Participants|309|309.0||||||
4047901|NCT01106677|3869824|B3||Between 18 and 65 years|Age||Participants|Count of Participants|309|309.0||||||
4047902|NCT01106677|3869825|B2||Between 18 and 65 years|Age||Participants|Count of Participants|314|314.0||||||
4047903|NCT01106677|3869826|B1||Between 18 and 65 years|Age||Participants|Count of Participants|146|146.0||||||
4047904|NCT01106677|3869822|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4047905|NCT01106677|3869823|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4047906|NCT01106677|3869824|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4047907|NCT01106677|3869825|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4047908|NCT01106677|3869826|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4047909|NCT01106651|3869889|B4|UNITED STATES||Region of Enrollment||participants|Number|298|298.0||||||
4047910|NCT01106651|3869890|B3|UNITED STATES||Region of Enrollment||participants|Number|97|97.0||||||
4047911|NCT01106651|3869891|B2|UNITED STATES||Region of Enrollment||participants|Number|98|98.0||||||
4047912|NCT01106651|3869892|B1|UNITED STATES||Region of Enrollment||participants|Number|103|103.0||||||
4047913|NCT01106651|3869889|B4|UNITED KINGDOM||Region of Enrollment||participants|Number|49|49.0||||||
4047914|NCT01106651|3869890|B3|UNITED KINGDOM||Region of Enrollment||participants|Number|8|8.0||||||
4047915|NCT01106651|3869891|B2|UNITED KINGDOM||Region of Enrollment||participants|Number|22|22.0||||||
4047916|NCT01106651|3869892|B1|UNITED KINGDOM||Region of Enrollment||participants|Number|19|19.0||||||
4047917|NCT01106651|3869889|B4|UKRAINE||Region of Enrollment||participants|Number|14|14.0||||||
4047918|NCT01106651|3869890|B3|UKRAINE||Region of Enrollment||participants|Number|3|3.0||||||
4047919|NCT01106651|3869891|B2|UKRAINE||Region of Enrollment||participants|Number|8|8.0||||||
4047920|NCT01106651|3869892|B1|UKRAINE||Region of Enrollment||participants|Number|3|3.0||||||
4047921|NCT01106651|3869889|B4|SWITZERLAND||Region of Enrollment||participants|Number|4|4.0||||||
4047922|NCT01106651|3869890|B3|SWITZERLAND||Region of Enrollment||participants|Number|0|0.0||||||
4047923|NCT01106651|3869891|B2|SWITZERLAND||Region of Enrollment||participants|Number|2|2.0||||||
4047924|NCT01106651|3869892|B1|SWITZERLAND||Region of Enrollment||participants|Number|2|2.0||||||
4047925|NCT01106651|3869889|B4|SWEDEN||Region of Enrollment||participants|Number|10|10.0||||||
4047926|NCT01106651|3869890|B3|SWEDEN||Region of Enrollment||participants|Number|2|2.0||||||
4047927|NCT01106651|3869891|B2|SWEDEN||Region of Enrollment||participants|Number|4|4.0||||||
4047928|NCT01106651|3869892|B1|SWEDEN||Region of Enrollment||participants|Number|4|4.0||||||
4047929|NCT01106651|3869889|B4|SPAIN||Region of Enrollment||participants|Number|13|13.0||||||
4047930|NCT01106651|3869890|B3|SPAIN||Region of Enrollment||participants|Number|8|8.0||||||
4047931|NCT01106651|3869891|B2|SPAIN||Region of Enrollment||participants|Number|3|3.0||||||
4047932|NCT01106651|3869892|B1|SPAIN||Region of Enrollment||participants|Number|2|2.0||||||
4047933|NCT01106651|3869889|B4|SOUTH AFRICA||Region of Enrollment||participants|Number|31|31.0||||||
4047934|NCT01106651|3869890|B3|SOUTH AFRICA||Region of Enrollment||participants|Number|10|10.0||||||
4047935|NCT01106651|3869891|B2|SOUTH AFRICA||Region of Enrollment||participants|Number|12|12.0||||||
4047936|NCT01106651|3869892|B1|SOUTH AFRICA||Region of Enrollment||participants|Number|9|9.0||||||
4047937|NCT01106651|3869889|B4|ROMANIA||Region of Enrollment||participants|Number|25|25.0||||||
4047938|NCT01106651|3869890|B3|ROMANIA||Region of Enrollment||participants|Number|7|7.0||||||
4047939|NCT01106651|3869891|B2|ROMANIA||Region of Enrollment||participants|Number|10|10.0||||||
4047940|NCT01106651|3869892|B1|ROMANIA||Region of Enrollment||participants|Number|8|8.0||||||
4047941|NCT01106651|3869889|B4|POLAND||Region of Enrollment||participants|Number|37|37.0||||||
4047942|NCT01106651|3869890|B3|POLAND||Region of Enrollment||participants|Number|14|14.0||||||
4047943|NCT01106651|3869891|B2|POLAND||Region of Enrollment||participants|Number|12|12.0||||||
4047944|NCT01106651|3869892|B1|POLAND||Region of Enrollment||participants|Number|11|11.0||||||
4047945|NCT01106651|3869889|B4|NEW ZEALAND||Region of Enrollment||participants|Number|37|37.0||||||
4047946|NCT01106651|3869890|B3|NEW ZEALAND||Region of Enrollment||participants|Number|11|11.0||||||
4047947|NCT01106651|3869891|B2|NEW ZEALAND||Region of Enrollment||participants|Number|10|10.0||||||
4047948|NCT01106651|3869892|B1|NEW ZEALAND||Region of Enrollment||participants|Number|16|16.0||||||
4047949|NCT01106651|3869889|B4|INDIA||Region of Enrollment||participants|Number|22|22.0||||||
4047950|NCT01106651|3869890|B3|INDIA||Region of Enrollment||participants|Number|11|11.0||||||
4047951|NCT01106651|3869891|B2|INDIA||Region of Enrollment||participants|Number|3|3.0||||||
4047952|NCT01106651|3869892|B1|INDIA||Region of Enrollment||participants|Number|8|8.0||||||
4047953|NCT01106651|3869889|B4|HONG KONG||Region of Enrollment||participants|Number|4|4.0||||||
4047954|NCT01106651|3869890|B3|HONG KONG||Region of Enrollment||participants|Number|2|2.0||||||
4047955|NCT01106651|3869891|B2|HONG KONG||Region of Enrollment||participants|Number|1|1.0||||||
4047956|NCT01106651|3869892|B1|HONG KONG||Region of Enrollment||participants|Number|1|1.0||||||
4047957|NCT01106651|3869889|B4|GREECE||Region of Enrollment||participants|Number|3|3.0||||||
4047958|NCT01106651|3869890|B3|GREECE||Region of Enrollment||participants|Number|1|1.0||||||
4047959|NCT01106651|3869891|B2|GREECE||Region of Enrollment||participants|Number|1|1.0||||||
4047960|NCT01106651|3869892|B1|GREECE||Region of Enrollment||participants|Number|1|1.0||||||
4047961|NCT01106651|3869889|B4|FRANCE||Region of Enrollment||participants|Number|7|7.0||||||
4047962|NCT01106651|3869890|B3|FRANCE||Region of Enrollment||participants|Number|3|3.0||||||
4047963|NCT01106651|3869891|B2|FRANCE||Region of Enrollment||participants|Number|2|2.0||||||
4047964|NCT01106651|3869892|B1|FRANCE||Region of Enrollment||participants|Number|2|2.0||||||
4047965|NCT01106651|3869889|B4|COLOMBIA||Region of Enrollment||participants|Number|53|53.0||||||
4047966|NCT01106651|3869890|B3|COLOMBIA||Region of Enrollment||participants|Number|20|20.0||||||
4047967|NCT01106651|3869891|B2|COLOMBIA||Region of Enrollment||participants|Number|15|15.0||||||
4047968|NCT01106651|3869892|B1|COLOMBIA||Region of Enrollment||participants|Number|18|18.0||||||
4047969|NCT01106651|3869889|B4|CANADA||Region of Enrollment||participants|Number|84|84.0||||||
4047970|NCT01106651|3869890|B3|CANADA||Region of Enrollment||participants|Number|28|28.0||||||
4047971|NCT01106651|3869891|B2|CANADA||Region of Enrollment||participants|Number|32|32.0||||||
4047972|NCT01106651|3869892|B1|CANADA||Region of Enrollment||participants|Number|24|24.0||||||
4047973|NCT01106651|3869889|B4|AUSTRALIA||Region of Enrollment||participants|Number|23|23.0||||||
4047974|NCT01106651|3869890|B3|AUSTRALIA||Region of Enrollment||participants|Number|11|11.0||||||
4047975|NCT01106651|3869891|B2|AUSTRALIA||Region of Enrollment||participants|Number|6|6.0||||||
4047976|NCT01106651|3869892|B1|AUSTRALIA||Region of Enrollment||participants|Number|6|6.0||||||
4047977|NCT01106651|3869889|B4||Male|Sex: Female, Male||Participants|Count of Participants|396|396.0||||||
4047978|NCT01106651|3869890|B3||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4047979|NCT01106651|3869891|B2||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4047980|NCT01106651|3869892|B1||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4047981|NCT01106651|3869889|B4||Female|Sex: Female, Male||Participants|Count of Participants|318|318.0||||||
4047982|NCT01106651|3869890|B3||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4047983|NCT01106651|3869891|B2||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4047984|NCT01106651|3869892|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4047985|NCT01106651|3869889|B4|||Age||years|Mean|63.6|63.6|Standard Deviation|6.24|6.24|||
4047986|NCT01106651|3869890|B3|||Age||years|Mean|63.4|63.4|Standard Deviation|5.99|5.99|||
4047987|NCT01106651|3869891|B2|||Age||years|Mean|64.3|64.3|Standard Deviation|6.46|6.46|||
4047988|NCT01106651|3869892|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|6.21|6.21|||
4047989|NCT01106651|3869889|B4||>=65 years|Age||Participants|Count of Participants|273|273.0||||||
4047990|NCT01106651|3869890|B3||>=65 years|Age||Participants|Count of Participants|87|87.0||||||
4047991|NCT01106651|3869891|B2||>=65 years|Age||Participants|Count of Participants|100|100.0||||||
4047992|NCT01106651|3869892|B1||>=65 years|Age||Participants|Count of Participants|86|86.0||||||
4047993|NCT01106651|3869889|B4||Between 18 and 65 years|Age||Participants|Count of Participants|441|441.0||||||
4047994|NCT01106651|3869890|B3||Between 18 and 65 years|Age||Participants|Count of Participants|149|149.0||||||
4047995|NCT01106651|3869891|B2||Between 18 and 65 years|Age||Participants|Count of Participants|141|141.0||||||
4047996|NCT01106651|3869892|B1||Between 18 and 65 years|Age||Participants|Count of Participants|151|151.0||||||
4047997|NCT01106651|3869889|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4047998|NCT01106651|3869890|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4047999|NCT01106651|3869891|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4048000|NCT01106651|3869892|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4048001|NCT01106625|3869944|B4|UNITED STATES||Region of Enrollment||participants|Number|225|225.0||||||
4048002|NCT01106625|3869945|B3|UNITED STATES||Region of Enrollment||participants|Number|70|70.0||||||
4048003|NCT01106625|3869946|B2|UNITED STATES||Region of Enrollment||participants|Number|74|74.0||||||
4048004|NCT01106625|3869947|B1|UNITED STATES||Region of Enrollment||participants|Number|81|81.0||||||
4048005|NCT01106625|3869944|B4|UNITED KINGDOM||Region of Enrollment||participants|Number|19|19.0||||||
4048006|NCT01106625|3869945|B3|UNITED KINGDOM||Region of Enrollment||participants|Number|5|5.0||||||
4048007|NCT01106625|3869946|B2|UNITED KINGDOM||Region of Enrollment||participants|Number|6|6.0||||||
4048008|NCT01106625|3869947|B1|UNITED KINGDOM||Region of Enrollment||participants|Number|8|8.0||||||
4048009|NCT01106625|3869944|B4|SPAIN||Region of Enrollment||participants|Number|20|20.0||||||
4048010|NCT01106625|3869945|B3|SPAIN||Region of Enrollment||participants|Number|8|8.0||||||
4048011|NCT01106625|3869946|B2|SPAIN||Region of Enrollment||participants|Number|7|7.0||||||
4048012|NCT01106625|3869947|B1|SPAIN||Region of Enrollment||participants|Number|5|5.0||||||
4048013|NCT01106625|3869944|B4|RUSSIAN FEDERATION||Region of Enrollment||participants|Number|35|35.0||||||
4048014|NCT01106625|3869945|B3|RUSSIAN FEDERATION||Region of Enrollment||participants|Number|8|8.0||||||
4048015|NCT01106625|3869946|B2|RUSSIAN FEDERATION||Region of Enrollment||participants|Number|13|13.0||||||
4048016|NCT01106625|3869947|B1|RUSSIAN FEDERATION||Region of Enrollment||participants|Number|14|14.0||||||
4048017|NCT01106625|3869944|B4|MEXICO||Region of Enrollment||participants|Number|33|33.0||||||
4048018|NCT01106625|3869945|B3|MEXICO||Region of Enrollment||participants|Number|11|11.0||||||
4048019|NCT01106625|3869946|B2|MEXICO||Region of Enrollment||participants|Number|11|11.0||||||
4048020|NCT01106625|3869947|B1|MEXICO||Region of Enrollment||participants|Number|11|11.0||||||
4048021|NCT01106625|3869944|B4|ISRAEL||Region of Enrollment||participants|Number|15|15.0||||||
4048022|NCT01106625|3869945|B3|ISRAEL||Region of Enrollment||participants|Number|8|8.0||||||
4048023|NCT01106625|3869946|B2|ISRAEL||Region of Enrollment||participants|Number|6|6.0||||||
4048024|NCT01106625|3869947|B1|ISRAEL||Region of Enrollment||participants|Number|1|1.0||||||
4048025|NCT01106625|3869944|B4|HUNGARY||Region of Enrollment||participants|Number|36|36.0||||||
4048026|NCT01106625|3869945|B3|HUNGARY||Region of Enrollment||participants|Number|11|11.0||||||
4048027|NCT01106625|3869946|B2|HUNGARY||Region of Enrollment||participants|Number|14|14.0||||||
4048028|NCT01106625|3869947|B1|HUNGARY||Region of Enrollment||participants|Number|11|11.0||||||
4048029|NCT01106625|3869944|B4|GUATEMALA||Region of Enrollment||participants|Number|43|43.0||||||
4048030|NCT01106625|3869945|B3|GUATEMALA||Region of Enrollment||participants|Number|16|16.0||||||
4048031|NCT01106625|3869946|B2|GUATEMALA||Region of Enrollment||participants|Number|12|12.0||||||
4048032|NCT01106625|3869947|B1|GUATEMALA||Region of Enrollment||participants|Number|15|15.0||||||
4048033|NCT01106625|3869944|B4|FRANCE||Region of Enrollment||participants|Number|20|20.0||||||
4048034|NCT01106625|3869945|B3|FRANCE||Region of Enrollment||participants|Number|9|9.0||||||
4048035|NCT01106625|3869946|B2|FRANCE||Region of Enrollment||participants|Number|7|7.0||||||
4048036|NCT01106625|3869947|B1|FRANCE||Region of Enrollment||participants|Number|4|4.0||||||
4048037|NCT01106625|3869944|B4|BELGIUM||Region of Enrollment||participants|Number|10|10.0||||||
4048038|NCT01106625|3869945|B3|BELGIUM||Region of Enrollment||participants|Number|6|6.0||||||
4048039|NCT01106625|3869946|B2|BELGIUM||Region of Enrollment||participants|Number|1|1.0||||||
4048040|NCT01106625|3869947|B1|BELGIUM||Region of Enrollment||participants|Number|3|3.0||||||
4048041|NCT01106625|3869944|B4|AUSTRALIA||Region of Enrollment||participants|Number|13|13.0||||||
4048042|NCT01106625|3869945|B3|AUSTRALIA||Region of Enrollment||participants|Number|4|4.0||||||
4048043|NCT01106625|3869946|B2|AUSTRALIA||Region of Enrollment||participants|Number|6|6.0||||||
4048044|NCT01106625|3869947|B1|AUSTRALIA||Region of Enrollment||participants|Number|3|3.0||||||
4048045|NCT01106625|3869944|B4||Male|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
4048046|NCT01106625|3869945|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4048047|NCT01106625|3869946|B2||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4048048|NCT01106625|3869947|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4048049|NCT01106625|3869944|B4||Female|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4048050|NCT01106625|3869945|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4048051|NCT01106625|3869946|B2||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4048052|NCT01106625|3869947|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4048053|NCT01106625|3869944|B4|||Age||years|Mean|56.7|56.7|Standard Deviation|9.3|9.3|||
4048054|NCT01106625|3869945|B3|||Age||years|Mean|56|56.0|Standard Deviation|8.95|8.95|||
4048055|NCT01106625|3869946|B2|||Age||years|Mean|57.3|57.3|Standard Deviation|10.47|10.47|||
4048056|NCT01106625|3869947|B1|||Age||years|Mean|56.7|56.7|Standard Deviation|8.36|8.36|||
4048057|NCT01106625|3869944|B4||>=65 years|Age||Participants|Count of Participants|84|84.0||||||
4048058|NCT01106625|3869945|B3||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4048059|NCT01106625|3869946|B2||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4048060|NCT01106625|3869947|B1||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4048061|NCT01106625|3869944|B4||Between 18 and 65 years|Age||Participants|Count of Participants|385|385.0||||||
4048062|NCT01106625|3869945|B3||Between 18 and 65 years|Age||Participants|Count of Participants|134|134.0||||||
4048063|NCT01106625|3869946|B2||Between 18 and 65 years|Age||Participants|Count of Participants|121|121.0||||||
4048064|NCT01106625|3869947|B1||Between 18 and 65 years|Age||Participants|Count of Participants|130|130.0||||||
4048065|NCT01106625|3869944|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4048066|NCT01106625|3869945|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4048067|NCT01106625|3869946|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4048068|NCT01106625|3869947|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4048069|NCT01106586|3869978|B3|> 500 μL||CD4 Cell Count (/µL)||participants|Number|125|125.0||||||
4048070|NCT01106586|3869979|B2|> 500 μL||CD4 Cell Count (/µL)||participants|Number|70|70.0||||||
4048071|NCT01106586|3869980|B1|> 500 μL||CD4 Cell Count (/µL)||participants|Number|55|55.0||||||
4048072|NCT01106586|3869978|B3|351 to ≤ 500 μL||CD4 Cell Count (/µL)||participants|Number|244|244.0||||||
4048073|NCT01106586|3869979|B2|351 to ≤ 500 μL||CD4 Cell Count (/µL)||participants|Number|122|122.0||||||
4048074|NCT01106586|3869980|B1|351 to ≤ 500 μL||CD4 Cell Count (/µL)||participants|Number|122|122.0||||||
4048075|NCT01106586|3869978|B3|201 to ≤ 350 μL||CD4 Cell Count (/µL)||participants|Number|246|246.0||||||
4048076|NCT01106586|3869979|B2|201 to ≤ 350 μL||CD4 Cell Count (/µL)||participants|Number|124|124.0||||||
4048077|NCT01106586|3869980|B1|201 to ≤ 350 μL||CD4 Cell Count (/µL)||participants|Number|122|122.0||||||
4048078|NCT01106586|3869978|B3|51 to ≤ 200 μL||CD4 Cell Count (/µL)||participants|Number|76|76.0||||||
4048079|NCT01106586|3869979|B2|51 to ≤ 200 μL||CD4 Cell Count (/µL)||participants|Number|34|34.0||||||
4048080|NCT01106586|3869980|B1|51 to ≤ 200 μL||CD4 Cell Count (/µL)||participants|Number|42|42.0||||||
4048081|NCT01106586|3869978|B3|≤ 50 μL||CD4 Cell Count (/µL)||participants|Number|17|17.0||||||
4048082|NCT01106586|3869979|B2|≤ 50 μL||CD4 Cell Count (/µL)||participants|Number|5|5.0||||||
4048083|NCT01106586|3869980|B1|≤ 50 μL||CD4 Cell Count (/µL)||participants|Number|12|12.0||||||
4048084|NCT01106586|3869978|B3|> 100,000 copies/mL||HIV-1 RNA Category (copies/mL)||participants|Number|291|291.0||||||
4048085|NCT01106586|3869979|B2|> 100,000 copies/mL||HIV-1 RNA Category (copies/mL)||participants|Number|141|141.0||||||
4048086|NCT01106586|3869980|B1|> 100,000 copies/mL||HIV-1 RNA Category (copies/mL)||participants|Number|150|150.0||||||
4048087|NCT01106586|3869978|B3|≤ 100,000 copies/mL||HIV-1 RNA Category (copies/mL)||participants|Number|417|417.0||||||
4048088|NCT01106586|3869979|B2|≤ 100,000 copies/mL||HIV-1 RNA Category (copies/mL)||participants|Number|214|214.0||||||
4048089|NCT01106586|3869980|B1|≤ 100,000 copies/mL||HIV-1 RNA Category (copies/mL)||participants|Number|203|203.0||||||
4048090|NCT01106586|3869978|B3|Not done||Hepatitis C Virus (HCV) Infection Status||participants|Number|1|1.0||||||
4048091|NCT01106586|3869979|B2|Not done||Hepatitis C Virus (HCV) Infection Status||participants|Number|1|1.0||||||
4048092|NCT01106586|3869980|B1|Not done||Hepatitis C Virus (HCV) Infection Status||participants|Number|0|0.0||||||
4048093|NCT01106586|3869978|B3|Indeterminate||Hepatitis C Virus (HCV) Infection Status||participants|Number|0|0.0||||||
4048094|NCT01106586|3869979|B2|Indeterminate||Hepatitis C Virus (HCV) Infection Status||participants|Number|0|0.0||||||
4048095|NCT01106586|3869980|B1|Indeterminate||Hepatitis C Virus (HCV) Infection Status||participants|Number|0|0.0||||||
4048096|NCT01106586|3869978|B3|Positive||Hepatitis C Virus (HCV) Infection Status||participants|Number|28|28.0||||||
4048097|NCT01106586|3869979|B2|Positive||Hepatitis C Virus (HCV) Infection Status||participants|Number|10|10.0||||||
4048098|NCT01106586|3869980|B1|Positive||Hepatitis C Virus (HCV) Infection Status||participants|Number|18|18.0||||||
4048099|NCT01106586|3869978|B3|Negative||Hepatitis C Virus (HCV) Infection Status||participants|Number|679|679.0||||||
4048100|NCT01106586|3869979|B2|Negative||Hepatitis C Virus (HCV) Infection Status||participants|Number|344|344.0||||||
4048101|NCT01106586|3869980|B1|Negative||Hepatitis C Virus (HCV) Infection Status||participants|Number|335|335.0||||||
4048102|NCT01106586|3869978|B3|Not done||Hepatitis B Virus (HBV) Infection Status||participants|Number|2|2.0||||||
4048103|NCT01106586|3869979|B2|Not done||Hepatitis B Virus (HBV) Infection Status||participants|Number|1|1.0||||||
4048104|NCT01106586|3869980|B1|Not done||Hepatitis B Virus (HBV) Infection Status||participants|Number|1|1.0||||||
4048105|NCT01106586|3869978|B3|Indeterminate||Hepatitis B Virus (HBV) Infection Status||participants|Number|1|1.0||||||
4048106|NCT01106586|3869979|B2|Indeterminate||Hepatitis B Virus (HBV) Infection Status||participants|Number|1|1.0||||||
4048107|NCT01106586|3869980|B1|Indeterminate||Hepatitis B Virus (HBV) Infection Status||participants|Number|0|0.0||||||
4048108|NCT01106586|3869978|B3|Positive||Hepatitis B Virus (HBV) Infection Status||participants|Number|12|12.0||||||
4048109|NCT01106586|3869979|B2|Positive||Hepatitis B Virus (HBV) Infection Status||participants|Number|7|7.0||||||
4048110|NCT01106586|3869980|B1|Positive||Hepatitis B Virus (HBV) Infection Status||participants|Number|5|5.0||||||
4048111|NCT01106586|3869978|B3|Negative||Hepatitis B Virus (HBV) Infection Status||participants|Number|693|693.0||||||
4048112|NCT01106586|3869979|B2|Negative||Hepatitis B Virus (HBV) Infection Status||participants|Number|346|346.0||||||
4048113|NCT01106586|3869980|B1|Negative||Hepatitis B Virus (HBV) Infection Status||participants|Number|347|347.0||||||
4048114|NCT01106586|3869978|B3|AIDS||HIV Disease Status||participants|Number|56|56.0||||||
4048115|NCT01106586|3869979|B2|AIDS||HIV Disease Status||participants|Number|24|24.0||||||
4048116|NCT01106586|3869980|B1|AIDS||HIV Disease Status||participants|Number|32|32.0||||||
4048117|NCT01106586|3869978|B3|Symptomatic HIV Infections||HIV Disease Status||participants|Number|74|74.0||||||
4048118|NCT01106586|3869979|B2|Symptomatic HIV Infections||HIV Disease Status||participants|Number|38|38.0||||||
4048119|NCT01106586|3869980|B1|Symptomatic HIV Infections||HIV Disease Status||participants|Number|36|36.0||||||
4048120|NCT01106586|3869978|B3|Asymptomatic||HIV Disease Status||participants|Number|578|578.0||||||
4048121|NCT01106586|3869979|B2|Asymptomatic||HIV Disease Status||participants|Number|293|293.0||||||
4048122|NCT01106586|3869980|B1|Asymptomatic||HIV Disease Status||participants|Number|285|285.0||||||
4048123|NCT01106586|3869978|B3|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
4048124|NCT01106586|3869979|B2|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
4048125|NCT01106586|3869980|B1|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
4048126|NCT01106586|3869978|B3|Germany||Region of Enrollment||participants|Number|65|65.0||||||
4048127|NCT01106586|3869979|B2|Germany||Region of Enrollment||participants|Number|36|36.0||||||
4048128|NCT01106586|3869980|B1|Germany||Region of Enrollment||participants|Number|29|29.0||||||
4048129|NCT01106586|3869978|B3|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
4048130|NCT01106586|3869979|B2|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
4048131|NCT01106586|3869980|B1|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
4048132|NCT01106586|3869978|B3|Denmark||Region of Enrollment||participants|Number|3|3.0||||||
4048133|NCT01106586|3869979|B2|Denmark||Region of Enrollment||participants|Number|2|2.0||||||
4048134|NCT01106586|3869980|B1|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
4048135|NCT01106586|3869978|B3|Australia||Region of Enrollment||participants|Number|62|62.0||||||
4048136|NCT01106586|3869979|B2|Australia||Region of Enrollment||participants|Number|32|32.0||||||
4048137|NCT01106586|3869980|B1|Australia||Region of Enrollment||participants|Number|30|30.0||||||
4048138|NCT01106586|3869978|B3|Belgium||Region of Enrollment||participants|Number|21|21.0||||||
4048139|NCT01106586|3869979|B2|Belgium||Region of Enrollment||participants|Number|12|12.0||||||
4048140|NCT01106586|3869980|B1|Belgium||Region of Enrollment||participants|Number|9|9.0||||||
4048141|NCT01106586|3869978|B3|Canada||Region of Enrollment||participants|Number|41|41.0||||||
4048142|NCT01106586|3869979|B2|Canada||Region of Enrollment||participants|Number|22|22.0||||||
4048143|NCT01106586|3869980|B1|Canada||Region of Enrollment||participants|Number|19|19.0||||||
4048144|NCT01106586|3869978|B3|Mexico||Region of Enrollment||participants|Number|5|5.0||||||
4048145|NCT01106586|3869979|B2|Mexico||Region of Enrollment||participants|Number|2|2.0||||||
4048146|NCT01106586|3869980|B1|Mexico||Region of Enrollment||participants|Number|3|3.0||||||
4048147|NCT01106586|3869978|B3|France||Region of Enrollment||participants|Number|46|46.0||||||
4048148|NCT01106586|3869979|B2|France||Region of Enrollment||participants|Number|23|23.0||||||
4048149|NCT01106586|3869980|B1|France||Region of Enrollment||participants|Number|23|23.0||||||
4048150|NCT01106586|3869978|B3|Italy||Region of Enrollment||participants|Number|14|14.0||||||
4048151|NCT01106586|3869979|B2|Italy||Region of Enrollment||participants|Number|5|5.0||||||
4048152|NCT01106586|3869980|B1|Italy||Region of Enrollment||participants|Number|9|9.0||||||
4048153|NCT01106586|3869978|B3|Switzerland||Region of Enrollment||participants|Number|2|2.0||||||
4048154|NCT01106586|3869979|B2|Switzerland||Region of Enrollment||participants|Number|2|2.0||||||
4048155|NCT01106586|3869980|B1|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
4048156|NCT01106586|3869978|B3|United Kingdom||Region of Enrollment||participants|Number|26|26.0||||||
4048157|NCT01106586|3869979|B2|United Kingdom||Region of Enrollment||participants|Number|15|15.0||||||
4048158|NCT01106586|3869980|B1|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
4048159|NCT01106586|3869978|B3|Austria||Region of Enrollment||participants|Number|20|20.0||||||
4048160|NCT01106586|3869979|B2|Austria||Region of Enrollment||participants|Number|8|8.0||||||
4048161|NCT01106586|3869980|B1|Austria||Region of Enrollment||participants|Number|12|12.0||||||
4048162|NCT01106586|3869978|B3|Thailand||Region of Enrollment||participants|Number|11|11.0||||||
4048163|NCT01106586|3869979|B2|Thailand||Region of Enrollment||participants|Number|4|4.0||||||
4048164|NCT01106586|3869980|B1|Thailand||Region of Enrollment||participants|Number|7|7.0||||||
4048165|NCT01106586|3869978|B3|United States||Region of Enrollment||participants|Number|382|382.0||||||
4048166|NCT01106586|3869979|B2|United States||Region of Enrollment||participants|Number|185|185.0||||||
4048167|NCT01106586|3869980|B1|United States||Region of Enrollment||participants|Number|197|197.0||||||
4048168|NCT01106586|3869978|B3|Portugal||Region of Enrollment||participants|Number|3|3.0||||||
4048169|NCT01106586|3869979|B2|Portugal||Region of Enrollment||participants|Number|2|2.0||||||
4048170|NCT01106586|3869980|B1|Portugal||Region of Enrollment||participants|Number|1|1.0||||||
4048171|NCT01106586|3869978|B3|Other||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4048172|NCT01106586|3869979|B2|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4048173|NCT01106586|3869980|B1|Other||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4048174|NCT01106586|3869978|B3|White||Race/Ethnicity, Customized||participants|Number|527|527.0||||||
4048175|NCT01106586|3869979|B2|White||Race/Ethnicity, Customized||participants|Number|277|277.0||||||
4048176|NCT01106586|3869980|B1|White||Race/Ethnicity, Customized||participants|Number|250|250.0||||||
4048177|NCT01106586|3869978|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4048178|NCT01106586|3869979|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4048179|NCT01106586|3869980|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4048180|NCT01106586|3869978|B3|Black or African Heritage||Race/Ethnicity, Customized||participants|Number|119|119.0||||||
4048181|NCT01106586|3869979|B2|Black or African Heritage||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4048182|NCT01106586|3869980|B1|Black or African Heritage||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
4048183|NCT01106586|3869978|B3|Asian||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4048184|NCT01106586|3869979|B2|Asian||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4048185|NCT01106586|3869980|B1|Asian||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4048186|NCT01106586|3869978|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4048187|NCT01106586|3869979|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4048188|NCT01106586|3869980|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4048189|NCT01106586|3869978|B3||Male|Sex: Female, Male||Participants|Count of Participants|640|640.0||||||
4048190|NCT01106586|3869979|B2||Male|Sex: Female, Male||Participants|Count of Participants|316|316.0||||||
4048191|NCT01106586|3869980|B1||Male|Sex: Female, Male||Participants|Count of Participants|324|324.0||||||
4048192|NCT01106586|3869978|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4048193|NCT01106586|3869979|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4048194|NCT01106586|3869980|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4048195|NCT01106586|3869978|B3|||Age||years|Mean|38|38.0|Standard Deviation|10.2|10.2|||
4048196|NCT01106586|3869979|B2|||Age||years|Mean|39|39.0|Standard Deviation|9.8|9.8|||
4048197|NCT01106586|3869980|B1|||Age||years|Mean|38|38.0|Standard Deviation|10.5|10.5|||
4048198|NCT01106534|3869999|B1|Other||Race/Ethnicity, Customized|Patient may be counted in more than one category|participants|Number|15|15.0||||||
4048199|NCT01106534|3869999|B1|Hispanic or Latino||Race/Ethnicity, Customized|Patient may be counted in more than one category|participants|Number|117|117.0||||||
4048200|NCT01106534|3869999|B1|White||Race/Ethnicity, Customized|Patient may be counted in more than one category|participants|Number|2577|2577.0||||||
4048201|NCT01106534|3869999|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized|Patient may be counted in more than one category|participants|Number|7|7.0||||||
4048202|NCT01106534|3869999|B1|Black or African Heritage||Race/Ethnicity, Customized|Patient may be counted in more than one category|participants|Number|231|231.0||||||
4048203|NCT01106534|3869999|B1|Asian||Race/Ethnicity, Customized|Patient may be counted in more than one category|participants|Number|49|49.0||||||
4048204|NCT01106534|3869999|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized|Patient may be counted in more than one category|participants|Number|23|23.0||||||
4048205|NCT01106534|3869999|B1||Male|Sex: Female, Male||Participants|Count of Participants|2127|2127.0||||||
4048206|NCT01106534|3869999|B1||Female|Sex: Female, Male||Participants|Count of Participants|870|870.0||||||
4048207|NCT01106534|3869999|B1|>= 75 years||Age, Customized||participants|Number|488|488.0||||||
4048208|NCT01106534|3869999|B1|>= 65 to < 75 years||Age, Customized||participants|Number|922|922.0||||||
4048209|NCT01106534|3869999|B1|< 65 years||Age, Customized||participants|Number|1587|1587.0||||||
4048210|NCT01106534|3869999|B1|||Age||years|Mean|64.27|64.27|Standard Deviation|10.39|10.39|||
4048211|NCT01106456|3870020|B3||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4048212|NCT01106456|3870021|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4048213|NCT01106456|3870022|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4048214|NCT01106456|3870020|B3||Female|Sex: Female, Male||Participants|Count of Participants|335|335.0||||||
4048215|NCT01106456|3870021|B2||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4048216|NCT01106456|3870022|B1||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4048217|NCT01106456|3870020|B3|||Age||years|Mean|44.3|44.3|Standard Deviation|13.13|13.13|||
4048218|NCT01106456|3870021|B2|||Age||years|Mean|43.12|43.12|Standard Deviation|13.22|13.22|||
4048219|NCT01106456|3870022|B1|||Age||years|Mean|45.43|45.43|Standard Deviation|12.98|12.98|||
4048220|NCT01106456|3870020|B3||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4048221|NCT01106456|3870021|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4048222|NCT01106456|3870022|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4048223|NCT01106456|3870020|B3||Between 18 and 65 years|Age||Participants|Count of Participants|418|418.0||||||
4048224|NCT01106456|3870021|B2||Between 18 and 65 years|Age||Participants|Count of Participants|206|206.0||||||
4048225|NCT01106456|3870022|B1||Between 18 and 65 years|Age||Participants|Count of Participants|212|212.0||||||
4048226|NCT01106456|3870020|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4048227|NCT01106456|3870021|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4048228|NCT01106456|3870022|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4048229|NCT01106430|3870029|B3|UNITED STATES||Region of Enrollment|All enrolled subjects defined as all randomized subjects (n = 267).|Participants|Number|138|138.0||||||
4048230|NCT01106430|3870030|B2|UNITED STATES||Region of Enrollment|All enrolled subjects defined as all randomized subjects (n = 267).|Participants|Number|68|68.0||||||
4048231|NCT01106430|3870031|B1|UNITED STATES||Region of Enrollment|All enrolled subjects defined as all randomized subjects (n = 267).|Participants|Number|70|70.0||||||
4048232|NCT01106430|3870029|B3|SWEDEN||Region of Enrollment|All enrolled subjects defined as all randomized subjects (n = 267).|Participants|Number|6|6.0||||||
4048233|NCT01106430|3870030|B2|SWEDEN||Region of Enrollment|All enrolled subjects defined as all randomized subjects (n = 267).|Participants|Number|3|3.0||||||
4048234|NCT01106430|3870031|B1|SWEDEN||Region of Enrollment|All enrolled subjects defined as all randomized subjects (n = 267).|Participants|Number|3|3.0||||||
4048235|NCT01106430|3870029|B3|SPAIN||Region of Enrollment|All enrolled subjects defined as all randomized subjects (n = 267).|Participants|Number|22|22.0||||||
4048236|NCT01106430|3870030|B2|SPAIN||Region of Enrollment|All enrolled subjects defined as all randomized subjects (n = 267).|Participants|Number|10|10.0||||||
4048237|NCT01106430|3870031|B1|SPAIN||Region of Enrollment|All enrolled subjects defined as all randomized subjects (n = 267).|Participants|Number|12|12.0||||||
4048238|NCT01106430|3870029|B3|POLAND||Region of Enrollment|All enrolled subjects defined as all randomized subjects (n = 267).|Participants|Number|1|1.0||||||
4048239|NCT01106430|3870030|B2|POLAND||Region of Enrollment|All enrolled subjects defined as all randomized subjects (n = 267).|Participants|Number|1|1.0||||||
4048240|NCT01106430|3870031|B1|POLAND||Region of Enrollment|All enrolled subjects defined as all randomized subjects (n = 267).|Participants|Number|0|0.0||||||
4048241|NCT01106430|3870029|B3|ITALY||Region of Enrollment|All enrolled subjects defined as all randomized subjects (n = 267).|Participants|Number|1|1.0||||||
4048242|NCT01106430|3870030|B2|ITALY||Region of Enrollment|All enrolled subjects defined as all randomized subjects (n = 267).|Participants|Number|0|0.0||||||
4048243|NCT01106430|3870031|B1|ITALY||Region of Enrollment|All enrolled subjects defined as all randomized subjects (n = 267).|Participants|Number|1|1.0||||||
4048244|NCT01106430|3870029|B3|HUNGARY||Region of Enrollment|All enrolled subjects defined as all randomized subjects (n = 267).|Participants|Number|20|20.0||||||
4048245|NCT01106430|3870030|B2|HUNGARY||Region of Enrollment|All enrolled subjects defined as all randomized subjects (n = 267).|Participants|Number|10|10.0||||||
4048246|NCT01106430|3870031|B1|HUNGARY||Region of Enrollment|All enrolled subjects defined as all randomized subjects (n = 267).|Participants|Number|10|10.0||||||
4048247|NCT01106430|3870029|B3|GERMANY||Region of Enrollment|All enrolled subjects defined as all randomized subjects (n = 267).|Participants|Number|42|42.0||||||
4048248|NCT01106430|3870030|B2|GERMANY||Region of Enrollment|All enrolled subjects defined as all randomized subjects (n = 267).|Participants|Number|22|22.0||||||
4048249|NCT01106430|3870031|B1|GERMANY||Region of Enrollment|All enrolled subjects defined as all randomized subjects (n = 267).|Participants|Number|20|20.0||||||
4048250|NCT01106430|3870029|B3|CANADA||Region of Enrollment|All enrolled subjects defined as all randomized subjects (n = 267).|Participants|Number|35|35.0||||||
4048251|NCT01106430|3870030|B2|CANADA||Region of Enrollment|All enrolled subjects defined as all randomized subjects (n = 267).|Participants|Number|18|18.0||||||
4048252|NCT01106430|3870031|B1|CANADA||Region of Enrollment|All enrolled subjects defined as all randomized subjects (n = 267).|Participants|Number|17|17.0||||||
4048253|NCT01106430|3870029|B3|BELGIUM||Region of Enrollment|All enrolled subjects defined as all randomized subjects (n = 267).|Participants|Number|2|2.0||||||
4048300|NCT01106391|3870068|B1|Free of diabetes||Diabetes||participants|Number|47|47.0||||||
4048254|NCT01106430|3870030|B2|BELGIUM||Region of Enrollment|All enrolled subjects defined as all randomized subjects (n = 267).|Participants|Number|2|2.0||||||
4048255|NCT01106430|3870031|B1|BELGIUM||Region of Enrollment|All enrolled subjects defined as all randomized subjects (n = 267).|Participants|Number|0|0.0||||||
4048256|NCT01106430|3870029|B3||Male|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4048257|NCT01106430|3870030|B2||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4048258|NCT01106430|3870031|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4048259|NCT01106430|3870029|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4048260|NCT01106430|3870030|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4048261|NCT01106430|3870031|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4048262|NCT01106430|3870029|B3|6 - 12 years||Age, Customized||Participants|Number|194|194.0||||||
4048263|NCT01106430|3870030|B2|6 - 12 years||Age, Customized||Participants|Number|100|100.0||||||
4048264|NCT01106430|3870031|B1|6 - 12 years||Age, Customized||Participants|Number|94|94.0||||||
4048265|NCT01106430|3870029|B3|13 - 17 years||Age, Customized||Participants|Number|68|68.0||||||
4048266|NCT01106430|3870030|B2|13 - 17 years||Age, Customized||Participants|Number|34|34.0||||||
4048267|NCT01106430|3870031|B1|13 - 17 years||Age, Customized||Participants|Number|34|34.0||||||
4048268|NCT01106430|3870029|B3|||Age||Years|Mean|10.6|10.6|Standard Deviation|2.93|2.93|||
4048269|NCT01106430|3870030|B2|||Age||Years|Mean|10.4|10.4|Standard Deviation|2.84|2.84|||
4048270|NCT01106430|3870031|B1|||Age||Years|Mean|10.9|10.9|Standard Deviation|3.01|3.01|||
4048271|NCT01106404|3870052|B3|||worst Numeric Pain Rating Scale (NPRS)|NPRS is a 11-point scale with numbers from 0 to 10, with 0 meaning “No pain” and 10 meaning “Pain as bad as you can imagine.” For worst NRPS, study subjects were instructed to “Please rate your pain by indicating the number that best describes your worst pain in the last 24 hours.”|units on a scale|Mean|7.60|7.6|Standard Deviation|1.41|1.41|||
4048272|NCT01106404|3870053|B2|||worst Numeric Pain Rating Scale (NPRS)|NPRS is a 11-point scale with numbers from 0 to 10, with 0 meaning “No pain” and 10 meaning “Pain as bad as you can imagine.” For worst NRPS, study subjects were instructed to “Please rate your pain by indicating the number that best describes your worst pain in the last 24 hours.”|units on a scale|Mean|7.60|7.6|Standard Deviation|1.63|1.63|||
4048273|NCT01106404|3870054|B1|||worst Numeric Pain Rating Scale (NPRS)|NPRS is a 11-point scale with numbers from 0 to 10, with 0 meaning “No pain” and 10 meaning “Pain as bad as you can imagine.” For worst NRPS, study subjects were instructed to “Please rate your pain by indicating the number that best describes your worst pain in the last 24 hours.”|units on a scale|Mean|7.60|7.6|Standard Deviation|1.15|1.15|||
4048274|NCT01106404|3870052|B3|||average Numeric Pain Rating Scale (NPRS)|NPRS is a 11-point scale with numbers from 0 to 10, with 0 meaning “No pain” and 10 meaning “Pain as bad as you can imagine.” For average NPRS, study subjects were instructed to “Please rate your pain by indicating the number that best describes your pain on average in the last 24 hours.”|units on a scale|Mean|6.06|6.06|Standard Deviation|1.86|1.86|||
4048275|NCT01106404|3870053|B2|||average Numeric Pain Rating Scale (NPRS)|NPRS is a 11-point scale with numbers from 0 to 10, with 0 meaning “No pain” and 10 meaning “Pain as bad as you can imagine.” For average NPRS, study subjects were instructed to “Please rate your pain by indicating the number that best describes your pain on average in the last 24 hours.”|units on a scale|Mean|5.88|5.88|Standard Deviation|2.15|2.15|||
4048276|NCT01106404|3870054|B1|||average Numeric Pain Rating Scale (NPRS)|NPRS is a 11-point scale with numbers from 0 to 10, with 0 meaning “No pain” and 10 meaning “Pain as bad as you can imagine.” For average NPRS, study subjects were instructed to “Please rate your pain by indicating the number that best describes your pain on average in the last 24 hours.”|units on a scale|Mean|6.26|6.26|Standard Deviation|1.48|1.48|||
4048277|NCT01106404|3870052|B3|United States||Region of Enrollment||participants|Number|76|76.0||||||
4048278|NCT01106404|3870053|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4048279|NCT01106404|3870054|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4048280|NCT01106404|3870052|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4048281|NCT01106404|3870053|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4048282|NCT01106404|3870054|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4048283|NCT01106404|3870052|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4048284|NCT01106404|3870053|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4048285|NCT01106404|3870054|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4048286|NCT01106404|3870052|B3|||Age||years|Mean|52.8|52.8|Standard Deviation|13.5|13.5|||
4048287|NCT01106404|3870053|B2|||Age||years|Mean|53.1|53.1|Standard Deviation|14.1|14.1|||
4048288|NCT01106404|3870054|B1|||Age||years|Mean|52.5|52.5|Standard Deviation|13.0|13.0|||
4048289|NCT01106404|3870052|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4048290|NCT01106404|3870053|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4048291|NCT01106404|3870054|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4048292|NCT01106404|3870052|B3||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4048293|NCT01106404|3870053|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4048294|NCT01106404|3870054|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4048295|NCT01106404|3870052|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4048296|NCT01106404|3870053|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4048297|NCT01106404|3870054|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4048298|NCT01106391|3870068|B1|Free of Hypertension||Hypertension||participants|Number|3|3.0||||||
4048299|NCT01106391|3870068|B1|Hypertension||Hypertension||participants|Number|57|57.0||||||
4048301|NCT01106391|3870068|B1|Non-insulin-dependent diabetes||Diabetes||participants|Number|10|10.0||||||
4048302|NCT01106391|3870068|B1|Insulin-dependent diabetes||Diabetes||participants|Number|3|3.0||||||
4048303|NCT01106391|3870068|B1|||Body mass index||kg/m²|Mean|26.7|26.7|Standard Deviation|3.1|3.1|||
4048304|NCT01106391|3870068|B1|Italy||Region of Enrollment||participants|Number|29|29.0||||||
4048305|NCT01106391|3870068|B1|Germany||Region of Enrollment||participants|Number|31|31.0||||||
4048306|NCT01106391|3870068|B1||Male|Gender||Participants|Count of Participants|57|57.0||||||
4048307|NCT01106391|3870068|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
4048308|NCT01106391|3870068|B1|||Age||years|Mean|74.4|74.4|Standard Deviation|6.9|6.9|||
4048309|NCT01106352|3870073|B6||Male|Gender||Participants|Count of Participants|70|70.0||||||
4048310|NCT01106352|3870074|B5||Male|Gender||Participants|Count of Participants|17|17.0||||||
4048311|NCT01106352|3870075|B4||Male|Gender||Participants|Count of Participants|36|36.0||||||
4048312|NCT01106352|3870076|B3||Male|Gender||Participants|Count of Participants|7|7.0||||||
4048313|NCT01106352|3870077|B2||Male|Gender||Participants|Count of Participants|3|3.0||||||
4048314|NCT01106352|3870078|B1||Male|Gender||Participants|Count of Participants|7|7.0||||||
4048315|NCT01106352|3870073|B6||Female|Gender||Participants|Count of Participants|0|0.0||||||
4048316|NCT01106352|3870074|B5||Female|Gender||Participants|Count of Participants|0|0.0||||||
4048317|NCT01106352|3870075|B4||Female|Gender||Participants|Count of Participants|0|0.0||||||
4048318|NCT01106352|3870076|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
4048319|NCT01106352|3870077|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
4048320|NCT01106352|3870078|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
4048321|NCT01106352|3870073|B6|>65 years||Age, Customized||participants|Number|45|45.0||||||
4048322|NCT01106352|3870074|B5|>65 years||Age, Customized||participants|Number|10|10.0||||||
4048323|NCT01106352|3870075|B4|>65 years||Age, Customized||participants|Number|25|25.0||||||
4048324|NCT01106352|3870076|B3|>65 years||Age, Customized||participants|Number|4|4.0||||||
4048325|NCT01106352|3870077|B2|>65 years||Age, Customized||participants|Number|1|1.0||||||
4048326|NCT01106352|3870078|B1|>65 years||Age, Customized||participants|Number|5|5.0||||||
4048327|NCT01106352|3870073|B6|Between 18 and 65 years||Age, Customized||participants|Number|25|25.0||||||
4048328|NCT01106352|3870074|B5|Between 18 and 65 years||Age, Customized||participants|Number|7|7.0||||||
4048329|NCT01106352|3870075|B4|Between 18 and 65 years||Age, Customized||participants|Number|11|11.0||||||
4048330|NCT01106352|3870076|B3|Between 18 and 65 years||Age, Customized||participants|Number|3|3.0||||||
4048331|NCT01106352|3870077|B2|Between 18 and 65 years||Age, Customized||participants|Number|2|2.0||||||
4048332|NCT01106352|3870078|B1|Between 18 and 65 years||Age, Customized||participants|Number|2|2.0||||||
4048333|NCT01106352|3870073|B6|<18 years||Age, Customized||participants|Number|0|0.0||||||
4048334|NCT01106352|3870074|B5|<18 years||Age, Customized||participants|Number|0|0.0||||||
4048335|NCT01106352|3870075|B4|<18 years||Age, Customized||participants|Number|0|0.0||||||
4048336|NCT01106352|3870076|B3|<18 years||Age, Customized||participants|Number|0|0.0||||||
4048337|NCT01106352|3870077|B2|<18 years||Age, Customized||participants|Number|0|0.0||||||
4048338|NCT01106352|3870078|B1|<18 years||Age, Customized||participants|Number|0|0.0||||||
4048339|NCT01106326|3870168|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4048340|NCT01106326|3870168|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4048341|NCT01106326|3870168|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4048342|NCT01106326|3870168|B1|||Age||years|Mean|13.6|13.6|Standard Deviation|1.1|1.1|||
4048343|NCT01106326|3870168|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4048344|NCT01106326|3870168|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4048345|NCT01106326|3870168|B1||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4048346|NCT01106287|3870174|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4048347|NCT01106287|3870175|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4048348|NCT01106287|3870176|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4048349|NCT01106287|3870177|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4048350|NCT01106287|3870178|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4048351|NCT01106287|3870174|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4048352|NCT01106287|3870175|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4048353|NCT01106287|3870176|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4048354|NCT01106287|3870177|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4048355|NCT01106287|3870178|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4048356|NCT01106287|3870174|B5|||Age||years|Mean|51.4|51.4|Standard Deviation|8.64|8.64|||
4048357|NCT01106287|3870175|B4|||Age||years|Mean|52.3|52.3|Standard Deviation|7.51|7.51|||
4048358|NCT01106287|3870176|B3|||Age||years|Mean|54.7|54.7|Standard Deviation|12.10|12.1|||
4048359|NCT01106287|3870177|B2|||Age||years|Mean|55.0|55.0|Standard Deviation|7.81|7.81|||
4048360|NCT01106287|3870178|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|7.19|7.19|||
4048361|NCT01106248|3870201|B1|France||Region of Enrollment||participants|Number|26|26.0||||||
4048362|NCT01106248|3870201|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4048363|NCT01106248|3870201|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048364|NCT01106248|3870201|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4048365|NCT01106248|3870201|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4048366|NCT01106248|3870201|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048367|NCT01106248|3870201|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048368|NCT01106248|3870201|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048369|NCT01106248|3870201|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4048370|NCT01106248|3870201|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4048371|NCT01106248|3870201|B1|||Age||years|Mean|55.9|55.9|Standard Deviation|12.28|12.28|||
4048372|NCT01106157|3870207|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4048373|NCT01106157|3870208|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4048374|NCT01106157|3870209|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4048375|NCT01106157|3870207|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4048376|NCT01106157|3870208|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4048377|NCT01106157|3870209|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4048378|NCT01106157|3870207|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4048379|NCT01106157|3870208|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4048380|NCT01106157|3870209|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4048381|NCT01106157|3870207|B3|||Age||years|Mean|23.61|23.61|Standard Deviation|10.0|10.0|||
4048382|NCT01106157|3870208|B2|||Age||years|Mean|23.55|23.55|Standard Deviation|10.6|10.6|||
4048383|NCT01106157|3870209|B1|||Age||years|Mean|23.64|23.64|Standard Deviation|10|10.0|||
4048384|NCT01106157|3870207|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4048385|NCT01106157|3870208|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4048386|NCT01106157|3870209|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4048387|NCT01106157|3870207|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4048388|NCT01106157|3870208|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4048389|NCT01106157|3870209|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4048390|NCT01106157|3870207|B3||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4048391|NCT01106157|3870208|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4048392|NCT01106157|3870209|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4048393|NCT01106092|3870234|B5|Asian-South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|312|312.0||||||
4048394|NCT01106092|3870235|B4|Asian-South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|78|78.0||||||
4048395|NCT01106092|3870236|B3|Asian-South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|78|78.0||||||
4048396|NCT01106092|3870237|B2|Asian-South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|78|78.0||||||
4048397|NCT01106092|3870238|B1|Asian-South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|78|78.0||||||
4048398|NCT01106092|3870234|B5||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4048399|NCT01106092|3870235|B4||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4048400|NCT01106092|3870236|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4048401|NCT01106092|3870237|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4048402|NCT01106092|3870238|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4048403|NCT01106092|3870234|B5||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4048404|NCT01106092|3870235|B4||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4048405|NCT01106092|3870236|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4048406|NCT01106092|3870237|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4048407|NCT01106092|3870238|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4048408|NCT01106092|3870234|B5|||Age||Months|Mean|17.65|17.65|Standard Deviation|3.44|3.44|||
4048409|NCT01106092|3870235|B4|||Age||Months|Mean|17.5|17.5|Standard Deviation|3.59|3.59|||
4048410|NCT01106092|3870236|B3|||Age||Months|Mean|17.7|17.7|Standard Deviation|3.38|3.38|||
4048411|NCT01106092|3870237|B2|||Age||Months|Mean|18|18.0|Standard Deviation|2.96|2.96|||
4048412|NCT01106092|3870238|B1|||Age||Months|Mean|17.4|17.4|Standard Deviation|3.81|3.81|||
4048413|NCT01106040|3870319|B1|United States||Region of Enrollment||participants|Number|153|153.0||||||
4048414|NCT01106040|3870319|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4048415|NCT01106040|3870319|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4048416|NCT01106040|3870319|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|12.4|12.4|||
4048417|NCT01106040|3870319|B1||>=65 years|Age||Participants|Count of Participants|52|52.0||||||
4048418|NCT01106040|3870319|B1||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
4048419|NCT01106040|3870319|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4048420|NCT01106027|3870324|B1|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4048421|NCT01106027|3870324|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4048422|NCT01106027|3870324|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4048423|NCT01106027|3870324|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4048424|NCT01106027|3870324|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4048425|NCT01106027|3870324|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4048426|NCT01106014|3870328|B3|||6-minute walk distance (6MWD) at baseline||Meters|Median|372|372.0|Full Range|||50.0|515.0|
4048427|NCT01106014|3870329|B2|||6-minute walk distance (6MWD) at baseline||Meters|Median|369|369.0|Full Range|||50.0|515.0|
4048428|NCT01106014|3870330|B1|||6-minute walk distance (6MWD) at baseline||Meters|Median|376|376.0|Full Range|||90.0|482.0|
4048429|NCT01106014|3870328|B3|||Time since PAH diagnosis||Years|Median|1.0|1.0|Full Range|||0.0|38.9|
4048430|NCT01106014|3870329|B2|||Time since PAH diagnosis||Years|Median|1.1|1.1|Full Range|||0.0|38.9|
4048431|NCT01106014|3870330|B1|||Time since PAH diagnosis||Years|Median|0.9|0.9|Full Range|||0.0|37.3|
4048432|NCT01106014|3870328|B3|ERA and PDE5I in combination||PAH medications at baseline|Number of patients receiving PAH background medication at the time of study drug start|Participants|Number|376|376.0||||||
4048433|NCT01106014|3870329|B2|ERA and PDE5I in combination||PAH medications at baseline|Number of patients receiving PAH background medication at the time of study drug start|Participants|Number|197|197.0||||||
4048434|NCT01106014|3870330|B1|ERA and PDE5I in combination||PAH medications at baseline|Number of patients receiving PAH background medication at the time of study drug start|Participants|Number|179|179.0||||||
4048435|NCT01106014|3870328|B3|Phosphodiesterase type 5 inhibitors (PDE5-I)||PAH medications at baseline|Number of patients receiving PAH background medication at the time of study drug start|Participants|Number|374|374.0||||||
4048436|NCT01106014|3870329|B2|Phosphodiesterase type 5 inhibitors (PDE5-I)||PAH medications at baseline|Number of patients receiving PAH background medication at the time of study drug start|Participants|Number|185|185.0||||||
4048437|NCT01106014|3870330|B1|Phosphodiesterase type 5 inhibitors (PDE5-I)||PAH medications at baseline|Number of patients receiving PAH background medication at the time of study drug start|Participants|Number|189|189.0||||||
4048438|NCT01106014|3870328|B3|Endothelin Receptor Agonists (ERA)||PAH medications at baseline|Number of patients receiving PAH background medication at the time of study drug start|Participants|Number|170|170.0||||||
4048439|NCT01106014|3870329|B2|Endothelin Receptor Agonists (ERA)||PAH medications at baseline|Number of patients receiving PAH background medication at the time of study drug start|Participants|Number|76|76.0||||||
4048440|NCT01106014|3870330|B1|Endothelin Receptor Agonists (ERA)||PAH medications at baseline|Number of patients receiving PAH background medication at the time of study drug start|Participants|Number|94|94.0||||||
4048441|NCT01106014|3870328|B3|None||PAH medications at baseline|Number of patients receiving PAH background medication at the time of study drug start|Participants|Number|236|236.0||||||
4048442|NCT01106014|3870329|B2|None||PAH medications at baseline|Number of patients receiving PAH background medication at the time of study drug start|Participants|Number|124|124.0||||||
4048443|NCT01106014|3870330|B1|None||PAH medications at baseline|Number of patients receiving PAH background medication at the time of study drug start|Participants|Number|112|112.0||||||
4048444|NCT01106014|3870328|B3|FC IV||Modified NYHA/WHO Functional class (FC)|Number of patients in each NYHA/WHO Functional class (FC) at screening. The WHO FC ranges from I to IV, with higher ranges indicating more severe functional restrictions|Participants|Number|11|11.0||||||
4048445|NCT01106014|3870329|B2|FC IV||Modified NYHA/WHO Functional class (FC)|Number of patients in each NYHA/WHO Functional class (FC) at screening. The WHO FC ranges from I to IV, with higher ranges indicating more severe functional restrictions|Participants|Number|8|8.0||||||
4048446|NCT01106014|3870330|B1|FC IV||Modified NYHA/WHO Functional class (FC)|Number of patients in each NYHA/WHO Functional class (FC) at screening. The WHO FC ranges from I to IV, with higher ranges indicating more severe functional restrictions|Participants|Number|3|3.0||||||
4048447|NCT01106014|3870328|B3|FC III||Modified NYHA/WHO Functional class (FC)|Number of patients in each NYHA/WHO Functional class (FC) at screening. The WHO FC ranges from I to IV, with higher ranges indicating more severe functional restrictions|Participants|Number|607|607.0||||||
4048448|NCT01106014|3870329|B2|FC III||Modified NYHA/WHO Functional class (FC)|Number of patients in each NYHA/WHO Functional class (FC) at screening. The WHO FC ranges from I to IV, with higher ranges indicating more severe functional restrictions|Participants|Number|314|314.0||||||
4048449|NCT01106014|3870330|B1|FC III||Modified NYHA/WHO Functional class (FC)|Number of patients in each NYHA/WHO Functional class (FC) at screening. The WHO FC ranges from I to IV, with higher ranges indicating more severe functional restrictions|Participants|Number|293|293.0||||||
4048450|NCT01106014|3870328|B3|FC II||Modified NYHA/WHO Functional class (FC)|Number of patients in each NYHA/WHO Functional class (FC) at screening. The WHO FC ranges from I to IV, with higher ranges indicating more severe functional restrictions|Participants|Number|529|529.0||||||
4048451|NCT01106014|3870329|B2|FC II||Modified NYHA/WHO Functional class (FC)|Number of patients in each NYHA/WHO Functional class (FC) at screening. The WHO FC ranges from I to IV, with higher ranges indicating more severe functional restrictions|Participants|Number|255|255.0||||||
4048452|NCT01106014|3870330|B1|FC II||Modified NYHA/WHO Functional class (FC)|Number of patients in each NYHA/WHO Functional class (FC) at screening. The WHO FC ranges from I to IV, with higher ranges indicating more severe functional restrictions|Participants|Number|274|274.0||||||
4048453|NCT01106014|3870328|B3|FC I||Modified NYHA/WHO Functional class (FC)|Number of patients in each NYHA/WHO Functional class (FC) at screening. The WHO FC ranges from I to IV, with higher ranges indicating more severe functional restrictions|Participants|Number|9|9.0||||||
4048454|NCT01106014|3870329|B2|FC I||Modified NYHA/WHO Functional class (FC)|Number of patients in each NYHA/WHO Functional class (FC) at screening. The WHO FC ranges from I to IV, with higher ranges indicating more severe functional restrictions|Participants|Number|5|5.0||||||
4048455|NCT01106014|3870330|B1|FC I||Modified NYHA/WHO Functional class (FC)|Number of patients in each NYHA/WHO Functional class (FC) at screening. The WHO FC ranges from I to IV, with higher ranges indicating more severe functional restrictions|Participants|Number|4|4.0||||||
4048456|NCT01106014|3870328|B3|Associated with HIV infection||PAH etiology|Number of patients in each PAH etiology category|Participants|Number|10|10.0||||||
4048457|NCT01106014|3870329|B2|Associated with HIV infection||PAH etiology|Number of patients in each PAH etiology category|Participants|Number|5|5.0||||||
4048513|NCT01105975|3870341|B11|||Fasting Triglycerides||mg/dL|Mean|139.8|139.8|Standard Deviation|71.1|71.1|||
4048458|NCT01106014|3870330|B1|Associated with HIV infection||PAH etiology|Number of patients in each PAH etiology category|Participants|Number|5|5.0||||||
4048459|NCT01106014|3870328|B3|Associated with drug or toxin exposure||PAH etiology|Number of patients in each PAH etiology category|Participants|Number|27|27.0||||||
4048460|NCT01106014|3870329|B2|Associated with drug or toxin exposure||PAH etiology|Number of patients in each PAH etiology category|Participants|Number|10|10.0||||||
4048461|NCT01106014|3870330|B1|Associated with drug or toxin exposure||PAH etiology|Number of patients in each PAH etiology category|Participants|Number|17|17.0||||||
4048462|NCT01106014|3870328|B3|Assoc. with corrected (>=12Mo) congenital shunts||PAH etiology|Number of patients in each PAH etiology category|Participants|Number|110|110.0||||||
4048463|NCT01106014|3870329|B2|Assoc. with corrected (>=12Mo) congenital shunts||PAH etiology|Number of patients in each PAH etiology category|Participants|Number|50|50.0||||||
4048464|NCT01106014|3870330|B1|Assoc. with corrected (>=12Mo) congenital shunts||PAH etiology|Number of patients in each PAH etiology category|Participants|Number|60|60.0||||||
4048465|NCT01106014|3870328|B3|Associated with connective tissue disease||PAH etiology|Number of patients in each PAH etiology category|Participants|Number|334|334.0||||||
4048466|NCT01106014|3870329|B2|Associated with connective tissue disease||PAH etiology|Number of patients in each PAH etiology category|Participants|Number|167|167.0||||||
4048467|NCT01106014|3870330|B1|Associated with connective tissue disease||PAH etiology|Number of patients in each PAH etiology category|Participants|Number|167|167.0||||||
4048468|NCT01106014|3870328|B3|Heritable||PAH etiology|Number of patients in each PAH etiology category|Participants|Number|26|26.0||||||
4048469|NCT01106014|3870329|B2|Heritable||PAH etiology|Number of patients in each PAH etiology category|Participants|Number|13|13.0||||||
4048470|NCT01106014|3870330|B1|Heritable||PAH etiology|Number of patients in each PAH etiology category|Participants|Number|13|13.0||||||
4048471|NCT01106014|3870328|B3|Idiopathic||PAH etiology|Number of patients in each PAH etiology category|Participants|Number|649|649.0||||||
4048472|NCT01106014|3870329|B2|Idiopathic||PAH etiology|Number of patients in each PAH etiology category|Participants|Number|337|337.0||||||
4048473|NCT01106014|3870330|B1|Idiopathic||PAH etiology|Number of patients in each PAH etiology category|Participants|Number|312|312.0||||||
4048474|NCT01106014|3870328|B3|Latin America||Region of Enrollment||Participants|Number|110|110.0||||||
4048475|NCT01106014|3870329|B2|Latin America||Region of Enrollment||Participants|Number|56|56.0||||||
4048476|NCT01106014|3870330|B1|Latin America||Region of Enrollment||Participants|Number|54|54.0||||||
4048477|NCT01106014|3870328|B3|North America||Region of Enrollment||Participants|Number|193|193.0||||||
4048478|NCT01106014|3870329|B2|North America||Region of Enrollment||Participants|Number|98|98.0||||||
4048479|NCT01106014|3870330|B1|North America||Region of Enrollment||Participants|Number|95|95.0||||||
4048480|NCT01106014|3870328|B3|Asia||Region of Enrollment||Participants|Number|228|228.0||||||
4048481|NCT01106014|3870329|B2|Asia||Region of Enrollment||Participants|Number|113|113.0||||||
4048482|NCT01106014|3870330|B1|Asia||Region of Enrollment||Participants|Number|115|115.0||||||
4048483|NCT01106014|3870328|B3|Eastern Europe||Region of Enrollment||Participants|Number|304|304.0||||||
4048484|NCT01106014|3870329|B2|Eastern Europe||Region of Enrollment||Participants|Number|155|155.0||||||
4048485|NCT01106014|3870330|B1|Eastern Europe||Region of Enrollment||Participants|Number|149|149.0||||||
4048486|NCT01106014|3870328|B3|Western Europe & Australia||Region of Enrollment||Participants|Number|321|321.0||||||
4048487|NCT01106014|3870329|B2|Western Europe & Australia||Region of Enrollment||Participants|Number|160|160.0||||||
4048488|NCT01106014|3870330|B1|Western Europe & Australia||Region of Enrollment||Participants|Number|161|161.0||||||
4048489|NCT01106014|3870328|B3|Other||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4048490|NCT01106014|3870329|B2|Other||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4048491|NCT01106014|3870330|B1|Other||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4048492|NCT01106014|3870328|B3|Black||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
4048493|NCT01106014|3870329|B2|Black||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4048494|NCT01106014|3870330|B1|Black||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4048495|NCT01106014|3870328|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|114|114.0||||||
4048496|NCT01106014|3870329|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|63|63.0||||||
4048497|NCT01106014|3870330|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|51|51.0||||||
4048498|NCT01106014|3870328|B3|Asian||Race/Ethnicity, Customized||Participants|Number|245|245.0||||||
4048499|NCT01106014|3870329|B2|Asian||Race/Ethnicity, Customized||Participants|Number|120|120.0||||||
4048500|NCT01106014|3870330|B1|Asian||Race/Ethnicity, Customized||Participants|Number|125|125.0||||||
4048501|NCT01106014|3870328|B3|Caucasion / White||Race/Ethnicity, Customized||Participants|Number|751|751.0||||||
4048502|NCT01106014|3870329|B2|Caucasion / White||Race/Ethnicity, Customized||Participants|Number|375|375.0||||||
4048503|NCT01106014|3870330|B1|Caucasion / White||Race/Ethnicity, Customized||Participants|Number|376|376.0||||||
4048504|NCT01106014|3870328|B3||Male|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
4048505|NCT01106014|3870329|B2||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4048506|NCT01106014|3870330|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4048507|NCT01106014|3870328|B3||Female|Sex: Female, Male||Participants|Count of Participants|923|923.0||||||
4048508|NCT01106014|3870329|B2||Female|Sex: Female, Male||Participants|Count of Participants|466|466.0||||||
4048509|NCT01106014|3870330|B1||Female|Sex: Female, Male||Participants|Count of Participants|457|457.0||||||
4048510|NCT01106014|3870328|B3|||Age||Years|Mean|48.1|48.1|Standard Deviation|15.37|15.37|||
4048511|NCT01106014|3870329|B2|||Age||Years|Mean|47.9|47.9|Standard Deviation|15.55|15.55|||
4048512|NCT01106014|3870330|B1|||Age||Years|Mean|48.2|48.2|Standard Deviation|15.19|15.19|||
4048514|NCT01105975|3870342|B10|||Fasting Triglycerides||mg/dL|Mean|138.1|138.1|Standard Deviation|69.0|69.0|||
4048515|NCT01105975|3870343|B9|||Fasting Triglycerides||mg/dL|Mean|142.8|142.8|Standard Deviation|65.6|65.6|||
4048516|NCT01105975|3870344|B8|||Fasting Triglycerides||mg/dL|Mean|142.4|142.4|Standard Deviation|62.4|62.4|||
4048517|NCT01105975|3870345|B7|||Fasting Triglycerides||mg/dL|Mean|145.3|145.3|Standard Deviation|84.6|84.6|||
4048518|NCT01105975|3870346|B6|||Fasting Triglycerides||mg/dL|Mean|133.0|133.0|Standard Deviation|67.8|67.8|||
4048519|NCT01105975|3870347|B5|||Fasting Triglycerides||mg/dL|Mean|144.1|144.1|Standard Deviation|83.4|83.4|||
4048520|NCT01105975|3870348|B4|||Fasting Triglycerides||mg/dL|Mean|154.4|154.4|Standard Deviation|93.0|93.0|||
4048521|NCT01105975|3870349|B3|||Fasting Triglycerides||mg/dL|Mean|133.1|133.1|Standard Deviation|69.8|69.8|||
4048522|NCT01105975|3870350|B2|||Fasting Triglycerides||mg/dL|Mean|129.8|129.8|Standard Deviation|51.7|51.7|||
4048523|NCT01105975|3870351|B1|||Fasting Triglycerides||mg/dL|Mean|133.9|133.9|Standard Deviation|56.6|56.6|||
4048524|NCT01105975|3870341|B11|||Low-Density Lipoprotein Cholesterol (LDL-C)||mg/dL|Mean|144.3|144.3|Standard Deviation|26.6|26.6|||
4048525|NCT01105975|3870342|B10|||Low-Density Lipoprotein Cholesterol (LDL-C)||mg/dL|Mean|145.7|145.7|Standard Deviation|21.8|21.8|||
4048526|NCT01105975|3870343|B9|||Low-Density Lipoprotein Cholesterol (LDL-C)||mg/dL|Mean|141.6|141.6|Standard Deviation|23.8|23.8|||
4048527|NCT01105975|3870344|B8|||Low-Density Lipoprotein Cholesterol (LDL-C)||mg/dL|Mean|143.7|143.7|Standard Deviation|29.1|29.1|||
4048528|NCT01105975|3870345|B7|||Low-Density Lipoprotein Cholesterol (LDL-C)||mg/dL|Mean|154.8|154.8|Standard Deviation|35.1|35.1|||
4048529|NCT01105975|3870346|B6|||Low-Density Lipoprotein Cholesterol (LDL-C)||mg/dL|Mean|143.6|143.6|Standard Deviation|26.0|26.0|||
4048530|NCT01105975|3870347|B5|||Low-Density Lipoprotein Cholesterol (LDL-C)||mg/dL|Mean|139.0|139.0|Standard Deviation|26.7|26.7|||
4048531|NCT01105975|3870348|B4|||Low-Density Lipoprotein Cholesterol (LDL-C)||mg/dL|Mean|147.3|147.3|Standard Deviation|21.6|21.6|||
4048532|NCT01105975|3870349|B3|||Low-Density Lipoprotein Cholesterol (LDL-C)||mg/dL|Mean|135.7|135.7|Standard Deviation|26.0|26.0|||
4048533|NCT01105975|3870350|B2|||Low-Density Lipoprotein Cholesterol (LDL-C)||mg/dL|Mean|148.0|148.0|Standard Deviation|25.0|25.0|||
4048534|NCT01105975|3870351|B1|||Low-Density Lipoprotein Cholesterol (LDL-C)||mg/dL|Mean|143.5|143.5|Standard Deviation|26.0|26.0|||
4048535|NCT01105975|3870341|B11|||High-Density Lipoprotein Cholesterol (HDL-C)||milligram/deciliter (mg/dL)|Mean|55.1|55.1|Standard Deviation|15.3|15.3|||
4048536|NCT01105975|3870342|B10|||High-Density Lipoprotein Cholesterol (HDL-C)||milligram/deciliter (mg/dL)|Mean|57.8|57.8|Standard Deviation|18.1|18.1|||
4048537|NCT01105975|3870343|B9|||High-Density Lipoprotein Cholesterol (HDL-C)||milligram/deciliter (mg/dL)|Mean|53.5|53.5|Standard Deviation|15.2|15.2|||
4048538|NCT01105975|3870344|B8|||High-Density Lipoprotein Cholesterol (HDL-C)||milligram/deciliter (mg/dL)|Mean|53.7|53.7|Standard Deviation|13.6|13.6|||
4048539|NCT01105975|3870345|B7|||High-Density Lipoprotein Cholesterol (HDL-C)||milligram/deciliter (mg/dL)|Mean|57.3|57.3|Standard Deviation|16.2|16.2|||
4048540|NCT01105975|3870346|B6|||High-Density Lipoprotein Cholesterol (HDL-C)||milligram/deciliter (mg/dL)|Mean|55.7|55.7|Standard Deviation|18.2|18.2|||
4048541|NCT01105975|3870347|B5|||High-Density Lipoprotein Cholesterol (HDL-C)||milligram/deciliter (mg/dL)|Mean|53.9|53.9|Standard Deviation|17.0|17.0|||
4048542|NCT01105975|3870348|B4|||High-Density Lipoprotein Cholesterol (HDL-C)||milligram/deciliter (mg/dL)|Mean|53.0|53.0|Standard Deviation|11.8|11.8|||
4048543|NCT01105975|3870349|B3|||High-Density Lipoprotein Cholesterol (HDL-C)||milligram/deciliter (mg/dL)|Mean|54.7|54.7|Standard Deviation|16.3|16.3|||
4048544|NCT01105975|3870350|B2|||High-Density Lipoprotein Cholesterol (HDL-C)||milligram/deciliter (mg/dL)|Mean|57.0|57.0|Standard Deviation|14.1|14.1|||
4048545|NCT01105975|3870351|B1|||High-Density Lipoprotein Cholesterol (HDL-C)||milligram/deciliter (mg/dL)|Mean|54.7|54.7|Standard Deviation|12.0|12.0|||
4048546|NCT01105975|3870341|B11|||Body Mass Index (BMI)||kilogram/square meter (kg/m²)|Mean|29.0|29.0|Standard Deviation|5.8|5.8|||
4048547|NCT01105975|3870342|B10|||Body Mass Index (BMI)||kilogram/square meter (kg/m²)|Mean|28.4|28.4|Standard Deviation|5.3|5.3|||
4048548|NCT01105975|3870343|B9|||Body Mass Index (BMI)||kilogram/square meter (kg/m²)|Mean|28.3|28.3|Standard Deviation|4.2|4.2|||
4048549|NCT01105975|3870344|B8|||Body Mass Index (BMI)||kilogram/square meter (kg/m²)|Mean|29.9|29.9|Standard Deviation|5.3|5.3|||
4048550|NCT01105975|3870345|B7|||Body Mass Index (BMI)||kilogram/square meter (kg/m²)|Mean|28.3|28.3|Standard Deviation|5.0|5.0|||
4048551|NCT01105975|3870346|B6|||Body Mass Index (BMI)||kilogram/square meter (kg/m²)|Mean|30.0|30.0|Standard Deviation|7.5|7.5|||
4048552|NCT01105975|3870347|B5|||Body Mass Index (BMI)||kilogram/square meter (kg/m²)|Mean|28.8|28.8|Standard Deviation|5.1|5.1|||
4048553|NCT01105975|3870348|B4|||Body Mass Index (BMI)||kilogram/square meter (kg/m²)|Mean|29.8|29.8|Standard Deviation|6.1|6.1|||
4048554|NCT01105975|3870349|B3|||Body Mass Index (BMI)||kilogram/square meter (kg/m²)|Mean|29.0|29.0|Standard Deviation|5.6|5.6|||
4048555|NCT01105975|3870350|B2|||Body Mass Index (BMI)||kilogram/square meter (kg/m²)|Mean|27.6|27.6|Standard Deviation|5.7|5.7|||
4048556|NCT01105975|3870351|B1|||Body Mass Index (BMI)||kilogram/square meter (kg/m²)|Mean|29.8|29.8|Standard Deviation|7.8|7.8|||
4048557|NCT01105975|3870341|B11|||Weight||kilogram|Mean|83.6|83.6|Standard Deviation|19.0|19.0|||
4048558|NCT01105975|3870342|B10|||Weight||kilogram|Mean|82.2|82.2|Standard Deviation|18.0|18.0|||
4048559|NCT01105975|3870343|B9|||Weight||kilogram|Mean|85.7|85.7|Standard Deviation|19.4|19.4|||
4048560|NCT01105975|3870344|B8|||Weight||kilogram|Mean|84.5|84.5|Standard Deviation|16.7|16.7|||
4048561|NCT01105975|3870345|B7|||Weight||kilogram|Mean|79.6|79.6|Standard Deviation|15.4|15.4|||
4048562|NCT01105975|3870346|B6|||Weight||kilogram|Mean|87.4|87.4|Standard Deviation|22.4|22.4|||
4048563|NCT01105975|3870347|B5|||Weight||kilogram|Mean|81.4|81.4|Standard Deviation|16.4|16.4|||
4048564|NCT01105975|3870348|B4|||Weight||kilogram|Mean|89.3|89.3|Standard Deviation|18.5|18.5|||
4048565|NCT01105975|3870349|B3|||Weight||kilogram|Mean|82.6|82.6|Standard Deviation|20.6|20.6|||
4048566|NCT01105975|3870350|B2|||Weight||kilogram|Mean|79.9|79.9|Standard Deviation|18.3|18.3|||
4048567|NCT01105975|3870351|B1|||Weight||kilogram|Mean|84.6|84.6|Standard Deviation|23.2|23.2|||
4048568|NCT01105975|3870341|B11|United Kingdom||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4048569|NCT01105975|3870342|B10|United Kingdom||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4048570|NCT01105975|3870343|B9|United Kingdom||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4048571|NCT01105975|3870344|B8|United Kingdom||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4048572|NCT01105975|3870345|B7|United Kingdom||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4048573|NCT01105975|3870346|B6|United Kingdom||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4048574|NCT01105975|3870347|B5|United Kingdom||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4048575|NCT01105975|3870348|B4|United Kingdom||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4048576|NCT01105975|3870349|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4048577|NCT01105975|3870350|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4048578|NCT01105975|3870351|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4048579|NCT01105975|3870341|B11|Netherlands||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
4048580|NCT01105975|3870342|B10|Netherlands||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4048581|NCT01105975|3870343|B9|Netherlands||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4048582|NCT01105975|3870344|B8|Netherlands||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4048583|NCT01105975|3870345|B7|Netherlands||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4048584|NCT01105975|3870346|B6|Netherlands||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4048585|NCT01105975|3870347|B5|Netherlands||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4048586|NCT01105975|3870348|B4|Netherlands||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4048587|NCT01105975|3870349|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4048588|NCT01105975|3870350|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4048589|NCT01105975|3870351|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4048590|NCT01105975|3870341|B11|Germany||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4048591|NCT01105975|3870342|B10|Germany||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4048592|NCT01105975|3870343|B9|Germany||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4048593|NCT01105975|3870344|B8|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4048594|NCT01105975|3870345|B7|Germany||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4048595|NCT01105975|3870346|B6|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4048596|NCT01105975|3870347|B5|Germany||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4048597|NCT01105975|3870348|B4|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4048598|NCT01105975|3870349|B3|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4048599|NCT01105975|3870350|B2|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4048600|NCT01105975|3870351|B1|Germany||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4048601|NCT01105975|3870341|B11|Denmark||Region of Enrollment||Participants|Count of Participants|102|102.0||||||
4048602|NCT01105975|3870342|B10|Denmark||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4048603|NCT01105975|3870343|B9|Denmark||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4048604|NCT01105975|3870344|B8|Denmark||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4048605|NCT01105975|3870345|B7|Denmark||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4048606|NCT01105975|3870346|B6|Denmark||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4048607|NCT01105975|3870347|B5|Denmark||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4048608|NCT01105975|3870348|B4|Denmark||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4048609|NCT01105975|3870349|B3|Denmark||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4048610|NCT01105975|3870350|B2|Denmark||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4048611|NCT01105975|3870351|B1|Denmark||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4048612|NCT01105975|3870341|B11|Poland||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4048613|NCT01105975|3870342|B10|Poland||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4048614|NCT01105975|3870343|B9|Poland||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4048615|NCT01105975|3870344|B8|Poland||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4048616|NCT01105975|3870345|B7|Poland||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4048617|NCT01105975|3870346|B6|Poland||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4048618|NCT01105975|3870347|B5|Poland||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4048619|NCT01105975|3870348|B4|Poland||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4048620|NCT01105975|3870349|B3|Poland||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4048621|NCT01105975|3870350|B2|Poland||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4048622|NCT01105975|3870351|B1|Poland||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4048623|NCT01105975|3870341|B11|United States||Region of Enrollment||Participants|Count of Participants|218|218.0||||||
4048624|NCT01105975|3870342|B10|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4048625|NCT01105975|3870343|B9|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4048626|NCT01105975|3870344|B8|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4048627|NCT01105975|3870345|B7|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
4048628|NCT01105975|3870346|B6|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4048629|NCT01105975|3870347|B5|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4048630|NCT01105975|3870348|B4|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4048631|NCT01105975|3870349|B3|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4048632|NCT01105975|3870350|B2|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4048633|NCT01105975|3870351|B1|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4048634|NCT01105975|3870341|B11||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048635|NCT01105975|3870342|B10||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048636|NCT01105975|3870343|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048637|NCT01105975|3870344|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048638|NCT01105975|3870345|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048639|NCT01105975|3870346|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048640|NCT01105975|3870347|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048641|NCT01105975|3870348|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048642|NCT01105975|3870349|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048643|NCT01105975|3870350|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048644|NCT01105975|3870351|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048645|NCT01105975|3870341|B11||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4048646|NCT01105975|3870342|B10||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048647|NCT01105975|3870343|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4048648|NCT01105975|3870344|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4048649|NCT01105975|3870345|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048650|NCT01105975|3870346|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048651|NCT01105975|3870347|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4048652|NCT01105975|3870348|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4048653|NCT01105975|3870349|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4048654|NCT01105975|3870350|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4048655|NCT01105975|3870351|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4048656|NCT01105975|3870341|B11||White|Race (NIH/OMB)||Participants|Count of Participants|365|365.0||||||
4048657|NCT01105975|3870342|B10||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4048658|NCT01105975|3870343|B9||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4048659|NCT01105975|3870344|B8||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4048660|NCT01105975|3870345|B7||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4048661|NCT01105975|3870346|B6||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4048662|NCT01105975|3870347|B5||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4048663|NCT01105975|3870348|B4||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4048664|NCT01105975|3870349|B3||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4048665|NCT01105975|3870350|B2||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4048666|NCT01105975|3870351|B1||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4048667|NCT01105975|3870341|B11||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4048668|NCT01105975|3870342|B10||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4048669|NCT01105975|3870343|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4048670|NCT01105975|3870344|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048671|NCT01105975|3870345|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4048672|NCT01105975|3870346|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4048673|NCT01105975|3870347|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4048674|NCT01105975|3870348|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4048675|NCT01105975|3870349|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4048676|NCT01105975|3870350|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4048677|NCT01105975|3870351|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4048678|NCT01105975|3870341|B11||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048679|NCT01105975|3870342|B10||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048680|NCT01105975|3870343|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048681|NCT01105975|3870344|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048682|NCT01105975|3870345|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048683|NCT01105975|3870346|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048684|NCT01105975|3870347|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048685|NCT01105975|3870348|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048686|NCT01105975|3870349|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048687|NCT01105975|3870350|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048688|NCT01105975|3870351|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048689|NCT01105975|3870341|B11||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4048690|NCT01105975|3870342|B10||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048691|NCT01105975|3870343|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048692|NCT01105975|3870344|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048693|NCT01105975|3870345|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048694|NCT01105975|3870346|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048695|NCT01105975|3870347|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048696|NCT01105975|3870348|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048697|NCT01105975|3870349|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048698|NCT01105975|3870350|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048699|NCT01105975|3870351|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4048700|NCT01105975|3870341|B11||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048701|NCT01105975|3870342|B10||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048702|NCT01105975|3870343|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048703|NCT01105975|3870344|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048704|NCT01105975|3870345|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048705|NCT01105975|3870346|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048706|NCT01105975|3870347|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048707|NCT01105975|3870348|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048708|NCT01105975|3870349|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048709|NCT01105975|3870350|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048710|NCT01105975|3870351|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048711|NCT01105975|3870341|B11||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
4048712|NCT01105975|3870342|B10||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4048713|NCT01105975|3870343|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4048714|NCT01105975|3870344|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4048715|NCT01105975|3870345|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4048716|NCT01105975|3870346|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4048717|NCT01105975|3870347|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4048718|NCT01105975|3870348|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4048719|NCT01105975|3870349|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4048720|NCT01105975|3870350|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4048721|NCT01105975|3870351|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4048722|NCT01105975|3870341|B11||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|282|282.0||||||
4048723|NCT01105975|3870342|B10||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4048724|NCT01105975|3870343|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4048725|NCT01105975|3870344|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4048726|NCT01105975|3870345|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4048727|NCT01105975|3870346|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4048728|NCT01105975|3870347|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4048729|NCT01105975|3870348|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4048730|NCT01105975|3870349|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4048731|NCT01105975|3870350|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4048792|NCT01105767|3870537|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
4048732|NCT01105975|3870351|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4048733|NCT01105975|3870341|B11||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4048734|NCT01105975|3870342|B10||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4048735|NCT01105975|3870343|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4048736|NCT01105975|3870344|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4048737|NCT01105975|3870345|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4048738|NCT01105975|3870346|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4048739|NCT01105975|3870347|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4048740|NCT01105975|3870348|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4048741|NCT01105975|3870349|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4048742|NCT01105975|3870350|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4048743|NCT01105975|3870351|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4048744|NCT01105975|3870341|B11||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4048745|NCT01105975|3870342|B10||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4048746|NCT01105975|3870343|B9||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4048747|NCT01105975|3870344|B8||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4048748|NCT01105975|3870345|B7||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4048749|NCT01105975|3870346|B6||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4048750|NCT01105975|3870347|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4048751|NCT01105975|3870348|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4048752|NCT01105975|3870349|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4048753|NCT01105975|3870350|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4048754|NCT01105975|3870351|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4048755|NCT01105975|3870341|B11||Female|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
4048756|NCT01105975|3870342|B10||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4048757|NCT01105975|3870343|B9||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4048758|NCT01105975|3870344|B8||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4048759|NCT01105975|3870345|B7||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4048760|NCT01105975|3870346|B6||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4048761|NCT01105975|3870347|B5||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4048762|NCT01105975|3870348|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4048763|NCT01105975|3870349|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4048764|NCT01105975|3870350|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4048765|NCT01105975|3870351|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4048766|NCT01105975|3870341|B11|||Age||years|Mean|58.3|58.3|Standard Deviation|10.8|10.8|||
4048767|NCT01105975|3870342|B10|||Age||years|Mean|59.7|59.7|Standard Deviation|10.1|10.1|||
4048768|NCT01105975|3870343|B9|||Age||years|Mean|57.4|57.4|Standard Deviation|12.6|12.6|||
4048769|NCT01105975|3870344|B8|||Age||years|Mean|58.4|58.4|Standard Deviation|9.0|9.0|||
4048770|NCT01105975|3870345|B7|||Age||years|Mean|61.3|61.3|Standard Deviation|10.0|10.0|||
4048771|NCT01105975|3870346|B6|||Age||years|Mean|57.4|57.4|Standard Deviation|11.8|11.8|||
4048772|NCT01105975|3870347|B5|||Age||years|Mean|57.8|57.8|Standard Deviation|11.3|11.3|||
4048773|NCT01105975|3870348|B4|||Age||years|Mean|55.2|55.2|Standard Deviation|10.5|10.5|||
4048774|NCT01105975|3870349|B3|||Age||years|Mean|58.8|58.8|Standard Deviation|12.2|12.2|||
4048775|NCT01105975|3870350|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|9.2|9.2|||
4048776|NCT01105975|3870351|B1|||Age||years|Mean|58.5|58.5|Standard Deviation|11.1|11.1|||
4048777|NCT01105936|3870508|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4048778|NCT01105936|3870508|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4048779|NCT01105936|3870508|B1|Years||Age, Customized||Years|Mean|68.5|68.5|Standard Deviation|7.97|7.97|||
4048780|NCT01105767|3870537|B4|Unknown||Race/Ethnicity, Customized||participants|Number|681|681.0||||||
4048781|NCT01105767|3870538|B3|Unknown||Race/Ethnicity, Customized||participants|Number|262|262.0||||||
4048782|NCT01105767|3870539|B2|Unknown||Race/Ethnicity, Customized||participants|Number|233|233.0||||||
4048783|NCT01105767|3870540|B1|Unknown||Race/Ethnicity, Customized||participants|Number|186|186.0||||||
4048784|NCT01105767|3870537|B4|Other, non-Hispanic||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4048785|NCT01105767|3870538|B3|Other, non-Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4048786|NCT01105767|3870539|B2|Other, non-Hispanic||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4048787|NCT01105767|3870540|B1|Other, non-Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4048788|NCT01105767|3870537|B4|Black, non-Hispanic||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4048789|NCT01105767|3870538|B3|Black, non-Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4048790|NCT01105767|3870539|B2|Black, non-Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4048791|NCT01105767|3870540|B1|Black, non-Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4048793|NCT01105767|3870538|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4048794|NCT01105767|3870539|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4048795|NCT01105767|3870540|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4048796|NCT01105767|3870537|B4|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|431|431.0||||||
4048797|NCT01105767|3870538|B3|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|172|172.0||||||
4048798|NCT01105767|3870539|B2|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|167|167.0||||||
4048799|NCT01105767|3870540|B1|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|92|92.0||||||
4048800|NCT01105767|3870537|B4||Male|Sex: Female, Male||Participants|Count of Participants|1203|1203.0||||||
4048801|NCT01105767|3870538|B3||Male|Sex: Female, Male||Participants|Count of Participants|461|461.0||||||
4048802|NCT01105767|3870539|B2||Male|Sex: Female, Male||Participants|Count of Participants|439|439.0||||||
4048803|NCT01105767|3870540|B1||Male|Sex: Female, Male||Participants|Count of Participants|303|303.0||||||
4048804|NCT01105767|3870537|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4048805|NCT01105767|3870538|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4048806|NCT01105767|3870539|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4048807|NCT01105767|3870540|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4048808|NCT01105767|3870537|B4|||Age||years|Mean|20.3|20.3|Standard Deviation|3.0|3.0|||
4048809|NCT01105767|3870538|B3|||Age||years|Mean|20.3|20.3|Standard Deviation|2.9|2.9|||
4048810|NCT01105767|3870539|B2|||Age||years|Mean|20.3|20.3|Standard Deviation|3.2|3.2|||
4048811|NCT01105767|3870540|B1|||Age||years|Mean|20.4|20.4|Standard Deviation|3.1|3.1|||
4048812|NCT01105754|3870553|B3|United States||Region of Enrollment||participants|Number|638|638.0||||||
4048813|NCT01105754|3870554|B2|United States||Region of Enrollment||participants|Number|319|319.0||||||
4048814|NCT01105754|3870555|B1|United States||Region of Enrollment||participants|Number|319|319.0||||||
4048815|NCT01105754|3870553|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4048816|NCT01105754|3870554|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4048817|NCT01105754|3870555|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4048818|NCT01105754|3870553|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|251|251.0||||||
4048819|NCT01105754|3870554|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
4048820|NCT01105754|3870555|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
4048821|NCT01105754|3870553|B3||White|Race (NIH/OMB)||Participants|Count of Participants|151|151.0||||||
4048822|NCT01105754|3870554|B2||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4048823|NCT01105754|3870555|B1||White|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
4048824|NCT01105754|3870553|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|230|230.0||||||
4048825|NCT01105754|3870554|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|127|127.0||||||
4048826|NCT01105754|3870555|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
4048827|NCT01105754|3870553|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048828|NCT01105754|3870554|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048829|NCT01105754|3870555|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048830|NCT01105754|3870553|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048831|NCT01105754|3870554|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048832|NCT01105754|3870555|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048833|NCT01105754|3870553|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048834|NCT01105754|3870554|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048835|NCT01105754|3870555|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048836|NCT01105754|3870553|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048837|NCT01105754|3870554|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048838|NCT01105754|3870555|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048839|NCT01105754|3870553|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|409|409.0||||||
4048840|NCT01105754|3870554|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|216|216.0||||||
4048841|NCT01105754|3870555|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|193|193.0||||||
4048842|NCT01105754|3870553|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|229|229.0||||||
4048843|NCT01105754|3870554|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
4048844|NCT01105754|3870555|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
4048845|NCT01105754|3870553|B3||Male|Sex: Female, Male||Participants|Count of Participants|367|367.0||||||
4048846|NCT01105754|3870554|B2||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4048847|NCT01105754|3870555|B1||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4048848|NCT01105754|3870553|B3||Female|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
4048849|NCT01105754|3870554|B2||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4048850|NCT01105754|3870555|B1||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4048851|NCT01105754|3870553|B3|||Age||years|Mean|6.71|6.71|Standard Deviation|3.0|3.0|||
4048852|NCT01105754|3870554|B2|||Age||years|Mean|6.72|6.72|Standard Deviation|3.0|3.0|||
4048853|NCT01105754|3870555|B1|||Age||years|Mean|6.70|6.7|Standard Deviation|2.9|2.9|||
4048854|NCT01105702|3870564|B1|Grade IV||World Health Organization Grade (staging)|"Grade III: Malignant although there is not always a big difference between grade II and grade III tumors. The cells of a grade III tumor are actively reproducing abnormal cells, which grow into nearby normal brain tissue. These tumors tend to recur, often as a grade IV.~Grade IV: These are the most malignant tumors. They reproduce rapidly, can have a bizarre appearance when viewed under the microscope, and easily grow into nearby normal brain tissue. These tumors form new blood vessels so they can maintain their rapid growth."|participants|Number|20|20.0||||||
4048855|NCT01105702|3870564|B1|Grade III||World Health Organization Grade (staging)|"Grade III: Malignant although there is not always a big difference between grade II and grade III tumors. The cells of a grade III tumor are actively reproducing abnormal cells, which grow into nearby normal brain tissue. These tumors tend to recur, often as a grade IV.~Grade IV: These are the most malignant tumors. They reproduce rapidly, can have a bizarre appearance when viewed under the microscope, and easily grow into nearby normal brain tissue. These tumors form new blood vessels so they can maintain their rapid growth."|participants|Number|8|8.0||||||
4048856|NCT01105702|3870564|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4048857|NCT01105702|3870564|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4048858|NCT01105702|3870564|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4048859|NCT01105702|3870564|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4048860|NCT01105702|3870564|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4048861|NCT01105702|3870564|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4048862|NCT01105702|3870564|B1|||Age||years|Median|56|56.0|Full Range|||23.0|77.0|
4048863|NCT01105650|3870571|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4048864|NCT01105650|3870572|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4048865|NCT01105650|3870573|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4048866|NCT01105650|3870574|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4048867|NCT01105650|3870571|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4048868|NCT01105650|3870572|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4048869|NCT01105650|3870573|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4048870|NCT01105650|3870574|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4048871|NCT01105650|3870571|B4||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4048872|NCT01105650|3870572|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4048873|NCT01105650|3870573|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4048874|NCT01105650|3870574|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4048875|NCT01105650|3870571|B4||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4048876|NCT01105650|3870572|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4048877|NCT01105650|3870573|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4048878|NCT01105650|3870574|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4048879|NCT01105650|3870571|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4048880|NCT01105650|3870572|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4048881|NCT01105650|3870573|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4048882|NCT01105650|3870574|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4048883|NCT01105533|3870594|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4048884|NCT01105533|3870594|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4048885|NCT01105533|3870594|B1|||Age||years|Mean|53.9|53.9|Standard Deviation|13.1|13.1|||
4048886|NCT01105377|3870690|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
4048887|NCT01105377|3870691|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4048888|NCT01105377|3870692|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4048889|NCT01105377|3870690|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4048890|NCT01105377|3870691|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4048891|NCT01105377|3870692|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4048892|NCT01105377|3870690|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4048893|NCT01105377|3870691|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4048894|NCT01105377|3870692|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4048895|NCT01105377|3870690|B3|||Age||years|Median|58.0|58.0|Full Range|||28.0|75.1|
4048896|NCT01105377|3870691|B2|||Age||years|Median|62.6|62.6|Full Range|||32.1|75.1|
4048897|NCT01105377|3870692|B1|||Age||years|Median|57.0|57.0|Full Range|||28.0|75.0|
4048898|NCT01105312|3870701|B4|United States||Region of Enrollment||participants|Number|28|28.0||||||
4048899|NCT01105312|3870702|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4048900|NCT01105312|3870703|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4048901|NCT01105312|3870704|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4048902|NCT01105312|3870701|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4048903|NCT01105312|3870702|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4048904|NCT01105312|3870703|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4048905|NCT01105312|3870704|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4048906|NCT01105312|3870701|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4048907|NCT01105312|3870702|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4048908|NCT01105312|3870703|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4048909|NCT01105312|3870704|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4048910|NCT01105312|3870701|B4|||Age||years|Median|62.5|62.5|Full Range|||43.0|75.0|
4048911|NCT01105312|3870702|B3|||Age||years|Median|63|63.0|Full Range|||43.0|68.0|
4048912|NCT01105312|3870703|B2|||Age||years|Median|66|66.0|Full Range|||56.0|75.0|
4048913|NCT01105312|3870704|B1|||Age||years|Median|60.5|60.5|Full Range|||43.0|75.0|
4048914|NCT01105312|3870701|B4||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4048915|NCT01105312|3870702|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4048916|NCT01105312|3870703|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4048917|NCT01105312|3870704|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4048918|NCT01105312|3870701|B4||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4048919|NCT01105312|3870702|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4048920|NCT01105312|3870703|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4048921|NCT01105312|3870704|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4048922|NCT01105312|3870701|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4048923|NCT01105312|3870702|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4048924|NCT01105312|3870703|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4048925|NCT01105312|3870704|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4048926|NCT01105247|3870722|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4048927|NCT01105247|3870723|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4048928|NCT01105247|3870724|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4048929|NCT01105247|3870722|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4048930|NCT01105247|3870723|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4048931|NCT01105247|3870724|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4048932|NCT01105247|3870722|B3||>=65 years|Age||Participants|Count of Participants|81|81.0||||||
4048933|NCT01105247|3870723|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4048934|NCT01105247|3870724|B1||>=65 years|Age||Participants|Count of Participants|74|74.0||||||
4048935|NCT01105247|3870722|B3||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4048936|NCT01105247|3870723|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4048937|NCT01105247|3870724|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4048938|NCT01105247|3870722|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4048939|NCT01105247|3870723|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4048940|NCT01105247|3870724|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4048941|NCT01105130|3870738|B4|United States||Region of Enrollment||participants|Number|140|140.0||||||
4048942|NCT01105130|3870739|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
4048943|NCT01105130|3870740|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
4048944|NCT01105130|3870741|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4048945|NCT01105130|3870738|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048946|NCT01105130|3870739|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048947|NCT01105130|3870740|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048948|NCT01105130|3870741|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048949|NCT01105130|3870738|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048950|NCT01105130|3870739|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048951|NCT01105130|3870740|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048952|NCT01105130|3870741|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048953|NCT01105130|3870738|B4||White|Race (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
4048954|NCT01105130|3870739|B3||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4048955|NCT01105130|3870740|B2||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4048956|NCT01105130|3870741|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4048957|NCT01105130|3870738|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4048958|NCT01105130|3870739|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4048959|NCT01105130|3870740|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4048960|NCT01105130|3870741|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4048961|NCT01105130|3870738|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048962|NCT01105130|3870739|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048963|NCT01105130|3870740|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048964|NCT01105130|3870741|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048965|NCT01105130|3870738|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4048966|NCT01105130|3870739|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4048967|NCT01105130|3870740|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048968|NCT01105130|3870741|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048969|NCT01105130|3870738|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048970|NCT01105130|3870739|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048971|NCT01105130|3870740|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048972|NCT01105130|3870741|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048973|NCT01105130|3870738|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4048974|NCT01105130|3870739|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4048975|NCT01105130|3870740|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4048976|NCT01105130|3870741|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4048977|NCT01105130|3870738|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|133|133.0||||||
4048978|NCT01105130|3870739|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4048979|NCT01105130|3870740|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4048980|NCT01105130|3870741|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4048981|NCT01105130|3870738|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4048982|NCT01105130|3870739|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4048983|NCT01105130|3870740|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4048984|NCT01105130|3870741|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4048985|NCT01105130|3870738|B4||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4048986|NCT01105130|3870739|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4048987|NCT01105130|3870740|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4048988|NCT01105130|3870741|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4048989|NCT01105130|3870738|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4048990|NCT01105130|3870739|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4048991|NCT01105130|3870740|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4048992|NCT01105130|3870741|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4048993|NCT01105130|3870738|B4|||Age||years|Median|68|68.0|Full Range|||48.0|80.0|
4048994|NCT01105130|3870739|B3|||Age||years|Median|67|67.0|Full Range|||53.0|80.0|
4048995|NCT01105130|3870740|B2|||Age||years|Median|68|68.0|Full Range|||54.0|80.0|
4048996|NCT01105130|3870741|B1|||Age||years|Median|68|68.0|Full Range|||48.0|78.0|
4048997|NCT01105130|3870738|B4||>=65 years|Age||Participants|Count of Participants|100|100.0||||||
4048998|NCT01105130|3870739|B3||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
4048999|NCT01105130|3870740|B2||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4049000|NCT01105130|3870741|B1||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
4049001|NCT01105130|3870738|B4||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4049002|NCT01105130|3870739|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4049003|NCT01105130|3870740|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4049004|NCT01105130|3870741|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4049005|NCT01105130|3870738|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4049006|NCT01105130|3870739|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4049007|NCT01105130|3870740|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4049008|NCT01105130|3870741|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4049009|NCT01105117|3870760|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4049010|NCT01105117|3870761|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4049011|NCT01105117|3870762|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4049012|NCT01105117|3870760|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4049013|NCT01105117|3870761|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4049014|NCT01105117|3870762|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4049015|NCT01105117|3870760|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4049016|NCT01105117|3870761|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4049017|NCT01105117|3870762|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4049018|NCT01105117|3870760|B3|||Age||years|Mean|44.5|44.5|Standard Deviation|14.8|14.8|||
4049019|NCT01105117|3870761|B2|||Age||years|Mean|34|34.0|Standard Deviation|0|0.0|||
4049020|NCT01105117|3870762|B1|||Age||years|Mean|55|55.0|Standard Deviation|0|0.0|||
4049021|NCT01105117|3870760|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4049022|NCT01105117|3870761|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4049023|NCT01105117|3870762|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4049024|NCT01105117|3870760|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4049025|NCT01105117|3870761|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4049026|NCT01105117|3870762|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4049027|NCT01105117|3870760|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4049028|NCT01105117|3870761|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4049029|NCT01105117|3870762|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4049030|NCT01105091|3870771|B3|Class IV||New York Heart Association (NYHA) Functional Class|Disease severity was assessed by NYHA classification of PH criteria: Class I: no limitation of physical activity (PA). Ordinary PA: no undue dyspnea/fatigue, chest pain, near syncope. Class II: slight limitation of PA. Comfortable at rest. Ordinary PA: undue dyspnea/fatigue, chest pain, near syncope. Class III: marked limitation of PA. Comfortable at rest. Less than ordinary PA: undue dyspnea/fatigue, chest pain, near syncope. Class IV: inability to carry out PA without symptoms. Right heart failure. Dyspnea/fatigue may even have been present at rest. Discomfort increased by any PA.|participants|Number|5|5.0||||||
4049031|NCT01105091|3870772|B2|Class IV||New York Heart Association (NYHA) Functional Class|Disease severity was assessed by NYHA classification of PH criteria: Class I: no limitation of physical activity (PA). Ordinary PA: no undue dyspnea/fatigue, chest pain, near syncope. Class II: slight limitation of PA. Comfortable at rest. Ordinary PA: undue dyspnea/fatigue, chest pain, near syncope. Class III: marked limitation of PA. Comfortable at rest. Less than ordinary PA: undue dyspnea/fatigue, chest pain, near syncope. Class IV: inability to carry out PA without symptoms. Right heart failure. Dyspnea/fatigue may even have been present at rest. Discomfort increased by any PA.|participants|Number|2|2.0||||||
4049032|NCT01105091|3870773|B1|Class IV||New York Heart Association (NYHA) Functional Class|Disease severity was assessed by NYHA classification of PH criteria: Class I: no limitation of physical activity (PA). Ordinary PA: no undue dyspnea/fatigue, chest pain, near syncope. Class II: slight limitation of PA. Comfortable at rest. Ordinary PA: undue dyspnea/fatigue, chest pain, near syncope. Class III: marked limitation of PA. Comfortable at rest. Less than ordinary PA: undue dyspnea/fatigue, chest pain, near syncope. Class IV: inability to carry out PA without symptoms. Right heart failure. Dyspnea/fatigue may even have been present at rest. Discomfort increased by any PA.|participants|Number|3|3.0||||||
4049033|NCT01105091|3870771|B3|Class III||New York Heart Association (NYHA) Functional Class|Disease severity was assessed by NYHA classification of PH criteria: Class I: no limitation of physical activity (PA). Ordinary PA: no undue dyspnea/fatigue, chest pain, near syncope. Class II: slight limitation of PA. Comfortable at rest. Ordinary PA: undue dyspnea/fatigue, chest pain, near syncope. Class III: marked limitation of PA. Comfortable at rest. Less than ordinary PA: undue dyspnea/fatigue, chest pain, near syncope. Class IV: inability to carry out PA without symptoms. Right heart failure. Dyspnea/fatigue may even have been present at rest. Discomfort increased by any PA.|participants|Number|25|25.0||||||
4049034|NCT01105091|3870772|B2|Class III||New York Heart Association (NYHA) Functional Class|Disease severity was assessed by NYHA classification of PH criteria: Class I: no limitation of physical activity (PA). Ordinary PA: no undue dyspnea/fatigue, chest pain, near syncope. Class II: slight limitation of PA. Comfortable at rest. Ordinary PA: undue dyspnea/fatigue, chest pain, near syncope. Class III: marked limitation of PA. Comfortable at rest. Less than ordinary PA: undue dyspnea/fatigue, chest pain, near syncope. Class IV: inability to carry out PA without symptoms. Right heart failure. Dyspnea/fatigue may even have been present at rest. Discomfort increased by any PA.|participants|Number|8|8.0||||||
4049035|NCT01105091|3870773|B1|Class III||New York Heart Association (NYHA) Functional Class|Disease severity was assessed by NYHA classification of PH criteria: Class I: no limitation of physical activity (PA). Ordinary PA: no undue dyspnea/fatigue, chest pain, near syncope. Class II: slight limitation of PA. Comfortable at rest. Ordinary PA: undue dyspnea/fatigue, chest pain, near syncope. Class III: marked limitation of PA. Comfortable at rest. Less than ordinary PA: undue dyspnea/fatigue, chest pain, near syncope. Class IV: inability to carry out PA without symptoms. Right heart failure. Dyspnea/fatigue may even have been present at rest. Discomfort increased by any PA.|participants|Number|17|17.0||||||
4049036|NCT01105091|3870771|B3|Class II||New York Heart Association (NYHA) Functional Class|Disease severity was assessed by NYHA classification of PH criteria: Class I: no limitation of physical activity (PA). Ordinary PA: no undue dyspnea/fatigue, chest pain, near syncope. Class II: slight limitation of PA. Comfortable at rest. Ordinary PA: undue dyspnea/fatigue, chest pain, near syncope. Class III: marked limitation of PA. Comfortable at rest. Less than ordinary PA: undue dyspnea/fatigue, chest pain, near syncope. Class IV: inability to carry out PA without symptoms. Right heart failure. Dyspnea/fatigue may even have been present at rest. Discomfort increased by any PA.|participants|Number|0|0.0||||||
4049037|NCT01105091|3870772|B2|Class II||New York Heart Association (NYHA) Functional Class|Disease severity was assessed by NYHA classification of PH criteria: Class I: no limitation of physical activity (PA). Ordinary PA: no undue dyspnea/fatigue, chest pain, near syncope. Class II: slight limitation of PA. Comfortable at rest. Ordinary PA: undue dyspnea/fatigue, chest pain, near syncope. Class III: marked limitation of PA. Comfortable at rest. Less than ordinary PA: undue dyspnea/fatigue, chest pain, near syncope. Class IV: inability to carry out PA without symptoms. Right heart failure. Dyspnea/fatigue may even have been present at rest. Discomfort increased by any PA.|participants|Number|0|0.0||||||
4049038|NCT01105091|3870773|B1|Class II||New York Heart Association (NYHA) Functional Class|Disease severity was assessed by NYHA classification of PH criteria: Class I: no limitation of physical activity (PA). Ordinary PA: no undue dyspnea/fatigue, chest pain, near syncope. Class II: slight limitation of PA. Comfortable at rest. Ordinary PA: undue dyspnea/fatigue, chest pain, near syncope. Class III: marked limitation of PA. Comfortable at rest. Less than ordinary PA: undue dyspnea/fatigue, chest pain, near syncope. Class IV: inability to carry out PA without symptoms. Right heart failure. Dyspnea/fatigue may even have been present at rest. Discomfort increased by any PA.|participants|Number|0|0.0||||||
4049039|NCT01105091|3870771|B3|Class I||New York Heart Association (NYHA) Functional Class|Disease severity was assessed by NYHA classification of PH criteria: Class I: no limitation of physical activity (PA). Ordinary PA: no undue dyspnea/fatigue, chest pain, near syncope. Class II: slight limitation of PA. Comfortable at rest. Ordinary PA: undue dyspnea/fatigue, chest pain, near syncope. Class III: marked limitation of PA. Comfortable at rest. Less than ordinary PA: undue dyspnea/fatigue, chest pain, near syncope. Class IV: inability to carry out PA without symptoms. Right heart failure. Dyspnea/fatigue may even have been present at rest. Discomfort increased by any PA.|participants|Number|0|0.0||||||
4049040|NCT01105091|3870772|B2|Class I||New York Heart Association (NYHA) Functional Class|Disease severity was assessed by NYHA classification of PH criteria: Class I: no limitation of physical activity (PA). Ordinary PA: no undue dyspnea/fatigue, chest pain, near syncope. Class II: slight limitation of PA. Comfortable at rest. Ordinary PA: undue dyspnea/fatigue, chest pain, near syncope. Class III: marked limitation of PA. Comfortable at rest. Less than ordinary PA: undue dyspnea/fatigue, chest pain, near syncope. Class IV: inability to carry out PA without symptoms. Right heart failure. Dyspnea/fatigue may even have been present at rest. Discomfort increased by any PA.|participants|Number|0|0.0||||||
4049041|NCT01105091|3870773|B1|Class I||New York Heart Association (NYHA) Functional Class|Disease severity was assessed by NYHA classification of PH criteria: Class I: no limitation of physical activity (PA). Ordinary PA: no undue dyspnea/fatigue, chest pain, near syncope. Class II: slight limitation of PA. Comfortable at rest. Ordinary PA: undue dyspnea/fatigue, chest pain, near syncope. Class III: marked limitation of PA. Comfortable at rest. Less than ordinary PA: undue dyspnea/fatigue, chest pain, near syncope. Class IV: inability to carry out PA without symptoms. Right heart failure. Dyspnea/fatigue may even have been present at rest. Discomfort increased by any PA.|participants|Number|0|0.0||||||
4049042|NCT01105091|3870771|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4049043|NCT01105091|3870772|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4049044|NCT01105091|3870773|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4049045|NCT01105091|3870771|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4049046|NCT01105091|3870772|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4049047|NCT01105091|3870773|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4049048|NCT01105091|3870771|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4049049|NCT01105091|3870772|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4049050|NCT01105091|3870773|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4049051|NCT01105091|3870771|B3|||Age||years|Mean|44.7|44.7|Standard Deviation|15.4|15.4|||
4049052|NCT01105091|3870772|B2|||Age||years|Mean|44.1|44.1|Standard Deviation|12.6|12.6|||
4049053|NCT01105091|3870773|B1|||Age||years|Mean|45.0|45.0|Standard Deviation|17.0|17.0|||
4049054|NCT01105091|3870771|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4049055|NCT01105091|3870772|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4049056|NCT01105091|3870773|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4049057|NCT01105091|3870771|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4049058|NCT01105091|3870772|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4049059|NCT01105091|3870773|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4049060|NCT01105091|3870771|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4049061|NCT01105091|3870772|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4049062|NCT01105091|3870773|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4049063|NCT01105065|3870798|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4049064|NCT01105065|3870798|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4049065|NCT01105065|3870798|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4049066|NCT01105065|3870798|B1|||Age|age range: 35 years to 80 years|years|Mean|57.1|57.1|Standard Deviation|10.8|10.8|||
4049067|NCT01104870|3870804|B4|Class IV||World Health Organization (WHO) Functional Class|Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Inability to carry out any physical activity without symptoms.|participants|Number|0|0.0||||||
4049068|NCT01104870|3870805|B3|Class IV||World Health Organization (WHO) Functional Class|Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Inability to carry out any physical activity without symptoms.|participants|Number|0|0.0||||||
4049069|NCT01104870|3870806|B2|Class IV||World Health Organization (WHO) Functional Class|Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Inability to carry out any physical activity without symptoms.|participants|Number|0|0.0||||||
4049070|NCT01104870|3870807|B1|Class IV||World Health Organization (WHO) Functional Class|Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Inability to carry out any physical activity without symptoms.|participants|Number|0|0.0||||||
4049071|NCT01104870|3870804|B4|Class III||World Health Organization (WHO) Functional Class|Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Inability to carry out any physical activity without symptoms.|participants|Number|39|39.0||||||
4049072|NCT01104870|3870805|B3|Class III||World Health Organization (WHO) Functional Class|Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Inability to carry out any physical activity without symptoms.|participants|Number|16|16.0||||||
4049073|NCT01104870|3870806|B2|Class III||World Health Organization (WHO) Functional Class|Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Inability to carry out any physical activity without symptoms.|participants|Number|14|14.0||||||
4049074|NCT01104870|3870807|B1|Class III||World Health Organization (WHO) Functional Class|Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Inability to carry out any physical activity without symptoms.|participants|Number|9|9.0||||||
4049075|NCT01104870|3870804|B4|Class II||World Health Organization (WHO) Functional Class|Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Inability to carry out any physical activity without symptoms.|participants|Number|11|11.0||||||
4049076|NCT01104870|3870805|B3|Class II||World Health Organization (WHO) Functional Class|Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Inability to carry out any physical activity without symptoms.|participants|Number|4|4.0||||||
4049077|NCT01104870|3870806|B2|Class II||World Health Organization (WHO) Functional Class|Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Inability to carry out any physical activity without symptoms.|participants|Number|5|5.0||||||
4049078|NCT01104870|3870807|B1|Class II||World Health Organization (WHO) Functional Class|Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Inability to carry out any physical activity without symptoms.|participants|Number|2|2.0||||||
4049079|NCT01104870|3870804|B4|Class I||World Health Organization (WHO) Functional Class|Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Inability to carry out any physical activity without symptoms.|participants|Number|0|0.0||||||
4049080|NCT01104870|3870805|B3|Class I||World Health Organization (WHO) Functional Class|Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Inability to carry out any physical activity without symptoms.|participants|Number|0|0.0||||||
4049081|NCT01104870|3870806|B2|Class I||World Health Organization (WHO) Functional Class|Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Inability to carry out any physical activity without symptoms.|participants|Number|0|0.0||||||
4049082|NCT01104870|3870807|B1|Class I||World Health Organization (WHO) Functional Class|Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Inability to carry out any physical activity without symptoms.|participants|Number|0|0.0||||||
4049083|NCT01104870|3870804|B4|||Baseline Six-Minute Walk Distance (6MWD)||meters|Mean|333.6|333.6|Standard Deviation|68.1|68.1|||
4049084|NCT01104870|3870805|B3|||Baseline Six-Minute Walk Distance (6MWD)||meters|Mean|311.4|311.4|Standard Deviation|67.4|67.4|||
4049085|NCT01104870|3870806|B2|||Baseline Six-Minute Walk Distance (6MWD)||meters|Mean|338.1|338.1|Standard Deviation|55.7|55.7|||
4049086|NCT01104870|3870807|B1|||Baseline Six-Minute Walk Distance (6MWD)||meters|Mean|366.0|366.0|Standard Deviation|79.6|79.6|||
4049087|NCT01104870|3870804|B4|No Background Therapy||Background PAH Therapy||participants|Number|24|24.0||||||
4049088|NCT01104870|3870805|B3|No Background Therapy||Background PAH Therapy||participants|Number|11|11.0||||||
4049089|NCT01104870|3870806|B2|No Background Therapy||Background PAH Therapy||participants|Number|9|9.0||||||
4049090|NCT01104870|3870807|B1|No Background Therapy||Background PAH Therapy||participants|Number|4|4.0||||||
4049091|NCT01104870|3870804|B4|PDE-5i||Background PAH Therapy||participants|Number|16|16.0||||||
4049092|NCT01104870|3870805|B3|PDE-5i||Background PAH Therapy||participants|Number|7|7.0||||||
4049093|NCT01104870|3870806|B2|PDE-5i||Background PAH Therapy||participants|Number|6|6.0||||||
4049094|NCT01104870|3870807|B1|PDE-5i||Background PAH Therapy||participants|Number|3|3.0||||||
4049095|NCT01104870|3870804|B4|ERA||Background PAH Therapy||participants|Number|9|9.0||||||
4049096|NCT01104870|3870805|B3|ERA||Background PAH Therapy||participants|Number|1|1.0||||||
4049097|NCT01104870|3870806|B2|ERA||Background PAH Therapy||participants|Number|4|4.0||||||
4049098|NCT01104870|3870807|B1|ERA||Background PAH Therapy||participants|Number|4|4.0||||||
4049099|NCT01104870|3870804|B4|Both PDE-5i and ERA Dual Therapy||Background PAH Therapy||participants|Number|1|1.0||||||
4049100|NCT01104870|3870805|B3|Both PDE-5i and ERA Dual Therapy||Background PAH Therapy||participants|Number|1|1.0||||||
4049101|NCT01104870|3870806|B2|Both PDE-5i and ERA Dual Therapy||Background PAH Therapy||participants|Number|0|0.0||||||
4049102|NCT01104870|3870807|B1|Both PDE-5i and ERA Dual Therapy||Background PAH Therapy||participants|Number|0|0.0||||||
4049103|NCT01104870|3870804|B4|PH associated with sarcoidosis||PAH History||participants|Number|2|2.0||||||
4049104|NCT01104870|3870805|B3|PH associated with sarcoidosis||PAH History||participants|Number|1|1.0||||||
4049105|NCT01104870|3870806|B2|PH associated with sarcoidosis||PAH History||participants|Number|0|0.0||||||
4049106|NCT01104870|3870807|B1|PH associated with sarcoidosis||PAH History||participants|Number|1|1.0||||||
4049107|NCT01104870|3870804|B4|PH associated with interstitial lung disease (ILD)||PAH History||participants|Number|7|7.0||||||
4049108|NCT01104870|3870805|B3|PH associated with interstitial lung disease (ILD)||PAH History||participants|Number|3|3.0||||||
4049109|NCT01104870|3870806|B2|PH associated with interstitial lung disease (ILD)||PAH History||participants|Number|4|4.0||||||
4049110|NCT01104870|3870807|B1|PH associated with interstitial lung disease (ILD)||PAH History||participants|Number|0|0.0||||||
4049111|NCT01104870|3870804|B4|PAH associated with HIV||PAH History||participants|Number|0|0.0||||||
4049112|NCT01104870|3870805|B3|PAH associated with HIV||PAH History||participants|Number|0|0.0||||||
4049113|NCT01104870|3870806|B2|PAH associated with HIV||PAH History||participants|Number|0|0.0||||||
4049114|NCT01104870|3870807|B1|PAH associated with HIV||PAH History||participants|Number|0|0.0||||||
4049115|NCT01104870|3870804|B4|PAH associated with connective tissue diseases||PAH History||participants|Number|24|24.0||||||
4049116|NCT01104870|3870805|B3|PAH associated with connective tissue diseases||PAH History||participants|Number|10|10.0||||||
4049117|NCT01104870|3870806|B2|PAH associated with connective tissue diseases||PAH History||participants|Number|9|9.0||||||
4049118|NCT01104870|3870807|B1|PAH associated with connective tissue diseases||PAH History||participants|Number|5|5.0||||||
4049119|NCT01104870|3870804|B4|Idiopathic, heritable or drug or toxin-induced PAH||PAH History||participants|Number|17|17.0||||||
4049120|NCT01104870|3870805|B3|Idiopathic, heritable or drug or toxin-induced PAH||PAH History||participants|Number|6|6.0||||||
4049121|NCT01104870|3870806|B2|Idiopathic, heritable or drug or toxin-induced PAH||PAH History||participants|Number|6|6.0||||||
4049122|NCT01104870|3870807|B1|Idiopathic, heritable or drug or toxin-induced PAH||PAH History||participants|Number|5|5.0||||||
4049123|NCT01104870|3870804|B4|United States||Region of Enrollment||participants|Number|50|50.0||||||
4049124|NCT01104870|3870805|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4049125|NCT01104870|3870806|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4049126|NCT01104870|3870807|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4049127|NCT01104870|3870804|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049128|NCT01104870|3870805|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049129|NCT01104870|3870806|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049130|NCT01104870|3870807|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049131|NCT01104870|3870804|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049132|NCT01104870|3870805|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049133|NCT01104870|3870806|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049134|NCT01104870|3870807|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049135|NCT01104870|3870804|B4||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4049136|NCT01104870|3870805|B3||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4049137|NCT01104870|3870806|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4049138|NCT01104870|3870807|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4049139|NCT01104870|3870804|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4049140|NCT01104870|3870805|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4049141|NCT01104870|3870806|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4049142|NCT01104870|3870807|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4049143|NCT01104870|3870804|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049144|NCT01104870|3870805|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049145|NCT01104870|3870806|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049146|NCT01104870|3870807|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049147|NCT01104870|3870804|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049148|NCT01104870|3870805|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049149|NCT01104870|3870806|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049150|NCT01104870|3870807|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049151|NCT01104870|3870804|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049152|NCT01104870|3870805|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049153|NCT01104870|3870806|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049154|NCT01104870|3870807|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049155|NCT01104870|3870804|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049156|NCT01104870|3870805|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049157|NCT01104870|3870806|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049158|NCT01104870|3870807|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049159|NCT01104870|3870804|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4049160|NCT01104870|3870805|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4049161|NCT01104870|3870806|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4049162|NCT01104870|3870807|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4049163|NCT01104870|3870804|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4049164|NCT01104870|3870805|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4049165|NCT01104870|3870806|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4049166|NCT01104870|3870807|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049167|NCT01104870|3870804|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4049168|NCT01104870|3870805|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4049169|NCT01104870|3870806|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4049170|NCT01104870|3870807|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4049171|NCT01104870|3870804|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4049172|NCT01104870|3870805|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4049173|NCT01104870|3870806|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4049174|NCT01104870|3870807|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4049175|NCT01104870|3870804|B4|||Age||years|Mean|57.1|57.1|Full Range|||22.0|75.0|
4049176|NCT01104870|3870805|B3|||Age||years|Mean|57.6|57.6|Full Range|||32.0|72.0|
4049177|NCT01104870|3870806|B2|||Age||years|Mean|58.9|58.9|Full Range|||43.0|75.0|
4049178|NCT01104870|3870807|B1|||Age||years|Mean|53.1|53.1|Full Range|||22.0|74.0|
4049179|NCT01104779|3870838|B4||Other|Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
4049180|NCT01104779|3870839|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4049181|NCT01104779|3870840|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4049182|NCT01104779|3870841|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4049183|NCT01104779|3870838|B4||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4049184|NCT01104779|3870839|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4049185|NCT01104779|3870840|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4049186|NCT01104779|3870841|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4049187|NCT01104779|3870838|B4||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4049188|NCT01104779|3870839|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4049189|NCT01104779|3870840|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4049190|NCT01104779|3870841|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4049191|NCT01104779|3870838|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|168|168.0||||||
4049192|NCT01104779|3870839|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|56|56.0||||||
4049193|NCT01104779|3870840|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|56|56.0||||||
4049194|NCT01104779|3870841|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|56|56.0||||||
4049195|NCT01104779|3870838|B4||Black or African-American|Race/Ethnicity, Customized||Participants|Count of Participants|160|160.0||||||
4049196|NCT01104779|3870839|B3||Black or African-American|Race/Ethnicity, Customized||Participants|Count of Participants|53|53.0||||||
4049197|NCT01104779|3870840|B2||Black or African-American|Race/Ethnicity, Customized||Participants|Count of Participants|56|56.0||||||
4049198|NCT01104779|3870841|B1||Black or African-American|Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
4049199|NCT01104779|3870838|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|84|84.0||||||
4049200|NCT01104779|3870839|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
4049201|NCT01104779|3870840|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
4049202|NCT01104779|3870841|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
4049203|NCT01104779|3870838|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049204|NCT01104779|3870839|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049205|NCT01104779|3870840|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049206|NCT01104779|3870841|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049207|NCT01104779|3870838|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|372|372.0||||||
4049208|NCT01104779|3870839|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|121|121.0||||||
4049209|NCT01104779|3870840|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|127|127.0||||||
4049210|NCT01104779|3870841|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
4049211|NCT01104779|3870838|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4049212|NCT01104779|3870839|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4049213|NCT01104779|3870840|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4049214|NCT01104779|3870841|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4049215|NCT01104779|3870838|B4||Female|Sex/Gender, Customized||Participants|Count of Participants|105|105.0||||||
4049216|NCT01104779|3870839|B3||Female|Sex/Gender, Customized||Participants|Count of Participants|35|35.0||||||
4049217|NCT01104779|3870840|B2||Female|Sex/Gender, Customized||Participants|Count of Participants|33|33.0||||||
4049218|NCT01104779|3870841|B1||Female|Sex/Gender, Customized||Participants|Count of Participants|37|37.0||||||
4049219|NCT01104779|3870838|B4||Male|Sex/Gender, Customized||Participants|Count of Participants|341|341.0||||||
4049220|NCT01104779|3870839|B3||Male|Sex/Gender, Customized||Participants|Count of Participants|113|113.0||||||
4049221|NCT01104779|3870840|B2||Male|Sex/Gender, Customized||Participants|Count of Participants|118|118.0||||||
4049222|NCT01104779|3870841|B1||Male|Sex/Gender, Customized||Participants|Count of Participants|110|110.0||||||
4049223|NCT01104779|3870838|B4|||Age||Years|Mean|36.3|36.3|Standard Deviation|10.4|10.4|||
4049224|NCT01104779|3870839|B3|||Age||Years|Mean|35.5|35.5|Standard Deviation|9.3|9.3|||
4049225|NCT01104779|3870840|B2|||Age||Years|Mean|36.6|36.6|Standard Deviation|10.5|10.5|||
4049226|NCT01104779|3870841|B1|||Age||Years|Mean|36.7|36.7|Standard Deviation|11.3|11.3|||
4049227|NCT01104766|3870854|B5||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|62|62.0||||||
4049228|NCT01104766|3870855|B4||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
4049229|NCT01104766|3870856|B3||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4049230|NCT01104766|3870857|B2||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4049231|NCT01104766|3870858|B1||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4049232|NCT01104766|3870854|B5||Other|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4049233|NCT01104766|3870855|B4||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4049234|NCT01104766|3870856|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4049235|NCT01104766|3870857|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4049236|NCT01104766|3870858|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4049237|NCT01104766|3870854|B5||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4049238|NCT01104766|3870855|B4||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4049239|NCT01104766|3870856|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4049240|NCT01104766|3870857|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4049241|NCT01104766|3870858|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4049242|NCT01104766|3870854|B5||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4049243|NCT01104766|3870855|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4049244|NCT01104766|3870856|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4049245|NCT01104766|3870857|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4049246|NCT01104766|3870858|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4049247|NCT01104766|3870854|B5||Black or African-American|Race/Ethnicity, Customized||Participants|Count of Participants|143|143.0||||||
4049248|NCT01104766|3870855|B4||Black or African-American|Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
4049249|NCT01104766|3870856|B3||Black or African-American|Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
4049250|NCT01104766|3870857|B2||Black or African-American|Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
4049251|NCT01104766|3870858|B1||Black or African-American|Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
4049252|NCT01104766|3870854|B5||White|Race/Ethnicity, Customized||Participants|Count of Participants|395|395.0||||||
4049253|NCT01104766|3870855|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|99|99.0||||||
4049254|NCT01104766|3870856|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|101|101.0||||||
4049255|NCT01104766|3870857|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|102|102.0||||||
4049256|NCT01104766|3870858|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|93|93.0||||||
4049257|NCT01104766|3870854|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4049258|NCT01104766|3870855|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4049259|NCT01104766|3870856|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4049260|NCT01104766|3870857|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4049261|NCT01104766|3870858|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4049262|NCT01104766|3870854|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|538|538.0||||||
4049263|NCT01104766|3870855|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
4049264|NCT01104766|3870856|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|133|133.0||||||
4049265|NCT01104766|3870857|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
4049266|NCT01104766|3870858|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|137|137.0||||||
4049267|NCT01104766|3870854|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4049268|NCT01104766|3870855|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4049269|NCT01104766|3870856|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4049270|NCT01104766|3870857|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4049271|NCT01104766|3870858|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4049272|NCT01104766|3870854|B5||Female|Sex/Gender, Customized||Participants|Count of Participants|227|227.0||||||
4049273|NCT01104766|3870855|B4||Female|Sex/Gender, Customized||Participants|Count of Participants|58|58.0||||||
4049274|NCT01104766|3870856|B3||Female|Sex/Gender, Customized||Participants|Count of Participants|57|57.0||||||
4049275|NCT01104766|3870857|B2||Female|Sex/Gender, Customized||Participants|Count of Participants|56|56.0||||||
4049276|NCT01104766|3870858|B1||Female|Sex/Gender, Customized||Participants|Count of Participants|56|56.0||||||
4049277|NCT01104766|3870854|B5||Male|Sex/Gender, Customized||Participants|Count of Participants|390|390.0||||||
4049278|NCT01104766|3870855|B4||Male|Sex/Gender, Customized||Participants|Count of Participants|94|94.0||||||
4049279|NCT01104766|3870856|B3||Male|Sex/Gender, Customized||Participants|Count of Participants|100|100.0||||||
4049280|NCT01104766|3870857|B2||Male|Sex/Gender, Customized||Participants|Count of Participants|99|99.0||||||
4049281|NCT01104766|3870858|B1||Male|Sex/Gender, Customized||Participants|Count of Participants|97|97.0||||||
4049282|NCT01104766|3870854|B5|||Age||Years|Mean|38.5|38.5|Standard Deviation|10.8|10.8|||
4049283|NCT01104766|3870855|B4|||Age||Years|Mean|39.3|39.3|Standard Deviation|10.8|10.8|||
4049284|NCT01104766|3870856|B3|||Age||Years|Mean|38.6|38.6|Standard Deviation|10.6|10.6|||
4049285|NCT01104766|3870857|B2|||Age||Years|Mean|37.9|37.9|Standard Deviation|10.6|10.6|||
4049286|NCT01104766|3870858|B1|||Age||Years|Mean|38.2|38.2|Standard Deviation|11.3|11.3|||
4049287|NCT01104701|3870875|B5|HbA1c ≥ 9.0%||Category of HbA1c||participants|Number|43|43.0||||||
4049288|NCT01104701|3870876|B4|HbA1c ≥ 9.0%||Category of HbA1c||participants|Number|9|9.0||||||
4049289|NCT01104701|3870877|B3|HbA1c ≥ 9.0%||Category of HbA1c||participants|Number|12|12.0||||||
4049290|NCT01104701|3870878|B2|HbA1c ≥ 9.0%||Category of HbA1c||participants|Number|12|12.0||||||
4049291|NCT01104701|3870879|B1|HbA1c ≥ 9.0%||Category of HbA1c||participants|Number|10|10.0||||||
4049292|NCT01104701|3870875|B5|HbA1c < 9.0%||Category of HbA1c||participants|Number|78|78.0||||||
4049293|NCT01104701|3870876|B4|HbA1c < 9.0%||Category of HbA1c||participants|Number|21|21.0||||||
4049294|NCT01104701|3870877|B3|HbA1c < 9.0%||Category of HbA1c||participants|Number|19|19.0||||||
4049295|NCT01104701|3870878|B2|HbA1c < 9.0%||Category of HbA1c||participants|Number|18|18.0||||||
4049296|NCT01104701|3870879|B1|HbA1c < 9.0%||Category of HbA1c||participants|Number|20|20.0||||||
4049297|NCT01104701|3870875|B5|||Mean Hemoglobin A1c (HbA1c)|HbA1c is measured as a percent (%) of all hemoglobin.|Percent of hemoglobin|Mean|8.52|8.52|Standard Deviation|1.21|1.21|||
4049298|NCT01104701|3870876|B4|||Mean Hemoglobin A1c (HbA1c)|HbA1c is measured as a percent (%) of all hemoglobin.|Percent of hemoglobin|Mean|8.37|8.37|Standard Deviation|1.34|1.34|||
4049299|NCT01104701|3870877|B3|||Mean Hemoglobin A1c (HbA1c)|HbA1c is measured as a percent (%) of all hemoglobin.|Percent of hemoglobin|Mean|8.54|8.54|Standard Deviation|1.18|1.18|||
4049300|NCT01104701|3870878|B2|||Mean Hemoglobin A1c (HbA1c)|HbA1c is measured as a percent (%) of all hemoglobin.|Percent of hemoglobin|Mean|8.54|8.54|Standard Deviation|1.18|1.18|||
4049301|NCT01104701|3870879|B1|||Mean Hemoglobin A1c (HbA1c)|HbA1c is measured as a percent (%) of all hemoglobin.|Percent of hemoglobin|Mean|8.64|8.64|Standard Deviation|1.19|1.19|||
4049302|NCT01104701|3870875|B5|United States||Region of Enrollment||participants|Number|121|121.0||||||
4049303|NCT01104701|3870876|B4|United States||Region of Enrollment||participants|Number|30|30.0||||||
4049304|NCT01104701|3870877|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4049305|NCT01104701|3870878|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4049306|NCT01104701|3870879|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4049307|NCT01104701|3870875|B5|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4049308|NCT01104701|3870876|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4049309|NCT01104701|3870877|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4049310|NCT01104701|3870878|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4049311|NCT01104701|3870879|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4049312|NCT01104701|3870875|B5|White||Race/Ethnicity, Customized||participants|Number|104|104.0||||||
4049313|NCT01104701|3870876|B4|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4049314|NCT01104701|3870877|B3|White||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4049315|NCT01104701|3870878|B2|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4049316|NCT01104701|3870879|B1|White||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4049317|NCT01104701|3870875|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4049318|NCT01104701|3870876|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4049319|NCT01104701|3870877|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4049320|NCT01104701|3870878|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4049321|NCT01104701|3870879|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4049322|NCT01104701|3870875|B5|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4049323|NCT01104701|3870876|B4|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4049324|NCT01104701|3870877|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4049325|NCT01104701|3870878|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4049326|NCT01104701|3870879|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4049327|NCT01104701|3870875|B5||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4049328|NCT01104701|3870876|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4049329|NCT01104701|3870877|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4049330|NCT01104701|3870878|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4049331|NCT01104701|3870879|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4049332|NCT01104701|3870875|B5||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4049333|NCT01104701|3870876|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4049334|NCT01104701|3870877|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4049335|NCT01104701|3870878|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4049336|NCT01104701|3870879|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4049337|NCT01104701|3870875|B5|Greater than, equal to (≥) 65 years of age||Age, Customized||participants|Number|11|11.0||||||
4049338|NCT01104701|3870876|B4|Greater than, equal to (≥) 65 years of age||Age, Customized||participants|Number|3|3.0||||||
4049339|NCT01104701|3870877|B3|Greater than, equal to (≥) 65 years of age||Age, Customized||participants|Number|5|5.0||||||
4049340|NCT01104701|3870878|B2|Greater than, equal to (≥) 65 years of age||Age, Customized||participants|Number|1|1.0||||||
4049341|NCT01104701|3870879|B1|Greater than, equal to (≥) 65 years of age||Age, Customized||participants|Number|2|2.0||||||
4049342|NCT01104701|3870875|B5|Less than (<) 65 years of age||Age, Customized||participants|Number|110|110.0||||||
4049343|NCT01104701|3870876|B4|Less than (<) 65 years of age||Age, Customized||participants|Number|27|27.0||||||
4049344|NCT01104701|3870877|B3|Less than (<) 65 years of age||Age, Customized||participants|Number|26|26.0||||||
4049345|NCT01104701|3870878|B2|Less than (<) 65 years of age||Age, Customized||participants|Number|29|29.0||||||
4049346|NCT01104701|3870879|B1|Less than (<) 65 years of age||Age, Customized||participants|Number|28|28.0||||||
4049347|NCT01104662|3870936|B9||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4049348|NCT01104662|3870937|B8||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4049349|NCT01104662|3870938|B7||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4049350|NCT01104662|3870939|B6||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4049351|NCT01104662|3870940|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4049352|NCT01104662|3870941|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4049353|NCT01104662|3870942|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4049354|NCT01104662|3870943|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4049355|NCT01104662|3870944|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4049356|NCT01104662|3870936|B9||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4049357|NCT01104662|3870937|B8||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4049358|NCT01104662|3870938|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4049359|NCT01104662|3870939|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4049360|NCT01104662|3870940|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4049361|NCT01104662|3870941|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4049362|NCT01104662|3870942|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4049363|NCT01104662|3870943|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4049364|NCT01104662|3870944|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4049365|NCT01104662|3870936|B9||GTE65|Age||Participants|Count of Participants|27|27.0||||||
4049366|NCT01104662|3870937|B8||GTE65|Age||Participants|Count of Participants|3|3.0||||||
4049367|NCT01104662|3870938|B7||GTE65|Age||Participants|Count of Participants|4|4.0||||||
4049368|NCT01104662|3870939|B6||GTE65|Age||Participants|Count of Participants|4|4.0||||||
4049369|NCT01104662|3870940|B5||GTE65|Age||Participants|Count of Participants|4|4.0||||||
4049370|NCT01104662|3870941|B4||GTE65|Age||Participants|Count of Participants|1|1.0||||||
4049371|NCT01104662|3870942|B3||GTE65|Age||Participants|Count of Participants|3|3.0||||||
4049372|NCT01104662|3870943|B2||GTE65|Age||Participants|Count of Participants|5|5.0||||||
4049373|NCT01104662|3870944|B1||GTE65|Age||Participants|Count of Participants|3|3.0||||||
4049374|NCT01104662|3870936|B9||BTWN|Age||Participants|Count of Participants|56|56.0||||||
4049375|NCT01104662|3870937|B8||BTWN|Age||Participants|Count of Participants|3|3.0||||||
4049376|NCT01104662|3870938|B7||BTWN|Age||Participants|Count of Participants|1|1.0||||||
4049377|NCT01104662|3870939|B6||BTWN|Age||Participants|Count of Participants|11|11.0||||||
4049378|NCT01104662|3870940|B5||BTWN|Age||Participants|Count of Participants|11|11.0||||||
4049379|NCT01104662|3870941|B4||BTWN|Age||Participants|Count of Participants|3|3.0||||||
4049380|NCT01104662|3870942|B3||BTWN|Age||Participants|Count of Participants|1|1.0||||||
4049381|NCT01104662|3870943|B2||BTWN|Age||Participants|Count of Participants|12|12.0||||||
4049382|NCT01104662|3870944|B1||BTWN|Age||Participants|Count of Participants|14|14.0||||||
4049383|NCT01104662|3870936|B9||LTE18|Age||Participants|Count of Participants|0|0.0||||||
4049384|NCT01104662|3870937|B8||LTE18|Age||Participants|Count of Participants|0|0.0||||||
4049385|NCT01104662|3870938|B7||LTE18|Age||Participants|Count of Participants|0|0.0||||||
4049386|NCT01104662|3870939|B6||LTE18|Age||Participants|Count of Participants|0|0.0||||||
4049387|NCT01104662|3870940|B5||LTE18|Age||Participants|Count of Participants|0|0.0||||||
4049388|NCT01104662|3870941|B4||LTE18|Age||Participants|Count of Participants|0|0.0||||||
4049389|NCT01104662|3870942|B3||LTE18|Age||Participants|Count of Participants|0|0.0||||||
4049390|NCT01104662|3870943|B2||LTE18|Age||Participants|Count of Participants|0|0.0||||||
4049391|NCT01104662|3870944|B1||LTE18|Age||Participants|Count of Participants|0|0.0||||||
4049392|NCT01104636|3870977|B1|Unspecified||Sex/Gender, Customized|Demographic data for 4 participants was not available.|participants|Number|1|1.0||||||
4049393|NCT01104636|3870977|B1|Female||Sex/Gender, Customized|Demographic data for 4 participants was not available.|participants|Number|503|503.0||||||
4049394|NCT01104636|3870977|B1|Male||Sex/Gender, Customized|Demographic data for 4 participants was not available.|participants|Number|669|669.0||||||
4049395|NCT01104636|3870977|B1|||Age|Demographic data for 4 participants was not available.|years|Mean|49.4|49.4|Standard Deviation|12.0|12.0|||
4049396|NCT01104584|3870982|B1|United States||Country||participants|Number|61|61.0||||||
4049397|NCT01104584|3870982|B1|Taiwan||Country||participants|Number|36|36.0||||||
4049398|NCT01104584|3870982|B1|Poland||Country||participants|Number|70|70.0||||||
4049399|NCT01104584|3870982|B1|India||Country||participants|Number|63|63.0||||||
4049400|NCT01104584|3870982|B1|Spain||Country||participants|Number|66|66.0||||||
4049401|NCT01104584|3870982|B1|Germany||Country||participants|Number|91|91.0||||||
4049402|NCT01104584|3870982|B1|Canada||Country||participants|Number|33|33.0||||||
4049403|NCT01104584|3870982|B1|Argentina||Country||participants|Number|19|19.0||||||
4049404|NCT01104584|3870982|B1|Missing||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4049405|NCT01104584|3870982|B1|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4049406|NCT01104584|3870982|B1|Black||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4049407|NCT01104584|3870982|B1|Asian||Race/Ethnicity, Customized||participants|Number|104|104.0||||||
4049408|NCT01104584|3870982|B1|White||Race/Ethnicity, Customized||participants|Number|310|310.0||||||
4049409|NCT01104584|3870982|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4049410|NCT01104584|3870982|B1||Female|Sex: Female, Male||Participants|Count of Participants|438|438.0||||||
4049411|NCT01104584|3870982|B1|||Age||years|Mean|57.1|57.1|Standard Deviation|10.7|10.7|||
4049412|NCT01104558|3871052|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4049413|NCT01104558|3871052|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4049414|NCT01104558|3871052|B1|||Age||years|Mean|56.05|56.05|Standard Deviation|13.43|13.43|||
4049415|NCT01104493|3871093|B3||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4049416|NCT01104493|3871094|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4049417|NCT01104493|3871095|B1||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4049418|NCT01104493|3871093|B3||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4049419|NCT01104493|3871094|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4049420|NCT01104493|3871095|B1||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4049421|NCT01104493|3871093|B3|||Age||years|Mean|32.5|32.5|Standard Deviation|8.7|8.7|||
4049422|NCT01104493|3871094|B2|||Age||years|Mean|32.4|32.4|Standard Deviation|8.3|8.3|||
4049423|NCT01104493|3871095|B1|||Age||years|Mean|32.5|32.5|Standard Deviation|8.8|8.8|||
4049424|NCT01104415|3871114|B1|Germany||Region of Enrollment||participants|Number|9|9.0||||||
4049425|NCT01104415|3871114|B1|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4049426|NCT01104415|3871114|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049427|NCT01104415|3871114|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049428|NCT01104415|3871114|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4049429|NCT01104415|3871114|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049430|NCT01104415|3871114|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049431|NCT01104415|3871114|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049432|NCT01104415|3871114|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049433|NCT01104415|3871114|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4049434|NCT01104415|3871114|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4049435|NCT01104415|3871114|B1|||Age||years|Mean|61.1|61.1|Standard Deviation|9.35|9.35|||
4049436|NCT01104402|3871136|B3|United States||Region of Enrollment||Participants|Count of Participants|267|267.0||||||
4049437|NCT01104402|3871137|B2|United States||Region of Enrollment||Participants|Count of Participants|135|135.0||||||
4049438|NCT01104402|3871138|B1|United States||Region of Enrollment||Participants|Count of Participants|132|132.0||||||
4049439|NCT01104402|3871136|B3||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4049440|NCT01104402|3871137|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4049441|NCT01104402|3871138|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4049442|NCT01104402|3871136|B3||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4049443|NCT01104402|3871137|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4049444|NCT01104402|3871138|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4049445|NCT01104402|3871136|B3|||Age||years|Mean|27.1|27.1|Standard Deviation|12.0|12.0|||
4049446|NCT01104402|3871137|B2|||Age||years|Mean|26.5|26.5|Standard Deviation|11.5|11.5|||
4049447|NCT01104402|3871138|B1|||Age||years|Mean|27.8|27.8|Standard Deviation|12.5|12.5|||
4049448|NCT01104402|3871136|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4049449|NCT01104402|3871137|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4049450|NCT01104402|3871138|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4049451|NCT01104402|3871136|B3||Between 18 and 65 years|Age||Participants|Count of Participants|190|190.0||||||
4049452|NCT01104402|3871137|B2||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
4049453|NCT01104402|3871138|B1||Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
4049454|NCT01104402|3871136|B3||<=18 years|Age||Participants|Count of Participants|77|77.0||||||
4049455|NCT01104402|3871137|B2||<=18 years|Age||Participants|Count of Participants|38|38.0||||||
4049456|NCT01104402|3871138|B1||<=18 years|Age||Participants|Count of Participants|39|39.0||||||
4049457|NCT01104376|3871157|B1|United States||Region of Enrollment||participants|Number|61|61.0||||||
4049458|NCT01104376|3871157|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049459|NCT01104376|3871157|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4049460|NCT01104376|3871157|B1||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4049461|NCT01104376|3871157|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4049462|NCT01104376|3871157|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049463|NCT01104376|3871157|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4049464|NCT01104376|3871157|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049465|NCT01104376|3871157|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4049466|NCT01104376|3871157|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4049467|NCT01104376|3871157|B1|||Age||years|Mean|31.9|31.9|Standard Deviation|11.5|11.5|||
4049468|NCT01104311|3871161|B3||Male|Gender||Participants|Count of Participants|77|77.0||||||
4049469|NCT01104311|3871162|B2||Male|Gender||Participants|Count of Participants|36|36.0||||||
4049470|NCT01104311|3871163|B1||Male|Gender||Participants|Count of Participants|41|41.0||||||
4049471|NCT01104311|3871161|B3||Female|Gender||Participants|Count of Participants|52|52.0||||||
4049472|NCT01104311|3871162|B2||Female|Gender||Participants|Count of Participants|27|27.0||||||
4049473|NCT01104311|3871163|B1||Female|Gender||Participants|Count of Participants|25|25.0||||||
4049474|NCT01104311|3871161|B3|||Age, Customized||years|Mean|64.2|64.2|Standard Deviation|9.85|9.85|||
4049475|NCT01104311|3871162|B2|||Age, Customized||years|Mean|63.5|63.5|Standard Deviation|11.2|11.2|||
4049476|NCT01104311|3871163|B1|||Age, Customized||years|Mean|64.8|64.8|Standard Deviation|8.5|8.5|||
4049477|NCT01104285|3871182|B3|United States||Region of Enrollment||participants|Number|198|198.0||||||
4049478|NCT01104285|3871183|B2|United States||Region of Enrollment||participants|Number|86|86.0||||||
4049479|NCT01104285|3871184|B1|United States||Region of Enrollment||participants|Number|112|112.0||||||
4049480|NCT01104285|3871182|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4049481|NCT01104285|3871183|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4049482|NCT01104285|3871184|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4049483|NCT01104285|3871182|B3||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4049484|NCT01104285|3871183|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4049485|NCT01104285|3871184|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4049486|NCT01104285|3871182|B3|||Age||years|Mean|78|78.0|Standard Deviation|9|9.0|||
4049487|NCT01104285|3871183|B2|||Age||years|Mean|77|77.0|Standard Deviation|11|11.0|||
4049488|NCT01104285|3871184|B1|||Age||years|Mean|78|78.0|Standard Deviation|9|9.0|||
4049489|NCT01104285|3871182|B3||>=65 years|Age||Participants|Count of Participants|171|171.0||||||
4049490|NCT01104285|3871183|B2||>=65 years|Age||Participants|Count of Participants|76|76.0||||||
4049491|NCT01104285|3871184|B1||>=65 years|Age||Participants|Count of Participants|95|95.0||||||
4049492|NCT01104285|3871182|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4049493|NCT01104285|3871183|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4049494|NCT01104285|3871184|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4049495|NCT01104285|3871182|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4049496|NCT01104285|3871183|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4049497|NCT01104285|3871184|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4049498|NCT01104246|3871191|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4049499|NCT01104246|3871191|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4049500|NCT01104246|3871191|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4049501|NCT01104246|3871191|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|8.70|8.7|||
4049502|NCT01104246|3871191|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4049503|NCT01104246|3871191|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4049504|NCT01104246|3871191|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4049505|NCT01104207|3871195|B3|||Tinnitus Functional Index|The TFI is a 25-item questionnaire that assesses tinnitus severity. The possible range of scores for the TFI is 0 to 100, with higher scores indicating more severe tinnitus.|units on a scale|Mean|42.7|42.7|Standard Deviation|20.8|20.8|||
4049506|NCT01104207|3871196|B2|||Tinnitus Functional Index|The TFI is a 25-item questionnaire that assesses tinnitus severity. The possible range of scores for the TFI is 0 to 100, with higher scores indicating more severe tinnitus.|units on a scale|Mean|40.6|40.6|Standard Deviation|22.2|22.2|||
4049507|NCT01104207|3871197|B1|||Tinnitus Functional Index|The TFI is a 25-item questionnaire that assesses tinnitus severity. The possible range of scores for the TFI is 0 to 100, with higher scores indicating more severe tinnitus.|units on a scale|Mean|44.8|44.8|Standard Deviation|19.4|19.4|||
4049508|NCT01104207|3871195|B3|United States||Region of Enrollment||participants|Number|70|70.0||||||
4049509|NCT01104207|3871196|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
4049510|NCT01104207|3871197|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4049511|NCT01104207|3871195|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4049512|NCT01104207|3871196|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4049513|NCT01104207|3871197|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4049514|NCT01104207|3871195|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4049515|NCT01104207|3871196|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4049516|NCT01104207|3871197|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4049517|NCT01104207|3871195|B3|||Age||years|Mean|60.6|60.6|Standard Deviation|8.9|8.9|||
4049518|NCT01104207|3871196|B2|||Age||years|Mean|62.8|62.8|Standard Deviation|8.3|8.3|||
4049519|NCT01104207|3871197|B1|||Age||years|Mean|58.3|58.3|Standard Deviation|9.5|9.5|||
4049520|NCT01104207|3871195|B3||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4049521|NCT01104207|3871196|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4049522|NCT01104207|3871197|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4049523|NCT01104207|3871195|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4049524|NCT01104207|3871196|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4049525|NCT01104207|3871197|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4049526|NCT01104207|3871195|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4049527|NCT01104207|3871196|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4049528|NCT01104207|3871197|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4049529|NCT01104155|3871204|B3|Gender|Female|Sex/Gender, Customized||Participants|Count of Participants|57|57.0||||||
4049530|NCT01104155|3871205|B2|Gender|Female|Sex/Gender, Customized||Participants|Count of Participants|27|27.0||||||
4049531|NCT01104155|3871206|B1|Gender|Female|Sex/Gender, Customized||Participants|Count of Participants|30|30.0||||||
4049532|NCT01104155|3871204|B3|Gender|Male|Sex/Gender, Customized||Participants|Count of Participants|66|66.0||||||
4049533|NCT01104155|3871205|B2|Gender|Male|Sex/Gender, Customized||Participants|Count of Participants|33|33.0||||||
4049534|NCT01104155|3871206|B1|Gender|Male|Sex/Gender, Customized||Participants|Count of Participants|33|33.0||||||
4049535|NCT01104155|3871204|B3|||Age||Years|Mean|62.4|62.4|Standard Deviation|10.57|10.57|||
4049536|NCT01104155|3871205|B2|||Age||Years|Mean|63.1|63.1|Standard Deviation|10.05|10.05|||
4049537|NCT01104155|3871206|B1|||Age||Years|Mean|61.7|61.7|Standard Deviation|11.08|11.08|||
4049538|NCT01104116|3871221|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049539|NCT01104116|3871221|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049540|NCT01104116|3871221|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4049541|NCT01104116|3871221|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049542|NCT01104116|3871221|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049543|NCT01104116|3871221|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049544|NCT01104116|3871221|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049545|NCT01104116|3871221|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4049546|NCT01104116|3871221|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4049547|NCT01104116|3871221|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4049548|NCT01104116|3871221|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4049549|NCT01104116|3871221|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4049550|NCT01104103|3871226|B3|United States||Region of Enrollment||participants|Number|467|467.0||||||
4049551|NCT01104103|3871227|B2|United States||Region of Enrollment||participants|Number|224|224.0||||||
4049552|NCT01104103|3871228|B1|United States||Region of Enrollment||participants|Number|243|243.0||||||
4049553|NCT01104103|3871226|B3|Male||Gender||participants|Number|228|228.0||||||
4049554|NCT01104103|3871227|B2|Male||Gender||participants|Number|113|113.0||||||
4049555|NCT01104103|3871228|B1|Male||Gender||participants|Number|115|115.0||||||
4049556|NCT01104103|3871226|B3|Female||Gender||participants|Number|226|226.0||||||
4049557|NCT01104103|3871227|B2|Female||Gender||participants|Number|104|104.0||||||
4049558|NCT01104103|3871228|B1|Female||Gender||participants|Number|122|122.0||||||
4049559|NCT01104103|3871226|B3|||Age||years|Mean|48.53|48.53|Standard Deviation|19.34|19.34|||
4049560|NCT01104103|3871227|B2|||Age||years|Mean|46.78|46.78|Standard Deviation|19.01|19.01|||
4049561|NCT01104103|3871228|B1|||Age||years|Mean|50.17|50.17|Standard Deviation|19.54|19.54|||
4049562|NCT01104103|3871226|B3|>=65 years||Age||participants|Number|103|103.0||||||
4049563|NCT01104103|3871227|B2|>=65 years||Age||participants|Number|43|43.0||||||
4049564|NCT01104103|3871228|B1|>=65 years||Age||participants|Number|60|60.0||||||
4049565|NCT01104103|3871226|B3|Between 18 and 65 years||Age||participants|Number|353|353.0||||||
4049566|NCT01104103|3871227|B2|Between 18 and 65 years||Age||participants|Number|178|178.0||||||
4049567|NCT01104103|3871228|B1|Between 18 and 65 years||Age||participants|Number|175|175.0||||||
4049568|NCT01104103|3871226|B3|<=18 years||Age||participants|Number|4|4.0||||||
4049569|NCT01104103|3871227|B2|<=18 years||Age||participants|Number|2|2.0||||||
4049570|NCT01104103|3871228|B1|<=18 years||Age||participants|Number|2|2.0||||||
4049571|NCT01103973|3871237|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4049572|NCT01103973|3871238|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4049573|NCT01103973|3871239|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4049574|NCT01103973|3871237|B3||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4049575|NCT01103973|3871238|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4049576|NCT01103973|3871239|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4049577|NCT01103973|3871237|B3|||Age||years|Mean|34|34.0|Standard Deviation|3.75|3.75|||
4049578|NCT01103973|3871238|B2|||Age||years|Mean|34|34.0|Standard Deviation|3.7|3.7|||
4049579|NCT01103973|3871239|B1|||Age||years|Mean|34|34.0|Standard Deviation|3.8|3.8|||
4049580|NCT01103960|3871248|B3|||Systolic blood pressure (SBP)||mmHg|Mean|146.35|146.35|Standard Deviation|11.66|11.66|||
4049581|NCT01103960|3871249|B2|||Systolic blood pressure (SBP)||mmHg|Mean|146.44|146.44|Standard Deviation|12.20|12.2|||
4049582|NCT01103960|3871250|B1|||Systolic blood pressure (SBP)||mmHg|Mean|146.27|146.27|Standard Deviation|11.15|11.15|||
4049583|NCT01103960|3871248|B3|||Diastolic blood pressure (DBP)||mmHg|Mean|97.53|97.53|Standard Deviation|5.97|5.97|||
4049584|NCT01103960|3871249|B2|||Diastolic blood pressure (DBP)||mmHg|Mean|97.21|97.21|Standard Deviation|5.46|5.46|||
4049585|NCT01103960|3871250|B1|||Diastolic blood pressure (DBP)||mmHg|Mean|97.84|97.84|Standard Deviation|6.43|6.43|||
4049586|NCT01103960|3871248|B3||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4049587|NCT01103960|3871249|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4049588|NCT01103960|3871250|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4049589|NCT01103960|3871248|B3||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4049590|NCT01103960|3871249|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4049591|NCT01103960|3871250|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4049592|NCT01103960|3871248|B3|||Age||Years|Mean|52.4|52.4|Standard Deviation|9.2|9.2|||
4049593|NCT01103960|3871249|B2|||Age||Years|Mean|52.4|52.4|Standard Deviation|8.7|8.7|||
4049594|NCT01103960|3871250|B1|||Age||Years|Mean|52.4|52.4|Standard Deviation|9.7|9.7|||
4049595|NCT01103934|3871275|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
4049596|NCT01103934|3871276|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4049597|NCT01103934|3871277|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4049598|NCT01103934|3871275|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4049599|NCT01103934|3871276|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4049600|NCT01103934|3871277|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4049601|NCT01103934|3871275|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4049602|NCT01103934|3871276|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4049603|NCT01103934|3871277|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4049604|NCT01103934|3871275|B3|||Age||years|Mean|28.4|28.4|Standard Deviation|7.9|7.9|||
4049605|NCT01103934|3871276|B2|||Age||years|Mean|29.5|29.5|Standard Deviation|9.3|9.3|||
4049606|NCT01103934|3871277|B1|||Age||years|Mean|27.3|27.3|Standard Deviation|6.1|6.1|||
4049607|NCT01103778|3871286|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4049608|NCT01103778|3871286|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049609|NCT01103778|3871286|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049610|NCT01103778|3871286|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4049611|NCT01103778|3871286|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4049612|NCT01103778|3871286|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049613|NCT01103778|3871286|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4049614|NCT01103778|3871286|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049615|NCT01103778|3871286|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4049616|NCT01103778|3871286|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4049617|NCT01103778|3871286|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4049618|NCT01103778|3871286|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4049619|NCT01103778|3871286|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4049620|NCT01103778|3871286|B1|||Age||years|Mean|35|35.0|Standard Deviation|12|12.0|||
4049621|NCT01103778|3871286|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4049622|NCT01103778|3871286|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4049623|NCT01103778|3871286|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4049624|NCT01103713|3871293|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4049625|NCT01103713|3871293|B1||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4049626|NCT01103713|3871293|B1|>35 years||Age, Customized||Participants|Number|0|0.0||||||
4049627|NCT01103713|3871293|B1|31-35 years||Age, Customized||Participants|Number|1|1.0||||||
4049628|NCT01103713|3871293|B1|26-30 years||Age, Customized||Participants|Number|1|1.0||||||
4049629|NCT01103713|3871293|B1|18-25 years||Age, Customized||Participants|Number|125|125.0||||||
4049630|NCT01103713|3871293|B1|16-17 years||Age, Customized||Participants|Number|41|41.0||||||
4049631|NCT01103713|3871293|B1|<16 years||Age, Customized||Participants|Number|0|0.0||||||
4049632|NCT01103492|3871319|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4049633|NCT01103492|3871319|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4049634|NCT01103492|3871319|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4049635|NCT01103492|3871319|B1|||Age||years|Mean|77|77.0|Standard Deviation|||||
4049636|NCT01103492|3871319|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4049637|NCT01103492|3871319|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4049638|NCT01103492|3871319|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4049639|NCT01103479|3871323|B4|Missing||Health Literacy||participants|Number|53|53.0||||||
4049640|NCT01103479|3871324|B3|Missing||Health Literacy||participants|Number|19|19.0||||||
4049641|NCT01103479|3871325|B2|Missing||Health Literacy||participants|Number|18|18.0||||||
4049642|NCT01103479|3871326|B1|Missing||Health Literacy||participants|Number|16|16.0||||||
4049643|NCT01103479|3871323|B4|Marginal/Adequate||Health Literacy||participants|Number|281|281.0||||||
4049644|NCT01103479|3871324|B3|Marginal/Adequate||Health Literacy||participants|Number|88|88.0||||||
4049645|NCT01103479|3871325|B2|Marginal/Adequate||Health Literacy||participants|Number|97|97.0||||||
4049646|NCT01103479|3871326|B1|Marginal/Adequate||Health Literacy||participants|Number|96|96.0||||||
4049647|NCT01103479|3871323|B4|Inadequate||Health Literacy||participants|Number|204|204.0||||||
4049648|NCT01103479|3871324|B3|Inadequate||Health Literacy||participants|Number|67|67.0||||||
4049649|NCT01103479|3871325|B2|Inadequate||Health Literacy||participants|Number|86|86.0||||||
4049650|NCT01103479|3871326|B1|Inadequate||Health Literacy||participants|Number|51|51.0||||||
4049651|NCT01103479|3871323|B4|Missing||Health status||participants|Number|2|2.0||||||
4049652|NCT01103479|3871324|B3|Missing||Health status||participants|Number|1|1.0||||||
4049653|NCT01103479|3871325|B2|Missing||Health status||participants|Number|0|0.0||||||
4049654|NCT01103479|3871326|B1|Missing||Health status||participants|Number|1|1.0||||||
4049655|NCT01103479|3871323|B4|Excellent||Health status||participants|Number|16|16.0||||||
4049656|NCT01103479|3871324|B3|Excellent||Health status||participants|Number|4|4.0||||||
4049657|NCT01103479|3871325|B2|Excellent||Health status||participants|Number|10|10.0||||||
4049658|NCT01103479|3871326|B1|Excellent||Health status||participants|Number|2|2.0||||||
4049659|NCT01103479|3871323|B4|Very Good||Health status||participants|Number|40|40.0||||||
4049660|NCT01103479|3871324|B3|Very Good||Health status||participants|Number|12|12.0||||||
4049661|NCT01103479|3871325|B2|Very Good||Health status||participants|Number|10|10.0||||||
4049662|NCT01103479|3871326|B1|Very Good||Health status||participants|Number|18|18.0||||||
4049663|NCT01103479|3871323|B4|Good||Health status||participants|Number|129|129.0||||||
4049664|NCT01103479|3871324|B3|Good||Health status||participants|Number|44|44.0||||||
4049665|NCT01103479|3871325|B2|Good||Health status||participants|Number|46|46.0||||||
4049666|NCT01103479|3871326|B1|Good||Health status||participants|Number|39|39.0||||||
4049667|NCT01103479|3871323|B4|Fair||Health status||participants|Number|270|270.0||||||
4049668|NCT01103479|3871324|B3|Fair||Health status||participants|Number|88|88.0||||||
4049669|NCT01103479|3871325|B2|Fair||Health status||participants|Number|107|107.0||||||
4049670|NCT01103479|3871326|B1|Fair||Health status||participants|Number|75|75.0||||||
4049671|NCT01103479|3871323|B4|Poor||Health status||participants|Number|81|81.0||||||
4049672|NCT01103479|3871324|B3|Poor||Health status||participants|Number|25|25.0||||||
4049673|NCT01103479|3871325|B2|Poor||Health status||participants|Number|28|28.0||||||
4049674|NCT01103479|3871326|B1|Poor||Health status||participants|Number|28|28.0||||||
4049675|NCT01103479|3871323|B4|Refused/Missing||Household Income||participants|Number|13|13.0||||||
4049676|NCT01103479|3871324|B3|Refused/Missing||Household Income||participants|Number|5|5.0||||||
4049677|NCT01103479|3871325|B2|Refused/Missing||Household Income||participants|Number|4|4.0||||||
4049678|NCT01103479|3871326|B1|Refused/Missing||Household Income||participants|Number|4|4.0||||||
4049679|NCT01103479|3871323|B4|Not sure/Don't know||Household Income||participants|Number|76|76.0||||||
4049680|NCT01103479|3871324|B3|Not sure/Don't know||Household Income||participants|Number|27|27.0||||||
4049681|NCT01103479|3871325|B2|Not sure/Don't know||Household Income||participants|Number|26|26.0||||||
4049682|NCT01103479|3871326|B1|Not sure/Don't know||Household Income||participants|Number|23|23.0||||||
4049683|NCT01103479|3871323|B4|$40,001 - $100,000/year||Household Income||participants|Number|27|27.0||||||
4049684|NCT01103479|3871324|B3|$40,001 - $100,000/year||Household Income||participants|Number|8|8.0||||||
4049685|NCT01103479|3871325|B2|$40,001 - $100,000/year||Household Income||participants|Number|6|6.0||||||
4049686|NCT01103479|3871326|B1|$40,001 - $100,000/year||Household Income||participants|Number|13|13.0||||||
4049687|NCT01103479|3871323|B4|$20,000 - $40,000/year||Household Income||participants|Number|73|73.0||||||
4049688|NCT01103479|3871324|B3|$20,000 - $40,000/year||Household Income||participants|Number|23|23.0||||||
4049689|NCT01103479|3871325|B2|$20,000 - $40,000/year||Household Income||participants|Number|28|28.0||||||
4049690|NCT01103479|3871326|B1|$20,000 - $40,000/year||Household Income||participants|Number|22|22.0||||||
4049691|NCT01103479|3871323|B4|<$20,000/year||Household Income||participants|Number|349|349.0||||||
4049692|NCT01103479|3871324|B3|<$20,000/year||Household Income||participants|Number|111|111.0||||||
4049693|NCT01103479|3871325|B2|<$20,000/year||Household Income||participants|Number|137|137.0||||||
4049694|NCT01103479|3871326|B1|<$20,000/year||Household Income||participants|Number|101|101.0||||||
4049695|NCT01103479|3871323|B4|Missing data||Years of Education||participants|Number|4|4.0||||||
4049696|NCT01103479|3871324|B3|Missing data||Years of Education||participants|Number|1|1.0||||||
4049697|NCT01103479|3871325|B2|Missing data||Years of Education||participants|Number|1|1.0||||||
4049698|NCT01103479|3871326|B1|Missing data||Years of Education||participants|Number|2|2.0||||||
4049699|NCT01103479|3871323|B4|13 or more years||Years of Education||participants|Number|260|260.0||||||
4049700|NCT01103479|3871324|B3|13 or more years||Years of Education||participants|Number|86|86.0||||||
4049701|NCT01103479|3871325|B2|13 or more years||Years of Education||participants|Number|98|98.0||||||
4049702|NCT01103479|3871326|B1|13 or more years||Years of Education||participants|Number|76|76.0||||||
4049703|NCT01103479|3871323|B4|7 - 12 years||Years of Education||participants|Number|157|157.0||||||
4049704|NCT01103479|3871324|B3|7 - 12 years||Years of Education||participants|Number|52|52.0||||||
4049705|NCT01103479|3871325|B2|7 - 12 years||Years of Education||participants|Number|64|64.0||||||
4049706|NCT01103479|3871326|B1|7 - 12 years||Years of Education||participants|Number|41|41.0||||||
4049707|NCT01103479|3871323|B4|0 - 6 years||Years of Education||participants|Number|117|117.0||||||
4049708|NCT01103479|3871324|B3|0 - 6 years||Years of Education||participants|Number|35|35.0||||||
4049709|NCT01103479|3871325|B2|0 - 6 years||Years of Education||participants|Number|38|38.0||||||
4049710|NCT01103479|3871326|B1|0 - 6 years||Years of Education||participants|Number|44|44.0||||||
4049711|NCT01103479|3871323|B4|Academic Health Center||Health Care System||participants|Number|111|111.0||||||
4049712|NCT01103479|3871324|B3|Academic Health Center||Health Care System||participants|Number|20|20.0||||||
4049713|NCT01103479|3871325|B2|Academic Health Center||Health Care System||participants|Number|27|27.0||||||
4049714|NCT01103479|3871326|B1|Academic Health Center||Health Care System||participants|Number|64|64.0||||||
4049715|NCT01103479|3871323|B4|Community FQHC||Health Care System||participants|Number|427|427.0||||||
4049716|NCT01103479|3871324|B3|Community FQHC||Health Care System||participants|Number|154|154.0||||||
4049717|NCT01103479|3871325|B2|Community FQHC||Health Care System||participants|Number|174|174.0||||||
4049718|NCT01103479|3871326|B1|Community FQHC||Health Care System||participants|Number|99|99.0||||||
4049719|NCT01103479|3871323|B4|Uninsured||Insurance Status (more than one may apply)||participants|Number|160|160.0||||||
4049720|NCT01103479|3871324|B3|Uninsured||Insurance Status (more than one may apply)||participants|Number|42|42.0||||||
4049721|NCT01103479|3871325|B2|Uninsured||Insurance Status (more than one may apply)||participants|Number|52|52.0||||||
4049722|NCT01103479|3871326|B1|Uninsured||Insurance Status (more than one may apply)||participants|Number|66|66.0||||||
4049723|NCT01103479|3871323|B4|Medicaid||Insurance Status (more than one may apply)||participants|Number|189|189.0||||||
4049724|NCT01103479|3871324|B3|Medicaid||Insurance Status (more than one may apply)||participants|Number|67|67.0||||||
4049725|NCT01103479|3871325|B2|Medicaid||Insurance Status (more than one may apply)||participants|Number|71|71.0||||||
4049726|NCT01103479|3871326|B1|Medicaid||Insurance Status (more than one may apply)||participants|Number|51|51.0||||||
4049727|NCT01103479|3871323|B4|Medicare||Insurance Status (more than one may apply)||participants|Number|167|167.0||||||
4049728|NCT01103479|3871324|B3|Medicare||Insurance Status (more than one may apply)||participants|Number|52|52.0||||||
4049729|NCT01103479|3871325|B2|Medicare||Insurance Status (more than one may apply)||participants|Number|68|68.0||||||
4049730|NCT01103479|3871326|B1|Medicare||Insurance Status (more than one may apply)||participants|Number|47|47.0||||||
4049731|NCT01103479|3871323|B4|Private||Insurance Status (more than one may apply)||participants|Number|78|78.0||||||
4049732|NCT01103479|3871324|B3|Private||Insurance Status (more than one may apply)||participants|Number|27|27.0||||||
4049733|NCT01103479|3871325|B2|Private||Insurance Status (more than one may apply)||participants|Number|30|30.0||||||
4049734|NCT01103479|3871326|B1|Private||Insurance Status (more than one may apply)||participants|Number|21|21.0||||||
4049735|NCT01103479|3871323|B4|Spanish||Survey Language||participants|Number|214|214.0||||||
4049736|NCT01103479|3871324|B3|Spanish||Survey Language||participants|Number|68|68.0||||||
4049737|NCT01103479|3871325|B2|Spanish||Survey Language||participants|Number|83|83.0||||||
4049738|NCT01103479|3871326|B1|Spanish||Survey Language||participants|Number|63|63.0||||||
4049739|NCT01103479|3871323|B4|English||Survey Language||participants|Number|324|324.0||||||
4049740|NCT01103479|3871324|B3|English||Survey Language||participants|Number|106|106.0||||||
4049741|NCT01103479|3871325|B2|English||Survey Language||participants|Number|118|118.0||||||
4049742|NCT01103479|3871326|B1|English||Survey Language||participants|Number|100|100.0||||||
4049743|NCT01103479|3871323|B4|United States||Region of Enrollment||participants|Number|538|538.0||||||
4049744|NCT01103479|3871324|B3|United States||Region of Enrollment||participants|Number|174|174.0||||||
4049745|NCT01103479|3871325|B2|United States||Region of Enrollment||participants|Number|201|201.0||||||
4049746|NCT01103479|3871326|B1|United States||Region of Enrollment||participants|Number|163|163.0||||||
4049747|NCT01103479|3871323|B4|Other/Missing||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4049748|NCT01103479|3871324|B3|Other/Missing||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4049749|NCT01103479|3871325|B2|Other/Missing||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4049750|NCT01103479|3871326|B1|Other/Missing||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4049751|NCT01103479|3871323|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|231|231.0||||||
4049752|NCT01103479|3871324|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|75|75.0||||||
4049753|NCT01103479|3871325|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|88|88.0||||||
4049754|NCT01103479|3871326|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
4049755|NCT01103479|3871323|B4|Non-Hispanic Black||Race/Ethnicity, Customized||participants|Number|286|286.0||||||
4049756|NCT01103479|3871324|B3|Non-Hispanic Black||Race/Ethnicity, Customized||participants|Number|93|93.0||||||
4049757|NCT01103479|3871325|B2|Non-Hispanic Black||Race/Ethnicity, Customized||participants|Number|111|111.0||||||
4049758|NCT01103479|3871326|B1|Non-Hispanic Black||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
4049759|NCT01103479|3871323|B4||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4049760|NCT01103479|3871324|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4049761|NCT01103479|3871325|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4049762|NCT01103479|3871326|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4049763|NCT01103479|3871323|B4||Female|Sex: Female, Male||Participants|Count of Participants|397|397.0||||||
4049764|NCT01103479|3871324|B3||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4049765|NCT01103479|3871325|B2||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4049766|NCT01103479|3871326|B1||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4049767|NCT01103479|3871323|B4|||Age||years|Mean|57.79|57.79|Standard Deviation|6.17|6.17|||
4049768|NCT01103479|3871324|B3|||Age||years|Mean|57.03|57.03|Standard Deviation|6.09|6.09|||
4049769|NCT01103479|3871325|B2|||Age||years|Mean|58.71|58.71|Standard Deviation|6.24|6.24|||
4049770|NCT01103479|3871326|B1|||Age||years|Mean|57.46|57.46|Standard Deviation|6.07|6.07|||
4049771|NCT01103466|3871341|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4049772|NCT01103466|3871341|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4049773|NCT01103466|3871341|B1|||Age||years|Mean|56|56.0|Standard Deviation|13.6|13.6|||
4049774|NCT01103440|3871351|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4049775|NCT01103440|3871352|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4049776|NCT01103440|3871353|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4049777|NCT01103440|3871351|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4049778|NCT01103440|3871352|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4049779|NCT01103440|3871353|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4049780|NCT01103440|3871351|B3|||Age||years|Mean|65.7|65.7|Standard Deviation|9|9.0|||
4049781|NCT01103440|3871352|B2|||Age||years|Mean|66.2|66.2|Standard Deviation|9|9.0|||
4049782|NCT01103440|3871353|B1|||Age||years|Mean|65.2|65.2|Standard Deviation|10|10.0|||
4049783|NCT01103414|3871362|B6|||HbA1c||percent|Mean|8.08|8.08|Standard Deviation|0.835|0.835|||
4049784|NCT01103414|3871363|B5|||HbA1c||percent|Mean|8.04|8.04|Standard Deviation|0.845|0.845|||
4049785|NCT01103414|3871364|B4|||HbA1c||percent|Mean|8.08|8.08|Standard Deviation|0.852|0.852|||
4049786|NCT01103414|3871365|B3|||HbA1c||percent|Mean|8.00|8.0|Standard Deviation|0.809|0.809|||
4049787|NCT01103414|3871366|B2|||HbA1c||percent|Mean|8.09|8.09|Standard Deviation|0.816|0.816|||
4049788|NCT01103414|3871367|B1|||HbA1c||percent|Mean|8.2|8.2|Standard Deviation|0.862|0.862|||
4049789|NCT01103414|3871362|B6|||Fasting plasma glucose||mg/dL|Mean|172.5|172.5|Standard Deviation|39.70|39.7|||
4049790|NCT01103414|3871363|B5|||Fasting plasma glucose||mg/dL|Mean|170.2|170.2|Standard Deviation|43.78|43.78|||
4049791|NCT01103414|3871364|B4|||Fasting plasma glucose||mg/dL|Mean|172.3|172.3|Standard Deviation|33.96|33.96|||
4049792|NCT01103414|3871365|B3|||Fasting plasma glucose||mg/dL|Mean|170.2|170.2|Standard Deviation|44.22|44.22|||
4049793|NCT01103414|3871366|B2|||Fasting plasma glucose||mg/dL|Mean|173.7|173.7|Standard Deviation|36.73|36.73|||
4049794|NCT01103414|3871367|B1|||Fasting plasma glucose||mg/dL|Mean|176.1|176.1|Standard Deviation|39.62|39.62|||
4049795|NCT01103414|3871362|B6|United States||Region of Enrollment||participants|Number|356|356.0||||||
4049796|NCT01103414|3871363|B5|United States||Region of Enrollment||participants|Number|71|71.0||||||
4049797|NCT01103414|3871364|B4|United States||Region of Enrollment||participants|Number|71|71.0||||||
4049798|NCT01103414|3871365|B3|United States||Region of Enrollment||participants|Number|71|71.0||||||
4049799|NCT01103414|3871366|B2|United States||Region of Enrollment||participants|Number|71|71.0||||||
4049800|NCT01103414|3871367|B1|United States||Region of Enrollment||participants|Number|72|72.0||||||
4049801|NCT01103414|3871362|B6||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4049802|NCT01103414|3871363|B5||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4049803|NCT01103414|3871364|B4||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4049804|NCT01103414|3871365|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4049805|NCT01103414|3871366|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4049806|NCT01103414|3871367|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4049807|NCT01103414|3871362|B6||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4049808|NCT01103414|3871363|B5||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4049809|NCT01103414|3871364|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4049810|NCT01103414|3871365|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4049811|NCT01103414|3871366|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4049812|NCT01103414|3871367|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4049813|NCT01103414|3871362|B6|||Age||years|Mean|54.7|54.7|Standard Deviation|9.47|9.47|||
4049814|NCT01103414|3871363|B5|||Age||years|Mean|53.4|53.4|Standard Deviation|8.76|8.76|||
4049815|NCT01103414|3871364|B4|||Age||years|Mean|54.2|54.2|Standard Deviation|9.90|9.9|||
4049816|NCT01103414|3871365|B3|||Age||years|Mean|56.0|56.0|Standard Deviation|8.76|8.76|||
4049817|NCT01103414|3871366|B2|||Age||years|Mean|55.5|55.5|Standard Deviation|10.19|10.19|||
4049818|NCT01103414|3871367|B1|||Age||years|Mean|54.3|54.3|Standard Deviation|9.70|9.7|||
4049819|NCT01103362|3871433|B1|Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4049820|NCT01103362|3871433|B1|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4049821|NCT01103362|3871433|B1|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4049822|NCT01103362|3871433|B1|Black/African American Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4049823|NCT01103362|3871433|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
4049824|NCT01103362|3871433|B1|White Hispanic||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
4049825|NCT01103362|3871433|B1|White||Race/Ethnicity, Customized||participants|Number|473|473.0||||||
4049826|NCT01103362|3871433|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4049827|NCT01103362|3871433|B1||Female|Sex: Female, Male||Participants|Count of Participants|596|596.0||||||
4049828|NCT01103362|3871433|B1|age||Age, Customized||years|Mean|45.7|45.7|Standard Deviation|11.9|11.9|||
4049829|NCT01103323|3871437|B3|Unknown||KRAS mutation|KRAS - Kirsten rat sarcoma viral oncogene homolog (protein), member of the RAS family of GTPases (guanosine triphosphate hydrolases)|Participants|Number|31|31.0||||||
4049830|NCT01103323|3871438|B2|Unknown||KRAS mutation|KRAS - Kirsten rat sarcoma viral oncogene homolog (protein), member of the RAS family of GTPases (guanosine triphosphate hydrolases)|Participants|Number|4|4.0||||||
4049831|NCT01103323|3871439|B1|Unknown||KRAS mutation|KRAS - Kirsten rat sarcoma viral oncogene homolog (protein), member of the RAS family of GTPases (guanosine triphosphate hydrolases)|Participants|Number|27|27.0||||||
4049832|NCT01103323|3871437|B3|Yes||KRAS mutation|KRAS - Kirsten rat sarcoma viral oncogene homolog (protein), member of the RAS family of GTPases (guanosine triphosphate hydrolases)|Participants|Number|430|430.0||||||
4049833|NCT01103323|3871438|B2|Yes||KRAS mutation|KRAS - Kirsten rat sarcoma viral oncogene homolog (protein), member of the RAS family of GTPases (guanosine triphosphate hydrolases)|Participants|Number|157|157.0||||||
4049834|NCT01103323|3871439|B1|Yes||KRAS mutation|KRAS - Kirsten rat sarcoma viral oncogene homolog (protein), member of the RAS family of GTPases (guanosine triphosphate hydrolases)|Participants|Number|273|273.0||||||
4049835|NCT01103323|3871437|B3|No||KRAS mutation|KRAS - Kirsten rat sarcoma viral oncogene homolog (protein), member of the RAS family of GTPases (guanosine triphosphate hydrolases)|Participants|Number|299|299.0||||||
4049836|NCT01103323|3871438|B2|No||KRAS mutation|KRAS - Kirsten rat sarcoma viral oncogene homolog (protein), member of the RAS family of GTPases (guanosine triphosphate hydrolases)|Participants|Number|94|94.0||||||
4049837|NCT01103323|3871439|B1|No||KRAS mutation|KRAS - Kirsten rat sarcoma viral oncogene homolog (protein), member of the RAS family of GTPases (guanosine triphosphate hydrolases)|Participants|Number|205|205.0||||||
4049838|NCT01103323|3871437|B3|1||Eastern Cooperative Oncology Group (ECOG) performance status (PS) before treatment|ECOG PS is a scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst). 0=Fully active without restriction; 1= Restricted in physically strenuous activity; 2= Ambulatory, capable of all selfcare; 3= Capable of limited selfcare; 4= Completely disabled; 5= Dead|Participants|Number|349|349.0||||||
4049839|NCT01103323|3871438|B2|1||Eastern Cooperative Oncology Group (ECOG) performance status (PS) before treatment|ECOG PS is a scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst). 0=Fully active without restriction; 1= Restricted in physically strenuous activity; 2= Ambulatory, capable of all selfcare; 3= Capable of limited selfcare; 4= Completely disabled; 5= Dead|Participants|Number|109|109.0||||||
4049840|NCT01103323|3871439|B1|1||Eastern Cooperative Oncology Group (ECOG) performance status (PS) before treatment|ECOG PS is a scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst). 0=Fully active without restriction; 1= Restricted in physically strenuous activity; 2= Ambulatory, capable of all selfcare; 3= Capable of limited selfcare; 4= Completely disabled; 5= Dead|Participants|Number|240|240.0||||||
4049841|NCT01103323|3871437|B3|0||Eastern Cooperative Oncology Group (ECOG) performance status (PS) before treatment|ECOG PS is a scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst). 0=Fully active without restriction; 1= Restricted in physically strenuous activity; 2= Ambulatory, capable of all selfcare; 3= Capable of limited selfcare; 4= Completely disabled; 5= Dead|Participants|Number|411|411.0||||||
4049842|NCT01103323|3871438|B2|0||Eastern Cooperative Oncology Group (ECOG) performance status (PS) before treatment|ECOG PS is a scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst). 0=Fully active without restriction; 1= Restricted in physically strenuous activity; 2= Ambulatory, capable of all selfcare; 3= Capable of limited selfcare; 4= Completely disabled; 5= Dead|Participants|Number|146|146.0||||||
4049843|NCT01103323|3871439|B1|0||Eastern Cooperative Oncology Group (ECOG) performance status (PS) before treatment|ECOG PS is a scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst). 0=Fully active without restriction; 1= Restricted in physically strenuous activity; 2= Ambulatory, capable of all selfcare; 3= Capable of limited selfcare; 4= Completely disabled; 5= Dead|Participants|Number|265|265.0||||||
4049844|NCT01103323|3871437|B3||Male|Sex: Female, Male||Participants|Count of Participants|464|464.0||||||
4049845|NCT01103323|3871438|B2||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4049846|NCT01103323|3871439|B1||Male|Sex: Female, Male||Participants|Count of Participants|311|311.0||||||
4049847|NCT01103323|3871437|B3||Female|Sex: Female, Male||Participants|Count of Participants|296|296.0||||||
4049848|NCT01103323|3871438|B2||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4049849|NCT01103323|3871439|B1||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4049850|NCT01103323|3871437|B3|||Age|The age of the patient in years at enrollment in the study.|Years|Mean|60.5|60.5|Full Range|||22.0|85.0|
4049851|NCT01103323|3871438|B2|||Age|The age of the patient in years at enrollment in the study.|Years|Mean|60.1|60.1|Full Range|||25.0|85.0|
4049852|NCT01103323|3871439|B1|||Age|The age of the patient in years at enrollment in the study.|Years|Mean|60.7|60.7|Full Range|||22.0|82.0|
4049853|NCT01103284|3871455|B3|||Fasting C-Peptide||nmol/L|Mean|0.398|0.398|Standard Deviation|0.1609|0.1609|||
4049854|NCT01103284|3871456|B2|||Fasting C-Peptide||nmol/L|Mean|0.407|0.407|Standard Deviation|0.1731|0.1731|||
4049855|NCT01103284|3871457|B1|||Fasting C-Peptide||nmol/L|Mean|0.388|0.388|Standard Deviation|0.1473|0.1473|||
4049856|NCT01103284|3871455|B3|||Daily Insulin Dose||IU/kg/day|Mean|0.311|0.311|Standard Deviation|0.1618|0.1618|||
4049857|NCT01103284|3871456|B2|||Daily Insulin Dose||IU/kg/day|Mean|0.317|0.317|Standard Deviation|0.1649|0.1649|||
4049858|NCT01103284|3871457|B1|||Daily Insulin Dose||IU/kg/day|Mean|0.305|0.305|Standard Deviation|0.1587|0.1587|||
4049859|NCT01103284|3871455|B3|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4049860|NCT01103284|3871456|B2|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4049861|NCT01103284|3871457|B1|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4049862|NCT01103284|3871455|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4049863|NCT01103284|3871456|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4049864|NCT01103284|3871457|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4049865|NCT01103284|3871455|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4049866|NCT01103284|3871456|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4049867|NCT01103284|3871457|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4049868|NCT01103284|3871455|B3|Oriental||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4049869|NCT01103284|3871456|B2|Oriental||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4049870|NCT01103284|3871457|B1|Oriental||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4049871|NCT01103284|3871455|B3|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4049872|NCT01103284|3871456|B2|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4049873|NCT01103284|3871457|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4049874|NCT01103284|3871455|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4049875|NCT01103284|3871456|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4049876|NCT01103284|3871457|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4049877|NCT01103284|3871455|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|449|449.0||||||
4049878|NCT01103284|3871456|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|225|225.0||||||
4049879|NCT01103284|3871457|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|224|224.0||||||
4049880|NCT01103284|3871455|B3||Male|Sex: Female, Male||Participants|Count of Participants|322|322.0||||||
4049881|NCT01103284|3871456|B2||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4049882|NCT01103284|3871457|B1||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4049883|NCT01103284|3871455|B3||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4049884|NCT01103284|3871456|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4049885|NCT01103284|3871457|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4049886|NCT01103284|3871455|B3|||Age, Customized||years|Median|27.0|27.0|Full Range|||20.0|45.0|
4049887|NCT01103284|3871456|B2|||Age, Customized||years|Median|27.0|27.0|Full Range|||20.0|45.0|
4049888|NCT01103284|3871457|B1|||Age, Customized||years|Median|27.0|27.0|Full Range|||20.0|45.0|
4049889|NCT01103284|3871455|B3|||Age||years|Mean|28.6|28.6|Standard Deviation|6.65|6.65|||
4049890|NCT01103284|3871456|B2|||Age||years|Mean|28.5|28.5|Standard Deviation|6.56|6.56|||
4049891|NCT01103284|3871457|B1|||Age||years|Mean|28.7|28.7|Standard Deviation|6.75|6.75|||
4049892|NCT01103271|3871472|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4049893|NCT01103271|3871473|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4049894|NCT01103271|3871474|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4049895|NCT01103271|3871472|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4049896|NCT01103271|3871473|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4049897|NCT01103271|3871474|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4049898|NCT01103271|3871472|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4049899|NCT01103271|3871473|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4049900|NCT01103271|3871474|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4049901|NCT01103271|3871472|B3|||Age||years|Mean|38.8|38.8|Standard Deviation|12.6|12.6|||
4049902|NCT01103271|3871473|B2|||Age||years|Mean|40.8|40.8|Standard Deviation|13.7|13.7|||
4049903|NCT01103271|3871474|B1|||Age||years|Mean|37.2|37.2|Standard Deviation|12.0|12.0|||
4049904|NCT01103271|3871472|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4049905|NCT01103271|3871473|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4049906|NCT01103271|3871474|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4049907|NCT01103271|3871472|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4049908|NCT01103271|3871473|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4049909|NCT01103271|3871474|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4049910|NCT01103271|3871472|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4049911|NCT01103271|3871473|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4049912|NCT01103271|3871474|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4049913|NCT01103245|3871482|B5|United States||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
4049914|NCT01103245|3871483|B4|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4049915|NCT01103245|3871484|B3|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4049916|NCT01103245|3871485|B2|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4049917|NCT01103245|3871486|B1|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4049918|NCT01103245|3871482|B5||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4049919|NCT01103245|3871483|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4049920|NCT01103245|3871484|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4049921|NCT01103245|3871485|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4049922|NCT01103245|3871486|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4049923|NCT01103245|3871482|B5||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4049924|NCT01103245|3871483|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4049925|NCT01103245|3871484|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4049926|NCT01103245|3871485|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4049927|NCT01103245|3871486|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4049928|NCT01103245|3871482|B5|||Age||years|Mean|45.3|45.3|Standard Deviation|11.2|11.2|||
4049929|NCT01103245|3871483|B4|||Age||years|Mean|42.8|42.8|Standard Deviation|13.8|13.8|||
4049930|NCT01103245|3871484|B3|||Age||years|Mean|44.0|44.0|Standard Deviation|11.6|11.6|||
4049931|NCT01103245|3871485|B2|||Age||years|Mean|46.8|46.8|Standard Deviation|8.4|8.4|||
4049932|NCT01103245|3871486|B1|||Age||years|Mean|46.8|46.8|Standard Deviation|11.8|11.8|||
4049933|NCT01103245|3871482|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4049934|NCT01103245|3871483|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4049935|NCT01103245|3871484|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4049936|NCT01103245|3871485|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4049937|NCT01103245|3871486|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4049938|NCT01103245|3871482|B5||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4049939|NCT01103245|3871483|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4049940|NCT01103245|3871484|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4049941|NCT01103245|3871485|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4049942|NCT01103245|3871486|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4049943|NCT01103245|3871482|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4049944|NCT01103245|3871483|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4049945|NCT01103245|3871484|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4049946|NCT01103245|3871485|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4049947|NCT01103245|3871486|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4049948|NCT01103232|3871503|B3|||Muscle strength||Newton meters|Mean|33.2|33.2|Standard Deviation|11.9|11.9|||
4049949|NCT01103232|3871504|B2|||Muscle strength||Newton meters|Mean|11.7|11.7|Standard Deviation|6.3|6.3|||
4049950|NCT01103232|3871505|B1|||Muscle strength||Newton meters|Mean|44.1|44.1|Standard Deviation|12.0|12.0|||
4049951|NCT01103232|3871503|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4049952|NCT01103232|3871504|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4049953|NCT01103232|3871505|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4049954|NCT01103232|3871503|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4049955|NCT01103232|3871504|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4049956|NCT01103232|3871505|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4049957|NCT01103232|3871503|B3|||Age||years|Mean|32|32.0|Standard Deviation|5.3|5.3|||
4049958|NCT01103232|3871504|B2|||Age||years|Mean|34.2|34.2|Standard Deviation|4.8|4.8|||
4049959|NCT01103232|3871505|B1|||Age||years|Mean|29.6|29.6|Standard Deviation|5.7|5.7|||
4049960|NCT01103232|3871503|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4049961|NCT01103232|3871504|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4049962|NCT01103232|3871505|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4049963|NCT01103232|3871503|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4049964|NCT01103232|3871504|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4049965|NCT01103232|3871505|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4049966|NCT01103232|3871503|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4049967|NCT01103232|3871504|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4049968|NCT01103232|3871505|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4049969|NCT01103141|3871512|B3||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4049970|NCT01103141|3871513|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4049971|NCT01103141|3871514|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4049972|NCT01103141|3871512|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4049973|NCT01103141|3871513|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4049974|NCT01103141|3871514|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4049975|NCT01103141|3871512|B3|||Age||years|Mean|62.3|62.3|Standard Deviation|11.8|11.8|||
4049976|NCT01103141|3871513|B2|||Age||years|Mean|63|63.0|Standard Deviation|12.3|12.3|||
4049977|NCT01103141|3871514|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|11.3|11.3|||
4049978|NCT01103063|3871521|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4049979|NCT01103063|3871522|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4049980|NCT01103063|3871523|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4049981|NCT01103063|3871521|B3||Female|Sex: Female, Male||Participants|Count of Participants|2891|2891.0||||||
4049982|NCT01103063|3871522|B2||Female|Sex: Female, Male||Participants|Count of Participants|1445|1445.0||||||
4049983|NCT01103063|3871523|B1||Female|Sex: Female, Male||Participants|Count of Participants|1446|1446.0||||||
4049984|NCT01103063|3871521|B3|||Age||Years|Mean|23.3|23.3|Standard Deviation|4.6|4.6|||
4049985|NCT01103063|3871522|B2|||Age||Years|Mean|23.3|23.3|Standard Deviation|4.6|4.6|||
4049986|NCT01103063|3871523|B1|||Age||Years|Mean|23.3|23.3|Standard Deviation|4.5|4.5|||
4049987|NCT01102972|3871590|B3|Non-reactive||Number of participants with the indicated Baseline Hepatitis C (HC) Status|The HC surface antigen is a protein present on the surface of the hepatitis C virus (HCV). It can be detected in the blood of participants with acute and chronic HCV infections. A non-reactive test result likely means that participants are not infected with HC, but does not exclude the possibility of exposure to or infection with HC.|participants|Number|270|270.0||||||
4049988|NCT01102972|3871591|B2|Non-reactive||Number of participants with the indicated Baseline Hepatitis C (HC) Status|The HC surface antigen is a protein present on the surface of the hepatitis C virus (HCV). It can be detected in the blood of participants with acute and chronic HCV infections. A non-reactive test result likely means that participants are not infected with HC, but does not exclude the possibility of exposure to or infection with HC.|participants|Number|89|89.0||||||
4049989|NCT01102972|3871592|B1|Non-reactive||Number of participants with the indicated Baseline Hepatitis C (HC) Status|The HC surface antigen is a protein present on the surface of the hepatitis C virus (HCV). It can be detected in the blood of participants with acute and chronic HCV infections. A non-reactive test result likely means that participants are not infected with HC, but does not exclude the possibility of exposure to or infection with HC.|participants|Number|181|181.0||||||
4050081|NCT01102803|3871655|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
4049990|NCT01102972|3871590|B3|Reactive||Number of participants with the indicated Baseline Hepatitis C (HC) Status|The HC surface antigen is a protein present on the surface of the hepatitis C virus (HCV). It can be detected in the blood of participants with acute and chronic HCV infections. A non-reactive test result likely means that participants are not infected with HC, but does not exclude the possibility of exposure to or infection with HC.|participants|Number|26|26.0||||||
4049991|NCT01102972|3871591|B2|Reactive||Number of participants with the indicated Baseline Hepatitis C (HC) Status|The HC surface antigen is a protein present on the surface of the hepatitis C virus (HCV). It can be detected in the blood of participants with acute and chronic HCV infections. A non-reactive test result likely means that participants are not infected with HC, but does not exclude the possibility of exposure to or infection with HC.|participants|Number|8|8.0||||||
4049992|NCT01102972|3871592|B1|Reactive||Number of participants with the indicated Baseline Hepatitis C (HC) Status|The HC surface antigen is a protein present on the surface of the hepatitis C virus (HCV). It can be detected in the blood of participants with acute and chronic HCV infections. A non-reactive test result likely means that participants are not infected with HC, but does not exclude the possibility of exposure to or infection with HC.|participants|Number|18|18.0||||||
4049993|NCT01102972|3871590|B3|Non-reactive||Number of participants with the indicated Baseline Hepatitis B (HB) Status|The HB surface antigen is a protein present on the surface of the hepatitis B virus (HBV). It can be detected in the blood of participants with acute and chronic HBV infections. A non-reactive test result likely means that participants are not infected with HB, but does not exclude the possibility of exposure to or infection with HB.|participants|Number|296|296.0||||||
4049994|NCT01102972|3871591|B2|Non-reactive||Number of participants with the indicated Baseline Hepatitis B (HB) Status|The HB surface antigen is a protein present on the surface of the hepatitis B virus (HBV). It can be detected in the blood of participants with acute and chronic HBV infections. A non-reactive test result likely means that participants are not infected with HB, but does not exclude the possibility of exposure to or infection with HB.|participants|Number|97|97.0||||||
4049995|NCT01102972|3871592|B1|Non-reactive||Number of participants with the indicated Baseline Hepatitis B (HB) Status|The HB surface antigen is a protein present on the surface of the hepatitis B virus (HBV). It can be detected in the blood of participants with acute and chronic HBV infections. A non-reactive test result likely means that participants are not infected with HB, but does not exclude the possibility of exposure to or infection with HB.|participants|Number|199|199.0||||||
4049996|NCT01102972|3871590|B3|Reactive||Number of participants with the indicated Baseline Hepatitis B (HB) Status|The HB surface antigen is a protein present on the surface of the hepatitis B virus (HBV). It can be detected in the blood of participants with acute and chronic HBV infections. A non-reactive test result likely means that participants are not infected with HB, but does not exclude the possibility of exposure to or infection with HB.|participants|Number|0|0.0||||||
4049997|NCT01102972|3871591|B2|Reactive||Number of participants with the indicated Baseline Hepatitis B (HB) Status|The HB surface antigen is a protein present on the surface of the hepatitis B virus (HBV). It can be detected in the blood of participants with acute and chronic HBV infections. A non-reactive test result likely means that participants are not infected with HB, but does not exclude the possibility of exposure to or infection with HB.|participants|Number|0|0.0||||||
4049998|NCT01102972|3871592|B1|Reactive||Number of participants with the indicated Baseline Hepatitis B (HB) Status|The HB surface antigen is a protein present on the surface of the hepatitis B virus (HBV). It can be detected in the blood of participants with acute and chronic HBV infections. A non-reactive test result likely means that participants are not infected with HB, but does not exclude the possibility of exposure to or infection with HB.|participants|Number|0|0.0||||||
4049999|NCT01102972|3871590|B3|||Median Baseline HIV-1 RNA Level||log10 copies/mL|Median|1.591|1.591|Full Range|||1.591|3.9|
4050000|NCT01102972|3871591|B2|||Median Baseline HIV-1 RNA Level||log10 copies/mL|Median|1.591|1.591|Full Range|||1.591|3.285|
4050001|NCT01102972|3871592|B1|||Median Baseline HIV-1 RNA Level||log10 copies/mL|Median|1.591|1.591|Full Range|||1.591|3.9|
4050002|NCT01102972|3871590|B3|||Median Baseline CD4+ Cell Count||cells per cubic millimeter|Median|491.5|491.5|Full Range|||77.0|1479.0|
4050003|NCT01102972|3871591|B2|||Median Baseline CD4+ Cell Count||cells per cubic millimeter|Median|480.0|480.0|Full Range|||108.0|1479.0|
4050004|NCT01102972|3871592|B1|||Median Baseline CD4+ Cell Count||cells per cubic millimeter|Median|492.0|492.0|Full Range|||77.0|1196.0|
4050005|NCT01102972|3871590|B3|Class C: AIDS indicator conditions||Number of participants with the indicated Center for Disease Control (CDC) Classification|Acquired Immunodeficiency Syndrome (AIDS) CDC classifications are Asymptomatic, Symptomatic, or AIDS. The CDC categorization of HIV/AIDS is based on the lowest documented CD4 cell count (Class A, >=500 cells per microliter [µl]; Class B, 200-499 cells/µl; Class C, <200 cells/µl) and on previously diagnosed HIV-related conditions.|participants|Number|54|54.0||||||
4050006|NCT01102972|3871591|B2|Class C: AIDS indicator conditions||Number of participants with the indicated Center for Disease Control (CDC) Classification|Acquired Immunodeficiency Syndrome (AIDS) CDC classifications are Asymptomatic, Symptomatic, or AIDS. The CDC categorization of HIV/AIDS is based on the lowest documented CD4 cell count (Class A, >=500 cells per microliter [µl]; Class B, 200-499 cells/µl; Class C, <200 cells/µl) and on previously diagnosed HIV-related conditions.|participants|Number|17|17.0||||||
4050007|NCT01102972|3871592|B1|Class C: AIDS indicator conditions||Number of participants with the indicated Center for Disease Control (CDC) Classification|Acquired Immunodeficiency Syndrome (AIDS) CDC classifications are Asymptomatic, Symptomatic, or AIDS. The CDC categorization of HIV/AIDS is based on the lowest documented CD4 cell count (Class A, >=500 cells per microliter [µl]; Class B, 200-499 cells/µl; Class C, <200 cells/µl) and on previously diagnosed HIV-related conditions.|participants|Number|37|37.0||||||
4050008|NCT01102972|3871590|B3|Class B: Symptomatic, not AIDS||Number of participants with the indicated Center for Disease Control (CDC) Classification|Acquired Immunodeficiency Syndrome (AIDS) CDC classifications are Asymptomatic, Symptomatic, or AIDS. The CDC categorization of HIV/AIDS is based on the lowest documented CD4 cell count (Class A, >=500 cells per microliter [µl]; Class B, 200-499 cells/µl; Class C, <200 cells/µl) and on previously diagnosed HIV-related conditions.|participants|Number|39|39.0||||||
4050082|NCT01102803|3871656|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4050083|NCT01102803|3871657|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4050009|NCT01102972|3871591|B2|Class B: Symptomatic, not AIDS||Number of participants with the indicated Center for Disease Control (CDC) Classification|Acquired Immunodeficiency Syndrome (AIDS) CDC classifications are Asymptomatic, Symptomatic, or AIDS. The CDC categorization of HIV/AIDS is based on the lowest documented CD4 cell count (Class A, >=500 cells per microliter [µl]; Class B, 200-499 cells/µl; Class C, <200 cells/µl) and on previously diagnosed HIV-related conditions.|participants|Number|13|13.0||||||
4050010|NCT01102972|3871592|B1|Class B: Symptomatic, not AIDS||Number of participants with the indicated Center for Disease Control (CDC) Classification|Acquired Immunodeficiency Syndrome (AIDS) CDC classifications are Asymptomatic, Symptomatic, or AIDS. The CDC categorization of HIV/AIDS is based on the lowest documented CD4 cell count (Class A, >=500 cells per microliter [µl]; Class B, 200-499 cells/µl; Class C, <200 cells/µl) and on previously diagnosed HIV-related conditions.|participants|Number|26|26.0||||||
4050011|NCT01102972|3871590|B3|Class A: Asymptomatic/lymphadenopathy/acute HIV||Number of participants with the indicated Center for Disease Control (CDC) Classification|Acquired Immunodeficiency Syndrome (AIDS) CDC classifications are Asymptomatic, Symptomatic, or AIDS. The CDC categorization of HIV/AIDS is based on the lowest documented CD4 cell count (Class A, >=500 cells per microliter [µl]; Class B, 200-499 cells/µl; Class C, <200 cells/µl) and on previously diagnosed HIV-related conditions.|participants|Number|203|203.0||||||
4050012|NCT01102972|3871591|B2|Class A: Asymptomatic/lymphadenopathy/acute HIV||Number of participants with the indicated Center for Disease Control (CDC) Classification|Acquired Immunodeficiency Syndrome (AIDS) CDC classifications are Asymptomatic, Symptomatic, or AIDS. The CDC categorization of HIV/AIDS is based on the lowest documented CD4 cell count (Class A, >=500 cells per microliter [µl]; Class B, 200-499 cells/µl; Class C, <200 cells/µl) and on previously diagnosed HIV-related conditions.|participants|Number|67|67.0||||||
4050013|NCT01102972|3871592|B1|Class A: Asymptomatic/lymphadenopathy/acute HIV||Number of participants with the indicated Center for Disease Control (CDC) Classification|Acquired Immunodeficiency Syndrome (AIDS) CDC classifications are Asymptomatic, Symptomatic, or AIDS. The CDC categorization of HIV/AIDS is based on the lowest documented CD4 cell count (Class A, >=500 cells per microliter [µl]; Class B, 200-499 cells/µl; Class C, <200 cells/µl) and on previously diagnosed HIV-related conditions.|participants|Number|136|136.0||||||
4050014|NCT01102972|3871590|B3|CD4+ cells >=200||Number of participants with the indicated Baseline CD4+ Cell Count|A CD4+ cell is a T lymphocyte that carries the CD4 antigen. Immunologic response was assessed by CD4+ counts, measured as the number of cells per cubic millimeter.|participants|Number|276|276.0||||||
4050015|NCT01102972|3871591|B2|CD4+ cells >=200||Number of participants with the indicated Baseline CD4+ Cell Count|A CD4+ cell is a T lymphocyte that carries the CD4 antigen. Immunologic response was assessed by CD4+ counts, measured as the number of cells per cubic millimeter.|participants|Number|91|91.0||||||
4050016|NCT01102972|3871592|B1|CD4+ cells >=200||Number of participants with the indicated Baseline CD4+ Cell Count|A CD4+ cell is a T lymphocyte that carries the CD4 antigen. Immunologic response was assessed by CD4+ counts, measured as the number of cells per cubic millimeter.|participants|Number|185|185.0||||||
4050017|NCT01102972|3871590|B3|CD4+ cells 50-<200||Number of participants with the indicated Baseline CD4+ Cell Count|A CD4+ cell is a T lymphocyte that carries the CD4 antigen. Immunologic response was assessed by CD4+ counts, measured as the number of cells per cubic millimeter.|participants|Number|20|20.0||||||
4050018|NCT01102972|3871591|B2|CD4+ cells 50-<200||Number of participants with the indicated Baseline CD4+ Cell Count|A CD4+ cell is a T lymphocyte that carries the CD4 antigen. Immunologic response was assessed by CD4+ counts, measured as the number of cells per cubic millimeter.|participants|Number|6|6.0||||||
4050019|NCT01102972|3871592|B1|CD4+ cells 50-<200||Number of participants with the indicated Baseline CD4+ Cell Count|A CD4+ cell is a T lymphocyte that carries the CD4 antigen. Immunologic response was assessed by CD4+ counts, measured as the number of cells per cubic millimeter.|participants|Number|14|14.0||||||
4050020|NCT01102972|3871590|B3|CD4+ cells <50||Number of participants with the indicated Baseline CD4+ Cell Count|A CD4+ cell is a T lymphocyte that carries the CD4 antigen. Immunologic response was assessed by CD4+ counts, measured as the number of cells per cubic millimeter.|participants|Number|0|0.0||||||
4050021|NCT01102972|3871591|B2|CD4+ cells <50||Number of participants with the indicated Baseline CD4+ Cell Count|A CD4+ cell is a T lymphocyte that carries the CD4 antigen. Immunologic response was assessed by CD4+ counts, measured as the number of cells per cubic millimeter.|participants|Number|0|0.0||||||
4050022|NCT01102972|3871592|B1|CD4+ cells <50||Number of participants with the indicated Baseline CD4+ Cell Count|A CD4+ cell is a T lymphocyte that carries the CD4 antigen. Immunologic response was assessed by CD4+ counts, measured as the number of cells per cubic millimeter.|participants|Number|0|0.0||||||
4050023|NCT01102972|3871590|B3|HIV-1 RNA >=75||Number of participants with the indicated baseline HIV-RNA level|HIV-1 RNA, Human Immunodeficiency Virus type 1 Ribonucleic acid. HIV-1 viral load was measured as virus copies per milliliter (mL) at baseline.|participants|Number|7|7.0||||||
4050024|NCT01102972|3871591|B2|HIV-1 RNA >=75||Number of participants with the indicated baseline HIV-RNA level|HIV-1 RNA, Human Immunodeficiency Virus type 1 Ribonucleic acid. HIV-1 viral load was measured as virus copies per milliliter (mL) at baseline.|participants|Number|2|2.0||||||
4050025|NCT01102972|3871592|B1|HIV-1 RNA >=75||Number of participants with the indicated baseline HIV-RNA level|HIV-1 RNA, Human Immunodeficiency Virus type 1 Ribonucleic acid. HIV-1 viral load was measured as virus copies per milliliter (mL) at baseline.|participants|Number|5|5.0||||||
4050026|NCT01102972|3871590|B3|HIV-1 RNA 50-<75||Number of participants with the indicated baseline HIV-RNA level|HIV-1 RNA, Human Immunodeficiency Virus type 1 Ribonucleic acid. HIV-1 viral load was measured as virus copies per milliliter (mL) at baseline.|participants|Number|4|4.0||||||
4050027|NCT01102972|3871591|B2|HIV-1 RNA 50-<75||Number of participants with the indicated baseline HIV-RNA level|HIV-1 RNA, Human Immunodeficiency Virus type 1 Ribonucleic acid. HIV-1 viral load was measured as virus copies per milliliter (mL) at baseline.|participants|Number|2|2.0||||||
4050028|NCT01102972|3871592|B1|HIV-1 RNA 50-<75||Number of participants with the indicated baseline HIV-RNA level|HIV-1 RNA, Human Immunodeficiency Virus type 1 Ribonucleic acid. HIV-1 viral load was measured as virus copies per milliliter (mL) at baseline.|participants|Number|2|2.0||||||
4050084|NCT01102803|3871655|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4050085|NCT01102803|3871656|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4050029|NCT01102972|3871590|B3|HIV-1 RNA <50||Number of participants with the indicated baseline HIV-RNA level|HIV-1 RNA, Human Immunodeficiency Virus type 1 Ribonucleic acid. HIV-1 viral load was measured as virus copies per milliliter (mL) at baseline.|participants|Number|285|285.0||||||
4050030|NCT01102972|3871591|B2|HIV-1 RNA <50||Number of participants with the indicated baseline HIV-RNA level|HIV-1 RNA, Human Immunodeficiency Virus type 1 Ribonucleic acid. HIV-1 viral load was measured as virus copies per milliliter (mL) at baseline.|participants|Number|93|93.0||||||
4050031|NCT01102972|3871592|B1|HIV-1 RNA <50||Number of participants with the indicated baseline HIV-RNA level|HIV-1 RNA, Human Immunodeficiency Virus type 1 Ribonucleic acid. HIV-1 viral load was measured as virus copies per milliliter (mL) at baseline.|participants|Number|192|192.0||||||
4050032|NCT01102972|3871590|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4050033|NCT01102972|3871591|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4050034|NCT01102972|3871592|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4050035|NCT01102972|3871590|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|175|175.0||||||
4050036|NCT01102972|3871591|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|55|55.0||||||
4050037|NCT01102972|3871592|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|120|120.0||||||
4050038|NCT01102972|3871590|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4050039|NCT01102972|3871591|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4050040|NCT01102972|3871592|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4050041|NCT01102972|3871590|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4050042|NCT01102972|3871591|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4050043|NCT01102972|3871592|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4050044|NCT01102972|3871590|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4050045|NCT01102972|3871591|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4050046|NCT01102972|3871592|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4050047|NCT01102972|3871590|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4050048|NCT01102972|3871591|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4050049|NCT01102972|3871592|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4050050|NCT01102972|3871590|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4050051|NCT01102972|3871591|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4050052|NCT01102972|3871592|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4050053|NCT01102972|3871590|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|102|102.0||||||
4050054|NCT01102972|3871591|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
4050055|NCT01102972|3871592|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|65|65.0||||||
4050056|NCT01102972|3871590|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050057|NCT01102972|3871591|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050058|NCT01102972|3871592|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050059|NCT01102972|3871590|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|219|219.0||||||
4050060|NCT01102972|3871591|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
4050061|NCT01102972|3871592|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|148|148.0||||||
4050062|NCT01102972|3871590|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
4050063|NCT01102972|3871591|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4050064|NCT01102972|3871592|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4050065|NCT01102972|3871590|B3||Male|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
4050066|NCT01102972|3871591|B2||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4050067|NCT01102972|3871592|B1||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4050068|NCT01102972|3871590|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4050069|NCT01102972|3871591|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4050070|NCT01102972|3871592|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4050071|NCT01102972|3871590|B3|||Age||Years|Mean|42.6|42.6|Standard Deviation|9.74|9.74|||
4050072|NCT01102972|3871591|B2|||Age||Years|Mean|42.3|42.3|Standard Deviation|10.20|10.2|||
4050073|NCT01102972|3871592|B1|||Age||Years|Mean|42.8|42.8|Standard Deviation|9.54|9.54|||
4050074|NCT01102894|3871645|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4050075|NCT01102894|3871645|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4050076|NCT01102894|3871645|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4050077|NCT01102894|3871645|B1|||Age||years|Mean|24|24.0|Standard Deviation|2|2.0|||
4050078|NCT01102894|3871645|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4050079|NCT01102894|3871645|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4050080|NCT01102894|3871645|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050086|NCT01102803|3871657|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4050087|NCT01102803|3871655|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4050088|NCT01102803|3871656|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4050089|NCT01102803|3871657|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4050090|NCT01102803|3871655|B3|||Age||years|Mean|33.8|33.8|Standard Deviation|15.74|15.74|||
4050091|NCT01102803|3871656|B2|||Age||years|Mean|29.33|29.33|Standard Deviation|14.67|14.67|||
4050092|NCT01102803|3871657|B1|||Age||years|Mean|37.71|37.71|Standard Deviation|16.81|16.81|||
4050093|NCT01102803|3871655|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4050094|NCT01102803|3871656|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4050095|NCT01102803|3871657|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4050096|NCT01102803|3871655|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4050097|NCT01102803|3871656|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4050098|NCT01102803|3871657|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4050099|NCT01102803|3871655|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050100|NCT01102803|3871656|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050101|NCT01102803|3871657|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050102|NCT01102777|3871670|B3|||Baseline daily step count; mean||steps|Mean|3497|3497.0|Standard Deviation|2220|2220.0|||
4050103|NCT01102777|3871671|B2|||Baseline daily step count; mean||steps|Mean|3484|3484.0|Standard Deviation|2309|2309.0|||
4050104|NCT01102777|3871672|B1|||Baseline daily step count; mean||steps|Mean|3521|3521.0|Standard Deviation|2058|2058.0|||
4050105|NCT01102777|3871670|B3|MMRS Dyspnea Score 2-4||Modified Medical Research Council (MMRC) Dyspnea score|The Modified Medical Research Council Dyspnea Scale, or MMRC, uses a simple grading system to assess a patient's level of dyspnea -- shortness of breath. Scores range from 0 to 4, with 4 indicating more limitations to daily activities.|participants|Number|73|73.0||||||
4050106|NCT01102777|3871671|B2|MMRS Dyspnea Score 2-4||Modified Medical Research Council (MMRC) Dyspnea score|The Modified Medical Research Council Dyspnea Scale, or MMRC, uses a simple grading system to assess a patient's level of dyspnea -- shortness of breath. Scores range from 0 to 4, with 4 indicating more limitations to daily activities.|participants|Number|46|46.0||||||
4050107|NCT01102777|3871672|B1|MMRS Dyspnea Score 2-4||Modified Medical Research Council (MMRC) Dyspnea score|The Modified Medical Research Council Dyspnea Scale, or MMRC, uses a simple grading system to assess a patient's level of dyspnea -- shortness of breath. Scores range from 0 to 4, with 4 indicating more limitations to daily activities.|participants|Number|27|27.0||||||
4050108|NCT01102777|3871670|B3|MMRS Dyspnea Score 0-1||Modified Medical Research Council (MMRC) Dyspnea score|The Modified Medical Research Council Dyspnea Scale, or MMRC, uses a simple grading system to assess a patient's level of dyspnea -- shortness of breath. Scores range from 0 to 4, with 4 indicating more limitations to daily activities.|participants|Number|166|166.0||||||
4050109|NCT01102777|3871671|B2|MMRS Dyspnea Score 0-1||Modified Medical Research Council (MMRC) Dyspnea score|The Modified Medical Research Council Dyspnea Scale, or MMRC, uses a simple grading system to assess a patient's level of dyspnea -- shortness of breath. Scores range from 0 to 4, with 4 indicating more limitations to daily activities.|participants|Number|109|109.0||||||
4050110|NCT01102777|3871672|B1|MMRS Dyspnea Score 0-1||Modified Medical Research Council (MMRC) Dyspnea score|The Modified Medical Research Council Dyspnea Scale, or MMRC, uses a simple grading system to assess a patient's level of dyspnea -- shortness of breath. Scores range from 0 to 4, with 4 indicating more limitations to daily activities.|participants|Number|57|57.0||||||
4050111|NCT01102777|3871670|B3|||St George's Respiratory Questionnaire (SGRQ)|Reflected here is the St George's Respiratory Questionnaire (SGRQ) Total Score. Scores range from 0 to 100, with higher scores indicating more limitations.|units on a scale|Mean|46.0|46.0|Standard Deviation|15.4|15.4|||
4050112|NCT01102777|3871671|B2|||St George's Respiratory Questionnaire (SGRQ)|Reflected here is the St George's Respiratory Questionnaire (SGRQ) Total Score. Scores range from 0 to 100, with higher scores indicating more limitations.|units on a scale|Mean|45.5|45.5|Standard Deviation|15.4|15.4|||
4050113|NCT01102777|3871672|B1|||St George's Respiratory Questionnaire (SGRQ)|Reflected here is the St George's Respiratory Questionnaire (SGRQ) Total Score. Scores range from 0 to 100, with higher scores indicating more limitations.|units on a scale|Mean|46.8|46.8|Standard Deviation|15.6|15.6|||
4050114|NCT01102777|3871670|B3|United States||Region of Enrollment||participants|Number|239|239.0||||||
4050115|NCT01102777|3871671|B2|United States||Region of Enrollment||participants|Number|155|155.0||||||
4050116|NCT01102777|3871672|B1|United States||Region of Enrollment||participants|Number|84|84.0||||||
4050117|NCT01102777|3871670|B3|Other/combined||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4050118|NCT01102777|3871671|B2|Other/combined||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4050119|NCT01102777|3871672|B1|Other/combined||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4050120|NCT01102777|3871670|B3|White||Race/Ethnicity, Customized||participants|Number|222|222.0||||||
4050121|NCT01102777|3871671|B2|White||Race/Ethnicity, Customized||participants|Number|143|143.0||||||
4050122|NCT01102777|3871672|B1|White||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
4050123|NCT01102777|3871670|B3|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4050124|NCT01102777|3871671|B2|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4050125|NCT01102777|3871672|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4050126|NCT01102777|3871670|B3||Male|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
4050127|NCT01102777|3871671|B2||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4050128|NCT01102777|3871672|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4050129|NCT01102777|3871670|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4050130|NCT01102777|3871671|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4050131|NCT01102777|3871672|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4050132|NCT01102777|3871670|B3|||Age||years|Mean|66.7|66.7|Standard Deviation|8.8|8.8|||
4050133|NCT01102777|3871671|B2|||Age||years|Mean|66.9|66.9|Standard Deviation|8.7|8.7|||
4050134|NCT01102777|3871672|B1|||Age||years|Mean|66.4|66.4|Standard Deviation|9.2|9.2|||
4050135|NCT01102764|3871697|B3|Unknown||Marital Status||participants|Number|3|3.0||||||
4050136|NCT01102764|3871698|B2|Unknown||Marital Status||participants|Number|2|2.0||||||
4050137|NCT01102764|3871699|B1|Unknown||Marital Status||participants|Number|1|1.0||||||
4050138|NCT01102764|3871697|B3|Widowed||Marital Status||participants|Number|3|3.0||||||
4050139|NCT01102764|3871698|B2|Widowed||Marital Status||participants|Number|2|2.0||||||
4050140|NCT01102764|3871699|B1|Widowed||Marital Status||participants|Number|1|1.0||||||
4050141|NCT01102764|3871697|B3|Separated/Divorced||Marital Status||participants|Number|23|23.0||||||
4050142|NCT01102764|3871698|B2|Separated/Divorced||Marital Status||participants|Number|12|12.0||||||
4050143|NCT01102764|3871699|B1|Separated/Divorced||Marital Status||participants|Number|11|11.0||||||
4050144|NCT01102764|3871697|B3|Married||Marital Status||participants|Number|73|73.0||||||
4050145|NCT01102764|3871698|B2|Married||Marital Status||participants|Number|37|37.0||||||
4050146|NCT01102764|3871699|B1|Married||Marital Status||participants|Number|36|36.0||||||
4050147|NCT01102764|3871697|B3|Never Married||Marital Status||participants|Number|30|30.0||||||
4050148|NCT01102764|3871698|B2|Never Married||Marital Status||participants|Number|15|15.0||||||
4050149|NCT01102764|3871699|B1|Never Married||Marital Status||participants|Number|15|15.0||||||
4050150|NCT01102764|3871697|B3|||Mean Service Connection Rating|"Veterans can have anywhere from 0% to 100% service connection rating aka disability compensation. Disability compensation is a monetary benefit paid to Veterans who are determined by VA to be disabled by an injury or illness that was incurred or aggravated during active military service. These disabilities are considered to be service connected. To be eligible for compensation, the Veteran must have been separated or discharged under conditions other than dishonorable."|units on a scale|Mean|53.5|53.5|Standard Deviation|37.9|37.9|||
4050151|NCT01102764|3871698|B2|||Mean Service Connection Rating|"Veterans can have anywhere from 0% to 100% service connection rating aka disability compensation. Disability compensation is a monetary benefit paid to Veterans who are determined by VA to be disabled by an injury or illness that was incurred or aggravated during active military service. These disabilities are considered to be service connected. To be eligible for compensation, the Veteran must have been separated or discharged under conditions other than dishonorable."|units on a scale|Mean|51.4|51.4|Standard Deviation|40.2|40.2|||
4050152|NCT01102764|3871699|B1|||Mean Service Connection Rating|"Veterans can have anywhere from 0% to 100% service connection rating aka disability compensation. Disability compensation is a monetary benefit paid to Veterans who are determined by VA to be disabled by an injury or illness that was incurred or aggravated during active military service. These disabilities are considered to be service connected. To be eligible for compensation, the Veteran must have been separated or discharged under conditions other than dishonorable."|units on a scale|Mean|55.8|55.8|Standard Deviation|35.7|35.7|||
4050153|NCT01102764|3871697|B3|United States||Region of Enrollment||participants|Number|132|132.0||||||
4050154|NCT01102764|3871698|B2|United States||Region of Enrollment||participants|Number|68|68.0||||||
4050155|NCT01102764|3871699|B1|United States||Region of Enrollment||participants|Number|64|64.0||||||
4050156|NCT01102764|3871697|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4050157|NCT01102764|3871698|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4050158|NCT01102764|3871699|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4050159|NCT01102764|3871697|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050160|NCT01102764|3871698|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050161|NCT01102764|3871699|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050162|NCT01102764|3871697|B3||White|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
4050163|NCT01102764|3871698|B2||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4050164|NCT01102764|3871699|B1||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4050165|NCT01102764|3871697|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4050166|NCT01102764|3871698|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4050167|NCT01102764|3871699|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4050168|NCT01102764|3871697|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050169|NCT01102764|3871698|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050170|NCT01102764|3871699|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050171|NCT01102764|3871697|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050172|NCT01102764|3871698|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050173|NCT01102764|3871699|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050174|NCT01102764|3871697|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050175|NCT01102764|3871698|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050176|NCT01102764|3871699|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050177|NCT01102764|3871697|B3||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4050178|NCT01102764|3871698|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4050179|NCT01102764|3871699|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4050180|NCT01102764|3871697|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4050181|NCT01102764|3871698|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4050182|NCT01102764|3871699|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4050183|NCT01102764|3871697|B3|||Age||years|Mean|41.8|41.8|Standard Deviation|14.5|14.5|||
4050184|NCT01102764|3871698|B2|||Age||years|Mean|42.9|42.9|Standard Deviation|14.1|14.1|||
4050185|NCT01102764|3871699|B1|||Age||years|Mean|40.7|40.7|Standard Deviation|14.9|14.9|||
4050186|NCT01102491|3871710|B3|Korea, Republic of||Region of Enrollment||participants|Number|142|142.0||||||
4050187|NCT01102491|3871711|B2|Korea, Republic of||Region of Enrollment||participants|Number|71|71.0||||||
4050188|NCT01102491|3871712|B1|Korea, Republic of||Region of Enrollment||participants|Number|71|71.0||||||
4050189|NCT01102491|3871710|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4050190|NCT01102491|3871711|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4050191|NCT01102491|3871712|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4050192|NCT01102491|3871710|B3||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4050193|NCT01102491|3871711|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4050194|NCT01102491|3871712|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4050195|NCT01102491|3871710|B3|||Age||years|Mean|69.1|69.1|Standard Deviation|6.8|6.8|||
4050196|NCT01102491|3871711|B2|||Age||years|Mean|69.0|69.0|Standard Deviation|7.5|7.5|||
4050197|NCT01102491|3871712|B1|||Age||years|Mean|69.1|69.1|Standard Deviation|6.3|6.3|||
4050198|NCT01102491|3871710|B3||>=65 years|Age||Participants|Count of Participants|113|113.0||||||
4050199|NCT01102491|3871711|B2||>=65 years|Age||Participants|Count of Participants|55|55.0||||||
4050200|NCT01102491|3871712|B1||>=65 years|Age||Participants|Count of Participants|58|58.0||||||
4050201|NCT01102491|3871710|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4050202|NCT01102491|3871711|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4050203|NCT01102491|3871712|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4050204|NCT01102491|3871710|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050205|NCT01102491|3871711|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050206|NCT01102491|3871712|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050207|NCT01102413|3871719|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4050208|NCT01102413|3871720|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4050209|NCT01102413|3871721|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4050210|NCT01102413|3871719|B3|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
4050211|NCT01102413|3871720|B2|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
4050212|NCT01102413|3871721|B1|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
4050213|NCT01102413|3871719|B3|Russian Federation||Region of Enrollment||participants|Number|17|17.0||||||
4050214|NCT01102413|3871720|B2|Russian Federation||Region of Enrollment||participants|Number|8|8.0||||||
4050215|NCT01102413|3871721|B1|Russian Federation||Region of Enrollment||participants|Number|9|9.0||||||
4050216|NCT01102413|3871719|B3|Poland||Region of Enrollment||participants|Number|8|8.0||||||
4050217|NCT01102413|3871720|B2|Poland||Region of Enrollment||participants|Number|4|4.0||||||
4050218|NCT01102413|3871721|B1|Poland||Region of Enrollment||participants|Number|4|4.0||||||
4050219|NCT01102413|3871719|B3|India||Region of Enrollment||participants|Number|202|202.0||||||
4050220|NCT01102413|3871720|B2|India||Region of Enrollment||participants|Number|64|64.0||||||
4050221|NCT01102413|3871721|B1|India||Region of Enrollment||participants|Number|138|138.0||||||
4050222|NCT01102413|3871719|B3|United Kingdom||Region of Enrollment||participants|Number|31|31.0||||||
4050223|NCT01102413|3871720|B2|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
4050224|NCT01102413|3871721|B1|United Kingdom||Region of Enrollment||participants|Number|19|19.0||||||
4050225|NCT01102413|3871719|B3|Germany||Region of Enrollment||participants|Number|31|31.0||||||
4050226|NCT01102413|3871720|B2|Germany||Region of Enrollment||participants|Number|11|11.0||||||
4050227|NCT01102413|3871721|B1|Germany||Region of Enrollment||participants|Number|20|20.0||||||
4050228|NCT01102413|3871719|B3|Austria||Region of Enrollment||participants|Number|21|21.0||||||
4050229|NCT01102413|3871720|B2|Austria||Region of Enrollment||participants|Number|5|5.0||||||
4050230|NCT01102413|3871721|B1|Austria||Region of Enrollment||participants|Number|16|16.0||||||
4050231|NCT01102413|3871719|B3|Denmark||Region of Enrollment||participants|Number|19|19.0||||||
4050232|NCT01102413|3871720|B2|Denmark||Region of Enrollment||participants|Number|6|6.0||||||
4050233|NCT01102413|3871721|B1|Denmark||Region of Enrollment||participants|Number|13|13.0||||||
4050234|NCT01102413|3871719|B3||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4050235|NCT01102413|3871720|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4050236|NCT01102413|3871721|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4050237|NCT01102413|3871719|B3||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4050238|NCT01102413|3871720|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4050239|NCT01102413|3871721|B1||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4050240|NCT01102413|3871719|B3||>=65 years|Age||Participants|Count of Participants|107|107.0||||||
4050241|NCT01102413|3871720|B2||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4050242|NCT01102413|3871721|B1||>=65 years|Age||Participants|Count of Participants|69|69.0||||||
4050243|NCT01102413|3871719|B3||Between 18 and 65 years|Age||Participants|Count of Participants|244|244.0||||||
4050244|NCT01102413|3871720|B2||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4050245|NCT01102413|3871721|B1||Between 18 and 65 years|Age||Participants|Count of Participants|164|164.0||||||
4050246|NCT01102413|3871719|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050247|NCT01102413|3871720|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050248|NCT01102413|3871721|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050249|NCT01102374|3871730|B3|||25-hydroxyvitamin D level||ng/ml|Mean|23.0|23.0|Standard Deviation|9.1|9.1|||
4050250|NCT01102374|3871731|B2|||25-hydroxyvitamin D level||ng/ml|Mean|23.0|23.0|Standard Deviation|9.9|9.9|||
4050251|NCT01102374|3871732|B1|||25-hydroxyvitamin D level||ng/ml|Mean|23.0|23.0|Standard Deviation|8.4|8.4|||
4050252|NCT01102374|3871730|B3|United States||Region of Enrollment||participants|Number|107|107.0||||||
4050253|NCT01102374|3871731|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
4050254|NCT01102374|3871732|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4050255|NCT01102374|3871730|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4050256|NCT01102374|3871731|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4050257|NCT01102374|3871732|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4050258|NCT01102374|3871730|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4050259|NCT01102374|3871731|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4050260|NCT01102374|3871732|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4050261|NCT01102374|3871730|B3|||Age||years|Mean|81|81.0|Standard Deviation|10|10.0|||
4050262|NCT01102374|3871731|B2|||Age||years|Mean|82|82.0|Standard Deviation|10|10.0|||
4050263|NCT01102374|3871732|B1|||Age||years|Mean|80|80.0|Standard Deviation|10|10.0|||
4050264|NCT01102270|3871767|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4050265|NCT01102270|3871767|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4050266|NCT01102270|3871767|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4050267|NCT01102270|3871767|B1|||Age||years|Mean|45|45.0|Standard Deviation|15|15.0|||
4050268|NCT01102270|3871767|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4050269|NCT01102270|3871767|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4050270|NCT01102270|3871767|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050271|NCT01102257|3871780|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4050272|NCT01102257|3871781|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4050273|NCT01102257|3871782|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4050274|NCT01102257|3871780|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4050275|NCT01102257|3871781|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4050276|NCT01102257|3871782|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4050277|NCT01102257|3871780|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4050278|NCT01102257|3871781|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4050279|NCT01102257|3871782|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4050280|NCT01102257|3871780|B3|||Age||years|Mean|56|56.0|Standard Deviation|14|14.0|||
4050281|NCT01102257|3871781|B2|||Age||years|Mean|57|57.0|Standard Deviation|15|15.0|||
4050282|NCT01102257|3871782|B1|||Age||years|Mean|55|55.0|Standard Deviation|14|14.0|||
4050283|NCT01102257|3871780|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4050284|NCT01102257|3871781|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4050285|NCT01102257|3871782|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4050286|NCT01102257|3871780|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4050287|NCT01102257|3871781|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4050288|NCT01102257|3871782|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4050289|NCT01102257|3871780|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050290|NCT01102257|3871781|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050291|NCT01102257|3871782|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050292|NCT01102218|3871789|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
4050293|NCT01102218|3871790|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4050294|NCT01102218|3871791|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4050295|NCT01102218|3871789|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4050296|NCT01102218|3871790|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4050297|NCT01102218|3871791|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4050298|NCT01102218|3871789|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4050299|NCT01102218|3871790|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4050300|NCT01102218|3871791|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4050301|NCT01102218|3871789|B3|||Age||years|Mean|56|56.0|Standard Deviation|13|13.0|||
4050302|NCT01102218|3871790|B2|||Age||years|Mean|57|57.0|Standard Deviation|14|14.0|||
4050303|NCT01102218|3871791|B1|||Age||years|Mean|56|56.0|Standard Deviation|12|12.0|||
4050304|NCT01102218|3871789|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4050305|NCT01102218|3871790|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4050306|NCT01102218|3871791|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4050307|NCT01102218|3871789|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4050308|NCT01102218|3871790|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4050309|NCT01102218|3871791|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4050310|NCT01102218|3871789|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050311|NCT01102218|3871790|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050312|NCT01102218|3871791|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050313|NCT01102140|3871798|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4050314|NCT01102140|3871799|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4050315|NCT01102140|3871800|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4050316|NCT01102140|3871798|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4050317|NCT01102140|3871799|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4050318|NCT01102140|3871800|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050319|NCT01102140|3871798|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050320|NCT01102140|3871799|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050321|NCT01102140|3871800|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050322|NCT01102140|3871798|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4050323|NCT01102140|3871799|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4050324|NCT01102140|3871800|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4050325|NCT01102140|3871798|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4050326|NCT01102140|3871799|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050327|NCT01102140|3871800|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4050328|NCT01102140|3871798|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050329|NCT01102140|3871799|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050330|NCT01102140|3871800|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050331|NCT01102140|3871798|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050332|NCT01102140|3871799|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050333|NCT01102140|3871800|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050334|NCT01102140|3871798|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050335|NCT01102140|3871799|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050336|NCT01102140|3871800|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050337|NCT01102140|3871798|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4050338|NCT01102140|3871799|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4050339|NCT01102140|3871800|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4050340|NCT01102140|3871798|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4050341|NCT01102140|3871799|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4050342|NCT01102140|3871800|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4050343|NCT01102140|3871798|B3|||Age||years|Median|57|57.0|Inter-Quartile Range|||50.0|64.0|
4050344|NCT01102140|3871799|B2|||Age||years|Median|58|58.0|Inter-Quartile Range|||52.0|64.0|
4050345|NCT01102140|3871800|B1|||Age||years|Median|57|57.0|Inter-Quartile Range|||49.0|64.0|
4050346|NCT01102140|3871798|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4050347|NCT01102140|3871799|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4050348|NCT01102140|3871800|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4050349|NCT01102140|3871798|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4050350|NCT01102140|3871799|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4050351|NCT01102140|3871800|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4050352|NCT01102140|3871798|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050353|NCT01102140|3871799|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050354|NCT01102140|3871800|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050355|NCT01101971|3871813|B1|Canada||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
4050356|NCT01101971|3871813|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4050357|NCT01101971|3871813|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4050358|NCT01101971|3871813|B1|||Age||years|Mean|24|24.0|Full Range|||20.0|40.0|
4050359|NCT01101958|3871817|B3|Sweden||Region of Enrollment||participants|Number|9|9.0||||||
4050360|NCT01101958|3871818|B2|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
4050361|NCT01101958|3871819|B1|Sweden||Region of Enrollment||participants|Number|7|7.0||||||
4050362|NCT01101958|3871817|B3|Germany||Region of Enrollment||participants|Number|57|57.0||||||
4050363|NCT01101958|3871818|B2|Germany||Region of Enrollment||participants|Number|23|23.0||||||
4050364|NCT01101958|3871819|B1|Germany||Region of Enrollment||participants|Number|34|34.0||||||
4050365|NCT01101958|3871817|B3|Netherlands||Region of Enrollment||participants|Number|30|30.0||||||
4050366|NCT01101958|3871818|B2|Netherlands||Region of Enrollment||participants|Number|9|9.0||||||
4050367|NCT01101958|3871819|B1|Netherlands||Region of Enrollment||participants|Number|21|21.0||||||
4050368|NCT01101958|3871817|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4050369|NCT01101958|3871818|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4050370|NCT01101958|3871819|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4050371|NCT01101958|3871817|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4050372|NCT01101958|3871818|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4050373|NCT01101958|3871819|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4050374|NCT01101958|3871817|B3|||Age||years|Mean|63|63.0|Standard Deviation|9|9.0|||
4050375|NCT01101958|3871818|B2|||Age||years|Mean|63|63.0|Standard Deviation|9|9.0|||
4050376|NCT01101958|3871819|B1|||Age||years|Mean|63|63.0|Standard Deviation|10|10.0|||
4050377|NCT01101880|3871826|B1|||Peripheral Blast||percent of white blood cells|Median|16|16.0|Full Range|||0.0|100.0|
4050378|NCT01101880|3871826|B1|||WBC||cells x 10^9/L|Median|12|12.0|Full Range|||0.8|761.3|
4050379|NCT01101880|3871826|B1|||FLT3 ITD mutation status|Number of participants with a FLT3 ITD mutation|Participants|Count of Participants|10|10.0||||||
4050380|NCT01101880|3871826|B1|||Antecedent hematological disorder (AHD)||Participants|Count of Participants|23|23.0||||||
4050381|NCT01101880|3871826|B1||Indeterminate|Cytogenetic Risk Factor||Participants|Count of Participants|1|1.0||||||
4050382|NCT01101880|3871826|B1||Unfavorable|Cytogenetic Risk Factor||Participants|Count of Participants|13|13.0||||||
4050383|NCT01101880|3871826|B1||Intermediate|Cytogenetic Risk Factor||Participants|Count of Participants|32|32.0||||||
4050384|NCT01101880|3871826|B1||Favorable|Cytogenetic Risk Factor||Participants|Count of Participants|4|4.0||||||
4050385|NCT01101880|3871826|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4050386|NCT01101880|3871826|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4050387|NCT01101880|3871826|B1|||Age||years|Median|53|53.0|Full Range|||22.0|64.0|
4050388|NCT01101867|3871835|B3|United States||Region of Enrollment||participants|Number|126|126.0||||||
4050389|NCT01101867|3871836|B2|United States||Region of Enrollment||participants|Number|63|63.0||||||
4050390|NCT01101867|3871837|B1|United States||Region of Enrollment||participants|Number|63|63.0||||||
4050391|NCT01101867|3871835|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4050392|NCT01101867|3871836|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4050393|NCT01101867|3871837|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4050394|NCT01101867|3871835|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4050395|NCT01101867|3871836|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4050396|NCT01101867|3871837|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4050397|NCT01101867|3871835|B3|||Age||years|Mean|57|57.0|Standard Deviation|11|11.0|||
4050398|NCT01101867|3871836|B2|||Age||years|Mean|56|56.0|Standard Deviation|12|12.0|||
4050399|NCT01101867|3871837|B1|||Age||years|Mean|57|57.0|Standard Deviation|10|10.0|||
4050400|NCT01101867|3871835|B3||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4050401|NCT01101867|3871836|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4050402|NCT01101867|3871837|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4050403|NCT01101867|3871835|B3||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
4050404|NCT01101867|3871836|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4050405|NCT01101867|3871837|B1||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4050406|NCT01101867|3871835|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050407|NCT01101867|3871836|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050408|NCT01101867|3871837|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050409|NCT01101841|3871854|B3|United States||Region of Enrollment||participants|Number|570|570.0||||||
4050410|NCT01101841|3871855|B2|United States||Region of Enrollment||participants|Number|285|285.0||||||
4050411|NCT01101841|3871856|B1|United States||Region of Enrollment||participants|Number|285|285.0||||||
4050412|NCT01101841|3871854|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4050413|NCT01101841|3871855|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4050414|NCT01101841|3871856|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4050415|NCT01101841|3871854|B3||Female|Sex: Female, Male||Participants|Count of Participants|570|570.0||||||
4050416|NCT01101841|3871855|B2||Female|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
4050417|NCT01101841|3871856|B1||Female|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
4050418|NCT01101841|3871854|B3|||Age||years|Mean|54.4|54.4|Standard Deviation|5.60|5.6|||
4050419|NCT01101841|3871855|B2|||Age||years|Mean|54.5|54.5|Standard Deviation|5.74|5.74|||
4050420|NCT01101841|3871856|B1|||Age||years|Mean|54.2|54.2|Standard Deviation|5.47|5.47|||
4050421|NCT01101841|3871854|B3||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
4050422|NCT01101841|3871855|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4050423|NCT01101841|3871856|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4050424|NCT01101841|3871854|B3||Between 18 and 65 years|Age||Participants|Count of Participants|536|536.0||||||
4050425|NCT01101841|3871855|B2||Between 18 and 65 years|Age||Participants|Count of Participants|267|267.0||||||
4050426|NCT01101841|3871856|B1||Between 18 and 65 years|Age||Participants|Count of Participants|269|269.0||||||
4050427|NCT01101841|3871854|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050428|NCT01101841|3871855|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050429|NCT01101841|3871856|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050430|NCT01101542|3871895|B1||Male|Sex: Female, Male|The baseline measure data here corresponds to Year 6 of surveillance.|Participants|Count of Participants|0|0.0||||||
4050431|NCT01101542|3871895|B1||Female|Sex: Female, Male|The baseline measure data here corresponds to Year 6 of surveillance.|Participants|Count of Participants|3091|3091.0||||||
4050432|NCT01101542|3871895|B1||Male|Sex: Female, Male|The baseline measure data here corresponds to Year 5 of surveillance.|Participants|Count of Participants|0|0.0||||||
4050433|NCT01101542|3871895|B1||Female|Sex: Female, Male|The baseline measure data here corresponds to Year 5 of surveillance.|Participants|Count of Participants|809|809.0||||||
4050434|NCT01101542|3871895|B1||Male|Sex: Female, Male|The baseline measure data here corresponds to Year 4 of surveillance.|Participants|Count of Participants|0|0.0||||||
4050435|NCT01101542|3871895|B1||Female|Sex: Female, Male|The baseline measure data here corresponds to Year 4 of surveillance.|Participants|Count of Participants|569|569.0||||||
4050436|NCT01101542|3871895|B1||Male|Sex: Female, Male|The baseline measure data here corresponds to Year 3 of surveillance.|Participants|Count of Participants|0|0.0||||||
4050437|NCT01101542|3871895|B1||Female|Sex: Female, Male|The baseline measure data here corresponds to Year 3 of surveillance.|Participants|Count of Participants|105|105.0||||||
4050438|NCT01101542|3871895|B1|||Age|The baseline measure data here corresponds to Year 6 of surveillance.|Years|Mean|20.5|20.5|Standard Deviation|3.82|3.82|||
4050439|NCT01101542|3871895|B1|||Age|The baseline measure data here corresponds to Year 5 of surveillance.|Years|Mean|20.9|20.9|Standard Deviation|3.06|3.06|||
4050440|NCT01101542|3871895|B1|||Age|The baseline measure data here corresponds to Year 4 of surveillance.|Years|Mean|20.8|20.8|Standard Deviation|3.87|3.87|||
4050441|NCT01101542|3871895|B1|||Age|The baseline measure data here corresponds to Year 3 of surveillance.|Years|Mean|20.4|20.4|Standard Deviation|3.72|3.72|||
4050442|NCT01101477|3871908|B4|Taiwan||Region of Enrollment||participants|Number|144|144.0||||||
4050443|NCT01101477|3871909|B3|Taiwan||Region of Enrollment||participants|Number|46|46.0||||||
4050444|NCT01101477|3871910|B2|Taiwan||Region of Enrollment||participants|Number|49|49.0||||||
4050445|NCT01101477|3871911|B1|Taiwan||Region of Enrollment||participants|Number|49|49.0||||||
4050446|NCT01101477|3871908|B4||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4050447|NCT01101477|3871909|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4050448|NCT01101477|3871910|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4050449|NCT01101477|3871911|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4050450|NCT01101477|3871908|B4||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4050451|NCT01101477|3871909|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4050452|NCT01101477|3871910|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4050453|NCT01101477|3871911|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4050454|NCT01101477|3871908|B4|||Age||years|Mean|62.4|62.4|Standard Deviation|13.6|13.6|||
4050455|NCT01101477|3871909|B3|||Age||years|Mean|63.4|63.4|Standard Deviation|14.4|14.4|||
4050456|NCT01101477|3871910|B2|||Age||years|Mean|62.6|62.6|Standard Deviation|13.5|13.5|||
4050457|NCT01101477|3871911|B1|||Age||years|Mean|61.4|61.4|Standard Deviation|13.0|13.0|||
4050458|NCT01101477|3871908|B4||>=65 years|Age||Participants|Count of Participants|68|68.0||||||
4050459|NCT01101477|3871909|B3||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4050460|NCT01101477|3871910|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4050461|NCT01101477|3871911|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4050462|NCT01101477|3871908|B4||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
4050463|NCT01101477|3871909|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4050464|NCT01101477|3871910|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4050465|NCT01101477|3871911|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4050466|NCT01101477|3871908|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050467|NCT01101477|3871909|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050468|NCT01101477|3871910|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050469|NCT01101477|3871911|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050470|NCT01101464|3871921|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4050471|NCT01101464|3871922|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4050472|NCT01101464|3871923|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4050473|NCT01101464|3871921|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4050474|NCT01101464|3871922|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4050475|NCT01101464|3871923|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4050476|NCT01101464|3871921|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4050477|NCT01101464|3871922|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4050478|NCT01101464|3871923|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4050479|NCT01101464|3871921|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4050480|NCT01101464|3871922|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4050481|NCT01101464|3871923|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4050482|NCT01101464|3871921|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050483|NCT01101464|3871922|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050484|NCT01101464|3871923|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050485|NCT01101321|3871934|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4050486|NCT01101321|3871934|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4050487|NCT01101321|3871934|B1|||Age||years|Mean|30|30.0|Standard Deviation|9.6|9.6|||
4050488|NCT01101308|3871945|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4050489|NCT01101308|3871945|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4050490|NCT01101308|3871945|B1|Age||Age||Years|Mean|29|29.0|Standard Deviation|9.3|9.3|||
4050491|NCT01101191|3871957|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4050492|NCT01101191|3871957|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4050493|NCT01101191|3871957|B1|Age||Age||Years|Mean|29|29.0|Standard Deviation|10.1|10.1|||
4050494|NCT01101178|3871969|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4050495|NCT01101178|3871969|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4050496|NCT01101178|3871969|B1|||Age||years|Mean|29|29.0|Standard Deviation|9.2|9.2|||
4050497|NCT01101165|3871981|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4050498|NCT01101165|3871981|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4050499|NCT01101165|3871981|B1|||Age||years|Mean|31|31.0|Standard Deviation|9.0|9.0|||
4050500|NCT01101035|3871992|B3|No||Use of Clopidogrel and Other Antiplatelet Drugs||Participants|Count of Participants|4964|4964.0||||||
4050501|NCT01101035|3871993|B2|No||Use of Clopidogrel and Other Antiplatelet Drugs||Participants|Count of Participants|2465|2465.0||||||
4050502|NCT01101035|3871994|B1|No||Use of Clopidogrel and Other Antiplatelet Drugs||Participants|Count of Participants|2499|2499.0||||||
4050503|NCT01101035|3871992|B3|Yes||Use of Clopidogrel and Other Antiplatelet Drugs||Participants|Count of Participants|1226|1226.0||||||
4050504|NCT01101035|3871993|B2|Yes||Use of Clopidogrel and Other Antiplatelet Drugs||Participants|Count of Participants|627|627.0||||||
4050505|NCT01101035|3871994|B1|Yes||Use of Clopidogrel and Other Antiplatelet Drugs||Participants|Count of Participants|599|599.0||||||
4050506|NCT01101035|3871992|B3|No||Use of Nonsteroidal Anti-Inflammatory Drug (NSAIDs)||Participants|Count of Participants|4426|4426.0||||||
4050507|NCT01101035|3871993|B2|No||Use of Nonsteroidal Anti-Inflammatory Drug (NSAIDs)||Participants|Count of Participants|2184|2184.0||||||
4050508|NCT01101035|3871994|B1|No||Use of Nonsteroidal Anti-Inflammatory Drug (NSAIDs)||Participants|Count of Participants|2242|2242.0||||||
4050509|NCT01101035|3871992|B3|Yes||Use of Nonsteroidal Anti-Inflammatory Drug (NSAIDs)||Participants|Count of Participants|1764|1764.0||||||
4050510|NCT01101035|3871993|B2|Yes||Use of Nonsteroidal Anti-Inflammatory Drug (NSAIDs)||Participants|Count of Participants|908|908.0||||||
4050511|NCT01101035|3871994|B1|Yes||Use of Nonsteroidal Anti-Inflammatory Drug (NSAIDs)||Participants|Count of Participants|856|856.0||||||
4050512|NCT01101035|3871992|B3|No||Use of any Dose of Aspirin||Participants|Count of Participants|2363|2363.0||||||
4050513|NCT01101035|3871993|B2|No||Use of any Dose of Aspirin||Participants|Count of Participants|1159|1159.0||||||
4050514|NCT01101035|3871994|B1|No||Use of any Dose of Aspirin||Participants|Count of Participants|1204|1204.0||||||
4050515|NCT01101035|3871992|B3|Yes||Use of any Dose of Aspirin||Participants|Count of Participants|3827|3827.0||||||
4050516|NCT01101035|3871993|B2|Yes||Use of any Dose of Aspirin||Participants|Count of Participants|1933|1933.0||||||
4050517|NCT01101035|3871994|B1|Yes||Use of any Dose of Aspirin||Participants|Count of Participants|1894|1894.0||||||
4050518|NCT01101035|3871992|B3|No||Use of Low Dose Aspirin|Dosing <325 mg aspirin per day is considered as low-dose aspirin|Participants|Count of Participants|3213|3213.0||||||
4050519|NCT01101035|3871993|B2|No||Use of Low Dose Aspirin|Dosing <325 mg aspirin per day is considered as low-dose aspirin|Participants|Count of Participants|1611|1611.0||||||
4050520|NCT01101035|3871994|B1|No||Use of Low Dose Aspirin|Dosing <325 mg aspirin per day is considered as low-dose aspirin|Participants|Count of Participants|1602|1602.0||||||
4050521|NCT01101035|3871992|B3|Yes||Use of Low Dose Aspirin|Dosing <325 mg aspirin per day is considered as low-dose aspirin|Participants|Count of Participants|2977|2977.0||||||
4050522|NCT01101035|3871993|B2|Yes||Use of Low Dose Aspirin|Dosing <325 mg aspirin per day is considered as low-dose aspirin|Participants|Count of Participants|1481|1481.0||||||
4050523|NCT01101035|3871994|B1|Yes||Use of Low Dose Aspirin|Dosing <325 mg aspirin per day is considered as low-dose aspirin|Participants|Count of Participants|1496|1496.0||||||
4050524|NCT01101035|3871992|B3|No||History of Kidney Stone||Participants|Count of Participants|4936|4936.0||||||
4050525|NCT01101035|3871993|B2|No||History of Kidney Stone||Participants|Count of Participants|2465|2465.0||||||
4050526|NCT01101035|3871994|B1|No||History of Kidney Stone||Participants|Count of Participants|2471|2471.0||||||
4050527|NCT01101035|3871992|B3|Yes||History of Kidney Stone||Participants|Count of Participants|1254|1254.0||||||
4050528|NCT01101035|3871993|B2|Yes||History of Kidney Stone||Participants|Count of Participants|627|627.0||||||
4050529|NCT01101035|3871994|B1|Yes||History of Kidney Stone||Participants|Count of Participants|627|627.0||||||
4050530|NCT01101035|3871992|B3|Normal||Renal Function|Moderate renal impairment: eCLcr=30 to 59 mL/min; mild renal impairment: eCLcr=60 to 89 mL/min; normal: eCLcr ≥90 mL/min. Seven subjects with Baseline eCLcr <30 mL/min and 1 subject with missing Baseline eCLcr|Participants|Count of Participants|467|467.0||||||
4050531|NCT01101035|3871993|B2|Normal||Renal Function|Moderate renal impairment: eCLcr=30 to 59 mL/min; mild renal impairment: eCLcr=60 to 89 mL/min; normal: eCLcr ≥90 mL/min. Seven subjects with Baseline eCLcr <30 mL/min and 1 subject with missing Baseline eCLcr|Participants|Count of Participants|228|228.0||||||
4050532|NCT01101035|3871994|B1|Normal||Renal Function|Moderate renal impairment: eCLcr=30 to 59 mL/min; mild renal impairment: eCLcr=60 to 89 mL/min; normal: eCLcr ≥90 mL/min. Seven subjects with Baseline eCLcr <30 mL/min and 1 subject with missing Baseline eCLcr|Participants|Count of Participants|239|239.0||||||
4050533|NCT01101035|3871992|B3|Mildly Impaired||Renal Function|Moderate renal impairment: eCLcr=30 to 59 mL/min; mild renal impairment: eCLcr=60 to 89 mL/min; normal: eCLcr ≥90 mL/min. Seven subjects with Baseline eCLcr <30 mL/min and 1 subject with missing Baseline eCLcr|Participants|Count of Participants|2448|2448.0||||||
4050534|NCT01101035|3871993|B2|Mildly Impaired||Renal Function|Moderate renal impairment: eCLcr=30 to 59 mL/min; mild renal impairment: eCLcr=60 to 89 mL/min; normal: eCLcr ≥90 mL/min. Seven subjects with Baseline eCLcr <30 mL/min and 1 subject with missing Baseline eCLcr|Participants|Count of Participants|1231|1231.0||||||
4050535|NCT01101035|3871994|B1|Mildly Impaired||Renal Function|Moderate renal impairment: eCLcr=30 to 59 mL/min; mild renal impairment: eCLcr=60 to 89 mL/min; normal: eCLcr ≥90 mL/min. Seven subjects with Baseline eCLcr <30 mL/min and 1 subject with missing Baseline eCLcr|Participants|Count of Participants|1217|1217.0||||||
4050536|NCT01101035|3871992|B3|Moderately Impaired||Renal Function|Moderate renal impairment: eCLcr=30 to 59 mL/min; mild renal impairment: eCLcr=60 to 89 mL/min; normal: eCLcr ≥90 mL/min. Seven subjects with Baseline eCLcr <30 mL/min and 1 subject with missing Baseline eCLcr|Participants|Count of Participants|3267|3267.0||||||
4050537|NCT01101035|3871993|B2|Moderately Impaired||Renal Function|Moderate renal impairment: eCLcr=30 to 59 mL/min; mild renal impairment: eCLcr=60 to 89 mL/min; normal: eCLcr ≥90 mL/min. Seven subjects with Baseline eCLcr <30 mL/min and 1 subject with missing Baseline eCLcr|Participants|Count of Participants|1631|1631.0||||||
4050538|NCT01101035|3871994|B1|Moderately Impaired||Renal Function|Moderate renal impairment: eCLcr=30 to 59 mL/min; mild renal impairment: eCLcr=60 to 89 mL/min; normal: eCLcr ≥90 mL/min. Seven subjects with Baseline eCLcr <30 mL/min and 1 subject with missing Baseline eCLcr|Participants|Count of Participants|1636|1636.0||||||
4050539|NCT01101035|3871992|B3|Current drinker||Alcohol History||Participants|Count of Participants|2997|2997.0||||||
4050540|NCT01101035|3871993|B2|Current drinker||Alcohol History||Participants|Count of Participants|1496|1496.0||||||
4050541|NCT01101035|3871994|B1|Current drinker||Alcohol History||Participants|Count of Participants|1501|1501.0||||||
4050542|NCT01101035|3871992|B3|Ex-drinker||Alcohol History||Participants|Count of Participants|1617|1617.0||||||
4050543|NCT01101035|3871993|B2|Ex-drinker||Alcohol History||Participants|Count of Participants|812|812.0||||||
4050544|NCT01101035|3871994|B1|Ex-drinker||Alcohol History||Participants|Count of Participants|805|805.0||||||
4050545|NCT01101035|3871992|B3|Never drank||Alcohol History||Participants|Count of Participants|1576|1576.0||||||
4050546|NCT01101035|3871993|B2|Never drank||Alcohol History||Participants|Count of Participants|784|784.0||||||
4050547|NCT01101035|3871994|B1|Never drank||Alcohol History||Participants|Count of Participants|792|792.0||||||
4050548|NCT01101035|3871992|B3|Current smoker||Smoking History||Participants|Count of Participants|805|805.0||||||
4050549|NCT01101035|3871993|B2|Current smoker||Smoking History||Participants|Count of Participants|415|415.0||||||
4050550|NCT01101035|3871994|B1|Current smoker||Smoking History||Participants|Count of Participants|390|390.0||||||
4050551|NCT01101035|3871992|B3|Ex-smoker||Smoking History||Participants|Count of Participants|3086|3086.0||||||
4050552|NCT01101035|3871993|B2|Ex-smoker||Smoking History||Participants|Count of Participants|1553|1553.0||||||
4050553|NCT01101035|3871994|B1|Ex-smoker||Smoking History||Participants|Count of Participants|1533|1533.0||||||
4050554|NCT01101035|3871992|B3|Never smoked||Smoking History||Participants|Count of Participants|2299|2299.0||||||
4050555|NCT01101035|3871993|B2|Never smoked||Smoking History||Participants|Count of Participants|1124|1124.0||||||
4050556|NCT01101035|3871994|B1|Never smoked||Smoking History||Participants|Count of Participants|1175|1175.0||||||
4050557|NCT01101035|3871992|B3|≥30||BMI Categorical|Body Mass Index = weight (kg)/[height (m)^2]|Participants|Count of Participants|4077|4077.0||||||
4050558|NCT01101035|3871993|B2|≥30||BMI Categorical|Body Mass Index = weight (kg)/[height (m)^2]|Participants|Count of Participants|2024|2024.0||||||
4050559|NCT01101035|3871994|B1|≥30||BMI Categorical|Body Mass Index = weight (kg)/[height (m)^2]|Participants|Count of Participants|2053|2053.0||||||
4050560|NCT01101035|3871992|B3|25-30||BMI Categorical|Body Mass Index = weight (kg)/[height (m)^2]|Participants|Count of Participants|1706|1706.0||||||
4050561|NCT01101035|3871993|B2|25-30||BMI Categorical|Body Mass Index = weight (kg)/[height (m)^2]|Participants|Count of Participants|862|862.0||||||
4050562|NCT01101035|3871994|B1|25-30||BMI Categorical|Body Mass Index = weight (kg)/[height (m)^2]|Participants|Count of Participants|844|844.0||||||
4050563|NCT01101035|3871992|B3|<25||BMI Categorical|Body Mass Index = weight (kg)/[height (m)^2]|Participants|Count of Participants|402|402.0||||||
4050564|NCT01101035|3871993|B2|<25||BMI Categorical|Body Mass Index = weight (kg)/[height (m)^2]|Participants|Count of Participants|201|201.0||||||
4050565|NCT01101035|3871994|B1|<25||BMI Categorical|Body Mass Index = weight (kg)/[height (m)^2]|Participants|Count of Participants|201|201.0||||||
4050566|NCT01101035|3871992|B3|||Body Mass Index (BMI)|Body Mass Index = weight (kg)/[height (m)^2]|kg/m^2|Median|32.3|32.3|Full Range|||17.0|75.0|
4050567|NCT01101035|3871993|B2|||Body Mass Index (BMI)|Body Mass Index = weight (kg)/[height (m)^2]|kg/m^2|Median|32.1|32.1|Full Range|||17.0|75.0|
4050568|NCT01101035|3871994|B1|||Body Mass Index (BMI)|Body Mass Index = weight (kg)/[height (m)^2]|kg/m^2|Median|32.5|32.5|Full Range|||18.0|73.0|
4050569|NCT01101035|3871992|B3|||Weight||kg|Mean|100.4|100.4|Standard Deviation|22.68|22.68|||
4050570|NCT01101035|3871993|B2|||Weight||kg|Mean|100.3|100.3|Standard Deviation|22.89|22.89|||
4050571|NCT01101035|3871994|B1|||Weight||kg|Mean|100.5|100.5|Standard Deviation|22.47|22.47|||
4050572|NCT01101035|3871992|B3|||Height||cm|Mean|173.0|173.0|Standard Deviation|9.65|9.65|||
4050573|NCT01101035|3871993|B2|||Height||cm|Mean|173.0|173.0|Standard Deviation|9.77|9.77|||
4050574|NCT01101035|3871994|B1|||Height||cm|Mean|172.9|172.9|Standard Deviation|9.54|9.54|||
4050575|NCT01101035|3871992|B3|United States||Region of Enrollment||Participants|Count of Participants|5316|5316.0||||||
4050576|NCT01101035|3871993|B2|United States||Region of Enrollment||Participants|Count of Participants|2665|2665.0||||||
4050577|NCT01101035|3871994|B1|United States||Region of Enrollment||Participants|Count of Participants|2651|2651.0||||||
4050578|NCT01101035|3871992|B3|Mexico||Region of Enrollment||Participants|Count of Participants|734|734.0||||||
4050579|NCT01101035|3871993|B2|Mexico||Region of Enrollment||Participants|Count of Participants|355|355.0||||||
4050580|NCT01101035|3871994|B1|Mexico||Region of Enrollment||Participants|Count of Participants|379|379.0||||||
4050581|NCT01101035|3871992|B3|Canada||Region of Enrollment||Participants|Count of Participants|140|140.0||||||
4050582|NCT01101035|3871993|B2|Canada||Region of Enrollment||Participants|Count of Participants|72|72.0||||||
4050583|NCT01101035|3871994|B1|Canada||Region of Enrollment||Participants|Count of Participants|68|68.0||||||
4050584|NCT01101035|3871992|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|5130|5130.0||||||
4050585|NCT01101035|3871993|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|2571|2571.0||||||
4050586|NCT01101035|3871994|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|2559|2559.0||||||
4050587|NCT01101035|3871992|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|1060|1060.0||||||
4050588|NCT01101035|3871993|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|521|521.0||||||
4050589|NCT01101035|3871994|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|539|539.0||||||
4050590|NCT01101035|3871992|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
4050591|NCT01101035|3871993|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
4050592|NCT01101035|3871994|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
4050593|NCT01101035|3871992|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|4300|4300.0||||||
4050594|NCT01101035|3871993|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|2140|2140.0||||||
4050595|NCT01101035|3871994|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|2160|2160.0||||||
4050596|NCT01101035|3871992|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
4050597|NCT01101035|3871993|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4050598|NCT01101035|3871994|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4050599|NCT01101035|3871992|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1145|1145.0||||||
4050600|NCT01101035|3871993|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|593|593.0||||||
4050601|NCT01101035|3871994|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|552|552.0||||||
4050602|NCT01101035|3871992|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|188|188.0||||||
4050603|NCT01101035|3871993|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|96|96.0||||||
4050604|NCT01101035|3871994|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|92|92.0||||||
4050605|NCT01101035|3871992|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|496|496.0||||||
4050606|NCT01101035|3871993|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|234|234.0||||||
4050607|NCT01101035|3871994|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|262|262.0||||||
4050608|NCT01101035|3871992|B3||Male|Sex: Female, Male||Participants|Count of Participants|5196|5196.0||||||
4050609|NCT01101035|3871993|B2||Male|Sex: Female, Male||Participants|Count of Participants|2592|2592.0||||||
4050610|NCT01101035|3871994|B1||Male|Sex: Female, Male||Participants|Count of Participants|2604|2604.0||||||
4050611|NCT01101035|3871992|B3||Female|Sex: Female, Male||Participants|Count of Participants|994|994.0||||||
4050612|NCT01101035|3871993|B2||Female|Sex: Female, Male||Participants|Count of Participants|500|500.0||||||
4050613|NCT01101035|3871994|B1||Female|Sex: Female, Male||Participants|Count of Participants|494|494.0||||||
4050614|NCT01101035|3871992|B3|≥75 years||Age, Customized||Participants|Count of Participants|871|871.0||||||
4050615|NCT01101035|3871993|B2|≥75 years||Age, Customized||Participants|Count of Participants|451|451.0||||||
4050616|NCT01101035|3871994|B1|≥75 years||Age, Customized||Participants|Count of Participants|420|420.0||||||
4050617|NCT01101035|3871992|B3|65 to <75 years||Age, Customized||Participants|Count of Participants|2229|2229.0||||||
4050618|NCT01101035|3871993|B2|65 to <75 years||Age, Customized||Participants|Count of Participants|1135|1135.0||||||
4050619|NCT01101035|3871994|B1|65 to <75 years||Age, Customized||Participants|Count of Participants|1094|1094.0||||||
4050620|NCT01101035|3871992|B3|<65 years||Age, Customized||Participants|Count of Participants|3090|3090.0||||||
4050621|NCT01101035|3871993|B2|<65 years||Age, Customized||Participants|Count of Participants|1506|1506.0||||||
4050622|NCT01101035|3871994|B1|<65 years||Age, Customized||Participants|Count of Participants|1584|1584.0||||||
4050623|NCT01101035|3871992|B3|||Age||years|Mean|64.8|64.8|Standard Deviation|8.53|8.53|||
4050624|NCT01101035|3871993|B2|||Age||years|Mean|65.0|65.0|Standard Deviation|8.49|8.49|||
4050625|NCT01101035|3871994|B1|||Age||years|Mean|64.6|64.6|Standard Deviation|8.58|8.58|||
4050626|NCT01101022|3872013|B3|United States||Region of Enrollment||participants|Number|159|159.0||||||
4050627|NCT01101022|3872014|B2|United States||Region of Enrollment||participants|Number|80|80.0||||||
4050628|NCT01101022|3872015|B1|United States||Region of Enrollment||participants|Number|79|79.0||||||
4050629|NCT01101022|3872013|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4050630|NCT01101022|3872014|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4050631|NCT01101022|3872015|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4050632|NCT01101022|3872013|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4050633|NCT01101022|3872014|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4050634|NCT01101022|3872015|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4050635|NCT01101022|3872013|B3|>55 years||Age, Customized||participants|Number|0|0.0||||||
4050636|NCT01101022|3872014|B2|>55 years||Age, Customized||participants|Number|0|0.0||||||
4050637|NCT01101022|3872015|B1|>55 years||Age, Customized||participants|Number|0|0.0||||||
4050638|NCT01101022|3872013|B3|18 to 55 years||Age, Customized||participants|Number|159|159.0||||||
4050639|NCT01101022|3872014|B2|18 to 55 years||Age, Customized||participants|Number|80|80.0||||||
4050640|NCT01101022|3872015|B1|18 to 55 years||Age, Customized||participants|Number|79|79.0||||||
4050641|NCT01101022|3872013|B3|<18 years||Age, Customized||participants|Number|0|0.0||||||
4050642|NCT01101022|3872014|B2|<18 years||Age, Customized||participants|Number|0|0.0||||||
4050643|NCT01101022|3872015|B1|<18 years||Age, Customized||participants|Number|0|0.0||||||
4050644|NCT01101022|3872013|B3|||Age||years|Mean|34.6|34.6|Standard Deviation|10.77|10.77|||
4050645|NCT01101022|3872014|B2|||Age||years|Mean|34.9|34.9|Standard Deviation|11.02|11.02|||
4050646|NCT01101022|3872015|B1|||Age||years|Mean|34.2|34.2|Standard Deviation|10.58|10.58|||
4050647|NCT01100944|3872050|B1|||Prior Neoadjuvant or Adjuvant Chemotherapy||Participants|Count of Participants|4|4.0||||||
4050648|NCT01100944|3872050|B1|||Prior Radiation||Participants|Count of Participants|7|7.0||||||
4050649|NCT01100944|3872050|B1|Debulking||Prior Surgery|11 patients had radical surgery including 2 who underwent debulking subsequently.|Participants|Count of Participants|2|2.0||||||
4050650|NCT01100944|3872050|B1|Radical||Prior Surgery|11 patients had radical surgery including 2 who underwent debulking subsequently.|Participants|Count of Participants|11|11.0||||||
4050651|NCT01100944|3872050|B1|IVB||Stage at Enrolment|"Masaoka Staging System:~Stage IVA is pleural or pericardial dissemination. Stage IVB is lymphogenous or hematogenous metastases."|Participants|Count of Participants|14|14.0||||||
4050652|NCT01100944|3872050|B1|IVA||Stage at Enrolment|"Masaoka Staging System:~Stage IVA is pleural or pericardial dissemination. Stage IVB is lymphogenous or hematogenous metastases."|Participants|Count of Participants|12|12.0||||||
4050653|NCT01100944|3872050|B1|Thymic carcinoma||Tumor Type|The World Health Organization (WHO) classification of epithelial thymic malignancies shown under Thymoma are defined as type B1: histology - predominantly cortical thymoma, type B2: histology - cortical thymoma, and type B3: histology - well-differentiated thymoma.|Participants|Count of Participants|14|14.0||||||
4050654|NCT01100944|3872050|B1|B3||Tumor Type|The World Health Organization (WHO) classification of epithelial thymic malignancies shown under Thymoma are defined as type B1: histology - predominantly cortical thymoma, type B2: histology - cortical thymoma, and type B3: histology - well-differentiated thymoma.|Participants|Count of Participants|3|3.0||||||
4050655|NCT01100944|3872050|B1|B2||Tumor Type|The World Health Organization (WHO) classification of epithelial thymic malignancies shown under Thymoma are defined as type B1: histology - predominantly cortical thymoma, type B2: histology - cortical thymoma, and type B3: histology - well-differentiated thymoma.|Participants|Count of Participants|7|7.0||||||
4050656|NCT01100944|3872050|B1|B1||Tumor Type|The World Health Organization (WHO) classification of epithelial thymic malignancies shown under Thymoma are defined as type B1: histology - predominantly cortical thymoma, type B2: histology - cortical thymoma, and type B3: histology - well-differentiated thymoma.|Participants|Count of Participants|2|2.0||||||
4050657|NCT01100944|3872050|B1|Thymoma||Tumor Type|The World Health Organization (WHO) classification of epithelial thymic malignancies shown under Thymoma are defined as type B1: histology - predominantly cortical thymoma, type B2: histology - cortical thymoma, and type B3: histology - well-differentiated thymoma.|Participants|Count of Participants|12|12.0||||||
4050658|NCT01100944|3872050|B1|Grade 1||ECOG Performance Status|"Eastern Cooperative Oncology Group (ECOG).~Grade 0 is normal activity. Fully active, able to carry on all pre-disease performance without restriction.~Grade 1 is symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work)."|Participants|Count of Participants|8|8.0||||||
4050659|NCT01100944|3872050|B1|Grade 0||ECOG Performance Status|"Eastern Cooperative Oncology Group (ECOG).~Grade 0 is normal activity. Fully active, able to carry on all pre-disease performance without restriction.~Grade 1 is symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work)."|Participants|Count of Participants|18|18.0||||||
4050660|NCT01100944|3872050|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4050661|NCT01100944|3872050|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050662|NCT01100944|3872050|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050663|NCT01100944|3872050|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4050664|NCT01100944|3872050|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4050665|NCT01100944|3872050|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050666|NCT01100944|3872050|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4050667|NCT01100944|3872050|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050668|NCT01100944|3872050|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4050669|NCT01100944|3872050|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4050670|NCT01100944|3872050|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4050671|NCT01100944|3872050|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4050672|NCT01100944|3872050|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4050673|NCT01100944|3872050|B1|||Age||years|Mean|53.9|53.9|Standard Deviation|13.3|13.3|||
4050674|NCT01100944|3872050|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4050675|NCT01100944|3872050|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4050676|NCT01100944|3872050|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050677|NCT01100931|3872097|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
4050678|NCT01100931|3872098|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4050679|NCT01100931|3872099|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4050680|NCT01100931|3872097|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4050681|NCT01100931|3872098|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4050682|NCT01100931|3872099|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050683|NCT01100931|3872097|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050684|NCT01100931|3872098|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050685|NCT01100931|3872099|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050686|NCT01100931|3872097|B3||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4050687|NCT01100931|3872098|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4050688|NCT01100931|3872099|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4050689|NCT01100931|3872097|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4050690|NCT01100931|3872098|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4050691|NCT01100931|3872099|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4050692|NCT01100931|3872097|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4050693|NCT01100931|3872098|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4050694|NCT01100931|3872099|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050695|NCT01100931|3872097|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4050696|NCT01100931|3872098|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050697|NCT01100931|3872099|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4050698|NCT01100931|3872097|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050699|NCT01100931|3872098|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050700|NCT01100931|3872099|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050701|NCT01100931|3872097|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050702|NCT01100931|3872098|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050703|NCT01100931|3872099|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050704|NCT01100931|3872097|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4050705|NCT01100931|3872098|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4050706|NCT01100931|3872099|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4050707|NCT01100931|3872097|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4050708|NCT01100931|3872098|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4050709|NCT01100931|3872099|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4050710|NCT01100931|3872097|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4050711|NCT01100931|3872098|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4050712|NCT01100931|3872099|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4050713|NCT01100931|3872097|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4050714|NCT01100931|3872098|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4050715|NCT01100931|3872099|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4050716|NCT01100931|3872097|B3|||Age||years|Mean|61.6|61.6|Standard Deviation|10.14|10.14|||
4050717|NCT01100931|3872098|B2|||Age||years|Mean|59.8|59.8|Standard Deviation|9.51|9.51|||
4050718|NCT01100931|3872099|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|10.72|10.72|||
4050719|NCT01100931|3872097|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4050720|NCT01100931|3872098|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4050721|NCT01100931|3872099|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4050722|NCT01100931|3872097|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4050723|NCT01100931|3872098|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4050724|NCT01100931|3872099|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4050725|NCT01100931|3872097|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050726|NCT01100931|3872098|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050727|NCT01100931|3872099|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050728|NCT01100853|3872108|B3|Iceland||Region of Enrollment||participants|Number|100|100.0||||||
4050729|NCT01100853|3872109|B2|Iceland||Region of Enrollment||participants|Number|49|49.0||||||
4050730|NCT01100853|3872110|B1|Iceland||Region of Enrollment||participants|Number|51|51.0||||||
4050731|NCT01100853|3872108|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4050732|NCT01100853|3872109|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4050733|NCT01100853|3872110|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4050734|NCT01100853|3872108|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4050735|NCT01100853|3872109|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4050736|NCT01100853|3872110|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4050737|NCT01100853|3872108|B3|||Age||years|Mean|31.55|31.55|Standard Deviation|1|1.0|||
4050738|NCT01100853|3872109|B2|||Age||years|Mean|31.59|31.59|Standard Deviation|1.34|1.34|||
4050739|NCT01100853|3872110|B1|||Age||years|Mean|31.51|31.51|Standard Deviation|1.11|1.11|||
4050740|NCT01100853|3872108|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4050741|NCT01100853|3872109|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4050742|NCT01100853|3872110|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4050743|NCT01100853|3872108|B3||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4050744|NCT01100853|3872109|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4050745|NCT01100853|3872110|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4050746|NCT01100853|3872108|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050747|NCT01100853|3872109|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050748|NCT01100853|3872110|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050749|NCT01100762|3872127|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4050750|NCT01100762|3872127|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4050751|NCT01100762|3872127|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4050752|NCT01100762|3872127|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4050753|NCT01100762|3872127|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050754|NCT01100723|3872148|B1||Male|Gender||Participants|Count of Participants|52|52.0||||||
4050755|NCT01100723|3872148|B1||Female|Gender||Participants|Count of Participants|40|40.0||||||
4050756|NCT01100723|3872148|B1||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4050757|NCT01100723|3872148|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4050758|NCT01100723|3872148|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050759|NCT01100658|3872157|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4050760|NCT01100658|3872157|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4050761|NCT01100658|3872157|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4050762|NCT01100658|3872157|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4050763|NCT01100658|3872157|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4050764|NCT01100606|3872162|B1|Severe Abdominal Pain||Number of Abdominal Pain Symptoms|Symptoms of pain was classified by severity as 0=none, 1=mild (no impairment of daily activities), 2=moderate (slight impairment of daily activities), and 3=severe (unable to perform daily activities). Average number of symptoms of specific severity for each participant was calculated from frequency of symptoms by the participant per day. Average number of symptoms during the screening period for total participants was summarized. Number of participants evaluable for this baseline characteristic was 12.|average number of pain symptoms per day|Mean|0.02|0.02|Standard Deviation|0.066|0.066|||
4050765|NCT01100606|3872162|B1|Moderate Abdominal Pain||Number of Abdominal Pain Symptoms|Symptoms of pain was classified by severity as 0=none, 1=mild (no impairment of daily activities), 2=moderate (slight impairment of daily activities), and 3=severe (unable to perform daily activities). Average number of symptoms of specific severity for each participant was calculated from frequency of symptoms by the participant per day. Average number of symptoms during the screening period for total participants was summarized. Number of participants evaluable for this baseline characteristic was 12.|average number of pain symptoms per day|Mean|0.09|0.09|Standard Deviation|0.185|0.185|||
4050766|NCT01100606|3872162|B1|Mild Abdominal Pain||Number of Abdominal Pain Symptoms|Symptoms of pain was classified by severity as 0=none, 1=mild (no impairment of daily activities), 2=moderate (slight impairment of daily activities), and 3=severe (unable to perform daily activities). Average number of symptoms of specific severity for each participant was calculated from frequency of symptoms by the participant per day. Average number of symptoms during the screening period for total participants was summarized. Number of participants evaluable for this baseline characteristic was 12.|average number of pain symptoms per day|Mean|0.23|0.23|Standard Deviation|0.409|0.409|||
4050767|NCT01100606|3872162|B1|Severe Flatulence||Number of Abdominal Symptoms: Flatulence|Flatulence is presence of excessive gas in the digestive tract. Symptoms of flatulence were classified by severity as 0=none, 1=mild (no impairment of daily activities), 2=moderate (slight impairment of daily activities), and 3=severe (unable to perform daily activities). Average number of symptoms of specific severity for each participant was calculated from frequency of symptoms by the participant per day. Average number of symptoms during the screening period for total participants was summarized. Number of participants evaluable for this baseline characteristic was 12.|average number of flatulence per day|Mean|0.03|0.03|Standard Deviation|0.099|0.099|||
4050768|NCT01100606|3872162|B1|Moderate Flatulence||Number of Abdominal Symptoms: Flatulence|Flatulence is presence of excessive gas in the digestive tract. Symptoms of flatulence were classified by severity as 0=none, 1=mild (no impairment of daily activities), 2=moderate (slight impairment of daily activities), and 3=severe (unable to perform daily activities). Average number of symptoms of specific severity for each participant was calculated from frequency of symptoms by the participant per day. Average number of symptoms during the screening period for total participants was summarized. Number of participants evaluable for this baseline characteristic was 12.|average number of flatulence per day|Mean|0.51|0.51|Standard Deviation|0.728|0.728|||
4050769|NCT01100606|3872162|B1|Mild Flatulence||Number of Abdominal Symptoms: Flatulence|Flatulence is presence of excessive gas in the digestive tract. Symptoms of flatulence were classified by severity as 0=none, 1=mild (no impairment of daily activities), 2=moderate (slight impairment of daily activities), and 3=severe (unable to perform daily activities). Average number of symptoms of specific severity for each participant was calculated from frequency of symptoms by the participant per day. Average number of symptoms during the screening period for total participants was summarized. Number of participants evaluable for this baseline characteristic was 12.|average number of flatulence per day|Mean|1.00|1.0|Standard Deviation|1.208|1.208|||
4050790|NCT01100567|3872188|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050770|NCT01100606|3872162|B1|Severe Bloating||Number of Abdominal Symptoms: Bloating|Bloating is swelling of the intestinal tract caused by excessive gas formation. Symptoms of bloating were classified by severity as 0=none, 1=mild (no impairment of daily activities), 2=moderate (slight impairment of daily activities), and 3=severe (unable to perform daily activities). Average number of symptoms of specific severity for each participant was calculated from frequency of symptoms by the participant per day. Average number of symptoms during the screening period for total participants was summarized. Number of participants evaluable for this baseline characteristic was 12.|average number of bloating per day|Mean|0|0.0|Standard Deviation|0|0.0|||
4050771|NCT01100606|3872162|B1|Moderate Bloating||Number of Abdominal Symptoms: Bloating|Bloating is swelling of the intestinal tract caused by excessive gas formation. Symptoms of bloating were classified by severity as 0=none, 1=mild (no impairment of daily activities), 2=moderate (slight impairment of daily activities), and 3=severe (unable to perform daily activities). Average number of symptoms of specific severity for each participant was calculated from frequency of symptoms by the participant per day. Average number of symptoms during the screening period for total participants was summarized. Number of participants evaluable for this baseline characteristic was 12.|average number of bloating per day|Mean|0.04|0.04|Standard Deviation|0.101|0.101|||
4050772|NCT01100606|3872162|B1|Mild Bloating||Number of Abdominal Symptoms: Bloating|Bloating is swelling of the intestinal tract caused by excessive gas formation. Symptoms of bloating were classified by severity as 0=none, 1=mild (no impairment of daily activities), 2=moderate (slight impairment of daily activities), and 3=severe (unable to perform daily activities). Average number of symptoms of specific severity for each participant was calculated from frequency of symptoms by the participant per day. Average number of symptoms during the screening period for total participants was summarized. Number of participants evaluable for this baseline characteristic was 12.|average number of bloating per day|Mean|0.12|0.12|Standard Deviation|0.281|0.281|||
4050773|NCT01100606|3872162|B1|With visible oil or grease||Number of Stools With Signs of Blood and Visible Oil or Grease|Average number of stools with signs of blood and visible oil or grease of each participant was calculated from number of stools with signs of blood and visible oil or grease by the participant per day. Average number of stools stools with signs of blood and visible oil or grease during the screening period for total participants was summarized. Number of participants evaluable for this baseline characteristic was 12.|average number of stools per day|Mean|0.11|0.11|Standard Deviation|0.147|0.147|||
4050774|NCT01100606|3872162|B1|With blood||Number of Stools With Signs of Blood and Visible Oil or Grease|Average number of stools with signs of blood and visible oil or grease of each participant was calculated from number of stools with signs of blood and visible oil or grease by the participant per day. Average number of stools stools with signs of blood and visible oil or grease during the screening period for total participants was summarized. Number of participants evaluable for this baseline characteristic was 12.|average number of stools per day|Mean|0|0.0|Standard Deviation|0|0.0|||
4050775|NCT01100606|3872162|B1|Diarrhea||Number of Stools Categorized as Per Consistency|Stool consistency was categorized as hard, formed/normal, soft and diarrhea. Average number of stools categorized as per consistency of each participant was calculated from number of stools of specific consistency by the participant per day. Average number of stools categorized as per consistency during the screening period for total participants was summarized. Number of participants evaluable for this baseline characteristic was 12.|average number of stools per day|Mean|0.48|0.48|Standard Deviation|0.801|0.801|||
4050776|NCT01100606|3872162|B1|Soft||Number of Stools Categorized as Per Consistency|Stool consistency was categorized as hard, formed/normal, soft and diarrhea. Average number of stools categorized as per consistency of each participant was calculated from number of stools of specific consistency by the participant per day. Average number of stools categorized as per consistency during the screening period for total participants was summarized. Number of participants evaluable for this baseline characteristic was 12.|average number of stools per day|Mean|0.91|0.91|Standard Deviation|0.777|0.777|||
4050777|NCT01100606|3872162|B1|Normal||Number of Stools Categorized as Per Consistency|Stool consistency was categorized as hard, formed/normal, soft and diarrhea. Average number of stools categorized as per consistency of each participant was calculated from number of stools of specific consistency by the participant per day. Average number of stools categorized as per consistency during the screening period for total participants was summarized. Number of participants evaluable for this baseline characteristic was 12.|average number of stools per day|Mean|1.18|1.18|Standard Deviation|1.129|1.129|||
4050778|NCT01100606|3872162|B1|Hard||Number of Stools Categorized as Per Consistency|Stool consistency was categorized as hard, formed/normal, soft and diarrhea. Average number of stools categorized as per consistency of each participant was calculated from number of stools of specific consistency by the participant per day. Average number of stools categorized as per consistency during the screening period for total participants was summarized. Number of participants evaluable for this baseline characteristic was 12.|average number of stools per day|Mean|0.11|0.11|Standard Deviation|0.255|0.255|||
4050779|NCT01100606|3872162|B1|||Average Daily Number of Stools|Average daily number of stools of each participant was calculated from frequency of stools by the participant per day. Average daily number of stools during the screening period for total participants was summarized. Number of participants evaluable for this baseline characteristic was 12.|average number of stools per day|Mean|2.73|2.73|Standard Deviation|1.393|1.393|||
4050780|NCT01100606|3872162|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4050781|NCT01100606|3872162|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4050782|NCT01100606|3872162|B1|||Age||months|Mean|5.7|5.7|Standard Deviation|3.15|3.15|||
4050783|NCT01100567|3872187|B3|||BMI Z-score||Z-score|Mean|-2.79|-2.79|Standard Deviation|2.2|2.2|||
4050784|NCT01100567|3872188|B2|||BMI Z-score||Z-score|Mean|-3.24|-3.24|Standard Deviation|2.66|2.66|||
4050785|NCT01100567|3872189|B1|||BMI Z-score||Z-score|Mean|-2.34|-2.34|Standard Deviation|1.6|1.6|||
4050786|NCT01100567|3872187|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
4050787|NCT01100567|3872188|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4050788|NCT01100567|3872189|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4050789|NCT01100567|3872187|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050791|NCT01100567|3872189|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050792|NCT01100567|3872187|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050793|NCT01100567|3872188|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050794|NCT01100567|3872189|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050795|NCT01100567|3872187|B3||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4050796|NCT01100567|3872188|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4050797|NCT01100567|3872189|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4050798|NCT01100567|3872187|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4050799|NCT01100567|3872188|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050800|NCT01100567|3872189|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4050801|NCT01100567|3872187|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050802|NCT01100567|3872188|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050803|NCT01100567|3872189|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050804|NCT01100567|3872187|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4050805|NCT01100567|3872188|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4050806|NCT01100567|3872189|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4050807|NCT01100567|3872187|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050808|NCT01100567|3872188|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050809|NCT01100567|3872189|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050810|NCT01100567|3872187|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050811|NCT01100567|3872188|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050812|NCT01100567|3872189|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050813|NCT01100567|3872187|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4050814|NCT01100567|3872188|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4050815|NCT01100567|3872189|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4050816|NCT01100567|3872187|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4050817|NCT01100567|3872188|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4050818|NCT01100567|3872189|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4050819|NCT01100567|3872187|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4050820|NCT01100567|3872188|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4050821|NCT01100567|3872189|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4050822|NCT01100567|3872187|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4050823|NCT01100567|3872188|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4050824|NCT01100567|3872189|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4050825|NCT01100567|3872187|B3|||Age||years|Mean|16.3|16.3|Standard Deviation|1.9|1.9|||
4050826|NCT01100567|3872188|B2|||Age||years|Mean|16.2|16.2|Standard Deviation|1.8|1.8|||
4050827|NCT01100567|3872189|B1|||Age||years|Mean|16.5|16.5|Standard Deviation|2.1|2.1|||
4050828|NCT01100528|3872198|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4050829|NCT01100528|3872198|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050830|NCT01100528|3872198|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050831|NCT01100528|3872198|B1||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4050832|NCT01100528|3872198|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050833|NCT01100528|3872198|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050834|NCT01100528|3872198|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050835|NCT01100528|3872198|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050836|NCT01100528|3872198|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050837|NCT01100528|3872198|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4050838|NCT01100528|3872198|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050839|NCT01100528|3872198|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4050840|NCT01100528|3872198|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4050841|NCT01100528|3872198|B1|70-79 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
4050842|NCT01100528|3872198|B1|60-69 years||Age, Customized||Participants|Count of Participants|9|9.0||||||
4050843|NCT01100528|3872198|B1|50-59 years||Age, Customized||Participants|Count of Participants|16|16.0||||||
4050844|NCT01100528|3872198|B1|40-49 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
4050845|NCT01100528|3872198|B1|30-39 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
4050846|NCT01100528|3872198|B1|20-29 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
4050847|NCT01100502|3872204|B3|Stable disease||Best Response to Salvage Therapy pre-ASCT||participants|Number|93|93.0||||||
4050848|NCT01100502|3872205|B2|Stable disease||Best Response to Salvage Therapy pre-ASCT||participants|Number|46|46.0||||||
4050849|NCT01100502|3872206|B1|Stable disease||Best Response to Salvage Therapy pre-ASCT||participants|Number|47|47.0||||||
4050850|NCT01100502|3872204|B3|Partial remission||Best Response to Salvage Therapy pre-ASCT||participants|Number|113|113.0||||||
4050851|NCT01100502|3872205|B2|Partial remission||Best Response to Salvage Therapy pre-ASCT||participants|Number|56|56.0||||||
4050852|NCT01100502|3872206|B1|Partial remission||Best Response to Salvage Therapy pre-ASCT||participants|Number|57|57.0||||||
4050853|NCT01100502|3872204|B3|Complete remission||Best Response to Salvage Therapy pre-ASCT||participants|Number|123|123.0||||||
4050854|NCT01100502|3872205|B2|Complete remission||Best Response to Salvage Therapy pre-ASCT||participants|Number|62|62.0||||||
4050855|NCT01100502|3872206|B1|Complete remission||Best Response to Salvage Therapy pre-ASCT||participants|Number|61|61.0||||||
4050856|NCT01100502|3872204|B3|Relapse 12 months or later with extranodal disease||Hodgkin Lymphoma Status after end of Frontline Therapy||participants|Number|26|26.0||||||
4050857|NCT01100502|3872205|B2|Relapse 12 months or later with extranodal disease||Hodgkin Lymphoma Status after end of Frontline Therapy||participants|Number|13|13.0||||||
4050858|NCT01100502|3872206|B1|Relapse 12 months or later with extranodal disease||Hodgkin Lymphoma Status after end of Frontline Therapy||participants|Number|13|13.0||||||
4050859|NCT01100502|3872204|B3|Relapse in less than 12 months||Hodgkin Lymphoma Status after end of Frontline Therapy||participants|Number|107|107.0||||||
4050860|NCT01100502|3872205|B2|Relapse in less than 12 months||Hodgkin Lymphoma Status after end of Frontline Therapy||participants|Number|54|54.0||||||
4050861|NCT01100502|3872206|B1|Relapse in less than 12 months||Hodgkin Lymphoma Status after end of Frontline Therapy||participants|Number|53|53.0||||||
4050862|NCT01100502|3872204|B3|Refractory||Hodgkin Lymphoma Status after end of Frontline Therapy||participants|Number|196|196.0||||||
4050863|NCT01100502|3872205|B2|Refractory||Hodgkin Lymphoma Status after end of Frontline Therapy||participants|Number|97|97.0||||||
4050864|NCT01100502|3872206|B1|Refractory||Hodgkin Lymphoma Status after end of Frontline Therapy||participants|Number|99|99.0||||||
4050865|NCT01100502|3872204|B3|2||Eastern Cooperative Oncology Group Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed <50% of the time; 3= In bed >50% of the time; 4=100% bedridden; 5=Dead|participants|Number|1|1.0||||||
4050866|NCT01100502|3872205|B2|2||Eastern Cooperative Oncology Group Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed <50% of the time; 3= In bed >50% of the time; 4=100% bedridden; 5=Dead|participants|Number|0|0.0||||||
4050867|NCT01100502|3872206|B1|2||Eastern Cooperative Oncology Group Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed <50% of the time; 3= In bed >50% of the time; 4=100% bedridden; 5=Dead|participants|Number|1|1.0||||||
4050868|NCT01100502|3872204|B3|1||Eastern Cooperative Oncology Group Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed <50% of the time; 3= In bed >50% of the time; 4=100% bedridden; 5=Dead|participants|Number|144|144.0||||||
4050869|NCT01100502|3872205|B2|1||Eastern Cooperative Oncology Group Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed <50% of the time; 3= In bed >50% of the time; 4=100% bedridden; 5=Dead|participants|Number|67|67.0||||||
4050870|NCT01100502|3872206|B1|1||Eastern Cooperative Oncology Group Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed <50% of the time; 3= In bed >50% of the time; 4=100% bedridden; 5=Dead|participants|Number|77|77.0||||||
4050871|NCT01100502|3872204|B3|0||Eastern Cooperative Oncology Group Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed <50% of the time; 3= In bed >50% of the time; 4=100% bedridden; 5=Dead|participants|Number|184|184.0||||||
4050872|NCT01100502|3872205|B2|0||Eastern Cooperative Oncology Group Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed <50% of the time; 3= In bed >50% of the time; 4=100% bedridden; 5=Dead|participants|Number|97|97.0||||||
4050873|NCT01100502|3872206|B1|0||Eastern Cooperative Oncology Group Performance Status|0=Normal activity; 1=Symptoms but ambulatory; 2=In bed <50% of the time; 3= In bed >50% of the time; 4=100% bedridden; 5=Dead|participants|Number|87|87.0||||||
4050874|NCT01100502|3872204|B3|Germany||Region of Enrollment||participants|Number|3|3.0||||||
4050875|NCT01100502|3872205|B2|Germany||Region of Enrollment||participants|Number|3|3.0||||||
4050876|NCT01100502|3872206|B1|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4050877|NCT01100502|3872204|B3|Bulgaria||Region of Enrollment||participants|Number|9|9.0||||||
4050878|NCT01100502|3872205|B2|Bulgaria||Region of Enrollment||participants|Number|2|2.0||||||
4050879|NCT01100502|3872206|B1|Bulgaria||Region of Enrollment||participants|Number|7|7.0||||||
4050880|NCT01100502|3872204|B3|Serbia||Region of Enrollment||participants|Number|9|9.0||||||
4050881|NCT01100502|3872205|B2|Serbia||Region of Enrollment||participants|Number|6|6.0||||||
4050882|NCT01100502|3872206|B1|Serbia||Region of Enrollment||participants|Number|3|3.0||||||
4050883|NCT01100502|3872204|B3|France||Region of Enrollment||participants|Number|13|13.0||||||
4050884|NCT01100502|3872205|B2|France||Region of Enrollment||participants|Number|5|5.0||||||
4050885|NCT01100502|3872206|B1|France||Region of Enrollment||participants|Number|8|8.0||||||
4050886|NCT01100502|3872204|B3|Italy||Region of Enrollment||participants|Number|16|16.0||||||
4050887|NCT01100502|3872205|B2|Italy||Region of Enrollment||participants|Number|7|7.0||||||
4050888|NCT01100502|3872206|B1|Italy||Region of Enrollment||participants|Number|9|9.0||||||
4050889|NCT01100502|3872204|B3|Poland||Region of Enrollment||participants|Number|54|54.0||||||
4050890|NCT01100502|3872205|B2|Poland||Region of Enrollment||participants|Number|28|28.0||||||
4050891|NCT01100502|3872206|B1|Poland||Region of Enrollment||participants|Number|26|26.0||||||
4050892|NCT01100502|3872204|B3|Czech Republic||Region of Enrollment||participants|Number|5|5.0||||||
4050893|NCT01100502|3872205|B2|Czech Republic||Region of Enrollment||participants|Number|0|0.0||||||
4050894|NCT01100502|3872206|B1|Czech Republic||Region of Enrollment||participants|Number|5|5.0||||||
4050895|NCT01100502|3872204|B3|Spain||Region of Enrollment||participants|Number|10|10.0||||||
4050896|NCT01100502|3872205|B2|Spain||Region of Enrollment||participants|Number|6|6.0||||||
4050897|NCT01100502|3872206|B1|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4050898|NCT01100502|3872204|B3|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4050899|NCT01100502|3872205|B2|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4050900|NCT01100502|3872206|B1|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4050901|NCT01100502|3872204|B3|United States||Region of Enrollment||participants|Number|135|135.0||||||
4050902|NCT01100502|3872205|B2|United States||Region of Enrollment||participants|Number|68|68.0||||||
4050903|NCT01100502|3872206|B1|United States||Region of Enrollment||participants|Number|67|67.0||||||
4050904|NCT01100502|3872204|B3|Hungary||Region of Enrollment||participants|Number|20|20.0||||||
4050905|NCT01100502|3872205|B2|Hungary||Region of Enrollment||participants|Number|11|11.0||||||
4050906|NCT01100502|3872206|B1|Hungary||Region of Enrollment||participants|Number|9|9.0||||||
4050907|NCT01100502|3872204|B3|Romania||Region of Enrollment||participants|Number|10|10.0||||||
4050908|NCT01100502|3872205|B2|Romania||Region of Enrollment||participants|Number|6|6.0||||||
4050909|NCT01100502|3872206|B1|Romania||Region of Enrollment||participants|Number|4|4.0||||||
4050910|NCT01100502|3872204|B3|Russian Federation||Region of Enrollment||participants|Number|39|39.0||||||
4050911|NCT01100502|3872205|B2|Russian Federation||Region of Enrollment||participants|Number|19|19.0||||||
4050912|NCT01100502|3872206|B1|Russian Federation||Region of Enrollment||participants|Number|20|20.0||||||
4050913|NCT01100502|3872204|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4050914|NCT01100502|3872205|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4050915|NCT01100502|3872206|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050916|NCT01100502|3872204|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050917|NCT01100502|3872205|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050918|NCT01100502|3872206|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050919|NCT01100502|3872204|B3||White|Race (NIH/OMB)||Participants|Count of Participants|309|309.0||||||
4050920|NCT01100502|3872205|B2||White|Race (NIH/OMB)||Participants|Count of Participants|156|156.0||||||
4050921|NCT01100502|3872206|B1||White|Race (NIH/OMB)||Participants|Count of Participants|153|153.0||||||
4050922|NCT01100502|3872204|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4050923|NCT01100502|3872205|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4050924|NCT01100502|3872206|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4050925|NCT01100502|3872204|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050926|NCT01100502|3872205|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050927|NCT01100502|3872206|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050928|NCT01100502|3872204|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4050929|NCT01100502|3872205|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4050930|NCT01100502|3872206|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4050931|NCT01100502|3872204|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050932|NCT01100502|3872205|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050933|NCT01100502|3872206|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050934|NCT01100502|3872204|B3||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4050935|NCT01100502|3872205|B2||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4050936|NCT01100502|3872206|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4050937|NCT01100502|3872204|B3||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4050938|NCT01100502|3872205|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4050939|NCT01100502|3872206|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4050940|NCT01100502|3872204|B3|||Age||years|Median|32|32.0|Full Range|||18.0|76.0|
4050941|NCT01100502|3872205|B2|||Age||years|Median|32|32.0|Full Range|||18.0|76.0|
4050942|NCT01100502|3872206|B1|||Age||years|Median|33|33.0|Full Range|||18.0|71.0|
4050943|NCT01100437|3872217|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4050944|NCT01100437|3872217|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4050945|NCT01100437|3872217|B1|||Age||years|Median|45.2|45.2|Full Range|||32.6|67.1|
4050946|NCT01100320|3872256|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4050947|NCT01100320|3872256|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4050948|NCT01100320|3872256|B1|||Age||years|Mean|33|33.0|Standard Deviation|8.7|8.7|||
4050949|NCT01100307|3872267|B3||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4050950|NCT01100307|3872268|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4050951|NCT01100307|3872269|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4050952|NCT01100307|3872267|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4050953|NCT01100307|3872268|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4050954|NCT01100307|3872269|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4050955|NCT01100307|3872267|B3||>=65 years|Age||Participants|Count of Participants|142|142.0||||||
4050956|NCT01100307|3872268|B2||>=65 years|Age||Participants|Count of Participants|71|71.0||||||
4050957|NCT01100307|3872269|B1||>=65 years|Age||Participants|Count of Participants|71|71.0||||||
4050958|NCT01100307|3872267|B3||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
4050959|NCT01100307|3872268|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4050960|NCT01100307|3872269|B1||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4050961|NCT01100307|3872267|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050962|NCT01100307|3872268|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050963|NCT01100307|3872269|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050964|NCT01100268|3872312|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4050965|NCT01100268|3872312|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4050966|NCT01100268|3872312|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4050967|NCT01100268|3872312|B1|||Age||years|Mean|43|43.0|Standard Deviation|5|5.0|||
4050968|NCT01100268|3872312|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4050969|NCT01100268|3872312|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4050970|NCT01100268|3872312|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4050971|NCT01100255|3872317|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050972|NCT01100255|3872318|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050973|NCT01100255|3872319|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050974|NCT01100255|3872317|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050975|NCT01100255|3872318|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050976|NCT01100255|3872319|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050977|NCT01100255|3872317|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4050978|NCT01100255|3872318|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4050979|NCT01100255|3872319|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4050980|NCT01100255|3872317|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4050981|NCT01100255|3872318|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4050982|NCT01100255|3872319|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4050983|NCT01100255|3872317|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050984|NCT01100255|3872318|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050985|NCT01100255|3872319|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050986|NCT01100255|3872317|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4050987|NCT01100255|3872318|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4050988|NCT01100255|3872319|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050989|NCT01100255|3872317|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050990|NCT01100255|3872318|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050991|NCT01100255|3872319|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050992|NCT01100255|3872317|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050993|NCT01100255|3872318|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050994|NCT01100255|3872319|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4050995|NCT01100255|3872317|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4050996|NCT01100255|3872318|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4050997|NCT01100255|3872319|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4050998|NCT01100255|3872317|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4050999|NCT01100255|3872318|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4051000|NCT01100255|3872319|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4051001|NCT01100255|3872317|B3||Male|Gender||Participants|Count of Participants|8|8.0||||||
4051002|NCT01100255|3872318|B2||Male|Gender||Participants|Count of Participants|4|4.0||||||
4051003|NCT01100255|3872319|B1||Male|Gender||Participants|Count of Participants|4|4.0||||||
4051004|NCT01100255|3872317|B3||Female|Gender||Participants|Count of Participants|7|7.0||||||
4051005|NCT01100255|3872318|B2||Female|Gender||Participants|Count of Participants|3|3.0||||||
4051006|NCT01100255|3872319|B1||Female|Gender||Participants|Count of Participants|4|4.0||||||
4051007|NCT01100255|3872317|B3|||Age||years|Mean|34|34.0|Standard Deviation|9|9.0|||
4051008|NCT01100255|3872318|B2|||Age||years|Mean|32|32.0|Standard Deviation|8|8.0|||
4051009|NCT01100255|3872319|B1|||Age||years|Mean|36|36.0|Standard Deviation|10|10.0|||
4051010|NCT01100242|3872326|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4051011|NCT01100242|3872326|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4051012|NCT01100242|3872326|B1|||Age||years|Median|61|61.0|Full Range|||44.0|80.0|
4051013|NCT01100112|3872332|B1|India||Region of Enrollment||participants|Number|60|60.0||||||
4051014|NCT01100112|3872332|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4051015|NCT01100112|3872332|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4051016|NCT01100112|3872332|B1|||Age||years|Mean|40.3|40.3|Standard Deviation|11.41|11.41|||
4051017|NCT01100112|3872332|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4051018|NCT01100112|3872332|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4051019|NCT01100112|3872332|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4051020|NCT01100086|3872339|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4051021|NCT01100086|3872339|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4051022|NCT01100086|3872339|B1|||Age||years|Mean|32|32.0|Standard Deviation|9.3|9.3|||
4051023|NCT01100073|3872350|B1|Category title missing||Sex/Gender, Customized||participants|Number|17|17.0||||||
4051024|NCT01100073|3872350|B1|Male||Sex/Gender, Customized||participants|Number|838|838.0||||||
4051025|NCT01100073|3872350|B1|Female||Sex/Gender, Customized||participants|Number|844|844.0||||||
4051026|NCT01100073|3872350|B1|||Age||years|Mean|66.4|66.4|Standard Deviation|9.70|9.7|||
4051027|NCT01099969|3872365|B5|United States||Region of Enrollment||participants|Number|60|60.0||||||
4051028|NCT01099969|3872366|B4|United States||Region of Enrollment||participants|Number|15|15.0||||||
4051029|NCT01099969|3872367|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4051030|NCT01099969|3872368|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4051031|NCT01099969|3872369|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4051032|NCT01099969|3872365|B5||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4051033|NCT01099969|3872366|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4051034|NCT01099969|3872367|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4051035|NCT01099969|3872368|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4051036|NCT01099969|3872369|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4051037|NCT01099969|3872365|B5||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4051038|NCT01099969|3872366|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4051039|NCT01099969|3872367|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4051040|NCT01099969|3872368|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4051041|NCT01099969|3872369|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4051042|NCT01099969|3872365|B5|||Age||years|Mean|49.5|49.5|Standard Deviation|15.1|15.1|||
4051043|NCT01099969|3872366|B4|||Age||years|Mean|50.7|50.7|Standard Deviation|15.7|15.7|||
4051044|NCT01099969|3872367|B3|||Age||years|Mean|50.4|50.4|Standard Deviation|14.1|14.1|||
4051045|NCT01099969|3872368|B2|||Age||years|Mean|41.2|41.2|Standard Deviation|14.4|14.4|||
4051046|NCT01099969|3872369|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|13.1|13.1|||
4051047|NCT01099917|3872394|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4051048|NCT01099917|3872394|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4051049|NCT01099917|3872394|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4051050|NCT01099917|3872394|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4051051|NCT01099917|3872394|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4051052|NCT01099774|3872398|B3||Male|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
4051053|NCT01099774|3872399|B2||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4051054|NCT01099774|3872400|B1||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4051055|NCT01099774|3872398|B3||Female|Sex: Female, Male||Participants|Count of Participants|351|351.0||||||
4051056|NCT01099774|3872399|B2||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4051057|NCT01099774|3872400|B1||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4051058|NCT01099774|3872398|B3|>65 years||Age, Customized||Participants|Number|285|285.0||||||
4051059|NCT01099774|3872399|B2|>65 years||Age, Customized||Participants|Number|150|150.0||||||
4051060|NCT01099774|3872400|B1|>65 years||Age, Customized||Participants|Number|135|135.0||||||
4051061|NCT01099774|3872398|B3|Between 45 and 65 years||Age, Customized||Participants|Number|293|293.0||||||
4051062|NCT01099774|3872399|B2|Between 45 and 65 years||Age, Customized||Participants|Number|134|134.0||||||
4051063|NCT01099774|3872400|B1|Between 45 and 65 years||Age, Customized||Participants|Number|159|159.0||||||
4051064|NCT01099774|3872398|B3|<45 years||Age, Customized||Participants|Number|19|19.0||||||
4051065|NCT01099774|3872399|B2|<45 years||Age, Customized||Participants|Number|11|11.0||||||
4051066|NCT01099774|3872400|B1|<45 years||Age, Customized||Participants|Number|8|8.0||||||
4051067|NCT01099761|3872413|B5|||Able to ambulate 10 meters in < 12 seconds||participants|Number|24|24.0||||||
4051068|NCT01099761|3872414|B4|||Able to ambulate 10 meters in < 12 seconds||participants|Number|6|6.0||||||
4051069|NCT01099761|3872416|B2|||Able to ambulate 10 meters in < 12 seconds||participants|Number|9|9.0||||||
4051070|NCT01099761|3872417|B1|||Able to ambulate 10 meters in < 12 seconds||participants|Number|9|9.0||||||
4051071|NCT01099761|3872413|B5|Canada||Region of Enrollment||participants|Number|24|24.0||||||
4051072|NCT01099761|3872414|B4|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4051073|NCT01099761|3872416|B2|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4051074|NCT01099761|3872417|B1|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4051075|NCT01099761|3872413|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051076|NCT01099761|3872414|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051077|NCT01099761|3872416|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051078|NCT01099761|3872417|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051079|NCT01099761|3872413|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4051080|NCT01099761|3872414|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4051081|NCT01099761|3872416|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4051082|NCT01099761|3872417|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4051083|NCT01099761|3872413|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051084|NCT01099761|3872414|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051085|NCT01099761|3872416|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051086|NCT01099761|3872417|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051087|NCT01099761|3872413|B5||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4051088|NCT01099761|3872414|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4051089|NCT01099761|3872416|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4051090|NCT01099761|3872417|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4051091|NCT01099761|3872413|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4051092|NCT01099761|3872414|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4051093|NCT01099761|3872416|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4051094|NCT01099761|3872417|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4051095|NCT01099761|3872413|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4051096|NCT01099761|3872414|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4051097|NCT01099761|3872416|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4051098|NCT01099761|3872417|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4051099|NCT01099761|3872413|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4051100|NCT01099761|3872414|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4051101|NCT01099761|3872416|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4051102|NCT01099761|3872417|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4051103|NCT01099761|3872413|B5||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
4051104|NCT01099761|3872414|B4||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4051105|NCT01099761|3872416|B2||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4051106|NCT01099761|3872417|B1||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4051107|NCT01099709|3872456|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4051108|NCT01099709|3872456|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4051109|NCT01099709|3872456|B1|||Age||years|Mean|28|28.0|Standard Deviation|8.9|8.9|||
4051110|NCT01099618|3872467|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051111|NCT01099618|3872468|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051112|NCT01099618|3872469|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051113|NCT01099618|3872470|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051114|NCT01099618|3872467|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051115|NCT01099618|3872468|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051116|NCT01099618|3872469|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051117|NCT01099618|3872470|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051118|NCT01099618|3872467|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051119|NCT01099618|3872468|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051120|NCT01099618|3872469|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051121|NCT01099618|3872470|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051122|NCT01099618|3872467|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4051123|NCT01099618|3872468|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4051124|NCT01099618|3872469|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4051125|NCT01099618|3872470|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4051126|NCT01099618|3872467|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051127|NCT01099618|3872468|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051128|NCT01099618|3872469|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051129|NCT01099618|3872470|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051130|NCT01099618|3872467|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051131|NCT01099618|3872468|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051132|NCT01099618|3872469|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051133|NCT01099618|3872470|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051134|NCT01099618|3872467|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051135|NCT01099618|3872468|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051136|NCT01099618|3872469|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051137|NCT01099618|3872470|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051138|NCT01099618|3872467|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4051139|NCT01099618|3872468|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4051140|NCT01099618|3872469|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4051141|NCT01099618|3872470|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4051142|NCT01099618|3872467|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4051143|NCT01099618|3872468|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4051144|NCT01099618|3872469|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4051145|NCT01099618|3872470|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4051146|NCT01099618|3872467|B4|||Age||years|Mean|48|48.0|Standard Deviation|9|9.0|||
4051147|NCT01099618|3872468|B3|||Age||years|Mean|48|48.0|Standard Deviation|7|7.0|||
4051148|NCT01099618|3872469|B2|||Age||years|Mean|50|50.0|Standard Deviation|11|11.0|||
4051149|NCT01099618|3872470|B1|||Age||years|Mean|48|48.0|Standard Deviation|9|9.0|||
4051150|NCT01099618|3872467|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4051151|NCT01099618|3872468|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4051152|NCT01099618|3872469|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4051153|NCT01099618|3872470|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4051154|NCT01099618|3872467|B4||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4051155|NCT01099618|3872468|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4051156|NCT01099618|3872469|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4051157|NCT01099618|3872470|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4051158|NCT01099618|3872467|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4051159|NCT01099618|3872468|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4051160|NCT01099618|3872469|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4051161|NCT01099618|3872470|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4051162|NCT01099579|3872480|B4|ARV experienced||Prior Antiretroviral (ARV) Treatment Use|ATV naive is defined as without prior exposure to ARV treatment; ARV experienced is defined as previous exposure to ARV drugs through prior treatment for HIV infection or through postnatal treatment with ≥1 ARVs for the prevention of mother-to-child-transmission in accordance with multiple international guidelines. Patients exposed to ARVs in utero or intrapartum were permitted in the study but were considered treatment naive.|Participants|Count of Participants|34|34.0||||||
4051163|NCT01099579|3872481|B3|ARV experienced||Prior Antiretroviral (ARV) Treatment Use|ATV naive is defined as without prior exposure to ARV treatment; ARV experienced is defined as previous exposure to ARV drugs through prior treatment for HIV infection or through postnatal treatment with ≥1 ARVs for the prevention of mother-to-child-transmission in accordance with multiple international guidelines. Patients exposed to ARVs in utero or intrapartum were permitted in the study but were considered treatment naive.|Participants|Count of Participants|11|11.0||||||
4051164|NCT01099579|3872482|B2|ARV experienced||Prior Antiretroviral (ARV) Treatment Use|ATV naive is defined as without prior exposure to ARV treatment; ARV experienced is defined as previous exposure to ARV drugs through prior treatment for HIV infection or through postnatal treatment with ≥1 ARVs for the prevention of mother-to-child-transmission in accordance with multiple international guidelines. Patients exposed to ARVs in utero or intrapartum were permitted in the study but were considered treatment naive.|Participants|Count of Participants|9|9.0||||||
4051165|NCT01099579|3872483|B1|ARV experienced||Prior Antiretroviral (ARV) Treatment Use|ATV naive is defined as without prior exposure to ARV treatment; ARV experienced is defined as previous exposure to ARV drugs through prior treatment for HIV infection or through postnatal treatment with ≥1 ARVs for the prevention of mother-to-child-transmission in accordance with multiple international guidelines. Patients exposed to ARVs in utero or intrapartum were permitted in the study but were considered treatment naive.|Participants|Count of Participants|14|14.0||||||
4051166|NCT01099579|3872480|B4|ARV naive||Prior Antiretroviral (ARV) Treatment Use|ATV naive is defined as without prior exposure to ARV treatment; ARV experienced is defined as previous exposure to ARV drugs through prior treatment for HIV infection or through postnatal treatment with ≥1 ARVs for the prevention of mother-to-child-transmission in accordance with multiple international guidelines. Patients exposed to ARVs in utero or intrapartum were permitted in the study but were considered treatment naive.|Participants|Count of Participants|22|22.0||||||
4051167|NCT01099579|3872481|B3|ARV naive||Prior Antiretroviral (ARV) Treatment Use|ATV naive is defined as without prior exposure to ARV treatment; ARV experienced is defined as previous exposure to ARV drugs through prior treatment for HIV infection or through postnatal treatment with ≥1 ARVs for the prevention of mother-to-child-transmission in accordance with multiple international guidelines. Patients exposed to ARVs in utero or intrapartum were permitted in the study but were considered treatment naive.|Participants|Count of Participants|5|5.0||||||
4051168|NCT01099579|3872482|B2|ARV naive||Prior Antiretroviral (ARV) Treatment Use|ATV naive is defined as without prior exposure to ARV treatment; ARV experienced is defined as previous exposure to ARV drugs through prior treatment for HIV infection or through postnatal treatment with ≥1 ARVs for the prevention of mother-to-child-transmission in accordance with multiple international guidelines. Patients exposed to ARVs in utero or intrapartum were permitted in the study but were considered treatment naive.|Participants|Count of Participants|10|10.0||||||
4051230|NCT01099579|3872480|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4051231|NCT01099579|3872481|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4051232|NCT01099579|3872482|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4051233|NCT01099579|3872483|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4051169|NCT01099579|3872483|B1|ARV naive||Prior Antiretroviral (ARV) Treatment Use|ATV naive is defined as without prior exposure to ARV treatment; ARV experienced is defined as previous exposure to ARV drugs through prior treatment for HIV infection or through postnatal treatment with ≥1 ARVs for the prevention of mother-to-child-transmission in accordance with multiple international guidelines. Patients exposed to ARVs in utero or intrapartum were permitted in the study but were considered treatment naive.|Participants|Count of Participants|7|7.0||||||
4051170|NCT01099579|3872480|B4|Not reported||CD4 Percent||Participants|Count of Participants|15|15.0||||||
4051171|NCT01099579|3872481|B3|Not reported||CD4 Percent||Participants|Count of Participants|5|5.0||||||
4051172|NCT01099579|3872482|B2|Not reported||CD4 Percent||Participants|Count of Participants|5|5.0||||||
4051173|NCT01099579|3872483|B1|Not reported||CD4 Percent||Participants|Count of Participants|5|5.0||||||
4051174|NCT01099579|3872480|B4|>=25||CD4 Percent||Participants|Count of Participants|19|19.0||||||
4051175|NCT01099579|3872481|B3|>=25||CD4 Percent||Participants|Count of Participants|6|6.0||||||
4051176|NCT01099579|3872482|B2|>=25||CD4 Percent||Participants|Count of Participants|6|6.0||||||
4051177|NCT01099579|3872483|B1|>=25||CD4 Percent||Participants|Count of Participants|7|7.0||||||
4051178|NCT01099579|3872480|B4|15 to <25||CD4 Percent||Participants|Count of Participants|17|17.0||||||
4051179|NCT01099579|3872481|B3|15 to <25||CD4 Percent||Participants|Count of Participants|4|4.0||||||
4051180|NCT01099579|3872482|B2|15 to <25||CD4 Percent||Participants|Count of Participants|6|6.0||||||
4051181|NCT01099579|3872483|B1|15 to <25||CD4 Percent||Participants|Count of Participants|7|7.0||||||
4051182|NCT01099579|3872480|B4|<15||CD4 Percent||Participants|Count of Participants|5|5.0||||||
4051183|NCT01099579|3872481|B3|<15||CD4 Percent||Participants|Count of Participants|1|1.0||||||
4051184|NCT01099579|3872482|B2|<15||CD4 Percent||Participants|Count of Participants|2|2.0||||||
4051185|NCT01099579|3872483|B1|<15||CD4 Percent||Participants|Count of Participants|2|2.0||||||
4051186|NCT01099579|3872480|B4|||CD4 Percent||Percentage|Mean|24.8|24.8|Standard Deviation|10.61|10.61|||
4051187|NCT01099579|3872481|B3|||CD4 Percent||Percentage|Mean|27.5|27.5|Standard Deviation|9.85|9.85|||
4051188|NCT01099579|3872482|B2|||CD4 Percent||Percentage|Mean|22.0|22.0|Standard Deviation|9.35|9.35|||
4051189|NCT01099579|3872483|B1|||CD4 Percent||Percentage|Mean|25.4|25.4|Standard Deviation|12.11|12.11|||
4051190|NCT01099579|3872480|B4|||CD4 Count||Cells/mm^3|Mean|1192.6|1192.6|Standard Deviation|784.08|784.08|||
4051191|NCT01099579|3872481|B3|||CD4 Count||Cells/mm^3|Mean|661.1|661.1|Standard Deviation|302.60|302.6|||
4051192|NCT01099579|3872482|B2|||CD4 Count||Cells/mm^3|Mean|1107.4|1107.4|Standard Deviation|643.25|643.25|||
4051193|NCT01099579|3872483|B1|||CD4 Count||Cells/mm^3|Mean|1594.1|1594.1|Standard Deviation|897.19|897.19|||
4051194|NCT01099579|3872480|B4|>100,000 c/mL||HIV RNA||c/mL|Number|32|32.0||||||
4051195|NCT01099579|3872481|B3|>100,000 c/mL||HIV RNA||c/mL|Number|4|4.0||||||
4051196|NCT01099579|3872482|B2|>100,000 c/mL||HIV RNA||c/mL|Number|10|10.0||||||
4051197|NCT01099579|3872483|B1|>100,000 c/mL||HIV RNA||c/mL|Number|18|18.0||||||
4051198|NCT01099579|3872480|B4|30,000 to 100,000 c/mL||HIV RNA||c/mL|Number|10|10.0||||||
4051199|NCT01099579|3872481|B3|30,000 to 100,000 c/mL||HIV RNA||c/mL|Number|3|3.0||||||
4051200|NCT01099579|3872482|B2|30,000 to 100,000 c/mL||HIV RNA||c/mL|Number|7|7.0||||||
4051201|NCT01099579|3872483|B1|30,000 to 100,000 c/mL||HIV RNA||c/mL|Number|0|0.0||||||
4051202|NCT01099579|3872480|B4|<30,000 c/mL||HIV RNA||c/mL|Number|14|14.0||||||
4051203|NCT01099579|3872481|B3|<30,000 c/mL||HIV RNA||c/mL|Number|9|9.0||||||
4051204|NCT01099579|3872482|B2|<30,000 c/mL||HIV RNA||c/mL|Number|2|2.0||||||
4051205|NCT01099579|3872483|B1|<30,000 c/mL||HIV RNA||c/mL|Number|3|3.0||||||
4051206|NCT01099579|3872480|B4|||HIV RNA||Log10 c/mL|Mean|4.62|4.62|Standard Deviation|0.617|0.617|||
4051207|NCT01099579|3872481|B3|||HIV RNA||Log10 c/mL|Mean|4.18|4.18|Standard Deviation|0.727|0.727|||
4051208|NCT01099579|3872482|B2|||HIV RNA||Log10 c/mL|Mean|4.83|4.83|Standard Deviation|0.268|0.268|||
4051209|NCT01099579|3872483|B1|||HIV RNA||Log10 c/mL|Mean|4.77|4.77|Standard Deviation|0.602|0.602|||
4051210|NCT01099579|3872480|B4|Thailand||Country||Participants|Count of Participants|1|1.0||||||
4051211|NCT01099579|3872481|B3|Thailand||Country||Participants|Count of Participants|0|0.0||||||
4051212|NCT01099579|3872482|B2|Thailand||Country||Participants|Count of Participants|1|1.0||||||
4051213|NCT01099579|3872483|B1|Thailand||Country||Participants|Count of Participants|0|0.0||||||
4051214|NCT01099579|3872480|B4|South Africa||Country||Participants|Count of Participants|38|38.0||||||
4051215|NCT01099579|3872481|B3|South Africa||Country||Participants|Count of Participants|8|8.0||||||
4051216|NCT01099579|3872482|B2|South Africa||Country||Participants|Count of Participants|13|13.0||||||
4051217|NCT01099579|3872483|B1|South Africa||Country||Participants|Count of Participants|17|17.0||||||
4051218|NCT01099579|3872480|B4|Peru||Country||Participants|Count of Participants|2|2.0||||||
4051219|NCT01099579|3872481|B3|Peru||Country||Participants|Count of Participants|1|1.0||||||
4051220|NCT01099579|3872482|B2|Peru||Country||Participants|Count of Participants|0|0.0||||||
4051221|NCT01099579|3872483|B1|Peru||Country||Participants|Count of Participants|1|1.0||||||
4051222|NCT01099579|3872480|B4|Mexico||Country||Participants|Count of Participants|9|9.0||||||
4051223|NCT01099579|3872481|B3|Mexico||Country||Participants|Count of Participants|4|4.0||||||
4051224|NCT01099579|3872482|B2|Mexico||Country||Participants|Count of Participants|3|3.0||||||
4051225|NCT01099579|3872483|B1|Mexico||Country||Participants|Count of Participants|2|2.0||||||
4051226|NCT01099579|3872480|B4|Chile||Country||Participants|Count of Participants|6|6.0||||||
4051227|NCT01099579|3872481|B3|Chile||Country||Participants|Count of Participants|3|3.0||||||
4051228|NCT01099579|3872482|B2|Chile||Country||Participants|Count of Participants|2|2.0||||||
4051229|NCT01099579|3872483|B1|Chile||Country||Participants|Count of Participants|1|1.0||||||
4051234|NCT01099579|3872480|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4051235|NCT01099579|3872481|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4051236|NCT01099579|3872482|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4051237|NCT01099579|3872483|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4051238|NCT01099579|3872480|B4|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
4051239|NCT01099579|3872481|B3|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4051240|NCT01099579|3872482|B2|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4051241|NCT01099579|3872483|B1|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4051242|NCT01099579|3872480|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4051243|NCT01099579|3872481|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4051244|NCT01099579|3872482|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4051245|NCT01099579|3872483|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4051246|NCT01099579|3872480|B4|Not reported||Race/Ethnicity, Customized||Participants|Count of Participants|55|55.0||||||
4051247|NCT01099579|3872481|B3|Not reported||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
4051248|NCT01099579|3872482|B2|Not reported||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
4051249|NCT01099579|3872483|B1|Not reported||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
4051250|NCT01099579|3872480|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4051251|NCT01099579|3872481|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4051252|NCT01099579|3872482|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4051253|NCT01099579|3872483|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4051254|NCT01099579|3872480|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4051255|NCT01099579|3872481|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4051256|NCT01099579|3872482|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4051257|NCT01099579|3872483|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4051258|NCT01099579|3872480|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4051259|NCT01099579|3872481|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4051260|NCT01099579|3872482|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4051261|NCT01099579|3872483|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4051262|NCT01099579|3872480|B4|||Age||Months|Mean|29.6|29.6|Standard Deviation|20.72|20.72|||
4051263|NCT01099579|3872481|B3|||Age||Months|Mean|52.1|52.1|Standard Deviation|10.49|10.49|||
4051264|NCT01099579|3872482|B2|||Age||Months|Mean|35.4|35.4|Standard Deviation|11.63|11.63|||
4051265|NCT01099579|3872483|B1|||Age||Months|Mean|7.3|7.3|Standard Deviation|4.05|4.05|||
4051266|NCT01099475|3872539|B3|malignant disease||Indication for resection||participants|Number|19|19.0||||||
4051267|NCT01099475|3872540|B2|malignant disease||Indication for resection||participants|Number|9|9.0||||||
4051268|NCT01099475|3872541|B1|malignant disease||Indication for resection||participants|Number|10|10.0||||||
4051269|NCT01099475|3872539|B3|benign disease||Indication for resection||participants|Number|1|1.0||||||
4051270|NCT01099475|3872540|B2|benign disease||Indication for resection||participants|Number|1|1.0||||||
4051271|NCT01099475|3872541|B1|benign disease||Indication for resection||participants|Number|0|0.0||||||
4051272|NCT01099475|3872539|B3|ASA 3||American Society of Anesthesiologists (ASA) classification|"The ASA (American Society of Anesthesiologists) physical status classification system is a system for assessing the fitness of cases before surgery and consists of a six-category physical status classification system. These are:~ASA 1. Healthy person. ASA 2. Mild systemic disease. ASA 3. Severe systemic disease. ASA 4. Severe systemic disease that is a constant threat to life. ASA 5. A moribund person who is not expected to survive without the operation. ASA 6. A declared brain-dead person whose organs are being removed for donor purposes"|participants|Number|5|5.0||||||
4051273|NCT01099475|3872540|B2|ASA 3||American Society of Anesthesiologists (ASA) classification|"The ASA (American Society of Anesthesiologists) physical status classification system is a system for assessing the fitness of cases before surgery and consists of a six-category physical status classification system. These are:~ASA 1. Healthy person. ASA 2. Mild systemic disease. ASA 3. Severe systemic disease. ASA 4. Severe systemic disease that is a constant threat to life. ASA 5. A moribund person who is not expected to survive without the operation. ASA 6. A declared brain-dead person whose organs are being removed for donor purposes"|participants|Number|3|3.0||||||
4051274|NCT01099475|3872541|B1|ASA 3||American Society of Anesthesiologists (ASA) classification|"The ASA (American Society of Anesthesiologists) physical status classification system is a system for assessing the fitness of cases before surgery and consists of a six-category physical status classification system. These are:~ASA 1. Healthy person. ASA 2. Mild systemic disease. ASA 3. Severe systemic disease. ASA 4. Severe systemic disease that is a constant threat to life. ASA 5. A moribund person who is not expected to survive without the operation. ASA 6. A declared brain-dead person whose organs are being removed for donor purposes"|participants|Number|2|2.0||||||
4051275|NCT01099475|3872539|B3|ASA 2||American Society of Anesthesiologists (ASA) classification|"The ASA (American Society of Anesthesiologists) physical status classification system is a system for assessing the fitness of cases before surgery and consists of a six-category physical status classification system. These are:~ASA 1. Healthy person. ASA 2. Mild systemic disease. ASA 3. Severe systemic disease. ASA 4. Severe systemic disease that is a constant threat to life. ASA 5. A moribund person who is not expected to survive without the operation. ASA 6. A declared brain-dead person whose organs are being removed for donor purposes"|participants|Number|13|13.0||||||
4051276|NCT01099475|3872540|B2|ASA 2||American Society of Anesthesiologists (ASA) classification|"The ASA (American Society of Anesthesiologists) physical status classification system is a system for assessing the fitness of cases before surgery and consists of a six-category physical status classification system. These are:~ASA 1. Healthy person. ASA 2. Mild systemic disease. ASA 3. Severe systemic disease. ASA 4. Severe systemic disease that is a constant threat to life. ASA 5. A moribund person who is not expected to survive without the operation. ASA 6. A declared brain-dead person whose organs are being removed for donor purposes"|participants|Number|5|5.0||||||
4051277|NCT01099475|3872541|B1|ASA 2||American Society of Anesthesiologists (ASA) classification|"The ASA (American Society of Anesthesiologists) physical status classification system is a system for assessing the fitness of cases before surgery and consists of a six-category physical status classification system. These are:~ASA 1. Healthy person. ASA 2. Mild systemic disease. ASA 3. Severe systemic disease. ASA 4. Severe systemic disease that is a constant threat to life. ASA 5. A moribund person who is not expected to survive without the operation. ASA 6. A declared brain-dead person whose organs are being removed for donor purposes"|participants|Number|8|8.0||||||
4051278|NCT01099475|3872539|B3|ASA 1||American Society of Anesthesiologists (ASA) classification|"The ASA (American Society of Anesthesiologists) physical status classification system is a system for assessing the fitness of cases before surgery and consists of a six-category physical status classification system. These are:~ASA 1. Healthy person. ASA 2. Mild systemic disease. ASA 3. Severe systemic disease. ASA 4. Severe systemic disease that is a constant threat to life. ASA 5. A moribund person who is not expected to survive without the operation. ASA 6. A declared brain-dead person whose organs are being removed for donor purposes"|participants|Number|2|2.0||||||
4051279|NCT01099475|3872540|B2|ASA 1||American Society of Anesthesiologists (ASA) classification|"The ASA (American Society of Anesthesiologists) physical status classification system is a system for assessing the fitness of cases before surgery and consists of a six-category physical status classification system. These are:~ASA 1. Healthy person. ASA 2. Mild systemic disease. ASA 3. Severe systemic disease. ASA 4. Severe systemic disease that is a constant threat to life. ASA 5. A moribund person who is not expected to survive without the operation. ASA 6. A declared brain-dead person whose organs are being removed for donor purposes"|participants|Number|2|2.0||||||
4051280|NCT01099475|3872541|B1|ASA 1||American Society of Anesthesiologists (ASA) classification|"The ASA (American Society of Anesthesiologists) physical status classification system is a system for assessing the fitness of cases before surgery and consists of a six-category physical status classification system. These are:~ASA 1. Healthy person. ASA 2. Mild systemic disease. ASA 3. Severe systemic disease. ASA 4. Severe systemic disease that is a constant threat to life. ASA 5. A moribund person who is not expected to survive without the operation. ASA 6. A declared brain-dead person whose organs are being removed for donor purposes"|participants|Number|0|0.0||||||
4051281|NCT01099475|3872539|B3|Netherlands||Region of Enrollment||participants|Number|20|20.0||||||
4051282|NCT01099475|3872540|B2|Netherlands||Region of Enrollment||participants|Number|10|10.0||||||
4051283|NCT01099475|3872541|B1|Netherlands||Region of Enrollment||participants|Number|10|10.0||||||
4051284|NCT01099475|3872539|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4051285|NCT01099475|3872540|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4051286|NCT01099475|3872541|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4051287|NCT01099475|3872539|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4051288|NCT01099475|3872540|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4051289|NCT01099475|3872541|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4051290|NCT01099475|3872539|B3|||Age||years|Median|62|62.0|Full Range|||30.0|80.0|
4051291|NCT01099475|3872540|B2|||Age||years|Median|62|62.0|Full Range|||30.0|77.0|
4051292|NCT01099475|3872541|B1|||Age||years|Median|64|64.0|Full Range|||48.0|80.0|
4051293|NCT01099397|3872554|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4051294|NCT01099397|3872554|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4051295|NCT01099397|3872554|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4051296|NCT01099397|3872554|B1|||Age||years|Mean|46.7|46.7|Standard Deviation|11.1|11.1|||
4051297|NCT01099397|3872554|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4051298|NCT01099397|3872554|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4051299|NCT01099397|3872554|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4051300|NCT01099358|3872559|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4051301|NCT01099358|3872559|B1|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4051302|NCT01099358|3872559|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4051303|NCT01099358|3872559|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051304|NCT01099358|3872559|B1||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4051305|NCT01099358|3872559|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4051306|NCT01099358|3872559|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051307|NCT01099358|3872559|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4051308|NCT01099358|3872559|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051309|NCT01099358|3872559|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4051310|NCT01099358|3872559|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4051311|NCT01099358|3872559|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4051312|NCT01099358|3872559|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4051313|NCT01099358|3872559|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4051314|NCT01099358|3872559|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|11.29|11.29|||
4051315|NCT01099267|3872581|B1|Germany||Region of Enrollment||participants|Number|36|36.0||||||
4051316|NCT01099267|3872581|B1|United States||Region of Enrollment||participants|Number|112|112.0||||||
4051317|NCT01099267|3872581|B1||Male|Gender||Participants|Count of Participants|51|51.0||||||
4051318|NCT01099267|3872581|B1||Female|Gender||Participants|Count of Participants|97|97.0||||||
4051319|NCT01099267|3872581|B1|||Age||years|Mean|70.0|70.0|Standard Deviation|10.50|10.5|||
4051320|NCT01099215|3872589|B3|STAGE IV - ULCERATION OR GANGRENE||Fontaine Classification||Participants|Number|5|5.0||||||
4051321|NCT01099215|3872590|B2|STAGE IV - ULCERATION OR GANGRENE||Fontaine Classification||Participants|Number|4|4.0||||||
4051322|NCT01099215|3872591|B1|STAGE IV - ULCERATION OR GANGRENE||Fontaine Classification||Participants|Number|1|1.0||||||
4051323|NCT01099215|3872589|B3|STAGE IIB-MODERATE TO SEVERE CLAUDICATION(<200M)||Fontaine Classification||Participants|Number|16|16.0||||||
4051324|NCT01099215|3872590|B2|STAGE IIB-MODERATE TO SEVERE CLAUDICATION(<200M)||Fontaine Classification||Participants|Number|6|6.0||||||
4051325|NCT01099215|3872591|B1|STAGE IIB-MODERATE TO SEVERE CLAUDICATION(<200M)||Fontaine Classification||Participants|Number|10|10.0||||||
4051326|NCT01099215|3872589|B3|||Resting Ankle Brachial Index, Leg with Target Lesion||participants|Mean|0.902|0.902|Standard Deviation|0.217|0.217|||
4051327|NCT01099215|3872590|B2|||Resting Ankle Brachial Index, Leg with Target Lesion||participants|Mean|0.851|0.851|Standard Deviation|0.258|0.258|||
4051328|NCT01099215|3872591|B1|||Resting Ankle Brachial Index, Leg with Target Lesion||participants|Mean|0.954|0.954|Standard Deviation|0.164|0.164|||
4051329|NCT01099215|3872589|B3|France||Region of Enrollment||participants|Number|21|21.0||||||
4051330|NCT01099215|3872590|B2|France||Region of Enrollment||participants|Number|10|10.0||||||
4051331|NCT01099215|3872591|B1|France||Region of Enrollment||participants|Number|11|11.0||||||
4051332|NCT01099215|3872589|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4051333|NCT01099215|3872590|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4051334|NCT01099215|3872591|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4051335|NCT01099215|3872589|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4051336|NCT01099215|3872590|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4051337|NCT01099215|3872591|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4051338|NCT01099215|3872589|B3|||Age|Age at Screening|Years|Mean|66.0|66.0|Standard Deviation|9.96|9.96|||
4051339|NCT01099215|3872590|B2|||Age|Age at Screening|Years|Mean|70.7|70.7|Standard Deviation|7.67|7.67|||
4051340|NCT01099215|3872591|B1|||Age|Age at Screening|Years|Mean|61.6|61.6|Standard Deviation|10.11|10.11|||
4051341|NCT01099202|3872628|B3|United States||Region of Enrollment||participants|Number|109|109.0||||||
4051342|NCT01099202|3872629|B2|United States||Region of Enrollment||participants|Number|54|54.0||||||
4051343|NCT01099202|3872630|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4051344|NCT01099202|3872628|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4051345|NCT01099202|3872629|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4051346|NCT01099202|3872630|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4051347|NCT01099202|3872628|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4051348|NCT01099202|3872629|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4051349|NCT01099202|3872630|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4051350|NCT01099202|3872628|B3|||Age||years|Median|41|41.0|Full Range|||15.0|84.0|
4051351|NCT01099202|3872629|B2|||Age||years|Median|42|42.0|Full Range|||15.0|84.0|
4051352|NCT01099202|3872630|B1|||Age||years|Median|39|39.0|Full Range|||18.0|76.0|
4051353|NCT01099111|3872639|B6|Saudi Arabia||Region of Enrollment||participants|Number|225|225.0||||||
4051354|NCT01099111|3872640|B5|Saudi Arabia||Region of Enrollment||participants|Number|50|50.0||||||
4051355|NCT01099111|3872641|B4|Saudi Arabia||Region of Enrollment||participants|Number|29|29.0||||||
4051356|NCT01099111|3872642|B3|Saudi Arabia||Region of Enrollment||participants|Number|46|46.0||||||
4051357|NCT01099111|3872643|B2|Saudi Arabia||Region of Enrollment||participants|Number|50|50.0||||||
4051358|NCT01099111|3872644|B1|Saudi Arabia||Region of Enrollment||participants|Number|50|50.0||||||
4051359|NCT01099111|3872639|B6||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4051360|NCT01099111|3872640|B5||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4051361|NCT01099111|3872641|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4051362|NCT01099111|3872642|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4051363|NCT01099111|3872643|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4051364|NCT01099111|3872644|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4051365|NCT01099111|3872639|B6||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4051366|NCT01099111|3872640|B5||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4051367|NCT01099111|3872641|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4051368|NCT01099111|3872642|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4051369|NCT01099111|3872643|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4051370|NCT01099111|3872644|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4051371|NCT01099111|3872639|B6|||Age||years|Mean|42.43|42.43|Standard Deviation|12.71|12.71|||
4051372|NCT01099111|3872640|B5|||Age||years|Mean|53.58|53.58|Standard Deviation|12.747|12.747|||
4051373|NCT01099111|3872641|B4|||Age||years|Mean|55.03|55.03|Standard Deviation|10.137|10.137|||
4051374|NCT01099111|3872642|B3|||Age||years|Mean|25.19|25.19|Standard Deviation|10.672|10.672|||
4051375|NCT01099111|3872643|B2|||Age||years|Mean|34.42|34.42|Standard Deviation|12.586|12.586|||
4051376|NCT01099111|3872644|B1|||Age||years|Mean|43.93|43.93|Standard Deviation|14.505|14.505|||
4051377|NCT01099111|3872639|B6||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4051378|NCT01099111|3872640|B5||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4051379|NCT01099111|3872641|B4||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4051380|NCT01099111|3872642|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4051381|NCT01099111|3872643|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4051382|NCT01099111|3872644|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4051383|NCT01099111|3872639|B6||Between 18 and 65 years|Age||Participants|Count of Participants|188|188.0||||||
4051384|NCT01099111|3872640|B5||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4051385|NCT01099111|3872641|B4||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4051386|NCT01099111|3872642|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4051387|NCT01099111|3872643|B2||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4051388|NCT01099111|3872644|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4051389|NCT01099111|3872639|B6||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4051390|NCT01099111|3872640|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4051391|NCT01099111|3872641|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4051392|NCT01099111|3872642|B3||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4051393|NCT01099111|3872643|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4051394|NCT01099111|3872644|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4051395|NCT01098851|3872660|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4051396|NCT01098851|3872661|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4051397|NCT01098851|3872662|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4051398|NCT01098851|3872660|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4051399|NCT01098851|3872661|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4051400|NCT01098851|3872662|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4051401|NCT01098851|3872660|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4051402|NCT01098851|3872661|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4051403|NCT01098851|3872662|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4051404|NCT01098851|3872660|B3|||Age||years|Mean|48|48.0|Standard Deviation|15|15.0|||
4051405|NCT01098851|3872661|B2|||Age||years|Mean|36|36.0|Standard Deviation|7|7.0|||
4051406|NCT01098851|3872662|B1|||Age||years|Mean|59|59.0|Standard Deviation|10|10.0|||
4051407|NCT01098851|3872660|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4051408|NCT01098851|3872661|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4051409|NCT01098851|3872662|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4051410|NCT01098851|3872660|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4051411|NCT01098851|3872661|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4051412|NCT01098851|3872662|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4051413|NCT01098851|3872660|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4051414|NCT01098851|3872661|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4051415|NCT01098851|3872662|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4051416|NCT01098812|3872671|B4|Canada||Region of Enrollment||participants|Number|22|22.0||||||
4051417|NCT01098812|3872672|B3|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4051418|NCT01098812|3872673|B2|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4051419|NCT01098812|3872674|B1|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4051420|NCT01098812|3872671|B4|United States||Region of Enrollment||participants|Number|247|247.0||||||
4051421|NCT01098812|3872672|B3|United States||Region of Enrollment||participants|Number|66|66.0||||||
4051422|NCT01098812|3872673|B2|United States||Region of Enrollment||participants|Number|94|94.0||||||
4051423|NCT01098812|3872674|B1|United States||Region of Enrollment||participants|Number|87|87.0||||||
4051424|NCT01098812|3872671|B4||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4051425|NCT01098812|3872672|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4051426|NCT01098812|3872673|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4051427|NCT01098812|3872674|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4051428|NCT01098812|3872671|B4||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4051429|NCT01098812|3872672|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4051430|NCT01098812|3872673|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4051431|NCT01098812|3872674|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4051432|NCT01098812|3872671|B4|>=80 years||Age, Customized||participants|Number|37|37.0||||||
4051433|NCT01098812|3872672|B3|>=80 years||Age, Customized||participants|Number|7|7.0||||||
4051434|NCT01098812|3872673|B2|>=80 years||Age, Customized||participants|Number|12|12.0||||||
4051435|NCT01098812|3872674|B1|>=80 years||Age, Customized||participants|Number|18|18.0||||||
4051436|NCT01098812|3872671|B4|70 through 79 years||Age, Customized||participants|Number|102|102.0||||||
4051437|NCT01098812|3872672|B3|70 through 79 years||Age, Customized||participants|Number|25|25.0||||||
4051438|NCT01098812|3872673|B2|70 through 79 years||Age, Customized||participants|Number|41|41.0||||||
4051439|NCT01098812|3872674|B1|70 through 79 years||Age, Customized||participants|Number|36|36.0||||||
4051440|NCT01098812|3872671|B4|60 through 69 years||Age, Customized||participants|Number|108|108.0||||||
4051441|NCT01098812|3872672|B3|60 through 69 years||Age, Customized||participants|Number|33|33.0||||||
4051442|NCT01098812|3872673|B2|60 through 69 years||Age, Customized||participants|Number|39|39.0||||||
4051443|NCT01098812|3872674|B1|60 through 69 years||Age, Customized||participants|Number|36|36.0||||||
4051444|NCT01098812|3872671|B4|<60 years||Age, Customized||participants|Number|22|22.0||||||
4051445|NCT01098812|3872672|B3|<60 years||Age, Customized||participants|Number|7|7.0||||||
4051446|NCT01098812|3872673|B2|<60 years||Age, Customized||participants|Number|10|10.0||||||
4051447|NCT01098812|3872674|B1|<60 years||Age, Customized||participants|Number|5|5.0||||||
4051448|NCT01098812|3872671|B4|||Age||years|Mean|70|70.0|Standard Deviation|9|9.0|||
4051449|NCT01098812|3872672|B3|||Age||years|Mean|69|69.0|Standard Deviation|9|9.0|||
4051450|NCT01098812|3872673|B2|||Age||years|Mean|70|70.0|Standard Deviation|8|8.0|||
4051451|NCT01098812|3872674|B1|||Age||years|Mean|71|71.0|Standard Deviation|9|9.0|||
4051452|NCT01098747|3872686|B5|Severe||Number of Participants with Pain Severity Score|Pain severity score was assessed on a 4-point categorical scale. Total possible pain severity score range was 0 to 3, where 0 = none, 1 = mild, 2 = moderate and 3 = severe.|Participants|Number|152|152.0||||||
4051453|NCT01098747|3872687|B4|Severe||Number of Participants with Pain Severity Score|Pain severity score was assessed on a 4-point categorical scale. Total possible pain severity score range was 0 to 3, where 0 = none, 1 = mild, 2 = moderate and 3 = severe.|Participants|Number|44|44.0||||||
4051454|NCT01098747|3872688|B3|Severe||Number of Participants with Pain Severity Score|Pain severity score was assessed on a 4-point categorical scale. Total possible pain severity score range was 0 to 3, where 0 = none, 1 = mild, 2 = moderate and 3 = severe.|Participants|Number|43|43.0||||||
4051455|NCT01098747|3872689|B2|Severe||Number of Participants with Pain Severity Score|Pain severity score was assessed on a 4-point categorical scale. Total possible pain severity score range was 0 to 3, where 0 = none, 1 = mild, 2 = moderate and 3 = severe.|Participants|Number|44|44.0||||||
4051456|NCT01098747|3872690|B1|Severe||Number of Participants with Pain Severity Score|Pain severity score was assessed on a 4-point categorical scale. Total possible pain severity score range was 0 to 3, where 0 = none, 1 = mild, 2 = moderate and 3 = severe.|Participants|Number|21|21.0||||||
4051457|NCT01098747|3872686|B5|Moderate||Number of Participants with Pain Severity Score|Pain severity score was assessed on a 4-point categorical scale. Total possible pain severity score range was 0 to 3, where 0 = none, 1 = mild, 2 = moderate and 3 = severe.|Participants|Number|164|164.0||||||
4051458|NCT01098747|3872687|B4|Moderate||Number of Participants with Pain Severity Score|Pain severity score was assessed on a 4-point categorical scale. Total possible pain severity score range was 0 to 3, where 0 = none, 1 = mild, 2 = moderate and 3 = severe.|Participants|Number|43|43.0||||||
4051459|NCT01098747|3872688|B3|Moderate||Number of Participants with Pain Severity Score|Pain severity score was assessed on a 4-point categorical scale. Total possible pain severity score range was 0 to 3, where 0 = none, 1 = mild, 2 = moderate and 3 = severe.|Participants|Number|43|43.0||||||
4051460|NCT01098747|3872689|B2|Moderate||Number of Participants with Pain Severity Score|Pain severity score was assessed on a 4-point categorical scale. Total possible pain severity score range was 0 to 3, where 0 = none, 1 = mild, 2 = moderate and 3 = severe.|Participants|Number|51|51.0||||||
4051461|NCT01098747|3872690|B1|Moderate||Number of Participants with Pain Severity Score|Pain severity score was assessed on a 4-point categorical scale. Total possible pain severity score range was 0 to 3, where 0 = none, 1 = mild, 2 = moderate and 3 = severe.|Participants|Number|27|27.0||||||
4051462|NCT01098747|3872686|B5||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4051463|NCT01098747|3872687|B4||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4051464|NCT01098747|3872688|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4051465|NCT01098747|3872689|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4051466|NCT01098747|3872690|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4051467|NCT01098747|3872686|B5||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4051468|NCT01098747|3872687|B4||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4051469|NCT01098747|3872688|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4051470|NCT01098747|3872689|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4051471|NCT01098747|3872690|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4051472|NCT01098747|3872686|B5|||Age||Years|Mean|18.5|18.5|Standard Deviation|2.1|2.1|||
4051473|NCT01098747|3872687|B4|||Age||Years|Mean|18.4|18.4|Standard Deviation|2.0|2.0|||
4051474|NCT01098747|3872688|B3|||Age||Years|Mean|18.6|18.6|Standard Deviation|2.3|2.3|||
4051475|NCT01098747|3872689|B2|||Age||Years|Mean|18.6|18.6|Standard Deviation|2.1|2.1|||
4051476|NCT01098747|3872690|B1|||Age||Years|Mean|18.1|18.1|Standard Deviation|1.6|1.6|||
4051477|NCT01098578|3872743|B1|Canada||Region of Enrollment||participants|Number|20|20.0||||||
4051478|NCT01098578|3872743|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4051479|NCT01098578|3872743|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4051480|NCT01098578|3872743|B1|||Age||years|Mean|57.8|57.8|Standard Deviation|20.06|20.06|||
4051481|NCT01098578|3872743|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4051482|NCT01098578|3872743|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4051483|NCT01098578|3872743|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4051484|NCT01098539|3872750|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|223|223.0||||||
4051539|NCT01098474|3872819|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4051485|NCT01098539|3872751|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|111|111.0||||||
4051486|NCT01098539|3872752|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|112|112.0||||||
4051487|NCT01098539|3872750|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4051488|NCT01098539|3872751|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4051489|NCT01098539|3872752|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4051490|NCT01098539|3872750|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4051491|NCT01098539|3872751|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4051492|NCT01098539|3872752|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4051493|NCT01098539|3872750|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
4051494|NCT01098539|3872751|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4051495|NCT01098539|3872752|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4051496|NCT01098539|3872750|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|55|55.0||||||
4051497|NCT01098539|3872751|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
4051498|NCT01098539|3872752|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|26|26.0||||||
4051499|NCT01098539|3872750|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|78|78.0||||||
4051500|NCT01098539|3872751|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|33|33.0||||||
4051501|NCT01098539|3872752|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|45|45.0||||||
4051502|NCT01098539|3872750|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
4051503|NCT01098539|3872751|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4051504|NCT01098539|3872752|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4051505|NCT01098539|3872750|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|78|78.0||||||
4051506|NCT01098539|3872751|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|42|42.0||||||
4051507|NCT01098539|3872752|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|36|36.0||||||
4051508|NCT01098539|3872750|B3||Male|Gender||Participants|Count of Participants|266|266.0||||||
4051509|NCT01098539|3872751|B2||Male|Gender||Participants|Count of Participants|130|130.0||||||
4051510|NCT01098539|3872752|B1||Male|Gender||Participants|Count of Participants|136|136.0||||||
4051511|NCT01098539|3872750|B3||Female|Gender||Participants|Count of Participants|229|229.0||||||
4051512|NCT01098539|3872751|B2||Female|Gender||Participants|Count of Participants|116|116.0||||||
4051513|NCT01098539|3872752|B1||Female|Gender||Participants|Count of Participants|113|113.0||||||
4051514|NCT01098539|3872750|B3|||Age||Years|Mean|63.3|63.3|Standard Deviation|8.69|8.69|||
4051515|NCT01098539|3872751|B2|||Age||Years|Mean|63.5|63.5|Standard Deviation|9.02|9.02|||
4051516|NCT01098539|3872752|B1|||Age||Years|Mean|63.2|63.2|Standard Deviation|8.37|8.37|||
4051517|NCT01098500|3872789|B1|Unknown||Sex/Gender, Customized||participants|Number|2|2.0||||||
4051518|NCT01098500|3872789|B1|Male||Sex/Gender, Customized||participants|Number|1737|1737.0||||||
4051519|NCT01098500|3872789|B1|Female||Sex/Gender, Customized||participants|Number|2061|2061.0||||||
4051520|NCT01098500|3872789|B1|||Age||Years|Mean|57|57.0|Standard Deviation|12|12.0|||
4051521|NCT01098487|3872804|B1|Missing||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4051522|NCT01098487|3872804|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|81|81.0||||||
4051523|NCT01098487|3872804|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4051524|NCT01098487|3872804|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
4051525|NCT01098487|3872804|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|47|47.0||||||
4051526|NCT01098487|3872804|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4051527|NCT01098487|3872804|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4051528|NCT01098487|3872804|B1|||Age|All Treated Subjects (ATS) Population: all participants who received at least one dose of study medication excluding the 5 participants from Center 082877.|Years|Mean|43.1|43.1|Standard Deviation|16.31|16.31|||
4051529|NCT01098474|3872816|B7|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|300|300.0||||||
4051530|NCT01098474|3872817|B6|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|49|49.0||||||
4051531|NCT01098474|3872818|B5|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|52|52.0||||||
4051532|NCT01098474|3872819|B4|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|49|49.0||||||
4051533|NCT01098474|3872820|B3|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
4051534|NCT01098474|3872821|B2|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
4051535|NCT01098474|3872822|B1|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
4051536|NCT01098474|3872816|B7||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4051537|NCT01098474|3872817|B6||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4051538|NCT01098474|3872818|B5||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4051540|NCT01098474|3872820|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4051541|NCT01098474|3872821|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4051542|NCT01098474|3872822|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4051543|NCT01098474|3872816|B7||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4051544|NCT01098474|3872817|B6||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4051545|NCT01098474|3872818|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4051546|NCT01098474|3872819|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4051547|NCT01098474|3872820|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4051548|NCT01098474|3872821|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4051549|NCT01098474|3872822|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4051550|NCT01098474|3872816|B7|||Age||Months|Mean|3.9|3.9|Standard Deviation|1.9|1.9|||
4051551|NCT01098474|3872817|B6|||Age||Months|Mean|2.1|2.1|Standard Deviation|0.31|0.31|||
4051552|NCT01098474|3872818|B5|||Age||Months|Mean|2|2.0|Standard Deviation|0.19|0.19|||
4051553|NCT01098474|3872819|B4|||Age||Months|Mean|2.1|2.1|Standard Deviation|0.28|0.28|||
4051554|NCT01098474|3872820|B3|||Age||Months|Mean|5.7|5.7|Standard Deviation|0.65|0.65|||
4051555|NCT01098474|3872821|B2|||Age||Months|Mean|5.7|5.7|Standard Deviation|0.61|0.61|||
4051556|NCT01098474|3872822|B1|||Age||Months|Mean|5.8|5.8|Standard Deviation|0.68|0.68|||
4051557|NCT01098461|3873057|B5|Asian - Japanese Heritage||Race/Ethnicity, Customized|Baseline data are reported for members of the Safety Population, comprised of all enrolled participants who received at least one dose of study treatment. Participants were analyzed according to treatment received.|participants|Number|212|212.0||||||
4051558|NCT01098461|3873058|B4|Asian - Japanese Heritage||Race/Ethnicity, Customized|Baseline data are reported for members of the Safety Population, comprised of all enrolled participants who received at least one dose of study treatment. Participants were analyzed according to treatment received.|participants|Number|53|53.0||||||
4051559|NCT01098461|3873059|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized|Baseline data are reported for members of the Safety Population, comprised of all enrolled participants who received at least one dose of study treatment. Participants were analyzed according to treatment received.|participants|Number|54|54.0||||||
4051560|NCT01098461|3873060|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized|Baseline data are reported for members of the Safety Population, comprised of all enrolled participants who received at least one dose of study treatment. Participants were analyzed according to treatment received.|participants|Number|52|52.0||||||
4051561|NCT01098461|3873061|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized|Baseline data are reported for members of the Safety Population, comprised of all enrolled participants who received at least one dose of study treatment. Participants were analyzed according to treatment received.|participants|Number|53|53.0||||||
4051562|NCT01098461|3873057|B5||Male|Gender|Baseline data are reported for members of the Safety Population, comprised of all enrolled participants who received at least one dose of study treatment. Participants were analyzed according to treatment received.|Participants|Count of Participants|148|148.0||||||
4051563|NCT01098461|3873058|B4||Male|Gender|Baseline data are reported for members of the Safety Population, comprised of all enrolled participants who received at least one dose of study treatment. Participants were analyzed according to treatment received.|Participants|Count of Participants|41|41.0||||||
4051564|NCT01098461|3873059|B3||Male|Gender|Baseline data are reported for members of the Safety Population, comprised of all enrolled participants who received at least one dose of study treatment. Participants were analyzed according to treatment received.|Participants|Count of Participants|38|38.0||||||
4051565|NCT01098461|3873060|B2||Male|Gender|Baseline data are reported for members of the Safety Population, comprised of all enrolled participants who received at least one dose of study treatment. Participants were analyzed according to treatment received.|Participants|Count of Participants|32|32.0||||||
4051566|NCT01098461|3873061|B1||Male|Gender|Baseline data are reported for members of the Safety Population, comprised of all enrolled participants who received at least one dose of study treatment. Participants were analyzed according to treatment received.|Participants|Count of Participants|37|37.0||||||
4051567|NCT01098461|3873057|B5||Female|Gender|Baseline data are reported for members of the Safety Population, comprised of all enrolled participants who received at least one dose of study treatment. Participants were analyzed according to treatment received.|Participants|Count of Participants|64|64.0||||||
4051568|NCT01098461|3873058|B4||Female|Gender|Baseline data are reported for members of the Safety Population, comprised of all enrolled participants who received at least one dose of study treatment. Participants were analyzed according to treatment received.|Participants|Count of Participants|12|12.0||||||
4051569|NCT01098461|3873059|B3||Female|Gender|Baseline data are reported for members of the Safety Population, comprised of all enrolled participants who received at least one dose of study treatment. Participants were analyzed according to treatment received.|Participants|Count of Participants|16|16.0||||||
4051570|NCT01098461|3873060|B2||Female|Gender|Baseline data are reported for members of the Safety Population, comprised of all enrolled participants who received at least one dose of study treatment. Participants were analyzed according to treatment received.|Participants|Count of Participants|20|20.0||||||
4051571|NCT01098461|3873061|B1||Female|Gender|Baseline data are reported for members of the Safety Population, comprised of all enrolled participants who received at least one dose of study treatment. Participants were analyzed according to treatment received.|Participants|Count of Participants|16|16.0||||||
4051572|NCT01098461|3873057|B5|||Age|Baseline data are reported for members of the Safety Population, comprised of all enrolled participants who received at least one dose of study treatment. Participants were analyzed according to treatment received.|Years|Mean|57.0|57.0|Standard Deviation|10.00|10.0|||
4051573|NCT01098461|3873058|B4|||Age|Baseline data are reported for members of the Safety Population, comprised of all enrolled participants who received at least one dose of study treatment. Participants were analyzed according to treatment received.|Years|Mean|59.1|59.1|Standard Deviation|8.49|8.49|||
4051574|NCT01098461|3873059|B3|||Age|Baseline data are reported for members of the Safety Population, comprised of all enrolled participants who received at least one dose of study treatment. Participants were analyzed according to treatment received.|Years|Mean|58.0|58.0|Standard Deviation|9.30|9.3|||
4051575|NCT01098461|3873060|B2|||Age|Baseline data are reported for members of the Safety Population, comprised of all enrolled participants who received at least one dose of study treatment. Participants were analyzed according to treatment received.|Years|Mean|53.3|53.3|Standard Deviation|10.29|10.29|||
4051576|NCT01098461|3873061|B1|||Age|Baseline data are reported for members of the Safety Population, comprised of all enrolled participants who received at least one dose of study treatment. Participants were analyzed according to treatment received.|Years|Mean|57.5|57.5|Standard Deviation|11.06|11.06|||
4051577|NCT01098318|3873094|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4051578|NCT01098318|3873095|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4051579|NCT01098318|3873096|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4051580|NCT01098318|3873097|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4051581|NCT01098318|3873094|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4051582|NCT01098318|3873095|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4051583|NCT01098318|3873096|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4051584|NCT01098318|3873097|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4051585|NCT01098318|3873094|B4|||Age||years|Mean|45.0|45.0|Standard Deviation|15.5|15.5|||
4051586|NCT01098318|3873095|B3|||Age||years|Mean|46.7|46.7|Standard Deviation|15.2|15.2|||
4051587|NCT01098318|3873096|B2|||Age||years|Mean|41.4|41.4|Standard Deviation|14.6|14.6|||
4051588|NCT01098318|3873097|B1|||Age||years|Mean|46.9|46.9|Standard Deviation|16.9|16.9|||
4051589|NCT01098305|3873122|B3||Male|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4051590|NCT01098305|3873123|B2||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4051591|NCT01098305|3873124|B1||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4051592|NCT01098305|3873122|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4051593|NCT01098305|3873123|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4051594|NCT01098305|3873124|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4051595|NCT01098305|3873122|B3|||Age||years|Mean|34.2|34.2|Standard Deviation|9.2|9.2|||
4051596|NCT01098305|3873123|B2|||Age||years|Mean|34.7|34.7|Standard Deviation|9.9|9.9|||
4051597|NCT01098305|3873124|B1|||Age||years|Mean|33.8|33.8|Standard Deviation|8.4|8.4|||
4051598|NCT01098253|3873133|B3|United States||Region of Enrollment||participants|Number|182|182.0||||||
4051599|NCT01098253|3873134|B2|United States||Region of Enrollment||participants|Number|88|88.0||||||
4051600|NCT01098253|3873135|B1|United States||Region of Enrollment||participants|Number|94|94.0||||||
4051601|NCT01098253|3873133|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4051602|NCT01098253|3873134|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4051603|NCT01098253|3873135|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4051604|NCT01098253|3873133|B3||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4051605|NCT01098253|3873134|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4051606|NCT01098253|3873135|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4051607|NCT01098253|3873133|B3|||Age||Years|Mean|57.4|57.4|Standard Deviation|10.3|10.3|||
4051608|NCT01098253|3873134|B2|||Age||Years|Mean|57.1|57.1|Standard Deviation|9.6|9.6|||
4051609|NCT01098253|3873135|B1|||Age||Years|Mean|57.8|57.8|Standard Deviation|9.4|9.4|||
4051610|NCT01098240|3873144|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4051611|NCT01098240|3873144|B1||Female|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
4051612|NCT01098240|3873144|B1|Greater than or equal to (>=) 65 years||Age, Customized||Participants|Number|3|3.0||||||
4051613|NCT01098240|3873144|B1|45 to 64 years||Age, Customized||Participants|Number|181|181.0||||||
4051614|NCT01098240|3873144|B1|18 to 44 years||Age, Customized||Participants|Number|113|113.0||||||
4051615|NCT01098162|3873176|B1|Germany||Region of Enrollment||participants|Number|520|520.0||||||
4051616|NCT01098162|3873176|B1|Other Race||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4051617|NCT01098162|3873176|B1|Black African||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4051618|NCT01098162|3873176|B1|Arabic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4051619|NCT01098162|3873176|B1|Asiatic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4051620|NCT01098162|3873176|B1|South European||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4051621|NCT01098162|3873176|B1|North/Middle European||Race/Ethnicity, Customized||participants|Number|484|484.0||||||
4051622|NCT01098162|3873176|B1||Male|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
4051623|NCT01098162|3873176|B1||Female|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
4051624|NCT01098162|3873176|B1|>= 65 years||Age, Customized||participants|Number|94|94.0||||||
4051625|NCT01098162|3873176|B1|> 18 years to <= 64 years||Age, Customized||participants|Number|419|419.0||||||
4051626|NCT01098162|3873176|B1|>= 16 years to <= 18 years||Age, Customized||participants|Number|7|7.0||||||
4051627|NCT01098162|3873176|B1|< 16 years||Age, Customized||participants|Number|0|0.0||||||
4051628|NCT01098162|3873176|B1|||Age||years|Mean|47.1|47.1|Standard Deviation|17.0|17.0|||
4051629|NCT01098110|3873185|B4||Male|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
4051630|NCT01098110|3873186|B3||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4051631|NCT01098110|3873187|B2||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4051632|NCT01098110|3873188|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4051633|NCT01098110|3873185|B4||Female|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4051634|NCT01098110|3873186|B3||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4051635|NCT01098110|3873187|B2||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4051636|NCT01098110|3873188|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4051637|NCT01098110|3873185|B4|||Age||Years|Mean|41.42|41.42|Standard Deviation|11.45|11.45|||
4051638|NCT01098110|3873186|B3|||Age||Years|Mean|41.11|41.11|Standard Deviation|12.27|12.27|||
4051639|NCT01098110|3873187|B2|||Age||Years|Mean|41.72|41.72|Standard Deviation|11.10|11.1|||
4051640|NCT01098110|3873188|B1|||Age||Years|Mean|41.41|41.41|Standard Deviation|11.00|11.0|||
4051641|NCT01098097|3873231|B1|Previous non-response type not known||Previous non-response type|Participants in the study previously failed to respond with a sustained virologic response to treatment with interferon alpha with or without ribavirin. The type of previous non-response was categorized at study baseline.|participants|Number|6|6.0||||||
4051642|NCT01098097|3873231|B1|Relapse||Previous non-response type|Participants in the study previously failed to respond with a sustained virologic response to treatment with interferon alpha with or without ribavirin. The type of previous non-response was categorized at study baseline.|participants|Number|544|544.0||||||
4051643|NCT01098097|3873231|B1|Virologic breakthrough||Previous non-response type|Participants in the study previously failed to respond with a sustained virologic response to treatment with interferon alpha with or without ribavirin. The type of previous non-response was categorized at study baseline.|participants|Number|67|67.0||||||
4051644|NCT01098097|3873231|B1|Null responder||Previous non-response type|Participants in the study previously failed to respond with a sustained virologic response to treatment with interferon alpha with or without ribavirin. The type of previous non-response was categorized at study baseline.|participants|Number|346|346.0||||||
4051645|NCT01098097|3873231|B1||Male|Sex: Female, Male||Participants|Count of Participants|543|543.0||||||
4051646|NCT01098097|3873231|B1||Female|Sex: Female, Male||Participants|Count of Participants|420|420.0||||||
4051647|NCT01098097|3873231|B1|||Age||years|Median|50|50.0|Full Range|||18.0|78.0|
4051648|NCT01098071|3873240|B1|Lebanon||Region of Enrollment||participants|Number|34|34.0||||||
4051649|NCT01098071|3873240|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4051650|NCT01098071|3873240|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4051651|NCT01098071|3873240|B1|||Age, Customized||Years|Mean|4.84|4.84|Full Range|||0.5|9.25|
4051652|NCT01098032|3873251|B3|Italy||Region of Enrollment||participants|Number|292|292.0||||||
4051653|NCT01098032|3873252|B2|Italy||Region of Enrollment||participants|Number|146|146.0||||||
4051654|NCT01098032|3873253|B1|Italy||Region of Enrollment||participants|Number|146|146.0||||||
4051655|NCT01098032|3873251|B3||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4051656|NCT01098032|3873252|B2||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4051657|NCT01098032|3873253|B1||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4051658|NCT01098032|3873251|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4051659|NCT01098032|3873252|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4051660|NCT01098032|3873253|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4051661|NCT01098032|3873251|B3|||Age||years|Mean|75|75.0|Standard Deviation|8|8.0|||
4051662|NCT01098032|3873252|B2|||Age||years|Mean|76|76.0|Standard Deviation|8|8.0|||
4051663|NCT01098032|3873253|B1|||Age||years|Mean|75|75.0|Standard Deviation|9|9.0|||
4051664|NCT01098032|3873251|B3||>=65 years|Age||Participants|Count of Participants|260|260.0||||||
4051665|NCT01098032|3873252|B2||>=65 years|Age||Participants|Count of Participants|133|133.0||||||
4051666|NCT01098032|3873253|B1||>=65 years|Age||Participants|Count of Participants|127|127.0||||||
4051667|NCT01098032|3873251|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4051668|NCT01098032|3873252|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4051669|NCT01098032|3873253|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4051670|NCT01098032|3873251|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4051671|NCT01098032|3873252|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4051672|NCT01098032|3873253|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4051673|NCT01098006|3873260|B5|Geographic Ancestry|Other: Latino|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4051674|NCT01098006|3873261|B4|Geographic Ancestry|Other: Latino|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4051675|NCT01098006|3873262|B3|Geographic Ancestry|Other: Latino|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4051676|NCT01098006|3873263|B2|Geographic Ancestry|Other: Latino|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4051677|NCT01098006|3873264|B1|Geographic Ancestry|Other: Latino|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4051678|NCT01098006|3873260|B5|Geographic Ancestry|Other: Kazakstan|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4051679|NCT01098006|3873261|B4|Geographic Ancestry|Other: Kazakstan|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4051680|NCT01098006|3873262|B3|Geographic Ancestry|Other: Kazakstan|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4051681|NCT01098006|3873263|B2|Geographic Ancestry|Other: Kazakstan|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4051682|NCT01098006|3873264|B1|Geographic Ancestry|Other: Kazakstan|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4051927|NCT01097616|3873536|B1||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4051683|NCT01098006|3873260|B5|Geographic Ancestry|White-Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
4051684|NCT01098006|3873261|B4|Geographic Ancestry|White-Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4051685|NCT01098006|3873262|B3|Geographic Ancestry|White-Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
4051686|NCT01098006|3873263|B2|Geographic Ancestry|White-Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4051687|NCT01098006|3873264|B1|Geographic Ancestry|White-Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4051688|NCT01098006|3873260|B5|Geographic Ancestry|White-Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
4051689|NCT01098006|3873261|B4|Geographic Ancestry|White-Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4051690|NCT01098006|3873262|B3|Geographic Ancestry|White-Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4051691|NCT01098006|3873263|B2|Geographic Ancestry|White-Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4051692|NCT01098006|3873264|B1|Geographic Ancestry|White-Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4051693|NCT01098006|3873260|B5|Geographic Ancestry|Asian-East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4051694|NCT01098006|3873261|B4|Geographic Ancestry|Asian-East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4051695|NCT01098006|3873262|B3|Geographic Ancestry|Asian-East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4051696|NCT01098006|3873263|B2|Geographic Ancestry|Asian-East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4051697|NCT01098006|3873264|B1|Geographic Ancestry|Asian-East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4051698|NCT01098006|3873260|B5|Geographic Ancestry|Asian-Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4051699|NCT01098006|3873261|B4|Geographic Ancestry|Asian-Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4051700|NCT01098006|3873262|B3|Geographic Ancestry|Asian-Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4051701|NCT01098006|3873263|B2|Geographic Ancestry|Asian-Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4051702|NCT01098006|3873264|B1|Geographic Ancestry|Asian-Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4051703|NCT01098006|3873260|B5|Geographic Ancestry|African heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
4051704|NCT01098006|3873261|B4|Geographic Ancestry|African heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4051705|NCT01098006|3873262|B3|Geographic Ancestry|African heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
4051706|NCT01098006|3873263|B2|Geographic Ancestry|African heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4051707|NCT01098006|3873264|B1|Geographic Ancestry|African heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4051708|NCT01098006|3873260|B5||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4051709|NCT01098006|3873261|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4051710|NCT01098006|3873262|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4051711|NCT01098006|3873263|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4051712|NCT01098006|3873264|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4051713|NCT01098006|3873260|B5||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4051714|NCT01098006|3873261|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4051715|NCT01098006|3873262|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4051716|NCT01098006|3873263|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4051717|NCT01098006|3873264|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4051718|NCT01098006|3873260|B5|||Age||Years|Mean|36.43|36.43|Standard Deviation|11.19|11.19|||
4051719|NCT01098006|3873261|B4|||Age||Years|Mean|39.7|39.7|Standard Deviation|15.1|15.1|||
4051720|NCT01098006|3873262|B3|||Age||Years|Mean|36.9|36.9|Standard Deviation|8.7|8.7|||
4051721|NCT01098006|3873263|B2|||Age||Years|Mean|34.0|34.0|Standard Deviation|14.2|14.2|||
4051722|NCT01098006|3873264|B1|||Age||Years|Mean|26.4|26.4|Standard Deviation|6.0|6.0|||
4051723|NCT01097915|3873341|B4|||healthy volunteers||participants|Number|170|170.0||||||
4051724|NCT01097915|3873342|B3|||healthy volunteers||participants|Number|50|50.0||||||
4051725|NCT01097915|3873343|B2|||healthy volunteers||participants|Number|70|70.0||||||
4051726|NCT01097915|3873344|B1|||healthy volunteers||participants|Number|50|50.0||||||
4051727|NCT01097915|3873341|B4|Italy||Region of Enrollment||participants|Number|170|170.0||||||
4051728|NCT01097915|3873342|B3|Italy||Region of Enrollment||participants|Number|50|50.0||||||
4051729|NCT01097915|3873343|B2|Italy||Region of Enrollment||participants|Number|70|70.0||||||
4051730|NCT01097915|3873344|B1|Italy||Region of Enrollment||participants|Number|50|50.0||||||
4051731|NCT01097915|3873341|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051732|NCT01097915|3873342|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051733|NCT01097915|3873343|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051734|NCT01097915|3873344|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051735|NCT01097915|3873341|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051736|NCT01097915|3873342|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051737|NCT01097915|3873343|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051738|NCT01097915|3873344|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051739|NCT01097915|3873341|B4||White|Race (NIH/OMB)||Participants|Count of Participants|170|170.0||||||
4051740|NCT01097915|3873342|B3||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4051741|NCT01097915|3873343|B2||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4051742|NCT01097915|3873344|B1||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4051743|NCT01097915|3873341|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051744|NCT01097915|3873342|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051745|NCT01097915|3873343|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051746|NCT01097915|3873344|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051747|NCT01097915|3873341|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051748|NCT01097915|3873342|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051749|NCT01097915|3873343|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051750|NCT01097915|3873344|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051751|NCT01097915|3873341|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051752|NCT01097915|3873342|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051753|NCT01097915|3873343|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051754|NCT01097915|3873344|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051755|NCT01097915|3873341|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051756|NCT01097915|3873342|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051757|NCT01097915|3873343|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051758|NCT01097915|3873344|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051759|NCT01097915|3873341|B4||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4051760|NCT01097915|3873342|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4051761|NCT01097915|3873343|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4051762|NCT01097915|3873344|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4051763|NCT01097915|3873341|B4||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4051764|NCT01097915|3873342|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4051765|NCT01097915|3873343|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4051766|NCT01097915|3873344|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4051767|NCT01097915|3873341|B4|||Age||years|Mean|25|25.0|Standard Deviation|7|7.0|||
4051768|NCT01097915|3873342|B3|||Age||years|Mean|25|25.0|Standard Deviation|6|6.0|||
4051769|NCT01097915|3873343|B2|||Age||years|Mean|25|25.0|Standard Deviation|8|8.0|||
4051770|NCT01097915|3873344|B1|||Age||years|Mean|25|25.0|Standard Deviation|7|7.0|||
4051771|NCT01097915|3873341|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4051772|NCT01097915|3873342|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4051773|NCT01097915|3873343|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4051774|NCT01097915|3873344|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4051775|NCT01097915|3873341|B4||Between 18 and 65 years|Age||Participants|Count of Participants|170|170.0||||||
4051776|NCT01097915|3873342|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4051777|NCT01097915|3873343|B2||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4051778|NCT01097915|3873344|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4051779|NCT01097915|3873341|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4051780|NCT01097915|3873342|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4051781|NCT01097915|3873343|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4051782|NCT01097915|3873344|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4051783|NCT01097863|3873368|B4||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4051784|NCT01097863|3873369|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4051785|NCT01097863|3873370|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4051786|NCT01097863|3873371|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4051787|NCT01097863|3873368|B4||Female|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4051788|NCT01097863|3873369|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4051789|NCT01097863|3873370|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4051790|NCT01097863|3873371|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4051791|NCT01097863|3873368|B4|||Age||years|Mean|34.5|34.5|Standard Deviation|11.1|11.1|||
4051792|NCT01097863|3873369|B3|||Age||years|Mean|34.1|34.1|Standard Deviation|10.8|10.8|||
4051793|NCT01097863|3873370|B2|||Age||years|Mean|33.3|33.3|Standard Deviation|11.7|11.7|||
4051794|NCT01097863|3873371|B1|||Age||years|Mean|36.2|36.2|Standard Deviation|10.6|10.6|||
4051795|NCT01097785|3873381|B3|||Muscle Sympathetic Nerve Activity||bursts/100 heartbeats|Mean|52|52.0|Standard Deviation|14|14.0|||
4051796|NCT01097785|3873382|B2|||Muscle Sympathetic Nerve Activity||bursts/100 heartbeats|Mean|59|59.0|Standard Deviation|13|13.0|||
4051797|NCT01097785|3873383|B1|||Muscle Sympathetic Nerve Activity||bursts/100 heartbeats|Mean|45|45.0|Standard Deviation|14|14.0|||
4051798|NCT01097785|3873381|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4051799|NCT01097785|3873382|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4051800|NCT01097785|3873383|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4051801|NCT01097785|3873381|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4051802|NCT01097785|3873382|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4051803|NCT01097785|3873383|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4051804|NCT01097785|3873381|B3|||Age||years|Mean|51|51.0|Standard Deviation|3|3.0|||
4051805|NCT01097785|3873382|B2|||Age||years|Mean|51|51.0|Standard Deviation|3|3.0|||
4051806|NCT01097785|3873383|B1|||Age||years|Mean|51|51.0|Standard Deviation|3|3.0|||
4051807|NCT01097694|3873392|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
4051808|NCT01097694|3873393|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4051809|NCT01097694|3873394|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4051810|NCT01097694|3873392|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4051811|NCT01097694|3873393|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4051812|NCT01097694|3873394|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051813|NCT01097694|3873392|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051814|NCT01097694|3873393|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051815|NCT01097694|3873394|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051816|NCT01097694|3873392|B3||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4051817|NCT01097694|3873393|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4051818|NCT01097694|3873394|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4051819|NCT01097694|3873392|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4051820|NCT01097694|3873393|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4051821|NCT01097694|3873394|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4051822|NCT01097694|3873392|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051823|NCT01097694|3873393|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051824|NCT01097694|3873394|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051825|NCT01097694|3873392|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4051826|NCT01097694|3873393|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4051827|NCT01097694|3873394|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4051828|NCT01097694|3873392|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051829|NCT01097694|3873393|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051830|NCT01097694|3873394|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051831|NCT01097694|3873392|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051832|NCT01097694|3873393|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051833|NCT01097694|3873394|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051834|NCT01097694|3873392|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4051835|NCT01097694|3873393|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4051836|NCT01097694|3873394|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4051837|NCT01097694|3873392|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4051838|NCT01097694|3873393|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4051839|NCT01097694|3873394|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4051840|NCT01097694|3873392|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4051841|NCT01097694|3873393|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4051842|NCT01097694|3873394|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4051843|NCT01097694|3873392|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4051844|NCT01097694|3873393|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4051845|NCT01097694|3873394|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4051846|NCT01097694|3873392|B3|||Age||years|Mean|40.1|40.1|Standard Deviation|11.1|11.1|||
4051847|NCT01097694|3873393|B2|||Age||years|Mean|37.7|37.7|Standard Deviation|11.8|11.8|||
4051848|NCT01097694|3873394|B1|||Age||years|Mean|40.2|40.2|Standard Deviation|10.2|10.2|||
4051849|NCT01097694|3873392|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4051850|NCT01097694|3873393|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4051851|NCT01097694|3873394|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4051852|NCT01097694|3873392|B3||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4051853|NCT01097694|3873393|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4051854|NCT01097694|3873394|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4051855|NCT01097694|3873392|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4051856|NCT01097694|3873393|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4051857|NCT01097694|3873394|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4051858|NCT01097668|3873455|B3|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
4051859|NCT01097668|3873456|B2|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4051860|NCT01097668|3873457|B1|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
4051861|NCT01097668|3873455|B3|Russian Federation||Region of Enrollment||participants|Number|34|34.0||||||
4051862|NCT01097668|3873456|B2|Russian Federation||Region of Enrollment||participants|Number|20|20.0||||||
4051863|NCT01097668|3873457|B1|Russian Federation||Region of Enrollment||participants|Number|14|14.0||||||
4051864|NCT01097668|3873455|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4051865|NCT01097668|3873456|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4051866|NCT01097668|3873457|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4051867|NCT01097668|3873455|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4051868|NCT01097668|3873456|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4051869|NCT01097668|3873457|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4051870|NCT01097668|3873455|B3|||Age||years|Mean|32.3|32.3|Full Range|||18.0|53.0|
4051871|NCT01097668|3873456|B2|||Age||years|Mean|31.6|31.6|Full Range|||18.0|52.0|
4051872|NCT01097668|3873457|B1|||Age||years|Mean|33.0|33.0|Full Range|||22.0|53.0|
4051873|NCT01097655|3873468|B1||Male|Sex: Female, Male||Participants|Count of Participants|2444|2444.0||||||
4051874|NCT01097655|3873468|B1||Female|Sex: Female, Male||Participants|Count of Participants|595|595.0||||||
4051875|NCT01097655|3873468|B1|||Age||years|Mean|40.7|40.7|Standard Deviation|10.1|10.1|||
4051876|NCT01097629|3873475|B4|||Latency to Onset of Persistent Sleep (LPS)|N=150, 299, 295, 744 for Suvorexant Low Dose, Suvorexant High Dose, Placebo and Total, respectively. LPS was assessed during sleep laboratory (PSG) assessment, which was conducted in a subset of the study population.|minutes|Mean|67.2|67.2|Standard Deviation|46.2|46.2|||
4051877|NCT01097629|3873476|B3|||Latency to Onset of Persistent Sleep (LPS)|N=150, 299, 295, 744 for Suvorexant Low Dose, Suvorexant High Dose, Placebo and Total, respectively. LPS was assessed during sleep laboratory (PSG) assessment, which was conducted in a subset of the study population.|minutes|Mean|68.0|68.0|Standard Deviation|42.8|42.8|||
4051878|NCT01097629|3873477|B2|||Latency to Onset of Persistent Sleep (LPS)|N=150, 299, 295, 744 for Suvorexant Low Dose, Suvorexant High Dose, Placebo and Total, respectively. LPS was assessed during sleep laboratory (PSG) assessment, which was conducted in a subset of the study population.|minutes|Mean|67.3|67.3|Standard Deviation|48.8|48.8|||
4051879|NCT01097629|3873478|B1|||Latency to Onset of Persistent Sleep (LPS)|N=150, 299, 295, 744 for Suvorexant Low Dose, Suvorexant High Dose, Placebo and Total, respectively. LPS was assessed during sleep laboratory (PSG) assessment, which was conducted in a subset of the study population.|minutes|Mean|65.3|65.3|Standard Deviation|47.8|47.8|||
4051880|NCT01097629|3873475|B4|||Mean Subjective Time to Sleep Onset (sTSOm)|N=238, 386, 383, 1007 for Suvorexant Low Dose, Suvorexant High Dose, Placebo and Total, respectively.|minutes|Mean|79.8|79.8|Standard Deviation|71.5|71.5|||
4051881|NCT01097629|3873476|B3|||Mean Subjective Time to Sleep Onset (sTSOm)|N=238, 386, 383, 1007 for Suvorexant Low Dose, Suvorexant High Dose, Placebo and Total, respectively.|minutes|Mean|81.3|81.3|Standard Deviation|76.2|76.2|||
4051882|NCT01097629|3873477|B2|||Mean Subjective Time to Sleep Onset (sTSOm)|N=238, 386, 383, 1007 for Suvorexant Low Dose, Suvorexant High Dose, Placebo and Total, respectively.|minutes|Mean|74.4|74.4|Standard Deviation|61.9|61.9|||
4051883|NCT01097629|3873478|B1|||Mean Subjective Time to Sleep Onset (sTSOm)|N=238, 386, 383, 1007 for Suvorexant Low Dose, Suvorexant High Dose, Placebo and Total, respectively.|minutes|Mean|86.0|86.0|Standard Deviation|77.6|77.6|||
4051884|NCT01097629|3873475|B4|||Wakefulness After Persistent Sleep Onset (WASO)|N=150, 299, 295, 744 for Suvorexant Low Dose, Suvorexant High Dose, Placebo and Total, respectively. WASO was assessed during sleep laboratory (polysomnography [PSG]) assessment, which was conducted in a subset of the study population.|minutes|Mean|119.0|119.0|Standard Deviation|50.3|50.3|||
4051885|NCT01097629|3873476|B3|||Wakefulness After Persistent Sleep Onset (WASO)|N=150, 299, 295, 744 for Suvorexant Low Dose, Suvorexant High Dose, Placebo and Total, respectively. WASO was assessed during sleep laboratory (polysomnography [PSG]) assessment, which was conducted in a subset of the study population.|minutes|Mean|118.4|118.4|Standard Deviation|49.1|49.1|||
4051886|NCT01097629|3873477|B2|||Wakefulness After Persistent Sleep Onset (WASO)|N=150, 299, 295, 744 for Suvorexant Low Dose, Suvorexant High Dose, Placebo and Total, respectively. WASO was assessed during sleep laboratory (polysomnography [PSG]) assessment, which was conducted in a subset of the study population.|minutes|Mean|119.4|119.4|Standard Deviation|51.3|51.3|||
4051887|NCT01097629|3873478|B1|||Wakefulness After Persistent Sleep Onset (WASO)|N=150, 299, 295, 744 for Suvorexant Low Dose, Suvorexant High Dose, Placebo and Total, respectively. WASO was assessed during sleep laboratory (polysomnography [PSG]) assessment, which was conducted in a subset of the study population.|minutes|Mean|119.6|119.6|Standard Deviation|50.8|50.8|||
4051888|NCT01097629|3873475|B4|||Mean Subjective Total Sleep Time (sTSTm)|N=238, 386, 383, 1007 for Suvorexant Low Dose, Suvorexant High Dose, Placebo and Total, respectively.|minutes|Mean|309.2|309.2|Standard Deviation|78.4|78.4|||
4051889|NCT01097629|3873476|B3|||Mean Subjective Total Sleep Time (sTSTm)|N=238, 386, 383, 1007 for Suvorexant Low Dose, Suvorexant High Dose, Placebo and Total, respectively.|minutes|Mean|309.7|309.7|Standard Deviation|77.1|77.1|||
4051890|NCT01097629|3873477|B2|||Mean Subjective Total Sleep Time (sTSTm)|N=238, 386, 383, 1007 for Suvorexant Low Dose, Suvorexant High Dose, Placebo and Total, respectively.|minutes|Mean|315.3|315.3|Standard Deviation|77.0|77.0|||
4051928|NCT01097616|3873533|B4|||Age||years|Mean|56|56.0|Standard Deviation|15|15.0|||
4051891|NCT01097629|3873478|B1|||Mean Subjective Total Sleep Time (sTSTm)|N=238, 386, 383, 1007 for Suvorexant Low Dose, Suvorexant High Dose, Placebo and Total, respectively.|minutes|Mean|298.3|298.3|Standard Deviation|81.9|81.9|||
4051892|NCT01097629|3873475|B4||Male|Sex: Female, Male||Participants|Count of Participants|338|338.0||||||
4051893|NCT01097629|3873476|B3||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4051894|NCT01097629|3873477|B2||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4051895|NCT01097629|3873478|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4051896|NCT01097629|3873475|B4||Female|Sex: Female, Male||Participants|Count of Participants|671|671.0||||||
4051897|NCT01097629|3873476|B3||Female|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
4051898|NCT01097629|3873477|B2||Female|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
4051899|NCT01097629|3873478|B1||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4051900|NCT01097629|3873475|B4|||Age||years|Mean|56|56.0|Standard Deviation|15|15.0|||
4051901|NCT01097629|3873476|B3|||Age||years|Mean|57|57.0|Standard Deviation|15|15.0|||
4051902|NCT01097629|3873477|B2|||Age||years|Mean|57|57.0|Standard Deviation|15|15.0|||
4051903|NCT01097629|3873478|B1|||Age||years|Mean|56|56.0|Standard Deviation|16|16.0|||
4051904|NCT01097616|3873533|B4|||Latency to Onset of Persistent Sleep (LPS)|N=193, 291, 290, 774 for Suvorexant Low Dose, Suvorexant High Dose, Placebo and Total, respectively. LPS was assessed during sleep laboratory (PSG) assessment, which was conducted in a subset of the study population.|minutes|Mean|65.2|65.2|Standard Deviation|43.8|43.8|||
4051905|NCT01097616|3873534|B3|||Latency to Onset of Persistent Sleep (LPS)|N=193, 291, 290, 774 for Suvorexant Low Dose, Suvorexant High Dose, Placebo and Total, respectively. LPS was assessed during sleep laboratory (PSG) assessment, which was conducted in a subset of the study population.|minutes|Mean|66.2|66.2|Standard Deviation|44.1|44.1|20.5|347.5|
4051906|NCT01097616|3873535|B2|||Latency to Onset of Persistent Sleep (LPS)|N=193, 291, 290, 774 for Suvorexant Low Dose, Suvorexant High Dose, Placebo and Total, respectively. LPS was assessed during sleep laboratory (PSG) assessment, which was conducted in a subset of the study population.|minutes|Mean|61.8|61.8|Standard Deviation|39.1|39.1|20.5|259.0|
4051907|NCT01097616|3873536|B1|||Latency to Onset of Persistent Sleep (LPS)|N=193, 291, 290, 774 for Suvorexant Low Dose, Suvorexant High Dose, Placebo and Total, respectively. LPS was assessed during sleep laboratory (PSG) assessment, which was conducted in a subset of the study population.|minutes|Mean|68.9|68.9|Standard Deviation|49.7|49.7|20.5|335.0|
4051908|NCT01097616|3873533|B4|||Mean Subjective Time to Sleep Onset (sTSOm)|N=252, 383, 384, 1019 for Suvorexant Low Dose, Suvorexant High Dose, Placebo and Total, respectively.|minutes|Mean|66.4|66.4|Standard Deviation|43.6|43.6|||
4051909|NCT01097616|3873534|B3|||Mean Subjective Time to Sleep Onset (sTSOm)|N=252, 383, 384, 1019 for Suvorexant Low Dose, Suvorexant High Dose, Placebo and Total, respectively.|minutes|Mean|66.9|66.9|Standard Deviation|40.5|40.5|10.0|300.0|
4051910|NCT01097616|3873535|B2|||Mean Subjective Time to Sleep Onset (sTSOm)|N=252, 383, 384, 1019 for Suvorexant Low Dose, Suvorexant High Dose, Placebo and Total, respectively.|minutes|Mean|68.0|68.0|Standard Deviation|50.1|50.1|9.4|480.0|
4051911|NCT01097616|3873536|B1|||Mean Subjective Time to Sleep Onset (sTSOm)|N=252, 383, 384, 1019 for Suvorexant Low Dose, Suvorexant High Dose, Placebo and Total, respectively.|minutes|Mean|63.3|63.3|Standard Deviation|37.1|37.1|10.0|330.0|
4051912|NCT01097616|3873533|B4|||Wakefulness After Persistent Sleep Onset (WASO)|N=193, 291, 290, 774 for Suvorexant Low Dose, Suvorexant High Dose, Placebo and Total, respectively. WASO was assessed during sleep laboratory (polysomnography [PSG]) assessment, which was conducted in a subset of the study population.|minutes|Mean|117.0|117.0|Standard Deviation|47.4|47.4|||
4051913|NCT01097616|3873534|B3|||Wakefulness After Persistent Sleep Onset (WASO)|N=193, 291, 290, 774 for Suvorexant Low Dose, Suvorexant High Dose, Placebo and Total, respectively. WASO was assessed during sleep laboratory (polysomnography [PSG]) assessment, which was conducted in a subset of the study population.|minutes|Mean|114.9|114.9|Standard Deviation|45.7|45.7|45.5|309.9|
4051914|NCT01097616|3873535|B2|||Wakefulness After Persistent Sleep Onset (WASO)|N=193, 291, 290, 774 for Suvorexant Low Dose, Suvorexant High Dose, Placebo and Total, respectively. WASO was assessed during sleep laboratory (polysomnography [PSG]) assessment, which was conducted in a subset of the study population.|minutes|Mean|117.7|117.7|Standard Deviation|49.6|49.6|46.0|343.0|
4051915|NCT01097616|3873536|B1|||Wakefulness After Persistent Sleep Onset (WASO)|N=193, 291, 290, 774 for Suvorexant Low Dose, Suvorexant High Dose, Placebo and Total, respectively. WASO was assessed during sleep laboratory (polysomnography [PSG]) assessment, which was conducted in a subset of the study population.|minutes|Mean|119.2|119.2|Standard Deviation|46.5|46.5|46.0|322.5|
4051916|NCT01097616|3873533|B4|||Mean Subjective Total Sleep Time (sTSTm)|N=252, 383, 384, 1019 for Suvorexant Low Dose, Suvorexant High Dose, Placebo and Total, respectively.|minutes|Mean|317.5|317.5|Standard Deviation|64.1|64.1|||
4051917|NCT01097616|3873534|B3|||Mean Subjective Total Sleep Time (sTSTm)|N=252, 383, 384, 1019 for Suvorexant Low Dose, Suvorexant High Dose, Placebo and Total, respectively.|minutes|Mean|315.7|315.7|Standard Deviation|65.1|65.1|67.9|548.4|
4051918|NCT01097616|3873535|B2|||Mean Subjective Total Sleep Time (sTSTm)|N=252, 383, 384, 1019 for Suvorexant Low Dose, Suvorexant High Dose, Placebo and Total, respectively.|minutes|Mean|316.1|316.1|Standard Deviation|67.2|67.2|0.0|467.7|
4051919|NCT01097616|3873536|B1|||Mean Subjective Total Sleep Time (sTSTm)|N=252, 383, 384, 1019 for Suvorexant Low Dose, Suvorexant High Dose, Placebo and Total, respectively.|minutes|Mean|322.4|322.4|Standard Deviation|57.3|57.3|148.0|500.0|
4051920|NCT01097616|3873533|B4||Male|Sex: Female, Male||Participants|Count of Participants|384|384.0||||||
4051921|NCT01097616|3873534|B3||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4051922|NCT01097616|3873535|B2||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4051923|NCT01097616|3873536|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4051924|NCT01097616|3873533|B4||Female|Sex: Female, Male||Participants|Count of Participants|637|637.0||||||
4051925|NCT01097616|3873534|B3||Female|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4051926|NCT01097616|3873535|B2||Female|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4051929|NCT01097616|3873534|B3|||Age||years|Mean|56|56.0|Standard Deviation|15|15.0|||
4051930|NCT01097616|3873535|B2|||Age||years|Mean|56|56.0|Standard Deviation|15|15.0|||
4051931|NCT01097616|3873536|B1|||Age||years|Mean|55|55.0|Standard Deviation|16|16.0|||
4051932|NCT01097460|3873614|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4051933|NCT01097460|3873614|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051934|NCT01097460|3873614|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4051935|NCT01097460|3873614|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051936|NCT01097460|3873614|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4051937|NCT01097460|3873614|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051938|NCT01097460|3873614|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4051939|NCT01097460|3873614|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4051940|NCT01097460|3873614|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051941|NCT01097460|3873614|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051942|NCT01097460|3873614|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4051943|NCT01097460|3873614|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4051944|NCT01097460|3873614|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4051945|NCT01097460|3873614|B1|||Age||years|Median|54|54.0|Standard Deviation|11.12|11.12|||
4051946|NCT01097421|3873618|B1||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4051947|NCT01097421|3873618|B1||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4051948|NCT01097421|3873618|B1|||Age||Years|Mean|70.6|70.6|Standard Deviation|9.5|9.5|||
4051949|NCT01097343|3873628|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4051950|NCT01097343|3873628|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4051951|NCT01097343|3873628|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4051952|NCT01097343|3873628|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|13.2|13.2|||
4051953|NCT01097343|3873628|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4051954|NCT01097343|3873628|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4051955|NCT01097343|3873628|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4051956|NCT01097304|3873635|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4051957|NCT01097304|3873635|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4051958|NCT01097304|3873635|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4051959|NCT01097304|3873635|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|10.4|10.4|||
4051960|NCT01097304|3873635|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4051961|NCT01097304|3873635|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4051962|NCT01097304|3873635|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4051963|NCT01097057|3873642|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4051964|NCT01097057|3873642|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4051965|NCT01097057|3873642|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4051966|NCT01097057|3873642|B1|||Age||Years|Median|66|66.0|Full Range|||42.0|72.0|
4051967|NCT01097057|3873642|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4051968|NCT01097057|3873642|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4051969|NCT01097057|3873642|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4051970|NCT01097005|3873649|B1|unknown||Sex/Gender, Customized||participants|Number|1|1.0||||||
4051971|NCT01097005|3873649|B1|Male||Sex/Gender, Customized||participants|Number|83|83.0||||||
4051972|NCT01097005|3873649|B1|Female||Sex/Gender, Customized||participants|Number|256|256.0||||||
4051973|NCT01097005|3873649|B1|unknown||Age, Customized||participants|Number|1|1.0||||||
4051974|NCT01097005|3873649|B1|>=75 years||Age, Customized||participants|Number|62|62.0||||||
4051975|NCT01097005|3873649|B1|65-74 years||Age, Customized||participants|Number|126|126.0||||||
4051976|NCT01097005|3873649|B1|45-64 years||Age, Customized||participants|Number|136|136.0||||||
4051977|NCT01097005|3873649|B1|<45 years||Age, Customized||participants|Number|15|15.0||||||
4051978|NCT01096875|3873655|B3|Turkey||Region of Enrollment||participants|Number|60|60.0||||||
4051979|NCT01096875|3873656|B2|Turkey||Region of Enrollment||participants|Number|30|30.0||||||
4051980|NCT01096875|3873657|B1|Turkey||Region of Enrollment||participants|Number|30|30.0||||||
4051981|NCT01096875|3873655|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4051982|NCT01096875|3873656|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4051983|NCT01096875|3873657|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4051984|NCT01096875|3873655|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4051985|NCT01096875|3873656|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4051986|NCT01096875|3873657|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4051987|NCT01096875|3873655|B3|||Age||years|Mean|61.6|61.6|Standard Deviation|8.4|8.4|||
4051988|NCT01096875|3873656|B2|||Age||years|Mean|62.2|62.2|Standard Deviation|8.1|8.1|||
4051989|NCT01096875|3873657|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|8.6|8.6|||
4051990|NCT01096875|3873655|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4051991|NCT01096875|3873656|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4051992|NCT01096875|3873657|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4051993|NCT01096875|3873655|B3||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4051994|NCT01096875|3873656|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4051995|NCT01096875|3873657|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4051996|NCT01096875|3873655|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4051997|NCT01096875|3873656|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4051998|NCT01096875|3873657|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4051999|NCT01096849|3873670|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4052000|NCT01096849|3873671|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4052001|NCT01096849|3873672|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4052002|NCT01096849|3873673|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4052003|NCT01096849|3873670|B4||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4052004|NCT01096849|3873671|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4052005|NCT01096849|3873672|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4052006|NCT01096849|3873673|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4052007|NCT01096849|3873670|B4|||Age||years|Mean|42.6|42.6|Standard Deviation|15.53|15.53|||
4052008|NCT01096849|3873671|B3|||Age||years|Mean|44.8|44.8|Standard Deviation|14.61|14.61|||
4052009|NCT01096849|3873672|B2|||Age||years|Mean|40.00|40.0|Standard Deviation|15.02|15.02|||
4052010|NCT01096849|3873673|B1|||Age||years|Mean|46.5|46.5|Standard Deviation|18.12|18.12|||
4052011|NCT01096849|3873670|B4||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4052012|NCT01096849|3873671|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4052013|NCT01096849|3873672|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4052014|NCT01096849|3873673|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4052015|NCT01096849|3873670|B4||Between 18 and 65 years|Age||Participants|Count of Participants|131|131.0||||||
4052016|NCT01096849|3873671|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4052017|NCT01096849|3873672|B2||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
4052018|NCT01096849|3873673|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4052019|NCT01096849|3873670|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4052020|NCT01096849|3873671|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4052021|NCT01096849|3873672|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4052022|NCT01096849|3873673|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4052023|NCT01096823|3873728|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4052024|NCT01096823|3873729|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4052025|NCT01096823|3873730|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4052026|NCT01096823|3873728|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4052027|NCT01096823|3873729|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4052028|NCT01096823|3873730|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4052029|NCT01096823|3873728|B3|||Age||years|Mean|28.3|28.3|Standard Deviation|3.9|3.9|||
4052030|NCT01096823|3873729|B2|||Age||years|Mean|27.1|27.1|Standard Deviation|4.2|4.2|||
4052031|NCT01096823|3873730|B1|||Age||years|Mean|29.9|29.9|Standard Deviation|2.9|2.9|||
4052032|NCT01096810|3873743|B1|||Bone Marrow Plasmacytosis||percentage of participants|Number|38|38.0||||||
4052033|NCT01096810|3873743|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4052034|NCT01096810|3873743|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4052035|NCT01096810|3873743|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4052036|NCT01096810|3873743|B1|||Age||years|Median|58|58.0|Full Range|||22.0|75.0|
4052037|NCT01096784|3873749|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4052038|NCT01096784|3873750|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4052039|NCT01096784|3873751|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4052040|NCT01096784|3873749|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4052041|NCT01096784|3873750|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4052042|NCT01096784|3873751|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4052043|NCT01096784|3873749|B3|||Age||Weeks|Mean|25.61|25.61|Standard Deviation|1.300|1.3|||
4052044|NCT01096784|3873750|B2|||Age||Weeks|Mean|25.62|25.62|Standard Deviation|1.397|1.397|||
4052045|NCT01096784|3873751|B1|||Age||Weeks|Mean|25.60|25.6|Standard Deviation|1.207|1.207|||
4052046|NCT01096771|3873784|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4052047|NCT01096771|3873785|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4052048|NCT01096771|3873786|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4052049|NCT01096771|3873784|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052050|NCT01096771|3873785|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052051|NCT01096771|3873786|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052052|NCT01096771|3873784|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052053|NCT01096771|3873785|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052054|NCT01096771|3873786|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052055|NCT01096771|3873784|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4052056|NCT01096771|3873785|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4052057|NCT01096771|3873786|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4052058|NCT01096771|3873784|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4052059|NCT01096771|3873785|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4052060|NCT01096771|3873786|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052061|NCT01096771|3873784|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052062|NCT01096771|3873785|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052063|NCT01096771|3873786|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052064|NCT01096771|3873784|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052065|NCT01096771|3873785|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052066|NCT01096771|3873786|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052067|NCT01096771|3873784|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052068|NCT01096771|3873785|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052069|NCT01096771|3873786|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052070|NCT01096771|3873784|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4052071|NCT01096771|3873785|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4052072|NCT01096771|3873786|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4052073|NCT01096771|3873784|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4052074|NCT01096771|3873785|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4052075|NCT01096771|3873786|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4052076|NCT01096771|3873784|B3|||Age||years|Mean|62|62.0|Standard Deviation|12.66|12.66|||
4052077|NCT01096771|3873785|B2|||Age||years|Mean|60|60.0|Standard Deviation|14.55|14.55|||
4052078|NCT01096771|3873786|B1|||Age||years|Mean|64|64.0|Standard Deviation|11.24|11.24|||
4052079|NCT01096680|3873811|B6|United States||Region of Enrollment||participants|Number|135|135.0||||||
4052080|NCT01096680|3873812|B5|United States||Region of Enrollment||participants|Number|27|27.0||||||
4052081|NCT01096680|3873813|B4|United States||Region of Enrollment||participants|Number|27|27.0||||||
4052082|NCT01096680|3873814|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
4052083|NCT01096680|3873815|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4052084|NCT01096680|3873816|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4052085|NCT01096680|3873811|B6||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4052086|NCT01096680|3873812|B5||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4052087|NCT01096680|3873813|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4052088|NCT01096680|3873814|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4052089|NCT01096680|3873815|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4052090|NCT01096680|3873816|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4052091|NCT01096680|3873811|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4052092|NCT01096680|3873812|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4052093|NCT01096680|3873813|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4052094|NCT01096680|3873814|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4052095|NCT01096680|3873815|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4052096|NCT01096680|3873816|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4052097|NCT01096680|3873811|B6|18 to 40 years||Age, Customized||participants|Number|135|135.0||||||
4052098|NCT01096680|3873812|B5|18 to 40 years||Age, Customized||participants|Number|27|27.0||||||
4052099|NCT01096680|3873813|B4|18 to 40 years||Age, Customized||participants|Number|27|27.0||||||
4052100|NCT01096680|3873814|B3|18 to 40 years||Age, Customized||participants|Number|27|27.0||||||
4052101|NCT01096680|3873815|B2|18 to 40 years||Age, Customized||participants|Number|27|27.0||||||
4052102|NCT01096680|3873816|B1|18 to 40 years||Age, Customized||participants|Number|27|27.0||||||
4052103|NCT01096680|3873811|B6|||Age||years|Mean|27.7|27.7|Standard Deviation|5.62|5.62|||
4052104|NCT01096680|3873812|B5|||Age||years|Mean|28.1|28.1|Standard Deviation|6.83|6.83|||
4052105|NCT01096680|3873813|B4|||Age||years|Mean|27.0|27.0|Standard Deviation|5.09|5.09|||
4052106|NCT01096680|3873814|B3|||Age||years|Mean|28.3|28.3|Standard Deviation|5.04|5.04|||
4052107|NCT01096680|3873815|B2|||Age||years|Mean|28.7|28.7|Standard Deviation|5.95|5.95|||
4052108|NCT01096680|3873816|B1|||Age||years|Mean|26.4|26.4|Standard Deviation|5.03|5.03|||
4052109|NCT01096667|3873852|B6||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4052110|NCT01096667|3873853|B5||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4052111|NCT01096667|3873854|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4052112|NCT01096667|3873855|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4052113|NCT01096667|3873856|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4052114|NCT01096667|3873857|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4052115|NCT01096667|3873852|B6||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4052116|NCT01096667|3873853|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4052117|NCT01096667|3873854|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4052118|NCT01096667|3873855|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4052119|NCT01096667|3873856|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4052120|NCT01096667|3873857|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4052121|NCT01096667|3873852|B6|65 years and older||Age, Customized||Participants|Number|9|9.0||||||
4052122|NCT01096667|3873853|B5|65 years and older||Age, Customized||Participants|Number|4|4.0||||||
4052123|NCT01096667|3873854|B4|65 years and older||Age, Customized||Participants|Number|0|0.0||||||
4052124|NCT01096667|3873855|B3|65 years and older||Age, Customized||Participants|Number|3|3.0||||||
4052125|NCT01096667|3873856|B2|65 years and older||Age, Customized||Participants|Number|1|1.0||||||
4052126|NCT01096667|3873857|B1|65 years and older||Age, Customized||Participants|Number|1|1.0||||||
4052127|NCT01096667|3873852|B6|Between 45 and 64 years||Age, Customized||Participants|Number|168|168.0||||||
4052128|NCT01096667|3873853|B5|Between 45 and 64 years||Age, Customized||Participants|Number|34|34.0||||||
4052129|NCT01096667|3873854|B4|Between 45 and 64 years||Age, Customized||Participants|Number|34|34.0||||||
4052130|NCT01096667|3873855|B3|Between 45 and 64 years||Age, Customized||Participants|Number|32|32.0||||||
4052131|NCT01096667|3873856|B2|Between 45 and 64 years||Age, Customized||Participants|Number|34|34.0||||||
4052132|NCT01096667|3873857|B1|Between 45 and 64 years||Age, Customized||Participants|Number|34|34.0||||||
4052133|NCT01096667|3873852|B6|Between 18 and 44 years||Age, Customized||Participants|Number|16|16.0||||||
4052134|NCT01096667|3873853|B5|Between 18 and 44 years||Age, Customized||Participants|Number|1|1.0||||||
4052135|NCT01096667|3873854|B4|Between 18 and 44 years||Age, Customized||Participants|Number|5|5.0||||||
4052136|NCT01096667|3873855|B3|Between 18 and 44 years||Age, Customized||Participants|Number|3|3.0||||||
4052137|NCT01096667|3873856|B2|Between 18 and 44 years||Age, Customized||Participants|Number|4|4.0||||||
4052138|NCT01096667|3873857|B1|Between 18 and 44 years||Age, Customized||Participants|Number|3|3.0||||||
4052139|NCT01096667|3873852|B6|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4052140|NCT01096667|3873853|B5|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4052141|NCT01096667|3873854|B4|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4052142|NCT01096667|3873855|B3|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4052143|NCT01096667|3873856|B2|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4052144|NCT01096667|3873857|B1|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4052145|NCT01096589|3873999|B5|United Kingdom||Region of Enrollment||participants|Number|70|70.0||||||
4052146|NCT01096589|3874000|B4|United Kingdom||Region of Enrollment||participants|Number|16|16.0||||||
4052147|NCT01096589|3874001|B3|United Kingdom||Region of Enrollment||participants|Number|20|20.0||||||
4052148|NCT01096589|3874002|B2|United Kingdom||Region of Enrollment||participants|Number|17|17.0||||||
4052149|NCT01096589|3874003|B1|United Kingdom||Region of Enrollment||participants|Number|17|17.0||||||
4052150|NCT01096589|3873999|B5|United States||Region of Enrollment||participants|Number|12|12.0||||||
4052151|NCT01096589|3874000|B4|United States||Region of Enrollment||participants|Number|2|2.0||||||
4052152|NCT01096589|3874001|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4052153|NCT01096589|3874002|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4052154|NCT01096589|3874003|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4052155|NCT01096589|3873999|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4052156|NCT01096589|3874000|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4052157|NCT01096589|3874001|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4052158|NCT01096589|3874002|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4052159|NCT01096589|3874003|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4052160|NCT01096589|3873999|B5||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4052161|NCT01096589|3874000|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4052162|NCT01096589|3874001|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4052163|NCT01096589|3874002|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4052164|NCT01096589|3874003|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4052165|NCT01096589|3873999|B5|||Age||years|Mean|60.16|60.16|Standard Deviation|13.85|13.85|||
4052166|NCT01096589|3874000|B4|||Age||years|Mean|56.22|56.22|Standard Deviation|14.78|14.78|||
4052167|NCT01096589|3874001|B3|||Age||years|Mean|62.27|62.27|Standard Deviation|13.25|13.25|||
4052168|NCT01096589|3874002|B2|||Age||years|Mean|61.85|61.85|Standard Deviation|14.49|14.49|||
4052169|NCT01096589|3874003|B1|||Age||years|Mean|59.73|59.73|Standard Deviation|13.29|13.29|||
4052170|NCT01096589|3873999|B5||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
4052171|NCT01096589|3874000|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4052172|NCT01096589|3874001|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4052173|NCT01096589|3874002|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4052174|NCT01096589|3874003|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4052175|NCT01096589|3873999|B5||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4052176|NCT01096589|3874000|B4||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4052177|NCT01096589|3874001|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4052178|NCT01096589|3874002|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4052179|NCT01096589|3874003|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4052180|NCT01096589|3873999|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4052181|NCT01096589|3874000|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4052182|NCT01096589|3874001|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4052183|NCT01096589|3874002|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4052184|NCT01096589|3874003|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4052185|NCT01096550|3874020|B3|United States||Region of Enrollment||participants|Number|345|345.0||||||
4052186|NCT01096550|3874021|B2|United States||Region of Enrollment||participants|Number|175|175.0||||||
4052187|NCT01096550|3874022|B1|United States||Region of Enrollment||participants|Number|170|170.0||||||
4052188|NCT01096550|3874020|B3||Male|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4052189|NCT01096550|3874021|B2||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4052190|NCT01096550|3874022|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4052191|NCT01096550|3874020|B3||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4052192|NCT01096550|3874021|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4052193|NCT01096550|3874022|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4052194|NCT01096550|3874020|B3|||Age||years|Mean|45.23|45.23|Standard Deviation|7.53|7.53|||
4052195|NCT01096550|3874021|B2|||Age||years|Mean|46.27|46.27|Standard Deviation|6.75|6.75|||
4052196|NCT01096550|3874022|B1|||Age||years|Mean|44.15|44.15|Standard Deviation|8.15|8.15|||
4052197|NCT01096550|3874020|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4052198|NCT01096550|3874021|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4052199|NCT01096550|3874022|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4052200|NCT01096550|3874020|B3||Between 18 and 65 years|Age||Participants|Count of Participants|342|342.0||||||
4052201|NCT01096550|3874021|B2||Between 18 and 65 years|Age||Participants|Count of Participants|174|174.0||||||
4052202|NCT01096550|3874022|B1||Between 18 and 65 years|Age||Participants|Count of Participants|168|168.0||||||
4052203|NCT01096550|3874020|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4052204|NCT01096550|3874021|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4052205|NCT01096550|3874022|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4052206|NCT01096446|3874029|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4052207|NCT01096446|3874030|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4052208|NCT01096446|3874031|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4052209|NCT01096446|3874029|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4052210|NCT01096446|3874030|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4052211|NCT01096446|3874031|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4052212|NCT01096446|3874029|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4052213|NCT01096446|3874030|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4052214|NCT01096446|3874031|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4052215|NCT01096446|3874029|B3|||Age|Gestational Age|weeks|Mean|24|24.0|Standard Deviation|0.5|0.5|||
4052216|NCT01096446|3874030|B2|||Age|Gestational Age|weeks|Mean|24.33|24.33|Standard Deviation|1|1.0|||
4052217|NCT01096446|3874031|B1|||Age|Gestational Age|weeks|Mean|23.7|23.7|Standard Deviation|0.68|0.68|||
4052218|NCT01096446|3874029|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4052219|NCT01096446|3874030|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4052220|NCT01096446|3874031|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4052221|NCT01096446|3874029|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4052222|NCT01096446|3874030|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4052223|NCT01096446|3874031|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4052224|NCT01096446|3874029|B3||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
4052225|NCT01096446|3874030|B2||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4052226|NCT01096446|3874031|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4052227|NCT01096342|3874037|B1|Singapore||Region of Enrollment||participants|Number|3|3.0||||||
4052228|NCT01096342|3874037|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4052229|NCT01096342|3874037|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4052230|NCT01096342|3874037|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4052231|NCT01096342|3874037|B1|||Age||years|Median|64|64.0|Full Range|||55.0|81.0|
4052232|NCT01096316|3874043|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4052233|NCT01096316|3874044|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4052234|NCT01096316|3874045|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4052235|NCT01096316|3874043|B3||Female|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4052236|NCT01096316|3874044|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4052237|NCT01096316|3874045|B1||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4052238|NCT01096316|3874043|B3|||Age||years|Mean|39.02|39.02|Standard Deviation|12.09|12.09|||
4052239|NCT01096316|3874044|B2|||Age||years|Mean|38.59|38.59|Standard Deviation|12.10|12.1|||
4052240|NCT01096316|3874045|B1|||Age||years|Mean|39.47|39.47|Standard Deviation|12.11|12.11|||
4052241|NCT01096186|3874056|B1|Spain||Region of Enrollment||participants|Number|9|9.0||||||
4052242|NCT01096186|3874056|B1|Estonia||Region of Enrollment||participants|Number|3|3.0||||||
4052243|NCT01096186|3874056|B1|Germany||Region of Enrollment||participants|Number|19|19.0||||||
4052244|NCT01096186|3874056|B1|Lithuania||Region of Enrollment||participants|Number|18|18.0||||||
4052245|NCT01096186|3874056|B1|Poland||Region of Enrollment||participants|Number|50|50.0||||||
4052246|NCT01096186|3874056|B1|Ukraine||Region of Enrollment||participants|Number|165|165.0||||||
4052247|NCT01096186|3874056|B1|United States||Region of Enrollment||participants|Number|260|260.0||||||
4052248|NCT01096186|3874056|B1|Romania||Region of Enrollment||participants|Number|43|43.0||||||
4052249|NCT01096186|3874056|B1|Latvia||Region of Enrollment||participants|Number|2|2.0||||||
4052250|NCT01096186|3874056|B1|Canada||Region of Enrollment||participants|Number|48|48.0||||||
4052251|NCT01096186|3874056|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4052252|NCT01096186|3874056|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4052253|NCT01096186|3874056|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4052254|NCT01096186|3874056|B1|White||Race/Ethnicity, Customized||participants|Number|608|608.0||||||
4052255|NCT01096186|3874056|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4052256|NCT01096186|3874056|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|582|582.0||||||
4052257|NCT01096186|3874056|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4052258|NCT01096186|3874056|B1||Male|Sex: Female, Male||Participants|Count of Participants|383|383.0||||||
4052259|NCT01096186|3874056|B1||Female|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
4052260|NCT01096186|3874056|B1|||Age||years|Mean|64.1|64.1|Standard Deviation|9.23|9.23|||
4052261|NCT01096056|3874062|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4052262|NCT01096056|3874063|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4052263|NCT01096056|3874064|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4052264|NCT01096056|3874062|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4052265|NCT01096056|3874063|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4052266|NCT01096056|3874064|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4052267|NCT01096056|3874062|B3|||Age||Months|Mean|20.90|20.9|Standard Deviation|8.92|8.92|||
4052268|NCT01096056|3874063|B2|||Age||Months|Mean|18.6|18.6|Standard Deviation|7.46|7.46|||
4052269|NCT01096056|3874064|B1|||Age||Months|Mean|23.2|23.2|Standard Deviation|9.82|9.82|||
4052270|NCT01096017|3874097|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4052271|NCT01096017|3874097|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4052272|NCT01096017|3874097|B1|||Age||Years|Mean|41.7|41.7|Standard Deviation|7.4|7.4|||
4052273|NCT01095978|3874126|B1|Ukraine||Region of Enrollment|Based on the per-protocol population (2800 participants).|Participants|Number|2800|2800.0||||||
4052274|NCT01095978|3874126|B1|Not reported||Sex/Gender, Customized|The gender of the participants was not collected in this study.|Participants|Number|2800|2800.0||||||
4052275|NCT01095978|3874126|B1|85 years or older||Age, Customized|Based on the per-protocol population (2800 participants).|Participants|Number|6|6.0||||||
4052276|NCT01095978|3874126|B1|65 to 84 years||Age, Customized|Based on the per-protocol population (2800 participants).|Participants|Number|190|190.0||||||
4052277|NCT01095978|3874126|B1|35 to 64 years||Age, Customized|Based on the per-protocol population (2800 participants).|Participants|Number|1777|1777.0||||||
4052278|NCT01095978|3874126|B1|21 to 34 years||Age, Customized|Based on the per-protocol population (2800 participants).|Participants|Number|763|763.0||||||
4052279|NCT01095978|3874126|B1|18 to 20 years||Age, Customized|Based on the per-protocol population (2800 participants).|Participants|Number|64|64.0||||||
4052280|NCT01095978|3874126|B1|||Age|Based on the per-protocol population (2800 participants).|years|Mean|43.41|43.41|Standard Deviation|13.79|13.79|||
4052281|NCT01095887|3874153|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4052282|NCT01095887|3874153|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4052283|NCT01095887|3874153|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4052284|NCT01095887|3874153|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4052285|NCT01095887|3874153|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4052286|NCT01095887|3874153|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4052287|NCT01095835|3874157|B4||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4052288|NCT01095835|3874158|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4052289|NCT01095835|3874159|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4052290|NCT01095835|3874160|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4052291|NCT01095835|3874157|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4052292|NCT01095835|3874158|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4052293|NCT01095835|3874159|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4052294|NCT01095835|3874160|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4052295|NCT01095835|3874157|B4|||Age||years|Mean|44.6|44.6|Standard Deviation|9.9|9.9|||
4052296|NCT01095835|3874158|B3|||Age||years|Mean|45.6|45.6|Standard Deviation|8.6|8.6|||
4052297|NCT01095835|3874159|B2|||Age||years|Mean|44.1|44.1|Standard Deviation|10.4|10.4|||
4052298|NCT01095835|3874160|B1|||Age||years|Mean|45.1|45.1|Standard Deviation|10.2|10.2|||
4052299|NCT01095796|3874198|B3|> 500||CD4 Cell Count (/µL)||participants|Number|149|149.0||||||
4052300|NCT01095796|3874199|B2|> 500||CD4 Cell Count (/µL)||participants|Number|69|69.0||||||
4052301|NCT01095796|3874200|B1|> 500||CD4 Cell Count (/µL)||participants|Number|80|80.0||||||
4052302|NCT01095796|3874198|B3|351 to ≤ 500||CD4 Cell Count (/µL)||participants|Number|249|249.0||||||
4052303|NCT01095796|3874199|B2|351 to ≤ 500||CD4 Cell Count (/µL)||participants|Number|136|136.0||||||
4052304|NCT01095796|3874200|B1|351 to ≤ 500||CD4 Cell Count (/µL)||participants|Number|113|113.0||||||
4052305|NCT01095796|3874198|B3|201 to ≤ 350||CD4 Cell Count (/µL)||participants|Number|208|208.0||||||
4052306|NCT01095796|3874199|B2|201 to ≤ 350||CD4 Cell Count (/µL)||participants|Number|96|96.0||||||
4052307|NCT01095796|3874200|B1|201 to ≤ 350||CD4 Cell Count (/µL)||participants|Number|112|112.0||||||
4052308|NCT01095796|3874198|B3|51 to ≤ 200||CD4 Cell Count (/µL)||participants|Number|81|81.0||||||
4052309|NCT01095796|3874199|B2|51 to ≤ 200||CD4 Cell Count (/µL)||participants|Number|45|45.0||||||
4052310|NCT01095796|3874200|B1|51 to ≤ 200||CD4 Cell Count (/µL)||participants|Number|36|36.0||||||
4052311|NCT01095796|3874198|B3|≤ 50||CD4 Cell Count (/µL)||participants|Number|13|13.0||||||
4052312|NCT01095796|3874199|B2|≤ 50||CD4 Cell Count (/µL)||participants|Number|6|6.0||||||
4052313|NCT01095796|3874200|B1|≤ 50||CD4 Cell Count (/µL)||participants|Number|7|7.0||||||
4052314|NCT01095796|3874198|B3|> 100,000||HIV-1 RNA Category (copies/mL)||participants|Number|234|234.0||||||
4052315|NCT01095796|3874199|B2|> 100,000||HIV-1 RNA Category (copies/mL)||participants|Number|116|116.0||||||
4052316|NCT01095796|3874200|B1|> 100,000||HIV-1 RNA Category (copies/mL)||participants|Number|118|118.0||||||
4052317|NCT01095796|3874198|B3|≤ 100,000||HIV-1 RNA Category (copies/mL)||participants|Number|466|466.0||||||
4052318|NCT01095796|3874199|B2|≤ 100,000||HIV-1 RNA Category (copies/mL)||participants|Number|236|236.0||||||
4052319|NCT01095796|3874200|B1|≤ 100,000||HIV-1 RNA Category (copies/mL)||participants|Number|230|230.0||||||
4052320|NCT01095796|3874198|B3|Positive||Hepatitis C Virus (HCV) Infection Status||participants|Number|32|32.0||||||
4052321|NCT01095796|3874199|B2|Positive||Hepatitis C Virus (HCV) Infection Status||participants|Number|15|15.0||||||
4052322|NCT01095796|3874200|B1|Positive||Hepatitis C Virus (HCV) Infection Status||participants|Number|17|17.0||||||
4052323|NCT01095796|3874198|B3|Negative||Hepatitis C Virus (HCV) Infection Status||participants|Number|668|668.0||||||
4052324|NCT01095796|3874199|B2|Negative||Hepatitis C Virus (HCV) Infection Status||participants|Number|337|337.0||||||
4052325|NCT01095796|3874200|B1|Negative||Hepatitis C Virus (HCV) Infection Status||participants|Number|331|331.0||||||
4052326|NCT01095796|3874198|B3|Positive||Hepatitis B Virus (HBV) Infection Status||participants|Number|14|14.0||||||
4052327|NCT01095796|3874199|B2|Positive||Hepatitis B Virus (HBV) Infection Status||participants|Number|9|9.0||||||
4052328|NCT01095796|3874200|B1|Positive||Hepatitis B Virus (HBV) Infection Status||participants|Number|5|5.0||||||
4052329|NCT01095796|3874198|B3|Negative||Hepatitis B Virus (HBV) Infection Status||participants|Number|686|686.0||||||
4052330|NCT01095796|3874199|B2|Negative||Hepatitis B Virus (HBV) Infection Status||participants|Number|343|343.0||||||
4052331|NCT01095796|3874200|B1|Negative||Hepatitis B Virus (HBV) Infection Status||participants|Number|343|343.0||||||
4052332|NCT01095796|3874198|B3|AIDS||HIV Disease Status||participants|Number|52|52.0||||||
4052333|NCT01095796|3874199|B2|AIDS||HIV Disease Status||participants|Number|24|24.0||||||
4052334|NCT01095796|3874200|B1|AIDS||HIV Disease Status||participants|Number|28|28.0||||||
4052335|NCT01095796|3874198|B3|Symptomatic HIV Infections||HIV Disease Status||participants|Number|63|63.0||||||
4052336|NCT01095796|3874199|B2|Symptomatic HIV Infections||HIV Disease Status||participants|Number|33|33.0||||||
4052337|NCT01095796|3874200|B1|Symptomatic HIV Infections||HIV Disease Status||participants|Number|30|30.0||||||
4052338|NCT01095796|3874198|B3|Asymptomatic||HIV Disease Status||participants|Number|585|585.0||||||
4052339|NCT01095796|3874199|B2|Asymptomatic||HIV Disease Status||participants|Number|295|295.0||||||
4052340|NCT01095796|3874200|B1|Asymptomatic||HIV Disease Status||participants|Number|290|290.0||||||
4052341|NCT01095796|3874198|B3|United States||Region of Enrollment||participants|Number|700|700.0||||||
4052342|NCT01095796|3874199|B2|United States||Region of Enrollment||participants|Number|352|352.0||||||
4052343|NCT01095796|3874200|B1|United States||Region of Enrollment||participants|Number|348|348.0||||||
4052344|NCT01095796|3874198|B3|Other||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4052345|NCT01095796|3874199|B2|Other||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4052346|NCT01095796|3874200|B1|Other||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4052347|NCT01095796|3874198|B3|White||Race/Ethnicity, Customized||participants|Number|441|441.0||||||
4052348|NCT01095796|3874199|B2|White||Race/Ethnicity, Customized||participants|Number|227|227.0||||||
4052349|NCT01095796|3874200|B1|White||Race/Ethnicity, Customized||participants|Number|214|214.0||||||
4052350|NCT01095796|3874198|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4052351|NCT01095796|3874199|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4052352|NCT01095796|3874200|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4052353|NCT01095796|3874198|B3|Black or African Heritage||Race/Ethnicity, Customized||participants|Number|197|197.0||||||
4052354|NCT01095796|3874199|B2|Black or African Heritage||Race/Ethnicity, Customized||participants|Number|91|91.0||||||
4052355|NCT01095796|3874200|B1|Black or African Heritage||Race/Ethnicity, Customized||participants|Number|106|106.0||||||
4052356|NCT01095796|3874198|B3|Asian||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4052357|NCT01095796|3874199|B2|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4052358|NCT01095796|3874200|B1|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4052359|NCT01095796|3874198|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4052360|NCT01095796|3874199|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4052361|NCT01095796|3874200|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4052362|NCT01095796|3874198|B3||Male|Sex: Female, Male||Participants|Count of Participants|623|623.0||||||
4052363|NCT01095796|3874199|B2||Male|Sex: Female, Male||Participants|Count of Participants|316|316.0||||||
4052364|NCT01095796|3874200|B1||Male|Sex: Female, Male||Participants|Count of Participants|307|307.0||||||
4052365|NCT01095796|3874198|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4052366|NCT01095796|3874199|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4052367|NCT01095796|3874200|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4052368|NCT01095796|3874198|B3|||Age||years|Mean|38|38.0|Standard Deviation|10.5|10.5|||
4052369|NCT01095796|3874199|B2|||Age||years|Mean|38|38.0|Standard Deviation|10.6|10.6|||
4052370|NCT01095796|3874200|B1|||Age||years|Mean|38|38.0|Standard Deviation|10.4|10.4|||
4052371|NCT01095757|3874219|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4052372|NCT01095757|3874219|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052373|NCT01095757|3874219|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052374|NCT01095757|3874219|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4052375|NCT01095757|3874219|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4052376|NCT01095757|3874219|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052377|NCT01095757|3874219|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4052378|NCT01095757|3874219|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052379|NCT01095757|3874219|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4052380|NCT01095757|3874219|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4052381|NCT01095757|3874219|B1|Lymphoma, n = 28||Age||years|Median|56|56.0|Full Range|||38.0|73.0|
4052382|NCT01095757|3874219|B1|Multiple Myeloma (MM), n = 17||Age||years|Median|58|58.0|Full Range|||33.0|72.0|
4052383|NCT01095666|3874228|B4|Korean||Race/Ethnicity, Customized||Participants|Number|28|28.0||||||
4052384|NCT01095666|3874229|B3|Korean||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4052385|NCT01095666|3874230|B2|Korean||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4052386|NCT01095666|3874231|B1|Korean||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4052387|NCT01095666|3874228|B4|Chinese||Race/Ethnicity, Customized||Participants|Number|382|382.0||||||
4052388|NCT01095666|3874229|B3|Chinese||Race/Ethnicity, Customized||Participants|Number|129|129.0||||||
4052389|NCT01095666|3874230|B2|Chinese||Race/Ethnicity, Customized||Participants|Number|127|127.0||||||
4052390|NCT01095666|3874231|B1|Chinese||Race/Ethnicity, Customized||Participants|Number|126|126.0||||||
4052391|NCT01095666|3874228|B4|Asian Indian||Race/Ethnicity, Customized||Participants|Number|34|34.0||||||
4052392|NCT01095666|3874229|B3|Asian Indian||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4052393|NCT01095666|3874230|B2|Asian Indian||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4052394|NCT01095666|3874231|B1|Asian Indian||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4052395|NCT01095666|3874228|B4|Female||Sex/Gender, Customized||Participants|Number|203|203.0||||||
4052396|NCT01095666|3874229|B3|Female||Sex/Gender, Customized||Participants|Number|64|64.0||||||
4052397|NCT01095666|3874230|B2|Female||Sex/Gender, Customized||Participants|Number|80|80.0||||||
4052398|NCT01095666|3874231|B1|Female||Sex/Gender, Customized||Participants|Number|59|59.0||||||
4052399|NCT01095666|3874228|B4|Male||Sex/Gender, Customized||Participants|Number|241|241.0||||||
4052400|NCT01095666|3874229|B3|Male||Sex/Gender, Customized||Participants|Number|88|88.0||||||
4052401|NCT01095666|3874230|B2|Male||Sex/Gender, Customized||Participants|Number|67|67.0||||||
4052402|NCT01095666|3874231|B1|Male||Sex/Gender, Customized||Participants|Number|86|86.0||||||
4052403|NCT01095666|3874228|B4|75 years and older||Age, Customized||Participants|Number|5|5.0||||||
4052404|NCT01095666|3874229|B3|75 years and older||Age, Customized||Participants|Number|1|1.0||||||
4052405|NCT01095666|3874230|B2|75 years and older||Age, Customized||Participants|Number|2|2.0||||||
4052406|NCT01095666|3874231|B1|75 years and older||Age, Customized||Participants|Number|2|2.0||||||
4052407|NCT01095666|3874228|B4|65 to younger than 75 years||Age, Customized||Participants|Number|52|52.0||||||
4052408|NCT01095666|3874229|B3|65 to younger than 75 years||Age, Customized||Participants|Number|25|25.0||||||
4052409|NCT01095666|3874230|B2|65 to younger than 75 years||Age, Customized||Participants|Number|13|13.0||||||
4052410|NCT01095666|3874231|B1|65 to younger than 75 years||Age, Customized||Participants|Number|14|14.0||||||
4052411|NCT01095666|3874228|B4|Yonger than 65 years||Age, Customized||Participants|Number|387|387.0||||||
4052412|NCT01095666|3874229|B3|Yonger than 65 years||Age, Customized||Participants|Number|126|126.0||||||
4052413|NCT01095666|3874230|B2|Yonger than 65 years||Age, Customized||Participants|Number|132|132.0||||||
4052414|NCT01095666|3874231|B1|Yonger than 65 years||Age, Customized||Participants|Number|129|129.0||||||
4052415|NCT01095666|3874228|B4|||Age||Years|Mean|53.8|53.8|Standard Deviation|9.29|9.29|||
4052416|NCT01095666|3874229|B3|||Age||Years|Mean|54.6|54.6|Standard Deviation|9.54|9.54|||
4052417|NCT01095666|3874230|B2|||Age||Years|Mean|53.1|53.1|Standard Deviation|9.09|9.09|||
4052418|NCT01095666|3874231|B1|||Age||Years|Mean|53.5|53.5|Standard Deviation|9.20|9.2|||
4052419|NCT01095653|3874253|B4|||Body Mass Index (BMI)||kg/m^2|Mean|25.62|25.62|Standard Deviation|3.465|3.465|||
4052420|NCT01095653|3874254|B3|||Body Mass Index (BMI)||kg/m^2|Mean|25.76|25.76|Standard Deviation|3.434|3.434|||
4052421|NCT01095653|3874255|B2|||Body Mass Index (BMI)||kg/m^2|Mean|25.17|25.17|Standard Deviation|3.285|3.285|||
4052422|NCT01095653|3874256|B1|||Body Mass Index (BMI)||kg/m^2|Mean|25.93|25.93|Standard Deviation|3.644|3.644|||
4052423|NCT01095653|3874253|B4|||Weight||kg|Mean|70.68|70.68|Standard Deviation|12.177|12.177|||
4052424|NCT01095653|3874254|B3|||Weight||kg|Mean|70.92|70.92|Standard Deviation|11.637|11.637|||
4052425|NCT01095653|3874255|B2|||Weight||kg|Mean|68.89|68.89|Standard Deviation|11.429|11.429|||
4052426|NCT01095653|3874256|B1|||Weight||kg|Mean|72.18|72.18|Standard Deviation|13.234|13.234|||
4052427|NCT01095653|3874253|B4|ASIAN OTHER||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4052428|NCT01095653|3874254|B3|ASIAN OTHER||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4052429|NCT01095653|3874255|B2|ASIAN OTHER||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4052430|NCT01095653|3874256|B1|ASIAN OTHER||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4052431|NCT01095653|3874253|B4|KOREAN||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4052432|NCT01095653|3874254|B3|KOREAN||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4052433|NCT01095653|3874255|B2|KOREAN||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4052434|NCT01095653|3874256|B1|KOREAN||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4052435|NCT01095653|3874253|B4|JAPANESE||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4052436|NCT01095653|3874254|B3|JAPANESE||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4052437|NCT01095653|3874255|B2|JAPANESE||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4052438|NCT01095653|3874256|B1|JAPANESE||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4052439|NCT01095653|3874253|B4|CHINESE||Race/Ethnicity, Customized||Participants|Number|348|348.0||||||
4052440|NCT01095653|3874254|B3|CHINESE||Race/Ethnicity, Customized||Participants|Number|117|117.0||||||
4052441|NCT01095653|3874255|B2|CHINESE||Race/Ethnicity, Customized||Participants|Number|114|114.0||||||
4052442|NCT01095653|3874256|B1|CHINESE||Race/Ethnicity, Customized||Participants|Number|117|117.0||||||
4052443|NCT01095653|3874253|B4|ASIAN INDIAN||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
4052444|NCT01095653|3874254|B3|ASIAN INDIAN||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4052445|NCT01095653|3874255|B2|ASIAN INDIAN||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4052446|NCT01095653|3874256|B1|ASIAN INDIAN||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4052447|NCT01095653|3874253|B4|Female||Sex/Gender, Customized||Participants|Number|136|136.0||||||
4052448|NCT01095653|3874254|B3|Female||Sex/Gender, Customized||Participants|Number|47|47.0||||||
4052449|NCT01095653|3874255|B2|Female||Sex/Gender, Customized||Participants|Number|44|44.0||||||
4052450|NCT01095653|3874256|B1|Female||Sex/Gender, Customized||Participants|Number|45|45.0||||||
4052451|NCT01095653|3874253|B4|Male||Sex/Gender, Customized||Participants|Number|257|257.0||||||
4052452|NCT01095653|3874254|B3|Male||Sex/Gender, Customized||Participants|Number|86|86.0||||||
4052453|NCT01095653|3874255|B2|Male||Sex/Gender, Customized||Participants|Number|84|84.0||||||
4052454|NCT01095653|3874256|B1|Male||Sex/Gender, Customized||Participants|Number|87|87.0||||||
4052455|NCT01095653|3874253|B4|75 years and older||Age, Customized||Participants|Number|7|7.0||||||
4052456|NCT01095653|3874254|B3|75 years and older||Age, Customized||Participants|Number|0|0.0||||||
4052457|NCT01095653|3874255|B2|75 years and older||Age, Customized||Participants|Number|6|6.0||||||
4052458|NCT01095653|3874256|B1|75 years and older||Age, Customized||Participants|Number|1|1.0||||||
4052459|NCT01095653|3874253|B4|65 to younger than 75 years||Age, Customized||Participants|Number|35|35.0||||||
4052460|NCT01095653|3874254|B3|65 to younger than 75 years||Age, Customized||Participants|Number|10|10.0||||||
4052461|NCT01095653|3874255|B2|65 to younger than 75 years||Age, Customized||Participants|Number|14|14.0||||||
4052462|NCT01095653|3874256|B1|65 to younger than 75 years||Age, Customized||Participants|Number|11|11.0||||||
4052463|NCT01095653|3874253|B4|Younger than 65 years||Age, Customized||Participants|Number|351|351.0||||||
4052464|NCT01095653|3874254|B3|Younger than 65 years||Age, Customized||Participants|Number|123|123.0||||||
4052465|NCT01095653|3874255|B2|Younger than 65 years||Age, Customized||Participants|Number|108|108.0||||||
4052466|NCT01095653|3874256|B1|Younger than 65 years||Age, Customized||Participants|Number|120|120.0||||||
4052467|NCT01095653|3874253|B4|||Age||Years|Mean|51.3|51.3|Standard Deviation|10.67|10.67|20.0|79.0|
4052468|NCT01095653|3874254|B3|||Age||Years|Mean|51.2|51.2|Standard Deviation|9.89|9.89|21.0|72.0|
4052469|NCT01095653|3874255|B2|||Age||Years|Mean|53.0|53.0|Standard Deviation|11.07|11.07|29.0|79.0|
4052470|NCT01095653|3874256|B1|||Age||Years|Mean|49.9|49.9|Standard Deviation|10.87|10.87|20.0|75.0|
4052471|NCT01095510|3874278|B4|United States||Region of Enrollment||participants|Number|9|9.0||||||
4052472|NCT01095510|3874279|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4052473|NCT01095510|3874280|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4052474|NCT01095510|3874281|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4052475|NCT01095510|3874278|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4052476|NCT01095510|3874279|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4052477|NCT01095510|3874280|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4052478|NCT01095510|3874281|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4052479|NCT01095510|3874278|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4052480|NCT01095510|3874279|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4052481|NCT01095510|3874280|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4052482|NCT01095510|3874281|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4052483|NCT01095510|3874278|B4|||Age||years|Median|9|9.0|Full Range|||6.0|11.0|
4052484|NCT01095510|3874279|B3|||Age||years|Median|10|10.0|Full Range|||8.0|11.0|
4052485|NCT01095510|3874280|B2|||Age||years|Median|9|9.0|Full Range|||7.0|9.0|
4052486|NCT01095510|3874281|B1|||Age||years|Median|7|7.0|Full Range|||6.0|9.0|
4052487|NCT01095497|3874301|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4052488|NCT01095497|3874302|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4052489|NCT01095497|3874303|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4052490|NCT01095497|3874301|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4052491|NCT01095497|3874302|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4052492|NCT01095497|3874303|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4052493|NCT01095497|3874301|B3|||Age||years|Mean|32.7|32.7|Standard Deviation|14.66|14.66|||
4052494|NCT01095497|3874302|B2|||Age||years|Mean|37.3|37.3|Standard Deviation|15.92|15.92|||
4052495|NCT01095497|3874303|B1|||Age||years|Mean|28.6|28.6|Standard Deviation|12.70|12.7|||
4052496|NCT01095250|3874312|B5|United States||Region of Enrollment||Participants|Number|5|5.0||||||
4052497|NCT01095250|3874313|B4|United States||Region of Enrollment||Participants|Number|1|1.0||||||
4052498|NCT01095250|3874314|B3|United States||Region of Enrollment||Participants|Number|1|1.0||||||
4052499|NCT01095250|3874315|B2|United States||Region of Enrollment||Participants|Number|1|1.0||||||
4052500|NCT01095250|3874316|B1|United States||Region of Enrollment||Participants|Number|2|2.0||||||
4052501|NCT01095250|3874312|B5|Singapore||Region of Enrollment||Participants|Number|1|1.0||||||
4052502|NCT01095250|3874313|B4|Singapore||Region of Enrollment||Participants|Number|0|0.0||||||
4052503|NCT01095250|3874314|B3|Singapore||Region of Enrollment||Participants|Number|0|0.0||||||
4052504|NCT01095250|3874315|B2|Singapore||Region of Enrollment||Participants|Number|0|0.0||||||
4052505|NCT01095250|3874316|B1|Singapore||Region of Enrollment||Participants|Number|1|1.0||||||
4052506|NCT01095250|3874312|B5|Japan||Region of Enrollment||Participants|Number|13|13.0||||||
4052507|NCT01095250|3874313|B4|Japan||Region of Enrollment||Participants|Number|2|2.0||||||
4052508|NCT01095250|3874314|B3|Japan||Region of Enrollment||Participants|Number|4|4.0||||||
4052509|NCT01095250|3874315|B2|Japan||Region of Enrollment||Participants|Number|3|3.0||||||
4052510|NCT01095250|3874316|B1|Japan||Region of Enrollment||Participants|Number|4|4.0||||||
4052511|NCT01095250|3874312|B5|Israel||Region of Enrollment||Participants|Number|3|3.0||||||
4052512|NCT01095250|3874313|B4|Israel||Region of Enrollment||Participants|Number|0|0.0||||||
4052513|NCT01095250|3874314|B3|Israel||Region of Enrollment||Participants|Number|1|1.0||||||
4052514|NCT01095250|3874315|B2|Israel||Region of Enrollment||Participants|Number|2|2.0||||||
4052515|NCT01095250|3874316|B1|Israel||Region of Enrollment||Participants|Number|0|0.0||||||
4052516|NCT01095250|3874312|B5|Hungary||Region of Enrollment||Participants|Number|2|2.0||||||
4052517|NCT01095250|3874313|B4|Hungary||Region of Enrollment||Participants|Number|0|0.0||||||
4052518|NCT01095250|3874314|B3|Hungary||Region of Enrollment||Participants|Number|0|0.0||||||
4052519|NCT01095250|3874315|B2|Hungary||Region of Enrollment||Participants|Number|1|1.0||||||
4052520|NCT01095250|3874316|B1|Hungary||Region of Enrollment||Participants|Number|1|1.0||||||
4052521|NCT01095250|3874312|B5|France||Region of Enrollment||Participants|Number|1|1.0||||||
4052522|NCT01095250|3874313|B4|France||Region of Enrollment||Participants|Number|0|0.0||||||
4052523|NCT01095250|3874314|B3|France||Region of Enrollment||Participants|Number|1|1.0||||||
4052524|NCT01095250|3874315|B2|France||Region of Enrollment||Participants|Number|0|0.0||||||
4052525|NCT01095250|3874316|B1|France||Region of Enrollment||Participants|Number|0|0.0||||||
4052526|NCT01095250|3874312|B5|Germany||Region of Enrollment||Participants|Number|1|1.0||||||
4052527|NCT01095250|3874313|B4|Germany||Region of Enrollment||Participants|Number|1|1.0||||||
4052528|NCT01095250|3874314|B3|Germany||Region of Enrollment||Participants|Number|0|0.0||||||
4052529|NCT01095250|3874315|B2|Germany||Region of Enrollment||Participants|Number|0|0.0||||||
4052530|NCT01095250|3874316|B1|Germany||Region of Enrollment||Participants|Number|0|0.0||||||
4052531|NCT01095250|3874312|B5|Switzerland||Region of Enrollment||Participants|Number|1|1.0||||||
4052532|NCT01095250|3874313|B4|Switzerland||Region of Enrollment||Participants|Number|0|0.0||||||
4052533|NCT01095250|3874314|B3|Switzerland||Region of Enrollment||Participants|Number|0|0.0||||||
4052534|NCT01095250|3874315|B2|Switzerland||Region of Enrollment||Participants|Number|1|1.0||||||
4052535|NCT01095250|3874316|B1|Switzerland||Region of Enrollment||Participants|Number|0|0.0||||||
4052536|NCT01095250|3874312|B5|Canada||Region of Enrollment||Participants|Number|4|4.0||||||
4052537|NCT01095250|3874313|B4|Canada||Region of Enrollment||Participants|Number|1|1.0||||||
4052538|NCT01095250|3874314|B3|Canada||Region of Enrollment||Participants|Number|1|1.0||||||
4052539|NCT01095250|3874315|B2|Canada||Region of Enrollment||Participants|Number|2|2.0||||||
4052540|NCT01095250|3874316|B1|Canada||Region of Enrollment||Participants|Number|0|0.0||||||
4052541|NCT01095250|3874312|B5||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4052542|NCT01095250|3874313|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4052543|NCT01095250|3874314|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4052544|NCT01095250|3874315|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4052545|NCT01095250|3874316|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4052546|NCT01095250|3874312|B5||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4052547|NCT01095250|3874313|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4052548|NCT01095250|3874314|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4052549|NCT01095250|3874315|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4052550|NCT01095250|3874316|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4052551|NCT01095250|3874312|B5|||Age||Years|Mean|47.1|47.1|Standard Deviation|15.47|15.47|||
4052552|NCT01095250|3874313|B4|||Age||Years|Mean|50.6|50.6|Standard Deviation|12.99|12.99|||
4052553|NCT01095250|3874314|B3|||Age||Years|Mean|44.6|44.6|Standard Deviation|15.99|15.99|||
4052554|NCT01095250|3874315|B2|||Age||Years|Mean|46.9|46.9|Standard Deviation|12.80|12.8|||
4052555|NCT01095250|3874316|B1|||Age||Years|Mean|47.5|47.5|Standard Deviation|21.13|21.13|||
4052556|NCT01095094|3874349|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4052557|NCT01095094|3874349|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052558|NCT01095094|3874349|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052559|NCT01095094|3874349|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4052560|NCT01095094|3874349|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052561|NCT01095094|3874349|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052562|NCT01095094|3874349|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052563|NCT01095094|3874349|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052564|NCT01095094|3874349|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052565|NCT01095094|3874349|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4052566|NCT01095094|3874349|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4052567|NCT01095094|3874349|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4052568|NCT01095094|3874349|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4052569|NCT01095094|3874349|B1|70-79 years||Age, Customized||Participants|Number|2|2.0||||||
4052570|NCT01095094|3874349|B1|60-69 years||Age, Customized||Participants|Number|1|1.0||||||
4052571|NCT01095094|3874349|B1|50-59 years||Age, Customized||Participants|Number|7|7.0||||||
4052572|NCT01095094|3874349|B1|40-49 years||Age, Customized||Participants|Number|5|5.0||||||
4052573|NCT01095094|3874349|B1|30-39 years||Age, Customized||Participants|Number|4|4.0||||||
4052574|NCT01094886|3874354|B1|Not Hispanic or Latino||Ethnicity||participants|Number|52|52.0||||||
4052575|NCT01094886|3874354|B1|Hispanic or Latino||Ethnicity||participants|Number|1|1.0||||||
4052576|NCT01094886|3874354|B1|eGFR Between 30 and 59 mL/min||Baseline Estimated Glomerular Filtration Rate (eGFR) From Local Lab||participants|Number|6|6.0||||||
4052577|NCT01094886|3874354|B1|eGFR >= 60 mL/min||Baseline Estimated Glomerular Filtration Rate (eGFR) From Local Lab||participants|Number|47|47.0||||||
4052578|NCT01094886|3874354|B1|||Baseline BMI||kg/m^2|Mean|29.5|29.5|Standard Deviation|6.78|6.78|||
4052579|NCT01094886|3874354|B1|Knee||Surgical Type||participants|Number|27|27.0||||||
4052580|NCT01094886|3874354|B1|Hip||Surgical Type||participants|Number|26|26.0||||||
4052581|NCT01094886|3874354|B1|UNITED STATES||Region of Enrollment||participants|Number|53|53.0||||||
4052582|NCT01094886|3874354|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4052583|NCT01094886|3874354|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4052584|NCT01094886|3874354|B1|||Age||years|Mean|70.5|70.5|Standard Deviation|11.14|11.14|||
4052585|NCT01094886|3874354|B1||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
4052586|NCT01094886|3874354|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4052587|NCT01094886|3874354|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4052588|NCT01094808|3874361|B4|||Body Mass Index (BMI)|Body mass index is defined as the individual's body weight divided by the square of his or her height.|kg/m^2|Mean|26.3|26.3|Standard Deviation|0.6|0.6|||
4052589|NCT01094808|3874362|B3|||Body Mass Index (BMI)|Body mass index is defined as the individual's body weight divided by the square of his or her height.|kg/m^2|Mean|26.4|26.4|Standard Deviation|4.4|4.4|||
4052590|NCT01094808|3874363|B2|||Body Mass Index (BMI)|Body mass index is defined as the individual's body weight divided by the square of his or her height.|kg/m^2|Mean|26.7|26.7|Standard Deviation|6.3|6.3|||
4052591|NCT01094808|3874364|B1|||Body Mass Index (BMI)|Body mass index is defined as the individual's body weight divided by the square of his or her height.|kg/m^2|Mean|25.8|25.8|Standard Deviation|3.7|3.7|||
4052592|NCT01094808|3874361|B4|United States||Region of Enrollment||participants|Number|62|62.0||||||
4052593|NCT01094808|3874362|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4052594|NCT01094808|3874363|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4052595|NCT01094808|3874364|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4052596|NCT01094808|3874361|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4052597|NCT01094808|3874362|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4052598|NCT01094808|3874363|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4052599|NCT01094808|3874364|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4052600|NCT01094808|3874361|B4||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4052601|NCT01094808|3874362|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4052602|NCT01094808|3874363|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4052603|NCT01094808|3874364|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4052604|NCT01094808|3874361|B4|||Age||years|Mean|32|32.0|Standard Deviation|11|11.0|||
4052605|NCT01094808|3874362|B3|||Age||years|Mean|31.6|31.6|Standard Deviation|11.8|11.8|||
4052606|NCT01094808|3874363|B2|||Age||years|Mean|32.4|32.4|Standard Deviation|9.1|9.1|||
4052607|NCT01094808|3874364|B1|||Age||years|Mean|32.2|32.2|Standard Deviation|11.9|11.9|||
4052608|NCT01094782|3874401|B7|United States||Region of Enrollment||participants|Number|248|248.0||||||
4052609|NCT01094782|3874402|B6|United States||Region of Enrollment||participants|Number|38|38.0||||||
4052610|NCT01094782|3874403|B5|United States||Region of Enrollment||participants|Number|42|42.0||||||
4052611|NCT01094782|3874404|B4|United States||Region of Enrollment||participants|Number|56|56.0||||||
4052612|NCT01094782|3874405|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
4052613|NCT01094782|3874406|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
4052614|NCT01094782|3874407|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4052615|NCT01094782|3874401|B7||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4052616|NCT01094782|3874402|B6||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4052617|NCT01094782|3874403|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4052618|NCT01094782|3874404|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4052619|NCT01094782|3874405|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4052620|NCT01094782|3874406|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4052621|NCT01094782|3874407|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4052622|NCT01094782|3874401|B7||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4052623|NCT01094782|3874402|B6||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4052624|NCT01094782|3874403|B5||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4052625|NCT01094782|3874404|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4052626|NCT01094782|3874405|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4052627|NCT01094782|3874406|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4052628|NCT01094782|3874407|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4052629|NCT01094782|3874401|B7||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4052630|NCT01094782|3874402|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4052631|NCT01094782|3874403|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4052632|NCT01094782|3874404|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4052633|NCT01094782|3874405|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4052634|NCT01094782|3874406|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4052635|NCT01094782|3874407|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4052636|NCT01094782|3874401|B7||Between 18 and 65 years|Age||Participants|Count of Participants|247|247.0||||||
4052637|NCT01094782|3874402|B6||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4052638|NCT01094782|3874403|B5||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4052639|NCT01094782|3874404|B4||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4052640|NCT01094782|3874405|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4052641|NCT01094782|3874406|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4052642|NCT01094782|3874407|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4052643|NCT01094782|3874401|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4052644|NCT01094782|3874402|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4052645|NCT01094782|3874403|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4052646|NCT01094782|3874404|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4052647|NCT01094782|3874405|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4052648|NCT01094782|3874406|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4052649|NCT01094782|3874407|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4052650|NCT01094743|3874456|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
4052651|NCT01094743|3874456|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4052652|NCT01094743|3874456|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4052653|NCT01094743|3874456|B1|||Age||years|Mean|28|28.0|Standard Deviation|5.76|5.76|||
4052654|NCT01094730|3874473|B1|United States||Region of Enrollment||participants|Number|183|183.0||||||
4052655|NCT01094730|3874473|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4052656|NCT01094730|3874473|B1||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4052657|NCT01094730|3874473|B1|||Age||years|Mean|27.5|27.5|Standard Deviation|5.78|5.78|||
4052658|NCT01094704|3874485|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4052659|NCT01094704|3874486|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4052660|NCT01094704|3874487|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4052661|NCT01094704|3874485|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4052662|NCT01094704|3874486|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4052663|NCT01094704|3874487|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4052664|NCT01094704|3874485|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4052665|NCT01094704|3874486|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4052666|NCT01094704|3874487|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4052667|NCT01094704|3874485|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4052668|NCT01094704|3874486|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4052669|NCT01094704|3874487|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4052670|NCT01094704|3874485|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4052671|NCT01094704|3874486|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4052672|NCT01094704|3874487|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4052673|NCT01094574|3874494|B7||Male|Gender||Participants|Count of Participants|7|7.0||||||
4052674|NCT01094574|3874495|B6||Male|Gender||Participants|Count of Participants|2|2.0||||||
4052675|NCT01094574|3874496|B5||Male|Gender||Participants|Count of Participants|0|0.0||||||
4052676|NCT01094574|3874497|B4||Male|Gender||Participants|Count of Participants|2|2.0||||||
4052677|NCT01094574|3874498|B3||Male|Gender||Participants|Count of Participants|1|1.0||||||
4052678|NCT01094574|3874499|B2||Male|Gender||Participants|Count of Participants|1|1.0||||||
4052679|NCT01094574|3874500|B1||Male|Gender||Participants|Count of Participants|1|1.0||||||
4052680|NCT01094574|3874494|B7||Female|Gender||Participants|Count of Participants|3|3.0||||||
4052681|NCT01094574|3874495|B6||Female|Gender||Participants|Count of Participants|0|0.0||||||
4052682|NCT01094574|3874496|B5||Female|Gender||Participants|Count of Participants|2|2.0||||||
4052683|NCT01094574|3874497|B4||Female|Gender||Participants|Count of Participants|0|0.0||||||
4052684|NCT01094574|3874498|B3||Female|Gender||Participants|Count of Participants|1|1.0||||||
4052685|NCT01094574|3874499|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
4052686|NCT01094574|3874500|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
4052687|NCT01094574|3874494|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4052688|NCT01094574|3874495|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4052689|NCT01094574|3874496|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4052690|NCT01094574|3874497|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4052691|NCT01094574|3874498|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4052692|NCT01094574|3874499|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4052693|NCT01094574|3874500|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4052694|NCT01094574|3874494|B7||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4052695|NCT01094574|3874495|B6||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4052696|NCT01094574|3874496|B5||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4052697|NCT01094574|3874497|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4052698|NCT01094574|3874498|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4052699|NCT01094574|3874499|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4052700|NCT01094574|3874500|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4052701|NCT01094574|3874494|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4052702|NCT01094574|3874495|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4052703|NCT01094574|3874496|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4052704|NCT01094574|3874497|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4052705|NCT01094574|3874498|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4052706|NCT01094574|3874499|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4052707|NCT01094574|3874500|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4052708|NCT01094561|3874552|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052709|NCT01094561|3874552|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4052710|NCT01094561|3874552|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4052711|NCT01094561|3874552|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4052712|NCT01094561|3874552|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052713|NCT01094561|3874552|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052714|NCT01094561|3874552|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052715|NCT01094561|3874552|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052716|NCT01094561|3874552|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4052717|NCT01094561|3874552|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4052718|NCT01094561|3874552|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4052719|NCT01094561|3874552|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4052720|NCT01094561|3874552|B1|>60 years||Age, Customized||participants|Number|11|11.0||||||
4052721|NCT01094561|3874552|B1|50-59 years||Age, Customized||participants|Number|9|9.0||||||
4052722|NCT01094561|3874552|B1|40-49 years||Age, Customized||participants|Number|2|2.0||||||
4052723|NCT01094561|3874552|B1|30-39 years||Age, Customized||participants|Number|1|1.0||||||
4052724|NCT01094561|3874552|B1|18-29 years||Age, Customized||participants|Number|0|0.0||||||
4052725|NCT01094548|3874557|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4052726|NCT01094548|3874558|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4052727|NCT01094548|3874559|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4052728|NCT01094548|3874557|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4052729|NCT01094548|3874558|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4052730|NCT01094548|3874559|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4052731|NCT01094548|3874557|B3|||Age||years|Mean|63.2|63.2|Standard Deviation|8.28|8.28|||
4052732|NCT01094548|3874558|B2|||Age||years|Mean|63.9|63.9|Standard Deviation|9.36|9.36|||
4052733|NCT01094548|3874559|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|7.26|7.26|||
4052734|NCT01094522|3874578|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4052735|NCT01094522|3874579|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4052736|NCT01094522|3874580|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4052737|NCT01094522|3874578|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4052738|NCT01094522|3874579|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4052739|NCT01094522|3874580|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4052740|NCT01094522|3874578|B3|||Age||years|Mean|1.19|1.19|Full Range|||0.01|5.39|
4052741|NCT01094522|3874579|B2|||Age||years|Mean|1.37|1.37|Full Range|||0.01|5.39|
4052742|NCT01094522|3874580|B1|||Age||years|Mean|1.00|1.0|Full Range|||0.01|3.79|
4052743|NCT01094301|3874591|B1|||Stroke Onset to Enrollment||Years|Mean|2.7|2.7|Standard Deviation|2.5|2.5|||
4052744|NCT01094301|3874591|B1||Ischemic and Intracerebral hemorrhage (ICH)|Type of Stroke||Participants|Count of Participants|1|1.0||||||
4052745|NCT01094301|3874591|B1||Ischemic only|Type of Stroke||Participants|Count of Participants|20|20.0||||||
4052746|NCT01094301|3874591|B1||Subarachnoid hemorrhage|Type of Stroke||Participants|Count of Participants|1|1.0||||||
4052747|NCT01094301|3874591|B1||Intracerebral hemorrhage|Type of Stroke||Participants|Count of Participants|2|2.0||||||
4052748|NCT01094301|3874591|B1||Hemorrhagic and Intracerebral hemorrhage (ICH)|Type of Stroke||Participants|Count of Participants|3|3.0||||||
4052749|NCT01094301|3874591|B1||Hemorrhagic only|Type of Stroke||Participants|Count of Participants|1|1.0||||||
4052750|NCT01094301|3874591|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052751|NCT01094301|3874591|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052752|NCT01094301|3874591|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4052753|NCT01094301|3874591|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4052754|NCT01094301|3874591|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052755|NCT01094301|3874591|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052756|NCT01094301|3874591|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052757|NCT01094301|3874591|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052758|NCT01094301|3874591|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4052759|NCT01094301|3874591|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052760|NCT01094301|3874591|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4052761|NCT01094301|3874591|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4052762|NCT01094301|3874591|B1|||Age||Years|Mean|56.2|56.2|Standard Deviation|11.0|11.0|||
4052763|NCT01094184|3874613|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4052764|NCT01094184|3874614|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4052765|NCT01094184|3874615|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4052766|NCT01094184|3874613|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4052767|NCT01094184|3874614|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4052768|NCT01094184|3874615|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4052769|NCT01094184|3874613|B3|||Age||years|Mean|54.2|54.2|Standard Deviation|13.64|13.64|||
4052770|NCT01094184|3874614|B2|||Age||years|Mean|58.4|58.4|Standard Deviation|9.22|9.22|||
4052771|NCT01094184|3874615|B1|||Age||years|Mean|52.8|52.8|Standard Deviation|14.74|14.74|||
4052772|NCT01094171|3874850|B1||Male|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4052773|NCT01094171|3874850|B1||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4052774|NCT01094171|3874850|B1|||Age||Months|Mean|3.40|3.4|Standard Deviation|0.50|0.5|||
4052775|NCT01094119|3874857|B3|||preoperative oral temperature||degrees C|Mean|36.2|36.2|Standard Deviation|.8|0.8|||
4052776|NCT01094119|3874858|B2|||preoperative oral temperature||degrees C|Mean|36.8|36.8|Standard Deviation|.8|0.8|||
4052777|NCT01094119|3874859|B1|||preoperative oral temperature||degrees C|Mean|36.2|36.2|Standard Deviation|.9|0.9|||
4052778|NCT01094119|3874857|B3|Canada||Region of Enrollment||participants|Number|24|24.0||||||
4052779|NCT01094119|3874858|B2|Canada||Region of Enrollment||participants|Number|13|13.0||||||
4052780|NCT01094119|3874859|B1|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4052781|NCT01094119|3874857|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
4052782|NCT01094119|3874858|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4052783|NCT01094119|3874859|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4052784|NCT01094119|3874857|B3|Not Caucasian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4052785|NCT01094119|3874858|B2|Not Caucasian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4052786|NCT01094119|3874859|B1|Not Caucasian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4052787|NCT01094119|3874857|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
4052788|NCT01094119|3874858|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4052789|NCT01094119|3874859|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4052790|NCT01094119|3874857|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4052791|NCT01094119|3874858|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4052792|NCT01094119|3874859|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4052793|NCT01094119|3874857|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4052794|NCT01094119|3874858|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4052795|NCT01094119|3874859|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4052796|NCT01094119|3874857|B3|||Age||years|Mean|51|51.0|Standard Deviation|14|14.0|||
4052797|NCT01094119|3874858|B2|||Age||years|Mean|51|51.0|Standard Deviation|15|15.0|||
4052798|NCT01094119|3874859|B1|||Age||years|Mean|51|51.0|Standard Deviation|13|13.0|||
4052799|NCT01093976|3874868|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4052800|NCT01093976|3874868|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4052801|NCT01093976|3874868|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4052802|NCT01093976|3874868|B1|||Age||years|Mean|33.29|33.29|Standard Deviation|8.86|8.86|||
4052803|NCT01093976|3874868|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4052804|NCT01093976|3874868|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4052805|NCT01093976|3874868|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4052806|NCT01093885|3874872|B1|||Extent of skin sclerosis|Modified Rodnan Skin Score (mRss), subjective skin scoring of 17 different areas on the body based on a score of 0 to 3 for each side based on the severity of skin tightness of each side, physician assessment, scale from 0-51 points with worse scores at the higher end of the range.|units on a scale|Mean|21|21.0|Standard Deviation|7.4|7.4|||
4052807|NCT01093885|3874872|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4052808|NCT01093885|3874872|B1||Male|Sex: Female, Male|Consecutive patients referred to the study|Participants|Count of Participants|5|5.0||||||
4052809|NCT01093885|3874872|B1||Female|Sex: Female, Male|Consecutive patients referred to the study|Participants|Count of Participants|10|10.0||||||
4052810|NCT01093885|3874872|B1|||Age||years|Mean|47.6|47.6|Standard Deviation|10.7|10.7|||
4052811|NCT01093846|3874877|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4052812|NCT01093846|3874878|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4052813|NCT01093846|3874879|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4052814|NCT01093846|3874880|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4052815|NCT01093846|3874877|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4052816|NCT01093846|3874878|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4052817|NCT01093846|3874879|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4052818|NCT01093846|3874880|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4052819|NCT01093846|3874877|B4|||Age||years|Mean|36.0|36.0|Standard Deviation|11.29|11.29|||
4052820|NCT01093846|3874878|B3|||Age||years|Mean|34.9|34.9|Standard Deviation|11.20|11.2|||
4052821|NCT01093846|3874879|B2|||Age||years|Mean|36.8|36.8|Standard Deviation|13.07|13.07|||
4052822|NCT01093846|3874880|B1|||Age||years|Mean|36.5|36.5|Standard Deviation|10.01|10.01|||
4052823|NCT01093794|3874888|B1|||Body Mass Index (BMI)||kg/m^2|Mean|22|22.0|Standard Deviation|1.22|1.22|||
4052824|NCT01093794|3874888|B1|China||Region of Enrollment||participants|Number|28|28.0||||||
4052825|NCT01093794|3874888|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4052826|NCT01093794|3874888|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4052827|NCT01093794|3874888|B1|||Age||years|Mean|28.6|28.6|Standard Deviation|5.61|5.61|||
4052828|NCT01093755|3874905|B3|Subjects not undergoing resection||Number undergoing Endoscopic Mucosal Resection||Participants|Number|2|2.0||||||
4052829|NCT01093755|3874906|B2|Subjects not undergoing resection||Number undergoing Endoscopic Mucosal Resection||Participants|Number|2|2.0||||||
4052830|NCT01093755|3874907|B1|Subjects not undergoing resection||Number undergoing Endoscopic Mucosal Resection||Participants|Number|0|0.0||||||
4052831|NCT01093755|3874905|B3|Subjects undergoing resection||Number undergoing Endoscopic Mucosal Resection||Participants|Number|28|28.0||||||
4052832|NCT01093755|3874906|B2|Subjects undergoing resection||Number undergoing Endoscopic Mucosal Resection||Participants|Number|12|12.0||||||
4052833|NCT01093755|3874907|B1|Subjects undergoing resection||Number undergoing Endoscopic Mucosal Resection||Participants|Number|16|16.0||||||
4052834|NCT01093755|3874905|B3|||Diaphragmatic Hernia length||cm|Mean|3.3|3.3|Standard Deviation|2.05|2.05|||
4052835|NCT01093755|3874906|B2|||Diaphragmatic Hernia length||cm|Mean|3.0|3.0|Standard Deviation|1.7|1.7|||
4052836|NCT01093755|3874907|B1|||Diaphragmatic Hernia length||cm|Mean|3.6|3.6|Standard Deviation|2.3|2.3|||
4052837|NCT01093755|3874905|B3|Subjects without Diaphragmatic Hernia||Diaphragmatic Hernia present||Participants|Number|2|2.0||||||
4052838|NCT01093755|3874906|B2|Subjects without Diaphragmatic Hernia||Diaphragmatic Hernia present||Participants|Number|1|1.0||||||
4052839|NCT01093755|3874907|B1|Subjects without Diaphragmatic Hernia||Diaphragmatic Hernia present||Participants|Number|1|1.0||||||
4052840|NCT01093755|3874905|B3|Subjects with Diaphragmatic Hernia||Diaphragmatic Hernia present||Participants|Number|28|28.0||||||
4052841|NCT01093755|3874906|B2|Subjects with Diaphragmatic Hernia||Diaphragmatic Hernia present||Participants|Number|13|13.0||||||
4052842|NCT01093755|3874907|B1|Subjects with Diaphragmatic Hernia||Diaphragmatic Hernia present||Participants|Number|15|15.0||||||
4052843|NCT01093755|3874905|B3|||Barrett's Esophagus segment length, pre-ablation||cm|Mean|5.06|5.06|Standard Deviation|3.84|3.84|||
4052844|NCT01093755|3874906|B2|||Barrett's Esophagus segment length, pre-ablation||cm|Mean|4.8|4.8|Standard Deviation|4.3|4.3|||
4052845|NCT01093755|3874907|B1|||Barrett's Esophagus segment length, pre-ablation||cm|Mean|5.3|5.3|Standard Deviation|3.5|3.5|||
4052846|NCT01093755|3874905|B3|||Body Mass Index||kg/height in meters^2|Mean|30.14|30.14|Standard Deviation|3.84|3.84|||
4052847|NCT01093755|3874906|B2|||Body Mass Index||kg/height in meters^2|Mean|29.3|29.3|Standard Deviation|4.2|4.2|||
4052848|NCT01093755|3874907|B1|||Body Mass Index||kg/height in meters^2|Mean|30.9|30.9|Standard Deviation|3.4|3.4|||
4052849|NCT01093755|3874905|B3|Subjects with Low-Grade Dysplasia||High Grade Dysplasia/Intramucosal Carcinoma||participants|Number|8|8.0||||||
4052850|NCT01093755|3874906|B2|Subjects with Low-Grade Dysplasia||High Grade Dysplasia/Intramucosal Carcinoma||participants|Number|4|4.0||||||
4052851|NCT01093755|3874907|B1|Subjects with Low-Grade Dysplasia||High Grade Dysplasia/Intramucosal Carcinoma||participants|Number|4|4.0||||||
4052852|NCT01093755|3874905|B3|Subjects with High-Grade Dysplasia/Carcinoma||High Grade Dysplasia/Intramucosal Carcinoma||participants|Number|22|22.0||||||
4052853|NCT01093755|3874906|B2|Subjects with High-Grade Dysplasia/Carcinoma||High Grade Dysplasia/Intramucosal Carcinoma||participants|Number|10|10.0||||||
4052854|NCT01093755|3874907|B1|Subjects with High-Grade Dysplasia/Carcinoma||High Grade Dysplasia/Intramucosal Carcinoma||participants|Number|12|12.0||||||
4052855|NCT01093755|3874905|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4052856|NCT01093755|3874906|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4052857|NCT01093755|3874907|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4052858|NCT01093755|3874905|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4052859|NCT01093755|3874906|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4052860|NCT01093755|3874907|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4052861|NCT01093755|3874905|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4052862|NCT01093755|3874906|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4052863|NCT01093755|3874907|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4052864|NCT01093755|3874905|B3|||Age||Years|Mean|61.5|61.5|Standard Deviation|8.14|8.14|||
4052865|NCT01093755|3874906|B2|||Age||Years|Mean|59.1|59.1|Standard Deviation|8.9|8.9|||
4052866|NCT01093755|3874907|B1|||Age||Years|Mean|63.9|63.9|Standard Deviation|6.9|6.9|||
4052867|NCT01093690|3874916|B3|Thailand||Region of Enrollment||participants|Number|162|162.0||||||
4052868|NCT01093690|3874917|B2|Thailand||Region of Enrollment||participants|Number|79|79.0||||||
4052869|NCT01093690|3874918|B1|Thailand||Region of Enrollment||participants|Number|83|83.0||||||
4052870|NCT01093690|3874916|B3||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4052871|NCT01093690|3874917|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4052872|NCT01093690|3874918|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4052873|NCT01093690|3874916|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4052874|NCT01093690|3874917|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4052875|NCT01093690|3874918|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4052876|NCT01093690|3874916|B3|>= 50 years||Age, Customized||participants|Number|83|83.0||||||
4052877|NCT01093690|3874917|B2|>= 50 years||Age, Customized||participants|Number|41|41.0||||||
4052878|NCT01093690|3874918|B1|>= 50 years||Age, Customized||participants|Number|42|42.0||||||
4052879|NCT01093690|3874916|B3|Between 18 and 50 years||Age, Customized||participants|Number|79|79.0||||||
4052880|NCT01093690|3874917|B2|Between 18 and 50 years||Age, Customized||participants|Number|38|38.0||||||
4052881|NCT01093690|3874918|B1|Between 18 and 50 years||Age, Customized||participants|Number|41|41.0||||||
4052882|NCT01093651|3874925|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4052883|NCT01093651|3874926|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4052884|NCT01093651|3874927|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4052885|NCT01093651|3874925|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4052886|NCT01093651|3874926|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4052887|NCT01093651|3874927|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4052888|NCT01093651|3874925|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4052889|NCT01093651|3874926|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4052890|NCT01093651|3874927|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4052891|NCT01093651|3874925|B3|||Age||years|Mean|38|38.0|Standard Deviation|12|12.0|||
4052892|NCT01093651|3874926|B2|||Age||years|Mean|36|36.0|Standard Deviation|9|9.0|||
4052893|NCT01093651|3874927|B1|||Age||years|Mean|40|40.0|Standard Deviation|15|15.0|||
4052894|NCT01093651|3874925|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4052895|NCT01093651|3874926|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4052896|NCT01093651|3874927|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4052897|NCT01093651|3874925|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4052898|NCT01093651|3874926|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4052899|NCT01093651|3874927|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4052900|NCT01093651|3874925|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4052901|NCT01093651|3874926|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4052902|NCT01093651|3874927|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4052903|NCT01093625|3874946|B3|United States||Region of Enrollment||participants|Number|98|98.0||||||
4052904|NCT01093625|3874947|B2|United States||Region of Enrollment||participants|Number|49|49.0||||||
4052905|NCT01093625|3874948|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
4052906|NCT01093625|3874946|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4052907|NCT01093625|3874947|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4052908|NCT01093625|3874948|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4052909|NCT01093625|3874946|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4052910|NCT01093625|3874947|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4052911|NCT01093625|3874948|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4052912|NCT01093625|3874946|B3|||Age||years|Mean|22.94|22.94|Standard Deviation|6.36|6.36|||
4052913|NCT01093625|3874947|B2|||Age||years|Mean|23.31|23.31|Standard Deviation|6.08|6.08|||
4052914|NCT01093625|3874948|B1|||Age||years|Mean|22.57|22.57|Standard Deviation|6.67|6.67|||
4052915|NCT01093625|3874946|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4052916|NCT01093625|3874947|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4052917|NCT01093625|3874948|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4052918|NCT01093625|3874946|B3||Between 18 and 65 years|Age||Participants|Count of Participants|98|98.0||||||
4052919|NCT01093625|3874947|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4052920|NCT01093625|3874948|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4052921|NCT01093625|3874946|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4052922|NCT01093625|3874947|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4052923|NCT01093625|3874948|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4052924|NCT01093599|3874967|B3|United States||Region of Enrollment||participants|Number|196|196.0||||||
4052925|NCT01093599|3874968|B2|United States||Region of Enrollment||participants|Number|105|105.0||||||
4052926|NCT01093599|3874969|B1|United States||Region of Enrollment||participants|Number|91|91.0||||||
4052927|NCT01093599|3874967|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4052928|NCT01093599|3874968|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4052929|NCT01093599|3874969|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4052930|NCT01093599|3874967|B3||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4052931|NCT01093599|3874968|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4052932|NCT01093599|3874969|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4052933|NCT01093599|3874967|B3|||Age||years|Mean|41.65|41.65|Standard Deviation|13.92|13.92|||
4052934|NCT01093599|3874968|B2|||Age||years|Mean|42.25|42.25|Standard Deviation|14.53|14.53|||
4052935|NCT01093599|3874969|B1|||Age||years|Mean|40.95|40.95|Standard Deviation|12.05|12.05|||
4052936|NCT01093534|3874976|B4|Other||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4052937|NCT01093534|3874977|B3|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4052938|NCT01093534|3874978|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4052939|NCT01093534|3874979|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4052940|NCT01093534|3874976|B4|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4052941|NCT01093534|3874977|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4052942|NCT01093534|3874978|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4052943|NCT01093534|3874979|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4052944|NCT01093534|3874976|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4052945|NCT01093534|3874977|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4052946|NCT01093534|3874978|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4052947|NCT01093534|3874979|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4052948|NCT01093534|3874976|B4|White||Race/Ethnicity, Customized||participants|Number|519|519.0||||||
4052949|NCT01093534|3874977|B3|White||Race/Ethnicity, Customized||participants|Number|165|165.0||||||
4052950|NCT01093534|3874978|B2|White||Race/Ethnicity, Customized||participants|Number|177|177.0||||||
4052951|NCT01093534|3874979|B1|White||Race/Ethnicity, Customized||participants|Number|177|177.0||||||
4052952|NCT01093534|3874976|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4052953|NCT01093534|3874977|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4052954|NCT01093534|3874978|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4052955|NCT01093534|3874979|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4052956|NCT01093534|3874976|B4||Female|Sex: Female, Male||Participants|Count of Participants|543|543.0||||||
4052957|NCT01093534|3874977|B3||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4052958|NCT01093534|3874978|B2||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4052959|NCT01093534|3874979|B1||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4052960|NCT01093534|3874976|B4|||Age||years|Mean|54.9|54.9|Standard Deviation|13.1|13.1|||
4052961|NCT01093534|3874977|B3|||Age||years|Mean|55.5|55.5|Standard Deviation|13.3|13.3|||
4052962|NCT01093534|3874978|B2|||Age||years|Mean|55.5|55.5|Standard Deviation|13.0|13.0|||
4052963|NCT01093534|3874979|B1|||Age||years|Mean|53.7|53.7|Standard Deviation|13.0|13.0|||
4052964|NCT01093521|3875086|B1|||Mean Pseudomonas aeruginosa quantitative sputum culture (CFU's/gr of sputum)||Million CFU/gr of sputum|Mean|116.7|116.7|Full Range|||0.378|866.0|
4052965|NCT01093521|3875086|B1|||Forced vital capacity (FVC)(in liters)||liters|Mean|3.60|3.6|Full Range|||1.84|6.11|
4052966|NCT01093521|3875086|B1|||Forced expiratory volume in one second (FEV1) (in liters)||liters|Mean|2.25|2.25|Full Range|||1.06|4.59|
4052967|NCT01093521|3875086|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4052968|NCT01093521|3875086|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4052969|NCT01093521|3875086|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4052970|NCT01093521|3875086|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4052971|NCT01093521|3875086|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4052972|NCT01093521|3875086|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052973|NCT01093521|3875086|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4052974|NCT01093521|3875086|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052975|NCT01093521|3875086|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052976|NCT01093521|3875086|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052977|NCT01093521|3875086|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052978|NCT01093521|3875086|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4052979|NCT01093521|3875086|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4052980|NCT01093521|3875086|B1|||Age||years|Mean|32.8|32.8|Standard Deviation|9.5|9.5|||
4052981|NCT01093482|3875101|B1||Male|Sex: Female, Male||Participants|Count of Participants|5046|5046.0||||||
4052982|NCT01093482|3875101|B1||Female|Sex: Female, Male||Participants|Count of Participants|3105|3105.0||||||
4052983|NCT01093482|3875101|B1|||Age||years|Mean|61|61.0|Standard Deviation|18|18.0|||
4052984|NCT01093482|3875101|B1||>=65 years|Age||Participants|Count of Participants|3918|3918.0||||||
4052985|NCT01093482|3875101|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4233|4233.0||||||
4052986|NCT01093482|3875101|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4052987|NCT01093469|3875105|B4|United States||Region of Enrollment||participants|Number|39|39.0||||||
4052988|NCT01093469|3875106|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4052989|NCT01093469|3875107|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4052990|NCT01093469|3875108|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4052991|NCT01093469|3875105|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052992|NCT01093469|3875106|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052993|NCT01093469|3875107|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052994|NCT01093469|3875108|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052995|NCT01093469|3875105|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4052996|NCT01093469|3875106|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052997|NCT01093469|3875107|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4052998|NCT01093469|3875108|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4052999|NCT01093469|3875105|B4||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4053000|NCT01093469|3875106|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4053001|NCT01093469|3875107|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4053002|NCT01093469|3875108|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4053003|NCT01093469|3875105|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4053004|NCT01093469|3875106|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4053005|NCT01093469|3875107|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4053006|NCT01093469|3875108|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4053007|NCT01093469|3875105|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053008|NCT01093469|3875106|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053009|NCT01093469|3875107|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053010|NCT01093469|3875108|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053011|NCT01093469|3875105|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4053012|NCT01093469|3875106|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053013|NCT01093469|3875107|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053014|NCT01093469|3875108|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4053015|NCT01093469|3875105|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053016|NCT01093469|3875106|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053017|NCT01093469|3875107|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053018|NCT01093469|3875108|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053019|NCT01093469|3875105|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053020|NCT01093469|3875106|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053021|NCT01093469|3875107|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053022|NCT01093469|3875108|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053023|NCT01093469|3875105|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4053024|NCT01093469|3875106|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4053025|NCT01093469|3875107|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4053026|NCT01093469|3875108|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4053027|NCT01093469|3875105|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4053028|NCT01093469|3875106|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4053029|NCT01093469|3875107|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053030|NCT01093469|3875108|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4053031|NCT01093469|3875105|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4053032|NCT01093469|3875106|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4053033|NCT01093469|3875107|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4053034|NCT01093469|3875108|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4053035|NCT01093469|3875105|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4053036|NCT01093469|3875106|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4053037|NCT01093469|3875107|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4053038|NCT01093469|3875108|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4053039|NCT01093469|3875105|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4053040|NCT01093469|3875106|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4053041|NCT01093469|3875107|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4053042|NCT01093469|3875108|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4053043|NCT01093469|3875105|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4053044|NCT01093469|3875106|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4053045|NCT01093469|3875107|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4053046|NCT01093469|3875108|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4053047|NCT01093469|3875105|B4||<=18 years|Age||Participants|Count of Participants|39|39.0||||||
4053048|NCT01093469|3875106|B3||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4053049|NCT01093469|3875107|B2||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4053050|NCT01093469|3875108|B1||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4053051|NCT01093417|3875118|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
4053052|NCT01093417|3875119|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4053053|NCT01093417|3875120|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4053054|NCT01093417|3875118|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4053055|NCT01093417|3875119|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4053056|NCT01093417|3875120|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4053057|NCT01093417|3875118|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4053058|NCT01093417|3875119|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4053059|NCT01093417|3875120|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4053060|NCT01093417|3875118|B3|||Age||years|Mean|45|45.0|Standard Deviation|9|9.0|||
4053061|NCT01093417|3875119|B2|||Age||years|Mean|47|47.0|Standard Deviation|8|8.0|||
4053062|NCT01093417|3875120|B1|||Age||years|Mean|40|40.0|Standard Deviation|10|10.0|||
4053063|NCT01093417|3875118|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4053064|NCT01093417|3875119|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4053065|NCT01093417|3875120|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4053066|NCT01093417|3875118|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4053067|NCT01093417|3875119|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4053068|NCT01093417|3875120|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4053069|NCT01093417|3875118|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4053070|NCT01093417|3875119|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4053071|NCT01093417|3875120|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4053072|NCT01093222|3875129|B1|None||Setting of Prior Chemotherapy||participants|Number|33|33.0||||||
4053073|NCT01093222|3875129|B1|Neoadjuvant||Setting of Prior Chemotherapy||participants|Number|0|0.0||||||
4053074|NCT01093222|3875129|B1|Adjuvant||Setting of Prior Chemotherapy||participants|Number|1|1.0||||||
4053075|NCT01093222|3875129|B1|No||Prior Radiation Therapy||participants|Number|34|34.0||||||
4053076|NCT01093222|3875129|B1|Yes||Prior Radiation Therapy||participants|Number|0|0.0||||||
4053077|NCT01093222|3875129|B1|Gallbladder||Primary Cancer||participants|Number|14|14.0||||||
4053078|NCT01093222|3875129|B1|Cholangiocarcinoma||Primary Cancer||participants|Number|20|20.0||||||
4053079|NCT01093222|3875129|B1|Locally Advanced||Current Status of Disease||participants|Number|6|6.0||||||
4053080|NCT01093222|3875129|B1|Distant Metastatic||Current Status of Disease||participants|Number|28|28.0||||||
4053081|NCT01093222|3875129|B1|No||Prior Surgery||participants|Number|20|20.0||||||
4053082|NCT01093222|3875129|B1|Yes||Prior Surgery||participants|Number|14|14.0||||||
4053083|NCT01093222|3875129|B1|No||Chemotherapy, multiple agents||participants|Number|33|33.0||||||
4053084|NCT01093222|3875129|B1|Yes||Chemotherapy, multiple agents||participants|Number|1|1.0||||||
4053085|NCT01093222|3875129|B1|1||Zubrod Performance Status|Zubrod Performance Status Scale: 0 - Fully active, able to carry on all pre-disease performance without restriction; 1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light sedentary nature; 2 - Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours; 3 - Capable of limited self-care, confined to bed or chair more than 50% of waking hours; 4 - Completely disabled, cannot carry on any self-care, totally confined to bed or chair|participants|Number|15|15.0||||||
4053086|NCT01093222|3875129|B1|0||Zubrod Performance Status|Zubrod Performance Status Scale: 0 - Fully active, able to carry on all pre-disease performance without restriction; 1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light sedentary nature; 2 - Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours; 3 - Capable of limited self-care, confined to bed or chair more than 50% of waking hours; 4 - Completely disabled, cannot carry on any self-care, totally confined to bed or chair|participants|Number|19|19.0||||||
4053087|NCT01093222|3875129|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4053088|NCT01093222|3875129|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053089|NCT01093222|3875129|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4053090|NCT01093222|3875129|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4053091|NCT01093222|3875129|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053092|NCT01093222|3875129|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4053093|NCT01093222|3875129|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053094|NCT01093222|3875129|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053095|NCT01093222|3875129|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4053096|NCT01093222|3875129|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4053097|NCT01093222|3875129|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4053098|NCT01093222|3875129|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4053099|NCT01093222|3875129|B1|||Age||years|Median|63|63.0|Full Range|||49.0|82.0|
4053100|NCT01093183|3875136|B1|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4053101|NCT01093183|3875136|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4053102|NCT01093183|3875136|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4053103|NCT01093183|3875136|B1|||Age||years|Median|76|76.0|Full Range|||50.0|86.0|
4053104|NCT01093027|3875145|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4053105|NCT01093027|3875146|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4053106|NCT01093027|3875147|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4053107|NCT01093027|3875145|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4053108|NCT01093027|3875146|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4053109|NCT01093027|3875147|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4053110|NCT01093027|3875145|B3|||Age||years|Mean|73.8|73.8|Standard Deviation|6.3|6.3|||
4053111|NCT01093027|3875146|B2|||Age||years|Mean|76.3|76.3|Standard Deviation|4.9|4.9|||
4053112|NCT01093027|3875147|B1|||Age||years|Mean|71.2|71.2|Standard Deviation|6.8|6.8|||
4053113|NCT01093014|3875156|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4053114|NCT01093014|3875157|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4053115|NCT01093014|3875158|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4053116|NCT01093014|3875159|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4053117|NCT01093014|3875156|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4053118|NCT01093014|3875157|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4053119|NCT01093014|3875158|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4053120|NCT01093014|3875159|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4053121|NCT01093014|3875156|B4|||Age||years|Mean|32.2|32.2|Standard Deviation|10.3|10.3|||
4053122|NCT01093014|3875157|B3|||Age||years|Mean|32.3|32.3|Standard Deviation|9.1|9.1|||
4053123|NCT01093014|3875158|B2|||Age||years|Mean|36.0|36.0|Standard Deviation|32.3|32.3|||
4053124|NCT01093014|3875159|B1|||Age||years|Mean|29.33|29.33|Standard Deviation|7.45|7.45|||
4053125|NCT01092923|3875178|B3|Australia||Region of Enrollment||participants|Number|20|20.0||||||
4053126|NCT01092923|3875179|B2|Australia||Region of Enrollment||participants|Number|10|10.0||||||
4053127|NCT01092923|3875180|B1|Australia||Region of Enrollment||participants|Number|10|10.0||||||
4053128|NCT01092923|3875178|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4053129|NCT01092923|3875179|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4053130|NCT01092923|3875180|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4053131|NCT01092923|3875178|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4053132|NCT01092923|3875179|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4053133|NCT01092923|3875180|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4053134|NCT01092923|3875178|B3|||Age||years|Mean|66|66.0|Standard Deviation|16|16.0|||
4053135|NCT01092923|3875179|B2|||Age||years|Mean|67|67.0|Standard Deviation|13|13.0|||
4053136|NCT01092923|3875180|B1|||Age||years|Mean|65|65.0|Standard Deviation|18|18.0|||
4053137|NCT01092923|3875178|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4053138|NCT01092923|3875179|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4053139|NCT01092923|3875180|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4053140|NCT01092923|3875178|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4053141|NCT01092923|3875179|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4053142|NCT01092923|3875180|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4053143|NCT01092923|3875178|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4053144|NCT01092923|3875179|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4053145|NCT01092923|3875180|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4053146|NCT01092910|3875190|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053147|NCT01092910|3875190|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053148|NCT01092910|3875190|B1||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4053149|NCT01092910|3875190|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053150|NCT01092910|3875190|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053151|NCT01092910|3875190|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4053152|NCT01092910|3875190|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053153|NCT01092910|3875190|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053154|NCT01092910|3875190|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4053155|NCT01092910|3875190|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053156|NCT01092910|3875190|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4053157|NCT01092910|3875190|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4053158|NCT01092910|3875190|B1|||Age||years|Mean|52.9|52.9|Standard Deviation|15.8|15.8|||
4053159|NCT01092832|3875200|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4053160|NCT01092832|3875201|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4053161|NCT01092832|3875202|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4053162|NCT01092832|3875200|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4053163|NCT01092832|3875201|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4053164|NCT01092832|3875202|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4053165|NCT01092832|3875200|B3|||Age||years|Mean|9.5|9.5|Standard Deviation|4.5|4.5|||
4053166|NCT01092832|3875201|B2|||Age||years|Mean|14.4|14.4|Standard Deviation|1.7|1.7|||
4053167|NCT01092832|3875202|B1|||Age||years|Mean|6.8|6.8|Standard Deviation|2.9|2.9|||
4053168|NCT01092780|3875215|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4053169|NCT01092780|3875215|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4053170|NCT01092780|3875215|B1|||Age||Years|Mean|50.0|50.0|Standard Deviation|7.7|7.7|32.0|62.0|
4053171|NCT01092767|3875248|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4053172|NCT01092767|3875248|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4053173|NCT01092767|3875248|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4053174|NCT01092767|3875248|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4053175|NCT01092767|3875248|B1|||Age||years|Mean|40.7|40.7|Standard Deviation|17.4|17.4|||
4053176|NCT01092767|3875248|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4053177|NCT01092767|3875248|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4053178|NCT01092767|3875248|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4053179|NCT01092728|3875252|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4053180|NCT01092728|3875253|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4053181|NCT01092728|3875254|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4053182|NCT01092728|3875252|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4053183|NCT01092728|3875253|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4053184|NCT01092728|3875254|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4053185|NCT01092728|3875252|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4053186|NCT01092728|3875253|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4053187|NCT01092728|3875254|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4053188|NCT01092728|3875252|B3|||Age||years|Median|71|71.0|Full Range|||43.0|81.0|
4053189|NCT01092728|3875253|B2|||Age||years|Median|66|66.0|Full Range|||43.0|79.0|
4053190|NCT01092728|3875254|B1|||Age||years|Median|76|76.0|Full Range|||74.0|81.0|
4053191|NCT01092702|3875263|B1|||Duration of alcohol recovery|Self reported number of months in recovery from alcohol dependence prior to study enrollment.|months|Median|29|29.0|Full Range|||6.0|217.0|
4053192|NCT01092702|3875263|B1|||cigarettes per day|Self reported average number of cigarettes smoked per day over the preceding 6 months prior to study enrollment.|cigarettes per day|Mean|20.3|20.3|Standard Deviation|5.0|5.0|||
4053193|NCT01092702|3875263|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4053194|NCT01092702|3875263|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4053195|NCT01092702|3875263|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4053196|NCT01092702|3875263|B1|||Age||years|Mean|42.9|42.9|Standard Deviation|10.5|10.5|||
4053197|NCT01092702|3875263|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4053198|NCT01092702|3875263|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4053199|NCT01092702|3875263|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4053200|NCT01092663|3875267|B3|||fasting triglycerides||micrograms/deciliter (mg/dL)|Mean|150.3|150.3|Standard Deviation|55.8|55.8|||
4053201|NCT01092663|3875268|B2|||fasting triglycerides||micrograms/deciliter (mg/dL)|Mean|147.4|147.4|Standard Deviation|59.8|59.8|||
4053202|NCT01092663|3875269|B1|||fasting triglycerides||micrograms/deciliter (mg/dL)|Mean|153.1|153.1|Standard Deviation|51.8|51.8|||
4053203|NCT01092663|3875267|B3|||Fasting HDL-cholesterol||micrograms/deciliter (mg/dL)|Mean|42.5|42.5|Standard Deviation|8.8|8.8|||
4053204|NCT01092663|3875268|B2|||Fasting HDL-cholesterol||micrograms/deciliter (mg/dL)|Mean|44.2|44.2|Standard Deviation|11.2|11.2|||
4053205|NCT01092663|3875269|B1|||Fasting HDL-cholesterol||micrograms/deciliter (mg/dL)|Mean|40.8|40.8|Standard Deviation|6.3|6.3|||
4053206|NCT01092663|3875267|B3|||Fasting LDL-cholesterol||micrograms/deciliter (mg/dL)|Mean|97.0|97.0|Standard Deviation|22.2|22.2|||
4053207|NCT01092663|3875268|B2|||Fasting LDL-cholesterol||micrograms/deciliter (mg/dL)|Mean|96.2|96.2|Standard Deviation|22.1|22.1|||
4053208|NCT01092663|3875269|B1|||Fasting LDL-cholesterol||micrograms/deciliter (mg/dL)|Mean|97.8|97.8|Standard Deviation|22.3|22.3|||
4053209|NCT01092663|3875267|B3|||Fasting total-cholesterol||micrograms/deciliter (mg/dL)|Mean|169.6|169.6|Standard Deviation|26.9|26.9|||
4053210|NCT01092663|3875268|B2|||Fasting total-cholesterol||micrograms/deciliter (mg/dL)|Mean|169.9|169.9|Standard Deviation|26.1|26.1|||
4053211|NCT01092663|3875269|B1|||Fasting total-cholesterol||micrograms/deciliter (mg/dL)|Mean|169.3|169.3|Standard Deviation|27.7|27.7|||
4053212|NCT01092663|3875267|B3|||Fasting Insulin||microunits/milliters (uU/ml)|Mean|13.4|13.4|Standard Deviation|7.7|7.7|||
4053213|NCT01092663|3875268|B2|||Fasting Insulin||microunits/milliters (uU/ml)|Mean|12.6|12.6|Standard Deviation|7.6|7.6|||
4053214|NCT01092663|3875269|B1|||Fasting Insulin||microunits/milliters (uU/ml)|Mean|14.1|14.1|Standard Deviation|7.8|7.8|||
4053215|NCT01092663|3875267|B3|||HOMA-beta cell||percentage|Mean|66.9|66.9|Standard Deviation|53.8|53.8|||
4053216|NCT01092663|3875268|B2|||HOMA-beta cell||percentage|Mean|68.8|68.8|Standard Deviation|63.1|63.1|||
4053217|NCT01092663|3875269|B1|||HOMA-beta cell||percentage|Mean|64.9|64.9|Standard Deviation|44.4|44.4|||
4053218|NCT01092663|3875267|B3|||HOMA-IR|There is no unit of measurement for HOMA-IR (Homeostatic model assessment - insulin resistance)|HOMA score|Mean|5.0|5.0|Standard Deviation|2.8|2.8|||
4053219|NCT01092663|3875268|B2|||HOMA-IR|There is no unit of measurement for HOMA-IR (Homeostatic model assessment - insulin resistance)|HOMA score|Mean|4.6|4.6|Standard Deviation|2.5|2.5|||
4053220|NCT01092663|3875269|B1|||HOMA-IR|There is no unit of measurement for HOMA-IR (Homeostatic model assessment - insulin resistance)|HOMA score|Mean|5.4|5.4|Standard Deviation|3.0|3.0|||
4053221|NCT01092663|3875267|B3|||Fasting Glucose|glucose measured in the plasma|millimole/liter (mmol/L)|Mean|8.8|8.8|Standard Deviation|2.5|2.5|||
4053222|NCT01092663|3875268|B2|||Fasting Glucose|glucose measured in the plasma|millimole/liter (mmol/L)|Mean|8.7|8.7|Standard Deviation|2.5|2.5|||
4053223|NCT01092663|3875269|B1|||Fasting Glucose|glucose measured in the plasma|millimole/liter (mmol/L)|Mean|8.9|8.9|Standard Deviation|2.5|2.5|||
4053224|NCT01092663|3875267|B3|||Hemoglobin A1c||percentage|Mean|8.0|8.0|Standard Deviation|1.0|1.0|||
4053225|NCT01092663|3875268|B2|||Hemoglobin A1c||percentage|Mean|8.0|8.0|Standard Deviation|1.1|1.1|||
4053226|NCT01092663|3875269|B1|||Hemoglobin A1c||percentage|Mean|8.0|8.0|Standard Deviation|0.9|0.9|||
4053227|NCT01092663|3875267|B3|||Fat Free Mass||kilograms|Mean|52.9|52.9|Standard Deviation|10.85|10.85|||
4053228|NCT01092663|3875268|B2|||Fat Free Mass||kilograms|Mean|54.4|54.4|Standard Deviation|11.4|11.4|||
4053229|NCT01092663|3875269|B1|||Fat Free Mass||kilograms|Mean|51.4|51.4|Standard Deviation|10.3|10.3|||
4053230|NCT01092663|3875267|B3|||BMI||kilograms/square meter (kg/m2)|Mean|30.8|30.8|Standard Deviation|4.2|4.2|||
4053231|NCT01092663|3875268|B2|||BMI||kilograms/square meter (kg/m2)|Mean|30.9|30.9|Standard Deviation|4.7|4.7|||
4053232|NCT01092663|3875269|B1|||BMI||kilograms/square meter (kg/m2)|Mean|30.7|30.7|Standard Deviation|3.7|3.7|||
4053233|NCT01092663|3875267|B3|||Weight||kilograms|Mean|84.85|84.85|Standard Deviation|16.15|16.15|||
4053234|NCT01092663|3875268|B2|||Weight||kilograms|Mean|85.1|85.1|Standard Deviation|17.0|17.0|||
4053235|NCT01092663|3875269|B1|||Weight||kilograms|Mean|84.6|84.6|Standard Deviation|15.3|15.3|||
4053236|NCT01092663|3875267|B3|United States||Region of Enrollment||participants|Number|61|61.0||||||
4053237|NCT01092663|3875268|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4053238|NCT01092663|3875269|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4053239|NCT01092663|3875267|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4053240|NCT01092663|3875268|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4053241|NCT01092663|3875269|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053242|NCT01092663|3875267|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053243|NCT01092663|3875268|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053244|NCT01092663|3875269|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053245|NCT01092663|3875267|B3||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4053246|NCT01092663|3875268|B2||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4053247|NCT01092663|3875269|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4053248|NCT01092663|3875267|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4053249|NCT01092663|3875268|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4053250|NCT01092663|3875269|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4053251|NCT01092663|3875267|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053252|NCT01092663|3875268|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053253|NCT01092663|3875269|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053254|NCT01092663|3875267|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053255|NCT01092663|3875268|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053256|NCT01092663|3875269|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053257|NCT01092663|3875267|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053258|NCT01092663|3875268|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053259|NCT01092663|3875269|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053260|NCT01092663|3875267|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053261|NCT01092663|3875268|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053262|NCT01092663|3875269|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053263|NCT01092663|3875267|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4053264|NCT01092663|3875268|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4053265|NCT01092663|3875269|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4053266|NCT01092663|3875267|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4053267|NCT01092663|3875268|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4053268|NCT01092663|3875269|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4053269|NCT01092663|3875267|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4053270|NCT01092663|3875268|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4053271|NCT01092663|3875269|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4053272|NCT01092663|3875267|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4053273|NCT01092663|3875268|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4053274|NCT01092663|3875269|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4053275|NCT01092663|3875267|B3|||Age||years|Mean|55.5|55.5|Standard Deviation|11|11.0|||
4053276|NCT01092663|3875268|B2|||Age||years|Mean|55|55.0|Standard Deviation|13|13.0|||
4053277|NCT01092663|3875269|B1|||Age||years|Mean|56|56.0|Standard Deviation|9|9.0|||
4053278|NCT01092663|3875267|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4053279|NCT01092663|3875268|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4053280|NCT01092663|3875269|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4053281|NCT01092663|3875267|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4053282|NCT01092663|3875268|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4053283|NCT01092663|3875269|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4053284|NCT01092663|3875267|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4053285|NCT01092663|3875268|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4053286|NCT01092663|3875269|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4053287|NCT01092637|3875316|B3||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4053288|NCT01092637|3875317|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4053289|NCT01092637|3875318|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4053290|NCT01092637|3875316|B3||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4053291|NCT01092637|3875317|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4053292|NCT01092637|3875318|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4053293|NCT01092637|3875316|B3|||Age||years|Median|6.25|6.25|Full Range|||6.02|8.82|
4053294|NCT01092637|3875317|B2|||Age||years|Median|6.24|6.24|Full Range|||6.02|7.26|
4053295|NCT01092637|3875318|B1|||Age||years|Median|6.27|6.27|Full Range|||6.03|8.82|
4053296|NCT01092559|3875329|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4053297|NCT01092559|3875329|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4053298|NCT01092559|3875329|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4053299|NCT01092559|3875329|B1|||Age||years|Mean|51|51.0|Standard Deviation|15.17|15.17|||
4053300|NCT01092559|3875329|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4053301|NCT01092559|3875329|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4053302|NCT01092559|3875329|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4053303|NCT01092546|3875334|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4053304|NCT01092546|3875334|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4053305|NCT01092546|3875334|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4053306|NCT01092546|3875334|B1|||Age||years|Mean|71|71.0|Standard Deviation|8.1|8.1|||
4053307|NCT01092546|3875334|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4053308|NCT01092546|3875334|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4053309|NCT01092546|3875334|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4053310|NCT01092507|3875339|B3|Thailand||Region of Enrollment||Participants|Number|299|299.0||||||
4053311|NCT01092507|3875340|B2|Thailand||Region of Enrollment||Participants|Number|150|150.0||||||
4053312|NCT01092507|3875341|B1|Thailand||Region of Enrollment||Participants|Number|149|149.0||||||
4053313|NCT01092507|3875339|B3||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4053314|NCT01092507|3875340|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4053315|NCT01092507|3875341|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4053316|NCT01092507|3875339|B3||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4053317|NCT01092507|3875340|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4053318|NCT01092507|3875341|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4053319|NCT01092507|3875339|B3|||Age||Months|Mean|13.2|13.2|Standard Deviation|2.00|2.0|||
4053320|NCT01092507|3875340|B2|||Age||Months|Mean|13.2|13.2|Standard Deviation|1.89|1.89|||
4053321|NCT01092507|3875341|B1|||Age||Months|Mean|13.1|13.1|Standard Deviation|2.11|2.11|||
4053322|NCT01092507|3875339|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4053323|NCT01092507|3875340|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4053324|NCT01092507|3875341|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4053325|NCT01092507|3875339|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4053326|NCT01092507|3875340|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4053327|NCT01092507|3875341|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4053328|NCT01092507|3875339|B3||<=18 years|Age||Participants|Count of Participants|299|299.0||||||
4053329|NCT01092507|3875340|B2||<=18 years|Age||Participants|Count of Participants|150|150.0||||||
4053330|NCT01092507|3875341|B1||<=18 years|Age||Participants|Count of Participants|149|149.0||||||
4053331|NCT01092442|3875360|B3|United States||Region of Enrollment||participants|Number|140|140.0||||||
4053332|NCT01092442|3875361|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
4053333|NCT01092442|3875362|B1|United States||Region of Enrollment||participants|Number|80|80.0||||||
4053334|NCT01092442|3875360|B3||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4053335|NCT01092442|3875361|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4053336|NCT01092442|3875362|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4053337|NCT01092442|3875360|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4053338|NCT01092442|3875361|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4053339|NCT01092442|3875362|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4053340|NCT01092442|3875360|B3|||Age||years|Mean|20.2|20.2|Standard Deviation|18.1|18.1|||
4053341|NCT01092442|3875361|B2|||Age||years|Mean|26.2|26.2|Standard Deviation|21.1|21.1|||
4053342|NCT01092442|3875362|B1|||Age||years|Mean|15.8|15.8|Standard Deviation|14.1|14.1|||
4053343|NCT01092442|3875360|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4053344|NCT01092442|3875361|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4053345|NCT01092442|3875362|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4053346|NCT01092442|3875360|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4053347|NCT01092442|3875361|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4053348|NCT01092442|3875362|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4053349|NCT01092442|3875360|B3||<=18 years|Age||Participants|Count of Participants|99|99.0||||||
4053350|NCT01092442|3875361|B2||<=18 years|Age||Participants|Count of Participants|33|33.0||||||
4053351|NCT01092442|3875362|B1||<=18 years|Age||Participants|Count of Participants|66|66.0||||||
4053352|NCT01092416|3875377|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4053353|NCT01092416|3875377|B1|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4053354|NCT01092416|3875377|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4053355|NCT01092416|3875377|B1|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4053356|NCT01092416|3875377|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4053357|NCT01092416|3875377|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|390|390.0||||||
4053358|NCT01092416|3875377|B1||Male|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
4053359|NCT01092416|3875377|B1||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4053360|NCT01092416|3875377|B1|||Age||years|Mean|71.4|71.4|Full Range|||37.4|92.2|
4053361|NCT01092364|3875386|B4|||Physical activity||kcal/week|Mean|879.7|879.7|Standard Deviation|1134.2|1134.2|||
4053362|NCT01092364|3875387|B3|||Physical activity||kcal/week|Mean|865.9|865.9|Standard Deviation|1133.9|1133.9|||
4053363|NCT01092364|3875388|B2|||Physical activity||kcal/week|Mean|1009.3|1009.3|Standard Deviation|1346.4|1346.4|||
4053364|NCT01092364|3875389|B1|||Physical activity||kcal/week|Mean|756.0|756.0|Standard Deviation|846.1|846.1|||
4053365|NCT01092364|3875386|B4|||Dietary intake|The Healthy Eating Index (HEI) will be used to measure dietary intake. HEI assesses conformance to the Dietary Guidelines for Americans. HEI scores can range from 0 to 100, with 0 representing the least overall healthy diet, and 100 representing the most overall healthy diet.|Scores on the HEI scale|Mean|51.0|51.0|Standard Deviation|4.1|4.1|||
4053417|NCT01092364|3875386|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053366|NCT01092364|3875387|B3|||Dietary intake|The Healthy Eating Index (HEI) will be used to measure dietary intake. HEI assesses conformance to the Dietary Guidelines for Americans. HEI scores can range from 0 to 100, with 0 representing the least overall healthy diet, and 100 representing the most overall healthy diet.|Scores on the HEI scale|Mean|50.7|50.7|Standard Deviation|4.4|4.4|||
4053367|NCT01092364|3875388|B2|||Dietary intake|The Healthy Eating Index (HEI) will be used to measure dietary intake. HEI assesses conformance to the Dietary Guidelines for Americans. HEI scores can range from 0 to 100, with 0 representing the least overall healthy diet, and 100 representing the most overall healthy diet.|Scores on the HEI scale|Mean|50.8|50.8|Standard Deviation|3.6|3.6|||
4053368|NCT01092364|3875389|B1|||Dietary intake|The Healthy Eating Index (HEI) will be used to measure dietary intake. HEI assesses conformance to the Dietary Guidelines for Americans. HEI scores can range from 0 to 100, with 0 representing the least overall healthy diet, and 100 representing the most overall healthy diet.|Scores on the HEI scale|Mean|51.6|51.6|Standard Deviation|4.2|4.2|||
4053369|NCT01092364|3875386|B4|Females||Waist Circumference||cm|Mean|108.2|108.2|Standard Deviation|16.8|16.8|||
4053370|NCT01092364|3875387|B3|Females||Waist Circumference||cm|Mean|107.9|107.9|Standard Deviation|15.7|15.7|||
4053371|NCT01092364|3875388|B2|Females||Waist Circumference||cm|Mean|107.4|107.4|Standard Deviation|16.4|16.4|||
4053372|NCT01092364|3875389|B1|Females||Waist Circumference||cm|Mean|109.3|109.3|Standard Deviation|18.4|18.4|||
4053373|NCT01092364|3875386|B4|Males||Waist Circumference||cm|Mean|111.7|111.7|Standard Deviation|16.3|16.3|||
4053374|NCT01092364|3875387|B3|Males||Waist Circumference||cm|Mean|109.8|109.8|Standard Deviation|14.6|14.6|||
4053375|NCT01092364|3875388|B2|Males||Waist Circumference||cm|Mean|111.5|111.5|Standard Deviation|16.4|16.4|||
4053376|NCT01092364|3875389|B1|Males||Waist Circumference||cm|Mean|113.8|113.8|Standard Deviation|17.9|17.9|||
4053377|NCT01092364|3875386|B4|||BMI||Kg/m^2|Mean|35.2|35.2|Standard Deviation|7.8|7.8|||
4053378|NCT01092364|3875387|B3|||BMI||Kg/m^2|Mean|35.1|35.1|Standard Deviation|7.5|7.5|||
4053379|NCT01092364|3875388|B2|||BMI||Kg/m^2|Mean|34.9|34.9|Standard Deviation|7.5|7.5|||
4053380|NCT01092364|3875389|B1|||BMI||Kg/m^2|Mean|35.7|35.7|Standard Deviation|8.2|8.2|||
4053381|NCT01092364|3875386|B4|||Weight||kg|Mean|101.0|101.0|Standard Deviation|23.7|23.7|||
4053382|NCT01092364|3875387|B3|||Weight||kg|Mean|101.3|101.3|Standard Deviation|22.6|22.6|||
4053383|NCT01092364|3875388|B2|||Weight||kg|Mean|99.3|99.3|Standard Deviation|23.4|23.4|||
4053384|NCT01092364|3875389|B1|||Weight||kg|Mean|102.4|102.4|Standard Deviation|25.2|25.2|||
4053385|NCT01092364|3875386|B4|United States||Region of Enrollment||Participants|Count of Participants|365|365.0||||||
4053386|NCT01092364|3875387|B3|United States||Region of Enrollment||Participants|Count of Participants|123|123.0||||||
4053387|NCT01092364|3875388|B2|United States||Region of Enrollment||Participants|Count of Participants|120|120.0||||||
4053388|NCT01092364|3875389|B1|United States||Region of Enrollment||Participants|Count of Participants|122|122.0||||||
4053389|NCT01092364|3875386|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4053390|NCT01092364|3875387|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4053391|NCT01092364|3875388|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4053392|NCT01092364|3875389|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4053393|NCT01092364|3875386|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4053394|NCT01092364|3875387|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4053395|NCT01092364|3875388|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4053396|NCT01092364|3875389|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053397|NCT01092364|3875386|B4||White|Race (NIH/OMB)||Participants|Count of Participants|203|203.0||||||
4053398|NCT01092364|3875387|B3||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4053399|NCT01092364|3875388|B2||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4053400|NCT01092364|3875389|B1||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4053401|NCT01092364|3875386|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
4053402|NCT01092364|3875387|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4053403|NCT01092364|3875388|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4053404|NCT01092364|3875389|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4053405|NCT01092364|3875386|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053406|NCT01092364|3875387|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053407|NCT01092364|3875388|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053408|NCT01092364|3875389|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053409|NCT01092364|3875386|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4053410|NCT01092364|3875387|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4053411|NCT01092364|3875388|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4053412|NCT01092364|3875389|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4053413|NCT01092364|3875386|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4053414|NCT01092364|3875387|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053415|NCT01092364|3875388|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4053416|NCT01092364|3875389|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4053418|NCT01092364|3875387|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053419|NCT01092364|3875388|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053420|NCT01092364|3875389|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053421|NCT01092364|3875386|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|344|344.0||||||
4053422|NCT01092364|3875387|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|118|118.0||||||
4053423|NCT01092364|3875388|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
4053424|NCT01092364|3875389|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
4053425|NCT01092364|3875386|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4053426|NCT01092364|3875387|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4053427|NCT01092364|3875388|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4053428|NCT01092364|3875389|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4053429|NCT01092364|3875386|B4||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4053430|NCT01092364|3875387|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4053431|NCT01092364|3875388|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4053432|NCT01092364|3875389|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4053433|NCT01092364|3875386|B4||Female|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
4053434|NCT01092364|3875387|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4053435|NCT01092364|3875388|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4053436|NCT01092364|3875389|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4053437|NCT01092364|3875386|B4|||Age||years|Mean|29.4|29.4|Standard Deviation|4.3|4.3|||
4053438|NCT01092364|3875387|B3|||Age||years|Mean|29.6|29.6|Standard Deviation|4.3|4.3|||
4053439|NCT01092364|3875388|B2|||Age||years|Mean|29.4|29.4|Standard Deviation|4.3|4.3|||
4053440|NCT01092364|3875389|B1|||Age||years|Mean|29.2|29.2|Standard Deviation|4.2|4.2|||
4053441|NCT01092364|3875386|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4053442|NCT01092364|3875387|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4053443|NCT01092364|3875388|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4053444|NCT01092364|3875389|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4053445|NCT01092364|3875386|B4||Between 18 and 65 years|Age||Participants|Count of Participants|365|365.0||||||
4053446|NCT01092364|3875387|B3||Between 18 and 65 years|Age||Participants|Count of Participants|123|123.0||||||
4053447|NCT01092364|3875388|B2||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
4053448|NCT01092364|3875389|B1||Between 18 and 65 years|Age||Participants|Count of Participants|122|122.0||||||
4053449|NCT01092364|3875386|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4053450|NCT01092364|3875387|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4053451|NCT01092364|3875388|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4053452|NCT01092364|3875389|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4053453|NCT01092338|3875399|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
4053454|NCT01092338|3875400|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4053455|NCT01092338|3875401|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4053456|NCT01092338|3875399|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4053457|NCT01092338|3875400|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4053458|NCT01092338|3875401|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4053459|NCT01092338|3875399|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4053460|NCT01092338|3875400|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4053461|NCT01092338|3875401|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4053462|NCT01092338|3875399|B3|||Age||years|Mean|18.7|18.7|Standard Deviation|4.7|4.7|||
4053463|NCT01092338|3875400|B2|||Age||years|Mean|19.1|19.1|Standard Deviation|5.0|5.0|||
4053464|NCT01092338|3875401|B1|||Age||years|Mean|18.4|18.4|Standard Deviation|4.5|4.5|||
4053465|NCT01092338|3875399|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4053466|NCT01092338|3875400|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4053467|NCT01092338|3875401|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4053468|NCT01092338|3875399|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4053469|NCT01092338|3875400|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4053470|NCT01092338|3875401|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4053471|NCT01092338|3875399|B3||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4053472|NCT01092338|3875400|B2||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4053473|NCT01092338|3875401|B1||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4053474|NCT01091974|3875410|B5|United States||Region of Enrollment||participants|Number|96|96.0||||||
4053475|NCT01091974|3875411|B4|United States||Region of Enrollment||participants|Number|24|24.0||||||
4053476|NCT01091974|3875412|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4053477|NCT01091974|3875413|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4053478|NCT01091974|3875414|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4053479|NCT01091974|3875410|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4053480|NCT01091974|3875411|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053481|NCT01091974|3875412|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4053482|NCT01091974|3875413|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053483|NCT01091974|3875414|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053484|NCT01091974|3875410|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053485|NCT01091974|3875411|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053486|NCT01091974|3875412|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053487|NCT01091974|3875413|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053488|NCT01091974|3875414|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053489|NCT01091974|3875410|B5||White|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4053490|NCT01091974|3875411|B4||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4053491|NCT01091974|3875412|B3||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4053492|NCT01091974|3875413|B2||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4053493|NCT01091974|3875414|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4053494|NCT01091974|3875410|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4053495|NCT01091974|3875411|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4053496|NCT01091974|3875412|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4053497|NCT01091974|3875413|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4053498|NCT01091974|3875414|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4053499|NCT01091974|3875410|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053500|NCT01091974|3875411|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053501|NCT01091974|3875412|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053502|NCT01091974|3875413|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053503|NCT01091974|3875414|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053504|NCT01091974|3875410|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053505|NCT01091974|3875411|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053506|NCT01091974|3875412|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053507|NCT01091974|3875413|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053508|NCT01091974|3875414|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053509|NCT01091974|3875410|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053510|NCT01091974|3875411|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053511|NCT01091974|3875412|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053512|NCT01091974|3875413|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053513|NCT01091974|3875414|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053514|NCT01091974|3875410|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4053515|NCT01091974|3875411|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4053516|NCT01091974|3875412|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4053517|NCT01091974|3875413|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4053518|NCT01091974|3875414|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4053519|NCT01091974|3875410|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
4053520|NCT01091974|3875411|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4053521|NCT01091974|3875412|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4053522|NCT01091974|3875413|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4053523|NCT01091974|3875414|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4053524|NCT01091974|3875410|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053525|NCT01091974|3875411|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053526|NCT01091974|3875412|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053527|NCT01091974|3875413|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053528|NCT01091974|3875414|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053529|NCT01091974|3875410|B5||Male|Gender||Participants|Count of Participants|12|12.0||||||
4053530|NCT01091974|3875411|B4||Male|Gender||Participants|Count of Participants|1|1.0||||||
4053531|NCT01091974|3875412|B3||Male|Gender||Participants|Count of Participants|7|7.0||||||
4053532|NCT01091974|3875413|B2||Male|Gender||Participants|Count of Participants|1|1.0||||||
4053533|NCT01091974|3875414|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
4053534|NCT01091974|3875410|B5||Female|Gender||Participants|Count of Participants|84|84.0||||||
4053535|NCT01091974|3875411|B4||Female|Gender||Participants|Count of Participants|23|23.0||||||
4053536|NCT01091974|3875412|B3||Female|Gender||Participants|Count of Participants|18|18.0||||||
4053537|NCT01091974|3875413|B2||Female|Gender||Participants|Count of Participants|22|22.0||||||
4053538|NCT01091974|3875414|B1||Female|Gender||Participants|Count of Participants|21|21.0||||||
4053539|NCT01091974|3875410|B5|||Age||years|Mean|56.1|56.1|Standard Deviation|10.0|10.0|||
4053540|NCT01091974|3875411|B4|||Age||years|Mean|57|57.0|Standard Deviation|7.4|7.4|||
4053541|NCT01091974|3875412|B3|||Age||years|Mean|52|52.0|Standard Deviation|11.5|11.5|||
4053542|NCT01091974|3875413|B2|||Age||years|Mean|56|56.0|Standard Deviation|10.2|10.2|||
4053543|NCT01091974|3875414|B1|||Age||years|Mean|59|59.0|Standard Deviation|9.9|9.9|||
4053544|NCT01091948|3875431|B3|IV: Only hard palate visible.||Modified Mallampati classification|Modified Mallampati classification was not collected for one patient in the GlideScope Video Laryngoscope group.|participants|Number|3|3.0||||||
4053545|NCT01091948|3875432|B2|IV: Only hard palate visible.||Modified Mallampati classification|Modified Mallampati classification was not collected for one patient in the GlideScope Video Laryngoscope group.|participants|Number|2|2.0||||||
4053546|NCT01091948|3875433|B1|IV: Only hard palate visible.||Modified Mallampati classification|Modified Mallampati classification was not collected for one patient in the GlideScope Video Laryngoscope group.|participants|Number|1|1.0||||||
4053547|NCT01091948|3875431|B3|III: Soft palate, base of uvula visible.||Modified Mallampati classification|Modified Mallampati classification was not collected for one patient in the GlideScope Video Laryngoscope group.|participants|Number|18|18.0||||||
4053548|NCT01091948|3875432|B2|III: Soft palate, base of uvula visible.||Modified Mallampati classification|Modified Mallampati classification was not collected for one patient in the GlideScope Video Laryngoscope group.|participants|Number|8|8.0||||||
4053549|NCT01091948|3875433|B1|III: Soft palate, base of uvula visible.||Modified Mallampati classification|Modified Mallampati classification was not collected for one patient in the GlideScope Video Laryngoscope group.|participants|Number|10|10.0||||||
4053550|NCT01091948|3875431|B3|II: Soft palate, uvula, fauces visible.||Modified Mallampati classification|Modified Mallampati classification was not collected for one patient in the GlideScope Video Laryngoscope group.|participants|Number|38|38.0||||||
4053551|NCT01091948|3875432|B2|II: Soft palate, uvula, fauces visible.||Modified Mallampati classification|Modified Mallampati classification was not collected for one patient in the GlideScope Video Laryngoscope group.|participants|Number|19|19.0||||||
4053552|NCT01091948|3875433|B1|II: Soft palate, uvula, fauces visible.||Modified Mallampati classification|Modified Mallampati classification was not collected for one patient in the GlideScope Video Laryngoscope group.|participants|Number|19|19.0||||||
4053553|NCT01091948|3875431|B3|I: Soft palate, uvula, fauces, pillars visible.||Modified Mallampati classification|Modified Mallampati classification was not collected for one patient in the GlideScope Video Laryngoscope group.|participants|Number|15|15.0||||||
4053554|NCT01091948|3875432|B2|I: Soft palate, uvula, fauces, pillars visible.||Modified Mallampati classification|Modified Mallampati classification was not collected for one patient in the GlideScope Video Laryngoscope group.|participants|Number|8|8.0||||||
4053555|NCT01091948|3875433|B1|I: Soft palate, uvula, fauces, pillars visible.||Modified Mallampati classification|Modified Mallampati classification was not collected for one patient in the GlideScope Video Laryngoscope group.|participants|Number|7|7.0||||||
4053556|NCT01091948|3875431|B3|III: A patient with severe systemic disease||ASA physical status||participants|Number|32|32.0||||||
4053557|NCT01091948|3875432|B2|III: A patient with severe systemic disease||ASA physical status||participants|Number|17|17.0||||||
4053558|NCT01091948|3875433|B1|III: A patient with severe systemic disease||ASA physical status||participants|Number|15|15.0||||||
4053559|NCT01091948|3875431|B3|II: A patient with mild systemic disease||ASA physical status||participants|Number|39|39.0||||||
4053560|NCT01091948|3875432|B2|II: A patient with mild systemic disease||ASA physical status||participants|Number|18|18.0||||||
4053561|NCT01091948|3875433|B1|II: A patient with mild systemic disease||ASA physical status||participants|Number|21|21.0||||||
4053562|NCT01091948|3875431|B3|I: A normal healthy patient||ASA physical status||participants|Number|4|4.0||||||
4053563|NCT01091948|3875432|B2|I: A normal healthy patient||ASA physical status||participants|Number|3|3.0||||||
4053564|NCT01091948|3875433|B1|I: A normal healthy patient||ASA physical status||participants|Number|1|1.0||||||
4053565|NCT01091948|3875431|B3|||Body mass index||kg/m^2|Median|37|37.0|Inter-Quartile Range|||33.0|46.0|
4053566|NCT01091948|3875432|B2|||Body mass index||kg/m^2|Median|36|36.0|Inter-Quartile Range|||34.0|44.0|
4053567|NCT01091948|3875433|B1|||Body mass index||kg/m^2|Median|37|37.0|Inter-Quartile Range|||33.0|49.0|
4053568|NCT01091948|3875431|B3|||Height||cm|Mean|169|169.0|Standard Deviation|11|11.0|||
4053569|NCT01091948|3875432|B2|||Height||cm|Mean|167|167.0|Standard Deviation|10|10.0|||
4053570|NCT01091948|3875433|B1|||Height||cm|Mean|171|171.0|Standard Deviation|12|12.0|||
4053571|NCT01091948|3875431|B3|||Weight||Kg|Median|110|110.0|Inter-Quartile Range|||93.0|126.0|
4053572|NCT01091948|3875432|B2|||Weight||Kg|Median|104|104.0|Inter-Quartile Range|||93.0|117.0|
4053573|NCT01091948|3875433|B1|||Weight||Kg|Median|117|117.0|Inter-Quartile Range|||95.0|141.0|
4053574|NCT01091948|3875431|B3|United States||Region of Enrollment||participants|Number|75|75.0||||||
4053575|NCT01091948|3875432|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
4053576|NCT01091948|3875433|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4053577|NCT01091948|3875431|B3|Others||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4053578|NCT01091948|3875432|B2|Others||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4053579|NCT01091948|3875433|B1|Others||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4053580|NCT01091948|3875431|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
4053581|NCT01091948|3875432|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4053582|NCT01091948|3875433|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4053583|NCT01091948|3875431|B3||Male|Gender||Participants|Count of Participants|31|31.0||||||
4053584|NCT01091948|3875432|B2||Male|Gender||Participants|Count of Participants|12|12.0||||||
4053585|NCT01091948|3875433|B1||Male|Gender||Participants|Count of Participants|19|19.0||||||
4053586|NCT01091948|3875431|B3||Female|Gender||Participants|Count of Participants|44|44.0||||||
4053587|NCT01091948|3875432|B2||Female|Gender||Participants|Count of Participants|26|26.0||||||
4053588|NCT01091948|3875433|B1||Female|Gender||Participants|Count of Participants|18|18.0||||||
4053589|NCT01091948|3875431|B3|||Age||years|Mean|53|53.0|Standard Deviation|13|13.0|||
4053590|NCT01091948|3875432|B2|||Age||years|Mean|52|52.0|Standard Deviation|16|16.0|||
4053591|NCT01091948|3875433|B1|||Age||years|Mean|54|54.0|Standard Deviation|11|11.0|||
4053592|NCT01091675|3875452|B1|Spain||Region of Enrollment||participants|Number|58|58.0||||||
4053593|NCT01091675|3875452|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053594|NCT01091675|3875452|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053595|NCT01091675|3875452|B1||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4053596|NCT01091675|3875452|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4053597|NCT01091675|3875452|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053598|NCT01091675|3875452|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053599|NCT01091675|3875452|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053600|NCT01091675|3875452|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053601|NCT01091675|3875452|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4053602|NCT01091675|3875452|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4053603|NCT01091675|3875452|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4053604|NCT01091675|3875452|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4053605|NCT01091675|3875452|B1|||Age|From a total of 58 patients recruited one did not met the exclusion criteria so 57 patients were included in the study.|years|Median|44|44.0|Full Range|||23.0|68.0|
4053606|NCT01091675|3875452|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4053607|NCT01091675|3875452|B1||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4053608|NCT01091675|3875452|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4053609|NCT01091662|3875456|B3|Serbia||Region of Enrollment||participants|Number|3|3.0||||||
4053610|NCT01091662|3875457|B2|Serbia||Region of Enrollment||participants|Number|3|3.0||||||
4053611|NCT01091662|3875458|B1|Serbia||Region of Enrollment||participants|Number|0|0.0||||||
4053612|NCT01091662|3875456|B3|Bulgaria||Region of Enrollment||participants|Number|25|25.0||||||
4053613|NCT01091662|3875457|B2|Bulgaria||Region of Enrollment||participants|Number|19|19.0||||||
4053614|NCT01091662|3875458|B1|Bulgaria||Region of Enrollment||participants|Number|6|6.0||||||
4053615|NCT01091662|3875456|B3|Ukraine||Region of Enrollment||participants|Number|68|68.0||||||
4053616|NCT01091662|3875457|B2|Ukraine||Region of Enrollment||participants|Number|42|42.0||||||
4053617|NCT01091662|3875458|B1|Ukraine||Region of Enrollment||participants|Number|26|26.0||||||
4053618|NCT01091662|3875456|B3|United States||Region of Enrollment||participants|Number|43|43.0||||||
4053619|NCT01091662|3875457|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4053620|NCT01091662|3875458|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4053621|NCT01091662|3875456|B3|Czech Republic||Region of Enrollment||participants|Number|33|33.0||||||
4053622|NCT01091662|3875457|B2|Czech Republic||Region of Enrollment||participants|Number|22|22.0||||||
4053623|NCT01091662|3875458|B1|Czech Republic||Region of Enrollment||participants|Number|11|11.0||||||
4053624|NCT01091662|3875456|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053625|NCT01091662|3875457|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053626|NCT01091662|3875458|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053627|NCT01091662|3875456|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|164|164.0||||||
4053628|NCT01091662|3875457|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
4053629|NCT01091662|3875458|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4053630|NCT01091662|3875456|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4053631|NCT01091662|3875457|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4053632|NCT01091662|3875458|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4053633|NCT01091662|3875456|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4053634|NCT01091662|3875457|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4053635|NCT01091662|3875458|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4053636|NCT01091662|3875456|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4053637|NCT01091662|3875457|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4053638|NCT01091662|3875458|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4053639|NCT01091662|3875456|B3|>65 years||Age, Customized||participants|Number|0|0.0||||||
4053640|NCT01091662|3875457|B2|>65 years||Age, Customized||participants|Number|0|0.0||||||
4053641|NCT01091662|3875458|B1|>65 years||Age, Customized||participants|Number|0|0.0||||||
4053642|NCT01091662|3875456|B3|40-65 years||Age, Customized||participants|Number|74|74.0||||||
4053643|NCT01091662|3875457|B2|40-65 years||Age, Customized||participants|Number|51|51.0||||||
4053644|NCT01091662|3875458|B1|40-65 years||Age, Customized||participants|Number|23|23.0||||||
4053645|NCT01091662|3875456|B3|18-39 years||Age, Customized||participants|Number|91|91.0||||||
4053646|NCT01091662|3875457|B2|18-39 years||Age, Customized||participants|Number|59|59.0||||||
4053647|NCT01091662|3875458|B1|18-39 years||Age, Customized||participants|Number|32|32.0||||||
4053648|NCT01091662|3875456|B3|<18 years||Age, Customized||participants|Number|7|7.0||||||
4053649|NCT01091662|3875457|B2|<18 years||Age, Customized||participants|Number|4|4.0||||||
4053650|NCT01091662|3875458|B1|<18 years||Age, Customized||participants|Number|3|3.0||||||
4053651|NCT01091662|3875456|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4053652|NCT01091662|3875457|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4053653|NCT01091662|3875458|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4053654|NCT01091662|3875456|B3||Between 18 and 65 years|Age||Participants|Count of Participants|165|165.0||||||
4053655|NCT01091662|3875457|B2||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
4053656|NCT01091662|3875458|B1||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4053657|NCT01091662|3875456|B3||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4053658|NCT01091662|3875457|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4053659|NCT01091662|3875458|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4053660|NCT01091519|3875495|B3||Male|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
4053661|NCT01091519|3875496|B2||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4053662|NCT01091519|3875497|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4053663|NCT01091519|3875495|B3||Female|Sex: Female, Male||Participants|Count of Participants|502|502.0||||||
4053664|NCT01091519|3875496|B2||Female|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
4053665|NCT01091519|3875497|B1||Female|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
4053666|NCT01091519|3875495|B3|Greater than or equal to (>=) 65 years||Age, Customized|For baseline characteristic age and gender, number of participants evaluable was 751.|participants|Number|466|466.0||||||
4053667|NCT01091519|3875496|B2|Greater than or equal to (>=) 65 years||Age, Customized|For baseline characteristic age and gender, number of participants evaluable was 751.|participants|Number|270|270.0||||||
4053668|NCT01091519|3875497|B1|Greater than or equal to (>=) 65 years||Age, Customized|For baseline characteristic age and gender, number of participants evaluable was 751.|participants|Number|196|196.0||||||
4053669|NCT01091519|3875495|B3|45 to 64 years||Age, Customized|For baseline characteristic age and gender, number of participants evaluable was 751.|participants|Number|246|246.0||||||
4053670|NCT01091519|3875496|B2|45 to 64 years||Age, Customized|For baseline characteristic age and gender, number of participants evaluable was 751.|participants|Number|132|132.0||||||
4053671|NCT01091519|3875497|B1|45 to 64 years||Age, Customized|For baseline characteristic age and gender, number of participants evaluable was 751.|participants|Number|114|114.0||||||
4053672|NCT01091519|3875495|B3|18 to 44 years||Age, Customized|For baseline characteristic age and gender, number of participants evaluable was 751.|participants|Number|39|39.0||||||
4053673|NCT01091519|3875496|B2|18 to 44 years||Age, Customized|For baseline characteristic age and gender, number of participants evaluable was 751.|participants|Number|19|19.0||||||
4053674|NCT01091519|3875497|B1|18 to 44 years||Age, Customized|For baseline characteristic age and gender, number of participants evaluable was 751.|participants|Number|20|20.0||||||
4053675|NCT01091519|3875495|B3|Less than (<) 18 years||Age, Customized|For baseline characteristic age and gender, number of participants evaluable was 751.|participants|Number|0|0.0||||||
4053676|NCT01091519|3875496|B2|Less than (<) 18 years||Age, Customized|For baseline characteristic age and gender, number of participants evaluable was 751.|participants|Number|0|0.0||||||
4053677|NCT01091519|3875497|B1|Less than (<) 18 years||Age, Customized|For baseline characteristic age and gender, number of participants evaluable was 751.|participants|Number|0|0.0||||||
4053678|NCT01091454|3875510|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
4053679|NCT01091454|3875510|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4053680|NCT01091454|3875510|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4053681|NCT01091454|3875510|B1|||Age||years|Median|57|57.0|Full Range|||34.0|76.0|
4053682|NCT01091428|3875519|B5|||Body Surface Area|Body Surface Area (m^2) = square root [height (cm) x weight (kg) / 3600].|m^2|Mean|1.802|1.802|Standard Deviation|0.21|0.21|||
4053683|NCT01091428|3875520|B4|||Body Surface Area|Body Surface Area (m^2) = square root [height (cm) x weight (kg) / 3600].|m^2|Mean|1.794|1.794|Standard Deviation|0.24|0.24|||
4053684|NCT01091428|3875521|B3|||Body Surface Area|Body Surface Area (m^2) = square root [height (cm) x weight (kg) / 3600].|m^2|Mean|1.776|1.776|Standard Deviation|0.20|0.2|||
4053685|NCT01091428|3875522|B2|||Body Surface Area|Body Surface Area (m^2) = square root [height (cm) x weight (kg) / 3600].|m^2|Mean|1.865|1.865|Standard Deviation|0.10|0.1|||
4053686|NCT01091428|3875523|B1|||Body Surface Area|Body Surface Area (m^2) = square root [height (cm) x weight (kg) / 3600].|m^2|Mean|1.850|1.85|Standard Deviation|0.21|0.21|||
4053687|NCT01091428|3875519|B5|||Weight||kg|Mean|72.59|72.59|Standard Deviation|16.37|16.37|||
4053688|NCT01091428|3875520|B4|||Weight||kg|Mean|72.50|72.5|Standard Deviation|18.71|18.71|||
4053689|NCT01091428|3875521|B3|||Weight||kg|Mean|70.42|70.42|Standard Deviation|14.78|14.78|||
4053690|NCT01091428|3875522|B2|||Weight||kg|Mean|76.29|76.29|Standard Deviation|7.29|7.29|||
4053691|NCT01091428|3875523|B1|||Weight||kg|Mean|75.86|75.86|Standard Deviation|16.41|16.41|||
4053692|NCT01091428|3875519|B5|||Height||cm|Mean|162.7|162.7|Standard Deviation|6.99|6.99|||
4053693|NCT01091428|3875520|B4|||Height||cm|Mean|161.9|161.9|Standard Deviation|7.30|7.3|||
4053694|NCT01091428|3875521|B3|||Height||cm|Mean|162.4|162.4|Standard Deviation|7.02|7.02|||
4053695|NCT01091428|3875522|B2|||Height||cm|Mean|164.5|164.5|Standard Deviation|6.38|6.38|||
4053696|NCT01091428|3875523|B1|||Height||cm|Mean|164.2|164.2|Standard Deviation|6.41|6.41|||
4053697|NCT01091428|3875519|B5|France||Region of Enrollment||participants|Number|31|31.0||||||
4053698|NCT01091428|3875520|B4|France||Region of Enrollment||participants|Number|16|16.0||||||
4053699|NCT01091428|3875521|B3|France||Region of Enrollment||participants|Number|15|15.0||||||
4053700|NCT01091428|3875522|B2|France||Region of Enrollment||participants|Number|0|0.0||||||
4053701|NCT01091428|3875523|B1|France||Region of Enrollment||participants|Number|0|0.0||||||
4053702|NCT01091428|3875519|B5|Poland||Region of Enrollment||participants|Number|18|18.0||||||
4053703|NCT01091428|3875520|B4|Poland||Region of Enrollment||participants|Number|8|8.0||||||
4053704|NCT01091428|3875521|B3|Poland||Region of Enrollment||participants|Number|10|10.0||||||
4053705|NCT01091428|3875522|B2|Poland||Region of Enrollment||participants|Number|0|0.0||||||
4053706|NCT01091428|3875523|B1|Poland||Region of Enrollment||participants|Number|0|0.0||||||
4053707|NCT01091428|3875519|B5|United States||Region of Enrollment||participants|Number|142|142.0||||||
4053708|NCT01091428|3875520|B4|United States||Region of Enrollment||participants|Number|45|45.0||||||
4053709|NCT01091428|3875521|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
4053710|NCT01091428|3875522|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4053711|NCT01091428|3875523|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4053712|NCT01091428|3875519|B5|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4053713|NCT01091428|3875520|B4|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4053714|NCT01091428|3875521|B3|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4053715|NCT01091428|3875522|B2|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4053716|NCT01091428|3875523|B1|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4053717|NCT01091428|3875519|B5|Not Reported||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4053718|NCT01091428|3875520|B4|Not Reported||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4053719|NCT01091428|3875521|B3|Not Reported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4053720|NCT01091428|3875522|B2|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4053721|NCT01091428|3875523|B1|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4053722|NCT01091428|3875519|B5|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4053723|NCT01091428|3875520|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4053724|NCT01091428|3875521|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4053725|NCT01091428|3875522|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4053726|NCT01091428|3875523|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4053727|NCT01091428|3875519|B5|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4053728|NCT01091428|3875520|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4053729|NCT01091428|3875521|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4053730|NCT01091428|3875522|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4053731|NCT01091428|3875523|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4053732|NCT01091428|3875519|B5|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4053733|NCT01091428|3875520|B4|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4053734|NCT01091428|3875521|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4053735|NCT01091428|3875522|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4053736|NCT01091428|3875523|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4053737|NCT01091428|3875519|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4053738|NCT01091428|3875520|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4053739|NCT01091428|3875521|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4053740|NCT01091428|3875522|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4053741|NCT01091428|3875523|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4053742|NCT01091428|3875519|B5|White||Race/Ethnicity, Customized||participants|Number|166|166.0||||||
4053743|NCT01091428|3875520|B4|White||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
4053744|NCT01091428|3875521|B3|White||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
4053745|NCT01091428|3875522|B2|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4053746|NCT01091428|3875523|B1|White||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4053747|NCT01091428|3875519|B5|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4053748|NCT01091428|3875520|B4|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4053749|NCT01091428|3875521|B3|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4053750|NCT01091428|3875522|B2|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4053751|NCT01091428|3875523|B1|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4053752|NCT01091428|3875519|B5|Not Reported||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4053753|NCT01091428|3875520|B4|Not Reported||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4053754|NCT01091428|3875521|B3|Not Reported||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4053755|NCT01091428|3875522|B2|Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4053756|NCT01091428|3875523|B1|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4053757|NCT01091428|3875519|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|170|170.0||||||
4053758|NCT01091428|3875520|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
4053759|NCT01091428|3875521|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|64|64.0||||||
4053760|NCT01091428|3875522|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4053761|NCT01091428|3875523|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4053762|NCT01091428|3875519|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4053763|NCT01091428|3875520|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4053764|NCT01091428|3875521|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4053765|NCT01091428|3875522|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4053766|NCT01091428|3875523|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4053767|NCT01091428|3875519|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4053768|NCT01091428|3875520|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4053769|NCT01091428|3875521|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4053770|NCT01091428|3875522|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4053771|NCT01091428|3875523|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4053772|NCT01091428|3875519|B5||Female|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4053773|NCT01091428|3875520|B4||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4053774|NCT01091428|3875521|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4053775|NCT01091428|3875522|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4053776|NCT01091428|3875523|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4053777|NCT01091428|3875519|B5|||Age||years|Mean|59.8|59.8|Standard Deviation|10.32|10.32|||
4053778|NCT01091428|3875520|B4|||Age||years|Mean|60.8|60.8|Standard Deviation|8.41|8.41|||
4053779|NCT01091428|3875521|B3|||Age||years|Mean|61.0|61.0|Standard Deviation|11.60|11.6|||
4053780|NCT01091428|3875522|B2|||Age||years|Mean|58.6|58.6|Standard Deviation|10.06|10.06|||
4053781|NCT01091428|3875523|B1|||Age||years|Mean|55.8|55.8|Standard Deviation|10.29|10.29|||
4053782|NCT01091259|3875627|B1|||Number of prior regimens||Regimens|Median|5|5.0|Full Range|||1.0|12.0|
4053783|NCT01091259|3875627|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4053784|NCT01091259|3875627|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4053785|NCT01091259|3875627|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053786|NCT01091259|3875627|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4053787|NCT01091259|3875627|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4053788|NCT01091259|3875627|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053789|NCT01091259|3875627|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4053790|NCT01091259|3875627|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053791|NCT01091259|3875627|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4053792|NCT01091259|3875627|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4053793|NCT01091259|3875627|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4053794|NCT01091259|3875627|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4053795|NCT01091259|3875627|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4053796|NCT01091259|3875627|B1|||Age||years|Median|62|62.0|Full Range|||47.0|79.0|
4053797|NCT01091246|3875635|B4||Male|Sex: Female, Male||Participants|Count of Participants|1136|1136.0||||||
4053798|NCT01091246|3875636|B3||Male|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4053799|NCT01091246|3875637|B2||Male|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4053800|NCT01091246|3875638|B1||Male|Sex: Female, Male||Participants|Count of Participants|678|678.0||||||
4053801|NCT01091246|3875635|B4||Female|Sex: Female, Male||Participants|Count of Participants|1176|1176.0||||||
4053802|NCT01091246|3875636|B3||Female|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
4053803|NCT01091246|3875637|B2||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4053804|NCT01091246|3875638|B1||Female|Sex: Female, Male||Participants|Count of Participants|707|707.0||||||
4053805|NCT01091246|3875635|B4|||Age||Years|Mean|6.7|6.7|Standard Deviation|3.8|3.8|||
4053806|NCT01091246|3875636|B3|||Age||Years|Mean|6.8|6.8|Standard Deviation|3.9|3.9|||
4053807|NCT01091246|3875637|B2|||Age||Years|Mean|6.8|6.8|Standard Deviation|3.8|3.8|||
4053808|NCT01091246|3875638|B1|||Age||Years|Mean|6.7|6.7|Standard Deviation|3.8|3.8|||
4053809|NCT01091155|3875714|B1|Netherlands||Region of Enrollment||participants|Number|10|10.0||||||
4053810|NCT01091155|3875714|B1|Germany||Region of Enrollment||participants|Number|9|9.0||||||
4053811|NCT01091155|3875714|B1|Israel||Region of Enrollment||participants|Number|13|13.0||||||
4053812|NCT01091155|3875714|B1|Austria||Region of Enrollment||participants|Number|46|46.0||||||
4053813|NCT01091155|3875714|B1|Belgium||Region of Enrollment||participants|Number|83|83.0||||||
4053814|NCT01091155|3875714|B1|United States||Region of Enrollment||participants|Number|127|127.0||||||
4053815|NCT01091155|3875714|B1||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4053816|NCT01091155|3875714|B1||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4053817|NCT01091155|3875714|B1|||Age||years|Mean|60|60.0|Standard Deviation|13.4|13.4|||
4053818|NCT01091155|3875714|B1||>=65 years|Age||Participants|Count of Participants|111|111.0||||||
4053819|NCT01091155|3875714|B1||Between 18 and 65 years|Age||Participants|Count of Participants|177|177.0||||||
4053820|NCT01091155|3875714|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4053821|NCT01091116|3875718|B6|||WOMAC VA 3.1 A score (Total pain)|"Western Ontario and McMaster Universities osteoarthritis index (WOMAC). The WOMAC VA 3.1 A score (total pain, range 0-500 mm) is the sum of VAS subscores (0-100 mm) attributed by the patient to each of the 5 questions referring to osteoarthritic pain experienced during the preceding 48 hours (pain domain).~The higher is the WOMAC VA 3.1 A score, the higher is the intensity of pain symptoms (0 = no pain ; 500 = extreme pain).~A decrease of the WOMAC VA 3.1 A score following tratment administration indicates a reduction of pain symptom."|mm|Mean|286|286.0|Standard Deviation|74|74.0|||
4053822|NCT01091116|3875719|B5|||WOMAC VA 3.1 A score (Total pain)|"Western Ontario and McMaster Universities osteoarthritis index (WOMAC). The WOMAC VA 3.1 A score (total pain, range 0-500 mm) is the sum of VAS subscores (0-100 mm) attributed by the patient to each of the 5 questions referring to osteoarthritic pain experienced during the preceding 48 hours (pain domain).~The higher is the WOMAC VA 3.1 A score, the higher is the intensity of pain symptoms (0 = no pain ; 500 = extreme pain).~A decrease of the WOMAC VA 3.1 A score following tratment administration indicates a reduction of pain symptom."|mm|Mean|284|284.0|Standard Deviation|79|79.0|||
4053823|NCT01091116|3875720|B4|||WOMAC VA 3.1 A score (Total pain)|"Western Ontario and McMaster Universities osteoarthritis index (WOMAC). The WOMAC VA 3.1 A score (total pain, range 0-500 mm) is the sum of VAS subscores (0-100 mm) attributed by the patient to each of the 5 questions referring to osteoarthritic pain experienced during the preceding 48 hours (pain domain).~The higher is the WOMAC VA 3.1 A score, the higher is the intensity of pain symptoms (0 = no pain ; 500 = extreme pain).~A decrease of the WOMAC VA 3.1 A score following tratment administration indicates a reduction of pain symptom."|mm|Mean|283|283.0|Standard Deviation|72|72.0|||
4053824|NCT01091116|3875721|B3|||WOMAC VA 3.1 A score (Total pain)|"Western Ontario and McMaster Universities osteoarthritis index (WOMAC). The WOMAC VA 3.1 A score (total pain, range 0-500 mm) is the sum of VAS subscores (0-100 mm) attributed by the patient to each of the 5 questions referring to osteoarthritic pain experienced during the preceding 48 hours (pain domain).~The higher is the WOMAC VA 3.1 A score, the higher is the intensity of pain symptoms (0 = no pain ; 500 = extreme pain).~A decrease of the WOMAC VA 3.1 A score following tratment administration indicates a reduction of pain symptom."|mm|Mean|293|293.0|Standard Deviation|73|73.0|||
4053825|NCT01091116|3875722|B2|||WOMAC VA 3.1 A score (Total pain)|"Western Ontario and McMaster Universities osteoarthritis index (WOMAC). The WOMAC VA 3.1 A score (total pain, range 0-500 mm) is the sum of VAS subscores (0-100 mm) attributed by the patient to each of the 5 questions referring to osteoarthritic pain experienced during the preceding 48 hours (pain domain).~The higher is the WOMAC VA 3.1 A score, the higher is the intensity of pain symptoms (0 = no pain ; 500 = extreme pain).~A decrease of the WOMAC VA 3.1 A score following tratment administration indicates a reduction of pain symptom."|mm|Mean|282|282.0|Standard Deviation|68|68.0|||
4053826|NCT01091116|3875723|B1|||WOMAC VA 3.1 A score (Total pain)|"Western Ontario and McMaster Universities osteoarthritis index (WOMAC). The WOMAC VA 3.1 A score (total pain, range 0-500 mm) is the sum of VAS subscores (0-100 mm) attributed by the patient to each of the 5 questions referring to osteoarthritic pain experienced during the preceding 48 hours (pain domain).~The higher is the WOMAC VA 3.1 A score, the higher is the intensity of pain symptoms (0 = no pain ; 500 = extreme pain).~A decrease of the WOMAC VA 3.1 A score following tratment administration indicates a reduction of pain symptom."|mm|Mean|288|288.0|Standard Deviation|80|80.0|||
4053827|NCT01091116|3875718|B6|missing information||Radiographic Osteoarthritis severity|"Based on Kellgren & Lawrence radiologic scale criteria (Grade 1 to 4):~narrowing of joint space~osteophytic stuctures~sclerosis~deformity of bone contour"|participants|Number|1|1.0||||||
4053828|NCT01091116|3875719|B5|missing information||Radiographic Osteoarthritis severity|"Based on Kellgren & Lawrence radiologic scale criteria (Grade 1 to 4):~narrowing of joint space~osteophytic stuctures~sclerosis~deformity of bone contour"|participants|Number|0|0.0||||||
4053829|NCT01091116|3875720|B4|missing information||Radiographic Osteoarthritis severity|"Based on Kellgren & Lawrence radiologic scale criteria (Grade 1 to 4):~narrowing of joint space~osteophytic stuctures~sclerosis~deformity of bone contour"|participants|Number|1|1.0||||||
4053830|NCT01091116|3875721|B3|missing information||Radiographic Osteoarthritis severity|"Based on Kellgren & Lawrence radiologic scale criteria (Grade 1 to 4):~narrowing of joint space~osteophytic stuctures~sclerosis~deformity of bone contour"|participants|Number|0|0.0||||||
4053831|NCT01091116|3875722|B2|missing information||Radiographic Osteoarthritis severity|"Based on Kellgren & Lawrence radiologic scale criteria (Grade 1 to 4):~narrowing of joint space~osteophytic stuctures~sclerosis~deformity of bone contour"|participants|Number|0|0.0||||||
4053832|NCT01091116|3875723|B1|missing information||Radiographic Osteoarthritis severity|"Based on Kellgren & Lawrence radiologic scale criteria (Grade 1 to 4):~narrowing of joint space~osteophytic stuctures~sclerosis~deformity of bone contour"|participants|Number|0|0.0||||||
4053833|NCT01091116|3875718|B6|Grade 4 Kellgren-Lawrence scale(severe)||Radiographic Osteoarthritis severity|"Based on Kellgren & Lawrence radiologic scale criteria (Grade 1 to 4):~narrowing of joint space~osteophytic stuctures~sclerosis~deformity of bone contour"|participants|Number|0|0.0||||||
4053834|NCT01091116|3875719|B5|Grade 4 Kellgren-Lawrence scale(severe)||Radiographic Osteoarthritis severity|"Based on Kellgren & Lawrence radiologic scale criteria (Grade 1 to 4):~narrowing of joint space~osteophytic stuctures~sclerosis~deformity of bone contour"|participants|Number|0|0.0||||||
4053835|NCT01091116|3875720|B4|Grade 4 Kellgren-Lawrence scale(severe)||Radiographic Osteoarthritis severity|"Based on Kellgren & Lawrence radiologic scale criteria (Grade 1 to 4):~narrowing of joint space~osteophytic stuctures~sclerosis~deformity of bone contour"|participants|Number|0|0.0||||||
4053836|NCT01091116|3875721|B3|Grade 4 Kellgren-Lawrence scale(severe)||Radiographic Osteoarthritis severity|"Based on Kellgren & Lawrence radiologic scale criteria (Grade 1 to 4):~narrowing of joint space~osteophytic stuctures~sclerosis~deformity of bone contour"|participants|Number|0|0.0||||||
4053837|NCT01091116|3875722|B2|Grade 4 Kellgren-Lawrence scale(severe)||Radiographic Osteoarthritis severity|"Based on Kellgren & Lawrence radiologic scale criteria (Grade 1 to 4):~narrowing of joint space~osteophytic stuctures~sclerosis~deformity of bone contour"|participants|Number|0|0.0||||||
4053838|NCT01091116|3875723|B1|Grade 4 Kellgren-Lawrence scale(severe)||Radiographic Osteoarthritis severity|"Based on Kellgren & Lawrence radiologic scale criteria (Grade 1 to 4):~narrowing of joint space~osteophytic stuctures~sclerosis~deformity of bone contour"|participants|Number|0|0.0||||||
4053839|NCT01091116|3875718|B6|Grade 3 Kellgren-Lawrence scale(moderate severity)||Radiographic Osteoarthritis severity|"Based on Kellgren & Lawrence radiologic scale criteria (Grade 1 to 4):~narrowing of joint space~osteophytic stuctures~sclerosis~deformity of bone contour"|participants|Number|198|198.0||||||
4053840|NCT01091116|3875719|B5|Grade 3 Kellgren-Lawrence scale(moderate severity)||Radiographic Osteoarthritis severity|"Based on Kellgren & Lawrence radiologic scale criteria (Grade 1 to 4):~narrowing of joint space~osteophytic stuctures~sclerosis~deformity of bone contour"|participants|Number|42|42.0||||||
4053841|NCT01091116|3875720|B4|Grade 3 Kellgren-Lawrence scale(moderate severity)||Radiographic Osteoarthritis severity|"Based on Kellgren & Lawrence radiologic scale criteria (Grade 1 to 4):~narrowing of joint space~osteophytic stuctures~sclerosis~deformity of bone contour"|participants|Number|42|42.0||||||
4053842|NCT01091116|3875721|B3|Grade 3 Kellgren-Lawrence scale(moderate severity)||Radiographic Osteoarthritis severity|"Based on Kellgren & Lawrence radiologic scale criteria (Grade 1 to 4):~narrowing of joint space~osteophytic stuctures~sclerosis~deformity of bone contour"|participants|Number|40|40.0||||||
4053843|NCT01091116|3875722|B2|Grade 3 Kellgren-Lawrence scale(moderate severity)||Radiographic Osteoarthritis severity|"Based on Kellgren & Lawrence radiologic scale criteria (Grade 1 to 4):~narrowing of joint space~osteophytic stuctures~sclerosis~deformity of bone contour"|participants|Number|43|43.0||||||
4053844|NCT01091116|3875723|B1|Grade 3 Kellgren-Lawrence scale(moderate severity)||Radiographic Osteoarthritis severity|"Based on Kellgren & Lawrence radiologic scale criteria (Grade 1 to 4):~narrowing of joint space~osteophytic stuctures~sclerosis~deformity of bone contour"|participants|Number|31|31.0||||||
4053845|NCT01091116|3875718|B6|Grade 2 Kellgren-Lawrence scale(minimal severity)||Radiographic Osteoarthritis severity|"Based on Kellgren & Lawrence radiologic scale criteria (Grade 1 to 4):~narrowing of joint space~osteophytic stuctures~sclerosis~deformity of bone contour"|participants|Number|224|224.0||||||
4053846|NCT01091116|3875719|B5|Grade 2 Kellgren-Lawrence scale(minimal severity)||Radiographic Osteoarthritis severity|"Based on Kellgren & Lawrence radiologic scale criteria (Grade 1 to 4):~narrowing of joint space~osteophytic stuctures~sclerosis~deformity of bone contour"|participants|Number|42|42.0||||||
4053847|NCT01091116|3875720|B4|Grade 2 Kellgren-Lawrence scale(minimal severity)||Radiographic Osteoarthritis severity|"Based on Kellgren & Lawrence radiologic scale criteria (Grade 1 to 4):~narrowing of joint space~osteophytic stuctures~sclerosis~deformity of bone contour"|participants|Number|41|41.0||||||
4053848|NCT01091116|3875721|B3|Grade 2 Kellgren-Lawrence scale(minimal severity)||Radiographic Osteoarthritis severity|"Based on Kellgren & Lawrence radiologic scale criteria (Grade 1 to 4):~narrowing of joint space~osteophytic stuctures~sclerosis~deformity of bone contour"|participants|Number|44|44.0||||||
4053849|NCT01091116|3875722|B2|Grade 2 Kellgren-Lawrence scale(minimal severity)||Radiographic Osteoarthritis severity|"Based on Kellgren & Lawrence radiologic scale criteria (Grade 1 to 4):~narrowing of joint space~osteophytic stuctures~sclerosis~deformity of bone contour"|participants|Number|45|45.0||||||
4053850|NCT01091116|3875723|B1|Grade 2 Kellgren-Lawrence scale(minimal severity)||Radiographic Osteoarthritis severity|"Based on Kellgren & Lawrence radiologic scale criteria (Grade 1 to 4):~narrowing of joint space~osteophytic stuctures~sclerosis~deformity of bone contour"|participants|Number|52|52.0||||||
4053851|NCT01091116|3875718|B6|Grade 1 Kellgren-Lawrence scale(doubtful severity)||Radiographic Osteoarthritis severity|"Based on Kellgren & Lawrence radiologic scale criteria (Grade 1 to 4):~narrowing of joint space~osteophytic stuctures~sclerosis~deformity of bone contour"|participants|Number|0|0.0||||||
4053852|NCT01091116|3875719|B5|Grade 1 Kellgren-Lawrence scale(doubtful severity)||Radiographic Osteoarthritis severity|"Based on Kellgren & Lawrence radiologic scale criteria (Grade 1 to 4):~narrowing of joint space~osteophytic stuctures~sclerosis~deformity of bone contour"|participants|Number|0|0.0||||||
4053853|NCT01091116|3875720|B4|Grade 1 Kellgren-Lawrence scale(doubtful severity)||Radiographic Osteoarthritis severity|"Based on Kellgren & Lawrence radiologic scale criteria (Grade 1 to 4):~narrowing of joint space~osteophytic stuctures~sclerosis~deformity of bone contour"|participants|Number|0|0.0||||||
4053854|NCT01091116|3875721|B3|Grade 1 Kellgren-Lawrence scale(doubtful severity)||Radiographic Osteoarthritis severity|"Based on Kellgren & Lawrence radiologic scale criteria (Grade 1 to 4):~narrowing of joint space~osteophytic stuctures~sclerosis~deformity of bone contour"|participants|Number|0|0.0||||||
4053855|NCT01091116|3875722|B2|Grade 1 Kellgren-Lawrence scale(doubtful severity)||Radiographic Osteoarthritis severity|"Based on Kellgren & Lawrence radiologic scale criteria (Grade 1 to 4):~narrowing of joint space~osteophytic stuctures~sclerosis~deformity of bone contour"|participants|Number|0|0.0||||||
4053856|NCT01091116|3875723|B1|Grade 1 Kellgren-Lawrence scale(doubtful severity)||Radiographic Osteoarthritis severity|"Based on Kellgren & Lawrence radiologic scale criteria (Grade 1 to 4):~narrowing of joint space~osteophytic stuctures~sclerosis~deformity of bone contour"|participants|Number|0|0.0||||||
4053857|NCT01091116|3875718|B6|||Duration of osteoarthritis symptoms||years|Mean|8.0|8.0|Standard Deviation|7.5|7.5|||
4053858|NCT01091116|3875719|B5|||Duration of osteoarthritis symptoms||years|Mean|6.5|6.5|Standard Deviation|6.4|6.4|||
4053859|NCT01091116|3875720|B4|||Duration of osteoarthritis symptoms||years|Mean|8.2|8.2|Standard Deviation|8.4|8.4|||
4053860|NCT01091116|3875721|B3|||Duration of osteoarthritis symptoms||years|Mean|7.9|7.9|Standard Deviation|6.6|6.6|||
4053861|NCT01091116|3875722|B2|||Duration of osteoarthritis symptoms||years|Mean|8.0|8.0|Standard Deviation|6.3|6.3|||
4053862|NCT01091116|3875723|B1|||Duration of osteoarthritis symptoms||years|Mean|9.7|9.7|Standard Deviation|9.2|9.2|||
4053863|NCT01091116|3875718|B6||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4053864|NCT01091116|3875719|B5||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4053865|NCT01091116|3875720|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4053866|NCT01091116|3875721|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4053867|NCT01091116|3875722|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4053868|NCT01091116|3875723|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4053869|NCT01091116|3875718|B6||Female|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
4053870|NCT01091116|3875719|B5||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4053871|NCT01091116|3875720|B4||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4053872|NCT01091116|3875721|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4053873|NCT01091116|3875722|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4053874|NCT01091116|3875723|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4053875|NCT01091116|3875718|B6|||Age||years|Mean|65.6|65.6|Standard Deviation|9.1|9.1|||
4053876|NCT01091116|3875719|B5|||Age||years|Mean|65.1|65.1|Standard Deviation|8.5|8.5|||
4053877|NCT01091116|3875720|B4|||Age||years|Mean|65.3|65.3|Standard Deviation|8.7|8.7|||
4053878|NCT01091116|3875721|B3|||Age||years|Mean|65.1|65.1|Standard Deviation|9.7|9.7|||
4053879|NCT01091116|3875722|B2|||Age||years|Mean|65.9|65.9|Standard Deviation|9.5|9.5|||
4053880|NCT01091116|3875723|B1|||Age||years|Mean|66.7|66.7|Standard Deviation|9.0|9.0|||
4053881|NCT01091103|3875779|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4053882|NCT01091103|3875779|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4053883|NCT01091103|3875779|B1|>= 75||Age, Customized||years|Number|19|19.0||||||
4053884|NCT01091103|3875779|B1|65 to < 75||Age, Customized||years|Number|18|18.0||||||
4053885|NCT01091103|3875779|B1|55 to < 65||Age, Customized||years|Number|17|17.0||||||
4053886|NCT01091103|3875779|B1|< 55||Age, Customized||years|Number|6|6.0||||||
4053887|NCT01091103|3875779|B1|||Age||years|Mean|67.9|67.9|Standard Deviation|9.99|9.99|||
4053888|NCT01090973|3875799|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4053889|NCT01090973|3875799|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4053890|NCT01090973|3875799|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4053891|NCT01090973|3875799|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4053892|NCT01090973|3875799|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4053893|NCT01090973|3875799|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4053894|NCT01090765|3875809|B7|United States||Region of Enrollment||participants|Number|21|21.0||||||
4053895|NCT01090765|3875810|B6|United States||Region of Enrollment||participants|Number|4|4.0||||||
4053896|NCT01090765|3875811|B5|United States||Region of Enrollment||participants|Number|6|6.0||||||
4053897|NCT01090765|3875812|B4|United States||Region of Enrollment||participants|Number|2|2.0||||||
4053898|NCT01090765|3875813|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4053899|NCT01090765|3875814|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4053900|NCT01090765|3875815|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4053901|NCT01090765|3875809|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053902|NCT01090765|3875810|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053903|NCT01090765|3875811|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053904|NCT01090765|3875812|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053905|NCT01090765|3875813|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053906|NCT01090765|3875814|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053907|NCT01090765|3875815|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053908|NCT01090765|3875809|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053909|NCT01090765|3875810|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053910|NCT01090765|3875811|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053911|NCT01090765|3875812|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053912|NCT01090765|3875813|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053913|NCT01090765|3875814|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053914|NCT01090765|3875815|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053915|NCT01090765|3875809|B7||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4053916|NCT01090765|3875810|B6||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4053917|NCT01090765|3875811|B5||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4053918|NCT01090765|3875812|B4||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4053919|NCT01090765|3875813|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4053920|NCT01090765|3875814|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4053921|NCT01090765|3875815|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4053922|NCT01090765|3875809|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4053923|NCT01090765|3875810|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4053924|NCT01090765|3875811|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4053925|NCT01090765|3875812|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4053926|NCT01090765|3875813|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4053927|NCT01090765|3875814|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4053928|NCT01090765|3875815|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053929|NCT01090765|3875809|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053930|NCT01090765|3875810|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053931|NCT01090765|3875811|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053932|NCT01090765|3875812|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053933|NCT01090765|3875813|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053934|NCT01090765|3875814|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053935|NCT01090765|3875815|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053936|NCT01090765|3875809|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053937|NCT01090765|3875810|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053938|NCT01090765|3875811|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053939|NCT01090765|3875812|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053940|NCT01090765|3875813|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053941|NCT01090765|3875814|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053942|NCT01090765|3875815|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053943|NCT01090765|3875809|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053944|NCT01090765|3875810|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053945|NCT01090765|3875811|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053946|NCT01090765|3875812|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053947|NCT01090765|3875813|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053948|NCT01090765|3875814|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053949|NCT01090765|3875815|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053950|NCT01090765|3875809|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053951|NCT01090765|3875810|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053952|NCT01090765|3875811|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053953|NCT01090765|3875812|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053954|NCT01090765|3875813|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053955|NCT01090765|3875814|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053956|NCT01090765|3875815|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053957|NCT01090765|3875809|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4053958|NCT01090765|3875810|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4053959|NCT01090765|3875811|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4053960|NCT01090765|3875812|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4053961|NCT01090765|3875813|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4053962|NCT01090765|3875814|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4053963|NCT01090765|3875815|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4053964|NCT01090765|3875809|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053965|NCT01090765|3875810|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053966|NCT01090765|3875811|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053967|NCT01090765|3875812|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053968|NCT01090765|3875813|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053969|NCT01090765|3875814|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053970|NCT01090765|3875815|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4053971|NCT01090765|3875809|B7||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4053972|NCT01090765|3875810|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4053973|NCT01090765|3875811|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4053974|NCT01090765|3875812|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4053975|NCT01090765|3875813|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4053976|NCT01090765|3875814|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4053977|NCT01090765|3875815|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4053978|NCT01090765|3875809|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4053979|NCT01090765|3875810|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4053980|NCT01090765|3875811|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4053981|NCT01090765|3875812|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4053982|NCT01090765|3875813|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4053983|NCT01090765|3875814|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4053984|NCT01090765|3875815|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4053985|NCT01090765|3875809|B7|||Age||years|Mean|64.32|64.32|Standard Deviation|11.09|11.09|||
4053986|NCT01090765|3875810|B6|||Age||years|Mean|61.8|61.8|Standard Deviation|7.56|7.56|||
4053987|NCT01090765|3875811|B5|||Age||years|Mean|65.83|65.83|Standard Deviation|12.56|12.56|||
4053988|NCT01090765|3875812|B4|||Age||years|Mean|63.15|63.15|Standard Deviation|4.45|4.45|||
4053989|NCT01090765|3875813|B3|||Age||years|Mean|66.53|66.53|Standard Deviation|16.14|16.14|||
4053990|NCT01090765|3875814|B2|||Age||years|Mean|62.37|62.37|Standard Deviation|9.01|9.01|||
4053991|NCT01090765|3875815|B1|||Age||years|Mean|65.2|65.2|Standard Deviation|19.05|19.05|||
4053992|NCT01090765|3875809|B7||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4053993|NCT01090765|3875810|B6||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4053994|NCT01090765|3875811|B5||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4053995|NCT01090765|3875812|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4053996|NCT01090765|3875813|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4053997|NCT01090765|3875814|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4053998|NCT01090765|3875815|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4053999|NCT01090765|3875809|B7||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4054000|NCT01090765|3875810|B6||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4054001|NCT01090765|3875811|B5||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4054002|NCT01090765|3875812|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4054003|NCT01090765|3875813|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4054004|NCT01090765|3875814|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4054005|NCT01090765|3875815|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4054006|NCT01090765|3875809|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4054007|NCT01090765|3875810|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4054008|NCT01090765|3875811|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4054009|NCT01090765|3875812|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4054010|NCT01090765|3875813|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4054011|NCT01090765|3875814|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4054012|NCT01090765|3875815|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4054013|NCT01090752|3875853|B3|Switzerland||Region of Enrollment||participants|Number|16|16.0||||||
4054014|NCT01090752|3875854|B2|Switzerland||Region of Enrollment||participants|Number|8|8.0||||||
4054015|NCT01090752|3875855|B1|Switzerland||Region of Enrollment||participants|Number|8|8.0||||||
4054016|NCT01090752|3875853|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4054017|NCT01090752|3875854|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4054018|NCT01090752|3875855|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4054019|NCT01090752|3875853|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4054020|NCT01090752|3875854|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4054021|NCT01090752|3875855|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4054022|NCT01090752|3875853|B3|||Age||years|Mean|52.5|52.5|Standard Deviation|2.8|2.8|||
4054023|NCT01090752|3875854|B2|||Age||years|Mean|52.5|52.5|Standard Deviation|2.8|2.8|||
4054024|NCT01090752|3875855|B1|||Age||years|Mean|52.5|52.5|Standard Deviation|2.8|2.8|||
4054025|NCT01090752|3875853|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4054026|NCT01090752|3875854|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4054027|NCT01090752|3875855|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4054028|NCT01090752|3875853|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4054029|NCT01090752|3875854|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4054030|NCT01090752|3875855|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4054031|NCT01090752|3875853|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4054032|NCT01090752|3875854|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4054033|NCT01090752|3875855|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4054034|NCT01090739|3875866|B1|||Internal Anal Sphincter Defect Extent||degrees|Mean|110.0|110.0|Standard Deviation|53.7|53.7|||
4054035|NCT01090739|3875866|B1|||External Anal Sphincter Defect Extent||degrees|Mean|95.3|95.3|Standard Deviation|45.0|45.0|||
4054036|NCT01090739|3875866|B1|Absent||Internal Anal Sphincter Defects||participants|Number|110|110.0||||||
4054037|NCT01090739|3875866|B1|Present||Internal Anal Sphincter Defects||participants|Number|42|42.0||||||
4054038|NCT01090739|3875866|B1|Absent||External Anal Sphincter Defects||participants|Number|73|73.0||||||
4054039|NCT01090739|3875866|B1|Present||External Anal Sphincter Defects||participants|Number|79|79.0||||||
4054040|NCT01090739|3875866|B1|Maximum tolerated volume||Anorectal Manometry - Volumes||cc|Mean|124.8|124.8|Standard Deviation|61.9|61.9|||
4054041|NCT01090739|3875866|B1|First sensation volume||Anorectal Manometry - Volumes||cc|Mean|43.1|43.1|Standard Deviation|30.9|30.9|||
4054042|NCT01090739|3875866|B1|Mean Maximum Squeeze Pressure||Anorectal Manometry - Pressures||mmHg|Mean|60.1|60.1|Standard Deviation|42.6|42.6|||
4054043|NCT01090739|3875866|B1|Mean Maximum Resting Pressure||Anorectal Manometry - Pressures||mmHg|Mean|31.5|31.5|Standard Deviation|21.9|21.9|||
4054044|NCT01090739|3875866|B1|Absent||Anal Resting Tone||participants|Number|11|11.0||||||
4054045|NCT01090739|3875866|B1|Present||Anal Resting Tone||participants|Number|141|141.0||||||
4054046|NCT01090739|3875866|B1|Absent||Hemorrhoids||participants|Number|118|118.0||||||
4054047|NCT01090739|3875866|B1|Present||Hemorrhoids||participants|Number|34|34.0||||||
4054048|NCT01090739|3875866|B1|Diet, medication and pelvic floor training||Failed Fecal Incontinence Conservative Therapy|Subjects had to fail at least two conservative therapies for their FI prior to entry into the study.|participants|Number|61|61.0||||||
4054049|NCT01090739|3875866|B1|Medication and pelvic floor muscle training||Failed Fecal Incontinence Conservative Therapy|Subjects had to fail at least two conservative therapies for their FI prior to entry into the study.|participants|Number|20|20.0||||||
4054050|NCT01090739|3875866|B1|Diet modification and pelvic floor muscle training||Failed Fecal Incontinence Conservative Therapy|Subjects had to fail at least two conservative therapies for their FI prior to entry into the study.|participants|Number|49|49.0||||||
4054051|NCT01090739|3875866|B1|Diet modification and medication||Failed Fecal Incontinence Conservative Therapy|Subjects had to fail at least two conservative therapies for their FI prior to entry into the study.|participants|Number|22|22.0||||||
4054052|NCT01090739|3875866|B1|Bile acid sequestrants||Baseline Fecal Incontinence Medication|Subjects taking medications does not equal 152 (number of subjects).|participants|Number|3|3.0||||||
4054053|NCT01090739|3875866|B1|Other meds||Baseline Fecal Incontinence Medication|Subjects taking medications does not equal 152 (number of subjects).|participants|Number|5|5.0||||||
4054054|NCT01090739|3875866|B1|Anti-cholinergic agents||Baseline Fecal Incontinence Medication|Subjects taking medications does not equal 152 (number of subjects).|participants|Number|6|6.0||||||
4054055|NCT01090739|3875866|B1|Osmotic laxatives||Baseline Fecal Incontinence Medication|Subjects taking medications does not equal 152 (number of subjects).|participants|Number|8|8.0||||||
4054056|NCT01090739|3875866|B1|Bulking agents||Baseline Fecal Incontinence Medication|Subjects taking medications does not equal 152 (number of subjects).|participants|Number|22|22.0||||||
4054057|NCT01090739|3875866|B1|Opioid-receptor agents||Baseline Fecal Incontinence Medication|Subjects taking medications does not equal 152 (number of subjects).|participants|Number|30|30.0||||||
4054058|NCT01090739|3875866|B1|Gallstones||Baseline Medical History|Subjects can have multiple medical history items so the total does not equal 152 (number of subjects).|participants|Number|2|2.0||||||
4054059|NCT01090739|3875866|B1|Rectal prolapse||Baseline Medical History|Subjects can have multiple medical history items so the total does not equal 152 (number of subjects).|participants|Number|6|6.0||||||
4054060|NCT01090739|3875866|B1|Vaginal prolapse||Baseline Medical History|Subjects can have multiple medical history items so the total does not equal 152 (number of subjects).|participants|Number|8|8.0||||||
4054061|NCT01090739|3875866|B1|Diabetes||Baseline Medical History|Subjects can have multiple medical history items so the total does not equal 152 (number of subjects).|participants|Number|19|19.0||||||
4054062|NCT01090739|3875866|B1|Vaginal atrophy||Baseline Medical History|Subjects can have multiple medical history items so the total does not equal 152 (number of subjects).|participants|Number|23|23.0||||||
4054063|NCT01090739|3875866|B1|Headaches||Baseline Medical History|Subjects can have multiple medical history items so the total does not equal 152 (number of subjects).|participants|Number|29|29.0||||||
4054064|NCT01090739|3875866|B1|Previous anal sphincter repair||Baseline Medical History|Subjects can have multiple medical history items so the total does not equal 152 (number of subjects).|participants|Number|31|31.0||||||
4054065|NCT01090739|3875866|B1|Irritable bowel syndrome||Baseline Medical History|Subjects can have multiple medical history items so the total does not equal 152 (number of subjects).|participants|Number|31|31.0||||||
4054066|NCT01090739|3875866|B1|Hemorrhoids||Baseline Medical History|Subjects can have multiple medical history items so the total does not equal 152 (number of subjects).|participants|Number|36|36.0||||||
4054067|NCT01090739|3875866|B1|Previous cholecystectomy||Baseline Medical History|Subjects can have multiple medical history items so the total does not equal 152 (number of subjects).|participants|Number|38|38.0||||||
4054068|NCT01090739|3875866|B1|Hypothroid||Baseline Medical History|Subjects can have multiple medical history items so the total does not equal 152 (number of subjects).|participants|Number|38|38.0||||||
4054069|NCT01090739|3875866|B1|Urinary incontinence||Baseline Medical History|Subjects can have multiple medical history items so the total does not equal 152 (number of subjects).|participants|Number|39|39.0||||||
4054070|NCT01090739|3875866|B1|Diverticulitis||Baseline Medical History|Subjects can have multiple medical history items so the total does not equal 152 (number of subjects).|participants|Number|41|41.0||||||
4054071|NCT01090739|3875866|B1|Pelvic area pain||Baseline Medical History|Subjects can have multiple medical history items so the total does not equal 152 (number of subjects).|participants|Number|52|52.0||||||
4054072|NCT01090739|3875866|B1|Hyperlipidemia||Baseline Medical History|Subjects can have multiple medical history items so the total does not equal 152 (number of subjects).|participants|Number|53|53.0||||||
4054073|NCT01090739|3875866|B1|Systemic pain||Baseline Medical History|Subjects can have multiple medical history items so the total does not equal 152 (number of subjects).|participants|Number|55|55.0||||||
4054074|NCT01090739|3875866|B1|Depressive disorder||Baseline Medical History|Subjects can have multiple medical history items so the total does not equal 152 (number of subjects).|participants|Number|56|56.0||||||
4054075|NCT01090739|3875866|B1|Hypertension||Baseline Medical History|Subjects can have multiple medical history items so the total does not equal 152 (number of subjects).|participants|Number|60|60.0||||||
4054076|NCT01090739|3875866|B1|Gastrointestional reflux disease||Baseline Medical History|Subjects can have multiple medical history items so the total does not equal 152 (number of subjects).|participants|Number|65|65.0||||||
4054077|NCT01090739|3875866|B1|Previous prolapse / UI repair||Baseline Medical History|Subjects can have multiple medical history items so the total does not equal 152 (number of subjects).|participants|Number|70|70.0||||||
4054078|NCT01090739|3875866|B1|Previous hysterectomy / oophorectomy||Baseline Medical History|Subjects can have multiple medical history items so the total does not equal 152 (number of subjects).|participants|Number|74|74.0||||||
4054079|NCT01090739|3875866|B1|Absent||Rectal soft tissue scarring||participants|Number|126|126.0||||||
4054080|NCT01090739|3875866|B1|Present||Rectal soft tissue scarring||participants|Number|26|26.0||||||
4054134|NCT01090492|3875886|B6||Between 45 to 64 years|Age, Customized||Participants|Count of Participants|26|26.0||||||
4054081|NCT01090739|3875866|B1|Other||Etiology of Fecal Incontinence|Subjects can have multiple etiologies so total does not equal 152 (number of subjects)|participants|Number|4|4.0||||||
4054082|NCT01090739|3875866|B1|Idiopathic/unknown||Etiology of Fecal Incontinence|Subjects can have multiple etiologies so total does not equal 152 (number of subjects)|participants|Number|62|62.0||||||
4054083|NCT01090739|3875866|B1|Obstetric trauma||Etiology of Fecal Incontinence|Subjects can have multiple etiologies so total does not equal 152 (number of subjects)|participants|Number|87|87.0||||||
4054084|NCT01090739|3875866|B1|Anorectal trauma||Etiology of Fecal Incontinence|Subjects can have multiple etiologies so total does not equal 152 (number of subjects)|participants|Number|6|6.0||||||
4054085|NCT01090739|3875866|B1|||Duration of Fecal Incontinence||months|Mean|110.0|110.0|Standard Deviation|113.5|113.5|||
4054086|NCT01090739|3875866|B1|# Rgular laxative use within past 5 years||Concomitant Use||participants|Number|18|18.0||||||
4054087|NCT01090739|3875866|B1|# Caffeine use on a regular basis||Concomitant Use||participants|Number|102|102.0||||||
4054088|NCT01090739|3875866|B1|# Smoked within past 6 months||Concomitant Use||participants|Number|8|8.0||||||
4054089|NCT01090739|3875866|B1|Post-menopausal||Menopausal Status||participants|Number|126|126.0||||||
4054090|NCT01090739|3875866|B1|Peri-menopausal||Menopausal Status||participants|Number|6|6.0||||||
4054091|NCT01090739|3875866|B1|Pre-menopausal||Menopausal Status||participants|Number|20|20.0||||||
4054092|NCT01090739|3875866|B1|||Obstetric History - # of Caesarean deliveries|women delivering via a caesarean procedure|number|Mean|0.1|0.1|Standard Deviation|0.5|0.5|||
4054093|NCT01090739|3875866|B1|||Obstetric History - # of Vaginal Deliveries|The number of times a women delivered vaginally|number|Mean|2.4|2.4|Standard Deviation|1.5|1.5|||
4054094|NCT01090739|3875866|B1|||Obstetric History - Parity|Parity is defined as the number of pregnancies carried to gestation|number|Mean|2.6|2.6|Standard Deviation|1.4|1.4|||
4054095|NCT01090739|3875866|B1|||Obstetric History - Gravidity|Number of times subjects have been pregnant|number|Mean|3.0|3.0|Standard Deviation|1.8|1.8|||
4054096|NCT01090739|3875866|B1|United States||Region of Enrollment||participants|Number|152|152.0||||||
4054097|NCT01090739|3875866|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4054098|NCT01090739|3875866|B1|Hispanic/Latina||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4054099|NCT01090739|3875866|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4054100|NCT01090739|3875866|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4054101|NCT01090739|3875866|B1|White/Caucasian||Race/Ethnicity, Customized||participants|Number|137|137.0||||||
4054102|NCT01090739|3875866|B1|Women||Sex/Gender, Customized||participants|Number|152|152.0||||||
4054103|NCT01090739|3875866|B1|||Age||years|Mean|59.6|59.6|Standard Deviation|9.7|9.7|||
4054104|NCT01090492|3875883|B9||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4054105|NCT01090492|3875884|B8||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4054106|NCT01090492|3875885|B7||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4054107|NCT01090492|3875886|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4054108|NCT01090492|3875887|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4054109|NCT01090492|3875888|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4054110|NCT01090492|3875889|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4054111|NCT01090492|3875890|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4054112|NCT01090492|3875891|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4054113|NCT01090492|3875883|B9||Female|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
4054114|NCT01090492|3875884|B8||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4054115|NCT01090492|3875885|B7||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4054116|NCT01090492|3875886|B6||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4054117|NCT01090492|3875887|B5||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4054118|NCT01090492|3875888|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4054119|NCT01090492|3875889|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4054120|NCT01090492|3875890|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4054121|NCT01090492|3875891|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4054122|NCT01090492|3875883|B9||Greater than or equal to (>=) 65 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
4054123|NCT01090492|3875884|B8||Greater than or equal to (>=) 65 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
4054124|NCT01090492|3875885|B7||Greater than or equal to (>=) 65 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
4054125|NCT01090492|3875886|B6||Greater than or equal to (>=) 65 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
4054126|NCT01090492|3875887|B5||Greater than or equal to (>=) 65 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
4054127|NCT01090492|3875888|B4||Greater than or equal to (>=) 65 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
4054128|NCT01090492|3875889|B3||Greater than or equal to (>=) 65 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
4054129|NCT01090492|3875890|B2||Greater than or equal to (>=) 65 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
4054130|NCT01090492|3875891|B1||Greater than or equal to (>=) 65 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
4054131|NCT01090492|3875883|B9||Between 45 to 64 years|Age, Customized||Participants|Count of Participants|146|146.0||||||
4054132|NCT01090492|3875884|B8||Between 45 to 64 years|Age, Customized||Participants|Count of Participants|24|24.0||||||
4054133|NCT01090492|3875885|B7||Between 45 to 64 years|Age, Customized||Participants|Count of Participants|16|16.0||||||
4054135|NCT01090492|3875887|B5||Between 45 to 64 years|Age, Customized||Participants|Count of Participants|22|22.0||||||
4054136|NCT01090492|3875888|B4||Between 45 to 64 years|Age, Customized||Participants|Count of Participants|14|14.0||||||
4054137|NCT01090492|3875889|B3||Between 45 to 64 years|Age, Customized||Participants|Count of Participants|15|15.0||||||
4054138|NCT01090492|3875890|B2||Between 45 to 64 years|Age, Customized||Participants|Count of Participants|16|16.0||||||
4054139|NCT01090492|3875891|B1||Between 45 to 64 years|Age, Customized||Participants|Count of Participants|13|13.0||||||
4054140|NCT01090492|3875883|B9||Between 18 to 44 years|Age, Customized||Participants|Count of Participants|95|95.0||||||
4054141|NCT01090492|3875884|B8||Between 18 to 44 years|Age, Customized||Participants|Count of Participants|9|9.0||||||
4054142|NCT01090492|3875885|B7||Between 18 to 44 years|Age, Customized||Participants|Count of Participants|16|16.0||||||
4054143|NCT01090492|3875886|B6||Between 18 to 44 years|Age, Customized||Participants|Count of Participants|6|6.0||||||
4054144|NCT01090492|3875887|B5||Between 18 to 44 years|Age, Customized||Participants|Count of Participants|10|10.0||||||
4054145|NCT01090492|3875888|B4||Between 18 to 44 years|Age, Customized||Participants|Count of Participants|14|14.0||||||
4054146|NCT01090492|3875889|B3||Between 18 to 44 years|Age, Customized||Participants|Count of Participants|14|14.0||||||
4054147|NCT01090492|3875890|B2||Between 18 to 44 years|Age, Customized||Participants|Count of Participants|12|12.0||||||
4054148|NCT01090492|3875891|B1||Between 18 to 44 years|Age, Customized||Participants|Count of Participants|14|14.0||||||
4054149|NCT01090479|3875955|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
4054150|NCT01090479|3875956|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
4054151|NCT01090479|3875957|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4054152|NCT01090479|3875955|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4054153|NCT01090479|3875956|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4054154|NCT01090479|3875957|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4054155|NCT01090479|3875955|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4054156|NCT01090479|3875956|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4054157|NCT01090479|3875957|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4054158|NCT01090479|3875955|B3|||Age||years|Mean|50.5|50.5|Standard Deviation|7|7.0|||
4054159|NCT01090479|3875956|B2|||Age||years|Mean|49.0|49.0|Standard Deviation|9|9.0|||
4054160|NCT01090479|3875957|B1|||Age||years|Mean|52.0|52.0|Standard Deviation|8|8.0|||
4054161|NCT01090479|3875955|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4054162|NCT01090479|3875956|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4054163|NCT01090479|3875957|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4054164|NCT01090479|3875955|B3||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
4054165|NCT01090479|3875956|B2||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4054166|NCT01090479|3875957|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4054167|NCT01090479|3875955|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4054168|NCT01090479|3875956|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4054169|NCT01090479|3875957|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4054170|NCT01090453|3875964|B3|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
4054171|NCT01090453|3875965|B2|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4054172|NCT01090453|3875966|B1|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4054173|NCT01090453|3875964|B3|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|426|426.0||||||
4054174|NCT01090453|3875965|B2|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|216|216.0||||||
4054175|NCT01090453|3875966|B1|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|210|210.0||||||
4054176|NCT01090453|3875964|B3|White-Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4054177|NCT01090453|3875965|B2|White-Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4054178|NCT01090453|3875966|B1|White-Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4054179|NCT01090453|3875964|B3|Asian-South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4054180|NCT01090453|3875965|B2|Asian-South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4054181|NCT01090453|3875966|B1|Asian-South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4054182|NCT01090453|3875964|B3|Asian-East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4054183|NCT01090453|3875965|B2|Asian-East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4054184|NCT01090453|3875966|B1|Asian-East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4054185|NCT01090453|3875964|B3|Asian-Central/South Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4054186|NCT01090453|3875965|B2|Asian-Central/South Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4054187|NCT01090453|3875966|B1|Asian-Central/South Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4054188|NCT01090453|3875964|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4054189|NCT01090453|3875965|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4054190|NCT01090453|3875966|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4054191|NCT01090453|3875964|B3|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4054192|NCT01090453|3875965|B2|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4054193|NCT01090453|3875966|B1|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4054194|NCT01090453|3875964|B3||Male|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
4054195|NCT01090453|3875965|B2||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4054196|NCT01090453|3875966|B1||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4054197|NCT01090453|3875964|B3||Female|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
4054198|NCT01090453|3875965|B2||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4054199|NCT01090453|3875966|B1||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4054200|NCT01090453|3875964|B3|||Age||Weeks|Mean|9.15|9.15|Standard Deviation|1.16|1.16|||
4054201|NCT01090453|3875965|B2|||Age||Weeks|Mean|9.20|9.2|Standard Deviation|1.17|1.17|||
4054202|NCT01090453|3875966|B1|||Age||Weeks|Mean|9.10|9.1|Standard Deviation|1.15|1.15|||
4054203|NCT01090427|3876015|B4|16-17 years||Age||participants|Number|55|55.0||||||
4054204|NCT01090427|3876016|B3|16-17 years||Age||participants|Number|16|16.0||||||
4054205|NCT01090427|3876017|B2|16-17 years||Age||participants|Number|17|17.0||||||
4054206|NCT01090427|3876018|B1|16-17 years||Age||participants|Number|22|22.0||||||
4054207|NCT01090427|3876015|B4|12-15 years||Age||participants|Number|55|55.0||||||
4054208|NCT01090427|3876016|B3|12-15 years||Age||participants|Number|20|20.0||||||
4054209|NCT01090427|3876017|B2|12-15 years||Age||participants|Number|20|20.0||||||
4054210|NCT01090427|3876018|B1|12-15 years||Age||participants|Number|15|15.0||||||
4054211|NCT01090427|3876015|B4||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4054212|NCT01090427|3876016|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4054213|NCT01090427|3876017|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4054214|NCT01090427|3876018|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4054215|NCT01090427|3876015|B4||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4054216|NCT01090427|3876016|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4054217|NCT01090427|3876017|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4054218|NCT01090427|3876018|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4054219|NCT01090427|3876015|B4|||Age||years|Mean|15.2|15.2|Standard Deviation|1.65|1.65|||
4054220|NCT01090427|3876016|B3|||Age||years|Mean|14.8|14.8|Standard Deviation|1.73|1.73|||
4054221|NCT01090427|3876017|B2|||Age||years|Mean|15.1|15.1|Standard Deviation|1.7|1.7|||
4054222|NCT01090427|3876018|B1|||Age||years|Mean|15.6|15.6|Standard Deviation|1.46|1.46|||
4054223|NCT01090323|3876057|B3|Italy||Region of Enrollment||participants|Number|10|10.0||||||
4054224|NCT01090323|3876058|B2|Italy||Region of Enrollment||participants|Number|3|3.0||||||
4054225|NCT01090323|3876059|B1|Italy||Region of Enrollment||participants|Number|7|7.0||||||
4054226|NCT01090323|3876057|B3|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4054227|NCT01090323|3876058|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4054228|NCT01090323|3876059|B1|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4054229|NCT01090323|3876057|B3|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4054230|NCT01090323|3876058|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4054231|NCT01090323|3876059|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4054232|NCT01090323|3876057|B3|United States||Region of Enrollment||participants|Number|156|156.0||||||
4054233|NCT01090323|3876058|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
4054234|NCT01090323|3876059|B1|United States||Region of Enrollment||participants|Number|110|110.0||||||
4054235|NCT01090323|3876057|B3|France||Region of Enrollment||participants|Number|12|12.0||||||
4054236|NCT01090323|3876058|B2|France||Region of Enrollment||participants|Number|2|2.0||||||
4054237|NCT01090323|3876059|B1|France||Region of Enrollment||participants|Number|10|10.0||||||
4054238|NCT01090323|3876057|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4054239|NCT01090323|3876058|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4054240|NCT01090323|3876059|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4054241|NCT01090323|3876057|B3||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4054242|NCT01090323|3876058|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4054243|NCT01090323|3876059|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4054244|NCT01090323|3876057|B3|16 - <65 years||Age, Customized||participants|Number|95|95.0||||||
4054245|NCT01090323|3876058|B2|16 - <65 years||Age, Customized||participants|Number|28|28.0||||||
4054246|NCT01090323|3876059|B1|16 - <65 years||Age, Customized||participants|Number|67|67.0||||||
4054247|NCT01090323|3876057|B3|12 - <16 years||Age, Customized||participants|Number|43|43.0||||||
4054248|NCT01090323|3876058|B2|12 - <16 years||Age, Customized||participants|Number|11|11.0||||||
4054249|NCT01090323|3876059|B1|12 - <16 years||Age, Customized||participants|Number|32|32.0||||||
4054250|NCT01090323|3876057|B3|<12 years||Age, Customized||participants|Number|47|47.0||||||
4054251|NCT01090323|3876058|B2|<12 years||Age, Customized||participants|Number|14|14.0||||||
4054252|NCT01090323|3876059|B1|<12 years||Age, Customized||participants|Number|33|33.0||||||
4054253|NCT01090310|3876068|B5||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4054254|NCT01090310|3876069|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4054255|NCT01090310|3876070|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4054256|NCT01090310|3876071|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4054257|NCT01090310|3876072|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4054258|NCT01090310|3876068|B5||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4054259|NCT01090310|3876069|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4054260|NCT01090310|3876070|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4054261|NCT01090310|3876071|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4054262|NCT01090310|3876072|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4054263|NCT01090310|3876068|B5|||Age||Years|Mean|47.6|47.6|Standard Deviation|13.60|13.6|||
4054264|NCT01090310|3876069|B4|||Age||Years|Mean|47.3|47.3|Standard Deviation|15.46|15.46|||
4054265|NCT01090310|3876070|B3|||Age||Years|Mean|47.7|47.7|Standard Deviation|13.50|13.5|||
4054266|NCT01090310|3876071|B2|||Age||Years|Mean|49.2|49.2|Standard Deviation|11.14|11.14|||
4054267|NCT01090310|3876072|B1|||Age||Years|Mean|46.2|46.2|Standard Deviation|14.29|14.29|||
4054268|NCT01090180|3876101|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
4054269|NCT01090180|3876102|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4054270|NCT01090180|3876103|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4054271|NCT01090180|3876101|B3|Declined to state||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4054272|NCT01090180|3876102|B2|Declined to state||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4054273|NCT01090180|3876103|B1|Declined to state||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4054274|NCT01090180|3876101|B3|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4054275|NCT01090180|3876102|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4054276|NCT01090180|3876103|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4054277|NCT01090180|3876101|B3|White, Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4054278|NCT01090180|3876102|B2|White, Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4054279|NCT01090180|3876103|B1|White, Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4054280|NCT01090180|3876101|B3|Black, non-Hispanic||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4054281|NCT01090180|3876102|B2|Black, non-Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4054282|NCT01090180|3876103|B1|Black, non-Hispanic||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4054283|NCT01090180|3876101|B3|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4054284|NCT01090180|3876102|B2|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4054285|NCT01090180|3876103|B1|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4054286|NCT01090180|3876101|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4054287|NCT01090180|3876102|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4054288|NCT01090180|3876103|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4054289|NCT01090180|3876101|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4054290|NCT01090180|3876102|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4054291|NCT01090180|3876103|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4054292|NCT01090180|3876101|B3|||Age||years|Mean|37.92|37.92|Standard Deviation|12.78|12.78|||
4054293|NCT01090180|3876102|B2|||Age||years|Mean|41.34|41.34|Standard Deviation|13.97|13.97|||
4054294|NCT01090180|3876103|B1|||Age||years|Mean|34.91|34.91|Standard Deviation|11.74|11.74|||
4054295|NCT01090102|3876112|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
4054296|NCT01090102|3876113|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4054297|NCT01090102|3876114|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4054298|NCT01090102|3876112|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4054299|NCT01090102|3876113|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4054300|NCT01090102|3876114|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4054301|NCT01090102|3876112|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4054302|NCT01090102|3876113|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4054303|NCT01090102|3876114|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4054304|NCT01090102|3876112|B3|||Age||years|Median|55|55.0|Inter-Quartile Range|||49.0|62.0|
4054305|NCT01090102|3876113|B2|||Age||years|Median|60|60.0|Inter-Quartile Range|||49.0|62.0|
4054306|NCT01090102|3876114|B1|||Age||years|Median|53|53.0|Inter-Quartile Range|||49.0|62.0|
4054307|NCT01090076|3876123|B3|Singapore||Region of Enrollment||participants|Number|26|26.0||||||
4054308|NCT01090076|3876124|B2|Singapore||Region of Enrollment||participants|Number|14|14.0||||||
4054309|NCT01090076|3876125|B1|Singapore||Region of Enrollment||participants|Number|12|12.0||||||
4054310|NCT01090076|3876123|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4054311|NCT01090076|3876124|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4054312|NCT01090076|3876125|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4054313|NCT01090076|3876123|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4054314|NCT01090076|3876124|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4054315|NCT01090076|3876125|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4054316|NCT01090076|3876123|B3|||Age||years|Mean|75.4|75.4|Standard Deviation|15.4|15.4|||
4054317|NCT01090076|3876124|B2|||Age||years|Mean|74.3|74.3|Standard Deviation|12.4|12.4|||
4054318|NCT01090076|3876125|B1|||Age||years|Mean|78.5|78.5|Standard Deviation|18.4|18.4|||
4054319|NCT01090076|3876123|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4054320|NCT01090076|3876124|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4054321|NCT01090076|3876125|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4054322|NCT01090076|3876123|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4054323|NCT01090076|3876124|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4054324|NCT01090076|3876125|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4054325|NCT01090076|3876123|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4054326|NCT01090076|3876124|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4054327|NCT01090076|3876125|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4054328|NCT01090063|3876136|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4054329|NCT01090063|3876136|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4054330|NCT01090063|3876136|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4054331|NCT01090063|3876136|B1|||Age||years|Mean|55|55.0|Standard Deviation|16|16.0|||
4054332|NCT01090063|3876136|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4054333|NCT01090063|3876136|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4054334|NCT01090063|3876136|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4054335|NCT01090050|3876150|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
4054336|NCT01090050|3876151|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4054337|NCT01090050|3876152|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4054338|NCT01090050|3876150|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4054339|NCT01090050|3876151|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4054340|NCT01090050|3876152|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4054341|NCT01090050|3876150|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4054342|NCT01090050|3876151|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4054343|NCT01090050|3876152|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4054344|NCT01090050|3876150|B3|||Age||years|Mean|40.9|40.9|Standard Deviation|11.4|11.4|||
4054345|NCT01090050|3876151|B2|||Age||years|Mean|37.0|37.0|Standard Deviation|8.6|8.6|||
4054346|NCT01090050|3876152|B1|||Age||years|Mean|43.8|43.8|Standard Deviation|12.6|12.6|||
4054347|NCT01090050|3876150|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4054348|NCT01090050|3876151|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4054349|NCT01090050|3876152|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4054350|NCT01090050|3876150|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4054351|NCT01090050|3876151|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4054352|NCT01090050|3876152|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4054353|NCT01090050|3876150|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4054354|NCT01090050|3876151|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4054355|NCT01090050|3876152|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4054356|NCT01090011|3876173|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4054357|NCT01090011|3876173|B1||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4054358|NCT01090011|3876173|B1|||Age||years|Mean|58.1|58.1|Standard Deviation|10.5|10.5|||
4054359|NCT01089751|3876241|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4054360|NCT01089751|3876242|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4054361|NCT01089751|3876243|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4054362|NCT01089751|3876241|B3||Female|Sex: Female, Male||Participants|Count of Participants|322|322.0||||||
4054363|NCT01089751|3876242|B2||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4054364|NCT01089751|3876243|B1||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4054365|NCT01089751|3876241|B3|||Age||Years|Mean|56.1|56.1|Full Range|||21.0|84.0|
4054366|NCT01089751|3876242|B2|||Age||Years|Mean|56.0|56.0|Full Range|||21.0|84.0|
4054367|NCT01089751|3876243|B1|||Age||Years|Mean|56.3|56.3|Full Range|||21.0|76.0|
4054368|NCT01089647|3876264|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
4054369|NCT01089647|3876265|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4054370|NCT01089647|3876266|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4054371|NCT01089647|3876264|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4054372|NCT01089647|3876264|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4054373|NCT01089647|3876265|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4054374|NCT01089647|3876266|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4054375|NCT01089647|3876264|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4054376|NCT01089647|3876265|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4054377|NCT01089647|3876266|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4054378|NCT01089647|3876264|B3||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4054379|NCT01089647|3876265|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4054380|NCT01089647|3876266|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4054381|NCT01089647|3876264|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4054382|NCT01089647|3876265|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4054383|NCT01089647|3876266|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4054384|NCT01089647|3876264|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4054385|NCT01089647|3876265|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4054386|NCT01089647|3876266|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4054387|NCT01089647|3876264|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4054388|NCT01089647|3876265|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4054389|NCT01089647|3876266|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4054390|NCT01089647|3876264|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4054391|NCT01089647|3876265|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4054392|NCT01089647|3876266|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4054393|NCT01089647|3876264|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4054394|NCT01089647|3876265|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4054395|NCT01089647|3876266|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4054396|NCT01089647|3876264|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4054397|NCT01089647|3876265|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4054398|NCT01089647|3876266|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4054399|NCT01089647|3876264|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4054400|NCT01089647|3876265|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4054401|NCT01089647|3876266|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4054402|NCT01089647|3876264|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4054403|NCT01089647|3876265|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4054404|NCT01089647|3876266|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4054405|NCT01089647|3876264|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4054406|NCT01089647|3876265|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4054407|NCT01089647|3876266|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4054408|NCT01089608|3876273|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4054409|NCT01089608|3876274|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4054410|NCT01089608|3876275|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4054411|NCT01089608|3876273|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4054412|NCT01089608|3876274|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4054413|NCT01089608|3876275|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4054414|NCT01089608|3876273|B3|||Age||years|Mean|56.2|56.2|Standard Deviation|16.1|16.1|||
4054415|NCT01089608|3876274|B2|||Age||years|Mean|55.7|55.7|Standard Deviation|16.1|16.1|||
4054416|NCT01089608|3876275|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|16.2|16.2|||
4054417|NCT01089595|3876282|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4054418|NCT01089595|3876283|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4054419|NCT01089595|3876284|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4054420|NCT01089595|3876282|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4054421|NCT01089595|3876283|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4054422|NCT01089595|3876284|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4054423|NCT01089595|3876282|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4054424|NCT01089595|3876283|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4054425|NCT01089595|3876284|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4054426|NCT01089595|3876282|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4054427|NCT01089595|3876283|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4054428|NCT01089595|3876284|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4054429|NCT01089595|3876282|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4054430|NCT01089595|3876283|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4054431|NCT01089595|3876284|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4054432|NCT01089595|3876282|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4054433|NCT01089595|3876283|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4054434|NCT01089595|3876284|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4054435|NCT01089582|3876293|B1|Venous insufficiency||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054624|NCT01089556|3876336|B1|Turkey||Region of Enrollment||participants|Number|5|5.0||||||
4054436|NCT01089582|3876293|B1|Varicose vein||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054437|NCT01089582|3876293|B1|Temporal arteritis||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054438|NCT01089582|3876293|B1|Hypertension||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|273|273.0||||||
4054439|NCT01089582|3876293|B1|Arterial disorder||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054440|NCT01089582|3876293|B1|Oesophageal operation||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054441|NCT01089582|3876293|B1|Cardiac pacemaker insertion||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054442|NCT01089582|3876293|B1|Cardiac operation||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054443|NCT01089582|3876293|B1|Lichen sclerosus||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054444|NCT01089582|3876293|B1|Chronic obstructive pulmonary disease||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|13|13.0||||||
4054445|NCT01089582|3876293|B1|Asthma||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|4|4.0||||||
4054446|NCT01089582|3876293|B1|Prostatomegaly||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|9|9.0||||||
4054447|NCT01089582|3876293|B1|Prostatic disorder||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054448|NCT01089582|3876293|B1|Benign prostatic hyperplasia||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|9|9.0||||||
4054449|NCT01089582|3876293|B1|Urinary retention||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054450|NCT01089582|3876293|B1|Urinary incontinence||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|2|2.0||||||
4054451|NCT01089582|3876293|B1|Renal failure chronic||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|2|2.0||||||
4054452|NCT01089582|3876293|B1|Renal failure||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054453|NCT01089582|3876293|B1|Incontinence||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054454|NCT01089582|3876293|B1|Glomerulonephritis||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054455|NCT01089582|3876293|B1|Stress||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|2|2.0||||||
4054456|NCT01089582|3876293|B1|Sleep disorder||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|3|3.0||||||
4054457|NCT01089582|3876293|B1|Schizophrenia, paranoid type||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054458|NCT01089582|3876293|B1|Schizophrenia||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|11|11.0||||||
4054459|NCT01089582|3876293|B1|Psychotic disorder due to a general medical condit||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|2|2.0||||||
4054460|NCT01089582|3876293|B1|Psychotic disorder||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|3|3.0||||||
4054461|NCT01089582|3876293|B1|Phobia||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054462|NCT01089582|3876293|B1|Personality change due to a general medical condit||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054463|NCT01089582|3876293|B1|Neurosis||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|2|2.0||||||
4054464|NCT01089582|3876293|B1|Depression||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|116|116.0||||||
4054465|NCT01089582|3876293|B1|Bipolar disorder||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054466|NCT01089582|3876293|B1|Anxiety disorder||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|3|3.0||||||
4054467|NCT01089582|3876293|B1|Abnormal behaviour||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|2|2.0||||||
4054468|NCT01089582|3876293|B1|Tremor||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054469|NCT01089582|3876293|B1|Sciatica||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|2|2.0||||||
4054625|NCT01089556|3876334|B3|Spain||Region of Enrollment||participants|Number|14|14.0||||||
4054470|NCT01089582|3876293|B1|Polyneuropathy||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|2|2.0||||||
4054471|NCT01089582|3876293|B1|Parkinson’s disease||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|16|16.0||||||
4054472|NCT01089582|3876293|B1|Myasthenia gravis||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054473|NCT01089582|3876293|B1|Multiple sclerosis||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|2|2.0||||||
4054474|NCT01089582|3876293|B1|Motor neurone disease||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054475|NCT01089582|3876293|B1|Migraine||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|2|2.0||||||
4054476|NCT01089582|3876293|B1|Headache||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054477|NCT01089582|3876293|B1|Extrapyramidal disorder||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|3|3.0||||||
4054478|NCT01089582|3876293|B1|Epilepsy||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|7|7.0||||||
4054479|NCT01089582|3876293|B1|Dystonia||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054480|NCT01089582|3876293|B1|Diabetic neuropathy||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054481|NCT01089582|3876293|B1|Dementia||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|2|2.0||||||
4054482|NCT01089582|3876293|B1|Cerebrovascular accident||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|16|16.0||||||
4054483|NCT01089582|3876293|B1|Cerebral ischaemia||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|51|51.0||||||
4054484|NCT01089582|3876293|B1|Carotid artery disease||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054485|NCT01089582|3876293|B1|Prostate cancer||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|3|3.0||||||
4054486|NCT01089582|3876293|B1|Haemangioma||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054487|NCT01089582|3876293|B1|Rheumatoid arthritis||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|3|3.0||||||
4054488|NCT01089582|3876293|B1|Osteoporosis||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|33|33.0||||||
4054489|NCT01089582|3876293|B1|Osteoarthritis||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|4|4.0||||||
4054490|NCT01089582|3876293|B1|Musculoskeletal pain||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054491|NCT01089582|3876293|B1|Arthropathy||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054492|NCT01089582|3876293|B1|Arthritis||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|2|2.0||||||
4054493|NCT01089582|3876293|B1|Hyperuricaemia||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|3|3.0||||||
4054494|NCT01089582|3876293|B1|Hyperlipidaemia||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|129|129.0||||||
4054495|NCT01089582|3876293|B1|Hypercholesterolaemia||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|2|2.0||||||
4054496|NCT01089582|3876293|B1|Dyslipidaemia||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054497|NCT01089582|3876293|B1|Diabetes mellitus||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|89|89.0||||||
4054498|NCT01089582|3876293|B1|Vitamin B12 decreased||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054499|NCT01089582|3876293|B1|Traumatic brain injury||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054500|NCT01089582|3876293|B1|Panencephalitis||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054501|NCT01089582|3876293|B1|Erysipelas||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054502|NCT01089582|3876293|B1|Sarcoidosis||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054503|NCT01089582|3876293|B1|Necrosis||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054504|NCT01089582|3876293|B1|Pancreatitis chronic||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054505|NCT01089582|3876293|B1|Gastrooesophageal reflux disease||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|3|3.0||||||
4054506|NCT01089582|3876293|B1|Diverticulum intestinal||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054507|NCT01089582|3876293|B1|Diverticulum||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054508|NCT01089582|3876293|B1|Colitis||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054509|NCT01089582|3876293|B1|Glaucoma||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054510|NCT01089582|3876293|B1|Eye disorder||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054511|NCT01089582|3876293|B1|Cataract||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|4|4.0||||||
4054512|NCT01089582|3876293|B1|Hypothyroidism||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|16|16.0||||||
4054513|NCT01089582|3876293|B1|Hyperthyroidism||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|7|7.0||||||
4054514|NCT01089582|3876293|B1|Goitre||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|3|3.0||||||
4054515|NCT01089582|3876293|B1|Vertigo||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|4|4.0||||||
4054516|NCT01089582|3876293|B1|Thalassaemia trait||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054517|NCT01089582|3876293|B1|Coronary artery disease||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|64|64.0||||||
4054518|NCT01089582|3876293|B1|Cardiac failure||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054519|NCT01089582|3876293|B1|Atrial fibrillation||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|7|7.0||||||
4054520|NCT01089582|3876293|B1|Arrhythmia||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054521|NCT01089582|3876293|B1|Aortic valve incompetence||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|1|1.0||||||
4054522|NCT01089582|3876293|B1|Iron deficiency anaemia||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|3|3.0||||||
4054523|NCT01089582|3876293|B1|Anaemia||Medical History|Participants were counted once per medical history but could be counted in more than one medical history.|participants|Number|4|4.0||||||
4054524|NCT01089582|3876293|B1|Unspecified||Sex/Gender, Customized||participants|Number|1|1.0||||||
4054525|NCT01089582|3876293|B1|Male||Sex/Gender, Customized||participants|Number|238|238.0||||||
4054526|NCT01089582|3876293|B1|Female||Sex/Gender, Customized||participants|Number|364|364.0||||||
4054527|NCT01089582|3876293|B1|Unspecified||Age, Customized||participants|Number|10|10.0||||||
4054528|NCT01089582|3876293|B1|65 years or older||Age, Customized||participants|Number|543|543.0||||||
4054529|NCT01089582|3876293|B1|45 to 64 years||Age, Customized||participants|Number|44|44.0||||||
4054530|NCT01089582|3876293|B1|18 to 44 years||Age, Customized||participants|Number|6|6.0||||||
4054531|NCT01089569|3876303|B4|United States||Region of Enrollment||Participants|Count of Participants|49|49.0||||||
4054532|NCT01089569|3876304|B3|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4054533|NCT01089569|3876305|B2|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
4054534|NCT01089569|3876306|B1|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4054535|NCT01089569|3876303|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4054536|NCT01089569|3876304|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4054537|NCT01089569|3876305|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4054538|NCT01089569|3876306|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4054539|NCT01089569|3876303|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4054540|NCT01089569|3876304|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4054541|NCT01089569|3876305|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4054542|NCT01089569|3876306|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4054543|NCT01089569|3876303|B4|||Age||years|Mean|56.3|56.3|Standard Deviation|8.0|8.0|||
4054544|NCT01089569|3876304|B3|||Age||years|Mean|56.7|56.7|Standard Deviation|8.7|8.7|||
4054545|NCT01089569|3876305|B2|||Age||years|Mean|53.8|53.8|Standard Deviation|7.4|7.4|||
4054546|NCT01089569|3876306|B1|||Age||years|Mean|58.6|58.6|Standard Deviation|7.8|7.8|||
4054547|NCT01089556|3876334|B3|||Pulse rate|Three participants in Duloxetine group and 1 participant in Pregabalin group had missing data and were not included in the calculation of mean and SD.|beats per minute (bpm)|Mean|75.8|75.8|Standard Deviation|10.92|10.92|||
4054548|NCT01089556|3876335|B2|||Pulse rate|Three participants in Duloxetine group and 1 participant in Pregabalin group had missing data and were not included in the calculation of mean and SD.|beats per minute (bpm)|Mean|75.6|75.6|Standard Deviation|11.05|11.05|||
4054626|NCT01089556|3876335|B2|Spain||Region of Enrollment||participants|Number|8|8.0||||||
4054549|NCT01089556|3876336|B1|||Pulse rate|Three participants in Duloxetine group and 1 participant in Pregabalin group had missing data and were not included in the calculation of mean and SD.|beats per minute (bpm)|Mean|76.0|76.0|Standard Deviation|10.81|10.81|||
4054550|NCT01089556|3876334|B3|Diastolic BP||Blood pressure (BP)|One participant in both Duloxetine group and Pregabalin group had missing data and were not included in the calculation of mean and SD.|millimeter of mercury (mm Hg)|Mean|77.1|77.1|Standard Deviation|9.74|9.74|||
4054551|NCT01089556|3876335|B2|Diastolic BP||Blood pressure (BP)|One participant in both Duloxetine group and Pregabalin group had missing data and were not included in the calculation of mean and SD.|millimeter of mercury (mm Hg)|Mean|76.7|76.7|Standard Deviation|9.43|9.43|||
4054552|NCT01089556|3876336|B1|Diastolic BP||Blood pressure (BP)|One participant in both Duloxetine group and Pregabalin group had missing data and were not included in the calculation of mean and SD.|millimeter of mercury (mm Hg)|Mean|77.6|77.6|Standard Deviation|10.04|10.04|||
4054553|NCT01089556|3876334|B3|Systolic BP||Blood pressure (BP)|One participant in both Duloxetine group and Pregabalin group had missing data and were not included in the calculation of mean and SD.|millimeter of mercury (mm Hg)|Mean|134.7|134.7|Standard Deviation|15.94|15.94|||
4054554|NCT01089556|3876335|B2|Systolic BP||Blood pressure (BP)|One participant in both Duloxetine group and Pregabalin group had missing data and were not included in the calculation of mean and SD.|millimeter of mercury (mm Hg)|Mean|134.3|134.3|Standard Deviation|15.62|15.62|||
4054555|NCT01089556|3876336|B1|Systolic BP||Blood pressure (BP)|One participant in both Duloxetine group and Pregabalin group had missing data and were not included in the calculation of mean and SD.|millimeter of mercury (mm Hg)|Mean|135.0|135.0|Standard Deviation|16.27|16.27|||
4054556|NCT01089556|3876334|B3|||Number of days hospitalized|Data presented are the number of days hospitalized due to DPNP during the last 8 weeks prior to entering Study Period II. There were 21 participants in Duloxetine group and 23 participants in Pregabalin group who had missing data and were not included in the calculation of mean and SD.|days|Mean|0.1|0.1|Standard Deviation|0.57|0.57|||
4054557|NCT01089556|3876335|B2|||Number of days hospitalized|Data presented are the number of days hospitalized due to DPNP during the last 8 weeks prior to entering Study Period II. There were 21 participants in Duloxetine group and 23 participants in Pregabalin group who had missing data and were not included in the calculation of mean and SD.|days|Mean|0.1|0.1|Standard Deviation|0.67|0.67|||
4054558|NCT01089556|3876336|B1|||Number of days hospitalized|Data presented are the number of days hospitalized due to DPNP during the last 8 weeks prior to entering Study Period II. There were 21 participants in Duloxetine group and 23 participants in Pregabalin group who had missing data and were not included in the calculation of mean and SD.|days|Mean|0.0|0.0|Standard Deviation|0.45|0.45|||
4054559|NCT01089556|3876334|B3|||Number of days of work/school missed|Data presented are the number of days of work/school missed due to diabetic peripheral neuropathic pain (DPNP) during the last 8 weeks prior to entering Study Period II. There were 278 participants in Duloxetine group and 281 participants in Pregabalin group who had missing data and were not included in the calculation of mean and SD.|days|Mean|1.8|1.8|Standard Deviation|6.56|6.56|||
4054560|NCT01089556|3876335|B2|||Number of days of work/school missed|Data presented are the number of days of work/school missed due to diabetic peripheral neuropathic pain (DPNP) during the last 8 weeks prior to entering Study Period II. There were 278 participants in Duloxetine group and 281 participants in Pregabalin group who had missing data and were not included in the calculation of mean and SD.|days|Mean|1.3|1.3|Standard Deviation|4.69|4.69|||
4054561|NCT01089556|3876336|B1|||Number of days of work/school missed|Data presented are the number of days of work/school missed due to diabetic peripheral neuropathic pain (DPNP) during the last 8 weeks prior to entering Study Period II. There were 278 participants in Duloxetine group and 281 participants in Pregabalin group who had missing data and were not included in the calculation of mean and SD.|days|Mean|2.3|2.3|Standard Deviation|7.98|7.98|||
4054562|NCT01089556|3876334|B3|||Average number of hours worked for pay per week|Data presented are average number of hours worked for pay per week during last 8 weeks prior to entering Study Period II. There were 275 participants in Duloxetine group and 281 participants in Pregabalin group who had missing data and were not included in the calculation of mean and SD.|hours|Mean|40.4|40.4|Standard Deviation|18.47|18.47|||
4054563|NCT01089556|3876335|B2|||Average number of hours worked for pay per week|Data presented are average number of hours worked for pay per week during last 8 weeks prior to entering Study Period II. There were 275 participants in Duloxetine group and 281 participants in Pregabalin group who had missing data and were not included in the calculation of mean and SD.|hours|Mean|41.4|41.4|Standard Deviation|16.36|16.36|||
4054564|NCT01089556|3876336|B1|||Average number of hours worked for pay per week|Data presented are average number of hours worked for pay per week during last 8 weeks prior to entering Study Period II. There were 275 participants in Duloxetine group and 281 participants in Pregabalin group who had missing data and were not included in the calculation of mean and SD.|hours|Mean|39.5|39.5|Standard Deviation|20.33|20.33|||
4054565|NCT01089556|3876334|B3|||Sheehan Disability Scale (SDS)|The SDS is completed by the participants and is used to assess the effect of their symptoms on work (Item 1), social (Item 2) and family life (Item 3). Each item is measured on a 0 (not at all) to 10 (extremely) point scale with higher values indicating greater disruption. Total scores is the sum of the 3 items and range from 0-30 with higher values indicating greater disruption in the participant's work/social/family life. There were 118 participants in Duloxetine group and 128 participants in Pregabalin group who had missing data and were not included in the calculation of mean and SD.|units on a scale|Mean|13.3|13.3|Standard Deviation|7.52|7.52|||
4054566|NCT01089556|3876335|B2|||Sheehan Disability Scale (SDS)|The SDS is completed by the participants and is used to assess the effect of their symptoms on work (Item 1), social (Item 2) and family life (Item 3). Each item is measured on a 0 (not at all) to 10 (extremely) point scale with higher values indicating greater disruption. Total scores is the sum of the 3 items and range from 0-30 with higher values indicating greater disruption in the participant's work/social/family life. There were 118 participants in Duloxetine group and 128 participants in Pregabalin group who had missing data and were not included in the calculation of mean and SD.|units on a scale|Mean|13.3|13.3|Standard Deviation|7.59|7.59|||
4054627|NCT01089556|3876336|B1|Spain||Region of Enrollment||participants|Number|6|6.0||||||
4054628|NCT01089556|3876334|B3|Greece||Region of Enrollment||participants|Number|28|28.0||||||
4054567|NCT01089556|3876336|B1|||Sheehan Disability Scale (SDS)|The SDS is completed by the participants and is used to assess the effect of their symptoms on work (Item 1), social (Item 2) and family life (Item 3). Each item is measured on a 0 (not at all) to 10 (extremely) point scale with higher values indicating greater disruption. Total scores is the sum of the 3 items and range from 0-30 with higher values indicating greater disruption in the participant's work/social/family life. There were 118 participants in Duloxetine group and 128 participants in Pregabalin group who had missing data and were not included in the calculation of mean and SD.|units on a scale|Mean|13.3|13.3|Standard Deviation|7.47|7.47|||
4054568|NCT01089556|3876334|B3|||Hospital Anxiety and Depression Scale (HADS) - Depression Subscale Score|A 14-item questionnaire with 2 subscales: anxiety and depression. Each item is rated on a 4-point scale (0-3), giving maximum scores of 21 for anxiety and for depression. Scores of 11 or more on either subscale are considered to be a significant case of psychological morbidity, while scores of 8-10 represent 'borderline' and 0-7, 'normal.' Two participants in Duloxetine group and 1 participant in Pregabalin group had missing data and were not included in the calculation of mean and SD.|units on a scale|Mean|5.5|5.5|Standard Deviation|4.04|4.04|||
4054569|NCT01089556|3876335|B2|||Hospital Anxiety and Depression Scale (HADS) - Depression Subscale Score|A 14-item questionnaire with 2 subscales: anxiety and depression. Each item is rated on a 4-point scale (0-3), giving maximum scores of 21 for anxiety and for depression. Scores of 11 or more on either subscale are considered to be a significant case of psychological morbidity, while scores of 8-10 represent 'borderline' and 0-7, 'normal.' Two participants in Duloxetine group and 1 participant in Pregabalin group had missing data and were not included in the calculation of mean and SD.|units on a scale|Mean|5.5|5.5|Standard Deviation|3.88|3.88|||
4054570|NCT01089556|3876336|B1|||Hospital Anxiety and Depression Scale (HADS) - Depression Subscale Score|A 14-item questionnaire with 2 subscales: anxiety and depression. Each item is rated on a 4-point scale (0-3), giving maximum scores of 21 for anxiety and for depression. Scores of 11 or more on either subscale are considered to be a significant case of psychological morbidity, while scores of 8-10 represent 'borderline' and 0-7, 'normal.' Two participants in Duloxetine group and 1 participant in Pregabalin group had missing data and were not included in the calculation of mean and SD.|units on a scale|Mean|5.5|5.5|Standard Deviation|4.19|4.19|||
4054571|NCT01089556|3876334|B3|||Hospital Anxiety and Depression Scale (HADS) - Anxiety Subscale Score|A 14-item questionnaire with 2 subscales: anxiety and depression. Each item is rated on a 4-point scale (0-3), giving maximum scores of 21 for anxiety and for depression. Scores of 11 or more on either subscale are considered to be a significant case of psychological morbidity, while scores of 8-10 represent 'borderline' and 0-7, 'normal.' Three participants in both Duloxetine group and Pregabalin group had missing data and were not included in the calculation of mean and SD.|units on a scale|Mean|6.7|6.7|Standard Deviation|4.31|4.31|||
4054572|NCT01089556|3876335|B2|||Hospital Anxiety and Depression Scale (HADS) - Anxiety Subscale Score|A 14-item questionnaire with 2 subscales: anxiety and depression. Each item is rated on a 4-point scale (0-3), giving maximum scores of 21 for anxiety and for depression. Scores of 11 or more on either subscale are considered to be a significant case of psychological morbidity, while scores of 8-10 represent 'borderline' and 0-7, 'normal.' Three participants in both Duloxetine group and Pregabalin group had missing data and were not included in the calculation of mean and SD.|units on a scale|Mean|6.6|6.6|Standard Deviation|4.32|4.32|||
4054573|NCT01089556|3876336|B1|||Hospital Anxiety and Depression Scale (HADS) - Anxiety Subscale Score|A 14-item questionnaire with 2 subscales: anxiety and depression. Each item is rated on a 4-point scale (0-3), giving maximum scores of 21 for anxiety and for depression. Scores of 11 or more on either subscale are considered to be a significant case of psychological morbidity, while scores of 8-10 represent 'borderline' and 0-7, 'normal.' Three participants in both Duloxetine group and Pregabalin group had missing data and were not included in the calculation of mean and SD.|units on a scale|Mean|6.8|6.8|Standard Deviation|4.31|4.31|||
4054574|NCT01089556|3876334|B3|||Neuropathic Pain Symptom Inventory (NPSI)|The NPSI is a 12-item self-administered questionnaire to assess 5 different dimensions of neuropathic pain: superficial spontaneous burning pain, deep spontaneous pressing pain, paroxysmal pain, evoked pains, and paresthesias/dysesthesias. Questionnaire generates a score in each of the relevant dimensions and a total score of 0-100. Higher score indicates a greater intensity of pain. Two participants in Duloxetine group and 6 participants in Pregabalin group had missing data and were not included in the calculation of mean and SD.|units on a scale|Mean|47.5|47.5|Standard Deviation|19.81|19.81|||
4054575|NCT01089556|3876335|B2|||Neuropathic Pain Symptom Inventory (NPSI)|The NPSI is a 12-item self-administered questionnaire to assess 5 different dimensions of neuropathic pain: superficial spontaneous burning pain, deep spontaneous pressing pain, paroxysmal pain, evoked pains, and paresthesias/dysesthesias. Questionnaire generates a score in each of the relevant dimensions and a total score of 0-100. Higher score indicates a greater intensity of pain. Two participants in Duloxetine group and 6 participants in Pregabalin group had missing data and were not included in the calculation of mean and SD.|units on a scale|Mean|47.7|47.7|Standard Deviation|20.46|20.46|||
4054576|NCT01089556|3876336|B1|||Neuropathic Pain Symptom Inventory (NPSI)|The NPSI is a 12-item self-administered questionnaire to assess 5 different dimensions of neuropathic pain: superficial spontaneous burning pain, deep spontaneous pressing pain, paroxysmal pain, evoked pains, and paresthesias/dysesthesias. Questionnaire generates a score in each of the relevant dimensions and a total score of 0-100. Higher score indicates a greater intensity of pain. Two participants in Duloxetine group and 6 participants in Pregabalin group had missing data and were not included in the calculation of mean and SD.|units on a scale|Mean|47.3|47.3|Standard Deviation|19.16|19.16|||
4054577|NCT01089556|3876334|B3|||Brief Pain Inventory (BPI) Severity: Average Pain Score|A self-reported scale that measures the severity of pain based on the average pain experienced over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine). Two participants in Pregabalin group had missing data and were not included in the calculation of mean and SD.|units on a scale|Mean|6.0|6.0|Standard Deviation|1.56|1.56|||
4054578|NCT01089556|3876335|B2|||Brief Pain Inventory (BPI) Severity: Average Pain Score|A self-reported scale that measures the severity of pain based on the average pain experienced over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine). Two participants in Pregabalin group had missing data and were not included in the calculation of mean and SD.|units on a scale|Mean|6.0|6.0|Standard Deviation|1.57|1.57|||
4054579|NCT01089556|3876336|B1|||Brief Pain Inventory (BPI) Severity: Average Pain Score|A self-reported scale that measures the severity of pain based on the average pain experienced over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine). Two participants in Pregabalin group had missing data and were not included in the calculation of mean and SD.|units on a scale|Mean|6.0|6.0|Standard Deviation|1.55|1.55|||
4054580|NCT01089556|3876334|B3|||Patient Global Impressions of Severity Scale (PGI-S)|Measures participant's perception of severity of illness at the time of assessment. Scores range from 1 (normal, not at all ill) to 7 (extremely ill).|units on a scale|Mean|3.4|3.4|Standard Deviation|1.42|1.42|||
4054581|NCT01089556|3876335|B2|||Patient Global Impressions of Severity Scale (PGI-S)|Measures participant's perception of severity of illness at the time of assessment. Scores range from 1 (normal, not at all ill) to 7 (extremely ill).|units on a scale|Mean|3.4|3.4|Standard Deviation|1.41|1.41|||
4054582|NCT01089556|3876336|B1|||Patient Global Impressions of Severity Scale (PGI-S)|Measures participant's perception of severity of illness at the time of assessment. Scores range from 1 (normal, not at all ill) to 7 (extremely ill).|units on a scale|Mean|3.4|3.4|Standard Deviation|1.42|1.42|||
4054583|NCT01089556|3876334|B3|||Clinical Global Impressions of Severity Scale (CGI-S)|The clinician recorded how ill the participant was at the time of assessment, in relation to the clinician’s total experience with this participant population. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill participants). One participant in Duloxetine group and 2 participants in Pregabalin group had missing data and were not included in the calculation of mean and standard deviation (SD).|units on a scale|Mean|4.0|4.0|Standard Deviation|1.08|1.08|||
4054584|NCT01089556|3876335|B2|||Clinical Global Impressions of Severity Scale (CGI-S)|The clinician recorded how ill the participant was at the time of assessment, in relation to the clinician’s total experience with this participant population. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill participants). One participant in Duloxetine group and 2 participants in Pregabalin group had missing data and were not included in the calculation of mean and standard deviation (SD).|units on a scale|Mean|4.0|4.0|Standard Deviation|1.09|1.09|||
4054585|NCT01089556|3876336|B1|||Clinical Global Impressions of Severity Scale (CGI-S)|The clinician recorded how ill the participant was at the time of assessment, in relation to the clinician’s total experience with this participant population. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill participants). One participant in Duloxetine group and 2 participants in Pregabalin group had missing data and were not included in the calculation of mean and standard deviation (SD).|units on a scale|Mean|4.0|4.0|Standard Deviation|1.07|1.07|||
4054586|NCT01089556|3876334|B3|Sweden||Region of Enrollment||participants|Number|28|28.0||||||
4054587|NCT01089556|3876335|B2|Sweden||Region of Enrollment||participants|Number|15|15.0||||||
4054588|NCT01089556|3876336|B1|Sweden||Region of Enrollment||participants|Number|13|13.0||||||
4054589|NCT01089556|3876334|B3|Korea, Republic of||Region of Enrollment||participants|Number|63|63.0||||||
4054590|NCT01089556|3876335|B2|Korea, Republic of||Region of Enrollment||participants|Number|32|32.0||||||
4054591|NCT01089556|3876336|B1|Korea, Republic of||Region of Enrollment||participants|Number|31|31.0||||||
4054592|NCT01089556|3876334|B3|Germany||Region of Enrollment||participants|Number|106|106.0||||||
4054593|NCT01089556|3876335|B2|Germany||Region of Enrollment||participants|Number|54|54.0||||||
4054594|NCT01089556|3876336|B1|Germany||Region of Enrollment||participants|Number|52|52.0||||||
4054595|NCT01089556|3876334|B3|Netherlands||Region of Enrollment||participants|Number|9|9.0||||||
4054596|NCT01089556|3876335|B2|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
4054597|NCT01089556|3876336|B1|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
4054598|NCT01089556|3876334|B3|Australia||Region of Enrollment||participants|Number|49|49.0||||||
4054599|NCT01089556|3876335|B2|Australia||Region of Enrollment||participants|Number|22|22.0||||||
4054600|NCT01089556|3876336|B1|Australia||Region of Enrollment||participants|Number|27|27.0||||||
4054601|NCT01089556|3876334|B3|Croatia||Region of Enrollment||participants|Number|56|56.0||||||
4054602|NCT01089556|3876335|B2|Croatia||Region of Enrollment||participants|Number|29|29.0||||||
4054603|NCT01089556|3876336|B1|Croatia||Region of Enrollment||participants|Number|27|27.0||||||
4054604|NCT01089556|3876334|B3|Poland||Region of Enrollment||participants|Number|113|113.0||||||
4054605|NCT01089556|3876335|B2|Poland||Region of Enrollment||participants|Number|57|57.0||||||
4054606|NCT01089556|3876336|B1|Poland||Region of Enrollment||participants|Number|56|56.0||||||
4054607|NCT01089556|3876334|B3|Canada||Region of Enrollment||participants|Number|38|38.0||||||
4054608|NCT01089556|3876335|B2|Canada||Region of Enrollment||participants|Number|19|19.0||||||
4054609|NCT01089556|3876336|B1|Canada||Region of Enrollment||participants|Number|19|19.0||||||
4054610|NCT01089556|3876334|B3|Mexico||Region of Enrollment||participants|Number|146|146.0||||||
4054611|NCT01089556|3876335|B2|Mexico||Region of Enrollment||participants|Number|71|71.0||||||
4054612|NCT01089556|3876336|B1|Mexico||Region of Enrollment||participants|Number|75|75.0||||||
4054613|NCT01089556|3876334|B3|France||Region of Enrollment||participants|Number|46|46.0||||||
4054614|NCT01089556|3876335|B2|France||Region of Enrollment||participants|Number|24|24.0||||||
4054615|NCT01089556|3876336|B1|France||Region of Enrollment||participants|Number|22|22.0||||||
4054616|NCT01089556|3876334|B3|Italy||Region of Enrollment||participants|Number|34|34.0||||||
4054617|NCT01089556|3876335|B2|Italy||Region of Enrollment||participants|Number|18|18.0||||||
4054618|NCT01089556|3876336|B1|Italy||Region of Enrollment||participants|Number|16|16.0||||||
4054619|NCT01089556|3876334|B3|United Kingdom||Region of Enrollment||participants|Number|62|62.0||||||
4054620|NCT01089556|3876335|B2|United Kingdom||Region of Enrollment||participants|Number|31|31.0||||||
4054621|NCT01089556|3876336|B1|United Kingdom||Region of Enrollment||participants|Number|31|31.0||||||
4054622|NCT01089556|3876334|B3|Turkey||Region of Enrollment||participants|Number|12|12.0||||||
4054623|NCT01089556|3876335|B2|Turkey||Region of Enrollment||participants|Number|7|7.0||||||
4054629|NCT01089556|3876335|B2|Greece||Region of Enrollment||participants|Number|12|12.0||||||
4054630|NCT01089556|3876336|B1|Greece||Region of Enrollment||participants|Number|16|16.0||||||
4054631|NCT01089556|3876334|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4054632|NCT01089556|3876335|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4054633|NCT01089556|3876336|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4054634|NCT01089556|3876334|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4054635|NCT01089556|3876335|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4054636|NCT01089556|3876336|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4054637|NCT01089556|3876334|B3||White|Race (NIH/OMB)||Participants|Count of Participants|652|652.0||||||
4054638|NCT01089556|3876335|B2||White|Race (NIH/OMB)||Participants|Count of Participants|328|328.0||||||
4054639|NCT01089556|3876336|B1||White|Race (NIH/OMB)||Participants|Count of Participants|324|324.0||||||
4054640|NCT01089556|3876334|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4054641|NCT01089556|3876335|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4054642|NCT01089556|3876336|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4054643|NCT01089556|3876334|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4054644|NCT01089556|3876335|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4054645|NCT01089556|3876336|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4054646|NCT01089556|3876334|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4054647|NCT01089556|3876335|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4054648|NCT01089556|3876336|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4054649|NCT01089556|3876334|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
4054650|NCT01089556|3876335|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4054651|NCT01089556|3876336|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4054652|NCT01089556|3876334|B3||Male|Sex: Female, Male||Participants|Count of Participants|448|448.0||||||
4054653|NCT01089556|3876335|B2||Male|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4054654|NCT01089556|3876336|B1||Male|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
4054655|NCT01089556|3876334|B3||Female|Sex: Female, Male||Participants|Count of Participants|356|356.0||||||
4054656|NCT01089556|3876335|B2||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4054657|NCT01089556|3876336|B1||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4054658|NCT01089556|3876334|B3|||Age||years|Mean|61.7|61.7|Standard Deviation|10.78|10.78|||
4054659|NCT01089556|3876335|B2|||Age||years|Mean|61.9|61.9|Standard Deviation|10.95|10.95|||
4054660|NCT01089556|3876336|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|10.62|10.62|||
4054661|NCT01089543|3876411|B5||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4054662|NCT01089543|3876412|B4||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4054663|NCT01089543|3876413|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4054664|NCT01089543|3876414|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4054665|NCT01089543|3876415|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4054666|NCT01089543|3876411|B5||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4054667|NCT01089543|3876412|B4||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4054668|NCT01089543|3876413|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4054669|NCT01089543|3876414|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4054670|NCT01089543|3876415|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4054671|NCT01089543|3876411|B5|||Age||years|Mean|47.3|47.3|Standard Deviation|15.5|15.5|||
4054672|NCT01089543|3876412|B4|||Age||years|Mean|45.8|45.8|Standard Deviation|15.5|15.5|||
4054673|NCT01089543|3876413|B3|||Age||years|Mean|46.4|46.4|Standard Deviation|14.8|14.8|||
4054674|NCT01089543|3876414|B2|||Age||years|Mean|50.2|50.2|Standard Deviation|16.5|16.5|||
4054675|NCT01089543|3876415|B1|||Age||years|Mean|46.9|46.9|Standard Deviation|14.9|14.9|||
4054676|NCT01089517|3876432|B4|South America||Region of Enrollment||participants|Number|10|10.0||||||
4054677|NCT01089517|3876433|B3|South America||Region of Enrollment||participants|Number|3|3.0||||||
4054678|NCT01089517|3876434|B2|South America||Region of Enrollment||participants|Number|3|3.0||||||
4054679|NCT01089517|3876435|B1|South America||Region of Enrollment||participants|Number|4|4.0||||||
4054680|NCT01089517|3876432|B4|Israel||Region of Enrollment||participants|Number|34|34.0||||||
4054681|NCT01089517|3876433|B3|Israel||Region of Enrollment||participants|Number|14|14.0||||||
4054682|NCT01089517|3876434|B2|Israel||Region of Enrollment||participants|Number|10|10.0||||||
4054683|NCT01089517|3876435|B1|Israel||Region of Enrollment||participants|Number|10|10.0||||||
4054684|NCT01089517|3876432|B4|Europe||Region of Enrollment||participants|Number|254|254.0||||||
4054685|NCT01089517|3876433|B3|Europe||Region of Enrollment||participants|Number|82|82.0||||||
4054686|NCT01089517|3876434|B2|Europe||Region of Enrollment||participants|Number|85|85.0||||||
4054687|NCT01089517|3876435|B1|Europe||Region of Enrollment||participants|Number|87|87.0||||||
4054688|NCT01089517|3876432|B4|United States||Region of Enrollment||participants|Number|151|151.0||||||
4054689|NCT01089517|3876433|B3|United States||Region of Enrollment||participants|Number|53|53.0||||||
4054690|NCT01089517|3876434|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
4054691|NCT01089517|3876435|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
4054692|NCT01089517|3876432|B4||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4054693|NCT01089517|3876433|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4054694|NCT01089517|3876434|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4054695|NCT01089517|3876435|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4054696|NCT01089517|3876432|B4||Female|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4054697|NCT01089517|3876433|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4054698|NCT01089517|3876434|B2||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4054699|NCT01089517|3876435|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4054700|NCT01089517|3876432|B4|||Age||years|Mean|77.8|77.8|Standard Deviation|8.16|8.16|||
4054701|NCT01089517|3876433|B3|||Age||years|Mean|77.8|77.8|Standard Deviation|8.36|8.36|||
4054702|NCT01089517|3876434|B2|||Age||years|Mean|77.6|77.6|Standard Deviation|8.19|8.19|||
4054703|NCT01089517|3876435|B1|||Age||years|Mean|78.0|78.0|Standard Deviation|7.98|7.98|||
4054704|NCT01089517|3876432|B4||>=65 years|Age||Participants|Count of Participants|420|420.0||||||
4054705|NCT01089517|3876433|B3||>=65 years|Age||Participants|Count of Participants|141|141.0||||||
4054706|NCT01089517|3876434|B2||>=65 years|Age||Participants|Count of Participants|139|139.0||||||
4054707|NCT01089517|3876435|B1||>=65 years|Age||Participants|Count of Participants|140|140.0||||||
4054708|NCT01089517|3876432|B4||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4054709|NCT01089517|3876433|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4054710|NCT01089517|3876434|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4054711|NCT01089517|3876435|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4054712|NCT01089517|3876432|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4054713|NCT01089517|3876433|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4054714|NCT01089517|3876434|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4054715|NCT01089517|3876435|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4054716|NCT01089504|3876451|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4054717|NCT01089504|3876452|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4054718|NCT01089504|3876453|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4054719|NCT01089504|3876451|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4054720|NCT01089504|3876452|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4054721|NCT01089504|3876453|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4054722|NCT01089504|3876451|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4054723|NCT01089504|3876452|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4054724|NCT01089504|3876453|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4054725|NCT01089504|3876451|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4054726|NCT01089504|3876452|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4054727|NCT01089504|3876453|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4054728|NCT01089504|3876451|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4054729|NCT01089504|3876452|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4054730|NCT01089504|3876453|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4054731|NCT01089504|3876451|B3||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4054732|NCT01089504|3876452|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4054733|NCT01089504|3876453|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4054734|NCT01089413|3876464|B4||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4054735|NCT01089413|3876465|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4054736|NCT01089413|3876466|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4054737|NCT01089413|3876467|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4054738|NCT01089413|3876464|B4||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4054739|NCT01089413|3876465|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4054740|NCT01089413|3876466|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4054741|NCT01089413|3876467|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4054742|NCT01089413|3876464|B4|||Age|Reported age data represents age at screening; calculated as: (screening date minus [-] birth date) divided by (/) 365.25.|years|Mean|66.3|66.3|Standard Deviation|10.2|10.2|||
4054743|NCT01089413|3876465|B3|||Age|Reported age data represents age at screening; calculated as: (screening date minus [-] birth date) divided by (/) 365.25.|years|Mean|83.8|83.8|Standard Deviation|2.4|2.4|||
4054744|NCT01089413|3876466|B2|||Age|Reported age data represents age at screening; calculated as: (screening date minus [-] birth date) divided by (/) 365.25.|years|Mean|74.3|74.3|Standard Deviation|2.7|2.7|||
4054745|NCT01089413|3876467|B1|||Age|Reported age data represents age at screening; calculated as: (screening date minus [-] birth date) divided by (/) 365.25.|years|Mean|60.0|60.0|Standard Deviation|7.7|7.7|||
4054746|NCT01089361|3876484|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4054747|NCT01089361|3876485|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4054748|NCT01089361|3876486|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4054749|NCT01089361|3876484|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4054750|NCT01089361|3876485|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4054751|NCT01089361|3876486|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4054752|NCT01089361|3876484|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4054753|NCT01089361|3876485|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4054754|NCT01089361|3876486|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4054755|NCT01089361|3876484|B3|||Age||years|Mean|61|61.0|Standard Deviation|15|15.0|||
4054756|NCT01089361|3876485|B2|||Age||years|Mean|60|60.0|Standard Deviation|11|11.0|||
4054757|NCT01089361|3876486|B1|||Age||years|Mean|63|63.0|Standard Deviation|19|19.0|||
4054758|NCT01089361|3876484|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4054759|NCT01089361|3876485|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4054760|NCT01089361|3876486|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4054761|NCT01089361|3876484|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4054762|NCT01089361|3876485|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4054763|NCT01089361|3876486|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4054764|NCT01089361|3876484|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4054765|NCT01089361|3876485|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4054766|NCT01089361|3876486|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4054767|NCT01089231|3876505|B5|Germany||Region of Enrollment||participants|Number|40|40.0||||||
4054768|NCT01089231|3876506|B4|Germany||Region of Enrollment||participants|Number|10|10.0||||||
4054769|NCT01089231|3876507|B3|Germany||Region of Enrollment||participants|Number|10|10.0||||||
4054770|NCT01089231|3876508|B2|Germany||Region of Enrollment||participants|Number|10|10.0||||||
4054771|NCT01089231|3876509|B1|Germany||Region of Enrollment||participants|Number|10|10.0||||||
4054772|NCT01089231|3876505|B5||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4054773|NCT01089231|3876506|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4054774|NCT01089231|3876507|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4054775|NCT01089231|3876508|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4054776|NCT01089231|3876509|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4054777|NCT01089231|3876505|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4054778|NCT01089231|3876506|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4054779|NCT01089231|3876507|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4054780|NCT01089231|3876508|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4054781|NCT01089231|3876509|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4054782|NCT01089231|3876505|B5|||Age||years|Mean|38.82|38.82|Standard Deviation|8.29|8.29|||
4054783|NCT01089231|3876506|B4|||Age||years|Mean|37.5|37.5|Standard Deviation|8.11|8.11|||
4054784|NCT01089231|3876507|B3|||Age||years|Mean|40.2|40.2|Standard Deviation|8.64|8.64|||
4054785|NCT01089231|3876508|B2|||Age||years|Mean|41.8|41.8|Standard Deviation|8.94|8.94|||
4054786|NCT01089231|3876509|B1|||Age||years|Mean|37.4|37.4|Standard Deviation|8.30|8.3|||
4054787|NCT01089231|3876505|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4054788|NCT01089231|3876506|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4054789|NCT01089231|3876507|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4054790|NCT01089231|3876508|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4054791|NCT01089231|3876509|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4054792|NCT01089231|3876505|B5||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4054793|NCT01089231|3876506|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4054794|NCT01089231|3876507|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4054795|NCT01089231|3876508|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4054796|NCT01089231|3876509|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4054797|NCT01089231|3876505|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4054798|NCT01089231|3876506|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4054799|NCT01089231|3876507|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4054800|NCT01089231|3876508|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4054801|NCT01089231|3876509|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4054802|NCT01089127|3876530|B7||Male|Sex: Female, Male||Participants|Count of Participants|296|296.0||||||
4054803|NCT01089127|3876531|B6||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4054804|NCT01089127|3876532|B5||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4054805|NCT01089127|3876533|B4||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4054806|NCT01089127|3876534|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4054807|NCT01089127|3876535|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4054808|NCT01089127|3876536|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4054809|NCT01089127|3876530|B7||Female|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4054810|NCT01089127|3876531|B6||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4054811|NCT01089127|3876532|B5||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4054812|NCT01089127|3876533|B4||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4054813|NCT01089127|3876534|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4054814|NCT01089127|3876535|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4054815|NCT01089127|3876536|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4054816|NCT01089127|3876530|B7|||Age|Baseline measures are based on safety population. 3 patients in the indacaterol 18.75 ug group, 1 patient in the indacaterol 37.5 ug group, and 1 patient in the salmeterol 50 ug group were randomized but were not exposed to study treatment and were not included in the calculation of demographic data.|years|Mean|62.6|62.6|Standard Deviation|9.20|9.2|||
4054817|NCT01089127|3876531|B6|||Age|Baseline measures are based on safety population. 3 patients in the indacaterol 18.75 ug group, 1 patient in the indacaterol 37.5 ug group, and 1 patient in the salmeterol 50 ug group were randomized but were not exposed to study treatment and were not included in the calculation of demographic data.|years|Mean|63.6|63.6|Standard Deviation|8.44|8.44|||
4054818|NCT01089127|3876532|B5|||Age|Baseline measures are based on safety population. 3 patients in the indacaterol 18.75 ug group, 1 patient in the indacaterol 37.5 ug group, and 1 patient in the salmeterol 50 ug group were randomized but were not exposed to study treatment and were not included in the calculation of demographic data.|years|Mean|62.4|62.4|Standard Deviation|9.52|9.52|||
4054819|NCT01089127|3876533|B4|||Age|Baseline measures are based on safety population. 3 patients in the indacaterol 18.75 ug group, 1 patient in the indacaterol 37.5 ug group, and 1 patient in the salmeterol 50 ug group were randomized but were not exposed to study treatment and were not included in the calculation of demographic data.|years|Mean|62.3|62.3|Standard Deviation|9.50|9.5|||
4054820|NCT01089127|3876534|B3|||Age|Baseline measures are based on safety population. 3 patients in the indacaterol 18.75 ug group, 1 patient in the indacaterol 37.5 ug group, and 1 patient in the salmeterol 50 ug group were randomized but were not exposed to study treatment and were not included in the calculation of demographic data.|years|Mean|62.6|62.6|Standard Deviation|9.30|9.3|||
4054821|NCT01089127|3876535|B2|||Age|Baseline measures are based on safety population. 3 patients in the indacaterol 18.75 ug group, 1 patient in the indacaterol 37.5 ug group, and 1 patient in the salmeterol 50 ug group were randomized but were not exposed to study treatment and were not included in the calculation of demographic data.|years|Mean|61.9|61.9|Standard Deviation|9.61|9.61|||
4054822|NCT01089127|3876536|B1|||Age|Baseline measures are based on safety population. 3 patients in the indacaterol 18.75 ug group, 1 patient in the indacaterol 37.5 ug group, and 1 patient in the salmeterol 50 ug group were randomized but were not exposed to study treatment and were not included in the calculation of demographic data.|years|Mean|62.8|62.8|Standard Deviation|8.95|8.95|||
4054823|NCT01089062|3876561|B7||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4054824|NCT01089062|3876562|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4054825|NCT01089062|3876563|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4054826|NCT01089062|3876564|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4054827|NCT01089062|3876565|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4054828|NCT01089062|3876566|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4054829|NCT01089062|3876567|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4054830|NCT01089062|3876561|B7||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4054831|NCT01089062|3876562|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4054832|NCT01089062|3876563|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4054833|NCT01089062|3876564|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4054834|NCT01089062|3876565|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4054835|NCT01089062|3876566|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4054836|NCT01089062|3876567|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4054837|NCT01089062|3876561|B7|||Age||years|Mean|26.6|26.6|Standard Deviation|6.6|6.6|||
4054838|NCT01089062|3876562|B6|||Age||years|Mean|24.8|24.8|Standard Deviation|7.2|7.2|||
4054839|NCT01089062|3876563|B5|||Age||years|Mean|26.5|26.5|Standard Deviation|7.4|7.4|||
4054840|NCT01089062|3876564|B4|||Age||years|Mean|30.3|30.3|Standard Deviation|4.7|4.7|||
4054841|NCT01089062|3876565|B3|||Age||years|Mean|28.2|28.2|Standard Deviation|8.2|8.2|||
4054842|NCT01089062|3876566|B2|||Age||years|Mean|23.4|23.4|Standard Deviation|3.9|3.9|||
4054843|NCT01089062|3876567|B1|||Age||years|Mean|26.6|26.6|Standard Deviation|9.2|9.2|||
4054844|NCT01089023|3876595|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4054845|NCT01089023|3876595|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4054846|NCT01089023|3876595|B1|||Age||years|Mean|44.89|44.89|Standard Deviation|13.677|13.677|||
4054847|NCT01088997|3876607|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4054848|NCT01088997|3876608|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4054849|NCT01088997|3876609|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4054850|NCT01088997|3876607|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4054851|NCT01088997|3876608|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4054852|NCT01088997|3876609|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4054853|NCT01088997|3876607|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4054854|NCT01088997|3876608|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4054855|NCT01088997|3876609|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4054856|NCT01088997|3876607|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4054857|NCT01088997|3876608|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4054858|NCT01088997|3876609|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4054859|NCT01088997|3876607|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4054860|NCT01088997|3876608|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4054861|NCT01088997|3876609|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4054862|NCT01088997|3876607|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4054863|NCT01088997|3876608|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4054864|NCT01088997|3876609|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4054865|NCT01088997|3876607|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4054866|NCT01088997|3876608|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4054867|NCT01088997|3876609|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4054868|NCT01088997|3876607|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4054869|NCT01088997|3876608|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4054870|NCT01088997|3876609|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4054871|NCT01088997|3876607|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4054872|NCT01088997|3876608|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4054873|NCT01088997|3876609|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4054874|NCT01088997|3876607|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4054875|NCT01088997|3876608|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4054876|NCT01088997|3876609|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4054877|NCT01088997|3876607|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4054878|NCT01088997|3876608|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4054879|NCT01088997|3876609|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4054880|NCT01088997|3876607|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4054881|NCT01088997|3876608|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4054882|NCT01088997|3876609|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4054883|NCT01088997|3876607|B3||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4054884|NCT01088997|3876608|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4054885|NCT01088997|3876609|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4054886|NCT01088984|3876619|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4054887|NCT01088984|3876620|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4054888|NCT01088984|3876621|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4054889|NCT01088984|3876619|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4054890|NCT01088984|3876620|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4054891|NCT01088984|3876621|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4054892|NCT01088984|3876619|B3|12 to 20 years||Age, Customized||participants|Number|16|16.0||||||
4054893|NCT01088984|3876620|B2|12 to 20 years||Age, Customized||participants|Number|12|12.0||||||
4054894|NCT01088984|3876621|B1|12 to 20 years||Age, Customized||participants|Number|4|4.0||||||
4054895|NCT01088984|3876619|B3|7 to 11 years||Age, Customized||participants|Number|13|13.0||||||
4054896|NCT01088984|3876620|B2|7 to 11 years||Age, Customized||participants|Number|10|10.0||||||
4054897|NCT01088984|3876621|B1|7 to 11 years||Age, Customized||participants|Number|3|3.0||||||
4054898|NCT01088984|3876619|B3|1 to 6 years||Age, Customized||participants|Number|14|14.0||||||
4054899|NCT01088984|3876620|B2|1 to 6 years||Age, Customized||participants|Number|10|10.0||||||
4054900|NCT01088984|3876621|B1|1 to 6 years||Age, Customized||participants|Number|4|4.0||||||
4054901|NCT01088984|3876619|B3|||Age||years|Mean|9.2|9.2|Standard Deviation|4.74|4.74|||
4054902|NCT01088984|3876620|B2|||Age||years|Mean|9.3|9.3|Standard Deviation|4.93|4.93|||
4054903|NCT01088984|3876621|B1|||Age||years|Mean|8.7|8.7|Standard Deviation|4.31|4.31|||
4054904|NCT01088711|3876640|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4054905|NCT01088711|3876641|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4054906|NCT01088711|3876642|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4054907|NCT01088711|3876643|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4054908|NCT01088711|3876644|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4054909|NCT01088711|3876640|B5||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4054910|NCT01088711|3876641|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4054911|NCT01088711|3876642|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4054912|NCT01088711|3876643|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4054913|NCT01088711|3876644|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4054914|NCT01088711|3876640|B5|||Age||Years|Mean|54.2|54.2|Standard Deviation|5.9|5.9|||
4054915|NCT01088711|3876641|B4|||Age||Years|Mean|61.0|61.0|Standard Deviation|8.5|8.5|||
4054916|NCT01088711|3876642|B3|||Age||Years|Mean|55.4|55.4|Standard Deviation|4.4|4.4|||
4054917|NCT01088711|3876643|B2|||Age||Years|Mean|56.2|56.2|Standard Deviation|7.6|7.6|||
4054918|NCT01088711|3876644|B1|||Age||Years|Mean|52.3|52.3|Standard Deviation|5.1|5.1|||
4054919|NCT01088672|3876671|B1|||NIHSS|"The National Institutes of Health Stroke Scale, or NIH Stroke Scale (NIHSS) is a tool used by healthcare providers to objectively quantify the impairment caused by a stroke. The maximum (worst) possible score is 42, with the minimum (best) score being a 0.~http://en.wikipedia.org/wiki/Nihss"|units on a scale|Mean|17.7|17.7|Standard Deviation|4.8|4.8|||
4054920|NCT01088672|3876671|B1|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
4054921|NCT01088672|3876671|B1|Germany||Region of Enrollment||participants|Number|19|19.0||||||
4054922|NCT01088672|3876671|B1|Austria||Region of Enrollment||participants|Number|16|16.0||||||
4054923|NCT01088672|3876671|B1|Spain||Region of Enrollment||participants|Number|22|22.0||||||
4054924|NCT01088672|3876671|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4054925|NCT01088672|3876671|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4054926|NCT01088672|3876671|B1|||Age||years|Mean|64.7|64.7|Standard Deviation|13.4|13.4|||
4054927|NCT01088646|3876677|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4054928|NCT01088646|3876677|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4054929|NCT01088646|3876677|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4054930|NCT01088646|3876677|B1|||Age||years|Mean|51|51.0|Standard Deviation|18.3|18.3|||
4054931|NCT01088646|3876677|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4054932|NCT01088646|3876677|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4054933|NCT01088646|3876677|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4054934|NCT01088529|3876681|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4054935|NCT01088529|3876682|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4054936|NCT01088529|3876683|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4054937|NCT01088529|3876681|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4054938|NCT01088529|3876682|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4054939|NCT01088529|3876683|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4054940|NCT01088529|3876681|B3|||Age||years|Mean|61|61.0|Standard Deviation|7.29|7.29|||
4054941|NCT01088529|3876682|B2|||Age||years|Mean|59.9|59.9|Standard Deviation|7.6|7.6|||
4054942|NCT01088529|3876683|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|7.14|7.14|||
4054943|NCT01088503|3876694|B4|United States||Region of Enrollment||participants|Number|12227|12227.0||||||
4054944|NCT01088503|3876695|B3|United States||Region of Enrollment||participants|Number|258|258.0||||||
4054945|NCT01088503|3876696|B2|United States||Region of Enrollment||participants|Number|8846|8846.0||||||
4054946|NCT01088503|3876697|B1|United States||Region of Enrollment||participants|Number|3123|3123.0||||||
4054947|NCT01088503|3876694|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
4054948|NCT01088503|3876695|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4054949|NCT01088503|3876696|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
4054950|NCT01088503|3876697|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4054951|NCT01088503|3876694|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4054952|NCT01088503|3876695|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4054953|NCT01088503|3876696|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4054954|NCT01088503|3876697|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4054955|NCT01088503|3876694|B4||White|Race (NIH/OMB)||Participants|Count of Participants|10753|10753.0||||||
4054956|NCT01088503|3876695|B3||White|Race (NIH/OMB)||Participants|Count of Participants|225|225.0||||||
4054957|NCT01088503|3876696|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7778|7778.0||||||
4054958|NCT01088503|3876697|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2750|2750.0||||||
4054959|NCT01088503|3876694|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1087|1087.0||||||
4054960|NCT01088503|3876695|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4054961|NCT01088503|3876696|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|820|820.0||||||
4054962|NCT01088503|3876697|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|237|237.0||||||
4054963|NCT01088503|3876694|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4054964|NCT01088503|3876695|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4054965|NCT01088503|3876696|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4054966|NCT01088503|3876697|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4054967|NCT01088503|3876694|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|150|150.0||||||
4054968|NCT01088503|3876695|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4054969|NCT01088503|3876696|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
4054970|NCT01088503|3876697|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4054971|NCT01088503|3876694|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4054972|NCT01088503|3876695|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4054973|NCT01088503|3876696|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4054974|NCT01088503|3876697|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4054975|NCT01088503|3876694|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4054976|NCT01088503|3876695|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4054977|NCT01088503|3876696|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4054978|NCT01088503|3876697|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4054979|NCT01088503|3876694|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11755|11755.0||||||
4054980|NCT01088503|3876695|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|244|244.0||||||
4054981|NCT01088503|3876696|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8525|8525.0||||||
4054982|NCT01088503|3876697|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2986|2986.0||||||
4054983|NCT01088503|3876694|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|413|413.0||||||
4054984|NCT01088503|3876695|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4054985|NCT01088503|3876696|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|271|271.0||||||
4054986|NCT01088503|3876697|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
4054987|NCT01088503|3876694|B4||Male|Sex: Female, Male||Participants|Count of Participants|8793|8793.0||||||
4054988|NCT01088503|3876695|B3||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4054989|NCT01088503|3876696|B2||Male|Sex: Female, Male||Participants|Count of Participants|6175|6175.0||||||
4054990|NCT01088503|3876697|B1||Male|Sex: Female, Male||Participants|Count of Participants|2451|2451.0||||||
4054991|NCT01088503|3876694|B4||Female|Sex: Female, Male||Participants|Count of Participants|3434|3434.0||||||
4054992|NCT01088503|3876695|B3||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4054993|NCT01088503|3876696|B2||Female|Sex: Female, Male||Participants|Count of Participants|2671|2671.0||||||
4054994|NCT01088503|3876697|B1||Female|Sex: Female, Male||Participants|Count of Participants|672|672.0||||||
4054995|NCT01088503|3876694|B4|<75 years||Age, Customized||participants|Number|10765|10765.0||||||
4054996|NCT01088503|3876695|B3|<75 years||Age, Customized||participants|Number|225|225.0||||||
4054997|NCT01088503|3876696|B2|<75 years||Age, Customized||participants|Number|7505|7505.0||||||
4054998|NCT01088503|3876697|B1|<75 years||Age, Customized||participants|Number|3035|3035.0||||||
4054999|NCT01088503|3876694|B4|≥75 years||Age, Customized||participants|Number|1462|1462.0||||||
4055000|NCT01088503|3876695|B3|≥75 years||Age, Customized||participants|Number|33|33.0||||||
4055001|NCT01088503|3876696|B2|≥75 years||Age, Customized||participants|Number|1341|1341.0||||||
4055002|NCT01088503|3876697|B1|≥75 years||Age, Customized||participants|Number|88|88.0||||||
4055003|NCT01088464|3876720|B4|1 = Ambulatory, Restricted Work Activity||Eastern Cooperative Oncology Group performance status (ECOG PS)|ECOG PS was used to classify participants according to their functional impairment. Score 0 = Fully active, able to carry on all pre-disease performance without restriction. Score 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, for example, light house work, office work.|participants|Number|9|9.0||||||
4055004|NCT01088464|3876721|B3|1 = Ambulatory, Restricted Work Activity||Eastern Cooperative Oncology Group performance status (ECOG PS)|ECOG PS was used to classify participants according to their functional impairment. Score 0 = Fully active, able to carry on all pre-disease performance without restriction. Score 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, for example, light house work, office work.|participants|Number|2|2.0||||||
4055005|NCT01088464|3876722|B2|1 = Ambulatory, Restricted Work Activity||Eastern Cooperative Oncology Group performance status (ECOG PS)|ECOG PS was used to classify participants according to their functional impairment. Score 0 = Fully active, able to carry on all pre-disease performance without restriction. Score 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, for example, light house work, office work.|participants|Number|5|5.0||||||
4055006|NCT01088464|3876723|B1|1 = Ambulatory, Restricted Work Activity||Eastern Cooperative Oncology Group performance status (ECOG PS)|ECOG PS was used to classify participants according to their functional impairment. Score 0 = Fully active, able to carry on all pre-disease performance without restriction. Score 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, for example, light house work, office work.|participants|Number|2|2.0||||||
4055007|NCT01088464|3876720|B4|0 = Fully Active||Eastern Cooperative Oncology Group performance status (ECOG PS)|ECOG PS was used to classify participants according to their functional impairment. Score 0 = Fully active, able to carry on all pre-disease performance without restriction. Score 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, for example, light house work, office work.|participants|Number|6|6.0||||||
4055008|NCT01088464|3876721|B3|0 = Fully Active||Eastern Cooperative Oncology Group performance status (ECOG PS)|ECOG PS was used to classify participants according to their functional impairment. Score 0 = Fully active, able to carry on all pre-disease performance without restriction. Score 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, for example, light house work, office work.|participants|Number|4|4.0||||||
4055009|NCT01088464|3876722|B2|0 = Fully Active||Eastern Cooperative Oncology Group performance status (ECOG PS)|ECOG PS was used to classify participants according to their functional impairment. Score 0 = Fully active, able to carry on all pre-disease performance without restriction. Score 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, for example, light house work, office work.|participants|Number|1|1.0||||||
4055052|NCT01088399|3876790|B2|Other less common specified diagnoses||Diagnosis Leading to GHD|Participants with available diagnosis designation at baseline (n=8670, 1616, 276, with 10562 total participants). Other less common specified diagnoses contains participants who had histories including cranial irradiation, empty sella, hypophysitis, congenital defect resulting in GHD.|participants|Number|198|198.0||||||
4055010|NCT01088464|3876723|B1|0 = Fully Active||Eastern Cooperative Oncology Group performance status (ECOG PS)|ECOG PS was used to classify participants according to their functional impairment. Score 0 = Fully active, able to carry on all pre-disease performance without restriction. Score 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, for example, light house work, office work.|participants|Number|1|1.0||||||
4055011|NCT01088464|3876720|B4|Japan||Region of Enrollment||participants|Number|15|15.0||||||
4055012|NCT01088464|3876721|B3|Japan||Region of Enrollment||participants|Number|6|6.0||||||
4055013|NCT01088464|3876722|B2|Japan||Region of Enrollment||participants|Number|6|6.0||||||
4055014|NCT01088464|3876723|B1|Japan||Region of Enrollment||participants|Number|3|3.0||||||
4055015|NCT01088464|3876720|B4|Japanese||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4055016|NCT01088464|3876721|B3|Japanese||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4055017|NCT01088464|3876722|B2|Japanese||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4055018|NCT01088464|3876723|B1|Japanese||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4055019|NCT01088464|3876720|B4||Male|Gender||Participants|Count of Participants|7|7.0||||||
4055020|NCT01088464|3876721|B3||Male|Gender||Participants|Count of Participants|2|2.0||||||
4055021|NCT01088464|3876722|B2||Male|Gender||Participants|Count of Participants|3|3.0||||||
4055022|NCT01088464|3876723|B1||Male|Gender||Participants|Count of Participants|2|2.0||||||
4055023|NCT01088464|3876720|B4||Female|Gender||Participants|Count of Participants|8|8.0||||||
4055024|NCT01088464|3876721|B3||Female|Gender||Participants|Count of Participants|4|4.0||||||
4055025|NCT01088464|3876722|B2||Female|Gender||Participants|Count of Participants|3|3.0||||||
4055026|NCT01088464|3876723|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
4055027|NCT01088464|3876720|B4|||Age||years|Median|61.2|61.2|Full Range|10.72|10.72|30.5|75.6|
4055028|NCT01088464|3876721|B3|||Age||years|Median|56.7|56.7|Full Range|9.50|9.5|51.3|75.6|
4055029|NCT01088464|3876722|B2|||Age||years|Median|64.5|64.5|Full Range|4.51|4.51|56.2|68.9|
4055030|NCT01088464|3876723|B1|||Age||years|Median|57.2|57.2|Full Range|20.02|20.02|30.5|69.6|
4055031|NCT01088438|3876775|B3|Non-White||Race/Ethnicity, Customized|"Number of participants identifying as White race."|participants|Number|125|125.0||||||
4055032|NCT01088438|3876776|B2|Non-White||Race/Ethnicity, Customized|"Number of participants identifying as White race."|participants|Number|61|61.0||||||
4055033|NCT01088438|3876777|B1|Non-White||Race/Ethnicity, Customized|"Number of participants identifying as White race."|participants|Number|64|64.0||||||
4055034|NCT01088438|3876775|B3|White||Race/Ethnicity, Customized|"Number of participants identifying as White race."|participants|Number|64|64.0||||||
4055035|NCT01088438|3876776|B2|White||Race/Ethnicity, Customized|"Number of participants identifying as White race."|participants|Number|34|34.0||||||
4055036|NCT01088438|3876777|B1|White||Race/Ethnicity, Customized|"Number of participants identifying as White race."|participants|Number|30|30.0||||||
4055037|NCT01088438|3876775|B3||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4055038|NCT01088438|3876776|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4055039|NCT01088438|3876777|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4055040|NCT01088438|3876775|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4055041|NCT01088438|3876776|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4055042|NCT01088438|3876777|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4055043|NCT01088438|3876775|B3|||Age||years|Mean|28.8|28.8|Standard Deviation|3.6|3.6|||
4055044|NCT01088438|3876776|B2|||Age||years|Mean|28.8|28.8|Standard Deviation|3.6|3.6|||
4055045|NCT01088438|3876777|B1|||Age||years|Mean|28.8|28.8|Standard Deviation|3.6|3.6|||
4055046|NCT01088399|3876788|B4|Causes other than listed above||Diagnosis Leading to GHD|Participants with available diagnosis designation at baseline (n=8670, 1616, 276, with 10562 total participants). Other less common specified diagnoses contains participants who had histories including cranial irradiation, empty sella, hypophysitis, congenital defect resulting in GHD.|participants|Number|573|573.0||||||
4055047|NCT01088399|3876789|B3|Causes other than listed above||Diagnosis Leading to GHD|Participants with available diagnosis designation at baseline (n=8670, 1616, 276, with 10562 total participants). Other less common specified diagnoses contains participants who had histories including cranial irradiation, empty sella, hypophysitis, congenital defect resulting in GHD.|participants|Number|21|21.0||||||
4055048|NCT01088399|3876790|B2|Causes other than listed above||Diagnosis Leading to GHD|Participants with available diagnosis designation at baseline (n=8670, 1616, 276, with 10562 total participants). Other less common specified diagnoses contains participants who had histories including cranial irradiation, empty sella, hypophysitis, congenital defect resulting in GHD.|participants|Number|94|94.0||||||
4055049|NCT01088399|3876791|B1|Causes other than listed above||Diagnosis Leading to GHD|Participants with available diagnosis designation at baseline (n=8670, 1616, 276, with 10562 total participants). Other less common specified diagnoses contains participants who had histories including cranial irradiation, empty sella, hypophysitis, congenital defect resulting in GHD.|participants|Number|458|458.0||||||
4055050|NCT01088399|3876788|B4|Other less common specified diagnoses||Diagnosis Leading to GHD|Participants with available diagnosis designation at baseline (n=8670, 1616, 276, with 10562 total participants). Other less common specified diagnoses contains participants who had histories including cranial irradiation, empty sella, hypophysitis, congenital defect resulting in GHD.|participants|Number|1304|1304.0||||||
4055051|NCT01088399|3876789|B3|Other less common specified diagnoses||Diagnosis Leading to GHD|Participants with available diagnosis designation at baseline (n=8670, 1616, 276, with 10562 total participants). Other less common specified diagnoses contains participants who had histories including cranial irradiation, empty sella, hypophysitis, congenital defect resulting in GHD.|participants|Number|79|79.0||||||
4055106|NCT01088399|3876788|B4|United States||Region of Enrollment||participants|Number|4990|4990.0||||||
4055053|NCT01088399|3876791|B1|Other less common specified diagnoses||Diagnosis Leading to GHD|Participants with available diagnosis designation at baseline (n=8670, 1616, 276, with 10562 total participants). Other less common specified diagnoses contains participants who had histories including cranial irradiation, empty sella, hypophysitis, congenital defect resulting in GHD.|participants|Number|1027|1027.0||||||
4055054|NCT01088399|3876788|B4|Pituitary hemorrhage/brain injury||Diagnosis Leading to GHD|Participants with available diagnosis designation at baseline (n=8670, 1616, 276, with 10562 total participants). Other less common specified diagnoses contains participants who had histories including cranial irradiation, empty sella, hypophysitis, congenital defect resulting in GHD.|participants|Number|518|518.0||||||
4055055|NCT01088399|3876789|B3|Pituitary hemorrhage/brain injury||Diagnosis Leading to GHD|Participants with available diagnosis designation at baseline (n=8670, 1616, 276, with 10562 total participants). Other less common specified diagnoses contains participants who had histories including cranial irradiation, empty sella, hypophysitis, congenital defect resulting in GHD.|participants|Number|4|4.0||||||
4055056|NCT01088399|3876790|B2|Pituitary hemorrhage/brain injury||Diagnosis Leading to GHD|Participants with available diagnosis designation at baseline (n=8670, 1616, 276, with 10562 total participants). Other less common specified diagnoses contains participants who had histories including cranial irradiation, empty sella, hypophysitis, congenital defect resulting in GHD.|participants|Number|59|59.0||||||
4055057|NCT01088399|3876791|B1|Pituitary hemorrhage/brain injury||Diagnosis Leading to GHD|Participants with available diagnosis designation at baseline (n=8670, 1616, 276, with 10562 total participants). Other less common specified diagnoses contains participants who had histories including cranial irradiation, empty sella, hypophysitis, congenital defect resulting in GHD.|participants|Number|455|455.0||||||
4055058|NCT01088399|3876788|B4|Idiopathic||Diagnosis Leading to GHD|Participants with available diagnosis designation at baseline (n=8670, 1616, 276, with 10562 total participants). Other less common specified diagnoses contains participants who had histories including cranial irradiation, empty sella, hypophysitis, congenital defect resulting in GHD.|participants|Number|1646|1646.0||||||
4055059|NCT01088399|3876789|B3|Idiopathic||Diagnosis Leading to GHD|Participants with available diagnosis designation at baseline (n=8670, 1616, 276, with 10562 total participants). Other less common specified diagnoses contains participants who had histories including cranial irradiation, empty sella, hypophysitis, congenital defect resulting in GHD.|participants|Number|88|88.0||||||
4055060|NCT01088399|3876790|B2|Idiopathic||Diagnosis Leading to GHD|Participants with available diagnosis designation at baseline (n=8670, 1616, 276, with 10562 total participants). Other less common specified diagnoses contains participants who had histories including cranial irradiation, empty sella, hypophysitis, congenital defect resulting in GHD.|participants|Number|177|177.0||||||
4055061|NCT01088399|3876791|B1|Idiopathic||Diagnosis Leading to GHD|Participants with available diagnosis designation at baseline (n=8670, 1616, 276, with 10562 total participants). Other less common specified diagnoses contains participants who had histories including cranial irradiation, empty sella, hypophysitis, congenital defect resulting in GHD.|participants|Number|1381|1381.0||||||
4055062|NCT01088399|3876788|B4|Other Tumor||Diagnosis Leading to GHD|Participants with available diagnosis designation at baseline (n=8670, 1616, 276, with 10562 total participants). Other less common specified diagnoses contains participants who had histories including cranial irradiation, empty sella, hypophysitis, congenital defect resulting in GHD.|participants|Number|797|797.0||||||
4055063|NCT01088399|3876789|B3|Other Tumor||Diagnosis Leading to GHD|Participants with available diagnosis designation at baseline (n=8670, 1616, 276, with 10562 total participants). Other less common specified diagnoses contains participants who had histories including cranial irradiation, empty sella, hypophysitis, congenital defect resulting in GHD.|participants|Number|7|7.0||||||
4055064|NCT01088399|3876790|B2|Other Tumor||Diagnosis Leading to GHD|Participants with available diagnosis designation at baseline (n=8670, 1616, 276, with 10562 total participants). Other less common specified diagnoses contains participants who had histories including cranial irradiation, empty sella, hypophysitis, congenital defect resulting in GHD.|participants|Number|137|137.0||||||
4055065|NCT01088399|3876791|B1|Other Tumor||Diagnosis Leading to GHD|Participants with available diagnosis designation at baseline (n=8670, 1616, 276, with 10562 total participants). Other less common specified diagnoses contains participants who had histories including cranial irradiation, empty sella, hypophysitis, congenital defect resulting in GHD.|participants|Number|653|653.0||||||
4055066|NCT01088399|3876788|B4|Craniopharyngioma||Diagnosis Leading to GHD|Participants with available diagnosis designation at baseline (n=8670, 1616, 276, with 10562 total participants). Other less common specified diagnoses contains participants who had histories including cranial irradiation, empty sella, hypophysitis, congenital defect resulting in GHD.|participants|Number|1122|1122.0||||||
4055067|NCT01088399|3876789|B3|Craniopharyngioma||Diagnosis Leading to GHD|Participants with available diagnosis designation at baseline (n=8670, 1616, 276, with 10562 total participants). Other less common specified diagnoses contains participants who had histories including cranial irradiation, empty sella, hypophysitis, congenital defect resulting in GHD.|participants|Number|24|24.0||||||
4055068|NCT01088399|3876790|B2|Craniopharyngioma||Diagnosis Leading to GHD|Participants with available diagnosis designation at baseline (n=8670, 1616, 276, with 10562 total participants). Other less common specified diagnoses contains participants who had histories including cranial irradiation, empty sella, hypophysitis, congenital defect resulting in GHD.|participants|Number|125|125.0||||||
4055069|NCT01088399|3876791|B1|Craniopharyngioma||Diagnosis Leading to GHD|Participants with available diagnosis designation at baseline (n=8670, 1616, 276, with 10562 total participants). Other less common specified diagnoses contains participants who had histories including cranial irradiation, empty sella, hypophysitis, congenital defect resulting in GHD.|participants|Number|973|973.0||||||
4055070|NCT01088399|3876788|B4|Pituitary adenoma||Diagnosis Leading to GHD|Participants with available diagnosis designation at baseline (n=8670, 1616, 276, with 10562 total participants). Other less common specified diagnoses contains participants who had histories including cranial irradiation, empty sella, hypophysitis, congenital defect resulting in GHD.|participants|Number|4713|4713.0||||||
4055071|NCT01088399|3876789|B3|Pituitary adenoma||Diagnosis Leading to GHD|Participants with available diagnosis designation at baseline (n=8670, 1616, 276, with 10562 total participants). Other less common specified diagnoses contains participants who had histories including cranial irradiation, empty sella, hypophysitis, congenital defect resulting in GHD.|participants|Number|79|79.0||||||
4055072|NCT01088399|3876790|B2|Pituitary adenoma||Diagnosis Leading to GHD|Participants with available diagnosis designation at baseline (n=8670, 1616, 276, with 10562 total participants). Other less common specified diagnoses contains participants who had histories including cranial irradiation, empty sella, hypophysitis, congenital defect resulting in GHD.|participants|Number|865|865.0||||||
4055073|NCT01088399|3876791|B1|Pituitary adenoma||Diagnosis Leading to GHD|Participants with available diagnosis designation at baseline (n=8670, 1616, 276, with 10562 total participants). Other less common specified diagnoses contains participants who had histories including cranial irradiation, empty sella, hypophysitis, congenital defect resulting in GHD.|participants|Number|3769|3769.0||||||
4055074|NCT01088399|3876788|B4|||Body Mass Index (BMI)|Participants with available BMI data at baseline (n=8263, 1452, 268, with 9983 total participants). Body mass index (BMI) is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|29.7|29.7|Standard Deviation|7.0|7.0|||
4055075|NCT01088399|3876789|B3|||Body Mass Index (BMI)|Participants with available BMI data at baseline (n=8263, 1452, 268, with 9983 total participants). Body mass index (BMI) is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|30.0|30.0|Standard Deviation|6.9|6.9|||
4055076|NCT01088399|3876790|B2|||Body Mass Index (BMI)|Participants with available BMI data at baseline (n=8263, 1452, 268, with 9983 total participants). Body mass index (BMI) is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|29.9|29.9|Standard Deviation|7.0|7.0|||
4055077|NCT01088399|3876791|B1|||Body Mass Index (BMI)|Participants with available BMI data at baseline (n=8263, 1452, 268, with 9983 total participants). Body mass index (BMI) is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|29.7|29.7|Standard Deviation|7.0|7.0|||
4055078|NCT01088399|3876788|B4|Any test except GHRH + Arg (n=6579;1178;168;7925)||Maximum Growth Hormone (GH) Peak on Stimulation Test|Participants with available maximum GH peak data at baseline (N=1175, 103, 51 with 1329 total participants analyzed). Maximum GH peak levels in response to medication (such as insulin or growth hormone releasing hormone (GHRH) plus arginine) or other intervention (such as exercise) was used to measure the ability of the pituitary gland to release GH and to diagnose and determine severity of GH deficiency. Severe GH deficiency in adults is a peak GH response of <3 milligrams/liter in response to an insulin tolerance test and is an accepted criterion for GH replacement therapy in adults.|nanograms per milliliter (ng/mL)|Mean|1.3|1.3|Standard Deviation|2.5|2.5|||
4055079|NCT01088399|3876789|B3|Any test except GHRH + Arg (n=6579;1178;168;7925)||Maximum Growth Hormone (GH) Peak on Stimulation Test|Participants with available maximum GH peak data at baseline (N=1175, 103, 51 with 1329 total participants analyzed). Maximum GH peak levels in response to medication (such as insulin or growth hormone releasing hormone (GHRH) plus arginine) or other intervention (such as exercise) was used to measure the ability of the pituitary gland to release GH and to diagnose and determine severity of GH deficiency. Severe GH deficiency in adults is a peak GH response of <3 milligrams/liter in response to an insulin tolerance test and is an accepted criterion for GH replacement therapy in adults.|nanograms per milliliter (ng/mL)|Mean|5.2|5.2|Standard Deviation|6.7|6.7|||
4055080|NCT01088399|3876790|B2|Any test except GHRH + Arg (n=6579;1178;168;7925)||Maximum Growth Hormone (GH) Peak on Stimulation Test|Participants with available maximum GH peak data at baseline (N=1175, 103, 51 with 1329 total participants analyzed). Maximum GH peak levels in response to medication (such as insulin or growth hormone releasing hormone (GHRH) plus arginine) or other intervention (such as exercise) was used to measure the ability of the pituitary gland to release GH and to diagnose and determine severity of GH deficiency. Severe GH deficiency in adults is a peak GH response of <3 milligrams/liter in response to an insulin tolerance test and is an accepted criterion for GH replacement therapy in adults.|nanograms per milliliter (ng/mL)|Mean|2.0|2.0|Standard Deviation|3.7|3.7|||
4055081|NCT01088399|3876791|B1|Any test except GHRH + Arg (n=6579;1178;168;7925)||Maximum Growth Hormone (GH) Peak on Stimulation Test|Participants with available maximum GH peak data at baseline (N=1175, 103, 51 with 1329 total participants analyzed). Maximum GH peak levels in response to medication (such as insulin or growth hormone releasing hormone (GHRH) plus arginine) or other intervention (such as exercise) was used to measure the ability of the pituitary gland to release GH and to diagnose and determine severity of GH deficiency. Severe GH deficiency in adults is a peak GH response of <3 milligrams/liter in response to an insulin tolerance test and is an accepted criterion for GH replacement therapy in adults.|nanograms per milliliter (ng/mL)|Mean|1.1|1.1|Standard Deviation|1.9|1.9|||
4055082|NCT01088399|3876788|B4|GHRH + Arginine (Arg, n=1175, 103, 51, 1329)||Maximum Growth Hormone (GH) Peak on Stimulation Test|Participants with available maximum GH peak data at baseline (N=1175, 103, 51 with 1329 total participants analyzed). Maximum GH peak levels in response to medication (such as insulin or growth hormone releasing hormone (GHRH) plus arginine) or other intervention (such as exercise) was used to measure the ability of the pituitary gland to release GH and to diagnose and determine severity of GH deficiency. Severe GH deficiency in adults is a peak GH response of <3 milligrams/liter in response to an insulin tolerance test and is an accepted criterion for GH replacement therapy in adults.|nanograms per milliliter (ng/mL)|Mean|2.8|2.8|Standard Deviation|4.4|4.4|||
4055083|NCT01088399|3876789|B3|GHRH + Arginine (Arg, n=1175, 103, 51, 1329)||Maximum Growth Hormone (GH) Peak on Stimulation Test|Participants with available maximum GH peak data at baseline (N=1175, 103, 51 with 1329 total participants analyzed). Maximum GH peak levels in response to medication (such as insulin or growth hormone releasing hormone (GHRH) plus arginine) or other intervention (such as exercise) was used to measure the ability of the pituitary gland to release GH and to diagnose and determine severity of GH deficiency. Severe GH deficiency in adults is a peak GH response of <3 milligrams/liter in response to an insulin tolerance test and is an accepted criterion for GH replacement therapy in adults.|nanograms per milliliter (ng/mL)|Mean|4.4|4.4|Standard Deviation|8.1|8.1|||
4055107|NCT01088399|3876789|B3|United States||Region of Enrollment||participants|Number|216|216.0||||||
4055108|NCT01088399|3876790|B2|United States||Region of Enrollment||participants|Number|1044|1044.0||||||
4055109|NCT01088399|3876791|B1|United States||Region of Enrollment||participants|Number|3730|3730.0||||||
4055110|NCT01088399|3876788|B4|United Kingdom||Region of Enrollment||participants|Number|559|559.0||||||
4055111|NCT01088399|3876789|B3|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4055084|NCT01088399|3876790|B2|GHRH + Arginine (Arg, n=1175, 103, 51, 1329)||Maximum Growth Hormone (GH) Peak on Stimulation Test|Participants with available maximum GH peak data at baseline (N=1175, 103, 51 with 1329 total participants analyzed). Maximum GH peak levels in response to medication (such as insulin or growth hormone releasing hormone (GHRH) plus arginine) or other intervention (such as exercise) was used to measure the ability of the pituitary gland to release GH and to diagnose and determine severity of GH deficiency. Severe GH deficiency in adults is a peak GH response of <3 milligrams/liter in response to an insulin tolerance test and is an accepted criterion for GH replacement therapy in adults.|nanograms per milliliter (ng/mL)|Mean|5.2|5.2|Standard Deviation|8.1|8.1|||
4055085|NCT01088399|3876791|B1|GHRH + Arginine (Arg, n=1175, 103, 51, 1329)||Maximum Growth Hormone (GH) Peak on Stimulation Test|Participants with available maximum GH peak data at baseline (N=1175, 103, 51 with 1329 total participants analyzed). Maximum GH peak levels in response to medication (such as insulin or growth hormone releasing hormone (GHRH) plus arginine) or other intervention (such as exercise) was used to measure the ability of the pituitary gland to release GH and to diagnose and determine severity of GH deficiency. Severe GH deficiency in adults is a peak GH response of <3 milligrams/liter in response to an insulin tolerance test and is an accepted criterion for GH replacement therapy in adults.|nanograms per milliliter (ng/mL)|Mean|2.5|2.5|Standard Deviation|3.5|3.5|||
4055086|NCT01088399|3876788|B4|||IGF-I Standard Deviations Score (SDS)|Participants with available IGF-I SDS data at baseline (n=3743, 645, 113 with 4501 total participants). IGF-I is primary mediator of growth hormone (GH) and is used to monitor GH effectiveness, treatment adherence and IGF-I excess. As endogenous levels of GH, thereby IGF-I, decline throughout adulthood values are converted to age and gender adjusted standard deviation scores (SDS) based on general population normal data. The SDS is the number of standard deviations a subjects IGF-I concentration is different from the general population mean, either positive or negative.|standard deviation scores|Mean|-2.73|-2.73|Standard Deviation|2.19|2.19|||
4055087|NCT01088399|3876789|B3|||IGF-I Standard Deviations Score (SDS)|Participants with available IGF-I SDS data at baseline (n=3743, 645, 113 with 4501 total participants). IGF-I is primary mediator of growth hormone (GH) and is used to monitor GH effectiveness, treatment adherence and IGF-I excess. As endogenous levels of GH, thereby IGF-I, decline throughout adulthood values are converted to age and gender adjusted standard deviation scores (SDS) based on general population normal data. The SDS is the number of standard deviations a subjects IGF-I concentration is different from the general population mean, either positive or negative.|standard deviation scores|Mean|-2.39|-2.39|Standard Deviation|2.03|2.03|||
4055088|NCT01088399|3876790|B2|||IGF-I Standard Deviations Score (SDS)|Participants with available IGF-I SDS data at baseline (n=3743, 645, 113 with 4501 total participants). IGF-I is primary mediator of growth hormone (GH) and is used to monitor GH effectiveness, treatment adherence and IGF-I excess. As endogenous levels of GH, thereby IGF-I, decline throughout adulthood values are converted to age and gender adjusted standard deviation scores (SDS) based on general population normal data. The SDS is the number of standard deviations a subjects IGF-I concentration is different from the general population mean, either positive or negative.|standard deviation scores|Mean|-2.82|-2.82|Standard Deviation|1.97|1.97|||
4055089|NCT01088399|3876791|B1|||IGF-I Standard Deviations Score (SDS)|Participants with available IGF-I SDS data at baseline (n=3743, 645, 113 with 4501 total participants). IGF-I is primary mediator of growth hormone (GH) and is used to monitor GH effectiveness, treatment adherence and IGF-I excess. As endogenous levels of GH, thereby IGF-I, decline throughout adulthood values are converted to age and gender adjusted standard deviation scores (SDS) based on general population normal data. The SDS is the number of standard deviations a subjects IGF-I concentration is different from the general population mean, either positive or negative.|standard deviation scores|Mean|-2.72|-2.72|Standard Deviation|2.23|2.23|||
4055090|NCT01088399|3876788|B4|||Insulin-like Growth Factor-I (IGF-I)|Participants with available IGF-I data at baseline (n=5531, 1009, 194 with 6734 total participants). IGF-I is primary mediator of growth hormone (GH) and is used to monitor GH effectiveness, treatment adherence and IGF-I excess.|micrograms per liter (mcg/L)|Mean|96.4|96.4|Standard Deviation|75.2|75.2|||
4055091|NCT01088399|3876789|B3|||Insulin-like Growth Factor-I (IGF-I)|Participants with available IGF-I data at baseline (n=5531, 1009, 194 with 6734 total participants). IGF-I is primary mediator of growth hormone (GH) and is used to monitor GH effectiveness, treatment adherence and IGF-I excess.|micrograms per liter (mcg/L)|Mean|95.5|95.5|Standard Deviation|63.7|63.7|||
4055092|NCT01088399|3876790|B2|||Insulin-like Growth Factor-I (IGF-I)|Participants with available IGF-I data at baseline (n=5531, 1009, 194 with 6734 total participants). IGF-I is primary mediator of growth hormone (GH) and is used to monitor GH effectiveness, treatment adherence and IGF-I excess.|micrograms per liter (mcg/L)|Mean|75.0|75.0|Standard Deviation|55.3|55.3|||
4055093|NCT01088399|3876791|B1|||Insulin-like Growth Factor-I (IGF-I)|Participants with available IGF-I data at baseline (n=5531, 1009, 194 with 6734 total participants). IGF-I is primary mediator of growth hormone (GH) and is used to monitor GH effectiveness, treatment adherence and IGF-I excess.|micrograms per liter (mcg/L)|Mean|100.4|100.4|Standard Deviation|78.0|78.0|||
4055094|NCT01088399|3876788|B4|Unknown||Growth Hormone Deficiency (GHD) Onset Type||participants|Number|111|111.0||||||
4055095|NCT01088399|3876789|B3|Unknown||Growth Hormone Deficiency (GHD) Onset Type||participants|Number|26|26.0||||||
4055096|NCT01088399|3876790|B2|Unknown||Growth Hormone Deficiency (GHD) Onset Type||participants|Number|39|39.0||||||
4055097|NCT01088399|3876791|B1|Unknown||Growth Hormone Deficiency (GHD) Onset Type||participants|Number|46|46.0||||||
4055098|NCT01088399|3876788|B4|Childhood||Growth Hormone Deficiency (GHD) Onset Type||participants|Number|1925|1925.0||||||
4055099|NCT01088399|3876789|B3|Childhood||Growth Hormone Deficiency (GHD) Onset Type||participants|Number|29|29.0||||||
4055100|NCT01088399|3876790|B2|Childhood||Growth Hormone Deficiency (GHD) Onset Type||participants|Number|194|194.0||||||
4055101|NCT01088399|3876791|B1|Childhood||Growth Hormone Deficiency (GHD) Onset Type||participants|Number|1702|1702.0||||||
4055102|NCT01088399|3876788|B4|Adult||Growth Hormone Deficiency (GHD) Onset Type||participants|Number|8637|8637.0||||||
4055103|NCT01088399|3876789|B3|Adult||Growth Hormone Deficiency (GHD) Onset Type||participants|Number|247|247.0||||||
4055104|NCT01088399|3876790|B2|Adult||Growth Hormone Deficiency (GHD) Onset Type||participants|Number|1422|1422.0||||||
4055105|NCT01088399|3876791|B1|Adult||Growth Hormone Deficiency (GHD) Onset Type||participants|Number|6968|6968.0||||||
4055112|NCT01088399|3876790|B2|United Kingdom||Region of Enrollment||participants|Number|15|15.0||||||
4055113|NCT01088399|3876791|B1|United Kingdom||Region of Enrollment||participants|Number|538|538.0||||||
4055114|NCT01088399|3876788|B4|Netherlands||Region of Enrollment||participants|Number|461|461.0||||||
4055115|NCT01088399|3876789|B3|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4055116|NCT01088399|3876790|B2|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4055117|NCT01088399|3876791|B1|Netherlands||Region of Enrollment||participants|Number|460|460.0||||||
4055118|NCT01088399|3876788|B4|Sweden||Region of Enrollment||participants|Number|360|360.0||||||
4055119|NCT01088399|3876789|B3|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
4055120|NCT01088399|3876790|B2|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
4055121|NCT01088399|3876791|B1|Sweden||Region of Enrollment||participants|Number|355|355.0||||||
4055122|NCT01088399|3876788|B4|Spain||Region of Enrollment||participants|Number|484|484.0||||||
4055123|NCT01088399|3876789|B3|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4055124|NCT01088399|3876790|B2|Spain||Region of Enrollment||participants|Number|55|55.0||||||
4055125|NCT01088399|3876791|B1|Spain||Region of Enrollment||participants|Number|427|427.0||||||
4055126|NCT01088399|3876788|B4|Norway||Region of Enrollment||participants|Number|17|17.0||||||
4055127|NCT01088399|3876789|B3|Norway||Region of Enrollment||participants|Number|0|0.0||||||
4055128|NCT01088399|3876790|B2|Norway||Region of Enrollment||participants|Number|0|0.0||||||
4055129|NCT01088399|3876791|B1|Norway||Region of Enrollment||participants|Number|17|17.0||||||
4055130|NCT01088399|3876788|B4|Japan||Region of Enrollment||participants|Number|509|509.0||||||
4055131|NCT01088399|3876789|B3|Japan||Region of Enrollment||participants|Number|0|0.0||||||
4055132|NCT01088399|3876790|B2|Japan||Region of Enrollment||participants|Number|102|102.0||||||
4055133|NCT01088399|3876791|B1|Japan||Region of Enrollment||participants|Number|407|407.0||||||
4055134|NCT01088399|3876788|B4|Italy||Region of Enrollment||participants|Number|1355|1355.0||||||
4055135|NCT01088399|3876789|B3|Italy||Region of Enrollment||participants|Number|49|49.0||||||
4055136|NCT01088399|3876790|B2|Italy||Region of Enrollment||participants|Number|64|64.0||||||
4055137|NCT01088399|3876791|B1|Italy||Region of Enrollment||participants|Number|1242|1242.0||||||
4055138|NCT01088399|3876788|B4|Iceland||Region of Enrollment||participants|Number|12|12.0||||||
4055139|NCT01088399|3876789|B3|Iceland||Region of Enrollment||participants|Number|1|1.0||||||
4055140|NCT01088399|3876790|B2|Iceland||Region of Enrollment||participants|Number|1|1.0||||||
4055141|NCT01088399|3876791|B1|Iceland||Region of Enrollment||participants|Number|10|10.0||||||
4055142|NCT01088399|3876788|B4|Hungary||Region of Enrollment||participants|Number|104|104.0||||||
4055143|NCT01088399|3876789|B3|Hungary||Region of Enrollment||participants|Number|0|0.0||||||
4055144|NCT01088399|3876790|B2|Hungary||Region of Enrollment||participants|Number|2|2.0||||||
4055145|NCT01088399|3876791|B1|Hungary||Region of Enrollment||participants|Number|102|102.0||||||
4055146|NCT01088399|3876788|B4|Germany||Region of Enrollment||participants|Number|659|659.0||||||
4055147|NCT01088399|3876789|B3|Germany||Region of Enrollment||participants|Number|19|19.0||||||
4055148|NCT01088399|3876790|B2|Germany||Region of Enrollment||participants|Number|87|87.0||||||
4055149|NCT01088399|3876791|B1|Germany||Region of Enrollment||participants|Number|553|553.0||||||
4055150|NCT01088399|3876788|B4|France||Region of Enrollment||participants|Number|676|676.0||||||
4055151|NCT01088399|3876789|B3|France||Region of Enrollment||participants|Number|6|6.0||||||
4055152|NCT01088399|3876790|B2|France||Region of Enrollment||participants|Number|218|218.0||||||
4055153|NCT01088399|3876791|B1|France||Region of Enrollment||participants|Number|452|452.0||||||
4055154|NCT01088399|3876788|B4|Denmark||Region of Enrollment||participants|Number|156|156.0||||||
4055155|NCT01088399|3876789|B3|Denmark||Region of Enrollment||participants|Number|0|0.0||||||
4055156|NCT01088399|3876790|B2|Denmark||Region of Enrollment||participants|Number|5|5.0||||||
4055157|NCT01088399|3876791|B1|Denmark||Region of Enrollment||participants|Number|151|151.0||||||
4055158|NCT01088399|3876788|B4|Czech Republic||Region of Enrollment||participants|Number|82|82.0||||||
4055159|NCT01088399|3876789|B3|Czech Republic||Region of Enrollment||participants|Number|0|0.0||||||
4055160|NCT01088399|3876790|B2|Czech Republic||Region of Enrollment||participants|Number|5|5.0||||||
4055161|NCT01088399|3876791|B1|Czech Republic||Region of Enrollment||participants|Number|77|77.0||||||
4055162|NCT01088399|3876788|B4|Canada||Region of Enrollment||participants|Number|114|114.0||||||
4055163|NCT01088399|3876789|B3|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4055164|NCT01088399|3876790|B2|Canada||Region of Enrollment||participants|Number|51|51.0||||||
4055165|NCT01088399|3876791|B1|Canada||Region of Enrollment||participants|Number|63|63.0||||||
4055166|NCT01088399|3876788|B4|Belgium||Region of Enrollment||participants|Number|56|56.0||||||
4055167|NCT01088399|3876789|B3|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
4055168|NCT01088399|3876790|B2|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4055169|NCT01088399|3876791|B1|Belgium||Region of Enrollment||participants|Number|55|55.0||||||
4055170|NCT01088399|3876788|B4|Austria||Region of Enrollment||participants|Number|79|79.0||||||
4055171|NCT01088399|3876789|B3|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4055172|NCT01088399|3876790|B2|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4055173|NCT01088399|3876791|B1|Austria||Region of Enrollment||participants|Number|77|77.0||||||
4055174|NCT01088399|3876788|B4|Unknown||Race/Ethnicity, Customized||participants|Number|1580|1580.0||||||
4055175|NCT01088399|3876789|B3|Unknown||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4055176|NCT01088399|3876790|B2|Unknown||Race/Ethnicity, Customized||participants|Number|198|198.0||||||
4055177|NCT01088399|3876791|B1|Unknown||Race/Ethnicity, Customized||participants|Number|1370|1370.0||||||
4055178|NCT01088399|3876788|B4|Declined To Provide||Race/Ethnicity, Customized||participants|Number|481|481.0||||||
4055179|NCT01088399|3876789|B3|Declined To Provide||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4055180|NCT01088399|3876790|B2|Declined To Provide||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
4055181|NCT01088399|3876791|B1|Declined To Provide||Race/Ethnicity, Customized||participants|Number|387|387.0||||||
4055182|NCT01088399|3876788|B4|Other||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
4055183|NCT01088399|3876789|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4055184|NCT01088399|3876790|B2|Other||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4055185|NCT01088399|3876791|B1|Other||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4055186|NCT01088399|3876788|B4|Western Asian||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4055187|NCT01088399|3876789|B3|Western Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4055188|NCT01088399|3876790|B2|Western Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4055189|NCT01088399|3876791|B1|Western Asian||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4055190|NCT01088399|3876788|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|224|224.0||||||
4055191|NCT01088399|3876789|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4055192|NCT01088399|3876790|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
4055193|NCT01088399|3876791|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|153|153.0||||||
4055194|NCT01088399|3876788|B4|East/Southeast Asian||Race/Ethnicity, Customized||participants|Number|596|596.0||||||
4055195|NCT01088399|3876789|B3|East/Southeast Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4055196|NCT01088399|3876790|B2|East/Southeast Asian||Race/Ethnicity, Customized||participants|Number|129|129.0||||||
4055197|NCT01088399|3876791|B1|East/Southeast Asian||Race/Ethnicity, Customized||participants|Number|460|460.0||||||
4055198|NCT01088399|3876788|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|7374|7374.0||||||
4055199|NCT01088399|3876789|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|236|236.0||||||
4055200|NCT01088399|3876790|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|1080|1080.0||||||
4055201|NCT01088399|3876791|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|6058|6058.0||||||
4055202|NCT01088399|3876788|B4|African Descent||Race/Ethnicity, Customized||participants|Number|336|336.0||||||
4055203|NCT01088399|3876789|B3|African Descent||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4055204|NCT01088399|3876790|B2|African Descent||Race/Ethnicity, Customized||participants|Number|96|96.0||||||
4055205|NCT01088399|3876791|B1|African Descent||Race/Ethnicity, Customized||participants|Number|226|226.0||||||
4055206|NCT01088399|3876788|B4||Male|Sex: Female, Male||Participants|Count of Participants|5646|5646.0||||||
4055207|NCT01088399|3876789|B3||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4055208|NCT01088399|3876790|B2||Male|Sex: Female, Male||Participants|Count of Participants|941|941.0||||||
4055209|NCT01088399|3876791|B1||Male|Sex: Female, Male||Participants|Count of Participants|4558|4558.0||||||
4055210|NCT01088399|3876788|B4||Female|Sex: Female, Male||Participants|Count of Participants|5027|5027.0||||||
4055211|NCT01088399|3876789|B3||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4055212|NCT01088399|3876790|B2||Female|Sex: Female, Male||Participants|Count of Participants|714|714.0||||||
4055213|NCT01088399|3876791|B1||Female|Sex: Female, Male||Participants|Count of Participants|4158|4158.0||||||
4055214|NCT01088399|3876788|B4|unknown||Age, Customized||participants|Number|4|4.0||||||
4055215|NCT01088399|3876789|B3|unknown||Age, Customized||participants|Number|1|1.0||||||
4055216|NCT01088399|3876790|B2|unknown||Age, Customized||participants|Number|1|1.0||||||
4055217|NCT01088399|3876791|B1|unknown||Age, Customized||participants|Number|2|2.0||||||
4055218|NCT01088399|3876788|B4|>=70 years||Age, Customized||participants|Number|706|706.0||||||
4055219|NCT01088399|3876789|B3|>=70 years||Age, Customized||participants|Number|13|13.0||||||
4055220|NCT01088399|3876790|B2|>=70 years||Age, Customized||participants|Number|272|272.0||||||
4055221|NCT01088399|3876791|B1|>=70 years||Age, Customized||participants|Number|421|421.0||||||
4055222|NCT01088399|3876788|B4|60 years to <70 years||Age, Customized||participants|Number|1478|1478.0||||||
4055223|NCT01088399|3876789|B3|60 years to <70 years||Age, Customized||participants|Number|38|38.0||||||
4055224|NCT01088399|3876790|B2|60 years to <70 years||Age, Customized||participants|Number|324|324.0||||||
4055225|NCT01088399|3876791|B1|60 years to <70 years||Age, Customized||participants|Number|1116|1116.0||||||
4055226|NCT01088399|3876788|B4|50 years to <60 years||Age, Customized||participants|Number|2501|2501.0||||||
4055227|NCT01088399|3876789|B3|50 years to <60 years||Age, Customized||participants|Number|74|74.0||||||
4055228|NCT01088399|3876790|B2|50 years to <60 years||Age, Customized||participants|Number|379|379.0||||||
4055229|NCT01088399|3876791|B1|50 years to <60 years||Age, Customized||participants|Number|2048|2048.0||||||
4055230|NCT01088399|3876788|B4|40 years to <50 years||Age, Customized||participants|Number|2369|2369.0||||||
4055231|NCT01088399|3876789|B3|40 years to <50 years||Age, Customized||participants|Number|76|76.0||||||
4055232|NCT01088399|3876790|B2|40 years to <50 years||Age, Customized||participants|Number|318|318.0||||||
4055233|NCT01088399|3876791|B1|40 years to <50 years||Age, Customized||participants|Number|1975|1975.0||||||
4055234|NCT01088399|3876788|B4|30 years to <40 years||Age, Customized||participants|Number|1702|1702.0||||||
4055235|NCT01088399|3876789|B3|30 years to <40 years||Age, Customized||participants|Number|54|54.0||||||
4055236|NCT01088399|3876790|B2|30 years to <40 years||Age, Customized||participants|Number|173|173.0||||||
4055237|NCT01088399|3876791|B1|30 years to <40 years||Age, Customized||participants|Number|1475|1475.0||||||
4055238|NCT01088399|3876788|B4|20 years to <30 years||Age, Customized||participants|Number|1446|1446.0||||||
4055239|NCT01088399|3876789|B3|20 years to <30 years||Age, Customized||participants|Number|36|36.0||||||
4055240|NCT01088399|3876790|B2|20 years to <30 years||Age, Customized||participants|Number|152|152.0||||||
4055241|NCT01088399|3876791|B1|20 years to <30 years||Age, Customized||participants|Number|1258|1258.0||||||
4055242|NCT01088399|3876788|B4|<20 years||Age, Customized||participants|Number|467|467.0||||||
4055243|NCT01088399|3876789|B3|<20 years||Age, Customized||participants|Number|10|10.0||||||
4055244|NCT01088399|3876790|B2|<20 years||Age, Customized||participants|Number|36|36.0||||||
4055245|NCT01088399|3876791|B1|<20 years||Age, Customized||participants|Number|421|421.0||||||
4055246|NCT01088295|3876816|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4055247|NCT01088295|3876816|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4055248|NCT01088295|3876816|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4055249|NCT01088295|3876816|B1|||Age||years|Mean|49|49.0|Standard Deviation|7.4|7.4|||
4055250|NCT01088295|3876816|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4055251|NCT01088295|3876816|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4055252|NCT01088295|3876816|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4055253|NCT01088243|3876820|B3|Former||Smoking Status||Count of Participants|Number|11|11.0||||||
4055254|NCT01088243|3876821|B2|Former||Smoking Status||Count of Participants|Number|3|3.0||||||
4055255|NCT01088243|3876822|B1|Former||Smoking Status||Count of Participants|Number|8|8.0||||||
4055256|NCT01088243|3876820|B3|Never||Smoking Status||Count of Participants|Number|7|7.0||||||
4055257|NCT01088243|3876821|B2|Never||Smoking Status||Count of Participants|Number|2|2.0||||||
4055258|NCT01088243|3876822|B1|Never||Smoking Status||Count of Participants|Number|5|5.0||||||
4055259|NCT01088243|3876820|B3|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4055260|NCT01088243|3876821|B2|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4055261|NCT01088243|3876822|B1|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4055262|NCT01088243|3876820|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4055263|NCT01088243|3876821|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4055264|NCT01088243|3876822|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4055265|NCT01088243|3876820|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4055266|NCT01088243|3876821|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4055267|NCT01088243|3876822|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4055268|NCT01088243|3876820|B3|||Age||years|Mean|63.16|63.16|Full Range|||49.0|79.0|
4055269|NCT01088243|3876821|B2|||Age||years|Mean|62.8|62.8|Full Range|||49.0|79.0|
4055270|NCT01088243|3876822|B1|||Age||years|Mean|63.3|63.3|Full Range|||53.0|74.0|
4055271|NCT01087996|3876839|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4055272|NCT01087996|3876840|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4055273|NCT01087996|3876841|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4055274|NCT01087996|3876839|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4055275|NCT01087996|3876840|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4055276|NCT01087996|3876841|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4055277|NCT01087996|3876839|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4055278|NCT01087996|3876840|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4055279|NCT01087996|3876841|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4055280|NCT01087996|3876839|B3|||Age||years|Mean|63.2|63.2|Standard Deviation|9.7|9.7|||
4055281|NCT01087996|3876840|B2|||Age||years|Mean|63.7|63.7|Standard Deviation|9.3|9.3|||
4055282|NCT01087996|3876841|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|10.5|10.5|||
4055283|NCT01087996|3876839|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4055284|NCT01087996|3876840|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4055285|NCT01087996|3876841|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4055286|NCT01087996|3876839|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4055287|NCT01087996|3876840|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4055288|NCT01087996|3876841|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4055289|NCT01087996|3876839|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4055290|NCT01087996|3876840|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4055291|NCT01087996|3876841|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4055292|NCT01087970|3876864|B1|EIP (n=57)||Performance Status Scale for Head and Neck Cancer (PSS-HNC)|Clinician measured speaking and eating disabilities of HNC participants that consists 3 subscales: normalcy of diet (NOD) measures ability of eating a normal diet, scale from 0 (non-oral feeding) to 100 (unrestricted diet); understandability of speech (UOS) measures the degree a clinician was able to understand participant's speech, scale from 0 (never understandable) to 100 (always understandable); eating in public (EIP) is based on clinician’s question to the participant, scale from 0 (always eats alone) to 100 (no restriction of place, food, or companion).|units on a scale|Mean|71.93|71.93|Standard Deviation|34.42|34.42|||
4055318|NCT01087957|3876875|B2|||Mini Mental Status Exam|The Mini Mental Status is a measure of cognitive function with a total possible score of 30 points. Any score greater than or equal to 27 points (out of 30) indicates a normal cognition. Below this, scores can indicate severe (≤9 points), moderate (10-18 points) or mild (19-24 points) cognitive impairment|units on a scale|Mean|27.62|27.62|Standard Deviation|2.44|2.44|||
4055293|NCT01087970|3876864|B1|UOS (n=57)||Performance Status Scale for Head and Neck Cancer (PSS-HNC)|Clinician measured speaking and eating disabilities of HNC participants that consists 3 subscales: normalcy of diet (NOD) measures ability of eating a normal diet, scale from 0 (non-oral feeding) to 100 (unrestricted diet); understandability of speech (UOS) measures the degree a clinician was able to understand participant's speech, scale from 0 (never understandable) to 100 (always understandable); eating in public (EIP) is based on clinician’s question to the participant, scale from 0 (always eats alone) to 100 (no restriction of place, food, or companion).|units on a scale|Mean|78.51|78.51|Standard Deviation|32.20|32.2|||
4055294|NCT01087970|3876864|B1|NOD (n=57)||Performance Status Scale for Head and Neck Cancer (PSS-HNC)|Clinician measured speaking and eating disabilities of HNC participants that consists 3 subscales: normalcy of diet (NOD) measures ability of eating a normal diet, scale from 0 (non-oral feeding) to 100 (unrestricted diet); understandability of speech (UOS) measures the degree a clinician was able to understand participant's speech, scale from 0 (never understandable) to 100 (always understandable); eating in public (EIP) is based on clinician’s question to the participant, scale from 0 (always eats alone) to 100 (no restriction of place, food, or companion).|units on a scale|Mean|56.32|56.32|Standard Deviation|37.87|37.87|||
4055295|NCT01087970|3876864|B1|Visual Analog Scale (VAS) Score (n=47)||European-Quality of Life-5 Dimension Instrument-3 Levels (EQ-5D-3L)|Participants assessed health-related QoL in 5 D (mobility, self-care, usual activities, pain/discomfort, anxiety/depression) as no problems/some or moderate problems/extreme problems. A regression equation defines a utility value for these health states to generate an index score from -0.594 (severe problems in all 5 D) to 1 (no problem in all 5 D) where 1=best possible health state. EQ-5D VAS rates participant's current health-related QoL on the day of questionnaire administration and is captured on a scale of 0 (worst imaginable health state) to 100 (best imaginable health state).|units on a scale|Mean|66.106|66.106|Standard Deviation|20.658|20.658|||
4055296|NCT01087970|3876864|B1|Index Score (n=47)||European-Quality of Life-5 Dimension Instrument-3 Levels (EQ-5D-3L)|Participants assessed health-related QoL in 5 D (mobility, self-care, usual activities, pain/discomfort, anxiety/depression) as no problems/some or moderate problems/extreme problems. A regression equation defines a utility value for these health states to generate an index score from -0.594 (severe problems in all 5 D) to 1 (no problem in all 5 D) where 1=best possible health state. EQ-5D VAS rates participant's current health-related QoL on the day of questionnaire administration and is captured on a scale of 0 (worst imaginable health state) to 100 (best imaginable health state).|units on a scale|Mean|0.721|0.721|Standard Deviation|0.248|0.248|||
4055297|NCT01087970|3876864|B1|United States||Region of Enrollment||participants|Number|69|69.0||||||
4055298|NCT01087970|3876864|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4055299|NCT01087970|3876864|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4055300|NCT01087970|3876864|B1||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4055301|NCT01087970|3876864|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4055302|NCT01087970|3876864|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4055303|NCT01087970|3876864|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4055304|NCT01087970|3876864|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4055305|NCT01087970|3876864|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4055306|NCT01087970|3876864|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4055307|NCT01087970|3876864|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4055308|NCT01087970|3876864|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4055309|NCT01087970|3876864|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4055310|NCT01087970|3876864|B1|||Age||years|Mean|61.9|61.9|Standard Deviation|10.3|10.3|||
4055311|NCT01087957|3876874|B3|||Body Mass Index||kilograms/meters squared|Mean|28.61|28.61|Standard Deviation|5.04|5.04|||
4055312|NCT01087957|3876875|B2|||Body Mass Index||kilograms/meters squared|Mean|27.98|27.98|Standard Deviation|4.93|4.93|||
4055313|NCT01087957|3876876|B1|||Body Mass Index||kilograms/meters squared|Mean|29.21|29.21|Standard Deviation|5.08|5.08|||
4055314|NCT01087957|3876874|B3|||Beck Depression Inventory|The Beck Depression inventory is a 21-question multiple-choice self-report inventory used for measuring the severity of depression. Each of the 21 questions is scored on a scale value of 0 to 3. Total score thresholds recommendations are as follows: 0–13: minimal depression; 14–19: mild depression; 20–28: moderate depression; and 29–63: severe depression. Higher total scores indicate more severe depressive symptoms.|units on a scale|Mean|8.05|8.05|Standard Deviation|6.45|6.45|||
4055315|NCT01087957|3876875|B2|||Beck Depression Inventory|The Beck Depression inventory is a 21-question multiple-choice self-report inventory used for measuring the severity of depression. Each of the 21 questions is scored on a scale value of 0 to 3. Total score thresholds recommendations are as follows: 0–13: minimal depression; 14–19: mild depression; 20–28: moderate depression; and 29–63: severe depression. Higher total scores indicate more severe depressive symptoms.|units on a scale|Mean|7.98|7.98|Standard Deviation|6.32|6.32|||
4055316|NCT01087957|3876876|B1|||Beck Depression Inventory|The Beck Depression inventory is a 21-question multiple-choice self-report inventory used for measuring the severity of depression. Each of the 21 questions is scored on a scale value of 0 to 3. Total score thresholds recommendations are as follows: 0–13: minimal depression; 14–19: mild depression; 20–28: moderate depression; and 29–63: severe depression. Higher total scores indicate more severe depressive symptoms.|units on a scale|Mean|8.08|8.08|Standard Deviation|6.58|6.58|||
4055317|NCT01087957|3876874|B3|||Mini Mental Status Exam|The Mini Mental Status is a measure of cognitive function with a total possible score of 30 points. Any score greater than or equal to 27 points (out of 30) indicates a normal cognition. Below this, scores can indicate severe (≤9 points), moderate (10-18 points) or mild (19-24 points) cognitive impairment|units on a scale|Mean|27.54|27.54|Standard Deviation|2.65|2.65|||
4055376|NCT01087918|3876949|B1|||Weight||kg|Mean|80.8|80.8|Standard Deviation|15.9|15.9|||
4055377|NCT01087918|3876947|B3|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4055319|NCT01087957|3876876|B1|||Mini Mental Status Exam|The Mini Mental Status is a measure of cognitive function with a total possible score of 30 points. Any score greater than or equal to 27 points (out of 30) indicates a normal cognition. Below this, scores can indicate severe (≤9 points), moderate (10-18 points) or mild (19-24 points) cognitive impairment|units on a scale|Mean|27.49|27.49|Standard Deviation|2.83|2.83|||
4055320|NCT01087957|3876874|B3|||Initial Gait Speed||meters/second|Mean|.47|0.47|Standard Deviation|.21|0.21|||
4055321|NCT01087957|3876875|B2|||Initial Gait Speed||meters/second|Mean|.449|0.449|Standard Deviation|.22|0.22|||
4055322|NCT01087957|3876876|B1|||Initial Gait Speed||meters/second|Mean|.487|0.487|Standard Deviation|.21|0.21|||
4055323|NCT01087957|3876874|B3|||Time Post Onset of Stroke||years|Mean|6.88|6.88|Standard Deviation|6.53|6.53|||
4055324|NCT01087957|3876875|B2|||Time Post Onset of Stroke||years|Mean|6.90|6.9|Standard Deviation|6.43|6.43|||
4055325|NCT01087957|3876876|B1|||Time Post Onset of Stroke||years|Mean|6.86|6.86|Standard Deviation|6.64|6.64|||
4055326|NCT01087957|3876874|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4055327|NCT01087957|3876875|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4055328|NCT01087957|3876876|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4055329|NCT01087957|3876874|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4055330|NCT01087957|3876875|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4055331|NCT01087957|3876876|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4055332|NCT01087957|3876874|B3||White|Race (NIH/OMB)||Participants|Count of Participants|364|364.0||||||
4055333|NCT01087957|3876875|B2||White|Race (NIH/OMB)||Participants|Count of Participants|177|177.0||||||
4055334|NCT01087957|3876876|B1||White|Race (NIH/OMB)||Participants|Count of Participants|187|187.0||||||
4055335|NCT01087957|3876874|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
4055336|NCT01087957|3876875|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4055337|NCT01087957|3876876|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4055338|NCT01087957|3876874|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4055339|NCT01087957|3876875|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4055340|NCT01087957|3876876|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4055341|NCT01087957|3876874|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4055342|NCT01087957|3876875|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4055343|NCT01087957|3876876|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4055344|NCT01087957|3876874|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4055345|NCT01087957|3876875|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4055346|NCT01087957|3876876|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4055347|NCT01087957|3876874|B3||Male|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
4055348|NCT01087957|3876875|B2||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4055349|NCT01087957|3876876|B1||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4055350|NCT01087957|3876874|B3||Female|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4055351|NCT01087957|3876875|B2||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4055352|NCT01087957|3876876|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4055353|NCT01087957|3876874|B3|||Age||years|Mean|64.09|64.09|Standard Deviation|11.58|11.58|||
4055354|NCT01087957|3876875|B2|||Age||years|Mean|63.87|63.87|Standard Deviation|11.33|11.33|||
4055355|NCT01087957|3876876|B1|||Age||years|Mean|64.30|64.3|Standard Deviation|12.01|12.01|||
4055356|NCT01087944|3876903|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4055357|NCT01087944|3876903|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4055358|NCT01087944|3876903|B1|||Age||Years|Mean|49.5|49.5|Standard Deviation|10.60|10.6|||
4055359|NCT01087931|3876932|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4055360|NCT01087931|3876933|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4055361|NCT01087931|3876934|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4055362|NCT01087931|3876932|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4055363|NCT01087931|3876933|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4055364|NCT01087931|3876934|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4055365|NCT01087931|3876932|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4055366|NCT01087931|3876933|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4055367|NCT01087931|3876934|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4055368|NCT01087931|3876932|B3|||Age||years|Mean|64|64.0|Standard Deviation|10|10.0|||
4055369|NCT01087931|3876933|B2|||Age||years|Mean|62|62.0|Standard Deviation|8|8.0|||
4055370|NCT01087931|3876934|B1|||Age||years|Mean|66|66.0|Standard Deviation|12|12.0|||
4055371|NCT01087918|3876947|B3|||Height||m|Mean|1.72|1.72|Standard Deviation|0.086|0.086|||
4055372|NCT01087918|3876948|B2|||Height||m|Mean|1.67|1.67|Standard Deviation|0.075|0.075|||
4055373|NCT01087918|3876949|B1|||Height||m|Mean|1.76|1.76|Standard Deviation|0.077|0.077|||
4055374|NCT01087918|3876947|B3|||Weight||kg|Mean|76.0|76.0|Standard Deviation|16.4|16.4|||
4055375|NCT01087918|3876948|B2|||Weight||kg|Mean|70.0|70.0|Standard Deviation|17.1|17.1|||
4055378|NCT01087918|3876948|B2|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4055379|NCT01087918|3876949|B1|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4055380|NCT01087918|3876947|B3|Switzerland||Region of Enrollment||participants|Number|7|7.0||||||
4055381|NCT01087918|3876948|B2|Switzerland||Region of Enrollment||participants|Number|3|3.0||||||
4055382|NCT01087918|3876949|B1|Switzerland||Region of Enrollment||participants|Number|4|4.0||||||
4055383|NCT01087918|3876947|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4055384|NCT01087918|3876948|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4055385|NCT01087918|3876949|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4055386|NCT01087918|3876947|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4055387|NCT01087918|3876948|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4055388|NCT01087918|3876949|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4055389|NCT01087918|3876947|B3|||Age||years|Mean|59.0|59.0|Standard Deviation|11.1|11.1|||
4055390|NCT01087918|3876948|B2|||Age||years|Mean|59.3|59.3|Standard Deviation|12.8|12.8|||
4055391|NCT01087918|3876949|B1|||Age||years|Mean|58.8|58.8|Standard Deviation|11.1|11.1|||
4055392|NCT01087918|3876947|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4055393|NCT01087918|3876948|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4055394|NCT01087918|3876949|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4055395|NCT01087918|3876947|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4055396|NCT01087918|3876948|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4055397|NCT01087918|3876949|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4055398|NCT01087918|3876947|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4055399|NCT01087918|3876948|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4055400|NCT01087918|3876949|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4055401|NCT01087905|3876976|B9|United States||Region of Enrollment||participants|Number|987|987.0||||||
4055402|NCT01087905|3876977|B8|United States||Region of Enrollment||participants|Number|127|127.0||||||
4055403|NCT01087905|3876978|B7|United States||Region of Enrollment||participants|Number|121|121.0||||||
4055404|NCT01087905|3876979|B6|United States||Region of Enrollment||participants|Number|127|127.0||||||
4055405|NCT01087905|3876980|B5|United States||Region of Enrollment||participants|Number|122|122.0||||||
4055406|NCT01087905|3876981|B4|United States||Region of Enrollment||participants|Number|122|122.0||||||
4055407|NCT01087905|3876982|B3|United States||Region of Enrollment||participants|Number|123|123.0||||||
4055408|NCT01087905|3876983|B2|United States||Region of Enrollment||participants|Number|126|126.0||||||
4055409|NCT01087905|3876984|B1|United States||Region of Enrollment||participants|Number|119|119.0||||||
4055410|NCT01087905|3876976|B9||Male|Gender||Participants|Count of Participants|418|418.0||||||
4055411|NCT01087905|3876977|B8||Male|Gender||Participants|Count of Participants|48|48.0||||||
4055412|NCT01087905|3876978|B7||Male|Gender||Participants|Count of Participants|47|47.0||||||
4055413|NCT01087905|3876979|B6||Male|Gender||Participants|Count of Participants|55|55.0||||||
4055414|NCT01087905|3876980|B5||Male|Gender||Participants|Count of Participants|47|47.0||||||
4055415|NCT01087905|3876981|B4||Male|Gender||Participants|Count of Participants|52|52.0||||||
4055416|NCT01087905|3876982|B3||Male|Gender||Participants|Count of Participants|60|60.0||||||
4055417|NCT01087905|3876983|B2||Male|Gender||Participants|Count of Participants|61|61.0||||||
4055418|NCT01087905|3876984|B1||Male|Gender||Participants|Count of Participants|48|48.0||||||
4055419|NCT01087905|3876976|B9||Female|Gender||Participants|Count of Participants|569|569.0||||||
4055420|NCT01087905|3876977|B8||Female|Gender||Participants|Count of Participants|79|79.0||||||
4055421|NCT01087905|3876978|B7||Female|Gender||Participants|Count of Participants|74|74.0||||||
4055422|NCT01087905|3876979|B6||Female|Gender||Participants|Count of Participants|72|72.0||||||
4055423|NCT01087905|3876980|B5||Female|Gender||Participants|Count of Participants|75|75.0||||||
4055424|NCT01087905|3876981|B4||Female|Gender||Participants|Count of Participants|70|70.0||||||
4055425|NCT01087905|3876982|B3||Female|Gender||Participants|Count of Participants|63|63.0||||||
4055426|NCT01087905|3876983|B2||Female|Gender||Participants|Count of Participants|65|65.0||||||
4055427|NCT01087905|3876984|B1||Female|Gender||Participants|Count of Participants|71|71.0||||||
4055428|NCT01087905|3876976|B9|||Age||years|Mean|41.93|41.93|Standard Deviation|12.96|12.96|||
4055429|NCT01087905|3876977|B8|||Age||years|Mean|40.03|40.03|Standard Deviation|13.31|13.31|||
4055430|NCT01087905|3876978|B7|||Age||years|Mean|42.61|42.61|Standard Deviation|13.51|13.51|||
4055431|NCT01087905|3876979|B6|||Age||years|Mean|43.18|43.18|Standard Deviation|13.627|13.627|||
4055432|NCT01087905|3876980|B5|||Age||years|Mean|41.74|41.74|Standard Deviation|14.19|14.19|||
4055433|NCT01087905|3876981|B4|||Age||years|Mean|40.84|40.84|Standard Deviation|11.96|11.96|||
4055434|NCT01087905|3876982|B3|||Age||years|Mean|41.39|41.39|Standard Deviation|11.24|11.24|||
4055435|NCT01087905|3876983|B2|||Age||years|Mean|43.35|43.35|Standard Deviation|12.61|12.61|||
4055436|NCT01087905|3876984|B1|||Age||years|Mean|42.33|42.33|Standard Deviation|12.99|12.99|||
4055437|NCT01087905|3876976|B9||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4055438|NCT01087905|3876977|B8||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4055439|NCT01087905|3876978|B7||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4055440|NCT01087905|3876979|B6||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4055441|NCT01087905|3876980|B5||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4055442|NCT01087905|3876981|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4055443|NCT01087905|3876982|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4055444|NCT01087905|3876983|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4055445|NCT01087905|3876984|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4055446|NCT01087905|3876976|B9||Between 18 and 65 years|Age||Participants|Count of Participants|946|946.0||||||
4055447|NCT01087905|3876977|B8||Between 18 and 65 years|Age||Participants|Count of Participants|123|123.0||||||
4055448|NCT01087905|3876978|B7||Between 18 and 65 years|Age||Participants|Count of Participants|114|114.0||||||
4055449|NCT01087905|3876979|B6||Between 18 and 65 years|Age||Participants|Count of Participants|119|119.0||||||
4055450|NCT01087905|3876980|B5||Between 18 and 65 years|Age||Participants|Count of Participants|116|116.0||||||
4055451|NCT01087905|3876981|B4||Between 18 and 65 years|Age||Participants|Count of Participants|119|119.0||||||
4055452|NCT01087905|3876982|B3||Between 18 and 65 years|Age||Participants|Count of Participants|121|121.0||||||
4055453|NCT01087905|3876983|B2||Between 18 and 65 years|Age||Participants|Count of Participants|119|119.0||||||
4055454|NCT01087905|3876984|B1||Between 18 and 65 years|Age||Participants|Count of Participants|115|115.0||||||
4055455|NCT01087905|3876976|B9||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4055456|NCT01087905|3876977|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4055457|NCT01087905|3876978|B7||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4055458|NCT01087905|3876979|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4055459|NCT01087905|3876980|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4055460|NCT01087905|3876981|B4||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4055461|NCT01087905|3876982|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4055462|NCT01087905|3876983|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4055463|NCT01087905|3876984|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4055464|NCT01087814|3877011|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4055465|NCT01087814|3877012|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4055466|NCT01087814|3877013|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4055467|NCT01087814|3877011|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4055468|NCT01087814|3877012|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4055469|NCT01087814|3877013|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4055470|NCT01087814|3877011|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4055471|NCT01087814|3877012|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4055472|NCT01087814|3877013|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4055473|NCT01087814|3877011|B3|||Age||years|Mean|26|26.0|Standard Deviation|6.03324|6.03324|||
4055474|NCT01087814|3877012|B2|||Age||years|Mean|25.875|25.875|Standard Deviation|2.53194|2.53194|||
4055475|NCT01087814|3877013|B1|||Age||years|Mean|26.125|26.125|Standard Deviation|8.45893|8.45893|||
4055476|NCT01087814|3877011|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4055477|NCT01087814|3877012|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4055478|NCT01087814|3877013|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4055479|NCT01087814|3877011|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4055480|NCT01087814|3877012|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4055481|NCT01087814|3877013|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4055482|NCT01087814|3877011|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4055483|NCT01087814|3877012|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4055484|NCT01087814|3877013|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4055485|NCT01087801|3877020|B3|United States||Region of Enrollment||participants|Number|55|55.0||||||
4055486|NCT01087801|3877021|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4055487|NCT01087801|3877022|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4055488|NCT01087801|3877020|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4055489|NCT01087801|3877021|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4055490|NCT01087801|3877022|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4055491|NCT01087801|3877020|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4055492|NCT01087801|3877021|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4055493|NCT01087801|3877022|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4055494|NCT01087801|3877020|B3|||Age||years|Mean|48.3|48.3|Standard Deviation|13.7|13.7|||
4055495|NCT01087801|3877021|B2|||Age||years|Mean|47.2|47.2|Standard Deviation|12.3|12.3|||
4055496|NCT01087801|3877022|B1|||Age||years|Mean|49.6|49.6|Standard Deviation|15.5|15.5|||
4055497|NCT01087801|3877020|B3||>=65 years|Age|The demographic data represents the intent to treat group when data was provided in cases where no demographic data was provided for a parameter, the number of observations was correspondenly reduced.|Participants|Count of Participants|5|5.0||||||
4055498|NCT01087801|3877021|B2||>=65 years|Age|The demographic data represents the intent to treat group when data was provided in cases where no demographic data was provided for a parameter, the number of observations was correspondenly reduced.|Participants|Count of Participants|2|2.0||||||
4055499|NCT01087801|3877022|B1||>=65 years|Age|The demographic data represents the intent to treat group when data was provided in cases where no demographic data was provided for a parameter, the number of observations was correspondenly reduced.|Participants|Count of Participants|3|3.0||||||
4055500|NCT01087801|3877020|B3||Between 18 and 65 years|Age|The demographic data represents the intent to treat group when data was provided in cases where no demographic data was provided for a parameter, the number of observations was correspondenly reduced.|Participants|Count of Participants|50|50.0||||||
4055501|NCT01087801|3877021|B2||Between 18 and 65 years|Age|The demographic data represents the intent to treat group when data was provided in cases where no demographic data was provided for a parameter, the number of observations was correspondenly reduced.|Participants|Count of Participants|27|27.0||||||
4055502|NCT01087801|3877022|B1||Between 18 and 65 years|Age|The demographic data represents the intent to treat group when data was provided in cases where no demographic data was provided for a parameter, the number of observations was correspondenly reduced.|Participants|Count of Participants|23|23.0||||||
4055503|NCT01087801|3877020|B3||<=18 years|Age|The demographic data represents the intent to treat group when data was provided in cases where no demographic data was provided for a parameter, the number of observations was correspondenly reduced.|Participants|Count of Participants|0|0.0||||||
4055504|NCT01087801|3877021|B2||<=18 years|Age|The demographic data represents the intent to treat group when data was provided in cases where no demographic data was provided for a parameter, the number of observations was correspondenly reduced.|Participants|Count of Participants|0|0.0||||||
4055505|NCT01087801|3877022|B1||<=18 years|Age|The demographic data represents the intent to treat group when data was provided in cases where no demographic data was provided for a parameter, the number of observations was correspondenly reduced.|Participants|Count of Participants|0|0.0||||||
4055506|NCT01087788|3877029|B4||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4055507|NCT01087788|3877030|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4055508|NCT01087788|3877031|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4055509|NCT01087788|3877032|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4055510|NCT01087788|3877029|B4||Female|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
4055511|NCT01087788|3877030|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4055512|NCT01087788|3877031|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4055513|NCT01087788|3877032|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4055514|NCT01087788|3877029|B4|||Age||years|Mean|47.6|47.6|Standard Deviation|11.4|11.4|||
4055515|NCT01087788|3877030|B3|||Age||years|Mean|47.1|47.1|Standard Deviation|10.8|10.8|||
4055516|NCT01087788|3877031|B2|||Age||years|Mean|48.2|48.2|Standard Deviation|12.3|12.3|||
4055517|NCT01087788|3877032|B1|||Age||years|Mean|47.3|47.3|Standard Deviation|11.1|11.1|||
4055518|NCT01087788|3877029|B4||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4055519|NCT01087788|3877030|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4055520|NCT01087788|3877031|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4055521|NCT01087788|3877032|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4055522|NCT01087788|3877029|B4||Between 18 and 65 years|Age||Participants|Count of Participants|383|383.0||||||
4055523|NCT01087788|3877030|B3||Between 18 and 65 years|Age||Participants|Count of Participants|128|128.0||||||
4055524|NCT01087788|3877031|B2||Between 18 and 65 years|Age||Participants|Count of Participants|126|126.0||||||
4055525|NCT01087788|3877032|B1||Between 18 and 65 years|Age||Participants|Count of Participants|129|129.0||||||
4055526|NCT01087788|3877029|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4055527|NCT01087788|3877030|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4055528|NCT01087788|3877031|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4055529|NCT01087788|3877032|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4055530|NCT01087762|3877061|B4|||Height||centimeter (cm)|Mean|171.739|171.739|Standard Deviation|9.834|9.834|||
4055531|NCT01087762|3877062|B3|||Height||centimeter (cm)|Mean|172.753|172.753|Standard Deviation|9.607|9.607|||
4055532|NCT01087762|3877063|B2|||Height||centimeter (cm)|Mean|171.769|171.769|Standard Deviation|10.171|10.171|||
4055533|NCT01087762|3877064|B1|||Height||centimeter (cm)|Mean|170.704|170.704|Standard Deviation|9.692|9.692|||
4055534|NCT01087762|3877061|B4|||Weight||kilogram (kg)|Mean|81.757|81.757|Standard Deviation|18.576|18.576|||
4055535|NCT01087762|3877062|B3|||Weight||kilogram (kg)|Mean|83.893|83.893|Standard Deviation|18.855|18.855|||
4055536|NCT01087762|3877063|B2|||Weight||kilogram (kg)|Mean|79.305|79.305|Standard Deviation|18.599|18.599|||
4055537|NCT01087762|3877064|B1|||Weight||kilogram (kg)|Mean|82.142|82.142|Standard Deviation|18.147|18.147|||
4055538|NCT01087762|3877061|B4||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4055539|NCT01087762|3877062|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4055540|NCT01087762|3877063|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4055541|NCT01087762|3877064|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4055542|NCT01087762|3877061|B4||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4055543|NCT01087762|3877062|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4055544|NCT01087762|3877063|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4055545|NCT01087762|3877064|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4055546|NCT01087762|3877061|B4|Mean age||Age||years|Mean|39.6|39.6|Standard Deviation|11.9|11.9|||
4055547|NCT01087762|3877062|B3|Mean age||Age||years|Mean|39.8|39.8|Standard Deviation|39.9|39.9|||
4055548|NCT01087762|3877063|B2|Mean age||Age||years|Mean|39.1|39.1|Standard Deviation|11.9|11.9|||
4055549|NCT01087762|3877064|B1|Mean age||Age||years|Mean|39.9|39.9|Standard Deviation|12.4|12.4|||
4055550|NCT01087762|3877061|B4||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4055551|NCT01087762|3877062|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4055552|NCT01087762|3877063|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4055553|NCT01087762|3877064|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4055554|NCT01087762|3877061|B4||Between 18 and 65 years|Age||Participants|Count of Participants|317|317.0||||||
4055555|NCT01087762|3877062|B3||Between 18 and 65 years|Age||Participants|Count of Participants|105|105.0||||||
4055556|NCT01087762|3877063|B2||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
4055557|NCT01087762|3877064|B1||Between 18 and 65 years|Age||Participants|Count of Participants|102|102.0||||||
4055558|NCT01087762|3877061|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4055559|NCT01087762|3877062|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4055560|NCT01087762|3877063|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4055561|NCT01087762|3877064|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4055562|NCT01087736|3877114|B3|Arousal subscale||Baseline PTSD Symptomatology|The Clinician-Administered PTSD Checklist (CAPS) was used at baseline to assess PTSD symptoms at baseline. The PTSD Checklist is a measure of the 17 DSM-IV symptoms of PTSD. Respondents rate on a scale from 1 (not at all) to 5 (extremely) how much they were bothered by each symptom in the past month. A total symptom severity score (range = 17 - 85) can be obtained by summing the scores from the 17 items, with higher scores indicating greater severity of PTSD symptoms. Mean scores may be calculated for subscales of intrusion (range 5-25), avoidance (range 7-35), and arousal (range 5-25).|units on a scale|Mean|25.0|25.0|Standard Deviation|5.6|5.6|||
4055563|NCT01087736|3877115|B2|Arousal subscale||Baseline PTSD Symptomatology|The Clinician-Administered PTSD Checklist (CAPS) was used at baseline to assess PTSD symptoms at baseline. The PTSD Checklist is a measure of the 17 DSM-IV symptoms of PTSD. Respondents rate on a scale from 1 (not at all) to 5 (extremely) how much they were bothered by each symptom in the past month. A total symptom severity score (range = 17 - 85) can be obtained by summing the scores from the 17 items, with higher scores indicating greater severity of PTSD symptoms. Mean scores may be calculated for subscales of intrusion (range 5-25), avoidance (range 7-35), and arousal (range 5-25).|units on a scale|Mean|26.4|26.4|Standard Deviation|4.1|4.1|||
4055564|NCT01087736|3877116|B1|Arousal subscale||Baseline PTSD Symptomatology|The Clinician-Administered PTSD Checklist (CAPS) was used at baseline to assess PTSD symptoms at baseline. The PTSD Checklist is a measure of the 17 DSM-IV symptoms of PTSD. Respondents rate on a scale from 1 (not at all) to 5 (extremely) how much they were bothered by each symptom in the past month. A total symptom severity score (range = 17 - 85) can be obtained by summing the scores from the 17 items, with higher scores indicating greater severity of PTSD symptoms. Mean scores may be calculated for subscales of intrusion (range 5-25), avoidance (range 7-35), and arousal (range 5-25).|units on a scale|Mean|23.5|23.5|Standard Deviation|6.7|6.7|||
4055565|NCT01087736|3877114|B3|Avoidance subscale||Baseline PTSD Symptomatology|The Clinician-Administered PTSD Checklist (CAPS) was used at baseline to assess PTSD symptoms at baseline. The PTSD Checklist is a measure of the 17 DSM-IV symptoms of PTSD. Respondents rate on a scale from 1 (not at all) to 5 (extremely) how much they were bothered by each symptom in the past month. A total symptom severity score (range = 17 - 85) can be obtained by summing the scores from the 17 items, with higher scores indicating greater severity of PTSD symptoms. Mean scores may be calculated for subscales of intrusion (range 5-25), avoidance (range 7-35), and arousal (range 5-25).|units on a scale|Mean|33.1|33.1|Standard Deviation|7.8|7.8|||
4055566|NCT01087736|3877115|B2|Avoidance subscale||Baseline PTSD Symptomatology|The Clinician-Administered PTSD Checklist (CAPS) was used at baseline to assess PTSD symptoms at baseline. The PTSD Checklist is a measure of the 17 DSM-IV symptoms of PTSD. Respondents rate on a scale from 1 (not at all) to 5 (extremely) how much they were bothered by each symptom in the past month. A total symptom severity score (range = 17 - 85) can be obtained by summing the scores from the 17 items, with higher scores indicating greater severity of PTSD symptoms. Mean scores may be calculated for subscales of intrusion (range 5-25), avoidance (range 7-35), and arousal (range 5-25).|units on a scale|Mean|34.8|34.8|Standard Deviation|8.9|8.9|||
4055567|NCT01087736|3877116|B1|Avoidance subscale||Baseline PTSD Symptomatology|The Clinician-Administered PTSD Checklist (CAPS) was used at baseline to assess PTSD symptoms at baseline. The PTSD Checklist is a measure of the 17 DSM-IV symptoms of PTSD. Respondents rate on a scale from 1 (not at all) to 5 (extremely) how much they were bothered by each symptom in the past month. A total symptom severity score (range = 17 - 85) can be obtained by summing the scores from the 17 items, with higher scores indicating greater severity of PTSD symptoms. Mean scores may be calculated for subscales of intrusion (range 5-25), avoidance (range 7-35), and arousal (range 5-25).|units on a scale|Mean|31.1|31.1|Standard Deviation|6.1|6.1|||
4055568|NCT01087736|3877114|B3|Intrusion subscale||Baseline PTSD Symptomatology|The Clinician-Administered PTSD Checklist (CAPS) was used at baseline to assess PTSD symptoms at baseline. The PTSD Checklist is a measure of the 17 DSM-IV symptoms of PTSD. Respondents rate on a scale from 1 (not at all) to 5 (extremely) how much they were bothered by each symptom in the past month. A total symptom severity score (range = 17 - 85) can be obtained by summing the scores from the 17 items, with higher scores indicating greater severity of PTSD symptoms. Mean scores may be calculated for subscales of intrusion (range 5-25), avoidance (range 7-35), and arousal (range 5-25).|units on a scale|Mean|20.2|20.2|Standard Deviation|6.0|6.0|||
4055569|NCT01087736|3877115|B2|Intrusion subscale||Baseline PTSD Symptomatology|The Clinician-Administered PTSD Checklist (CAPS) was used at baseline to assess PTSD symptoms at baseline. The PTSD Checklist is a measure of the 17 DSM-IV symptoms of PTSD. Respondents rate on a scale from 1 (not at all) to 5 (extremely) how much they were bothered by each symptom in the past month. A total symptom severity score (range = 17 - 85) can be obtained by summing the scores from the 17 items, with higher scores indicating greater severity of PTSD symptoms. Mean scores may be calculated for subscales of intrusion (range 5-25), avoidance (range 7-35), and arousal (range 5-25).|units on a scale|Mean|21.9|21.9|Standard Deviation|6.9|6.9|||
4055582|NCT01087736|3877116|B1|||Percent heavy drinking days per week|"The Alcohol Timeline Followback (TLFB) is a drinking assessment interview that obtains estimates of daily drinking and has been evaluated with clinical and nonclinical populations. Using a calendar, people provided retrospective estimates of their daily drinking over the 90 day period prior to study screening.~HDD: day on which >4 (men) or >3 (women) standard alcoholic drinks were consumed Standard alcoholic drink defined as containing 13.6 g of pure alcohol."|percent days in a week|Mean|58.5|58.5|Standard Deviation|33.7|33.7|||
4055570|NCT01087736|3877116|B1|Intrusion subscale||Baseline PTSD Symptomatology|The Clinician-Administered PTSD Checklist (CAPS) was used at baseline to assess PTSD symptoms at baseline. The PTSD Checklist is a measure of the 17 DSM-IV symptoms of PTSD. Respondents rate on a scale from 1 (not at all) to 5 (extremely) how much they were bothered by each symptom in the past month. A total symptom severity score (range = 17 - 85) can be obtained by summing the scores from the 17 items, with higher scores indicating greater severity of PTSD symptoms. Mean scores may be calculated for subscales of intrusion (range 5-25), avoidance (range 7-35), and arousal (range 5-25).|units on a scale|Mean|18.2|18.2|Standard Deviation|4.3|4.3|||
4055571|NCT01087736|3877114|B3|PTSD total score||Baseline PTSD Symptomatology|The Clinician-Administered PTSD Checklist (CAPS) was used at baseline to assess PTSD symptoms at baseline. The PTSD Checklist is a measure of the 17 DSM-IV symptoms of PTSD. Respondents rate on a scale from 1 (not at all) to 5 (extremely) how much they were bothered by each symptom in the past month. A total symptom severity score (range = 17 - 85) can be obtained by summing the scores from the 17 items, with higher scores indicating greater severity of PTSD symptoms. Mean scores may be calculated for subscales of intrusion (range 5-25), avoidance (range 7-35), and arousal (range 5-25).|units on a scale|Mean|78.3|78.3|Standard Deviation|16.6|16.6|||
4055572|NCT01087736|3877115|B2|PTSD total score||Baseline PTSD Symptomatology|The Clinician-Administered PTSD Checklist (CAPS) was used at baseline to assess PTSD symptoms at baseline. The PTSD Checklist is a measure of the 17 DSM-IV symptoms of PTSD. Respondents rate on a scale from 1 (not at all) to 5 (extremely) how much they were bothered by each symptom in the past month. A total symptom severity score (range = 17 - 85) can be obtained by summing the scores from the 17 items, with higher scores indicating greater severity of PTSD symptoms. Mean scores may be calculated for subscales of intrusion (range 5-25), avoidance (range 7-35), and arousal (range 5-25).|units on a scale|Mean|83.1|83.1|Standard Deviation|17.3|17.3|||
4055573|NCT01087736|3877116|B1|PTSD total score||Baseline PTSD Symptomatology|The Clinician-Administered PTSD Checklist (CAPS) was used at baseline to assess PTSD symptoms at baseline. The PTSD Checklist is a measure of the 17 DSM-IV symptoms of PTSD. Respondents rate on a scale from 1 (not at all) to 5 (extremely) how much they were bothered by each symptom in the past month. A total symptom severity score (range = 17 - 85) can be obtained by summing the scores from the 17 items, with higher scores indicating greater severity of PTSD symptoms. Mean scores may be calculated for subscales of intrusion (range 5-25), avoidance (range 7-35), and arousal (range 5-25).|units on a scale|Mean|72.8|72.8|Standard Deviation|14.3|14.3|||
4055574|NCT01087736|3877114|B3|||Average drinks per drinking day|"The Alcohol Timeline Followback (TLFB) is a drinking assessment interview that obtains estimates of daily drinking and has been evaluated with clinical and nonclinical populations. Using a calendar, people provided retrospective estimates of their daily drinking over the 90 day period prior to study screening.~DD: day on which alcohol was consumed Standard alcoholic drink defined as containing 13.6 g of pure alcohol."|Drinks|Mean|11.0|11.0|Standard Deviation|5.3|5.3|||
4055575|NCT01087736|3877115|B2|||Average drinks per drinking day|"The Alcohol Timeline Followback (TLFB) is a drinking assessment interview that obtains estimates of daily drinking and has been evaluated with clinical and nonclinical populations. Using a calendar, people provided retrospective estimates of their daily drinking over the 90 day period prior to study screening.~DD: day on which alcohol was consumed Standard alcoholic drink defined as containing 13.6 g of pure alcohol."|Drinks|Mean|10.9|10.9|Standard Deviation|4.7|4.7|||
4055576|NCT01087736|3877116|B1|||Average drinks per drinking day|"The Alcohol Timeline Followback (TLFB) is a drinking assessment interview that obtains estimates of daily drinking and has been evaluated with clinical and nonclinical populations. Using a calendar, people provided retrospective estimates of their daily drinking over the 90 day period prior to study screening.~DD: day on which alcohol was consumed Standard alcoholic drink defined as containing 13.6 g of pure alcohol."|Drinks|Mean|11.1|11.1|Standard Deviation|6.1|6.1|||
4055577|NCT01087736|3877114|B3|||Average drinks per week|"The Alcohol Timeline Followback (TLFB) is a drinking assessment interview that obtains estimates of daily drinking and has been evaluated with clinical and nonclinical populations. Using a calendar, people provided retrospective estimates of their daily drinking over the 90 day period prior to study screening.~Standard alcoholic drink defined as containing 13.6 g of pure alcohol."|Drinks|Mean|55.5|55.5|Standard Deviation|29.4|29.4|||
4055578|NCT01087736|3877115|B2|||Average drinks per week|"The Alcohol Timeline Followback (TLFB) is a drinking assessment interview that obtains estimates of daily drinking and has been evaluated with clinical and nonclinical populations. Using a calendar, people provided retrospective estimates of their daily drinking over the 90 day period prior to study screening.~Standard alcoholic drink defined as containing 13.6 g of pure alcohol."|Drinks|Mean|58.2|58.2|Standard Deviation|25.4|25.4|||
4055579|NCT01087736|3877116|B1|||Average drinks per week|"The Alcohol Timeline Followback (TLFB) is a drinking assessment interview that obtains estimates of daily drinking and has been evaluated with clinical and nonclinical populations. Using a calendar, people provided retrospective estimates of their daily drinking over the 90 day period prior to study screening.~Standard alcoholic drink defined as containing 13.6 g of pure alcohol."|Drinks|Mean|52.4|52.4|Standard Deviation|34.2|34.2|||
4055580|NCT01087736|3877114|B3|||Percent heavy drinking days per week|"The Alcohol Timeline Followback (TLFB) is a drinking assessment interview that obtains estimates of daily drinking and has been evaluated with clinical and nonclinical populations. Using a calendar, people provided retrospective estimates of their daily drinking over the 90 day period prior to study screening.~HDD: day on which >4 (men) or >3 (women) standard alcoholic drinks were consumed Standard alcoholic drink defined as containing 13.6 g of pure alcohol."|percent days in a week|Mean|66.0|66.0|Standard Deviation|31.3|31.3|||
4055581|NCT01087736|3877115|B2|||Percent heavy drinking days per week|"The Alcohol Timeline Followback (TLFB) is a drinking assessment interview that obtains estimates of daily drinking and has been evaluated with clinical and nonclinical populations. Using a calendar, people provided retrospective estimates of their daily drinking over the 90 day period prior to study screening.~HDD: day on which >4 (men) or >3 (women) standard alcoholic drinks were consumed Standard alcoholic drink defined as containing 13.6 g of pure alcohol."|percent days in a week|Mean|72.6|72.6|Standard Deviation|28.5|28.5|||
4055605|NCT01087736|3877115|B2|Comorbid substance use disorder absent||Comorbid substance use disorder||participants|Number|11|11.0||||||
4055606|NCT01087736|3877116|B1|Comorbid substance use disorder absent||Comorbid substance use disorder||participants|Number|9|9.0||||||
4055583|NCT01087736|3877114|B3|||Percent drinking days per week|"The Alcohol Timeline Followback (TLFB) is a drinking assessment interview that obtains estimates of daily drinking and has been evaluated with clinical and nonclinical populations. Using a calendar, people provided retrospective estimates of their daily drinking over the 90 day period prior to study screening.~DD: day on which alcohol was consumed"|percent days in a week|Mean|77.1|77.1|Standard Deviation|25.8|25.8|||
4055584|NCT01087736|3877115|B2|||Percent drinking days per week|"The Alcohol Timeline Followback (TLFB) is a drinking assessment interview that obtains estimates of daily drinking and has been evaluated with clinical and nonclinical populations. Using a calendar, people provided retrospective estimates of their daily drinking over the 90 day period prior to study screening.~DD: day on which alcohol was consumed"|percent days in a week|Mean|80.4|80.4|Standard Deviation|21.5|21.5|||
4055585|NCT01087736|3877116|B1|||Percent drinking days per week|"The Alcohol Timeline Followback (TLFB) is a drinking assessment interview that obtains estimates of daily drinking and has been evaluated with clinical and nonclinical populations. Using a calendar, people provided retrospective estimates of their daily drinking over the 90 day period prior to study screening.~DD: day on which alcohol was consumed"|percent days in a week|Mean|73.3|73.3|Standard Deviation|30.3|30.3|||
4055586|NCT01087736|3877114|B3|||Alcohol Use Disorders Identification Test|The Alcohol Use Disorders Identification Test (AUDIT) score is the sum of 10 questions about alcohol consumption, each with scores ranging from 0 to 4, and total AUDIT score ranges from 0-40. Higher scores indicate greater likelihood of hazardous and harmful drinking, and may also reflect greater severity of alcohol problems and dependence, as well as a greater need for more intensive treatment.|units on a scale|Mean|24.9|24.9|Standard Deviation|7.8|7.8|||
4055587|NCT01087736|3877115|B2|||Alcohol Use Disorders Identification Test|The Alcohol Use Disorders Identification Test (AUDIT) score is the sum of 10 questions about alcohol consumption, each with scores ranging from 0 to 4, and total AUDIT score ranges from 0-40. Higher scores indicate greater likelihood of hazardous and harmful drinking, and may also reflect greater severity of alcohol problems and dependence, as well as a greater need for more intensive treatment.|units on a scale|Mean|23.0|23.0|Standard Deviation|7.5|7.5|||
4055588|NCT01087736|3877116|B1|||Alcohol Use Disorders Identification Test|The Alcohol Use Disorders Identification Test (AUDIT) score is the sum of 10 questions about alcohol consumption, each with scores ranging from 0 to 4, and total AUDIT score ranges from 0-40. Higher scores indicate greater likelihood of hazardous and harmful drinking, and may also reflect greater severity of alcohol problems and dependence, as well as a greater need for more intensive treatment.|units on a scale|Mean|27.1|27.1|Standard Deviation|7.9|7.9|||
4055589|NCT01087736|3877114|B3|||BAI|"The Beck Anxiety Inventory (BAI) consists of twenty-one questions about how the subject has been feeling in the last week, expressed as common symptoms of anxiety (such as numbness and tingling, sweating not due to heat, and fear of the worst happening).Each question has the same set of four possible answer choices, ranging from 0 to 3 points: NOT AT ALL (0), MILDLY (1), MODERATELY (2), SEVERELY (3). Total BAI scores range from 0 - 63, with higher scores indicating greater severity.~0-7: minimal level of anxiety 8-15: mild anxiety 16-25: moderate anxiety 26-63: severe anxiety"|units on a scale|Mean|24.0|24.0|Standard Deviation|13.3|13.3|||
4055590|NCT01087736|3877115|B2|||BAI|"The Beck Anxiety Inventory (BAI) consists of twenty-one questions about how the subject has been feeling in the last week, expressed as common symptoms of anxiety (such as numbness and tingling, sweating not due to heat, and fear of the worst happening).Each question has the same set of four possible answer choices, ranging from 0 to 3 points: NOT AT ALL (0), MILDLY (1), MODERATELY (2), SEVERELY (3). Total BAI scores range from 0 - 63, with higher scores indicating greater severity.~0-7: minimal level of anxiety 8-15: mild anxiety 16-25: moderate anxiety 26-63: severe anxiety"|units on a scale|Mean|27.4|27.4|Standard Deviation|13.3|13.3|||
4055591|NCT01087736|3877116|B1|||BAI|"The Beck Anxiety Inventory (BAI) consists of twenty-one questions about how the subject has been feeling in the last week, expressed as common symptoms of anxiety (such as numbness and tingling, sweating not due to heat, and fear of the worst happening).Each question has the same set of four possible answer choices, ranging from 0 to 3 points: NOT AT ALL (0), MILDLY (1), MODERATELY (2), SEVERELY (3). Total BAI scores range from 0 - 63, with higher scores indicating greater severity.~0-7: minimal level of anxiety 8-15: mild anxiety 16-25: moderate anxiety 26-63: severe anxiety"|units on a scale|Mean|20.4|20.4|Standard Deviation|12.7|12.7|||
4055592|NCT01087736|3877114|B3|||BDI|Depression was assessed using the Beck Depression Inventory, scores range from 0-63, with scores over 40 indicating severe depression and scores under 10 indicating normal mood symptoms.|units on a scale|Mean|24.9|24.9|Standard Deviation|11.9|11.9|||
4055593|NCT01087736|3877115|B2|||BDI|Depression was assessed using the Beck Depression Inventory, scores range from 0-63, with scores over 40 indicating severe depression and scores under 10 indicating normal mood symptoms.|units on a scale|Mean|26.3|26.3|Standard Deviation|12.3|12.3|||
4055594|NCT01087736|3877116|B1|||BDI|Depression was assessed using the Beck Depression Inventory, scores range from 0-63, with scores over 40 indicating severe depression and scores under 10 indicating normal mood symptoms.|units on a scale|Mean|23.4|23.4|Standard Deviation|11.6|11.6|||
4055595|NCT01087736|3877114|B3|No prior substance use disorder treatment||Prior treatment for substance use disorder||participants|Number|9|9.0||||||
4055596|NCT01087736|3877115|B2|No prior substance use disorder treatment||Prior treatment for substance use disorder||participants|Number|6|6.0||||||
4055597|NCT01087736|3877116|B1|No prior substance use disorder treatment||Prior treatment for substance use disorder||participants|Number|3|3.0||||||
4055598|NCT01087736|3877114|B3|Outpatient treatment||Prior treatment for substance use disorder||participants|Number|15|15.0||||||
4055599|NCT01087736|3877115|B2|Outpatient treatment||Prior treatment for substance use disorder||participants|Number|8|8.0||||||
4055600|NCT01087736|3877116|B1|Outpatient treatment||Prior treatment for substance use disorder||participants|Number|7|7.0||||||
4055601|NCT01087736|3877114|B3|Residential treatment||Prior treatment for substance use disorder||participants|Number|6|6.0||||||
4055602|NCT01087736|3877115|B2|Residential treatment||Prior treatment for substance use disorder||participants|Number|2|2.0||||||
4055603|NCT01087736|3877116|B1|Residential treatment||Prior treatment for substance use disorder||participants|Number|4|4.0||||||
4055604|NCT01087736|3877114|B3|Comorbid substance use disorder absent||Comorbid substance use disorder||participants|Number|20|20.0||||||
4055607|NCT01087736|3877114|B3|Comorbid substance use disorder present||Comorbid substance use disorder||participants|Number|10|10.0||||||
4055608|NCT01087736|3877115|B2|Comorbid substance use disorder present||Comorbid substance use disorder||participants|Number|5|5.0||||||
4055609|NCT01087736|3877116|B1|Comorbid substance use disorder present||Comorbid substance use disorder||participants|Number|5|5.0||||||
4055610|NCT01087736|3877114|B3|No combat exposure||History of combat exposure||participants|Number|8|8.0||||||
4055611|NCT01087736|3877115|B2|No combat exposure||History of combat exposure||participants|Number|4|4.0||||||
4055612|NCT01087736|3877116|B1|No combat exposure||History of combat exposure||participants|Number|4|4.0||||||
4055613|NCT01087736|3877114|B3|Combat exposure||History of combat exposure||participants|Number|22|22.0||||||
4055614|NCT01087736|3877115|B2|Combat exposure||History of combat exposure||participants|Number|12|12.0||||||
4055615|NCT01087736|3877116|B1|Combat exposure||History of combat exposure||participants|Number|10|10.0||||||
4055616|NCT01087736|3877114|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4055617|NCT01087736|3877115|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4055618|NCT01087736|3877116|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4055619|NCT01087736|3877114|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4055620|NCT01087736|3877115|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4055621|NCT01087736|3877116|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4055622|NCT01087736|3877114|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4055623|NCT01087736|3877115|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4055624|NCT01087736|3877116|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4055625|NCT01087736|3877114|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4055626|NCT01087736|3877115|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4055627|NCT01087736|3877116|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4055628|NCT01087736|3877114|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4055629|NCT01087736|3877115|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4055630|NCT01087736|3877116|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4055631|NCT01087736|3877114|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4055632|NCT01087736|3877115|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4055633|NCT01087736|3877116|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4055634|NCT01087736|3877114|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4055635|NCT01087736|3877115|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4055636|NCT01087736|3877116|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4055637|NCT01087736|3877114|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4055638|NCT01087736|3877115|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4055639|NCT01087736|3877116|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4055640|NCT01087736|3877114|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4055641|NCT01087736|3877115|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4055642|NCT01087736|3877116|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4055643|NCT01087736|3877114|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4055644|NCT01087736|3877115|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4055645|NCT01087736|3877116|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4055646|NCT01087736|3877114|B3|||Age||years|Mean|50|50.0|Standard Deviation|13.1|13.1|||
4055647|NCT01087736|3877115|B2|||Age||years|Mean|50.4|50.4|Standard Deviation|12.8|12.8|||
4055648|NCT01087736|3877116|B1|||Age||years|Mean|49.5|49.5|Standard Deviation|13.9|13.9|||
4055649|NCT01087723|3877125|B3|||Medical history: Participant Has Had Previous myocardial infarction (MI)||participants|Number|493|493.0||||||
4055650|NCT01087723|3877126|B2|||Medical history: Participant Has Had Previous myocardial infarction (MI)||participants|Number|113|113.0||||||
4055651|NCT01087723|3877127|B1|||Medical history: Participant Has Had Previous myocardial infarction (MI)||participants|Number|380|380.0||||||
4055652|NCT01087723|3877125|B3|||Medical history: Participant Has Hyperlipidemia|Participant has known hyperlipidemia or is on lipid-lowering drugs|participants|Number|815|815.0||||||
4055653|NCT01087723|3877126|B2|||Medical history: Participant Has Hyperlipidemia|Participant has known hyperlipidemia or is on lipid-lowering drugs|participants|Number|417|417.0||||||
4055654|NCT01087723|3877127|B1|||Medical history: Participant Has Hyperlipidemia|Participant has known hyperlipidemia or is on lipid-lowering drugs|participants|Number|398|398.0||||||
4055655|NCT01087723|3877125|B3|||Medical history: Participant Has Hypertension||participants|Number|963|963.0||||||
4055656|NCT01087723|3877126|B2|||Medical history: Participant Has Hypertension||participants|Number|504|504.0||||||
4055657|NCT01087723|3877127|B1|||Medical history: Participant Has Hypertension||participants|Number|459|459.0||||||
4055658|NCT01087723|3877125|B3|||Medical history: Participant Is a Current smoker (within past 30 days)||participants|Number|925|925.0||||||
4055659|NCT01087723|3877126|B2|||Medical history: Participant Is a Current smoker (within past 30 days)||participants|Number|472|472.0||||||
4055660|NCT01087723|3877127|B1|||Medical history: Participant Is a Current smoker (within past 30 days)||participants|Number|453|453.0||||||
4055661|NCT01087723|3877125|B3|||Medical history: Participant Has Diabetes||participants|Number|296|296.0||||||
4055662|NCT01087723|3877126|B2|||Medical history: Participant Has Diabetes||participants|Number|169|169.0||||||
4055663|NCT01087723|3877127|B1|||Medical history: Participant Has Diabetes||participants|Number|127|127.0||||||
4055664|NCT01087723|3877125|B3|Slovenia||Region of Enrollment||participants|Number|13|13.0||||||
4055665|NCT01087723|3877126|B2|Slovenia||Region of Enrollment||participants|Number|6|6.0||||||
4055666|NCT01087723|3877127|B1|Slovenia||Region of Enrollment||participants|Number|7|7.0||||||
4055667|NCT01087723|3877125|B3|Germany||Region of Enrollment||participants|Number|279|279.0||||||
4055668|NCT01087723|3877126|B2|Germany||Region of Enrollment||participants|Number|140|140.0||||||
4055669|NCT01087723|3877127|B1|Germany||Region of Enrollment||participants|Number|139|139.0||||||
4055670|NCT01087723|3877125|B3|France||Region of Enrollment||participants|Number|795|795.0||||||
4055671|NCT01087723|3877126|B2|France||Region of Enrollment||participants|Number|397|397.0||||||
4055672|NCT01087723|3877127|B1|France||Region of Enrollment||participants|Number|398|398.0||||||
4055673|NCT01087723|3877125|B3|Italy||Region of Enrollment||participants|Number|72|72.0||||||
4055674|NCT01087723|3877126|B2|Italy||Region of Enrollment||participants|Number|41|41.0||||||
4055675|NCT01087723|3877127|B1|Italy||Region of Enrollment||participants|Number|31|31.0||||||
4055676|NCT01087723|3877125|B3|Poland||Region of Enrollment||participants|Number|111|111.0||||||
4055677|NCT01087723|3877126|B2|Poland||Region of Enrollment||participants|Number|56|56.0||||||
4055678|NCT01087723|3877127|B1|Poland||Region of Enrollment||participants|Number|55|55.0||||||
4055679|NCT01087723|3877125|B3|Denmark||Region of Enrollment||participants|Number|150|150.0||||||
4055680|NCT01087723|3877126|B2|Denmark||Region of Enrollment||participants|Number|72|72.0||||||
4055681|NCT01087723|3877127|B1|Denmark||Region of Enrollment||participants|Number|78|78.0||||||
4055682|NCT01087723|3877125|B3|Netherlands||Region of Enrollment||participants|Number|768|768.0||||||
4055683|NCT01087723|3877126|B2|Netherlands||Region of Enrollment||participants|Number|391|391.0||||||
4055684|NCT01087723|3877127|B1|Netherlands||Region of Enrollment||participants|Number|377|377.0||||||
4055685|NCT01087723|3877125|B3|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
4055686|NCT01087723|3877126|B2|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
4055687|NCT01087723|3877127|B1|Czech Republic||Region of Enrollment||participants|Number|0|0.0||||||
4055688|NCT01087723|3877125|B3|Austria||Region of Enrollment||participants|Number|9|9.0||||||
4055689|NCT01087723|3877126|B2|Austria||Region of Enrollment||participants|Number|5|5.0||||||
4055690|NCT01087723|3877127|B1|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4055691|NCT01087723|3877125|B3||Male|Sex: Female, Male||Participants|Count of Participants|1675|1675.0||||||
4055692|NCT01087723|3877126|B2||Male|Sex: Female, Male||Participants|Count of Participants|861|861.0||||||
4055693|NCT01087723|3877127|B1||Male|Sex: Female, Male||Participants|Count of Participants|814|814.0||||||
4055694|NCT01087723|3877125|B3||Female|Sex: Female, Male||Participants|Count of Participants|523|523.0||||||
4055695|NCT01087723|3877126|B2||Female|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
4055696|NCT01087723|3877127|B1||Female|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4055697|NCT01087723|3877125|B3|||Age||years|Mean|61.7|61.7|Standard Deviation|13.0|13.0|||
4055698|NCT01087723|3877126|B2|||Age||years|Mean|62.0|62.0|Standard Deviation|13.1|13.1|||
4055699|NCT01087723|3877127|B1|||Age||years|Mean|61.4|61.4|Standard Deviation|12.8|12.8|||
4055700|NCT01087541|3877150|B3|Spain||Region of Enrollment||participants|Number|6830|6830.0||||||
4055701|NCT01087541|3877151|B2|Spain||Region of Enrollment||participants|Number|3523|3523.0||||||
4055702|NCT01087541|3877152|B1|Spain||Region of Enrollment||participants|Number|3307|3307.0||||||
4055703|NCT01087541|3877150|B3||Male|Sex: Female, Male||Participants|Count of Participants|2923|2923.0||||||
4055704|NCT01087541|3877151|B2||Male|Sex: Female, Male||Participants|Count of Participants|1523|1523.0||||||
4055705|NCT01087541|3877152|B1||Male|Sex: Female, Male||Participants|Count of Participants|1400|1400.0||||||
4055706|NCT01087541|3877150|B3||Female|Sex: Female, Male||Participants|Count of Participants|3907|3907.0||||||
4055707|NCT01087541|3877151|B2||Female|Sex: Female, Male||Participants|Count of Participants|2000|2000.0||||||
4055708|NCT01087541|3877152|B1||Female|Sex: Female, Male||Participants|Count of Participants|1907|1907.0||||||
4055709|NCT01087541|3877150|B3||>=65 years|Age||Participants|Count of Participants|842|842.0||||||
4055710|NCT01087541|3877151|B2||>=65 years|Age||Participants|Count of Participants|522|522.0||||||
4055711|NCT01087541|3877152|B1||>=65 years|Age||Participants|Count of Participants|320|320.0||||||
4055712|NCT01087541|3877150|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5988|5988.0||||||
4055713|NCT01087541|3877151|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3001|3001.0||||||
4055714|NCT01087541|3877152|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2987|2987.0||||||
4055715|NCT01087541|3877150|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4055716|NCT01087541|3877151|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4055717|NCT01087541|3877152|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4055718|NCT01087528|3877169|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4055719|NCT01087528|3877169|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4055720|NCT01087528|3877169|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4055721|NCT01087528|3877169|B1|||Age||years|Mean|60.22|60.22|Standard Deviation|6.87|6.87|||
4055722|NCT01087528|3877169|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4055723|NCT01087528|3877169|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4055724|NCT01087528|3877169|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4055725|NCT01087502|3877173|B3|<30 (severe or endstage renal impairment)||eGFR based on Modification of Diet in Renal Disease (MDRD) formula|eGFR based on FAS up to 12 weeks (N=123, 118, 241). eGFR means Estimated glomerular filtration rate.|participants|Number|81|81.0||||||
4055726|NCT01087502|3877174|B2|<30 (severe or endstage renal impairment)||eGFR based on Modification of Diet in Renal Disease (MDRD) formula|eGFR based on FAS up to 12 weeks (N=123, 118, 241). eGFR means Estimated glomerular filtration rate.|participants|Number|36|36.0||||||
4055727|NCT01087502|3877175|B1|<30 (severe or endstage renal impairment)||eGFR based on Modification of Diet in Renal Disease (MDRD) formula|eGFR based on FAS up to 12 weeks (N=123, 118, 241). eGFR means Estimated glomerular filtration rate.|participants|Number|45|45.0||||||
4055728|NCT01087502|3877173|B3|30 to <60 (moderate renal impairment)||eGFR based on Modification of Diet in Renal Disease (MDRD) formula|eGFR based on FAS up to 12 weeks (N=123, 118, 241). eGFR means Estimated glomerular filtration rate.|participants|Number|149|149.0||||||
4055729|NCT01087502|3877174|B2|30 to <60 (moderate renal impairment)||eGFR based on Modification of Diet in Renal Disease (MDRD) formula|eGFR based on FAS up to 12 weeks (N=123, 118, 241). eGFR means Estimated glomerular filtration rate.|participants|Number|76|76.0||||||
4055730|NCT01087502|3877175|B1|30 to <60 (moderate renal impairment)||eGFR based on Modification of Diet in Renal Disease (MDRD) formula|eGFR based on FAS up to 12 weeks (N=123, 118, 241). eGFR means Estimated glomerular filtration rate.|participants|Number|73|73.0||||||
4055731|NCT01087502|3877173|B3|60 to <90 (mild renal impairment)||eGFR based on Modification of Diet in Renal Disease (MDRD) formula|eGFR based on FAS up to 12 weeks (N=123, 118, 241). eGFR means Estimated glomerular filtration rate.|participants|Number|11|11.0||||||
4055732|NCT01087502|3877174|B2|60 to <90 (mild renal impairment)||eGFR based on Modification of Diet in Renal Disease (MDRD) formula|eGFR based on FAS up to 12 weeks (N=123, 118, 241). eGFR means Estimated glomerular filtration rate.|participants|Number|6|6.0||||||
4055733|NCT01087502|3877175|B1|60 to <90 (mild renal impairment)||eGFR based on Modification of Diet in Renal Disease (MDRD) formula|eGFR based on FAS up to 12 weeks (N=123, 118, 241). eGFR means Estimated glomerular filtration rate.|participants|Number|5|5.0||||||
4055734|NCT01087502|3877173|B3|>=90 (normal renal function)||eGFR based on Modification of Diet in Renal Disease (MDRD) formula|eGFR based on FAS up to 12 weeks (N=123, 118, 241). eGFR means Estimated glomerular filtration rate.|participants|Number|0|0.0||||||
4055735|NCT01087502|3877174|B2|>=90 (normal renal function)||eGFR based on Modification of Diet in Renal Disease (MDRD) formula|eGFR based on FAS up to 12 weeks (N=123, 118, 241). eGFR means Estimated glomerular filtration rate.|participants|Number|0|0.0||||||
4055736|NCT01087502|3877175|B1|>=90 (normal renal function)||eGFR based on Modification of Diet in Renal Disease (MDRD) formula|eGFR based on FAS up to 12 weeks (N=123, 118, 241). eGFR means Estimated glomerular filtration rate.|participants|Number|0|0.0||||||
4055737|NCT01087502|3877173|B3|<30 (severe or endstage renal impairment)||eGFR based on Modification of Diet in Renal Disease (MDRD) formula|eGFR based on FAS up to 52 weeks (N=122, 113, 235). eGFR means Estimated glomerular filtration rate.|Participants|Number|80|80.0||||||
4055738|NCT01087502|3877174|B2|<30 (severe or endstage renal impairment)||eGFR based on Modification of Diet in Renal Disease (MDRD) formula|eGFR based on FAS up to 52 weeks (N=122, 113, 235). eGFR means Estimated glomerular filtration rate.|Participants|Number|35|35.0||||||
4055739|NCT01087502|3877175|B1|<30 (severe or endstage renal impairment)||eGFR based on Modification of Diet in Renal Disease (MDRD) formula|eGFR based on FAS up to 52 weeks (N=122, 113, 235). eGFR means Estimated glomerular filtration rate.|Participants|Number|45|45.0||||||
4055740|NCT01087502|3877173|B3|30 to <60 (moderate renal impairment)||eGFR based on Modification of Diet in Renal Disease (MDRD) formula|eGFR based on FAS up to 52 weeks (N=122, 113, 235). eGFR means Estimated glomerular filtration rate.|Participants|Number|145|145.0||||||
4055741|NCT01087502|3877174|B2|30 to <60 (moderate renal impairment)||eGFR based on Modification of Diet in Renal Disease (MDRD) formula|eGFR based on FAS up to 52 weeks (N=122, 113, 235). eGFR means Estimated glomerular filtration rate.|Participants|Number|72|72.0||||||
4055742|NCT01087502|3877175|B1|30 to <60 (moderate renal impairment)||eGFR based on Modification of Diet in Renal Disease (MDRD) formula|eGFR based on FAS up to 52 weeks (N=122, 113, 235). eGFR means Estimated glomerular filtration rate.|Participants|Number|73|73.0||||||
4055743|NCT01087502|3877173|B3|60 to <90 (mild renal impairment)||eGFR based on Modification of Diet in Renal Disease (MDRD) formula|eGFR based on FAS up to 52 weeks (N=122, 113, 235). eGFR means Estimated glomerular filtration rate.|Participants|Number|10|10.0||||||
4055744|NCT01087502|3877174|B2|60 to <90 (mild renal impairment)||eGFR based on Modification of Diet in Renal Disease (MDRD) formula|eGFR based on FAS up to 52 weeks (N=122, 113, 235). eGFR means Estimated glomerular filtration rate.|Participants|Number|6|6.0||||||
4055745|NCT01087502|3877175|B1|60 to <90 (mild renal impairment)||eGFR based on Modification of Diet in Renal Disease (MDRD) formula|eGFR based on FAS up to 52 weeks (N=122, 113, 235). eGFR means Estimated glomerular filtration rate.|Participants|Number|4|4.0||||||
4055746|NCT01087502|3877173|B3|>=90 (normal renal function)||eGFR based on Modification of Diet in Renal Disease (MDRD) formula|eGFR based on FAS up to 52 weeks (N=122, 113, 235). eGFR means Estimated glomerular filtration rate.|Participants|Number|0|0.0||||||
4055747|NCT01087502|3877174|B2|>=90 (normal renal function)||eGFR based on Modification of Diet in Renal Disease (MDRD) formula|eGFR based on FAS up to 52 weeks (N=122, 113, 235). eGFR means Estimated glomerular filtration rate.|Participants|Number|0|0.0||||||
4055748|NCT01087502|3877175|B1|>=90 (normal renal function)||eGFR based on Modification of Diet in Renal Disease (MDRD) formula|eGFR based on FAS up to 52 weeks (N=122, 113, 235). eGFR means Estimated glomerular filtration rate.|Participants|Number|0|0.0||||||
4055749|NCT01087502|3877173|B3|||Fasting Plasma Glucose (FPG)|FPG based on FAS up to 12 weeks (N=121, 117, 238)|mg/dL|Mean|151.8|151.8|Standard Deviation|49.7|49.7|||
4055750|NCT01087502|3877174|B2|||Fasting Plasma Glucose (FPG)|FPG based on FAS up to 12 weeks (N=121, 117, 238)|mg/dL|Mean|154.4|154.4|Standard Deviation|46.1|46.1|||
4055751|NCT01087502|3877175|B1|||Fasting Plasma Glucose (FPG)|FPG based on FAS up to 12 weeks (N=121, 117, 238)|mg/dL|Mean|149.3|149.3|Standard Deviation|53.0|53.0|||
4055752|NCT01087502|3877173|B3|||Fasting Plasma Glucose (FPG)|FPG based on Full analysis set (FAS) up to 52 weeks (N=120, 113, 233)|mg/dL|Mean|152.4|152.4|Standard Deviation|49.6|49.6|||
4055753|NCT01087502|3877174|B2|||Fasting Plasma Glucose (FPG)|FPG based on Full analysis set (FAS) up to 52 weeks (N=120, 113, 233)|mg/dL|Mean|155.3|155.3|Standard Deviation|45.6|45.6|||
4055754|NCT01087502|3877175|B1|||Fasting Plasma Glucose (FPG)|FPG based on Full analysis set (FAS) up to 52 weeks (N=120, 113, 233)|mg/dL|Mean|149.7|149.7|Standard Deviation|53.1|53.1|||
4055755|NCT01087502|3877173|B3|||Glycosylated Hemoglobin A1 (HbA1c)|HbA1c based on Full analysis set (FAS) up to 12 weeks (N=121, 117, 238)|Percent|Mean|8.05|8.05|Standard Deviation|0.91|0.91|||
4055756|NCT01087502|3877174|B2|||Glycosylated Hemoglobin A1 (HbA1c)|HbA1c based on Full analysis set (FAS) up to 12 weeks (N=121, 117, 238)|Percent|Mean|8.08|8.08|Standard Deviation|0.88|0.88|||
4055757|NCT01087502|3877175|B1|||Glycosylated Hemoglobin A1 (HbA1c)|HbA1c based on Full analysis set (FAS) up to 12 weeks (N=121, 117, 238)|Percent|Mean|8.02|8.02|Standard Deviation|0.94|0.94|||
4055758|NCT01087502|3877173|B3|||Glycosylated Hemoglobin A1 (HbA1c)|HbA1c based on Full analysis set (FAS) up to 52 weeks (N=120, 113, 233)|Percent|Mean|8.05|8.05|Standard Deviation|0.91|0.91|||
4055759|NCT01087502|3877174|B2|||Glycosylated Hemoglobin A1 (HbA1c)|HbA1c based on Full analysis set (FAS) up to 52 weeks (N=120, 113, 233)|Percent|Mean|8.08|8.08|Standard Deviation|0.89|0.89|||
4055760|NCT01087502|3877175|B1|||Glycosylated Hemoglobin A1 (HbA1c)|HbA1c based on Full analysis set (FAS) up to 52 weeks (N=120, 113, 233)|Percent|Mean|8.03|8.03|Standard Deviation|0.94|0.94|||
4055761|NCT01087502|3877173|B3|||Body mass index (BMI) continuous|BMI for patient set up to 12 weeks (N=123, 118, 241)|kg/m^2|Mean|32.06|32.06|Standard Deviation|6.19|6.19|||
4055762|NCT01087502|3877174|B2|||Body mass index (BMI) continuous|BMI for patient set up to 12 weeks (N=123, 118, 241)|kg/m^2|Mean|32.20|32.2|Standard Deviation|6.13|6.13|||
4055763|NCT01087502|3877175|B1|||Body mass index (BMI) continuous|BMI for patient set up to 12 weeks (N=123, 118, 241)|kg/m^2|Mean|31.93|31.93|Standard Deviation|6.27|6.27|||
4055764|NCT01087502|3877173|B3|||Body mass index (BMI) continuous|BMI for patient set up to 52 weeks.|kg/m^2|Mean|32.09|32.09|Standard Deviation|6.13|6.13|||
4055765|NCT01087502|3877174|B2|||Body mass index (BMI) continuous|BMI for patient set up to 52 weeks.|kg/m^2|Mean|32.22|32.22|Standard Deviation|5.99|5.99|||
4055766|NCT01087502|3877175|B1|||Body mass index (BMI) continuous|BMI for patient set up to 52 weeks.|kg/m^2|Mean|31.97|31.97|Standard Deviation|6.28|6.28|||
4055767|NCT01087502|3877173|B3|Male||Gender|Gender for patient set up to 12 weeks (N=123, 118, 241)|participants|Number|154|154.0||||||
4055768|NCT01087502|3877174|B2|Male||Gender|Gender for patient set up to 12 weeks (N=123, 118, 241)|participants|Number|74|74.0||||||
4055769|NCT01087502|3877175|B1|Male||Gender|Gender for patient set up to 12 weeks (N=123, 118, 241)|participants|Number|80|80.0||||||
4055770|NCT01087502|3877173|B3|Female||Gender|Gender for patient set up to 12 weeks (N=123, 118, 241)|participants|Number|87|87.0||||||
4055771|NCT01087502|3877174|B2|Female||Gender|Gender for patient set up to 12 weeks (N=123, 118, 241)|participants|Number|44|44.0||||||
4055772|NCT01087502|3877175|B1|Female||Gender|Gender for patient set up to 12 weeks (N=123, 118, 241)|participants|Number|43|43.0||||||
4055773|NCT01087502|3877173|B3||Male|Sex: Female, Male|Gender for patient set up to 52 weeks.|Participants|Count of Participants|149|149.0||||||
4055774|NCT01087502|3877174|B2||Male|Sex: Female, Male|Gender for patient set up to 52 weeks.|Participants|Count of Participants|70|70.0||||||
4055775|NCT01087502|3877175|B1||Male|Sex: Female, Male|Gender for patient set up to 52 weeks.|Participants|Count of Participants|79|79.0||||||
4055776|NCT01087502|3877173|B3||Female|Sex: Female, Male|Gender for patient set up to 52 weeks.|Participants|Count of Participants|86|86.0||||||
4055777|NCT01087502|3877174|B2||Female|Sex: Female, Male|Gender for patient set up to 52 weeks.|Participants|Count of Participants|43|43.0||||||
4055778|NCT01087502|3877175|B1||Female|Sex: Female, Male|Gender for patient set up to 52 weeks.|Participants|Count of Participants|43|43.0||||||
4055779|NCT01087502|3877173|B3|||Age|Age Continuous for patient set up to 12 weeks (N=123, 118, 241)|years|Mean|66.2|66.2|Standard Deviation|9.7|9.7|||
4055780|NCT01087502|3877174|B2|||Age|Age Continuous for patient set up to 12 weeks (N=123, 118, 241)|years|Mean|66.9|66.9|Standard Deviation|9.4|9.4|||
4055781|NCT01087502|3877175|B1|||Age|Age Continuous for patient set up to 12 weeks (N=123, 118, 241)|years|Mean|65.6|65.6|Standard Deviation|10.0|10.0|||
4055782|NCT01087502|3877173|B3|||Age|Age Continuous for patient set up to 52 weeks|Years|Mean|66.6|66.6|Standard Deviation|9.3|9.3|||
4055783|NCT01087502|3877174|B2|||Age|Age Continuous for patient set up to 52 weeks|Years|Mean|67.3|67.3|Standard Deviation|9.2|9.2|||
4055784|NCT01087502|3877175|B1|||Age|Age Continuous for patient set up to 52 weeks|Years|Mean|65.9|65.9|Standard Deviation|9.4|9.4|||
4055785|NCT01087489|3877195|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
4055786|NCT01087489|3877195|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4055787|NCT01087489|3877195|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4055788|NCT01087489|3877195|B1|||Age||years|Mean|74|74.0|Standard Deviation|12|12.0|||
4055789|NCT01087489|3877195|B1||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
4055790|NCT01087489|3877195|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4055791|NCT01087489|3877195|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4055792|NCT01086969|3877206|B4|India||Region of Enrollment||Participants|Number|300|300.0||||||
4055793|NCT01086969|3877207|B3|India||Region of Enrollment||Participants|Number|100|100.0||||||
4055794|NCT01086969|3877208|B2|India||Region of Enrollment||Participants|Number|100|100.0||||||
4055795|NCT01086969|3877209|B1|India||Region of Enrollment||Participants|Number|100|100.0||||||
4055796|NCT01086969|3877206|B4||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4055797|NCT01086969|3877207|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4055798|NCT01086969|3877208|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4055799|NCT01086969|3877209|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4055800|NCT01086969|3877206|B4||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4055801|NCT01086969|3877207|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4055802|NCT01086969|3877208|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4055803|NCT01086969|3877209|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4055804|NCT01086969|3877206|B4|||Age||Years|Mean|18.7|18.7|Standard Deviation|13.1|13.1|||
4055805|NCT01086969|3877207|B3|||Age||Years|Mean|34.8|34.8|Standard Deviation|9.2|9.2|||
4055806|NCT01086969|3877208|B2|||Age||Years|Mean|14.2|14.2|Standard Deviation|1.4|1.4|||
4055807|NCT01086969|3877209|B1|||Age||Years|Mean|7.2|7.2|Standard Deviation|3.1|3.1|||
4055808|NCT01086969|3877206|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4055809|NCT01086969|3877207|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4055810|NCT01086969|3877208|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4055811|NCT01086969|3877209|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4055812|NCT01086969|3877206|B4||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4055813|NCT01086969|3877207|B3||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4055814|NCT01086969|3877208|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4055815|NCT01086969|3877209|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4055816|NCT01086969|3877206|B4||<=18 years|Age||Participants|Count of Participants|200|200.0||||||
4055817|NCT01086969|3877207|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4055818|NCT01086969|3877208|B2||<=18 years|Age||Participants|Count of Participants|100|100.0||||||
4055819|NCT01086969|3877209|B1||<=18 years|Age||Participants|Count of Participants|100|100.0||||||
4055820|NCT01086852|3877228|B1|||FX:C at diagnosis (IU/dL)||IU/dL|Median|7.5|7.5|Full Range|||7.0|8.0|
4055821|NCT01086852|3877228|B1|India||Region of Enrollment||participants|Number|0|0.0||||||
4055822|NCT01086852|3877228|B1|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4055823|NCT01086852|3877228|B1|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4055824|NCT01086852|3877228|B1|Turkey||Region of Enrollment||participants|Number|0|0.0||||||
4055825|NCT01086852|3877228|B1|Spain||Region of Enrollment||participants|Number|0|0.0||||||
4055826|NCT01086852|3877228|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4055827|NCT01086852|3877228|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4055828|NCT01086852|3877228|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4055829|NCT01086852|3877228|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4055830|NCT01086852|3877228|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4055831|NCT01086852|3877228|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4055832|NCT01086852|3877228|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4055833|NCT01086852|3877228|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4055834|NCT01086852|3877228|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4055835|NCT01086852|3877228|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4055836|NCT01086852|3877228|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4055837|NCT01086852|3877228|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4055838|NCT01086852|3877228|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4055839|NCT01086852|3877228|B1|||Age||years|Median|57|57.0|Full Range|||55.0|59.0|
4055840|NCT01086852|3877228|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4055841|NCT01086852|3877228|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4055842|NCT01086852|3877228|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4055843|NCT01086761|3877239|B6||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4055844|NCT01086761|3877240|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4055845|NCT01086761|3877241|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4055846|NCT01086761|3877242|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4055847|NCT01086761|3877243|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4055848|NCT01086761|3877244|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4055849|NCT01086761|3877239|B6||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4055850|NCT01086761|3877240|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4055851|NCT01086761|3877241|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4055852|NCT01086761|3877242|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4055853|NCT01086761|3877243|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4055854|NCT01086761|3877244|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4055855|NCT01086761|3877239|B6|||Age||Years|Mean|78.3|78.3|Standard Deviation|5.3|5.3|||
4055856|NCT01086761|3877240|B5|||Age||Years|Mean|77.8|77.8|Standard Deviation|9.4|9.4|||
4055857|NCT01086761|3877241|B4|||Age||Years|Mean|79.0|79.0|Standard Deviation|3.0|3.0|||
4055858|NCT01086761|3877242|B3|||Age||Years|Mean|77.5|77.5|Standard Deviation|6.0|6.0|||
4055859|NCT01086761|3877243|B2|||Age||Years|Mean|78.6|78.6|Standard Deviation|3.2|3.2|||
4055860|NCT01086761|3877244|B1|||Age||Years|Mean|78.2|78.2|Standard Deviation|6.3|6.3|||
4055861|NCT01086605|3877287|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
4055862|NCT01086605|3877288|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4055863|NCT01086605|3877289|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4055864|NCT01086605|3877287|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4055865|NCT01086605|3877288|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4055866|NCT01086605|3877289|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4055867|NCT01086605|3877287|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4055868|NCT01086605|3877288|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4055869|NCT01086605|3877289|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4055870|NCT01086605|3877287|B3|||Age||years|Median|55.5|55.5|Full Range|||38.0|79.0|
4055871|NCT01086605|3877288|B2|||Age||years|Median|52.5|52.5|Full Range|||38.0|75.0|
4055872|NCT01086605|3877289|B1|||Age||years|Median|56.5|56.5|Full Range|||42.0|79.0|
4055873|NCT01086475|3877305|B3|United States||Region of Enrollment||participants|Number|67|67.0||||||
4055874|NCT01086475|3877306|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4055875|NCT01086475|3877307|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4055876|NCT01086475|3877305|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4055877|NCT01086475|3877306|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4055878|NCT01086475|3877307|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4055879|NCT01086475|3877305|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4055880|NCT01086475|3877306|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4055881|NCT01086475|3877307|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4055882|NCT01086475|3877305|B3|||Age||Years|Mean|8.41|8.41|Standard Deviation|1.78|1.78|||
4055883|NCT01086475|3877306|B2|||Age||Years|Mean|8.34|8.34|Standard Deviation|1.70|1.7|||
4055884|NCT01086475|3877307|B1|||Age||Years|Mean|8.49|8.49|Standard Deviation|1.88|1.88|||
4055885|NCT01086475|3877305|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4055886|NCT01086475|3877306|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4055887|NCT01086475|3877307|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4055888|NCT01086475|3877305|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4055889|NCT01086475|3877306|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4055890|NCT01086475|3877307|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4055891|NCT01086475|3877305|B3||<=18 years|Age||Participants|Count of Participants|67|67.0||||||
4055892|NCT01086475|3877306|B2||<=18 years|Age||Participants|Count of Participants|33|33.0||||||
4055893|NCT01086475|3877307|B1||<=18 years|Age||Participants|Count of Participants|34|34.0||||||
4055894|NCT01086423|3877318|B4|Asian-Chinese heritage||Race/Ethnicity, Customized||Participants|Count of Participants|984|984.0||||||
4055895|NCT01086423|3877319|B3|Asian-Chinese heritage||Race/Ethnicity, Customized||Participants|Count of Participants|330|330.0||||||
4055896|NCT01086423|3877320|B2|Asian-Chinese heritage||Race/Ethnicity, Customized||Participants|Count of Participants|324|324.0||||||
4055897|NCT01086423|3877321|B1|Asian-Chinese heritage||Race/Ethnicity, Customized||Participants|Count of Participants|330|330.0||||||
4055898|NCT01086423|3877318|B4||Male|Sex: Female, Male||Participants|Count of Participants|541|541.0||||||
4055899|NCT01086423|3877319|B3||Male|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4055900|NCT01086423|3877320|B2||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4055901|NCT01086423|3877321|B1||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4055902|NCT01086423|3877318|B4||Female|Sex: Female, Male||Participants|Count of Participants|443|443.0||||||
4055903|NCT01086423|3877319|B3||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4055904|NCT01086423|3877320|B2||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4055905|NCT01086423|3877321|B1||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4055906|NCT01086423|3877318|B4|||Age||Weeks|Mean|11.35|11.35|Standard Deviation|2.36|2.36|||
4055907|NCT01086423|3877319|B3|||Age||Weeks|Mean|9.9|9.9|Standard Deviation|1.17|1.17|||
4055908|NCT01086423|3877320|B2|||Age||Weeks|Mean|14.3|14.3|Standard Deviation|1.14|1.14|||
4055909|NCT01086423|3877321|B1|||Age||Weeks|Mean|9.9|9.9|Standard Deviation|1.12|1.12|||
4055910|NCT01086410|3877364|B5|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|179|179.0||||||
4055911|NCT01086410|3877365|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4055912|NCT01086410|3877366|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|53|53.0||||||
4055913|NCT01086410|3877367|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|56|56.0||||||
4055914|NCT01086410|3877368|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|55|55.0||||||
4055915|NCT01086410|3877364|B5|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4055916|NCT01086410|3877365|B4|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4055917|NCT01086410|3877366|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4055918|NCT01086410|3877367|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4055919|NCT01086410|3877368|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4055920|NCT01086410|3877364|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4055921|NCT01086410|3877365|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4055922|NCT01086410|3877366|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4055923|NCT01086410|3877367|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4055924|NCT01086410|3877368|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4055925|NCT01086410|3877364|B5|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4055926|NCT01086410|3877365|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4055927|NCT01086410|3877366|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4055928|NCT01086410|3877367|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4055929|NCT01086410|3877368|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4055930|NCT01086410|3877364|B5||Male|Gender||Participants|Count of Participants|98|98.0||||||
4055931|NCT01086410|3877365|B4||Male|Gender||Participants|Count of Participants|9|9.0||||||
4055932|NCT01086410|3877366|B3||Male|Gender||Participants|Count of Participants|33|33.0||||||
4055933|NCT01086410|3877367|B2||Male|Gender||Participants|Count of Participants|25|25.0||||||
4055934|NCT01086410|3877368|B1||Male|Gender||Participants|Count of Participants|31|31.0||||||
4055935|NCT01086410|3877364|B5||Female|Gender||Participants|Count of Participants|87|87.0||||||
4055936|NCT01086410|3877365|B4||Female|Gender||Participants|Count of Participants|6|6.0||||||
4055937|NCT01086410|3877366|B3||Female|Gender||Participants|Count of Participants|23|23.0||||||
4055938|NCT01086410|3877367|B2||Female|Gender||Participants|Count of Participants|31|31.0||||||
4055939|NCT01086410|3877368|B1||Female|Gender||Participants|Count of Participants|27|27.0||||||
4055940|NCT01086410|3877364|B5|||Age||Years|Mean|35.1|35.1|Standard Deviation|14.82|14.82|||
4055941|NCT01086410|3877365|B4|||Age||Years|Mean|37.5|37.5|Standard Deviation|14.19|14.19|||
4055942|NCT01086410|3877366|B3|||Age||Years|Mean|34.0|34.0|Standard Deviation|13.74|13.74|||
4055943|NCT01086410|3877367|B2|||Age||Years|Mean|34.4|34.4|Standard Deviation|15.63|15.63|||
4055944|NCT01086410|3877368|B1|||Age||Years|Mean|36.1|36.1|Standard Deviation|15.42|15.42|||
4055945|NCT01086384|3877465|B3|Mixed Race||Race/Ethnicity, Customized|Baseline characteristic data were collected in members of the Intent-to-Treat Population, comprised of all participants randomized to treatment who received at least one dose of study medication.|participants|Number|212|212.0||||||
4055946|NCT01086384|3877466|B2|Mixed Race||Race/Ethnicity, Customized|Baseline characteristic data were collected in members of the Intent-to-Treat Population, comprised of all participants randomized to treatment who received at least one dose of study medication.|participants|Number|108|108.0||||||
4055947|NCT01086384|3877467|B1|Mixed Race||Race/Ethnicity, Customized|Baseline characteristic data were collected in members of the Intent-to-Treat Population, comprised of all participants randomized to treatment who received at least one dose of study medication.|participants|Number|104|104.0||||||
4055948|NCT01086384|3877465|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|Baseline characteristic data were collected in members of the Intent-to-Treat Population, comprised of all participants randomized to treatment who received at least one dose of study medication.|participants|Number|1476|1476.0||||||
4055949|NCT01086384|3877466|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|Baseline characteristic data were collected in members of the Intent-to-Treat Population, comprised of all participants randomized to treatment who received at least one dose of study medication.|participants|Number|738|738.0||||||
4055950|NCT01086384|3877467|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|Baseline characteristic data were collected in members of the Intent-to-Treat Population, comprised of all participants randomized to treatment who received at least one dose of study medication.|participants|Number|738|738.0||||||
4055951|NCT01086384|3877465|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized|Baseline characteristic data were collected in members of the Intent-to-Treat Population, comprised of all participants randomized to treatment who received at least one dose of study medication.|participants|Number|7|7.0||||||
4055952|NCT01086384|3877466|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized|Baseline characteristic data were collected in members of the Intent-to-Treat Population, comprised of all participants randomized to treatment who received at least one dose of study medication.|participants|Number|2|2.0||||||
4055953|NCT01086384|3877467|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized|Baseline characteristic data were collected in members of the Intent-to-Treat Population, comprised of all participants randomized to treatment who received at least one dose of study medication.|participants|Number|5|5.0||||||
4055954|NCT01086384|3877465|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|Baseline characteristic data were collected in members of the Intent-to-Treat Population, comprised of all participants randomized to treatment who received at least one dose of study medication.|participants|Number|2|2.0||||||
4055955|NCT01086384|3877466|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|Baseline characteristic data were collected in members of the Intent-to-Treat Population, comprised of all participants randomized to treatment who received at least one dose of study medication.|participants|Number|0|0.0||||||
4055956|NCT01086384|3877467|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|Baseline characteristic data were collected in members of the Intent-to-Treat Population, comprised of all participants randomized to treatment who received at least one dose of study medication.|participants|Number|2|2.0||||||
4055957|NCT01086384|3877465|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Baseline characteristic data were collected in members of the Intent-to-Treat Population, comprised of all participants randomized to treatment who received at least one dose of study medication.|participants|Number|157|157.0||||||
4055958|NCT01086384|3877466|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Baseline characteristic data were collected in members of the Intent-to-Treat Population, comprised of all participants randomized to treatment who received at least one dose of study medication.|participants|Number|78|78.0||||||
4056041|NCT01085968|3877584|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4055959|NCT01086384|3877467|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Baseline characteristic data were collected in members of the Intent-to-Treat Population, comprised of all participants randomized to treatment who received at least one dose of study medication.|participants|Number|79|79.0||||||
4055960|NCT01086384|3877465|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized|Baseline characteristic data were collected in members of the Intent-to-Treat Population, comprised of all participants randomized to treatment who received at least one dose of study medication.|participants|Number|62|62.0||||||
4055961|NCT01086384|3877466|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized|Baseline characteristic data were collected in members of the Intent-to-Treat Population, comprised of all participants randomized to treatment who received at least one dose of study medication.|participants|Number|32|32.0||||||
4055962|NCT01086384|3877467|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized|Baseline characteristic data were collected in members of the Intent-to-Treat Population, comprised of all participants randomized to treatment who received at least one dose of study medication.|participants|Number|30|30.0||||||
4055963|NCT01086384|3877465|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized|Baseline characteristic data were collected in members of the Intent-to-Treat Population, comprised of all participants randomized to treatment who received at least one dose of study medication.|participants|Number|1|1.0||||||
4055964|NCT01086384|3877466|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized|Baseline characteristic data were collected in members of the Intent-to-Treat Population, comprised of all participants randomized to treatment who received at least one dose of study medication.|participants|Number|0|0.0||||||
4055965|NCT01086384|3877467|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized|Baseline characteristic data were collected in members of the Intent-to-Treat Population, comprised of all participants randomized to treatment who received at least one dose of study medication.|participants|Number|1|1.0||||||
4055966|NCT01086384|3877465|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Baseline characteristic data were collected in members of the Intent-to-Treat Population, comprised of all participants randomized to treatment who received at least one dose of study medication.|participants|Number|2|2.0||||||
4055967|NCT01086384|3877466|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Baseline characteristic data were collected in members of the Intent-to-Treat Population, comprised of all participants randomized to treatment who received at least one dose of study medication.|participants|Number|2|2.0||||||
4055968|NCT01086384|3877467|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Baseline characteristic data were collected in members of the Intent-to-Treat Population, comprised of all participants randomized to treatment who received at least one dose of study medication.|participants|Number|0|0.0||||||
4055969|NCT01086384|3877465|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|Baseline characteristic data were collected in members of the Intent-to-Treat Population, comprised of all participants randomized to treatment who received at least one dose of study medication.|participants|Number|13|13.0||||||
4055970|NCT01086384|3877466|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|Baseline characteristic data were collected in members of the Intent-to-Treat Population, comprised of all participants randomized to treatment who received at least one dose of study medication.|participants|Number|9|9.0||||||
4055971|NCT01086384|3877467|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Baseline characteristic data were collected in members of the Intent-to-Treat Population, comprised of all participants randomized to treatment who received at least one dose of study medication.|participants|Number|4|4.0||||||
4055972|NCT01086384|3877465|B3|African American/African Heritage||Race/Ethnicity, Customized|Baseline characteristic data were collected in members of the Intent-to-Treat Population, comprised of all participants randomized to treatment who received at least one dose of study medication.|participants|Number|87|87.0||||||
4055973|NCT01086384|3877466|B2|African American/African Heritage||Race/Ethnicity, Customized|Baseline characteristic data were collected in members of the Intent-to-Treat Population, comprised of all participants randomized to treatment who received at least one dose of study medication.|participants|Number|40|40.0||||||
4055974|NCT01086384|3877467|B1|African American/African Heritage||Race/Ethnicity, Customized|Baseline characteristic data were collected in members of the Intent-to-Treat Population, comprised of all participants randomized to treatment who received at least one dose of study medication.|participants|Number|47|47.0||||||
4055975|NCT01086384|3877465|B3||Male|Sex: Female, Male|Baseline characteristic data were collected in members of the Intent-to-Treat Population, comprised of all participants randomized to treatment who received at least one dose of study medication.|Participants|Count of Participants|669|669.0||||||
4055976|NCT01086384|3877466|B2||Male|Sex: Female, Male|Baseline characteristic data were collected in members of the Intent-to-Treat Population, comprised of all participants randomized to treatment who received at least one dose of study medication.|Participants|Count of Participants|348|348.0||||||
4055977|NCT01086384|3877467|B1||Male|Sex: Female, Male|Baseline characteristic data were collected in members of the Intent-to-Treat Population, comprised of all participants randomized to treatment who received at least one dose of study medication.|Participants|Count of Participants|321|321.0||||||
4055978|NCT01086384|3877465|B3||Female|Sex: Female, Male|Baseline characteristic data were collected in members of the Intent-to-Treat Population, comprised of all participants randomized to treatment who received at least one dose of study medication.|Participants|Count of Participants|1350|1350.0||||||
4055979|NCT01086384|3877466|B2||Female|Sex: Female, Male|Baseline characteristic data were collected in members of the Intent-to-Treat Population, comprised of all participants randomized to treatment who received at least one dose of study medication.|Participants|Count of Participants|661|661.0||||||
4055980|NCT01086384|3877467|B1||Female|Sex: Female, Male|Baseline characteristic data were collected in members of the Intent-to-Treat Population, comprised of all participants randomized to treatment who received at least one dose of study medication.|Participants|Count of Participants|689|689.0||||||
4055981|NCT01086384|3877465|B3|||Age|Baseline characteristic data were collected in members of the Intent-to-Treat Population, comprised of all participants randomized to treatment who received at least one dose of study medication.|Years|Mean|41.7|41.7|Standard Deviation|16.96|16.96|||
4056042|NCT01085968|3877585|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4055982|NCT01086384|3877466|B2|||Age|Baseline characteristic data were collected in members of the Intent-to-Treat Population, comprised of all participants randomized to treatment who received at least one dose of study medication.|Years|Mean|41.1|41.1|Standard Deviation|17.10|17.1|||
4055983|NCT01086384|3877467|B1|||Age|Baseline characteristic data were collected in members of the Intent-to-Treat Population, comprised of all participants randomized to treatment who received at least one dose of study medication.|Years|Mean|42.3|42.3|Standard Deviation|16.82|16.82|||
4055984|NCT01086358|3877479|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4055985|NCT01086358|3877479|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4055986|NCT01086358|3877479|B1||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4055987|NCT01086358|3877479|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4055988|NCT01086358|3877479|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4055989|NCT01086358|3877479|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4055990|NCT01086358|3877479|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4055991|NCT01086358|3877479|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4055992|NCT01086358|3877479|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4055993|NCT01086358|3877479|B1|||Age||years|Mean|41.4|41.4|Standard Deviation|9.4|9.4|||
4055994|NCT01086228|3877492|B1|Japan||Region of Enrollment||participants|Number|2009|2009.0||||||
4055995|NCT01086228|3877492|B1||Male|Sex: Female, Male||Participants|Count of Participants|1528|1528.0||||||
4055996|NCT01086228|3877492|B1||Female|Sex: Female, Male||Participants|Count of Participants|481|481.0||||||
4055997|NCT01086228|3877492|B1|||Age||years|Median|70.0|70.0|Standard Deviation|10.1|10.1|||
4055998|NCT01086215|3877546|B5|Italy||Region of Enrollment||participants|Number|3|3.0||||||
4055999|NCT01086215|3877547|B4|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4056000|NCT01086215|3877548|B3|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4056001|NCT01086215|3877549|B2|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4056002|NCT01086215|3877550|B1|Italy||Region of Enrollment||participants|Number|3|3.0||||||
4056003|NCT01086215|3877546|B5|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4056004|NCT01086215|3877547|B4|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4056005|NCT01086215|3877548|B3|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4056006|NCT01086215|3877549|B2|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4056007|NCT01086215|3877550|B1|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4056008|NCT01086215|3877546|B5|Slovakia||Region of Enrollment||participants|Number|65|65.0||||||
4056009|NCT01086215|3877547|B4|Slovakia||Region of Enrollment||participants|Number|0|0.0||||||
4056010|NCT01086215|3877548|B3|Slovakia||Region of Enrollment||participants|Number|0|0.0||||||
4056011|NCT01086215|3877549|B2|Slovakia||Region of Enrollment||participants|Number|11|11.0||||||
4056012|NCT01086215|3877550|B1|Slovakia||Region of Enrollment||participants|Number|54|54.0||||||
4056013|NCT01086215|3877546|B5|United States||Region of Enrollment||participants|Number|430|430.0||||||
4056014|NCT01086215|3877547|B4|United States||Region of Enrollment||participants|Number|13|13.0||||||
4056015|NCT01086215|3877548|B3|United States||Region of Enrollment||participants|Number|73|73.0||||||
4056016|NCT01086215|3877549|B2|United States||Region of Enrollment||participants|Number|190|190.0||||||
4056017|NCT01086215|3877550|B1|United States||Region of Enrollment||participants|Number|154|154.0||||||
4056018|NCT01086215|3877546|B5||Male|Sex: Female, Male||Participants|Count of Participants|292|292.0||||||
4056019|NCT01086215|3877547|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4056020|NCT01086215|3877548|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4056021|NCT01086215|3877549|B2||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4056022|NCT01086215|3877550|B1||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4056023|NCT01086215|3877546|B5||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4056024|NCT01086215|3877547|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4056025|NCT01086215|3877548|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4056026|NCT01086215|3877549|B2||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4056027|NCT01086215|3877550|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4056028|NCT01086215|3877546|B5|||Age||years|Mean|58.1|58.1|Standard Deviation|15.16|15.16|||
4056029|NCT01086215|3877547|B4|||Age||years|Mean|56.5|56.5|Standard Deviation|12.07|12.07|||
4056030|NCT01086215|3877548|B3|||Age||years|Mean|61.6|61.6|Standard Deviation|13.94|13.94|||
4056031|NCT01086215|3877549|B2|||Age||years|Mean|51.3|51.3|Standard Deviation|16.37|16.37|||
4056032|NCT01086215|3877550|B1|||Age||years|Mean|63.6|63.6|Standard Deviation|11.59|11.59|||
4056033|NCT01086033|3877571|B1|Greece||Region of Enrollment||participants|Number|566|566.0||||||
4056034|NCT01086033|3877571|B1||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4056035|NCT01086033|3877571|B1||Female|Sex: Female, Male||Participants|Count of Participants|456|456.0||||||
4056036|NCT01086033|3877571|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|13.2|13.2|||
4056037|NCT01085968|3877583|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
4056038|NCT01085968|3877584|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4056039|NCT01085968|3877585|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4056040|NCT01085968|3877583|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056043|NCT01085968|3877583|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4056044|NCT01085968|3877584|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4056045|NCT01085968|3877585|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4056046|NCT01085968|3877583|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4056047|NCT01085968|3877584|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4056048|NCT01085968|3877585|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4056049|NCT01085968|3877583|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4056050|NCT01085968|3877584|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4056051|NCT01085968|3877585|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4056052|NCT01085968|3877583|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4056053|NCT01085968|3877584|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4056054|NCT01085968|3877585|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4056055|NCT01085968|3877583|B3|||Age||years|Mean|66.852|66.852|Standard Deviation|6.651|6.651|||
4056056|NCT01085968|3877584|B2|||Age||years|Mean|65.56|65.56|Standard Deviation|6.777|6.777|||
4056057|NCT01085968|3877585|B1|||Age||years|Mean|67.965|67.965|Standard Deviation|6.450|6.45|||
4056058|NCT01085903|3877600|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4056059|NCT01085903|3877601|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056060|NCT01085903|3877602|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4056061|NCT01085903|3877600|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056062|NCT01085903|3877601|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056063|NCT01085903|3877602|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056064|NCT01085903|3877600|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4056065|NCT01085903|3877601|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4056066|NCT01085903|3877602|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4056067|NCT01085903|3877600|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4056068|NCT01085903|3877601|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4056069|NCT01085903|3877602|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4056070|NCT01085903|3877600|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056071|NCT01085903|3877601|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056072|NCT01085903|3877602|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056073|NCT01085903|3877600|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056074|NCT01085903|3877601|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056075|NCT01085903|3877602|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056076|NCT01085903|3877600|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056077|NCT01085903|3877601|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056078|NCT01085903|3877602|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056079|NCT01085903|3877600|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4056080|NCT01085903|3877601|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4056081|NCT01085903|3877602|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4056082|NCT01085903|3877600|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4056083|NCT01085903|3877601|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4056084|NCT01085903|3877602|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4056085|NCT01085903|3877600|B3|||Age||years|Mean|58.2|58.2|Standard Deviation|15.3|15.3|||
4056086|NCT01085903|3877601|B2|||Age||years|Mean|71.429|71.429|Standard Deviation|9.914|9.914|||
4056087|NCT01085903|3877602|B1|||Age||years|Mean|51.286|51.286|Standard Deviation|21.462|21.462|||
4056088|NCT01085825|3877628|B3|||Mean sac diameter||mm|Mean|7.9|7.9|Standard Deviation|2.3|2.3|||
4056089|NCT01085825|3877629|B2|||Mean sac diameter||mm|Mean|7.8|7.8|Standard Deviation|2.3|2.3|||
4056090|NCT01085825|3877630|B1|||Mean sac diameter||mm|Mean|8.0|8.0|Standard Deviation|2.4|2.4|||
4056091|NCT01085825|3877628|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
4056092|NCT01085825|3877629|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
4056093|NCT01085825|3877630|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4056094|NCT01085825|3877628|B3||Female|Gender||Participants|Count of Participants|500|500.0||||||
4056095|NCT01085825|3877629|B2||Female|Gender||Participants|Count of Participants|248|248.0||||||
4056096|NCT01085825|3877630|B1||Female|Gender||Participants|Count of Participants|252|252.0||||||
4056097|NCT01085825|3877628|B3|||Age||years|Mean|25.4|25.4|Standard Deviation|5|5.0|||
4056098|NCT01085825|3877629|B2|||Age||years|Mean|25.4|25.4|Standard Deviation|5|5.0|||
4056099|NCT01085825|3877630|B1|||Age||years|Mean|25.3|25.3|Standard Deviation|5|5.0|||
4056100|NCT01085786|3877637|B3|Taiwan||Region of Enrollment||participants|Number|240|240.0||||||
4056101|NCT01085786|3877638|B2|Taiwan||Region of Enrollment||participants|Number|117|117.0||||||
4056102|NCT01085786|3877639|B1|Taiwan||Region of Enrollment||participants|Number|123|123.0||||||
4056103|NCT01085786|3877637|B3||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4056104|NCT01085786|3877638|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4056105|NCT01085786|3877639|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4056106|NCT01085786|3877637|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4056107|NCT01085786|3877638|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4056108|NCT01085786|3877639|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4056109|NCT01085786|3877637|B3|||Age||years|Mean|54.7|54.7|Standard Deviation|12.1|12.1|||
4056110|NCT01085786|3877638|B2|||Age||years|Mean|54.3|54.3|Standard Deviation|11.4|11.4|||
4056111|NCT01085786|3877639|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|11.8|11.8|||
4056112|NCT01085786|3877637|B3||>=65 years|Age||Participants|Count of Participants|52|52.0||||||
4056113|NCT01085786|3877638|B2||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4056114|NCT01085786|3877639|B1||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4056115|NCT01085786|3877637|B3||Between 18 and 65 years|Age||Participants|Count of Participants|188|188.0||||||
4056116|NCT01085786|3877638|B2||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
4056117|NCT01085786|3877639|B1||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
4056118|NCT01085786|3877637|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056119|NCT01085786|3877638|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056120|NCT01085786|3877639|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056121|NCT01085760|3877646|B5|United States||Region of Enrollment||participants|Number|35|35.0||||||
4056122|NCT01085760|3877647|B4|United States||Region of Enrollment||participants|Number|9|9.0||||||
4056123|NCT01085760|3877648|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4056124|NCT01085760|3877649|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4056125|NCT01085760|3877650|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4056126|NCT01085760|3877646|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4056127|NCT01085760|3877647|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4056128|NCT01085760|3877648|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4056129|NCT01085760|3877649|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4056130|NCT01085760|3877650|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4056131|NCT01085760|3877646|B5||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4056132|NCT01085760|3877647|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4056133|NCT01085760|3877648|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4056134|NCT01085760|3877649|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4056135|NCT01085760|3877650|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4056136|NCT01085760|3877646|B5|||Age||years|Median|40|40.0|Full Range|||20.0|70.0|
4056137|NCT01085760|3877647|B4|||Age||years|Median|40|40.0|Full Range|||20.0|60.0|
4056138|NCT01085760|3877648|B3|||Age||years|Median|35|35.0|Full Range|||21.0|64.0|
4056139|NCT01085760|3877649|B2|||Age||years|Median|42|42.0|Full Range|||27.0|70.0|
4056140|NCT01085760|3877650|B1|||Age||years|Median|40|40.0|Full Range|||20.0|60.0|
4056141|NCT01085760|3877646|B5||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4056142|NCT01085760|3877647|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4056143|NCT01085760|3877648|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4056144|NCT01085760|3877649|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4056145|NCT01085760|3877650|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4056146|NCT01085760|3877646|B5||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4056147|NCT01085760|3877647|B4||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4056148|NCT01085760|3877648|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4056149|NCT01085760|3877649|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4056150|NCT01085760|3877650|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4056151|NCT01085760|3877646|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056152|NCT01085760|3877647|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056153|NCT01085760|3877648|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056154|NCT01085760|3877649|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056155|NCT01085760|3877650|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056156|NCT01085734|3877675|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4056157|NCT01085734|3877676|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4056158|NCT01085734|3877677|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4056159|NCT01085734|3877675|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4056160|NCT01085734|3877676|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4056161|NCT01085734|3877677|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4056162|NCT01085734|3877675|B3|||Age||years|Mean|68|68.0|Standard Deviation|16|16.0|||
4056163|NCT01085734|3877676|B2|||Age||years|Mean|69|69.0|Standard Deviation|19|19.0|||
4056164|NCT01085734|3877677|B1|||Age||years|Mean|67|67.0|Standard Deviation|13|13.0|||
4056165|NCT01085734|3877675|B3||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4056166|NCT01085734|3877676|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4056167|NCT01085734|3877677|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4056168|NCT01085734|3877675|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4056169|NCT01085734|3877676|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4056170|NCT01085734|3877677|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4056171|NCT01085734|3877675|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056172|NCT01085734|3877676|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056173|NCT01085734|3877677|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056174|NCT01085682|3877688|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4056175|NCT01085682|3877689|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4056176|NCT01085682|3877690|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4056177|NCT01085682|3877688|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4056178|NCT01085682|3877689|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4056179|NCT01085682|3877690|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4056180|NCT01085682|3877688|B3|||Age||years|Mean|55|55.0|Standard Deviation|3|3.0|||
4056181|NCT01085682|3877689|B2|||Age||years|Mean|55|55.0|Standard Deviation|3|3.0|||
4056182|NCT01085682|3877690|B1|||Age||years|Mean|55|55.0|Standard Deviation|3|3.0|||
4056183|NCT01085643|3877697|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4056184|NCT01085643|3877697|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4056185|NCT01085643|3877697|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4056186|NCT01085643|3877697|B1|||Age||years|Mean|45|45.0|Standard Deviation|1|1.0|||
4056187|NCT01085643|3877697|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4056188|NCT01085643|3877697|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4056189|NCT01085643|3877697|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056190|NCT01085591|3877706|B4||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4056191|NCT01085591|3877707|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4056192|NCT01085591|3877708|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4056193|NCT01085591|3877709|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4056194|NCT01085591|3877706|B4||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4056195|NCT01085591|3877707|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4056196|NCT01085591|3877708|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4056197|NCT01085591|3877709|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4056198|NCT01085591|3877706|B4||GTE65|Age||Participants|Count of Participants|79|79.0||||||
4056199|NCT01085591|3877707|B3||GTE65|Age||Participants|Count of Participants|30|30.0||||||
4056200|NCT01085591|3877708|B2||GTE65|Age||Participants|Count of Participants|28|28.0||||||
4056201|NCT01085591|3877709|B1||GTE65|Age||Participants|Count of Participants|21|21.0||||||
4056202|NCT01085591|3877706|B4||BTWN|Age||Participants|Count of Participants|130|130.0||||||
4056203|NCT01085591|3877707|B3||BTWN|Age||Participants|Count of Participants|40|40.0||||||
4056204|NCT01085591|3877708|B2||BTWN|Age||Participants|Count of Participants|43|43.0||||||
4056205|NCT01085591|3877709|B1||BTWN|Age||Participants|Count of Participants|47|47.0||||||
4056206|NCT01085591|3877706|B4||LTE18|Age||Participants|Count of Participants|0|0.0||||||
4056207|NCT01085591|3877707|B3||LTE18|Age||Participants|Count of Participants|0|0.0||||||
4056208|NCT01085591|3877708|B2||LTE18|Age||Participants|Count of Participants|0|0.0||||||
4056209|NCT01085591|3877709|B1||LTE18|Age||Participants|Count of Participants|0|0.0||||||
4056210|NCT01085539|3877734|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4056211|NCT01085539|3877734|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4056212|NCT01085539|3877734|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4056213|NCT01085539|3877734|B1|||Age||years|Mean|0.73|0.73|Standard Deviation|0.02|0.02|||
4056214|NCT01085539|3877734|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4056215|NCT01085539|3877734|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4056216|NCT01085539|3877734|B1||<=18 years|Age||Participants|Count of Participants|50|50.0||||||
4056217|NCT01085513|3877738|B3|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
4056218|NCT01085513|3877739|B2|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
4056219|NCT01085513|3877740|B1|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
4056220|NCT01085513|3877738|B3|Italy||Region of Enrollment||participants|Number|19|19.0||||||
4056221|NCT01085513|3877739|B2|Italy||Region of Enrollment||participants|Number|3|3.0||||||
4056222|NCT01085513|3877740|B1|Italy||Region of Enrollment||participants|Number|16|16.0||||||
4056223|NCT01085513|3877738|B3|Spain||Region of Enrollment||participants|Number|84|84.0||||||
4056224|NCT01085513|3877739|B2|Spain||Region of Enrollment||participants|Number|47|47.0||||||
4056225|NCT01085513|3877740|B1|Spain||Region of Enrollment||participants|Number|37|37.0||||||
4056226|NCT01085513|3877738|B3|Belgium||Region of Enrollment||participants|Number|30|30.0||||||
4056227|NCT01085513|3877739|B2|Belgium||Region of Enrollment||participants|Number|16|16.0||||||
4056228|NCT01085513|3877740|B1|Belgium||Region of Enrollment||participants|Number|14|14.0||||||
4056229|NCT01085513|3877738|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4056230|NCT01085513|3877739|B2|United States||Region of Enrollment||participants|Number|0|0.0||||||
4056231|NCT01085513|3877740|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4056232|NCT01085513|3877738|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4056233|NCT01085513|3877739|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4056234|NCT01085513|3877740|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4056235|NCT01085513|3877738|B3||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4056236|NCT01085513|3877739|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4056237|NCT01085513|3877740|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4056238|NCT01085513|3877738|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4056239|NCT01085513|3877739|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4056240|NCT01085513|3877740|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4056241|NCT01085513|3877738|B3||Between 18 and 65 years|Age||Participants|Count of Participants|132|132.0||||||
4056242|NCT01085513|3877739|B2||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4056243|NCT01085513|3877740|B1||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
4056244|NCT01085513|3877738|B3||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4056245|NCT01085513|3877739|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4056246|NCT01085513|3877740|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4056247|NCT01085513|3877738|B3|||Age||years|Mean|40.34|40.34|Standard Deviation|14.49|14.49|||
4056248|NCT01085513|3877739|B2|||Age||years|Mean|40.5|40.5|Standard Deviation|13.6|13.6|||
4056249|NCT01085513|3877740|B1|||Age||years|Mean|40.2|40.2|Standard Deviation|15.34|15.34|||
4056250|NCT01085500|3877747|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4056251|NCT01085500|3877748|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4056252|NCT01085500|3877749|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4056253|NCT01085500|3877747|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4056254|NCT01085500|3877748|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4056255|NCT01085500|3877749|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4056256|NCT01085500|3877747|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4056257|NCT01085500|3877748|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4056258|NCT01085500|3877749|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4056259|NCT01085500|3877747|B3|||Age||years|Mean|30|30.0|Standard Deviation|2|2.0|||
4056260|NCT01085500|3877748|B2|||Age||years|Mean|30|30.0|Standard Deviation|3|3.0|||
4056261|NCT01085500|3877749|B1|||Age||years|Mean|30|30.0|Standard Deviation|2|2.0|||
4056262|NCT01085500|3877747|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4056263|NCT01085500|3877748|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4056264|NCT01085500|3877749|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4056265|NCT01085500|3877747|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4056266|NCT01085500|3877748|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4056267|NCT01085500|3877749|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4056268|NCT01085500|3877747|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056269|NCT01085500|3877748|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056270|NCT01085500|3877749|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056271|NCT01085357|3877760|B3||Male|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
4056272|NCT01085357|3877761|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4056273|NCT01085357|3877762|B1||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4056274|NCT01085357|3877760|B3||Female|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
4056275|NCT01085357|3877761|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4056276|NCT01085357|3877762|B1||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4056277|NCT01085357|3877760|B3|||Age||years|Mean|70.3|70.3|Standard Deviation|8.37|8.37|||
4056278|NCT01085357|3877761|B2|||Age||years|Mean|70.2|70.2|Standard Deviation|8.17|8.17|||
4056279|NCT01085357|3877762|B1|||Age||years|Mean|70.3|70.3|Standard Deviation|8.45|8.45|||
4056280|NCT01085331|3877773|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4056281|NCT01085331|3877774|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4056282|NCT01085331|3877775|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4056283|NCT01085331|3877773|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4056284|NCT01085331|3877774|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4056285|NCT01085331|3877775|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4056286|NCT01085331|3877773|B3|||Age||Years|Mean|61.6|61.6|Standard Deviation|13.7|13.7|||
4056287|NCT01085331|3877774|B2|||Age||Years|Mean|60.4|60.4|Standard Deviation|17.2|17.2|||
4056288|NCT01085331|3877775|B1|||Age||Years|Mean|62.3|62.3|Standard Deviation|12.0|12.0|||
4056289|NCT01085318|3877813|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
4056290|NCT01085318|3877814|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4056291|NCT01085318|3877815|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4056292|NCT01085318|3877813|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4056293|NCT01085318|3877814|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4056294|NCT01085318|3877815|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4056295|NCT01085318|3877813|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4056296|NCT01085318|3877814|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4056297|NCT01085318|3877815|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4056298|NCT01085318|3877813|B3|||Age||years|Mean|38.6|38.6|Standard Deviation|10.21|10.21|||
4056299|NCT01085318|3877814|B2|||Age||years|Mean|36.7|36.7|Standard Deviation|10.31|10.31|||
4056300|NCT01085318|3877815|B1|||Age||years|Mean|39.9|39.9|Standard Deviation|10.17|10.17|||
4056301|NCT01085318|3877813|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4056302|NCT01085318|3877814|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4056303|NCT01085318|3877815|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4056304|NCT01085318|3877813|B3||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4056305|NCT01085318|3877814|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4056306|NCT01085318|3877815|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4056307|NCT01085318|3877813|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056308|NCT01085318|3877814|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056309|NCT01085318|3877815|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056310|NCT01085214|3877826|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4056311|NCT01085214|3877826|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4056312|NCT01085214|3877826|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4056313|NCT01085214|3877826|B1|||Age||years|Median|65|65.0|Full Range|||43.0|81.0|
4056314|NCT01085214|3877826|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4056315|NCT01085214|3877826|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4056316|NCT01085214|3877826|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056317|NCT01085201|3877833|B6|United States||Region of Enrollment||participants|Number|33|33.0||||||
4056318|NCT01085201|3877834|B5|United States||Region of Enrollment||participants|Number|3|3.0||||||
4056319|NCT01085201|3877835|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
4056320|NCT01085201|3877836|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4056321|NCT01085201|3877837|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4056322|NCT01085201|3877838|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4056323|NCT01085201|3877833|B6||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4056324|NCT01085201|3877834|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4056325|NCT01085201|3877835|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4056326|NCT01085201|3877836|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4056327|NCT01085201|3877837|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4056328|NCT01085201|3877838|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4056329|NCT01085201|3877833|B6||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4056330|NCT01085201|3877834|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4056331|NCT01085201|3877835|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4056332|NCT01085201|3877836|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4056333|NCT01085201|3877837|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4056334|NCT01085201|3877838|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4056335|NCT01085201|3877833|B6|||Age||years|Mean|30.9|30.9|Standard Deviation|9.86|9.86|||
4056336|NCT01085201|3877834|B5|||Age||years|Mean|16.77|16.77|Standard Deviation|0.89|0.89|||
4056337|NCT01085201|3877835|B4|||Age||years|Mean|31.61|31.61|Standard Deviation|6.42|6.42|||
4056338|NCT01085201|3877836|B3|||Age||years|Mean|23.68|23.68|Standard Deviation|5.05|5.05|||
4056339|NCT01085201|3877837|B2|||Age||years|Mean|33.84|33.84|Standard Deviation|8.75|8.75|||
4056340|NCT01085201|3877838|B1|||Age||years|Mean|33.71|33.71|Standard Deviation|10.49|10.49|||
4056341|NCT01085201|3877833|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4056342|NCT01085201|3877834|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4056343|NCT01085201|3877835|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4056344|NCT01085201|3877836|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4056345|NCT01085201|3877837|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4056346|NCT01085201|3877838|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4056347|NCT01085201|3877833|B6||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4056348|NCT01085201|3877834|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4056349|NCT01085201|3877835|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4056350|NCT01085201|3877836|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4056351|NCT01085201|3877837|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4056352|NCT01085201|3877838|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4056353|NCT01085201|3877833|B6||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4056354|NCT01085201|3877834|B5||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4056355|NCT01085201|3877835|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056356|NCT01085201|3877836|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056357|NCT01085201|3877837|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056358|NCT01085201|3877838|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056359|NCT01085136|3877864|B1|Missing||Histologic classification||Participants|Number|1|1.0||||||
4056360|NCT01085136|3877864|B1|Other||Histologic classification||Participants|Number|78|78.0||||||
4056361|NCT01085136|3877864|B1|Squamous||Histologic classification||Participants|Number|90|90.0||||||
4056362|NCT01085136|3877864|B1|Adenocarcinoma||Histologic classification||Participants|Number|985|985.0||||||
4056363|NCT01085136|3877864|B1|Other current or ex−smoker||Smoking history||Participants|Number|407|407.0||||||
4056364|NCT01085136|3877864|B1|<15 pack years & stopped >1 year before diagnosis||Smoking history||Participants|Number|132|132.0||||||
4056365|NCT01085136|3877864|B1|Never smoked||Smoking history||Participants|Number|615|615.0||||||
4056366|NCT01085136|3877864|B1|2||Baseline Eastern Cooperative Oncology Group (ECOG) performance score|Subjects were graded based on following ECOG PS grade criteria: Grade 0: Fully active, able to carry on all pre-disease performance without restriction. Grade 1: Restricted in physically strenuous activity but ambulatory & able to carry out work of a light nature. Grade 2: Ambulatory & capable of all selfcare but unable to carry out any work activities. Up & about more than 50% of waking hours. Grade 3: Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours. Grade 4: Completely disabled. Totally confined to bed or chair. Grade 5: Dead.|Participants|Number|122|122.0||||||
4056367|NCT01085136|3877864|B1|1||Baseline Eastern Cooperative Oncology Group (ECOG) performance score|Subjects were graded based on following ECOG PS grade criteria: Grade 0: Fully active, able to carry on all pre-disease performance without restriction. Grade 1: Restricted in physically strenuous activity but ambulatory & able to carry out work of a light nature. Grade 2: Ambulatory & capable of all selfcare but unable to carry out any work activities. Up & about more than 50% of waking hours. Grade 3: Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours. Grade 4: Completely disabled. Totally confined to bed or chair. Grade 5: Dead.|Participants|Number|691|691.0||||||
4056368|NCT01085136|3877864|B1|0||Baseline Eastern Cooperative Oncology Group (ECOG) performance score|Subjects were graded based on following ECOG PS grade criteria: Grade 0: Fully active, able to carry on all pre-disease performance without restriction. Grade 1: Restricted in physically strenuous activity but ambulatory & able to carry out work of a light nature. Grade 2: Ambulatory & capable of all selfcare but unable to carry out any work activities. Up & about more than 50% of waking hours. Grade 3: Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours. Grade 4: Completely disabled. Totally confined to bed or chair. Grade 5: Dead.|Participants|Number|341|341.0||||||
4056369|NCT01085136|3877864|B1|Unknown||Race/Ethnicity, Customized||Participants|Number|175|175.0||||||
4056370|NCT01085136|3877864|B1|Other||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
4056371|NCT01085136|3877864|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|459|459.0||||||
4056372|NCT01085136|3877864|B1|Eastern Asian||Race/Ethnicity, Customized||Participants|Number|491|491.0||||||
4056373|NCT01085136|3877864|B1||Male|Sex: Female, Male||Participants|Count of Participants|500|500.0||||||
4056374|NCT01085136|3877864|B1||Female|Sex: Female, Male||Participants|Count of Participants|654|654.0||||||
4056375|NCT01085136|3877864|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|10.9|10.9|||
4056376|NCT01085136|3877864|B1||>=65 years|Age||Participants|Count of Participants|413|413.0||||||
4056377|NCT01085136|3877864|B1||Between 18 and 65 years|Age||Participants|Count of Participants|741|741.0||||||
4056378|NCT01085136|3877864|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056379|NCT01085045|3877882|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4056380|NCT01085045|3877882|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4056381|NCT01085045|3877882|B1|||Age||Years|Mean|63.4|63.4|Standard Deviation|8.92|8.92|||
4056382|NCT01085006|3877982|B3|Iran, Islamic Republic of||Region of Enrollment||participants|Number|100|100.0||||||
4056383|NCT01085006|3877983|B2|Iran, Islamic Republic of||Region of Enrollment||participants|Number|50|50.0||||||
4056384|NCT01085006|3877984|B1|Iran, Islamic Republic of||Region of Enrollment||participants|Number|50|50.0||||||
4056385|NCT01085006|3877982|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4056386|NCT01085006|3877983|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4056387|NCT01085006|3877984|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4056388|NCT01085006|3877982|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4056389|NCT01085006|3877983|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4056390|NCT01085006|3877984|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4056391|NCT01085006|3877982|B3|||Age||years|Mean|27.3|27.3|Standard Deviation|3.7|3.7|||
4056392|NCT01085006|3877983|B2|||Age||years|Mean|27.6|27.6|Standard Deviation|4.1|4.1|||
4056393|NCT01085006|3877984|B1|||Age||years|Mean|27|27.0|Standard Deviation|3.4|3.4|||
4056394|NCT01085006|3877982|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4056395|NCT01085006|3877983|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4056396|NCT01085006|3877984|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4056397|NCT01085006|3877982|B3||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4056398|NCT01085006|3877983|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4056399|NCT01085006|3877984|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4056400|NCT01085006|3877982|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056401|NCT01085006|3877983|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056402|NCT01085006|3877984|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056403|NCT01084759|3877991|B1|Patients without RECIST evaluable disease||RECIST evaluable soft tissue metastases||participants|Number|6|6.0||||||
4056404|NCT01084759|3877991|B1|Patients with RECIST evaluable disease||RECIST evaluable soft tissue metastases||participants|Number|10|10.0||||||
4056405|NCT01084759|3877991|B1|Patients without bone metastases||Bone metastases||participants|Number|13|13.0||||||
4056406|NCT01084759|3877991|B1|Patients with bone metastases||Bone metastases||participants|Number|3|3.0||||||
4056407|NCT01084759|3877991|B1|3 second line agents||Number of second line hormonal therapies received|Second line hormonal therapies were defined as any agent that inhibits androgen receptor (AR) signaling (e.g. AR antagonist, inhibitors of extragonadal testosterone synthesis).|participants|Number|2|2.0||||||
4056408|NCT01084759|3877991|B1|2 second line agents||Number of second line hormonal therapies received|Second line hormonal therapies were defined as any agent that inhibits androgen receptor (AR) signaling (e.g. AR antagonist, inhibitors of extragonadal testosterone synthesis).|participants|Number|3|3.0||||||
4056409|NCT01084759|3877991|B1|1 second line agent||Number of second line hormonal therapies received|Second line hormonal therapies were defined as any agent that inhibits androgen receptor (AR) signaling (e.g. AR antagonist, inhibitors of extragonadal testosterone synthesis).|participants|Number|9|9.0||||||
4056410|NCT01084759|3877991|B1|None||Number of second line hormonal therapies received|Second line hormonal therapies were defined as any agent that inhibits androgen receptor (AR) signaling (e.g. AR antagonist, inhibitors of extragonadal testosterone synthesis).|participants|Number|2|2.0||||||
4056411|NCT01084759|3877991|B1|||Length of continuous androgen deprivation therapy||months|Median|45.5|45.5|Full Range|||12.0|146.0|
4056412|NCT01084759|3877991|B1|Gleason score 9||Baseline Gleason Grade (higher grade indicates more pathologic atypia)|Gleason score was based on clinical interpretation of the needle biopsy specimen or prostatectomy specimen by an expert pathologist.|participants|Number|2|2.0||||||
4056413|NCT01084759|3877991|B1|Gleason score 8||Baseline Gleason Grade (higher grade indicates more pathologic atypia)|Gleason score was based on clinical interpretation of the needle biopsy specimen or prostatectomy specimen by an expert pathologist.|participants|Number|3|3.0||||||
4056414|NCT01084759|3877991|B1|Gleason score 7||Baseline Gleason Grade (higher grade indicates more pathologic atypia)|Gleason score was based on clinical interpretation of the needle biopsy specimen or prostatectomy specimen by an expert pathologist.|participants|Number|7|7.0||||||
4056415|NCT01084759|3877991|B1|Gleason score 6||Baseline Gleason Grade (higher grade indicates more pathologic atypia)|Gleason score was based on clinical interpretation of the needle biopsy specimen or prostatectomy specimen by an expert pathologist.|participants|Number|4|4.0||||||
4056416|NCT01084759|3877991|B1|||Testosterone|Note: The limit of detection for this assay is 20 ng/dL. Patients with an undetectable testosterone level were assigned a value of 20 ng/dL.|ng/dL|Median|20|20.0|Full Range|||20.0|41.0|
4056417|NCT01084759|3877991|B1|||Prostate Specific Antigen (PSA)||ng/mL|Median|20|20.0|Full Range|||1.4|819.1|
4056418|NCT01084759|3877991|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056419|NCT01084759|3877991|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056420|NCT01084759|3877991|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4056421|NCT01084759|3877991|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4056422|NCT01084759|3877991|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056423|NCT01084759|3877991|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056424|NCT01084759|3877991|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056425|NCT01084759|3877991|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4056426|NCT01084759|3877991|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4056427|NCT01084759|3877991|B1|||Age||years|Median|71|71.0|Full Range|||56.0|87.0|
4056428|NCT01084707|3877997|B1|Sweden||Region of Enrollment||participants|Number|40|40.0||||||
4056429|NCT01084707|3877997|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4056430|NCT01084707|3877997|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4056431|NCT01084707|3877997|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4056432|NCT01084707|3877997|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4056433|NCT01084707|3877997|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056434|NCT01084668|3878031|B1|Austria||Region of Enrollment||participants|Number|42|42.0||||||
4056435|NCT01084668|3878031|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4056436|NCT01084668|3878031|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4056437|NCT01084668|3878031|B1|||Age||years|Mean|47.1|47.1|Standard Deviation|11.5|11.5|||
4056438|NCT01084603|3878040|B1|Sweden||Region of Enrollment||participants|Number|45|45.0||||||
4056439|NCT01084603|3878040|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4056440|NCT01084603|3878040|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4056441|NCT01084603|3878040|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4056442|NCT01084603|3878040|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4056443|NCT01084603|3878040|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056444|NCT01084551|3878073|B4|Japan||Region of Enrollment||participants|Number|284|284.0||||||
4056445|NCT01084551|3878074|B3|Japan||Region of Enrollment||participants|Number|94|94.0||||||
4056446|NCT01084551|3878075|B2|Japan||Region of Enrollment||participants|Number|95|95.0||||||
4056447|NCT01084551|3878076|B1|Japan||Region of Enrollment||participants|Number|95|95.0||||||
4056448|NCT01084551|3878073|B4||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4056449|NCT01084551|3878074|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4056450|NCT01084551|3878075|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4056451|NCT01084551|3878076|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4056452|NCT01084551|3878073|B4||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4056453|NCT01084551|3878074|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4056454|NCT01084551|3878075|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4056455|NCT01084551|3878076|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4056456|NCT01084551|3878073|B4||>=65 years|Age||Participants|Count of Participants|65|65.0||||||
4056457|NCT01084551|3878074|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4056458|NCT01084551|3878075|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4056459|NCT01084551|3878076|B1||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4056460|NCT01084551|3878073|B4||Between 18 and 65 years|Age||Participants|Count of Participants|219|219.0||||||
4056461|NCT01084551|3878074|B3||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
4056462|NCT01084551|3878075|B2||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
4056463|NCT01084551|3878076|B1||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4056464|NCT01084551|3878073|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056465|NCT01084551|3878074|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056466|NCT01084551|3878075|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056467|NCT01084551|3878076|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056468|NCT01084551|3878073|B4|||Age||years|Mean|51.7|51.7|Standard Deviation|14.1|14.1|||
4056469|NCT01084551|3878074|B3|||Age||years|Mean|50.9|50.9|Standard Deviation|13.7|13.7|||
4056470|NCT01084551|3878075|B2|||Age||years|Mean|50.7|50.7|Standard Deviation|13.3|13.3|||
4056471|NCT01084551|3878076|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|15.3|15.3|||
4056472|NCT01084538|3878116|B1||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4056473|NCT01084538|3878116|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4056474|NCT01084538|3878116|B1|||Age||years|Mean|55.3|55.3|Standard Deviation|12.9|12.9|||
4056475|NCT01084278|3878123|B6|||Body Mass Index (BMI)||kg/m^2|Mean|27.60|27.6|Standard Deviation|5.28|5.28|||
4056476|NCT01084278|3878124|B5|||Body Mass Index (BMI)||kg/m^2|Mean|25.66|25.66|Standard Deviation|5.018|5.018|||
4056477|NCT01084278|3878125|B4|||Body Mass Index (BMI)||kg/m^2|Mean|33.96|33.96|Standard Deviation|4.489|4.489|||
4056478|NCT01084278|3878126|B3|||Body Mass Index (BMI)||kg/m^2|Mean|28.64|28.64|Standard Deviation|4.823|4.823|||
4056479|NCT01084278|3878127|B2|||Body Mass Index (BMI)||kg/m^2|Mean|23.18|23.18|Standard Deviation|2.560|2.56|||
4056480|NCT01084278|3878128|B1|||Body Mass Index (BMI)||kg/m^2|Mean|26.54|26.54|Standard Deviation|2.113|2.113|||
4056481|NCT01084278|3878123|B6|||Weight||kg|Mean|78.95|78.95|Standard Deviation|18.47|18.47|||
4056482|NCT01084278|3878124|B5|||Weight||kg|Mean|73.86|73.86|Standard Deviation|22.287|22.287|||
4056483|NCT01084278|3878125|B4|||Weight||kg|Mean|100.81|100.81|Standard Deviation|16.856|16.856|||
4056484|NCT01084278|3878126|B3|||Weight||kg|Mean|77.55|77.55|Standard Deviation|10.667|10.667|||
4056485|NCT01084278|3878127|B2|||Weight||kg|Mean|65.55|65.55|Standard Deviation|9.904|9.904|||
4056486|NCT01084278|3878128|B1|||Weight||kg|Mean|77.09|77.09|Standard Deviation|8.494|8.494|||
4056487|NCT01084278|3878123|B6|||Height||cm|Mean|169.09|169.09|Standard Deviation|9.27|9.27|||
4056488|NCT01084278|3878124|B5|||Height||cm|Mean|168.05|168.05|Standard Deviation|11.991|11.991|||
4056489|NCT01084278|3878125|B4|||Height||cm|Mean|172.06|172.06|Standard Deviation|8.643|8.643|||
4056490|NCT01084278|3878126|B3|||Height||cm|Mean|164.83|164.83|Standard Deviation|9.054|9.054|||
4056491|NCT01084278|3878127|B2|||Height||cm|Mean|167.94|167.94|Standard Deviation|8.865|8.865|||
4056492|NCT01084278|3878128|B1|||Height||cm|Mean|170.33|170.33|Standard Deviation|7.722|7.722|||
4056493|NCT01084278|3878123|B6|||Creatinine Clearance/estimated Glomerular Filtration Rate|Creatinine Clearance for Healthy Treatment Group and estimated Glomerular Filtration Rate for Mild, Moderate, Severe and ESRD Treatment Groups.|mL/min|Mean|55.70|55.7|Standard Deviation|36.61|36.61|||
4056494|NCT01084278|3878124|B5|||Creatinine Clearance/estimated Glomerular Filtration Rate|Creatinine Clearance for Healthy Treatment Group and estimated Glomerular Filtration Rate for Mild, Moderate, Severe and ESRD Treatment Groups.|mL/min|Mean|10.9|10.9|Standard Deviation|2.97|2.97|||
4056495|NCT01084278|3878125|B4|||Creatinine Clearance/estimated Glomerular Filtration Rate|Creatinine Clearance for Healthy Treatment Group and estimated Glomerular Filtration Rate for Mild, Moderate, Severe and ESRD Treatment Groups.|mL/min|Mean|22|22.0|Standard Deviation|4.17|4.17|||
4056496|NCT01084278|3878126|B3|||Creatinine Clearance/estimated Glomerular Filtration Rate|Creatinine Clearance for Healthy Treatment Group and estimated Glomerular Filtration Rate for Mild, Moderate, Severe and ESRD Treatment Groups.|mL/min|Mean|40.0|40.0|Standard Deviation|6.78|6.78|||
4056497|NCT01084278|3878127|B2|||Creatinine Clearance/estimated Glomerular Filtration Rate|Creatinine Clearance for Healthy Treatment Group and estimated Glomerular Filtration Rate for Mild, Moderate, Severe and ESRD Treatment Groups.|mL/min|Mean|73.3|73.3|Standard Deviation|8.10|8.1|||
4056498|NCT01084278|3878128|B1|||Creatinine Clearance/estimated Glomerular Filtration Rate|Creatinine Clearance for Healthy Treatment Group and estimated Glomerular Filtration Rate for Mild, Moderate, Severe and ESRD Treatment Groups.|mL/min|Mean|111.49|111.49|Standard Deviation|22.651|22.651|||
4056499|NCT01084278|3878123|B6|No||Child Bearing Potential|Counts are based on the number of female participants.|participants|Number|17|17.0||||||
4056500|NCT01084278|3878124|B5|No||Child Bearing Potential|Counts are based on the number of female participants.|participants|Number|2|2.0||||||
4056501|NCT01084278|3878125|B4|No||Child Bearing Potential|Counts are based on the number of female participants.|participants|Number|4|4.0||||||
4056502|NCT01084278|3878126|B3|No||Child Bearing Potential|Counts are based on the number of female participants.|participants|Number|3|3.0||||||
4056560|NCT01084278|3878124|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4056503|NCT01084278|3878127|B2|No||Child Bearing Potential|Counts are based on the number of female participants.|participants|Number|4|4.0||||||
4056504|NCT01084278|3878128|B1|No||Child Bearing Potential|Counts are based on the number of female participants.|participants|Number|4|4.0||||||
4056505|NCT01084278|3878123|B6|Yes||Child Bearing Potential|Counts are based on the number of female participants.|participants|Number|3|3.0||||||
4056506|NCT01084278|3878124|B5|Yes||Child Bearing Potential|Counts are based on the number of female participants.|participants|Number|2|2.0||||||
4056507|NCT01084278|3878125|B4|Yes||Child Bearing Potential|Counts are based on the number of female participants.|participants|Number|0|0.0||||||
4056508|NCT01084278|3878126|B3|Yes||Child Bearing Potential|Counts are based on the number of female participants.|participants|Number|1|1.0||||||
4056509|NCT01084278|3878127|B2|Yes||Child Bearing Potential|Counts are based on the number of female participants.|participants|Number|0|0.0||||||
4056510|NCT01084278|3878128|B1|Yes||Child Bearing Potential|Counts are based on the number of female participants.|participants|Number|0|0.0||||||
4056511|NCT01084278|3878123|B6|United States||Region of Enrollment||participants|Number|40|40.0||||||
4056512|NCT01084278|3878124|B5|United States||Region of Enrollment||participants|Number|8|8.0||||||
4056513|NCT01084278|3878125|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
4056514|NCT01084278|3878126|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4056515|NCT01084278|3878127|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4056516|NCT01084278|3878128|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4056517|NCT01084278|3878123|B6|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4056518|NCT01084278|3878124|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4056519|NCT01084278|3878125|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4056520|NCT01084278|3878126|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4056521|NCT01084278|3878127|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4056522|NCT01084278|3878128|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4056523|NCT01084278|3878123|B6|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4056524|NCT01084278|3878124|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4056525|NCT01084278|3878125|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4056526|NCT01084278|3878126|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4056527|NCT01084278|3878127|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4056528|NCT01084278|3878128|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4056529|NCT01084278|3878123|B6|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4056530|NCT01084278|3878124|B5|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4056531|NCT01084278|3878125|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4056532|NCT01084278|3878126|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4056533|NCT01084278|3878127|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4056534|NCT01084278|3878128|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4056535|NCT01084278|3878123|B6|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4056536|NCT01084278|3878124|B5|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4056537|NCT01084278|3878125|B4|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4056538|NCT01084278|3878126|B3|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4056539|NCT01084278|3878127|B2|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4056540|NCT01084278|3878128|B1|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4056541|NCT01084278|3878123|B6|Native Hawaiian or other pacific islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4056542|NCT01084278|3878124|B5|Native Hawaiian or other pacific islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4056543|NCT01084278|3878125|B4|Native Hawaiian or other pacific islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4056544|NCT01084278|3878126|B3|Native Hawaiian or other pacific islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4056545|NCT01084278|3878127|B2|Native Hawaiian or other pacific islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4056546|NCT01084278|3878128|B1|Native Hawaiian or other pacific islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4056547|NCT01084278|3878123|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4056548|NCT01084278|3878124|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4056549|NCT01084278|3878125|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4056550|NCT01084278|3878126|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4056551|NCT01084278|3878127|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4056552|NCT01084278|3878128|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4056553|NCT01084278|3878123|B6|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4056554|NCT01084278|3878124|B5|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4056555|NCT01084278|3878125|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4056556|NCT01084278|3878126|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4056557|NCT01084278|3878127|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4056558|NCT01084278|3878128|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4056559|NCT01084278|3878123|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4056561|NCT01084278|3878125|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4056562|NCT01084278|3878126|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4056563|NCT01084278|3878127|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4056564|NCT01084278|3878128|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4056565|NCT01084278|3878123|B6||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4056566|NCT01084278|3878124|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4056567|NCT01084278|3878125|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4056568|NCT01084278|3878126|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4056569|NCT01084278|3878127|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4056570|NCT01084278|3878128|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4056571|NCT01084278|3878123|B6||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4056572|NCT01084278|3878124|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4056573|NCT01084278|3878125|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4056574|NCT01084278|3878126|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4056575|NCT01084278|3878127|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4056576|NCT01084278|3878128|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4056577|NCT01084278|3878123|B6|||Age||years|Mean|55.85|55.85|Standard Deviation|10.96|10.96|||
4056578|NCT01084278|3878124|B5|||Age||years|Mean|42.2|42.2|Standard Deviation|12.85|12.85|||
4056579|NCT01084278|3878125|B4|||Age||years|Mean|57.6|57.6|Standard Deviation|8.48|8.48|||
4056580|NCT01084278|3878126|B3|||Age||years|Mean|63.0|63.0|Standard Deviation|5.4|5.4|||
4056581|NCT01084278|3878127|B2|||Age||years|Mean|63.9|63.9|Standard Deviation|3.94|3.94|||
4056582|NCT01084278|3878128|B1|||Age||years|Mean|52.5|52.5|Standard Deviation|5.29|5.29|||
4056583|NCT01084265|3878213|B1||Male|Sex: Female, Male|"Demographic data for only N = 30 participants was reported as 1 participant did not meet the inclusion criteria."|Participants|Count of Participants|0|0.0||||||
4056584|NCT01084265|3878213|B1||Female|Sex: Female, Male|"Demographic data for only N = 30 participants was reported as 1 participant did not meet the inclusion criteria."|Participants|Count of Participants|30|30.0||||||
4056585|NCT01084265|3878213|B1|||Age|"Demographic data for only N = 30 participants was reported as 1 participant did not meet the inclusion criteria."|years|Mean|30.1|30.1|Standard Deviation|4.09|4.09|||
4056586|NCT01084239|3878225|B3|United States||Region of Enrollment||participants|Number|1000|1000.0||||||
4056587|NCT01084239|3878226|B2|United States||Region of Enrollment||participants|Number|499|499.0||||||
4056588|NCT01084239|3878227|B1|United States||Region of Enrollment||participants|Number|501|501.0||||||
4056589|NCT01084239|3878225|B3||Male|Sex: Female, Male||Participants|Count of Participants|532|532.0||||||
4056590|NCT01084239|3878226|B2||Male|Sex: Female, Male||Participants|Count of Participants|270|270.0||||||
4056591|NCT01084239|3878227|B1||Male|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
4056592|NCT01084239|3878225|B3||Female|Sex: Female, Male||Participants|Count of Participants|468|468.0||||||
4056593|NCT01084239|3878226|B2||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4056594|NCT01084239|3878227|B1||Female|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
4056595|NCT01084239|3878225|B3|||Age||years|Mean|54|54.0|Standard Deviation|8|8.0|||
4056596|NCT01084239|3878226|B2|||Age||years|Mean|54|54.0|Standard Deviation|8|8.0|||
4056597|NCT01084239|3878227|B1|||Age||years|Mean|54|54.0|Standard Deviation|8|8.0|||
4056598|NCT01084239|3878225|B3||>=65 years|Age||Participants|Count of Participants|127|127.0||||||
4056599|NCT01084239|3878226|B2||>=65 years|Age||Participants|Count of Participants|59|59.0||||||
4056600|NCT01084239|3878227|B1||>=65 years|Age||Participants|Count of Participants|68|68.0||||||
4056601|NCT01084239|3878225|B3||Between 18 and 65 years|Age||Participants|Count of Participants|873|873.0||||||
4056602|NCT01084239|3878226|B2||Between 18 and 65 years|Age||Participants|Count of Participants|440|440.0||||||
4056603|NCT01084239|3878227|B1||Between 18 and 65 years|Age||Participants|Count of Participants|433|433.0||||||
4056604|NCT01084239|3878225|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056605|NCT01084239|3878226|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056606|NCT01084239|3878227|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056607|NCT01084174|3878244|B3|||Atopic dermatitis||Participants|Count of Participants|12|12.0||||||
4056608|NCT01084174|3878245|B2|||Atopic dermatitis||Participants|Count of Participants|6|6.0||||||
4056609|NCT01084174|3878246|B1|||Atopic dermatitis||Participants|Count of Participants|6|6.0||||||
4056610|NCT01084174|3878244|B3|||Other food allergies||Participants|Count of Participants|20|20.0||||||
4056611|NCT01084174|3878245|B2|||Other food allergies||Participants|Count of Participants|10|10.0||||||
4056612|NCT01084174|3878246|B1|||Other food allergies||Participants|Count of Participants|10|10.0||||||
4056613|NCT01084174|3878244|B3|||Prior history of peanut anaphylaxis||Participants|Count of Participants|7|7.0||||||
4056614|NCT01084174|3878245|B2|||Prior history of peanut anaphylaxis||Participants|Count of Participants|6|6.0||||||
4056615|NCT01084174|3878246|B1|||Prior history of peanut anaphylaxis||Participants|Count of Participants|1|1.0||||||
4056616|NCT01084174|3878244|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4056617|NCT01084174|3878245|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4056618|NCT01084174|3878246|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4056619|NCT01084174|3878244|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4056620|NCT01084174|3878245|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4056621|NCT01084174|3878246|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4056622|NCT01084174|3878244|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4056623|NCT01084174|3878245|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4056624|NCT01084174|3878246|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4056625|NCT01084174|3878244|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4056626|NCT01084174|3878245|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4056627|NCT01084174|3878246|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4056628|NCT01084174|3878244|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4056629|NCT01084174|3878245|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4056630|NCT01084174|3878246|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4056631|NCT01084174|3878244|B3||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
4056632|NCT01084174|3878245|B2||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4056633|NCT01084174|3878246|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4056634|NCT01084148|3878265|B3||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4056635|NCT01084148|3878266|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4056636|NCT01084148|3878267|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4056637|NCT01084148|3878265|B3||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4056638|NCT01084148|3878266|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4056639|NCT01084148|3878267|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4056640|NCT01084148|3878265|B3|||Age||years|Mean|64.65|64.65|Full Range|||23.0|89.0|
4056641|NCT01084148|3878266|B2|||Age||years|Mean|64.5|64.5|Full Range|||23.0|82.0|
4056642|NCT01084148|3878267|B1|||Age||years|Mean|64.8|64.8|Full Range|||26.0|89.0|
4056643|NCT01084135|3878276|B5|United States||Region of Enrollment||participants|Number|31|31.0||||||
4056644|NCT01084135|3878277|B4|United States||Region of Enrollment||participants|Number|4|4.0||||||
4056645|NCT01084135|3878278|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4056646|NCT01084135|3878279|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4056647|NCT01084135|3878280|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4056648|NCT01084135|3878276|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4056649|NCT01084135|3878277|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4056650|NCT01084135|3878278|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4056651|NCT01084135|3878279|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4056652|NCT01084135|3878280|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4056653|NCT01084135|3878276|B5||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4056654|NCT01084135|3878277|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4056655|NCT01084135|3878278|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4056656|NCT01084135|3878279|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4056657|NCT01084135|3878280|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4056658|NCT01084135|3878276|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4056659|NCT01084135|3878277|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4056660|NCT01084135|3878278|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4056661|NCT01084135|3878279|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4056662|NCT01084135|3878280|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4056663|NCT01084135|3878276|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4056664|NCT01084135|3878277|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4056665|NCT01084135|3878278|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4056666|NCT01084135|3878279|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4056667|NCT01084135|3878280|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4056668|NCT01084135|3878276|B5||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
4056669|NCT01084135|3878277|B4||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4056670|NCT01084135|3878278|B3||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4056671|NCT01084135|3878279|B2||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4056672|NCT01084135|3878280|B1||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4056673|NCT01084083|3878291|B1|United States||Region of Enrollment||participants|Number|80|80.0||||||
4056674|NCT01084083|3878291|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4056675|NCT01084083|3878291|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4056676|NCT01084083|3878291|B1|||Age||Years|Median|57|57.0|Full Range|||35.0|73.0|
4056677|NCT01084005|3878297|B3|||Fasting Plasma Glucose (FPG)|Based upon the FAS with 78 and 160 patients|mg/dL|Mean|149.9|149.9|Standard Deviation|29.2|29.2|||
4056678|NCT01084005|3878298|B2|||Fasting Plasma Glucose (FPG)|Based upon the FAS with 78 and 160 patients|mg/dL|Mean|152.7|152.7|Standard Deviation|28.7|28.7|||
4056679|NCT01084005|3878299|B1|||Fasting Plasma Glucose (FPG)|Based upon the FAS with 78 and 160 patients|mg/dL|Mean|144.1|144.1|Standard Deviation|29.6|29.6|||
4056680|NCT01084005|3878297|B3|||Glycosylated Hemoglobin A1 (HbA1c)|Based upon the full analysis set (FAS) with 78 and 160 patients|Percent|Mean|7.78|7.78|Standard Deviation|0.76|0.76|||
4056681|NCT01084005|3878298|B2|||Glycosylated Hemoglobin A1 (HbA1c)|Based upon the full analysis set (FAS) with 78 and 160 patients|Percent|Mean|7.82|7.82|Standard Deviation|0.78|0.78|||
4056682|NCT01084005|3878299|B1|||Glycosylated Hemoglobin A1 (HbA1c)|Based upon the full analysis set (FAS) with 78 and 160 patients|Percent|Mean|7.70|7.7|Standard Deviation|0.70|0.7|||
4056683|NCT01084005|3878297|B3|||Body mass index (BMI) continuous||kg/m^2|Mean|29.67|29.67|Standard Deviation|4.67|4.67|||
4056684|NCT01084005|3878298|B2|||Body mass index (BMI) continuous||kg/m^2|Mean|29.60|29.6|Standard Deviation|4.74|4.74|||
4056685|NCT01084005|3878299|B1|||Body mass index (BMI) continuous||kg/m^2|Mean|29.80|29.8|Standard Deviation|4.54|4.54|||
4056686|NCT01084005|3878297|B3||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4056687|NCT01084005|3878298|B2||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4056688|NCT01084005|3878299|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4056689|NCT01084005|3878297|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4056690|NCT01084005|3878298|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4056691|NCT01084005|3878299|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4056692|NCT01084005|3878297|B3|||Age||Years|Mean|74.9|74.9|Standard Deviation|4.3|4.3|||
4056693|NCT01084005|3878298|B2|||Age||Years|Mean|74.9|74.9|Standard Deviation|4.4|4.4|||
4056694|NCT01084005|3878299|B1|||Age||Years|Mean|74.9|74.9|Standard Deviation|4.2|4.2|||
4056695|NCT01083979|3878328|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4056696|NCT01083979|3878328|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4056697|NCT01083979|3878328|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
4056698|NCT01083979|3878328|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4056699|NCT01083979|3878328|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4056700|NCT01083979|3878328|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056701|NCT01083901|3878333|B4|||Fat mass|Total body fat mass measured by DXA (Hologic Discovery W, version 12.6)|kg|Mean|27.0|27.0|Standard Deviation|10.0|10.0|||
4056702|NCT01083901|3878334|B3|||Fat mass|Total body fat mass measured by DXA (Hologic Discovery W, version 12.6)|kg|Mean|25.2|25.2|Standard Deviation|9.6|9.6|||
4056703|NCT01083901|3878335|B2|||Fat mass|Total body fat mass measured by DXA (Hologic Discovery W, version 12.6)|kg|Mean|25.8|25.8|Standard Deviation|5.3|5.3|||
4056704|NCT01083901|3878336|B1|||Fat mass|Total body fat mass measured by DXA (Hologic Discovery W, version 12.6)|kg|Mean|29.3|29.3|Standard Deviation|12.6|12.6|||
4056705|NCT01083901|3878333|B4|||Fat-free mass|Total body fat-free mass measured by DXA (Hologic Discovery W, version 12.6)|kg|Mean|63.4|63.4|Standard Deviation|8.0|8.0|||
4056706|NCT01083901|3878334|B3|||Fat-free mass|Total body fat-free mass measured by DXA (Hologic Discovery W, version 12.6)|kg|Mean|62.7|62.7|Standard Deviation|9.1|9.1|||
4056707|NCT01083901|3878335|B2|||Fat-free mass|Total body fat-free mass measured by DXA (Hologic Discovery W, version 12.6)|kg|Mean|63.5|63.5|Standard Deviation|8.2|8.2|||
4056708|NCT01083901|3878336|B1|||Fat-free mass|Total body fat-free mass measured by DXA (Hologic Discovery W, version 12.6)|kg|Mean|65.2|65.2|Standard Deviation|6.1|6.1|||
4056709|NCT01083901|3878333|B4|||Weight||kg|Mean|90.4|90.4|Standard Deviation|16.4|16.4|||
4056710|NCT01083901|3878334|B3|||Weight||kg|Mean|87.9|87.9|Standard Deviation|18.0|18.0|||
4056711|NCT01083901|3878335|B2|||Weight||kg|Mean|89.3|89.3|Standard Deviation|12.5|12.5|||
4056712|NCT01083901|3878336|B1|||Weight||kg|Mean|94.5|94.5|Standard Deviation|16.6|16.6|||
4056713|NCT01083901|3878333|B4|||Height||cm|Mean|178|178.0|Standard Deviation|6.4|6.4|||
4056714|NCT01083901|3878334|B3|||Height||cm|Mean|176|176.0|Standard Deviation|7|7.0|||
4056715|NCT01083901|3878335|B2|||Height||cm|Mean|178|178.0|Standard Deviation|10|10.0|||
4056716|NCT01083901|3878336|B1|||Height||cm|Mean|181|181.0|Standard Deviation|8|8.0|||
4056717|NCT01083901|3878333|B4||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4056718|NCT01083901|3878334|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4056719|NCT01083901|3878335|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4056720|NCT01083901|3878336|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4056721|NCT01083901|3878333|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4056722|NCT01083901|3878334|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4056723|NCT01083901|3878335|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4056724|NCT01083901|3878336|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4056725|NCT01083901|3878333|B4|United States||Age||years|Mean|61|61.0|Standard Deviation|6|6.0|||
4056726|NCT01083901|3878334|B3|United States||Age||years|Mean|62|62.0|Standard Deviation|7|7.0|||
4056727|NCT01083901|3878335|B2|United States||Age||years|Mean|58|58.0|Standard Deviation|6|6.0|||
4056728|NCT01083901|3878336|B1|United States||Age||years|Mean|63|63.0|Standard Deviation|5|5.0|||
4056729|NCT01083849|3878355|B3|||Duration of Secondary Hyperparathyroidism|Duration of Secondary Hyperparathyroidism until the start of the study|months|Mean|39.5|39.5|Standard Deviation|35.8|35.8|||
4056730|NCT01083849|3878356|B2|||Duration of Secondary Hyperparathyroidism|Duration of Secondary Hyperparathyroidism until the start of the study|months|Mean|43.9|43.9|Standard Deviation|36.6|36.6|||
4056731|NCT01083849|3878357|B1|||Duration of Secondary Hyperparathyroidism|Duration of Secondary Hyperparathyroidism until the start of the study|months|Mean|17.7|17.7|Standard Deviation|20.6|20.6|||
4056732|NCT01083849|3878355|B3|||Duration of Chronic Kidney Disease|Duration of Chronic Kidney Disease until the start of the study|months|Mean|67.5|67.5|Standard Deviation|59.6|59.6|||
4056733|NCT01083849|3878356|B2|||Duration of Chronic Kidney Disease|Duration of Chronic Kidney Disease until the start of the study|months|Mean|71.2|71.2|Standard Deviation|61.1|61.1|||
4056734|NCT01083849|3878357|B1|||Duration of Chronic Kidney Disease|Duration of Chronic Kidney Disease until the start of the study|months|Mean|39.3|39.3|Standard Deviation|36.0|36.0|||
4056735|NCT01083849|3878355|B3||Male|Sex: Female, Male||Participants|Count of Participants|421|421.0||||||
4056736|NCT01083849|3878356|B2||Male|Sex: Female, Male||Participants|Count of Participants|347|347.0||||||
4056737|NCT01083849|3878357|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4056738|NCT01083849|3878355|B3||Female|Sex: Female, Male||Participants|Count of Participants|338|338.0||||||
4056739|NCT01083849|3878356|B2||Female|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
4056740|NCT01083849|3878357|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4056741|NCT01083849|3878355|B3|||Age||years|Mean|62.8|62.8|Standard Deviation|14.8|14.8|||
4056742|NCT01083849|3878356|B2|||Age||years|Mean|62.5|62.5|Standard Deviation|14.9|14.9|||
4056743|NCT01083849|3878357|B1|||Age||years|Mean|64.2|64.2|Standard Deviation|13.9|13.9|||
4056744|NCT01083810|3878378|B4|Germany||Region of Enrollment||participants|Number|284|284.0||||||
4056745|NCT01083810|3878379|B3|Germany||Region of Enrollment||participants|Number|55|55.0||||||
4056746|NCT01083810|3878380|B2|Germany||Region of Enrollment||participants|Number|92|92.0||||||
4056747|NCT01083810|3878381|B1|Germany||Region of Enrollment||participants|Number|137|137.0||||||
4056748|NCT01083810|3878378|B4|Gender not reported||Sex/Gender, Customized||Participants|Number|1|1.0||||||
4056749|NCT01083810|3878379|B3|Gender not reported||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4056750|NCT01083810|3878380|B2|Gender not reported||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4056751|NCT01083810|3878381|B1|Gender not reported||Sex/Gender, Customized||Participants|Number|1|1.0||||||
4056752|NCT01083810|3878378|B4|Male||Sex/Gender, Customized||Participants|Number|235|235.0||||||
4056753|NCT01083810|3878379|B3|Male||Sex/Gender, Customized||Participants|Number|35|35.0||||||
4056754|NCT01083810|3878380|B2|Male||Sex/Gender, Customized||Participants|Number|81|81.0||||||
4056755|NCT01083810|3878381|B1|Male||Sex/Gender, Customized||Participants|Number|119|119.0||||||
4056756|NCT01083810|3878378|B4|Female||Sex/Gender, Customized||Participants|Number|48|48.0||||||
4056757|NCT01083810|3878379|B3|Female||Sex/Gender, Customized||Participants|Number|20|20.0||||||
4056758|NCT01083810|3878380|B2|Female||Sex/Gender, Customized||Participants|Number|11|11.0||||||
4056759|NCT01083810|3878381|B1|Female||Sex/Gender, Customized||Participants|Number|17|17.0||||||
4056760|NCT01083810|3878378|B4|>= 18 years of age (exact age not reported)||Age, Customized||Participants|Number|284|284.0||||||
4056761|NCT01083810|3878379|B3|>= 18 years of age (exact age not reported)||Age, Customized||Participants|Number|55|55.0||||||
4056762|NCT01083810|3878380|B2|>= 18 years of age (exact age not reported)||Age, Customized||Participants|Number|92|92.0||||||
4056763|NCT01083810|3878381|B1|>= 18 years of age (exact age not reported)||Age, Customized||Participants|Number|137|137.0||||||
4056764|NCT01083771|3878404|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4056765|NCT01083771|3878404|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4056766|NCT01083771|3878404|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4056767|NCT01083771|3878404|B1|||Age||years|Mean|69.9|69.9|Full Range|||58.0|80.0|
4056768|NCT01083771|3878404|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4056769|NCT01083771|3878404|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4056770|NCT01083771|3878404|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056771|NCT01083758|3878409|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4056772|NCT01083758|3878409|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4056773|NCT01083758|3878409|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4056774|NCT01083758|3878409|B1|||Age||years|Mean|14.8|14.8|Standard Deviation|1.7|1.7|||
4056775|NCT01083758|3878409|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4056776|NCT01083758|3878409|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4056777|NCT01083758|3878409|B1||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
4056778|NCT01083732|3878440|B4||Male|Gender||Participants|Count of Participants|11|11.0||||||
4056779|NCT01083732|3878441|B3||Male|Gender||Participants|Count of Participants|1|1.0||||||
4056780|NCT01083732|3878442|B2||Male|Gender||Participants|Count of Participants|6|6.0||||||
4056781|NCT01083732|3878443|B1||Male|Gender||Participants|Count of Participants|4|4.0||||||
4056782|NCT01083732|3878440|B4||Female|Gender||Participants|Count of Participants|7|7.0||||||
4056783|NCT01083732|3878441|B3||Female|Gender||Participants|Count of Participants|2|2.0||||||
4056784|NCT01083732|3878442|B2||Female|Gender||Participants|Count of Participants|3|3.0||||||
4056785|NCT01083732|3878443|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
4056786|NCT01083732|3878440|B4|||Age||years|Mean|4.3|4.3|Standard Deviation|3.3|3.3|||
4056787|NCT01083732|3878441|B3|||Age||years|Mean|8.3|8.3|Standard Deviation|2.5|2.5|||
4056788|NCT01083732|3878442|B2|||Age||years|Mean|5.2|5.2|Standard Deviation|2.6|2.6|||
4056789|NCT01083732|3878443|B1|||Age||years|Mean|1.0|1.0|Standard Deviation|0.0|0.0|||
4056790|NCT01083706|3878496|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4056791|NCT01083706|3878496|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4056792|NCT01083706|3878496|B1|||Age||years|Median|52|52.0|Full Range|||23.0|76.0|
4056793|NCT01083693|3878502|B4|||Duration of underlying disease|Average duration (years) of underlying disease|years|Mean|7.7|7.7|Standard Deviation|8.5|8.5|||
4056794|NCT01083693|3878503|B3|||Duration of underlying disease|Average duration (years) of underlying disease|years|Mean|8.9|8.9|Standard Deviation|11.4|11.4|||
4056795|NCT01083693|3878504|B2|||Duration of underlying disease|Average duration (years) of underlying disease|years|Mean|6.2|6.2|Standard Deviation|6.8|6.8|||
4056796|NCT01083693|3878505|B1|||Duration of underlying disease|Average duration (years) of underlying disease|years|Mean|7.6|7.6|Standard Deviation|7.4|7.4|||
4056797|NCT01083693|3878502|B4|Austria||Region of Enrollment||participants|Number|161|161.0||||||
4056798|NCT01083693|3878503|B3|Austria||Region of Enrollment||participants|Number|40|40.0||||||
4056799|NCT01083693|3878504|B2|Austria||Region of Enrollment||participants|Number|28|28.0||||||
4056800|NCT01083693|3878505|B1|Austria||Region of Enrollment||participants|Number|93|93.0||||||
4056801|NCT01083693|3878502|B4||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4056802|NCT01083693|3878503|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4056803|NCT01083693|3878504|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4056804|NCT01083693|3878505|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4056805|NCT01083693|3878502|B4||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4056806|NCT01083693|3878503|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4056807|NCT01083693|3878504|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4056808|NCT01083693|3878505|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4056809|NCT01083693|3878502|B4|||Age||years|Mean|50.9|50.9|Standard Deviation|14.3|14.3|||
4056810|NCT01083693|3878503|B3|||Age||years|Mean|42.0|42.0|Standard Deviation|12.9|12.9|||
4056811|NCT01083693|3878504|B2|||Age||years|Mean|47.9|47.9|Standard Deviation|8.1|8.1|||
4056812|NCT01083693|3878505|B1|||Age||years|Mean|55.7|55.7|Standard Deviation|14.2|14.2|||
4056813|NCT01083680|3878542|B1||Male|Sex: Female, Male||Participants|Count of Participants|1583|1583.0||||||
4056814|NCT01083680|3878542|B1||Female|Sex: Female, Male||Participants|Count of Participants|2500|2500.0||||||
4056815|NCT01083680|3878542|B1|||Age||years|Mean|36.6|36.6|Standard Deviation|12.7|12.7|||
4056816|NCT01083667|3878551|B1|Germany||Region of Enrollment|enrollment of subjects in US and Europe|participants|Number|4|4.0||||||
4056817|NCT01083667|3878551|B1|Italy||Region of Enrollment|enrollment of subjects in US and Europe|participants|Number|8|8.0||||||
4056818|NCT01083667|3878551|B1|United States||Region of Enrollment|enrollment of subjects in US and Europe|participants|Number|20|20.0||||||
4056819|NCT01083667|3878551|B1||Male|Sex: Female, Male|gender of subjects enrolled|Participants|Count of Participants|16|16.0||||||
4056820|NCT01083667|3878551|B1||Female|Sex: Female, Male|gender of subjects enrolled|Participants|Count of Participants|16|16.0||||||
4056821|NCT01083667|3878551|B1|||Age||years|Mean|48|48.0|Full Range|||19.0|72.0|
4056822|NCT01083667|3878551|B1||>=65 years|Age|age of subjects enrolled|Participants|Count of Participants|1|1.0||||||
4056823|NCT01083667|3878551|B1||Between 18 and 65 years|Age|age of subjects enrolled|Participants|Count of Participants|31|31.0||||||
4056824|NCT01083667|3878551|B1||<=18 years|Age|age of subjects enrolled|Participants|Count of Participants|0|0.0||||||
4056825|NCT01083654|3878556|B3|United States||Region of Enrollment||participants|Number|103|103.0||||||
4056826|NCT01083654|3878557|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
4056827|NCT01083654|3878558|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
4056828|NCT01083654|3878556|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056829|NCT01083654|3878557|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056830|NCT01083654|3878558|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056831|NCT01083654|3878556|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056832|NCT01083654|3878557|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056833|NCT01083654|3878558|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056834|NCT01083654|3878556|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056835|NCT01083654|3878557|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056836|NCT01083654|3878558|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056837|NCT01083654|3878556|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056838|NCT01083654|3878557|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056839|NCT01083654|3878558|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056840|NCT01083654|3878556|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056841|NCT01083654|3878557|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056842|NCT01083654|3878558|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056843|NCT01083654|3878556|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056844|NCT01083654|3878557|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056845|NCT01083654|3878558|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056846|NCT01083654|3878556|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
4056847|NCT01083654|3878557|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4056848|NCT01083654|3878558|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4056849|NCT01083654|3878556|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4056850|NCT01083654|3878557|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4056851|NCT01083654|3878558|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4056852|NCT01083654|3878556|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4056853|NCT01083654|3878557|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4056854|NCT01083654|3878558|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4056855|NCT01083654|3878556|B3|||Age||years|Mean|39.8|39.8|Standard Deviation|13.1|13.1|||
4056856|NCT01083654|3878557|B2|||Age||years|Mean|40.1|40.1|Standard Deviation|12.7|12.7|||
4056857|NCT01083654|3878558|B1|||Age||years|Mean|39.4|39.4|Standard Deviation|13.5|13.5|||
4056858|NCT01083641|3878565|B1|Stage IV||Stage at Diagnosis|"Breast cancer stages:~I: tumor =<2cm and no lymph nodes involved.~II: tumor measures 2cm-5cm, or cancer has spread to lymph nodes under the arm on the same side as the breast cancer.~III: Tumor >2cm and cancer is extensive in the underarm lymph nodes, or has spread to other lymph nodes or tissues near the breast.~IV: Cancer has spread beyond the breast, underarm, and internal mammary lymph nodes to other parts of the body near to or distant from the breast."|Participants|Count of Participants|1|1.0||||||
4056859|NCT01083641|3878565|B1|Stage III||Stage at Diagnosis|"Breast cancer stages:~I: tumor =<2cm and no lymph nodes involved.~II: tumor measures 2cm-5cm, or cancer has spread to lymph nodes under the arm on the same side as the breast cancer.~III: Tumor >2cm and cancer is extensive in the underarm lymph nodes, or has spread to other lymph nodes or tissues near the breast.~IV: Cancer has spread beyond the breast, underarm, and internal mammary lymph nodes to other parts of the body near to or distant from the breast."|Participants|Count of Participants|4|4.0||||||
4056860|NCT01083641|3878565|B1|Stage II||Stage at Diagnosis|"Breast cancer stages:~I: tumor =<2cm and no lymph nodes involved.~II: tumor measures 2cm-5cm, or cancer has spread to lymph nodes under the arm on the same side as the breast cancer.~III: Tumor >2cm and cancer is extensive in the underarm lymph nodes, or has spread to other lymph nodes or tissues near the breast.~IV: Cancer has spread beyond the breast, underarm, and internal mammary lymph nodes to other parts of the body near to or distant from the breast."|Participants|Count of Participants|9|9.0||||||
4056861|NCT01083641|3878565|B1|Stage I||Stage at Diagnosis|"Breast cancer stages:~I: tumor =<2cm and no lymph nodes involved.~II: tumor measures 2cm-5cm, or cancer has spread to lymph nodes under the arm on the same side as the breast cancer.~III: Tumor >2cm and cancer is extensive in the underarm lymph nodes, or has spread to other lymph nodes or tissues near the breast.~IV: Cancer has spread beyond the breast, underarm, and internal mammary lymph nodes to other parts of the body near to or distant from the breast."|Participants|Count of Participants|3|3.0||||||
4056862|NCT01083641|3878565|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4056863|NCT01083641|3878565|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4056864|NCT01083641|3878565|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056865|NCT01083641|3878565|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4056866|NCT01083641|3878565|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056867|NCT01083641|3878565|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056868|NCT01083641|3878565|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4056869|NCT01083641|3878565|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4056870|NCT01083641|3878565|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4056871|NCT01083641|3878565|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4056872|NCT01083641|3878565|B1|||Age||years|Median|57.9|57.9|Full Range|||34.0|90.0|
4056873|NCT01083602|3878572|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4056874|NCT01083602|3878572|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4056875|NCT01083602|3878572|B1|||Age||years|Mean|61.9|61.9|Standard Deviation|10.54|10.54|||
4056876|NCT01083576|3878581|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
4056877|NCT01083576|3878582|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4056878|NCT01083576|3878583|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4056879|NCT01083576|3878581|B3|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4056880|NCT01083576|3878582|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4056881|NCT01083576|3878583|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4056882|NCT01083576|3878581|B3|Mestizo||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
4056883|NCT01083576|3878582|B2|Mestizo||Race/Ethnicity, Customized||Participants|Number|15|15.0||93.3|93.3|||
4056884|NCT01083576|3878583|B1|Mestizo||Race/Ethnicity, Customized||Participants|Number|14|14.0||100|100.0|||
4056885|NCT01083576|3878581|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4056886|NCT01083576|3878582|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4056887|NCT01083576|3878583|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4056888|NCT01083576|3878581|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4056889|NCT01083576|3878582|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4056890|NCT01083576|3878583|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4056891|NCT01083576|3878581|B3|||Age||years|Mean|24.7|24.7|Standard Deviation|15.8|15.8|||
4056892|NCT01083576|3878582|B2|||Age||years|Mean|25.5|25.5|Standard Deviation|15.9|15.9|||
4056893|NCT01083576|3878583|B1|||Age||years|Mean|24.0|24.0|Standard Deviation|16.2|16.2|||
4056894|NCT01083485|3878612|B3|Finland||Region of Enrollment||participants|Number|137|137.0||||||
4056895|NCT01083485|3878613|B2|Finland||Region of Enrollment||participants|Number|67|67.0||||||
4056896|NCT01083485|3878614|B1|Finland||Region of Enrollment||participants|Number|70|70.0||||||
4056897|NCT01083485|3878612|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4056898|NCT01083485|3878613|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4056899|NCT01083485|3878614|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4056900|NCT01083485|3878612|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4056901|NCT01083485|3878613|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4056902|NCT01083485|3878614|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4056903|NCT01083485|3878612|B3|||Age||years|Mean|64|64.0|Standard Deviation|6.7|6.7|||
4056904|NCT01083485|3878613|B2|||Age||years|Mean|64|64.0|Standard Deviation|6.7|6.7|||
4056905|NCT01083485|3878614|B1|||Age||years|Mean|64|64.0|Standard Deviation|6.7|6.7|||
4056906|NCT01083485|3878612|B3||>=65 years|Age||Participants|Count of Participants|68|68.0||||||
4056907|NCT01083485|3878613|B2||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
4056908|NCT01083485|3878614|B1||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
4056909|NCT01083485|3878612|B3||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
4056910|NCT01083485|3878613|B2||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4056911|NCT01083485|3878614|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4056912|NCT01083485|3878612|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056913|NCT01083485|3878613|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056914|NCT01083485|3878614|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056915|NCT01083472|3878623|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4056916|NCT01083472|3878624|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4056917|NCT01083472|3878625|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4056918|NCT01083472|3878623|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4056919|NCT01083472|3878624|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4056920|NCT01083472|3878625|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4056921|NCT01083472|3878623|B3|||Age||years|Mean|68.5|68.5|Standard Deviation|9.22|9.22|||
4056922|NCT01083472|3878624|B2|||Age||years|Mean|67|67.0|Standard Deviation|8.49|8.49|||
4056923|NCT01083472|3878625|B1|||Age||years|Mean|70|70.0|Standard Deviation|9.94|9.94|||
4056924|NCT01083316|3878632|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4056925|NCT01083316|3878632|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4056926|NCT01083316|3878632|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4056927|NCT01083316|3878632|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4056928|NCT01083316|3878632|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4056929|NCT01083199|3878638|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4056930|NCT01083199|3878638|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4056931|NCT01083199|3878638|B1|||Age||Years|Mean|64.7|64.7|Standard Deviation|7.9|7.9|||
4056932|NCT01083186|3878643|B1||Male|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
4056933|NCT01083186|3878643|B1||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4056934|NCT01083186|3878643|B1|||Age||years|Mean|67.4|67.4|Standard Deviation|13.6|13.6|||
4056935|NCT01083173|3878684|B1|Long-Term Surveillance Males||Sex/Gender, Customized||participants|Number|432|432.0||||||
4056936|NCT01083173|3878684|B1|Long-Term Surveillance Females||Sex/Gender, Customized||participants|Number|47|47.0||||||
4056937|NCT01083173|3878684|B1|Main Surveillance Males||Sex/Gender, Customized||participants|Number|524|524.0||||||
4056938|NCT01083173|3878684|B1|Main Surveillance Females||Sex/Gender, Customized||participants|Number|56|56.0||||||
4056939|NCT01083173|3878684|B1|Long-term Surveillance n=479||Age, Customized||years|Mean|41|41.0|Standard Deviation|12.1|12.1|||
4056940|NCT01083173|3878684|B1|Main Surveillance n= 580||Age, Customized||years|Mean|41.3|41.3|Standard Deviation|12.5|12.5|||
4056941|NCT01083160|3878703|B1|Mexico||Region of Enrollment||participants|Number|82|82.0||||||
4056942|NCT01083160|3878703|B1|Gender not reported||Sex/Gender, Customized||participants|Number|3|3.0||||||
4056943|NCT01083160|3878703|B1|Male||Sex/Gender, Customized||participants|Number|13|13.0||||||
4056944|NCT01083160|3878703|B1|Female||Sex/Gender, Customized||participants|Number|66|66.0||||||
4056945|NCT01083160|3878703|B1|||Age||years|Mean|48.34|48.34|Standard Deviation|11.56|11.56|||
4056946|NCT01083121|3878710|B1|Psoriasis||Indication||participants|Number|1|1.0||||||
4056947|NCT01083121|3878710|B1|Crohn's disease||Indication||participants|Number|73|73.0||||||
4056948|NCT01083121|3878710|B1|Ankylosing spondylitis||Indication||participants|Number|925|925.0||||||
4056949|NCT01083121|3878710|B1|Psoriatic arthritis||Indication||participants|Number|47|47.0||||||
4056950|NCT01083121|3878710|B1|Rheumatoid arthritis||Indication||participants|Number|652|652.0||||||
4056951|NCT01083121|3878710|B1|Korea, Republic of||Region of Enrollment||participants|Number|1,698|1.0||||||
4056952|NCT01083121|3878710|B1||Male|Sex: Female, Male||Participants|Count of Participants|969|969.0||||||
4056953|NCT01083121|3878710|B1||Female|Sex: Female, Male||Participants|Count of Participants|729|729.0||||||
4056954|NCT01083121|3878710|B1|||Age||years|Mean|41.80|41.8|Standard Deviation|13.89|13.89|||
4056955|NCT01082965|3878718|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4056956|NCT01082965|3878719|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4056957|NCT01082965|3878720|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4056958|NCT01082965|3878718|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4056959|NCT01082965|3878719|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4056960|NCT01082965|3878720|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4056961|NCT01082965|3878718|B3|||Age||years|Mean|72.9|72.9|Standard Deviation|8.5|8.5|||
4056962|NCT01082965|3878719|B2|||Age||years|Mean|70.6|70.6|Standard Deviation|6.9|6.9|||
4056963|NCT01082965|3878720|B1|||Age||years|Mean|74.7|74.7|Standard Deviation|9.6|9.6|||
4056964|NCT01082952|3878739|B3|Saudi Arabia||Region of Enrollment||participants|Number|12|12.0||||||
4056965|NCT01082952|3878740|B2|Saudi Arabia||Region of Enrollment||participants|Number|6|6.0||||||
4056966|NCT01082952|3878741|B1|Saudi Arabia||Region of Enrollment||participants|Number|6|6.0||||||
4056967|NCT01082952|3878739|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4056968|NCT01082952|3878740|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4056969|NCT01082952|3878741|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4056970|NCT01082952|3878739|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4056971|NCT01082952|3878740|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4056972|NCT01082952|3878741|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4056973|NCT01082952|3878739|B3|||Age||years|Mean|23.5|23.5|Standard Deviation|2.75|2.75|||
4056974|NCT01082952|3878740|B2|||Age||years|Mean|24|24.0|Standard Deviation|2.5|2.5|||
4056975|NCT01082952|3878741|B1|||Age||years|Mean|23|23.0|Standard Deviation|3|3.0|||
4056976|NCT01082952|3878739|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4056977|NCT01082952|3878740|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4056978|NCT01082952|3878741|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4056979|NCT01082952|3878739|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4056980|NCT01082952|3878740|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4056981|NCT01082952|3878741|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4056982|NCT01082952|3878739|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4056983|NCT01082952|3878740|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4056984|NCT01082952|3878741|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4056985|NCT01082939|3878750|B1|United States||Region of Enrollment||participants|Number|80|80.0||||||
4056986|NCT01082939|3878750|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4056987|NCT01082939|3878750|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4056988|NCT01082939|3878750|B1|||Age||years|Median|59.5|59.5|Full Range|||39.0|79.0|
4056989|NCT01082874|3878754|B5|Germany||Region of Enrollment||participants|Number|31|31.0||||||
4056990|NCT01082874|3878755|B4|Germany||Region of Enrollment||participants|Number|7|7.0||||||
4056991|NCT01082874|3878756|B3|Germany||Region of Enrollment||participants|Number|11|11.0||||||
4056992|NCT01082874|3878757|B2|Germany||Region of Enrollment||participants|Number|7|7.0||||||
4056993|NCT01082874|3878758|B1|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4056994|NCT01082874|3878754|B5|Peru||Region of Enrollment||participants|Number|172|172.0||||||
4056995|NCT01082874|3878755|B4|Peru||Region of Enrollment||participants|Number|44|44.0||||||
4056996|NCT01082874|3878756|B3|Peru||Region of Enrollment||participants|Number|43|43.0||||||
4056997|NCT01082874|3878757|B2|Peru||Region of Enrollment||participants|Number|44|44.0||||||
4056998|NCT01082874|3878758|B1|Peru||Region of Enrollment||participants|Number|41|41.0||||||
4056999|NCT01082874|3878754|B5|France||Region of Enrollment||participants|Number|89|89.0||||||
4057000|NCT01082874|3878755|B4|France||Region of Enrollment||participants|Number|20|20.0||||||
4057001|NCT01082874|3878756|B3|France||Region of Enrollment||participants|Number|24|24.0||||||
4057002|NCT01082874|3878757|B2|France||Region of Enrollment||participants|Number|24|24.0||||||
4057003|NCT01082874|3878758|B1|France||Region of Enrollment||participants|Number|21|21.0||||||
4057004|NCT01082874|3878754|B5|Chile||Region of Enrollment||participants|Number|153|153.0||||||
4057005|NCT01082874|3878755|B4|Chile||Region of Enrollment||participants|Number|39|39.0||||||
4057006|NCT01082874|3878756|B3|Chile||Region of Enrollment||participants|Number|38|38.0||||||
4057007|NCT01082874|3878757|B2|Chile||Region of Enrollment||participants|Number|38|38.0||||||
4057008|NCT01082874|3878758|B1|Chile||Region of Enrollment||participants|Number|38|38.0||||||
4057009|NCT01082874|3878754|B5|Australia||Region of Enrollment||participants|Number|470|470.0||||||
4057010|NCT01082874|3878755|B4|Australia||Region of Enrollment||participants|Number|118|118.0||||||
4057011|NCT01082874|3878756|B3|Australia||Region of Enrollment||participants|Number|113|113.0||||||
4057012|NCT01082874|3878757|B2|Australia||Region of Enrollment||participants|Number|120|120.0||||||
4057013|NCT01082874|3878758|B1|Australia||Region of Enrollment||participants|Number|119|119.0||||||
4057014|NCT01082874|3878754|B5|South Africa||Region of Enrollment||participants|Number|353|353.0||||||
4057015|NCT01082874|3878755|B4|South Africa||Region of Enrollment||participants|Number|90|90.0||||||
4057016|NCT01082874|3878756|B3|South Africa||Region of Enrollment||participants|Number|89|89.0||||||
4057017|NCT01082874|3878757|B2|South Africa||Region of Enrollment||participants|Number|87|87.0||||||
4057018|NCT01082874|3878758|B1|South Africa||Region of Enrollment||participants|Number|87|87.0||||||
4057019|NCT01082874|3878754|B5|Italy||Region of Enrollment||participants|Number|154|154.0||||||
4057020|NCT01082874|3878755|B4|Italy||Region of Enrollment||participants|Number|38|38.0||||||
4057021|NCT01082874|3878756|B3|Italy||Region of Enrollment||participants|Number|38|38.0||||||
4057022|NCT01082874|3878757|B2|Italy||Region of Enrollment||participants|Number|39|39.0||||||
4057023|NCT01082874|3878758|B1|Italy||Region of Enrollment||participants|Number|39|39.0||||||
4057024|NCT01082874|3878754|B5|Denmark||Region of Enrollment||participants|Number|321|321.0||||||
4057025|NCT01082874|3878755|B4|Denmark||Region of Enrollment||participants|Number|81|81.0||||||
4057026|NCT01082874|3878756|B3|Denmark||Region of Enrollment||participants|Number|80|80.0||||||
4057027|NCT01082874|3878757|B2|Denmark||Region of Enrollment||participants|Number|80|80.0||||||
4057028|NCT01082874|3878758|B1|Denmark||Region of Enrollment||participants|Number|80|80.0||||||
4057029|NCT01082874|3878754|B5|Brazil||Region of Enrollment||participants|Number|57|57.0||||||
4057030|NCT01082874|3878755|B4|Brazil||Region of Enrollment||participants|Number|16|16.0||||||
4057031|NCT01082874|3878756|B3|Brazil||Region of Enrollment||participants|Number|16|16.0||||||
4057032|NCT01082874|3878757|B2|Brazil||Region of Enrollment||participants|Number|12|12.0||||||
4057033|NCT01082874|3878758|B1|Brazil||Region of Enrollment||participants|Number|13|13.0||||||
4057034|NCT01082874|3878754|B5|Belgium||Region of Enrollment||participants|Number|184|184.0||||||
4057035|NCT01082874|3878755|B4|Belgium||Region of Enrollment||participants|Number|47|47.0||||||
4057036|NCT01082874|3878756|B3|Belgium||Region of Enrollment||participants|Number|46|46.0||||||
4057037|NCT01082874|3878757|B2|Belgium||Region of Enrollment||participants|Number|47|47.0||||||
4057038|NCT01082874|3878758|B1|Belgium||Region of Enrollment||participants|Number|44|44.0||||||
4057039|NCT01082874|3878754|B5|Pakistan||Region of Enrollment||participants|Number|175|175.0||||||
4057040|NCT01082874|3878755|B4|Pakistan||Region of Enrollment||participants|Number|44|44.0||||||
4057041|NCT01082874|3878756|B3|Pakistan||Region of Enrollment||participants|Number|44|44.0||||||
4057042|NCT01082874|3878757|B2|Pakistan||Region of Enrollment||participants|Number|44|44.0||||||
4057043|NCT01082874|3878758|B1|Pakistan||Region of Enrollment||participants|Number|43|43.0||||||
4057044|NCT01082874|3878754|B5|Austria||Region of Enrollment||participants|Number|176|176.0||||||
4057045|NCT01082874|3878755|B4|Austria||Region of Enrollment||participants|Number|46|46.0||||||
4057046|NCT01082874|3878756|B3|Austria||Region of Enrollment||participants|Number|42|42.0||||||
4057047|NCT01082874|3878757|B2|Austria||Region of Enrollment||participants|Number|44|44.0||||||
4057048|NCT01082874|3878758|B1|Austria||Region of Enrollment||participants|Number|44|44.0||||||
4057049|NCT01082874|3878754|B5|Canada||Region of Enrollment||participants|Number|3498|3498.0||||||
4057050|NCT01082874|3878755|B4|Canada||Region of Enrollment||participants|Number|873|873.0||||||
4057051|NCT01082874|3878756|B3|Canada||Region of Enrollment||participants|Number|872|872.0||||||
4057052|NCT01082874|3878757|B2|Canada||Region of Enrollment||participants|Number|878|878.0||||||
4057053|NCT01082874|3878758|B1|Canada||Region of Enrollment||participants|Number|875|875.0||||||
4057054|NCT01082874|3878754|B5|New Zealand||Region of Enrollment||participants|Number|46|46.0||||||
4057055|NCT01082874|3878755|B4|New Zealand||Region of Enrollment||participants|Number|10|10.0||||||
4057056|NCT01082874|3878756|B3|New Zealand||Region of Enrollment||participants|Number|11|11.0||||||
4057057|NCT01082874|3878757|B2|New Zealand||Region of Enrollment||participants|Number|11|11.0||||||
4057058|NCT01082874|3878758|B1|New Zealand||Region of Enrollment||participants|Number|14|14.0||||||
4057059|NCT01082874|3878754|B5|Spain||Region of Enrollment||participants|Number|538|538.0||||||
4057060|NCT01082874|3878755|B4|Spain||Region of Enrollment||participants|Number|135|135.0||||||
4057061|NCT01082874|3878756|B3|Spain||Region of Enrollment||participants|Number|131|131.0||||||
4057062|NCT01082874|3878757|B2|Spain||Region of Enrollment||participants|Number|139|139.0||||||
4057063|NCT01082874|3878758|B1|Spain||Region of Enrollment||participants|Number|133|133.0||||||
4057064|NCT01082874|3878754|B5|India||Region of Enrollment||participants|Number|595|595.0||||||
4057065|NCT01082874|3878755|B4|India||Region of Enrollment||participants|Number|146|146.0||||||
4057066|NCT01082874|3878756|B3|India||Region of Enrollment||participants|Number|151|151.0||||||
4057067|NCT01082874|3878757|B2|India||Region of Enrollment||participants|Number|149|149.0||||||
4057068|NCT01082874|3878758|B1|India||Region of Enrollment||participants|Number|149|149.0||||||
4057069|NCT01082874|3878754|B5|Switzerland||Region of Enrollment||participants|Number|96|96.0||||||
4057070|NCT01082874|3878755|B4|Switzerland||Region of Enrollment||participants|Number|23|23.0||||||
4057071|NCT01082874|3878756|B3|Switzerland||Region of Enrollment||participants|Number|25|25.0||||||
4057072|NCT01082874|3878757|B2|Switzerland||Region of Enrollment||participants|Number|24|24.0||||||
4057073|NCT01082874|3878758|B1|Switzerland||Region of Enrollment||participants|Number|24|24.0||||||
4057074|NCT01082874|3878754|B5|Malaysia||Region of Enrollment||participants|Number|120|120.0||||||
4057075|NCT01082874|3878755|B4|Malaysia||Region of Enrollment||participants|Number|32|32.0||||||
4057076|NCT01082874|3878756|B3|Malaysia||Region of Enrollment||participants|Number|30|30.0||||||
4057077|NCT01082874|3878757|B2|Malaysia||Region of Enrollment||participants|Number|28|28.0||||||
4057078|NCT01082874|3878758|B1|Malaysia||Region of Enrollment||participants|Number|30|30.0||||||
4057079|NCT01082874|3878754|B5|United Kingdom||Region of Enrollment||participants|Number|86|86.0||||||
4057080|NCT01082874|3878755|B4|United Kingdom||Region of Enrollment||participants|Number|20|20.0||||||
4057081|NCT01082874|3878756|B3|United Kingdom||Region of Enrollment||participants|Number|22|22.0||||||
4057082|NCT01082874|3878757|B2|United Kingdom||Region of Enrollment||participants|Number|22|22.0||||||
4057083|NCT01082874|3878758|B1|United Kingdom||Region of Enrollment||participants|Number|22|22.0||||||
4057084|NCT01082874|3878754|B5|United States||Region of Enrollment||participants|Number|1760|1760.0||||||
4057085|NCT01082874|3878755|B4|United States||Region of Enrollment||participants|Number|440|440.0||||||
4057086|NCT01082874|3878756|B3|United States||Region of Enrollment||participants|Number|437|437.0||||||
4057087|NCT01082874|3878757|B2|United States||Region of Enrollment||participants|Number|440|440.0||||||
4057088|NCT01082874|3878758|B1|United States||Region of Enrollment||participants|Number|443|443.0||||||
4057089|NCT01082874|3878754|B5|Hong Kong||Region of Enrollment||participants|Number|276|276.0||||||
4057090|NCT01082874|3878755|B4|Hong Kong||Region of Enrollment||participants|Number|68|68.0||||||
4057091|NCT01082874|3878756|B3|Hong Kong||Region of Enrollment||participants|Number|69|69.0||||||
4057092|NCT01082874|3878757|B2|Hong Kong||Region of Enrollment||participants|Number|70|70.0||||||
4057093|NCT01082874|3878758|B1|Hong Kong||Region of Enrollment||participants|Number|69|69.0||||||
4057094|NCT01082874|3878754|B5|Argentina||Region of Enrollment||participants|Number|11|11.0||||||
4057095|NCT01082874|3878755|B4|Argentina||Region of Enrollment||participants|Number|3|3.0||||||
4057096|NCT01082874|3878756|B3|Argentina||Region of Enrollment||participants|Number|3|3.0||||||
4057097|NCT01082874|3878757|B2|Argentina||Region of Enrollment||participants|Number|2|2.0||||||
4057098|NCT01082874|3878758|B1|Argentina||Region of Enrollment||participants|Number|3|3.0||||||
4057099|NCT01082874|3878754|B5|Colombia||Region of Enrollment||participants|Number|649|649.0||||||
4057100|NCT01082874|3878755|B4|Colombia||Region of Enrollment||participants|Number|162|162.0||||||
4057101|NCT01082874|3878756|B3|Colombia||Region of Enrollment||participants|Number|164|164.0||||||
4057102|NCT01082874|3878757|B2|Colombia||Region of Enrollment||participants|Number|161|161.0||||||
4057103|NCT01082874|3878758|B1|Colombia||Region of Enrollment||participants|Number|162|162.0||||||
4057104|NCT01082874|3878754|B5|Male||Gender||participants|Number|5283|5283.0||||||
4057105|NCT01082874|3878755|B4|Male||Gender||participants|Number|1340|1340.0||||||
4057106|NCT01082874|3878756|B3|Male||Gender||participants|Number|1310|1310.0||||||
4057107|NCT01082874|3878757|B2|Male||Gender||participants|Number|1346|1346.0||||||
4057108|NCT01082874|3878758|B1|Male||Gender||participants|Number|1287|1287.0||||||
4057109|NCT01082874|3878754|B5|Female||Gender||participants|Number|4724|4724.0||||||
4057110|NCT01082874|3878755|B4|Female||Gender||participants|Number|1160|1160.0||||||
4057111|NCT01082874|3878756|B3|Female||Gender||participants|Number|1188|1188.0||||||
4057112|NCT01082874|3878757|B2|Female||Gender||participants|Number|1164|1164.0||||||
4057113|NCT01082874|3878758|B1|Female||Gender||participants|Number|1212|1212.0||||||
4057114|NCT01082874|3878754|B5|||Age||years|Mean|68.6|68.6|Standard Deviation|10.3|10.3|||
4057115|NCT01082874|3878755|B4|||Age||years|Mean|68.5|68.5|Standard Deviation|10.3|10.3|||
4057116|NCT01082874|3878756|B3|||Age||years|Mean|68.7|68.7|Standard Deviation|10.2|10.2|||
4057117|NCT01082874|3878757|B2|||Age||years|Mean|68.6|68.6|Standard Deviation|10.3|10.3|||
4057118|NCT01082874|3878758|B1|||Age||years|Mean|68.4|68.4|Standard Deviation|10.4|10.4|||
4057119|NCT01082874|3878754|B5||>=65 years|Age||Participants|Count of Participants|6599|6599.0||||||
4057120|NCT01082874|3878755|B4||>=65 years|Age||Participants|Count of Participants|1636|1636.0||||||
4057121|NCT01082874|3878756|B3||>=65 years|Age||Participants|Count of Participants|1663|1663.0||||||
4057122|NCT01082874|3878757|B2||>=65 years|Age||Participants|Count of Participants|1674|1674.0||||||
4057123|NCT01082874|3878758|B1||>=65 years|Age||Participants|Count of Participants|1626|1626.0||||||
4057124|NCT01082874|3878754|B5||Between 18 and 65 years|Age||Participants|Count of Participants|3411|3411.0||||||
4057125|NCT01082874|3878755|B4||Between 18 and 65 years|Age||Participants|Count of Participants|866|866.0||||||
4057126|NCT01082874|3878756|B3||Between 18 and 65 years|Age||Participants|Count of Participants|836|836.0||||||
4057127|NCT01082874|3878757|B2||Between 18 and 65 years|Age||Participants|Count of Participants|836|836.0||||||
4057128|NCT01082874|3878758|B1||Between 18 and 65 years|Age||Participants|Count of Participants|873|873.0||||||
4057129|NCT01082874|3878754|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4057130|NCT01082874|3878755|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4057131|NCT01082874|3878756|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4057132|NCT01082874|3878757|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4057133|NCT01082874|3878758|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4057134|NCT01082640|3878771|B4|Mixed||Composition of most recent passed stone|Number of participants with a kidney stone passage was 2, 1 and 3 in each treatment arm respectively.|participants|Number|1|1.0||||||
4057135|NCT01082640|3878772|B3|Mixed||Composition of most recent passed stone|Number of participants with a kidney stone passage was 2, 1 and 3 in each treatment arm respectively.|participants|Number|0|0.0||||||
4057136|NCT01082640|3878773|B2|Mixed||Composition of most recent passed stone|Number of participants with a kidney stone passage was 2, 1 and 3 in each treatment arm respectively.|participants|Number|1|1.0||||||
4057137|NCT01082640|3878774|B1|Mixed||Composition of most recent passed stone|Number of participants with a kidney stone passage was 2, 1 and 3 in each treatment arm respectively.|participants|Number|0|0.0||||||
4057138|NCT01082640|3878771|B4|Calcium citrate||Composition of most recent passed stone|Number of participants with a kidney stone passage was 2, 1 and 3 in each treatment arm respectively.|participants|Number|1|1.0||||||
4057139|NCT01082640|3878772|B3|Calcium citrate||Composition of most recent passed stone|Number of participants with a kidney stone passage was 2, 1 and 3 in each treatment arm respectively.|participants|Number|1|1.0||||||
4057140|NCT01082640|3878773|B2|Calcium citrate||Composition of most recent passed stone|Number of participants with a kidney stone passage was 2, 1 and 3 in each treatment arm respectively.|participants|Number|0|0.0||||||
4057141|NCT01082640|3878774|B1|Calcium citrate||Composition of most recent passed stone|Number of participants with a kidney stone passage was 2, 1 and 3 in each treatment arm respectively.|participants|Number|0|0.0||||||
4057142|NCT01082640|3878771|B4|Uric acid||Composition of most recent passed stone|Number of participants with a kidney stone passage was 2, 1 and 3 in each treatment arm respectively.|participants|Number|2|2.0||||||
4057143|NCT01082640|3878772|B3|Uric acid||Composition of most recent passed stone|Number of participants with a kidney stone passage was 2, 1 and 3 in each treatment arm respectively.|participants|Number|1|1.0||||||
4057144|NCT01082640|3878773|B2|Uric acid||Composition of most recent passed stone|Number of participants with a kidney stone passage was 2, 1 and 3 in each treatment arm respectively.|participants|Number|0|0.0||||||
4057187|NCT01082640|3878772|B3|4 to less than 6 months ago||Time since last gout flare||participants|Number|2|2.0||||||
4057145|NCT01082640|3878774|B1|Uric acid||Composition of most recent passed stone|Number of participants with a kidney stone passage was 2, 1 and 3 in each treatment arm respectively.|participants|Number|1|1.0||||||
4057146|NCT01082640|3878771|B4|Calcium Oxalate||Composition of most recent passed stone|Number of participants with a kidney stone passage was 2, 1 and 3 in each treatment arm respectively.|participants|Number|2|2.0||||||
4057147|NCT01082640|3878772|B3|Calcium Oxalate||Composition of most recent passed stone|Number of participants with a kidney stone passage was 2, 1 and 3 in each treatment arm respectively.|participants|Number|1|1.0||||||
4057148|NCT01082640|3878773|B2|Calcium Oxalate||Composition of most recent passed stone|Number of participants with a kidney stone passage was 2, 1 and 3 in each treatment arm respectively.|participants|Number|0|0.0||||||
4057149|NCT01082640|3878774|B1|Calcium Oxalate||Composition of most recent passed stone|Number of participants with a kidney stone passage was 2, 1 and 3 in each treatment arm respectively.|participants|Number|1|1.0||||||
4057150|NCT01082640|3878771|B4|||Kidney Stone Passage|The number of participants with kidney stone episodes was 5, 6 and 11 in each treatment arm respectively.|participants|Number|6|6.0||||||
4057151|NCT01082640|3878772|B3|||Kidney Stone Passage|The number of participants with kidney stone episodes was 5, 6 and 11 in each treatment arm respectively.|participants|Number|3|3.0||||||
4057152|NCT01082640|3878773|B2|||Kidney Stone Passage|The number of participants with kidney stone episodes was 5, 6 and 11 in each treatment arm respectively.|participants|Number|1|1.0||||||
4057153|NCT01082640|3878774|B1|||Kidney Stone Passage|The number of participants with kidney stone episodes was 5, 6 and 11 in each treatment arm respectively.|participants|Number|2|2.0||||||
4057154|NCT01082640|3878771|B4|||Number of Lifetime Kidney Stone Episodes||episodes|Mean|2.8|2.8|Standard Deviation|2.56|2.56|||
4057155|NCT01082640|3878772|B3|||Number of Lifetime Kidney Stone Episodes||episodes|Mean|1.8|1.8|Standard Deviation|1.78|1.78|||
4057156|NCT01082640|3878773|B2|||Number of Lifetime Kidney Stone Episodes||episodes|Mean|3.0|3.0|Standard Deviation|1.67|1.67|||
4057157|NCT01082640|3878774|B1|||Number of Lifetime Kidney Stone Episodes||episodes|Mean|4.8|4.8|Standard Deviation|3.90|3.9|||
4057158|NCT01082640|3878771|B4|Other||Previous urate-lowering therapy|Participants may have received more than one urate-lowering therapy.|participants|Number|7|7.0||||||
4057159|NCT01082640|3878772|B3|Other||Previous urate-lowering therapy|Participants may have received more than one urate-lowering therapy.|participants|Number|2|2.0||||||
4057160|NCT01082640|3878773|B2|Other||Previous urate-lowering therapy|Participants may have received more than one urate-lowering therapy.|participants|Number|2|2.0||||||
4057161|NCT01082640|3878774|B1|Other||Previous urate-lowering therapy|Participants may have received more than one urate-lowering therapy.|participants|Number|3|3.0||||||
4057162|NCT01082640|3878771|B4|None||Previous urate-lowering therapy|Participants may have received more than one urate-lowering therapy.|participants|Number|26|26.0||||||
4057163|NCT01082640|3878772|B3|None||Previous urate-lowering therapy|Participants may have received more than one urate-lowering therapy.|participants|Number|9|9.0||||||
4057164|NCT01082640|3878773|B2|None||Previous urate-lowering therapy|Participants may have received more than one urate-lowering therapy.|participants|Number|6|6.0||||||
4057165|NCT01082640|3878774|B1|None||Previous urate-lowering therapy|Participants may have received more than one urate-lowering therapy.|participants|Number|11|11.0||||||
4057166|NCT01082640|3878771|B4|Probenecid||Previous urate-lowering therapy|Participants may have received more than one urate-lowering therapy.|participants|Number|1|1.0||||||
4057167|NCT01082640|3878772|B3|Probenecid||Previous urate-lowering therapy|Participants may have received more than one urate-lowering therapy.|participants|Number|1|1.0||||||
4057168|NCT01082640|3878773|B2|Probenecid||Previous urate-lowering therapy|Participants may have received more than one urate-lowering therapy.|participants|Number|0|0.0||||||
4057169|NCT01082640|3878774|B1|Probenecid||Previous urate-lowering therapy|Participants may have received more than one urate-lowering therapy.|participants|Number|0|0.0||||||
4057170|NCT01082640|3878771|B4|Allopurinol||Previous urate-lowering therapy|Participants may have received more than one urate-lowering therapy.|participants|Number|62|62.0||||||
4057171|NCT01082640|3878772|B3|Allopurinol||Previous urate-lowering therapy|Participants may have received more than one urate-lowering therapy.|participants|Number|21|21.0||||||
4057172|NCT01082640|3878773|B2|Allopurinol||Previous urate-lowering therapy|Participants may have received more than one urate-lowering therapy.|participants|Number|22|22.0||||||
4057173|NCT01082640|3878774|B1|Allopurinol||Previous urate-lowering therapy|Participants may have received more than one urate-lowering therapy.|participants|Number|19|19.0||||||
4057174|NCT01082640|3878771|B4|Febuxostat||Previous urate-lowering therapy|Participants may have received more than one urate-lowering therapy.|participants|Number|7|7.0||||||
4057175|NCT01082640|3878772|B3|Febuxostat||Previous urate-lowering therapy|Participants may have received more than one urate-lowering therapy.|participants|Number|2|2.0||||||
4057176|NCT01082640|3878773|B2|Febuxostat||Previous urate-lowering therapy|Participants may have received more than one urate-lowering therapy.|participants|Number|5|5.0||||||
4057177|NCT01082640|3878774|B1|Febuxostat||Previous urate-lowering therapy|Participants may have received more than one urate-lowering therapy.|participants|Number|0|0.0||||||
4057178|NCT01082640|3878771|B4|more than 1 year ago||Time since last gout flare||participants|Number|24|24.0||||||
4057179|NCT01082640|3878772|B3|more than 1 year ago||Time since last gout flare||participants|Number|9|9.0||||||
4057180|NCT01082640|3878773|B2|more than 1 year ago||Time since last gout flare||participants|Number|8|8.0||||||
4057181|NCT01082640|3878774|B1|more than 1 year ago||Time since last gout flare||participants|Number|7|7.0||||||
4057182|NCT01082640|3878771|B4|6 to less than 12 months ago||Time since last gout flare||participants|Number|33|33.0||||||
4057183|NCT01082640|3878772|B3|6 to less than 12 months ago||Time since last gout flare||participants|Number|11|11.0||||||
4057184|NCT01082640|3878773|B2|6 to less than 12 months ago||Time since last gout flare||participants|Number|8|8.0||||||
4057185|NCT01082640|3878774|B1|6 to less than 12 months ago||Time since last gout flare||participants|Number|14|14.0||||||
4057186|NCT01082640|3878771|B4|4 to less than 6 months ago||Time since last gout flare||participants|Number|10|10.0||||||
4057188|NCT01082640|3878773|B2|4 to less than 6 months ago||Time since last gout flare||participants|Number|4|4.0||||||
4057189|NCT01082640|3878774|B1|4 to less than 6 months ago||Time since last gout flare||participants|Number|4|4.0||||||
4057190|NCT01082640|3878771|B4|1 to less than 4 months ago||Time since last gout flare||participants|Number|14|14.0||||||
4057191|NCT01082640|3878772|B3|1 to less than 4 months ago||Time since last gout flare||participants|Number|5|5.0||||||
4057192|NCT01082640|3878773|B2|1 to less than 4 months ago||Time since last gout flare||participants|Number|7|7.0||||||
4057193|NCT01082640|3878774|B1|1 to less than 4 months ago||Time since last gout flare||participants|Number|2|2.0||||||
4057194|NCT01082640|3878771|B4|Less than 1 month ago||Time since last gout flare||participants|Number|15|15.0||||||
4057195|NCT01082640|3878772|B3|Less than 1 month ago||Time since last gout flare||participants|Number|5|5.0||||||
4057196|NCT01082640|3878773|B2|Less than 1 month ago||Time since last gout flare||participants|Number|5|5.0||||||
4057197|NCT01082640|3878774|B1|Less than 1 month ago||Time since last gout flare||participants|Number|5|5.0||||||
4057198|NCT01082640|3878771|B4|More than 6||Gout flares in the past year|Not all participants had a gout flare within the last year.|participnts|Number|10|10.0||||||
4057199|NCT01082640|3878772|B3|More than 6||Gout flares in the past year|Not all participants had a gout flare within the last year.|participnts|Number|5|5.0||||||
4057200|NCT01082640|3878773|B2|More than 6||Gout flares in the past year|Not all participants had a gout flare within the last year.|participnts|Number|3|3.0||||||
4057201|NCT01082640|3878774|B1|More than 6||Gout flares in the past year|Not all participants had a gout flare within the last year.|participnts|Number|2|2.0||||||
4057202|NCT01082640|3878771|B4|4-6 flares||Gout flares in the past year|Not all participants had a gout flare within the last year.|participnts|Number|15|15.0||||||
4057203|NCT01082640|3878772|B3|4-6 flares||Gout flares in the past year|Not all participants had a gout flare within the last year.|participnts|Number|3|3.0||||||
4057204|NCT01082640|3878773|B2|4-6 flares||Gout flares in the past year|Not all participants had a gout flare within the last year.|participnts|Number|8|8.0||||||
4057205|NCT01082640|3878774|B1|4-6 flares||Gout flares in the past year|Not all participants had a gout flare within the last year.|participnts|Number|4|4.0||||||
4057206|NCT01082640|3878771|B4|1-3 flares||Gout flares in the past year|Not all participants had a gout flare within the last year.|participnts|Number|56|56.0||||||
4057207|NCT01082640|3878772|B3|1-3 flares||Gout flares in the past year|Not all participants had a gout flare within the last year.|participnts|Number|19|19.0||||||
4057208|NCT01082640|3878773|B2|1-3 flares||Gout flares in the past year|Not all participants had a gout flare within the last year.|participnts|Number|16|16.0||||||
4057209|NCT01082640|3878774|B1|1-3 flares||Gout flares in the past year|Not all participants had a gout flare within the last year.|participnts|Number|21|21.0||||||
4057210|NCT01082640|3878771|B4|≥10 mg/dL||Serum Urate Categories||participants|Number|58|58.0||||||
4057211|NCT01082640|3878772|B3|≥10 mg/dL||Serum Urate Categories||participants|Number|18|18.0||||||
4057212|NCT01082640|3878773|B2|≥10 mg/dL||Serum Urate Categories||participants|Number|21|21.0||||||
4057213|NCT01082640|3878774|B1|≥10 mg/dL||Serum Urate Categories||participants|Number|19|19.0||||||
4057214|NCT01082640|3878771|B4|9.0 to <10.0 mg/dL||Serum Urate Categories||participants|Number|22|22.0||||||
4057215|NCT01082640|3878772|B3|9.0 to <10.0 mg/dL||Serum Urate Categories||participants|Number|10|10.0||||||
4057216|NCT01082640|3878773|B2|9.0 to <10.0 mg/dL||Serum Urate Categories||participants|Number|6|6.0||||||
4057217|NCT01082640|3878774|B1|9.0 to <10.0 mg/dL||Serum Urate Categories||participants|Number|6|6.0||||||
4057218|NCT01082640|3878771|B4|<9.0 mg/dL||Serum Urate Categories||participants|Number|16|16.0||||||
4057219|NCT01082640|3878772|B3|<9.0 mg/dL||Serum Urate Categories||participants|Number|4|4.0||||||
4057220|NCT01082640|3878773|B2|<9.0 mg/dL||Serum Urate Categories||participants|Number|5|5.0||||||
4057221|NCT01082640|3878774|B1|<9.0 mg/dL||Serum Urate Categories||participants|Number|7|7.0||||||
4057222|NCT01082640|3878771|B4|||Serum Urate||mg/dL|Mean|10.5|10.5|Standard Deviation|1.70|1.7|||
4057223|NCT01082640|3878772|B3|||Serum Urate||mg/dL|Mean|10.4|10.4|Standard Deviation|1.70|1.7|||
4057224|NCT01082640|3878773|B2|||Serum Urate||mg/dL|Mean|10.4|10.4|Standard Deviation|1.43|1.43|||
4057225|NCT01082640|3878774|B1|||Serum Urate||mg/dL|Mean|10.8|10.8|Standard Deviation|1.96|1.96|||
4057226|NCT01082640|3878771|B4|Greater than 2.5 mg/dL||Serum creatinine level||participants|Number|30|30.0||||||
4057227|NCT01082640|3878772|B3|Greater than 2.5 mg/dL||Serum creatinine level||participants|Number|9|9.0||||||
4057228|NCT01082640|3878773|B2|Greater than 2.5 mg/dL||Serum creatinine level||participants|Number|6|6.0||||||
4057229|NCT01082640|3878774|B1|Greater than 2.5 mg/dL||Serum creatinine level||participants|Number|15|15.0||||||
4057230|NCT01082640|3878771|B4|2.0 to <2.5 mg/dL||Serum creatinine level||participants|Number|29|29.0||||||
4057231|NCT01082640|3878772|B3|2.0 to <2.5 mg/dL||Serum creatinine level||participants|Number|9|9.0||||||
4057232|NCT01082640|3878773|B2|2.0 to <2.5 mg/dL||Serum creatinine level||participants|Number|13|13.0||||||
4057233|NCT01082640|3878774|B1|2.0 to <2.5 mg/dL||Serum creatinine level||participants|Number|7|7.0||||||
4057234|NCT01082640|3878771|B4|Less than 2.0 mg/dL||Serum creatinine level||participants|Number|37|37.0||||||
4057235|NCT01082640|3878772|B3|Less than 2.0 mg/dL||Serum creatinine level||participants|Number|14|14.0||||||
4057236|NCT01082640|3878773|B2|Less than 2.0 mg/dL||Serum creatinine level||participants|Number|13|13.0||||||
4057237|NCT01082640|3878774|B1|Less than 2.0 mg/dL||Serum creatinine level||participants|Number|10|10.0||||||
4057238|NCT01082640|3878771|B4|Moderately impaired||Renal History Based on Creatinine Clearance|Estimated creatinine clearance based on estimated glomerular filtration rate (eGFR) using the Modification of Diet in Renal Disease (MDRD) calculation. Moderately impaired = eGFR ≥ 30-50 mL/min, Severely impaired = eGFR ≥ 15- 29 mL/min.|participants|Number|60|60.0||||||
4057277|NCT01082640|3878774|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4057239|NCT01082640|3878772|B3|Moderately impaired||Renal History Based on Creatinine Clearance|Estimated creatinine clearance based on estimated glomerular filtration rate (eGFR) using the Modification of Diet in Renal Disease (MDRD) calculation. Moderately impaired = eGFR ≥ 30-50 mL/min, Severely impaired = eGFR ≥ 15- 29 mL/min.|participants|Number|22|22.0||||||
4057240|NCT01082640|3878773|B2|Moderately impaired||Renal History Based on Creatinine Clearance|Estimated creatinine clearance based on estimated glomerular filtration rate (eGFR) using the Modification of Diet in Renal Disease (MDRD) calculation. Moderately impaired = eGFR ≥ 30-50 mL/min, Severely impaired = eGFR ≥ 15- 29 mL/min.|participants|Number|23|23.0||||||
4057241|NCT01082640|3878774|B1|Moderately impaired||Renal History Based on Creatinine Clearance|Estimated creatinine clearance based on estimated glomerular filtration rate (eGFR) using the Modification of Diet in Renal Disease (MDRD) calculation. Moderately impaired = eGFR ≥ 30-50 mL/min, Severely impaired = eGFR ≥ 15- 29 mL/min.|participants|Number|15|15.0||||||
4057242|NCT01082640|3878771|B4|Severely impaired||Renal History Based on Creatinine Clearance|Estimated creatinine clearance based on estimated glomerular filtration rate (eGFR) using the Modification of Diet in Renal Disease (MDRD) calculation. Moderately impaired = eGFR ≥ 30-50 mL/min, Severely impaired = eGFR ≥ 15- 29 mL/min.|participants|Number|36|36.0||||||
4057243|NCT01082640|3878772|B3|Severely impaired||Renal History Based on Creatinine Clearance|Estimated creatinine clearance based on estimated glomerular filtration rate (eGFR) using the Modification of Diet in Renal Disease (MDRD) calculation. Moderately impaired = eGFR ≥ 30-50 mL/min, Severely impaired = eGFR ≥ 15- 29 mL/min.|participants|Number|10|10.0||||||
4057244|NCT01082640|3878773|B2|Severely impaired||Renal History Based on Creatinine Clearance|Estimated creatinine clearance based on estimated glomerular filtration rate (eGFR) using the Modification of Diet in Renal Disease (MDRD) calculation. Moderately impaired = eGFR ≥ 30-50 mL/min, Severely impaired = eGFR ≥ 15- 29 mL/min.|participants|Number|9|9.0||||||
4057245|NCT01082640|3878774|B1|Severely impaired||Renal History Based on Creatinine Clearance|Estimated creatinine clearance based on estimated glomerular filtration rate (eGFR) using the Modification of Diet in Renal Disease (MDRD) calculation. Moderately impaired = eGFR ≥ 30-50 mL/min, Severely impaired = eGFR ≥ 15- 29 mL/min.|participants|Number|17|17.0||||||
4057246|NCT01082640|3878771|B4|None||Prior Use of ARB or ACEi|ARB = angiotensin receptor blocker ACEi = angiotensin converting enzyme inhibitors|participants|Number|33|33.0||||||
4057247|NCT01082640|3878772|B3|None||Prior Use of ARB or ACEi|ARB = angiotensin receptor blocker ACEi = angiotensin converting enzyme inhibitors|participants|Number|11|11.0||||||
4057248|NCT01082640|3878773|B2|None||Prior Use of ARB or ACEi|ARB = angiotensin receptor blocker ACEi = angiotensin converting enzyme inhibitors|participants|Number|11|11.0||||||
4057249|NCT01082640|3878774|B1|None||Prior Use of ARB or ACEi|ARB = angiotensin receptor blocker ACEi = angiotensin converting enzyme inhibitors|participants|Number|11|11.0||||||
4057250|NCT01082640|3878771|B4|Angiotensin converting enzyme inhibitors (ACEi)||Prior Use of ARB or ACEi|ARB = angiotensin receptor blocker ACEi = angiotensin converting enzyme inhibitors|participants|Number|39|39.0||||||
4057251|NCT01082640|3878772|B3|Angiotensin converting enzyme inhibitors (ACEi)||Prior Use of ARB or ACEi|ARB = angiotensin receptor blocker ACEi = angiotensin converting enzyme inhibitors|participants|Number|13|13.0||||||
4057252|NCT01082640|3878773|B2|Angiotensin converting enzyme inhibitors (ACEi)||Prior Use of ARB or ACEi|ARB = angiotensin receptor blocker ACEi = angiotensin converting enzyme inhibitors|participants|Number|13|13.0||||||
4057253|NCT01082640|3878774|B1|Angiotensin converting enzyme inhibitors (ACEi)||Prior Use of ARB or ACEi|ARB = angiotensin receptor blocker ACEi = angiotensin converting enzyme inhibitors|participants|Number|13|13.0||||||
4057254|NCT01082640|3878771|B4|Angiotensin receptor blocker (ARB)||Prior Use of ARB or ACEi|ARB = angiotensin receptor blocker ACEi = angiotensin converting enzyme inhibitors|participants|Number|24|24.0||||||
4057255|NCT01082640|3878772|B3|Angiotensin receptor blocker (ARB)||Prior Use of ARB or ACEi|ARB = angiotensin receptor blocker ACEi = angiotensin converting enzyme inhibitors|participants|Number|8|8.0||||||
4057256|NCT01082640|3878773|B2|Angiotensin receptor blocker (ARB)||Prior Use of ARB or ACEi|ARB = angiotensin receptor blocker ACEi = angiotensin converting enzyme inhibitors|participants|Number|8|8.0||||||
4057257|NCT01082640|3878774|B1|Angiotensin receptor blocker (ARB)||Prior Use of ARB or ACEi|ARB = angiotensin receptor blocker ACEi = angiotensin converting enzyme inhibitors|participants|Number|8|8.0||||||
4057258|NCT01082640|3878771|B4|||Body Mass Index (BMI)||kg/m^2|Mean|33.4|33.4|Standard Deviation|6.67|6.67|||
4057259|NCT01082640|3878772|B3|||Body Mass Index (BMI)||kg/m^2|Mean|34.2|34.2|Standard Deviation|7.30|7.3|||
4057260|NCT01082640|3878773|B2|||Body Mass Index (BMI)||kg/m^2|Mean|32.8|32.8|Standard Deviation|6.45|6.45|||
4057261|NCT01082640|3878774|B1|||Body Mass Index (BMI)||kg/m^2|Mean|33.3|33.3|Standard Deviation|6.36|6.36|||
4057262|NCT01082640|3878771|B4|||Weight||kg|Mean|100.7|100.7|Standard Deviation|24.42|24.42|||
4057263|NCT01082640|3878772|B3|||Weight||kg|Mean|102.6|102.6|Standard Deviation|25.85|25.85|||
4057264|NCT01082640|3878773|B2|||Weight||kg|Mean|98.8|98.8|Standard Deviation|19.84|19.84|||
4057265|NCT01082640|3878774|B1|||Weight||kg|Mean|100.7|100.7|Standard Deviation|27.54|27.54|||
4057266|NCT01082640|3878771|B4|||Height||cm|Mean|173.1|173.1|Standard Deviation|10.16|10.16|||
4057267|NCT01082640|3878772|B3|||Height||cm|Mean|172.8|172.8|Standard Deviation|9.48|9.48|||
4057268|NCT01082640|3878773|B2|||Height||cm|Mean|173.8|173.8|Standard Deviation|9.60|9.6|||
4057269|NCT01082640|3878774|B1|||Height||cm|Mean|172.6|172.6|Standard Deviation|11.55|11.55|||
4057270|NCT01082640|3878771|B4|United States||Region of Enrollment||participants|Number|96|96.0||||||
4057271|NCT01082640|3878772|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4057272|NCT01082640|3878773|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
4057273|NCT01082640|3878774|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4057274|NCT01082640|3878771|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4057275|NCT01082640|3878772|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4057276|NCT01082640|3878773|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4057278|NCT01082640|3878771|B4|White||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
4057279|NCT01082640|3878772|B3|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4057280|NCT01082640|3878773|B2|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4057281|NCT01082640|3878774|B1|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4057282|NCT01082640|3878771|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4057283|NCT01082640|3878772|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4057284|NCT01082640|3878773|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4057285|NCT01082640|3878774|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4057286|NCT01082640|3878771|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4057287|NCT01082640|3878772|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4057288|NCT01082640|3878773|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4057289|NCT01082640|3878774|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4057290|NCT01082640|3878771|B4|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4057291|NCT01082640|3878772|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4057292|NCT01082640|3878773|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4057293|NCT01082640|3878774|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4057294|NCT01082640|3878771|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4057295|NCT01082640|3878772|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4057296|NCT01082640|3878773|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4057297|NCT01082640|3878774|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4057298|NCT01082640|3878771|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|88|88.0||||||
4057299|NCT01082640|3878772|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4057300|NCT01082640|3878773|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4057301|NCT01082640|3878774|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4057302|NCT01082640|3878771|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4057303|NCT01082640|3878772|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4057304|NCT01082640|3878773|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4057305|NCT01082640|3878774|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4057306|NCT01082640|3878771|B4||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4057307|NCT01082640|3878772|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4057308|NCT01082640|3878773|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4057309|NCT01082640|3878774|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4057310|NCT01082640|3878771|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4057311|NCT01082640|3878772|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4057312|NCT01082640|3878773|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4057313|NCT01082640|3878774|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4057314|NCT01082640|3878771|B4|||Age||years|Mean|65.7|65.7|Standard Deviation|10.57|10.57|||
4057315|NCT01082640|3878772|B3|||Age||years|Mean|63.6|63.6|Standard Deviation|8.15|8.15|||
4057316|NCT01082640|3878773|B2|||Age||years|Mean|67.3|67.3|Standard Deviation|11.11|11.11|||
4057317|NCT01082640|3878774|B1|||Age||years|Mean|66.3|66.3|Standard Deviation|12.05|12.05|||
4057318|NCT01082614|3878796|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
4057319|NCT01082614|3878797|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4057320|NCT01082614|3878798|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4057321|NCT01082614|3878796|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4057322|NCT01082614|3878797|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4057323|NCT01082614|3878798|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4057324|NCT01082614|3878796|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4057325|NCT01082614|3878797|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4057326|NCT01082614|3878798|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4057327|NCT01082614|3878796|B3|||Age||years|Mean|58.95|58.95|Standard Deviation|16|16.0|||
4057328|NCT01082614|3878797|B2|||Age||years|Mean|53.5|53.5|Standard Deviation|16.2|16.2|||
4057329|NCT01082614|3878798|B1|||Age||years|Mean|64.4|64.4|Standard Deviation|15.8|15.8|||
4057330|NCT01082614|3878796|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4057331|NCT01082614|3878797|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4057332|NCT01082614|3878798|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4057333|NCT01082614|3878796|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4057334|NCT01082614|3878797|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4057335|NCT01082614|3878798|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4057336|NCT01082614|3878796|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4057337|NCT01082614|3878797|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4057338|NCT01082614|3878798|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4057339|NCT01082588|3878809|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4057340|NCT01082588|3878810|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4057341|NCT01082588|3878811|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4057342|NCT01082588|3878809|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4057343|NCT01082588|3878810|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4057344|NCT01082588|3878811|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4057345|NCT01082588|3878809|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4057346|NCT01082588|3878810|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4057347|NCT01082588|3878811|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4057348|NCT01082588|3878809|B3|||Age||years|Mean|44.84|44.84|Standard Deviation|11.35|11.35|||
4057349|NCT01082588|3878810|B2|||Age||years|Mean|45.08|45.08|Standard Deviation|12.54|12.54|||
4057350|NCT01082588|3878811|B1|||Age||years|Mean|43.11|43.11|Standard Deviation|11.06|11.06|||
4057351|NCT01082588|3878809|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4057352|NCT01082588|3878810|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4057353|NCT01082588|3878811|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4057354|NCT01082588|3878809|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4057355|NCT01082588|3878810|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4057356|NCT01082588|3878811|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4057357|NCT01082588|3878809|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4057358|NCT01082588|3878810|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4057359|NCT01082588|3878811|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4057360|NCT01082575|3878830|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
4057361|NCT01082575|3878830|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4057362|NCT01082575|3878830|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4057363|NCT01082575|3878830|B1|||Age||years|Mean|63.79|63.79|Standard Deviation|12.018|12.018|||
4057364|NCT01082575|3878830|B1||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
4057365|NCT01082575|3878830|B1||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4057366|NCT01082575|3878830|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4057367|NCT01082380|3878835|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4057368|NCT01082380|3878835|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4057369|NCT01082380|3878835|B1|||Age||years|Mean|43.2|43.2|Standard Deviation|1.8|1.8|||
4057370|NCT01082367|3878868|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4057371|NCT01082367|3878869|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4057372|NCT01082367|3878870|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4057373|NCT01082367|3878868|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4057374|NCT01082367|3878869|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4057375|NCT01082367|3878870|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4057376|NCT01082367|3878868|B3|||Age||Years|Mean|2.8|2.8|Standard Deviation|1.93|1.93|||
4057377|NCT01082367|3878869|B2|||Age||Years|Mean|2.7|2.7|Standard Deviation|1.93|1.93|||
4057378|NCT01082367|3878870|B1|||Age||Years|Mean|2.9|2.9|Standard Deviation|1.96|1.96|||
4057379|NCT01082328|3878885|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4057380|NCT01082328|3878885|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4057381|NCT01082328|3878885|B1|||Age||years|Mean|21.0|21.0|Standard Deviation|12.1|12.1|||
4057382|NCT01082211|3878894|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4057383|NCT01082211|3878894|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4057384|NCT01082211|3878894|B1|||Age||years|Median|67|67.0|Full Range|||44.0|86.0|
4057385|NCT01082159|3878906|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4057386|NCT01082159|3878906|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4057387|NCT01082159|3878906|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4057388|NCT01082159|3878906|B1|||Age||years|Mean|68.3|68.3|Standard Deviation|12.1|12.1|||
4057389|NCT01082159|3878906|B1||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
4057390|NCT01082159|3878906|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4057391|NCT01082159|3878906|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4057392|NCT01082081|3878912|B4|Severe||Number of participants with pain severity score measured on a rating scale|Pain severity score was assessed on a 4-point categorical verbal rating scale. Total possible pain severity score range was none, mild, moderate and severe.|Participants|Number|58|58.0||||||
4057393|NCT01082081|3878913|B3|Severe||Number of participants with pain severity score measured on a rating scale|Pain severity score was assessed on a 4-point categorical verbal rating scale. Total possible pain severity score range was none, mild, moderate and severe.|Participants|Number|12|12.0||||||
4057394|NCT01082081|3878914|B2|Severe||Number of participants with pain severity score measured on a rating scale|Pain severity score was assessed on a 4-point categorical verbal rating scale. Total possible pain severity score range was none, mild, moderate and severe.|Participants|Number|22|22.0||||||
4057446|NCT01081912|3878980|B1||Between 18 and 65 years|Age||Participants|Count of Participants|462|462.0||||||
4057395|NCT01082081|3878915|B1|Severe||Number of participants with pain severity score measured on a rating scale|Pain severity score was assessed on a 4-point categorical verbal rating scale. Total possible pain severity score range was none, mild, moderate and severe.|Participants|Number|24|24.0||||||
4057396|NCT01082081|3878912|B4|Moderate||Number of participants with pain severity score measured on a rating scale|Pain severity score was assessed on a 4-point categorical verbal rating scale. Total possible pain severity score range was none, mild, moderate and severe.|Participants|Number|242|242.0||||||
4057397|NCT01082081|3878913|B3|Moderate||Number of participants with pain severity score measured on a rating scale|Pain severity score was assessed on a 4-point categorical verbal rating scale. Total possible pain severity score range was none, mild, moderate and severe.|Participants|Number|48|48.0||||||
4057398|NCT01082081|3878914|B2|Moderate||Number of participants with pain severity score measured on a rating scale|Pain severity score was assessed on a 4-point categorical verbal rating scale. Total possible pain severity score range was none, mild, moderate and severe.|Participants|Number|97|97.0||||||
4057399|NCT01082081|3878915|B1|Moderate||Number of participants with pain severity score measured on a rating scale|Pain severity score was assessed on a 4-point categorical verbal rating scale. Total possible pain severity score range was none, mild, moderate and severe.|Participants|Number|97|97.0||||||
4057400|NCT01082081|3878912|B4||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4057401|NCT01082081|3878913|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4057402|NCT01082081|3878914|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4057403|NCT01082081|3878915|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4057404|NCT01082081|3878912|B4||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4057405|NCT01082081|3878913|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4057406|NCT01082081|3878914|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4057407|NCT01082081|3878915|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4057408|NCT01082081|3878912|B4|||Age||Years|Mean|23.9|23.9|Standard Deviation|4.5|4.5|||
4057409|NCT01082081|3878913|B3|||Age||Years|Mean|23.5|23.5|Standard Deviation|4.9|4.9|||
4057410|NCT01082081|3878914|B2|||Age||Years|Mean|23.9|23.9|Standard Deviation|3.9|3.9|||
4057411|NCT01082081|3878915|B1|||Age||Years|Mean|24.0|24.0|Standard Deviation|5.0|5.0|||
4057412|NCT01081951|3878967|B3|PD >12 months after completion||Time to disease progression on completion of the previous platinum therapy||Participants|Number|83|83.0||||||
4057413|NCT01081951|3878968|B2|PD >12 months after completion||Time to disease progression on completion of the previous platinum therapy||Participants|Number|41|41.0||||||
4057414|NCT01081951|3878969|B1|PD >12 months after completion||Time to disease progression on completion of the previous platinum therapy||Participants|Number|42|42.0||||||
4057415|NCT01081951|3878967|B3|PD > 6 to ≤ 12 months after completion||Time to disease progression on completion of the previous platinum therapy||Participants|Number|79|79.0||||||
4057416|NCT01081951|3878968|B2|PD > 6 to ≤ 12 months after completion||Time to disease progression on completion of the previous platinum therapy||Participants|Number|40|40.0||||||
4057417|NCT01081951|3878969|B1|PD > 6 to ≤ 12 months after completion||Time to disease progression on completion of the previous platinum therapy||Participants|Number|39|39.0||||||
4057418|NCT01081951|3878967|B3|>1||Number of prior platinum-containing treatment lines||Participants|Number|51|51.0||||||
4057419|NCT01081951|3878968|B2|>1||Number of prior platinum-containing treatment lines||Participants|Number|28|28.0||||||
4057420|NCT01081951|3878969|B1|>1||Number of prior platinum-containing treatment lines||Participants|Number|23|23.0||||||
4057421|NCT01081951|3878967|B3|1||Number of prior platinum-containing treatment lines||Participants|Number|111|111.0||||||
4057422|NCT01081951|3878968|B2|1||Number of prior platinum-containing treatment lines||Participants|Number|53|53.0||||||
4057423|NCT01081951|3878969|B1|1||Number of prior platinum-containing treatment lines||Participants|Number|58|58.0||||||
4057424|NCT01081951|3878967|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4057425|NCT01081951|3878968|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4057426|NCT01081951|3878969|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4057427|NCT01081951|3878967|B3||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4057428|NCT01081951|3878968|B2||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4057429|NCT01081951|3878969|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4057430|NCT01081951|3878967|B3|≥ 65||Age, Customized||Participants|Number|45|45.0||||||
4057431|NCT01081951|3878968|B2|≥ 65||Age, Customized||Participants|Number|24|24.0||||||
4057432|NCT01081951|3878969|B1|≥ 65||Age, Customized||Participants|Number|21|21.0||||||
4057433|NCT01081951|3878967|B3|≥ 50 - < 65||Age, Customized||Participants|Number|85|85.0||||||
4057434|NCT01081951|3878968|B2|≥ 50 - < 65||Age, Customized||Participants|Number|40|40.0||||||
4057435|NCT01081951|3878969|B1|≥ 50 - < 65||Age, Customized||Participants|Number|45|45.0||||||
4057436|NCT01081951|3878967|B3|< 50||Age, Customized||Participants|Number|32|32.0||||||
4057437|NCT01081951|3878968|B2|< 50||Age, Customized||Participants|Number|17|17.0||||||
4057438|NCT01081951|3878969|B1|< 50||Age, Customized||Participants|Number|15|15.0||||||
4057439|NCT01081951|3878967|B3|||Age||years|Mean|58.5|58.5|Standard Deviation|10.3|10.3|||
4057440|NCT01081951|3878968|B2|||Age||years|Mean|59.0|59.0|Standard Deviation|10.7|10.7|||
4057441|NCT01081951|3878969|B1|||Age||years|Mean|57.9|57.9|Standard Deviation|10.0|10.0|||
4057442|NCT01081912|3878980|B1|United States||Region of Enrollment||participants|Number|510|510.0||||||
4057443|NCT01081912|3878980|B1||Male|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
4057444|NCT01081912|3878980|B1||Female|Sex: Female, Male||Participants|Count of Participants|273|273.0||||||
4057445|NCT01081912|3878980|B1||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4057447|NCT01081912|3878980|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4057448|NCT01081886|3878989|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4057449|NCT01081886|3878990|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4057450|NCT01081886|3878991|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4057451|NCT01081886|3878989|B3|Male||Gender||participants|Number|0|0.0||||||
4057452|NCT01081886|3878990|B2|Male||Gender||participants|Number|NA|||||||An integrity audit found that the data for this study could not be analyzed owing to unverifiable source documentation.
4057453|NCT01081886|3878991|B1|Male||Gender||participants|Number|NA|||||||An integrity audit found that the data for this study could not be analyzed owing to unverifiable source documentation.
4057454|NCT01081886|3878989|B3|Female||Gender||participants|Number|0|0.0||||||
4057455|NCT01081886|3878990|B2|Female||Gender||participants|Number|NA|||||||An integrity audit found that the data for this study could not be analyzed owing to unverifiable source documentation.
4057456|NCT01081886|3878991|B1|Female||Gender||participants|Number|NA|||||||An integrity audit found that the data for this study could not be analyzed owing to unverifiable source documentation.
4057457|NCT01081886|3878989|B3|21 to 80 years||Age, Customized|An integrity audit found that the data for this study could not be analyzed owing to unverifiable source documentation. The protocol-specified age range is used for this baseline measure.|participants|Number|24|24.0||||||
4057458|NCT01081886|3878990|B2|21 to 80 years||Age, Customized|An integrity audit found that the data for this study could not be analyzed owing to unverifiable source documentation. The protocol-specified age range is used for this baseline measure.|participants|Number|13|13.0||||||
4057459|NCT01081886|3878991|B1|21 to 80 years||Age, Customized|An integrity audit found that the data for this study could not be analyzed owing to unverifiable source documentation. The protocol-specified age range is used for this baseline measure.|participants|Number|11|11.0||||||
4057460|NCT01081873|3879000|B1||Male|Sex: Female, Male||Participants|Count of Participants|2714|2714.0||||||
4057461|NCT01081873|3879000|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4057462|NCT01081873|3879000|B1|||Age||years|Mean|75.39|75.39|Standard Deviation|7.92|7.92|||
4057463|NCT01081873|3879000|B1|||Age||years|Median|76.18|76.18|Full Range|||46.3|98.2|
4057464|NCT01081834|3879067|B6|UNITED STATES||Region of Enrollment||participants|Number|200|200.0||||||
4057465|NCT01081834|3879068|B5|UNITED STATES||Region of Enrollment||participants|Number|15|15.0||||||
4057466|NCT01081834|3879069|B4|UNITED STATES||Region of Enrollment||participants|Number|15|15.0||||||
4057467|NCT01081834|3879070|B3|UNITED STATES||Region of Enrollment||participants|Number|52|52.0||||||
4057468|NCT01081834|3879071|B2|UNITED STATES||Region of Enrollment||participants|Number|62|62.0||||||
4057469|NCT01081834|3879072|B1|UNITED STATES||Region of Enrollment||participants|Number|56|56.0||||||
4057470|NCT01081834|3879067|B6|SWEDEN||Region of Enrollment||participants|Number|48|48.0||||||
4057471|NCT01081834|3879068|B5|SWEDEN||Region of Enrollment||participants|Number|1|1.0||||||
4057472|NCT01081834|3879069|B4|SWEDEN||Region of Enrollment||participants|Number|0|0.0||||||
4057473|NCT01081834|3879070|B3|SWEDEN||Region of Enrollment||participants|Number|18|18.0||||||
4057474|NCT01081834|3879071|B2|SWEDEN||Region of Enrollment||participants|Number|18|18.0||||||
4057475|NCT01081834|3879072|B1|SWEDEN||Region of Enrollment||participants|Number|11|11.0||||||
4057476|NCT01081834|3879067|B6|SPAIN||Region of Enrollment||participants|Number|8|8.0||||||
4057477|NCT01081834|3879068|B5|SPAIN||Region of Enrollment||participants|Number|0|0.0||||||
4057478|NCT01081834|3879069|B4|SPAIN||Region of Enrollment||participants|Number|0|0.0||||||
4057479|NCT01081834|3879070|B3|SPAIN||Region of Enrollment||participants|Number|3|3.0||||||
4057480|NCT01081834|3879071|B2|SPAIN||Region of Enrollment||participants|Number|2|2.0||||||
4057481|NCT01081834|3879072|B1|SPAIN||Region of Enrollment||participants|Number|3|3.0||||||
4057482|NCT01081834|3879067|B6|SOUTH KOREA||Region of Enrollment||participants|Number|27|27.0||||||
4057483|NCT01081834|3879068|B5|SOUTH KOREA||Region of Enrollment||participants|Number|1|1.0||||||
4057484|NCT01081834|3879069|B4|SOUTH KOREA||Region of Enrollment||participants|Number|1|1.0||||||
4057485|NCT01081834|3879070|B3|SOUTH KOREA||Region of Enrollment||participants|Number|7|7.0||||||
4057486|NCT01081834|3879071|B2|SOUTH KOREA||Region of Enrollment||participants|Number|8|8.0||||||
4057487|NCT01081834|3879072|B1|SOUTH KOREA||Region of Enrollment||participants|Number|10|10.0||||||
4057488|NCT01081834|3879067|B6|SOUTH AFRICA||Region of Enrollment||participants|Number|29|29.0||||||
4057489|NCT01081834|3879068|B5|SOUTH AFRICA||Region of Enrollment||participants|Number|2|2.0||||||
4057490|NCT01081834|3879069|B4|SOUTH AFRICA||Region of Enrollment||participants|Number|1|1.0||||||
4057491|NCT01081834|3879070|B3|SOUTH AFRICA||Region of Enrollment||participants|Number|11|11.0||||||
4057492|NCT01081834|3879071|B2|SOUTH AFRICA||Region of Enrollment||participants|Number|6|6.0||||||
4057493|NCT01081834|3879072|B1|SOUTH AFRICA||Region of Enrollment||participants|Number|9|9.0||||||
4057494|NCT01081834|3879067|B6|ROMANIA||Region of Enrollment||participants|Number|60|60.0||||||
4057495|NCT01081834|3879068|B5|ROMANIA||Region of Enrollment||participants|Number|4|4.0||||||
4057496|NCT01081834|3879069|B4|ROMANIA||Region of Enrollment||participants|Number|2|2.0||||||
4057497|NCT01081834|3879070|B3|ROMANIA||Region of Enrollment||participants|Number|18|18.0||||||
4057498|NCT01081834|3879071|B2|ROMANIA||Region of Enrollment||participants|Number|16|16.0||||||
4057499|NCT01081834|3879072|B1|ROMANIA||Region of Enrollment||participants|Number|20|20.0||||||
4057500|NCT01081834|3879067|B6|POLAND||Region of Enrollment||participants|Number|8|8.0||||||
4057501|NCT01081834|3879068|B5|POLAND||Region of Enrollment||participants|Number|0|0.0||||||
4057502|NCT01081834|3879069|B4|POLAND||Region of Enrollment||participants|Number|0|0.0||||||
4057503|NCT01081834|3879070|B3|POLAND||Region of Enrollment||participants|Number|3|3.0||||||
4057504|NCT01081834|3879071|B2|POLAND||Region of Enrollment||participants|Number|4|4.0||||||
4057505|NCT01081834|3879072|B1|POLAND||Region of Enrollment||participants|Number|1|1.0||||||
4057506|NCT01081834|3879067|B6|PHILIPPINES||Region of Enrollment||participants|Number|21|21.0||||||
4057507|NCT01081834|3879068|B5|PHILIPPINES||Region of Enrollment||participants|Number|4|4.0||||||
4057508|NCT01081834|3879069|B4|PHILIPPINES||Region of Enrollment||participants|Number|4|4.0||||||
4057509|NCT01081834|3879070|B3|PHILIPPINES||Region of Enrollment||participants|Number|6|6.0||||||
4057510|NCT01081834|3879071|B2|PHILIPPINES||Region of Enrollment||participants|Number|4|4.0||||||
4057511|NCT01081834|3879072|B1|PHILIPPINES||Region of Enrollment||participants|Number|3|3.0||||||
4057512|NCT01081834|3879067|B6|MEXICO||Region of Enrollment||participants|Number|65|65.0||||||
4057513|NCT01081834|3879068|B5|MEXICO||Region of Enrollment||participants|Number|2|2.0||||||
4057514|NCT01081834|3879069|B4|MEXICO||Region of Enrollment||participants|Number|2|2.0||||||
4057515|NCT01081834|3879070|B3|MEXICO||Region of Enrollment||participants|Number|19|19.0||||||
4057516|NCT01081834|3879071|B2|MEXICO||Region of Enrollment||participants|Number|23|23.0||||||
4057517|NCT01081834|3879072|B1|MEXICO||Region of Enrollment||participants|Number|19|19.0||||||
4057518|NCT01081834|3879067|B6|MALAYSIA||Region of Enrollment||participants|Number|16|16.0||||||
4057519|NCT01081834|3879068|B5|MALAYSIA||Region of Enrollment||participants|Number|0|0.0||||||
4057520|NCT01081834|3879069|B4|MALAYSIA||Region of Enrollment||participants|Number|1|1.0||||||
4057521|NCT01081834|3879070|B3|MALAYSIA||Region of Enrollment||participants|Number|7|7.0||||||
4057522|NCT01081834|3879071|B2|MALAYSIA||Region of Enrollment||participants|Number|2|2.0||||||
4057523|NCT01081834|3879072|B1|MALAYSIA||Region of Enrollment||participants|Number|6|6.0||||||
4057524|NCT01081834|3879067|B6|LITHUANIA||Region of Enrollment||participants|Number|42|42.0||||||
4057525|NCT01081834|3879068|B5|LITHUANIA||Region of Enrollment||participants|Number|1|1.0||||||
4057526|NCT01081834|3879069|B4|LITHUANIA||Region of Enrollment||participants|Number|2|2.0||||||
4057527|NCT01081834|3879070|B3|LITHUANIA||Region of Enrollment||participants|Number|12|12.0||||||
4057528|NCT01081834|3879071|B2|LITHUANIA||Region of Enrollment||participants|Number|10|10.0||||||
4057529|NCT01081834|3879072|B1|LITHUANIA||Region of Enrollment||participants|Number|17|17.0||||||
4057530|NCT01081834|3879067|B6|INDIA||Region of Enrollment||participants|Number|34|34.0||||||
4057531|NCT01081834|3879068|B5|INDIA||Region of Enrollment||participants|Number|2|2.0||||||
4057532|NCT01081834|3879069|B4|INDIA||Region of Enrollment||participants|Number|5|5.0||||||
4057533|NCT01081834|3879070|B3|INDIA||Region of Enrollment||participants|Number|8|8.0||||||
4057534|NCT01081834|3879071|B2|INDIA||Region of Enrollment||participants|Number|11|11.0||||||
4057535|NCT01081834|3879072|B1|INDIA||Region of Enrollment||participants|Number|8|8.0||||||
4057536|NCT01081834|3879067|B6|ICELAND||Region of Enrollment||participants|Number|20|20.0||||||
4057537|NCT01081834|3879068|B5|ICELAND||Region of Enrollment||participants|Number|2|2.0||||||
4057538|NCT01081834|3879069|B4|ICELAND||Region of Enrollment||participants|Number|2|2.0||||||
4057539|NCT01081834|3879070|B3|ICELAND||Region of Enrollment||participants|Number|8|8.0||||||
4057540|NCT01081834|3879071|B2|ICELAND||Region of Enrollment||participants|Number|4|4.0||||||
4057541|NCT01081834|3879072|B1|ICELAND||Region of Enrollment||participants|Number|4|4.0||||||
4057542|NCT01081834|3879067|B6|GUATEMALA||Region of Enrollment||participants|Number|52|52.0||||||
4057543|NCT01081834|3879068|B5|GUATEMALA||Region of Enrollment||participants|Number|10|10.0||||||
4057544|NCT01081834|3879069|B4|GUATEMALA||Region of Enrollment||participants|Number|9|9.0||||||
4057545|NCT01081834|3879070|B3|GUATEMALA||Region of Enrollment||participants|Number|13|13.0||||||
4057546|NCT01081834|3879071|B2|GUATEMALA||Region of Enrollment||participants|Number|10|10.0||||||
4057547|NCT01081834|3879072|B1|GUATEMALA||Region of Enrollment||participants|Number|10|10.0||||||
4057548|NCT01081834|3879067|B6|ESTONIA||Region of Enrollment||participants|Number|16|16.0||||||
4057549|NCT01081834|3879068|B5|ESTONIA||Region of Enrollment||participants|Number|0|0.0||||||
4057550|NCT01081834|3879069|B4|ESTONIA||Region of Enrollment||participants|Number|0|0.0||||||
4057551|NCT01081834|3879070|B3|ESTONIA||Region of Enrollment||participants|Number|5|5.0||||||
4057552|NCT01081834|3879071|B2|ESTONIA||Region of Enrollment||participants|Number|5|5.0||||||
4057553|NCT01081834|3879072|B1|ESTONIA||Region of Enrollment||participants|Number|6|6.0||||||
4057554|NCT01081834|3879067|B6|COLOMBIA||Region of Enrollment||participants|Number|25|25.0||||||
4057555|NCT01081834|3879068|B5|COLOMBIA||Region of Enrollment||participants|Number|0|0.0||||||
4057556|NCT01081834|3879069|B4|COLOMBIA||Region of Enrollment||participants|Number|3|3.0||||||
4057557|NCT01081834|3879070|B3|COLOMBIA||Region of Enrollment||participants|Number|6|6.0||||||
4057558|NCT01081834|3879071|B2|COLOMBIA||Region of Enrollment||participants|Number|8|8.0||||||
4057559|NCT01081834|3879072|B1|COLOMBIA||Region of Enrollment||participants|Number|8|8.0||||||
4057560|NCT01081834|3879067|B6|AUSTRIA||Region of Enrollment||participants|Number|4|4.0||||||
4057561|NCT01081834|3879068|B5|AUSTRIA||Region of Enrollment||participants|Number|0|0.0||||||
4057562|NCT01081834|3879069|B4|AUSTRIA||Region of Enrollment||participants|Number|0|0.0||||||
4057563|NCT01081834|3879070|B3|AUSTRIA||Region of Enrollment||participants|Number|1|1.0||||||
4057564|NCT01081834|3879071|B2|AUSTRIA||Region of Enrollment||participants|Number|2|2.0||||||
4057565|NCT01081834|3879072|B1|AUSTRIA||Region of Enrollment||participants|Number|1|1.0||||||
4057566|NCT01081834|3879067|B6||Male|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
4057567|NCT01081834|3879068|B5||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4057568|NCT01081834|3879069|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4057569|NCT01081834|3879070|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4057570|NCT01081834|3879071|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4057571|NCT01081834|3879072|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4057572|NCT01081834|3879067|B6||Female|Sex: Female, Male||Participants|Count of Participants|375|375.0||||||
4057573|NCT01081834|3879068|B5||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4057574|NCT01081834|3879069|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4057575|NCT01081834|3879070|B3||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4057576|NCT01081834|3879071|B2||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4057577|NCT01081834|3879072|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4057578|NCT01081834|3879067|B6|||Age||years|Mean|54.5|54.5|Standard Deviation|10.85|10.85|||
4057579|NCT01081834|3879068|B5|||Age||years|Mean|48.8|48.8|Standard Deviation|10.92|10.92|||
4057580|NCT01081834|3879069|B4|||Age||years|Mean|49.7|49.7|Standard Deviation|11.12|11.12|||
4057581|NCT01081834|3879070|B3|||Age||years|Mean|55.3|55.3|Standard Deviation|10.17|10.17|||
4057582|NCT01081834|3879071|B2|||Age||years|Mean|55.1|55.1|Standard Deviation|10.83|10.83|||
4057583|NCT01081834|3879072|B1|||Age||years|Mean|55.7|55.7|Standard Deviation|10.88|10.88|||
4057584|NCT01081834|3879067|B6||>=65 years|Age||Participants|Count of Participants|126|126.0||||||
4057585|NCT01081834|3879068|B5||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4057586|NCT01081834|3879069|B4||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4057587|NCT01081834|3879070|B3||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
4057588|NCT01081834|3879071|B2||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4057589|NCT01081834|3879072|B1||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
4057590|NCT01081834|3879067|B6||Between 18 and 65 years|Age||Participants|Count of Participants|549|549.0||||||
4057591|NCT01081834|3879068|B5||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4057592|NCT01081834|3879069|B4||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4057593|NCT01081834|3879070|B3||Between 18 and 65 years|Age||Participants|Count of Participants|160|160.0||||||
4057594|NCT01081834|3879071|B2||Between 18 and 65 years|Age||Participants|Count of Participants|156|156.0||||||
4057595|NCT01081834|3879072|B1||Between 18 and 65 years|Age||Participants|Count of Participants|150|150.0||||||
4057596|NCT01081834|3879067|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4057597|NCT01081834|3879068|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4057598|NCT01081834|3879069|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4057599|NCT01081834|3879070|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4057600|NCT01081834|3879071|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4057601|NCT01081834|3879072|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4057602|NCT01081795|3879134|B4||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4057603|NCT01081795|3879135|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4057604|NCT01081795|3879136|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4057605|NCT01081795|3879137|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4057606|NCT01081795|3879134|B4||Female|Sex: Female, Male||Participants|Count of Participants|306|306.0||||||
4057607|NCT01081795|3879135|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4057608|NCT01081795|3879136|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4057609|NCT01081795|3879137|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4057610|NCT01081795|3879134|B4|||Age||Years|Mean|40.3|40.3|Standard Deviation|9.22|9.22|||
4057611|NCT01081795|3879135|B3|||Age||Years|Mean|41.2|41.2|Standard Deviation|9.10|9.1|||
4057612|NCT01081795|3879136|B2|||Age||Years|Mean|39.5|39.5|Standard Deviation|9.25|9.25|||
4057613|NCT01081795|3879137|B1|||Age||Years|Mean|40.4|40.4|Standard Deviation|9.30|9.3|||
4057614|NCT01081769|3879174|B3|UKRAINE||Region of Enrollment||participants|Number|150|150.0||||||
4057615|NCT01081769|3879175|B2|UKRAINE||Region of Enrollment||participants|Number|79|79.0||||||
4057616|NCT01081769|3879176|B1|UKRAINE||Region of Enrollment||participants|Number|71|71.0||||||
4057617|NCT01081769|3879174|B3|TURKEY||Region of Enrollment||participants|Number|20|20.0||||||
4057618|NCT01081769|3879175|B2|TURKEY||Region of Enrollment||participants|Number|9|9.0||||||
4057619|NCT01081769|3879176|B1|TURKEY||Region of Enrollment||participants|Number|11|11.0||||||
4057620|NCT01081769|3879174|B3|TAIWAN, PROVINCE OF CHINA||Region of Enrollment||participants|Number|9|9.0||||||
4057621|NCT01081769|3879175|B2|TAIWAN, PROVINCE OF CHINA||Region of Enrollment||participants|Number|5|5.0||||||
4057622|NCT01081769|3879176|B1|TAIWAN, PROVINCE OF CHINA||Region of Enrollment||participants|Number|4|4.0||||||
4057623|NCT01081769|3879174|B3|SPAIN||Region of Enrollment||participants|Number|7|7.0||||||
4057624|NCT01081769|3879175|B2|SPAIN||Region of Enrollment||participants|Number|4|4.0||||||
4057625|NCT01081769|3879176|B1|SPAIN||Region of Enrollment||participants|Number|3|3.0||||||
4057626|NCT01081769|3879174|B3|SOUTH AFRICA||Region of Enrollment||participants|Number|50|50.0||||||
4057627|NCT01081769|3879175|B2|SOUTH AFRICA||Region of Enrollment||participants|Number|24|24.0||||||
4057628|NCT01081769|3879176|B1|SOUTH AFRICA||Region of Enrollment||participants|Number|26|26.0||||||
4057629|NCT01081769|3879174|B3|SLOVAKIA||Region of Enrollment||participants|Number|27|27.0||||||
4057630|NCT01081769|3879175|B2|SLOVAKIA||Region of Enrollment||participants|Number|14|14.0||||||
4057631|NCT01081769|3879176|B1|SLOVAKIA||Region of Enrollment||participants|Number|13|13.0||||||
4057632|NCT01081769|3879174|B3|RUSSIAN FEDERATION||Region of Enrollment||participants|Number|180|180.0||||||
4057633|NCT01081769|3879175|B2|RUSSIAN FEDERATION||Region of Enrollment||participants|Number|90|90.0||||||
4057634|NCT01081769|3879176|B1|RUSSIAN FEDERATION||Region of Enrollment||participants|Number|90|90.0||||||
4057635|NCT01081769|3879174|B3|ROMANIA||Region of Enrollment||participants|Number|27|27.0||||||
4057636|NCT01081769|3879175|B2|ROMANIA||Region of Enrollment||participants|Number|14|14.0||||||
4057637|NCT01081769|3879176|B1|ROMANIA||Region of Enrollment||participants|Number|13|13.0||||||
4057638|NCT01081769|3879174|B3|POLAND||Region of Enrollment||participants|Number|22|22.0||||||
4057639|NCT01081769|3879175|B2|POLAND||Region of Enrollment||participants|Number|11|11.0||||||
4057640|NCT01081769|3879176|B1|POLAND||Region of Enrollment||participants|Number|11|11.0||||||
4057641|NCT01081769|3879174|B3|LITHUANIA||Region of Enrollment||participants|Number|27|27.0||||||
4057642|NCT01081769|3879175|B2|LITHUANIA||Region of Enrollment||participants|Number|14|14.0||||||
4057643|NCT01081769|3879176|B1|LITHUANIA||Region of Enrollment||participants|Number|13|13.0||||||
4057644|NCT01081769|3879174|B3|KOREA, REPUBLIC OF KOREA||Region of Enrollment||participants|Number|6|6.0||||||
4057645|NCT01081769|3879175|B2|KOREA, REPUBLIC OF KOREA||Region of Enrollment||participants|Number|4|4.0||||||
4057646|NCT01081769|3879176|B1|KOREA, REPUBLIC OF KOREA||Region of Enrollment||participants|Number|2|2.0||||||
4057647|NCT01081769|3879174|B3|JORDAN||Region of Enrollment||participants|Number|26|26.0||||||
4057648|NCT01081769|3879175|B2|JORDAN||Region of Enrollment||participants|Number|11|11.0||||||
4057649|NCT01081769|3879176|B1|JORDAN||Region of Enrollment||participants|Number|15|15.0||||||
4057650|NCT01081769|3879174|B3|ITALY||Region of Enrollment||participants|Number|21|21.0||||||
4057651|NCT01081769|3879175|B2|ITALY||Region of Enrollment||participants|Number|11|11.0||||||
4057652|NCT01081769|3879176|B1|ITALY||Region of Enrollment||participants|Number|10|10.0||||||
4057653|NCT01081769|3879174|B3|ISRAEL||Region of Enrollment||participants|Number|11|11.0||||||
4057654|NCT01081769|3879175|B2|ISRAEL||Region of Enrollment||participants|Number|5|5.0||||||
4057655|NCT01081769|3879176|B1|ISRAEL||Region of Enrollment||participants|Number|6|6.0||||||
4057656|NCT01081769|3879174|B3|HUNGARY||Region of Enrollment||participants|Number|31|31.0||||||
4057657|NCT01081769|3879175|B2|HUNGARY||Region of Enrollment||participants|Number|16|16.0||||||
4057658|NCT01081769|3879176|B1|HUNGARY||Region of Enrollment||participants|Number|15|15.0||||||
4057659|NCT01081769|3879174|B3|GERMANY||Region of Enrollment||participants|Number|5|5.0||||||
4057660|NCT01081769|3879175|B2|GERMANY||Region of Enrollment||participants|Number|2|2.0||||||
4057661|NCT01081769|3879176|B1|GERMANY||Region of Enrollment||participants|Number|3|3.0||||||
4057662|NCT01081769|3879174|B3|FRANCE||Region of Enrollment||participants|Number|8|8.0||||||
4057663|NCT01081769|3879175|B2|FRANCE||Region of Enrollment||participants|Number|4|4.0||||||
4057664|NCT01081769|3879176|B1|FRANCE||Region of Enrollment||participants|Number|4|4.0||||||
4057665|NCT01081769|3879174|B3|ESTONIA||Region of Enrollment||participants|Number|5|5.0||||||
4057666|NCT01081769|3879175|B2|ESTONIA||Region of Enrollment||participants|Number|3|3.0||||||
4057667|NCT01081769|3879176|B1|ESTONIA||Region of Enrollment||participants|Number|2|2.0||||||
4057668|NCT01081769|3879174|B3|EGYPT||Region of Enrollment||participants|Number|30|30.0||||||
4057669|NCT01081769|3879175|B2|EGYPT||Region of Enrollment||participants|Number|14|14.0||||||
4057670|NCT01081769|3879176|B1|EGYPT||Region of Enrollment||participants|Number|16|16.0||||||
4057671|NCT01081769|3879174|B3|CZECH REPUBLIC||Region of Enrollment||participants|Number|35|35.0||||||
4057672|NCT01081769|3879175|B2|CZECH REPUBLIC||Region of Enrollment||participants|Number|21|21.0||||||
4057673|NCT01081769|3879176|B1|CZECH REPUBLIC||Region of Enrollment||participants|Number|14|14.0||||||
4057674|NCT01081769|3879174|B3|CROATIA||Region of Enrollment||participants|Number|24|24.0||||||
4057675|NCT01081769|3879175|B2|CROATIA||Region of Enrollment||participants|Number|12|12.0||||||
4057676|NCT01081769|3879176|B1|CROATIA||Region of Enrollment||participants|Number|12|12.0||||||
4057677|NCT01081769|3879174|B3|BULGARIA||Region of Enrollment||participants|Number|30|30.0||||||
4057678|NCT01081769|3879175|B2|BULGARIA||Region of Enrollment||participants|Number|15|15.0||||||
4057679|NCT01081769|3879176|B1|BULGARIA||Region of Enrollment||participants|Number|15|15.0||||||
4057680|NCT01081769|3879174|B3|BELGIUM||Region of Enrollment||participants|Number|12|12.0||||||
4057681|NCT01081769|3879175|B2|BELGIUM||Region of Enrollment||participants|Number|5|5.0||||||
4057682|NCT01081769|3879176|B1|BELGIUM||Region of Enrollment||participants|Number|7|7.0||||||
4057683|NCT01081769|3879174|B3|AUSTRIA||Region of Enrollment||participants|Number|1|1.0||||||
4057684|NCT01081769|3879175|B2|AUSTRIA||Region of Enrollment||participants|Number|1|1.0||||||
4057685|NCT01081769|3879176|B1|AUSTRIA||Region of Enrollment||participants|Number|0|0.0||||||
4057686|NCT01081769|3879174|B3||Male|Sex: Female, Male||Participants|Count of Participants|446|446.0||||||
4057687|NCT01081769|3879175|B2||Male|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
4057688|NCT01081769|3879176|B1||Male|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4057689|NCT01081769|3879174|B3||Female|Sex: Female, Male||Participants|Count of Participants|318|318.0||||||
4057690|NCT01081769|3879175|B2||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4057691|NCT01081769|3879176|B1||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4057692|NCT01081769|3879174|B3|||Age||years|Mean|32.5|32.5|Standard Deviation|10.36|10.36|||
4057693|NCT01081769|3879175|B2|||Age||years|Mean|32.4|32.4|Standard Deviation|10|10.0|||
4057694|NCT01081769|3879176|B1|||Age||years|Mean|32.5|32.5|Standard Deviation|10.73|10.73|||
4057783|NCT01081041|3879365|B2|Locoregional||Disease Stage at Study Entry||participants|Number|34|34.0||||||
4057695|NCT01081665|3879211|B1|||Time since diagnosis of secondary hyperparathyroidism|At study entry, the amount of time that had elapsed since participants were first diagnosed with hyperparathyroidism, a condition where the parathyroid glands make too much parathyroid hormone, causing an imbalance of calcium and phosphorous in the body. Based on data reported by 228 participants.|years|Mean|2.0|2.0|Standard Deviation|3.1|3.1|||
4057696|NCT01081665|3879211|B1|||Time since starting haemodialysis|At study entry, the amount of time that had elapsed from participants first starting haemodialysis, a procedure that filters the blood to remove harmful wastes.|years|Mean|3.6|3.6|Standard Deviation|4.4|4.4|||
4057697|NCT01081665|3879211|B1|||Time since chronic kidney disease diagnosis|The amount of time elapsed from the time the participant was diagnosed with chronic kidney disease to study entry. Based on data reported by 222 participants.|years|Mean|8.8|8.8|Standard Deviation|6.8|6.8|||
4057698|NCT01081665|3879211|B1|||Age at chronic kidney disease diagnosis|The age of participants when they were diagnosed with chronic kidney disease. Based on data reported by 222 participants.|years|Mean|53.6|53.6|Standard Deviation|14.7|14.7|||
4057699|NCT01081665|3879211|B1|Greece||Region of Enrollment||participants|Number|237|237.0||||||
4057700|NCT01081665|3879211|B1||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4057701|NCT01081665|3879211|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4057702|NCT01081665|3879211|B1|||Age||years|Mean|62.6|62.6|Standard Deviation|13.7|13.7|||
4057703|NCT01081626|3879221|B3||Male|Sex: Female, Male|Data for baseline measure (gender) was available for 122 and 125 participants in CLD protocol and LD protocol arm, respectively, who were treated and had at least 1 efficacy evaluation.|Participants|Count of Participants|0|0.0||||||
4057704|NCT01081626|3879222|B2||Male|Sex: Female, Male|Data for baseline measure (gender) was available for 122 and 125 participants in CLD protocol and LD protocol arm, respectively, who were treated and had at least 1 efficacy evaluation.|Participants|Count of Participants|0|0.0||||||
4057705|NCT01081626|3879223|B1||Male|Sex: Female, Male|Data for baseline measure (gender) was available for 122 and 125 participants in CLD protocol and LD protocol arm, respectively, who were treated and had at least 1 efficacy evaluation.|Participants|Count of Participants|0|0.0||||||
4057706|NCT01081626|3879221|B3||Female|Sex: Female, Male|Data for baseline measure (gender) was available for 122 and 125 participants in CLD protocol and LD protocol arm, respectively, who were treated and had at least 1 efficacy evaluation.|Participants|Count of Participants|247|247.0||||||
4057707|NCT01081626|3879222|B2||Female|Sex: Female, Male|Data for baseline measure (gender) was available for 122 and 125 participants in CLD protocol and LD protocol arm, respectively, who were treated and had at least 1 efficacy evaluation.|Participants|Count of Participants|125|125.0||||||
4057708|NCT01081626|3879223|B1||Female|Sex: Female, Male|Data for baseline measure (gender) was available for 122 and 125 participants in CLD protocol and LD protocol arm, respectively, who were treated and had at least 1 efficacy evaluation.|Participants|Count of Participants|122|122.0||||||
4057709|NCT01081626|3879221|B3|||Age|Data for baseline measure (age) was available for 122 and 125 participants in CLD protocol and LD protocol arm, respectively, who were treated and had at least 1 efficacy evaluation.|years|Mean|27.70|27.7|Standard Deviation|4.37|4.37|||
4057710|NCT01081626|3879222|B2|||Age|Data for baseline measure (age) was available for 122 and 125 participants in CLD protocol and LD protocol arm, respectively, who were treated and had at least 1 efficacy evaluation.|years|Mean|27.88|27.88|Standard Deviation|4.33|4.33|||
4057711|NCT01081626|3879223|B1|||Age|Data for baseline measure (age) was available for 122 and 125 participants in CLD protocol and LD protocol arm, respectively, who were treated and had at least 1 efficacy evaluation.|years|Mean|27.51|27.51|Standard Deviation|4.42|4.42|||
4057712|NCT01081301|3879250|B1|||Non-Death Revised Grief Experience Inventory|The NDRGEI is a 22-item scale measuring four domains of the grief experience for people who are not bereaved (item examples are in brackets): 1) existential concerns (e.g. “I feel lost and helpless”), 2) depression (e.g. “I cry easily”), 3) guilt (e.g. “I have feelings of guilt”), and 4) distress (e.g. “My arms and legs feel very heavy”). Responses are scored on a 6-point scale, ranging from slight disagreement to strong agreement, with a higher total score indicating more grief and loss. The Non-Death Revised Grief Experience Inventory has a minimum score of 22 and a maximum score of 132.|units on a scale|Mean|72.82|72.82|Standard Deviation|23.92|23.92|||
4057713|NCT01081301|3879250|B1|||Short Form Health Survey Version 2 - Physical Health|The SF-12v2 was developed as a shorter yet valid alternative to the SF 36 as a measure of quality of life. The SF-12v2 produces a physical health component summary score (PCS), and a mental health component summary score (MCS), but not a total summary score. Scores range from 0 (poor health) to 100 (perfect health). The SF-12v2 physical summary and mental health summary scores correlate very highly (r=0.95 and 0.96 respectively) with the SF-36 and have reported test-retest reliability of r=0.89 and 0.76 respectively.|units on a scale|Mean|45.17|45.17|Standard Deviation|3.87|3.87|||
4057714|NCT01081301|3879250|B1|||Short Form Health Survey Version 2 - Mental Health|The SF-12v2 was developed as a shorter yet valid alternative to the SF 36 as a measure of quality of life. The SF-12v2 produces a physical health component summary score (PCS), and a mental health component summary score (MCS), but not a total summary score. Scores range from 0 (poor health) to 100 (perfect health). The SF-12v2 physical summary and mental health summary scores correlate very highly (r=0.95 and 0.96 respectively) with the SF-36 and have reported test-retest reliability of r=0.89 and 0.76 respectively.|units on a scale|Mean|43.59|43.59|Standard Deviation|5.35|5.35|||
4057715|NCT01081301|3879250|B1|||General Self-Efficacy Scale|This likert type scale has 10 items which produces a total perceived general self-efficacy score. Responses are made on a 4 point scale. Scores range from 10 to a maximum score of 40; the higher scores the higher participant feelings of self-efficacy. The GSES has been found to be a reliable and valid measure in many populations and countries and has been used in a study of hope and family caregivers of women with breast cancer. Reliability ranges from r=0.76 to r=0.90 and criterion related reliability was r=0.80, p<0.05.|units on a scale|Mean|31.1|31.1|Standard Deviation|3.94|3.94|||
4057784|NCT01081041|3879366|B1|Locoregional||Disease Stage at Study Entry||participants|Number|6|6.0||||||
4057785|NCT01081041|3879363|B4|Canada||Region of Enrollment|Region of enrollment not available for 1 participant in the cetuximab manufactured by BI reporting group; N=70.|participants|Number|61|61.0||||||
4057716|NCT01081301|3879250|B1|||Herth Hope Index|The Herth Hope Index provides a summative hope score and scores for three sub-scales of hope: a) temporality and future, b) positive readiness and expectancy, and c) interconnectedness. It is a 12 item likert response scale (1-4) with summative scores ranging from 12-48, with a higher score denoting greater hope. It has reported reliability (test-retest r=0. 91, p<0. 05) and validity (concurrent validity, r=0. 84, p<.0 05; criterion, r=. 92, p< 0.05; divergent, r=-.73, p<0. 05).|units on a scale|Mean|37.79|37.79|Standard Deviation|5.97|5.97|||
4057717|NCT01081301|3879250|B1|Canada||Region of Enrollment||participants|Number|36|36.0||||||
4057718|NCT01081301|3879250|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4057719|NCT01081301|3879250|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4057720|NCT01081301|3879250|B1|||Age||years|Mean|59|59.0|Standard Deviation|11.6|11.6|||
4057721|NCT01081249|3879288|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4057722|NCT01081249|3879288|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4057723|NCT01081249|3879288|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4057724|NCT01081249|3879288|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4057725|NCT01081249|3879288|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4057726|NCT01081249|3879288|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4057727|NCT01081145|3879295|B1|UNITED STATES||Region of Enrollment||Participants|Number|278|278.0||||||
4057728|NCT01081145|3879295|B1|UNITED KINGDOM||Region of Enrollment||Participants|Number|25|25.0||||||
4057729|NCT01081145|3879295|B1|SWEDEN||Region of Enrollment||Participants|Number|5|5.0||||||
4057730|NCT01081145|3879295|B1|SPAIN||Region of Enrollment||Participants|Number|68|68.0||||||
4057731|NCT01081145|3879295|B1|NETHERLANDS||Region of Enrollment||Participants|Number|29|29.0||||||
4057732|NCT01081145|3879295|B1|ITALY||Region of Enrollment||Participants|Number|31|31.0||||||
4057733|NCT01081145|3879295|B1|GERMANY||Region of Enrollment||Participants|Number|27|27.0||||||
4057734|NCT01081145|3879295|B1|FRANCE||Region of Enrollment||Participants|Number|14|14.0||||||
4057735|NCT01081145|3879295|B1|CANADA||Region of Enrollment||Participants|Number|30|30.0||||||
4057736|NCT01081145|3879295|B1|BELGIUM||Region of Enrollment||Participants|Number|19|19.0||||||
4057737|NCT01081145|3879295|B1||Male|Sex: Female, Male||Participants|Count of Participants|396|396.0||||||
4057738|NCT01081145|3879295|B1||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4057739|NCT01081145|3879295|B1|13-17 years||Age, Customized||Participants|Number|135|135.0||||||
4057740|NCT01081145|3879295|B1|6-12 years||Age, Customized||Participants|Number|391|391.0||||||
4057741|NCT01081145|3879295|B1|||Age||Years|Mean|10.7|10.7|Standard Deviation|2.7|2.7|||
4057742|NCT01081132|3879322|B3|UNITED STATES||Region of Enrollment|All randomized subjects (n = 314)|Participants|Number|314|314.0||||||
4057743|NCT01081132|3879323|B2|UNITED STATES||Region of Enrollment|All randomized subjects (n = 314)|Participants|Number|157|157.0||||||
4057744|NCT01081132|3879324|B1|UNITED STATES||Region of Enrollment|All randomized subjects (n = 314)|Participants|Number|157|157.0||||||
4057745|NCT01081132|3879322|B3||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4057746|NCT01081132|3879323|B2||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4057747|NCT01081132|3879324|B1||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4057748|NCT01081132|3879322|B3||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4057749|NCT01081132|3879323|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4057750|NCT01081132|3879324|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4057751|NCT01081132|3879322|B3|<18 years||Age, Customized||Participants|Number|312|312.0||||||
4057752|NCT01081132|3879323|B2|<18 years||Age, Customized||Participants|Number|157|157.0||||||
4057753|NCT01081132|3879324|B1|<18 years||Age, Customized||Participants|Number|155|155.0||||||
4057754|NCT01081132|3879322|B3|||Age||Years|Mean|14.5|14.5|Standard Deviation|1.39|1.39|||
4057755|NCT01081132|3879323|B2|||Age||Years|Mean|14.5|14.5|Standard Deviation|1.35|1.35|||
4057756|NCT01081132|3879324|B1|||Age||Years|Mean|14.6|14.6|Standard Deviation|1.44|1.44|||
4057757|NCT01081041|3879363|B4|KPS 100||Karnofsky Performance Status (KPS)|The KPS rates the performance status and neurological functioning of a participant on a scale from KPS 0 (Dead) to KPS 100 (No complaints; no evidence of disease) in increments of 10. KPS 90 (Able to carry on normal activity; minor signs or symptoms of disease), KPS 80 (Normal activity with effort; some signs or symptoms of disease), and KPS 70 (Cares for self; unable to carry on normal activity or do active work).|participants|Number|23|23.0||||||
4057758|NCT01081041|3879364|B3|KPS 100||Karnofsky Performance Status (KPS)|The KPS rates the performance status and neurological functioning of a participant on a scale from KPS 0 (Dead) to KPS 100 (No complaints; no evidence of disease) in increments of 10. KPS 90 (Able to carry on normal activity; minor signs or symptoms of disease), KPS 80 (Normal activity with effort; some signs or symptoms of disease), and KPS 70 (Cares for self; unable to carry on normal activity or do active work).|participants|Number|11|11.0||||||
4057759|NCT01081041|3879365|B2|KPS 100||Karnofsky Performance Status (KPS)|The KPS rates the performance status and neurological functioning of a participant on a scale from KPS 0 (Dead) to KPS 100 (No complaints; no evidence of disease) in increments of 10. KPS 90 (Able to carry on normal activity; minor signs or symptoms of disease), KPS 80 (Normal activity with effort; some signs or symptoms of disease), and KPS 70 (Cares for self; unable to carry on normal activity or do active work).|participants|Number|8|8.0||||||
4057760|NCT01081041|3879366|B1|KPS 100||Karnofsky Performance Status (KPS)|The KPS rates the performance status and neurological functioning of a participant on a scale from KPS 0 (Dead) to KPS 100 (No complaints; no evidence of disease) in increments of 10. KPS 90 (Able to carry on normal activity; minor signs or symptoms of disease), KPS 80 (Normal activity with effort; some signs or symptoms of disease), and KPS 70 (Cares for self; unable to carry on normal activity or do active work).|participants|Number|4|4.0||||||
4057761|NCT01081041|3879363|B4|KPS 90||Karnofsky Performance Status (KPS)|The KPS rates the performance status and neurological functioning of a participant on a scale from KPS 0 (Dead) to KPS 100 (No complaints; no evidence of disease) in increments of 10. KPS 90 (Able to carry on normal activity; minor signs or symptoms of disease), KPS 80 (Normal activity with effort; some signs or symptoms of disease), and KPS 70 (Cares for self; unable to carry on normal activity or do active work).|participants|Number|68|68.0||||||
4057762|NCT01081041|3879364|B3|KPS 90||Karnofsky Performance Status (KPS)|The KPS rates the performance status and neurological functioning of a participant on a scale from KPS 0 (Dead) to KPS 100 (No complaints; no evidence of disease) in increments of 10. KPS 90 (Able to carry on normal activity; minor signs or symptoms of disease), KPS 80 (Normal activity with effort; some signs or symptoms of disease), and KPS 70 (Cares for self; unable to carry on normal activity or do active work).|participants|Number|31|31.0||||||
4057763|NCT01081041|3879365|B2|KPS 90||Karnofsky Performance Status (KPS)|The KPS rates the performance status and neurological functioning of a participant on a scale from KPS 0 (Dead) to KPS 100 (No complaints; no evidence of disease) in increments of 10. KPS 90 (Able to carry on normal activity; minor signs or symptoms of disease), KPS 80 (Normal activity with effort; some signs or symptoms of disease), and KPS 70 (Cares for self; unable to carry on normal activity or do active work).|participants|Number|32|32.0||||||
4057764|NCT01081041|3879366|B1|KPS 90||Karnofsky Performance Status (KPS)|The KPS rates the performance status and neurological functioning of a participant on a scale from KPS 0 (Dead) to KPS 100 (No complaints; no evidence of disease) in increments of 10. KPS 90 (Able to carry on normal activity; minor signs or symptoms of disease), KPS 80 (Normal activity with effort; some signs or symptoms of disease), and KPS 70 (Cares for self; unable to carry on normal activity or do active work).|participants|Number|5|5.0||||||
4057765|NCT01081041|3879363|B4|KPS 80||Karnofsky Performance Status (KPS)|The KPS rates the performance status and neurological functioning of a participant on a scale from KPS 0 (Dead) to KPS 100 (No complaints; no evidence of disease) in increments of 10. KPS 90 (Able to carry on normal activity; minor signs or symptoms of disease), KPS 80 (Normal activity with effort; some signs or symptoms of disease), and KPS 70 (Cares for self; unable to carry on normal activity or do active work).|participants|Number|69|69.0||||||
4057766|NCT01081041|3879364|B3|KPS 80||Karnofsky Performance Status (KPS)|The KPS rates the performance status and neurological functioning of a participant on a scale from KPS 0 (Dead) to KPS 100 (No complaints; no evidence of disease) in increments of 10. KPS 90 (Able to carry on normal activity; minor signs or symptoms of disease), KPS 80 (Normal activity with effort; some signs or symptoms of disease), and KPS 70 (Cares for self; unable to carry on normal activity or do active work).|participants|Number|22|22.0||||||
4057767|NCT01081041|3879365|B2|KPS 80||Karnofsky Performance Status (KPS)|The KPS rates the performance status and neurological functioning of a participant on a scale from KPS 0 (Dead) to KPS 100 (No complaints; no evidence of disease) in increments of 10. KPS 90 (Able to carry on normal activity; minor signs or symptoms of disease), KPS 80 (Normal activity with effort; some signs or symptoms of disease), and KPS 70 (Cares for self; unable to carry on normal activity or do active work).|participants|Number|28|28.0||||||
4057768|NCT01081041|3879366|B1|KPS 80||Karnofsky Performance Status (KPS)|The KPS rates the performance status and neurological functioning of a participant on a scale from KPS 0 (Dead) to KPS 100 (No complaints; no evidence of disease) in increments of 10. KPS 90 (Able to carry on normal activity; minor signs or symptoms of disease), KPS 80 (Normal activity with effort; some signs or symptoms of disease), and KPS 70 (Cares for self; unable to carry on normal activity or do active work).|participants|Number|19|19.0||||||
4057769|NCT01081041|3879363|B4|KPS 70||Karnofsky Performance Status (KPS)|The KPS rates the performance status and neurological functioning of a participant on a scale from KPS 0 (Dead) to KPS 100 (No complaints; no evidence of disease) in increments of 10. KPS 90 (Able to carry on normal activity; minor signs or symptoms of disease), KPS 80 (Normal activity with effort; some signs or symptoms of disease), and KPS 70 (Cares for self; unable to carry on normal activity or do active work).|participants|Number|21|21.0||||||
4057770|NCT01081041|3879364|B3|KPS 70||Karnofsky Performance Status (KPS)|The KPS rates the performance status and neurological functioning of a participant on a scale from KPS 0 (Dead) to KPS 100 (No complaints; no evidence of disease) in increments of 10. KPS 90 (Able to carry on normal activity; minor signs or symptoms of disease), KPS 80 (Normal activity with effort; some signs or symptoms of disease), and KPS 70 (Cares for self; unable to carry on normal activity or do active work).|participants|Number|7|7.0||||||
4057771|NCT01081041|3879365|B2|KPS 70||Karnofsky Performance Status (KPS)|The KPS rates the performance status and neurological functioning of a participant on a scale from KPS 0 (Dead) to KPS 100 (No complaints; no evidence of disease) in increments of 10. KPS 90 (Able to carry on normal activity; minor signs or symptoms of disease), KPS 80 (Normal activity with effort; some signs or symptoms of disease), and KPS 70 (Cares for self; unable to carry on normal activity or do active work).|participants|Number|9|9.0||||||
4057772|NCT01081041|3879366|B1|KPS 70||Karnofsky Performance Status (KPS)|The KPS rates the performance status and neurological functioning of a participant on a scale from KPS 0 (Dead) to KPS 100 (No complaints; no evidence of disease) in increments of 10. KPS 90 (Able to carry on normal activity; minor signs or symptoms of disease), KPS 80 (Normal activity with effort; some signs or symptoms of disease), and KPS 70 (Cares for self; unable to carry on normal activity or do active work).|participants|Number|5|5.0||||||
4057773|NCT01081041|3879363|B4|Unknown or not reported||Disease Stage at Study Entry||participants|Number|1|1.0||||||
4057774|NCT01081041|3879364|B3|Unknown or not reported||Disease Stage at Study Entry||participants|Number|1|1.0||||||
4057775|NCT01081041|3879365|B2|Unknown or not reported||Disease Stage at Study Entry||participants|Number|0|0.0||||||
4057776|NCT01081041|3879366|B1|Unknown or not reported||Disease Stage at Study Entry||participants|Number|0|0.0||||||
4057777|NCT01081041|3879363|B4|Metastatic||Disease Stage at Study Entry||participants|Number|108|108.0||||||
4057778|NCT01081041|3879364|B3|Metastatic||Disease Stage at Study Entry||participants|Number|38|38.0||||||
4057779|NCT01081041|3879365|B2|Metastatic||Disease Stage at Study Entry||participants|Number|43|43.0||||||
4057780|NCT01081041|3879366|B1|Metastatic||Disease Stage at Study Entry||participants|Number|27|27.0||||||
4057781|NCT01081041|3879363|B4|Locoregional||Disease Stage at Study Entry||participants|Number|72|72.0||||||
4057782|NCT01081041|3879364|B3|Locoregional||Disease Stage at Study Entry||participants|Number|32|32.0||||||
4057786|NCT01081041|3879364|B3|Canada||Region of Enrollment|Region of enrollment not available for 1 participant in the cetuximab manufactured by BI reporting group; N=70.|participants|Number|27|27.0||||||
4057787|NCT01081041|3879365|B2|Canada||Region of Enrollment|Region of enrollment not available for 1 participant in the cetuximab manufactured by BI reporting group; N=70.|participants|Number|29|29.0||||||
4057788|NCT01081041|3879366|B1|Canada||Region of Enrollment|Region of enrollment not available for 1 participant in the cetuximab manufactured by BI reporting group; N=70.|participants|Number|5|5.0||||||
4057789|NCT01081041|3879363|B4|Mexico||Region of Enrollment|Region of enrollment not available for 1 participant in the cetuximab manufactured by BI reporting group; N=70.|participants|Number|39|39.0||||||
4057790|NCT01081041|3879364|B3|Mexico||Region of Enrollment|Region of enrollment not available for 1 participant in the cetuximab manufactured by BI reporting group; N=70.|participants|Number|15|15.0||||||
4057791|NCT01081041|3879365|B2|Mexico||Region of Enrollment|Region of enrollment not available for 1 participant in the cetuximab manufactured by BI reporting group; N=70.|participants|Number|23|23.0||||||
4057792|NCT01081041|3879366|B1|Mexico||Region of Enrollment|Region of enrollment not available for 1 participant in the cetuximab manufactured by BI reporting group; N=70.|participants|Number|1|1.0||||||
4057793|NCT01081041|3879363|B4|United States||Region of Enrollment|Region of enrollment not available for 1 participant in the cetuximab manufactured by BI reporting group; N=70.|participants|Number|80|80.0||||||
4057794|NCT01081041|3879364|B3|United States||Region of Enrollment|Region of enrollment not available for 1 participant in the cetuximab manufactured by BI reporting group; N=70.|participants|Number|28|28.0||||||
4057795|NCT01081041|3879365|B2|United States||Region of Enrollment|Region of enrollment not available for 1 participant in the cetuximab manufactured by BI reporting group; N=70.|participants|Number|25|25.0||||||
4057796|NCT01081041|3879366|B1|United States||Region of Enrollment|Region of enrollment not available for 1 participant in the cetuximab manufactured by BI reporting group; N=70.|participants|Number|27|27.0||||||
4057797|NCT01081041|3879363|B4|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4057798|NCT01081041|3879364|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4057799|NCT01081041|3879365|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4057800|NCT01081041|3879366|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4057801|NCT01081041|3879363|B4|More than 1 race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4057802|NCT01081041|3879364|B3|More than 1 race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4057803|NCT01081041|3879365|B2|More than 1 race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4057804|NCT01081041|3879366|B1|More than 1 race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4057805|NCT01081041|3879363|B4|White||Race/Ethnicity, Customized||participants|Number|138|138.0||||||
4057806|NCT01081041|3879364|B3|White||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
4057807|NCT01081041|3879365|B2|White||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
4057808|NCT01081041|3879366|B1|White||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4057809|NCT01081041|3879363|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4057810|NCT01081041|3879364|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4057811|NCT01081041|3879365|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4057812|NCT01081041|3879366|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4057813|NCT01081041|3879363|B4|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4057814|NCT01081041|3879364|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4057815|NCT01081041|3879365|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4057816|NCT01081041|3879366|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4057817|NCT01081041|3879363|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4057818|NCT01081041|3879364|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4057819|NCT01081041|3879365|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4057820|NCT01081041|3879366|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4057821|NCT01081041|3879363|B4|Unknown or Not Reported||Sex/Gender, Customized||participants|Number|1|1.0||||||
4057822|NCT01081041|3879364|B3|Unknown or Not Reported||Sex/Gender, Customized||participants|Number|1|1.0||||||
4057823|NCT01081041|3879365|B2|Unknown or Not Reported||Sex/Gender, Customized||participants|Number|0|0.0||||||
4057824|NCT01081041|3879366|B1|Unknown or Not Reported||Sex/Gender, Customized||participants|Number|0|0.0||||||
4057825|NCT01081041|3879363|B4|Male||Sex/Gender, Customized||participants|Number|145|145.0||||||
4057826|NCT01081041|3879364|B3|Male||Sex/Gender, Customized||participants|Number|55|55.0||||||
4057827|NCT01081041|3879365|B2|Male||Sex/Gender, Customized||participants|Number|68|68.0||||||
4057828|NCT01081041|3879366|B1|Male||Sex/Gender, Customized||participants|Number|22|22.0||||||
4057829|NCT01081041|3879363|B4|Female||Sex/Gender, Customized||participants|Number|35|35.0||||||
4057830|NCT01081041|3879364|B3|Female||Sex/Gender, Customized||participants|Number|15|15.0||||||
4057831|NCT01081041|3879365|B2|Female||Sex/Gender, Customized||participants|Number|9|9.0||||||
4057832|NCT01081041|3879366|B1|Female||Sex/Gender, Customized||participants|Number|11|11.0||||||
4057833|NCT01081041|3879363|B4|||Age||years|Mean|59.0|59.0|Standard Deviation|10.47|10.47|||
4057834|NCT01081041|3879364|B3|||Age||years|Mean|59.4|59.4|Standard Deviation|10.49|10.49|||
4057835|NCT01081041|3879365|B2|||Age||years|Mean|57.1|57.1|Standard Deviation|10.75|10.75|||
4057836|NCT01081041|3879366|B1|||Age||years|Mean|62.9|62.9|Standard Deviation|8.74|8.74|||
4057837|NCT01080976|3879396|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4057838|NCT01080976|3879397|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4057839|NCT01080976|3879398|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4057840|NCT01080976|3879396|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4057841|NCT01080976|3879397|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4057842|NCT01080976|3879398|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4057843|NCT01080976|3879396|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4057844|NCT01080976|3879397|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4057845|NCT01080976|3879398|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4057846|NCT01080976|3879396|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4057847|NCT01080976|3879397|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4057848|NCT01080976|3879398|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4057849|NCT01080976|3879396|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4057850|NCT01080976|3879397|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4057851|NCT01080976|3879398|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4057852|NCT01080807|3879407|B3|United States||Region of Enrollment||participants|Number|383|383.0||||||
4057853|NCT01080807|3879408|B2|United States||Region of Enrollment||participants|Number|190|190.0||||||
4057854|NCT01080807|3879409|B1|United States||Region of Enrollment||participants|Number|193|193.0||||||
4057855|NCT01080807|3879407|B3||Male|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4057856|NCT01080807|3879408|B2||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4057857|NCT01080807|3879409|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4057858|NCT01080807|3879407|B3||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4057859|NCT01080807|3879408|B2||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4057860|NCT01080807|3879409|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4057861|NCT01080807|3879407|B3|||Age||years|Mean|36.4|36.4|Standard Deviation|10.72|10.72|||
4057862|NCT01080807|3879408|B2|||Age||years|Mean|36.1|36.1|Standard Deviation|10.75|10.75|||
4057863|NCT01080807|3879409|B1|||Age||years|Mean|36.7|36.7|Standard Deviation|10.71|10.71|||
4057864|NCT01080807|3879407|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4057865|NCT01080807|3879408|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4057866|NCT01080807|3879409|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4057867|NCT01080807|3879407|B3||Between 18 and 65 years|Age||Participants|Count of Participants|383|383.0||||||
4057868|NCT01080807|3879408|B2||Between 18 and 65 years|Age||Participants|Count of Participants|190|190.0||||||
4057869|NCT01080807|3879409|B1||Between 18 and 65 years|Age||Participants|Count of Participants|193|193.0||||||
4057870|NCT01080807|3879407|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4057871|NCT01080807|3879408|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4057872|NCT01080807|3879409|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4057873|NCT01080794|3879464|B5||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4057874|NCT01080794|3879465|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4057875|NCT01080794|3879466|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4057876|NCT01080794|3879467|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4057877|NCT01080794|3879468|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4057878|NCT01080794|3879464|B5||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4057879|NCT01080794|3879465|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4057880|NCT01080794|3879466|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4057881|NCT01080794|3879467|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4057882|NCT01080794|3879468|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4057883|NCT01080794|3879464|B5|||Age||years|Mean|66.3|66.3|Standard Deviation|10.1|10.1|||
4057884|NCT01080794|3879465|B4|||Age||years|Mean|66.2|66.2|Standard Deviation|12.7|12.7|||
4057885|NCT01080794|3879466|B3|||Age||years|Mean|67.3|67.3|Standard Deviation|12.7|12.7|||
4057886|NCT01080794|3879467|B2|||Age||years|Mean|62.7|62.7|Standard Deviation|13.0|13.0|||
4057887|NCT01080794|3879468|B1|||Age||years|Mean|68.2|68.2|Standard Deviation|8.0|8.0|||
4057888|NCT01080768|3879517|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4057889|NCT01080768|3879518|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4057890|NCT01080768|3879519|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4057891|NCT01080768|3879517|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4057892|NCT01080768|3879518|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4057893|NCT01080768|3879519|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4057894|NCT01080768|3879517|B3|||Age||years|Mean|56.8|56.8|Standard Deviation|5.40|5.4|||
4057895|NCT01080768|3879518|B2|||Age||years|Mean|58.0|58.0|Standard Deviation|4.49|4.49|||
4057896|NCT01080768|3879519|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|6.21|6.21|||
4057897|NCT01080716|3879526|B5|Thailand||Region of Enrollment||participants|Number|39|39.0||||||
4057898|NCT01080716|3879527|B4|Thailand||Region of Enrollment||participants|Number|10|10.0||||||
4057899|NCT01080716|3879528|B3|Thailand||Region of Enrollment||participants|Number|10|10.0||||||
4057900|NCT01080716|3879529|B2|Thailand||Region of Enrollment||participants|Number|6|6.0||||||
4057901|NCT01080716|3879530|B1|Thailand||Region of Enrollment||participants|Number|13|13.0||||||
4057902|NCT01080716|3879526|B5||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4057903|NCT01080716|3879527|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4057904|NCT01080716|3879528|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4057905|NCT01080716|3879529|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4057906|NCT01080716|3879530|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4057907|NCT01080716|3879526|B5||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4057908|NCT01080716|3879527|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4057909|NCT01080716|3879528|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4057910|NCT01080716|3879529|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4057911|NCT01080716|3879530|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4057912|NCT01080716|3879526|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4057913|NCT01080716|3879527|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4057914|NCT01080716|3879528|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4057915|NCT01080716|3879529|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4057916|NCT01080716|3879530|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4057917|NCT01080716|3879526|B5||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4057918|NCT01080716|3879527|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4057919|NCT01080716|3879528|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4057920|NCT01080716|3879529|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4057921|NCT01080716|3879530|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4057922|NCT01080716|3879526|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4057923|NCT01080716|3879527|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4057924|NCT01080716|3879528|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4057925|NCT01080716|3879529|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4057926|NCT01080716|3879530|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4057927|NCT01080677|3879547|B4|United States||Region of Enrollment||participants|Number|60|60.0||||||
4057928|NCT01080677|3879548|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4057929|NCT01080677|3879549|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4057930|NCT01080677|3879550|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4057931|NCT01080677|3879547|B4||Male|Gender||Participants|Count of Participants|30|30.0||||||
4057932|NCT01080677|3879548|B3||Male|Gender||Participants|Count of Participants|10|10.0||||||
4057933|NCT01080677|3879549|B2||Male|Gender||Participants|Count of Participants|10|10.0||||||
4057934|NCT01080677|3879550|B1||Male|Gender||Participants|Count of Participants|10|10.0||||||
4057935|NCT01080677|3879547|B4||Female|Gender||Participants|Count of Participants|30|30.0||||||
4057936|NCT01080677|3879548|B3||Female|Gender||Participants|Count of Participants|10|10.0||||||
4057937|NCT01080677|3879549|B2||Female|Gender||Participants|Count of Participants|10|10.0||||||
4057938|NCT01080677|3879550|B1||Female|Gender||Participants|Count of Participants|10|10.0||||||
4057939|NCT01080677|3879547|B4||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4057940|NCT01080677|3879548|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4057941|NCT01080677|3879549|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4057942|NCT01080677|3879550|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4057943|NCT01080677|3879547|B4||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4057944|NCT01080677|3879548|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4057945|NCT01080677|3879549|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4057946|NCT01080677|3879550|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4057947|NCT01080677|3879547|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4057948|NCT01080677|3879548|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4057949|NCT01080677|3879549|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4057950|NCT01080677|3879550|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4057951|NCT01080625|3879569|B4|Korea, Republic of||Region of Enrollment||participants|Number|96|96.0||||||
4057952|NCT01080625|3879570|B3|Korea, Republic of||Region of Enrollment||participants|Number|32|32.0||||||
4057953|NCT01080625|3879571|B2|Korea, Republic of||Region of Enrollment||participants|Number|33|33.0||||||
4057954|NCT01080625|3879572|B1|Korea, Republic of||Region of Enrollment||participants|Number|31|31.0||||||
4057955|NCT01080625|3879569|B4||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4057956|NCT01080625|3879570|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4057957|NCT01080625|3879571|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4057958|NCT01080625|3879572|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4057959|NCT01080625|3879569|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4057960|NCT01080625|3879570|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4057961|NCT01080625|3879571|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4057962|NCT01080625|3879572|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4057963|NCT01080625|3879569|B4|||Age||years|Mean|53|53.0|Standard Deviation|10|10.0|||
4057964|NCT01080625|3879570|B3|||Age||years|Mean|52|52.0|Standard Deviation|11|11.0|||
4057965|NCT01080625|3879571|B2|||Age||years|Mean|55|55.0|Standard Deviation|10|10.0|||
4057966|NCT01080625|3879572|B1|||Age||years|Mean|52|52.0|Standard Deviation|9|9.0|||
4057967|NCT01080625|3879569|B4||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4057968|NCT01080625|3879570|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4057969|NCT01080625|3879571|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4057970|NCT01080625|3879572|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4057971|NCT01080625|3879569|B4||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
4057972|NCT01080625|3879570|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4057973|NCT01080625|3879571|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4057974|NCT01080625|3879572|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4057975|NCT01080625|3879569|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4057976|NCT01080625|3879570|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4057977|NCT01080625|3879571|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4057978|NCT01080625|3879572|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4057979|NCT01080391|3879582|B3||No|Prior Lenalidomide Exposure||Participants|Count of Participants|634|634.0||||||
4057980|NCT01080391|3879583|B2||No|Prior Lenalidomide Exposure||Participants|Count of Participants|316|316.0||||||
4057981|NCT01080391|3879584|B1||No|Prior Lenalidomide Exposure||Participants|Count of Participants|318|318.0||||||
4057982|NCT01080391|3879582|B3||Yes|Prior Lenalidomide Exposure||Participants|Count of Participants|158|158.0||||||
4057983|NCT01080391|3879583|B2||Yes|Prior Lenalidomide Exposure||Participants|Count of Participants|80|80.0||||||
4057984|NCT01080391|3879584|B1||Yes|Prior Lenalidomide Exposure||Participants|Count of Participants|78|78.0||||||
4057985|NCT01080391|3879582|B3||No|Prior Bortezomib Exposure||Participants|Count of Participants|270|270.0||||||
4057986|NCT01080391|3879583|B2||No|Prior Bortezomib Exposure||Participants|Count of Participants|135|135.0||||||
4057987|NCT01080391|3879584|B1||No|Prior Bortezomib Exposure||Participants|Count of Participants|135|135.0||||||
4057988|NCT01080391|3879582|B3||Yes|Prior Bortezomib Exposure||Participants|Count of Participants|522|522.0||||||
4057989|NCT01080391|3879583|B2||Yes|Prior Bortezomib Exposure||Participants|Count of Participants|261|261.0||||||
4057990|NCT01080391|3879584|B1||Yes|Prior Bortezomib Exposure||Participants|Count of Participants|261|261.0||||||
4057991|NCT01080391|3879582|B3||≥ 2.5 mg/L|Serum β2 Microglobulin||Participants|Count of Participants|638|638.0||||||
4057992|NCT01080391|3879583|B2||≥ 2.5 mg/L|Serum β2 Microglobulin||Participants|Count of Participants|319|319.0||||||
4057993|NCT01080391|3879584|B1||≥ 2.5 mg/L|Serum β2 Microglobulin||Participants|Count of Participants|319|319.0||||||
4057994|NCT01080391|3879582|B3||< 2.5 mg/L|Serum β2 Microglobulin||Participants|Count of Participants|154|154.0||||||
4057995|NCT01080391|3879583|B2||< 2.5 mg/L|Serum β2 Microglobulin||Participants|Count of Participants|77|77.0||||||
4057996|NCT01080391|3879584|B1||< 2.5 mg/L|Serum β2 Microglobulin||Participants|Count of Participants|77|77.0||||||
4057997|NCT01080391|3879582|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4057998|NCT01080391|3879583|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4057999|NCT01080391|3879584|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4058000|NCT01080391|3879582|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|754|754.0||||||
4058001|NCT01080391|3879583|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|377|377.0||||||
4058002|NCT01080391|3879584|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|377|377.0||||||
4058003|NCT01080391|3879582|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
4058004|NCT01080391|3879583|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4058005|NCT01080391|3879584|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4058006|NCT01080391|3879582|B3||Asian/Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4058007|NCT01080391|3879583|B2||Asian/Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4058008|NCT01080391|3879584|B1||Asian/Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4058009|NCT01080391|3879582|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4058010|NCT01080391|3879583|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4058011|NCT01080391|3879584|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4058012|NCT01080391|3879582|B3||Male|Sex: Female, Male||Participants|Count of Participants|447|447.0||||||
4058013|NCT01080391|3879583|B2||Male|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
4058014|NCT01080391|3879584|B1||Male|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
4058015|NCT01080391|3879582|B3||Female|Sex: Female, Male||Participants|Count of Participants|345|345.0||||||
4058016|NCT01080391|3879583|B2||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4058017|NCT01080391|3879584|B1||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4058018|NCT01080391|3879582|B3|||Age||years|Mean|63.9|63.9|Standard Deviation|9.14|9.14|||
4058019|NCT01080391|3879583|B2|||Age||years|Mean|63.3|63.3|Standard Deviation|9.21|9.21|||
4058020|NCT01080391|3879584|B1|||Age||years|Mean|64.5|64.5|Standard Deviation|9.04|9.04|||
4058021|NCT01080326|3879603|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4058022|NCT01080326|3879603|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4058023|NCT01080326|3879603|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4058024|NCT01080326|3879603|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4058025|NCT01080326|3879603|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4058026|NCT01080326|3879603|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4058027|NCT01080300|3879607|B3|Severe||Frequency of hot flashes|Number of hot flashes in a 24-hour period.|hot flashes|Mean|6.8|6.8|Standard Deviation|8.4|8.4|||
4058028|NCT01080300|3879608|B2|Severe||Frequency of hot flashes|Number of hot flashes in a 24-hour period.|hot flashes|Mean|6.5|6.5|Standard Deviation|5.4|5.4|||
4058029|NCT01080300|3879609|B1|Severe||Frequency of hot flashes|Number of hot flashes in a 24-hour period.|hot flashes|Mean|7.1|7.1|Standard Deviation|10.6|10.6|||
4058030|NCT01080300|3879607|B3|Moderate||Frequency of hot flashes|Number of hot flashes in a 24-hour period.|hot flashes|Mean|6.3|6.3|Standard Deviation|5.1|5.1|||
4058031|NCT01080300|3879608|B2|Moderate||Frequency of hot flashes|Number of hot flashes in a 24-hour period.|hot flashes|Mean|6.1|6.1|Standard Deviation|4.9|4.9|||
4058032|NCT01080300|3879609|B1|Moderate||Frequency of hot flashes|Number of hot flashes in a 24-hour period.|hot flashes|Mean|6.4|6.4|Standard Deviation|5.3|5.3|||
4058033|NCT01080300|3879607|B3|Mild||Frequency of hot flashes|Number of hot flashes in a 24-hour period.|hot flashes|Mean|1.5|1.5|Standard Deviation|3.1|3.1|||
4058034|NCT01080300|3879608|B2|Mild||Frequency of hot flashes|Number of hot flashes in a 24-hour period.|hot flashes|Mean|1.5|1.5|Standard Deviation|3.3|3.3|||
4058035|NCT01080300|3879609|B1|Mild||Frequency of hot flashes|Number of hot flashes in a 24-hour period.|hot flashes|Mean|1.5|1.5|Standard Deviation|2.8|2.8|||
4058036|NCT01080300|3879607|B3|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4058037|NCT01080300|3879608|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4058038|NCT01080300|3879609|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4058039|NCT01080300|3879607|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4058040|NCT01080300|3879608|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4058041|NCT01080300|3879609|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4058042|NCT01080300|3879607|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4058043|NCT01080300|3879608|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4058044|NCT01080300|3879609|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4058045|NCT01080300|3879607|B3|Black||Race/Ethnicity, Customized||participants|Number|156|156.0||||||
4058046|NCT01080300|3879608|B2|Black||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
4058047|NCT01080300|3879609|B1|Black||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
4058048|NCT01080300|3879607|B3|White||Race/Ethnicity, Customized||participants|Number|412|412.0||||||
4058049|NCT01080300|3879608|B2|White||Race/Ethnicity, Customized||participants|Number|197|197.0||||||
4058050|NCT01080300|3879609|B1|White||Race/Ethnicity, Customized||participants|Number|215|215.0||||||
4058051|NCT01080300|3879607|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4058052|NCT01080300|3879608|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4058053|NCT01080300|3879609|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4058054|NCT01080300|3879607|B3||Female|Sex: Female, Male||Participants|Count of Participants|593|593.0||||||
4058055|NCT01080300|3879608|B2||Female|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
4058056|NCT01080300|3879609|B1||Female|Sex: Female, Male||Participants|Count of Participants|299|299.0||||||
4058057|NCT01080300|3879607|B3|>=65 years||Age, Customized||participants|Number|31|31.0||||||
4058058|NCT01080300|3879608|B2|>=65 years||Age, Customized||participants|Number|12|12.0||||||
4058059|NCT01080300|3879609|B1|>=65 years||Age, Customized||participants|Number|19|19.0||||||
4058060|NCT01080300|3879607|B3|< 65 years||Age, Customized||participants|Number|562|562.0||||||
4058061|NCT01080300|3879608|B2|< 65 years||Age, Customized||participants|Number|282|282.0||||||
4058062|NCT01080300|3879609|B1|< 65 years||Age, Customized||participants|Number|280|280.0||||||
4058063|NCT01080300|3879607|B3|||Age||years|Mean|54.0|54.0|Standard Deviation|6.1|6.1|||
4058064|NCT01080300|3879608|B2|||Age||years|Mean|54.0|54.0|Standard Deviation|6.0|6.0|||
4058065|NCT01080300|3879609|B1|||Age||years|Mean|54.0|54.0|Standard Deviation|6.1|6.1|||
4058066|NCT01080261|3879618|B1|TIMI 3||Lesion Characteristic - Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion; TIMI 1 - Penetration with minimal perfusion; TIMI 2 - Partial perfusion; TIMI 3 - Complete perfusion|lesions|Number|56|56.0||||||
4058067|NCT01080261|3879618|B1|TIMI 2||Lesion Characteristic - Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion; TIMI 1 - Penetration with minimal perfusion; TIMI 2 - Partial perfusion; TIMI 3 - Complete perfusion|lesions|Number|3|3.0||||||
4058068|NCT01080261|3879618|B1|TIMI 1||Lesion Characteristic - Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion; TIMI 1 - Penetration with minimal perfusion; TIMI 2 - Partial perfusion; TIMI 3 - Complete perfusion|lesions|Number|1|1.0||||||
4058069|NCT01080261|3879618|B1|TIMI 0||Lesion Characteristic - Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion; TIMI 1 - Penetration with minimal perfusion; TIMI 2 - Partial perfusion; TIMI 3 - Complete perfusion|lesions|Number|0|0.0||||||
4058093|NCT01080261|3879618|B1|Hypertension Requiring Medication||Cardiac Risk Factors|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|51|51.0||||||
4058094|NCT01080261|3879618|B1|Hyperlipidemia Requiring Medication||Cardiac Risk Factors|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|46|46.0||||||
4058070|NCT01080261|3879618|B1|Type C||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A:minimally complex, readily accessible, non angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, absence of thrombus.~Type B:moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, presence of thrombus; type B1 has one adverse characteristic and B2 has ≥2. Type C:severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|lesions|Number|12|12.0||||||
4058071|NCT01080261|3879618|B1|Type B2||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A:minimally complex, readily accessible, non angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, absence of thrombus.~Type B:moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, presence of thrombus; type B1 has one adverse characteristic and B2 has ≥2. Type C:severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|lesions|Number|27|27.0||||||
4058072|NCT01080261|3879618|B1|Type B1||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A:minimally complex, readily accessible, non angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, absence of thrombus.~Type B:moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, presence of thrombus; type B1 has one adverse characteristic and B2 has ≥2. Type C:severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|lesions|Number|17|17.0||||||
4058073|NCT01080261|3879618|B1|Type A||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A:minimally complex, readily accessible, non angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, absence of thrombus.~Type B:moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, presence of thrombus; type B1 has one adverse characteristic and B2 has ≥2. Type C:severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|lesions|Number|4|4.0||||||
4058074|NCT01080261|3879618|B1|Bifurcation||Lesion Characteristics|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group. Not all participants have one of these lesion characteristics.|participants|Number|4|4.0||||||
4058075|NCT01080261|3879618|B1|Total Occlusion||Lesion Characteristics|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group. Not all participants have one of these lesion characteristics.|participants|Number|1|1.0||||||
4058076|NCT01080261|3879618|B1|Calcification, any||Lesion Characteristics|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group. Not all participants have one of these lesion characteristics.|participants|Number|12|12.0||||||
4058077|NCT01080261|3879618|B1|Tortuosity, any||Lesion Characteristics|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group. Not all participants have one of these lesion characteristics.|participants|Number|10|10.0||||||
4058078|NCT01080261|3879618|B1|> 90 Degree Bend||Lesion Characteristics|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group. Not all participants have one of these lesion characteristics.|participants|Number|0|0.0||||||
4058079|NCT01080261|3879618|B1|> 45 Degree Bend||Lesion Characteristics|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group. Not all participants have one of these lesion characteristics.|participants|Number|12|12.0||||||
4058080|NCT01080261|3879618|B1|Eccentric Lesion||Lesion Characteristics|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group. Not all participants have one of these lesion characteristics.|participants|Number|34|34.0||||||
4058081|NCT01080261|3879618|B1|||Lesion Characteristic: Percent Diameter Stenosis|Extent of stenosis of the target lesion (measured as percent of area stenosed)|percent stenosis|Mean|72.52|72.52|Standard Deviation|11.27|11.27|||
4058082|NCT01080261|3879618|B1|Lesion Length||Lesion Characteristics||millimeter|Mean|12.91|12.91|Standard Deviation|5.91|5.91|||
4058083|NCT01080261|3879618|B1|Minimum Lumen Diameter||Lesion Characteristics||millimeter|Mean|0.56|0.56|Standard Deviation|0.25|0.25|||
4058084|NCT01080261|3879618|B1|Reference Vessel Diameter||Lesion Characteristics||millimeter|Mean|2.02|2.02|Standard Deviation|0.26|0.26|||
4058085|NCT01080261|3879618|B1|Distal||Lesion Characteristic: Lesion Location||lesions|Number|10|10.0||||||
4058086|NCT01080261|3879618|B1|Mid||Lesion Characteristic: Lesion Location||lesions|Number|16|16.0||||||
4058087|NCT01080261|3879618|B1|Proximal||Lesion Characteristic: Lesion Location||lesions|Number|23|23.0||||||
4058088|NCT01080261|3879618|B1|Ostial||Lesion Characteristic: Lesion Location||lesions|Number|11|11.0||||||
4058089|NCT01080261|3879618|B1|Right Coronary Artery||Lesion Characteristic: Target Lesion Vessel||Lesions|Number|16|16.0||||||
4058090|NCT01080261|3879618|B1|Left Circumflex Artery||Lesion Characteristic: Target Lesion Vessel||Lesions|Number|20|20.0||||||
4058091|NCT01080261|3879618|B1|Left Anterior Descending Artery||Lesion Characteristic: Target Lesion Vessel||Lesions|Number|24|24.0||||||
4058092|NCT01080261|3879618|B1|Family History of Coronary Artery Disease||Cardiac Risk Factors|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|13|13.0||||||
4058131|NCT01080209|3879640|B8||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4058095|NCT01080261|3879618|B1|Medically Treated Diabetes||Cardiac Risk Factors|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|22|22.0||||||
4058096|NCT01080261|3879618|B1|Smoking, Ever||Cardiac Risk Factors|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|37|37.0||||||
4058097|NCT01080261|3879618|B1|||Cardiac History: Left Ventricular Ejection Fraction|Left ventricular ejection fraction (LVEF) is an assessment of the amount of blood emptied from the left ventricle during systolic contraction, which is indicative of global ventricular function.|percent|Mean|63.27|63.27|Standard Deviation|10.35|10.35|||
4058098|NCT01080261|3879618|B1|Silent Ischemia||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|12|12.0||||||
4058099|NCT01080261|3879618|B1|Unstable Angina||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|8|8.0||||||
4058100|NCT01080261|3879618|B1|Stable Angina||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|43|43.0||||||
4058101|NCT01080261|3879618|B1|Congestive Heart Failure||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|6|6.0||||||
4058102|NCT01080261|3879618|B1|Previous Myocardial Infarction (MI)||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|16|16.0||||||
4058103|NCT01080261|3879618|B1|Previous Coronary Artery Bypass Graft (CABG)||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|1|1.0||||||
4058104|NCT01080261|3879618|B1|Previous Percutaneous Coronary Intervention (PCI)||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|40|40.0||||||
4058105|NCT01080261|3879618|B1|History of Gastrointestinal Bleeding||Comorbidities|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group. Not all participants have one of these comorbidity measures.|participant|Number|0|0.0||||||
4058106|NCT01080261|3879618|B1|History of Renal Disease||Comorbidities|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group. Not all participants have one of these comorbidity measures.|participant|Number|10|10.0||||||
4058107|NCT01080261|3879618|B1|History of Cerebrovascular Accident||Comorbidities|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group. Not all participants have one of these comorbidity measures.|participant|Number|11|11.0||||||
4058108|NCT01080261|3879618|B1|History of Transient Ischemic Attack||Comorbidities|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group. Not all participants have one of these comorbidity measures.|participant|Number|1|1.0||||||
4058109|NCT01080261|3879618|B1|History of Peripheral Vascular Disease||Comorbidities|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group. Not all participants have one of these comorbidity measures.|participant|Number|5|5.0||||||
4058110|NCT01080261|3879618|B1|Japan||Region of Enrollment||participants|Number|60|60.0||||||
4058111|NCT01080261|3879618|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4058112|NCT01080261|3879618|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4058113|NCT01080261|3879618|B1|||Age||years|Mean|69.20|69.2|Standard Deviation|9.84|9.84|||
4058114|NCT01080261|3879618|B1||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
4058115|NCT01080261|3879618|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4058116|NCT01080261|3879618|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4058117|NCT01080248|3879633|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4058118|NCT01080248|3879633|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4058119|NCT01080248|3879633|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4058120|NCT01080248|3879633|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4058121|NCT01080248|3879633|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4058122|NCT01080248|3879633|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4058123|NCT01080209|3879640|B8||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4058124|NCT01080209|3879641|B7||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4058125|NCT01080209|3879642|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4058126|NCT01080209|3879643|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4058127|NCT01080209|3879644|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4058128|NCT01080209|3879645|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4058129|NCT01080209|3879646|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4058130|NCT01080209|3879647|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4058132|NCT01080209|3879641|B7||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4058133|NCT01080209|3879642|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4058134|NCT01080209|3879643|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4058135|NCT01080209|3879644|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4058136|NCT01080209|3879645|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4058137|NCT01080209|3879646|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4058138|NCT01080209|3879647|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4058139|NCT01080209|3879640|B8|≥85 years||Age, Customized||Participants|Number|23|23.0||||||
4058140|NCT01080209|3879641|B7|≥85 years||Age, Customized||Participants|Number|5|5.0||||||
4058141|NCT01080209|3879642|B6|≥85 years||Age, Customized||Participants|Number|1|1.0||||||
4058142|NCT01080209|3879643|B5|≥85 years||Age, Customized||Participants|Number|0|0.0||||||
4058143|NCT01080209|3879644|B4|≥85 years||Age, Customized||Participants|Number|3|3.0||||||
4058144|NCT01080209|3879645|B3|≥85 years||Age, Customized||Participants|Number|6|6.0||||||
4058145|NCT01080209|3879646|B2|≥85 years||Age, Customized||Participants|Number|1|1.0||||||
4058146|NCT01080209|3879647|B1|≥85 years||Age, Customized||Participants|Number|7|7.0||||||
4058147|NCT01080209|3879640|B8|Between 65 and 84 years||Age, Customized||Participants|Number|121|121.0||||||
4058148|NCT01080209|3879641|B7|Between 65 and 84 years||Age, Customized||Participants|Number|26|26.0||||||
4058149|NCT01080209|3879642|B6|Between 65 and 84 years||Age, Customized||Participants|Number|1|1.0||||||
4058150|NCT01080209|3879643|B5|Between 65 and 84 years||Age, Customized||Participants|Number|3|3.0||||||
4058151|NCT01080209|3879644|B4|Between 65 and 84 years||Age, Customized||Participants|Number|19|19.0||||||
4058152|NCT01080209|3879645|B3|Between 65 and 84 years||Age, Customized||Participants|Number|24|24.0||||||
4058153|NCT01080209|3879646|B2|Between 65 and 84 years||Age, Customized||Participants|Number|29|29.0||||||
4058154|NCT01080209|3879647|B1|Between 65 and 84 years||Age, Customized||Participants|Number|19|19.0||||||
4058155|NCT01080209|3879640|B8|18 to 64 years||Age, Customized||Participants|Number|71|71.0||||||
4058156|NCT01080209|3879641|B7|18 to 64 years||Age, Customized||Participants|Number|20|20.0||||||
4058157|NCT01080209|3879642|B6|18 to 64 years||Age, Customized||Participants|Number|0|0.0||||||
4058158|NCT01080209|3879643|B5|18 to 64 years||Age, Customized||Participants|Number|3|3.0||||||
4058159|NCT01080209|3879644|B4|18 to 64 years||Age, Customized||Participants|Number|20|20.0||||||
4058160|NCT01080209|3879645|B3|18 to 64 years||Age, Customized||Participants|Number|3|3.0||||||
4058161|NCT01080209|3879646|B2|18 to 64 years||Age, Customized||Participants|Number|23|23.0||||||
4058162|NCT01080209|3879647|B1|18 to 64 years||Age, Customized||Participants|Number|2|2.0||||||
4058163|NCT01080196|3879676|B3|United States||Region of Enrollment||participants|Number|134|134.0||||||
4058164|NCT01080196|3879677|B2|United States||Region of Enrollment||participants|Number|66|66.0||||||
4058165|NCT01080196|3879678|B1|United States||Region of Enrollment||participants|Number|68|68.0||||||
4058166|NCT01080196|3879676|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4058167|NCT01080196|3879677|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4058168|NCT01080196|3879678|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4058169|NCT01080196|3879676|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4058170|NCT01080196|3879677|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4058171|NCT01080196|3879678|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4058172|NCT01080196|3879676|B3|||Age||years|Mean|76.1|76.1|Standard Deviation|7.2|7.2|||
4058173|NCT01080196|3879677|B2|||Age||years|Mean|75.59|75.59|Standard Deviation|6.98|6.98|||
4058174|NCT01080196|3879678|B1|||Age||years|Mean|76.59|76.59|Standard Deviation|7.39|7.39|||
4058175|NCT01080131|3879693|B3||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4058176|NCT01080131|3879694|B2||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4058177|NCT01080131|3879695|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4058178|NCT01080131|3879693|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4058179|NCT01080131|3879694|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4058180|NCT01080131|3879695|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4058181|NCT01080131|3879693|B3|||Age||years|Mean|51.6|51.6|Standard Deviation|12.21|12.21|||
4058182|NCT01080131|3879694|B2|||Age||years|Mean|52.6|52.6|Standard Deviation|12.28|12.28|||
4058183|NCT01080131|3879695|B1|||Age||years|Mean|50.6|50.6|Standard Deviation|12.10|12.1|||
4058184|NCT01080118|3879773|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4058185|NCT01080118|3879774|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4058186|NCT01080118|3879775|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4058187|NCT01080118|3879773|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4058188|NCT01080118|3879774|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4058189|NCT01080118|3879775|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4058190|NCT01080118|3879773|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4058191|NCT01080118|3879774|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4058192|NCT01080118|3879775|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4058193|NCT01080118|3879773|B3|||Age||years|Mean|27.75|27.75|Standard Deviation|2.5|2.5|||
4058194|NCT01080118|3879774|B2|||Age||years|Mean|27.5|27.5|Standard Deviation|2|2.0|||
4058195|NCT01080118|3879775|B1|||Age||years|Mean|28|28.0|Standard Deviation|3|3.0|||
4058196|NCT01080118|3879773|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4058197|NCT01080118|3879774|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4058198|NCT01080118|3879775|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4058199|NCT01080118|3879773|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4058200|NCT01080118|3879774|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4058201|NCT01080118|3879775|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4058202|NCT01080118|3879773|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4058203|NCT01080118|3879774|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4058204|NCT01080118|3879775|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4058205|NCT01079988|3879786|B6|Canada||Region of Enrollment||participants|Number|41|41.0||||||
4058206|NCT01079988|3879787|B5|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4058207|NCT01079988|3879788|B4|Canada||Region of Enrollment||participants|Number|20|20.0||||||
4058208|NCT01079988|3879789|B3|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4058209|NCT01079988|3879790|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4058210|NCT01079988|3879791|B1|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4058211|NCT01079988|3879786|B6||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4058212|NCT01079988|3879787|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4058213|NCT01079988|3879788|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4058214|NCT01079988|3879789|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4058215|NCT01079988|3879790|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4058216|NCT01079988|3879791|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4058217|NCT01079988|3879786|B6||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4058218|NCT01079988|3879787|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4058219|NCT01079988|3879788|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4058220|NCT01079988|3879789|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4058221|NCT01079988|3879790|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4058222|NCT01079988|3879791|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4058223|NCT01079988|3879786|B6|||Age||years|Mean|46|46.0|Standard Deviation|11|11.0|||
4058224|NCT01079988|3879787|B5|||Age||years|Mean|47|47.0|Standard Deviation|3|3.0|||
4058225|NCT01079988|3879788|B4|||Age||years|Mean|49|49.0|Standard Deviation|10|10.0|||
4058226|NCT01079988|3879789|B3|||Age||years|Mean|44|44.0|Standard Deviation|11|11.0|||
4058227|NCT01079988|3879790|B2|||Age||years|Mean|41|41.0|Standard Deviation|||||
4058228|NCT01079988|3879791|B1|||Age||years|Mean|43|43.0|Standard Deviation|12|12.0|||
4058229|NCT01079962|3879812|B3||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4058230|NCT01079962|3879813|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4058231|NCT01079962|3879814|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4058232|NCT01079962|3879812|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4058233|NCT01079962|3879813|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4058234|NCT01079962|3879814|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4058235|NCT01079962|3879812|B3|||Age||Years|Mean|52.2|52.2|Standard Deviation|10.2|10.2|21.0|75.0|
4058236|NCT01079962|3879813|B2|||Age||Years|Mean|52.2|52.2|Standard Deviation|9.3|9.3|21.0|75.0|
4058237|NCT01079962|3879814|B1|||Age||Years|Mean|52.0|52.0|Standard Deviation|11.2|11.2|25.0|74.0|
4058238|NCT01079949|3879841|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4058239|NCT01079949|3879842|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4058240|NCT01079949|3879843|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4058241|NCT01079949|3879841|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4058242|NCT01079949|3879842|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4058243|NCT01079949|3879843|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4058244|NCT01079949|3879841|B3|||Age||years|Mean|36.4|36.4|Standard Deviation|2.8|2.8|||
4058245|NCT01079949|3879842|B2|||Age||years|Mean|36.3|36.3|Standard Deviation|3.0|3.0|||
4058246|NCT01079949|3879843|B1|||Age||years|Mean|36.6|36.6|Standard Deviation|2.6|2.6|||
4058247|NCT01079936|3879886|B5|United States||Region of Enrollment||participants|Number|59|59.0||||||
4058248|NCT01079936|3879887|B4|United States||Region of Enrollment||participants|Number|26|26.0||||||
4058249|NCT01079936|3879888|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4058250|NCT01079936|3879889|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4058251|NCT01079936|3879890|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4058252|NCT01079936|3879886|B5||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4058253|NCT01079936|3879887|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4058254|NCT01079936|3879888|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4058255|NCT01079936|3879889|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4058256|NCT01079936|3879890|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4058257|NCT01079936|3879886|B5||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4058258|NCT01079936|3879887|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4058259|NCT01079936|3879888|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4058260|NCT01079936|3879889|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4058261|NCT01079936|3879890|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4058262|NCT01079936|3879886|B5|||Age||years|Median|59.5|59.5|Full Range|||34.0|72.0|
4058263|NCT01079936|3879887|B4|||Age||years|Median|60|60.0|Full Range|||52.0|71.0|
4058264|NCT01079936|3879888|B3|||Age||years|Median|55|55.0|Full Range|||34.0|72.0|
4058265|NCT01079936|3879889|B2|||Age||years|Median|66|66.0|Full Range|||53.0|70.0|
4058266|NCT01079936|3879890|B1|||Age||years|Median|59|59.0|Full Range|||50.0|63.0|
4058267|NCT01079832|3879913|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4058268|NCT01079832|3879913|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4058269|NCT01079832|3879913|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4058270|NCT01079832|3879913|B1||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4058271|NCT01079832|3879913|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4058272|NCT01079832|3879913|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4058273|NCT01079832|3879913|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4058274|NCT01079832|3879913|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4058275|NCT01079832|3879913|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4058276|NCT01079832|3879913|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4058277|NCT01079832|3879913|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4058278|NCT01079832|3879913|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4058279|NCT01079832|3879913|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4058280|NCT01079832|3879913|B1|||Age||years|Median|66|66.0|Full Range|||27.0|82.0|
4058281|NCT01079806|3879921|B3|Other||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4058282|NCT01079806|3879922|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4058283|NCT01079806|3879923|B1|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4058284|NCT01079806|3879921|B3|White||Race/Ethnicity, Customized||Participants|Number|71|71.0||||||
4058285|NCT01079806|3879922|B2|White||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
4058286|NCT01079806|3879923|B1|White||Race/Ethnicity, Customized||Participants|Number|44|44.0||||||
4058287|NCT01079806|3879921|B3|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4058288|NCT01079806|3879922|B2|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4058289|NCT01079806|3879923|B1|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4058290|NCT01079806|3879921|B3|Black/African American||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4058291|NCT01079806|3879922|B2|Black/African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4058292|NCT01079806|3879923|B1|Black/African American||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4058293|NCT01079806|3879921|B3|Asian||Race/Ethnicity, Customized||Participants|Number|87|87.0||||||
4058294|NCT01079806|3879922|B2|Asian||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
4058295|NCT01079806|3879923|B1|Asian||Race/Ethnicity, Customized||Participants|Number|57|57.0||||||
4058296|NCT01079806|3879921|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|109|109.0||||||
4058297|NCT01079806|3879922|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4058298|NCT01079806|3879923|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4058299|NCT01079806|3879921|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
4058300|NCT01079806|3879922|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4058301|NCT01079806|3879923|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4058302|NCT01079806|3879921|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4058303|NCT01079806|3879922|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4058304|NCT01079806|3879923|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4058305|NCT01079806|3879921|B3||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4058306|NCT01079806|3879922|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4058307|NCT01079806|3879923|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4058308|NCT01079806|3879921|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4058309|NCT01079806|3879922|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4058310|NCT01079806|3879923|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4058311|NCT01079806|3879921|B3|>12 years to <18 years||Age, Customized||Participants|Number|93|93.0||||||
4058312|NCT01079806|3879922|B2|>12 years to <18 years||Age, Customized||Participants|Number|31|31.0||||||
4058313|NCT01079806|3879923|B1|>12 years to <18 years||Age, Customized||Participants|Number|62|62.0||||||
4058314|NCT01079806|3879921|B3|>6 years to <=12 years||Age, Customized||Participants|Number|46|46.0||||||
4058315|NCT01079806|3879922|B2|>6 years to <=12 years||Age, Customized||Participants|Number|15|15.0||||||
4058316|NCT01079806|3879923|B1|>6 years to <=12 years||Age, Customized||Participants|Number|31|31.0||||||
4058317|NCT01079806|3879921|B3|>=2 years to <=6 years||Age, Customized||Participants|Number|41|41.0||||||
4058318|NCT01079806|3879922|B2|>=2 years to <=6 years||Age, Customized||Participants|Number|14|14.0||||||
4058319|NCT01079806|3879923|B1|>=2 years to <=6 years||Age, Customized||Participants|Number|27|27.0||||||
4058320|NCT01079806|3879921|B3|||Age||Years|Mean|10.6|10.6|Standard Deviation|4.84|4.84|||
4058321|NCT01079806|3879922|B2|||Age||Years|Mean|10.8|10.8|Standard Deviation|4.82|4.82|||
4058322|NCT01079806|3879923|B1|||Age||Years|Mean|10.5|10.5|Standard Deviation|4.87|4.87|||
4058323|NCT01079741|3879944|B6|IV||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|4|4.0||||||
4058324|NCT01079741|3879945|B5|IV||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|2|2.0||||||
4058325|NCT01079741|3879946|B4|IV||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|2|2.0||||||
4058326|NCT01079741|3879947|B3|IV||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|0|0.0||||||
4058327|NCT01079741|3879948|B2|IV||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|0|0.0||||||
4058328|NCT01079741|3879949|B1|IV||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|0|0.0||||||
4058329|NCT01079741|3879944|B6|IIIC||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|13|13.0||||||
4058330|NCT01079741|3879945|B5|IIIC||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|4|4.0||||||
4058331|NCT01079741|3879946|B4|IIIC||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|4|4.0||||||
4058332|NCT01079741|3879947|B3|IIIC||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|2|2.0||||||
4058373|NCT01079741|3879946|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4058374|NCT01079741|3879947|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4058333|NCT01079741|3879948|B2|IIIC||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|3|3.0||||||
4058334|NCT01079741|3879949|B1|IIIC||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|0|0.0||||||
4058335|NCT01079741|3879944|B6|IIIB||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|9|9.0||||||
4058336|NCT01079741|3879945|B5|IIIB||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|3|3.0||||||
4058337|NCT01079741|3879946|B4|IIIB||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|4|4.0||||||
4058338|NCT01079741|3879947|B3|IIIB||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|0|0.0||||||
4058339|NCT01079741|3879948|B2|IIIB||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|1|1.0||||||
4058340|NCT01079741|3879949|B1|IIIB||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|1|1.0||||||
4058341|NCT01079741|3879944|B6|IIIA||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|3|3.0||||||
4058342|NCT01079741|3879945|B5|IIIA||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|2|2.0||||||
4058343|NCT01079741|3879946|B4|IIIA||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|0|0.0||||||
4058375|NCT01079741|3879948|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4058376|NCT01079741|3879949|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4058377|NCT01079741|3879944|B6|||Age||years|Median|55|55.0|Full Range|||21.0|74.0|
4058344|NCT01079741|3879947|B3|IIIA||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|0|0.0||||||
4058345|NCT01079741|3879948|B2|IIIA||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|0|0.0||||||
4058346|NCT01079741|3879949|B1|IIIA||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|1|1.0||||||
4058347|NCT01079741|3879944|B6|IIC||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|2|2.0||||||
4058348|NCT01079741|3879945|B5|IIC||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|1|1.0||||||
4058349|NCT01079741|3879946|B4|IIC||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|0|0.0||||||
4058350|NCT01079741|3879947|B3|IIC||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|0|0.0||||||
4058351|NCT01079741|3879948|B2|IIC||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|0|0.0||||||
4058352|NCT01079741|3879949|B1|IIC||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|1|1.0||||||
4058353|NCT01079741|3879944|B6|IIB||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|2|2.0||||||
4058354|NCT01079741|3879945|B5|IIB||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|0|0.0||||||
4058378|NCT01079741|3879945|B5|||Age||years|Median|57|57.0|Full Range|||24.0|83.0|
4058379|NCT01079741|3879946|B4|||Age||years|Median|50|50.0|Full Range|||21.0|69.0|
4058380|NCT01079741|3879947|B3|||Age||years|Median|73|73.0|Full Range|||64.0|78.0|
4058355|NCT01079741|3879946|B4|IIB||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|1|1.0||||||
4058356|NCT01079741|3879947|B3|IIB||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|1|1.0||||||
4058357|NCT01079741|3879948|B2|IIB||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|0|0.0||||||
4058358|NCT01079741|3879949|B1|IIB||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|0|0.0||||||
4058359|NCT01079741|3879944|B6|IIA||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|1|1.0||||||
4058360|NCT01079741|3879945|B5|IIA||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|0|0.0||||||
4058361|NCT01079741|3879946|B4|IIA||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|1|1.0||||||
4058362|NCT01079741|3879947|B3|IIA||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|0|0.0||||||
4058363|NCT01079741|3879948|B2|IIA||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|0|0.0||||||
4058364|NCT01079741|3879949|B1|IIA||Pathologic Staging|IIA - Melanoma thickness1-2mm with ulceration or 2-4mm without ulceration; IIB - 2-4 mm thickness with ulceration or 4mm without ulceration IIC - thickness >4mm with ulceration IIIA - thickness any size, no ulcerations, 1-3 nodes micrometasis IIIB - thickness any size, 1-3 nodes, with or without ulcerations, micrometasis or macrometasis IIIC - thickness any size, with or without ulcerations 1-3 nodes, micrometasis, marcrometasis, or in transit mets(s)/satellite(s) without metastatic nodes IV - any thickness, with or without ulcerations, nay nodes, any distant metastases|Participants|Count of Participants|0|0.0||||||
4058365|NCT01079741|3879944|B6||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4058366|NCT01079741|3879945|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4058367|NCT01079741|3879946|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4058368|NCT01079741|3879947|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4058369|NCT01079741|3879948|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4058370|NCT01079741|3879949|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4058371|NCT01079741|3879944|B6||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4058372|NCT01079741|3879945|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4058381|NCT01079741|3879948|B2|||Age||years|Median|65|65.0|Full Range|||39.0|74.0|
4058382|NCT01079741|3879949|B1|||Age||years|Median|64|64.0|Full Range|||42.0|72.0|
4058383|NCT01079598|3879967|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4058384|NCT01079598|3879967|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4058385|NCT01079598|3879967|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4058386|NCT01079598|3879967|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4058387|NCT01079598|3879967|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4058388|NCT01079598|3879967|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4058389|NCT01079390|3879974|B4|United States||Region of Enrollment||participants|Number|44|44.0||||||
4058390|NCT01079390|3879975|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4058391|NCT01079390|3879976|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4058392|NCT01079390|3879977|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4058393|NCT01079390|3879974|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4058394|NCT01079390|3879975|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4058395|NCT01079390|3879976|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4058396|NCT01079390|3879977|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4058397|NCT01079390|3879974|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4058398|NCT01079390|3879975|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4058399|NCT01079390|3879976|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4058400|NCT01079390|3879977|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4058401|NCT01079390|3879974|B4|||Age||years|Mean|58|58.0|Standard Deviation|8|8.0|||
4058402|NCT01079390|3879975|B3|||Age||years|Mean|54|54.0|Standard Deviation|7|7.0|||
4058403|NCT01079390|3879976|B2|||Age||years|Mean|58|58.0|Standard Deviation|8|8.0|||
4058404|NCT01079390|3879977|B1|||Age||years|Mean|60|60.0|Standard Deviation|9|9.0|||
4058405|NCT01079390|3879974|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4058406|NCT01079390|3879975|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4058407|NCT01079390|3879976|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4058408|NCT01079390|3879977|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4058409|NCT01079390|3879974|B4||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4058410|NCT01079390|3879975|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4058411|NCT01079390|3879976|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4058412|NCT01079390|3879977|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4058413|NCT01079390|3879974|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4058414|NCT01079390|3879975|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4058415|NCT01079390|3879976|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4058416|NCT01079390|3879977|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4058417|NCT01079299|3879989|B3|United States||Region of Enrollment||participants|Number|52|52.0||||||
4058418|NCT01079299|3879990|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4058419|NCT01079299|3879991|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4058420|NCT01079299|3879989|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4058421|NCT01079299|3879990|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4058422|NCT01079299|3879991|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4058423|NCT01079299|3879989|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4058424|NCT01079299|3879990|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4058425|NCT01079299|3879991|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4058426|NCT01079299|3879989|B3|||Age||years|Mean|62|62.0|Standard Deviation|5|5.0|||
4058427|NCT01079299|3879990|B2|||Age||years|Mean|59|59.0|Standard Deviation|4.9|4.9|||
4058428|NCT01079299|3879991|B1|||Age||years|Mean|66|66.0|Standard Deviation|5.6|5.6|||
4058429|NCT01079299|3879989|B3||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4058430|NCT01079299|3879990|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4058431|NCT01079299|3879991|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4058432|NCT01079299|3879989|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4058433|NCT01079299|3879990|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4058434|NCT01079299|3879991|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4058435|NCT01079299|3879989|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4058436|NCT01079299|3879990|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4058437|NCT01079299|3879991|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4058438|NCT01079234|3879998|B4|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.8|9.8|Standard Deviation|4.1|4.1|||
4058439|NCT01079234|3879999|B3|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.7|9.7|Standard Deviation|4.2|4.2|||
4058440|NCT01079234|3880000|B2|||Fasting plasma glucose (FPG)||mmol/L|Mean|10.0|10.0|Standard Deviation|4.0|4.0|||
4058441|NCT01079234|3880001|B1|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.6|9.6|Standard Deviation|4.1|4.1|||
4058442|NCT01079234|3879998|B4|||HbA1c (glycosylated haemoglobin)||percentage of glycosylated haemoglobin|Mean|7.7|7.7|Standard Deviation|0.9|0.9|||
4058443|NCT01079234|3879999|B3|||HbA1c (glycosylated haemoglobin)||percentage of glycosylated haemoglobin|Mean|7.7|7.7|Standard Deviation|0.9|0.9|||
4058444|NCT01079234|3880000|B2|||HbA1c (glycosylated haemoglobin)||percentage of glycosylated haemoglobin|Mean|7.7|7.7|Standard Deviation|0.9|0.9|||
4058445|NCT01079234|3880001|B1|||HbA1c (glycosylated haemoglobin)||percentage of glycosylated haemoglobin|Mean|7.7|7.7|Standard Deviation|1.0|1.0|||
4058446|NCT01079234|3879998|B4||Male|Gender||Participants|Count of Participants|284|284.0||||||
4058447|NCT01079234|3879999|B3||Male|Gender||Participants|Count of Participants|88|88.0||||||
4058448|NCT01079234|3880000|B2||Male|Gender||Participants|Count of Participants|94|94.0||||||
4058449|NCT01079234|3880001|B1||Male|Gender||Participants|Count of Participants|102|102.0||||||
4058450|NCT01079234|3879998|B4||Female|Gender||Participants|Count of Participants|209|209.0||||||
4058451|NCT01079234|3879999|B3||Female|Gender||Participants|Count of Participants|76|76.0||||||
4058452|NCT01079234|3880000|B2||Female|Gender||Participants|Count of Participants|71|71.0||||||
4058453|NCT01079234|3880001|B1||Female|Gender||Participants|Count of Participants|62|62.0||||||
4058454|NCT01079234|3879998|B4|||Age||years|Mean|43.7|43.7|Standard Deviation|13.1|13.1|||
4058455|NCT01079234|3879999|B3|||Age||years|Mean|44.1|44.1|Standard Deviation|12.6|12.6|||
4058456|NCT01079234|3880000|B2|||Age||years|Mean|44.5|44.5|Standard Deviation|13.1|13.1|||
4058457|NCT01079234|3880001|B1|||Age||years|Mean|42.6|42.6|Standard Deviation|13.4|13.4|||
4058458|NCT01079195|3880022|B1|||Waist Circumference||cm|Mean|97.8|97.8|Standard Deviation|13.1|13.1|||
4058459|NCT01079195|3880022|B1|||Body Weight||kg|Mean|87.1|87.1|Standard Deviation|15.2|15.2|||
4058460|NCT01079195|3880022|B1|||Body Mass Index||kg/m^2|Mean|30.0|30.0|Standard Deviation|4.8|4.8|||
4058461|NCT01079195|3880022|B1|Risk factors not reported||Risk Factors for Developing Diabetes||participants|Number|1366|1366.0||||||
4058462|NCT01079195|3880022|B1|Diabetes||Risk Factors for Developing Diabetes||participants|Number|288|288.0||||||
4058463|NCT01079195|3880022|B1|Positive Family History, Obesity, and IFG||Risk Factors for Developing Diabetes||participants|Number|1091|1091.0||||||
4058464|NCT01079195|3880022|B1|Obesity and IFG||Risk Factors for Developing Diabetes||participants|Number|1344|1344.0||||||
4058465|NCT01079195|3880022|B1|Positive Family History and IFG||Risk Factors for Developing Diabetes||participants|Number|563|563.0||||||
4058466|NCT01079195|3880022|B1|Positive Family History and Obesity||Risk Factors for Developing Diabetes||participants|Number|2983|2983.0||||||
4058467|NCT01079195|3880022|B1|Impaired Fasting Glucose (IFG)||Risk Factors for Developing Diabetes||participants|Number|506|506.0||||||
4058468|NCT01079195|3880022|B1|Obesity||Risk Factors for Developing Diabetes||participants|Number|3661|3661.0||||||
4058469|NCT01079195|3880022|B1|Positive Family History of Diabetes||Risk Factors for Developing Diabetes||participants|Number|2891|2891.0||||||
4058470|NCT01079195|3880022|B1|Time since diagnosis not reported||Time Since Diagnosis of Essential Hypertension||participants|Number|405|405.0||||||
4058471|NCT01079195|3880022|B1|10 years or more||Time Since Diagnosis of Essential Hypertension||participants|Number|4153|4153.0||||||
4058472|NCT01079195|3880022|B1|Between 5 and 10 years||Time Since Diagnosis of Essential Hypertension||participants|Number|4187|4187.0||||||
4058473|NCT01079195|3880022|B1|Between 3 and 5 years||Time Since Diagnosis of Essential Hypertension||participants|Number|2482|2482.0||||||
4058474|NCT01079195|3880022|B1|Between 2 and 3 years||Time Since Diagnosis of Essential Hypertension||participants|Number|1573|1573.0||||||
4058475|NCT01079195|3880022|B1|Between 1 and 2 years||Time Since Diagnosis of Essential Hypertension||participants|Number|1536|1536.0||||||
4058476|NCT01079195|3880022|B1|Less than 1 year||Time Since Diagnosis of Essential Hypertension||participants|Number|108|108.0||||||
4058477|NCT01079195|3880022|B1|At study inclusion||Time Since Diagnosis of Essential Hypertension||participants|Number|249|249.0||||||
4058478|NCT01079195|3880022|B1|Ukraine||Region of Enrollment||participants|Number|988|988.0||||||
4058479|NCT01079195|3880022|B1|Slovenia||Region of Enrollment||participants|Number|1238|1238.0||||||
4058480|NCT01079195|3880022|B1|Slovakia||Region of Enrollment||participants|Number|3179|3179.0||||||
4058481|NCT01079195|3880022|B1|Russian Federation||Region of Enrollment||participants|Number|2085|2085.0||||||
4058482|NCT01079195|3880022|B1|Romania||Region of Enrollment||participants|Number|1251|1251.0||||||
4058483|NCT01079195|3880022|B1|Czech Republic||Region of Enrollment||participants|Number|5643|5643.0||||||
4058484|NCT01079195|3880022|B1|Bulgaria||Region of Enrollment||participants|Number|309|309.0||||||
4058485|NCT01079195|3880022|B1|Gender not reported||Sex/Gender, Customized||participants|Number|100|100.0||||||
4058486|NCT01079195|3880022|B1|Male||Sex/Gender, Customized||participants|Number|7034|7034.0||||||
4058487|NCT01079195|3880022|B1|Female||Sex/Gender, Customized||participants|Number|7559|7559.0||||||
4058488|NCT01079195|3880022|B1|Age not reported||Age, Customized||participants|Number|41|41.0||||||
4058489|NCT01079195|3880022|B1|65 and older||Age, Customized||participants|Number|4085|4085.0||||||
4058490|NCT01079195|3880022|B1|Over 18 and less than 65||Age, Customized||participants|Number|10565|10565.0||||||
4058491|NCT01079195|3880022|B1|18 years of age or younger||Age, Customized||participants|Number|2|2.0||||||
4058492|NCT01079195|3880022|B1|||Age||years|Mean|57.8|57.8|Standard Deviation|11.5|11.5|||
4058493|NCT01079182|3880028|B1|||Human Leukocyte Antigen (HLA) B27 Positive Status||Percentage of participants|Number|84.4|84.4||||||
4058494|NCT01079182|3880028|B1|||Duration of Ankylosing Spondylitis (AS) Symptoms||Years|Mean|14.4|14.4|Standard Deviation|10.8|10.8|||
4058495|NCT01079182|3880028|B1|Male||Gender|N= 4680 as the complete set of parameters was not available for each participant.|Participants|Number|3060|3060.0||||||
4058496|NCT01079182|3880028|B1|Female||Gender|N= 4680 as the complete set of parameters was not available for each participant.|Participants|Number|1620|1620.0||||||
4058497|NCT01079182|3880028|B1|||Age|N= 4680 as the complete set of parameters was not available for each participant.|Years|Mean|43.1|43.1|Standard Deviation|12.1|12.1|||
4058498|NCT01079143|3880055|B5|||BMI||kg/m^2|Mean|25.4|25.4|Standard Deviation|4.4|4.4|||
4058499|NCT01079143|3880056|B4|||BMI||kg/m^2|Mean|25.3|25.3|Standard Deviation|4.2|4.2|||
4058500|NCT01079143|3880057|B3|||BMI||kg/m^2|Mean|25.6|25.6|Standard Deviation|4.0|4.0|||
4058501|NCT01079143|3880058|B2|||BMI||kg/m^2|Mean|26.0|26.0|Standard Deviation|4.6|4.6|||
4058502|NCT01079143|3880059|B1|||BMI||kg/m^2|Mean|24.3|24.3|Standard Deviation|4.6|4.6|||
4058503|NCT01079143|3880055|B5||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4058504|NCT01079143|3880056|B4||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4058505|NCT01079143|3880057|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4058506|NCT01079143|3880058|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4058507|NCT01079143|3880059|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4058508|NCT01079143|3880055|B5||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4058509|NCT01079143|3880056|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4058510|NCT01079143|3880057|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4058511|NCT01079143|3880058|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4058512|NCT01079143|3880059|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4058513|NCT01079143|3880055|B5|||Age||years|Mean|49.3|49.3|Standard Deviation|11.7|11.7|||
4058514|NCT01079143|3880056|B4|||Age||years|Mean|50.7|50.7|Standard Deviation|11.7|11.7|||
4058515|NCT01079143|3880057|B3|||Age||years|Mean|50.0|50.0|Standard Deviation|10.0|10.0|||
4058516|NCT01079143|3880058|B2|||Age||years|Mean|46.4|46.4|Standard Deviation|12.9|12.9|||
4058517|NCT01079143|3880059|B1|||Age||years|Mean|51.2|51.2|Standard Deviation|10.7|10.7|||
4058518|NCT01079130|3880130|B7||Male|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
4058519|NCT01079130|3880131|B6||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4058520|NCT01079130|3880132|B5||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4058521|NCT01079130|3880133|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4058522|NCT01079130|3880134|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4058523|NCT01079130|3880135|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4058524|NCT01079130|3880136|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4058525|NCT01079130|3880130|B7||Female|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
4058526|NCT01079130|3880131|B6||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4058527|NCT01079130|3880132|B5||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4058528|NCT01079130|3880133|B4||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4058529|NCT01079130|3880134|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4058530|NCT01079130|3880135|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4058531|NCT01079130|3880136|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4058532|NCT01079130|3880130|B7|||Age|All baseline measures are based on the Full Analysis Set (FAS) that includes all participants who received at least one dose of study drug.|years|Mean|41.1|41.1|Standard Deviation|14.65|14.65|||
4058533|NCT01079130|3880131|B6|||Age|All baseline measures are based on the Full Analysis Set (FAS) that includes all participants who received at least one dose of study drug.|years|Mean|40.6|40.6|Standard Deviation|14.17|14.17|||
4058534|NCT01079130|3880132|B5|||Age|All baseline measures are based on the Full Analysis Set (FAS) that includes all participants who received at least one dose of study drug.|years|Mean|40.9|40.9|Standard Deviation|14.56|14.56|||
4058535|NCT01079130|3880133|B4|||Age|All baseline measures are based on the Full Analysis Set (FAS) that includes all participants who received at least one dose of study drug.|years|Mean|41.0|41.0|Standard Deviation|15.20|15.2|||
4058536|NCT01079130|3880134|B3|||Age|All baseline measures are based on the Full Analysis Set (FAS) that includes all participants who received at least one dose of study drug.|years|Mean|40.2|40.2|Standard Deviation|14.71|14.71|||
4058537|NCT01079130|3880135|B2|||Age|All baseline measures are based on the Full Analysis Set (FAS) that includes all participants who received at least one dose of study drug.|years|Mean|41.9|41.9|Standard Deviation|14.96|14.96|||
4058538|NCT01079130|3880136|B1|||Age|All baseline measures are based on the Full Analysis Set (FAS) that includes all participants who received at least one dose of study drug.|years|Mean|42.0|42.0|Standard Deviation|14.64|14.64|||
4058539|NCT01078974|3880161|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4058540|NCT01078974|3880161|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4058541|NCT01078974|3880161|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4058542|NCT01078974|3880161|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4058543|NCT01078974|3880161|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4058544|NCT01078974|3880161|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4058545|NCT01078974|3880161|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4058546|NCT01078974|3880161|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4058547|NCT01078974|3880161|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4058548|NCT01078974|3880161|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4058549|NCT01078974|3880161|B1|||Age||years|Median|64|64.0|Standard Deviation|7.27|7.27|||
4058550|NCT01078974|3880161|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4058551|NCT01078974|3880161|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4058552|NCT01078974|3880161|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4058553|NCT01078922|3880166|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4058554|NCT01078922|3880166|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4058555|NCT01078922|3880166|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4058556|NCT01078922|3880166|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4058557|NCT01078922|3880166|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4058558|NCT01078922|3880166|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4058559|NCT01078909|3880171|B6||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4058560|NCT01078909|3880172|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4058561|NCT01078909|3880173|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4058562|NCT01078909|3880174|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4058563|NCT01078909|3880175|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4058564|NCT01078909|3880176|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4058565|NCT01078909|3880171|B6||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4058566|NCT01078909|3880172|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4058567|NCT01078909|3880173|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4058568|NCT01078909|3880174|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4058569|NCT01078909|3880175|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4058570|NCT01078909|3880176|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4058571|NCT01078909|3880171|B6|||Age||years|Mean|26.1|26.1|Standard Deviation|6.7|6.7|||
4058572|NCT01078909|3880172|B5|||Age||years|Mean|25.7|25.7|Standard Deviation|6.7|6.7|||
4058573|NCT01078909|3880173|B4|||Age||years|Mean|26.0|26.0|Standard Deviation|5.9|5.9|||
4058574|NCT01078909|3880174|B3|||Age||years|Mean|25.8|25.8|Standard Deviation|6.4|6.4|||
4058575|NCT01078909|3880175|B2|||Age||years|Mean|27.1|27.1|Standard Deviation|7.3|7.3|||
4058576|NCT01078909|3880176|B1|||Age||years|Mean|25.8|25.8|Standard Deviation|7.2|7.2|||
4058577|NCT01078844|3880202|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4058578|NCT01078844|3880202|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4058579|NCT01078844|3880202|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4058580|NCT01078844|3880202|B1|Age, years (18-85||Age, Customized||Participants|Count of Participants|4|4.0||||||
4058581|NCT01078805|3880207|B1|Height loss||Physician Criteria for Initiating FORTEO Therapy|Study investigators were provided a questionnaire that was populated with specific criteria they could choose from when they initiated Forteo therapy for their patients. They could have chosen more than one criteria, thus participants could have been counted multiple times. Participants are those who took at least one dose of study drug and had reasons documented to initiate Forteo therapy. The number of total participants analyzed is 4073.|participants|Number|697|697.0||||||
4058582|NCT01078805|3880207|B1|Participant request||Physician Criteria for Initiating FORTEO Therapy|Study investigators were provided a questionnaire that was populated with specific criteria they could choose from when they initiated Forteo therapy for their patients. They could have chosen more than one criteria, thus participants could have been counted multiple times. Participants are those who took at least one dose of study drug and had reasons documented to initiate Forteo therapy. The number of total participants analyzed is 4073.|participants|Number|247|247.0||||||
4058583|NCT01078805|3880207|B1|Absence of prior authorization criteria||Physician Criteria for Initiating FORTEO Therapy|Study investigators were provided a questionnaire that was populated with specific criteria they could choose from when they initiated Forteo therapy for their patients. They could have chosen more than one criteria, thus participants could have been counted multiple times. Participants are those who took at least one dose of study drug and had reasons documented to initiate Forteo therapy. The number of total participants analyzed is 4073.|participants|Number|193|193.0||||||
4058584|NCT01078805|3880207|B1|Adequate insurance coverage||Physician Criteria for Initiating FORTEO Therapy|Study investigators were provided a questionnaire that was populated with specific criteria they could choose from when they initiated Forteo therapy for their patients. They could have chosen more than one criteria, thus participants could have been counted multiple times. Participants are those who took at least one dose of study drug and had reasons documented to initiate Forteo therapy. The number of total participants analyzed is 4073.|participants|Number|925|925.0||||||
4058585|NCT01078805|3880207|B1|Intolerance to previous osteoporosis therapy||Physician Criteria for Initiating FORTEO Therapy|Study investigators were provided a questionnaire that was populated with specific criteria they could choose from when they initiated Forteo therapy for their patients. They could have chosen more than one criteria, thus participants could have been counted multiple times. Participants are those who took at least one dose of study drug and had reasons documented to initiate Forteo therapy. The number of total participants analyzed is 4073.|participants|Number|891|891.0||||||
4058586|NCT01078805|3880207|B1|Participant met Forteo threshold -per investigator||Physician Criteria for Initiating FORTEO Therapy|Study investigators were provided a questionnaire that was populated with specific criteria they could choose from when they initiated Forteo therapy for their patients. They could have chosen more than one criteria, thus participants could have been counted multiple times. Participants are those who took at least one dose of study drug and had reasons documented to initiate Forteo therapy. The number of total participants analyzed is 4073.|participants|Number|2215|2215.0||||||
4058587|NCT01078805|3880207|B1|Inadequate response to previous therapy||Physician Criteria for Initiating FORTEO Therapy|Study investigators were provided a questionnaire that was populated with specific criteria they could choose from when they initiated Forteo therapy for their patients. They could have chosen more than one criteria, thus participants could have been counted multiple times. Participants are those who took at least one dose of study drug and had reasons documented to initiate Forteo therapy. The number of total participants analyzed is 4073.|participants|Number|2261|2261.0||||||
4058684|NCT01078662|3880253|B5|White||Race/Ethnicity, Customized|Race|Participants|Number|11|11.0||||||
4058588|NCT01078805|3880207|B1|Multiple fracture risk factors - per investigator||Physician Criteria for Initiating FORTEO Therapy|Study investigators were provided a questionnaire that was populated with specific criteria they could choose from when they initiated Forteo therapy for their patients. They could have chosen more than one criteria, thus participants could have been counted multiple times. Participants are those who took at least one dose of study drug and had reasons documented to initiate Forteo therapy. The number of total participants analyzed is 4073.|participants|Number|3395|3395.0||||||
4058589|NCT01078805|3880207|B1|New osteoporotic fracture||Physician Criteria for Initiating FORTEO Therapy|Study investigators were provided a questionnaire that was populated with specific criteria they could choose from when they initiated Forteo therapy for their patients. They could have chosen more than one criteria, thus participants could have been counted multiple times. Participants are those who took at least one dose of study drug and had reasons documented to initiate Forteo therapy. The number of total participants analyzed is 4073.|participants|Number|848|848.0||||||
4058590|NCT01078805|3880207|B1|United States||Region of Enrollment||participants|Number|3720|3720.0||||||
4058591|NCT01078805|3880207|B1|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4058592|NCT01078805|3880207|B1|Other||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4058593|NCT01078805|3880207|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|321|321.0||||||
4058594|NCT01078805|3880207|B1|East Asian||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4058595|NCT01078805|3880207|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|3282|3282.0||||||
4058596|NCT01078805|3880207|B1|Asian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4058597|NCT01078805|3880207|B1|African||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
4058598|NCT01078805|3880207|B1|Unknown||Sex/Gender, Customized||participants|Number|1|1.0||||||
4058599|NCT01078805|3880207|B1|Male||Sex/Gender, Customized||participants|Number|369|369.0||||||
4058600|NCT01078805|3880207|B1|Female||Sex/Gender, Customized||participants|Number|3350|3350.0||||||
4058601|NCT01078805|3880207|B1|||Age||years|Mean|67.96|67.96|Standard Deviation|11.72|11.72|||
4058602|NCT01078753|3880219|B3|Prior therapy||Prior treatment of Nocturnal Enuresis with Therapy|Therapies for treatment of Nocturnal Enuresis might include life-skill guidance, bladder control training, psychotherapy, or behaviour conditioning therapy.|participants|Number|89|89.0||||||
4058603|NCT01078753|3880220|B2|Prior therapy||Prior treatment of Nocturnal Enuresis with Therapy|Therapies for treatment of Nocturnal Enuresis might include life-skill guidance, bladder control training, psychotherapy, or behaviour conditioning therapy.|participants|Number|44|44.0||||||
4058604|NCT01078753|3880221|B1|Prior therapy||Prior treatment of Nocturnal Enuresis with Therapy|Therapies for treatment of Nocturnal Enuresis might include life-skill guidance, bladder control training, psychotherapy, or behaviour conditioning therapy.|participants|Number|45|45.0||||||
4058605|NCT01078753|3880219|B3|No prior therapy||Prior treatment of Nocturnal Enuresis with Therapy|Therapies for treatment of Nocturnal Enuresis might include life-skill guidance, bladder control training, psychotherapy, or behaviour conditioning therapy.|participants|Number|0|0.0||||||
4058606|NCT01078753|3880220|B2|No prior therapy||Prior treatment of Nocturnal Enuresis with Therapy|Therapies for treatment of Nocturnal Enuresis might include life-skill guidance, bladder control training, psychotherapy, or behaviour conditioning therapy.|participants|Number|0|0.0||||||
4058607|NCT01078753|3880221|B1|No prior therapy||Prior treatment of Nocturnal Enuresis with Therapy|Therapies for treatment of Nocturnal Enuresis might include life-skill guidance, bladder control training, psychotherapy, or behaviour conditioning therapy.|participants|Number|0|0.0||||||
4058608|NCT01078753|3880219|B3|Prior treatment received||Prior treatment of Nocturnal Enuresis with Drugs||participants|Number|0|0.0||||||
4058609|NCT01078753|3880220|B2|Prior treatment received||Prior treatment of Nocturnal Enuresis with Drugs||participants|Number|0|0.0||||||
4058610|NCT01078753|3880221|B1|Prior treatment received||Prior treatment of Nocturnal Enuresis with Drugs||participants|Number|0|0.0||||||
4058611|NCT01078753|3880219|B3|No prior treatment||Prior treatment of Nocturnal Enuresis with Drugs||participants|Number|89|89.0||||||
4058612|NCT01078753|3880220|B2|No prior treatment||Prior treatment of Nocturnal Enuresis with Drugs||participants|Number|44|44.0||||||
4058613|NCT01078753|3880221|B1|No prior treatment||Prior treatment of Nocturnal Enuresis with Drugs||participants|Number|45|45.0||||||
4058614|NCT01078753|3880219|B3|14 wet nights||Number of Wet Nights during Baseline by stratification criteria|The number of wet nights recorded during the 14-day Baseline period is reported for each of the stratification categories.|participants|Number|27|27.0||||||
4058615|NCT01078753|3880220|B2|14 wet nights||Number of Wet Nights during Baseline by stratification criteria|The number of wet nights recorded during the 14-day Baseline period is reported for each of the stratification categories.|participants|Number|14|14.0||||||
4058616|NCT01078753|3880221|B1|14 wet nights||Number of Wet Nights during Baseline by stratification criteria|The number of wet nights recorded during the 14-day Baseline period is reported for each of the stratification categories.|participants|Number|13|13.0||||||
4058617|NCT01078753|3880219|B3|10 to 13 wet nights||Number of Wet Nights during Baseline by stratification criteria|The number of wet nights recorded during the 14-day Baseline period is reported for each of the stratification categories.|participants|Number|62|62.0||||||
4058618|NCT01078753|3880220|B2|10 to 13 wet nights||Number of Wet Nights during Baseline by stratification criteria|The number of wet nights recorded during the 14-day Baseline period is reported for each of the stratification categories.|participants|Number|30|30.0||||||
4058619|NCT01078753|3880221|B1|10 to 13 wet nights||Number of Wet Nights during Baseline by stratification criteria|The number of wet nights recorded during the 14-day Baseline period is reported for each of the stratification categories.|participants|Number|32|32.0||||||
4058620|NCT01078753|3880219|B3|||Number of Wet Nights during Baseline|Number of Wet Nights recorded during the 14-day Baseline period.|days|Mean|12.3|12.3|Standard Deviation|1.5|1.5|||
4058621|NCT01078753|3880220|B2|||Number of Wet Nights during Baseline|Number of Wet Nights recorded during the 14-day Baseline period.|days|Mean|12.4|12.4|Standard Deviation|1.5|1.5|||
4058622|NCT01078753|3880221|B1|||Number of Wet Nights during Baseline|Number of Wet Nights recorded during the 14-day Baseline period.|days|Mean|12.2|12.2|Standard Deviation|1.5|1.5|||
4058623|NCT01078753|3880219|B3|||Body Mass Index (BMI)||kg/m˄2|Mean|16.44|16.44|Standard Deviation|2.14|2.14|||
4058624|NCT01078753|3880220|B2|||Body Mass Index (BMI)||kg/m˄2|Mean|16.43|16.43|Standard Deviation|1.77|1.77|||
4058625|NCT01078753|3880221|B1|||Body Mass Index (BMI)||kg/m˄2|Mean|16.46|16.46|Standard Deviation|2.47|2.47|||
4058626|NCT01078753|3880219|B3|||Weight||kg|Mean|27.30|27.3|Standard Deviation|7.01|7.01|||
4058627|NCT01078753|3880220|B2|||Weight||kg|Mean|27.01|27.01|Standard Deviation|5.32|5.32|||
4058628|NCT01078753|3880221|B1|||Weight||kg|Mean|27.59|27.59|Standard Deviation|8.40|8.4|||
4058629|NCT01078753|3880219|B3|||Height||cm|Mean|127.92|127.92|Standard Deviation|10.01|10.01|||
4058630|NCT01078753|3880220|B2|||Height||cm|Mean|127.68|127.68|Standard Deviation|8.61|8.61|||
4058631|NCT01078753|3880221|B1|||Height||cm|Mean|128.14|128.14|Standard Deviation|11.30|11.3|||
4058632|NCT01078753|3880219|B3|Japan||Region of Enrollment||participants|Number|89|89.0||||||
4058633|NCT01078753|3880220|B2|Japan||Region of Enrollment||participants|Number|44|44.0||||||
4058634|NCT01078753|3880221|B1|Japan||Region of Enrollment||participants|Number|45|45.0||||||
4058635|NCT01078753|3880219|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4058636|NCT01078753|3880220|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4058637|NCT01078753|3880221|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4058638|NCT01078753|3880219|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4058639|NCT01078753|3880220|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4058640|NCT01078753|3880221|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4058641|NCT01078753|3880219|B3|10 to15 years old||Age, Customized||participants|Number|17|17.0||||||
4058642|NCT01078753|3880220|B2|10 to15 years old||Age, Customized||participants|Number|8|8.0||||||
4058643|NCT01078753|3880221|B1|10 to15 years old||Age, Customized||participants|Number|9|9.0||||||
4058644|NCT01078753|3880219|B3|6 to 9 years old||Age, Customized||participants|Number|72|72.0||||||
4058645|NCT01078753|3880220|B2|6 to 9 years old||Age, Customized||participants|Number|36|36.0||||||
4058646|NCT01078753|3880221|B1|6 to 9 years old||Age, Customized||participants|Number|36|36.0||||||
4058647|NCT01078753|3880219|B3|||Age||years|Mean|8.1|8.1|Standard Deviation|1.5|1.5|||
4058648|NCT01078753|3880220|B2|||Age||years|Mean|8.1|8.1|Standard Deviation|1.4|1.4|||
4058649|NCT01078753|3880221|B1|||Age||years|Mean|8.2|8.2|Standard Deviation|1.6|1.6|||
4058650|NCT01078675|3880232|B3|non-Caucasian||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
4058651|NCT01078675|3880233|B2|non-Caucasian||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4058652|NCT01078675|3880234|B1|non-Caucasian||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
4058653|NCT01078675|3880232|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|231|231.0||||||
4058654|NCT01078675|3880233|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|53|53.0||||||
4058655|NCT01078675|3880234|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|178|178.0||||||
4058656|NCT01078675|3880232|B3||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4058657|NCT01078675|3880233|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4058658|NCT01078675|3880234|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4058659|NCT01078675|3880232|B3||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4058660|NCT01078675|3880233|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4058661|NCT01078675|3880234|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4058662|NCT01078675|3880232|B3|Years||Age||Years|Mean|11.55|11.55|Standard Deviation|3.43|3.43|||
4058663|NCT01078675|3880233|B2|Years||Age||Years|Mean|11.5|11.5|Standard Deviation|3.53|3.53|||
4058664|NCT01078675|3880234|B1|Years||Age||Years|Mean|11.6|11.6|Standard Deviation|3.33|3.33|||
4058665|NCT01078662|3880252|B6|Other||Race/Ethnicity, Customized|Race|Participants|Number|2|2.0||||||
4058666|NCT01078662|3880253|B5|Other||Race/Ethnicity, Customized|Race|Participants|Number|0|0.0||||||
4058667|NCT01078662|3880254|B4|Other||Race/Ethnicity, Customized|Race|Participants|Number|0|0.0||||||
4058668|NCT01078662|3880255|B3|Other||Race/Ethnicity, Customized|Race|Participants|Number|0|0.0||||||
4058669|NCT01078662|3880256|B2|Other||Race/Ethnicity, Customized|Race|Participants|Number|1|1.0||||||
4058670|NCT01078662|3880257|B1|Other||Race/Ethnicity, Customized|Race|Participants|Number|1|1.0||||||
4058671|NCT01078662|3880252|B6|Asian||Race/Ethnicity, Customized|Race|Participants|Number|11|11.0||||||
4058672|NCT01078662|3880253|B5|Asian||Race/Ethnicity, Customized|Race|Participants|Number|1|1.0||||||
4058673|NCT01078662|3880254|B4|Asian||Race/Ethnicity, Customized|Race|Participants|Number|0|0.0||||||
4058674|NCT01078662|3880255|B3|Asian||Race/Ethnicity, Customized|Race|Participants|Number|1|1.0||||||
4058675|NCT01078662|3880256|B2|Asian||Race/Ethnicity, Customized|Race|Participants|Number|8|8.0||||||
4058676|NCT01078662|3880257|B1|Asian||Race/Ethnicity, Customized|Race|Participants|Number|1|1.0||||||
4058677|NCT01078662|3880252|B6|Black or African American||Race/Ethnicity, Customized|Race|Participants|Number|2|2.0||||||
4058678|NCT01078662|3880253|B5|Black or African American||Race/Ethnicity, Customized|Race|Participants|Number|0|0.0||||||
4058679|NCT01078662|3880254|B4|Black or African American||Race/Ethnicity, Customized|Race|Participants|Number|0|0.0||||||
4058680|NCT01078662|3880255|B3|Black or African American||Race/Ethnicity, Customized|Race|Participants|Number|1|1.0||||||
4058681|NCT01078662|3880256|B2|Black or African American||Race/Ethnicity, Customized|Race|Participants|Number|1|1.0||||||
4058682|NCT01078662|3880257|B1|Black or African American||Race/Ethnicity, Customized|Race|Participants|Number|0|0.0||||||
4058683|NCT01078662|3880252|B6|White||Race/Ethnicity, Customized|Race|Participants|Number|283|283.0||||||
4058685|NCT01078662|3880254|B4|White||Race/Ethnicity, Customized|Race|Participants|Number|8|8.0||||||
4058686|NCT01078662|3880255|B3|White||Race/Ethnicity, Customized|Race|Participants|Number|21|21.0||||||
4058687|NCT01078662|3880256|B2|White||Race/Ethnicity, Customized|Race|Participants|Number|183|183.0||||||
4058688|NCT01078662|3880257|B1|White||Race/Ethnicity, Customized|Race|Participants|Number|60|60.0||||||
4058689|NCT01078662|3880252|B6||Male|Sex: Female, Male|Gender|Participants|Count of Participants|26|26.0||||||
4058690|NCT01078662|3880253|B5||Male|Sex: Female, Male|Gender|Participants|Count of Participants|4|4.0||||||
4058691|NCT01078662|3880254|B4||Male|Sex: Female, Male|Gender|Participants|Count of Participants|8|8.0||||||
4058692|NCT01078662|3880255|B3||Male|Sex: Female, Male|Gender|Participants|Count of Participants|13|13.0||||||
4058693|NCT01078662|3880256|B2||Male|Sex: Female, Male|Gender|Participants|Count of Participants|0|0.0||||||
4058694|NCT01078662|3880257|B1||Male|Sex: Female, Male|Gender|Participants|Count of Participants|1|1.0||||||
4058695|NCT01078662|3880252|B6||Female|Sex: Female, Male|Gender|Participants|Count of Participants|272|272.0||||||
4058696|NCT01078662|3880253|B5||Female|Sex: Female, Male|Gender|Participants|Count of Participants|8|8.0||||||
4058697|NCT01078662|3880254|B4||Female|Sex: Female, Male|Gender|Participants|Count of Participants|0|0.0||||||
4058698|NCT01078662|3880255|B3||Female|Sex: Female, Male|Gender|Participants|Count of Participants|10|10.0||||||
4058699|NCT01078662|3880256|B2||Female|Sex: Female, Male|Gender|Participants|Count of Participants|193|193.0||||||
4058700|NCT01078662|3880257|B1||Female|Sex: Female, Male|Gender|Participants|Count of Participants|61|61.0||||||
4058701|NCT01078662|3880252|B6|>= 65 years||Age, Customized|Age by category|Participants|Number|48|48.0||||||
4058702|NCT01078662|3880253|B5|>= 65 years||Age, Customized|Age by category|Participants|Number|3|3.0||||||
4058703|NCT01078662|3880254|B4|>= 65 years||Age, Customized|Age by category|Participants|Number|5|5.0||||||
4058704|NCT01078662|3880255|B3|>= 65 years||Age, Customized|Age by category|Participants|Number|3|3.0||||||
4058705|NCT01078662|3880256|B2|>= 65 years||Age, Customized|Age by category|Participants|Number|36|36.0||||||
4058706|NCT01078662|3880257|B1|>= 65 years||Age, Customized|Age by category|Participants|Number|1|1.0||||||
4058707|NCT01078662|3880252|B6|>=50 to <65 years||Age, Customized|Age by category|Participants|Number|167|167.0||||||
4058708|NCT01078662|3880253|B5|>=50 to <65 years||Age, Customized|Age by category|Participants|Number|5|5.0||||||
4058709|NCT01078662|3880254|B4|>=50 to <65 years||Age, Customized|Age by category|Participants|Number|3|3.0||||||
4058710|NCT01078662|3880255|B3|>=50 to <65 years||Age, Customized|Age by category|Participants|Number|14|14.0||||||
4058711|NCT01078662|3880256|B2|>=50 to <65 years||Age, Customized|Age by category|Participants|Number|117|117.0||||||
4058712|NCT01078662|3880257|B1|>=50 to <65 years||Age, Customized|Age by category|Participants|Number|28|28.0||||||
4058713|NCT01078662|3880252|B6|< 50 years||Age, Customized|Age by category|Participants|Number|83|83.0||||||
4058714|NCT01078662|3880253|B5|< 50 years||Age, Customized|Age by category|Participants|Number|4|4.0||||||
4058715|NCT01078662|3880254|B4|< 50 years||Age, Customized|Age by category|Participants|Number|0|0.0||||||
4058716|NCT01078662|3880255|B3|< 50 years||Age, Customized|Age by category|Participants|Number|6|6.0||||||
4058717|NCT01078662|3880256|B2|< 50 years||Age, Customized|Age by category|Participants|Number|40|40.0||||||
4058718|NCT01078662|3880257|B1|< 50 years||Age, Customized|Age by category|Participants|Number|33|33.0||||||
4058719|NCT01078662|3880252|B6|||Age|Age at time of screening|years|Mean|55.3|55.3|Standard Deviation|10.3|10.3|||
4058720|NCT01078662|3880253|B5|||Age|Age at time of screening|years|Mean|54.9|54.9|Standard Deviation|12.38|12.38|||
4058721|NCT01078662|3880254|B4|||Age|Age at time of screening|years|Mean|66.6|66.6|Standard Deviation|9.86|9.86|||
4058722|NCT01078662|3880255|B3|||Age|Age at time of screening|years|Mean|57.1|57.1|Standard Deviation|7.99|7.99|||
4058723|NCT01078662|3880256|B2|||Age|Age at time of screening|years|Mean|57.2|57.2|Standard Deviation|9.28|9.28|||
4058724|NCT01078662|3880257|B1|||Age|Age at time of screening|years|Mean|47.6|47.6|Standard Deviation|9.69|9.69|||
4058725|NCT01078623|3880300|B1||Male|Gender||Participants|Count of Participants|95|95.0||||||
4058726|NCT01078623|3880300|B1||Female|Gender||Participants|Count of Participants|40|40.0||||||
4058727|NCT01078623|3880300|B1|||Age||Years|Mean|60.4|60.4|Standard Deviation|7.93|7.93|||
4058728|NCT01078584|3880341|B1|Renal Dysfunction Participants (n=196)||Baseline Diastolic Blood Pressure (DBP)|Of the participants in the ITT cohort (n=7993), 7991 had baseline DBP measurements available.|mm Hg|Mean|83.0|83.0|Standard Deviation|12.0|12.0|||
4058729|NCT01078584|3880341|B1|Diabetic Participants (n=1883)||Baseline Diastolic Blood Pressure (DBP)|Of the participants in the ITT cohort (n=7993), 7991 had baseline DBP measurements available.|mm Hg|Mean|85.7|85.7|Standard Deviation|10.5|10.5|||
4058730|NCT01078584|3880341|B1|All Participants (n=7991)||Baseline Diastolic Blood Pressure (DBP)|Of the participants in the ITT cohort (n=7993), 7991 had baseline DBP measurements available.|mm Hg|Mean|89.7|89.7|Standard Deviation|10.7|10.7|||
4058731|NCT01078584|3880341|B1|ISH Participants (n=2207)||Baseline Systolic Blood Pressure (SBP)|ISH=isolated systolic hypertension. Of the participants in the ITT cohort (n=7993), 7992 had baseline SBP measurements available.|mm Hg|Mean|153.0|153.0|Standard Deviation|10.9|10.9|||
4058732|NCT01078584|3880341|B1|Renal Dysfunction Participants (n=196)||Baseline Systolic Blood Pressure (SBP)|ISH=isolated systolic hypertension. Of the participants in the ITT cohort (n=7993), 7992 had baseline SBP measurements available.|mm Hg|Mean|147.6|147.6|Standard Deviation|17.1|17.1|||
4058733|NCT01078584|3880341|B1|Diabetic Participants (n=1883)||Baseline Systolic Blood Pressure (SBP)|ISH=isolated systolic hypertension. Of the participants in the ITT cohort (n=7993), 7992 had baseline SBP measurements available.|mm Hg|Mean|145.8|145.8|Standard Deviation|15.7|15.7|||
4058734|NCT01078584|3880341|B1|All Participants (n=7992)||Baseline Systolic Blood Pressure (SBP)|ISH=isolated systolic hypertension. Of the participants in the ITT cohort (n=7993), 7992 had baseline SBP measurements available.|mm Hg|Mean|150.8|150.8|Standard Deviation|15.6|15.6|||
4058735|NCT01078584|3880341|B1|Diabetic Participants (n=1009)||Baseline Microalbuminuria (MAU)|Of the participants in the ITT cohort (n=7993), 2476 had MAU measurements at baseline. Of the diabetic participants in the ITT cohort (n=1883), 1009 had MAU measurements at baseline.|mg/L|Mean|55.1|55.1|Standard Deviation|191.5|191.5|||
4058736|NCT01078584|3880341|B1|All Participants (n=2476)||Baseline Microalbuminuria (MAU)|Of the participants in the ITT cohort (n=7993), 2476 had MAU measurements at baseline. Of the diabetic participants in the ITT cohort (n=1883), 1009 had MAU measurements at baseline.|mg/L|Mean|36.5|36.5|Standard Deviation|142.2|142.2|||
4058737|NCT01078584|3880341|B1|Diabetic Participants (n=1178)||Baseline Estimated Glomerular Filtration Rate (eGFR)|Of the participants in the ITT cohort (n=7993), 3965 had eGFR measurements at baseline. Of the diabetic participants in the ITT cohort (n=1883), 1178 had eGFR measurements at baseline.|mL/min|Mean|77.7|77.7|Standard Deviation|24.2|24.2|||
4058738|NCT01078584|3880341|B1|All Participants (n=3965)||Baseline Estimated Glomerular Filtration Rate (eGFR)|Of the participants in the ITT cohort (n=7993), 3965 had eGFR measurements at baseline. Of the diabetic participants in the ITT cohort (n=1883), 1178 had eGFR measurements at baseline.|mL/min|Mean|76.9|76.9|Standard Deviation|20.3|20.3|||
4058739|NCT01078584|3880341|B1|Canada||Region of Enrollment||participants|Number|7993|7993.0||||||
4058740|NCT01078584|3880341|B1|Unknown||Sex/Gender, Customized||participants|Number|33|33.0||||||
4058741|NCT01078584|3880341|B1|Male||Sex/Gender, Customized||participants|Number|4283|4283.0||||||
4058742|NCT01078584|3880341|B1|Female||Sex/Gender, Customized||participants|Number|3677|3677.0||||||
4058743|NCT01078584|3880341|B1|||Age||years|Mean|58.3|58.3|Standard Deviation|13.1|13.1|||
4058744|NCT01078571|3880422|B1|No previous rheumatoid arthritis treatment||Previous Rheumatoid Arthritis Treatment|Whether or not participants had taken medication for rheumatoid arthritis within the last 5 years. Based on the ITT population (591).|participants|Number|3|3.0||||||
4058745|NCT01078571|3880422|B1|Had previous rheumatoid arthritis treatment||Previous Rheumatoid Arthritis Treatment|Whether or not participants had taken medication for rheumatoid arthritis within the last 5 years. Based on the ITT population (591).|participants|Number|588|588.0||||||
4058746|NCT01078571|3880422|B1|Rheumatoid Factor Results Unknown or Missing||Positivity of the Rheumatoid Factor|The number of participants testing positive or negative for rheumatoid factor. Based on the ITT population (591).|participants|Number|17|17.0||||||
4058747|NCT01078571|3880422|B1|Negative for Rheumatoid Factor||Positivity of the Rheumatoid Factor|The number of participants testing positive or negative for rheumatoid factor. Based on the ITT population (591).|participants|Number|114|114.0||||||
4058748|NCT01078571|3880422|B1|Positive for Rheumatoid Factor||Positivity of the Rheumatoid Factor|The number of participants testing positive or negative for rheumatoid factor. Based on the ITT population (591).|participants|Number|460|460.0||||||
4058749|NCT01078571|3880422|B1|||Time from Diagnosis of Rheumatoid Arthritis|The number of years since the participant first received a diagnosis of rheumatoid arthritis. Based on the ITT population minus 91 who did not report the time since first diagnosis (500).|Years|Mean|8.56|8.56|Standard Deviation|6.86|6.86|||
4058750|NCT01078571|3880422|B1|Spain||Region of Enrollment|Based on the ITT population (591).|participants|Number|591|591.0||||||
4058751|NCT01078571|3880422|B1|Gender not reported||Sex/Gender, Customized|Based on the ITT population (591).|participants|Number|3|3.0||||||
4058752|NCT01078571|3880422|B1|Male||Sex/Gender, Customized|Based on the ITT population (591).|participants|Number|127|127.0||||||
4058753|NCT01078571|3880422|B1|Female||Sex/Gender, Customized|Based on the ITT population (591).|participants|Number|461|461.0||||||
4058754|NCT01078571|3880422|B1|||Age|Based on the ITT population minus 5 who did not report their age (586).|years|Mean|54.15|54.15|Standard Deviation|12.43|12.43|||
4058755|NCT01078545|3880438|B1|Lack of data||Gleason score|The Gleason score classifies each participant's prostate cancer based on how the cells look under the microscope. Prostate cancers often have areas with different grades, so a grade is assigned to the 2 areas that make up most of the cancer. The Gleason score is the sum of these 2 grades, resulting in a number from 2 to 10. The higher the Gleason score the more likely it is that the cancer will grow faster and spread beyond the prostate.|participants|Number|3|3.0||||||
4058756|NCT01078545|3880438|B1|10||Gleason score|The Gleason score classifies each participant's prostate cancer based on how the cells look under the microscope. Prostate cancers often have areas with different grades, so a grade is assigned to the 2 areas that make up most of the cancer. The Gleason score is the sum of these 2 grades, resulting in a number from 2 to 10. The higher the Gleason score the more likely it is that the cancer will grow faster and spread beyond the prostate.|participants|Number|13|13.0||||||
4058757|NCT01078545|3880438|B1|9||Gleason score|The Gleason score classifies each participant's prostate cancer based on how the cells look under the microscope. Prostate cancers often have areas with different grades, so a grade is assigned to the 2 areas that make up most of the cancer. The Gleason score is the sum of these 2 grades, resulting in a number from 2 to 10. The higher the Gleason score the more likely it is that the cancer will grow faster and spread beyond the prostate.|participants|Number|41|41.0||||||
4058758|NCT01078545|3880438|B1|8||Gleason score|The Gleason score classifies each participant's prostate cancer based on how the cells look under the microscope. Prostate cancers often have areas with different grades, so a grade is assigned to the 2 areas that make up most of the cancer. The Gleason score is the sum of these 2 grades, resulting in a number from 2 to 10. The higher the Gleason score the more likely it is that the cancer will grow faster and spread beyond the prostate.|participants|Number|167|167.0||||||
4058759|NCT01078545|3880438|B1|7||Gleason score|The Gleason score classifies each participant's prostate cancer based on how the cells look under the microscope. Prostate cancers often have areas with different grades, so a grade is assigned to the 2 areas that make up most of the cancer. The Gleason score is the sum of these 2 grades, resulting in a number from 2 to 10. The higher the Gleason score the more likely it is that the cancer will grow faster and spread beyond the prostate.|participants|Number|262|262.0||||||
4058760|NCT01078545|3880438|B1|6||Gleason score|The Gleason score classifies each participant's prostate cancer based on how the cells look under the microscope. Prostate cancers often have areas with different grades, so a grade is assigned to the 2 areas that make up most of the cancer. The Gleason score is the sum of these 2 grades, resulting in a number from 2 to 10. The higher the Gleason score the more likely it is that the cancer will grow faster and spread beyond the prostate.|participants|Number|151|151.0||||||
4058761|NCT01078545|3880438|B1|5||Gleason score|The Gleason score classifies each participant's prostate cancer based on how the cells look under the microscope. Prostate cancers often have areas with different grades, so a grade is assigned to the 2 areas that make up most of the cancer. The Gleason score is the sum of these 2 grades, resulting in a number from 2 to 10. The higher the Gleason score the more likely it is that the cancer will grow faster and spread beyond the prostate.|participants|Number|53|53.0||||||
4058762|NCT01078545|3880438|B1|4||Gleason score|The Gleason score classifies each participant's prostate cancer based on how the cells look under the microscope. Prostate cancers often have areas with different grades, so a grade is assigned to the 2 areas that make up most of the cancer. The Gleason score is the sum of these 2 grades, resulting in a number from 2 to 10. The higher the Gleason score the more likely it is that the cancer will grow faster and spread beyond the prostate.|participants|Number|35|35.0||||||
4058763|NCT01078545|3880438|B1|3||Gleason score|The Gleason score classifies each participant's prostate cancer based on how the cells look under the microscope. Prostate cancers often have areas with different grades, so a grade is assigned to the 2 areas that make up most of the cancer. The Gleason score is the sum of these 2 grades, resulting in a number from 2 to 10. The higher the Gleason score the more likely it is that the cancer will grow faster and spread beyond the prostate.|participants|Number|3|3.0||||||
4058764|NCT01078545|3880438|B1|2||Gleason score|The Gleason score classifies each participant's prostate cancer based on how the cells look under the microscope. Prostate cancers often have areas with different grades, so a grade is assigned to the 2 areas that make up most of the cancer. The Gleason score is the sum of these 2 grades, resulting in a number from 2 to 10. The higher the Gleason score the more likely it is that the cancer will grow faster and spread beyond the prostate.|participants|Number|1|1.0||||||
4058765|NCT01078545|3880438|B1|Lack of data||Prostate cancer type||Participants|Number|1|1.0||||||
4058766|NCT01078545|3880438|B1|Localized||Prostate cancer type||Participants|Number|39|39.0||||||
4058767|NCT01078545|3880438|B1|Advanced with metastases||Prostate cancer type||Participants|Number|127|127.0||||||
4058768|NCT01078545|3880438|B1|Locally advanced||Prostate cancer type||Participants|Number|562|562.0||||||
4058769|NCT01078545|3880438|B1|||Prostate-Specific Antigen (PSA) concentration|The mean prostate-specific antigen (PSA) concentration at Baseline. Results based on 718 participants.|ng/mL|Mean|55.8|55.8|Standard Deviation|291.5|291.5|||
4058770|NCT01078545|3880438|B1|||Age at diagnosis of prostate cancer|Age of participant when diagnosed with prostate cancer. Results based on 724 participants.|years|Mean|70.7|70.7|Standard Deviation|7.1|7.1|||
4058771|NCT01078545|3880438|B1|Ukraine||Region of Enrollment||participants|Number|70|70.0||||||
4058772|NCT01078545|3880438|B1|Poland||Region of Enrollment||participants|Number|659|659.0||||||
4058773|NCT01078545|3880438|B1||Male|Sex: Female, Male||Participants|Count of Participants|729|729.0||||||
4058774|NCT01078545|3880438|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4058775|NCT01078545|3880438|B1|||Age||years|Mean|71.2|71.2|Standard Deviation|7.2|7.2|||
4058776|NCT01078454|3880446|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4058777|NCT01078454|3880447|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4058778|NCT01078454|3880448|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4058779|NCT01078454|3880446|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4058780|NCT01078454|3880447|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4058781|NCT01078454|3880448|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4058782|NCT01078454|3880446|B3|||Age||years|Median|67|67.0|Full Range|||44.0|78.0|
4058783|NCT01078454|3880447|B2|||Age||years|Median|66|66.0|Full Range|||44.0|72.0|
4058784|NCT01078454|3880448|B1|||Age||years|Median|68|68.0|Full Range|||61.0|78.0|
4058785|NCT01078441|3880455|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4058786|NCT01078441|3880455|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4058787|NCT01078441|3880455|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4058788|NCT01078441|3880455|B1|||Age||years|Median|51|51.0|Full Range|||48.0|54.0|
4058789|NCT01078402|3880459|B4|High Disease Activity (BASDAI score ≥4)||Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) score|BASDAI score was calculated using a questionnaire with 6 questions that participant completes by marking answers on a 10-centimeter visual analog scale with responses that range from 0 (none) to 10 (very severe) and measures severity of fatigue, spinal and peripheral joint pain, localized tenderness and morning stiffness. The final BASDAI score ranges from 0 to 10.|participants|Number|270|270.0||||||
4058790|NCT01078402|3880460|B3|High Disease Activity (BASDAI score ≥4)||Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) score|BASDAI score was calculated using a questionnaire with 6 questions that participant completes by marking answers on a 10-centimeter visual analog scale with responses that range from 0 (none) to 10 (very severe) and measures severity of fatigue, spinal and peripheral joint pain, localized tenderness and morning stiffness. The final BASDAI score ranges from 0 to 10.|participants|Number|217|217.0||||||
4058791|NCT01078402|3880461|B2|High Disease Activity (BASDAI score ≥4)||Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) score|BASDAI score was calculated using a questionnaire with 6 questions that participant completes by marking answers on a 10-centimeter visual analog scale with responses that range from 0 (none) to 10 (very severe) and measures severity of fatigue, spinal and peripheral joint pain, localized tenderness and morning stiffness. The final BASDAI score ranges from 0 to 10.|participants|Number|53|53.0||||||
4058792|NCT01078402|3880462|B1|High Disease Activity (BASDAI score ≥4)||Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) score|BASDAI score was calculated using a questionnaire with 6 questions that participant completes by marking answers on a 10-centimeter visual analog scale with responses that range from 0 (none) to 10 (very severe) and measures severity of fatigue, spinal and peripheral joint pain, localized tenderness and morning stiffness. The final BASDAI score ranges from 0 to 10.|participants|Number|NA|||||||This assessment was for participants with PsA and AS only, per protocol.
4058843|NCT01078389|3880495|B1|Current Drinker||Alcohol History||participants|Number|103|103.0||||||
4058844|NCT01078389|3880493|B3|Never Drank||Alcohol History||participants|Number|72|72.0||||||
4058793|NCT01078402|3880459|B4|Low Disease Activity (BASDAI score <4)||Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) score|BASDAI score was calculated using a questionnaire with 6 questions that participant completes by marking answers on a 10-centimeter visual analog scale with responses that range from 0 (none) to 10 (very severe) and measures severity of fatigue, spinal and peripheral joint pain, localized tenderness and morning stiffness. The final BASDAI score ranges from 0 to 10.|participants|Number|17|17.0||||||
4058794|NCT01078402|3880460|B3|Low Disease Activity (BASDAI score <4)||Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) score|BASDAI score was calculated using a questionnaire with 6 questions that participant completes by marking answers on a 10-centimeter visual analog scale with responses that range from 0 (none) to 10 (very severe) and measures severity of fatigue, spinal and peripheral joint pain, localized tenderness and morning stiffness. The final BASDAI score ranges from 0 to 10.|participants|Number|10|10.0||||||
4058795|NCT01078402|3880461|B2|Low Disease Activity (BASDAI score <4)||Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) score|BASDAI score was calculated using a questionnaire with 6 questions that participant completes by marking answers on a 10-centimeter visual analog scale with responses that range from 0 (none) to 10 (very severe) and measures severity of fatigue, spinal and peripheral joint pain, localized tenderness and morning stiffness. The final BASDAI score ranges from 0 to 10.|participants|Number|7|7.0||||||
4058796|NCT01078402|3880462|B1|Low Disease Activity (BASDAI score <4)||Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) score|BASDAI score was calculated using a questionnaire with 6 questions that participant completes by marking answers on a 10-centimeter visual analog scale with responses that range from 0 (none) to 10 (very severe) and measures severity of fatigue, spinal and peripheral joint pain, localized tenderness and morning stiffness. The final BASDAI score ranges from 0 to 10.|participants|Number|NA|||||||This assessment was for participants with PsA and AS only, per protocol.
4058797|NCT01078402|3880459|B4|Missing||Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) score|BASDAI score was calculated using a questionnaire with 6 questions that participant completes by marking answers on a 10-centimeter visual analog scale with responses that range from 0 (none) to 10 (very severe) and measures severity of fatigue, spinal and peripheral joint pain, localized tenderness and morning stiffness. The final BASDAI score ranges from 0 to 10.|participants|Number|71|71.0||||||
4058798|NCT01078402|3880460|B3|Missing||Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) score|BASDAI score was calculated using a questionnaire with 6 questions that participant completes by marking answers on a 10-centimeter visual analog scale with responses that range from 0 (none) to 10 (very severe) and measures severity of fatigue, spinal and peripheral joint pain, localized tenderness and morning stiffness. The final BASDAI score ranges from 0 to 10.|participants|Number|7|7.0||||||
4058799|NCT01078402|3880461|B2|Missing||Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) score|BASDAI score was calculated using a questionnaire with 6 questions that participant completes by marking answers on a 10-centimeter visual analog scale with responses that range from 0 (none) to 10 (very severe) and measures severity of fatigue, spinal and peripheral joint pain, localized tenderness and morning stiffness. The final BASDAI score ranges from 0 to 10.|participants|Number|64|64.0||||||
4058800|NCT01078402|3880462|B1|Missing||Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) score|BASDAI score was calculated using a questionnaire with 6 questions that participant completes by marking answers on a 10-centimeter visual analog scale with responses that range from 0 (none) to 10 (very severe) and measures severity of fatigue, spinal and peripheral joint pain, localized tenderness and morning stiffness. The final BASDAI score ranges from 0 to 10.|participants|Number|NA|||||||This assessment was for participants with PsA and AS only, per protocol.
4058801|NCT01078402|3880459|B4|High Disease Activity (score ≥5.1)||Disease Activity Score (DAS28)|DAS28 score is calculated using the number of tender and swollen joints (out of 28 counted), erythrocyte sedimentation rate (ESR) level, and the patient's global assessment of disease activity. The calculated range of DAS28 is 0.49 to 9.07, with scores below 3.2 indicating low disease activity.|participants|Number|376|376.0||||||
4058802|NCT01078402|3880460|B3|High Disease Activity (score ≥5.1)||Disease Activity Score (DAS28)|DAS28 score is calculated using the number of tender and swollen joints (out of 28 counted), erythrocyte sedimentation rate (ESR) level, and the patient's global assessment of disease activity. The calculated range of DAS28 is 0.49 to 9.07, with scores below 3.2 indicating low disease activity.|participants|Number|NA|||||||This assessment was for participants with RA only, per protocol.
4058803|NCT01078402|3880461|B2|High Disease Activity (score ≥5.1)||Disease Activity Score (DAS28)|DAS28 score is calculated using the number of tender and swollen joints (out of 28 counted), erythrocyte sedimentation rate (ESR) level, and the patient's global assessment of disease activity. The calculated range of DAS28 is 0.49 to 9.07, with scores below 3.2 indicating low disease activity.|participants|Number|NA|||||||This assessment was for participants with RA only, per protocol.
4058804|NCT01078402|3880462|B1|High Disease Activity (score ≥5.1)||Disease Activity Score (DAS28)|DAS28 score is calculated using the number of tender and swollen joints (out of 28 counted), erythrocyte sedimentation rate (ESR) level, and the patient's global assessment of disease activity. The calculated range of DAS28 is 0.49 to 9.07, with scores below 3.2 indicating low disease activity.|participants|Number|376|376.0||||||
4058805|NCT01078402|3880459|B4|Moderate Disease Activity (score ≥3.2 and <5.1)||Disease Activity Score (DAS28)|DAS28 score is calculated using the number of tender and swollen joints (out of 28 counted), erythrocyte sedimentation rate (ESR) level, and the patient's global assessment of disease activity. The calculated range of DAS28 is 0.49 to 9.07, with scores below 3.2 indicating low disease activity.|participants|Number|37|37.0||||||
4058806|NCT01078402|3880460|B3|Moderate Disease Activity (score ≥3.2 and <5.1)||Disease Activity Score (DAS28)|DAS28 score is calculated using the number of tender and swollen joints (out of 28 counted), erythrocyte sedimentation rate (ESR) level, and the patient's global assessment of disease activity. The calculated range of DAS28 is 0.49 to 9.07, with scores below 3.2 indicating low disease activity.|participants|Number|NA|||||||This assessment was for participants with RA only, per protocol.
4058807|NCT01078402|3880461|B2|Moderate Disease Activity (score ≥3.2 and <5.1)||Disease Activity Score (DAS28)|DAS28 score is calculated using the number of tender and swollen joints (out of 28 counted), erythrocyte sedimentation rate (ESR) level, and the patient's global assessment of disease activity. The calculated range of DAS28 is 0.49 to 9.07, with scores below 3.2 indicating low disease activity.|participants|Number|NA|||||||This assessment was for participants with RA only, per protocol.
4058808|NCT01078402|3880462|B1|Moderate Disease Activity (score ≥3.2 and <5.1)||Disease Activity Score (DAS28)|DAS28 score is calculated using the number of tender and swollen joints (out of 28 counted), erythrocyte sedimentation rate (ESR) level, and the patient's global assessment of disease activity. The calculated range of DAS28 is 0.49 to 9.07, with scores below 3.2 indicating low disease activity.|participants|Number|37|37.0||||||
4058809|NCT01078402|3880459|B4|Low Disease Activity (score ≥2.6 and <3.2)||Disease Activity Score (DAS28)|DAS28 score is calculated using the number of tender and swollen joints (out of 28 counted), erythrocyte sedimentation rate (ESR) level, and the patient's global assessment of disease activity. The calculated range of DAS28 is 0.49 to 9.07, with scores below 3.2 indicating low disease activity.|participants|Number|1|1.0||||||
4058810|NCT01078402|3880460|B3|Low Disease Activity (score ≥2.6 and <3.2)||Disease Activity Score (DAS28)|DAS28 score is calculated using the number of tender and swollen joints (out of 28 counted), erythrocyte sedimentation rate (ESR) level, and the patient's global assessment of disease activity. The calculated range of DAS28 is 0.49 to 9.07, with scores below 3.2 indicating low disease activity.|participants|Number|NA|||||||This assessment was for participants with RA only, per protocol.
4058811|NCT01078402|3880461|B2|Low Disease Activity (score ≥2.6 and <3.2)||Disease Activity Score (DAS28)|DAS28 score is calculated using the number of tender and swollen joints (out of 28 counted), erythrocyte sedimentation rate (ESR) level, and the patient's global assessment of disease activity. The calculated range of DAS28 is 0.49 to 9.07, with scores below 3.2 indicating low disease activity.|participants|Number|NA|||||||This assessment was for participants with RA only, per protocol.
4058812|NCT01078402|3880462|B1|Low Disease Activity (score ≥2.6 and <3.2)||Disease Activity Score (DAS28)|DAS28 score is calculated using the number of tender and swollen joints (out of 28 counted), erythrocyte sedimentation rate (ESR) level, and the patient's global assessment of disease activity. The calculated range of DAS28 is 0.49 to 9.07, with scores below 3.2 indicating low disease activity.|participants|Number|1|1.0||||||
4058813|NCT01078402|3880459|B4|Missing||Disease Activity Score (DAS28)|DAS28 score is calculated using the number of tender and swollen joints (out of 28 counted), erythrocyte sedimentation rate (ESR) level, and the patient's global assessment of disease activity. The calculated range of DAS28 is 0.49 to 9.07, with scores below 3.2 indicating low disease activity.|participants|Number|17|17.0||||||
4058814|NCT01078402|3880460|B3|Missing||Disease Activity Score (DAS28)|DAS28 score is calculated using the number of tender and swollen joints (out of 28 counted), erythrocyte sedimentation rate (ESR) level, and the patient's global assessment of disease activity. The calculated range of DAS28 is 0.49 to 9.07, with scores below 3.2 indicating low disease activity.|participants|Number|NA|||||||This assessment was for participants with RA only, per protocol.
4058815|NCT01078402|3880461|B2|Missing||Disease Activity Score (DAS28)|DAS28 score is calculated using the number of tender and swollen joints (out of 28 counted), erythrocyte sedimentation rate (ESR) level, and the patient's global assessment of disease activity. The calculated range of DAS28 is 0.49 to 9.07, with scores below 3.2 indicating low disease activity.|participants|Number|NA|||||||This assessment was for participants with RA only, per protocol.
4058816|NCT01078402|3880462|B1|Missing||Disease Activity Score (DAS28)|DAS28 score is calculated using the number of tender and swollen joints (out of 28 counted), erythrocyte sedimentation rate (ESR) level, and the patient's global assessment of disease activity. The calculated range of DAS28 is 0.49 to 9.07, with scores below 3.2 indicating low disease activity.|participants|Number|17|17.0||||||
4058817|NCT01078402|3880459|B4||Male|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
4058818|NCT01078402|3880460|B3||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4058819|NCT01078402|3880461|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4058820|NCT01078402|3880462|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4058821|NCT01078402|3880459|B4||Female|Sex: Female, Male||Participants|Count of Participants|481|481.0||||||
4058822|NCT01078402|3880460|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4058823|NCT01078402|3880461|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4058824|NCT01078402|3880462|B1||Female|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
4058825|NCT01078402|3880459|B4|||Age||years|Mean|49.3|49.3|Standard Deviation|13.3|13.3|||
4058826|NCT01078402|3880460|B3|||Age||years|Mean|41.5|41.5|Standard Deviation|13.0|13.0|||
4058827|NCT01078402|3880461|B2|||Age||years|Mean|47.8|47.8|Standard Deviation|12.4|12.4|||
4058828|NCT01078402|3880462|B1|||Age||years|Mean|54.0|54.0|Standard Deviation|11.5|11.5|||
4058829|NCT01078389|3880493|B3|Normal MDRD||Renal History (Modification of Diet in Renal Disease [MDRD])||participants|Number|89|89.0||||||
4058830|NCT01078389|3880494|B2|Normal MDRD||Renal History (Modification of Diet in Renal Disease [MDRD])||participants|Number|40|40.0||||||
4058831|NCT01078389|3880495|B1|Normal MDRD||Renal History (Modification of Diet in Renal Disease [MDRD])||participants|Number|49|49.0||||||
4058832|NCT01078389|3880493|B3|Mildly Impaired MDRD||Renal History (Modification of Diet in Renal Disease [MDRD])||participants|Number|220|220.0||||||
4058833|NCT01078389|3880494|B2|Mildly Impaired MDRD||Renal History (Modification of Diet in Renal Disease [MDRD])||participants|Number|115|115.0||||||
4058834|NCT01078389|3880495|B1|Mildly Impaired MDRD||Renal History (Modification of Diet in Renal Disease [MDRD])||participants|Number|105|105.0||||||
4058835|NCT01078389|3880493|B3|Moderately Impaired MDRD||Renal History (Modification of Diet in Renal Disease [MDRD])||participants|Number|5|5.0||||||
4058836|NCT01078389|3880494|B2|Moderately Impaired MDRD||Renal History (Modification of Diet in Renal Disease [MDRD])||participants|Number|2|2.0||||||
4058837|NCT01078389|3880495|B1|Moderately Impaired MDRD||Renal History (Modification of Diet in Renal Disease [MDRD])||participants|Number|3|3.0||||||
4058838|NCT01078389|3880493|B3|Ex-Drinker||Alcohol History||participants|Number|33|33.0||||||
4058839|NCT01078389|3880494|B2|Ex-Drinker||Alcohol History||participants|Number|16|16.0||||||
4058840|NCT01078389|3880495|B1|Ex-Drinker||Alcohol History||participants|Number|17|17.0||||||
4058841|NCT01078389|3880493|B3|Current Drinker||Alcohol History||participants|Number|209|209.0||||||
4058842|NCT01078389|3880494|B2|Current Drinker||Alcohol History||participants|Number|106|106.0||||||
4058845|NCT01078389|3880494|B2|Never Drank||Alcohol History||participants|Number|35|35.0||||||
4058846|NCT01078389|3880495|B1|Never Drank||Alcohol History||participants|Number|37|37.0||||||
4058847|NCT01078389|3880493|B3|Ex-Smoker||Smoking History||participants|Number|79|79.0||||||
4058848|NCT01078389|3880494|B2|Ex-Smoker||Smoking History||participants|Number|38|38.0||||||
4058849|NCT01078389|3880495|B1|Ex-Smoker||Smoking History||participants|Number|41|41.0||||||
4058850|NCT01078389|3880493|B3|Current Smoker||Smoking History||participants|Number|57|57.0||||||
4058851|NCT01078389|3880494|B2|Current Smoker||Smoking History||participants|Number|25|25.0||||||
4058852|NCT01078389|3880495|B1|Current Smoker||Smoking History||participants|Number|32|32.0||||||
4058853|NCT01078389|3880493|B3|Never Smoked||Smoking History||participants|Number|178|178.0||||||
4058854|NCT01078389|3880494|B2|Never Smoked||Smoking History||participants|Number|94|94.0||||||
4058855|NCT01078389|3880495|B1|Never Smoked||Smoking History||participants|Number|84|84.0||||||
4058856|NCT01078389|3880493|B3|≥30 kg/m^2||BMI Categories||participants|Number|209|209.0||||||
4058857|NCT01078389|3880494|B2|≥30 kg/m^2||BMI Categories||participants|Number|100|100.0||||||
4058858|NCT01078389|3880495|B1|≥30 kg/m^2||BMI Categories||participants|Number|109|109.0||||||
4058859|NCT01078389|3880493|B3|25 to <30 kg/m^2||BMI Categories||participants|Number|83|83.0||||||
4058860|NCT01078389|3880494|B2|25 to <30 kg/m^2||BMI Categories||participants|Number|46|46.0||||||
4058861|NCT01078389|3880495|B1|25 to <30 kg/m^2||BMI Categories||participants|Number|37|37.0||||||
4058862|NCT01078389|3880493|B3|<25 kg/m^2||BMI Categories||participants|Number|22|22.0||||||
4058863|NCT01078389|3880494|B2|<25 kg/m^2||BMI Categories||participants|Number|11|11.0||||||
4058864|NCT01078389|3880495|B1|<25 kg/m^2||BMI Categories||participants|Number|11|11.0||||||
4058865|NCT01078389|3880493|B3|||Body Mass Index (BMI)||kg/m^2|Mean|32.7|32.7|Standard Deviation|6.32|6.32|||
4058866|NCT01078389|3880494|B2|||Body Mass Index (BMI)||kg/m^2|Mean|32.3|32.3|Standard Deviation|6.23|6.23|||
4058867|NCT01078389|3880495|B1|||Body Mass Index (BMI)||kg/m^2|Mean|33.1|33.1|Standard Deviation|6.40|6.4|||
4058868|NCT01078389|3880493|B3|||Weight||kg|Mean|101.7|101.7|Standard Deviation|21.04|21.04|||
4058869|NCT01078389|3880494|B2|||Weight||kg|Mean|100.7|100.7|Standard Deviation|21.20|21.2|||
4058870|NCT01078389|3880495|B1|||Weight||kg|Mean|102.8|102.8|Standard Deviation|20.88|20.88|||
4058871|NCT01078389|3880493|B3|||Height||cm|Mean|176.4|176.4|Standard Deviation|8.79|8.79|||
4058872|NCT01078389|3880494|B2|||Height||cm|Mean|176.5|176.5|Standard Deviation|8.36|8.36|||
4058873|NCT01078389|3880495|B1|||Height||cm|Mean|176.3|176.3|Standard Deviation|9.22|9.22|||
4058874|NCT01078389|3880493|B3|United States||Region of Enrollment||participants|Number|314|314.0||||||
4058875|NCT01078389|3880494|B2|United States||Region of Enrollment||participants|Number|157|157.0||||||
4058876|NCT01078389|3880495|B1|United States||Region of Enrollment||participants|Number|157|157.0||||||
4058877|NCT01078389|3880493|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|252|252.0||||||
4058878|NCT01078389|3880494|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|121|121.0||||||
4058879|NCT01078389|3880495|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|131|131.0||||||
4058880|NCT01078389|3880493|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
4058881|NCT01078389|3880494|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4058882|NCT01078389|3880495|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4058883|NCT01078389|3880493|B3|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4058884|NCT01078389|3880494|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4058885|NCT01078389|3880495|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4058886|NCT01078389|3880493|B3|White||Race/Ethnicity, Customized||participants|Number|240|240.0||||||
4058887|NCT01078389|3880494|B2|White||Race/Ethnicity, Customized||participants|Number|121|121.0||||||
4058888|NCT01078389|3880495|B1|White||Race/Ethnicity, Customized||participants|Number|119|119.0||||||
4058889|NCT01078389|3880493|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4058890|NCT01078389|3880494|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4058891|NCT01078389|3880495|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4058892|NCT01078389|3880493|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4058893|NCT01078389|3880494|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4058894|NCT01078389|3880495|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4058895|NCT01078389|3880493|B3|Asian||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4058896|NCT01078389|3880494|B2|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4058897|NCT01078389|3880495|B1|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4058898|NCT01078389|3880493|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4058899|NCT01078389|3880494|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4058900|NCT01078389|3880495|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4058901|NCT01078389|3880493|B3||Male|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
4058902|NCT01078389|3880494|B2||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4058903|NCT01078389|3880495|B1||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4058904|NCT01078389|3880493|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4058905|NCT01078389|3880494|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4058906|NCT01078389|3880495|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4058907|NCT01078389|3880493|B3|≥65 years||Age, Customized||participants|Number|39|39.0||||||
4058908|NCT01078389|3880494|B2|≥65 years||Age, Customized||participants|Number|16|16.0||||||
4058909|NCT01078389|3880495|B1|≥65 years||Age, Customized||participants|Number|23|23.0||||||
4058910|NCT01078389|3880493|B3|45 to <65 years||Age, Customized||participants|Number|184|184.0||||||
4058911|NCT01078389|3880494|B2|45 to <65 years||Age, Customized||participants|Number|99|99.0||||||
4058912|NCT01078389|3880495|B1|45 to <65 years||Age, Customized||participants|Number|85|85.0||||||
4058913|NCT01078389|3880493|B3|<45 years||Age, Customized||participants|Number|91|91.0||||||
4058914|NCT01078389|3880494|B2|<45 years||Age, Customized||participants|Number|42|42.0||||||
4058915|NCT01078389|3880495|B1|<45 years||Age, Customized||participants|Number|49|49.0||||||
4058916|NCT01078389|3880493|B3|||Age||years|Mean|50.8|50.8|Standard Deviation|12.04|12.04|||
4058917|NCT01078389|3880494|B2|||Age||years|Mean|50.1|50.1|Standard Deviation|11.72|11.72|||
4058918|NCT01078389|3880495|B1|||Age||years|Mean|51.4|51.4|Standard Deviation|12.36|12.36|||
4058919|NCT01078376|3880510|B5|||Body Mass Index (BMI)||kg/m^2|Mean|24.54|24.54|Standard Deviation|6.625|6.625|||
4058920|NCT01078376|3880511|B4|||Body Mass Index (BMI)||kg/m^2|Mean|15.67|15.67|Standard Deviation|0.551|0.551|||
4058921|NCT01078376|3880512|B3|||Body Mass Index (BMI)||kg/m^2|Mean|24.29|24.29|Standard Deviation|8.327|8.327|||
4058922|NCT01078376|3880513|B2|||Body Mass Index (BMI)||kg/m^2|Mean|27.22|27.22|Standard Deviation|6.611|6.611|||
4058923|NCT01078376|3880514|B1|||Body Mass Index (BMI)||kg/m^2|Mean|25.06|25.06|Standard Deviation|3.345|3.345|||
4058924|NCT01078376|3880510|B5|||Weight||kg|Mean|60.69|60.69|Standard Deviation|23.859|23.859|||
4058925|NCT01078376|3880511|B4|||Weight||kg|Mean|18.30|18.3|Standard Deviation|4.026|4.026|||
4058926|NCT01078376|3880512|B3|||Weight||kg|Mean|48.50|48.5|Standard Deviation|22.523|22.523|||
4058927|NCT01078376|3880513|B2|||Weight||kg|Mean|71.71|71.71|Standard Deviation|15.512|15.512|||
4058928|NCT01078376|3880514|B1|||Weight||kg|Mean|74.64|74.64|Standard Deviation|11.207|11.207|||
4058929|NCT01078376|3880510|B5|||Height||cm|Mean|153.6|153.6|Standard Deviation|23.45|23.45|||
4058930|NCT01078376|3880511|B4|||Height||cm|Mean|107.7|107.7|Standard Deviation|11.06|11.06|||
4058931|NCT01078376|3880512|B3|||Height||cm|Mean|138.6|138.6|Standard Deviation|12.74|12.74|||
4058932|NCT01078376|3880513|B2|||Height||cm|Mean|163.1|163.1|Standard Deviation|11.72|11.72|||
4058933|NCT01078376|3880514|B1|||Height||cm|Mean|172.6|172.6|Standard Deviation|9.70|9.7|||
4058934|NCT01078376|3880510|B5|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4058935|NCT01078376|3880511|B4|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4058936|NCT01078376|3880512|B3|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4058937|NCT01078376|3880513|B2|White||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4058938|NCT01078376|3880514|B1|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4058939|NCT01078376|3880510|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4058940|NCT01078376|3880511|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4058941|NCT01078376|3880512|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4058942|NCT01078376|3880513|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4058943|NCT01078376|3880514|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4058944|NCT01078376|3880510|B5|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4058945|NCT01078376|3880511|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4058946|NCT01078376|3880512|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4058947|NCT01078376|3880513|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4058948|NCT01078376|3880514|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4058949|NCT01078376|3880510|B5|Not Reported||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4058950|NCT01078376|3880511|B4|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4058951|NCT01078376|3880512|B3|Not Reported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4058952|NCT01078376|3880513|B2|Not Reported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4058953|NCT01078376|3880514|B1|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4058954|NCT01078376|3880510|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4058955|NCT01078376|3880511|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4058956|NCT01078376|3880512|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4058957|NCT01078376|3880513|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4058958|NCT01078376|3880514|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4058959|NCT01078376|3880510|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4058960|NCT01078376|3880511|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4058961|NCT01078376|3880512|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4058962|NCT01078376|3880513|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4058963|NCT01078376|3880514|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4058964|NCT01078376|3880510|B5||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4058965|NCT01078376|3880511|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4058966|NCT01078376|3880512|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4058967|NCT01078376|3880513|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4058968|NCT01078376|3880514|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4058969|NCT01078376|3880510|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4058970|NCT01078376|3880511|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4058971|NCT01078376|3880512|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4058972|NCT01078376|3880513|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4058973|NCT01078376|3880514|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4058974|NCT01078376|3880510|B5|||Age||years|Mean|16.2|16.2|Standard Deviation|9.81|9.81|||
4058975|NCT01078376|3880511|B4|||Age||years|Mean|4.7|4.7|Standard Deviation|0.58|0.58|||
4058976|NCT01078376|3880512|B3|||Age||years|Mean|9.1|9.1|Standard Deviation|2.10|2.1|||
4058977|NCT01078376|3880513|B2|||Age||years|Mean|14.2|14.2|Standard Deviation|1.64|1.64|||
4058978|NCT01078376|3880514|B1|||Age||years|Mean|28.3|28.3|Standard Deviation|7.78|7.78|||
4058979|NCT01078363|3880636|B3||Male|Gender||Participants|Count of Participants|68|68.0||||||
4058980|NCT01078363|3880637|B2||Male|Gender||Participants|Count of Participants|32|32.0||||||
4058981|NCT01078363|3880638|B1||Male|Gender||Participants|Count of Participants|36|36.0||||||
4058982|NCT01078363|3880636|B3||Female|Gender||Participants|Count of Participants|28|28.0||||||
4058983|NCT01078363|3880637|B2||Female|Gender||Participants|Count of Participants|17|17.0||||||
4058984|NCT01078363|3880638|B1||Female|Gender||Participants|Count of Participants|11|11.0||||||
4058985|NCT01078363|3880636|B3|||Age||years|Mean|53|53.0|Standard Deviation|16|16.0|||
4058986|NCT01078363|3880637|B2|||Age||years|Mean|52|52.0|Standard Deviation|17|17.0|||
4058987|NCT01078363|3880638|B1|||Age||years|Mean|55|55.0|Standard Deviation|15|15.0|||
4058988|NCT01078298|3880655|B3||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4058989|NCT01078298|3880656|B2||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4058990|NCT01078298|3880657|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4058991|NCT01078298|3880655|B3||Female|Sex: Female, Male||Participants|Count of Participants|329|329.0||||||
4058992|NCT01078298|3880656|B2||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4058993|NCT01078298|3880657|B1||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4058994|NCT01078298|3880655|B3|Greater than or equal to 65 years||Age, Customized||participants|Number|15|15.0||||||
4058995|NCT01078298|3880656|B2|Greater than or equal to 65 years||Age, Customized||participants|Number|11|11.0||||||
4058996|NCT01078298|3880657|B1|Greater than or equal to 65 years||Age, Customized||participants|Number|4|4.0||||||
4058997|NCT01078298|3880655|B3|45 to 64 years||Age, Customized||participants|Number|306|306.0||||||
4058998|NCT01078298|3880656|B2|45 to 64 years||Age, Customized||participants|Number|160|160.0||||||
4058999|NCT01078298|3880657|B1|45 to 64 years||Age, Customized||participants|Number|146|146.0||||||
4059000|NCT01078298|3880655|B3|18 to 44 years||Age, Customized||participants|Number|204|204.0||||||
4059001|NCT01078298|3880656|B2|18 to 44 years||Age, Customized||participants|Number|98|98.0||||||
4059002|NCT01078298|3880657|B1|18 to 44 years||Age, Customized||participants|Number|106|106.0||||||
4059003|NCT01078246|3880684|B8||Male|Sex: Female, Male||Participants|Count of Participants|6367|6367.0||||||
4059004|NCT01078246|3880685|B7||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4059005|NCT01078246|3880686|B6||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4059006|NCT01078246|3880687|B5||Male|Sex: Female, Male||Participants|Count of Participants|2970|2970.0||||||
4059007|NCT01078246|3880688|B4||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4059008|NCT01078246|3880689|B3||Male|Sex: Female, Male||Participants|Count of Participants|1768|1768.0||||||
4059009|NCT01078246|3880690|B2||Male|Sex: Female, Male||Participants|Count of Participants|364|364.0||||||
4059010|NCT01078246|3880691|B1||Male|Sex: Female, Male||Participants|Count of Participants|920|920.0||||||
4059011|NCT01078246|3880684|B8||Female|Sex: Female, Male||Participants|Count of Participants|757|757.0||||||
4059012|NCT01078246|3880685|B7||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4059013|NCT01078246|3880686|B6||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4059014|NCT01078246|3880687|B5||Female|Sex: Female, Male||Participants|Count of Participants|340|340.0||||||
4059015|NCT01078246|3880688|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4059016|NCT01078246|3880689|B3||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4059017|NCT01078246|3880690|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4059018|NCT01078246|3880691|B1||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4059019|NCT01078246|3880684|B8|||Age||Years|Mean|45.0|45.0|Standard Deviation|11.1|11.1|||
4059020|NCT01078246|3880685|B7|||Age||Years|Mean|45.5|45.5|Standard Deviation|9.9|9.9|||
4059021|NCT01078246|3880686|B6|||Age||Years|Mean|46.8|46.8|Standard Deviation|12.4|12.4|||
4059022|NCT01078246|3880687|B5|||Age||Years|Mean|43.0|43.0|Standard Deviation|11.5|11.5|||
4059023|NCT01078246|3880688|B4|||Age||Years|Mean|44.9|44.9|Standard Deviation|9.9|9.9|||
4059024|NCT01078246|3880689|B3|||Age||Years|Mean|45.8|45.8|Standard Deviation|10.1|10.1|||
4059025|NCT01078246|3880690|B2|||Age||Years|Mean|49.2|49.2|Standard Deviation|10.0|10.0|||
4059026|NCT01078246|3880691|B1|||Age||Years|Mean|48.2|48.2|Standard Deviation|10.7|10.7|||
4059027|NCT01078233|3880723|B7||Male|Sex: Female, Male||Participants|Count of Participants|4873|4873.0||||||
4059028|NCT01078233|3880724|B6||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4059029|NCT01078233|3880725|B5||Male|Sex: Female, Male||Participants|Count of Participants|2326|2326.0||||||
4059030|NCT01078233|3880726|B4||Male|Sex: Female, Male||Participants|Count of Participants|457|457.0||||||
4059031|NCT01078233|3880727|B3||Male|Sex: Female, Male||Participants|Count of Participants|1259|1259.0||||||
4059032|NCT01078233|3880728|B2||Male|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
4059033|NCT01078233|3880729|B1||Male|Sex: Female, Male||Participants|Count of Participants|480|480.0||||||
4059034|NCT01078233|3880723|B7||Female|Sex: Female, Male||Participants|Count of Participants|1744|1744.0||||||
4059035|NCT01078233|3880724|B6||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4059036|NCT01078233|3880725|B5||Female|Sex: Female, Male||Participants|Count of Participants|873|873.0||||||
4059037|NCT01078233|3880726|B4||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4059038|NCT01078233|3880727|B3||Female|Sex: Female, Male||Participants|Count of Participants|422|422.0||||||
4059039|NCT01078233|3880728|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4059040|NCT01078233|3880729|B1||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4059041|NCT01078233|3880723|B7|||Age||Years|Median|44|44.0|Inter-Quartile Range|||37.0|51.0|
4059042|NCT01078233|3880724|B6|||Age||Years|Median|50|50.0|Inter-Quartile Range|||45.0|57.0|
4059043|NCT01078233|3880725|B5|||Age||Years|Median|42|42.0|Inter-Quartile Range|||34.0|50.0|
4059044|NCT01078233|3880726|B4|||Age||Years|Median|47|47.0|Inter-Quartile Range|||41.0|53.0|
4059045|NCT01078233|3880727|B3|||Age||Years|Median|44|44.0|Inter-Quartile Range|||39.0|50.0|
4059046|NCT01078233|3880728|B2|||Age||Years|Median|49|49.0|Inter-Quartile Range|||44.0|55.0|
4059047|NCT01078233|3880729|B1|||Age||Years|Median|49|49.0|Inter-Quartile Range|||44.0|55.0|
4059048|NCT01078220|3880751|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4059049|NCT01078220|3880751|B1||Female|Sex: Female, Male||Participants|Count of Participants|189629|189629.0||||||
4059050|NCT01078220|3880751|B1|>26 years||Age, Customized||Participants|Number|1679|1679.0||||||
4059051|NCT01078220|3880751|B1|Between 16 and 26 years||Age, Customized||Participants|Number|91066|91066.0||||||
4059052|NCT01078220|3880751|B1|Between 9 and 15 years||Age, Customized||Participants|Number|96839|96839.0||||||
4059053|NCT01078220|3880751|B1|<9 years||Age, Customized||Participants|Number|45|45.0||||||
4059054|NCT01078207|3880761|B1|Canada||Region of Enrollment||participants|Number|100|100.0||||||
4059055|NCT01078207|3880761|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4059056|NCT01078207|3880761|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4059057|NCT01078207|3880761|B1|||Age||years|Mean|65.1|65.1|Standard Deviation|9.2|9.2|||
4059058|NCT01078207|3880761|B1||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
4059059|NCT01078207|3880761|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4059060|NCT01078207|3880761|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4059061|NCT01078168|3880766|B3|||MMSE|MMSE: Mini-Mental State Examination; can be used to systematically and thoroughly assess mental status; range: 0-30; a score of 23 or lower is indicative of cognitive impairment|units on a scale|Mean|22.2|22.2|Standard Deviation|4.5|4.5|||
4059062|NCT01078168|3880767|B2|||MMSE|MMSE: Mini-Mental State Examination; can be used to systematically and thoroughly assess mental status; range: 0-30; a score of 23 or lower is indicative of cognitive impairment|units on a scale|Mean|23.9|23.9|Standard Deviation|4.3|4.3|||
4059063|NCT01078168|3880768|B1|||MMSE|MMSE: Mini-Mental State Examination; can be used to systematically and thoroughly assess mental status; range: 0-30; a score of 23 or lower is indicative of cognitive impairment|units on a scale|Mean|20.4|20.4|Standard Deviation|4.2|4.2|||
4059064|NCT01078168|3880766|B3|Germany||Region of Enrollment||participants|Number|21|21.0||||||
4059065|NCT01078168|3880767|B2|Germany||Region of Enrollment||participants|Number|10|10.0||||||
4059066|NCT01078168|3880768|B1|Germany||Region of Enrollment||participants|Number|11|11.0||||||
4059067|NCT01078168|3880766|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4059068|NCT01078168|3880767|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4059069|NCT01078168|3880768|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4059070|NCT01078168|3880766|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4059071|NCT01078168|3880767|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4059072|NCT01078168|3880768|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4059073|NCT01078168|3880766|B3|||Age||years|Mean|69.33|69.33|Standard Deviation|7.9|7.9|||
4059074|NCT01078168|3880767|B2|||Age||years|Mean|73|73.0|Standard Deviation|3.8|3.8|||
4059075|NCT01078168|3880768|B1|||Age||years|Mean|66.9|66.9|Standard Deviation|9.6|9.6|||
4059076|NCT01078155|3880775|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4059077|NCT01078155|3880775|B1||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4059078|NCT01078155|3880775|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4059079|NCT01078155|3880775|B1||Between 18 and 65 years|Age||Participants|Count of Participants|123|123.0||||||
4059080|NCT01078155|3880775|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4059081|NCT01078116|3880791|B1|Greece||Region of Enrollment|Based on population of 121 participants analyzed.|participants|Number|121|121.0||||||
4059082|NCT01078116|3880791|B1||Male|Sex: Female, Male|Based on population of 121 participants analyzed.|Participants|Count of Participants|21|21.0||||||
4059083|NCT01078116|3880791|B1||Female|Sex: Female, Male|Based on population of 121 participants analyzed.|Participants|Count of Participants|100|100.0||||||
4059084|NCT01078116|3880791|B1|||Age|Based on population of 121 participants analyzed.|years|Mean|56.2|56.2|Standard Deviation|12.9|12.9|||
4059085|NCT01078090|3880799|B1|Germany||Region of Enrollment||participants|Number|5745|5745.0||||||
4059086|NCT01078090|3880799|B1|Male||Gender|Gender data missing for 2 participants|participants|Number|1315|1315.0||||||
4059087|NCT01078090|3880799|B1|Female||Gender|Gender data missing for 2 participants|participants|Number|4428|4428.0||||||
4059088|NCT01078090|3880799|B1|||Age|Age data available for 5,727 participants|years|Mean|54.8|54.8|Standard Deviation|12.8|12.8|||
4059089|NCT01077973|3880840|B4|Severe||Number of Participants with Pain Severity Score|Pain severity score was assessed on a 4-point categorical scale. Total possible pain severity score range was 0 to 3, where 0 = none, 1 = mild, 2 = moderately severe and 3 = severe.|Participants|Number|53|53.0||||||
4059090|NCT01077973|3880841|B3|Severe||Number of Participants with Pain Severity Score|Pain severity score was assessed on a 4-point categorical scale. Total possible pain severity score range was 0 to 3, where 0 = none, 1 = mild, 2 = moderately severe and 3 = severe.|Participants|Number|21|21.0||||||
4059091|NCT01077973|3880842|B2|Severe||Number of Participants with Pain Severity Score|Pain severity score was assessed on a 4-point categorical scale. Total possible pain severity score range was 0 to 3, where 0 = none, 1 = mild, 2 = moderately severe and 3 = severe.|Participants|Number|21|21.0||||||
4059092|NCT01077973|3880843|B1|Severe||Number of Participants with Pain Severity Score|Pain severity score was assessed on a 4-point categorical scale. Total possible pain severity score range was 0 to 3, where 0 = none, 1 = mild, 2 = moderately severe and 3 = severe.|Participants|Number|11|11.0||||||
4059093|NCT01077973|3880840|B4|Moderately severe||Number of Participants with Pain Severity Score|Pain severity score was assessed on a 4-point categorical scale. Total possible pain severity score range was 0 to 3, where 0 = none, 1 = mild, 2 = moderately severe and 3 = severe.|Participants|Number|147|147.0||||||
4059094|NCT01077973|3880841|B3|Moderately severe||Number of Participants with Pain Severity Score|Pain severity score was assessed on a 4-point categorical scale. Total possible pain severity score range was 0 to 3, where 0 = none, 1 = mild, 2 = moderately severe and 3 = severe.|Participants|Number|59|59.0||||||
4059095|NCT01077973|3880842|B2|Moderately severe||Number of Participants with Pain Severity Score|Pain severity score was assessed on a 4-point categorical scale. Total possible pain severity score range was 0 to 3, where 0 = none, 1 = mild, 2 = moderately severe and 3 = severe.|Participants|Number|58|58.0||||||
4059096|NCT01077973|3880843|B1|Moderately severe||Number of Participants with Pain Severity Score|Pain severity score was assessed on a 4-point categorical scale. Total possible pain severity score range was 0 to 3, where 0 = none, 1 = mild, 2 = moderately severe and 3 = severe.|Participants|Number|30|30.0||||||
4059097|NCT01077973|3880840|B4||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4059098|NCT01077973|3880841|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4059099|NCT01077973|3880842|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4059100|NCT01077973|3880843|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4059101|NCT01077973|3880840|B4||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4059102|NCT01077973|3880841|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4059103|NCT01077973|3880842|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4059104|NCT01077973|3880843|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4059105|NCT01077973|3880840|B4|||Age||Years|Mean|42.3|42.3|Standard Deviation|13.6|13.6|||
4059106|NCT01077973|3880841|B3|||Age||Years|Mean|40.9|40.9|Standard Deviation|14.0|14.0|||
4059107|NCT01077973|3880842|B2|||Age||Years|Mean|43.4|43.4|Standard Deviation|13.3|13.3|||
4059108|NCT01077973|3880843|B1|||Age||Years|Mean|42.9|42.9|Standard Deviation|13.5|13.5|||
4059109|NCT01077960|3880893|B1|||Waist Circumference|N=116|cm|Mean|97.3|97.3|Standard Deviation|9.6|9.6|||
4059110|NCT01077960|3880893|B1|||Trunk Fat|n=106|kg|Mean|10.4|10.4|Standard Deviation|4.9|4.9|||
4059111|NCT01077960|3880893|B1|||Oral Glucose Tolerance Testing - Fasting Insulin|n=111|mcIU/mL|Mean|11.4|11.4|Standard Deviation|13.6|13.6|||
4059112|NCT01077960|3880893|B1|||Oral Glucose Tolerance Testing - Fasting Glucose|n=124|mg/dL|Mean|94.5|94.5|Standard Deviation|14.7|14.7|||
4059113|NCT01077960|3880893|B1|||Oral Glucose Tolerance Testing - 120 Minute Glucose|n=105|mg/dL|Mean|102.3|102.3|Standard Deviation|35.7|35.7|||
4059114|NCT01077960|3880893|B1|||Insulin-like Growth Factor I|n=112|ng/mL|Mean|242.6|242.6|Standard Deviation|132.8|132.8|||
4059115|NCT01077960|3880893|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4059116|NCT01077960|3880893|B1|United States||Region of Enrollment||participants|Number|125|125.0||||||
4059117|NCT01077960|3880893|B1||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4059118|NCT01077960|3880893|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4059119|NCT01077960|3880893|B1|||Age||years|Mean|45.4|45.4|Standard Deviation|7.1|7.1|||
4059120|NCT01077960|3880893|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4059121|NCT01077960|3880893|B1||Between 18 and 65 years|Age||Participants|Count of Participants|126|126.0||||||
4059122|NCT01077960|3880893|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4059123|NCT01077921|3880902|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
4059124|NCT01077921|3880903|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4059125|NCT01077921|3880904|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4059126|NCT01077921|3880902|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4059127|NCT01077921|3880903|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4059128|NCT01077921|3880904|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4059129|NCT01077921|3880902|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4059130|NCT01077921|3880903|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4059131|NCT01077921|3880904|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4059132|NCT01077921|3880902|B3|||Age||years|Median|30.4|30.4|Inter-Quartile Range|||25.6|39.6|
4059133|NCT01077921|3880903|B2|||Age||years|Median|26.1|26.1|Inter-Quartile Range|||24.7|32.7|
4059134|NCT01077921|3880904|B1|||Age||years|Median|34.2|34.2|Inter-Quartile Range|||29.4|40.8|
4059135|NCT01077856|3880935|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4059136|NCT01077856|3880936|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4059137|NCT01077856|3880937|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4059138|NCT01077856|3880938|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4059139|NCT01077856|3880935|B4||Female|Sex: Female, Male||Participants|Count of Participants|54516|54516.0||||||
4059140|NCT01077856|3880936|B3||Female|Sex: Female, Male||Participants|Count of Participants|15713|15713.0||||||
4059141|NCT01077856|3880937|B2||Female|Sex: Female, Male||Participants|Count of Participants|16604|16604.0||||||
4059142|NCT01077856|3880938|B1||Female|Sex: Female, Male||Participants|Count of Participants|22199|22199.0||||||
4059143|NCT01077856|3880935|B4|||Age||Years|Median|32.0|32.0|Inter-Quartile Range|||24.8|39.0|
4059144|NCT01077856|3880936|B3|||Age||Years|Median|33.2|33.2|Inter-Quartile Range|||26.1|39.5|
4059145|NCT01077856|3880937|B2|||Age||Years|Median|31.0|31.0|Inter-Quartile Range|||24.0|38.0|
4059146|NCT01077856|3880938|B1|||Age||Years|Median|31.9|31.9|Inter-Quartile Range|||24.3|39.0|
4059147|NCT01077830|3881119|B3||Male|Sex: Female, Male||Participants|Count of Participants|820|820.0||||||
4059148|NCT01077830|3881120|B2||Male|Sex: Female, Male||Participants|Count of Participants|410|410.0||||||
4059149|NCT01077830|3881121|B1||Male|Sex: Female, Male||Participants|Count of Participants|410|410.0||||||
4059150|NCT01077830|3881119|B3||Female|Sex: Female, Male||Participants|Count of Participants|539|539.0||||||
4059151|NCT01077830|3881120|B2||Female|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
4059152|NCT01077830|3881121|B1||Female|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
4059153|NCT01077830|3881119|B3|≥80 years||Age, Customized||Participants|Number|336|336.0||||||
4059154|NCT01077830|3881120|B2|≥80 years||Age, Customized||Participants|Number|165|165.0||||||
4059155|NCT01077830|3881121|B1|≥80 years||Age, Customized||Participants|Number|171|171.0||||||
4059156|NCT01077830|3881119|B3|70 to 79 years||Age, Customized||Participants|Number|484|484.0||||||
4059157|NCT01077830|3881120|B2|70 to 79 years||Age, Customized||Participants|Number|234|234.0||||||
4059158|NCT01077830|3881121|B1|70 to 79 years||Age, Customized||Participants|Number|250|250.0||||||
4059159|NCT01077830|3881119|B3|60 to 69 years||Age, Customized||Participants|Number|349|349.0||||||
4059160|NCT01077830|3881120|B2|60 to 69 years||Age, Customized||Participants|Number|189|189.0||||||
4059161|NCT01077830|3881121|B1|60 to 69 years||Age, Customized||Participants|Number|160|160.0||||||
4059162|NCT01077830|3881119|B3|50 to 59 years||Age, Customized||Participants|Number|183|183.0||||||
4059163|NCT01077830|3881120|B2|50 to 59 years||Age, Customized||Participants|Number|91|91.0||||||
4059164|NCT01077830|3881121|B1|50 to 59 years||Age, Customized||Participants|Number|92|92.0||||||
4059165|NCT01077830|3881119|B3|< 50 years||Age, Customized||Participants|Number|7|7.0||||||
4059166|NCT01077830|3881120|B2|< 50 years||Age, Customized||Participants|Number|3|3.0||||||
4059167|NCT01077830|3881121|B1|< 50 years||Age, Customized||Participants|Number|4|4.0||||||
4059168|NCT01077817|3881132|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4059169|NCT01077817|3881132|B1||Female|Sex: Female, Male||Participants|Count of Participants|684815|684815.0||||||
4059170|NCT01077817|3881132|B1|≥55||Age, Customized||Participants|Number|684815|684815.0||||||
4059171|NCT01077817|3881132|B1|<55||Age, Customized||Participants|Number|0|0.0||||||
4059172|NCT01077804|3881143|B1|United States||Region of Enrollment||participants|Number|7585|7585.0||||||
4059173|NCT01077804|3881143|B1||Male|Sex: Female, Male||Participants|Count of Participants|3871|3871.0||||||
4059174|NCT01077804|3881143|B1||Female|Sex: Female, Male||Participants|Count of Participants|3714|3714.0||||||
4059175|NCT01077804|3881143|B1|||Age, Customized||Participants|Number|7585|7585.0||||||
4059176|NCT01077739|3881150|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4059177|NCT01077739|3881151|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4059178|NCT01077739|3881152|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4059179|NCT01077739|3881150|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4059180|NCT01077739|3881151|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4059181|NCT01077739|3881152|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4059182|NCT01077739|3881150|B3|||Age||years|Mean|63.1|63.1|Standard Deviation|9.0|9.0|||
4059183|NCT01077739|3881151|B2|||Age||years|Mean|64.9|64.9|Standard Deviation|8.7|8.7|||
4059184|NCT01077739|3881152|B1|||Age||years|Mean|59.6|59.6|Standard Deviation|8.9|8.9|||
4059185|NCT01077713|3881165|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4059186|NCT01077713|3881166|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4059187|NCT01077713|3881167|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4059188|NCT01077713|3881165|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4059189|NCT01077713|3881166|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4059190|NCT01077713|3881167|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4059191|NCT01077713|3881165|B3|||Age||years|Mean|74.0|74.0|Standard Deviation|3.3|3.3|||
4059192|NCT01077713|3881166|B2|||Age||years|Mean|73.8|73.8|Standard Deviation|3.5|3.5|||
4059193|NCT01077713|3881167|B1|||Age||years|Mean|74.2|74.2|Standard Deviation|3.2|3.2|||
4059194|NCT01077622|3881192|B1|Asian – Japanese Heritage||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4059195|NCT01077622|3881192|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4059196|NCT01077622|3881192|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4059197|NCT01077622|3881192|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4059198|NCT01077622|3881192|B1|||Age||Years|Mean|66.3|66.3|Standard Deviation|5.87|5.87|||
4059199|NCT01077596|3881238|B13|Users of NSAIDs||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|48378|48378.0||||||
4059200|NCT01077596|3881239|B12|Users of NSAIDs||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|17887|17887.0||||||
4059201|NCT01077596|3881240|B11|Users of NSAIDs||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|1800|1800.0||||||
4059202|NCT01077596|3881241|B10|Users of NSAIDs||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|23730|23730.0||||||
4059203|NCT01077596|3881242|B9|Users of NSAIDs||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|2340|2340.0||||||
4059204|NCT01077596|3881243|B8|Users of NSAIDs||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|0|0.0||||||
4059205|NCT01077596|3881244|B7|Users of NSAIDs||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|0|0.0||||||
4059206|NCT01077596|3881245|B6|Users of NSAIDs||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|0|0.0||||||
4059207|NCT01077596|3881246|B5|Users of NSAIDs||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|0|0.0||||||
4059208|NCT01077596|3881247|B4|Users of NSAIDs||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|1123|1123.0||||||
4059209|NCT01077596|3881248|B3|Users of NSAIDs||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|370|370.0||||||
4059210|NCT01077596|3881249|B2|Users of NSAIDs||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|859|859.0||||||
4059211|NCT01077596|3881250|B1|Users of NSAIDs||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|269|269.0||||||
4059212|NCT01077596|3881238|B13|Users of hormone replacement therapy (HRT)||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|19856|19856.0||||||
4059213|NCT01077596|3881239|B12|Users of hormone replacement therapy (HRT)||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|0|0.0||||||
4059214|NCT01077596|3881240|B11|Users of hormone replacement therapy (HRT)||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|0|0.0||||||
4059215|NCT01077596|3881241|B10|Users of hormone replacement therapy (HRT)||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|17184|17184.0||||||
4059216|NCT01077596|3881242|B9|Users of hormone replacement therapy (HRT)||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|1796|1796.0||||||
4059217|NCT01077596|3881243|B8|Users of hormone replacement therapy (HRT)||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|441|441.0||||||
4059218|NCT01077596|3881244|B7|Users of hormone replacement therapy (HRT)||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|153|153.0||||||
4059219|NCT01077596|3881245|B6|Users of hormone replacement therapy (HRT)||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|0|0.0||||||
4059220|NCT01077596|3881246|B5|Users of hormone replacement therapy (HRT)||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|0|0.0||||||
4059221|NCT01077596|3881247|B4|Users of hormone replacement therapy (HRT)||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|0|0.0||||||
4059222|NCT01077596|3881248|B3|Users of hormone replacement therapy (HRT)||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|0|0.0||||||
4059223|NCT01077596|3881249|B2|Users of hormone replacement therapy (HRT)||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|225|225.0||||||
4059224|NCT01077596|3881250|B1|Users of hormone replacement therapy (HRT)||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|57|57.0||||||
4059225|NCT01077596|3881238|B13|Users of oral contraceptives (OC)||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|2289|2289.0||||||
4059226|NCT01077596|3881239|B12|Users of oral contraceptives (OC)||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|0|0.0||||||
4059227|NCT01077596|3881240|B11|Users of oral contraceptives (OC)||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|0|0.0||||||
4059228|NCT01077596|3881241|B10|Users of oral contraceptives (OC)||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|1987|1987.0||||||
4059229|NCT01077596|3881242|B9|Users of oral contraceptives (OC)||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|236|236.0||||||
4059321|NCT01077596|3881243|B8||Female|Sex: Female, Male||Participants|Count of Participants|837|837.0||||||
4059322|NCT01077596|3881244|B7||Female|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
4059323|NCT01077596|3881245|B6||Female|Sex: Female, Male||Participants|Count of Participants|273|273.0||||||
4059230|NCT01077596|3881243|B8|Users of oral contraceptives (OC)||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|45|45.0||||||
4059231|NCT01077596|3881244|B7|Users of oral contraceptives (OC)||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|8|8.0||||||
4059232|NCT01077596|3881245|B6|Users of oral contraceptives (OC)||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|0|0.0||||||
4059233|NCT01077596|3881246|B5|Users of oral contraceptives (OC)||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|0|0.0||||||
4059234|NCT01077596|3881247|B4|Users of oral contraceptives (OC)||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|0|0.0||||||
4059235|NCT01077596|3881248|B3|Users of oral contraceptives (OC)||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|0|0.0||||||
4059236|NCT01077596|3881249|B2|Users of oral contraceptives (OC)||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|7|7.0||||||
4059237|NCT01077596|3881250|B1|Users of oral contraceptives (OC)||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|6|6.0||||||
4059238|NCT01077596|3881238|B13|Ever dx with inflammatory bowel disease (IBD)||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|10|10.0||||||
4059239|NCT01077596|3881239|B12|Ever dx with inflammatory bowel disease (IBD)||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|0|0.0||||||
4059240|NCT01077596|3881240|B11|Ever dx with inflammatory bowel disease (IBD)||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|0|0.0||||||
4059241|NCT01077596|3881241|B10|Ever dx with inflammatory bowel disease (IBD)||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|0|0.0||||||
4059242|NCT01077596|3881242|B9|Ever dx with inflammatory bowel disease (IBD)||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|0|0.0||||||
4059243|NCT01077596|3881243|B8|Ever dx with inflammatory bowel disease (IBD)||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|0|0.0||||||
4059244|NCT01077596|3881244|B7|Ever dx with inflammatory bowel disease (IBD)||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|0|0.0||||||
4059324|NCT01077596|3881246|B5||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4059325|NCT01077596|3881247|B4||Female|Sex: Female, Male||Participants|Count of Participants|525|525.0||||||
4059326|NCT01077596|3881248|B3||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4059245|NCT01077596|3881245|B6|Ever dx with inflammatory bowel disease (IBD)||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|0|0.0||||||
4059246|NCT01077596|3881246|B5|Ever dx with inflammatory bowel disease (IBD)||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|0|0.0||||||
4059247|NCT01077596|3881247|B4|Ever dx with inflammatory bowel disease (IBD)||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|0|0.0||||||
4059248|NCT01077596|3881248|B3|Ever dx with inflammatory bowel disease (IBD)||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|0|0.0||||||
4059249|NCT01077596|3881249|B2|Ever dx with inflammatory bowel disease (IBD)||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|9|9.0||||||
4059250|NCT01077596|3881250|B1|Ever dx with inflammatory bowel disease (IBD)||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|1|1.0||||||
4059251|NCT01077596|3881238|B13|Ever diagnosed (dx) with depression||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|20758|20758.0||||||
4059252|NCT01077596|3881239|B12|Ever diagnosed (dx) with depression||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|6700|6700.0||||||
4059253|NCT01077596|3881240|B11|Ever diagnosed (dx) with depression||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|677|677.0||||||
4059254|NCT01077596|3881241|B10|Ever diagnosed (dx) with depression||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|10541|10541.0||||||
4059255|NCT01077596|3881242|B9|Ever diagnosed (dx) with depression||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|1091|1091.0||||||
4059256|NCT01077596|3881243|B8|Ever diagnosed (dx) with depression||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|319|319.0||||||
4059257|NCT01077596|3881244|B7|Ever diagnosed (dx) with depression||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|119|119.0||||||
4059258|NCT01077596|3881245|B6|Ever diagnosed (dx) with depression||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|273|273.0||||||
4059259|NCT01077596|3881246|B5|Ever diagnosed (dx) with depression||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|83|83.0||||||
4059327|NCT01077596|3881249|B2||Female|Sex: Female, Male||Participants|Count of Participants|378|378.0||||||
4059328|NCT01077596|3881250|B1||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4059260|NCT01077596|3881247|B4|Ever diagnosed (dx) with depression||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|408|408.0||||||
4059261|NCT01077596|3881248|B3|Ever diagnosed (dx) with depression||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|108|108.0||||||
4059262|NCT01077596|3881249|B2|Ever diagnosed (dx) with depression||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|329|329.0||||||
4059263|NCT01077596|3881250|B1|Ever diagnosed (dx) with depression||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|110|110.0||||||
4059264|NCT01077596|3881238|B13|Unknown smoking status||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|323|323.0||||||
4059265|NCT01077596|3881239|B12|Unknown smoking status||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|0|0.0||||||
4059266|NCT01077596|3881240|B11|Unknown smoking status||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|0|0.0||||||
4059267|NCT01077596|3881241|B10|Unknown smoking status||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|0|0.0||||||
4059268|NCT01077596|3881242|B9|Unknown smoking status||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|0|0.0||||||
4059269|NCT01077596|3881243|B8|Unknown smoking status||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|27|27.0||||||
4059270|NCT01077596|3881244|B7|Unknown smoking status||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|4|4.0||||||
4059271|NCT01077596|3881245|B6|Unknown smoking status||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|29|29.0||||||
4059272|NCT01077596|3881246|B5|Unknown smoking status||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|1|1.0||||||
4059273|NCT01077596|3881247|B4|Unknown smoking status||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|183|183.0||||||
4059274|NCT01077596|3881248|B3|Unknown smoking status||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|5|5.0||||||
4059275|NCT01077596|3881249|B2|Unknown smoking status||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|70|70.0||||||
4059276|NCT01077596|3881250|B1|Unknown smoking status||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|4|4.0||||||
4059277|NCT01077596|3881238|B13|Ever smokers||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|3446|3446.0||||||
4059278|NCT01077596|3881239|B12|Ever smokers||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|0|0.0||||||
4059279|NCT01077596|3881240|B11|Ever smokers||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|0|0.0||||||
4059280|NCT01077596|3881241|B10|Ever smokers||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|0|0.0||||||
4059281|NCT01077596|3881242|B9|Ever smokers||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|0|0.0||||||
4059282|NCT01077596|3881243|B8|Ever smokers||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|389|389.0||||||
4059283|NCT01077596|3881244|B7|Ever smokers||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|142|142.0||||||
4059284|NCT01077596|3881245|B6|Ever smokers||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|573|573.0||||||
4059285|NCT01077596|3881246|B5|Ever smokers||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|247|247.0||||||
4059286|NCT01077596|3881247|B4|Ever smokers||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|772|772.0||||||
4059287|NCT01077596|3881248|B3|Ever smokers||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|428|428.0||||||
4059288|NCT01077596|3881249|B2|Ever smokers||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|643|643.0||||||
4059289|NCT01077596|3881250|B1|Ever smokers||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|252|252.0||||||
4059290|NCT01077596|3881238|B13|Exposed to multiple antidepressants||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|11308|11308.0||||||
4059291|NCT01077596|3881239|B12|Exposed to multiple antidepressants||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|3782|3782.0||||||
4059329|NCT01077596|3881238|B13|>=75 years||Age, Customized||Participants|Number|13727|13727.0||||||
4059292|NCT01077596|3881240|B11|Exposed to multiple antidepressants||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|340|340.0||||||
4059293|NCT01077596|3881241|B10|Exposed to multiple antidepressants||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|5756|5756.0||||||
4059294|NCT01077596|3881242|B9|Exposed to multiple antidepressants||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|564|564.0||||||
4059295|NCT01077596|3881243|B8|Exposed to multiple antidepressants||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|162|162.0||||||
4059296|NCT01077596|3881244|B7|Exposed to multiple antidepressants||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|53|53.0||||||
4059297|NCT01077596|3881245|B6|Exposed to multiple antidepressants||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|147|147.0||||||
4059298|NCT01077596|3881246|B5|Exposed to multiple antidepressants||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|44|44.0||||||
4059299|NCT01077596|3881247|B4|Exposed to multiple antidepressants||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|191|191.0||||||
4059300|NCT01077596|3881248|B3|Exposed to multiple antidepressants||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|62|62.0||||||
4059301|NCT01077596|3881249|B2|Exposed to multiple antidepressants||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|160|160.0||||||
4059302|NCT01077596|3881250|B1|Exposed to multiple antidepressants||Number of participants diagnosed with the indicated conditions and using the indicated therapies|A value of “0” indicates that no data are available for that particular treatment arm. Smoking status data were not collected for breast cancer and prostate cancer cases and controls, as it is not a necessary variable for analysis. NSAIDS, non-steroidal anti-inflammatory drugs.|participants|Number|47|47.0||||||
4059303|NCT01077596|3881238|B13||Male|Sex: Female, Male||Participants|Count of Participants|27200|27200.0||||||
4059304|NCT01077596|3881239|B12||Male|Sex: Female, Male||Participants|Count of Participants|22150|22150.0||||||
4059305|NCT01077596|3881240|B11||Male|Sex: Female, Male||Participants|Count of Participants|2215|2215.0||||||
4059306|NCT01077596|3881241|B10||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4059307|NCT01077596|3881242|B9||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4059308|NCT01077596|3881243|B8||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4059309|NCT01077596|3881244|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4059310|NCT01077596|3881245|B6||Male|Sex: Female, Male||Participants|Count of Participants|609|609.0||||||
4059311|NCT01077596|3881246|B5||Male|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4059312|NCT01077596|3881247|B4||Male|Sex: Female, Male||Participants|Count of Participants|845|845.0||||||
4059313|NCT01077596|3881248|B3||Male|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
4059314|NCT01077596|3881249|B2||Male|Sex: Female, Male||Participants|Count of Participants|672|672.0||||||
4059315|NCT01077596|3881250|B1||Male|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
4059316|NCT01077596|3881238|B13||Female|Sex: Female, Male||Participants|Count of Participants|33975|33975.0||||||
4059317|NCT01077596|3881239|B12||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4059318|NCT01077596|3881240|B11||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4059319|NCT01077596|3881241|B10||Female|Sex: Female, Male||Participants|Count of Participants|28420|28420.0||||||
4059320|NCT01077596|3881242|B9||Female|Sex: Female, Male||Participants|Count of Participants|2842|2842.0||||||
4059330|NCT01077596|3881239|B12|>=75 years||Age, Customized||Participants|Number|4760|4760.0||||||
4059331|NCT01077596|3881240|B11|>=75 years||Age, Customized||Participants|Number|476|476.0||||||
4059332|NCT01077596|3881241|B10|>=75 years||Age, Customized||Participants|Number|6080|6080.0||||||
4059333|NCT01077596|3881242|B9|>=75 years||Age, Customized||Participants|Number|608|608.0||||||
4059334|NCT01077596|3881243|B8|>=75 years||Age, Customized||Participants|Number|196|196.0||||||
4059335|NCT01077596|3881244|B7|>=75 years||Age, Customized||Participants|Number|75|75.0||||||
4059336|NCT01077596|3881245|B6|>=75 years||Age, Customized||Participants|Number|330|330.0||||||
4059337|NCT01077596|3881246|B5|>=75 years||Age, Customized||Participants|Number|110|110.0||||||
4059338|NCT01077596|3881247|B4|>=75 years||Age, Customized||Participants|Number|447|447.0||||||
4059339|NCT01077596|3881248|B3|>=75 years||Age, Customized||Participants|Number|149|149.0||||||
4059340|NCT01077596|3881249|B2|>=75 years||Age, Customized||Participants|Number|372|372.0||||||
4059341|NCT01077596|3881250|B1|>=75 years||Age, Customized||Participants|Number|124|124.0||||||
4059342|NCT01077596|3881238|B13|65-74 years||Age, Customized||Participants|Number|19260|19260.0||||||
4059343|NCT01077596|3881239|B12|65-74 years||Age, Customized||Participants|Number|8770|8770.0||||||
4059344|NCT01077596|3881240|B11|65-74 years||Age, Customized||Participants|Number|877|877.0||||||
4059345|NCT01077596|3881241|B10|65-74 years||Age, Customized||Participants|Number|7070|7070.0||||||
4059346|NCT01077596|3881242|B9|65-74 years||Age, Customized||Participants|Number|707|707.0||||||
4059347|NCT01077596|3881243|B8|65-74 years||Age, Customized||Participants|Number|224|224.0||||||
4059348|NCT01077596|3881244|B7|65-74 years||Age, Customized||Participants|Number|84|84.0||||||
4059349|NCT01077596|3881245|B6|65-74 years||Age, Customized||Participants|Number|312|312.0||||||
4059350|NCT01077596|3881246|B5|65-74 years||Age, Customized||Participants|Number|104|104.0||||||
4059351|NCT01077596|3881247|B4|65-74 years||Age, Customized||Participants|Number|477|477.0||||||
4059352|NCT01077596|3881248|B3|65-74 years||Age, Customized||Participants|Number|159|159.0||||||
4059353|NCT01077596|3881249|B2|65-74 years||Age, Customized||Participants|Number|357|357.0||||||
4059354|NCT01077596|3881250|B1|65-74 years||Age, Customized||Participants|Number|119|119.0||||||
4059355|NCT01077596|3881238|B13|55-64 years||Age, Customized||Participants|Number|17985|17985.0||||||
4059356|NCT01077596|3881239|B12|55-64 years||Age, Customized||Participants|Number|6690|6690.0||||||
4059357|NCT01077596|3881240|B11|55-64 years||Age, Customized||Participants|Number|669|669.0||||||
4059358|NCT01077596|3881241|B10|55-64 years||Age, Customized||Participants|Number|8490|8490.0||||||
4059359|NCT01077596|3881242|B9|55-64 years||Age, Customized||Participants|Number|849|849.0||||||
4059360|NCT01077596|3881243|B8|55-64 years||Age, Customized||Participants|Number|245|245.0||||||
4059361|NCT01077596|3881244|B7|55-64 years||Age, Customized||Participants|Number|90|90.0||||||
4059362|NCT01077596|3881245|B6|55-64 years||Age, Customized||Participants|Number|189|189.0||||||
4059363|NCT01077596|3881246|B5|55-64 years||Age, Customized||Participants|Number|63|63.0||||||
4059364|NCT01077596|3881247|B4|55-64 years||Age, Customized||Participants|Number|306|306.0||||||
4059365|NCT01077596|3881248|B3|55-64 years||Age, Customized||Participants|Number|102|102.0||||||
4059366|NCT01077596|3881249|B2|55-64 years||Age, Customized||Participants|Number|219|219.0||||||
4059367|NCT01077596|3881250|B1|55-64 years||Age, Customized||Participants|Number|73|73.0||||||
4059368|NCT01077596|3881238|B13|45-54 years||Age, Customized||Participants|Number|10203|10203.0||||||
4059369|NCT01077596|3881239|B12|45-54 years||Age, Customized||Participants|Number|1930|1930.0||||||
4059370|NCT01077596|3881240|B11|45-54 years||Age, Customized||Participants|Number|193|193.0||||||
4059371|NCT01077596|3881241|B10|45-54 years||Age, Customized||Participants|Number|6780|6780.0||||||
4059372|NCT01077596|3881242|B9|45-54 years||Age, Customized||Participants|Number|678|678.0||||||
4059373|NCT01077596|3881243|B8|45-54 years||Age, Customized||Participants|Number|172|172.0||||||
4059374|NCT01077596|3881244|B7|45-54 years||Age, Customized||Participants|Number|59|59.0||||||
4059375|NCT01077596|3881245|B6|45-54 years||Age, Customized||Participants|Number|51|51.0||||||
4059376|NCT01077596|3881246|B5|45-54 years||Age, Customized||Participants|Number|17|17.0||||||
4059377|NCT01077596|3881247|B4|45-54 years||Age, Customized||Participants|Number|140|140.0||||||
4059378|NCT01077596|3881248|B3|45-54 years||Age, Customized||Participants|Number|47|47.0||||||
4059379|NCT01077596|3881249|B2|45-54 years||Age, Customized||Participants|Number|102|102.0||||||
4059380|NCT01077596|3881250|B1|45-54 years||Age, Customized||Participants|Number|34|34.0||||||
4059381|NCT01077544|3881310|B3|||Body Mass Index (BMI)||kg/m^2|Mean|17.887|17.887|Standard Deviation|2.7795|2.7795|||
4059382|NCT01077544|3881311|B2|||Body Mass Index (BMI)||kg/m^2|Mean|18.944|18.944|Standard Deviation|3.4563|3.4563|||
4059383|NCT01077544|3881312|B1|||Body Mass Index (BMI)||kg/m^2|Mean|16.962|16.962|Standard Deviation|1.7654|1.7654|||
4059384|NCT01077544|3881310|B3|||Height||cm|Mean|137.7|137.7|Standard Deviation|23.02|23.02|||
4059385|NCT01077544|3881311|B2|||Height||cm|Mean|158.0|158.0|Standard Deviation|16.32|16.32|||
4059386|NCT01077544|3881312|B1|||Height||cm|Mean|119.9|119.9|Standard Deviation|7.49|7.49|||
4059387|NCT01077544|3881310|B3|||Weight||kg|Mean|35.93|35.93|Standard Deviation|17.328|17.328|||
4059388|NCT01077544|3881311|B2|||Weight||kg|Mean|48.89|48.89|Standard Deviation|17.533|17.533|||
4059389|NCT01077544|3881312|B1|||Weight||kg|Mean|24.60|24.6|Standard Deviation|4.739|4.739|||
4059390|NCT01077544|3881310|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4059391|NCT01077544|3881311|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4059392|NCT01077544|3881312|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4059393|NCT01077544|3881310|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4059394|NCT01077544|3881311|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4059395|NCT01077544|3881312|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4059396|NCT01077544|3881310|B3|||Age||Years|Mean|10.0|10.0|Standard Deviation|4.12|4.12|||
4059397|NCT01077544|3881311|B2|||Age||Years|Mean|13.7|13.7|Standard Deviation|2.81|2.81|||
4059398|NCT01077544|3881312|B1|||Age||Years|Mean|6.8|6.8|Standard Deviation|1.16|1.16|||
4059399|NCT01077401|3881339|B3|United States||Region of Enrollment||participants|Number|152|152.0||||||
4059400|NCT01077401|3881340|B2|United States||Region of Enrollment||participants|Number|75|75.0||||||
4059401|NCT01077401|3881341|B1|United States||Region of Enrollment||participants|Number|77|77.0||||||
4059402|NCT01077401|3881339|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4059403|NCT01077401|3881340|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4059404|NCT01077401|3881341|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4059405|NCT01077401|3881339|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4059406|NCT01077401|3881340|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4059407|NCT01077401|3881341|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4059408|NCT01077401|3881339|B3||White|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
4059409|NCT01077401|3881340|B2||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4059410|NCT01077401|3881341|B1||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4059411|NCT01077401|3881339|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4059412|NCT01077401|3881340|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4059413|NCT01077401|3881341|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4059414|NCT01077401|3881339|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4059415|NCT01077401|3881340|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4059416|NCT01077401|3881341|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4059417|NCT01077401|3881339|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4059418|NCT01077401|3881340|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4059419|NCT01077401|3881341|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4059420|NCT01077401|3881339|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4059421|NCT01077401|3881340|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4059422|NCT01077401|3881341|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4059423|NCT01077401|3881339|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4059424|NCT01077401|3881340|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4059425|NCT01077401|3881341|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4059426|NCT01077401|3881339|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4059427|NCT01077401|3881340|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4059428|NCT01077401|3881341|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4059429|NCT01077401|3881339|B3|||Age||years|Mean|64.1|64.1|Full Range|||35.0|87.0|
4059430|NCT01077401|3881340|B2|||Age||years|Mean|63.5|63.5|Full Range|||48.0|84.0|
4059431|NCT01077401|3881341|B1|||Age||years|Mean|64.8|64.8|Full Range|||35.0|87.0|
4059432|NCT01077375|3881352|B3|United States||Region of Enrollment||participants|Number|106|106.0||||||
4059433|NCT01077375|3881353|B2|United States||Region of Enrollment||participants|Number|85|85.0||||||
4059434|NCT01077375|3881354|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4059435|NCT01077375|3881352|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4059436|NCT01077375|3881353|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4059437|NCT01077375|3881354|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4059438|NCT01077375|3881352|B3||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4059439|NCT01077375|3881353|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4059440|NCT01077375|3881354|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4059441|NCT01077375|3881352|B3|60 to 70||Age, Customized||participants|Number|12|12.0||||||
4059442|NCT01077375|3881353|B2|60 to 70||Age, Customized||participants|Number|8|8.0||||||
4059443|NCT01077375|3881354|B1|60 to 70||Age, Customized||participants|Number|4|4.0||||||
4059444|NCT01077375|3881352|B3|18 to 59||Age, Customized||participants|Number|94|94.0||||||
4059445|NCT01077375|3881353|B2|18 to 59||Age, Customized||participants|Number|77|77.0||||||
4059446|NCT01077375|3881354|B1|18 to 59||Age, Customized||participants|Number|17|17.0||||||
4059447|NCT01077375|3881352|B3|||Age||years|Mean|48.5|48.5|Standard Deviation|10.6|10.6|||
4059448|NCT01077375|3881353|B2|||Age||years|Mean|48.5|48.5|Standard Deviation|10.5|10.5|||
4059449|NCT01077375|3881354|B1|||Age||years|Mean|48.5|48.5|Standard Deviation|11.3|11.3|||
4059450|NCT01077362|3881363|B4||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4059451|NCT01077362|3881364|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4059452|NCT01077362|3881365|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4059453|NCT01077362|3881366|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4059454|NCT01077362|3881363|B4||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4059455|NCT01077362|3881364|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4059456|NCT01077362|3881365|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4059457|NCT01077362|3881366|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4059458|NCT01077362|3881363|B4|||Age||years|Mean|47.9|47.9|Standard Deviation|11.57|11.57|||
4059459|NCT01077362|3881364|B3|||Age||years|Mean|48.2|48.2|Standard Deviation|12.36|12.36|||
4059460|NCT01077362|3881365|B2|||Age||years|Mean|48|48.0|Standard Deviation|11.21|11.21|||
4059461|NCT01077362|3881366|B1|||Age||years|Mean|47.6|47.6|Standard Deviation|11.19|11.19|||
4059462|NCT01077323|3881401|B4|||Has a History of Type 2 Diabetes|Has a History of Type 2 Diabetes|participants|Number|159927|159927.0||||||
4059463|NCT01077323|3881402|B3|||Has a History of Type 2 Diabetes|Has a History of Type 2 Diabetes|participants|Number|0|0.0||||||
4059464|NCT01077323|3881403|B2|||Has a History of Type 2 Diabetes|Has a History of Type 2 Diabetes|participants|Number|138218|138218.0||||||
4059465|NCT01077323|3881404|B1|||Has a History of Type 2 Diabetes|Has a History of Type 2 Diabetes|participants|Number|21709|21709.0||||||
4059466|NCT01077323|3881401|B4|||Has a History of Type 1 Diabetes|Has a History of Type 1 Diabetes|participants|Number|22162|22162.0||||||
4059467|NCT01077323|3881402|B3|||Has a History of Type 1 Diabetes|Has a History of Type 1 Diabetes|participants|Number|0|0.0||||||
4059468|NCT01077323|3881403|B2|||Has a History of Type 1 Diabetes|Has a History of Type 1 Diabetes|participants|Number|19368|19368.0||||||
4059469|NCT01077323|3881404|B1|||Has a History of Type 1 Diabetes|Has a History of Type 1 Diabetes|participants|Number|2794|2794.0||||||
4059470|NCT01077323|3881401|B4|||Has a History of Stroke/Transient Ischemic Attack|Has a History of Stroke/Transient Ischemic Attack|participants|Number|5847|5847.0||||||
4059471|NCT01077323|3881402|B3|||Has a History of Stroke/Transient Ischemic Attack|Has a History of Stroke/Transient Ischemic Attack|participants|Number|336|336.0||||||
4059472|NCT01077323|3881403|B2|||Has a History of Stroke/Transient Ischemic Attack|Has a History of Stroke/Transient Ischemic Attack|participants|Number|5088|5088.0||||||
4059473|NCT01077323|3881404|B1|||Has a History of Stroke/Transient Ischemic Attack|Has a History of Stroke/Transient Ischemic Attack|participants|Number|423|423.0||||||
4059474|NCT01077323|3881401|B4|||Has a History of Retinopathy|Has a History of Retinopathy|participants|Number|8048|8048.0||||||
4059475|NCT01077323|3881402|B3|||Has a History of Retinopathy|Has a History of Retinopathy|participants|Number|76|76.0||||||
4059476|NCT01077323|3881403|B2|||Has a History of Retinopathy|Has a History of Retinopathy|participants|Number|6693|6693.0||||||
4059477|NCT01077323|3881404|B1|||Has a History of Retinopathy|Has a History of Retinopathy|participants|Number|1279|1279.0||||||
4059478|NCT01077323|3881401|B4|||Has a History of Renal Impairment/Dialysis|Has a History of Renal Impairment/Dialysis|participants|Number|9530|9530.0||||||
4059479|NCT01077323|3881402|B3|||Has a History of Renal Impairment/Dialysis|Has a History of Renal Impairment/Dialysis|participants|Number|312|312.0||||||
4059480|NCT01077323|3881403|B2|||Has a History of Renal Impairment/Dialysis|Has a History of Renal Impairment/Dialysis|participants|Number|8257|8257.0||||||
4059481|NCT01077323|3881404|B1|||Has a History of Renal Impairment/Dialysis|Has a History of Renal Impairment/Dialysis|participants|Number|961|961.0||||||
4059482|NCT01077323|3881401|B4|||Has a History of Peripheral Neuropathy|Has a History of Peripheral Neuropathy|participants|Number|12048|12048.0||||||
4059483|NCT01077323|3881402|B3|||Has a History of Peripheral Neuropathy|Has a History of Peripheral Neuropathy|participants|Number|11|11.0||||||
4059484|NCT01077323|3881403|B2|||Has a History of Peripheral Neuropathy|Has a History of Peripheral Neuropathy|participants|Number|9581|9581.0||||||
4059485|NCT01077323|3881404|B1|||Has a History of Peripheral Neuropathy|Has a History of Peripheral Neuropathy|participants|Number|2456|2456.0||||||
4059486|NCT01077323|3881401|B4|||Has a History of Obesity|Has a History of Obesity|participants|Number|24270|24270.0||||||
4059487|NCT01077323|3881402|B3|||Has a History of Obesity|Has a History of Obesity|participants|Number|1230|1230.0||||||
4059488|NCT01077323|3881403|B2|||Has a History of Obesity|Has a History of Obesity|participants|Number|18933|18933.0||||||
4059489|NCT01077323|3881404|B1|||Has a History of Obesity|Has a History of Obesity|participants|Number|4107|4107.0||||||
4059490|NCT01077323|3881401|B4|||Has a History of Myocardial Infarction|Has a History of Myocardial Infarction|participants|Number|4445|4445.0||||||
4059491|NCT01077323|3881402|B3|||Has a History of Myocardial Infarction|Has a History of Myocardial Infarction|participants|Number|193|193.0||||||
4059492|NCT01077323|3881403|B2|||Has a History of Myocardial Infarction|Has a History of Myocardial Infarction|participants|Number|3951|3951.0||||||
4059493|NCT01077323|3881404|B1|||Has a History of Myocardial Infarction|Has a History of Myocardial Infarction|participants|Number|301|301.0||||||
4059494|NCT01077323|3881401|B4|||Has a History of Ischemic Heart Disease|Has a History of Ischemic Heart Disease|participants|Number|29903|29903.0||||||
4059495|NCT01077323|3881402|B3|||Has a History of Ischemic Heart Disease|Has a History of Ischemic Heart Disease|participants|Number|1775|1775.0||||||
4059496|NCT01077323|3881403|B2|||Has a History of Ischemic Heart Disease|Has a History of Ischemic Heart Disease|participants|Number|24900|24900.0||||||
4059497|NCT01077323|3881404|B1|||Has a History of Ischemic Heart Disease|Has a History of Ischemic Heart Disease|participants|Number|3228|3228.0||||||
4059498|NCT01077323|3881401|B4|||Has a History of Hypertension|Has a History of Hypertension|participants|Number|141050|141050.0||||||
4059499|NCT01077323|3881402|B3|||Has a History of Hypertension|Has a History of Hypertension|participants|Number|10121|10121.0||||||
4059500|NCT01077323|3881403|B2|||Has a History of Hypertension|Has a History of Hypertension|participants|Number|114593|114593.0||||||
4059501|NCT01077323|3881404|B1|||Has a History of Hypertension|Has a History of Hypertension|participants|Number|16336|16336.0||||||
4059502|NCT01077323|3881401|B4|||Has a History of Hyperlipidemia|Has a History of Hyperlipidemia|participants|Number|160303|160303.0||||||
4059503|NCT01077323|3881402|B3|||Has a History of Hyperlipidemia|Has a History of Hyperlipidemia|participants|Number|13178|13178.0||||||
4059504|NCT01077323|3881403|B2|||Has a History of Hyperlipidemia|Has a History of Hyperlipidemia|participants|Number|127384|127384.0||||||
4059505|NCT01077323|3881404|B1|||Has a History of Hyperlipidemia|Has a History of Hyperlipidemia|participants|Number|19741|19741.0||||||
4059506|NCT01077323|3881401|B4|||Has a History of Congestive Heart Failure|Has a History of Congestive Heart Failure|participants|Number|9362|9362.0||||||
4059507|NCT01077323|3881402|B3|||Has a History of Congestive Heart Failure|Has a History of Congestive Heart Failure|participants|Number|315|315.0||||||
4059508|NCT01077323|3881403|B2|||Has a History of Congestive Heart Failure|Has a History of Congestive Heart Failure|participants|Number|8227|8227.0||||||
4059509|NCT01077323|3881404|B1|||Has a History of Congestive Heart Failure|Has a History of Congestive Heart Failure|participants|Number|820|820.0||||||
4059510|NCT01077323|3881401|B4||Male|Sex: Female, Male||Participants|Count of Participants|181981|181981.0||||||
4059511|NCT01077323|3881402|B3||Male|Sex: Female, Male||Participants|Count of Participants|51067|51067.0||||||
4059512|NCT01077323|3881403|B2||Male|Sex: Female, Male||Participants|Count of Participants|119576|119576.0||||||
4059513|NCT01077323|3881404|B1||Male|Sex: Female, Male||Participants|Count of Participants|11338|11338.0||||||
4059514|NCT01077323|3881401|B4||Female|Sex: Female, Male||Participants|Count of Participants|181785|181785.0||||||
4059515|NCT01077323|3881402|B3||Female|Sex: Female, Male||Participants|Count of Participants|52444|52444.0||||||
4059516|NCT01077323|3881403|B2||Female|Sex: Female, Male||Participants|Count of Participants|114960|114960.0||||||
4059517|NCT01077323|3881404|B1||Female|Sex: Female, Male||Participants|Count of Participants|14381|14381.0||||||
4059518|NCT01077323|3881401|B4||>=65 years|Age||Participants|Count of Participants|36332|36332.0||||||
4059519|NCT01077323|3881402|B3||>=65 years|Age||Participants|Count of Participants|4926|4926.0||||||
4059520|NCT01077323|3881403|B2||>=65 years|Age||Participants|Count of Participants|29237|29237.0||||||
4059521|NCT01077323|3881404|B1||>=65 years|Age||Participants|Count of Participants|2169|2169.0||||||
4059522|NCT01077323|3881401|B4||Between 18 and 65 years|Age||Participants|Count of Participants|299435|299435.0||||||
4059523|NCT01077323|3881402|B3||Between 18 and 65 years|Age||Participants|Count of Participants|73622|73622.0||||||
4059524|NCT01077323|3881403|B2||Between 18 and 65 years|Age||Participants|Count of Participants|202317|202317.0||||||
4059525|NCT01077323|3881404|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23496|23496.0||||||
4059526|NCT01077323|3881401|B4||<=18 years|Age||Participants|Count of Participants|27999|27999.0||||||
4059527|NCT01077323|3881402|B3||<=18 years|Age||Participants|Count of Participants|24963|24963.0||||||
4059528|NCT01077323|3881403|B2||<=18 years|Age||Participants|Count of Participants|2982|2982.0||||||
4059529|NCT01077323|3881404|B1||<=18 years|Age||Participants|Count of Participants|54|54.0||||||
4059530|NCT01077310|3881423|B3|Possible Dependence||Alcohol use severity by AUDIT||participants|Number|87|87.0||||||
4059531|NCT01077310|3881424|B2|Possible Dependence||Alcohol use severity by AUDIT||participants|Number|27|27.0||||||
4059532|NCT01077310|3881425|B1|Possible Dependence||Alcohol use severity by AUDIT||participants|Number|60|60.0||||||
4059533|NCT01077310|3881423|B3|Harmful Drinking||Alcohol use severity by AUDIT||participants|Number|4|4.0||||||
4059534|NCT01077310|3881424|B2|Harmful Drinking||Alcohol use severity by AUDIT||participants|Number|4|4.0||||||
4059535|NCT01077310|3881425|B1|Harmful Drinking||Alcohol use severity by AUDIT||participants|Number|0|0.0||||||
4059536|NCT01077310|3881423|B3|Hazardous Drinking||Alcohol use severity by AUDIT||participants|Number|7|7.0||||||
4059537|NCT01077310|3881424|B2|Hazardous Drinking||Alcohol use severity by AUDIT||participants|Number|2|2.0||||||
4059538|NCT01077310|3881425|B1|Hazardous Drinking||Alcohol use severity by AUDIT||participants|Number|5|5.0||||||
4059539|NCT01077310|3881423|B3|Abstinent or Low Risk Drinking||Alcohol use severity by AUDIT||participants|Number|2|2.0||||||
4059540|NCT01077310|3881424|B2|Abstinent or Low Risk Drinking||Alcohol use severity by AUDIT||participants|Number|0|0.0||||||
4059541|NCT01077310|3881425|B1|Abstinent or Low Risk Drinking||Alcohol use severity by AUDIT||participants|Number|2|2.0||||||
4059542|NCT01077310|3881423|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
4059543|NCT01077310|3881424|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4059544|NCT01077310|3881425|B1|United States||Region of Enrollment||participants|Number|67|67.0||||||
4059545|NCT01077310|3881423|B3|White (non Hispanic)||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4059546|NCT01077310|3881424|B2|White (non Hispanic)||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4059547|NCT01077310|3881425|B1|White (non Hispanic)||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4059548|NCT01077310|3881423|B3|Black (non Hispanic)||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
4059549|NCT01077310|3881424|B2|Black (non Hispanic)||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4059550|NCT01077310|3881425|B1|Black (non Hispanic)||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4059551|NCT01077310|3881423|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4059552|NCT01077310|3881424|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4059553|NCT01077310|3881425|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4059554|NCT01077310|3881423|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4059555|NCT01077310|3881424|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4059556|NCT01077310|3881425|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4059557|NCT01077310|3881423|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4059558|NCT01077310|3881424|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4059559|NCT01077310|3881425|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4059560|NCT01077310|3881423|B3|||Age||years|Mean|45.0|45.0|Standard Deviation|8.4|8.4|||
4059561|NCT01077310|3881424|B2|||Age||years|Mean|45.2|45.2|Standard Deviation|8.9|8.9|||
4059562|NCT01077310|3881425|B1|||Age||years|Mean|44.9|44.9|Standard Deviation|8.1|8.1|||
4059563|NCT01077310|3881423|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4059564|NCT01077310|3881424|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4059565|NCT01077310|3881425|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4059566|NCT01077310|3881423|B3||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4059567|NCT01077310|3881424|B2||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4059568|NCT01077310|3881425|B1||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
4059569|NCT01077310|3881423|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4059570|NCT01077310|3881424|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4059571|NCT01077310|3881425|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4059572|NCT01077284|3881446|B4|||Baseline in-plane Diameter of the largest Calcium Oxalate Stone||mm|Mean|9.91|9.91|Standard Deviation|5.590|5.59|||
4059573|NCT01077284|3881447|B3|||Baseline in-plane Diameter of the largest Calcium Oxalate Stone||mm|Mean|8.22|8.22|Standard Deviation|3.756|3.756|||
4059574|NCT01077284|3881448|B2|||Baseline in-plane Diameter of the largest Calcium Oxalate Stone||mm|Mean|9.34|9.34|Standard Deviation|4.311|4.311|||
4059575|NCT01077284|3881449|B1|||Baseline in-plane Diameter of the largest Calcium Oxalate Stone||mm|Mean|12.24|12.24|Standard Deviation|7.363|7.363|||
4059576|NCT01077284|3881446|B4|Other drug therapy||Use of kidney stone drug||participants|Number|8|8.0||||||
4059577|NCT01077284|3881447|B3|Other drug therapy||Use of kidney stone drug||participants|Number|3|3.0||||||
4059578|NCT01077284|3881448|B2|Other drug therapy||Use of kidney stone drug||participants|Number|2|2.0||||||
4059579|NCT01077284|3881449|B1|Other drug therapy||Use of kidney stone drug||participants|Number|3|3.0||||||
4059580|NCT01077284|3881446|B4|Allopurinol||Use of kidney stone drug||participants|Number|3|3.0||||||
4059581|NCT01077284|3881447|B3|Allopurinol||Use of kidney stone drug||participants|Number|0|0.0||||||
4059582|NCT01077284|3881448|B2|Allopurinol||Use of kidney stone drug||participants|Number|1|1.0||||||
4059583|NCT01077284|3881449|B1|Allopurinol||Use of kidney stone drug||participants|Number|2|2.0||||||
4059584|NCT01077284|3881446|B4|None||Use of kidney stone drug||participants|Number|88|88.0||||||
4059585|NCT01077284|3881447|B3|None||Use of kidney stone drug||participants|Number|30|30.0||||||
4059586|NCT01077284|3881448|B2|None||Use of kidney stone drug||participants|Number|30|30.0||||||
4059587|NCT01077284|3881449|B1|None||Use of kidney stone drug||participants|Number|28|28.0||||||
4059588|NCT01077284|3881446|B4|Stone Procedure||Kidney stone procedures|Participants may have had more than one kidney stone procedure.|participants|Number|55|55.0||||||
4059589|NCT01077284|3881447|B3|Stone Procedure||Kidney stone procedures|Participants may have had more than one kidney stone procedure.|participants|Number|15|15.0||||||
4059590|NCT01077284|3881448|B2|Stone Procedure||Kidney stone procedures|Participants may have had more than one kidney stone procedure.|participants|Number|20|20.0||||||
4059591|NCT01077284|3881449|B1|Stone Procedure||Kidney stone procedures|Participants may have had more than one kidney stone procedure.|participants|Number|20|20.0||||||
4059592|NCT01077284|3881446|B4|Other procedure||Kidney stone procedures|Participants may have had more than one kidney stone procedure.|participants|Number|8|8.0||||||
4059593|NCT01077284|3881447|B3|Other procedure||Kidney stone procedures|Participants may have had more than one kidney stone procedure.|participants|Number|2|2.0||||||
4059594|NCT01077284|3881448|B2|Other procedure||Kidney stone procedures|Participants may have had more than one kidney stone procedure.|participants|Number|4|4.0||||||
4059595|NCT01077284|3881449|B1|Other procedure||Kidney stone procedures|Participants may have had more than one kidney stone procedure.|participants|Number|2|2.0||||||
4059596|NCT01077284|3881446|B4|Open surgery||Kidney stone procedures|Participants may have had more than one kidney stone procedure.|participants|Number|6|6.0||||||
4059597|NCT01077284|3881447|B3|Open surgery||Kidney stone procedures|Participants may have had more than one kidney stone procedure.|participants|Number|2|2.0||||||
4059598|NCT01077284|3881448|B2|Open surgery||Kidney stone procedures|Participants may have had more than one kidney stone procedure.|participants|Number|2|2.0||||||
4059599|NCT01077284|3881449|B1|Open surgery||Kidney stone procedures|Participants may have had more than one kidney stone procedure.|participants|Number|2|2.0||||||
4059600|NCT01077284|3881446|B4|Nephrolithotomy/Nephrolithotripsy||Kidney stone procedures|Participants may have had more than one kidney stone procedure.|participants|Number|5|5.0||||||
4059601|NCT01077284|3881447|B3|Nephrolithotomy/Nephrolithotripsy||Kidney stone procedures|Participants may have had more than one kidney stone procedure.|participants|Number|0|0.0||||||
4059602|NCT01077284|3881448|B2|Nephrolithotomy/Nephrolithotripsy||Kidney stone procedures|Participants may have had more than one kidney stone procedure.|participants|Number|2|2.0||||||
4059603|NCT01077284|3881449|B1|Nephrolithotomy/Nephrolithotripsy||Kidney stone procedures|Participants may have had more than one kidney stone procedure.|participants|Number|3|3.0||||||
4059604|NCT01077284|3881446|B4|Ureteroscopy||Kidney stone procedures|Participants may have had more than one kidney stone procedure.|participants|Number|24|24.0||||||
4059605|NCT01077284|3881447|B3|Ureteroscopy||Kidney stone procedures|Participants may have had more than one kidney stone procedure.|participants|Number|9|9.0||||||
4059606|NCT01077284|3881448|B2|Ureteroscopy||Kidney stone procedures|Participants may have had more than one kidney stone procedure.|participants|Number|6|6.0||||||
4059607|NCT01077284|3881449|B1|Ureteroscopy||Kidney stone procedures|Participants may have had more than one kidney stone procedure.|participants|Number|9|9.0||||||
4059608|NCT01077284|3881446|B4|Shock Wave Lithotripsy||Kidney stone procedures|Participants may have had more than one kidney stone procedure.|participants|Number|51|51.0||||||
4059609|NCT01077284|3881447|B3|Shock Wave Lithotripsy||Kidney stone procedures|Participants may have had more than one kidney stone procedure.|participants|Number|14|14.0||||||
4059610|NCT01077284|3881448|B2|Shock Wave Lithotripsy||Kidney stone procedures|Participants may have had more than one kidney stone procedure.|participants|Number|20|20.0||||||
4059611|NCT01077284|3881449|B1|Shock Wave Lithotripsy||Kidney stone procedures|Participants may have had more than one kidney stone procedure.|participants|Number|17|17.0||||||
4059612|NCT01077284|3881446|B4|None||Kidney stone procedures|Participants may have had more than one kidney stone procedure.|participants|Number|44|44.0||||||
4059613|NCT01077284|3881447|B3|None||Kidney stone procedures|Participants may have had more than one kidney stone procedure.|participants|Number|18|18.0||||||
4059614|NCT01077284|3881448|B2|None||Kidney stone procedures|Participants may have had more than one kidney stone procedure.|participants|Number|13|13.0||||||
4059615|NCT01077284|3881449|B1|None||Kidney stone procedures|Participants may have had more than one kidney stone procedure.|participants|Number|13|13.0||||||
4059616|NCT01077284|3881446|B4|Unknown||Composition of most recent passed stone|Includes participants with a kidney stone passage: 27, 33 and 29 participants for each treatment group, respectively.|participants|Number|52|52.0||||||
4059617|NCT01077284|3881447|B3|Unknown||Composition of most recent passed stone|Includes participants with a kidney stone passage: 27, 33 and 29 participants for each treatment group, respectively.|participants|Number|15|15.0||||||
4059618|NCT01077284|3881448|B2|Unknown||Composition of most recent passed stone|Includes participants with a kidney stone passage: 27, 33 and 29 participants for each treatment group, respectively.|participants|Number|19|19.0||||||
4059619|NCT01077284|3881449|B1|Unknown||Composition of most recent passed stone|Includes participants with a kidney stone passage: 27, 33 and 29 participants for each treatment group, respectively.|participants|Number|18|18.0||||||
4059620|NCT01077284|3881446|B4|Calcium citrate||Composition of most recent passed stone|Includes participants with a kidney stone passage: 27, 33 and 29 participants for each treatment group, respectively.|participants|Number|1|1.0||||||
4059621|NCT01077284|3881447|B3|Calcium citrate||Composition of most recent passed stone|Includes participants with a kidney stone passage: 27, 33 and 29 participants for each treatment group, respectively.|participants|Number|1|1.0||||||
4059622|NCT01077284|3881448|B2|Calcium citrate||Composition of most recent passed stone|Includes participants with a kidney stone passage: 27, 33 and 29 participants for each treatment group, respectively.|participants|Number|0|0.0||||||
4059623|NCT01077284|3881449|B1|Calcium citrate||Composition of most recent passed stone|Includes participants with a kidney stone passage: 27, 33 and 29 participants for each treatment group, respectively.|participants|Number|0|0.0||||||
4059624|NCT01077284|3881446|B4|Uric acid||Composition of most recent passed stone|Includes participants with a kidney stone passage: 27, 33 and 29 participants for each treatment group, respectively.|participants|Number|1|1.0||||||
4059625|NCT01077284|3881447|B3|Uric acid||Composition of most recent passed stone|Includes participants with a kidney stone passage: 27, 33 and 29 participants for each treatment group, respectively.|participants|Number|0|0.0||||||
4059626|NCT01077284|3881448|B2|Uric acid||Composition of most recent passed stone|Includes participants with a kidney stone passage: 27, 33 and 29 participants for each treatment group, respectively.|participants|Number|0|0.0||||||
4059627|NCT01077284|3881449|B1|Uric acid||Composition of most recent passed stone|Includes participants with a kidney stone passage: 27, 33 and 29 participants for each treatment group, respectively.|participants|Number|1|1.0||||||
4059628|NCT01077284|3881446|B4|Calcium Oxalate||Composition of most recent passed stone|Includes participants with a kidney stone passage: 27, 33 and 29 participants for each treatment group, respectively.|participants|Number|35|35.0||||||
4059629|NCT01077284|3881447|B3|Calcium Oxalate||Composition of most recent passed stone|Includes participants with a kidney stone passage: 27, 33 and 29 participants for each treatment group, respectively.|participants|Number|13|13.0||||||
4059630|NCT01077284|3881448|B2|Calcium Oxalate||Composition of most recent passed stone|Includes participants with a kidney stone passage: 27, 33 and 29 participants for each treatment group, respectively.|participants|Number|14|14.0||||||
4059631|NCT01077284|3881449|B1|Calcium Oxalate||Composition of most recent passed stone|Includes participants with a kidney stone passage: 27, 33 and 29 participants for each treatment group, respectively.|participants|Number|8|8.0||||||
4059632|NCT01077284|3881446|B4|Yes||Kidney stone passage||participants|Number|89|89.0||||||
4059633|NCT01077284|3881447|B3|Yes||Kidney stone passage||participants|Number|29|29.0||||||
4059634|NCT01077284|3881448|B2|Yes||Kidney stone passage||participants|Number|33|33.0||||||
4059635|NCT01077284|3881449|B1|Yes||Kidney stone passage||participants|Number|27|27.0||||||
4059636|NCT01077284|3881446|B4|No||Kidney stone passage||participants|Number|10|10.0||||||
4059637|NCT01077284|3881447|B3|No||Kidney stone passage||participants|Number|4|4.0||||||
4059638|NCT01077284|3881448|B2|No||Kidney stone passage||participants|Number|0|0.0||||||
4059639|NCT01077284|3881449|B1|No||Kidney stone passage||participants|Number|6|6.0||||||
4059640|NCT01077284|3881446|B4|||Lifetime kidney stone episodes||kidney stone episodes|Mean|10.9|10.9|Standard Deviation|15.38|15.38|||
4059641|NCT01077284|3881447|B3|||Lifetime kidney stone episodes||kidney stone episodes|Mean|11.3|11.3|Standard Deviation|14.97|14.97|||
4059642|NCT01077284|3881448|B2|||Lifetime kidney stone episodes||kidney stone episodes|Mean|12.5|12.5|Standard Deviation|19.72|19.72|||
4059643|NCT01077284|3881449|B1|||Lifetime kidney stone episodes||kidney stone episodes|Mean|8.8|8.8|Standard Deviation|10.18|10.18|||
4059644|NCT01077284|3881446|B4|||24-hour urinary calcium||mg/24 hours|Mean|272.2|272.2|Standard Deviation|90.00|90.0|||
4059645|NCT01077284|3881447|B3|||24-hour urinary calcium||mg/24 hours|Mean|278.7|278.7|Standard Deviation|99.62|99.62|||
4059646|NCT01077284|3881448|B2|||24-hour urinary calcium||mg/24 hours|Mean|297.9|297.9|Standard Deviation|77.60|77.6|||
4059647|NCT01077284|3881449|B1|||24-hour urinary calcium||mg/24 hours|Mean|240.1|240.1|Standard Deviation|84.08|84.08|||
4059648|NCT01077284|3881446|B4|>987 mg/24 hours (T2)||24-hour urine uric acid categories|Categories are based on tertiles, T1: 33.3rd percentile and T2: 66.6th percentile.|participants|Number|34|34.0||||||
4059649|NCT01077284|3881447|B3|>987 mg/24 hours (T2)||24-hour urine uric acid categories|Categories are based on tertiles, T1: 33.3rd percentile and T2: 66.6th percentile.|participants|Number|8|8.0||||||
4059650|NCT01077284|3881448|B2|>987 mg/24 hours (T2)||24-hour urine uric acid categories|Categories are based on tertiles, T1: 33.3rd percentile and T2: 66.6th percentile.|participants|Number|11|11.0||||||
4059651|NCT01077284|3881449|B1|>987 mg/24 hours (T2)||24-hour urine uric acid categories|Categories are based on tertiles, T1: 33.3rd percentile and T2: 66.6th percentile.|participants|Number|15|15.0||||||
4059652|NCT01077284|3881446|B4|>820 to ≤987 mg/24 hours||24-hour urine uric acid categories|Categories are based on tertiles, T1: 33.3rd percentile and T2: 66.6th percentile.|participants|Number|32|32.0||||||
4059653|NCT01077284|3881447|B3|>820 to ≤987 mg/24 hours||24-hour urine uric acid categories|Categories are based on tertiles, T1: 33.3rd percentile and T2: 66.6th percentile.|participants|Number|14|14.0||||||
4059654|NCT01077284|3881448|B2|>820 to ≤987 mg/24 hours||24-hour urine uric acid categories|Categories are based on tertiles, T1: 33.3rd percentile and T2: 66.6th percentile.|participants|Number|9|9.0||||||
4059655|NCT01077284|3881449|B1|>820 to ≤987 mg/24 hours||24-hour urine uric acid categories|Categories are based on tertiles, T1: 33.3rd percentile and T2: 66.6th percentile.|participants|Number|9|9.0||||||
4059656|NCT01077284|3881446|B4|≤820 mg/24 hours (T1)||24-hour urine uric acid categories|Categories are based on tertiles, T1: 33.3rd percentile and T2: 66.6th percentile.|participants|Number|33|33.0||||||
4059657|NCT01077284|3881447|B3|≤820 mg/24 hours (T1)||24-hour urine uric acid categories|Categories are based on tertiles, T1: 33.3rd percentile and T2: 66.6th percentile.|participants|Number|11|11.0||||||
4059658|NCT01077284|3881448|B2|≤820 mg/24 hours (T1)||24-hour urine uric acid categories|Categories are based on tertiles, T1: 33.3rd percentile and T2: 66.6th percentile.|participants|Number|13|13.0||||||
4059659|NCT01077284|3881449|B1|≤820 mg/24 hours (T1)||24-hour urine uric acid categories|Categories are based on tertiles, T1: 33.3rd percentile and T2: 66.6th percentile.|participants|Number|9|9.0||||||
4059660|NCT01077284|3881446|B4|||24-hour urine uric acid||mg/24 hours|Mean|952.7|952.7|Standard Deviation|210.44|210.44|||
4059661|NCT01077284|3881447|B3|||24-hour urine uric acid||mg/24 hours|Mean|909.4|909.4|Standard Deviation|166.43|166.43|||
4059662|NCT01077284|3881448|B2|||24-hour urine uric acid||mg/24 hours|Mean|948.1|948.1|Standard Deviation|231.16|231.16|||
4059663|NCT01077284|3881449|B1|||24-hour urine uric acid||mg/24 hours|Mean|1000.6|1000.6|Standard Deviation|223.99|223.99|||
4059664|NCT01077284|3881446|B4|Normal||Renal history|Moderately impaired = measured creatinine clearance (mCLcr) 30-59 mL/min, mildly impaired = mCLcr 60-89 mL/min, and normal = mCLcr ≥90 mL/min.|participants|Number|96|96.0||||||
4059665|NCT01077284|3881447|B3|Normal||Renal history|Moderately impaired = measured creatinine clearance (mCLcr) 30-59 mL/min, mildly impaired = mCLcr 60-89 mL/min, and normal = mCLcr ≥90 mL/min.|participants|Number|32|32.0||||||
4059666|NCT01077284|3881448|B2|Normal||Renal history|Moderately impaired = measured creatinine clearance (mCLcr) 30-59 mL/min, mildly impaired = mCLcr 60-89 mL/min, and normal = mCLcr ≥90 mL/min.|participants|Number|33|33.0||||||
4059667|NCT01077284|3881449|B1|Normal||Renal history|Moderately impaired = measured creatinine clearance (mCLcr) 30-59 mL/min, mildly impaired = mCLcr 60-89 mL/min, and normal = mCLcr ≥90 mL/min.|participants|Number|31|31.0||||||
4059668|NCT01077284|3881446|B4|Mildly impaired||Renal history|Moderately impaired = measured creatinine clearance (mCLcr) 30-59 mL/min, mildly impaired = mCLcr 60-89 mL/min, and normal = mCLcr ≥90 mL/min.|participants|Number|3|3.0||||||
4059669|NCT01077284|3881447|B3|Mildly impaired||Renal history|Moderately impaired = measured creatinine clearance (mCLcr) 30-59 mL/min, mildly impaired = mCLcr 60-89 mL/min, and normal = mCLcr ≥90 mL/min.|participants|Number|1|1.0||||||
4059670|NCT01077284|3881448|B2|Mildly impaired||Renal history|Moderately impaired = measured creatinine clearance (mCLcr) 30-59 mL/min, mildly impaired = mCLcr 60-89 mL/min, and normal = mCLcr ≥90 mL/min.|participants|Number|0|0.0||||||
4059671|NCT01077284|3881449|B1|Mildly impaired||Renal history|Moderately impaired = measured creatinine clearance (mCLcr) 30-59 mL/min, mildly impaired = mCLcr 60-89 mL/min, and normal = mCLcr ≥90 mL/min.|participants|Number|2|2.0||||||
4059672|NCT01077284|3881446|B4|Moderately impaired||Renal history|Moderately impaired = measured creatinine clearance (mCLcr) 30-59 mL/min, mildly impaired = mCLcr 60-89 mL/min, and normal = mCLcr ≥90 mL/min.|participants|Number|0|0.0||||||
4059673|NCT01077284|3881447|B3|Moderately impaired||Renal history|Moderately impaired = measured creatinine clearance (mCLcr) 30-59 mL/min, mildly impaired = mCLcr 60-89 mL/min, and normal = mCLcr ≥90 mL/min.|participants|Number|0|0.0||||||
4059674|NCT01077284|3881448|B2|Moderately impaired||Renal history|Moderately impaired = measured creatinine clearance (mCLcr) 30-59 mL/min, mildly impaired = mCLcr 60-89 mL/min, and normal = mCLcr ≥90 mL/min.|participants|Number|0|0.0||||||
4059675|NCT01077284|3881449|B1|Moderately impaired||Renal history|Moderately impaired = measured creatinine clearance (mCLcr) 30-59 mL/min, mildly impaired = mCLcr 60-89 mL/min, and normal = mCLcr ≥90 mL/min.|participants|Number|0|0.0||||||
4059676|NCT01077284|3881446|B4|≥10 mg/dL||Baseline Serum Urate categories||participants|Number|2|2.0||||||
4059677|NCT01077284|3881447|B3|≥10 mg/dL||Baseline Serum Urate categories||participants|Number|0|0.0||||||
4059678|NCT01077284|3881448|B2|≥10 mg/dL||Baseline Serum Urate categories||participants|Number|2|2.0||||||
4059679|NCT01077284|3881449|B1|≥10 mg/dL||Baseline Serum Urate categories||participants|Number|0|0.0||||||
4059680|NCT01077284|3881446|B4|9.0 to <10 mg/dL||Baseline Serum Urate categories||participants|Number|3|3.0||||||
4059681|NCT01077284|3881447|B3|9.0 to <10 mg/dL||Baseline Serum Urate categories||participants|Number|1|1.0||||||
4059682|NCT01077284|3881448|B2|9.0 to <10 mg/dL||Baseline Serum Urate categories||participants|Number|0|0.0||||||
4059683|NCT01077284|3881449|B1|9.0 to <10 mg/dL||Baseline Serum Urate categories||participants|Number|2|2.0||||||
4059684|NCT01077284|3881446|B4|<9.0 mg/dL||Baseline Serum Urate categories||participants|Number|94|94.0||||||
4059685|NCT01077284|3881447|B3|<9.0 mg/dL||Baseline Serum Urate categories||participants|Number|32|32.0||||||
4059686|NCT01077284|3881448|B2|<9.0 mg/dL||Baseline Serum Urate categories||participants|Number|31|31.0||||||
4059687|NCT01077284|3881449|B1|<9.0 mg/dL||Baseline Serum Urate categories||participants|Number|31|31.0||||||
4059688|NCT01077284|3881446|B4|||Baseline Serum Urate||mg/dL|Mean|6.3|6.3|Standard Deviation|1.45|1.45|||
4059689|NCT01077284|3881447|B3|||Baseline Serum Urate||mg/dL|Mean|6.3|6.3|Standard Deviation|1.24|1.24|||
4059690|NCT01077284|3881448|B2|||Baseline Serum Urate||mg/dL|Mean|6.3|6.3|Standard Deviation|1.49|1.49|||
4059691|NCT01077284|3881449|B1|||Baseline Serum Urate||mg/dL|Mean|6.2|6.2|Standard Deviation|1.63|1.63|||
4059692|NCT01077284|3881446|B4|≥30 kg/m^2||Body mass index categories||participants|Number|65|65.0||||||
4059693|NCT01077284|3881447|B3|≥30 kg/m^2||Body mass index categories||participants|Number|24|24.0||||||
4059694|NCT01077284|3881448|B2|≥30 kg/m^2||Body mass index categories||participants|Number|18|18.0||||||
4059695|NCT01077284|3881449|B1|≥30 kg/m^2||Body mass index categories||participants|Number|23|23.0||||||
4059696|NCT01077284|3881446|B4|25 to <30 kg/m^2||Body mass index categories||participants|Number|29|29.0||||||
4059697|NCT01077284|3881447|B3|25 to <30 kg/m^2||Body mass index categories||participants|Number|7|7.0||||||
4059698|NCT01077284|3881448|B2|25 to <30 kg/m^2||Body mass index categories||participants|Number|14|14.0||||||
4059699|NCT01077284|3881449|B1|25 to <30 kg/m^2||Body mass index categories||participants|Number|8|8.0||||||
4059700|NCT01077284|3881446|B4|18.5 to <25 kg/m^2||Body mass index categories||participants|Number|5|5.0||||||
4059701|NCT01077284|3881447|B3|18.5 to <25 kg/m^2||Body mass index categories||participants|Number|2|2.0||||||
4059702|NCT01077284|3881448|B2|18.5 to <25 kg/m^2||Body mass index categories||participants|Number|1|1.0||||||
4059703|NCT01077284|3881449|B1|18.5 to <25 kg/m^2||Body mass index categories||participants|Number|2|2.0||||||
4059704|NCT01077284|3881446|B4|||Body mass index (BMI)||kg/m^2|Mean|32.8|32.8|Standard Deviation|5.89|5.89|||
4059705|NCT01077284|3881447|B3|||Body mass index (BMI)||kg/m^2|Mean|33.1|33.1|Standard Deviation|6.29|6.29|||
4059706|NCT01077284|3881448|B2|||Body mass index (BMI)||kg/m^2|Mean|32.3|32.3|Standard Deviation|5.82|5.82|||
4059707|NCT01077284|3881449|B1|||Body mass index (BMI)||kg/m^2|Mean|32.9|32.9|Standard Deviation|5.71|5.71|||
4059708|NCT01077284|3881446|B4|||Weight||kg|Mean|99.9|99.9|Standard Deviation|19.38|19.38|||
4059709|NCT01077284|3881447|B3|||Weight||kg|Mean|100.8|100.8|Standard Deviation|20.23|20.23|||
4059710|NCT01077284|3881448|B2|||Weight||kg|Mean|100.9|100.9|Standard Deviation|20.13|20.13|||
4059711|NCT01077284|3881449|B1|||Weight||kg|Mean|98.0|98.0|Standard Deviation|18.17|18.17|||
4059712|NCT01077284|3881446|B4|||Height||cm|Mean|174.5|174.5|Standard Deviation|10.14|10.14|||
4059713|NCT01077284|3881447|B3|||Height||cm|Mean|174.3|174.3|Standard Deviation|9.31|9.31|||
4059714|NCT01077284|3881448|B2|||Height||cm|Mean|176.5|176.5|Standard Deviation|7.71|7.71|||
4059715|NCT01077284|3881449|B1|||Height||cm|Mean|172.6|172.6|Standard Deviation|12.67|12.67|||
4059716|NCT01077284|3881446|B4|United States||Region of Enrollment||participants|Number|99|99.0||||||
4059717|NCT01077284|3881447|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
4059718|NCT01077284|3881448|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4059719|NCT01077284|3881449|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4059720|NCT01077284|3881446|B4|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4059721|NCT01077284|3881447|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4059722|NCT01077284|3881448|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4059723|NCT01077284|3881449|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4059724|NCT01077284|3881446|B4|White||Race/Ethnicity, Customized||participants|Number|86|86.0||||||
4059725|NCT01077284|3881447|B3|White||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4059726|NCT01077284|3881448|B2|White||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4059727|NCT01077284|3881449|B1|White||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4059728|NCT01077284|3881446|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4059729|NCT01077284|3881447|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4059730|NCT01077284|3881448|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4059731|NCT01077284|3881449|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4059732|NCT01077284|3881446|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4059733|NCT01077284|3881447|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4059734|NCT01077284|3881448|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4059735|NCT01077284|3881449|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4059736|NCT01077284|3881446|B4|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4059737|NCT01077284|3881447|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4059738|NCT01077284|3881448|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4059739|NCT01077284|3881449|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4059740|NCT01077284|3881446|B4|Non-Hispanic and Latino||Race/Ethnicity, Customized||participants|Number|80|80.0||||||
4059741|NCT01077284|3881447|B3|Non-Hispanic and Latino||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4059742|NCT01077284|3881448|B2|Non-Hispanic and Latino||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4059743|NCT01077284|3881449|B1|Non-Hispanic and Latino||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4059744|NCT01077284|3881446|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4059745|NCT01077284|3881447|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4059746|NCT01077284|3881448|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4059747|NCT01077284|3881449|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4059748|NCT01077284|3881446|B4||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4059749|NCT01077284|3881447|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4059750|NCT01077284|3881448|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4059751|NCT01077284|3881449|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4059752|NCT01077284|3881446|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4059753|NCT01077284|3881447|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4059754|NCT01077284|3881448|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4059755|NCT01077284|3881449|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4059756|NCT01077284|3881446|B4|||Age||years|Mean|47.4|47.4|Standard Deviation|10.39|10.39|||
4059757|NCT01077284|3881447|B3|||Age||years|Mean|46.5|46.5|Standard Deviation|11.54|11.54|||
4059758|NCT01077284|3881448|B2|||Age||years|Mean|46.5|46.5|Standard Deviation|9.95|9.95|||
4059759|NCT01077284|3881449|B1|||Age||years|Mean|49.1|49.1|Standard Deviation|9.69|9.69|||
4059760|NCT01077271|3881468|B5|||Body weight|The body weight of participants at the first study visit.|kilograms|Mean|3.9|3.9|Standard Deviation|1.5|1.5|||
4059761|NCT01077271|3881469|B4|||Body weight|The body weight of participants at the first study visit.|kilograms|Mean|3.5|3.5|Standard Deviation|1.1|1.1|||
4059762|NCT01077271|3881470|B3|||Body weight|The body weight of participants at the first study visit.|kilograms|Mean|4.1|4.1|Standard Deviation|1.6|1.6|||
4059763|NCT01077271|3881471|B2|||Body weight|The body weight of participants at the first study visit.|kilograms|Mean|3.8|3.8|Standard Deviation|1.5|1.5|||
4059764|NCT01077271|3881472|B1|||Body weight|The body weight of participants at the first study visit.|kilograms|Mean|3.9|3.9|Standard Deviation|1.4|1.4|||
4059765|NCT01077271|3881468|B5|35 weeks||Gestational age|The gestational age of participants at birth in week of gestation.|Participants|Number|18|18.0||||||
4059766|NCT01077271|3881469|B4|35 weeks||Gestational age|The gestational age of participants at birth in week of gestation.|Participants|Number|0|0.0||||||
4059767|NCT01077271|3881470|B3|35 weeks||Gestational age|The gestational age of participants at birth in week of gestation.|Participants|Number|4|4.0||||||
4059768|NCT01077271|3881471|B2|35 weeks||Gestational age|The gestational age of participants at birth in week of gestation.|Participants|Number|8|8.0||||||
4059769|NCT01077271|3881472|B1|35 weeks||Gestational age|The gestational age of participants at birth in week of gestation.|Participants|Number|6|6.0||||||
4059770|NCT01077271|3881468|B5|34 weeks||Gestational age|The gestational age of participants at birth in week of gestation.|Participants|Number|42|42.0||||||
4059771|NCT01077271|3881469|B4|34 weeks||Gestational age|The gestational age of participants at birth in week of gestation.|Participants|Number|3|3.0||||||
4059772|NCT01077271|3881470|B3|34 weeks||Gestational age|The gestational age of participants at birth in week of gestation.|Participants|Number|12|12.0||||||
4059773|NCT01077271|3881471|B2|34 weeks||Gestational age|The gestational age of participants at birth in week of gestation.|Participants|Number|18|18.0||||||
4059774|NCT01077271|3881472|B1|34 weeks||Gestational age|The gestational age of participants at birth in week of gestation.|Participants|Number|9|9.0||||||
4059775|NCT01077271|3881468|B5|33 weeks||Gestational age|The gestational age of participants at birth in week of gestation.|Participants|Number|57|57.0||||||
4059776|NCT01077271|3881469|B4|33 weeks||Gestational age|The gestational age of participants at birth in week of gestation.|Participants|Number|1|1.0||||||
4059777|NCT01077271|3881470|B3|33 weeks||Gestational age|The gestational age of participants at birth in week of gestation.|Participants|Number|14|14.0||||||
4059778|NCT01077271|3881471|B2|33 weeks||Gestational age|The gestational age of participants at birth in week of gestation.|Participants|Number|18|18.0||||||
4059779|NCT01077271|3881472|B1|33 weeks||Gestational age|The gestational age of participants at birth in week of gestation.|Participants|Number|24|24.0||||||
4059780|NCT01077271|3881468|B5|31 weeks||Gestational age|The gestational age of participants at birth in week of gestation.|Participants|Number|1|1.0||||||
4059781|NCT01077271|3881469|B4|31 weeks||Gestational age|The gestational age of participants at birth in week of gestation.|Participants|Number|0|0.0||||||
4059782|NCT01077271|3881470|B3|31 weeks||Gestational age|The gestational age of participants at birth in week of gestation.|Participants|Number|1|1.0||||||
4059783|NCT01077271|3881471|B2|31 weeks||Gestational age|The gestational age of participants at birth in week of gestation.|Participants|Number|0|0.0||||||
4059784|NCT01077271|3881472|B1|31 weeks||Gestational age|The gestational age of participants at birth in week of gestation.|Participants|Number|0|0.0||||||
4059785|NCT01077271|3881468|B5|28 weeks||Gestational age|The gestational age of participants at birth in week of gestation.|Participants|Number|1|1.0||||||
4059786|NCT01077271|3881469|B4|28 weeks||Gestational age|The gestational age of participants at birth in week of gestation.|Participants|Number|0|0.0||||||
4059787|NCT01077271|3881470|B3|28 weeks||Gestational age|The gestational age of participants at birth in week of gestation.|Participants|Number|1|1.0||||||
4059788|NCT01077271|3881471|B2|28 weeks||Gestational age|The gestational age of participants at birth in week of gestation.|Participants|Number|0|0.0||||||
4059789|NCT01077271|3881472|B1|28 weeks||Gestational age|The gestational age of participants at birth in week of gestation.|Participants|Number|0|0.0||||||
4059790|NCT01077271|3881468|B5|23 weeks||Gestational age|The gestational age of participants at birth in week of gestation.|Participants|Number|1|1.0||||||
4059791|NCT01077271|3881469|B4|23 weeks||Gestational age|The gestational age of participants at birth in week of gestation.|Participants|Number|0|0.0||||||
4059792|NCT01077271|3881470|B3|23 weeks||Gestational age|The gestational age of participants at birth in week of gestation.|Participants|Number|0|0.0||||||
4059793|NCT01077271|3881471|B2|23 weeks||Gestational age|The gestational age of participants at birth in week of gestation.|Participants|Number|1|1.0||||||
4059794|NCT01077271|3881472|B1|23 weeks||Gestational age|The gestational age of participants at birth in week of gestation.|Participants|Number|0|0.0||||||
4059795|NCT01077271|3881468|B5||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4059796|NCT01077271|3881469|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4059797|NCT01077271|3881470|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4059798|NCT01077271|3881471|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4059799|NCT01077271|3881472|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4059800|NCT01077271|3881468|B5||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4059801|NCT01077271|3881469|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4059802|NCT01077271|3881470|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4059803|NCT01077271|3881471|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4059804|NCT01077271|3881472|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4059805|NCT01077271|3881468|B5|Age not reported||Age, Customized|The chronological age of participants at study entry.|Participants|Number|1|1.0||||||
4059806|NCT01077271|3881469|B4|Age not reported||Age, Customized|The chronological age of participants at study entry.|Participants|Number|0|0.0||||||
4059807|NCT01077271|3881470|B3|Age not reported||Age, Customized|The chronological age of participants at study entry.|Participants|Number|0|0.0||||||
4059808|NCT01077271|3881471|B2|Age not reported||Age, Customized|The chronological age of participants at study entry.|Participants|Number|0|0.0||||||
4059809|NCT01077271|3881472|B1|Age not reported||Age, Customized|The chronological age of participants at study entry.|Participants|Number|1|1.0||||||
4059810|NCT01077271|3881468|B5|10 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|2|2.0||||||
4059811|NCT01077271|3881469|B4|10 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|0|0.0||||||
4059812|NCT01077271|3881470|B3|10 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|0|0.0||||||
4059813|NCT01077271|3881471|B2|10 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|0|0.0||||||
4059814|NCT01077271|3881472|B1|10 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|2|2.0||||||
4059815|NCT01077271|3881468|B5|9 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|1|1.0||||||
4059816|NCT01077271|3881469|B4|9 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|0|0.0||||||
4059817|NCT01077271|3881470|B3|9 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|1|1.0||||||
4059818|NCT01077271|3881471|B2|9 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|0|0.0||||||
4059819|NCT01077271|3881472|B1|9 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|0|0.0||||||
4059820|NCT01077271|3881468|B5|8 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|2|2.0||||||
4059821|NCT01077271|3881469|B4|8 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|0|0.0||||||
4059822|NCT01077271|3881470|B3|8 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|0|0.0||||||
4059823|NCT01077271|3881471|B2|8 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|2|2.0||||||
4059824|NCT01077271|3881472|B1|8 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|0|0.0||||||
4059825|NCT01077271|3881468|B5|7 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|1|1.0||||||
4059826|NCT01077271|3881469|B4|7 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|0|0.0||||||
4059827|NCT01077271|3881470|B3|7 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|1|1.0||||||
4059828|NCT01077271|3881471|B2|7 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|0|0.0||||||
4059829|NCT01077271|3881472|B1|7 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|0|0.0||||||
4059830|NCT01077271|3881468|B5|6 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|5|5.0||||||
4059831|NCT01077271|3881469|B4|6 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|0|0.0||||||
4059832|NCT01077271|3881470|B3|6 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|0|0.0||||||
4059833|NCT01077271|3881471|B2|6 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|4|4.0||||||
4059834|NCT01077271|3881472|B1|6 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|1|1.0||||||
4059835|NCT01077271|3881468|B5|5 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|5|5.0||||||
4059836|NCT01077271|3881469|B4|5 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|0|0.0||||||
4059837|NCT01077271|3881470|B3|5 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|1|1.0||||||
4059838|NCT01077271|3881471|B2|5 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|4|4.0||||||
4059839|NCT01077271|3881472|B1|5 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|0|0.0||||||
4059840|NCT01077271|3881468|B5|4 to 4.5 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|4|4.0||||||
4059841|NCT01077271|3881469|B4|4 to 4.5 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|0|0.0||||||
4059842|NCT01077271|3881470|B3|4 to 4.5 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|2|2.0||||||
4059843|NCT01077271|3881471|B2|4 to 4.5 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|1|1.0||||||
4059844|NCT01077271|3881472|B1|4 to 4.5 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|1|1.0||||||
4059845|NCT01077271|3881468|B5|3 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|14|14.0||||||
4059846|NCT01077271|3881469|B4|3 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|0|0.0||||||
4059847|NCT01077271|3881470|B3|3 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|4|4.0||||||
4059848|NCT01077271|3881471|B2|3 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|6|6.0||||||
4059849|NCT01077271|3881472|B1|3 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|4|4.0||||||
4059850|NCT01077271|3881468|B5|Greater than 1 and less than or equal to 2 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|48|48.0||||||
4059851|NCT01077271|3881469|B4|Greater than 1 and less than or equal to 2 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|3|3.0||||||
4059852|NCT01077271|3881470|B3|Greater than 1 and less than or equal to 2 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|14|14.0||||||
4059853|NCT01077271|3881471|B2|Greater than 1 and less than or equal to 2 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|12|12.0||||||
4059854|NCT01077271|3881472|B1|Greater than 1 and less than or equal to 2 months||Age, Customized|The chronological age of participants at study entry.|Participants|Number|19|19.0||||||
4059855|NCT01077271|3881468|B5|1 month||Age, Customized|The chronological age of participants at study entry.|Participants|Number|32|32.0||||||
4059856|NCT01077271|3881469|B4|1 month||Age, Customized|The chronological age of participants at study entry.|Participants|Number|0|0.0||||||
4059857|NCT01077271|3881470|B3|1 month||Age, Customized|The chronological age of participants at study entry.|Participants|Number|7|7.0||||||
4059858|NCT01077271|3881471|B2|1 month||Age, Customized|The chronological age of participants at study entry.|Participants|Number|15|15.0||||||
4059859|NCT01077271|3881472|B1|1 month||Age, Customized|The chronological age of participants at study entry.|Participants|Number|10|10.0||||||
4059860|NCT01077271|3881468|B5|Less than 1 month||Age, Customized|The chronological age of participants at study entry.|Participants|Number|5|5.0||||||
4059861|NCT01077271|3881469|B4|Less than 1 month||Age, Customized|The chronological age of participants at study entry.|Participants|Number|1|1.0||||||
4059862|NCT01077271|3881470|B3|Less than 1 month||Age, Customized|The chronological age of participants at study entry.|Participants|Number|2|2.0||||||
4059863|NCT01077271|3881471|B2|Less than 1 month||Age, Customized|The chronological age of participants at study entry.|Participants|Number|1|1.0||||||
4059864|NCT01077271|3881472|B1|Less than 1 month||Age, Customized|The chronological age of participants at study entry.|Participants|Number|1|1.0||||||
4059865|NCT01077258|3881510|B1|Germany||Region of Enrollment||participants|Number|4208|4208.0||||||
4059866|NCT01077258|3881510|B1|Male||Gender|Gender data available for 4157 participants|participants|Number|958|958.0||||||
4059867|NCT01077258|3881510|B1|Female||Gender|Gender data available for 4157 participants|participants|Number|3199|3199.0||||||
4059868|NCT01077258|3881510|B1|||Age|Age data was available for 4147 participants|years|Mean|54.6|54.6|Standard Deviation|13.2|13.2|||
4059869|NCT01077193|3881546|B1|Czech Republic||Region of Enrollment||participants|Number|15|15.0||||||
4059870|NCT01077193|3881546|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4059871|NCT01077193|3881546|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4059872|NCT01077193|3881546|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4059873|NCT01077193|3881546|B1|||Age||years|Mean|43.4|43.4|Standard Deviation|10.43|10.43|||
4059874|NCT01077193|3881546|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4059875|NCT01077193|3881546|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4059876|NCT01077193|3881546|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4059877|NCT01077154|3881550|B3||Not Evaluable/Missing|Breast Cancer Histopathologic Grade|Tumor grade was determined according to the Nottingham Combined Histological Grading System, based on morphological features (tubule formation, nuclear pleomorphism, and mitotic count), by assigning a value of 1 (favorable) to 3 (unfavorable) for each feature. Scores for the 3 categories were added to give a combined histopathologic grade score: Grade (G)1 (low grade; favorable) = total score of 3, 4, or 5; G2 (intermediate) = total score of 6 or 7; G3 (high; unfavorable) = total score of 8 or 9.|Participants|Count of Participants|140|140.0||||||
4059878|NCT01077154|3881551|B2||Not Evaluable/Missing|Breast Cancer Histopathologic Grade|Tumor grade was determined according to the Nottingham Combined Histological Grading System, based on morphological features (tubule formation, nuclear pleomorphism, and mitotic count), by assigning a value of 1 (favorable) to 3 (unfavorable) for each feature. Scores for the 3 categories were added to give a combined histopathologic grade score: Grade (G)1 (low grade; favorable) = total score of 3, 4, or 5; G2 (intermediate) = total score of 6 or 7; G3 (high; unfavorable) = total score of 8 or 9.|Participants|Count of Participants|62|62.0||||||
4059879|NCT01077154|3881552|B1||Not Evaluable/Missing|Breast Cancer Histopathologic Grade|Tumor grade was determined according to the Nottingham Combined Histological Grading System, based on morphological features (tubule formation, nuclear pleomorphism, and mitotic count), by assigning a value of 1 (favorable) to 3 (unfavorable) for each feature. Scores for the 3 categories were added to give a combined histopathologic grade score: Grade (G)1 (low grade; favorable) = total score of 3, 4, or 5; G2 (intermediate) = total score of 6 or 7; G3 (high; unfavorable) = total score of 8 or 9.|Participants|Count of Participants|78|78.0||||||
4059880|NCT01077154|3881550|B3||Grade 3 = High|Breast Cancer Histopathologic Grade|Tumor grade was determined according to the Nottingham Combined Histological Grading System, based on morphological features (tubule formation, nuclear pleomorphism, and mitotic count), by assigning a value of 1 (favorable) to 3 (unfavorable) for each feature. Scores for the 3 categories were added to give a combined histopathologic grade score: Grade (G)1 (low grade; favorable) = total score of 3, 4, or 5; G2 (intermediate) = total score of 6 or 7; G3 (high; unfavorable) = total score of 8 or 9.|Participants|Count of Participants|1844|1844.0||||||
4059934|NCT01077154|3881550|B3||HER-2 positive|Human Epidermal Growth Factor Receptor 2 (HER-2) Status (Strata per Randomization)||Participants|Count of Participants|982|982.0||||||
4059881|NCT01077154|3881551|B2||Grade 3 = High|Breast Cancer Histopathologic Grade|Tumor grade was determined according to the Nottingham Combined Histological Grading System, based on morphological features (tubule formation, nuclear pleomorphism, and mitotic count), by assigning a value of 1 (favorable) to 3 (unfavorable) for each feature. Scores for the 3 categories were added to give a combined histopathologic grade score: Grade (G)1 (low grade; favorable) = total score of 3, 4, or 5; G2 (intermediate) = total score of 6 or 7; G3 (high; unfavorable) = total score of 8 or 9.|Participants|Count of Participants|906|906.0||||||
4059882|NCT01077154|3881552|B1||Grade 3 = High|Breast Cancer Histopathologic Grade|Tumor grade was determined according to the Nottingham Combined Histological Grading System, based on morphological features (tubule formation, nuclear pleomorphism, and mitotic count), by assigning a value of 1 (favorable) to 3 (unfavorable) for each feature. Scores for the 3 categories were added to give a combined histopathologic grade score: Grade (G)1 (low grade; favorable) = total score of 3, 4, or 5; G2 (intermediate) = total score of 6 or 7; G3 (high; unfavorable) = total score of 8 or 9.|Participants|Count of Participants|938|938.0||||||
4059883|NCT01077154|3881550|B3||Grade 2 = Intermediate|Breast Cancer Histopathologic Grade|Tumor grade was determined according to the Nottingham Combined Histological Grading System, based on morphological features (tubule formation, nuclear pleomorphism, and mitotic count), by assigning a value of 1 (favorable) to 3 (unfavorable) for each feature. Scores for the 3 categories were added to give a combined histopathologic grade score: Grade (G)1 (low grade; favorable) = total score of 3, 4, or 5; G2 (intermediate) = total score of 6 or 7; G3 (high; unfavorable) = total score of 8 or 9.|Participants|Count of Participants|2094|2094.0||||||
4059884|NCT01077154|3881551|B2||Grade 2 = Intermediate|Breast Cancer Histopathologic Grade|Tumor grade was determined according to the Nottingham Combined Histological Grading System, based on morphological features (tubule formation, nuclear pleomorphism, and mitotic count), by assigning a value of 1 (favorable) to 3 (unfavorable) for each feature. Scores for the 3 categories were added to give a combined histopathologic grade score: Grade (G)1 (low grade; favorable) = total score of 3, 4, or 5; G2 (intermediate) = total score of 6 or 7; G3 (high; unfavorable) = total score of 8 or 9.|Participants|Count of Participants|1079|1079.0||||||
4059885|NCT01077154|3881552|B1||Grade 2 = Intermediate|Breast Cancer Histopathologic Grade|Tumor grade was determined according to the Nottingham Combined Histological Grading System, based on morphological features (tubule formation, nuclear pleomorphism, and mitotic count), by assigning a value of 1 (favorable) to 3 (unfavorable) for each feature. Scores for the 3 categories were added to give a combined histopathologic grade score: Grade (G)1 (low grade; favorable) = total score of 3, 4, or 5; G2 (intermediate) = total score of 6 or 7; G3 (high; unfavorable) = total score of 8 or 9.|Participants|Count of Participants|1015|1015.0||||||
4059886|NCT01077154|3881550|B3||Grade 1 = Low|Breast Cancer Histopathologic Grade|Tumor grade was determined according to the Nottingham Combined Histological Grading System, based on morphological features (tubule formation, nuclear pleomorphism, and mitotic count), by assigning a value of 1 (favorable) to 3 (unfavorable) for each feature. Scores for the 3 categories were added to give a combined histopathologic grade score: Grade (G)1 (low grade; favorable) = total score of 3, 4, or 5; G2 (intermediate) = total score of 6 or 7; G3 (high; unfavorable) = total score of 8 or 9.|Participants|Count of Participants|431|431.0||||||
4059887|NCT01077154|3881551|B2||Grade 1 = Low|Breast Cancer Histopathologic Grade|Tumor grade was determined according to the Nottingham Combined Histological Grading System, based on morphological features (tubule formation, nuclear pleomorphism, and mitotic count), by assigning a value of 1 (favorable) to 3 (unfavorable) for each feature. Scores for the 3 categories were added to give a combined histopathologic grade score: Grade (G)1 (low grade; favorable) = total score of 3, 4, or 5; G2 (intermediate) = total score of 6 or 7; G3 (high; unfavorable) = total score of 8 or 9.|Participants|Count of Participants|209|209.0||||||
4059888|NCT01077154|3881552|B1||Grade 1 = Low|Breast Cancer Histopathologic Grade|Tumor grade was determined according to the Nottingham Combined Histological Grading System, based on morphological features (tubule formation, nuclear pleomorphism, and mitotic count), by assigning a value of 1 (favorable) to 3 (unfavorable) for each feature. Scores for the 3 categories were added to give a combined histopathologic grade score: Grade (G)1 (low grade; favorable) = total score of 3, 4, or 5; G2 (intermediate) = total score of 6 or 7; G3 (high; unfavorable) = total score of 8 or 9.|Participants|Count of Participants|222|222.0||||||
4059889|NCT01077154|3881550|B3||Nx|Lymph Node Status|Clinical and pathologic regional lymph node (LN) status (by American Joint Committee on Cancer (AJCC)): N0 = no LN metastasis or pathologic (p) micrometastases <2.0 mm; N1 = Ipsilateral level I, II axillary (Ax) LN or p micrometastases >2.0mm or in internal mammary (IM) LN; N2 = fixed ipsilateral level I, II Ax LNs or clinically detected IM LNs only or pLN metastases in 4-9 Ax LNs; N3 = ipsilateral level III infraclavicular (IC) LNs or clinically detected IM LNs with other level I/II Ax LNs or supraclavicular (SC) LNs or pLN metastases in ≥10 Ax LNs; NX =LNs cannot be assessed.|Participants|Count of Participants|33|33.0||||||
4059890|NCT01077154|3881551|B2||Nx|Lymph Node Status|Clinical and pathologic regional lymph node (LN) status (by American Joint Committee on Cancer (AJCC)): N0 = no LN metastasis or pathologic (p) micrometastases <2.0 mm; N1 = Ipsilateral level I, II axillary (Ax) LN or p micrometastases >2.0mm or in internal mammary (IM) LN; N2 = fixed ipsilateral level I, II Ax LNs or clinically detected IM LNs only or pLN metastases in 4-9 Ax LNs; N3 = ipsilateral level III infraclavicular (IC) LNs or clinically detected IM LNs with other level I/II Ax LNs or supraclavicular (SC) LNs or pLN metastases in ≥10 Ax LNs; NX =LNs cannot be assessed.|Participants|Count of Participants|15|15.0||||||
4059891|NCT01077154|3881552|B1||Nx|Lymph Node Status|Clinical and pathologic regional lymph node (LN) status (by American Joint Committee on Cancer (AJCC)): N0 = no LN metastasis or pathologic (p) micrometastases <2.0 mm; N1 = Ipsilateral level I, II axillary (Ax) LN or p micrometastases >2.0mm or in internal mammary (IM) LN; N2 = fixed ipsilateral level I, II Ax LNs or clinically detected IM LNs only or pLN metastases in 4-9 Ax LNs; N3 = ipsilateral level III infraclavicular (IC) LNs or clinically detected IM LNs with other level I/II Ax LNs or supraclavicular (SC) LNs or pLN metastases in ≥10 Ax LNs; NX =LNs cannot be assessed.|Participants|Count of Participants|18|18.0||||||
4059935|NCT01077154|3881551|B2||HER-2 positive|Human Epidermal Growth Factor Receptor 2 (HER-2) Status (Strata per Randomization)||Participants|Count of Participants|492|492.0||||||
4059936|NCT01077154|3881552|B1||HER-2 positive|Human Epidermal Growth Factor Receptor 2 (HER-2) Status (Strata per Randomization)||Participants|Count of Participants|490|490.0||||||
4059978|NCT01077154|3881552|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4059892|NCT01077154|3881550|B3||N3|Lymph Node Status|Clinical and pathologic regional lymph node (LN) status (by American Joint Committee on Cancer (AJCC)): N0 = no LN metastasis or pathologic (p) micrometastases <2.0 mm; N1 = Ipsilateral level I, II axillary (Ax) LN or p micrometastases >2.0mm or in internal mammary (IM) LN; N2 = fixed ipsilateral level I, II Ax LNs or clinically detected IM LNs only or pLN metastases in 4-9 Ax LNs; N3 = ipsilateral level III infraclavicular (IC) LNs or clinically detected IM LNs with other level I/II Ax LNs or supraclavicular (SC) LNs or pLN metastases in ≥10 Ax LNs; NX =LNs cannot be assessed.|Participants|Count of Participants|454|454.0||||||
4059893|NCT01077154|3881551|B2||N3|Lymph Node Status|Clinical and pathologic regional lymph node (LN) status (by American Joint Committee on Cancer (AJCC)): N0 = no LN metastasis or pathologic (p) micrometastases <2.0 mm; N1 = Ipsilateral level I, II axillary (Ax) LN or p micrometastases >2.0mm or in internal mammary (IM) LN; N2 = fixed ipsilateral level I, II Ax LNs or clinically detected IM LNs only or pLN metastases in 4-9 Ax LNs; N3 = ipsilateral level III infraclavicular (IC) LNs or clinically detected IM LNs with other level I/II Ax LNs or supraclavicular (SC) LNs or pLN metastases in ≥10 Ax LNs; NX =LNs cannot be assessed.|Participants|Count of Participants|224|224.0||||||
4059894|NCT01077154|3881552|B1||N3|Lymph Node Status|Clinical and pathologic regional lymph node (LN) status (by American Joint Committee on Cancer (AJCC)): N0 = no LN metastasis or pathologic (p) micrometastases <2.0 mm; N1 = Ipsilateral level I, II axillary (Ax) LN or p micrometastases >2.0mm or in internal mammary (IM) LN; N2 = fixed ipsilateral level I, II Ax LNs or clinically detected IM LNs only or pLN metastases in 4-9 Ax LNs; N3 = ipsilateral level III infraclavicular (IC) LNs or clinically detected IM LNs with other level I/II Ax LNs or supraclavicular (SC) LNs or pLN metastases in ≥10 Ax LNs; NX =LNs cannot be assessed.|Participants|Count of Participants|230|230.0||||||
4059895|NCT01077154|3881550|B3||N2|Lymph Node Status|Clinical and pathologic regional lymph node (LN) status (by American Joint Committee on Cancer (AJCC)): N0 = no LN metastasis or pathologic (p) micrometastases <2.0 mm; N1 = Ipsilateral level I, II axillary (Ax) LN or p micrometastases >2.0mm or in internal mammary (IM) LN; N2 = fixed ipsilateral level I, II Ax LNs or clinically detected IM LNs only or pLN metastases in 4-9 Ax LNs; N3 = ipsilateral level III infraclavicular (IC) LNs or clinically detected IM LNs with other level I/II Ax LNs or supraclavicular (SC) LNs or pLN metastases in ≥10 Ax LNs; NX =LNs cannot be assessed.|Participants|Count of Participants|1011|1011.0||||||
4059896|NCT01077154|3881551|B2||N2|Lymph Node Status|Clinical and pathologic regional lymph node (LN) status (by American Joint Committee on Cancer (AJCC)): N0 = no LN metastasis or pathologic (p) micrometastases <2.0 mm; N1 = Ipsilateral level I, II axillary (Ax) LN or p micrometastases >2.0mm or in internal mammary (IM) LN; N2 = fixed ipsilateral level I, II Ax LNs or clinically detected IM LNs only or pLN metastases in 4-9 Ax LNs; N3 = ipsilateral level III infraclavicular (IC) LNs or clinically detected IM LNs with other level I/II Ax LNs or supraclavicular (SC) LNs or pLN metastases in ≥10 Ax LNs; NX =LNs cannot be assessed.|Participants|Count of Participants|505|505.0||||||
4059897|NCT01077154|3881552|B1||N2|Lymph Node Status|Clinical and pathologic regional lymph node (LN) status (by American Joint Committee on Cancer (AJCC)): N0 = no LN metastasis or pathologic (p) micrometastases <2.0 mm; N1 = Ipsilateral level I, II axillary (Ax) LN or p micrometastases >2.0mm or in internal mammary (IM) LN; N2 = fixed ipsilateral level I, II Ax LNs or clinically detected IM LNs only or pLN metastases in 4-9 Ax LNs; N3 = ipsilateral level III infraclavicular (IC) LNs or clinically detected IM LNs with other level I/II Ax LNs or supraclavicular (SC) LNs or pLN metastases in ≥10 Ax LNs; NX =LNs cannot be assessed.|Participants|Count of Participants|506|506.0||||||
4059898|NCT01077154|3881550|B3||N1|Lymph Node Status|Clinical and pathologic regional lymph node (LN) status (by American Joint Committee on Cancer (AJCC)): N0 = no LN metastasis or pathologic (p) micrometastases <2.0 mm; N1 = Ipsilateral level I, II axillary (Ax) LN or p micrometastases >2.0mm or in internal mammary (IM) LN; N2 = fixed ipsilateral level I, II Ax LNs or clinically detected IM LNs only or pLN metastases in 4-9 Ax LNs; N3 = ipsilateral level III infraclavicular (IC) LNs or clinically detected IM LNs with other level I/II Ax LNs or supraclavicular (SC) LNs or pLN metastases in ≥10 Ax LNs; NX =LNs cannot be assessed.|Participants|Count of Participants|2750|2750.0||||||
4059899|NCT01077154|3881551|B2||N1|Lymph Node Status|Clinical and pathologic regional lymph node (LN) status (by American Joint Committee on Cancer (AJCC)): N0 = no LN metastasis or pathologic (p) micrometastases <2.0 mm; N1 = Ipsilateral level I, II axillary (Ax) LN or p micrometastases >2.0mm or in internal mammary (IM) LN; N2 = fixed ipsilateral level I, II Ax LNs or clinically detected IM LNs only or pLN metastases in 4-9 Ax LNs; N3 = ipsilateral level III infraclavicular (IC) LNs or clinically detected IM LNs with other level I/II Ax LNs or supraclavicular (SC) LNs or pLN metastases in ≥10 Ax LNs; NX =LNs cannot be assessed.|Participants|Count of Participants|1381|1381.0||||||
4059900|NCT01077154|3881552|B1||N1|Lymph Node Status|Clinical and pathologic regional lymph node (LN) status (by American Joint Committee on Cancer (AJCC)): N0 = no LN metastasis or pathologic (p) micrometastases <2.0 mm; N1 = Ipsilateral level I, II axillary (Ax) LN or p micrometastases >2.0mm or in internal mammary (IM) LN; N2 = fixed ipsilateral level I, II Ax LNs or clinically detected IM LNs only or pLN metastases in 4-9 Ax LNs; N3 = ipsilateral level III infraclavicular (IC) LNs or clinically detected IM LNs with other level I/II Ax LNs or supraclavicular (SC) LNs or pLN metastases in ≥10 Ax LNs; NX =LNs cannot be assessed.|Participants|Count of Participants|1369|1369.0||||||
4059901|NCT01077154|3881550|B3||N0|Lymph Node Status|Clinical and pathologic regional lymph node (LN) status (by American Joint Committee on Cancer (AJCC)): N0 = no LN metastasis or pathologic (p) micrometastases <2.0 mm; N1 = Ipsilateral level I, II axillary (Ax) LN or p micrometastases >2.0mm or in internal mammary (IM) LN; N2 = fixed ipsilateral level I, II Ax LNs or clinically detected IM LNs only or pLN metastases in 4-9 Ax LNs; N3 = ipsilateral level III infraclavicular (IC) LNs or clinically detected IM LNs with other level I/II Ax LNs or supraclavicular (SC) LNs or pLN metastases in ≥10 Ax LNs; NX =LNs cannot be assessed.|Participants|Count of Participants|261|261.0||||||
4059902|NCT01077154|3881551|B2||N0|Lymph Node Status|Clinical and pathologic regional lymph node (LN) status (by American Joint Committee on Cancer (AJCC)): N0 = no LN metastasis or pathologic (p) micrometastases <2.0 mm; N1 = Ipsilateral level I, II axillary (Ax) LN or p micrometastases >2.0mm or in internal mammary (IM) LN; N2 = fixed ipsilateral level I, II Ax LNs or clinically detected IM LNs only or pLN metastases in 4-9 Ax LNs; N3 = ipsilateral level III infraclavicular (IC) LNs or clinically detected IM LNs with other level I/II Ax LNs or supraclavicular (SC) LNs or pLN metastases in ≥10 Ax LNs; NX =LNs cannot be assessed.|Participants|Count of Participants|131|131.0||||||
4059976|NCT01077154|3881550|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4059903|NCT01077154|3881552|B1||N0|Lymph Node Status|Clinical and pathologic regional lymph node (LN) status (by American Joint Committee on Cancer (AJCC)): N0 = no LN metastasis or pathologic (p) micrometastases <2.0 mm; N1 = Ipsilateral level I, II axillary (Ax) LN or p micrometastases >2.0mm or in internal mammary (IM) LN; N2 = fixed ipsilateral level I, II Ax LNs or clinically detected IM LNs only or pLN metastases in 4-9 Ax LNs; N3 = ipsilateral level III infraclavicular (IC) LNs or clinically detected IM LNs with other level I/II Ax LNs or supraclavicular (SC) LNs or pLN metastases in ≥10 Ax LNs; NX =LNs cannot be assessed.|Participants|Count of Participants|130|130.0||||||
4059904|NCT01077154|3881550|B3||Missing|Molecular Subtypes of Breast Cancer|Hormone receptor (HR; estrogen receptor [ER] / progesterone receptor [PR]); HR positive = ER and/or PR positive; HR negative = ER and PR negative|Participants|Count of Participants|2|2.0||||||
4059905|NCT01077154|3881551|B2||Missing|Molecular Subtypes of Breast Cancer|Hormone receptor (HR; estrogen receptor [ER] / progesterone receptor [PR]); HR positive = ER and/or PR positive; HR negative = ER and PR negative|Participants|Count of Participants|1|1.0||||||
4059906|NCT01077154|3881552|B1||Missing|Molecular Subtypes of Breast Cancer|Hormone receptor (HR; estrogen receptor [ER] / progesterone receptor [PR]); HR positive = ER and/or PR positive; HR negative = ER and PR negative|Participants|Count of Participants|1|1.0||||||
4059907|NCT01077154|3881550|B3||HR negative and HER-2 negative|Molecular Subtypes of Breast Cancer|Hormone receptor (HR; estrogen receptor [ER] / progesterone receptor [PR]); HR positive = ER and/or PR positive; HR negative = ER and PR negative|Participants|Count of Participants|684|684.0||||||
4059908|NCT01077154|3881551|B2||HR negative and HER-2 negative|Molecular Subtypes of Breast Cancer|Hormone receptor (HR; estrogen receptor [ER] / progesterone receptor [PR]); HR positive = ER and/or PR positive; HR negative = ER and PR negative|Participants|Count of Participants|343|343.0||||||
4059909|NCT01077154|3881552|B1||HR negative and HER-2 negative|Molecular Subtypes of Breast Cancer|Hormone receptor (HR; estrogen receptor [ER] / progesterone receptor [PR]); HR positive = ER and/or PR positive; HR negative = ER and PR negative|Participants|Count of Participants|341|341.0||||||
4059910|NCT01077154|3881550|B3||HR negative and HER-2 positive|Molecular Subtypes of Breast Cancer|Hormone receptor (HR; estrogen receptor [ER] / progesterone receptor [PR]); HR positive = ER and/or PR positive; HR negative = ER and PR negative|Participants|Count of Participants|331|331.0||||||
4059911|NCT01077154|3881551|B2||HR negative and HER-2 positive|Molecular Subtypes of Breast Cancer|Hormone receptor (HR; estrogen receptor [ER] / progesterone receptor [PR]); HR positive = ER and/or PR positive; HR negative = ER and PR negative|Participants|Count of Participants|168|168.0||||||
4059912|NCT01077154|3881552|B1||HR negative and HER-2 positive|Molecular Subtypes of Breast Cancer|Hormone receptor (HR; estrogen receptor [ER] / progesterone receptor [PR]); HR positive = ER and/or PR positive; HR negative = ER and PR negative|Participants|Count of Participants|163|163.0||||||
4059913|NCT01077154|3881550|B3||HR positive and HER-2 negative|Molecular Subtypes of Breast Cancer|Hormone receptor (HR; estrogen receptor [ER] / progesterone receptor [PR]); HR positive = ER and/or PR positive; HR negative = ER and PR negative|Participants|Count of Participants|2918|2918.0||||||
4059914|NCT01077154|3881551|B2||HR positive and HER-2 negative|Molecular Subtypes of Breast Cancer|Hormone receptor (HR; estrogen receptor [ER] / progesterone receptor [PR]); HR positive = ER and/or PR positive; HR negative = ER and PR negative|Participants|Count of Participants|1458|1458.0||||||
4059915|NCT01077154|3881552|B1||HR positive and HER-2 negative|Molecular Subtypes of Breast Cancer|Hormone receptor (HR; estrogen receptor [ER] / progesterone receptor [PR]); HR positive = ER and/or PR positive; HR negative = ER and PR negative|Participants|Count of Participants|1460|1460.0||||||
4059916|NCT01077154|3881550|B3||HR positive and HER-2 positive|Molecular Subtypes of Breast Cancer|Hormone receptor (HR; estrogen receptor [ER] / progesterone receptor [PR]); HR positive = ER and/or PR positive; HR negative = ER and PR negative|Participants|Count of Participants|574|574.0||||||
4059917|NCT01077154|3881551|B2||HR positive and HER-2 positive|Molecular Subtypes of Breast Cancer|Hormone receptor (HR; estrogen receptor [ER] / progesterone receptor [PR]); HR positive = ER and/or PR positive; HR negative = ER and PR negative|Participants|Count of Participants|286|286.0||||||
4059918|NCT01077154|3881552|B1||HR positive and HER-2 positive|Molecular Subtypes of Breast Cancer|Hormone receptor (HR; estrogen receptor [ER] / progesterone receptor [PR]); HR positive = ER and/or PR positive; HR negative = ER and PR negative|Participants|Count of Participants|288|288.0||||||
4059919|NCT01077154|3881550|B3||Other|Geographic Region (Strata per Randomization)||Participants|Count of Participants|4247|4247.0||||||
4059920|NCT01077154|3881551|B2||Other|Geographic Region (Strata per Randomization)||Participants|Count of Participants|2125|2125.0||||||
4059921|NCT01077154|3881552|B1||Other|Geographic Region (Strata per Randomization)||Participants|Count of Participants|2122|2122.0||||||
4059922|NCT01077154|3881550|B3||Japan|Geographic Region (Strata per Randomization)||Participants|Count of Participants|262|262.0||||||
4059923|NCT01077154|3881551|B2||Japan|Geographic Region (Strata per Randomization)||Participants|Count of Participants|131|131.0||||||
4059924|NCT01077154|3881552|B1||Japan|Geographic Region (Strata per Randomization)||Participants|Count of Participants|131|131.0||||||
4059925|NCT01077154|3881550|B3||≥ 50 years|Age (Strata per Randomization)||Participants|Count of Participants|2454|2454.0||||||
4059926|NCT01077154|3881551|B2||≥ 50 years|Age (Strata per Randomization)||Participants|Count of Participants|1227|1227.0||||||
4059927|NCT01077154|3881552|B1||≥ 50 years|Age (Strata per Randomization)||Participants|Count of Participants|1227|1227.0||||||
4059928|NCT01077154|3881550|B3||< 50 years|Age (Strata per Randomization)||Participants|Count of Participants|2055|2055.0||||||
4059929|NCT01077154|3881551|B2||< 50 years|Age (Strata per Randomization)||Participants|Count of Participants|1029|1029.0||||||
4059930|NCT01077154|3881552|B1||< 50 years|Age (Strata per Randomization)||Participants|Count of Participants|1026|1026.0||||||
4059931|NCT01077154|3881550|B3||HER-2 negative|Human Epidermal Growth Factor Receptor 2 (HER-2) Status (Strata per Randomization)||Participants|Count of Participants|3527|3527.0||||||
4059932|NCT01077154|3881551|B2||HER-2 negative|Human Epidermal Growth Factor Receptor 2 (HER-2) Status (Strata per Randomization)||Participants|Count of Participants|1764|1764.0||||||
4059933|NCT01077154|3881552|B1||HER-2 negative|Human Epidermal Growth Factor Receptor 2 (HER-2) Status (Strata per Randomization)||Participants|Count of Participants|1763|1763.0||||||
4059937|NCT01077154|3881550|B3||ER and PR negative|Hormone Receptor Status (Strata per Randomization)|"Hormone receptor (estrogen receptor [ER] / progesterone receptor [PR]) status~ER and/or PR positive~ER and PR negative"|Participants|Count of Participants|1022|1022.0||||||
4059938|NCT01077154|3881551|B2||ER and PR negative|Hormone Receptor Status (Strata per Randomization)|"Hormone receptor (estrogen receptor [ER] / progesterone receptor [PR]) status~ER and/or PR positive~ER and PR negative"|Participants|Count of Participants|509|509.0||||||
4059939|NCT01077154|3881552|B1||ER and PR negative|Hormone Receptor Status (Strata per Randomization)|"Hormone receptor (estrogen receptor [ER] / progesterone receptor [PR]) status~ER and/or PR positive~ER and PR negative"|Participants|Count of Participants|513|513.0||||||
4059940|NCT01077154|3881550|B3||ER and/or PR positive|Hormone Receptor Status (Strata per Randomization)|"Hormone receptor (estrogen receptor [ER] / progesterone receptor [PR]) status~ER and/or PR positive~ER and PR negative"|Participants|Count of Participants|3487|3487.0||||||
4059941|NCT01077154|3881551|B2||ER and/or PR positive|Hormone Receptor Status (Strata per Randomization)|"Hormone receptor (estrogen receptor [ER] / progesterone receptor [PR]) status~ER and/or PR positive~ER and PR negative"|Participants|Count of Participants|1747|1747.0||||||
4059942|NCT01077154|3881552|B1||ER and/or PR positive|Hormone Receptor Status (Strata per Randomization)|"Hormone receptor (estrogen receptor [ER] / progesterone receptor [PR]) status~ER and/or PR positive~ER and PR negative"|Participants|Count of Participants|1740|1740.0||||||
4059943|NCT01077154|3881550|B3||Adjuvant therapy / lymph node positive|Breast Cancer Therapy / Lymph Node Status (Strata per Randomization)|"Breast cancer therapy / lymph node (LN) status:~neo-adjuvant therapy / any LN status;~adjuvant therapy / LN negative (based on axillary LN dissection, or based on sentinel node [SN] status);~adjuvant therapy / LN positive"|Participants|Count of Participants|3274|3274.0||||||
4059944|NCT01077154|3881551|B2||Adjuvant therapy / lymph node positive|Breast Cancer Therapy / Lymph Node Status (Strata per Randomization)|"Breast cancer therapy / lymph node (LN) status:~neo-adjuvant therapy / any LN status;~adjuvant therapy / LN negative (based on axillary LN dissection, or based on sentinel node [SN] status);~adjuvant therapy / LN positive"|Participants|Count of Participants|1639|1639.0||||||
4059945|NCT01077154|3881552|B1||Adjuvant therapy / lymph node positive|Breast Cancer Therapy / Lymph Node Status (Strata per Randomization)|"Breast cancer therapy / lymph node (LN) status:~neo-adjuvant therapy / any LN status;~adjuvant therapy / LN negative (based on axillary LN dissection, or based on sentinel node [SN] status);~adjuvant therapy / LN positive"|Participants|Count of Participants|1635|1635.0||||||
4059946|NCT01077154|3881550|B3||Adjuvant therapy / lymph node negative|Breast Cancer Therapy / Lymph Node Status (Strata per Randomization)|"Breast cancer therapy / lymph node (LN) status:~neo-adjuvant therapy / any LN status;~adjuvant therapy / LN negative (based on axillary LN dissection, or based on sentinel node [SN] status);~adjuvant therapy / LN positive"|Participants|Count of Participants|133|133.0||||||
4059947|NCT01077154|3881551|B2||Adjuvant therapy / lymph node negative|Breast Cancer Therapy / Lymph Node Status (Strata per Randomization)|"Breast cancer therapy / lymph node (LN) status:~neo-adjuvant therapy / any LN status;~adjuvant therapy / LN negative (based on axillary LN dissection, or based on sentinel node [SN] status);~adjuvant therapy / LN positive"|Participants|Count of Participants|65|65.0||||||
4059948|NCT01077154|3881552|B1||Adjuvant therapy / lymph node negative|Breast Cancer Therapy / Lymph Node Status (Strata per Randomization)|"Breast cancer therapy / lymph node (LN) status:~neo-adjuvant therapy / any LN status;~adjuvant therapy / LN negative (based on axillary LN dissection, or based on sentinel node [SN] status);~adjuvant therapy / LN positive"|Participants|Count of Participants|68|68.0||||||
4059949|NCT01077154|3881550|B3||Neo-adjuvant therapy / any lymph node status|Breast Cancer Therapy / Lymph Node Status (Strata per Randomization)|"Breast cancer therapy / lymph node (LN) status:~neo-adjuvant therapy / any LN status;~adjuvant therapy / LN negative (based on axillary LN dissection, or based on sentinel node [SN] status);~adjuvant therapy / LN positive"|Participants|Count of Participants|1102|1102.0||||||
4059950|NCT01077154|3881551|B2||Neo-adjuvant therapy / any lymph node status|Breast Cancer Therapy / Lymph Node Status (Strata per Randomization)|"Breast cancer therapy / lymph node (LN) status:~neo-adjuvant therapy / any LN status;~adjuvant therapy / LN negative (based on axillary LN dissection, or based on sentinel node [SN] status);~adjuvant therapy / LN positive"|Participants|Count of Participants|552|552.0||||||
4059951|NCT01077154|3881552|B1||Neo-adjuvant therapy / any lymph node status|Breast Cancer Therapy / Lymph Node Status (Strata per Randomization)|"Breast cancer therapy / lymph node (LN) status:~neo-adjuvant therapy / any LN status;~adjuvant therapy / LN negative (based on axillary LN dissection, or based on sentinel node [SN] status);~adjuvant therapy / LN positive"|Participants|Count of Participants|550|550.0||||||
4059952|NCT01077154|3881550|B3||Missing|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|2|2.0||||||
4059953|NCT01077154|3881551|B2||Missing|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|2|2.0||||||
4059954|NCT01077154|3881552|B1||Missing|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|0|0.0||||||
4059977|NCT01077154|3881551|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4059955|NCT01077154|3881550|B3||2 (Ambulatory, unable to work)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|3|3.0||||||
4059956|NCT01077154|3881551|B2||2 (Ambulatory, unable to work)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|3|3.0||||||
4059957|NCT01077154|3881552|B1||2 (Ambulatory, unable to work)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|0|0.0||||||
4059958|NCT01077154|3881550|B3||1 (Restricted but ambulatory)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|669|669.0||||||
4059959|NCT01077154|3881551|B2||1 (Restricted but ambulatory)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|329|329.0||||||
4059960|NCT01077154|3881552|B1||1 (Restricted but ambulatory)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|340|340.0||||||
4059961|NCT01077154|3881550|B3||0 (Fully active)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|3835|3835.0||||||
4059962|NCT01077154|3881551|B2||0 (Fully active)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|1922|1922.0||||||
4059963|NCT01077154|3881552|B1||0 (Fully active)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|1913|1913.0||||||
4059964|NCT01077154|3881550|B3||Postmenopausal|Menopausal Status||Participants|Count of Participants|2149|2149.0||||||
4059965|NCT01077154|3881551|B2||Postmenopausal|Menopausal Status||Participants|Count of Participants|1061|1061.0||||||
4059966|NCT01077154|3881552|B1||Postmenopausal|Menopausal Status||Participants|Count of Participants|1088|1088.0||||||
4059967|NCT01077154|3881550|B3||Premenopausal|Menopausal Status||Participants|Count of Participants|2360|2360.0||||||
4059968|NCT01077154|3881551|B2||Premenopausal|Menopausal Status||Participants|Count of Participants|1195|1195.0||||||
4059969|NCT01077154|3881552|B1||Premenopausal|Menopausal Status||Participants|Count of Participants|1165|1165.0||||||
4059970|NCT01077154|3881550|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
4059971|NCT01077154|3881551|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
4059972|NCT01077154|3881552|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
4059973|NCT01077154|3881550|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4059974|NCT01077154|3881551|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4059975|NCT01077154|3881552|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4059979|NCT01077154|3881550|B3||Black|Race/Ethnicity, Customized||Participants|Count of Participants|144|144.0||||||
4059980|NCT01077154|3881551|B2||Black|Race/Ethnicity, Customized||Participants|Count of Participants|74|74.0||||||
4059981|NCT01077154|3881552|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|70|70.0||||||
4059982|NCT01077154|3881550|B3||Hispanic/Latino|Race/Ethnicity, Customized||Participants|Count of Participants|247|247.0||||||
4059983|NCT01077154|3881551|B2||Hispanic/Latino|Race/Ethnicity, Customized||Participants|Count of Participants|135|135.0||||||
4059984|NCT01077154|3881552|B1||Hispanic/Latino|Race/Ethnicity, Customized||Participants|Count of Participants|112|112.0||||||
4059985|NCT01077154|3881550|B3||Japanese|Race/Ethnicity, Customized||Participants|Count of Participants|269|269.0||||||
4059986|NCT01077154|3881551|B2||Japanese|Race/Ethnicity, Customized||Participants|Count of Participants|135|135.0||||||
4059987|NCT01077154|3881552|B1||Japanese|Race/Ethnicity, Customized||Participants|Count of Participants|134|134.0||||||
4059988|NCT01077154|3881550|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|435|435.0||||||
4059989|NCT01077154|3881551|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|213|213.0||||||
4059990|NCT01077154|3881552|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|222|222.0||||||
4059991|NCT01077154|3881550|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|3368|3368.0||||||
4059992|NCT01077154|3881551|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|1676|1676.0||||||
4059993|NCT01077154|3881552|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|1692|1692.0||||||
4059994|NCT01077154|3881550|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4059995|NCT01077154|3881551|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4059996|NCT01077154|3881552|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4059997|NCT01077154|3881550|B3||Female|Sex: Female, Male||Participants|Count of Participants|4509|4509.0||||||
4059998|NCT01077154|3881551|B2||Female|Sex: Female, Male||Participants|Count of Participants|2256|2256.0||||||
4059999|NCT01077154|3881552|B1||Female|Sex: Female, Male||Participants|Count of Participants|2253|2253.0||||||
4060000|NCT01077154|3881550|B3||≥ 85 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
4060001|NCT01077154|3881551|B2||≥ 85 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
4060002|NCT01077154|3881552|B1||≥ 85 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
4060003|NCT01077154|3881550|B3||75 - 84 years|Age, Customized||Participants|Count of Participants|69|69.0||||||
4060004|NCT01077154|3881551|B2||75 - 84 years|Age, Customized||Participants|Count of Participants|36|36.0||||||
4060005|NCT01077154|3881552|B1||75 - 84 years|Age, Customized||Participants|Count of Participants|33|33.0||||||
4060006|NCT01077154|3881550|B3||65 - 74 years|Age, Customized||Participants|Count of Participants|519|519.0||||||
4060007|NCT01077154|3881551|B2||65 - 74 years|Age, Customized||Participants|Count of Participants|260|260.0||||||
4060008|NCT01077154|3881552|B1||65 - 74 years|Age, Customized||Participants|Count of Participants|259|259.0||||||
4060009|NCT01077154|3881550|B3||18 - 64 years|Age, Customized||Participants|Count of Participants|3919|3919.0||||||
4060010|NCT01077154|3881551|B2||18 - 64 years|Age, Customized||Participants|Count of Participants|1959|1959.0||||||
4060011|NCT01077154|3881552|B1||18 - 64 years|Age, Customized||Participants|Count of Participants|1960|1960.0||||||
4060012|NCT01077154|3881550|B3|||Age||years|Mean|51.5|51.5|Standard Deviation|10.7|10.7|||
4060013|NCT01077154|3881551|B2|||Age||years|Mean|51.4|51.4|Standard Deviation|10.7|10.7|||
4060014|NCT01077154|3881552|B1|||Age||years|Mean|51.6|51.6|Standard Deviation|10.6|10.6|||
4060015|NCT01077128|3881567|B1|Epirus||Regions of Greece||Participants|Number|2|2.0||||||
4060016|NCT01077128|3881567|B1|South Aegean||Regions of Greece||Participants|Number|2|2.0||||||
4060017|NCT01077128|3881567|B1|West Macedonia||Regions of Greece||Participants|Number|3|3.0||||||
4060018|NCT01077128|3881567|B1|Ionian Islands||Regions of Greece||Participants|Number|4|4.0||||||
4060019|NCT01077128|3881567|B1|North Aegean||Regions of Greece||Participants|Number|8|8.0||||||
4060020|NCT01077128|3881567|B1|Peloponnese||Regions of Greece||Participants|Number|16|16.0||||||
4060021|NCT01077128|3881567|B1|Central Greece||Regions of Greece||Participants|Number|16|16.0||||||
4060022|NCT01077128|3881567|B1|Thessaly||Regions of Greece||Participants|Number|18|18.0||||||
4060023|NCT01077128|3881567|B1|East Macedonia and Thrace||Regions of Greece||Participants|Number|20|20.0||||||
4060024|NCT01077128|3881567|B1|West Greece||Regions of Greece||Participants|Number|33|33.0||||||
4060025|NCT01077128|3881567|B1|Crete||Regions of Greece||Participants|Number|41|41.0||||||
4060026|NCT01077128|3881567|B1|Central Macedonia||Regions of Greece||Participants|Number|71|71.0||||||
4060027|NCT01077128|3881567|B1|Attica||Regions of Greece||Participants|Number|266|266.0||||||
4060028|NCT01077128|3881567|B1|Greece||Region of Enrollment||participants|Number|500|500.0||||||
4060029|NCT01077128|3881567|B1||Male|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
4060030|NCT01077128|3881567|B1||Female|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4060031|NCT01077128|3881567|B1|>=18 years||Age, Customized||participants|Number|500|500.0||||||
4060032|NCT01077076|3881625|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4060033|NCT01077076|3881625|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4060034|NCT01077076|3881625|B1|||Age||years|Mean|27.8|27.8|Standard Deviation|7.25|7.25|||
4060035|NCT01077063|3881638|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4060036|NCT01077063|3881639|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4060037|NCT01077063|3881640|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4060038|NCT01077063|3881638|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060039|NCT01077063|3881639|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060040|NCT01077063|3881640|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060041|NCT01077063|3881638|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4060042|NCT01077063|3881639|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4060043|NCT01077063|3881640|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4060044|NCT01077063|3881638|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060045|NCT01077063|3881639|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060046|NCT01077063|3881640|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060047|NCT01077063|3881638|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060048|NCT01077063|3881639|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060049|NCT01077063|3881640|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060050|NCT01077063|3881638|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060051|NCT01077063|3881639|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060052|NCT01077063|3881640|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060053|NCT01077063|3881638|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4060054|NCT01077063|3881639|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4060055|NCT01077063|3881640|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4060056|NCT01077063|3881638|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4060057|NCT01077063|3881639|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060058|NCT01077063|3881640|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4060059|NCT01077063|3881638|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060060|NCT01077063|3881639|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060061|NCT01077063|3881640|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060062|NCT01077063|3881638|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060063|NCT01077063|3881639|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060064|NCT01077063|3881640|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060065|NCT01077063|3881638|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060066|NCT01077063|3881639|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060067|NCT01077063|3881640|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060068|NCT01077063|3881638|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4060069|NCT01077063|3881639|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4060070|NCT01077063|3881640|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4060071|NCT01077063|3881638|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4060072|NCT01077063|3881639|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4060073|NCT01077063|3881640|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4060074|NCT01077063|3881638|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4060075|NCT01077063|3881639|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4060076|NCT01077063|3881640|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4060077|NCT01077063|3881638|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4060078|NCT01077063|3881639|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4060079|NCT01077063|3881640|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4060080|NCT01077063|3881638|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4060081|NCT01077063|3881639|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4060082|NCT01077063|3881640|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4060083|NCT01077063|3881638|B3|||Age||years|Mean|54.42|54.42|Full Range|||42.0|70.0|
4060084|NCT01077063|3881639|B2|||Age||years|Mean|55|55.0|Full Range|||45.0|70.0|
4060085|NCT01077063|3881640|B1|||Age||years|Mean|53.67|53.67|Full Range|||42.0|62.0|
4060086|NCT01077050|3881647|B1|Europe||Region of Enrollment||participants|Number|1484|1484.0||||||
4060087|NCT01077050|3881647|B1|United States||Region of Enrollment||participants|Number|458|458.0||||||
4060088|NCT01077050|3881647|B1||Male|Sex: Female, Male||Participants|Count of Participants|929|929.0||||||
4060089|NCT01077050|3881647|B1||Female|Sex: Female, Male||Participants|Count of Participants|1013|1013.0||||||
4060090|NCT01077050|3881647|B1|||Age||years|Mean|49.8|49.8|Standard Deviation|16.9|16.9|||
4060091|NCT01077050|3881647|B1||>=65 years|Age||Participants|Count of Participants|443|443.0||||||
4060092|NCT01077050|3881647|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1499|1499.0||||||
4060093|NCT01077050|3881647|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4060094|NCT01077024|3881651|B3|||Weight||pounds|Mean|184.0|184.0|Standard Deviation|43.96|43.96|||
4060095|NCT01077024|3881652|B2|||Weight||pounds|Mean|183.3|183.3|Standard Deviation|44.21|44.21|||
4060096|NCT01077024|3881653|B1|||Weight||pounds|Mean|184.8|184.8|Standard Deviation|43.77|43.77|||
4060097|NCT01077024|3881651|B3|United States||Region of Enrollment||participants|Number|538|538.0||||||
4060098|NCT01077024|3881652|B2|United States||Region of Enrollment||participants|Number|271|271.0||||||
4060099|NCT01077024|3881653|B1|United States||Region of Enrollment||participants|Number|267|267.0||||||
4060100|NCT01077024|3881651|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4060101|NCT01077024|3881652|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4060102|NCT01077024|3881653|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4060103|NCT01077024|3881651|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|466|466.0||||||
4060104|NCT01077024|3881652|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|236|236.0||||||
4060105|NCT01077024|3881653|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|230|230.0||||||
4060106|NCT01077024|3881651|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4060107|NCT01077024|3881652|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4060108|NCT01077024|3881653|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4060109|NCT01077024|3881651|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4060110|NCT01077024|3881652|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4060111|NCT01077024|3881653|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4060112|NCT01077024|3881651|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4060113|NCT01077024|3881652|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4060114|NCT01077024|3881653|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4060115|NCT01077024|3881651|B3||White|Race (NIH/OMB)||Participants|Count of Participants|320|320.0||||||
4060116|NCT01077024|3881652|B2||White|Race (NIH/OMB)||Participants|Count of Participants|158|158.0||||||
4060117|NCT01077024|3881653|B1||White|Race (NIH/OMB)||Participants|Count of Participants|162|162.0||||||
4060118|NCT01077024|3881651|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|171|171.0||||||
4060119|NCT01077024|3881652|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
4060120|NCT01077024|3881653|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
4060121|NCT01077024|3881651|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4060122|NCT01077024|3881652|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4060123|NCT01077024|3881653|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060124|NCT01077024|3881651|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4060125|NCT01077024|3881652|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060126|NCT01077024|3881653|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4060127|NCT01077024|3881651|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4060128|NCT01077024|3881652|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4060129|NCT01077024|3881653|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4060130|NCT01077024|3881651|B3||Male|Sex: Female, Male||Participants|Count of Participants|280|280.0||||||
4060131|NCT01077024|3881652|B2||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4060132|NCT01077024|3881653|B1||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4060133|NCT01077024|3881651|B3||Female|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
4060134|NCT01077024|3881652|B2||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4060135|NCT01077024|3881653|B1||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4060136|NCT01077024|3881651|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4060137|NCT01077024|3881652|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4060138|NCT01077024|3881653|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4060139|NCT01077024|3881651|B3||Between 18 and 65 years|Age||Participants|Count of Participants|537|537.0||||||
4060140|NCT01077024|3881652|B2||Between 18 and 65 years|Age||Participants|Count of Participants|271|271.0||||||
4060141|NCT01077024|3881653|B1||Between 18 and 65 years|Age||Participants|Count of Participants|266|266.0||||||
4060142|NCT01077024|3881651|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4060143|NCT01077024|3881652|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4060144|NCT01077024|3881653|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4060145|NCT01076985|3881672|B1|Japan||Region of Enrollment||participants|Number|24|24.0||||||
4060146|NCT01076985|3881672|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4060147|NCT01076985|3881672|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4060148|NCT01076985|3881672|B1|||Age||years|Mean|30|30.0|Standard Deviation|5.7|5.7|||
4060149|NCT01076985|3881672|B1|||Age||years|Median|30|30.0|Full Range|||21.0|41.0|
4060150|NCT01076972|3881678|B1|Japan||Region of Enrollment||participants|Number|1184|1184.0||||||
4060151|NCT01076972|3881678|B1||Male|Sex: Female, Male||Participants|Count of Participants|1078|1078.0||||||
4060152|NCT01076972|3881678|B1||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4060153|NCT01076972|3881678|B1|>=65 years||Age, Customized||participants|Number|25|25.0||||||
4060154|NCT01076972|3881678|B1|Between 15 and 64 years||Age, Customized||participants|Number|1155|1155.0||||||
4060155|NCT01076972|3881678|B1|<=14 years||Age, Customized||participants|Number|4|4.0||||||
4060156|NCT01076972|3881678|B1|||Age||years|Mean|39.7|39.7|Standard Deviation|11.0|11.0|||
4060157|NCT01076959|3881693|B1|Japan||Region of Enrollment||participants|Number|7740|7740.0||||||
4060158|NCT01076959|3881693|B1||Male|Sex: Female, Male||Participants|Count of Participants|1352|1352.0||||||
4060159|NCT01076959|3881693|B1||Female|Sex: Female, Male||Participants|Count of Participants|6388|6388.0||||||
4060160|NCT01076959|3881693|B1|No data||Age, Customized||participants|Number|1|1.0||||||
4060161|NCT01076959|3881693|B1|>=90||Age, Customized||participants|Number|4|4.0||||||
4060162|NCT01076959|3881693|B1|>=80-<90||Age, Customized||participants|Number|261|261.0||||||
4060163|NCT01076959|3881693|B1|>=70-<80||Age, Customized||participants|Number|1676|1676.0||||||
4060164|NCT01076959|3881693|B1|>=60-<70||Age, Customized||participants|Number|2515|2515.0||||||
4060165|NCT01076959|3881693|B1|>=50-<60||Age, Customized||participants|Number|1803|1803.0||||||
4060166|NCT01076959|3881693|B1|>=40-<50||Age, Customized||participants|Number|828|828.0||||||
4060167|NCT01076959|3881693|B1|>=30-<40||Age, Customized||participants|Number|461|461.0||||||
4060168|NCT01076959|3881693|B1|>=20-<30||Age, Customized||participants|Number|165|165.0||||||
4060169|NCT01076959|3881693|B1|<20 years||Age, Customized||participants|Number|26|26.0||||||
4060170|NCT01076959|3881693|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|13.0|13.0|||
4060171|NCT01076686|3881710|B5|United States||Region of Enrollment||participants|Number|94|94.0||||||
4060172|NCT01076686|3881711|B4|United States||Region of Enrollment||participants|Number|31|31.0||||||
4060173|NCT01076686|3881712|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4060174|NCT01076686|3881713|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4060175|NCT01076686|3881714|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4060176|NCT01076686|3881710|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4060177|NCT01076686|3881711|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4060178|NCT01076686|3881712|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4060179|NCT01076686|3881713|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4060180|NCT01076686|3881714|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4060181|NCT01076686|3881710|B5||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4060182|NCT01076686|3881711|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4060183|NCT01076686|3881712|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4060184|NCT01076686|3881713|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4060185|NCT01076686|3881714|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4060186|NCT01076686|3881710|B5|||Age||years|Mean|32|32.0|Standard Deviation|7.2|7.2|||
4060187|NCT01076686|3881711|B4|||Age||years|Mean|33|33.0|Standard Deviation|7.6|7.6|||
4060188|NCT01076686|3881712|B3|||Age||years|Mean|31|31.0|Standard Deviation|7.1|7.1|||
4060189|NCT01076686|3881713|B2|||Age||years|Mean|29|29.0|Standard Deviation|6.3|6.3|||
4060190|NCT01076686|3881714|B1|||Age||years|Mean|32|32.0|Standard Deviation|7.2|7.2|||
4060191|NCT01076686|3881710|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4060192|NCT01076686|3881711|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4060193|NCT01076686|3881712|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4060194|NCT01076686|3881713|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4060195|NCT01076686|3881714|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4060196|NCT01076686|3881710|B5||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
4060197|NCT01076686|3881711|B4||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4060198|NCT01076686|3881712|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4060199|NCT01076686|3881713|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4060200|NCT01076686|3881714|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4060201|NCT01076686|3881710|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4060202|NCT01076686|3881711|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4060203|NCT01076686|3881712|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4060204|NCT01076686|3881713|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4060205|NCT01076686|3881714|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4060206|NCT01076647|3881727|B3|||Body Weight||kg|Mean|91.8|91.8|Standard Deviation|18.5|18.5|||
4060207|NCT01076647|3881728|B2|||Body Weight||kg|Mean|91.4|91.4|Standard Deviation|18.7|18.7|||
4060208|NCT01076647|3881729|B1|||Body Weight||kg|Mean|92.3|92.3|Standard Deviation|18.3|18.3|||
4060209|NCT01076647|3881727|B3|||Glycosylated haemoglobin (HbaA1c)||percentage of glycosylated haemoglobin|Mean|8.3|8.3|Standard Deviation|0.8|0.8|||
4060210|NCT01076647|3881728|B2|||Glycosylated haemoglobin (HbaA1c)||percentage of glycosylated haemoglobin|Mean|8.3|8.3|Standard Deviation|0.8|0.8|||
4060211|NCT01076647|3881729|B1|||Glycosylated haemoglobin (HbaA1c)||percentage of glycosylated haemoglobin|Mean|8.3|8.3|Standard Deviation|0.8|0.8|||
4060212|NCT01076647|3881727|B3||Male|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
4060213|NCT01076647|3881728|B2||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4060214|NCT01076647|3881729|B1||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4060215|NCT01076647|3881727|B3||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4060216|NCT01076647|3881728|B2||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4060217|NCT01076647|3881729|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4060218|NCT01076647|3881727|B3|||Age||years|Mean|57.4|57.4|Standard Deviation|10.2|10.2|||
4060219|NCT01076647|3881728|B2|||Age||years|Mean|57.5|57.5|Standard Deviation|10.7|10.7|||
4060220|NCT01076647|3881729|B1|||Age||years|Mean|57.3|57.3|Standard Deviation|9.6|9.6|||
4060221|NCT01076504|3881738|B1|United States||Region of Enrollment||participants|Number|80|80.0||||||
4060222|NCT01076504|3881738|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4060223|NCT01076504|3881738|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4060224|NCT01076504|3881738|B1|||Age||years|Median|65|65.0|Full Range|||45.0|85.0|
4060225|NCT01076452|3881746|B3|United States||Region of Enrollment||participants|Number|299|299.0||||||
4060226|NCT01076452|3881747|B2|United States||Region of Enrollment||participants|Number|152|152.0||||||
4060227|NCT01076452|3881748|B1|United States||Region of Enrollment||participants|Number|147|147.0||||||
4060228|NCT01076452|3881746|B3||Male|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
4060229|NCT01076452|3881747|B2||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4060230|NCT01076452|3881748|B1||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4060231|NCT01076452|3881746|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4060232|NCT01076452|3881747|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4060233|NCT01076452|3881748|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4060234|NCT01076452|3881746|B3|||Age||years|Mean|61.8|61.8|Standard Deviation|8.6|8.6|||
4060235|NCT01076452|3881747|B2|||Age||years|Mean|61.8|61.8|Standard Deviation|8.7|8.7|||
4060236|NCT01076452|3881748|B1|||Age||years|Mean|61.9|61.9|Standard Deviation|8.7|8.7|||
4060237|NCT01076452|3881746|B3||>=65 years|Age||Participants|Count of Participants|69|69.0||||||
4060238|NCT01076452|3881747|B2||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
4060239|NCT01076452|3881748|B1||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
4060240|NCT01076452|3881746|B3||Between 18 and 65 years|Age||Participants|Count of Participants|230|230.0||||||
4060241|NCT01076452|3881747|B2||Between 18 and 65 years|Age||Participants|Count of Participants|117|117.0||||||
4060242|NCT01076452|3881748|B1||Between 18 and 65 years|Age||Participants|Count of Participants|113|113.0||||||
4060243|NCT01076452|3881746|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4060244|NCT01076452|3881747|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4060245|NCT01076452|3881748|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4060246|NCT01076400|3881761|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4060247|NCT01076400|3881761|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4060248|NCT01076400|3881761|B1|||Age||Years|Mean|50.3|50.3|Standard Deviation|3.5|3.5|||
4060249|NCT01076361|3881769|B1|Not Reportable per Local Laws/Regulations||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4060250|NCT01076361|3881769|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4060251|NCT01076361|3881769|B1|Race/Ethnicity not collected||Race/Ethnicity, Customized||participants|Number|345|345.0||||||
4060252|NCT01076361|3881769|B1|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4060253|NCT01076361|3881769|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4060254|NCT01076361|3881769|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4060255|NCT01076361|3881769|B1||Male|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
4060256|NCT01076361|3881769|B1||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4060257|NCT01076361|3881769|B1|20 + Years||Age, Customized||participants|Number|145|145.0||||||
4060258|NCT01076361|3881769|B1|13 - 19 Years||Age, Customized||participants|Number|49|49.0||||||
4060259|NCT01076361|3881769|B1|0 - 12 Years||Age, Customized||participants|Number|155|155.0||||||
4060260|NCT01076361|3881769|B1|Unknown||Age, Customized||participants|Number|21|21.0||||||
4060261|NCT01076348|3881773|B1|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
4060262|NCT01076348|3881773|B1|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4060263|NCT01076348|3881773|B1|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4060264|NCT01076348|3881773|B1|Denmark||Region of Enrollment||participants|Number|0|0.0||||||
4060265|NCT01076348|3881773|B1|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4060266|NCT01076348|3881773|B1|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
4060267|NCT01076348|3881773|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4060268|NCT01076348|3881773|B1|France||Region of Enrollment||participants|Number|0|0.0||||||
4060269|NCT01076348|3881773|B1|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4060270|NCT01076348|3881773|B1|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
4060271|NCT01076348|3881773|B1|Austria||Region of Enrollment||participants|Number|0|0.0||||||
4060272|NCT01076348|3881773|B1|Spain||Region of Enrollment||participants|Number|0|0.0||||||
4060273|NCT01076348|3881773|B1|United States||Region of Enrollment||participants|Number|72|72.0||||||
4060274|NCT01076348|3881773|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4060275|NCT01076348|3881773|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4060276|NCT01076348|3881773|B1|||Age||years|Mean|61.8|61.8|Standard Deviation|15.5|15.5|||
4060277|NCT01076348|3881773|B1||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
4060278|NCT01076348|3881773|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4060279|NCT01076348|3881773|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4060280|NCT01076335|3881777|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4060281|NCT01076335|3881777|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4060282|NCT01076335|3881777|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4060283|NCT01076335|3881777|B1|||Age||years|Median|61.5|61.5|Full Range|||38.0|75.0|
4060284|NCT01076296|3881781|B1||Male|Sex: Female, Male||Participants|Count of Participants|344|344.0||||||
4060285|NCT01076296|3881781|B1||Female|Sex: Female, Male||Participants|Count of Participants|656|656.0||||||
4060286|NCT01076296|3881781|B1|||Age||years|Mean|60.9|60.9|Standard Deviation|15.4|15.4|||
4060287|NCT01076283|3881806|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4060288|NCT01076283|3881807|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4060289|NCT01076283|3881808|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4060290|NCT01076283|3881806|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4060291|NCT01076283|3881807|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4060292|NCT01076283|3881808|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4060293|NCT01076283|3881806|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4060294|NCT01076283|3881807|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4060295|NCT01076283|3881808|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4060296|NCT01076283|3881806|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4060297|NCT01076283|3881807|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4060298|NCT01076283|3881808|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4060299|NCT01076283|3881806|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4060300|NCT01076283|3881807|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4060301|NCT01076283|3881808|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4060302|NCT01076283|3881806|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4060303|NCT01076283|3881807|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4060304|NCT01076283|3881808|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4060305|NCT01076270|3881817|B1|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4060306|NCT01076270|3881817|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060307|NCT01076270|3881817|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060308|NCT01076270|3881817|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4060309|NCT01076270|3881817|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060310|NCT01076270|3881817|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060311|NCT01076270|3881817|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060312|NCT01076270|3881817|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060313|NCT01076270|3881817|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060314|NCT01076270|3881817|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4060315|NCT01076270|3881817|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060316|NCT01076270|3881817|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4060317|NCT01076270|3881817|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4060318|NCT01076270|3881817|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4060319|NCT01076270|3881817|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4060320|NCT01076270|3881817|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4060321|NCT01076244|3881822|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4060322|NCT01076244|3881822|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4060323|NCT01076244|3881822|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4060324|NCT01076244|3881822|B1|||Age||years|Mean|66.1|66.1|Standard Deviation|8.7|8.7|||
4060325|NCT01076244|3881822|B1||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4060326|NCT01076244|3881822|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4060327|NCT01076244|3881822|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4060328|NCT01076192|3881829|B1||Male|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
4060329|NCT01076192|3881829|B1||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
4060330|NCT01076192|3881829|B1|||Age||years|Mean|46.48|46.48|Standard Deviation|13.26|13.26|||
4060331|NCT01076179|3881844|B1||Male|Sex: Female, Male||Participants|Count of Participants|431|431.0||||||
4060332|NCT01076179|3881844|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4060333|NCT01076179|3881844|B1|||Age||years|Mean|45.4|45.4|Standard Deviation|11.1|11.1|||
4060334|NCT01076166|3881867|B1|LRTI not reported||Risk Factor--Lower Respiratory Tract Infections|The frequency in which participants had experienced lower respiratory tract infections (LRTI) in the past, for the per protocol population (308 participants).|participants|Number|161|161.0||||||
4060335|NCT01076166|3881867|B1|LRTI > 10 times per year||Risk Factor--Lower Respiratory Tract Infections|The frequency in which participants had experienced lower respiratory tract infections (LRTI) in the past, for the per protocol population (308 participants).|participants|Number|0|0.0||||||
4060336|NCT01076166|3881867|B1|LRTI 7 to 10 times per year||Risk Factor--Lower Respiratory Tract Infections|The frequency in which participants had experienced lower respiratory tract infections (LRTI) in the past, for the per protocol population (308 participants).|participants|Number|9|9.0||||||
4060455|NCT01075971|3882004|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4060337|NCT01076166|3881867|B1|LRTI 3 to 6 times per year||Risk Factor--Lower Respiratory Tract Infections|The frequency in which participants had experienced lower respiratory tract infections (LRTI) in the past, for the per protocol population (308 participants).|participants|Number|27|27.0||||||
4060338|NCT01076166|3881867|B1|LRTI 1 to 2 times per year||Risk Factor--Lower Respiratory Tract Infections|The frequency in which participants had experienced lower respiratory tract infections (LRTI) in the past, for the per protocol population (308 participants).|participants|Number|111|111.0||||||
4060339|NCT01076166|3881867|B1|URTI not reported||Risk Factor--Upper Respiratory Tract Infections|The frequency in which participants had experienced upper respiratory tract infections (URTI) in the past, for the per protocol population (308 participants).|participants|Number|129|129.0||||||
4060340|NCT01076166|3881867|B1|URTI > 10 times per year||Risk Factor--Upper Respiratory Tract Infections|The frequency in which participants had experienced upper respiratory tract infections (URTI) in the past, for the per protocol population (308 participants).|participants|Number|0|0.0||||||
4060341|NCT01076166|3881867|B1|URTI 7 to 10 times per year||Risk Factor--Upper Respiratory Tract Infections|The frequency in which participants had experienced upper respiratory tract infections (URTI) in the past, for the per protocol population (308 participants).|participants|Number|5|5.0||||||
4060342|NCT01076166|3881867|B1|URTI 3 to 6 times per year||Risk Factor--Upper Respiratory Tract Infections|The frequency in which participants had experienced upper respiratory tract infections (URTI) in the past, for the per protocol population (308 participants).|participants|Number|76|76.0||||||
4060343|NCT01076166|3881867|B1|URTI 1 to 2 times per year||Risk Factor--Upper Respiratory Tract Infections|The frequency in which participants had experienced upper respiratory tract infections (URTI) in the past, for the per protocol population (308 participants).|participants|Number|98|98.0||||||
4060344|NCT01076166|3881867|B1|Pneumonia||Diagnosis|Participant diagnosis at study entry for the per protocol population (308 participants).|participants|Number|30|30.0||||||
4060345|NCT01076166|3881867|B1|Bronchitis||Diagnosis|Participant diagnosis at study entry for the per protocol population (308 participants).|participants|Number|278|278.0||||||
4060346|NCT01076166|3881867|B1|Thailand||Region of Enrollment|Based on per protocol population (308 participants).|participants|Number|308|308.0||||||
4060347|NCT01076166|3881867|B1||Male|Sex: Female, Male|Based on per protocol population (308 participants).|Participants|Count of Participants|161|161.0||||||
4060348|NCT01076166|3881867|B1||Female|Sex: Female, Male|Based on per protocol population (308 participants).|Participants|Count of Participants|147|147.0||||||
4060349|NCT01076166|3881867|B1|> 5 and < 12 years||Age, Customized|Based on per protocol population (308 participants).|participants|Number|110|110.0||||||
4060350|NCT01076166|3881867|B1|Between 3 and 5 years||Age, Customized|Based on per protocol population (308 participants).|participants|Number|118|118.0||||||
4060351|NCT01076166|3881867|B1|> 6 months to 3 years||Age, Customized|Based on per protocol population (308 participants).|participants|Number|80|80.0||||||
4060352|NCT01076166|3881867|B1|||Age|Based on per protocol population (308 participants).|years|Median|4.2|4.2|Full Range|||0.5|11.9|
4060353|NCT01076153|3881874|B1|Participant did not smoke||Risk factor: Smoking status|Whether or not participants smoked cigarettes for the per-protocol population (694 participants).|participants|Number|530|530.0||||||
4060354|NCT01076153|3881874|B1|Participant was a smoker||Risk factor: Smoking status|Whether or not participants smoked cigarettes for the per-protocol population (694 participants).|participants|Number|164|164.0||||||
4060355|NCT01076153|3881874|B1|Both upper and lower respiratory tract infections||Diagnosis|Participant diagnosis at study entry for the per-protocol population (694 participants).|participants|Number|19|19.0||||||
4060356|NCT01076153|3881874|B1|Lower respiratory tract infection||Diagnosis|Participant diagnosis at study entry for the per-protocol population (694 participants).|participants|Number|165|165.0||||||
4060357|NCT01076153|3881874|B1|Upper respiratory tract infection||Diagnosis|Participant diagnosis at study entry for the per-protocol population (694 participants).|participants|Number|510|510.0||||||
4060358|NCT01076153|3881874|B1|Thailand||Region of Enrollment|Based on per-protocol population (694 participants).|participants|Number|694|694.0||||||
4060359|NCT01076153|3881874|B1||Male|Sex: Female, Male|Based on per-protocol population (694 participants).|Participants|Count of Participants|290|290.0||||||
4060360|NCT01076153|3881874|B1||Female|Sex: Female, Male|Based on per-protocol population (694 participants).|Participants|Count of Participants|404|404.0||||||
4060361|NCT01076153|3881874|B1|Over 60 years||Age, Customized|Based on per-protocol population (694 participants).|participants|Number|65|65.0||||||
4060362|NCT01076153|3881874|B1|51 to 60 years||Age, Customized|Based on per-protocol population (694 participants).|participants|Number|102|102.0||||||
4060363|NCT01076153|3881874|B1|41 to 50 years||Age, Customized|Based on per-protocol population (694 participants).|participants|Number|141|141.0||||||
4060364|NCT01076153|3881874|B1|31 to 40 years||Age, Customized|Based on per-protocol population (694 participants).|participants|Number|204|204.0||||||
4060365|NCT01076153|3881874|B1|21 to 30 years||Age, Customized|Based on per-protocol population (694 participants).|participants|Number|154|154.0||||||
4060366|NCT01076153|3881874|B1|18 to 20 years||Age, Customized|Based on per-protocol population (694 participants).|participants|Number|28|28.0||||||
4060367|NCT01076153|3881874|B1|||Age|Based on per-protocol population (694 participants).|years|Mean|41.16|41.16|Standard Deviation|14.22|14.22|||
4060368|NCT01076088|3881882|B7|||2-hour post meal glucose (2-h PMG)|Participants with data: sita50/met500, n=121; sita50/met850, n=125; met500, n=125; met850, n=123; sita100, n=119; placebo; n=126; total, n=739|mg/dL|Mean|299.0|299.0|Standard Deviation|76.2|76.2|||
4060369|NCT01076088|3881883|B6|||2-hour post meal glucose (2-h PMG)|Participants with data: sita50/met500, n=121; sita50/met850, n=125; met500, n=125; met850, n=123; sita100, n=119; placebo; n=126; total, n=739|mg/dL|Mean|308.3|308.3|Standard Deviation|83.6|83.6|||
4060370|NCT01076088|3881884|B5|||2-hour post meal glucose (2-h PMG)|Participants with data: sita50/met500, n=121; sita50/met850, n=125; met500, n=125; met850, n=123; sita100, n=119; placebo; n=126; total, n=739|mg/dL|Mean|297.7|297.7|Standard Deviation|74.7|74.7|||
4060456|NCT01075971|3882004|B1|||Age||years|Mean|37.94|37.94|Standard Deviation|7.58|7.58|||
4060457|NCT01075958|3882008|B1|United Kingdom||Region of Enrollment||participants|Number|283|283.0||||||
4060371|NCT01076088|3881885|B4|||2-hour post meal glucose (2-h PMG)|Participants with data: sita50/met500, n=121; sita50/met850, n=125; met500, n=125; met850, n=123; sita100, n=119; placebo; n=126; total, n=739|mg/dL|Mean|298.8|298.8|Standard Deviation|74.6|74.6|||
4060372|NCT01076088|3881886|B3|||2-hour post meal glucose (2-h PMG)|Participants with data: sita50/met500, n=121; sita50/met850, n=125; met500, n=125; met850, n=123; sita100, n=119; placebo; n=126; total, n=739|mg/dL|Mean|303.2|303.2|Standard Deviation|74.1|74.1|||
4060373|NCT01076088|3881887|B2|||2-hour post meal glucose (2-h PMG)|Participants with data: sita50/met500, n=121; sita50/met850, n=125; met500, n=125; met850, n=123; sita100, n=119; placebo; n=126; total, n=739|mg/dL|Mean|292.9|292.9|Standard Deviation|68.4|68.4|||
4060374|NCT01076088|3881888|B1|||2-hour post meal glucose (2-h PMG)|Participants with data: sita50/met500, n=121; sita50/met850, n=125; met500, n=125; met850, n=123; sita100, n=119; placebo; n=126; total, n=739|mg/dL|Mean|292.7|292.7|Standard Deviation|81.2|81.2|||
4060375|NCT01076088|3881882|B7|||Fasting plasma glucose (FPG)||mg/dL|Mean|182.3|182.3|Standard Deviation|45.0|45.0|||
4060376|NCT01076088|3881883|B6|||Fasting plasma glucose (FPG)||mg/dL|Mean|185.8|185.8|Standard Deviation|47.3|47.3|||
4060377|NCT01076088|3881884|B5|||Fasting plasma glucose (FPG)||mg/dL|Mean|182.5|182.5|Standard Deviation|44.0|44.0|||
4060378|NCT01076088|3881885|B4|||Fasting plasma glucose (FPG)||mg/dL|Mean|183.5|183.5|Standard Deviation|47.7|47.7|||
4060379|NCT01076088|3881886|B3|||Fasting plasma glucose (FPG)||mg/dL|Mean|184.6|184.6|Standard Deviation|46.8|46.8|||
4060380|NCT01076088|3881887|B2|||Fasting plasma glucose (FPG)||mg/dL|Mean|181.9|181.9|Standard Deviation|43.0|43.0|||
4060381|NCT01076088|3881888|B1|||Fasting plasma glucose (FPG)||mg/dL|Mean|175.6|175.6|Standard Deviation|40.6|40.6|||
4060382|NCT01076088|3881882|B7|||Hemoglobin A1c (A1C)||Percent of glycosylated hemoglobin|Mean|8.70|8.7|Standard Deviation|1.04|1.04|||
4060383|NCT01076088|3881883|B6|||Hemoglobin A1c (A1C)||Percent of glycosylated hemoglobin|Mean|8.97|8.97|Standard Deviation|1.05|1.05|||
4060384|NCT01076088|3881884|B5|||Hemoglobin A1c (A1C)||Percent of glycosylated hemoglobin|Mean|8.74|8.74|Standard Deviation|1.14|1.14|||
4060385|NCT01076088|3881885|B4|||Hemoglobin A1c (A1C)||Percent of glycosylated hemoglobin|Mean|8.67|8.67|Standard Deviation|1.08|1.08|||
4060386|NCT01076088|3881886|B3|||Hemoglobin A1c (A1C)||Percent of glycosylated hemoglobin|Mean|8.69|8.69|Standard Deviation|0.99|0.99|||
4060387|NCT01076088|3881887|B2|||Hemoglobin A1c (A1C)||Percent of glycosylated hemoglobin|Mean|8.66|8.66|Standard Deviation|0.95|0.95|||
4060388|NCT01076088|3881888|B1|||Hemoglobin A1c (A1C)||Percent of glycosylated hemoglobin|Mean|8.46|8.46|Standard Deviation|0.97|0.97|||
4060389|NCT01076088|3881882|B7||Male|Sex: Female, Male||Participants|Count of Participants|457|457.0||||||
4060390|NCT01076088|3881883|B6||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4060391|NCT01076088|3881884|B5||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4060392|NCT01076088|3881885|B4||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4060393|NCT01076088|3881886|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4060394|NCT01076088|3881887|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4060395|NCT01076088|3881888|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4060396|NCT01076088|3881882|B7||Female|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
4060397|NCT01076088|3881883|B6||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4060398|NCT01076088|3881884|B5||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4060399|NCT01076088|3881885|B4||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4060400|NCT01076088|3881886|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4060401|NCT01076088|3881887|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4060402|NCT01076088|3881888|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4060403|NCT01076088|3881882|B7|||Age||Years|Mean|52.7|52.7|Standard Deviation|10.0|10.0|||
4060404|NCT01076088|3881883|B6|||Age||Years|Mean|53.6|53.6|Standard Deviation|9.7|9.7|||
4060405|NCT01076088|3881884|B5|||Age||Years|Mean|51.7|51.7|Standard Deviation|10.2|10.2|||
4060406|NCT01076088|3881885|B4|||Age||Years|Mean|53.0|53.0|Standard Deviation|10.3|10.3|||
4060407|NCT01076088|3881886|B3|||Age||Years|Mean|52.6|52.6|Standard Deviation|9.5|9.5|||
4060408|NCT01076088|3881887|B2|||Age||Years|Mean|52.4|52.4|Standard Deviation|9.3|9.3|||
4060409|NCT01076088|3881888|B1|||Age||Years|Mean|52.6|52.6|Standard Deviation|11.3|11.3|||
4060410|NCT01076075|3881919|B3|||Fasting Plasma Glucose|Number of Baseline Participants for Sitagliptin (210) and for Placebo/Pioglitazone (212). Five participants (Sitagliptin: 3, Placebo/Pioglitazone: 2) were excluded from analyses due to one site's non-compliance.|mg/dL|Mean|164.9|164.9|Standard Deviation|42.4|42.4|||
4060411|NCT01076075|3881920|B2|||Fasting Plasma Glucose|Number of Baseline Participants for Sitagliptin (210) and for Placebo/Pioglitazone (212). Five participants (Sitagliptin: 3, Placebo/Pioglitazone: 2) were excluded from analyses due to one site's non-compliance.|mg/dL|Mean|165.0|165.0|Standard Deviation|43.9|43.9|||
4060412|NCT01076075|3881921|B1|||Fasting Plasma Glucose|Number of Baseline Participants for Sitagliptin (210) and for Placebo/Pioglitazone (212). Five participants (Sitagliptin: 3, Placebo/Pioglitazone: 2) were excluded from analyses due to one site's non-compliance.|mg/dL|Mean|164.8|164.8|Standard Deviation|40.8|40.8|||
4060413|NCT01076075|3881919|B3|||2-Hour Post-Meal Glucose|Number of Baseline Participants for Sitagliptin (202) and for Placebo/Pioglitazone (208). Five participants (Sitagliptin: 3, Placebo/Pioglitazone: 2) were excluded from analyses due to one site's non-compliance.|mg/dL|Mean|241.8|241.8|Standard Deviation|64.8|64.8|||
4060414|NCT01076075|3881920|B2|||2-Hour Post-Meal Glucose|Number of Baseline Participants for Sitagliptin (202) and for Placebo/Pioglitazone (208). Five participants (Sitagliptin: 3, Placebo/Pioglitazone: 2) were excluded from analyses due to one site's non-compliance.|mg/dL|Mean|243.3|243.3|Standard Deviation|68.8|68.8|||
4060458|NCT01075958|3882008|B1||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4060415|NCT01076075|3881921|B1|||2-Hour Post-Meal Glucose|Number of Baseline Participants for Sitagliptin (202) and for Placebo/Pioglitazone (208). Five participants (Sitagliptin: 3, Placebo/Pioglitazone: 2) were excluded from analyses due to one site's non-compliance.|mg/dL|Mean|240.3|240.3|Standard Deviation|60.6|60.6|||
4060416|NCT01076075|3881919|B3|||Hemoglobin A1C|Number of Baseline Participants for Sitagliptin (210) and for Placebo/Pioglitazone (212). Five participants (Sitagliptin: 3, Placebo/Pioglitazone: 2) were excluded from analyses due to one site's non-compliance.|Percentage of glycosylated hemoglobin|Mean|8.4|8.4|Standard Deviation|0.8|0.8|||
4060417|NCT01076075|3881920|B2|||Hemoglobin A1C|Number of Baseline Participants for Sitagliptin (210) and for Placebo/Pioglitazone (212). Five participants (Sitagliptin: 3, Placebo/Pioglitazone: 2) were excluded from analyses due to one site's non-compliance.|Percentage of glycosylated hemoglobin|Mean|8.4|8.4|Standard Deviation|0.9|0.9|||
4060418|NCT01076075|3881921|B1|||Hemoglobin A1C|Number of Baseline Participants for Sitagliptin (210) and for Placebo/Pioglitazone (212). Five participants (Sitagliptin: 3, Placebo/Pioglitazone: 2) were excluded from analyses due to one site's non-compliance.|Percentage of glycosylated hemoglobin|Mean|8.4|8.4|Standard Deviation|0.8|0.8|||
4060419|NCT01076075|3881919|B3||Male|Sex: Female, Male|Number of Baseline Participants for Sitagliptin (210) and for Placebo/Pioglitazone (212). Five participants (Sitagliptin: 3, Placebo/Pioglitazone: 2) were excluded from analyses due to one site's non-compliance.|Participants|Count of Participants|193|193.0||||||
4060420|NCT01076075|3881920|B2||Male|Sex: Female, Male|Number of Baseline Participants for Sitagliptin (210) and for Placebo/Pioglitazone (212). Five participants (Sitagliptin: 3, Placebo/Pioglitazone: 2) were excluded from analyses due to one site's non-compliance.|Participants|Count of Participants|98|98.0||||||
4060421|NCT01076075|3881921|B1||Male|Sex: Female, Male|Number of Baseline Participants for Sitagliptin (210) and for Placebo/Pioglitazone (212). Five participants (Sitagliptin: 3, Placebo/Pioglitazone: 2) were excluded from analyses due to one site's non-compliance.|Participants|Count of Participants|95|95.0||||||
4060422|NCT01076075|3881919|B3||Female|Sex: Female, Male|Number of Baseline Participants for Sitagliptin (210) and for Placebo/Pioglitazone (212). Five participants (Sitagliptin: 3, Placebo/Pioglitazone: 2) were excluded from analyses due to one site's non-compliance.|Participants|Count of Participants|229|229.0||||||
4060423|NCT01076075|3881920|B2||Female|Sex: Female, Male|Number of Baseline Participants for Sitagliptin (210) and for Placebo/Pioglitazone (212). Five participants (Sitagliptin: 3, Placebo/Pioglitazone: 2) were excluded from analyses due to one site's non-compliance.|Participants|Count of Participants|114|114.0||||||
4060424|NCT01076075|3881921|B1||Female|Sex: Female, Male|Number of Baseline Participants for Sitagliptin (210) and for Placebo/Pioglitazone (212). Five participants (Sitagliptin: 3, Placebo/Pioglitazone: 2) were excluded from analyses due to one site's non-compliance.|Participants|Count of Participants|115|115.0||||||
4060425|NCT01076075|3881919|B3|||Age|Number of Baseline Participants for Sitagliptin (210) and for Placebo/Pioglitazone (212). Five participants (Sitagliptin: 3, Placebo/Pioglitazone: 2) were excluded from analyses due to one site's non-compliance.|years|Mean|54.9|54.9|Standard Deviation|9.9|9.9|||
4060426|NCT01076075|3881920|B2|||Age|Number of Baseline Participants for Sitagliptin (210) and for Placebo/Pioglitazone (212). Five participants (Sitagliptin: 3, Placebo/Pioglitazone: 2) were excluded from analyses due to one site's non-compliance.|years|Mean|55.4|55.4|Standard Deviation|10.2|10.2|||
4060427|NCT01076075|3881921|B1|||Age|Number of Baseline Participants for Sitagliptin (210) and for Placebo/Pioglitazone (212). Five participants (Sitagliptin: 3, Placebo/Pioglitazone: 2) were excluded from analyses due to one site's non-compliance.|years|Mean|54.4|54.4|Standard Deviation|9.6|9.6|||
4060428|NCT01076036|3881936|B1|Colombia||Region of Enrollment||participants|Number|8|8.0||||||
4060429|NCT01076036|3881936|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4060430|NCT01076036|3881936|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4060431|NCT01076036|3881936|B1|||Age||years|Mean|67.8|67.8|Standard Deviation|10.7|10.7|||
4060432|NCT01076036|3881936|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4060433|NCT01076036|3881936|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4060434|NCT01076036|3881936|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4060435|NCT01075984|3881941|B6||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4060436|NCT01075984|3881942|B5||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4060437|NCT01075984|3881943|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4060438|NCT01075984|3881944|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4060439|NCT01075984|3881945|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4060440|NCT01075984|3881946|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4060441|NCT01075984|3881941|B6||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4060442|NCT01075984|3881942|B5||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4060443|NCT01075984|3881943|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4060444|NCT01075984|3881944|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4060445|NCT01075984|3881945|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4060446|NCT01075984|3881946|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4060447|NCT01075984|3881941|B6|||Age||Years|Mean|51.3|51.3|Standard Deviation|14.7|14.7|||
4060448|NCT01075984|3881942|B5|||Age||Years|Mean|50.7|50.7|Standard Deviation|14.7|14.7|||
4060449|NCT01075984|3881943|B4|||Age||Years|Mean|52.4|52.4|Standard Deviation|13.4|13.4|||
4060450|NCT01075984|3881944|B3|||Age||Years|Mean|49.1|49.1|Standard Deviation|14.7|14.7|||
4060451|NCT01075984|3881945|B2|||Age||Years|Mean|59.5|59.5|Standard Deviation|12.3|12.3|||
4060452|NCT01075984|3881946|B1|||Age||Years|Mean|56.8|56.8|Standard Deviation|17.4|17.4|||
4060453|NCT01075971|3882004|B1|France||Region of Enrollment||participants|Number|52|52.0||||||
4060454|NCT01075971|3882004|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4060459|NCT01075958|3882008|B1||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4060460|NCT01075958|3882008|B1|||Age||years|Mean|22.47|22.47|Standard Deviation|3.95|3.95|||
4060461|NCT01075958|3882008|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4060462|NCT01075958|3882008|B1||Between 18 and 65 years|Age||Participants|Count of Participants|283|283.0||||||
4060463|NCT01075958|3882008|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4060464|NCT01075815|3882022|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4060465|NCT01075815|3882023|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4060466|NCT01075815|3882024|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4060467|NCT01075815|3882022|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4060468|NCT01075815|3882023|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4060469|NCT01075815|3882024|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4060470|NCT01075815|3882022|B3|||Age||years|Mean|37.2|37.2|Standard Deviation|1.9|1.9|||
4060471|NCT01075815|3882023|B2|||Age||years|Mean|37.3|37.3|Standard Deviation|1.5|1.5|||
4060472|NCT01075815|3882024|B1|||Age||years|Mean|37.2|37.2|Standard Deviation|2.2|2.2|||
4060473|NCT01075763|3882061|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4060474|NCT01075763|3882062|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4060475|NCT01075763|3882063|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4060476|NCT01075763|3882061|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4060477|NCT01075763|3882062|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4060478|NCT01075763|3882063|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4060479|NCT01075763|3882061|B3|||Age||years|Mean|63.71|63.71|Standard Deviation|7.87|7.87|||
4060480|NCT01075763|3882062|B2|||Age||years|Mean|64.58|64.58|Standard Deviation|6.41|6.41|||
4060481|NCT01075763|3882063|B1|||Age||years|Mean|63.00|63.0|Standard Deviation|9.08|9.08|||
4060482|NCT01075685|3882086|B3|||Weekly alcohol intake at baseline|"Number of participants for this measure: 225 in intervention group, 263 in control group.~The unit of standard drink is a drink containing 10g of pure alcohol. Participants had to report their weekly alcohol intake in a diary, in which they could choose among 21 glasses of various capacities and containing various alcoholic drinks. Each of those glasses was then converted into standard drinks."|standard drinks|Mean|16.8|16.8|Standard Deviation|13.3|13.3|||
4060483|NCT01075685|3882087|B2|||Weekly alcohol intake at baseline|"Number of participants for this measure: 225 in intervention group, 263 in control group.~The unit of standard drink is a drink containing 10g of pure alcohol. Participants had to report their weekly alcohol intake in a diary, in which they could choose among 21 glasses of various capacities and containing various alcoholic drinks. Each of those glasses was then converted into standard drinks."|standard drinks|Mean|16.2|16.2|Standard Deviation|13.2|13.2|||
4060484|NCT01075685|3882088|B1|||Weekly alcohol intake at baseline|"Number of participants for this measure: 225 in intervention group, 263 in control group.~The unit of standard drink is a drink containing 10g of pure alcohol. Participants had to report their weekly alcohol intake in a diary, in which they could choose among 21 glasses of various capacities and containing various alcoholic drinks. Each of those glasses was then converted into standard drinks."|standard drinks|Mean|17.5|17.5|Standard Deviation|13.3|13.3|||
4060485|NCT01075685|3882086|B3|||AUDIT score|"The Alcohol Use Disorders Identification Test (AUDIT) consists of 10 questions about recent alcohol use, alcohol dependence symptoms, and alcohol-related problems. Each question has a set of responses to choose from, and each response has a score ranging from 0 to 4. All the response scores are then added, which gives the AUDIT score.~AUDIT score ranges from 0 to 40 and is interpreted as follows:~5 (female) / 6 (male) or less: low-risk drinking~6 (female) / 7 (male) to 12: hazardous drinking~13 or more: possible alcohol dependence."|Units on a scale|Mean|8.7|8.7|Standard Deviation|1.8|1.8|||
4060486|NCT01075685|3882087|B2|||AUDIT score|"The Alcohol Use Disorders Identification Test (AUDIT) consists of 10 questions about recent alcohol use, alcohol dependence symptoms, and alcohol-related problems. Each question has a set of responses to choose from, and each response has a score ranging from 0 to 4. All the response scores are then added, which gives the AUDIT score.~AUDIT score ranges from 0 to 40 and is interpreted as follows:~5 (female) / 6 (male) or less: low-risk drinking~6 (female) / 7 (male) to 12: hazardous drinking~13 or more: possible alcohol dependence."|Units on a scale|Mean|8.8|8.8|Standard Deviation|1.8|1.8|||
4060487|NCT01075685|3882088|B1|||AUDIT score|"The Alcohol Use Disorders Identification Test (AUDIT) consists of 10 questions about recent alcohol use, alcohol dependence symptoms, and alcohol-related problems. Each question has a set of responses to choose from, and each response has a score ranging from 0 to 4. All the response scores are then added, which gives the AUDIT score.~AUDIT score ranges from 0 to 40 and is interpreted as follows:~5 (female) / 6 (male) or less: low-risk drinking~6 (female) / 7 (male) to 12: hazardous drinking~13 or more: possible alcohol dependence."|Units on a scale|Mean|8.7|8.7|Standard Deviation|1.9|1.9|||
4060488|NCT01075685|3882086|B3||Male|Sex: Female, Male||Participants|Count of Participants|785|785.0||||||
4060489|NCT01075685|3882087|B2||Male|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
4060490|NCT01075685|3882088|B1||Male|Sex: Female, Male||Participants|Count of Participants|502|502.0||||||
4060491|NCT01075685|3882086|B3||Female|Sex: Female, Male||Participants|Count of Participants|362|362.0||||||
4060492|NCT01075685|3882087|B2||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4060493|NCT01075685|3882088|B1||Female|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
4060494|NCT01075685|3882086|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4060495|NCT01075685|3882087|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4060496|NCT01075685|3882088|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4060497|NCT01075685|3882086|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1126|1126.0||||||
4060498|NCT01075685|3882087|B2||Between 18 and 65 years|Age||Participants|Count of Participants|408|408.0||||||
4060499|NCT01075685|3882088|B1||Between 18 and 65 years|Age||Participants|Count of Participants|718|718.0||||||
4060500|NCT01075685|3882086|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4060501|NCT01075685|3882087|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4060502|NCT01075685|3882088|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4060503|NCT01075646|3882101|B5|||Size of incision||cm|Median|23.79|23.79|Inter-Quartile Range|||4.0|37.0|
4060504|NCT01075646|3882102|B4|||Size of incision||cm|Median|29.67|29.67|Inter-Quartile Range|||27.69|31.65|
4060505|NCT01075646|3882103|B3|||Size of incision||cm|Median|31.5|31.5|Inter-Quartile Range|||29.19|33.82|
4060506|NCT01075646|3882104|B2|||Size of incision||cm|Median|17.5|17.5|Inter-Quartile Range|||5.0|37.0|
4060507|NCT01075646|3882105|B1|||Size of incision||cm|Median|16.5|16.5|Inter-Quartile Range|||4.0|40.0|
4060508|NCT01075646|3882101|B5|||Duration of surgery||minutes|Median|241.95|241.95|Inter-Quartile Range|||80.0|420.0|
4060509|NCT01075646|3882102|B4|||Duration of surgery||minutes|Median|263.57|263.57|Inter-Quartile Range|||240.42|286.73|
4060510|NCT01075646|3882103|B3|||Duration of surgery||minutes|Median|274.26|274.26|Inter-Quartile Range|||254.95|293.58|
4060511|NCT01075646|3882104|B2|||Duration of surgery||minutes|Median|225|225.0|Inter-Quartile Range|||90.0|420.0|
4060512|NCT01075646|3882105|B1|||Duration of surgery||minutes|Median|205|205.0|Inter-Quartile Range|||80.0|410.0|
4060513|NCT01075646|3882101|B5|radiofrequency||Surgical procedure||participants|Number|1|1.0||||||
4060514|NCT01075646|3882102|B4|radiofrequency||Surgical procedure||participants|Number|0|0.0||||||
4060515|NCT01075646|3882103|B3|radiofrequency||Surgical procedure||participants|Number|1|1.0||||||
4060516|NCT01075646|3882104|B2|radiofrequency||Surgical procedure||participants|Number|0|0.0||||||
4060517|NCT01075646|3882105|B1|radiofrequency||Surgical procedure||participants|Number|0|0.0||||||
4060518|NCT01075646|3882101|B5|minor hepatectomy||Surgical procedure||participants|Number|59|59.0||||||
4060519|NCT01075646|3882102|B4|minor hepatectomy||Surgical procedure||participants|Number|29|29.0||||||
4060520|NCT01075646|3882103|B3|minor hepatectomy||Surgical procedure||participants|Number|30|30.0||||||
4060521|NCT01075646|3882104|B2|minor hepatectomy||Surgical procedure||participants|Number|0|0.0||||||
4060522|NCT01075646|3882105|B1|minor hepatectomy||Surgical procedure||participants|Number|0|0.0||||||
4060523|NCT01075646|3882101|B5|mayor hepatectomy||Surgical procedure||participants|Number|39|39.0||||||
4060524|NCT01075646|3882102|B4|mayor hepatectomy||Surgical procedure||participants|Number|17|17.0||||||
4060525|NCT01075646|3882103|B3|mayor hepatectomy||Surgical procedure||participants|Number|22|22.0||||||
4060526|NCT01075646|3882104|B2|mayor hepatectomy||Surgical procedure||participants|Number|0|0.0||||||
4060527|NCT01075646|3882105|B1|mayor hepatectomy||Surgical procedure||participants|Number|0|0.0||||||
4060528|NCT01075646|3882101|B5|Rectal resections||Surgical procedure||participants|Number|21|21.0||||||
4060529|NCT01075646|3882102|B4|Rectal resections||Surgical procedure||participants|Number|0|0.0||||||
4060530|NCT01075646|3882103|B3|Rectal resections||Surgical procedure||participants|Number|0|0.0||||||
4060531|NCT01075646|3882104|B2|Rectal resections||Surgical procedure||participants|Number|10|10.0||||||
4060532|NCT01075646|3882105|B1|Rectal resections||Surgical procedure||participants|Number|11|11.0||||||
4060533|NCT01075646|3882101|B5|Total colectomy||Surgical procedure||participants|Number|5|5.0||||||
4060534|NCT01075646|3882102|B4|Total colectomy||Surgical procedure||participants|Number|0|0.0||||||
4060535|NCT01075646|3882103|B3|Total colectomy||Surgical procedure||participants|Number|0|0.0||||||
4060536|NCT01075646|3882104|B2|Total colectomy||Surgical procedure||participants|Number|4|4.0||||||
4060537|NCT01075646|3882105|B1|Total colectomy||Surgical procedure||participants|Number|1|1.0||||||
4060538|NCT01075646|3882101|B5|Left hemicolectomy||Surgical procedure||participants|Number|29|29.0||||||
4060539|NCT01075646|3882102|B4|Left hemicolectomy||Surgical procedure||participants|Number|0|0.0||||||
4060540|NCT01075646|3882103|B3|Left hemicolectomy||Surgical procedure||participants|Number|0|0.0||||||
4060541|NCT01075646|3882104|B2|Left hemicolectomy||Surgical procedure||participants|Number|15|15.0||||||
4060542|NCT01075646|3882105|B1|Left hemicolectomy||Surgical procedure||participants|Number|14|14.0||||||
4060543|NCT01075646|3882101|B5|Right hemicolectomy||Surgical procedure||participants|Number|12|12.0||||||
4060544|NCT01075646|3882102|B4|Right hemicolectomy||Surgical procedure||participants|Number|0|0.0||||||
4060545|NCT01075646|3882103|B3|Right hemicolectomy||Surgical procedure||participants|Number|0|0.0||||||
4060546|NCT01075646|3882104|B2|Right hemicolectomy||Surgical procedure||participants|Number|5|5.0||||||
4060547|NCT01075646|3882105|B1|Right hemicolectomy||Surgical procedure||participants|Number|7|7.0||||||
4060548|NCT01075646|3882101|B5|No||Chronic respiratory insuficiency||participants|Number|159|159.0||||||
4060549|NCT01075646|3882102|B4|No||Chronic respiratory insuficiency||participants|Number|46|46.0||||||
4060550|NCT01075646|3882103|B3|No||Chronic respiratory insuficiency||participants|Number|52|52.0||||||
4060551|NCT01075646|3882104|B2|No||Chronic respiratory insuficiency||participants|Number|34|34.0||||||
4060552|NCT01075646|3882105|B1|No||Chronic respiratory insuficiency||participants|Number|27|27.0||||||
4060553|NCT01075646|3882101|B5|Yes||Chronic respiratory insuficiency||participants|Number|7|7.0||||||
4060554|NCT01075646|3882102|B4|Yes||Chronic respiratory insuficiency||participants|Number|0|0.0||||||
4060555|NCT01075646|3882103|B3|Yes||Chronic respiratory insuficiency||participants|Number|1|1.0||||||
4060556|NCT01075646|3882104|B2|Yes||Chronic respiratory insuficiency||participants|Number|0|0.0||||||
4060557|NCT01075646|3882105|B1|Yes||Chronic respiratory insuficiency||participants|Number|6|6.0||||||
4060558|NCT01075646|3882101|B5|No||Myocardial disease||participants|Number|161|161.0||||||
4060559|NCT01075646|3882102|B4|No||Myocardial disease||participants|Number|44|44.0||||||
4060560|NCT01075646|3882103|B3|No||Myocardial disease||participants|Number|51|51.0||||||
4060561|NCT01075646|3882104|B2|No||Myocardial disease||participants|Number|34|34.0||||||
4060562|NCT01075646|3882105|B1|No||Myocardial disease||participants|Number|32|32.0||||||
4060563|NCT01075646|3882101|B5|Yes||Myocardial disease||participants|Number|5|5.0||||||
4060564|NCT01075646|3882102|B4|Yes||Myocardial disease||participants|Number|2|2.0||||||
4060565|NCT01075646|3882103|B3|Yes||Myocardial disease||participants|Number|2|2.0||||||
4060566|NCT01075646|3882104|B2|Yes||Myocardial disease||participants|Number|0|0.0||||||
4060567|NCT01075646|3882105|B1|Yes||Myocardial disease||participants|Number|1|1.0||||||
4060568|NCT01075646|3882101|B5|No||Stroke||participants|Number|158|158.0||||||
4060569|NCT01075646|3882102|B4|No||Stroke||participants|Number|44|44.0||||||
4060570|NCT01075646|3882103|B3|No||Stroke||participants|Number|51|51.0||||||
4060571|NCT01075646|3882104|B2|No||Stroke||participants|Number|33|33.0||||||
4060572|NCT01075646|3882105|B1|No||Stroke||participants|Number|30|30.0||||||
4060573|NCT01075646|3882101|B5|Yes||Stroke||participants|Number|8|8.0||||||
4060574|NCT01075646|3882102|B4|Yes||Stroke||participants|Number|2|2.0||||||
4060575|NCT01075646|3882103|B3|Yes||Stroke||participants|Number|2|2.0||||||
4060576|NCT01075646|3882104|B2|Yes||Stroke||participants|Number|1|1.0||||||
4060577|NCT01075646|3882105|B1|Yes||Stroke||participants|Number|3|3.0||||||
4060578|NCT01075646|3882101|B5|No||Anemia||participants|Number|157|157.0||||||
4060579|NCT01075646|3882102|B4|No||Anemia||participants|Number|44|44.0||||||
4060580|NCT01075646|3882103|B3|No||Anemia||participants|Number|51|51.0||||||
4060581|NCT01075646|3882104|B2|No||Anemia||participants|Number|32|32.0||||||
4060582|NCT01075646|3882105|B1|No||Anemia||participants|Number|30|30.0||||||
4060583|NCT01075646|3882101|B5|Yes||Anemia||participants|Number|9|9.0||||||
4060584|NCT01075646|3882102|B4|Yes||Anemia||participants|Number|2|2.0||||||
4060585|NCT01075646|3882103|B3|Yes||Anemia||participants|Number|2|2.0||||||
4060586|NCT01075646|3882104|B2|Yes||Anemia||participants|Number|2|2.0||||||
4060587|NCT01075646|3882105|B1|Yes||Anemia||participants|Number|3|3.0||||||
4060588|NCT01075646|3882101|B5|No||Antiplatelet drugs||participants|Number|153|153.0||||||
4060589|NCT01075646|3882102|B4|No||Antiplatelet drugs||participants|Number|45|45.0||||||
4060590|NCT01075646|3882103|B3|No||Antiplatelet drugs||participants|Number|50|50.0||||||
4060591|NCT01075646|3882104|B2|No||Antiplatelet drugs||participants|Number|30|30.0||||||
4060592|NCT01075646|3882105|B1|No||Antiplatelet drugs||participants|Number|28|28.0||||||
4060593|NCT01075646|3882101|B5|Yes||Antiplatelet drugs||participants|Number|13|13.0||||||
4060594|NCT01075646|3882102|B4|Yes||Antiplatelet drugs||participants|Number|1|1.0||||||
4060595|NCT01075646|3882103|B3|Yes||Antiplatelet drugs||participants|Number|3|3.0||||||
4060596|NCT01075646|3882104|B2|Yes||Antiplatelet drugs||participants|Number|4|4.0||||||
4060597|NCT01075646|3882105|B1|Yes||Antiplatelet drugs||participants|Number|5|5.0||||||
4060598|NCT01075646|3882101|B5|No||Diabetes||participants|Number|128|128.0||||||
4060599|NCT01075646|3882102|B4|No||Diabetes||participants|Number|35|35.0||||||
4060600|NCT01075646|3882103|B3|No||Diabetes||participants|Number|43|43.0||||||
4060601|NCT01075646|3882104|B2|No||Diabetes||participants|Number|27|27.0||||||
4060602|NCT01075646|3882105|B1|No||Diabetes||participants|Number|23|23.0||||||
4060603|NCT01075646|3882101|B5|Yes||Diabetes||participants|Number|38|38.0||||||
4060604|NCT01075646|3882102|B4|Yes||Diabetes||participants|Number|11|11.0||||||
4060605|NCT01075646|3882103|B3|Yes||Diabetes||participants|Number|10|10.0||||||
4060606|NCT01075646|3882104|B2|Yes||Diabetes||participants|Number|7|7.0||||||
4060607|NCT01075646|3882105|B1|Yes||Diabetes||participants|Number|10|10.0||||||
4060608|NCT01075646|3882101|B5|No||Hypertension||participants|Number|96|96.0||||||
4060609|NCT01075646|3882102|B4|No||Hypertension||participants|Number|31|31.0||||||
4060610|NCT01075646|3882103|B3|No||Hypertension||participants|Number|30|30.0||||||
4060611|NCT01075646|3882104|B2|No||Hypertension||participants|Number|17|17.0||||||
4060612|NCT01075646|3882105|B1|No||Hypertension||participants|Number|18|18.0||||||
4060613|NCT01075646|3882101|B5|Yes||Hypertension||participants|Number|70|70.0||||||
4060614|NCT01075646|3882102|B4|Yes||Hypertension||participants|Number|15|15.0||||||
4060615|NCT01075646|3882103|B3|Yes||Hypertension||participants|Number|23|23.0||||||
4060616|NCT01075646|3882104|B2|Yes||Hypertension||participants|Number|17|17.0||||||
4060617|NCT01075646|3882105|B1|Yes||Hypertension||participants|Number|15|15.0||||||
4060618|NCT01075646|3882101|B5||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4060619|NCT01075646|3882102|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4060620|NCT01075646|3882103|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4060621|NCT01075646|3882104|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4060622|NCT01075646|3882105|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4060623|NCT01075646|3882101|B5||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4060624|NCT01075646|3882102|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4060625|NCT01075646|3882103|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4060626|NCT01075646|3882104|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4060627|NCT01075646|3882105|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4060628|NCT01075646|3882101|B5|||Age||years|Median|62.96|62.96|Inter-Quartile Range|||18.0|80.0|
4060629|NCT01075646|3882102|B4|||Age||years|Median|59.73|59.73|Inter-Quartile Range|||56.54|62.92|
4060630|NCT01075646|3882103|B3|||Age||years|Median|63.62|63.62|Inter-Quartile Range|||61.38|65.85|
4060631|NCT01075646|3882104|B2|||Age||years|Median|64.5|64.5|Inter-Quartile Range|||18.0|78.0|
4060632|NCT01075646|3882105|B1|||Age||years|Median|64|64.0|Inter-Quartile Range|||41.0|80.0|
4060633|NCT01075412|3882138|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4060634|NCT01075412|3882139|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4060635|NCT01075412|3882140|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4060636|NCT01075412|3882138|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4060637|NCT01075412|3882139|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4060638|NCT01075412|3882140|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4060639|NCT01075412|3882138|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4060640|NCT01075412|3882139|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4060641|NCT01075412|3882140|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4060642|NCT01075412|3882138|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4060643|NCT01075412|3882139|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4060644|NCT01075412|3882140|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4060645|NCT01075412|3882138|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4060646|NCT01075412|3882139|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4060647|NCT01075412|3882140|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4060648|NCT01075412|3882138|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4060649|NCT01075412|3882139|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4060650|NCT01075412|3882140|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4060651|NCT01075399|3882151|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4060652|NCT01075399|3882151|B1|Korea, Republic of||Region of Enrollment||participants|Number|10|10.0||||||
4060653|NCT01075399|3882151|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4060654|NCT01075399|3882151|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4060655|NCT01075399|3882151|B1|||Age||years|Mean|59.0|59.0|Standard Deviation|9.35|9.35|||
4060656|NCT01075399|3882151|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4060657|NCT01075399|3882151|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4060658|NCT01075399|3882151|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4060659|NCT01075347|3882155|B3|Taiwan||Region of Enrollment||participants|Number|165|165.0||||||
4060660|NCT01075347|3882156|B2|Taiwan||Region of Enrollment||participants|Number|83|83.0||||||
4060661|NCT01075347|3882157|B1|Taiwan||Region of Enrollment||participants|Number|82|82.0||||||
4060662|NCT01075347|3882155|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4060663|NCT01075347|3882156|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4060664|NCT01075347|3882157|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4060665|NCT01075347|3882155|B3||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4060666|NCT01075347|3882156|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4060667|NCT01075347|3882157|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4060668|NCT01075347|3882155|B3|||Age||years|Mean|60.3|60.3|Standard Deviation|19.3|19.3|||
4060669|NCT01075347|3882156|B2|||Age||years|Mean|59.8|59.8|Standard Deviation|17.6|17.6|||
4060670|NCT01075347|3882157|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|18.1|18.1|||
4060671|NCT01075347|3882155|B3||>=65 years|Age||Participants|Count of Participants|78|78.0||||||
4060672|NCT01075347|3882156|B2||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4060673|NCT01075347|3882157|B1||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
4060674|NCT01075347|3882155|B3||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
4060675|NCT01075347|3882156|B2||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4060676|NCT01075347|3882157|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4060677|NCT01075347|3882155|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4060678|NCT01075347|3882156|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4060679|NCT01075347|3882157|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4060680|NCT01075282|3882166|B4|||Fasting Serum Glucose||millimoles per liter (mmol/L)|Mean|9.07|9.07|Standard Deviation|2.69|2.69|||
4060681|NCT01075282|3882167|B3|||Fasting Serum Glucose||millimoles per liter (mmol/L)|Mean|9.08|9.08|Standard Deviation|2.66|2.66|||
4060682|NCT01075282|3882168|B2|||Fasting Serum Glucose||millimoles per liter (mmol/L)|Mean|8.96|8.96|Standard Deviation|2.70|2.7|||
4060683|NCT01075282|3882169|B1|||Fasting Serum Glucose||millimoles per liter (mmol/L)|Mean|9.16|9.16|Standard Deviation|2.73|2.73|||
4060684|NCT01075282|3882166|B4|||Duration of Diabetes||years|Mean|9.10|9.1|Standard Deviation|6.04|6.04|||
4060685|NCT01075282|3882167|B3|||Duration of Diabetes||years|Mean|8.87|8.87|Standard Deviation|5.98|5.98|||
4060686|NCT01075282|3882168|B2|||Duration of Diabetes||years|Mean|9.28|9.28|Standard Deviation|5.93|5.93|||
4060687|NCT01075282|3882169|B1|||Duration of Diabetes||years|Mean|9.13|9.13|Standard Deviation|6.22|6.22|||
4060688|NCT01075282|3882166|B4|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|8.14|8.14|Standard Deviation|0.99|0.99|||
4060689|NCT01075282|3882167|B3|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|8.10|8.1|Standard Deviation|0.95|0.95|||
4060690|NCT01075282|3882168|B2|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|8.13|8.13|Standard Deviation|0.98|0.98|||
4060691|NCT01075282|3882169|B1|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|8.18|8.18|Standard Deviation|1.03|1.03|||
4060692|NCT01075282|3882166|B4|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|31.55|31.55|Standard Deviation|5.46|5.46|||
4060693|NCT01075282|3882167|B3|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|31.91|31.91|Standard Deviation|5.76|5.76|||
4060694|NCT01075282|3882168|B2|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|31.51|31.51|Standard Deviation|5.41|5.41|||
4060695|NCT01075282|3882169|B1|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|31.23|31.23|Standard Deviation|5.21|5.21|||
4060696|NCT01075282|3882166|B4|||Body Weight||kilograms|Mean|86.31|86.31|Standard Deviation|18.56|18.56|||
4060697|NCT01075282|3882167|B3|||Body Weight||kilograms|Mean|87.66|87.66|Standard Deviation|19.62|19.62|||
4060698|NCT01075282|3882168|B2|||Body Weight||kilograms|Mean|86.18|86.18|Standard Deviation|18.15|18.15|||
4060699|NCT01075282|3882169|B1|||Body Weight||kilograms|Mean|85.13|85.13|Standard Deviation|17.90|17.9|||
4060700|NCT01075282|3882166|B4|Korea, Republic of||Region of Enrollment||participants|Number|5|5.0||||||
4060701|NCT01075282|3882167|B3|Korea, Republic of||Region of Enrollment||participants|Number|1|1.0||||||
4060702|NCT01075282|3882168|B2|Korea, Republic of||Region of Enrollment||participants|Number|3|3.0||||||
4060703|NCT01075282|3882169|B1|Korea, Republic of||Region of Enrollment||participants|Number|1|1.0||||||
4060704|NCT01075282|3882166|B4|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
4060705|NCT01075282|3882167|B3|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
4060706|NCT01075282|3882168|B2|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
4060707|NCT01075282|3882169|B1|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
4060708|NCT01075282|3882166|B4|Australia||Region of Enrollment||participants|Number|39|39.0||||||
4060709|NCT01075282|3882167|B3|Australia||Region of Enrollment||participants|Number|13|13.0||||||
4060710|NCT01075282|3882168|B2|Australia||Region of Enrollment||participants|Number|13|13.0||||||
4060711|NCT01075282|3882169|B1|Australia||Region of Enrollment||participants|Number|13|13.0||||||
4060712|NCT01075282|3882166|B4|Romania||Region of Enrollment||participants|Number|67|67.0||||||
4060713|NCT01075282|3882167|B3|Romania||Region of Enrollment||participants|Number|22|22.0||||||
4060714|NCT01075282|3882168|B2|Romania||Region of Enrollment||participants|Number|22|22.0||||||
4060715|NCT01075282|3882169|B1|Romania||Region of Enrollment||participants|Number|23|23.0||||||
4060716|NCT01075282|3882166|B4|Croatia||Region of Enrollment||participants|Number|11|11.0||||||
4060717|NCT01075282|3882167|B3|Croatia||Region of Enrollment||participants|Number|4|4.0||||||
4060718|NCT01075282|3882168|B2|Croatia||Region of Enrollment||participants|Number|4|4.0||||||
4060719|NCT01075282|3882169|B1|Croatia||Region of Enrollment||participants|Number|3|3.0||||||
4060720|NCT01075282|3882166|B4|Poland||Region of Enrollment||participants|Number|51|51.0||||||
4060721|NCT01075282|3882167|B3|Poland||Region of Enrollment||participants|Number|17|17.0||||||
4060722|NCT01075282|3882168|B2|Poland||Region of Enrollment||participants|Number|18|18.0||||||
4060723|NCT01075282|3882169|B1|Poland||Region of Enrollment||participants|Number|16|16.0||||||
4060724|NCT01075282|3882166|B4|Brazil||Region of Enrollment||participants|Number|18|18.0||||||
4060725|NCT01075282|3882167|B3|Brazil||Region of Enrollment||participants|Number|7|7.0||||||
4060726|NCT01075282|3882168|B2|Brazil||Region of Enrollment||participants|Number|5|5.0||||||
4060727|NCT01075282|3882169|B1|Brazil||Region of Enrollment||participants|Number|6|6.0||||||
4060728|NCT01075282|3882166|B4|Belgium||Region of Enrollment||participants|Number|15|15.0||||||
4060729|NCT01075282|3882167|B3|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
4060730|NCT01075282|3882168|B2|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
4060731|NCT01075282|3882169|B1|Belgium||Region of Enrollment||participants|Number|7|7.0||||||
4060732|NCT01075282|3882166|B4|Argentina||Region of Enrollment||participants|Number|163|163.0||||||
4060733|NCT01075282|3882167|B3|Argentina||Region of Enrollment||participants|Number|54|54.0||||||
4060734|NCT01075282|3882168|B2|Argentina||Region of Enrollment||participants|Number|54|54.0||||||
4060735|NCT01075282|3882169|B1|Argentina||Region of Enrollment||participants|Number|55|55.0||||||
4060736|NCT01075282|3882166|B4|Canada||Region of Enrollment||participants|Number|75|75.0||||||
4060737|NCT01075282|3882167|B3|Canada||Region of Enrollment||participants|Number|24|24.0||||||
4060738|NCT01075282|3882168|B2|Canada||Region of Enrollment||participants|Number|25|25.0||||||
4060739|NCT01075282|3882169|B1|Canada||Region of Enrollment||participants|Number|26|26.0||||||
4060740|NCT01075282|3882166|B4|Mexico||Region of Enrollment||participants|Number|84|84.0||||||
4060741|NCT01075282|3882167|B3|Mexico||Region of Enrollment||participants|Number|27|27.0||||||
4060742|NCT01075282|3882168|B2|Mexico||Region of Enrollment||participants|Number|28|28.0||||||
4060743|NCT01075282|3882169|B1|Mexico||Region of Enrollment||participants|Number|29|29.0||||||
4060744|NCT01075282|3882166|B4|Hungary||Region of Enrollment||participants|Number|47|47.0||||||
4060745|NCT01075282|3882167|B3|Hungary||Region of Enrollment||participants|Number|15|15.0||||||
4060746|NCT01075282|3882168|B2|Hungary||Region of Enrollment||participants|Number|16|16.0||||||
4060747|NCT01075282|3882169|B1|Hungary||Region of Enrollment||participants|Number|16|16.0||||||
4060748|NCT01075282|3882166|B4|Czech Republic||Region of Enrollment||participants|Number|39|39.0||||||
4060749|NCT01075282|3882167|B3|Czech Republic||Region of Enrollment||participants|Number|13|13.0||||||
4060750|NCT01075282|3882168|B2|Czech Republic||Region of Enrollment||participants|Number|14|14.0||||||
4060751|NCT01075282|3882169|B1|Czech Republic||Region of Enrollment||participants|Number|12|12.0||||||
4060752|NCT01075282|3882166|B4|France||Region of Enrollment||participants|Number|6|6.0||||||
4060753|NCT01075282|3882167|B3|France||Region of Enrollment||participants|Number|1|1.0||||||
4060754|NCT01075282|3882168|B2|France||Region of Enrollment||participants|Number|3|3.0||||||
4060755|NCT01075282|3882169|B1|France||Region of Enrollment||participants|Number|2|2.0||||||
4060756|NCT01075282|3882166|B4|India||Region of Enrollment||participants|Number|84|84.0||||||
4060757|NCT01075282|3882167|B3|India||Region of Enrollment||participants|Number|27|27.0||||||
4060758|NCT01075282|3882168|B2|India||Region of Enrollment||participants|Number|27|27.0||||||
4060759|NCT01075282|3882169|B1|India||Region of Enrollment||participants|Number|30|30.0||||||
4060760|NCT01075282|3882166|B4|Italy||Region of Enrollment||participants|Number|6|6.0||||||
4060761|NCT01075282|3882167|B3|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4060762|NCT01075282|3882168|B2|Italy||Region of Enrollment||participants|Number|3|3.0||||||
4060763|NCT01075282|3882169|B1|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4060764|NCT01075282|3882166|B4|Spain||Region of Enrollment||participants|Number|35|35.0||||||
4060765|NCT01075282|3882167|B3|Spain||Region of Enrollment||participants|Number|13|13.0||||||
4060766|NCT01075282|3882168|B2|Spain||Region of Enrollment||participants|Number|12|12.0||||||
4060767|NCT01075282|3882169|B1|Spain||Region of Enrollment||participants|Number|10|10.0||||||
4060768|NCT01075282|3882166|B4|Greece||Region of Enrollment||participants|Number|19|19.0||||||
4060769|NCT01075282|3882167|B3|Greece||Region of Enrollment||participants|Number|7|7.0||||||
4060770|NCT01075282|3882168|B2|Greece||Region of Enrollment||participants|Number|6|6.0||||||
4060771|NCT01075282|3882169|B1|Greece||Region of Enrollment||participants|Number|6|6.0||||||
4060772|NCT01075282|3882166|B4|Slovakia||Region of Enrollment||participants|Number|2|2.0||||||
4060773|NCT01075282|3882167|B3|Slovakia||Region of Enrollment||participants|Number|0|0.0||||||
4060774|NCT01075282|3882168|B2|Slovakia||Region of Enrollment||participants|Number|1|1.0||||||
4060775|NCT01075282|3882169|B1|Slovakia||Region of Enrollment||participants|Number|1|1.0||||||
4060776|NCT01075282|3882166|B4|Taiwan||Region of Enrollment||participants|Number|38|38.0||||||
4060777|NCT01075282|3882167|B3|Taiwan||Region of Enrollment||participants|Number|12|12.0||||||
4060778|NCT01075282|3882168|B2|Taiwan||Region of Enrollment||participants|Number|13|13.0||||||
4060779|NCT01075282|3882169|B1|Taiwan||Region of Enrollment||participants|Number|13|13.0||||||
4060780|NCT01075282|3882166|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060781|NCT01075282|3882167|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060782|NCT01075282|3882168|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060783|NCT01075282|3882169|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060784|NCT01075282|3882166|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4060785|NCT01075282|3882167|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4060786|NCT01075282|3882168|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4060787|NCT01075282|3882169|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4060788|NCT01075282|3882166|B4||White|Race (NIH/OMB)||Participants|Count of Participants|570|570.0||||||
4060789|NCT01075282|3882167|B3||White|Race (NIH/OMB)||Participants|Count of Participants|184|184.0||||||
4060790|NCT01075282|3882168|B2||White|Race (NIH/OMB)||Participants|Count of Participants|193|193.0||||||
4060791|NCT01075282|3882169|B1||White|Race (NIH/OMB)||Participants|Count of Participants|193|193.0||||||
4060792|NCT01075282|3882166|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4060793|NCT01075282|3882167|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4060794|NCT01075282|3882168|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4060795|NCT01075282|3882169|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4060796|NCT01075282|3882166|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060797|NCT01075282|3882167|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060798|NCT01075282|3882168|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060799|NCT01075282|3882169|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060800|NCT01075282|3882166|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|137|137.0||||||
4060801|NCT01075282|3882167|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4060802|NCT01075282|3882168|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4060803|NCT01075282|3882169|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4060804|NCT01075282|3882166|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
4060805|NCT01075282|3882167|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4060806|NCT01075282|3882168|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4060807|NCT01075282|3882169|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4060808|NCT01075282|3882166|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060809|NCT01075282|3882167|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060810|NCT01075282|3882168|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060811|NCT01075282|3882169|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060812|NCT01075282|3882166|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|516|516.0||||||
4060813|NCT01075282|3882167|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|165|165.0||||||
4060814|NCT01075282|3882168|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|176|176.0||||||
4060815|NCT01075282|3882169|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|175|175.0||||||
4060816|NCT01075282|3882166|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|291|291.0||||||
4060817|NCT01075282|3882167|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
4060818|NCT01075282|3882168|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4060819|NCT01075282|3882169|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
4060820|NCT01075282|3882166|B4||Male|Sex: Female, Male||Participants|Count of Participants|414|414.0||||||
4060821|NCT01075282|3882167|B3||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4060822|NCT01075282|3882168|B2||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4060823|NCT01075282|3882169|B1||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4060824|NCT01075282|3882166|B4||Female|Sex: Female, Male||Participants|Count of Participants|393|393.0||||||
4060825|NCT01075282|3882167|B3||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4060826|NCT01075282|3882168|B2||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4060827|NCT01075282|3882169|B1||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4060828|NCT01075282|3882166|B4|||Age||years|Mean|56.66|56.66|Standard Deviation|9.47|9.47|||
4060829|NCT01075282|3882167|B3|||Age||years|Mean|57.21|57.21|Standard Deviation|9.38|9.38|||
4060830|NCT01075282|3882168|B2|||Age||years|Mean|56.56|56.56|Standard Deviation|9.27|9.27|||
4060831|NCT01075282|3882169|B1|||Age||years|Mean|56.24|56.24|Standard Deviation|9.76|9.76|||
4060832|NCT01075256|3882251|B4||Male|Sex: Female, Male|Safety population reported as treated- one randomized participant in the High concentration group received placebo and is included in the placebo count.|Participants|Count of Participants|41|41.0||||||
4060833|NCT01075256|3882252|B3||Male|Sex: Female, Male|Safety population reported as treated- one randomized participant in the High concentration group received placebo and is included in the placebo count.|Participants|Count of Participants|12|12.0||||||
4060834|NCT01075256|3882253|B2||Male|Sex: Female, Male|Safety population reported as treated- one randomized participant in the High concentration group received placebo and is included in the placebo count.|Participants|Count of Participants|14|14.0||||||
4060835|NCT01075256|3882254|B1||Male|Sex: Female, Male|Safety population reported as treated- one randomized participant in the High concentration group received placebo and is included in the placebo count.|Participants|Count of Participants|15|15.0||||||
4060836|NCT01075256|3882251|B4||Female|Sex: Female, Male|Safety population reported as treated- one randomized participant in the High concentration group received placebo and is included in the placebo count.|Participants|Count of Participants|154|154.0||||||
4060837|NCT01075256|3882252|B3||Female|Sex: Female, Male|Safety population reported as treated- one randomized participant in the High concentration group received placebo and is included in the placebo count.|Participants|Count of Participants|54|54.0||||||
4060838|NCT01075256|3882253|B2||Female|Sex: Female, Male|Safety population reported as treated- one randomized participant in the High concentration group received placebo and is included in the placebo count.|Participants|Count of Participants|49|49.0||||||
4060839|NCT01075256|3882254|B1||Female|Sex: Female, Male|Safety population reported as treated- one randomized participant in the High concentration group received placebo and is included in the placebo count.|Participants|Count of Participants|51|51.0||||||
4060840|NCT01075256|3882251|B4|||Age||years|Mean|37.51|37.51|Standard Deviation|9.239|9.239|||
4060841|NCT01075256|3882252|B3|||Age||years|Mean|36.61|36.61|Standard Deviation|9.885|9.885|||
4060842|NCT01075256|3882253|B2|||Age||years|Mean|37.63|37.63|Standard Deviation|8.920|8.92|||
4060843|NCT01075256|3882254|B1|||Age||years|Mean|38.30|38.3|Standard Deviation|8.925|8.925|||
4060844|NCT01075243|3882285|B4|Severe||Number of participants with pain severity score measured on a rating scale|Pain severity score was assessed on a 4-point categorical verbal rating scale. Total possible pain severity score range was no pain, mild pain, moderate and severe.|Participants|Number|133|133.0||||||
4060845|NCT01075243|3882286|B3|Severe||Number of participants with pain severity score measured on a rating scale|Pain severity score was assessed on a 4-point categorical verbal rating scale. Total possible pain severity score range was no pain, mild pain, moderate and severe.|Participants|Number|27|27.0||||||
4060846|NCT01075243|3882287|B2|Severe||Number of participants with pain severity score measured on a rating scale|Pain severity score was assessed on a 4-point categorical verbal rating scale. Total possible pain severity score range was no pain, mild pain, moderate and severe.|Participants|Number|52|52.0||||||
4060847|NCT01075243|3882288|B1|Severe||Number of participants with pain severity score measured on a rating scale|Pain severity score was assessed on a 4-point categorical verbal rating scale. Total possible pain severity score range was no pain, mild pain, moderate and severe.|Participants|Number|54|54.0||||||
4060848|NCT01075243|3882285|B4|Moderate||Number of participants with pain severity score measured on a rating scale|Pain severity score was assessed on a 4-point categorical verbal rating scale. Total possible pain severity score range was no pain, mild pain, moderate and severe.|Participants|Number|268|268.0||||||
4060849|NCT01075243|3882286|B3|Moderate||Number of participants with pain severity score measured on a rating scale|Pain severity score was assessed on a 4-point categorical verbal rating scale. Total possible pain severity score range was no pain, mild pain, moderate and severe.|Participants|Number|53|53.0||||||
4060850|NCT01075243|3882287|B2|Moderate||Number of participants with pain severity score measured on a rating scale|Pain severity score was assessed on a 4-point categorical verbal rating scale. Total possible pain severity score range was no pain, mild pain, moderate and severe.|Participants|Number|106|106.0||||||
4060910|NCT01075178|3882385|B3|Italy||Region of Enrollment||participants|Number|153|153.0||||||
4060851|NCT01075243|3882288|B1|Moderate||Number of participants with pain severity score measured on a rating scale|Pain severity score was assessed on a 4-point categorical verbal rating scale. Total possible pain severity score range was no pain, mild pain, moderate and severe.|Participants|Number|109|109.0||||||
4060852|NCT01075243|3882285|B4||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4060853|NCT01075243|3882286|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4060854|NCT01075243|3882287|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4060855|NCT01075243|3882288|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4060856|NCT01075243|3882285|B4||Female|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
4060857|NCT01075243|3882286|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4060858|NCT01075243|3882287|B2||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4060859|NCT01075243|3882288|B1||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4060860|NCT01075243|3882285|B4|||Age||Years|Mean|20.2|20.2|Standard Deviation|2.61|2.61|||
4060861|NCT01075243|3882286|B3|||Age||Years|Mean|20.6|20.6|Standard Deviation|2.76|2.76|||
4060862|NCT01075243|3882287|B2|||Age||Years|Mean|20.4|20.4|Standard Deviation|2.81|2.81|||
4060863|NCT01075243|3882288|B1|||Age||Years|Mean|19.7|19.7|Standard Deviation|2.26|2.26|||
4060864|NCT01075217|3882340|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4060865|NCT01075217|3882341|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4060866|NCT01075217|3882342|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4060867|NCT01075217|3882340|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4060868|NCT01075217|3882341|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4060869|NCT01075217|3882342|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4060870|NCT01075217|3882340|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4060871|NCT01075217|3882341|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4060872|NCT01075217|3882342|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4060873|NCT01075217|3882340|B3|White||Race/Ethnicity, Customized||participants|Number|139|139.0||||||
4060874|NCT01075217|3882341|B2|White||Race/Ethnicity, Customized||participants|Number|71|71.0||||||
4060875|NCT01075217|3882342|B1|White||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
4060876|NCT01075217|3882340|B3||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4060877|NCT01075217|3882341|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4060878|NCT01075217|3882342|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4060879|NCT01075217|3882340|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4060880|NCT01075217|3882341|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4060881|NCT01075217|3882342|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4060882|NCT01075217|3882340|B3|||Age||years|Mean|63.6|63.6|Standard Deviation|8.70|8.7|||
4060883|NCT01075217|3882341|B2|||Age||years|Mean|63.1|63.1|Standard Deviation|8.65|8.65|||
4060884|NCT01075217|3882342|B1|||Age||years|Mean|64.1|64.1|Standard Deviation|8.77|8.77|||
4060885|NCT01075204|3882359|B1|Saudi Arabia||Region of Enrollment||participants|Number|215|215.0||||||
4060886|NCT01075204|3882359|B1|Egypt||Region of Enrollment||participants|Number|120|120.0||||||
4060887|NCT01075204|3882359|B1|Missing||Sex/Gender, Customized||participants|Number|8|8.0||||||
4060888|NCT01075204|3882359|B1|Female||Sex/Gender, Customized||participants|Number|122|122.0||||||
4060889|NCT01075204|3882359|B1|Male||Sex/Gender, Customized||participants|Number|205|205.0||||||
4060890|NCT01075204|3882359|B1|||Age|Age data provided for 330 participants.|years|Mean|35.48|35.48|Standard Deviation|12.552|12.552|||
4060891|NCT01075191|3882376|B1|Germany||Region of Enrollment||participants|Number|60|60.0||||||
4060892|NCT01075191|3882376|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4060893|NCT01075191|3882376|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4060894|NCT01075191|3882376|B1|||Age|In 10 participants, age was missing.|years|Mean|44.2|44.2|Standard Deviation|9.0|9.0|||
4060895|NCT01075178|3882385|B3|Fully corrected congenital heart disease||Corrective cardiac surgery||participants|Number|3|3.0||||||
4060896|NCT01075178|3882386|B2|Fully corrected congenital heart disease||Corrective cardiac surgery||participants|Number|3|3.0||||||
4060897|NCT01075178|3882387|B1|Fully corrected congenital heart disease||Corrective cardiac surgery||participants|Number|0|0.0||||||
4060898|NCT01075178|3882385|B3|Partially corrected congenital heart disease||Corrective cardiac surgery||participants|Number|1046|1046.0||||||
4060899|NCT01075178|3882386|B2|Partially corrected congenital heart disease||Corrective cardiac surgery||participants|Number|521|521.0||||||
4060900|NCT01075178|3882387|B1|Partially corrected congenital heart disease||Corrective cardiac surgery||participants|Number|525|525.0||||||
4060901|NCT01075178|3882385|B3|None||Corrective cardiac surgery||participants|Number|969|969.0||||||
4060902|NCT01075178|3882386|B2|None||Corrective cardiac surgery||participants|Number|485|485.0||||||
4060903|NCT01075178|3882387|B1|None||Corrective cardiac surgery||participants|Number|484|484.0||||||
4060904|NCT01075178|3882385|B3|Acyanotic||Cardiac lesion||participants|Number|1043|1043.0||||||
4060905|NCT01075178|3882386|B2|Acyanotic||Cardiac lesion||participants|Number|522|522.0||||||
4060906|NCT01075178|3882387|B1|Acyanotic||Cardiac lesion||participants|Number|521|521.0||||||
4060907|NCT01075178|3882385|B3|Cyanotic||Cardiac lesion||participants|Number|975|975.0||||||
4060908|NCT01075178|3882386|B2|Cyanotic||Cardiac lesion||participants|Number|487|487.0||||||
4060909|NCT01075178|3882387|B1|Cyanotic||Cardiac lesion||participants|Number|488|488.0||||||
4060911|NCT01075178|3882386|B2|Italy||Region of Enrollment||participants|Number|42|42.0||||||
4060912|NCT01075178|3882387|B1|Italy||Region of Enrollment||participants|Number|111|111.0||||||
4060913|NCT01075178|3882385|B3|United Kingdom||Region of Enrollment||participants|Number|151|151.0||||||
4060914|NCT01075178|3882386|B2|United Kingdom||Region of Enrollment||participants|Number|59|59.0||||||
4060915|NCT01075178|3882387|B1|United Kingdom||Region of Enrollment||participants|Number|92|92.0||||||
4060916|NCT01075178|3882385|B3|Germany||Region of Enrollment||participants|Number|187|187.0||||||
4060917|NCT01075178|3882386|B2|Germany||Region of Enrollment||participants|Number|90|90.0||||||
4060918|NCT01075178|3882387|B1|Germany||Region of Enrollment||participants|Number|97|97.0||||||
4060919|NCT01075178|3882385|B3|Norway||Region of Enrollment||participants|Number|19|19.0||||||
4060920|NCT01075178|3882386|B2|Norway||Region of Enrollment||participants|Number|7|7.0||||||
4060921|NCT01075178|3882387|B1|Norway||Region of Enrollment||participants|Number|12|12.0||||||
4060922|NCT01075178|3882385|B3|Austria||Region of Enrollment||participants|Number|149|149.0||||||
4060923|NCT01075178|3882386|B2|Austria||Region of Enrollment||participants|Number|53|53.0||||||
4060924|NCT01075178|3882387|B1|Austria||Region of Enrollment||participants|Number|96|96.0||||||
4060925|NCT01075178|3882385|B3|Belgium||Region of Enrollment||participants|Number|192|192.0||||||
4060926|NCT01075178|3882386|B2|Belgium||Region of Enrollment||participants|Number|115|115.0||||||
4060927|NCT01075178|3882387|B1|Belgium||Region of Enrollment||participants|Number|77|77.0||||||
4060928|NCT01075178|3882385|B3|Poland||Region of Enrollment||participants|Number|278|278.0||||||
4060929|NCT01075178|3882386|B2|Poland||Region of Enrollment||participants|Number|242|242.0||||||
4060930|NCT01075178|3882387|B1|Poland||Region of Enrollment||participants|Number|36|36.0||||||
4060931|NCT01075178|3882385|B3|Spain||Region of Enrollment||participants|Number|454|454.0||||||
4060932|NCT01075178|3882386|B2|Spain||Region of Enrollment||participants|Number|170|170.0||||||
4060933|NCT01075178|3882387|B1|Spain||Region of Enrollment||participants|Number|284|284.0||||||
4060934|NCT01075178|3882385|B3|Slovenia||Region of Enrollment||participants|Number|36|36.0||||||
4060935|NCT01075178|3882386|B2|Slovenia||Region of Enrollment||participants|Number|20|20.0||||||
4060936|NCT01075178|3882387|B1|Slovenia||Region of Enrollment||participants|Number|16|16.0||||||
4060937|NCT01075178|3882385|B3|France||Region of Enrollment||participants|Number|399|399.0||||||
4060938|NCT01075178|3882386|B2|France||Region of Enrollment||participants|Number|211|211.0||||||
4060939|NCT01075178|3882387|B1|France||Region of Enrollment||participants|Number|188|188.0||||||
4060940|NCT01075178|3882385|B3||Male|Sex: Female, Male||Participants|Count of Participants|1119|1119.0||||||
4060941|NCT01075178|3882386|B2||Male|Sex: Female, Male||Participants|Count of Participants|547|547.0||||||
4060942|NCT01075178|3882387|B1||Male|Sex: Female, Male||Participants|Count of Participants|572|572.0||||||
4060943|NCT01075178|3882385|B3||Female|Sex: Female, Male||Participants|Count of Participants|899|899.0||||||
4060944|NCT01075178|3882386|B2||Female|Sex: Female, Male||Participants|Count of Participants|462|462.0||||||
4060945|NCT01075178|3882387|B1||Female|Sex: Female, Male||Participants|Count of Participants|437|437.0||||||
4060946|NCT01075178|3882385|B3|||Age||months|Mean|5.4|5.4|Standard Deviation|4.98|4.98|||
4060947|NCT01075178|3882386|B2|||Age||months|Mean|5.4|5.4|Standard Deviation|5.05|5.05|||
4060948|NCT01075178|3882387|B1|||Age||months|Mean|5.4|5.4|Standard Deviation|4.91|4.91|||
4060949|NCT01075178|3882385|B3|>6 months||Age||participants|Number|711|711.0||||||
4060950|NCT01075178|3882386|B2|>6 months||Age||participants|Number|353|353.0||||||
4060951|NCT01075178|3882387|B1|>6 months||Age||participants|Number|358|358.0||||||
4060952|NCT01075178|3882385|B3|<=6 months||Age||participants|Number|1307|1307.0||||||
4060953|NCT01075178|3882386|B2|<=6 months||Age||participants|Number|656|656.0||||||
4060954|NCT01075178|3882387|B1|<=6 months||Age||participants|Number|651|651.0||||||
4060955|NCT01075152|3882400|B3|||HIV-1 Viral Load||log10 copies/mL|Median|5.5|5.5|Inter-Quartile Range|||5.2|5.8|
4060956|NCT01075152|3882401|B2|||HIV-1 Viral Load||log10 copies/mL|Median|5.5|5.5|Inter-Quartile Range|||5.3|5.8|
4060957|NCT01075152|3882402|B1|||HIV-1 Viral Load||log10 copies/mL|Median|5.5|5.5|Inter-Quartile Range|||5.2|5.8|
4060958|NCT01075152|3882400|B3|||CSF Cryptococcal Antigen titer, 1:xxxx|as performed by serial dilutions with lateral flow assay (LFA)|titers|Median|6400|6400.0|Inter-Quartile Range|||2000.0|16000.0|
4060959|NCT01075152|3882401|B2|||CSF Cryptococcal Antigen titer, 1:xxxx|as performed by serial dilutions with lateral flow assay (LFA)|titers|Median|4000|4000.0|Inter-Quartile Range|||1000.0|14400.0|
4060960|NCT01075152|3882402|B1|||CSF Cryptococcal Antigen titer, 1:xxxx|as performed by serial dilutions with lateral flow assay (LFA)|titers|Median|8000|8000.0|Inter-Quartile Range|||2000.0|16000.0|
4060961|NCT01075152|3882400|B3|||CSF Quantitative Culture, baseline||log10 colony forming units/mL of CSF|Median|5.1|5.1|Inter-Quartile Range|||4.0|5.6|
4060962|NCT01075152|3882401|B2|||CSF Quantitative Culture, baseline||log10 colony forming units/mL of CSF|Median|4.8|4.8|Inter-Quartile Range|||3.8|5.5|
4060963|NCT01075152|3882402|B1|||CSF Quantitative Culture, baseline||log10 colony forming units/mL of CSF|Median|5.3|5.3|Inter-Quartile Range|||4.2|5.7|
4060964|NCT01075152|3882400|B3|||CD4 Count, baseline||cells/mcL|Median|23|23.0|Inter-Quartile Range|||10.0|73.0|
4060965|NCT01075152|3882401|B2|||CD4 Count, baseline||cells/mcL|Median|28|28.0|Inter-Quartile Range|||11.0|76.0|
4060966|NCT01075152|3882402|B1|||CD4 Count, baseline||cells/mcL|Median|19|19.0|Inter-Quartile Range|||9.0|69.0|
4060967|NCT01075152|3882400|B3|South Africa||Region of Enrollment||participants|Number|25|25.0||||||
4060968|NCT01075152|3882401|B2|South Africa||Region of Enrollment||participants|Number|12|12.0||||||
4060969|NCT01075152|3882402|B1|South Africa||Region of Enrollment||participants|Number|13|13.0||||||
4060970|NCT01075152|3882400|B3|Uganda||Region of Enrollment||participants|Number|152|152.0||||||
4060971|NCT01075152|3882401|B2|Uganda||Region of Enrollment||participants|Number|77|77.0||||||
4060972|NCT01075152|3882402|B1|Uganda||Region of Enrollment||participants|Number|75|75.0||||||
4060973|NCT01075152|3882400|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060974|NCT01075152|3882401|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060975|NCT01075152|3882402|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060976|NCT01075152|3882400|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060977|NCT01075152|3882401|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060978|NCT01075152|3882402|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060979|NCT01075152|3882400|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060980|NCT01075152|3882401|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060981|NCT01075152|3882402|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060982|NCT01075152|3882400|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|177|177.0||||||
4060983|NCT01075152|3882401|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
4060984|NCT01075152|3882402|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
4060985|NCT01075152|3882400|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060986|NCT01075152|3882401|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060987|NCT01075152|3882402|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060988|NCT01075152|3882400|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060989|NCT01075152|3882401|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060990|NCT01075152|3882402|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060991|NCT01075152|3882400|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060992|NCT01075152|3882401|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060993|NCT01075152|3882402|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4060994|NCT01075152|3882400|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4060995|NCT01075152|3882401|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4060996|NCT01075152|3882402|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4060997|NCT01075152|3882400|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4060998|NCT01075152|3882401|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4060999|NCT01075152|3882402|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4061000|NCT01075152|3882400|B3|||Age||years|Median|35|35.0|Inter-Quartile Range|||29.0|40.0|
4061001|NCT01075152|3882401|B2|||Age||years|Median|36|36.0|Inter-Quartile Range|||30.0|40.0|
4061002|NCT01075152|3882402|B1|||Age||years|Median|35|35.0|Inter-Quartile Range|||28.0|40.0|
4061003|NCT01075100|3882427|B3|United States||Region of Enrollment||participants|Number|103|103.0||||||
4061004|NCT01075100|3882428|B2|United States||Region of Enrollment||participants|Number|54|54.0||||||
4061005|NCT01075100|3882429|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
4061006|NCT01075100|3882427|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4061007|NCT01075100|3882428|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4061008|NCT01075100|3882429|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4061009|NCT01075100|3882427|B3|Black||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4061010|NCT01075100|3882428|B2|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4061011|NCT01075100|3882429|B1|Black||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4061012|NCT01075100|3882427|B3|Hawaiian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4061013|NCT01075100|3882428|B2|Hawaiian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4061014|NCT01075100|3882429|B1|Hawaiian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4061015|NCT01075100|3882427|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4061016|NCT01075100|3882428|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4061017|NCT01075100|3882429|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4061018|NCT01075100|3882427|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
4061019|NCT01075100|3882428|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4061020|NCT01075100|3882429|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4061021|NCT01075100|3882427|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4061022|NCT01075100|3882428|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4061023|NCT01075100|3882429|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4061024|NCT01075100|3882427|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4061025|NCT01075100|3882428|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4061026|NCT01075100|3882429|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4061027|NCT01075100|3882427|B3|||Age||years|Mean|55.9|55.9|Standard Deviation|9.9|9.9|||
4061028|NCT01075100|3882428|B2|||Age||years|Mean|56.7|56.7|Standard Deviation|10.6|10.6|||
4061029|NCT01075100|3882429|B1|||Age||years|Mean|55.0|55.0|Standard Deviation|9.0|9.0|||
4061030|NCT01075087|3882446|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4061031|NCT01075087|3882447|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4061032|NCT01075087|3882448|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4061033|NCT01075087|3882446|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4061034|NCT01075087|3882447|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4061035|NCT01075087|3882448|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4061036|NCT01075087|3882446|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4061037|NCT01075087|3882447|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4061038|NCT01075087|3882448|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4061039|NCT01075087|3882446|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4061040|NCT01075087|3882447|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4061041|NCT01075087|3882448|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4061042|NCT01075087|3882446|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4061043|NCT01075087|3882447|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4061044|NCT01075087|3882448|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4061045|NCT01075087|3882446|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4061046|NCT01075087|3882447|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4061047|NCT01075087|3882448|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4061048|NCT01075087|3882446|B3|||Age||years|Median|48|48.0|Full Range|||36.0|54.0|
4061049|NCT01075087|3882447|B2|||Age||years|Median|47|47.0|Full Range|||39.0|53.0|
4061050|NCT01075087|3882448|B1|||Age||years|Median|50|50.0|Full Range|||36.0|54.0|
4061051|NCT01075074|3882457|B4|United States||Region of Enrollment||participants|Number|75|75.0||||||
4061052|NCT01075074|3882458|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4061053|NCT01075074|3882459|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4061054|NCT01075074|3882460|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4061055|NCT01075074|3882457|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4061056|NCT01075074|3882458|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4061057|NCT01075074|3882459|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4061058|NCT01075074|3882460|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4061059|NCT01075074|3882457|B4||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4061060|NCT01075074|3882458|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4061061|NCT01075074|3882459|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4061062|NCT01075074|3882460|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4061063|NCT01075074|3882457|B4|||Age||years|Mean|37|37.0|Standard Deviation|9|9.0|||
4061064|NCT01075074|3882458|B3|||Age||years|Mean|35|35.0|Standard Deviation|9|9.0|||
4061065|NCT01075074|3882459|B2|||Age||years|Mean|38|38.0|Standard Deviation|10|10.0|||
4061066|NCT01075074|3882460|B1|||Age||years|Mean|38|38.0|Standard Deviation|8|8.0|||
4061067|NCT01075074|3882457|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4061068|NCT01075074|3882458|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4061069|NCT01075074|3882459|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4061070|NCT01075074|3882460|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4061071|NCT01075074|3882457|B4||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4061072|NCT01075074|3882458|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4061073|NCT01075074|3882459|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4061074|NCT01075074|3882460|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4061075|NCT01075074|3882457|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4061076|NCT01075074|3882458|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4061077|NCT01075074|3882459|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4061078|NCT01075074|3882460|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4061079|NCT01074944|3882479|B1||Male|Gender||Participants|Count of Participants|89|89.0||||||
4061080|NCT01074944|3882479|B1||Female|Gender||Participants|Count of Participants|81|81.0||||||
4061081|NCT01074944|3882479|B1|||Age||years|Mean|37.7|37.7|Standard Deviation|15.1|15.1|||
4061082|NCT01074931|3882537|B1|Not reported||Other Chronic Diseases Present|Whether or not the participant had a chronic disease that had developed previously or was identified at study entry.|participants|Number|2|2.0||||||
4061083|NCT01074931|3882537|B1|Yes||Other Chronic Diseases Present|Whether or not the participant had a chronic disease that had developed previously or was identified at study entry.|participants|Number|29|29.0||||||
4061084|NCT01074931|3882537|B1|No||Other Chronic Diseases Present|Whether or not the participant had a chronic disease that had developed previously or was identified at study entry.|participants|Number|67|67.0||||||
4061085|NCT01074931|3882537|B1|Not reported||Antiretroviral Treatment within Previous 6 Months|Whether or not the participant had antiretroviral treatment within 6 months prior to study entry.|Particpants|Number|1|1.0||||||
4061086|NCT01074931|3882537|B1|No||Antiretroviral Treatment within Previous 6 Months|Whether or not the participant had antiretroviral treatment within 6 months prior to study entry.|Particpants|Number|8|8.0||||||
4061087|NCT01074931|3882537|B1|Yes||Antiretroviral Treatment within Previous 6 Months|Whether or not the participant had antiretroviral treatment within 6 months prior to study entry.|Particpants|Number|89|89.0||||||
4061088|NCT01074931|3882537|B1|Severe lipodystrophy present||Lipodystrophy|The presence and severity of lipodystrophy (abnormal body fat distribution) at study entry.|Participants|Number|1|1.0||||||
4061089|NCT01074931|3882537|B1|Moderate lipodystrophy present||Lipodystrophy|The presence and severity of lipodystrophy (abnormal body fat distribution) at study entry.|Participants|Number|11|11.0||||||
4061090|NCT01074931|3882537|B1|Mild lipodystrophy present||Lipodystrophy|The presence and severity of lipodystrophy (abnormal body fat distribution) at study entry.|Participants|Number|30|30.0||||||
4061091|NCT01074931|3882537|B1|Lipodystrophy not present||Lipodystrophy|The presence and severity of lipodystrophy (abnormal body fat distribution) at study entry.|Participants|Number|56|56.0||||||
4061092|NCT01074931|3882537|B1|||Body Weight|Participant body weight at study entry.|kilograms|Mean|56.91|56.91|Standard Deviation|11.14|11.14|||
4061093|NCT01074931|3882537|B1|Stage 4 (severe symptoms)||WHO Clinical Staging|Participants were staged according to the World Health Organization (WHO) clinical classification of established HIV infection: Stage 1 (asymptomatic), Stage 2 (mild symptoms), Stage 3 (advanced symptoms), and Stage 4 (severe symptoms).|Participants|Number|36|36.0||||||
4061094|NCT01074931|3882537|B1|Stage 3 (advanced symptoms)||WHO Clinical Staging|Participants were staged according to the World Health Organization (WHO) clinical classification of established HIV infection: Stage 1 (asymptomatic), Stage 2 (mild symptoms), Stage 3 (advanced symptoms), and Stage 4 (severe symptoms).|Participants|Number|32|32.0||||||
4061095|NCT01074931|3882537|B1|Stage 2 (mild symptoms)||WHO Clinical Staging|Participants were staged according to the World Health Organization (WHO) clinical classification of established HIV infection: Stage 1 (asymptomatic), Stage 2 (mild symptoms), Stage 3 (advanced symptoms), and Stage 4 (severe symptoms).|Participants|Number|22|22.0||||||
4061096|NCT01074931|3882537|B1|Stage 1 (asymptomatic)||WHO Clinical Staging|Participants were staged according to the World Health Organization (WHO) clinical classification of established HIV infection: Stage 1 (asymptomatic), Stage 2 (mild symptoms), Stage 3 (advanced symptoms), and Stage 4 (severe symptoms).|Participants|Number|8|8.0||||||
4061097|NCT01074931|3882537|B1|Treatment-naive||Participant Classification|Participants were classified as either treatment-naive or treatment experienced.|Participants|Number|8|8.0||||||
4061098|NCT01074931|3882537|B1|Treatment-experienced||Participant Classification|Participants were classified as either treatment-naive or treatment experienced.|Participants|Number|90|90.0||||||
4061099|NCT01074931|3882537|B1|||Age at HIV-1 Diagnosis|The mean age at which participants were diagnosed with HIV-1, based on 97 participants.|years|Mean|36.35|36.35|Standard Deviation|10.89|10.89|||
4061100|NCT01074931|3882537|B1|China||Region of Enrollment||participants|Number|98|98.0||||||
4061101|NCT01074931|3882537|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4061102|NCT01074931|3882537|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4061103|NCT01074931|3882537|B1|||Age||years|Mean|39.86|39.86|Standard Deviation|10.41|10.41|||
4061104|NCT01074658|3882549|B1||Male|Sex: Female, Male||Participants|Count of Participants|501|501.0||||||
4061105|NCT01074658|3882549|B1||Female|Sex: Female, Male||Participants|Count of Participants|514|514.0||||||
4061106|NCT01074658|3882549|B1|||Age||years|Mean|81.1|81.1|Standard Deviation|6.4|6.4|||
4061107|NCT01074554|3882555|B3||Male|Gender||Participants|Count of Participants|10|10.0||||||
4061108|NCT01074554|3882556|B2||Male|Gender||Participants|Count of Participants|5|5.0||||||
4061109|NCT01074554|3882557|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
4061110|NCT01074554|3882555|B3||Female|Gender||Participants|Count of Participants|19|19.0||||||
4061111|NCT01074554|3882556|B2||Female|Gender||Participants|Count of Participants|10|10.0||||||
4061112|NCT01074554|3882557|B1||Female|Gender||Participants|Count of Participants|9|9.0||||||
4061113|NCT01074554|3882555|B3|||Age||years|Median|53|53.0|Inter-Quartile Range|||42.0|58.0|
4061114|NCT01074554|3882556|B2|||Age||years|Median|53|53.0|Inter-Quartile Range|||42.0|57.0|
4061115|NCT01074554|3882557|B1|||Age||years|Median|55|55.0|Inter-Quartile Range|||41.0|60.0|
4061116|NCT01074502|3882568|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4061117|NCT01074502|3882568|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4061118|NCT01074502|3882568|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4061119|NCT01074502|3882568|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4061120|NCT01074502|3882568|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4061121|NCT01074502|3882568|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4061122|NCT01074463|3882577|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4061123|NCT01074463|3882578|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4061124|NCT01074463|3882579|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4061125|NCT01074463|3882577|B3|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4061126|NCT01074463|3882578|B2|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4061127|NCT01074463|3882579|B1|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4061128|NCT01074463|3882577|B3|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4061129|NCT01074463|3882578|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4061130|NCT01074463|3882579|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4061131|NCT01074463|3882577|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4061132|NCT01074463|3882578|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4061133|NCT01074463|3882579|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4061134|NCT01074463|3882577|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4061135|NCT01074463|3882578|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4061136|NCT01074463|3882579|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4061137|NCT01074463|3882577|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4061138|NCT01074463|3882578|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4061139|NCT01074463|3882579|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4061140|NCT01074463|3882577|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4061141|NCT01074463|3882578|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4061142|NCT01074463|3882579|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4061143|NCT01074463|3882577|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4061144|NCT01074463|3882578|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4061145|NCT01074463|3882579|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4061146|NCT01074463|3882577|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4061147|NCT01074463|3882578|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4061148|NCT01074463|3882579|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4061149|NCT01074450|3882590|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4061150|NCT01074450|3882591|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4061151|NCT01074450|3882592|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4061152|NCT01074450|3882590|B3|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4061153|NCT01074450|3882591|B2|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4061154|NCT01074450|3882592|B1|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4061155|NCT01074450|3882590|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4061156|NCT01074450|3882591|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4061157|NCT01074450|3882592|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4061158|NCT01074450|3882590|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4061159|NCT01074450|3882591|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4061160|NCT01074450|3882592|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4061161|NCT01074450|3882590|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4061162|NCT01074450|3882591|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4061163|NCT01074450|3882592|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4061164|NCT01074450|3882590|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4061165|NCT01074450|3882591|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4061166|NCT01074450|3882592|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4061167|NCT01074450|3882590|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4061168|NCT01074450|3882591|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4061169|NCT01074450|3882592|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4061170|NCT01074450|3882590|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4061171|NCT01074450|3882591|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4061172|NCT01074450|3882592|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4061173|NCT01074437|3882603|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4061174|NCT01074437|3882604|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4061175|NCT01074437|3882605|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4061176|NCT01074437|3882603|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4061177|NCT01074437|3882604|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4061178|NCT01074437|3882605|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4061179|NCT01074437|3882603|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4061180|NCT01074437|3882604|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4061181|NCT01074437|3882605|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4061182|NCT01074437|3882603|B3|||Age||years|Mean|0.2|0.2|Standard Deviation|0.1|0.1|||
4061183|NCT01074437|3882604|B2|||Age||years|Mean|0.2|0.2|Standard Deviation|0.1|0.1|||
4061184|NCT01074437|3882605|B1|||Age||years|Mean|0.2|0.2|Standard Deviation|0.1|0.1|||
4061185|NCT01074437|3882603|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4061186|NCT01074437|3882604|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4061187|NCT01074437|3882605|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4061188|NCT01074437|3882603|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4061189|NCT01074437|3882604|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4061190|NCT01074437|3882605|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4061191|NCT01074437|3882603|B3||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4061192|NCT01074437|3882604|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4061193|NCT01074437|3882605|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4061194|NCT01074307|3882620|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4061195|NCT01074307|3882621|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4061196|NCT01074307|3882622|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4061197|NCT01074307|3882620|B3||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4061198|NCT01074307|3882621|B2||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4061199|NCT01074307|3882622|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4061200|NCT01074307|3882620|B3|||Age||years|Mean|59.38|59.38|Standard Deviation|12.24|12.24|||
4061201|NCT01074307|3882621|B2|||Age||years|Mean|57.68|57.68|Standard Deviation|12.28|12.28|||
4061202|NCT01074307|3882622|B1|||Age||years|Mean|62.88|62.88|Standard Deviation|11.52|11.52|||
4061203|NCT01074268|3882643|B3|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.8|9.8|Standard Deviation|4.0|4.0|||
4061204|NCT01074268|3882644|B2|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.5|9.5|Standard Deviation|4.0|4.0|||
4061205|NCT01074268|3882645|B1|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.9|9.9|Standard Deviation|4.0|4.0|||
4061206|NCT01074268|3882643|B3|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.0|8.0|Standard Deviation|0.9|0.9|||
4061207|NCT01074268|3882644|B2|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.0|8.0|Standard Deviation|0.9|0.9|||
4061208|NCT01074268|3882645|B1|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.0|8.0|Standard Deviation|1.0|1.0|||
4061209|NCT01074268|3882643|B3||Male|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
4061210|NCT01074268|3882644|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4061211|NCT01074268|3882645|B1||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4061212|NCT01074268|3882643|B3||Female|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
4061213|NCT01074268|3882644|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4061214|NCT01074268|3882645|B1||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4061215|NCT01074268|3882643|B3|||Age||years|Mean|41.3|41.3|Standard Deviation|14.7|14.7|||
4061216|NCT01074268|3882644|B2|||Age||years|Mean|41.7|41.7|Standard Deviation|14.4|14.4|||
4061217|NCT01074268|3882645|B1|||Age||years|Mean|41.1|41.1|Standard Deviation|14.9|14.9|||
4061218|NCT01074255|3882672|B1|Female||Sex/Gender, Customized||Participants|Number|1410|1410.0||||||
4061219|NCT01074255|3882672|B1|Male||Sex/Gender, Customized||Participants|Number|1729|1729.0||||||
4061220|NCT01074255|3882672|B1|≥70 years||Age, Customized||Participants|Number|353|353.0||||||
4061221|NCT01074255|3882672|B1|60 to 69 years||Age, Customized||Participants|Number|957|957.0||||||
4061222|NCT01074255|3882672|B1|50 to 59 years||Age, Customized||Participants|Number|898|898.0||||||
4061223|NCT01074255|3882672|B1|40 to 49 years||Age, Customized||Participants|Number|635|635.0||||||
4061224|NCT01074255|3882672|B1|<40 years||Age, Customized||Participants|Number|296|296.0||||||
4061225|NCT01074242|3882676|B1||Male|Sex: Female, Male||Participants|Count of Participants|1703|1703.0||||||
4061226|NCT01074242|3882676|B1||Female|Sex: Female, Male||Participants|Count of Participants|1692|1692.0||||||
4061227|NCT01074242|3882676|B1|>10 weeks||Age, Customized||Participants|Number|565|565.0||||||
4061228|NCT01074242|3882676|B1|Between 8 and 10 weeks||Age, Customized||Participants|Number|2740|2740.0||||||
4061229|NCT01074242|3882676|B1|<8 weeks||Age, Customized||Participants|Number|90|90.0||||||
4061230|NCT01074242|3882676|B1|||Age||Weeks|Mean|9.57|9.57|Standard Deviation|1.03|1.03|||
4061231|NCT01074229|3882681|B4|United States||Region of Enrollment||participants|Number|75|75.0||||||
4061232|NCT01074229|3882682|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4061233|NCT01074229|3882683|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4061234|NCT01074229|3882684|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4061235|NCT01074229|3882681|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4061236|NCT01074229|3882682|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4061237|NCT01074229|3882683|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4061238|NCT01074229|3882684|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4061239|NCT01074229|3882681|B4||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4061240|NCT01074229|3882682|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4061241|NCT01074229|3882683|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4061242|NCT01074229|3882684|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4061243|NCT01074229|3882681|B4|||Age||years|Mean|46.55|46.55|Standard Deviation|7.2|7.2|||
4061244|NCT01074229|3882682|B3|||Age||years|Mean|46.76|46.76|Standard Deviation|6.4|6.4|||
4061245|NCT01074229|3882683|B2|||Age||years|Mean|45.4|45.4|Standard Deviation|4.5|4.5|||
4061246|NCT01074229|3882684|B1|||Age||years|Mean|47.4|47.4|Standard Deviation|9.6|9.6|||
4061247|NCT01074229|3882681|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4061248|NCT01074229|3882682|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4061249|NCT01074229|3882683|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4061250|NCT01074229|3882684|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4061251|NCT01074229|3882681|B4||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4061252|NCT01074229|3882682|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4061253|NCT01074229|3882683|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4061254|NCT01074229|3882684|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4061255|NCT01074229|3882681|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4061256|NCT01074229|3882682|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4061257|NCT01074229|3882683|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4061258|NCT01074229|3882684|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4061259|NCT01074216|3882697|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4061260|NCT01074216|3882697|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4061261|NCT01074216|3882697|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4061262|NCT01074216|3882697|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4061263|NCT01074216|3882697|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4061264|NCT01074177|3882701|B1||S768I|EGFR Mutation|The specific mutation that occurred in the gene for Epidermal Growth Factor Receptor (EGFR)|Participants|Count of Participants|1|1.0||||||
4061265|NCT01074177|3882701|B1||G719A|EGFR Mutation|The specific mutation that occurred in the gene for Epidermal Growth Factor Receptor (EGFR)|Participants|Count of Participants|2|2.0||||||
4061266|NCT01074177|3882701|B1||Exon 20 insertion|EGFR Mutation|The specific mutation that occurred in the gene for Epidermal Growth Factor Receptor (EGFR)|Participants|Count of Participants|3|3.0||||||
4061267|NCT01074177|3882701|B1||L858R|EGFR Mutation|The specific mutation that occurred in the gene for Epidermal Growth Factor Receptor (EGFR)|Participants|Count of Participants|8|8.0||||||
4061268|NCT01074177|3882701|B1||Exon 19 deletion|EGFR Mutation|The specific mutation that occurred in the gene for Epidermal Growth Factor Receptor (EGFR)|Participants|Count of Participants|10|10.0||||||
4061269|NCT01074177|3882701|B1||No|Prior Chemotherapy||Participants|Count of Participants|18|18.0||||||
4061270|NCT01074177|3882701|B1||Yes|Prior Chemotherapy||Participants|Count of Participants|6|6.0||||||
4061271|NCT01074177|3882701|B1||No|Brain Metastasis Present||Participants|Count of Participants|13|13.0||||||
4061272|NCT01074177|3882701|B1||Yes|Brain Metastasis Present||Participants|Count of Participants|11|11.0||||||
4061273|NCT01074177|3882701|B1|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
4061274|NCT01074177|3882701|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4061275|NCT01074177|3882701|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4061276|NCT01074177|3882701|B1|||Age||years|Median|57|57.0|Full Range|||27.0|83.0|
4061277|NCT01074164|3882708|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4061278|NCT01074164|3882709|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4061279|NCT01074164|3882710|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4061280|NCT01074164|3882708|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4061281|NCT01074164|3882709|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4061282|NCT01074164|3882710|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4061283|NCT01074164|3882708|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4061284|NCT01074164|3882709|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4061285|NCT01074164|3882710|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4061286|NCT01074164|3882708|B3|||Age||years|Mean|37.3|37.3|Standard Deviation|15.2|15.2|||
4061287|NCT01074164|3882709|B2|||Age||years|Mean|35.1|35.1|Standard Deviation|11.3|11.3|||
4061288|NCT01074164|3882710|B1|||Age||years|Mean|39.7|39.7|Standard Deviation|18.3|18.3|||
4061289|NCT01074164|3882708|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4061290|NCT01074164|3882709|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4061291|NCT01074164|3882710|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4061292|NCT01074164|3882708|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4061293|NCT01074164|3882709|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4061294|NCT01074164|3882710|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4061295|NCT01074164|3882708|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4061296|NCT01074164|3882709|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4061297|NCT01074164|3882710|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4061298|NCT01074125|3882729|B4|Puerto Rico||Region of Enrollment||participants|Number|8|8.0||||||
4061299|NCT01074125|3882730|B3|Puerto Rico||Region of Enrollment||participants|Number|3|3.0||||||
4061300|NCT01074125|3882731|B2|Puerto Rico||Region of Enrollment||participants|Number|2|2.0||||||
4061301|NCT01074125|3882732|B1|Puerto Rico||Region of Enrollment||participants|Number|3|3.0||||||
4061302|NCT01074125|3882729|B4|United States||Region of Enrollment||participants|Number|138|138.0||||||
4061303|NCT01074125|3882730|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4061304|NCT01074125|3882731|B2|United States||Region of Enrollment||participants|Number|49|49.0||||||
4061305|NCT01074125|3882732|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
4061306|NCT01074125|3882729|B4||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4061307|NCT01074125|3882730|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4061308|NCT01074125|3882731|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4061309|NCT01074125|3882732|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4061310|NCT01074125|3882729|B4||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4061311|NCT01074125|3882730|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4061312|NCT01074125|3882731|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4061313|NCT01074125|3882732|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4061314|NCT01074125|3882729|B4||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4061315|NCT01074125|3882730|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4061316|NCT01074125|3882731|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4061317|NCT01074125|3882732|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4061318|NCT01074125|3882729|B4||Between 18 and 65 years|Age||Participants|Count of Participants|115|115.0||||||
4061319|NCT01074125|3882730|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4061376|NCT01074047|3882761|B1||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4061320|NCT01074125|3882731|B2||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4061321|NCT01074125|3882732|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4061322|NCT01074125|3882729|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4061323|NCT01074125|3882730|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4061324|NCT01074125|3882731|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4061325|NCT01074125|3882732|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4061326|NCT01074099|3882748|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4061327|NCT01074099|3882749|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4061328|NCT01074099|3882750|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4061329|NCT01074099|3882748|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4061330|NCT01074099|3882749|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4061331|NCT01074099|3882750|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4061332|NCT01074099|3882748|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4061333|NCT01074099|3882749|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4061334|NCT01074099|3882750|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4061335|NCT01074099|3882748|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4061336|NCT01074099|3882749|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4061337|NCT01074099|3882750|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4061338|NCT01074099|3882748|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4061339|NCT01074099|3882749|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4061340|NCT01074099|3882750|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4061341|NCT01074099|3882748|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4061342|NCT01074099|3882749|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4061343|NCT01074099|3882750|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4061344|NCT01074047|3882759|B3|||Bone Marrow-Blasts Counts|Baseline clinical characteristics, including percentage of bone marrow blasts were assessed centrally and locally. Central values are included here. Baseline blasts were the last non-missing value on or prior to the date of randomization. The bone marrow blasts cells are not typically found in the circulating blood of healthy individuals. Abnormal immature white blood cells (blasts) fill the bone marrow and spill into the bloodstream.|Percentage of Bone Marrow Blasts|Mean|68.5|68.5|Standard Deviation|23.56|23.56|||
4061345|NCT01074047|3882760|B2|||Bone Marrow-Blasts Counts|Baseline clinical characteristics, including percentage of bone marrow blasts were assessed centrally and locally. Central values are included here. Baseline blasts were the last non-missing value on or prior to the date of randomization. The bone marrow blasts cells are not typically found in the circulating blood of healthy individuals. Abnormal immature white blood cells (blasts) fill the bone marrow and spill into the bloodstream.|Percentage of Bone Marrow Blasts|Mean|70.2|70.2|Standard Deviation|22.28|22.28|||
4061346|NCT01074047|3882761|B1|||Bone Marrow-Blasts Counts|Baseline clinical characteristics, including percentage of bone marrow blasts were assessed centrally and locally. Central values are included here. Baseline blasts were the last non-missing value on or prior to the date of randomization. The bone marrow blasts cells are not typically found in the circulating blood of healthy individuals. Abnormal immature white blood cells (blasts) fill the bone marrow and spill into the bloodstream.|Percentage of Bone Marrow Blasts|Mean|66.6|66.6|Standard Deviation|24.71|24.71|||
4061347|NCT01074047|3882759|B3|AML not otherwise specified||World Health Organization Acute Myeloid Leukemia (AML) Classification|"WHO categories include:~Those with AML with recurrent genetic abnormalities. Includes subtypes with multiple chromosome translocations and mutations.~Those with AML with myelodysplasia-related changes. Includes those with prior myelodysplastic syndrome (MDS) or myeloproliferative disease and has transformed to AML.~Those with therapy related myeloid neoplasms and have had prior chemotherapy and/or radiation and subsequently develop AML or MDS~Those with AML not otherwise specified and include subtypes that do not fall into the above categories."|participants|Number|296|296.0||||||
4061348|NCT01074047|3882760|B2|AML not otherwise specified||World Health Organization Acute Myeloid Leukemia (AML) Classification|"WHO categories include:~Those with AML with recurrent genetic abnormalities. Includes subtypes with multiple chromosome translocations and mutations.~Those with AML with myelodysplasia-related changes. Includes those with prior myelodysplastic syndrome (MDS) or myeloproliferative disease and has transformed to AML.~Those with therapy related myeloid neoplasms and have had prior chemotherapy and/or radiation and subsequently develop AML or MDS~Those with AML not otherwise specified and include subtypes that do not fall into the above categories."|participants|Number|143|143.0||||||
4061349|NCT01074047|3882761|B1|AML not otherwise specified||World Health Organization Acute Myeloid Leukemia (AML) Classification|"WHO categories include:~Those with AML with recurrent genetic abnormalities. Includes subtypes with multiple chromosome translocations and mutations.~Those with AML with myelodysplasia-related changes. Includes those with prior myelodysplastic syndrome (MDS) or myeloproliferative disease and has transformed to AML.~Those with therapy related myeloid neoplasms and have had prior chemotherapy and/or radiation and subsequently develop AML or MDS~Those with AML not otherwise specified and include subtypes that do not fall into the above categories."|participants|Number|153|153.0||||||
4061350|NCT01074047|3882759|B3|AML with recurrent genetic abnormalities||World Health Organization Acute Myeloid Leukemia (AML) Classification|"WHO categories include:~Those with AML with recurrent genetic abnormalities. Includes subtypes with multiple chromosome translocations and mutations.~Those with AML with myelodysplasia-related changes. Includes those with prior myelodysplastic syndrome (MDS) or myeloproliferative disease and has transformed to AML.~Those with therapy related myeloid neoplasms and have had prior chemotherapy and/or radiation and subsequently develop AML or MDS~Those with AML not otherwise specified and include subtypes that do not fall into the above categories."|participants|Number|14|14.0||||||
4061377|NCT01074047|3882759|B3||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4061351|NCT01074047|3882760|B2|AML with recurrent genetic abnormalities||World Health Organization Acute Myeloid Leukemia (AML) Classification|"WHO categories include:~Those with AML with recurrent genetic abnormalities. Includes subtypes with multiple chromosome translocations and mutations.~Those with AML with myelodysplasia-related changes. Includes those with prior myelodysplastic syndrome (MDS) or myeloproliferative disease and has transformed to AML.~Those with therapy related myeloid neoplasms and have had prior chemotherapy and/or radiation and subsequently develop AML or MDS~Those with AML not otherwise specified and include subtypes that do not fall into the above categories."|participants|Number|9|9.0||||||
4061352|NCT01074047|3882761|B1|AML with recurrent genetic abnormalities||World Health Organization Acute Myeloid Leukemia (AML) Classification|"WHO categories include:~Those with AML with recurrent genetic abnormalities. Includes subtypes with multiple chromosome translocations and mutations.~Those with AML with myelodysplasia-related changes. Includes those with prior myelodysplastic syndrome (MDS) or myeloproliferative disease and has transformed to AML.~Those with therapy related myeloid neoplasms and have had prior chemotherapy and/or radiation and subsequently develop AML or MDS~Those with AML not otherwise specified and include subtypes that do not fall into the above categories."|participants|Number|5|5.0||||||
4061353|NCT01074047|3882759|B3|Therapy-related myeloid neoplasms||World Health Organization Acute Myeloid Leukemia (AML) Classification|"WHO categories include:~Those with AML with recurrent genetic abnormalities. Includes subtypes with multiple chromosome translocations and mutations.~Those with AML with myelodysplasia-related changes. Includes those with prior myelodysplastic syndrome (MDS) or myeloproliferative disease and has transformed to AML.~Those with therapy related myeloid neoplasms and have had prior chemotherapy and/or radiation and subsequently develop AML or MDS~Those with AML not otherwise specified and include subtypes that do not fall into the above categories."|participants|Number|158|158.0||||||
4061354|NCT01074047|3882760|B2|Therapy-related myeloid neoplasms||World Health Organization Acute Myeloid Leukemia (AML) Classification|"WHO categories include:~Those with AML with recurrent genetic abnormalities. Includes subtypes with multiple chromosome translocations and mutations.~Those with AML with myelodysplasia-related changes. Includes those with prior myelodysplastic syndrome (MDS) or myeloproliferative disease and has transformed to AML.~Those with therapy related myeloid neoplasms and have had prior chemotherapy and/or radiation and subsequently develop AML or MDS~Those with AML not otherwise specified and include subtypes that do not fall into the above categories."|participants|Number|12|12.0||||||
4061355|NCT01074047|3882761|B1|Therapy-related myeloid neoplasms||World Health Organization Acute Myeloid Leukemia (AML) Classification|"WHO categories include:~Those with AML with recurrent genetic abnormalities. Includes subtypes with multiple chromosome translocations and mutations.~Those with AML with myelodysplasia-related changes. Includes those with prior myelodysplastic syndrome (MDS) or myeloproliferative disease and has transformed to AML.~Those with therapy related myeloid neoplasms and have had prior chemotherapy and/or radiation and subsequently develop AML or MDS~Those with AML not otherwise specified and include subtypes that do not fall into the above categories."|participants|Number|8|8.0||||||
4061356|NCT01074047|3882759|B3|AML with myelodysplasia-related changes||World Health Organization Acute Myeloid Leukemia (AML) Classification|"WHO categories include:~Those with AML with recurrent genetic abnormalities. Includes subtypes with multiple chromosome translocations and mutations.~Those with AML with myelodysplasia-related changes. Includes those with prior myelodysplastic syndrome (MDS) or myeloproliferative disease and has transformed to AML.~Those with therapy related myeloid neoplasms and have had prior chemotherapy and/or radiation and subsequently develop AML or MDS~Those with AML not otherwise specified and include subtypes that do not fall into the above categories."|participants|Number|158|158.0||||||
4061357|NCT01074047|3882760|B2|AML with myelodysplasia-related changes||World Health Organization Acute Myeloid Leukemia (AML) Classification|"WHO categories include:~Those with AML with recurrent genetic abnormalities. Includes subtypes with multiple chromosome translocations and mutations.~Those with AML with myelodysplasia-related changes. Includes those with prior myelodysplastic syndrome (MDS) or myeloproliferative disease and has transformed to AML.~Those with therapy related myeloid neoplasms and have had prior chemotherapy and/or radiation and subsequently develop AML or MDS~Those with AML not otherwise specified and include subtypes that do not fall into the above categories."|participants|Number|83|83.0||||||
4061358|NCT01074047|3882761|B1|AML with myelodysplasia-related changes||World Health Organization Acute Myeloid Leukemia (AML) Classification|"WHO categories include:~Those with AML with recurrent genetic abnormalities. Includes subtypes with multiple chromosome translocations and mutations.~Those with AML with myelodysplasia-related changes. Includes those with prior myelodysplastic syndrome (MDS) or myeloproliferative disease and has transformed to AML.~Those with therapy related myeloid neoplasms and have had prior chemotherapy and/or radiation and subsequently develop AML or MDS~Those with AML not otherwise specified and include subtypes that do not fall into the above categories."|participants|Number|75|75.0||||||
4061359|NCT01074047|3882759|B3|4 = Completely disabled||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity), 1 = Restricted activity but ambulatory, 2 = Ambulatory but unable to carry out work activities, 3 = Limited Self Care; 4 = Completely Disabled, No self care (Least Favorable Activity)|participants|Number|0|0.0||||||
4061360|NCT01074047|3882760|B2|4 = Completely disabled||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity), 1 = Restricted activity but ambulatory, 2 = Ambulatory but unable to carry out work activities, 3 = Limited Self Care; 4 = Completely Disabled, No self care (Least Favorable Activity)|participants|Number|0|0.0||||||
4061361|NCT01074047|3882761|B1|4 = Completely disabled||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity), 1 = Restricted activity but ambulatory, 2 = Ambulatory but unable to carry out work activities, 3 = Limited Self Care; 4 = Completely Disabled, No self care (Least Favorable Activity)|participants|Number|0|0.0||||||
4061378|NCT01074047|3882760|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4061362|NCT01074047|3882759|B3|3 = Limited Self Care||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity), 1 = Restricted activity but ambulatory, 2 = Ambulatory but unable to carry out work activities, 3 = Limited Self Care; 4 = Completely Disabled, No self care (Least Favorable Activity)|participants|Number|0|0.0||||||
4061363|NCT01074047|3882760|B2|3 = Limited Self Care||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity), 1 = Restricted activity but ambulatory, 2 = Ambulatory but unable to carry out work activities, 3 = Limited Self Care; 4 = Completely Disabled, No self care (Least Favorable Activity)|participants|Number|0|0.0||||||
4061364|NCT01074047|3882761|B1|3 = Limited Self Care||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity), 1 = Restricted activity but ambulatory, 2 = Ambulatory but unable to carry out work activities, 3 = Limited Self Care; 4 = Completely Disabled, No self care (Least Favorable Activity)|participants|Number|0|0.0||||||
4061365|NCT01074047|3882759|B3|2 = Ambulatory but unable to work||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity), 1 = Restricted activity but ambulatory, 2 = Ambulatory but unable to carry out work activities, 3 = Limited Self Care; 4 = Completely Disabled, No self care (Least Favorable Activity)|participants|Number|113|113.0||||||
4061366|NCT01074047|3882760|B2|2 = Ambulatory but unable to work||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity), 1 = Restricted activity but ambulatory, 2 = Ambulatory but unable to carry out work activities, 3 = Limited Self Care; 4 = Completely Disabled, No self care (Least Favorable Activity)|participants|Number|58|58.0||||||
4061367|NCT01074047|3882761|B1|2 = Ambulatory but unable to work||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity), 1 = Restricted activity but ambulatory, 2 = Ambulatory but unable to carry out work activities, 3 = Limited Self Care; 4 = Completely Disabled, No self care (Least Favorable Activity)|participants|Number|55|55.0||||||
4061368|NCT01074047|3882759|B3|1 = Restrictive but Ambulatory||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity), 1 = Restricted activity but ambulatory, 2 = Ambulatory but unable to carry out work activities, 3 = Limited Self Care; 4 = Completely Disabled, No self care (Least Favorable Activity)|participants|Number|264|264.0||||||
4061369|NCT01074047|3882760|B2|1 = Restrictive but Ambulatory||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity), 1 = Restricted activity but ambulatory, 2 = Ambulatory but unable to carry out work activities, 3 = Limited Self Care; 4 = Completely Disabled, No self care (Least Favorable Activity)|participants|Number|132|132.0||||||
4061370|NCT01074047|3882761|B1|1 = Restrictive but Ambulatory||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity), 1 = Restricted activity but ambulatory, 2 = Ambulatory but unable to carry out work activities, 3 = Limited Self Care; 4 = Completely Disabled, No self care (Least Favorable Activity)|participants|Number|132|132.0||||||
4061371|NCT01074047|3882759|B3|0 = Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity), 1 = Restricted activity but ambulatory, 2 = Ambulatory but unable to carry out work activities, 3 = Limited Self Care; 4 = Completely Disabled, No self care (Least Favorable Activity)|participants|Number|111|111.0||||||
4061372|NCT01074047|3882760|B2|0 = Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity), 1 = Restricted activity but ambulatory, 2 = Ambulatory but unable to carry out work activities, 3 = Limited Self Care; 4 = Completely Disabled, No self care (Least Favorable Activity)|participants|Number|57|57.0||||||
4061373|NCT01074047|3882761|B1|0 = Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity), 1 = Restricted activity but ambulatory, 2 = Ambulatory but unable to carry out work activities, 3 = Limited Self Care; 4 = Completely Disabled, No self care (Least Favorable Activity)|participants|Number|54|54.0||||||
4061374|NCT01074047|3882759|B3||Male|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
4061375|NCT01074047|3882760|B2||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4061379|NCT01074047|3882761|B1||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4061380|NCT01074047|3882759|B3|≥75 years||Age, Customized||participants|Number|265|265.0||||||
4061381|NCT01074047|3882760|B2|≥75 years||Age, Customized||participants|Number|127|127.0||||||
4061382|NCT01074047|3882761|B1|≥75 years||Age, Customized||participants|Number|138|138.0||||||
4061383|NCT01074047|3882759|B3|<75 years||Age, Customized||participants|Number|223|223.0||||||
4061384|NCT01074047|3882760|B2|<75 years||Age, Customized||participants|Number|120|120.0||||||
4061385|NCT01074047|3882761|B1|<75 years||Age, Customized||participants|Number|103|103.0||||||
4061386|NCT01074047|3882759|B3|||Age||years|Mean|75.2|75.2|Standard Deviation|5.58|5.58|||
4061387|NCT01074047|3882760|B2|||Age||years|Mean|75.1|75.1|Standard Deviation|5.57|5.57|||
4061388|NCT01074047|3882761|B1|||Age||years|Mean|75.4|75.4|Standard Deviation|5.60|5.6|||
4061389|NCT01074034|3882836|B1|United States||Region of Enrollment||Participants|Count of Participants|211|211.0||||||
4061390|NCT01074034|3882836|B1||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4061391|NCT01074034|3882836|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4061392|NCT01074034|3882836|B1|||Age||years|Mean|71.7|71.7|Standard Deviation|10.4|10.4|||
4061393|NCT01074008|3882841|B10||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4061394|NCT01074008|3882842|B9||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4061395|NCT01074008|3882843|B8||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4061396|NCT01074008|3882844|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4061397|NCT01074008|3882845|B6||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4061398|NCT01074008|3882846|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4061399|NCT01074008|3882847|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4061400|NCT01074008|3882848|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4061401|NCT01074008|3882849|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4061402|NCT01074008|3882850|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4061403|NCT01074008|3882841|B10||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4061404|NCT01074008|3882842|B9||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4061405|NCT01074008|3882843|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4061406|NCT01074008|3882844|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4061407|NCT01074008|3882845|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4061408|NCT01074008|3882846|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4061409|NCT01074008|3882847|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4061410|NCT01074008|3882848|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4061411|NCT01074008|3882849|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4061412|NCT01074008|3882850|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4061413|NCT01074008|3882841|B10|||Age||years|Mean|50.2|50.2|Standard Deviation|8.01|8.01|||
4061414|NCT01074008|3882842|B9|||Age||years|Mean|51.5|51.5|Standard Deviation|6.36|6.36|||
4061415|NCT01074008|3882843|B8|||Age||years|Mean|53.5|53.5|Standard Deviation|6.46|6.46|||
4061416|NCT01074008|3882844|B7|||Age||years|Mean|49.6|49.6|Standard Deviation|8.37|8.37|||
4061417|NCT01074008|3882845|B6|||Age||years|Mean|40.9|40.9|Standard Deviation|11.25|11.25|||
4061418|NCT01074008|3882846|B5|||Age||years|Mean|51.3|51.3|Standard Deviation|7.76|7.76|||
4061419|NCT01074008|3882847|B4|||Age||years|Mean|53.5|53.5|Standard Deviation|5.40|5.4|||
4061420|NCT01074008|3882848|B3|||Age||years|Mean|50.6|50.6|Standard Deviation|9.26|9.26|||
4061421|NCT01074008|3882849|B2|||Age||years|Mean|50.9|50.9|Standard Deviation|2.59|2.59|||
4061422|NCT01074008|3882850|B1|||Age||years|Mean|48.4|48.4|Standard Deviation|9.36|9.36|||
4061423|NCT01073943|3882966|B3|||Body Mass Index||kg/m^2|Mean|29.365|29.365|Standard Deviation|5.7634|5.7634|||
4061424|NCT01073943|3882967|B2|||Body Mass Index||kg/m^2|Mean|29.541|29.541|Standard Deviation|6.1688|6.1688|||
4061425|NCT01073943|3882968|B1|||Body Mass Index||kg/m^2|Mean|29.185|29.185|Standard Deviation|5.3209|5.3209|||
4061426|NCT01073943|3882966|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4061427|NCT01073943|3882967|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4061428|NCT01073943|3882968|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4061429|NCT01073943|3882966|B3|White||Race/Ethnicity, Customized||participants|Number|542|542.0||||||
4061430|NCT01073943|3882967|B2|White||Race/Ethnicity, Customized||participants|Number|268|268.0||||||
4061431|NCT01073943|3882968|B1|White||Race/Ethnicity, Customized||participants|Number|274|274.0||||||
4061432|NCT01073943|3882966|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
4061433|NCT01073943|3882967|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4061434|NCT01073943|3882968|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4061435|NCT01073943|3882966|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4061436|NCT01073943|3882967|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4061437|NCT01073943|3882968|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4061438|NCT01073943|3882966|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4061439|NCT01073943|3882967|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4061440|NCT01073943|3882968|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4061441|NCT01073943|3882966|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4061442|NCT01073943|3882967|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4061443|NCT01073943|3882968|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4061444|NCT01073943|3882966|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061445|NCT01073943|3882967|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061446|NCT01073943|3882968|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061447|NCT01073943|3882966|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|575|575.0||||||
4061448|NCT01073943|3882967|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|287|287.0||||||
4061449|NCT01073943|3882968|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|288|288.0||||||
4061450|NCT01073943|3882966|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4061451|NCT01073943|3882967|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4061452|NCT01073943|3882968|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4061453|NCT01073943|3882966|B3||Male|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
4061454|NCT01073943|3882967|B2||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4061455|NCT01073943|3882968|B1||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4061456|NCT01073943|3882966|B3||Female|Sex: Female, Male||Participants|Count of Participants|381|381.0||||||
4061457|NCT01073943|3882967|B2||Female|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4061458|NCT01073943|3882968|B1||Female|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4061459|NCT01073943|3882966|B3|||Age||years|Mean|56.5|56.5|Standard Deviation|9.89|9.89|||
4061460|NCT01073943|3882967|B2|||Age||years|Mean|56.2|56.2|Standard Deviation|10.11|10.11|||
4061461|NCT01073943|3882968|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|9.66|9.66|||
4061462|NCT01073930|3882993|B3|||Body Mass Index (BMI)||kg/m^2|Mean|29.5|29.5|Standard Deviation|6.01|6.01|||
4061463|NCT01073930|3882994|B2|||Body Mass Index (BMI)||kg/m^2|Mean|29.6|29.6|Standard Deviation|6.34|6.34|||
4061464|NCT01073930|3882995|B1|||Body Mass Index (BMI)||kg/m^2|Mean|29.4|29.4|Standard Deviation|5.68|5.68|||
4061465|NCT01073930|3882993|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4061466|NCT01073930|3882994|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4061467|NCT01073930|3882995|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4061468|NCT01073930|3882993|B3|White||Race/Ethnicity, Customized||participants|Number|533|533.0||||||
4061469|NCT01073930|3882994|B2|White||Race/Ethnicity, Customized||participants|Number|268|268.0||||||
4061470|NCT01073930|3882995|B1|White||Race/Ethnicity, Customized||participants|Number|265|265.0||||||
4061471|NCT01073930|3882993|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
4061472|NCT01073930|3882994|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4061473|NCT01073930|3882995|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4061474|NCT01073930|3882993|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4061475|NCT01073930|3882994|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4061476|NCT01073930|3882995|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4061477|NCT01073930|3882993|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4061478|NCT01073930|3882994|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4061479|NCT01073930|3882995|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4061480|NCT01073930|3882993|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4061481|NCT01073930|3882994|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4061482|NCT01073930|3882995|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4061483|NCT01073930|3882993|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061484|NCT01073930|3882994|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061485|NCT01073930|3882995|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061486|NCT01073930|3882993|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|591|591.0||||||
4061487|NCT01073930|3882994|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|293|293.0||||||
4061488|NCT01073930|3882995|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|298|298.0||||||
4061489|NCT01073930|3882993|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4061490|NCT01073930|3882994|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4061491|NCT01073930|3882995|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4061492|NCT01073930|3882993|B3||Male|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
4061493|NCT01073930|3882994|B2||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4061494|NCT01073930|3882995|B1||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4061495|NCT01073930|3882993|B3||Female|Sex: Female, Male||Participants|Count of Participants|355|355.0||||||
4061496|NCT01073930|3882994|B2||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4061497|NCT01073930|3882995|B1||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4061498|NCT01073930|3882993|B3|||Age||years|Mean|55.2|55.2|Standard Deviation|10.02|10.02|||
4061499|NCT01073930|3882994|B2|||Age||years|Mean|55.7|55.7|Standard Deviation|10.00|10.0|||
4061500|NCT01073930|3882995|B1|||Age||years|Mean|54.8|54.8|Standard Deviation|10.04|10.04|||
4061501|NCT01073865|3883018|B3|Asia|Republic of Korea|Region of Enrollment||Participants|Count of Participants|28|28.0||||||
4061502|NCT01073865|3883019|B2|Asia|Republic of Korea|Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4061503|NCT01073865|3883020|B1|Asia|Republic of Korea|Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4061504|NCT01073865|3883018|B3|Asia|Taiwan|Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4061505|NCT01073865|3883019|B2|Asia|Taiwan|Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4061506|NCT01073865|3883020|B1|Asia|Taiwan|Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4061507|NCT01073865|3883018|B3|Asia|Thailand|Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4061508|NCT01073865|3883019|B2|Asia|Thailand|Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4061509|NCT01073865|3883020|B1|Asia|Thailand|Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4061510|NCT01073865|3883018|B3|Asia|Philippines|Region of Enrollment||Participants|Count of Participants|44|44.0||||||
4061511|NCT01073865|3883019|B2|Asia|Philippines|Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4061512|NCT01073865|3883020|B1|Asia|Philippines|Region of Enrollment||Participants|Count of Participants|21|21.0||||||
4061513|NCT01073865|3883018|B3|Asia|Japan|Region of Enrollment||Participants|Count of Participants|59|59.0||||||
4061514|NCT01073865|3883019|B2|Asia|Japan|Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4061515|NCT01073865|3883020|B1|Asia|Japan|Region of Enrollment||Participants|Count of Participants|29|29.0||||||
4061516|NCT01073865|3883018|B3|Asia|India|Region of Enrollment||Participants|Count of Participants|56|56.0||||||
4061517|NCT01073865|3883019|B2|Asia|India|Region of Enrollment||Participants|Count of Participants|27|27.0||||||
4061518|NCT01073865|3883020|B1|Asia|India|Region of Enrollment||Participants|Count of Participants|29|29.0||||||
4061519|NCT01073865|3883018|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4061520|NCT01073865|3883019|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4061521|NCT01073865|3883020|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4061522|NCT01073865|3883018|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|222|222.0||||||
4061523|NCT01073865|3883019|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|113|113.0||||||
4061524|NCT01073865|3883020|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|109|109.0||||||
4061525|NCT01073865|3883018|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061526|NCT01073865|3883019|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061527|NCT01073865|3883020|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061528|NCT01073865|3883018|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|222|222.0||||||
4061529|NCT01073865|3883019|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
4061530|NCT01073865|3883020|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|109|109.0||||||
4061531|NCT01073865|3883018|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061532|NCT01073865|3883019|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061533|NCT01073865|3883020|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061534|NCT01073865|3883018|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4061535|NCT01073865|3883019|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4061536|NCT01073865|3883020|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4061537|NCT01073865|3883018|B3||Female|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4061538|NCT01073865|3883019|B2||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4061539|NCT01073865|3883020|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4061540|NCT01073865|3883018|B3|||Age||years|Mean|40.9|40.9|Standard Deviation|6.4|6.4|||
4061541|NCT01073865|3883019|B2|||Age||years|Mean|40.9|40.9|Standard Deviation|6.0|6.0|||
4061542|NCT01073865|3883020|B1|||Age||years|Mean|40.9|40.9|Standard Deviation|6.9|6.9|||
4061543|NCT01073657|3883031|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061544|NCT01073657|3883032|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061545|NCT01073657|3883033|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061546|NCT01073657|3883031|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061547|NCT01073657|3883032|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061548|NCT01073657|3883033|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061549|NCT01073657|3883031|B3||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4061550|NCT01073657|3883032|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4061551|NCT01073657|3883033|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4061552|NCT01073657|3883031|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4061553|NCT01073657|3883032|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4061554|NCT01073657|3883033|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4061617|NCT01073566|3883101|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4061555|NCT01073657|3883031|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061556|NCT01073657|3883032|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061557|NCT01073657|3883033|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061558|NCT01073657|3883031|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061559|NCT01073657|3883032|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061560|NCT01073657|3883033|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061561|NCT01073657|3883031|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061562|NCT01073657|3883032|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061563|NCT01073657|3883033|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061564|NCT01073657|3883031|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4061565|NCT01073657|3883032|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4061566|NCT01073657|3883033|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4061567|NCT01073657|3883031|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4061568|NCT01073657|3883032|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4061569|NCT01073657|3883033|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4061570|NCT01073657|3883031|B3|||Age||years|Mean|29|29.0|Full Range|||21.0|37.0|
4061571|NCT01073657|3883032|B2|||Age||years|Mean|29|29.0|Full Range|||21.0|36.0|
4061572|NCT01073657|3883033|B1|||Age||years|Mean|29|29.0|Full Range|||23.0|37.0|
4061573|NCT01073631|3883040|B1||Male|Sex: Female, Male||Participants|Count of Participants|332|332.0||||||
4061574|NCT01073631|3883040|B1||Female|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4061575|NCT01073631|3883040|B1|>=65 years||Age, Customized||Participants|Number|105|105.0||||||
4061576|NCT01073631|3883040|B1|Between 45 and 64 years||Age, Customized||Participants|Number|207|207.0||||||
4061577|NCT01073631|3883040|B1|Between 18 and 44 years||Age, Customized||Participants|Number|157|157.0||||||
4061578|NCT01073631|3883040|B1|<18 years||Age, Customized||Participants|Number|74|74.0||||||
4061579|NCT01073618|3883045|B1||Male|Sex: Female, Male||Participants|Count of Participants|417|417.0||||||
4061580|NCT01073618|3883045|B1||Female|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4061581|NCT01073618|3883045|B1|>=65 years||Age, Customized||participants|Number|95|95.0||||||
4061582|NCT01073618|3883045|B1|Between 45 and 64 years||Age, Customized||participants|Number|282|282.0||||||
4061583|NCT01073618|3883045|B1|Between 18 and 44 years||Age, Customized||participants|Number|218|218.0||||||
4061584|NCT01073618|3883045|B1|<18 years||Age, Customized||participants|Number|97|97.0||||||
4061585|NCT01073605|3883050|B4||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4061586|NCT01073605|3883051|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4061587|NCT01073605|3883052|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4061588|NCT01073605|3883053|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4061589|NCT01073605|3883050|B4||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4061590|NCT01073605|3883051|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4061591|NCT01073605|3883052|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4061592|NCT01073605|3883053|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4061593|NCT01073605|3883050|B4|>= 12 years||Age, Customized||Participants|Number|1|1.0||||||
4061594|NCT01073605|3883051|B3|>= 12 years||Age, Customized||Participants|Number|0|0.0||||||
4061595|NCT01073605|3883052|B2|>= 12 years||Age, Customized||Participants|Number|0|0.0||||||
4061596|NCT01073605|3883053|B1|>= 12 years||Age, Customized||Participants|Number|1|1.0||||||
4061597|NCT01073605|3883050|B4|8 - 12 years||Age, Customized||Participants|Number|86|86.0||||||
4061598|NCT01073605|3883051|B3|8 - 12 years||Age, Customized||Participants|Number|33|33.0||||||
4061599|NCT01073605|3883052|B2|8 - 12 years||Age, Customized||Participants|Number|30|30.0||||||
4061600|NCT01073605|3883053|B1|8 - 12 years||Age, Customized||Participants|Number|23|23.0||||||
4061601|NCT01073605|3883050|B4|4 - 8 years||Age, Customized||Participants|Number|90|90.0||||||
4061602|NCT01073605|3883051|B3|4 - 8 years||Age, Customized||Participants|Number|29|29.0||||||
4061603|NCT01073605|3883052|B2|4 - 8 years||Age, Customized||Participants|Number|32|32.0||||||
4061604|NCT01073605|3883053|B1|4 - 8 years||Age, Customized||Participants|Number|29|29.0||||||
4061605|NCT01073605|3883050|B4|< 4 years||Age, Customized||Participants|Number|29|29.0||||||
4061606|NCT01073605|3883051|B3|< 4 years||Age, Customized||Participants|Number|6|6.0||||||
4061607|NCT01073605|3883052|B2|< 4 years||Age, Customized||Participants|Number|8|8.0||||||
4061608|NCT01073605|3883053|B1|< 4 years||Age, Customized||Participants|Number|15|15.0||||||
4061609|NCT01073566|3883099|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
4061610|NCT01073566|3883100|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4061611|NCT01073566|3883101|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4061612|NCT01073566|3883099|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4061613|NCT01073566|3883100|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4061614|NCT01073566|3883101|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4061615|NCT01073566|3883099|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4061616|NCT01073566|3883100|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4061618|NCT01073566|3883099|B3|||Age||years|Mean|47.3|47.3|Standard Deviation|15.4|15.4|||
4061619|NCT01073566|3883100|B2|||Age||years|Mean|44.9|44.9|Standard Deviation|15.3|15.3|||
4061620|NCT01073566|3883101|B1|||Age||years|Mean|49.8|49.8|Standard Deviation|15.5|15.5|||
4061621|NCT01073566|3883099|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4061622|NCT01073566|3883100|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4061623|NCT01073566|3883101|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4061624|NCT01073566|3883099|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4061625|NCT01073566|3883100|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4061626|NCT01073566|3883101|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4061627|NCT01073566|3883099|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4061628|NCT01073566|3883100|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4061629|NCT01073566|3883101|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4061630|NCT01073462|3883114|B1|Diastolic||Blood Pressure|Blood pressure data were available for 66 participants|mm Hg|Mean|75.1|75.1|Standard Deviation|11.5|11.5|||
4061631|NCT01073462|3883114|B1|Systolic||Blood Pressure|Blood pressure data were available for 66 participants|mm Hg|Mean|137.2|137.2|Standard Deviation|19.4|19.4|||
4061632|NCT01073462|3883114|B1|Austria||Region of Enrollment||participants|Number|67|67.0||||||
4061633|NCT01073462|3883114|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4061634|NCT01073462|3883114|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4061635|NCT01073462|3883114|B1|||Age||years|Mean|63.5|63.5|Standard Deviation|13.8|13.8|||
4061636|NCT01073449|3883125|B1|Italy||Region of Enrollment||participants|Number|3362|3362.0||||||
4061637|NCT01073449|3883125|B1||Male|Sex: Female, Male||Participants|Count of Participants|2206|2206.0||||||
4061638|NCT01073449|3883125|B1||Female|Sex: Female, Male||Participants|Count of Participants|1156|1156.0||||||
4061639|NCT01073449|3883125|B1|||Age||years|Mean|73.36|73.36|Standard Deviation|12.16|12.16|||
4061640|NCT01073449|3883125|B1||>=65 years|Age||Participants|Count of Participants|2718|2718.0||||||
4061641|NCT01073449|3883125|B1||Between 18 and 65 years|Age||Participants|Count of Participants|640|640.0||||||
4061642|NCT01073449|3883125|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4061643|NCT01073293|3883131|B3||Male|Sex: Female, Male||Participants|Count of Participants|526|526.0||||||
4061644|NCT01073293|3883132|B2||Male|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
4061645|NCT01073293|3883133|B1||Male|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
4061646|NCT01073293|3883131|B3||Female|Sex: Female, Male||Participants|Count of Participants|528|528.0||||||
4061647|NCT01073293|3883132|B2||Female|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
4061648|NCT01073293|3883133|B1||Female|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
4061649|NCT01073293|3883131|B3|||Age||Years|Mean|12.4|12.4|Standard Deviation|1.2|1.2|||
4061650|NCT01073293|3883132|B2|||Age||Years|Mean|12.4|12.4|Standard Deviation|1.2|1.2|||
4061651|NCT01073293|3883133|B1|||Age||Years|Mean|12.4|12.4|Standard Deviation|1.2|1.2|||
4061652|NCT01073267|3883156|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4061653|NCT01073267|3883156|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4061654|NCT01073267|3883156|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4061655|NCT01073267|3883156|B1|||Age||years|Median|69|69.0|Full Range|||48.0|69.0|
4061656|NCT01073163|3883160|B1|Score=4||Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale scores were: 0=fully active, able to carry on all pre-disease performance without restriction; 1=restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=dead.|participants|Number|0|0.0||||||
4061657|NCT01073163|3883160|B1|Score=3||Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale scores were: 0=fully active, able to carry on all pre-disease performance without restriction; 1=restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=dead.|participants|Number|0|0.0||||||
4061658|NCT01073163|3883160|B1|Score=2||Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale scores were: 0=fully active, able to carry on all pre-disease performance without restriction; 1=restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=dead.|participants|Number|5|5.0||||||
4061659|NCT01073163|3883160|B1|Score=1||Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale scores were: 0=fully active, able to carry on all pre-disease performance without restriction; 1=restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=dead.|participants|Number|20|20.0||||||
4061712|NCT01072929|3883183|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061660|NCT01073163|3883160|B1|Score=0||Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale scores were: 0=fully active, able to carry on all pre-disease performance without restriction; 1=restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=dead.|participants|Number|29|29.0||||||
4061661|NCT01073163|3883160|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4061662|NCT01073163|3883160|B1|White||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4061663|NCT01073163|3883160|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4061664|NCT01073163|3883160|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4061665|NCT01073163|3883160|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4061666|NCT01073163|3883160|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4061667|NCT01073163|3883160|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4061668|NCT01073163|3883160|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4061669|NCT01073163|3883160|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4061670|NCT01073163|3883160|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4061671|NCT01073163|3883160|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4061672|NCT01073163|3883160|B1|AgeContinuous||Age||years|Mean|62.9|62.9|Standard Deviation|10.50|10.5|||
4061673|NCT01072929|3883180|B4|||Time Since First Diagnosis for Bipolar||years|Mean|11.0|11.0|Standard Deviation|8.69|8.69|||
4061674|NCT01072929|3883181|B3|||Time Since First Diagnosis for Bipolar||years|Mean|13.7|13.7|Standard Deviation|10.23|10.23|||
4061675|NCT01072929|3883182|B2|||Time Since First Diagnosis for Bipolar||years|Mean|10.6|10.6|Standard Deviation|8.55|8.55|||
4061676|NCT01072929|3883183|B1|||Time Since First Diagnosis for Bipolar||years|Mean|10.9|10.9|Standard Deviation|8.51|8.51|||
4061677|NCT01072929|3883180|B4|||Time Since Start of Current Depressive Episode||weeks|Mean|13.4|13.4|Standard Deviation|10.07|10.07|||
4061678|NCT01072929|3883181|B3|||Time Since Start of Current Depressive Episode||weeks|Mean|15.2|15.2|Standard Deviation|10.42|10.42|||
4061679|NCT01072929|3883182|B2|||Time Since Start of Current Depressive Episode||weeks|Mean|12.9|12.9|Standard Deviation|9.38|9.38|||
4061680|NCT01072929|3883183|B1|||Time Since Start of Current Depressive Episode||weeks|Mean|13.7|13.7|Standard Deviation|10.69|10.69|||
4061681|NCT01072929|3883180|B4|||Body Mass Index||kg/m^2|Mean|29.7|29.7|Standard Deviation|6.94|6.94|||
4061682|NCT01072929|3883181|B3|||Body Mass Index||kg/m^2|Mean|31.3|31.3|Standard Deviation|6.56|6.56|||
4061683|NCT01072929|3883182|B2|||Body Mass Index||kg/m^2|Mean|29.7|29.7|Standard Deviation|6.91|6.91|||
4061684|NCT01072929|3883183|B1|||Body Mass Index||kg/m^2|Mean|29.5|29.5|Standard Deviation|7.04|7.04|||
4061685|NCT01072929|3883180|B4|||Height||cm|Mean|167.8|167.8|Standard Deviation|9.80|9.8|||
4061686|NCT01072929|3883181|B3|||Height||cm|Mean|167.2|167.2|Standard Deviation|7.57|7.57|||
4061687|NCT01072929|3883182|B2|||Height||cm|Mean|167.2|167.2|Standard Deviation|9.32|9.32|||
4061688|NCT01072929|3883183|B1|||Height||cm|Mean|168.4|168.4|Standard Deviation|10.56|10.56|||
4061689|NCT01072929|3883180|B4|||Weight||kg|Mean|83.8|83.8|Standard Deviation|21.53|21.53|||
4061690|NCT01072929|3883181|B3|||Weight||kg|Mean|87.3|87.3|Standard Deviation|20.46|20.46|||
4061691|NCT01072929|3883182|B2|||Weight||kg|Mean|83.1|83.1|Standard Deviation|20.65|20.65|||
4061692|NCT01072929|3883183|B1|||Weight||kg|Mean|83.9|83.9|Standard Deviation|22.78|22.78|||
4061693|NCT01072929|3883180|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4061694|NCT01072929|3883181|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4061695|NCT01072929|3883182|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4061696|NCT01072929|3883183|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4061697|NCT01072929|3883180|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061698|NCT01072929|3883181|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061699|NCT01072929|3883182|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061700|NCT01072929|3883183|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061701|NCT01072929|3883180|B4||White|Race (NIH/OMB)||Participants|Count of Participants|369|369.0||||||
4061702|NCT01072929|3883181|B3||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4061703|NCT01072929|3883182|B2||White|Race (NIH/OMB)||Participants|Count of Participants|179|179.0||||||
4061704|NCT01072929|3883183|B1||White|Race (NIH/OMB)||Participants|Count of Participants|163|163.0||||||
4061705|NCT01072929|3883180|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4061706|NCT01072929|3883181|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4061707|NCT01072929|3883182|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4061708|NCT01072929|3883183|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4061709|NCT01072929|3883180|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4061710|NCT01072929|3883181|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061711|NCT01072929|3883182|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4061713|NCT01072929|3883180|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4061714|NCT01072929|3883181|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061715|NCT01072929|3883182|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4061716|NCT01072929|3883183|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4061717|NCT01072929|3883180|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4061718|NCT01072929|3883181|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4061719|NCT01072929|3883182|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061720|NCT01072929|3883183|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061721|NCT01072929|3883180|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4061722|NCT01072929|3883181|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061723|NCT01072929|3883182|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4061724|NCT01072929|3883183|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4061725|NCT01072929|3883180|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|365|365.0||||||
4061726|NCT01072929|3883181|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4061727|NCT01072929|3883182|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
4061728|NCT01072929|3883183|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|166|166.0||||||
4061729|NCT01072929|3883180|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4061730|NCT01072929|3883181|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4061731|NCT01072929|3883182|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4061732|NCT01072929|3883183|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4061733|NCT01072929|3883180|B4||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4061734|NCT01072929|3883181|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4061735|NCT01072929|3883182|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4061736|NCT01072929|3883183|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4061737|NCT01072929|3883180|B4||Female|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
4061738|NCT01072929|3883181|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4061739|NCT01072929|3883182|B2||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4061740|NCT01072929|3883183|B1||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4061741|NCT01072929|3883180|B4|||Age||years|Mean|43.4|43.4|Standard Deviation|10.99|10.99|||
4061742|NCT01072929|3883181|B3|||Age||years|Mean|44.8|44.8|Standard Deviation|11.78|11.78|||
4061743|NCT01072929|3883182|B2|||Age||years|Mean|44.0|44.0|Standard Deviation|11.34|11.34|||
4061744|NCT01072929|3883183|B1|||Age||years|Mean|42.6|42.6|Standard Deviation|10.47|10.47|||
4061745|NCT01072877|3883259|B6|||BMI||kg/m^2|Mean|28.2|28.2|Standard Deviation|5.64|5.64|||
4061746|NCT01072877|3883260|B5|||BMI||kg/m^2|Mean|28.3|28.3|Standard Deviation|5.40|5.4|||
4061747|NCT01072877|3883261|B4|||BMI||kg/m^2|Mean|28.6|28.6|Standard Deviation|5.41|5.41|||
4061748|NCT01072877|3883262|B3|||BMI||kg/m^2|Mean|27.4|27.4|Standard Deviation|5.75|5.75|||
4061749|NCT01072877|3883263|B2|||BMI||kg/m^2|Mean|28.8|28.8|Standard Deviation|5.77|5.77|||
4061750|NCT01072877|3883264|B1|||BMI||kg/m^2|Mean|27.7|27.7|Standard Deviation|5.95|5.95|||
4061751|NCT01072877|3883259|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061752|NCT01072877|3883260|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061753|NCT01072877|3883261|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061754|NCT01072877|3883262|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061755|NCT01072877|3883263|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061756|NCT01072877|3883264|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061757|NCT01072877|3883259|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4061758|NCT01072877|3883260|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4061759|NCT01072877|3883261|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4061760|NCT01072877|3883262|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4061761|NCT01072877|3883263|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4061762|NCT01072877|3883264|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061763|NCT01072877|3883259|B6||White|Race (NIH/OMB)||Participants|Count of Participants|260|260.0||||||
4061764|NCT01072877|3883260|B5||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4061765|NCT01072877|3883261|B4||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4061766|NCT01072877|3883262|B3||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4061767|NCT01072877|3883263|B2||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4061768|NCT01072877|3883264|B1||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4061769|NCT01072877|3883259|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4061770|NCT01072877|3883260|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4061771|NCT01072877|3883261|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4061772|NCT01072877|3883262|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4061773|NCT01072877|3883263|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4061774|NCT01072877|3883264|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061775|NCT01072877|3883259|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4061776|NCT01072877|3883260|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061777|NCT01072877|3883261|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061778|NCT01072877|3883262|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4061779|NCT01072877|3883263|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061780|NCT01072877|3883264|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061781|NCT01072877|3883259|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4061782|NCT01072877|3883260|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061783|NCT01072877|3883261|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061784|NCT01072877|3883262|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061785|NCT01072877|3883263|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061786|NCT01072877|3883264|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4061787|NCT01072877|3883259|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4061788|NCT01072877|3883260|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061789|NCT01072877|3883261|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061790|NCT01072877|3883262|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061791|NCT01072877|3883263|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061792|NCT01072877|3883264|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4061793|NCT01072877|3883259|B6||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4061794|NCT01072877|3883260|B5||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4061795|NCT01072877|3883261|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4061796|NCT01072877|3883262|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4061797|NCT01072877|3883263|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4061798|NCT01072877|3883264|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4061799|NCT01072877|3883259|B6||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4061800|NCT01072877|3883260|B5||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4061801|NCT01072877|3883261|B4||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4061802|NCT01072877|3883262|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4061803|NCT01072877|3883263|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4061804|NCT01072877|3883264|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4061805|NCT01072877|3883259|B6|||Age||years|Mean|48.9|48.9|Standard Deviation|10.54|10.54|||
4061806|NCT01072877|3883260|B5|||Age||years|Mean|49.7|49.7|Standard Deviation|10.49|10.49|||
4061807|NCT01072877|3883261|B4|||Age||years|Mean|48.8|48.8|Standard Deviation|8.78|8.78|||
4061808|NCT01072877|3883262|B3|||Age||years|Mean|48.2|48.2|Standard Deviation|11.78|11.78|||
4061809|NCT01072877|3883263|B2|||Age||years|Mean|51.6|51.6|Standard Deviation|9.60|9.6|||
4061810|NCT01072877|3883264|B1|||Age||years|Mean|46.0|46.0|Standard Deviation|11.31|11.31|||
4061811|NCT01072773|3883290|B1|||Prior Treatment|Number of previous regimens used for the treatment of amyloidosis. There is no limit to the number of prior therapies provided there is adequate residual organ function.|Prior Treatments|Mean|6.5|6.5|Full Range|||1.0|11.0|
4061812|NCT01072773|3883290|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4061813|NCT01072773|3883290|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4061814|NCT01072773|3883290|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4061815|NCT01072773|3883290|B1|||Age||years|Median|69|69.0|Full Range|||67.0|71.0|
4061816|NCT01072773|3883290|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4061817|NCT01072773|3883290|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4061818|NCT01072773|3883290|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4061819|NCT01072669|3883299|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4061820|NCT01072669|3883300|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4061821|NCT01072669|3883301|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4061822|NCT01072669|3883299|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4061823|NCT01072669|3883300|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4061824|NCT01072669|3883301|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4061825|NCT01072669|3883299|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4061826|NCT01072669|3883300|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4061827|NCT01072669|3883301|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4061828|NCT01072669|3883299|B3|||Age||years|Mean|49.7|49.7|Standard Deviation|12.1|12.1|||
4061829|NCT01072669|3883300|B2|||Age||years|Mean|46.8|46.8|Standard Deviation|10.5|10.5|||
4061830|NCT01072669|3883301|B1|||Age||years|Mean|50.6|50.6|Standard Deviation|12.8|12.8|||
4061831|NCT01072656|3883308|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4061832|NCT01072656|3883309|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4061833|NCT01072656|3883310|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4061834|NCT01072656|3883308|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061835|NCT01072656|3883309|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061836|NCT01072656|3883310|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061837|NCT01072656|3883308|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4061838|NCT01072656|3883309|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4061839|NCT01072656|3883310|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4061840|NCT01072656|3883308|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4061841|NCT01072656|3883309|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4061842|NCT01072656|3883310|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4061843|NCT01072656|3883308|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4061844|NCT01072656|3883309|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4061845|NCT01072656|3883310|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4061846|NCT01072656|3883308|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4061847|NCT01072656|3883309|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4061848|NCT01072656|3883310|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4061849|NCT01072656|3883308|B3|||Age||years|Mean|52|52.0|Standard Deviation|5.5|5.5|||
4061850|NCT01072656|3883309|B2|||Age||years|Mean|54|54.0|Standard Deviation|5.3|5.3|||
4061851|NCT01072656|3883310|B1|||Age||years|Mean|51|51.0|Standard Deviation|5.9|5.9|||
4061852|NCT01072643|3883321|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4061853|NCT01072643|3883321|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4061854|NCT01072643|3883321|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4061855|NCT01072643|3883321|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4061856|NCT01072643|3883321|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4061857|NCT01072630|3883328|B4|||Time Since First Diagnosis for Bipolar||years|Mean|11.6|11.6|Standard Deviation|9.62|9.62|||
4061858|NCT01072630|3883329|B3|||Time Since First Diagnosis for Bipolar||years|Mean|13.3|13.3|Standard Deviation|10.96|10.96|||
4061859|NCT01072630|3883330|B2|||Time Since First Diagnosis for Bipolar||years|Mean|11.7|11.7|Standard Deviation|9.49|9.49|||
4061860|NCT01072630|3883331|B1|||Time Since First Diagnosis for Bipolar||years|Mean|11.4|11.4|Standard Deviation|9.57|9.57|||
4061861|NCT01072630|3883328|B4|||Time Since Start of Current Depressive Episode||weeks|Mean|12.0|12.0|Standard Deviation|8.46|8.46|||
4061862|NCT01072630|3883329|B3|||Time Since Start of Current Depressive Episode||weeks|Mean|14.7|14.7|Standard Deviation|8.73|8.73|||
4061863|NCT01072630|3883330|B2|||Time Since Start of Current Depressive Episode||weeks|Mean|12.4|12.4|Standard Deviation|8.99|8.99|||
4061864|NCT01072630|3883331|B1|||Time Since Start of Current Depressive Episode||weeks|Mean|11.2|11.2|Standard Deviation|7.79|7.79|||
4061865|NCT01072630|3883328|B4|||Body Mass Index||kg/m^2|Mean|30.3|30.3|Standard Deviation|6.73|6.73|||
4061866|NCT01072630|3883329|B3|||Body Mass Index||kg/m^2|Mean|33.6|33.6|Standard Deviation|7.58|7.58|||
4061867|NCT01072630|3883330|B2|||Body Mass Index||kg/m^2|Mean|29.9|29.9|Standard Deviation|6.39|6.39|||
4061868|NCT01072630|3883331|B1|||Body Mass Index||kg/m^2|Mean|30.2|30.2|Standard Deviation|6.86|6.86|||
4061869|NCT01072630|3883328|B4|||Height||cm|Mean|169.7|169.7|Standard Deviation|9.57|9.57|||
4061870|NCT01072630|3883329|B3|||Height||cm|Mean|170.4|170.4|Standard Deviation|8.25|8.25|||
4061871|NCT01072630|3883330|B2|||Height||cm|Mean|169.9|169.9|Standard Deviation|9.44|9.44|||
4061872|NCT01072630|3883331|B1|||Height||cm|Mean|169.6|169.6|Standard Deviation|9.88|9.88|||
4061873|NCT01072630|3883328|B4|||Weight||kg|Mean|87.1|87.1|Standard Deviation|19.96|19.96|||
4061874|NCT01072630|3883329|B3|||Weight||kg|Mean|96.7|96.7|Standard Deviation|21.91|21.91|||
4061875|NCT01072630|3883330|B2|||Weight||kg|Mean|86.3|86.3|Standard Deviation|19.21|19.21|||
4061876|NCT01072630|3883331|B1|||Weight||kg|Mean|86.7|86.7|Standard Deviation|20.21|20.21|||
4061877|NCT01072630|3883328|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4061878|NCT01072630|3883329|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4061879|NCT01072630|3883330|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4061880|NCT01072630|3883331|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4061881|NCT01072630|3883328|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061882|NCT01072630|3883329|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061883|NCT01072630|3883330|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061884|NCT01072630|3883331|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061885|NCT01072630|3883328|B4||White|Race (NIH/OMB)||Participants|Count of Participants|342|342.0||||||
4061886|NCT01072630|3883329|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4061887|NCT01072630|3883330|B2||White|Race (NIH/OMB)||Participants|Count of Participants|166|166.0||||||
4061888|NCT01072630|3883331|B1||White|Race (NIH/OMB)||Participants|Count of Participants|162|162.0||||||
4061889|NCT01072630|3883328|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|116|116.0||||||
4061890|NCT01072630|3883329|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4061891|NCT01072630|3883330|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4061892|NCT01072630|3883331|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4061893|NCT01072630|3883328|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4061894|NCT01072630|3883329|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061895|NCT01072630|3883330|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061896|NCT01072630|3883331|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4061897|NCT01072630|3883328|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4061898|NCT01072630|3883329|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4061899|NCT01072630|3883330|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4061900|NCT01072630|3883331|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4061901|NCT01072630|3883328|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4061902|NCT01072630|3883329|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061903|NCT01072630|3883330|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061904|NCT01072630|3883331|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4061905|NCT01072630|3883328|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4061906|NCT01072630|3883329|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4061907|NCT01072630|3883330|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4061908|NCT01072630|3883331|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4061909|NCT01072630|3883328|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|437|437.0||||||
4061910|NCT01072630|3883329|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4061911|NCT01072630|3883330|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|206|206.0||||||
4061912|NCT01072630|3883331|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|203|203.0||||||
4061913|NCT01072630|3883328|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4061914|NCT01072630|3883329|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4061915|NCT01072630|3883330|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4061916|NCT01072630|3883331|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4061917|NCT01072630|3883328|B4||Male|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
4061918|NCT01072630|3883329|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4061919|NCT01072630|3883330|B2||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4061920|NCT01072630|3883331|B1||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4061921|NCT01072630|3883328|B4||Female|Sex: Female, Male||Participants|Count of Participants|273|273.0||||||
4061922|NCT01072630|3883329|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4061923|NCT01072630|3883330|B2||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4061924|NCT01072630|3883331|B1||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4061925|NCT01072630|3883328|B4|||Age||years|Mean|43.9|43.9|Standard Deviation|10.89|10.89|||
4061926|NCT01072630|3883329|B3|||Age||years|Mean|41.2|41.2|Standard Deviation|12.60|12.6|||
4061927|NCT01072630|3883330|B2|||Age||years|Mean|44.4|44.4|Standard Deviation|11.00|11.0|||
4061928|NCT01072630|3883331|B1|||Age||years|Mean|43.8|43.8|Standard Deviation|10.52|10.52|||
4061929|NCT01072617|3883407|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4061930|NCT01072617|3883407|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4061931|NCT01072617|3883407|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4061932|NCT01072617|3883407|B1|||Age||years|Mean|41|41.0|Standard Deviation|9.2|9.2|||
4061933|NCT01072539|3883414|B1|Severe||Severity of Infection||Participants|Number|810|810.0||||||
4061934|NCT01072539|3883414|B1|Moderate||Severity of Infection||Participants|Number|2072|2072.0||||||
4061935|NCT01072539|3883414|B1|Mild||Severity of Infection||Participants|Number|287|287.0||||||
4061936|NCT01072539|3883414|B1|cIAI + CAP||Infection Site|cSSSI: Complicated skin and skin structure infection; cIAI: Complicated intra-abdominal infection; CAP: Community-acquired bacterial pneumonia.|Participants|Number|2|2.0||||||
4061937|NCT01072539|3883414|B1|cIAI + cSSSI||Infection Site|cSSSI: Complicated skin and skin structure infection; cIAI: Complicated intra-abdominal infection; CAP: Community-acquired bacterial pneumonia.|Participants|Number|2|2.0||||||
4061938|NCT01072539|3883414|B1|CAP||Infection Site|cSSSI: Complicated skin and skin structure infection; cIAI: Complicated intra-abdominal infection; CAP: Community-acquired bacterial pneumonia.|Participants|Number|242|242.0||||||
4061939|NCT01072539|3883414|B1|cIAI||Infection Site|cSSSI: Complicated skin and skin structure infection; cIAI: Complicated intra-abdominal infection; CAP: Community-acquired bacterial pneumonia.|Participants|Number|1947|1947.0||||||
4061940|NCT01072539|3883414|B1|cSSSI||Infection Site|cSSSI: Complicated skin and skin structure infection; cIAI: Complicated intra-abdominal infection; CAP: Community-acquired bacterial pneumonia.|Participants|Number|976|976.0||||||
4061941|NCT01072539|3883414|B1||Male|Sex: Female, Male||Participants|Count of Participants|2080|2080.0||||||
4061942|NCT01072539|3883414|B1||Female|Sex: Female, Male||Participants|Count of Participants|1089|1089.0||||||
4061943|NCT01072539|3883414|B1|>=65 years||Age, Customized||Participants|Number|1381|1381.0||||||
4061944|NCT01072539|3883414|B1|50 to 64 years||Age, Customized||Participants|Number|1116|1116.0||||||
4061945|NCT01072539|3883414|B1|40 to 49 years||Age, Customized||Participants|Number|346|346.0||||||
4061946|NCT01072539|3883414|B1|30 to 39 years||Age, Customized||Participants|Number|200|200.0||||||
4061947|NCT01072539|3883414|B1|<30 years||Age, Customized||Participants|Number|126|126.0||||||
4061948|NCT01072526|3883422|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4061949|NCT01072526|3883422|B1||Male|Gender||Participants|Count of Participants|2|2.0||||||
4061950|NCT01072526|3883422|B1||Female|Gender||Participants|Count of Participants|4|4.0||||||
4061951|NCT01072526|3883422|B1|||Age||years|Mean|67|67.0|Standard Deviation|6.6|6.6|||
4061952|NCT01072526|3883422|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4061953|NCT01072526|3883422|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4061954|NCT01072526|3883422|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4061955|NCT01072500|3883436|B3|||Chronic lung disease|The number of participants in this measurement (chronic lung disease) are the ones who self-reported this history.|participants|Number|253|253.0||||||
4061956|NCT01072500|3883437|B2|||Chronic lung disease|The number of participants in this measurement (chronic lung disease) are the ones who self-reported this history.|participants|Number|123|123.0||||||
4061957|NCT01072500|3883438|B1|||Chronic lung disease|The number of participants in this measurement (chronic lung disease) are the ones who self-reported this history.|participants|Number|130|130.0||||||
4061958|NCT01072500|3883436|B3|||Diabetes/High Blood Sugar|The number of participants in this measurement (diabetes/high blood sugar) are the ones who self-reported this history.|participants|Number|414|414.0||||||
4061959|NCT01072500|3883437|B2|||Diabetes/High Blood Sugar|The number of participants in this measurement (diabetes/high blood sugar) are the ones who self-reported this history.|participants|Number|216|216.0||||||
4061960|NCT01072500|3883438|B1|||Diabetes/High Blood Sugar|The number of participants in this measurement (diabetes/high blood sugar) are the ones who self-reported this history.|participants|Number|198|198.0||||||
4061961|NCT01072500|3883436|B3|||Cancer|The number of participants in this measurement (cancer) are the ones who self-reported this history.|participants|Number|370|370.0||||||
4061962|NCT01072500|3883437|B2|||Cancer|The number of participants in this measurement (cancer) are the ones who self-reported this history.|participants|Number|192|192.0||||||
4061963|NCT01072500|3883438|B1|||Cancer|The number of participants in this measurement (cancer) are the ones who self-reported this history.|participants|Number|178|178.0||||||
4061964|NCT01072500|3883436|B3|||Stroke|The number of participants in this measurement (stroke) are the ones who self-reported this history.|participants|Number|109|109.0||||||
4061965|NCT01072500|3883437|B2|||Stroke|The number of participants in this measurement (stroke) are the ones who self-reported this history.|participants|Number|52|52.0||||||
4061966|NCT01072500|3883438|B1|||Stroke|The number of participants in this measurement (stroke) are the ones who self-reported this history.|participants|Number|57|57.0||||||
4061967|NCT01072500|3883436|B3|||Pacemaker|The number of participants in this measurement (pacemaker) are the ones who self-reported this history.|participants|Number|66|66.0||||||
4061968|NCT01072500|3883437|B2|||Pacemaker|The number of participants in this measurement (pacemaker) are the ones who self-reported this history.|participants|Number|33|33.0||||||
4061969|NCT01072500|3883438|B1|||Pacemaker|The number of participants in this measurement (pacemaker) are the ones who self-reported this history.|participants|Number|33|33.0||||||
4061970|NCT01072500|3883436|B3|||Heart failure/congestive heart failure|The number of participants in this measurement (heart failure/congestive heart failure) are the ones who self-reported this history.|participants|Number|71|71.0||||||
4061971|NCT01072500|3883437|B2|||Heart failure/congestive heart failure|The number of participants in this measurement (heart failure/congestive heart failure) are the ones who self-reported this history.|participants|Number|45|45.0||||||
4061972|NCT01072500|3883438|B1|||Heart failure/congestive heart failure|The number of participants in this measurement (heart failure/congestive heart failure) are the ones who self-reported this history.|participants|Number|26|26.0||||||
4061973|NCT01072500|3883436|B3|||Heart Attack/Coronary/MI|The number of participants in this measurement (heart attack/coronary/MI) are the ones who self-reported this history.|participants|Number|129|129.0||||||
4061974|NCT01072500|3883437|B2|||Heart Attack/Coronary/MI|The number of participants in this measurement (heart attack/coronary/MI) are the ones who self-reported this history.|participants|Number|69|69.0||||||
4061975|NCT01072500|3883438|B1|||Heart Attack/Coronary/MI|The number of participants in this measurement (heart attack/coronary/MI) are the ones who self-reported this history.|participants|Number|60|60.0||||||
4061976|NCT01072500|3883436|B3|||High blood pressure/hypertension|The number of participants in this measurement (high blood pressure) are the ones who self-reported this history.|participants|Number|1151|1151.0||||||
4061977|NCT01072500|3883437|B2|||High blood pressure/hypertension|The number of participants in this measurement (high blood pressure) are the ones who self-reported this history.|participants|Number|578|578.0||||||
4061978|NCT01072500|3883438|B1|||High blood pressure/hypertension|The number of participants in this measurement (high blood pressure) are the ones who self-reported this history.|participants|Number|573|573.0||||||
4061979|NCT01072500|3883436|B3|||Body Mass Index, mean||kg/m^2|Mean|30.2|30.2|Standard Deviation|6.1|6.1|||
4061980|NCT01072500|3883437|B2|||Body Mass Index, mean||kg/m^2|Mean|30.3|30.3|Standard Deviation|6.2|6.2|||
4061981|NCT01072500|3883438|B1|||Body Mass Index, mean||kg/m^2|Mean|30.1|30.1|Standard Deviation|5.9|5.9|||
4061982|NCT01072500|3883436|B3|||Weight (kg)||kg|Mean|81.9|81.9|Standard Deviation|18.8|18.8|||
4061983|NCT01072500|3883437|B2|||Weight (kg)||kg|Mean|82.0|82.0|Standard Deviation|19.3|19.3|||
4061984|NCT01072500|3883438|B1|||Weight (kg)||kg|Mean|81.9|81.9|Standard Deviation|18.4|18.4|||
4061985|NCT01072500|3883436|B3|||Diastolic Blood Pressure|mean of two measures|mmHg|Mean|68.2|68.2|Standard Deviation|10.2|10.2|||
4061986|NCT01072500|3883437|B2|||Diastolic Blood Pressure|mean of two measures|mmHg|Mean|67.7|67.7|Standard Deviation|10.1|10.1|||
4061987|NCT01072500|3883438|B1|||Diastolic Blood Pressure|mean of two measures|mmHg|Mean|68.7|68.7|Standard Deviation|10.3|10.3|||
4061988|NCT01072500|3883436|B3|||Systolic Blood Pressure|mean of two measures|mmHg|Mean|127.4|127.4|Standard Deviation|18.0|18.0|||
4061989|NCT01072500|3883437|B2|||Systolic Blood Pressure|mean of two measures|mmHg|Mean|127.0|127.0|Standard Deviation|17.8|17.8|||
4061990|NCT01072500|3883438|B1|||Systolic Blood Pressure|mean of two measures|mmHg|Mean|127.9|127.9|Standard Deviation|18.1|18.1|||
4061991|NCT01072500|3883436|B3|||Total Cholesterol||mg/dL|Mean|178.9|178.9|Standard Deviation|39.8|39.8|||
4061992|NCT01072500|3883437|B2|||Total Cholesterol||mg/dL|Mean|178.5|178.5|Standard Deviation|39.9|39.9|||
4061993|NCT01072500|3883438|B1|||Total Cholesterol||mg/dL|Mean|179.3|179.3|Standard Deviation|39.6|39.6|||
4061994|NCT01072500|3883436|B3|||CHAMPS 18 Total Score|Community Health Activities Model Program for Seniors - Activity Questionnaire Score is based on hours of moderate-intensity exercise-related activities per week (frequency/week) Total score is the sum of each activity's frequency. The minimum total score is 0 and the maximum is 168.|hours/week|Mean|17.0|17.0|Standard Deviation|33.0|33.0|||
4061995|NCT01072500|3883437|B2|||CHAMPS 18 Total Score|Community Health Activities Model Program for Seniors - Activity Questionnaire Score is based on hours of moderate-intensity exercise-related activities per week (frequency/week) Total score is the sum of each activity's frequency. The minimum total score is 0 and the maximum is 168.|hours/week|Mean|18.2|18.2|Standard Deviation|33.8|33.8|||
4061996|NCT01072500|3883438|B1|||CHAMPS 18 Total Score|Community Health Activities Model Program for Seniors - Activity Questionnaire Score is based on hours of moderate-intensity exercise-related activities per week (frequency/week) Total score is the sum of each activity's frequency. The minimum total score is 0 and the maximum is 168.|hours/week|Mean|15.9|15.9|Standard Deviation|32.1|32.1|||
4061997|NCT01072500|3883436|B3|||3MSE Score, 0-100 scale, mean|Modified Mini-Mental State Exam Higher scores indicate better cognition score|units on a scale|Mean|91.5|91.5|Standard Deviation|5.5|5.5|||
4061998|NCT01072500|3883437|B2|||3MSE Score, 0-100 scale, mean|Modified Mini-Mental State Exam Higher scores indicate better cognition score|units on a scale|Mean|91.6|91.6|Standard Deviation|5.5|5.5|||
4061999|NCT01072500|3883438|B1|||3MSE Score, 0-100 scale, mean|Modified Mini-Mental State Exam Higher scores indicate better cognition score|units on a scale|Mean|91.5|91.5|Standard Deviation|5.6|5.6|||
4062000|NCT01072500|3883436|B3|||Total SPPB Score|This is the Short Physical Performance Battery with a Scale from 0-12. Lower scores represent worse physical performance. Three subscales (balance, gait speed, and chair stand) are summed to create the total score.|units on a scale|Mean|7.4|7.4|Standard Deviation|1.6|1.6|||
4062001|NCT01072500|3883437|B2|||Total SPPB Score|This is the Short Physical Performance Battery with a Scale from 0-12. Lower scores represent worse physical performance. Three subscales (balance, gait speed, and chair stand) are summed to create the total score.|units on a scale|Mean|7.3|7.3|Standard Deviation|1.6|1.6|||
4062002|NCT01072500|3883438|B1|||Total SPPB Score|This is the Short Physical Performance Battery with a Scale from 0-12. Lower scores represent worse physical performance. Three subscales (balance, gait speed, and chair stand) are summed to create the total score.|units on a scale|Mean|7.4|7.4|Standard Deviation|1.6|1.6|||
4062003|NCT01072500|3883436|B3|Unknown||Education||participants|Number|5|5.0||||||
4062004|NCT01072500|3883437|B2|Unknown||Education||participants|Number|4|4.0||||||
4062005|NCT01072500|3883438|B1|Unknown||Education||participants|Number|1|1.0||||||
4062006|NCT01072500|3883436|B3|Other||Education||participants|Number|58|58.0||||||
4062007|NCT01072500|3883437|B2|Other||Education||participants|Number|26|26.0||||||
4062008|NCT01072500|3883438|B1|Other||Education||participants|Number|32|32.0||||||
4062009|NCT01072500|3883436|B3|Post Graduate||Education||participants|Number|402|402.0||||||
4062010|NCT01072500|3883437|B2|Post Graduate||Education||participants|Number|208|208.0||||||
4062011|NCT01072500|3883438|B1|Post Graduate||Education||participants|Number|194|194.0||||||
4062012|NCT01072500|3883436|B3|College (13-17)||Education||participants|Number|641|641.0||||||
4062013|NCT01072500|3883437|B2|College (13-17)||Education||participants|Number|320|320.0||||||
4062014|NCT01072500|3883438|B1|College (13-17)||Education||participants|Number|321|321.0||||||
4062015|NCT01072500|3883436|B3|High school/equivalent (9-12)||Education||participants|Number|484|484.0||||||
4062016|NCT01072500|3883437|B2|High school/equivalent (9-12)||Education||participants|Number|236|236.0||||||
4062017|NCT01072500|3883438|B1|High school/equivalent (9-12)||Education||participants|Number|248|248.0||||||
4062018|NCT01072500|3883436|B3|Elementary School (k-8)||Education||participants|Number|32|32.0||||||
4062019|NCT01072500|3883437|B2|Elementary School (k-8)||Education||participants|Number|17|17.0||||||
4062020|NCT01072500|3883438|B1|Elementary School (k-8)||Education||participants|Number|15|15.0||||||
4062021|NCT01072500|3883436|B3|No formal eduction||Education||participants|Number|13|13.0||||||
4062022|NCT01072500|3883437|B2|No formal eduction||Education||participants|Number|6|6.0||||||
4062023|NCT01072500|3883438|B1|No formal eduction||Education||participants|Number|7|7.0||||||
4062024|NCT01072500|3883436|B3|Refused/Missing||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4062025|NCT01072500|3883437|B2|Refused/Missing||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4062026|NCT01072500|3883438|B1|Refused/Missing||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4062027|NCT01072500|3883436|B3|Other/Mixed||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4062028|NCT01072500|3883437|B2|Other/Mixed||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4062029|NCT01072500|3883438|B1|Other/Mixed||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4062030|NCT01072500|3883436|B3|Asian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4062031|NCT01072500|3883437|B2|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4062032|NCT01072500|3883438|B1|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4062033|NCT01072500|3883436|B3|African American||Race/Ethnicity, Customized||participants|Number|288|288.0||||||
4062034|NCT01072500|3883437|B2|African American||Race/Ethnicity, Customized||participants|Number|125|125.0||||||
4062035|NCT01072500|3883438|B1|African American||Race/Ethnicity, Customized||participants|Number|163|163.0||||||
4062036|NCT01072500|3883436|B3|White||Race/Ethnicity, Customized||participants|Number|1239|1239.0||||||
4062037|NCT01072500|3883437|B2|White||Race/Ethnicity, Customized||participants|Number|635|635.0||||||
4062038|NCT01072500|3883438|B1|White||Race/Ethnicity, Customized||participants|Number|604|604.0||||||
4062039|NCT01072500|3883436|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
4062040|NCT01072500|3883437|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4062041|NCT01072500|3883438|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4062042|NCT01072500|3883436|B3||Male|Sex: Female, Male||Participants|Count of Participants|537|537.0||||||
4062043|NCT01072500|3883437|B2||Male|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
4062044|NCT01072500|3883438|B1||Male|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
4062045|NCT01072500|3883436|B3||Female|Sex: Female, Male||Participants|Count of Participants|1098|1098.0||||||
4062046|NCT01072500|3883437|B2||Female|Sex: Female, Male||Participants|Count of Participants|551|551.0||||||
4062047|NCT01072500|3883438|B1||Female|Sex: Female, Male||Participants|Count of Participants|547|547.0||||||
4062048|NCT01072500|3883436|B3|||Age|These represent data that was measured and analyzed. We have verified the standard deviation is the same in both arms.|years|Mean|78.9|78.9|Standard Deviation|5.2|5.2|||
4062049|NCT01072500|3883437|B2|||Age|These represent data that was measured and analyzed. We have verified the standard deviation is the same in both arms.|years|Mean|79.1|79.1|Standard Deviation|5.2|5.2|||
4062050|NCT01072500|3883438|B1|||Age|These represent data that was measured and analyzed. We have verified the standard deviation is the same in both arms.|years|Mean|78.7|78.7|Standard Deviation|5.2|5.2|||
4062051|NCT01072448|3883447|B3||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4062052|NCT01072448|3883448|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4062053|NCT01072448|3883449|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4062054|NCT01072448|3883447|B3||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4062055|NCT01072448|3883448|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4062056|NCT01072448|3883449|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4062057|NCT01072448|3883447|B3|||Age||years|Mean|64.0|64.0|Standard Deviation|8.86|8.86|||
4062058|NCT01072448|3883448|B2|||Age||years|Mean|64.1|64.1|Standard Deviation|9.43|9.43|||
4062059|NCT01072448|3883449|B1|||Age||years|Mean|64.0|64.0|Standard Deviation|8.29|8.29|||
4062060|NCT01072409|3883458|B1|||Preoperative CNC word score - Treated ear|The test consists of 10 lists with 50 monosyllabic words in each list. Subject responses are scored for both words and phonemes correct in the correct sequence. Subjects will be tested using a configuration of speech at 0º azimuth in quiet|percent correct|Mean|5.6|5.6|Standard Deviation|1.4|1.4|||
4062061|NCT01072409|3883458|B1|||Age at onset of hearing loss||years|Mean|40.8|40.8|Full Range|||3.0|80.0|
4062062|NCT01072409|3883458|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4062063|NCT01072409|3883458|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4062064|NCT01072409|3883458|B1|||Age||years|Mean|63.6|63.6|Full Range|||18.0|89.0|
4062065|NCT01072396|3883462|B3|||Duration of COPD (Chronic Obstructive Pulmonary Disease)||years|Mean|4.9|4.9|Standard Deviation|5.2|5.2|||
4062066|NCT01072396|3883463|B2|||Duration of COPD (Chronic Obstructive Pulmonary Disease)||years|Mean|5.3|5.3|Standard Deviation|5.7|5.7|||
4062067|NCT01072396|3883464|B1|||Duration of COPD (Chronic Obstructive Pulmonary Disease)||years|Mean|4.4|4.4|Standard Deviation|4.6|4.6|||
4062068|NCT01072396|3883462|B3|||Smoking history||pack years|Mean|47.0|47.0|Standard Deviation|22.3|22.3|||
4062069|NCT01072396|3883463|B2|||Smoking history||pack years|Mean|48.1|48.1|Standard Deviation|20.0|20.0|||
4062070|NCT01072396|3883464|B1|||Smoking history||pack years|Mean|46.0|46.0|Standard Deviation|24.4|24.4|||
4062071|NCT01072396|3883462|B3|Currently smokes||Smoking Status||Participants|Number|59|59.0||||||
4062072|NCT01072396|3883463|B2|Currently smokes||Smoking Status||Participants|Number|29|29.0||||||
4062073|NCT01072396|3883464|B1|Currently smokes||Smoking Status||Participants|Number|30|30.0||||||
4062074|NCT01072396|3883462|B3|Ex-smoker||Smoking Status||Participants|Number|67|67.0||||||
4062075|NCT01072396|3883463|B2|Ex-smoker||Smoking Status||Participants|Number|34|34.0||||||
4062076|NCT01072396|3883464|B1|Ex-smoker||Smoking Status||Participants|Number|33|33.0||||||
4062077|NCT01072396|3883462|B3|White||Race/Ethnicity, Customized||Participants|Number|114|114.0||||||
4062078|NCT01072396|3883463|B2|White||Race/Ethnicity, Customized||Participants|Number|57|57.0||||||
4062079|NCT01072396|3883464|B1|White||Race/Ethnicity, Customized||Participants|Number|57|57.0||||||
4062080|NCT01072396|3883462|B3|Black||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4062081|NCT01072396|3883463|B2|Black||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4062082|NCT01072396|3883464|B1|Black||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4062083|NCT01072396|3883462|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4062084|NCT01072396|3883463|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4062085|NCT01072396|3883464|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4062086|NCT01072396|3883462|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4062087|NCT01072396|3883463|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4062088|NCT01072396|3883464|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4062089|NCT01072396|3883462|B3|>65 years||Age, Customized||Participants|Number|40|40.0||||||
4062090|NCT01072396|3883463|B2|>65 years||Age, Customized||Participants|Number|19|19.0||||||
4062091|NCT01072396|3883464|B1|>65 years||Age, Customized||Participants|Number|21|21.0||||||
4062092|NCT01072396|3883462|B3|>55 to <=65 years||Age, Customized||Participants|Number|51|51.0||||||
4062093|NCT01072396|3883463|B2|>55 to <=65 years||Age, Customized||Participants|Number|23|23.0||||||
4062094|NCT01072396|3883464|B1|>55 to <=65 years||Age, Customized||Participants|Number|28|28.0||||||
4062095|NCT01072396|3883462|B3|<=55 years||Age, Customized||Participants|Number|35|35.0||||||
4062096|NCT01072396|3883463|B2|<=55 years||Age, Customized||Participants|Number|21|21.0||||||
4062097|NCT01072396|3883464|B1|<=55 years||Age, Customized||Participants|Number|14|14.0||||||
4062098|NCT01072396|3883462|B3|||Age||years|Mean|61.2|61.2|Standard Deviation|8.8|8.8|||
4062099|NCT01072396|3883463|B2|||Age||years|Mean|60.5|60.5|Standard Deviation|8.6|8.6|||
4062100|NCT01072396|3883464|B1|||Age||years|Mean|61.8|61.8|Standard Deviation|9.1|9.1|||
4062101|NCT01072357|3883475|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4062102|NCT01072357|3883476|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062103|NCT01072357|3883477|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4062104|NCT01072357|3883475|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4062105|NCT01072357|3883476|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4062106|NCT01072357|3883477|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4062107|NCT01072357|3883475|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4062108|NCT01072357|3883476|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4062109|NCT01072357|3883477|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4062110|NCT01072357|3883475|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
4062111|NCT01072357|3883476|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4062112|NCT01072357|3883477|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4062113|NCT01072357|3883475|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4062114|NCT01072357|3883476|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4062115|NCT01072357|3883477|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4062116|NCT01072357|3883475|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4062117|NCT01072357|3883476|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4062118|NCT01072357|3883477|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4062119|NCT01072357|3883475|B3|||Age||years|Mean|67.2|67.2|Standard Deviation|15.5|15.5|||
4062120|NCT01072357|3883476|B2|||Age||years|Mean|63.0|63.0|Standard Deviation|13.0|13.0|||
4062121|NCT01072357|3883477|B1|||Age||years|Mean|71.3|71.3|Standard Deviation|17.0|17.0|||
4062122|NCT01072344|3883486|B3|United States||Region of Enrollment||participants|Number|93|93.0||||||
4062123|NCT01072344|3883487|B2|United States||Region of Enrollment||participants|Number|47|47.0||||||
4062124|NCT01072344|3883488|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4062125|NCT01072344|3883486|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4062126|NCT01072344|3883487|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4062127|NCT01072344|3883488|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4062128|NCT01072344|3883486|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4062129|NCT01072344|3883487|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4062130|NCT01072344|3883488|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4062131|NCT01072344|3883486|B3|||Age||years|Mean|47.3|47.3|Standard Deviation|15.3|15.3|||
4062132|NCT01072344|3883487|B2|||Age||years|Mean|45.4|45.4|Standard Deviation|16.1|16.1|||
4062133|NCT01072344|3883488|B1|||Age||years|Mean|49.2|49.2|Standard Deviation|14.3|14.3|||
4062134|NCT01072344|3883486|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4062135|NCT01072344|3883487|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4062136|NCT01072344|3883488|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4062137|NCT01072344|3883486|B3||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
4062138|NCT01072344|3883487|B2||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4062139|NCT01072344|3883488|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4062140|NCT01072344|3883486|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4062141|NCT01072344|3883487|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4062142|NCT01072344|3883488|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4062143|NCT01072331|3883503|B4||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4062144|NCT01072331|3883504|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4062145|NCT01072331|3883505|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4062146|NCT01072331|3883506|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4062147|NCT01072331|3883503|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4062148|NCT01072331|3883504|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4062149|NCT01072331|3883505|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4062150|NCT01072331|3883506|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4062151|NCT01072331|3883503|B4|||Age||years|Mean|57.2|57.2|Standard Deviation|9.8|9.8|||
4062152|NCT01072331|3883504|B3|||Age||years|Mean|58.6|58.6|Standard Deviation|8.9|8.9|||
4062153|NCT01072331|3883505|B2|||Age||years|Mean|57.1|57.1|Standard Deviation|8.7|8.7|||
4062154|NCT01072331|3883506|B1|||Age||years|Mean|56.1|56.1|Standard Deviation|11.5|11.5|||
4062155|NCT01072201|3883525|B3|Italy||Region of Enrollment||participants|Number|60|60.0||||||
4062156|NCT01072201|3883526|B2|Italy||Region of Enrollment||participants|Number|30|30.0||||||
4062157|NCT01072201|3883527|B1|Italy||Region of Enrollment||participants|Number|30|30.0||||||
4062158|NCT01072201|3883525|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4062159|NCT01072201|3883526|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4062160|NCT01072201|3883527|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4062161|NCT01072201|3883525|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4062162|NCT01072201|3883526|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4062163|NCT01072201|3883527|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4062164|NCT01072201|3883525|B3|||Age||years|Mean|57.59|57.59|Standard Deviation|7.61|7.61|||
4062165|NCT01072201|3883526|B2|||Age||years|Mean|57.83|57.83|Standard Deviation|7.97|7.97|||
4062166|NCT01072201|3883527|B1|||Age||years|Mean|57.36|57.36|Standard Deviation|7.38|7.38|||
4062167|NCT01072201|3883525|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4062168|NCT01072201|3883526|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4062169|NCT01072201|3883527|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4062170|NCT01072201|3883525|B3||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4062171|NCT01072201|3883526|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4062172|NCT01072201|3883527|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4062173|NCT01072201|3883525|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4062174|NCT01072201|3883526|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4062175|NCT01072201|3883527|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4062176|NCT01072188|3883538|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
4062177|NCT01072188|3883539|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4062178|NCT01072188|3883540|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4062179|NCT01072188|3883538|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4062180|NCT01072188|3883539|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4062181|NCT01072188|3883540|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4062182|NCT01072188|3883538|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4062183|NCT01072188|3883539|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4062184|NCT01072188|3883540|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4062185|NCT01072188|3883538|B3|||Age||years|Mean|45|45.0|Standard Deviation|9.66|9.66|||
4062186|NCT01072188|3883539|B2|||Age||years|Mean|45.91|45.91|Standard Deviation|11.41|11.41|||
4062187|NCT01072188|3883540|B1|||Age||years|Mean|44.13|44.13|Standard Deviation|7.78|7.78|||
4062188|NCT01072188|3883538|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4062189|NCT01072188|3883539|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4062190|NCT01072188|3883540|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4062191|NCT01072188|3883538|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4062192|NCT01072188|3883539|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4062193|NCT01072188|3883540|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4062194|NCT01072188|3883538|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4062195|NCT01072188|3883539|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4062196|NCT01072188|3883540|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4062197|NCT01072175|3883549|B13||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4062198|NCT01072175|3883550|B12||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062199|NCT01072175|3883551|B11||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062200|NCT01072175|3883552|B10||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062201|NCT01072175|3883553|B9||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062202|NCT01072175|3883554|B8||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062203|NCT01072175|3883555|B7||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062204|NCT01072175|3883556|B6||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4062205|NCT01072175|3883557|B5||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062206|NCT01072175|3883558|B4||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062207|NCT01072175|3883559|B3||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4062208|NCT01072175|3883560|B2||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062209|NCT01072175|3883561|B1||Missing|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062210|NCT01072175|3883549|B13||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4062211|NCT01072175|3883550|B12||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062212|NCT01072175|3883551|B11||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062213|NCT01072175|3883552|B10||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062214|NCT01072175|3883553|B9||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062215|NCT01072175|3883554|B8||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4062216|NCT01072175|3883555|B7||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062217|NCT01072175|3883556|B6||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062218|NCT01072175|3883557|B5||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4062219|NCT01072175|3883558|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062220|NCT01072175|3883559|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062221|NCT01072175|3883560|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062222|NCT01072175|3883561|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062223|NCT01072175|3883549|B13||African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4062224|NCT01072175|3883550|B12||African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062225|NCT01072175|3883551|B11||African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062226|NCT01072175|3883552|B10||African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062227|NCT01072175|3883553|B9||African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062228|NCT01072175|3883554|B8||African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062229|NCT01072175|3883555|B7||African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062230|NCT01072175|3883556|B6||African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062231|NCT01072175|3883557|B5||African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062232|NCT01072175|3883558|B4||African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4062233|NCT01072175|3883559|B3||African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062234|NCT01072175|3883560|B2||African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062235|NCT01072175|3883561|B1||African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062236|NCT01072175|3883549|B13||Asian & White|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4062237|NCT01072175|3883550|B12||Asian & White|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062238|NCT01072175|3883551|B11||Asian & White|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062239|NCT01072175|3883552|B10||Asian & White|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062240|NCT01072175|3883553|B9||Asian & White|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062241|NCT01072175|3883554|B8||Asian & White|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062242|NCT01072175|3883555|B7||Asian & White|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062243|NCT01072175|3883556|B6||Asian & White|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062244|NCT01072175|3883557|B5||Asian & White|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062245|NCT01072175|3883558|B4||Asian & White|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062246|NCT01072175|3883559|B3||Asian & White|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062247|NCT01072175|3883560|B2||Asian & White|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4062248|NCT01072175|3883561|B1||Asian & White|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4062249|NCT01072175|3883549|B13||White|Race/Ethnicity, Customized||Participants|Count of Participants|407|407.0||||||
4062250|NCT01072175|3883550|B12||White|Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
4062251|NCT01072175|3883551|B11||White|Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
4062252|NCT01072175|3883552|B10||White|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
4062253|NCT01072175|3883553|B9||White|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4062254|NCT01072175|3883554|B8||White|Race/Ethnicity, Customized||Participants|Count of Participants|53|53.0||||||
4062255|NCT01072175|3883555|B7||White|Race/Ethnicity, Customized||Participants|Count of Participants|54|54.0||||||
4062256|NCT01072175|3883556|B6||White|Race/Ethnicity, Customized||Participants|Count of Participants|52|52.0||||||
4062257|NCT01072175|3883557|B5||White|Race/Ethnicity, Customized||Participants|Count of Participants|77|77.0||||||
4062258|NCT01072175|3883558|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
4062259|NCT01072175|3883559|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
4062260|NCT01072175|3883560|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4062261|NCT01072175|3883561|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4062262|NCT01072175|3883549|B13||Male|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4062263|NCT01072175|3883550|B12||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4062264|NCT01072175|3883551|B11||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4062265|NCT01072175|3883552|B10||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4062266|NCT01072175|3883553|B9||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4062267|NCT01072175|3883554|B8||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4062268|NCT01072175|3883555|B7||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4062269|NCT01072175|3883556|B6||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4062270|NCT01072175|3883557|B5||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4062271|NCT01072175|3883558|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4062272|NCT01072175|3883559|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4062273|NCT01072175|3883560|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4062274|NCT01072175|3883561|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4062275|NCT01072175|3883549|B13||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4062276|NCT01072175|3883550|B12||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4062277|NCT01072175|3883551|B11||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4062278|NCT01072175|3883552|B10||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4062279|NCT01072175|3883553|B9||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4062280|NCT01072175|3883554|B8||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4062281|NCT01072175|3883555|B7||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4062282|NCT01072175|3883556|B6||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4062283|NCT01072175|3883557|B5||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4062284|NCT01072175|3883558|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4062285|NCT01072175|3883559|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4062286|NCT01072175|3883560|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4062287|NCT01072175|3883561|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4062288|NCT01072175|3883549|B13|||Age||Years|Mean|52.8|52.8|Standard Deviation|13.74|13.74|||
4062289|NCT01072175|3883550|B12|||Age||Years|Mean|56.7|56.7|Standard Deviation|14.08|14.08|||
4062290|NCT01072175|3883551|B11|||Age||Years|Mean|52.8|52.8|Standard Deviation|14.57|14.57|||
4062291|NCT01072175|3883552|B10|||Age||Years|Mean|53.1|53.1|Standard Deviation|17.04|17.04|||
4062292|NCT01072175|3883553|B9|||Age||Years|Mean|51.8|51.8|Standard Deviation|12.39|12.39|||
4062293|NCT01072175|3883554|B8|||Age||Years|Mean|55.9|55.9|Standard Deviation|11.85|11.85|||
4062294|NCT01072175|3883555|B7|||Age||Years|Mean|49.9|49.9|Standard Deviation|14.70|14.7|||
4062295|NCT01072175|3883556|B6|||Age||Years|Mean|51.8|51.8|Standard Deviation|15.19|15.19|||
4062296|NCT01072175|3883557|B5|||Age||Years|Mean|51.5|51.5|Standard Deviation|12.82|12.82|||
4062297|NCT01072175|3883558|B4|||Age||Years|Mean|52.2|52.2|Standard Deviation|12.09|12.09|||
4062298|NCT01072175|3883559|B3|||Age||Years|Mean|54.2|54.2|Standard Deviation|13.24|13.24|||
4062299|NCT01072175|3883560|B2|||Age||Years|Mean|48.2|48.2|Standard Deviation|7.28|7.28|||
4062300|NCT01072175|3883561|B1|||Age||Years|Mean|52.8|52.8|Standard Deviation|16.04|16.04|||
4062301|NCT01072149|3883756|B1|White||Race/Ethnicity, Customized|Baseline data were collected in members of the Intent-to-Treat Population, comprised of all participants who had been randomized to and received at least one dose of randomised double-blind study medication in any treatment period.|participants|Number|48|48.0||||||
4062302|NCT01072149|3883756|B1|African American/African Heritage||Race/Ethnicity, Customized|Baseline data were collected in members of the Intent-to-Treat Population, comprised of all participants who had been randomized to and received at least one dose of randomised double-blind study medication in any treatment period.|participants|Number|6|6.0||||||
4062303|NCT01072149|3883756|B1||Male|Sex: Female, Male|Baseline data were collected in members of the Intent-to-Treat Population, comprised of all participants who had been randomized to and received at least one dose of randomised double-blind study medication in any treatment period.|Participants|Count of Participants|25|25.0||||||
4062304|NCT01072149|3883756|B1||Female|Sex: Female, Male|Baseline data were collected in members of the Intent-to-Treat Population, comprised of all participants who had been randomized to and received at least one dose of randomised double-blind study medication in any treatment period.|Participants|Count of Participants|29|29.0||||||
4062305|NCT01072149|3883756|B1|||Age|Baseline data were collected in members of the Intent-to-Treat Population, comprised of all participants who had been randomized to and received at least one dose of randomised double-blind study medication in any treatment period.|Years|Mean|57.9|57.9|Standard Deviation|9.24|9.24|||
4062306|NCT01072136|3883791|B3|United States||Region of Enrollment||participants|Number|55|55.0||||||
4062307|NCT01072136|3883792|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4062308|NCT01072136|3883793|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4062309|NCT01072136|3883791|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4062310|NCT01072136|3883792|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4062311|NCT01072136|3883793|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4062312|NCT01072136|3883791|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4062313|NCT01072136|3883792|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4062314|NCT01072136|3883793|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4062315|NCT01072136|3883791|B3|||Age||years|Mean|25.8|25.8|Standard Deviation|6.4|6.4|||
4062316|NCT01072136|3883792|B2|||Age||years|Mean|25.8|25.8|Standard Deviation|6.3|6.3|||
4062317|NCT01072136|3883793|B1|||Age||years|Mean|25.8|25.8|Standard Deviation|6.6|6.6|||
4062318|NCT01072136|3883791|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4062319|NCT01072136|3883792|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4062320|NCT01072136|3883793|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4062321|NCT01072136|3883791|B3||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4062322|NCT01072136|3883792|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4062323|NCT01072136|3883793|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4062324|NCT01072136|3883791|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4062325|NCT01072136|3883792|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4062326|NCT01072136|3883793|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4062327|NCT01072032|3883816|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
4062328|NCT01072032|3883817|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4062329|NCT01072032|3883818|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4062330|NCT01072032|3883816|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4062331|NCT01072032|3883817|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4062332|NCT01072032|3883818|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4062333|NCT01072032|3883816|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4062334|NCT01072032|3883817|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4062335|NCT01072032|3883818|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4062336|NCT01072032|3883816|B3|||Age||years|Mean|60.5|60.5|Standard Deviation|4.8|4.8|||
4062337|NCT01072032|3883817|B2|||Age||years|Mean|59.2|59.2|Standard Deviation|5.4|5.4|||
4062338|NCT01072032|3883818|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|4.3|4.3|||
4062339|NCT01072032|3883816|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4062340|NCT01072032|3883817|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4062341|NCT01072032|3883818|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4062342|NCT01072032|3883816|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4062343|NCT01072032|3883817|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4062344|NCT01072032|3883818|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4062345|NCT01072032|3883816|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4062346|NCT01072032|3883817|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4062347|NCT01072032|3883818|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4062348|NCT01072006|3883829|B5|United States||Region of Enrollment||participants|Number|30|30.0||||||
4062349|NCT01072006|3883830|B4|United States||Region of Enrollment||participants|Number|11|11.0||||||
4062350|NCT01072006|3883832|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4062351|NCT01072006|3883833|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4062352|NCT01072006|3883829|B5||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4062353|NCT01072006|3883830|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4062354|NCT01072006|3883831|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4062355|NCT01072006|3883832|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4062356|NCT01072006|3883833|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4062357|NCT01072006|3883829|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4062358|NCT01072006|3883830|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4062359|NCT01072006|3883831|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4062360|NCT01072006|3883832|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4062361|NCT01072006|3883833|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4062362|NCT01072006|3883829|B5|||Age||years|Mean|30.6|30.6|Standard Deviation|4.7|4.7|||
4062363|NCT01072006|3883830|B4|||Age||years|Mean|28.8|28.8|Standard Deviation|4.3|4.3|||
4062364|NCT01072006|3883832|B2|||Age||years|Mean|33.8|33.8|Standard Deviation|7.2|7.2|||
4062365|NCT01072006|3883833|B1|||Age||years|Mean|30.8|30.8|Standard Deviation|3.5|3.5|||
4062366|NCT01072006|3883829|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4062367|NCT01072006|3883830|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4062368|NCT01072006|3883831|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4062369|NCT01072006|3883832|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4062370|NCT01072006|3883833|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4062371|NCT01072006|3883829|B5||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4062372|NCT01072006|3883830|B4||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4062373|NCT01072006|3883831|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4062374|NCT01072006|3883832|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4062375|NCT01072006|3883833|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4062376|NCT01072006|3883829|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4062377|NCT01072006|3883830|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4062378|NCT01072006|3883831|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4062379|NCT01072006|3883832|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4062380|NCT01072006|3883833|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4062381|NCT01071915|3883862|B1|||Serum Protsate-Specific Antigen (PSA) Levels||ng/mL|Median|19.2|19.2|Full Range|||1.59|100.0|
4062382|NCT01071915|3883862|B1|||Serum Testosterone Level||nanograms per milliliter (ng/mL)|Median|4.03|4.03|Full Range|||1.08|10.7|
4062430|NCT01071395|3883911|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4062383|NCT01071915|3883862|B1|Not Classifiable||Stage of Prostate Cancer|FAS. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. Some participants did not have their prostate cancer classified for the complete TNM scale (13 participants).|Participants|Number|13|13.0||||||
4062384|NCT01071915|3883862|B1|Metastatic||Stage of Prostate Cancer|FAS. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. Some participants did not have their prostate cancer classified for the complete TNM scale (13 participants).|Participants|Number|39|39.0||||||
4062385|NCT01071915|3883862|B1|Locally Advanced||Stage of Prostate Cancer|FAS. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. Some participants did not have their prostate cancer classified for the complete TNM scale (13 participants).|Participants|Number|60|60.0||||||
4062386|NCT01071915|3883862|B1|Localized||Stage of Prostate Cancer|FAS. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. Some participants did not have their prostate cancer classified for the complete TNM scale (13 participants).|Participants|Number|43|43.0||||||
4062387|NCT01071915|3883862|B1|Gleason Score 7-10||Gleason Score|"FAS. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.~1 patient did not have a Gleason Score"|Participants|Number|130|130.0||||||
4062388|NCT01071915|3883862|B1|Gleason Score 5-6||Gleason Score|"FAS. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.~1 patient did not have a Gleason Score"|Participants|Number|24|24.0||||||
4062389|NCT01071915|3883862|B1|Gleason Score 2-4||Gleason Score|"FAS. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.~1 patient did not have a Gleason Score"|Participants|Number|0|0.0||||||
4062390|NCT01071915|3883862|B1|||Body Mass Index (BMI)||kilogram per square meter|Mean|23.8|23.8|Standard Deviation|2.98|2.98|||
4062391|NCT01071915|3883862|B1|Korea, Republic of||Region of Enrollment||participants|Number|155|155.0||||||
4062392|NCT01071915|3883862|B1||Male|Sex: Female, Male|Baseline values based on FAS|Participants|Count of Participants|155|155.0||||||
4062393|NCT01071915|3883862|B1||Female|Sex: Female, Male|Baseline values based on FAS|Participants|Count of Participants|0|0.0||||||
4062394|NCT01071915|3883862|B1|||Age||years|Mean|72.6|72.6|Standard Deviation|8.08|8.08|||
4062395|NCT01071798|3883872|B1||Male|Sex: Female, Male||Participants|Count of Participants|454|454.0||||||
4062396|NCT01071798|3883872|B1||Female|Sex: Female, Male||Participants|Count of Participants|1199|1199.0||||||
4062397|NCT01071798|3883872|B1|||Age||years|Median|60.0|60.0|Inter-Quartile Range|||52.0|71.0|
4062398|NCT01071538|3883892|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4062399|NCT01071538|3883892|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4062400|NCT01071538|3883892|B1|||Age||years|Mean|60.7|60.7|Standard Deviation|5.6|5.6|||
4062401|NCT01071512|3883902|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4062402|NCT01071512|3883902|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4062403|NCT01071512|3883902|B1|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4062404|NCT01071512|3883902|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4062405|NCT01071512|3883902|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4062406|NCT01071512|3883902|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4062407|NCT01071512|3883902|B1|||Age||years|Mean|39|39.0|Standard Deviation|9|9.0|||
4062408|NCT01071395|3883910|B3|||Hoehn & Yahr Stage|The Hoehn and Yahr stage is a 0 to 5 Likert-type rating of global parkinsonian impairment with 0 representing no impairment and 5 representing inability to get out of bed or a wheelchair.|units on a scale|Median|2|2.0|Full Range|||1.0|4.0|
4062409|NCT01071395|3883911|B2|||Hoehn & Yahr Stage|The Hoehn and Yahr stage is a 0 to 5 Likert-type rating of global parkinsonian impairment with 0 representing no impairment and 5 representing inability to get out of bed or a wheelchair.|units on a scale|Median|2|2.0|Full Range|||1.0|4.0|
4062410|NCT01071395|3883912|B1|||Hoehn & Yahr Stage|The Hoehn and Yahr stage is a 0 to 5 Likert-type rating of global parkinsonian impairment with 0 representing no impairment and 5 representing inability to get out of bed or a wheelchair.|units on a scale|Median|2|2.0|Full Range|||1.0|4.0|
4062411|NCT01071395|3883910|B3|||MDS-UPDRS Part IV|The Movement Disorder Society sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part IV provides a measure of complications of anti-parkinsonian treatment for the patient. These complications include such items as dyskinesia and dystonia. Each item is rated on a 0 to 4 Likert type scale with 0 representing no impairment and 4 representing severe impairment. Total Part IV score can range from 0 to 24.|units on a scale|Mean|9.2|9.2|Standard Deviation|3.4|3.4|||
4062431|NCT01071395|3883912|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4062432|NCT01071395|3883910|B3|France||Region of Enrollment||participants|Number|6|6.0||||||
4062433|NCT01071395|3883911|B2|France||Region of Enrollment||participants|Number|4|4.0||||||
4062412|NCT01071395|3883911|B2|||MDS-UPDRS Part IV|The Movement Disorder Society sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part IV provides a measure of complications of anti-parkinsonian treatment for the patient. These complications include such items as dyskinesia and dystonia. Each item is rated on a 0 to 4 Likert type scale with 0 representing no impairment and 4 representing severe impairment. Total Part IV score can range from 0 to 24.|units on a scale|Mean|9.9|9.9|Standard Deviation|3.6|3.6|||
4062413|NCT01071395|3883912|B1|||MDS-UPDRS Part IV|The Movement Disorder Society sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part IV provides a measure of complications of anti-parkinsonian treatment for the patient. These complications include such items as dyskinesia and dystonia. Each item is rated on a 0 to 4 Likert type scale with 0 representing no impairment and 4 representing severe impairment. Total Part IV score can range from 0 to 24.|units on a scale|Mean|8.5|8.5|Standard Deviation|3.1|3.1|||
4062414|NCT01071395|3883910|B3|||MDS-UPDRS Part III|The Movement Disorder Society sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part III provides an objective (rater administered) measure of Parkinsonian motor impairment for the patient. These ratings are based on physical examination of the patient for signs such as tremor, rigidity, bradykinesia and postural instability. Each item is rated on a 0 to 4 Likert type scale with 0 representing no impairment and 4 representing severe impairment. Total Part III score can range from 0 to 132.|units on a scale|Mean|22.5|22.5|Standard Deviation|12.2|12.2|||
4062415|NCT01071395|3883911|B2|||MDS-UPDRS Part III|The Movement Disorder Society sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part III provides an objective (rater administered) measure of Parkinsonian motor impairment for the patient. These ratings are based on physical examination of the patient for signs such as tremor, rigidity, bradykinesia and postural instability. Each item is rated on a 0 to 4 Likert type scale with 0 representing no impairment and 4 representing severe impairment. Total Part III score can range from 0 to 132.|units on a scale|Mean|20.3|20.3|Standard Deviation|13.6|13.6|||
4062416|NCT01071395|3883912|B1|||MDS-UPDRS Part III|The Movement Disorder Society sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part III provides an objective (rater administered) measure of Parkinsonian motor impairment for the patient. These ratings are based on physical examination of the patient for signs such as tremor, rigidity, bradykinesia and postural instability. Each item is rated on a 0 to 4 Likert type scale with 0 representing no impairment and 4 representing severe impairment. Total Part III score can range from 0 to 132.|units on a scale|Mean|24.3|24.3|Standard Deviation|10.7|10.7|||
4062417|NCT01071395|3883910|B3|||MDS-UPDRS Part II|The Movement Disorder Society sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part II provides a measure of Motor Experiences of Daily Living for the patient using a Patient Reported Outcome approach. These motor experiences include such items as walking, fine motor or tremor disturbances. Each item is rated on a 0 to 4 Likert type scale with 0 representing no impairment and 4 representing severe impairment. Total Part II score can range from 0 to 52.|units on a scale|Mean|14.0|14.0|Standard Deviation|6.1|6.1|||
4062418|NCT01071395|3883911|B2|||MDS-UPDRS Part II|The Movement Disorder Society sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part II provides a measure of Motor Experiences of Daily Living for the patient using a Patient Reported Outcome approach. These motor experiences include such items as walking, fine motor or tremor disturbances. Each item is rated on a 0 to 4 Likert type scale with 0 representing no impairment and 4 representing severe impairment. Total Part II score can range from 0 to 52.|units on a scale|Mean|14.3|14.3|Standard Deviation|6.5|6.5|||
4062419|NCT01071395|3883912|B1|||MDS-UPDRS Part II|The Movement Disorder Society sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part II provides a measure of Motor Experiences of Daily Living for the patient using a Patient Reported Outcome approach. These motor experiences include such items as walking, fine motor or tremor disturbances. Each item is rated on a 0 to 4 Likert type scale with 0 representing no impairment and 4 representing severe impairment. Total Part II score can range from 0 to 52.|units on a scale|Mean|13.8|13.8|Standard Deviation|5.8|5.8|||
4062420|NCT01071395|3883910|B3|||Movement Disorder Society revision of the Unified Parkinson's Disease Rating Scale MDS-UPDRS Part I|The Movement Disorder Society sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part I provides a measure of Non-Motor Experiences of Daily Living for the patient. These non-motor experiences include such items as cognitive function, psychosis and mood disturbances. Each item is rated on a 0 to 4 Likert type scale with 0 representing no impairment and 4 representing severe impairment. Part I score can range from 0 to 52.|units on a scale|Mean|10.0|10.0|Standard Deviation|5.2|5.2|||
4062421|NCT01071395|3883911|B2|||Movement Disorder Society revision of the Unified Parkinson's Disease Rating Scale MDS-UPDRS Part I|The Movement Disorder Society sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part I provides a measure of Non-Motor Experiences of Daily Living for the patient. These non-motor experiences include such items as cognitive function, psychosis and mood disturbances. Each item is rated on a 0 to 4 Likert type scale with 0 representing no impairment and 4 representing severe impairment. Part I score can range from 0 to 52.|units on a scale|Mean|10.2|10.2|Standard Deviation|5.2|5.2|||
4062422|NCT01071395|3883912|B1|||Movement Disorder Society revision of the Unified Parkinson's Disease Rating Scale MDS-UPDRS Part I|The Movement Disorder Society sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part I provides a measure of Non-Motor Experiences of Daily Living for the patient. These non-motor experiences include such items as cognitive function, psychosis and mood disturbances. Each item is rated on a 0 to 4 Likert type scale with 0 representing no impairment and 4 representing severe impairment. Part I score can range from 0 to 52.|units on a scale|Mean|9.8|9.8|Standard Deviation|5.2|5.2|||
4062423|NCT01071395|3883910|B3|Austria||Region of Enrollment||participants|Number|9|9.0||||||
4062424|NCT01071395|3883911|B2|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4062425|NCT01071395|3883912|B1|Austria||Region of Enrollment||participants|Number|5|5.0||||||
4062426|NCT01071395|3883910|B3|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4062427|NCT01071395|3883911|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4062428|NCT01071395|3883912|B1|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4062429|NCT01071395|3883910|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
4062434|NCT01071395|3883912|B1|France||Region of Enrollment||participants|Number|2|2.0||||||
4062435|NCT01071395|3883910|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4062436|NCT01071395|3883911|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4062437|NCT01071395|3883912|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4062438|NCT01071395|3883910|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4062439|NCT01071395|3883911|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4062440|NCT01071395|3883912|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4062441|NCT01071395|3883910|B3|||Age||years|Mean|66.8|66.8|Standard Deviation|7.7|7.7|||
4062442|NCT01071395|3883911|B2|||Age||years|Mean|68.5|68.5|Standard Deviation|6.9|6.9|||
4062443|NCT01071395|3883912|B1|||Age||years|Mean|65.4|65.4|Standard Deviation|8.2|8.2|||
4062444|NCT01071356|3883919|B3|United States||Region of Enrollment||participants|Number|217|217.0||||||
4062445|NCT01071356|3883920|B2|United States||Region of Enrollment||participants|Number|106|106.0||||||
4062446|NCT01071356|3883921|B1|United States||Region of Enrollment||participants|Number|111|111.0||||||
4062447|NCT01071356|3883919|B3||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4062448|NCT01071356|3883920|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4062449|NCT01071356|3883921|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4062450|NCT01071356|3883919|B3||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4062451|NCT01071356|3883920|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4062452|NCT01071356|3883921|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4062453|NCT01071356|3883919|B3|||Age||years|Mean|38.6|38.6|Standard Deviation|10.2|10.2|||
4062454|NCT01071356|3883920|B2|||Age||years|Mean|38.9|38.9|Standard Deviation|10.8|10.8|||
4062455|NCT01071356|3883921|B1|||Age||years|Mean|38.3|38.3|Standard Deviation|9.7|9.7|||
4062456|NCT01071356|3883919|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4062457|NCT01071356|3883920|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4062458|NCT01071356|3883921|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4062459|NCT01071356|3883919|B3||Between 18 and 65 years|Age||Participants|Count of Participants|216|216.0||||||
4062460|NCT01071356|3883920|B2||Between 18 and 65 years|Age||Participants|Count of Participants|105|105.0||||||
4062461|NCT01071356|3883921|B1||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
4062462|NCT01071356|3883919|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4062463|NCT01071356|3883920|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4062464|NCT01071356|3883921|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4062465|NCT01071317|3883930|B3|||Pre-existing migraine-related functional impairment as measured by the MIDAS scale|The Migraine Disability Assessment (MIDAS) Test is a brief, self-administered questionnaire designed to quantify headache-related disability over a 3 month period. It is a 5-question instrument used to determine the severity of the underlying migraine disorder. Each question is scored from 0 to 90; the total minimum and total maximum scores are 0 and 450 respectively. A total score of 0 indicates no impairment. A total score greater than 20 indicates severe migraine related functional impairment.|units on a scale|Median|12|12.0|Inter-Quartile Range|||9.0|25.0|
4062466|NCT01071317|3883931|B2|||Pre-existing migraine-related functional impairment as measured by the MIDAS scale|The Migraine Disability Assessment (MIDAS) Test is a brief, self-administered questionnaire designed to quantify headache-related disability over a 3 month period. It is a 5-question instrument used to determine the severity of the underlying migraine disorder. Each question is scored from 0 to 90; the total minimum and total maximum scores are 0 and 450 respectively. A total score of 0 indicates no impairment. A total score greater than 20 indicates severe migraine related functional impairment.|units on a scale|Median|13|13.0|Inter-Quartile Range|||9.0|31.0|
4062467|NCT01071317|3883932|B1|||Pre-existing migraine-related functional impairment as measured by the MIDAS scale|The Migraine Disability Assessment (MIDAS) Test is a brief, self-administered questionnaire designed to quantify headache-related disability over a 3 month period. It is a 5-question instrument used to determine the severity of the underlying migraine disorder. Each question is scored from 0 to 90; the total minimum and total maximum scores are 0 and 450 respectively. A total score of 0 indicates no impairment. A total score greater than 20 indicates severe migraine related functional impairment.|units on a scale|Median|10|10.0|Inter-Quartile Range|||7.0|18.0|
4062468|NCT01071317|3883930|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4062469|NCT01071317|3883931|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4062470|NCT01071317|3883932|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4062471|NCT01071317|3883930|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4062472|NCT01071317|3883930|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4062473|NCT01071317|3883931|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4062474|NCT01071317|3883932|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4062475|NCT01071317|3883930|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4062476|NCT01071317|3883931|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4062477|NCT01071317|3883932|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4062478|NCT01071317|3883930|B3|||Age||years|Mean|34|34.0|Standard Deviation|9|9.0|||
4062479|NCT01071317|3883931|B2|||Age||years|Mean|35|35.0|Standard Deviation|9|9.0|||
4062480|NCT01071317|3883932|B1|||Age||years|Mean|33|33.0|Standard Deviation|9|9.0|||
4062481|NCT01071278|3883945|B1|Germany||Region of Enrollment||participants|Number|2359|2359.0||||||
4062482|NCT01071278|3883945|B1|Not reported||Sex/Gender, Customized||participants|Number|11|11.0||||||
4062483|NCT01071278|3883945|B1|Female||Sex/Gender, Customized||participants|Number|776|776.0||||||
4062484|NCT01071278|3883945|B1|Male||Sex/Gender, Customized||participants|Number|1572|1572.0||||||
4062485|NCT01071278|3883945|B1|||Age|Age data was missing 13 of the 2359 participants in the ITT Population.|years|Mean|61.1|61.1|Full Range|||20.0|94.0|
4062486|NCT01071252|3883951|B6||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4062487|NCT01071252|3883952|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4062488|NCT01071252|3883953|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4062489|NCT01071252|3883954|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4062490|NCT01071252|3883955|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4062491|NCT01071252|3883956|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4062492|NCT01071252|3883951|B6||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4062493|NCT01071252|3883952|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4062494|NCT01071252|3883953|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4062495|NCT01071252|3883954|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4062496|NCT01071252|3883955|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4062497|NCT01071252|3883956|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4062498|NCT01071252|3883951|B6|||Age||years|Mean|45.9|45.9|Standard Deviation|12.07|12.07|||
4062499|NCT01071252|3883952|B5|||Age||years|Mean|45.9|45.9|Standard Deviation|10.88|10.88|||
4062500|NCT01071252|3883953|B4|||Age||years|Mean|45.4|45.4|Standard Deviation|11.64|11.64|||
4062501|NCT01071252|3883954|B3|||Age||years|Mean|45.8|45.8|Standard Deviation|12.36|12.36|||
4062502|NCT01071252|3883955|B2|||Age||years|Mean|46.3|46.3|Standard Deviation|13.43|13.43|||
4062503|NCT01071252|3883956|B1|||Age||years|Mean|46.1|46.1|Standard Deviation|12.65|12.65|||
4062504|NCT01071200|3883986|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4062505|NCT01071200|3883987|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4062506|NCT01071200|3883988|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4062507|NCT01071200|3883986|B3||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4062508|NCT01071200|3883987|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4062509|NCT01071200|3883988|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4062510|NCT01071200|3883986|B3|||Age||years|Mean|35.3|35.3|Standard Deviation|3.4|3.4|||
4062511|NCT01071200|3883987|B2|||Age||years|Mean|35.0|35.0|Standard Deviation|3.8|3.8|||
4062512|NCT01071200|3883988|B1|||Age||years|Mean|35.6|35.6|Standard Deviation|2.9|2.9|||
4062513|NCT01071096|3884021|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4062514|NCT01071096|3884021|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4062515|NCT01071096|3884021|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4062516|NCT01071096|3884021|B1|||Age||years|Mean|48.45|48.45|Standard Deviation|12.87|12.87|||
4062517|NCT01071096|3884021|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4062518|NCT01071096|3884021|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4062519|NCT01071096|3884021|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4062520|NCT01071083|3884041|B6||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4062521|NCT01071083|3884042|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4062522|NCT01071083|3884043|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4062523|NCT01071083|3884044|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4062524|NCT01071083|3884045|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4062525|NCT01071083|3884046|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4062526|NCT01071083|3884041|B6||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4062527|NCT01071083|3884042|B5||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4062528|NCT01071083|3884043|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4062529|NCT01071083|3884044|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4062530|NCT01071083|3884045|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4062531|NCT01071083|3884046|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4062532|NCT01071083|3884041|B6|||Age||Years|Mean|41.2|41.2|Standard Deviation|9.85|9.85|||
4062533|NCT01071083|3884042|B5|||Age||Years|Mean|40.1|40.1|Standard Deviation|9.96|9.96|||
4062534|NCT01071083|3884043|B4|||Age||Years|Mean|44.1|44.1|Standard Deviation|7.85|7.85|||
4062535|NCT01071083|3884044|B3|||Age||Years|Mean|45.1|45.1|Standard Deviation|9.92|9.92|||
4062536|NCT01071083|3884045|B2|||Age||Years|Mean|40.0|40.0|Standard Deviation|10.36|10.36|||
4062537|NCT01071083|3884046|B1|||Age||Years|Mean|41.2|41.2|Standard Deviation|9.70|9.7|||
4062538|NCT01071070|3884067|B3|China||Region of Enrollment||participants|Number|216|216.0||||||
4062539|NCT01071070|3884068|B2|China||Region of Enrollment||participants|Number|108|108.0||||||
4062540|NCT01071070|3884069|B1|China||Region of Enrollment||participants|Number|108|108.0||||||
4062541|NCT01071070|3884067|B3||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4062542|NCT01071070|3884068|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4062543|NCT01071070|3884069|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4062544|NCT01071070|3884067|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4062545|NCT01071070|3884068|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4062546|NCT01071070|3884069|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4062547|NCT01071070|3884067|B3|>=65 years||Age, Customized||Participants|Number|32|32.0||||||
4062548|NCT01071070|3884068|B2|>=65 years||Age, Customized||Participants|Number|15|15.0||||||
4062549|NCT01071070|3884069|B1|>=65 years||Age, Customized||Participants|Number|17|17.0||||||
4062550|NCT01071070|3884067|B3|< 65 years||Age, Customized||Participants|Number|184|184.0||||||
4062551|NCT01071070|3884068|B2|< 65 years||Age, Customized||Participants|Number|93|93.0||||||
4062552|NCT01071070|3884069|B1|< 65 years||Age, Customized||Participants|Number|91|91.0||||||
4062553|NCT01071070|3884067|B3|||Age||years|Mean|50.6|50.6|Standard Deviation|13.09|13.09|||
4062554|NCT01071070|3884068|B2|||Age||years|Mean|50.8|50.8|Standard Deviation|12.67|12.67|||
4062555|NCT01071070|3884069|B1|||Age||years|Mean|50.5|50.5|Standard Deviation|13.55|13.55|||
4062556|NCT01071044|3884092|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4062557|NCT01071044|3884093|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4062558|NCT01071044|3884094|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4062559|NCT01071044|3884092|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4062560|NCT01071044|3884093|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4062561|NCT01071044|3884094|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4062562|NCT01071044|3884092|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4062563|NCT01071044|3884093|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4062564|NCT01071044|3884094|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4062565|NCT01071044|3884092|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4062566|NCT01071044|3884093|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4062567|NCT01071044|3884094|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4062568|NCT01071044|3884092|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4062569|NCT01071044|3884093|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4062570|NCT01071044|3884094|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4062571|NCT01071044|3884092|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4062572|NCT01071044|3884093|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4062573|NCT01071044|3884094|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4062574|NCT01070979|3884113|B4|United States||Region of Enrollment||participants|Number|249|249.0||||||
4062575|NCT01070979|3884114|B3|United States||Region of Enrollment||participants|Number|85|85.0||||||
4062576|NCT01070979|3884115|B2|United States||Region of Enrollment||participants|Number|85|85.0||||||
4062577|NCT01070979|3884116|B1|United States||Region of Enrollment||participants|Number|79|79.0||||||
4062578|NCT01070979|3884113|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4062579|NCT01070979|3884114|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4062580|NCT01070979|3884115|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4062581|NCT01070979|3884116|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4062582|NCT01070979|3884113|B4||Female|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
4062583|NCT01070979|3884114|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4062584|NCT01070979|3884115|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4062585|NCT01070979|3884116|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4062586|NCT01070979|3884113|B4|||Age||years|Mean|52.8|52.8|Standard Deviation|6.7|6.7|||
4062587|NCT01070979|3884114|B3|||Age||years|Mean|53.8|53.8|Standard Deviation|6.3|6.3|||
4062588|NCT01070979|3884115|B2|||Age||years|Mean|52.3|52.3|Standard Deviation|7.0|7.0|||
4062589|NCT01070979|3884116|B1|||Age||years|Mean|52.2|52.2|Standard Deviation|6.6|6.6|||
4062590|NCT01070966|3884144|B1|Female||Sex/Gender, Customized||participants|Number|1081|1081.0||||||
4062591|NCT01070966|3884144|B1|Male||Sex/Gender, Customized||participants|Number|930|930.0||||||
4062592|NCT01070966|3884144|B1|80 ≤age <90||Age, Customized||Participants|Number|28|28.0||||||
4062593|NCT01070966|3884144|B1|70 ≤age <80||Age, Customized||Participants|Number|256|256.0||||||
4062594|NCT01070966|3884144|B1|60 ≤age <70||Age, Customized||Participants|Number|600|600.0||||||
4062595|NCT01070966|3884144|B1|50 ≤age <60||Age, Customized||Participants|Number|598|598.0||||||
4062596|NCT01070966|3884144|B1|40 ≤age <50||Age, Customized||Participants|Number|391|391.0||||||
4062597|NCT01070966|3884144|B1|30 ≤age <40||Age, Customized||Participants|Number|111|111.0||||||
4062598|NCT01070966|3884144|B1|20 ≤age <30||Age, Customized||Participants|Number|22|22.0||||||
4062599|NCT01070966|3884144|B1|10 ≤age <20||Age, Customized||Participants|Number|5|5.0||||||
4062600|NCT01070953|3884155|B1||Male|Sex: Female, Male||Participants|Count of Participants|1675|1675.0||||||
4062601|NCT01070953|3884155|B1||Female|Sex: Female, Male||Participants|Count of Participants|1861|1861.0||||||
4062602|NCT01070953|3884155|B1|age ≥ 90||Age, Customized||participants|Number|2|2.0||||||
4062603|NCT01070953|3884155|B1|80 ≤ age < 90||Age, Customized||participants|Number|72|72.0||||||
4062604|NCT01070953|3884155|B1|70 ≤ age < 80||Age, Customized||participants|Number|451|451.0||||||
4062605|NCT01070953|3884155|B1|60 ≤ age < 70||Age, Customized||participants|Number|1023|1023.0||||||
4062606|NCT01070953|3884155|B1|50 ≤ age < 60||Age, Customized||participants|Number|1091|1091.0||||||
4062607|NCT01070953|3884155|B1|40 ≤ age < 50||Age, Customized||participants|Number|682|682.0||||||
4062608|NCT01070953|3884155|B1|30 ≤ age < 40||Age, Customized||participants|Number|186|186.0||||||
4062609|NCT01070953|3884155|B1|20 ≤ age < 30||Age, Customized||participants|Number|25|25.0||||||
4062610|NCT01070953|3884155|B1|age < 20||Age, Customized||participants|Number|4|4.0||||||
4062611|NCT01070888|3884166|B3|||FEV1 fall % predicted with exercise||percent fall in FEV1|Mean|45.9|45.9|Standard Deviation|25.6|25.6|||
4062612|NCT01070888|3884167|B2|||FEV1 fall % predicted with exercise||percent fall in FEV1|Mean|61.1|61.1|Standard Deviation|13.0|13.0|||
4062613|NCT01070888|3884168|B1|||FEV1 fall % predicted with exercise||percent fall in FEV1|Mean|15.5|15.5|Standard Deviation|0.6|0.6|||
4062614|NCT01070888|3884166|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4062615|NCT01070888|3884167|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4062616|NCT01070888|3884168|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4062617|NCT01070888|3884166|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4062618|NCT01070888|3884167|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4062619|NCT01070888|3884168|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4062620|NCT01070888|3884166|B3|||Age||years|Mean|24.8|24.8|Full Range|||15.0|41.0|
4062621|NCT01070888|3884167|B2|||Age||years|Mean|22.5|22.5|Full Range|||15.0|33.0|
4062622|NCT01070888|3884168|B1|||Age||years|Mean|29.5|29.5|Full Range|||18.0|41.0|
4062623|NCT01070810|3884175|B3|||BMI||kg/m^2|Mean|29|29.0|Standard Deviation|8|8.0|||
4062624|NCT01070810|3884176|B2|||BMI||kg/m^2|Mean|29|29.0|Standard Deviation|9|9.0|||
4062625|NCT01070810|3884177|B1|||BMI||kg/m^2|Mean|29|29.0|Standard Deviation|7|7.0|||
4062626|NCT01070810|3884175|B3|United States||Region of Enrollment||participants|Number|88|88.0||||||
4062627|NCT01070810|3884176|B2|United States||Region of Enrollment||participants|Number|43|43.0||||||
4062628|NCT01070810|3884177|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4062629|NCT01070810|3884175|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4062630|NCT01070810|3884176|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4062631|NCT01070810|3884177|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4062632|NCT01070810|3884175|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4062633|NCT01070810|3884176|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4062634|NCT01070810|3884177|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4062635|NCT01070810|3884175|B3||White|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
4062636|NCT01070810|3884176|B2||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4062637|NCT01070810|3884177|B1||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4062638|NCT01070810|3884175|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4062639|NCT01070810|3884176|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4062640|NCT01070810|3884177|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4062641|NCT01070810|3884175|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4062642|NCT01070810|3884176|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4062643|NCT01070810|3884177|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4062644|NCT01070810|3884175|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4062645|NCT01070810|3884176|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4062646|NCT01070810|3884177|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4062647|NCT01070810|3884175|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4062648|NCT01070810|3884176|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4062649|NCT01070810|3884177|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4062650|NCT01070810|3884175|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4062651|NCT01070810|3884176|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4062652|NCT01070810|3884177|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4062653|NCT01070810|3884175|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4062654|NCT01070810|3884176|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4062655|NCT01070810|3884177|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4062656|NCT01070810|3884175|B3|||Age||years|Mean|67|67.0|Standard Deviation|16|16.0|||
4062657|NCT01070810|3884176|B2|||Age||years|Mean|70|70.0|Standard Deviation|14|14.0|||
4062658|NCT01070810|3884177|B1|||Age||years|Mean|65|65.0|Standard Deviation|17|17.0|||
4062659|NCT01070784|3884192|B3||Male|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4062660|NCT01070784|3884193|B2||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4062661|NCT01070784|3884194|B1||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4062662|NCT01070784|3884192|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4062663|NCT01070784|3884193|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4062664|NCT01070784|3884194|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4062665|NCT01070784|3884192|B3|||Age||Years|Mean|70.8|70.8|Full Range|||40.0|87.0|
4062666|NCT01070784|3884193|B2|||Age||Years|Mean|71.5|71.5|Full Range|||54.0|85.0|
4062667|NCT01070784|3884194|B1|||Age||Years|Mean|70.1|70.1|Full Range|||40.0|87.0|
4062668|NCT01070771|3884283|B1|United Kingdom||Region of Enrollment||participants|Number|200|200.0||||||
4062669|NCT01070771|3884283|B1|Ireland||Region of Enrollment||participants|Number|0|0.0||||||
4062670|NCT01070771|3884283|B1||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4062671|NCT01070771|3884283|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4062672|NCT01070771|3884283|B1|||Age||years|Mean|64|64.0|Standard Deviation|10|10.0|||
4062673|NCT01070693|3884288|B3|Finland||Region of Enrollment||participants|Number|299|299.0||||||
4062674|NCT01070693|3884289|B2|Finland||Region of Enrollment||participants|Number|149|149.0||||||
4062675|NCT01070693|3884290|B1|Finland||Region of Enrollment||participants|Number|150|150.0||||||
4062676|NCT01070693|3884288|B3||Male|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
4062677|NCT01070693|3884289|B2||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4062678|NCT01070693|3884290|B1||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4062679|NCT01070693|3884288|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4062680|NCT01070693|3884289|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4062681|NCT01070693|3884290|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4062682|NCT01070693|3884288|B3|||Age||years|Median|46|46.0|Full Range|||19.0|72.0|
4062683|NCT01070693|3884289|B2|||Age||years|Median|47|47.0|Full Range|||20.0|70.0|
4062684|NCT01070693|3884290|B1|||Age||years|Median|46|46.0|Full Range|||19.0|72.0|
4062685|NCT01070550|3884297|B7|Unknown||Sex/Gender, Customized||Participants|Number|1|1.0||||||
4062686|NCT01070550|3884298|B6|Unknown||Sex/Gender, Customized||Participants|Number|1|1.0||||||
4062687|NCT01070550|3884299|B5|Unknown||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4062688|NCT01070550|3884300|B4|Unknown||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4062689|NCT01070550|3884301|B3|Unknown||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4062690|NCT01070550|3884302|B2|Unknown||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4062691|NCT01070550|3884303|B1|Unknown||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4062692|NCT01070550|3884297|B7|Male||Sex/Gender, Customized||Participants|Number|2597|2597.0||||||
4062693|NCT01070550|3884298|B6|Male||Sex/Gender, Customized||Participants|Number|25|25.0||||||
4062694|NCT01070550|3884299|B5|Male||Sex/Gender, Customized||Participants|Number|17|17.0||||||
4062695|NCT01070550|3884300|B4|Male||Sex/Gender, Customized||Participants|Number|147|147.0||||||
4062696|NCT01070550|3884301|B3|Male||Sex/Gender, Customized||Participants|Number|501|501.0||||||
4062697|NCT01070550|3884302|B2|Male||Sex/Gender, Customized||Participants|Number|161|161.0||||||
4062698|NCT01070550|3884303|B1|Male||Sex/Gender, Customized||Participants|Number|1746|1746.0||||||
4062699|NCT01070550|3884297|B7|Female||Sex/Gender, Customized||Participants|Number|2082|2082.0||||||
4062700|NCT01070550|3884298|B6|Female||Sex/Gender, Customized||Participants|Number|16|16.0||||||
4062701|NCT01070550|3884299|B5|Female||Sex/Gender, Customized||Participants|Number|4|4.0||||||
4062702|NCT01070550|3884300|B4|Female||Sex/Gender, Customized||Participants|Number|54|54.0||||||
4062703|NCT01070550|3884301|B3|Female||Sex/Gender, Customized||Participants|Number|243|243.0||||||
4062704|NCT01070550|3884302|B2|Female||Sex/Gender, Customized||Participants|Number|155|155.0||||||
4062705|NCT01070550|3884303|B1|Female||Sex/Gender, Customized||Participants|Number|1610|1610.0||||||
4062706|NCT01070550|3884297|B7|||Age||Years|Mean|46.3|46.3|Standard Deviation|11.86|11.86|||
4062707|NCT01070550|3884298|B6|||Age||Years|Mean|44.9|44.9|Standard Deviation|10.62|10.62|||
4062708|NCT01070550|3884299|B5|||Age||Years|Mean|52.5|52.5|Standard Deviation|11.81|11.81|||
4062709|NCT01070550|3884300|B4|||Age||Years|Mean|43.1|43.1|Standard Deviation|9.87|9.87|||
4062710|NCT01070550|3884301|B3|||Age||Years|Mean|40.8|40.8|Standard Deviation|10.25|10.25|||
4062711|NCT01070550|3884302|B2|||Age||Years|Mean|52.0|52.0|Standard Deviation|11.74|11.74|||
4062712|NCT01070550|3884303|B1|||Age||Years|Mean|47.1|47.1|Standard Deviation|11.87|11.87|||
4062713|NCT01070394|3884448|B1|Other/Mixed Ethnicity||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4062714|NCT01070394|3884448|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4062715|NCT01070394|3884448|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4062716|NCT01070394|3884448|B1|Black or African-American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4062717|NCT01070394|3884448|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4062718|NCT01070394|3884448|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4062719|NCT01070394|3884448|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4062720|NCT01070394|3884448|B1|||Age||years|Mean|36.4|36.4|Standard Deviation|8.9|8.9|||
4062721|NCT01070381|3884459|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4062722|NCT01070381|3884459|B1||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4062723|NCT01070381|3884459|B1|||Age||years|Mean|33.2|33.2|Standard Deviation|9.4|9.4|||
4062724|NCT01070329|3884466|B3|||Number of Previous Major Depressive Disorder (MDD) Episodes||number of previous episodes|Mean|3.61|3.61|Standard Deviation|3.38|3.38|||
4062725|NCT01070329|3884467|B2|||Number of Previous Major Depressive Disorder (MDD) Episodes||number of previous episodes|Mean|3.65|3.65|Standard Deviation|3.42|3.42|||
4062726|NCT01070329|3884468|B1|||Number of Previous Major Depressive Disorder (MDD) Episodes||number of previous episodes|Mean|3.58|3.58|Standard Deviation|3.34|3.34|||
4062727|NCT01070329|3884466|B3|||Sheehan Disability Scale -Total Score (SDS Total)|The SDS is completed by the participant and is used to assess the effect of the participant's symptoms on their work/social/family life. Total scores range from 0 to 30 with higher values indicating greater disruption in the participant's work/social/family life.|units on a scale|Mean|19.02|19.02|Standard Deviation|5.86|5.86|||
4062728|NCT01070329|3884467|B2|||Sheehan Disability Scale -Total Score (SDS Total)|The SDS is completed by the participant and is used to assess the effect of the participant's symptoms on their work/social/family life. Total scores range from 0 to 30 with higher values indicating greater disruption in the participant's work/social/family life.|units on a scale|Mean|18.88|18.88|Standard Deviation|5.70|5.7|||
4062729|NCT01070329|3884468|B1|||Sheehan Disability Scale -Total Score (SDS Total)|The SDS is completed by the participant and is used to assess the effect of the participant's symptoms on their work/social/family life. Total scores range from 0 to 30 with higher values indicating greater disruption in the participant's work/social/family life.|units on a scale|Mean|19.16|19.16|Standard Deviation|6.02|6.02|||
4062730|NCT01070329|3884466|B3|||Sheehan Disability Scale-Item 3 (SDS-Item 3)|The SDS is completed by the participant and Item 3 is used to assess the effect of the participant's symptoms on their family life/home responsibilities. Scores range from 0 to 10 with higher values indicating greater disruption in the participant's family life/home responsibilities.|units on a scale|Mean|6.36|6.36|Standard Deviation|2.11|2.11|||
4062731|NCT01070329|3884467|B2|||Sheehan Disability Scale-Item 3 (SDS-Item 3)|The SDS is completed by the participant and Item 3 is used to assess the effect of the participant's symptoms on their family life/home responsibilities. Scores range from 0 to 10 with higher values indicating greater disruption in the participant's family life/home responsibilities.|units on a scale|Mean|6.31|6.31|Standard Deviation|2.05|2.05|||
4062732|NCT01070329|3884468|B1|||Sheehan Disability Scale-Item 3 (SDS-Item 3)|The SDS is completed by the participant and Item 3 is used to assess the effect of the participant's symptoms on their family life/home responsibilities. Scores range from 0 to 10 with higher values indicating greater disruption in the participant's family life/home responsibilities.|units on a scale|Mean|6.41|6.41|Standard Deviation|2.17|2.17|||
4062733|NCT01070329|3884466|B3|||Sheehan Disability Scale-Item 2 (SDS-Item 2)|The SDS is completed by the participant and Item 2 is used to assess the effect of the participant's symptoms on their social life/leisure activities. Scores range from 0 to 10 with higher values indicating greater disruption in the patient's social life.|units on a scale|Mean|6.40|6.4|Standard Deviation|2.16|2.16|||
4062734|NCT01070329|3884467|B2|||Sheehan Disability Scale-Item 2 (SDS-Item 2)|The SDS is completed by the participant and Item 2 is used to assess the effect of the participant's symptoms on their social life/leisure activities. Scores range from 0 to 10 with higher values indicating greater disruption in the patient's social life.|units on a scale|Mean|6.30|6.3|Standard Deviation|2.11|2.11|||
4062735|NCT01070329|3884468|B1|||Sheehan Disability Scale-Item 2 (SDS-Item 2)|The SDS is completed by the participant and Item 2 is used to assess the effect of the participant's symptoms on their social life/leisure activities. Scores range from 0 to 10 with higher values indicating greater disruption in the patient's social life.|units on a scale|Mean|6.51|6.51|Standard Deviation|2.20|2.2|||
4062736|NCT01070329|3884466|B3|||Sheehan Disability Scale-Item 1 (SDS-Item 1), N=187, 193, 380|The SDS is completed by the participant and Item 1 is used to assess the effect of the participant's symptoms on their work/school schedule. Scores range from 0 to 10 with higher values indicating greater disruption in the participant's work/school life.|units on a scale|Mean|6.10|6.1|Standard Deviation|2.05|2.05|||
4062737|NCT01070329|3884467|B2|||Sheehan Disability Scale-Item 1 (SDS-Item 1), N=187, 193, 380|The SDS is completed by the participant and Item 1 is used to assess the effect of the participant's symptoms on their work/school schedule. Scores range from 0 to 10 with higher values indicating greater disruption in the participant's work/school life.|units on a scale|Mean|6.22|6.22|Standard Deviation|2.04|2.04|||
4062738|NCT01070329|3884468|B1|||Sheehan Disability Scale-Item 1 (SDS-Item 1), N=187, 193, 380|The SDS is completed by the participant and Item 1 is used to assess the effect of the participant's symptoms on their work/school schedule. Scores range from 0 to 10 with higher values indicating greater disruption in the participant's work/school life.|units on a scale|Mean|5.97|5.97|Standard Deviation|2.06|2.06|||
4062739|NCT01070329|3884466|B3|||Montgomery-Asberg Depression Rating Scale (MADRS) Total Score|The MADRS is a rating scale for severity of depressive mood symptoms. The MADRS has a 10-item checklist. Items are rated on a scale of 0-6, for a total score range of 0 (low severity of depressive symptoms) to 60 (high severity of depressive symptoms).|units on a scale|Mean|29.95|29.95|Standard Deviation|4.76|4.76|||
4062740|NCT01070329|3884467|B2|||Montgomery-Asberg Depression Rating Scale (MADRS) Total Score|The MADRS is a rating scale for severity of depressive mood symptoms. The MADRS has a 10-item checklist. Items are rated on a scale of 0-6, for a total score range of 0 (low severity of depressive symptoms) to 60 (high severity of depressive symptoms).|units on a scale|Mean|29.84|29.84|Standard Deviation|4.82|4.82|||
4062741|NCT01070329|3884468|B1|||Montgomery-Asberg Depression Rating Scale (MADRS) Total Score|The MADRS is a rating scale for severity of depressive mood symptoms. The MADRS has a 10-item checklist. Items are rated on a scale of 0-6, for a total score range of 0 (low severity of depressive symptoms) to 60 (high severity of depressive symptoms).|units on a scale|Mean|30.06|30.06|Standard Deviation|4.72|4.72|||
4062742|NCT01070329|3884466|B3|||Clinical Global Impressions of Severity Scale (CGI-S)|The CGI-S measures severity of illness at the time of assessment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|4.39|4.39|Standard Deviation|0.54|0.54|||
4062743|NCT01070329|3884467|B2|||Clinical Global Impressions of Severity Scale (CGI-S)|The CGI-S measures severity of illness at the time of assessment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|4.38|4.38|Standard Deviation|0.53|0.53|||
4062744|NCT01070329|3884468|B1|||Clinical Global Impressions of Severity Scale (CGI-S)|The CGI-S measures severity of illness at the time of assessment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|4.39|4.39|Standard Deviation|0.56|0.56|||
4062745|NCT01070329|3884466|B3|||Brief Pain Inventory - Interference (BPI-I)|The BPI-I scores range from 0 (does not interfere) to 10 (completely interferes). There are 7 questions assessing the interference of pain in the past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|6.01|6.01|Standard Deviation|2.00|2.0|||
4062775|NCT01070329|3884466|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
4062776|NCT01070329|3884467|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4062746|NCT01070329|3884467|B2|||Brief Pain Inventory - Interference (BPI-I)|The BPI-I scores range from 0 (does not interfere) to 10 (completely interferes). There are 7 questions assessing the interference of pain in the past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|5.98|5.98|Standard Deviation|1.97|1.97|||
4062747|NCT01070329|3884468|B1|||Brief Pain Inventory - Interference (BPI-I)|The BPI-I scores range from 0 (does not interfere) to 10 (completely interferes). There are 7 questions assessing the interference of pain in the past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|6.04|6.04|Standard Deviation|2.03|2.03|||
4062748|NCT01070329|3884466|B3|||Brief Pain Inventory Severity: Pain Right Now Score (BPI-S: Pain Right Now)|The BPI-S: Pain Right Now is a self-reported scale that measures the severity of pain based on the pain right now. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|5.34|5.34|Standard Deviation|2.16|2.16|||
4062749|NCT01070329|3884467|B2|||Brief Pain Inventory Severity: Pain Right Now Score (BPI-S: Pain Right Now)|The BPI-S: Pain Right Now is a self-reported scale that measures the severity of pain based on the pain right now. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|5.26|5.26|Standard Deviation|2.18|2.18|||
4062750|NCT01070329|3884468|B1|||Brief Pain Inventory Severity: Pain Right Now Score (BPI-S: Pain Right Now)|The BPI-S: Pain Right Now is a self-reported scale that measures the severity of pain based on the pain right now. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|5.41|5.41|Standard Deviation|2.13|2.13|||
4062751|NCT01070329|3884466|B3|||Brief Pain Inventory Severity: Average Pain Score (BPI-S: Average Pain)|The BPI-S: Average Pain is a self-reported scale that measures the severity of pain based on the average pain experienced over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|5.70|5.7|Standard Deviation|1.66|1.66|||
4062752|NCT01070329|3884467|B2|||Brief Pain Inventory Severity: Average Pain Score (BPI-S: Average Pain)|The BPI-S: Average Pain is a self-reported scale that measures the severity of pain based on the average pain experienced over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|5.63|5.63|Standard Deviation|1.69|1.69|||
4062753|NCT01070329|3884468|B1|||Brief Pain Inventory Severity: Average Pain Score (BPI-S: Average Pain)|The BPI-S: Average Pain is a self-reported scale that measures the severity of pain based on the average pain experienced over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|5.78|5.78|Standard Deviation|1.64|1.64|||
4062754|NCT01070329|3884466|B3|||Brief Pain Inventory Severity: Least Pain Score (BPI-S: Least Pain)|The BPI-S: Least Pain is a self-reported scale that measures the severity of pain based on the least pain experienced over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|4.18|4.18|Standard Deviation|1.98|1.98|||
4062755|NCT01070329|3884467|B2|||Brief Pain Inventory Severity: Least Pain Score (BPI-S: Least Pain)|The BPI-S: Least Pain is a self-reported scale that measures the severity of pain based on the least pain experienced over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|4.11|4.11|Standard Deviation|1.97|1.97|||
4062756|NCT01070329|3884468|B1|||Brief Pain Inventory Severity: Least Pain Score (BPI-S: Least Pain)|The BPI-S: Least Pain is a self-reported scale that measures the severity of pain based on the least pain experienced over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|4.25|4.25|Standard Deviation|1.99|1.99|||
4062757|NCT01070329|3884466|B3|||Brief Pain Inventory Severity: Worst Pain Score (BPI-S: Worst Pain)|The BPI-S: Worst Pain is a self-reported scale that measures the severity of pain based on the worst pain experienced over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|6.97|6.97|Standard Deviation|1.67|1.67|||
4062758|NCT01070329|3884467|B2|||Brief Pain Inventory Severity: Worst Pain Score (BPI-S: Worst Pain)|The BPI-S: Worst Pain is a self-reported scale that measures the severity of pain based on the worst pain experienced over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|6.88|6.88|Standard Deviation|1.67|1.67|||
4062759|NCT01070329|3884468|B1|||Brief Pain Inventory Severity: Worst Pain Score (BPI-S: Worst Pain)|The BPI-S: Worst Pain is a self-reported scale that measures the severity of pain based on the worst pain experienced over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|7.06|7.06|Standard Deviation|1.67|1.67|||
4062760|NCT01070329|3884466|B3|Puerto Rico||Region of Enrollment||participants|Number|37|37.0||||||
4062761|NCT01070329|3884467|B2|Puerto Rico||Region of Enrollment||participants|Number|18|18.0||||||
4062762|NCT01070329|3884468|B1|Puerto Rico||Region of Enrollment||participants|Number|19|19.0||||||
4062763|NCT01070329|3884466|B3|United States||Region of Enrollment||participants|Number|490|490.0||||||
4062764|NCT01070329|3884467|B2|United States||Region of Enrollment||participants|Number|248|248.0||||||
4062765|NCT01070329|3884468|B1|United States||Region of Enrollment||participants|Number|242|242.0||||||
4062766|NCT01070329|3884466|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4062767|NCT01070329|3884467|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4062768|NCT01070329|3884468|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4062769|NCT01070329|3884466|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4062770|NCT01070329|3884467|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4062771|NCT01070329|3884468|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4062772|NCT01070329|3884466|B3||White|Race (NIH/OMB)||Participants|Count of Participants|374|374.0||||||
4062773|NCT01070329|3884467|B2||White|Race (NIH/OMB)||Participants|Count of Participants|190|190.0||||||
4062774|NCT01070329|3884468|B1||White|Race (NIH/OMB)||Participants|Count of Participants|184|184.0||||||
4062777|NCT01070329|3884468|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4062778|NCT01070329|3884466|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4062779|NCT01070329|3884467|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4062780|NCT01070329|3884468|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4062781|NCT01070329|3884466|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4062782|NCT01070329|3884467|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4062783|NCT01070329|3884468|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4062784|NCT01070329|3884466|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4062785|NCT01070329|3884467|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4062786|NCT01070329|3884468|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4062787|NCT01070329|3884466|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4062788|NCT01070329|3884467|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4062789|NCT01070329|3884468|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4062790|NCT01070329|3884466|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|457|457.0||||||
4062791|NCT01070329|3884467|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|234|234.0||||||
4062792|NCT01070329|3884468|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|223|223.0||||||
4062793|NCT01070329|3884466|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4062794|NCT01070329|3884467|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4062795|NCT01070329|3884468|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4062796|NCT01070329|3884466|B3||Male|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4062797|NCT01070329|3884467|B2||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4062798|NCT01070329|3884468|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4062799|NCT01070329|3884466|B3||Female|Sex: Female, Male||Participants|Count of Participants|361|361.0||||||
4062800|NCT01070329|3884467|B2||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4062801|NCT01070329|3884468|B1||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4062802|NCT01070329|3884466|B3|||Age||years|Mean|44.68|44.68|Standard Deviation|12.42|12.42|||
4062803|NCT01070329|3884467|B2|||Age||years|Mean|44.21|44.21|Standard Deviation|12.38|12.38|||
4062804|NCT01070329|3884468|B1|||Age||years|Mean|45.15|45.15|Standard Deviation|12.47|12.47|||
4062805|NCT01070316|3884501|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4062806|NCT01070316|3884501|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4062807|NCT01070316|3884501|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4062808|NCT01070316|3884501|B1|||Age||years|Mean|8.8|8.8|Standard Deviation|5.3|5.3|||
4062809|NCT01070316|3884501|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4062810|NCT01070316|3884501|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4062811|NCT01070316|3884501|B1||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
4062812|NCT01070303|3884506|B3|United States||Region of Enrollment||participants|Number|177|177.0||||||
4062813|NCT01070303|3884507|B2|United States||Region of Enrollment||participants|Number|132|132.0||||||
4062814|NCT01070303|3884508|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4062815|NCT01070303|3884506|B3||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4062816|NCT01070303|3884507|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4062817|NCT01070303|3884508|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4062818|NCT01070303|3884506|B3||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4062819|NCT01070303|3884507|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4062820|NCT01070303|3884508|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4062821|NCT01070303|3884506|B3|||Age||years|Mean|38.1|38.1|Standard Deviation|12.19|12.19|||
4062822|NCT01070303|3884507|B2|||Age||years|Mean|38.9|38.9|Standard Deviation|12.53|12.53|||
4062823|NCT01070303|3884508|B1|||Age||years|Mean|35.5|35.5|Standard Deviation|10.88|10.88|||
4062824|NCT01070173|3884564|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4062825|NCT01070173|3884565|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4062826|NCT01070173|3884566|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4062827|NCT01070173|3884567|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4062828|NCT01070173|3884564|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4062829|NCT01070173|3884565|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4062830|NCT01070173|3884566|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4062831|NCT01070173|3884567|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4062832|NCT01070173|3884564|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4062833|NCT01070173|3884565|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4062834|NCT01070173|3884566|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4062835|NCT01070173|3884567|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4062836|NCT01070173|3884564|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4062837|NCT01070173|3884565|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4062838|NCT01070173|3884566|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4062839|NCT01070173|3884567|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4062840|NCT01070173|3884564|B4||<=18 years|Age||Participants|Count of Participants|52|52.0||||||
4062841|NCT01070173|3884565|B3||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4062842|NCT01070173|3884566|B2||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4062843|NCT01070173|3884567|B1||<=18 years|Age||Participants|Count of Participants|33|33.0||||||
4062844|NCT01070043|3884580|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4062845|NCT01070043|3884581|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4062846|NCT01070043|3884582|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4062847|NCT01070043|3884580|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4062848|NCT01070043|3884581|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4062849|NCT01070043|3884582|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4062850|NCT01070043|3884580|B3|||Age|Baseline measurements were based on safety/intent-to-treat (ITT) population.|years|Mean|57.31|57.31|Standard Deviation|13.81|13.81|||
4062851|NCT01070043|3884581|B2|||Age|Baseline measurements were based on safety/intent-to-treat (ITT) population.|years|Mean|55.13|55.13|Standard Deviation|11.81|11.81|||
4062852|NCT01070043|3884582|B1|||Age|Baseline measurements were based on safety/intent-to-treat (ITT) population.|years|Mean|59.50|59.5|Standard Deviation|13.81|13.81|||
4062853|NCT01069939|3884598|B3|Negative||Helicobacter pylori status|8 participants had a missing for this measurement (3 participants in Esomeprazole 20 mg group and 5 participants in Placebo group). Negative means a patient had no Helicobacter pylori infection and Positive means a patient had Helicobacter pylori infection.|Participants|Number|233|233.0||||||
4062854|NCT01069939|3884599|B2|Negative||Helicobacter pylori status|8 participants had a missing for this measurement (3 participants in Esomeprazole 20 mg group and 5 participants in Placebo group). Negative means a patient had no Helicobacter pylori infection and Positive means a patient had Helicobacter pylori infection.|Participants|Number|116|116.0||||||
4062855|NCT01069939|3884600|B1|Negative||Helicobacter pylori status|8 participants had a missing for this measurement (3 participants in Esomeprazole 20 mg group and 5 participants in Placebo group). Negative means a patient had no Helicobacter pylori infection and Positive means a patient had Helicobacter pylori infection.|Participants|Number|117|117.0||||||
4062856|NCT01069939|3884598|B3|Positive||Helicobacter pylori status|8 participants had a missing for this measurement (3 participants in Esomeprazole 20 mg group and 5 participants in Placebo group). Negative means a patient had no Helicobacter pylori infection and Positive means a patient had Helicobacter pylori infection.|Participants|Number|186|186.0||||||
4062857|NCT01069939|3884599|B2|Positive||Helicobacter pylori status|8 participants had a missing for this measurement (3 participants in Esomeprazole 20 mg group and 5 participants in Placebo group). Negative means a patient had no Helicobacter pylori infection and Positive means a patient had Helicobacter pylori infection.|Participants|Number|93|93.0||||||
4062858|NCT01069939|3884600|B1|Positive||Helicobacter pylori status|8 participants had a missing for this measurement (3 participants in Esomeprazole 20 mg group and 5 participants in Placebo group). Negative means a patient had no Helicobacter pylori infection and Positive means a patient had Helicobacter pylori infection.|Participants|Number|93|93.0||||||
4062859|NCT01069939|3884598|B3|Korea, Republic of||Region of Enrollment||Participants|Number|64|64.0||||||
4062860|NCT01069939|3884599|B2|Korea, Republic of||Region of Enrollment||Participants|Number|33|33.0||||||
4062861|NCT01069939|3884600|B1|Korea, Republic of||Region of Enrollment||Participants|Number|31|31.0||||||
4062862|NCT01069939|3884598|B3|Japan||Region of Enrollment||Participants|Number|320|320.0||||||
4062863|NCT01069939|3884599|B2|Japan||Region of Enrollment||Participants|Number|160|160.0||||||
4062864|NCT01069939|3884600|B1|Japan||Region of Enrollment||Participants|Number|160|160.0||||||
4062865|NCT01069939|3884598|B3|Taiwan||Region of Enrollment||Participants|Number|43|43.0||||||
4062866|NCT01069939|3884599|B2|Taiwan||Region of Enrollment||Participants|Number|21|21.0||||||
4062867|NCT01069939|3884600|B1|Taiwan||Region of Enrollment||Participants|Number|22|22.0||||||
4062868|NCT01069939|3884598|B3||Male|Sex: Female, Male||Participants|Count of Participants|338|338.0||||||
4062869|NCT01069939|3884599|B2||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4062870|NCT01069939|3884600|B1||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4062871|NCT01069939|3884598|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4062872|NCT01069939|3884599|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4062873|NCT01069939|3884600|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4062874|NCT01069939|3884598|B3|>=75 years||Age, Customized||Participants|Number|100|100.0||||||
4062875|NCT01069939|3884599|B2|>=75 years||Age, Customized||Participants|Number|54|54.0||||||
4062876|NCT01069939|3884600|B1|>=75 years||Age, Customized||Participants|Number|46|46.0||||||
4062877|NCT01069939|3884598|B3|Between 65 and 74 years||Age, Customized||Participants|Number|171|171.0||||||
4062878|NCT01069939|3884599|B2|Between 65 and 74 years||Age, Customized||Participants|Number|89|89.0||||||
4062879|NCT01069939|3884600|B1|Between 65 and 74 years||Age, Customized||Participants|Number|82|82.0||||||
4062880|NCT01069939|3884598|B3|<=64years||Age, Customized||Participants|Number|156|156.0||||||
4062881|NCT01069939|3884599|B2|<=64years||Age, Customized||Participants|Number|71|71.0||||||
4062882|NCT01069939|3884600|B1|<=64years||Age, Customized||Participants|Number|85|85.0||||||
4062883|NCT01069900|3884625|B3||Male|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
4062884|NCT01069900|3884626|B2||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4062885|NCT01069900|3884627|B1||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4062886|NCT01069900|3884625|B3||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4062887|NCT01069900|3884626|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4062888|NCT01069900|3884627|B1||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4062889|NCT01069900|3884625|B3|3 months - < 2 years||Age, Customized||Subjects|Number|1|1.0||||||
4062890|NCT01069900|3884626|B2|3 months - < 2 years||Age, Customized||Subjects|Number|0|0.0||||||
4062891|NCT01069900|3884627|B1|3 months - < 2 years||Age, Customized||Subjects|Number|1|1.0||||||
4062892|NCT01069900|3884625|B3|2 - < 6 years||Age, Customized||Subjects|Number|21|21.0||||||
4062893|NCT01069900|3884626|B2|2 - < 6 years||Age, Customized||Subjects|Number|7|7.0||||||
4062894|NCT01069900|3884627|B1|2 - < 6 years||Age, Customized||Subjects|Number|14|14.0||||||
4062895|NCT01069900|3884625|B3|6 - < 12 years||Age, Customized||Subjects|Number|152|152.0||||||
4062896|NCT01069900|3884626|B2|6 - < 12 years||Age, Customized||Subjects|Number|52|52.0||||||
4062897|NCT01069900|3884627|B1|6 - < 12 years||Age, Customized||Subjects|Number|100|100.0||||||
4062898|NCT01069900|3884625|B3|12 - < 18 years||Age, Customized||Subjects|Number|284|284.0||||||
4062899|NCT01069900|3884626|B2|12 - < 18 years||Age, Customized||Subjects|Number|94|94.0||||||
4062900|NCT01069900|3884627|B1|12 - < 18 years||Age, Customized||Subjects|Number|190|190.0||||||
4062901|NCT01069900|3884625|B3|||Age||years|Mean|12.049|12.049|Standard Deviation|3.602|3.602|||
4062902|NCT01069900|3884626|B2|||Age||years|Mean|12.046|12.046|Standard Deviation|3.495|3.495|||
4062903|NCT01069900|3884627|B1|||Age||years|Mean|12.05|12.05|Standard Deviation|3.66|3.66|||
4062904|NCT01069861|3884672|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4062905|NCT01069861|3884672|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4062906|NCT01069861|3884672|B1|||Age||days|Mean|1.5|1.5|Standard Deviation|0.5|0.5|||
4062907|NCT01069627|3884685|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4062908|NCT01069627|3884685|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4062909|NCT01069627|3884685|B1|||Age||years|Mean|51|51.0|Standard Deviation|15|15.0|||
4062910|NCT01069562|3884706|B3|India||Region of Enrollment||participants|Number|40|40.0||||||
4062911|NCT01069562|3884707|B2|India||Region of Enrollment||participants|Number|20|20.0||||||
4062912|NCT01069562|3884708|B1|India||Region of Enrollment||participants|Number|20|20.0||||||
4062913|NCT01069562|3884706|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4062914|NCT01069562|3884707|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4062915|NCT01069562|3884708|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4062916|NCT01069562|3884706|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4062917|NCT01069562|3884707|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4062918|NCT01069562|3884708|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4062919|NCT01069562|3884706|B3|||Age||years|Mean|46.4|46.4|Standard Deviation|14.5|14.5|||
4062920|NCT01069562|3884707|B2|||Age||years|Mean|46.4|46.4|Standard Deviation|14.1|14.1|||
4062921|NCT01069562|3884708|B1|||Age||years|Mean|46.4|46.4|Standard Deviation|15.2|15.2|||
4062922|NCT01069562|3884706|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4062923|NCT01069562|3884707|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4062924|NCT01069562|3884708|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4062925|NCT01069562|3884706|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4062926|NCT01069562|3884707|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4062927|NCT01069562|3884708|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4062928|NCT01069562|3884706|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4062929|NCT01069562|3884707|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4062930|NCT01069562|3884708|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4062931|NCT01069523|3884733|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
4062932|NCT01069523|3884734|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4062933|NCT01069523|3884735|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4062934|NCT01069523|3884733|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4062935|NCT01069523|3884734|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4062936|NCT01069523|3884735|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4062937|NCT01069523|3884733|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4062938|NCT01069523|3884734|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4062939|NCT01069523|3884735|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4062940|NCT01069523|3884733|B3|||Age||years|Mean|8.29|8.29|Standard Deviation|1.5|1.5|||
4062941|NCT01069523|3884734|B2|||Age||years|Mean|7.8|7.8|Standard Deviation|1.2|1.2|||
4062942|NCT01069523|3884735|B1|||Age||years|Mean|8.78|8.78|Standard Deviation|1.8|1.8|||
4062943|NCT01069523|3884733|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4062944|NCT01069523|3884734|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4062945|NCT01069523|3884735|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4062946|NCT01069523|3884733|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4062947|NCT01069523|3884734|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4062948|NCT01069523|3884735|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4062949|NCT01069523|3884733|B3||<=18 years|Age||Participants|Count of Participants|29|29.0||||||
4062950|NCT01069523|3884734|B2||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4062951|NCT01069523|3884735|B1||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4062952|NCT01069484|3884744|B3|Negative pad test||Urinary incontinence (positive pad test)||participants|Number|114|114.0||||||
4062953|NCT01069484|3884745|B2|Negative pad test||Urinary incontinence (positive pad test)||participants|Number|54|54.0||||||
4062954|NCT01069484|3884746|B1|Negative pad test||Urinary incontinence (positive pad test)||participants|Number|60|60.0||||||
4062955|NCT01069484|3884744|B3|Positive pad test||Urinary incontinence (positive pad test)||participants|Number|61|61.0||||||
4062956|NCT01069484|3884745|B2|Positive pad test||Urinary incontinence (positive pad test)||participants|Number|34|34.0||||||
4062957|NCT01069484|3884746|B1|Positive pad test||Urinary incontinence (positive pad test)||participants|Number|27|27.0||||||
4062958|NCT01069484|3884744|B3|Urinary continent women||Urinary Incontinence (Prevalence)||participants|Number|97|97.0||||||
4062959|NCT01069484|3884745|B2|Urinary continent women||Urinary Incontinence (Prevalence)||participants|Number|44|44.0||||||
4062960|NCT01069484|3884746|B1|Urinary continent women||Urinary Incontinence (Prevalence)||participants|Number|53|53.0||||||
4062961|NCT01069484|3884744|B3|Urinary incontinent women||Urinary Incontinence (Prevalence)||participants|Number|78|78.0||||||
4062962|NCT01069484|3884745|B2|Urinary incontinent women||Urinary Incontinence (Prevalence)||participants|Number|44|44.0||||||
4062963|NCT01069484|3884746|B1|Urinary incontinent women||Urinary Incontinence (Prevalence)||participants|Number|34|34.0||||||
4062964|NCT01069484|3884744|B3|No major defect||Major defect of the levator ani muscle||participants|Number|120|120.0||||||
4062965|NCT01069484|3884745|B2|No major defect||Major defect of the levator ani muscle||participants|Number|60|60.0||||||
4062966|NCT01069484|3884746|B1|No major defect||Major defect of the levator ani muscle||participants|Number|60|60.0||||||
4062967|NCT01069484|3884744|B3|Major defect||Major defect of the levator ani muscle||participants|Number|55|55.0||||||
4062968|NCT01069484|3884745|B2|Major defect||Major defect of the levator ani muscle||participants|Number|28|28.0||||||
4062969|NCT01069484|3884746|B1|Major defect||Major defect of the levator ani muscle||participants|Number|27|27.0||||||
4062970|NCT01069484|3884744|B3|Single||Civil status||participants|Number|9|9.0||||||
4062971|NCT01069484|3884745|B2|Single||Civil status||participants|Number|2|2.0||||||
4062972|NCT01069484|3884746|B1|Single||Civil status||participants|Number|7|7.0||||||
4062973|NCT01069484|3884744|B3|Married or cohabitant||Civil status||participants|Number|166|166.0||||||
4062974|NCT01069484|3884745|B2|Married or cohabitant||Civil status||participants|Number|86|86.0||||||
4062975|NCT01069484|3884746|B1|Married or cohabitant||Civil status||participants|Number|80|80.0||||||
4062976|NCT01069484|3884744|B3|Primary school, high school, other||Level of education||participants|Number|32|32.0||||||
4062977|NCT01069484|3884745|B2|Primary school, high school, other||Level of education||participants|Number|9|9.0||||||
4062978|NCT01069484|3884746|B1|Primary school, high school, other||Level of education||participants|Number|23|23.0||||||
4062979|NCT01069484|3884744|B3|College or university||Level of education||participants|Number|143|143.0||||||
4062980|NCT01069484|3884745|B2|College or university||Level of education||participants|Number|79|79.0||||||
4062981|NCT01069484|3884746|B1|College or university||Level of education||participants|Number|64|64.0||||||
4062982|NCT01069484|3884744|B3|||Body mass index (BMI)||kg/m2|Mean|25.7|25.7|Standard Deviation|4.0|4.0|||
4062983|NCT01069484|3884745|B2|||Body mass index (BMI)||kg/m2|Mean|25.3|25.3|Standard Deviation|3.9|3.9|||
4062984|NCT01069484|3884746|B1|||Body mass index (BMI)||kg/m2|Mean|26.0|26.0|Standard Deviation|4.1|4.1|||
4062985|NCT01069484|3884744|B3||Male|Sex: Female, Male|Only primiparous women who delivered a singleton baby vaginally were included. They were included 6 weeks after delivery (mean: 6.1 week, standard deviation: 0.9).|Participants|Count of Participants|0|0.0||||||
4062986|NCT01069484|3884745|B2||Male|Sex: Female, Male|Only primiparous women who delivered a singleton baby vaginally were included. They were included 6 weeks after delivery (mean: 6.1 week, standard deviation: 0.9).|Participants|Count of Participants|0|0.0||||||
4062987|NCT01069484|3884746|B1||Male|Sex: Female, Male|Only primiparous women who delivered a singleton baby vaginally were included. They were included 6 weeks after delivery (mean: 6.1 week, standard deviation: 0.9).|Participants|Count of Participants|0|0.0||||||
4062988|NCT01069484|3884744|B3||Female|Sex: Female, Male|Only primiparous women who delivered a singleton baby vaginally were included. They were included 6 weeks after delivery (mean: 6.1 week, standard deviation: 0.9).|Participants|Count of Participants|175|175.0||||||
4062989|NCT01069484|3884745|B2||Female|Sex: Female, Male|Only primiparous women who delivered a singleton baby vaginally were included. They were included 6 weeks after delivery (mean: 6.1 week, standard deviation: 0.9).|Participants|Count of Participants|88|88.0||||||
4062990|NCT01069484|3884746|B1||Female|Sex: Female, Male|Only primiparous women who delivered a singleton baby vaginally were included. They were included 6 weeks after delivery (mean: 6.1 week, standard deviation: 0.9).|Participants|Count of Participants|87|87.0||||||
4062991|NCT01069484|3884744|B3|||Age||years|Mean|29.8|29.8|Standard Deviation|4.1|4.1|||
4062992|NCT01069484|3884745|B2|||Age||years|Mean|30.1|30.1|Standard Deviation|4.0|4.0|||
4062993|NCT01069484|3884746|B1|||Age||years|Mean|29.5|29.5|Standard Deviation|4.3|4.3|||
4062994|NCT01069419|3884755|B1||Male|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
4062995|NCT01069419|3884755|B1||Female|Sex: Female, Male||Participants|Count of Participants|870|870.0||||||
4062996|NCT01069419|3884755|B1|||Age|One subject's age data was missing. Age continuous calculation is based on n=1116.|years|Mean|55.1|55.1|Standard Deviation|12.4|12.4|||
4062997|NCT01069419|3884755|B1|Missing||Age, Customized||Participants|Number|1|1.0||||||
4062998|NCT01069419|3884755|B1|>=65 years||Age, Customized||Participants|Number|268|268.0||||||
4062999|NCT01069419|3884755|B1|Between 18 and 65 years||Age, Customized||Participants|Number|848|848.0||||||
4063000|NCT01069419|3884755|B1|<=18 years||Age, Customized||Participants|Number|0|0.0||||||
4063001|NCT01069354|3884762|B1|VI: never burns, tans profusely||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|5|5.0||||||
4063002|NCT01069354|3884762|B1|V: rarely burns, tans profusely||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|5|5.0||||||
4063003|NCT01069354|3884762|B1|IV: burns minimally, tans moderately & easily||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|8|8.0||||||
4063004|NCT01069354|3884762|B1|III: burns moderately, tans moderately & uniformly||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|59|59.0||||||
4063005|NCT01069354|3884762|B1|II: burns easily, tans minimally with difficulty||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|19|19.0||||||
4063006|NCT01069354|3884762|B1|I: burns easily, never tans||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|6|6.0||||||
4063007|NCT01069354|3884762|B1|Canada||Region of Enrollment||participants|Number|102|102.0||||||
4063008|NCT01069354|3884762|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4063009|NCT01069354|3884762|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4063010|NCT01069354|3884762|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4063011|NCT01069354|3884762|B1|African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4063012|NCT01069354|3884762|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|88|88.0||||||
4063013|NCT01069354|3884762|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4063014|NCT01069354|3884762|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4063015|NCT01069354|3884762|B1|||Age, Customized||years|Mean|48.85|48.85|Standard Deviation|9.43|9.43|||
4063016|NCT01069341|3884784|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4063017|NCT01069341|3884784|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4063018|NCT01069341|3884784|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4063019|NCT01069341|3884784|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4063020|NCT01069341|3884784|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4063021|NCT01069289|3884795|B3||Male|Sex: Female, Male||Participants|Count of Participants|1150|1150.0||||||
4063022|NCT01069289|3884796|B2||Male|Sex: Female, Male||Participants|Count of Participants|593|593.0||||||
4063023|NCT01069289|3884797|B1||Male|Sex: Female, Male||Participants|Count of Participants|557|557.0||||||
4063024|NCT01069289|3884795|B3||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4063025|NCT01069289|3884796|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4063026|NCT01069289|3884797|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4063027|NCT01069289|3884795|B3|||Age||Years|Mean|65.1|65.1|Full Range|||40.0|89.0|
4063028|NCT01069289|3884796|B2|||Age||Years|Mean|65.6|65.6|Full Range|||40.0|87.0|
4063029|NCT01069289|3884797|B1|||Age||Years|Mean|64.5|64.5|Full Range|||40.0|89.0|
4063030|NCT01069185|3884836|B3|||PRISM|The PRISM score predicts the risk of mortality in critical children. It evaluates the degree of severity of the illness. Ranges are established between 0-100. As highest the number as highest the probability of dead.|units on a scale|Median|23|23.0|Inter-Quartile Range|||15.0|26.5|
4063031|NCT01069185|3884837|B2|||PRISM|The PRISM score predicts the risk of mortality in critical children. It evaluates the degree of severity of the illness. Ranges are established between 0-100. As highest the number as highest the probability of dead.|units on a scale|Median|23|23.0|Inter-Quartile Range|||17.0|27.0|
4063032|NCT01069185|3884838|B1|||PRISM|The PRISM score predicts the risk of mortality in critical children. It evaluates the degree of severity of the illness. Ranges are established between 0-100. As highest the number as highest the probability of dead.|units on a scale|Median|23|23.0|Inter-Quartile Range|||14.0|28.0|
4063033|NCT01069185|3884836|B3|||Weight||Kgs|Median|15|15.0|Inter-Quartile Range|||7.6|30.0|
4063034|NCT01069185|3884837|B2|||Weight||Kgs|Median|15|15.0|Inter-Quartile Range|||10.0|30.0|
4063035|NCT01069185|3884838|B1|||Weight||Kgs|Median|15|15.0|Inter-Quartile Range|||7.0|31.0|
4063036|NCT01069185|3884836|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4063037|NCT01069185|3884837|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4063038|NCT01069185|3884838|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4063039|NCT01069185|3884836|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4063040|NCT01069185|3884837|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4063041|NCT01069185|3884838|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4063042|NCT01069185|3884836|B3|||Age||months|Median|40.5|40.5|Inter-Quartile Range|||8.3|107.1|
4063043|NCT01069185|3884837|B2|||Age||months|Median|56|56.0|Inter-Quartile Range|||14.0|108.0|
4063044|NCT01069185|3884838|B1|||Age||months|Median|34|34.0|Inter-Quartile Range|||7.0|104.0|
4063045|NCT01069172|3884847|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4063046|NCT01069172|3884847|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4063047|NCT01069172|3884847|B1|||Age||years|Mean|70.1|70.1|Standard Deviation|5.90|5.9|||
4063048|NCT01069003|3884864|B4|Canada||Region of Enrollment||participants|Number|96|96.0||||||
4063049|NCT01069003|3884865|B3|Canada||Region of Enrollment||participants|Number|42|42.0||||||
4063050|NCT01069003|3884866|B2|Canada||Region of Enrollment||participants|Number|27|27.0||||||
4063051|NCT01069003|3884867|B1|Canada||Region of Enrollment||participants|Number|27|27.0||||||
4063052|NCT01069003|3884864|B4|United States||Region of Enrollment||participants|Number|2166|2166.0||||||
4063053|NCT01069003|3884865|B3|United States||Region of Enrollment||participants|Number|1409|1409.0||||||
4063054|NCT01069003|3884866|B2|United States||Region of Enrollment||participants|Number|385|385.0||||||
4063055|NCT01069003|3884867|B1|United States||Region of Enrollment||participants|Number|372|372.0||||||
4063056|NCT01069003|3884864|B4||Male|Sex: Female, Male||Participants|Count of Participants|1575|1575.0||||||
4063057|NCT01069003|3884865|B3||Male|Sex: Female, Male||Participants|Count of Participants|1002|1002.0||||||
4063058|NCT01069003|3884866|B2||Male|Sex: Female, Male||Participants|Count of Participants|296|296.0||||||
4063059|NCT01069003|3884867|B1||Male|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
4063060|NCT01069003|3884864|B4||Female|Sex: Female, Male||Participants|Count of Participants|687|687.0||||||
4063061|NCT01069003|3884865|B3||Female|Sex: Female, Male||Participants|Count of Participants|449|449.0||||||
4063062|NCT01069003|3884866|B2||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4063063|NCT01069003|3884867|B1||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4063064|NCT01069003|3884864|B4|||Age||years|Mean|63.3|63.3|Standard Deviation|10.9|10.9|||
4063065|NCT01069003|3884865|B3|||Age||years|Mean|64.6|64.6|Standard Deviation|11.3|11.3|||
4063066|NCT01069003|3884866|B2|||Age||years|Mean|62.5|62.5|Standard Deviation|10.7|10.7|||
4063067|NCT01069003|3884867|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|10.7|10.7|||
4063068|NCT01068964|3884883|B3||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4063069|NCT01068964|3884884|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4063070|NCT01068964|3884885|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4063071|NCT01068964|3884883|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4063072|NCT01068964|3884884|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4063073|NCT01068964|3884885|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4063074|NCT01068964|3884883|B3|||Age||years|Mean|45.02|45.02|Standard Deviation|15.51|15.51|||
4063075|NCT01068964|3884884|B2|||Age||years|Mean|44.28|44.28|Standard Deviation|16.28|16.28|||
4063076|NCT01068964|3884885|B1|||Age||years|Mean|45.73|45.73|Standard Deviation|14.77|14.77|||
4063077|NCT01068912|3884892|B4|Neither||Virus type identification||participants|Number|182|182.0||||||
4063078|NCT01068912|3884893|B3|Neither||Virus type identification||participants|Number|72|72.0||||||
4063079|NCT01068912|3884894|B2|Neither||Virus type identification||participants|Number|67|67.0||||||
4063080|NCT01068912|3884895|B1|Neither||Virus type identification||participants|Number|43|43.0||||||
4063081|NCT01068912|3884892|B4|Other||Virus type identification||participants|Number|1|1.0||||||
4063082|NCT01068912|3884893|B3|Other||Virus type identification||participants|Number|0|0.0||||||
4063083|NCT01068912|3884894|B2|Other||Virus type identification||participants|Number|0|0.0||||||
4063084|NCT01068912|3884895|B1|Other||Virus type identification||participants|Number|1|1.0||||||
4063085|NCT01068912|3884892|B4|B||Virus type identification||participants|Number|63|63.0||||||
4063086|NCT01068912|3884893|B3|B||Virus type identification||participants|Number|20|20.0||||||
4063087|NCT01068912|3884894|B2|B||Virus type identification||participants|Number|23|23.0||||||
4063088|NCT01068912|3884895|B1|B||Virus type identification||participants|Number|20|20.0||||||
4063089|NCT01068912|3884892|B4|A (H3N2)||Virus type identification||participants|Number|162|162.0||||||
4063090|NCT01068912|3884893|B3|A (H3N2)||Virus type identification||participants|Number|66|66.0||||||
4063091|NCT01068912|3884894|B2|A (H3N2)||Virus type identification||participants|Number|67|67.0||||||
4063092|NCT01068912|3884895|B1|A (H3N2)||Virus type identification||participants|Number|29|29.0||||||
4063093|NCT01068912|3884892|B4|A (H1N1) pdm||Virus type identification||participants|Number|110|110.0||||||
4063094|NCT01068912|3884893|B3|A (H1N1) pdm||Virus type identification||participants|Number|39|39.0||||||
4063095|NCT01068912|3884894|B2|A (H1N1) pdm||Virus type identification||participants|Number|32|32.0||||||
4063096|NCT01068912|3884895|B1|A (H1N1) pdm||Virus type identification||participants|Number|39|39.0||||||
4063097|NCT01068912|3884892|B4|Influenza negative||Rapid Antigen Test Result|Tested positive for influenza A or B by a commercially available rapid antigen test of the nasopharynx. A patient with a negative rapid antigen test result was enrolled if the sponsor and investigator agreed that there was a known influenza outbreak circulating in the community.|participants|Number|73|73.0||||||
4063127|NCT01068912|3884894|B2|Australia||Region of Enrollment||participants|Number|9|9.0||||||
4063128|NCT01068912|3884895|B1|Australia||Region of Enrollment||participants|Number|7|7.0||||||
4063098|NCT01068912|3884893|B3|Influenza negative||Rapid Antigen Test Result|Tested positive for influenza A or B by a commercially available rapid antigen test of the nasopharynx. A patient with a negative rapid antigen test result was enrolled if the sponsor and investigator agreed that there was a known influenza outbreak circulating in the community.|participants|Number|28|28.0||||||
4063099|NCT01068912|3884894|B2|Influenza negative||Rapid Antigen Test Result|Tested positive for influenza A or B by a commercially available rapid antigen test of the nasopharynx. A patient with a negative rapid antigen test result was enrolled if the sponsor and investigator agreed that there was a known influenza outbreak circulating in the community.|participants|Number|26|26.0||||||
4063100|NCT01068912|3884895|B1|Influenza negative||Rapid Antigen Test Result|Tested positive for influenza A or B by a commercially available rapid antigen test of the nasopharynx. A patient with a negative rapid antigen test result was enrolled if the sponsor and investigator agreed that there was a known influenza outbreak circulating in the community.|participants|Number|19|19.0||||||
4063101|NCT01068912|3884892|B4|Type A and B positive||Rapid Antigen Test Result|Tested positive for influenza A or B by a commercially available rapid antigen test of the nasopharynx. A patient with a negative rapid antigen test result was enrolled if the sponsor and investigator agreed that there was a known influenza outbreak circulating in the community.|participants|Number|13|13.0||||||
4063102|NCT01068912|3884893|B3|Type A and B positive||Rapid Antigen Test Result|Tested positive for influenza A or B by a commercially available rapid antigen test of the nasopharynx. A patient with a negative rapid antigen test result was enrolled if the sponsor and investigator agreed that there was a known influenza outbreak circulating in the community.|participants|Number|2|2.0||||||
4063103|NCT01068912|3884894|B2|Type A and B positive||Rapid Antigen Test Result|Tested positive for influenza A or B by a commercially available rapid antigen test of the nasopharynx. A patient with a negative rapid antigen test result was enrolled if the sponsor and investigator agreed that there was a known influenza outbreak circulating in the community.|participants|Number|5|5.0||||||
4063104|NCT01068912|3884895|B1|Type A and B positive||Rapid Antigen Test Result|Tested positive for influenza A or B by a commercially available rapid antigen test of the nasopharynx. A patient with a negative rapid antigen test result was enrolled if the sponsor and investigator agreed that there was a known influenza outbreak circulating in the community.|participants|Number|6|6.0||||||
4063105|NCT01068912|3884892|B4|Type B positive||Rapid Antigen Test Result|Tested positive for influenza A or B by a commercially available rapid antigen test of the nasopharynx. A patient with a negative rapid antigen test result was enrolled if the sponsor and investigator agreed that there was a known influenza outbreak circulating in the community.|participants|Number|118|118.0||||||
4063106|NCT01068912|3884893|B3|Type B positive||Rapid Antigen Test Result|Tested positive for influenza A or B by a commercially available rapid antigen test of the nasopharynx. A patient with a negative rapid antigen test result was enrolled if the sponsor and investigator agreed that there was a known influenza outbreak circulating in the community.|participants|Number|43|43.0||||||
4063107|NCT01068912|3884894|B2|Type B positive||Rapid Antigen Test Result|Tested positive for influenza A or B by a commercially available rapid antigen test of the nasopharynx. A patient with a negative rapid antigen test result was enrolled if the sponsor and investigator agreed that there was a known influenza outbreak circulating in the community.|participants|Number|45|45.0||||||
4063108|NCT01068912|3884895|B1|Type B positive||Rapid Antigen Test Result|Tested positive for influenza A or B by a commercially available rapid antigen test of the nasopharynx. A patient with a negative rapid antigen test result was enrolled if the sponsor and investigator agreed that there was a known influenza outbreak circulating in the community.|participants|Number|30|30.0||||||
4063109|NCT01068912|3884892|B4|Type A Positive||Rapid Antigen Test Result|Tested positive for influenza A or B by a commercially available rapid antigen test of the nasopharynx. A patient with a negative rapid antigen test result was enrolled if the sponsor and investigator agreed that there was a known influenza outbreak circulating in the community.|participants|Number|314|314.0||||||
4063110|NCT01068912|3884893|B3|Type A Positive||Rapid Antigen Test Result|Tested positive for influenza A or B by a commercially available rapid antigen test of the nasopharynx. A patient with a negative rapid antigen test result was enrolled if the sponsor and investigator agreed that there was a known influenza outbreak circulating in the community.|participants|Number|124|124.0||||||
4063111|NCT01068912|3884894|B2|Type A Positive||Rapid Antigen Test Result|Tested positive for influenza A or B by a commercially available rapid antigen test of the nasopharynx. A patient with a negative rapid antigen test result was enrolled if the sponsor and investigator agreed that there was a known influenza outbreak circulating in the community.|participants|Number|113|113.0||||||
4063112|NCT01068912|3884895|B1|Type A Positive||Rapid Antigen Test Result|Tested positive for influenza A or B by a commercially available rapid antigen test of the nasopharynx. A patient with a negative rapid antigen test result was enrolled if the sponsor and investigator agreed that there was a known influenza outbreak circulating in the community.|participants|Number|77|77.0||||||
4063113|NCT01068912|3884892|B4|New Zealand||Region of Enrollment||participants|Number|21|21.0||||||
4063114|NCT01068912|3884893|B3|New Zealand||Region of Enrollment||participants|Number|10|10.0||||||
4063115|NCT01068912|3884894|B2|New Zealand||Region of Enrollment||participants|Number|5|5.0||||||
4063116|NCT01068912|3884895|B1|New Zealand||Region of Enrollment||participants|Number|6|6.0||||||
4063117|NCT01068912|3884892|B4|Chile||Region of Enrollment||participants|Number|18|18.0||||||
4063118|NCT01068912|3884893|B3|Chile||Region of Enrollment||participants|Number|7|7.0||||||
4063119|NCT01068912|3884894|B2|Chile||Region of Enrollment||participants|Number|9|9.0||||||
4063120|NCT01068912|3884895|B1|Chile||Region of Enrollment||participants|Number|2|2.0||||||
4063121|NCT01068912|3884892|B4|South Africa||Region of Enrollment||participants|Number|26|26.0||||||
4063122|NCT01068912|3884893|B3|South Africa||Region of Enrollment||participants|Number|8|8.0||||||
4063123|NCT01068912|3884894|B2|South Africa||Region of Enrollment||participants|Number|10|10.0||||||
4063124|NCT01068912|3884895|B1|South Africa||Region of Enrollment||participants|Number|8|8.0||||||
4063125|NCT01068912|3884892|B4|Australia||Region of Enrollment||participants|Number|24|24.0||||||
4063126|NCT01068912|3884893|B3|Australia||Region of Enrollment||participants|Number|8|8.0||||||
4063129|NCT01068912|3884892|B4|Peru||Region of Enrollment||participants|Number|96|96.0||||||
4063130|NCT01068912|3884893|B3|Peru||Region of Enrollment||participants|Number|36|36.0||||||
4063131|NCT01068912|3884894|B2|Peru||Region of Enrollment||participants|Number|36|36.0||||||
4063132|NCT01068912|3884895|B1|Peru||Region of Enrollment||participants|Number|24|24.0||||||
4063133|NCT01068912|3884892|B4|United States||Region of Enrollment||participants|Number|333|333.0||||||
4063134|NCT01068912|3884893|B3|United States||Region of Enrollment||participants|Number|128|128.0||||||
4063135|NCT01068912|3884894|B2|United States||Region of Enrollment||participants|Number|120|120.0||||||
4063136|NCT01068912|3884895|B1|United States||Region of Enrollment||participants|Number|85|85.0||||||
4063137|NCT01068912|3884892|B4|More than one race, excluding Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4063138|NCT01068912|3884893|B3|More than one race, excluding Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4063139|NCT01068912|3884894|B2|More than one race, excluding Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4063140|NCT01068912|3884895|B1|More than one race, excluding Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4063141|NCT01068912|3884892|B4|More than one race, including Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4063142|NCT01068912|3884893|B3|More than one race, including Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4063143|NCT01068912|3884894|B2|More than one race, including Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4063144|NCT01068912|3884895|B1|More than one race, including Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4063145|NCT01068912|3884892|B4|Other||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4063146|NCT01068912|3884893|B3|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4063147|NCT01068912|3884894|B2|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4063148|NCT01068912|3884895|B1|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4063149|NCT01068912|3884892|B4|White||Race/Ethnicity, Customized||participants|Number|290|290.0||||||
4063150|NCT01068912|3884893|B3|White||Race/Ethnicity, Customized||participants|Number|115|115.0||||||
4063151|NCT01068912|3884894|B2|White||Race/Ethnicity, Customized||participants|Number|103|103.0||||||
4063152|NCT01068912|3884895|B1|White||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
4063153|NCT01068912|3884892|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4063154|NCT01068912|3884893|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4063155|NCT01068912|3884894|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4063156|NCT01068912|3884895|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4063157|NCT01068912|3884892|B4|Mestizo||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4063158|NCT01068912|3884893|B3|Mestizo||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4063159|NCT01068912|3884894|B2|Mestizo||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4063160|NCT01068912|3884895|B1|Mestizo||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4063161|NCT01068912|3884892|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
4063162|NCT01068912|3884893|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4063163|NCT01068912|3884894|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4063164|NCT01068912|3884895|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4063165|NCT01068912|3884892|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
4063166|NCT01068912|3884893|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4063167|NCT01068912|3884894|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4063168|NCT01068912|3884895|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4063169|NCT01068912|3884892|B4|Asian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4063170|NCT01068912|3884893|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4063171|NCT01068912|3884894|B2|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4063172|NCT01068912|3884895|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4063173|NCT01068912|3884892|B4||Male|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
4063174|NCT01068912|3884893|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4063175|NCT01068912|3884894|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4063176|NCT01068912|3884895|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4063177|NCT01068912|3884892|B4||Female|Sex: Female, Male||Participants|Count of Participants|284|284.0||||||
4063178|NCT01068912|3884893|B3||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4063179|NCT01068912|3884894|B2||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4063180|NCT01068912|3884895|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4063181|NCT01068912|3884892|B4|||Age||years|Mean|42.5|42.5|Full Range|||20.0|80.0|
4063182|NCT01068912|3884893|B3|||Age||years|Mean|42.7|42.7|Full Range|||20.0|80.0|
4063183|NCT01068912|3884894|B2|||Age||years|Mean|42.6|42.6|Full Range|||20.0|75.0|
4063184|NCT01068912|3884895|B1|||Age||years|Mean|42.2|42.2|Full Range|||20.0|79.0|
4063185|NCT01068860|3884905|B11||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4063186|NCT01068860|3884906|B10||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4063187|NCT01068860|3884907|B9||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4063188|NCT01068860|3884908|B8||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4063189|NCT01068860|3884909|B7||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4063190|NCT01068860|3884910|B6||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4063191|NCT01068860|3884911|B5||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4063192|NCT01068860|3884912|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4063193|NCT01068860|3884913|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4063194|NCT01068860|3884914|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4063195|NCT01068860|3884915|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4063196|NCT01068860|3884905|B11||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4063197|NCT01068860|3884906|B10||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4063198|NCT01068860|3884907|B9||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4063199|NCT01068860|3884908|B8||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4063200|NCT01068860|3884909|B7||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4063201|NCT01068860|3884910|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4063202|NCT01068860|3884911|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4063203|NCT01068860|3884912|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4063204|NCT01068860|3884913|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4063205|NCT01068860|3884914|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4063206|NCT01068860|3884915|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4063207|NCT01068860|3884905|B11|||Age, Customized||years|Mean|57.4|57.4|Standard Deviation|10.16|10.16|||
4063208|NCT01068860|3884906|B10|||Age, Customized||years|Mean|57.6|57.6|Standard Deviation|10.07|10.07|||
4063209|NCT01068860|3884907|B9|||Age, Customized||years|Mean|52.8|52.8|Standard Deviation|10.90|10.9|||
4063210|NCT01068860|3884908|B8|||Age, Customized||years|Mean|57.0|57.0|Standard Deviation|13.86|13.86|||
4063211|NCT01068860|3884909|B7|||Age, Customized||years|Mean|58.6|58.6|Standard Deviation|10.11|10.11|||
4063212|NCT01068860|3884910|B6|||Age, Customized||years|Mean|57.2|57.2|Standard Deviation|9.39|9.39|||
4063213|NCT01068860|3884911|B5|||Age, Customized||years|Mean|59.1|59.1|Standard Deviation|10.63|10.63|||
4063214|NCT01068860|3884912|B4|||Age, Customized||years|Mean|59.4|59.4|Standard Deviation|8.02|8.02|||
4063215|NCT01068860|3884913|B3|||Age, Customized||years|Mean|60.0|60.0|Standard Deviation|8.17|8.17|||
4063216|NCT01068860|3884914|B2|||Age, Customized||years|Mean|56.5|56.5|Standard Deviation|9.30|9.3|||
4063217|NCT01068860|3884915|B1|||Age, Customized||years|Mean|55.9|55.9|Standard Deviation|10.50|10.5|||
4063218|NCT01068821|3885096|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4063219|NCT01068821|3885097|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4063220|NCT01068821|3885098|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4063221|NCT01068821|3885096|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4063222|NCT01068821|3885097|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4063223|NCT01068821|3885098|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4063224|NCT01068821|3885096|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4063225|NCT01068821|3885097|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4063226|NCT01068821|3885098|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4063227|NCT01068821|3885096|B3|||Age||years|Mean|54.6|54.6|Standard Deviation|12.2|12.2|||
4063228|NCT01068821|3885097|B2|||Age||years|Mean|53.6|53.6|Standard Deviation|12.7|12.7|||
4063229|NCT01068821|3885098|B1|||Age||years|Mean|55.5|55.5|Standard Deviation|11.8|11.8|||
4063230|NCT01068821|3885096|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4063231|NCT01068821|3885097|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4063232|NCT01068821|3885098|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4063233|NCT01068821|3885096|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4063234|NCT01068821|3885097|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4063235|NCT01068821|3885098|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4063236|NCT01068821|3885096|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4063237|NCT01068821|3885097|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4063238|NCT01068821|3885098|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4063239|NCT01068769|3885107|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4063240|NCT01068769|3885107|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4063241|NCT01068769|3885107|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4063242|NCT01068769|3885107|B1|||Age||years|Median|56|56.0|Full Range|||25.0|76.0|
4063243|NCT01068743|3885112|B1|||Body Mass Index (BMI)||kg/m^2|Mean|27.4|27.4|Standard Deviation|3.05|3.05|||
4063244|NCT01068743|3885112|B1|||Weight||kg|Mean|79.7|79.7|Standard Deviation|13.7|13.7|||
4063245|NCT01068743|3885112|B1|||Height||cm|Mean|170.2|170.2|Standard Deviation|12.0|12.0|||
4063246|NCT01068743|3885112|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4063247|NCT01068743|3885112|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063248|NCT01068743|3885112|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063249|NCT01068743|3885112|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4063250|NCT01068743|3885112|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4063251|NCT01068743|3885112|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063252|NCT01068743|3885112|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063253|NCT01068743|3885112|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063254|NCT01068743|3885112|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063255|NCT01068743|3885112|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4063256|NCT01068743|3885112|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4063257|NCT01068743|3885112|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4063258|NCT01068743|3885112|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4063259|NCT01068743|3885112|B1|||Age||years|Mean|35.5|35.5|Standard Deviation|10.61|10.61|||
4063260|NCT01068730|3885189|B1|||Body Mass Index||kg/m^2|Mean|26.58|26.58|Standard Deviation|3.64|3.64|||
4063261|NCT01068730|3885189|B1|||Weight||kg|Mean|77.02|77.02|Standard Deviation|15.88|15.88|||
4063262|NCT01068730|3885189|B1|||Height||Centimeter|Mean|169.54|169.54|Standard Deviation|11.44|11.44|||
4063263|NCT01068730|3885189|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4063264|NCT01068730|3885189|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4063265|NCT01068730|3885189|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4063266|NCT01068730|3885189|B1|White||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
4063267|NCT01068730|3885189|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4063268|NCT01068730|3885189|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4063269|NCT01068730|3885189|B1|||Age||years|Mean|34.6|34.6|Standard Deviation|11.05|11.05|||
4063270|NCT01068717|3885246|B1|White||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4063271|NCT01068717|3885246|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4063272|NCT01068717|3885246|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063273|NCT01068717|3885246|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4063274|NCT01068717|3885246|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4063275|NCT01068717|3885246|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4063276|NCT01068717|3885246|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4063277|NCT01068717|3885246|B1|||Age, Customized||Years|Median|32|32.0|Full Range|||23.0|49.0|
4063278|NCT01068717|3885246|B1|||Age, Customized||years|Mean|33.6|33.6|Standard Deviation|7.42|7.42|||
4063279|NCT01068678|3885303|B3|||Fasting Plasma Glucose||mmol/L|Mean|9.5|9.5|Standard Deviation|2.4|2.4|||
4063280|NCT01068678|3885304|B2|||Fasting Plasma Glucose||mmol/L|Mean|9.6|9.6|Standard Deviation|2.4|2.4|||
4063281|NCT01068678|3885305|B1|||Fasting Plasma Glucose||mmol/L|Mean|9.3|9.3|Standard Deviation|2.4|2.4|||
4063282|NCT01068678|3885303|B3|||Body weight||kg|Mean|93.3|93.3|Standard Deviation|18.9|18.9|||
4063283|NCT01068678|3885304|B2|||Body weight||kg|Mean|95.7|95.7|Standard Deviation|19.0|19.0|||
4063284|NCT01068678|3885305|B1|||Body weight||kg|Mean|90.8|90.8|Standard Deviation|18.6|18.6|||
4063285|NCT01068678|3885303|B3|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.2|8.2|Standard Deviation|0.8|0.8|||
4063286|NCT01068678|3885304|B2|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.3|8.3|Standard Deviation|0.9|0.9|||
4063287|NCT01068678|3885305|B1|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.2|8.2|Standard Deviation|0.8|0.8|||
4063288|NCT01068678|3885303|B3||Male|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
4063289|NCT01068678|3885304|B2||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4063290|NCT01068678|3885305|B1||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4063291|NCT01068678|3885303|B3||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4063292|NCT01068678|3885304|B2||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4063293|NCT01068678|3885305|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4063294|NCT01068678|3885303|B3|||Age||years|Mean|58.1|58.1|Standard Deviation|9.8|9.8|||
4063295|NCT01068678|3885304|B2|||Age||years|Mean|57.9|57.9|Standard Deviation|9.7|9.7|||
4063296|NCT01068678|3885305|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|9.9|9.9|||
4063297|NCT01068665|3885314|B3|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.6|9.6|Standard Deviation|2.7|2.7|||
4063298|NCT01068665|3885315|B2|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.7|9.7|Standard Deviation|2.6|2.6|||
4063299|NCT01068665|3885316|B1|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.6|9.6|Standard Deviation|2.9|2.9|||
4063300|NCT01068665|3885314|B3|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.3|8.3|Standard Deviation|0.9|0.9|||
4063301|NCT01068665|3885315|B2|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.2|8.2|Standard Deviation|0.9|0.9|||
4063302|NCT01068665|3885316|B1|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.3|8.3|Standard Deviation|1.0|1.0|||
4063303|NCT01068665|3885314|B3||Male|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
4063304|NCT01068665|3885315|B2||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4063305|NCT01068665|3885316|B1||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4063306|NCT01068665|3885314|B3||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4063307|NCT01068665|3885315|B2||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4063308|NCT01068665|3885316|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4063309|NCT01068665|3885314|B3|||Age||years|Mean|57.5|57.5|Standard Deviation|9.2|9.2|||
4063310|NCT01068665|3885315|B2|||Age||years|Mean|57.3|57.3|Standard Deviation|9.4|9.4|||
4063311|NCT01068665|3885316|B1|||Age||years|Mean|57.8|57.8|Standard Deviation|9.0|9.0|||
4063312|NCT01068652|3885325|B3|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.7|8.7|Standard Deviation|1.1|1.1|||
4063313|NCT01068652|3885326|B2|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.7|8.7|Standard Deviation|1.1|1.1|||
4063314|NCT01068652|3885327|B1|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.6|8.6|Standard Deviation|1.1|1.1|||
4063315|NCT01068652|3885325|B3|Other||Race/Ethnicity, Customized||participants|Number|225|225.0||||||
4063316|NCT01068652|3885326|B2|Other||Race/Ethnicity, Customized||participants|Number|113|113.0||||||
4063317|NCT01068652|3885327|B1|Other||Race/Ethnicity, Customized||participants|Number|112|112.0||||||
4063318|NCT01068652|3885325|B3|Asian||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4063319|NCT01068652|3885326|B2|Asian||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4063320|NCT01068652|3885327|B1|Asian||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4063321|NCT01068652|3885325|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4063322|NCT01068652|3885326|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4063323|NCT01068652|3885327|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4063324|NCT01068652|3885325|B3|White||Race/Ethnicity, Customized||participants|Number|112|112.0||||||
4063325|NCT01068652|3885326|B2|White||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
4063326|NCT01068652|3885327|B1|White||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
4063327|NCT01068652|3885325|B3||Male|Gender||Participants|Count of Participants|162|162.0||||||
4063328|NCT01068652|3885326|B2||Male|Gender||Participants|Count of Participants|75|75.0||||||
4063329|NCT01068652|3885327|B1||Male|Gender||Participants|Count of Participants|87|87.0||||||
4063330|NCT01068652|3885325|B3||Female|Gender||Participants|Count of Participants|241|241.0||||||
4063331|NCT01068652|3885326|B2||Female|Gender||Participants|Count of Participants|128|128.0||||||
4063332|NCT01068652|3885327|B1||Female|Gender||Participants|Count of Participants|113|113.0||||||
4063333|NCT01068652|3885325|B3|||Age||years|Mean|52.8|52.8|Standard Deviation|9.6|9.6|||
4063334|NCT01068652|3885326|B2|||Age||years|Mean|52.6|52.6|Standard Deviation|10.1|10.1|||
4063335|NCT01068652|3885327|B1|||Age||years|Mean|53.0|53.0|Standard Deviation|9.0|9.0|||
4063336|NCT01068626|3885366|B3|||Fasting insulin||IU|Mean|12|12.0|Standard Deviation|8.5|8.5|||
4063337|NCT01068626|3885367|B2|||Fasting insulin||IU|Mean|13|13.0|Standard Deviation|9.4|9.4|||
4063338|NCT01068626|3885368|B1|||Fasting insulin||IU|Mean|12|12.0|Standard Deviation|4.8|4.8|||
4063339|NCT01068626|3885366|B3|||Fasting glucose||mmol/L|Mean|5.3|5.3|Standard Deviation|0.5|0.5|||
4063340|NCT01068626|3885367|B2|||Fasting glucose||mmol/L|Mean|5.3|5.3|Standard Deviation|0.5|0.5|||
4063341|NCT01068626|3885368|B1|||Fasting glucose||mmol/L|Mean|5.3|5.3|Standard Deviation|0.5|0.5|||
4063342|NCT01068626|3885366|B3|||LDL cholesterol||mmol/L|Mean|3.69|3.69|Standard Deviation|0.74|0.74|||
4063343|NCT01068626|3885367|B2|||LDL cholesterol||mmol/L|Mean|3.77|3.77|Standard Deviation|0.79|0.79|||
4063344|NCT01068626|3885368|B1|||LDL cholesterol||mmol/L|Mean|3.59|3.59|Standard Deviation|0.78|0.78|||
4063345|NCT01068626|3885366|B3|||Liver density|Liver density measured by computed tomography|Hounsfield units|Mean|50|50.0|Standard Deviation|12|12.0|||
4063346|NCT01068626|3885367|B2|||Liver density|Liver density measured by computed tomography|Hounsfield units|Mean|49|49.0|Standard Deviation|14|14.0|||
4063347|NCT01068626|3885368|B1|||Liver density|Liver density measured by computed tomography|Hounsfield units|Mean|52|52.0|Standard Deviation|10|10.0|||
4063348|NCT01068626|3885366|B3|||Visceral/subcutaneous adipose tissue area ratio||ratio|Mean|0.77|0.77|Standard Deviation|0.26|0.26|||
4063349|NCT01068626|3885367|B2|||Visceral/subcutaneous adipose tissue area ratio||ratio|Mean|0.75|0.75|Standard Deviation|0.27|0.27|||
4063350|NCT01068626|3885368|B1|||Visceral/subcutaneous adipose tissue area ratio||ratio|Mean|0.79|0.79|Standard Deviation|0.25|0.25|||
4063351|NCT01068626|3885366|B3|||Subcutaneous adipose tissue area|Subcutaneous adipose tissue area measured with CT at the level of the fourth lumbar vertebrae.|cm2|Mean|300|300.0|Standard Deviation|86|86.0|||
4063352|NCT01068626|3885367|B2|||Subcutaneous adipose tissue area|Subcutaneous adipose tissue area measured with CT at the level of the fourth lumbar vertebrae.|cm2|Mean|310|310.0|Standard Deviation|101|101.0|||
4063353|NCT01068626|3885368|B1|||Subcutaneous adipose tissue area|Subcutaneous adipose tissue area measured with CT at the level of the fourth lumbar vertebrae.|cm2|Mean|289|289.0|Standard Deviation|69|69.0|||
4063354|NCT01068626|3885366|B3|||Visceral adipose tissue area|Visceral adipose tissue area measured with CT at the level of the fourth lumbar vertebrae.|cm2|Mean|220|220.0|Standard Deviation|69|69.0|||
4063355|NCT01068626|3885367|B2|||Visceral adipose tissue area|Visceral adipose tissue area measured with CT at the level of the fourth lumbar vertebrae.|cm2|Mean|219|219.0|Standard Deviation|73|73.0|||
4063356|NCT01068626|3885368|B1|||Visceral adipose tissue area|Visceral adipose tissue area measured with CT at the level of the fourth lumbar vertebrae.|cm2|Mean|221|221.0|Standard Deviation|66|66.0|||
4063357|NCT01068626|3885366|B3|NO||Current smoker||participants|Number|50|50.0||||||
4063358|NCT01068626|3885367|B2|NO||Current smoker||participants|Number|23|23.0||||||
4063359|NCT01068626|3885368|B1|NO||Current smoker||participants|Number|27|27.0||||||
4063360|NCT01068626|3885366|B3|YES||Current smoker||participants|Number|9|9.0||||||
4063361|NCT01068626|3885367|B2|YES||Current smoker||participants|Number|6|6.0||||||
4063362|NCT01068626|3885368|B1|YES||Current smoker||participants|Number|3|3.0||||||
4063363|NCT01068626|3885366|B3|NO||Hypertension||participants|Number|44|44.0||||||
4063364|NCT01068626|3885367|B2|NO||Hypertension||participants|Number|22|22.0||||||
4063365|NCT01068626|3885368|B1|NO||Hypertension||participants|Number|22|22.0||||||
4063366|NCT01068626|3885366|B3|YES||Hypertension||participants|Number|15|15.0||||||
4063367|NCT01068626|3885367|B2|YES||Hypertension||participants|Number|7|7.0||||||
4063368|NCT01068626|3885368|B1|YES||Hypertension||participants|Number|8|8.0||||||
4063369|NCT01068626|3885366|B3|||Height||m|Mean|1.81|1.81|Standard Deviation|0.07|0.07|||
4063370|NCT01068626|3885367|B2|||Height||m|Mean|1.80|1.8|Standard Deviation|0.07|0.07|||
4063371|NCT01068626|3885368|B1|||Height||m|Mean|1.82|1.82|Standard Deviation|0.06|0.06|||
4063372|NCT01068626|3885366|B3|||Weight||kg|Mean|100|100.0|Standard Deviation|13|13.0|||
4063373|NCT01068626|3885367|B2|||Weight||kg|Mean|100|100.0|Standard Deviation|13|13.0|||
4063374|NCT01068626|3885368|B1|||Weight||kg|Mean|100|100.0|Standard Deviation|12|12.0|||
4063375|NCT01068626|3885366|B3|Sweden||Region of Enrollment||participants|Number|59|59.0||||||
4063376|NCT01068626|3885367|B2|Sweden||Region of Enrollment||participants|Number|29|29.0||||||
4063377|NCT01068626|3885368|B1|Sweden||Region of Enrollment||participants|Number|30|30.0||||||
4063378|NCT01068626|3885366|B3|Male||Sex/Gender, Customized||participants|Number|59|59.0||||||
4063379|NCT01068626|3885367|B2|Male||Sex/Gender, Customized||participants|Number|29|29.0||||||
4063380|NCT01068626|3885368|B1|Male||Sex/Gender, Customized||participants|Number|30|30.0||||||
4063381|NCT01068626|3885366|B3|||Age||years|Mean|54|54.0|Standard Deviation|4.7|4.7|||
4063382|NCT01068626|3885367|B2|||Age||years|Mean|55|55.0|Standard Deviation|4.1|4.1|||
4063383|NCT01068626|3885368|B1|||Age||years|Mean|54|54.0|Standard Deviation|5.2|5.2|||
4063384|NCT01068626|3885366|B3|Between 18 and 65 years||Age, Customized||participants|Number|59|59.0||||||
4063385|NCT01068626|3885367|B2|Between 18 and 65 years||Age, Customized||participants|Number|29|29.0||||||
4063386|NCT01068626|3885368|B1|Between 18 and 65 years||Age, Customized||participants|Number|30|30.0||||||
4063387|NCT01068600|3885385|B3||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4063388|NCT01068600|3885386|B2||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4063389|NCT01068600|3885387|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4063390|NCT01068600|3885385|B3||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4063391|NCT01068600|3885386|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4063392|NCT01068600|3885387|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4063393|NCT01068600|3885385|B3|||Age||years|Mean|61.4|61.4|Standard Deviation|9.83|9.83|||
4063394|NCT01068600|3885386|B2|||Age||years|Mean|61.5|61.5|Standard Deviation|9.85|9.85|||
4063395|NCT01068600|3885387|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|9.83|9.83|||
4063396|NCT01068548|3885396|B3|United States||Region of Enrollment||participants|Number|129|129.0||||||
4063397|NCT01068548|3885397|B2|United States||Region of Enrollment||participants|Number|63|63.0||||||
4063398|NCT01068548|3885398|B1|United States||Region of Enrollment||participants|Number|66|66.0||||||
4063399|NCT01068548|3885396|B3||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4063400|NCT01068548|3885397|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4063401|NCT01068548|3885398|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4063402|NCT01068548|3885396|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4063403|NCT01068548|3885397|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4063404|NCT01068548|3885398|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4063405|NCT01068548|3885396|B3||>=65 years|Age||Participants|Count of Participants|79|79.0||||||
4063406|NCT01068548|3885397|B2||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4063407|NCT01068548|3885398|B1||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
4063408|NCT01068548|3885396|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4063409|NCT01068548|3885397|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4063410|NCT01068548|3885398|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4063411|NCT01068548|3885396|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4063412|NCT01068548|3885397|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4063413|NCT01068548|3885398|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4063414|NCT01068548|3885396|B3|||Age||years|Mean|69.7|69.7|Standard Deviation|12.8|12.8|||
4063415|NCT01068548|3885397|B2|||Age||years|Mean|69.2|69.2|Standard Deviation|12.4|12.4|||
4063416|NCT01068548|3885398|B1|||Age||years|Mean|70.1|70.1|Standard Deviation|13.2|13.2|||
4063417|NCT01068509|3885405|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4063418|NCT01068509|3885406|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4063419|NCT01068509|3885407|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4063420|NCT01068509|3885408|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4063421|NCT01068509|3885405|B4||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4063422|NCT01068509|3885406|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4063423|NCT01068509|3885407|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4063424|NCT01068509|3885408|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4063425|NCT01068509|3885405|B4|||Age||Years|Mean|56.1|56.1|Standard Deviation|9.1|9.1|||
4063426|NCT01068509|3885406|B3|||Age||Years|Mean|56.2|56.2|Standard Deviation|9.5|9.5|||
4063427|NCT01068509|3885407|B2|||Age||Years|Mean|56.8|56.8|Standard Deviation|8.5|8.5|||
4063428|NCT01068509|3885408|B1|||Age||Years|Mean|52.4|52.4|Standard Deviation|10.3|10.3|||
4063429|NCT01068418|3885423|B1|||Pre-Intervention Serum calcium concentration||mg/dL|Mean|8.94|8.94|Standard Deviation|0.30|0.3|||
4063430|NCT01068418|3885423|B1|||Pre-Intervention Parathyroid hormone concentration||pg/mL|Mean|46.36|46.36|Standard Deviation|16.09|16.09|||
4063431|NCT01068418|3885423|B1|||Pre-Intervention 25-hydroxyvitamin D3||ng/mL|Mean|18.20|18.2|Standard Deviation|6.76|6.76|||
4063432|NCT01068418|3885423|B1|||Pre-Intervention Mean Arterial Pressure||mmHg|Mean|105.6|105.6|Standard Deviation|7.22|7.22|||
4063433|NCT01068418|3885423|B1|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4063434|NCT01068418|3885423|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063435|NCT01068418|3885423|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063436|NCT01068418|3885423|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4063437|NCT01068418|3885423|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4063438|NCT01068418|3885423|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063439|NCT01068418|3885423|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063440|NCT01068418|3885423|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063441|NCT01068418|3885423|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4063442|NCT01068418|3885423|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4063443|NCT01068418|3885423|B1|||Age||years|Mean|49.6|49.6|Standard Deviation|9.2|9.2|||
4063444|NCT01068262|3885428|B5||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4063445|NCT01068262|3885429|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4063446|NCT01068262|3885430|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4063447|NCT01068262|3885431|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4063448|NCT01068262|3885432|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4063449|NCT01068262|3885428|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4063450|NCT01068262|3885429|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4063451|NCT01068262|3885430|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4063452|NCT01068262|3885431|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4063453|NCT01068262|3885432|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4063454|NCT01068262|3885428|B5|||Age|Baseline age in each of the four study treatment groups and the total study population|years|Mean|58.07|58.07|Standard Deviation|6.84|6.84|||
4063455|NCT01068262|3885429|B4|||Age|Baseline age in each of the four study treatment groups and the total study population|years|Mean|65.00|65.0|Standard Deviation|14.14|14.14|||
4063456|NCT01068262|3885430|B3|||Age|Baseline age in each of the four study treatment groups and the total study population|years|Mean|57.50|57.5|Standard Deviation|7.59|7.59|||
4063457|NCT01068262|3885431|B2|||Age|Baseline age in each of the four study treatment groups and the total study population|years|Mean|56.44|56.44|Standard Deviation|6.60|6.6|||
4063458|NCT01068262|3885432|B1|||Age|Baseline age in each of the four study treatment groups and the total study population|years|Mean|58.35|58.35|Standard Deviation|6.11|6.11|||
4063459|NCT01068158|3885463|B3|United States||Region of Enrollment||Participants|Number|371|371.0||||||
4063460|NCT01068158|3885464|B2|United States||Region of Enrollment||Participants|Number|202|202.0||||||
4063461|NCT01068158|3885465|B1|United States||Region of Enrollment||Participants|Number|169|169.0||||||
4063462|NCT01068158|3885463|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4063463|NCT01068158|3885464|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4063464|NCT01068158|3885465|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4063465|NCT01068158|3885463|B3||Female|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
4063466|NCT01068158|3885464|B2||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4063467|NCT01068158|3885465|B1||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4063468|NCT01068158|3885463|B3|||Age||Years|Mean|14.82|14.82|Standard Deviation|13.60|13.6|||
4063469|NCT01068158|3885464|B2|||Age||Years|Mean|15.19|15.19|Standard Deviation|13.85|13.85|||
4063470|NCT01068158|3885465|B1|||Age||Years|Mean|14.37|14.37|Standard Deviation|13.33|13.33|||
4063471|NCT01068158|3885463|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4063472|NCT01068158|3885464|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4063473|NCT01068158|3885465|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4063474|NCT01068158|3885463|B3||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
4063475|NCT01068158|3885464|B2||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4063476|NCT01068158|3885465|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4063477|NCT01068158|3885463|B3||<=18 years|Age||Participants|Count of Participants|276|276.0||||||
4063478|NCT01068158|3885464|B2||<=18 years|Age||Participants|Count of Participants|150|150.0||||||
4063479|NCT01068158|3885465|B1||<=18 years|Age||Participants|Count of Participants|126|126.0||||||
4063480|NCT01067976|3885478|B1|United States||Country||participants|Number|51|51.0||||||
4063481|NCT01067976|3885478|B1|Switzerland||Country||participants|Number|4|4.0||||||
4063482|NCT01067976|3885478|B1|Korea (South)||Country||participants|Number|102|102.0||||||
4063483|NCT01067976|3885478|B1|Italy||Country||participants|Number|25|25.0||||||
4063484|NCT01067976|3885478|B1|Germany||Country||participants|Number|172|172.0||||||
4063485|NCT01067976|3885478|B1|Finland||Country||participants|Number|53|53.0||||||
4063486|NCT01067976|3885478|B1|Colombia||Country||participants|Number|19|19.0||||||
4063487|NCT01067976|3885478|B1|Native Hawaiian/other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4063488|NCT01067976|3885478|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4063489|NCT01067976|3885478|B1|Asian||Race/Ethnicity, Customized||participants|Number|103|103.0||||||
4063490|NCT01067976|3885478|B1|White||Race/Ethnicity, Customized||participants|Number|320|320.0||||||
4063491|NCT01067976|3885478|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4063492|NCT01067976|3885478|B1||Female|Sex: Female, Male||Participants|Count of Participants|426|426.0||||||
4063493|NCT01067976|3885478|B1|||Age||years|Mean|55.5|55.5|Standard Deviation|10.4|10.4|||
4063494|NCT01067846|3885537|B3|United States||Region of Enrollment||participants|Number|59|59.0||||||
4063495|NCT01067846|3885538|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4063496|NCT01067846|3885539|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4063497|NCT01067846|3885537|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4063498|NCT01067846|3885538|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4063499|NCT01067846|3885539|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4063500|NCT01067846|3885537|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4063501|NCT01067846|3885538|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4063502|NCT01067846|3885539|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4063503|NCT01067846|3885537|B3|||Age||years|Mean|44|44.0|Standard Deviation|7.97|7.97|||
4063504|NCT01067846|3885538|B2|||Age||years|Mean|45|45.0|Standard Deviation|9.13|9.13|||
4063505|NCT01067846|3885539|B1|||Age||years|Mean|44|44.0|Standard Deviation|6.67|6.67|||
4063506|NCT01067846|3885537|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4063507|NCT01067846|3885538|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4063508|NCT01067846|3885539|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4063509|NCT01067846|3885537|B3||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4063510|NCT01067846|3885538|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4063511|NCT01067846|3885539|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4063512|NCT01067846|3885537|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4063513|NCT01067846|3885538|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4063514|NCT01067846|3885539|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4063515|NCT01067781|3885548|B5||Male|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
4063516|NCT01067781|3885549|B4||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4063517|NCT01067781|3885550|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4063518|NCT01067781|3885551|B2||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4063519|NCT01067781|3885552|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4063520|NCT01067781|3885548|B5||Female|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
4063521|NCT01067781|3885549|B4||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4063522|NCT01067781|3885550|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4063523|NCT01067781|3885551|B2||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4063524|NCT01067781|3885552|B1||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4063525|NCT01067781|3885548|B5|||Age||years|Mean|35.3|35.3|Standard Deviation|13.0|13.0|||
4063526|NCT01067781|3885549|B4|||Age||years|Mean|35.7|35.7|Standard Deviation|12.8|12.8|||
4063527|NCT01067781|3885550|B3|||Age||years|Mean|35.0|35.0|Standard Deviation|13.6|13.6|||
4063528|NCT01067781|3885551|B2|||Age||years|Mean|35.3|35.3|Standard Deviation|13.1|13.1|||
4063529|NCT01067781|3885552|B1|||Age||years|Mean|36.0|36.0|Standard Deviation|12.8|12.8|||
4063530|NCT01067768|3885563|B3|Another||Unit placement|Site of insertion of the catheter|participants|Number|24|24.0||||||
4063531|NCT01067768|3885564|B2|Another||Unit placement|Site of insertion of the catheter|participants|Number|16|16.0||||||
4063532|NCT01067768|3885565|B1|Another||Unit placement|Site of insertion of the catheter|participants|Number|8|8.0||||||
4063533|NCT01067768|3885563|B3|Before admission||Unit placement|Site of insertion of the catheter|participants|Number|98|98.0||||||
4063534|NCT01067768|3885564|B2|Before admission||Unit placement|Site of insertion of the catheter|participants|Number|49|49.0||||||
4063535|NCT01067768|3885565|B1|Before admission||Unit placement|Site of insertion of the catheter|participants|Number|49|49.0||||||
4063536|NCT01067768|3885563|B3|General room||Unit placement|Site of insertion of the catheter|participants|Number|58|58.0||||||
4063537|NCT01067768|3885564|B2|General room||Unit placement|Site of insertion of the catheter|participants|Number|24|24.0||||||
4063538|NCT01067768|3885565|B1|General room||Unit placement|Site of insertion of the catheter|participants|Number|34|34.0||||||
4063539|NCT01067768|3885563|B3|Surgery||Unit placement|Site of insertion of the catheter|participants|Number|553|553.0||||||
4063540|NCT01067768|3885564|B2|Surgery||Unit placement|Site of insertion of the catheter|participants|Number|282|282.0||||||
4063541|NCT01067768|3885565|B1|Surgery||Unit placement|Site of insertion of the catheter|participants|Number|271|271.0||||||
4063542|NCT01067768|3885563|B3|Critical care||Unit placement|Site of insertion of the catheter|participants|Number|134|134.0||||||
4063543|NCT01067768|3885564|B2|Critical care||Unit placement|Site of insertion of the catheter|participants|Number|67|67.0||||||
4063544|NCT01067768|3885565|B1|Critical care||Unit placement|Site of insertion of the catheter|participants|Number|67|67.0||||||
4063545|NCT01067768|3885563|B3|Emergency||Unit placement|Site of insertion of the catheter|participants|Number|342|342.0||||||
4063546|NCT01067768|3885564|B2|Emergency||Unit placement|Site of insertion of the catheter|participants|Number|167|167.0||||||
4063547|NCT01067768|3885565|B1|Emergency||Unit placement|Site of insertion of the catheter|participants|Number|175|175.0||||||
4063548|NCT01067768|3885563|B3|None||Indication of catheter||participants|Number|3|3.0||||||
4063549|NCT01067768|3885564|B2|None||Indication of catheter||participants|Number|1|1.0||||||
4063550|NCT01067768|3885565|B1|None||Indication of catheter||participants|Number|2|2.0||||||
4063551|NCT01067768|3885563|B3|Procedures||Indication of catheter||participants|Number|619|619.0||||||
4063552|NCT01067768|3885564|B2|Procedures||Indication of catheter||participants|Number|316|316.0||||||
4063553|NCT01067768|3885565|B1|Procedures||Indication of catheter||participants|Number|303|303.0||||||
4063554|NCT01067768|3885563|B3|Monitoring||Indication of catheter||participants|Number|537|537.0||||||
4063555|NCT01067768|3885564|B2|Monitoring||Indication of catheter||participants|Number|269|269.0||||||
4063556|NCT01067768|3885565|B1|Monitoring||Indication of catheter||participants|Number|268|268.0||||||
4063557|NCT01067768|3885563|B3|Incontinence||Indication of catheter||participants|Number|3|3.0||||||
4063558|NCT01067768|3885564|B2|Incontinence||Indication of catheter||participants|Number|0|0.0||||||
4063559|NCT01067768|3885565|B1|Incontinence||Indication of catheter||participants|Number|3|3.0||||||
4063560|NCT01067768|3885563|B3|Obstruction||Indication of catheter||participants|Number|47|47.0||||||
4063561|NCT01067768|3885564|B2|Obstruction||Indication of catheter||participants|Number|19|19.0||||||
4063562|NCT01067768|3885565|B1|Obstruction||Indication of catheter||participants|Number|28|28.0||||||
4063563|NCT01067768|3885563|B3|No||Kidney failure|Creatinine greater than 2 mg/dL at any time during hospitalization|participants|Number|1011|1011.0||||||
4063564|NCT01067768|3885564|B2|No||Kidney failure|Creatinine greater than 2 mg/dL at any time during hospitalization|participants|Number|511|511.0||||||
4063565|NCT01067768|3885565|B1|No||Kidney failure|Creatinine greater than 2 mg/dL at any time during hospitalization|participants|Number|500|500.0||||||
4063566|NCT01067768|3885563|B3|Yes||Kidney failure|Creatinine greater than 2 mg/dL at any time during hospitalization|participants|Number|198|198.0||||||
4063567|NCT01067768|3885564|B2|Yes||Kidney failure|Creatinine greater than 2 mg/dL at any time during hospitalization|participants|Number|94|94.0||||||
4063568|NCT01067768|3885565|B1|Yes||Kidney failure|Creatinine greater than 2 mg/dL at any time during hospitalization|participants|Number|104|104.0||||||
4063569|NCT01067768|3885563|B3|No||Diabetes|Diabetes mellitus registered as a personal history or diagnosed on admission|participants|Number|1037|1037.0||||||
4063570|NCT01067768|3885564|B2|No||Diabetes|Diabetes mellitus registered as a personal history or diagnosed on admission|participants|Number|521|521.0||||||
4063571|NCT01067768|3885565|B1|No||Diabetes|Diabetes mellitus registered as a personal history or diagnosed on admission|participants|Number|516|516.0||||||
4063572|NCT01067768|3885563|B3|Yes||Diabetes|Diabetes mellitus registered as a personal history or diagnosed on admission|participants|Number|172|172.0||||||
4063573|NCT01067768|3885564|B2|Yes||Diabetes|Diabetes mellitus registered as a personal history or diagnosed on admission|participants|Number|84|84.0||||||
4063574|NCT01067768|3885565|B1|Yes||Diabetes|Diabetes mellitus registered as a personal history or diagnosed on admission|participants|Number|88|88.0||||||
4063575|NCT01067768|3885563|B3||Male|Sex: Female, Male||Participants|Count of Participants|706|706.0||||||
4063576|NCT01067768|3885564|B2||Male|Sex: Female, Male||Participants|Count of Participants|352|352.0||||||
4063577|NCT01067768|3885565|B1||Male|Sex: Female, Male||Participants|Count of Participants|354|354.0||||||
4063578|NCT01067768|3885563|B3||Female|Sex: Female, Male||Participants|Count of Participants|503|503.0||||||
4063579|NCT01067768|3885564|B2||Female|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
4063580|NCT01067768|3885565|B1||Female|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
4063581|NCT01067768|3885563|B3|||Age||years|Median|55.5|55.5|Inter-Quartile Range|||37.0|69.0|
4063582|NCT01067768|3885564|B2|||Age||years|Median|56|56.0|Inter-Quartile Range|||37.0|69.0|
4063583|NCT01067768|3885565|B1|||Age||years|Median|55|55.0|Inter-Quartile Range|||38.0|69.0|
4063584|NCT01067716|3885574|B4|Canada||Region of Enrollment||participants|Number|79|79.0||||||
4063585|NCT01067716|3885575|B3|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4063586|NCT01067716|3885576|B2|Canada||Region of Enrollment||participants|Number|13|13.0||||||
4063587|NCT01067716|3885577|B1|Canada||Region of Enrollment||participants|Number|57|57.0||||||
4063588|NCT01067716|3885574|B4||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4063589|NCT01067716|3885575|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4063590|NCT01067716|3885576|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4063591|NCT01067716|3885577|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4063592|NCT01067716|3885574|B4||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4063593|NCT01067716|3885575|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4063594|NCT01067716|3885576|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4063595|NCT01067716|3885577|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4063596|NCT01067716|3885574|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4063597|NCT01067716|3885575|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4063598|NCT01067716|3885576|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4063599|NCT01067716|3885577|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4063600|NCT01067716|3885574|B4||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
4063601|NCT01067716|3885575|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4063602|NCT01067716|3885576|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4063603|NCT01067716|3885577|B1||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4063604|NCT01067716|3885574|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4063605|NCT01067716|3885575|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4063606|NCT01067716|3885576|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4063607|NCT01067716|3885577|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4063608|NCT01067521|3885596|B3|||Sienax Normalized Brain Volume at Baseline|Sienax estimates total brain tissue volume, from a single image, normalised for skull size.|mL|Mean|1535.206|1535.206|Standard Deviation|110.6347|110.6347|||
4063609|NCT01067521|3885597|B2|||Sienax Normalized Brain Volume at Baseline|Sienax estimates total brain tissue volume, from a single image, normalised for skull size.|mL|Mean|1537.899|1537.899|Standard Deviation|110.7549|110.7549|||
4063610|NCT01067521|3885598|B1|||Sienax Normalized Brain Volume at Baseline|Sienax estimates total brain tissue volume, from a single image, normalised for skull size.|mL|Mean|1533.888|1533.888|Standard Deviation|110.6107|110.6107|||
4063611|NCT01067521|3885596|B3|||Number of T2 Lesions Per Participant at Baseline||lesions|Mean|37.5|37.5|Standard Deviation|26.45|26.45|||
4063612|NCT01067521|3885597|B2|||Number of T2 Lesions Per Participant at Baseline||lesions|Mean|36.7|36.7|Standard Deviation|26.68|26.68|||
4063613|NCT01067521|3885598|B1|||Number of T2 Lesions Per Participant at Baseline||lesions|Mean|38.0|38.0|Standard Deviation|26.34|26.34|||
4063614|NCT01067521|3885596|B3|||Number of T1 Gadolinium (Gd)-Enhanced Lesions per Participant at Baseline||lesions|Mean|1.6|1.6|Standard Deviation|4.39|4.39|||
4063615|NCT01067521|3885597|B2|||Number of T1 Gadolinium (Gd)-Enhanced Lesions per Participant at Baseline||lesions|Mean|1.4|1.4|Standard Deviation|3.69|3.69|||
4063616|NCT01067521|3885598|B1|||Number of T1 Gadolinium (Gd)-Enhanced Lesions per Participant at Baseline||lesions|Mean|1.7|1.7|Standard Deviation|4.70|4.7|||
4063617|NCT01067521|3885596|B3|||Time from Multiple Sclerosis (MS) Diagnosis||years|Mean|3.76|3.76|Standard Deviation|4.904|4.904|||
4063618|NCT01067521|3885597|B2|||Time from Multiple Sclerosis (MS) Diagnosis||years|Mean|3.88|3.88|Standard Deviation|4.744|4.744|||
4063619|NCT01067521|3885598|B1|||Time from Multiple Sclerosis (MS) Diagnosis||years|Mean|3.70|3.7|Standard Deviation|4.982|4.982|||
4063620|NCT01067521|3885596|B3|||Time from First Symptom||years|Mean|7.66|7.66|Standard Deviation|6.621|6.621|||
4063621|NCT01067521|3885597|B2|||Time from First Symptom||years|Mean|7.61|7.61|Standard Deviation|6.360|6.36|||
4063622|NCT01067521|3885598|B1|||Time from First Symptom||years|Mean|7.68|7.68|Standard Deviation|6.748|6.748|||
4063623|NCT01067521|3885596|B3|||Body Mass Index (BMI)||kg/m^2|Mean|24.40|24.4|Standard Deviation|4.739|4.739|||
4063624|NCT01067521|3885597|B2|||Body Mass Index (BMI)||kg/m^2|Mean|24.44|24.44|Standard Deviation|4.804|4.804|||
4063625|NCT01067521|3885598|B1|||Body Mass Index (BMI)||kg/m^2|Mean|24.38|24.38|Standard Deviation|4.709|4.709|||
4063626|NCT01067521|3885596|B3||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4063627|NCT01067521|3885597|B2||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4063628|NCT01067521|3885598|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4063629|NCT01067521|3885596|B3||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|1394|1394.0||||||
4063630|NCT01067521|3885597|B2||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|460|460.0||||||
4063631|NCT01067521|3885598|B1||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|934|934.0||||||
4063632|NCT01067521|3885596|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|1371|1371.0||||||
4063633|NCT01067521|3885597|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|455|455.0||||||
4063634|NCT01067521|3885598|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|916|916.0||||||
4063635|NCT01067521|3885596|B3||Other, not specified|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
4063636|NCT01067521|3885597|B2||Other, not specified|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4063637|NCT01067521|3885598|B1||Other, not specified|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4063638|NCT01067521|3885596|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
4063639|NCT01067521|3885597|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4063640|NCT01067521|3885598|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4063641|NCT01067521|3885596|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4063642|NCT01067521|3885597|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4063643|NCT01067521|3885598|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4063644|NCT01067521|3885596|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4063645|NCT01067521|3885597|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4063646|NCT01067521|3885598|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4063647|NCT01067521|3885596|B3||Male|Sex: Female, Male||Participants|Count of Participants|450|450.0||||||
4063648|NCT01067521|3885597|B2||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4063649|NCT01067521|3885598|B1||Male|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
4063650|NCT01067521|3885596|B3||Female|Sex: Female, Male||Participants|Count of Participants|954|954.0||||||
4063651|NCT01067521|3885597|B2||Female|Sex: Female, Male||Participants|Count of Participants|313|313.0||||||
4063652|NCT01067521|3885598|B1||Female|Sex: Female, Male||Participants|Count of Participants|641|641.0||||||
4063653|NCT01067521|3885596|B3|||Age||years|Mean|37.61|37.61|Standard Deviation|9.346|9.346|||
4063654|NCT01067521|3885597|B2|||Age||years|Mean|38.12|38.12|Standard Deviation|9.222|9.222|||
4063655|NCT01067521|3885598|B1|||Age||years|Mean|37.36|37.36|Standard Deviation|9.401|9.401|||
4063656|NCT01067456|3885623|B3|United States||Region of Enrollment||participants|Number|59|59.0||||||
4063657|NCT01067456|3885624|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4063658|NCT01067456|3885625|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4063659|NCT01067456|3885623|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4063660|NCT01067456|3885624|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4063661|NCT01067456|3885625|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4063662|NCT01067456|3885623|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4063663|NCT01067456|3885624|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4063664|NCT01067456|3885625|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4063665|NCT01067456|3885623|B3|||Age||years|Mean|51|51.0|Standard Deviation|11|11.0|||
4063666|NCT01067456|3885624|B2|||Age||years|Mean|53|53.0|Standard Deviation|11|11.0|||
4063667|NCT01067456|3885625|B1|||Age||years|Mean|50|50.0|Standard Deviation|12|12.0|||
4063668|NCT01067352|3885636|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4063669|NCT01067352|3885637|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4063670|NCT01067352|3885638|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4063671|NCT01067352|3885639|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4063672|NCT01067352|3885636|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4063673|NCT01067352|3885637|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4063674|NCT01067352|3885638|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4063675|NCT01067352|3885639|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4063676|NCT01067352|3885636|B4|||Age||years|Mean|5.3|5.3|Standard Deviation|0.9|0.9|||
4063677|NCT01067352|3885637|B3|||Age||years|Mean|5.2|5.2|Standard Deviation|0.4|0.4|||
4063678|NCT01067352|3885638|B2|||Age||years|Mean|5.0|5.0|Standard Deviation|0.7|0.7|||
4063679|NCT01067352|3885639|B1|||Age||years|Mean|5.7|5.7|Standard Deviation|1.2|1.2|||
4063680|NCT01067339|3885655|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
4063681|NCT01067339|3885656|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4063682|NCT01067339|3885657|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4063683|NCT01067339|3885655|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4063684|NCT01067339|3885656|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4063685|NCT01067339|3885657|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4063686|NCT01067339|3885655|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4063687|NCT01067339|3885656|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4063688|NCT01067339|3885657|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4063689|NCT01067339|3885655|B3|||Age||years|Mean|54.5|54.5|Standard Deviation|11.0|11.0|||
4063690|NCT01067339|3885656|B2|||Age||years|Mean|54.0|54.0|Standard Deviation|10.5|10.5|||
4063691|NCT01067339|3885657|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|11.7|11.7|||
4063692|NCT01067326|3885666|B3|United States||Region of Enrollment|"Not all baseline data were available from started subjects, therefore baseline data for completed subjects is presented."|participants|Number|17|17.0||||||
4063693|NCT01067326|3885667|B2|United States||Region of Enrollment|"Not all baseline data were available from started subjects, therefore baseline data for completed subjects is presented."|participants|Number|5|5.0||||||
4063694|NCT01067326|3885668|B1|United States||Region of Enrollment|"Not all baseline data were available from started subjects, therefore baseline data for completed subjects is presented."|participants|Number|12|12.0||||||
4063695|NCT01067326|3885666|B3||Male|Sex: Female, Male|"Not all baseline data were available from started subjects, therefore baseline data for completed subjects is presented."|Participants|Count of Participants|9|9.0||||||
4063696|NCT01067326|3885667|B2||Male|Sex: Female, Male|"Not all baseline data were available from started subjects, therefore baseline data for completed subjects is presented."|Participants|Count of Participants|4|4.0||||||
4063697|NCT01067326|3885668|B1||Male|Sex: Female, Male|"Not all baseline data were available from started subjects, therefore baseline data for completed subjects is presented."|Participants|Count of Participants|5|5.0||||||
4063698|NCT01067326|3885666|B3||Female|Sex: Female, Male|"Not all baseline data were available from started subjects, therefore baseline data for completed subjects is presented."|Participants|Count of Participants|8|8.0||||||
4063699|NCT01067326|3885667|B2||Female|Sex: Female, Male|"Not all baseline data were available from started subjects, therefore baseline data for completed subjects is presented."|Participants|Count of Participants|1|1.0||||||
4063700|NCT01067326|3885668|B1||Female|Sex: Female, Male|"Not all baseline data were available from started subjects, therefore baseline data for completed subjects is presented."|Participants|Count of Participants|7|7.0||||||
4063701|NCT01067326|3885666|B3|||Age|"Not all baseline data were available from started subjects, therefore only baseline data for completed subjects is presented."|years|Mean|45.4|45.4|Standard Deviation|18.2|18.2|||
4063702|NCT01067326|3885667|B2|||Age|"Not all baseline data were available from started subjects, therefore only baseline data for completed subjects is presented."|years|Mean|51.0|51.0|Standard Deviation|20.7|20.7|||
4063754|NCT01066897|3885746|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063703|NCT01067326|3885668|B1|||Age|"Not all baseline data were available from started subjects, therefore only baseline data for completed subjects is presented."|years|Mean|43.1|43.1|Standard Deviation|17.5|17.5|||
4063704|NCT01067144|3885681|B3||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4063705|NCT01067144|3885682|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4063706|NCT01067144|3885683|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4063707|NCT01067144|3885681|B3||Female|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
4063708|NCT01067144|3885682|B2||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4063709|NCT01067144|3885683|B1||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4063710|NCT01067144|3885681|B3|||Age||years|Mean|56.7|56.7|Standard Deviation|11.7|11.7|||
4063711|NCT01067144|3885682|B2|||Age||years|Mean|57.0|57.0|Standard Deviation|11.7|11.7|||
4063712|NCT01067144|3885683|B1|||Age||years|Mean|56.4|56.4|Standard Deviation|11.8|11.8|||
4063713|NCT01067105|3885700|B1|||Baseline AM Instantaneous Total Nasal Symptom Score (iTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, iTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TNSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Median|5.12|5.12|Standard Deviation|3.05|3.05|||
4063714|NCT01067105|3885700|B1|||Baseline AM Reflective Total Nasal Symptom Score (rTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|5.66|5.66|Standard Deviation|3.07|3.07|||
4063715|NCT01067105|3885700|B1|Multiple||Race/Ethnicity||participants|Number|4|4.0||||||
4063716|NCT01067105|3885700|B1|Other||Race/Ethnicity||participants|Number|7|7.0||||||
4063717|NCT01067105|3885700|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity||participants|Number|3|3.0||||||
4063718|NCT01067105|3885700|B1|American Indian or Alaska Native||Race/Ethnicity||participants|Number|1|1.0||||||
4063719|NCT01067105|3885700|B1|Asian||Race/Ethnicity||participants|Number|15|15.0||||||
4063720|NCT01067105|3885700|B1|Black or African American||Race/Ethnicity||participants|Number|104|104.0||||||
4063721|NCT01067105|3885700|B1|White/Caucasian||Race/Ethnicity||participants|Number|690|690.0||||||
4063722|NCT01067105|3885700|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063723|NCT01067105|3885700|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|664|664.0||||||
4063724|NCT01067105|3885700|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|160|160.0||||||
4063725|NCT01067105|3885700|B1||Male|Sex: Female, Male||Participants|Count of Participants|295|295.0||||||
4063726|NCT01067105|3885700|B1||Female|Sex: Female, Male||Participants|Count of Participants|529|529.0||||||
4063727|NCT01067105|3885700|B1|||Age||years|Mean|38.5|38.5|Standard Deviation|13.2|13.2|||
4063728|NCT01067105|3885700|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4063729|NCT01067105|3885700|B1||Between 18 and 65 years|Age||Participants|Count of Participants|743|743.0||||||
4063730|NCT01067105|3885700|B1||<=18 years|Age||Participants|Count of Participants|64|64.0||||||
4063731|NCT01066923|3885717|B5|United States||Region of Enrollment||participants|Number|102|102.0||||||
4063732|NCT01066923|3885718|B4|United States||Region of Enrollment||participants|Number|23|23.0||||||
4063733|NCT01066923|3885719|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4063734|NCT01066923|3885720|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4063735|NCT01066923|3885721|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4063736|NCT01066923|3885717|B5||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4063737|NCT01066923|3885718|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4063738|NCT01066923|3885719|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4063739|NCT01066923|3885720|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4063740|NCT01066923|3885721|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4063741|NCT01066923|3885717|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4063742|NCT01066923|3885718|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4063743|NCT01066923|3885719|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4063744|NCT01066923|3885720|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4063745|NCT01066923|3885721|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4063746|NCT01066923|3885717|B5|||Age||years|Mean|31.8|31.8|Standard Deviation|8.6|8.6|||
4063747|NCT01066923|3885718|B4|||Age||years|Mean|34.5|34.5|Standard Deviation|9.3|9.3|||
4063748|NCT01066923|3885719|B3|||Age||years|Mean|30.5|30.5|Standard Deviation|8.5|8.5|||
4063749|NCT01066923|3885720|B2|||Age||years|Mean|29.3|29.3|Standard Deviation|8.6|8.6|||
4063750|NCT01066923|3885721|B1|||Age||years|Mean|33.2|33.2|Standard Deviation|10.1|10.1|||
4063751|NCT01066897|3885746|B3|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4063752|NCT01066897|3885747|B2|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4063753|NCT01066897|3885748|B1|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4063755|NCT01066897|3885747|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063756|NCT01066897|3885748|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063757|NCT01066897|3885746|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063758|NCT01066897|3885747|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063759|NCT01066897|3885748|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063760|NCT01066897|3885746|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4063761|NCT01066897|3885747|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4063762|NCT01066897|3885748|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4063763|NCT01066897|3885746|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4063764|NCT01066897|3885747|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4063765|NCT01066897|3885748|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063766|NCT01066897|3885746|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063767|NCT01066897|3885747|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063768|NCT01066897|3885748|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063769|NCT01066897|3885746|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4063770|NCT01066897|3885747|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4063771|NCT01066897|3885748|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063772|NCT01066897|3885746|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063773|NCT01066897|3885747|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063774|NCT01066897|3885748|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063775|NCT01066897|3885746|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4063776|NCT01066897|3885747|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4063777|NCT01066897|3885748|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4063778|NCT01066897|3885746|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4063779|NCT01066897|3885747|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4063780|NCT01066897|3885748|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4063781|NCT01066897|3885746|B3|||Age||years|Mean|38.81|38.81|Standard Deviation|14.41|14.41|||
4063782|NCT01066897|3885747|B2|||Age||years|Mean|34.78|34.78|Standard Deviation|14.0|14.0|||
4063783|NCT01066897|3885748|B1|||Age||years|Mean|44.00|44.0|Standard Deviation|14.12|14.12|||
4063784|NCT01066871|3885759|B5||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4063785|NCT01066871|3885760|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4063786|NCT01066871|3885761|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4063787|NCT01066871|3885762|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4063788|NCT01066871|3885763|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4063789|NCT01066871|3885759|B5||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4063790|NCT01066871|3885760|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4063791|NCT01066871|3885761|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4063792|NCT01066871|3885762|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4063793|NCT01066871|3885763|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4063794|NCT01066871|3885759|B5|Greater than or equal to (>=) 40 years||Age, Customized||participants|Number|13|13.0||||||
4063795|NCT01066871|3885760|B4|Greater than or equal to (>=) 40 years||Age, Customized||participants|Number|2|2.0||||||
4063796|NCT01066871|3885761|B3|Greater than or equal to (>=) 40 years||Age, Customized||participants|Number|4|4.0||||||
4063797|NCT01066871|3885762|B2|Greater than or equal to (>=) 40 years||Age, Customized||participants|Number|3|3.0||||||
4063798|NCT01066871|3885763|B1|Greater than or equal to (>=) 40 years||Age, Customized||participants|Number|4|4.0||||||
4063799|NCT01066871|3885759|B5|Less than (<) 40 years||Age, Customized||participants|Number|61|61.0||||||
4063800|NCT01066871|3885760|B4|Less than (<) 40 years||Age, Customized||participants|Number|16|16.0||||||
4063801|NCT01066871|3885761|B3|Less than (<) 40 years||Age, Customized||participants|Number|14|14.0||||||
4063802|NCT01066871|3885762|B2|Less than (<) 40 years||Age, Customized||participants|Number|15|15.0||||||
4063803|NCT01066871|3885763|B1|Less than (<) 40 years||Age, Customized||participants|Number|16|16.0||||||
4063804|NCT01066819|3885824|B7||Male|Sex: Female, Male||Participants|Count of Participants|964|964.0||||||
4063805|NCT01066819|3885825|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4063806|NCT01066819|3885826|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4063807|NCT01066819|3885827|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4063808|NCT01066819|3885828|B3||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4063809|NCT01066819|3885829|B2||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4063810|NCT01066819|3885830|B1||Male|Sex: Female, Male||Participants|Count of Participants|587|587.0||||||
4063811|NCT01066819|3885824|B7||Female|Sex: Female, Male||Participants|Count of Participants|692|692.0||||||
4063812|NCT01066819|3885825|B6||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4063813|NCT01066819|3885826|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4063814|NCT01066819|3885827|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4063815|NCT01066819|3885828|B3||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4063816|NCT01066819|3885829|B2||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4063817|NCT01066819|3885830|B1||Female|Sex: Female, Male||Participants|Count of Participants|419|419.0||||||
4063818|NCT01066819|3885824|B7|||Age||years|Mean|48.4|48.4|Standard Deviation|9.71|9.71|||
4063819|NCT01066819|3885825|B6|||Age||years|Mean|45.6|45.6|Standard Deviation|10.72|10.72|||
4063820|NCT01066819|3885826|B5|||Age||years|Mean|53.3|53.3|Standard Deviation|10.48|10.48|||
4063821|NCT01066819|3885827|B4|||Age||years|Mean|46.4|46.4|Standard Deviation|10.59|10.59|||
4063822|NCT01066819|3885828|B3|||Age||years|Mean|46.9|46.9|Standard Deviation|9.41|9.41|||
4063823|NCT01066819|3885829|B2|||Age||years|Mean|49.7|49.7|Standard Deviation|9.74|9.74|||
4063824|NCT01066819|3885830|B1|||Age||years|Mean|48.4|48.4|Standard Deviation|9.68|9.68|||
4063825|NCT01066793|3885970|B7||Male|Sex: Female, Male||Participants|Count of Participants|1326|1326.0||||||
4063826|NCT01066793|3885971|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4063827|NCT01066793|3885972|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4063828|NCT01066793|3885973|B4||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4063829|NCT01066793|3885974|B3||Male|Sex: Female, Male||Participants|Count of Participants|350|350.0||||||
4063830|NCT01066793|3885975|B2||Male|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
4063831|NCT01066793|3885976|B1||Male|Sex: Female, Male||Participants|Count of Participants|596|596.0||||||
4063832|NCT01066793|3885970|B7||Female|Sex: Female, Male||Participants|Count of Participants|1017|1017.0||||||
4063833|NCT01066793|3885971|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4063834|NCT01066793|3885972|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4063835|NCT01066793|3885973|B4||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4063836|NCT01066793|3885974|B3||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4063837|NCT01066793|3885975|B2||Female|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
4063838|NCT01066793|3885976|B1||Female|Sex: Female, Male||Participants|Count of Participants|532|532.0||||||
4063839|NCT01066793|3885970|B7|||Age||years|Mean|48.5|48.5|Standard Deviation|12.71|12.71|||
4063840|NCT01066793|3885971|B6|||Age||years|Mean|51.4|51.4|Standard Deviation|13.24|13.24|||
4063841|NCT01066793|3885972|B5|||Age||years|Mean|52.7|52.7|Standard Deviation|12.82|12.82|||
4063842|NCT01066793|3885973|B4|||Age||years|Mean|46.6|46.6|Standard Deviation|11.56|11.56|||
4063843|NCT01066793|3885974|B3|||Age||years|Mean|40.6|40.6|Standard Deviation|9.20|9.2|||
4063844|NCT01066793|3885975|B2|||Age||years|Mean|54.2|54.2|Standard Deviation|12.52|12.52|||
4063845|NCT01066793|3885976|B1|||Age||years|Mean|49.1|49.1|Standard Deviation|12.52|12.52|||
4063846|NCT01066780|3886121|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4063847|NCT01066780|3886121|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4063848|NCT01066780|3886121|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4063849|NCT01066780|3886121|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4063850|NCT01066780|3886121|B1|||Age||years|Mean|58.5|58.5|Standard Deviation|16.00|16.0|||
4063851|NCT01066780|3886121|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4063852|NCT01066780|3886121|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4063853|NCT01066780|3886121|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4063854|NCT01066624|3886126|B4|United States||Region of Enrollment||participants|Number|117|117.0||||||
4063855|NCT01066624|3886127|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
4063856|NCT01066624|3886128|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4063857|NCT01066624|3886129|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4063858|NCT01066624|3886126|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063859|NCT01066624|3886127|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063860|NCT01066624|3886128|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063861|NCT01066624|3886129|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063862|NCT01066624|3886126|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063863|NCT01066624|3886127|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063864|NCT01066624|3886128|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063865|NCT01066624|3886129|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063866|NCT01066624|3886126|B4||White|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
4063867|NCT01066624|3886127|B3||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4063868|NCT01066624|3886128|B2||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4063869|NCT01066624|3886129|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4063870|NCT01066624|3886126|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4063871|NCT01066624|3886127|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4063872|NCT01066624|3886128|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4063873|NCT01066624|3886129|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4063874|NCT01066624|3886126|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063875|NCT01066624|3886127|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063876|NCT01066624|3886128|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063877|NCT01066624|3886129|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063878|NCT01066624|3886126|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063879|NCT01066624|3886127|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063880|NCT01066624|3886128|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063881|NCT01066624|3886129|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063882|NCT01066624|3886126|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063883|NCT01066624|3886127|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063884|NCT01066624|3886128|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063885|NCT01066624|3886129|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063886|NCT01066624|3886126|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063887|NCT01066624|3886127|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063888|NCT01066624|3886128|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063889|NCT01066624|3886129|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063890|NCT01066624|3886126|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4063891|NCT01066624|3886127|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4063892|NCT01066624|3886128|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4063893|NCT01066624|3886129|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4063894|NCT01066624|3886126|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4063895|NCT01066624|3886127|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4063896|NCT01066624|3886128|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4063897|NCT01066624|3886129|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4063898|NCT01066624|3886126|B4||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4063899|NCT01066624|3886127|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4063900|NCT01066624|3886128|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4063901|NCT01066624|3886129|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4063902|NCT01066624|3886126|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4063903|NCT01066624|3886127|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4063904|NCT01066624|3886128|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4063905|NCT01066624|3886129|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4063906|NCT01066624|3886126|B4|||Age||years|Mean|62|62.0|Full Range|||39.0|75.0|
4063907|NCT01066624|3886127|B3|||Age||years|Mean|62|62.0|Full Range|||45.0|68.0|
4063908|NCT01066624|3886128|B2|||Age||years|Mean|62|62.0|Full Range|||39.0|75.0|
4063909|NCT01066624|3886129|B1|||Age||years|Mean|61.5|61.5|Full Range|||43.0|70.0|
4063910|NCT01066624|3886126|B4||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4063911|NCT01066624|3886127|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4063912|NCT01066624|3886128|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4063913|NCT01066624|3886129|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4063914|NCT01066624|3886126|B4||Between 18 and 65 years|Age||Participants|Count of Participants|88|88.0||||||
4063915|NCT01066624|3886127|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4063916|NCT01066624|3886128|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4063917|NCT01066624|3886129|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4063918|NCT01066624|3886126|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4063919|NCT01066624|3886127|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4063920|NCT01066624|3886128|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4063921|NCT01066624|3886129|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4063922|NCT01066585|3886139|B3|United States||Region of Enrollment||Participants|Number|410|410.0||||||
4063923|NCT01066585|3886140|B2|United States||Region of Enrollment||Participants|Number|199|199.0||||||
4063924|NCT01066585|3886141|B1|United States||Region of Enrollment||Participants|Number|211|211.0||||||
4063925|NCT01066585|3886139|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4063926|NCT01066585|3886140|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4063927|NCT01066585|3886141|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4063928|NCT01066585|3886139|B3||Female|Sex: Female, Male||Participants|Count of Participants|336|336.0||||||
4063929|NCT01066585|3886140|B2||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4063930|NCT01066585|3886141|B1||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4063931|NCT01066585|3886139|B3|||Age||Years|Mean|14.47|14.47|Standard Deviation|12.76|12.76|||
4063932|NCT01066585|3886140|B2|||Age||Years|Mean|15.05|15.05|Standard Deviation|13.52|13.52|||
4063933|NCT01066585|3886141|B1|||Age||Years|Mean|13.92|13.92|Standard Deviation|12.00|12.0|||
4063934|NCT01066585|3886139|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4063935|NCT01066585|3886140|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4063936|NCT01066585|3886141|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4063937|NCT01066585|3886139|B3||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
4063938|NCT01066585|3886140|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4063939|NCT01066585|3886141|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4063940|NCT01066585|3886139|B3||<=18 years|Age||Participants|Count of Participants|313|313.0||||||
4063941|NCT01066585|3886140|B2||<=18 years|Age||Participants|Count of Participants|149|149.0||||||
4063942|NCT01066585|3886141|B1||<=18 years|Age||Participants|Count of Participants|164|164.0||||||
4063943|NCT01066546|3886154|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4063944|NCT01066546|3886154|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4063945|NCT01066546|3886154|B1|Greater than 85 years||Age, Customized||participants|Number|1|1.0||||||
4063946|NCT01066546|3886154|B1|80 to 85 years||Age, Customized||participants|Number|2|2.0||||||
4063947|NCT01066546|3886154|B1|70 to 79 years||Age, Customized||participants|Number|1|1.0||||||
4063948|NCT01066546|3886154|B1|60 to 69 years||Age, Customized||participants|Number|0|0.0||||||
4063949|NCT01066546|3886154|B1|50 to 59 years||Age, Customized||participants|Number|1|1.0||||||
4063950|NCT01066546|3886154|B1|Less than 50 years||Age, Customized||participants|Number|0|0.0||||||
4063951|NCT01066520|3886165|B4|Spain||Region of Enrollment||participants|Number|420|420.0||||||
4063952|NCT01066520|3886166|B3|Spain||Region of Enrollment||participants|Number|137|137.0||||||
4063953|NCT01066520|3886167|B2|Spain||Region of Enrollment||participants|Number|140|140.0||||||
4063954|NCT01066520|3886168|B1|Spain||Region of Enrollment||participants|Number|143|143.0||||||
4063955|NCT01066520|3886165|B4||Male|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
4063956|NCT01066520|3886166|B3||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4063957|NCT01066520|3886167|B2||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4063958|NCT01066520|3886168|B1||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4063959|NCT01066520|3886165|B4||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4063960|NCT01066520|3886166|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4063961|NCT01066520|3886167|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4063962|NCT01066520|3886168|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4063963|NCT01066520|3886165|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4063964|NCT01066520|3886166|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4063965|NCT01066520|3886167|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4063966|NCT01066520|3886168|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4063967|NCT01066520|3886165|B4||Between 18 and 65 years|Age||Participants|Count of Participants|420|420.0||||||
4063968|NCT01066520|3886166|B3||Between 18 and 65 years|Age||Participants|Count of Participants|137|137.0||||||
4063969|NCT01066520|3886167|B2||Between 18 and 65 years|Age||Participants|Count of Participants|140|140.0||||||
4063970|NCT01066520|3886168|B1||Between 18 and 65 years|Age||Participants|Count of Participants|143|143.0||||||
4063971|NCT01066520|3886165|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4063972|NCT01066520|3886166|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4063973|NCT01066520|3886167|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4063974|NCT01066520|3886168|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4063975|NCT01066156|3886184|B1|United States||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
4063976|NCT01066156|3886184|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4063977|NCT01066156|3886184|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4063978|NCT01066156|3886184|B1|||Age||years|Mean|51.3|51.3|Standard Deviation|8.3|8.3|||
4063979|NCT01066156|3886184|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4063980|NCT01066156|3886184|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4063981|NCT01066156|3886184|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4063982|NCT01066143|3886188|B1||Male|Sex: Female, Male|8 subjects signed the consent but were later found to be ineligible|||0|0.0||||||
4063983|NCT01066143|3886188|B1||Female|Sex: Female, Male|8 subjects signed the consent but were later found to be ineligible|||0|0.0||||||
4063984|NCT01066143|3886188|B1||>=65 years|Age|8 subjects signed the consent but were later found to be ineligible|||0|0.0||||||
4063985|NCT01066143|3886188|B1||Between 18 and 65 years|Age|8 subjects signed the consent but were later found to be ineligible|||0|0.0||||||
4063986|NCT01066143|3886188|B1||<=18 years|Age|8 subjects signed the consent but were later found to be ineligible|||0|0.0||||||
4063987|NCT01066104|3886192|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4063988|NCT01066104|3886193|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4063989|NCT01066104|3886194|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063990|NCT01066104|3886192|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4063991|NCT01066104|3886193|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4063992|NCT01066104|3886194|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4063993|NCT01066104|3886192|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4063994|NCT01066104|3886193|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4063995|NCT01066104|3886194|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4063996|NCT01066104|3886192|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4063997|NCT01066104|3886193|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4063998|NCT01066104|3886194|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4063999|NCT01066104|3886192|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064000|NCT01066104|3886193|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064001|NCT01066104|3886194|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064002|NCT01066104|3886192|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064003|NCT01066104|3886193|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064004|NCT01066104|3886194|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064005|NCT01066104|3886192|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064006|NCT01066104|3886193|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064007|NCT01066104|3886194|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064008|NCT01066104|3886192|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064009|NCT01066104|3886193|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064010|NCT01066104|3886194|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064011|NCT01066104|3886192|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4064012|NCT01066104|3886193|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4064013|NCT01066104|3886194|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4064014|NCT01066104|3886192|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4064015|NCT01066104|3886193|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4064016|NCT01066104|3886194|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4064017|NCT01066104|3886192|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4064018|NCT01066104|3886193|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4064019|NCT01066104|3886194|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4064020|NCT01066104|3886192|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4064021|NCT01066104|3886193|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4064022|NCT01066104|3886194|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4064023|NCT01066104|3886192|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4064024|NCT01066104|3886193|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4064025|NCT01066104|3886194|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4064026|NCT01066104|3886192|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4064027|NCT01066104|3886193|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4064028|NCT01066104|3886194|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4064029|NCT01066104|3886192|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4064030|NCT01066104|3886193|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4064031|NCT01066104|3886194|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4064032|NCT01066052|3886203|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4064033|NCT01066052|3886204|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4064034|NCT01066052|3886205|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4064035|NCT01066052|3886203|B3||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4064036|NCT01066052|3886204|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4064037|NCT01066052|3886205|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4064038|NCT01066052|3886203|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4064039|NCT01066052|3886204|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4064040|NCT01066052|3886205|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4064041|NCT01066052|3886203|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4064042|NCT01066052|3886204|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4064043|NCT01066052|3886205|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4064044|NCT01066052|3886203|B3||<=18 years|Age||Participants|Count of Participants|115|115.0||||||
4064045|NCT01066052|3886204|B2||<=18 years|Age||Participants|Count of Participants|51|51.0||||||
4064046|NCT01066052|3886205|B1||<=18 years|Age||Participants|Count of Participants|64|64.0||||||
4064047|NCT01066039|3886217|B1||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4064048|NCT01066039|3886217|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4064049|NCT01066039|3886217|B1|||Age||years|Mean|59.1|59.1|Standard Deviation|8.8|8.8|||
4064050|NCT01066000|3886230|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4064051|NCT01066000|3886230|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4064052|NCT01066000|3886230|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|13.4|13.4|||
4064053|NCT01065844|3886241|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4064054|NCT01065844|3886241|B1||Male|Sex/Gender, Customized|Self-reported gender at time of study enrollment|Participants|Count of Participants|6|6.0||||||
4064055|NCT01065844|3886241|B1||Female|Sex/Gender, Customized|Self-reported gender at time of study enrollment|Participants|Count of Participants|9|9.0||||||
4064056|NCT01065844|3886241|B1||>=65 years|Age, Customized|Age, in years, of study participants at consent|Participants|Count of Participants|3|3.0||||||
4064057|NCT01065844|3886241|B1||Between 18 and 65 years|Age, Customized|Age, in years, of study participants at consent|Participants|Count of Participants|12|12.0||||||
4064058|NCT01065844|3886241|B1||<=18 years|Age, Customized|Age, in years, of study participants at consent|Participants|Count of Participants|0|0.0||||||
4064059|NCT01065818|3886245|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4064060|NCT01065818|3886245|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4064061|NCT01065818|3886245|B1|>18 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
4064062|NCT01065779|3886249|B1|Excluded from Analysis||Sex/Gender, Customized||participants|Number|82|82.0||||||
4064063|NCT01065779|3886249|B1|Male||Sex/Gender, Customized||participants|Number|57|57.0||||||
4064064|NCT01065779|3886249|B1|Female||Sex/Gender, Customized||participants|Number|741|741.0||||||
4064065|NCT01065779|3886249|B1|||Age||years|Mean|67.12|67.12|Standard Deviation|9.05|9.05|||
4064066|NCT01065766|3886260|B1||Male|Sex: Female, Male||Participants|Count of Participants|2120|2120.0||||||
4064067|NCT01065766|3886260|B1||Female|Sex: Female, Male||Participants|Count of Participants|1913|1913.0||||||
4064068|NCT01065766|3886260|B1|||Age||Years|Mean|58.22|58.22|Standard Deviation|11.55|11.55|||
4064069|NCT01065714|3886272|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4064070|NCT01065714|3886272|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4064071|NCT01065714|3886272|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4064072|NCT01065714|3886272|B1|||Age||years|Mean|35|35.0|Standard Deviation|16.0|16.0|||
4064073|NCT01065714|3886272|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4064074|NCT01065714|3886272|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4064075|NCT01065714|3886272|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4064076|NCT01065597|3886279|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4064077|NCT01065597|3886279|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4064078|NCT01065597|3886279|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4064079|NCT01065597|3886279|B1|||Age||years|Mean|41.3|41.3|Standard Deviation|13|13.0|||
4064080|NCT01065597|3886279|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4064081|NCT01065597|3886279|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4064082|NCT01065597|3886279|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4064083|NCT01065558|3886286|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4064084|NCT01065558|3886286|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4064085|NCT01065558|3886286|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4064086|NCT01065558|3886286|B1|||Age||years|Mean|20.4|20.4|Standard Deviation|17.9|17.9|||
4064087|NCT01065558|3886286|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4064088|NCT01065558|3886286|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4064089|NCT01065558|3886286|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4064090|NCT01065506|3886291|B3|||ASI-3|Throughout treatment and follow-up, we assessed Anxiety Sensitivity using the Anxiety Sensitivity Index-3 (ASI-3). Recent research has supported using a cut-off score of 23 to identify high AS individuals with this instrument. ASI was assessed via self-report online prior to each assessment visit. ASI scores range from 0 to 72. Lower anxiety sensitivity scores in this study are indicative of better outcomes.|units on a scale|Mean|18.32|18.32|Standard Deviation|11.62|11.62|||
4064091|NCT01065506|3886292|B2|||ASI-3|Throughout treatment and follow-up, we assessed Anxiety Sensitivity using the Anxiety Sensitivity Index-3 (ASI-3). Recent research has supported using a cut-off score of 23 to identify high AS individuals with this instrument. ASI was assessed via self-report online prior to each assessment visit. ASI scores range from 0 to 72. Lower anxiety sensitivity scores in this study are indicative of better outcomes.|units on a scale|Mean|18.04|18.04|Standard Deviation|12.72|12.72|||
4064092|NCT01065506|3886293|B1|||ASI-3|Throughout treatment and follow-up, we assessed Anxiety Sensitivity using the Anxiety Sensitivity Index-3 (ASI-3). Recent research has supported using a cut-off score of 23 to identify high AS individuals with this instrument. ASI was assessed via self-report online prior to each assessment visit. ASI scores range from 0 to 72. Lower anxiety sensitivity scores in this study are indicative of better outcomes.|units on a scale|Mean|18.63|18.63|Standard Deviation|10.36|10.36|||
4064093|NCT01065506|3886291|B3|United States||Region of Enrollment||participants|Number|136|136.0||||||
4064094|NCT01065506|3886292|B2|United States||Region of Enrollment||participants|Number|72|72.0||||||
4064095|NCT01065506|3886293|B1|United States||Region of Enrollment||participants|Number|64|64.0||||||
4064096|NCT01065506|3886291|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4064097|NCT01065506|3886292|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4064098|NCT01065506|3886293|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4064099|NCT01065506|3886291|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064100|NCT01065506|3886292|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064101|NCT01065506|3886293|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064102|NCT01065506|3886291|B3||White|Race (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
4064103|NCT01065506|3886292|B2||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4064104|NCT01065506|3886293|B1||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4064105|NCT01065506|3886291|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4064106|NCT01065506|3886292|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4064107|NCT01065506|3886293|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4064108|NCT01065506|3886291|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064109|NCT01065506|3886292|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064110|NCT01065506|3886293|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064111|NCT01065506|3886291|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4064112|NCT01065506|3886292|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4064113|NCT01065506|3886293|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4064114|NCT01065506|3886291|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064115|NCT01065506|3886292|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064116|NCT01065506|3886293|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064117|NCT01065506|3886291|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4064118|NCT01065506|3886292|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4064119|NCT01065506|3886293|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4064120|NCT01065506|3886291|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4064121|NCT01065506|3886292|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4064122|NCT01065506|3886293|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4064123|NCT01065506|3886291|B3|||Age||years|Mean|44.19|44.19|Standard Deviation|11.29|11.29|||
4064124|NCT01065506|3886292|B2|||Age||years|Mean|43.12|43.12|Standard Deviation|11.26|11.26|||
4064125|NCT01065506|3886293|B1|||Age||years|Mean|45.39|45.39|Standard Deviation|11.30|11.3|||
4064126|NCT01065480|3886300|B3|United States||Region of Enrollment||Participants|Count of Participants|91|91.0||||||
4064127|NCT01065480|3886301|B2|United States||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
4064128|NCT01065480|3886302|B1|United States||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
4064129|NCT01065480|3886300|B3|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4064130|NCT01065480|3886301|B2|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4064131|NCT01065480|3886302|B1|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4064132|NCT01065480|3886300|B3|Race/Ethnicity|American Indian or Native American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4064133|NCT01065480|3886301|B2|Race/Ethnicity|American Indian or Native American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4064134|NCT01065480|3886302|B1|Race/Ethnicity|American Indian or Native American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4064135|NCT01065480|3886300|B3|Race/Ethnicity|Asian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4064136|NCT01065480|3886301|B2|Race/Ethnicity|Asian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4064137|NCT01065480|3886302|B1|Race/Ethnicity|Asian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4064138|NCT01065480|3886300|B3|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
4064139|NCT01065480|3886301|B2|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
4064140|NCT01065480|3886302|B1|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4064141|NCT01065480|3886300|B3|Race/Ethnicity|Black, not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
4064142|NCT01065480|3886301|B2|Race/Ethnicity|Black, not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4064143|NCT01065480|3886302|B1|Race/Ethnicity|Black, not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
4064144|NCT01065480|3886300|B3|Race/Ethnicity|White, not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
4064145|NCT01065480|3886301|B2|Race/Ethnicity|White, not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4064146|NCT01065480|3886302|B1|Race/Ethnicity|White, not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4064147|NCT01065480|3886300|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4064148|NCT01065480|3886301|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4064149|NCT01065480|3886302|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4064150|NCT01065480|3886300|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4064151|NCT01065480|3886301|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4064152|NCT01065480|3886302|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4064153|NCT01065480|3886300|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4064154|NCT01065480|3886301|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4064155|NCT01065480|3886302|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4064156|NCT01065480|3886300|B3||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
4064157|NCT01065480|3886301|B2||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4064158|NCT01065480|3886302|B1||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4064159|NCT01065480|3886300|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4064160|NCT01065480|3886301|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4064161|NCT01065480|3886302|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4064162|NCT01065454|3886309|B5|Amiodarone||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|24|24.0||||||
4064163|NCT01065454|3886310|B4|Amiodarone||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|8|8.0||||||
4064164|NCT01065454|3886311|B3|Amiodarone||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|4|4.0||||||
4064165|NCT01065454|3886312|B2|Amiodarone||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|3|3.0||||||
4064166|NCT01065454|3886313|B1|Amiodarone||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|9|9.0||||||
4064167|NCT01065454|3886309|B5|Oral anticoagulants||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|102|102.0||||||
4064168|NCT01065454|3886310|B4|Oral anticoagulants||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|33|33.0||||||
4064169|NCT01065454|3886311|B3|Oral anticoagulants||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|15|15.0||||||
4064170|NCT01065454|3886312|B2|Oral anticoagulants||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|16|16.0||||||
4064171|NCT01065454|3886313|B1|Oral anticoagulants||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|38|38.0||||||
4064172|NCT01065454|3886309|B5|Cardiac glycosides||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|72|72.0||||||
4064173|NCT01065454|3886310|B4|Cardiac glycosides||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|28|28.0||||||
4064174|NCT01065454|3886311|B3|Cardiac glycosides||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|6|6.0||||||
4064175|NCT01065454|3886312|B2|Cardiac glycosides||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|12|12.0||||||
4064176|NCT01065454|3886313|B1|Cardiac glycosides||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|28|28.0||||||
4064177|NCT01065454|3886309|B5|Thiazide diuretics||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|32|32.0||||||
4064178|NCT01065454|3886310|B4|Thiazide diuretics||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|10|10.0||||||
4064179|NCT01065454|3886311|B3|Thiazide diuretics||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|7|7.0||||||
4064180|NCT01065454|3886312|B2|Thiazide diuretics||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|3|3.0||||||
4064181|NCT01065454|3886313|B1|Thiazide diuretics||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|12|12.0||||||
4064182|NCT01065454|3886309|B5|Loop diuretics||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|188|188.0||||||
4064183|NCT01065454|3886310|B4|Loop diuretics||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|68|68.0||||||
4064184|NCT01065454|3886311|B3|Loop diuretics||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|29|29.0||||||
4064185|NCT01065454|3886312|B2|Loop diuretics||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|31|31.0||||||
4064186|NCT01065454|3886313|B1|Loop diuretics||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|62|62.0||||||
4064187|NCT01065454|3886309|B5|Beta-blockers with alpha-blocking activity||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|86|86.0||||||
4064188|NCT01065454|3886310|B4|Beta-blockers with alpha-blocking activity||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|30|30.0||||||
4064189|NCT01065454|3886311|B3|Beta-blockers with alpha-blocking activity||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|11|11.0||||||
4064190|NCT01065454|3886312|B2|Beta-blockers with alpha-blocking activity||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|15|15.0||||||
4064191|NCT01065454|3886313|B1|Beta-blockers with alpha-blocking activity||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|30|30.0||||||
4064192|NCT01065454|3886309|B5|Beta-blockers||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|100|100.0||||||
4064193|NCT01065454|3886310|B4|Beta-blockers||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|32|32.0||||||
4064194|NCT01065454|3886311|B3|Beta-blockers||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|21|21.0||||||
4064195|NCT01065454|3886312|B2|Beta-blockers||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|16|16.0||||||
4064196|NCT01065454|3886313|B1|Beta-blockers||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|31|31.0||||||
4064197|NCT01065454|3886309|B5|Aldosterone antagonists||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|153|153.0||||||
4064198|NCT01065454|3886310|B4|Aldosterone antagonists||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|53|53.0||||||
4064199|NCT01065454|3886311|B3|Aldosterone antagonists||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|23|23.0||||||
4064200|NCT01065454|3886312|B2|Aldosterone antagonists||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|26|26.0||||||
4064201|NCT01065454|3886313|B1|Aldosterone antagonists||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|51|51.0||||||
4064202|NCT01065454|3886309|B5|Angiotensin II receptor blockers||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|57|57.0||||||
4064203|NCT01065454|3886310|B4|Angiotensin II receptor blockers||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|19|19.0||||||
4064204|NCT01065454|3886311|B3|Angiotensin II receptor blockers||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|10|10.0||||||
4064205|NCT01065454|3886312|B2|Angiotensin II receptor blockers||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|8|8.0||||||
4064206|NCT01065454|3886313|B1|Angiotensin II receptor blockers||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|20|20.0||||||
4064207|NCT01065454|3886309|B5|Angiotensin-converting enzyme inhibitors||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|142|142.0||||||
4064208|NCT01065454|3886310|B4|Angiotensin-converting enzyme inhibitors||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|46|46.0||||||
4064209|NCT01065454|3886311|B3|Angiotensin-converting enzyme inhibitors||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|21|21.0||||||
4064210|NCT01065454|3886312|B2|Angiotensin-converting enzyme inhibitors||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|25|25.0||||||
4064211|NCT01065454|3886313|B1|Angiotensin-converting enzyme inhibitors||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|50|50.0||||||
4064212|NCT01065454|3886309|B5|Cardiac devices||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|120|120.0||||||
4064213|NCT01065454|3886310|B4|Cardiac devices||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|44|44.0||||||
4064214|NCT01065454|3886311|B3|Cardiac devices||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|21|21.0||||||
4064215|NCT01065454|3886312|B2|Cardiac devices||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|17|17.0||||||
4064216|NCT01065454|3886313|B1|Cardiac devices||Baseline drug and device therapy|A single patient could have more than one drug and device therapy.|Participants|Number|38|38.0||||||
4064217|NCT01065454|3886309|B5|||Number of participants with pacemaker rhythm||Participants|Number|50|50.0||||||
4064218|NCT01065454|3886310|B4|||Number of participants with pacemaker rhythm||Participants|Number|17|17.0||||||
4064219|NCT01065454|3886311|B3|||Number of participants with pacemaker rhythm||Participants|Number|7|7.0||||||
4064220|NCT01065454|3886312|B2|||Number of participants with pacemaker rhythm||Participants|Number|9|9.0||||||
4064221|NCT01065454|3886313|B1|||Number of participants with pacemaker rhythm||Participants|Number|17|17.0||||||
4064222|NCT01065454|3886309|B5|||Number of participants with atrial flutter||Participants|Number|2|2.0||||||
4064223|NCT01065454|3886310|B4|||Number of participants with atrial flutter||Participants|Number|1|1.0||||||
4064224|NCT01065454|3886311|B3|||Number of participants with atrial flutter||Participants|Number|1|1.0||||||
4064225|NCT01065454|3886312|B2|||Number of participants with atrial flutter||Participants|Number|0|0.0||||||
4064226|NCT01065454|3886313|B1|||Number of participants with atrial flutter||Participants|Number|0|0.0||||||
4064227|NCT01065454|3886309|B5|||Number of participants with atrial fibrillation||Participants|Number|24|24.0||||||
4064228|NCT01065454|3886310|B4|||Number of participants with atrial fibrillation||Participants|Number|9|9.0||||||
4064229|NCT01065454|3886311|B3|||Number of participants with atrial fibrillation||Participants|Number|3|3.0||||||
4064230|NCT01065454|3886312|B2|||Number of participants with atrial fibrillation||Participants|Number|3|3.0||||||
4064231|NCT01065454|3886313|B1|||Number of participants with atrial fibrillation||Participants|Number|9|9.0||||||
4064232|NCT01065454|3886309|B5|||Glomerular filtration rate (GFR)||mL/min/1.73m^2|Mean|68.7|68.7|Standard Deviation|19.91|19.91|||
4064233|NCT01065454|3886310|B4|||Glomerular filtration rate (GFR)||mL/min/1.73m^2|Mean|68.7|68.7|Standard Deviation|19.90|19.9|||
4064234|NCT01065454|3886311|B3|||Glomerular filtration rate (GFR)||mL/min/1.73m^2|Mean|72.0|72.0|Standard Deviation|17.90|17.9|||
4064235|NCT01065454|3886312|B2|||Glomerular filtration rate (GFR)||mL/min/1.73m^2|Mean|72.6|72.6|Standard Deviation|22.70|22.7|||
4064236|NCT01065454|3886313|B1|||Glomerular filtration rate (GFR)||mL/min/1.73m^2|Mean|65.1|65.1|Standard Deviation|19.10|19.1|||
4064237|NCT01065454|3886309|B5|||Number of participants with diabetes mellitus (including subtypes)||Participants|Number|87|87.0||||||
4064238|NCT01065454|3886310|B4|||Number of participants with diabetes mellitus (including subtypes)||Participants|Number|34|34.0||||||
4064239|NCT01065454|3886311|B3|||Number of participants with diabetes mellitus (including subtypes)||Participants|Number|13|13.0||||||
4064240|NCT01065454|3886312|B2|||Number of participants with diabetes mellitus (including subtypes)||Participants|Number|10|10.0||||||
4064241|NCT01065454|3886313|B1|||Number of participants with diabetes mellitus (including subtypes)||Participants|Number|30|30.0||||||
4064298|NCT01065454|3886310|B4|||Age||Years|Mean|58.9|58.9|Standard Deviation|11.2|11.2|||
4064299|NCT01065454|3886311|B3|||Age||Years|Mean|57.2|57.2|Standard Deviation|9.9|9.9|||
4064300|NCT01065454|3886312|B2|||Age||Years|Mean|55.1|55.1|Standard Deviation|13.2|13.2|||
4064242|NCT01065454|3886309|B5|IV||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (Patients with PH but without resulting limitation of physical activity) to class IV (Patients with PH with inability to carry out any physical activity without symptoms. These patients manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement, changes to a higher functional class resemble deterioration of pulmonary arterial hypertension (PAH).|Participants|Number|5|5.0||||||
4064243|NCT01065454|3886310|B4|IV||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (Patients with PH but without resulting limitation of physical activity) to class IV (Patients with PH with inability to carry out any physical activity without symptoms. These patients manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement, changes to a higher functional class resemble deterioration of pulmonary arterial hypertension (PAH).|Participants|Number|4|4.0||||||
4064244|NCT01065454|3886311|B3|IV||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (Patients with PH but without resulting limitation of physical activity) to class IV (Patients with PH with inability to carry out any physical activity without symptoms. These patients manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement, changes to a higher functional class resemble deterioration of pulmonary arterial hypertension (PAH).|Participants|Number|0|0.0||||||
4064245|NCT01065454|3886312|B2|IV||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (Patients with PH but without resulting limitation of physical activity) to class IV (Patients with PH with inability to carry out any physical activity without symptoms. These patients manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement, changes to a higher functional class resemble deterioration of pulmonary arterial hypertension (PAH).|Participants|Number|0|0.0||||||
4064246|NCT01065454|3886313|B1|IV||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (Patients with PH but without resulting limitation of physical activity) to class IV (Patients with PH with inability to carry out any physical activity without symptoms. These patients manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement, changes to a higher functional class resemble deterioration of pulmonary arterial hypertension (PAH).|Participants|Number|1|1.0||||||
4064247|NCT01065454|3886309|B5|III||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (Patients with PH but without resulting limitation of physical activity) to class IV (Patients with PH with inability to carry out any physical activity without symptoms. These patients manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement, changes to a higher functional class resemble deterioration of pulmonary arterial hypertension (PAH).|Participants|Number|76|76.0||||||
4064248|NCT01065454|3886310|B4|III||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (Patients with PH but without resulting limitation of physical activity) to class IV (Patients with PH with inability to carry out any physical activity without symptoms. These patients manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement, changes to a higher functional class resemble deterioration of pulmonary arterial hypertension (PAH).|Participants|Number|23|23.0||||||
4064249|NCT01065454|3886311|B3|III||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (Patients with PH but without resulting limitation of physical activity) to class IV (Patients with PH with inability to carry out any physical activity without symptoms. These patients manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement, changes to a higher functional class resemble deterioration of pulmonary arterial hypertension (PAH).|Participants|Number|9|9.0||||||
4064250|NCT01065454|3886312|B2|III||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (Patients with PH but without resulting limitation of physical activity) to class IV (Patients with PH with inability to carry out any physical activity without symptoms. These patients manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement, changes to a higher functional class resemble deterioration of pulmonary arterial hypertension (PAH).|Participants|Number|13|13.0||||||
4064251|NCT01065454|3886313|B1|III||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (Patients with PH but without resulting limitation of physical activity) to class IV (Patients with PH with inability to carry out any physical activity without symptoms. These patients manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement, changes to a higher functional class resemble deterioration of pulmonary arterial hypertension (PAH).|Participants|Number|31|31.0||||||
4064252|NCT01065454|3886309|B5|II||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (Patients with PH but without resulting limitation of physical activity) to class IV (Patients with PH with inability to carry out any physical activity without symptoms. These patients manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement, changes to a higher functional class resemble deterioration of pulmonary arterial hypertension (PAH).|Participants|Number|120|120.0||||||
4064253|NCT01065454|3886310|B4|II||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (Patients with PH but without resulting limitation of physical activity) to class IV (Patients with PH with inability to carry out any physical activity without symptoms. These patients manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement, changes to a higher functional class resemble deterioration of pulmonary arterial hypertension (PAH).|Participants|Number|42|42.0||||||
4064301|NCT01065454|3886313|B1|||Age||Years|Mean|59.3|59.3|Standard Deviation|10.8|10.8|||
4064302|NCT01065428|3886426|B3|China||Region of Enrollment||participants|Number|52|52.0||||||
4064303|NCT01065428|3886427|B2|China||Region of Enrollment||participants|Number|35|35.0||||||
4064304|NCT01065428|3886428|B1|China||Region of Enrollment||participants|Number|17|17.0||||||
4064254|NCT01065454|3886311|B3|II||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (Patients with PH but without resulting limitation of physical activity) to class IV (Patients with PH with inability to carry out any physical activity without symptoms. These patients manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement, changes to a higher functional class resemble deterioration of pulmonary arterial hypertension (PAH).|Participants|Number|23|23.0||||||
4064255|NCT01065454|3886312|B2|II||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (Patients with PH but without resulting limitation of physical activity) to class IV (Patients with PH with inability to carry out any physical activity without symptoms. These patients manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement, changes to a higher functional class resemble deterioration of pulmonary arterial hypertension (PAH).|Participants|Number|20|20.0||||||
4064256|NCT01065454|3886313|B1|II||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (Patients with PH but without resulting limitation of physical activity) to class IV (Patients with PH with inability to carry out any physical activity without symptoms. These patients manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement, changes to a higher functional class resemble deterioration of pulmonary arterial hypertension (PAH).|Participants|Number|35|35.0||||||
4064257|NCT01065454|3886309|B5|Data missing||Etiology||Participants|Number|3|3.0||||||
4064258|NCT01065454|3886310|B4|Data missing||Etiology||Participants|Number|1|1.0||||||
4064259|NCT01065454|3886311|B3|Data missing||Etiology||Participants|Number|1|1.0||||||
4064260|NCT01065454|3886312|B2|Data missing||Etiology||Participants|Number|1|1.0||||||
4064261|NCT01065454|3886313|B1|Data missing||Etiology||Participants|Number|0|0.0||||||
4064262|NCT01065454|3886309|B5|Non-ischemic cardiomyopathy||Etiology||Participants|Number|108|108.0||||||
4064263|NCT01065454|3886310|B4|Non-ischemic cardiomyopathy||Etiology||Participants|Number|34|34.0||||||
4064264|NCT01065454|3886311|B3|Non-ischemic cardiomyopathy||Etiology||Participants|Number|17|17.0||||||
4064265|NCT01065454|3886312|B2|Non-ischemic cardiomyopathy||Etiology||Participants|Number|20|20.0||||||
4064266|NCT01065454|3886313|B1|Non-ischemic cardiomyopathy||Etiology||Participants|Number|37|37.0||||||
4064267|NCT01065454|3886309|B5|Ischemic cardiomyopathy||Etiology||Participants|Number|90|90.0||||||
4064268|NCT01065454|3886310|B4|Ischemic cardiomyopathy||Etiology||Participants|Number|34|34.0||||||
4064269|NCT01065454|3886311|B3|Ischemic cardiomyopathy||Etiology||Participants|Number|14|14.0||||||
4064270|NCT01065454|3886312|B2|Ischemic cardiomyopathy||Etiology||Participants|Number|12|12.0||||||
4064271|NCT01065454|3886313|B1|Ischemic cardiomyopathy||Etiology||Participants|Number|30|30.0||||||
4064272|NCT01065454|3886309|B5|||Left ventricular ejection fraction (LVEF)|LVEF is a calculated echocardiography parameter.|Percentage|Mean|27.8|27.8|Standard Deviation|5.24|5.24|||
4064273|NCT01065454|3886310|B4|||Left ventricular ejection fraction (LVEF)|LVEF is a calculated echocardiography parameter.|Percentage|Mean|27.1|27.1|Standard Deviation|5.02|5.02|||
4064274|NCT01065454|3886311|B3|||Left ventricular ejection fraction (LVEF)|LVEF is a calculated echocardiography parameter.|Percentage|Mean|27.0|27.0|Standard Deviation|5.21|5.21|||
4064275|NCT01065454|3886312|B2|||Left ventricular ejection fraction (LVEF)|LVEF is a calculated echocardiography parameter.|Percentage|Mean|28.8|28.8|Standard Deviation|4.54|4.54|||
4064276|NCT01065454|3886313|B1|||Left ventricular ejection fraction (LVEF)|LVEF is a calculated echocardiography parameter.|Percentage|Mean|28.4|28.4|Standard Deviation|5.72|5.72|||
4064277|NCT01065454|3886309|B5|||6-minute walking distance|6MWD is a measure for the evaluation of functional exercise capacity.|Meters|Mean|390.5|390.5|Standard Deviation|116.94|116.94|||
4064278|NCT01065454|3886310|B4|||6-minute walking distance|6MWD is a measure for the evaluation of functional exercise capacity.|Meters|Mean|382.1|382.1|Standard Deviation|123.51|123.51|||
4064279|NCT01065454|3886311|B3|||6-minute walking distance|6MWD is a measure for the evaluation of functional exercise capacity.|Meters|Mean|416.6|416.6|Standard Deviation|95.77|95.77|||
4064280|NCT01065454|3886312|B2|||6-minute walking distance|6MWD is a measure for the evaluation of functional exercise capacity.|Meters|Mean|401.9|401.9|Standard Deviation|101.75|101.75|||
4064281|NCT01065454|3886313|B1|||6-minute walking distance|6MWD is a measure for the evaluation of functional exercise capacity.|Meters|Mean|380.9|380.9|Standard Deviation|125.80|125.8|||
4064282|NCT01065454|3886309|B5|||Body mass index||kg/m^2|Mean|28.73|28.73|Standard Deviation|5.44|5.44|||
4064283|NCT01065454|3886310|B4|||Body mass index||kg/m^2|Mean|28.65|28.65|Standard Deviation|5.89|5.89|||
4064284|NCT01065454|3886311|B3|||Body mass index||kg/m^2|Mean|29.20|29.2|Standard Deviation|5.64|5.64|||
4064285|NCT01065454|3886312|B2|||Body mass index||kg/m^2|Mean|28.16|28.16|Standard Deviation|4.72|4.72|||
4064286|NCT01065454|3886313|B1|||Body mass index||kg/m^2|Mean|28.87|28.87|Standard Deviation|5.27|5.27|||
4064287|NCT01065454|3886309|B5||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4064288|NCT01065454|3886310|B4||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4064289|NCT01065454|3886311|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4064290|NCT01065454|3886312|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4064291|NCT01065454|3886313|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4064292|NCT01065454|3886309|B5||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4064293|NCT01065454|3886310|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4064294|NCT01065454|3886311|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4064295|NCT01065454|3886312|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4064296|NCT01065454|3886313|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4064297|NCT01065454|3886309|B5|||Age||Years|Mean|58.1|58.1|Standard Deviation|11.2|11.2|||
4064305|NCT01065428|3886426|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4064306|NCT01065428|3886427|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4064307|NCT01065428|3886428|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4064308|NCT01065428|3886426|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4064309|NCT01065428|3886427|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4064310|NCT01065428|3886428|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4064311|NCT01065428|3886426|B3|||Age||years|Mean|68.8|68.8|Standard Deviation|16.4|16.4|||
4064312|NCT01065428|3886427|B2|||Age||years|Mean|65.2|65.2|Standard Deviation|18.5|18.5|||
4064313|NCT01065428|3886428|B1|||Age||years|Mean|76.0|76.0|Standard Deviation|6.4|6.4|||
4064314|NCT01065428|3886426|B3||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4064315|NCT01065428|3886427|B2||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4064316|NCT01065428|3886428|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4064317|NCT01065428|3886426|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4064318|NCT01065428|3886427|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4064319|NCT01065428|3886428|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4064320|NCT01065428|3886426|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4064321|NCT01065428|3886427|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4064322|NCT01065428|3886428|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4064323|NCT01065350|3886437|B3|ASA Status 2||American Society of Anesthesiology (ASA) Physical Status|"ASA Physical Status 1 - A normal healthy patient~ASA Physical Status 2 - A patient with mild systemic disease"|Participants|Number|49|49.0||||||
4064324|NCT01065350|3886438|B2|ASA Status 2||American Society of Anesthesiology (ASA) Physical Status|"ASA Physical Status 1 - A normal healthy patient~ASA Physical Status 2 - A patient with mild systemic disease"|Participants|Number|27|27.0||||||
4064325|NCT01065350|3886439|B1|ASA Status 2||American Society of Anesthesiology (ASA) Physical Status|"ASA Physical Status 1 - A normal healthy patient~ASA Physical Status 2 - A patient with mild systemic disease"|Participants|Number|22|22.0||||||
4064326|NCT01065350|3886437|B3|ASA Status 1||American Society of Anesthesiology (ASA) Physical Status|"ASA Physical Status 1 - A normal healthy patient~ASA Physical Status 2 - A patient with mild systemic disease"|Participants|Number|35|35.0||||||
4064327|NCT01065350|3886438|B2|ASA Status 1||American Society of Anesthesiology (ASA) Physical Status|"ASA Physical Status 1 - A normal healthy patient~ASA Physical Status 2 - A patient with mild systemic disease"|Participants|Number|14|14.0||||||
4064328|NCT01065350|3886439|B1|ASA Status 1||American Society of Anesthesiology (ASA) Physical Status|"ASA Physical Status 1 - A normal healthy patient~ASA Physical Status 2 - A patient with mild systemic disease"|Participants|Number|21|21.0||||||
4064329|NCT01065350|3886437|B3|||Heart Rate|Mean pre-operative heart rate|beats per minute|Mean|73|73.0|Standard Deviation|15|15.0|||
4064330|NCT01065350|3886438|B2|||Heart Rate|Mean pre-operative heart rate|beats per minute|Mean|73|73.0|Standard Deviation|14|14.0|||
4064331|NCT01065350|3886439|B1|||Heart Rate|Mean pre-operative heart rate|beats per minute|Mean|72|72.0|Standard Deviation|16|16.0|||
4064332|NCT01065350|3886437|B3|||Diastolic Blood Pressure|Mean pre-operative diastolic blood pressure|millimeters of mercury (mm Hg)|Mean|76|76.0|Standard Deviation|11|11.0|||
4064333|NCT01065350|3886438|B2|||Diastolic Blood Pressure|Mean pre-operative diastolic blood pressure|millimeters of mercury (mm Hg)|Mean|76|76.0|Standard Deviation|10|10.0|||
4064334|NCT01065350|3886439|B1|||Diastolic Blood Pressure|Mean pre-operative diastolic blood pressure|millimeters of mercury (mm Hg)|Mean|76|76.0|Standard Deviation|12|12.0|||
4064335|NCT01065350|3886437|B3|||Systolic Blood Pressure|Mean pre-operative systolic blood pressure|millimeters of mercury (mm Hg)|Mean|124.19|124.19|Standard Deviation|16.41|16.41|||
4064336|NCT01065350|3886438|B2|||Systolic Blood Pressure|Mean pre-operative systolic blood pressure|millimeters of mercury (mm Hg)|Mean|122|122.0|Standard Deviation|15|15.0|||
4064337|NCT01065350|3886439|B1|||Systolic Blood Pressure|Mean pre-operative systolic blood pressure|millimeters of mercury (mm Hg)|Mean|125|125.0|Standard Deviation|17|17.0|||
4064338|NCT01065350|3886437|B3|||Body Height||centimeters|Mean|169.40|169.4|Standard Deviation|9.03|9.03|||
4064339|NCT01065350|3886438|B2|||Body Height||centimeters|Mean|168.9|168.9|Standard Deviation|9.2|9.2|||
4064340|NCT01065350|3886439|B1|||Body Height||centimeters|Mean|169.9|169.9|Standard Deviation|9.1|9.1|||
4064341|NCT01065350|3886437|B3|||Body Weight||kilograms|Mean|68.97|68.97|Standard Deviation|11.41|11.41|||
4064342|NCT01065350|3886438|B2|||Body Weight||kilograms|Mean|68.9|68.9|Standard Deviation|11.2|11.2|||
4064343|NCT01065350|3886439|B1|||Body Weight||kilograms|Mean|69.2|69.2|Standard Deviation|11.7|11.7|||
4064344|NCT01065350|3886437|B3|United States||Region of Enrollment||participants|Number|84|84.0||||||
4064345|NCT01065350|3886438|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
4064346|NCT01065350|3886439|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4064347|NCT01065350|3886437|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4064348|NCT01065350|3886438|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4064349|NCT01065350|3886439|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4064350|NCT01065350|3886437|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4064351|NCT01065350|3886438|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4064352|NCT01065350|3886439|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4064353|NCT01065350|3886437|B3|||Age||years|Mean|42.68|42.68|Standard Deviation|11.51|11.51|||
4064354|NCT01065350|3886438|B2|||Age||years|Mean|42|42.0|Standard Deviation|12|12.0|||
4064355|NCT01065350|3886439|B1|||Age||years|Mean|43|43.0|Standard Deviation|11|11.0|||
4064356|NCT01065051|3886472|B3|Male||Gender||Participants|Number|1|1.0||||||
4064357|NCT01065051|3886474|B1|Male||Gender||Participants|Number|1|1.0||||||
4064358|NCT01065051|3886472|B3|Female||Gender||Participants|Number|0|0.0||||||
4064359|NCT01065051|3886474|B1|Female||Gender||Participants|Number|0|0.0||||||
4064360|NCT01065051|3886472|B3|>=65 years||Age, Customized||Participants|Number|1|1.0||||||
4064361|NCT01065051|3886474|B1|>=65 years||Age, Customized||Participants|Number|1|1.0||||||
4064362|NCT01065051|3886472|B3|<65 years||Age, Customized||Participants|Number|0|0.0||||||
4064363|NCT01065051|3886474|B1|<65 years||Age, Customized||Participants|Number|0|0.0||||||
4064364|NCT01064947|3886501|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4064365|NCT01064947|3886501|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4064366|NCT01064947|3886501|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4064367|NCT01064947|3886501|B1|||Age||years|Mean|36.6|36.6|Full Range|||2.1|76.9|
4064368|NCT01064882|3886509|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4064369|NCT01064882|3886510|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4064370|NCT01064882|3886511|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4064371|NCT01064882|3886512|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4064372|NCT01064882|3886509|B4||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4064373|NCT01064882|3886510|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4064374|NCT01064882|3886511|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4064375|NCT01064882|3886512|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4064376|NCT01064882|3886509|B4|||Age||years|Mean|46.3|46.3|Full Range|||31.0|55.0|
4064377|NCT01064882|3886510|B3|||Age||years|Mean|46.7|46.7|Full Range|||31.0|55.0|
4064378|NCT01064882|3886511|B2|||Age||years|Mean|45.4|45.4|Full Range|||33.0|55.0|
4064379|NCT01064882|3886512|B1|||Age||years|Mean|46.9|46.9|Full Range|||32.0|55.0|
4064380|NCT01064856|3886540|B3|||Short Form-36 Health Status Survey™ Version 2 (SF-36™V2) Physical Component Score (PCS)|The SF-36™V2 is a 36-item generic health-related quality of life measure to assess the participant's view of their health consisting of 2 components: physical and mental. Scores range from 0 to 100. Higher scores indicate a better health state.|units on a scale|Mean|34.52|34.52|Standard Deviation|7.76|7.76|||
4064381|NCT01064856|3886541|B2|||Short Form-36 Health Status Survey™ Version 2 (SF-36™V2) Physical Component Score (PCS)|The SF-36™V2 is a 36-item generic health-related quality of life measure to assess the participant's view of their health consisting of 2 components: physical and mental. Scores range from 0 to 100. Higher scores indicate a better health state.|units on a scale|Mean|34.48|34.48|Standard Deviation|7.62|7.62|||
4064382|NCT01064856|3886542|B1|||Short Form-36 Health Status Survey™ Version 2 (SF-36™V2) Physical Component Score (PCS)|The SF-36™V2 is a 36-item generic health-related quality of life measure to assess the participant's view of their health consisting of 2 components: physical and mental. Scores range from 0 to 100. Higher scores indicate a better health state.|units on a scale|Mean|34.56|34.56|Standard Deviation|7.93|7.93|||
4064383|NCT01064856|3886540|B3|||Dactylitis Count|Assessment of the presence or absence of dactylitis as well as grading of tenderness and swelling in all 20 of the participants' digits was performed. Tenderness at each site was quantified from absent to severe. Swelling was quantified from mild to severe. Total Dactylitis Assessment scores ranging from 0 (0 digits with dactylitis) to 20 (worst possible score; 20 digits with dactylitis). One participant in the Double-blind (DB) Adalimumab arm did not have a baseline dactylitis count.|units on a scale|Mean|0.50|0.5|Standard Deviation|1.11|1.11|||
4064384|NCT01064856|3886541|B2|||Dactylitis Count|Assessment of the presence or absence of dactylitis as well as grading of tenderness and swelling in all 20 of the participants' digits was performed. Tenderness at each site was quantified from absent to severe. Swelling was quantified from mild to severe. Total Dactylitis Assessment scores ranging from 0 (0 digits with dactylitis) to 20 (worst possible score; 20 digits with dactylitis). One participant in the Double-blind (DB) Adalimumab arm did not have a baseline dactylitis count.|units on a scale|Mean|0.65|0.65|Standard Deviation|1.25|1.25|||
4064385|NCT01064856|3886542|B1|||Dactylitis Count|Assessment of the presence or absence of dactylitis as well as grading of tenderness and swelling in all 20 of the participants' digits was performed. Tenderness at each site was quantified from absent to severe. Swelling was quantified from mild to severe. Total Dactylitis Assessment scores ranging from 0 (0 digits with dactylitis) to 20 (worst possible score; 20 digits with dactylitis). One participant in the Double-blind (DB) Adalimumab arm did not have a baseline dactylitis count.|units on a scale|Mean|0.35|0.35|Standard Deviation|0.94|0.94|||
4064386|NCT01064856|3886540|B3|||Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)|The BASDAI consisted of a VAS scale used to answer 6 questions pertaining to symptoms experienced by the participant for the past week. Each question on the BASDAI was reported in centimeters (0 [none] to 10 [very severe] with one question's possible answers being in time increments [0 hours to ≥ 2 hours]). The overall BASDAI score ranges from 0 to 10 cm. Lower scores indicate less disease activity.|units on a scale|Mean|5.62|5.62|Standard Deviation|1.66|1.66|||
4064387|NCT01064856|3886541|B2|||Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)|The BASDAI consisted of a VAS scale used to answer 6 questions pertaining to symptoms experienced by the participant for the past week. Each question on the BASDAI was reported in centimeters (0 [none] to 10 [very severe] with one question's possible answers being in time increments [0 hours to ≥ 2 hours]). The overall BASDAI score ranges from 0 to 10 cm. Lower scores indicate less disease activity.|units on a scale|Mean|5.57|5.57|Standard Deviation|1.58|1.58|||
4064388|NCT01064856|3886542|B1|||Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)|The BASDAI consisted of a VAS scale used to answer 6 questions pertaining to symptoms experienced by the participant for the past week. Each question on the BASDAI was reported in centimeters (0 [none] to 10 [very severe] with one question's possible answers being in time increments [0 hours to ≥ 2 hours]). The overall BASDAI score ranges from 0 to 10 cm. Lower scores indicate less disease activity.|units on a scale|Mean|5.68|5.68|Standard Deviation|1.74|1.74|||
4064389|NCT01064856|3886540|B3|||Ankylosing Spondylitis Disease Activity Score (ASDAS)|The ASDAS is a continuous disease activity score: low score indicates lower disease activity and higher values indicate higher disease activity. The score ranges from 0 to no defined upper limit. It is categorized into 4 disease activity states based on score: inactive disease (< 1.3), moderate (≥ 1.3 to < 2.1), high (≥ 2.1 to ≤ 3.5), and very high (> 3.5). One participant in the Placebo arm did not have a baseline ASDAS assessment.|units on a scale|Mean|2.99|2.99|Standard Deviation|0.82|0.82|||
4064390|NCT01064856|3886541|B2|||Ankylosing Spondylitis Disease Activity Score (ASDAS)|The ASDAS is a continuous disease activity score: low score indicates lower disease activity and higher values indicate higher disease activity. The score ranges from 0 to no defined upper limit. It is categorized into 4 disease activity states based on score: inactive disease (< 1.3), moderate (≥ 1.3 to < 2.1), high (≥ 2.1 to ≤ 3.5), and very high (> 3.5). One participant in the Placebo arm did not have a baseline ASDAS assessment.|units on a scale|Mean|3.06|3.06|Standard Deviation|0.80|0.8|||
4064391|NCT01064856|3886542|B1|||Ankylosing Spondylitis Disease Activity Score (ASDAS)|The ASDAS is a continuous disease activity score: low score indicates lower disease activity and higher values indicate higher disease activity. The score ranges from 0 to no defined upper limit. It is categorized into 4 disease activity states based on score: inactive disease (< 1.3), moderate (≥ 1.3 to < 2.1), high (≥ 2.1 to ≤ 3.5), and very high (> 3.5). One participant in the Placebo arm did not have a baseline ASDAS assessment.|units on a scale|Mean|2.92|2.92|Standard Deviation|0.84|0.84|||
4064392|NCT01064856|3886540|B3|||Physician Global Assessment (PGA) of Disease Activity|PGA of Disease Activity as measured by a 100 mm VAS where 0=no symptoms and 100=maximum symptoms.|units on a scale|Mean|58.68|58.68|Standard Deviation|15.31|15.31|||
4064393|NCT01064856|3886541|B2|||Physician Global Assessment (PGA) of Disease Activity|PGA of Disease Activity as measured by a 100 mm VAS where 0=no symptoms and 100=maximum symptoms.|units on a scale|Mean|57.02|57.02|Standard Deviation|14.98|14.98|||
4064394|NCT01064856|3886542|B1|||Physician Global Assessment (PGA) of Disease Activity|PGA of Disease Activity as measured by a 100 mm VAS where 0=no symptoms and 100=maximum symptoms.|units on a scale|Mean|60.29|60.29|Standard Deviation|15.53|15.53|||
4064395|NCT01064856|3886540|B3|||PTGA – Pain|PTGA – Pain as measured by a 100 mm VAS where 0=no pain and 100=maximum pain.|units on a scale|Mean|64.94|64.94|Standard Deviation|14.94|14.94|||
4064396|NCT01064856|3886541|B2|||PTGA – Pain|PTGA – Pain as measured by a 100 mm VAS where 0=no pain and 100=maximum pain.|units on a scale|Mean|65.60|65.6|Standard Deviation|15.89|15.89|||
4064397|NCT01064856|3886542|B1|||PTGA – Pain|PTGA – Pain as measured by a 100 mm VAS where 0=no pain and 100=maximum pain.|units on a scale|Mean|64.30|64.3|Standard Deviation|14.03|14.03|||
4064398|NCT01064856|3886540|B3|||Patient Global Assessment (PTGA) of Disease Activity|PTGA of Disease Activity as measured by a 100 mm visual analogue scale (VAS) where 0=no symptoms and 100=maximum symptoms.|mm|Mean|65.82|65.82|Standard Deviation|15.50|15.5|||
4064399|NCT01064856|3886541|B2|||Patient Global Assessment (PTGA) of Disease Activity|PTGA of Disease Activity as measured by a 100 mm visual analogue scale (VAS) where 0=no symptoms and 100=maximum symptoms.|mm|Mean|66.43|66.43|Standard Deviation|15.86|15.86|||
4064400|NCT01064856|3886542|B1|||Patient Global Assessment (PTGA) of Disease Activity|PTGA of Disease Activity as measured by a 100 mm visual analogue scale (VAS) where 0=no symptoms and 100=maximum symptoms.|mm|Mean|65.24|65.24|Standard Deviation|15.22|15.22|||
4064401|NCT01064856|3886540|B3|||Total Enthesitis Count|Total enthesitis count in the sum of all unique, individual enthesis location included in the Leeds, SPARCC and MASES entheses indices. Scores range from 0 (0 sites with enthesitis) to 29 (29 sites with enthesitis).|units on a scale|Mean|7.02|7.02|Standard Deviation|6.81|6.81|||
4064402|NCT01064856|3886541|B2|||Total Enthesitis Count|Total enthesitis count in the sum of all unique, individual enthesis location included in the Leeds, SPARCC and MASES entheses indices. Scores range from 0 (0 sites with enthesitis) to 29 (29 sites with enthesitis).|units on a scale|Mean|7.33|7.33|Standard Deviation|6.69|6.69|||
4064403|NCT01064856|3886542|B1|||Total Enthesitis Count|Total enthesitis count in the sum of all unique, individual enthesis location included in the Leeds, SPARCC and MASES entheses indices. Scores range from 0 (0 sites with enthesitis) to 29 (29 sites with enthesitis).|units on a scale|Mean|6.73|6.73|Standard Deviation|6.95|6.95|||
4064404|NCT01064856|3886540|B3|||Spondyloarthritis Research Consortium of Canada (SPARCC) Enthesitis Score|Assessment of enthesitis was performed in 16 domains. Each domain was graded for the presence (1) and absence (0) of tenderness yielding total SPARCC scores ranging from 0 (0 sites with tenderness) to 16 (worst possible score; 16 sites with tenderness).|units on a scale|Mean|3.94|3.94|Standard Deviation|3.90|3.9|||
4064405|NCT01064856|3886541|B2|||Spondyloarthritis Research Consortium of Canada (SPARCC) Enthesitis Score|Assessment of enthesitis was performed in 16 domains. Each domain was graded for the presence (1) and absence (0) of tenderness yielding total SPARCC scores ranging from 0 (0 sites with tenderness) to 16 (worst possible score; 16 sites with tenderness).|units on a scale|Mean|4.05|4.05|Standard Deviation|3.78|3.78|||
4064406|NCT01064856|3886542|B1|||Spondyloarthritis Research Consortium of Canada (SPARCC) Enthesitis Score|Assessment of enthesitis was performed in 16 domains. Each domain was graded for the presence (1) and absence (0) of tenderness yielding total SPARCC scores ranging from 0 (0 sites with tenderness) to 16 (worst possible score; 16 sites with tenderness).|units on a scale|Mean|3.83|3.83|Standard Deviation|4.03|4.03|||
4064407|NCT01064856|3886540|B3|||Leeds Enthesitis Index|Assessment of enthesitis was performed in 6 domains. Each domain was graded for the presence (1) and absence (0) of tenderness yielding total Leeds Enthesitis Index scores ranging from 0 (0 sites with tenderness) to 6 (worst possible score; 6 sites with tenderness).|units on a scale|Mean|1.45|1.45|Standard Deviation|1.63|1.63|||
4064408|NCT01064856|3886541|B2|||Leeds Enthesitis Index|Assessment of enthesitis was performed in 6 domains. Each domain was graded for the presence (1) and absence (0) of tenderness yielding total Leeds Enthesitis Index scores ranging from 0 (0 sites with tenderness) to 6 (worst possible score; 6 sites with tenderness).|units on a scale|Mean|1.42|1.42|Standard Deviation|1.61|1.61|||
4064409|NCT01064856|3886542|B1|||Leeds Enthesitis Index|Assessment of enthesitis was performed in 6 domains. Each domain was graded for the presence (1) and absence (0) of tenderness yielding total Leeds Enthesitis Index scores ranging from 0 (0 sites with tenderness) to 6 (worst possible score; 6 sites with tenderness).|units on a scale|Mean|1.49|1.49|Standard Deviation|1.66|1.66|||
4064410|NCT01064856|3886540|B3|||Maastricht Ankylosing Spondylitis Enthesitis Score (MASES)|Assessment of enthesitis was performed in 7 domains. Each domain was graded for the presence (1) and absence (0) of tenderness yielding total MASES ranging from 0 (0 sites with tenderness) to 13 (worst possible score; 13 sites with tenderness).|units on a scale|Mean|3.36|3.36|Standard Deviation|3.50|3.5|||
4064411|NCT01064856|3886541|B2|||Maastricht Ankylosing Spondylitis Enthesitis Score (MASES)|Assessment of enthesitis was performed in 7 domains. Each domain was graded for the presence (1) and absence (0) of tenderness yielding total MASES ranging from 0 (0 sites with tenderness) to 13 (worst possible score; 13 sites with tenderness).|units on a scale|Mean|3.59|3.59|Standard Deviation|3.39|3.39|||
4064412|NCT01064856|3886542|B1|||Maastricht Ankylosing Spondylitis Enthesitis Score (MASES)|Assessment of enthesitis was performed in 7 domains. Each domain was graded for the presence (1) and absence (0) of tenderness yielding total MASES ranging from 0 (0 sites with tenderness) to 13 (worst possible score; 13 sites with tenderness).|units on a scale|Mean|3.13|3.13|Standard Deviation|3.60|3.6|||
4064413|NCT01064856|3886540|B3|||Swollen Joint Count (76 Joints)|Seventy-six joints were assessed for swelling by physical examination. Swelling of each joint was classified as present (1) or absent (0), for a total possible score of 0 (0 joints with swelling) to 76 (worst possible score/ 76 joints with swelling).|units on a scale|Mean|6.70|6.7|Standard Deviation|6.87|6.87|||
4064414|NCT01064856|3886541|B2|||Swollen Joint Count (76 Joints)|Seventy-six joints were assessed for swelling by physical examination. Swelling of each joint was classified as present (1) or absent (0), for a total possible score of 0 (0 joints with swelling) to 76 (worst possible score/ 76 joints with swelling).|units on a scale|Mean|7.31|7.31|Standard Deviation|7.99|7.99|||
4064415|NCT01064856|3886542|B1|||Swollen Joint Count (76 Joints)|Seventy-six joints were assessed for swelling by physical examination. Swelling of each joint was classified as present (1) or absent (0), for a total possible score of 0 (0 joints with swelling) to 76 (worst possible score/ 76 joints with swelling).|units on a scale|Mean|6.12|6.12|Standard Deviation|5.58|5.58|||
4064416|NCT01064856|3886540|B3|||Tender Joint Count (78 Joints)|Seventy-eight joints were assessed for tenderness by physical examination. Tenderness of each joint was classified as present (1) or absent (0), for a total possible score of 0 (0 joints with tenderness) to 78 (worst possible score/ 78 joints with tenderness).|units on a scale|Mean|13.28|13.28|Standard Deviation|14.46|14.46|||
4064417|NCT01064856|3886541|B2|||Tender Joint Count (78 Joints)|Seventy-eight joints were assessed for tenderness by physical examination. Tenderness of each joint was classified as present (1) or absent (0), for a total possible score of 0 (0 joints with tenderness) to 78 (worst possible score/ 78 joints with tenderness).|units on a scale|Mean|13.62|13.62|Standard Deviation|16.10|16.1|||
4064418|NCT01064856|3886542|B1|||Tender Joint Count (78 Joints)|Seventy-eight joints were assessed for tenderness by physical examination. Tenderness of each joint was classified as present (1) or absent (0), for a total possible score of 0 (0 joints with tenderness) to 78 (worst possible score/ 78 joints with tenderness).|units on a scale|Mean|12.95|12.95|Standard Deviation|12.79|12.79|||
4064419|NCT01064856|3886540|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4064420|NCT01064856|3886541|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4064421|NCT01064856|3886542|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4064422|NCT01064856|3886540|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4064423|NCT01064856|3886541|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4064424|NCT01064856|3886542|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4064425|NCT01064856|3886540|B3|||Age||years|Mean|40.6|40.6|Standard Deviation|11.94|11.94|||
4064426|NCT01064856|3886541|B2|||Age||years|Mean|38.5|38.5|Standard Deviation|12.77|12.77|||
4064427|NCT01064856|3886542|B1|||Age||years|Mean|42.5|42.5|Standard Deviation|10.79|10.79|||
4064428|NCT01064830|3886576|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4064429|NCT01064830|3886577|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4064430|NCT01064830|3886578|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4064431|NCT01064830|3886576|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4064432|NCT01064830|3886577|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4064433|NCT01064830|3886578|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4064434|NCT01064830|3886576|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4064435|NCT01064830|3886577|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4064436|NCT01064830|3886578|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4064437|NCT01064830|3886576|B3|||Age||years|Mean|51.6|51.6|Standard Deviation|14.3|14.3|||
4064438|NCT01064830|3886577|B2|||Age||years|Mean|54.8|54.8|Standard Deviation|10.02|10.02|||
4064439|NCT01064830|3886578|B1|||Age||years|Mean|48.0|48.0|Standard Deviation|17.76|17.76|||
4064440|NCT01064830|3886576|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4064441|NCT01064830|3886577|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4064442|NCT01064830|3886578|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4064443|NCT01064830|3886576|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4064444|NCT01064830|3886577|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4064445|NCT01064830|3886578|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4064446|NCT01064830|3886576|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4064447|NCT01064830|3886577|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4064448|NCT01064830|3886578|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4064449|NCT01064817|3886587|B3|United Kingdom||Region of Enrollment||participants|Number|30|30.0||||||
4064450|NCT01064817|3886588|B2|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
4064451|NCT01064817|3886589|B1|United Kingdom||Region of Enrollment||participants|Number|19|19.0||||||
4064452|NCT01064817|3886587|B3|Netherlands||Region of Enrollment||participants|Number|7|7.0||||||
4064453|NCT01064817|3886588|B2|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
4064454|NCT01064817|3886589|B1|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
4064455|NCT01064817|3886587|B3|Belgium||Region of Enrollment||participants|Number|14|14.0||||||
4064456|NCT01064817|3886588|B2|Belgium||Region of Enrollment||participants|Number|9|9.0||||||
4064457|NCT01064817|3886589|B1|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
4064458|NCT01064817|3886587|B3|Czech Republic||Region of Enrollment||participants|Number|73|73.0||||||
4064459|NCT01064817|3886588|B2|Czech Republic||Region of Enrollment||participants|Number|39|39.0||||||
4064460|NCT01064817|3886589|B1|Czech Republic||Region of Enrollment||participants|Number|34|34.0||||||
4064461|NCT01064817|3886587|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064462|NCT01064817|3886588|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064463|NCT01064817|3886589|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064464|NCT01064817|3886587|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
4064465|NCT01064817|3886588|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4064466|NCT01064817|3886589|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4064467|NCT01064817|3886587|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4064468|NCT01064817|3886588|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4064469|NCT01064817|3886589|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4064470|NCT01064817|3886587|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064471|NCT01064817|3886588|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064472|NCT01064817|3886589|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064473|NCT01064817|3886587|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064474|NCT01064817|3886588|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064475|NCT01064817|3886589|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064476|NCT01064817|3886587|B3||White|Race (NIH/OMB)||Participants|Count of Participants|117|117.0||||||
4064477|NCT01064817|3886588|B2||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4064478|NCT01064817|3886589|B1||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4064479|NCT01064817|3886587|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4064480|NCT01064817|3886588|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4064481|NCT01064817|3886589|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4064482|NCT01064817|3886587|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064483|NCT01064817|3886588|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064484|NCT01064817|3886589|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064485|NCT01064817|3886587|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064486|NCT01064817|3886588|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064487|NCT01064817|3886589|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064488|NCT01064817|3886587|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064489|NCT01064817|3886588|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064490|NCT01064817|3886589|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064491|NCT01064817|3886587|B3||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4064492|NCT01064817|3886588|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4064493|NCT01064817|3886589|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4064494|NCT01064817|3886587|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4064495|NCT01064817|3886588|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4064496|NCT01064817|3886589|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4064497|NCT01064817|3886587|B3|||Age||years|Median|66|66.0|Full Range|||35.0|87.0|
4064498|NCT01064817|3886588|B2|||Age||years|Median|68|68.0|Full Range|||39.0|87.0|
4064499|NCT01064817|3886589|B1|||Age||years|Median|65|65.0|Full Range|||35.0|83.0|
4064500|NCT01064739|3886602|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4064501|NCT01064739|3886602|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4064502|NCT01064739|3886602|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4064503|NCT01064739|3886602|B1|||Age||years|Mean|35.2|35.2|Standard Deviation|12.9|12.9|||
4064504|NCT01064739|3886602|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4064505|NCT01064739|3886602|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4064506|NCT01064739|3886602|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4064507|NCT01064713|3886658|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4064508|NCT01064713|3886659|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4064509|NCT01064713|3886660|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4064510|NCT01064713|3886658|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4064511|NCT01064713|3886659|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4064512|NCT01064713|3886660|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4064513|NCT01064713|3886658|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4064514|NCT01064713|3886659|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4064515|NCT01064713|3886660|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4064516|NCT01064713|3886658|B3|||Age||years|Median|68|68.0|Full Range|||48.0|88.0|
4064517|NCT01064713|3886659|B2|||Age||years|Median|64|64.0|Full Range|||53.0|87.0|
4064518|NCT01064713|3886660|B1|||Age||years|Median|68|68.0|Full Range|||48.0|88.0|
4064519|NCT01064687|3886669|B5|||Fasting Serum Glucose||millimoles per liter (mmol/L)|Mean|9.02|9.02|Standard Deviation|2.97|2.97|||
4064520|NCT01064687|3886670|B4|||Fasting Serum Glucose||millimoles per liter (mmol/L)|Mean|9.22|9.22|Standard Deviation|3.01|3.01|||
4064521|NCT01064687|3886671|B3|||Fasting Serum Glucose||millimoles per liter (mmol/L)|Mean|9.11|9.11|Standard Deviation|3.04|3.04|||
4064522|NCT01064687|3886672|B2|||Fasting Serum Glucose||millimoles per liter (mmol/L)|Mean|8.84|8.84|Standard Deviation|2.76|2.76|||
4064523|NCT01064687|3886673|B1|||Fasting Serum Glucose||millimoles per liter (mmol/L)|Mean|9.00|9.0|Standard Deviation|3.09|3.09|||
4064524|NCT01064687|3886669|B5|||Duration of Diabetes||years|Mean|8.76|8.76|Standard Deviation|5.61|5.61|||
4064525|NCT01064687|3886670|B4|||Duration of Diabetes||years|Mean|8.60|8.6|Standard Deviation|5.78|5.78|||
4064526|NCT01064687|3886671|B3|||Duration of Diabetes||years|Mean|8.84|8.84|Standard Deviation|5.71|5.71|||
4064527|NCT01064687|3886672|B2|||Duration of Diabetes||years|Mean|8.78|8.78|Standard Deviation|5.47|5.47|||
4064528|NCT01064687|3886673|B1|||Duration of Diabetes||years|Mean|8.76|8.76|Standard Deviation|5.59|5.59|||
4064529|NCT01064687|3886669|B5|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|8.07|8.07|Standard Deviation|1.31|1.31|||
4064530|NCT01064687|3886670|B4|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|8.06|8.06|Standard Deviation|1.31|1.31|||
4064531|NCT01064687|3886671|B3|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|8.07|8.07|Standard Deviation|1.34|1.34|||
4064532|NCT01064687|3886672|B2|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|8.05|8.05|Standard Deviation|1.24|1.24|||
4064533|NCT01064687|3886673|B1|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|8.10|8.1|Standard Deviation|1.34|1.34|||
4064534|NCT01064687|3886669|B5|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per meter squared (kg/m^2)|Mean|33.16|33.16|Standard Deviation|5.43|5.43|||
4064535|NCT01064687|3886670|B4|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per meter squared (kg/m^2)|Mean|32.90|32.9|Standard Deviation|5.66|5.66|||
4064536|NCT01064687|3886671|B3|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per meter squared (kg/m^2)|Mean|33.54|33.54|Standard Deviation|5.36|5.36|||
4064537|NCT01064687|3886672|B2|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per meter squared (kg/m^2)|Mean|33.00|33.0|Standard Deviation|5.50|5.5|||
4064538|NCT01064687|3886673|B1|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per meter squared (kg/m^2)|Mean|33.09|33.09|Standard Deviation|5.33|5.33|||
4064539|NCT01064687|3886669|B5|||Body Weight||kilograms|Mean|96.04|96.04|Standard Deviation|19.64|19.64|||
4064540|NCT01064687|3886670|B4|||Body Weight||kilograms|Mean|94.12|94.12|Standard Deviation|19.28|19.28|||
4064541|NCT01064687|3886671|B3|||Body Weight||kilograms|Mean|97.37|97.37|Standard Deviation|18.87|18.87|||
4064542|NCT01064687|3886672|B2|||Body Weight||kilograms|Mean|95.53|95.53|Standard Deviation|20.56|20.56|||
4064543|NCT01064687|3886673|B1|||Body Weight||kilograms|Mean|96.22|96.22|Standard Deviation|19.63|19.63|||
4064544|NCT01064687|3886669|B5|Argentina||Region of Enrollment||participants|Number|61|61.0||||||
4064545|NCT01064687|3886670|B4|Argentina||Region of Enrollment||participants|Number|9|9.0||||||
4064546|NCT01064687|3886671|B3|Argentina||Region of Enrollment||participants|Number|18|18.0||||||
4064547|NCT01064687|3886672|B2|Argentina||Region of Enrollment||participants|Number|18|18.0||||||
4064548|NCT01064687|3886673|B1|Argentina||Region of Enrollment||participants|Number|16|16.0||||||
4064549|NCT01064687|3886669|B5|Mexico||Region of Enrollment||participants|Number|127|127.0||||||
4064550|NCT01064687|3886670|B4|Mexico||Region of Enrollment||participants|Number|19|19.0||||||
4064551|NCT01064687|3886671|B3|Mexico||Region of Enrollment||participants|Number|35|35.0||||||
4064552|NCT01064687|3886672|B2|Mexico||Region of Enrollment||participants|Number|36|36.0||||||
4064553|NCT01064687|3886673|B1|Mexico||Region of Enrollment||participants|Number|37|37.0||||||
4064554|NCT01064687|3886669|B5|United States||Region of Enrollment||participants|Number|788|788.0||||||
4064555|NCT01064687|3886670|B4|United States||Region of Enrollment||participants|Number|113|113.0||||||
4064556|NCT01064687|3886671|B3|United States||Region of Enrollment||participants|Number|223|223.0||||||
4064557|NCT01064687|3886672|B2|United States||Region of Enrollment||participants|Number|226|226.0||||||
4064558|NCT01064687|3886673|B1|United States||Region of Enrollment||participants|Number|226|226.0||||||
4064559|NCT01064687|3886669|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4064560|NCT01064687|3886670|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064561|NCT01064687|3886671|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4064562|NCT01064687|3886672|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064563|NCT01064687|3886673|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064564|NCT01064687|3886669|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4064565|NCT01064687|3886670|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4064566|NCT01064687|3886671|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4064567|NCT01064687|3886672|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4064568|NCT01064687|3886673|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4064569|NCT01064687|3886669|B5||White|Race (NIH/OMB)||Participants|Count of Participants|726|726.0||||||
4064570|NCT01064687|3886670|B4||White|Race (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
4064571|NCT01064687|3886671|B3||White|Race (NIH/OMB)||Participants|Count of Participants|211|211.0||||||
4064572|NCT01064687|3886672|B2||White|Race (NIH/OMB)||Participants|Count of Participants|207|207.0||||||
4064573|NCT01064687|3886673|B1||White|Race (NIH/OMB)||Participants|Count of Participants|205|205.0||||||
4064574|NCT01064687|3886669|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
4064575|NCT01064687|3886670|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4064576|NCT01064687|3886671|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4064577|NCT01064687|3886672|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4064578|NCT01064687|3886673|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4064579|NCT01064687|3886669|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4064580|NCT01064687|3886670|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064581|NCT01064687|3886671|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4064582|NCT01064687|3886672|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4064583|NCT01064687|3886673|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4064584|NCT01064687|3886669|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4064585|NCT01064687|3886670|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4064586|NCT01064687|3886671|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4064587|NCT01064687|3886672|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4064588|NCT01064687|3886673|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4064589|NCT01064687|3886669|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|135|135.0||||||
4064590|NCT01064687|3886670|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4064591|NCT01064687|3886671|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4064592|NCT01064687|3886672|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4064593|NCT01064687|3886673|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4064594|NCT01064687|3886669|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4064595|NCT01064687|3886670|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064596|NCT01064687|3886671|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4064597|NCT01064687|3886672|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064598|NCT01064687|3886673|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064599|NCT01064687|3886669|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|644|644.0||||||
4064600|NCT01064687|3886670|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4064601|NCT01064687|3886671|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|184|184.0||||||
4064602|NCT01064687|3886672|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|178|178.0||||||
4064603|NCT01064687|3886673|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|186|186.0||||||
4064604|NCT01064687|3886669|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|331|331.0||||||
4064605|NCT01064687|3886670|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4064606|NCT01064687|3886671|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
4064607|NCT01064687|3886672|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
4064608|NCT01064687|3886673|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
4064609|NCT01064687|3886669|B5||Male|Sex: Female, Male||Participants|Count of Participants|570|570.0||||||
4064610|NCT01064687|3886670|B4||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4064611|NCT01064687|3886671|B3||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4064612|NCT01064687|3886672|B2||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4064613|NCT01064687|3886673|B1||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4064614|NCT01064687|3886669|B5||Female|Sex: Female, Male||Participants|Count of Participants|406|406.0||||||
4064615|NCT01064687|3886670|B4||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4064616|NCT01064687|3886671|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4064617|NCT01064687|3886672|B2||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4064618|NCT01064687|3886673|B1||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4064619|NCT01064687|3886669|B5|||Age||years|Mean|55.65|55.65|Standard Deviation|9.81|9.81|||
4064620|NCT01064687|3886670|B4|||Age||years|Mean|54.56|54.56|Standard Deviation|10.01|10.01|||
4064621|NCT01064687|3886671|B3|||Age||years|Mean|55.45|55.45|Standard Deviation|10.15|10.15|||
4064622|NCT01064687|3886672|B2|||Age||years|Mean|55.79|55.79|Standard Deviation|9.45|9.45|||
4064623|NCT01064687|3886673|B1|||Age||years|Mean|56.25|56.25|Standard Deviation|9.72|9.72|||
4064624|NCT01064622|3886853|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4064625|NCT01064622|3886854|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064626|NCT01064622|3886855|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4064627|NCT01064622|3886856|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4064628|NCT01064622|3886853|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064629|NCT01064622|3886854|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064630|NCT01064622|3886855|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064631|NCT01064622|3886856|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064632|NCT01064622|3886853|B4||White|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
4064633|NCT01064622|3886854|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4064634|NCT01064622|3886855|B2||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4064635|NCT01064622|3886856|B1||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4064636|NCT01064622|3886853|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4064637|NCT01064622|3886854|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064638|NCT01064622|3886855|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4064639|NCT01064622|3886856|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4064640|NCT01064622|3886853|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064641|NCT01064622|3886854|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064642|NCT01064622|3886855|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064643|NCT01064622|3886856|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064644|NCT01064622|3886853|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4064645|NCT01064622|3886854|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064646|NCT01064622|3886855|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4064647|NCT01064622|3886856|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064648|NCT01064622|3886853|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4064649|NCT01064622|3886854|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064650|NCT01064622|3886855|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4064651|NCT01064622|3886856|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064652|NCT01064622|3886853|B4||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4064653|NCT01064622|3886854|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4064654|NCT01064622|3886855|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4064655|NCT01064622|3886856|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4064656|NCT01064622|3886853|B4||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4064657|NCT01064622|3886854|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4064658|NCT01064622|3886855|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4064659|NCT01064622|3886856|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4064660|NCT01064622|3886853|B4|||Age|One age value missing from Arm I.|years|Mean|64.1|64.1|Full Range|||39.0|84.0|
4064661|NCT01064622|3886854|B3|||Age|One age value missing from Arm I.|years|Mean|56.7|56.7|Full Range|||43.0|72.0|
4064662|NCT01064622|3886855|B2|||Age|One age value missing from Arm I.|years|Mean|64.7|64.7|Full Range|||49.0|82.0|
4064663|NCT01064622|3886856|B1|||Age|One age value missing from Arm I.|years|Mean|64.5|64.5|Full Range|||39.0|84.0|
4064664|NCT01064414|3886878|B4|UNITED STATES||Region of Enrollment||participants|Number|47|47.0||||||
4064665|NCT01064414|3886879|B3|UNITED STATES||Region of Enrollment||participants|Number|17|17.0||||||
4064666|NCT01064414|3886880|B2|UNITED STATES||Region of Enrollment||participants|Number|14|14.0||||||
4064667|NCT01064414|3886881|B1|UNITED STATES||Region of Enrollment||participants|Number|16|16.0||||||
4064668|NCT01064414|3886878|B4|SPAIN||Region of Enrollment||participants|Number|17|17.0||||||
4064669|NCT01064414|3886879|B3|SPAIN||Region of Enrollment||participants|Number|8|8.0||||||
4064670|NCT01064414|3886880|B2|SPAIN||Region of Enrollment||participants|Number|5|5.0||||||
4064671|NCT01064414|3886881|B1|SPAIN||Region of Enrollment||participants|Number|4|4.0||||||
4064672|NCT01064414|3886878|B4|SOUTH KOREA||Region of Enrollment||participants|Number|2|2.0||||||
4064673|NCT01064414|3886879|B3|SOUTH KOREA||Region of Enrollment||participants|Number|0|0.0||||||
4064674|NCT01064414|3886880|B2|SOUTH KOREA||Region of Enrollment||participants|Number|1|1.0||||||
4064675|NCT01064414|3886881|B1|SOUTH KOREA||Region of Enrollment||participants|Number|1|1.0||||||
4064676|NCT01064414|3886878|B4|SOUTH AFRICA||Region of Enrollment||participants|Number|6|6.0||||||
4064677|NCT01064414|3886879|B3|SOUTH AFRICA||Region of Enrollment||participants|Number|1|1.0||||||
4064678|NCT01064414|3886880|B2|SOUTH AFRICA||Region of Enrollment||participants|Number|3|3.0||||||
4064679|NCT01064414|3886881|B1|SOUTH AFRICA||Region of Enrollment||participants|Number|2|2.0||||||
4064680|NCT01064414|3886878|B4|RUSSIAN FEDERATION||Region of Enrollment||participants|Number|30|30.0||||||
4064681|NCT01064414|3886879|B3|RUSSIAN FEDERATION||Region of Enrollment||participants|Number|9|9.0||||||
4064682|NCT01064414|3886880|B2|RUSSIAN FEDERATION||Region of Enrollment||participants|Number|11|11.0||||||
4064683|NCT01064414|3886881|B1|RUSSIAN FEDERATION||Region of Enrollment||participants|Number|10|10.0||||||
4064684|NCT01064414|3886878|B4|ROMANIA||Region of Enrollment||participants|Number|5|5.0||||||
4064685|NCT01064414|3886879|B3|ROMANIA||Region of Enrollment||participants|Number|2|2.0||||||
4064686|NCT01064414|3886880|B2|ROMANIA||Region of Enrollment||participants|Number|1|1.0||||||
4064687|NCT01064414|3886881|B1|ROMANIA||Region of Enrollment||participants|Number|2|2.0||||||
4064688|NCT01064414|3886878|B4|POLAND||Region of Enrollment||participants|Number|14|14.0||||||
4064689|NCT01064414|3886879|B3|POLAND||Region of Enrollment||participants|Number|4|4.0||||||
4064690|NCT01064414|3886880|B2|POLAND||Region of Enrollment||participants|Number|5|5.0||||||
4064691|NCT01064414|3886881|B1|POLAND||Region of Enrollment||participants|Number|5|5.0||||||
4064692|NCT01064414|3886878|B4|NEW ZEALAND||Region of Enrollment||participants|Number|14|14.0||||||
4064693|NCT01064414|3886879|B3|NEW ZEALAND||Region of Enrollment||participants|Number|5|5.0||||||
4064694|NCT01064414|3886880|B2|NEW ZEALAND||Region of Enrollment||participants|Number|2|2.0||||||
4064695|NCT01064414|3886881|B1|NEW ZEALAND||Region of Enrollment||participants|Number|7|7.0||||||
4064696|NCT01064414|3886878|B4|MEXICO||Region of Enrollment||participants|Number|4|4.0||||||
4064697|NCT01064414|3886879|B3|MEXICO||Region of Enrollment||participants|Number|2|2.0||||||
4064698|NCT01064414|3886880|B2|MEXICO||Region of Enrollment||participants|Number|2|2.0||||||
4064699|NCT01064414|3886881|B1|MEXICO||Region of Enrollment||participants|Number|0|0.0||||||
4064700|NCT01064414|3886878|B4|MALAYSIA||Region of Enrollment||participants|Number|14|14.0||||||
4064701|NCT01064414|3886879|B3|MALAYSIA||Region of Enrollment||participants|Number|8|8.0||||||
4064702|NCT01064414|3886880|B2|MALAYSIA||Region of Enrollment||participants|Number|4|4.0||||||
4064703|NCT01064414|3886881|B1|MALAYSIA||Region of Enrollment||participants|Number|2|2.0||||||
4064704|NCT01064414|3886878|B4|LATVIA||Region of Enrollment||participants|Number|7|7.0||||||
4064705|NCT01064414|3886879|B3|LATVIA||Region of Enrollment||participants|Number|4|4.0||||||
4064706|NCT01064414|3886880|B2|LATVIA||Region of Enrollment||participants|Number|1|1.0||||||
4064707|NCT01064414|3886881|B1|LATVIA||Region of Enrollment||participants|Number|2|2.0||||||
4064708|NCT01064414|3886878|B4|ITALY||Region of Enrollment||participants|Number|6|6.0||||||
4064709|NCT01064414|3886879|B3|ITALY||Region of Enrollment||participants|Number|1|1.0||||||
4064710|NCT01064414|3886880|B2|ITALY||Region of Enrollment||participants|Number|1|1.0||||||
4064711|NCT01064414|3886881|B1|ITALY||Region of Enrollment||participants|Number|4|4.0||||||
4064712|NCT01064414|3886878|B4|INDIA||Region of Enrollment||participants|Number|9|9.0||||||
4064713|NCT01064414|3886879|B3|INDIA||Region of Enrollment||participants|Number|3|3.0||||||
4064714|NCT01064414|3886880|B2|INDIA||Region of Enrollment||participants|Number|3|3.0||||||
4064715|NCT01064414|3886881|B1|INDIA||Region of Enrollment||participants|Number|3|3.0||||||
4064716|NCT01064414|3886878|B4|GERMANY||Region of Enrollment||participants|Number|18|18.0||||||
4064717|NCT01064414|3886879|B3|GERMANY||Region of Enrollment||participants|Number|2|2.0||||||
4064718|NCT01064414|3886880|B2|GERMANY||Region of Enrollment||participants|Number|10|10.0||||||
4064719|NCT01064414|3886881|B1|GERMANY||Region of Enrollment||participants|Number|6|6.0||||||
4064720|NCT01064414|3886878|B4|FRANCE||Region of Enrollment||participants|Number|16|16.0||||||
4064721|NCT01064414|3886879|B3|FRANCE||Region of Enrollment||participants|Number|4|4.0||||||
4064722|NCT01064414|3886880|B2|FRANCE||Region of Enrollment||participants|Number|5|5.0||||||
4064723|NCT01064414|3886881|B1|FRANCE||Region of Enrollment||participants|Number|7|7.0||||||
4064724|NCT01064414|3886878|B4|CANADA||Region of Enrollment||participants|Number|21|21.0||||||
4064725|NCT01064414|3886879|B3|CANADA||Region of Enrollment||participants|Number|3|3.0||||||
4064726|NCT01064414|3886880|B2|CANADA||Region of Enrollment||participants|Number|11|11.0||||||
4064727|NCT01064414|3886881|B1|CANADA||Region of Enrollment||participants|Number|7|7.0||||||
4064728|NCT01064414|3886878|B4|BRAZIL||Region of Enrollment||participants|Number|13|13.0||||||
4064729|NCT01064414|3886879|B3|BRAZIL||Region of Enrollment||participants|Number|5|5.0||||||
4064730|NCT01064414|3886880|B2|BRAZIL||Region of Enrollment||participants|Number|4|4.0||||||
4064731|NCT01064414|3886881|B1|BRAZIL||Region of Enrollment||participants|Number|4|4.0||||||
4064732|NCT01064414|3886878|B4|BELGIUM||Region of Enrollment||participants|Number|12|12.0||||||
4064733|NCT01064414|3886879|B3|BELGIUM||Region of Enrollment||participants|Number|6|6.0||||||
4064734|NCT01064414|3886880|B2|BELGIUM||Region of Enrollment||participants|Number|1|1.0||||||
4064735|NCT01064414|3886881|B1|BELGIUM||Region of Enrollment||participants|Number|5|5.0||||||
4064736|NCT01064414|3886878|B4|AUSTRALIA||Region of Enrollment||participants|Number|14|14.0||||||
4064737|NCT01064414|3886879|B3|AUSTRALIA||Region of Enrollment||participants|Number|5|5.0||||||
4064738|NCT01064414|3886880|B2|AUSTRALIA||Region of Enrollment||participants|Number|6|6.0||||||
4064739|NCT01064414|3886881|B1|AUSTRALIA||Region of Enrollment||participants|Number|3|3.0||||||
4064740|NCT01064414|3886878|B4||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4064741|NCT01064414|3886879|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4064742|NCT01064414|3886880|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4064743|NCT01064414|3886881|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4064744|NCT01064414|3886878|B4||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4064745|NCT01064414|3886879|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4064746|NCT01064414|3886880|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4064747|NCT01064414|3886881|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4064748|NCT01064414|3886878|B4|||Age||years|Mean|68.5|68.5|Standard Deviation|8.28|8.28|||
4064749|NCT01064414|3886879|B3|||Age||years|Mean|67.9|67.9|Standard Deviation|8.24|8.24|||
4064750|NCT01064414|3886880|B2|||Age||years|Mean|69.5|69.5|Standard Deviation|8.2|8.2|||
4064751|NCT01064414|3886881|B1|||Age||years|Mean|68.2|68.2|Standard Deviation|8.4|8.4|||
4064752|NCT01064414|3886878|B4||>=65 years|Age||Participants|Count of Participants|186|186.0||||||
4064753|NCT01064414|3886879|B3||>=65 years|Age||Participants|Count of Participants|57|57.0||||||
4064754|NCT01064414|3886880|B2||>=65 years|Age||Participants|Count of Participants|66|66.0||||||
4064755|NCT01064414|3886881|B1||>=65 years|Age||Participants|Count of Participants|63|63.0||||||
4064756|NCT01064414|3886878|B4||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
4064757|NCT01064414|3886879|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4064758|NCT01064414|3886880|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4064759|NCT01064414|3886881|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4064760|NCT01064414|3886878|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4064761|NCT01064414|3886879|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4064762|NCT01064414|3886880|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4064763|NCT01064414|3886881|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4064764|NCT01064401|3886900|B3||Male|Sex: Female, Male||Participants|Count of Participants|589|589.0||||||
4064765|NCT01064401|3886901|B2||Male|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
4064766|NCT01064401|3886902|B1||Male|Sex: Female, Male||Participants|Count of Participants|295|295.0||||||
4064767|NCT01064401|3886900|B3||Female|Sex: Female, Male||Participants|Count of Participants|1252|1252.0||||||
4064768|NCT01064401|3886901|B2||Female|Sex: Female, Male||Participants|Count of Participants|625|625.0||||||
4064769|NCT01064401|3886902|B1||Female|Sex: Female, Male||Participants|Count of Participants|627|627.0||||||
4064770|NCT01064401|3886900|B3|> 55 years||Age, Customized||participants|Number|2|2.0||||||
4064771|NCT01064401|3886901|B2|> 55 years||Age, Customized||participants|Number|1|1.0||||||
4064772|NCT01064401|3886902|B1|> 55 years||Age, Customized||participants|Number|1|1.0||||||
4064773|NCT01064401|3886900|B3|50 to 55 years||Age, Customized||participants|Number|182|182.0||||||
4064774|NCT01064401|3886901|B2|50 to 55 years||Age, Customized||participants|Number|96|96.0||||||
4064775|NCT01064401|3886902|B1|50 to 55 years||Age, Customized||participants|Number|86|86.0||||||
4064776|NCT01064401|3886900|B3|40 to 49 years||Age, Customized||participants|Number|506|506.0||||||
4064777|NCT01064401|3886901|B2|40 to 49 years||Age, Customized||participants|Number|250|250.0||||||
4064778|NCT01064401|3886902|B1|40 to 49 years||Age, Customized||participants|Number|256|256.0||||||
4064779|NCT01064401|3886900|B3|30 to 39 years||Age, Customized||participants|Number|649|649.0||||||
4064780|NCT01064401|3886901|B2|30 to 39 years||Age, Customized||participants|Number|322|322.0||||||
4064781|NCT01064401|3886902|B1|30 to 39 years||Age, Customized||participants|Number|327|327.0||||||
4064782|NCT01064401|3886900|B3|20 to 29 years||Age, Customized||participants|Number|463|463.0||||||
4064783|NCT01064401|3886901|B2|20 to 29 years||Age, Customized||participants|Number|236|236.0||||||
4064784|NCT01064401|3886902|B1|20 to 29 years||Age, Customized||participants|Number|227|227.0||||||
4064785|NCT01064401|3886900|B3|18 to 19 years||Age, Customized||participants|Number|39|39.0||||||
4064786|NCT01064401|3886901|B2|18 to 19 years||Age, Customized||participants|Number|14|14.0||||||
4064787|NCT01064401|3886902|B1|18 to 19 years||Age, Customized||participants|Number|25|25.0||||||
4064788|NCT01064401|3886900|B3|||Age||years|Mean|36.3|36.3|Standard Deviation|9.34|9.34|||
4064789|NCT01064401|3886901|B2|||Age||years|Mean|36.4|36.4|Standard Deviation|9.36|9.36|||
4064790|NCT01064401|3886902|B1|||Age||years|Mean|36.2|36.2|Standard Deviation|9.32|9.32|||
4064791|NCT01064362|3886917|B3|Hospitalization for cerebrovascular disease||Number of participants with the indicated major risk factors or other key characteristics|Non-specific non-steroidal anti-inflammatory drugs, ns-NSAIDs; PAU, prior antithrombotic use.|participants|Number|31|31.0||||||
4064792|NCT01064362|3886918|B2|Hospitalization for cerebrovascular disease||Number of participants with the indicated major risk factors or other key characteristics|Non-specific non-steroidal anti-inflammatory drugs, ns-NSAIDs; PAU, prior antithrombotic use.|participants|Number|30|30.0||||||
4064793|NCT01064362|3886919|B1|Hospitalization for cerebrovascular disease||Number of participants with the indicated major risk factors or other key characteristics|Non-specific non-steroidal anti-inflammatory drugs, ns-NSAIDs; PAU, prior antithrombotic use.|participants|Number|1|1.0||||||
4064794|NCT01064362|3886917|B3|Cardiovascular disease||Number of participants with the indicated major risk factors or other key characteristics|Non-specific non-steroidal anti-inflammatory drugs, ns-NSAIDs; PAU, prior antithrombotic use.|participants|Number|3301|3301.0||||||
4064795|NCT01064362|3886918|B2|Cardiovascular disease||Number of participants with the indicated major risk factors or other key characteristics|Non-specific non-steroidal anti-inflammatory drugs, ns-NSAIDs; PAU, prior antithrombotic use.|participants|Number|2923|2923.0||||||
4064796|NCT01064362|3886919|B1|Cardiovascular disease||Number of participants with the indicated major risk factors or other key characteristics|Non-specific non-steroidal anti-inflammatory drugs, ns-NSAIDs; PAU, prior antithrombotic use.|participants|Number|378|378.0||||||
4064797|NCT01064362|3886917|B3|Hypertension||Number of participants with the indicated major risk factors or other key characteristics|Non-specific non-steroidal anti-inflammatory drugs, ns-NSAIDs; PAU, prior antithrombotic use.|participants|Number|6409|6409.0||||||
4064798|NCT01064362|3886918|B2|Hypertension||Number of participants with the indicated major risk factors or other key characteristics|Non-specific non-steroidal anti-inflammatory drugs, ns-NSAIDs; PAU, prior antithrombotic use.|participants|Number|5645|5645.0||||||
4064799|NCT01064362|3886919|B1|Hypertension||Number of participants with the indicated major risk factors or other key characteristics|Non-specific non-steroidal anti-inflammatory drugs, ns-NSAIDs; PAU, prior antithrombotic use.|participants|Number|764|764.0||||||
4064800|NCT01064362|3886917|B3|Hospitalization for thrombocytopenia||Number of participants with the indicated major risk factors or other key characteristics|Non-specific non-steroidal anti-inflammatory drugs, ns-NSAIDs; PAU, prior antithrombotic use.|participants|Number|1|1.0||||||
4064801|NCT01064362|3886918|B2|Hospitalization for thrombocytopenia||Number of participants with the indicated major risk factors or other key characteristics|Non-specific non-steroidal anti-inflammatory drugs, ns-NSAIDs; PAU, prior antithrombotic use.|participants|Number|0|0.0||||||
4064802|NCT01064362|3886919|B1|Hospitalization for thrombocytopenia||Number of participants with the indicated major risk factors or other key characteristics|Non-specific non-steroidal anti-inflammatory drugs, ns-NSAIDs; PAU, prior antithrombotic use.|participants|Number|1|1.0||||||
4064803|NCT01064362|3886917|B3|Hospitalization for cancer||Number of participants with the indicated major risk factors or other key characteristics|Non-specific non-steroidal anti-inflammatory drugs, ns-NSAIDs; PAU, prior antithrombotic use.|participants|Number|107|107.0||||||
4064804|NCT01064362|3886918|B2|Hospitalization for cancer||Number of participants with the indicated major risk factors or other key characteristics|Non-specific non-steroidal anti-inflammatory drugs, ns-NSAIDs; PAU, prior antithrombotic use.|participants|Number|100|100.0||||||
4064805|NCT01064362|3886919|B1|Hospitalization for cancer||Number of participants with the indicated major risk factors or other key characteristics|Non-specific non-steroidal anti-inflammatory drugs, ns-NSAIDs; PAU, prior antithrombotic use.|participants|Number|7|7.0||||||
4064806|NCT01064362|3886917|B3|Hospitalization for hypercoagulable state||Number of participants with the indicated major risk factors or other key characteristics|Non-specific non-steroidal anti-inflammatory drugs, ns-NSAIDs; PAU, prior antithrombotic use.|participants|Number|0|0.0||||||
4064807|NCT01064362|3886918|B2|Hospitalization for hypercoagulable state||Number of participants with the indicated major risk factors or other key characteristics|Non-specific non-steroidal anti-inflammatory drugs, ns-NSAIDs; PAU, prior antithrombotic use.|participants|Number|0|0.0||||||
4064808|NCT01064362|3886919|B1|Hospitalization for hypercoagulable state||Number of participants with the indicated major risk factors or other key characteristics|Non-specific non-steroidal anti-inflammatory drugs, ns-NSAIDs; PAU, prior antithrombotic use.|participants|Number|0|0.0||||||
4064809|NCT01064362|3886917|B3|Use of ns-NSAIDs||Number of participants with the indicated major risk factors or other key characteristics|Non-specific non-steroidal anti-inflammatory drugs, ns-NSAIDs; PAU, prior antithrombotic use.|participants|Number|3112|3112.0||||||
4064810|NCT01064362|3886918|B2|Use of ns-NSAIDs||Number of participants with the indicated major risk factors or other key characteristics|Non-specific non-steroidal anti-inflammatory drugs, ns-NSAIDs; PAU, prior antithrombotic use.|participants|Number|2717|2717.0||||||
4064811|NCT01064362|3886919|B1|Use of ns-NSAIDs||Number of participants with the indicated major risk factors or other key characteristics|Non-specific non-steroidal anti-inflammatory drugs, ns-NSAIDs; PAU, prior antithrombotic use.|participants|Number|395|395.0||||||
4064812|NCT01064362|3886917|B3|Use of platelet inhibitors||Number of participants with the indicated major risk factors or other key characteristics|Non-specific non-steroidal anti-inflammatory drugs, ns-NSAIDs; PAU, prior antithrombotic use.|participants|Number|2903|2903.0||||||
4064813|NCT01064362|3886918|B2|Use of platelet inhibitors||Number of participants with the indicated major risk factors or other key characteristics|Non-specific non-steroidal anti-inflammatory drugs, ns-NSAIDs; PAU, prior antithrombotic use.|participants|Number|2610|2610.0||||||
4064814|NCT01064362|3886919|B1|Use of platelet inhibitors||Number of participants with the indicated major risk factors or other key characteristics|Non-specific non-steroidal anti-inflammatory drugs, ns-NSAIDs; PAU, prior antithrombotic use.|participants|Number|293|293.0||||||
4064815|NCT01064362|3886917|B3|PAU: Multiple agents||Number of participants with the indicated major risk factors or other key characteristics|Non-specific non-steroidal anti-inflammatory drugs, ns-NSAIDs; PAU, prior antithrombotic use.|participants|Number|11|11.0||||||
4064816|NCT01064362|3886918|B2|PAU: Multiple agents||Number of participants with the indicated major risk factors or other key characteristics|Non-specific non-steroidal anti-inflammatory drugs, ns-NSAIDs; PAU, prior antithrombotic use.|participants|Number|11|11.0||||||
4064817|NCT01064362|3886919|B1|PAU: Multiple agents||Number of participants with the indicated major risk factors or other key characteristics|Non-specific non-steroidal anti-inflammatory drugs, ns-NSAIDs; PAU, prior antithrombotic use.|participants|Number|0|0.0||||||
4064818|NCT01064362|3886917|B3|PAU: Fondaparinux||Number of participants with the indicated major risk factors or other key characteristics|Non-specific non-steroidal anti-inflammatory drugs, ns-NSAIDs; PAU, prior antithrombotic use.|participants|Number|2|2.0||||||
4064819|NCT01064362|3886918|B2|PAU: Fondaparinux||Number of participants with the indicated major risk factors or other key characteristics|Non-specific non-steroidal anti-inflammatory drugs, ns-NSAIDs; PAU, prior antithrombotic use.|participants|Number|0|0.0||||||
4064820|NCT01064362|3886919|B1|PAU: Fondaparinux||Number of participants with the indicated major risk factors or other key characteristics|Non-specific non-steroidal anti-inflammatory drugs, ns-NSAIDs; PAU, prior antithrombotic use.|participants|Number|2|2.0||||||
4064821|NCT01064362|3886917|B3|PAU: Vitamin K Antagonist (VKA)||Number of participants with the indicated major risk factors or other key characteristics|Non-specific non-steroidal anti-inflammatory drugs, ns-NSAIDs; PAU, prior antithrombotic use.|participants|Number|381|381.0||||||
4064822|NCT01064362|3886918|B2|PAU: Vitamin K Antagonist (VKA)||Number of participants with the indicated major risk factors or other key characteristics|Non-specific non-steroidal anti-inflammatory drugs, ns-NSAIDs; PAU, prior antithrombotic use.|participants|Number|351|351.0||||||
4064823|NCT01064362|3886919|B1|PAU: Vitamin K Antagonist (VKA)||Number of participants with the indicated major risk factors or other key characteristics|Non-specific non-steroidal anti-inflammatory drugs, ns-NSAIDs; PAU, prior antithrombotic use.|participants|Number|30|30.0||||||
4064864|NCT01064362|3886918|B2||Female|Sex: Female, Male||Participants|Count of Participants|8280|8280.0||||||
4064914|NCT01064284|3887032|B1|Modified prophylaxis||Treatment Regimen||participants|Number|43|43.0||||||
4064824|NCT01064362|3886917|B3|PAU: LMWHs||Number of participants with the indicated major risk factors or other key characteristics|Non-specific non-steroidal anti-inflammatory drugs, ns-NSAIDs; PAU, prior antithrombotic use.|participants|Number|45|45.0||||||
4064825|NCT01064362|3886918|B2|PAU: LMWHs||Number of participants with the indicated major risk factors or other key characteristics|Non-specific non-steroidal anti-inflammatory drugs, ns-NSAIDs; PAU, prior antithrombotic use.|participants|Number|42|42.0||||||
4064826|NCT01064362|3886919|B1|PAU: LMWHs||Number of participants with the indicated major risk factors or other key characteristics|Non-specific non-steroidal anti-inflammatory drugs, ns-NSAIDs; PAU, prior antithrombotic use.|participants|Number|3|3.0||||||
4064827|NCT01064362|3886917|B3|PAU: Heparin||Number of participants with the indicated major risk factors or other key characteristics|Non-specific non-steroidal anti-inflammatory drugs, ns-NSAIDs; PAU, prior antithrombotic use.|participants|Number|1|1.0||||||
4064828|NCT01064362|3886918|B2|PAU: Heparin||Number of participants with the indicated major risk factors or other key characteristics|Non-specific non-steroidal anti-inflammatory drugs, ns-NSAIDs; PAU, prior antithrombotic use.|participants|Number|1|1.0||||||
4064829|NCT01064362|3886919|B1|PAU: Heparin||Number of participants with the indicated major risk factors or other key characteristics|Non-specific non-steroidal anti-inflammatory drugs, ns-NSAIDs; PAU, prior antithrombotic use.|participants|Number|0|0.0||||||
4064830|NCT01064362|3886917|B3|>=43 days||Number of participants with the indicated duration of follow-up|Follow-up includes time in the hospital.|participants|Number|4289|4289.0||||||
4064831|NCT01064362|3886918|B2|>=43 days||Number of participants with the indicated duration of follow-up|Follow-up includes time in the hospital.|participants|Number|4124|4124.0||||||
4064832|NCT01064362|3886919|B1|>=43 days||Number of participants with the indicated duration of follow-up|Follow-up includes time in the hospital.|participants|Number|165|165.0||||||
4064833|NCT01064362|3886917|B3|29-42 days||Number of participants with the indicated duration of follow-up|Follow-up includes time in the hospital.|participants|Number|2359|2359.0||||||
4064834|NCT01064362|3886918|B2|29-42 days||Number of participants with the indicated duration of follow-up|Follow-up includes time in the hospital.|participants|Number|2232|2232.0||||||
4064835|NCT01064362|3886919|B1|29-42 days||Number of participants with the indicated duration of follow-up|Follow-up includes time in the hospital.|participants|Number|127|127.0||||||
4064836|NCT01064362|3886917|B3|15-28 days||Number of participants with the indicated duration of follow-up|Follow-up includes time in the hospital.|participants|Number|1673|1673.0||||||
4064837|NCT01064362|3886918|B2|15-28 days||Number of participants with the indicated duration of follow-up|Follow-up includes time in the hospital.|participants|Number|1196|1196.0||||||
4064838|NCT01064362|3886919|B1|15-28 days||Number of participants with the indicated duration of follow-up|Follow-up includes time in the hospital.|participants|Number|477|477.0||||||
4064839|NCT01064362|3886917|B3|1-14 days||Number of participants with the indicated duration of follow-up|Follow-up includes time in the hospital.|participants|Number|5121|5121.0||||||
4064840|NCT01064362|3886918|B2|1-14 days||Number of participants with the indicated duration of follow-up|Follow-up includes time in the hospital.|participants|Number|4331|4331.0||||||
4064841|NCT01064362|3886919|B1|1-14 days||Number of participants with the indicated duration of follow-up|Follow-up includes time in the hospital.|participants|Number|790|790.0||||||
4064842|NCT01064362|3886917|B3|Hip surgery||Number of participants hospitalized because of hip surgery and knee surgery||participants|Number|9955|9955.0||||||
4064843|NCT01064362|3886918|B2|Hip surgery||Number of participants hospitalized because of hip surgery and knee surgery||participants|Number|8810|8810.0||||||
4064844|NCT01064362|3886919|B1|Hip surgery||Number of participants hospitalized because of hip surgery and knee surgery||participants|Number|1145|1145.0||||||
4064845|NCT01064362|3886917|B3|Knee surgery||Number of participants hospitalized because of hip surgery and knee surgery||participants|Number|3487|3487.0||||||
4064846|NCT01064362|3886918|B2|Knee surgery||Number of participants hospitalized because of hip surgery and knee surgery||participants|Number|3073|3073.0||||||
4064847|NCT01064362|3886919|B1|Knee surgery||Number of participants hospitalized because of hip surgery and knee surgery||participants|Number|414|414.0||||||
4064848|NCT01064362|3886917|B3|>=15 days||Number of participants with the indicated duration of their in-hospital stay||participants|Number|2546|2546.0||||||
4064849|NCT01064362|3886918|B2|>=15 days||Number of participants with the indicated duration of their in-hospital stay||participants|Number|2484|2484.0||||||
4064850|NCT01064362|3886919|B1|>=15 days||Number of participants with the indicated duration of their in-hospital stay||participants|Number|62|62.0||||||
4064851|NCT01064362|3886917|B3|11-14 days||Number of participants with the indicated duration of their in-hospital stay||participants|Number|1683|1683.0||||||
4064852|NCT01064362|3886918|B2|11-14 days||Number of participants with the indicated duration of their in-hospital stay||participants|Number|1608|1608.0||||||
4064853|NCT01064362|3886919|B1|11-14 days||Number of participants with the indicated duration of their in-hospital stay||participants|Number|75|75.0||||||
4064854|NCT01064362|3886917|B3|8-10 days||Number of participants with the indicated duration of their in-hospital stay||participants|Number|3393|3393.0||||||
4064855|NCT01064362|3886918|B2|8-10 days||Number of participants with the indicated duration of their in-hospital stay||participants|Number|2965|2965.0||||||
4064856|NCT01064362|3886919|B1|8-10 days||Number of participants with the indicated duration of their in-hospital stay||participants|Number|428|428.0||||||
4064857|NCT01064362|3886917|B3|0-7 days||Number of participants with the indicated duration of their in-hospital stay||participants|Number|5820|5820.0||||||
4064858|NCT01064362|3886918|B2|0-7 days||Number of participants with the indicated duration of their in-hospital stay||participants|Number|4826|4826.0||||||
4064859|NCT01064362|3886919|B1|0-7 days||Number of participants with the indicated duration of their in-hospital stay||participants|Number|994|994.0||||||
4064860|NCT01064362|3886917|B3||Male|Sex: Female, Male||Participants|Count of Participants|4064|4064.0||||||
4064861|NCT01064362|3886918|B2||Male|Sex: Female, Male||Participants|Count of Participants|3603|3603.0||||||
4064862|NCT01064362|3886919|B1||Male|Sex: Female, Male||Participants|Count of Participants|461|461.0||||||
4064863|NCT01064362|3886917|B3||Female|Sex: Female, Male||Participants|Count of Participants|9378|9378.0||||||
4064865|NCT01064362|3886919|B1||Female|Sex: Female, Male||Participants|Count of Participants|1098|1098.0||||||
4064866|NCT01064362|3886917|B3|>=75 years||Age, Customized|Number of participants falling into the indicated age ranges|Participants|Number|6001|6001.0||||||
4064867|NCT01064362|3886918|B2|>=75 years||Age, Customized|Number of participants falling into the indicated age ranges|Participants|Number|5488|5488.0||||||
4064868|NCT01064362|3886919|B1|>=75 years||Age, Customized|Number of participants falling into the indicated age ranges|Participants|Number|513|513.0||||||
4064869|NCT01064362|3886917|B3|65-74 years||Age, Customized|Number of participants falling into the indicated age ranges|Participants|Number|4001|4001.0||||||
4064870|NCT01064362|3886918|B2|65-74 years||Age, Customized|Number of participants falling into the indicated age ranges|Participants|Number|3433|3433.0||||||
4064871|NCT01064362|3886919|B1|65-74 years||Age, Customized|Number of participants falling into the indicated age ranges|Participants|Number|568|568.0||||||
4064872|NCT01064362|3886917|B3|18-64 years||Age, Customized|Number of participants falling into the indicated age ranges|Participants|Number|3440|3440.0||||||
4064873|NCT01064362|3886918|B2|18-64 years||Age, Customized|Number of participants falling into the indicated age ranges|Participants|Number|2962|2962.0||||||
4064874|NCT01064362|3886919|B1|18-64 years||Age, Customized|Number of participants falling into the indicated age ranges|Participants|Number|478|478.0||||||
4064875|NCT01064323|3886928|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4064876|NCT01064323|3886928|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4064877|NCT01064323|3886928|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4064878|NCT01064323|3886928|B1|24-39 years old||Age, Customized||Participants|Count of Participants|10|10.0||||||
4064879|NCT01064310|3886950|B3|Missing||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4064880|NCT01064310|3886951|B2|Missing||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4064881|NCT01064310|3886952|B1|Missing||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4064882|NCT01064310|3886950|B3|White||Race/Ethnicity, Customized||participants|Number|157|157.0||||||
4064883|NCT01064310|3886951|B2|White||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
4064884|NCT01064310|3886952|B1|White||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
4064885|NCT01064310|3886950|B3|Asian-Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4064886|NCT01064310|3886951|B2|Asian-Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4064887|NCT01064310|3886952|B1|Asian-Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4064888|NCT01064310|3886950|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4064889|NCT01064310|3886951|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4064890|NCT01064310|3886952|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4064891|NCT01064310|3886950|B3||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4064892|NCT01064310|3886951|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4064893|NCT01064310|3886952|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4064894|NCT01064310|3886950|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4064895|NCT01064310|3886951|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4064896|NCT01064310|3886952|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4064897|NCT01064310|3886950|B3|||Age||Years|Mean|62.2|62.2|Standard Deviation|10.48|10.48|||
4064898|NCT01064310|3886951|B2|||Age||Years|Mean|62.2|62.2|Standard Deviation|11.35|11.35|||
4064899|NCT01064310|3886952|B1|||Age||Years|Mean|62.1|62.1|Standard Deviation|9.56|9.56|||
4064900|NCT01064297|3886981|B4||Male|Sex: Female, Male|Prospectively enrolled pregnancies with pregnancy outcome known or lost to follow-up.|Participants|Count of Participants|0|0.0||||||
4064901|NCT01064297|3886982|B3||Male|Sex: Female, Male|Prospectively enrolled pregnancies with pregnancy outcome known or lost to follow-up.|Participants|Count of Participants|0|0.0||||||
4064902|NCT01064297|3886983|B2||Male|Sex: Female, Male|Prospectively enrolled pregnancies with pregnancy outcome known or lost to follow-up.|Participants|Count of Participants|0|0.0||||||
4064903|NCT01064297|3886984|B1||Male|Sex: Female, Male|Prospectively enrolled pregnancies with pregnancy outcome known or lost to follow-up.|Participants|Count of Participants|0|0.0||||||
4064904|NCT01064297|3886981|B4||Female|Sex: Female, Male|Prospectively enrolled pregnancies with pregnancy outcome known or lost to follow-up.|Participants|Count of Participants|3416|3416.0||||||
4064905|NCT01064297|3886982|B3||Female|Sex: Female, Male|Prospectively enrolled pregnancies with pregnancy outcome known or lost to follow-up.|Participants|Count of Participants|630|630.0||||||
4064906|NCT01064297|3886983|B2||Female|Sex: Female, Male|Prospectively enrolled pregnancies with pregnancy outcome known or lost to follow-up.|Participants|Count of Participants|219|219.0||||||
4064907|NCT01064297|3886984|B1||Female|Sex: Female, Male|Prospectively enrolled pregnancies with pregnancy outcome known or lost to follow-up.|Participants|Count of Participants|2567|2567.0||||||
4064908|NCT01064297|3886981|B4|||Age|Prospectively enrolled pregnancies with pregnancy outcome known or lost to follow-up.|years|Mean|27.8|27.8|Standard Deviation|5.89|5.89|||
4064909|NCT01064297|3886982|B3|||Age|Prospectively enrolled pregnancies with pregnancy outcome known or lost to follow-up.|years|Mean|28.1|28.1|Standard Deviation|6.08|6.08|||
4064910|NCT01064297|3886983|B2|||Age|Prospectively enrolled pregnancies with pregnancy outcome known or lost to follow-up.|years|Mean|25.8|25.8|Standard Deviation|5.49|5.49|||
4064911|NCT01064297|3886984|B1|||Age|Prospectively enrolled pregnancies with pregnancy outcome known or lost to follow-up.|years|Mean|27.9|27.9|Standard Deviation|5.84|5.84|||
4064912|NCT01064284|3887030|B3|Modified prophylaxis||Treatment Regimen||participants|Number|94|94.0||||||
4064913|NCT01064284|3887031|B2|Modified prophylaxis||Treatment Regimen||participants|Number|51|51.0||||||
4064915|NCT01064284|3887030|B3|Standard prophylaxis||Treatment Regimen||participants|Number|40|40.0||||||
4064916|NCT01064284|3887031|B2|Standard prophylaxis||Treatment Regimen||participants|Number|19|19.0||||||
4064917|NCT01064284|3887032|B1|Standard prophylaxis||Treatment Regimen||participants|Number|21|21.0||||||
4064918|NCT01064284|3887030|B3|On-demand||Treatment Regimen||participants|Number|117|117.0||||||
4064919|NCT01064284|3887031|B2|On-demand||Treatment Regimen||participants|Number|56|56.0||||||
4064920|NCT01064284|3887032|B1|On-demand||Treatment Regimen||participants|Number|61|61.0||||||
4064921|NCT01064284|3887030|B3|Null mutation||Mutation Status||participants|Number|197|197.0||||||
4064922|NCT01064284|3887031|B2|Null mutation||Mutation Status||participants|Number|96|96.0||||||
4064923|NCT01064284|3887032|B1|Null mutation||Mutation Status||participants|Number|101|101.0||||||
4064924|NCT01064284|3887030|B3|Non-null mutation||Mutation Status||participants|Number|37|37.0||||||
4064925|NCT01064284|3887031|B2|Non-null mutation||Mutation Status||participants|Number|21|21.0||||||
4064926|NCT01064284|3887032|B1|Non-null mutation||Mutation Status||participants|Number|16|16.0||||||
4064927|NCT01064284|3887030|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4064928|NCT01064284|3887031|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4064929|NCT01064284|3887032|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4064930|NCT01064284|3887030|B3|Turkey||Region of Enrollment||participants|Number|3|3.0||||||
4064931|NCT01064284|3887031|B2|Turkey||Region of Enrollment||participants|Number|1|1.0||||||
4064932|NCT01064284|3887032|B1|Turkey||Region of Enrollment||participants|Number|2|2.0||||||
4064933|NCT01064284|3887030|B3|Spain||Region of Enrollment||participants|Number|6|6.0||||||
4064934|NCT01064284|3887031|B2|Spain||Region of Enrollment||participants|Number|3|3.0||||||
4064935|NCT01064284|3887032|B1|Spain||Region of Enrollment||participants|Number|3|3.0||||||
4064936|NCT01064284|3887030|B3|South Africa||Region of Enrollment||participants|Number|4|4.0||||||
4064937|NCT01064284|3887031|B2|South Africa||Region of Enrollment||participants|Number|2|2.0||||||
4064938|NCT01064284|3887032|B1|South Africa||Region of Enrollment||participants|Number|2|2.0||||||
4064939|NCT01064284|3887030|B3|Saudi Arabia||Region of Enrollment||participants|Number|1|1.0||||||
4064940|NCT01064284|3887031|B2|Saudi Arabia||Region of Enrollment||participants|Number|0|0.0||||||
4064941|NCT01064284|3887032|B1|Saudi Arabia||Region of Enrollment||participants|Number|1|1.0||||||
4064942|NCT01064284|3887030|B3|Mexico||Region of Enrollment||participants|Number|6|6.0||||||
4064943|NCT01064284|3887031|B2|Mexico||Region of Enrollment||participants|Number|2|2.0||||||
4064944|NCT01064284|3887032|B1|Mexico||Region of Enrollment||participants|Number|4|4.0||||||
4064945|NCT01064284|3887030|B3|Italy||Region of Enrollment||participants|Number|9|9.0||||||
4064946|NCT01064284|3887031|B2|Italy||Region of Enrollment||participants|Number|4|4.0||||||
4064947|NCT01064284|3887032|B1|Italy||Region of Enrollment||participants|Number|5|5.0||||||
4064948|NCT01064284|3887030|B3|Iran||Region of Enrollment||participants|Number|32|32.0||||||
4064949|NCT01064284|3887031|B2|Iran||Region of Enrollment||participants|Number|18|18.0||||||
4064950|NCT01064284|3887032|B1|Iran||Region of Enrollment||participants|Number|14|14.0||||||
4064951|NCT01064284|3887030|B3|India||Region of Enrollment||participants|Number|83|83.0||||||
4064952|NCT01064284|3887031|B2|India||Region of Enrollment||participants|Number|43|43.0||||||
4064953|NCT01064284|3887032|B1|India||Region of Enrollment||participants|Number|40|40.0||||||
4064954|NCT01064284|3887030|B3|Egypt||Region of Enrollment||participants|Number|75|75.0||||||
4064955|NCT01064284|3887031|B2|Egypt||Region of Enrollment||participants|Number|37|37.0||||||
4064956|NCT01064284|3887032|B1|Egypt||Region of Enrollment||participants|Number|38|38.0||||||
4064957|NCT01064284|3887030|B3|Chile||Region of Enrollment||participants|Number|4|4.0||||||
4064958|NCT01064284|3887031|B2|Chile||Region of Enrollment||participants|Number|3|3.0||||||
4064959|NCT01064284|3887032|B1|Chile||Region of Enrollment||participants|Number|1|1.0||||||
4064960|NCT01064284|3887030|B3|Brazil||Region of Enrollment||participants|Number|4|4.0||||||
4064961|NCT01064284|3887031|B2|Brazil||Region of Enrollment||participants|Number|2|2.0||||||
4064962|NCT01064284|3887032|B1|Brazil||Region of Enrollment||participants|Number|2|2.0||||||
4064963|NCT01064284|3887030|B3|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4064964|NCT01064284|3887031|B2|Austria||Region of Enrollment||participants|Number|2|2.0||||||
4064965|NCT01064284|3887032|B1|Austria||Region of Enrollment||participants|Number|2|2.0||||||
4064966|NCT01064284|3887030|B3|Argentina||Region of Enrollment||participants|Number|2|2.0||||||
4064967|NCT01064284|3887031|B2|Argentina||Region of Enrollment||participants|Number|0|0.0||||||
4064968|NCT01064284|3887032|B1|Argentina||Region of Enrollment||participants|Number|2|2.0||||||
4064969|NCT01064284|3887030|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
4064970|NCT01064284|3887031|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4064971|NCT01064284|3887032|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4064972|NCT01064284|3887030|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064973|NCT01064284|3887031|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064974|NCT01064284|3887032|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064975|NCT01064284|3887030|B3||White|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
4064976|NCT01064284|3887031|B2||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4064977|NCT01064284|3887032|B1||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4065100|NCT01063855|3887137|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4064978|NCT01064284|3887030|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4064979|NCT01064284|3887031|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4064980|NCT01064284|3887032|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4064981|NCT01064284|3887030|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064982|NCT01064284|3887031|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064983|NCT01064284|3887032|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064984|NCT01064284|3887030|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
4064985|NCT01064284|3887031|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4064986|NCT01064284|3887032|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4064987|NCT01064284|3887030|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064988|NCT01064284|3887031|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064989|NCT01064284|3887032|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4064990|NCT01064284|3887030|B3||Male|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4064991|NCT01064284|3887031|B2||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4064992|NCT01064284|3887032|B1||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4064993|NCT01064284|3887030|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4064994|NCT01064284|3887031|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4064995|NCT01064284|3887032|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4064996|NCT01064284|3887030|B3|||Age|Age at first treatment|months|Mean|20.2|20.2|Standard Deviation|21.68|21.68|||
4064997|NCT01064284|3887031|B2|||Age|Age at first treatment|months|Mean|21.3|21.3|Standard Deviation|16.3|16.3|||
4064998|NCT01064284|3887032|B1|||Age|Age at first treatment|months|Mean|19.1|19.1|Standard Deviation|14.3|14.3|||
4064999|NCT01064167|3887053|B3|China||Region of Enrollment||participants|Number|260|260.0||||||
4065000|NCT01064167|3887054|B2|China||Region of Enrollment||participants|Number|130|130.0||||||
4065001|NCT01064167|3887055|B1|China||Region of Enrollment||participants|Number|130|130.0||||||
4065002|NCT01064167|3887053|B3||Male|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4065003|NCT01064167|3887054|B2||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4065004|NCT01064167|3887055|B1||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4065005|NCT01064167|3887053|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4065006|NCT01064167|3887054|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4065007|NCT01064167|3887055|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4065008|NCT01064167|3887053|B3|||Age||years|Mean|60.4|60.4|Standard Deviation|8.5|8.5|||
4065009|NCT01064167|3887054|B2|||Age||years|Mean|60|60.0|Standard Deviation|8.5|8.5|||
4065010|NCT01064167|3887055|B1|||Age||years|Mean|60.5|60.5|Standard Deviation|8.0|8.0|||
4065011|NCT01064167|3887053|B3||>=65 years|Age||Participants|Count of Participants|85|85.0||||||
4065012|NCT01064167|3887054|B2||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
4065013|NCT01064167|3887055|B1||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
4065014|NCT01064167|3887053|B3||Between 18 and 65 years|Age||Participants|Count of Participants|175|175.0||||||
4065015|NCT01064167|3887054|B2||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
4065016|NCT01064167|3887055|B1||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
4065017|NCT01064167|3887053|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4065018|NCT01064167|3887054|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4065019|NCT01064167|3887055|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4065020|NCT01064076|3887064|B1|New Zealand||Region of Enrollment||participants|Number|29|29.0||||||
4065021|NCT01064076|3887064|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4065022|NCT01064076|3887064|B1|Netherlands||Region of Enrollment||participants|Number|16|16.0||||||
4065023|NCT01064076|3887064|B1|United States||Region of Enrollment||participants|Number|275|275.0||||||
4065024|NCT01064076|3887064|B1||Male|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
4065025|NCT01064076|3887064|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4065026|NCT01064076|3887064|B1|||Age||years|Mean|51.9|51.9|Standard Deviation|15.5|15.5|||
4065027|NCT01064076|3887064|B1||>=65 years|Age||Participants|Count of Participants|68|68.0||||||
4065028|NCT01064076|3887064|B1||Between 18 and 65 years|Age||Participants|Count of Participants|253|253.0||||||
4065029|NCT01064076|3887064|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4065030|NCT01063907|3887069|B1|||Body Surface Area (BSA)||m^2|Mean|1.87|1.87|Standard Deviation|0.27|0.27|||
4065031|NCT01063907|3887069|B1|United Kingdom||Region of Enrollment||participants|Number|57|57.0||||||
4065032|NCT01063907|3887069|B1|Philippines||Region of Enrollment||participants|Number|20|20.0||||||
4065033|NCT01063907|3887069|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4065034|NCT01063907|3887069|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4065035|NCT01063907|3887069|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4065036|NCT01063907|3887069|B1||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4065037|NCT01063907|3887069|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4065038|NCT01063907|3887069|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4065039|NCT01063907|3887069|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4065040|NCT01063907|3887069|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4065041|NCT01063907|3887069|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4065042|NCT01063907|3887069|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4065043|NCT01063907|3887069|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|9.3|9.3|||
4065044|NCT01063881|3887100|B4|||Baseline BMI||kg/cm^2|Mean|24.9|24.9|Standard Deviation|2.99|2.99|||
4065045|NCT01063881|3887101|B3|||Baseline BMI||kg/cm^2|Mean|23.9|23.9|Standard Deviation|2.78|2.78|||
4065046|NCT01063881|3887102|B2|||Baseline BMI||kg/cm^2|Mean|25.3|25.3|Standard Deviation|3.20|3.2|||
4065047|NCT01063881|3887103|B1|||Baseline BMI||kg/cm^2|Mean|24.7|24.7|Standard Deviation|2.79|2.79|||
4065048|NCT01063881|3887100|B4||Male|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
4065049|NCT01063881|3887101|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4065050|NCT01063881|3887102|B2||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4065051|NCT01063881|3887103|B1||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4065052|NCT01063881|3887100|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4065053|NCT01063881|3887101|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4065054|NCT01063881|3887102|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4065055|NCT01063881|3887103|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4065056|NCT01063881|3887100|B4|||Age||years|Mean|45.9|45.9|Standard Deviation|10.39|10.39|||
4065057|NCT01063881|3887101|B3|||Age||years|Mean|41.1|41.1|Standard Deviation|7.77|7.77|||
4065058|NCT01063881|3887102|B2|||Age||years|Mean|46.9|46.9|Standard Deviation|10.47|10.47|||
4065059|NCT01063881|3887103|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|10.43|10.43|||
4065060|NCT01063881|3887100|B4||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4065061|NCT01063881|3887101|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4065062|NCT01063881|3887102|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4065063|NCT01063881|3887103|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4065064|NCT01063881|3887100|B4||Between 18 and 65 years|Age||Participants|Count of Participants|276|276.0||||||
4065065|NCT01063881|3887101|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4065066|NCT01063881|3887102|B2||Between 18 and 65 years|Age||Participants|Count of Participants|121|121.0||||||
4065067|NCT01063881|3887103|B1||Between 18 and 65 years|Age||Participants|Count of Participants|142|142.0||||||
4065068|NCT01063881|3887100|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4065069|NCT01063881|3887101|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4065070|NCT01063881|3887102|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4065071|NCT01063881|3887103|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4065072|NCT01063868|3887127|B3|||Region Enroll (United States of America)||participants|Number|47|47.0||||||
4065073|NCT01063868|3887128|B2|||Region Enroll (United States of America)||participants|Number|12|12.0||||||
4065074|NCT01063868|3887129|B1|||Region Enroll (United States of America)||participants|Number|35|35.0||||||
4065075|NCT01063868|3887127|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4065076|NCT01063868|3887128|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4065077|NCT01063868|3887129|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4065078|NCT01063868|3887127|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4065079|NCT01063868|3887128|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4065080|NCT01063868|3887129|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4065081|NCT01063868|3887127|B3|||Age||years|Mean|58.2|58.2|Standard Deviation|11.64|11.64|||
4065082|NCT01063868|3887128|B2|||Age||years|Mean|60.1|60.1|Standard Deviation|9.23|9.23|||
4065083|NCT01063868|3887129|B1|||Age||years|Mean|57.5|57.5|Standard Deviation|12.41|12.41|||
4065084|NCT01063868|3887127|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4065085|NCT01063868|3887128|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4065086|NCT01063868|3887129|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4065087|NCT01063868|3887127|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4065088|NCT01063868|3887128|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4065089|NCT01063868|3887129|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4065090|NCT01063868|3887127|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4065091|NCT01063868|3887128|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4065092|NCT01063868|3887129|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4065093|NCT01063855|3887136|B3|||Baseline BMI||kg/cm2|Mean|27.2|27.2|Standard Deviation|4.52|4.52|||
4065094|NCT01063855|3887137|B2|||Baseline BMI||kg/cm2|Mean|27.1|27.1|Standard Deviation|4.55|4.55|||
4065095|NCT01063855|3887138|B1|||Baseline BMI||kg/cm2|Mean|27.2|27.2|Standard Deviation|4.50|4.5|||
4065096|NCT01063855|3887136|B3||Male|Sex: Female, Male||Participants|Count of Participants|495|495.0||||||
4065097|NCT01063855|3887137|B2||Male|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
4065098|NCT01063855|3887138|B1||Male|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4065099|NCT01063855|3887136|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4065101|NCT01063855|3887138|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4065102|NCT01063855|3887136|B3|||Age||years|Mean|48.7|48.7|Standard Deviation|11.61|11.61|||
4065103|NCT01063855|3887137|B2|||Age||years|Mean|49.5|49.5|Standard Deviation|11.23|11.23|||
4065104|NCT01063855|3887138|B1|||Age||years|Mean|47.9|47.9|Standard Deviation|11.96|11.96|||
4065105|NCT01063855|3887136|B3||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4065106|NCT01063855|3887137|B2||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4065107|NCT01063855|3887138|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4065108|NCT01063855|3887136|B3||Between 18 and 65 years|Age||Participants|Count of Participants|459|459.0||||||
4065109|NCT01063855|3887137|B2||Between 18 and 65 years|Age||Participants|Count of Participants|231|231.0||||||
4065110|NCT01063855|3887138|B1||Between 18 and 65 years|Age||Participants|Count of Participants|228|228.0||||||
4065111|NCT01063855|3887136|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4065112|NCT01063855|3887137|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4065113|NCT01063855|3887138|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4065114|NCT01063829|3887161|B5|Germany||Region of Enrollment||participants|Number|62|62.0||||||
4065115|NCT01063829|3887162|B4|Germany||Region of Enrollment||participants|Number|18|18.0||||||
4065116|NCT01063829|3887163|B3|Germany||Region of Enrollment||participants|Number|17|17.0||||||
4065117|NCT01063829|3887164|B2|Germany||Region of Enrollment||participants|Number|12|12.0||||||
4065118|NCT01063829|3887165|B1|Germany||Region of Enrollment||participants|Number|15|15.0||||||
4065119|NCT01063829|3887161|B5|United States||Region of Enrollment||participants|Number|69|69.0||||||
4065120|NCT01063829|3887162|B4|United States||Region of Enrollment||participants|Number|15|15.0||||||
4065121|NCT01063829|3887163|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4065122|NCT01063829|3887164|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4065123|NCT01063829|3887165|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4065124|NCT01063829|3887161|B5||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4065125|NCT01063829|3887162|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4065126|NCT01063829|3887163|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4065127|NCT01063829|3887164|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4065128|NCT01063829|3887165|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4065129|NCT01063829|3887161|B5||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4065130|NCT01063829|3887162|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4065131|NCT01063829|3887163|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4065132|NCT01063829|3887164|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4065133|NCT01063829|3887165|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4065134|NCT01063829|3887161|B5|||Age||years|Mean|51.1|51.1|Standard Deviation|12.62|12.62|||
4065135|NCT01063829|3887162|B4|||Age||years|Mean|51.8|51.8|Standard Deviation|13.41|13.41|||
4065136|NCT01063829|3887163|B3|||Age||years|Mean|50.7|50.7|Standard Deviation|11.78|11.78|||
4065137|NCT01063829|3887164|B2|||Age||years|Mean|51.6|51.6|Standard Deviation|12.79|12.79|||
4065138|NCT01063829|3887165|B1|||Age||years|Mean|50.5|50.5|Standard Deviation|13.03|13.03|||
4065139|NCT01063764|3887186|B1|No||Hospitalization Status||participants|Number|73|73.0||||||
4065140|NCT01063764|3887186|B1|Yes||Hospitalization Status||participants|Number|0|0.0||||||
4065141|NCT01063764|3887186|B1|||Body Mass Index (BMI)||kilogram / meter^2 (kg/m^2)|Mean|17.15|17.15|Standard Deviation|2.99|2.99|||
4065142|NCT01063764|3887186|B1|||Height||centimeter (cm)|Mean|134.55|134.55|Standard Deviation|20.69|20.69|||
4065143|NCT01063764|3887186|B1|||Body Weight||kilogram (kg)|Mean|32.43|32.43|Standard Deviation|13.20|13.2|||
4065144|NCT01063764|3887186|B1|>=12 - <16 years||Age||participants|Number|29|29.0||||||
4065145|NCT01063764|3887186|B1|>=8 - <12 years||Age||participants|Number|22|22.0||||||
4065146|NCT01063764|3887186|B1|>=4 - <8 years||Age||participants|Number|22|22.0||||||
4065147|NCT01063764|3887186|B1|Japan||Region of Enrollment||participants|Number|73|73.0||||||
4065148|NCT01063764|3887186|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4065149|NCT01063764|3887186|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4065150|NCT01063764|3887186|B1|||Age||years|Mean|10.1|10.1|Standard Deviation|3.4|3.4|||
4065151|NCT01063712|3887200|B1|Bolivia||Region of Enrollment||units=participants|Number|29|29.0||||||
4065152|NCT01063712|3887200|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4065153|NCT01063712|3887200|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4065154|NCT01063712|3887200|B1|||Age||years|Mean|5|5.0|Standard Deviation|4.8|4.8|||
4065155|NCT01063712|3887200|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4065156|NCT01063712|3887200|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4065157|NCT01063712|3887200|B1||<=18 years|Age||Participants|Count of Participants|28|28.0||||||
4065158|NCT01063595|3887205|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4065159|NCT01063595|3887205|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4065160|NCT01063595|3887205|B1|||Age||Years|Mean|32.6|32.6|Standard Deviation|9.11|9.11|||
4065161|NCT01063517|3887216|B3|Positive||ATM status|Ataxia-Telangiectasia Mutation (ATM) protein testing|Participants|Number|61|61.0||||||
4065162|NCT01063517|3887217|B2|Positive||ATM status|Ataxia-Telangiectasia Mutation (ATM) protein testing|Participants|Number|30|30.0||||||
4065163|NCT01063517|3887218|B1|Positive||ATM status|Ataxia-Telangiectasia Mutation (ATM) protein testing|Participants|Number|31|31.0||||||
4065164|NCT01063517|3887216|B3|Negative||ATM status|Ataxia-Telangiectasia Mutation (ATM) protein testing|Participants|Number|63|63.0||||||
4065165|NCT01063517|3887217|B2|Negative||ATM status|Ataxia-Telangiectasia Mutation (ATM) protein testing|Participants|Number|32|32.0||||||
4065166|NCT01063517|3887218|B1|Negative||ATM status|Ataxia-Telangiectasia Mutation (ATM) protein testing|Participants|Number|31|31.0||||||
4065167|NCT01063517|3887216|B3|Other||Race/Ethnicity, Customized|Race|Participants|Number|0|0.0||||||
4065168|NCT01063517|3887217|B2|Other||Race/Ethnicity, Customized|Race|Participants|Number|0|0.0||||||
4065169|NCT01063517|3887218|B1|Other||Race/Ethnicity, Customized|Race|Participants|Number|0|0.0||||||
4065170|NCT01063517|3887216|B3|Asian||Race/Ethnicity, Customized|Race|Participants|Number|124|124.0||||||
4065171|NCT01063517|3887217|B2|Asian||Race/Ethnicity, Customized|Race|Participants|Number|62|62.0||||||
4065172|NCT01063517|3887218|B1|Asian||Race/Ethnicity, Customized|Race|Participants|Number|62|62.0||||||
4065173|NCT01063517|3887216|B3||Male|Sex: Female, Male|Gender|Participants|Count of Participants|93|93.0||||||
4065174|NCT01063517|3887217|B2||Male|Sex: Female, Male|Gender|Participants|Count of Participants|44|44.0||||||
4065175|NCT01063517|3887218|B1||Male|Sex: Female, Male|Gender|Participants|Count of Participants|49|49.0||||||
4065176|NCT01063517|3887216|B3||Female|Sex: Female, Male|Gender|Participants|Count of Participants|31|31.0||||||
4065177|NCT01063517|3887217|B2||Female|Sex: Female, Male|Gender|Participants|Count of Participants|18|18.0||||||
4065178|NCT01063517|3887218|B1||Female|Sex: Female, Male|Gender|Participants|Count of Participants|13|13.0||||||
4065179|NCT01063517|3887216|B3|>= 65 years||Age, Customized|Age category|Participants|Number|49|49.0||||||
4065180|NCT01063517|3887217|B2|>= 65 years||Age, Customized|Age category|Participants|Number|22|22.0||||||
4065181|NCT01063517|3887218|B1|>= 65 years||Age, Customized|Age category|Participants|Number|27|27.0||||||
4065182|NCT01063517|3887216|B3|>=50 to <65 years||Age, Customized|Age category|Participants|Number|52|52.0||||||
4065183|NCT01063517|3887217|B2|>=50 to <65 years||Age, Customized|Age category|Participants|Number|30|30.0||||||
4065184|NCT01063517|3887218|B1|>=50 to <65 years||Age, Customized|Age category|Participants|Number|22|22.0||||||
4065185|NCT01063517|3887216|B3|< 50 years||Age, Customized|Age category|Participants|Number|23|23.0||||||
4065186|NCT01063517|3887217|B2|< 50 years||Age, Customized|Age category|Participants|Number|10|10.0||||||
4065187|NCT01063517|3887218|B1|< 50 years||Age, Customized|Age category|Participants|Number|13|13.0||||||
4065188|NCT01063517|3887216|B3|||Age|Age at time of randomisation|years|Mean|59.2|59.2|Standard Deviation|11.75|11.75|||
4065189|NCT01063517|3887217|B2|||Age|Age at time of randomisation|years|Mean|59.4|59.4|Standard Deviation|11.98|11.98|||
4065190|NCT01063517|3887218|B1|||Age|Age at time of randomisation|years|Mean|59.0|59.0|Standard Deviation|11.61|11.61|||
4065191|NCT01063348|3887257|B3|No||Any Psychiatric Comorbidity||participants|Number|32|32.0||||||
4065192|NCT01063348|3887258|B2|No||Any Psychiatric Comorbidity||participants|Number|17|17.0||||||
4065193|NCT01063348|3887259|B1|No||Any Psychiatric Comorbidity||participants|Number|15|15.0||||||
4065194|NCT01063348|3887257|B3|Yes||Any Psychiatric Comorbidity||participants|Number|34|34.0||||||
4065195|NCT01063348|3887258|B2|Yes||Any Psychiatric Comorbidity||participants|Number|14|14.0||||||
4065196|NCT01063348|3887259|B1|Yes||Any Psychiatric Comorbidity||participants|Number|20|20.0||||||
4065197|NCT01063348|3887257|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4065198|NCT01063348|3887258|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4065199|NCT01063348|3887259|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4065200|NCT01063348|3887257|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4065201|NCT01063348|3887258|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4065202|NCT01063348|3887259|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4065203|NCT01063348|3887257|B3|||Age||years|Mean|34.8|34.8|Standard Deviation|11.0|11.0|||
4065204|NCT01063348|3887258|B2|||Age||years|Mean|34.7|34.7|Standard Deviation|10.5|10.5|||
4065205|NCT01063348|3887259|B1|||Age||years|Mean|34.9|34.9|Standard Deviation|11.6|11.6|||
4065206|NCT01063153|3887268|B3|United States||Region of Enrollment||participants|Number|71|71.0||||||
4065207|NCT01063153|3887269|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
4065208|NCT01063153|3887270|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4065209|NCT01063153|3887268|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4065210|NCT01063153|3887269|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4065211|NCT01063153|3887270|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4065212|NCT01063153|3887268|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4065213|NCT01063153|3887269|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4065214|NCT01063153|3887270|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4065215|NCT01063153|3887268|B3|||Age||years|Mean|34.0|34.0|Standard Deviation|10.8|10.8|||
4065216|NCT01063153|3887269|B2|||Age||years|Mean|35.5|35.5|Standard Deviation|10.5|10.5|||
4065217|NCT01063153|3887270|B1|||Age||years|Mean|32.2|32.2|Standard Deviation|11.0|11.0|||
4065218|NCT01063153|3887268|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4065219|NCT01063153|3887269|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4065220|NCT01063153|3887270|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4065221|NCT01063153|3887268|B3||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4065222|NCT01063153|3887269|B2||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4065223|NCT01063153|3887270|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4065224|NCT01063153|3887268|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4065225|NCT01063153|3887269|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4065226|NCT01063153|3887270|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4065227|NCT01063075|3887281|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4065228|NCT01063075|3887281|B1|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4065229|NCT01063075|3887281|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4065230|NCT01063075|3887281|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4065231|NCT01063075|3887281|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4065232|NCT01063075|3887281|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4065233|NCT01063075|3887281|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4065234|NCT01063075|3887281|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4065235|NCT01063075|3887281|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4065236|NCT01063075|3887281|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4065237|NCT01063075|3887281|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4065238|NCT01063075|3887281|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4065239|NCT01063075|3887281|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4065240|NCT01063075|3887281|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4065241|NCT01063075|3887281|B1|||Age||years|Mean|58.20|58.2|Standard Deviation|12.88|12.88|||
4065242|NCT01063062|3887300|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4065243|NCT01063062|3887301|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4065244|NCT01063062|3887302|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4065245|NCT01063062|3887300|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4065246|NCT01063062|3887301|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4065247|NCT01063062|3887302|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4065248|NCT01063062|3887300|B3|||Age||years|Mean|40.64|40.64|Standard Deviation|12.10|12.1|||
4065249|NCT01063062|3887301|B2|||Age||years|Mean|41.76|41.76|Standard Deviation|11.84|11.84|||
4065250|NCT01063062|3887302|B1|||Age||years|Mean|37.78|37.78|Standard Deviation|12.47|12.47|||
4065251|NCT01063049|3887341|B4|United States||Region of Enrollment||participants|Number|600|600.0||||||
4065252|NCT01063049|3887342|B3|United States||Region of Enrollment||participants|Number|200|200.0||||||
4065253|NCT01063049|3887343|B2|United States||Region of Enrollment||participants|Number|200|200.0||||||
4065254|NCT01063049|3887344|B1|United States||Region of Enrollment||participants|Number|200|200.0||||||
4065255|NCT01063049|3887341|B4||Male|Sex: Female, Male||Participants|Count of Participants|329|329.0||||||
4065256|NCT01063049|3887342|B3||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4065257|NCT01063049|3887343|B2||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4065258|NCT01063049|3887344|B1||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4065259|NCT01063049|3887341|B4||Female|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
4065260|NCT01063049|3887342|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4065261|NCT01063049|3887343|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4065262|NCT01063049|3887344|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4065263|NCT01063049|3887341|B4|||Age||years|Mean|60.4|60.4|Standard Deviation|13.2|13.2|||
4065264|NCT01063049|3887342|B3|||Age||years|Mean|61.3|61.3|Standard Deviation|12.5|12.5|||
4065265|NCT01063049|3887343|B2|||Age||years|Mean|59.7|59.7|Standard Deviation|13.8|13.8|||
4065266|NCT01063049|3887344|B1|||Age||years|Mean|60.2|60.2|Standard Deviation|13.2|13.2|||
4065267|NCT01063049|3887341|B4||>=65 years|Age||Participants|Count of Participants|240|240.0||||||
4065268|NCT01063049|3887342|B3||>=65 years|Age||Participants|Count of Participants|80|80.0||||||
4065269|NCT01063049|3887343|B2||>=65 years|Age||Participants|Count of Participants|80|80.0||||||
4065270|NCT01063049|3887344|B1||>=65 years|Age||Participants|Count of Participants|80|80.0||||||
4065271|NCT01063049|3887341|B4||Between 18 and 65 years|Age||Participants|Count of Participants|360|360.0||||||
4065272|NCT01063049|3887342|B3||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
4065273|NCT01063049|3887343|B2||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
4065274|NCT01063049|3887344|B1||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
4065275|NCT01063049|3887341|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4065276|NCT01063049|3887342|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4065277|NCT01063049|3887343|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4065278|NCT01063049|3887344|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4065279|NCT01063036|3887357|B1|Missing||Treatment Failure Prior to Baseline||participants|Number|1|1.0||||||
4065280|NCT01063036|3887357|B1|Partial Virological Breakthrough||Treatment Failure Prior to Baseline||participants|Number|52|52.0||||||
4065281|NCT01063036|3887357|B1|Virological Breakthrough||Treatment Failure Prior to Baseline||participants|Number|30|30.0||||||
4065282|NCT01063036|3887357|B1|Primary Non-Response||Treatment Failure Prior to Baseline||participants|Number|9|9.0||||||
4065283|NCT01063036|3887357|B1|Missing HBV DNA test||Baseline HBV Subtype||Participants|Number|1|1.0||||||
4065284|NCT01063036|3887357|B1|Insufficient HBV DNA||Baseline HBV Subtype||Participants|Number|23|23.0||||||
4065285|NCT01063036|3887357|B1|HBV Subtype Indeterminate||Baseline HBV Subtype||Participants|Number|3|3.0||||||
4065286|NCT01063036|3887357|B1|HBV Subtype H||Baseline HBV Subtype||Participants|Number|1|1.0||||||
4065287|NCT01063036|3887357|B1|HBV Subtype G||Baseline HBV Subtype||Participants|Number|1|1.0||||||
4065288|NCT01063036|3887357|B1|HBV Subtype E||Baseline HBV Subtype||Participants|Number|4|4.0||||||
4065289|NCT01063036|3887357|B1|HBV Subtype D||Baseline HBV Subtype||Participants|Number|35|35.0||||||
4065290|NCT01063036|3887357|B1|HBV Subtype C||Baseline HBV Subtype||Participants|Number|1|1.0||||||
4065291|NCT01063036|3887357|B1|HBV Subtype B||Baseline HBV Subtype||Participants|Number|2|2.0||||||
4065292|NCT01063036|3887357|B1|HBV Subtype A||Baseline HBV Subtype||Participants|Number|21|21.0||||||
4065293|NCT01063036|3887357|B1|Negative for Hepatitis B Surface Antigen||Baseline Hepatitis B Surface Antigen||participants|Number|0|0.0||||||
4065294|NCT01063036|3887357|B1|Positive for Hepatitis B Surface Antigen||Baseline Hepatitis B Surface Antigen||participants|Number|92|92.0||||||
4065295|NCT01063036|3887357|B1|missing Hepatitis B e antibody test||Baseline Hepatitis B e Antibody||participants|Number|2|2.0||||||
4065296|NCT01063036|3887357|B1|Intermediate Hepatitis B e antibody||Baseline Hepatitis B e Antibody||participants|Number|2|2.0||||||
4065297|NCT01063036|3887357|B1|Negative for Hepatitis B e antibody||Baseline Hepatitis B e Antibody||participants|Number|56|56.0||||||
4065298|NCT01063036|3887357|B1|Positive for Hepatitis B e antibody||Baseline Hepatitis B e Antibody||participants|Number|32|32.0||||||
4065299|NCT01063036|3887357|B1|missing Hepatitis B e antigen test||Baseline Hepatitis B e Antigen||participants|Number|2|2.0||||||
4065300|NCT01063036|3887357|B1|Negative for Hepatitis B e antigen||Baseline Hepatitis B e Antigen||participants|Number|34|34.0||||||
4065301|NCT01063036|3887357|B1|Positive for Hepatitis B e antigen||Baseline Hepatitis B e Antigen||participants|Number|56|56.0||||||
4065302|NCT01063036|3887357|B1|||HBV DNA by PCR (log10 IU/mL)|Hepatitis B virus deoxyribonucleic acid (HBV DNA) by polymerase chain reaction (PCR) was measured using the Roche COBAS(REGISTERED) TaqMan - High Pure System (HPS) assay. The results were reported in log 10 international units per milliliter (IU/mL), with the limit of quantification (LOQ) = 29 IU/mL and lower limit of detection (LLD) = 6 IU/mL. HBV DNA measurements were transformed by the log10 scale when analyzed as a continuous variable, using log10(LOQ-1) for values below LOQ.|log10 IU/mL|Median|3.674|3.674|Full Range|||1.45|9.3|
4065303|NCT01063036|3887357|B1|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4065304|NCT01063036|3887357|B1|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
4065305|NCT01063036|3887357|B1|Germany||Region of Enrollment||participants|Number|23|23.0||||||
4065306|NCT01063036|3887357|B1|Romania||Region of Enrollment||participants|Number|20|20.0||||||
4065307|NCT01063036|3887357|B1|Poland||Region of Enrollment||participants|Number|32|32.0||||||
4065308|NCT01063036|3887357|B1|France||Region of Enrollment||participants|Number|10|10.0||||||
4065309|NCT01063036|3887357|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4065310|NCT01063036|3887357|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4065311|NCT01063036|3887357|B1|||Age||years|Median|42.0|42.0|Full Range|||18.0|84.0|
4065312|NCT01062893|3887371|B3|United States||Region of Enrollment||participants|Number|55|55.0||||||
4065313|NCT01062893|3887372|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4065314|NCT01062893|3887373|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4065315|NCT01062893|3887371|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4065316|NCT01062893|3887372|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4065317|NCT01062893|3887373|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4065318|NCT01062893|3887371|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4065319|NCT01062893|3887372|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4065320|NCT01062893|3887373|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4065321|NCT01062893|3887371|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4065322|NCT01062893|3887372|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4065323|NCT01062893|3887373|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4065324|NCT01062893|3887371|B3||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4065325|NCT01062893|3887372|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4065326|NCT01062893|3887373|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4065327|NCT01062893|3887371|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4065328|NCT01062893|3887372|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4065329|NCT01062893|3887373|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4065330|NCT01062841|3887400|B3|Both Urinary Catheter and Feeding Tube||Indwelling Device Use||participants|Number|53|53.0||||||
4065331|NCT01062841|3887401|B2|Both Urinary Catheter and Feeding Tube||Indwelling Device Use||participants|Number|29|29.0||||||
4065332|NCT01062841|3887402|B1|Both Urinary Catheter and Feeding Tube||Indwelling Device Use||participants|Number|24|24.0||||||
4065333|NCT01062841|3887400|B3|Feeding Tube||Indwelling Device Use||participants|Number|100|100.0||||||
4065334|NCT01062841|3887401|B2|Feeding Tube||Indwelling Device Use||participants|Number|54|54.0||||||
4065335|NCT01062841|3887402|B1|Feeding Tube||Indwelling Device Use||participants|Number|46|46.0||||||
4065336|NCT01062841|3887400|B3|Indwelling Urinary Catheter||Indwelling Device Use||participants|Number|163|163.0||||||
4065337|NCT01062841|3887401|B2|Indwelling Urinary Catheter||Indwelling Device Use||participants|Number|79|79.0||||||
4065338|NCT01062841|3887402|B1|Indwelling Urinary Catheter||Indwelling Device Use||participants|Number|84|84.0||||||
4065339|NCT01062841|3887400|B3|||Physical Self-Maintenance Scale|Functional disability was assessed using Lawton and Brody’s physical self-maintenance scale. Patients are evaluated on their ability to perform six activities of daily living (toileting, feeding, dressing, grooming, bathing, physical ambulation), with 1 = independent, 2 = needs reminders, 3 = needs moderate assistance, 4 = needs extensive assistance, 5 = needs full assistance or resistant to care. The total physical self-maintenance scale ranges from 6 to 30, with increasing scores indicating increasing disability to perform activities of daily living.|units on a scale|Mean|22.4|22.4|Standard Deviation|4.1|4.1|||
4065340|NCT01062841|3887401|B2|||Physical Self-Maintenance Scale|Functional disability was assessed using Lawton and Brody’s physical self-maintenance scale. Patients are evaluated on their ability to perform six activities of daily living (toileting, feeding, dressing, grooming, bathing, physical ambulation), with 1 = independent, 2 = needs reminders, 3 = needs moderate assistance, 4 = needs extensive assistance, 5 = needs full assistance or resistant to care. The total physical self-maintenance scale ranges from 6 to 30, with increasing scores indicating increasing disability to perform activities of daily living.|units on a scale|Mean|22.1|22.1|Standard Deviation|4.1|4.1|||
4065341|NCT01062841|3887402|B1|||Physical Self-Maintenance Scale|Functional disability was assessed using Lawton and Brody’s physical self-maintenance scale. Patients are evaluated on their ability to perform six activities of daily living (toileting, feeding, dressing, grooming, bathing, physical ambulation), with 1 = independent, 2 = needs reminders, 3 = needs moderate assistance, 4 = needs extensive assistance, 5 = needs full assistance or resistant to care. The total physical self-maintenance scale ranges from 6 to 30, with increasing scores indicating increasing disability to perform activities of daily living.|units on a scale|Mean|22.6|22.6|Standard Deviation|4.1|4.1|||
4065342|NCT01062841|3887400|B3|||Charlson's Comorbidity Score|Charlson's comorbidity score is a weighted index that takes into account the number and seriousness of comorbid disease. It is a classification of comorbid conditions what might alter the risk of mortality in longitudinal studies. 19 conditions are scored with 1, 2, 3, or 6 points. Total Score Range 0 to 37, with increasing scores indicating increasing burden of comorbidity (by increased number of comorbid conditions present, or increased severity of conditions present).|units on a scale|Mean|2.9|2.9|Standard Deviation|1.9|1.9|||
4065343|NCT01062841|3887401|B2|||Charlson's Comorbidity Score|Charlson's comorbidity score is a weighted index that takes into account the number and seriousness of comorbid disease. It is a classification of comorbid conditions what might alter the risk of mortality in longitudinal studies. 19 conditions are scored with 1, 2, 3, or 6 points. Total Score Range 0 to 37, with increasing scores indicating increasing burden of comorbidity (by increased number of comorbid conditions present, or increased severity of conditions present).|units on a scale|Mean|2.9|2.9|Standard Deviation|2.1|2.1|||
4065344|NCT01062841|3887402|B1|||Charlson's Comorbidity Score|Charlson's comorbidity score is a weighted index that takes into account the number and seriousness of comorbid disease. It is a classification of comorbid conditions what might alter the risk of mortality in longitudinal studies. 19 conditions are scored with 1, 2, 3, or 6 points. Total Score Range 0 to 37, with increasing scores indicating increasing burden of comorbidity (by increased number of comorbid conditions present, or increased severity of conditions present).|units on a scale|Mean|2.8|2.8|Standard Deviation|1.6|1.6|||
4065345|NCT01062841|3887400|B3|United States||Region of Enrollment||participants|Number|316|316.0||||||
4065346|NCT01062841|3887401|B2|United States||Region of Enrollment||participants|Number|162|162.0||||||
4065347|NCT01062841|3887402|B1|United States||Region of Enrollment||participants|Number|154|154.0||||||
4065348|NCT01062841|3887400|B3|Other Race||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4065349|NCT01062841|3887401|B2|Other Race||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4065350|NCT01062841|3887402|B1|Other Race||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4065351|NCT01062841|3887400|B3|White Race||Race/Ethnicity, Customized||participants|Number|276|276.0||||||
4065352|NCT01062841|3887401|B2|White Race||Race/Ethnicity, Customized||participants|Number|144|144.0||||||
4065353|NCT01062841|3887402|B1|White Race||Race/Ethnicity, Customized||participants|Number|132|132.0||||||
4065354|NCT01062841|3887400|B3||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4065355|NCT01062841|3887401|B2||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4065356|NCT01062841|3887402|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4065357|NCT01062841|3887400|B3||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4065358|NCT01062841|3887401|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4065359|NCT01062841|3887402|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4065360|NCT01062841|3887400|B3|||Age||years|Mean|73.1|73.1|Standard Deviation|12.95|12.95|||
4065361|NCT01062841|3887401|B2|||Age||years|Mean|72.2|72.2|Standard Deviation|13.5|13.5|||
4065362|NCT01062841|3887402|B1|||Age||years|Mean|74.0|74.0|Standard Deviation|12.4|12.4|||
4065363|NCT01062763|3887431|B3|Denmark||Region of Enrollment||participants|Number|119|119.0||||||
4065364|NCT01062763|3887432|B2|Denmark||Region of Enrollment||participants|Number|58|58.0||||||
4065365|NCT01062763|3887433|B1|Denmark||Region of Enrollment||participants|Number|61|61.0||||||
4065366|NCT01062763|3887431|B3||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4065367|NCT01062763|3887432|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4065368|NCT01062763|3887433|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4065369|NCT01062763|3887431|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4065370|NCT01062763|3887432|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4065371|NCT01062763|3887433|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4065372|NCT01062763|3887431|B3|||Age||years|Mean|63.4|63.4|Standard Deviation|6.9|6.9|||
4065373|NCT01062763|3887432|B2|||Age||years|Mean|63.9|63.9|Standard Deviation|6.9|6.9|||
4065374|NCT01062763|3887433|B1|||Age||years|Mean|62.9|62.9|Standard Deviation|7.1|7.1|||
4065375|NCT01062763|3887431|B3||>=65 years|Age||Participants|Count of Participants|57|57.0||||||
4065376|NCT01062763|3887432|B2||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4065377|NCT01062763|3887433|B1||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4065378|NCT01062763|3887431|B3||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4065379|NCT01062763|3887432|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4065380|NCT01062763|3887433|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4065381|NCT01062763|3887431|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4065382|NCT01062763|3887432|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4065383|NCT01062763|3887433|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4065384|NCT01062425|3887444|B3||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4065385|NCT01062425|3887445|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4065386|NCT01062425|3887446|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4065387|NCT01062425|3887444|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4065388|NCT01062425|3887445|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4065389|NCT01062425|3887446|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4065390|NCT01062425|3887444|B3|||Age||years|Median|60|60.0|Full Range|||27.0|83.0|
4065391|NCT01062425|3887445|B2|||Age||years|Median|61|61.0|Full Range|||27.0|83.0|
4065392|NCT01062425|3887446|B1|||Age||years|Median|59|59.0|Full Range|||37.0|82.0|
4065393|NCT01062399|3887459|B6||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4065394|NCT01062399|3887460|B5||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4065395|NCT01062399|3887461|B4||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4065396|NCT01062399|3887462|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4065397|NCT01062399|3887463|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4065398|NCT01062399|3887464|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4065399|NCT01062399|3887459|B6||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4065400|NCT01062399|3887460|B5||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4065401|NCT01062399|3887461|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4065402|NCT01062399|3887462|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4065403|NCT01062399|3887463|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4065404|NCT01062399|3887464|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4065405|NCT01062399|3887459|B6|||Age||years|Median|59|59.0|Full Range|||23.0|82.0|
4065406|NCT01062399|3887460|B5|||Age||years|Median|61|61.0|Full Range|||25.0|82.0|
4065407|NCT01062399|3887461|B4|||Age||years|Median|57|57.0|Full Range|||23.0|79.0|
4065408|NCT01062399|3887462|B3|||Age||years|Median|57|57.0|Full Range|||31.0|73.0|
4065409|NCT01062399|3887463|B2|||Age||years|Median|57|57.0|Full Range|||39.0|69.0|
4065410|NCT01062399|3887464|B1|||Age||years|Median|58|58.0|Full Range|||39.0|72.0|
4065411|NCT01062308|3887487|B3|India||Region of Enrollment||participants|Number|162|162.0||||||
4065412|NCT01062308|3887488|B2|India||Region of Enrollment||participants|Number|82|82.0||||||
4065413|NCT01062308|3887489|B1|India||Region of Enrollment||participants|Number|80|80.0||||||
4065414|NCT01062308|3887487|B3||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4065415|NCT01062308|3887488|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4065416|NCT01062308|3887489|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4065417|NCT01062308|3887487|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4065418|NCT01062308|3887488|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4065419|NCT01062308|3887489|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4065420|NCT01062308|3887487|B3|||Age||years|Mean|58|58.0|Standard Deviation|13|13.0|||
4065421|NCT01062308|3887488|B2|||Age||years|Mean|60|60.0|Standard Deviation|13|13.0|||
4065422|NCT01062308|3887489|B1|||Age||years|Mean|56|56.0|Standard Deviation|13|13.0|||
4065423|NCT01062308|3887487|B3||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4065424|NCT01062308|3887488|B2||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4065425|NCT01062308|3887489|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4065426|NCT01062308|3887487|B3||Between 18 and 65 years|Age||Participants|Count of Participants|123|123.0||||||
4065427|NCT01062308|3887488|B2||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4065428|NCT01062308|3887489|B1||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4065429|NCT01062308|3887487|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4065430|NCT01062308|3887488|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4065431|NCT01062308|3887489|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4065432|NCT01062269|3887498|B1|||Total Enrollment Numbers|Although 3 different arms are used in this study, there is only one study group. All subjects receive all 3 treatment arms on the same day, just in varying orders. Thus, total enrollment number is reflective of all study subjects who participated in the trial.|Participants|Number|42|42.0||||||
4065433|NCT01062269|3887498|B1|United States||Region of Enrollment|Although 3 different arms are used in this study, there is only one study group. All subjects receive all 3 treatment arms on the same day, just in varying orders. Thus, the regions of enrollment are the same for all three arms.|participants|Number|42|42.0||||||
4065487|NCT01062074|3887563|B1||Female|Sex: Female, Male||Participants|Count of Participants|3549|3549.0||||||
4065488|NCT01062074|3887563|B1|>=19 years||Age, Customized||Participants|Number|2748|2748.0||||||
4065434|NCT01062269|3887498|B1||Male|Sex: Female, Male|Although 3 different arms are used in this study, there is only one study group. All subjects receive all 3 treatment arms on the same day, just in varying orders. Thus, the gender characteristics are the same for all three arms.|Participants|Count of Participants|26|26.0||||||
4065435|NCT01062269|3887498|B1||Female|Sex: Female, Male|Although 3 different arms are used in this study, there is only one study group. All subjects receive all 3 treatment arms on the same day, just in varying orders. Thus, the gender characteristics are the same for all three arms.|Participants|Count of Participants|16|16.0||||||
4065436|NCT01062269|3887498|B1|||Age|Although 3 different arms are used in this study, there is only one study group. All subjects receive all 3 treatment arms on the same day, just in varying orders. Thus, the age characteristics are the same for all three arms.|years|Mean|51.2|51.2|Standard Deviation|10.1|10.1|||
4065437|NCT01062269|3887498|B1||>=65 years|Age|Although 3 different arms are used in this study, there is only one study group. All subjects receive all 3 treatment arms on the same day, just in varying orders. Thus, the age characteristics are the same for all three arms.|Participants|Count of Participants|2|2.0||||||
4065438|NCT01062269|3887498|B1||Between 18 and 65 years|Age|Although 3 different arms are used in this study, there is only one study group. All subjects receive all 3 treatment arms on the same day, just in varying orders. Thus, the age characteristics are the same for all three arms.|Participants|Count of Participants|40|40.0||||||
4065439|NCT01062269|3887498|B1||<=18 years|Age|Although 3 different arms are used in this study, there is only one study group. All subjects receive all 3 treatment arms on the same day, just in varying orders. Thus, the age characteristics are the same for all three arms.|Participants|Count of Participants|0|0.0||||||
4065440|NCT01062256|3887509|B4||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4065441|NCT01062256|3887510|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4065442|NCT01062256|3887511|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4065443|NCT01062256|3887512|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4065444|NCT01062256|3887509|B4||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4065445|NCT01062256|3887510|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4065446|NCT01062256|3887511|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4065447|NCT01062256|3887512|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4065448|NCT01062256|3887509|B4|||Age||years|Mean|32.3|32.3|Standard Deviation|10.8|10.8|||
4065449|NCT01062256|3887510|B3|||Age||years|Mean|32.4|32.4|Standard Deviation|11.1|11.1|||
4065450|NCT01062256|3887511|B2|||Age||years|Mean|33.5|33.5|Standard Deviation|11.2|11.2|||
4065451|NCT01062256|3887512|B1|||Age||years|Mean|29.9|29.9|Standard Deviation|9.5|9.5|||
4065452|NCT01062230|3887537|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4065453|NCT01062230|3887537|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4065454|NCT01062230|3887537|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4065455|NCT01062230|3887537|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4065456|NCT01062230|3887537|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4065457|NCT01062230|3887537|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4065458|NCT01062230|3887537|B1|||Age||Years|Median|71|71.0|Standard Deviation|9.58|9.58|||
4065459|NCT01062165|3887541|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4065460|NCT01062165|3887541|B1||Male|Gender||Participants|Count of Participants|9|9.0||||||
4065461|NCT01062165|3887541|B1||Female|Gender||Participants|Count of Participants|9|9.0||||||
4065462|NCT01062165|3887541|B1|||Age||years|Mean|41.1|41.1|Standard Deviation|13.2|13.2|||
4065463|NCT01062165|3887541|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4065464|NCT01062165|3887541|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4065465|NCT01062165|3887541|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4065466|NCT01062113|3887545|B4||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4065467|NCT01062113|3887546|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4065468|NCT01062113|3887547|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4065469|NCT01062113|3887548|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4065470|NCT01062113|3887545|B4||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4065471|NCT01062113|3887546|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4065472|NCT01062113|3887547|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4065473|NCT01062113|3887548|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4065474|NCT01062113|3887545|B4|>= 65 years||Age, Customized||participants|Number|0|0.0||||||
4065475|NCT01062113|3887546|B3|>= 65 years||Age, Customized||participants|Number|0|0.0||||||
4065476|NCT01062113|3887547|B2|>= 65 years||Age, Customized||participants|Number|0|0.0||||||
4065477|NCT01062113|3887548|B1|>= 65 years||Age, Customized||participants|Number|0|0.0||||||
4065478|NCT01062113|3887545|B4|Between 18 and 64||Age, Customized||participants|Number|255|255.0||||||
4065479|NCT01062113|3887546|B3|Between 18 and 64||Age, Customized||participants|Number|58|58.0||||||
4065480|NCT01062113|3887547|B2|Between 18 and 64||Age, Customized||participants|Number|64|64.0||||||
4065481|NCT01062113|3887548|B1|Between 18 and 64||Age, Customized||participants|Number|133|133.0||||||
4065482|NCT01062113|3887545|B4|< 18 years||Age, Customized||participants|Number|0|0.0||||||
4065483|NCT01062113|3887546|B3|< 18 years||Age, Customized||participants|Number|0|0.0||||||
4065484|NCT01062113|3887547|B2|< 18 years||Age, Customized||participants|Number|0|0.0||||||
4065485|NCT01062113|3887548|B1|< 18 years||Age, Customized||participants|Number|0|0.0||||||
4065486|NCT01062074|3887563|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4065489|NCT01062074|3887563|B1|>=12 years and <19 years||Age, Customized||Participants|Number|735|735.0||||||
4065490|NCT01062074|3887563|B1|<12 years||Age, Customized||Participants|Number|122|122.0||||||
4065491|NCT01062074|3887563|B1|||Age||Years|Mean|20.79|20.79|Standard Deviation|4.02|4.02|||
4065492|NCT01062061|3887568|B1||Male|Sex: Female, Male||Participants|Count of Participants|380|380.0||||||
4065493|NCT01062061|3887568|B1||Female|Sex: Female, Male||Participants|Count of Participants|347|347.0||||||
4065494|NCT01062061|3887568|B1|≥2 years||Age, Customized||Participants|Number|41|41.0||||||
4065495|NCT01062061|3887568|B1|<2 years||Age, Customized||Participants|Number|686|686.0||||||
4065496|NCT01062061|3887568|B1|||Age||years|Mean|1.19|1.19|Standard Deviation|0.92|0.92|||
4065497|NCT01061866|3887582|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4065498|NCT01061866|3887582|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4065499|NCT01061866|3887582|B1|||Age||years|Mean|25|25.0|Standard Deviation|3|3.0|||
4065500|NCT01061866|3887582|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4065501|NCT01061866|3887582|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4065502|NCT01061866|3887582|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4065503|NCT01061775|3887586|B1|||Child Eating Behaviour Questionnaire|The Child Eating Behaviour Questionnaire (CEBQ) was designed as parent-report measure comprised of 35 items, each rated on a five-point likert scale that ranges from never to always. We utilized the CEBQ as a self-report measure during this study; it has not been validated for such use. For the purposes of this study, we looked at the Satiety Responsiveness Subscale Scores (5 questions; total scores could range from 5-25 with lower scores denoting a lower level of satiety).|units on a scale|Mean|11.47|11.47|Full Range|||5.0|16.0|
4065504|NCT01061775|3887586|B1|||Waist to Height Ratio||cm|Mean|0.98|0.98|Standard Deviation|0.08|0.08|||
4065505|NCT01061775|3887586|B1|||Hip Circumference||cm|Mean|113.5|113.5|Standard Deviation|16|16.0|||
4065506|NCT01061775|3887586|B1|||Waist Circumference||cm|Mean|111.6|111.6|Standard Deviation|19.5|19.5|||
4065507|NCT01061775|3887586|B1|||Weight||kg|Mean|89|89.0|Standard Deviation|28.2|28.2|||
4065508|NCT01061775|3887586|B1|||Height||cm|Mean|160.8|160.8|Standard Deviation|14.3|14.3|||
4065509|NCT01061775|3887586|B1|||BMI||kg/m^2|Mean|35|35.0|Full Range|||26.9|45.8|
4065510|NCT01061775|3887586|B1|Thalamic astrocytoma||Tumor Type||participants|Number|1|1.0||||||
4065511|NCT01061775|3887586|B1|Suprarasellar germinoma||Tumor Type||participants|Number|2|2.0||||||
4065512|NCT01061775|3887586|B1|Optic chiasm-hypothalamic glioma||Tumor Type||participants|Number|2|2.0||||||
4065513|NCT01061775|3887586|B1|Craniopharyngioma||Tumor Type||participants|Number|14|14.0||||||
4065514|NCT01061775|3887586|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4065515|NCT01061775|3887586|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4065516|NCT01061775|3887586|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4065517|NCT01061775|3887586|B1|||Age||years|Median|15|15.0|Full Range|||10.0|21.0|
4065518|NCT01061775|3887586|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4065519|NCT01061775|3887586|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4065520|NCT01061775|3887586|B1||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4065521|NCT01061736|3887593|B11||Male|Sex: Female, Male||Participants|Count of Participants|313|313.0||||||
4065522|NCT01061736|3887594|B10||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4065523|NCT01061736|3887595|B9||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4065524|NCT01061736|3887596|B8||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4065525|NCT01061736|3887597|B7||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4065526|NCT01061736|3887598|B6||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4065527|NCT01061736|3887599|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4065528|NCT01061736|3887600|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4065529|NCT01061736|3887601|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4065530|NCT01061736|3887602|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4065531|NCT01061736|3887603|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4065532|NCT01061736|3887593|B11||Female|Sex: Female, Male||Participants|Count of Participants|1362|1362.0||||||
4065533|NCT01061736|3887594|B10||Female|Sex: Female, Male||Participants|Count of Participants|346|346.0||||||
4065534|NCT01061736|3887595|B9||Female|Sex: Female, Male||Participants|Count of Participants|359|359.0||||||
4065535|NCT01061736|3887596|B8||Female|Sex: Female, Male||Participants|Count of Participants|345|345.0||||||
4065536|NCT01061736|3887597|B7||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4065537|NCT01061736|3887598|B6||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4065538|NCT01061736|3887599|B5||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4065539|NCT01061736|3887600|B4||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4065540|NCT01061736|3887601|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4065541|NCT01061736|3887602|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4065542|NCT01061736|3887603|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4065543|NCT01061736|3887593|B11|||Age||years|Mean|51.04|51.04|Standard Deviation|11.79|11.79|||
4065544|NCT01061736|3887594|B10|||Age||years|Mean|51.1|51.1|Standard Deviation|11.2|11.2|||
4065545|NCT01061736|3887595|B9|||Age||years|Mean|50.8|50.8|Standard Deviation|12.0|12.0|||
4065546|NCT01061736|3887596|B8|||Age||years|Mean|50.3|50.3|Standard Deviation|11.9|11.9|||
4065547|NCT01061736|3887597|B7|||Age||years|Mean|51.1|51.1|Standard Deviation|11.5|11.5|||
4065548|NCT01061736|3887598|B6|||Age||years|Mean|55.2|55.2|Standard Deviation|12.5|12.5|||
4065549|NCT01061736|3887599|B5|||Age||years|Mean|48.7|48.7|Standard Deviation|12.4|12.4|||
4065550|NCT01061736|3887600|B4|||Age||years|Mean|51.2|51.2|Standard Deviation|12.9|12.9|||
4065551|NCT01061736|3887601|B3|||Age||years|Mean|53.5|53.5|Standard Deviation|11.8|11.8|||
4065552|NCT01061736|3887602|B2|||Age||years|Mean|50.9|50.9|Standard Deviation|11.1|11.1|||
4065553|NCT01061736|3887603|B1|||Age||years|Mean|53.9|53.9|Standard Deviation|12.3|12.3|||
4065554|NCT01061723|3887645|B7||Male|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4065555|NCT01061723|3887646|B6||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4065556|NCT01061723|3887647|B5||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4065557|NCT01061723|3887648|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4065558|NCT01061723|3887649|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4065559|NCT01061723|3887650|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4065560|NCT01061723|3887651|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4065561|NCT01061723|3887645|B7||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4065562|NCT01061723|3887646|B6||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4065563|NCT01061723|3887647|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4065564|NCT01061723|3887648|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4065565|NCT01061723|3887649|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4065566|NCT01061723|3887650|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4065567|NCT01061723|3887651|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4065568|NCT01061723|3887645|B7|||Age||years|Mean|40.7|40.7|Standard Deviation|11.2|11.2|||
4065569|NCT01061723|3887646|B6|||Age||years|Mean|41.1|41.1|Standard Deviation|11.1|11.1|||
4065570|NCT01061723|3887647|B5|||Age||years|Mean|37.2|37.2|Standard Deviation|10.4|10.4|||
4065571|NCT01061723|3887648|B4|||Age||years|Mean|40.4|40.4|Standard Deviation|11.5|11.5|||
4065572|NCT01061723|3887649|B3|||Age||years|Mean|43.0|43.0|Standard Deviation|11.3|11.3|||
4065573|NCT01061723|3887650|B2|||Age||years|Mean|42.4|42.4|Standard Deviation|10.8|10.8|||
4065574|NCT01061723|3887651|B1|||Age||years|Mean|40.3|40.3|Standard Deviation|11.7|11.7|||
4065575|NCT01061710|3887736|B1|Male||Sex/Gender, Customized||participants|Number|6|6.0||||||
4065576|NCT01061710|3887736|B1|Female||Sex/Gender, Customized||participants|Number|0|0.0||||||
4065577|NCT01061710|3887736|B1|>=65 years||Age, Customized||participants|Number|3|3.0||||||
4065578|NCT01061710|3887736|B1|<65 years||Age, Customized||participants|Number|3|3.0||||||
4065579|NCT01061671|3887744|B3|No||Use of supplemental oxygen within previous 12 mo||participants|Number|465|465.0||||||
4065580|NCT01061671|3887745|B2|No||Use of supplemental oxygen within previous 12 mo||participants|Number|230|230.0||||||
4065581|NCT01061671|3887746|B1|No||Use of supplemental oxygen within previous 12 mo||participants|Number|235|235.0||||||
4065582|NCT01061671|3887744|B3|Yes||Use of supplemental oxygen within previous 12 mo||participants|Number|420|420.0||||||
4065583|NCT01061671|3887745|B2|Yes||Use of supplemental oxygen within previous 12 mo||participants|Number|222|222.0||||||
4065584|NCT01061671|3887746|B1|Yes||Use of supplemental oxygen within previous 12 mo||participants|Number|198|198.0||||||
4065585|NCT01061671|3887744|B3|No||Systemic glucocorticoid or antibiotic use within previous 12 mo||participants|Number|136|136.0||||||
4065586|NCT01061671|3887745|B2|No||Systemic glucocorticoid or antibiotic use within previous 12 mo||participants|Number|70|70.0||||||
4065587|NCT01061671|3887746|B1|No||Systemic glucocorticoid or antibiotic use within previous 12 mo||participants|Number|66|66.0||||||
4065588|NCT01061671|3887744|B3|Yes||Systemic glucocorticoid or antibiotic use within previous 12 mo||participants|Number|749|749.0||||||
4065589|NCT01061671|3887745|B2|Yes||Systemic glucocorticoid or antibiotic use within previous 12 mo||participants|Number|382|382.0||||||
4065590|NCT01061671|3887746|B1|Yes||Systemic glucocorticoid or antibiotic use within previous 12 mo||participants|Number|367|367.0||||||
4065591|NCT01061671|3887744|B3|No||Acute COPD Exacerbation requiring Hospitalization or ED visit within previous 12 mo|Acute COPD (Chronic Obstructive Pulmonary Disease) Exacerbation requiring Hospitalization or Emergency Department visit within previous 12 months|participants|Number|431|431.0||||||
4065592|NCT01061671|3887745|B2|No||Acute COPD Exacerbation requiring Hospitalization or ED visit within previous 12 mo|Acute COPD (Chronic Obstructive Pulmonary Disease) Exacerbation requiring Hospitalization or Emergency Department visit within previous 12 months|participants|Number|214|214.0||||||
4065593|NCT01061671|3887746|B1|No||Acute COPD Exacerbation requiring Hospitalization or ED visit within previous 12 mo|Acute COPD (Chronic Obstructive Pulmonary Disease) Exacerbation requiring Hospitalization or Emergency Department visit within previous 12 months|participants|Number|217|217.0||||||
4065594|NCT01061671|3887744|B3|Yes||Acute COPD Exacerbation requiring Hospitalization or ED visit within previous 12 mo|Acute COPD (Chronic Obstructive Pulmonary Disease) Exacerbation requiring Hospitalization or Emergency Department visit within previous 12 months|participants|Number|454|454.0||||||
4065595|NCT01061671|3887745|B2|Yes||Acute COPD Exacerbation requiring Hospitalization or ED visit within previous 12 mo|Acute COPD (Chronic Obstructive Pulmonary Disease) Exacerbation requiring Hospitalization or Emergency Department visit within previous 12 months|participants|Number|238|238.0||||||
4065596|NCT01061671|3887746|B1|Yes||Acute COPD Exacerbation requiring Hospitalization or ED visit within previous 12 mo|Acute COPD (Chronic Obstructive Pulmonary Disease) Exacerbation requiring Hospitalization or Emergency Department visit within previous 12 months|participants|Number|216|216.0||||||
4065597|NCT01061671|3887744|B3|||FEV1 (% Predicted)||percent predicted|Mean|41.6|41.6|Standard Deviation|17.7|17.7|||
4065598|NCT01061671|3887745|B2|||FEV1 (% Predicted)||percent predicted|Mean|41.6|41.6|Standard Deviation|17.6|17.6|||
4065599|NCT01061671|3887746|B1|||FEV1 (% Predicted)||percent predicted|Mean|41.5|41.5|Standard Deviation|17.8|17.8|||
4065600|NCT01061671|3887744|B3|||FEV1/FVC (forced expiratory volume at one second/forced vital capacity)||Ratio|Mean|0.44|0.44|Standard Deviation|0.13|0.13|||
4065601|NCT01061671|3887745|B2|||FEV1/FVC (forced expiratory volume at one second/forced vital capacity)||Ratio|Mean|0.44|0.44|Standard Deviation|0.13|0.13|||
4065602|NCT01061671|3887746|B1|||FEV1/FVC (forced expiratory volume at one second/forced vital capacity)||Ratio|Mean|0.44|0.44|Standard Deviation|0.13|0.13|||
4065603|NCT01061671|3887744|B3|||Post‐bronchodilator FEV1 (forced expiratory volume at one second)||liters (L)|Mean|1.19|1.19|Standard Deviation|0.57|0.57|||
4065604|NCT01061671|3887745|B2|||Post‐bronchodilator FEV1 (forced expiratory volume at one second)||liters (L)|Mean|1.19|1.19|Standard Deviation|0.56|0.56|||
4065605|NCT01061671|3887746|B1|||Post‐bronchodilator FEV1 (forced expiratory volume at one second)||liters (L)|Mean|1.19|1.19|Standard Deviation|0.58|0.58|||
4065606|NCT01061671|3887744|B3|||Smoking History (Pack Years)||Pack Years|Mean|50.6|50.6|Standard Deviation|27.4|27.4|||
4065607|NCT01061671|3887745|B2|||Smoking History (Pack Years)||Pack Years|Mean|51.2|51.2|Standard Deviation|28.7|28.7|||
4065608|NCT01061671|3887746|B1|||Smoking History (Pack Years)||Pack Years|Mean|50.0|50.0|Standard Deviation|26.1|26.1|||
4065609|NCT01061671|3887744|B3|Canada||Region of Enrollment||participants|Number|147|147.0||||||
4065610|NCT01061671|3887745|B2|Canada||Region of Enrollment||participants|Number|76|76.0||||||
4065611|NCT01061671|3887746|B1|Canada||Region of Enrollment||participants|Number|71|71.0||||||
4065612|NCT01061671|3887744|B3|United States||Region of Enrollment||participants|Number|738|738.0||||||
4065613|NCT01061671|3887745|B2|United States||Region of Enrollment||participants|Number|376|376.0||||||
4065614|NCT01061671|3887746|B1|United States||Region of Enrollment||participants|Number|362|362.0||||||
4065615|NCT01061671|3887744|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4065616|NCT01061671|3887745|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4065617|NCT01061671|3887746|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4065618|NCT01061671|3887744|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4065619|NCT01061671|3887745|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4065620|NCT01061671|3887746|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4065621|NCT01061671|3887744|B3||White|Race (NIH/OMB)||Participants|Count of Participants|674|674.0||||||
4065622|NCT01061671|3887745|B2||White|Race (NIH/OMB)||Participants|Count of Participants|346|346.0||||||
4065623|NCT01061671|3887746|B1||White|Race (NIH/OMB)||Participants|Count of Participants|328|328.0||||||
4065624|NCT01061671|3887744|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|190|190.0||||||
4065625|NCT01061671|3887745|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
4065626|NCT01061671|3887746|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
4065627|NCT01061671|3887744|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4065628|NCT01061671|3887745|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4065629|NCT01061671|3887746|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4065630|NCT01061671|3887744|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4065631|NCT01061671|3887745|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4065632|NCT01061671|3887746|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4065633|NCT01061671|3887744|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4065634|NCT01061671|3887745|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4065635|NCT01061671|3887746|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4065636|NCT01061671|3887744|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4065637|NCT01061671|3887745|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4065638|NCT01061671|3887746|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4065639|NCT01061671|3887744|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|874|874.0||||||
4065640|NCT01061671|3887745|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|445|445.0||||||
4065641|NCT01061671|3887746|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|429|429.0||||||
4065642|NCT01061671|3887744|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4065643|NCT01061671|3887745|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4065644|NCT01061671|3887746|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4065645|NCT01061671|3887744|B3||Male|Sex: Female, Male||Participants|Count of Participants|498|498.0||||||
4065646|NCT01061671|3887745|B2||Male|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
4065647|NCT01061671|3887746|B1||Male|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
4065648|NCT01061671|3887744|B3||Female|Sex: Female, Male||Participants|Count of Participants|387|387.0||||||
4065649|NCT01061671|3887745|B2||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4065650|NCT01061671|3887746|B1||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4065651|NCT01061671|3887744|B3|||Age||years|Mean|62.2|62.2|Standard Deviation|8.4|8.4|||
4065652|NCT01061671|3887745|B2|||Age||years|Mean|62.3|62.3|Standard Deviation|8.4|8.4|||
4065653|NCT01061671|3887746|B1|||Age||years|Mean|62.2|62.2|Standard Deviation|8.5|8.5|||
4065654|NCT01061606|3887759|B1|Unknown||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4065655|NCT01061606|3887759|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4065656|NCT01061606|3887759|B1|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4065657|NCT01061606|3887759|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4065658|NCT01061606|3887759|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4065659|NCT01061606|3887759|B1|||Age||years|Median|62|62.0|Full Range|||47.0|72.0|
4065660|NCT01061567|3887768|B1|Male||Gender|The documentation of gender was missing for 15 patients.|participants|Number|889|889.0||||||
4065661|NCT01061567|3887768|B1|Female||Gender|The documentation of gender was missing for 15 patients.|participants|Number|910|910.0||||||
4065662|NCT01061567|3887768|B1|||Age|For 19 patients no data for age was documented, so the age was available for N=1795 patients|years|Mean|68.8|68.8|Standard Deviation|9.2|9.2|||
4065663|NCT01061528|3887777|B3|United States||Region of Enrollment||participants|Number|116|116.0||||||
4065664|NCT01061528|3887778|B2|United States||Region of Enrollment||participants|Number|54|54.0||||||
4065665|NCT01061528|3887779|B1|United States||Region of Enrollment||participants|Number|62|62.0||||||
4065666|NCT01061528|3887777|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4065667|NCT01061528|3887778|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4065668|NCT01061528|3887779|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4065669|NCT01061528|3887777|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4065670|NCT01061528|3887778|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4065671|NCT01061528|3887779|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4065672|NCT01061528|3887777|B3|||Age||years|Mean|46.06|46.06|Standard Deviation|11.23|11.23|||
4065673|NCT01061528|3887778|B2|||Age||years|Mean|47.31|47.31|Standard Deviation|10.98|10.98|||
4065674|NCT01061528|3887779|B1|||Age||years|Mean|44.97|44.97|Standard Deviation|11.45|11.45|||
4065675|NCT01061528|3887777|B3||>=65 years|Age|The measure is a count of the number of participants enrolled in the study at baseline.|Participants|Count of Participants|0|0.0||||||
4065676|NCT01061528|3887778|B2||>=65 years|Age|The measure is a count of the number of participants enrolled in the study at baseline.|Participants|Count of Participants|0|0.0||||||
4065677|NCT01061528|3887779|B1||>=65 years|Age|The measure is a count of the number of participants enrolled in the study at baseline.|Participants|Count of Participants|0|0.0||||||
4065678|NCT01061528|3887777|B3||Between 18 and 65 years|Age|The measure is a count of the number of participants enrolled in the study at baseline.|Participants|Count of Participants|116|116.0||||||
4065679|NCT01061528|3887778|B2||Between 18 and 65 years|Age|The measure is a count of the number of participants enrolled in the study at baseline.|Participants|Count of Participants|54|54.0||||||
4065680|NCT01061528|3887779|B1||Between 18 and 65 years|Age|The measure is a count of the number of participants enrolled in the study at baseline.|Participants|Count of Participants|62|62.0||||||
4065681|NCT01061528|3887777|B3||<=18 years|Age|The measure is a count of the number of participants enrolled in the study at baseline.|Participants|Count of Participants|0|0.0||||||
4065682|NCT01061528|3887778|B2||<=18 years|Age|The measure is a count of the number of participants enrolled in the study at baseline.|Participants|Count of Participants|0|0.0||||||
4065683|NCT01061528|3887779|B1||<=18 years|Age|The measure is a count of the number of participants enrolled in the study at baseline.|Participants|Count of Participants|0|0.0||||||
4065684|NCT01061476|3887786|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4065685|NCT01061476|3887786|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4065686|NCT01061476|3887786|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4065687|NCT01061476|3887786|B1|||Age||years|Mean|48.3|48.3|Standard Deviation|18.2|18.2|||
4065688|NCT01061476|3887786|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4065689|NCT01061476|3887786|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4065690|NCT01061476|3887786|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4065691|NCT01061385|3887790|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4065692|NCT01061385|3887791|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4065693|NCT01061385|3887792|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4065694|NCT01061385|3887790|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4065695|NCT01061385|3887791|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4065696|NCT01061385|3887792|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4065697|NCT01061385|3887790|B3|||Age||years|Mean|40.8|40.8|Full Range|||26.0|59.0|
4065698|NCT01061385|3887791|B2|||Age||years|Mean|45.3|45.3|Full Range|||37.0|55.0|
4065699|NCT01061385|3887792|B1|||Age||years|Mean|38.9|38.9|Full Range|||26.0|59.0|
4065700|NCT01061359|3887801|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4065701|NCT01061359|3887801|B1||Female|Sex: Female, Male||Participants|Count of Participants|1972|1972.0||||||
4065702|NCT01061359|3887801|B1|Unknown||Age, Customized||participants|Number|54|54.0||||||
4065703|NCT01061359|3887801|B1|>=80 and <90 years||Age, Customized||participants|Number|1|1.0||||||
4065704|NCT01061359|3887801|B1|>=70 and <80 years||Age, Customized||participants|Number|101|101.0||||||
4065705|NCT01061359|3887801|B1|>=60 and <70 years||Age, Customized||participants|Number|557|557.0||||||
4065706|NCT01061359|3887801|B1|>=50 and <60 years||Age, Customized||participants|Number|568|568.0||||||
4065707|NCT01061359|3887801|B1|>=40 and <50 years||Age, Customized||participants|Number|512|512.0||||||
4065708|NCT01061359|3887801|B1|>=30 and <40 years||Age, Customized||participants|Number|167|167.0||||||
4065709|NCT01061359|3887801|B1|>=20 and <30 years||Age, Customized||participants|Number|12|12.0||||||
4065710|NCT01061359|3887801|B1|||Age||years|Median|54.73|54.73|Full Range|||25.36|80.42|
4065711|NCT01061333|3887807|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4065712|NCT01061333|3887807|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4065713|NCT01061333|3887807|B1|||Age||years|Mean|31.94|31.94|Standard Deviation|7.47|7.47|||
4065714|NCT01061177|3887846|B1|Missing||ECOG performance score|ECOG = Eastern Cooperative Oncology Group|Participants|Number|2|2.0||||||
4065715|NCT01061177|3887846|B1|Completely disabled (4)||ECOG performance score|ECOG = Eastern Cooperative Oncology Group|Participants|Number|0|0.0||||||
4065716|NCT01061177|3887846|B1|Limited self care (3)||ECOG performance score|ECOG = Eastern Cooperative Oncology Group|Participants|Number|0|0.0||||||
4065717|NCT01061177|3887846|B1|Only self care (2)||ECOG performance score|ECOG = Eastern Cooperative Oncology Group|Participants|Number|21|21.0||||||
4065718|NCT01061177|3887846|B1|Only light work (1)||ECOG performance score|ECOG = Eastern Cooperative Oncology Group|Participants|Number|199|199.0||||||
4065719|NCT01061177|3887846|B1|No restrictions (0)||ECOG performance score|ECOG = Eastern Cooperative Oncology Group|Participants|Number|867|867.0||||||
4065720|NCT01061177|3887846|B1|||Weight at baseline||Kg|Mean|77.47|77.47|Standard Deviation|15.730|15.73|||
4065721|NCT01061177|3887846|B1|Other||Race/Ethnicity, Customized||Participants|Number|31|31.0||||||
4065722|NCT01061177|3887846|B1|Native American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4065723|NCT01061177|3887846|B1|Oriental||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4065724|NCT01061177|3887846|B1|Black||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4065725|NCT01061177|3887846|B1|Caucacian||Race/Ethnicity, Customized||Participants|Number|1045|1045.0||||||
4065726|NCT01061177|3887846|B1||Male|Gender||Participants|Count of Participants|642|642.0||||||
4065727|NCT01061177|3887846|B1||Female|Gender||Participants|Count of Participants|447|447.0||||||
4065728|NCT01061177|3887846|B1|||Age||Years|Mean|51.6|51.6|Standard Deviation|14.87|14.87|||
4065729|NCT01061151|3887865|B5||No ARVs during the current pregnancy|The Last ARV Regimen before Entry during the Current Pregnancy||Participants|Count of Participants|2873|2873.0||||||
4065730|NCT01061151|3887866|B4||No ARVs during the current pregnancy|The Last ARV Regimen before Entry during the Current Pregnancy||Participants|Count of Participants|153|153.0||||||
4065731|NCT01061151|3887867|B3||No ARVs during the current pregnancy|The Last ARV Regimen before Entry during the Current Pregnancy||Participants|Count of Participants|317|317.0||||||
4065732|NCT01061151|3887868|B2||No ARVs during the current pregnancy|The Last ARV Regimen before Entry during the Current Pregnancy||Participants|Count of Participants|1200|1200.0||||||
4065733|NCT01061151|3887869|B1||No ARVs during the current pregnancy|The Last ARV Regimen before Entry during the Current Pregnancy||Participants|Count of Participants|1203|1203.0||||||
4065734|NCT01061151|3887865|B5||One NRTI|The Last ARV Regimen before Entry during the Current Pregnancy||Participants|Count of Participants|787|787.0||||||
4065735|NCT01061151|3887866|B4||One NRTI|The Last ARV Regimen before Entry during the Current Pregnancy||Participants|Count of Participants|0|0.0||||||
4065736|NCT01061151|3887867|B3||One NRTI|The Last ARV Regimen before Entry during the Current Pregnancy||Participants|Count of Participants|125|125.0||||||
4065737|NCT01061151|3887868|B2||One NRTI|The Last ARV Regimen before Entry during the Current Pregnancy||Participants|Count of Participants|336|336.0||||||
4065738|NCT01061151|3887869|B1||One NRTI|The Last ARV Regimen before Entry during the Current Pregnancy||Participants|Count of Participants|326|326.0||||||
4065739|NCT01061151|3887865|B5||sdNVP|The Last ARV Regimen before Entry during the Current Pregnancy||Participants|Count of Participants|40|40.0||||||
4065740|NCT01061151|3887866|B4||sdNVP|The Last ARV Regimen before Entry during the Current Pregnancy||Participants|Count of Participants|33|33.0||||||
4065741|NCT01061151|3887867|B3||sdNVP|The Last ARV Regimen before Entry during the Current Pregnancy||Participants|Count of Participants|0|0.0||||||
4065742|NCT01061151|3887868|B2||sdNVP|The Last ARV Regimen before Entry during the Current Pregnancy||Participants|Count of Participants|2|2.0||||||
4065743|NCT01061151|3887869|B1||sdNVP|The Last ARV Regimen before Entry during the Current Pregnancy||Participants|Count of Participants|5|5.0||||||
4065744|NCT01061151|3887865|B5||sdNVP+ZDV|The Last ARV Regimen before Entry during the Current Pregnancy||Participants|Count of Participants|3|3.0||||||
4065745|NCT01061151|3887866|B4||sdNVP+ZDV|The Last ARV Regimen before Entry during the Current Pregnancy||Participants|Count of Participants|1|1.0||||||
4065746|NCT01061151|3887867|B3||sdNVP+ZDV|The Last ARV Regimen before Entry during the Current Pregnancy||Participants|Count of Participants|0|0.0||||||
4065747|NCT01061151|3887868|B2||sdNVP+ZDV|The Last ARV Regimen before Entry during the Current Pregnancy||Participants|Count of Participants|0|0.0||||||
4065748|NCT01061151|3887869|B1||sdNVP+ZDV|The Last ARV Regimen before Entry during the Current Pregnancy||Participants|Count of Participants|2|2.0||||||
4065749|NCT01061151|3887865|B5||Two NRTIs|The Last ARV Regimen before Entry during the Current Pregnancy||Participants|Count of Participants|20|20.0||||||
4065750|NCT01061151|3887866|B4||Two NRTIs|The Last ARV Regimen before Entry during the Current Pregnancy||Participants|Count of Participants|10|10.0||||||
4065751|NCT01061151|3887867|B3||Two NRTIs|The Last ARV Regimen before Entry during the Current Pregnancy||Participants|Count of Participants|3|3.0||||||
4065752|NCT01061151|3887868|B2||Two NRTIs|The Last ARV Regimen before Entry during the Current Pregnancy||Participants|Count of Participants|5|5.0||||||
4065753|NCT01061151|3887869|B1||Two NRTIs|The Last ARV Regimen before Entry during the Current Pregnancy||Participants|Count of Participants|2|2.0||||||
4065754|NCT01061151|3887865|B5||HAART including NNRTI|The Last ARV Regimen before Entry during the Current Pregnancy||Participants|Count of Participants|9|9.0||||||
4065755|NCT01061151|3887866|B4||HAART including NNRTI|The Last ARV Regimen before Entry during the Current Pregnancy||Participants|Count of Participants|7|7.0||||||
4065756|NCT01061151|3887867|B3||HAART including NNRTI|The Last ARV Regimen before Entry during the Current Pregnancy||Participants|Count of Participants|0|0.0||||||
4065757|NCT01061151|3887868|B2||HAART including NNRTI|The Last ARV Regimen before Entry during the Current Pregnancy||Participants|Count of Participants|1|1.0||||||
4065758|NCT01061151|3887869|B1||HAART including NNRTI|The Last ARV Regimen before Entry during the Current Pregnancy||Participants|Count of Participants|1|1.0||||||
4065759|NCT01061151|3887865|B5||No ARVs for prior PMTCT/no prior pregnancy|The Most Complex ARV Regimen for Prior PMTCT||Participants|Count of Participants|3522|3522.0||||||
4065760|NCT01061151|3887866|B4||No ARVs for prior PMTCT/no prior pregnancy|The Most Complex ARV Regimen for Prior PMTCT||Participants|Count of Participants|202|202.0||||||
4065761|NCT01061151|3887867|B3||No ARVs for prior PMTCT/no prior pregnancy|The Most Complex ARV Regimen for Prior PMTCT||Participants|Count of Participants|422|422.0||||||
4065762|NCT01061151|3887868|B2||No ARVs for prior PMTCT/no prior pregnancy|The Most Complex ARV Regimen for Prior PMTCT||Participants|Count of Participants|1442|1442.0||||||
4065763|NCT01061151|3887869|B1||No ARVs for prior PMTCT/no prior pregnancy|The Most Complex ARV Regimen for Prior PMTCT||Participants|Count of Participants|1456|1456.0||||||
4065764|NCT01061151|3887865|B5||One NRTI|The Most Complex ARV Regimen for Prior PMTCT||Participants|Count of Participants|4|4.0||||||
4065765|NCT01061151|3887866|B4||One NRTI|The Most Complex ARV Regimen for Prior PMTCT||Participants|Count of Participants|0|0.0||||||
4065766|NCT01061151|3887867|B3||One NRTI|The Most Complex ARV Regimen for Prior PMTCT||Participants|Count of Participants|0|0.0||||||
4065767|NCT01061151|3887868|B2||One NRTI|The Most Complex ARV Regimen for Prior PMTCT||Participants|Count of Participants|2|2.0||||||
4065768|NCT01061151|3887869|B1||One NRTI|The Most Complex ARV Regimen for Prior PMTCT||Participants|Count of Participants|2|2.0||||||
4065769|NCT01061151|3887865|B5||One PI|The Most Complex ARV Regimen for Prior PMTCT||Participants|Count of Participants|1|1.0||||||
4065770|NCT01061151|3887866|B4||One PI|The Most Complex ARV Regimen for Prior PMTCT||Participants|Count of Participants|0|0.0||||||
4065771|NCT01061151|3887867|B3||One PI|The Most Complex ARV Regimen for Prior PMTCT||Participants|Count of Participants|0|0.0||||||
4065772|NCT01061151|3887868|B2||One PI|The Most Complex ARV Regimen for Prior PMTCT||Participants|Count of Participants|1|1.0||||||
4065773|NCT01061151|3887869|B1||One PI|The Most Complex ARV Regimen for Prior PMTCT||Participants|Count of Participants|0|0.0||||||
4065774|NCT01061151|3887865|B5||sdNVP|The Most Complex ARV Regimen for Prior PMTCT||Participants|Count of Participants|104|104.0||||||
4065775|NCT01061151|3887866|B4||sdNVP|The Most Complex ARV Regimen for Prior PMTCT||Participants|Count of Participants|2|2.0||||||
4065776|NCT01061151|3887867|B3||sdNVP|The Most Complex ARV Regimen for Prior PMTCT||Participants|Count of Participants|15|15.0||||||
4065777|NCT01061151|3887868|B2||sdNVP|The Most Complex ARV Regimen for Prior PMTCT||Participants|Count of Participants|46|46.0||||||
4065778|NCT01061151|3887869|B1||sdNVP|The Most Complex ARV Regimen for Prior PMTCT||Participants|Count of Participants|41|41.0||||||
4065779|NCT01061151|3887865|B5||sdNVP+ZDV|The Most Complex ARV Regimen for Prior PMTCT||Participants|Count of Participants|87|87.0||||||
4065780|NCT01061151|3887866|B4||sdNVP+ZDV|The Most Complex ARV Regimen for Prior PMTCT||Participants|Count of Participants|0|0.0||||||
4065781|NCT01061151|3887867|B3||sdNVP+ZDV|The Most Complex ARV Regimen for Prior PMTCT||Participants|Count of Participants|6|6.0||||||
4065782|NCT01061151|3887868|B2||sdNVP+ZDV|The Most Complex ARV Regimen for Prior PMTCT||Participants|Count of Participants|48|48.0||||||
4065783|NCT01061151|3887869|B1||sdNVP+ZDV|The Most Complex ARV Regimen for Prior PMTCT||Participants|Count of Participants|33|33.0||||||
4065784|NCT01061151|3887865|B5||HAART including NNRTI|The Most Complex ARV Regimen for Prior PMTCT||Participants|Count of Participants|14|14.0||||||
4065785|NCT01061151|3887866|B4||HAART including NNRTI|The Most Complex ARV Regimen for Prior PMTCT||Participants|Count of Participants|0|0.0||||||
4065786|NCT01061151|3887867|B3||HAART including NNRTI|The Most Complex ARV Regimen for Prior PMTCT||Participants|Count of Participants|2|2.0||||||
4065787|NCT01061151|3887868|B2||HAART including NNRTI|The Most Complex ARV Regimen for Prior PMTCT||Participants|Count of Participants|5|5.0||||||
4065788|NCT01061151|3887869|B1||HAART including NNRTI|The Most Complex ARV Regimen for Prior PMTCT||Participants|Count of Participants|7|7.0||||||
4065789|NCT01061151|3887865|B5||>= 37 weeks|Gestational age at study entry||Participants|Count of Participants|120|120.0||||||
4065790|NCT01061151|3887866|B4||>= 37 weeks|Gestational age at study entry||Participants|Count of Participants|9|9.0||||||
4065791|NCT01061151|3887867|B3||>= 37 weeks|Gestational age at study entry||Participants|Count of Participants|18|18.0||||||
4065792|NCT01061151|3887868|B2||>= 37 weeks|Gestational age at study entry||Participants|Count of Participants|47|47.0||||||
4065793|NCT01061151|3887869|B1||>= 37 weeks|Gestational age at study entry||Participants|Count of Participants|46|46.0||||||
4065794|NCT01061151|3887865|B5||34 - < 37 weeks|Gestational age at study entry||Participants|Count of Participants|275|275.0||||||
4065795|NCT01061151|3887866|B4||34 - < 37 weeks|Gestational age at study entry||Participants|Count of Participants|0|0.0||||||
4065796|NCT01061151|3887867|B3||34 - < 37 weeks|Gestational age at study entry||Participants|Count of Participants|45|45.0||||||
4065797|NCT01061151|3887868|B2||34 - < 37 weeks|Gestational age at study entry||Participants|Count of Participants|113|113.0||||||
4065798|NCT01061151|3887869|B1||34 - < 37 weeks|Gestational age at study entry||Participants|Count of Participants|117|117.0||||||
4065799|NCT01061151|3887865|B5||28 - <34 weeks|Gestational age at study entry||Participants|Count of Participants|903|903.0||||||
4065800|NCT01061151|3887866|B4||28 - <34 weeks|Gestational age at study entry||Participants|Count of Participants|1|1.0||||||
4065801|NCT01061151|3887867|B3||28 - <34 weeks|Gestational age at study entry||Participants|Count of Participants|116|116.0||||||
4065802|NCT01061151|3887868|B2||28 - <34 weeks|Gestational age at study entry||Participants|Count of Participants|368|368.0||||||
4065803|NCT01061151|3887869|B1||28 - <34 weeks|Gestational age at study entry||Participants|Count of Participants|418|418.0||||||
4065804|NCT01061151|3887865|B5||14 - <28 weeks|Gestational age at study entry||Participants|Count of Participants|2228|2228.0||||||
4065805|NCT01061151|3887866|B4||14 - <28 weeks|Gestational age at study entry||Participants|Count of Participants|0|0.0||||||
4065806|NCT01061151|3887867|B3||14 - <28 weeks|Gestational age at study entry||Participants|Count of Participants|264|264.0||||||
4065807|NCT01061151|3887868|B2||14 - <28 weeks|Gestational age at study entry||Participants|Count of Participants|1008|1008.0||||||
4065808|NCT01061151|3887869|B1||14 - <28 weeks|Gestational age at study entry||Participants|Count of Participants|956|956.0||||||
4065809|NCT01061151|3887865|B5||<14 weeks|Gestational age at study entry||Participants|Count of Participants|20|20.0||||||
4065810|NCT01061151|3887866|B4||<14 weeks|Gestational age at study entry||Participants|Count of Participants|0|0.0||||||
4065811|NCT01061151|3887867|B3||<14 weeks|Gestational age at study entry||Participants|Count of Participants|2|2.0||||||
4065812|NCT01061151|3887868|B2||<14 weeks|Gestational age at study entry||Participants|Count of Participants|8|8.0||||||
4065813|NCT01061151|3887869|B1||<14 weeks|Gestational age at study entry||Participants|Count of Participants|10|10.0||||||
4065814|NCT01061151|3887865|B5|||Gestational age at study entry (weeks)||weeks|Median|25.6|25.6|Inter-Quartile Range|||21.1|30.4|
4065815|NCT01061151|3887866|B4|||Gestational age at study entry (weeks)||weeks|Median|38.6|38.6|Inter-Quartile Range|||37.3|40.0|
4065816|NCT01061151|3887867|B3|||Gestational age at study entry (weeks)||weeks|Median|26|26.0|Inter-Quartile Range|||21.9|31.1|
4065817|NCT01061151|3887868|B2|||Gestational age at study entry (weeks)||weeks|Median|25.2|25.2|Inter-Quartile Range|||20.6|30.1|
4065818|NCT01061151|3887869|B1|||Gestational age at study entry (weeks)||weeks|Median|25.7|25.7|Inter-Quartile Range|||20.9|30.3|
4065819|NCT01061151|3887865|B5||> 120 ml/min|Calculated Creatinine Clearance (ml/min)||Participants|Count of Participants|3376|3376.0||||||
4065820|NCT01061151|3887866|B4||> 120 ml/min|Calculated Creatinine Clearance (ml/min)||Participants|Count of Participants|154|154.0||||||
4065821|NCT01061151|3887867|B3||> 120 ml/min|Calculated Creatinine Clearance (ml/min)||Participants|Count of Participants|397|397.0||||||
4065822|NCT01061151|3887868|B2||> 120 ml/min|Calculated Creatinine Clearance (ml/min)||Participants|Count of Participants|1401|1401.0||||||
4065823|NCT01061151|3887869|B1||> 120 ml/min|Calculated Creatinine Clearance (ml/min)||Participants|Count of Participants|1424|1424.0||||||
4065824|NCT01061151|3887865|B5||> 100 - 120 ml/min|Calculated Creatinine Clearance (ml/min)||Participants|Count of Participants|268|268.0||||||
4065825|NCT01061151|3887866|B4||> 100 - 120 ml/min|Calculated Creatinine Clearance (ml/min)||Participants|Count of Participants|31|31.0||||||
4065826|NCT01061151|3887867|B3||> 100 - 120 ml/min|Calculated Creatinine Clearance (ml/min)||Participants|Count of Participants|39|39.0||||||
4065827|NCT01061151|3887868|B2||> 100 - 120 ml/min|Calculated Creatinine Clearance (ml/min)||Participants|Count of Participants|108|108.0||||||
4065828|NCT01061151|3887869|B1||> 100 - 120 ml/min|Calculated Creatinine Clearance (ml/min)||Participants|Count of Participants|90|90.0||||||
4065829|NCT01061151|3887865|B5||> 80 - 100 ml/min|Calculated Creatinine Clearance (ml/min)||Participants|Count of Participants|74|74.0||||||
4065830|NCT01061151|3887866|B4||> 80 - 100 ml/min|Calculated Creatinine Clearance (ml/min)||Participants|Count of Participants|10|10.0||||||
4065831|NCT01061151|3887867|B3||> 80 - 100 ml/min|Calculated Creatinine Clearance (ml/min)||Participants|Count of Participants|6|6.0||||||
4065832|NCT01061151|3887868|B2||> 80 - 100 ml/min|Calculated Creatinine Clearance (ml/min)||Participants|Count of Participants|31|31.0||||||
4065833|NCT01061151|3887869|B1||> 80 - 100 ml/min|Calculated Creatinine Clearance (ml/min)||Participants|Count of Participants|27|27.0||||||
4065834|NCT01061151|3887865|B5||> 60 - 80 ml/min|Calculated Creatinine Clearance (ml/min)||Participants|Count of Participants|14|14.0||||||
4065835|NCT01061151|3887866|B4||> 60 - 80 ml/min|Calculated Creatinine Clearance (ml/min)||Participants|Count of Participants|2|2.0||||||
4065836|NCT01061151|3887867|B3||> 60 - 80 ml/min|Calculated Creatinine Clearance (ml/min)||Participants|Count of Participants|2|2.0||||||
4065837|NCT01061151|3887868|B2||> 60 - 80 ml/min|Calculated Creatinine Clearance (ml/min)||Participants|Count of Participants|5|5.0||||||
4065838|NCT01061151|3887869|B1||> 60 - 80 ml/min|Calculated Creatinine Clearance (ml/min)||Participants|Count of Participants|5|5.0||||||
4065839|NCT01061151|3887865|B5||> 50 - 60 ml/min|Calculated Creatinine Clearance (ml/min)||Participants|Count of Participants|3|3.0||||||
4065840|NCT01061151|3887866|B4||> 50 - 60 ml/min|Calculated Creatinine Clearance (ml/min)||Participants|Count of Participants|1|1.0||||||
4065841|NCT01061151|3887867|B3||> 50 - 60 ml/min|Calculated Creatinine Clearance (ml/min)||Participants|Count of Participants|1|1.0||||||
4065842|NCT01061151|3887868|B2||> 50 - 60 ml/min|Calculated Creatinine Clearance (ml/min)||Participants|Count of Participants|0|0.0||||||
4065843|NCT01061151|3887869|B1||> 50 - 60 ml/min|Calculated Creatinine Clearance (ml/min)||Participants|Count of Participants|1|1.0||||||
4065844|NCT01061151|3887865|B5||<= 50 ml/min|Calculated Creatinine Clearance (ml/min)||Participants|Count of Participants|1|1.0||||||
4065845|NCT01061151|3887866|B4||<= 50 ml/min|Calculated Creatinine Clearance (ml/min)||Participants|Count of Participants|1|1.0||||||
4065846|NCT01061151|3887867|B3||<= 50 ml/min|Calculated Creatinine Clearance (ml/min)||Participants|Count of Participants|0|0.0||||||
4065847|NCT01061151|3887868|B2||<= 50 ml/min|Calculated Creatinine Clearance (ml/min)||Participants|Count of Participants|0|0.0||||||
4065848|NCT01061151|3887869|B1||<= 50 ml/min|Calculated Creatinine Clearance (ml/min)||Participants|Count of Participants|0|0.0||||||
4065849|NCT01061151|3887865|B5||Clinical stage III|WHO Clinical Staging of HIV/AIDS|Clinical staging of HIV/AIDS by WHO definitions (WHO, 2007). Staging is based on clinical findings that guide the diagnosis, evaluation, and management of HIV/AIDS. Clinical stages are categorized as 1 through 4, progressing from primary HIV infection to advanced HIV/AIDS. These stages are defined by specific clinical conditions or symptoms as described in the reference.|Participants|Count of Participants|3|3.0||||||
4065850|NCT01061151|3887866|B4||Clinical stage III|WHO Clinical Staging of HIV/AIDS|Clinical staging of HIV/AIDS by WHO definitions (WHO, 2007). Staging is based on clinical findings that guide the diagnosis, evaluation, and management of HIV/AIDS. Clinical stages are categorized as 1 through 4, progressing from primary HIV infection to advanced HIV/AIDS. These stages are defined by specific clinical conditions or symptoms as described in the reference.|Participants|Count of Participants|0|0.0||||||
4065851|NCT01061151|3887867|B3||Clinical stage III|WHO Clinical Staging of HIV/AIDS|Clinical staging of HIV/AIDS by WHO definitions (WHO, 2007). Staging is based on clinical findings that guide the diagnosis, evaluation, and management of HIV/AIDS. Clinical stages are categorized as 1 through 4, progressing from primary HIV infection to advanced HIV/AIDS. These stages are defined by specific clinical conditions or symptoms as described in the reference.|Participants|Count of Participants|0|0.0||||||
4065852|NCT01061151|3887868|B2||Clinical stage III|WHO Clinical Staging of HIV/AIDS|Clinical staging of HIV/AIDS by WHO definitions (WHO, 2007). Staging is based on clinical findings that guide the diagnosis, evaluation, and management of HIV/AIDS. Clinical stages are categorized as 1 through 4, progressing from primary HIV infection to advanced HIV/AIDS. These stages are defined by specific clinical conditions or symptoms as described in the reference.|Participants|Count of Participants|2|2.0||||||
4065853|NCT01061151|3887869|B1||Clinical stage III|WHO Clinical Staging of HIV/AIDS|Clinical staging of HIV/AIDS by WHO definitions (WHO, 2007). Staging is based on clinical findings that guide the diagnosis, evaluation, and management of HIV/AIDS. Clinical stages are categorized as 1 through 4, progressing from primary HIV infection to advanced HIV/AIDS. These stages are defined by specific clinical conditions or symptoms as described in the reference.|Participants|Count of Participants|1|1.0||||||
4065854|NCT01061151|3887865|B5||Clinical stage II|WHO Clinical Staging of HIV/AIDS|Clinical staging of HIV/AIDS by WHO definitions (WHO, 2007). Staging is based on clinical findings that guide the diagnosis, evaluation, and management of HIV/AIDS. Clinical stages are categorized as 1 through 4, progressing from primary HIV infection to advanced HIV/AIDS. These stages are defined by specific clinical conditions or symptoms as described in the reference.|Participants|Count of Participants|99|99.0||||||
4065855|NCT01061151|3887866|B4||Clinical stage II|WHO Clinical Staging of HIV/AIDS|Clinical staging of HIV/AIDS by WHO definitions (WHO, 2007). Staging is based on clinical findings that guide the diagnosis, evaluation, and management of HIV/AIDS. Clinical stages are categorized as 1 through 4, progressing from primary HIV infection to advanced HIV/AIDS. These stages are defined by specific clinical conditions or symptoms as described in the reference.|Participants|Count of Participants|4|4.0||||||
4065856|NCT01061151|3887867|B3||Clinical stage II|WHO Clinical Staging of HIV/AIDS|Clinical staging of HIV/AIDS by WHO definitions (WHO, 2007). Staging is based on clinical findings that guide the diagnosis, evaluation, and management of HIV/AIDS. Clinical stages are categorized as 1 through 4, progressing from primary HIV infection to advanced HIV/AIDS. These stages are defined by specific clinical conditions or symptoms as described in the reference.|Participants|Count of Participants|11|11.0||||||
4065857|NCT01061151|3887868|B2||Clinical stage II|WHO Clinical Staging of HIV/AIDS|Clinical staging of HIV/AIDS by WHO definitions (WHO, 2007). Staging is based on clinical findings that guide the diagnosis, evaluation, and management of HIV/AIDS. Clinical stages are categorized as 1 through 4, progressing from primary HIV infection to advanced HIV/AIDS. These stages are defined by specific clinical conditions or symptoms as described in the reference.|Participants|Count of Participants|34|34.0||||||
4065858|NCT01061151|3887869|B1||Clinical stage II|WHO Clinical Staging of HIV/AIDS|Clinical staging of HIV/AIDS by WHO definitions (WHO, 2007). Staging is based on clinical findings that guide the diagnosis, evaluation, and management of HIV/AIDS. Clinical stages are categorized as 1 through 4, progressing from primary HIV infection to advanced HIV/AIDS. These stages are defined by specific clinical conditions or symptoms as described in the reference.|Participants|Count of Participants|50|50.0||||||
4065859|NCT01061151|3887865|B5||Clinical stage I|WHO Clinical Staging of HIV/AIDS|Clinical staging of HIV/AIDS by WHO definitions (WHO, 2007). Staging is based on clinical findings that guide the diagnosis, evaluation, and management of HIV/AIDS. Clinical stages are categorized as 1 through 4, progressing from primary HIV infection to advanced HIV/AIDS. These stages are defined by specific clinical conditions or symptoms as described in the reference.|Participants|Count of Participants|3598|3598.0||||||
4065860|NCT01061151|3887866|B4||Clinical stage I|WHO Clinical Staging of HIV/AIDS|Clinical staging of HIV/AIDS by WHO definitions (WHO, 2007). Staging is based on clinical findings that guide the diagnosis, evaluation, and management of HIV/AIDS. Clinical stages are categorized as 1 through 4, progressing from primary HIV infection to advanced HIV/AIDS. These stages are defined by specific clinical conditions or symptoms as described in the reference.|Participants|Count of Participants|165|165.0||||||
4065861|NCT01061151|3887867|B3||Clinical stage I|WHO Clinical Staging of HIV/AIDS|Clinical staging of HIV/AIDS by WHO definitions (WHO, 2007). Staging is based on clinical findings that guide the diagnosis, evaluation, and management of HIV/AIDS. Clinical stages are categorized as 1 through 4, progressing from primary HIV infection to advanced HIV/AIDS. These stages are defined by specific clinical conditions or symptoms as described in the reference.|Participants|Count of Participants|434|434.0||||||
4065862|NCT01061151|3887868|B2||Clinical stage I|WHO Clinical Staging of HIV/AIDS|Clinical staging of HIV/AIDS by WHO definitions (WHO, 2007). Staging is based on clinical findings that guide the diagnosis, evaluation, and management of HIV/AIDS. Clinical stages are categorized as 1 through 4, progressing from primary HIV infection to advanced HIV/AIDS. These stages are defined by specific clinical conditions or symptoms as described in the reference.|Participants|Count of Participants|1506|1506.0||||||
4065863|NCT01061151|3887869|B1||Clinical stage I|WHO Clinical Staging of HIV/AIDS|Clinical staging of HIV/AIDS by WHO definitions (WHO, 2007). Staging is based on clinical findings that guide the diagnosis, evaluation, and management of HIV/AIDS. Clinical stages are categorized as 1 through 4, progressing from primary HIV infection to advanced HIV/AIDS. These stages are defined by specific clinical conditions or symptoms as described in the reference.|Participants|Count of Participants|1493|1493.0||||||
4065864|NCT01061151|3887865|B5|||Serum Creatinine||mg/dL|Median|0.5|0.5|Inter-Quartile Range|||0.4|0.6|
4065865|NCT01061151|3887866|B4|||Serum Creatinine||mg/dL|Median|0.6|0.6|Inter-Quartile Range|||0.5|0.6|
4065866|NCT01061151|3887867|B3|||Serum Creatinine||mg/dL|Median|0.5|0.5|Inter-Quartile Range|||0.4|0.6|
4065867|NCT01061151|3887868|B2|||Serum Creatinine||mg/dL|Median|0.5|0.5|Inter-Quartile Range|||0.4|0.6|
4065868|NCT01061151|3887869|B1|||Serum Creatinine||mg/dL|Median|0.5|0.5|Inter-Quartile Range|||0.4|0.6|
4065869|NCT01061151|3887865|B5|||Platelet count||cells/mm^3|Median|239000|239000.0|Inter-Quartile Range|||200000.0|285000.0|
4065870|NCT01061151|3887866|B4|||Platelet count||cells/mm^3|Median|255000|255000.0|Inter-Quartile Range|||217000.0|321000.0|
4065871|NCT01061151|3887867|B3|||Platelet count||cells/mm^3|Median|242500|242500.0|Inter-Quartile Range|||203000.0|290000.0|
4065872|NCT01061151|3887868|B2|||Platelet count||cells/mm^3|Median|236000|236000.0|Inter-Quartile Range|||196000.0|282000.0|
4065873|NCT01061151|3887869|B1|||Platelet count||cells/mm^3|Median|238000|238000.0|Inter-Quartile Range|||200000.0|282000.0|
4065874|NCT01061151|3887865|B5|||Absolute Neutrophil Count at Baseline||cells/mm^3|Median|4220|4220.0|Inter-Quartile Range|||3297.0|5400.0|
4065875|NCT01061151|3887866|B4|||Absolute Neutrophil Count at Baseline||cells/mm^3|Median|5680|5680.0|Inter-Quartile Range|||4342.5|7662.5|
4065876|NCT01061151|3887867|B3|||Absolute Neutrophil Count at Baseline||cells/mm^3|Median|3990|3990.0|Inter-Quartile Range|||3220.0|4990.0|
4065877|NCT01061151|3887868|B2|||Absolute Neutrophil Count at Baseline||cells/mm^3|Median|4209|4209.0|Inter-Quartile Range|||3297.0|5300.0|
4065878|NCT01061151|3887869|B1|||Absolute Neutrophil Count at Baseline||cells/mm^3|Median|4140|4140.0|Inter-Quartile Range|||3250.0|5360.0|
4065879|NCT01061151|3887865|B5|||WBC||(cells/mm^3)|Median|6900|6900.0|Inter-Quartile Range|||5700.0|8250.0|
4065880|NCT01061151|3887866|B4|||WBC||(cells/mm^3)|Median|8660|8660.0|Inter-Quartile Range|||6895.0|10755.0|
4065881|NCT01061151|3887867|B3|||WBC||(cells/mm^3)|Median|6840|6840.0|Inter-Quartile Range|||5700.0|7900.0|
4065882|NCT01061151|3887868|B2|||WBC||(cells/mm^3)|Median|6900|6900.0|Inter-Quartile Range|||5700.0|8200.0|
4065883|NCT01061151|3887869|B1|||WBC||(cells/mm^3)|Median|6800|6800.0|Inter-Quartile Range|||5670.0|8200.0|
4065884|NCT01061151|3887865|B5|||Hemoglobin||g/dl|Median|11|11.0|Inter-Quartile Range|||10.2|11.8|
4065885|NCT01061151|3887866|B4|||Hemoglobin||g/dl|Median|10.6|10.6|Inter-Quartile Range|||9.5|11.7|
4065886|NCT01061151|3887867|B3|||Hemoglobin||g/dl|Median|11|11.0|Inter-Quartile Range|||10.3|11.8|
4065887|NCT01061151|3887868|B2|||Hemoglobin||g/dl|Median|11.1|11.1|Inter-Quartile Range|||10.3|11.8|
4065888|NCT01061151|3887869|B1|||Hemoglobin||g/dl|Median|11|11.0|Inter-Quartile Range|||10.2|11.8|
4065889|NCT01061151|3887865|B5|||ALT (SGPT)||units/liter|Median|12|12.0|Inter-Quartile Range|||10.0|16.0|
4065890|NCT01061151|3887866|B4|||ALT (SGPT)||units/liter|Median|16.5|16.5|Inter-Quartile Range|||12.0|22.0|
4065891|NCT01061151|3887867|B3|||ALT (SGPT)||units/liter|Median|12|12.0|Inter-Quartile Range|||9.0|15.0|
4065892|NCT01061151|3887868|B2|||ALT (SGPT)||units/liter|Median|12|12.0|Inter-Quartile Range|||9.0|15.0|
4065893|NCT01061151|3887869|B1|||ALT (SGPT)||units/liter|Median|12|12.0|Inter-Quartile Range|||10.0|16.0|
4065894|NCT01061151|3887865|B5|||CD4 count at screening||cells/mm^3|Median|530|530.0|Inter-Quartile Range|||434.0|670.0|
4065895|NCT01061151|3887866|B4|||CD4 count at screening||cells/mm^3|Median|520|520.0|Inter-Quartile Range|||353.0|723.0|
4065896|NCT01061151|3887867|B3|||CD4 count at screening||cells/mm^3|Median|538|538.0|Inter-Quartile Range|||434.0|684.0|
4065897|NCT01061151|3887868|B2|||CD4 count at screening||cells/mm^3|Median|526|526.0|Inter-Quartile Range|||439.0|651.0|
4065898|NCT01061151|3887869|B1|||CD4 count at screening||cells/mm^3|Median|534|534.0|Inter-Quartile Range|||435.0|678.0|
4065899|NCT01061151|3887865|B5|||Viral Load at enrollment||log10 copies/mL|Median|3.9|3.9|Inter-Quartile Range|||3.2|4.4|
4065900|NCT01061151|3887866|B4|||Viral Load at enrollment||log10 copies/mL|Median|4.1|4.1|Inter-Quartile Range|||3.4|4.6|
4065901|NCT01061151|3887867|B3|||Viral Load at enrollment||log10 copies/mL|Median|3.9|3.9|Inter-Quartile Range|||3.3|4.5|
4065902|NCT01061151|3887868|B2|||Viral Load at enrollment||log10 copies/mL|Median|3.9|3.9|Inter-Quartile Range|||3.3|4.5|
4065903|NCT01061151|3887869|B1|||Viral Load at enrollment||log10 copies/mL|Median|3.8|3.8|Inter-Quartile Range|||3.2|4.4|
4065904|NCT01061151|3887865|B5|||HIV RNA level prior to randomization||copies/ml|Median|7409|7409.0|Inter-Quartile Range|||1708.0|26350.0|
4065905|NCT01061151|3887866|B4|||HIV RNA level prior to randomization||copies/ml|Median|12140|12140.0|Inter-Quartile Range|||2407.5|39138.5|
4065906|NCT01061151|3887867|B3|||HIV RNA level prior to randomization||copies/ml|Median|8393|8393.0|Inter-Quartile Range|||1909.0|28454.0|
4065907|NCT01061151|3887868|B2|||HIV RNA level prior to randomization||copies/ml|Median|8002|8002.0|Inter-Quartile Range|||1854.0|28767.0|
4065908|NCT01061151|3887869|B1|||HIV RNA level prior to randomization||copies/ml|Median|6409|6409.0|Inter-Quartile Range|||1450.5|22720.0|
4065909|NCT01061151|3887865|B5|||BMI||kg/m^2|Median|26|26.0|Inter-Quartile Range|||23.4|29.6|
4065910|NCT01061151|3887866|B4|||BMI||kg/m^2|Median|23.6|23.6|Inter-Quartile Range|||21.8|26.8|
4065911|NCT01061151|3887867|B3|||BMI||kg/m^2|Median|26.3|26.3|Inter-Quartile Range|||23.5|30.1|
4065912|NCT01061151|3887868|B2|||BMI||kg/m^2|Median|26.3|26.3|Inter-Quartile Range|||23.4|29.8|
4065913|NCT01061151|3887869|B1|||BMI||kg/m^2|Median|25.9|25.9|Inter-Quartile Range|||23.5|29.5|
4065914|NCT01061151|3887865|B5|||Weight||kg|Median|64|64.0|Inter-Quartile Range|||57.5|74.0|
4065915|NCT01061151|3887866|B4|||Weight||kg|Median|60.9|60.9|Inter-Quartile Range|||53.0|68.9|
4065916|NCT01061151|3887867|B3|||Weight||kg|Median|64.4|64.4|Inter-Quartile Range|||58.0|75.9|
4065917|NCT01061151|3887868|B2|||Weight||kg|Median|64.6|64.6|Inter-Quartile Range|||58.0|74.1|
4065918|NCT01061151|3887869|B1|||Weight||kg|Median|64|64.0|Inter-Quartile Range|||57.5|73.5|
4065919|NCT01061151|3887865|B5|India||Region of Enrollment||Participants|Count of Participants|111|111.0||||||
4065920|NCT01061151|3887866|B4|India||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4065921|NCT01061151|3887867|B3|India||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4065922|NCT01061151|3887868|B2|India||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
4065923|NCT01061151|3887869|B1|India||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
4065924|NCT01061151|3887865|B5|Zambia||Region of Enrollment||Participants|Count of Participants|83|83.0||||||
4065925|NCT01061151|3887866|B4|Zambia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4065926|NCT01061151|3887867|B3|Zambia||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4065927|NCT01061151|3887868|B2|Zambia||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
4065928|NCT01061151|3887869|B1|Zambia||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
4065929|NCT01061151|3887865|B5|Zimbabwe||Region of Enrollment||Participants|Count of Participants|688|688.0||||||
4065930|NCT01061151|3887866|B4|Zimbabwe||Region of Enrollment||Participants|Count of Participants|116|116.0||||||
4065931|NCT01061151|3887867|B3|Zimbabwe||Region of Enrollment||Participants|Count of Participants|99|99.0||||||
4065932|NCT01061151|3887868|B2|Zimbabwe||Region of Enrollment||Participants|Count of Participants|236|236.0||||||
4065933|NCT01061151|3887869|B1|Zimbabwe||Region of Enrollment||Participants|Count of Participants|237|237.0||||||
4065934|NCT01061151|3887865|B5|Uganda||Region of Enrollment||Participants|Count of Participants|506|506.0||||||
4065935|NCT01061151|3887866|B4|Uganda||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4065936|NCT01061151|3887867|B3|Uganda||Region of Enrollment||Participants|Count of Participants|85|85.0||||||
4065937|NCT01061151|3887868|B2|Uganda||Region of Enrollment||Participants|Count of Participants|205|205.0||||||
4065938|NCT01061151|3887869|B1|Uganda||Region of Enrollment||Participants|Count of Participants|207|207.0||||||
4065939|NCT01061151|3887865|B5|South Africa||Region of Enrollment||Participants|Count of Participants|1128|1128.0||||||
4065940|NCT01061151|3887866|B4|South Africa||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
4065941|NCT01061151|3887867|B3|South Africa||Region of Enrollment||Participants|Count of Participants|78|78.0||||||
4065942|NCT01061151|3887868|B2|South Africa||Region of Enrollment||Participants|Count of Participants|510|510.0||||||
4065943|NCT01061151|3887869|B1|South Africa||Region of Enrollment||Participants|Count of Participants|513|513.0||||||
4065944|NCT01061151|3887865|B5|Tanzania||Region of Enrollment||Participants|Count of Participants|57|57.0||||||
4065945|NCT01061151|3887866|B4|Tanzania||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4065946|NCT01061151|3887867|B3|Tanzania||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4065947|NCT01061151|3887868|B2|Tanzania||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
4065948|NCT01061151|3887869|B1|Tanzania||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4065949|NCT01061151|3887865|B5|Malawi||Region of Enrollment||Participants|Count of Participants|1168|1168.0||||||
4065950|NCT01061151|3887866|B4|Malawi||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
4065951|NCT01061151|3887867|B3|Malawi||Region of Enrollment||Participants|Count of Participants|155|155.0||||||
4065952|NCT01061151|3887868|B2|Malawi||Region of Enrollment||Participants|Count of Participants|493|493.0||||||
4065953|NCT01061151|3887869|B1|Malawi||Region of Enrollment||Participants|Count of Participants|489|489.0||||||
4065954|NCT01061151|3887865|B5|Asian, Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|113|113.0||||||
4065955|NCT01061151|3887866|B4|Asian, Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
4065956|NCT01061151|3887867|B3|Asian, Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4065957|NCT01061151|3887868|B2|Asian, Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
4065958|NCT01061151|3887869|B1|Asian, Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
4065959|NCT01061151|3887865|B5|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
4065960|NCT01061151|3887866|B4|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4065961|NCT01061151|3887867|B3|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4065962|NCT01061151|3887868|B2|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4065963|NCT01061151|3887869|B1|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4065964|NCT01061151|3887865|B5|Black Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|3603|3603.0||||||
4065965|NCT01061151|3887866|B4|Black Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|183|183.0||||||
4065966|NCT01061151|3887867|B3|Black Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|440|440.0||||||
4065967|NCT01061151|3887868|B2|Black Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1487|1487.0||||||
4065968|NCT01061151|3887869|B1|Black Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1493|1493.0||||||
4065969|NCT01061151|3887865|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4065970|NCT01061151|3887866|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4065971|NCT01061151|3887867|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4065972|NCT01061151|3887868|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4065973|NCT01061151|3887869|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4065974|NCT01061151|3887865|B5||Female|Sex: Female, Male||Participants|Count of Participants|3741|3741.0||||||
4065975|NCT01061151|3887866|B4||Female|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4065976|NCT01061151|3887867|B3||Female|Sex: Female, Male||Participants|Count of Participants|445|445.0||||||
4065977|NCT01061151|3887868|B2||Female|Sex: Female, Male||Participants|Count of Participants|1545|1545.0||||||
4065978|NCT01061151|3887869|B1||Female|Sex: Female, Male||Participants|Count of Participants|1547|1547.0||||||
4065979|NCT01061151|3887865|B5|||Age||years|Median|26.5|26.5|Inter-Quartile Range|||23.0|30.3|
4065980|NCT01061151|3887866|B4|||Age||years|Median|26.8|26.8|Inter-Quartile Range|||23.2|31.1|
4065981|NCT01061151|3887867|B3|||Age||years|Median|26.4|26.4|Inter-Quartile Range|||22.7|30.4|
4065982|NCT01061151|3887868|B2|||Age||years|Median|26.6|26.6|Inter-Quartile Range|||23.3|30.3|
4065983|NCT01061151|3887869|B1|||Age||years|Median|26.5|26.5|Inter-Quartile Range|||22.8|30.1|
4065984|NCT01061034|3887924|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4065985|NCT01061034|3887924|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4065986|NCT01061034|3887924|B1|||Age||years|Mean|39.3|39.3|Standard Deviation|12.5|12.5|||
4065987|NCT01061034|3887924|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4065988|NCT01061034|3887924|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4065989|NCT01061034|3887924|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4065990|NCT01061008|3887929|B3|United Kingdom||Region of Enrollment||participants|Number|31|31.0||||||
4065991|NCT01061008|3887930|B2|United Kingdom||Region of Enrollment||participants|Number|15|15.0||||||
4065992|NCT01061008|3887931|B1|United Kingdom||Region of Enrollment||participants|Number|16|16.0||||||
4065993|NCT01061008|3887929|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4065994|NCT01061008|3887930|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4065995|NCT01061008|3887931|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4065996|NCT01061008|3887929|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4065997|NCT01061008|3887930|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4065998|NCT01061008|3887931|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4065999|NCT01061008|3887929|B3|||Age||years|Mean|56|56.0|Standard Deviation|12|12.0|||
4066000|NCT01061008|3887930|B2|||Age||years|Mean|60|60.0|Standard Deviation|11|11.0|||
4066001|NCT01061008|3887931|B1|||Age||years|Mean|52|52.0|Standard Deviation|14|14.0|||
4066002|NCT01061008|3887929|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4066003|NCT01061008|3887930|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4066004|NCT01061008|3887931|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4066005|NCT01061008|3887929|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4066006|NCT01061008|3887930|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4066007|NCT01061008|3887931|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4066008|NCT01061008|3887929|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4066009|NCT01061008|3887930|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4066010|NCT01061008|3887931|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4066011|NCT01060670|3887938|B3|Netherlands Antilles||Region of Enrollment||participants|Number|4|4.0||||||
4066012|NCT01060670|3887939|B2|Netherlands Antilles||Region of Enrollment||participants|Number|2|2.0||||||
4066013|NCT01060670|3887940|B1|Netherlands Antilles||Region of Enrollment||participants|Number|2|2.0||||||
4066014|NCT01060670|3887938|B3|United States||Region of Enrollment||participants|Number|303|303.0||||||
4066015|NCT01060670|3887939|B2|United States||Region of Enrollment||participants|Number|151|151.0||||||
4066016|NCT01060670|3887940|B1|United States||Region of Enrollment||participants|Number|152|152.0||||||
4066017|NCT01060670|3887938|B3||Male|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
4066018|NCT01060670|3887939|B2||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4066019|NCT01060670|3887940|B1||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4066020|NCT01060670|3887938|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4066021|NCT01060670|3887939|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4066022|NCT01060670|3887940|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4066023|NCT01060670|3887938|B3|||Age||years|Mean|56.5|56.5|Full Range|||28.0|82.0|
4066024|NCT01060670|3887939|B2|||Age||years|Mean|57.3|57.3|Full Range|||28.0|82.0|
4066025|NCT01060670|3887940|B1|||Age||years|Mean|55.8|55.8|Full Range|||31.0|82.0|
4066026|NCT01060592|3887959|B3|United States||Region of Enrollment||participants|Number|84|84.0||||||
4066027|NCT01060592|3887960|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
4066028|NCT01060592|3887961|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
4066029|NCT01060592|3887959|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4066030|NCT01060592|3887960|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4066031|NCT01060592|3887961|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4066032|NCT01060592|3887959|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4066033|NCT01060592|3887960|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4066034|NCT01060592|3887961|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4066035|NCT01060592|3887959|B3|||Age||years|Mean|42.8|42.8|Standard Deviation|11.7|11.7|||
4066036|NCT01060592|3887960|B2|||Age||years|Mean|40.1|40.1|Standard Deviation|11.6|11.6|||
4066037|NCT01060592|3887961|B1|||Age||years|Mean|43.0|43.0|Standard Deviation|11.6|11.6|||
4066038|NCT01060553|3887976|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4066039|NCT01060553|3887976|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4066040|NCT01060553|3887976|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4066041|NCT01060553|3887976|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4066042|NCT01060553|3887976|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4066043|NCT01060553|3887976|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4066044|NCT01060540|3887982|B3|unknown||Genetic risk||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4066045|NCT01060540|3887983|B2|unknown||Genetic risk||participants|Number|NA|||||||not tested
4066046|NCT01060540|3887984|B1|unknown||Genetic risk||participants|Number|2|2.0||||||
4066047|NCT01060540|3887982|B3|low||Genetic risk||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4066048|NCT01060540|3887983|B2|low||Genetic risk||participants|Number|NA|||||||not tested
4066049|NCT01060540|3887984|B1|low||Genetic risk||participants|Number|114|114.0||||||
4066050|NCT01060540|3887982|B3|moderate||Genetic risk||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4066051|NCT01060540|3887983|B2|moderate||Genetic risk||participants|Number|NA|||||||not tested
4066052|NCT01060540|3887984|B1|moderate||Genetic risk||participants|Number|113|113.0||||||
4066053|NCT01060540|3887982|B3|high||Genetic risk||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4066054|NCT01060540|3887983|B2|high||Genetic risk||participants|Number|NA|||||||not tested
4066055|NCT01060540|3887984|B1|high||Genetic risk||participants|Number|74|74.0||||||
4066056|NCT01060540|3887982|B3|unknown||Lifetime risk||participants|Number|2|2.0||||||
4066057|NCT01060540|3887983|B2|unknown||Lifetime risk||participants|Number|1|1.0||||||
4066058|NCT01060540|3887984|B1|unknown||Lifetime risk||participants|Number|1|1.0||||||
4066059|NCT01060540|3887982|B3|low||Lifetime risk||participants|Number|13|13.0||||||
4066060|NCT01060540|3887983|B2|low||Lifetime risk||participants|Number|5|5.0||||||
4066061|NCT01060540|3887984|B1|low||Lifetime risk||participants|Number|8|8.0||||||
4066062|NCT01060540|3887982|B3|moderate||Lifetime risk||participants|Number|180|180.0||||||
4066063|NCT01060540|3887983|B2|moderate||Lifetime risk||participants|Number|99|99.0||||||
4066064|NCT01060540|3887984|B1|moderate||Lifetime risk||participants|Number|81|81.0||||||
4066065|NCT01060540|3887982|B3|high||Lifetime risk||participants|Number|406|406.0||||||
4066066|NCT01060540|3887983|B2|high||Lifetime risk||participants|Number|193|193.0||||||
4066067|NCT01060540|3887984|B1|high||Lifetime risk||participants|Number|213|213.0||||||
4066068|NCT01060540|3887982|B3|unknown||Family history risk||participants|Number|8|8.0||||||
4066069|NCT01060540|3887983|B2|unknown||Family history risk||participants|Number|4|4.0||||||
4066070|NCT01060540|3887984|B1|unknown||Family history risk||participants|Number|4|4.0||||||
4066071|NCT01060540|3887982|B3|low||Family history risk||participants|Number|281|281.0||||||
4066072|NCT01060540|3887983|B2|low||Family history risk||participants|Number|140|140.0||||||
4066073|NCT01060540|3887984|B1|low||Family history risk||participants|Number|141|141.0||||||
4066074|NCT01060540|3887982|B3|moderate||Family history risk||participants|Number|173|173.0||||||
4066075|NCT01060540|3887983|B2|moderate||Family history risk||participants|Number|94|94.0||||||
4066076|NCT01060540|3887984|B1|moderate||Family history risk||participants|Number|79|79.0||||||
4066077|NCT01060540|3887982|B3|high||Family history risk||participants|Number|139|139.0||||||
4066078|NCT01060540|3887983|B2|high||Family history risk||participants|Number|60|60.0||||||
4066079|NCT01060540|3887984|B1|high||Family history risk||participants|Number|79|79.0||||||
4066080|NCT01060540|3887982|B3|BMI<35 kg/m^2||Body mass index (BMI) stratification||participants|Number|421|421.0||||||
4066081|NCT01060540|3887983|B2|BMI<35 kg/m^2||Body mass index (BMI) stratification||participants|Number|213|213.0||||||
4066082|NCT01060540|3887984|B1|BMI<35 kg/m^2||Body mass index (BMI) stratification||participants|Number|208|208.0||||||
4066083|NCT01060540|3887982|B3|BMI >= 35 kg/m^2||Body mass index (BMI) stratification||participants|Number|180|180.0||||||
4066084|NCT01060540|3887983|B2|BMI >= 35 kg/m^2||Body mass index (BMI) stratification||participants|Number|85|85.0||||||
4066085|NCT01060540|3887984|B1|BMI >= 35 kg/m^2||Body mass index (BMI) stratification||participants|Number|95|95.0||||||
4066086|NCT01060540|3887982|B3|||Weight||kg|Mean|101.8|101.8|Standard Deviation|18.3|18.3|||
4066087|NCT01060540|3887983|B2|||Weight||kg|Mean|100.7|100.7|Standard Deviation|18.9|18.9|||
4066088|NCT01060540|3887984|B1|||Weight||kg|Mean|103.8|103.8|Standard Deviation|17.7|17.7|||
4066089|NCT01060540|3887982|B3|Some post-high school education||Education||participants|Number|447|447.0||||||
4066090|NCT01060540|3887983|B2|Some post-high school education||Education||participants|Number|226|226.0||||||
4066091|NCT01060540|3887984|B1|Some post-high school education||Education||participants|Number|221|221.0||||||
4066092|NCT01060540|3887982|B3|High school graduate or less||Education||participants|Number|154|154.0||||||
4066093|NCT01060540|3887983|B2|High school graduate or less||Education||participants|Number|72|72.0||||||
4066094|NCT01060540|3887984|B1|High school graduate or less||Education||participants|Number|82|82.0||||||
4066095|NCT01060540|3887982|B3|United States||Region of Enrollment||participants|Number|601|601.0||||||
4066096|NCT01060540|3887983|B2|United States||Region of Enrollment||participants|Number|298|298.0||||||
4066097|NCT01060540|3887984|B1|United States||Region of Enrollment||participants|Number|303|303.0||||||
4066098|NCT01060540|3887982|B3|Other||Race/Ethnicity, Customized||participants|Number|349|349.0||||||
4066099|NCT01060540|3887983|B2|Other||Race/Ethnicity, Customized||participants|Number|183|183.0||||||
4066100|NCT01060540|3887984|B1|Other||Race/Ethnicity, Customized||participants|Number|166|166.0||||||
4066101|NCT01060540|3887982|B3|Non-Hispanic White||Race/Ethnicity, Customized||participants|Number|252|252.0||||||
4066102|NCT01060540|3887983|B2|Non-Hispanic White||Race/Ethnicity, Customized||participants|Number|115|115.0||||||
4066103|NCT01060540|3887984|B1|Non-Hispanic White||Race/Ethnicity, Customized||participants|Number|137|137.0||||||
4066104|NCT01060540|3887982|B3||Male|Sex: Female, Male||Participants|Count of Participants|483|483.0||||||
4066105|NCT01060540|3887983|B2||Male|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4066106|NCT01060540|3887984|B1||Male|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
4066107|NCT01060540|3887982|B3||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4066108|NCT01060540|3887983|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4066109|NCT01060540|3887984|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4066110|NCT01060540|3887982|B3|||Age||years|Mean|54.1|54.1|Standard Deviation|8.7|8.7|||
4066111|NCT01060540|3887983|B2|||Age||years|Mean|54.4|54.4|Standard Deviation|8.4|8.4|||
4066112|NCT01060540|3887984|B1|||Age||years|Mean|53.9|53.9|Standard Deviation|9.1|9.1|||
4066113|NCT01060384|3887999|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4066114|NCT01060384|3887999|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066115|NCT01060384|3887999|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4066116|NCT01060384|3887999|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066117|NCT01060384|3887999|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4066118|NCT01060384|3887999|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4066119|NCT01060384|3887999|B1|||Age||years|Median|63.4|63.4|Full Range|||35.5|80.7|
4066120|NCT01060150|3888012|B1|||Learning Skill Test (LST) Total Score|The LST measures learning ability of student. It is composed of 7 sections: self control, participation, task accomplishment, reading, writing, test taking and information processing. It consists of 70 items for middle school student and 80 items for high school student. Each item is rated on 5-point Likert scale (1=never to 5=always). Total score range:70-350 (middle school) and 80-400 (high school). In result analysis, each sub-score and total score was converted to T-score for normalization. Score range of T-score: 1-100 with a mean of 50. Higher score indicates better ability for learning.|T-score|Mean|40.97|40.97|Standard Deviation|11.07|11.07|||
4066121|NCT01060150|3888012|B1|||Clinical Global Impression - Severity (CGI-S) Score|"The CGI-S rating scale is a 7 point global assessment that measures the clinician's impression of the severity of illness exhibited by a participant. A rating of 1 is equivalent to Normal, not at all ill and a rating of 7 is equivalent to Among the most extremely ill participants. Higher scores indicate worsening."|Units on a scale|Mean|4.88|4.88|Standard Deviation|0.79|0.79|||
4066122|NCT01060150|3888012|B1|||Korean Version of Attention-Deficit/Hyperactivity Disorder (ADHD) Rating Scale (K-ARS) Score|The K-ARS is a rating scale that is used for the ADHD diagnosis and the assessment of treatment efficacy and comprises 18 items in total on the basis of Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV), each item being rated from 0-3 points. The total score ranges from 0-54 with higher score indicating more severity of the condition.|Units on a scale|Mean|27.58|27.58|Standard Deviation|8.92|8.92|||
4066123|NCT01060150|3888012|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4066124|NCT01060150|3888012|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4066125|NCT01060150|3888012|B1|||Age||Years|Mean|15.24|15.24|Standard Deviation|1.43|1.43|||
4066126|NCT01060124|3888027|B1||Male|Sex: Female, Male|Out of a total of 103 participants, data for baseline characteristic (gender) was available only for 98 participants.|Participants|Count of Participants|63|63.0||||||
4066127|NCT01060124|3888027|B1||Female|Sex: Female, Male|Out of a total of 103 participants, data for baseline characteristic (gender) was available only for 98 participants.|Participants|Count of Participants|35|35.0||||||
4066128|NCT01060124|3888027|B1|||Age|Out of a total of 103 participants, data for baseline characteristic (age) was available only for 98 participants.|years|Mean|60.81|60.81|Standard Deviation|12.93|12.93|||
4066129|NCT01060111|3888035|B4||Male|Sex: Female, Male|Gender was measured for ITT population which was defined as participants who took topiramate at least once and had migraine improvement data at the Week 6.|Participants|Count of Participants|31|31.0||||||
4066130|NCT01060111|3888036|B3||Male|Sex: Female, Male|Gender was measured for ITT population which was defined as participants who took topiramate at least once and had migraine improvement data at the Week 6.|Participants|Count of Participants|15|15.0||||||
4066131|NCT01060111|3888037|B2||Male|Sex: Female, Male|Gender was measured for ITT population which was defined as participants who took topiramate at least once and had migraine improvement data at the Week 6.|Participants|Count of Participants|7|7.0||||||
4066132|NCT01060111|3888038|B1||Male|Sex: Female, Male|Gender was measured for ITT population which was defined as participants who took topiramate at least once and had migraine improvement data at the Week 6.|Participants|Count of Participants|9|9.0||||||
4066133|NCT01060111|3888035|B4||Female|Sex: Female, Male|Gender was measured for ITT population which was defined as participants who took topiramate at least once and had migraine improvement data at the Week 6.|Participants|Count of Participants|211|211.0||||||
4066134|NCT01060111|3888036|B3||Female|Sex: Female, Male|Gender was measured for ITT population which was defined as participants who took topiramate at least once and had migraine improvement data at the Week 6.|Participants|Count of Participants|63|63.0||||||
4066135|NCT01060111|3888037|B2||Female|Sex: Female, Male|Gender was measured for ITT population which was defined as participants who took topiramate at least once and had migraine improvement data at the Week 6.|Participants|Count of Participants|76|76.0||||||
4066136|NCT01060111|3888038|B1||Female|Sex: Female, Male|Gender was measured for ITT population which was defined as participants who took topiramate at least once and had migraine improvement data at the Week 6.|Participants|Count of Participants|72|72.0||||||
4066137|NCT01060111|3888035|B4|Age 60 and over||Age, Customized|Age, Customized was measured for ITT population which was defined as participants who took topiramate at least once and had migraine improvement data at the Week 6. Here 'N=239' (80, 82, and 78 for topiramate standard, topiramate slow, topiramate slow and propranolol booster groups respectively) signifies the participants who were evaluated for this Baseline characteristic.|Participants|Number|11|11.0||||||
4066138|NCT01060111|3888036|B3|Age 60 and over||Age, Customized|Age, Customized was measured for ITT population which was defined as participants who took topiramate at least once and had migraine improvement data at the Week 6. Here 'N=239' (80, 82, and 78 for topiramate standard, topiramate slow, topiramate slow and propranolol booster groups respectively) signifies the participants who were evaluated for this Baseline characteristic.|Participants|Number|2|2.0||||||
4066260|NCT01059903|3888203|B1|||Body Mass Index (BMI)||kg/m^2|Mean|24.42|24.42|Standard Deviation|2.71|2.71|||
4066261|NCT01059903|3888201|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066139|NCT01060111|3888037|B2|Age 60 and over||Age, Customized|Age, Customized was measured for ITT population which was defined as participants who took topiramate at least once and had migraine improvement data at the Week 6. Here 'N=239' (80, 82, and 78 for topiramate standard, topiramate slow, topiramate slow and propranolol booster groups respectively) signifies the participants who were evaluated for this Baseline characteristic.|Participants|Number|2|2.0||||||
4066140|NCT01060111|3888038|B1|Age 60 and over||Age, Customized|Age, Customized was measured for ITT population which was defined as participants who took topiramate at least once and had migraine improvement data at the Week 6. Here 'N=239' (80, 82, and 78 for topiramate standard, topiramate slow, topiramate slow and propranolol booster groups respectively) signifies the participants who were evaluated for this Baseline characteristic.|Participants|Number|7|7.0||||||
4066141|NCT01060111|3888035|B4|Age 50 and over but younger than age 60||Age, Customized|Age, Customized was measured for ITT population which was defined as participants who took topiramate at least once and had migraine improvement data at the Week 6. Here 'N=239' (80, 82, and 78 for topiramate standard, topiramate slow, topiramate slow and propranolol booster groups respectively) signifies the participants who were evaluated for this Baseline characteristic.|Participants|Number|29|29.0||||||
4066142|NCT01060111|3888036|B3|Age 50 and over but younger than age 60||Age, Customized|Age, Customized was measured for ITT population which was defined as participants who took topiramate at least once and had migraine improvement data at the Week 6. Here 'N=239' (80, 82, and 78 for topiramate standard, topiramate slow, topiramate slow and propranolol booster groups respectively) signifies the participants who were evaluated for this Baseline characteristic.|Participants|Number|7|7.0||||||
4066143|NCT01060111|3888037|B2|Age 50 and over but younger than age 60||Age, Customized|Age, Customized was measured for ITT population which was defined as participants who took topiramate at least once and had migraine improvement data at the Week 6. Here 'N=239' (80, 82, and 78 for topiramate standard, topiramate slow, topiramate slow and propranolol booster groups respectively) signifies the participants who were evaluated for this Baseline characteristic.|Participants|Number|11|11.0||||||
4066144|NCT01060111|3888038|B1|Age 50 and over but younger than age 60||Age, Customized|Age, Customized was measured for ITT population which was defined as participants who took topiramate at least once and had migraine improvement data at the Week 6. Here 'N=239' (80, 82, and 78 for topiramate standard, topiramate slow, topiramate slow and propranolol booster groups respectively) signifies the participants who were evaluated for this Baseline characteristic.|Participants|Number|11|11.0||||||
4066145|NCT01060111|3888035|B4|Age 40 and over but younger than age 50||Age, Customized|Age, Customized was measured for ITT population which was defined as participants who took topiramate at least once and had migraine improvement data at the Week 6. Here 'N=239' (80, 82, and 78 for topiramate standard, topiramate slow, topiramate slow and propranolol booster groups respectively) signifies the participants who were evaluated for this Baseline characteristic.|Participants|Number|57|57.0||||||
4066146|NCT01060111|3888036|B3|Age 40 and over but younger than age 50||Age, Customized|Age, Customized was measured for ITT population which was defined as participants who took topiramate at least once and had migraine improvement data at the Week 6. Here 'N=239' (80, 82, and 78 for topiramate standard, topiramate slow, topiramate slow and propranolol booster groups respectively) signifies the participants who were evaluated for this Baseline characteristic.|Participants|Number|16|16.0||||||
4066147|NCT01060111|3888037|B2|Age 40 and over but younger than age 50||Age, Customized|Age, Customized was measured for ITT population which was defined as participants who took topiramate at least once and had migraine improvement data at the Week 6. Here 'N=239' (80, 82, and 78 for topiramate standard, topiramate slow, topiramate slow and propranolol booster groups respectively) signifies the participants who were evaluated for this Baseline characteristic.|Participants|Number|19|19.0||||||
4066148|NCT01060111|3888038|B1|Age 40 and over but younger than age 50||Age, Customized|Age, Customized was measured for ITT population which was defined as participants who took topiramate at least once and had migraine improvement data at the Week 6. Here 'N=239' (80, 82, and 78 for topiramate standard, topiramate slow, topiramate slow and propranolol booster groups respectively) signifies the participants who were evaluated for this Baseline characteristic.|Participants|Number|22|22.0||||||
4066149|NCT01060111|3888035|B4|Age 30 and over but younger than age 40||Age, Customized|Age, Customized was measured for ITT population which was defined as participants who took topiramate at least once and had migraine improvement data at the Week 6. Here 'N=239' (80, 82, and 78 for topiramate standard, topiramate slow, topiramate slow and propranolol booster groups respectively) signifies the participants who were evaluated for this Baseline characteristic.|Participants|Number|81|81.0||||||
4066150|NCT01060111|3888036|B3|Age 30 and over but younger than age 40||Age, Customized|Age, Customized was measured for ITT population which was defined as participants who took topiramate at least once and had migraine improvement data at the Week 6. Here 'N=239' (80, 82, and 78 for topiramate standard, topiramate slow, topiramate slow and propranolol booster groups respectively) signifies the participants who were evaluated for this Baseline characteristic.|Participants|Number|30|30.0||||||
4066151|NCT01060111|3888037|B2|Age 30 and over but younger than age 40||Age, Customized|Age, Customized was measured for ITT population which was defined as participants who took topiramate at least once and had migraine improvement data at the Week 6. Here 'N=239' (80, 82, and 78 for topiramate standard, topiramate slow, topiramate slow and propranolol booster groups respectively) signifies the participants who were evaluated for this Baseline characteristic.|Participants|Number|27|27.0||||||
4066152|NCT01060111|3888038|B1|Age 30 and over but younger than age 40||Age, Customized|Age, Customized was measured for ITT population which was defined as participants who took topiramate at least once and had migraine improvement data at the Week 6. Here 'N=239' (80, 82, and 78 for topiramate standard, topiramate slow, topiramate slow and propranolol booster groups respectively) signifies the participants who were evaluated for this Baseline characteristic.|Participants|Number|24|24.0||||||
4066153|NCT01060111|3888035|B4|Age 20 and over but younger than age 30||Age, Customized|Age, Customized was measured for ITT population which was defined as participants who took topiramate at least once and had migraine improvement data at the Week 6. Here 'N=239' (80, 82, and 78 for topiramate standard, topiramate slow, topiramate slow and propranolol booster groups respectively) signifies the participants who were evaluated for this Baseline characteristic.|Participants|Number|61|61.0||||||
4066262|NCT01059903|3888202|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066154|NCT01060111|3888036|B3|Age 20 and over but younger than age 30||Age, Customized|Age, Customized was measured for ITT population which was defined as participants who took topiramate at least once and had migraine improvement data at the Week 6. Here 'N=239' (80, 82, and 78 for topiramate standard, topiramate slow, topiramate slow and propranolol booster groups respectively) signifies the participants who were evaluated for this Baseline characteristic.|Participants|Number|22|22.0||||||
4066155|NCT01060111|3888037|B2|Age 20 and over but younger than age 30||Age, Customized|Age, Customized was measured for ITT population which was defined as participants who took topiramate at least once and had migraine improvement data at the Week 6. Here 'N=239' (80, 82, and 78 for topiramate standard, topiramate slow, topiramate slow and propranolol booster groups respectively) signifies the participants who were evaluated for this Baseline characteristic.|Participants|Number|23|23.0||||||
4066156|NCT01060111|3888038|B1|Age 20 and over but younger than age 30||Age, Customized|Age, Customized was measured for ITT population which was defined as participants who took topiramate at least once and had migraine improvement data at the Week 6. Here 'N=239' (80, 82, and 78 for topiramate standard, topiramate slow, topiramate slow and propranolol booster groups respectively) signifies the participants who were evaluated for this Baseline characteristic.|Participants|Number|16|16.0||||||
4066157|NCT01060072|3888057|B3|Germany||Region of Enrollment||participants|Number|16|16.0||||||
4066158|NCT01060072|3888058|B2|Germany||Region of Enrollment||participants|Number|8|8.0||||||
4066159|NCT01060072|3888059|B1|Germany||Region of Enrollment||participants|Number|8|8.0||||||
4066160|NCT01060072|3888057|B3|United States||Region of Enrollment||participants|Number|391|391.0||||||
4066161|NCT01060072|3888058|B2|United States||Region of Enrollment||participants|Number|193|193.0||||||
4066162|NCT01060072|3888059|B1|United States||Region of Enrollment||participants|Number|198|198.0||||||
4066163|NCT01060072|3888057|B3||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4066164|NCT01060072|3888058|B2||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4066165|NCT01060072|3888059|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4066166|NCT01060072|3888057|B3||Female|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
4066167|NCT01060072|3888058|B2||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4066168|NCT01060072|3888059|B1||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4066169|NCT01060072|3888057|B3|||Age|Intent to treat Population (ITT)|years|Mean|68.9|68.9|Standard Deviation|9.62|9.62|||
4066170|NCT01060072|3888058|B2|||Age|Intent to treat Population (ITT)|years|Mean|69.4|69.4|Standard Deviation|9.56|9.56|||
4066171|NCT01060072|3888059|B1|||Age|Intent to treat Population (ITT)|years|Mean|68.3|68.3|Standard Deviation|9.66|9.66|||
4066172|NCT01060059|3888074|B3|||Glycosylated hemoglobin (HbA1c)||percent|Mean|8.9|8.9|Standard Deviation|1.39|1.39|||
4066173|NCT01060059|3888075|B2|||Glycosylated hemoglobin (HbA1c)||percent|Mean|9.2|9.2|Standard Deviation|1.40|1.4|||
4066174|NCT01060059|3888076|B1|||Glycosylated hemoglobin (HbA1c)||percent|Mean|8.7|8.7|Standard Deviation|1.34|1.34|||
4066175|NCT01060059|3888074|B3|||Weight||kg|Mean|88.6|88.6|Standard Deviation|20.91|20.91|||
4066176|NCT01060059|3888075|B2|||Weight||kg|Mean|79.5|79.5|Standard Deviation|15.82|15.82|||
4066177|NCT01060059|3888076|B1|||Weight||kg|Mean|97.5|97.5|Standard Deviation|21.39|21.39|||
4066178|NCT01060059|3888074|B3||Male|Sex: Female, Male||Participants|Count of Participants|493|493.0||||||
4066179|NCT01060059|3888075|B2||Male|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
4066180|NCT01060059|3888076|B1||Male|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
4066181|NCT01060059|3888074|B3||Female|Sex: Female, Male||Participants|Count of Participants|389|389.0||||||
4066182|NCT01060059|3888075|B2||Female|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4066183|NCT01060059|3888076|B1||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4066184|NCT01060059|3888074|B3|||Age||years|Mean|62.5|62.5|Standard Deviation|10.19|10.19|||
4066185|NCT01060059|3888075|B2|||Age||years|Mean|65.9|65.9|Standard Deviation|9.62|9.62|||
4066186|NCT01060059|3888076|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|9.65|9.65|||
4066187|NCT01060020|3888127|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066188|NCT01060020|3888127|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066189|NCT01060020|3888127|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4066190|NCT01060020|3888127|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4066191|NCT01060020|3888127|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066192|NCT01060020|3888127|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066193|NCT01060020|3888127|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066194|NCT01060020|3888127|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4066195|NCT01060020|3888127|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4066196|NCT01060020|3888127|B1|||Age||years|Mean|86|86.0|Standard Deviation|10|10.0|||
4066197|NCT01060007|3888135|B1|cM1||Clinical M stage|"M0: No distant metastasis.~M1: Distant metastasis."|participants|Number|7|7.0||||||
4066198|NCT01060007|3888135|B1|cM0||Clinical M stage|"M0: No distant metastasis.~M1: Distant metastasis."|participants|Number|69|69.0||||||
4066199|NCT01060007|3888135|B1|cN+||Clinical N stage|"N0: No regional lymph node metastasis.~N+: Metastases in 1 or greater lymph node(s)"|participants|Number|59|59.0||||||
4066200|NCT01060007|3888135|B1|cN0||Clinical N stage|"N0: No regional lymph node metastasis.~N+: Metastases in 1 or greater lymph node(s)"|participants|Number|17|17.0||||||
4066201|NCT01060007|3888135|B1|cT4||Clinical T stage|"T3: Tumor invades through the muscularis propria into pericolorectal tissues~T4a: Tumor penetrates to the surface of the visceral peritoneum~T4b: Tumor directly invades or is adherent to other organs or structures"|participants|Number|7|7.0||||||
4066202|NCT01060007|3888135|B1|cT3||Clinical T stage|"T3: Tumor invades through the muscularis propria into pericolorectal tissues~T4a: Tumor penetrates to the surface of the visceral peritoneum~T4b: Tumor directly invades or is adherent to other organs or structures"|participants|Number|69|69.0||||||
4066203|NCT01060007|3888135|B1|United States||Region of Enrollment||participants|Number|76|76.0||||||
4066204|NCT01060007|3888135|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4066205|NCT01060007|3888135|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4066206|NCT01060007|3888135|B1|||Age||years|Mean|56.4|56.4|Standard Deviation|1.3|1.3|||
4066207|NCT01059994|3888149|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4066208|NCT01059994|3888150|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4066209|NCT01059994|3888151|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4066210|NCT01059994|3888152|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4066211|NCT01059994|3888153|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4066212|NCT01059994|3888149|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4066213|NCT01059994|3888150|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4066214|NCT01059994|3888151|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4066215|NCT01059994|3888152|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4066216|NCT01059994|3888153|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4066217|NCT01059994|3888149|B5|||Age, Customized||years|Mean|51|51.0|Standard Deviation|23|23.0|||
4066218|NCT01059994|3888150|B4|||Age, Customized||years|Mean|74|74.0|Standard Deviation|4|4.0|||
4066219|NCT01059994|3888151|B3|||Age, Customized||years|Mean|63|63.0|Standard Deviation|5|5.0|||
4066220|NCT01059994|3888152|B2|||Age, Customized||years|Mean|29|29.0|Standard Deviation|4|4.0|||
4066221|NCT01059994|3888153|B1|||Age, Customized||years|Mean|25|25.0|Standard Deviation|6|6.0|||
4066222|NCT01059929|3888170|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066223|NCT01059929|3888171|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066224|NCT01059929|3888172|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066225|NCT01059929|3888170|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066226|NCT01059929|3888171|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066227|NCT01059929|3888172|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066228|NCT01059929|3888170|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4066229|NCT01059929|3888171|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4066230|NCT01059929|3888172|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4066231|NCT01059929|3888170|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4066232|NCT01059929|3888171|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4066233|NCT01059929|3888172|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4066234|NCT01059929|3888170|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066235|NCT01059929|3888171|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066236|NCT01059929|3888172|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066237|NCT01059929|3888170|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4066238|NCT01059929|3888171|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066239|NCT01059929|3888172|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4066240|NCT01059929|3888170|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066241|NCT01059929|3888171|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066242|NCT01059929|3888172|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066243|NCT01059929|3888170|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4066244|NCT01059929|3888171|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4066245|NCT01059929|3888172|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4066246|NCT01059929|3888170|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4066247|NCT01059929|3888171|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4066248|NCT01059929|3888172|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4066249|NCT01059929|3888170|B3|||Age||years|Mean|63.8|63.8|Full Range|||21.0|89.0|
4066250|NCT01059929|3888171|B2|||Age||years|Mean|67|67.0|Full Range|||21.0|89.0|
4066251|NCT01059929|3888172|B1|||Age||years|Mean|60.5|60.5|Full Range|||33.0|87.0|
4066252|NCT01059903|3888201|B3|||Weight||kilogramm (kg)|Mean|79.36|79.36|Standard Deviation|10.26|10.26|||
4066253|NCT01059903|3888202|B2|||Weight||kilogramm (kg)|Mean|78.88|78.88|Standard Deviation|9.14|9.14|||
4066254|NCT01059903|3888203|B1|||Weight||kilogramm (kg)|Mean|79.94|79.94|Standard Deviation|11.74|11.74|||
4066255|NCT01059903|3888201|B3|||Height||meter (m)|Mean|1.807|1.807|Standard Deviation|0.069|0.069|||
4066256|NCT01059903|3888202|B2|||Height||meter (m)|Mean|1.807|1.807|Standard Deviation|0.058|0.058|||
4066257|NCT01059903|3888203|B1|||Height||meter (m)|Mean|1.807|1.807|Standard Deviation|0.083|0.083|||
4066258|NCT01059903|3888201|B3|||Body Mass Index (BMI)||kg/m^2|Mean|24.28|24.28|Standard Deviation|2.70|2.7|||
4066259|NCT01059903|3888202|B2|||Body Mass Index (BMI)||kg/m^2|Mean|24.16|24.16|Standard Deviation|2.75|2.75|||
4066263|NCT01059903|3888203|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066264|NCT01059903|3888201|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066265|NCT01059903|3888202|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066266|NCT01059903|3888203|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066267|NCT01059903|3888201|B3||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4066268|NCT01059903|3888202|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4066269|NCT01059903|3888203|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4066270|NCT01059903|3888201|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066271|NCT01059903|3888202|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066272|NCT01059903|3888203|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066273|NCT01059903|3888201|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066274|NCT01059903|3888202|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066275|NCT01059903|3888203|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066276|NCT01059903|3888201|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066277|NCT01059903|3888202|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066278|NCT01059903|3888203|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066279|NCT01059903|3888201|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066280|NCT01059903|3888202|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066281|NCT01059903|3888203|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066282|NCT01059903|3888201|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066283|NCT01059903|3888202|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066284|NCT01059903|3888203|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066285|NCT01059903|3888201|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4066286|NCT01059903|3888202|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4066287|NCT01059903|3888203|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4066288|NCT01059903|3888201|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066289|NCT01059903|3888202|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066290|NCT01059903|3888203|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066291|NCT01059903|3888201|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4066292|NCT01059903|3888202|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4066293|NCT01059903|3888203|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4066294|NCT01059903|3888201|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4066295|NCT01059903|3888202|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4066296|NCT01059903|3888203|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4066297|NCT01059903|3888201|B3|||Age||years|Mean|36.3|36.3|Standard Deviation|11.0|11.0|||
4066298|NCT01059903|3888202|B2|||Age||years|Mean|35.6|35.6|Standard Deviation|9.6|9.6|||
4066299|NCT01059903|3888203|B1|||Age||years|Mean|37.1|37.1|Standard Deviation|12.6|12.6|||
4066300|NCT01059877|3888238|B3|||Trail making A|The Trail Making Test (TMT) is used to investigate deficits in cognitive processing speed and executive function. Part A consists of 25 circles on a piece of paper with the numbers 1-25 in random order in the circles. The patient starts with number one and draws a line from that circle to the circle with number two, etc. to number 25. More errors indicate poorer performance.|errors at task|Mean|3.56|3.56|Full Range|||0.0|14.0|
4066301|NCT01059877|3888239|B2|||Trail making A|The Trail Making Test (TMT) is used to investigate deficits in cognitive processing speed and executive function. Part A consists of 25 circles on a piece of paper with the numbers 1-25 in random order in the circles. The patient starts with number one and draws a line from that circle to the circle with number two, etc. to number 25. More errors indicate poorer performance.|errors at task|Mean|9.00|9.0|Full Range|||3.0|14.0|
4066302|NCT01059877|3888240|B1|||Trail making A|The Trail Making Test (TMT) is used to investigate deficits in cognitive processing speed and executive function. Part A consists of 25 circles on a piece of paper with the numbers 1-25 in random order in the circles. The patient starts with number one and draws a line from that circle to the circle with number two, etc. to number 25. More errors indicate poorer performance.|errors at task|Mean|0.83|0.83|Full Range|||0.0|5.0|
4066303|NCT01059877|3888238|B3|||Delayed word recall|Delayed Word Recall is a subscale of the Alzheimer’s Disease Assessment Scale-Cognitive (ADAS-Cog), a measure of cognitive impairment. Higher scores indicate greater impairment. Range: 0-10.|units on a scale|Mean|0.798|0.798|Full Range|||0.0|4.0|
4066304|NCT01059877|3888239|B2|||Delayed word recall|Delayed Word Recall is a subscale of the Alzheimer’s Disease Assessment Scale-Cognitive (ADAS-Cog), a measure of cognitive impairment. Higher scores indicate greater impairment. Range: 0-10.|units on a scale|Mean|1.33|1.33|Full Range|||0.0|4.0|
4066305|NCT01059877|3888240|B1|||Delayed word recall|Delayed Word Recall is a subscale of the Alzheimer’s Disease Assessment Scale-Cognitive (ADAS-Cog), a measure of cognitive impairment. Higher scores indicate greater impairment. Range: 0-10.|units on a scale|Mean|0.50|0.5|Full Range|||0.0|1.0|
4066306|NCT01059877|3888238|B3|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4066307|NCT01059877|3888239|B2|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4066308|NCT01059877|3888240|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4066309|NCT01059877|3888238|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4066310|NCT01059877|3888238|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4066311|NCT01059877|3888239|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4066312|NCT01059877|3888240|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4066313|NCT01059877|3888238|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4066314|NCT01059877|3888239|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4066315|NCT01059877|3888240|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4066316|NCT01059877|3888238|B3|||Age||years|Mean|81|81.0|Full Range|||74.0|96.0|
4066317|NCT01059877|3888239|B2|||Age||years|Mean|84|84.0|Full Range|||76.0|96.0|
4066318|NCT01059877|3888240|B1|||Age||years|Mean|80|80.0|Full Range|||74.0|89.0|
4066319|NCT01059864|3888247|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4066320|NCT01059864|3888247|B1||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4066321|NCT01059864|3888247|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|11.5|11.5|||
4066322|NCT01059851|3888296|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4066323|NCT01059851|3888297|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4066324|NCT01059851|3888298|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4066325|NCT01059851|3888296|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4066326|NCT01059851|3888297|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4066327|NCT01059851|3888298|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4066328|NCT01059851|3888296|B3|||Age||years|Mean|49.4|49.4|Standard Deviation|11.7|11.7|||
4066329|NCT01059851|3888297|B2|||Age||years|Mean|48.1|48.1|Standard Deviation|11.6|11.6|||
4066330|NCT01059851|3888298|B1|||Age||years|Mean|50.6|50.6|Standard Deviation|12.5|12.5|||
4066331|NCT01059825|3888317|B7||Male|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
4066332|NCT01059825|3888318|B6||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4066333|NCT01059825|3888319|B5||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4066334|NCT01059825|3888320|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4066335|NCT01059825|3888321|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4066336|NCT01059825|3888322|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4066337|NCT01059825|3888323|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4066338|NCT01059825|3888317|B7||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4066339|NCT01059825|3888318|B6||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4066340|NCT01059825|3888319|B5||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4066341|NCT01059825|3888320|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4066342|NCT01059825|3888321|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4066343|NCT01059825|3888322|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4066344|NCT01059825|3888323|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4066345|NCT01059825|3888317|B7|>= 65 years||Age, Customized||Participants|Number|43|43.0||||||
4066346|NCT01059825|3888318|B6|>= 65 years||Age, Customized||Participants|Number|9|9.0||||||
4066347|NCT01059825|3888319|B5|>= 65 years||Age, Customized||Participants|Number|7|7.0||||||
4066348|NCT01059825|3888320|B4|>= 65 years||Age, Customized||Participants|Number|7|7.0||||||
4066349|NCT01059825|3888321|B3|>= 65 years||Age, Customized||Participants|Number|7|7.0||||||
4066350|NCT01059825|3888322|B2|>= 65 years||Age, Customized||Participants|Number|8|8.0||||||
4066351|NCT01059825|3888323|B1|>= 65 years||Age, Customized||Participants|Number|5|5.0||||||
4066352|NCT01059825|3888317|B7|45-64 years||Age, Customized||Participants|Number|238|238.0||||||
4066353|NCT01059825|3888318|B6|45-64 years||Age, Customized||Participants|Number|33|33.0||||||
4066354|NCT01059825|3888319|B5|45-64 years||Age, Customized||Participants|Number|39|39.0||||||
4066355|NCT01059825|3888320|B4|45-64 years||Age, Customized||Participants|Number|47|47.0||||||
4066356|NCT01059825|3888321|B3|45-64 years||Age, Customized||Participants|Number|42|42.0||||||
4066357|NCT01059825|3888322|B2|45-64 years||Age, Customized||Participants|Number|36|36.0||||||
4066358|NCT01059825|3888323|B1|45-64 years||Age, Customized||Participants|Number|41|41.0||||||
4066359|NCT01059825|3888317|B7|18-44 years||Age, Customized||Participants|Number|47|47.0||||||
4066360|NCT01059825|3888318|B6|18-44 years||Age, Customized||Participants|Number|13|13.0||||||
4066361|NCT01059825|3888319|B5|18-44 years||Age, Customized||Participants|Number|9|9.0||||||
4066362|NCT01059825|3888320|B4|18-44 years||Age, Customized||Participants|Number|1|1.0||||||
4066363|NCT01059825|3888321|B3|18-44 years||Age, Customized||Participants|Number|6|6.0||||||
4066364|NCT01059825|3888322|B2|18-44 years||Age, Customized||Participants|Number|10|10.0||||||
4066365|NCT01059825|3888323|B1|18-44 years||Age, Customized||Participants|Number|8|8.0||||||
4066366|NCT01059825|3888317|B7|< 18 years||Age, Customized||Participants|Number|0|0.0||||||
4066367|NCT01059825|3888318|B6|< 18 years||Age, Customized||Participants|Number|0|0.0||||||
4066368|NCT01059825|3888319|B5|< 18 years||Age, Customized||Participants|Number|0|0.0||||||
4066369|NCT01059825|3888320|B4|< 18 years||Age, Customized||Participants|Number|0|0.0||||||
4066370|NCT01059825|3888321|B3|< 18 years||Age, Customized||Participants|Number|0|0.0||||||
4066371|NCT01059825|3888322|B2|< 18 years||Age, Customized||Participants|Number|0|0.0||||||
4066372|NCT01059825|3888323|B1|< 18 years||Age, Customized||Participants|Number|0|0.0||||||
4066373|NCT01059812|3888514|B3|||Body weight at randomisation||kg|Mean|66.0|66.0|Standard Deviation|11.2|11.2|||
4066374|NCT01059812|3888515|B2|||Body weight at randomisation||kg|Mean|66.0|66.0|Standard Deviation|11.2|11.2|||
4066375|NCT01059812|3888516|B1|||Body weight at randomisation||kg|Mean|66.1|66.1|Standard Deviation|11.2|11.2|||
4066376|NCT01059812|3888514|B3|||Fasting plasma glucose (FPG)||mmol/L|Mean|7.9|7.9|Standard Deviation|2.5|2.5|||
4066377|NCT01059812|3888515|B2|||Fasting plasma glucose (FPG)||mmol/L|Mean|7.9|7.9|Standard Deviation|2.5|2.5|||
4066378|NCT01059812|3888516|B1|||Fasting plasma glucose (FPG)||mmol/L|Mean|7.9|7.9|Standard Deviation|2.5|2.5|||
4066379|NCT01059812|3888514|B3|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.4|8.4|Standard Deviation|0.8|0.8|||
4066380|NCT01059812|3888515|B2|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.4|8.4|Standard Deviation|0.9|0.9|||
4066381|NCT01059812|3888516|B1|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.4|8.4|Standard Deviation|0.8|0.8|||
4066382|NCT01059812|3888514|B3||Male|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4066383|NCT01059812|3888515|B2||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4066384|NCT01059812|3888516|B1||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4066385|NCT01059812|3888514|B3||Female|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4066386|NCT01059812|3888515|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4066387|NCT01059812|3888516|B1||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4066388|NCT01059812|3888514|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|10.0|10.0|||
4066389|NCT01059812|3888515|B2|||Age||years|Mean|61.2|61.2|Standard Deviation|9.5|9.5|||
4066390|NCT01059812|3888516|B1|||Age||years|Mean|59.1|59.1|Standard Deviation|10.2|10.2|||
4066391|NCT01059799|3888531|B3|||Fasting plasma glucose (FPG)||mmol/L|Mean|8.5|8.5|Standard Deviation|2.0|2.0|||
4066392|NCT01059799|3888532|B2|||Fasting plasma glucose (FPG)||mmol/L|Mean|8.6|8.6|Standard Deviation|1.9|1.9|||
4066393|NCT01059799|3888533|B1|||Fasting plasma glucose (FPG)||mmol/L|Mean|8.4|8.4|Standard Deviation|2.1|2.1|||
4066394|NCT01059799|3888531|B3|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.5|8.5|Standard Deviation|0.8|0.8|||
4066395|NCT01059799|3888532|B2|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.5|8.5|Standard Deviation|0.8|0.8|||
4066396|NCT01059799|3888533|B1|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.4|8.4|Standard Deviation|0.8|0.8|||
4066397|NCT01059799|3888531|B3||Male|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
4066398|NCT01059799|3888532|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4066399|NCT01059799|3888533|B1||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4066400|NCT01059799|3888531|B3||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4066401|NCT01059799|3888532|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4066402|NCT01059799|3888533|B1||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4066403|NCT01059799|3888531|B3|||Age||years|Mean|58.6|58.6|Standard Deviation|9.9|9.9|||
4066404|NCT01059799|3888532|B2|||Age||years|Mean|58.1|58.1|Standard Deviation|10.1|10.1|||
4066405|NCT01059799|3888533|B1|||Age||years|Mean|58.8|58.8|Standard Deviation|9.8|9.8|||
4066406|NCT01059773|3888546|B3|> 100 kg||Weight, Categorized||participants|Number|98|98.0||||||
4066407|NCT01059773|3888547|B2|> 100 kg||Weight, Categorized||participants|Number|49|49.0||||||
4066408|NCT01059773|3888548|B1|> 100 kg||Weight, Categorized||participants|Number|49|49.0||||||
4066409|NCT01059773|3888546|B3|<= 100 kg||Weight, Categorized||participants|Number|391|391.0||||||
4066410|NCT01059773|3888547|B2|<= 100 kg||Weight, Categorized||participants|Number|196|196.0||||||
4066411|NCT01059773|3888548|B1|<= 100 kg||Weight, Categorized||participants|Number|195|195.0||||||
4066412|NCT01059773|3888546|B3||Male|Sex: Female, Male||Participants|Count of Participants|332|332.0||||||
4066413|NCT01059773|3888547|B2||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4066414|NCT01059773|3888548|B1||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4066415|NCT01059773|3888546|B3||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4066416|NCT01059773|3888547|B2||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4066417|NCT01059773|3888548|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4066418|NCT01059773|3888546|B3|>=60 years||Age, Customized||participants|Number|75|75.0||||||
4066419|NCT01059773|3888547|B2|>=60 years||Age, Customized||participants|Number|42|42.0||||||
4066420|NCT01059773|3888548|B1|>=60 years||Age, Customized||participants|Number|33|33.0||||||
4066421|NCT01059773|3888546|B3|50-59 years||Age, Customized||participants|Number|116|116.0||||||
4066422|NCT01059773|3888547|B2|50-59 years||Age, Customized||participants|Number|60|60.0||||||
4066423|NCT01059773|3888548|B1|50-59 years||Age, Customized||participants|Number|56|56.0||||||
4066424|NCT01059773|3888546|B3|40-49 years||Age, Customized||participants|Number|144|144.0||||||
4066425|NCT01059773|3888547|B2|40-49 years||Age, Customized||participants|Number|75|75.0||||||
4066426|NCT01059773|3888548|B1|40-49 years||Age, Customized||participants|Number|69|69.0||||||
4066427|NCT01059773|3888546|B3|30-39 years||Age, Customized||participants|Number|105|105.0||||||
4066428|NCT01059773|3888547|B2|30-39 years||Age, Customized||participants|Number|48|48.0||||||
4066429|NCT01059773|3888548|B1|30-39 years||Age, Customized||participants|Number|57|57.0||||||
4066430|NCT01059773|3888546|B3|18-29 years||Age, Customized||participants|Number|49|49.0||||||
4066431|NCT01059773|3888547|B2|18-29 years||Age, Customized||participants|Number|20|20.0||||||
4066432|NCT01059773|3888548|B1|18-29 years||Age, Customized||participants|Number|29|29.0||||||
4066433|NCT01059773|3888546|B3|||Age||years|Mean|46.2|46.2|Standard Deviation|12.4|12.4|||
4066434|NCT01059773|3888547|B2|||Age||years|Mean|47.3|47.3|Standard Deviation|12.6|12.6|||
4066435|NCT01059773|3888548|B1|||Age||years|Mean|45.1|45.1|Standard Deviation|12.1|12.1|||
4066436|NCT01059760|3888579|B3|||Hemoglobin A1C||percentage|Mean|5.4|5.4|Standard Deviation|0.3|0.3|||
4066437|NCT01059760|3888580|B2|||Hemoglobin A1C||percentage|Mean|5.3|5.3|Standard Deviation|0.3|0.3|||
4066438|NCT01059760|3888581|B1|||Hemoglobin A1C||percentage|Mean|5.5|5.5|Standard Deviation|0.3|0.3|||
4066439|NCT01059760|3888579|B3|||Body Mass Index (BMI)||kg/m^2|Mean|27.8|27.8|Standard Deviation|1.3|1.3|||
4066440|NCT01059760|3888580|B2|||Body Mass Index (BMI)||kg/m^2|Mean|27.3|27.3|Standard Deviation|6.1|6.1|||
4066441|NCT01059760|3888581|B1|||Body Mass Index (BMI)||kg/m^2|Mean|28.4|28.4|Standard Deviation|7.1|7.1|||
4066442|NCT01059760|3888579|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4066443|NCT01059760|3888580|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4066444|NCT01059760|3888581|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4066445|NCT01059760|3888579|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4066446|NCT01059760|3888580|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4066447|NCT01059760|3888581|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4066448|NCT01059760|3888579|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4066449|NCT01059760|3888580|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4066450|NCT01059760|3888581|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4066451|NCT01059760|3888579|B3|||Age||years|Mean|43.6|43.6|Standard Deviation|13.5|13.5|||
4066452|NCT01059760|3888580|B2|||Age||years|Mean|44.0|44.0|Standard Deviation|14.0|14.0|||
4066453|NCT01059760|3888581|B1|||Age||years|Mean|43.3|43.3|Standard Deviation|13.6|13.6|||
4066454|NCT01059643|3888688|B1|Squamous Cell Carcinoma of the Head and Neck||Tumor Type||participants|Number|13|13.0||||||
4066455|NCT01059643|3888688|B1|Prostate Cancer||Tumor Type||participants|Number|18|18.0||||||
4066456|NCT01059643|3888688|B1|Ovarian Cancer||Tumor Type||participants|Number|13|13.0||||||
4066457|NCT01059643|3888688|B1|Non-Small Cell Lung Cancer||Tumor Type||participants|Number|29|29.0||||||
4066458|NCT01059643|3888688|B1|Gastroesophageal Cancer||Tumor Type||participants|Number|13|13.0||||||
4066459|NCT01059643|3888688|B1|Colorectal Cancer||Tumor Type||participants|Number|17|17.0||||||
4066460|NCT01059643|3888688|B1|United States||Region of Enrollment||Participants|Count of Participants|103|103.0||||||
4066461|NCT01059643|3888688|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066462|NCT01059643|3888688|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066463|NCT01059643|3888688|B1||White|Race (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
4066464|NCT01059643|3888688|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4066465|NCT01059643|3888688|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066466|NCT01059643|3888688|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4066467|NCT01059643|3888688|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066468|NCT01059643|3888688|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066469|NCT01059643|3888688|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
4066470|NCT01059643|3888688|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4066471|NCT01059643|3888688|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4066472|NCT01059643|3888688|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4066473|NCT01059643|3888688|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|10.30|10.3|||
4066474|NCT01059630|3888701|B3||Male|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
4066475|NCT01059630|3888702|B2||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4066476|NCT01059630|3888703|B1||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4066477|NCT01059630|3888701|B3||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4066478|NCT01059630|3888702|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4066479|NCT01059630|3888703|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4066480|NCT01059630|3888701|B3|||Age||years|Mean|61.9|61.9|Standard Deviation|11.4|11.4|||
4066481|NCT01059630|3888702|B2|||Age||years|Mean|61.9|61.9|Standard Deviation|11.3|11.3|||
4066482|NCT01059630|3888703|B1|||Age||years|Mean|61.9|61.9|Standard Deviation|11.4|11.4|||
4066483|NCT01059617|3888760|B5||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4066484|NCT01059617|3888761|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4066485|NCT01059617|3888762|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4066486|NCT01059617|3888763|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4066487|NCT01059617|3888764|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4066488|NCT01059617|3888760|B5||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4066489|NCT01059617|3888761|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4066490|NCT01059617|3888762|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4066491|NCT01059617|3888763|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4066492|NCT01059617|3888764|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4066493|NCT01059617|3888760|B5|||Age||Years|Mean|29.3|29.3|Standard Deviation|6.73|6.73|||
4066494|NCT01059617|3888761|B4|||Age||Years|Mean|29.8|29.8|Standard Deviation|7.24|7.24|||
4066495|NCT01059617|3888762|B3|||Age||Years|Mean|28.6|28.6|Standard Deviation|6.17|6.17|||
4066496|NCT01059617|3888763|B2|||Age||Years|Mean|29.0|29.0|Standard Deviation|7.05|7.05|||
4066497|NCT01059617|3888764|B1|||Age||Years|Mean|29.6|29.6|Standard Deviation|6.44|6.44|||
4066498|NCT01059565|3888935|B3|||Burkholderia spp colony-forming units (CFU) in sputum|Participants in the Full Analysis Set with evaluable assessments for Burkholderia spp. CFU in sputum at baseline were analyzed, which included 30 in the AZLI group, 32 in the placebo group, and 62 total.|log_10 CFU per gram|Mean|6.40|6.4|Standard Deviation|2.48|2.48|||
4066499|NCT01059565|3888936|B2|||Burkholderia spp colony-forming units (CFU) in sputum|Participants in the Full Analysis Set with evaluable assessments for Burkholderia spp. CFU in sputum at baseline were analyzed, which included 30 in the AZLI group, 32 in the placebo group, and 62 total.|log_10 CFU per gram|Mean|6.41|6.41|Standard Deviation|2.52|2.52|||
4066500|NCT01059565|3888937|B1|||Burkholderia spp colony-forming units (CFU) in sputum|Participants in the Full Analysis Set with evaluable assessments for Burkholderia spp. CFU in sputum at baseline were analyzed, which included 30 in the AZLI group, 32 in the placebo group, and 62 total.|log_10 CFU per gram|Mean|6.39|6.39|Standard Deviation|2.47|2.47|||
4066501|NCT01059565|3888935|B3|||Body Mass Index (BMI)||kg/m^2|Mean|21.3|21.3|Standard Deviation|3.9|3.9|||
4066502|NCT01059565|3888936|B2|||Body Mass Index (BMI)||kg/m^2|Mean|20.7|20.7|Standard Deviation|3.2|3.2|||
4066503|NCT01059565|3888937|B1|||Body Mass Index (BMI)||kg/m^2|Mean|21.9|21.9|Standard Deviation|4.5|4.5|||
4066504|NCT01059565|3888935|B3|||Cystic Fibrosis Questionnaire - Revised (CFQ-R) Respiratory Symptoms Scale (RSS) Score|Respiratory symptoms (e.g., coughing, congestion, wheezing) were assessed with the CFQ-R Respiratory Symptoms Scale (RSS). The range of scores (units) is 0 to 100 with higher scores indicating fewer symptoms.|units on a scale|Mean|58.6|58.6|Standard Deviation|19.4|19.4|||
4066505|NCT01059565|3888936|B2|||Cystic Fibrosis Questionnaire - Revised (CFQ-R) Respiratory Symptoms Scale (RSS) Score|Respiratory symptoms (e.g., coughing, congestion, wheezing) were assessed with the CFQ-R Respiratory Symptoms Scale (RSS). The range of scores (units) is 0 to 100 with higher scores indicating fewer symptoms.|units on a scale|Mean|59.0|59.0|Standard Deviation|17.6|17.6|||
4066506|NCT01059565|3888937|B1|||Cystic Fibrosis Questionnaire - Revised (CFQ-R) Respiratory Symptoms Scale (RSS) Score|Respiratory symptoms (e.g., coughing, congestion, wheezing) were assessed with the CFQ-R Respiratory Symptoms Scale (RSS). The range of scores (units) is 0 to 100 with higher scores indicating fewer symptoms.|units on a scale|Mean|58.3|58.3|Standard Deviation|21.4|21.4|||
4066507|NCT01059565|3888935|B3|||Forced expiratory flow 25% to 75% (FEF25-75)|FEF25-75 is defined as the forced expiratory flow from 25% to 75% of the FVC.|liters per second|Mean|1.32|1.32|Standard Deviation|1.09|1.09|||
4066508|NCT01059565|3888936|B2|||Forced expiratory flow 25% to 75% (FEF25-75)|FEF25-75 is defined as the forced expiratory flow from 25% to 75% of the FVC.|liters per second|Mean|1.31|1.31|Standard Deviation|1.22|1.22|||
4066509|NCT01059565|3888937|B1|||Forced expiratory flow 25% to 75% (FEF25-75)|FEF25-75 is defined as the forced expiratory flow from 25% to 75% of the FVC.|liters per second|Mean|1.33|1.33|Standard Deviation|0.95|0.95|||
4066510|NCT01059565|3888935|B3|||Forced vital capacity (FVC)|FVC is defined as the volume of air that can forcibly be blown out after taking a full breath.|liters|Mean|3.11|3.11|Standard Deviation|1.16|1.16|||
4066511|NCT01059565|3888936|B2|||Forced vital capacity (FVC)|FVC is defined as the volume of air that can forcibly be blown out after taking a full breath.|liters|Mean|2.99|2.99|Standard Deviation|1.14|1.14|||
4066512|NCT01059565|3888937|B1|||Forced vital capacity (FVC)|FVC is defined as the volume of air that can forcibly be blown out after taking a full breath.|liters|Mean|3.23|3.23|Standard Deviation|1.18|1.18|||
4066513|NCT01059565|3888935|B3|||FEV1|FEV1 is defined as the maximal volume of air that can be exhaled in 1 second.|liters|Mean|2.02|2.02|Standard Deviation|0.95|0.95|||
4066514|NCT01059565|3888936|B2|||FEV1|FEV1 is defined as the maximal volume of air that can be exhaled in 1 second.|liters|Mean|1.93|1.93|Standard Deviation|0.96|0.96|||
4066515|NCT01059565|3888937|B1|||FEV1|FEV1 is defined as the maximal volume of air that can be exhaled in 1 second.|liters|Mean|2.13|2.13|Standard Deviation|0.93|0.93|||
4066516|NCT01059565|3888935|B3|||Forced expiratory volume in 1 second (FEV1) percent predicted|FEV1 % predicted is defined as FEV1 % of the patient divided by the average FEV1 % in the population for any person of similar age, sex and body composition.|percentage of FEV1 % predicted|Mean|56.47|56.47|Standard Deviation|23.02|23.02|||
4066517|NCT01059565|3888936|B2|||Forced expiratory volume in 1 second (FEV1) percent predicted|FEV1 % predicted is defined as FEV1 % of the patient divided by the average FEV1 % in the population for any person of similar age, sex and body composition.|percentage of FEV1 % predicted|Mean|52.59|52.59|Standard Deviation|23.71|23.71|||
4066518|NCT01059565|3888937|B1|||Forced expiratory volume in 1 second (FEV1) percent predicted|FEV1 % predicted is defined as FEV1 % of the patient divided by the average FEV1 % in the population for any person of similar age, sex and body composition.|percentage of FEV1 % predicted|Mean|60.67|60.67|Standard Deviation|21.71|21.71|||
4066519|NCT01059565|3888935|B3|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4066520|NCT01059565|3888936|B2|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4066521|NCT01059565|3888937|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4066522|NCT01059565|3888935|B3|United States||Region of Enrollment||participants|Number|94|94.0||||||
4066523|NCT01059565|3888936|B2|United States||Region of Enrollment||participants|Number|49|49.0||||||
4066524|NCT01059565|3888937|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4066525|NCT01059565|3888935|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4066526|NCT01059565|3888936|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4066527|NCT01059565|3888937|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4066528|NCT01059565|3888935|B3|White||Race/Ethnicity, Customized||participants|Number|96|96.0||||||
4066529|NCT01059565|3888936|B2|White||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
4066530|NCT01059565|3888937|B1|White||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4066531|NCT01059565|3888935|B3|Black or African Heritage||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4066532|NCT01059565|3888936|B2|Black or African Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4066533|NCT01059565|3888937|B1|Black or African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4066534|NCT01059565|3888935|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066535|NCT01059565|3888936|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066536|NCT01059565|3888937|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066537|NCT01059565|3888935|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
4066538|NCT01059565|3888936|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4066539|NCT01059565|3888937|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4066540|NCT01059565|3888935|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4066541|NCT01059565|3888936|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4066542|NCT01059565|3888937|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066543|NCT01059565|3888935|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4066544|NCT01059565|3888936|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4066545|NCT01059565|3888937|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4066546|NCT01059565|3888935|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4066547|NCT01059565|3888936|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4066548|NCT01059565|3888937|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4066549|NCT01059565|3888935|B3|≥ 18 years||Age, Customized||participants|Number|83|83.0||||||
4066550|NCT01059565|3888936|B2|≥ 18 years||Age, Customized||participants|Number|41|41.0||||||
4066551|NCT01059565|3888937|B1|≥ 18 years||Age, Customized||participants|Number|42|42.0||||||
4066552|NCT01059565|3888935|B3|> 12 to < 18 years||Age, Customized||participants|Number|11|11.0||||||
4066553|NCT01059565|3888936|B2|> 12 to < 18 years||Age, Customized||participants|Number|8|8.0||||||
4066554|NCT01059565|3888937|B1|> 12 to < 18 years||Age, Customized||participants|Number|3|3.0||||||
4066555|NCT01059565|3888935|B3|≥ 6 to ≤ 12 years||Age, Customized||participants|Number|6|6.0||||||
4066556|NCT01059565|3888936|B2|≥ 6 to ≤ 12 years||Age, Customized||participants|Number|3|3.0||||||
4066557|NCT01059565|3888937|B1|≥ 6 to ≤ 12 years||Age, Customized||participants|Number|3|3.0||||||
4066558|NCT01059565|3888935|B3|||Age||years|Mean|26.3|26.3|Standard Deviation|10.2|10.2|||
4066559|NCT01059565|3888936|B2|||Age||years|Mean|24.7|24.7|Standard Deviation|10.0|10.0|||
4066560|NCT01059565|3888937|B1|||Age||years|Mean|28.0|28.0|Standard Deviation|10.3|10.3|||
4066561|NCT01059526|3888972|B3|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4066562|NCT01059526|3888973|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4066563|NCT01059526|3888974|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4066564|NCT01059526|3888972|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4066565|NCT01059526|3888973|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4066566|NCT01059526|3888974|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4066567|NCT01059526|3888972|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4066568|NCT01059526|3888973|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4066569|NCT01059526|3888974|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4066570|NCT01059526|3888972|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4066571|NCT01059526|3888973|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4066572|NCT01059526|3888974|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4066573|NCT01059526|3888972|B3|||Age||years|Mean|43.0|43.0|Standard Deviation|16.08|16.08|||
4066574|NCT01059526|3888973|B2|||Age||years|Mean|38.3|38.3|Standard Deviation|14.86|14.86|||
4066575|NCT01059526|3888974|B1|||Age||years|Mean|48.2|48.2|Standard Deviation|16.09|16.09|||
4066576|NCT01059357|3888983|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4066577|NCT01059357|3888983|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4066578|NCT01059357|3888983|B1|||Age||years|Mean|51.64|51.64|Full Range|||27.0|80.0|
4066579|NCT01059344|3888992|B3|India||Region of Enrollment||participants|Number|57|57.0||||||
4066580|NCT01059344|3888993|B2|India||Region of Enrollment||participants|Number|31|31.0||||||
4066581|NCT01059344|3888994|B1|India||Region of Enrollment||participants|Number|26|26.0||||||
4066582|NCT01059344|3888992|B3|Belarus||Region of Enrollment||participants|Number|91|91.0||||||
4066583|NCT01059344|3888993|B2|Belarus||Region of Enrollment||participants|Number|44|44.0||||||
4066584|NCT01059344|3888994|B1|Belarus||Region of Enrollment||participants|Number|47|47.0||||||
4066585|NCT01059344|3888992|B3|Ukraine||Region of Enrollment||participants|Number|109|109.0||||||
4066586|NCT01059344|3888993|B2|Ukraine||Region of Enrollment||participants|Number|55|55.0||||||
4066587|NCT01059344|3888994|B1|Ukraine||Region of Enrollment||participants|Number|54|54.0||||||
4066588|NCT01059344|3888992|B3|Turkey||Region of Enrollment||participants|Number|24|24.0||||||
4066589|NCT01059344|3888993|B2|Turkey||Region of Enrollment||participants|Number|11|11.0||||||
4066590|NCT01059344|3888994|B1|Turkey||Region of Enrollment||participants|Number|13|13.0||||||
4066591|NCT01059344|3888992|B3|Asian||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
4066592|NCT01059344|3888993|B2|Asian||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4066593|NCT01059344|3888994|B1|Asian||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4066594|NCT01059344|3888992|B3|White||Race/Ethnicity, Customized||participants|Number|224|224.0||||||
4066595|NCT01059344|3888993|B2|White||Race/Ethnicity, Customized||participants|Number|110|110.0||||||
4066596|NCT01059344|3888994|B1|White||Race/Ethnicity, Customized||participants|Number|114|114.0||||||
4066597|NCT01059344|3888992|B3||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4066598|NCT01059344|3888993|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4066599|NCT01059344|3888994|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4066600|NCT01059344|3888992|B3||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4066601|NCT01059344|3888993|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4066602|NCT01059344|3888994|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4066603|NCT01059344|3888992|B3|||Age||years|Mean|41.8|41.8|Standard Deviation|14.1|14.1|||
4066604|NCT01059344|3888993|B2|||Age||years|Mean|40.72|40.72|Standard Deviation|13.8|13.8|||
4066605|NCT01059344|3888994|B1|||Age||years|Mean|42.6|42.6|Standard Deviation|14.3|14.3|||
4066606|NCT01059305|3889013|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4066607|NCT01059305|3889013|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4066608|NCT01059305|3889013|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4066609|NCT01059305|3889013|B1|||Age||years|Median|70|70.0|Full Range|||58.0|81.0|
4066610|NCT01059175|3889017|B3|||LVESV (left ventricular end-systolic volume)||milliliter|Mean|151|151.0|Standard Deviation|59.8|59.8|||
4066611|NCT01059175|3889018|B2|||LVESV (left ventricular end-systolic volume)||milliliter|Mean|149|149.0|Standard Deviation|58.7|58.7|||
4066612|NCT01059175|3889019|B1|||LVESV (left ventricular end-systolic volume)||milliliter|Mean|154|154.0|Standard Deviation|61.8|61.8|||
4066613|NCT01059175|3889017|B3|||LVEDV (left ventricular end-diastolic volume)||milliliter|Mean|213|213.0|Standard Deviation|75.7|75.7|||
4066614|NCT01059175|3889018|B2|||LVEDV (left ventricular end-diastolic volume)||milliliter|Mean|206|206.0|Standard Deviation|63.9|63.9|||
4066615|NCT01059175|3889019|B1|||LVEDV (left ventricular end-diastolic volume)||milliliter|Mean|219|219.0|Standard Deviation|85.8|85.8|||
4066616|NCT01059175|3889017|B3|||LVEF % (left ventricle ejection fraction)||percent|Mean|26.4|26.4|Standard Deviation|6.4|6.4|||
4066617|NCT01059175|3889018|B2|||LVEF % (left ventricle ejection fraction)||percent|Mean|25.9|25.9|Standard Deviation|7.0|7.0|||
4066618|NCT01059175|3889019|B1|||LVEF % (left ventricle ejection fraction)||percent|Mean|26.9|26.9|Standard Deviation|6.0|6.0|||
4066619|NCT01059175|3889017|B3|||Time from first CRT implant||months|Mean|40.6|40.6|Standard Deviation|26.2|26.2|||
4066620|NCT01059175|3889018|B2|||Time from first CRT implant||months|Mean|37.8|37.8|Standard Deviation|23.7|23.7|||
4066621|NCT01059175|3889019|B1|||Time from first CRT implant||months|Mean|43.5|43.5|Standard Deviation|28.4|28.4|||
4066622|NCT01059175|3889017|B3|||Paced QRS duration||milliseconds|Mean|160|160.0|Standard Deviation|36.8|36.8|||
4066623|NCT01059175|3889018|B2|||Paced QRS duration||milliseconds|Mean|155|155.0|Standard Deviation|42.2|42.2|||
4066624|NCT01059175|3889019|B1|||Paced QRS duration||milliseconds|Mean|165|165.0|Standard Deviation|30.5|30.5|||
4066625|NCT01059175|3889017|B3|||Patients with ischemic heart disease||participants|Number|46|46.0||||||
4066626|NCT01059175|3889018|B2|||Patients with ischemic heart disease||participants|Number|24|24.0||||||
4066627|NCT01059175|3889019|B1|||Patients with ischemic heart disease||participants|Number|22|22.0||||||
4066628|NCT01059175|3889017|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4066629|NCT01059175|3889018|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4066630|NCT01059175|3889019|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4066631|NCT01059175|3889017|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4066632|NCT01059175|3889018|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4066633|NCT01059175|3889019|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4066634|NCT01059175|3889017|B3|||Age||years|Mean|71.3|71.3|Standard Deviation|7.8|7.8|||
4066635|NCT01059175|3889018|B2|||Age||years|Mean|72.2|72.2|Standard Deviation|7.9|7.9|||
4066636|NCT01059175|3889019|B1|||Age||years|Mean|70.5|70.5|Standard Deviation|7.7|7.7|||
4066637|NCT01059071|3889042|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4066638|NCT01059071|3889042|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066639|NCT01059071|3889042|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4066640|NCT01059071|3889042|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4066641|NCT01059071|3889042|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066642|NCT01059071|3889042|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066643|NCT01059071|3889042|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066644|NCT01059071|3889042|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4066645|NCT01059071|3889042|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4066646|NCT01059071|3889042|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4066647|NCT01059071|3889042|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4066648|NCT01059071|3889042|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4066649|NCT01059071|3889042|B1|||Age||years|Mean|8.75|8.75|Full Range|||1.0|17.0|
4066650|NCT01058993|3889057|B1|||blood neutrophil levels|On days 1, 3, 5, 8 and 10 a small sample of blood was drawn for CBC, Differential and Smear Evaluation, performed for determination of blood cell counts before and at 30 minutes, 1, 2, 4, 6, 9 and 12 hours after the drug was given. This required placement of a catheter that was left in place for 12 hours for ease of serial blood sampling. On the days between injections of plerixafor/AMD3100, a sample of blood was taken once in the morning via a needle in an arm vein.|10^9 per Liter|Mean|0.7|0.7|Standard Deviation|0.6|0.6|||
4066651|NCT01058993|3889057|B1|||Blood neutrophil count (in myelokathexis)||10^9 per Liter|Mean|0.7|0.7|Full Range|||0.2|1.8|
4066652|NCT01058993|3889057|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4066653|NCT01058993|3889057|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4066654|NCT01058993|3889057|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4066655|NCT01058993|3889057|B1|||Age||years|Mean|42.7|42.7|Standard Deviation|17.0|17.0|||
4066656|NCT01058993|3889057|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4066657|NCT01058993|3889057|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4066658|NCT01058993|3889057|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4066659|NCT01058941|3889061|B3|United States||Region of Enrollment||participants|Number|67|67.0||||||
4066660|NCT01058941|3889062|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4066661|NCT01058941|3889063|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4066662|NCT01058941|3889061|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4066663|NCT01058941|3889062|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4066664|NCT01058941|3889063|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066665|NCT01058941|3889061|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066666|NCT01058941|3889062|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066667|NCT01058941|3889063|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066668|NCT01058941|3889061|B3||White|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4066669|NCT01058941|3889062|B2||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4066670|NCT01058941|3889063|B1||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4066671|NCT01058941|3889061|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4066672|NCT01058941|3889062|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4066673|NCT01058941|3889063|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4066674|NCT01058941|3889061|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066675|NCT01058941|3889062|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066676|NCT01058941|3889063|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066677|NCT01058941|3889061|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066678|NCT01058941|3889062|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066679|NCT01058941|3889063|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066680|NCT01058941|3889061|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4066681|NCT01058941|3889062|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4066682|NCT01058941|3889063|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066683|NCT01058941|3889061|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4066684|NCT01058941|3889062|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4066685|NCT01058941|3889063|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066686|NCT01058941|3889061|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4066687|NCT01058941|3889062|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4066688|NCT01058941|3889063|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4066689|NCT01058941|3889061|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066690|NCT01058941|3889062|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066691|NCT01058941|3889063|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066692|NCT01058941|3889061|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4066693|NCT01058941|3889062|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4066694|NCT01058941|3889063|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4066695|NCT01058941|3889061|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4066696|NCT01058941|3889062|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4066697|NCT01058941|3889063|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4066698|NCT01058941|3889061|B3|||Age||years|Mean|74.7|74.7|Full Range|||52.0|92.0|
4066699|NCT01058941|3889062|B2|||Age||years|Mean|76.2|76.2|Full Range|||52.0|89.0|
4066700|NCT01058941|3889063|B1|||Age||years|Mean|73.3|73.3|Full Range|||56.0|92.0|
4066701|NCT01058941|3889061|B3||>=65 years|Age||Participants|Count of Participants|58|58.0||||||
4066702|NCT01058941|3889062|B2||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4066703|NCT01058941|3889063|B1||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4066704|NCT01058941|3889061|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4066705|NCT01058941|3889062|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4066706|NCT01058941|3889063|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4066707|NCT01058941|3889061|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4066708|NCT01058941|3889062|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4066709|NCT01058941|3889063|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4066710|NCT01058863|3889072|B1|||Weight||kg|Mean|89.6|89.6|Standard Deviation|22.77|22.77|||
4066711|NCT01058863|3889072|B1|||Height||cm|Mean|169.1|169.1|Standard Deviation|9.49|9.49|||
4066712|NCT01058863|3889072|B1|Latino or Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4066713|NCT01058863|3889072|B1|Not Latino or Hispanic||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
4066714|NCT01058863|3889072|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4066715|NCT01058863|3889072|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4066716|NCT01058863|3889072|B1|White||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
4066717|NCT01058863|3889072|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4066718|NCT01058863|3889072|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4066719|NCT01058863|3889072|B1|>65 years||Age, Customized||participants|Number|4|4.0||||||
4066720|NCT01058863|3889072|B1|18 to 65 years||Age, Customized||participants|Number|64|64.0||||||
4066721|NCT01058863|3889072|B1|12 to <18 years||Age, Customized||participants|Number|3|3.0||||||
4066722|NCT01058863|3889072|B1|||Age||years|Mean|43.3|43.3|Standard Deviation|14.78|14.78|||
4066723|NCT01058668|3889090|B4|||Body Mass Index (BMI)||kg/meter(m)^2|Mean|28.08|28.08|Standard Deviation|5.12|5.12|||
4066724|NCT01058668|3889091|B3|||Body Mass Index (BMI)||kg/meter(m)^2|Mean|28.04|28.04|Standard Deviation|4.92|4.92|||
4066725|NCT01058668|3889092|B2|||Body Mass Index (BMI)||kg/meter(m)^2|Mean|28.22|28.22|Standard Deviation|5.29|5.29|||
4066726|NCT01058668|3889093|B1|||Body Mass Index (BMI)||kg/meter(m)^2|Mean|27.99|27.99|Standard Deviation|5.15|5.15|||
4066727|NCT01058668|3889090|B4|||Height||centimeter (cm)|Mean|170.72|170.72|Standard Deviation|9.45|9.45|||
4066728|NCT01058668|3889091|B3|||Height||centimeter (cm)|Mean|170.25|170.25|Standard Deviation|9.36|9.36|||
4066729|NCT01058668|3889092|B2|||Height||centimeter (cm)|Mean|170.99|170.99|Standard Deviation|9.15|9.15|||
4066730|NCT01058668|3889093|B1|||Height||centimeter (cm)|Mean|170.93|170.93|Standard Deviation|9.88|9.88|||
4066731|NCT01058668|3889090|B4|||Weight||kilogram (kg)|Mean|81.87|81.87|Standard Deviation|16.30|16.3|||
4066732|NCT01058668|3889091|B3|||Weight||kilogram (kg)|Mean|81.49|81.49|Standard Deviation|16.78|16.78|||
4066733|NCT01058668|3889092|B2|||Weight||kilogram (kg)|Mean|82.42|82.42|Standard Deviation|16.22|16.22|||
4066734|NCT01058668|3889093|B1|||Weight||kilogram (kg)|Mean|81.70|81.7|Standard Deviation|15.96|15.96|||
4066735|NCT01058668|3889090|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4066736|NCT01058668|3889091|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4066737|NCT01058668|3889092|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4066738|NCT01058668|3889093|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4066739|NCT01058668|3889090|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4066740|NCT01058668|3889091|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4066741|NCT01058668|3889092|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4066742|NCT01058668|3889093|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4066743|NCT01058668|3889090|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4066744|NCT01058668|3889091|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4066745|NCT01058668|3889092|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4066746|NCT01058668|3889093|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4066747|NCT01058668|3889090|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4066748|NCT01058668|3889091|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4066749|NCT01058668|3889092|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4066750|NCT01058668|3889093|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4066751|NCT01058668|3889090|B4|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|139|139.0||||||
4066752|NCT01058668|3889091|B3|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
4066753|NCT01058668|3889092|B2|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
4066754|NCT01058668|3889093|B1|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
4066755|NCT01058668|3889090|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|345|345.0||||||
4066756|NCT01058668|3889091|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|114|114.0||||||
4066757|NCT01058668|3889092|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|117|117.0||||||
4066758|NCT01058668|3889093|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|114|114.0||||||
4066759|NCT01058668|3889090|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066760|NCT01058668|3889091|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066761|NCT01058668|3889092|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066762|NCT01058668|3889093|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066763|NCT01058668|3889090|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|473|473.0||||||
4066764|NCT01058668|3889091|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|165|165.0||||||
4066765|NCT01058668|3889092|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|157|157.0||||||
4066766|NCT01058668|3889093|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|151|151.0||||||
4066767|NCT01058668|3889090|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4066768|NCT01058668|3889091|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4066769|NCT01058668|3889092|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4066770|NCT01058668|3889093|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4066771|NCT01058668|3889090|B4||Male|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
4066772|NCT01058668|3889091|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4066773|NCT01058668|3889092|B2||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4066774|NCT01058668|3889093|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4066775|NCT01058668|3889090|B4||Female|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
4066776|NCT01058668|3889091|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4066777|NCT01058668|3889092|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4066778|NCT01058668|3889093|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4066779|NCT01058668|3889090|B4|||Age||years|Mean|41.9|41.9|Standard Deviation|11.7|11.7|||
4066780|NCT01058668|3889091|B3|||Age||years|Mean|41.2|41.2|Standard Deviation|11.3|11.3|||
4066781|NCT01058668|3889092|B2|||Age||years|Mean|43.1|43.1|Standard Deviation|12.2|12.2|||
4066782|NCT01058668|3889093|B1|||Age||years|Mean|41.5|41.5|Standard Deviation|11.4|11.4|||
4066783|NCT01058655|3889106|B5|United States||Region of Enrollment||Participants|Count of Participants|56|56.0||||||
4066784|NCT01058655|3889107|B4|United States||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
4066785|NCT01058655|3889108|B3|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4066786|NCT01058655|3889109|B2|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4066787|NCT01058655|3889110|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4066788|NCT01058655|3889106|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066789|NCT01058655|3889107|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066790|NCT01058655|3889108|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066791|NCT01058655|3889109|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066792|NCT01058655|3889110|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066793|NCT01058655|3889106|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4066794|NCT01058655|3889107|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4066795|NCT01058655|3889108|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066796|NCT01058655|3889109|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066797|NCT01058655|3889110|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066798|NCT01058655|3889106|B5||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4066799|NCT01058655|3889107|B4||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4066800|NCT01058655|3889108|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4066801|NCT01058655|3889109|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4066802|NCT01058655|3889110|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4066803|NCT01058655|3889106|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4066804|NCT01058655|3889107|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4066805|NCT01058655|3889108|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4066806|NCT01058655|3889109|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066807|NCT01058655|3889110|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4066808|NCT01058655|3889106|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066809|NCT01058655|3889107|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066810|NCT01058655|3889108|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066811|NCT01058655|3889109|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066812|NCT01058655|3889110|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066813|NCT01058655|3889106|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4066814|NCT01058655|3889107|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4066815|NCT01058655|3889108|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066816|NCT01058655|3889109|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066817|NCT01058655|3889110|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066818|NCT01058655|3889106|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066819|NCT01058655|3889107|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066820|NCT01058655|3889108|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066821|NCT01058655|3889109|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066822|NCT01058655|3889110|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066823|NCT01058655|3889106|B5||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4066824|NCT01058655|3889107|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4066825|NCT01058655|3889108|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4066826|NCT01058655|3889109|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4066827|NCT01058655|3889110|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4066828|NCT01058655|3889106|B5||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4066829|NCT01058655|3889107|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4066830|NCT01058655|3889108|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4066831|NCT01058655|3889109|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4066832|NCT01058655|3889110|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4066833|NCT01058655|3889106|B5|||Age||years|Median|59|59.0|Full Range|||36.0|82.0|
4066834|NCT01058655|3889107|B4|||Age||years|Median|56|56.0|Full Range|||36.0|82.0|
4066835|NCT01058655|3889108|B3|||Age||years|Median|63|63.0|Full Range|||48.0|82.0|
4066836|NCT01058655|3889109|B2|||Age||years|Median|47|47.0|Full Range|||40.0|68.0|
4066837|NCT01058655|3889110|B1|||Age||years|Median|58|58.0|Full Range|||50.0|70.0|
4066838|NCT01058642|3889127|B5|United States||Region of Enrollment||participants|Number|41|41.0||||||
4066839|NCT01058642|3889128|B4|United States||Region of Enrollment||participants|Number|9|9.0||||||
4066840|NCT01058642|3889129|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4066841|NCT01058642|3889130|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4066842|NCT01058642|3889131|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4066843|NCT01058642|3889127|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066844|NCT01058642|3889128|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066845|NCT01058642|3889129|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066846|NCT01058642|3889130|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066847|NCT01058642|3889131|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066848|NCT01058642|3889127|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066849|NCT01058642|3889128|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066850|NCT01058642|3889129|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066851|NCT01058642|3889130|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066852|NCT01058642|3889131|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066853|NCT01058642|3889127|B5||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4066854|NCT01058642|3889128|B4||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4066855|NCT01058642|3889129|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4066856|NCT01058642|3889130|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4066857|NCT01058642|3889131|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4066858|NCT01058642|3889127|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4066859|NCT01058642|3889128|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4066860|NCT01058642|3889129|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066861|NCT01058642|3889130|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4066862|NCT01058642|3889131|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4066863|NCT01058642|3889127|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066864|NCT01058642|3889128|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066865|NCT01058642|3889129|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066866|NCT01058642|3889130|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066867|NCT01058642|3889131|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066868|NCT01058642|3889127|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066869|NCT01058642|3889128|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066870|NCT01058642|3889129|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066871|NCT01058642|3889130|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066872|NCT01058642|3889131|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066873|NCT01058642|3889127|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066874|NCT01058642|3889128|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066875|NCT01058642|3889129|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066876|NCT01058642|3889130|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066877|NCT01058642|3889131|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066878|NCT01058642|3889127|B5||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4066879|NCT01058642|3889128|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4066880|NCT01058642|3889129|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4066881|NCT01058642|3889130|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4066882|NCT01058642|3889131|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4066883|NCT01058642|3889127|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4066884|NCT01058642|3889128|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4066885|NCT01058642|3889129|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4066886|NCT01058642|3889130|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4066887|NCT01058642|3889131|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4066888|NCT01058642|3889127|B5|||Age||years|Mean|62.5|62.5|Standard Deviation|11.46|11.46|||
4066889|NCT01058642|3889128|B4|||Age||years|Mean|67.4|67.4|Standard Deviation|8.03|8.03|||
4066890|NCT01058642|3889129|B3|||Age||years|Mean|67.1|67.1|Standard Deviation|6.98|6.98|||
4066891|NCT01058642|3889130|B2|||Age||years|Mean|58.9|58.9|Standard Deviation|16.01|16.01|||
4066892|NCT01058642|3889131|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|8.17|8.17|||
4066893|NCT01058421|3889142|B3|Male||Sex/Gender, Customized||participants|Number|70|70.0||||||
4066894|NCT01058421|3889143|B2|Male||Sex/Gender, Customized||participants|Number|35|35.0||||||
4066895|NCT01058421|3889144|B1|Male||Sex/Gender, Customized||participants|Number|35|35.0||||||
4066896|NCT01058421|3889142|B3|Female||Sex/Gender, Customized||participants|Number|50|50.0||||||
4066897|NCT01058421|3889143|B2|Female||Sex/Gender, Customized||participants|Number|26|26.0||||||
4066898|NCT01058421|3889144|B1|Female||Sex/Gender, Customized||participants|Number|24|24.0||||||
4066899|NCT01058421|3889142|B3|||Age||years|Median|53|53.0|Full Range|||34.0|70.0|
4066900|NCT01058421|3889143|B2|||Age||years|Median|49|49.0|Full Range|||34.0|64.0|
4066901|NCT01058421|3889144|B1|||Age||years|Median|56|56.0|Full Range|||42.0|70.0|
4066902|NCT01058395|3889167|B3|United States||Region of Enrollment|Disability Rating Scale|Participants|Count of Participants|15|15.0||||||
4066903|NCT01058395|3889168|B2|United States||Region of Enrollment|Disability Rating Scale|Participants|Count of Participants|8|8.0||||||
4066904|NCT01058395|3889169|B1|United States||Region of Enrollment|Disability Rating Scale|Participants|Count of Participants|7|7.0||||||
4066905|NCT01058395|3889167|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066906|NCT01058395|3889168|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066907|NCT01058395|3889169|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066908|NCT01058395|3889167|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066909|NCT01058395|3889168|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066910|NCT01058395|3889169|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066911|NCT01058395|3889167|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4066912|NCT01058395|3889168|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4066913|NCT01058395|3889169|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4066914|NCT01058395|3889167|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4066915|NCT01058395|3889168|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4066916|NCT01058395|3889169|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4066917|NCT01058395|3889167|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066918|NCT01058395|3889168|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066919|NCT01058395|3889169|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066920|NCT01058395|3889167|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066921|NCT01058395|3889168|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066922|NCT01058395|3889169|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066923|NCT01058395|3889167|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066924|NCT01058395|3889168|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066925|NCT01058395|3889169|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066926|NCT01058395|3889167|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4066927|NCT01058395|3889168|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4066928|NCT01058395|3889169|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4066929|NCT01058395|3889167|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4066930|NCT01058395|3889168|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4066931|NCT01058395|3889169|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4066932|NCT01058395|3889167|B3|||Age||years|Mean|43|43.0|Full Range|||21.0|71.0|
4066933|NCT01058395|3889168|B2|||Age||years|Mean|40|40.0|Full Range|||21.0|64.0|
4066934|NCT01058395|3889169|B1|||Age||years|Mean|46|46.0|Full Range|||21.0|71.0|
4066935|NCT01058395|3889167|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4066936|NCT01058395|3889168|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4066937|NCT01058395|3889169|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4066938|NCT01058395|3889167|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4066939|NCT01058395|3889168|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4066940|NCT01058395|3889169|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4066941|NCT01058395|3889167|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4066942|NCT01058395|3889168|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4066943|NCT01058395|3889169|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4066944|NCT01058356|3889179|B1|Korea, Republic of||Region of Enrollment||participants|Number|214|214.0||||||
4066945|NCT01058356|3889179|B1||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4066946|NCT01058356|3889179|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4066947|NCT01058356|3889179|B1|||Age||years|Mean|60.5|60.5|Standard Deviation|15.5|15.5|||
4066948|NCT01058356|3889179|B1||>=65 years|Age||Participants|Count of Participants|102|102.0||||||
4066949|NCT01058356|3889179|B1||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
4066950|NCT01058356|3889179|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4066951|NCT01058304|3889184|B3|||Short Performance Physical Battery (SPPB)|This battery of objective physical function tests examines participants’ balance (3 tests), gait speed (8-foot walk), and time to rise from a chair and return to the seated position five times. For each test, the possible range if scores is 0-4, for a total range of 0-20 for all five tests, with higher scores indicating better function.|units on a scale|Mean|9.1|9.1|Standard Deviation|2.0|2.0|||
4066952|NCT01058304|3889185|B2|||Short Performance Physical Battery (SPPB)|This battery of objective physical function tests examines participants’ balance (3 tests), gait speed (8-foot walk), and time to rise from a chair and return to the seated position five times. For each test, the possible range if scores is 0-4, for a total range of 0-20 for all five tests, with higher scores indicating better function.|units on a scale|Mean|9.1|9.1|Standard Deviation|2.1|2.1|||
4066953|NCT01058304|3889186|B1|||Short Performance Physical Battery (SPPB)|This battery of objective physical function tests examines participants’ balance (3 tests), gait speed (8-foot walk), and time to rise from a chair and return to the seated position five times. For each test, the possible range if scores is 0-4, for a total range of 0-20 for all five tests, with higher scores indicating better function.|units on a scale|Mean|9.2|9.2|Standard Deviation|1.9|1.9|||
4066954|NCT01058304|3889184|B3|||Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Total Score|WOMAC is a measure of lower extremity pain (5 items), stiffness (2 items), and function (17 items). All items are rated on a Likert scale of 0 (no symptoms) to 4 (extreme symptoms). The total score ranges from 0-96, with higher scores indicating worse symptoms.|units on a scale|Mean|43.7|43.7|Standard Deviation|14.7|14.7|||
4066955|NCT01058304|3889185|B2|||Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Total Score|WOMAC is a measure of lower extremity pain (5 items), stiffness (2 items), and function (17 items). All items are rated on a Likert scale of 0 (no symptoms) to 4 (extreme symptoms). The total score ranges from 0-96, with higher scores indicating worse symptoms.|units on a scale|Mean|43.3|43.3|Standard Deviation|14.5|14.5|||
4066956|NCT01058304|3889186|B1|||Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Total Score|WOMAC is a measure of lower extremity pain (5 items), stiffness (2 items), and function (17 items). All items are rated on a Likert scale of 0 (no symptoms) to 4 (extreme symptoms). The total score ranges from 0-96, with higher scores indicating worse symptoms.|units on a scale|Mean|44.2|44.2|Standard Deviation|14.9|14.9|||
4066957|NCT01058304|3889184|B3|Non-White||Race/Ethnicity, Customized||participants|Number|184|184.0||||||
4066958|NCT01058304|3889185|B2|Non-White||Race/Ethnicity, Customized||participants|Number|93|93.0||||||
4066959|NCT01058304|3889186|B1|Non-White||Race/Ethnicity, Customized||participants|Number|91|91.0||||||
4066960|NCT01058304|3889184|B3|White||Race/Ethnicity, Customized||participants|Number|136|136.0||||||
4066961|NCT01058304|3889185|B2|White||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
4066962|NCT01058304|3889186|B1|White||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
4066963|NCT01058304|3889184|B3||Male|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
4066964|NCT01058304|3889185|B2||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4066965|NCT01058304|3889186|B1||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4066966|NCT01058304|3889184|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4066967|NCT01058304|3889185|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4066968|NCT01058304|3889186|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4066969|NCT01058304|3889184|B3|||Age||years|Mean|60.0|60.0|Standard Deviation|9.8|9.8|||
4066970|NCT01058304|3889185|B2|||Age||years|Mean|60.8|60.8|Standard Deviation|10.0|10.0|||
4066971|NCT01058304|3889186|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|9.6|9.6|||
4066972|NCT01058265|3889195|B3|||Height||cm|Mean|164.6|164.6|Standard Deviation|16.2|16.2|||
4066973|NCT01058265|3889196|B2|||Height||cm|Mean|161.3|161.3|Standard Deviation|20.3|20.3|||
4066974|NCT01058265|3889197|B1|||Height||cm|Mean|168.4|168.4|Standard Deviation|8.1|8.1|||
4066975|NCT01058265|3889195|B3|||Weight||kg|Mean|73.6|73.6|Standard Deviation|21.7|21.7|||
4066976|NCT01058265|3889196|B2|||Weight||kg|Mean|76.1|76.1|Standard Deviation|24.6|24.6|||
4066977|NCT01058265|3889197|B1|||Weight||kg|Mean|70.5|70.5|Standard Deviation|17.8|17.8|||
4066978|NCT01058265|3889195|B3|Both||Reason for appointment||Participants|Number|4|4.0||||||
4066979|NCT01058265|3889196|B2|Both||Reason for appointment||Participants|Number|3|3.0||||||
4066980|NCT01058265|3889197|B1|Both||Reason for appointment||Participants|Number|1|1.0||||||
4066981|NCT01058265|3889195|B3|Pain||Reason for appointment||Participants|Number|20|20.0||||||
4066982|NCT01058265|3889196|B2|Pain||Reason for appointment||Participants|Number|14|14.0||||||
4066983|NCT01058265|3889197|B1|Pain||Reason for appointment||Participants|Number|6|6.0||||||
4066984|NCT01058265|3889195|B3|Fatigue||Reason for appointment||Participants|Number|23|23.0||||||
4066985|NCT01058265|3889196|B2|Fatigue||Reason for appointment||Participants|Number|8|8.0||||||
4066986|NCT01058265|3889197|B1|Fatigue||Reason for appointment||Participants|Number|15|15.0||||||
4066987|NCT01058265|3889195|B3|Other/Unknown||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4066988|NCT01058265|3889196|B2|Other/Unknown||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4066989|NCT01058265|3889197|B1|Other/Unknown||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4066990|NCT01058265|3889195|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4066991|NCT01058265|3889196|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4066992|NCT01058265|3889197|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4066993|NCT01058265|3889195|B3|White||Race/Ethnicity, Customized||Participants|Number|42|42.0||||||
4066994|NCT01058265|3889196|B2|White||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4066995|NCT01058265|3889197|B1|White||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
4066996|NCT01058265|3889195|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066997|NCT01058265|3889196|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066998|NCT01058265|3889197|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4066999|NCT01058265|3889195|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4067000|NCT01058265|3889196|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4067001|NCT01058265|3889197|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4067002|NCT01058265|3889195|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4067003|NCT01058265|3889196|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4067004|NCT01058265|3889197|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4067005|NCT01058265|3889195|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4067006|NCT01058265|3889196|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4067007|NCT01058265|3889197|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4067008|NCT01058265|3889195|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4067009|NCT01058265|3889196|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4067010|NCT01058265|3889197|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4067011|NCT01058265|3889195|B3|||Age||Year|Median|44.7|44.7|Inter-Quartile Range|||34.8|57.2|
4067012|NCT01058265|3889196|B2|||Age||Year|Median|51.8|51.8|Inter-Quartile Range|||37.0|62.4|
4067013|NCT01058265|3889197|B1|||Age||Year|Median|43.4|43.4|Inter-Quartile Range|||28.8|53.3|
4067014|NCT01058239|3889206|B1|PTLD/monomorphic, DLBCL||WHO Classification|"World Health Organization (WHO) disease classification.~PTLD: Post-transplant lymphoproliferative disease~DLBCL: diffuse large B-cell lymphoma."|Participants|Count of Participants|5|5.0||||||
4067015|NCT01058239|3889206|B1|PTLD/polymorphic||WHO Classification|"World Health Organization (WHO) disease classification.~PTLD: Post-transplant lymphoproliferative disease~DLBCL: diffuse large B-cell lymphoma."|Participants|Count of Participants|2|2.0||||||
4067016|NCT01058239|3889206|B1|2||ECOG Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status 0: Asymptomatic (Fully active)~Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out light work)~Symptomatic <50% in bed during the day (Ambulatory and capable of all self care but unable to carry out any work activities)~Symptomatic, >50% in bed, but not bedbound (Capable of only limited self-care, confined to bed or chair 50% or more of waking hours)~Bedbound (Completely disabled. Cannot carry on any self-care)~Death"|Participants|Count of Participants|1|1.0||||||
4067017|NCT01058239|3889206|B1|1||ECOG Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status 0: Asymptomatic (Fully active)~Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out light work)~Symptomatic <50% in bed during the day (Ambulatory and capable of all self care but unable to carry out any work activities)~Symptomatic, >50% in bed, but not bedbound (Capable of only limited self-care, confined to bed or chair 50% or more of waking hours)~Bedbound (Completely disabled. Cannot carry on any self-care)~Death"|Participants|Count of Participants|2|2.0||||||
4067018|NCT01058239|3889206|B1|0||ECOG Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status 0: Asymptomatic (Fully active)~Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out light work)~Symptomatic <50% in bed during the day (Ambulatory and capable of all self care but unable to carry out any work activities)~Symptomatic, >50% in bed, but not bedbound (Capable of only limited self-care, confined to bed or chair 50% or more of waking hours)~Bedbound (Completely disabled. Cannot carry on any self-care)~Death"|Participants|Count of Participants|4|4.0||||||
4067019|NCT01058239|3889206|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4067020|NCT01058239|3889206|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4067021|NCT01058239|3889206|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4067022|NCT01058239|3889206|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4067023|NCT01058239|3889206|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4067024|NCT01058239|3889206|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4067025|NCT01058239|3889206|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4067026|NCT01058239|3889206|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4067027|NCT01058239|3889206|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4067028|NCT01058239|3889206|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4067029|NCT01058239|3889206|B1|71+ years||Age, Customized||Participants|Count of Participants|3|3.0||||||
4067030|NCT01058239|3889206|B1|61-70 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
4067031|NCT01058239|3889206|B1|51-60 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4067032|NCT01058239|3889206|B1|≤ 50 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
4067033|NCT01058239|3889206|B1|||Age||years|Median|67|67.0|Full Range|||46.0|71.0|
4067034|NCT01058096|3889215|B3|||Body Mass Index (BMI)||kg/meter(m)^2|Mean|25.48|25.48|Standard Deviation|5.98|5.98|||
4067035|NCT01058096|3889216|B2|||Body Mass Index (BMI)||kg/meter(m)^2|Mean|25.24|25.24|Standard Deviation|5.98|5.98|||
4067036|NCT01058096|3889217|B1|||Body Mass Index (BMI)||kg/meter(m)^2|Mean|25.73|25.73|Standard Deviation|5.98|5.98|||
4067037|NCT01058096|3889215|B3|||Height||centimeter (cm)|Mean|165.79|165.79|Standard Deviation|10.66|10.66|||
4067038|NCT01058096|3889216|B2|||Height||centimeter (cm)|Mean|165.21|165.21|Standard Deviation|10.68|10.68|||
4067039|NCT01058096|3889217|B1|||Height||centimeter (cm)|Mean|166.39|166.39|Standard Deviation|10.64|10.64|||
4067040|NCT01058096|3889215|B3|||Weight||kilogram (kg)|Mean|70.69|70.69|Standard Deviation|20.17|20.17|||
4067041|NCT01058096|3889216|B2|||Weight||kilogram (kg)|Mean|69.55|69.55|Standard Deviation|20.06|20.06|||
4067042|NCT01058096|3889217|B1|||Weight||kilogram (kg)|Mean|71.86|71.86|Standard Deviation|20.27|20.27|||
4067043|NCT01058096|3889215|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4067044|NCT01058096|3889216|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4067045|NCT01058096|3889217|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4067046|NCT01058096|3889215|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4067047|NCT01058096|3889216|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4067048|NCT01058096|3889217|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4067049|NCT01058096|3889215|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|179|179.0||||||
4067050|NCT01058096|3889216|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|91|91.0||||||
4067051|NCT01058096|3889217|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|88|88.0||||||
4067052|NCT01058096|3889215|B3|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|62|62.0||||||
4067053|NCT01058096|3889216|B2|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
4067054|NCT01058096|3889217|B1|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
4067055|NCT01058096|3889215|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|66|66.0||||||
4067056|NCT01058096|3889216|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
4067057|NCT01058096|3889217|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
4067058|NCT01058096|3889215|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4067059|NCT01058096|3889216|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4067060|NCT01058096|3889217|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4067061|NCT01058096|3889215|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|302|302.0||||||
4067062|NCT01058096|3889216|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|153|153.0||||||
4067063|NCT01058096|3889217|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|149|149.0||||||
4067064|NCT01058096|3889215|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4067065|NCT01058096|3889216|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4067066|NCT01058096|3889217|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4067067|NCT01058096|3889215|B3||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4067068|NCT01058096|3889216|B2||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4067069|NCT01058096|3889217|B1||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4067070|NCT01058096|3889215|B3||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4067071|NCT01058096|3889216|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4067072|NCT01058096|3889217|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4067073|NCT01058096|3889215|B3|||Age||years|Mean|36.3|36.3|Standard Deviation|11.5|11.5|||
4067074|NCT01058096|3889216|B2|||Age||years|Mean|35.8|35.8|Standard Deviation|11.4|11.4|||
4067075|NCT01058096|3889217|B1|||Age||years|Mean|36.7|36.7|Standard Deviation|11.8|11.8|||
4067076|NCT01058070|3889226|B1|||Gastroesophageal Reflux Disease-Health Related Quality of Life (GERD-HRQL)|Scoring scale is from 0 to 5 with 0=no symptoms to 5=symptoms are incapacitating. The maximum value score is 50.|scores on a scale|Number|26.5|26.5||||||
4067077|NCT01058070|3889226|B1|||% time esophageal pH<4|The time during which esophageal pH is less than 4.0 divided by the total recording time expressed in percentage.|percentage|Mean|11.9|11.9|Full Range|||2.7|38.2|
4067078|NCT01058070|3889226|B1|||Body Mass Index (BMI)||kg/m^2|Mean|25.7|25.7|Full Range|||19.0|38.0|
4067079|NCT01058070|3889226|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4067080|NCT01058070|3889226|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4067081|NCT01058070|3889226|B1|||Age||years|Mean|42.8|42.8|Full Range|||19.0|71.0|
4067082|NCT01058005|3889231|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4067083|NCT01058005|3889232|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4067084|NCT01058005|3889233|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4067085|NCT01058005|3889234|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4067086|NCT01058005|3889231|B4||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4067087|NCT01058005|3889232|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4067088|NCT01058005|3889233|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4067089|NCT01058005|3889234|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4067090|NCT01058005|3889231|B4|||Age||years|Mean|37.1|37.1|Standard Deviation|10.52|10.52|||
4067091|NCT01058005|3889232|B3|||Age||years|Mean|37.6|37.6|Standard Deviation|13.16|13.16|||
4067092|NCT01058005|3889233|B2|||Age||years|Mean|39.0|39.0|Standard Deviation|10.0|10.0|||
4067093|NCT01058005|3889234|B1|||Age||years|Mean|35.8|35.8|Standard Deviation|9.51|9.51|||
4067094|NCT01057901|3889244|B3|Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4067095|NCT01057901|3889245|B2|Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4067096|NCT01057901|3889246|B1|Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4067097|NCT01057901|3889244|B3|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4067098|NCT01057901|3889245|B2|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4067099|NCT01057901|3889246|B1|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4067100|NCT01057901|3889244|B3|Asian Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4067101|NCT01057901|3889245|B2|Asian Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4067102|NCT01057901|3889246|B1|Asian Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4067103|NCT01057901|3889244|B3|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4067104|NCT01057901|3889245|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4067105|NCT01057901|3889246|B1|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4067106|NCT01057901|3889244|B3|Black/African American Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4067107|NCT01057901|3889245|B2|Black/African American Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4067108|NCT01057901|3889246|B1|Black/African American Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4067109|NCT01057901|3889244|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4067110|NCT01057901|3889245|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4067111|NCT01057901|3889246|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4067112|NCT01057901|3889244|B3|White Hispanic||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4067113|NCT01057901|3889245|B2|White Hispanic||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4067114|NCT01057901|3889246|B1|White Hispanic||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4067115|NCT01057901|3889244|B3|White||Race/Ethnicity, Customized||participants|Number|634|634.0||||||
4067116|NCT01057901|3889245|B2|White||Race/Ethnicity, Customized||participants|Number|310|310.0||||||
4067117|NCT01057901|3889246|B1|White||Race/Ethnicity, Customized||participants|Number|324|324.0||||||
4067118|NCT01057901|3889244|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4067119|NCT01057901|3889245|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4067120|NCT01057901|3889246|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4067121|NCT01057901|3889244|B3||Female|Sex: Female, Male||Participants|Count of Participants|748|748.0||||||
4067122|NCT01057901|3889245|B2||Female|Sex: Female, Male||Participants|Count of Participants|372|372.0||||||
4067123|NCT01057901|3889246|B1||Female|Sex: Female, Male||Participants|Count of Participants|376|376.0||||||
4067124|NCT01057901|3889244|B3|65 years and older||Age, Customized||participants|Number|49|49.0||||||
4067125|NCT01057901|3889245|B2|65 years and older||Age, Customized||participants|Number|27|27.0||||||
4067126|NCT01057901|3889246|B1|65 years and older||Age, Customized||participants|Number|22|22.0||||||
4067127|NCT01057901|3889244|B3|55-64||Age, Customized||participants|Number|408|408.0||||||
4067128|NCT01057901|3889245|B2|55-64||Age, Customized||participants|Number|212|212.0||||||
4067129|NCT01057901|3889246|B1|55-64||Age, Customized||participants|Number|196|196.0||||||
4067130|NCT01057901|3889244|B3|45-54 years||Age, Customized||participants|Number|282|282.0||||||
4067131|NCT01057901|3889245|B2|45-54 years||Age, Customized||participants|Number|128|128.0||||||
4067132|NCT01057901|3889246|B1|45-54 years||Age, Customized||participants|Number|154|154.0||||||
4067133|NCT01057901|3889244|B3|less than 45 years||Age, Customized||participants|Number|9|9.0||||||
4067134|NCT01057901|3889245|B2|less than 45 years||Age, Customized||participants|Number|5|5.0||||||
4067135|NCT01057901|3889246|B1|less than 45 years||Age, Customized||participants|Number|4|4.0||||||
4067136|NCT01057888|3889255|B4||Male|Sex: Female, Male||Participants|Count of Participants|2078|2078.0||||||
4067137|NCT01057888|3889256|B3||Male|Sex: Female, Male||Participants|Count of Participants|714|714.0||||||
4067138|NCT01057888|3889257|B2||Male|Sex: Female, Male||Participants|Count of Participants|640|640.0||||||
4067139|NCT01057888|3889258|B1||Male|Sex: Female, Male||Participants|Count of Participants|724|724.0||||||
4067140|NCT01057888|3889255|B4||Female|Sex: Female, Male||Participants|Count of Participants|2037|2037.0||||||
4067141|NCT01057888|3889256|B3||Female|Sex: Female, Male||Participants|Count of Participants|682|682.0||||||
4067142|NCT01057888|3889257|B2||Female|Sex: Female, Male||Participants|Count of Participants|656|656.0||||||
4067143|NCT01057888|3889258|B1||Female|Sex: Female, Male||Participants|Count of Participants|699|699.0||||||
4067144|NCT01057888|3889255|B4|||Age||years|Mean|14.4|14.4|Standard Deviation|2.0|2.0|||
4067145|NCT01057888|3889256|B3|||Age||years|Mean|14.4|14.4|Standard Deviation|2.0|2.0|||
4067146|NCT01057888|3889257|B2|||Age||years|Mean|14.5|14.5|Standard Deviation|2.0|2.0|||
4067147|NCT01057888|3889258|B1|||Age||years|Mean|14.4|14.4|Standard Deviation|2.0|2.0|||
4067148|NCT01057888|3889255|B4|>=65 years||Age||participants|Number|0|0.0||||||
4067149|NCT01057888|3889256|B3|>=65 years||Age||participants|Number|0|0.0||||||
4067150|NCT01057888|3889257|B2|>=65 years||Age||participants|Number|0|0.0||||||
4067151|NCT01057888|3889258|B1|>=65 years||Age||participants|Number|0|0.0||||||
4067152|NCT01057888|3889255|B4|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
4067153|NCT01057888|3889256|B3|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
4067154|NCT01057888|3889257|B2|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
4067155|NCT01057888|3889258|B1|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
4067156|NCT01057888|3889255|B4|<=18 years||Age||participants|Number|4115|4115.0||||||
4067157|NCT01057888|3889256|B3|<=18 years||Age||participants|Number|1,396|1.0||||||
4067158|NCT01057888|3889257|B2|<=18 years||Age||participants|Number|1,296|1.0||||||
4067159|NCT01057888|3889258|B1|<=18 years||Age||participants|Number|1,423|1.0||||||
4067160|NCT01057862|3889269|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4067161|NCT01057862|3889270|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4067162|NCT01057862|3889271|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4067163|NCT01057862|3889269|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4067164|NCT01057862|3889270|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4067165|NCT01057862|3889271|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4067166|NCT01057862|3889269|B3|||Age||years|Mean|55.11|55.11|Standard Deviation|9.17|9.17|||
4067167|NCT01057862|3889270|B2|||Age||years|Mean|52.75|52.75|Standard Deviation|9|9.0|||
4067168|NCT01057862|3889271|B1|||Age||years|Mean|57|57.0|Standard Deviation|9.9|9.9|||
4067169|NCT01057810|3889280|B3|Australia||Region of Enrollment||participants|Number|57|57.0||||||
4067170|NCT01057810|3889281|B2|Australia||Region of Enrollment||participants|Number|33|33.0||||||
4067171|NCT01057810|3889282|B1|Australia||Region of Enrollment||participants|Number|24|24.0||||||
4067172|NCT01057810|3889280|B3|Europe||Region of Enrollment||participants|Number|235|235.0||||||
4067173|NCT01057810|3889281|B2|Europe||Region of Enrollment||participants|Number|161|161.0||||||
4067174|NCT01057810|3889282|B1|Europe||Region of Enrollment||participants|Number|74|74.0||||||
4067175|NCT01057810|3889280|B3|South America||Region of Enrollment||participants|Number|77|77.0||||||
4067176|NCT01057810|3889281|B2|South America||Region of Enrollment||participants|Number|52|52.0||||||
4067177|NCT01057810|3889282|B1|South America||Region of Enrollment||participants|Number|25|25.0||||||
4067178|NCT01057810|3889280|B3|North America||Region of Enrollment||participants|Number|233|233.0||||||
4067179|NCT01057810|3889281|B2|North America||Region of Enrollment||participants|Number|154|154.0||||||
4067180|NCT01057810|3889282|B1|North America||Region of Enrollment||participants|Number|79|79.0||||||
4067181|NCT01057810|3889280|B3||Male|Sex: Female, Male||Participants|Count of Participants|602|602.0||||||
4067182|NCT01057810|3889281|B2||Male|Sex: Female, Male||Participants|Count of Participants|400|400.0||||||
4067183|NCT01057810|3889282|B1||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4067184|NCT01057810|3889280|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4067185|NCT01057810|3889281|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4067186|NCT01057810|3889282|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4067187|NCT01057810|3889280|B3|>= 65 years||Age, Customized||participants|Number|433|433.0||||||
4067188|NCT01057810|3889281|B2|>= 65 years||Age, Customized||participants|Number|296|296.0||||||
4067189|NCT01057810|3889282|B1|>= 65 years||Age, Customized||participants|Number|137|137.0||||||
4067190|NCT01057810|3889280|B3|< 65 years||Age, Customized||participants|Number|169|169.0||||||
4067191|NCT01057810|3889281|B2|< 65 years||Age, Customized||participants|Number|104|104.0||||||
4067192|NCT01057810|3889282|B1|< 65 years||Age, Customized||participants|Number|65|65.0||||||
4067193|NCT01057810|3889280|B3|||Age||years|Mean|69.0|69.0|Full Range|||42.0|92.0|
4067194|NCT01057810|3889281|B2|||Age||years|Mean|69.3|69.3|Full Range|||44.0|91.0|
4067195|NCT01057810|3889282|B1|||Age||years|Mean|68.6|68.6|Full Range|||42.0|92.0|
4067196|NCT01057693|3889299|B1||Male|Sex: Female, Male||Participants|Count of Participants|363|363.0||||||
4067197|NCT01057693|3889299|B1||Female|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
4067198|NCT01057693|3889299|B1|>=65 Years||Age, Customized||participants|Number|190|190.0||||||
4067199|NCT01057693|3889299|B1|45 to 64 Years||Age, Customized||participants|Number|417|417.0||||||
4067200|NCT01057693|3889299|B1|18 to 44 Years||Age, Customized||participants|Number|58|58.0||||||
4067201|NCT01057589|3889347|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4067202|NCT01057589|3889347|B1|Spain||Region of Enrollment||participants|Number|13|13.0||||||
4067203|NCT01057589|3889347|B1|Italy||Region of Enrollment||participants|Number|8|8.0||||||
4067204|NCT01057589|3889347|B1|Germany||Region of Enrollment||participants|Number|32|32.0||||||
4067205|NCT01057589|3889347|B1|France||Region of Enrollment||participants|Number|4|4.0||||||
4067206|NCT01057589|3889347|B1|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
4067207|NCT01057589|3889347|B1|White||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
4067208|NCT01057589|3889347|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4067209|NCT01057589|3889347|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4067210|NCT01057589|3889347|B1|||Age||years|Mean|61.8|61.8|Standard Deviation|9.56|9.56|||
4067211|NCT01057433|3889356|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4067212|NCT01057433|3889356|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4067213|NCT01057433|3889356|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4067214|NCT01057433|3889356|B1|||Age||years|Mean|33.8|33.8|Standard Deviation|8.24|8.24|||
4067215|NCT01057433|3889356|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4067216|NCT01057433|3889356|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4067217|NCT01057433|3889356|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4067218|NCT01057394|3889360|B1|Italy||Region of Enrollment||participants|Number|5|5.0||||||
4067219|NCT01057394|3889360|B1|Czech Republic||Region of Enrollment||participants|Number|16|16.0||||||
4067220|NCT01057394|3889360|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4067221|NCT01057394|3889360|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4067222|NCT01057394|3889360|B1|||Age||years|Mean|59|59.0|Standard Deviation|8|8.0|||
4067223|NCT01057277|3889365|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4067224|NCT01057277|3889365|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4067225|NCT01057277|3889365|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4067226|NCT01057277|3889365|B1|||Age||years|Mean|58.6|58.6|Full Range|||49.0|71.0|
4067227|NCT01057277|3889365|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4067228|NCT01057277|3889365|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4067229|NCT01057277|3889365|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4067230|NCT01057251|3889369|B3|United States||Region of Enrollment||participants|Number|432|432.0||||||
4067231|NCT01057251|3889370|B2|United States||Region of Enrollment||participants|Number|142|142.0||||||
4067232|NCT01057251|3889371|B1|United States||Region of Enrollment||participants|Number|290|290.0||||||
4067233|NCT01057251|3889369|B3||Male|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4067234|NCT01057251|3889370|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4067235|NCT01057251|3889371|B1||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4067236|NCT01057251|3889369|B3||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4067237|NCT01057251|3889370|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4067238|NCT01057251|3889371|B1||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4067239|NCT01057251|3889369|B3|||Age||years|Mean|50.6|50.6|Standard Deviation|8.4|8.4|||
4067240|NCT01057251|3889370|B2|||Age||years|Mean|49.7|49.7|Standard Deviation|9.0|9.0|||
4067241|NCT01057251|3889371|B1|||Age||years|Mean|51.1|51.1|Standard Deviation|8.1|8.1|||
4067242|NCT01057251|3889369|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4067243|NCT01057251|3889370|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4067244|NCT01057251|3889371|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4067245|NCT01057251|3889369|B3||Between 18 and 65 years|Age||Participants|Count of Participants|432|432.0||||||
4067246|NCT01057251|3889370|B2||Between 18 and 65 years|Age||Participants|Count of Participants|142|142.0||||||
4067247|NCT01057251|3889371|B1||Between 18 and 65 years|Age||Participants|Count of Participants|290|290.0||||||
4067248|NCT01057251|3889369|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4067249|NCT01057251|3889370|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4067250|NCT01057251|3889371|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4067251|NCT01057225|3889380|B1|United States||Region of Enrollment||participants|Number|64|64.0||||||
4067252|NCT01057225|3889380|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4067253|NCT01057225|3889380|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4067254|NCT01057225|3889380|B1||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4067255|NCT01057225|3889380|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4067256|NCT01057225|3889380|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4067257|NCT01057225|3889380|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4067258|NCT01057225|3889380|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4067259|NCT01057225|3889380|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4067260|NCT01057225|3889380|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4067261|NCT01057225|3889380|B1|||Age||years|Median|62.5|62.5|Full Range|||27.0|82.0|
4067262|NCT01057121|3889405|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
4067263|NCT01057121|3889406|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4067264|NCT01057121|3889407|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4067265|NCT01057121|3889405|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4067266|NCT01057121|3889406|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4067267|NCT01057121|3889407|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4067268|NCT01057121|3889405|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4067269|NCT01057121|3889406|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4067270|NCT01057121|3889407|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4067271|NCT01057121|3889405|B3||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4067272|NCT01057121|3889406|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4067273|NCT01057121|3889407|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4067274|NCT01057121|3889405|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4067275|NCT01057121|3889406|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4067276|NCT01057121|3889407|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4067277|NCT01057121|3889405|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4067278|NCT01057121|3889406|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4067279|NCT01057121|3889407|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4067280|NCT01057121|3889405|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4067281|NCT01057121|3889406|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4067282|NCT01057121|3889407|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4067283|NCT01057121|3889405|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4067284|NCT01057121|3889406|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4067285|NCT01057121|3889407|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4067286|NCT01057121|3889405|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4067287|NCT01057121|3889406|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4067288|NCT01057121|3889407|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4067289|NCT01057121|3889405|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4067290|NCT01057121|3889406|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4067291|NCT01057121|3889407|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4067292|NCT01057121|3889405|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4067293|NCT01057121|3889406|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4067294|NCT01057121|3889407|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4067295|NCT01057121|3889405|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4067296|NCT01057121|3889406|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4067297|NCT01057121|3889407|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4067298|NCT01057121|3889405|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4067299|NCT01057121|3889406|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4067300|NCT01057121|3889407|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4067301|NCT01057121|3889405|B3|||Age||years|Mean|47.0|47.0|Standard Deviation|9.6|9.6|||
4067302|NCT01057121|3889406|B2|||Age||years|Mean|46.9|46.9|Standard Deviation|8.2|8.2|||
4067303|NCT01057121|3889407|B1|||Age||years|Mean|47.2|47.2|Standard Deviation|11.8|11.8|||
4067304|NCT01057017|3889440|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4067305|NCT01057017|3889440|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4067306|NCT01057017|3889440|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4067307|NCT01057017|3889440|B1|||Age||years|Mean|54|54.0|Standard Deviation|1|1.0|||
4067308|NCT01057017|3889440|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4067309|NCT01057017|3889440|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4067310|NCT01057017|3889440|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4067311|NCT01056913|3889444|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4067312|NCT01056913|3889444|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4067313|NCT01056913|3889444|B1|||Age||years|Median|67|67.0|Full Range|||23.0|87.0|
4067314|NCT01056822|3889448|B3|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4067315|NCT01056822|3889449|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4067316|NCT01056822|3889450|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4067317|NCT01056822|3889448|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4067318|NCT01056822|3889449|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4067319|NCT01056822|3889450|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4067320|NCT01056822|3889448|B3|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4067321|NCT01056822|3889449|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4067322|NCT01056822|3889450|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4067323|NCT01056822|3889448|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|75|75.0||||||
4067324|NCT01056822|3889449|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4067325|NCT01056822|3889450|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4067326|NCT01056822|3889448|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4067327|NCT01056822|3889449|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4067328|NCT01056822|3889450|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4067329|NCT01056822|3889448|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4067330|NCT01056822|3889449|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4067331|NCT01056822|3889450|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4067332|NCT01056822|3889448|B3|||Age||years|Mean|50.83|50.83|Standard Deviation|11.56|11.56|||
4067333|NCT01056822|3889449|B2|||Age||years|Mean|48.50|48.5|Standard Deviation|12.86|12.86|||
4067334|NCT01056822|3889450|B1|||Age||years|Mean|52.88|52.88|Standard Deviation|9.99|9.99|||
4067335|NCT01056718|3889500|B1|||Quality of Life|"Subjects completed an EuroQol (EQ-SD) Quality of Life questionnaire which is a standardized measure of health status developed by the EuroQol group as a simple general measure of health. The EuroQol, records the subject's self reported assessment of his/her overall health on a vertical, visual analogue scale where 100 is the best imaginable health state and 0 is the worst imaginable health state."|units on a scale|Mean|77|77.0|Standard Deviation|12|12.0|||
4067336|NCT01056718|3889500|B1|||Pulmonary Vein Peak Diastolic Velocity||cm/s|Mean|47|47.0|Standard Deviation|13|13.0|||
4067337|NCT01056718|3889500|B1|||Pulmonary Vein Peak Systolic Velocity||cm/s|Mean|62|62.0|Standard Deviation|13|13.0|||
4067338|NCT01056718|3889500|B1|||E/e' Ratio|Mitral Valve E velocity to tissue doppler e' velocity|Ratio|Mean|10.8|10.8|Standard Deviation|4.7|4.7|||
4067339|NCT01056718|3889500|B1|||Mitral Valve Tissue Doppler Velocity (a')||cm/s|Mean|11.8|11.8|Standard Deviation|2.9|2.9|||
4067340|NCT01056718|3889500|B1|||Mitral Valve Tissue Doppler Velocity (e')||cm/s|Mean|7.6|7.6|Standard Deviation|1.9|1.9|||
4067341|NCT01056718|3889500|B1|||Mitral Valve Deceleration Time||ms|Mean|229|229.0|Standard Deviation|62|62.0|||
4067342|NCT01056718|3889500|B1|||Mitral Valve E/A Ratio|Mitral valve doppler E velocity to A velocity|Ratio|Mean|.86|0.86|Standard Deviation|.18|0.18|||
4067343|NCT01056718|3889500|B1|||Mitral Valve Inflow (A) Velocity||cm/s|Mean|91|91.0|Standard Deviation|21|21.0|||
4067344|NCT01056718|3889500|B1|||Mitral Valve Inflow (E) Velocity||cm/s|Mean|77|77.0|Standard Deviation|24|24.0|||
4067345|NCT01056718|3889500|B1|||LV Mass||grams|Mean|163|163.0|Standard Deviation|52|52.0|||
4067346|NCT01056718|3889500|B1|||LV End Systolic Diameter||cm|Mean|3.0|3.0|Standard Deviation|0.8|0.8|||
4067347|NCT01056718|3889500|B1|||LV End Diastolic Diameter||cm|Mean|4.7|4.7|Standard Deviation|0.5|0.5|||
4067348|NCT01056718|3889500|B1|||Stress Cardiac Output||L per minute|Mean|5.6|5.6|Standard Deviation|2.2|2.2|||
4067349|NCT01056718|3889500|B1|||Resting Cardiac Output||L per minute|Mean|3.1|3.1|Standard Deviation|1.1|1.1|||
4067350|NCT01056718|3889500|B1|||Stress Stroke Volume||ml|Mean|47|47.0|Standard Deviation|13|13.0|||
4067351|NCT01056718|3889500|B1|||Resting Stroke Volume||ml|Mean|46|46.0|Standard Deviation|15|15.0|||
4067352|NCT01056718|3889500|B1|||Stress EF||Percent of LV end diastolic volume|Mean|67|67.0|Standard Deviation|10|10.0|||
4067353|NCT01056718|3889500|B1|||Resting Ejection Fraction (EF)|Ejection fraction = LV end diastolic volume - LV end systolic volume divided by LV end diastolic volume X 100|Percent of LV end diastolic volume|Mean|61|61.0|Standard Deviation|10|10.0|||
4067354|NCT01056718|3889500|B1|||Stress Heart Rate||Beats per Minute|Mean|136|136.0|Standard Deviation|24|24.0|||
4067355|NCT01056718|3889500|B1|||Resting Heart Rate||Beats per Minute|Mean|69|69.0|Standard Deviation|11|11.0|||
4067356|NCT01056718|3889500|B1|||Peak Stress Diastolic BP||mm Hg|Mean|75|75.0|Standard Deviation|15|15.0|||
4067357|NCT01056718|3889500|B1|||Peak Stress Systolic BP||mm Hg|Mean|178|178.0|Standard Deviation|23|23.0|||
4067358|NCT01056718|3889500|B1|||Resting Diastolic BP||mm Hg|Mean|79|79.0|Standard Deviation|11|11.0|||
4067359|NCT01056718|3889500|B1|||Metabolic Equivalent|One MET is defined as 3.5 mL 02 uptake/kg per minute|Mets|Mean|6.2|6.2|Standard Deviation|3.1|3.1|||
4067360|NCT01056718|3889500|B1|||Exercise Duration||seconds|Mean|385|385.0|Standard Deviation|174|174.0|||
4067361|NCT01056718|3889500|B1|||Resting Systolic BP||mm Hg|Mean|145|145.0|Standard Deviation|19|19.0|||
4067362|NCT01056718|3889500|B1|||BMI||kg/m2|Mean|31|31.0|Standard Deviation|5|5.0|||
4067363|NCT01056718|3889500|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
4067364|NCT01056718|3889500|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4067365|NCT01056718|3889500|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4067366|NCT01056718|3889500|B1|||Age||Years|Mean|66|66.0|Standard Deviation|10|10.0|||
4067367|NCT01056718|3889500|B1||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
4067368|NCT01056718|3889500|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4067369|NCT01056718|3889500|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4067370|NCT01056653|3889530|B4|Life Change||Perceptions of Parenting an Infant - What Being the Parent of a Baby Is Like (WPL-R) Scale|"Collected when the infant was 4 months old.~A 25-item self-report measure that looks at the perceptions the parents have of caring for an infant. There are 3 subscales: Evaluation, Centrality, and Life Change. Each item is on the 9-point scale.~Higher scores reflect having more of the attribute."|Scores on a scale|Mean|6.43|6.43|Standard Deviation|1.30|1.3|||
4067371|NCT01056653|3889531|B3|Life Change||Perceptions of Parenting an Infant - What Being the Parent of a Baby Is Like (WPL-R) Scale|"Collected when the infant was 4 months old.~A 25-item self-report measure that looks at the perceptions the parents have of caring for an infant. There are 3 subscales: Evaluation, Centrality, and Life Change. Each item is on the 9-point scale.~Higher scores reflect having more of the attribute."|Scores on a scale|Mean|6.28|6.28|Standard Deviation|1.39|1.39|||
4067372|NCT01056653|3889532|B2|Life Change||Perceptions of Parenting an Infant - What Being the Parent of a Baby Is Like (WPL-R) Scale|"Collected when the infant was 4 months old.~A 25-item self-report measure that looks at the perceptions the parents have of caring for an infant. There are 3 subscales: Evaluation, Centrality, and Life Change. Each item is on the 9-point scale.~Higher scores reflect having more of the attribute."|Scores on a scale|Mean|6.03|6.03|Standard Deviation|1.50|1.5|||
4067373|NCT01056653|3889533|B1|Life Change||Perceptions of Parenting an Infant - What Being the Parent of a Baby Is Like (WPL-R) Scale|"Collected when the infant was 4 months old.~A 25-item self-report measure that looks at the perceptions the parents have of caring for an infant. There are 3 subscales: Evaluation, Centrality, and Life Change. Each item is on the 9-point scale.~Higher scores reflect having more of the attribute."|Scores on a scale|Mean|6.77|6.77|Standard Deviation|1.02|1.02|||
4067374|NCT01056653|3889530|B4|Centrality||Perceptions of Parenting an Infant - What Being the Parent of a Baby Is Like (WPL-R) Scale|"Collected when the infant was 4 months old.~A 25-item self-report measure that looks at the perceptions the parents have of caring for an infant. There are 3 subscales: Evaluation, Centrality, and Life Change. Each item is on the 9-point scale.~Higher scores reflect having more of the attribute."|Scores on a scale|Mean|6.79|6.79|Standard Deviation|0.92|0.92|||
4067375|NCT01056653|3889531|B3|Centrality||Perceptions of Parenting an Infant - What Being the Parent of a Baby Is Like (WPL-R) Scale|"Collected when the infant was 4 months old.~A 25-item self-report measure that looks at the perceptions the parents have of caring for an infant. There are 3 subscales: Evaluation, Centrality, and Life Change. Each item is on the 9-point scale.~Higher scores reflect having more of the attribute."|Scores on a scale|Mean|6.75|6.75|Standard Deviation|1.04|1.04|||
4067376|NCT01056653|3889532|B2|Centrality||Perceptions of Parenting an Infant - What Being the Parent of a Baby Is Like (WPL-R) Scale|"Collected when the infant was 4 months old.~A 25-item self-report measure that looks at the perceptions the parents have of caring for an infant. There are 3 subscales: Evaluation, Centrality, and Life Change. Each item is on the 9-point scale.~Higher scores reflect having more of the attribute."|Scores on a scale|Mean|6.47|6.47|Standard Deviation|0.81|0.81|||
4067377|NCT01056653|3889533|B1|Centrality||Perceptions of Parenting an Infant - What Being the Parent of a Baby Is Like (WPL-R) Scale|"Collected when the infant was 4 months old.~A 25-item self-report measure that looks at the perceptions the parents have of caring for an infant. There are 3 subscales: Evaluation, Centrality, and Life Change. Each item is on the 9-point scale.~Higher scores reflect having more of the attribute."|Scores on a scale|Mean|6.99|6.99|Standard Deviation|0.81|0.81|||
4067378|NCT01056653|3889530|B4|Evaluation||Perceptions of Parenting an Infant - What Being the Parent of a Baby Is Like (WPL-R) Scale|"Collected when the infant was 4 months old.~A 25-item self-report measure that looks at the perceptions the parents have of caring for an infant. There are 3 subscales: Evaluation, Centrality, and Life Change. Each item is on the 9-point scale.~Higher scores reflect having more of the attribute."|Scores on a scale|Mean|7.56|7.56|Standard Deviation|0.72|0.72|||
4067379|NCT01056653|3889531|B3|Evaluation||Perceptions of Parenting an Infant - What Being the Parent of a Baby Is Like (WPL-R) Scale|"Collected when the infant was 4 months old.~A 25-item self-report measure that looks at the perceptions the parents have of caring for an infant. There are 3 subscales: Evaluation, Centrality, and Life Change. Each item is on the 9-point scale.~Higher scores reflect having more of the attribute."|Scores on a scale|Mean|7.52|7.52|Standard Deviation|0.80|0.8|||
4067380|NCT01056653|3889532|B2|Evaluation||Perceptions of Parenting an Infant - What Being the Parent of a Baby Is Like (WPL-R) Scale|"Collected when the infant was 4 months old.~A 25-item self-report measure that looks at the perceptions the parents have of caring for an infant. There are 3 subscales: Evaluation, Centrality, and Life Change. Each item is on the 9-point scale.~Higher scores reflect having more of the attribute."|Scores on a scale|Mean|7.58|7.58|Standard Deviation|0.72|0.72|||
4067381|NCT01056653|3889533|B1|Evaluation||Perceptions of Parenting an Infant - What Being the Parent of a Baby Is Like (WPL-R) Scale|"Collected when the infant was 4 months old.~A 25-item self-report measure that looks at the perceptions the parents have of caring for an infant. There are 3 subscales: Evaluation, Centrality, and Life Change. Each item is on the 9-point scale.~Higher scores reflect having more of the attribute."|Scores on a scale|Mean|7.58|7.58|Standard Deviation|0.64|0.64|||
4067382|NCT01056653|3889530|B4|Parent Domain||Parenting Stress - Parenting Stress Index - Third Edition (PSI-3)|"Collected when the infant was 4 months old.~A 120-item self-report questionnaire with two domains of parent (51 items) and child (50 items) stress. Higher scores indicate more stress."|Scores on a scale|Mean|107.79|107.79|Standard Deviation|17.95|17.95|||
4067383|NCT01056653|3889531|B3|Parent Domain||Parenting Stress - Parenting Stress Index - Third Edition (PSI-3)|"Collected when the infant was 4 months old.~A 120-item self-report questionnaire with two domains of parent (51 items) and child (50 items) stress. Higher scores indicate more stress."|Scores on a scale|Mean|108.60|108.6|Standard Deviation|19.56|19.56|||
4067384|NCT01056653|3889532|B2|Parent Domain||Parenting Stress - Parenting Stress Index - Third Edition (PSI-3)|"Collected when the infant was 4 months old.~A 120-item self-report questionnaire with two domains of parent (51 items) and child (50 items) stress. Higher scores indicate more stress."|Scores on a scale|Mean|107.00|107.0|Standard Deviation|19.73|19.73|||
4067385|NCT01056653|3889533|B1|Parent Domain||Parenting Stress - Parenting Stress Index - Third Edition (PSI-3)|"Collected when the infant was 4 months old.~A 120-item self-report questionnaire with two domains of parent (51 items) and child (50 items) stress. Higher scores indicate more stress."|Scores on a scale|Mean|107.46|107.46|Standard Deviation|15.73|15.73|||
4067386|NCT01056653|3889530|B4|Child Domain||Parenting Stress - Parenting Stress Index - Third Edition (PSI-3)|"Collected when the infant was 4 months old.~A 120-item self-report questionnaire with two domains of parent (51 items) and child (50 items) stress. Higher scores indicate more stress."|Scores on a scale|Mean|96.54|96.54|Standard Deviation|16.35|16.35|||
4067387|NCT01056653|3889531|B3|Child Domain||Parenting Stress - Parenting Stress Index - Third Edition (PSI-3)|"Collected when the infant was 4 months old.~A 120-item self-report questionnaire with two domains of parent (51 items) and child (50 items) stress. Higher scores indicate more stress."|Scores on a scale|Mean|96.71|96.71|Standard Deviation|15.90|15.9|||
4067388|NCT01056653|3889532|B2|Child Domain||Parenting Stress - Parenting Stress Index - Third Edition (PSI-3)|"Collected when the infant was 4 months old.~A 120-item self-report questionnaire with two domains of parent (51 items) and child (50 items) stress. Higher scores indicate more stress."|Scores on a scale|Mean|96.57|96.57|Standard Deviation|17.00|17.0|||
4067389|NCT01056653|3889533|B1|Child Domain||Parenting Stress - Parenting Stress Index - Third Edition (PSI-3)|"Collected when the infant was 4 months old.~A 120-item self-report questionnaire with two domains of parent (51 items) and child (50 items) stress. Higher scores indicate more stress."|Scores on a scale|Mean|96.37|96.37|Standard Deviation|16.78|16.78|||
4067484|NCT01056653|3889532|B2|$40,000-$59,999||Household income||participants|Number|2|2.0||||||
4067390|NCT01056653|3889530|B4|Subscale - Response to Distress||Parent Child Interaction Teaching Scale (PCITS)|"Collected when the infant was 4 months old. Assesses parent-infant interaction skills. Used for children from birth to 3 years of age. It is an observational measure of the presence of behaviours in parent-infant interactions.~The Parent Total (50 items) is the sum of 4 subscales: Sensitivity to Cues (11 items), Response to Distress (11 items), Social-Emotional Growth Fostering (11 items), and Cognitive Growth Fostering (17 items). Higher scores on all subscales and higher total scores reflect more optimal parent-infant interactions."|Scores on a scale|Mean|10.17|10.17|Standard Deviation|0.86|0.86|||
4067391|NCT01056653|3889531|B3|Subscale - Response to Distress||Parent Child Interaction Teaching Scale (PCITS)|"Collected when the infant was 4 months old. Assesses parent-infant interaction skills. Used for children from birth to 3 years of age. It is an observational measure of the presence of behaviours in parent-infant interactions.~The Parent Total (50 items) is the sum of 4 subscales: Sensitivity to Cues (11 items), Response to Distress (11 items), Social-Emotional Growth Fostering (11 items), and Cognitive Growth Fostering (17 items). Higher scores on all subscales and higher total scores reflect more optimal parent-infant interactions."|Scores on a scale|Mean|10.17|10.17|Standard Deviation|0.76|0.76|||
4067392|NCT01056653|3889532|B2|Subscale - Response to Distress||Parent Child Interaction Teaching Scale (PCITS)|"Collected when the infant was 4 months old. Assesses parent-infant interaction skills. Used for children from birth to 3 years of age. It is an observational measure of the presence of behaviours in parent-infant interactions.~The Parent Total (50 items) is the sum of 4 subscales: Sensitivity to Cues (11 items), Response to Distress (11 items), Social-Emotional Growth Fostering (11 items), and Cognitive Growth Fostering (17 items). Higher scores on all subscales and higher total scores reflect more optimal parent-infant interactions."|Scores on a scale|Mean|10.22|10.22|Standard Deviation|0.80|0.8|||
4067393|NCT01056653|3889533|B1|Subscale - Response to Distress||Parent Child Interaction Teaching Scale (PCITS)|"Collected when the infant was 4 months old. Assesses parent-infant interaction skills. Used for children from birth to 3 years of age. It is an observational measure of the presence of behaviours in parent-infant interactions.~The Parent Total (50 items) is the sum of 4 subscales: Sensitivity to Cues (11 items), Response to Distress (11 items), Social-Emotional Growth Fostering (11 items), and Cognitive Growth Fostering (17 items). Higher scores on all subscales and higher total scores reflect more optimal parent-infant interactions."|Scores on a scale|Mean|10.15|10.15|Standard Deviation|0.99|0.99|||
4067394|NCT01056653|3889530|B4|Subscale - Cognitive Growth Fostering||Parent Child Interaction Teaching Scale (PCITS)|"Collected when the infant was 4 months old. Assesses parent-infant interaction skills. Used for children from birth to 3 years of age. It is an observational measure of the presence of behaviours in parent-infant interactions.~The Parent Total (50 items) is the sum of 4 subscales: Sensitivity to Cues (11 items), Response to Distress (11 items), Social-Emotional Growth Fostering (11 items), and Cognitive Growth Fostering (17 items). Higher scores on all subscales and higher total scores reflect more optimal parent-infant interactions."|Scores on a scale|Mean|11.69|11.69|Standard Deviation|2.32|2.32|||
4067395|NCT01056653|3889531|B3|Subscale - Cognitive Growth Fostering||Parent Child Interaction Teaching Scale (PCITS)|"Collected when the infant was 4 months old. Assesses parent-infant interaction skills. Used for children from birth to 3 years of age. It is an observational measure of the presence of behaviours in parent-infant interactions.~The Parent Total (50 items) is the sum of 4 subscales: Sensitivity to Cues (11 items), Response to Distress (11 items), Social-Emotional Growth Fostering (11 items), and Cognitive Growth Fostering (17 items). Higher scores on all subscales and higher total scores reflect more optimal parent-infant interactions."|Scores on a scale|Mean|11.52|11.52|Standard Deviation|2.65|2.65|||
4067396|NCT01056653|3889532|B2|Subscale - Cognitive Growth Fostering||Parent Child Interaction Teaching Scale (PCITS)|"Collected when the infant was 4 months old. Assesses parent-infant interaction skills. Used for children from birth to 3 years of age. It is an observational measure of the presence of behaviours in parent-infant interactions.~The Parent Total (50 items) is the sum of 4 subscales: Sensitivity to Cues (11 items), Response to Distress (11 items), Social-Emotional Growth Fostering (11 items), and Cognitive Growth Fostering (17 items). Higher scores on all subscales and higher total scores reflect more optimal parent-infant interactions."|Scores on a scale|Mean|12.13|12.13|Standard Deviation|1.91|1.91|||
4067397|NCT01056653|3889533|B1|Subscale - Cognitive Growth Fostering||Parent Child Interaction Teaching Scale (PCITS)|"Collected when the infant was 4 months old. Assesses parent-infant interaction skills. Used for children from birth to 3 years of age. It is an observational measure of the presence of behaviours in parent-infant interactions.~The Parent Total (50 items) is the sum of 4 subscales: Sensitivity to Cues (11 items), Response to Distress (11 items), Social-Emotional Growth Fostering (11 items), and Cognitive Growth Fostering (17 items). Higher scores on all subscales and higher total scores reflect more optimal parent-infant interactions."|Scores on a scale|Mean|11.63|11.63|Standard Deviation|2.20|2.2|||
4067398|NCT01056653|3889530|B4|Subscale - Socioemotional Growth Fostering||Parent Child Interaction Teaching Scale (PCITS)|"Collected when the infant was 4 months old. Assesses parent-infant interaction skills. Used for children from birth to 3 years of age. It is an observational measure of the presence of behaviours in parent-infant interactions.~The Parent Total (50 items) is the sum of 4 subscales: Sensitivity to Cues (11 items), Response to Distress (11 items), Social-Emotional Growth Fostering (11 items), and Cognitive Growth Fostering (17 items). Higher scores on all subscales and higher total scores reflect more optimal parent-infant interactions."|Scores on a scale|Mean|8.57|8.57|Standard Deviation|1.61|1.61|||
4067399|NCT01056653|3889531|B3|Subscale - Socioemotional Growth Fostering||Parent Child Interaction Teaching Scale (PCITS)|"Collected when the infant was 4 months old. Assesses parent-infant interaction skills. Used for children from birth to 3 years of age. It is an observational measure of the presence of behaviours in parent-infant interactions.~The Parent Total (50 items) is the sum of 4 subscales: Sensitivity to Cues (11 items), Response to Distress (11 items), Social-Emotional Growth Fostering (11 items), and Cognitive Growth Fostering (17 items). Higher scores on all subscales and higher total scores reflect more optimal parent-infant interactions."|Scores on a scale|Mean|8.69|8.69|Standard Deviation|1.70|1.7|||
4067411|NCT01056653|3889531|B3|Spanish||Main Language Spoken at Home|Speaking mainly English at home was one of the eligibility criteria. Participants who answered anything but English in the 4 month questionnaire would have indicated at recruitment when their baby was born that they speak mainly English at home.|participants|Number|1|1.0||||||
4067485|NCT01056653|3889533|B1|$40,000-$59,999||Household income||participants|Number|3|3.0||||||
4067400|NCT01056653|3889532|B2|Subscale - Socioemotional Growth Fostering||Parent Child Interaction Teaching Scale (PCITS)|"Collected when the infant was 4 months old. Assesses parent-infant interaction skills. Used for children from birth to 3 years of age. It is an observational measure of the presence of behaviours in parent-infant interactions.~The Parent Total (50 items) is the sum of 4 subscales: Sensitivity to Cues (11 items), Response to Distress (11 items), Social-Emotional Growth Fostering (11 items), and Cognitive Growth Fostering (17 items). Higher scores on all subscales and higher total scores reflect more optimal parent-infant interactions."|Scores on a scale|Mean|8.83|8.83|Standard Deviation|1.30|1.3|||
4067401|NCT01056653|3889533|B1|Subscale - Socioemotional Growth Fostering||Parent Child Interaction Teaching Scale (PCITS)|"Collected when the infant was 4 months old. Assesses parent-infant interaction skills. Used for children from birth to 3 years of age. It is an observational measure of the presence of behaviours in parent-infant interactions.~The Parent Total (50 items) is the sum of 4 subscales: Sensitivity to Cues (11 items), Response to Distress (11 items), Social-Emotional Growth Fostering (11 items), and Cognitive Growth Fostering (17 items). Higher scores on all subscales and higher total scores reflect more optimal parent-infant interactions."|Scores on a scale|Mean|8.33|8.33|Standard Deviation|1.65|1.65|||
4067402|NCT01056653|3889530|B4|Subscale - Sensitivity to Cues||Parent Child Interaction Teaching Scale (PCITS)|"Collected when the infant was 4 months old. Assesses parent-infant interaction skills. Used for children from birth to 3 years of age. It is an observational measure of the presence of behaviours in parent-infant interactions.~The Parent Total (50 items) is the sum of 4 subscales: Sensitivity to Cues (11 items), Response to Distress (11 items), Social-Emotional Growth Fostering (11 items), and Cognitive Growth Fostering (17 items). Higher scores on all subscales and higher total scores reflect more optimal parent-infant interactions."|Scores on a scale|Mean|9.69|9.69|Standard Deviation|1.26|1.26|||
4067403|NCT01056653|3889531|B3|Subscale - Sensitivity to Cues||Parent Child Interaction Teaching Scale (PCITS)|"Collected when the infant was 4 months old. Assesses parent-infant interaction skills. Used for children from birth to 3 years of age. It is an observational measure of the presence of behaviours in parent-infant interactions.~The Parent Total (50 items) is the sum of 4 subscales: Sensitivity to Cues (11 items), Response to Distress (11 items), Social-Emotional Growth Fostering (11 items), and Cognitive Growth Fostering (17 items). Higher scores on all subscales and higher total scores reflect more optimal parent-infant interactions."|Scores on a scale|Mean|9.88|9.88|Standard Deviation|1.11|1.11|||
4067404|NCT01056653|3889532|B2|Subscale - Sensitivity to Cues||Parent Child Interaction Teaching Scale (PCITS)|"Collected when the infant was 4 months old. Assesses parent-infant interaction skills. Used for children from birth to 3 years of age. It is an observational measure of the presence of behaviours in parent-infant interactions.~The Parent Total (50 items) is the sum of 4 subscales: Sensitivity to Cues (11 items), Response to Distress (11 items), Social-Emotional Growth Fostering (11 items), and Cognitive Growth Fostering (17 items). Higher scores on all subscales and higher total scores reflect more optimal parent-infant interactions."|Scores on a scale|Mean|9.52|9.52|Standard Deviation|1.31|1.31|||
4067405|NCT01056653|3889533|B1|Subscale - Sensitivity to Cues||Parent Child Interaction Teaching Scale (PCITS)|"Collected when the infant was 4 months old. Assesses parent-infant interaction skills. Used for children from birth to 3 years of age. It is an observational measure of the presence of behaviours in parent-infant interactions.~The Parent Total (50 items) is the sum of 4 subscales: Sensitivity to Cues (11 items), Response to Distress (11 items), Social-Emotional Growth Fostering (11 items), and Cognitive Growth Fostering (17 items). Higher scores on all subscales and higher total scores reflect more optimal parent-infant interactions."|Scores on a scale|Mean|9.61|9.61|Standard Deviation|1.37|1.37|||
4067406|NCT01056653|3889530|B4|Parent Total||Parent Child Interaction Teaching Scale (PCITS)|"Collected when the infant was 4 months old. Assesses parent-infant interaction skills. Used for children from birth to 3 years of age. It is an observational measure of the presence of behaviours in parent-infant interactions.~The Parent Total (50 items) is the sum of 4 subscales: Sensitivity to Cues (11 items), Response to Distress (11 items), Social-Emotional Growth Fostering (11 items), and Cognitive Growth Fostering (17 items). Higher scores on all subscales and higher total scores reflect more optimal parent-infant interactions."|Scores on a scale|Mean|40.13|40.13|Standard Deviation|4.18|4.18|||
4067407|NCT01056653|3889531|B3|Parent Total||Parent Child Interaction Teaching Scale (PCITS)|"Collected when the infant was 4 months old. Assesses parent-infant interaction skills. Used for children from birth to 3 years of age. It is an observational measure of the presence of behaviours in parent-infant interactions.~The Parent Total (50 items) is the sum of 4 subscales: Sensitivity to Cues (11 items), Response to Distress (11 items), Social-Emotional Growth Fostering (11 items), and Cognitive Growth Fostering (17 items). Higher scores on all subscales and higher total scores reflect more optimal parent-infant interactions."|Scores on a scale|Mean|40.26|40.26|Standard Deviation|4.13|4.13|||
4067408|NCT01056653|3889532|B2|Parent Total||Parent Child Interaction Teaching Scale (PCITS)|"Collected when the infant was 4 months old. Assesses parent-infant interaction skills. Used for children from birth to 3 years of age. It is an observational measure of the presence of behaviours in parent-infant interactions.~The Parent Total (50 items) is the sum of 4 subscales: Sensitivity to Cues (11 items), Response to Distress (11 items), Social-Emotional Growth Fostering (11 items), and Cognitive Growth Fostering (17 items). Higher scores on all subscales and higher total scores reflect more optimal parent-infant interactions."|Scores on a scale|Mean|40.70|40.7|Standard Deviation|3.89|3.89|||
4067409|NCT01056653|3889533|B1|Parent Total||Parent Child Interaction Teaching Scale (PCITS)|"Collected when the infant was 4 months old. Assesses parent-infant interaction skills. Used for children from birth to 3 years of age. It is an observational measure of the presence of behaviours in parent-infant interactions.~The Parent Total (50 items) is the sum of 4 subscales: Sensitivity to Cues (11 items), Response to Distress (11 items), Social-Emotional Growth Fostering (11 items), and Cognitive Growth Fostering (17 items). Higher scores on all subscales and higher total scores reflect more optimal parent-infant interactions."|Scores on a scale|Mean|39.72|39.72|Standard Deviation|4.41|4.41|||
4067410|NCT01056653|3889530|B4|Spanish||Main Language Spoken at Home|Speaking mainly English at home was one of the eligibility criteria. Participants who answered anything but English in the 4 month questionnaire would have indicated at recruitment when their baby was born that they speak mainly English at home.|participants|Number|1|1.0||||||
4067481|NCT01056653|3889533|B1|$60,000-$79,999||Household income||participants|Number|4|4.0||||||
4067482|NCT01056653|3889530|B4|$40,000-$59,999||Household income||participants|Number|8|8.0||||||
4067412|NCT01056653|3889532|B2|Spanish||Main Language Spoken at Home|Speaking mainly English at home was one of the eligibility criteria. Participants who answered anything but English in the 4 month questionnaire would have indicated at recruitment when their baby was born that they speak mainly English at home.|participants|Number|0|0.0||||||
4067413|NCT01056653|3889533|B1|Spanish||Main Language Spoken at Home|Speaking mainly English at home was one of the eligibility criteria. Participants who answered anything but English in the 4 month questionnaire would have indicated at recruitment when their baby was born that they speak mainly English at home.|participants|Number|0|0.0||||||
4067414|NCT01056653|3889530|B4|Punjabi||Main Language Spoken at Home|Speaking mainly English at home was one of the eligibility criteria. Participants who answered anything but English in the 4 month questionnaire would have indicated at recruitment when their baby was born that they speak mainly English at home.|participants|Number|1|1.0||||||
4067415|NCT01056653|3889531|B3|Punjabi||Main Language Spoken at Home|Speaking mainly English at home was one of the eligibility criteria. Participants who answered anything but English in the 4 month questionnaire would have indicated at recruitment when their baby was born that they speak mainly English at home.|participants|Number|0|0.0||||||
4067416|NCT01056653|3889532|B2|Punjabi||Main Language Spoken at Home|Speaking mainly English at home was one of the eligibility criteria. Participants who answered anything but English in the 4 month questionnaire would have indicated at recruitment when their baby was born that they speak mainly English at home.|participants|Number|0|0.0||||||
4067417|NCT01056653|3889533|B1|Punjabi||Main Language Spoken at Home|Speaking mainly English at home was one of the eligibility criteria. Participants who answered anything but English in the 4 month questionnaire would have indicated at recruitment when their baby was born that they speak mainly English at home.|participants|Number|1|1.0||||||
4067418|NCT01056653|3889530|B4|Oriya||Main Language Spoken at Home|Speaking mainly English at home was one of the eligibility criteria. Participants who answered anything but English in the 4 month questionnaire would have indicated at recruitment when their baby was born that they speak mainly English at home.|participants|Number|1|1.0||||||
4067419|NCT01056653|3889531|B3|Oriya||Main Language Spoken at Home|Speaking mainly English at home was one of the eligibility criteria. Participants who answered anything but English in the 4 month questionnaire would have indicated at recruitment when their baby was born that they speak mainly English at home.|participants|Number|0|0.0||||||
4067420|NCT01056653|3889532|B2|Oriya||Main Language Spoken at Home|Speaking mainly English at home was one of the eligibility criteria. Participants who answered anything but English in the 4 month questionnaire would have indicated at recruitment when their baby was born that they speak mainly English at home.|participants|Number|1|1.0||||||
4067421|NCT01056653|3889533|B1|Oriya||Main Language Spoken at Home|Speaking mainly English at home was one of the eligibility criteria. Participants who answered anything but English in the 4 month questionnaire would have indicated at recruitment when their baby was born that they speak mainly English at home.|participants|Number|0|0.0||||||
4067422|NCT01056653|3889530|B4|French||Main Language Spoken at Home|Speaking mainly English at home was one of the eligibility criteria. Participants who answered anything but English in the 4 month questionnaire would have indicated at recruitment when their baby was born that they speak mainly English at home.|participants|Number|1|1.0||||||
4067423|NCT01056653|3889531|B3|French||Main Language Spoken at Home|Speaking mainly English at home was one of the eligibility criteria. Participants who answered anything but English in the 4 month questionnaire would have indicated at recruitment when their baby was born that they speak mainly English at home.|participants|Number|1|1.0||||||
4067424|NCT01056653|3889532|B2|French||Main Language Spoken at Home|Speaking mainly English at home was one of the eligibility criteria. Participants who answered anything but English in the 4 month questionnaire would have indicated at recruitment when their baby was born that they speak mainly English at home.|participants|Number|0|0.0||||||
4067425|NCT01056653|3889533|B1|French||Main Language Spoken at Home|Speaking mainly English at home was one of the eligibility criteria. Participants who answered anything but English in the 4 month questionnaire would have indicated at recruitment when their baby was born that they speak mainly English at home.|participants|Number|0|0.0||||||
4067426|NCT01056653|3889530|B4|Farsi||Main Language Spoken at Home|Speaking mainly English at home was one of the eligibility criteria. Participants who answered anything but English in the 4 month questionnaire would have indicated at recruitment when their baby was born that they speak mainly English at home.|participants|Number|1|1.0||||||
4067427|NCT01056653|3889531|B3|Farsi||Main Language Spoken at Home|Speaking mainly English at home was one of the eligibility criteria. Participants who answered anything but English in the 4 month questionnaire would have indicated at recruitment when their baby was born that they speak mainly English at home.|participants|Number|0|0.0||||||
4067428|NCT01056653|3889532|B2|Farsi||Main Language Spoken at Home|Speaking mainly English at home was one of the eligibility criteria. Participants who answered anything but English in the 4 month questionnaire would have indicated at recruitment when their baby was born that they speak mainly English at home.|participants|Number|0|0.0||||||
4067429|NCT01056653|3889533|B1|Farsi||Main Language Spoken at Home|Speaking mainly English at home was one of the eligibility criteria. Participants who answered anything but English in the 4 month questionnaire would have indicated at recruitment when their baby was born that they speak mainly English at home.|participants|Number|1|1.0||||||
4067430|NCT01056653|3889530|B4|Chinese||Main Language Spoken at Home|Speaking mainly English at home was one of the eligibility criteria. Participants who answered anything but English in the 4 month questionnaire would have indicated at recruitment when their baby was born that they speak mainly English at home.|participants|Number|1|1.0||||||
4067431|NCT01056653|3889531|B3|Chinese||Main Language Spoken at Home|Speaking mainly English at home was one of the eligibility criteria. Participants who answered anything but English in the 4 month questionnaire would have indicated at recruitment when their baby was born that they speak mainly English at home.|participants|Number|0|0.0||||||
4067432|NCT01056653|3889532|B2|Chinese||Main Language Spoken at Home|Speaking mainly English at home was one of the eligibility criteria. Participants who answered anything but English in the 4 month questionnaire would have indicated at recruitment when their baby was born that they speak mainly English at home.|participants|Number|0|0.0||||||
4067483|NCT01056653|3889531|B3|$40,000-$59,999||Household income||participants|Number|3|3.0||||||
4067433|NCT01056653|3889533|B1|Chinese||Main Language Spoken at Home|Speaking mainly English at home was one of the eligibility criteria. Participants who answered anything but English in the 4 month questionnaire would have indicated at recruitment when their baby was born that they speak mainly English at home.|participants|Number|1|1.0||||||
4067434|NCT01056653|3889530|B4|English||Main Language Spoken at Home|Speaking mainly English at home was one of the eligibility criteria. Participants who answered anything but English in the 4 month questionnaire would have indicated at recruitment when their baby was born that they speak mainly English at home.|participants|Number|105|105.0||||||
4067435|NCT01056653|3889531|B3|English||Main Language Spoken at Home|Speaking mainly English at home was one of the eligibility criteria. Participants who answered anything but English in the 4 month questionnaire would have indicated at recruitment when their baby was born that they speak mainly English at home.|participants|Number|40|40.0||||||
4067436|NCT01056653|3889532|B2|English||Main Language Spoken at Home|Speaking mainly English at home was one of the eligibility criteria. Participants who answered anything but English in the 4 month questionnaire would have indicated at recruitment when their baby was born that they speak mainly English at home.|participants|Number|22|22.0||||||
4067437|NCT01056653|3889533|B1|English||Main Language Spoken at Home|Speaking mainly English at home was one of the eligibility criteria. Participants who answered anything but English in the 4 month questionnaire would have indicated at recruitment when their baby was born that they speak mainly English at home.|participants|Number|43|43.0||||||
4067438|NCT01056653|3889530|B4|Common law/living with partner/living as married||Marital Status|Participants had to be married or living together to be able to participate in the study.|participants|Number|19|19.0||||||
4067439|NCT01056653|3889531|B3|Common law/living with partner/living as married||Marital Status|Participants had to be married or living together to be able to participate in the study.|participants|Number|7|7.0||||||
4067440|NCT01056653|3889532|B2|Common law/living with partner/living as married||Marital Status|Participants had to be married or living together to be able to participate in the study.|participants|Number|3|3.0||||||
4067441|NCT01056653|3889533|B1|Common law/living with partner/living as married||Marital Status|Participants had to be married or living together to be able to participate in the study.|participants|Number|9|9.0||||||
4067442|NCT01056653|3889530|B4|Married||Marital Status|Participants had to be married or living together to be able to participate in the study.|participants|Number|92|92.0||||||
4067443|NCT01056653|3889531|B3|Married||Marital Status|Participants had to be married or living together to be able to participate in the study.|participants|Number|35|35.0||||||
4067444|NCT01056653|3889532|B2|Married||Marital Status|Participants had to be married or living together to be able to participate in the study.|participants|Number|20|20.0||||||
4067445|NCT01056653|3889533|B1|Married||Marital Status|Participants had to be married or living together to be able to participate in the study.|participants|Number|37|37.0||||||
4067446|NCT01056653|3889530|B4|Other||Employment Status||participants|Number|1|1.0||||||
4067447|NCT01056653|3889531|B3|Other||Employment Status||participants|Number|1|1.0||||||
4067448|NCT01056653|3889532|B2|Other||Employment Status||participants|Number|0|0.0||||||
4067449|NCT01056653|3889533|B1|Other||Employment Status||participants|Number|0|0.0||||||
4067450|NCT01056653|3889530|B4|Caring for family||Employment Status||participants|Number|1|1.0||||||
4067451|NCT01056653|3889531|B3|Caring for family||Employment Status||participants|Number|0|0.0||||||
4067452|NCT01056653|3889532|B2|Caring for family||Employment Status||participants|Number|1|1.0||||||
4067453|NCT01056653|3889533|B1|Caring for family||Employment Status||participants|Number|0|0.0||||||
4067454|NCT01056653|3889530|B4|Going to school||Employment Status||participants|Number|0|0.0||||||
4067455|NCT01056653|3889531|B3|Going to school||Employment Status||participants|Number|0|0.0||||||
4067456|NCT01056653|3889532|B2|Going to school||Employment Status||participants|Number|0|0.0||||||
4067457|NCT01056653|3889533|B1|Going to school||Employment Status||participants|Number|0|0.0||||||
4067458|NCT01056653|3889530|B4|Looking for work||Employment Status||participants|Number|3|3.0||||||
4067459|NCT01056653|3889531|B3|Looking for work||Employment Status||participants|Number|1|1.0||||||
4067460|NCT01056653|3889532|B2|Looking for work||Employment Status||participants|Number|1|1.0||||||
4067461|NCT01056653|3889533|B1|Looking for work||Employment Status||participants|Number|1|1.0||||||
4067462|NCT01056653|3889530|B4|On parental leave||Employment Status||participants|Number|2|2.0||||||
4067463|NCT01056653|3889531|B3|On parental leave||Employment Status||participants|Number|1|1.0||||||
4067464|NCT01056653|3889532|B2|On parental leave||Employment Status||participants|Number|0|0.0||||||
4067465|NCT01056653|3889533|B1|On parental leave||Employment Status||participants|Number|1|1.0||||||
4067466|NCT01056653|3889530|B4|Working (Full- or part-time)||Employment Status||participants|Number|104|104.0||||||
4067467|NCT01056653|3889531|B3|Working (Full- or part-time)||Employment Status||participants|Number|39|39.0||||||
4067468|NCT01056653|3889532|B2|Working (Full- or part-time)||Employment Status||participants|Number|21|21.0||||||
4067469|NCT01056653|3889533|B1|Working (Full- or part-time)||Employment Status||participants|Number|44|44.0||||||
4067470|NCT01056653|3889530|B4|>=$100,000||Household income||participants|Number|75|75.0||||||
4067471|NCT01056653|3889531|B3|>=$100,000||Household income||participants|Number|31|31.0||||||
4067472|NCT01056653|3889532|B2|>=$100,000||Household income||participants|Number|13|13.0||||||
4067473|NCT01056653|3889533|B1|>=$100,000||Household income||participants|Number|31|31.0||||||
4067474|NCT01056653|3889530|B4|$80,000-$99,999||Household income||participants|Number|14|14.0||||||
4067475|NCT01056653|3889531|B3|$80,000-$99,999||Household income||participants|Number|6|6.0||||||
4067476|NCT01056653|3889532|B2|$80,000-$99,999||Household income||participants|Number|3|3.0||||||
4067477|NCT01056653|3889533|B1|$80,000-$99,999||Household income||participants|Number|5|5.0||||||
4067478|NCT01056653|3889530|B4|$60,000-$79,999||Household income||participants|Number|9|9.0||||||
4067479|NCT01056653|3889531|B3|$60,000-$79,999||Household income||participants|Number|0|0.0||||||
4067480|NCT01056653|3889532|B2|$60,000-$79,999||Household income||participants|Number|5|5.0||||||
4067486|NCT01056653|3889530|B4|<$40,000||Household income||participants|Number|5|5.0||||||
4067487|NCT01056653|3889531|B3|<$40,000||Household income||participants|Number|2|2.0||||||
4067488|NCT01056653|3889532|B2|<$40,000||Household income||participants|Number|0|0.0||||||
4067489|NCT01056653|3889533|B1|<$40,000||Household income||participants|Number|3|3.0||||||
4067490|NCT01056653|3889530|B4|Postgraduate degree||Education level||participants|Number|18|18.0||||||
4067491|NCT01056653|3889531|B3|Postgraduate degree||Education level||participants|Number|7|7.0||||||
4067492|NCT01056653|3889532|B2|Postgraduate degree||Education level||participants|Number|5|5.0||||||
4067493|NCT01056653|3889533|B1|Postgraduate degree||Education level||participants|Number|6|6.0||||||
4067494|NCT01056653|3889530|B4|University degree||Education level||participants|Number|42|42.0||||||
4067495|NCT01056653|3889531|B3|University degree||Education level||participants|Number|16|16.0||||||
4067496|NCT01056653|3889532|B2|University degree||Education level||participants|Number|8|8.0||||||
4067497|NCT01056653|3889533|B1|University degree||Education level||participants|Number|18|18.0||||||
4067498|NCT01056653|3889530|B4|Completed college/technical school||Education level||participants|Number|24|24.0||||||
4067499|NCT01056653|3889531|B3|Completed college/technical school||Education level||participants|Number|8|8.0||||||
4067500|NCT01056653|3889532|B2|Completed college/technical school||Education level||participants|Number|4|4.0||||||
4067501|NCT01056653|3889533|B1|Completed college/technical school||Education level||participants|Number|12|12.0||||||
4067502|NCT01056653|3889530|B4|Partial university/college/technical school||Education level||participants|Number|18|18.0||||||
4067503|NCT01056653|3889531|B3|Partial university/college/technical school||Education level||participants|Number|9|9.0||||||
4067504|NCT01056653|3889532|B2|Partial university/college/technical school||Education level||participants|Number|4|4.0||||||
4067505|NCT01056653|3889533|B1|Partial university/college/technical school||Education level||participants|Number|5|5.0||||||
4067506|NCT01056653|3889530|B4|High school or less||Education level||participants|Number|9|9.0||||||
4067507|NCT01056653|3889531|B3|High school or less||Education level||participants|Number|2|2.0||||||
4067508|NCT01056653|3889532|B2|High school or less||Education level||participants|Number|2|2.0||||||
4067509|NCT01056653|3889533|B1|High school or less||Education level||participants|Number|5|5.0||||||
4067510|NCT01056653|3889530|B4|||Infants gestational age||days|Mean|249.08|249.08|Standard Deviation|6.41|6.41|||
4067511|NCT01056653|3889531|B3|||Infants gestational age||days|Mean|249|249.0|Standard Deviation|6.61|6.61|||
4067512|NCT01056653|3889532|B2|||Infants gestational age||days|Mean|248|248.0|Standard Deviation|6.40|6.4|||
4067513|NCT01056653|3889533|B1|||Infants gestational age||days|Mean|250|250.0|Standard Deviation|6.27|6.27|||
4067514|NCT01056653|3889530|B4|Females||Sex of the Infant||infants|Number|48|48.0||||||
4067515|NCT01056653|3889531|B3|Females||Sex of the Infant||infants|Number|17|17.0||||||
4067516|NCT01056653|3889532|B2|Females||Sex of the Infant||infants|Number|11|11.0||||||
4067517|NCT01056653|3889533|B1|Females||Sex of the Infant||infants|Number|20|20.0||||||
4067518|NCT01056653|3889530|B4|Males||Sex of the Infant||infants|Number|63|63.0||||||
4067519|NCT01056653|3889531|B3|Males||Sex of the Infant||infants|Number|25|25.0||||||
4067520|NCT01056653|3889532|B2|Males||Sex of the Infant||infants|Number|12|12.0||||||
4067521|NCT01056653|3889533|B1|Males||Sex of the Infant||infants|Number|26|26.0||||||
4067522|NCT01056653|3889530|B4|Did Not Answer||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4067523|NCT01056653|3889531|B3|Did Not Answer||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4067524|NCT01056653|3889532|B2|Did Not Answer||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4067525|NCT01056653|3889533|B1|Did Not Answer||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4067526|NCT01056653|3889530|B4|More than one Option Selected||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4067527|NCT01056653|3889531|B3|More than one Option Selected||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4067528|NCT01056653|3889532|B2|More than one Option Selected||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4067529|NCT01056653|3889533|B1|More than one Option Selected||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4067530|NCT01056653|3889530|B4|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4067531|NCT01056653|3889531|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4067532|NCT01056653|3889532|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4067533|NCT01056653|3889533|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4067534|NCT01056653|3889530|B4|Latin American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4067535|NCT01056653|3889531|B3|Latin American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4067536|NCT01056653|3889532|B2|Latin American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4067537|NCT01056653|3889533|B1|Latin American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4067538|NCT01056653|3889530|B4|North American First Nations||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4067539|NCT01056653|3889531|B3|North American First Nations||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4067540|NCT01056653|3889532|B2|North American First Nations||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4067541|NCT01056653|3889533|B1|North American First Nations||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4067542|NCT01056653|3889530|B4|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4067543|NCT01056653|3889531|B3|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4067544|NCT01056653|3889532|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4067545|NCT01056653|3889533|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4067546|NCT01056653|3889530|B4|Arab/West Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4067547|NCT01056653|3889531|B3|Arab/West Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4067548|NCT01056653|3889532|B2|Arab/West Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4067549|NCT01056653|3889533|B1|Arab/West Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4067550|NCT01056653|3889530|B4|South Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4067551|NCT01056653|3889531|B3|South Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4067552|NCT01056653|3889532|B2|South Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4067553|NCT01056653|3889533|B1|South Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4067554|NCT01056653|3889530|B4|Chinese||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4067555|NCT01056653|3889531|B3|Chinese||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4067556|NCT01056653|3889532|B2|Chinese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4067557|NCT01056653|3889533|B1|Chinese||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4067558|NCT01056653|3889530|B4|Filipino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4067559|NCT01056653|3889531|B3|Filipino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4067560|NCT01056653|3889532|B2|Filipino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4067561|NCT01056653|3889533|B1|Filipino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4067562|NCT01056653|3889530|B4|European||Race/Ethnicity, Customized||participants|Number|84|84.0||||||
4067563|NCT01056653|3889531|B3|European||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4067564|NCT01056653|3889532|B2|European||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4067565|NCT01056653|3889533|B1|European||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4067566|NCT01056653|3889530|B4||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4067567|NCT01056653|3889531|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4067568|NCT01056653|3889532|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4067569|NCT01056653|3889533|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4067570|NCT01056653|3889530|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4067571|NCT01056653|3889531|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4067572|NCT01056653|3889532|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4067573|NCT01056653|3889533|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4067574|NCT01056653|3889530|B4|||Age||years|Mean|34.13|34.13|Standard Deviation|5.85|5.85|||
4067575|NCT01056653|3889531|B3|||Age||years|Mean|34.47|34.47|Standard Deviation|6.01|6.01|||
4067576|NCT01056653|3889532|B2|||Age||years|Mean|34.28|34.28|Standard Deviation|4.24|4.24|||
4067577|NCT01056653|3889533|B1|||Age||years|Mean|33.7|33.7|Standard Deviation|6.44|6.44|||
4067578|NCT01056640|3889549|B3||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4067579|NCT01056640|3889550|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4067580|NCT01056640|3889551|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4067581|NCT01056640|3889549|B3||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4067582|NCT01056640|3889550|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4067583|NCT01056640|3889551|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4067584|NCT01056640|3889549|B3|||Age||years|Mean|80.3|80.3|Standard Deviation|8.2|8.2|||
4067585|NCT01056640|3889550|B2|||Age||years|Mean|80.2|80.2|Standard Deviation|7.6|7.6|||
4067586|NCT01056640|3889551|B1|||Age||years|Mean|80.3|80.3|Standard Deviation|8.9|8.9|||
4067587|NCT01056640|3889549|B3||>=65 years|Age||Participants|Count of Participants|197|197.0||||||
4067588|NCT01056640|3889550|B2||>=65 years|Age||Participants|Count of Participants|100|100.0||||||
4067589|NCT01056640|3889551|B1||>=65 years|Age||Participants|Count of Participants|97|97.0||||||
4067590|NCT01056640|3889549|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4067591|NCT01056640|3889550|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4067592|NCT01056640|3889551|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4067593|NCT01056640|3889549|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4067594|NCT01056640|3889550|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4067595|NCT01056640|3889551|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4067596|NCT01056601|3889558|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4067597|NCT01056601|3889558|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4067598|NCT01056601|3889558|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4067599|NCT01056601|3889558|B1|||Age||years|Mean|58|58.0|Standard Deviation|13|13.0|||
4067600|NCT01056601|3889558|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4067601|NCT01056601|3889558|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4067602|NCT01056601|3889558|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4067603|NCT01056523|3889564|B1||Other FAB subtypes|FAB subtype|FAB - French American British leukemia classification|Participants|Count of Participants|7|7.0||||||
4067604|NCT01056523|3889564|B1||FAB sutype M4/M5|FAB subtype|FAB - French American British leukemia classification|Participants|Count of Participants|22|22.0||||||
4067605|NCT01056523|3889564|B1||Male|Gender||Participants|Count of Participants|15|15.0||||||
4067606|NCT01056523|3889564|B1||Female|Gender||Participants|Count of Participants|14|14.0||||||
4067607|NCT01056523|3889564|B1|||Age||years|Median|65|65.0|Full Range|||22.0|83.0|
4067608|NCT01056510|3889578|B3||Male|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4067609|NCT01056510|3889579|B2||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4067610|NCT01056510|3889580|B1||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4067611|NCT01056510|3889578|B3||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4067612|NCT01056510|3889579|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4067613|NCT01056510|3889580|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4067614|NCT01056510|3889578|B3|||Age||years|Mean|70.3|70.3|Standard Deviation|9.87|9.87|||
4067615|NCT01056510|3889579|B2|||Age||years|Mean|70.1|70.1|Standard Deviation|9.88|9.88|||
4067616|NCT01056510|3889580|B1|||Age||years|Mean|70.6|70.6|Standard Deviation|9.87|9.87|||
4067617|NCT01056484|3889625|B3|United States||Region of Enrollment||participants|Number|123|123.0||||||
4067618|NCT01056484|3889626|B2|United States||Region of Enrollment||participants|Number|59|59.0||||||
4067619|NCT01056484|3889627|B1|United States||Region of Enrollment||participants|Number|64|64.0||||||
4067620|NCT01056484|3889625|B3||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4067621|NCT01056484|3889626|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4067622|NCT01056484|3889627|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4067623|NCT01056484|3889625|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4067624|NCT01056484|3889626|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4067625|NCT01056484|3889627|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4067626|NCT01056484|3889625|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4067627|NCT01056484|3889626|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4067628|NCT01056484|3889627|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4067629|NCT01056484|3889625|B3||Between 18 and 65 years|Age||Participants|Count of Participants|122|122.0||||||
4067630|NCT01056484|3889626|B2||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4067631|NCT01056484|3889627|B1||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4067632|NCT01056484|3889625|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4067633|NCT01056484|3889626|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4067634|NCT01056484|3889627|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4067635|NCT01056484|3889625|B3|||Age||years|Mean|41.2|41.2|Standard Deviation|11.9|11.9|||
4067636|NCT01056484|3889626|B2|||Age||years|Mean|41.9|41.9|Standard Deviation|11.9|11.9|||
4067637|NCT01056484|3889627|B1|||Age||years|Mean|40.5|40.5|Standard Deviation|12.1|12.1|||
4067638|NCT01056380|3889642|B3|United States||Region of Enrollment||participants|Number|79|79.0||||||
4067639|NCT01056380|3889643|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
4067640|NCT01056380|3889644|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4067641|NCT01056380|3889642|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4067642|NCT01056380|3889643|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4067643|NCT01056380|3889644|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4067644|NCT01056380|3889642|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4067645|NCT01056380|3889643|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4067646|NCT01056380|3889644|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4067647|NCT01056380|3889642|B3|||Age||years|Mean|38.2|38.2|Standard Deviation|13.8|13.8|||
4067648|NCT01056380|3889643|B2|||Age||years|Mean|37.9|37.9|Standard Deviation|13.3|13.3|||
4067649|NCT01056380|3889644|B1|||Age||years|Mean|38.6|38.6|Standard Deviation|14.4|14.4|||
4067650|NCT01056380|3889642|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4067651|NCT01056380|3889643|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4067652|NCT01056380|3889644|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4067653|NCT01056380|3889642|B3||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
4067654|NCT01056380|3889643|B2||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4067655|NCT01056380|3889644|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4067656|NCT01056380|3889642|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4067657|NCT01056380|3889643|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4067658|NCT01056380|3889644|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4067659|NCT01056341|3889667|B6|NONE FACE||Infantile hemangioma localization||participants|Number|138|138.0||||||
4067660|NCT01056341|3889668|B5|NONE FACE||Infantile hemangioma localization||participants|Number|30|30.0||||||
4067661|NCT01056341|3889669|B4|NONE FACE||Infantile hemangioma localization||participants|Number|36|36.0||||||
4067662|NCT01056341|3889670|B3|NONE FACE||Infantile hemangioma localization||participants|Number|30|30.0||||||
4067663|NCT01056341|3889671|B2|NONE FACE||Infantile hemangioma localization||participants|Number|27|27.0||||||
4067664|NCT01056341|3889672|B1|NONE FACE||Infantile hemangioma localization||participants|Number|15|15.0||||||
4067665|NCT01056341|3889667|B6|FACE||Infantile hemangioma localization||participants|Number|318|318.0||||||
4067666|NCT01056341|3889668|B5|FACE||Infantile hemangioma localization||participants|Number|71|71.0||||||
4067667|NCT01056341|3889669|B4|FACE||Infantile hemangioma localization||participants|Number|64|64.0||||||
4067668|NCT01056341|3889670|B3|FACE||Infantile hemangioma localization||participants|Number|72|72.0||||||
4067669|NCT01056341|3889671|B2|FACE||Infantile hemangioma localization||participants|Number|71|71.0||||||
4067670|NCT01056341|3889672|B1|FACE||Infantile hemangioma localization||participants|Number|40|40.0||||||
4067671|NCT01056341|3889667|B6|New Zealand||Region of Enrollment||participants|Number|5|5.0||||||
4067672|NCT01056341|3889668|B5|New Zealand||Region of Enrollment||participants|Number|3|3.0||||||
4067673|NCT01056341|3889669|B4|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
4067674|NCT01056341|3889670|B3|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
4067675|NCT01056341|3889671|B2|New Zealand||Region of Enrollment||participants|Number|0|0.0||||||
4067676|NCT01056341|3889672|B1|New Zealand||Region of Enrollment||participants|Number|0|0.0||||||
4067677|NCT01056341|3889667|B6|Germany||Region of Enrollment||participants|Number|60|60.0||||||
4067678|NCT01056341|3889668|B5|Germany||Region of Enrollment||participants|Number|9|9.0||||||
4067679|NCT01056341|3889669|B4|Germany||Region of Enrollment||participants|Number|17|17.0||||||
4067680|NCT01056341|3889670|B3|Germany||Region of Enrollment||participants|Number|9|9.0||||||
4067681|NCT01056341|3889671|B2|Germany||Region of Enrollment||participants|Number|17|17.0||||||
4067682|NCT01056341|3889672|B1|Germany||Region of Enrollment||participants|Number|8|8.0||||||
4067683|NCT01056341|3889667|B6|Australia||Region of Enrollment||participants|Number|32|32.0||||||
4067684|NCT01056341|3889668|B5|Australia||Region of Enrollment||participants|Number|7|7.0||||||
4067685|NCT01056341|3889669|B4|Australia||Region of Enrollment||participants|Number|5|5.0||||||
4067686|NCT01056341|3889670|B3|Australia||Region of Enrollment||participants|Number|14|14.0||||||
4067687|NCT01056341|3889671|B2|Australia||Region of Enrollment||participants|Number|5|5.0||||||
4067688|NCT01056341|3889672|B1|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4067689|NCT01056341|3889667|B6|Peru||Region of Enrollment||participants|Number|35|35.0||||||
4067690|NCT01056341|3889668|B5|Peru||Region of Enrollment||participants|Number|12|12.0||||||
4067691|NCT01056341|3889669|B4|Peru||Region of Enrollment||participants|Number|8|8.0||||||
4067692|NCT01056341|3889670|B3|Peru||Region of Enrollment||participants|Number|9|9.0||||||
4067693|NCT01056341|3889671|B2|Peru||Region of Enrollment||participants|Number|5|5.0||||||
4067694|NCT01056341|3889672|B1|Peru||Region of Enrollment||participants|Number|1|1.0||||||
4067695|NCT01056341|3889667|B6|Romania||Region of Enrollment||participants|Number|7|7.0||||||
4067696|NCT01056341|3889668|B5|Romania||Region of Enrollment||participants|Number|2|2.0||||||
4067697|NCT01056341|3889669|B4|Romania||Region of Enrollment||participants|Number|0|0.0||||||
4067698|NCT01056341|3889670|B3|Romania||Region of Enrollment||participants|Number|1|1.0||||||
4067699|NCT01056341|3889671|B2|Romania||Region of Enrollment||participants|Number|2|2.0||||||
4067700|NCT01056341|3889672|B1|Romania||Region of Enrollment||participants|Number|2|2.0||||||
4067701|NCT01056341|3889667|B6|Poland||Region of Enrollment||participants|Number|26|26.0||||||
4067702|NCT01056341|3889668|B5|Poland||Region of Enrollment||participants|Number|4|4.0||||||
4067703|NCT01056341|3889669|B4|Poland||Region of Enrollment||participants|Number|8|8.0||||||
4067704|NCT01056341|3889670|B3|Poland||Region of Enrollment||participants|Number|6|6.0||||||
4067705|NCT01056341|3889671|B2|Poland||Region of Enrollment||participants|Number|4|4.0||||||
4067706|NCT01056341|3889672|B1|Poland||Region of Enrollment||participants|Number|4|4.0||||||
4067707|NCT01056341|3889667|B6|Canada||Region of Enrollment||participants|Number|18|18.0||||||
4067708|NCT01056341|3889668|B5|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4067709|NCT01056341|3889669|B4|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4067710|NCT01056341|3889670|B3|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4067711|NCT01056341|3889671|B2|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4067712|NCT01056341|3889672|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4067713|NCT01056341|3889667|B6|Mexico||Region of Enrollment||participants|Number|5|5.0||||||
4067714|NCT01056341|3889668|B5|Mexico||Region of Enrollment||participants|Number|0|0.0||||||
4067715|NCT01056341|3889669|B4|Mexico||Region of Enrollment||participants|Number|3|3.0||||||
4067716|NCT01056341|3889670|B3|Mexico||Region of Enrollment||participants|Number|0|0.0||||||
4067717|NCT01056341|3889671|B2|Mexico||Region of Enrollment||participants|Number|2|2.0||||||
4067718|NCT01056341|3889672|B1|Mexico||Region of Enrollment||participants|Number|0|0.0||||||
4067719|NCT01056341|3889667|B6|Hungary||Region of Enrollment||participants|Number|11|11.0||||||
4067720|NCT01056341|3889668|B5|Hungary||Region of Enrollment||participants|Number|2|2.0||||||
4067721|NCT01056341|3889669|B4|Hungary||Region of Enrollment||participants|Number|2|2.0||||||
4067722|NCT01056341|3889670|B3|Hungary||Region of Enrollment||participants|Number|4|4.0||||||
4067723|NCT01056341|3889671|B2|Hungary||Region of Enrollment||participants|Number|2|2.0||||||
4067724|NCT01056341|3889672|B1|Hungary||Region of Enrollment||participants|Number|1|1.0||||||
4067725|NCT01056341|3889667|B6|Czech Republic||Region of Enrollment||participants|Number|8|8.0||||||
4067726|NCT01056341|3889668|B5|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
4067727|NCT01056341|3889669|B4|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
4067728|NCT01056341|3889670|B3|Czech Republic||Region of Enrollment||participants|Number|3|3.0||||||
4067729|NCT01056341|3889671|B2|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
4067730|NCT01056341|3889672|B1|Czech Republic||Region of Enrollment||participants|Number|2|2.0||||||
4067731|NCT01056341|3889667|B6|France||Region of Enrollment||participants|Number|114|114.0||||||
4067732|NCT01056341|3889668|B5|France||Region of Enrollment||participants|Number|28|28.0||||||
4067733|NCT01056341|3889669|B4|France||Region of Enrollment||participants|Number|22|22.0||||||
4067734|NCT01056341|3889670|B3|France||Region of Enrollment||participants|Number|18|18.0||||||
4067735|NCT01056341|3889671|B2|France||Region of Enrollment||participants|Number|25|25.0||||||
4067736|NCT01056341|3889672|B1|France||Region of Enrollment||participants|Number|21|21.0||||||
4067737|NCT01056341|3889667|B6|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4067738|NCT01056341|3889668|B5|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4067739|NCT01056341|3889669|B4|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4067740|NCT01056341|3889670|B3|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4067741|NCT01056341|3889671|B2|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4067742|NCT01056341|3889672|B1|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4067743|NCT01056341|3889667|B6|Russian Federation||Region of Enrollment||participants|Number|3|3.0||||||
4067744|NCT01056341|3889668|B5|Russian Federation||Region of Enrollment||participants|Number|1|1.0||||||
4067745|NCT01056341|3889669|B4|Russian Federation||Region of Enrollment||participants|Number|1|1.0||||||
4067746|NCT01056341|3889670|B3|Russian Federation||Region of Enrollment||participants|Number|0|0.0||||||
4067747|NCT01056341|3889671|B2|Russian Federation||Region of Enrollment||participants|Number|1|1.0||||||
4067748|NCT01056341|3889672|B1|Russian Federation||Region of Enrollment||participants|Number|0|0.0||||||
4067749|NCT01056341|3889667|B6|Lithuania||Region of Enrollment||participants|Number|18|18.0||||||
4067750|NCT01056341|3889668|B5|Lithuania||Region of Enrollment||participants|Number|5|5.0||||||
4067751|NCT01056341|3889669|B4|Lithuania||Region of Enrollment||participants|Number|1|1.0||||||
4067752|NCT01056341|3889670|B3|Lithuania||Region of Enrollment||participants|Number|4|4.0||||||
4067753|NCT01056341|3889671|B2|Lithuania||Region of Enrollment||participants|Number|7|7.0||||||
4067754|NCT01056341|3889672|B1|Lithuania||Region of Enrollment||participants|Number|1|1.0||||||
4067755|NCT01056341|3889667|B6|Spain||Region of Enrollment||participants|Number|59|59.0||||||
4067756|NCT01056341|3889668|B5|Spain||Region of Enrollment||participants|Number|14|14.0||||||
4067757|NCT01056341|3889669|B4|Spain||Region of Enrollment||participants|Number|17|17.0||||||
4067758|NCT01056341|3889670|B3|Spain||Region of Enrollment||participants|Number|14|14.0||||||
4067759|NCT01056341|3889671|B2|Spain||Region of Enrollment||participants|Number|9|9.0||||||
4067760|NCT01056341|3889672|B1|Spain||Region of Enrollment||participants|Number|5|5.0||||||
4067761|NCT01056341|3889667|B6|United States||Region of Enrollment||participants|Number|53|53.0||||||
4067762|NCT01056341|3889668|B5|United States||Region of Enrollment||participants|Number|10|10.0||||||
4067763|NCT01056341|3889669|B4|United States||Region of Enrollment||participants|Number|11|11.0||||||
4067764|NCT01056341|3889670|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4067765|NCT01056341|3889671|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4067766|NCT01056341|3889672|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4067767|NCT01056341|3889667|B6||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4067768|NCT01056341|3889668|B5||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4067769|NCT01056341|3889669|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4067770|NCT01056341|3889670|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4067771|NCT01056341|3889671|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4067772|NCT01056341|3889672|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4067773|NCT01056341|3889667|B6||Female|Sex: Female, Male||Participants|Count of Participants|325|325.0||||||
4067774|NCT01056341|3889668|B5||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4067775|NCT01056341|3889669|B4||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4067776|NCT01056341|3889670|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4067777|NCT01056341|3889671|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4067778|NCT01056341|3889672|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4067779|NCT01056341|3889667|B6|||Age||DAYS|Mean|103.85|103.85|Standard Deviation|31.02|31.02|||
4067780|NCT01056341|3889668|B5|||Age||DAYS|Mean|101.63|101.63|Standard Deviation|31.00|31.0|||
4067781|NCT01056341|3889669|B4|||Age||DAYS|Mean|107.53|107.53|Standard Deviation|30.14|30.14|||
4067782|NCT01056341|3889670|B3|||Age||DAYS|Mean|102.65|102.65|Standard Deviation|30.12|30.12|||
4067783|NCT01056341|3889671|B2|||Age||DAYS|Mean|103.58|103.58|Standard Deviation|33.07|33.07|||
4067784|NCT01056341|3889672|B1|||Age||DAYS|Mean|103.91|103.91|Standard Deviation|31.06|31.06|||
4067785|NCT01056328|3889695|B3|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4067786|NCT01056328|3889696|B2|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4067787|NCT01056328|3889697|B1|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4067788|NCT01056328|3889695|B3|Korea, Republic of||Region of Enrollment||participants|Number|16|16.0||||||
4067789|NCT01056328|3889696|B2|Korea, Republic of||Region of Enrollment||participants|Number|7|7.0||||||
4067790|NCT01056328|3889697|B1|Korea, Republic of||Region of Enrollment||participants|Number|9|9.0||||||
4067791|NCT01056328|3889695|B3|United States||Region of Enrollment||participants|Number|298|298.0||||||
4067792|NCT01056328|3889696|B2|United States||Region of Enrollment||participants|Number|149|149.0||||||
4067793|NCT01056328|3889697|B1|United States||Region of Enrollment||participants|Number|149|149.0||||||
4067794|NCT01056328|3889695|B3||Male|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4067795|NCT01056328|3889696|B2||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4067796|NCT01056328|3889697|B1||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4067797|NCT01056328|3889695|B3||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4067798|NCT01056328|3889696|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4067799|NCT01056328|3889697|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4067800|NCT01056328|3889695|B3||>=65 years|Age||Participants|Count of Participants|132|132.0||||||
4067801|NCT01056328|3889696|B2||>=65 years|Age||Participants|Count of Participants|64|64.0||||||
4067802|NCT01056328|3889697|B1||>=65 years|Age||Participants|Count of Participants|68|68.0||||||
4067803|NCT01056328|3889695|B3||Between 18 and 65 years|Age||Participants|Count of Participants|192|192.0||||||
4067804|NCT01056328|3889696|B2||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
4067805|NCT01056328|3889697|B1||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
4067806|NCT01056328|3889695|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4067807|NCT01056328|3889696|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4067808|NCT01056328|3889697|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4067809|NCT01056328|3889695|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|11.2|11.2|||
4067810|NCT01056328|3889696|B2|||Age||years|Mean|60.6|60.6|Standard Deviation|9.7|9.7|||
4067811|NCT01056328|3889697|B1|||Age||years|Mean|58.5|58.5|Standard Deviation|12.4|12.4|||
4067812|NCT01056315|3889712|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4067813|NCT01056315|3889713|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4067814|NCT01056315|3889714|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4067815|NCT01056315|3889712|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4067816|NCT01056315|3889713|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4067817|NCT01056315|3889714|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4067818|NCT01056315|3889712|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4067819|NCT01056315|3889713|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4067820|NCT01056315|3889714|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4067821|NCT01056315|3889712|B3|||Age||years|Mean|59.79|59.79|Standard Deviation|9.568|9.568|||
4067822|NCT01056315|3889713|B2|||Age||years|Mean|60.27|60.27|Standard Deviation|10.438|10.438|||
4067823|NCT01056315|3889714|B1|||Age||years|Mean|59.38|59.38|Standard Deviation|8.942|8.942|||
4067824|NCT01056315|3889712|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4067825|NCT01056315|3889713|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4067826|NCT01056315|3889714|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4067827|NCT01056315|3889712|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4067828|NCT01056315|3889713|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4067829|NCT01056315|3889714|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4067830|NCT01056315|3889712|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4067831|NCT01056315|3889713|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4067832|NCT01056315|3889714|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4067833|NCT01056289|3889749|B1||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4067834|NCT01056289|3889749|B1||Female|Sex: Female, Male||Participants|Count of Participants|330|330.0||||||
4067835|NCT01056289|3889749|B1|||Age||years|Mean|46.5|46.5|Standard Deviation|13.0|13.0|||
4067836|NCT01056276|3889767|B3|United States||Region of Enrollment||participants|Number|59|59.0||||||
4067837|NCT01056276|3889768|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
4067838|NCT01056276|3889769|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4067839|NCT01056276|3889767|B3|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4067840|NCT01056276|3889768|B2|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4067841|NCT01056276|3889769|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4067842|NCT01056276|3889767|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4067843|NCT01056276|3889768|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4067844|NCT01056276|3889769|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4067845|NCT01056276|3889767|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
4067846|NCT01056276|3889768|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
4067847|NCT01056276|3889769|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4067848|NCT01056276|3889767|B3|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4067849|NCT01056276|3889768|B2|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4067850|NCT01056276|3889769|B1|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4067851|NCT01056276|3889767|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4067852|NCT01056276|3889768|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4067853|NCT01056276|3889769|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4067854|NCT01056276|3889767|B3|American Indian/Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4067855|NCT01056276|3889768|B2|American Indian/Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4067856|NCT01056276|3889769|B1|American Indian/Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4067857|NCT01056276|3889767|B3||unknown|Sex/Gender, Customized||Participants|Count of Participants|1|1.0||||||
4067858|NCT01056276|3889768|B2||unknown|Sex/Gender, Customized||Participants|Count of Participants|1|1.0||||||
4067859|NCT01056276|3889769|B1||unknown|Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
4067860|NCT01056276|3889767|B3||male|Sex/Gender, Customized||Participants|Count of Participants|39|39.0||||||
4067861|NCT01056276|3889768|B2||male|Sex/Gender, Customized||Participants|Count of Participants|26|26.0||||||
4067862|NCT01056276|3889769|B1||male|Sex/Gender, Customized||Participants|Count of Participants|13|13.0||||||
4067863|NCT01056276|3889767|B3||female|Sex/Gender, Customized||Participants|Count of Participants|19|19.0||||||
4067864|NCT01056276|3889768|B2||female|Sex/Gender, Customized||Participants|Count of Participants|14|14.0||||||
4067865|NCT01056276|3889769|B1||female|Sex/Gender, Customized||Participants|Count of Participants|5|5.0||||||
4067866|NCT01056276|3889767|B3|||Age||years|Median|75|75.0|Full Range|||45.0|89.0|
4067867|NCT01056276|3889768|B2|||Age||years|Median|75|75.0|Full Range|||45.0|89.0|
4067868|NCT01056276|3889769|B1|||Age||years|Median|75|75.0|Full Range|||55.0|81.0|
4067869|NCT01056263|3889784|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4067870|NCT01056263|3889784|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4067871|NCT01056263|3889784|B1|||Age||years|Mean|58.8|58.8|Standard Deviation|11.3|11.3|||
4067872|NCT01056198|3889788|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
4067873|NCT01056198|3889789|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4067874|NCT01056198|3889790|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4067875|NCT01056198|3889788|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4067876|NCT01056198|3889789|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4067877|NCT01056198|3889790|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4067878|NCT01056198|3889788|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4067879|NCT01056198|3889789|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4067880|NCT01056198|3889790|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4067881|NCT01056198|3889788|B3|||Age||years|Mean|61.0|61.0|Standard Deviation|11.8|11.8|||
4067882|NCT01056198|3889789|B2|||Age||years|Mean|63.5|63.5|Standard Deviation|9.8|9.8|||
4067883|NCT01056198|3889790|B1|||Age||years|Mean|58.5|58.5|Standard Deviation|13.3|13.3|||
4067884|NCT01056198|3889788|B3||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4067885|NCT01056198|3889789|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4067886|NCT01056198|3889790|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4067887|NCT01056198|3889788|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4067888|NCT01056198|3889789|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4067889|NCT01056198|3889790|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4067890|NCT01056198|3889788|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4067891|NCT01056198|3889789|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4067892|NCT01056198|3889790|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4067893|NCT01056107|3889803|B5|||Stool Consistency|"The subjects rated their stool consistency using the Bristol Stool Scale. The Bristol Stool Scale is a medical aid designed to classify the form of human feces into seven categories or types. Types 1 and 2 indicate constipation with 3 and 4 being the ideal stools especially the latter, as they are the easiest to defecate, and 5-7 tending towards diarrhea."|units on a scale|Mean|2.7|2.7|Standard Deviation|1.2|1.2|||
4067894|NCT01056107|3889804|B4|||Stool Consistency|"The subjects rated their stool consistency using the Bristol Stool Scale. The Bristol Stool Scale is a medical aid designed to classify the form of human feces into seven categories or types. Types 1 and 2 indicate constipation with 3 and 4 being the ideal stools especially the latter, as they are the easiest to defecate, and 5-7 tending towards diarrhea."|units on a scale|Mean|2.4|2.4|Standard Deviation|0.9|0.9|||
4067895|NCT01056107|3889805|B3|||Stool Consistency|"The subjects rated their stool consistency using the Bristol Stool Scale. The Bristol Stool Scale is a medical aid designed to classify the form of human feces into seven categories or types. Types 1 and 2 indicate constipation with 3 and 4 being the ideal stools especially the latter, as they are the easiest to defecate, and 5-7 tending towards diarrhea."|units on a scale|Mean|2.8|2.8|Standard Deviation|1.8|1.8|||
4067896|NCT01056107|3889806|B2|||Stool Consistency|"The subjects rated their stool consistency using the Bristol Stool Scale. The Bristol Stool Scale is a medical aid designed to classify the form of human feces into seven categories or types. Types 1 and 2 indicate constipation with 3 and 4 being the ideal stools especially the latter, as they are the easiest to defecate, and 5-7 tending towards diarrhea."|units on a scale|Mean|3.0|3.0|Standard Deviation|0.8|0.8|||
4067897|NCT01056107|3889807|B1|||Stool Consistency|"The subjects rated their stool consistency using the Bristol Stool Scale. The Bristol Stool Scale is a medical aid designed to classify the form of human feces into seven categories or types. Types 1 and 2 indicate constipation with 3 and 4 being the ideal stools especially the latter, as they are the easiest to defecate, and 5-7 tending towards diarrhea."|units on a scale|Mean|2.8|2.8|Standard Deviation|1.1|1.1|||
4067898|NCT01056107|3889803|B5|||Stool frequency||Stools/day|Mean|0.8|0.8|Standard Deviation|0.5|0.5|||
4067899|NCT01056107|3889804|B4|||Stool frequency||Stools/day|Mean|0.7|0.7|Standard Deviation|0.4|0.4|||
4067900|NCT01056107|3889805|B3|||Stool frequency||Stools/day|Mean|0.8|0.8|Standard Deviation|0.6|0.6|||
4067901|NCT01056107|3889806|B2|||Stool frequency||Stools/day|Mean|1.0|1.0|Standard Deviation|0.8|0.8|||
4067902|NCT01056107|3889807|B1|||Stool frequency||Stools/day|Mean|0.7|0.7|Standard Deviation|0.3|0.3|||
4067903|NCT01056107|3889803|B5|||Body Mass Index (BMI)||kg/m^2|Mean|26.9|26.9|Standard Deviation|4.5|4.5|||
4067904|NCT01056107|3889804|B4|||Body Mass Index (BMI)||kg/m^2|Mean|27.7|27.7|Standard Deviation|4.0|4.0|||
4067905|NCT01056107|3889805|B3|||Body Mass Index (BMI)||kg/m^2|Mean|26.4|26.4|Standard Deviation|4.8|4.8|||
4067906|NCT01056107|3889806|B2|||Body Mass Index (BMI)||kg/m^2|Mean|26.4|26.4|Standard Deviation|5.5|5.5|||
4067907|NCT01056107|3889807|B1|||Body Mass Index (BMI)||kg/m^2|Mean|27.2|27.2|Standard Deviation|3.8|3.8|||
4067908|NCT01056107|3889803|B5|United States||Region of Enrollment||participants|Number|46|46.0||||||
4067909|NCT01056107|3889804|B4|United States||Region of Enrollment||participants|Number|12|12.0||||||
4067910|NCT01056107|3889805|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4067911|NCT01056107|3889806|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4067912|NCT01056107|3889807|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4067913|NCT01056107|3889803|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4067914|NCT01056107|3889804|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4067915|NCT01056107|3889805|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4067916|NCT01056107|3889806|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4067917|NCT01056107|3889807|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4067918|NCT01056107|3889803|B5||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4067919|NCT01056107|3889804|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4067920|NCT01056107|3889805|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4067921|NCT01056107|3889806|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4067922|NCT01056107|3889807|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4067923|NCT01056107|3889803|B5|||Age||years|Mean|42.4|42.4|Standard Deviation|9.5|9.5|||
4067924|NCT01056107|3889804|B4|||Age||years|Mean|43.8|43.8|Standard Deviation|8.0|8.0|||
4067925|NCT01056107|3889805|B3|||Age||years|Mean|42.0|42.0|Standard Deviation|11.9|11.9|||
4067926|NCT01056107|3889806|B2|||Age||years|Mean|40.2|40.2|Standard Deviation|11.7|11.7|||
4067927|NCT01056107|3889807|B1|||Age||years|Mean|43.4|43.4|Standard Deviation|6.0|6.0|||
4067928|NCT01056016|3889856|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
4067929|NCT01056016|3889857|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4067930|NCT01056016|3889858|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4067931|NCT01056016|3889856|B3||Male|Gender||Participants|Count of Participants|20|20.0||||||
4067932|NCT01056016|3889857|B2||Male|Gender||Participants|Count of Participants|13|13.0||||||
4067933|NCT01056016|3889858|B1||Male|Gender||Participants|Count of Participants|7|7.0||||||
4067934|NCT01056016|3889856|B3||Female|Gender||Participants|Count of Participants|29|29.0||||||
4067935|NCT01056016|3889857|B2||Female|Gender||Participants|Count of Participants|14|14.0||||||
4067936|NCT01056016|3889858|B1||Female|Gender||Participants|Count of Participants|15|15.0||||||
4067937|NCT01056016|3889856|B3|||Age||Years|Mean|46.8|46.8|Standard Deviation|10.7|10.7|||
4067938|NCT01056016|3889857|B2|||Age||Years|Mean|46.6|46.6|Standard Deviation|11.3|11.3|||
4067939|NCT01056016|3889858|B1|||Age||Years|Mean|47.0|47.0|Standard Deviation|10.3|10.3|||
4067940|NCT01055886|3889865|B3|United States||Region of Enrollment||participants|Number|65|65.0||||||
4067941|NCT01055886|3889866|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
4067942|NCT01055886|3889867|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4067943|NCT01055886|3889865|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4067944|NCT01055886|3889866|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4067945|NCT01055886|3889867|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4067946|NCT01055886|3889865|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4067947|NCT01055886|3889866|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4067948|NCT01055886|3889867|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4067949|NCT01055886|3889865|B3|||Age||years|Mean|41.91|41.91|Standard Deviation|9.27|9.27|||
4067950|NCT01055886|3889866|B2|||Age||years|Mean|42.69|42.69|Standard Deviation|7.81|7.81|||
4067951|NCT01055886|3889867|B1|||Age||years|Mean|41.15|41.15|Standard Deviation|10.57|10.57|||
4067952|NCT01055834|3889878|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4067953|NCT01055834|3889879|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4067954|NCT01055834|3889880|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4067955|NCT01055834|3889878|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4067956|NCT01055834|3889879|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4067957|NCT01055834|3889880|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4067958|NCT01055834|3889878|B3|||Age||years|Mean|31.2|31.2|Standard Deviation|8.0|8.0|||
4067959|NCT01055834|3889879|B2|||Age||years|Mean|33.0|33.0|Standard Deviation|9.4|9.4|||
4067960|NCT01055834|3889880|B1|||Age||years|Mean|29.3|29.3|Standard Deviation|6.0|6.0|||
4067961|NCT01055782|3889893|B3|Denmark||Region of Enrollment||participants|Number|1004|1004.0||||||
4067962|NCT01055782|3889894|B2|Denmark||Region of Enrollment||participants|Number|449|449.0||||||
4067963|NCT01055782|3889895|B1|Denmark||Region of Enrollment||participants|Number|555|555.0||||||
4067964|NCT01055782|3889893|B3||Male|Sex: Female, Male||Participants|Count of Participants|440|440.0||||||
4067965|NCT01055782|3889894|B2||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4067966|NCT01055782|3889895|B1||Male|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
4067967|NCT01055782|3889893|B3||Female|Sex: Female, Male||Participants|Count of Participants|564|564.0||||||
4067968|NCT01055782|3889894|B2||Female|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
4067969|NCT01055782|3889895|B1||Female|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
4067970|NCT01055782|3889893|B3|||Age||years|Mean|56|56.0|Standard Deviation|15|15.0|||
4067971|NCT01055782|3889894|B2|||Age||years|Mean|56|56.0|Standard Deviation|15|15.0|||
4067972|NCT01055782|3889895|B1|||Age||years|Mean|56|56.0|Standard Deviation|14|14.0|||
4067973|NCT01055782|3889893|B3||>=65 years|Age||Participants|Count of Participants|325|325.0||||||
4067974|NCT01055782|3889894|B2||>=65 years|Age||Participants|Count of Participants|152|152.0||||||
4067975|NCT01055782|3889895|B1||>=65 years|Age||Participants|Count of Participants|173|173.0||||||
4067976|NCT01055782|3889893|B3||Between 18 and 65 years|Age||Participants|Count of Participants|679|679.0||||||
4067977|NCT01055782|3889894|B2||Between 18 and 65 years|Age||Participants|Count of Participants|297|297.0||||||
4067978|NCT01055782|3889895|B1||Between 18 and 65 years|Age||Participants|Count of Participants|382|382.0||||||
4067979|NCT01055782|3889893|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4067980|NCT01055782|3889894|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4067981|NCT01055782|3889895|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4067982|NCT01055769|3889904|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4067983|NCT01055769|3889904|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4067984|NCT01055769|3889904|B1|||Age||Years|Mean|25.4|25.4|Standard Deviation|2.1|2.1|||
4067985|NCT01055704|3889919|B5||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4067986|NCT01055704|3889920|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4067987|NCT01055704|3889921|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4067988|NCT01055704|3889922|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4067989|NCT01055704|3889923|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4067990|NCT01055704|3889919|B5||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4067991|NCT01055704|3889920|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4067992|NCT01055704|3889921|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4067993|NCT01055704|3889922|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4067994|NCT01055704|3889923|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4067995|NCT01055704|3889919|B5|||Age||years|Mean|37.5|37.5|Standard Deviation|2.4|2.4|||
4067996|NCT01055704|3889920|B4|||Age||years|Mean|36.1|36.1|Standard Deviation|3.6|3.6|||
4067997|NCT01055704|3889921|B3|||Age||years|Mean|31.6|31.6|Standard Deviation|2.7|2.7|||
4067998|NCT01055704|3889922|B2|||Age||years|Mean|39.4|39.4|Standard Deviation|3.8|3.8|||
4067999|NCT01055704|3889923|B1|||Age||years|Mean|33.9|33.9|Standard Deviation|2.6|2.6|||
4068000|NCT01055704|3889919|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4068001|NCT01055704|3889920|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4068002|NCT01055704|3889921|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4068003|NCT01055704|3889922|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4068004|NCT01055704|3889923|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4068005|NCT01055704|3889919|B5||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4068006|NCT01055704|3889920|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4068007|NCT01055704|3889921|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4068008|NCT01055704|3889922|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4068009|NCT01055704|3889923|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4068010|NCT01055704|3889919|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068011|NCT01055704|3889920|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068012|NCT01055704|3889921|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068013|NCT01055704|3889922|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068014|NCT01055704|3889923|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068015|NCT01055639|3889964|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068016|NCT01055639|3889965|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068017|NCT01055639|3889966|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068018|NCT01055639|3889964|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4068019|NCT01055639|3889965|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4068020|NCT01055639|3889966|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4068021|NCT01055639|3889964|B3||White|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
4068022|NCT01055639|3889965|B2||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4068023|NCT01055639|3889966|B1||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4068024|NCT01055639|3889964|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4068025|NCT01055639|3889965|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4068026|NCT01055639|3889966|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4068027|NCT01055639|3889964|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4068028|NCT01055639|3889965|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4068029|NCT01055639|3889966|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068030|NCT01055639|3889964|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4068031|NCT01055639|3889965|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4068032|NCT01055639|3889966|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4068033|NCT01055639|3889964|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4068034|NCT01055639|3889965|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068035|NCT01055639|3889966|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4068036|NCT01055639|3889964|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068037|NCT01055639|3889965|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068038|NCT01055639|3889966|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068039|NCT01055639|3889964|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
4068040|NCT01055639|3889965|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4068041|NCT01055639|3889966|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4068042|NCT01055639|3889964|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4068043|NCT01055639|3889965|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4068044|NCT01055639|3889966|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4068045|NCT01055639|3889964|B3||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4068046|NCT01055639|3889965|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4068047|NCT01055639|3889966|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4068048|NCT01055639|3889964|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4068049|NCT01055639|3889965|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4068050|NCT01055639|3889966|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4068051|NCT01055639|3889964|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4068052|NCT01055639|3889965|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4068053|NCT01055639|3889966|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4068054|NCT01055639|3889964|B3||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
4068055|NCT01055639|3889965|B2||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4068056|NCT01055639|3889966|B1||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4068057|NCT01055639|3889964|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068058|NCT01055639|3889965|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068059|NCT01055639|3889966|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068060|NCT01055613|3889989|B3|United States||Region of Enrollment||participants|Number|300|300.0||||||
4068061|NCT01055613|3889990|B2|United States||Region of Enrollment||participants|Number|100|100.0||||||
4068062|NCT01055613|3889991|B1|United States||Region of Enrollment||participants|Number|200|200.0||||||
4068063|NCT01055613|3889989|B3|American Indian or Native Alaskian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4068064|NCT01055613|3889990|B2|American Indian or Native Alaskian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4068065|NCT01055613|3889991|B1|American Indian or Native Alaskian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4068066|NCT01055613|3889989|B3|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4068067|NCT01055613|3889990|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4068068|NCT01055613|3889991|B1|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4068069|NCT01055613|3889989|B3|White||Race/Ethnicity, Customized||participants|Number|273|273.0||||||
4068070|NCT01055613|3889990|B2|White||Race/Ethnicity, Customized||participants|Number|88|88.0||||||
4068071|NCT01055613|3889991|B1|White||Race/Ethnicity, Customized||participants|Number|185|185.0||||||
4068072|NCT01055613|3889989|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4068073|NCT01055613|3889990|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4068074|NCT01055613|3889991|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4068075|NCT01055613|3889989|B3|Native Hawaiian or other Island Pacificer||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4068076|NCT01055613|3889990|B2|Native Hawaiian or other Island Pacificer||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4068077|NCT01055613|3889991|B1|Native Hawaiian or other Island Pacificer||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4068078|NCT01055613|3889989|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4068079|NCT01055613|3889990|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4068080|NCT01055613|3889991|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4068081|NCT01055613|3889989|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4068082|NCT01055613|3889990|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4068083|NCT01055613|3889991|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4068084|NCT01055613|3889989|B3||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4068085|NCT01055613|3889990|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4068086|NCT01055613|3889991|B1||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4068087|NCT01055613|3889989|B3|||Age||years|Mean|31.73|31.73|Standard Deviation|8.928|8.928|||
4068088|NCT01055613|3889990|B2|||Age||years|Mean|31.05|31.05|Standard Deviation|8.624|8.624|||
4068089|NCT01055613|3889991|B1|||Age||years|Mean|32.40|32.4|Standard Deviation|9.231|9.231|||
4068090|NCT01055457|3890000|B11|United States||Region of Enrollment||participants|Number|295|295.0||||||
4068091|NCT01055457|3890001|B10|United States||Region of Enrollment||participants|Number|20|20.0||||||
4068092|NCT01055457|3890002|B9|United States||Region of Enrollment||participants|Number|20|20.0||||||
4068093|NCT01055457|3890003|B8|United States||Region of Enrollment||participants|Number|19|19.0||||||
4068094|NCT01055457|3890004|B7|United States||Region of Enrollment||participants|Number|19|19.0||||||
4068095|NCT01055457|3890005|B6|United States||Region of Enrollment||participants|Number|18|18.0||||||
4068096|NCT01055457|3890006|B5|United States||Region of Enrollment||participants|Number|41|41.0||||||
4068097|NCT01055457|3890007|B4|United States||Region of Enrollment||participants|Number|40|40.0||||||
4068098|NCT01055457|3890008|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
4068099|NCT01055457|3890009|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4068100|NCT01055457|3890010|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4068101|NCT01055457|3890000|B11||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4068102|NCT01055457|3890001|B10||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4068103|NCT01055457|3890002|B9||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4068104|NCT01055457|3890003|B8||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4068105|NCT01055457|3890004|B7||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4068106|NCT01055457|3890005|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4068107|NCT01055457|3890006|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4068108|NCT01055457|3890007|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4068109|NCT01055457|3890008|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4068110|NCT01055457|3890009|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4068111|NCT01055457|3890010|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4068112|NCT01055457|3890000|B11||Female|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4068113|NCT01055457|3890001|B10||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4068114|NCT01055457|3890002|B9||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4068115|NCT01055457|3890003|B8||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4068116|NCT01055457|3890004|B7||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4068117|NCT01055457|3890005|B6||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4068118|NCT01055457|3890006|B5||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4068119|NCT01055457|3890007|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4068120|NCT01055457|3890008|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4068121|NCT01055457|3890009|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4068122|NCT01055457|3890010|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4068123|NCT01055457|3890000|B11|Solution 1(etafilcon A)||Age||years|Mean|30.89|30.89|Standard Deviation|9.012|9.012|||
4068124|NCT01055457|3890001|B10|Solution 1(etafilcon A)||Age||years|Mean|32.15|32.15|Standard Deviation|8.079|8.079|||
4068125|NCT01055457|3890002|B9|Solution 1(etafilcon A)||Age||years|Mean|30.10|30.1|Standard Deviation|9.554|9.554|||
4068126|NCT01055457|3890003|B8|Solution 1(etafilcon A)||Age||years|Mean|34.26|34.26|Standard Deviation|8.738|8.738|||
4068127|NCT01055457|3890004|B7|Solution 1(etafilcon A)||Age||years|Mean|29.95|29.95|Standard Deviation|6.417|6.417|||
4068128|NCT01055457|3890005|B6|Solution 1(etafilcon A)||Age||years|Mean|32.48|32.48|Standard Deviation|7.845|7.845|||
4068129|NCT01055457|3890006|B5|Solution 1(etafilcon A)||Age||years|Mean|29.10|29.1|Standard Deviation|7.993|7.993|||
4068130|NCT01055457|3890007|B4|Solution 1(etafilcon A)||Age||years|Mean|29.45|29.45|Standard Deviation|9.333|9.333|||
4068131|NCT01055457|3890008|B3|Solution 1(etafilcon A)||Age||years|Mean|32.16|32.16|Standard Deviation|8.526|8.526|||
4068132|NCT01055457|3890009|B2|Solution 1(etafilcon A)||Age||years|Mean|31.58|31.58|Standard Deviation|9.459|9.459|||
4068133|NCT01055457|3890010|B1|Solution 1(etafilcon A)||Age||years|Mean|30.17|30.17|Standard Deviation|8.692|8.692|||
4068134|NCT01055314|3890051|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4068135|NCT01055314|3890052|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4068136|NCT01055314|3890053|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4068137|NCT01055314|3890051|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068138|NCT01055314|3890052|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068139|NCT01055314|3890053|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068140|NCT01055314|3890051|B3||White|Race (NIH/OMB)||Participants|Count of Participants|127|127.0||||||
4068141|NCT01055314|3890052|B2||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4068142|NCT01055314|3890053|B1||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4068143|NCT01055314|3890051|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4068144|NCT01055314|3890052|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4068145|NCT01055314|3890053|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4068146|NCT01055314|3890051|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4068147|NCT01055314|3890052|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4068148|NCT01055314|3890053|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4068149|NCT01055314|3890051|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4068150|NCT01055314|3890052|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068151|NCT01055314|3890053|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4068152|NCT01055314|3890051|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068153|NCT01055314|3890052|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068154|NCT01055314|3890053|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068155|NCT01055314|3890051|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4068156|NCT01055314|3890052|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4068157|NCT01055314|3890053|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4068158|NCT01055314|3890051|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
4068159|NCT01055314|3890052|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4068160|NCT01055314|3890053|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
4068161|NCT01055314|3890051|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4068162|NCT01055314|3890052|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4068163|NCT01055314|3890053|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4068164|NCT01055314|3890051|B3||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4068165|NCT01055314|3890052|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4068166|NCT01055314|3890053|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4068167|NCT01055314|3890051|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4068168|NCT01055314|3890052|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4068169|NCT01055314|3890053|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4068170|NCT01055314|3890051|B3|||Age||Months|Mean|157.69|157.69|Standard Deviation|72.62|72.62|||
4068171|NCT01055314|3890052|B2|||Age||Months|Mean|152.04|152.04|Standard Deviation|79.20|79.2|||
4068172|NCT01055314|3890053|B1|||Age||Months|Mean|161.93|161.93|Standard Deviation|67.36|67.36|||
4068173|NCT01055262|3890066|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4068174|NCT01055262|3890066|B1||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4068175|NCT01055262|3890066|B1|||Age||years|Mean|55.9|55.9|Full Range|||35.0|87.0|
4068176|NCT01055223|3890077|B1||Male|Sex: Female, Male||Participants|Count of Participants|60745|60745.0||||||
4068177|NCT01055223|3890077|B1||Female|Sex: Female, Male||Participants|Count of Participants|37738|37738.0||||||
4068178|NCT01055223|3890077|B1|||Age||Years|Mean|52.2|52.2|Standard Deviation|8.33|8.33|||
4068179|NCT01055197|3890105|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4068180|NCT01055197|3890106|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4068181|NCT01055197|3890107|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4068182|NCT01055197|3890105|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4068183|NCT01055197|3890106|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4068184|NCT01055197|3890107|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4068185|NCT01055197|3890105|B3|||Age||years|Median|63|63.0|Full Range|||35.0|86.0|
4068186|NCT01055197|3890106|B2|||Age||years|Median|66|66.0|Full Range|||35.0|86.0|
4068187|NCT01055197|3890107|B1|||Age||years|Median|61|61.0|Full Range|||47.0|81.0|
4068188|NCT01055184|3890122|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4068189|NCT01055184|3890122|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4068190|NCT01055184|3890122|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4068191|NCT01055184|3890122|B1|>70 years||Age, Customized||participants|Number|14|14.0||||||
4068192|NCT01055184|3890122|B1|60-70 years||Age, Customized||participants|Number|20|20.0||||||
4068193|NCT01055171|3890126|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4068194|NCT01055171|3890127|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4068195|NCT01055171|3890128|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4068196|NCT01055171|3890126|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4068197|NCT01055171|3890127|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4068198|NCT01055171|3890128|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4068199|NCT01055171|3890126|B3|Less than 35 years||Age, Customized||Participants|Number|13|13.0||||||
4068200|NCT01055171|3890127|B2|Less than 35 years||Age, Customized||Participants|Number|6|6.0||||||
4068201|NCT01055171|3890128|B1|Less than 35 years||Age, Customized||Participants|Number|7|7.0||||||
4068202|NCT01055171|3890126|B3|Greater than or equal to 35 years||Age, Customized||Participants|Number|31|31.0||||||
4068203|NCT01055171|3890127|B2|Greater than or equal to 35 years||Age, Customized||Participants|Number|17|17.0||||||
4068204|NCT01055171|3890128|B1|Greater than or equal to 35 years||Age, Customized||Participants|Number|14|14.0||||||
4068205|NCT01055132|3890143|B1|United States||Region of Enrollment||participants|Number|69|69.0||||||
4068206|NCT01055132|3890143|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4068207|NCT01055132|3890143|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4068208|NCT01055132|3890143|B1|||Age||years|Mean|29.1|29.1|Standard Deviation|5.27|5.27|||
4068209|NCT01055028|3890155|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068210|NCT01055028|3890156|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068211|NCT01055028|3890157|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068212|NCT01055028|3890155|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068213|NCT01055028|3890156|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068214|NCT01055028|3890157|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068215|NCT01055028|3890155|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4068216|NCT01055028|3890156|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4068217|NCT01055028|3890157|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4068218|NCT01055028|3890155|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4068219|NCT01055028|3890156|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068220|NCT01055028|3890157|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4068221|NCT01055028|3890155|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068222|NCT01055028|3890156|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068223|NCT01055028|3890157|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068224|NCT01055028|3890155|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4068225|NCT01055028|3890156|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4068226|NCT01055028|3890157|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068227|NCT01055028|3890155|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068228|NCT01055028|3890156|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068229|NCT01055028|3890157|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068230|NCT01055028|3890155|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068231|NCT01055028|3890156|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068232|NCT01055028|3890157|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068233|NCT01055028|3890155|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4068234|NCT01055028|3890156|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4068235|NCT01055028|3890157|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4068236|NCT01055028|3890155|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4068237|NCT01055028|3890156|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068238|NCT01055028|3890157|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4068239|NCT01055028|3890155|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4068240|NCT01055028|3890156|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4068241|NCT01055028|3890157|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4068242|NCT01055028|3890155|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4068243|NCT01055028|3890156|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4068244|NCT01055028|3890157|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4068245|NCT01055028|3890155|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4068246|NCT01055028|3890156|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4068247|NCT01055028|3890157|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4068248|NCT01055028|3890155|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4068249|NCT01055028|3890156|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4068250|NCT01055028|3890157|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4068251|NCT01055028|3890155|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068252|NCT01055028|3890156|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068253|NCT01055028|3890157|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068254|NCT01054976|3890172|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4068255|NCT01054976|3890172|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4068256|NCT01054976|3890172|B1|||Age||Years|Mean|73.24|73.24|Standard Deviation|7.969|7.969|||
4068257|NCT01054911|3890180|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4068258|NCT01054911|3890180|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4068259|NCT01054911|3890180|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4068260|NCT01054911|3890180|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4068261|NCT01054911|3890180|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4068262|NCT01054911|3890180|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068263|NCT01054885|3890187|B7|White||Race/Ethnicity, Customized||Participants|Number|1155|1155.0||||||
4068264|NCT01054885|3890188|B6|White||Race/Ethnicity, Customized||Participants|Number|192|192.0||||||
4068265|NCT01054885|3890189|B5|White||Race/Ethnicity, Customized||Participants|Number|190|190.0||||||
4068266|NCT01054885|3890190|B4|White||Race/Ethnicity, Customized||Participants|Number|196|196.0||||||
4068267|NCT01054885|3890191|B3|White||Race/Ethnicity, Customized||Participants|Number|183|183.0||||||
4068268|NCT01054885|3890192|B2|White||Race/Ethnicity, Customized||Participants|Number|197|197.0||||||
4068269|NCT01054885|3890193|B1|White||Race/Ethnicity, Customized||Participants|Number|197|197.0||||||
4068270|NCT01054885|3890187|B7|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||Participants|Number|50|50.0||||||
4068271|NCT01054885|3890188|B6|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4068272|NCT01054885|3890189|B5|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4068273|NCT01054885|3890190|B4|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4068274|NCT01054885|3890191|B3|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4068275|NCT01054885|3890192|B2|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4068276|NCT01054885|3890193|B1|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4068277|NCT01054885|3890187|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4068278|NCT01054885|3890188|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4068279|NCT01054885|3890189|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4068280|NCT01054885|3890190|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4068281|NCT01054885|3890191|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4068282|NCT01054885|3890192|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4068283|NCT01054885|3890193|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4068284|NCT01054885|3890187|B7|African American/African Heritage (HER)||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4068285|NCT01054885|3890188|B6|African American/African Heritage (HER)||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4068286|NCT01054885|3890189|B5|African American/African Heritage (HER)||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4068287|NCT01054885|3890190|B4|African American/African Heritage (HER)||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4068288|NCT01054885|3890191|B3|African American/African Heritage (HER)||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4068289|NCT01054885|3890192|B2|African American/African Heritage (HER)||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4068290|NCT01054885|3890193|B1|African American/African Heritage (HER)||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4068291|NCT01054885|3890187|B7||Male|Sex: Female, Male||Participants|Count of Participants|885|885.0||||||
4068292|NCT01054885|3890188|B6||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4068293|NCT01054885|3890189|B5||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4068294|NCT01054885|3890190|B4||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4068295|NCT01054885|3890191|B3||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4068296|NCT01054885|3890192|B2||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4068297|NCT01054885|3890193|B1||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4068298|NCT01054885|3890187|B7||Female|Sex: Female, Male||Participants|Count of Participants|339|339.0||||||
4068299|NCT01054885|3890188|B6||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4068300|NCT01054885|3890189|B5||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4068301|NCT01054885|3890190|B4||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4068302|NCT01054885|3890191|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4068303|NCT01054885|3890192|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4068304|NCT01054885|3890193|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4068305|NCT01054885|3890187|B7|||Age||Years|Mean|61.6|61.6|Standard Deviation|8.58|8.58|||
4068306|NCT01054885|3890188|B6|||Age||Years|Mean|61.1|61.1|Standard Deviation|8.67|8.67|||
4068307|NCT01054885|3890189|B5|||Age||Years|Mean|61.9|61.9|Standard Deviation|8.79|8.79|||
4068308|NCT01054885|3890190|B4|||Age||Years|Mean|61.2|61.2|Standard Deviation|8.62|8.62|||
4068309|NCT01054885|3890191|B3|||Age||Years|Mean|61.8|61.8|Standard Deviation|9.02|9.02|||
4068310|NCT01054885|3890192|B2|||Age||Years|Mean|61.8|61.8|Standard Deviation|8.28|8.28|||
4068311|NCT01054885|3890193|B1|||Age||Years|Mean|61.9|61.9|Standard Deviation|8.14|8.14|||
4068312|NCT01054846|3890237|B3||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4068313|NCT01054846|3890238|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4068314|NCT01054846|3890239|B1||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4068315|NCT01054846|3890237|B3||Female|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4068316|NCT01054846|3890238|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4068317|NCT01054846|3890239|B1||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4068318|NCT01054846|3890237|B3||5 years|Age, Customized||Participants|Count of Participants|133|133.0||||||
4068319|NCT01054846|3890238|B2||5 years|Age, Customized||Participants|Count of Participants|23|23.0||||||
4068320|NCT01054846|3890239|B1||5 years|Age, Customized||Participants|Count of Participants|110|110.0||||||
4068321|NCT01054846|3890237|B3||4 years|Age, Customized||Participants|Count of Participants|158|158.0||||||
4068322|NCT01054846|3890238|B2||4 years|Age, Customized||Participants|Count of Participants|33|33.0||||||
4068323|NCT01054846|3890239|B1||4 years|Age, Customized||Participants|Count of Participants|125|125.0||||||
4068324|NCT01054846|3890237|B3||3 years|Age, Customized||Participants|Count of Participants|99|99.0||||||
4068325|NCT01054846|3890238|B2||3 years|Age, Customized||Participants|Count of Participants|12|12.0||||||
4068326|NCT01054846|3890239|B1||3 years|Age, Customized||Participants|Count of Participants|87|87.0||||||
4068327|NCT01054820|3890247|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4068328|NCT01054820|3890247|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4068329|NCT01054820|3890247|B1|||Age||years|Mean|38.8|38.8|Standard Deviation|12.4|12.4|||
4068330|NCT01054742|3890261|B1|Russian Federation||Region of Enrollment||participants|Number|2|2.0||||||
4068331|NCT01054742|3890261|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4068332|NCT01054742|3890261|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4068333|NCT01054742|3890261|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4068334|NCT01054742|3890261|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4068335|NCT01054742|3890261|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068336|NCT01054729|3890265|B5|CT/TT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|46|46.0||||||
4068337|NCT01054729|3890266|B4|CT/TT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|10|10.0||||||
4068338|NCT01054729|3890267|B3|CT/TT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|11|11.0||||||
4068339|NCT01054729|3890268|B2|CT/TT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|13|13.0||||||
4068340|NCT01054729|3890269|B1|CT/TT||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|12|12.0||||||
4068341|NCT01054729|3890265|B5|CC||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|17|17.0||||||
4068342|NCT01054729|3890266|B4|CC||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|4|4.0||||||
4068343|NCT01054729|3890267|B3|CC||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|4|4.0||||||
4068344|NCT01054729|3890268|B2|CC||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|5|5.0||||||
4068345|NCT01054729|3890269|B1|CC||IL28b Genotype|CC, CT, and TT alleles are different forms of the IL28b gene.|participants|Number|4|4.0||||||
4068346|NCT01054729|3890265|B5|||Alanine Aminotransferase (ALT)||IU/L|Mean|76.2|76.2|Standard Deviation|50.08|50.08|||
4068347|NCT01054729|3890266|B4|||Alanine Aminotransferase (ALT)||IU/L|Mean|70.0|70.0|Standard Deviation|40.73|40.73|||
4068348|NCT01054729|3890267|B3|||Alanine Aminotransferase (ALT)||IU/L|Mean|95.4|95.4|Standard Deviation|75.86|75.86|||
4068349|NCT01054729|3890268|B2|||Alanine Aminotransferase (ALT)||IU/L|Mean|72.6|72.6|Standard Deviation|46.45|46.45|||
4068350|NCT01054729|3890269|B1|||Alanine Aminotransferase (ALT)||IU/L|Mean|69.0|69.0|Standard Deviation|29.69|29.69|||
4068351|NCT01054729|3890265|B5|Cirrhosis||Liver Biopsy Fibrosis Score||participants|Number|0|0.0||||||
4068352|NCT01054729|3890266|B4|Cirrhosis||Liver Biopsy Fibrosis Score||participants|Number|0|0.0||||||
4068353|NCT01054729|3890267|B3|Cirrhosis||Liver Biopsy Fibrosis Score||participants|Number|0|0.0||||||
4068354|NCT01054729|3890268|B2|Cirrhosis||Liver Biopsy Fibrosis Score||participants|Number|0|0.0||||||
4068355|NCT01054729|3890269|B1|Cirrhosis||Liver Biopsy Fibrosis Score||participants|Number|0|0.0||||||
4068356|NCT01054729|3890265|B5|Bridging Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|4|4.0||||||
4068357|NCT01054729|3890266|B4|Bridging Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|1|1.0||||||
4068358|NCT01054729|3890267|B3|Bridging Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|1|1.0||||||
4068359|NCT01054729|3890268|B2|Bridging Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|2|2.0||||||
4068360|NCT01054729|3890269|B1|Bridging Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|0|0.0||||||
4068361|NCT01054729|3890265|B5|Portal Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|39|39.0||||||
4068362|NCT01054729|3890266|B4|Portal Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|9|9.0||||||
4068363|NCT01054729|3890267|B3|Portal Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|9|9.0||||||
4068364|NCT01054729|3890268|B2|Portal Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|10|10.0||||||
4068365|NCT01054729|3890269|B1|Portal Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|11|11.0||||||
4068366|NCT01054729|3890265|B5|None or Minimal Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|20|20.0||||||
4068367|NCT01054729|3890266|B4|None or Minimal Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|4|4.0||||||
4068368|NCT01054729|3890267|B3|None or Minimal Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|5|5.0||||||
4068369|NCT01054729|3890268|B2|None or Minimal Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|6|6.0||||||
4068370|NCT01054729|3890269|B1|None or Minimal Fibrosis||Liver Biopsy Fibrosis Score||participants|Number|5|5.0||||||
4068371|NCT01054729|3890265|B5|> 800,000||HCV RNA Level (IU/mL)||participants|Number|52|52.0||||||
4068372|NCT01054729|3890266|B4|> 800,000||HCV RNA Level (IU/mL)||participants|Number|10|10.0||||||
4068373|NCT01054729|3890267|B3|> 800,000||HCV RNA Level (IU/mL)||participants|Number|12|12.0||||||
4068374|NCT01054729|3890268|B2|> 800,000||HCV RNA Level (IU/mL)||participants|Number|15|15.0||||||
4068375|NCT01054729|3890269|B1|> 800,000||HCV RNA Level (IU/mL)||participants|Number|15|15.0||||||
4068376|NCT01054729|3890265|B5|≤ 800,000||HCV RNA Level (IU/mL)||participants|Number|11|11.0||||||
4068377|NCT01054729|3890266|B4|≤ 800,000||HCV RNA Level (IU/mL)||participants|Number|4|4.0||||||
4068378|NCT01054729|3890267|B3|≤ 800,000||HCV RNA Level (IU/mL)||participants|Number|3|3.0||||||
4068379|NCT01054729|3890268|B2|≤ 800,000||HCV RNA Level (IU/mL)||participants|Number|3|3.0||||||
4068380|NCT01054729|3890269|B1|≤ 800,000||HCV RNA Level (IU/mL)||participants|Number|1|1.0||||||
4068381|NCT01054729|3890265|B5|||Hepatitis C (HCV) RNA||log10 IU/mL|Mean|6.47|6.47|Standard Deviation|0.655|0.655|||
4068382|NCT01054729|3890266|B4|||Hepatitis C (HCV) RNA||log10 IU/mL|Mean|6.48|6.48|Standard Deviation|0.666|0.666|||
4068383|NCT01054729|3890267|B3|||Hepatitis C (HCV) RNA||log10 IU/mL|Mean|6.49|6.49|Standard Deviation|0.602|0.602|||
4068384|NCT01054729|3890268|B2|||Hepatitis C (HCV) RNA||log10 IU/mL|Mean|6.28|6.28|Standard Deviation|0.813|0.813|||
4068385|NCT01054729|3890269|B1|||Hepatitis C (HCV) RNA||log10 IU/mL|Mean|6.64|6.64|Standard Deviation|0.476|0.476|||
4068386|NCT01054729|3890265|B5|White||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
4068387|NCT01054729|3890266|B4|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4068388|NCT01054729|3890267|B3|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4068389|NCT01054729|3890268|B2|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4068390|NCT01054729|3890269|B1|White||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4068391|NCT01054729|3890265|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4068392|NCT01054729|3890266|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4068393|NCT01054729|3890267|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4068394|NCT01054729|3890268|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4068395|NCT01054729|3890269|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4068396|NCT01054729|3890265|B5|American Indian or Alaska native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4068397|NCT01054729|3890266|B4|American Indian or Alaska native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4068398|NCT01054729|3890267|B3|American Indian or Alaska native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4068399|NCT01054729|3890268|B2|American Indian or Alaska native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4068400|NCT01054729|3890269|B1|American Indian or Alaska native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4068401|NCT01054729|3890265|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068402|NCT01054729|3890266|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068403|NCT01054729|3890267|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068404|NCT01054729|3890268|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068405|NCT01054729|3890269|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068406|NCT01054729|3890265|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4068407|NCT01054729|3890266|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4068408|NCT01054729|3890267|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4068409|NCT01054729|3890268|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4068410|NCT01054729|3890269|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4068411|NCT01054729|3890265|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4068412|NCT01054729|3890266|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4068413|NCT01054729|3890267|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4068414|NCT01054729|3890268|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4068415|NCT01054729|3890269|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4068416|NCT01054729|3890265|B5||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4068417|NCT01054729|3890266|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4068418|NCT01054729|3890267|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4068419|NCT01054729|3890268|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4068420|NCT01054729|3890269|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4068421|NCT01054729|3890265|B5||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4068422|NCT01054729|3890266|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4068423|NCT01054729|3890267|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4068424|NCT01054729|3890268|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4068425|NCT01054729|3890269|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4068426|NCT01054729|3890265|B5|||Age||years|Mean|45.0|45.0|Standard Deviation|9.38|9.38|||
4068427|NCT01054729|3890266|B4|||Age||years|Mean|46.6|46.6|Standard Deviation|11.44|11.44|||
4068428|NCT01054729|3890267|B3|||Age||years|Mean|44.9|44.9|Standard Deviation|8.43|8.43|||
4068429|NCT01054729|3890268|B2|||Age||years|Mean|44.4|44.4|Standard Deviation|8.34|8.34|||
4068430|NCT01054729|3890269|B1|||Age||years|Mean|44.4|44.4|Standard Deviation|10.10|10.1|||
4068431|NCT01054703|3890333|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4068432|NCT01054703|3890333|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4068433|NCT01054703|3890333|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4068434|NCT01054703|3890333|B1|||Age||years|Mean|50.1|50.1|Standard Deviation|9.6|9.6|||
4068435|NCT01054703|3890333|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4068436|NCT01054703|3890333|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4068437|NCT01054703|3890333|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068438|NCT01054625|3890337|B4|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4068439|NCT01054625|3890338|B3|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4068440|NCT01054625|3890339|B2|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4068441|NCT01054625|3890340|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4068442|NCT01054625|3890337|B4|Belgium||Region of Enrollment||participants|Number|19|19.0||||||
4068443|NCT01054625|3890338|B3|Belgium||Region of Enrollment||participants|Number|6|6.0||||||
4068444|NCT01054625|3890339|B2|Belgium||Region of Enrollment||participants|Number|7|7.0||||||
4068445|NCT01054625|3890340|B1|Belgium||Region of Enrollment||participants|Number|6|6.0||||||
4068446|NCT01054625|3890337|B4|Slovakia||Region of Enrollment||participants|Number|4|4.0||||||
4068447|NCT01054625|3890338|B3|Slovakia||Region of Enrollment||participants|Number|3|3.0||||||
4068448|NCT01054625|3890339|B2|Slovakia||Region of Enrollment||participants|Number|1|1.0||||||
4068449|NCT01054625|3890340|B1|Slovakia||Region of Enrollment||participants|Number|0|0.0||||||
4068450|NCT01054625|3890337|B4|Hungary||Region of Enrollment||participants|Number|2|2.0||||||
4068451|NCT01054625|3890338|B3|Hungary||Region of Enrollment||participants|Number|0|0.0||||||
4068452|NCT01054625|3890339|B2|Hungary||Region of Enrollment||participants|Number|1|1.0||||||
4068453|NCT01054625|3890340|B1|Hungary||Region of Enrollment||participants|Number|1|1.0||||||
4068454|NCT01054625|3890337|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4068455|NCT01054625|3890338|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4068456|NCT01054625|3890339|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4068457|NCT01054625|3890340|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4068458|NCT01054625|3890337|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4068459|NCT01054625|3890338|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4068460|NCT01054625|3890339|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4068461|NCT01054625|3890340|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4068462|NCT01054625|3890337|B4|||Age||years|Mean|60|60.0|Standard Deviation|9|9.0|||
4068463|NCT01054625|3890338|B3|||Age||years|Mean|59|59.0|Standard Deviation|5|5.0|||
4068464|NCT01054625|3890339|B2|||Age||years|Mean|63|63.0|Standard Deviation|11|11.0|||
4068465|NCT01054625|3890340|B1|||Age||years|Mean|57|57.0|Standard Deviation|8|8.0|||
4068466|NCT01054625|3890337|B4||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4068467|NCT01054625|3890338|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4068468|NCT01054625|3890339|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4068469|NCT01054625|3890340|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4068470|NCT01054625|3890337|B4||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4068471|NCT01054625|3890338|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4068472|NCT01054625|3890339|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4068473|NCT01054625|3890340|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4068474|NCT01054625|3890337|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068475|NCT01054625|3890338|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068476|NCT01054625|3890339|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068477|NCT01054625|3890340|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068478|NCT01054599|3890368|B3|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4068479|NCT01054599|3890369|B2|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4068480|NCT01054599|3890370|B1|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4068481|NCT01054599|3890368|B3|Race/Ethnicity|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4068482|NCT01054599|3890369|B2|Race/Ethnicity|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4068483|NCT01054599|3890370|B1|Race/Ethnicity|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4068484|NCT01054599|3890368|B3|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4068485|NCT01054599|3890369|B2|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4068486|NCT01054599|3890370|B1|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4068487|NCT01054599|3890368|B3|Race/Ethnicity|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4068488|NCT01054599|3890369|B2|Race/Ethnicity|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4068489|NCT01054599|3890370|B1|Race/Ethnicity|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4068490|NCT01054599|3890368|B3|Race/Ethnicity|Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4068491|NCT01054599|3890369|B2|Race/Ethnicity|Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4068492|NCT01054599|3890370|B1|Race/Ethnicity|Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4068493|NCT01054599|3890368|B3|Race/Ethnicity|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4068494|NCT01054599|3890369|B2|Race/Ethnicity|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4068495|NCT01054599|3890370|B1|Race/Ethnicity|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4068496|NCT01054599|3890368|B3|Race/Ethnicity|White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
4068497|NCT01054599|3890369|B2|Race/Ethnicity|White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
4068498|NCT01054599|3890370|B1|Race/Ethnicity|White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4068499|NCT01054599|3890368|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4068500|NCT01054599|3890369|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4068501|NCT01054599|3890370|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4068502|NCT01054599|3890368|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4068503|NCT01054599|3890369|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4068504|NCT01054599|3890370|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4068505|NCT01054599|3890368|B3|||Age||years|Mean|44.6|44.6|Standard Deviation|12.6|12.6|||
4068506|NCT01054599|3890369|B2|||Age||years|Mean|45.3|45.3|Standard Deviation|12.6|12.6|||
4068507|NCT01054599|3890370|B1|||Age||years|Mean|43.7|43.7|Standard Deviation|13.1|13.1|||
4068508|NCT01054586|3890379|B5|Baseline ALT Unknown||Number of participants with the indicated alanine aminotransferase (ALT) levels at baseline|Participant characteristics at baseline according to treatment group. The number of participants with the indicated ALT levels was recorded. IU/L = International Units per Liter.|participants|Number|20|20.0||||||
4068509|NCT01054586|3890380|B4|Baseline ALT Unknown||Number of participants with the indicated alanine aminotransferase (ALT) levels at baseline|Participant characteristics at baseline according to treatment group. The number of participants with the indicated ALT levels was recorded. IU/L = International Units per Liter.|participants|Number|15|15.0||||||
4068510|NCT01054586|3890381|B3|Baseline ALT Unknown||Number of participants with the indicated alanine aminotransferase (ALT) levels at baseline|Participant characteristics at baseline according to treatment group. The number of participants with the indicated ALT levels was recorded. IU/L = International Units per Liter.|participants|Number|1|1.0||||||
4068511|NCT01054586|3890382|B2|Baseline ALT Unknown||Number of participants with the indicated alanine aminotransferase (ALT) levels at baseline|Participant characteristics at baseline according to treatment group. The number of participants with the indicated ALT levels was recorded. IU/L = International Units per Liter.|participants|Number|2|2.0||||||
4068512|NCT01054586|3890383|B1|Baseline ALT Unknown||Number of participants with the indicated alanine aminotransferase (ALT) levels at baseline|Participant characteristics at baseline according to treatment group. The number of participants with the indicated ALT levels was recorded. IU/L = International Units per Liter.|participants|Number|2|2.0||||||
4068513|NCT01054586|3890379|B5|Baseline ALT > 200 IU/L||Number of participants with the indicated alanine aminotransferase (ALT) levels at baseline|Participant characteristics at baseline according to treatment group. The number of participants with the indicated ALT levels was recorded. IU/L = International Units per Liter.|participants|Number|7|7.0||||||
4068514|NCT01054586|3890380|B4|Baseline ALT > 200 IU/L||Number of participants with the indicated alanine aminotransferase (ALT) levels at baseline|Participant characteristics at baseline according to treatment group. The number of participants with the indicated ALT levels was recorded. IU/L = International Units per Liter.|participants|Number|3|3.0||||||
4068515|NCT01054586|3890381|B3|Baseline ALT > 200 IU/L||Number of participants with the indicated alanine aminotransferase (ALT) levels at baseline|Participant characteristics at baseline according to treatment group. The number of participants with the indicated ALT levels was recorded. IU/L = International Units per Liter.|participants|Number|1|1.0||||||
4068516|NCT01054586|3890382|B2|Baseline ALT > 200 IU/L||Number of participants with the indicated alanine aminotransferase (ALT) levels at baseline|Participant characteristics at baseline according to treatment group. The number of participants with the indicated ALT levels was recorded. IU/L = International Units per Liter.|participants|Number|2|2.0||||||
4068517|NCT01054586|3890383|B1|Baseline ALT > 200 IU/L||Number of participants with the indicated alanine aminotransferase (ALT) levels at baseline|Participant characteristics at baseline according to treatment group. The number of participants with the indicated ALT levels was recorded. IU/L = International Units per Liter.|participants|Number|1|1.0||||||
4068518|NCT01054586|3890379|B5|Baseline ALT <= 200 IU/L||Number of participants with the indicated alanine aminotransferase (ALT) levels at baseline|Participant characteristics at baseline according to treatment group. The number of participants with the indicated ALT levels was recorded. IU/L = International Units per Liter.|participants|Number|140|140.0||||||
4068519|NCT01054586|3890380|B4|Baseline ALT <= 200 IU/L||Number of participants with the indicated alanine aminotransferase (ALT) levels at baseline|Participant characteristics at baseline according to treatment group. The number of participants with the indicated ALT levels was recorded. IU/L = International Units per Liter.|participants|Number|83|83.0||||||
4068520|NCT01054586|3890381|B3|Baseline ALT <= 200 IU/L||Number of participants with the indicated alanine aminotransferase (ALT) levels at baseline|Participant characteristics at baseline according to treatment group. The number of participants with the indicated ALT levels was recorded. IU/L = International Units per Liter.|participants|Number|6|6.0||||||
4068521|NCT01054586|3890382|B2|Baseline ALT <= 200 IU/L||Number of participants with the indicated alanine aminotransferase (ALT) levels at baseline|Participant characteristics at baseline according to treatment group. The number of participants with the indicated ALT levels was recorded. IU/L = International Units per Liter.|participants|Number|11|11.0||||||
4068522|NCT01054586|3890383|B1|Baseline ALT <= 200 IU/L||Number of participants with the indicated alanine aminotransferase (ALT) levels at baseline|Participant characteristics at baseline according to treatment group. The number of participants with the indicated ALT levels was recorded. IU/L = International Units per Liter.|participants|Number|40|40.0||||||
4068523|NCT01054586|3890379|B5|||Number of participants with acquired immunodeficiency syndrome (AIDS) at baseline|Participant characteristics at baseline according to treatment group. The number of participants with AIDS was recorded.|participants|Number|36|36.0||||||
4068570|NCT01054586|3890381|B3|||Age||years|Median|44|44.0|Full Range|||36.0|53.0|
4068524|NCT01054586|3890380|B4|||Number of participants with acquired immunodeficiency syndrome (AIDS) at baseline|Participant characteristics at baseline according to treatment group. The number of participants with AIDS was recorded.|participants|Number|24|24.0||||||
4068525|NCT01054586|3890381|B3|||Number of participants with acquired immunodeficiency syndrome (AIDS) at baseline|Participant characteristics at baseline according to treatment group. The number of participants with AIDS was recorded.|participants|Number|3|3.0||||||
4068526|NCT01054586|3890382|B2|||Number of participants with acquired immunodeficiency syndrome (AIDS) at baseline|Participant characteristics at baseline according to treatment group. The number of participants with AIDS was recorded.|participants|Number|0|0.0||||||
4068527|NCT01054586|3890383|B1|||Number of participants with acquired immunodeficiency syndrome (AIDS) at baseline|Participant characteristics at baseline according to treatment group. The number of participants with AIDS was recorded.|participants|Number|9|9.0||||||
4068528|NCT01054586|3890379|B5|||Number of participants who were ART naïve at baseline|Participant characteristics at baseline according to treatment group. The number of participants who had not received antiretroviral therapy (ART) was recorded.|participants|Number|69|69.0||||||
4068529|NCT01054586|3890380|B4|||Number of participants who were ART naïve at baseline|Participant characteristics at baseline according to treatment group. The number of participants who had not received antiretroviral therapy (ART) was recorded.|participants|Number|50|50.0||||||
4068530|NCT01054586|3890381|B3|||Number of participants who were ART naïve at baseline|Participant characteristics at baseline according to treatment group. The number of participants who had not received antiretroviral therapy (ART) was recorded.|participants|Number|2|2.0||||||
4068531|NCT01054586|3890382|B2|||Number of participants who were ART naïve at baseline|Participant characteristics at baseline according to treatment group. The number of participants who had not received antiretroviral therapy (ART) was recorded.|participants|Number|5|5.0||||||
4068532|NCT01054586|3890383|B1|||Number of participants who were ART naïve at baseline|Participant characteristics at baseline according to treatment group. The number of participants who had not received antiretroviral therapy (ART) was recorded.|participants|Number|12|12.0||||||
4068533|NCT01054586|3890379|B5|HBs-Ag positive test||Number of participants positive for Hepatitis B and/or C at baseline|Participant characteristics at baseline according to treatment group. Participants were tested for Hepatitis C antibody (HCV-Ab) and Hepatitis B surface antigen (HBs-Ag).|participants|Number|34|34.0||||||
4068534|NCT01054586|3890380|B4|HBs-Ag positive test||Number of participants positive for Hepatitis B and/or C at baseline|Participant characteristics at baseline according to treatment group. Participants were tested for Hepatitis C antibody (HCV-Ab) and Hepatitis B surface antigen (HBs-Ag).|participants|Number|21|21.0||||||
4068535|NCT01054586|3890381|B3|HBs-Ag positive test||Number of participants positive for Hepatitis B and/or C at baseline|Participant characteristics at baseline according to treatment group. Participants were tested for Hepatitis C antibody (HCV-Ab) and Hepatitis B surface antigen (HBs-Ag).|participants|Number|2|2.0||||||
4068536|NCT01054586|3890382|B2|HBs-Ag positive test||Number of participants positive for Hepatitis B and/or C at baseline|Participant characteristics at baseline according to treatment group. Participants were tested for Hepatitis C antibody (HCV-Ab) and Hepatitis B surface antigen (HBs-Ag).|participants|Number|2|2.0||||||
4068537|NCT01054586|3890383|B1|HBs-Ag positive test||Number of participants positive for Hepatitis B and/or C at baseline|Participant characteristics at baseline according to treatment group. Participants were tested for Hepatitis C antibody (HCV-Ab) and Hepatitis B surface antigen (HBs-Ag).|participants|Number|9|9.0||||||
4068538|NCT01054586|3890379|B5|HCV-Ab positive test||Number of participants positive for Hepatitis B and/or C at baseline|Participant characteristics at baseline according to treatment group. Participants were tested for Hepatitis C antibody (HCV-Ab) and Hepatitis B surface antigen (HBs-Ag).|participants|Number|140|140.0||||||
4068539|NCT01054586|3890380|B4|HCV-Ab positive test||Number of participants positive for Hepatitis B and/or C at baseline|Participant characteristics at baseline according to treatment group. Participants were tested for Hepatitis C antibody (HCV-Ab) and Hepatitis B surface antigen (HBs-Ag).|participants|Number|82|82.0||||||
4068540|NCT01054586|3890381|B3|HCV-Ab positive test||Number of participants positive for Hepatitis B and/or C at baseline|Participant characteristics at baseline according to treatment group. Participants were tested for Hepatitis C antibody (HCV-Ab) and Hepatitis B surface antigen (HBs-Ag).|participants|Number|7|7.0||||||
4068541|NCT01054586|3890382|B2|HCV-Ab positive test||Number of participants positive for Hepatitis B and/or C at baseline|Participant characteristics at baseline according to treatment group. Participants were tested for Hepatitis C antibody (HCV-Ab) and Hepatitis B surface antigen (HBs-Ag).|participants|Number|14|14.0||||||
4068542|NCT01054586|3890383|B1|HCV-Ab positive test||Number of participants positive for Hepatitis B and/or C at baseline|Participant characteristics at baseline according to treatment group. Participants were tested for Hepatitis C antibody (HCV-Ab) and Hepatitis B surface antigen (HBs-Ag).|participants|Number|37|37.0||||||
4068543|NCT01054586|3890379|B5|Cohort - ICONA||Cohort Distribution|Source population from three human immunodeficiency virus (HIV)-infected patient cohorts: ICONA (Italian Cohort of Antiretroviral Naïve Patients), treatment naïve participants at initial presentation in Italy; HEPAVIH, HIV-hepatitis coinfected in France; MASTER (Management Standardizzato di Terapia Antiretrovirale), HIV-infected participants who are either treatment experienced or naïve patients in Italy|participants|Number|29|29.0||||||
4068544|NCT01054586|3890380|B4|Cohort - ICONA||Cohort Distribution|Source population from three human immunodeficiency virus (HIV)-infected patient cohorts: ICONA (Italian Cohort of Antiretroviral Naïve Patients), treatment naïve participants at initial presentation in Italy; HEPAVIH, HIV-hepatitis coinfected in France; MASTER (Management Standardizzato di Terapia Antiretrovirale), HIV-infected participants who are either treatment experienced or naïve patients in Italy|participants|Number|23|23.0||||||
4068545|NCT01054586|3890381|B3|Cohort - ICONA||Cohort Distribution|Source population from three human immunodeficiency virus (HIV)-infected patient cohorts: ICONA (Italian Cohort of Antiretroviral Naïve Patients), treatment naïve participants at initial presentation in Italy; HEPAVIH, HIV-hepatitis coinfected in France; MASTER (Management Standardizzato di Terapia Antiretrovirale), HIV-infected participants who are either treatment experienced or naïve patients in Italy|participants|Number|2|2.0||||||
4068571|NCT01054586|3890382|B2|||Age||years|Median|45|45.0|Full Range|||29.0|51.0|
4068546|NCT01054586|3890382|B2|Cohort - ICONA||Cohort Distribution|Source population from three human immunodeficiency virus (HIV)-infected patient cohorts: ICONA (Italian Cohort of Antiretroviral Naïve Patients), treatment naïve participants at initial presentation in Italy; HEPAVIH, HIV-hepatitis coinfected in France; MASTER (Management Standardizzato di Terapia Antiretrovirale), HIV-infected participants who are either treatment experienced or naïve patients in Italy|participants|Number|0|0.0||||||
4068547|NCT01054586|3890383|B1|Cohort - ICONA||Cohort Distribution|Source population from three human immunodeficiency virus (HIV)-infected patient cohorts: ICONA (Italian Cohort of Antiretroviral Naïve Patients), treatment naïve participants at initial presentation in Italy; HEPAVIH, HIV-hepatitis coinfected in France; MASTER (Management Standardizzato di Terapia Antiretrovirale), HIV-infected participants who are either treatment experienced or naïve patients in Italy|participants|Number|4|4.0||||||
4068548|NCT01054586|3890379|B5|Cohort - HEPAVIH||Cohort Distribution|Source population from three human immunodeficiency virus (HIV)-infected patient cohorts: ICONA (Italian Cohort of Antiretroviral Naïve Patients), treatment naïve participants at initial presentation in Italy; HEPAVIH, HIV-hepatitis coinfected in France; MASTER (Management Standardizzato di Terapia Antiretrovirale), HIV-infected participants who are either treatment experienced or naïve patients in Italy|participants|Number|13|13.0||||||
4068549|NCT01054586|3890380|B4|Cohort - HEPAVIH||Cohort Distribution|Source population from three human immunodeficiency virus (HIV)-infected patient cohorts: ICONA (Italian Cohort of Antiretroviral Naïve Patients), treatment naïve participants at initial presentation in Italy; HEPAVIH, HIV-hepatitis coinfected in France; MASTER (Management Standardizzato di Terapia Antiretrovirale), HIV-infected participants who are either treatment experienced or naïve patients in Italy|participants|Number|6|6.0||||||
4068550|NCT01054586|3890381|B3|Cohort - HEPAVIH||Cohort Distribution|Source population from three human immunodeficiency virus (HIV)-infected patient cohorts: ICONA (Italian Cohort of Antiretroviral Naïve Patients), treatment naïve participants at initial presentation in Italy; HEPAVIH, HIV-hepatitis coinfected in France; MASTER (Management Standardizzato di Terapia Antiretrovirale), HIV-infected participants who are either treatment experienced or naïve patients in Italy|participants|Number|2|2.0||||||
4068551|NCT01054586|3890382|B2|Cohort - HEPAVIH||Cohort Distribution|Source population from three human immunodeficiency virus (HIV)-infected patient cohorts: ICONA (Italian Cohort of Antiretroviral Naïve Patients), treatment naïve participants at initial presentation in Italy; HEPAVIH, HIV-hepatitis coinfected in France; MASTER (Management Standardizzato di Terapia Antiretrovirale), HIV-infected participants who are either treatment experienced or naïve patients in Italy|participants|Number|2|2.0||||||
4068552|NCT01054586|3890383|B1|Cohort - HEPAVIH||Cohort Distribution|Source population from three human immunodeficiency virus (HIV)-infected patient cohorts: ICONA (Italian Cohort of Antiretroviral Naïve Patients), treatment naïve participants at initial presentation in Italy; HEPAVIH, HIV-hepatitis coinfected in France; MASTER (Management Standardizzato di Terapia Antiretrovirale), HIV-infected participants who are either treatment experienced or naïve patients in Italy|participants|Number|3|3.0||||||
4068553|NCT01054586|3890379|B5|Cohort - MASTER||Cohort Distribution|Source population from three human immunodeficiency virus (HIV)-infected patient cohorts: ICONA (Italian Cohort of Antiretroviral Naïve Patients), treatment naïve participants at initial presentation in Italy; HEPAVIH, HIV-hepatitis coinfected in France; MASTER (Management Standardizzato di Terapia Antiretrovirale), HIV-infected participants who are either treatment experienced or naïve patients in Italy|participants|Number|125|125.0||||||
4068554|NCT01054586|3890380|B4|Cohort - MASTER||Cohort Distribution|Source population from three human immunodeficiency virus (HIV)-infected patient cohorts: ICONA (Italian Cohort of Antiretroviral Naïve Patients), treatment naïve participants at initial presentation in Italy; HEPAVIH, HIV-hepatitis coinfected in France; MASTER (Management Standardizzato di Terapia Antiretrovirale), HIV-infected participants who are either treatment experienced or naïve patients in Italy|participants|Number|72|72.0||||||
4068555|NCT01054586|3890381|B3|Cohort - MASTER||Cohort Distribution|Source population from three human immunodeficiency virus (HIV)-infected patient cohorts: ICONA (Italian Cohort of Antiretroviral Naïve Patients), treatment naïve participants at initial presentation in Italy; HEPAVIH, HIV-hepatitis coinfected in France; MASTER (Management Standardizzato di Terapia Antiretrovirale), HIV-infected participants who are either treatment experienced or naïve patients in Italy|participants|Number|4|4.0||||||
4068556|NCT01054586|3890382|B2|Cohort - MASTER||Cohort Distribution|Source population from three human immunodeficiency virus (HIV)-infected patient cohorts: ICONA (Italian Cohort of Antiretroviral Naïve Patients), treatment naïve participants at initial presentation in Italy; HEPAVIH, HIV-hepatitis coinfected in France; MASTER (Management Standardizzato di Terapia Antiretrovirale), HIV-infected participants who are either treatment experienced or naïve patients in Italy|participants|Number|13|13.0||||||
4068557|NCT01054586|3890383|B1|Cohort - MASTER||Cohort Distribution|Source population from three human immunodeficiency virus (HIV)-infected patient cohorts: ICONA (Italian Cohort of Antiretroviral Naïve Patients), treatment naïve participants at initial presentation in Italy; HEPAVIH, HIV-hepatitis coinfected in France; MASTER (Management Standardizzato di Terapia Antiretrovirale), HIV-infected participants who are either treatment experienced or naïve patients in Italy|participants|Number|36|36.0||||||
4068558|NCT01054586|3890379|B5||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4068559|NCT01054586|3890380|B4||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4068560|NCT01054586|3890381|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4068561|NCT01054586|3890382|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4068562|NCT01054586|3890383|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4068563|NCT01054586|3890379|B5||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4068564|NCT01054586|3890380|B4||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4068565|NCT01054586|3890381|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4068566|NCT01054586|3890382|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4068567|NCT01054586|3890383|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4068568|NCT01054586|3890379|B5|||Age||years|Median|44|44.0|Full Range|||25.0|74.0|
4068569|NCT01054586|3890380|B4|||Age||years|Median|44|44.0|Full Range|||25.0|74.0|
4068572|NCT01054586|3890383|B1|||Age||years|Median|45|45.0|Full Range|||36.0|62.0|
4068573|NCT01054573|3890474|B5|Other||Region of Enrollment||participants|Number|16|16.0||||||
4068574|NCT01054573|3890475|B4|Other||Region of Enrollment||participants|Number|9|9.0||||||
4068575|NCT01054573|3890476|B3|Other||Region of Enrollment||participants|Number|5|5.0||||||
4068576|NCT01054573|3890477|B2|Other||Region of Enrollment||participants|Number|2|2.0||||||
4068577|NCT01054573|3890478|B1|Other||Region of Enrollment||participants|Number|0|0.0||||||
4068578|NCT01054573|3890474|B5|North America||Region of Enrollment||participants|Number|23|23.0||||||
4068579|NCT01054573|3890475|B4|North America||Region of Enrollment||participants|Number|4|4.0||||||
4068580|NCT01054573|3890476|B3|North America||Region of Enrollment||participants|Number|7|7.0||||||
4068581|NCT01054573|3890477|B2|North America||Region of Enrollment||participants|Number|12|12.0||||||
4068582|NCT01054573|3890478|B1|North America||Region of Enrollment||participants|Number|0|0.0||||||
4068583|NCT01054573|3890474|B5|Europe||Region of Enrollment||participants|Number|51|51.0||||||
4068584|NCT01054573|3890475|B4|Europe||Region of Enrollment||participants|Number|14|14.0||||||
4068585|NCT01054573|3890476|B3|Europe||Region of Enrollment||participants|Number|10|10.0||||||
4068586|NCT01054573|3890477|B2|Europe||Region of Enrollment||participants|Number|18|18.0||||||
4068587|NCT01054573|3890478|B1|Europe||Region of Enrollment||participants|Number|9|9.0||||||
4068588|NCT01054573|3890474|B5||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4068589|NCT01054573|3890475|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4068590|NCT01054573|3890476|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4068591|NCT01054573|3890477|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4068592|NCT01054573|3890478|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4068593|NCT01054573|3890474|B5||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4068594|NCT01054573|3890475|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4068595|NCT01054573|3890476|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4068596|NCT01054573|3890477|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4068597|NCT01054573|3890478|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4068598|NCT01054573|3890474|B5|||Age||years|Median|53|53.0|Inter-Quartile Range|||45.0|60.0|
4068599|NCT01054573|3890475|B4|||Age||years|Median|55|55.0|Inter-Quartile Range|||46.0|66.0|
4068600|NCT01054573|3890476|B3|||Age||years|Median|50.5|50.5|Inter-Quartile Range|||47.0|58.0|
4068601|NCT01054573|3890477|B2|||Age||years|Median|51.5|51.5|Inter-Quartile Range|||42.0|59.5|
4068602|NCT01054573|3890478|B1|||Age||years|Median|52|52.0|Inter-Quartile Range|||49.0|61.0|
4068603|NCT01054573|3890474|B5||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4068604|NCT01054573|3890475|B4||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4068605|NCT01054573|3890476|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4068606|NCT01054573|3890477|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4068607|NCT01054573|3890478|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4068608|NCT01054573|3890474|B5||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4068609|NCT01054573|3890475|B4||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4068610|NCT01054573|3890476|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4068611|NCT01054573|3890477|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4068612|NCT01054573|3890478|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4068613|NCT01054573|3890474|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068614|NCT01054573|3890475|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068615|NCT01054573|3890476|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068616|NCT01054573|3890477|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068617|NCT01054573|3890478|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068618|NCT01054560|3890525|B3|Europe||Region of Enrollment||participants|Number|2|2.0||||||
4068619|NCT01054560|3890526|B2|Europe||Region of Enrollment||participants|Number|1|1.0||||||
4068620|NCT01054560|3890527|B1|Europe||Region of Enrollment||participants|Number|1|1.0||||||
4068621|NCT01054560|3890525|B3|United States||Region of Enrollment||participants|Number|111|111.0||||||
4068622|NCT01054560|3890526|B2|United States||Region of Enrollment||participants|Number|54|54.0||||||
4068623|NCT01054560|3890527|B1|United States||Region of Enrollment||participants|Number|57|57.0||||||
4068624|NCT01054560|3890525|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4068625|NCT01054560|3890526|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4068626|NCT01054560|3890527|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4068627|NCT01054560|3890525|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4068628|NCT01054560|3890526|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4068629|NCT01054560|3890527|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4068630|NCT01054560|3890525|B3|||Age||years|Mean|67.1|67.1|Standard Deviation|11.5|11.5|||
4068631|NCT01054560|3890526|B2|||Age||years|Mean|67.1|67.1|Standard Deviation|11.1|11.1|||
4068632|NCT01054560|3890527|B1|||Age||years|Mean|67.1|67.1|Standard Deviation|12.0|12.0|||
4068633|NCT01054560|3890525|B3||>=65 years|Age||Participants|Count of Participants|69|69.0||||||
4068634|NCT01054560|3890526|B2||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
4068635|NCT01054560|3890527|B1||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4068636|NCT01054560|3890525|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4068637|NCT01054560|3890526|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4068638|NCT01054560|3890527|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4068639|NCT01054560|3890525|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068640|NCT01054560|3890526|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068641|NCT01054560|3890527|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068642|NCT01054404|3890550|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4068643|NCT01054404|3890551|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4068644|NCT01054404|3890552|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4068645|NCT01054404|3890550|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4068646|NCT01054404|3890551|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4068647|NCT01054404|3890552|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4068648|NCT01054404|3890550|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4068649|NCT01054404|3890551|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4068650|NCT01054404|3890552|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4068651|NCT01054404|3890550|B3|||Age||years|Mean|51.6|51.6|Standard Deviation|15.7|15.7|||
4068652|NCT01054404|3890551|B2|||Age||years|Mean|52.1|52.1|Standard Deviation|15.6|15.6|||
4068653|NCT01054404|3890552|B1|||Age||years|Mean|51|51.0|Standard Deviation|16.6|16.6|||
4068654|NCT01054404|3890550|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4068655|NCT01054404|3890551|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4068656|NCT01054404|3890552|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4068657|NCT01054404|3890550|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4068658|NCT01054404|3890551|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4068659|NCT01054404|3890552|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4068660|NCT01054404|3890550|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068661|NCT01054404|3890551|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068662|NCT01054404|3890552|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068663|NCT01054339|3890559|B4|||Serum total alpha-1 antitrypsin concentration|Average of values at screening and baseline visits. Includes 1 phenotype SZ subject in low dose group.|microMolar|Mean|4.31|4.31|Standard Deviation|1.88|1.88|||
4068664|NCT01054339|3890560|B3|||Serum total alpha-1 antitrypsin concentration|Average of values at screening and baseline visits. Includes 1 phenotype SZ subject in low dose group.|microMolar|Mean|3.45|3.45|Standard Deviation|0.19|0.19|||
4068665|NCT01054339|3890561|B2|||Serum total alpha-1 antitrypsin concentration|Average of values at screening and baseline visits. Includes 1 phenotype SZ subject in low dose group.|microMolar|Mean|3.54|3.54|Standard Deviation|0.12|0.12|||
4068666|NCT01054339|3890562|B1|||Serum total alpha-1 antitrypsin concentration|Average of values at screening and baseline visits. Includes 1 phenotype SZ subject in low dose group.|microMolar|Mean|6.56|6.56|Standard Deviation|2.00|2.0|||
4068667|NCT01054339|3890559|B4|SZ||Alpha-1 antitrypsin phenotype|Alpha-1 antitrypsin phenotype determined by isoelectric focusing gel electrophoresis|participants|Number|1|1.0||||||
4068668|NCT01054339|3890560|B3|SZ||Alpha-1 antitrypsin phenotype|Alpha-1 antitrypsin phenotype determined by isoelectric focusing gel electrophoresis|participants|Number|0|0.0||||||
4068669|NCT01054339|3890561|B2|SZ||Alpha-1 antitrypsin phenotype|Alpha-1 antitrypsin phenotype determined by isoelectric focusing gel electrophoresis|participants|Number|0|0.0||||||
4068670|NCT01054339|3890562|B1|SZ||Alpha-1 antitrypsin phenotype|Alpha-1 antitrypsin phenotype determined by isoelectric focusing gel electrophoresis|participants|Number|1|1.0||||||
4068671|NCT01054339|3890559|B4|ZZ||Alpha-1 antitrypsin phenotype|Alpha-1 antitrypsin phenotype determined by isoelectric focusing gel electrophoresis|participants|Number|8|8.0||||||
4068672|NCT01054339|3890560|B3|ZZ||Alpha-1 antitrypsin phenotype|Alpha-1 antitrypsin phenotype determined by isoelectric focusing gel electrophoresis|participants|Number|3|3.0||||||
4068673|NCT01054339|3890561|B2|ZZ||Alpha-1 antitrypsin phenotype|Alpha-1 antitrypsin phenotype determined by isoelectric focusing gel electrophoresis|participants|Number|3|3.0||||||
4068674|NCT01054339|3890562|B1|ZZ||Alpha-1 antitrypsin phenotype|Alpha-1 antitrypsin phenotype determined by isoelectric focusing gel electrophoresis|participants|Number|2|2.0||||||
4068675|NCT01054339|3890559|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4068676|NCT01054339|3890560|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4068677|NCT01054339|3890561|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4068678|NCT01054339|3890562|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4068679|NCT01054339|3890559|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4068680|NCT01054339|3890560|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4068681|NCT01054339|3890561|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4068682|NCT01054339|3890562|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4068683|NCT01054339|3890559|B4|||Age||years|Mean|51.1|51.1|Standard Deviation|14.3|14.3|||
4068684|NCT01054339|3890560|B3|||Age||years|Mean|54.3|54.3|Standard Deviation|3.5|3.5|||
4068685|NCT01054339|3890561|B2|||Age||years|Mean|48.7|48.7|Standard Deviation|9.3|9.3|||
4068686|NCT01054339|3890562|B1|||Age||years|Mean|50.3|50.3|Standard Deviation|26.4|26.4|||
4068687|NCT01054339|3890559|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4068688|NCT01054339|3890560|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4068689|NCT01054339|3890561|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4068690|NCT01054339|3890562|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4068691|NCT01054339|3890559|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4068692|NCT01054339|3890560|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4068693|NCT01054339|3890561|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4068694|NCT01054339|3890562|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4068695|NCT01054339|3890559|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068696|NCT01054339|3890560|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068697|NCT01054339|3890561|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068698|NCT01054339|3890562|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068699|NCT01054300|3890578|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4068700|NCT01054300|3890579|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4068701|NCT01054300|3890580|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4068702|NCT01054300|3890578|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4068703|NCT01054300|3890579|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4068704|NCT01054300|3890580|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4068705|NCT01054300|3890578|B3|65 years or older||Age, Customized||Participants|Number|3|3.0||||||
4068706|NCT01054300|3890579|B2|65 years or older||Age, Customized||Participants|Number|1|1.0||||||
4068707|NCT01054300|3890580|B1|65 years or older||Age, Customized||Participants|Number|2|2.0||||||
4068708|NCT01054300|3890578|B3|45 - 64 years||Age, Customized||Participants|Number|35|35.0||||||
4068709|NCT01054300|3890579|B2|45 - 64 years||Age, Customized||Participants|Number|18|18.0||||||
4068710|NCT01054300|3890580|B1|45 - 64 years||Age, Customized||Participants|Number|17|17.0||||||
4068711|NCT01054300|3890578|B3|18 - 44 years||Age, Customized||Participants|Number|14|14.0||||||
4068712|NCT01054300|3890579|B2|18 - 44 years||Age, Customized||Participants|Number|7|7.0||||||
4068713|NCT01054300|3890580|B1|18 - 44 years||Age, Customized||Participants|Number|7|7.0||||||
4068714|NCT01054222|3890633|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4068715|NCT01054222|3890633|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4068716|NCT01054222|3890633|B1|||Age||Years|Mean|75.4|75.4|Standard Deviation|6.0|6.0|||
4068717|NCT01054209|3890652|B3|||Incidence IPH||participants|Number|116|116.0||||||
4068718|NCT01054209|3890653|B2|||Incidence IPH||participants|Number|58|58.0||||||
4068719|NCT01054209|3890654|B1|||Incidence IPH||participants|Number|58|58.0||||||
4068720|NCT01054209|3890652|B3|United Kingdom||Region of Enrollment||participants|Number|116|116.0||||||
4068721|NCT01054209|3890653|B2|United Kingdom||Region of Enrollment||participants|Number|58|58.0||||||
4068722|NCT01054209|3890654|B1|United Kingdom||Region of Enrollment||participants|Number|58|58.0||||||
4068723|NCT01054209|3890652|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4068724|NCT01054209|3890653|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4068725|NCT01054209|3890654|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4068726|NCT01054209|3890652|B3||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4068727|NCT01054209|3890653|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4068728|NCT01054209|3890654|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4068729|NCT01054209|3890652|B3|||Age||years|Mean|34.0|34.0|Standard Deviation|5.8|5.8|||
4068730|NCT01054209|3890653|B2|||Age||years|Mean|34.3|34.3|Standard Deviation|5.9|5.9|||
4068731|NCT01054209|3890654|B1|||Age||years|Mean|33.6|33.6|Standard Deviation|5.8|5.8|||
4068732|NCT01054183|3890661|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4068733|NCT01054183|3890662|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4068734|NCT01054183|3890663|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4068735|NCT01054183|3890661|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4068736|NCT01054183|3890662|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4068737|NCT01054183|3890663|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4068738|NCT01054183|3890661|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4068739|NCT01054183|3890662|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4068740|NCT01054183|3890663|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4068741|NCT01054183|3890661|B3|||Age||years|Mean|1.8|1.8|Standard Deviation|3.71|3.71|||
4068742|NCT01054183|3890662|B2|||Age||years|Mean|1.5|1.5|Standard Deviation|3.02|3.02|||
4068743|NCT01054183|3890663|B1|||Age||years|Mean|2.1|2.1|Standard Deviation|4.56|4.56|||
4068744|NCT01054183|3890661|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4068745|NCT01054183|3890662|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4068746|NCT01054183|3890663|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4068747|NCT01054183|3890661|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4068748|NCT01054183|3890662|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4068749|NCT01054183|3890663|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4068750|NCT01054183|3890661|B3||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
4068751|NCT01054183|3890662|B2||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4068752|NCT01054183|3890663|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4068753|NCT01054170|3890672|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4068754|NCT01054170|3890673|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4068755|NCT01054170|3890674|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4068756|NCT01054170|3890672|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4068757|NCT01054170|3890673|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4068758|NCT01054170|3890674|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4068759|NCT01054170|3890672|B3|||Age||years|Mean|7.45|7.45|Standard Deviation|131|131.0|||
4068760|NCT01054170|3890673|B2|||Age||years|Mean|7.7|7.7|Standard Deviation|66|66.0|||
4068761|NCT01054170|3890674|B1|||Age||years|Mean|7.2|7.2|Standard Deviation|65|65.0|||
4068762|NCT01054079|3890727|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4068763|NCT01054079|3890727|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4068764|NCT01054079|3890727|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4068765|NCT01054079|3890727|B1|||Age||years|Mean|66.6|66.6|Standard Deviation|7.1|7.1|||
4068766|NCT01054079|3890727|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4068767|NCT01054079|3890727|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4068768|NCT01054079|3890727|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068769|NCT01053988|3890735|B6|White||Race/Ethnicity, Customized||Participants|Number|741|741.0||||||
4068770|NCT01053988|3890736|B5|White||Race/Ethnicity, Customized||Participants|Number|150|150.0||||||
4068771|NCT01053988|3890737|B4|White||Race/Ethnicity, Customized||Participants|Number|156|156.0||||||
4068772|NCT01053988|3890738|B3|White||Race/Ethnicity, Customized||Participants|Number|141|141.0||||||
4068773|NCT01053988|3890739|B2|White||Race/Ethnicity, Customized||Participants|Number|139|139.0||||||
4068774|NCT01053988|3890740|B1|White||Race/Ethnicity, Customized||Participants|Number|155|155.0||||||
4068775|NCT01053988|3890735|B6|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||Participants|Number|253|253.0||||||
4068776|NCT01053988|3890736|B5|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||Participants|Number|46|46.0||||||
4068777|NCT01053988|3890737|B4|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||Participants|Number|43|43.0||||||
4068778|NCT01053988|3890738|B3|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||Participants|Number|56|56.0||||||
4068779|NCT01053988|3890739|B2|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||Participants|Number|64|64.0||||||
4068780|NCT01053988|3890740|B1|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||Participants|Number|44|44.0||||||
4068781|NCT01053988|3890735|B6|Central/South Asian HER||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4068782|NCT01053988|3890736|B5|Central/South Asian HER||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4068783|NCT01053988|3890737|B4|Central/South Asian HER||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4068784|NCT01053988|3890738|B3|Central/South Asian HER||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4068785|NCT01053988|3890739|B2|Central/South Asian HER||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4068786|NCT01053988|3890740|B1|Central/South Asian HER||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4068787|NCT01053988|3890735|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4068788|NCT01053988|3890736|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4068789|NCT01053988|3890737|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4068790|NCT01053988|3890738|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4068791|NCT01053988|3890739|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4068792|NCT01053988|3890740|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4068793|NCT01053988|3890735|B6|African American/African Heritage (HER)||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
4068794|NCT01053988|3890736|B5|African American/African Heritage (HER)||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4068795|NCT01053988|3890737|B4|African American/African Heritage (HER)||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4068796|NCT01053988|3890738|B3|African American/African Heritage (HER)||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4068797|NCT01053988|3890739|B2|African American/African Heritage (HER)||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4068798|NCT01053988|3890740|B1|African American/African Heritage (HER)||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4068799|NCT01053988|3890735|B6||Male|Sex: Female, Male||Participants|Count of Participants|685|685.0||||||
4068800|NCT01053988|3890736|B5||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4068801|NCT01053988|3890737|B4||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4068802|NCT01053988|3890738|B3||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4068803|NCT01053988|3890739|B2||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4068804|NCT01053988|3890740|B1||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4068805|NCT01053988|3890735|B6||Female|Sex: Female, Male||Participants|Count of Participants|345|345.0||||||
4068806|NCT01053988|3890736|B5||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4068807|NCT01053988|3890737|B4||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4068808|NCT01053988|3890738|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4068809|NCT01053988|3890739|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4068810|NCT01053988|3890740|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4068811|NCT01053988|3890735|B6|||Age||Years|Mean|62.7|62.7|Standard Deviation|9.09|9.09|||
4068812|NCT01053988|3890736|B5|||Age||Years|Mean|62.3|62.3|Standard Deviation|8.49|8.49|||
4068813|NCT01053988|3890737|B4|||Age||Years|Mean|62.8|62.8|Standard Deviation|9.13|9.13|||
4068814|NCT01053988|3890738|B3|||Age||Years|Mean|63.4|63.4|Standard Deviation|9.58|9.58|||
4068815|NCT01053988|3890739|B2|||Age||Years|Mean|62.7|62.7|Standard Deviation|9.47|9.47|||
4068816|NCT01053988|3890740|B1|||Age||Years|Mean|62.1|62.1|Standard Deviation|8.80|8.8|||
4068817|NCT01053897|3890777|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4068818|NCT01053897|3890777|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4068819|NCT01053897|3890777|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4068820|NCT01053897|3890777|B1|||Age||years|Mean|48|48.0|Standard Deviation|9.43|9.43|||
4068821|NCT01053897|3890777|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4068822|NCT01053897|3890777|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4068823|NCT01053897|3890777|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068824|NCT01053819|3890789|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4068825|NCT01053819|3890789|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4068826|NCT01053819|3890789|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4068827|NCT01053819|3890789|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4068828|NCT01053819|3890789|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4068829|NCT01053819|3890789|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068830|NCT01053741|3890794|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4068831|NCT01053741|3890795|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4068832|NCT01053741|3890796|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4068833|NCT01053741|3890794|B3|Male gender||Sex/Gender, Customized||Participants|Count of Participants|10|10.0||||||
4068834|NCT01053741|3890795|B2|Male gender||Sex/Gender, Customized||Participants|Count of Participants|5|5.0||||||
4068835|NCT01053741|3890796|B1|Male gender||Sex/Gender, Customized||Participants|Count of Participants|5|5.0||||||
4068836|NCT01053741|3890794|B3|||Age||years|Median|41.5|41.5|Full Range|||21.0|50.0|
4068837|NCT01053741|3890795|B2|||Age||years|Median|40|40.0|Full Range|||21.0|48.0|
4068838|NCT01053741|3890796|B1|||Age||years|Median|44|44.0|Full Range|||34.0|50.0|
4068839|NCT01053663|3890803|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4068840|NCT01053663|3890804|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4068841|NCT01053663|3890805|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4068842|NCT01053663|3890806|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4068843|NCT01053663|3890803|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4068844|NCT01053663|3890804|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4068845|NCT01053663|3890805|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4068846|NCT01053663|3890806|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4068847|NCT01053663|3890803|B4|||Age||days|Mean|143.2|143.2|Standard Deviation|82.9|82.9|||
4068848|NCT01053663|3890804|B3|||Age||days|Mean|23.0|23.0|Standard Deviation|||||
4068849|NCT01053663|3890805|B2|||Age||days|Mean|41.0|41.0|Standard Deviation|||||
4068850|NCT01053663|3890806|B1|||Age||days|Mean|175.0|175.0|Standard Deviation|62.0|62.0|||
4068851|NCT01053507|3890847|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4068852|NCT01053507|3890848|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4068853|NCT01053507|3890849|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4068854|NCT01053507|3890847|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4068855|NCT01053507|3890848|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4068856|NCT01053507|3890849|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4068857|NCT01053507|3890847|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4068858|NCT01053507|3890848|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4068859|NCT01053507|3890849|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4068860|NCT01053507|3890847|B3|||Age||years|Mean|38.48|38.48|Standard Deviation|11.14|11.14|||
4068861|NCT01053507|3890848|B2|||Age||years|Mean|35.83|35.83|Standard Deviation|12.01|12.01|||
4068862|NCT01053507|3890849|B1|||Age||years|Mean|41.36|41.36|Standard Deviation|9.83|9.83|||
4068863|NCT01053429|3890864|B1|Among the most extremely ill||CGI-S status - Per protocol population (PP)|Single-item clinician rated scale to rate severity of illness over time. Scores range 1 (normal) to 7 (among the most extremely ill); higher score=more affected. PP= ITT group, study treatment for at least 8 (± 1 week) since enrollment, observed for final efficacy (inpatient visit, phone call). N=participants with evaluable data at observation.|participants|Number|39|39.0||||||
4068864|NCT01053429|3890864|B1|Severely ill||CGI-S status - Per protocol population (PP)|Single-item clinician rated scale to rate severity of illness over time. Scores range 1 (normal) to 7 (among the most extremely ill); higher score=more affected. PP= ITT group, study treatment for at least 8 (± 1 week) since enrollment, observed for final efficacy (inpatient visit, phone call). N=participants with evaluable data at observation.|participants|Number|266|266.0||||||
4068890|NCT01053247|3890891|B4|Central America||Region of Enrollment||participants|Number|27|27.0||||||
4068865|NCT01053429|3890864|B1|Markedly ill||CGI-S status - Per protocol population (PP)|Single-item clinician rated scale to rate severity of illness over time. Scores range 1 (normal) to 7 (among the most extremely ill); higher score=more affected. PP= ITT group, study treatment for at least 8 (± 1 week) since enrollment, observed for final efficacy (inpatient visit, phone call). N=participants with evaluable data at observation.|participants|Number|547|547.0||||||
4068866|NCT01053429|3890864|B1|Moderately ill||CGI-S status - Per protocol population (PP)|Single-item clinician rated scale to rate severity of illness over time. Scores range 1 (normal) to 7 (among the most extremely ill); higher score=more affected. PP= ITT group, study treatment for at least 8 (± 1 week) since enrollment, observed for final efficacy (inpatient visit, phone call). N=participants with evaluable data at observation.|participants|Number|877|877.0||||||
4068867|NCT01053429|3890864|B1|Mildly ill||CGI-S status - Per protocol population (PP)|Single-item clinician rated scale to rate severity of illness over time. Scores range 1 (normal) to 7 (among the most extremely ill); higher score=more affected. PP= ITT group, study treatment for at least 8 (± 1 week) since enrollment, observed for final efficacy (inpatient visit, phone call). N=participants with evaluable data at observation.|participants|Number|454|454.0||||||
4068868|NCT01053429|3890864|B1|Borderline mentally ill||CGI-S status - Per protocol population (PP)|Single-item clinician rated scale to rate severity of illness over time. Scores range 1 (normal) to 7 (among the most extremely ill); higher score=more affected. PP= ITT group, study treatment for at least 8 (± 1 week) since enrollment, observed for final efficacy (inpatient visit, phone call). N=participants with evaluable data at observation.|participants|Number|68|68.0||||||
4068869|NCT01053429|3890864|B1|Normal, not ill at all||CGI-S status - Per protocol population (PP)|Single-item clinician rated scale to rate severity of illness over time. Scores range 1 (normal) to 7 (among the most extremely ill); higher score=more affected. PP= ITT group, study treatment for at least 8 (± 1 week) since enrollment, observed for final efficacy (inpatient visit, phone call). N=participants with evaluable data at observation.|participants|Number|3|3.0||||||
4068870|NCT01053429|3890864|B1|Among the most extremely ill||Clinical Global Impression of Severity (CGI-S) status - Intent to treat population (ITT)|Single-item clinician rated scale to rate severity of illness over time. Scores range 1 (normal, not ill at all) to 7 (among the most extremely ill); higher score=more affected. ITT=administered at least 1 dose of study treatment at least once a week and observed for at least 1 efficacy assessment. N=participants with evaluable data at observation.|participants|Number|54|54.0||||||
4068871|NCT01053429|3890864|B1|Severely ill||Clinical Global Impression of Severity (CGI-S) status - Intent to treat population (ITT)|Single-item clinician rated scale to rate severity of illness over time. Scores range 1 (normal, not ill at all) to 7 (among the most extremely ill); higher score=more affected. ITT=administered at least 1 dose of study treatment at least once a week and observed for at least 1 efficacy assessment. N=participants with evaluable data at observation.|participants|Number|440|440.0||||||
4068872|NCT01053429|3890864|B1|Markedly ill||Clinical Global Impression of Severity (CGI-S) status - Intent to treat population (ITT)|Single-item clinician rated scale to rate severity of illness over time. Scores range 1 (normal, not ill at all) to 7 (among the most extremely ill); higher score=more affected. ITT=administered at least 1 dose of study treatment at least once a week and observed for at least 1 efficacy assessment. N=participants with evaluable data at observation.|participants|Number|808|808.0||||||
4068873|NCT01053429|3890864|B1|Moderately ill||Clinical Global Impression of Severity (CGI-S) status - Intent to treat population (ITT)|Single-item clinician rated scale to rate severity of illness over time. Scores range 1 (normal, not ill at all) to 7 (among the most extremely ill); higher score=more affected. ITT=administered at least 1 dose of study treatment at least once a week and observed for at least 1 efficacy assessment. N=participants with evaluable data at observation.|participants|Number|1264|1264.0||||||
4068874|NCT01053429|3890864|B1|Mildly ill||Clinical Global Impression of Severity (CGI-S) status - Intent to treat population (ITT)|Single-item clinician rated scale to rate severity of illness over time. Scores range 1 (normal, not ill at all) to 7 (among the most extremely ill); higher score=more affected. ITT=administered at least 1 dose of study treatment at least once a week and observed for at least 1 efficacy assessment. N=participants with evaluable data at observation.|participants|Number|669|669.0||||||
4068875|NCT01053429|3890864|B1|Borderline mentally ill||Clinical Global Impression of Severity (CGI-S) status - Intent to treat population (ITT)|Single-item clinician rated scale to rate severity of illness over time. Scores range 1 (normal, not ill at all) to 7 (among the most extremely ill); higher score=more affected. ITT=administered at least 1 dose of study treatment at least once a week and observed for at least 1 efficacy assessment. N=participants with evaluable data at observation.|participants|Number|110|110.0||||||
4068876|NCT01053429|3890864|B1|Normal, not ill at all||Clinical Global Impression of Severity (CGI-S) status - Intent to treat population (ITT)|Single-item clinician rated scale to rate severity of illness over time. Scores range 1 (normal, not ill at all) to 7 (among the most extremely ill); higher score=more affected. ITT=administered at least 1 dose of study treatment at least once a week and observed for at least 1 efficacy assessment. N=participants with evaluable data at observation.|participants|Number|6|6.0||||||
4068877|NCT01053429|3890864|B1||Male|Sex: Female, Male||Participants|Count of Participants|1465|1465.0||||||
4068878|NCT01053429|3890864|B1||Female|Sex: Female, Male||Participants|Count of Participants|1926|1926.0||||||
4068879|NCT01053429|3890864|B1|>=65 years||Age, Customized||participants|Number|186|186.0||||||
4068880|NCT01053429|3890864|B1|Between 45 and 64 years||Age, Customized||participants|Number|723|723.0||||||
4068881|NCT01053429|3890864|B1|Between 18 and 44 years||Age, Customized||participants|Number|2377|2377.0||||||
4068882|NCT01053429|3890864|B1|<18 years||Age, Customized||participants|Number|105|105.0||||||
4068883|NCT01053312|3890873|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4068884|NCT01053312|3890873|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4068885|NCT01053312|3890873|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4068886|NCT01053312|3890873|B1|||Age||years|Mean|70|70.0|Standard Deviation|8.7|8.7|||
4068887|NCT01053312|3890873|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4068888|NCT01053312|3890873|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4068889|NCT01053312|3890873|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068891|NCT01053247|3890892|B3|Central America||Region of Enrollment||participants|Number|9|9.0||||||
4068892|NCT01053247|3890893|B2|Central America||Region of Enrollment||participants|Number|7|7.0||||||
4068893|NCT01053247|3890894|B1|Central America||Region of Enrollment||participants|Number|11|11.0||||||
4068894|NCT01053247|3890891|B4|United States||Region of Enrollment||participants|Number|766|766.0||||||
4068895|NCT01053247|3890892|B3|United States||Region of Enrollment||participants|Number|255|255.0||||||
4068896|NCT01053247|3890893|B2|United States||Region of Enrollment||participants|Number|253|253.0||||||
4068897|NCT01053247|3890894|B1|United States||Region of Enrollment||participants|Number|258|258.0||||||
4068898|NCT01053247|3890891|B4||Male|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
4068899|NCT01053247|3890892|B3||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4068900|NCT01053247|3890893|B2||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4068901|NCT01053247|3890894|B1||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4068902|NCT01053247|3890891|B4||Female|Sex: Female, Male||Participants|Count of Participants|467|467.0||||||
4068903|NCT01053247|3890892|B3||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4068904|NCT01053247|3890893|B2||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4068905|NCT01053247|3890894|B1||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4068906|NCT01053247|3890891|B4|Age||Age, Customized||years|Mean|43.3|43.3|Standard Deviation|16.70|16.7|||
4068907|NCT01053247|3890892|B3|Age||Age, Customized||years|Mean|43.3|43.3|Standard Deviation|17.14|17.14|||
4068908|NCT01053247|3890893|B2|Age||Age, Customized||years|Mean|43.7|43.7|Standard Deviation|16.74|16.74|||
4068909|NCT01053247|3890894|B1|Age||Age, Customized||years|Mean|43.0|43.0|Standard Deviation|16.29|16.29|||
4068910|NCT01053156|3890904|B3|United States||Region of Enrollment||participants|Number|55|55.0||||||
4068911|NCT01053156|3890905|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4068912|NCT01053156|3890906|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4068913|NCT01053156|3890904|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4068914|NCT01053156|3890905|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4068915|NCT01053156|3890906|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4068916|NCT01053156|3890904|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4068917|NCT01053156|3890905|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4068918|NCT01053156|3890906|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4068919|NCT01053156|3890904|B3|||Age||years|Mean|9.21|9.21|Standard Deviation|3.57|3.57|||
4068920|NCT01053156|3890905|B2|||Age||years|Mean|9.4|9.4|Standard Deviation|3.39|3.39|||
4068921|NCT01053156|3890906|B1|||Age||years|Mean|9.01|9.01|Standard Deviation|3.76|3.76|||
4068922|NCT01053156|3890904|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4068923|NCT01053156|3890905|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4068924|NCT01053156|3890906|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4068925|NCT01053156|3890904|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4068926|NCT01053156|3890905|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4068927|NCT01053156|3890906|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4068928|NCT01053156|3890904|B3||<=18 years|Age||Participants|Count of Participants|55|55.0||||||
4068929|NCT01053156|3890905|B2||<=18 years|Age||Participants|Count of Participants|27|27.0||||||
4068930|NCT01053156|3890906|B1||<=18 years|Age||Participants|Count of Participants|28|28.0||||||
4068931|NCT01053078|3890943|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4068932|NCT01053078|3890944|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4068933|NCT01053078|3890945|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4068934|NCT01053078|3890943|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4068935|NCT01053078|3890944|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4068936|NCT01053078|3890945|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4068937|NCT01053078|3890943|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4068938|NCT01053078|3890944|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4068939|NCT01053078|3890945|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4068940|NCT01053078|3890943|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4068941|NCT01053078|3890944|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4068942|NCT01053078|3890945|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4068943|NCT01053078|3890943|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4068944|NCT01053078|3890944|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4068945|NCT01053078|3890945|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4068946|NCT01053078|3890943|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068947|NCT01053078|3890944|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068948|NCT01053078|3890945|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068949|NCT01053078|3890943|B3|||Age||years|Mean|42|42.0|Standard Deviation|14|14.0|||
4068950|NCT01053078|3890944|B2|||Age||years|Mean|39|39.0|Standard Deviation|10|10.0|||
4068951|NCT01053078|3890945|B1|||Age||years|Mean|47|47.0|Standard Deviation|13|13.0|||
4068952|NCT01053000|3890952|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4068953|NCT01053000|3890952|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4068954|NCT01053000|3890952|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4068955|NCT01053000|3890952|B1|||Age||years|Mean|75.4|75.4|Standard Deviation|11.6|11.6|||
4068956|NCT01053000|3890952|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4068957|NCT01053000|3890952|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4068958|NCT01053000|3890952|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068959|NCT01052948|3890959|B5||Male|Sex: Female, Male||Participants|Count of Participants|21799|21799.0||||||
4068960|NCT01052948|3890960|B4||Male|Sex: Female, Male||Participants|Count of Participants|7319|7319.0||||||
4068961|NCT01052948|3890961|B3||Male|Sex: Female, Male||Participants|Count of Participants|1749|1749.0||||||
4068962|NCT01052948|3890962|B2||Male|Sex: Female, Male||Participants|Count of Participants|7003|7003.0||||||
4068963|NCT01052948|3890963|B1||Male|Sex: Female, Male||Participants|Count of Participants|5728|5728.0||||||
4068964|NCT01052948|3890959|B5||Female|Sex: Female, Male||Participants|Count of Participants|65140|65140.0||||||
4068965|NCT01052948|3890960|B4||Female|Sex: Female, Male||Participants|Count of Participants|21992|21992.0||||||
4068966|NCT01052948|3890961|B3||Female|Sex: Female, Male||Participants|Count of Participants|13398|13398.0||||||
4068967|NCT01052948|3890962|B2||Female|Sex: Female, Male||Participants|Count of Participants|7666|7666.0||||||
4068968|NCT01052948|3890963|B1||Female|Sex: Female, Male||Participants|Count of Participants|22084|22084.0||||||
4068969|NCT01052948|3890959|B5|||Age||years|Mean|52.0|52.0|Standard Deviation|21.4|21.4|||
4068970|NCT01052948|3890960|B4|||Age||years|Mean|49.4|49.4|Standard Deviation|0.1|0.1|||
4068971|NCT01052948|3890961|B3|||Age||years|Mean|40.0|40.0|Standard Deviation|0.1|0.1|||
4068972|NCT01052948|3890962|B2|||Age||years|Mean|76.8|76.8|Standard Deviation|0.1|0.1|||
4068973|NCT01052948|3890963|B1|||Age||years|Mean|48.7|48.7|Standard Deviation|20.1|20.1|||
4068974|NCT01052844|3890988|B3|Brazil||Region of Enrollment||participants|Number|80|80.0||||||
4068975|NCT01052844|3890989|B2|Brazil||Region of Enrollment||participants|Number|40|40.0||||||
4068976|NCT01052844|3890990|B1|Brazil||Region of Enrollment||participants|Number|40|40.0||||||
4068977|NCT01052844|3890988|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4068978|NCT01052844|3890989|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4068979|NCT01052844|3890990|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4068980|NCT01052844|3890988|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4068981|NCT01052844|3890989|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4068982|NCT01052844|3890990|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4068983|NCT01052844|3890988|B3|||Age||years|Mean|53.9|53.9|Standard Deviation|10.2|10.2|||
4068984|NCT01052844|3890989|B2|||Age||years|Mean|55.6|55.6|Standard Deviation|9.9|9.9|||
4068985|NCT01052844|3890990|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|10.4|10.4|||
4068986|NCT01052844|3890988|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4068987|NCT01052844|3890989|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4068988|NCT01052844|3890990|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4068989|NCT01052844|3890988|B3||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
4068990|NCT01052844|3890989|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4068991|NCT01052844|3890990|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4068992|NCT01052844|3890988|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068993|NCT01052844|3890989|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068994|NCT01052844|3890990|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4068995|NCT01052831|3890999|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068996|NCT01052831|3891000|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068997|NCT01052831|3891001|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4068998|NCT01052831|3890999|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4068999|NCT01052831|3891000|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4069000|NCT01052831|3891001|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4069001|NCT01052831|3890999|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4069002|NCT01052831|3891000|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4069003|NCT01052831|3891001|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069004|NCT01052831|3890999|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4069005|NCT01052831|3891000|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4069006|NCT01052831|3891001|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4069007|NCT01052831|3890999|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4069008|NCT01052831|3891000|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4069009|NCT01052831|3891001|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4069010|NCT01052831|3890999|B3|||Age||years|Mean|61.2|61.2|Standard Deviation|8.5|8.5|||
4069011|NCT01052831|3891000|B2|||Age||years|Mean|61.0|61.0|Standard Deviation|8.2|8.2|||
4069012|NCT01052831|3891001|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|9.0|9.0|||
4069013|NCT01052779|3891010|B3||Nondialysis|Dialysis Status||Participants|Count of Participants|92|92.0||||||
4069014|NCT01052779|3891011|B2||Nondialysis|Dialysis Status||Participants|Count of Participants|46|46.0||||||
4069015|NCT01052779|3891012|B1||Nondialysis|Dialysis Status||Participants|Count of Participants|46|46.0||||||
4069016|NCT01052779|3891010|B3||Hemodialysis|Dialysis Status||Participants|Count of Participants|70|70.0||||||
4069017|NCT01052779|3891011|B2||Hemodialysis|Dialysis Status||Participants|Count of Participants|36|36.0||||||
4069018|NCT01052779|3891012|B1||Hemodialysis|Dialysis Status||Participants|Count of Participants|34|34.0||||||
4069019|NCT01052779|3891010|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4069020|NCT01052779|3891011|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4069021|NCT01052779|3891012|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4069022|NCT01052779|3891010|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4069023|NCT01052779|3891011|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4069024|NCT01052779|3891012|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4069025|NCT01052779|3891010|B3|||Age||years|Mean|62.6|62.6|Standard Deviation|15.05|15.05|||
4069026|NCT01052779|3891011|B2|||Age||years|Mean|63.3|63.3|Standard Deviation|15.16|15.16|||
4069027|NCT01052779|3891012|B1|||Age||years|Mean|61.9|61.9|Standard Deviation|15.00|15.0|||
4069028|NCT01052714|3891021|B3|||Age at Onset||years|Mean|29.58|29.58|Standard Deviation|11.6|11.6|||
4069029|NCT01052714|3891022|B2|||Age at Onset||years|Mean|30.11|30.11|Standard Deviation|12.8|12.8|||
4069030|NCT01052714|3891023|B1|||Age at Onset||years|Mean|29.07|29.07|Standard Deviation|10.4|10.4|||
4069031|NCT01052714|3891021|B3|||Length of Illness||years|Mean|21.43|21.43|Standard Deviation|13.5|13.5|||
4069032|NCT01052714|3891022|B2|||Length of Illness||years|Mean|21.46|21.46|Standard Deviation|14.0|14.0|||
4069033|NCT01052714|3891023|B1|||Length of Illness||years|Mean|21.40|21.4|Standard Deviation|13.1|13.1|||
4069034|NCT01052714|3891021|B3|Multiple||Antipsychotic (Weight Gain Risk)|"Seven Usual Care and seven Lifestyle Balance participants were documented to be on Multiple antipsychotic medications. They are reported in the Multiple category, and also contribute to the tally of each of those antipsychotic medications."|Participants|Count of Participants|14|14.0||||||
4069035|NCT01052714|3891022|B2|Multiple||Antipsychotic (Weight Gain Risk)|"Seven Usual Care and seven Lifestyle Balance participants were documented to be on Multiple antipsychotic medications. They are reported in the Multiple category, and also contribute to the tally of each of those antipsychotic medications."|Participants|Count of Participants|7|7.0||||||
4069036|NCT01052714|3891023|B1|Multiple||Antipsychotic (Weight Gain Risk)|"Seven Usual Care and seven Lifestyle Balance participants were documented to be on Multiple antipsychotic medications. They are reported in the Multiple category, and also contribute to the tally of each of those antipsychotic medications."|Participants|Count of Participants|7|7.0||||||
4069037|NCT01052714|3891021|B3|Other||Antipsychotic (Weight Gain Risk)|"Seven Usual Care and seven Lifestyle Balance participants were documented to be on Multiple antipsychotic medications. They are reported in the Multiple category, and also contribute to the tally of each of those antipsychotic medications."|Participants|Count of Participants|12|12.0||||||
4069038|NCT01052714|3891022|B2|Other||Antipsychotic (Weight Gain Risk)|"Seven Usual Care and seven Lifestyle Balance participants were documented to be on Multiple antipsychotic medications. They are reported in the Multiple category, and also contribute to the tally of each of those antipsychotic medications."|Participants|Count of Participants|7|7.0||||||
4069039|NCT01052714|3891023|B1|Other||Antipsychotic (Weight Gain Risk)|"Seven Usual Care and seven Lifestyle Balance participants were documented to be on Multiple antipsychotic medications. They are reported in the Multiple category, and also contribute to the tally of each of those antipsychotic medications."|Participants|Count of Participants|5|5.0||||||
4069040|NCT01052714|3891021|B3|Aripiprazole/Ziprasidone (Low)||Antipsychotic (Weight Gain Risk)|"Seven Usual Care and seven Lifestyle Balance participants were documented to be on Multiple antipsychotic medications. They are reported in the Multiple category, and also contribute to the tally of each of those antipsychotic medications."|Participants|Count of Participants|46|46.0||||||
4069041|NCT01052714|3891022|B2|Aripiprazole/Ziprasidone (Low)||Antipsychotic (Weight Gain Risk)|"Seven Usual Care and seven Lifestyle Balance participants were documented to be on Multiple antipsychotic medications. They are reported in the Multiple category, and also contribute to the tally of each of those antipsychotic medications."|Participants|Count of Participants|24|24.0||||||
4069042|NCT01052714|3891023|B1|Aripiprazole/Ziprasidone (Low)||Antipsychotic (Weight Gain Risk)|"Seven Usual Care and seven Lifestyle Balance participants were documented to be on Multiple antipsychotic medications. They are reported in the Multiple category, and also contribute to the tally of each of those antipsychotic medications."|Participants|Count of Participants|22|22.0||||||
4069043|NCT01052714|3891021|B3|Risperidone/Quetiapine (Med)||Antipsychotic (Weight Gain Risk)|"Seven Usual Care and seven Lifestyle Balance participants were documented to be on Multiple antipsychotic medications. They are reported in the Multiple category, and also contribute to the tally of each of those antipsychotic medications."|Participants|Count of Participants|60|60.0||||||
4069044|NCT01052714|3891022|B2|Risperidone/Quetiapine (Med)||Antipsychotic (Weight Gain Risk)|"Seven Usual Care and seven Lifestyle Balance participants were documented to be on Multiple antipsychotic medications. They are reported in the Multiple category, and also contribute to the tally of each of those antipsychotic medications."|Participants|Count of Participants|30|30.0||||||
4069045|NCT01052714|3891023|B1|Risperidone/Quetiapine (Med)||Antipsychotic (Weight Gain Risk)|"Seven Usual Care and seven Lifestyle Balance participants were documented to be on Multiple antipsychotic medications. They are reported in the Multiple category, and also contribute to the tally of each of those antipsychotic medications."|Participants|Count of Participants|30|30.0||||||
4069046|NCT01052714|3891021|B3|Olanzapine/Clozapine (High)||Antipsychotic (Weight Gain Risk)|"Seven Usual Care and seven Lifestyle Balance participants were documented to be on Multiple antipsychotic medications. They are reported in the Multiple category, and also contribute to the tally of each of those antipsychotic medications."|Participants|Count of Participants|17|17.0||||||
4069134|NCT01052714|3891022|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4069047|NCT01052714|3891022|B2|Olanzapine/Clozapine (High)||Antipsychotic (Weight Gain Risk)|"Seven Usual Care and seven Lifestyle Balance participants were documented to be on Multiple antipsychotic medications. They are reported in the Multiple category, and also contribute to the tally of each of those antipsychotic medications."|Participants|Count of Participants|8|8.0||||||
4069048|NCT01052714|3891023|B1|Olanzapine/Clozapine (High)||Antipsychotic (Weight Gain Risk)|"Seven Usual Care and seven Lifestyle Balance participants were documented to be on Multiple antipsychotic medications. They are reported in the Multiple category, and also contribute to the tally of each of those antipsychotic medications."|Participants|Count of Participants|9|9.0||||||
4069049|NCT01052714|3891021|B3|Other||Diagnosis|Based on Diagnostic and Statistical Manual-IV criteria|Participants|Count of Participants|12|12.0||||||
4069050|NCT01052714|3891022|B2|Other||Diagnosis|Based on Diagnostic and Statistical Manual-IV criteria|Participants|Count of Participants|6|6.0||||||
4069051|NCT01052714|3891023|B1|Other||Diagnosis|Based on Diagnostic and Statistical Manual-IV criteria|Participants|Count of Participants|6|6.0||||||
4069052|NCT01052714|3891021|B3|Multiple||Diagnosis|Based on Diagnostic and Statistical Manual-IV criteria|Participants|Count of Participants|17|17.0||||||
4069053|NCT01052714|3891022|B2|Multiple||Diagnosis|Based on Diagnostic and Statistical Manual-IV criteria|Participants|Count of Participants|10|10.0||||||
4069054|NCT01052714|3891023|B1|Multiple||Diagnosis|Based on Diagnostic and Statistical Manual-IV criteria|Participants|Count of Participants|7|7.0||||||
4069055|NCT01052714|3891021|B3|Bipolar||Diagnosis|Based on Diagnostic and Statistical Manual-IV criteria|Participants|Count of Participants|17|17.0||||||
4069056|NCT01052714|3891022|B2|Bipolar||Diagnosis|Based on Diagnostic and Statistical Manual-IV criteria|Participants|Count of Participants|5|5.0||||||
4069057|NCT01052714|3891023|B1|Bipolar||Diagnosis|Based on Diagnostic and Statistical Manual-IV criteria|Participants|Count of Participants|12|12.0||||||
4069058|NCT01052714|3891021|B3|Schizoaffective||Diagnosis|Based on Diagnostic and Statistical Manual-IV criteria|Participants|Count of Participants|35|35.0||||||
4069059|NCT01052714|3891022|B2|Schizoaffective||Diagnosis|Based on Diagnostic and Statistical Manual-IV criteria|Participants|Count of Participants|22|22.0||||||
4069060|NCT01052714|3891023|B1|Schizoaffective||Diagnosis|Based on Diagnostic and Statistical Manual-IV criteria|Participants|Count of Participants|13|13.0||||||
4069061|NCT01052714|3891021|B3|Schizophrenia||Diagnosis|Based on Diagnostic and Statistical Manual-IV criteria|Participants|Count of Participants|40|40.0||||||
4069062|NCT01052714|3891022|B2|Schizophrenia||Diagnosis|Based on Diagnostic and Statistical Manual-IV criteria|Participants|Count of Participants|19|19.0||||||
4069063|NCT01052714|3891023|B1|Schizophrenia||Diagnosis|Based on Diagnostic and Statistical Manual-IV criteria|Participants|Count of Participants|21|21.0||||||
4069064|NCT01052714|3891021|B3|None||Job Status|Self-selected description of employment situation. Unpaid=homemaker, student, volunteer; None=retired, disabled.|Participants|Count of Participants|92|92.0||||||
4069065|NCT01052714|3891022|B2|None||Job Status|Self-selected description of employment situation. Unpaid=homemaker, student, volunteer; None=retired, disabled.|Participants|Count of Participants|44|44.0||||||
4069066|NCT01052714|3891023|B1|None||Job Status|Self-selected description of employment situation. Unpaid=homemaker, student, volunteer; None=retired, disabled.|Participants|Count of Participants|48|48.0||||||
4069067|NCT01052714|3891021|B3|Unpaid Work||Job Status|Self-selected description of employment situation. Unpaid=homemaker, student, volunteer; None=retired, disabled.|Participants|Count of Participants|15|15.0||||||
4069068|NCT01052714|3891022|B2|Unpaid Work||Job Status|Self-selected description of employment situation. Unpaid=homemaker, student, volunteer; None=retired, disabled.|Participants|Count of Participants|8|8.0||||||
4069069|NCT01052714|3891023|B1|Unpaid Work||Job Status|Self-selected description of employment situation. Unpaid=homemaker, student, volunteer; None=retired, disabled.|Participants|Count of Participants|7|7.0||||||
4069070|NCT01052714|3891021|B3|Paid Work||Job Status|Self-selected description of employment situation. Unpaid=homemaker, student, volunteer; None=retired, disabled.|Participants|Count of Participants|12|12.0||||||
4069071|NCT01052714|3891022|B2|Paid Work||Job Status|Self-selected description of employment situation. Unpaid=homemaker, student, volunteer; None=retired, disabled.|Participants|Count of Participants|9|9.0||||||
4069072|NCT01052714|3891023|B1|Paid Work||Job Status|Self-selected description of employment situation. Unpaid=homemaker, student, volunteer; None=retired, disabled.|Participants|Count of Participants|3|3.0||||||
4069073|NCT01052714|3891021|B3|Divorced/Widower||Marital Status||Participants|Count of Participants|43|43.0||||||
4069074|NCT01052714|3891022|B2|Divorced/Widower||Marital Status||Participants|Count of Participants|17|17.0||||||
4069075|NCT01052714|3891023|B1|Divorced/Widower||Marital Status||Participants|Count of Participants|26|26.0||||||
4069076|NCT01052714|3891021|B3|Single/Cohabiting||Marital Status||Participants|Count of Participants|61|61.0||||||
4069077|NCT01052714|3891022|B2|Single/Cohabiting||Marital Status||Participants|Count of Participants|33|33.0||||||
4069078|NCT01052714|3891023|B1|Single/Cohabiting||Marital Status||Participants|Count of Participants|28|28.0||||||
4069079|NCT01052714|3891021|B3|Married||Marital Status||Participants|Count of Participants|17|17.0||||||
4069080|NCT01052714|3891022|B2|Married||Marital Status||Participants|Count of Participants|12|12.0||||||
4069081|NCT01052714|3891023|B1|Married||Marital Status||Participants|Count of Participants|5|5.0||||||
4069082|NCT01052714|3891021|B3|Higher Prof. Degree||Education|Self-selected description of highest education level reached.|Participants|Count of Participants|3|3.0||||||
4069083|NCT01052714|3891022|B2|Higher Prof. Degree||Education|Self-selected description of highest education level reached.|Participants|Count of Participants|2|2.0||||||
4069084|NCT01052714|3891023|B1|Higher Prof. Degree||Education|Self-selected description of highest education level reached.|Participants|Count of Participants|1|1.0||||||
4069085|NCT01052714|3891021|B3|Bachelor's or Equivalent Degree||Education|Self-selected description of highest education level reached.|Participants|Count of Participants|16|16.0||||||
4069086|NCT01052714|3891022|B2|Bachelor's or Equivalent Degree||Education|Self-selected description of highest education level reached.|Participants|Count of Participants|10|10.0||||||
4069135|NCT01052714|3891023|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4069087|NCT01052714|3891023|B1|Bachelor's or Equivalent Degree||Education|Self-selected description of highest education level reached.|Participants|Count of Participants|6|6.0||||||
4069088|NCT01052714|3891021|B3|High School Diploma/GED||Education|Self-selected description of highest education level reached.|Participants|Count of Participants|96|96.0||||||
4069089|NCT01052714|3891022|B2|High School Diploma/GED||Education|Self-selected description of highest education level reached.|Participants|Count of Participants|47|47.0||||||
4069090|NCT01052714|3891023|B1|High School Diploma/GED||Education|Self-selected description of highest education level reached.|Participants|Count of Participants|49|49.0||||||
4069091|NCT01052714|3891021|B3|No diploma||Education|Self-selected description of highest education level reached.|Participants|Count of Participants|5|5.0||||||
4069092|NCT01052714|3891022|B2|No diploma||Education|Self-selected description of highest education level reached.|Participants|Count of Participants|3|3.0||||||
4069093|NCT01052714|3891023|B1|No diploma||Education|Self-selected description of highest education level reached.|Participants|Count of Participants|2|2.0||||||
4069094|NCT01052714|3891021|B3|Transitional||Living Situation|Self-selected description of living situation.|Participants|Count of Participants|4|4.0||||||
4069095|NCT01052714|3891022|B2|Transitional||Living Situation|Self-selected description of living situation.|Participants|Count of Participants|1|1.0||||||
4069096|NCT01052714|3891023|B1|Transitional||Living Situation|Self-selected description of living situation.|Participants|Count of Participants|3|3.0||||||
4069097|NCT01052714|3891021|B3|Board and Care||Living Situation|Self-selected description of living situation.|Participants|Count of Participants|33|33.0||||||
4069098|NCT01052714|3891022|B2|Board and Care||Living Situation|Self-selected description of living situation.|Participants|Count of Participants|16|16.0||||||
4069099|NCT01052714|3891023|B1|Board and Care||Living Situation|Self-selected description of living situation.|Participants|Count of Participants|17|17.0||||||
4069100|NCT01052714|3891021|B3|With Relatives||Living Situation|Self-selected description of living situation.|Participants|Count of Participants|21|21.0||||||
4069101|NCT01052714|3891022|B2|With Relatives||Living Situation|Self-selected description of living situation.|Participants|Count of Participants|11|11.0||||||
4069102|NCT01052714|3891023|B1|With Relatives||Living Situation|Self-selected description of living situation.|Participants|Count of Participants|10|10.0||||||
4069103|NCT01052714|3891021|B3|Rental Home/Apt||Living Situation|Self-selected description of living situation.|Participants|Count of Participants|49|49.0||||||
4069104|NCT01052714|3891022|B2|Rental Home/Apt||Living Situation|Self-selected description of living situation.|Participants|Count of Participants|23|23.0||||||
4069105|NCT01052714|3891023|B1|Rental Home/Apt||Living Situation|Self-selected description of living situation.|Participants|Count of Participants|26|26.0||||||
4069106|NCT01052714|3891021|B3|Own Home||Living Situation|Self-selected description of living situation.|Participants|Count of Participants|13|13.0||||||
4069107|NCT01052714|3891022|B2|Own Home||Living Situation|Self-selected description of living situation.|Participants|Count of Participants|11|11.0||||||
4069108|NCT01052714|3891023|B1|Own Home||Living Situation|Self-selected description of living situation.|Participants|Count of Participants|2|2.0||||||
4069109|NCT01052714|3891021|B3|United States||Region of Enrollment||participants|Number|121|121.0||||||
4069110|NCT01052714|3891022|B2|United States||Region of Enrollment||participants|Number|62|62.0||||||
4069111|NCT01052714|3891023|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
4069112|NCT01052714|3891021|B3|Mixed Heritage or Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4069113|NCT01052714|3891022|B2|Mixed Heritage or Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4069114|NCT01052714|3891023|B1|Mixed Heritage or Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4069115|NCT01052714|3891021|B3|Native American or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4069116|NCT01052714|3891022|B2|Native American or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4069117|NCT01052714|3891023|B1|Native American or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4069118|NCT01052714|3891021|B3|Hispanic, Latino, or Spanish Origin||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
4069119|NCT01052714|3891022|B2|Hispanic, Latino, or Spanish Origin||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4069120|NCT01052714|3891023|B1|Hispanic, Latino, or Spanish Origin||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4069121|NCT01052714|3891021|B3|Caucasian, White||Race/Ethnicity, Customized||Participants|Count of Participants|53|53.0||||||
4069122|NCT01052714|3891022|B2|Caucasian, White||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
4069123|NCT01052714|3891023|B1|Caucasian, White||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
4069124|NCT01052714|3891021|B3|Asian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4069125|NCT01052714|3891022|B2|Asian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4069126|NCT01052714|3891023|B1|Asian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4069127|NCT01052714|3891021|B3|African American or Black||Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
4069128|NCT01052714|3891022|B2|African American or Black||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
4069129|NCT01052714|3891023|B1|African American or Black||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
4069130|NCT01052714|3891021|B3||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4069131|NCT01052714|3891022|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4069132|NCT01052714|3891023|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4069133|NCT01052714|3891021|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4069136|NCT01052714|3891021|B3|||Age||years|Mean|51.22|51.22|Standard Deviation|9.6|9.6|||
4069137|NCT01052714|3891022|B2|||Age||years|Mean|51.87|51.87|Standard Deviation|9.3|9.3|||
4069138|NCT01052714|3891023|B1|||Age||years|Mean|50.54|50.54|Standard Deviation|10.0|10.0|||
4069139|NCT01052714|3891021|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4069140|NCT01052714|3891022|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4069141|NCT01052714|3891023|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4069142|NCT01052714|3891021|B3||Between 18 and 65 years|Age||Participants|Count of Participants|119|119.0||||||
4069143|NCT01052714|3891022|B2||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4069144|NCT01052714|3891023|B1||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4069145|NCT01052714|3891021|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069146|NCT01052714|3891022|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069147|NCT01052714|3891023|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069148|NCT01052701|3891065|B3|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
4069149|NCT01052701|3891066|B2|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4069150|NCT01052701|3891067|B1|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4069151|NCT01052701|3891065|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4069152|NCT01052701|3891066|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4069153|NCT01052701|3891067|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4069154|NCT01052701|3891065|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4069155|NCT01052701|3891066|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4069156|NCT01052701|3891067|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4069157|NCT01052701|3891065|B3|||Age||years|Median|52|52.0|Inter-Quartile Range|||49.0|58.0|
4069158|NCT01052701|3891066|B2|||Age||years|Median|50|50.0|Inter-Quartile Range|||48.0|54.0|
4069159|NCT01052701|3891067|B1|||Age||years|Median|54|54.0|Inter-Quartile Range|||50.0|58.0|
4069160|NCT01052701|3891065|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4069161|NCT01052701|3891066|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4069162|NCT01052701|3891067|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4069163|NCT01052701|3891065|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4069164|NCT01052701|3891066|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4069165|NCT01052701|3891067|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4069166|NCT01052701|3891065|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069167|NCT01052701|3891066|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069168|NCT01052701|3891067|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069169|NCT01052662|3891076|B4|||Inhibitory Control (mean % error)|Antisaccade Task: Participants view a computer screen displaying two placeholder outline boxes on either side of a fixation cross. Subjects are instructed to look away from the go signal when it appears inside one of the placeholder boxes. For each trial, the first saccade that follows the go signal will be labeled an impulsivity error (i.e., a prosaccade) if it lands on the box containing the go signal and a correct response (i.e., an antisaccade) if it lands in the goal box. This task is an excellent measure of the control over impulsive behavior with higher scores indicating worse control.|mean percentage of error (prosaccade)|Mean|0.21|0.21|Standard Deviation|0.17|0.17|||
4069170|NCT01052662|3891077|B3|||Inhibitory Control (mean % error)|Antisaccade Task: Participants view a computer screen displaying two placeholder outline boxes on either side of a fixation cross. Subjects are instructed to look away from the go signal when it appears inside one of the placeholder boxes. For each trial, the first saccade that follows the go signal will be labeled an impulsivity error (i.e., a prosaccade) if it lands on the box containing the go signal and a correct response (i.e., an antisaccade) if it lands in the goal box. This task is an excellent measure of the control over impulsive behavior with higher scores indicating worse control.|mean percentage of error (prosaccade)|Mean|0.2|0.2|Standard Deviation|0.17|0.17|||
4069171|NCT01052662|3891078|B2|||Inhibitory Control (mean % error)|Antisaccade Task: Participants view a computer screen displaying two placeholder outline boxes on either side of a fixation cross. Subjects are instructed to look away from the go signal when it appears inside one of the placeholder boxes. For each trial, the first saccade that follows the go signal will be labeled an impulsivity error (i.e., a prosaccade) if it lands on the box containing the go signal and a correct response (i.e., an antisaccade) if it lands in the goal box. This task is an excellent measure of the control over impulsive behavior with higher scores indicating worse control.|mean percentage of error (prosaccade)|Mean|0.2|0.2|Standard Deviation|0.11|0.11|||
4069172|NCT01052662|3891079|B1|||Inhibitory Control (mean % error)|Antisaccade Task: Participants view a computer screen displaying two placeholder outline boxes on either side of a fixation cross. Subjects are instructed to look away from the go signal when it appears inside one of the placeholder boxes. For each trial, the first saccade that follows the go signal will be labeled an impulsivity error (i.e., a prosaccade) if it lands on the box containing the go signal and a correct response (i.e., an antisaccade) if it lands in the goal box. This task is an excellent measure of the control over impulsive behavior with higher scores indicating worse control.|mean percentage of error (prosaccade)|Mean|0.24|0.24|Standard Deviation|0.2|0.2|||
4069173|NCT01052662|3891076|B4|||Barratt Impulsivity Questionnaire|The Barratt Impulsivity Questionnaire is a brief, participant-administered 30-item, self-rating scale where participants answer questions regarding behavior and planning using a four-point scale (1= Rarely/Never, 2= Occasionally, 3= Often, 4= Almost always/Always) where the maximum overall impulsivity score is 120 indicating more impulsive and the minimum score is 30.|units on a scale|Mean|70.8|70.8|Standard Deviation|11.3|11.3|||
4069230|NCT01052662|3891077|B3|||Age||years|Mean|22.4|22.4|Standard Deviation|2.1|2.1|||
4069174|NCT01052662|3891077|B3|||Barratt Impulsivity Questionnaire|The Barratt Impulsivity Questionnaire is a brief, participant-administered 30-item, self-rating scale where participants answer questions regarding behavior and planning using a four-point scale (1= Rarely/Never, 2= Occasionally, 3= Often, 4= Almost always/Always) where the maximum overall impulsivity score is 120 indicating more impulsive and the minimum score is 30.|units on a scale|Mean|69.7|69.7|Standard Deviation|12.7|12.7|||
4069175|NCT01052662|3891078|B2|||Barratt Impulsivity Questionnaire|The Barratt Impulsivity Questionnaire is a brief, participant-administered 30-item, self-rating scale where participants answer questions regarding behavior and planning using a four-point scale (1= Rarely/Never, 2= Occasionally, 3= Often, 4= Almost always/Always) where the maximum overall impulsivity score is 120 indicating more impulsive and the minimum score is 30.|units on a scale|Mean|70.4|70.4|Standard Deviation|10.3|10.3|||
4069176|NCT01052662|3891079|B1|||Barratt Impulsivity Questionnaire|The Barratt Impulsivity Questionnaire is a brief, participant-administered 30-item, self-rating scale where participants answer questions regarding behavior and planning using a four-point scale (1= Rarely/Never, 2= Occasionally, 3= Often, 4= Almost always/Always) where the maximum overall impulsivity score is 120 indicating more impulsive and the minimum score is 30.|units on a scale|Mean|72.4|72.4|Standard Deviation|10.9|10.9|||
4069177|NCT01052662|3891076|B4|||Center for Epidemiologic Studies Depression scale (CES-D)|CES-D is a 20-item self-report measure of depressive symptoms. CES-D was administered at intake and weekly. The range of scores is from 0 to 60, with higher scores reflecting increased depressive symptoms. The CES-D does not heavily depend on pathological items or somatic symptoms compared with other scales.|units on a scale|Mean|22.4|22.4|Standard Deviation|9.9|9.9|||
4069178|NCT01052662|3891077|B3|||Center for Epidemiologic Studies Depression scale (CES-D)|CES-D is a 20-item self-report measure of depressive symptoms. CES-D was administered at intake and weekly. The range of scores is from 0 to 60, with higher scores reflecting increased depressive symptoms. The CES-D does not heavily depend on pathological items or somatic symptoms compared with other scales.|units on a scale|Mean|22.8|22.8|Standard Deviation|11|11.0|||
4069179|NCT01052662|3891078|B2|||Center for Epidemiologic Studies Depression scale (CES-D)|CES-D is a 20-item self-report measure of depressive symptoms. CES-D was administered at intake and weekly. The range of scores is from 0 to 60, with higher scores reflecting increased depressive symptoms. The CES-D does not heavily depend on pathological items or somatic symptoms compared with other scales.|units on a scale|Mean|20|20.0|Standard Deviation|9.7|9.7|||
4069180|NCT01052662|3891079|B1|||Center for Epidemiologic Studies Depression scale (CES-D)|CES-D is a 20-item self-report measure of depressive symptoms. CES-D was administered at intake and weekly. The range of scores is from 0 to 60, with higher scores reflecting increased depressive symptoms. The CES-D does not heavily depend on pathological items or somatic symptoms compared with other scales.|units on a scale|Mean|23.6|23.6|Standard Deviation|9|9.0|||
4069181|NCT01052662|3891076|B4|||Heroin Craving Questionnaire – Short Form 14 (HCQ-SF-14)|"The Heroin Craving Questionnaire – Short Form 14 (HCQ-SF-14) consists of 14 statements about the respondent’s feelings and thoughts about using heroin as he or she is completing the questionnaire (i.e., right now). This instrument obtains a reflection of the respondent’s general heroin craving. This instrument was modified to include craving for prescription opioids. Each item is scored on a scale ranging from 1 for Strongly Disagree to 7 for Strongly Agree. The total score is the average of the sum all 14 items with range from 1 to 7 with higher score indicating worse craving."|units on a scale|Mean|4.3|4.3|Standard Deviation|1|1.0|||
4069182|NCT01052662|3891077|B3|||Heroin Craving Questionnaire – Short Form 14 (HCQ-SF-14)|"The Heroin Craving Questionnaire – Short Form 14 (HCQ-SF-14) consists of 14 statements about the respondent’s feelings and thoughts about using heroin as he or she is completing the questionnaire (i.e., right now). This instrument obtains a reflection of the respondent’s general heroin craving. This instrument was modified to include craving for prescription opioids. Each item is scored on a scale ranging from 1 for Strongly Disagree to 7 for Strongly Agree. The total score is the average of the sum all 14 items with range from 1 to 7 with higher score indicating worse craving."|units on a scale|Mean|4.3|4.3|Standard Deviation|1|1.0|||
4069183|NCT01052662|3891078|B2|||Heroin Craving Questionnaire – Short Form 14 (HCQ-SF-14)|"The Heroin Craving Questionnaire – Short Form 14 (HCQ-SF-14) consists of 14 statements about the respondent’s feelings and thoughts about using heroin as he or she is completing the questionnaire (i.e., right now). This instrument obtains a reflection of the respondent’s general heroin craving. This instrument was modified to include craving for prescription opioids. Each item is scored on a scale ranging from 1 for Strongly Disagree to 7 for Strongly Agree. The total score is the average of the sum all 14 items with range from 1 to 7 with higher score indicating worse craving."|units on a scale|Mean|4.5|4.5|Standard Deviation|1|1.0|||
4069184|NCT01052662|3891079|B1|||Heroin Craving Questionnaire – Short Form 14 (HCQ-SF-14)|"The Heroin Craving Questionnaire – Short Form 14 (HCQ-SF-14) consists of 14 statements about the respondent’s feelings and thoughts about using heroin as he or she is completing the questionnaire (i.e., right now). This instrument obtains a reflection of the respondent’s general heroin craving. This instrument was modified to include craving for prescription opioids. Each item is scored on a scale ranging from 1 for Strongly Disagree to 7 for Strongly Agree. The total score is the average of the sum all 14 items with range from 1 to 7 with higher score indicating worse craving."|units on a scale|Mean|4.2|4.2|Standard Deviation|1.1|1.1|||
4069185|NCT01052662|3891076|B4|||Clinical Opiate Withdrawal Scale (COWS)|The COWS is an 11-item interviewer administered questionnaire designed to provide a description of signs and symptoms of opiate withdrawal that can be observed directly in the participant (e.g., sweating, runny nose, etc). Scores range from 0 to 36. Score 5-12 = Mild, 13-24 = Moderate, 25-36 = Moderately Severe and more than 36 = Severe Withdrawal.|units on a scale|Mean|9.2|9.2|Standard Deviation|3.1|3.1|||
4069186|NCT01052662|3891077|B3|||Clinical Opiate Withdrawal Scale (COWS)|The COWS is an 11-item interviewer administered questionnaire designed to provide a description of signs and symptoms of opiate withdrawal that can be observed directly in the participant (e.g., sweating, runny nose, etc). Scores range from 0 to 36. Score 5-12 = Mild, 13-24 = Moderate, 25-36 = Moderately Severe and more than 36 = Severe Withdrawal.|units on a scale|Mean|9.1|9.1|Standard Deviation|2.7|2.7|||
4069231|NCT01052662|3891078|B2|||Age||years|Mean|22.4|22.4|Standard Deviation|2|2.0|||
4069232|NCT01052662|3891079|B1|||Age||years|Mean|23|23.0|Standard Deviation|1.9|1.9|||
4069233|NCT01052545|3891095|B3|Longterm Care||Department|*data missing for 5 pts|participants|Number|390|390.0||||||
4069187|NCT01052662|3891078|B2|||Clinical Opiate Withdrawal Scale (COWS)|The COWS is an 11-item interviewer administered questionnaire designed to provide a description of signs and symptoms of opiate withdrawal that can be observed directly in the participant (e.g., sweating, runny nose, etc). Scores range from 0 to 36. Score 5-12 = Mild, 13-24 = Moderate, 25-36 = Moderately Severe and more than 36 = Severe Withdrawal.|units on a scale|Mean|8.3|8.3|Standard Deviation|2.8|2.8|||
4069188|NCT01052662|3891079|B1|||Clinical Opiate Withdrawal Scale (COWS)|The COWS is an 11-item interviewer administered questionnaire designed to provide a description of signs and symptoms of opiate withdrawal that can be observed directly in the participant (e.g., sweating, runny nose, etc). Scores range from 0 to 36. Score 5-12 = Mild, 13-24 = Moderate, 25-36 = Moderately Severe and more than 36 = Severe Withdrawal.|units on a scale|Mean|10.4|10.4|Standard Deviation|3.7|3.7|||
4069189|NCT01052662|3891076|B4|||Severity of Dependence Scale|Performed at screening, we used this scale for urn randomization based on the severity of opiate dependence score. This instrument has 5 questions that are scored on a four-point scale from 0 ( never/almost never or not difficult) to 3 (always/nearly always or impossible). Overall scores range from 0 to 15, with scores above 10 indicating high severity.|units on a scale|Mean|11.5|11.5|Standard Deviation|2.4|2.4|||
4069190|NCT01052662|3891077|B3|||Severity of Dependence Scale|Performed at screening, we used this scale for urn randomization based on the severity of opiate dependence score. This instrument has 5 questions that are scored on a four-point scale from 0 ( never/almost never or not difficult) to 3 (always/nearly always or impossible). Overall scores range from 0 to 15, with scores above 10 indicating high severity.|units on a scale|Mean|11.7|11.7|Standard Deviation|2.5|2.5|||
4069191|NCT01052662|3891078|B2|||Severity of Dependence Scale|Performed at screening, we used this scale for urn randomization based on the severity of opiate dependence score. This instrument has 5 questions that are scored on a four-point scale from 0 ( never/almost never or not difficult) to 3 (always/nearly always or impossible). Overall scores range from 0 to 15, with scores above 10 indicating high severity.|units on a scale|Mean|11.7|11.7|Standard Deviation|2.5|2.5|||
4069192|NCT01052662|3891079|B1|||Severity of Dependence Scale|Performed at screening, we used this scale for urn randomization based on the severity of opiate dependence score. This instrument has 5 questions that are scored on a four-point scale from 0 ( never/almost never or not difficult) to 3 (always/nearly always or impossible). Overall scores range from 0 to 15, with scores above 10 indicating high severity.|units on a scale|Mean|11.2|11.2|Standard Deviation|2.1|2.1|||
4069193|NCT01052662|3891076|B4|Opioid Analgesic use||Years of opioid use||years|Mean|3.2|3.2|Standard Deviation|1.9|1.9|||
4069194|NCT01052662|3891077|B3|Opioid Analgesic use||Years of opioid use||years|Mean|3.7|3.7|Standard Deviation|2.2|2.2|||
4069195|NCT01052662|3891078|B2|Opioid Analgesic use||Years of opioid use||years|Mean|2.9|2.9|Standard Deviation|1.3|1.3|||
4069196|NCT01052662|3891079|B1|Opioid Analgesic use||Years of opioid use||years|Mean|2.8|2.8|Standard Deviation|2.1|2.1|||
4069197|NCT01052662|3891076|B4|Heroin use||Years of opioid use||years|Mean|1.08|1.08|Standard Deviation|2.1|2.1|||
4069198|NCT01052662|3891077|B3|Heroin use||Years of opioid use||years|Mean|1.1|1.1|Standard Deviation|2.3|2.3|||
4069199|NCT01052662|3891078|B2|Heroin use||Years of opioid use||years|Mean|1|1.0|Standard Deviation|1.6|1.6|||
4069200|NCT01052662|3891079|B1|Heroin use||Years of opioid use||years|Mean|1.1|1.1|Standard Deviation|2.5|2.5|||
4069201|NCT01052662|3891076|B4|Opioid analgesic use||Opioid use||participants|Number|63|63.0||||||
4069202|NCT01052662|3891077|B3|Opioid analgesic use||Opioid use||participants|Number|24|24.0||||||
4069203|NCT01052662|3891078|B2|Opioid analgesic use||Opioid use||participants|Number|17|17.0||||||
4069204|NCT01052662|3891079|B1|Opioid analgesic use||Opioid use||participants|Number|22|22.0||||||
4069205|NCT01052662|3891076|B4|Heroin use||Opioid use||participants|Number|17|17.0||||||
4069206|NCT01052662|3891077|B3|Heroin use||Opioid use||participants|Number|5|5.0||||||
4069207|NCT01052662|3891078|B2|Heroin use||Opioid use||participants|Number|7|7.0||||||
4069208|NCT01052662|3891079|B1|Heroin use||Opioid use||participants|Number|5|5.0||||||
4069209|NCT01052662|3891076|B4|United States||Region of Enrollment||participants|Number|80|80.0||||||
4069210|NCT01052662|3891077|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
4069211|NCT01052662|3891078|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4069212|NCT01052662|3891079|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4069213|NCT01052662|3891076|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4069214|NCT01052662|3891077|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4069215|NCT01052662|3891078|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4069216|NCT01052662|3891079|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4069217|NCT01052662|3891076|B4|Caucacian||Race/Ethnicity, Customized||participants|Number|73|73.0||||||
4069218|NCT01052662|3891077|B3|Caucacian||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4069219|NCT01052662|3891078|B2|Caucacian||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4069220|NCT01052662|3891079|B1|Caucacian||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4069221|NCT01052662|3891076|B4||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4069222|NCT01052662|3891077|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4069223|NCT01052662|3891078|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4069224|NCT01052662|3891079|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4069225|NCT01052662|3891076|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4069226|NCT01052662|3891077|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4069227|NCT01052662|3891078|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4069228|NCT01052662|3891079|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4069229|NCT01052662|3891076|B4|||Age||years|Mean|22.6|22.6|Standard Deviation|1.9|1.9|||
4069234|NCT01052545|3891096|B2|Longterm Care||Department|*data missing for 5 pts|participants|Number|132|132.0||||||
4069235|NCT01052545|3891097|B1|Longterm Care||Department|*data missing for 5 pts|participants|Number|258|258.0||||||
4069236|NCT01052545|3891095|B3|Medicine||Department|*data missing for 5 pts|participants|Number|1203|1203.0||||||
4069237|NCT01052545|3891096|B2|Medicine||Department|*data missing for 5 pts|participants|Number|594|594.0||||||
4069238|NCT01052545|3891097|B1|Medicine||Department|*data missing for 5 pts|participants|Number|609|609.0||||||
4069239|NCT01052545|3891095|B3|other||Urinary catheter type|*data missing for 2 pts|participants|Number|141|141.0||||||
4069240|NCT01052545|3891096|B2|other||Urinary catheter type|*data missing for 2 pts|participants|Number|126|126.0||||||
4069241|NCT01052545|3891097|B1|other||Urinary catheter type|*data missing for 2 pts|participants|Number|15|15.0||||||
4069242|NCT01052545|3891095|B3|Condom||Urinary catheter type|*data missing for 2 pts|participants|Number|501|501.0||||||
4069243|NCT01052545|3891096|B2|Condom||Urinary catheter type|*data missing for 2 pts|participants|Number|160|160.0||||||
4069244|NCT01052545|3891097|B1|Condom||Urinary catheter type|*data missing for 2 pts|participants|Number|341|341.0||||||
4069245|NCT01052545|3891095|B3|Foley||Urinary catheter type|*data missing for 2 pts|participants|Number|954|954.0||||||
4069246|NCT01052545|3891096|B2|Foley||Urinary catheter type|*data missing for 2 pts|participants|Number|444|444.0||||||
4069247|NCT01052545|3891097|B1|Foley||Urinary catheter type|*data missing for 2 pts|participants|Number|510|510.0||||||
4069248|NCT01052545|3891095|B3|Male||Gender|*data missing for 43 pts|participants|Number|1517|1517.0||||||
4069249|NCT01052545|3891096|B2|Male||Gender|*data missing for 43 pts|participants|Number|701|701.0||||||
4069250|NCT01052545|3891097|B1|Male||Gender|*data missing for 43 pts|participants|Number|816|816.0||||||
4069251|NCT01052545|3891095|B3|Female||Gender|*data missing for 43 pts|participants|Number|38|38.0||||||
4069252|NCT01052545|3891096|B2|Female||Gender|*data missing for 43 pts|participants|Number|19|19.0||||||
4069253|NCT01052545|3891097|B1|Female||Gender|*data missing for 43 pts|participants|Number|19|19.0||||||
4069254|NCT01052545|3891095|B3|||Age||years|Mean|72|72.0|Standard Deviation|12|12.0|||
4069255|NCT01052545|3891096|B2|||Age||years|Mean|72|72.0|Standard Deviation|13|13.0|||
4069256|NCT01052545|3891097|B1|||Age||years|Mean|72|72.0|Standard Deviation|12|12.0|||
4069257|NCT01052480|3891110|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4069258|NCT01052480|3891111|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4069259|NCT01052480|3891112|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4069260|NCT01052480|3891110|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4069261|NCT01052480|3891111|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4069262|NCT01052480|3891112|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4069263|NCT01052480|3891110|B3||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4069264|NCT01052480|3891111|B2||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4069265|NCT01052480|3891112|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4069266|NCT01052480|3891110|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4069267|NCT01052480|3891111|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4069268|NCT01052480|3891112|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4069269|NCT01052480|3891110|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069270|NCT01052480|3891111|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069271|NCT01052480|3891112|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069272|NCT01052480|3891110|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4069273|NCT01052480|3891111|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4069274|NCT01052480|3891112|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069275|NCT01052480|3891110|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069276|NCT01052480|3891111|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069277|NCT01052480|3891112|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069278|NCT01052480|3891110|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4069279|NCT01052480|3891111|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4069280|NCT01052480|3891112|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4069281|NCT01052480|3891110|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
4069282|NCT01052480|3891111|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4069283|NCT01052480|3891112|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4069284|NCT01052480|3891110|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4069285|NCT01052480|3891111|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4069286|NCT01052480|3891112|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4069287|NCT01052480|3891110|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4069288|NCT01052480|3891111|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4069289|NCT01052480|3891112|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4069290|NCT01052480|3891110|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4069291|NCT01052480|3891111|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4069292|NCT01052480|3891112|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4069293|NCT01052480|3891110|B3|>=18||Age, Customized|The <18 and >=18 categories match a protocol-specified division, so it is most appropriate to present categorized age this way.|Participants|Count of Participants|87|87.0||||||
4069294|NCT01052480|3891111|B2|>=18||Age, Customized|The <18 and >=18 categories match a protocol-specified division, so it is most appropriate to present categorized age this way.|Participants|Count of Participants|42|42.0||||||
4069295|NCT01052480|3891112|B1|>=18||Age, Customized|The <18 and >=18 categories match a protocol-specified division, so it is most appropriate to present categorized age this way.|Participants|Count of Participants|45|45.0||||||
4069296|NCT01052480|3891110|B3|<18||Age, Customized|The <18 and >=18 categories match a protocol-specified division, so it is most appropriate to present categorized age this way.|Participants|Count of Participants|11|11.0||||||
4069297|NCT01052480|3891111|B2|<18||Age, Customized|The <18 and >=18 categories match a protocol-specified division, so it is most appropriate to present categorized age this way.|Participants|Count of Participants|7|7.0||||||
4069298|NCT01052480|3891112|B1|<18||Age, Customized|The <18 and >=18 categories match a protocol-specified division, so it is most appropriate to present categorized age this way.|Participants|Count of Participants|4|4.0||||||
4069299|NCT01052480|3891110|B3|||Age||years|Median|53|53.0|Inter-Quartile Range|||38.0|69.0|
4069300|NCT01052480|3891111|B2|||Age||years|Median|57|57.0|Inter-Quartile Range|||39.0|71.0|
4069301|NCT01052480|3891112|B1|||Age||years|Median|50|50.0|Inter-Quartile Range|||38.0|66.0|
4069302|NCT01052428|3891161|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
4069303|NCT01052428|3891162|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4069304|NCT01052428|3891163|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4069305|NCT01052428|3891161|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4069306|NCT01052428|3891162|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4069307|NCT01052428|3891163|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4069308|NCT01052428|3891161|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4069309|NCT01052428|3891162|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4069310|NCT01052428|3891163|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4069311|NCT01052428|3891161|B3|||Age||years|Mean|54.2|54.2|Standard Deviation|9.3|9.3|||
4069312|NCT01052428|3891162|B2|||Age||years|Mean|55.9|55.9|Standard Deviation|9.2|9.2|||
4069313|NCT01052428|3891163|B1|||Age||years|Mean|52.6|52.6|Standard Deviation|9.3|9.3|||
4069314|NCT01052428|3891161|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4069315|NCT01052428|3891162|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4069316|NCT01052428|3891163|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4069317|NCT01052428|3891161|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4069318|NCT01052428|3891162|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4069319|NCT01052428|3891163|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4069320|NCT01052428|3891161|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069321|NCT01052428|3891162|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069322|NCT01052428|3891163|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069323|NCT01052272|3891182|B5|United States||Region of Enrollment||participants|Number|72|72.0||||||
4069324|NCT01052272|3891183|B4|United States||Region of Enrollment||participants|Number|18|18.0||||||
4069325|NCT01052272|3891184|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4069326|NCT01052272|3891185|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4069327|NCT01052272|3891186|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4069328|NCT01052272|3891182|B5||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4069329|NCT01052272|3891183|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4069330|NCT01052272|3891184|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4069331|NCT01052272|3891185|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4069332|NCT01052272|3891186|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4069333|NCT01052272|3891182|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4069334|NCT01052272|3891183|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4069335|NCT01052272|3891184|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4069336|NCT01052272|3891185|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4069337|NCT01052272|3891186|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4069338|NCT01052272|3891182|B5|||Age||years|Mean|60.44|60.44|Standard Deviation|10.69|10.69|||
4069339|NCT01052272|3891183|B4|||Age||years|Mean|62|62.0|Standard Deviation|10.86|10.86|||
4069340|NCT01052272|3891184|B3|||Age||years|Mean|60.67|60.67|Standard Deviation|10.57|10.57|||
4069341|NCT01052272|3891185|B2|||Age||years|Mean|60.94|60.94|Standard Deviation|11.27|11.27|||
4069342|NCT01052272|3891186|B1|||Age||years|Mean|58.17|58.17|Standard Deviation|10.61|10.61|||
4069343|NCT01052272|3891182|B5||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4069344|NCT01052272|3891183|B4||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4069345|NCT01052272|3891184|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4069346|NCT01052272|3891185|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4069347|NCT01052272|3891186|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4069348|NCT01052272|3891182|B5||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4069349|NCT01052272|3891183|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4069350|NCT01052272|3891184|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4069351|NCT01052272|3891185|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4069352|NCT01052272|3891186|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4069353|NCT01052272|3891182|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069354|NCT01052272|3891183|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069355|NCT01052272|3891184|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069356|NCT01052272|3891185|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069357|NCT01052272|3891186|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069358|NCT01052207|3891223|B3|United States||Region of Enrollment||participants|Number|102|102.0||||||
4069359|NCT01052207|3891224|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
4069360|NCT01052207|3891225|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4069361|NCT01052207|3891223|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069362|NCT01052207|3891224|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069363|NCT01052207|3891225|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069364|NCT01052207|3891223|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
4069365|NCT01052207|3891224|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4069366|NCT01052207|3891225|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4069367|NCT01052207|3891223|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4069368|NCT01052207|3891224|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4069369|NCT01052207|3891225|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4069370|NCT01052207|3891223|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4069371|NCT01052207|3891224|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4069372|NCT01052207|3891225|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4069373|NCT01052207|3891223|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069374|NCT01052207|3891224|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069375|NCT01052207|3891225|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069376|NCT01052207|3891223|B3||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4069377|NCT01052207|3891224|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4069378|NCT01052207|3891225|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4069379|NCT01052207|3891223|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4069380|NCT01052207|3891224|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4069381|NCT01052207|3891225|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4069382|NCT01052207|3891223|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069383|NCT01052207|3891224|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069384|NCT01052207|3891225|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069385|NCT01052207|3891223|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069386|NCT01052207|3891224|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069387|NCT01052207|3891225|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069388|NCT01052207|3891223|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069389|NCT01052207|3891224|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069390|NCT01052207|3891225|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069391|NCT01052207|3891223|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4069392|NCT01052207|3891224|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4069393|NCT01052207|3891225|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4069394|NCT01052207|3891223|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4069395|NCT01052207|3891224|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4069396|NCT01052207|3891225|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4069397|NCT01052207|3891223|B3|||Age||years|Mean|9.7|9.7|Standard Deviation|5.3|5.3|||
4069398|NCT01052207|3891224|B2|||Age||years|Mean|8|8.0|Standard Deviation|4.5|4.5|||
4069399|NCT01052207|3891225|B1|||Age||years|Mean|10.9|10.9|Standard Deviation|5.6|5.6|||
4069400|NCT01052116|3891232|B3|||FEV1||Liters|Median|2.43|2.43|Inter-Quartile Range|||1.99|2.91|
4069401|NCT01052116|3891233|B2|||FEV1||Liters|Median|2.40|2.4|Inter-Quartile Range|||2.01|2.91|
4069402|NCT01052116|3891234|B1|||FEV1||Liters|Median|2.44|2.44|Inter-Quartile Range|||1.96|2.93|
4069403|NCT01052116|3891232|B3||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4069404|NCT01052116|3891233|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4069405|NCT01052116|3891234|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4069406|NCT01052116|3891232|B3||Female|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
4069407|NCT01052116|3891233|B2||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4069408|NCT01052116|3891234|B1||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4069409|NCT01052116|3891232|B3|||Age||years|Median|36|36.0|Inter-Quartile Range|||18.0|49.0|
4069410|NCT01052116|3891233|B2|||Age||years|Median|34|34.0|Inter-Quartile Range|||20.0|49.0|
4069411|NCT01052116|3891234|B1|||Age||years|Median|38|38.0|Inter-Quartile Range|||17.0|49.0|
4069412|NCT01052077|3891241|B3||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4069413|NCT01052077|3891242|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4069414|NCT01052077|3891243|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4069415|NCT01052077|3891241|B3||Female|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
4069416|NCT01052077|3891242|B2||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4069417|NCT01052077|3891243|B1||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4069418|NCT01052077|3891241|B3|||Age||Years|Mean|43.5|43.5|Standard Deviation|11.8|11.8|||
4069419|NCT01052077|3891242|B2|||Age||Years|Mean|42.4|42.4|Standard Deviation|11.7|11.7|||
4069420|NCT01052077|3891243|B1|||Age||Years|Mean|44.7|44.7|Standard Deviation|11.7|11.7|||
4069421|NCT01052038|3891270|B4|United States||Region of Enrollment||participants|Number|120|120.0||||||
4069422|NCT01052038|3891271|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4069423|NCT01052038|3891272|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4069424|NCT01052038|3891273|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4069425|NCT01052038|3891270|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4069426|NCT01052038|3891271|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4069427|NCT01052038|3891272|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4069428|NCT01052038|3891273|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4069429|NCT01052038|3891270|B4||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4069430|NCT01052038|3891271|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4069431|NCT01052038|3891272|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4069432|NCT01052038|3891273|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4069433|NCT01052038|3891270|B4|||Age||years|Mean|37|37.0|Standard Deviation|9|9.0|||
4069434|NCT01052038|3891271|B3|||Age||years|Mean|39|39.0|Standard Deviation|11|11.0|||
4069435|NCT01052038|3891272|B2|||Age||years|Mean|36|36.0|Standard Deviation|7|7.0|||
4069436|NCT01052038|3891273|B1|||Age||years|Mean|36|36.0|Standard Deviation|11|11.0|||
4069437|NCT01052038|3891270|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4069438|NCT01052038|3891271|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4069439|NCT01052038|3891272|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4069440|NCT01052038|3891273|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4069441|NCT01052038|3891270|B4||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
4069442|NCT01052038|3891271|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4069443|NCT01052038|3891272|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4069444|NCT01052038|3891273|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4069445|NCT01052038|3891270|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069446|NCT01052038|3891271|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069447|NCT01052038|3891272|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069448|NCT01052038|3891273|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069449|NCT01051986|3891295|B3|Korea, Republic of||Region of Enrollment||participants|Number|224|224.0||||||
4069450|NCT01051986|3891296|B2|Korea, Republic of||Region of Enrollment||participants|Number|112|112.0||||||
4069451|NCT01051986|3891297|B1|Korea, Republic of||Region of Enrollment||participants|Number|112|112.0||||||
4069452|NCT01051986|3891295|B3||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4069453|NCT01051986|3891296|B2||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4069454|NCT01051986|3891297|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4069455|NCT01051986|3891295|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4069456|NCT01051986|3891296|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4069457|NCT01051986|3891297|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4069458|NCT01051986|3891295|B3|||Age||years|Mean|63.0|63.0|Standard Deviation|7.9|7.9|||
4069459|NCT01051986|3891296|B2|||Age||years|Mean|63.3|63.3|Standard Deviation|7.8|7.8|||
4069460|NCT01051986|3891297|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|8.0|8.0|||
4069461|NCT01051986|3891295|B3||>=65 years|Age||Participants|Count of Participants|103|103.0||||||
4069462|NCT01051986|3891296|B2||>=65 years|Age||Participants|Count of Participants|54|54.0||||||
4069463|NCT01051986|3891297|B1||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
4069464|NCT01051986|3891295|B3||Between 18 and 65 years|Age||Participants|Count of Participants|121|121.0||||||
4069465|NCT01051986|3891296|B2||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4069466|NCT01051986|3891297|B1||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4069467|NCT01051986|3891295|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069468|NCT01051986|3891296|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069469|NCT01051986|3891297|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069470|NCT01051921|3891312|B1|United States||Region of Enrollment||participants|Number|67|67.0||||||
4069471|NCT01051921|3891312|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4069472|NCT01051921|3891312|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4069473|NCT01051921|3891312|B1|||Age||years|Mean|52.1|52.1|Standard Deviation|7.9|7.9|||
4069474|NCT01051921|3891312|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4069475|NCT01051921|3891312|B1||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4069476|NCT01051921|3891312|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069477|NCT01051856|3891317|B3|||Body Mass Index (BMI)|34 participants in the TissueLink arm were included in the BMI analysis; the data were not available on one participant.|kg/m^2|Mean|28.09|28.09|Standard Deviation|5.15|5.15|||
4069478|NCT01051856|3891318|B2|||Body Mass Index (BMI)|34 participants in the TissueLink arm were included in the BMI analysis; the data were not available on one participant.|kg/m^2|Mean|28.56|28.56|Standard Deviation|5.25|5.25|||
4069479|NCT01051856|3891319|B1|||Body Mass Index (BMI)|34 participants in the TissueLink arm were included in the BMI analysis; the data were not available on one participant.|kg/m^2|Mean|27.60|27.6|Standard Deviation|5.08|5.08|||
4069480|NCT01051856|3891317|B3|United States||Region of Enrollment||participants|Number|67|67.0||||||
4069481|NCT01051856|3891318|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
4069482|NCT01051856|3891319|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4069483|NCT01051856|3891317|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4069484|NCT01051856|3891318|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4069485|NCT01051856|3891319|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4069486|NCT01051856|3891317|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4069487|NCT01051856|3891318|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4069488|NCT01051856|3891319|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4069489|NCT01051856|3891317|B3|||Age||years|Mean|57.99|57.99|Standard Deviation|12.79|12.79|||
4069490|NCT01051856|3891318|B2|||Age||years|Mean|56.29|56.29|Standard Deviation|12.79|12.79|||
4069491|NCT01051856|3891319|B1|||Age||years|Mean|59.84|59.84|Standard Deviation|12.73|12.73|||
4069492|NCT01051817|3891328|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4069493|NCT01051817|3891329|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4069494|NCT01051817|3891330|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4069495|NCT01051817|3891328|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069496|NCT01051817|3891329|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069497|NCT01051817|3891330|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069498|NCT01051817|3891328|B3||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
4069499|NCT01051817|3891329|B2||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4069500|NCT01051817|3891330|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4069501|NCT01051817|3891328|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069502|NCT01051817|3891329|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069503|NCT01051817|3891330|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069504|NCT01051817|3891328|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069505|NCT01051817|3891329|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069506|NCT01051817|3891330|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069507|NCT01051817|3891328|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069508|NCT01051817|3891329|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069509|NCT01051817|3891330|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069510|NCT01051817|3891328|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069511|NCT01051817|3891329|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069512|NCT01051817|3891330|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069513|NCT01051817|3891328|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069514|NCT01051817|3891329|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069515|NCT01051817|3891330|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069516|NCT01051817|3891328|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
4069517|NCT01051817|3891329|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4069518|NCT01051817|3891330|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4069519|NCT01051817|3891328|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4069520|NCT01051817|3891329|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4069521|NCT01051817|3891330|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4069522|NCT01051817|3891328|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4069523|NCT01051817|3891329|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4069524|NCT01051817|3891330|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4069525|NCT01051817|3891328|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4069526|NCT01051817|3891329|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4069527|NCT01051817|3891330|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4069528|NCT01051817|3891328|B3|||Age||years|Mean|34.5|34.5|Standard Deviation|9.95|9.95|||
4069529|NCT01051817|3891329|B2|||Age||years|Mean|32.7|32.7|Standard Deviation|9.9|9.9|||
4069530|NCT01051817|3891330|B1|||Age||years|Mean|36.1|36.1|Standard Deviation|9.8|9.8|||
4069531|NCT01051791|3891341|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4069532|NCT01051791|3891341|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4069533|NCT01051791|3891341|B1|||Age||years|Median|63|63.0|Full Range|||51.0|81.0|
4069534|NCT01051778|3891348|B3|Egypt||Region of Enrollment||participants|Number|60|60.0||||||
4069535|NCT01051778|3891349|B2|Egypt||Region of Enrollment||participants|Number|30|30.0||||||
4069536|NCT01051778|3891350|B1|Egypt||Region of Enrollment||participants|Number|30|30.0||||||
4069537|NCT01051778|3891348|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4069538|NCT01051778|3891349|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4069539|NCT01051778|3891350|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4069540|NCT01051778|3891348|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4069541|NCT01051778|3891349|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4069542|NCT01051778|3891350|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4069543|NCT01051778|3891348|B3|||Age||years|Mean|28.016|28.016|Standard Deviation|3.362|3.362|||
4069544|NCT01051778|3891349|B2|||Age||years|Mean|28.57|28.57|Standard Deviation|3.48|3.48|||
4069545|NCT01051778|3891350|B1|||Age||years|Mean|27.47|27.47|Standard Deviation|3.20|3.2|||
4069546|NCT01051778|3891348|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4069547|NCT01051778|3891349|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4069548|NCT01051778|3891350|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4069549|NCT01051778|3891348|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4069550|NCT01051778|3891349|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4069551|NCT01051778|3891350|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4069552|NCT01051778|3891348|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069553|NCT01051778|3891349|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069554|NCT01051778|3891350|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069555|NCT01051739|3891357|B3|United States||Region of Enrollment||Participants|Count of Participants|180|180.0||||||
4069556|NCT01051739|3891358|B2|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
4069557|NCT01051739|3891359|B1|United States||Region of Enrollment||Participants|Count of Participants|120|120.0||||||
4069558|NCT01051739|3891357|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4069559|NCT01051739|3891358|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4069560|NCT01051739|3891359|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4069561|NCT01051739|3891357|B3||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4069562|NCT01051739|3891358|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4069563|NCT01051739|3891359|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4069564|NCT01051739|3891357|B3|||Age||years|Mean|64|64.0|Standard Deviation|9|9.0|||
4069565|NCT01051739|3891358|B2|||Age||years|Mean|61|61.0|Standard Deviation|9|9.0|||
4069566|NCT01051739|3891359|B1|||Age||years|Mean|68|68.0|Standard Deviation|9|9.0|||
4069567|NCT01051739|3891357|B3||>=65 years|Age||Participants|Count of Participants|114|114.0||||||
4069568|NCT01051739|3891358|B2||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4069569|NCT01051739|3891359|B1||>=65 years|Age||Participants|Count of Participants|95|95.0||||||
4069570|NCT01051739|3891357|B3||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4069571|NCT01051739|3891358|B2||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4069572|NCT01051739|3891359|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4069573|NCT01051739|3891357|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069574|NCT01051739|3891358|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069575|NCT01051739|3891359|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069576|NCT01051570|3891366|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4069577|NCT01051570|3891366|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4069578|NCT01051570|3891366|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4069579|NCT01051570|3891366|B1|||Age||years|Median|69|69.0|Full Range|||54.0|86.0|
4069580|NCT01051557|3891370|B8|United States||Region of Enrollment||participants|Number|36|36.0||||||
4069581|NCT01051557|3891371|B7|United States||Region of Enrollment||participants|Number|6|6.0||||||
4069582|NCT01051557|3891372|B6|United States||Region of Enrollment||participants|Number|6|6.0||||||
4069583|NCT01051557|3891373|B5|United States||Region of Enrollment||participants|Number|8|8.0||||||
4069584|NCT01051557|3891374|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
4069585|NCT01051557|3891375|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4069586|NCT01051557|3891376|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4069587|NCT01051557|3891377|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4069588|NCT01051557|3891370|B8||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4069589|NCT01051557|3891371|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4069590|NCT01051557|3891372|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4069591|NCT01051557|3891373|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4069592|NCT01051557|3891374|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4069593|NCT01051557|3891375|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4069594|NCT01051557|3891376|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4069595|NCT01051557|3891377|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4069596|NCT01051557|3891370|B8||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4069597|NCT01051557|3891371|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4069598|NCT01051557|3891372|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4069599|NCT01051557|3891373|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4069600|NCT01051557|3891374|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4069601|NCT01051557|3891375|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4069602|NCT01051557|3891376|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4069603|NCT01051557|3891377|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4069604|NCT01051557|3891370|B8||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4069605|NCT01051557|3891371|B7||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4069606|NCT01051557|3891372|B6||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4069607|NCT01051557|3891373|B5||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4069608|NCT01051557|3891374|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4069609|NCT01051557|3891375|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4069610|NCT01051557|3891376|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4069611|NCT01051557|3891377|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4069612|NCT01051557|3891370|B8||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4069613|NCT01051557|3891371|B7||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4069614|NCT01051557|3891372|B6||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4069615|NCT01051557|3891373|B5||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4069616|NCT01051557|3891374|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4069617|NCT01051557|3891375|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4069618|NCT01051557|3891376|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4069619|NCT01051557|3891377|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4069620|NCT01051557|3891370|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069621|NCT01051557|3891371|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069622|NCT01051557|3891372|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069623|NCT01051557|3891373|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069624|NCT01051557|3891374|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069625|NCT01051557|3891375|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069626|NCT01051557|3891376|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069627|NCT01051557|3891377|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069628|NCT01051466|3891400|B3|United Kingdom||Region of Enrollment||participants|Number|60|60.0||||||
4069629|NCT01051466|3891401|B2|United Kingdom||Region of Enrollment||participants|Number|28|28.0||||||
4069630|NCT01051466|3891402|B1|United Kingdom||Region of Enrollment||participants|Number|32|32.0||||||
4069631|NCT01051466|3891400|B3|Black||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4069632|NCT01051466|3891401|B2|Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4069633|NCT01051466|3891402|B1|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4069634|NCT01051466|3891400|B3|Asian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4069635|NCT01051466|3891401|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4069636|NCT01051466|3891402|B1|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4069637|NCT01051466|3891400|B3|White||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4069638|NCT01051466|3891401|B2|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4069639|NCT01051466|3891402|B1|White||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4069640|NCT01051466|3891400|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4069641|NCT01051466|3891401|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4069642|NCT01051466|3891402|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4069643|NCT01051466|3891400|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4069644|NCT01051466|3891401|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4069645|NCT01051466|3891402|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4069646|NCT01051466|3891400|B3|||Age||years|Mean|39.74|39.74|Standard Deviation|10.35|10.35|||
4069647|NCT01051466|3891401|B2|||Age||years|Mean|39.19|39.19|Standard Deviation|9.41|9.41|||
4069648|NCT01051466|3891402|B1|||Age||years|Mean|40.21|40.21|Standard Deviation|11.23|11.23|||
4069649|NCT01051440|3891435|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4069650|NCT01051440|3891436|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4069651|NCT01051440|3891437|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4069652|NCT01051440|3891435|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4069653|NCT01051440|3891436|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4069654|NCT01051440|3891437|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4069655|NCT01051440|3891435|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4069656|NCT01051440|3891436|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4069657|NCT01051440|3891437|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4069658|NCT01051440|3891435|B3|||Age||years|Mean|34|34.0|Standard Deviation|5.7|5.7|||
4069659|NCT01051440|3891436|B2|||Age||years|Mean|30|30.0|Standard Deviation|0|0.0|||
4069660|NCT01051440|3891437|B1|||Age||years|Mean|38|38.0|Standard Deviation|0|0.0|||
4069661|NCT01051440|3891435|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4069662|NCT01051440|3891436|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4069663|NCT01051440|3891437|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4069664|NCT01051440|3891435|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4069665|NCT01051440|3891436|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4069666|NCT01051440|3891437|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4069667|NCT01051440|3891435|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069668|NCT01051440|3891436|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069669|NCT01051440|3891437|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069670|NCT01051349|3891448|B1||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4069671|NCT01051349|3891448|B1||Female|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
4069672|NCT01051349|3891448|B1|||Age||years|Mean|38.4|38.4|Standard Deviation|8.74|8.74|||
4069673|NCT01051323|3891475|B3||Male|Sex: Female, Male||Participants|Count of Participants|873|873.0||||||
4069674|NCT01051323|3891476|B2||Male|Sex: Female, Male||Participants|Count of Participants|705|705.0||||||
4069675|NCT01051323|3891477|B1||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4069676|NCT01051323|3891475|B3||Female|Sex: Female, Male||Participants|Count of Participants|637|637.0||||||
4069677|NCT01051323|3891476|B2||Female|Sex: Female, Male||Participants|Count of Participants|479|479.0||||||
4069678|NCT01051323|3891477|B1||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4069679|NCT01051323|3891475|B3|||Age||years|Mean|68.8|68.8|Standard Deviation|13.8|13.8|||
4069680|NCT01051323|3891476|B2|||Age||years|Mean|68.0|68.0|Standard Deviation|13.8|13.8|||
4069681|NCT01051323|3891477|B1|||Age||years|Mean|71.8|71.8|Standard Deviation|13.3|13.3|||
4069682|NCT01051063|3891499|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4069683|NCT01051063|3891500|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4069684|NCT01051063|3891501|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4069685|NCT01051063|3891499|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4069686|NCT01051063|3891500|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4069687|NCT01051063|3891501|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4069688|NCT01051063|3891499|B3|||Age||Years|Mean|66.3|66.3|Standard Deviation|8.2|8.2|||
4069689|NCT01051063|3891500|B2|||Age||Years|Mean|64.2|64.2|Standard Deviation|8.5|8.5|||
4069690|NCT01051063|3891501|B1|||Age||Years|Mean|67.2|67.2|Standard Deviation|8.3|8.3|||
4069691|NCT01050998|3891517|B6||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4069692|NCT01050998|3891518|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4069693|NCT01050998|3891519|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4069694|NCT01050998|3891520|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4069695|NCT01050998|3891521|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4069696|NCT01050998|3891522|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4069697|NCT01050998|3891517|B6||Female|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
4069698|NCT01050998|3891518|B5||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4069699|NCT01050998|3891519|B4||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4069700|NCT01050998|3891520|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4069701|NCT01050998|3891521|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4069702|NCT01050998|3891522|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4069703|NCT01050998|3891517|B6|||Age||years|Mean|51.7|51.7|Standard Deviation|11.9|11.9|||
4069704|NCT01050998|3891518|B5|||Age||years|Mean|52.1|52.1|Standard Deviation|12.8|12.8|||
4069705|NCT01050998|3891519|B4|||Age||years|Mean|50.1|50.1|Standard Deviation|12.1|12.1|||
4069706|NCT01050998|3891520|B3|||Age||years|Mean|52.7|52.7|Standard Deviation|10.3|10.3|||
4069707|NCT01050998|3891521|B2|||Age||years|Mean|51.1|51.1|Standard Deviation|12.1|12.1|||
4069708|NCT01050998|3891522|B1|||Age||years|Mean|52.2|52.2|Standard Deviation|11.9|11.9|||
4069709|NCT01050946|3891850|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4069710|NCT01050946|3891850|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4069711|NCT01050946|3891850|B1|||Age||years|Mean|61|61.0|Standard Deviation|||||
4069712|NCT01050946|3891850|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4069713|NCT01050946|3891850|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4069714|NCT01050946|3891850|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069715|NCT01050816|3891860|B1|Korea, Republic of||Region of Enrollment||participants|Number|30|30.0||||||
4069716|NCT01050816|3891860|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4069717|NCT01050816|3891860|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4069718|NCT01050816|3891860|B1|||Age||years|Mean|36.67|36.67|Standard Deviation|11.44|11.44|||
4069719|NCT01050816|3891860|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4069720|NCT01050816|3891860|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4069721|NCT01050816|3891860|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069722|NCT01050790|3891866|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4069723|NCT01050790|3891866|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069724|NCT01050790|3891866|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069725|NCT01050790|3891866|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4069726|NCT01050790|3891866|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4069727|NCT01050790|3891866|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069728|NCT01050790|3891866|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069729|NCT01050790|3891866|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069730|NCT01050790|3891866|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069731|NCT01050790|3891866|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4069732|NCT01050790|3891866|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069733|NCT01050790|3891866|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4069734|NCT01050790|3891866|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4069735|NCT01050790|3891866|B1|||Age||years|Mean|59.59|59.59|Standard Deviation|7.23|7.23|||
4069736|NCT01050790|3891866|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4069737|NCT01050790|3891866|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4069738|NCT01050790|3891866|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069739|NCT01050764|3891876|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4069740|NCT01050764|3891876|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069741|NCT01050764|3891876|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4069742|NCT01050764|3891876|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4069743|NCT01050764|3891876|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069744|NCT01050764|3891876|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4069745|NCT01050764|3891876|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069746|NCT01050764|3891876|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069747|NCT01050764|3891876|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4069748|NCT01050764|3891876|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4069749|NCT01050764|3891876|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4069750|NCT01050764|3891876|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4069751|NCT01050764|3891876|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4069752|NCT01050764|3891876|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4069753|NCT01050764|3891876|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069754|NCT01050673|3891885|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4069755|NCT01050673|3891886|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4069756|NCT01050673|3891887|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4069757|NCT01050673|3891885|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4069758|NCT01050673|3891886|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4069759|NCT01050673|3891887|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4069760|NCT01050673|3891885|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4069761|NCT01050673|3891886|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4069762|NCT01050673|3891887|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4069763|NCT01050673|3891885|B3|||Age||years|Mean|54.5|54.5|Standard Deviation|14.7|14.7|||
4069764|NCT01050673|3891886|B2|||Age||years|Mean|57.1|57.1|Standard Deviation|13.7|13.7|||
4069765|NCT01050673|3891887|B1|||Age||years|Mean|52.2|52.2|Standard Deviation|15.5|15.5|||
4069766|NCT01050673|3891885|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4069767|NCT01050673|3891886|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4069768|NCT01050673|3891887|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4069769|NCT01050673|3891885|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4069770|NCT01050673|3891886|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4069771|NCT01050673|3891887|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4069772|NCT01050673|3891885|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069773|NCT01050673|3891886|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069774|NCT01050673|3891887|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069775|NCT01050660|3891910|B3|||Gestational age at enrollement|Gestational age, in full completed weeks at enrollement.|weeks|Mean|26.5|26.5|Standard Deviation|1.8|1.8|||
4069776|NCT01050660|3891911|B2|||Gestational age at enrollement|Gestational age, in full completed weeks at enrollement.|weeks|Mean|26.6|26.6|Standard Deviation|1.8|1.8|||
4069777|NCT01050660|3891912|B1|||Gestational age at enrollement|Gestational age, in full completed weeks at enrollement.|weeks|Mean|26.4|26.4|Standard Deviation|1.8|1.8|||
4069778|NCT01050660|3891910|B3|United States||Region of Enrollment||participants|Number|136|136.0||||||
4069779|NCT01050660|3891911|B2|United States||Region of Enrollment||participants|Number|69|69.0||||||
4069780|NCT01050660|3891912|B1|United States||Region of Enrollment||participants|Number|67|67.0||||||
4069781|NCT01050660|3891910|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4069782|NCT01050660|3891911|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4069783|NCT01050660|3891912|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4069784|NCT01050660|3891910|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4069785|NCT01050660|3891911|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4069786|NCT01050660|3891912|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4069787|NCT01050660|3891910|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4069788|NCT01050660|3891911|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4069789|NCT01050660|3891912|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4069790|NCT01050660|3891910|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4069791|NCT01050660|3891911|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4069792|NCT01050660|3891912|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4069793|NCT01050660|3891910|B3||<=18 years|Age||Participants|Count of Participants|136|136.0||||||
4069794|NCT01050660|3891911|B2||<=18 years|Age||Participants|Count of Participants|69|69.0||||||
4069795|NCT01050660|3891912|B1||<=18 years|Age||Participants|Count of Participants|67|67.0||||||
4069796|NCT01050647|3891937|B3|||History of prior preterm birth||Participants|Count of Participants|3|3.0||||||
4069797|NCT01050647|3891938|B2|||History of prior preterm birth||Participants|Count of Participants|0|0.0||||||
4069798|NCT01050647|3891939|B1|||History of prior preterm birth||Participants|Count of Participants|3|3.0||||||
4069799|NCT01050647|3891937|B3|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
4069800|NCT01050647|3891938|B2|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4069801|NCT01050647|3891939|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4069802|NCT01050647|3891937|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4069803|NCT01050647|3891938|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4069804|NCT01050647|3891939|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4069805|NCT01050647|3891937|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069806|NCT01050647|3891938|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069807|NCT01050647|3891939|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069808|NCT01050647|3891937|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4069809|NCT01050647|3891938|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4069810|NCT01050647|3891939|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4069811|NCT01050647|3891937|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4069812|NCT01050647|3891938|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069813|NCT01050647|3891939|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4069814|NCT01050647|3891937|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069815|NCT01050647|3891938|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069816|NCT01050647|3891939|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069817|NCT01050647|3891937|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4069818|NCT01050647|3891938|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069819|NCT01050647|3891939|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4069820|NCT01050647|3891937|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069821|NCT01050647|3891938|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069822|NCT01050647|3891939|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069823|NCT01050647|3891937|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4069824|NCT01050647|3891938|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4069825|NCT01050647|3891939|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069826|NCT01050647|3891937|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4069827|NCT01050647|3891938|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4069828|NCT01050647|3891939|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4069829|NCT01050647|3891937|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4069830|NCT01050647|3891938|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4069831|NCT01050647|3891939|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4069832|NCT01050647|3891937|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4069833|NCT01050647|3891938|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4069834|NCT01050647|3891939|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4069835|NCT01050647|3891937|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4069836|NCT01050647|3891938|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4069837|NCT01050647|3891939|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4069838|NCT01050647|3891937|B3|||Age||years|Mean|31.7|31.7|Standard Deviation|1.95|1.95|||
4069839|NCT01050647|3891938|B2|||Age||years|Mean|31.7|31.7|Standard Deviation|2.0|2.0|||
4069840|NCT01050647|3891939|B1|||Age||years|Mean|31.7|31.7|Standard Deviation|1.9|1.9|||
4069841|NCT01050634|3891956|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4069842|NCT01050634|3891956|B1||Female|Sex: Female, Male||Participants|Count of Participants|924|924.0||||||
4069843|NCT01050634|3891956|B1|Unspecified||Age, Customized||Participants|Number|33|33.0||||||
4069844|NCT01050634|3891956|B1|>= 65 years||Age, Customized||Participants|Number|417|417.0||||||
4069845|NCT01050634|3891956|B1|45-64 years||Age, Customized||Participants|Number|450|450.0||||||
4069846|NCT01050634|3891956|B1|18-44 years||Age, Customized||Participants|Number|24|24.0||||||
4069847|NCT01050582|3891964|B3|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
4069848|NCT01050582|3891965|B2|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
4069849|NCT01050582|3891966|B1|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
4069850|NCT01050582|3891964|B3|Greece||Region of Enrollment||participants|Number|5|5.0||||||
4069851|NCT01050582|3891965|B2|Greece||Region of Enrollment||participants|Number|2|2.0||||||
4069852|NCT01050582|3891966|B1|Greece||Region of Enrollment||participants|Number|3|3.0||||||
4069853|NCT01050582|3891964|B3|Netherlands||Region of Enrollment||participants|Number|8|8.0||||||
4069854|NCT01050582|3891965|B2|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4069855|NCT01050582|3891966|B1|Netherlands||Region of Enrollment||participants|Number|8|8.0||||||
4069856|NCT01050582|3891964|B3|Poland||Region of Enrollment||participants|Number|22|22.0||||||
4069857|NCT01050582|3891965|B2|Poland||Region of Enrollment||participants|Number|3|3.0||||||
4069858|NCT01050582|3891966|B1|Poland||Region of Enrollment||participants|Number|19|19.0||||||
4069859|NCT01050582|3891964|B3|Germany||Region of Enrollment||participants|Number|47|47.0||||||
4069860|NCT01050582|3891965|B2|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4069861|NCT01050582|3891966|B1|Germany||Region of Enrollment||participants|Number|41|41.0||||||
4069862|NCT01050582|3891964|B3|United States||Region of Enrollment||participants|Number|99|99.0||||||
4069863|NCT01050582|3891965|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4069864|NCT01050582|3891966|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
4069865|NCT01050582|3891964|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4069866|NCT01050582|3891965|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4069867|NCT01050582|3891966|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4069868|NCT01050582|3891964|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4069869|NCT01050582|3891965|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4069870|NCT01050582|3891966|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4069871|NCT01050582|3891964|B3||White|Race (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
4069872|NCT01050582|3891965|B2||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4069873|NCT01050582|3891966|B1||White|Race (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
4069874|NCT01050582|3891964|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4069875|NCT01050582|3891965|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4069876|NCT01050582|3891966|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4069877|NCT01050582|3891964|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069878|NCT01050582|3891965|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069879|NCT01050582|3891966|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069880|NCT01050582|3891964|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4069881|NCT01050582|3891965|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4069882|NCT01050582|3891966|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4069883|NCT01050582|3891964|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069884|NCT01050582|3891965|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069885|NCT01050582|3891966|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4069886|NCT01050582|3891964|B3||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4069887|NCT01050582|3891965|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4069888|NCT01050582|3891966|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4069889|NCT01050582|3891964|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4069890|NCT01050582|3891965|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4069891|NCT01050582|3891966|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4069892|NCT01050582|3891964|B3|||Age||years|Mean|12|12.0|Standard Deviation|2.5|2.5|||
4069893|NCT01050582|3891965|B2|||Age||years|Mean|12|12.0|Standard Deviation|2.5|2.5|||
4069894|NCT01050582|3891966|B1|||Age||years|Mean|12|12.0|Standard Deviation|2.5|2.5|||
4069895|NCT01050569|3891977|B4|United States||Region of Enrollment||participants|Number|235|235.0||||||
4069896|NCT01050569|3891978|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
4069897|NCT01050569|3891979|B2|United States||Region of Enrollment||participants|Number|76|76.0||||||
4069898|NCT01050569|3891980|B1|United States||Region of Enrollment||participants|Number|79|79.0||||||
4069899|NCT01050569|3891977|B4||Male|Gender||Participants|Count of Participants|99|99.0||||||
4069900|NCT01050569|3891978|B3||Male|Gender||Participants|Count of Participants|34|34.0||||||
4069901|NCT01050569|3891979|B2||Male|Gender||Participants|Count of Participants|33|33.0||||||
4069902|NCT01050569|3891980|B1||Male|Gender||Participants|Count of Participants|32|32.0||||||
4069903|NCT01050569|3891977|B4||Female|Gender||Participants|Count of Participants|136|136.0||||||
4069904|NCT01050569|3891978|B3||Female|Gender||Participants|Count of Participants|46|46.0||||||
4069905|NCT01050569|3891979|B2||Female|Gender||Participants|Count of Participants|43|43.0||||||
4069906|NCT01050569|3891980|B1||Female|Gender||Participants|Count of Participants|47|47.0||||||
4069907|NCT01050569|3891977|B4|||Age||years|Mean|47.0|47.0|Standard Deviation|11.7|11.7|||
4069908|NCT01050569|3891978|B3|||Age||years|Mean|47.3|47.3|Standard Deviation|11.0|11.0|||
4069909|NCT01050569|3891979|B2|||Age||years|Mean|47.0|47.0|Standard Deviation|11.9|11.9|||
4069910|NCT01050569|3891980|B1|||Age||years|Mean|46.5|46.5|Standard Deviation|12.2|12.2|||
4069911|NCT01050569|3891977|B4||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4069912|NCT01050569|3891978|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4069913|NCT01050569|3891979|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4069914|NCT01050569|3891980|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4069915|NCT01050569|3891977|B4||Between 18 and 65 years|Age||Participants|Count of Participants|225|225.0||||||
4069916|NCT01050569|3891978|B3||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
4069917|NCT01050569|3891979|B2||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
4069918|NCT01050569|3891980|B1||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4069919|NCT01050569|3891977|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069920|NCT01050569|3891978|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069921|NCT01050569|3891979|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069922|NCT01050569|3891980|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069923|NCT01050543|3891999|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4069924|NCT01050543|3892000|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4069925|NCT01050543|3892001|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4069926|NCT01050543|3891999|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4069927|NCT01050543|3892000|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4069928|NCT01050543|3892001|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4069929|NCT01050543|3891999|B3|||Age||years|Mean|42.0|42.0|Standard Deviation|13.9|13.9|||
4069930|NCT01050543|3892000|B2|||Age||years|Mean|42.6|42.6|Standard Deviation|14.0|14.0|||
4069931|NCT01050543|3892001|B1|||Age||years|Mean|41.3|41.3|Standard Deviation|14.0|14.0|||
4069932|NCT01050530|3892008|B3|Japan||Region of Enrollment||participants|Number|162|162.0||||||
4069933|NCT01050530|3892009|B2|Japan||Region of Enrollment||participants|Number|80|80.0||||||
4069934|NCT01050530|3892010|B1|Japan||Region of Enrollment||participants|Number|82|82.0||||||
4069935|NCT01050530|3892008|B3||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4069936|NCT01050530|3892009|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4069937|NCT01050530|3892010|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4069938|NCT01050530|3892008|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4069939|NCT01050530|3892009|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4069940|NCT01050530|3892010|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4069941|NCT01050530|3892008|B3||>=65 years|Age||Participants|Count of Participants|101|101.0||||||
4069942|NCT01050530|3892009|B2||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
4069943|NCT01050530|3892010|B1||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
4069944|NCT01050530|3892008|B3||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4069945|NCT01050530|3892009|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4069946|NCT01050530|3892010|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4069947|NCT01050530|3892008|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069948|NCT01050530|3892009|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069949|NCT01050530|3892010|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069950|NCT01050530|3892008|B3|||Age||years|Mean|66.4|66.4|Standard Deviation|9.1|9.1|||
4069951|NCT01050530|3892009|B2|||Age||years|Mean|66.4|66.4|Standard Deviation|8.7|8.7|||
4069952|NCT01050530|3892010|B1|||Age||years|Mean|66.3|66.3|Standard Deviation|9.4|9.4|||
4069953|NCT01050257|3892019|B4||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4069954|NCT01050257|3892020|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4069955|NCT01050257|3892021|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4069956|NCT01050257|3892022|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4069957|NCT01050257|3892019|B4||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4069958|NCT01050257|3892020|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4069959|NCT01050257|3892021|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4069960|NCT01050257|3892022|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4069961|NCT01050257|3892019|B4|||Age||years|Mean|47.4|47.4|Standard Deviation|18.93|18.93|||
4069962|NCT01050257|3892020|B3|||Age||years|Mean|66.9|66.9|Standard Deviation|18.28|18.28|||
4069963|NCT01050257|3892021|B2|||Age||years|Mean|44.3|44.3|Standard Deviation|18.09|18.09|||
4069964|NCT01050257|3892022|B1|||Age||years|Mean|44.8|44.8|Standard Deviation|16.68|16.68|||
4069965|NCT01050218|3892059|B1||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4069966|NCT01050218|3892059|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4069967|NCT01050218|3892059|B1|||Age||years|Mean|59.84|59.84|Standard Deviation|8.90|8.9|||
4069968|NCT01050205|3892063|B3|United States||Region of Enrollment||participants|Number|223|223.0||||||
4069969|NCT01050205|3892064|B2|United States||Region of Enrollment||participants|Number|75|75.0||||||
4069970|NCT01050205|3892065|B1|United States||Region of Enrollment||participants|Number|148|148.0||||||
4069971|NCT01050205|3892063|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4069972|NCT01050205|3892064|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4069973|NCT01050205|3892065|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4069974|NCT01050205|3892063|B3||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4069975|NCT01050205|3892064|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4069976|NCT01050205|3892065|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4069977|NCT01050205|3892063|B3|||Age||years|Mean|58.4|58.4|Standard Deviation|11.5|11.5|||
4069978|NCT01050205|3892064|B2|||Age||years|Mean|57.2|57.2|Standard Deviation|11.6|11.6|||
4069979|NCT01050205|3892065|B1|||Age||years|Mean|59.0|59.0|Standard Deviation|11.4|11.4|||
4069980|NCT01050153|3892094|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4069981|NCT01050153|3892095|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4069982|NCT01050153|3892096|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4069983|NCT01050153|3892094|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4069984|NCT01050153|3892095|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4069985|NCT01050153|3892096|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4069986|NCT01050153|3892094|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4069987|NCT01050153|3892095|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4069988|NCT01050153|3892096|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4069989|NCT01050153|3892094|B3|||Age||years|Mean|39.24|39.24|Standard Deviation|13.19|13.19|||
4069990|NCT01050153|3892095|B2|||Age||years|Mean|38.44|38.44|Standard Deviation|14.34|14.34|||
4069991|NCT01050153|3892096|B1|||Age||years|Mean|40.04|40.04|Standard Deviation|12.18|12.18|||
4069992|NCT01050153|3892094|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4069993|NCT01050153|3892095|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4069994|NCT01050153|3892096|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4069995|NCT01050153|3892094|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4069996|NCT01050153|3892095|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4069997|NCT01050153|3892096|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4069998|NCT01050153|3892094|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4069999|NCT01050153|3892095|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4070000|NCT01050153|3892096|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4070001|NCT01050062|3892121|B3||Male|Sex: Female, Male||Participants|Count of Participants|669|669.0||||||
4070002|NCT01050062|3892122|B2||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4070003|NCT01050062|3892123|B1||Male|Sex: Female, Male||Participants|Count of Participants|500|500.0||||||
4070004|NCT01050062|3892121|B3||Female|Sex: Female, Male||Participants|Count of Participants|756|756.0||||||
4070005|NCT01050062|3892122|B2||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4070006|NCT01050062|3892123|B1||Female|Sex: Female, Male||Participants|Count of Participants|570|570.0||||||
4070007|NCT01050062|3892121|B3|||Age||years|Mean|68.9|68.9|Standard Deviation|12.2|12.2|||
4070008|NCT01050062|3892122|B2|||Age||years|Mean|69.8|69.8|Standard Deviation|12.5|12.5|||
4070009|NCT01050062|3892123|B1|||Age||years|Mean|68.6|68.6|Standard Deviation|12.0|12.0|||
4070010|NCT01049984|3892144|B3|||Parkinson's Disease Duration|Years since first diagnosis. Data based on the modified intent to treat population of 159, 162 participants.|years|Mean|2.13|2.13|Standard Deviation|2.083|2.083|||
4070011|NCT01049984|3892145|B2|||Parkinson's Disease Duration|Years since first diagnosis. Data based on the modified intent to treat population of 159, 162 participants.|years|Mean|2.07|2.07|Standard Deviation|1.940|1.94|||
4070012|NCT01049984|3892146|B1|||Parkinson's Disease Duration|Years since first diagnosis. Data based on the modified intent to treat population of 159, 162 participants.|years|Mean|2.19|2.19|Standard Deviation|2.224|2.224|||
4070013|NCT01049984|3892144|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070014|NCT01049984|3892145|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070015|NCT01049984|3892146|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070016|NCT01049984|3892144|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4070017|NCT01049984|3892145|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4070018|NCT01049984|3892146|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4070019|NCT01049984|3892144|B3||White|Race (NIH/OMB)||Participants|Count of Participants|307|307.0||||||
4070020|NCT01049984|3892145|B2||White|Race (NIH/OMB)||Participants|Count of Participants|151|151.0||||||
4070021|NCT01049984|3892146|B1||White|Race (NIH/OMB)||Participants|Count of Participants|156|156.0||||||
4070022|NCT01049984|3892144|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4070023|NCT01049984|3892145|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4070024|NCT01049984|3892146|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4070025|NCT01049984|3892144|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4070026|NCT01049984|3892145|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4070027|NCT01049984|3892146|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070028|NCT01049984|3892144|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4070029|NCT01049984|3892145|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4070030|NCT01049984|3892146|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4070031|NCT01049984|3892144|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070032|NCT01049984|3892145|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070033|NCT01049984|3892146|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070034|NCT01049984|3892144|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4070035|NCT01049984|3892145|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070036|NCT01049984|3892146|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4070037|NCT01049984|3892144|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|309|309.0||||||
4070038|NCT01049984|3892145|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|155|155.0||||||
4070039|NCT01049984|3892146|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|154|154.0||||||
4070040|NCT01049984|3892144|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4070041|NCT01049984|3892145|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4070042|NCT01049984|3892146|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4070043|NCT01049984|3892144|B3||Male|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
4070044|NCT01049984|3892145|B2||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4070045|NCT01049984|3892146|B1||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4070046|NCT01049984|3892144|B3||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4070047|NCT01049984|3892145|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4070048|NCT01049984|3892146|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4070049|NCT01049984|3892144|B3|>=75 years||Age, Customized||participants|Number|31|31.0||||||
4070050|NCT01049984|3892145|B2|>=75 years||Age, Customized||participants|Number|15|15.0||||||
4070051|NCT01049984|3892146|B1|>=75 years||Age, Customized||participants|Number|16|16.0||||||
4070052|NCT01049984|3892144|B3|65 to <75 years||Age, Customized||participants|Number|109|109.0||||||
4070053|NCT01049984|3892145|B2|65 to <75 years||Age, Customized||participants|Number|60|60.0||||||
4070054|NCT01049984|3892146|B1|65 to <75 years||Age, Customized||participants|Number|49|49.0||||||
4070055|NCT01049984|3892144|B3|30 to <65 years||Age, Customized||participants|Number|186|186.0||||||
4070056|NCT01049984|3892145|B2|30 to <65 years||Age, Customized||participants|Number|89|89.0||||||
4070057|NCT01049984|3892146|B1|30 to <65 years||Age, Customized||participants|Number|97|97.0||||||
4070058|NCT01049984|3892144|B3|||Age||years|Mean|62.5|62.5|Standard Deviation|9.67|9.67|||
4070059|NCT01049984|3892145|B2|||Age||years|Mean|62.8|62.8|Standard Deviation|10.06|10.06|||
4070060|NCT01049984|3892146|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|9.27|9.27|||
4070061|NCT01049945|3892163|B3|United States||Region of Enrollment||participants|Number|70|70.0||||||
4070062|NCT01049945|3892164|B2|United States||Region of Enrollment||participants|Number|55|55.0||||||
4070063|NCT01049945|3892165|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4070064|NCT01049945|3892163|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4070065|NCT01049945|3892164|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4070066|NCT01049945|3892165|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4070067|NCT01049945|3892163|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4070068|NCT01049945|3892164|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4070069|NCT01049945|3892165|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4070070|NCT01049945|3892163|B3|||Age||years|Median|62.3|62.3|Full Range|||40.1|86.3|
4070071|NCT01049945|3892164|B2|||Age||years|Median|61.9|61.9|Full Range|||40.1|86.3|
4070072|NCT01049945|3892165|B1|||Age||years|Median|63.5|63.5|Full Range|||41.8|75.0|
4070073|NCT01049802|3892184|B3|||Fugl-Meyer Score|Upper extremity Fugl-Meyer Score measures of motor impairment in hemiplegic upper limb of patients with stroke. The scoring follows the natural progression of motor recovery as defined by Twitchell (Brain. 1951; 64:443-480). The score was developed by Axel Fugl-Meyer and it has been validated (Scand J Rehab Med. 1975; 7:13-31; Stroke. 2009; 40: 1386-1391). The scale ranges 0-66 with 66 representing normal motor function and 0 representing no movement. There are 33 movement items each scored 0 (cannot perform), 1 (peforms partially), 2 (performs flawlessly)|units on a scale|Mean|26.4|26.4|Standard Deviation|12.4|12.4|||
4070074|NCT01049802|3892185|B2|||Fugl-Meyer Score|Upper extremity Fugl-Meyer Score measures of motor impairment in hemiplegic upper limb of patients with stroke. The scoring follows the natural progression of motor recovery as defined by Twitchell (Brain. 1951; 64:443-480). The score was developed by Axel Fugl-Meyer and it has been validated (Scand J Rehab Med. 1975; 7:13-31; Stroke. 2009; 40: 1386-1391). The scale ranges 0-66 with 66 representing normal motor function and 0 representing no movement. There are 33 movement items each scored 0 (cannot perform), 1 (peforms partially), 2 (performs flawlessly)|units on a scale|Mean|31.5|31.5|Standard Deviation|15.3|15.3|||
4070075|NCT01049802|3892186|B1|||Fugl-Meyer Score|Upper extremity Fugl-Meyer Score measures of motor impairment in hemiplegic upper limb of patients with stroke. The scoring follows the natural progression of motor recovery as defined by Twitchell (Brain. 1951; 64:443-480). The score was developed by Axel Fugl-Meyer and it has been validated (Scand J Rehab Med. 1975; 7:13-31; Stroke. 2009; 40: 1386-1391). The scale ranges 0-66 with 66 representing normal motor function and 0 representing no movement. There are 33 movement items each scored 0 (cannot perform), 1 (peforms partially), 2 (performs flawlessly)|units on a scale|Mean|23.8|23.8|Standard Deviation|10.2|10.2|||
4070076|NCT01049802|3892184|B3||Male|Gender||Participants|Count of Participants|17|17.0||||||
4070077|NCT01049802|3892185|B2||Male|Gender||Participants|Count of Participants|5|5.0||||||
4070078|NCT01049802|3892186|B1||Male|Gender||Participants|Count of Participants|12|12.0||||||
4070079|NCT01049802|3892184|B3||Female|Gender||Participants|Count of Participants|13|13.0||||||
4070080|NCT01049802|3892185|B2||Female|Gender||Participants|Count of Participants|5|5.0||||||
4070081|NCT01049802|3892186|B1||Female|Gender||Participants|Count of Participants|8|8.0||||||
4070082|NCT01049802|3892184|B3|||Age||years|Mean|55.3|55.3|Full Range|||20.0|90.0|
4070083|NCT01049802|3892185|B2|||Age||years|Mean|48.1|48.1|Full Range|||20.0|74.0|
4070084|NCT01049802|3892186|B1|||Age||years|Mean|59.0|59.0|Full Range|||22.0|90.0|
4070085|NCT01049802|3892184|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4070086|NCT01049802|3892185|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4070087|NCT01049802|3892186|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4070088|NCT01049802|3892184|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4070089|NCT01049802|3892185|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4070090|NCT01049802|3892186|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4070091|NCT01049802|3892184|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4070092|NCT01049802|3892185|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4070093|NCT01049802|3892186|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4070094|NCT01049776|3892201|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4070095|NCT01049776|3892201|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4070096|NCT01049776|3892201|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070097|NCT01049776|3892201|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4070098|NCT01049776|3892201|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070099|NCT01049776|3892201|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070100|NCT01049776|3892201|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070101|NCT01049776|3892201|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070102|NCT01049776|3892201|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4070103|NCT01049776|3892201|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4070104|NCT01049776|3892201|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4070105|NCT01049776|3892201|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4070106|NCT01049776|3892201|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4070107|NCT01049581|3892205|B3|Taiwan||Region of Enrollment||participants|Number|27|27.0||||||
4070108|NCT01049581|3892206|B2|Taiwan||Region of Enrollment||participants|Number|14|14.0||||||
4070109|NCT01049581|3892207|B1|Taiwan||Region of Enrollment||participants|Number|13|13.0||||||
4070110|NCT01049581|3892205|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4070111|NCT01049581|3892206|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4070112|NCT01049581|3892207|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4070113|NCT01049581|3892205|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4070114|NCT01049581|3892206|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4070115|NCT01049581|3892207|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4070116|NCT01049581|3892205|B3|||Age||years|Mean|7|7.0|Standard Deviation|0.25|0.25|||
4070117|NCT01049581|3892206|B2|||Age||years|Mean|6|6.0|Standard Deviation|2.5|2.5|||
4070118|NCT01049581|3892207|B1|||Age||years|Mean|7|7.0|Standard Deviation|3|3.0|||
4070119|NCT01049581|3892205|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4070120|NCT01049581|3892206|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4070121|NCT01049581|3892207|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4070122|NCT01049581|3892205|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4070123|NCT01049581|3892206|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4070124|NCT01049581|3892207|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4070125|NCT01049581|3892205|B3||<=18 years|Age||Participants|Count of Participants|27|27.0||||||
4070126|NCT01049581|3892206|B2||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4070127|NCT01049581|3892207|B1||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4070128|NCT01049503|3892217|B7||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4070129|NCT01049503|3892218|B6||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4070130|NCT01049503|3892219|B5||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4070131|NCT01049503|3892220|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4070132|NCT01049503|3892221|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4070133|NCT01049503|3892222|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4070134|NCT01049503|3892223|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4070135|NCT01049503|3892217|B7||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4070136|NCT01049503|3892218|B6||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4070137|NCT01049503|3892219|B5||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4070138|NCT01049503|3892220|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4070139|NCT01049503|3892221|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4070140|NCT01049503|3892222|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4070141|NCT01049503|3892223|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4070142|NCT01049503|3892217|B7|>= 2 years and <= 4 years||Age, Customized||Participants|Number|315|315.0||||||
4070143|NCT01049503|3892218|B6|>= 2 years and <= 4 years||Age, Customized||Participants|Number|48|48.0||||||
4070144|NCT01049503|3892219|B5|>= 2 years and <= 4 years||Age, Customized||Participants|Number|56|56.0||||||
4070145|NCT01049503|3892220|B4|>= 2 years and <= 4 years||Age, Customized||Participants|Number|55|55.0||||||
4070146|NCT01049503|3892221|B3|>= 2 years and <= 4 years||Age, Customized||Participants|Number|56|56.0||||||
4070147|NCT01049503|3892222|B2|>= 2 years and <= 4 years||Age, Customized||Participants|Number|48|48.0||||||
4070148|NCT01049503|3892223|B1|>= 2 years and <= 4 years||Age, Customized||Participants|Number|52|52.0||||||
4070149|NCT01049412|3892257|B3|Israel||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4070150|NCT01049412|3892258|B2|Israel||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4070151|NCT01049412|3892259|B1|Israel||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4070152|NCT01049412|3892257|B3|United States||Region of Enrollment||Participants|Count of Participants|126|126.0||||||
4070153|NCT01049412|3892258|B2|United States||Region of Enrollment||Participants|Count of Participants|64|64.0||||||
4070154|NCT01049412|3892259|B1|United States||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
4070155|NCT01049412|3892257|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|129|129.0||||||
4070156|NCT01049412|3892258|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|64|64.0||||||
4070157|NCT01049412|3892259|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|65|65.0||||||
4070158|NCT01049412|3892257|B3|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4070159|NCT01049412|3892258|B2|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4070160|NCT01049412|3892259|B1|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4070161|NCT01049412|3892257|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4070162|NCT01049412|3892258|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4070163|NCT01049412|3892259|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4070164|NCT01049412|3892257|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4070165|NCT01049412|3892258|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4070166|NCT01049412|3892259|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4070167|NCT01049412|3892257|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4070168|NCT01049412|3892258|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4070169|NCT01049412|3892259|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4070170|NCT01049412|3892257|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4070171|NCT01049412|3892258|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4070172|NCT01049412|3892259|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4070173|NCT01049412|3892257|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4070174|NCT01049412|3892258|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4070175|NCT01049412|3892259|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4070176|NCT01049412|3892257|B3|||Age||years|Mean|38.17|38.17|Standard Deviation|11.85|11.85|||
4070177|NCT01049412|3892258|B2|||Age||years|Mean|39.53|39.53|Standard Deviation|12.28|12.28|||
4070178|NCT01049412|3892259|B1|||Age||years|Mean|36.82|36.82|Standard Deviation|11.34|11.34|||
4070179|NCT01049373|3892287|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4070180|NCT01049373|3892288|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4070181|NCT01049373|3892289|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4070182|NCT01049373|3892287|B3||Female|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4070183|NCT01049373|3892288|B2||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4070184|NCT01049373|3892289|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4070185|NCT01049373|3892287|B3||>=65 years|Age||Participants|Count of Participants|58|58.0||||||
4070186|NCT01049373|3892288|B2||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4070187|NCT01049373|3892289|B1||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4070188|NCT01049373|3892287|B3||Between 18 and 65 years|Age||Participants|Count of Participants|163|163.0||||||
4070189|NCT01049373|3892288|B2||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
4070190|NCT01049373|3892289|B1||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
4070191|NCT01049373|3892287|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4070192|NCT01049373|3892288|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4070193|NCT01049373|3892289|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4070194|NCT01049360|3892304|B1||Male|Gender||Participants|Count of Participants|55|55.0||||||
4070195|NCT01049360|3892304|B1||Female|Gender||Participants|Count of Participants|73|73.0||||||
4070196|NCT01049360|3892304|B1|||Age||Years|Mean|61.5|61.5|Standard Deviation|8.8|8.8|||
4070197|NCT01049334|3892345|B3|||Swollen Throat Scale (SwoTS)|"he participant was asked to evaluate how swollen his/her throat felt using a 100-mm visual analog scale. The patient was instructed to swallow and Place a line on the scale that best characterizes how swollen your throat feels now. A mark at 0-mm indicated not swollen and 100-mm indicated very swollen."|units on a scale|Mean|77.8|77.8|Standard Deviation|13.07|13.07|||
4070198|NCT01049334|3892346|B2|||Swollen Throat Scale (SwoTS)|"he participant was asked to evaluate how swollen his/her throat felt using a 100-mm visual analog scale. The patient was instructed to swallow and Place a line on the scale that best characterizes how swollen your throat feels now. A mark at 0-mm indicated not swollen and 100-mm indicated very swollen."|units on a scale|Mean|79.0|79.0|Standard Deviation|12.05|12.05|||
4070199|NCT01049334|3892347|B1|||Swollen Throat Scale (SwoTS)|"he participant was asked to evaluate how swollen his/her throat felt using a 100-mm visual analog scale. The patient was instructed to swallow and Place a line on the scale that best characterizes how swollen your throat feels now. A mark at 0-mm indicated not swollen and 100-mm indicated very swollen."|units on a scale|Mean|76.6|76.6|Standard Deviation|13.98|13.98|||
4070200|NCT01049334|3892345|B3|||Difficulty Swallowing Scale (DSS)|"Participants were asked to evaluate his/her difficulty swallowing (dysphagia) using a 100-mm visual analog scale. Participants were instructed to swallow and Place a line on the scale that best characterizes how difficult it is to swallow now. A mark at 0-mm indicated no difficulty and 100-mm indicated very difficult."|units on a scale|Mean|76.6|76.6|Standard Deviation|11.72|11.72|||
4070201|NCT01049334|3892346|B2|||Difficulty Swallowing Scale (DSS)|"Participants were asked to evaluate his/her difficulty swallowing (dysphagia) using a 100-mm visual analog scale. Participants were instructed to swallow and Place a line on the scale that best characterizes how difficult it is to swallow now. A mark at 0-mm indicated no difficulty and 100-mm indicated very difficult."|units on a scale|Mean|76.3|76.3|Standard Deviation|11.04|11.04|||
4070202|NCT01049334|3892347|B1|||Difficulty Swallowing Scale (DSS)|"Participants were asked to evaluate his/her difficulty swallowing (dysphagia) using a 100-mm visual analog scale. Participants were instructed to swallow and Place a line on the scale that best characterizes how difficult it is to swallow now. A mark at 0-mm indicated no difficulty and 100-mm indicated very difficult."|units on a scale|Mean|76.9|76.9|Standard Deviation|12.41|12.41|||
4070203|NCT01049334|3892345|B3|||Sore Throat Pain Intensity Scale (STPIS)|STPIS measures sore throat pain intensity on a 100-mm visual analog scale completed by participants. A mark at 0-mm indicates no pain upon swallowing and 100-mm indicates severe pain.|units on a scale|Mean|79.7|79.7|Standard Deviation|8.27|8.27|||
4070204|NCT01049334|3892346|B2|||Sore Throat Pain Intensity Scale (STPIS)|STPIS measures sore throat pain intensity on a 100-mm visual analog scale completed by participants. A mark at 0-mm indicates no pain upon swallowing and 100-mm indicates severe pain.|units on a scale|Mean|80.5|80.5|Standard Deviation|7.92|7.92|||
4070205|NCT01049334|3892347|B1|||Sore Throat Pain Intensity Scale (STPIS)|STPIS measures sore throat pain intensity on a 100-mm visual analog scale completed by participants. A mark at 0-mm indicates no pain upon swallowing and 100-mm indicates severe pain.|units on a scale|Mean|78.8|78.8|Standard Deviation|8.56|8.56|||
4070206|NCT01049334|3892345|B3|Other, not specified||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4070207|NCT01049334|3892346|B2|Other, not specified||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4070208|NCT01049334|3892347|B1|Other, not specified||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4070209|NCT01049334|3892345|B3|Multi-racial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4070210|NCT01049334|3892346|B2|Multi-racial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4070211|NCT01049334|3892347|B1|Multi-racial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4070212|NCT01049334|3892345|B3|White||Race/Ethnicity, Customized||participants|Number|187|187.0||||||
4070213|NCT01049334|3892346|B2|White||Race/Ethnicity, Customized||participants|Number|95|95.0||||||
4070214|NCT01049334|3892347|B1|White||Race/Ethnicity, Customized||participants|Number|92|92.0||||||
4070215|NCT01049334|3892345|B3|Black or African||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4070216|NCT01049334|3892346|B2|Black or African||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4070217|NCT01049334|3892347|B1|Black or African||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4070218|NCT01049334|3892345|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4070219|NCT01049334|3892346|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4070220|NCT01049334|3892347|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4070221|NCT01049334|3892345|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4070222|NCT01049334|3892346|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4070223|NCT01049334|3892347|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4070224|NCT01049334|3892345|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|193|193.0||||||
4070225|NCT01049334|3892346|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|97|97.0||||||
4070226|NCT01049334|3892347|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|96|96.0||||||
4070227|NCT01049334|3892345|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4070228|NCT01049334|3892346|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4070229|NCT01049334|3892347|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4070230|NCT01049334|3892345|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4070231|NCT01049334|3892346|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4070232|NCT01049334|3892347|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4070233|NCT01049334|3892345|B3||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4070234|NCT01049334|3892346|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4070235|NCT01049334|3892347|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4070236|NCT01049334|3892345|B3|||Age||years|Mean|19.8|19.8|Standard Deviation|1.47|1.47|||
4070237|NCT01049334|3892346|B2|||Age||years|Mean|19.8|19.8|Standard Deviation|1.47|1.47|||
4070238|NCT01049334|3892347|B1|||Age||years|Mean|19.8|19.8|Standard Deviation|1.48|1.48|||
4070239|NCT01049308|3892384|B1|||Hospitalizations in past year||hospitalizations|Mean|.58|0.58|Standard Deviation|1.12|1.12|||
4070240|NCT01049308|3892384|B1|||Prescribing providers||prescribing providers|Mean|5.4|5.4|Standard Deviation|2.4|2.4|||
4070241|NCT01049308|3892384|B1|No||Received treatment in heart failure specialty clinic||participants|Number|108|108.0||||||
4070242|NCT01049308|3892384|B1|Yes||Received treatment in heart failure specialty clinic||participants|Number|143|143.0||||||
4070243|NCT01049308|3892384|B1|Unknown/not reported||Other illicit substance use||participants|Number|3|3.0||||||
4070244|NCT01049308|3892384|B1|Current use||Other illicit substance use||participants|Number|1|1.0||||||
4070245|NCT01049308|3892384|B1|Past use||Other illicit substance use||participants|Number|57|57.0||||||
4070246|NCT01049308|3892384|B1|Never||Other illicit substance use||participants|Number|190|190.0||||||
4070247|NCT01049308|3892384|B1|Unknown/not reported||Marijuana use||participants|Number|3|3.0||||||
4070248|NCT01049308|3892384|B1|Current use||Marijuana use||participants|Number|14|14.0||||||
4070249|NCT01049308|3892384|B1|Past use||Marijuana use||participants|Number|78|78.0||||||
4070250|NCT01049308|3892384|B1|Never||Marijuana use||participants|Number|156|156.0||||||
4070251|NCT01049308|3892384|B1|Current use greater than 3 drinks per week||Alcohol use||participants|Number|29|29.0||||||
4070252|NCT01049308|3892384|B1|Current use less than or equal to 3 drinks/week||Alcohol use||participants|Number|59|59.0||||||
4070253|NCT01049308|3892384|B1|Former use||Alcohol use||participants|Number|83|83.0||||||
4070254|NCT01049308|3892384|B1|Never||Alcohol use||participants|Number|80|80.0||||||
4070255|NCT01049308|3892384|B1|Unknown/not reported||Tobacco use||participants|Number|3|3.0||||||
4070256|NCT01049308|3892384|B1|Current smoker||Tobacco use||participants|Number|47|47.0||||||
4070257|NCT01049308|3892384|B1|Former smoker||Tobacco use||participants|Number|154|154.0||||||
4070258|NCT01049308|3892384|B1|Never smoked||Tobacco use||participants|Number|47|47.0||||||
4070259|NCT01049308|3892384|B1|Unknown/not reported||History of PTSD||participants|Number|3|3.0||||||
4070260|NCT01049308|3892384|B1|No||History of PTSD||participants|Number|201|201.0||||||
4070261|NCT01049308|3892384|B1|Yes||History of PTSD||participants|Number|47|47.0||||||
4070262|NCT01049308|3892384|B1|||Geriatric Depression Scale|Geriatric Depression Scale (GDS) is a validated self-report measure consisting of 30 questions used to screen elderly people for depression. Cutoff scores are as follows: 0-9 normal, 10-19 mildly depressed, 20-30 severely depressed.|scores on a scale|Mean|13.3|13.3|Standard Deviation|3.80|3.8|||
4070263|NCT01049308|3892384|B1|Unknown/not reported||History of depression||participants|Number|1|1.0||||||
4070264|NCT01049308|3892384|B1|No||History of depression||participants|Number|174|174.0||||||
4070265|NCT01049308|3892384|B1|Yes||History of depression||participants|Number|76|76.0||||||
4070266|NCT01049308|3892384|B1|||Left ventricular ejection fraction||%|Mean|37.5|37.5|Standard Deviation|16.90|16.9|||
4070267|NCT01049308|3892384|B1|Not reported/unknown||Left ventricular ejection fraction||participants|Number|2|2.0||||||
4070268|NCT01049308|3892384|B1|<=40%||Left ventricular ejection fraction||participants|Number|164|164.0||||||
4070269|NCT01049308|3892384|B1|>40%||Left ventricular ejection fraction||participants|Number|85|85.0||||||
4070270|NCT01049308|3892384|B1|Not reported/unknown||Heart failure cause||participants|Number|13|13.0||||||
4070271|NCT01049308|3892384|B1|Non-ischemic||Heart failure cause||participants|Number|107|107.0||||||
4070272|NCT01049308|3892384|B1|Ischemic||Heart failure cause||participants|Number|131|131.0||||||
4070273|NCT01049308|3892384|B1|Not reported/unknown||Heart Failure duration||participants|Number|2|2.0||||||
4070274|NCT01049308|3892384|B1|Greater than 5 years||Heart Failure duration||participants|Number|123|123.0||||||
4070275|NCT01049308|3892384|B1|1-5 years||Heart Failure duration||participants|Number|104|104.0||||||
4070276|NCT01049308|3892384|B1|Less than 1 year||Heart Failure duration||participants|Number|22|22.0||||||
4070277|NCT01049308|3892384|B1|||Hemoglobin A1c||%|Mean|6.8|6.8|Standard Deviation|1.5|1.5|||
4070278|NCT01049308|3892384|B1|||Brain natriuretic peptide level||pg/mL|Mean|274.7|274.7|Standard Deviation|497|497.0|||
4070279|NCT01049308|3892384|B1|||Thyroid-stimulating hormone||uiU/mL|Mean|2.99|2.99|Standard Deviation|4.39|4.39|||
4070280|NCT01049308|3892384|B1|||Serum creatinine level||mg/dL|Mean|1.59|1.59|Standard Deviation|1.84|1.84|||
4070281|NCT01049308|3892384|B1|||Hemoglobin level||g/dL|Mean|13.6|13.6|Standard Deviation|2.19|2.19|||
4070282|NCT01049308|3892384|B1|||Vitamin B12 level||pg/mL|Mean|556.8|556.8|Standard Deviation|298.26|298.26|||
4070283|NCT01049308|3892384|B1|||Thiamine level||nmol/L|Mean|169|169.0|Standard Deviation|95.60|95.6|||
4070284|NCT01049308|3892384|B1|||Systolic blood pressure||mm hG|Mean|125.8|125.8|Standard Deviation|19.67|19.67|||
4070285|NCT01049308|3892384|B1|No||History of stroke||participants|Number|225|225.0||||||
4070286|NCT01049308|3892384|B1|Yes||History of stroke||participants|Number|26|26.0||||||
4070287|NCT01049308|3892384|B1|No||History of atrial fibrillation||participants|Number|169|169.0||||||
4070288|NCT01049308|3892384|B1|Yes||History of atrial fibrillation||participants|Number|82|82.0||||||
4070289|NCT01049308|3892384|B1|Do not have diagnosis||Obstructive sleep apnea||participants|Number|183|183.0||||||
4070290|NCT01049308|3892384|B1|Have diagnosis||Obstructive sleep apnea||participants|Number|68|68.0||||||
4070291|NCT01049308|3892384|B1|Do not have diagnosis||Hypertension||participants|Number|58|58.0||||||
4070292|NCT01049308|3892384|B1|Have diagnosis||Hypertension||participants|Number|193|193.0||||||
4070293|NCT01049308|3892384|B1|Do not have diagnosis||Coronary Artery Disease||participants|Number|91|91.0||||||
4070294|NCT01049308|3892384|B1|Have diagnosis||Coronary Artery Disease||participants|Number|160|160.0||||||
4070295|NCT01049308|3892384|B1|Do not have diagnosis||Diabetes (I or II)||participants|Number|117|117.0||||||
4070296|NCT01049308|3892384|B1|Have diagnosis||Diabetes (I or II)||participants|Number|134|134.0||||||
4070297|NCT01049308|3892384|B1|Not reported/unknown||self-perceived financial status||participants|Number|30|30.0||||||
4070298|NCT01049308|3892384|B1|Affects ability to care for health||self-perceived financial status||participants|Number|110|110.0||||||
4070299|NCT01049308|3892384|B1|Does not affect ability to care for health||self-perceived financial status||participants|Number|111|111.0||||||
4070300|NCT01049308|3892384|B1|Not reported/unknown||education||participants|Number|3|3.0||||||
4070301|NCT01049308|3892384|B1|College degree or above||education||participants|Number|60|60.0||||||
4070302|NCT01049308|3892384|B1|Some college||education||participants|Number|103|103.0||||||
4070303|NCT01049308|3892384|B1|High school diploma||education||participants|Number|60|60.0||||||
4070304|NCT01049308|3892384|B1|Less than high school||education||participants|Number|25|25.0||||||
4070305|NCT01049308|3892384|B1|Not reported||Living arrangement||participants|Number|2|2.0||||||
4070306|NCT01049308|3892384|B1|Other||Living arrangement||participants|Number|22|22.0||||||
4070307|NCT01049308|3892384|B1|Live with children||Living arrangement||participants|Number|17|17.0||||||
4070308|NCT01049308|3892384|B1|Live with spouse/partner||Living arrangement||participants|Number|142|142.0||||||
4070309|NCT01049308|3892384|B1|Live alone||Living arrangement||participants|Number|68|68.0||||||
4070310|NCT01049308|3892384|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4070311|NCT01049308|3892384|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070312|NCT01049308|3892384|B1||White|Race (NIH/OMB)||Participants|Count of Participants|180|180.0||||||
4070313|NCT01049308|3892384|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4070314|NCT01049308|3892384|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070315|NCT01049308|3892384|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070316|NCT01049308|3892384|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070317|NCT01049308|3892384|B1||Male|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
4070318|NCT01049308|3892384|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4070319|NCT01049308|3892384|B1|||Age||years|Mean|66.4|66.4|Standard Deviation|9.8|9.8|||
4070320|NCT01049243|3892391|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4070321|NCT01049243|3892391|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4070322|NCT01049243|3892391|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4070323|NCT01049243|3892391|B1|||Age||years|Median|27|27.0|Full Range|||17.0|62.0|
4070324|NCT01049217|3892396|B3||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4070325|NCT01049217|3892397|B2||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4070326|NCT01049217|3892398|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4070327|NCT01049217|3892396|B3||Female|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
4070328|NCT01049217|3892397|B2||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4070329|NCT01049217|3892398|B1||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4070330|NCT01049217|3892396|B3|||Age||years|Mean|41.7|41.7|Standard Deviation|8.7|8.7|||
4070331|NCT01049217|3892397|B2|||Age||years|Mean|42.3|42.3|Standard Deviation|8.4|8.4|||
4070332|NCT01049217|3892398|B1|||Age||years|Mean|41.2|41.2|Standard Deviation|9.0|9.0|||
4070333|NCT01049009|3892469|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4070334|NCT01049009|3892470|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4070335|NCT01049009|3892471|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4070336|NCT01049009|3892469|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4070337|NCT01049009|3892470|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4070338|NCT01049009|3892471|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4070339|NCT01049009|3892469|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4070340|NCT01049009|3892470|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4070341|NCT01049009|3892471|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4070342|NCT01049009|3892469|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4070343|NCT01049009|3892470|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4070344|NCT01049009|3892471|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4070345|NCT01049009|3892469|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4070346|NCT01049009|3892470|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4070347|NCT01049009|3892471|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4070348|NCT01048944|3892480|B5|United States||Region of Enrollment||participants|Number|126|126.0||||||
4070349|NCT01048944|3892481|B4|United States||Region of Enrollment||participants|Number|21|21.0||||||
4070350|NCT01048944|3892482|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
4070351|NCT01048944|3892483|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
4070352|NCT01048944|3892484|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4070353|NCT01048944|3892480|B5||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4070354|NCT01048944|3892481|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4070355|NCT01048944|3892482|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4070356|NCT01048944|3892483|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4070357|NCT01048944|3892484|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4070358|NCT01048944|3892480|B5||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4070359|NCT01048944|3892481|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4070360|NCT01048944|3892482|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4070361|NCT01048944|3892483|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4070362|NCT01048944|3892484|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4070363|NCT01048944|3892480|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4070364|NCT01048944|3892481|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4070365|NCT01048944|3892482|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4070366|NCT01048944|3892483|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4070367|NCT01048944|3892484|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4070368|NCT01048944|3892480|B5||Between 18 and 65 years|Age||Participants|Count of Participants|119|119.0||||||
4070369|NCT01048944|3892481|B4||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4070370|NCT01048944|3892482|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4070371|NCT01048944|3892483|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4070372|NCT01048944|3892484|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4070373|NCT01048944|3892480|B5||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4070374|NCT01048944|3892481|B4||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4070375|NCT01048944|3892482|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4070376|NCT01048944|3892483|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4070377|NCT01048944|3892484|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4070378|NCT01048944|3892480|B5|||Age||years|Mean|30.64|30.64|Standard Deviation|10.97|10.97|||
4070379|NCT01048944|3892481|B4|||Age||years|Mean|26.8|26.8|Standard Deviation|10.42|10.42|||
4070380|NCT01048944|3892482|B3|||Age||years|Mean|31.49|31.49|Standard Deviation|10.44|10.44|||
4070381|NCT01048944|3892483|B2|||Age||years|Mean|30.84|30.84|Standard Deviation|11.00|11.0|||
4070382|NCT01048944|3892484|B1|||Age||years|Mean|31.85|31.85|Standard Deviation|11.76|11.76|||
4070383|NCT01048879|3892501|B4|United States||Region of Enrollment||participants|Number|15|15.0||||||
4070384|NCT01048879|3892502|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4070385|NCT01048879|3892503|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4070386|NCT01048879|3892504|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4070387|NCT01048879|3892501|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4070388|NCT01048879|3892502|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4070389|NCT01048879|3892503|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4070390|NCT01048879|3892504|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4070391|NCT01048879|3892501|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4070392|NCT01048879|3892502|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4070393|NCT01048879|3892503|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4070394|NCT01048879|3892504|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4070395|NCT01048879|3892501|B4|||Age||years|Mean|33.8|33.8|Standard Deviation|12.4|12.4|||
4070396|NCT01048879|3892502|B3|||Age||years|Mean|32.2|32.2|Standard Deviation|16.1|16.1|||
4070397|NCT01048879|3892503|B2|||Age||years|Mean|33.0|33.0|Standard Deviation|10.2|10.2|||
4070398|NCT01048879|3892504|B1|||Age||years|Mean|48|48.0|Standard Deviation|0|0.0|||
4070399|NCT01048879|3892501|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4070400|NCT01048879|3892502|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4070401|NCT01048879|3892503|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4070402|NCT01048879|3892504|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4070403|NCT01048879|3892501|B4||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4070404|NCT01048879|3892502|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4070405|NCT01048879|3892503|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4070406|NCT01048879|3892504|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4070407|NCT01048879|3892501|B4||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4070408|NCT01048879|3892502|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4070409|NCT01048879|3892503|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4070410|NCT01048879|3892504|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4070411|NCT01048866|3892517|B3|||Swollen Throat Scale (SwoTS)|"SwoTS measures how swollen a participant's throat felt using a 100-mm visual analog scale completed by participants. Participants were instructed to swallow and Place a line on the scale that best characterizes how swollen your throat feels now. A mark at 0-mm indicated not swollen and 100-mm indicated very swollen."|units on a scale|Mean|76.0|76.0|Standard Deviation|12.80|12.8|||
4070412|NCT01048866|3892518|B2|||Swollen Throat Scale (SwoTS)|"SwoTS measures how swollen a participant's throat felt using a 100-mm visual analog scale completed by participants. Participants were instructed to swallow and Place a line on the scale that best characterizes how swollen your throat feels now. A mark at 0-mm indicated not swollen and 100-mm indicated very swollen."|units on a scale|Mean|76.0|76.0|Standard Deviation|12.7|12.7|||
4070413|NCT01048866|3892519|B1|||Swollen Throat Scale (SwoTS)|"SwoTS measures how swollen a participant's throat felt using a 100-mm visual analog scale completed by participants. Participants were instructed to swallow and Place a line on the scale that best characterizes how swollen your throat feels now. A mark at 0-mm indicated not swollen and 100-mm indicated very swollen."|units on a scale|Mean|76.0|76.0|Standard Deviation|12.90|12.9|||
4070414|NCT01048866|3892517|B3|||Difficulty Swallowing Scale (DSS)|"DSS measures difficulty swallowing (dysphagia) using a 100-mm visual analog scale completed by participants. Participants were instructed to swallow and Place a line on the scale that best characterizes how difficult it is to swallow now. A mark at 0-mm indicated not difficult and 100-mm indicated very difficult."|units on a scale|Mean|78.0|78.0|Standard Deviation|10.45|10.45|||
4070415|NCT01048866|3892518|B2|||Difficulty Swallowing Scale (DSS)|"DSS measures difficulty swallowing (dysphagia) using a 100-mm visual analog scale completed by participants. Participants were instructed to swallow and Place a line on the scale that best characterizes how difficult it is to swallow now. A mark at 0-mm indicated not difficult and 100-mm indicated very difficult."|units on a scale|Mean|78.2|78.2|Standard Deviation|10.3|10.3|||
4070416|NCT01048866|3892519|B1|||Difficulty Swallowing Scale (DSS)|"DSS measures difficulty swallowing (dysphagia) using a 100-mm visual analog scale completed by participants. Participants were instructed to swallow and Place a line on the scale that best characterizes how difficult it is to swallow now. A mark at 0-mm indicated not difficult and 100-mm indicated very difficult."|units on a scale|Mean|77.9|77.9|Standard Deviation|10.55|10.55|||
4070417|NCT01048866|3892517|B3|||Sore Throat Pain Intensity Scale (STPIS)|STPIS measures sore throat pain intensity on a 100-mm visual analog scale completed by participants. A mark at 0-mm indicates no pain upon swallowing and 100-mm indicates severe pain.|units on a scale|Mean|79.1|79.1|Standard Deviation|8.21|8.21|||
4070418|NCT01048866|3892518|B2|||Sore Throat Pain Intensity Scale (STPIS)|STPIS measures sore throat pain intensity on a 100-mm visual analog scale completed by participants. A mark at 0-mm indicates no pain upon swallowing and 100-mm indicates severe pain.|units on a scale|Mean|79.1|79.1|Standard Deviation|8.37|8.37|||
4070419|NCT01048866|3892519|B1|||Sore Throat Pain Intensity Scale (STPIS)|STPIS measures sore throat pain intensity on a 100-mm visual analog scale completed by participants. A mark at 0-mm indicates no pain upon swallowing and 100-mm indicates severe pain.|units on a scale|Mean|79.1|79.1|Standard Deviation|8.09|8.09|||
4070420|NCT01048866|3892517|B3|Non-Hispanic or non-Latino||Race/Ethnicity, Customized||participants|Number|172|172.0||||||
4070421|NCT01048866|3892518|B2|Non-Hispanic or non-Latino||Race/Ethnicity, Customized||participants|Number|87|87.0||||||
4070422|NCT01048866|3892519|B1|Non-Hispanic or non-Latino||Race/Ethnicity, Customized||participants|Number|85|85.0||||||
4070423|NCT01048866|3892517|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4070424|NCT01048866|3892518|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4070425|NCT01048866|3892519|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4070426|NCT01048866|3892517|B3|Other, not specified||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4070427|NCT01048866|3892518|B2|Other, not specified||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4070428|NCT01048866|3892519|B1|Other, not specified||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4070429|NCT01048866|3892517|B3|Multi-racial (no primary)||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4070430|NCT01048866|3892518|B2|Multi-racial (no primary)||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4070431|NCT01048866|3892519|B1|Multi-racial (no primary)||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4070432|NCT01048866|3892517|B3|White||Race/Ethnicity, Customized||participants|Number|134|134.0||||||
4070433|NCT01048866|3892518|B2|White||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
4070434|NCT01048866|3892519|B1|White||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
4070435|NCT01048866|3892517|B3|Black or African||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4070436|NCT01048866|3892518|B2|Black or African||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4070437|NCT01048866|3892519|B1|Black or African||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4070438|NCT01048866|3892517|B3|Asian||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4070439|NCT01048866|3892518|B2|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4070440|NCT01048866|3892519|B1|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4070441|NCT01048866|3892517|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4070442|NCT01048866|3892518|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4070443|NCT01048866|3892519|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4070444|NCT01048866|3892517|B3||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4070445|NCT01048866|3892518|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4070446|NCT01048866|3892519|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4070447|NCT01048866|3892517|B3|||Age||years|Mean|33.9|33.9|Standard Deviation|11.0|11.0|||
4070448|NCT01048866|3892518|B2|||Age||years|Mean|34.2|34.2|Standard Deviation|11.17|11.17|||
4070449|NCT01048866|3892519|B1|||Age||years|Mean|33.5|33.5|Standard Deviation|11.03|11.03|||
4070450|NCT01048788|3892562|B4|Japan||Region of Enrollment||participants|Number|51|51.0||||||
4070451|NCT01048788|3892563|B3|Japan||Region of Enrollment||participants|Number|13|13.0||||||
4070452|NCT01048788|3892564|B2|Japan||Region of Enrollment||participants|Number|30|30.0||||||
4070453|NCT01048788|3892565|B1|Japan||Region of Enrollment||participants|Number|8|8.0||||||
4070454|NCT01048788|3892562|B4||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4070455|NCT01048788|3892563|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4070456|NCT01048788|3892564|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4070457|NCT01048788|3892565|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4070458|NCT01048788|3892562|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4070459|NCT01048788|3892563|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4070460|NCT01048788|3892564|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4070461|NCT01048788|3892565|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4070462|NCT01048788|3892562|B4||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4070463|NCT01048788|3892563|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4070464|NCT01048788|3892564|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4070465|NCT01048788|3892565|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4070466|NCT01048788|3892562|B4||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4070467|NCT01048788|3892563|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4070468|NCT01048788|3892564|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4070469|NCT01048788|3892565|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4070470|NCT01048788|3892562|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4070471|NCT01048788|3892563|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4070472|NCT01048788|3892564|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4070473|NCT01048788|3892565|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4070474|NCT01048788|3892562|B4|||Age||years|Mean|63.5|63.5|Standard Deviation|8.9|8.9|||
4070475|NCT01048788|3892563|B3|||Age||years|Mean|61.0|61.0|Standard Deviation|11.4|11.4|||
4070476|NCT01048788|3892564|B2|||Age||years|Mean|63.9|63.9|Standard Deviation|8.2|8.2|||
4070477|NCT01048788|3892565|B1|||Age||years|Mean|66.3|66.3|Standard Deviation|6.8|6.8|||
4070478|NCT01048723|3892575|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4070479|NCT01048723|3892575|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4070480|NCT01048723|3892575|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4070481|NCT01048723|3892575|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4070482|NCT01048723|3892575|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4070483|NCT01048723|3892575|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4070484|NCT01048697|3892582|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4070485|NCT01048697|3892582|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4070486|NCT01048697|3892582|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4070487|NCT01048697|3892582|B1|||Age||years|Mean|36.6|36.6|Standard Deviation|11.3|11.3|||
4070488|NCT01048697|3892582|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4070489|NCT01048697|3892582|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4070490|NCT01048697|3892582|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4070491|NCT01048671|3892586|B4|||Time Since Human Immunodeficiency Virus (HIV) Infection Diagnosis||Years|Mean|11.1|11.1|Standard Deviation|7.7|7.7|||
4070492|NCT01048671|3892587|B3|||Time Since Human Immunodeficiency Virus (HIV) Infection Diagnosis||Years|Mean|11.6|11.6|Standard Deviation|7.5|7.5|||
4070493|NCT01048671|3892588|B2|||Time Since Human Immunodeficiency Virus (HIV) Infection Diagnosis||Years|Mean|13.0|13.0|Standard Deviation|7.0|7.0|||
4070494|NCT01048671|3892589|B1|||Time Since Human Immunodeficiency Virus (HIV) Infection Diagnosis||Years|Mean|2.8|2.8|Standard Deviation|4.7|4.7|||
4070495|NCT01048671|3892586|B4||Male|Sex: Female, Male||Participants|Count of Participants|307|307.0||||||
4070496|NCT01048671|3892587|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4070497|NCT01048671|3892588|B2||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4070498|NCT01048671|3892589|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4070499|NCT01048671|3892586|B4||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4070500|NCT01048671|3892587|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4070501|NCT01048671|3892588|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4070502|NCT01048671|3892589|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4070503|NCT01048671|3892586|B4|||Age||Years|Mean|46.4|46.4|Standard Deviation|10.6|10.6|||
4070504|NCT01048671|3892587|B3|||Age||Years|Mean|46.5|46.5|Standard Deviation|10.4|10.4|||
4070505|NCT01048671|3892588|B2|||Age||Years|Mean|47.3|47.3|Standard Deviation|10.1|10.1|||
4070506|NCT01048671|3892589|B1|||Age||Years|Mean|42.9|42.9|Standard Deviation|12.0|12.0|||
4070507|NCT01048658|3892612|B3|United States||Region of Enrollment||participants|Number|160|160.0||||||
4070508|NCT01048658|3892613|B2|United States||Region of Enrollment||participants|Number|80|80.0||||||
4070509|NCT01048658|3892614|B1|United States||Region of Enrollment||participants|Number|80|80.0||||||
4070510|NCT01048658|3892612|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4070511|NCT01048658|3892613|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4070512|NCT01048658|3892614|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4070513|NCT01048658|3892612|B3||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4070514|NCT01048658|3892613|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4070515|NCT01048658|3892614|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4070516|NCT01048658|3892612|B3|||Age||years|Mean|25.9|25.9|Standard Deviation|6.0|6.0|||
4070517|NCT01048658|3892613|B2|||Age||years|Mean|25.9|25.9|Standard Deviation|5.9|5.9|||
4070518|NCT01048658|3892614|B1|||Age||years|Mean|25.9|25.9|Standard Deviation|6.2|6.2|||
4070519|NCT01048606|3892629|B5|||Body Mass Index||kg/m2|Mean|30.9|30.9|Standard Deviation|5.1|5.1|||
4070520|NCT01048606|3892630|B4|||Body Mass Index||kg/m2|Mean|31.1|31.1|Standard Deviation|2.9|2.9|||
4070521|NCT01048606|3892631|B3|||Body Mass Index||kg/m2|Mean|30.3|30.3|Standard Deviation|5.3|5.3|||
4070522|NCT01048606|3892632|B2|||Body Mass Index||kg/m2|Mean|33.8|33.8|Standard Deviation|5.8|5.8|||
4070523|NCT01048606|3892633|B1|||Body Mass Index||kg/m2|Mean|29.8|29.8|Standard Deviation|4.7|4.7|||
4070524|NCT01048606|3892629|B5|Canada||Region of Enrollment||participants|Number|79|79.0||||||
4070525|NCT01048606|3892630|B4|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4070526|NCT01048606|3892631|B3|Canada||Region of Enrollment||participants|Number|26|26.0||||||
4070527|NCT01048606|3892632|B2|Canada||Region of Enrollment||participants|Number|15|15.0||||||
4070528|NCT01048606|3892633|B1|Canada||Region of Enrollment||participants|Number|28|28.0||||||
4070529|NCT01048606|3892629|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4070530|NCT01048606|3892630|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4070531|NCT01048606|3892631|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4070532|NCT01048606|3892632|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4070533|NCT01048606|3892633|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4070534|NCT01048606|3892629|B5||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4070535|NCT01048606|3892630|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4070536|NCT01048606|3892631|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4070537|NCT01048606|3892632|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4070538|NCT01048606|3892633|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4070539|NCT01048606|3892629|B5|||Age||years|Mean|60.4|60.4|Standard Deviation|4.8|4.8|||
4070540|NCT01048606|3892630|B4|||Age||years|Mean|61.7|61.7|Standard Deviation|3.9|3.9|||
4070541|NCT01048606|3892631|B3|||Age||years|Mean|60.5|60.5|Standard Deviation|3.8|3.8|||
4070542|NCT01048606|3892632|B2|||Age||years|Mean|58.4|58.4|Standard Deviation|4.3|4.3|||
4070543|NCT01048606|3892633|B1|||Age||years|Mean|59.5|59.5|Standard Deviation|5.7|5.7|||
4070544|NCT01048593|3892646|B4|Unknown||Sex/Gender, Customized|The number of male/female per treatment group was not recorded.|participants|Number|6|6.0||||||
4070545|NCT01048593|3892647|B3|Unknown||Sex/Gender, Customized|The number of male/female per treatment group was not recorded.|participants|Number|1|1.0||||||
4070546|NCT01048593|3892648|B2|Unknown||Sex/Gender, Customized|The number of male/female per treatment group was not recorded.|participants|Number|2|2.0||||||
4070547|NCT01048593|3892649|B1|Unknown||Sex/Gender, Customized|The number of male/female per treatment group was not recorded.|participants|Number|3|3.0||||||
4070548|NCT01048593|3892646|B4|Male||Sex/Gender, Customized|The number of male/female per treatment group was not recorded.|participants|Number|0|0.0||||||
4070549|NCT01048593|3892647|B3|Male||Sex/Gender, Customized|The number of male/female per treatment group was not recorded.|participants|Number|0|0.0||||||
4070550|NCT01048593|3892648|B2|Male||Sex/Gender, Customized|The number of male/female per treatment group was not recorded.|participants|Number|0|0.0||||||
4070551|NCT01048593|3892649|B1|Male||Sex/Gender, Customized|The number of male/female per treatment group was not recorded.|participants|Number|0|0.0||||||
4070552|NCT01048593|3892646|B4|Female||Sex/Gender, Customized|The number of male/female per treatment group was not recorded.|participants|Number|0|0.0||||||
4070553|NCT01048593|3892647|B3|Female||Sex/Gender, Customized|The number of male/female per treatment group was not recorded.|participants|Number|0|0.0||||||
4070554|NCT01048593|3892648|B2|Female||Sex/Gender, Customized|The number of male/female per treatment group was not recorded.|participants|Number|0|0.0||||||
4070555|NCT01048593|3892649|B1|Female||Sex/Gender, Customized|The number of male/female per treatment group was not recorded.|participants|Number|0|0.0||||||
4070556|NCT01048593|3892646|B4|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4070557|NCT01048593|3892647|B3|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4070558|NCT01048593|3892648|B2|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4070559|NCT01048593|3892649|B1|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4070560|NCT01048593|3892646|B4|Between 18 and 65 years||Age, Customized||participants|Number|6|6.0||||||
4070561|NCT01048593|3892647|B3|Between 18 and 65 years||Age, Customized||participants|Number|1|1.0||||||
4070562|NCT01048593|3892648|B2|Between 18 and 65 years||Age, Customized||participants|Number|2|2.0||||||
4070563|NCT01048593|3892649|B1|Between 18 and 65 years||Age, Customized||participants|Number|3|3.0||||||
4070564|NCT01048593|3892646|B4|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4070565|NCT01048593|3892647|B3|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4070566|NCT01048593|3892648|B2|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4070567|NCT01048593|3892649|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4070568|NCT01048541|3892671|B1|Germany||Region of Enrollment||participants|Number|37|37.0||||||
4070569|NCT01048541|3892671|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4070570|NCT01048541|3892671|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4070571|NCT01048541|3892671|B1|||Age||years|Mean|39.5|39.5|Standard Deviation|12.7|12.7|||
4070572|NCT01048541|3892671|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4070573|NCT01048541|3892671|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4070574|NCT01048541|3892671|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4070575|NCT01048502|3892678|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070576|NCT01048502|3892679|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070577|NCT01048502|3892680|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070578|NCT01048502|3892681|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070579|NCT01048502|3892682|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070580|NCT01048502|3892678|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070581|NCT01048502|3892679|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070582|NCT01048502|3892680|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070583|NCT01048502|3892681|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070584|NCT01048502|3892682|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070585|NCT01048502|3892678|B5||White|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4070586|NCT01048502|3892679|B4||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4070587|NCT01048502|3892680|B3||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4070588|NCT01048502|3892681|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4070589|NCT01048502|3892682|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4070590|NCT01048502|3892678|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4070591|NCT01048502|3892679|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4070592|NCT01048502|3892680|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4070593|NCT01048502|3892681|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4070594|NCT01048502|3892682|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4070595|NCT01048502|3892678|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070596|NCT01048502|3892679|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070597|NCT01048502|3892680|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070598|NCT01048502|3892681|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070599|NCT01048502|3892682|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070600|NCT01048502|3892678|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4070601|NCT01048502|3892679|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4070602|NCT01048502|3892680|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4070603|NCT01048502|3892681|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4070604|NCT01048502|3892682|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4070605|NCT01048502|3892678|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070606|NCT01048502|3892679|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070607|NCT01048502|3892680|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070608|NCT01048502|3892681|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070609|NCT01048502|3892682|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070610|NCT01048502|3892678|B5||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4070611|NCT01048502|3892679|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4070612|NCT01048502|3892680|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4070613|NCT01048502|3892681|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4070614|NCT01048502|3892682|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4070615|NCT01048502|3892678|B5||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4070616|NCT01048502|3892679|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4070617|NCT01048502|3892680|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4070618|NCT01048502|3892681|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4070619|NCT01048502|3892682|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4070620|NCT01048502|3892678|B5|||Age||years|Mean|25.75|25.75|Full Range|||18.0|43.0|
4070621|NCT01048502|3892679|B4|||Age||years|Mean|24.68|24.68|Full Range|||19.0|36.0|
4070622|NCT01048502|3892680|B3|||Age||years|Mean|26.68|26.68|Full Range|||18.0|42.0|
4070623|NCT01048502|3892681|B2|||Age||years|Mean|25.96|25.96|Full Range|||18.0|43.0|
4070624|NCT01048502|3892682|B1|||Age||years|Mean|25.58|25.58|Full Range|||21.0|43.0|
4070625|NCT01048424|3892696|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4070626|NCT01048424|3892697|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4070627|NCT01048424|3892698|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4070628|NCT01048424|3892696|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4070629|NCT01048424|3892697|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4070630|NCT01048424|3892698|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4070631|NCT01048424|3892696|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4070632|NCT01048424|3892697|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4070633|NCT01048424|3892698|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4070634|NCT01048424|3892696|B3|||Age||years|Mean|56|56.0|Standard Deviation|15|15.0|||
4070635|NCT01048424|3892697|B2|||Age||years|Mean|54.73|54.73|Standard Deviation|16.8|16.8|||
4070636|NCT01048424|3892698|B1|||Age||years|Mean|56.7|56.7|Standard Deviation|10.9|10.9|||
4070637|NCT01048424|3892696|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4070638|NCT01048424|3892697|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4070639|NCT01048424|3892698|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4070640|NCT01048424|3892696|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4070641|NCT01048424|3892697|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4070642|NCT01048424|3892698|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4070643|NCT01048424|3892696|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4070644|NCT01048424|3892697|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4070645|NCT01048424|3892698|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4070646|NCT01048333|3892721|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4070647|NCT01048333|3892721|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4070648|NCT01048333|3892721|B1|||Age||years|Mean|66.5|66.5|Full Range|||41.0|84.0|
4070649|NCT01048242|3892746|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
4070650|NCT01048242|3892747|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4070651|NCT01048242|3892748|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4070652|NCT01048242|3892746|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4070653|NCT01048242|3892747|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4070654|NCT01048242|3892748|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4070655|NCT01048242|3892746|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4070656|NCT01048242|3892747|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4070657|NCT01048242|3892748|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4070658|NCT01048242|3892746|B3|||Age||years|Mean|72|72.0|Standard Deviation|5.6|5.6|||
4070659|NCT01048242|3892747|B2|||Age||years|Mean|70.6|70.6|Standard Deviation|3.5|3.5|||
4070660|NCT01048242|3892748|B1|||Age||years|Mean|73.6|73.6|Standard Deviation|5.6|5.6|||
4070661|NCT01048242|3892746|B3||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4070662|NCT01048242|3892747|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4070663|NCT01048242|3892748|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4070664|NCT01048242|3892746|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4070665|NCT01048242|3892747|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4070666|NCT01048242|3892748|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4070667|NCT01048242|3892746|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4070668|NCT01048242|3892747|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4070669|NCT01048242|3892748|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4070670|NCT01048125|3892755|B3|United States||Region of Enrollment||||0|0.0||||||
4070671|NCT01048125|3892755|B3||Male|Gender||||0|0.0||||||
4070672|NCT01048125|3892755|B3||Female|Gender||||0|0.0||||||
4070673|NCT01048125|3892755|B3||>=65 years|Age||||0|0.0||||||
4070674|NCT01048125|3892755|B3||Between 18 and 65 years|Age||||0|0.0||||||
4070675|NCT01048125|3892755|B3||<=18 years|Age||||0|0.0||||||
4070676|NCT01048099|3892764|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4070677|NCT01048099|3892764|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4070678|NCT01048099|3892764|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4070679|NCT01048099|3892764|B1|||Age||years|Median|65|65.0|Full Range|||47.0|83.0|
4070680|NCT01047839|3892772|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4070681|NCT01047839|3892773|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4070682|NCT01047839|3892774|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070683|NCT01047839|3892775|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070684|NCT01047839|3892772|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070685|NCT01047839|3892773|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070686|NCT01047839|3892774|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070687|NCT01047839|3892775|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070688|NCT01047839|3892772|B4||White|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
4070689|NCT01047839|3892773|B3||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4070690|NCT01047839|3892774|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4070691|NCT01047839|3892775|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4070692|NCT01047839|3892772|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4070693|NCT01047839|3892773|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070694|NCT01047839|3892774|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4070695|NCT01047839|3892775|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4070696|NCT01047839|3892772|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070697|NCT01047839|3892773|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070698|NCT01047839|3892774|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070699|NCT01047839|3892775|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070700|NCT01047839|3892772|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4070701|NCT01047839|3892773|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4070702|NCT01047839|3892774|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4070703|NCT01047839|3892775|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4070704|NCT01047839|3892772|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070705|NCT01047839|3892773|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070706|NCT01047839|3892774|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070707|NCT01047839|3892775|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4070708|NCT01047839|3892772|B4||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4070709|NCT01047839|3892773|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4070710|NCT01047839|3892774|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4070711|NCT01047839|3892775|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4070712|NCT01047839|3892772|B4||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4070713|NCT01047839|3892773|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4070714|NCT01047839|3892774|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4070715|NCT01047839|3892775|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4070716|NCT01047839|3892772|B4|||Age||years|Mean|11.62|11.62|Standard Deviation|5.605|5.605|||
4070717|NCT01047839|3892773|B3|||Age||years|Mean|15.90|15.9|Standard Deviation|1.176|1.176|||
4070718|NCT01047839|3892774|B2|||Age||years|Mean|6.98|6.98|Standard Deviation|2.417|2.417|||
4070719|NCT01047839|3892775|B1|||Age||years|Mean|1.81|1.81|Standard Deviation|0.811|0.811|||
4070720|NCT01047709|3892785|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4070721|NCT01047709|3892785|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4070722|NCT01047709|3892785|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4070723|NCT01047709|3892785|B1|||Age||years|Mean|59|59.0|Standard Deviation|12|12.0|||
4070724|NCT01047709|3892785|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4070725|NCT01047709|3892785|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4070726|NCT01047709|3892785|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4070727|NCT01047553|3892792|B3||Male|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
4070728|NCT01047553|3892793|B2||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4070729|NCT01047553|3892794|B1||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4070730|NCT01047553|3892792|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4070731|NCT01047553|3892793|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4070732|NCT01047553|3892794|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4070733|NCT01047553|3892792|B3|||Age||Years|Mean|70.6|70.6|Full Range|||43.0|88.0|
4070734|NCT01047553|3892793|B2|||Age||Years|Mean|70.3|70.3|Full Range|||50.0|83.0|
4070735|NCT01047553|3892794|B1|||Age||Years|Mean|70.8|70.8|Full Range|||43.0|88.0|
4070736|NCT01047527|3892877|B4||Male|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
4070737|NCT01047527|3892878|B3||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4070738|NCT01047527|3892879|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4070739|NCT01047527|3892880|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4070740|NCT01047527|3892877|B4||Female|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
4070741|NCT01047527|3892878|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4070742|NCT01047527|3892879|B2||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4070743|NCT01047527|3892880|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4070744|NCT01047527|3892877|B4|||Age||years|Mean|46.4|46.4|Standard Deviation|12.1|12.1|||
4070745|NCT01047527|3892878|B3|||Age||years|Mean|46.4|46.4|Standard Deviation|12.1|12.1|||
4070746|NCT01047527|3892879|B2|||Age||years|Mean|46.9|46.9|Standard Deviation|12.2|12.2|||
4070747|NCT01047527|3892880|B1|||Age||years|Mean|45.9|45.9|Standard Deviation|12.3|12.3|||
4070748|NCT01047475|3892891|B3|Taiwan||Region of Enrollment||participants|Number|72|72.0||||||
4070749|NCT01047475|3892892|B2|Taiwan||Region of Enrollment||participants|Number|38|38.0||||||
4070750|NCT01047475|3892893|B1|Taiwan||Region of Enrollment||participants|Number|34|34.0||||||
4070751|NCT01047475|3892891|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4070752|NCT01047475|3892892|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4070753|NCT01047475|3892893|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4070754|NCT01047475|3892891|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4070755|NCT01047475|3892892|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4070756|NCT01047475|3892893|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4070757|NCT01047475|3892891|B3|Age||Age||years|Mean|62.6|62.6|Standard Deviation|13.46|13.46|||
4070758|NCT01047475|3892892|B2|Age||Age||years|Mean|63.0|63.0|Standard Deviation|13.42|13.42|||
4070759|NCT01047475|3892893|B1|Age||Age||years|Mean|62.2|62.2|Standard Deviation|13.71|13.71|||
4070760|NCT01047475|3892891|B3||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4070761|NCT01047475|3892892|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4070762|NCT01047475|3892893|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4070763|NCT01047475|3892891|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4070764|NCT01047475|3892892|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4070765|NCT01047475|3892893|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4070766|NCT01047475|3892891|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4070767|NCT01047475|3892892|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4070768|NCT01047475|3892893|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4070769|NCT01047436|3892900|B3|Rwanda||Region of Enrollment||participants|Number|31|31.0||||||
4070770|NCT01047436|3892901|B2|Rwanda||Region of Enrollment||participants|Number|15|15.0||||||
4070771|NCT01047436|3892902|B1|Rwanda||Region of Enrollment||participants|Number|16|16.0||||||
4070772|NCT01047436|3892900|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4070773|NCT01047436|3892901|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4070774|NCT01047436|3892902|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4070775|NCT01047436|3892900|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4070776|NCT01047436|3892901|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4070777|NCT01047436|3892902|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4070778|NCT01047436|3892900|B3|||Age||years|Mean|3.32|3.32|Standard Deviation|2.00|2.0|||
4070779|NCT01047436|3892901|B2|||Age||years|Mean|3.64|3.64|Standard Deviation|2.46|2.46|||
4070780|NCT01047436|3892902|B1|||Age||years|Mean|3.03|3.03|Standard Deviation|1.50|1.5|||
4070781|NCT01047436|3892900|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4070782|NCT01047436|3892901|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4070783|NCT01047436|3892902|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4070784|NCT01047436|3892900|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4070785|NCT01047436|3892901|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4070786|NCT01047436|3892902|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4070787|NCT01047436|3892900|B3||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
4070788|NCT01047436|3892901|B2||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4070789|NCT01047436|3892902|B1||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4070790|NCT01047358|3892919|B1|Second-Line Therapy for Advanced Cancer||Treatment Indication||Participants|Number|125|125.0||||||
4070791|NCT01047358|3892919|B1|Adjuvant Therapy for Early Breast Cancer||Treatment Indication||Participants|Number|81|81.0||||||
4070792|NCT01047358|3892919|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4070793|NCT01047358|3892919|B1||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
4070794|NCT01047358|3892919|B1|||Age||Years|Mean|57.2|57.2|Standard Deviation|9.9|9.9|||
4070795|NCT01047345|3892926|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4070796|NCT01047345|3892927|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4070797|NCT01047345|3892928|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4070798|NCT01047345|3892926|B3||Female|Sex: Female, Male||Participants|Count of Participants|924|924.0||||||
4070799|NCT01047345|3892927|B2||Female|Sex: Female, Male||Participants|Count of Participants|306|306.0||||||
4070800|NCT01047345|3892928|B1||Female|Sex: Female, Male||Participants|Count of Participants|618|618.0||||||
4070801|NCT01047345|3892926|B3|16 to 26 years||Age, Customized||Participants|Number|742|742.0||||||
4070802|NCT01047345|3892927|B2|16 to 26 years||Age, Customized||Participants|Number|246|246.0||||||
4070803|NCT01047345|3892928|B1|16 to 26 years||Age, Customized||Participants|Number|496|496.0||||||
4070804|NCT01047345|3892926|B3|12 to 15 years||Age, Customized||Participants|Number|182|182.0||||||
4070805|NCT01047345|3892927|B2|12 to 15 years||Age, Customized||Participants|Number|60|60.0||||||
4070806|NCT01047345|3892928|B1|12 to 15 years||Age, Customized||Participants|Number|122|122.0||||||
4070807|NCT01047332|3892950|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4070808|NCT01047332|3892951|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4070809|NCT01047332|3892952|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4070810|NCT01047332|3892950|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4070811|NCT01047332|3892951|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4070812|NCT01047332|3892952|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4070813|NCT01047332|3892950|B3|||Age||years|Mean|66|66.0|Standard Deviation|14|14.0|||
4070814|NCT01047332|3892951|B2|||Age||years|Mean|66|66.0|Standard Deviation|14|14.0|||
4070815|NCT01047332|3892952|B1|||Age||years|Mean|65|65.0|Standard Deviation|13|13.0|||
4070816|NCT01047306|3892965|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4070817|NCT01047306|3892966|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4070818|NCT01047306|3892967|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4070819|NCT01047306|3892965|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4070820|NCT01047306|3892966|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4070821|NCT01047306|3892967|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4070822|NCT01047306|3892965|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4070823|NCT01047306|3892966|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4070824|NCT01047306|3892967|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4070825|NCT01047306|3892965|B3|||Age||years|Mean|6.24|6.24|Standard Deviation|4.452|4.452|||
4070826|NCT01047306|3892966|B2|||Age||years|Mean|12.44|12.44|Standard Deviation|4.500|4.5|||
4070827|NCT01047306|3892967|B1|||Age||years|Mean|4.29|4.29|Standard Deviation|1.996|1.996|||
4070828|NCT01047293|3893042|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4070829|NCT01047293|3893042|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4070830|NCT01047293|3893042|B1|||Age||years|Median|51|51.0|Full Range|||23.0|81.0|
4070831|NCT01047241|3893052|B1|||Preprocedural pain intensity||units on a scale|Median|0.0|0.0|Inter-Quartile Range|||0.0|2.0|
4070832|NCT01047241|3893052|B1|||Height||cm|Mean|138.4|138.4|Standard Deviation|32.0|32.0|||
4070833|NCT01047241|3893052|B1|||Weight||kg|Mean|34.9|34.9|Standard Deviation|20.1|20.1|||
4070834|NCT01047241|3893052|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4070835|NCT01047241|3893052|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4070836|NCT01047241|3893052|B1|||Age||years|Mean|8.8|8.8|Standard Deviation|4.9|4.9|||
4070837|NCT01047189|3893061|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4070838|NCT01047189|3893062|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4070839|NCT01047189|3893063|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4070840|NCT01047189|3893061|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4070841|NCT01047189|3893062|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4070842|NCT01047189|3893063|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4070843|NCT01047189|3893061|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4070844|NCT01047189|3893062|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4070845|NCT01047189|3893063|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4070846|NCT01047189|3893061|B3|||Age||years|Mean|23.1|23.1|Full Range|||13.0|40.0|
4070847|NCT01047189|3893062|B2|||Age||years|Mean|26.2|26.2|Full Range|||15.0|40.0|
4070848|NCT01047189|3893063|B1|||Age||years|Mean|20.1|20.1|Full Range|||13.0|35.0|
4070849|NCT01047189|3893061|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4070850|NCT01047189|3893062|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4070851|NCT01047189|3893063|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4070852|NCT01047189|3893061|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4070853|NCT01047189|3893062|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4070854|NCT01047189|3893063|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4070855|NCT01047189|3893061|B3||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4070856|NCT01047189|3893062|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4070857|NCT01047189|3893063|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4070858|NCT01047007|3893072|B5|||Number of Prior Chemotherapy Regimens|The study required participants to have a solid tumor that failed to respond to standard therapy or progressed despite standard therapy as demonstrated by the number of prior chemotherapy regimens received.|Prior regimens|Mean|3.1|3.1|Standard Deviation|0.9|0.9|||
4070859|NCT01047007|3893074|B3|||Number of Prior Chemotherapy Regimens|The study required participants to have a solid tumor that failed to respond to standard therapy or progressed despite standard therapy as demonstrated by the number of prior chemotherapy regimens received.|Prior regimens|Mean|4.0|4.0|Standard Deviation|0.0|0.0|||
4070860|NCT01047007|3893075|B2|||Number of Prior Chemotherapy Regimens|The study required participants to have a solid tumor that failed to respond to standard therapy or progressed despite standard therapy as demonstrated by the number of prior chemotherapy regimens received.|Prior regimens|Mean|3.3|3.3|Standard Deviation|0.8|0.8|||
4070861|NCT01047007|3893076|B1|||Number of Prior Chemotherapy Regimens|The study required participants to have a solid tumor that failed to respond to standard therapy or progressed despite standard therapy as demonstrated by the number of prior chemotherapy regimens received.|Prior regimens|Mean|2.0|2.0|Standard Deviation|0.0|0.0|||
4070862|NCT01047007|3893072|B5|ECOG Score = 1||ECOG Performance Status|The ECOG scale of performance status is a measurement of how the disease impacts the daily living abilities of the participant. It describes a participant’s level of functioning in terms of their ability to care for themself, daily activity, and physical ability. The scale ranges from 0 (fully active) to 5 (dead). The study required participants to have a score of 0 (fully active, able to carry on all pre-disease performance without restriction) or 1 (restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature).|Participants|Number|4|4.0||||||
4070863|NCT01047007|3893074|B3|ECOG Score = 1||ECOG Performance Status|The ECOG scale of performance status is a measurement of how the disease impacts the daily living abilities of the participant. It describes a participant’s level of functioning in terms of their ability to care for themself, daily activity, and physical ability. The scale ranges from 0 (fully active) to 5 (dead). The study required participants to have a score of 0 (fully active, able to carry on all pre-disease performance without restriction) or 1 (restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature).|Participants|Number|0|0.0||||||
4070864|NCT01047007|3893075|B2|ECOG Score = 1||ECOG Performance Status|The ECOG scale of performance status is a measurement of how the disease impacts the daily living abilities of the participant. It describes a participant’s level of functioning in terms of their ability to care for themself, daily activity, and physical ability. The scale ranges from 0 (fully active) to 5 (dead). The study required participants to have a score of 0 (fully active, able to carry on all pre-disease performance without restriction) or 1 (restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature).|Participants|Number|3|3.0||||||
4070865|NCT01047007|3893076|B1|ECOG Score = 1||ECOG Performance Status|The ECOG scale of performance status is a measurement of how the disease impacts the daily living abilities of the participant. It describes a participant’s level of functioning in terms of their ability to care for themself, daily activity, and physical ability. The scale ranges from 0 (fully active) to 5 (dead). The study required participants to have a score of 0 (fully active, able to carry on all pre-disease performance without restriction) or 1 (restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature).|Participants|Number|1|1.0||||||
4070866|NCT01047007|3893072|B5|ECOG Score = 0||ECOG Performance Status|The ECOG scale of performance status is a measurement of how the disease impacts the daily living abilities of the participant. It describes a participant’s level of functioning in terms of their ability to care for themself, daily activity, and physical ability. The scale ranges from 0 (fully active) to 5 (dead). The study required participants to have a score of 0 (fully active, able to carry on all pre-disease performance without restriction) or 1 (restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature).|Participants|Number|7|7.0||||||
4070867|NCT01047007|3893074|B3|ECOG Score = 0||ECOG Performance Status|The ECOG scale of performance status is a measurement of how the disease impacts the daily living abilities of the participant. It describes a participant’s level of functioning in terms of their ability to care for themself, daily activity, and physical ability. The scale ranges from 0 (fully active) to 5 (dead). The study required participants to have a score of 0 (fully active, able to carry on all pre-disease performance without restriction) or 1 (restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature).|Participants|Number|2|2.0||||||
4070868|NCT01047007|3893075|B2|ECOG Score = 0||ECOG Performance Status|The ECOG scale of performance status is a measurement of how the disease impacts the daily living abilities of the participant. It describes a participant’s level of functioning in terms of their ability to care for themself, daily activity, and physical ability. The scale ranges from 0 (fully active) to 5 (dead). The study required participants to have a score of 0 (fully active, able to carry on all pre-disease performance without restriction) or 1 (restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature).|Participants|Number|3|3.0||||||
4070869|NCT01047007|3893076|B1|ECOG Score = 0||ECOG Performance Status|The ECOG scale of performance status is a measurement of how the disease impacts the daily living abilities of the participant. It describes a participant’s level of functioning in terms of their ability to care for themself, daily activity, and physical ability. The scale ranges from 0 (fully active) to 5 (dead). The study required participants to have a score of 0 (fully active, able to carry on all pre-disease performance without restriction) or 1 (restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature).|Participants|Number|2|2.0||||||
4070870|NCT01047007|3893072|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4070871|NCT01047007|3893074|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4070872|NCT01047007|3893075|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4070873|NCT01047007|3893076|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4070874|NCT01047007|3893072|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4070875|NCT01047007|3893074|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4070876|NCT01047007|3893075|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4070877|NCT01047007|3893076|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4070878|NCT01047007|3893072|B5|||Age||Years|Mean|62.1|62.1|Standard Deviation|6.4|6.4|||
4070879|NCT01047007|3893074|B3|||Age||Years|Mean|59.0|59.0|Standard Deviation|5.7|5.7|||
4070880|NCT01047007|3893075|B2|||Age||Years|Mean|62.7|62.7|Standard Deviation|7.9|7.9|||
4070881|NCT01047007|3893076|B1|||Age||Years|Mean|63.0|63.0|Standard Deviation|4.4|4.4|||
4070882|NCT01046903|3893090|B1|||Concomitant Study Medications||Participants|Number|NA|||||||Data for this pre-specified outcome measure was collected and reported in individual participant listings but not statistically summarized for analysis.
4070883|NCT01046903|3893090|B1|||Prior Study Medications||Participants|Number|NA|||||||Data for this pre-specified outcome measure was collected and reported in individual participant listings but not statistically summarized for analysis.
4070884|NCT01046903|3893090|B1|||Prior Surgery History||Participants|Number|NA|||||||Data for this pre-specified outcome measure was collected and reported in individual participant listings but not statistically summarized for analysis.
4070885|NCT01046903|3893090|B1|||Thromboembolic Disease Assessment|Thromboembolism is the formation of blood clot in the blood vessels due to an embolus (a detached intravascular mass capable of clogging arterial capillary beds at a site far from its origin).Thromboembolic disease was assessed based on clinical examination only (presence of symptoms).|Participants|Number|NA|||||||Data for this pre-specified outcome measure was collected and reported in individual participant listings but not statistically summarized for analysis.
4070886|NCT01046903|3893090|B1|||Procedures After Primary Diagnosis||Participants|Number|NA|||||||Data for this pre-specified outcome measure was collected and reported in individual participant listings but not statistically summarized for analysis.
4070887|NCT01046903|3893090|B1|||Medical history||Participants|Number|NA|||||||Data for this pre-specified outcome measure was collected and reported in individual participant listings but not statistically summarized for analysis.
4070888|NCT01046903|3893090|B1|||Primary diagnosis||Participants|Number|NA|||||||Data for this pre-specified outcome measure was collected and reported in individual participant listings but not statistically summarized for analysis.
4070889|NCT01046903|3893090|B1||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4070890|NCT01046903|3893090|B1||Female|Sex: Female, Male||Participants|Count of Participants|340|340.0||||||
4070891|NCT01046903|3893090|B1|||Age||Years|Mean|63.5|63.5|Standard Deviation|12.6|12.6|||
4070892|NCT01046877|3893103|B1|Singapore||Region of Enrollment||participants|Number|25|25.0||||||
4070893|NCT01046877|3893103|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4070894|NCT01046877|3893103|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4070895|NCT01046877|3893103|B1|||Age||years|Mean|5.5|5.5|Standard Deviation|2.7|2.7|||
4070896|NCT01046695|3893117|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4070897|NCT01046695|3893118|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4070898|NCT01046695|3893119|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4070899|NCT01046695|3893117|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4070900|NCT01046695|3893118|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4070901|NCT01046695|3893119|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4070902|NCT01046695|3893117|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4070903|NCT01046695|3893118|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4070904|NCT01046695|3893119|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4070905|NCT01046695|3893117|B3|||Age||years|Median|63|63.0|Full Range|||30.0|84.0|
4070906|NCT01046695|3893118|B2|||Age||years|Median|63|63.0|Full Range|||41.0|84.0|
4070907|NCT01046695|3893119|B1|||Age||years|Median|63|63.0|Full Range|||30.0|78.0|
4070908|NCT01046682|3893130|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4070909|NCT01046682|3893131|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4070910|NCT01046682|3893132|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4070911|NCT01046682|3893130|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4070912|NCT01046682|3893131|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4070913|NCT01046682|3893132|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4070914|NCT01046682|3893130|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4070915|NCT01046682|3893131|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4070916|NCT01046682|3893132|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4070917|NCT01046682|3893130|B3|||Age||years|Median|46|46.0|Inter-Quartile Range|||43.5|50.0|
4070918|NCT01046682|3893131|B2|||Age||years|Median|46|46.0|Inter-Quartile Range|||44.0|52.5|
4070919|NCT01046682|3893132|B1|||Age||years|Median|46.5|46.5|Inter-Quartile Range|||42.5|49.0|
4070920|NCT01046682|3893130|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4070921|NCT01046682|3893131|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4070922|NCT01046682|3893132|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4070923|NCT01046682|3893130|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4070924|NCT01046682|3893131|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4070925|NCT01046682|3893132|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4070926|NCT01046682|3893130|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4070927|NCT01046682|3893131|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4070928|NCT01046682|3893132|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4070929|NCT01046643|3893139|B3|||BMI||kg/m²|Mean|27.69|27.69|Standard Deviation|5.17|5.17|||
4070930|NCT01046643|3893140|B2|||BMI||kg/m²|Mean|28.38|28.38|Standard Deviation|3.8|3.8|||
4070931|NCT01046643|3893141|B1|||BMI||kg/m²|Mean|27.13|27.13|Standard Deviation|6.13|6.13|||
4070932|NCT01046643|3893139|B3|||Follicle-Stimulating Hormone||mIU/mL|Mean|87.19|87.19|Standard Deviation|29.11|29.11|||
4070933|NCT01046643|3893140|B2|||Follicle-Stimulating Hormone||mIU/mL|Mean|80.86|80.86|Standard Deviation|21.60|21.6|||
4070934|NCT01046643|3893141|B1|||Follicle-Stimulating Hormone||mIU/mL|Mean|92.34|92.34|Standard Deviation|33.85|33.85|||
4070935|NCT01046643|3893139|B3|||Estradiol||pg/mL|Mean|16.24|16.24|Standard Deviation|6.40|6.4|||
4070936|NCT01046643|3893140|B2|||Estradiol||pg/mL|Mean|14.38|14.38|Standard Deviation|6.25|6.25|||
4070937|NCT01046643|3893141|B1|||Estradiol||pg/mL|Mean|17.75|17.75|Standard Deviation|6.30|6.3|||
4070938|NCT01046643|3893139|B3|||Education||years|Mean|16.4|16.4|Standard Deviation|2.8|2.8|||
4070939|NCT01046643|3893140|B2|||Education||years|Mean|17.19|17.19|Standard Deviation|2.67|2.67|||
4070940|NCT01046643|3893141|B1|||Education||years|Mean|15.75|15.75|Standard Deviation|2.82|2.82|||
4070941|NCT01046643|3893139|B3|||Months since Last Menstrual Period||months|Mean|18.41|18.41|Standard Deviation|9.63|9.63|||
4070942|NCT01046643|3893140|B2|||Months since Last Menstrual Period||months|Mean|16.69|16.69|Standard Deviation|9.80|9.8|||
4070943|NCT01046643|3893141|B1|||Months since Last Menstrual Period||months|Mean|19.81|19.81|Standard Deviation|9.57|9.57|||
4070944|NCT01046643|3893139|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4070945|NCT01046643|3893140|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4070946|NCT01046643|3893141|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4070947|NCT01046643|3893139|B3|Male||Gender||participants|Number|0|0.0||||||
4070948|NCT01046643|3893140|B2|Male||Gender||participants|Number|0|0.0||||||
4070949|NCT01046643|3893141|B1|Male||Gender||participants|Number|0|0.0||||||
4070950|NCT01046643|3893139|B3|Female||Gender||participants|Number|16|16.0||||||
4070951|NCT01046643|3893140|B2|Female||Gender||participants|Number|7|7.0||||||
4070952|NCT01046643|3893141|B1|Female||Gender||participants|Number|9|9.0||||||
4070953|NCT01046643|3893139|B3|||Age||years|Mean|51.5|51.5|Standard Deviation|2.5|2.5|||
4070954|NCT01046643|3893140|B2|||Age||years|Mean|51.2|51.2|Standard Deviation|2.9|2.9|||
4070955|NCT01046643|3893141|B1|||Age||years|Mean|51.8|51.8|Standard Deviation|2.2|2.2|||
4070956|NCT01046565|3893166|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4070957|NCT01046565|3893166|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4070958|NCT01046565|3893166|B1|||Age||years|Mean|44.75|44.75|Standard Deviation|13.39|13.39|||
4070959|NCT01046396|3893175|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4070960|NCT01046396|3893175|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4070961|NCT01046396|3893175|B1|||Age||years|Mean|38.87|38.87|Standard Deviation|13.43|13.43|||
4070962|NCT01046253|3893184|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4070963|NCT01046253|3893185|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4070964|NCT01046253|3893186|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4070965|NCT01046253|3893184|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4070966|NCT01046253|3893185|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4070967|NCT01046253|3893186|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4070968|NCT01046253|3893184|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4070969|NCT01046253|3893185|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4070970|NCT01046253|3893186|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4070971|NCT01046253|3893184|B3|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4070972|NCT01046253|3893185|B2|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4070973|NCT01046253|3893186|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4070974|NCT01046253|3893184|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4070975|NCT01046253|3893185|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4070976|NCT01046253|3893186|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4070977|NCT01046253|3893184|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4070978|NCT01046253|3893185|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4070979|NCT01046253|3893186|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4070980|NCT01046253|3893184|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4070981|NCT01046253|3893185|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4070982|NCT01046253|3893186|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4070983|NCT01046253|3893184|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4070984|NCT01046253|3893185|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4070985|NCT01046253|3893186|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4070986|NCT01046253|3893184|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4070987|NCT01046253|3893185|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4070988|NCT01046253|3893186|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4070989|NCT01046136|3893197|B3|United States||Region of Enrollment||participants|Number|378|378.0||||||
4070990|NCT01046136|3893198|B2|United States||Region of Enrollment||participants|Number|190|190.0||||||
4070991|NCT01046136|3893199|B1|United States||Region of Enrollment||participants|Number|188|188.0||||||
4070992|NCT01046136|3893197|B3||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4070993|NCT01046136|3893198|B2||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4070994|NCT01046136|3893199|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4070995|NCT01046136|3893197|B3||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4070996|NCT01046136|3893198|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4070997|NCT01046136|3893199|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4070998|NCT01046136|3893197|B3|||Age||years|Mean|41.0|41.0|Standard Deviation|14.47|14.47|||
4070999|NCT01046136|3893198|B2|||Age||years|Mean|40.8|40.8|Standard Deviation|15.04|15.04|||
4071000|NCT01046136|3893199|B1|||Age||years|Mean|41.1|41.1|Standard Deviation|13.91|13.91|||
4071001|NCT01046136|3893197|B3||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4071002|NCT01046136|3893198|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4071003|NCT01046136|3893199|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4071004|NCT01046136|3893197|B3||Between 18 and 65 years|Age||Participants|Count of Participants|353|353.0||||||
4071005|NCT01046136|3893198|B2||Between 18 and 65 years|Age||Participants|Count of Participants|175|175.0||||||
4071006|NCT01046136|3893199|B1||Between 18 and 65 years|Age||Participants|Count of Participants|178|178.0||||||
4071007|NCT01046136|3893197|B3||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4071008|NCT01046136|3893198|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4071009|NCT01046136|3893199|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4071010|NCT01046110|3893210|B3|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.7|9.7|Standard Deviation|2.9|2.9|||
4071011|NCT01046110|3893211|B2|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.9|9.9|Standard Deviation|3.1|3.1|||
4071012|NCT01046110|3893212|B1|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.4|9.4|Standard Deviation|2.6|2.6|||
4071013|NCT01046110|3893210|B3|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.9|8.9|Standard Deviation|1.0|1.0|||
4071014|NCT01046110|3893211|B2|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|9.0|9.0|Standard Deviation|1.0|1.0|||
4071015|NCT01046110|3893212|B1|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.8|8.8|Standard Deviation|1.0|1.0|||
4071016|NCT01046110|3893210|B3||Male|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
4071017|NCT01046110|3893211|B2||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4071018|NCT01046110|3893212|B1||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4071019|NCT01046110|3893210|B3||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4071020|NCT01046110|3893211|B2||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4071021|NCT01046110|3893212|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4071022|NCT01046110|3893210|B3|||Age||years|Mean|55.7|55.7|Standard Deviation|10.9|10.9|||
4071023|NCT01046110|3893211|B2|||Age||years|Mean|54.9|54.9|Standard Deviation|11.4|11.4|||
4071024|NCT01046110|3893212|B1|||Age||years|Mean|56.4|56.4|Standard Deviation|10.2|10.2|||
4071025|NCT01046084|3893221|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4071026|NCT01046084|3893222|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4071027|NCT01046084|3893223|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4071028|NCT01046084|3893221|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4071029|NCT01046084|3893222|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4071030|NCT01046084|3893223|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4071031|NCT01046084|3893221|B3|Black||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4071032|NCT01046084|3893222|B2|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4071033|NCT01046084|3893223|B1|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4071034|NCT01046084|3893221|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4071035|NCT01046084|3893222|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4071036|NCT01046084|3893223|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4071037|NCT01046084|3893221|B3|American Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4071038|NCT01046084|3893222|B2|American Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4071039|NCT01046084|3893223|B1|American Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4071040|NCT01046084|3893221|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4071041|NCT01046084|3893222|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4071042|NCT01046084|3893223|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4071043|NCT01046084|3893221|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4071044|NCT01046084|3893222|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4071045|NCT01046084|3893223|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4071046|NCT01046084|3893221|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4071047|NCT01046084|3893222|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4071048|NCT01046084|3893223|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4071049|NCT01046084|3893221|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4071050|NCT01046084|3893222|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4071051|NCT01046084|3893223|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4071052|NCT01046084|3893221|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4071053|NCT01046084|3893222|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4071054|NCT01046084|3893223|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4071055|NCT01045993|3893234|B5|R VAS at Plus 5 degrees (beyond maximum)||Flexibility Assessment: Rotation (VAS)|Flexibility assessed using Paris Plinth table with maximum rotation at waist of plus or minus 30 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|56.77|56.77|Standard Deviation|26.08|26.08|||
4071313|NCT01045551|3893362|B1||Female|Gender||Participants|Count of Participants|7|7.0||||||
4071314|NCT01045551|3893362|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4071315|NCT01045551|3893362|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4071056|NCT01045993|3893235|B4|R VAS at Plus 5 degrees (beyond maximum)||Flexibility Assessment: Rotation (VAS)|Flexibility assessed using Paris Plinth table with maximum rotation at waist of plus or minus 30 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|50.92|50.92|Standard Deviation|26.61|26.61|||
4071057|NCT01045993|3893236|B3|R VAS at Plus 5 degrees (beyond maximum)||Flexibility Assessment: Rotation (VAS)|Flexibility assessed using Paris Plinth table with maximum rotation at waist of plus or minus 30 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|64.20|64.2|Standard Deviation|11.50|11.5|||
4071058|NCT01045993|3893237|B2|R VAS at Plus 5 degrees (beyond maximum)||Flexibility Assessment: Rotation (VAS)|Flexibility assessed using Paris Plinth table with maximum rotation at waist of plus or minus 30 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|66.40|66.4|Standard Deviation|28.17|28.17|||
4071059|NCT01045993|3893238|B1|R VAS at Plus 5 degrees (beyond maximum)||Flexibility Assessment: Rotation (VAS)|Flexibility assessed using Paris Plinth table with maximum rotation at waist of plus or minus 30 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|59.12|59.12|Standard Deviation|27.10|27.1|||
4071060|NCT01045993|3893234|B5|L VAS at Plus 5 degrees (beyond maximum)||Flexibility Assessment: Rotation (VAS)|Flexibility assessed using Paris Plinth table with maximum rotation at waist of plus or minus 30 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|54.93|54.93|Standard Deviation|23.10|23.1|||
4071061|NCT01045993|3893235|B4|L VAS at Plus 5 degrees (beyond maximum)||Flexibility Assessment: Rotation (VAS)|Flexibility assessed using Paris Plinth table with maximum rotation at waist of plus or minus 30 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|49.24|49.24|Standard Deviation|22.12|22.12|||
4071062|NCT01045993|3893236|B3|L VAS at Plus 5 degrees (beyond maximum)||Flexibility Assessment: Rotation (VAS)|Flexibility assessed using Paris Plinth table with maximum rotation at waist of plus or minus 30 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|65.80|65.8|Standard Deviation|12.19|12.19|||
4071063|NCT01045993|3893237|B2|L VAS at Plus 5 degrees (beyond maximum)||Flexibility Assessment: Rotation (VAS)|Flexibility assessed using Paris Plinth table with maximum rotation at waist of plus or minus 30 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|63.80|63.8|Standard Deviation|18.79|18.79|||
4071064|NCT01045993|3893238|B1|L VAS at Plus 5 degrees (beyond maximum)||Flexibility Assessment: Rotation (VAS)|Flexibility assessed using Paris Plinth table with maximum rotation at waist of plus or minus 30 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|56.62|56.62|Standard Deviation|25.62|25.62|||
4071065|NCT01045993|3893234|B5|R VAS at Minus 5 degrees||Flexibility Assessment: Rotation (VAS)|Flexibility assessed using Paris Plinth table with maximum rotation at waist of plus or minus 30 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|38.75|38.75|Standard Deviation|23.12|23.12|||
4071088|NCT01045993|3893237|B2|R Plus 5 degrees (beyond maximum)||Flexibility Assessment: Rotation (Angle)|Flexibility assessed using Paris Plinth table with maximum rotation at waist movement of plus or minus 30 degrees for left, and right, movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|18.46|18.46|Standard Deviation|3.73|3.73|||
4071066|NCT01045993|3893235|B4|R VAS at Minus 5 degrees||Flexibility Assessment: Rotation (VAS)|Flexibility assessed using Paris Plinth table with maximum rotation at waist of plus or minus 30 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|36.56|36.56|Standard Deviation|25.02|25.02|||
4071067|NCT01045993|3893236|B3|R VAS at Minus 5 degrees||Flexibility Assessment: Rotation (VAS)|Flexibility assessed using Paris Plinth table with maximum rotation at waist of plus or minus 30 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|47.40|47.4|Standard Deviation|15.84|15.84|||
4071068|NCT01045993|3893237|B2|R VAS at Minus 5 degrees||Flexibility Assessment: Rotation (VAS)|Flexibility assessed using Paris Plinth table with maximum rotation at waist of plus or minus 30 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|44.20|44.2|Standard Deviation|27.47|27.47|||
4071069|NCT01045993|3893238|B1|R VAS at Minus 5 degrees||Flexibility Assessment: Rotation (VAS)|Flexibility assessed using Paris Plinth table with maximum rotation at waist of plus or minus 30 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|38.15|38.15|Standard Deviation|22.26|22.26|||
4071070|NCT01045993|3893234|B5|L VAS at Minus 5 degrees||Flexibility Assessment: Rotation (VAS)|Flexibility assessed using Paris Plinth table with maximum rotation at waist of plus or minus 30 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|37.05|37.05|Standard Deviation|21.77|21.77|||
4071071|NCT01045993|3893235|B4|L VAS at Minus 5 degrees||Flexibility Assessment: Rotation (VAS)|Flexibility assessed using Paris Plinth table with maximum rotation at waist of plus or minus 30 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|33.24|33.24|Standard Deviation|22.28|22.28|||
4071072|NCT01045993|3893236|B3|L VAS at Minus 5 degrees||Flexibility Assessment: Rotation (VAS)|Flexibility assessed using Paris Plinth table with maximum rotation at waist of plus or minus 30 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|46.60|46.6|Standard Deviation|21.24|21.24|||
4071073|NCT01045993|3893237|B2|L VAS at Minus 5 degrees||Flexibility Assessment: Rotation (VAS)|Flexibility assessed using Paris Plinth table with maximum rotation at waist of plus or minus 30 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|47.20|47.2|Standard Deviation|22.94|22.94|||
4071074|NCT01045993|3893238|B1|L VAS at Minus 5 degrees||Flexibility Assessment: Rotation (VAS)|Flexibility assessed using Paris Plinth table with maximum rotation at waist of plus or minus 30 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|36.92|36.92|Standard Deviation|21.25|21.25|||
4071075|NCT01045993|3893234|B5|R VAS at Maximum degrees||Flexibility Assessment: Rotation (VAS)|Flexibility assessed using Paris Plinth table with maximum rotation at waist of plus or minus 30 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|52.28|52.28|Standard Deviation|23.56|23.56|||
4071076|NCT01045993|3893235|B4|R VAS at Maximum degrees||Flexibility Assessment: Rotation (VAS)|Flexibility assessed using Paris Plinth table with maximum rotation at waist of plus or minus 30 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|49.64|49.64|Standard Deviation|25.97|25.97|||
4071077|NCT01045993|3893236|B3|R VAS at Maximum degrees||Flexibility Assessment: Rotation (VAS)|Flexibility assessed using Paris Plinth table with maximum rotation at waist of plus or minus 30 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|61.60|61.6|Standard Deviation|15.84|15.84|||
4071078|NCT01045993|3893237|B2|R VAS at Maximum degrees||Flexibility Assessment: Rotation (VAS)|Flexibility assessed using Paris Plinth table with maximum rotation at waist of plus or minus 30 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|59.40|59.4|Standard Deviation|31.09|31.09|||
4071079|NCT01045993|3893238|B1|R VAS at Maximum degrees||Flexibility Assessment: Rotation (VAS)|Flexibility assessed using Paris Plinth table with maximum rotation at waist of plus or minus 30 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|51.65|51.65|Standard Deviation|21.33|21.33|||
4071080|NCT01045993|3893234|B5|L VAS at Maximum degrees||Flexibility Assessment: Rotation (VAS)|Flexibility assessed using Paris Plinth table with maximum rotation at waist of plus or minus 30 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|52.28|52.28|Standard Deviation|22.81|22.81|||
4071081|NCT01045993|3893235|B4|L VAS at Maximum degrees||Flexibility Assessment: Rotation (VAS)|Flexibility assessed using Paris Plinth table with maximum rotation at waist of plus or minus 30 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|48.80|48.8|Standard Deviation|23.41|23.41|||
4071082|NCT01045993|3893236|B3|L VAS at Maximum degrees||Flexibility Assessment: Rotation (VAS)|Flexibility assessed using Paris Plinth table with maximum rotation at waist of plus or minus 30 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|60.60|60.6|Standard Deviation|12.30|12.3|||
4071083|NCT01045993|3893237|B2|L VAS at Maximum degrees||Flexibility Assessment: Rotation (VAS)|Flexibility assessed using Paris Plinth table with maximum rotation at waist of plus or minus 30 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|60.00|60.0|Standard Deviation|23.74|23.74|||
4071084|NCT01045993|3893238|B1|L VAS at Maximum degrees||Flexibility Assessment: Rotation (VAS)|Flexibility assessed using Paris Plinth table with maximum rotation at waist of plus or minus 30 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|52.54|52.54|Standard Deviation|23.88|23.88|||
4071085|NCT01045993|3893234|B5|R Plus 5 degrees (beyond maximum)||Flexibility Assessment: Rotation (Angle)|Flexibility assessed using Paris Plinth table with maximum rotation at waist movement of plus or minus 30 degrees for left, and right, movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|18.38|18.38|Standard Deviation|4.10|4.1|||
4071086|NCT01045993|3893235|B4|R Plus 5 degrees (beyond maximum)||Flexibility Assessment: Rotation (Angle)|Flexibility assessed using Paris Plinth table with maximum rotation at waist movement of plus or minus 30 degrees for left, and right, movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|18.32|18.32|Standard Deviation|4.30|4.3|||
4071087|NCT01045993|3893236|B3|R Plus 5 degrees (beyond maximum)||Flexibility Assessment: Rotation (Angle)|Flexibility assessed using Paris Plinth table with maximum rotation at waist movement of plus or minus 30 degrees for left, and right, movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|18.06|18.06|Standard Deviation|4.39|4.39|||
4071316|NCT01045551|3893362|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4071317|NCT01045447|3893370|B3|||Fasting plasma glucose (FPG)||mmol/L|Mean|7.9|7.9|Standard Deviation|2.7|2.7|||
4071318|NCT01045447|3893371|B2|||Fasting plasma glucose (FPG)||mmol/L|Mean|7.8|7.8|Standard Deviation|2.8|2.8|||
4071089|NCT01045993|3893238|B1|R Plus 5 degrees (beyond maximum)||Flexibility Assessment: Rotation (Angle)|Flexibility assessed using Paris Plinth table with maximum rotation at waist movement of plus or minus 30 degrees for left, and right, movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|18.48|18.48|Standard Deviation|4.14|4.14|||
4071090|NCT01045993|3893234|B5|L Plus 5 degrees (beyond maximum)||Flexibility Assessment: Rotation (Angle)|Flexibility assessed using Paris Plinth table with maximum rotation at waist movement of plus or minus 30 degrees for left, and right, movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|17.98|17.98|Standard Deviation|3.75|3.75|||
4071091|NCT01045993|3893235|B4|L Plus 5 degrees (beyond maximum)||Flexibility Assessment: Rotation (Angle)|Flexibility assessed using Paris Plinth table with maximum rotation at waist movement of plus or minus 30 degrees for left, and right, movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|18.24|18.24|Standard Deviation|4.12|4.12|||
4071092|NCT01045993|3893236|B3|L Plus 5 degrees (beyond maximum)||Flexibility Assessment: Rotation (Angle)|Flexibility assessed using Paris Plinth table with maximum rotation at waist movement of plus or minus 30 degrees for left, and right, movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|17.12|17.12|Standard Deviation|5.13|5.13|||
4071093|NCT01045993|3893237|B2|L Plus 5 degrees (beyond maximum)||Flexibility Assessment: Rotation (Angle)|Flexibility assessed using Paris Plinth table with maximum rotation at waist movement of plus or minus 30 degrees for left, and right, movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|17.66|17.66|Standard Deviation|3.73|3.73|||
4071094|NCT01045993|3893238|B1|L Plus 5 degrees (beyond maximum)||Flexibility Assessment: Rotation (Angle)|Flexibility assessed using Paris Plinth table with maximum rotation at waist movement of plus or minus 30 degrees for left, and right, movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|17.95|17.95|Standard Deviation|3.28|3.28|||
4071095|NCT01045993|3893234|B5|R Minus 5 degrees||Flexibility Assessment: Rotation (Angle)|Flexibility assessed using Paris Plinth table with maximum rotation at waist movement of plus or minus 30 degrees for left, and right, movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|11.34|11.34|Standard Deviation|4.49|4.49|||
4071096|NCT01045993|3893235|B4|R Minus 5 degrees||Flexibility Assessment: Rotation (Angle)|Flexibility assessed using Paris Plinth table with maximum rotation at waist movement of plus or minus 30 degrees for left, and right, movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|11.56|11.56|Standard Deviation|4.46|4.46|||
4071097|NCT01045993|3893236|B3|R Minus 5 degrees||Flexibility Assessment: Rotation (Angle)|Flexibility assessed using Paris Plinth table with maximum rotation at waist movement of plus or minus 30 degrees for left, and right, movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|10.74|10.74|Standard Deviation|6.12|6.12|||
4071098|NCT01045993|3893237|B2|R Minus 5 degrees||Flexibility Assessment: Rotation (Angle)|Flexibility assessed using Paris Plinth table with maximum rotation at waist movement of plus or minus 30 degrees for left, and right, movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|11.28|11.28|Standard Deviation|4.38|4.38|||
4071099|NCT01045993|3893238|B1|R Minus 5 degrees||Flexibility Assessment: Rotation (Angle)|Flexibility assessed using Paris Plinth table with maximum rotation at waist movement of plus or minus 30 degrees for left, and right, movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|11.27|11.27|Standard Deviation|4.48|4.48|||
4071100|NCT01045993|3893234|B5|L Minus 5 degrees||Flexibility Assessment: Rotation (Angle)|Flexibility assessed using Paris Plinth table with maximum rotation at waist movement of plus or minus 30 degrees for left, and right, movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|10.83|10.83|Standard Deviation|4.31|4.31|||
4071101|NCT01045993|3893235|B4|L Minus 5 degrees||Flexibility Assessment: Rotation (Angle)|Flexibility assessed using Paris Plinth table with maximum rotation at waist movement of plus or minus 30 degrees for left, and right, movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|11.46|11.46|Standard Deviation|4.33|4.33|||
4071319|NCT01045447|3893372|B1|||Fasting plasma glucose (FPG)||mmol/L|Mean|8.0|8.0|Standard Deviation|2.5|2.5|||
4071464|NCT01045421|3893387|B1|Chinese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4071102|NCT01045993|3893236|B3|L Minus 5 degrees||Flexibility Assessment: Rotation (Angle)|Flexibility assessed using Paris Plinth table with maximum rotation at waist movement of plus or minus 30 degrees for left, and right, movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|10.42|10.42|Standard Deviation|6.19|6.19|||
4071103|NCT01045993|3893237|B2|L Minus 5 degrees||Flexibility Assessment: Rotation (Angle)|Flexibility assessed using Paris Plinth table with maximum rotation at waist movement of plus or minus 30 degrees for left, and right, movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|11.30|11.3|Standard Deviation|4.09|4.09|||
4071104|NCT01045993|3893238|B1|L Minus 5 degrees||Flexibility Assessment: Rotation (Angle)|Flexibility assessed using Paris Plinth table with maximum rotation at waist movement of plus or minus 30 degrees for left, and right, movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|10.21|10.21|Standard Deviation|4.12|4.12|||
4071105|NCT01045993|3893234|B5|R Maximum degrees||Flexibility Assessment: Rotation (Angle)|Flexibility assessed using Paris Plinth table with maximum rotation at waist movement of plus or minus 30 degrees for left, and right, movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|16.81|16.81|Standard Deviation|4.71|4.71|||
4071106|NCT01045993|3893235|B4|R Maximum degrees||Flexibility Assessment: Rotation (Angle)|Flexibility assessed using Paris Plinth table with maximum rotation at waist movement of plus or minus 30 degrees for left, and right, movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|16.91|16.91|Standard Deviation|4.78|4.78|||
4071107|NCT01045993|3893236|B3|R Maximum degrees||Flexibility Assessment: Rotation (Angle)|Flexibility assessed using Paris Plinth table with maximum rotation at waist movement of plus or minus 30 degrees for left, and right, movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|16.62|16.62|Standard Deviation|6.19|6.19|||
4071108|NCT01045993|3893237|B2|R Maximum degrees||Flexibility Assessment: Rotation (Angle)|Flexibility assessed using Paris Plinth table with maximum rotation at waist movement of plus or minus 30 degrees for left, and right, movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|16.66|16.66|Standard Deviation|4.26|4.26|||
4071109|NCT01045993|3893238|B1|R Maximum degrees||Flexibility Assessment: Rotation (Angle)|Flexibility assessed using Paris Plinth table with maximum rotation at waist movement of plus or minus 30 degrees for left, and right, movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|16.78|16.78|Standard Deviation|4.73|4.73|||
4071110|NCT01045993|3893234|B5|L Maximum degrees||Flexibility Assessment: Rotation (Angle)|Flexibility assessed using Paris Plinth table with maximum rotation at waist movement of plus or minus 30 degrees for left, and right, movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|16.39|16.39|Standard Deviation|4.35|4.35|||
4071111|NCT01045993|3893235|B4|L Maximum degrees||Flexibility Assessment: Rotation (Angle)|Flexibility assessed using Paris Plinth table with maximum rotation at waist movement of plus or minus 30 degrees for left, and right, movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|17.03|17.03|Standard Deviation|4.40|4.4|||
4071112|NCT01045993|3893236|B3|L Maximum degrees||Flexibility Assessment: Rotation (Angle)|Flexibility assessed using Paris Plinth table with maximum rotation at waist movement of plus or minus 30 degrees for left, and right, movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|15.96|15.96|Standard Deviation|6.44|6.44|||
4071113|NCT01045993|3893237|B2|L Maximum degrees||Flexibility Assessment: Rotation (Angle)|Flexibility assessed using Paris Plinth table with maximum rotation at waist movement of plus or minus 30 degrees for left, and right, movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|17.36|17.36|Standard Deviation|3.77|3.77|||
4071114|NCT01045993|3893238|B1|L Maximum degrees||Flexibility Assessment: Rotation (Angle)|Flexibility assessed using Paris Plinth table with maximum rotation at waist movement of plus or minus 30 degrees for left, and right, movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|15.67|15.67|Standard Deviation|4.08|4.08|||
4071320|NCT01045447|3893370|B3|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.3|8.3|Standard Deviation|0.9|0.9|||
4071321|NCT01045447|3893371|B2|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.4|8.4|Standard Deviation|1.0|1.0|||
4071115|NCT01045993|3893234|B5|R VAS at Plus 5 degrees (beyond maximum)||Flexibility Assessment: Side-to-side (VAS)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|47.08|47.08|Standard Deviation|23.05|23.05|||
4071116|NCT01045993|3893235|B4|R VAS at Plus 5 degrees (beyond maximum)||Flexibility Assessment: Side-to-side (VAS)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|44.92|44.92|Standard Deviation|21.85|21.85|||
4071117|NCT01045993|3893236|B3|R VAS at Plus 5 degrees (beyond maximum)||Flexibility Assessment: Side-to-side (VAS)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|55.60|55.6|Standard Deviation|13.63|13.63|||
4071118|NCT01045993|3893237|B2|R VAS at Plus 5 degrees (beyond maximum)||Flexibility Assessment: Side-to-side (VAS)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|42.40|42.4|Standard Deviation|22.03|22.03|||
4071119|NCT01045993|3893238|B1|R VAS at Plus 5 degrees (beyond maximum)||Flexibility Assessment: Side-to-side (VAS)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|48.42|48.42|Standard Deviation|26.16|26.16|||
4071120|NCT01045993|3893234|B5|L VAS at Plus 5 degrees (beyond maximum)||Flexibility Assessment: Side-to-side (VAS)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|38.95|38.95|Standard Deviation|24.95|24.95|||
4071121|NCT01045993|3893235|B4|L VAS at Plus 5 degrees (beyond maximum)||Flexibility Assessment: Side-to-side (VAS)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|37.64|37.64|Standard Deviation|25.93|25.93|||
4071122|NCT01045993|3893236|B3|L VAS at Plus 5 degrees (beyond maximum)||Flexibility Assessment: Side-to-side (VAS)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|48.20|48.2|Standard Deviation|22.83|22.83|||
4071123|NCT01045993|3893237|B2|L VAS at Plus 5 degrees (beyond maximum)||Flexibility Assessment: Side-to-side (VAS)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|27.80|27.8|Standard Deviation|15.42|15.42|||
4071124|NCT01045993|3893238|B1|L VAS at Plus 5 degrees (beyond maximum)||Flexibility Assessment: Side-to-side (VAS)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|40.58|40.58|Standard Deviation|26.10|26.1|||
4071196|NCT01045993|3893235|B4|Minus 5 degrees||Flexibility Assessment: Extension (Angle)|Flexibility assessed using Paris Plinth table with maximum extension (as if performing a sit-up) of 20 degrees movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|9.01|9.01|Standard Deviation|4.28|4.28|||
4071125|NCT01045993|3893234|B5|R VAS at Minus 5 degrees||Flexibility Assessment: Side-to-side (VAS)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|25.02|25.02|Standard Deviation|18.68|18.68|||
4071126|NCT01045993|3893235|B4|R VAS at Minus 5 degrees||Flexibility Assessment: Side-to-side (VAS)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|24.96|24.96|Standard Deviation|18.75|18.75|||
4071127|NCT01045993|3893236|B3|R VAS at Minus 5 degrees||Flexibility Assessment: Side-to-side (VAS)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|34.00|34.0|Standard Deviation|19.96|19.96|||
4071128|NCT01045993|3893237|B2|R VAS at Minus 5 degrees||Flexibility Assessment: Side-to-side (VAS)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|19.80|19.8|Standard Deviation|13.92|13.92|||
4071129|NCT01045993|3893238|B1|R VAS at Minus 5 degrees||Flexibility Assessment: Side-to-side (VAS)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|24.35|24.35|Standard Deviation|19.57|19.57|||
4071130|NCT01045993|3893234|B5|L VAS at Minus 5 degrees||Flexibility Assessment: Side-to-side (VAS)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|23.49|23.49|Standard Deviation|19.66|19.66|||
4071131|NCT01045993|3893235|B4|L VAS at Minus 5 degrees||Flexibility Assessment: Side-to-side (VAS)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|22.80|22.8|Standard Deviation|18.77|18.77|||
4071132|NCT01045993|3893236|B3|L VAS at Minus 5 degrees||Flexibility Assessment: Side-to-side (VAS)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|28.20|28.2|Standard Deviation|14.46|14.46|||
4071133|NCT01045993|3893237|B2|L VAS at Minus 5 degrees||Flexibility Assessment: Side-to-side (VAS)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|15.20|15.2|Standard Deviation|9.47|9.47|||
4071134|NCT01045993|3893238|B1|L VAS at Minus 5 degrees||Flexibility Assessment: Side-to-side (VAS)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|24.85|24.85|Standard Deviation|22.82|22.82|||
4071135|NCT01045993|3893234|B5|R VAS at Maximum degrees||Flexibility Assessment: Side-to-side (VAS)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|46.39|46.39|Standard Deviation|22.03|22.03|||
4071136|NCT01045993|3893235|B4|R VAS at Maximum degrees||Flexibility Assessment: Side-to-side (VAS)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|45.40|45.4|Standard Deviation|20.69|20.69|||
4071137|NCT01045993|3893236|B3|R VAS at Maximum degrees||Flexibility Assessment: Side-to-side (VAS)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|52.20|52.2|Standard Deviation|14.45|14.45|||
4071138|NCT01045993|3893237|B2|R VAS at Maximum degrees||Flexibility Assessment: Side-to-side (VAS)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|40.40|40.4|Standard Deviation|20.97|20.97|||
4071139|NCT01045993|3893238|B1|R VAS at Maximum degrees||Flexibility Assessment: Side-to-side (VAS)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|47.38|47.38|Standard Deviation|25.18|25.18|||
4071140|NCT01045993|3893234|B5|L VAS at Maximum degrees||Flexibility Assessment: Side-to-side (VAS)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|38.87|38.87|Standard Deviation|23.29|23.29|||
4071141|NCT01045993|3893235|B4|L VAS at Maximum degrees||Flexibility Assessment: Side-to-side (VAS)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|35.24|35.24|Standard Deviation|25.87|25.87|||
4071142|NCT01045993|3893236|B3|L VAS at Maximum degrees||Flexibility Assessment: Side-to-side (VAS)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|43.60|43.6|Standard Deviation|21.28|21.28|||
4071143|NCT01045993|3893237|B2|L VAS at Maximum degrees||Flexibility Assessment: Side-to-side (VAS)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|32.40|32.4|Standard Deviation|14.64|14.64|||
4071144|NCT01045993|3893238|B1|L VAS at Maximum degrees||Flexibility Assessment: Side-to-side (VAS)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|42.69|42.69|Standard Deviation|22.61|22.61|||
4071145|NCT01045993|3893234|B5|R Plus 5 degrees (beyond maximum)||Flexibility Assessment: Side-to-Side (Angle)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left (L), and right (R), movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|7.20|7.2|Standard Deviation|1.47|1.47|||
4071146|NCT01045993|3893235|B4|R Plus 5 degrees (beyond maximum)||Flexibility Assessment: Side-to-Side (Angle)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left (L), and right (R), movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|7.02|7.02|Standard Deviation|1.68|1.68|||
4071297|NCT01045707|3893337|B3||Male|Gender||Participants|Count of Participants|261|261.0||||||
4071298|NCT01045707|3893338|B2||Male|Gender||Participants|Count of Participants|136|136.0||||||
4071147|NCT01045993|3893236|B3|R Plus 5 degrees (beyond maximum)||Flexibility Assessment: Side-to-Side (Angle)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left (L), and right (R), movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|7.00|7.0|Standard Deviation|1.39|1.39|||
4071148|NCT01045993|3893237|B2|R Plus 5 degrees (beyond maximum)||Flexibility Assessment: Side-to-Side (Angle)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left (L), and right (R), movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|7.70|7.7|Standard Deviation|0.67|0.67|||
4071149|NCT01045993|3893238|B1|R Plus 5 degrees (beyond maximum)||Flexibility Assessment: Side-to-Side (Angle)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left (L), and right (R), movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|7.33|7.33|Standard Deviation|1.41|1.41|||
4071150|NCT01045993|3893234|B5|L Plus 5 degrees (beyond maximum)||Flexibility Assessment: Side-to-Side (Angle)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left (L), and right (R), movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|7.26|7.26|Standard Deviation|1.56|1.56|||
4071151|NCT01045993|3893235|B4|L Plus 5 degrees (beyond maximum)||Flexibility Assessment: Side-to-Side (Angle)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left (L), and right (R), movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|7.42|7.42|Standard Deviation|1.40|1.4|||
4071152|NCT01045993|3893236|B3|L Plus 5 degrees (beyond maximum)||Flexibility Assessment: Side-to-Side (Angle)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left (L), and right (R), movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|6.60|6.6|Standard Deviation|2.19|2.19|||
4071153|NCT01045993|3893237|B2|L Plus 5 degrees (beyond maximum)||Flexibility Assessment: Side-to-Side (Angle)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left (L), and right (R), movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|7.40|7.4|Standard Deviation|1.34|1.34|||
4071154|NCT01045993|3893238|B1|L Plus 5 degrees (beyond maximum)||Flexibility Assessment: Side-to-Side (Angle)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left (L), and right (R), movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|7.22|7.22|Standard Deviation|1.66|1.66|||
4071155|NCT01045993|3893234|B5|R Minus 5 degrees||Flexibility Assessment: Side-to-Side (Angle)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left (L), and right (R), movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|2.00|2.0|Standard Deviation|1.25|1.25|||
4071156|NCT01045993|3893235|B4|R Minus 5 degrees||Flexibility Assessment: Side-to-Side (Angle)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left (L), and right (R), movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|1.92|1.92|Standard Deviation|1.19|1.19|||
4071157|NCT01045993|3893236|B3|R Minus 5 degrees||Flexibility Assessment: Side-to-Side (Angle)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left (L), and right (R), movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|1.80|1.8|Standard Deviation|1.64|1.64|||
4071158|NCT01045993|3893237|B2|R Minus 5 degrees||Flexibility Assessment: Side-to-Side (Angle)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left (L), and right (R), movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|2.40|2.4|Standard Deviation|1.34|1.34|||
4071159|NCT01045993|3893238|B1|R Minus 5 degrees||Flexibility Assessment: Side-to-Side (Angle)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left (L), and right (R), movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|2.05|2.05|Standard Deviation|1.27|1.27|||
4071299|NCT01045707|3893339|B1||Male|Gender||Participants|Count of Participants|125|125.0||||||
4071160|NCT01045993|3893234|B5|L Minus 5 degrees||Flexibility Assessment: Side-to-Side (Angle)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left (L), and right (R), movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|2.23|2.23|Standard Deviation|1.15|1.15|||
4071161|NCT01045993|3893235|B4|L Minus 5 degrees||Flexibility Assessment: Side-to-Side (Angle)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left (L), and right (R), movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|2.32|2.32|Standard Deviation|1.07|1.07|||
4071162|NCT01045993|3893236|B3|L Minus 5 degrees||Flexibility Assessment: Side-to-Side (Angle)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left (L), and right (R), movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|2.00|2.0|Standard Deviation|1.41|1.41|||
4071163|NCT01045993|3893237|B2|L Minus 5 degrees||Flexibility Assessment: Side-to-Side (Angle)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left (L), and right (R), movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|2.40|2.4|Standard Deviation|1.34|1.34|||
4071164|NCT01045993|3893238|B1|L Minus 5 degrees||Flexibility Assessment: Side-to-Side (Angle)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left (L), and right (R), movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|2.15|2.15|Standard Deviation|1.19|1.19|||
4071165|NCT01045993|3893234|B5|R Maximum degrees||Flexibility Assessment: Side-to-Side (Angle)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left (L), and right (R), movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|6.81|6.81|Standard Deviation|1.74|1.74|||
4071166|NCT01045993|3893235|B4|R Maximum degrees||Flexibility Assessment: Side-to-Side (Angle)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left (L), and right (R), movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|6.76|6.76|Standard Deviation|1.80|1.8|||
4071167|NCT01045993|3893236|B3|R Maximum degrees||Flexibility Assessment: Side-to-Side (Angle)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left (L), and right (R), movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|6.50|6.5|Standard Deviation|2.06|2.06|||
4071168|NCT01045993|3893237|B2|R Maximum degrees||Flexibility Assessment: Side-to-Side (Angle)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left (L), and right (R), movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|7.40|7.4|Standard Deviation|1.34|1.34|||
4071169|NCT01045993|3893238|B1|R Maximum degrees||Flexibility Assessment: Side-to-Side (Angle)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left (L), and right (R), movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|6.80|6.8|Standard Deviation|1.76|1.76|||
4071170|NCT01045993|3893234|B5|L Maximum degrees||Flexibility Assessment: Side-to-Side (Angle)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left (L), and right (R), movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|7.01|7.01|Standard Deviation|1.65|1.65|||
4071171|NCT01045993|3893235|B4|L Maximum degrees||Flexibility Assessment: Side-to-Side (Angle)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left (L), and right (R), movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|7.16|7.16|Standard Deviation|1.50|1.5|||
4071172|NCT01045993|3893236|B3|L Maximum degrees||Flexibility Assessment: Side-to-Side (Angle)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left (L), and right (R), movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|6.50|6.5|Standard Deviation|2.40|2.4|||
4071300|NCT01045707|3893337|B3||Female|Gender||Participants|Count of Participants|268|268.0||||||
4071301|NCT01045707|3893338|B2||Female|Gender||Participants|Count of Participants|127|127.0||||||
4071173|NCT01045993|3893237|B2|L Maximum degrees||Flexibility Assessment: Side-to-Side (Angle)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left (L), and right (R), movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|7.20|7.2|Standard Deviation|1.79|1.79|||
4071174|NCT01045993|3893238|B1|L Maximum degrees||Flexibility Assessment: Side-to-Side (Angle)|Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left (L), and right (R), movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|6.92|6.92|Standard Deviation|1.69|1.69|||
4071175|NCT01045993|3893234|B5|VAS at Plus 5 degrees (beyond maximum)||Flexibility Assessment: Extension (visual analog scale ([VAS])|Flexibility assessed using Paris Plinth table with maximum extension (as if performing a sit-up) of 20 degrees movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|54.79|54.79|Standard Deviation|23.78|23.78|||
4071176|NCT01045993|3893235|B4|VAS at Plus 5 degrees (beyond maximum)||Flexibility Assessment: Extension (visual analog scale ([VAS])|Flexibility assessed using Paris Plinth table with maximum extension (as if performing a sit-up) of 20 degrees movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|52.60|52.6|Standard Deviation|27.47|27.47|||
4071177|NCT01045993|3893236|B3|VAS at Plus 5 degrees (beyond maximum)||Flexibility Assessment: Extension (visual analog scale ([VAS])|Flexibility assessed using Paris Plinth table with maximum extension (as if performing a sit-up) of 20 degrees movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|59.40|59.4|Standard Deviation|14.28|14.28|||
4071178|NCT01045993|3893237|B2|VAS at Plus 5 degrees (beyond maximum)||Flexibility Assessment: Extension (visual analog scale ([VAS])|Flexibility assessed using Paris Plinth table with maximum extension (as if performing a sit-up) of 20 degrees movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|50.00|50.0|Standard Deviation|32.64|32.64|||
4071179|NCT01045993|3893238|B1|VAS at Plus 5 degrees (beyond maximum)||Flexibility Assessment: Extension (visual analog scale ([VAS])|Flexibility assessed using Paris Plinth table with maximum extension (as if performing a sit-up) of 20 degrees movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|56.92|56.92|Standard Deviation|20.27|20.27|||
4071180|NCT01045993|3893234|B5|VAS at Minus 5 degrees||Flexibility Assessment: Extension (visual analog scale ([VAS])|Flexibility assessed using Paris Plinth table with maximum extension (as if performing a sit-up) of 20 degrees movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|31.30|31.3|Standard Deviation|20.11|20.11|||
4071181|NCT01045993|3893235|B4|VAS at Minus 5 degrees||Flexibility Assessment: Extension (visual analog scale ([VAS])|Flexibility assessed using Paris Plinth table with maximum extension (as if performing a sit-up) of 20 degrees movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|29.36|29.36|Standard Deviation|22.37|22.37|||
4071182|NCT01045993|3893236|B3|VAS at Minus 5 degrees||Flexibility Assessment: Extension (visual analog scale ([VAS])|Flexibility assessed using Paris Plinth table with maximum extension (as if performing a sit-up) of 20 degrees movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|34.00|34.0|Standard Deviation|11.51|11.51|||
4071183|NCT01045993|3893237|B2|VAS at Minus 5 degrees||Flexibility Assessment: Extension (visual analog scale ([VAS])|Flexibility assessed using Paris Plinth table with maximum extension (as if performing a sit-up) of 20 degrees movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|26.60|26.6|Standard Deviation|22.00|22.0|||
4071302|NCT01045707|3893339|B1||Female|Gender||Participants|Count of Participants|141|141.0||||||
4071184|NCT01045993|3893238|B1|VAS at Minus 5 degrees||Flexibility Assessment: Extension (visual analog scale ([VAS])|Flexibility assessed using Paris Plinth table with maximum extension (as if performing a sit-up) of 20 degrees movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|33.54|33.54|Standard Deviation|19.41|19.41|||
4071185|NCT01045993|3893234|B5|VAS at Maximum degrees||Flexibility Assessment: Extension (visual analog scale ([VAS])|Flexibility assessed using Paris Plinth table with maximum extension (as if performing a sit-up) of 20 degrees movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|45.84|45.84|Standard Deviation|19.26|19.26|||
4071186|NCT01045993|3893235|B4|VAS at Maximum degrees||Flexibility Assessment: Extension (visual analog scale ([VAS])|Flexibility assessed using Paris Plinth table with maximum extension (as if performing a sit-up) of 20 degrees movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|43.40|43.4|Standard Deviation|23.35|23.35|||
4071187|NCT01045993|3893236|B3|VAS at Maximum degrees||Flexibility Assessment: Extension (visual analog scale ([VAS])|Flexibility assessed using Paris Plinth table with maximum extension (as if performing a sit-up) of 20 degrees movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|48.20|48.2|Standard Deviation|13.52|13.52|||
4071188|NCT01045993|3893237|B2|VAS at Maximum degrees||Flexibility Assessment: Extension (visual analog scale ([VAS])|Flexibility assessed using Paris Plinth table with maximum extension (as if performing a sit-up) of 20 degrees movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|41.00|41.0|Standard Deviation|21.21|21.21|||
4071189|NCT01045993|3893238|B1|VAS at Maximum degrees||Flexibility Assessment: Extension (visual analog scale ([VAS])|Flexibility assessed using Paris Plinth table with maximum extension (as if performing a sit-up) of 20 degrees movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.|millimeters|Mean|48.65|48.65|Standard Deviation|15.69|15.69|||
4071190|NCT01045993|3893234|B5|Plus 5 degrees (beyond maximum)||Flexibility Assessment: Extension (Angle)|Flexibility assessed using Paris Plinth table with maximum extension (as if performing a sit-up) of 20 degrees movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|17.63|17.63|Standard Deviation|4.08|4.08|||
4071191|NCT01045993|3893235|B4|Plus 5 degrees (beyond maximum)||Flexibility Assessment: Extension (Angle)|Flexibility assessed using Paris Plinth table with maximum extension (as if performing a sit-up) of 20 degrees movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|17.59|17.59|Standard Deviation|4.02|4.02|||
4071192|NCT01045993|3893236|B3|Plus 5 degrees (beyond maximum)||Flexibility Assessment: Extension (Angle)|Flexibility assessed using Paris Plinth table with maximum extension (as if performing a sit-up) of 20 degrees movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|18.78|18.78|Standard Deviation|4.35|4.35|||
4071193|NCT01045993|3893237|B2|Plus 5 degrees (beyond maximum)||Flexibility Assessment: Extension (Angle)|Flexibility assessed using Paris Plinth table with maximum extension (as if performing a sit-up) of 20 degrees movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|18.50|18.5|Standard Deviation|2.24|2.24|||
4071194|NCT01045993|3893238|B1|Plus 5 degrees (beyond maximum)||Flexibility Assessment: Extension (Angle)|Flexibility assessed using Paris Plinth table with maximum extension (as if performing a sit-up) of 20 degrees movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|17.28|17.28|Standard Deviation|4.48|4.48|||
4071195|NCT01045993|3893234|B5|Minus 5 degrees||Flexibility Assessment: Extension (Angle)|Flexibility assessed using Paris Plinth table with maximum extension (as if performing a sit-up) of 20 degrees movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|9.91|9.91|Standard Deviation|4.32|4.32|||
4071303|NCT01045707|3893337|B3|||Age||years|Mean|56.9|56.9|Standard Deviation|9.1|9.1|||
4071197|NCT01045993|3893236|B3|Minus 5 degrees||Flexibility Assessment: Extension (Angle)|Flexibility assessed using Paris Plinth table with maximum extension (as if performing a sit-up) of 20 degrees movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|11.62|11.62|Standard Deviation|3.70|3.7|||
4071198|NCT01045993|3893237|B2|Minus 5 degrees||Flexibility Assessment: Extension (Angle)|Flexibility assessed using Paris Plinth table with maximum extension (as if performing a sit-up) of 20 degrees movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|11.26|11.26|Standard Deviation|5.04|5.04|||
4071199|NCT01045993|3893238|B1|Minus 5 degrees||Flexibility Assessment: Extension (Angle)|Flexibility assessed using Paris Plinth table with maximum extension (as if performing a sit-up) of 20 degrees movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|10.19|10.19|Standard Deviation|4.38|4.38|||
4071200|NCT01045993|3893234|B5|Maximum degrees||Flexibility Assessment: Extension (Angle)|Flexibility assessed using Paris Plinth table with maximum extension (as if performing a sit-up) of 20 degrees movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|15.02|15.02|Standard Deviation|4.48|4.48|||
4071201|NCT01045993|3893235|B4|Maximum degrees||Flexibility Assessment: Extension (Angle)|Flexibility assessed using Paris Plinth table with maximum extension (as if performing a sit-up) of 20 degrees movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|14.07|14.07|Standard Deviation|4.51|4.51|||
4071202|NCT01045993|3893236|B3|Maximum degrees||Flexibility Assessment: Extension (Angle)|Flexibility assessed using Paris Plinth table with maximum extension (as if performing a sit-up) of 20 degrees movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|16.80|16.8|Standard Deviation|3.89|3.89|||
4071203|NCT01045993|3893237|B2|Maximum degrees||Flexibility Assessment: Extension (Angle)|Flexibility assessed using Paris Plinth table with maximum extension (as if performing a sit-up) of 20 degrees movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|16.48|16.48|Standard Deviation|4.82|4.82|||
4071204|NCT01045993|3893238|B1|Maximum degrees||Flexibility Assessment: Extension (Angle)|Flexibility assessed using Paris Plinth table with maximum extension (as if performing a sit-up) of 20 degrees movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.|degree of angle|Mean|15.31|15.31|Standard Deviation|4.53|4.53|||
4071205|NCT01045993|3893234|B5|||Back Stiffness Score|Participant rated their low back muscle stiffness by placing a line on a visual analog scale (VAS) in response to the question “Please indicate a number from 0 through 100 that best describes your low back muscle stiffness”. VAS scaled as 0 millimeters (mm) to 100 mm in length with 0 (no muscle stiffness) up to 100 (most possible stiffness).|millimeters|Mean|49.15|49.15|Standard Deviation|16.67|16.67|||
4071206|NCT01045993|3893235|B4|||Back Stiffness Score|Participant rated their low back muscle stiffness by placing a line on a visual analog scale (VAS) in response to the question “Please indicate a number from 0 through 100 that best describes your low back muscle stiffness”. VAS scaled as 0 millimeters (mm) to 100 mm in length with 0 (no muscle stiffness) up to 100 (most possible stiffness).|millimeters|Mean|51.24|51.24|Standard Deviation|20.32|20.32|||
4071207|NCT01045993|3893236|B3|||Back Stiffness Score|Participant rated their low back muscle stiffness by placing a line on a visual analog scale (VAS) in response to the question “Please indicate a number from 0 through 100 that best describes your low back muscle stiffness”. VAS scaled as 0 millimeters (mm) to 100 mm in length with 0 (no muscle stiffness) up to 100 (most possible stiffness).|millimeters|Mean|50.00|50.0|Standard Deviation|10.61|10.61|||
4071208|NCT01045993|3893237|B2|||Back Stiffness Score|Participant rated their low back muscle stiffness by placing a line on a visual analog scale (VAS) in response to the question “Please indicate a number from 0 through 100 that best describes your low back muscle stiffness”. VAS scaled as 0 millimeters (mm) to 100 mm in length with 0 (no muscle stiffness) up to 100 (most possible stiffness).|millimeters|Mean|55.00|55.0|Standard Deviation|18.71|18.71|||
4071209|NCT01045993|3893238|B1|||Back Stiffness Score|Participant rated their low back muscle stiffness by placing a line on a visual analog scale (VAS) in response to the question “Please indicate a number from 0 through 100 that best describes your low back muscle stiffness”. VAS scaled as 0 millimeters (mm) to 100 mm in length with 0 (no muscle stiffness) up to 100 (most possible stiffness).|millimeters|Mean|45.85|45.85|Standard Deviation|13.18|13.18|||
4071210|NCT01045993|3893234|B5|Extreme=5||Number of participants with categorical score for pain intensity|"Participant rated the severity of their pain on a 6-point scale in response to the question How much pain are you experiencing in your lower back right now. Scored as None=0, Mild=1, Moderate=2, Moderately severe=3, Severe=4, Extreme=5. Participant was asked to remember the level of pain experienced at this time as a reference for any pain relief experienced at later time points."|participants|Number|0|0.0||||||
4071304|NCT01045707|3893338|B2|||Age||years|Mean|56.4|56.4|Standard Deviation|9.2|9.2|||
4071305|NCT01045707|3893339|B1|||Age||years|Mean|57.4|57.4|Standard Deviation|9.0|9.0|||
4071306|NCT01045694|3893356|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4071307|NCT01045694|3893356|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4071211|NCT01045993|3893235|B4|Extreme=5||Number of participants with categorical score for pain intensity|"Participant rated the severity of their pain on a 6-point scale in response to the question How much pain are you experiencing in your lower back right now. Scored as None=0, Mild=1, Moderate=2, Moderately severe=3, Severe=4, Extreme=5. Participant was asked to remember the level of pain experienced at this time as a reference for any pain relief experienced at later time points."|participants|Number|0|0.0||||||
4071212|NCT01045993|3893236|B3|Extreme=5||Number of participants with categorical score for pain intensity|"Participant rated the severity of their pain on a 6-point scale in response to the question How much pain are you experiencing in your lower back right now. Scored as None=0, Mild=1, Moderate=2, Moderately severe=3, Severe=4, Extreme=5. Participant was asked to remember the level of pain experienced at this time as a reference for any pain relief experienced at later time points."|participants|Number|0|0.0||||||
4071213|NCT01045993|3893237|B2|Extreme=5||Number of participants with categorical score for pain intensity|"Participant rated the severity of their pain on a 6-point scale in response to the question How much pain are you experiencing in your lower back right now. Scored as None=0, Mild=1, Moderate=2, Moderately severe=3, Severe=4, Extreme=5. Participant was asked to remember the level of pain experienced at this time as a reference for any pain relief experienced at later time points."|participants|Number|0|0.0||||||
4071214|NCT01045993|3893238|B1|Extreme=5||Number of participants with categorical score for pain intensity|"Participant rated the severity of their pain on a 6-point scale in response to the question How much pain are you experiencing in your lower back right now. Scored as None=0, Mild=1, Moderate=2, Moderately severe=3, Severe=4, Extreme=5. Participant was asked to remember the level of pain experienced at this time as a reference for any pain relief experienced at later time points."|participants|Number|0|0.0||||||
4071215|NCT01045993|3893234|B5|Severe=4||Number of participants with categorical score for pain intensity|"Participant rated the severity of their pain on a 6-point scale in response to the question How much pain are you experiencing in your lower back right now. Scored as None=0, Mild=1, Moderate=2, Moderately severe=3, Severe=4, Extreme=5. Participant was asked to remember the level of pain experienced at this time as a reference for any pain relief experienced at later time points."|participants|Number|2|2.0||||||
4071216|NCT01045993|3893235|B4|Severe=4||Number of participants with categorical score for pain intensity|"Participant rated the severity of their pain on a 6-point scale in response to the question How much pain are you experiencing in your lower back right now. Scored as None=0, Mild=1, Moderate=2, Moderately severe=3, Severe=4, Extreme=5. Participant was asked to remember the level of pain experienced at this time as a reference for any pain relief experienced at later time points."|participants|Number|1|1.0||||||
4071217|NCT01045993|3893236|B3|Severe=4||Number of participants with categorical score for pain intensity|"Participant rated the severity of their pain on a 6-point scale in response to the question How much pain are you experiencing in your lower back right now. Scored as None=0, Mild=1, Moderate=2, Moderately severe=3, Severe=4, Extreme=5. Participant was asked to remember the level of pain experienced at this time as a reference for any pain relief experienced at later time points."|participants|Number|0|0.0||||||
4071218|NCT01045993|3893237|B2|Severe=4||Number of participants with categorical score for pain intensity|"Participant rated the severity of their pain on a 6-point scale in response to the question How much pain are you experiencing in your lower back right now. Scored as None=0, Mild=1, Moderate=2, Moderately severe=3, Severe=4, Extreme=5. Participant was asked to remember the level of pain experienced at this time as a reference for any pain relief experienced at later time points."|participants|Number|1|1.0||||||
4071219|NCT01045993|3893238|B1|Severe=4||Number of participants with categorical score for pain intensity|"Participant rated the severity of their pain on a 6-point scale in response to the question How much pain are you experiencing in your lower back right now. Scored as None=0, Mild=1, Moderate=2, Moderately severe=3, Severe=4, Extreme=5. Participant was asked to remember the level of pain experienced at this time as a reference for any pain relief experienced at later time points."|participants|Number|0|0.0||||||
4071220|NCT01045993|3893234|B5|Moderately severe=3||Number of participants with categorical score for pain intensity|"Participant rated the severity of their pain on a 6-point scale in response to the question How much pain are you experiencing in your lower back right now. Scored as None=0, Mild=1, Moderate=2, Moderately severe=3, Severe=4, Extreme=5. Participant was asked to remember the level of pain experienced at this time as a reference for any pain relief experienced at later time points."|participants|Number|15|15.0||||||
4071221|NCT01045993|3893235|B4|Moderately severe=3||Number of participants with categorical score for pain intensity|"Participant rated the severity of their pain on a 6-point scale in response to the question How much pain are you experiencing in your lower back right now. Scored as None=0, Mild=1, Moderate=2, Moderately severe=3, Severe=4, Extreme=5. Participant was asked to remember the level of pain experienced at this time as a reference for any pain relief experienced at later time points."|participants|Number|4|4.0||||||
4071222|NCT01045993|3893236|B3|Moderately severe=3||Number of participants with categorical score for pain intensity|"Participant rated the severity of their pain on a 6-point scale in response to the question How much pain are you experiencing in your lower back right now. Scored as None=0, Mild=1, Moderate=2, Moderately severe=3, Severe=4, Extreme=5. Participant was asked to remember the level of pain experienced at this time as a reference for any pain relief experienced at later time points."|participants|Number|3|3.0||||||
4071223|NCT01045993|3893237|B2|Moderately severe=3||Number of participants with categorical score for pain intensity|"Participant rated the severity of their pain on a 6-point scale in response to the question How much pain are you experiencing in your lower back right now. Scored as None=0, Mild=1, Moderate=2, Moderately severe=3, Severe=4, Extreme=5. Participant was asked to remember the level of pain experienced at this time as a reference for any pain relief experienced at later time points."|participants|Number|1|1.0||||||
4071224|NCT01045993|3893238|B1|Moderately severe=3||Number of participants with categorical score for pain intensity|"Participant rated the severity of their pain on a 6-point scale in response to the question How much pain are you experiencing in your lower back right now. Scored as None=0, Mild=1, Moderate=2, Moderately severe=3, Severe=4, Extreme=5. Participant was asked to remember the level of pain experienced at this time as a reference for any pain relief experienced at later time points."|participants|Number|7|7.0||||||
4071308|NCT01045694|3893356|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4071309|NCT01045694|3893356|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4071225|NCT01045993|3893234|B5|Moderate=2||Number of participants with categorical score for pain intensity|"Participant rated the severity of their pain on a 6-point scale in response to the question How much pain are you experiencing in your lower back right now. Scored as None=0, Mild=1, Moderate=2, Moderately severe=3, Severe=4, Extreme=5. Participant was asked to remember the level of pain experienced at this time as a reference for any pain relief experienced at later time points."|participants|Number|44|44.0||||||
4071226|NCT01045993|3893235|B4|Moderate=2||Number of participants with categorical score for pain intensity|"Participant rated the severity of their pain on a 6-point scale in response to the question How much pain are you experiencing in your lower back right now. Scored as None=0, Mild=1, Moderate=2, Moderately severe=3, Severe=4, Extreme=5. Participant was asked to remember the level of pain experienced at this time as a reference for any pain relief experienced at later time points."|participants|Number|20|20.0||||||
4071227|NCT01045993|3893236|B3|Moderate=2||Number of participants with categorical score for pain intensity|"Participant rated the severity of their pain on a 6-point scale in response to the question How much pain are you experiencing in your lower back right now. Scored as None=0, Mild=1, Moderate=2, Moderately severe=3, Severe=4, Extreme=5. Participant was asked to remember the level of pain experienced at this time as a reference for any pain relief experienced at later time points."|participants|Number|2|2.0||||||
4071228|NCT01045993|3893237|B2|Moderate=2||Number of participants with categorical score for pain intensity|"Participant rated the severity of their pain on a 6-point scale in response to the question How much pain are you experiencing in your lower back right now. Scored as None=0, Mild=1, Moderate=2, Moderately severe=3, Severe=4, Extreme=5. Participant was asked to remember the level of pain experienced at this time as a reference for any pain relief experienced at later time points."|participants|Number|3|3.0||||||
4071229|NCT01045993|3893238|B1|Moderate=2||Number of participants with categorical score for pain intensity|"Participant rated the severity of their pain on a 6-point scale in response to the question How much pain are you experiencing in your lower back right now. Scored as None=0, Mild=1, Moderate=2, Moderately severe=3, Severe=4, Extreme=5. Participant was asked to remember the level of pain experienced at this time as a reference for any pain relief experienced at later time points."|participants|Number|19|19.0||||||
4071230|NCT01045993|3893234|B5|Mild=1||Number of participants with categorical score for pain intensity|"Participant rated the severity of their pain on a 6-point scale in response to the question How much pain are you experiencing in your lower back right now. Scored as None=0, Mild=1, Moderate=2, Moderately severe=3, Severe=4, Extreme=5. Participant was asked to remember the level of pain experienced at this time as a reference for any pain relief experienced at later time points."|participants|Number|0|0.0||||||
4071231|NCT01045993|3893235|B4|Mild=1||Number of participants with categorical score for pain intensity|"Participant rated the severity of their pain on a 6-point scale in response to the question How much pain are you experiencing in your lower back right now. Scored as None=0, Mild=1, Moderate=2, Moderately severe=3, Severe=4, Extreme=5. Participant was asked to remember the level of pain experienced at this time as a reference for any pain relief experienced at later time points."|participants|Number|0|0.0||||||
4071232|NCT01045993|3893236|B3|Mild=1||Number of participants with categorical score for pain intensity|"Participant rated the severity of their pain on a 6-point scale in response to the question How much pain are you experiencing in your lower back right now. Scored as None=0, Mild=1, Moderate=2, Moderately severe=3, Severe=4, Extreme=5. Participant was asked to remember the level of pain experienced at this time as a reference for any pain relief experienced at later time points."|participants|Number|0|0.0||||||
4071233|NCT01045993|3893237|B2|Mild=1||Number of participants with categorical score for pain intensity|"Participant rated the severity of their pain on a 6-point scale in response to the question How much pain are you experiencing in your lower back right now. Scored as None=0, Mild=1, Moderate=2, Moderately severe=3, Severe=4, Extreme=5. Participant was asked to remember the level of pain experienced at this time as a reference for any pain relief experienced at later time points."|participants|Number|0|0.0||||||
4071234|NCT01045993|3893238|B1|Mild=1||Number of participants with categorical score for pain intensity|"Participant rated the severity of their pain on a 6-point scale in response to the question How much pain are you experiencing in your lower back right now. Scored as None=0, Mild=1, Moderate=2, Moderately severe=3, Severe=4, Extreme=5. Participant was asked to remember the level of pain experienced at this time as a reference for any pain relief experienced at later time points."|participants|Number|0|0.0||||||
4071235|NCT01045993|3893234|B5|None=0||Number of participants with categorical score for pain intensity|"Participant rated the severity of their pain on a 6-point scale in response to the question How much pain are you experiencing in your lower back right now. Scored as None=0, Mild=1, Moderate=2, Moderately severe=3, Severe=4, Extreme=5. Participant was asked to remember the level of pain experienced at this time as a reference for any pain relief experienced at later time points."|participants|Number|0|0.0||||||
4071236|NCT01045993|3893235|B4|None=0||Number of participants with categorical score for pain intensity|"Participant rated the severity of their pain on a 6-point scale in response to the question How much pain are you experiencing in your lower back right now. Scored as None=0, Mild=1, Moderate=2, Moderately severe=3, Severe=4, Extreme=5. Participant was asked to remember the level of pain experienced at this time as a reference for any pain relief experienced at later time points."|participants|Number|0|0.0||||||
4071237|NCT01045993|3893236|B3|None=0||Number of participants with categorical score for pain intensity|"Participant rated the severity of their pain on a 6-point scale in response to the question How much pain are you experiencing in your lower back right now. Scored as None=0, Mild=1, Moderate=2, Moderately severe=3, Severe=4, Extreme=5. Participant was asked to remember the level of pain experienced at this time as a reference for any pain relief experienced at later time points."|participants|Number|0|0.0||||||
4071238|NCT01045993|3893237|B2|None=0||Number of participants with categorical score for pain intensity|"Participant rated the severity of their pain on a 6-point scale in response to the question How much pain are you experiencing in your lower back right now. Scored as None=0, Mild=1, Moderate=2, Moderately severe=3, Severe=4, Extreme=5. Participant was asked to remember the level of pain experienced at this time as a reference for any pain relief experienced at later time points."|participants|Number|0|0.0||||||
4071310|NCT01045694|3893356|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4071311|NCT01045694|3893356|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4071312|NCT01045551|3893362|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
4071239|NCT01045993|3893238|B1|None=0||Number of participants with categorical score for pain intensity|"Participant rated the severity of their pain on a 6-point scale in response to the question How much pain are you experiencing in your lower back right now. Scored as None=0, Mild=1, Moderate=2, Moderately severe=3, Severe=4, Extreme=5. Participant was asked to remember the level of pain experienced at this time as a reference for any pain relief experienced at later time points."|participants|Number|0|0.0||||||
4071240|NCT01045993|3893234|B5||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4071241|NCT01045993|3893235|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4071242|NCT01045993|3893236|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4071243|NCT01045993|3893237|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4071244|NCT01045993|3893238|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4071245|NCT01045993|3893234|B5||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4071246|NCT01045993|3893235|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4071247|NCT01045993|3893236|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4071248|NCT01045993|3893237|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4071249|NCT01045993|3893238|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4071250|NCT01045993|3893234|B5|||Age||years|Mean|29.1|29.1|Standard Deviation|6.8|6.8|||
4071251|NCT01045993|3893235|B4|||Age||years|Mean|28.8|28.8|Standard Deviation|7.7|7.7|||
4071252|NCT01045993|3893236|B3|||Age||years|Mean|30.0|30.0|Standard Deviation|7.2|7.2|||
4071253|NCT01045993|3893237|B2|||Age||years|Mean|25.6|25.6|Standard Deviation|5.4|5.4|||
4071254|NCT01045993|3893238|B1|||Age||years|Mean|30.0|30.0|Standard Deviation|6.0|6.0|||
4071255|NCT01045967|3893315|B3|United States||Region of Enrollment||participants|Number|56|56.0||||||
4071256|NCT01045967|3893316|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4071257|NCT01045967|3893317|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4071258|NCT01045967|3893315|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4071259|NCT01045967|3893316|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4071260|NCT01045967|3893317|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4071261|NCT01045967|3893315|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4071262|NCT01045967|3893316|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4071263|NCT01045967|3893317|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4071264|NCT01045967|3893315|B3|White||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
4071265|NCT01045967|3893316|B2|White||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4071266|NCT01045967|3893317|B1|White||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4071267|NCT01045967|3893315|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4071268|NCT01045967|3893316|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4071269|NCT01045967|3893317|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4071270|NCT01045967|3893315|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4071271|NCT01045967|3893316|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4071272|NCT01045967|3893317|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4071273|NCT01045967|3893315|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4071274|NCT01045967|3893316|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4071275|NCT01045967|3893317|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4071276|NCT01045967|3893315|B3||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4071277|NCT01045967|3893316|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4071278|NCT01045967|3893317|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4071279|NCT01045967|3893315|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4071280|NCT01045967|3893316|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4071281|NCT01045967|3893317|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4071282|NCT01045798|3893328|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4071283|NCT01045798|3893329|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4071284|NCT01045798|3893330|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4071285|NCT01045798|3893328|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4071286|NCT01045798|3893329|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4071287|NCT01045798|3893330|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4071288|NCT01045798|3893328|B3|||Age||years|Mean|56.1|56.1|Standard Deviation|15.1|15.1|||
4071289|NCT01045798|3893329|B2|||Age||years|Mean|53.0|53.0|Standard Deviation|10.6|10.6|||
4071290|NCT01045798|3893330|B1|||Age||years|Mean|60.2|60.2|Standard Deviation|20.1|20.1|||
4071291|NCT01045707|3893337|B3|||Fasting plasma glucose (FPG)||mmol/L|Mean|10.2|10.2|Standard Deviation|2.9|2.9|||
4071292|NCT01045707|3893338|B2|||Fasting plasma glucose (FPG)||mmol/L|Mean|10.4|10.4|Standard Deviation|2.8|2.8|||
4071293|NCT01045707|3893339|B1|||Fasting plasma glucose (FPG)||mmol/L|Mean|10.1|10.1|Standard Deviation|2.9|2.9|||
4071294|NCT01045707|3893337|B3|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.9|8.9|Standard Deviation|0.9|0.9|||
4071295|NCT01045707|3893338|B2|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.9|8.9|Standard Deviation|0.9|0.9|||
4071296|NCT01045707|3893339|B1|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.9|8.9|Standard Deviation|1.0|1.0|||
4071322|NCT01045447|3893372|B1|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.3|8.3|Standard Deviation|0.8|0.8|||
4071323|NCT01045447|3893370|B3||Male|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
4071324|NCT01045447|3893371|B2||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4071325|NCT01045447|3893372|B1||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4071326|NCT01045447|3893370|B3||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4071327|NCT01045447|3893371|B2||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4071328|NCT01045447|3893372|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4071329|NCT01045447|3893370|B3|||Age||years|Mean|58.1|58.1|Standard Deviation|9.8|9.8|||
4071330|NCT01045447|3893371|B2|||Age||years|Mean|58.4|58.4|Standard Deviation|10.1|10.1|||
4071331|NCT01045447|3893372|B1|||Age||years|Mean|57.8|57.8|Standard Deviation|9.5|9.5|||
4071332|NCT01045421|3893381|B7|1||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG performance status assesses a participant's physical ability on a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead.|participants|Number|188|188.0||||||
4071333|NCT01045421|3893382|B6|1||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG performance status assesses a participant's physical ability on a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead.|participants|Number|47|47.0||||||
4071334|NCT01045421|3893383|B5|1||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG performance status assesses a participant's physical ability on a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead.|participants|Number|19|19.0||||||
4071335|NCT01045421|3893384|B4|1||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG performance status assesses a participant's physical ability on a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead.|participants|Number|38|38.0||||||
4071336|NCT01045421|3893385|B3|1||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG performance status assesses a participant's physical ability on a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead.|participants|Number|34|34.0||||||
4071337|NCT01045421|3893386|B2|1||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG performance status assesses a participant's physical ability on a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead.|participants|Number|30|30.0||||||
4071338|NCT01045421|3893387|B1|1||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG performance status assesses a participant's physical ability on a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead.|participants|Number|20|20.0||||||
4071339|NCT01045421|3893381|B7|0||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG performance status assesses a participant's physical ability on a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead.|participants|Number|85|85.0||||||
4071340|NCT01045421|3893382|B6|0||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG performance status assesses a participant's physical ability on a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead.|participants|Number|13|13.0||||||
4071453|NCT01045421|3893383|B5|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4071454|NCT01045421|3893384|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4071455|NCT01045421|3893385|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4071341|NCT01045421|3893383|B5|0||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG performance status assesses a participant's physical ability on a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead.|participants|Number|7|7.0||||||
4071342|NCT01045421|3893384|B4|0||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG performance status assesses a participant's physical ability on a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead.|participants|Number|17|17.0||||||
4071343|NCT01045421|3893385|B3|0||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG performance status assesses a participant's physical ability on a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead.|participants|Number|21|21.0||||||
4071344|NCT01045421|3893386|B2|0||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG performance status assesses a participant's physical ability on a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead.|participants|Number|23|23.0||||||
4071345|NCT01045421|3893387|B1|0||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG performance status assesses a participant's physical ability on a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead.|participants|Number|4|4.0||||||
4071346|NCT01045421|3893381|B7|IVC||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|25|25.0||||||
4071347|NCT01045421|3893382|B6|IVC||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|0|0.0||||||
4071348|NCT01045421|3893383|B5|IVC||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|0|0.0||||||
4071349|NCT01045421|3893384|B4|IVC||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|25|25.0||||||
4071350|NCT01045421|3893385|B3|IVC||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|0|0.0||||||
4071351|NCT01045421|3893386|B2|IVC||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|0|0.0||||||
4071352|NCT01045421|3893387|B1|IVC||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|0|0.0||||||
4071353|NCT01045421|3893381|B7|IVB||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|3|3.0||||||
4071354|NCT01045421|3893382|B6|IVB||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|0|0.0||||||
4071355|NCT01045421|3893383|B5|IVB||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|0|0.0||||||
4071356|NCT01045421|3893384|B4|IVB||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|2|2.0||||||
4071357|NCT01045421|3893385|B3|IVB||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|0|0.0||||||
4071358|NCT01045421|3893386|B2|IVB||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|0|0.0||||||
4071359|NCT01045421|3893387|B1|IVB||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|1|1.0||||||
4071360|NCT01045421|3893381|B7|IVA||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|24|24.0||||||
4071361|NCT01045421|3893382|B6|IVA||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|0|0.0||||||
4071362|NCT01045421|3893383|B5|IVA||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|0|0.0||||||
4071363|NCT01045421|3893384|B4|IVA||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|23|23.0||||||
4071364|NCT01045421|3893385|B3|IVA||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|0|0.0||||||
4071365|NCT01045421|3893386|B2|IVA||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|0|0.0||||||
4071366|NCT01045421|3893387|B1|IVA||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|1|1.0||||||
4071367|NCT01045421|3893381|B7|IV||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|201|201.0||||||
4071456|NCT01045421|3893386|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4071457|NCT01045421|3893387|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4071368|NCT01045421|3893382|B6|IV||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|57|57.0||||||
4071369|NCT01045421|3893383|B5|IV||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|21|21.0||||||
4071370|NCT01045421|3893384|B4|IV||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|2|2.0||||||
4071371|NCT01045421|3893385|B3|IV||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|54|54.0||||||
4071372|NCT01045421|3893386|B2|IV||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|48|48.0||||||
4071373|NCT01045421|3893387|B1|IV||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|19|19.0||||||
4071374|NCT01045421|3893381|B7|IIIC||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|1|1.0||||||
4071375|NCT01045421|3893382|B6|IIIC||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|0|0.0||||||
4071376|NCT01045421|3893383|B5|IIIC||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|0|0.0||||||
4071377|NCT01045421|3893384|B4|IIIC||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|0|0.0||||||
4071378|NCT01045421|3893385|B3|IIIC||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|0|0.0||||||
4071379|NCT01045421|3893386|B2|IIIC||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|1|1.0||||||
4071380|NCT01045421|3893387|B1|IIIC||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|0|0.0||||||
4071381|NCT01045421|3893381|B7|IIIB||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|10|10.0||||||
4071458|NCT01045421|3893381|B7|Chinese||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4071459|NCT01045421|3893382|B6|Chinese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4071382|NCT01045421|3893382|B6|IIIB||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|2|2.0||||||
4071383|NCT01045421|3893383|B5|IIIB||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|5|5.0||||||
4071384|NCT01045421|3893384|B4|IIIB||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|0|0.0||||||
4071385|NCT01045421|3893385|B3|IIIB||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|0|0.0||||||
4071386|NCT01045421|3893386|B2|IIIB||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|3|3.0||||||
4071387|NCT01045421|3893387|B1|IIIB||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|0|0.0||||||
4071388|NCT01045421|3893381|B7|IIIA||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|3|3.0||||||
4071389|NCT01045421|3893382|B6|IIIA||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|1|1.0||||||
4071390|NCT01045421|3893383|B5|IIIA||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|0|0.0||||||
4071391|NCT01045421|3893384|B4|IIIA||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|0|0.0||||||
4071392|NCT01045421|3893385|B3|IIIA||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|0|0.0||||||
4071393|NCT01045421|3893386|B2|IIIA||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|1|1.0||||||
4071394|NCT01045421|3893387|B1|IIIA||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|1|1.0||||||
4071395|NCT01045421|3893381|B7|III||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|4|4.0||||||
4071460|NCT01045421|3893383|B5|Chinese||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4071461|NCT01045421|3893384|B4|Chinese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4071396|NCT01045421|3893382|B6|III||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|0|0.0||||||
4071397|NCT01045421|3893383|B5|III||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|0|0.0||||||
4071398|NCT01045421|3893384|B4|III||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|2|2.0||||||
4071399|NCT01045421|3893385|B3|III||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|1|1.0||||||
4071400|NCT01045421|3893386|B2|III||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|0|0.0||||||
4071401|NCT01045421|3893387|B1|III||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|1|1.0||||||
4071402|NCT01045421|3893381|B7|II||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|1|1.0||||||
4071403|NCT01045421|3893382|B6|II||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|0|0.0||||||
4071404|NCT01045421|3893383|B5|II||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|0|0.0||||||
4071405|NCT01045421|3893384|B4|II||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|1|1.0||||||
4071406|NCT01045421|3893385|B3|II||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|0|0.0||||||
4071407|NCT01045421|3893386|B2|II||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|0|0.0||||||
4071408|NCT01045421|3893387|B1|II||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|0|0.0||||||
4071409|NCT01045421|3893381|B7|IA||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|1|1.0||||||
4071462|NCT01045421|3893385|B3|Chinese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4071463|NCT01045421|3893386|B2|Chinese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4071410|NCT01045421|3893382|B6|IA||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|0|0.0||||||
4071411|NCT01045421|3893383|B5|IA||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|0|0.0||||||
4071412|NCT01045421|3893384|B4|IA||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|0|0.0||||||
4071413|NCT01045421|3893385|B3|IA||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|0|0.0||||||
4071414|NCT01045421|3893386|B2|IA||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|0|0.0||||||
4071415|NCT01045421|3893387|B1|IA||Disease stage at study entry|Assessment of disease stage for Medical History and Physical Examination at baseline were assessed according to the criteria set by the American Joint Committee on Cancer Tumor Staging version 7.0. The exact definition of a stage vary depending on the tumor type. Stage I cancers are the least advanced and often have a better prognosis. Higher stage cancers are often more advanced but in many cases can still be treated successfully.|participants|Number|1|1.0||||||
4071416|NCT01045421|3893381|B7|United States||Region of Enrollment||participants|Number|155|155.0||||||
4071417|NCT01045421|3893382|B6|United States||Region of Enrollment||participants|Number|30|30.0||||||
4071418|NCT01045421|3893383|B5|United States||Region of Enrollment||participants|Number|16|16.0||||||
4071419|NCT01045421|3893384|B4|United States||Region of Enrollment||participants|Number|35|35.0||||||
4071420|NCT01045421|3893385|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
4071421|NCT01045421|3893386|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4071422|NCT01045421|3893387|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4071423|NCT01045421|3893381|B7|Poland||Region of Enrollment||participants|Number|9|9.0||||||
4071424|NCT01045421|3893382|B6|Poland||Region of Enrollment||participants|Number|7|7.0||||||
4071425|NCT01045421|3893383|B5|Poland||Region of Enrollment||participants|Number|0|0.0||||||
4071426|NCT01045421|3893384|B4|Poland||Region of Enrollment||participants|Number|1|1.0||||||
4071427|NCT01045421|3893385|B3|Poland||Region of Enrollment||participants|Number|0|0.0||||||
4071428|NCT01045421|3893386|B2|Poland||Region of Enrollment||participants|Number|1|1.0||||||
4071429|NCT01045421|3893387|B1|Poland||Region of Enrollment||participants|Number|0|0.0||||||
4071430|NCT01045421|3893381|B7|France||Region of Enrollment||participants|Number|40|40.0||||||
4071431|NCT01045421|3893382|B6|France||Region of Enrollment||participants|Number|8|8.0||||||
4071432|NCT01045421|3893383|B5|France||Region of Enrollment||participants|Number|3|3.0||||||
4071433|NCT01045421|3893384|B4|France||Region of Enrollment||participants|Number|11|11.0||||||
4071434|NCT01045421|3893385|B3|France||Region of Enrollment||participants|Number|8|8.0||||||
4071435|NCT01045421|3893386|B2|France||Region of Enrollment||participants|Number|10|10.0||||||
4071436|NCT01045421|3893387|B1|France||Region of Enrollment||participants|Number|0|0.0||||||
4071437|NCT01045421|3893381|B7|Czech Republic||Region of Enrollment||participants|Number|69|69.0||||||
4071438|NCT01045421|3893382|B6|Czech Republic||Region of Enrollment||participants|Number|15|15.0||||||
4071439|NCT01045421|3893383|B5|Czech Republic||Region of Enrollment||participants|Number|7|7.0||||||
4071440|NCT01045421|3893384|B4|Czech Republic||Region of Enrollment||participants|Number|8|8.0||||||
4071441|NCT01045421|3893385|B3|Czech Republic||Region of Enrollment||participants|Number|20|20.0||||||
4071442|NCT01045421|3893386|B2|Czech Republic||Region of Enrollment||participants|Number|19|19.0||||||
4071443|NCT01045421|3893387|B1|Czech Republic||Region of Enrollment||participants|Number|0|0.0||||||
4071444|NCT01045421|3893381|B7|Not reported||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4071445|NCT01045421|3893382|B6|Not reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4071446|NCT01045421|3893383|B5|Not reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4071447|NCT01045421|3893384|B4|Not reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4071448|NCT01045421|3893385|B3|Not reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4071449|NCT01045421|3893386|B2|Not reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4071450|NCT01045421|3893387|B1|Not reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4071451|NCT01045421|3893381|B7|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4071452|NCT01045421|3893382|B6|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4071465|NCT01045421|3893381|B7|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4071466|NCT01045421|3893382|B6|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4071467|NCT01045421|3893383|B5|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4071468|NCT01045421|3893384|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4071469|NCT01045421|3893385|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4071470|NCT01045421|3893386|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4071471|NCT01045421|3893387|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4071472|NCT01045421|3893381|B7|Black or African American||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4071473|NCT01045421|3893382|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4071474|NCT01045421|3893383|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4071475|NCT01045421|3893384|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4071476|NCT01045421|3893385|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4071477|NCT01045421|3893386|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4071478|NCT01045421|3893387|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4071479|NCT01045421|3893381|B7|White||Race/Ethnicity, Customized||participants|Number|249|249.0||||||
4071480|NCT01045421|3893382|B6|White||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
4071481|NCT01045421|3893383|B5|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4071482|NCT01045421|3893384|B4|White||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
4071483|NCT01045421|3893385|B3|White||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4071484|NCT01045421|3893386|B2|White||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4071485|NCT01045421|3893387|B1|White||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4071486|NCT01045421|3893381|B7|Not reported||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4071487|NCT01045421|3893382|B6|Not reported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4071488|NCT01045421|3893383|B5|Not reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4071489|NCT01045421|3893384|B4|Not reported||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4071490|NCT01045421|3893385|B3|Not reported||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4071491|NCT01045421|3893386|B2|Not reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4071492|NCT01045421|3893387|B1|Not reported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4071493|NCT01045421|3893381|B7|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|248|248.0||||||
4071494|NCT01045421|3893382|B6|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
4071495|NCT01045421|3893383|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4071496|NCT01045421|3893384|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
4071497|NCT01045421|3893385|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4071498|NCT01045421|3893386|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
4071499|NCT01045421|3893387|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4071500|NCT01045421|3893381|B7|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4071501|NCT01045421|3893382|B6|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4071502|NCT01045421|3893383|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4071503|NCT01045421|3893384|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4071504|NCT01045421|3893385|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4071505|NCT01045421|3893386|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4071506|NCT01045421|3893387|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4071507|NCT01045421|3893381|B7||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4071508|NCT01045421|3893382|B6||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4071509|NCT01045421|3893383|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4071510|NCT01045421|3893384|B4||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4071511|NCT01045421|3893385|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4071512|NCT01045421|3893386|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4071513|NCT01045421|3893387|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4071514|NCT01045421|3893381|B7||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4071515|NCT01045421|3893382|B6||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4071516|NCT01045421|3893383|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4071517|NCT01045421|3893384|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4071518|NCT01045421|3893385|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4071519|NCT01045421|3893386|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4071520|NCT01045421|3893387|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4071521|NCT01045421|3893381|B7|85 years and over||Age, Customized||participants|Number|1|1.0||||||
4071522|NCT01045421|3893382|B6|85 years and over||Age, Customized||participants|Number|0|0.0||||||
4071523|NCT01045421|3893383|B5|85 years and over||Age, Customized||participants|Number|0|0.0||||||
4071524|NCT01045421|3893384|B4|85 years and over||Age, Customized||participants|Number|0|0.0||||||
4071525|NCT01045421|3893385|B3|85 years and over||Age, Customized||participants|Number|1|1.0||||||
4071526|NCT01045421|3893386|B2|85 years and over||Age, Customized||participants|Number|0|0.0||||||
4071527|NCT01045421|3893387|B1|85 years and over||Age, Customized||participants|Number|0|0.0||||||
4071528|NCT01045421|3893381|B7|65-84 years||Age, Customized||participants|Number|92|92.0||||||
4071529|NCT01045421|3893382|B6|65-84 years||Age, Customized||participants|Number|22|22.0||||||
4071530|NCT01045421|3893383|B5|65-84 years||Age, Customized||participants|Number|9|9.0||||||
4071531|NCT01045421|3893384|B4|65-84 years||Age, Customized||participants|Number|17|17.0||||||
4071532|NCT01045421|3893385|B3|65-84 years||Age, Customized||participants|Number|21|21.0||||||
4071533|NCT01045421|3893386|B2|65-84 years||Age, Customized||participants|Number|16|16.0||||||
4071534|NCT01045421|3893387|B1|65-84 years||Age, Customized||participants|Number|7|7.0||||||
4071535|NCT01045421|3893381|B7|18-64 years||Age, Customized||participants|Number|180|180.0||||||
4071536|NCT01045421|3893382|B6|18-64 years||Age, Customized||participants|Number|38|38.0||||||
4071537|NCT01045421|3893383|B5|18-64 years||Age, Customized||participants|Number|17|17.0||||||
4071538|NCT01045421|3893384|B4|18-64 years||Age, Customized||participants|Number|38|38.0||||||
4071539|NCT01045421|3893385|B3|18-64 years||Age, Customized||participants|Number|33|33.0||||||
4071540|NCT01045421|3893386|B2|18-64 years||Age, Customized||participants|Number|37|37.0||||||
4071541|NCT01045421|3893387|B1|18-64 years||Age, Customized||participants|Number|17|17.0||||||
4071542|NCT01045265|3893477|B1|||CD4 Count||cells/mm^3|Median|450|450.0|Inter-Quartile Range|||289.0|585.0|
4071543|NCT01045265|3893477|B1|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4071544|NCT01045265|3893477|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4071545|NCT01045265|3893477|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4071546|NCT01045265|3893477|B1|||Age||years|Median|48|48.0|Inter-Quartile Range|||42.0|53.0|
4071547|NCT01045265|3893477|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4071548|NCT01045265|3893477|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4071549|NCT01045265|3893477|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4071550|NCT01045187|3893484|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4071551|NCT01045187|3893484|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4071552|NCT01045187|3893484|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4071553|NCT01045187|3893484|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|7.8|7.8|||
4071554|NCT01045187|3893484|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4071555|NCT01045187|3893484|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4071556|NCT01045187|3893484|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4071557|NCT01045161|3893488|B4|Canada||Region of Enrollment|Part B|participants|Number|6|6.0||||||
4071558|NCT01045161|3893489|B3|Canada||Region of Enrollment|Part B|participants|Number|2|2.0||||||
4071559|NCT01045161|3893490|B2|Canada||Region of Enrollment|Part B|participants|Number|2|2.0||||||
4071560|NCT01045161|3893491|B1|Canada||Region of Enrollment|Part B|participants|Number|2|2.0||||||
4071561|NCT01045161|3893488|B4|United States||Region of Enrollment|Part B|participants|Number|442|442.0||||||
4071562|NCT01045161|3893489|B3|United States||Region of Enrollment|Part B|participants|Number|145|145.0||||||
4071563|NCT01045161|3893490|B2|United States||Region of Enrollment|Part B|participants|Number|152|152.0||||||
4071564|NCT01045161|3893491|B1|United States||Region of Enrollment|Part B|participants|Number|145|145.0||||||
4071565|NCT01045161|3893488|B4|Canada||Region of Enrollment|Part A|participants|Number|6|6.0||||||
4071566|NCT01045161|3893489|B3|Canada||Region of Enrollment|Part A|participants|Number|2|2.0||||||
4071567|NCT01045161|3893490|B2|Canada||Region of Enrollment|Part A|participants|Number|2|2.0||||||
4071568|NCT01045161|3893491|B1|Canada||Region of Enrollment|Part A|participants|Number|2|2.0||||||
4071569|NCT01045161|3893488|B4|United States||Region of Enrollment|Part A|participants|Number|536|536.0||||||
4071570|NCT01045161|3893489|B3|United States||Region of Enrollment|Part A|participants|Number|175|175.0||||||
4071571|NCT01045161|3893490|B2|United States||Region of Enrollment|Part A|participants|Number|181|181.0||||||
4071572|NCT01045161|3893491|B1|United States||Region of Enrollment|Part A|participants|Number|180|180.0||||||
4071573|NCT01045161|3893488|B4||Male|Gender|Part B|Participants|Count of Participants|288|288.0||||||
4071574|NCT01045161|3893489|B3||Male|Gender|Part B|Participants|Count of Participants|89|89.0||||||
4071575|NCT01045161|3893490|B2||Male|Gender|Part B|Participants|Count of Participants|99|99.0||||||
4071576|NCT01045161|3893491|B1||Male|Gender|Part B|Participants|Count of Participants|100|100.0||||||
4071577|NCT01045161|3893488|B4||Female|Gender|Part B|Participants|Count of Participants|254|254.0||||||
4071578|NCT01045161|3893489|B3||Female|Gender|Part B|Participants|Count of Participants|88|88.0||||||
4071579|NCT01045161|3893490|B2||Female|Gender|Part B|Participants|Count of Participants|84|84.0||||||
4071580|NCT01045161|3893491|B1||Female|Gender|Part B|Participants|Count of Participants|82|82.0||||||
4071581|NCT01045161|3893488|B4||Male|Gender|Part A|Participants|Count of Participants|288|288.0||||||
4071582|NCT01045161|3893489|B3||Male|Gender|Part A|Participants|Count of Participants|89|89.0||||||
4071583|NCT01045161|3893490|B2||Male|Gender|Part A|Participants|Count of Participants|99|99.0||||||
4071584|NCT01045161|3893491|B1||Male|Gender|Part A|Participants|Count of Participants|100|100.0||||||
4071585|NCT01045161|3893488|B4||Female|Gender|Part A|Participants|Count of Participants|254|254.0||||||
4071586|NCT01045161|3893489|B3||Female|Gender|Part A|Participants|Count of Participants|88|88.0||||||
4071587|NCT01045161|3893490|B2||Female|Gender|Part A|Participants|Count of Participants|84|84.0||||||
4071588|NCT01045161|3893491|B1||Female|Gender|Part A|Participants|Count of Participants|82|82.0||||||
4071589|NCT01045161|3893488|B4|≥ 70 years - Part B||Age, Customized||participants|Number|104|104.0||||||
4071590|NCT01045161|3893489|B3|≥ 70 years - Part B||Age, Customized||participants|Number|34|34.0||||||
4071591|NCT01045161|3893490|B2|≥ 70 years - Part B||Age, Customized||participants|Number|41|41.0||||||
4071592|NCT01045161|3893491|B1|≥ 70 years - Part B||Age, Customized||participants|Number|29|29.0||||||
4071593|NCT01045161|3893488|B4|≥ 60 to < 70 years - Part B||Age, Customized||participants|Number|192|192.0||||||
4071594|NCT01045161|3893489|B3|≥ 60 to < 70 years - Part B||Age, Customized||participants|Number|67|67.0||||||
4071595|NCT01045161|3893490|B2|≥ 60 to < 70 years - Part B||Age, Customized||participants|Number|67|67.0||||||
4071596|NCT01045161|3893491|B1|≥ 60 to < 70 years - Part B||Age, Customized||participants|Number|58|58.0||||||
4071597|NCT01045161|3893488|B4|≥ 40 to < 60 years - Part B||Age, Customized||participants|Number|152|152.0||||||
4071598|NCT01045161|3893489|B3|≥ 40 to < 60 years - Part B||Age, Customized||participants|Number|46|46.0||||||
4071599|NCT01045161|3893490|B2|≥ 40 to < 60 years - Part B||Age, Customized||participants|Number|46|46.0||||||
4071600|NCT01045161|3893491|B1|≥ 40 to < 60 years - Part B||Age, Customized||participants|Number|60|60.0||||||
4071601|NCT01045161|3893488|B4|≥ 70 years - Part A||Age, Customized||participants|Number|128|128.0||||||
4071602|NCT01045161|3893489|B3|≥ 70 years - Part A||Age, Customized||participants|Number|43|43.0||||||
4071603|NCT01045161|3893490|B2|≥ 70 years - Part A||Age, Customized||participants|Number|47|47.0||||||
4071604|NCT01045161|3893491|B1|≥ 70 years - Part A||Age, Customized||participants|Number|38|38.0||||||
4071605|NCT01045161|3893488|B4|≥ 60 to < 70 years - Part A||Age, Customized||participants|Number|228|228.0||||||
4071606|NCT01045161|3893489|B3|≥ 60 to < 70 years - Part A||Age, Customized||participants|Number|77|77.0||||||
4071607|NCT01045161|3893490|B2|≥ 60 to < 70 years - Part A||Age, Customized||participants|Number|79|79.0||||||
4071608|NCT01045161|3893491|B1|≥ 60 to < 70 years - Part A||Age, Customized||participants|Number|72|72.0||||||
4071609|NCT01045161|3893488|B4|≥ 40 to < 60 years - Part A||Age, Customized||participants|Number|186|186.0||||||
4071610|NCT01045161|3893489|B3|≥ 40 to < 60 years - Part A||Age, Customized||participants|Number|57|57.0||||||
4071611|NCT01045161|3893490|B2|≥ 40 to < 60 years - Part A||Age, Customized||participants|Number|57|57.0||||||
4071612|NCT01045161|3893491|B1|≥ 40 to < 60 years - Part A||Age, Customized||participants|Number|72|72.0||||||
4071613|NCT01045161|3893488|B4|Part B||Age||years|Mean|62.8|62.8|Standard Deviation|8.7|8.7|||
4071614|NCT01045161|3893489|B3|Part B||Age||years|Mean|63.1|63.1|Standard Deviation|8.6|8.6|||
4071615|NCT01045161|3893490|B2|Part B||Age||years|Mean|63.8|63.8|Standard Deviation|8.2|8.2|||
4071616|NCT01045161|3893491|B1|Part B||Age||years|Mean|61.3|61.3|Standard Deviation|9.1|9.1|||
4071617|NCT01045161|3893488|B4|Part A||Age||years|Mean|62.8|62.8|Standard Deviation|8.9|8.9|||
4071618|NCT01045161|3893489|B3|Part A||Age||years|Mean|63.2|63.2|Standard Deviation|9.0|9.0|||
4071619|NCT01045161|3893490|B2|Part A||Age||years|Mean|63.4|63.4|Standard Deviation|8.5|8.5|||
4071620|NCT01045161|3893491|B1|Part A||Age||years|Mean|61.7|61.7|Standard Deviation|9.3|9.3|||
4071621|NCT01045122|3893513|B1|||Respiratory Disturbance Index|The Degree of respiratory instability will be quantified in terms of the following measurements: a Respiratory Disturbance Index in events per hour.|events per hour|Mean|39.99|39.99|Standard Deviation|40.1|40.1|||
4071622|NCT01045122|3893513|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4071623|NCT01045122|3893513|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4071624|NCT01045122|3893513|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4071625|NCT01045122|3893513|B1|||Age||years|Mean|49|49.0|Standard Deviation|13.7|13.7|||
4071626|NCT01045122|3893513|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4071627|NCT01045122|3893513|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4071628|NCT01045122|3893513|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4071629|NCT01045096|3893520|B4|||Body Mass Index (BMI)|Height for one patient in the Dexlansoprazole 15 mg group was incorrectly reported (as 38 cm instead of 96.52 cm) and is included in the mean BMI reported here. The mean BMI excluding this patient is 16.52 kg/m^2.|kg/m^2|Mean|19.2|19.2|Standard Deviation|11.73|11.73|||
4071630|NCT01045096|3893521|B3|||Body Mass Index (BMI)|Height for one patient in the Dexlansoprazole 15 mg group was incorrectly reported (as 38 cm instead of 96.52 cm) and is included in the mean BMI reported here. The mean BMI excluding this patient is 16.52 kg/m^2.|kg/m^2|Mean|19.0|19.0|Standard Deviation|2.56|2.56|||
4071631|NCT01045096|3893522|B2|||Body Mass Index (BMI)|Height for one patient in the Dexlansoprazole 15 mg group was incorrectly reported (as 38 cm instead of 96.52 cm) and is included in the mean BMI reported here. The mean BMI excluding this patient is 16.52 kg/m^2.|kg/m^2|Mean|16.4|16.4|Standard Deviation|3.09|3.09|||
4071632|NCT01045096|3893523|B1|||Body Mass Index (BMI)|Height for one patient in the Dexlansoprazole 15 mg group was incorrectly reported (as 38 cm instead of 96.52 cm) and is included in the mean BMI reported here. The mean BMI excluding this patient is 16.52 kg/m^2.|kg/m^2|Mean|22.3|22.3|Standard Deviation|20.08|20.08|||
4071633|NCT01045096|3893520|B4|≥ 25.4 kg||Mean Weight per Weight Group||kg|Mean|40.3|40.3|Standard Deviation|8.51|8.51|||
4071634|NCT01045096|3893521|B3|≥ 25.4 kg||Mean Weight per Weight Group||kg|Mean|41.0|41.0|Standard Deviation|8.50|8.5|||
4071635|NCT01045096|3893522|B2|≥ 25.4 kg||Mean Weight per Weight Group||kg|Mean|39.1|39.1|Standard Deviation|9.19|9.19|||
4071636|NCT01045096|3893523|B1|≥ 25.4 kg||Mean Weight per Weight Group||kg|Mean|NA||Standard Deviation|NA||||There were no participants in this group
4071637|NCT01045096|3893520|B4|12.7 kg - < 25.4 kg||Mean Weight per Weight Group||kg|Mean|19.6|19.6|Standard Deviation|4.17|4.17|||
4071638|NCT01045096|3893521|B3|12.7 kg - < 25.4 kg||Mean Weight per Weight Group||kg|Mean|NA||Standard Deviation|NA||||There were no participants in this group
4071639|NCT01045096|3893522|B2|12.7 kg - < 25.4 kg||Mean Weight per Weight Group||kg|Mean|20.3|20.3|Standard Deviation|3.67|3.67|||
4071640|NCT01045096|3893523|B1|12.7 kg - < 25.4 kg||Mean Weight per Weight Group||kg|Mean|19.0|19.0|Standard Deviation|4.76|4.76|||
4071641|NCT01045096|3893520|B4|8.6 kg - < 12.7 kg||Mean Weight per Weight Group||kg|Mean|11.1|11.1|Standard Deviation|1.05|1.05|||
4071642|NCT01045096|3893521|B3|8.6 kg - < 12.7 kg||Mean Weight per Weight Group||kg|Mean|NA||Standard Deviation|NA||||There were no participants in this group
4071643|NCT01045096|3893522|B2|8.6 kg - < 12.7 kg||Mean Weight per Weight Group||kg|Mean|NA||Standard Deviation|NA||||There were no participants in this group
4071644|NCT01045096|3893523|B1|8.6 kg - < 12.7 kg||Mean Weight per Weight Group||kg|Mean|11.1|11.1|Standard Deviation|1.05|1.05|||
4071645|NCT01045096|3893520|B4|≥ 25.4 kg||Number of Participants per Weight Group||participants|Number|18|18.0||||||
4071646|NCT01045096|3893521|B3|≥ 25.4 kg||Number of Participants per Weight Group||participants|Number|12|12.0||||||
4071647|NCT01045096|3893522|B2|≥ 25.4 kg||Number of Participants per Weight Group||participants|Number|6|6.0||||||
4071648|NCT01045096|3893523|B1|≥ 25.4 kg||Number of Participants per Weight Group||participants|Number|0|0.0||||||
4071649|NCT01045096|3893520|B4|12.7 kg - < 25.4 kg||Number of Participants per Weight Group||participants|Number|13|13.0||||||
4071650|NCT01045096|3893521|B3|12.7 kg - < 25.4 kg||Number of Participants per Weight Group||participants|Number|0|0.0||||||
4071651|NCT01045096|3893522|B2|12.7 kg - < 25.4 kg||Number of Participants per Weight Group||participants|Number|6|6.0||||||
4071652|NCT01045096|3893523|B1|12.7 kg - < 25.4 kg||Number of Participants per Weight Group||participants|Number|7|7.0||||||
4071653|NCT01045096|3893520|B4|8.6 kg - < 12.7 kg||Number of Participants per Weight Group||participants|Number|5|5.0||||||
4071654|NCT01045096|3893521|B3|8.6 kg - < 12.7 kg||Number of Participants per Weight Group||participants|Number|0|0.0||||||
4071655|NCT01045096|3893522|B2|8.6 kg - < 12.7 kg||Number of Participants per Weight Group||participants|Number|0|0.0||||||
4071656|NCT01045096|3893523|B1|8.6 kg - < 12.7 kg||Number of Participants per Weight Group||participants|Number|5|5.0||||||
4071657|NCT01045096|3893520|B4|||Overall Mean Weight||kg|Mean|28.8|28.8|Standard Deviation|13.64|13.64|||
4071658|NCT01045096|3893521|B3|||Overall Mean Weight||kg|Mean|41.0|41.0|Standard Deviation|8.50|8.5|||
4071659|NCT01045096|3893522|B2|||Overall Mean Weight||kg|Mean|29.7|29.7|Standard Deviation|11.86|11.86|||
4071660|NCT01045096|3893523|B1|||Overall Mean Weight||kg|Mean|15.7|15.7|Standard Deviation|5.43|5.43|||
4071661|NCT01045096|3893520|B4|||Mean height|Height for one patient in the Dexlansoprazole 15 mg group was incorrectly reported (as 38 cm instead of 96.52 cm) and is included in the mean height reported here. The mean height excluding this patient is 97.45 cm.|cm|Mean|123.6|123.6|Standard Deviation|29.17|29.17|||
4071662|NCT01045096|3893521|B3|||Mean height|Height for one patient in the Dexlansoprazole 15 mg group was incorrectly reported (as 38 cm instead of 96.52 cm) and is included in the mean height reported here. The mean height excluding this patient is 97.45 cm.|cm|Mean|146.3|146.3|Standard Deviation|8.73|8.73|||
4071663|NCT01045096|3893522|B2|||Mean height|Height for one patient in the Dexlansoprazole 15 mg group was incorrectly reported (as 38 cm instead of 96.52 cm) and is included in the mean height reported here. The mean height excluding this patient is 97.45 cm.|cm|Mean|131.9|131.9|Standard Deviation|18.80|18.8|||
4071664|NCT01045096|3893523|B1|||Mean height|Height for one patient in the Dexlansoprazole 15 mg group was incorrectly reported (as 38 cm instead of 96.52 cm) and is included in the mean height reported here. The mean height excluding this patient is 97.45 cm.|cm|Mean|92.5|92.5|Standard Deviation|24.16|24.16|||
4071665|NCT01045096|3893520|B4|United States||Region of Enrollment||participants|Number|36|36.0||||||
4071666|NCT01045096|3893521|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4071667|NCT01045096|3893522|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4071668|NCT01045096|3893523|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4071669|NCT01045096|3893520|B4|Multiracial||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4071670|NCT01045096|3893521|B3|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4071671|NCT01045096|3893522|B2|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4071672|NCT01045096|3893523|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4071673|NCT01045096|3893520|B4|White||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4071674|NCT01045096|3893521|B3|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4071675|NCT01045096|3893522|B2|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4071676|NCT01045096|3893523|B1|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4071677|NCT01045096|3893520|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4071678|NCT01045096|3893521|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4071679|NCT01045096|3893522|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4071680|NCT01045096|3893523|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4071681|NCT01045096|3893520|B4|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4071682|NCT01045096|3893521|B3|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4071683|NCT01045096|3893522|B2|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4071684|NCT01045096|3893523|B1|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4071685|NCT01045096|3893520|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4071686|NCT01045096|3893521|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4071687|NCT01045096|3893522|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4071688|NCT01045096|3893523|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4071689|NCT01045096|3893520|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4071690|NCT01045096|3893521|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4071691|NCT01045096|3893522|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4071692|NCT01045096|3893523|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4071693|NCT01045096|3893520|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4071694|NCT01045096|3893521|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4071695|NCT01045096|3893522|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4071696|NCT01045096|3893523|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4071697|NCT01045096|3893520|B4|||Age||years|Mean|7.1|7.1|Standard Deviation|3.50|3.5|||
4071698|NCT01045096|3893521|B3|||Age||years|Mean|10.2|10.2|Standard Deviation|0.72|0.72|||
4071699|NCT01045096|3893522|B2|||Age||years|Mean|7.8|7.8|Standard Deviation|2.89|2.89|||
4071700|NCT01045096|3893523|B1|||Age||years|Mean|3.3|3.3|Standard Deviation|1.97|1.97|||
4071701|NCT01045057|3893551|B1|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
4071702|NCT01045057|3893551|B1|Germany||Region of Enrollment||participants|Number|13|13.0||||||
4071703|NCT01045057|3893551|B1|Belgium||Region of Enrollment||participants|Number|7|7.0||||||
4071704|NCT01045057|3893551|B1|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4071705|NCT01045057|3893551|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4071706|NCT01045057|3893551|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4071707|NCT01045057|3893551|B1|||Age||years|Mean|62|62.0|Standard Deviation|7.8|7.8|||
4071708|NCT01045057|3893551|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4071709|NCT01045057|3893551|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4071710|NCT01045057|3893551|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4071711|NCT01045031|3893558|B3||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4071712|NCT01045031|3893559|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4071713|NCT01045031|3893560|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4071714|NCT01045031|3893558|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4071715|NCT01045031|3893559|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4071716|NCT01045031|3893560|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4071717|NCT01045031|3893558|B3|||Age||years|Mean|65.9|65.9|Standard Deviation|4.4|4.4|||
4071718|NCT01045031|3893559|B2|||Age||years|Mean|65.9|65.9|Standard Deviation|4.1|4.1|||
4071719|NCT01045031|3893560|B1|||Age||years|Mean|66.0|66.0|Standard Deviation|4.7|4.7|||
4071720|NCT01044862|3893571|B4|United States||Region of Enrollment||participants|Number|900|900.0||||||
4071721|NCT01044862|3893572|B3|United States||Region of Enrollment||participants|Number|301|301.0||||||
4071722|NCT01044862|3893573|B2|United States||Region of Enrollment||participants|Number|300|300.0||||||
4071723|NCT01044862|3893574|B1|United States||Region of Enrollment||participants|Number|299|299.0||||||
4071724|NCT01044862|3893571|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4071725|NCT01044862|3893572|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4071726|NCT01044862|3893573|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4071727|NCT01044862|3893574|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4071728|NCT01044862|3893571|B4||Female|Sex: Female, Male||Participants|Count of Participants|900|900.0||||||
4071729|NCT01044862|3893572|B3||Female|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
4071730|NCT01044862|3893573|B2||Female|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
4071731|NCT01044862|3893574|B1||Female|Sex: Female, Male||Participants|Count of Participants|299|299.0||||||
4071732|NCT01044862|3893571|B4|||Age||years|Mean|32.2|32.2|Standard Deviation|4.4|4.4|||
4071733|NCT01044862|3893572|B3|||Age||years|Mean|32.2|32.2|Standard Deviation|4.1|4.1|||
4071734|NCT01044862|3893573|B2|||Age||years|Mean|32.0|32.0|Standard Deviation|4.6|4.6|||
4071735|NCT01044862|3893574|B1|||Age||years|Mean|32.2|32.2|Standard Deviation|4.3|4.3|||
4071736|NCT01044771|3893593|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4071737|NCT01044771|3893593|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4071738|NCT01044771|3893593|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4071739|NCT01044771|3893593|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4071740|NCT01044771|3893593|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4071741|NCT01044771|3893593|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4071742|NCT01044771|3893593|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4071743|NCT01044771|3893593|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4071744|NCT01044771|3893593|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4071745|NCT01044771|3893593|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4071746|NCT01044771|3893593|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4071747|NCT01044771|3893593|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4071748|NCT01044771|3893593|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4071749|NCT01044758|3893598|B8|United States||Region of Enrollment||participants|Number|71|71.0||||||
4071750|NCT01044758|3893599|B7|United States||Region of Enrollment||participants|Number|17|17.0||||||
4071751|NCT01044758|3893600|B6|United States||Region of Enrollment||participants|Number|8|8.0||||||
4071752|NCT01044758|3893601|B5|United States||Region of Enrollment||participants|Number|9|9.0||||||
4071753|NCT01044758|3893602|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
4071754|NCT01044758|3893603|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4071755|NCT01044758|3893604|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4071756|NCT01044758|3893605|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4071757|NCT01044758|3893598|B8||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4071758|NCT01044758|3893599|B7||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4071759|NCT01044758|3893600|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4071760|NCT01044758|3893601|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4071761|NCT01044758|3893602|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4071762|NCT01044758|3893603|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4071763|NCT01044758|3893604|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4071764|NCT01044758|3893605|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4071765|NCT01044758|3893598|B8||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4071766|NCT01044758|3893599|B7||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4071767|NCT01044758|3893600|B6||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4071768|NCT01044758|3893601|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4071769|NCT01044758|3893602|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4071770|NCT01044758|3893603|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4071771|NCT01044758|3893604|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4071772|NCT01044758|3893605|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4071773|NCT01044758|3893598|B8||>=65 years|Age||Participants|Count of Participants|64|64.0||||||
4071774|NCT01044758|3893599|B7||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4071775|NCT01044758|3893600|B6||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4071776|NCT01044758|3893601|B5||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4071777|NCT01044758|3893602|B4||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4071778|NCT01044758|3893603|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4071779|NCT01044758|3893604|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4071780|NCT01044758|3893605|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4071781|NCT01044758|3893598|B8||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4071782|NCT01044758|3893599|B7||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4071783|NCT01044758|3893600|B6||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4071784|NCT01044758|3893601|B5||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4071785|NCT01044758|3893602|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4071786|NCT01044758|3893603|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4071787|NCT01044758|3893604|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4071788|NCT01044758|3893605|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4071789|NCT01044758|3893598|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4071790|NCT01044758|3893599|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4071791|NCT01044758|3893600|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4071792|NCT01044758|3893601|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4071793|NCT01044758|3893602|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4071794|NCT01044758|3893603|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4071795|NCT01044758|3893604|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4071796|NCT01044758|3893605|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4071797|NCT01044732|3893634|B3|Diagnostic||Indication for colonoscopy procedure||participants in ITT population|Number|87|87.0||||||
4071798|NCT01044732|3893635|B2|Diagnostic||Indication for colonoscopy procedure||participants in ITT population|Number|41|41.0||||||
4071799|NCT01044732|3893636|B1|Diagnostic||Indication for colonoscopy procedure||participants in ITT population|Number|46|46.0||||||
4071800|NCT01044732|3893634|B3|Surveillance||Indication for colonoscopy procedure||participants in ITT population|Number|96|96.0||||||
4071801|NCT01044732|3893635|B2|Surveillance||Indication for colonoscopy procedure||participants in ITT population|Number|55|55.0||||||
4071802|NCT01044732|3893636|B1|Surveillance||Indication for colonoscopy procedure||participants in ITT population|Number|41|41.0||||||
4071803|NCT01044732|3893634|B3|Screening||Indication for colonoscopy procedure||participants in ITT population|Number|189|189.0||||||
4071804|NCT01044732|3893635|B2|Screening||Indication for colonoscopy procedure||participants in ITT population|Number|92|92.0||||||
4071805|NCT01044732|3893636|B1|Screening||Indication for colonoscopy procedure||participants in ITT population|Number|97|97.0||||||
4071806|NCT01044732|3893634|B3|United Kingdom||Region of Enrollment||participants in ITT population|Number|3|3.0||||||
4071807|NCT01044732|3893635|B2|United Kingdom||Region of Enrollment||participants in ITT population|Number|1|1.0||||||
4071808|NCT01044732|3893636|B1|United Kingdom||Region of Enrollment||participants in ITT population|Number|2|2.0||||||
4071809|NCT01044732|3893634|B3|Italy||Region of Enrollment||participants in ITT population|Number|53|53.0||||||
4071930|NCT01044537|3893711|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4071810|NCT01044732|3893635|B2|Italy||Region of Enrollment||participants in ITT population|Number|28|28.0||||||
4071811|NCT01044732|3893636|B1|Italy||Region of Enrollment||participants in ITT population|Number|25|25.0||||||
4071812|NCT01044732|3893634|B3|United States||Region of Enrollment||participants in ITT population|Number|225|225.0||||||
4071813|NCT01044732|3893635|B2|United States||Region of Enrollment||participants in ITT population|Number|111|111.0||||||
4071814|NCT01044732|3893636|B1|United States||Region of Enrollment||participants in ITT population|Number|114|114.0||||||
4071815|NCT01044732|3893634|B3|Belgium||Region of Enrollment||participants in ITT population|Number|50|50.0||||||
4071816|NCT01044732|3893635|B2|Belgium||Region of Enrollment||participants in ITT population|Number|26|26.0||||||
4071817|NCT01044732|3893636|B1|Belgium||Region of Enrollment||participants in ITT population|Number|24|24.0||||||
4071818|NCT01044732|3893634|B3|Netherlands||Region of Enrollment||participants in ITT population|Number|41|41.0||||||
4071819|NCT01044732|3893635|B2|Netherlands||Region of Enrollment||participants in ITT population|Number|22|22.0||||||
4071820|NCT01044732|3893636|B1|Netherlands||Region of Enrollment||participants in ITT population|Number|19|19.0||||||
4071821|NCT01044732|3893634|B3||Male|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
4071822|NCT01044732|3893635|B2||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4071823|NCT01044732|3893636|B1||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4071824|NCT01044732|3893634|B3||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4071825|NCT01044732|3893635|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4071826|NCT01044732|3893636|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4071827|NCT01044732|3893634|B3|||Age||years|Mean|57.8|57.8|Standard Deviation|9.7|9.7|||
4071828|NCT01044732|3893635|B2|||Age||years|Mean|58.0|58.0|Standard Deviation|9.7|9.7|||
4071829|NCT01044732|3893636|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|9.8|9.8|||
4071830|NCT01044706|3893645|B3|Canada||Region of Enrollment||participants|Number|60|60.0||||||
4071831|NCT01044706|3893646|B2|Canada||Region of Enrollment||participants|Number|30|30.0||||||
4071832|NCT01044706|3893647|B1|Canada||Region of Enrollment||participants|Number|30|30.0||||||
4071833|NCT01044706|3893645|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4071834|NCT01044706|3893646|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4071835|NCT01044706|3893647|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4071836|NCT01044706|3893645|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4071837|NCT01044706|3893646|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4071838|NCT01044706|3893647|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4071839|NCT01044706|3893645|B3|||Age||years|Mean|39.03|39.03|Standard Deviation|14.18|14.18|||
4071840|NCT01044706|3893646|B2|||Age||years|Mean|37.93|37.93|Standard Deviation|14.41|14.41|||
4071841|NCT01044706|3893647|B1|||Age||years|Mean|40.13|40.13|Standard Deviation|14.10|14.1|||
4071842|NCT01044706|3893645|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4071843|NCT01044706|3893646|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4071844|NCT01044706|3893647|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4071845|NCT01044706|3893645|B3||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4071846|NCT01044706|3893646|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4071847|NCT01044706|3893647|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4071848|NCT01044706|3893645|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4071849|NCT01044706|3893646|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4071850|NCT01044706|3893647|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4071851|NCT01044693|3893656|B1|||Plasma norepinephrine, upright||pg/mL|Mean|253|253.0|Standard Deviation|209|209.0|||
4071852|NCT01044693|3893656|B1|||Plasma norepinephrine, supine||pg/mL|Mean|136|136.0|Standard Deviation|98|98.0|||
4071853|NCT01044693|3893656|B1|||Heart rate, upright||bpm|Mean|83|83.0|Standard Deviation|15|15.0|||
4071854|NCT01044693|3893656|B1|||Heart rate, supine||bpm|Mean|68|68.0|Standard Deviation|10|10.0|||
4071855|NCT01044693|3893656|B1|||Systolic BP, upright||mm Hg|Mean|83|83.0|Standard Deviation|25|25.0|||
4071856|NCT01044693|3893656|B1|||Systolic BP, supine||mm Hg|Mean|169|169.0|Standard Deviation|24|24.0|||
4071857|NCT01044693|3893656|B1|No||Medical history of essential hypertension||participants|Number|16|16.0||||||
4071858|NCT01044693|3893656|B1|yes||Medical history of essential hypertension||participants|Number|4|4.0||||||
4071859|NCT01044693|3893656|B1|Multiple System Atrophy||Diagnosis||participants|Number|6|6.0||||||
4071860|NCT01044693|3893656|B1|Parkinson Disease with autonomic failure||Diagnosis||participants|Number|4|4.0||||||
4071861|NCT01044693|3893656|B1|Pure autonomic failure||Diagnosis||participants|Number|10|10.0||||||
4071862|NCT01044693|3893656|B1|||Duration of disease||years|Mean|8|8.0|Standard Deviation|6|6.0|||
4071863|NCT01044693|3893656|B1|||BMI||kg/m2|Mean|25.6|25.6|Standard Deviation|3.2|3.2|||
4071864|NCT01044693|3893656|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4071865|NCT01044693|3893656|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4071866|NCT01044693|3893656|B1|||Age||years|Mean|69|69.0|Standard Deviation|8|8.0|||
4071867|NCT01044589|3893693|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4071868|NCT01044589|3893694|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4071869|NCT01044589|3893695|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4071870|NCT01044589|3893693|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4071871|NCT01044589|3893694|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4071872|NCT01044589|3893695|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4071873|NCT01044589|3893693|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4071874|NCT01044589|3893694|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4071875|NCT01044589|3893695|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4071876|NCT01044589|3893693|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4071877|NCT01044589|3893694|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4071878|NCT01044589|3893695|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4071879|NCT01044589|3893693|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4071880|NCT01044589|3893694|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4071881|NCT01044589|3893695|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4071882|NCT01044589|3893693|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4071883|NCT01044589|3893694|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4071884|NCT01044589|3893695|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4071885|NCT01044589|3893693|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4071886|NCT01044589|3893694|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4071887|NCT01044589|3893695|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4071888|NCT01044589|3893693|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4071889|NCT01044589|3893694|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4071890|NCT01044589|3893695|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4071891|NCT01044589|3893693|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4071892|NCT01044589|3893694|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4071893|NCT01044589|3893695|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4071894|NCT01044589|3893693|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4071895|NCT01044589|3893694|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4071896|NCT01044589|3893695|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4071897|NCT01044589|3893693|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4071898|NCT01044589|3893694|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4071899|NCT01044589|3893695|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4071900|NCT01044589|3893693|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4071901|NCT01044589|3893694|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4071902|NCT01044589|3893695|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4071903|NCT01044589|3893693|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4071904|NCT01044589|3893694|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4071905|NCT01044589|3893695|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4071906|NCT01044589|3893693|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4071907|NCT01044589|3893694|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4071908|NCT01044589|3893695|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4071909|NCT01044589|3893693|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4071910|NCT01044589|3893694|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4071911|NCT01044589|3893695|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4071912|NCT01044589|3893693|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4071913|NCT01044589|3893694|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4071914|NCT01044589|3893695|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4071915|NCT01044537|3893704|B8||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4071916|NCT01044537|3893705|B7||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4071917|NCT01044537|3893706|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4071918|NCT01044537|3893707|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4071919|NCT01044537|3893708|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4071920|NCT01044537|3893709|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4071921|NCT01044537|3893710|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4071922|NCT01044537|3893711|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4071923|NCT01044537|3893704|B8||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4071924|NCT01044537|3893705|B7||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4071925|NCT01044537|3893706|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4071926|NCT01044537|3893707|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4071927|NCT01044537|3893708|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4071928|NCT01044537|3893709|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4071929|NCT01044537|3893710|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4071931|NCT01044537|3893704|B8|||Age||years|Mean|53.7|53.7|Standard Deviation|7.9|7.9|||
4071932|NCT01044537|3893705|B7|||Age||years|Mean|53.7|53.7|Standard Deviation|7.8|7.8|||
4071933|NCT01044537|3893706|B6|||Age||years|Mean|49.0|49.0|Standard Deviation|10.0|10.0|||
4071934|NCT01044537|3893707|B5|||Age||years|Mean|55.0|55.0|Standard Deviation|8.1|8.1|||
4071935|NCT01044537|3893708|B4|||Age||years|Mean|58.8|58.8|Standard Deviation|4.6|4.6|||
4071936|NCT01044537|3893709|B3|||Age||years|Mean|52.0|52.0|Standard Deviation|6.8|6.8|||
4071937|NCT01044537|3893710|B2|||Age||years|Mean|52.2|52.2|Standard Deviation|8.8|8.8|||
4071938|NCT01044537|3893711|B1|||Age||years|Mean|55.0|55.0|Standard Deviation|9.0|9.0|||
4071939|NCT01044498|3893824|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4071940|NCT01044498|3893825|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4071941|NCT01044498|3893826|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4071942|NCT01044498|3893824|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4071943|NCT01044498|3893825|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4071944|NCT01044498|3893826|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4071945|NCT01044498|3893824|B3|||Age||years|Mean|30.7|30.7|Standard Deviation|8.22|8.22|||
4071946|NCT01044498|3893825|B2|||Age||years|Mean|25.7|25.7|Standard Deviation|5.04|5.04|||
4071947|NCT01044498|3893826|B1|||Age||years|Mean|35.8|35.8|Standard Deviation|7.66|7.66|||
4071948|NCT01044459|3893851|B3|Canada||Region of Enrollment||participants|Number|13|13.0||||||
4071949|NCT01044459|3893852|B2|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4071950|NCT01044459|3893853|B1|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4071951|NCT01044459|3893851|B3|United States||Region of Enrollment||participants|Number|589|589.0||||||
4071952|NCT01044459|3893852|B2|United States||Region of Enrollment||participants|Number|284|284.0||||||
4071953|NCT01044459|3893853|B1|United States||Region of Enrollment||participants|Number|305|305.0||||||
4071954|NCT01044459|3893851|B3||Male|Sex: Female, Male||Participants|Count of Participants|351|351.0||||||
4071955|NCT01044459|3893852|B2||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4071956|NCT01044459|3893853|B1||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4071957|NCT01044459|3893851|B3||Female|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4071958|NCT01044459|3893852|B2||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4071959|NCT01044459|3893853|B1||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4071960|NCT01044459|3893851|B3|≥ 70 years||Age, Customized||participants|Number|179|179.0||||||
4071961|NCT01044459|3893852|B2|≥ 70 years||Age, Customized||participants|Number|96|96.0||||||
4071962|NCT01044459|3893853|B1|≥ 70 years||Age, Customized||participants|Number|83|83.0||||||
4071963|NCT01044459|3893851|B3|≥ 60 to < 70 years||Age, Customized||participants|Number|214|214.0||||||
4071964|NCT01044459|3893852|B2|≥ 60 to < 70 years||Age, Customized||participants|Number|99|99.0||||||
4071965|NCT01044459|3893853|B1|≥ 60 to < 70 years||Age, Customized||participants|Number|115|115.0||||||
4071966|NCT01044459|3893851|B3|≥ 40 to < 60 years||Age, Customized||participants|Number|209|209.0||||||
4071967|NCT01044459|3893852|B2|≥ 40 to < 60 years||Age, Customized||participants|Number|96|96.0||||||
4071968|NCT01044459|3893853|B1|≥ 40 to < 60 years||Age, Customized||participants|Number|113|113.0||||||
4071969|NCT01044459|3893851|B3|||Age||years|Mean|63.6|63.6|Standard Deviation|9.7|9.7|||
4071970|NCT01044459|3893852|B2|||Age||years|Mean|64.2|64.2|Standard Deviation|9.9|9.9|||
4071971|NCT01044459|3893853|B1|||Age||years|Mean|63.0|63.0|Standard Deviation|9.5|9.5|||
4071972|NCT01044303|3893862|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4071973|NCT01044303|3893862|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4071974|NCT01044303|3893862|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4071975|NCT01044303|3893862|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4071976|NCT01044303|3893862|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4071977|NCT01044303|3893862|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4071978|NCT01044290|3893869|B4|Disability||Working Status||participants|Number|61|61.0||||||
4071979|NCT01044290|3893870|B3|Disability||Working Status||participants|Number|18|18.0||||||
4071980|NCT01044290|3893871|B2|Disability||Working Status||participants|Number|20|20.0||||||
4071981|NCT01044290|3893872|B1|Disability||Working Status||participants|Number|23|23.0||||||
4071982|NCT01044290|3893869|B4|Retired||Working Status||participants|Number|126|126.0||||||
4071983|NCT01044290|3893870|B3|Retired||Working Status||participants|Number|41|41.0||||||
4071984|NCT01044290|3893871|B2|Retired||Working Status||participants|Number|41|41.0||||||
4071985|NCT01044290|3893872|B1|Retired||Working Status||participants|Number|44|44.0||||||
4071986|NCT01044290|3893869|B4|Not working||Working Status||participants|Number|19|19.0||||||
4071987|NCT01044290|3893870|B3|Not working||Working Status||participants|Number|9|9.0||||||
4071988|NCT01044290|3893871|B2|Not working||Working Status||participants|Number|6|6.0||||||
4071989|NCT01044290|3893872|B1|Not working||Working Status||participants|Number|4|4.0||||||
4071990|NCT01044290|3893869|B4|Working for pay, part or full-time||Working Status||participants|Number|15|15.0||||||
4071991|NCT01044290|3893870|B3|Working for pay, part or full-time||Working Status||participants|Number|4|4.0||||||
4071992|NCT01044290|3893871|B2|Working for pay, part or full-time||Working Status||participants|Number|7|7.0||||||
4071993|NCT01044290|3893872|B1|Working for pay, part or full-time||Working Status||participants|Number|4|4.0||||||
4071994|NCT01044290|3893869|B4|Have enough money for special things||Financial Status||participants|Number|55|55.0||||||
4071995|NCT01044290|3893870|B3|Have enough money for special things||Financial Status||participants|Number|21|21.0||||||
4071996|NCT01044290|3893871|B2|Have enough money for special things||Financial Status||participants|Number|16|16.0||||||
4071997|NCT01044290|3893872|B1|Have enough money for special things||Financial Status||participants|Number|18|18.0||||||
4071998|NCT01044290|3893869|B4|Pay bills but little spare money||Financial Status||participants|Number|72|72.0||||||
4071999|NCT01044290|3893870|B3|Pay bills but little spare money||Financial Status||participants|Number|22|22.0||||||
4072000|NCT01044290|3893871|B2|Pay bills but little spare money||Financial Status||participants|Number|25|25.0||||||
4072001|NCT01044290|3893872|B1|Pay bills but little spare money||Financial Status||participants|Number|25|25.0||||||
4072002|NCT01044290|3893869|B4|Money to pay bills but need to cut back||Financial Status||participants|Number|58|58.0||||||
4072003|NCT01044290|3893870|B3|Money to pay bills but need to cut back||Financial Status||participants|Number|19|19.0||||||
4072004|NCT01044290|3893871|B2|Money to pay bills but need to cut back||Financial Status||participants|Number|19|19.0||||||
4072005|NCT01044290|3893872|B1|Money to pay bills but need to cut back||Financial Status||participants|Number|20|20.0||||||
4072006|NCT01044290|3893869|B4|Difficulty paying the bills||Financial Status||participants|Number|36|36.0||||||
4072007|NCT01044290|3893870|B3|Difficulty paying the bills||Financial Status||participants|Number|10|10.0||||||
4072008|NCT01044290|3893871|B2|Difficulty paying the bills||Financial Status||participants|Number|14|14.0||||||
4072009|NCT01044290|3893872|B1|Difficulty paying the bills||Financial Status||participants|Number|12|12.0||||||
4072010|NCT01044290|3893869|B4|Missing||Religion||participants|Number|3|3.0||||||
4072011|NCT01044290|3893870|B3|Missing||Religion||participants|Number|2|2.0||||||
4072012|NCT01044290|3893871|B2|Missing||Religion||participants|Number|1|1.0||||||
4072013|NCT01044290|3893872|B1|Missing||Religion||participants|Number|0|0.0||||||
4072014|NCT01044290|3893869|B4|Not a member of a religion||Religion||participants|Number|10|10.0||||||
4072015|NCT01044290|3893870|B3|Not a member of a religion||Religion||participants|Number|5|5.0||||||
4072016|NCT01044290|3893871|B2|Not a member of a religion||Religion||participants|Number|3|3.0||||||
4072017|NCT01044290|3893872|B1|Not a member of a religion||Religion||participants|Number|2|2.0||||||
4072018|NCT01044290|3893869|B4|Other||Religion||participants|Number|5|5.0||||||
4072019|NCT01044290|3893870|B3|Other||Religion||participants|Number|3|3.0||||||
4072020|NCT01044290|3893871|B2|Other||Religion||participants|Number|1|1.0||||||
4072021|NCT01044290|3893872|B1|Other||Religion||participants|Number|1|1.0||||||
4072022|NCT01044290|3893869|B4|Christian||Religion||participants|Number|203|203.0||||||
4072023|NCT01044290|3893870|B3|Christian||Religion||participants|Number|62|62.0||||||
4072024|NCT01044290|3893871|B2|Christian||Religion||participants|Number|69|69.0||||||
4072025|NCT01044290|3893872|B1|Christian||Religion||participants|Number|72|72.0||||||
4072026|NCT01044290|3893869|B4|some graduate/professional or higher degree||Highest level of Education||participants|Number|16|16.0||||||
4072027|NCT01044290|3893870|B3|some graduate/professional or higher degree||Highest level of Education||participants|Number|6|6.0||||||
4072028|NCT01044290|3893871|B2|some graduate/professional or higher degree||Highest level of Education||participants|Number|5|5.0||||||
4072029|NCT01044290|3893872|B1|some graduate/professional or higher degree||Highest level of Education||participants|Number|5|5.0||||||
4072030|NCT01044290|3893869|B4|Bachelor's degree||Highest level of Education||participants|Number|21|21.0||||||
4072031|NCT01044290|3893870|B3|Bachelor's degree||Highest level of Education||participants|Number|9|9.0||||||
4072032|NCT01044290|3893871|B2|Bachelor's degree||Highest level of Education||participants|Number|4|4.0||||||
4072033|NCT01044290|3893872|B1|Bachelor's degree||Highest level of Education||participants|Number|8|8.0||||||
4072034|NCT01044290|3893869|B4|Some college, associate, trade school||Highest level of Education||participants|Number|84|84.0||||||
4072035|NCT01044290|3893870|B3|Some college, associate, trade school||Highest level of Education||participants|Number|24|24.0||||||
4072036|NCT01044290|3893871|B2|Some college, associate, trade school||Highest level of Education||participants|Number|29|29.0||||||
4072037|NCT01044290|3893872|B1|Some college, associate, trade school||Highest level of Education||participants|Number|31|31.0||||||
4072038|NCT01044290|3893869|B4|HS degree or GED||Highest level of Education||participants|Number|79|79.0||||||
4072039|NCT01044290|3893870|B3|HS degree or GED||Highest level of Education||participants|Number|25|25.0||||||
4072040|NCT01044290|3893871|B2|HS degree or GED||Highest level of Education||participants|Number|29|29.0||||||
4072041|NCT01044290|3893872|B1|HS degree or GED||Highest level of Education||participants|Number|25|25.0||||||
4072042|NCT01044290|3893869|B4|Less than High School (HS) degree||Highest level of Education||participants|Number|21|21.0||||||
4072043|NCT01044290|3893870|B3|Less than High School (HS) degree||Highest level of Education||participants|Number|8|8.0||||||
4072044|NCT01044290|3893871|B2|Less than High School (HS) degree||Highest level of Education||participants|Number|7|7.0||||||
4072045|NCT01044290|3893872|B1|Less than High School (HS) degree||Highest level of Education||participants|Number|6|6.0||||||
4072046|NCT01044290|3893869|B4|Low (less or = 60)||Palliative Performance Scale - Stratification variable|The Palliative Performance Scale was used to assess functional status of participants. It was used as a stratification variable in randomization to assure that all arms of the trial had equal numbers of participants at similar levels of functional abilities, and illness severity. Scale range is 0 -100 where higher numbers indicate higher function.|participants|Number|57|57.0||||||
4072085|NCT01044290|3893872|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072086|NCT01044290|3893869|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072047|NCT01044290|3893870|B3|Low (less or = 60)||Palliative Performance Scale - Stratification variable|The Palliative Performance Scale was used to assess functional status of participants. It was used as a stratification variable in randomization to assure that all arms of the trial had equal numbers of participants at similar levels of functional abilities, and illness severity. Scale range is 0 -100 where higher numbers indicate higher function.|participants|Number|18|18.0||||||
4072048|NCT01044290|3893871|B2|Low (less or = 60)||Palliative Performance Scale - Stratification variable|The Palliative Performance Scale was used to assess functional status of participants. It was used as a stratification variable in randomization to assure that all arms of the trial had equal numbers of participants at similar levels of functional abilities, and illness severity. Scale range is 0 -100 where higher numbers indicate higher function.|participants|Number|19|19.0||||||
4072049|NCT01044290|3893872|B1|Low (less or = 60)||Palliative Performance Scale - Stratification variable|The Palliative Performance Scale was used to assess functional status of participants. It was used as a stratification variable in randomization to assure that all arms of the trial had equal numbers of participants at similar levels of functional abilities, and illness severity. Scale range is 0 -100 where higher numbers indicate higher function.|participants|Number|20|20.0||||||
4072050|NCT01044290|3893869|B4|High (greater or = 70)||Palliative Performance Scale - Stratification variable|The Palliative Performance Scale was used to assess functional status of participants. It was used as a stratification variable in randomization to assure that all arms of the trial had equal numbers of participants at similar levels of functional abilities, and illness severity. Scale range is 0 -100 where higher numbers indicate higher function.|participants|Number|164|164.0||||||
4072051|NCT01044290|3893870|B3|High (greater or = 70)||Palliative Performance Scale - Stratification variable|The Palliative Performance Scale was used to assess functional status of participants. It was used as a stratification variable in randomization to assure that all arms of the trial had equal numbers of participants at similar levels of functional abilities, and illness severity. Scale range is 0 -100 where higher numbers indicate higher function.|participants|Number|54|54.0||||||
4072052|NCT01044290|3893871|B2|High (greater or = 70)||Palliative Performance Scale - Stratification variable|The Palliative Performance Scale was used to assess functional status of participants. It was used as a stratification variable in randomization to assure that all arms of the trial had equal numbers of participants at similar levels of functional abilities, and illness severity. Scale range is 0 -100 where higher numbers indicate higher function.|participants|Number|55|55.0||||||
4072053|NCT01044290|3893872|B1|High (greater or = 70)||Palliative Performance Scale - Stratification variable|The Palliative Performance Scale was used to assess functional status of participants. It was used as a stratification variable in randomization to assure that all arms of the trial had equal numbers of participants at similar levels of functional abilities, and illness severity. Scale range is 0 -100 where higher numbers indicate higher function.|participants|Number|55|55.0||||||
4072054|NCT01044290|3893869|B4|United States||Region of Enrollment||participants|Number|221|221.0||||||
4072055|NCT01044290|3893870|B3|United States||Region of Enrollment||participants|Number|72|72.0||||||
4072056|NCT01044290|3893871|B2|United States||Region of Enrollment||participants|Number|74|74.0||||||
4072057|NCT01044290|3893872|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
4072058|NCT01044290|3893869|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072059|NCT01044290|3893870|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072060|NCT01044290|3893871|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072061|NCT01044290|3893872|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072062|NCT01044290|3893869|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4072063|NCT01044290|3893870|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4072064|NCT01044290|3893871|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4072065|NCT01044290|3893872|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4072066|NCT01044290|3893869|B4||White|Race (NIH/OMB)||Participants|Count of Participants|117|117.0||||||
4072067|NCT01044290|3893870|B3||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4072068|NCT01044290|3893871|B2||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4072069|NCT01044290|3893872|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4072070|NCT01044290|3893869|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
4072071|NCT01044290|3893870|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4072072|NCT01044290|3893871|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4072073|NCT01044290|3893872|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4072074|NCT01044290|3893869|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072075|NCT01044290|3893870|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072076|NCT01044290|3893871|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072077|NCT01044290|3893872|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072078|NCT01044290|3893869|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072079|NCT01044290|3893870|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072080|NCT01044290|3893871|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072081|NCT01044290|3893872|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072082|NCT01044290|3893869|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072083|NCT01044290|3893870|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072084|NCT01044290|3893871|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072087|NCT01044290|3893870|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072088|NCT01044290|3893871|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072089|NCT01044290|3893872|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072090|NCT01044290|3893869|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|218|218.0||||||
4072091|NCT01044290|3893870|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4072092|NCT01044290|3893871|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
4072093|NCT01044290|3893872|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4072094|NCT01044290|3893869|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4072095|NCT01044290|3893870|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4072096|NCT01044290|3893871|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4072097|NCT01044290|3893872|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072098|NCT01044290|3893869|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4072099|NCT01044290|3893870|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4072100|NCT01044290|3893871|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4072101|NCT01044290|3893872|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4072102|NCT01044290|3893869|B4||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4072103|NCT01044290|3893870|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4072104|NCT01044290|3893871|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4072105|NCT01044290|3893872|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4072106|NCT01044290|3893869|B4|||Age||years|Mean|67.8|67.8|Standard Deviation|9.2|9.2|||
4072107|NCT01044290|3893870|B3|||Age||years|Mean|66.4|66.4|Standard Deviation|8.3|8.3|||
4072108|NCT01044290|3893871|B2|||Age||years|Mean|68.2|68.2|Standard Deviation|9.8|9.8|||
4072109|NCT01044290|3893872|B1|||Age||years|Mean|68.7|68.7|Standard Deviation|9.4|9.4|||
4072110|NCT01044264|3893897|B4|United States||Region of Enrollment||participants|Number|602|602.0||||||
4072111|NCT01044264|3893898|B3|United States||Region of Enrollment||participants|Number|200|200.0||||||
4072112|NCT01044264|3893899|B2|United States||Region of Enrollment||participants|Number|202|202.0||||||
4072113|NCT01044264|3893900|B1|United States||Region of Enrollment||participants|Number|200|200.0||||||
4072114|NCT01044264|3893897|B4||Male|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
4072115|NCT01044264|3893898|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4072116|NCT01044264|3893899|B2||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4072117|NCT01044264|3893900|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4072118|NCT01044264|3893897|B4||Female|Sex: Female, Male||Participants|Count of Participants|317|317.0||||||
4072119|NCT01044264|3893898|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4072120|NCT01044264|3893899|B2||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4072121|NCT01044264|3893900|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4072122|NCT01044264|3893897|B4|||Age||years|Mean|19.6|19.6|Standard Deviation|7.6|7.6|||
4072123|NCT01044264|3893898|B3|||Age||years|Mean|20.1|20.1|Standard Deviation|8.3|8.3|||
4072124|NCT01044264|3893899|B2|||Age||years|Mean|19.5|19.5|Standard Deviation|7.1|7.1|||
4072125|NCT01044264|3893900|B1|||Age||years|Mean|19.2|19.2|Standard Deviation|7.3|7.3|||
4072126|NCT01044264|3893897|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4072127|NCT01044264|3893898|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4072128|NCT01044264|3893899|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4072129|NCT01044264|3893900|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4072130|NCT01044264|3893897|B4||Between 18 and 65 years|Age||Participants|Count of Participants|259|259.0||||||
4072131|NCT01044264|3893898|B3||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
4072132|NCT01044264|3893899|B2||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
4072133|NCT01044264|3893900|B1||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
4072134|NCT01044264|3893897|B4||<=18 years|Age||Participants|Count of Participants|343|343.0||||||
4072135|NCT01044264|3893898|B3||<=18 years|Age||Participants|Count of Participants|113|113.0||||||
4072136|NCT01044264|3893899|B2||<=18 years|Age||Participants|Count of Participants|113|113.0||||||
4072137|NCT01044264|3893900|B1||<=18 years|Age||Participants|Count of Participants|117|117.0||||||
4072138|NCT01044212|3893910|B3|United States||Region of Enrollment||participants|Number|72|72.0||||||
4072139|NCT01044212|3893911|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4072140|NCT01044212|3893912|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4072141|NCT01044212|3893910|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4072142|NCT01044212|3893911|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4072143|NCT01044212|3893912|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4072144|NCT01044212|3893910|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4072145|NCT01044212|3893911|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4072146|NCT01044212|3893912|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4072147|NCT01044212|3893910|B3|||Age||years|Mean|61|61.0|Standard Deviation|9.5|9.5|||
4072148|NCT01044212|3893911|B2|||Age||years|Mean|63|63.0|Standard Deviation|9|9.0|||
4072149|NCT01044212|3893912|B1|||Age||years|Mean|58|58.0|Standard Deviation|10|10.0|||
4072150|NCT01044212|3893910|B3||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4072151|NCT01044212|3893911|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4072152|NCT01044212|3893912|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4072153|NCT01044212|3893910|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4072154|NCT01044212|3893911|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4072155|NCT01044212|3893912|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4072156|NCT01044212|3893910|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4072157|NCT01044212|3893911|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4072158|NCT01044212|3893912|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4072159|NCT01044056|3893923|B4|Netherlands||Region of Enrollment||participants|Number|24|24.0||||||
4072160|NCT01044056|3893924|B3|Netherlands||Region of Enrollment||participants|Number|8|8.0||||||
4072161|NCT01044056|3893925|B2|Netherlands||Region of Enrollment||participants|Number|8|8.0||||||
4072162|NCT01044056|3893926|B1|Netherlands||Region of Enrollment||participants|Number|8|8.0||||||
4072163|NCT01044056|3893923|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4072164|NCT01044056|3893924|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4072165|NCT01044056|3893925|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4072166|NCT01044056|3893926|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4072167|NCT01044056|3893923|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4072168|NCT01044056|3893924|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4072169|NCT01044056|3893925|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4072170|NCT01044056|3893926|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4072171|NCT01044056|3893923|B4|||Age||years|Mean|24.5|24.5|Standard Deviation|5.24|5.24|||
4072172|NCT01044056|3893924|B3|||Age||years|Mean|23.1|23.1|Standard Deviation|3.64|3.64|||
4072173|NCT01044056|3893925|B2|||Age||years|Mean|24.8|24.8|Standard Deviation|6.59|6.59|||
4072174|NCT01044056|3893926|B1|||Age||years|Mean|25.6|25.6|Standard Deviation|5.44|5.44|||
4072175|NCT01044030|3893945|B3|Other/Refused/unknown||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4072176|NCT01044030|3893946|B2|Other/Refused/unknown||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4072177|NCT01044030|3893947|B1|Other/Refused/unknown||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4072178|NCT01044030|3893945|B3|Black, non-Hispanic||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4072179|NCT01044030|3893946|B2|Black, non-Hispanic||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4072180|NCT01044030|3893947|B1|Black, non-Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4072181|NCT01044030|3893945|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4072182|NCT01044030|3893946|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4072183|NCT01044030|3893947|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4072184|NCT01044030|3893945|B3|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|224|224.0||||||
4072185|NCT01044030|3893946|B2|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|114|114.0||||||
4072186|NCT01044030|3893947|B1|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|110|110.0||||||
4072187|NCT01044030|3893945|B3||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4072188|NCT01044030|3893946|B2||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4072189|NCT01044030|3893947|B1||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4072190|NCT01044030|3893945|B3||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4072191|NCT01044030|3893946|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4072192|NCT01044030|3893947|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4072193|NCT01044030|3893945|B3|||Age||months|Mean|21.9|21.9|Standard Deviation|13.7|13.7|||
4072194|NCT01044030|3893946|B2|||Age||months|Mean|21.5|21.5|Standard Deviation|13.7|13.7|||
4072195|NCT01044030|3893947|B1|||Age||months|Mean|22.3|22.3|Standard Deviation|13.7|13.7|||
4072196|NCT01043939|3893962|B1|||Triglycerides||mg/dL|Mean|78|78.0|Standard Deviation|33.7|33.7|||
4072197|NCT01043939|3893962|B1|||High-density lipoprotein (HDL) Cholesterol||mg/dL|Mean|50|50.0|Standard Deviation|10.9|10.9|||
4072198|NCT01043939|3893962|B1|||Low-density lipoprotein (LDL) Cholesterol||mg/dL|Mean|95|95.0|Standard Deviation|20.1|20.1|||
4072199|NCT01043939|3893962|B1|||Fasting insulin||mU/L|Mean|6.3|6.3|Standard Deviation|4.7|4.7|||
4072200|NCT01043939|3893962|B1|||Fasting glucose||mg/dL|Mean|78|78.0|Standard Deviation|7.0|7.0|||
4072201|NCT01043939|3893962|B1|||Diastolic blood pressure||mmHg|Mean|59|59.0|Standard Deviation|8.3|8.3|||
4072202|NCT01043939|3893962|B1|||Systolic blood pressure||mmHg|Mean|111|111.0|Standard Deviation|9.6|9.6|||
4072203|NCT01043939|3893962|B1|||Body Mass Index|Measured in kilograms/m^2 at beginning of study.|kg/m^2|Mean|22|22.0|Standard Deviation|3.2|3.2|||
4072204|NCT01043939|3893962|B1|||Height|Measured in centimeters are beginning of study.|Centimeters|Mean|165|165.0|Standard Deviation|11.6|11.6|||
4072205|NCT01043939|3893962|B1|||Weight|Measured in kilograms at beginning of study.|kilograms|Mean|60|60.0|Standard Deviation|13.8|13.8|||
4072206|NCT01043939|3893962|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4072207|NCT01043939|3893962|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4072208|NCT01043939|3893962|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4072209|NCT01043939|3893962|B1|||Age||years|Mean|15.8|15.8|Standard Deviation|2.6|2.6|||
4072210|NCT01043939|3893962|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4072211|NCT01043939|3893962|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4072212|NCT01043939|3893962|B1||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
4072213|NCT01043926|3893975|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4072214|NCT01043926|3893976|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4072215|NCT01043926|3893977|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4072216|NCT01043926|3893975|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4072217|NCT01043926|3893976|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4072218|NCT01043926|3893977|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4072219|NCT01043926|3893975|B3|||Age||years|Mean|57.3|57.3|Standard Deviation|4.5|4.5|||
4072220|NCT01043926|3893976|B2|||Age||years|Mean|57|57.0|Standard Deviation|4.0|4.0|||
4072221|NCT01043926|3893977|B1|||Age||years|Mean|58|58.0|Standard Deviation|5.1|5.1|||
4072222|NCT01043874|3893994|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4072223|NCT01043874|3893994|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4072224|NCT01043874|3893994|B1|||Age||years|Mean|49.5|49.5|Standard Deviation|14.89|14.89|||
4072225|NCT01043705|3894001|B4||Male|Sex: Female, Male||Participants|Count of Participants|398|398.0||||||
4072226|NCT01043705|3894002|B3||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4072227|NCT01043705|3894003|B2||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4072228|NCT01043705|3894004|B1||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4072229|NCT01043705|3894001|B4||Female|Sex: Female, Male||Participants|Count of Participants|1217|1217.0||||||
4072230|NCT01043705|3894002|B3||Female|Sex: Female, Male||Participants|Count of Participants|444|444.0||||||
4072231|NCT01043705|3894003|B2||Female|Sex: Female, Male||Participants|Count of Participants|434|434.0||||||
4072232|NCT01043705|3894004|B1||Female|Sex: Female, Male||Participants|Count of Participants|339|339.0||||||
4072233|NCT01043705|3894001|B4|||Age||Years|Median|72|72.0|Standard Deviation|11.45|11.45|||
4072234|NCT01043705|3894002|B3|||Age||Years|Median|73|73.0|Standard Deviation|10.70|10.7|||
4072235|NCT01043705|3894003|B2|||Age||Years|Median|73|73.0|Standard Deviation|10.94|10.94|||
4072236|NCT01043705|3894004|B1|||Age||Years|Median|70|70.0|Standard Deviation|12.01|12.01|||
4072237|NCT01043653|3894016|B1||Male|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
4072238|NCT01043653|3894016|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4072239|NCT01043653|3894016|B1|||Age||years|Mean|51.3|51.3|Standard Deviation|8.4|8.4|||
4072240|NCT01043640|3894021|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4072241|NCT01043640|3894021|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4072242|NCT01043640|3894021|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4072243|NCT01043640|3894021|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4072244|NCT01043640|3894021|B1||<=18 years|Age||Participants|Count of Participants|46|46.0||||||
4072245|NCT01043562|3894036|B1|Other||Anti-arrhythmic medications at testing|Number of anti-arrhythmic medications and number of subjects did not correlate 1:1, with 5 subjects on >1 anti-arrhythmic agent and some subjects not receiving any anti-arrhythmic agent. For this reason, the total count of anti-arrhythmic medications does not equal the subject number.|participants|Number|3|3.0||||||
4072246|NCT01043562|3894036|B1|Amiodarone||Anti-arrhythmic medications at testing|Number of anti-arrhythmic medications and number of subjects did not correlate 1:1, with 5 subjects on >1 anti-arrhythmic agent and some subjects not receiving any anti-arrhythmic agent. For this reason, the total count of anti-arrhythmic medications does not equal the subject number.|participants|Number|2|2.0||||||
4072247|NCT01043562|3894036|B1|Calcium-channel blocker||Anti-arrhythmic medications at testing|Number of anti-arrhythmic medications and number of subjects did not correlate 1:1, with 5 subjects on >1 anti-arrhythmic agent and some subjects not receiving any anti-arrhythmic agent. For this reason, the total count of anti-arrhythmic medications does not equal the subject number.|participants|Number|3|3.0||||||
4072248|NCT01043562|3894036|B1|Beta-blocker||Anti-arrhythmic medications at testing|Number of anti-arrhythmic medications and number of subjects did not correlate 1:1, with 5 subjects on >1 anti-arrhythmic agent and some subjects not receiving any anti-arrhythmic agent. For this reason, the total count of anti-arrhythmic medications does not equal the subject number.|participants|Number|13|13.0||||||
4072249|NCT01043562|3894036|B1||Surveillance|Indication for defibrillation threshold testing||Participants|Count of Participants|3|3.0||||||
4072250|NCT01043562|3894036|B1||Generator change|Indication for defibrillation threshold testing||Participants|Count of Participants|5|5.0||||||
4072251|NCT01043562|3894036|B1||Lead revision|Indication for defibrillation threshold testing||Participants|Count of Participants|5|5.0||||||
4072252|NCT01043562|3894036|B1||New implant|Indication for defibrillation threshold testing||Participants|Count of Participants|7|7.0||||||
4072253|NCT01043562|3894036|B1||Pleural|Location of high-voltage coil||Participants|Count of Participants|1|1.0||||||
4072254|NCT01043562|3894036|B1||Subcutaneous|Location of high-voltage coil||Participants|Count of Participants|1|1.0||||||
4072255|NCT01043562|3894036|B1||Pericardial|Location of high-voltage coil||Participants|Count of Participants|6|6.0||||||
4072256|NCT01043562|3894036|B1||Transveous dual coil|Location of high-voltage coil||Participants|Count of Participants|5|5.0||||||
4072257|NCT01043562|3894036|B1||Transvenous single coil|Location of high-voltage coil||Participants|Count of Participants|7|7.0||||||
4072258|NCT01043562|3894036|B1||Nontransvenous|ICD system configuration||Participants|Count of Participants|8|8.0||||||
4072259|NCT01043562|3894036|B1||Transvenous|ICD system configuration||Participants|Count of Participants|12|12.0||||||
4072260|NCT01043562|3894036|B1|||Weight (kg)||kilograms|Median|48|48.0|Inter-Quartile Range|||22.0|57.0|
4072261|NCT01043562|3894036|B1||Cardiomyopathy|Cardiac diagnosis||Participants|Count of Participants|4|4.0||||||
4072262|NCT01043562|3894036|B1||Congenital heart disease|Cardiac diagnosis||Participants|Count of Participants|5|5.0||||||
4072263|NCT01043562|3894036|B1||Channelopathy|Cardiac diagnosis||Participants|Count of Participants|11|11.0||||||
4072264|NCT01043562|3894036|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4072265|NCT01043562|3894036|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4072266|NCT01043562|3894036|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4072267|NCT01043562|3894036|B1|||Age||years|Median|16|16.0|Inter-Quartile Range|||8.0|23.0|
4072268|NCT01043523|3894043|B1|No||Physical examination performed at postinjection timepoint|Number of participants received physical examination up to 24 hours after injection of Eovist/Primovist. Changes in the physical examination were recorded as adverse events (AEs).|Participants|Number|17|17.0||||||
4072269|NCT01043523|3894043|B1|Yes||Physical examination performed at postinjection timepoint|Number of participants received physical examination up to 24 hours after injection of Eovist/Primovist. Changes in the physical examination were recorded as adverse events (AEs).|Participants|Number|35|35.0||||||
4072270|NCT01043523|3894043|B1|No||Physical examination performed at preinjection timepoint|Number of participants received physical examination within14 days prior to injection.|Participants|Number|16|16.0||||||
4072271|NCT01043523|3894043|B1|Yes||Physical examination performed at preinjection timepoint|Number of participants received physical examination within14 days prior to injection.|Participants|Number|36|36.0||||||
4072272|NCT01043523|3894043|B1|No clinical indication||Indication for magnetic resonance imaging (MRI)||Participants|Number|1|1.0||||||
4072273|NCT01043523|3894043|B1|Biliary atresia||Indication for magnetic resonance imaging (MRI)||Participants|Number|1|1.0||||||
4072274|NCT01043523|3894043|B1|Cystic fibrosis||Indication for magnetic resonance imaging (MRI)||Participants|Number|1|1.0||||||
4072275|NCT01043523|3894043|B1|Suspected or known focal liver lesions||Indication for magnetic resonance imaging (MRI)||Participants|Number|49|49.0||||||
4072276|NCT01043523|3894043|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4072277|NCT01043523|3894043|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4072278|NCT01043523|3894043|B1|>12 years to <18 years||Age, Customized||Participants|Number|13|13.0||||||
4072279|NCT01043523|3894043|B1|>2 years to ≤12 years||Age, Customized||Participants|Number|25|25.0||||||
4072280|NCT01043523|3894043|B1|>2 months to ≤2 years||Age, Customized||Participants|Number|14|14.0||||||
4072281|NCT01043432|3894068|B5|||History of TBI (Present or Absent) - Lifetime OSU TBI-ID|Lifetime History TBI (Present or Absent)|participants|Number|73|73.0||||||
4072282|NCT01043432|3894069|B4|||History of TBI (Present or Absent) - Lifetime OSU TBI-ID|Lifetime History TBI (Present or Absent)|participants|Number|0|0.0||||||
4072283|NCT01043432|3894070|B3|||History of TBI (Present or Absent) - Lifetime OSU TBI-ID|Lifetime History TBI (Present or Absent)|participants|Number|0|0.0||||||
4072284|NCT01043432|3894071|B2|||History of TBI (Present or Absent) - Lifetime OSU TBI-ID|Lifetime History TBI (Present or Absent)|participants|Number|51|51.0||||||
4072285|NCT01043432|3894072|B1|||History of TBI (Present or Absent) - Lifetime OSU TBI-ID|Lifetime History TBI (Present or Absent)|participants|Number|22|22.0||||||
4072286|NCT01043432|3894068|B5|United States||Region of Enrollment||participants|Number|133|133.0||||||
4072287|NCT01043432|3894069|B4|United States||Region of Enrollment||participants|Number|48|48.0||||||
4072288|NCT01043432|3894070|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4072289|NCT01043432|3894071|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
4072290|NCT01043432|3894072|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4072291|NCT01043432|3894068|B5||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4072292|NCT01043432|3894069|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4072293|NCT01043432|3894070|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4072294|NCT01043432|3894071|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4072295|NCT01043432|3894072|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4072296|NCT01043432|3894068|B5||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4072297|NCT01043432|3894069|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4072298|NCT01043432|3894070|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4072299|NCT01043432|3894071|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4072300|NCT01043432|3894072|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4072301|NCT01043432|3894068|B5|||Age||years|Mean|52.7|52.7|Standard Deviation|8.9|8.9|||
4072302|NCT01043432|3894069|B4|||Age||years|Mean|54.2|54.2|Standard Deviation|7.6|7.6|||
4072303|NCT01043432|3894070|B3|||Age||years|Mean|51.7|51.7|Standard Deviation|12|12.0|||
4072304|NCT01043432|3894071|B2|||Age||years|Mean|53|53.0|Standard Deviation|8.5|8.5|||
4072305|NCT01043432|3894072|B1|||Age||years|Mean|49.5|49.5|Standard Deviation|10.3|10.3|||
4072306|NCT01043432|3894068|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4072307|NCT01043432|3894069|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4072308|NCT01043432|3894070|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4072309|NCT01043432|3894071|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4072310|NCT01043432|3894072|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4072311|NCT01043432|3894068|B5||Between 18 and 65 years|Age||Participants|Count of Participants|133|133.0||||||
4072312|NCT01043432|3894069|B4||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4072313|NCT01043432|3894070|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4072314|NCT01043432|3894071|B2||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4072315|NCT01043432|3894072|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4072316|NCT01043432|3894068|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4072317|NCT01043432|3894069|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4072318|NCT01043432|3894070|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4072319|NCT01043432|3894071|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4072320|NCT01043432|3894072|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4072321|NCT01043393|3894082|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4072322|NCT01043393|3894083|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4072323|NCT01043393|3894084|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4072324|NCT01043393|3894082|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4072325|NCT01043393|3894083|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4072326|NCT01043393|3894084|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4072327|NCT01043393|3894082|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4072328|NCT01043393|3894083|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4072329|NCT01043393|3894084|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4072330|NCT01043393|3894082|B3|||Age||years|Median|49.42|49.42|Full Range|4.77|4.77|18.0|74.0|
4072331|NCT01043393|3894083|B2|||Age||years|Median|46.75|46.75|Full Range|5.99|5.99|18.0|74.0|
4072332|NCT01043393|3894084|B1|||Age||years|Median|52.08|52.08|Full Range|3.55|3.55|18.0|74.0|
4072333|NCT01043185|3894095|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4072334|NCT01043185|3894095|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4072335|NCT01043185|3894095|B1|||Age||Years|Mean|43.3|43.3|Full Range|||18.0|68.0|
4072336|NCT01043146|3894131|B7||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4072337|NCT01043146|3894132|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4072338|NCT01043146|3894133|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4072339|NCT01043146|3894134|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4072340|NCT01043146|3894135|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4072341|NCT01043146|3894136|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4072342|NCT01043146|3894137|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4072343|NCT01043146|3894131|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4072344|NCT01043146|3894132|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4072345|NCT01043146|3894133|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4072346|NCT01043146|3894134|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4072347|NCT01043146|3894135|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4072348|NCT01043146|3894136|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4072349|NCT01043146|3894137|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4072350|NCT01043146|3894131|B7|||Age||years|Mean|31.6|31.6|Standard Deviation|8.15|8.15|||
4072351|NCT01043146|3894132|B6|||Age||years|Mean|27.5|27.5|Standard Deviation|8.35|8.35|||
4072352|NCT01043146|3894133|B5|||Age||years|Mean|30.1|30.1|Standard Deviation|8.66|8.66|||
4072353|NCT01043146|3894134|B4|||Age||years|Mean|31.9|31.9|Standard Deviation|7.77|7.77|||
4072354|NCT01043146|3894135|B3|||Age||years|Mean|33.1|33.1|Standard Deviation|8.94|8.94|||
4072355|NCT01043146|3894136|B2|||Age||years|Mean|32.5|32.5|Standard Deviation|7.09|7.09|||
4072356|NCT01043146|3894137|B1|||Age||years|Mean|34.1|34.1|Standard Deviation|8.61|8.61|||
4072357|NCT01043146|3894131|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4072358|NCT01043146|3894132|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4072359|NCT01043146|3894133|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4072360|NCT01043146|3894134|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4072361|NCT01043146|3894135|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4072362|NCT01043146|3894136|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4072363|NCT01043146|3894137|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4072364|NCT01043146|3894131|B7||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4072365|NCT01043146|3894132|B6||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4072366|NCT01043146|3894133|B5||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4072367|NCT01043146|3894134|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4072368|NCT01043146|3894135|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4072369|NCT01043146|3894136|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4072370|NCT01043146|3894137|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4072371|NCT01043146|3894131|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4072372|NCT01043146|3894132|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4072373|NCT01043146|3894133|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4072374|NCT01043146|3894134|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4072375|NCT01043146|3894135|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4072376|NCT01043146|3894136|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4072377|NCT01043146|3894137|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4072378|NCT01043133|3894156|B3|United States||Region of Enrollment||participants|Number|155|155.0||||||
4072379|NCT01043133|3894157|B2|United States||Region of Enrollment||participants|Number|80|80.0||||||
4072380|NCT01043133|3894158|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
4072381|NCT01043133|3894156|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4072382|NCT01043133|3894157|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4072383|NCT01043133|3894158|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4072384|NCT01043133|3894156|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4072385|NCT01043133|3894157|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4072386|NCT01043133|3894158|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4072387|NCT01043133|3894156|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4072388|NCT01043133|3894157|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4072389|NCT01043133|3894158|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4072390|NCT01043133|3894156|B3||Between 18 and 65 years|Age||Participants|Count of Participants|155|155.0||||||
4072391|NCT01043133|3894157|B2||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4072392|NCT01043133|3894158|B1||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4072393|NCT01043133|3894156|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4072394|NCT01043133|3894157|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4072395|NCT01043133|3894158|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4072396|NCT01043094|3894167|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4072397|NCT01043094|3894168|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4072398|NCT01043094|3894169|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4072399|NCT01043094|3894167|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4072400|NCT01043094|3894168|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4072401|NCT01043094|3894169|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4072402|NCT01043094|3894167|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4072403|NCT01043094|3894168|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4072404|NCT01043094|3894169|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4072405|NCT01043094|3894167|B3|||Age||years|Mean|53.1|53.1|Standard Deviation|10.74|10.74|||
4072406|NCT01043094|3894168|B2|||Age||years|Mean|52.0|52.0|Standard Deviation|2.62|2.62|||
4072407|NCT01043094|3894169|B1|||Age||years|Mean|54.1|54.1|Standard Deviation|15.41|15.41|||
4072408|NCT01043094|3894167|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4072409|NCT01043094|3894168|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4072410|NCT01043094|3894169|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4072411|NCT01043094|3894167|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4072412|NCT01043094|3894168|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4072413|NCT01043094|3894169|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4072414|NCT01043094|3894167|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4072415|NCT01043094|3894168|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4072416|NCT01043094|3894169|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4072417|NCT01042977|3894178|B3|>= 30 kg/m²||Number of participants with BMI >= 27 kg/m2 at baseline||Participants|Number|664|664.0||||||
4072418|NCT01042977|3894179|B2|>= 30 kg/m²||Number of participants with BMI >= 27 kg/m2 at baseline||Participants|Number|325|325.0||||||
4072419|NCT01042977|3894180|B1|>= 30 kg/m²||Number of participants with BMI >= 27 kg/m2 at baseline||Participants|Number|339|339.0||||||
4072420|NCT01042977|3894178|B3|>= 27 kg/m²||Number of participants with BMI >= 27 kg/m2 at baseline||Participants|Number|844|844.0||||||
4072421|NCT01042977|3894179|B2|>= 27 kg/m²||Number of participants with BMI >= 27 kg/m2 at baseline||Participants|Number|416|416.0||||||
4072422|NCT01042977|3894180|B1|>= 27 kg/m²||Number of participants with BMI >= 27 kg/m2 at baseline||Participants|Number|428|428.0||||||
4072423|NCT01042977|3894178|B3|>= 25 kg/m²||Number of participants with BMI >= 27 kg/m2 at baseline||Participants|Number|916|916.0||||||
4072424|NCT01042977|3894179|B2|>= 25 kg/m²||Number of participants with BMI >= 27 kg/m2 at baseline||Participants|Number|451|451.0||||||
4072425|NCT01042977|3894180|B1|>= 25 kg/m²||Number of participants with BMI >= 27 kg/m2 at baseline||Participants|Number|465|465.0||||||
4072426|NCT01042977|3894178|B3|< 25 kg/m²||Number of participants with BMI >= 27 kg/m2 at baseline||Participants|Number|46|46.0||||||
4072427|NCT01042977|3894179|B2|< 25 kg/m²||Number of participants with BMI >= 27 kg/m2 at baseline||Participants|Number|31|31.0||||||
4072428|NCT01042977|3894180|B1|< 25 kg/m²||Number of participants with BMI >= 27 kg/m2 at baseline||Participants|Number|15|15.0||||||
4072429|NCT01042977|3894178|B3|||Systolic Blood Pressure||mmHg|Mean|134.7|134.7|Standard Deviation|14.24|14.24|||
4072430|NCT01042977|3894179|B2|||Systolic Blood Pressure||mmHg|Mean|134.6|134.6|Standard Deviation|13.96|13.96|||
4072431|NCT01042977|3894180|B1|||Systolic Blood Pressure||mmHg|Mean|134.9|134.9|Standard Deviation|14.53|14.53|||
4072432|NCT01042977|3894178|B3|||Body weight||kg|Mean|93.88|93.88|Standard Deviation|17.332|17.332|||
4072433|NCT01042977|3894179|B2|||Body weight||kg|Mean|93.23|93.23|Standard Deviation|16.842|16.842|||
4072434|NCT01042977|3894180|B1|||Body weight||kg|Mean|94.53|94.53|Standard Deviation|17.804|17.804|||
4072435|NCT01042977|3894178|B3|||HbA1c||Percent|Mean|8.06|8.06|Standard Deviation|0.777|0.777|||
4072436|NCT01042977|3894179|B2|||HbA1c||Percent|Mean|8.08|8.08|Standard Deviation|0.795|0.795|||
4072437|NCT01042977|3894180|B1|||HbA1c||Percent|Mean|8.04|8.04|Standard Deviation|0.759|0.759|||
4072438|NCT01042977|3894178|B3|Other||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
4072439|NCT01042977|3894179|B2|Other||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4072440|NCT01042977|3894180|B1|Other||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4072441|NCT01042977|3894178|B3|Asian||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4072442|NCT01042977|3894179|B2|Asian||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4072443|NCT01042977|3894180|B1|Asian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4072444|NCT01042977|3894178|B3|Black/African American||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4072445|NCT01042977|3894179|B2|Black/African American||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4072446|NCT01042977|3894180|B1|Black/African American||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4072447|NCT01042977|3894178|B3|White||Race/Ethnicity, Customized||Participants|Number|903|903.0||||||
4072448|NCT01042977|3894179|B2|White||Race/Ethnicity, Customized||Participants|Number|449|449.0||||||
4072449|NCT01042977|3894180|B1|White||Race/Ethnicity, Customized||Participants|Number|454|454.0||||||
4072450|NCT01042977|3894178|B3||Male|Sex: Female, Male||Participants|Count of Participants|644|644.0||||||
4072451|NCT01042977|3894179|B2||Male|Sex: Female, Male||Participants|Count of Participants|323|323.0||||||
4072452|NCT01042977|3894180|B1||Male|Sex: Female, Male||Participants|Count of Participants|321|321.0||||||
4072453|NCT01042977|3894178|B3||Female|Sex: Female, Male||Participants|Count of Participants|318|318.0||||||
4072454|NCT01042977|3894179|B2||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4072455|NCT01042977|3894180|B1||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4072456|NCT01042977|3894178|B3|||Age||Years|Mean|63.8|63.8|Standard Deviation|7.31|7.31|||
4072457|NCT01042977|3894179|B2|||Age||Years|Mean|63.6|63.6|Standard Deviation|7.02|7.02|||
4072458|NCT01042977|3894180|B1|||Age||Years|Mean|63.9|63.9|Standard Deviation|7.60|7.6|||
4072459|NCT01042938|3894199|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
4072460|NCT01042938|3894200|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4072461|NCT01042938|3894201|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4072462|NCT01042938|3894199|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4072463|NCT01042938|3894200|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4072464|NCT01042938|3894201|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4072465|NCT01042938|3894199|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4072466|NCT01042938|3894200|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4072467|NCT01042938|3894201|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4072468|NCT01042938|3894199|B3|||Age||years|Mean|51.8|51.8|Standard Deviation|8.21|8.21|||
4072469|NCT01042938|3894200|B2|||Age||years|Mean|53.7|53.7|Standard Deviation|7.55|7.55|||
4072470|NCT01042938|3894201|B1|||Age||years|Mean|50.4|50.4|Standard Deviation|9.51|9.51|||
4072471|NCT01042938|3894199|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4072472|NCT01042938|3894200|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4072473|NCT01042938|3894201|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4072474|NCT01042938|3894199|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4072475|NCT01042938|3894200|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4072476|NCT01042938|3894201|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4072477|NCT01042938|3894199|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4072478|NCT01042938|3894200|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4072479|NCT01042938|3894201|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4072480|NCT01042795|3894214|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4072481|NCT01042795|3894214|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4072482|NCT01042795|3894214|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4072483|NCT01042795|3894214|B1|18-85 years||Age, Customized||Participants|Count of Participants|7|7.0||||||
4072484|NCT01042678|3894218|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4072485|NCT01042678|3894219|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4072486|NCT01042678|3894220|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4072487|NCT01042678|3894221|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4072488|NCT01042678|3894218|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4072489|NCT01042678|3894219|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4072490|NCT01042678|3894220|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4072491|NCT01042678|3894221|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4072492|NCT01042678|3894218|B4|||Age||Years|Mean|64.8|64.8|Standard Deviation|9.2|9.2|||
4072493|NCT01042678|3894219|B3|||Age||Years|Mean|64.2|64.2|Standard Deviation|10.3|10.3|||
4072494|NCT01042678|3894220|B2|||Age||Years|Mean|67.5|67.5|Standard Deviation|9.9|9.9|||
4072495|NCT01042678|3894221|B1|||Age||Years|Mean|62.7|62.7|Standard Deviation|8.4|8.4|||
4072496|NCT01042613|3894249|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4072497|NCT01042613|3894250|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4072498|NCT01042613|3894251|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4072499|NCT01042613|3894249|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4072500|NCT01042613|3894250|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4072501|NCT01042613|3894251|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4072502|NCT01042613|3894249|B3|||Age||years|Mean|5.54|5.54|Standard Deviation|3.79|3.79|||
4072503|NCT01042613|3894250|B2|||Age||years|Mean|5.37|5.37|Standard Deviation|3.88|3.88|||
4072504|NCT01042613|3894251|B1|||Age||years|Mean|5.72|5.72|Standard Deviation|3.72|3.72|||
4072505|NCT01042600|3894262|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4072506|NCT01042600|3894263|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4072507|NCT01042600|3894264|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4072508|NCT01042600|3894262|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4072509|NCT01042600|3894263|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4072510|NCT01042600|3894264|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4072511|NCT01042600|3894262|B3|Gestational age >=33 weeks||Age, Customized||participants|Number|32|32.0||||||
4072512|NCT01042600|3894263|B2|Gestational age >=33 weeks||Age, Customized||participants|Number|19|19.0||||||
4072513|NCT01042600|3894264|B1|Gestational age >=33 weeks||Age, Customized||participants|Number|13|13.0||||||
4072514|NCT01042600|3894262|B3|Gestational age <33 weeks||Age, Customized||participants|Number|29|29.0||||||
4072515|NCT01042600|3894263|B2|Gestational age <33 weeks||Age, Customized||participants|Number|11|11.0||||||
4072516|NCT01042600|3894264|B1|Gestational age <33 weeks||Age, Customized||participants|Number|18|18.0||||||
4072517|NCT01042535|3894273|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4072518|NCT01042535|3894273|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4072519|NCT01042535|3894273|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4072520|NCT01042535|3894273|B1|||Age||years|Mean|52.68|52.68|Full Range|||27.0|73.0|
4072521|NCT01042535|3894273|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4072522|NCT01042535|3894273|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4072523|NCT01042535|3894273|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4072524|NCT01042509|3894281|B1|Mexico||Region of Enrollment||participants|Number|15|15.0||||||
4072525|NCT01042509|3894281|B1||Male|Gender||Participants|Count of Participants|10|10.0||||||
4072526|NCT01042509|3894281|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
4072527|NCT01042509|3894281|B1|||Age||years|Mean|41|41.0|Standard Deviation|20|20.0|||
4072528|NCT01042509|3894281|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4072529|NCT01042509|3894281|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4072530|NCT01042509|3894281|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4072531|NCT01042496|3894286|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
4072532|NCT01042496|3894287|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4072533|NCT01042496|3894288|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4072534|NCT01042496|3894286|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4072535|NCT01042496|3894287|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4072536|NCT01042496|3894288|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4072537|NCT01042496|3894286|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4072538|NCT01042496|3894287|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4072539|NCT01042496|3894288|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4072540|NCT01042496|3894286|B3|||Age||years|Mean|35.61|35.61|Standard Deviation|11.69|11.69|||
4072541|NCT01042496|3894287|B2|||Age||years|Mean|35.18|35.18|Standard Deviation|10.1|10.1|||
4072542|NCT01042496|3894288|B1|||Age||years|Mean|36.10|36.1|Standard Deviation|13.44|13.44|||
4072543|NCT01042392|3894305|B3||Male|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
4072544|NCT01042392|3894306|B2||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4072545|NCT01042392|3894307|B1||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4072546|NCT01042392|3894305|B3||Female|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4072547|NCT01042392|3894306|B2||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4072548|NCT01042392|3894307|B1||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4072549|NCT01042392|3894305|B3|>= 75 years||Age, Customized||Participants|Number|57|57.0||||||
4072550|NCT01042392|3894306|B2|>= 75 years||Age, Customized||Participants|Number|31|31.0||||||
4072551|NCT01042392|3894307|B1|>= 75 years||Age, Customized||Participants|Number|26|26.0||||||
4072552|NCT01042392|3894305|B3|65 - 74 years||Age, Customized||Participants|Number|120|120.0||||||
4072553|NCT01042392|3894306|B2|65 - 74 years||Age, Customized||Participants|Number|64|64.0||||||
4072554|NCT01042392|3894307|B1|65 - 74 years||Age, Customized||Participants|Number|56|56.0||||||
4072555|NCT01042392|3894305|B3|50 - 64 years||Age, Customized||Participants|Number|234|234.0||||||
4072556|NCT01042392|3894306|B2|50 - 64 years||Age, Customized||Participants|Number|115|115.0||||||
4072557|NCT01042392|3894307|B1|50 - 64 years||Age, Customized||Participants|Number|119|119.0||||||
4072558|NCT01042392|3894305|B3|< 50 years||Age, Customized||Participants|Number|95|95.0||||||
4072559|NCT01042392|3894306|B2|< 50 years||Age, Customized||Participants|Number|39|39.0||||||
4072560|NCT01042392|3894307|B1|< 50 years||Age, Customized||Participants|Number|56|56.0||||||
4072561|NCT01042392|3894305|B3|||Age||years|Mean|60.4|60.4|Standard Deviation|11.5|11.5|||
4072562|NCT01042392|3894306|B2|||Age||years|Mean|61.0|61.0|Standard Deviation|11.4|11.4|||
4072563|NCT01042392|3894307|B1|||Age||years|Mean|59.8|59.8|Standard Deviation|11.6|11.6|||
4072564|NCT01042366|3894336|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4072565|NCT01042366|3894337|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4072566|NCT01042366|3894338|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4072567|NCT01042366|3894339|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4072568|NCT01042366|3894336|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4072569|NCT01042366|3894337|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4072570|NCT01042366|3894338|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4072571|NCT01042366|3894339|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4072572|NCT01042366|3894336|B4|||Age||years|Median|49|49.0|Full Range|||32.0|81.0|
4072573|NCT01042366|3894337|B3|||Age||years|Median|54|54.0|Full Range|||49.0|81.0|
4072574|NCT01042366|3894338|B2|||Age||years|Median|44.5|44.5|Full Range|||32.0|59.0|
4072575|NCT01042366|3894339|B1|||Age||years|Median|66|66.0|Full Range|||43.0|72.0|
4072576|NCT01042288|3894350|B1|United States||Region of Enrollment||participants|Number|69|69.0||||||
4072577|NCT01042288|3894350|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4072578|NCT01042288|3894350|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4072579|NCT01042288|3894350|B1|||Age||years|Median|65|65.0|Full Range|||50.0|83.0|
4072580|NCT01042236|3894358|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4072581|NCT01042236|3894358|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4072582|NCT01042236|3894358|B1|||Age||Years|Mean|47.9|47.9|Standard Deviation|8.4|8.4|||
4072583|NCT01042158|3894400|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4072584|NCT01042158|3894400|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072585|NCT01042158|3894400|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4072586|NCT01042158|3894400|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4072587|NCT01042158|3894400|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4072588|NCT01042158|3894400|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072589|NCT01042158|3894400|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072590|NCT01042158|3894400|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072591|NCT01042158|3894400|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4072592|NCT01042158|3894400|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4072593|NCT01042158|3894400|B1|||Age||years|Mean|59.9|59.9|Standard Deviation|10.9|10.9|||
4072594|NCT01042145|3894407|B3|United States||Region of Enrollment||participants|Number|87|87.0||||||
4072595|NCT01042145|3894408|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
4072596|NCT01042145|3894409|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4072597|NCT01042145|3894407|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4072598|NCT01042145|3894408|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4072599|NCT01042145|3894409|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4072600|NCT01042145|3894407|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4072601|NCT01042145|3894408|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4072602|NCT01042145|3894409|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4072603|NCT01042145|3894407|B3|||Age||years|Mean|2.9|2.9|Standard Deviation|1.5|1.5|||
4072604|NCT01042145|3894408|B2|||Age||years|Mean|3.11|3.11|Standard Deviation|1.58|1.58|||
4072605|NCT01042145|3894409|B1|||Age||years|Mean|2.67|2.67|Standard Deviation|1.43|1.43|||
4072606|NCT01042145|3894407|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4072607|NCT01042145|3894408|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4072608|NCT01042145|3894409|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4072609|NCT01042145|3894407|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4072610|NCT01042145|3894408|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4072611|NCT01042145|3894409|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4072612|NCT01042145|3894407|B3||<=18 years|Age||Participants|Count of Participants|87|87.0||||||
4072613|NCT01042145|3894408|B2||<=18 years|Age||Participants|Count of Participants|46|46.0||||||
4072614|NCT01042145|3894409|B1||<=18 years|Age||Participants|Count of Participants|41|41.0||||||
4072615|NCT01042093|3894426|B5|United States||Region of Enrollment||participants|Number|160|160.0||||||
4072616|NCT01042093|3894427|B4|United States||Region of Enrollment||participants|Number|40|40.0||||||
4072617|NCT01042093|3894428|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4072618|NCT01042093|3894429|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4072619|NCT01042093|3894430|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4072620|NCT01042093|3894426|B5||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4072621|NCT01042093|3894427|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4072622|NCT01042093|3894428|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4072623|NCT01042093|3894429|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4072624|NCT01042093|3894430|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4072625|NCT01042093|3894426|B5||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4072626|NCT01042093|3894427|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4072627|NCT01042093|3894428|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4072628|NCT01042093|3894429|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4072629|NCT01042093|3894430|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4072630|NCT01042093|3894426|B5|||Age||years|Mean|67.64|67.64|Standard Deviation|8.10|8.1|||
4072631|NCT01042093|3894427|B4|||Age||years|Mean|69.25|69.25|Standard Deviation|8.67|8.67|||
4072632|NCT01042093|3894428|B3|||Age||years|Mean|68.26|68.26|Standard Deviation|7.47|7.47|||
4072633|NCT01042093|3894429|B2|||Age||years|Mean|66.29|66.29|Standard Deviation|8.20|8.2|||
4072634|NCT01042093|3894430|B1|||Age||years|Mean|66.74|66.74|Standard Deviation|8.07|8.07|||
4072635|NCT01042093|3894426|B5||>=65 years|Age||Participants|Count of Participants|101|101.0||||||
4072636|NCT01042093|3894427|B4||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4072637|NCT01042093|3894428|B3||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4072638|NCT01042093|3894429|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4072639|NCT01042093|3894430|B1||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4072640|NCT01042093|3894426|B5||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4072641|NCT01042093|3894427|B4||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4072642|NCT01042093|3894428|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4072643|NCT01042093|3894429|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4072644|NCT01042093|3894430|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4072645|NCT01042093|3894426|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4072646|NCT01042093|3894427|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4072647|NCT01042093|3894428|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4072648|NCT01042093|3894429|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4072649|NCT01042093|3894430|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4072650|NCT01041976|3894451|B3|United States||Region of Enrollment||participants|Number|84|84.0||||||
4072651|NCT01041976|3894452|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
4072652|NCT01041976|3894453|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4072653|NCT01041976|3894451|B3|Hispanic/Latino, Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4072654|NCT01041976|3894452|B2|Hispanic/Latino, Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4072655|NCT01041976|3894453|B1|Hispanic/Latino, Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4072656|NCT01041976|3894451|B3|Hispanic/Latino, White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4072657|NCT01041976|3894452|B2|Hispanic/Latino, White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4072658|NCT01041976|3894453|B1|Hispanic/Latino, White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4072659|NCT01041976|3894451|B3|Multi-racial||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4072660|NCT01041976|3894452|B2|Multi-racial||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4072661|NCT01041976|3894453|B1|Multi-racial||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4072662|NCT01041976|3894451|B3|White||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
4072663|NCT01041976|3894452|B2|White||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4072664|NCT01041976|3894453|B1|White||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4072665|NCT01041976|3894451|B3|Black/African-American||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4072666|NCT01041976|3894452|B2|Black/African-American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4072667|NCT01041976|3894453|B1|Black/African-American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4072668|NCT01041976|3894451|B3|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4072669|NCT01041976|3894452|B2|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4072670|NCT01041976|3894453|B1|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4072671|NCT01041976|3894451|B3|American Indian/Alaskan||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4072672|NCT01041976|3894452|B2|American Indian/Alaskan||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4072673|NCT01041976|3894453|B1|American Indian/Alaskan||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4072674|NCT01041976|3894451|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4072675|NCT01041976|3894452|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4072676|NCT01041976|3894453|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4072677|NCT01041976|3894451|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4072678|NCT01041976|3894452|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4072679|NCT01041976|3894453|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4072680|NCT01041976|3894451|B3|||Age||years|Mean|53.0|53.0|Standard Deviation|9.8|9.8|||
4072681|NCT01041976|3894452|B2|||Age||years|Mean|53.0|53.0|Standard Deviation|8.6|8.6|||
4072682|NCT01041976|3894453|B1|||Age||years|Mean|52.9|52.9|Standard Deviation|11.0|11.0|||
4072683|NCT01041859|3894462|B3|USA||Region Enroll||participants|Number|272|272.0||||||
4072684|NCT01041859|3894463|B2|USA||Region Enroll||participants|Number|130|130.0||||||
4072685|NCT01041859|3894464|B1|USA||Region Enroll||participants|Number|142|142.0||||||
4072686|NCT01041859|3894462|B3|Canada||Region Enroll||participants|Number|46|46.0||||||
4072687|NCT01041859|3894463|B2|Canada||Region Enroll||participants|Number|22|22.0||||||
4072688|NCT01041859|3894464|B1|Canada||Region Enroll||participants|Number|24|24.0||||||
4072689|NCT01041859|3894462|B3||Male|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4072690|NCT01041859|3894463|B2||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4072691|NCT01041859|3894464|B1||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4072692|NCT01041859|3894462|B3||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4072693|NCT01041859|3894463|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4072694|NCT01041859|3894464|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4072695|NCT01041859|3894462|B3|||Age||years|Mean|58.7|58.7|Standard Deviation|9.87|9.87|||
4072696|NCT01041859|3894463|B2|||Age||years|Mean|59|59.0|Standard Deviation|9.00|9.0|||
4072697|NCT01041859|3894464|B1|||Age||years|Mean|58.5|58.5|Standard Deviation|10.63|10.63|||
4072698|NCT01041859|3894462|B3||>=65 years|Age||Participants|Count of Participants|87|87.0||||||
4072699|NCT01041859|3894463|B2||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
4072700|NCT01041859|3894464|B1||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
4072701|NCT01041859|3894462|B3||Between 18 and 65 years|Age||Participants|Count of Participants|231|231.0||||||
4072702|NCT01041859|3894463|B2||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
4072703|NCT01041859|3894464|B1||Between 18 and 65 years|Age||Participants|Count of Participants|122|122.0||||||
4072704|NCT01041859|3894462|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4072705|NCT01041859|3894463|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4072706|NCT01041859|3894464|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4072707|NCT01041781|3894481|B3|United States||Region of Enrollment||Participants|Count of Participants|312|312.0||||||
4072708|NCT01041781|3894482|B2|United States||Region of Enrollment||Participants|Count of Participants|158|158.0||||||
4072709|NCT01041781|3894483|B1|United States||Region of Enrollment||Participants|Count of Participants|154|154.0||||||
4072710|NCT01041781|3894481|B3||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4072711|NCT01041781|3894482|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4072712|NCT01041781|3894483|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4072713|NCT01041781|3894481|B3||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4072714|NCT01041781|3894482|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4072715|NCT01041781|3894483|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4072716|NCT01041781|3894481|B3|||Age||years|Median|64.0|64.0|Full Range|||36.0|89.0|
4072717|NCT01041781|3894482|B2|||Age||years|Median|64.0|64.0|Full Range|||36.0|89.0|
4072718|NCT01041781|3894483|B1|||Age||years|Median|64.0|64.0|Full Range|||38.0|83.0|
4072719|NCT01041638|3894502|B1|United States||Region of Enrollment||participants|Number|105|105.0||||||
4072720|NCT01041638|3894502|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4072721|NCT01041638|3894502|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
4072722|NCT01041638|3894502|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4072723|NCT01041638|3894502|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4072724|NCT01041638|3894502|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072725|NCT01041638|3894502|B1||White|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
4072726|NCT01041638|3894502|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4072727|NCT01041638|3894502|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072728|NCT01041638|3894502|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4072729|NCT01041638|3894502|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4072730|NCT01041638|3894502|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4072731|NCT01041638|3894502|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4072732|NCT01041638|3894502|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4072733|NCT01041638|3894502|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4072734|NCT01041638|3894502|B1||<=18 years|Age||Participants|Count of Participants|103|103.0||||||
4072735|NCT01041638|3894502|B1|||Age||years|Median|4.1|4.1|Standard Deviation|4.0|4.0|||
4072736|NCT01041573|3894506|B5|Philippines||Region of Enrollment||participants|Number|1869|1869.0||||||
4072737|NCT01041573|3894507|B4|Philippines||Region of Enrollment||participants|Number|64|64.0||||||
4072738|NCT01041573|3894508|B3|Philippines||Region of Enrollment||participants|Number|394|394.0||||||
4072739|NCT01041573|3894509|B2|Philippines||Region of Enrollment||participants|Number|871|871.0||||||
4072740|NCT01041573|3894510|B1|Philippines||Region of Enrollment||participants|Number|540|540.0||||||
4072741|NCT01041573|3894506|B5||Male|Sex: Female, Male||Participants|Count of Participants|944|944.0||||||
4072742|NCT01041573|3894507|B4||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4072743|NCT01041573|3894508|B3||Male|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4072744|NCT01041573|3894509|B2||Male|Sex: Female, Male||Participants|Count of Participants|422|422.0||||||
4072745|NCT01041573|3894510|B1||Male|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
4072746|NCT01041573|3894506|B5||Female|Sex: Female, Male||Participants|Count of Participants|925|925.0||||||
4072747|NCT01041573|3894507|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4072748|NCT01041573|3894508|B3||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4072749|NCT01041573|3894509|B2||Female|Sex: Female, Male||Participants|Count of Participants|449|449.0||||||
4072750|NCT01041573|3894510|B1||Female|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
4072751|NCT01041573|3894506|B5|12 years - < 18 years||Age, Customized||participants|Number|320|320.0||||||
4072752|NCT01041573|3894507|B4|12 years - < 18 years||Age, Customized||participants|Number|0|0.0||||||
4072753|NCT01041573|3894508|B3|12 years - < 18 years||Age, Customized||participants|Number|80|80.0||||||
4072754|NCT01041573|3894509|B2|12 years - < 18 years||Age, Customized||participants|Number|0|0.0||||||
4072755|NCT01041573|3894510|B1|12 years - < 18 years||Age, Customized||participants|Number|240|240.0||||||
4072756|NCT01041573|3894506|B5|3 years - < 12 years||Age, Customized||participants|Number|501|501.0||||||
4072757|NCT01041573|3894507|B4|3 years - < 12 years||Age, Customized||participants|Number|0|0.0||||||
4072758|NCT01041573|3894508|B3|3 years - < 12 years||Age, Customized||participants|Number|101|101.0||||||
4072759|NCT01041573|3894509|B2|3 years - < 12 years||Age, Customized||participants|Number|100|100.0||||||
4072760|NCT01041573|3894510|B1|3 years - < 12 years||Age, Customized||participants|Number|300|300.0||||||
4072761|NCT01041573|3894506|B5|1 year - < 3 years||Age, Customized||participants|Number|853|853.0||||||
4072762|NCT01041573|3894507|B4|1 year - < 3 years||Age, Customized||participants|Number|0|0.0||||||
4072763|NCT01041573|3894508|B3|1 year - < 3 years||Age, Customized||participants|Number|213|213.0||||||
4072764|NCT01041573|3894509|B2|1 year - < 3 years||Age, Customized||participants|Number|640|640.0||||||
4072765|NCT01041573|3894510|B1|1 year - < 3 years||Age, Customized||participants|Number|0|0.0||||||
4072766|NCT01041573|3894506|B5|2 months - < 1 year||Age, Customized||participants|Number|195|195.0||||||
4072767|NCT01041573|3894507|B4|2 months - < 1 year||Age, Customized||participants|Number|64|64.0||||||
4072768|NCT01041573|3894508|B3|2 months - < 1 year||Age, Customized||participants|Number|0|0.0||||||
4072769|NCT01041573|3894509|B2|2 months - < 1 year||Age, Customized||participants|Number|131|131.0||||||
4072770|NCT01041573|3894510|B1|2 months - < 1 year||Age, Customized||participants|Number|0|0.0||||||
4072771|NCT01041417|3894523|B3|United States||Region of Enrollment||participants|Number|159|159.0||||||
4072772|NCT01041417|3894524|B2|United States||Region of Enrollment||participants|Number|79|79.0||||||
4072773|NCT01041417|3894525|B1|United States||Region of Enrollment||participants|Number|80|80.0||||||
4072774|NCT01041417|3894523|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4072775|NCT01041417|3894524|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072776|NCT01041417|3894525|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4072777|NCT01041417|3894523|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072778|NCT01041417|3894524|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072779|NCT01041417|3894525|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072780|NCT01041417|3894523|B3||White|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
4072781|NCT01041417|3894524|B2||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4072782|NCT01041417|3894525|B1||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4072783|NCT01041417|3894523|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
4072784|NCT01041417|3894524|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4072785|NCT01041417|3894525|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4072786|NCT01041417|3894523|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072787|NCT01041417|3894524|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072788|NCT01041417|3894525|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072789|NCT01041417|3894523|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072790|NCT01041417|3894524|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072791|NCT01041417|3894525|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072792|NCT01041417|3894523|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072793|NCT01041417|3894524|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072794|NCT01041417|3894525|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072795|NCT01041417|3894523|B3||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4072796|NCT01041417|3894524|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4072797|NCT01041417|3894525|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4072798|NCT01041417|3894523|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4072799|NCT01041417|3894524|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4072800|NCT01041417|3894525|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4072801|NCT01041417|3894523|B3|||Age||years|Mean|63.9|63.9|Standard Deviation|7.9|7.9|||
4072802|NCT01041417|3894524|B2|||Age||years|Mean|63.6|63.6|Standard Deviation|7.9|7.9|||
4072803|NCT01041417|3894525|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|7.9|7.9|||
4072804|NCT01041404|3894562|B3||Male|Sex: Female, Male||Participants|Count of Participants|444|444.0||||||
4072805|NCT01041404|3894563|B2||Male|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
4072806|NCT01041404|3894564|B1||Male|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4072807|NCT01041404|3894562|B3||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4072808|NCT01041404|3894563|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4072809|NCT01041404|3894564|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4072810|NCT01041404|3894562|B3|||Age||years|Mean|59.0|59.0|Standard Deviation|10.99|10.99|||
4072811|NCT01041404|3894563|B2|||Age||years|Mean|59.4|59.4|Standard Deviation|10.75|10.75|||
4072812|NCT01041404|3894564|B1|||Age||years|Mean|58.5|58.5|Standard Deviation|11.22|11.22|||
4072813|NCT01041287|3894604|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4072814|NCT01041287|3894605|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4072815|NCT01041287|3894606|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4072816|NCT01041287|3894604|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4072817|NCT01041287|3894605|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4072818|NCT01041287|3894606|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4072819|NCT01041287|3894604|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4072820|NCT01041287|3894605|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4072821|NCT01041287|3894606|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4072822|NCT01041287|3894604|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4072823|NCT01041287|3894605|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4072824|NCT01041287|3894606|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4072825|NCT01041287|3894604|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4072826|NCT01041287|3894605|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4072827|NCT01041287|3894606|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4072828|NCT01041274|3894617|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4072829|NCT01041274|3894618|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4072830|NCT01041274|3894619|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4072831|NCT01041274|3894617|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072832|NCT01041274|3894618|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072833|NCT01041274|3894619|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072834|NCT01041274|3894617|B3||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4072835|NCT01041274|3894618|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4072836|NCT01041274|3894619|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4072837|NCT01041274|3894617|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4072838|NCT01041274|3894618|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4072839|NCT01041274|3894619|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4072840|NCT01041274|3894617|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072841|NCT01041274|3894618|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072842|NCT01041274|3894619|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072843|NCT01041274|3894617|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4072844|NCT01041274|3894618|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4072845|NCT01041274|3894619|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4072846|NCT01041274|3894617|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072847|NCT01041274|3894618|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072848|NCT01041274|3894619|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072849|NCT01041274|3894617|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4072850|NCT01041274|3894618|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4072851|NCT01041274|3894619|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4072852|NCT01041274|3894617|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4072853|NCT01041274|3894618|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4072854|NCT01041274|3894619|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4072855|NCT01041274|3894617|B3|||Age||Years|Mean|23.44|23.44|Standard Deviation|4.85|4.85|||
4072856|NCT01041274|3894618|B2|||Age||Years|Mean|23.69|23.69|Standard Deviation|4.63|4.63|||
4072857|NCT01041274|3894619|B1|||Age||Years|Mean|23.2|23.2|Standard Deviation|5.09|5.09|||
4072858|NCT01041209|3894632|B3|Argentina||Region of Enrollment||participants|Number|120|120.0||||||
4072859|NCT01041209|3894633|B2|Argentina||Region of Enrollment||participants|Number|60|60.0||||||
4072860|NCT01041209|3894634|B1|Argentina||Region of Enrollment||participants|Number|60|60.0||||||
4072861|NCT01041209|3894632|B3||Male|Gender||Participants|Count of Participants|57|57.0||||||
4072862|NCT01041209|3894633|B2||Male|Gender||Participants|Count of Participants|30|30.0||||||
4072863|NCT01041209|3894634|B1||Male|Gender||Participants|Count of Participants|27|27.0||||||
4072864|NCT01041209|3894632|B3||Female|Gender||Participants|Count of Participants|63|63.0||||||
4072865|NCT01041209|3894633|B2||Female|Gender||Participants|Count of Participants|30|30.0||||||
4072866|NCT01041209|3894634|B1||Female|Gender||Participants|Count of Participants|33|33.0||||||
4072867|NCT01041209|3894632|B3|||Age||years|Mean|24.2|24.2|Standard Deviation|14.1|14.1|||
4072868|NCT01041209|3894633|B2|||Age||years|Mean|26.1|26.1|Standard Deviation|13.2|13.2|||
4072869|NCT01041209|3894634|B1|||Age||years|Mean|22.4|22.4|Standard Deviation|13.2|13.2|||
4072870|NCT01041209|3894632|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4072871|NCT01041209|3894633|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4072872|NCT01041209|3894634|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4072873|NCT01041209|3894632|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4072874|NCT01041209|3894633|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4072875|NCT01041209|3894634|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4072876|NCT01041209|3894632|B3||<=18 years|Age||Participants|Count of Participants|120|120.0||||||
4072877|NCT01041209|3894633|B2||<=18 years|Age||Participants|Count of Participants|60|60.0||||||
4072878|NCT01041209|3894634|B1||<=18 years|Age||Participants|Count of Participants|60|60.0||||||
4072879|NCT01040871|3894643|B3|Ireland||Region of Enrollment||participants|Number|2|2.0||||||
4072880|NCT01040871|3894644|B2|Ireland||Region of Enrollment||participants|Number|0|0.0||||||
4072881|NCT01040871|3894645|B1|Ireland||Region of Enrollment||participants|Number|2|2.0||||||
4072882|NCT01040871|3894643|B3|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
4072883|NCT01040871|3894644|B2|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4072884|NCT01040871|3894645|B1|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
4072885|NCT01040871|3894643|B3|France||Region of Enrollment||participants|Number|6|6.0||||||
4072886|NCT01040871|3894644|B2|France||Region of Enrollment||participants|Number|4|4.0||||||
4072887|NCT01040871|3894645|B1|France||Region of Enrollment||participants|Number|2|2.0||||||
4072888|NCT01040871|3894643|B3|Spain||Region of Enrollment||participants|Number|7|7.0||||||
4072889|NCT01040871|3894644|B2|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4072890|NCT01040871|3894645|B1|Spain||Region of Enrollment||participants|Number|5|5.0||||||
4072891|NCT01040871|3894643|B3|Czech Republic||Region of Enrollment||participants|Number|7|7.0||||||
4072892|NCT01040871|3894644|B2|Czech Republic||Region of Enrollment||participants|Number|4|4.0||||||
4072893|NCT01040871|3894645|B1|Czech Republic||Region of Enrollment||participants|Number|3|3.0||||||
4072894|NCT01040871|3894643|B3|Italy||Region of Enrollment||participants|Number|8|8.0||||||
4072895|NCT01040871|3894644|B2|Italy||Region of Enrollment||participants|Number|6|6.0||||||
4072896|NCT01040871|3894645|B1|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4072897|NCT01040871|3894643|B3|Portugal||Region of Enrollment||participants|Number|12|12.0||||||
4072898|NCT01040871|3894644|B2|Portugal||Region of Enrollment||participants|Number|7|7.0||||||
4072899|NCT01040871|3894645|B1|Portugal||Region of Enrollment||participants|Number|5|5.0||||||
4072900|NCT01040871|3894643|B3|Germany||Region of Enrollment||participants|Number|21|21.0||||||
4072901|NCT01040871|3894644|B2|Germany||Region of Enrollment||participants|Number|8|8.0||||||
4072902|NCT01040871|3894645|B1|Germany||Region of Enrollment||participants|Number|13|13.0||||||
4072903|NCT01040871|3894643|B3|Mexico||Region of Enrollment||participants|Number|1|1.0||||||
4072904|NCT01040871|3894644|B2|Mexico||Region of Enrollment||participants|Number|1|1.0||||||
4072905|NCT01040871|3894645|B1|Mexico||Region of Enrollment||participants|Number|0|0.0||||||
4072906|NCT01040871|3894643|B3|Singapore||Region of Enrollment||participants|Number|3|3.0||||||
4072907|NCT01040871|3894644|B2|Singapore||Region of Enrollment||participants|Number|1|1.0||||||
4072908|NCT01040871|3894645|B1|Singapore||Region of Enrollment||participants|Number|2|2.0||||||
4072909|NCT01040871|3894643|B3|Argentina||Region of Enrollment||participants|Number|3|3.0||||||
4072910|NCT01040871|3894644|B2|Argentina||Region of Enrollment||participants|Number|1|1.0||||||
4072911|NCT01040871|3894645|B1|Argentina||Region of Enrollment||participants|Number|2|2.0||||||
4072912|NCT01040871|3894643|B3|Brazil||Region of Enrollment||participants|Number|5|5.0||||||
4072913|NCT01040871|3894644|B2|Brazil||Region of Enrollment||participants|Number|3|3.0||||||
4072914|NCT01040871|3894645|B1|Brazil||Region of Enrollment||participants|Number|2|2.0||||||
4072915|NCT01040871|3894643|B3|India||Region of Enrollment||participants|Number|6|6.0||||||
4072916|NCT01040871|3894644|B2|India||Region of Enrollment||participants|Number|4|4.0||||||
4072917|NCT01040871|3894645|B1|India||Region of Enrollment||participants|Number|2|2.0||||||
4072918|NCT01040871|3894643|B3|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4072919|NCT01040871|3894644|B2|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4072920|NCT01040871|3894645|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4072921|NCT01040871|3894643|B3|Malaysia||Region of Enrollment||participants|Number|8|8.0||||||
4072922|NCT01040871|3894644|B2|Malaysia||Region of Enrollment||participants|Number|3|3.0||||||
4072923|NCT01040871|3894645|B1|Malaysia||Region of Enrollment||participants|Number|5|5.0||||||
4072924|NCT01040871|3894643|B3|Korea, Republic of||Region of Enrollment||participants|Number|12|12.0||||||
4072925|NCT01040871|3894644|B2|Korea, Republic of||Region of Enrollment||participants|Number|6|6.0||||||
4072926|NCT01040871|3894645|B1|Korea, Republic of||Region of Enrollment||participants|Number|6|6.0||||||
4072927|NCT01040871|3894643|B3|Turkey||Region of Enrollment||participants|Number|16|16.0||||||
4072928|NCT01040871|3894644|B2|Turkey||Region of Enrollment||participants|Number|12|12.0||||||
4072929|NCT01040871|3894645|B1|Turkey||Region of Enrollment||participants|Number|4|4.0||||||
4072930|NCT01040871|3894643|B3|Russian Federation||Region of Enrollment||participants|Number|36|36.0||||||
4072931|NCT01040871|3894644|B2|Russian Federation||Region of Enrollment||participants|Number|14|14.0||||||
4072932|NCT01040871|3894645|B1|Russian Federation||Region of Enrollment||participants|Number|22|22.0||||||
4072933|NCT01040871|3894643|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4072934|NCT01040871|3894644|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4072935|NCT01040871|3894645|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4072936|NCT01040871|3894643|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4072937|NCT01040871|3894644|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4072938|NCT01040871|3894645|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4072939|NCT01040871|3894643|B3|||Age||years|Mean|57.2|57.2|Standard Deviation|14.41|14.41|||
4072940|NCT01040871|3894644|B2|||Age||years|Mean|57.8|57.8|Standard Deviation|13.83|13.83|||
4072941|NCT01040871|3894645|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|15.00|15.0|||
4072942|NCT01040858|3894664|B3|||Satisfaction with Life Scale|A brief measure of global life satisfaction. It measures the sum of satisfaction ratings for 5 items on a scale from 1 (strongly disagree) to 7 (strongly agree). The total score ranges from 5 to 35 with higher scores indicating greater satifaction.|units on a scale|Mean|16.6|16.6|Standard Deviation|7.2|7.2|||
4072943|NCT01040858|3894665|B2|||Satisfaction with Life Scale|A brief measure of global life satisfaction. It measures the sum of satisfaction ratings for 5 items on a scale from 1 (strongly disagree) to 7 (strongly agree). The total score ranges from 5 to 35 with higher scores indicating greater satifaction.|units on a scale|Mean|16.73|16.73|Standard Deviation|7.1|7.1|||
4072944|NCT01040858|3894666|B1|||Satisfaction with Life Scale|A brief measure of global life satisfaction. It measures the sum of satisfaction ratings for 5 items on a scale from 1 (strongly disagree) to 7 (strongly agree). The total score ranges from 5 to 35 with higher scores indicating greater satifaction.|units on a scale|Mean|16.30|16.3|Standard Deviation|7.5|7.5|||
4072945|NCT01040858|3894664|B3|||Severity of Dependence Scale|A brief substance dependence measure. It measures the sum of severity ratings for 5 symptoms on a scale from 0 (never) to 3 (always). The total score ranges from 0 15.|units on a scale|Mean|0.70|0.7|Standard Deviation|1.78|1.78|||
4072946|NCT01040858|3894665|B2|||Severity of Dependence Scale|A brief substance dependence measure. It measures the sum of severity ratings for 5 symptoms on a scale from 0 (never) to 3 (always). The total score ranges from 0 15.|units on a scale|Mean|0.46|0.46|Standard Deviation|1.2|1.2|||
4072947|NCT01040858|3894666|B1|||Severity of Dependence Scale|A brief substance dependence measure. It measures the sum of severity ratings for 5 symptoms on a scale from 0 (never) to 3 (always). The total score ranges from 0 15.|units on a scale|Mean|1.04|1.04|Standard Deviation|2.3|2.3|||
4072948|NCT01040858|3894664|B3|||Beck Depression Inventory, Second Edition|A depression symptom severity measures based on DSM-IV diagnostic criteria. It measures the sum of severity ratings for 21 symptoms on a scale from 0 (none) to 3 (severe). BDI total score ranges from 0 to 63.|units on a scale|Mean|25.11|25.11|Standard Deviation|12.34|12.34|||
4072949|NCT01040858|3894665|B2|||Beck Depression Inventory, Second Edition|A depression symptom severity measures based on DSM-IV diagnostic criteria. It measures the sum of severity ratings for 21 symptoms on a scale from 0 (none) to 3 (severe). BDI total score ranges from 0 to 63.|units on a scale|Mean|25.3|25.3|Standard Deviation|12.6|12.6|||
4072950|NCT01040858|3894666|B1|||Beck Depression Inventory, Second Edition|A depression symptom severity measures based on DSM-IV diagnostic criteria. It measures the sum of severity ratings for 21 symptoms on a scale from 0 (none) to 3 (severe). BDI total score ranges from 0 to 63.|units on a scale|Mean|24.9|24.9|Standard Deviation|12.2|12.2|||
4072951|NCT01040858|3894664|B3|||PTSD Checklist–Military Version|A PTSD symptom severity measures based on DSM-IV diagnostic criteria. It measures the sum of severit ratings for 17 symptoms on a scale from 1 (not at all) to 5 (extremely). PCL-M total score ranges from 17 to 85.|units on a scale|Mean|58.31|58.31|Standard Deviation|14.4|14.4|||
4072952|NCT01040858|3894665|B2|||PTSD Checklist–Military Version|A PTSD symptom severity measures based on DSM-IV diagnostic criteria. It measures the sum of severit ratings for 17 symptoms on a scale from 1 (not at all) to 5 (extremely). PCL-M total score ranges from 17 to 85.|units on a scale|Mean|58.94|58.94|Standard Deviation|14.5|14.5|||
4072953|NCT01040858|3894666|B1|||PTSD Checklist–Military Version|A PTSD symptom severity measures based on DSM-IV diagnostic criteria. It measures the sum of severit ratings for 17 symptoms on a scale from 1 (not at all) to 5 (extremely). PCL-M total score ranges from 17 to 85.|units on a scale|Mean|57.50|57.5|Standard Deviation|14.5|14.5|||
4072954|NCT01040858|3894664|B3|||Delis-Kaplan Executive Function System, Letter Fluency Subtest|A measure of verbal fluency, generativity, and processing speed. A scaled score of Letter Fluency portion of the test was used. The scores ranged from 0 to 20 with higher scores indicating better outcomes.|units on a scale|Mean|10.01|10.01|Standard Deviation|3.5|3.5|||
4072955|NCT01040858|3894665|B2|||Delis-Kaplan Executive Function System, Letter Fluency Subtest|A measure of verbal fluency, generativity, and processing speed. A scaled score of Letter Fluency portion of the test was used. The scores ranged from 0 to 20 with higher scores indicating better outcomes.|units on a scale|Mean|10.18|10.18|Standard Deviation|3.7|3.7|||
4072956|NCT01040858|3894666|B1|||Delis-Kaplan Executive Function System, Letter Fluency Subtest|A measure of verbal fluency, generativity, and processing speed. A scaled score of Letter Fluency portion of the test was used. The scores ranged from 0 to 20 with higher scores indicating better outcomes.|units on a scale|Mean|9.78|9.78|Standard Deviation|3.3|3.3|||
4072957|NCT01040858|3894664|B3|||Delis-Kaplan Executive Function System, Trails Subtest|A visual-motor task used to measure flexibility in thinking (executive function) and processing speed. Scaled score for Condition 4 was used, and possible scores ranges from 0 to 20 with higher scores indicating better outcome.|units on a scale|Mean|9.31|9.31|Standard Deviation|3|3.0|||
4073031|NCT01040845|3894697|B1||<=18 years|Age|age range: >=18 and <=45|Participants|Count of Participants|0|0.0||||||
4072958|NCT01040858|3894665|B2|||Delis-Kaplan Executive Function System, Trails Subtest|A visual-motor task used to measure flexibility in thinking (executive function) and processing speed. Scaled score for Condition 4 was used, and possible scores ranges from 0 to 20 with higher scores indicating better outcome.|units on a scale|Mean|9.84|9.84|Standard Deviation|2|2.0|||
4072959|NCT01040858|3894666|B1|||Delis-Kaplan Executive Function System, Trails Subtest|A visual-motor task used to measure flexibility in thinking (executive function) and processing speed. Scaled score for Condition 4 was used, and possible scores ranges from 0 to 20 with higher scores indicating better outcome.|units on a scale|Mean|9.3|9.3|Standard Deviation|3|3.0|||
4072960|NCT01040858|3894664|B3|||Wechsler Adult Intelligence Scale–Digit Span|A measure of attention and working memory. Total score was used, and it ranges from 0 to 48, with higher scores indicating greater attentional capacity.|units on a scale|Mean|26.53|26.53|Standard Deviation|6.0|6.0|||
4072961|NCT01040858|3894665|B2|||Wechsler Adult Intelligence Scale–Digit Span|A measure of attention and working memory. Total score was used, and it ranges from 0 to 48, with higher scores indicating greater attentional capacity.|units on a scale|Mean|27.10|27.1|Standard Deviation|6.41|6.41|||
4072962|NCT01040858|3894666|B1|||Wechsler Adult Intelligence Scale–Digit Span|A measure of attention and working memory. Total score was used, and it ranges from 0 to 48, with higher scores indicating greater attentional capacity.|units on a scale|Mean|25.76|25.76|Standard Deviation|5.42|5.42|||
4072963|NCT01040858|3894664|B3|||Hopkins Verbal Memory Test–Revised|Verbal list learning and delayed recall. Total recall T-score was used for the analyses. Total recall T-score ranges from 13 (severely impaired) to 86 (very superior).|units on a scale|Mean|40.95|40.95|Standard Deviation|11.7|11.7|||
4072964|NCT01040858|3894665|B2|||Hopkins Verbal Memory Test–Revised|Verbal list learning and delayed recall. Total recall T-score was used for the analyses. Total recall T-score ranges from 13 (severely impaired) to 86 (very superior).|units on a scale|Mean|40.48|40.48|Standard Deviation|12.2|12.2|||
4072965|NCT01040858|3894666|B1|||Hopkins Verbal Memory Test–Revised|Verbal list learning and delayed recall. Total recall T-score was used for the analyses. Total recall T-score ranges from 13 (severely impaired) to 86 (very superior).|units on a scale|Mean|41.6|41.6|Standard Deviation|11.2|11.2|||
4072966|NCT01040858|3894664|B3|||The Wide Range Achievement Test-IV|Reading subtest that provides an estimate of baseline cognitive ability. This assessment was administered only at baseline, and was not repeated. The total score ranges from 55 (lower cognitive ability) to 145 (higher cognitive ability).|units on a scale|Mean|98.56|98.56|Standard Deviation|8.6|8.6|||
4072967|NCT01040858|3894665|B2|||The Wide Range Achievement Test-IV|Reading subtest that provides an estimate of baseline cognitive ability. This assessment was administered only at baseline, and was not repeated. The total score ranges from 55 (lower cognitive ability) to 145 (higher cognitive ability).|units on a scale|Mean|99.70|99.7|Standard Deviation|8.3|8.3|||
4072968|NCT01040858|3894666|B1|||The Wide Range Achievement Test-IV|Reading subtest that provides an estimate of baseline cognitive ability. This assessment was administered only at baseline, and was not repeated. The total score ranges from 55 (lower cognitive ability) to 145 (higher cognitive ability).|units on a scale|Mean|97.02|97.02|Standard Deviation|8.75|8.75|||
4072969|NCT01040858|3894664|B3|||Memory Compensation Questionnaire|The MCQ is a 44-item self-report questionnaire that rates the extent to which patients use various strategies to improve memory performance relevant to daily living. The MCQ measures the sum of memory strategies used on a scale from 0 (never) to 4 (always). The total score ranges from 0 to 176.|units on a scale|Mean|119.03|119.03|Standard Deviation|24.7|24.7|||
4072970|NCT01040858|3894665|B2|||Memory Compensation Questionnaire|The MCQ is a 44-item self-report questionnaire that rates the extent to which patients use various strategies to improve memory performance relevant to daily living. The MCQ measures the sum of memory strategies used on a scale from 0 (never) to 4 (always). The total score ranges from 0 to 176.|units on a scale|Mean|118.5|118.5|Standard Deviation|7|7.0|||
4072971|NCT01040858|3894666|B1|||Memory Compensation Questionnaire|The MCQ is a 44-item self-report questionnaire that rates the extent to which patients use various strategies to improve memory performance relevant to daily living. The MCQ measures the sum of memory strategies used on a scale from 0 (never) to 4 (always). The total score ranges from 0 to 176.|units on a scale|Mean|119.8|119.8|Standard Deviation|24|24.0|||
4072972|NCT01040858|3894664|B3|||Multiple Sclerosis Neuropsychological Screening Questionnaire–Patient Version|A self-report measure of severity of attention and organizational problems. It measures the sum of severity ratings on a scale from 0 (never) to 4 (very often). The total score ranges from 0 to 64.|units on a scale|Mean|37.3|37.3|Standard Deviation|9.7|9.7|||
4072973|NCT01040858|3894665|B2|||Multiple Sclerosis Neuropsychological Screening Questionnaire–Patient Version|A self-report measure of severity of attention and organizational problems. It measures the sum of severity ratings on a scale from 0 (never) to 4 (very often). The total score ranges from 0 to 64.|units on a scale|Mean|37.0|37.0|Standard Deviation|10|10.0|||
4072974|NCT01040858|3894666|B1|||Multiple Sclerosis Neuropsychological Screening Questionnaire–Patient Version|A self-report measure of severity of attention and organizational problems. It measures the sum of severity ratings on a scale from 0 (never) to 4 (very often). The total score ranges from 0 to 64.|units on a scale|Mean|37.8|37.8|Standard Deviation|9|9.0|||
4072975|NCT01040858|3894664|B3|||Prospective-Retrospective Memory Questionnaire|A 16-item self-report severity measure of prospective and retrospective memory problems relevant to everyday life. The measure reports the sum of severity ratings on a scale from 1 (never) to 5 (very often). The PRMQ total score ranges from 16 to 80.|units on a scale|Mean|56.1|56.1|Standard Deviation|9.5|9.5|||
4072976|NCT01040858|3894665|B2|||Prospective-Retrospective Memory Questionnaire|A 16-item self-report severity measure of prospective and retrospective memory problems relevant to everyday life. The measure reports the sum of severity ratings on a scale from 1 (never) to 5 (very often). The PRMQ total score ranges from 16 to 80.|units on a scale|Mean|55.4|55.4|Standard Deviation|10|10.0|||
4072977|NCT01040858|3894666|B1|||Prospective-Retrospective Memory Questionnaire|A 16-item self-report severity measure of prospective and retrospective memory problems relevant to everyday life. The measure reports the sum of severity ratings on a scale from 1 (never) to 5 (very often). The PRMQ total score ranges from 16 to 80.|units on a scale|Mean|57.2|57.2|Standard Deviation|8|8.0|||
4073032|NCT01040832|3894711|B3||Male|Gender||Participants|Count of Participants|90|90.0||||||
4072978|NCT01040858|3894664|B3|||The Neurobehavioral Symptom Inventory|A post-concussive symptom measure. The total score on the measure is the sum of severity ratings for 22 symptoms on a scale from 0 (none) to 4 (very severe). NSI total score ranges from 0 to 88.|units on a scale|Mean|44.90|44.9|Standard Deviation|14.01|14.01|||
4072979|NCT01040858|3894665|B2|||The Neurobehavioral Symptom Inventory|A post-concussive symptom measure. The total score on the measure is the sum of severity ratings for 22 symptoms on a scale from 0 (none) to 4 (very severe). NSI total score ranges from 0 to 88.|units on a scale|Mean|44.8|44.8|Standard Deviation|14.5|14.5|||
4072980|NCT01040858|3894666|B1|||The Neurobehavioral Symptom Inventory|A post-concussive symptom measure. The total score on the measure is the sum of severity ratings for 22 symptoms on a scale from 0 (none) to 4 (very severe). NSI total score ranges from 0 to 88.|units on a scale|Mean|45.04|45.04|Standard Deviation|16.32|16.32|||
4072981|NCT01040858|3894664|B3||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4072982|NCT01040858|3894665|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4072983|NCT01040858|3894666|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4072984|NCT01040858|3894664|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4072985|NCT01040858|3894665|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4072986|NCT01040858|3894666|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4072987|NCT01040858|3894664|B3|||Age||years|Mean|34.8|34.8|Standard Deviation|7.9|7.9|||
4072988|NCT01040858|3894665|B2|||Age||years|Mean|35.4|35.4|Standard Deviation|8|8.0|||
4072989|NCT01040858|3894666|B1|||Age||years|Mean|34.8|34.8|Standard Deviation|7|7.0|||
4072990|NCT01040845|3894695|B3|United States||Region of Enrollment||participants|Number|30.0|30.0||||||
4072991|NCT01040845|3894696|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4072992|NCT01040845|3894697|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4072993|NCT01040845|3894695|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0.0|0.0||||||
4072994|NCT01040845|3894696|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072995|NCT01040845|3894697|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072996|NCT01040845|3894695|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0.0|0.0||||||
4072997|NCT01040845|3894696|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072998|NCT01040845|3894697|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4072999|NCT01040845|3894695|B3||White|Race (NIH/OMB)||Participants|Count of Participants|30.0|30.0||||||
4073000|NCT01040845|3894696|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4073001|NCT01040845|3894697|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4073002|NCT01040845|3894695|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0.0|0.0||||||
4073003|NCT01040845|3894696|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073004|NCT01040845|3894697|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073005|NCT01040845|3894695|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0.0|0.0||||||
4073006|NCT01040845|3894696|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073007|NCT01040845|3894697|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073008|NCT01040845|3894695|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0.0|0.0||||||
4073009|NCT01040845|3894696|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073010|NCT01040845|3894697|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073011|NCT01040845|3894695|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0.0|0.0||||||
4073012|NCT01040845|3894696|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073013|NCT01040845|3894697|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073014|NCT01040845|3894695|B3||Male|Sex: Female, Male||Participants|Count of Participants|0.0|0.0||||||
4073015|NCT01040845|3894696|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4073016|NCT01040845|3894697|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4073017|NCT01040845|3894695|B3||Female|Sex: Female, Male||Participants|Count of Participants|30.0|30.0||||||
4073018|NCT01040845|3894696|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4073019|NCT01040845|3894697|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4073020|NCT01040845|3894695|B3|||Age||years|Mean|23.9|23.9|Standard Deviation|6.3|6.3|||
4073021|NCT01040845|3894696|B2|||Age||years|Mean|23.9|23.9|Standard Deviation|4.2|4.2|||
4073022|NCT01040845|3894697|B1|||Age||years|Mean|23.8|23.8|Standard Deviation|7.9|7.9|||
4073023|NCT01040845|3894695|B3||>=65 years|Age|age range: >=18 and <=45|Participants|Count of Participants|0.0|0.0||||||
4073024|NCT01040845|3894696|B2||>=65 years|Age|age range: >=18 and <=45|Participants|Count of Participants|0|0.0||||||
4073025|NCT01040845|3894697|B1||>=65 years|Age|age range: >=18 and <=45|Participants|Count of Participants|0|0.0||||||
4073026|NCT01040845|3894695|B3||Between 18 and 65 years|Age|age range: >=18 and <=45|Participants|Count of Participants|30.0|30.0||||||
4073027|NCT01040845|3894696|B2||Between 18 and 65 years|Age|age range: >=18 and <=45|Participants|Count of Participants|15|15.0||||||
4073028|NCT01040845|3894697|B1||Between 18 and 65 years|Age|age range: >=18 and <=45|Participants|Count of Participants|15|15.0||||||
4073029|NCT01040845|3894695|B3||<=18 years|Age|age range: >=18 and <=45|Participants|Count of Participants|0.0|0.0||||||
4073030|NCT01040845|3894696|B2||<=18 years|Age|age range: >=18 and <=45|Participants|Count of Participants|0|0.0||||||
4073033|NCT01040832|3894712|B2||Male|Gender||Participants|Count of Participants|45|45.0||||||
4073034|NCT01040832|3894713|B1||Male|Gender||Participants|Count of Participants|45|45.0||||||
4073035|NCT01040832|3894711|B3||Female|Gender||Participants|Count of Participants|16|16.0||||||
4073036|NCT01040832|3894712|B2||Female|Gender||Participants|Count of Participants|8|8.0||||||
4073037|NCT01040832|3894713|B1||Female|Gender||Participants|Count of Participants|8|8.0||||||
4073038|NCT01040832|3894711|B3|||Age||years|Mean|56.8|56.8|Standard Deviation|8.62|8.62|||
4073039|NCT01040832|3894712|B2|||Age||years|Mean|56.8|56.8|Standard Deviation|10.03|10.03|||
4073040|NCT01040832|3894713|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|7.03|7.03|||
4073041|NCT01040819|3894728|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4073042|NCT01040819|3894729|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4073043|NCT01040819|3894730|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4073044|NCT01040819|3894728|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4073045|NCT01040819|3894729|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4073046|NCT01040819|3894730|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4073047|NCT01040819|3894728|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4073048|NCT01040819|3894729|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4073049|NCT01040819|3894730|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4073050|NCT01040819|3894728|B3|||Age||years|Mean|56|56.0|Standard Deviation|5|5.0|||
4073051|NCT01040819|3894729|B2|||Age||years|Mean|58|58.0|Standard Deviation|6|6.0|||
4073052|NCT01040819|3894730|B1|||Age||years|Mean|54|54.0|Standard Deviation|4|4.0|||
4073053|NCT01040819|3894728|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4073054|NCT01040819|3894729|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4073055|NCT01040819|3894730|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4073056|NCT01040819|3894728|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4073057|NCT01040819|3894729|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4073058|NCT01040819|3894730|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4073059|NCT01040819|3894728|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073060|NCT01040819|3894729|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073061|NCT01040819|3894730|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073062|NCT01040793|3894737|B1||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4073063|NCT01040793|3894737|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4073064|NCT01040793|3894737|B1|||Age||years|Mean|60.6|60.6|Standard Deviation|7.7|7.7|||
4073065|NCT01040780|3894819|B3|China||Region of Enrollment||participants|Number|399|399.0||||||
4073066|NCT01040780|3894820|B2|China||Region of Enrollment||participants|Number|199|199.0||||||
4073067|NCT01040780|3894821|B1|China||Region of Enrollment||participants|Number|200|200.0||||||
4073068|NCT01040780|3894819|B3||Male|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
4073069|NCT01040780|3894820|B2||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4073070|NCT01040780|3894821|B1||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4073071|NCT01040780|3894819|B3||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4073072|NCT01040780|3894820|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4073073|NCT01040780|3894821|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4073074|NCT01040780|3894819|B3|||Age||years|Mean|55.98|55.98|Standard Deviation|9.79|9.79|||
4073075|NCT01040780|3894820|B2|||Age||years|Mean|56.43|56.43|Standard Deviation|9.43|9.43|||
4073076|NCT01040780|3894821|B1|||Age||years|Mean|55.52|55.52|Standard Deviation|10.14|10.14|||
4073077|NCT01040780|3894819|B3||>=65 years|Age||Participants|Count of Participants|76|76.0||||||
4073078|NCT01040780|3894820|B2||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
4073079|NCT01040780|3894821|B1||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4073080|NCT01040780|3894819|B3||Between 18 and 65 years|Age||Participants|Count of Participants|323|323.0||||||
4073081|NCT01040780|3894820|B2||Between 18 and 65 years|Age||Participants|Count of Participants|159|159.0||||||
4073082|NCT01040780|3894821|B1||Between 18 and 65 years|Age||Participants|Count of Participants|164|164.0||||||
4073083|NCT01040780|3894819|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073084|NCT01040780|3894820|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073085|NCT01040780|3894821|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073086|NCT01040728|3894836|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4073087|NCT01040728|3894836|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4073088|NCT01040728|3894836|B1|||Age||years|Mean|62.7|62.7|Standard Deviation|7.9|7.9|||
4073089|NCT01040689|3894909|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4073090|NCT01040689|3894909|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4073091|NCT01040689|3894909|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|8.8|8.8|||
4073092|NCT01040624|3894982|B3|United States||Region of Enrollment||participants|Number|77|77.0||||||
4073093|NCT01040624|3894983|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4073094|NCT01040624|3894984|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
4073095|NCT01040624|3894982|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4073096|NCT01040624|3894983|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4073097|NCT01040624|3894984|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4073098|NCT01040624|3894982|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4073099|NCT01040624|3894983|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4073100|NCT01040624|3894984|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4073101|NCT01040624|3894982|B3|||Age||years|Median|68|68.0|Full Range|||51.0|80.0|
4073102|NCT01040624|3894983|B2|||Age||years|Median|69|69.0|Full Range|||51.0|79.0|
4073103|NCT01040624|3894984|B1|||Age||years|Median|68|68.0|Full Range|||52.0|80.0|
4073104|NCT01040624|3894982|B3||>=65 years|Age||Participants|Count of Participants|57|57.0||||||
4073105|NCT01040624|3894983|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4073106|NCT01040624|3894984|B1||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
4073107|NCT01040624|3894982|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4073108|NCT01040624|3894983|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4073109|NCT01040624|3894984|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4073110|NCT01040624|3894982|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073111|NCT01040624|3894983|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073112|NCT01040624|3894984|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073113|NCT01040403|3894991|B1||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4073114|NCT01040403|3894991|B1||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4073115|NCT01040403|3894991|B1|||Age||years|Mean|63.3|63.3|Standard Deviation|8.2|8.2|||
4073116|NCT01040351|3895177|B3|Egypt||Region of Enrollment||participants|Number|110|110.0||||||
4073117|NCT01040351|3895178|B2|Egypt||Region of Enrollment||participants|Number|55|55.0||||||
4073118|NCT01040351|3895179|B1|Egypt||Region of Enrollment||participants|Number|55|55.0||||||
4073119|NCT01040351|3895177|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4073120|NCT01040351|3895178|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4073121|NCT01040351|3895179|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4073122|NCT01040351|3895177|B3||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4073123|NCT01040351|3895178|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4073124|NCT01040351|3895179|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4073125|NCT01040351|3895177|B3|||Age||years|Mean|28.77|28.77|Standard Deviation|3.86|3.86|||
4073126|NCT01040351|3895178|B2|||Age||years|Mean|29.38|29.38|Standard Deviation|4.0|4.0|||
4073127|NCT01040351|3895179|B1|||Age||years|Mean|28.16|28.16|Standard Deviation|3.6|3.6|||
4073128|NCT01040351|3895177|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4073129|NCT01040351|3895178|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4073130|NCT01040351|3895179|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4073131|NCT01040351|3895177|B3||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
4073132|NCT01040351|3895178|B2||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4073133|NCT01040351|3895179|B1||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4073134|NCT01040351|3895177|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073135|NCT01040351|3895178|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073136|NCT01040351|3895179|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073137|NCT01040260|3895188|B3|United States||Region of Enrollment||participants|Number|103|103.0||||||
4073138|NCT01040260|3895189|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
4073139|NCT01040260|3895190|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
4073140|NCT01040260|3895188|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4073141|NCT01040260|3895189|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4073142|NCT01040260|3895190|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4073143|NCT01040260|3895188|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4073144|NCT01040260|3895189|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4073145|NCT01040260|3895190|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4073146|NCT01040260|3895188|B3|||Age||years|Mean|46.3|46.3|Standard Deviation|12.8|12.8|||
4073147|NCT01040260|3895189|B2|||Age||years|Mean|47.3|47.3|Standard Deviation|12.0|12.0|||
4073148|NCT01040260|3895190|B1|||Age||years|Mean|45.4|45.4|Standard Deviation|13.5|13.5|||
4073149|NCT01040260|3895188|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4073150|NCT01040260|3895189|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4073151|NCT01040260|3895190|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4073152|NCT01040260|3895188|B3||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4073153|NCT01040260|3895189|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4073154|NCT01040260|3895190|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4073155|NCT01040260|3895188|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073156|NCT01040260|3895189|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073157|NCT01040260|3895190|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073158|NCT01040208|3895197|B4|United States||Region of Enrollment||participants|Number|111|111.0||||||
4073159|NCT01040208|3895198|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
4073160|NCT01040208|3895199|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4073161|NCT01040208|3895200|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4073162|NCT01040208|3895197|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4073163|NCT01040208|3895198|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4073164|NCT01040208|3895199|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4073165|NCT01040208|3895200|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4073166|NCT01040208|3895197|B4||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4073167|NCT01040208|3895198|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4073168|NCT01040208|3895199|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4073169|NCT01040208|3895200|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4073170|NCT01040208|3895197|B4|||Age||years|Mean|37.5|37.5|Standard Deviation|7.3|7.3|||
4073171|NCT01040208|3895198|B3|||Age||years|Mean|37.7|37.7|Standard Deviation|7.1|7.1|||
4073172|NCT01040208|3895199|B2|||Age||years|Mean|36.9|36.9|Standard Deviation|8.0|8.0|||
4073173|NCT01040208|3895200|B1|||Age||years|Mean|37.8|37.8|Standard Deviation|7.2|7.2|||
4073174|NCT01040208|3895197|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4073175|NCT01040208|3895198|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4073176|NCT01040208|3895199|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4073177|NCT01040208|3895200|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4073178|NCT01040208|3895197|B4||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
4073179|NCT01040208|3895198|B3||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4073180|NCT01040208|3895199|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4073181|NCT01040208|3895200|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4073182|NCT01040208|3895197|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073183|NCT01040208|3895198|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073184|NCT01040208|3895199|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073185|NCT01040208|3895200|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073186|NCT01040169|3895216|B3|United States||Region of Enrollment||participants|Number|79|79.0||||||
4073187|NCT01040169|3895217|B2|United States||Region of Enrollment||participants|Number|44|44.0||||||
4073188|NCT01040169|3895218|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4073189|NCT01040169|3895216|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4073190|NCT01040169|3895217|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4073191|NCT01040169|3895218|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4073192|NCT01040169|3895216|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4073193|NCT01040169|3895217|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4073194|NCT01040169|3895218|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4073195|NCT01040169|3895216|B3|||Age||years|Mean|36.34|36.34|Standard Deviation|9.23|9.23|||
4073196|NCT01040169|3895217|B2|||Age||years|Mean|35.55|35.55|Standard Deviation|8.9|8.9|||
4073197|NCT01040169|3895218|B1|||Age||years|Mean|37.34|37.34|Standard Deviation|9.1|9.1|||
4073198|NCT01040169|3895216|B3||>=65 years|Age||Participants|Count of Participants|1.0|1.0||||||
4073199|NCT01040169|3895217|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4073200|NCT01040169|3895218|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4073201|NCT01040169|3895216|B3||Between 18 and 65 years|Age||Participants|Count of Participants|78.0|78.0||||||
4073202|NCT01040169|3895217|B2||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4073203|NCT01040169|3895218|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4073204|NCT01040169|3895216|B3||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4073205|NCT01040169|3895217|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073206|NCT01040169|3895218|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073207|NCT01040130|3895227|B1||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4073208|NCT01040130|3895227|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4073209|NCT01040130|3895227|B1|||Age||years|Mean|60.6|60.6|Standard Deviation|7.7|7.7|||
4073210|NCT01040052|3895309|B1|Vietnam||Region of Enrollment||participants|Number|30|30.0||||||
4073211|NCT01040052|3895309|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4073212|NCT01040052|3895309|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4073213|NCT01040052|3895309|B1|||Age||Years|Mean|35.1|35.1|Standard Deviation|5.82|5.82|||
4073214|NCT01040052|3895309|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4073215|NCT01040052|3895309|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4073216|NCT01040052|3895309|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073217|NCT01039792|3895313|B3|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
4073218|NCT01039792|3895314|B2|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
4073219|NCT01039792|3895315|B1|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4073220|NCT01039792|3895313|B3||Male|Gender||Participants|Count of Participants|40|40.0||||||
4073221|NCT01039792|3895314|B2||Male|Gender||Participants|Count of Participants|21|21.0||||||
4073222|NCT01039792|3895315|B1||Male|Gender||Participants|Count of Participants|19|19.0||||||
4073223|NCT01039792|3895313|B3||Female|Gender||Participants|Count of Participants|10|10.0||||||
4073224|NCT01039792|3895314|B2||Female|Gender||Participants|Count of Participants|6|6.0||||||
4073225|NCT01039792|3895315|B1||Female|Gender||Participants|Count of Participants|4|4.0||||||
4073226|NCT01039792|3895313|B3|||Age||months|Mean|63|63.0|Standard Deviation|16|16.0|||
4073227|NCT01039792|3895314|B2|||Age||months|Mean|67|67.0|Standard Deviation|16|16.0|||
4073228|NCT01039792|3895315|B1|||Age||months|Mean|58|58.0|Standard Deviation|14|14.0|||
4073229|NCT01039792|3895313|B3||>=65 years|Age|Male and female subjects between 3 and 7 years of age with a diagnosis of autism.|Participants|Count of Participants|0|0.0||||||
4073230|NCT01039792|3895314|B2||>=65 years|Age|Male and female subjects between 3 and 7 years of age with a diagnosis of autism.|Participants|Count of Participants|0|0.0||||||
4073231|NCT01039792|3895315|B1||>=65 years|Age|Male and female subjects between 3 and 7 years of age with a diagnosis of autism.|Participants|Count of Participants|0|0.0||||||
4073232|NCT01039792|3895313|B3||Between 18 and 65 years|Age|Male and female subjects between 3 and 7 years of age with a diagnosis of autism.|Participants|Count of Participants|0|0.0||||||
4073233|NCT01039792|3895314|B2||Between 18 and 65 years|Age|Male and female subjects between 3 and 7 years of age with a diagnosis of autism.|Participants|Count of Participants|0|0.0||||||
4073234|NCT01039792|3895315|B1||Between 18 and 65 years|Age|Male and female subjects between 3 and 7 years of age with a diagnosis of autism.|Participants|Count of Participants|0|0.0||||||
4073235|NCT01039792|3895313|B3||<=18 years|Age|Male and female subjects between 3 and 7 years of age with a diagnosis of autism.|Participants|Count of Participants|50|50.0||||||
4073236|NCT01039792|3895314|B2||<=18 years|Age|Male and female subjects between 3 and 7 years of age with a diagnosis of autism.|Participants|Count of Participants|27|27.0||||||
4073237|NCT01039792|3895315|B1||<=18 years|Age|Male and female subjects between 3 and 7 years of age with a diagnosis of autism.|Participants|Count of Participants|23|23.0||||||
4073238|NCT01039688|3895322|B4||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4073239|NCT01039688|3895323|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4073240|NCT01039688|3895324|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4073241|NCT01039688|3895325|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4073242|NCT01039688|3895322|B4||Female|Sex: Female, Male||Participants|Count of Participants|758|758.0||||||
4073243|NCT01039688|3895323|B3||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4073244|NCT01039688|3895324|B2||Female|Sex: Female, Male||Participants|Count of Participants|327|327.0||||||
4073245|NCT01039688|3895325|B1||Female|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
4073246|NCT01039688|3895322|B4|||Age||years|Mean|49.6|49.6|Standard Deviation|12.7|12.7|||
4073247|NCT01039688|3895323|B3|||Age||years|Mean|48.8|48.8|Standard Deviation|13.3|13.3|||
4073248|NCT01039688|3895324|B2|||Age||years|Mean|49.3|49.3|Standard Deviation|12.8|12.8|||
4073249|NCT01039688|3895325|B1|||Age||years|Mean|50.3|50.3|Standard Deviation|12.2|12.2|||
4073250|NCT01039675|3895596|B3|White||Race/Ethnicity, Customized||Participants|Number|44|44.0||||||
4073251|NCT01039675|3895597|B2|White||Race/Ethnicity, Customized||Participants|Number|36|36.0||||||
4073252|NCT01039675|3895598|B1|White||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4073253|NCT01039675|3895596|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4073254|NCT01039675|3895597|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4073255|NCT01039675|3895598|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4073256|NCT01039675|3895596|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4073257|NCT01039675|3895597|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4073258|NCT01039675|3895598|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4073259|NCT01039675|3895596|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4073260|NCT01039675|3895597|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4073261|NCT01039675|3895598|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4073262|NCT01039675|3895596|B3|||Age||Years|Mean|59.1|59.1|Standard Deviation|9.43|9.43|||
4073263|NCT01039675|3895597|B2|||Age||Years|Mean|59.2|59.2|Standard Deviation|9.48|9.48|||
4073264|NCT01039675|3895598|B1|||Age||Years|Mean|58.7|58.7|Standard Deviation|9.77|9.77|||
4073265|NCT01039584|3895609|B4|South America||Region of Enrollment||participants|Number|209|209.0||||||
4073266|NCT01039584|3895610|B3|South America||Region of Enrollment||participants|Number|42|42.0||||||
4073267|NCT01039584|3895611|B2|South America||Region of Enrollment||participants|Number|83|83.0||||||
4073268|NCT01039584|3895612|B1|South America||Region of Enrollment||participants|Number|84|84.0||||||
4073269|NCT01039584|3895609|B4|Central America||Region of Enrollment||participants|Number|133|133.0||||||
4073270|NCT01039584|3895610|B3|Central America||Region of Enrollment||participants|Number|26|26.0||||||
4073271|NCT01039584|3895611|B2|Central America||Region of Enrollment||participants|Number|53|53.0||||||
4073272|NCT01039584|3895612|B1|Central America||Region of Enrollment||participants|Number|54|54.0||||||
4073273|NCT01039584|3895609|B4|United States||Region of Enrollment||participants|Number|269|269.0||||||
4073274|NCT01039584|3895610|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
4073275|NCT01039584|3895611|B2|United States||Region of Enrollment||participants|Number|107|107.0||||||
4073276|NCT01039584|3895612|B1|United States||Region of Enrollment||participants|Number|108|108.0||||||
4073277|NCT01039584|3895609|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4073278|NCT01039584|3895610|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4073279|NCT01039584|3895611|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4073280|NCT01039584|3895612|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4073281|NCT01039584|3895609|B4||Female|Sex: Female, Male||Participants|Count of Participants|611|611.0||||||
4073282|NCT01039584|3895610|B3||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4073283|NCT01039584|3895611|B2||Female|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
4073284|NCT01039584|3895612|B1||Female|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
4073285|NCT01039584|3895609|B4|||Age||years|Mean|32.3|32.3|Standard Deviation|10.35|10.35|||
4073286|NCT01039584|3895610|B3|||Age||years|Mean|33.3|33.3|Standard Deviation|11.15|11.15|||
4073287|NCT01039584|3895611|B2|||Age||years|Mean|32.1|32.1|Standard Deviation|10.02|10.02|||
4073288|NCT01039584|3895612|B1|||Age||years|Mean|32.1|32.1|Standard Deviation|10.29|10.29|||
4073289|NCT01039584|3895609|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4073290|NCT01039584|3895610|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4073291|NCT01039584|3895611|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4073292|NCT01039584|3895612|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4073293|NCT01039584|3895609|B4||Between 18 and 65 years|Age||Participants|Count of Participants|591|591.0||||||
4073294|NCT01039584|3895610|B3||Between 18 and 65 years|Age||Participants|Count of Participants|117|117.0||||||
4073295|NCT01039584|3895611|B2||Between 18 and 65 years|Age||Participants|Count of Participants|238|238.0||||||
4073296|NCT01039584|3895612|B1||Between 18 and 65 years|Age||Participants|Count of Participants|236|236.0||||||
4073297|NCT01039584|3895609|B4||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
4073298|NCT01039584|3895610|B3||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4073299|NCT01039584|3895611|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4073300|NCT01039584|3895612|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4073301|NCT01039519|3895628|B1|Unknown||Best Response From Prior Systemic Treatment|"Target Lesion Response Criteria, RECIST (version 1.0)~Complete response - disappearance of all target lesions~Partial response - at least a 30% decrease in the sum of the longest diameter of target lesions~Stable disease - neither sufficient shrinkage to qualify for partial response nor sufficient increase to qualify for progressive disease~Progressive disease - at least a 20% increase in the sum of the longest diameter of target lesions, taking as reference the smallest sum longest diameter recorded since the treatment started or the appearance of 1 or more new lesions"|participants|Number|0|0.0||||||
4073302|NCT01039519|3895628|B1|Progressive disease||Best Response From Prior Systemic Treatment|"Target Lesion Response Criteria, RECIST (version 1.0)~Complete response - disappearance of all target lesions~Partial response - at least a 30% decrease in the sum of the longest diameter of target lesions~Stable disease - neither sufficient shrinkage to qualify for partial response nor sufficient increase to qualify for progressive disease~Progressive disease - at least a 20% increase in the sum of the longest diameter of target lesions, taking as reference the smallest sum longest diameter recorded since the treatment started or the appearance of 1 or more new lesions"|participants|Number|1|1.0||||||
4073303|NCT01039519|3895628|B1|Stable Disease||Best Response From Prior Systemic Treatment|"Target Lesion Response Criteria, RECIST (version 1.0)~Complete response - disappearance of all target lesions~Partial response - at least a 30% decrease in the sum of the longest diameter of target lesions~Stable disease - neither sufficient shrinkage to qualify for partial response nor sufficient increase to qualify for progressive disease~Progressive disease - at least a 20% increase in the sum of the longest diameter of target lesions, taking as reference the smallest sum longest diameter recorded since the treatment started or the appearance of 1 or more new lesions"|participants|Number|17|17.0||||||
4073304|NCT01039519|3895628|B1|Partial response||Best Response From Prior Systemic Treatment|"Target Lesion Response Criteria, RECIST (version 1.0)~Complete response - disappearance of all target lesions~Partial response - at least a 30% decrease in the sum of the longest diameter of target lesions~Stable disease - neither sufficient shrinkage to qualify for partial response nor sufficient increase to qualify for progressive disease~Progressive disease - at least a 20% increase in the sum of the longest diameter of target lesions, taking as reference the smallest sum longest diameter recorded since the treatment started or the appearance of 1 or more new lesions"|participants|Number|6|6.0||||||
4073305|NCT01039519|3895628|B1|Complete response||Best Response From Prior Systemic Treatment|"Target Lesion Response Criteria, RECIST (version 1.0)~Complete response - disappearance of all target lesions~Partial response - at least a 30% decrease in the sum of the longest diameter of target lesions~Stable disease - neither sufficient shrinkage to qualify for partial response nor sufficient increase to qualify for progressive disease~Progressive disease - at least a 20% increase in the sum of the longest diameter of target lesions, taking as reference the smallest sum longest diameter recorded since the treatment started or the appearance of 1 or more new lesions"|participants|Number|3|3.0||||||
4073306|NCT01039519|3895628|B1|||Number of Prior Systemic Treatment Regimens for GIST||regimens|Mean|5.85|5.85|Standard Deviation|2.476|2.476|||
4073307|NCT01039519|3895628|B1|No||Prior Systemic Treatment for GIST||participants|Number|0|0.0||||||
4073308|NCT01039519|3895628|B1|Yes||Prior Systemic Treatment for GIST||participants|Number|27|27.0||||||
4073309|NCT01039519|3895628|B1|Unknown||Any Prior Exposure to Heat Shock Protein 90 (HSP90) Inhibitors||participants|Number|1|1.0||||||
4073310|NCT01039519|3895628|B1|No||Any Prior Exposure to Heat Shock Protein 90 (HSP90) Inhibitors||participants|Number|21|21.0||||||
4073311|NCT01039519|3895628|B1|Yes||Any Prior Exposure to Heat Shock Protein 90 (HSP90) Inhibitors||participants|Number|5|5.0||||||
4073360|NCT01039376|3895663|B2|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4073361|NCT01039376|3895664|B1|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4073362|NCT01039376|3895662|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4073675|NCT01038609|3895844|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4073312|NCT01039519|3895628|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction;~Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature;~Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours;~Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours;~Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or Chair."|participants|Number|13|13.0||||||
4073313|NCT01039519|3895628|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction;~Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature;~Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours;~Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours;~Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or Chair."|participants|Number|14|14.0||||||
4073314|NCT01039519|3895628|B1|||Time from Metastatic/Unresectable GIST Diagnosis to Consent|N = 20 participants GIST = gastrointestinal stromal tumor|months|Mean|46.77|46.77|Standard Deviation|28.606|28.606|||
4073315|NCT01039519|3895628|B1|||Time from Initial Gastrointestinal Stromal Tumor (GIST) Diagnosis to Consent|N = 25 participants|months|Mean|68.71|68.71|Standard Deviation|34.699|34.699|||
4073316|NCT01039519|3895628|B1|||Body Surface Area (BSA)||m^2|Mean|1.863|1.863|Standard Deviation|0.2909|0.2909|||
4073317|NCT01039519|3895628|B1|||Height||cm|Mean|171.57|171.57|Standard Deviation|10.295|10.295|||
4073318|NCT01039519|3895628|B1|||Weight||kg|Mean|74.94|74.94|Standard Deviation|22.095|22.095|||
4073319|NCT01039519|3895628|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073320|NCT01039519|3895628|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073321|NCT01039519|3895628|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4073322|NCT01039519|3895628|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4073323|NCT01039519|3895628|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073324|NCT01039519|3895628|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4073325|NCT01039519|3895628|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073326|NCT01039519|3895628|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073327|NCT01039519|3895628|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4073328|NCT01039519|3895628|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073329|NCT01039519|3895628|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4073330|NCT01039519|3895628|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4073331|NCT01039519|3895628|B1|||Age||years|Mean|54.4|54.4|Standard Deviation|8.35|8.35|||
4073332|NCT01039428|3895637|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4073333|NCT01039428|3895638|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4073334|NCT01039428|3895639|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4073335|NCT01039428|3895637|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4073336|NCT01039428|3895638|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4073337|NCT01039428|3895639|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4073338|NCT01039428|3895637|B3|||Age||years|Mean|56.4|56.4|Standard Deviation|11.0|11.0|||
4073339|NCT01039428|3895638|B2|||Age||years|Mean|55.7|55.7|Standard Deviation|11.3|11.3|||
4073340|NCT01039428|3895639|B1|||Age||years|Mean|57.1|57.1|Standard Deviation|11.0|11.0|||
4073341|NCT01039376|3895662|B3|Missing||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4073342|NCT01039376|3895663|B2|Missing||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4073343|NCT01039376|3895664|B1|Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4073344|NCT01039376|3895662|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4073345|NCT01039376|3895663|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4073346|NCT01039376|3895664|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4073347|NCT01039376|3895662|B3|White - Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4073348|NCT01039376|3895663|B2|White - Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4073349|NCT01039376|3895664|B1|White - Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4073350|NCT01039376|3895662|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|448|448.0||||||
4073351|NCT01039376|3895663|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|224|224.0||||||
4073352|NCT01039376|3895664|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|224|224.0||||||
4073353|NCT01039376|3895662|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4073354|NCT01039376|3895663|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4073355|NCT01039376|3895664|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4073356|NCT01039376|3895662|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4073357|NCT01039376|3895663|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4073358|NCT01039376|3895664|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4073359|NCT01039376|3895662|B3|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4073363|NCT01039376|3895663|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4073364|NCT01039376|3895664|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4073365|NCT01039376|3895662|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4073366|NCT01039376|3895663|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4073367|NCT01039376|3895664|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4073368|NCT01039376|3895662|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4073369|NCT01039376|3895663|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4073370|NCT01039376|3895664|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4073371|NCT01039376|3895662|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4073372|NCT01039376|3895663|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4073373|NCT01039376|3895664|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4073374|NCT01039376|3895662|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4073375|NCT01039376|3895663|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4073376|NCT01039376|3895664|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4073377|NCT01039376|3895662|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4073378|NCT01039376|3895663|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4073379|NCT01039376|3895664|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4073380|NCT01039376|3895662|B3||Male|Sex: Female, Male||Participants|Count of Participants|320|320.0||||||
4073381|NCT01039376|3895663|B2||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4073382|NCT01039376|3895664|B1||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4073383|NCT01039376|3895662|B3||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4073384|NCT01039376|3895663|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4073385|NCT01039376|3895664|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4073386|NCT01039376|3895662|B3|||Age||Years|Mean|64.0|64.0|Standard Deviation|9.95|9.95|||
4073387|NCT01039376|3895663|B2|||Age||Years|Mean|64.2|64.2|Standard Deviation|9.62|9.62|||
4073388|NCT01039376|3895664|B1|||Age||Years|Mean|63.8|63.8|Standard Deviation|10.28|10.28|||
4073389|NCT01039207|3895723|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073390|NCT01039207|3895723|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073391|NCT01039207|3895723|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4073392|NCT01039207|3895723|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4073393|NCT01039207|3895723|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073394|NCT01039207|3895723|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073395|NCT01039207|3895723|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073396|NCT01039207|3895723|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4073397|NCT01039207|3895723|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4073398|NCT01039207|3895723|B1|80-89 years||Age, Customized||participants|Number|2|2.0||||||
4073399|NCT01039207|3895723|B1|70-79 years||Age, Customized||participants|Number|10|10.0||||||
4073400|NCT01039207|3895723|B1|60-69 years||Age, Customized||participants|Number|9|9.0||||||
4073401|NCT01039207|3895723|B1|50-59 years||Age, Customized||participants|Number|6|6.0||||||
4073402|NCT01039207|3895723|B1|40-49 years||Age, Customized||participants|Number|4|4.0||||||
4073403|NCT01038921|3895731|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
4073404|NCT01038921|3895732|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4073405|NCT01038921|3895733|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4073406|NCT01038921|3895731|B3||Unknown or Not Reported|Race (NIH/OMB)|Melatonin First Placebo First Caucasian 13 11 African American 6 7 Other 0 2|Participants|Count of Participants|0|0.0||||||
4073407|NCT01038921|3895732|B2||Unknown or Not Reported|Race (NIH/OMB)|Melatonin First Placebo First Caucasian 13 11 African American 6 7 Other 0 2|Participants|Count of Participants|0|0.0||||||
4073408|NCT01038921|3895733|B1||Unknown or Not Reported|Race (NIH/OMB)|Melatonin First Placebo First Caucasian 13 11 African American 6 7 Other 0 2|Participants|Count of Participants|0|0.0||||||
4073409|NCT01038921|3895731|B3||More than one race|Race (NIH/OMB)|Melatonin First Placebo First Caucasian 13 11 African American 6 7 Other 0 2|Participants|Count of Participants|0|0.0||||||
4073410|NCT01038921|3895732|B2||More than one race|Race (NIH/OMB)|Melatonin First Placebo First Caucasian 13 11 African American 6 7 Other 0 2|Participants|Count of Participants|0|0.0||||||
4073411|NCT01038921|3895733|B1||More than one race|Race (NIH/OMB)|Melatonin First Placebo First Caucasian 13 11 African American 6 7 Other 0 2|Participants|Count of Participants|0|0.0||||||
4073412|NCT01038921|3895731|B3||White|Race (NIH/OMB)|Melatonin First Placebo First Caucasian 13 11 African American 6 7 Other 0 2|Participants|Count of Participants|24|24.0||||||
4073413|NCT01038921|3895732|B2||White|Race (NIH/OMB)|Melatonin First Placebo First Caucasian 13 11 African American 6 7 Other 0 2|Participants|Count of Participants|11|11.0||||||
4073414|NCT01038921|3895733|B1||White|Race (NIH/OMB)|Melatonin First Placebo First Caucasian 13 11 African American 6 7 Other 0 2|Participants|Count of Participants|13|13.0||||||
4073496|NCT01038752|3895756|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4073415|NCT01038921|3895731|B3||Black or African American|Race (NIH/OMB)|Melatonin First Placebo First Caucasian 13 11 African American 6 7 Other 0 2|Participants|Count of Participants|13|13.0||||||
4073416|NCT01038921|3895732|B2||Black or African American|Race (NIH/OMB)|Melatonin First Placebo First Caucasian 13 11 African American 6 7 Other 0 2|Participants|Count of Participants|7|7.0||||||
4073417|NCT01038921|3895733|B1||Black or African American|Race (NIH/OMB)|Melatonin First Placebo First Caucasian 13 11 African American 6 7 Other 0 2|Participants|Count of Participants|6|6.0||||||
4073418|NCT01038921|3895731|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Melatonin First Placebo First Caucasian 13 11 African American 6 7 Other 0 2|Participants|Count of Participants|1|1.0||||||
4073419|NCT01038921|3895732|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Melatonin First Placebo First Caucasian 13 11 African American 6 7 Other 0 2|Participants|Count of Participants|1|1.0||||||
4073420|NCT01038921|3895733|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Melatonin First Placebo First Caucasian 13 11 African American 6 7 Other 0 2|Participants|Count of Participants|0|0.0||||||
4073421|NCT01038921|3895731|B3||Asian|Race (NIH/OMB)|Melatonin First Placebo First Caucasian 13 11 African American 6 7 Other 0 2|Participants|Count of Participants|1|1.0||||||
4073422|NCT01038921|3895732|B2||Asian|Race (NIH/OMB)|Melatonin First Placebo First Caucasian 13 11 African American 6 7 Other 0 2|Participants|Count of Participants|1|1.0||||||
4073423|NCT01038921|3895733|B1||Asian|Race (NIH/OMB)|Melatonin First Placebo First Caucasian 13 11 African American 6 7 Other 0 2|Participants|Count of Participants|0|0.0||||||
4073424|NCT01038921|3895731|B3||American Indian or Alaska Native|Race (NIH/OMB)|Melatonin First Placebo First Caucasian 13 11 African American 6 7 Other 0 2|Participants|Count of Participants|0|0.0||||||
4073425|NCT01038921|3895732|B2||American Indian or Alaska Native|Race (NIH/OMB)|Melatonin First Placebo First Caucasian 13 11 African American 6 7 Other 0 2|Participants|Count of Participants|0|0.0||||||
4073426|NCT01038921|3895733|B1||American Indian or Alaska Native|Race (NIH/OMB)|Melatonin First Placebo First Caucasian 13 11 African American 6 7 Other 0 2|Participants|Count of Participants|0|0.0||||||
4073427|NCT01038921|3895731|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4073428|NCT01038921|3895732|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4073429|NCT01038921|3895733|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4073430|NCT01038921|3895731|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4073431|NCT01038921|3895732|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4073432|NCT01038921|3895733|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4073433|NCT01038921|3895731|B3|||Age||years|Mean|58.9|58.9|Standard Deviation|10.4|10.4|||
4073434|NCT01038921|3895732|B2|||Age||years|Mean|57.6|57.6|Standard Deviation|10.1|10.1|||
4073435|NCT01038921|3895733|B1|||Age||years|Mean|62.7|62.7|Standard Deviation|9.6|9.6|||
4073436|NCT01038921|3895731|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4073437|NCT01038921|3895732|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4073438|NCT01038921|3895733|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4073439|NCT01038921|3895731|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4073440|NCT01038921|3895732|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4073441|NCT01038921|3895733|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4073442|NCT01038921|3895731|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073443|NCT01038921|3895732|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073444|NCT01038921|3895733|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073445|NCT01038869|3895740|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4073446|NCT01038869|3895740|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4073447|NCT01038869|3895740|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4073448|NCT01038869|3895740|B1|||Age||years|Mean|24|24.0|Standard Deviation|10.63|10.63|||
4073449|NCT01038869|3895740|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4073450|NCT01038869|3895740|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4073451|NCT01038869|3895740|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4073452|NCT01038856|3895748|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4073453|NCT01038856|3895748|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4073454|NCT01038856|3895748|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4073455|NCT01038856|3895748|B1|||Age||years|Median|63|63.0|Full Range|||26.0|78.0|
4073456|NCT01038856|3895748|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4073457|NCT01038856|3895748|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4073458|NCT01038856|3895748|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073459|NCT01038752|3895755|B3|Nonsquamous||Non-small cell lung cancer (NSCLC) Disease Type||participants|Number|10|10.0||||||
4073460|NCT01038752|3895756|B2|Nonsquamous||Non-small cell lung cancer (NSCLC) Disease Type||participants|Number|4|4.0||||||
4073461|NCT01038752|3895757|B1|Nonsquamous||Non-small cell lung cancer (NSCLC) Disease Type||participants|Number|6|6.0||||||
4073462|NCT01038752|3895755|B3|Squamous||Non-small cell lung cancer (NSCLC) Disease Type||participants|Number|4|4.0||||||
4073463|NCT01038752|3895756|B2|Squamous||Non-small cell lung cancer (NSCLC) Disease Type||participants|Number|2|2.0||||||
4073464|NCT01038752|3895757|B1|Squamous||Non-small cell lung cancer (NSCLC) Disease Type||participants|Number|2|2.0||||||
4073497|NCT01038752|3895757|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4073498|NCT01038752|3895755|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073465|NCT01038752|3895755|B3|IV||Non-small cell lung cancer (NSCLC) Disease Stage at Entry|"Stage I: The cancer is confined only to the lungs.~Stage II: The cancer is in the lung and nearby lymph nodes.~Stage III: Cancer is found in the lung and in the lymph nodes in the middle of the chest. There are two subtypes:~A: Cancer has spread only to lymph nodes on the same side of the chest where the cancer started.~B: Cancer has spread to the lymph nodes on the opposite side of the chest, or above the collar bone.~Stage IV: When the cancer has metastasized to both lungs, to fluid in the area around the lungs, or to another part of the body, such as the liver or other organs."|participants|Number|13|13.0||||||
4073466|NCT01038752|3895756|B2|IV||Non-small cell lung cancer (NSCLC) Disease Stage at Entry|"Stage I: The cancer is confined only to the lungs.~Stage II: The cancer is in the lung and nearby lymph nodes.~Stage III: Cancer is found in the lung and in the lymph nodes in the middle of the chest. There are two subtypes:~A: Cancer has spread only to lymph nodes on the same side of the chest where the cancer started.~B: Cancer has spread to the lymph nodes on the opposite side of the chest, or above the collar bone.~Stage IV: When the cancer has metastasized to both lungs, to fluid in the area around the lungs, or to another part of the body, such as the liver or other organs."|participants|Number|6|6.0||||||
4073467|NCT01038752|3895757|B1|IV||Non-small cell lung cancer (NSCLC) Disease Stage at Entry|"Stage I: The cancer is confined only to the lungs.~Stage II: The cancer is in the lung and nearby lymph nodes.~Stage III: Cancer is found in the lung and in the lymph nodes in the middle of the chest. There are two subtypes:~A: Cancer has spread only to lymph nodes on the same side of the chest where the cancer started.~B: Cancer has spread to the lymph nodes on the opposite side of the chest, or above the collar bone.~Stage IV: When the cancer has metastasized to both lungs, to fluid in the area around the lungs, or to another part of the body, such as the liver or other organs."|participants|Number|7|7.0||||||
4073468|NCT01038752|3895755|B3|IIIB||Non-small cell lung cancer (NSCLC) Disease Stage at Entry|"Stage I: The cancer is confined only to the lungs.~Stage II: The cancer is in the lung and nearby lymph nodes.~Stage III: Cancer is found in the lung and in the lymph nodes in the middle of the chest. There are two subtypes:~A: Cancer has spread only to lymph nodes on the same side of the chest where the cancer started.~B: Cancer has spread to the lymph nodes on the opposite side of the chest, or above the collar bone.~Stage IV: When the cancer has metastasized to both lungs, to fluid in the area around the lungs, or to another part of the body, such as the liver or other organs."|participants|Number|1|1.0||||||
4073469|NCT01038752|3895756|B2|IIIB||Non-small cell lung cancer (NSCLC) Disease Stage at Entry|"Stage I: The cancer is confined only to the lungs.~Stage II: The cancer is in the lung and nearby lymph nodes.~Stage III: Cancer is found in the lung and in the lymph nodes in the middle of the chest. There are two subtypes:~A: Cancer has spread only to lymph nodes on the same side of the chest where the cancer started.~B: Cancer has spread to the lymph nodes on the opposite side of the chest, or above the collar bone.~Stage IV: When the cancer has metastasized to both lungs, to fluid in the area around the lungs, or to another part of the body, such as the liver or other organs."|participants|Number|0|0.0||||||
4073470|NCT01038752|3895757|B1|IIIB||Non-small cell lung cancer (NSCLC) Disease Stage at Entry|"Stage I: The cancer is confined only to the lungs.~Stage II: The cancer is in the lung and nearby lymph nodes.~Stage III: Cancer is found in the lung and in the lymph nodes in the middle of the chest. There are two subtypes:~A: Cancer has spread only to lymph nodes on the same side of the chest where the cancer started.~B: Cancer has spread to the lymph nodes on the opposite side of the chest, or above the collar bone.~Stage IV: When the cancer has metastasized to both lungs, to fluid in the area around the lungs, or to another part of the body, such as the liver or other organs."|participants|Number|1|1.0||||||
4073471|NCT01038752|3895755|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073472|NCT01038752|3895756|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073473|NCT01038752|3895757|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073474|NCT01038752|3895755|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073475|NCT01038752|3895756|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073476|NCT01038752|3895757|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073477|NCT01038752|3895755|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4073478|NCT01038752|3895756|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4073479|NCT01038752|3895757|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4073480|NCT01038752|3895755|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4073481|NCT01038752|3895756|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4073482|NCT01038752|3895757|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4073483|NCT01038752|3895755|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073484|NCT01038752|3895756|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073485|NCT01038752|3895757|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073486|NCT01038752|3895755|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073487|NCT01038752|3895756|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073488|NCT01038752|3895757|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073489|NCT01038752|3895755|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073490|NCT01038752|3895756|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073491|NCT01038752|3895757|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073492|NCT01038752|3895755|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073493|NCT01038752|3895756|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073494|NCT01038752|3895757|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073495|NCT01038752|3895755|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4073499|NCT01038752|3895756|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073500|NCT01038752|3895757|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073501|NCT01038752|3895755|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4073502|NCT01038752|3895756|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4073503|NCT01038752|3895757|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4073504|NCT01038752|3895755|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4073505|NCT01038752|3895756|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4073506|NCT01038752|3895757|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4073507|NCT01038752|3895755|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4073508|NCT01038752|3895756|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4073509|NCT01038752|3895757|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4073510|NCT01038752|3895755|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4073511|NCT01038752|3895756|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4073512|NCT01038752|3895757|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4073513|NCT01038752|3895755|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073514|NCT01038752|3895756|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073515|NCT01038752|3895757|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073516|NCT01038713|3895778|B4|United States||Region of Enrollment||participants|Number|54|54.0||||||
4073517|NCT01038713|3895779|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4073518|NCT01038713|3895780|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4073519|NCT01038713|3895781|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4073520|NCT01038713|3895778|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4073521|NCT01038713|3895779|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4073522|NCT01038713|3895780|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4073523|NCT01038713|3895781|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4073524|NCT01038713|3895778|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4073525|NCT01038713|3895779|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4073526|NCT01038713|3895780|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4073527|NCT01038713|3895781|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4073528|NCT01038713|3895778|B4|||Age||years|Mean|65.9|65.9|Standard Deviation|9.74|9.74|||
4073529|NCT01038713|3895779|B3|||Age||years|Mean|67.2|67.2|Standard Deviation|11.4|11.4|||
4073530|NCT01038713|3895780|B2|||Age||years|Mean|64.8|64.8|Standard Deviation|8.47|8.47|||
4073531|NCT01038713|3895781|B1|||Age||years|Mean|65.9|65.9|Standard Deviation|9.67|9.67|||
4073532|NCT01038635|3895803|B10|United States||Region of Enrollment||participants|Number|88|88.0||||||
4073533|NCT01038635|3895804|B9|United States||Region of Enrollment||participants|Number|40|40.0||||||
4073534|NCT01038635|3895805|B8|United States||Region of Enrollment||participants|Number|20|20.0||||||
4073535|NCT01038635|3895806|B7|United States||Region of Enrollment||participants|Number|7|7.0||||||
4073536|NCT01038635|3895807|B6|United States||Region of Enrollment||participants|Number|3|3.0||||||
4073537|NCT01038635|3895808|B5|United States||Region of Enrollment||participants|Number|4|4.0||||||
4073538|NCT01038635|3895809|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
4073539|NCT01038635|3895810|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4073540|NCT01038635|3895811|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4073541|NCT01038635|3895812|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4073542|NCT01038635|3895803|B10||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4073543|NCT01038635|3895804|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4073544|NCT01038635|3895805|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073545|NCT01038635|3895806|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4073546|NCT01038635|3895807|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073547|NCT01038635|3895808|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073548|NCT01038635|3895809|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073549|NCT01038635|3895810|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073550|NCT01038635|3895811|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073551|NCT01038635|3895812|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073552|NCT01038635|3895803|B10||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073553|NCT01038635|3895804|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073554|NCT01038635|3895805|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073555|NCT01038635|3895806|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073556|NCT01038635|3895807|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073557|NCT01038635|3895808|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073558|NCT01038635|3895809|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073559|NCT01038635|3895810|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073560|NCT01038635|3895811|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073561|NCT01038635|3895812|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073562|NCT01038635|3895803|B10||White|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
4073563|NCT01038635|3895804|B9||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4073564|NCT01038635|3895805|B8||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4073565|NCT01038635|3895806|B7||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4073566|NCT01038635|3895807|B6||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4073567|NCT01038635|3895808|B5||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4073568|NCT01038635|3895809|B4||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4073569|NCT01038635|3895810|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4073570|NCT01038635|3895811|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4073571|NCT01038635|3895812|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4073572|NCT01038635|3895803|B10||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4073573|NCT01038635|3895804|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4073574|NCT01038635|3895805|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4073575|NCT01038635|3895806|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4073576|NCT01038635|3895807|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4073577|NCT01038635|3895808|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073578|NCT01038635|3895809|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073579|NCT01038635|3895810|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073580|NCT01038635|3895811|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4073581|NCT01038635|3895812|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073582|NCT01038635|3895803|B10||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073583|NCT01038635|3895804|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073584|NCT01038635|3895805|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073585|NCT01038635|3895806|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073586|NCT01038635|3895807|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073587|NCT01038635|3895808|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073588|NCT01038635|3895809|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073589|NCT01038635|3895810|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073590|NCT01038635|3895811|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073591|NCT01038635|3895812|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073592|NCT01038635|3895803|B10||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073593|NCT01038635|3895804|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073594|NCT01038635|3895805|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073595|NCT01038635|3895806|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073596|NCT01038635|3895807|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073597|NCT01038635|3895808|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073598|NCT01038635|3895809|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073599|NCT01038635|3895810|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073600|NCT01038635|3895811|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073601|NCT01038635|3895812|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073602|NCT01038635|3895803|B10||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073603|NCT01038635|3895804|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073604|NCT01038635|3895805|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073605|NCT01038635|3895806|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073606|NCT01038635|3895807|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073607|NCT01038635|3895808|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073608|NCT01038635|3895809|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073609|NCT01038635|3895810|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073610|NCT01038635|3895811|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073611|NCT01038635|3895812|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073612|NCT01038635|3895803|B10||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4073613|NCT01038635|3895804|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4073614|NCT01038635|3895805|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073615|NCT01038635|3895806|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4073616|NCT01038635|3895807|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073617|NCT01038635|3895808|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073618|NCT01038635|3895809|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073619|NCT01038635|3895810|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073620|NCT01038635|3895811|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073621|NCT01038635|3895812|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073622|NCT01038635|3895803|B10||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
4073623|NCT01038635|3895804|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4073624|NCT01038635|3895805|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4073625|NCT01038635|3895806|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4073626|NCT01038635|3895807|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4073627|NCT01038635|3895808|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4073628|NCT01038635|3895809|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4073629|NCT01038635|3895810|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4073630|NCT01038635|3895811|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4073631|NCT01038635|3895812|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4073632|NCT01038635|3895803|B10||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4073633|NCT01038635|3895804|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073634|NCT01038635|3895805|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4073635|NCT01038635|3895806|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073636|NCT01038635|3895807|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073637|NCT01038635|3895808|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073638|NCT01038635|3895809|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4073639|NCT01038635|3895810|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073640|NCT01038635|3895811|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4073641|NCT01038635|3895812|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4073642|NCT01038635|3895803|B10||Male|Gender||Participants|Count of Participants|48|48.0||||||
4073643|NCT01038635|3895804|B9||Male|Gender||Participants|Count of Participants|24|24.0||||||
4073644|NCT01038635|3895805|B8||Male|Gender||Participants|Count of Participants|11|11.0||||||
4073645|NCT01038635|3895806|B7||Male|Gender||Participants|Count of Participants|3|3.0||||||
4073646|NCT01038635|3895807|B6||Male|Gender||Participants|Count of Participants|1|1.0||||||
4073647|NCT01038635|3895808|B5||Male|Gender||Participants|Count of Participants|2|2.0||||||
4073648|NCT01038635|3895809|B4||Male|Gender||Participants|Count of Participants|1|1.0||||||
4073649|NCT01038635|3895810|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
4073650|NCT01038635|3895811|B2||Male|Gender||Participants|Count of Participants|2|2.0||||||
4073651|NCT01038635|3895812|B1||Male|Gender||Participants|Count of Participants|4|4.0||||||
4073652|NCT01038635|3895803|B10||Female|Gender||Participants|Count of Participants|40|40.0||||||
4073653|NCT01038635|3895804|B9||Female|Gender||Participants|Count of Participants|16|16.0||||||
4073654|NCT01038635|3895805|B8||Female|Gender||Participants|Count of Participants|9|9.0||||||
4073655|NCT01038635|3895806|B7||Female|Gender||Participants|Count of Participants|4|4.0||||||
4073656|NCT01038635|3895807|B6||Female|Gender||Participants|Count of Participants|2|2.0||||||
4073657|NCT01038635|3895808|B5||Female|Gender||Participants|Count of Participants|2|2.0||||||
4073658|NCT01038635|3895809|B4||Female|Gender||Participants|Count of Participants|2|2.0||||||
4073659|NCT01038635|3895810|B3||Female|Gender||Participants|Count of Participants|3|3.0||||||
4073660|NCT01038635|3895811|B2||Female|Gender||Participants|Count of Participants|1|1.0||||||
4073661|NCT01038635|3895812|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
4073662|NCT01038635|3895803|B10|||Age||years|Median|67|67.0|Full Range|||32.0|88.0|
4073663|NCT01038635|3895804|B9|||Age||years|Median|66|66.0|Full Range|||38.0|85.0|
4073664|NCT01038635|3895805|B8|||Age||years|Median|72|72.0|Full Range|||36.0|88.0|
4073665|NCT01038635|3895806|B7|||Age||years|Median|63|63.0|Full Range|||32.0|70.0|
4073666|NCT01038635|3895807|B6|||Age||years|Median|64|64.0|Full Range|||63.0|77.0|
4073667|NCT01038635|3895808|B5|||Age||years|Median|71|71.0|Full Range|||65.0|79.0|
4073668|NCT01038635|3895809|B4|||Age||years|Median|66|66.0|Full Range|||54.0|71.0|
4073669|NCT01038635|3895810|B3|||Age||years|Median|66|66.0|Full Range|||65.0|69.0|
4073670|NCT01038635|3895811|B2|||Age||years|Median|54|54.0|Full Range|||54.0|66.0|
4073671|NCT01038635|3895812|B1|||Age||years|Median|65|65.0|Full Range|||55.0|79.0|
4073672|NCT01038609|3895841|B6||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4073673|NCT01038609|3895842|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4073674|NCT01038609|3895843|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4073676|NCT01038609|3895845|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4073677|NCT01038609|3895846|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4073678|NCT01038609|3895841|B6||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4073679|NCT01038609|3895842|B5||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4073680|NCT01038609|3895843|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4073681|NCT01038609|3895844|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4073682|NCT01038609|3895845|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4073683|NCT01038609|3895846|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4073684|NCT01038609|3895841|B6|||Age||years|Mean|43.0|43.0|Standard Deviation|12.85|12.85|||
4073685|NCT01038609|3895842|B5|||Age||years|Mean|45.2|45.2|Standard Deviation|12.47|12.47|||
4073686|NCT01038609|3895843|B4|||Age||years|Mean|40.4|40.4|Standard Deviation|13.16|13.16|||
4073687|NCT01038609|3895844|B3|||Age||years|Mean|40.2|40.2|Standard Deviation|11.31|11.31|||
4073688|NCT01038609|3895845|B2|||Age||years|Mean|44.0|44.0|Standard Deviation|12.93|12.93|||
4073689|NCT01038609|3895846|B1|||Age||years|Mean|44.9|44.9|Standard Deviation|13.83|13.83|||
4073690|NCT01038336|3895892|B4|||Cues to action score|Cues to action is a Health Belief Model construct defined as external influences that promote a health behavior (e.g. symptoms, media communications, or information from a healthcare provider). Here it refers to prompts from others about protecting hearing. Cues to action was assessed with 2 items in the Knowledge, Attitudes, and Behaviors Questionnaire. Scores range from -50 to +50. A higher score indicates more cues to action.|Units on a scale -50 to +50|Mean|21.4|21.4|Standard Deviation|26.9|26.9|||
4073691|NCT01038336|3895893|B3|||Cues to action score|Cues to action is a Health Belief Model construct defined as external influences that promote a health behavior (e.g. symptoms, media communications, or information from a healthcare provider). Here it refers to prompts from others about protecting hearing. Cues to action was assessed with 2 items in the Knowledge, Attitudes, and Behaviors Questionnaire. Scores range from -50 to +50. A higher score indicates more cues to action.|Units on a scale -50 to +50|Mean|26.4|26.4|Standard Deviation|24.1|24.1|||
4073692|NCT01038336|3895894|B2|||Cues to action score|Cues to action is a Health Belief Model construct defined as external influences that promote a health behavior (e.g. symptoms, media communications, or information from a healthcare provider). Here it refers to prompts from others about protecting hearing. Cues to action was assessed with 2 items in the Knowledge, Attitudes, and Behaviors Questionnaire. Scores range from -50 to +50. A higher score indicates more cues to action.|Units on a scale -50 to +50|Mean|20.5|20.5|Standard Deviation|27.7|27.7|||
4073693|NCT01038336|3895895|B1|||Cues to action score|Cues to action is a Health Belief Model construct defined as external influences that promote a health behavior (e.g. symptoms, media communications, or information from a healthcare provider). Here it refers to prompts from others about protecting hearing. Cues to action was assessed with 2 items in the Knowledge, Attitudes, and Behaviors Questionnaire. Scores range from -50 to +50. A higher score indicates more cues to action.|Units on a scale -50 to +50|Mean|17.1|17.1|Standard Deviation|28.4|28.4|||
4073694|NCT01038336|3895892|B4|||Self-efficacy score|Perceived Self-efficacy is a Health Belief Model construct defined as an individual's assessment of their ability to successfully adopt a health behavior. Here it is the extent to which the individual believes they have the capacity to their protect hearing. It was assessed with 4 items in the Knowledge, Attitudes, and Behaviors Questionnaire. Scores range from -50 to +50. A higher score indicates greater perceived self-efficacy.|Units on a scale -50 to +50|Mean|10.9|10.9|Standard Deviation|23.2|23.2|||
4073695|NCT01038336|3895893|B3|||Self-efficacy score|Perceived Self-efficacy is a Health Belief Model construct defined as an individual's assessment of their ability to successfully adopt a health behavior. Here it is the extent to which the individual believes they have the capacity to their protect hearing. It was assessed with 4 items in the Knowledge, Attitudes, and Behaviors Questionnaire. Scores range from -50 to +50. A higher score indicates greater perceived self-efficacy.|Units on a scale -50 to +50|Mean|9.6|9.6|Standard Deviation|23.6|23.6|||
4073696|NCT01038336|3895894|B2|||Self-efficacy score|Perceived Self-efficacy is a Health Belief Model construct defined as an individual's assessment of their ability to successfully adopt a health behavior. Here it is the extent to which the individual believes they have the capacity to their protect hearing. It was assessed with 4 items in the Knowledge, Attitudes, and Behaviors Questionnaire. Scores range from -50 to +50. A higher score indicates greater perceived self-efficacy.|Units on a scale -50 to +50|Mean|9.4|9.4|Standard Deviation|22.9|22.9|||
4073697|NCT01038336|3895895|B1|||Self-efficacy score|Perceived Self-efficacy is a Health Belief Model construct defined as an individual's assessment of their ability to successfully adopt a health behavior. Here it is the extent to which the individual believes they have the capacity to their protect hearing. It was assessed with 4 items in the Knowledge, Attitudes, and Behaviors Questionnaire. Scores range from -50 to +50. A higher score indicates greater perceived self-efficacy.|Units on a scale -50 to +50|Mean|13.7|13.7|Standard Deviation|23.3|23.3|||
4073698|NCT01038336|3895892|B4|||Barriers score|Perceived Barriers is a Health Belief Model construct defined as an individual's assessment of the influences that discourage adoption of a health behavior. Here it assesses the extent to which the individual perceives protecting hearing to be negative. Perceived Barriers was assessed with 3 items in the Knowledge, Attitudes, and Behaviors Questionnaire. Scores range from -50 to +50. A higher score indicates fewer perceived barriers.|Units on a scale -50 to +50|Mean|15.6|15.6|Standard Deviation|24.2|24.2|||
4073699|NCT01038336|3895893|B3|||Barriers score|Perceived Barriers is a Health Belief Model construct defined as an individual's assessment of the influences that discourage adoption of a health behavior. Here it assesses the extent to which the individual perceives protecting hearing to be negative. Perceived Barriers was assessed with 3 items in the Knowledge, Attitudes, and Behaviors Questionnaire. Scores range from -50 to +50. A higher score indicates fewer perceived barriers.|Units on a scale -50 to +50|Mean|15.2|15.2|Standard Deviation|26.2|26.2|||
4073754|NCT01038323|3895926|B4||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4073755|NCT01038323|3895927|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4073700|NCT01038336|3895894|B2|||Barriers score|Perceived Barriers is a Health Belief Model construct defined as an individual's assessment of the influences that discourage adoption of a health behavior. Here it assesses the extent to which the individual perceives protecting hearing to be negative. Perceived Barriers was assessed with 3 items in the Knowledge, Attitudes, and Behaviors Questionnaire. Scores range from -50 to +50. A higher score indicates fewer perceived barriers.|Units on a scale -50 to +50|Mean|15.5|15.5|Standard Deviation|24.1|24.1|||
4073701|NCT01038336|3895895|B1|||Barriers score|Perceived Barriers is a Health Belief Model construct defined as an individual's assessment of the influences that discourage adoption of a health behavior. Here it assesses the extent to which the individual perceives protecting hearing to be negative. Perceived Barriers was assessed with 3 items in the Knowledge, Attitudes, and Behaviors Questionnaire. Scores range from -50 to +50. A higher score indicates fewer perceived barriers.|Units on a scale -50 to +50|Mean|16.1|16.1|Standard Deviation|22.7|22.7|||
4073702|NCT01038336|3895892|B4|||Benefits score|Perceived Benefit is a construct from the Health Belief Model defined as an individual's assessment of the positive consequences of adopting a health behavior. Here that is the belief that hearing well is important. Perceived Benefit was assessed with 7 items in the Knowledge, Attitudes, and Behaviors Questionnaire. Scores range from -50 to +50. A higher score indicates greater perceived benefit.|Units on scale -50 to +50|Mean|41.0|41.0|Standard Deviation|10.4|10.4|||
4073703|NCT01038336|3895893|B3|||Benefits score|Perceived Benefit is a construct from the Health Belief Model defined as an individual's assessment of the positive consequences of adopting a health behavior. Here that is the belief that hearing well is important. Perceived Benefit was assessed with 7 items in the Knowledge, Attitudes, and Behaviors Questionnaire. Scores range from -50 to +50. A higher score indicates greater perceived benefit.|Units on scale -50 to +50|Mean|42.3|42.3|Standard Deviation|8.7|8.7|||
4073704|NCT01038336|3895894|B2|||Benefits score|Perceived Benefit is a construct from the Health Belief Model defined as an individual's assessment of the positive consequences of adopting a health behavior. Here that is the belief that hearing well is important. Perceived Benefit was assessed with 7 items in the Knowledge, Attitudes, and Behaviors Questionnaire. Scores range from -50 to +50. A higher score indicates greater perceived benefit.|Units on scale -50 to +50|Mean|41.4|41.4|Standard Deviation|9.3|9.3|||
4073705|NCT01038336|3895895|B1|||Benefits score|Perceived Benefit is a construct from the Health Belief Model defined as an individual's assessment of the positive consequences of adopting a health behavior. Here that is the belief that hearing well is important. Perceived Benefit was assessed with 7 items in the Knowledge, Attitudes, and Behaviors Questionnaire. Scores range from -50 to +50. A higher score indicates greater perceived benefit.|Units on scale -50 to +50|Mean|39.4|39.4|Standard Deviation|12.7|12.7|||
4073706|NCT01038336|3895892|B4|||Severity score|Perceived Severity is a construct from the Health Belief Model defined as an individual's assessment of the seriousness of a condition. Here it assesses the extent to which the individual believes that a hearing loss would have negative consequences. Perceived Severity was assessed with 3 items in the Knowledge, Attitudes, and Behaviors Questionnaire. Scores range from -50 to +50. A higher score indicates greater perceived severity.|units on a scale -50 to +50|Mean|32.0|32.0|Standard Deviation|16.7|16.7|||
4073707|NCT01038336|3895893|B3|||Severity score|Perceived Severity is a construct from the Health Belief Model defined as an individual's assessment of the seriousness of a condition. Here it assesses the extent to which the individual believes that a hearing loss would have negative consequences. Perceived Severity was assessed with 3 items in the Knowledge, Attitudes, and Behaviors Questionnaire. Scores range from -50 to +50. A higher score indicates greater perceived severity.|units on a scale -50 to +50|Mean|32.8|32.8|Standard Deviation|14.0|14.0|||
4073708|NCT01038336|3895894|B2|||Severity score|Perceived Severity is a construct from the Health Belief Model defined as an individual's assessment of the seriousness of a condition. Here it assesses the extent to which the individual believes that a hearing loss would have negative consequences. Perceived Severity was assessed with 3 items in the Knowledge, Attitudes, and Behaviors Questionnaire. Scores range from -50 to +50. A higher score indicates greater perceived severity.|units on a scale -50 to +50|Mean|33.3|33.3|Standard Deviation|16.6|16.6|||
4073709|NCT01038336|3895895|B1|||Severity score|Perceived Severity is a construct from the Health Belief Model defined as an individual's assessment of the seriousness of a condition. Here it assesses the extent to which the individual believes that a hearing loss would have negative consequences. Perceived Severity was assessed with 3 items in the Knowledge, Attitudes, and Behaviors Questionnaire. Scores range from -50 to +50. A higher score indicates greater perceived severity.|units on a scale -50 to +50|Mean|30.0|30.0|Standard Deviation|19.4|19.4|||
4073710|NCT01038336|3895892|B4|||Susceptibility score|Perceived Susceptibility is a construct from the Health Belief Model defined as an individual's assessment of the risk of acquiring a condition. Here it assesses the extent to which the individual feels vulnerable to hearing loss. Perceived Susceptibility was assessed with 5 items in the Knowledge, Attitudes, and Behaviors Questionnaire. Scores range from -50 to +50. A higher score indicates greater perceived susceptibility.|units on a scale -50 to +50|Mean|28.8|28.8|Standard Deviation|7.2|7.2|||
4073711|NCT01038336|3895893|B3|||Susceptibility score|Perceived Susceptibility is a construct from the Health Belief Model defined as an individual's assessment of the risk of acquiring a condition. Here it assesses the extent to which the individual feels vulnerable to hearing loss. Perceived Susceptibility was assessed with 5 items in the Knowledge, Attitudes, and Behaviors Questionnaire. Scores range from -50 to +50. A higher score indicates greater perceived susceptibility.|units on a scale -50 to +50|Mean|30.5|30.5|Standard Deviation|6.2|6.2|||
4073712|NCT01038336|3895894|B2|||Susceptibility score|Perceived Susceptibility is a construct from the Health Belief Model defined as an individual's assessment of the risk of acquiring a condition. Here it assesses the extent to which the individual feels vulnerable to hearing loss. Perceived Susceptibility was assessed with 5 items in the Knowledge, Attitudes, and Behaviors Questionnaire. Scores range from -50 to +50. A higher score indicates greater perceived susceptibility.|units on a scale -50 to +50|Mean|29.2|29.2|Standard Deviation|5.8|5.8|||
4073756|NCT01038323|3895928|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4073757|NCT01038323|3895929|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4073758|NCT01038323|3895926|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073759|NCT01038323|3895927|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073713|NCT01038336|3895895|B1|||Susceptibility score|Perceived Susceptibility is a construct from the Health Belief Model defined as an individual's assessment of the risk of acquiring a condition. Here it assesses the extent to which the individual feels vulnerable to hearing loss. Perceived Susceptibility was assessed with 5 items in the Knowledge, Attitudes, and Behaviors Questionnaire. Scores range from -50 to +50. A higher score indicates greater perceived susceptibility.|units on a scale -50 to +50|Mean|26.7|26.7|Standard Deviation|8.8|8.8|||
4073714|NCT01038336|3895892|B4|||Knowledge about hearing conservation|Knowledge about hearing conservation was assessed with 16 items in the the Knowledge, Attitudes, and Behaviors Questionnaire (KAB; Saunders et al., 2014). It is a validated questionnaire that assesses knowledge about and attitudes toward hearing and hearing loss prevention. The Knowledge scale is scored as a percent correct, with a higher score indicating more knowledge.|percent of correct answers|Mean|56.3|56.3|Standard Deviation|15.7|15.7|||
4073715|NCT01038336|3895893|B3|||Knowledge about hearing conservation|Knowledge about hearing conservation was assessed with 16 items in the the Knowledge, Attitudes, and Behaviors Questionnaire (KAB; Saunders et al., 2014). It is a validated questionnaire that assesses knowledge about and attitudes toward hearing and hearing loss prevention. The Knowledge scale is scored as a percent correct, with a higher score indicating more knowledge.|percent of correct answers|Mean|56.7|56.7|Standard Deviation|14.8|14.8|||
4073716|NCT01038336|3895894|B2|||Knowledge about hearing conservation|Knowledge about hearing conservation was assessed with 16 items in the the Knowledge, Attitudes, and Behaviors Questionnaire (KAB; Saunders et al., 2014). It is a validated questionnaire that assesses knowledge about and attitudes toward hearing and hearing loss prevention. The Knowledge scale is scored as a percent correct, with a higher score indicating more knowledge.|percent of correct answers|Mean|55.1|55.1|Standard Deviation|16.3|16.3|||
4073717|NCT01038336|3895895|B1|||Knowledge about hearing conservation|Knowledge about hearing conservation was assessed with 16 items in the the Knowledge, Attitudes, and Behaviors Questionnaire (KAB; Saunders et al., 2014). It is a validated questionnaire that assesses knowledge about and attitudes toward hearing and hearing loss prevention. The Knowledge scale is scored as a percent correct, with a higher score indicating more knowledge.|percent of correct answers|Mean|57.1|57.1|Standard Deviation|16.2|16.2|||
4073718|NCT01038336|3895892|B4||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4073719|NCT01038336|3895893|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4073720|NCT01038336|3895894|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4073721|NCT01038336|3895895|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4073722|NCT01038336|3895892|B4||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4073723|NCT01038336|3895893|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4073724|NCT01038336|3895894|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4073725|NCT01038336|3895895|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4073726|NCT01038336|3895892|B4|||Age||years|Mean|38.3|38.3|Standard Deviation|12.2|12.2|||
4073727|NCT01038336|3895893|B3|||Age||years|Mean|42.2|42.2|Standard Deviation|11.1|11.1|||
4073728|NCT01038336|3895894|B2|||Age||years|Mean|37.9|37.9|Standard Deviation|11.8|11.8|||
4073729|NCT01038336|3895895|B1|||Age||years|Mean|34.8|34.8|Standard Deviation|12.8|12.8|||
4073730|NCT01038323|3895926|B4|||Weekly average pain intensity score|Average of daily pain scores within a one-week period (scale from 0 to 10, with 10 being the worse possible pain)|units on a scale|Mean|6.3|6.3|Standard Deviation|1.2|1.2|||
4073731|NCT01038323|3895927|B3|||Weekly average pain intensity score|Average of daily pain scores within a one-week period (scale from 0 to 10, with 10 being the worse possible pain)|units on a scale|Mean|6.3|6.3|Standard Deviation|1.3|1.3|||
4073732|NCT01038323|3895928|B2|||Weekly average pain intensity score|Average of daily pain scores within a one-week period (scale from 0 to 10, with 10 being the worse possible pain)|units on a scale|Mean|6.3|6.3|Standard Deviation|1.3|1.3|||
4073733|NCT01038323|3895929|B1|||Weekly average pain intensity score|Average of daily pain scores within a one-week period (scale from 0 to 10, with 10 being the worse possible pain)|units on a scale|Mean|6.2|6.2|Standard Deviation|1.2|1.2|||
4073734|NCT01038323|3895926|B4|United States||Region of Enrollment||participants|Number|58|58.0||||||
4073735|NCT01038323|3895927|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4073736|NCT01038323|3895928|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4073737|NCT01038323|3895929|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4073738|NCT01038323|3895926|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4073739|NCT01038323|3895927|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4073740|NCT01038323|3895928|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4073741|NCT01038323|3895929|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4073742|NCT01038323|3895926|B4||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4073743|NCT01038323|3895927|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4073744|NCT01038323|3895928|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4073745|NCT01038323|3895929|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4073746|NCT01038323|3895926|B4|||Age||years|Mean|46.5|46.5|Standard Deviation|10.3|10.3|||
4073747|NCT01038323|3895927|B3|||Age||years|Mean|47.11|47.11|Standard Deviation|11.9|11.9|||
4073748|NCT01038323|3895928|B2|||Age||years|Mean|47.8|47.8|Standard Deviation|10.6|10.6|||
4073749|NCT01038323|3895929|B1|||Age||years|Mean|44.8|44.8|Standard Deviation|8.8|8.8|||
4073750|NCT01038323|3895926|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4073751|NCT01038323|3895927|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4073752|NCT01038323|3895928|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4073753|NCT01038323|3895929|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4073760|NCT01038323|3895928|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073761|NCT01038323|3895929|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073762|NCT01038128|3895945|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4073763|NCT01038128|3895945|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4073764|NCT01038128|3895945|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4073765|NCT01038128|3895945|B1|||Age||years|Mean|41.5|41.5|Standard Deviation|18.6|18.6|||
4073766|NCT01038128|3895945|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4073767|NCT01038128|3895945|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4073768|NCT01038128|3895945|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073769|NCT01037452|3895953|B5|United States||Region of Enrollment||participants|Number|120|120.0||||||
4073770|NCT01037452|3895954|B4|United States||Region of Enrollment||participants|Number|30|30.0||||||
4073771|NCT01037452|3895955|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4073772|NCT01037452|3895956|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4073773|NCT01037452|3895957|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4073774|NCT01037452|3895953|B5||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4073775|NCT01037452|3895954|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4073776|NCT01037452|3895955|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4073777|NCT01037452|3895956|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4073778|NCT01037452|3895957|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4073779|NCT01037452|3895953|B5||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4073780|NCT01037452|3895954|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4073781|NCT01037452|3895955|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4073782|NCT01037452|3895956|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4073783|NCT01037452|3895957|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4073784|NCT01037452|3895953|B5|||Age||years|Mean|31.7|31.7|Standard Deviation|12.1|12.1|||
4073785|NCT01037452|3895954|B4|||Age||years|Mean|31.9|31.9|Standard Deviation|12.6|12.6|||
4073786|NCT01037452|3895955|B3|||Age||years|Mean|30.9|30.9|Standard Deviation|13.3|13.3|||
4073787|NCT01037452|3895956|B2|||Age||years|Mean|30.4|30.4|Standard Deviation|11.1|11.1|||
4073788|NCT01037452|3895957|B1|||Age||years|Mean|33.7|33.7|Standard Deviation|11.5|11.5|||
4073789|NCT01037452|3895953|B5||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4073790|NCT01037452|3895954|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4073791|NCT01037452|3895955|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4073792|NCT01037452|3895956|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4073793|NCT01037452|3895957|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4073794|NCT01037452|3895953|B5||Between 18 and 65 years|Age||Participants|Count of Participants|119|119.0||||||
4073795|NCT01037452|3895954|B4||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4073796|NCT01037452|3895955|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4073797|NCT01037452|3895956|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4073798|NCT01037452|3895957|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4073799|NCT01037452|3895953|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073800|NCT01037452|3895954|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073801|NCT01037452|3895955|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073802|NCT01037452|3895956|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073803|NCT01037452|3895957|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073804|NCT01037309|3895982|B7|Sweden||Region of Enrollment||participants|Number|4|4.0||||||
4073805|NCT01037309|3895983|B6|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
4073806|NCT01037309|3895984|B5|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
4073807|NCT01037309|3895985|B4|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
4073808|NCT01037309|3895986|B3|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
4073809|NCT01037309|3895987|B2|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
4073810|NCT01037309|3895988|B1|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
4073811|NCT01037309|3895982|B7|Italy||Region of Enrollment||participants|Number|7|7.0||||||
4073812|NCT01037309|3895983|B6|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4073813|NCT01037309|3895984|B5|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4073814|NCT01037309|3895985|B4|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4073815|NCT01037309|3895986|B3|Italy||Region of Enrollment||participants|Number|3|3.0||||||
4073816|NCT01037309|3895987|B2|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4073817|NCT01037309|3895988|B1|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4073818|NCT01037309|3895982|B7|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4073819|NCT01037309|3895983|B6|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4073820|NCT01037309|3895984|B5|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4073821|NCT01037309|3895985|B4|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4073822|NCT01037309|3895986|B3|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4073823|NCT01037309|3895987|B2|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4073824|NCT01037309|3895988|B1|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4073825|NCT01037309|3895982|B7|Belgium||Region of Enrollment||participants|Number|6|6.0||||||
4073826|NCT01037309|3895983|B6|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4073827|NCT01037309|3895984|B5|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4073828|NCT01037309|3895985|B4|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
4073829|NCT01037309|3895986|B3|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
4073830|NCT01037309|3895987|B2|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4073831|NCT01037309|3895988|B1|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
4073832|NCT01037309|3895982|B7||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4073833|NCT01037309|3895983|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4073834|NCT01037309|3895984|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4073835|NCT01037309|3895985|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4073836|NCT01037309|3895986|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4073837|NCT01037309|3895987|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4073838|NCT01037309|3895988|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4073839|NCT01037309|3895982|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4073840|NCT01037309|3895983|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4073841|NCT01037309|3895984|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4073842|NCT01037309|3895985|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4073843|NCT01037309|3895986|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4073844|NCT01037309|3895987|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4073845|NCT01037309|3895988|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4073846|NCT01037309|3895982|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4073847|NCT01037309|3895983|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4073848|NCT01037309|3895984|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4073849|NCT01037309|3895985|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4073850|NCT01037309|3895986|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4073851|NCT01037309|3895987|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4073852|NCT01037309|3895988|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4073853|NCT01037309|3895982|B7||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4073854|NCT01037309|3895983|B6||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4073855|NCT01037309|3895984|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4073856|NCT01037309|3895985|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4073857|NCT01037309|3895986|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4073858|NCT01037309|3895987|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4073859|NCT01037309|3895988|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4073860|NCT01037309|3895982|B7||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
4073861|NCT01037309|3895983|B6||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4073862|NCT01037309|3895984|B5||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4073863|NCT01037309|3895985|B4||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4073864|NCT01037309|3895986|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4073865|NCT01037309|3895987|B2||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4073866|NCT01037309|3895988|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4073867|NCT01037244|3896034|B5|United States||Region of Enrollment||participants|Number|618|618.0||||||
4073868|NCT01037244|3896035|B4|United States||Region of Enrollment||participants|Number|154|154.0||||||
4073869|NCT01037244|3896036|B3|United States||Region of Enrollment||participants|Number|158|158.0||||||
4073870|NCT01037244|3896037|B2|United States||Region of Enrollment||participants|Number|152|152.0||||||
4073871|NCT01037244|3896038|B1|United States||Region of Enrollment||participants|Number|154|154.0||||||
4073872|NCT01037244|3896034|B5||Male|Sex: Female, Male||Participants|Count of Participants|618|618.0||||||
4073873|NCT01037244|3896035|B4||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4073874|NCT01037244|3896036|B3||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4073875|NCT01037244|3896037|B2||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4073876|NCT01037244|3896038|B1||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4073877|NCT01037244|3896034|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4073878|NCT01037244|3896035|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4073879|NCT01037244|3896036|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4073880|NCT01037244|3896037|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4073881|NCT01037244|3896038|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4073882|NCT01037244|3896034|B5|||Age, Customized|Safety Population|years|Mean|59.3|59.3|Standard Deviation|10.17|10.17|||
4073883|NCT01037244|3896035|B4|||Age, Customized|Safety Population|years|Mean|60.3|60.3|Standard Deviation|10.16|10.16|||
4073884|NCT01037244|3896036|B3|||Age, Customized|Safety Population|years|Mean|58.5|58.5|Standard Deviation|10.75|10.75|||
4073885|NCT01037244|3896037|B2|||Age, Customized|Safety Population|years|Mean|59.5|59.5|Standard Deviation|9.69|9.69|||
4073886|NCT01037244|3896038|B1|||Age, Customized|Safety Population|years|Mean|59.0|59.0|Standard Deviation|10.03|10.03|||
4073887|NCT01037218|3896099|B5|United States||Region of Enrollment||participants|Number|601|601.0||||||
4073888|NCT01037218|3896100|B4|United States||Region of Enrollment||participants|Number|150|150.0||||||
4073889|NCT01037218|3896101|B3|United States||Region of Enrollment||participants|Number|155|155.0||||||
4073890|NCT01037218|3896102|B2|United States||Region of Enrollment||participants|Number|149|149.0||||||
4073891|NCT01037218|3896103|B1|United States||Region of Enrollment||participants|Number|147|147.0||||||
4073892|NCT01037218|3896099|B5|Unknown or Not Reported||Race (NIH/OMB)|Safety Population|Participants|Number|3|3.0||||||
4073893|NCT01037218|3896100|B4|Unknown or Not Reported||Race (NIH/OMB)|Safety Population|Participants|Number|3|3.0||||||
4073894|NCT01037218|3896101|B3|Unknown or Not Reported||Race (NIH/OMB)|Safety Population|Participants|Number|0|0.0||||||
4073895|NCT01037218|3896102|B2|Unknown or Not Reported||Race (NIH/OMB)|Safety Population|Participants|Number|0|0.0||||||
4073896|NCT01037218|3896103|B1|Unknown or Not Reported||Race (NIH/OMB)|Safety Population|Participants|Number|0|0.0||||||
4073897|NCT01037218|3896099|B5|More than one race||Race (NIH/OMB)|Safety Population|Participants|Number|0|0.0||||||
4073898|NCT01037218|3896100|B4|More than one race||Race (NIH/OMB)|Safety Population|Participants|Number|0|0.0||||||
4073899|NCT01037218|3896101|B3|More than one race||Race (NIH/OMB)|Safety Population|Participants|Number|0|0.0||||||
4073900|NCT01037218|3896102|B2|More than one race||Race (NIH/OMB)|Safety Population|Participants|Number|0|0.0||||||
4073901|NCT01037218|3896103|B1|More than one race||Race (NIH/OMB)|Safety Population|Participants|Number|0|0.0||||||
4073902|NCT01037218|3896099|B5|White||Race (NIH/OMB)|Safety Population|Participants|Number|520|520.0||||||
4073903|NCT01037218|3896100|B4|White||Race (NIH/OMB)|Safety Population|Participants|Number|127|127.0||||||
4073904|NCT01037218|3896101|B3|White||Race (NIH/OMB)|Safety Population|Participants|Number|139|139.0||||||
4073905|NCT01037218|3896102|B2|White||Race (NIH/OMB)|Safety Population|Participants|Number|125|125.0||||||
4073906|NCT01037218|3896103|B1|White||Race (NIH/OMB)|Safety Population|Participants|Number|129|129.0||||||
4073907|NCT01037218|3896099|B5|Black or African American||Race (NIH/OMB)|Safety Population|Participants|Number|69|69.0||||||
4073908|NCT01037218|3896100|B4|Black or African American||Race (NIH/OMB)|Safety Population|Participants|Number|19|19.0||||||
4073909|NCT01037218|3896101|B3|Black or African American||Race (NIH/OMB)|Safety Population|Participants|Number|13|13.0||||||
4073910|NCT01037218|3896102|B2|Black or African American||Race (NIH/OMB)|Safety Population|Participants|Number|20|20.0||||||
4073911|NCT01037218|3896103|B1|Black or African American||Race (NIH/OMB)|Safety Population|Participants|Number|17|17.0||||||
4073912|NCT01037218|3896099|B5|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|Safety Population|Participants|Number|0|0.0||||||
4073913|NCT01037218|3896100|B4|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|Safety Population|Participants|Number|0|0.0||||||
4073914|NCT01037218|3896101|B3|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|Safety Population|Participants|Number|0|0.0||||||
4073915|NCT01037218|3896102|B2|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|Safety Population|Participants|Number|0|0.0||||||
4073916|NCT01037218|3896103|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|Safety Population|Participants|Number|0|0.0||||||
4073917|NCT01037218|3896099|B5|Asian||Race (NIH/OMB)|Safety Population|Participants|Number|3|3.0||||||
4073918|NCT01037218|3896100|B4|Asian||Race (NIH/OMB)|Safety Population|Participants|Number|1|1.0||||||
4073919|NCT01037218|3896101|B3|Asian||Race (NIH/OMB)|Safety Population|Participants|Number|1|1.0||||||
4073920|NCT01037218|3896102|B2|Asian||Race (NIH/OMB)|Safety Population|Participants|Number|1|1.0||||||
4073921|NCT01037218|3896103|B1|Asian||Race (NIH/OMB)|Safety Population|Participants|Number|0|0.0||||||
4073922|NCT01037218|3896099|B5|American Indian or Alaska Native||Race (NIH/OMB)|Safety Population|Participants|Number|4|4.0||||||
4073923|NCT01037218|3896100|B4|American Indian or Alaska Native||Race (NIH/OMB)|Safety Population|Participants|Number|0|0.0||||||
4073924|NCT01037218|3896101|B3|American Indian or Alaska Native||Race (NIH/OMB)|Safety Population|Participants|Number|1|1.0||||||
4073925|NCT01037218|3896102|B2|American Indian or Alaska Native||Race (NIH/OMB)|Safety Population|Participants|Number|2|2.0||||||
4073926|NCT01037218|3896103|B1|American Indian or Alaska Native||Race (NIH/OMB)|Safety Population|Participants|Number|1|1.0||||||
4073927|NCT01037218|3896099|B5|Unknown or Not Reported||Ethnicity (NIH/OMB)|Race Safety Population|Participants|Number|0|0.0||||||
4073928|NCT01037218|3896100|B4|Unknown or Not Reported||Ethnicity (NIH/OMB)|Race Safety Population|Participants|Number|0|0.0||||||
4073929|NCT01037218|3896101|B3|Unknown or Not Reported||Ethnicity (NIH/OMB)|Race Safety Population|Participants|Number|0|0.0||||||
4073930|NCT01037218|3896102|B2|Unknown or Not Reported||Ethnicity (NIH/OMB)|Race Safety Population|Participants|Number|0|0.0||||||
4073931|NCT01037218|3896103|B1|Unknown or Not Reported||Ethnicity (NIH/OMB)|Race Safety Population|Participants|Number|0|0.0||||||
4073932|NCT01037218|3896099|B5|Not Hispanic or Latino||Ethnicity (NIH/OMB)|Race Safety Population|Participants|Number|570|570.0||||||
4073933|NCT01037218|3896100|B4|Not Hispanic or Latino||Ethnicity (NIH/OMB)|Race Safety Population|Participants|Number|142|142.0||||||
4073934|NCT01037218|3896101|B3|Not Hispanic or Latino||Ethnicity (NIH/OMB)|Race Safety Population|Participants|Number|145|145.0||||||
4073935|NCT01037218|3896102|B2|Not Hispanic or Latino||Ethnicity (NIH/OMB)|Race Safety Population|Participants|Number|143|143.0||||||
4073936|NCT01037218|3896103|B1|Not Hispanic or Latino||Ethnicity (NIH/OMB)|Race Safety Population|Participants|Number|140|140.0||||||
4073937|NCT01037218|3896099|B5|Hispanic or Latino||Ethnicity (NIH/OMB)|Race Safety Population|Participants|Number|29|29.0||||||
4073938|NCT01037218|3896100|B4|Hispanic or Latino||Ethnicity (NIH/OMB)|Race Safety Population|Participants|Number|8|8.0||||||
4073939|NCT01037218|3896101|B3|Hispanic or Latino||Ethnicity (NIH/OMB)|Race Safety Population|Participants|Number|9|9.0||||||
4074058|NCT01036529|3896278|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4073940|NCT01037218|3896102|B2|Hispanic or Latino||Ethnicity (NIH/OMB)|Race Safety Population|Participants|Number|5|5.0||||||
4073941|NCT01037218|3896103|B1|Hispanic or Latino||Ethnicity (NIH/OMB)|Race Safety Population|Participants|Number|7|7.0||||||
4073942|NCT01037218|3896099|B5||Male|Sex: Female, Male||Participants|Count of Participants|601|601.0||||||
4073943|NCT01037218|3896100|B4||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4073944|NCT01037218|3896101|B3||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4073945|NCT01037218|3896102|B2||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4073946|NCT01037218|3896103|B1||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4073947|NCT01037218|3896099|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4073948|NCT01037218|3896100|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4073949|NCT01037218|3896101|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4073950|NCT01037218|3896102|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4073951|NCT01037218|3896103|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4073952|NCT01037218|3896099|B5|||Age|Safety Population|years|Mean|58.4|58.4|Standard Deviation|9.77|9.77|||
4073953|NCT01037218|3896100|B4|||Age|Safety Population|years|Mean|58.9|58.9|Standard Deviation|10.31|10.31|||
4073954|NCT01037218|3896101|B3|||Age|Safety Population|years|Mean|58.7|58.7|Standard Deviation|9.48|9.48|||
4073955|NCT01037218|3896102|B2|||Age|Safety Population|years|Mean|56.8|56.8|Standard Deviation|10.22|10.22|||
4073956|NCT01037218|3896103|B1|||Age|Safety Population|years|Mean|59.1|59.1|Standard Deviation|8.92|8.92|||
4073957|NCT01037192|3896164|B3|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4073958|NCT01037192|3896165|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4073959|NCT01037192|3896166|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4073960|NCT01037192|3896164|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4073961|NCT01037192|3896165|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4073962|NCT01037192|3896166|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4073963|NCT01037192|3896164|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4073964|NCT01037192|3896165|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4073965|NCT01037192|3896166|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4073966|NCT01037192|3896164|B3|||Age||years|Mean|48|48.0|Standard Deviation|10|10.0|||
4073967|NCT01037192|3896165|B2|||Age||years|Mean|49|49.0|Standard Deviation|||||
4073968|NCT01037192|3896166|B1|||Age||years|Mean|48|48.0|Standard Deviation|12|12.0|||
4073969|NCT01037192|3896164|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4073970|NCT01037192|3896165|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4073971|NCT01037192|3896166|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4073972|NCT01037192|3896164|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4073973|NCT01037192|3896165|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4073974|NCT01037192|3896166|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4073975|NCT01037192|3896164|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073976|NCT01037192|3896165|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073977|NCT01037192|3896166|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4073978|NCT01037127|3896175|B3|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|96|96.0||||||
4073979|NCT01037127|3896176|B2|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|56|56.0||||||
4073980|NCT01037127|3896177|B1|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
4073981|NCT01037127|3896175|B3|White-Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4073982|NCT01037127|3896176|B2|White-Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4073983|NCT01037127|3896177|B1|White-Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4073984|NCT01037127|3896175|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4073985|NCT01037127|3896176|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4073986|NCT01037127|3896177|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4073987|NCT01037127|3896175|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4073988|NCT01037127|3896176|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4073989|NCT01037127|3896177|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4073990|NCT01037127|3896175|B3|||Age||Years|Mean|54.7|54.7|Standard Deviation|13.37|13.37|||
4073991|NCT01037127|3896176|B2|||Age||Years|Mean|54.0|54.0|Standard Deviation|12.60|12.6|||
4073992|NCT01037127|3896177|B1|||Age||Years|Mean|55.6|55.6|Standard Deviation|14.52|14.52|||
4073993|NCT01037114|3896210|B1|Male||Gender|The baseline measure data here corresponds to Year 20|Subjects|Number|9|9.0||||||
4073994|NCT01037114|3896210|B1|Female||Gender|The baseline measure data here corresponds to Year 20|Subjects|Number|36|36.0||||||
4073995|NCT01037114|3896210|B1|Male||Gender|The baseline measure data here corresponds to Year 19|Subjects|Number|9|9.0||||||
4073996|NCT01037114|3896210|B1|Female||Gender|The baseline measure data here corresponds to Year 19|Subjects|Number|36|36.0||||||
4073997|NCT01037114|3896210|B1|Male||Gender|The baseline measure data here corresponds to Year 18|Subjects|Number|9|9.0||||||
4073998|NCT01037114|3896210|B1|Female||Gender|The baseline measure data here corresponds to Year 18|Subjects|Number|35|35.0||||||
4073999|NCT01037114|3896210|B1|Male||Gender|The baseline measure data here corresponds to Year 17|Subjects|Number|10|10.0||||||
4074000|NCT01037114|3896210|B1|Female||Gender|The baseline measure data here corresponds to Year 17|Subjects|Number|38|38.0||||||
4074001|NCT01037114|3896210|B1||Male|Sex: Female, Male|The baseline measure data here corresponds to Year 16|Participants|Count of Participants|9|9.0||||||
4074002|NCT01037114|3896210|B1||Female|Sex: Female, Male|The baseline measure data here corresponds to Year 16|Participants|Count of Participants|40|40.0||||||
4074003|NCT01037114|3896210|B1|||Age|The baseline measure data here corresponds to Year 20|Years|Mean|41.7|41.7|Standard Deviation|5.9|5.9|||
4074004|NCT01037114|3896210|B1|||Age|The baseline measure data here corresponds to Year 19|Years|Mean|40.7|40.7|Standard Deviation|5.88|5.88|||
4074005|NCT01037114|3896210|B1|||Age|The baseline measure data here corresponds to Year 18|Years|Mean|39.7|39.7|Standard Deviation|5.89|5.89|||
4074006|NCT01037114|3896210|B1|||Age|The baseline measure data here corresponds to Year 17|Years|Mean|38.6|38.6|Standard Deviation|5.73|5.73|||
4074007|NCT01037114|3896210|B1|||Age|The baseline measure data here corresponds to Year 16|Years|Mean|37.4|37.4|Standard Deviation|5.66|5.66|||
4074008|NCT01037088|3896223|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4074009|NCT01037088|3896223|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4074010|NCT01037088|3896223|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4074011|NCT01037088|3896223|B1|||Age||years|Mean|50|50.0|Standard Deviation|11|11.0|||
4074012|NCT01037088|3896223|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4074013|NCT01037088|3896223|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4074014|NCT01037088|3896223|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4074015|NCT01036802|3896234|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4074016|NCT01036802|3896235|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4074017|NCT01036802|3896236|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4074018|NCT01036802|3896234|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4074019|NCT01036802|3896235|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4074020|NCT01036802|3896236|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4074021|NCT01036802|3896234|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4074022|NCT01036802|3896235|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4074023|NCT01036802|3896236|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4074024|NCT01036802|3896234|B3|||Age||years|Mean|37.3|37.3|Standard Deviation|16.01|16.01|||
4074025|NCT01036802|3896235|B2|||Age||years|Mean|53|53.0|Standard Deviation|||||
4074026|NCT01036802|3896236|B1|||Age||years|Mean|29.5|29.5|Standard Deviation|12.02|12.02|||
4074027|NCT01036802|3896234|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4074028|NCT01036802|3896235|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4074029|NCT01036802|3896236|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4074030|NCT01036802|3896234|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4074031|NCT01036802|3896235|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4074032|NCT01036802|3896236|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4074033|NCT01036802|3896234|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4074034|NCT01036802|3896235|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4074035|NCT01036802|3896236|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4074036|NCT01036763|3896255|B1||Male|Sex: Female, Male||Participants|Count of Participants|798|798.0||||||
4074037|NCT01036763|3896255|B1||Female|Sex: Female, Male||Participants|Count of Participants|466|466.0||||||
4074038|NCT01036763|3896255|B1|>= 65 years||Age, Customized||Years|Number|695|695.0||||||
4074039|NCT01036763|3896255|B1|< 65 years||Age, Customized||Years|Number|569|569.0||||||
4074040|NCT01036763|3896255|B1|||Age||Years|Mean|65.3|65.3|Standard Deviation|10.5|10.5|||
4074041|NCT01036724|3896265|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4074042|NCT01036724|3896266|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4074043|NCT01036724|3896267|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4074044|NCT01036724|3896265|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4074045|NCT01036724|3896266|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4074046|NCT01036724|3896267|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4074047|NCT01036724|3896265|B3|||Age||years|Median|58|58.0|Full Range|||22.0|79.0|
4074048|NCT01036724|3896266|B2|||Age||years|Median|57|57.0|Full Range|||36.0|79.0|
4074049|NCT01036724|3896267|B1|||Age||years|Median|58|58.0|Full Range|||22.0|74.0|
4074050|NCT01036529|3896276|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4074051|NCT01036529|3896277|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4074052|NCT01036529|3896278|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4074053|NCT01036529|3896276|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074054|NCT01036529|3896277|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074055|NCT01036529|3896278|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074056|NCT01036529|3896276|B3||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4074057|NCT01036529|3896277|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4074059|NCT01036529|3896276|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4074060|NCT01036529|3896277|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4074061|NCT01036529|3896278|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4074062|NCT01036529|3896276|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074063|NCT01036529|3896277|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074064|NCT01036529|3896278|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074065|NCT01036529|3896276|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074066|NCT01036529|3896277|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074067|NCT01036529|3896278|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074068|NCT01036529|3896276|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074069|NCT01036529|3896277|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074070|NCT01036529|3896278|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074071|NCT01036529|3896276|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4074072|NCT01036529|3896277|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4074073|NCT01036529|3896278|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4074074|NCT01036529|3896276|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4074075|NCT01036529|3896277|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4074076|NCT01036529|3896278|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4074077|NCT01036529|3896276|B3|||Age||years|Mean|54.9|54.9|Standard Deviation|13.9|13.9|||
4074078|NCT01036529|3896277|B2|||Age||years|Mean|57|57.0|Standard Deviation|15.3|15.3|||
4074079|NCT01036529|3896278|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|12|12.0|||
4074080|NCT01036490|3896285|B3|||Body mass index||kg/m^2|Mean|37|37.0|Standard Deviation|4.5|4.5|||
4074081|NCT01036490|3896286|B2|||Body mass index||kg/m^2|Mean|37.4|37.4|Standard Deviation|4.2|4.2|||
4074082|NCT01036490|3896287|B1|||Body mass index||kg/m^2|Mean|36.2|36.2|Standard Deviation|4.8|4.8|||
4074083|NCT01036490|3896285|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4074084|NCT01036490|3896286|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4074085|NCT01036490|3896287|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4074086|NCT01036490|3896285|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4074087|NCT01036490|3896286|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4074088|NCT01036490|3896287|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4074089|NCT01036490|3896285|B3|||Age||years|Mean|66|66.0|Standard Deviation|8.0|8.0|||
4074090|NCT01036490|3896286|B2|||Age||years|Mean|67|67.0|Standard Deviation|7.5|7.5|||
4074091|NCT01036490|3896287|B1|||Age||years|Mean|65|65.0|Standard Deviation|8.7|8.7|||
4074092|NCT01036438|3896304|B3|Germany||Region of Enrollment||participants|Number|54|54.0||||||
4074093|NCT01036438|3896305|B2|Germany||Region of Enrollment||participants|Number|26|26.0||||||
4074094|NCT01036438|3896306|B1|Germany||Region of Enrollment||participants|Number|28|28.0||||||
4074095|NCT01036438|3896304|B3|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
4074096|NCT01036438|3896305|B2|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4074097|NCT01036438|3896306|B1|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4074098|NCT01036438|3896304|B3|Czech Republic||Region of Enrollment||participants|Number|94|94.0||||||
4074099|NCT01036438|3896305|B2|Czech Republic||Region of Enrollment||participants|Number|47|47.0||||||
4074100|NCT01036438|3896306|B1|Czech Republic||Region of Enrollment||participants|Number|47|47.0||||||
4074101|NCT01036438|3896304|B3|France||Region of Enrollment||participants|Number|51|51.0||||||
4074102|NCT01036438|3896305|B2|France||Region of Enrollment||participants|Number|26|26.0||||||
4074103|NCT01036438|3896306|B1|France||Region of Enrollment||participants|Number|25|25.0||||||
4074104|NCT01036438|3896304|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4074105|NCT01036438|3896305|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4074106|NCT01036438|3896306|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4074107|NCT01036438|3896304|B3||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4074108|NCT01036438|3896305|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4074109|NCT01036438|3896306|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4074110|NCT01036438|3896304|B3||>=65 years|Age||Participants|Count of Participants|112|112.0||||||
4074111|NCT01036438|3896305|B2||>=65 years|Age||Participants|Count of Participants|58|58.0||||||
4074112|NCT01036438|3896306|B1||>=65 years|Age||Participants|Count of Participants|54|54.0||||||
4074113|NCT01036438|3896304|B3||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
4074114|NCT01036438|3896305|B2||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4074115|NCT01036438|3896306|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4074116|NCT01036438|3896304|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4074117|NCT01036438|3896305|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4074118|NCT01036438|3896306|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4074119|NCT01036438|3896304|B3|||Age||years|Mean|67.5|67.5|Standard Deviation|14.2|14.2|||
4074120|NCT01036438|3896305|B2|||Age||years|Mean|68.4|68.4|Standard Deviation|13.4|13.4|||
4074121|NCT01036438|3896306|B1|||Age||years|Mean|66.4|66.4|Standard Deviation|14.9|14.9|||
4074122|NCT01036321|3896313|B3|United States||Region of Enrollment||participants|Number|71|71.0||||||
4074123|NCT01036321|3896314|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
4074124|NCT01036321|3896315|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4074125|NCT01036321|3896313|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4074126|NCT01036321|3896314|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4074127|NCT01036321|3896315|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4074128|NCT01036321|3896313|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074129|NCT01036321|3896314|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074130|NCT01036321|3896315|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074131|NCT01036321|3896313|B3||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4074132|NCT01036321|3896314|B2||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4074133|NCT01036321|3896315|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4074134|NCT01036321|3896313|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4074135|NCT01036321|3896314|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4074136|NCT01036321|3896315|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4074137|NCT01036321|3896313|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074138|NCT01036321|3896314|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074139|NCT01036321|3896315|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074140|NCT01036321|3896313|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074141|NCT01036321|3896314|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074142|NCT01036321|3896315|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074143|NCT01036321|3896313|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4074144|NCT01036321|3896314|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4074145|NCT01036321|3896315|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074146|NCT01036321|3896313|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4074147|NCT01036321|3896314|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4074148|NCT01036321|3896315|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4074149|NCT01036321|3896313|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4074150|NCT01036321|3896314|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4074151|NCT01036321|3896315|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4074152|NCT01036321|3896313|B3|||Age||years|Mean|58.9|58.9|Standard Deviation|7.4|7.4|||
4074153|NCT01036321|3896314|B2|||Age||years|Mean|59.1|59.1|Standard Deviation|7.4|7.4|||
4074154|NCT01036321|3896315|B1|||Age||years|Mean|58.8|58.8|Standard Deviation|7.5|7.5|||
4074155|NCT01036165|3896340|B1|United States||Region of Enrollment||participants|Number|103|103.0||||||
4074156|NCT01036165|3896340|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4074157|NCT01036165|3896340|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4074158|NCT01036165|3896340|B1|||Age||years|Mean|46.4|46.4|Standard Deviation|9.35|9.35|||
4074159|NCT01036165|3896340|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4074160|NCT01036165|3896340|B1||Between 18 and 65 years|Age||Participants|Count of Participants|103|103.0||||||
4074161|NCT01036165|3896340|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4074162|NCT01036022|3896345|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074163|NCT01036022|3896346|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074164|NCT01036022|3896347|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074165|NCT01036022|3896348|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074166|NCT01036022|3896349|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074167|NCT01036022|3896350|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074168|NCT01036022|3896351|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074169|NCT01036022|3896345|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074170|NCT01036022|3896346|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074171|NCT01036022|3896347|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074172|NCT01036022|3896348|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074173|NCT01036022|3896349|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074174|NCT01036022|3896350|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074175|NCT01036022|3896351|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074176|NCT01036022|3896345|B7||White|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
4074177|NCT01036022|3896346|B6||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4074178|NCT01036022|3896347|B5||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4074179|NCT01036022|3896348|B4||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4074180|NCT01036022|3896349|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4074181|NCT01036022|3896350|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4074182|NCT01036022|3896351|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4074183|NCT01036022|3896345|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4074184|NCT01036022|3896346|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4074185|NCT01036022|3896347|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074186|NCT01036022|3896348|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4074187|NCT01036022|3896349|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074188|NCT01036022|3896350|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074189|NCT01036022|3896351|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074190|NCT01036022|3896345|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074191|NCT01036022|3896346|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074192|NCT01036022|3896347|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074193|NCT01036022|3896348|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074194|NCT01036022|3896349|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074195|NCT01036022|3896350|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074196|NCT01036022|3896351|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074197|NCT01036022|3896345|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4074198|NCT01036022|3896346|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4074199|NCT01036022|3896347|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4074200|NCT01036022|3896348|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074201|NCT01036022|3896349|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074202|NCT01036022|3896350|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074203|NCT01036022|3896351|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4074204|NCT01036022|3896345|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074205|NCT01036022|3896346|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074206|NCT01036022|3896347|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074207|NCT01036022|3896348|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074208|NCT01036022|3896349|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074209|NCT01036022|3896350|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074210|NCT01036022|3896351|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074211|NCT01036022|3896345|B7||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4074212|NCT01036022|3896346|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4074213|NCT01036022|3896347|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4074214|NCT01036022|3896348|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4074215|NCT01036022|3896349|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4074216|NCT01036022|3896350|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4074217|NCT01036022|3896351|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4074218|NCT01036022|3896345|B7||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4074219|NCT01036022|3896346|B6||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4074220|NCT01036022|3896347|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4074221|NCT01036022|3896348|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4074222|NCT01036022|3896349|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4074223|NCT01036022|3896350|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4074224|NCT01036022|3896351|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4074225|NCT01036022|3896345|B7|||Age||Years|Mean|46.1|46.1|Standard Deviation|13.34|13.34|||
4074226|NCT01036022|3896346|B6|||Age||Years|Mean|47.8|47.8|Standard Deviation|13.34|13.34|||
4074227|NCT01036022|3896347|B5|||Age||Years|Mean|42.0|42.0|Standard Deviation|13.99|13.99|||
4074228|NCT01036022|3896348|B4|||Age||Years|Mean|39.0|39.0|Standard Deviation|11.17|11.17|||
4074229|NCT01036022|3896349|B3|||Age||Years|Mean|53.4|53.4|Standard Deviation|13.53|13.53|||
4074230|NCT01036022|3896350|B2|||Age||Years|Mean|51.9|51.9|Standard Deviation|9.59|9.59|||
4074231|NCT01036022|3896351|B1|||Age||Years|Mean|43.0|43.0|Standard Deviation|13.56|13.56|||
4074232|NCT01036009|3896456|B3|United States||Region of Enrollment||participants|Number|43|43.0||||||
4074233|NCT01036009|3896457|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4074234|NCT01036009|3896458|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4074235|NCT01036009|3896456|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4074236|NCT01036009|3896457|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4074237|NCT01036009|3896458|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4074238|NCT01036009|3896456|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4074239|NCT01036009|3896457|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4074240|NCT01036009|3896458|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4074241|NCT01036009|3896456|B3|||Age||years|Mean|10.84|10.84|Standard Deviation|6.5|6.5|||
4074242|NCT01036009|3896457|B2|||Age||years|Mean|11.3|11.3|Standard Deviation|6|6.0|||
4074243|NCT01036009|3896458|B1|||Age||years|Mean|10.12|10.12|Standard Deviation|7.25|7.25|||
4074244|NCT01035944|3896473|B5|United States||Region of Enrollment||participants|Number|37|37.0||||||
4074245|NCT01035944|3896474|B4|United States||Region of Enrollment||participants|Number|4|4.0||||||
4074246|NCT01035944|3896475|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4074247|NCT01035944|3896476|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4074248|NCT01035944|3896477|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4074249|NCT01035944|3896473|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4074250|NCT01035944|3896474|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4074251|NCT01035944|3896475|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4074252|NCT01035944|3896476|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4074253|NCT01035944|3896477|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4074254|NCT01035944|3896473|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4074255|NCT01035944|3896474|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4074256|NCT01035944|3896475|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4074257|NCT01035944|3896476|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4074258|NCT01035944|3896477|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4074259|NCT01035944|3896473|B5|||Age||years|Mean|57.05|57.05|Standard Deviation|19.1|19.1|||
4074260|NCT01035944|3896474|B4|||Age||years|Mean|64.50|64.5|Standard Deviation|20.8|20.8|||
4074261|NCT01035944|3896475|B3|||Age||years|Mean|70.80|70.8|Standard Deviation|19.9|19.9|||
4074262|NCT01035944|3896476|B2|||Age||years|Mean|51.64|51.64|Standard Deviation|16.2|16.2|||
4074263|NCT01035944|3896477|B1|||Age||years|Mean|55.43|55.43|Standard Deviation|20.0|20.0|||
4074264|NCT01035905|3896490|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4074265|NCT01035905|3896491|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4074266|NCT01035905|3896492|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4074267|NCT01035905|3896490|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4074268|NCT01035905|3896491|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4074269|NCT01035905|3896492|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4074270|NCT01035905|3896490|B3|||Age||years|Mean|33.7|33.7|Standard Deviation|10.4|10.4|||
4074271|NCT01035905|3896491|B2|||Age||years|Mean|35.7|35.7|Standard Deviation|11.9|11.9|||
4074272|NCT01035905|3896492|B1|||Age||years|Mean|31.7|31.7|Standard Deviation|8.4|8.4|||
4074273|NCT01035788|3896499|B3|||State-Trait Anxiety Inventory State Subscale|The State subscale of the State-Trait Anxiety Inventory (STAI) is a self-report measure of current anxiety symptoms. The scores range 20-80 and higher scores indicate higher levels of current anxiety.|units on a scale|Mean|50.9|50.9|Standard Deviation|10.7|10.7|||
4074274|NCT01035788|3896500|B2|||State-Trait Anxiety Inventory State Subscale|The State subscale of the State-Trait Anxiety Inventory (STAI) is a self-report measure of current anxiety symptoms. The scores range 20-80 and higher scores indicate higher levels of current anxiety.|units on a scale|Mean|49.8|49.8|Standard Deviation|12.7|12.7|||
4074275|NCT01035788|3896501|B1|||State-Trait Anxiety Inventory State Subscale|The State subscale of the State-Trait Anxiety Inventory (STAI) is a self-report measure of current anxiety symptoms. The scores range 20-80 and higher scores indicate higher levels of current anxiety.|units on a scale|Mean|51.9|51.9|Standard Deviation|8.3|8.3|||
4074276|NCT01035788|3896499|B3|||Beck Depression Inventory II (BDI)|The Beck Depression Inventory (BDI) is a 21 item self-report measure of symptoms of depression over the course of the past two weeks. Items are rated on a 4-point scale ranging from zero to three. Ratings for each item are summed yielding total scores between zero and 63. Higher scores indicate higher levels of depressive symptoms.|units on a scale|Mean|26.2|26.2|Standard Deviation|9.5|9.5|||
4074277|NCT01035788|3896500|B2|||Beck Depression Inventory II (BDI)|The Beck Depression Inventory (BDI) is a 21 item self-report measure of symptoms of depression over the course of the past two weeks. Items are rated on a 4-point scale ranging from zero to three. Ratings for each item are summed yielding total scores between zero and 63. Higher scores indicate higher levels of depressive symptoms.|units on a scale|Mean|26.8|26.8|Standard Deviation|9.6|9.6|||
4074278|NCT01035788|3896501|B1|||Beck Depression Inventory II (BDI)|The Beck Depression Inventory (BDI) is a 21 item self-report measure of symptoms of depression over the course of the past two weeks. Items are rated on a 4-point scale ranging from zero to three. Ratings for each item are summed yielding total scores between zero and 63. Higher scores indicate higher levels of depressive symptoms.|units on a scale|Mean|25.6|25.6|Standard Deviation|9.5|9.5|||
4074279|NCT01035788|3896499|B3|||Dyadic Adjustment Scale (DAS)|The Dyadic Adjustment Scale (DAS) is a 32-item self-report inventory designed to measure partner perceptions of the quality of an intimate dyadic relationship. Scores range from 0-151, with higher scores indicating higher satisfaction. A total score of 98 or higher indicates relationship satisfaction.|units on a scale|Mean|97.9|97.9|Standard Deviation|22.1|22.1|||
4074314|NCT01035788|3896501|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4074315|NCT01035788|3896499|B3|||Age||years|Mean|39.9|39.9|Standard Deviation|10.3|10.3|||
4074316|NCT01035788|3896500|B2|||Age||years|Mean|41.0|41.0|Standard Deviation|11.3|11.3|||
4074280|NCT01035788|3896500|B2|||Dyadic Adjustment Scale (DAS)|The Dyadic Adjustment Scale (DAS) is a 32-item self-report inventory designed to measure partner perceptions of the quality of an intimate dyadic relationship. Scores range from 0-151, with higher scores indicating higher satisfaction. A total score of 98 or higher indicates relationship satisfaction.|units on a scale|Mean|96.0|96.0|Standard Deviation|25.0|25.0|||
4074281|NCT01035788|3896501|B1|||Dyadic Adjustment Scale (DAS)|The Dyadic Adjustment Scale (DAS) is a 32-item self-report inventory designed to measure partner perceptions of the quality of an intimate dyadic relationship. Scores range from 0-151, with higher scores indicating higher satisfaction. A total score of 98 or higher indicates relationship satisfaction.|units on a scale|Mean|99.7|99.7|Standard Deviation|19.2|19.2|||
4074282|NCT01035788|3896499|B3|||PTSD Checklist (PCL)|The PTSD Checklist (PCL) is a 17-item self-report measure of PTSD symptom severity corresponding to the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (APA, 2000) PTSD symptoms. The score range is 17-85 and higher scores indicated greater PTSD symptoms severity.|units on a scale|Mean|57.4|57.4|Standard Deviation|9.2|9.2|||
4074283|NCT01035788|3896500|B2|||PTSD Checklist (PCL)|The PTSD Checklist (PCL) is a 17-item self-report measure of PTSD symptom severity corresponding to the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (APA, 2000) PTSD symptoms. The score range is 17-85 and higher scores indicated greater PTSD symptoms severity.|units on a scale|Mean|57.2|57.2|Standard Deviation|10.5|10.5|||
4074284|NCT01035788|3896501|B1|||PTSD Checklist (PCL)|The PTSD Checklist (PCL) is a 17-item self-report measure of PTSD symptom severity corresponding to the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (APA, 2000) PTSD symptoms. The score range is 17-85 and higher scores indicated greater PTSD symptoms severity.|units on a scale|Mean|57.6|57.6|Standard Deviation|7.8|7.8|||
4074285|NCT01035788|3896499|B3|||Clinician Administered PTSD Scale (CAPS)|The Clinician Administered PTSD Scale (CAPS) is a semi-structured interview that evaluates PTSD symptoms and diagnostic status according to the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (APA, 2000). The intensity and frequency of each symptom is separately on a 5 point Likert scale ranging from zero to four. The total CAPS symptom severity score ranges from 0-136, with higher scores indicating greater PTSD symptoms severity. For the purposes of this study, a score of 45 or greater confirmed a diagnosis of PTSD.|units on a scale|Mean|70.7|70.7|Standard Deviation|13.1|13.1|||
4074286|NCT01035788|3896500|B2|||Clinician Administered PTSD Scale (CAPS)|The Clinician Administered PTSD Scale (CAPS) is a semi-structured interview that evaluates PTSD symptoms and diagnostic status according to the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (APA, 2000). The intensity and frequency of each symptom is separately on a 5 point Likert scale ranging from zero to four. The total CAPS symptom severity score ranges from 0-136, with higher scores indicating greater PTSD symptoms severity. For the purposes of this study, a score of 45 or greater confirmed a diagnosis of PTSD.|units on a scale|Mean|70.4|70.4|Standard Deviation|13.9|13.9|||
4074287|NCT01035788|3896501|B1|||Clinician Administered PTSD Scale (CAPS)|The Clinician Administered PTSD Scale (CAPS) is a semi-structured interview that evaluates PTSD symptoms and diagnostic status according to the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (APA, 2000). The intensity and frequency of each symptom is separately on a 5 point Likert scale ranging from zero to four. The total CAPS symptom severity score ranges from 0-136, with higher scores indicating greater PTSD symptoms severity. For the purposes of this study, a score of 45 or greater confirmed a diagnosis of PTSD.|units on a scale|Mean|71.1|71.1|Standard Deviation|12.4|12.4|||
4074288|NCT01035788|3896499|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4074289|NCT01035788|3896500|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4074290|NCT01035788|3896501|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4074291|NCT01035788|3896499|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074292|NCT01035788|3896500|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074293|NCT01035788|3896501|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074294|NCT01035788|3896499|B3||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4074295|NCT01035788|3896500|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4074296|NCT01035788|3896501|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4074297|NCT01035788|3896499|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4074298|NCT01035788|3896500|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4074299|NCT01035788|3896501|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074300|NCT01035788|3896499|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074301|NCT01035788|3896500|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074302|NCT01035788|3896501|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074303|NCT01035788|3896499|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074304|NCT01035788|3896500|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074305|NCT01035788|3896501|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074306|NCT01035788|3896499|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074307|NCT01035788|3896500|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074308|NCT01035788|3896501|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074309|NCT01035788|3896499|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4074310|NCT01035788|3896500|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4074311|NCT01035788|3896501|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4074312|NCT01035788|3896499|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4074313|NCT01035788|3896500|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4074317|NCT01035788|3896501|B1|||Age||years|Mean|38.9|38.9|Standard Deviation|9.2|9.2|||
4074318|NCT01035749|3896508|B5||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4074319|NCT01035749|3896509|B4||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4074320|NCT01035749|3896510|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4074321|NCT01035749|3896511|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4074322|NCT01035749|3896512|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4074323|NCT01035749|3896508|B5||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4074324|NCT01035749|3896509|B4||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4074325|NCT01035749|3896510|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4074326|NCT01035749|3896511|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4074327|NCT01035749|3896512|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4074328|NCT01035749|3896508|B5|||Age||Years|Mean|14.19|14.19|Standard Deviation|2.14|2.14|||
4074329|NCT01035749|3896509|B4|||Age||Years|Mean|14.1|14.1|Standard Deviation|2.13|2.13|||
4074330|NCT01035749|3896510|B3|||Age||Years|Mean|14.6|14.6|Standard Deviation|1.84|1.84|||
4074331|NCT01035749|3896511|B2|||Age||Years|Mean|14.5|14.5|Standard Deviation|2.2|2.2|||
4074332|NCT01035749|3896512|B1|||Age||Years|Mean|13.6|13.6|Standard Deviation|2.27|2.27|||
4074333|NCT01035658|3896633|B5|United States||Region of Enrollment||participants|Number|22|22.0||||||
4074334|NCT01035658|3896634|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
4074335|NCT01035658|3896635|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4074336|NCT01035658|3896636|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4074337|NCT01035658|3896637|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4074338|NCT01035658|3896633|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4074339|NCT01035658|3896634|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4074340|NCT01035658|3896635|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4074341|NCT01035658|3896636|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4074342|NCT01035658|3896637|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4074343|NCT01035658|3896633|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4074344|NCT01035658|3896634|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4074345|NCT01035658|3896635|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4074346|NCT01035658|3896636|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4074347|NCT01035658|3896637|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4074348|NCT01035658|3896633|B5|||Age||years|Median|64|64.0|Full Range|||31.0|90.0|
4074349|NCT01035658|3896634|B4|||Age||years|Median|57|57.0|Full Range|||49.0|79.0|
4074350|NCT01035658|3896635|B3|||Age||years|Median|64|64.0|Full Range|||51.0|64.0|
4074351|NCT01035658|3896636|B2|||Age||years|Median|74|74.0|Full Range|||31.0|90.0|
4074352|NCT01035658|3896637|B1|||Age||years|Median|62|62.0|Full Range|||51.0|69.0|
4074353|NCT01035606|3896663|B4|United States||Region of Enrollment||participants|Number|49|49.0||||||
4074354|NCT01035606|3896664|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4074355|NCT01035606|3896665|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4074356|NCT01035606|3896666|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4074357|NCT01035606|3896663|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4074358|NCT01035606|3896664|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4074359|NCT01035606|3896665|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4074360|NCT01035606|3896666|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4074361|NCT01035606|3896663|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4074362|NCT01035606|3896664|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4074363|NCT01035606|3896665|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4074364|NCT01035606|3896666|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4074365|NCT01035606|3896663|B4|||Age||years|Mean|51.1|51.1|Standard Deviation|12.1|12.1|||
4074366|NCT01035606|3896664|B3|||Age||years|Mean|51.8|51.8|Standard Deviation|12.0|12.0|||
4074367|NCT01035606|3896665|B2|||Age||years|Mean|50.4|50.4|Standard Deviation|12.2|12.2|||
4074368|NCT01035606|3896666|B1|||Age||years|Mean|50.4|50.4|Standard Deviation|12.2|12.2|||
4074369|NCT01035606|3896663|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4074370|NCT01035606|3896664|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4074371|NCT01035606|3896665|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4074372|NCT01035606|3896666|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4074373|NCT01035606|3896663|B4||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4074374|NCT01035606|3896664|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4074375|NCT01035606|3896665|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4074376|NCT01035606|3896666|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4074377|NCT01035606|3896663|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4074378|NCT01035606|3896664|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4074379|NCT01035606|3896665|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4074380|NCT01035606|3896666|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4074381|NCT01035346|3896682|B3|||Body Temperature||Degrees Fahrenheit|Mean|100.76|100.76|Standard Deviation|0.74|0.74|||
4074382|NCT01035346|3896683|B2|||Body Temperature||Degrees Fahrenheit|Mean|100.58|100.58|Standard Deviation|0.66|0.66|||
4074383|NCT01035346|3896684|B1|||Body Temperature||Degrees Fahrenheit|Mean|100.99|100.99|Standard Deviation|0.83|0.83|||
4074384|NCT01035346|3896682|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4074385|NCT01035346|3896683|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4074386|NCT01035346|3896684|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4074387|NCT01035346|3896682|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4074388|NCT01035346|3896683|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4074389|NCT01035346|3896684|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4074390|NCT01035346|3896682|B3|||Age||years|Mean|34.8|34.8|Standard Deviation|16.5|16.5|||
4074391|NCT01035346|3896683|B2|||Age||years|Mean|37.3|37.3|Standard Deviation|17.9|17.9|||
4074392|NCT01035346|3896684|B1|||Age||years|Mean|31.4|31.4|Standard Deviation|15.3|15.3|||
4074393|NCT01035333|3896703|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4074394|NCT01035333|3896703|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4074395|NCT01035333|3896703|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4074396|NCT01035333|3896703|B1|||Age||years|Mean|40.9|40.9|Standard Deviation|11.4|11.4|||
4074397|NCT01035333|3896703|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4074398|NCT01035333|3896703|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4074399|NCT01035333|3896703|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4074400|NCT01035255|3896708|B3||Male|Sex: Female, Male||Participants|Count of Participants|6595|6595.0||||||
4074401|NCT01035255|3896709|B2||Male|Sex: Female, Male||Participants|Count of Participants|3274|3274.0||||||
4074402|NCT01035255|3896710|B1||Male|Sex: Female, Male||Participants|Count of Participants|3321|3321.0||||||
4074403|NCT01035255|3896708|B3||Female|Sex: Female, Male||Participants|Count of Participants|1847|1847.0||||||
4074404|NCT01035255|3896709|B2||Female|Sex: Female, Male||Participants|Count of Participants|959|959.0||||||
4074405|NCT01035255|3896710|B1||Female|Sex: Female, Male||Participants|Count of Participants|888|888.0||||||
4074406|NCT01035255|3896708|B3|||Age||years|Mean|63.80|63.8|Standard Deviation|11.385|11.385|||
4074407|NCT01035255|3896709|B2|||Age||years|Mean|63.82|63.82|Standard Deviation|11.25|11.25|||
4074408|NCT01035255|3896710|B1|||Age||years|Mean|63.78|63.78|Standard Deviation|11.520|11.52|||
4074409|NCT01035229|3896727|B3|||BMI||kg/m^2|Mean|24.6|24.6|Standard Deviation|4.76|4.76|||
4074410|NCT01035229|3896728|B2|||BMI||kg/m^2|Mean|24.8|24.8|Standard Deviation|4.99|4.99|||
4074411|NCT01035229|3896729|B1|||BMI||kg/m^2|Mean|24.5|24.5|Standard Deviation|4.64|4.64|||
4074412|NCT01035229|3896727|B3|||Height||cm|Mean|168.3|168.3|Standard Deviation|8.73|8.73|||
4074413|NCT01035229|3896728|B2|||Height||cm|Mean|169.2|169.2|Standard Deviation|8.84|8.84|||
4074414|NCT01035229|3896729|B1|||Height||cm|Mean|167.9|167.9|Standard Deviation|8.66|8.66|||
4074415|NCT01035229|3896727|B3|||Weight||kg|Mean|70.2|70.2|Standard Deviation|16.35|16.35|||
4074416|NCT01035229|3896728|B2|||Weight||kg|Mean|71.3|71.3|Standard Deviation|17.71|17.71|||
4074417|NCT01035229|3896729|B1|||Weight||kg|Mean|69.6|69.6|Standard Deviation|15.62|15.62|||
4074418|NCT01035229|3896727|B3|Other||Race/Ethnicity, Customized||Participants|Number|39|39.0||||||
4074419|NCT01035229|3896728|B2|Other||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4074420|NCT01035229|3896729|B1|Other||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
4074421|NCT01035229|3896727|B3|Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4074422|NCT01035229|3896728|B2|Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4074423|NCT01035229|3896729|B1|Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4074424|NCT01035229|3896727|B3|Asian||Race/Ethnicity, Customized||Participants|Number|195|195.0||||||
4074425|NCT01035229|3896728|B2|Asian||Race/Ethnicity, Customized||Participants|Number|58|58.0||||||
4074426|NCT01035229|3896729|B1|Asian||Race/Ethnicity, Customized||Participants|Number|137|137.0||||||
4074427|NCT01035229|3896727|B3|Black||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4074428|NCT01035229|3896728|B2|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4074429|NCT01035229|3896729|B1|Black||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4074430|NCT01035229|3896727|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|302|302.0||||||
4074431|NCT01035229|3896728|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|110|110.0||||||
4074432|NCT01035229|3896729|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|192|192.0||||||
4074433|NCT01035229|3896727|B3||Male|Sex: Female, Male||Participants|Count of Participants|463|463.0||||||
4074434|NCT01035229|3896728|B2||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4074435|NCT01035229|3896729|B1||Male|Sex: Female, Male||Participants|Count of Participants|303|303.0||||||
4074436|NCT01035229|3896727|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4074437|NCT01035229|3896728|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4074438|NCT01035229|3896729|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4074439|NCT01035229|3896727|B3|>= 65 years||Age, Customized||Participants|Number|298|298.0||||||
4074440|NCT01035229|3896728|B2|>= 65 years||Age, Customized||Participants|Number|91|91.0||||||
4074441|NCT01035229|3896729|B1|>= 65 years||Age, Customized||Participants|Number|207|207.0||||||
4074442|NCT01035229|3896727|B3|>=55 - <65 years||Age, Customized||Participants|Number|161|161.0||||||
4074443|NCT01035229|3896728|B2|>=55 - <65 years||Age, Customized||Participants|Number|61|61.0||||||
4074444|NCT01035229|3896729|B1|>=55 - <65 years||Age, Customized||Participants|Number|100|100.0||||||
4074445|NCT01035229|3896727|B3|>=35 - <55 years||Age, Customized||Participants|Number|79|79.0||||||
4074446|NCT01035229|3896728|B2|>=35 - <55 years||Age, Customized||Participants|Number|31|31.0||||||
4074447|NCT01035229|3896729|B1|>=35 - <55 years||Age, Customized||Participants|Number|48|48.0||||||
4074448|NCT01035229|3896727|B3|< 35 years||Age, Customized||Participants|Number|8|8.0||||||
4074449|NCT01035229|3896728|B2|< 35 years||Age, Customized||Participants|Number|1|1.0||||||
4074450|NCT01035229|3896729|B1|< 35 years||Age, Customized||Participants|Number|7|7.0||||||
4074451|NCT01035229|3896727|B3|||Age||Years|Mean|64.8|64.8|Standard Deviation|11.28|11.28|||
4074452|NCT01035229|3896728|B2|||Age||Years|Mean|64.2|64.2|Standard Deviation|10.41|10.41|||
4074453|NCT01035229|3896729|B1|||Age||Years|Mean|65.1|65.1|Standard Deviation|11.70|11.7|||
4074454|NCT01035151|3896748|B3|||Nicotine Dependence Score|The Fagerstrom Test for Nicotine Dependence was assessed to measure nicotine dependence. The scale ranges from minimum score of 0 to a maximum score of 10. The higher the score, the higher the nicotine dependence.|units on a scale|Mean|4.7|4.7|Standard Deviation|2.2|2.2|||
4074455|NCT01035151|3896749|B2|||Nicotine Dependence Score|The Fagerstrom Test for Nicotine Dependence was assessed to measure nicotine dependence. The scale ranges from minimum score of 0 to a maximum score of 10. The higher the score, the higher the nicotine dependence.|units on a scale|Mean|4.7|4.7|Standard Deviation|2.2|2.2|||
4074456|NCT01035151|3896750|B1|||Nicotine Dependence Score|The Fagerstrom Test for Nicotine Dependence was assessed to measure nicotine dependence. The scale ranges from minimum score of 0 to a maximum score of 10. The higher the score, the higher the nicotine dependence.|units on a scale|Mean|4.8|4.8|Standard Deviation|2.2|2.2|||
4074457|NCT01035151|3896748|B3|United States||Region of Enrollment||Participants|Count of Participants|409|409.0||||||
4074458|NCT01035151|3896749|B2|United States||Region of Enrollment||Participants|Count of Participants|200|200.0||||||
4074459|NCT01035151|3896750|B1|United States||Region of Enrollment||Participants|Count of Participants|209|209.0||||||
4074460|NCT01035151|3896748|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4074461|NCT01035151|3896749|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074462|NCT01035151|3896750|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4074463|NCT01035151|3896748|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4074464|NCT01035151|3896749|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4074465|NCT01035151|3896750|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4074466|NCT01035151|3896748|B3||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4074467|NCT01035151|3896749|B2||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4074468|NCT01035151|3896750|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4074469|NCT01035151|3896748|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|349|349.0||||||
4074470|NCT01035151|3896749|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|157|157.0||||||
4074471|NCT01035151|3896750|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|192|192.0||||||
4074472|NCT01035151|3896748|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4074473|NCT01035151|3896749|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4074474|NCT01035151|3896750|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074475|NCT01035151|3896748|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4074476|NCT01035151|3896749|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074477|NCT01035151|3896750|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4074478|NCT01035151|3896748|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4074479|NCT01035151|3896749|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4074480|NCT01035151|3896750|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4074481|NCT01035151|3896748|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4074482|NCT01035151|3896749|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4074483|NCT01035151|3896750|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4074484|NCT01035151|3896748|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|370|370.0||||||
4074485|NCT01035151|3896749|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|180|180.0||||||
4074486|NCT01035151|3896750|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|190|190.0||||||
4074487|NCT01035151|3896748|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4074488|NCT01035151|3896749|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4074489|NCT01035151|3896750|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4074490|NCT01035151|3896748|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4074491|NCT01035151|3896749|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4074492|NCT01035151|3896750|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4074493|NCT01035151|3896748|B3||Female|Sex: Female, Male||Participants|Count of Participants|409|409.0||||||
4074494|NCT01035151|3896749|B2||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4074495|NCT01035151|3896750|B1||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4074496|NCT01035151|3896748|B3|||Age||years|Mean|42|42.0|Standard Deviation|14|14.0|||
4074497|NCT01035151|3896749|B2|||Age||years|Mean|41|41.0|Standard Deviation|14.1|14.1|||
4074498|NCT01035151|3896750|B1|||Age||years|Mean|43|43.0|Standard Deviation|15.6|15.6|||
4074499|NCT01035138|3896757|B4|||Alzheimer's Disease Cooperative Study Activities of Daily Living Inventory (ADCS-ADL)|The ADCS-ADL was a 23-item inventory developed as a rater-administered questionnaire answered by the participant's caregiver. It measures both basic and instrumental activities of daily living. The total ADCS-ADL score ranged from 0-78, with lower scores indicating greater disease severity.|units on a scale|Mean|63.9|63.9|Standard Deviation|10.9|10.9|||
4074500|NCT01035138|3896758|B3|||Alzheimer's Disease Cooperative Study Activities of Daily Living Inventory (ADCS-ADL)|The ADCS-ADL was a 23-item inventory developed as a rater-administered questionnaire answered by the participant's caregiver. It measures both basic and instrumental activities of daily living. The total ADCS-ADL score ranged from 0-78, with lower scores indicating greater disease severity.|units on a scale|Mean|62.2|62.2|Standard Deviation|12.2|12.2|||
4074501|NCT01035138|3896759|B2|||Alzheimer's Disease Cooperative Study Activities of Daily Living Inventory (ADCS-ADL)|The ADCS-ADL was a 23-item inventory developed as a rater-administered questionnaire answered by the participant's caregiver. It measures both basic and instrumental activities of daily living. The total ADCS-ADL score ranged from 0-78, with lower scores indicating greater disease severity.|units on a scale|Mean|65.5|65.5|Standard Deviation|9.0|9.0|||
4074502|NCT01035138|3896760|B1|||Alzheimer's Disease Cooperative Study Activities of Daily Living Inventory (ADCS-ADL)|The ADCS-ADL was a 23-item inventory developed as a rater-administered questionnaire answered by the participant's caregiver. It measures both basic and instrumental activities of daily living. The total ADCS-ADL score ranged from 0-78, with lower scores indicating greater disease severity.|units on a scale|Mean|63.7|63.7|Standard Deviation|11.4|11.4|||
4074503|NCT01035138|3896757|B4|||Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog11)|The cognitive subscale of the ADAS (ADAS-Cog11) was used as a primary efficacy measure and consisted of 11 items assessing areas of function most typically impaired in AD: orientation, verbal memory, language, and praxis. The scale ranged from 0-70, with higher scores indicating greater disease severity.|units on a scale|Mean|21.1|21.1|Standard Deviation|8.7|8.7|||
4074504|NCT01035138|3896758|B3|||Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog11)|The cognitive subscale of the ADAS (ADAS-Cog11) was used as a primary efficacy measure and consisted of 11 items assessing areas of function most typically impaired in AD: orientation, verbal memory, language, and praxis. The scale ranged from 0-70, with higher scores indicating greater disease severity.|units on a scale|Mean|21.5|21.5|Standard Deviation|9.3|9.3|||
4074505|NCT01035138|3896759|B2|||Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog11)|The cognitive subscale of the ADAS (ADAS-Cog11) was used as a primary efficacy measure and consisted of 11 items assessing areas of function most typically impaired in AD: orientation, verbal memory, language, and praxis. The scale ranged from 0-70, with higher scores indicating greater disease severity.|units on a scale|Mean|21.1|21.1|Standard Deviation|8.5|8.5|||
4074506|NCT01035138|3896760|B1|||Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog11)|The cognitive subscale of the ADAS (ADAS-Cog11) was used as a primary efficacy measure and consisted of 11 items assessing areas of function most typically impaired in AD: orientation, verbal memory, language, and praxis. The scale ranged from 0-70, with higher scores indicating greater disease severity.|units on a scale|Mean|21.0|21.0|Standard Deviation|8.5|8.5|||
4074507|NCT01035138|3896757|B4|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
4074508|NCT01035138|3896758|B3|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
4074509|NCT01035138|3896759|B2|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
4074510|NCT01035138|3896760|B1|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
4074511|NCT01035138|3896757|B4|Japan||Region of Enrollment||participants|Number|11|11.0||||||
4074512|NCT01035138|3896758|B3|Japan||Region of Enrollment||participants|Number|3|3.0||||||
4074513|NCT01035138|3896759|B2|Japan||Region of Enrollment||participants|Number|2|2.0||||||
4074514|NCT01035138|3896760|B1|Japan||Region of Enrollment||participants|Number|6|6.0||||||
4074515|NCT01035138|3896757|B4|Germany||Region of Enrollment||participants|Number|18|18.0||||||
4074516|NCT01035138|3896758|B3|Germany||Region of Enrollment||participants|Number|5|5.0||||||
4074517|NCT01035138|3896759|B2|Germany||Region of Enrollment||participants|Number|5|5.0||||||
4074518|NCT01035138|3896760|B1|Germany||Region of Enrollment||participants|Number|8|8.0||||||
4074519|NCT01035138|3896757|B4|South Africa||Region of Enrollment||participants|Number|1|1.0||||||
4074520|NCT01035138|3896758|B3|South Africa||Region of Enrollment||participants|Number|0|0.0||||||
4074521|NCT01035138|3896759|B2|South Africa||Region of Enrollment||participants|Number|0|0.0||||||
4074522|NCT01035138|3896760|B1|South Africa||Region of Enrollment||participants|Number|1|1.0||||||
4074523|NCT01035138|3896757|B4|Australia||Region of Enrollment||participants|Number|6|6.0||||||
4074524|NCT01035138|3896758|B3|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4074525|NCT01035138|3896759|B2|Australia||Region of Enrollment||participants|Number|3|3.0||||||
4074526|NCT01035138|3896760|B1|Australia||Region of Enrollment||participants|Number|3|3.0||||||
4074527|NCT01035138|3896757|B4|Poland||Region of Enrollment||participants|Number|2|2.0||||||
4074528|NCT01035138|3896758|B3|Poland||Region of Enrollment||participants|Number|2|2.0||||||
4074529|NCT01035138|3896759|B2|Poland||Region of Enrollment||participants|Number|0|0.0||||||
4074530|NCT01035138|3896760|B1|Poland||Region of Enrollment||participants|Number|0|0.0||||||
4074531|NCT01035138|3896757|B4|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4074532|NCT01035138|3896758|B3|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4074533|NCT01035138|3896759|B2|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4074534|NCT01035138|3896760|B1|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4074535|NCT01035138|3896757|B4|France||Region of Enrollment||participants|Number|2|2.0||||||
4074536|NCT01035138|3896758|B3|France||Region of Enrollment||participants|Number|0|0.0||||||
4074537|NCT01035138|3896759|B2|France||Region of Enrollment||participants|Number|0|0.0||||||
4074538|NCT01035138|3896760|B1|France||Region of Enrollment||participants|Number|2|2.0||||||
4074539|NCT01035138|3896757|B4|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4074540|NCT01035138|3896758|B3|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4074541|NCT01035138|3896759|B2|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4074542|NCT01035138|3896760|B1|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4074543|NCT01035138|3896757|B4|Israel||Region of Enrollment||participants|Number|5|5.0||||||
4074544|NCT01035138|3896758|B3|Israel||Region of Enrollment||participants|Number|2|2.0||||||
4074545|NCT01035138|3896759|B2|Israel||Region of Enrollment||participants|Number|1|1.0||||||
4074546|NCT01035138|3896760|B1|Israel||Region of Enrollment||participants|Number|2|2.0||||||
4074547|NCT01035138|3896757|B4|Chile||Region of Enrollment||participants|Number|3|3.0||||||
4074548|NCT01035138|3896758|B3|Chile||Region of Enrollment||participants|Number|0|0.0||||||
4074549|NCT01035138|3896759|B2|Chile||Region of Enrollment||participants|Number|2|2.0||||||
4074550|NCT01035138|3896760|B1|Chile||Region of Enrollment||participants|Number|1|1.0||||||
4074551|NCT01035138|3896757|B4|Spain||Region of Enrollment||participants|Number|6|6.0||||||
4074552|NCT01035138|3896758|B3|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4074553|NCT01035138|3896759|B2|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4074554|NCT01035138|3896760|B1|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4074555|NCT01035138|3896757|B4|Finland||Region of Enrollment||participants|Number|3|3.0||||||
4074556|NCT01035138|3896758|B3|Finland||Region of Enrollment||participants|Number|0|0.0||||||
4074557|NCT01035138|3896759|B2|Finland||Region of Enrollment||participants|Number|0|0.0||||||
4074558|NCT01035138|3896760|B1|Finland||Region of Enrollment||participants|Number|3|3.0||||||
4074559|NCT01035138|3896757|B4|United States||Region of Enrollment||participants|Number|107|107.0||||||
4074560|NCT01035138|3896758|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
4074561|NCT01035138|3896759|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
4074562|NCT01035138|3896760|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4074563|NCT01035138|3896757|B4|Multi-racial||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4074564|NCT01035138|3896758|B3|Multi-racial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4074565|NCT01035138|3896759|B2|Multi-racial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4074566|NCT01035138|3896760|B1|Multi-racial||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4074567|NCT01035138|3896757|B4|Asian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4074568|NCT01035138|3896758|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4074569|NCT01035138|3896759|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4074570|NCT01035138|3896760|B1|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4074571|NCT01035138|3896757|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4074572|NCT01035138|3896758|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4074573|NCT01035138|3896759|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4074574|NCT01035138|3896760|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4074575|NCT01035138|3896757|B4|White||Race/Ethnicity, Customized||participants|Number|161|161.0||||||
4074576|NCT01035138|3896758|B3|White||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4074577|NCT01035138|3896759|B2|White||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
4074578|NCT01035138|3896760|B1|White||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
4074579|NCT01035138|3896757|B4||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4074580|NCT01035138|3896758|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4074581|NCT01035138|3896759|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4074582|NCT01035138|3896760|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4074583|NCT01035138|3896757|B4||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4074584|NCT01035138|3896758|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4074585|NCT01035138|3896759|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4074586|NCT01035138|3896760|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4074587|NCT01035138|3896757|B4|||Age||years|Mean|73.9|73.9|Standard Deviation|8.7|8.7|||
4074588|NCT01035138|3896758|B3|||Age||years|Mean|74.1|74.1|Standard Deviation|9.5|9.5|||
4074589|NCT01035138|3896759|B2|||Age||years|Mean|73.5|73.5|Standard Deviation|8.7|8.7|||
4074590|NCT01035138|3896760|B1|||Age||years|Mean|74.1|74.1|Standard Deviation|8.3|8.3|||
4074591|NCT01035060|3896816|B3|United States||Region of Enrollment||participants|Number|68|68.0||||||
4074592|NCT01035060|3896817|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4074593|NCT01035060|3896818|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4074594|NCT01035060|3896816|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4074595|NCT01035060|3896817|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4074596|NCT01035060|3896818|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4074597|NCT01035060|3896816|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4074598|NCT01035060|3896817|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4074599|NCT01035060|3896818|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4074600|NCT01035060|3896816|B3||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4074601|NCT01035060|3896817|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4074602|NCT01035060|3896818|B1||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4074603|NCT01035060|3896816|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4074604|NCT01035060|3896817|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4074605|NCT01035060|3896818|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4074606|NCT01035060|3896816|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4074607|NCT01035060|3896817|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4074608|NCT01035060|3896818|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4074609|NCT01035047|3896825|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074610|NCT01035047|3896826|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074611|NCT01035047|3896827|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074612|NCT01035047|3896825|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4074613|NCT01035047|3896826|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074614|NCT01035047|3896827|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4074615|NCT01035047|3896825|B3||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4074616|NCT01035047|3896826|B2||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4074617|NCT01035047|3896827|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4074618|NCT01035047|3896825|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4074619|NCT01035047|3896826|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4074620|NCT01035047|3896827|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4074621|NCT01035047|3896825|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074622|NCT01035047|3896826|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074623|NCT01035047|3896827|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074624|NCT01035047|3896825|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074625|NCT01035047|3896826|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074626|NCT01035047|3896827|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074627|NCT01035047|3896825|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074628|NCT01035047|3896826|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074629|NCT01035047|3896827|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074630|NCT01035047|3896825|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074631|NCT01035047|3896826|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074632|NCT01035047|3896827|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074633|NCT01035047|3896825|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
4074634|NCT01035047|3896826|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4074635|NCT01035047|3896827|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4074636|NCT01035047|3896825|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4074637|NCT01035047|3896826|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074638|NCT01035047|3896827|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4074639|NCT01035047|3896825|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4074640|NCT01035047|3896826|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4074641|NCT01035047|3896827|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4074642|NCT01035047|3896825|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4074643|NCT01035047|3896826|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4074644|NCT01035047|3896827|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4074645|NCT01035047|3896825|B3|||Age||years|Median|56|56.0|Full Range|||35.0|91.0|
4074646|NCT01035047|3896826|B2|||Age||years|Median|59|59.0|Full Range|||40.0|76.0|
4074647|NCT01035047|3896827|B1|||Age||years|Median|54|54.0|Full Range|||35.0|91.0|
4074648|NCT01035047|3896825|B3||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4074649|NCT01035047|3896826|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4074650|NCT01035047|3896827|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4074651|NCT01035047|3896825|B3||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
4074652|NCT01035047|3896826|B2||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4074653|NCT01035047|3896827|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4074654|NCT01035047|3896825|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4074655|NCT01035047|3896826|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4074656|NCT01035047|3896827|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4074657|NCT01034709|3896842|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
4074658|NCT01034709|3896844|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4074659|NCT01034709|3896842|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4074660|NCT01034709|3896844|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4074661|NCT01034709|3896842|B3|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4074662|NCT01034709|3896844|B1|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4074663|NCT01034709|3896842|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4074664|NCT01034709|3896844|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4074665|NCT01034709|3896842|B3|White/Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4074666|NCT01034709|3896844|B1|White/Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4074667|NCT01034709|3896842|B3|White/Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4074668|NCT01034709|3896844|B1|White/Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4074669|NCT01034709|3896842|B3|Black/Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4074670|NCT01034709|3896844|B1|Black/Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4074671|NCT01034709|3896842|B3|Black or African American/ Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4074672|NCT01034709|3896844|B1|Black or African American/ Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4074673|NCT01034709|3896842|B3|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4074674|NCT01034709|3896844|B1|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4074675|NCT01034709|3896842|B3|Male||Gender||participants|Number|25|25.0||||||
4074676|NCT01034709|3896844|B1|Male||Gender||participants|Number|25|25.0||||||
4074677|NCT01034709|3896842|B3|Female||Gender||participants|Number|19|19.0||||||
4074678|NCT01034709|3896844|B1|Female||Gender||participants|Number|19|19.0||||||
4074679|NCT01034709|3896842|B3|||Age||years|Mean|49|49.0|Full Range|||22.0|72.0|
4074680|NCT01034709|3896844|B1|||Age||years|Mean|49|49.0|Full Range|||22.0|72.0|
4074681|NCT01034657|3896851|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4074682|NCT01034657|3896851|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4074683|NCT01034657|3896851|B1|||Age||Years|Mean|65.4|65.4|Standard Deviation|7.70|7.7|||
4074684|NCT01034631|3896891|B4|>=4 Prior Therapies||Number of Prior Therapies||Participants|Count of Participants|56|56.0||||||
4074685|NCT01034631|3896892|B3|>=4 Prior Therapies||Number of Prior Therapies||Participants|Count of Participants|23|23.0||||||
4074686|NCT01034631|3896893|B2|>=4 Prior Therapies||Number of Prior Therapies||Participants|Count of Participants|21|21.0||||||
4074687|NCT01034631|3896894|B1|>=4 Prior Therapies||Number of Prior Therapies||Participants|Count of Participants|12|12.0||||||
4074688|NCT01034631|3896891|B4|3 Prior Therapies||Number of Prior Therapies||Participants|Count of Participants|28|28.0||||||
4074689|NCT01034631|3896892|B3|3 Prior Therapies||Number of Prior Therapies||Participants|Count of Participants|15|15.0||||||
4074690|NCT01034631|3896893|B2|3 Prior Therapies||Number of Prior Therapies||Participants|Count of Participants|10|10.0||||||
4074691|NCT01034631|3896894|B1|3 Prior Therapies||Number of Prior Therapies||Participants|Count of Participants|3|3.0||||||
4074692|NCT01034631|3896891|B4|2 Prior Therapies||Number of Prior Therapies||Participants|Count of Participants|42|42.0||||||
4074693|NCT01034631|3896892|B3|2 Prior Therapies||Number of Prior Therapies||Participants|Count of Participants|18|18.0||||||
4074694|NCT01034631|3896893|B2|2 Prior Therapies||Number of Prior Therapies||Participants|Count of Participants|24|24.0||||||
4074695|NCT01034631|3896894|B1|2 Prior Therapies||Number of Prior Therapies||Participants|Count of Participants|0|0.0||||||
4074696|NCT01034631|3896891|B4|1 Prior Therapy||Number of Prior Therapies||Participants|Count of Participants|27|27.0||||||
4074697|NCT01034631|3896892|B3|1 Prior Therapy||Number of Prior Therapies||Participants|Count of Participants|13|13.0||||||
4074698|NCT01034631|3896893|B2|1 Prior Therapy||Number of Prior Therapies||Participants|Count of Participants|14|14.0||||||
4074699|NCT01034631|3896894|B1|1 Prior Therapy||Number of Prior Therapies||Participants|Count of Participants|0|0.0||||||
4074700|NCT01034631|3896891|B4|Brain||Metastatic Site||Participants|Count of Participants|10|10.0||||||
4074701|NCT01034631|3896892|B3|Brain||Metastatic Site||Participants|Count of Participants|5|5.0||||||
4074702|NCT01034631|3896893|B2|Brain||Metastatic Site||Participants|Count of Participants|3|3.0||||||
4074703|NCT01034631|3896894|B1|Brain||Metastatic Site||Participants|Count of Participants|2|2.0||||||
4074704|NCT01034631|3896891|B4|Bone||Metastatic Site||Participants|Count of Participants|53|53.0||||||
4074705|NCT01034631|3896892|B3|Bone||Metastatic Site||Participants|Count of Participants|24|24.0||||||
4074706|NCT01034631|3896893|B2|Bone||Metastatic Site||Participants|Count of Participants|21|21.0||||||
4074707|NCT01034631|3896894|B1|Bone||Metastatic Site||Participants|Count of Participants|8|8.0||||||
4074708|NCT01034631|3896891|B4|Liver||Metastatic Site||Participants|Count of Participants|32|32.0||||||
4074709|NCT01034631|3896892|B3|Liver||Metastatic Site||Participants|Count of Participants|13|13.0||||||
4074710|NCT01034631|3896893|B2|Liver||Metastatic Site||Participants|Count of Participants|13|13.0||||||
4074711|NCT01034631|3896894|B1|Liver||Metastatic Site||Participants|Count of Participants|6|6.0||||||
4074712|NCT01034631|3896891|B4|Lung||Metastatic Site||Participants|Count of Participants|124|124.0||||||
4074713|NCT01034631|3896892|B3|Lung||Metastatic Site||Participants|Count of Participants|54|54.0||||||
4074714|NCT01034631|3896893|B2|Lung||Metastatic Site||Participants|Count of Participants|57|57.0||||||
4074715|NCT01034631|3896894|B1|Lung||Metastatic Site||Participants|Count of Participants|13|13.0||||||
4074716|NCT01034631|3896891|B4|MSKCC Risk Group - Poor||Memorial Sloan Kettering Cancer Center Risk Group (MSKCC||Participants|Count of Participants|14|14.0||||||
4074717|NCT01034631|3896892|B3|MSKCC Risk Group - Poor||Memorial Sloan Kettering Cancer Center Risk Group (MSKCC||Participants|Count of Participants|6|6.0||||||
4074718|NCT01034631|3896893|B2|MSKCC Risk Group - Poor||Memorial Sloan Kettering Cancer Center Risk Group (MSKCC||Participants|Count of Participants|7|7.0||||||
4074719|NCT01034631|3896894|B1|MSKCC Risk Group - Poor||Memorial Sloan Kettering Cancer Center Risk Group (MSKCC||Participants|Count of Participants|1|1.0||||||
4074720|NCT01034631|3896891|B4|MSKCC Risk Group - Intermediate||Memorial Sloan Kettering Cancer Center Risk Group (MSKCC||Participants|Count of Participants|103|103.0||||||
4074721|NCT01034631|3896892|B3|MSKCC Risk Group - Intermediate||Memorial Sloan Kettering Cancer Center Risk Group (MSKCC||Participants|Count of Participants|47|47.0||||||
4074722|NCT01034631|3896893|B2|MSKCC Risk Group - Intermediate||Memorial Sloan Kettering Cancer Center Risk Group (MSKCC||Participants|Count of Participants|45|45.0||||||
4074723|NCT01034631|3896894|B1|MSKCC Risk Group - Intermediate||Memorial Sloan Kettering Cancer Center Risk Group (MSKCC||Participants|Count of Participants|11|11.0||||||
4074724|NCT01034631|3896891|B4|MSKCC Risk Group - Good||Memorial Sloan Kettering Cancer Center Risk Group (MSKCC||Participants|Count of Participants|36|36.0||||||
4074725|NCT01034631|3896892|B3|MSKCC Risk Group - Good||Memorial Sloan Kettering Cancer Center Risk Group (MSKCC||Participants|Count of Participants|16|16.0||||||
4074726|NCT01034631|3896893|B2|MSKCC Risk Group - Good||Memorial Sloan Kettering Cancer Center Risk Group (MSKCC||Participants|Count of Participants|17|17.0||||||
4074727|NCT01034631|3896894|B1|MSKCC Risk Group - Good||Memorial Sloan Kettering Cancer Center Risk Group (MSKCC||Participants|Count of Participants|3|3.0||||||
4074728|NCT01034631|3896891|B4||KPS 70|Initial Karnovksy Performance Score (KPS)|Karnofsky Performance Status (KPS) is a general indicator of a subject's well being and ability to carry on daily activities. The KPS scale ranges from 0-100 in 10 unit increments where 100=Normal; no complaints; no evidence of disease and 0=Dead|Participants|Count of Participants|13|13.0||||||
4074729|NCT01034631|3896892|B3||KPS 70|Initial Karnovksy Performance Score (KPS)|Karnofsky Performance Status (KPS) is a general indicator of a subject's well being and ability to carry on daily activities. The KPS scale ranges from 0-100 in 10 unit increments where 100=Normal; no complaints; no evidence of disease and 0=Dead|Participants|Count of Participants|5|5.0||||||
4074730|NCT01034631|3896893|B2||KPS 70|Initial Karnovksy Performance Score (KPS)|Karnofsky Performance Status (KPS) is a general indicator of a subject's well being and ability to carry on daily activities. The KPS scale ranges from 0-100 in 10 unit increments where 100=Normal; no complaints; no evidence of disease and 0=Dead|Participants|Count of Participants|4|4.0||||||
4074731|NCT01034631|3896894|B1||KPS 70|Initial Karnovksy Performance Score (KPS)|Karnofsky Performance Status (KPS) is a general indicator of a subject's well being and ability to carry on daily activities. The KPS scale ranges from 0-100 in 10 unit increments where 100=Normal; no complaints; no evidence of disease and 0=Dead|Participants|Count of Participants|4|4.0||||||
4074732|NCT01034631|3896891|B4||KPS 80|Initial Karnovksy Performance Score (KPS)|Karnofsky Performance Status (KPS) is a general indicator of a subject's well being and ability to carry on daily activities. The KPS scale ranges from 0-100 in 10 unit increments where 100=Normal; no complaints; no evidence of disease and 0=Dead|Participants|Count of Participants|30|30.0||||||
4074733|NCT01034631|3896892|B3||KPS 80|Initial Karnovksy Performance Score (KPS)|Karnofsky Performance Status (KPS) is a general indicator of a subject's well being and ability to carry on daily activities. The KPS scale ranges from 0-100 in 10 unit increments where 100=Normal; no complaints; no evidence of disease and 0=Dead|Participants|Count of Participants|15|15.0||||||
4074734|NCT01034631|3896893|B2||KPS 80|Initial Karnovksy Performance Score (KPS)|Karnofsky Performance Status (KPS) is a general indicator of a subject's well being and ability to carry on daily activities. The KPS scale ranges from 0-100 in 10 unit increments where 100=Normal; no complaints; no evidence of disease and 0=Dead|Participants|Count of Participants|13|13.0||||||
4074735|NCT01034631|3896894|B1||KPS 80|Initial Karnovksy Performance Score (KPS)|Karnofsky Performance Status (KPS) is a general indicator of a subject's well being and ability to carry on daily activities. The KPS scale ranges from 0-100 in 10 unit increments where 100=Normal; no complaints; no evidence of disease and 0=Dead|Participants|Count of Participants|2|2.0||||||
4074736|NCT01034631|3896891|B4||KPS 90|Initial Karnovksy Performance Score (KPS)|Karnofsky Performance Status (KPS) is a general indicator of a subject's well being and ability to carry on daily activities. The KPS scale ranges from 0-100 in 10 unit increments where 100=Normal; no complaints; no evidence of disease and 0=Dead|Participants|Count of Participants|56|56.0||||||
4074737|NCT01034631|3896892|B3||KPS 90|Initial Karnovksy Performance Score (KPS)|Karnofsky Performance Status (KPS) is a general indicator of a subject's well being and ability to carry on daily activities. The KPS scale ranges from 0-100 in 10 unit increments where 100=Normal; no complaints; no evidence of disease and 0=Dead|Participants|Count of Participants|24|24.0||||||
4074738|NCT01034631|3896893|B2||KPS 90|Initial Karnovksy Performance Score (KPS)|Karnofsky Performance Status (KPS) is a general indicator of a subject's well being and ability to carry on daily activities. The KPS scale ranges from 0-100 in 10 unit increments where 100=Normal; no complaints; no evidence of disease and 0=Dead|Participants|Count of Participants|23|23.0||||||
4074739|NCT01034631|3896894|B1||KPS 90|Initial Karnovksy Performance Score (KPS)|Karnofsky Performance Status (KPS) is a general indicator of a subject's well being and ability to carry on daily activities. The KPS scale ranges from 0-100 in 10 unit increments where 100=Normal; no complaints; no evidence of disease and 0=Dead|Participants|Count of Participants|9|9.0||||||
4074740|NCT01034631|3896891|B4||KPS 100|Initial Karnovksy Performance Score (KPS)|Karnofsky Performance Status (KPS) is a general indicator of a subject's well being and ability to carry on daily activities. The KPS scale ranges from 0-100 in 10 unit increments where 100=Normal; no complaints; no evidence of disease and 0=Dead|Participants|Count of Participants|54|54.0||||||
4074741|NCT01034631|3896892|B3||KPS 100|Initial Karnovksy Performance Score (KPS)|Karnofsky Performance Status (KPS) is a general indicator of a subject's well being and ability to carry on daily activities. The KPS scale ranges from 0-100 in 10 unit increments where 100=Normal; no complaints; no evidence of disease and 0=Dead|Participants|Count of Participants|25|25.0||||||
4074796|NCT01034592|3896915|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4074797|NCT01034592|3896915|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4074742|NCT01034631|3896893|B2||KPS 100|Initial Karnovksy Performance Score (KPS)|Karnofsky Performance Status (KPS) is a general indicator of a subject's well being and ability to carry on daily activities. The KPS scale ranges from 0-100 in 10 unit increments where 100=Normal; no complaints; no evidence of disease and 0=Dead|Participants|Count of Participants|29|29.0||||||
4074743|NCT01034631|3896894|B1||KPS 100|Initial Karnovksy Performance Score (KPS)|Karnofsky Performance Status (KPS) is a general indicator of a subject's well being and ability to carry on daily activities. The KPS scale ranges from 0-100 in 10 unit increments where 100=Normal; no complaints; no evidence of disease and 0=Dead|Participants|Count of Participants|0|0.0||||||
4074744|NCT01034631|3896891|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4074745|NCT01034631|3896892|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074746|NCT01034631|3896893|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4074747|NCT01034631|3896894|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074748|NCT01034631|3896891|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074749|NCT01034631|3896892|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074750|NCT01034631|3896893|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074751|NCT01034631|3896894|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074752|NCT01034631|3896891|B4||White|Race (NIH/OMB)||Participants|Count of Participants|133|133.0||||||
4074753|NCT01034631|3896892|B3||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4074754|NCT01034631|3896893|B2||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4074755|NCT01034631|3896894|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4074756|NCT01034631|3896891|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4074757|NCT01034631|3896892|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4074758|NCT01034631|3896893|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4074759|NCT01034631|3896894|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4074760|NCT01034631|3896891|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074761|NCT01034631|3896892|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074762|NCT01034631|3896893|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074763|NCT01034631|3896894|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074764|NCT01034631|3896891|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4074765|NCT01034631|3896892|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4074766|NCT01034631|3896893|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4074767|NCT01034631|3896894|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074768|NCT01034631|3896891|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4074769|NCT01034631|3896892|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4074770|NCT01034631|3896893|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074771|NCT01034631|3896894|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074772|NCT01034631|3896891|B4||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4074773|NCT01034631|3896892|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4074774|NCT01034631|3896893|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4074775|NCT01034631|3896894|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4074776|NCT01034631|3896891|B4||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4074777|NCT01034631|3896892|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4074778|NCT01034631|3896893|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4074779|NCT01034631|3896894|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4074780|NCT01034631|3896891|B4|||Age||years|Mean|62|62.0|Standard Deviation|9|9.0|||
4074781|NCT01034631|3896892|B3|||Age||years|Mean|63|63.0|Standard Deviation|9|9.0|||
4074782|NCT01034631|3896893|B2|||Age||years|Mean|62|62.0|Standard Deviation|9|9.0|||
4074783|NCT01034631|3896894|B1|||Age||years|Mean|58|58.0|Standard Deviation|9|9.0|||
4074784|NCT01034592|3896915|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4074785|NCT01034592|3896915|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074786|NCT01034592|3896915|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074787|NCT01034592|3896915|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4074788|NCT01034592|3896915|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074789|NCT01034592|3896915|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074790|NCT01034592|3896915|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074791|NCT01034592|3896915|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074792|NCT01034592|3896915|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074793|NCT01034592|3896915|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4074794|NCT01034592|3896915|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4074795|NCT01034592|3896915|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4074798|NCT01034592|3896915|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4074799|NCT01034592|3896915|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4074800|NCT01034579|3896925|B3||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4074801|NCT01034579|3896926|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4074802|NCT01034579|3896927|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4074803|NCT01034579|3896925|B3||Female|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4074804|NCT01034579|3896926|B2||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4074805|NCT01034579|3896927|B1||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4074806|NCT01034579|3896925|B3|||Age||years|Mean|36.9|36.9|Standard Deviation|9.5|9.5|||
4074807|NCT01034579|3896926|B2|||Age||years|Mean|37.4|37.4|Standard Deviation|9.5|9.5|||
4074808|NCT01034579|3896927|B1|||Age||years|Mean|36.4|36.4|Standard Deviation|9.5|9.5|||
4074809|NCT01034553|3896942|B1|||Previous treatment|Previous treatment for this study is defined as any prior therapy given to the patient for treatment of Myeloma.|participants|Number|26|26.0||||||
4074810|NCT01034553|3896942|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4074811|NCT01034553|3896942|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4074812|NCT01034553|3896942|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4074813|NCT01034553|3896942|B1|||Age||years|Median|64.5|64.5|Full Range|||46.0|79.0|
4074814|NCT01034540|3896961|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4074815|NCT01034540|3896962|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4074816|NCT01034540|3896963|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4074817|NCT01034540|3896961|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4074818|NCT01034540|3896962|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4074819|NCT01034540|3896963|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4074820|NCT01034540|3896961|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4074821|NCT01034540|3896962|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4074822|NCT01034540|3896963|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4074823|NCT01034540|3896961|B3|||Age||years|Mean|54.2|54.2|Standard Deviation|2.8|2.8|||
4074824|NCT01034540|3896962|B2|||Age||years|Mean|60.0|60.0|Standard Deviation|1.7|1.7|||
4074825|NCT01034540|3896963|B1|||Age||years|Mean|47.9|47.9|Standard Deviation|5.0|5.0|||
4074826|NCT01034540|3896961|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4074827|NCT01034540|3896962|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4074828|NCT01034540|3896963|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4074829|NCT01034540|3896961|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4074830|NCT01034540|3896962|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4074831|NCT01034540|3896963|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4074832|NCT01034540|3896961|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4074833|NCT01034540|3896962|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4074834|NCT01034540|3896963|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4074835|NCT01034462|3896972|B3|||Body Mass Index (BMI)||Kilograms Per Meter Squared|Mean|29.40|29.4|Standard Deviation|5.37|5.37|||
4074836|NCT01034462|3896973|B2|||Body Mass Index (BMI)||Kilograms Per Meter Squared|Mean|29.20|29.2|Standard Deviation|5.45|5.45|||
4074837|NCT01034462|3896974|B1|||Body Mass Index (BMI)||Kilograms Per Meter Squared|Mean|29.60|29.6|Standard Deviation|5.30|5.3|||
4074838|NCT01034462|3896972|B3|||Weight||kg|Mean|84.52|84.52|Standard Deviation|18.55|18.55|||
4074839|NCT01034462|3896973|B2|||Weight||kg|Mean|84.47|84.47|Standard Deviation|18.98|18.98|||
4074840|NCT01034462|3896974|B1|||Weight||kg|Mean|84.58|84.58|Standard Deviation|18.15|18.15|||
4074841|NCT01034462|3896972|B3|United States||Region of Enrollment||participants|Number|434|434.0||||||
4074842|NCT01034462|3896973|B2|United States||Region of Enrollment||participants|Number|217|217.0||||||
4074843|NCT01034462|3896974|B1|United States||Region of Enrollment||participants|Number|217|217.0||||||
4074844|NCT01034462|3896972|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|396|396.0||||||
4074845|NCT01034462|3896973|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|196|196.0||||||
4074846|NCT01034462|3896974|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|200|200.0||||||
4074847|NCT01034462|3896972|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4074848|NCT01034462|3896973|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4074849|NCT01034462|3896974|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4074850|NCT01034462|3896972|B3|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4074851|NCT01034462|3896973|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4074852|NCT01034462|3896974|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4074853|NCT01034462|3896972|B3|American Indian or Alaska native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4074854|NCT01034462|3896973|B2|American Indian or Alaska native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4074855|NCT01034462|3896974|B1|American Indian or Alaska native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4074856|NCT01034462|3896972|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4074857|NCT01034462|3896973|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4074858|NCT01034462|3896974|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4074859|NCT01034462|3896972|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
4074860|NCT01034462|3896973|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4074861|NCT01034462|3896974|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4074862|NCT01034462|3896972|B3|White||Race/Ethnicity, Customized||participants|Number|359|359.0||||||
4074863|NCT01034462|3896973|B2|White||Race/Ethnicity, Customized||participants|Number|177|177.0||||||
4074864|NCT01034462|3896974|B1|White||Race/Ethnicity, Customized||participants|Number|182|182.0||||||
4074865|NCT01034462|3896972|B3||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4074866|NCT01034462|3896973|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4074867|NCT01034462|3896974|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4074868|NCT01034462|3896972|B3||Female|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
4074869|NCT01034462|3896973|B2||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4074870|NCT01034462|3896974|B1||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4074871|NCT01034462|3896972|B3|60 years to 80 years||Age, Customized||participants|Number|61|61.0||||||
4074872|NCT01034462|3896973|B2|60 years to 80 years||Age, Customized||participants|Number|29|29.0||||||
4074873|NCT01034462|3896974|B1|60 years to 80 years||Age, Customized||participants|Number|32|32.0||||||
4074874|NCT01034462|3896972|B3|50 years to 59 years||Age, Customized||participants|Number|125|125.0||||||
4074875|NCT01034462|3896973|B2|50 years to 59 years||Age, Customized||participants|Number|68|68.0||||||
4074876|NCT01034462|3896974|B1|50 years to 59 years||Age, Customized||participants|Number|57|57.0||||||
4074877|NCT01034462|3896972|B3|40 years to 49 years||Age, Customized||participants|Number|91|91.0||||||
4074878|NCT01034462|3896973|B2|40 years to 49 years||Age, Customized||participants|Number|40|40.0||||||
4074879|NCT01034462|3896974|B1|40 years to 49 years||Age, Customized||participants|Number|51|51.0||||||
4074880|NCT01034462|3896972|B3|30 years to 39 years||Age, Customized||participants|Number|81|81.0||||||
4074881|NCT01034462|3896973|B2|30 years to 39 years||Age, Customized||participants|Number|44|44.0||||||
4074882|NCT01034462|3896974|B1|30 years to 39 years||Age, Customized||participants|Number|37|37.0||||||
4074883|NCT01034462|3896972|B3|20 years to 29 years||Age, Customized||participants|Number|72|72.0||||||
4074884|NCT01034462|3896973|B2|20 years to 29 years||Age, Customized||participants|Number|34|34.0||||||
4074885|NCT01034462|3896974|B1|20 years to 29 years||Age, Customized||participants|Number|38|38.0||||||
4074886|NCT01034462|3896972|B3|18 years to 19 years||Age, Customized||participants|Number|4|4.0||||||
4074887|NCT01034462|3896973|B2|18 years to 19 years||Age, Customized||participants|Number|2|2.0||||||
4074888|NCT01034462|3896974|B1|18 years to 19 years||Age, Customized||participants|Number|2|2.0||||||
4074889|NCT01034462|3896972|B3|||Age||years|Mean|44.8|44.8|Standard Deviation|13.5|13.5|||
4074890|NCT01034462|3896973|B2|||Age||years|Mean|45.0|45.0|Standard Deviation|13.2|13.2|||
4074891|NCT01034462|3896974|B1|||Age||years|Mean|44.6|44.6|Standard Deviation|13.9|13.9|||
4074892|NCT01034397|3896983|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4074893|NCT01034397|3896984|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4074894|NCT01034397|3896985|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4074895|NCT01034397|3896983|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4074896|NCT01034397|3896984|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4074897|NCT01034397|3896985|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4074898|NCT01034397|3896983|B3|||Age||years|Median|54|54.0|Full Range|||28.0|79.0|
4074899|NCT01034397|3896984|B2|||Age||years|Median|54|54.0|Full Range|||28.0|79.0|
4074900|NCT01034397|3896985|B1|||Age||years|Median|54|54.0|Full Range|||45.0|69.0|
4074901|NCT01034358|3897135|B1|Active||Disease Activity at First HPV vaccine dose|Participants were categorized as either having quiescent (inactivity or dormancy) or active disease activity at baseline, prior to first HPV vaccine dose.|participants|Number|6|6.0||||||
4074902|NCT01034358|3897135|B1|Quiescent||Disease Activity at First HPV vaccine dose|Participants were categorized as either having quiescent (inactivity or dormancy) or active disease activity at baseline, prior to first HPV vaccine dose.|participants|Number|9|9.0||||||
4074903|NCT01034358|3897135|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4074904|NCT01034358|3897135|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4074905|NCT01034358|3897135|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4074906|NCT01034358|3897135|B1|||Age||years|Mean|19.3|19.3|Standard Deviation|3.68|3.68|||
4074907|NCT01034358|3897135|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4074908|NCT01034358|3897135|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4074909|NCT01034358|3897135|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4074910|NCT01034306|3897139|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4074911|NCT01034306|3897140|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4074912|NCT01034306|3897141|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4074913|NCT01034306|3897139|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4074914|NCT01034306|3897140|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4074915|NCT01034306|3897141|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4074916|NCT01034306|3897139|B3|||Age||years|Mean|59|59.0|Standard Deviation|8.92|8.92|||
4074917|NCT01034306|3897140|B2|||Age||years|Mean|61.7|61.7|Standard Deviation|6.89|6.89|||
4074918|NCT01034306|3897141|B1|||Age||years|Mean|56.7|56.7|Standard Deviation|9.87|9.87|||
4074919|NCT01034176|3897148|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
4074920|NCT01034176|3897149|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4074921|NCT01034176|3897150|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4074922|NCT01034176|3897148|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4074923|NCT01034176|3897149|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4074924|NCT01034176|3897150|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4074925|NCT01034176|3897148|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4074926|NCT01034176|3897149|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4074927|NCT01034176|3897150|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4074928|NCT01034176|3897148|B3|Age at time of consent||Age|Age at time of consent|years|Mean|55.36|55.36|Full Range|||25.0|74.0|
4074929|NCT01034176|3897149|B2|Age at time of consent||Age|Age at time of consent|years|Mean|54.9|54.9|Full Range|||25.0|70.0|
4074930|NCT01034176|3897150|B1|Age at time of consent||Age|Age at time of consent|years|Mean|56.22|56.22|Full Range|||32.0|74.0|
4074931|NCT01034163|3897159|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4074932|NCT01034163|3897160|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4074933|NCT01034163|3897161|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4074934|NCT01034163|3897159|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4074935|NCT01034163|3897160|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4074936|NCT01034163|3897161|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4074937|NCT01034163|3897159|B3|||Age||Years|Mean|32.9|32.9|Standard Deviation|10.66|10.66|||
4074938|NCT01034163|3897160|B2|||Age||Years|Mean|30.6|30.6|Standard Deviation|10.56|10.56|||
4074939|NCT01034163|3897161|B1|||Age||Years|Mean|34.0|34.0|Standard Deviation|10.72|10.72|||
4074940|NCT01034137|3897168|B4||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4074941|NCT01034137|3897169|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4074942|NCT01034137|3897170|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4074943|NCT01034137|3897171|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4074944|NCT01034137|3897168|B4||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4074945|NCT01034137|3897169|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4074946|NCT01034137|3897170|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4074947|NCT01034137|3897171|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4074948|NCT01034137|3897168|B4|||Age||years|Mean|53.4|53.4|Standard Deviation|12.8|12.8|||
4074949|NCT01034137|3897169|B3|||Age||years|Mean|52.2|52.2|Standard Deviation|13.7|13.7|||
4074950|NCT01034137|3897170|B2|||Age||years|Mean|55.0|55.0|Standard Deviation|12.9|12.9|||
4074951|NCT01034137|3897171|B1|||Age||years|Mean|53.1|53.1|Standard Deviation|11.8|11.8|||
4074952|NCT01034137|3897168|B4||>=65 years|Age||Participants|Count of Participants|66|66.0||||||
4074953|NCT01034137|3897169|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4074954|NCT01034137|3897170|B2||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4074955|NCT01034137|3897171|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4074956|NCT01034137|3897168|B4||Between 18 and 65 years|Age||Participants|Count of Participants|251|251.0||||||
4074957|NCT01034137|3897169|B3||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
4074958|NCT01034137|3897170|B2||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
4074959|NCT01034137|3897171|B1||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
4074960|NCT01034137|3897168|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4074961|NCT01034137|3897169|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4074962|NCT01034137|3897170|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4074963|NCT01034137|3897171|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4074964|NCT01034111|3897304|B1|||Baseline Fasting Plasma Glucose||mmol/L|Mean|8.9|8.9|Standard Deviation|1.5|1.5|||
4074965|NCT01034111|3897304|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4074966|NCT01034111|3897304|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4074967|NCT01034111|3897304|B1|>= 60 years||Age, Customized||Participants|Number|10|10.0||||||
4074968|NCT01034111|3897304|B1|51 to 60 years||Age, Customized||Participants|Number|7|7.0||||||
4074969|NCT01034111|3897304|B1|41 to 50 years||Age, Customized||Participants|Number|8|8.0||||||
4074970|NCT01034111|3897304|B1|<= 40 years||Age, Customized||Participants|Number|5|5.0||||||
4074971|NCT01033942|3897309|B4|No||Unprotected Anal or Vaginal Sex with Woman||participants|Number|55|55.0||||||
4074972|NCT01033942|3897310|B3|No||Unprotected Anal or Vaginal Sex with Woman||participants|Number|18|18.0||||||
4074973|NCT01033942|3897311|B2|No||Unprotected Anal or Vaginal Sex with Woman||participants|Number|17|17.0||||||
4074974|NCT01033942|3897312|B1|No||Unprotected Anal or Vaginal Sex with Woman||participants|Number|20|20.0||||||
4074975|NCT01033942|3897309|B4|Yes||Unprotected Anal or Vaginal Sex with Woman||participants|Number|3|3.0||||||
4074976|NCT01033942|3897310|B3|Yes||Unprotected Anal or Vaginal Sex with Woman||participants|Number|1|1.0||||||
4074977|NCT01033942|3897311|B2|Yes||Unprotected Anal or Vaginal Sex with Woman||participants|Number|2|2.0||||||
4074978|NCT01033942|3897312|B1|Yes||Unprotected Anal or Vaginal Sex with Woman||participants|Number|0|0.0||||||
4074979|NCT01033942|3897309|B4|No||Unprotected Anal Sex with Man in Past 30 Days||participants|Number|34|34.0||||||
4074980|NCT01033942|3897310|B3|No||Unprotected Anal Sex with Man in Past 30 Days||participants|Number|11|11.0||||||
4074981|NCT01033942|3897311|B2|No||Unprotected Anal Sex with Man in Past 30 Days||participants|Number|12|12.0||||||
4074982|NCT01033942|3897312|B1|No||Unprotected Anal Sex with Man in Past 30 Days||participants|Number|11|11.0||||||
4074983|NCT01033942|3897309|B4|Yes||Unprotected Anal Sex with Man in Past 30 Days||participants|Number|24|24.0||||||
4074984|NCT01033942|3897310|B3|Yes||Unprotected Anal Sex with Man in Past 30 Days||participants|Number|8|8.0||||||
4074985|NCT01033942|3897311|B2|Yes||Unprotected Anal Sex with Man in Past 30 Days||participants|Number|7|7.0||||||
4074986|NCT01033942|3897312|B1|Yes||Unprotected Anal Sex with Man in Past 30 Days||participants|Number|9|9.0||||||
4074987|NCT01033942|3897309|B4|Have Exchanged Sex for Money or Place to Stay||Housing Experience (Responded YES)|Not all participants answered every question|participants|Number|10|10.0||||||
4074988|NCT01033942|3897310|B3|Have Exchanged Sex for Money or Place to Stay||Housing Experience (Responded YES)|Not all participants answered every question|participants|Number|5|5.0||||||
4074989|NCT01033942|3897311|B2|Have Exchanged Sex for Money or Place to Stay||Housing Experience (Responded YES)|Not all participants answered every question|participants|Number|3|3.0||||||
4074990|NCT01033942|3897312|B1|Have Exchanged Sex for Money or Place to Stay||Housing Experience (Responded YES)|Not all participants answered every question|participants|Number|2|2.0||||||
4074991|NCT01033942|3897309|B4|Spent at least 1 Night in Shelter S||Housing Experience (Responded YES)|Not all participants answered every question|participants|Number|19|19.0||||||
4074992|NCT01033942|3897310|B3|Spent at least 1 Night in Shelter S||Housing Experience (Responded YES)|Not all participants answered every question|participants|Number|8|8.0||||||
4074993|NCT01033942|3897311|B2|Spent at least 1 Night in Shelter S||Housing Experience (Responded YES)|Not all participants answered every question|participants|Number|6|6.0||||||
4074994|NCT01033942|3897312|B1|Spent at least 1 Night in Shelter S||Housing Experience (Responded YES)|Not all participants answered every question|participants|Number|5|5.0||||||
4074995|NCT01033942|3897309|B4|Kicked out of House Due to Sexual Orientation||Housing Experience (Responded YES)|Not all participants answered every question|participants|Number|9|9.0||||||
4074996|NCT01033942|3897310|B3|Kicked out of House Due to Sexual Orientation||Housing Experience (Responded YES)|Not all participants answered every question|participants|Number|3|3.0||||||
4074997|NCT01033942|3897311|B2|Kicked out of House Due to Sexual Orientation||Housing Experience (Responded YES)|Not all participants answered every question|participants|Number|2|2.0||||||
4074998|NCT01033942|3897312|B1|Kicked out of House Due to Sexual Orientation||Housing Experience (Responded YES)|Not all participants answered every question|participants|Number|4|4.0||||||
4074999|NCT01033942|3897309|B4|Part Time||Current Employment||participants|Number|20|20.0||||||
4075000|NCT01033942|3897310|B3|Part Time||Current Employment||participants|Number|8|8.0||||||
4075001|NCT01033942|3897311|B2|Part Time||Current Employment||participants|Number|6|6.0||||||
4075002|NCT01033942|3897312|B1|Part Time||Current Employment||participants|Number|6|6.0||||||
4075003|NCT01033942|3897309|B4|Full Time||Current Employment||participants|Number|6|6.0||||||
4075004|NCT01033942|3897310|B3|Full Time||Current Employment||participants|Number|2|2.0||||||
4075005|NCT01033942|3897311|B2|Full Time||Current Employment||participants|Number|2|2.0||||||
4075006|NCT01033942|3897312|B1|Full Time||Current Employment||participants|Number|2|2.0||||||
4075007|NCT01033942|3897309|B4|Unemployed||Current Employment||participants|Number|32|32.0||||||
4075008|NCT01033942|3897310|B3|Unemployed||Current Employment||participants|Number|9|9.0||||||
4075009|NCT01033942|3897311|B2|Unemployed||Current Employment||participants|Number|11|11.0||||||
4075010|NCT01033942|3897312|B1|Unemployed||Current Employment||participants|Number|12|12.0||||||
4075011|NCT01033942|3897309|B4|Some College||Education|Not all participants answered every question.|participants|Number|30|30.0||||||
4075012|NCT01033942|3897310|B3|Some College||Education|Not all participants answered every question.|participants|Number|8|8.0||||||
4075013|NCT01033942|3897311|B2|Some College||Education|Not all participants answered every question.|participants|Number|14|14.0||||||
4075014|NCT01033942|3897312|B1|Some College||Education|Not all participants answered every question.|participants|Number|8|8.0||||||
4075015|NCT01033942|3897309|B4|Highschool Diploma||Education|Not all participants answered every question.|participants|Number|18|18.0||||||
4075016|NCT01033942|3897310|B3|Highschool Diploma||Education|Not all participants answered every question.|participants|Number|5|5.0||||||
4075017|NCT01033942|3897311|B2|Highschool Diploma||Education|Not all participants answered every question.|participants|Number|3|3.0||||||
4075018|NCT01033942|3897312|B1|Highschool Diploma||Education|Not all participants answered every question.|participants|Number|10|10.0||||||
4075019|NCT01033942|3897309|B4|GED||Education|Not all participants answered every question.|participants|Number|2|2.0||||||
4075020|NCT01033942|3897310|B3|GED||Education|Not all participants answered every question.|participants|Number|1|1.0||||||
4075021|NCT01033942|3897311|B2|GED||Education|Not all participants answered every question.|participants|Number|1|1.0||||||
4075022|NCT01033942|3897312|B1|GED||Education|Not all participants answered every question.|participants|Number|0|0.0||||||
4075023|NCT01033942|3897309|B4|Eighth Grade of Less||Education|Not all participants answered every question.|participants|Number|1|1.0||||||
4075024|NCT01033942|3897310|B3|Eighth Grade of Less||Education|Not all participants answered every question.|participants|Number|1|1.0||||||
4075025|NCT01033942|3897311|B2|Eighth Grade of Less||Education|Not all participants answered every question.|participants|Number|0|0.0||||||
4075026|NCT01033942|3897312|B1|Eighth Grade of Less||Education|Not all participants answered every question.|participants|Number|0|0.0||||||
4075027|NCT01033942|3897309|B4|United States||Region of Enrollment||participants|Number|58|58.0||||||
4075028|NCT01033942|3897310|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4075029|NCT01033942|3897311|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4075030|NCT01033942|3897312|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4075031|NCT01033942|3897309|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4075032|NCT01033942|3897310|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4075033|NCT01033942|3897311|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4075034|NCT01033942|3897312|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4075035|NCT01033942|3897309|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4075036|NCT01033942|3897310|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4075037|NCT01033942|3897311|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4075038|NCT01033942|3897312|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4075039|NCT01033942|3897309|B4||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4075040|NCT01033942|3897310|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4075041|NCT01033942|3897311|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4075042|NCT01033942|3897312|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4075043|NCT01033942|3897309|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4075044|NCT01033942|3897310|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4075045|NCT01033942|3897311|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4075046|NCT01033942|3897312|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4075047|NCT01033942|3897309|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4075048|NCT01033942|3897310|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4075049|NCT01033942|3897311|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4075050|NCT01033942|3897312|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4075051|NCT01033942|3897309|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4075052|NCT01033942|3897310|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4075053|NCT01033942|3897311|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4075054|NCT01033942|3897312|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4075055|NCT01033942|3897309|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4075056|NCT01033942|3897310|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4075057|NCT01033942|3897311|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4075058|NCT01033942|3897312|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4075059|NCT01033942|3897309|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4075060|NCT01033942|3897310|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4075061|NCT01033942|3897311|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4075062|NCT01033942|3897312|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4075063|NCT01033942|3897309|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4075064|NCT01033942|3897310|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4075065|NCT01033942|3897311|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4075066|NCT01033942|3897312|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4075067|NCT01033942|3897309|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4075068|NCT01033942|3897310|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4075069|NCT01033942|3897311|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4075070|NCT01033942|3897312|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4075071|NCT01033942|3897309|B4||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4075072|NCT01033942|3897310|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4075073|NCT01033942|3897311|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4075074|NCT01033942|3897312|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4075075|NCT01033942|3897309|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4075076|NCT01033942|3897310|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4075077|NCT01033942|3897311|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4075078|NCT01033942|3897312|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4075079|NCT01033942|3897309|B4|||Age||years|Mean|19.97|19.97|Standard Deviation|1.30|1.3|||
4075080|NCT01033942|3897310|B3|||Age||years|Mean|19.84|19.84|Standard Deviation|0.96|0.96|||
4075081|NCT01033942|3897311|B2|||Age||years|Mean|20.26|20.26|Standard Deviation|1.45|1.45|||
4075082|NCT01033942|3897312|B1|||Age||years|Mean|19.8|19.8|Standard Deviation|1.44|1.44|||
4075083|NCT01033864|3897584|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4075084|NCT01033864|3897585|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4075085|NCT01033864|3897586|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4075086|NCT01033864|3897584|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4075087|NCT01033864|3897585|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4075088|NCT01033864|3897586|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4075089|NCT01033864|3897584|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|9.68|9.68|0.0|0.0|
4075090|NCT01033864|3897585|B2|||Age||years|Mean|58.0|58.0|Standard Deviation|8.04|8.04|49.0|74.0|
4075091|NCT01033864|3897586|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|11.06|11.06|42.0|76.0|
4075092|NCT01033851|3897610|B3|United States||Region of Enrollment||participants|Number|89|89.0||||||
4075093|NCT01033851|3897611|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
4075094|NCT01033851|3897612|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4075095|NCT01033851|3897610|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4075096|NCT01033851|3897611|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4075097|NCT01033851|3897612|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4075098|NCT01033851|3897610|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4075099|NCT01033851|3897611|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4075100|NCT01033851|3897612|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4075101|NCT01033851|3897610|B3|||Age||years|Mean|39|39.0|Standard Deviation|13|13.0|||
4075102|NCT01033851|3897611|B2|||Age||years|Mean|37|37.0|Standard Deviation|12|12.0|||
4075103|NCT01033851|3897612|B1|||Age||years|Mean|41|41.0|Standard Deviation|14|14.0|||
4075104|NCT01033851|3897610|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4075105|NCT01033851|3897611|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4075106|NCT01033851|3897612|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4075107|NCT01033851|3897610|B3||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
4075108|NCT01033851|3897611|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4075109|NCT01033851|3897612|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4075110|NCT01033851|3897610|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4075111|NCT01033851|3897611|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4075112|NCT01033851|3897612|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4075113|NCT01033825|3897621|B8|Multiple||Race/Ethnicity, customized||particpants|Number|3|3.0||||||
4075114|NCT01033825|3897622|B7|Multiple||Race/Ethnicity, customized||particpants|Number|1|1.0||||||
4075115|NCT01033825|3897623|B6|Multiple||Race/Ethnicity, customized||particpants|Number|1|1.0||||||
4075116|NCT01033825|3897624|B5|Multiple||Race/Ethnicity, customized||particpants|Number|0|0.0||||||
4075117|NCT01033825|3897625|B4|Multiple||Race/Ethnicity, customized||particpants|Number|1|1.0||||||
4075118|NCT01033825|3897626|B3|Multiple||Race/Ethnicity, customized||particpants|Number|0|0.0||||||
4075119|NCT01033825|3897627|B2|Multiple||Race/Ethnicity, customized||particpants|Number|0|0.0||||||
4075120|NCT01033825|3897628|B1|Multiple||Race/Ethnicity, customized||particpants|Number|0|0.0||||||
4075121|NCT01033825|3897621|B8|Other||Race/Ethnicity, customized||particpants|Number|1|1.0||||||
4075122|NCT01033825|3897622|B7|Other||Race/Ethnicity, customized||particpants|Number|1|1.0||||||
4075123|NCT01033825|3897623|B6|Other||Race/Ethnicity, customized||particpants|Number|0|0.0||||||
4075124|NCT01033825|3897624|B5|Other||Race/Ethnicity, customized||particpants|Number|0|0.0||||||
4075125|NCT01033825|3897625|B4|Other||Race/Ethnicity, customized||particpants|Number|0|0.0||||||
4075126|NCT01033825|3897626|B3|Other||Race/Ethnicity, customized||particpants|Number|0|0.0||||||
4075127|NCT01033825|3897627|B2|Other||Race/Ethnicity, customized||particpants|Number|0|0.0||||||
4075128|NCT01033825|3897628|B1|Other||Race/Ethnicity, customized||particpants|Number|0|0.0||||||
4075129|NCT01033825|3897621|B8|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, customized||particpants|Number|0|0.0||||||
4075130|NCT01033825|3897622|B7|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, customized||particpants|Number|0|0.0||||||
4075131|NCT01033825|3897623|B6|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, customized||particpants|Number|0|0.0||||||
4075132|NCT01033825|3897624|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, customized||particpants|Number|0|0.0||||||
4075133|NCT01033825|3897625|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, customized||particpants|Number|0|0.0||||||
4075134|NCT01033825|3897626|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, customized||particpants|Number|0|0.0||||||
4075135|NCT01033825|3897627|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, customized||particpants|Number|0|0.0||||||
4075136|NCT01033825|3897628|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, customized||particpants|Number|0|0.0||||||
4075137|NCT01033825|3897621|B8|American Indian or Alaska Native||Race/Ethnicity, customized||particpants|Number|2|2.0||||||
4075138|NCT01033825|3897622|B7|American Indian or Alaska Native||Race/Ethnicity, customized||particpants|Number|0|0.0||||||
4075139|NCT01033825|3897623|B6|American Indian or Alaska Native||Race/Ethnicity, customized||particpants|Number|0|0.0||||||
4075140|NCT01033825|3897624|B5|American Indian or Alaska Native||Race/Ethnicity, customized||particpants|Number|1|1.0||||||
4075141|NCT01033825|3897625|B4|American Indian or Alaska Native||Race/Ethnicity, customized||particpants|Number|1|1.0||||||
4075142|NCT01033825|3897626|B3|American Indian or Alaska Native||Race/Ethnicity, customized||particpants|Number|0|0.0||||||
4075143|NCT01033825|3897627|B2|American Indian or Alaska Native||Race/Ethnicity, customized||particpants|Number|0|0.0||||||
4075144|NCT01033825|3897628|B1|American Indian or Alaska Native||Race/Ethnicity, customized||particpants|Number|0|0.0||||||
4075145|NCT01033825|3897621|B8|Asian||Race/Ethnicity, customized||particpants|Number|6|6.0||||||
4075146|NCT01033825|3897622|B7|Asian||Race/Ethnicity, customized||particpants|Number|0|0.0||||||
4075147|NCT01033825|3897623|B6|Asian||Race/Ethnicity, customized||particpants|Number|0|0.0||||||
4075148|NCT01033825|3897624|B5|Asian||Race/Ethnicity, customized||particpants|Number|0|0.0||||||
4075149|NCT01033825|3897625|B4|Asian||Race/Ethnicity, customized||particpants|Number|0|0.0||||||
4075150|NCT01033825|3897626|B3|Asian||Race/Ethnicity, customized||particpants|Number|0|0.0||||||
4075151|NCT01033825|3897627|B2|Asian||Race/Ethnicity, customized||particpants|Number|5|5.0||||||
4075152|NCT01033825|3897628|B1|Asian||Race/Ethnicity, customized||particpants|Number|1|1.0||||||
4075153|NCT01033825|3897621|B8|Black or African American||Race/Ethnicity, customized||particpants|Number|22|22.0||||||
4075154|NCT01033825|3897622|B7|Black or African American||Race/Ethnicity, customized||particpants|Number|1|1.0||||||
4075155|NCT01033825|3897623|B6|Black or African American||Race/Ethnicity, customized||particpants|Number|2|2.0||||||
4075156|NCT01033825|3897624|B5|Black or African American||Race/Ethnicity, customized||particpants|Number|5|5.0||||||
4075157|NCT01033825|3897625|B4|Black or African American||Race/Ethnicity, customized||particpants|Number|4|4.0||||||
4075158|NCT01033825|3897626|B3|Black or African American||Race/Ethnicity, customized||particpants|Number|5|5.0||||||
4075159|NCT01033825|3897627|B2|Black or African American||Race/Ethnicity, customized||particpants|Number|4|4.0||||||
4075160|NCT01033825|3897628|B1|Black or African American||Race/Ethnicity, customized||particpants|Number|1|1.0||||||
4075161|NCT01033825|3897621|B8|White/Caucasian||Race/Ethnicity, customized||particpants|Number|276|276.0||||||
4075162|NCT01033825|3897622|B7|White/Caucasian||Race/Ethnicity, customized||particpants|Number|15|15.0||||||
4075163|NCT01033825|3897623|B6|White/Caucasian||Race/Ethnicity, customized||particpants|Number|15|15.0||||||
4075164|NCT01033825|3897624|B5|White/Caucasian||Race/Ethnicity, customized||particpants|Number|52|52.0||||||
4075165|NCT01033825|3897625|B4|White/Caucasian||Race/Ethnicity, customized||particpants|Number|42|42.0||||||
4075166|NCT01033825|3897626|B3|White/Caucasian||Race/Ethnicity, customized||particpants|Number|52|52.0||||||
4075167|NCT01033825|3897627|B2|White/Caucasian||Race/Ethnicity, customized||particpants|Number|51|51.0||||||
4075168|NCT01033825|3897628|B1|White/Caucasian||Race/Ethnicity, customized||particpants|Number|49|49.0||||||
4075169|NCT01033825|3897621|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4075170|NCT01033825|3897622|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4075171|NCT01033825|3897623|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4075172|NCT01033825|3897624|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4075173|NCT01033825|3897625|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4075174|NCT01033825|3897626|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4075175|NCT01033825|3897627|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4075176|NCT01033825|3897628|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4075177|NCT01033825|3897621|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|250|250.0||||||
4075178|NCT01033825|3897622|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4075179|NCT01033825|3897623|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4075180|NCT01033825|3897624|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4075181|NCT01033825|3897625|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4075182|NCT01033825|3897626|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4075183|NCT01033825|3897627|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4075184|NCT01033825|3897628|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4075185|NCT01033825|3897621|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4075186|NCT01033825|3897622|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4075187|NCT01033825|3897623|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4075188|NCT01033825|3897624|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4075189|NCT01033825|3897625|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4075190|NCT01033825|3897626|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4075191|NCT01033825|3897627|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4075192|NCT01033825|3897628|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4075193|NCT01033825|3897621|B8||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4075194|NCT01033825|3897622|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4075195|NCT01033825|3897623|B6||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4075196|NCT01033825|3897624|B5||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4075197|NCT01033825|3897625|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4075198|NCT01033825|3897626|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4075199|NCT01033825|3897627|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4075200|NCT01033825|3897628|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4075201|NCT01033825|3897621|B8||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4075202|NCT01033825|3897622|B7||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4075203|NCT01033825|3897623|B6||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4075204|NCT01033825|3897624|B5||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4075205|NCT01033825|3897625|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4075206|NCT01033825|3897626|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4075207|NCT01033825|3897627|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4075208|NCT01033825|3897628|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4075209|NCT01033825|3897621|B8|||Age||years|Mean|34.26|34.26|Standard Deviation|14.01|14.01|||
4075210|NCT01033825|3897622|B7|||Age||years|Mean|34.0|34.0|Standard Deviation|134.41|134.41|||
4075211|NCT01033825|3897623|B6|||Age||years|Mean|35.4|35.4|Standard Deviation|12.94|12.94|||
4075212|NCT01033825|3897624|B5|||Age||years|Mean|35.5|35.5|Standard Deviation|14.55|14.55|||
4075213|NCT01033825|3897625|B4|||Age||years|Mean|32.3|32.3|Standard Deviation|12.53|12.53|||
4075214|NCT01033825|3897626|B3|||Age||years|Mean|33.0|33.0|Standard Deviation|15.69|15.69|||
4075215|NCT01033825|3897627|B2|||Age||years|Mean|34.5|34.5|Standard Deviation|13.42|13.42|||
4075216|NCT01033825|3897628|B1|||Age||years|Mean|35.8|35.8|Standard Deviation|13.62|13.62|||
4075217|NCT01033825|3897621|B8||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4075218|NCT01033825|3897622|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4075219|NCT01033825|3897623|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4075220|NCT01033825|3897624|B5||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4075221|NCT01033825|3897625|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4075222|NCT01033825|3897626|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4075223|NCT01033825|3897627|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4075224|NCT01033825|3897628|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4075225|NCT01033825|3897621|B8||Between 18 and 65 years|Age||Participants|Count of Participants|259|259.0||||||
4075226|NCT01033825|3897622|B7||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4075227|NCT01033825|3897623|B6||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4075228|NCT01033825|3897624|B5||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4075229|NCT01033825|3897625|B4||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4075230|NCT01033825|3897626|B3||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4075231|NCT01033825|3897627|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4075232|NCT01033825|3897628|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4075233|NCT01033825|3897621|B8||<=18 years|Age||Participants|Count of Participants|48|48.0||||||
4075234|NCT01033825|3897622|B7||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4075235|NCT01033825|3897623|B6||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4075236|NCT01033825|3897624|B5||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4075237|NCT01033825|3897625|B4||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4075238|NCT01033825|3897626|B3||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4075239|NCT01033825|3897627|B2||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4075240|NCT01033825|3897628|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4075241|NCT01033747|3897853|B3|Italy||Region of Enrollment||participants|Number|70|70.0||||||
4075242|NCT01033747|3897854|B2|Italy||Region of Enrollment||participants|Number|19|19.0||||||
4075243|NCT01033747|3897855|B1|Italy||Region of Enrollment||participants|Number|51|51.0||||||
4075244|NCT01033747|3897853|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4075245|NCT01033747|3897854|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4075246|NCT01033747|3897855|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4075247|NCT01033747|3897853|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4075248|NCT01033747|3897854|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4075249|NCT01033747|3897855|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4075250|NCT01033747|3897853|B3|50 to 65 years||Age, Customized||participants|Number|1|1.0||||||
4075251|NCT01033747|3897854|B2|50 to 65 years||Age, Customized||participants|Number|0|0.0||||||
4075252|NCT01033747|3897855|B1|50 to 65 years||Age, Customized||participants|Number|1|1.0||||||
4075253|NCT01033747|3897853|B3|16 to 49||Age, Customized||participants|Number|69|69.0||||||
4075254|NCT01033747|3897854|B2|16 to 49||Age, Customized||participants|Number|19|19.0||||||
4075255|NCT01033747|3897855|B1|16 to 49||Age, Customized||participants|Number|50|50.0||||||
4075256|NCT01033747|3897853|B3|||Age||years|Mean|24.5|24.5|Standard Deviation|5.02|5.02|||
4075257|NCT01033747|3897854|B2|||Age||years|Mean|23.8|23.8|Standard Deviation|3.76|3.76|||
4075258|NCT01033747|3897855|B1|||Age||years|Mean|24.7|24.7|Standard Deviation|5.43|5.43|||
4075259|NCT01033734|3897864|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4075260|NCT01033734|3897864|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4075261|NCT01033734|3897864|B1|||Age||years|Mean|4.8|4.8|Standard Deviation|3.1|3.1|||
4075262|NCT01033565|3897916|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4075263|NCT01033565|3897916|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4075264|NCT01033565|3897916|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4075265|NCT01033565|3897916|B1|||Age||years|Mean|8|8.0|Standard Deviation|||||
4075266|NCT01033565|3897916|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4075267|NCT01033565|3897916|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4075268|NCT01033565|3897916|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4075269|NCT01033487|3897920|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4075270|NCT01033487|3897920|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4075271|NCT01033487|3897920|B1|||Age||Years|Mean|58.7|58.7|Standard Deviation|9.3|9.3|||
4075272|NCT01033448|3897983|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4075273|NCT01033448|3897983|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4075274|NCT01033448|3897983|B1|||Age||Years|Mean|47.9|47.9|Standard Deviation|10.4|10.4|||
4075275|NCT01033383|3897991|B5|United States||Region of Enrollment||participants|Number|80|80.0||||||
4075276|NCT01033383|3897992|B4|United States||Region of Enrollment||participants|Number|20|20.0||||||
4075277|NCT01033383|3897993|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4075278|NCT01033383|3897994|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4075279|NCT01033383|3897995|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4075280|NCT01033383|3897991|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4075281|NCT01033383|3897992|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4075282|NCT01033383|3897993|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4075283|NCT01033383|3897994|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4075284|NCT01033383|3897995|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4075285|NCT01033383|3897991|B5||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4075286|NCT01033383|3897992|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4075287|NCT01033383|3897993|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4075288|NCT01033383|3897994|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4075289|NCT01033383|3897995|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4075290|NCT01033383|3897991|B5|||Age||years|Mean|89.1|89.1|Standard Deviation|7|7.0|||
4075291|NCT01033383|3897992|B4|||Age||years|Mean|90.4|90.4|Standard Deviation|7|7.0|||
4075292|NCT01033383|3897993|B3|||Age||years|Mean|88.8|88.8|Standard Deviation|5|5.0|||
4075293|NCT01033383|3897994|B2|||Age||years|Mean|88.4|88.4|Standard Deviation|7|7.0|||
4075294|NCT01033383|3897995|B1|||Age||years|Mean|88.8|88.8|Standard Deviation|8|8.0|||
4075295|NCT01033383|3897991|B5||>=65 years|Age||Participants|Count of Participants|80|80.0||||||
4075296|NCT01033383|3897992|B4||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4075297|NCT01033383|3897993|B3||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4075298|NCT01033383|3897994|B2||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4075299|NCT01033383|3897995|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4075300|NCT01033383|3897991|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4075301|NCT01033383|3897992|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4075302|NCT01033383|3897993|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4075303|NCT01033383|3897994|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4075304|NCT01033383|3897995|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4075305|NCT01033383|3897991|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4075306|NCT01033383|3897992|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4075307|NCT01033383|3897993|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4075308|NCT01033383|3897994|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4075309|NCT01033383|3897995|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4075310|NCT01033227|3898016|B3|||Sbeta+thalassemia||Participants|Count of Participants|1|1.0||||||
4075311|NCT01033227|3898017|B2|||Sbeta+thalassemia||Participants|Count of Participants|0|0.0||||||
4075312|NCT01033227|3898018|B1|||Sbeta+thalassemia||Participants|Count of Participants|1|1.0||||||
4075313|NCT01033227|3898016|B3|||Sickle Cell Disease hb SS||Participants|Count of Participants|4|4.0||||||
4075314|NCT01033227|3898017|B2|||Sickle Cell Disease hb SS||Participants|Count of Participants|1|1.0||||||
4075315|NCT01033227|3898018|B1|||Sickle Cell Disease hb SS||Participants|Count of Participants|3|3.0||||||
4075316|NCT01033227|3898016|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4075317|NCT01033227|3898017|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4075318|NCT01033227|3898018|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4075319|NCT01033227|3898016|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4075320|NCT01033227|3898017|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4075321|NCT01033227|3898018|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4075322|NCT01033227|3898016|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4075323|NCT01033227|3898017|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4075324|NCT01033227|3898018|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4075325|NCT01033227|3898016|B3|||Age||years|Mean|16|16.0|Full Range|||11.0|20.0|
4075326|NCT01033227|3898017|B2|||Age||years|Mean|15.5|15.5|Full Range|||11.0|20.0|
4075327|NCT01033227|3898018|B1|||Age||years|Mean|16|16.0|Full Range|||15.0|17.0|
4075328|NCT01033227|3898016|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4075329|NCT01033227|3898017|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4075330|NCT01033227|3898018|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4075331|NCT01033227|3898016|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4075332|NCT01033227|3898017|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4075333|NCT01033227|3898018|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4075334|NCT01033227|3898016|B3||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4075335|NCT01033227|3898017|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4075336|NCT01033227|3898018|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4075337|NCT01033136|3898027|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4075338|NCT01033136|3898028|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4075339|NCT01033136|3898029|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4075340|NCT01033136|3898027|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4075341|NCT01033136|3898028|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4075342|NCT01033136|3898029|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4075343|NCT01033136|3898027|B3|Latino||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4075344|NCT01033136|3898028|B2|Latino||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4075345|NCT01033136|3898029|B1|Latino||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4075346|NCT01033136|3898027|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
4075347|NCT01033136|3898028|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4075348|NCT01033136|3898029|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4075349|NCT01033136|3898027|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
4075350|NCT01033136|3898028|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4075351|NCT01033136|3898029|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4075352|NCT01033136|3898027|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4075353|NCT01033136|3898028|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4075354|NCT01033136|3898029|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4075355|NCT01033136|3898027|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4075356|NCT01033136|3898028|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4075357|NCT01033136|3898029|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4075358|NCT01033136|3898027|B3|||Age||years|Mean|42.12|42.12|Standard Deviation|13.40|13.4|||
4075359|NCT01033136|3898028|B2|||Age||years|Mean|41.56|41.56|Standard Deviation|13.26|13.26|||
4075360|NCT01033136|3898029|B1|||Age||years|Mean|42.61|42.61|Standard Deviation|13.70|13.7|||
4075361|NCT01033136|3898027|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4075362|NCT01033136|3898028|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4075363|NCT01033136|3898029|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4075364|NCT01033136|3898027|B3||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4075365|NCT01033136|3898028|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4075366|NCT01033136|3898029|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4075367|NCT01033136|3898027|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4075368|NCT01033136|3898028|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4075369|NCT01033136|3898029|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4075370|NCT01033071|3898038|B4|Missing||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2); Mild renal impairment(60 to <90 mL/min/1.73 m2); Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)"|participants|Number|1|1.0||||||
4075371|NCT01033071|3898039|B3|Missing||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2); Mild renal impairment(60 to <90 mL/min/1.73 m2); Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)"|participants|Number|1|1.0||||||
4075372|NCT01033071|3898040|B2|Missing||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2); Mild renal impairment(60 to <90 mL/min/1.73 m2); Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)"|participants|Number|0|0.0||||||
4075373|NCT01033071|3898041|B1|Missing||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2); Mild renal impairment(60 to <90 mL/min/1.73 m2); Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)"|participants|Number|0|0.0||||||
4075374|NCT01033071|3898038|B4|≥90||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2); Mild renal impairment(60 to <90 mL/min/1.73 m2); Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)"|participants|Number|299|299.0||||||
4075375|NCT01033071|3898039|B3|≥90||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2); Mild renal impairment(60 to <90 mL/min/1.73 m2); Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)"|participants|Number|91|91.0||||||
4075408|NCT01033071|3898040|B2|United States||Region of Enrollment||participants|Number|277|277.0||||||
4075409|NCT01033071|3898041|B1|United States||Region of Enrollment||participants|Number|276|276.0||||||
4075376|NCT01033071|3898040|B2|≥90||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2); Mild renal impairment(60 to <90 mL/min/1.73 m2); Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)"|participants|Number|103|103.0||||||
4075377|NCT01033071|3898041|B1|≥90||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2); Mild renal impairment(60 to <90 mL/min/1.73 m2); Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)"|participants|Number|105|105.0||||||
4075378|NCT01033071|3898038|B4|≥60 to <90||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2); Mild renal impairment(60 to <90 mL/min/1.73 m2); Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)"|participants|Number|690|690.0||||||
4075379|NCT01033071|3898039|B3|≥60 to <90||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2); Mild renal impairment(60 to <90 mL/min/1.73 m2); Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)"|participants|Number|246|246.0||||||
4075380|NCT01033071|3898040|B2|≥60 to <90||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2); Mild renal impairment(60 to <90 mL/min/1.73 m2); Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)"|participants|Number|220|220.0||||||
4075381|NCT01033071|3898041|B1|≥60 to <90||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2); Mild renal impairment(60 to <90 mL/min/1.73 m2); Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)"|participants|Number|224|224.0||||||
4075382|NCT01033071|3898038|B4|≥30 to <60||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2); Mild renal impairment(60 to <90 mL/min/1.73 m2); Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)"|participants|Number|80|80.0||||||
4075383|NCT01033071|3898039|B3|≥30 to <60||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2); Mild renal impairment(60 to <90 mL/min/1.73 m2); Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)"|participants|Number|25|25.0||||||
4075384|NCT01033071|3898040|B2|≥30 to <60||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2); Mild renal impairment(60 to <90 mL/min/1.73 m2); Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)"|participants|Number|29|29.0||||||
4075385|NCT01033071|3898041|B1|≥30 to <60||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2); Mild renal impairment(60 to <90 mL/min/1.73 m2); Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)"|participants|Number|26|26.0||||||
4075386|NCT01033071|3898038|B4|≥0 to <30||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2); Mild renal impairment(60 to <90 mL/min/1.73 m2); Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)"|participants|Number|1|1.0||||||
4075387|NCT01033071|3898039|B3|≥0 to <30||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2); Mild renal impairment(60 to <90 mL/min/1.73 m2); Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)"|participants|Number|1|1.0||||||
4075388|NCT01033071|3898040|B2|≥0 to <30||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2); Mild renal impairment(60 to <90 mL/min/1.73 m2); Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)"|participants|Number|0|0.0||||||
4075389|NCT01033071|3898041|B1|≥0 to <30||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2); Mild renal impairment(60 to <90 mL/min/1.73 m2); Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)"|participants|Number|0|0.0||||||
4075390|NCT01033071|3898038|B4|||Body Mass Index (BMI)||kg/m2|Mean|31.6|31.6|Standard Deviation|6.15|6.15|||
4075391|NCT01033071|3898039|B3|||Body Mass Index (BMI)||kg/m2|Mean|31.6|31.6|Standard Deviation|5.92|5.92|||
4075392|NCT01033071|3898040|B2|||Body Mass Index (BMI)||kg/m2|Mean|31.9|31.9|Standard Deviation|6.59|6.59|||
4075393|NCT01033071|3898041|B1|||Body Mass Index (BMI)||kg/m2|Mean|31.4|31.4|Standard Deviation|5.94|5.94|||
4075394|NCT01033071|3898038|B4|||Height||cm|Mean|170.0|170.0|Standard Deviation|10.42|10.42|||
4075395|NCT01033071|3898039|B3|||Height||cm|Mean|169.4|169.4|Standard Deviation|10.15|10.15|||
4075396|NCT01033071|3898040|B2|||Height||cm|Mean|169.3|169.3|Standard Deviation|10.88|10.88|||
4075397|NCT01033071|3898041|B1|||Height||cm|Mean|171.2|171.2|Standard Deviation|10.15|10.15|||
4075398|NCT01033071|3898038|B4|||Weight||kg|Mean|91.54|91.54|Standard Deviation|19.960|19.96|||
4075399|NCT01033071|3898039|B3|||Weight||kg|Mean|90.83|90.83|Standard Deviation|18.590|18.59|||
4075400|NCT01033071|3898040|B2|||Weight||kg|Mean|91.47|91.47|Standard Deviation|20.987|20.987|||
4075401|NCT01033071|3898041|B1|||Weight||kg|Mean|92.34|92.34|Standard Deviation|20.296|20.296|||
4075402|NCT01033071|3898038|B4|Canada||Region of Enrollment||participants|Number|233|233.0||||||
4075403|NCT01033071|3898039|B3|Canada||Region of Enrollment||participants|Number|79|79.0||||||
4075404|NCT01033071|3898040|B2|Canada||Region of Enrollment||participants|Number|75|75.0||||||
4075405|NCT01033071|3898041|B1|Canada||Region of Enrollment||participants|Number|79|79.0||||||
4075406|NCT01033071|3898038|B4|United States||Region of Enrollment||participants|Number|838|838.0||||||
4075407|NCT01033071|3898039|B3|United States||Region of Enrollment||participants|Number|285|285.0||||||
4075410|NCT01033071|3898038|B4|Unknown or Not Reported||Race (NIH/OMB)|A participant could have chosen more than 1 category for race; if so, they were included in each category indicated and were also included in the multiracial category.|participants|Number|0|0.0||||||
4075411|NCT01033071|3898039|B3|Unknown or Not Reported||Race (NIH/OMB)|A participant could have chosen more than 1 category for race; if so, they were included in each category indicated and were also included in the multiracial category.|participants|Number|0|0.0||||||
4075412|NCT01033071|3898040|B2|Unknown or Not Reported||Race (NIH/OMB)|A participant could have chosen more than 1 category for race; if so, they were included in each category indicated and were also included in the multiracial category.|participants|Number|0|0.0||||||
4075413|NCT01033071|3898041|B1|Unknown or Not Reported||Race (NIH/OMB)|A participant could have chosen more than 1 category for race; if so, they were included in each category indicated and were also included in the multiracial category.|participants|Number|0|0.0||||||
4075414|NCT01033071|3898038|B4|More than one race||Race (NIH/OMB)|A participant could have chosen more than 1 category for race; if so, they were included in each category indicated and were also included in the multiracial category.|participants|Number|4|4.0||||||
4075415|NCT01033071|3898039|B3|More than one race||Race (NIH/OMB)|A participant could have chosen more than 1 category for race; if so, they were included in each category indicated and were also included in the multiracial category.|participants|Number|1|1.0||||||
4075416|NCT01033071|3898040|B2|More than one race||Race (NIH/OMB)|A participant could have chosen more than 1 category for race; if so, they were included in each category indicated and were also included in the multiracial category.|participants|Number|2|2.0||||||
4075417|NCT01033071|3898041|B1|More than one race||Race (NIH/OMB)|A participant could have chosen more than 1 category for race; if so, they were included in each category indicated and were also included in the multiracial category.|participants|Number|1|1.0||||||
4075418|NCT01033071|3898038|B4|White||Race (NIH/OMB)|A participant could have chosen more than 1 category for race; if so, they were included in each category indicated and were also included in the multiracial category.|participants|Number|786|786.0||||||
4075419|NCT01033071|3898039|B3|White||Race (NIH/OMB)|A participant could have chosen more than 1 category for race; if so, they were included in each category indicated and were also included in the multiracial category.|participants|Number|267|267.0||||||
4075420|NCT01033071|3898040|B2|White||Race (NIH/OMB)|A participant could have chosen more than 1 category for race; if so, they were included in each category indicated and were also included in the multiracial category.|participants|Number|258|258.0||||||
4075421|NCT01033071|3898041|B1|White||Race (NIH/OMB)|A participant could have chosen more than 1 category for race; if so, they were included in each category indicated and were also included in the multiracial category.|participants|Number|261|261.0||||||
4075422|NCT01033071|3898038|B4|Black or African American||Race (NIH/OMB)|A participant could have chosen more than 1 category for race; if so, they were included in each category indicated and were also included in the multiracial category.|participants|Number|240|240.0||||||
4075423|NCT01033071|3898039|B3|Black or African American||Race (NIH/OMB)|A participant could have chosen more than 1 category for race; if so, they were included in each category indicated and were also included in the multiracial category.|participants|Number|80|80.0||||||
4075424|NCT01033071|3898040|B2|Black or African American||Race (NIH/OMB)|A participant could have chosen more than 1 category for race; if so, they were included in each category indicated and were also included in the multiracial category.|participants|Number|80|80.0||||||
4075425|NCT01033071|3898041|B1|Black or African American||Race (NIH/OMB)|A participant could have chosen more than 1 category for race; if so, they were included in each category indicated and were also included in the multiracial category.|participants|Number|80|80.0||||||
4075426|NCT01033071|3898038|B4|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|A participant could have chosen more than 1 category for race; if so, they were included in each category indicated and were also included in the multiracial category.|participants|Number|3|3.0||||||
4075427|NCT01033071|3898039|B3|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|A participant could have chosen more than 1 category for race; if so, they were included in each category indicated and were also included in the multiracial category.|participants|Number|2|2.0||||||
4075428|NCT01033071|3898040|B2|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|A participant could have chosen more than 1 category for race; if so, they were included in each category indicated and were also included in the multiracial category.|participants|Number|1|1.0||||||
4075429|NCT01033071|3898041|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|A participant could have chosen more than 1 category for race; if so, they were included in each category indicated and were also included in the multiracial category.|participants|Number|0|0.0||||||
4075430|NCT01033071|3898038|B4|Asian||Race (NIH/OMB)|A participant could have chosen more than 1 category for race; if so, they were included in each category indicated and were also included in the multiracial category.|participants|Number|35|35.0||||||
4075431|NCT01033071|3898039|B3|Asian||Race (NIH/OMB)|A participant could have chosen more than 1 category for race; if so, they were included in each category indicated and were also included in the multiracial category.|participants|Number|11|11.0||||||
4075432|NCT01033071|3898040|B2|Asian||Race (NIH/OMB)|A participant could have chosen more than 1 category for race; if so, they were included in each category indicated and were also included in the multiracial category.|participants|Number|11|11.0||||||
4075433|NCT01033071|3898041|B1|Asian||Race (NIH/OMB)|A participant could have chosen more than 1 category for race; if so, they were included in each category indicated and were also included in the multiracial category.|participants|Number|13|13.0||||||
4075434|NCT01033071|3898038|B4|American Indian or Alaska Native||Race (NIH/OMB)|A participant could have chosen more than 1 category for race; if so, they were included in each category indicated and were also included in the multiracial category.|participants|Number|12|12.0||||||
4075435|NCT01033071|3898039|B3|American Indian or Alaska Native||Race (NIH/OMB)|A participant could have chosen more than 1 category for race; if so, they were included in each category indicated and were also included in the multiracial category.|participants|Number|5|5.0||||||
4075491|NCT01032993|3898123|B2|No||Hypertension||participants|Number|4|4.0||||||
4075492|NCT01032993|3898124|B1|No||Hypertension||participants|Number|5|5.0||||||
4075436|NCT01033071|3898040|B2|American Indian or Alaska Native||Race (NIH/OMB)|A participant could have chosen more than 1 category for race; if so, they were included in each category indicated and were also included in the multiracial category.|participants|Number|5|5.0||||||
4075437|NCT01033071|3898041|B1|American Indian or Alaska Native||Race (NIH/OMB)|A participant could have chosen more than 1 category for race; if so, they were included in each category indicated and were also included in the multiracial category.|participants|Number|2|2.0||||||
4075438|NCT01033071|3898038|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|233|233.0||||||
4075439|NCT01033071|3898039|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
4075440|NCT01033071|3898040|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4075441|NCT01033071|3898041|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
4075442|NCT01033071|3898038|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|740|740.0||||||
4075443|NCT01033071|3898039|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|251|251.0||||||
4075444|NCT01033071|3898040|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|241|241.0||||||
4075445|NCT01033071|3898041|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|248|248.0||||||
4075446|NCT01033071|3898038|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
4075447|NCT01033071|3898039|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4075448|NCT01033071|3898040|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4075449|NCT01033071|3898041|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4075450|NCT01033071|3898038|B4||Male|Sex: Female, Male||Participants|Count of Participants|629|629.0||||||
4075451|NCT01033071|3898039|B3||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4075452|NCT01033071|3898040|B2||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4075453|NCT01033071|3898041|B1||Male|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4075454|NCT01033071|3898038|B4||Female|Sex: Female, Male||Participants|Count of Participants|442|442.0||||||
4075455|NCT01033071|3898039|B3||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4075456|NCT01033071|3898040|B2||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4075457|NCT01033071|3898041|B1||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4075458|NCT01033071|3898038|B4|≥65 years||Age, Customized||participants|Number|236|236.0||||||
4075459|NCT01033071|3898039|B3|≥65 years||Age, Customized||participants|Number|84|84.0||||||
4075460|NCT01033071|3898040|B2|≥65 years||Age, Customized||participants|Number|78|78.0||||||
4075461|NCT01033071|3898041|B1|≥65 years||Age, Customized||participants|Number|74|74.0||||||
4075462|NCT01033071|3898038|B4|Between 45 to 64 years||Age, Customized||participants|Number|710|710.0||||||
4075463|NCT01033071|3898039|B3|Between 45 to 64 years||Age, Customized||participants|Number|234|234.0||||||
4075464|NCT01033071|3898040|B2|Between 45 to 64 years||Age, Customized||participants|Number|241|241.0||||||
4075465|NCT01033071|3898041|B1|Between 45 to 64 years||Age, Customized||participants|Number|235|235.0||||||
4075466|NCT01033071|3898038|B4|<45 years||Age, Customized||participants|Number|125|125.0||||||
4075467|NCT01033071|3898039|B3|<45 years||Age, Customized||participants|Number|46|46.0||||||
4075468|NCT01033071|3898040|B2|<45 years||Age, Customized||participants|Number|33|33.0||||||
4075469|NCT01033071|3898041|B1|<45 years||Age, Customized||participants|Number|46|46.0||||||
4075470|NCT01033071|3898038|B4|||Age||years|Mean|56.6|56.6|Standard Deviation|10.47|10.47|||
4075471|NCT01033071|3898039|B3|||Age||years|Mean|56.7|56.7|Standard Deviation|10.86|10.86|||
4075472|NCT01033071|3898040|B2|||Age||years|Mean|56.7|56.7|Standard Deviation|10.07|10.07|||
4075473|NCT01033071|3898041|B1|||Age||years|Mean|56.4|56.4|Standard Deviation|10.49|10.49|||
4075474|NCT01033032|3898102|B1|United States||Region of Enrollment||participants|Number|78|78.0||||||
4075475|NCT01033032|3898102|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4075476|NCT01033032|3898102|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4075477|NCT01033032|3898102|B1|||Age||Years|Median|58|58.0|Full Range|||27.0|86.0|
4075478|NCT01033019|3898112|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4075479|NCT01033019|3898113|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4075480|NCT01033019|3898114|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4075481|NCT01033019|3898112|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4075482|NCT01033019|3898113|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4075483|NCT01033019|3898114|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4075484|NCT01033019|3898112|B3|||Age||Years|Mean|63|63.0|Standard Deviation|7.4|7.4|||
4075485|NCT01033019|3898113|B2|||Age||Years|Mean|63|63.0|Standard Deviation|7.5|7.5|||
4075486|NCT01033019|3898114|B1|||Age||Years|Mean|63|63.0|Standard Deviation|7.3|7.3|||
4075487|NCT01032993|3898122|B3|||Pain (baseline) visual analog scale (0-10)|Pain was rated on a scale from 0 to 10, where 0 =n o pain and 10 = pain as bad as you can imagine|units on a scale|Mean|4.6|4.6|Standard Deviation|2.0|2.0|||
4075488|NCT01032993|3898123|B2|||Pain (baseline) visual analog scale (0-10)|Pain was rated on a scale from 0 to 10, where 0 =n o pain and 10 = pain as bad as you can imagine|units on a scale|Mean|4.9|4.9|Standard Deviation|1.9|1.9|||
4075489|NCT01032993|3898124|B1|||Pain (baseline) visual analog scale (0-10)|Pain was rated on a scale from 0 to 10, where 0 =n o pain and 10 = pain as bad as you can imagine|units on a scale|Mean|4.4|4.4|Standard Deviation|2.2|2.2|||
4075490|NCT01032993|3898122|B3|No||Hypertension||participants|Number|9|9.0||||||
4075493|NCT01032993|3898122|B3|Yes||Hypertension||participants|Number|30|30.0||||||
4075494|NCT01032993|3898123|B2|Yes||Hypertension||participants|Number|16|16.0||||||
4075495|NCT01032993|3898124|B1|Yes||Hypertension||participants|Number|14|14.0||||||
4075496|NCT01032993|3898122|B3|No||Diabetes||participants|Number|30|30.0||||||
4075497|NCT01032993|3898123|B2|No||Diabetes||participants|Number|16|16.0||||||
4075498|NCT01032993|3898124|B1|No||Diabetes||participants|Number|14|14.0||||||
4075499|NCT01032993|3898122|B3|Yes||Diabetes||participants|Number|9|9.0||||||
4075500|NCT01032993|3898123|B2|Yes||Diabetes||participants|Number|4|4.0||||||
4075501|NCT01032993|3898124|B1|Yes||Diabetes||participants|Number|5|5.0||||||
4075502|NCT01032993|3898122|B3|None/Light||Exercise||participants|Number|21|21.0||||||
4075503|NCT01032993|3898123|B2|None/Light||Exercise||participants|Number|12|12.0||||||
4075504|NCT01032993|3898124|B1|None/Light||Exercise||participants|Number|9|9.0||||||
4075505|NCT01032993|3898122|B3|Moderate/Vigorous||Exercise||participants|Number|18|18.0||||||
4075506|NCT01032993|3898123|B2|Moderate/Vigorous||Exercise||participants|Number|8|8.0||||||
4075507|NCT01032993|3898124|B1|Moderate/Vigorous||Exercise||participants|Number|10|10.0||||||
4075508|NCT01032993|3898122|B3|5 or more||Alcohol Servings/Day||participants|Number|5|5.0||||||
4075509|NCT01032993|3898123|B2|5 or more||Alcohol Servings/Day||participants|Number|3|3.0||||||
4075510|NCT01032993|3898124|B1|5 or more||Alcohol Servings/Day||participants|Number|2|2.0||||||
4075511|NCT01032993|3898122|B3|2 to 4||Alcohol Servings/Day||participants|Number|18|18.0||||||
4075512|NCT01032993|3898123|B2|2 to 4||Alcohol Servings/Day||participants|Number|9|9.0||||||
4075513|NCT01032993|3898124|B1|2 to 4||Alcohol Servings/Day||participants|Number|9|9.0||||||
4075514|NCT01032993|3898122|B3|0 to 1||Alcohol Servings/Day||participants|Number|16|16.0||||||
4075515|NCT01032993|3898123|B2|0 to 1||Alcohol Servings/Day||participants|Number|8|8.0||||||
4075516|NCT01032993|3898124|B1|0 to 1||Alcohol Servings/Day||participants|Number|8|8.0||||||
4075517|NCT01032993|3898122|B3|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4075518|NCT01032993|3898123|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4075519|NCT01032993|3898124|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4075520|NCT01032993|3898122|B3|Non-Hispanic White||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4075521|NCT01032993|3898123|B2|Non-Hispanic White||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4075522|NCT01032993|3898124|B1|Non-Hispanic White||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4075523|NCT01032993|3898122|B3||Male|Gender||Participants|Count of Participants|19|19.0||||||
4075524|NCT01032993|3898123|B2||Male|Gender||Participants|Count of Participants|14|14.0||||||
4075525|NCT01032993|3898124|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
4075526|NCT01032993|3898122|B3||Female|Gender||Participants|Count of Participants|20|20.0||||||
4075527|NCT01032993|3898123|B2||Female|Gender||Participants|Count of Participants|6|6.0||||||
4075528|NCT01032993|3898124|B1||Female|Gender||Participants|Count of Participants|14|14.0||||||
4075529|NCT01032993|3898122|B3|||Age||years|Mean|61.0|61.0|Standard Deviation|9.7|9.7|||
4075530|NCT01032993|3898123|B2|||Age||years|Mean|60.1|60.1|Standard Deviation|11.2|11.2|||
4075531|NCT01032993|3898124|B1|||Age||years|Mean|62.0|62.0|Standard Deviation|7.9|7.9|||
4075532|NCT01032928|3898137|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4075533|NCT01032928|3898137|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4075534|NCT01032928|3898137|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4075535|NCT01032928|3898137|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4075536|NCT01032928|3898137|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4075537|NCT01032928|3898137|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4075538|NCT01032928|3898137|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4075539|NCT01032928|3898137|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4075540|NCT01032928|3898137|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4075541|NCT01032928|3898137|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4075542|NCT01032928|3898137|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4075543|NCT01032928|3898137|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4075544|NCT01032928|3898137|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4075545|NCT01032928|3898137|B1|||Age||years|Mean|61|61.0|Standard Deviation|11|11.0|||
4075546|NCT01032928|3898137|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4075547|NCT01032928|3898137|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4075548|NCT01032928|3898137|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4075549|NCT01032915|3898149|B5||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4075550|NCT01032915|3898150|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4075551|NCT01032915|3898151|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4075552|NCT01032915|3898152|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4075553|NCT01032915|3898153|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4075554|NCT01032915|3898149|B5||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4075555|NCT01032915|3898150|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4075556|NCT01032915|3898151|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4075557|NCT01032915|3898152|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4075558|NCT01032915|3898153|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4075559|NCT01032915|3898149|B5|||Age||Years|Mean|47.6|47.6|Standard Deviation|13.6|13.6|||
4075560|NCT01032915|3898150|B4|||Age||Years|Mean|47.3|47.3|Standard Deviation|15.46|15.46|||
4075561|NCT01032915|3898151|B3|||Age||Years|Mean|47.7|47.7|Standard Deviation|13.5|13.5|||
4075562|NCT01032915|3898152|B2|||Age||Years|Mean|49.2|49.2|Standard Deviation|11.14|11.14|||
4075563|NCT01032915|3898153|B1|||Age||Years|Mean|46.2|46.2|Standard Deviation|14.29|14.29|||
4075564|NCT01032889|3898178|B4|3||Clinician-Reported Submental Fat Rating Scale (CR-SMFRS) Rating|"CR-SMFRS Ratings:~0 = Absent submental convexity: No localized submental fat evident;~1 = Mild submental convexity: Minimal, localized submental fat;~2 = Moderate submental convexity: Prominent, localized submental fat;~3 = Severe submental convexity: Marked, localized submental fat;~4 = Extreme submental convexity."|participants|Number|72|72.0||||||
4075565|NCT01032889|3898179|B3|3||Clinician-Reported Submental Fat Rating Scale (CR-SMFRS) Rating|"CR-SMFRS Ratings:~0 = Absent submental convexity: No localized submental fat evident;~1 = Mild submental convexity: Minimal, localized submental fat;~2 = Moderate submental convexity: Prominent, localized submental fat;~3 = Severe submental convexity: Marked, localized submental fat;~4 = Extreme submental convexity."|participants|Number|27|27.0||||||
4075566|NCT01032889|3898180|B2|3||Clinician-Reported Submental Fat Rating Scale (CR-SMFRS) Rating|"CR-SMFRS Ratings:~0 = Absent submental convexity: No localized submental fat evident;~1 = Mild submental convexity: Minimal, localized submental fat;~2 = Moderate submental convexity: Prominent, localized submental fat;~3 = Severe submental convexity: Marked, localized submental fat;~4 = Extreme submental convexity."|participants|Number|21|21.0||||||
4075567|NCT01032889|3898181|B1|3||Clinician-Reported Submental Fat Rating Scale (CR-SMFRS) Rating|"CR-SMFRS Ratings:~0 = Absent submental convexity: No localized submental fat evident;~1 = Mild submental convexity: Minimal, localized submental fat;~2 = Moderate submental convexity: Prominent, localized submental fat;~3 = Severe submental convexity: Marked, localized submental fat;~4 = Extreme submental convexity."|participants|Number|24|24.0||||||
4075568|NCT01032889|3898178|B4|2||Clinician-Reported Submental Fat Rating Scale (CR-SMFRS) Rating|"CR-SMFRS Ratings:~0 = Absent submental convexity: No localized submental fat evident;~1 = Mild submental convexity: Minimal, localized submental fat;~2 = Moderate submental convexity: Prominent, localized submental fat;~3 = Severe submental convexity: Marked, localized submental fat;~4 = Extreme submental convexity."|participants|Number|57|57.0||||||
4075569|NCT01032889|3898179|B3|2||Clinician-Reported Submental Fat Rating Scale (CR-SMFRS) Rating|"CR-SMFRS Ratings:~0 = Absent submental convexity: No localized submental fat evident;~1 = Mild submental convexity: Minimal, localized submental fat;~2 = Moderate submental convexity: Prominent, localized submental fat;~3 = Severe submental convexity: Marked, localized submental fat;~4 = Extreme submental convexity."|participants|Number|18|18.0||||||
4075570|NCT01032889|3898180|B2|2||Clinician-Reported Submental Fat Rating Scale (CR-SMFRS) Rating|"CR-SMFRS Ratings:~0 = Absent submental convexity: No localized submental fat evident;~1 = Mild submental convexity: Minimal, localized submental fat;~2 = Moderate submental convexity: Prominent, localized submental fat;~3 = Severe submental convexity: Marked, localized submental fat;~4 = Extreme submental convexity."|participants|Number|22|22.0||||||
4075571|NCT01032889|3898181|B1|2||Clinician-Reported Submental Fat Rating Scale (CR-SMFRS) Rating|"CR-SMFRS Ratings:~0 = Absent submental convexity: No localized submental fat evident;~1 = Mild submental convexity: Minimal, localized submental fat;~2 = Moderate submental convexity: Prominent, localized submental fat;~3 = Severe submental convexity: Marked, localized submental fat;~4 = Extreme submental convexity."|participants|Number|17|17.0||||||
4075572|NCT01032889|3898178|B4|IV - VI||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|40|40.0||||||
4075573|NCT01032889|3898179|B3|IV - VI||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|12|12.0||||||
4075574|NCT01032889|3898180|B2|IV - VI||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|17|17.0||||||
4075575|NCT01032889|3898181|B1|IV - VI||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|11|11.0||||||
4075576|NCT01032889|3898178|B4|I - III||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|89|89.0||||||
4075614|NCT01032889|3898180|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4075577|NCT01032889|3898179|B3|I - III||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|33|33.0||||||
4075578|NCT01032889|3898180|B2|I - III||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|26|26.0||||||
4075579|NCT01032889|3898181|B1|I - III||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|30|30.0||||||
4075580|NCT01032889|3898178|B4|||Body Mass Index (BMI)|Data available for 40, 43 and 45 participants in each treatment arm respectively.|kg/m²|Mean|30.70|30.7|Standard Deviation|5.665|5.665|||
4075581|NCT01032889|3898179|B3|||Body Mass Index (BMI)|Data available for 40, 43 and 45 participants in each treatment arm respectively.|kg/m²|Mean|30.85|30.85|Standard Deviation|5.315|5.315|||
4075582|NCT01032889|3898180|B2|||Body Mass Index (BMI)|Data available for 40, 43 and 45 participants in each treatment arm respectively.|kg/m²|Mean|31.48|31.48|Standard Deviation|6.633|6.633|||
4075583|NCT01032889|3898181|B1|||Body Mass Index (BMI)|Data available for 40, 43 and 45 participants in each treatment arm respectively.|kg/m²|Mean|29.68|29.68|Standard Deviation|4.845|4.845|||
4075584|NCT01032889|3898178|B4|||Weight|Data available for 40, 43 and 45 participants in each treatment arm respectively.|kg|Mean|87.39|87.39|Standard Deviation|17.851|17.851|||
4075585|NCT01032889|3898179|B3|||Weight|Data available for 40, 43 and 45 participants in each treatment arm respectively.|kg|Mean|87.78|87.78|Standard Deviation|16.059|16.059|||
4075586|NCT01032889|3898180|B2|||Weight|Data available for 40, 43 and 45 participants in each treatment arm respectively.|kg|Mean|89.32|89.32|Standard Deviation|21.225|21.225|||
4075587|NCT01032889|3898181|B1|||Weight|Data available for 40, 43 and 45 participants in each treatment arm respectively.|kg|Mean|84.88|84.88|Standard Deviation|15.835|15.835|||
4075588|NCT01032889|3898178|B4|Other||Race/Ethnicity, Customized|Participants could select more than one category.|participants|Number|3|3.0||||||
4075589|NCT01032889|3898179|B3|Other||Race/Ethnicity, Customized|Participants could select more than one category.|participants|Number|1|1.0||||||
4075590|NCT01032889|3898180|B2|Other||Race/Ethnicity, Customized|Participants could select more than one category.|participants|Number|1|1.0||||||
4075591|NCT01032889|3898181|B1|Other||Race/Ethnicity, Customized|Participants could select more than one category.|participants|Number|1|1.0||||||
4075592|NCT01032889|3898178|B4|Asian||Race/Ethnicity, Customized|Participants could select more than one category.|participants|Number|3|3.0||||||
4075593|NCT01032889|3898179|B3|Asian||Race/Ethnicity, Customized|Participants could select more than one category.|participants|Number|2|2.0||||||
4075594|NCT01032889|3898180|B2|Asian||Race/Ethnicity, Customized|Participants could select more than one category.|participants|Number|0|0.0||||||
4075595|NCT01032889|3898181|B1|Asian||Race/Ethnicity, Customized|Participants could select more than one category.|participants|Number|1|1.0||||||
4075596|NCT01032889|3898178|B4|Black or African American||Race/Ethnicity, Customized|Participants could select more than one category.|participants|Number|7|7.0||||||
4075597|NCT01032889|3898179|B3|Black or African American||Race/Ethnicity, Customized|Participants could select more than one category.|participants|Number|2|2.0||||||
4075598|NCT01032889|3898180|B2|Black or African American||Race/Ethnicity, Customized|Participants could select more than one category.|participants|Number|2|2.0||||||
4075599|NCT01032889|3898181|B1|Black or African American||Race/Ethnicity, Customized|Participants could select more than one category.|participants|Number|3|3.0||||||
4075600|NCT01032889|3898178|B4|Hispanic or Latino||Race/Ethnicity, Customized|Participants could select more than one category.|participants|Number|11|11.0||||||
4075601|NCT01032889|3898179|B3|Hispanic or Latino||Race/Ethnicity, Customized|Participants could select more than one category.|participants|Number|4|4.0||||||
4075602|NCT01032889|3898180|B2|Hispanic or Latino||Race/Ethnicity, Customized|Participants could select more than one category.|participants|Number|6|6.0||||||
4075603|NCT01032889|3898181|B1|Hispanic or Latino||Race/Ethnicity, Customized|Participants could select more than one category.|participants|Number|1|1.0||||||
4075604|NCT01032889|3898178|B4|White||Race/Ethnicity, Customized|Participants could select more than one category.|participants|Number|109|109.0||||||
4075605|NCT01032889|3898179|B3|White||Race/Ethnicity, Customized|Participants could select more than one category.|participants|Number|36|36.0||||||
4075606|NCT01032889|3898180|B2|White||Race/Ethnicity, Customized|Participants could select more than one category.|participants|Number|35|35.0||||||
4075607|NCT01032889|3898181|B1|White||Race/Ethnicity, Customized|Participants could select more than one category.|participants|Number|38|38.0||||||
4075608|NCT01032889|3898178|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4075609|NCT01032889|3898179|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4075610|NCT01032889|3898180|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4075611|NCT01032889|3898181|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4075612|NCT01032889|3898178|B4||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4075613|NCT01032889|3898179|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4075615|NCT01032889|3898181|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4075616|NCT01032889|3898178|B4|||Age||years|Mean|46.1|46.1|Standard Deviation|9.72|9.72|||
4075617|NCT01032889|3898179|B3|||Age||years|Mean|47.4|47.4|Standard Deviation|10.20|10.2|||
4075618|NCT01032889|3898180|B2|||Age||years|Mean|45.6|45.6|Standard Deviation|9.43|9.43|||
4075619|NCT01032889|3898181|B1|||Age||years|Mean|45.3|45.3|Standard Deviation|9.57|9.57|||
4075620|NCT01032850|3898203|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4075621|NCT01032850|3898203|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4075622|NCT01032850|3898203|B1|||Age||years|Median|61|61.0|Full Range|||54.0|79.0|
4075623|NCT01032837|3898210|B5|White/Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4075624|NCT01032837|3898211|B4|White/Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4075625|NCT01032837|3898212|B3|White/Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4075626|NCT01032837|3898213|B2|White/Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4075627|NCT01032837|3898214|B1|White/Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4075628|NCT01032837|3898210|B5|White||Race/Ethnicity, Customized||participants|Number|86|86.0||||||
4075629|NCT01032837|3898211|B4|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4075630|NCT01032837|3898212|B3|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4075631|NCT01032837|3898213|B2|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4075632|NCT01032837|3898214|B1|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4075633|NCT01032837|3898210|B5|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4075634|NCT01032837|3898211|B4|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4075635|NCT01032837|3898212|B3|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4075636|NCT01032837|3898213|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4075637|NCT01032837|3898214|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4075638|NCT01032837|3898210|B5|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4075639|NCT01032837|3898211|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4075640|NCT01032837|3898212|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4075641|NCT01032837|3898213|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4075642|NCT01032837|3898214|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4075643|NCT01032837|3898210|B5||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4075644|NCT01032837|3898211|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4075645|NCT01032837|3898212|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4075646|NCT01032837|3898213|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4075647|NCT01032837|3898214|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4075648|NCT01032837|3898210|B5||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4075649|NCT01032837|3898211|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4075650|NCT01032837|3898212|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4075651|NCT01032837|3898213|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4075652|NCT01032837|3898214|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4075653|NCT01032837|3898210|B5|>18 years||Age, Customized|Overall number of baseline participants is based on the Intent-to-Treat population.|participants|Number|61|61.0||||||
4075654|NCT01032837|3898211|B4|>18 years||Age, Customized|Overall number of baseline participants is based on the Intent-to-Treat population.|participants|Number|15|15.0||||||
4075655|NCT01032837|3898212|B3|>18 years||Age, Customized|Overall number of baseline participants is based on the Intent-to-Treat population.|participants|Number|13|13.0||||||
4075656|NCT01032837|3898213|B2|>18 years||Age, Customized|Overall number of baseline participants is based on the Intent-to-Treat population.|participants|Number|17|17.0||||||
4075657|NCT01032837|3898214|B1|>18 years||Age, Customized|Overall number of baseline participants is based on the Intent-to-Treat population.|participants|Number|16|16.0||||||
4075658|NCT01032837|3898210|B5|13 to ≤18 years||Age, Customized|Overall number of baseline participants is based on the Intent-to-Treat population.|participants|Number|13|13.0||||||
4075659|NCT01032837|3898211|B4|13 to ≤18 years||Age, Customized|Overall number of baseline participants is based on the Intent-to-Treat population.|participants|Number|3|3.0||||||
4075660|NCT01032837|3898212|B3|13 to ≤18 years||Age, Customized|Overall number of baseline participants is based on the Intent-to-Treat population.|participants|Number|5|5.0||||||
4075661|NCT01032837|3898213|B2|13 to ≤18 years||Age, Customized|Overall number of baseline participants is based on the Intent-to-Treat population.|participants|Number|2|2.0||||||
4075662|NCT01032837|3898214|B1|13 to ≤18 years||Age, Customized|Overall number of baseline participants is based on the Intent-to-Treat population.|participants|Number|3|3.0||||||
4075663|NCT01032837|3898210|B5|1 to <13 years||Age, Customized|Overall number of baseline participants is based on the Intent-to-Treat population.|participants|Number|27|27.0||||||
4075664|NCT01032837|3898211|B4|1 to <13 years||Age, Customized|Overall number of baseline participants is based on the Intent-to-Treat population.|participants|Number|6|6.0||||||
4075665|NCT01032837|3898212|B3|1 to <13 years||Age, Customized|Overall number of baseline participants is based on the Intent-to-Treat population.|participants|Number|7|7.0||||||
4075666|NCT01032837|3898213|B2|1 to <13 years||Age, Customized|Overall number of baseline participants is based on the Intent-to-Treat population.|participants|Number|7|7.0||||||
4075667|NCT01032837|3898214|B1|1 to <13 years||Age, Customized|Overall number of baseline participants is based on the Intent-to-Treat population.|participants|Number|7|7.0||||||
4075668|NCT01032759|3898263|B3|United States||Region of Enrollment||participants|Number|63|63.0||||||
4075669|NCT01032759|3898264|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
4075670|NCT01032759|3898265|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4075671|NCT01032759|3898263|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4075672|NCT01032759|3898264|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4075673|NCT01032759|3898265|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4075674|NCT01032759|3898263|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4075675|NCT01032759|3898264|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4075676|NCT01032759|3898265|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4075677|NCT01032759|3898263|B3|||Age||years|Mean|59|59.0|Standard Deviation|7|7.0|||
4075678|NCT01032759|3898264|B2|||Age||years|Mean|59|59.0|Standard Deviation|7|7.0|||
4075679|NCT01032759|3898265|B1|||Age||years|Mean|60|60.0|Standard Deviation|7|7.0|||
4075680|NCT01032733|3898284|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
4075681|NCT01032733|3898285|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4075682|NCT01032733|3898286|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4075683|NCT01032733|3898284|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4075684|NCT01032733|3898285|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4075685|NCT01032733|3898286|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4075686|NCT01032733|3898284|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4075687|NCT01032733|3898285|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4075688|NCT01032733|3898286|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4075689|NCT01032733|3898284|B3|||Age||years|Mean|63.7|63.7|Standard Deviation|5.59|5.59|||
4075690|NCT01032733|3898285|B2|||Age||years|Mean|63.7|63.7|Standard Deviation|6.7|6.7|||
4075691|NCT01032733|3898286|B1|||Age||years|Mean|63.7|63.7|Standard Deviation|4.5|4.5|||
4075692|NCT01032733|3898284|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4075693|NCT01032733|3898285|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4075694|NCT01032733|3898286|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4075695|NCT01032733|3898284|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4075696|NCT01032733|3898285|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4075697|NCT01032733|3898286|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4075698|NCT01032733|3898284|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4075699|NCT01032733|3898285|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4075700|NCT01032733|3898286|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4075701|NCT01032694|3898301|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4075702|NCT01032694|3898302|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4075703|NCT01032694|3898303|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4075704|NCT01032694|3898301|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4075705|NCT01032694|3898302|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4075706|NCT01032694|3898303|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4075707|NCT01032694|3898301|B3|||Age||Years|Mean|43.9|43.9|Standard Deviation|15.4|15.4|||
4075708|NCT01032694|3898302|B2|||Age||Years|Mean|40.1|40.1|Standard Deviation|7.9|7.9|||
4075709|NCT01032694|3898303|B1|||Age||Years|Mean|45.8|45.8|Standard Deviation|18.0|18.0|||
4075710|NCT01032629|3898314|B4|United States||Region of Enrollment||Participants|Count of Participants|727|727.0||||||
4075711|NCT01032629|3898315|B3|United States||Region of Enrollment||Participants|Count of Participants|249|249.0||||||
4075712|NCT01032629|3898316|B2|United States||Region of Enrollment||Participants|Count of Participants|238|238.0||||||
4075713|NCT01032629|3898317|B1|United States||Region of Enrollment||Participants|Count of Participants|240|240.0||||||
4075714|NCT01032629|3898314|B4|United Kingdom||Region of Enrollment||Participants|Count of Participants|92|92.0||||||
4075715|NCT01032629|3898315|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
4075716|NCT01032629|3898316|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
4075717|NCT01032629|3898317|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
4075718|NCT01032629|3898314|B4|Ukraine||Region of Enrollment||Participants|Count of Participants|147|147.0||||||
4075719|NCT01032629|3898315|B3|Ukraine||Region of Enrollment||Participants|Count of Participants|58|58.0||||||
4075720|NCT01032629|3898316|B2|Ukraine||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
4075721|NCT01032629|3898317|B1|Ukraine||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
4075722|NCT01032629|3898314|B4|Sweden||Region of Enrollment||Participants|Count of Participants|71|71.0||||||
4075723|NCT01032629|3898315|B3|Sweden||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4075724|NCT01032629|3898316|B2|Sweden||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
4075725|NCT01032629|3898317|B1|Sweden||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4075726|NCT01032629|3898314|B4|Spain||Region of Enrollment||Participants|Count of Participants|209|209.0||||||
4075727|NCT01032629|3898315|B3|Spain||Region of Enrollment||Participants|Count of Participants|71|71.0||||||
4075728|NCT01032629|3898316|B2|Spain||Region of Enrollment||Participants|Count of Participants|74|74.0||||||
4075729|NCT01032629|3898317|B1|Spain||Region of Enrollment||Participants|Count of Participants|64|64.0||||||
4075730|NCT01032629|3898314|B4|Russia||Region of Enrollment||Participants|Count of Participants|389|389.0||||||
4075731|NCT01032629|3898315|B3|Russia||Region of Enrollment||Participants|Count of Participants|125|125.0||||||
4075732|NCT01032629|3898316|B2|Russia||Region of Enrollment||Participants|Count of Participants|118|118.0||||||
4075733|NCT01032629|3898317|B1|Russia||Region of Enrollment||Participants|Count of Participants|146|146.0||||||
4075734|NCT01032629|3898314|B4|Poland||Region of Enrollment||Participants|Count of Participants|144|144.0||||||
4075735|NCT01032629|3898315|B3|Poland||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
4075736|NCT01032629|3898316|B2|Poland||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
4075737|NCT01032629|3898317|B1|Poland||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
4075738|NCT01032629|3898314|B4|Norway||Region of Enrollment||Participants|Count of Participants|109|109.0||||||
4075739|NCT01032629|3898315|B3|Norway||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
4075740|NCT01032629|3898316|B2|Norway||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
4075741|NCT01032629|3898317|B1|Norway||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
4075742|NCT01032629|3898314|B4|New Zealand||Region of Enrollment||Participants|Count of Participants|74|74.0||||||
4075743|NCT01032629|3898315|B3|New Zealand||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4075744|NCT01032629|3898316|B2|New Zealand||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4075745|NCT01032629|3898317|B1|New Zealand||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
4075746|NCT01032629|3898314|B4|Netherlands||Region of Enrollment||Participants|Count of Participants|228|228.0||||||
4075747|NCT01032629|3898315|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|81|81.0||||||
4075748|NCT01032629|3898316|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|77|77.0||||||
4075749|NCT01032629|3898317|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|70|70.0||||||
4075750|NCT01032629|3898314|B4|Mexico||Region of Enrollment||Participants|Count of Participants|124|124.0||||||
4075751|NCT01032629|3898315|B3|Mexico||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
4075752|NCT01032629|3898316|B2|Mexico||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
4075753|NCT01032629|3898317|B1|Mexico||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
4075754|NCT01032629|3898314|B4|Malaysia||Region of Enrollment||Participants|Count of Participants|73|73.0||||||
4075755|NCT01032629|3898315|B3|Malaysia||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
4075756|NCT01032629|3898316|B2|Malaysia||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
4075757|NCT01032629|3898317|B1|Malaysia||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
4075758|NCT01032629|3898314|B4|Luxembourg||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4075759|NCT01032629|3898315|B3|Luxembourg||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4075760|NCT01032629|3898316|B2|Luxembourg||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4075761|NCT01032629|3898317|B1|Luxembourg||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4075762|NCT01032629|3898314|B4|Israel||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4075763|NCT01032629|3898315|B3|Israel||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4075764|NCT01032629|3898316|B2|Israel||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4075765|NCT01032629|3898317|B1|Israel||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4075766|NCT01032629|3898314|B4|India||Region of Enrollment||Participants|Count of Participants|695|695.0||||||
4075767|NCT01032629|3898315|B3|India||Region of Enrollment||Participants|Count of Participants|234|234.0||||||
4075768|NCT01032629|3898316|B2|India||Region of Enrollment||Participants|Count of Participants|232|232.0||||||
4075769|NCT01032629|3898317|B1|India||Region of Enrollment||Participants|Count of Participants|229|229.0||||||
4075770|NCT01032629|3898314|B4|Hungary||Region of Enrollment||Participants|Count of Participants|125|125.0||||||
4075771|NCT01032629|3898315|B3|Hungary||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
4075772|NCT01032629|3898316|B2|Hungary||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
4075773|NCT01032629|3898317|B1|Hungary||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
4075774|NCT01032629|3898314|B4|Germany||Region of Enrollment||Participants|Count of Participants|175|175.0||||||
4075775|NCT01032629|3898315|B3|Germany||Region of Enrollment||Participants|Count of Participants|66|66.0||||||
4075776|NCT01032629|3898316|B2|Germany||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
4075777|NCT01032629|3898317|B1|Germany||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
4075778|NCT01032629|3898314|B4|Estonia||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
4075779|NCT01032629|3898315|B3|Estonia||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4075780|NCT01032629|3898316|B2|Estonia||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4075781|NCT01032629|3898317|B1|Estonia||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4075782|NCT01032629|3898314|B4|Czech Republic||Region of Enrollment||Participants|Count of Participants|117|117.0||||||
4075783|NCT01032629|3898315|B3|Czech Republic||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
4075784|NCT01032629|3898316|B2|Czech Republic||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
4075785|NCT01032629|3898317|B1|Czech Republic||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
4075786|NCT01032629|3898314|B4|Colombia||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4075787|NCT01032629|3898315|B3|Colombia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4075788|NCT01032629|3898316|B2|Colombia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4075789|NCT01032629|3898317|B1|Colombia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4075790|NCT01032629|3898314|B4|Canada||Region of Enrollment||Participants|Count of Participants|396|396.0||||||
4075791|NCT01032629|3898315|B3|Canada||Region of Enrollment||Participants|Count of Participants|123|123.0||||||
4075792|NCT01032629|3898316|B2|Canada||Region of Enrollment||Participants|Count of Participants|139|139.0||||||
4075793|NCT01032629|3898317|B1|Canada||Region of Enrollment||Participants|Count of Participants|134|134.0||||||
4075794|NCT01032629|3898314|B4|Belgium||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
4075795|NCT01032629|3898315|B3|Belgium||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4075796|NCT01032629|3898316|B2|Belgium||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4075797|NCT01032629|3898317|B1|Belgium||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4075798|NCT01032629|3898314|B4|Australia||Region of Enrollment||Participants|Count of Participants|177|177.0||||||
4075799|NCT01032629|3898315|B3|Australia||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
4075800|NCT01032629|3898316|B2|Australia||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
4075801|NCT01032629|3898317|B1|Australia||Region of Enrollment||Participants|Count of Participants|57|57.0||||||
4075802|NCT01032629|3898314|B4|Argentina||Region of Enrollment||Participants|Count of Participants|160|160.0||||||
4075803|NCT01032629|3898315|B3|Argentina||Region of Enrollment||Participants|Count of Participants|55|55.0||||||
4075804|NCT01032629|3898316|B2|Argentina||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
4075805|NCT01032629|3898317|B1|Argentina||Region of Enrollment||Participants|Count of Participants|57|57.0||||||
4075806|NCT01032629|3898314|B4|White Non- Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2811|2811.0||||||
4075807|NCT01032629|3898315|B3|White Non- Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|948|948.0||||||
4075808|NCT01032629|3898316|B2|White Non- Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|934|934.0||||||
4075809|NCT01032629|3898317|B1|White Non- Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|929|929.0||||||
4075810|NCT01032629|3898314|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|256|256.0||||||
4075811|NCT01032629|3898315|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|88|88.0||||||
4075812|NCT01032629|3898316|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|86|86.0||||||
4075813|NCT01032629|3898317|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|82|82.0||||||
4075814|NCT01032629|3898314|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|363|363.0||||||
4075815|NCT01032629|3898315|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|106|106.0||||||
4075816|NCT01032629|3898316|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|123|123.0||||||
4075817|NCT01032629|3898317|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|134|134.0||||||
4075818|NCT01032629|3898314|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|105|105.0||||||
4075819|NCT01032629|3898315|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
4075820|NCT01032629|3898316|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
4075821|NCT01032629|3898317|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
4075822|NCT01032629|3898314|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|795|795.0||||||
4075823|NCT01032629|3898315|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|263|263.0||||||
4075824|NCT01032629|3898316|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|270|270.0||||||
4075825|NCT01032629|3898317|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|262|262.0||||||
4075826|NCT01032629|3898314|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|209|209.0||||||
4075827|NCT01032629|3898315|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4075828|NCT01032629|3898316|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4075829|NCT01032629|3898317|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4075830|NCT01032629|3898314|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4075831|NCT01032629|3898315|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4075832|NCT01032629|3898316|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4075833|NCT01032629|3898317|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4075834|NCT01032629|3898314|B4||White|Race (NIH/OMB)||Participants|Count of Participants|3179|3179.0||||||
4075835|NCT01032629|3898315|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1055|1055.0||||||
4075836|NCT01032629|3898316|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1060|1060.0||||||
4075837|NCT01032629|3898317|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1064|1064.0||||||
4075838|NCT01032629|3898314|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
4075839|NCT01032629|3898315|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4075840|NCT01032629|3898316|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4075841|NCT01032629|3898317|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4075842|NCT01032629|3898314|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4075843|NCT01032629|3898315|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4075844|NCT01032629|3898316|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4075845|NCT01032629|3898317|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4075846|NCT01032629|3898314|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|795|795.0||||||
4075847|NCT01032629|3898315|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|263|263.0||||||
4075848|NCT01032629|3898316|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|270|270.0||||||
4075849|NCT01032629|3898317|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|262|262.0||||||
4075850|NCT01032629|3898314|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4075851|NCT01032629|3898315|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4075852|NCT01032629|3898316|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4075853|NCT01032629|3898317|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4075854|NCT01032629|3898314|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4075855|NCT01032629|3898315|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4075856|NCT01032629|3898316|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4075857|NCT01032629|3898317|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4075858|NCT01032629|3898314|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3905|3905.0||||||
4075859|NCT01032629|3898315|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1317|1317.0||||||
4075860|NCT01032629|3898316|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1300|1300.0||||||
4075861|NCT01032629|3898317|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1288|1288.0||||||
4075862|NCT01032629|3898314|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|416|416.0||||||
4075863|NCT01032629|3898315|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
4075864|NCT01032629|3898316|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|142|142.0||||||
4075865|NCT01032629|3898317|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|149|149.0||||||
4075866|NCT01032629|3898314|B4||Male|Sex: Female, Male||Participants|Count of Participants|2861|2861.0||||||
4075867|NCT01032629|3898315|B3||Male|Sex: Female, Male||Participants|Count of Participants|944|944.0||||||
4075868|NCT01032629|3898316|B2||Male|Sex: Female, Male||Participants|Count of Participants|961|961.0||||||
4075869|NCT01032629|3898317|B1||Male|Sex: Female, Male||Participants|Count of Participants|956|956.0||||||
4075870|NCT01032629|3898314|B4||Female|Sex: Female, Male||Participants|Count of Participants|1469|1469.0||||||
4075871|NCT01032629|3898315|B3||Female|Sex: Female, Male||Participants|Count of Participants|499|499.0||||||
4075872|NCT01032629|3898316|B2||Female|Sex: Female, Male||Participants|Count of Participants|484|484.0||||||
4075873|NCT01032629|3898317|B1||Female|Sex: Female, Male||Participants|Count of Participants|486|486.0||||||
4075874|NCT01032629|3898314|B4|||Age||Years|Mean|62.4|62.4|Standard Deviation|8.02|8.02|||
4075875|NCT01032629|3898315|B3|||Age||Years|Mean|62.8|62.8|Standard Deviation|8.13|8.13|||
4075876|NCT01032629|3898316|B2|||Age||Years|Mean|62.2|62.2|Standard Deviation|8|8.0|||
4075877|NCT01032629|3898317|B1|||Age||Years|Mean|62.3|62.3|Standard Deviation|7.94|7.94|||
4075878|NCT01032538|3898364|B1|Norway||Region of Enrollment||participants|Number|96|96.0||||||
4075879|NCT01032538|3898364|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4075880|NCT01032538|3898364|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4075881|NCT01032538|3898364|B1|||Age||years|Mean|65|65.0|Standard Deviation|6.5|6.5|||
4075882|NCT01032538|3898364|B1||>=65 years|Age||Participants|Count of Participants|54|54.0||||||
4075883|NCT01032538|3898364|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4075884|NCT01032538|3898364|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4075885|NCT01032382|3898370|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4075886|NCT01032382|3898371|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4075887|NCT01032382|3898372|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4075888|NCT01032382|3898370|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4075889|NCT01032382|3898371|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4075890|NCT01032382|3898372|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4075891|NCT01032382|3898370|B3|Children (5 to 11 years)||Age, Customized||participants|Number|13|13.0||||||
4075892|NCT01032382|3898371|B2|Children (5 to 11 years)||Age, Customized||participants|Number|7|7.0||||||
4075893|NCT01032382|3898372|B1|Children (5 to 11 years)||Age, Customized||participants|Number|6|6.0||||||
4075894|NCT01032382|3898370|B3|Children (12 to 17 years)||Age, Customized||participants|Number|8|8.0||||||
4075895|NCT01032382|3898371|B2|Children (12 to 17 years)||Age, Customized||participants|Number|3|3.0||||||
4075896|NCT01032382|3898372|B1|Children (12 to 17 years)||Age, Customized||participants|Number|5|5.0||||||
4075897|NCT01032382|3898370|B3|Adults (18+ years)||Age, Customized||participants|Number|9|9.0||||||
4075898|NCT01032382|3898371|B2|Adults (18+ years)||Age, Customized||participants|Number|4|4.0||||||
4075899|NCT01032382|3898372|B1|Adults (18+ years)||Age, Customized||participants|Number|5|5.0||||||
4075900|NCT01032382|3898370|B3|||Age||years|Mean|19.5|19.5|Standard Deviation|15.5|15.5|||
4075901|NCT01032382|3898371|B2|||Age||years|Mean|18.2|18.2|Standard Deviation|15.1|15.1|||
4075902|NCT01032382|3898372|B1|||Age||years|Mean|20.7|20.7|Standard Deviation|16.2|16.2|||
4075903|NCT01032291|3898399|B4|3-5||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|0|0.0||||||
4075904|NCT01032291|3898400|B3|3-5||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|0|0.0||||||
4075905|NCT01032291|3898401|B2|3-5||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|0|0.0||||||
4075906|NCT01032291|3898402|B1|3-5||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|0|0.0||||||
4075907|NCT01032291|3898399|B4|2||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|1|1.0||||||
4075908|NCT01032291|3898400|B3|2||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|0|0.0||||||
4075909|NCT01032291|3898401|B2|2||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|1|1.0||||||
4075910|NCT01032291|3898402|B1|2||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|0|0.0||||||
4075911|NCT01032291|3898399|B4|1||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|19|19.0||||||
4075912|NCT01032291|3898400|B3|1||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|7|7.0||||||
4075913|NCT01032291|3898401|B2|1||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|10|10.0||||||
4075914|NCT01032291|3898402|B1|1||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|2|2.0||||||
4075915|NCT01032291|3898399|B4|0||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|30|30.0||||||
4075916|NCT01032291|3898400|B3|0||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|14|14.0||||||
4075917|NCT01032291|3898401|B2|0||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|10|10.0||||||
4075918|NCT01032291|3898402|B1|0||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|6|6.0||||||
4075919|NCT01032291|3898399|B4|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
4075920|NCT01032291|3898400|B3|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4075921|NCT01032291|3898401|B2|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4075922|NCT01032291|3898402|B1|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4075923|NCT01032291|3898399|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4075924|NCT01032291|3898400|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4075925|NCT01032291|3898401|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4075926|NCT01032291|3898402|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4075927|NCT01032291|3898399|B4|Other (Not Specified)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4075928|NCT01032291|3898400|B3|Other (Not Specified)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4075929|NCT01032291|3898401|B2|Other (Not Specified)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4075930|NCT01032291|3898402|B1|Other (Not Specified)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4075931|NCT01032291|3898399|B4|Caucasian (White)||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4075932|NCT01032291|3898400|B3|Caucasian (White)||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4075933|NCT01032291|3898401|B2|Caucasian (White)||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4075934|NCT01032291|3898402|B1|Caucasian (White)||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4075935|NCT01032291|3898399|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4075936|NCT01032291|3898400|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4075937|NCT01032291|3898401|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4075938|NCT01032291|3898402|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4075939|NCT01032291|3898399|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4075940|NCT01032291|3898400|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4075941|NCT01032291|3898401|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4075942|NCT01032291|3898402|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4075943|NCT01032291|3898399|B4|>65 years||Age, Customized|All baseline measures are reported from the safety population.|participants|Number|9|9.0||||||
4075944|NCT01032291|3898400|B3|>65 years||Age, Customized|All baseline measures are reported from the safety population.|participants|Number|3|3.0||||||
4075945|NCT01032291|3898401|B2|>65 years||Age, Customized|All baseline measures are reported from the safety population.|participants|Number|5|5.0||||||
4075946|NCT01032291|3898402|B1|>65 years||Age, Customized|All baseline measures are reported from the safety population.|participants|Number|1|1.0||||||
4075947|NCT01032291|3898399|B4|<= 65 years||Age, Customized|All baseline measures are reported from the safety population.|participants|Number|41|41.0||||||
4075948|NCT01032291|3898400|B3|<= 65 years||Age, Customized|All baseline measures are reported from the safety population.|participants|Number|18|18.0||||||
4075949|NCT01032291|3898401|B2|<= 65 years||Age, Customized|All baseline measures are reported from the safety population.|participants|Number|16|16.0||||||
4075950|NCT01032291|3898402|B1|<= 65 years||Age, Customized|All baseline measures are reported from the safety population.|participants|Number|7|7.0||||||
4075951|NCT01032265|3898428|B3|Unknown||Menopausal status||Participants|Number|9|9.0||||||
4075952|NCT01032265|3898429|B2|Unknown||Menopausal status||Participants|Number|4|4.0||||||
4075953|NCT01032265|3898430|B1|Unknown||Menopausal status||Participants|Number|5|5.0||||||
4075954|NCT01032265|3898428|B3|Not postmenopausal||Menopausal status||Participants|Number|150|150.0||||||
4075955|NCT01032265|3898429|B2|Not postmenopausal||Menopausal status||Participants|Number|77|77.0||||||
4075956|NCT01032265|3898430|B1|Not postmenopausal||Menopausal status||Participants|Number|73|73.0||||||
4075957|NCT01032265|3898428|B3|Postmenopausal||Menopausal status||Participants|Number|91|91.0||||||
4075958|NCT01032265|3898429|B2|Postmenopausal||Menopausal status||Participants|Number|43|43.0||||||
4075959|NCT01032265|3898430|B1|Postmenopausal||Menopausal status||Participants|Number|48|48.0||||||
4075960|NCT01032265|3898428|B3|4 children||Parity|number of births|Participants|Number|22|22.0||||||
4075961|NCT01032265|3898429|B2|4 children||Parity|number of births|Participants|Number|11|11.0||||||
4075962|NCT01032265|3898430|B1|4 children||Parity|number of births|Participants|Number|11|11.0||||||
4075963|NCT01032265|3898428|B3|3 children||Parity|number of births|Participants|Number|52|52.0||||||
4075964|NCT01032265|3898429|B2|3 children||Parity|number of births|Participants|Number|21|21.0||||||
4075965|NCT01032265|3898430|B1|3 children||Parity|number of births|Participants|Number|31|31.0||||||
4075966|NCT01032265|3898428|B3|2 children||Parity|number of births|Participants|Number|123|123.0||||||
4075967|NCT01032265|3898429|B2|2 children||Parity|number of births|Participants|Number|61|61.0||||||
4075968|NCT01032265|3898430|B1|2 children||Parity|number of births|Participants|Number|62|62.0||||||
4075969|NCT01032265|3898428|B3|1 child||Parity|number of births|Participants|Number|35|35.0||||||
4075970|NCT01032265|3898429|B2|1 child||Parity|number of births|Participants|Number|20|20.0||||||
4075971|NCT01032265|3898430|B1|1 child||Parity|number of births|Participants|Number|15|15.0||||||
4075972|NCT01032265|3898428|B3|Nulliparous||Parity|number of births|Participants|Number|18|18.0||||||
4075973|NCT01032265|3898429|B2|Nulliparous||Parity|number of births|Participants|Number|11|11.0||||||
4075974|NCT01032265|3898430|B1|Nulliparous||Parity|number of births|Participants|Number|7|7.0||||||
4075975|NCT01032265|3898428|B3|Lower||Education||Participants|Number|62|62.0||||||
4075976|NCT01032265|3898429|B2|Lower||Education||Participants|Number|36|36.0||||||
4075977|NCT01032265|3898430|B1|Lower||Education||Participants|Number|26|26.0||||||
4075978|NCT01032265|3898428|B3|< 3 years at university level||Education||Participants|Number|53|53.0||||||
4075979|NCT01032265|3898429|B2|< 3 years at university level||Education||Participants|Number|25|25.0||||||
4075980|NCT01032265|3898430|B1|< 3 years at university level||Education||Participants|Number|28|28.0||||||
4075981|NCT01032265|3898428|B3|>=3 years at university level||Education||Participants|Number|135|135.0||||||
4075982|NCT01032265|3898429|B2|>=3 years at university level||Education||Participants|Number|63|63.0||||||
4075983|NCT01032265|3898430|B1|>=3 years at university level||Education||Participants|Number|72|72.0||||||
4075984|NCT01032265|3898428|B3|Non-smoker||Smoking||Participants|Number|241|241.0||||||
4075985|NCT01032265|3898429|B2|Non-smoker||Smoking||Participants|Number|120|120.0||||||
4075986|NCT01032265|3898430|B1|Non-smoker||Smoking||Participants|Number|121|121.0||||||
4075987|NCT01032265|3898428|B3|Smoker||Smoking||Participants|Number|9|9.0||||||
4075988|NCT01032265|3898429|B2|Smoker||Smoking||Participants|Number|4|4.0||||||
4075989|NCT01032265|3898430|B1|Smoker||Smoking||Participants|Number|5|5.0||||||
4075990|NCT01032265|3898428|B3|||Body Mass index||kg/m2|Mean|24.6|24.6|Standard Deviation|3.9|3.9|||
4075991|NCT01032265|3898429|B2|||Body Mass index||kg/m2|Mean|24.7|24.7|Standard Deviation|4.2|4.2|||
4075992|NCT01032265|3898430|B1|||Body Mass index||kg/m2|Mean|24.5|24.5|Standard Deviation|3.6|3.6|||
4075993|NCT01032265|3898428|B3|Sweden||Region of Enrollment||participants|Number|250|250.0||||||
4075994|NCT01032265|3898429|B2|Sweden||Region of Enrollment||participants|Number|124|124.0||||||
4075995|NCT01032265|3898430|B1|Sweden||Region of Enrollment||participants|Number|126|126.0||||||
4075996|NCT01032265|3898428|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4075997|NCT01032265|3898429|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4075998|NCT01032265|3898430|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4075999|NCT01032265|3898428|B3||Female|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
4076000|NCT01032265|3898429|B2||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4076001|NCT01032265|3898430|B1||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4076002|NCT01032265|3898428|B3|||Age||years|Mean|48.6|48.6|Standard Deviation|10.2|10.2|||
4076003|NCT01032265|3898429|B2|||Age||years|Mean|47.9|47.9|Standard Deviation|10.6|10.6|||
4076004|NCT01032265|3898430|B1|||Age||years|Mean|49.4|49.4|Standard Deviation|9.8|9.8|||
4076005|NCT01032239|3898449|B3|||Time since stroke||years|Mean|4.76|4.76|Standard Deviation|3.62|3.62|||
4076006|NCT01032239|3898450|B2|||Time since stroke||years|Mean|4.55|4.55|Standard Deviation|3.73|3.73|||
4076007|NCT01032239|3898451|B1|||Time since stroke||years|Mean|4.95|4.95|Standard Deviation|3.56|3.56|||
4076008|NCT01032239|3898449|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4076009|NCT01032239|3898450|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4076010|NCT01032239|3898451|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4076011|NCT01032239|3898449|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
4076012|NCT01032239|3898450|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
4076013|NCT01032239|3898451|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
4076014|NCT01032239|3898449|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4076015|NCT01032239|3898450|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4076016|NCT01032239|3898451|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4076017|NCT01032239|3898449|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4076018|NCT01032239|3898450|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4076019|NCT01032239|3898451|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4076020|NCT01032239|3898449|B3|||Age||years|Mean|55.89|55.89|Standard Deviation|9.90|9.9|||
4076021|NCT01032239|3898450|B2|||Age||years|Mean|55.67|55.67|Standard Deviation|8.60|8.6|||
4076022|NCT01032239|3898451|B1|||Age||years|Mean|56.09|56.09|Standard Deviation|11.12|11.12|||
4076023|NCT01032200|3898480|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
4076024|NCT01032200|3898481|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4076025|NCT01032200|3898482|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4076026|NCT01032200|3898480|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076027|NCT01032200|3898481|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076028|NCT01032200|3898482|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076029|NCT01032200|3898480|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076030|NCT01032200|3898481|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076031|NCT01032200|3898482|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076032|NCT01032200|3898480|B3||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4076033|NCT01032200|3898481|B2||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4076034|NCT01032200|3898482|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4076035|NCT01032200|3898480|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4076036|NCT01032200|3898481|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4076037|NCT01032200|3898482|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076038|NCT01032200|3898480|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076039|NCT01032200|3898481|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076040|NCT01032200|3898482|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076041|NCT01032200|3898480|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4076042|NCT01032200|3898481|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4076043|NCT01032200|3898482|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076044|NCT01032200|3898480|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076045|NCT01032200|3898481|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076046|NCT01032200|3898482|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076047|NCT01032200|3898480|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076048|NCT01032200|3898481|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076049|NCT01032200|3898482|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076050|NCT01032200|3898480|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4076051|NCT01032200|3898481|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4076052|NCT01032200|3898482|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4076053|NCT01032200|3898480|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4076054|NCT01032200|3898481|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076055|NCT01032200|3898482|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4076056|NCT01032200|3898480|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4076057|NCT01032200|3898481|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4076058|NCT01032200|3898482|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4076059|NCT01032200|3898480|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4076060|NCT01032200|3898481|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4076061|NCT01032200|3898482|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4076062|NCT01032200|3898480|B3|||Age||years|Median|59|59.0|Full Range|||20.0|79.0|
4076063|NCT01032200|3898481|B2|||Age||years|Median|58|58.0|Full Range|||29.0|79.0|
4076064|NCT01032200|3898482|B1|||Age||years|Median|59|59.0|Full Range|||28.0|78.0|
4076065|NCT01032200|3898480|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4076066|NCT01032200|3898481|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4076067|NCT01032200|3898482|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4076068|NCT01032200|3898480|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4076069|NCT01032200|3898481|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4076070|NCT01032200|3898482|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4076071|NCT01032200|3898480|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076072|NCT01032200|3898481|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076073|NCT01032200|3898482|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076074|NCT01032174|3898497|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4076075|NCT01032174|3898498|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4076076|NCT01032174|3898499|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4076077|NCT01032174|3898497|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4076078|NCT01032174|3898498|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4076079|NCT01032174|3898499|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4076080|NCT01032174|3898497|B3|||Age||years|Mean|37.6|37.6|Standard Deviation|12.5|12.5|||
4076081|NCT01032174|3898498|B2|||Age||years|Mean|38.4|38.4|Standard Deviation|13.4|13.4|||
4076082|NCT01032174|3898499|B1|||Age||years|Mean|36.9|36.9|Standard Deviation|11.6|11.6|||
4076083|NCT01032135|3898510|B6|United States||Region of Enrollment||participants|Number|500|500.0||||||
4076084|NCT01032135|3898511|B5|United States||Region of Enrollment||participants|Number|43|43.0||||||
4076085|NCT01032135|3898512|B4|United States||Region of Enrollment||participants|Number|41|41.0||||||
4076086|NCT01032135|3898513|B3|United States||Region of Enrollment||participants|Number|96|96.0||||||
4076087|NCT01032135|3898514|B2|United States||Region of Enrollment||participants|Number|93|93.0||||||
4076088|NCT01032135|3898515|B1|United States||Region of Enrollment||participants|Number|227|227.0||||||
4076089|NCT01032135|3898510|B6||Male|Sex: Female, Male||Participants|Count of Participants|405|405.0||||||
4076090|NCT01032135|3898511|B5||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4076091|NCT01032135|3898512|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4076092|NCT01032135|3898513|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4076093|NCT01032135|3898514|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4076094|NCT01032135|3898515|B1||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4076095|NCT01032135|3898510|B6||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4076096|NCT01032135|3898511|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4076097|NCT01032135|3898512|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4076098|NCT01032135|3898513|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4076099|NCT01032135|3898514|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4076100|NCT01032135|3898515|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4076101|NCT01032135|3898510|B6|||Age||years|Mean|48.29|48.29|Standard Deviation|8.92|8.92|||
4076102|NCT01032135|3898511|B5|||Age||years|Mean|48.5|48.5|Standard Deviation|9.64|9.64|||
4076103|NCT01032135|3898512|B4|||Age||years|Mean|47.8|47.8|Standard Deviation|9.42|9.42|||
4076104|NCT01032135|3898513|B3|||Age||years|Mean|47.7|47.7|Standard Deviation|9.38|9.38|||
4076105|NCT01032135|3898514|B2|||Age||years|Mean|48.02|48.02|Standard Deviation|9.84|9.84|||
4076106|NCT01032135|3898515|B1|||Age||years|Mean|49.4|49.4|Standard Deviation|8.35|8.35|||
4076107|NCT01032135|3898510|B6||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4076108|NCT01032135|3898511|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4076109|NCT01032135|3898512|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4076110|NCT01032135|3898513|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4076111|NCT01032135|3898514|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4076112|NCT01032135|3898515|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4076113|NCT01032135|3898510|B6||Between 18 and 65 years|Age||Participants|Count of Participants|493|493.0||||||
4076114|NCT01032135|3898511|B5||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4076115|NCT01032135|3898512|B4||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4076116|NCT01032135|3898513|B3||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
4076117|NCT01032135|3898514|B2||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
4076118|NCT01032135|3898515|B1||Between 18 and 65 years|Age||Participants|Count of Participants|224|224.0||||||
4076119|NCT01032135|3898510|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076120|NCT01032135|3898511|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076121|NCT01032135|3898512|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076122|NCT01032135|3898513|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076123|NCT01032135|3898514|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076124|NCT01032135|3898515|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076125|NCT01032070|3898738|B3|||Total Number of Disease Recurrences||recurrences|Median|2|2.0|Full Range|1.7|1.7|1.0|9.0|
4076126|NCT01032070|3898739|B2|||Total Number of Disease Recurrences||recurrences|Median|2|2.0|Full Range|0.8|0.8|1.0|3.0|
4076127|NCT01032070|3898740|B1|||Total Number of Disease Recurrences||recurrences|Median|3|3.0|Full Range|2.1|2.1|1.0|9.0|
4076128|NCT01032070|3898738|B3|Myxopapillary Ependymoma||Tumor Type for Initial Disease Diagnosis||participants|Number|1|1.0||||||
4076129|NCT01032070|3898739|B2|Myxopapillary Ependymoma||Tumor Type for Initial Disease Diagnosis||participants|Number|0|0.0||||||
4076130|NCT01032070|3898740|B1|Myxopapillary Ependymoma||Tumor Type for Initial Disease Diagnosis||participants|Number|1|1.0||||||
4076131|NCT01032070|3898738|B3|Ependymoma||Tumor Type for Initial Disease Diagnosis||participants|Number|9|9.0||||||
4076132|NCT01032070|3898739|B2|Ependymoma||Tumor Type for Initial Disease Diagnosis||participants|Number|3|3.0||||||
4076133|NCT01032070|3898740|B1|Ependymoma||Tumor Type for Initial Disease Diagnosis||participants|Number|6|6.0||||||
4076134|NCT01032070|3898738|B3|Anaplastic Ependymoma||Tumor Type for Initial Disease Diagnosis||participants|Number|15|15.0||||||
4076135|NCT01032070|3898739|B2|Anaplastic Ependymoma||Tumor Type for Initial Disease Diagnosis||participants|Number|9|9.0||||||
4076136|NCT01032070|3898740|B1|Anaplastic Ependymoma||Tumor Type for Initial Disease Diagnosis||participants|Number|6|6.0||||||
4076137|NCT01032070|3898738|B3|||Body Surface Area (BSA)||m^2|Mean|1.35|1.35|Standard Deviation|0.521|0.521|||
4076138|NCT01032070|3898739|B2|||Body Surface Area (BSA)||m^2|Mean|1.17|1.17|Standard Deviation|0.439|0.439|||
4076139|NCT01032070|3898740|B1|||Body Surface Area (BSA)||m^2|Mean|1.51|1.51|Standard Deviation|0.556|0.556|||
4076140|NCT01032070|3898738|B3|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4076141|NCT01032070|3898739|B2|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4076142|NCT01032070|3898740|B1|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4076143|NCT01032070|3898738|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4076144|NCT01032070|3898739|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4076145|NCT01032070|3898740|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4076146|NCT01032070|3898738|B3|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4076147|NCT01032070|3898739|B2|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4076148|NCT01032070|3898740|B1|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4076149|NCT01032070|3898738|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4076150|NCT01032070|3898739|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4076151|NCT01032070|3898740|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4076152|NCT01032070|3898738|B3|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4076153|NCT01032070|3898739|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4076154|NCT01032070|3898740|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4076155|NCT01032070|3898738|B3|Asian - Southeast Asia||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4076156|NCT01032070|3898739|B2|Asian - Southeast Asia||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4076157|NCT01032070|3898740|B1|Asian - Southeast Asia||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4076158|NCT01032070|3898738|B3|Asian - Indian Subcontinent||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4076159|NCT01032070|3898739|B2|Asian - Indian Subcontinent||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4076160|NCT01032070|3898740|B1|Asian - Indian Subcontinent||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4076161|NCT01032070|3898738|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4076162|NCT01032070|3898739|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4076163|NCT01032070|3898740|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4076164|NCT01032070|3898738|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4076165|NCT01032070|3898739|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4076166|NCT01032070|3898740|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4076167|NCT01032070|3898738|B3|||Age||years|Mean|11.1|11.1|Standard Deviation|5.67|5.67|||
4076168|NCT01032070|3898739|B2|||Age||years|Mean|9.2|9.2|Standard Deviation|4.99|4.99|||
4076169|NCT01032070|3898740|B1|||Age||years|Mean|12.8|12.8|Standard Deviation|5.87|5.87|||
4076170|NCT01032044|3898768|B3||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4076171|NCT01032044|3898769|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4076172|NCT01032044|3898770|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4076173|NCT01032044|3898768|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4076174|NCT01032044|3898769|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4076175|NCT01032044|3898770|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4076176|NCT01032044|3898768|B3|||Age||years|Mean|68.8|68.8|Full Range|||45.4|87.2|
4076177|NCT01032044|3898769|B2|||Age||years|Mean|69.6|69.6|Full Range|||50.2|86.1|
4076178|NCT01032044|3898770|B1|||Age||years|Mean|67.9|67.9|Full Range|||45.4|87.2|
4076179|NCT01032018|3898777|B3|Bundle branch block/uncertain type of MI||Type of presenting acute coronary syndrome|MI = Myocardial Infarction|participants|Number|3|3.0||||||
4076180|NCT01032018|3898778|B2|Bundle branch block/uncertain type of MI||Type of presenting acute coronary syndrome|MI = Myocardial Infarction|participants|Number|1|1.0||||||
4076181|NCT01032018|3898779|B1|Bundle branch block/uncertain type of MI||Type of presenting acute coronary syndrome|MI = Myocardial Infarction|participants|Number|2|2.0||||||
4076182|NCT01032018|3898777|B3|ST-segment elevated MI||Type of presenting acute coronary syndrome|MI = Myocardial Infarction|participants|Number|40|40.0||||||
4076183|NCT01032018|3898778|B2|ST-segment elevated MI||Type of presenting acute coronary syndrome|MI = Myocardial Infarction|participants|Number|19|19.0||||||
4076184|NCT01032018|3898779|B1|ST-segment elevated MI||Type of presenting acute coronary syndrome|MI = Myocardial Infarction|participants|Number|21|21.0||||||
4076185|NCT01032018|3898777|B3|Non-ST segment elevated MI||Type of presenting acute coronary syndrome|MI = Myocardial Infarction|participants|Number|37|37.0||||||
4076186|NCT01032018|3898778|B2|Non-ST segment elevated MI||Type of presenting acute coronary syndrome|MI = Myocardial Infarction|participants|Number|18|18.0||||||
4076187|NCT01032018|3898779|B1|Non-ST segment elevated MI||Type of presenting acute coronary syndrome|MI = Myocardial Infarction|participants|Number|19|19.0||||||
4076188|NCT01032018|3898777|B3|Unstable angina||Type of presenting acute coronary syndrome|MI = Myocardial Infarction|participants|Number|70|70.0||||||
4076189|NCT01032018|3898778|B2|Unstable angina||Type of presenting acute coronary syndrome|MI = Myocardial Infarction|participants|Number|35|35.0||||||
4076190|NCT01032018|3898779|B1|Unstable angina||Type of presenting acute coronary syndrome|MI = Myocardial Infarction|participants|Number|35|35.0||||||
4076191|NCT01032018|3898777|B3|BDI score >= 16||Beck Depression Inventory Score, categorical||participants|Number|102|102.0||||||
4076192|NCT01032018|3898778|B2|BDI score >= 16||Beck Depression Inventory Score, categorical||participants|Number|52|52.0||||||
4076193|NCT01032018|3898779|B1|BDI score >= 16||Beck Depression Inventory Score, categorical||participants|Number|50|50.0||||||
4076194|NCT01032018|3898777|B3|BDI score < 16||Beck Depression Inventory Score, categorical||participants|Number|48|48.0||||||
4076195|NCT01032018|3898778|B2|BDI score < 16||Beck Depression Inventory Score, categorical||participants|Number|21|21.0||||||
4076196|NCT01032018|3898779|B1|BDI score < 16||Beck Depression Inventory Score, categorical||participants|Number|27|27.0||||||
4076197|NCT01032018|3898777|B3|||Beck Depression Inventory Score, continuous|The Beck Depression Inventory (BDI) is a 21-item multiple choice, self-report instrument that is used to assess the severity of symptoms of depression. The score ranges from 0 (no symptoms) to 63 (worst symptoms).|Scores on a scale|Mean|20.8|20.8|Standard Deviation|7.7|7.7|||
4076198|NCT01032018|3898778|B2|||Beck Depression Inventory Score, continuous|The Beck Depression Inventory (BDI) is a 21-item multiple choice, self-report instrument that is used to assess the severity of symptoms of depression. The score ranges from 0 (no symptoms) to 63 (worst symptoms).|Scores on a scale|Mean|21.0|21.0|Standard Deviation|7.6|7.6|||
4076199|NCT01032018|3898779|B1|||Beck Depression Inventory Score, continuous|The Beck Depression Inventory (BDI) is a 21-item multiple choice, self-report instrument that is used to assess the severity of symptoms of depression. The score ranges from 0 (no symptoms) to 63 (worst symptoms).|Scores on a scale|Mean|20.6|20.6|Standard Deviation|7.8|7.8|||
4076200|NCT01032018|3898777|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4076201|NCT01032018|3898778|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4076202|NCT01032018|3898779|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4076203|NCT01032018|3898777|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076204|NCT01032018|3898778|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076205|NCT01032018|3898779|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076206|NCT01032018|3898777|B3||White|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
4076207|NCT01032018|3898778|B2||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4076208|NCT01032018|3898779|B1||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4076209|NCT01032018|3898777|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4076210|NCT01032018|3898778|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4076211|NCT01032018|3898779|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4076212|NCT01032018|3898777|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4076213|NCT01032018|3898778|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076214|NCT01032018|3898779|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4076215|NCT01032018|3898777|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076216|NCT01032018|3898778|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076217|NCT01032018|3898779|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076218|NCT01032018|3898777|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4076219|NCT01032018|3898778|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4076220|NCT01032018|3898779|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076221|NCT01032018|3898777|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4076222|NCT01032018|3898778|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4076223|NCT01032018|3898779|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076224|NCT01032018|3898777|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
4076225|NCT01032018|3898778|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4076226|NCT01032018|3898779|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4076227|NCT01032018|3898777|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4076228|NCT01032018|3898778|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4076229|NCT01032018|3898779|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4076230|NCT01032018|3898777|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4076231|NCT01032018|3898778|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4076232|NCT01032018|3898779|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4076233|NCT01032018|3898777|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4076234|NCT01032018|3898778|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4076235|NCT01032018|3898779|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4076236|NCT01032018|3898777|B3|||Age||years|Mean|59.6|59.6|Standard Deviation|10.4|10.4|||
4076237|NCT01032018|3898778|B2|||Age||years|Mean|59.2|59.2|Standard Deviation|9.7|9.7|||
4076238|NCT01032018|3898779|B1|||Age||years|Mean|60.0|60.0|Standard Deviation|11.1|11.1|||
4076239|NCT01031979|3898788|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4076240|NCT01031979|3898789|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4076241|NCT01031979|3898790|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4076242|NCT01031979|3898788|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4076243|NCT01031979|3898789|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4076244|NCT01031979|3898790|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4076245|NCT01031979|3898788|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4076246|NCT01031979|3898789|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4076247|NCT01031979|3898790|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4076248|NCT01031979|3898788|B3|||Age||years|Mean|32.4|32.4|Full Range|||18.0|45.0|
4076249|NCT01031979|3898789|B2|||Age||years|Mean|29.9|29.9|Full Range|||18.0|45.0|
4076250|NCT01031979|3898790|B1|||Age||years|Mean|34.6|34.6|Full Range|||18.0|45.0|
4076251|NCT01031979|3898788|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4076252|NCT01031979|3898789|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4076253|NCT01031979|3898790|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4076254|NCT01031979|3898788|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4076255|NCT01031979|3898789|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4076256|NCT01031979|3898790|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4076257|NCT01031979|3898788|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076258|NCT01031979|3898789|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076259|NCT01031979|3898790|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076260|NCT01031953|3898803|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4076261|NCT01031953|3898803|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4076262|NCT01031953|3898803|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4076263|NCT01031953|3898803|B1|||Age||years|Mean|45|45.0|Standard Deviation|12|12.0|||
4076264|NCT01031953|3898803|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4076265|NCT01031953|3898803|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4076266|NCT01031953|3898803|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076267|NCT01031914|3898814|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4076268|NCT01031914|3898814|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4076269|NCT01031914|3898814|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4076270|NCT01031914|3898814|B1|||Age||years|Mean|48.1|48.1|Standard Deviation|11.9|11.9|||
4076271|NCT01031914|3898814|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4076272|NCT01031914|3898814|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4076273|NCT01031914|3898814|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076274|NCT01031836|3898818|B7||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4076275|NCT01031836|3898819|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4076276|NCT01031836|3898820|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4076277|NCT01031836|3898821|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4076278|NCT01031836|3898822|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4076279|NCT01031836|3898823|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4076280|NCT01031836|3898824|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4076281|NCT01031836|3898818|B7||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4076282|NCT01031836|3898819|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4076283|NCT01031836|3898820|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4076284|NCT01031836|3898821|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4076285|NCT01031836|3898822|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4076286|NCT01031836|3898823|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4076287|NCT01031836|3898824|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4076288|NCT01031836|3898818|B7|||Age||years|Mean|40|40.0|Standard Deviation|11|11.0|||
4076289|NCT01031836|3898819|B6|||Age||years|Mean|48|48.0|Standard Deviation|13|13.0|||
4076290|NCT01031836|3898820|B5|||Age||years|Mean|46|46.0|Standard Deviation|10|10.0|||
4076291|NCT01031836|3898821|B4|||Age||years|Mean|37|37.0|Standard Deviation|9|9.0|||
4076292|NCT01031836|3898822|B3|||Age||years|Mean|34|34.0|Standard Deviation|9|9.0|||
4076293|NCT01031836|3898823|B2|||Age||years|Mean|43|43.0|Standard Deviation|13|13.0|||
4076294|NCT01031836|3898824|B1|||Age||years|Mean|30|30.0|Standard Deviation|3|3.0|||
4076295|NCT01031810|3898879|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4076296|NCT01031810|3898879|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4076297|NCT01031810|3898879|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4076298|NCT01031810|3898879|B1|||Age||years|Mean|43.3|43.3|Standard Deviation|10.5|10.5|||
4076299|NCT01031810|3898879|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4076300|NCT01031810|3898879|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4076301|NCT01031810|3898879|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076302|NCT01031706|3898888|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4076303|NCT01031706|3898889|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4076304|NCT01031706|3898890|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4076305|NCT01031706|3898888|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4076306|NCT01031706|3898889|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4076307|NCT01031706|3898890|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4076308|NCT01031706|3898888|B3|||Age||years|Mean|11.1|11.1|Standard Deviation|3.5|3.5|||
4076309|NCT01031706|3898889|B2|||Age||years|Mean|9.8|9.8|Standard Deviation|3.6|3.6|||
4076310|NCT01031706|3898890|B1|||Age||years|Mean|11.9|11.9|Standard Deviation|3.3|3.3|||
4076311|NCT01031680|3898899|B3|>= 30 kg/m²||Body Mass Index (BMI)||Participants|Number|595|595.0||||||
4076312|NCT01031680|3898900|B2|>= 30 kg/m²||Body Mass Index (BMI)||Participants|Number|304|304.0||||||
4076313|NCT01031680|3898901|B1|>= 30 kg/m²||Body Mass Index (BMI)||Participants|Number|291|291.0||||||
4076314|NCT01031680|3898899|B3|>= 27 kg/m²||Body Mass Index (BMI)||Participants|Number|785|785.0||||||
4076315|NCT01031680|3898900|B2|>= 27 kg/m²||Body Mass Index (BMI)||Participants|Number|397|397.0||||||
4076316|NCT01031680|3898901|B1|>= 27 kg/m²||Body Mass Index (BMI)||Participants|Number|388|388.0||||||
4076317|NCT01031680|3898899|B3|>= 25 kg/m²||Body Mass Index (BMI)||Participants|Number|855|855.0||||||
4076318|NCT01031680|3898900|B2|>= 25 kg/m²||Body Mass Index (BMI)||Participants|Number|429|429.0||||||
4076319|NCT01031680|3898901|B1|>= 25 kg/m²||Body Mass Index (BMI)||Participants|Number|426|426.0||||||
4076320|NCT01031680|3898899|B3|< 25 kg/m²||Body Mass Index (BMI)||Participants|Number|59|59.0||||||
4076321|NCT01031680|3898900|B2|< 25 kg/m²||Body Mass Index (BMI)||Participants|Number|30|30.0||||||
4076322|NCT01031680|3898901|B1|< 25 kg/m²||Body Mass Index (BMI)||Participants|Number|29|29.0||||||
4076323|NCT01031680|3898899|B3|||Total Body Weight||kg|Mean|93.11|93.11|Standard Deviation|19.985|19.985|||
4076324|NCT01031680|3898900|B2|||Total Body Weight||kg|Mean|93.59|93.59|Standard Deviation|19.467|19.467|||
4076325|NCT01031680|3898901|B1|||Total Body Weight||kg|Mean|92.63|92.63|Standard Deviation|20.504|20.504|||
4076326|NCT01031680|3898899|B3|||Seated Systolic Blood Pressure||mm Hg|Mean|133.2|133.2|Standard Deviation|13.64|13.64|||
4076327|NCT01031680|3898900|B2|||Seated Systolic Blood Pressure||mm Hg|Mean|133.0|133.0|Standard Deviation|13.81|13.81|||
4076328|NCT01031680|3898901|B1|||Seated Systolic Blood Pressure||mm Hg|Mean|133.5|133.5|Standard Deviation|13.48|13.48|||
4076329|NCT01031680|3898899|B3|||Haemoglobin A1c (HbA1c)||Percent|Mean|8.13|8.13|Standard Deviation|0.823|0.823|||
4076330|NCT01031680|3898900|B2|||Haemoglobin A1c (HbA1c)||Percent|Mean|8.08|8.08|Standard Deviation|0.802|0.802|||
4076331|NCT01031680|3898901|B1|||Haemoglobin A1c (HbA1c)||Percent|Mean|8.18|8.18|Standard Deviation|0.841|0.841|||
4076332|NCT01031680|3898899|B3||Male|Sex: Female, Male||Participants|Count of Participants|624|624.0||||||
4076333|NCT01031680|3898900|B2||Male|Sex: Female, Male||Participants|Count of Participants|315|315.0||||||
4076334|NCT01031680|3898901|B1||Male|Sex: Female, Male||Participants|Count of Participants|309|309.0||||||
4076335|NCT01031680|3898899|B3||Female|Sex: Female, Male||Participants|Count of Participants|290|290.0||||||
4076336|NCT01031680|3898900|B2||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4076337|NCT01031680|3898901|B1||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4076338|NCT01031680|3898899|B3|>=75||Age, Customized||Participants|Number|59|59.0||||||
4076339|NCT01031680|3898900|B2|>=75||Age, Customized||Participants|Number|31|31.0||||||
4076340|NCT01031680|3898901|B1|>=75||Age, Customized||Participants|Number|28|28.0||||||
4076341|NCT01031680|3898899|B3|>=65 and <75||Age, Customized||Participants|Number|329|329.0||||||
4076342|NCT01031680|3898900|B2|>=65 and <75||Age, Customized||Participants|Number|165|165.0||||||
4076343|NCT01031680|3898901|B1|>=65 and <75||Age, Customized||Participants|Number|164|164.0||||||
4076344|NCT01031680|3898899|B3|>=55 and <65||Age, Customized||Participants|Number|394|394.0||||||
4076345|NCT01031680|3898900|B2|>=55 and <65||Age, Customized||Participants|Number|189|189.0||||||
4076346|NCT01031680|3898901|B1|>=55 and <65||Age, Customized||Participants|Number|205|205.0||||||
4076347|NCT01031680|3898899|B3|<55||Age, Customized||Participants|Number|132|132.0||||||
4076348|NCT01031680|3898900|B2|<55||Age, Customized||Participants|Number|74|74.0||||||
4076349|NCT01031680|3898901|B1|<55||Age, Customized||Participants|Number|58|58.0||||||
4076350|NCT01031680|3898899|B3|||Age||Years|Mean|62.9|62.9|Standard Deviation|7.32|7.32|||
4076351|NCT01031680|3898900|B2|||Age||Years|Mean|63.0|63.0|Standard Deviation|7.66|7.66|||
4076352|NCT01031680|3898901|B1|||Age||Years|Mean|62.8|62.8|Standard Deviation|6.97|6.97|||
4076353|NCT01031628|3898918|B5|United States||Region of Enrollment||participants|Number|4|4.0||||||
4076354|NCT01031628|3898920|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4076355|NCT01031628|3898921|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4076356|NCT01031628|3898918|B5|Male||Gender||participants|Number|2|2.0||||||
4076357|NCT01031628|3898920|B3|Male||Gender||participants|Number|2|2.0||||||
4076358|NCT01031628|3898921|B2|Male||Gender||participants|Number|0|0.0||||||
4076359|NCT01031628|3898918|B5|Female||Gender||participants|Number|2|2.0||||||
4076360|NCT01031628|3898920|B3|Female||Gender||participants|Number|1|1.0||||||
4076361|NCT01031628|3898921|B2|Female||Gender||participants|Number|1|1.0||||||
4076362|NCT01031628|3898918|B5|||Age||years|Mean|60.25|60.25|Standard Deviation|7.68|7.68|||
4076363|NCT01031628|3898920|B3|||Age||years|Mean|56.7|56.7|Standard Deviation|8.39|8.39|||
4076364|NCT01031628|3898921|B2|||Age||years|Mean|71|71.0|Standard Deviation|||||
4076365|NCT01031628|3898918|B5|>=65 years||Age||participants|Number|1|1.0||||||
4076366|NCT01031628|3898920|B3|>=65 years||Age||participants|Number|0|0.0||||||
4076367|NCT01031628|3898921|B2|>=65 years||Age||participants|Number|1|1.0||||||
4076368|NCT01031628|3898918|B5|Between 18 and 65 years||Age||participants|Number|3|3.0||||||
4076369|NCT01031628|3898920|B3|Between 18 and 65 years||Age||participants|Number|3|3.0||||||
4076370|NCT01031628|3898921|B2|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
4076371|NCT01031628|3898918|B5|<=18 years||Age||participants|Number|0|0.0||||||
4076372|NCT01031628|3898920|B3|<=18 years||Age||participants|Number|0|0.0||||||
4076373|NCT01031628|3898921|B2|<=18 years||Age||participants|Number|0|0.0||||||
4076374|NCT01031550|3898935|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4076375|NCT01031550|3898936|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4076376|NCT01031550|3898937|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4076377|NCT01031550|3898935|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4076378|NCT01031550|3898936|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4076379|NCT01031550|3898937|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4076380|NCT01031550|3898935|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4076381|NCT01031550|3898936|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4076382|NCT01031550|3898937|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4076383|NCT01031550|3898935|B3|||Age||years|Mean|39|39.0|Standard Deviation|9|9.0|||
4076384|NCT01031550|3898936|B2|||Age||years|Mean|38|38.0|Standard Deviation|8|8.0|||
4076385|NCT01031550|3898937|B1|||Age||years|Mean|40|40.0|Standard Deviation|10|10.0|||
4076386|NCT01031550|3898935|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4076387|NCT01031550|3898936|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4076388|NCT01031550|3898937|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4076389|NCT01031550|3898935|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4076390|NCT01031550|3898936|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4076391|NCT01031550|3898937|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4076392|NCT01031550|3898935|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076393|NCT01031550|3898936|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076394|NCT01031550|3898937|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076395|NCT01031537|3898950|B1|||Tick-Borne Encephalitis Virus Antibody Neutralization Titer|"Tick-Borne Encephalitis Virus Neutralization antibody level is a laboratory test collected via peripheral venipuncture.~Titer levels > 1:10 reflect the presence of protective antibodies to Tick-Borne Encephalitis Virus.~Presence of protective antibody titers at baseline indicate either prior successful immunization or previous infection from Tick-Borne Encephalitis Virus."|Participants|Count of Participants|6|6.0||||||
4076396|NCT01031537|3898950|B1|United States||Region of Enrollment||Participants|Count of Participants|66|66.0||||||
4076397|NCT01031537|3898950|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076398|NCT01031537|3898950|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4076399|NCT01031537|3898950|B1||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4076400|NCT01031537|3898950|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076401|NCT01031537|3898950|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076402|NCT01031537|3898950|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4076403|NCT01031537|3898950|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4076404|NCT01031537|3898950|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076405|NCT01031537|3898950|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4076406|NCT01031537|3898950|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4076407|NCT01031537|3898950|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4076408|NCT01031537|3898950|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4076409|NCT01031537|3898950|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4076410|NCT01031537|3898950|B1||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4076411|NCT01031537|3898950|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076412|NCT01031498|3898955|B4|United States||Region of Enrollment||participants|Number|150|150.0||||||
4076413|NCT01031498|3898956|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4076414|NCT01031498|3898957|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
4076415|NCT01031498|3898958|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
4076416|NCT01031498|3898955|B4||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4076417|NCT01031498|3898956|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4076418|NCT01031498|3898957|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4076419|NCT01031498|3898958|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4076420|NCT01031498|3898955|B4||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4076421|NCT01031498|3898956|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4076422|NCT01031498|3898957|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4076423|NCT01031498|3898958|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4076424|NCT01031498|3898955|B4|||Age||years|Median|53|53.0|Full Range|||18.0|72.0|
4076425|NCT01031498|3898956|B3|||Age||years|Median|53|53.0|Full Range|||18.0|72.0|
4076426|NCT01031498|3898957|B2|||Age||years|Median|52|52.0|Full Range|||25.0|68.0|
4076427|NCT01031498|3898958|B1|||Age||years|Median|54|54.0|Full Range|||23.0|69.0|
4076428|NCT01031446|3898968|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4076429|NCT01031446|3898968|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4076430|NCT01031446|3898968|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4076431|NCT01031446|3898968|B1|||Age||years|Mean|52|52.0|Standard Deviation|11|11.0|||
4076432|NCT01031446|3898968|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4076433|NCT01031446|3898968|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4076434|NCT01031446|3898968|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076435|NCT01031381|3898977|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076436|NCT01031381|3898977|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076437|NCT01031381|3898977|B1||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4076438|NCT01031381|3898977|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4076439|NCT01031381|3898977|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076440|NCT01031381|3898977|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076441|NCT01031381|3898977|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076442|NCT01031381|3898977|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4076443|NCT01031381|3898977|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4076444|NCT01031381|3898977|B1|||Age||years|Median|60.5|60.5|Full Range|||28.0|82.0|
4076445|NCT01031134|3898982|B3|United States||Region of Enrollment||Participants|Count of Participants|202|202.0||||||
4076446|NCT01031134|3898983|B2|United States||Region of Enrollment||Participants|Count of Participants|88|88.0||||||
4076447|NCT01031134|3898984|B1|United States||Region of Enrollment||Participants|Count of Participants|114|114.0||||||
4076448|NCT01031134|3898982|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076449|NCT01031134|3898983|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076450|NCT01031134|3898984|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076451|NCT01031134|3898982|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4076452|NCT01031134|3898983|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4076453|NCT01031134|3898984|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4076454|NCT01031134|3898982|B3||White|Race (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
4076455|NCT01031134|3898983|B2||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4076456|NCT01031134|3898984|B1||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4076457|NCT01031134|3898982|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4076458|NCT01031134|3898983|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4076459|NCT01031134|3898984|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4076460|NCT01031134|3898982|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076461|NCT01031134|3898983|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076462|NCT01031134|3898984|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076463|NCT01031134|3898982|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076464|NCT01031134|3898983|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076465|NCT01031134|3898984|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076466|NCT01031134|3898982|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4076467|NCT01031134|3898983|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4076468|NCT01031134|3898984|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076469|NCT01031134|3898982|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076470|NCT01031134|3898983|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076471|NCT01031134|3898984|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076472|NCT01031134|3898982|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4076473|NCT01031134|3898983|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4076474|NCT01031134|3898984|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4076475|NCT01031134|3898982|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|184|184.0||||||
4076476|NCT01031134|3898983|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
4076477|NCT01031134|3898984|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
4076478|NCT01031134|3898982|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4076479|NCT01031134|3898983|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4076480|NCT01031134|3898984|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4076481|NCT01031134|3898982|B3||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4076482|NCT01031134|3898983|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4076483|NCT01031134|3898984|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4076484|NCT01031134|3898982|B3||>=65 years|Age||Participants|Count of Participants|202|202.0||||||
4076485|NCT01031134|3898983|B2||>=65 years|Age||Participants|Count of Participants|88|88.0||||||
4076486|NCT01031134|3898984|B1||>=65 years|Age||Participants|Count of Participants|114|114.0||||||
4076487|NCT01031134|3898982|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4076488|NCT01031134|3898983|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4076489|NCT01031134|3898984|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4076490|NCT01031134|3898982|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076491|NCT01031134|3898983|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076492|NCT01031134|3898984|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076493|NCT01031095|3898993|B3|Turkey||Region of Enrollment||participants|Number|200|200.0||||||
4076494|NCT01031095|3898994|B2|Turkey||Region of Enrollment||participants|Number|100|100.0||||||
4076495|NCT01031095|3898995|B1|Turkey||Region of Enrollment||participants|Number|100|100.0||||||
4076496|NCT01031095|3898993|B3||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4076497|NCT01031095|3898994|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4076498|NCT01031095|3898995|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4076499|NCT01031095|3898993|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4076500|NCT01031095|3898994|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4076501|NCT01031095|3898995|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4076502|NCT01031095|3898993|B3|||Age||years|Mean|59.06|59.06|Standard Deviation|10.46|10.46|||
4076503|NCT01031095|3898994|B2|||Age||years|Mean|58.99|58.99|Standard Deviation|11.24|11.24|||
4076504|NCT01031095|3898995|B1|||Age||years|Mean|59.11|59.11|Standard Deviation|9.68|9.68|||
4076505|NCT01031095|3898993|B3||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
4076506|NCT01031095|3898994|B2||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4076507|NCT01031095|3898995|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4076508|NCT01031095|3898993|B3||Between 18 and 65 years|Age||Participants|Count of Participants|160|160.0||||||
4076509|NCT01031095|3898994|B2||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4076510|NCT01031095|3898995|B1||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4076511|NCT01031095|3898993|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076512|NCT01031095|3898994|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076513|NCT01031095|3898995|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076514|NCT01031043|3899002|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4076515|NCT01031043|3899002|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4076516|NCT01031043|3899002|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4076517|NCT01031043|3899002|B1|||Age||years|Median|48|48.0|Standard Deviation|9.8|9.8|||
4076518|NCT01031004|3899006|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4076519|NCT01031004|3899007|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4076520|NCT01031004|3899008|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4076521|NCT01031004|3899006|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4076522|NCT01031004|3899007|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4076523|NCT01031004|3899008|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4076524|NCT01031004|3899006|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4076525|NCT01031004|3899007|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4076526|NCT01031004|3899008|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4076527|NCT01031004|3899006|B3|||Age||years|Mean|29.2|29.2|Standard Deviation|8.13|8.13|||
4076528|NCT01031004|3899007|B2|||Age||years|Mean|29.2|29.2|Standard Deviation|8.08|8.08|||
4076529|NCT01031004|3899008|B1|||Age||years|Mean|29.2|29.2|Standard Deviation|8.19|8.19|||
4076530|NCT01030965|3899049|B5|African American/African Heritage & White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4076531|NCT01030965|3899050|B4|African American/African Heritage & White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4076532|NCT01030965|3899051|B3|African American/African Heritage & White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4076533|NCT01030965|3899052|B2|African American/African Heritage & White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4076534|NCT01030965|3899053|B1|African American/African Heritage & White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4076535|NCT01030965|3899049|B5|White||Race/Ethnicity, Customized||Participants|Number|275|275.0||||||
4076536|NCT01030965|3899050|B4|White||Race/Ethnicity, Customized||Participants|Number|69|69.0||||||
4076537|NCT01030965|3899051|B3|White||Race/Ethnicity, Customized||Participants|Number|69|69.0||||||
4076538|NCT01030965|3899052|B2|White||Race/Ethnicity, Customized||Participants|Number|67|67.0||||||
4076539|NCT01030965|3899053|B1|White||Race/Ethnicity, Customized||Participants|Number|70|70.0||||||
4076540|NCT01030965|3899049|B5|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4076541|NCT01030965|3899050|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4076542|NCT01030965|3899051|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4076543|NCT01030965|3899052|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4076544|NCT01030965|3899053|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4076545|NCT01030965|3899049|B5||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4076546|NCT01030965|3899050|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4076547|NCT01030965|3899051|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4076548|NCT01030965|3899052|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4076549|NCT01030965|3899053|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4076550|NCT01030965|3899049|B5||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4076551|NCT01030965|3899050|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4076552|NCT01030965|3899051|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4076553|NCT01030965|3899052|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4076554|NCT01030965|3899053|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4076555|NCT01030965|3899049|B5|||Age||Years|Mean|61.4|61.4|Standard Deviation|8.41|8.41|||
4076556|NCT01030965|3899050|B4|||Age||Years|Mean|62.6|62.6|Standard Deviation|9.30|9.3|||
4076557|NCT01030965|3899051|B3|||Age||Years|Mean|60.3|60.3|Standard Deviation|8.45|8.45|||
4076558|NCT01030965|3899052|B2|||Age||Years|Mean|60.1|60.1|Standard Deviation|8.75|8.75|||
4076559|NCT01030965|3899053|B1|||Age||Years|Mean|62.3|62.3|Standard Deviation|6.80|6.8|||
4076560|NCT01030952|3899074|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4076561|NCT01030952|3899075|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||55.7|55.7|||
4076562|NCT01030952|3899076|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||60.78|60.78|||
4076563|NCT01030952|3899074|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4076564|NCT01030952|3899075|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||44.23|44.23|||
4076565|NCT01030952|3899076|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||39.22|39.22|||
4076566|NCT01030952|3899074|B3|||Age||years|Mean|53.5|53.5|Standard Deviation|9.81|9.81|||
4076567|NCT01030952|3899075|B2|||Age||years|Mean|53.7|53.7|Standard Deviation|9.36|9.36|||
4076568|NCT01030952|3899076|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|10.34|10.34|||
4076569|NCT01030822|3899111|B4||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4076570|NCT01030822|3899112|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4076571|NCT01030822|3899113|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4076572|NCT01030822|3899114|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4076573|NCT01030822|3899111|B4||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4076574|NCT01030822|3899112|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4076575|NCT01030822|3899113|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4076576|NCT01030822|3899114|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4076577|NCT01030822|3899111|B4|||Age||Months|Mean|14.65|14.65|Standard Deviation|2.49|2.49|||
4076578|NCT01030822|3899112|B3|||Age||Months|Mean|16.1|16.1|Standard Deviation|1.18|1.18|||
4076579|NCT01030822|3899113|B2|||Age||Months|Mean|15.6|15.6|Standard Deviation|1.27|1.27|||
4076580|NCT01030822|3899114|B1|||Age||Months|Mean|12.5|12.5|Standard Deviation|2.74|2.74|||
4076581|NCT01030757|3899163|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4076582|NCT01030757|3899163|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4076583|NCT01030757|3899163|B1|||Age||years|Median|73|73.0|Full Range|||68.0|77.0|
4076584|NCT01030718|3899168|B4|||Height||cm|Median|163.25|163.25|Full Range|||145.7|180.3|
4076585|NCT01030718|3899169|B3|||Height||cm|Median|164.50|164.5|Full Range|||151.7|171.7|
4076586|NCT01030718|3899170|B2|||Height||cm|Median|161.00|161.0|Full Range|||145.7|174.5|
4076587|NCT01030718|3899171|B1|||Height||cm|Median|163.65|163.65|Full Range|||147.0|180.3|
4076588|NCT01030718|3899168|B4|||Body Weight||kg|Median|60.55|60.55|Full Range|||37.0|86.5|
4076589|NCT01030718|3899169|B3|||Body Weight||kg|Median|53.20|53.2|Full Range|||37.0|77.8|
4076590|NCT01030718|3899170|B2|||Body Weight||kg|Median|58.00|58.0|Full Range|||43.6|76.6|
4076591|NCT01030718|3899171|B1|||Body Weight||kg|Median|64.05|64.05|Full Range|||44.0|86.5|
4076592|NCT01030718|3899168|B4|Intolerant||Imatinib Status|Resistance to Imatinib=Previously been treated with imatinib at a dose of ≥ 400 mg/day AND developed progressive disease while receiving imatinib at that dose. Intolerance to Imatinib=A subject is defined as being intolerant to imatinib if he or she had a Grade ≥3 toxicity considered at least possibly related to imatinib at a dose of ≤400 mg/day which led to discontinuation of therapy.|participants|Number|19|19.0||||||
4076593|NCT01030718|3899169|B3|Intolerant||Imatinib Status|Resistance to Imatinib=Previously been treated with imatinib at a dose of ≥ 400 mg/day AND developed progressive disease while receiving imatinib at that dose. Intolerance to Imatinib=A subject is defined as being intolerant to imatinib if he or she had a Grade ≥3 toxicity considered at least possibly related to imatinib at a dose of ≤400 mg/day which led to discontinuation of therapy.|participants|Number|4|4.0||||||
4076594|NCT01030718|3899170|B2|Intolerant||Imatinib Status|Resistance to Imatinib=Previously been treated with imatinib at a dose of ≥ 400 mg/day AND developed progressive disease while receiving imatinib at that dose. Intolerance to Imatinib=A subject is defined as being intolerant to imatinib if he or she had a Grade ≥3 toxicity considered at least possibly related to imatinib at a dose of ≤400 mg/day which led to discontinuation of therapy.|participants|Number|3|3.0||||||
4076595|NCT01030718|3899171|B1|Intolerant||Imatinib Status|Resistance to Imatinib=Previously been treated with imatinib at a dose of ≥ 400 mg/day AND developed progressive disease while receiving imatinib at that dose. Intolerance to Imatinib=A subject is defined as being intolerant to imatinib if he or she had a Grade ≥3 toxicity considered at least possibly related to imatinib at a dose of ≤400 mg/day which led to discontinuation of therapy.|participants|Number|12|12.0||||||
4076596|NCT01030718|3899168|B4|Resistant||Imatinib Status|Resistance to Imatinib=Previously been treated with imatinib at a dose of ≥ 400 mg/day AND developed progressive disease while receiving imatinib at that dose. Intolerance to Imatinib=A subject is defined as being intolerant to imatinib if he or she had a Grade ≥3 toxicity considered at least possibly related to imatinib at a dose of ≤400 mg/day which led to discontinuation of therapy.|participants|Number|35|35.0||||||
4076689|NCT01030536|3899257|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4076597|NCT01030718|3899169|B3|Resistant||Imatinib Status|Resistance to Imatinib=Previously been treated with imatinib at a dose of ≥ 400 mg/day AND developed progressive disease while receiving imatinib at that dose. Intolerance to Imatinib=A subject is defined as being intolerant to imatinib if he or she had a Grade ≥3 toxicity considered at least possibly related to imatinib at a dose of ≤400 mg/day which led to discontinuation of therapy.|participants|Number|9|9.0||||||
4076598|NCT01030718|3899170|B2|Resistant||Imatinib Status|Resistance to Imatinib=Previously been treated with imatinib at a dose of ≥ 400 mg/day AND developed progressive disease while receiving imatinib at that dose. Intolerance to Imatinib=A subject is defined as being intolerant to imatinib if he or she had a Grade ≥3 toxicity considered at least possibly related to imatinib at a dose of ≤400 mg/day which led to discontinuation of therapy.|participants|Number|8|8.0||||||
4076599|NCT01030718|3899171|B1|Resistant||Imatinib Status|Resistance to Imatinib=Previously been treated with imatinib at a dose of ≥ 400 mg/day AND developed progressive disease while receiving imatinib at that dose. Intolerance to Imatinib=A subject is defined as being intolerant to imatinib if he or she had a Grade ≥3 toxicity considered at least possibly related to imatinib at a dose of ≤400 mg/day which led to discontinuation of therapy.|participants|Number|18|18.0||||||
4076600|NCT01030718|3899168|B4|Status = 5||Eastern Oncology Cooperative Group Performance Status|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|0|0.0||||||
4076601|NCT01030718|3899169|B3|Status = 5||Eastern Oncology Cooperative Group Performance Status|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|0|0.0||||||
4076602|NCT01030718|3899170|B2|Status = 5||Eastern Oncology Cooperative Group Performance Status|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|0|0.0||||||
4076603|NCT01030718|3899171|B1|Status = 5||Eastern Oncology Cooperative Group Performance Status|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|0|0.0||||||
4076604|NCT01030718|3899168|B4|Status = 4||Eastern Oncology Cooperative Group Performance Status|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|0|0.0||||||
4076605|NCT01030718|3899169|B3|Status = 4||Eastern Oncology Cooperative Group Performance Status|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|0|0.0||||||
4076606|NCT01030718|3899170|B2|Status = 4||Eastern Oncology Cooperative Group Performance Status|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|0|0.0||||||
4076607|NCT01030718|3899171|B1|Status = 4||Eastern Oncology Cooperative Group Performance Status|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|0|0.0||||||
4076608|NCT01030718|3899168|B4|Status = 3||Eastern Oncology Cooperative Group Performance Status|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|0|0.0||||||
4076609|NCT01030718|3899169|B3|Status = 3||Eastern Oncology Cooperative Group Performance Status|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|0|0.0||||||
4076683|NCT01030653|3899245|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4076684|NCT01030653|3899243|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076685|NCT01030653|3899244|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076686|NCT01030653|3899245|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076610|NCT01030718|3899170|B2|Status = 3||Eastern Oncology Cooperative Group Performance Status|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|0|0.0||||||
4076611|NCT01030718|3899171|B1|Status = 3||Eastern Oncology Cooperative Group Performance Status|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|0|0.0||||||
4076612|NCT01030718|3899168|B4|Status = 2||Eastern Oncology Cooperative Group Performance Status|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|0|0.0||||||
4076613|NCT01030718|3899169|B3|Status = 2||Eastern Oncology Cooperative Group Performance Status|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|0|0.0||||||
4076614|NCT01030718|3899170|B2|Status = 2||Eastern Oncology Cooperative Group Performance Status|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|0|0.0||||||
4076615|NCT01030718|3899171|B1|Status = 2||Eastern Oncology Cooperative Group Performance Status|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|0|0.0||||||
4076616|NCT01030718|3899168|B4|Status = 1||Eastern Oncology Cooperative Group Performance Status|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|12|12.0||||||
4076617|NCT01030718|3899169|B3|Status = 1||Eastern Oncology Cooperative Group Performance Status|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|4|4.0||||||
4076618|NCT01030718|3899170|B2|Status = 1||Eastern Oncology Cooperative Group Performance Status|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|5|5.0||||||
4076619|NCT01030718|3899171|B1|Status = 1||Eastern Oncology Cooperative Group Performance Status|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|3|3.0||||||
4076620|NCT01030718|3899168|B4|Status = 0||Eastern Oncology Cooperative Group Performance Status|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|42|42.0||||||
4076621|NCT01030718|3899169|B3|Status = 0||Eastern Oncology Cooperative Group Performance Status|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|9|9.0||||||
4076622|NCT01030718|3899170|B2|Status = 0||Eastern Oncology Cooperative Group Performance Status|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|6|6.0||||||
4076687|NCT01030536|3899255|B6||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4076688|NCT01030536|3899256|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4076623|NCT01030718|3899171|B1|Status = 0||Eastern Oncology Cooperative Group Performance Status|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|27|27.0||||||
4076624|NCT01030718|3899168|B4|Japan||Region of Enrollment||participants|Number|54|54.0||||||
4076625|NCT01030718|3899169|B3|Japan||Region of Enrollment||participants|Number|13|13.0||||||
4076626|NCT01030718|3899170|B2|Japan||Region of Enrollment||participants|Number|11|11.0||||||
4076627|NCT01030718|3899171|B1|Japan||Region of Enrollment||participants|Number|30|30.0||||||
4076628|NCT01030718|3899168|B4||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4076629|NCT01030718|3899169|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4076630|NCT01030718|3899170|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4076631|NCT01030718|3899171|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4076632|NCT01030718|3899168|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4076633|NCT01030718|3899169|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4076634|NCT01030718|3899170|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4076635|NCT01030718|3899171|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4076636|NCT01030718|3899168|B4|||Age||years|Median|55.5|55.5|Full Range|||27.0|73.0|
4076637|NCT01030718|3899169|B3|||Age||years|Median|64.0|64.0|Full Range|||29.0|70.0|
4076638|NCT01030718|3899170|B2|||Age||years|Median|57.0|57.0|Full Range|||31.0|73.0|
4076639|NCT01030718|3899171|B1|||Age||years|Median|51.5|51.5|Full Range|||27.0|68.0|
4076640|NCT01030718|3899168|B4|>=65 years||Age, Customized||participants|Number|10|10.0||||||
4076641|NCT01030718|3899169|B3|>=65 years||Age, Customized||participants|Number|3|3.0||||||
4076642|NCT01030718|3899170|B2|>=65 years||Age, Customized||participants|Number|3|3.0||||||
4076643|NCT01030718|3899171|B1|>=65 years||Age, Customized||participants|Number|4|4.0||||||
4076644|NCT01030718|3899168|B4|<65 years||Age, Customized||participants|Number|44|44.0||||||
4076645|NCT01030718|3899169|B3|<65 years||Age, Customized||participants|Number|10|10.0||||||
4076646|NCT01030718|3899170|B2|<65 years||Age, Customized||participants|Number|8|8.0||||||
4076647|NCT01030718|3899171|B1|<65 years||Age, Customized||participants|Number|26|26.0||||||
4076648|NCT01030666|3899232|B3|Germany||Region of Enrollment||participants|Number|61|61.0||||||
4076649|NCT01030666|3899233|B2|Germany||Region of Enrollment||participants|Number|33|33.0||||||
4076650|NCT01030666|3899234|B1|Germany||Region of Enrollment||participants|Number|28|28.0||||||
4076651|NCT01030666|3899232|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4076652|NCT01030666|3899233|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4076653|NCT01030666|3899234|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4076654|NCT01030666|3899232|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4076655|NCT01030666|3899233|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4076656|NCT01030666|3899234|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4076657|NCT01030666|3899232|B3|||Age||years|Mean|51.5|51.5|Standard Deviation|10.4|10.4|||
4076658|NCT01030666|3899233|B2|||Age||years|Mean|49.2|49.2|Standard Deviation|10|10.0|||
4076659|NCT01030666|3899234|B1|||Age||years|Mean|54.2|54.2|Standard Deviation|10.3|10.3|||
4076660|NCT01030666|3899232|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4076661|NCT01030666|3899233|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4076662|NCT01030666|3899234|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4076663|NCT01030666|3899232|B3||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4076664|NCT01030666|3899233|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4076665|NCT01030666|3899234|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4076666|NCT01030666|3899232|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076667|NCT01030666|3899233|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076668|NCT01030666|3899234|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076669|NCT01030653|3899243|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4076670|NCT01030653|3899244|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4076671|NCT01030653|3899245|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4076672|NCT01030653|3899243|B3||Male|Gender||Participants|Count of Participants|2|2.0||||||
4076673|NCT01030653|3899244|B2||Male|Gender||Participants|Count of Participants|1|1.0||||||
4076674|NCT01030653|3899245|B1||Male|Gender||Participants|Count of Participants|1|1.0||||||
4076675|NCT01030653|3899243|B3||Female|Gender||Participants|Count of Participants|6|6.0||||||
4076676|NCT01030653|3899244|B2||Female|Gender||Participants|Count of Participants|3|3.0||||||
4076677|NCT01030653|3899245|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
4076678|NCT01030653|3899243|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4076679|NCT01030653|3899244|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4076680|NCT01030653|3899245|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4076681|NCT01030653|3899243|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4076682|NCT01030653|3899244|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4076690|NCT01030536|3899258|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4076691|NCT01030536|3899259|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4076692|NCT01030536|3899260|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4076693|NCT01030536|3899255|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4076694|NCT01030536|3899256|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4076695|NCT01030536|3899257|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4076696|NCT01030536|3899258|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4076697|NCT01030536|3899259|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4076698|NCT01030536|3899260|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4076699|NCT01030536|3899255|B6|Age||Age||years|Mean|59.6|59.6|Standard Deviation|12.4|12.4|||
4076700|NCT01030536|3899256|B5|Age||Age||years|Mean|66.0|66.0|Standard Deviation|NA||||Data was not calculated
4076701|NCT01030536|3899257|B4|Age||Age||years|Mean|52.3|52.3|Standard Deviation|14.6|14.6|||
4076702|NCT01030536|3899258|B3|Age||Age||years|Mean|63.5|63.5|Standard Deviation|10.0|10.0|||
4076703|NCT01030536|3899259|B2|Age||Age||years|Mean|53.7|53.7|Standard Deviation|16.9|16.9|||
4076704|NCT01030536|3899260|B1|Age||Age||years|Mean|63.4|63.4|Standard Deviation|8.7|8.7|||
4076705|NCT01030458|3899367|B3|Cameroon||Region of Enrollment||participants|Number|43|43.0||||||
4076706|NCT01030458|3899368|B2|Cameroon||Region of Enrollment||participants|Number|21|21.0||||||
4076707|NCT01030458|3899369|B1|Cameroon||Region of Enrollment||participants|Number|22|22.0||||||
4076708|NCT01030458|3899367|B3|Gabon||Region of Enrollment||participants|Number|8|8.0||||||
4076709|NCT01030458|3899368|B2|Gabon||Region of Enrollment||participants|Number|2|2.0||||||
4076710|NCT01030458|3899369|B1|Gabon||Region of Enrollment||participants|Number|6|6.0||||||
4076711|NCT01030458|3899367|B3|Senegal||Region of Enrollment||participants|Number|40|40.0||||||
4076712|NCT01030458|3899368|B2|Senegal||Region of Enrollment||participants|Number|20|20.0||||||
4076713|NCT01030458|3899369|B1|Senegal||Region of Enrollment||participants|Number|20|20.0||||||
4076714|NCT01030458|3899367|B3|Nigeria||Region of Enrollment||participants|Number|92|92.0||||||
4076715|NCT01030458|3899368|B2|Nigeria||Region of Enrollment||participants|Number|46|46.0||||||
4076716|NCT01030458|3899369|B1|Nigeria||Region of Enrollment||participants|Number|46|46.0||||||
4076717|NCT01030458|3899367|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4076718|NCT01030458|3899368|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4076719|NCT01030458|3899369|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4076720|NCT01030458|3899367|B3||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4076721|NCT01030458|3899368|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4076722|NCT01030458|3899369|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4076723|NCT01030458|3899367|B3|||Age||years|Mean|51.2|51.2|Standard Deviation|9.0|9.0|||
4076724|NCT01030458|3899368|B2|||Age||years|Mean|51.2|51.2|Standard Deviation|8.7|8.7|||
4076725|NCT01030458|3899369|B1|||Age||years|Mean|51.3|51.3|Standard Deviation|9.3|9.3|||
4076726|NCT01030458|3899367|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4076727|NCT01030458|3899368|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4076728|NCT01030458|3899369|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4076729|NCT01030458|3899367|B3||Between 18 and 65 years|Age||Participants|Count of Participants|171|171.0||||||
4076730|NCT01030458|3899368|B2||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
4076731|NCT01030458|3899369|B1||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
4076732|NCT01030458|3899367|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076733|NCT01030458|3899368|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076734|NCT01030458|3899369|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076735|NCT01030406|3899382|B6|United States||Region of Enrollment||participants|Number|47|47.0||||||
4076736|NCT01030406|3899383|B5|United States||Region of Enrollment||participants|Number|9|9.0||||||
4076737|NCT01030406|3899384|B4|United States||Region of Enrollment||participants|Number|9|9.0||||||
4076738|NCT01030406|3899385|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4076739|NCT01030406|3899386|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4076740|NCT01030406|3899387|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4076741|NCT01030406|3899382|B6||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4076742|NCT01030406|3899383|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4076743|NCT01030406|3899384|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4076744|NCT01030406|3899385|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4076745|NCT01030406|3899386|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4076746|NCT01030406|3899387|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4076747|NCT01030406|3899382|B6||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4076748|NCT01030406|3899383|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4076749|NCT01030406|3899384|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4076750|NCT01030406|3899385|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4076751|NCT01030406|3899386|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4076752|NCT01030406|3899387|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4076753|NCT01030406|3899382|B6|||Age||years|Mean|23.9|23.9|Standard Deviation|4.83|4.83|||
4076754|NCT01030406|3899383|B5|||Age||years|Mean|23.9|23.9|Standard Deviation|4.83|4.83|||
4076755|NCT01030406|3899384|B4|||Age||years|Mean|23.9|23.9|Standard Deviation|4.83|4.83|||
4076756|NCT01030406|3899385|B3|||Age||years|Mean|23.9|23.9|Standard Deviation|4.83|4.83|||
4076757|NCT01030406|3899386|B2|||Age||years|Mean|23.9|23.9|Standard Deviation|4.83|4.83|||
4076758|NCT01030406|3899387|B1|||Age||years|Mean|23.9|23.9|Standard Deviation|4.83|4.83|||
4076759|NCT01030406|3899382|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4076760|NCT01030406|3899383|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4076761|NCT01030406|3899384|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4076762|NCT01030406|3899385|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4076763|NCT01030406|3899386|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4076764|NCT01030406|3899387|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4076765|NCT01030406|3899382|B6||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4076766|NCT01030406|3899383|B5||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4076767|NCT01030406|3899384|B4||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4076768|NCT01030406|3899385|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4076769|NCT01030406|3899386|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4076770|NCT01030406|3899387|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4076771|NCT01030406|3899382|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076772|NCT01030406|3899383|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076773|NCT01030406|3899384|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076774|NCT01030406|3899385|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076775|NCT01030406|3899386|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076776|NCT01030406|3899387|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076777|NCT01030341|3899403|B1|||Volume consumed in a liquid nutrient satiety test|The liquid nutrient satiety test involves drinking Ensure in 5 minutes until full. The outcome of interest is the amount drank in mL.|mL|Mean|420|420.0|Standard Deviation|258|258.0|||
4076778|NCT01030341|3899403|B1|||Volume of Water consumed for water load satiety test|The Water Load Satiety Test involves drinking cool water over 5 minutes until full. The outcome of interest is the volume of water drank in mL.|mL|Mean|430|430.0|Standard Deviation|207|207.0|||
4076779|NCT01030341|3899403|B1|||PAGI-QOL|The Patient Assessment of Upper Gastrointestinal Disorders-Quality of LIfe (PAGI-QOL) contains 30 items with 5 subscales: (1) daily activities; (2) clothing; (3) diet/food habits; (4) relationship; and (5) psychological well-being and distress. Items are scored on a 6-point Likert scale, with response options ranging from 0 (none) to 5 (all of the time). Subscale scores are calculated by averaging the item responses within a each subscale after reversing item scores. A total score is calculated by averaging subscale scores, with higher values indicating improved quality of life.|units on a scale|Mean|2.4|2.4|Standard Deviation|1.1|1.1|||
4076780|NCT01030341|3899403|B1|||GCSI score|The Gastroparesis Cardinal Symptom Index (GCSI) is the mean of 3 subscales: nausea/vomiting (3 items), post-prandial fullness/early satiety (4 items), and bloating (2 items). Subscale scores were calculated by averaging across items within a subscale. A 6-point Likert scale was used for scoring individual items ranging from 0 (none) to 5 (very severe).|units on a scale|Mean|3.3|3.3|Standard Deviation|0.8|0.8|||
4076781|NCT01030341|3899403|B1|||4 hr gastric retention||percentage|Mean|32|32.0|Standard Deviation|20|20.0|||
4076782|NCT01030341|3899403|B1|||2 hr gastric retention||percentage|Mean|63|63.0|Standard Deviation|20|20.0|||
4076783|NCT01030341|3899403|B1|||Hemoglobin A1c||percentage|Mean|9.4|9.4|Standard Deviation|1.4|1.4|||
4076784|NCT01030341|3899403|B1|||Body mass index||kg/m^2|Mean|29|29.0|Standard Deviation|8|8.0|||
4076785|NCT01030341|3899403|B1|||Known diabetes duration||years|Mean|21|21.0|Standard Deviation|11|11.0|||
4076786|NCT01030341|3899403|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4076787|NCT01030341|3899403|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076788|NCT01030341|3899403|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4076789|NCT01030341|3899403|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4076790|NCT01030341|3899403|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4076791|NCT01030341|3899403|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4076792|NCT01030341|3899403|B1|||Age||years|Mean|45|45.0|Standard Deviation|12|12.0|||
4076793|NCT01030289|3899408|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4076794|NCT01030289|3899408|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4076795|NCT01030289|3899408|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4076796|NCT01030289|3899408|B1|||Age||years|Mean|32.47|32.47|Standard Deviation|10.85|10.85|||
4076797|NCT01030289|3899408|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4076798|NCT01030289|3899408|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4076799|NCT01030289|3899408|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076800|NCT01030133|3899424|B3|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
4076801|NCT01030133|3899425|B2|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4076802|NCT01030133|3899426|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4076803|NCT01030133|3899424|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4076804|NCT01030133|3899425|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4076805|NCT01030133|3899426|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4076806|NCT01030133|3899424|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4076807|NCT01030133|3899425|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4076808|NCT01030133|3899426|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4076809|NCT01030133|3899424|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4076810|NCT01030133|3899425|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4076811|NCT01030133|3899426|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4076812|NCT01030133|3899424|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4076813|NCT01030133|3899425|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4076814|NCT01030133|3899426|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4076815|NCT01030133|3899424|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076816|NCT01030133|3899425|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076817|NCT01030133|3899426|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076818|NCT01029925|3899439|B1|ECOG status 2||ECOG status||participants|Number|2|2.0||||||
4076819|NCT01029925|3899439|B1|ECOG status 1||ECOG status||participants|Number|3|3.0||||||
4076820|NCT01029925|3899439|B1|ECOG status 0||ECOG status||participants|Number|2|2.0||||||
4076821|NCT01029925|3899439|B1|Stage IV NSCLC||stage at diagnosis||participants|Number|6|6.0||||||
4076822|NCT01029925|3899439|B1|Stage II breast cancer||stage at diagnosis||participants|Number|1|1.0||||||
4076823|NCT01029925|3899439|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076824|NCT01029925|3899439|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076825|NCT01029925|3899439|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4076826|NCT01029925|3899439|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076827|NCT01029925|3899439|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076828|NCT01029925|3899439|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4076829|NCT01029925|3899439|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076830|NCT01029925|3899439|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4076831|NCT01029925|3899439|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4076832|NCT01029925|3899439|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4076833|NCT01029925|3899439|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4076834|NCT01029925|3899439|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076835|NCT01029912|3899443|B3|||Gait velocity (cm/sec)|Gait velocity was assessed using a motion capture and analysis system which collected spatio-temporal data as the participant walked 5-meters 10 times at a self-selected comfortable speed within the field of view of the motion capture system. A higher gait velocity is considered to be a better outcome.|cm/sec|Mean|39.1|39.1|Standard Deviation|20.4|20.4|||
4076836|NCT01029912|3899444|B2|||Gait velocity (cm/sec)|Gait velocity was assessed using a motion capture and analysis system which collected spatio-temporal data as the participant walked 5-meters 10 times at a self-selected comfortable speed within the field of view of the motion capture system. A higher gait velocity is considered to be a better outcome.|cm/sec|Mean|38.3|38.3|Standard Deviation|19.1|19.1|||
4076837|NCT01029912|3899445|B1|||Gait velocity (cm/sec)|Gait velocity was assessed using a motion capture and analysis system which collected spatio-temporal data as the participant walked 5-meters 10 times at a self-selected comfortable speed within the field of view of the motion capture system. A higher gait velocity is considered to be a better outcome.|cm/sec|Mean|39.9|39.9|Standard Deviation|22.3|22.3|||
4076838|NCT01029912|3899443|B3|||Time to complete Modified Emory Functional Ambulation Profile (MEFAP) in seconds|The MEFAP is a measure of functional ambulation, measuring the time to ambulate through 5 common environmental terrains: 1) 5-meter walk on a hard floor, 2) 5-meter walk on a carpeted floor, 3) rise from a chair, 3-meter walk, return to seated position, 4) standardized obstacle course (bricks to step over), 5) stair ascent and descent. The five times subscores were added to derive a total time. Lower times are considered to be a better outcome.|seconds|Mean|119.7|119.7|Standard Deviation|84.5|84.5|||
4076839|NCT01029912|3899444|B2|||Time to complete Modified Emory Functional Ambulation Profile (MEFAP) in seconds|The MEFAP is a measure of functional ambulation, measuring the time to ambulate through 5 common environmental terrains: 1) 5-meter walk on a hard floor, 2) 5-meter walk on a carpeted floor, 3) rise from a chair, 3-meter walk, return to seated position, 4) standardized obstacle course (bricks to step over), 5) stair ascent and descent. The five times subscores were added to derive a total time. Lower times are considered to be a better outcome.|seconds|Mean|118.6|118.6|Standard Deviation|86.5|86.5|||
4076840|NCT01029912|3899445|B1|||Time to complete Modified Emory Functional Ambulation Profile (MEFAP) in seconds|The MEFAP is a measure of functional ambulation, measuring the time to ambulate through 5 common environmental terrains: 1) 5-meter walk on a hard floor, 2) 5-meter walk on a carpeted floor, 3) rise from a chair, 3-meter walk, return to seated position, 4) standardized obstacle course (bricks to step over), 5) stair ascent and descent. The five times subscores were added to derive a total time. Lower times are considered to be a better outcome.|seconds|Mean|120.7|120.7|Standard Deviation|86.3|86.3|||
4076841|NCT01029912|3899443|B3|||Lower Extremity Fugl-Meyer Score|The Lower Extremity Fugl-Meyer (LEFM) Assessment measures lower limb motor impairment. Participants are asked to attempt to perform isolated and simultaneous movements of the hip, knee, and ankle. Each movement attempt is graded on a 3-point ordinal scale (0, cannot perform; 1, perform partially; and 2, perform fully). These subscores are summed to provide a maximum score of 34, minimum score of 0. Higher scores are considered to be a better outcome.|units on a scale|Mean|19.0|19.0|Standard Deviation|6.8|6.8|||
4076842|NCT01029912|3899444|B2|||Lower Extremity Fugl-Meyer Score|The Lower Extremity Fugl-Meyer (LEFM) Assessment measures lower limb motor impairment. Participants are asked to attempt to perform isolated and simultaneous movements of the hip, knee, and ankle. Each movement attempt is graded on a 3-point ordinal scale (0, cannot perform; 1, perform partially; and 2, perform fully). These subscores are summed to provide a maximum score of 34, minimum score of 0. Higher scores are considered to be a better outcome.|units on a scale|Mean|18.9|18.9|Standard Deviation|7.0|7.0|||
4076843|NCT01029912|3899445|B1|||Lower Extremity Fugl-Meyer Score|The Lower Extremity Fugl-Meyer (LEFM) Assessment measures lower limb motor impairment. Participants are asked to attempt to perform isolated and simultaneous movements of the hip, knee, and ankle. Each movement attempt is graded on a 3-point ordinal scale (0, cannot perform; 1, perform partially; and 2, perform fully). These subscores are summed to provide a maximum score of 34, minimum score of 0. Higher scores are considered to be a better outcome.|units on a scale|Mean|19.1|19.1|Standard Deviation|6.8|6.8|||
4076844|NCT01029912|3899443|B3|||Years Since Stroke||years|Mean|3.1|3.1|Standard Deviation|3.0|3.0|||
4076845|NCT01029912|3899444|B2|||Years Since Stroke||years|Mean|3.6|3.6|Standard Deviation|3.9|3.9|||
4076846|NCT01029912|3899445|B1|||Years Since Stroke||years|Mean|2.7|2.7|Standard Deviation|1.8|1.8|||
4076847|NCT01029912|3899443|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076848|NCT01029912|3899444|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076849|NCT01029912|3899445|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076850|NCT01029912|3899443|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076851|NCT01029912|3899444|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076852|NCT01029912|3899445|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076853|NCT01029912|3899443|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4076854|NCT01029912|3899444|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4076855|NCT01029912|3899445|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4076856|NCT01029912|3899443|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4076857|NCT01029912|3899444|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4076858|NCT01029912|3899445|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4076859|NCT01029912|3899443|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076860|NCT01029912|3899444|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076861|NCT01029912|3899445|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076862|NCT01029912|3899443|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076863|NCT01029912|3899444|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076864|NCT01029912|3899445|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076865|NCT01029912|3899443|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076866|NCT01029912|3899444|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076867|NCT01029912|3899445|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076868|NCT01029912|3899443|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4076869|NCT01029912|3899444|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4076870|NCT01029912|3899445|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4076871|NCT01029912|3899443|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4076872|NCT01029912|3899444|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4076873|NCT01029912|3899445|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4076874|NCT01029912|3899443|B3|||Age||years|Mean|58.0|58.0|Standard Deviation|11.4|11.4|||
4076875|NCT01029912|3899444|B2|||Age||years|Mean|59.3|59.3|Standard Deviation|9.1|9.1|||
4076876|NCT01029912|3899445|B1|||Age||years|Mean|56.7|56.7|Standard Deviation|13.7|13.7|||
4076877|NCT01029886|3899456|B3|MET+SU+PIO||Background Oral Antidiabetic Agent (OAD)||participants|Number|2|2.0||||||
4076878|NCT01029886|3899457|B2|MET+SU+PIO||Background Oral Antidiabetic Agent (OAD)||participants|Number|1|1.0||||||
4076879|NCT01029886|3899458|B1|MET+SU+PIO||Background Oral Antidiabetic Agent (OAD)||participants|Number|1|1.0||||||
4076880|NCT01029886|3899456|B3|MET+PIO||Background Oral Antidiabetic Agent (OAD)||participants|Number|34|34.0||||||
4076881|NCT01029886|3899457|B2|MET+PIO||Background Oral Antidiabetic Agent (OAD)||participants|Number|18|18.0||||||
4076882|NCT01029886|3899458|B1|MET+PIO||Background Oral Antidiabetic Agent (OAD)||participants|Number|16|16.0||||||
4076883|NCT01029886|3899456|B3|MET+SU||Background Oral Antidiabetic Agent (OAD)||participants|Number|552|552.0||||||
4076884|NCT01029886|3899457|B2|MET+SU||Background Oral Antidiabetic Agent (OAD)||participants|Number|277|277.0||||||
4076885|NCT01029886|3899458|B1|MET+SU||Background Oral Antidiabetic Agent (OAD)||participants|Number|275|275.0||||||
4076886|NCT01029886|3899456|B3|Pioglitazone (PIO)||Background Oral Antidiabetic Agent (OAD)||participants|Number|1|1.0||||||
4076887|NCT01029886|3899457|B2|Pioglitazone (PIO)||Background Oral Antidiabetic Agent (OAD)||participants|Number|0|0.0||||||
4076888|NCT01029886|3899458|B1|Pioglitazone (PIO)||Background Oral Antidiabetic Agent (OAD)||participants|Number|1|1.0||||||
4076889|NCT01029886|3899456|B3|Sulfonylurea (SU)||Background Oral Antidiabetic Agent (OAD)||participants|Number|36|36.0||||||
4076890|NCT01029886|3899457|B2|Sulfonylurea (SU)||Background Oral Antidiabetic Agent (OAD)||participants|Number|18|18.0||||||
4076891|NCT01029886|3899458|B1|Sulfonylurea (SU)||Background Oral Antidiabetic Agent (OAD)||participants|Number|18|18.0||||||
4076892|NCT01029886|3899456|B3|Metformin (MET)||Background Oral Antidiabetic Agent (OAD)||participants|Number|286|286.0||||||
4076893|NCT01029886|3899457|B2|Metformin (MET)||Background Oral Antidiabetic Agent (OAD)||participants|Number|136|136.0||||||
4076894|NCT01029886|3899458|B1|Metformin (MET)||Background Oral Antidiabetic Agent (OAD)||participants|Number|150|150.0||||||
4076895|NCT01029886|3899456|B3|||Weight||kg|Mean|91.00|91.0|Standard Deviation|19.288|19.288|||
4076896|NCT01029886|3899457|B2|||Weight||kg|Mean|91.13|91.13|Standard Deviation|19.118|19.118|||
4076897|NCT01029886|3899458|B1|||Weight||kg|Mean|90.88|90.88|Standard Deviation|19.472|19.472|||
4076898|NCT01029886|3899456|B3|||Glycosylated hemoglobin (HbA1c)||percentage of total hemoglobin|Mean|8.44|8.44|Standard Deviation|1.004|1.004|||
4076899|NCT01029886|3899457|B2|||Glycosylated hemoglobin (HbA1c)||percentage of total hemoglobin|Mean|8.43|8.43|Standard Deviation|0.996|0.996|||
4076900|NCT01029886|3899458|B1|||Glycosylated hemoglobin (HbA1c)||percentage of total hemoglobin|Mean|8.45|8.45|Standard Deviation|1.014|1.014|||
4076901|NCT01029886|3899456|B3||Male|Sex: Female, Male||Participants|Count of Participants|499|499.0||||||
4076902|NCT01029886|3899457|B2||Male|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4076903|NCT01029886|3899458|B1||Male|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
4076904|NCT01029886|3899456|B3||Female|Sex: Female, Male||Participants|Count of Participants|412|412.0||||||
4076905|NCT01029886|3899457|B2||Female|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4076906|NCT01029886|3899458|B1||Female|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4076907|NCT01029886|3899456|B3|||Age||years|Mean|56.6|56.6|Standard Deviation|9.51|9.51|||
4076908|NCT01029886|3899457|B2|||Age||years|Mean|56.7|56.7|Standard Deviation|9.59|9.59|||
4076909|NCT01029886|3899458|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|9.43|9.43|||
4076910|NCT01029886|3899456|B3||>=65 years|Age||Participants|Count of Participants|165|165.0||||||
4076911|NCT01029886|3899457|B2||>=65 years|Age||Participants|Count of Participants|90|90.0||||||
4076912|NCT01029886|3899458|B1||>=65 years|Age||Participants|Count of Participants|75|75.0||||||
4076913|NCT01029886|3899456|B3||Between 18 and 65 years|Age||Participants|Count of Participants|746|746.0||||||
4076914|NCT01029886|3899457|B2||Between 18 and 65 years|Age||Participants|Count of Participants|360|360.0||||||
4076915|NCT01029886|3899458|B1||Between 18 and 65 years|Age||Participants|Count of Participants|386|386.0||||||
4076916|NCT01029886|3899456|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076917|NCT01029886|3899457|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076918|NCT01029886|3899458|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4076919|NCT01029795|3899485|B3|||Percentage of Glycosylated Fraction of Hemoglobin A1c|HbA1c: hemoglobin A1c, glycosylated fraction of hemoglobin A (%)|percentage of glycosylated hemoglobin|Mean|7.83|7.83|Standard Deviation|0.91|0.91|||
4076920|NCT01029795|3899486|B2|||Percentage of Glycosylated Fraction of Hemoglobin A1c|HbA1c: hemoglobin A1c, glycosylated fraction of hemoglobin A (%)|percentage of glycosylated hemoglobin|Mean|7.78|7.78|Standard Deviation|1.02|1.02|||
4076921|NCT01029795|3899487|B1|||Percentage of Glycosylated Fraction of Hemoglobin A1c|HbA1c: hemoglobin A1c, glycosylated fraction of hemoglobin A (%)|percentage of glycosylated hemoglobin|Mean|7.90|7.9|Standard Deviation|0.75|0.75|||
4076922|NCT01029795|3899485|B3|||Duration of Diabetes in Years||year|Mean|7.03|7.03|Standard Deviation|5.38|5.38|||
4076923|NCT01029795|3899486|B2|||Duration of Diabetes in Years||year|Mean|7.73|7.73|Standard Deviation|5.64|5.64|||
4076924|NCT01029795|3899487|B1|||Duration of Diabetes in Years||year|Mean|6.08|6.08|Standard Deviation|5.03|5.03|||
4076925|NCT01029795|3899485|B3|Spain||Region of Enrollment|There were no participants from Germany.|participants|Number|9|9.0||||||
4076926|NCT01029795|3899486|B2|Spain||Region of Enrollment|There were no participants from Germany.|participants|Number|5|5.0||||||
4076927|NCT01029795|3899487|B1|Spain||Region of Enrollment|There were no participants from Germany.|participants|Number|4|4.0||||||
4076928|NCT01029795|3899485|B3|Russian Federation||Region of Enrollment|There were no participants from Germany.|participants|Number|4|4.0||||||
4076929|NCT01029795|3899486|B2|Russian Federation||Region of Enrollment|There were no participants from Germany.|participants|Number|2|2.0||||||
4076930|NCT01029795|3899487|B1|Russian Federation||Region of Enrollment|There were no participants from Germany.|participants|Number|2|2.0||||||
4076931|NCT01029795|3899485|B3|Israel||Region of Enrollment|There were no participants from Germany.|participants|Number|3|3.0||||||
4076932|NCT01029795|3899486|B2|Israel||Region of Enrollment|There were no participants from Germany.|participants|Number|1|1.0||||||
4076933|NCT01029795|3899487|B1|Israel||Region of Enrollment|There were no participants from Germany.|participants|Number|2|2.0||||||
4076934|NCT01029795|3899485|B3|Czech Republic||Region of Enrollment|There were no participants from Germany.|participants|Number|3|3.0||||||
4076935|NCT01029795|3899486|B2|Czech Republic||Region of Enrollment|There were no participants from Germany.|participants|Number|2|2.0||||||
4076936|NCT01029795|3899487|B1|Czech Republic||Region of Enrollment|There were no participants from Germany.|participants|Number|1|1.0||||||
4076937|NCT01029795|3899485|B3|Austria||Region of Enrollment|There were no participants from Germany.|participants|Number|5|5.0||||||
4076938|NCT01029795|3899486|B2|Austria||Region of Enrollment|There were no participants from Germany.|participants|Number|3|3.0||||||
4076939|NCT01029795|3899487|B1|Austria||Region of Enrollment|There were no participants from Germany.|participants|Number|2|2.0||||||
4076940|NCT01029795|3899485|B3|Australia||Region of Enrollment|There were no participants from Germany.|participants|Number|14|14.0||||||
4076941|NCT01029795|3899486|B2|Australia||Region of Enrollment|There were no participants from Germany.|participants|Number|9|9.0||||||
4076942|NCT01029795|3899487|B1|Australia||Region of Enrollment|There were no participants from Germany.|participants|Number|5|5.0||||||
4076943|NCT01029795|3899485|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076944|NCT01029795|3899486|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076945|NCT01029795|3899487|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076946|NCT01029795|3899485|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4076947|NCT01029795|3899486|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4076948|NCT01029795|3899487|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4076949|NCT01029795|3899485|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4076950|NCT01029795|3899486|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4076951|NCT01029795|3899487|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076952|NCT01029795|3899485|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4076953|NCT01029795|3899486|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4076954|NCT01029795|3899487|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4076955|NCT01029795|3899485|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4076956|NCT01029795|3899486|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4076957|NCT01029795|3899487|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4076958|NCT01029795|3899485|B3|||Age||years|Mean|59.54|59.54|Standard Deviation|6.16|6.16|||
4076959|NCT01029795|3899486|B2|||Age||years|Mean|59.38|59.38|Standard Deviation|5.86|5.86|||
4076960|NCT01029795|3899487|B1|||Age||years|Mean|59.76|59.76|Standard Deviation|6.74|6.74|||
4076961|NCT01029782|3899540|B3|Canada||Region of Enrollment||participants|Number|203|203.0||||||
4076962|NCT01029782|3899541|B2|Canada||Region of Enrollment||participants|Number|101|101.0||||||
4076963|NCT01029782|3899542|B1|Canada||Region of Enrollment||participants|Number|102|102.0||||||
4076964|NCT01029782|3899540|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4076965|NCT01029782|3899540|B3||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4076966|NCT01029782|3899541|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4076967|NCT01029782|3899542|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4076968|NCT01029782|3899540|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4076969|NCT01029782|3899541|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4076970|NCT01029782|3899542|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4076971|NCT01029782|3899540|B3|||Age||years|Mean|53.62|53.62|Standard Deviation|18.72|18.72|||
4076972|NCT01029782|3899541|B2|||Age||years|Mean|52.01|52.01|Standard Deviation|19.64|19.64|||
4076973|NCT01029782|3899542|B1|||Age||years|Mean|55.21|55.21|Standard Deviation|17.71|17.71|||
4076974|NCT01029730|3899549|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4076975|NCT01029730|3899549|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4076976|NCT01029730|3899549|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4076977|NCT01029730|3899549|B1|||Age||years|Median|64|64.0|Full Range|||30.0|89.0|
4076978|NCT01029704|3899556|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076979|NCT01029704|3899557|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076980|NCT01029704|3899558|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076981|NCT01029704|3899559|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076982|NCT01029704|3899560|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076983|NCT01029704|3899561|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4076984|NCT01029704|3899556|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4076985|NCT01029704|3899557|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4076986|NCT01029704|3899558|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4076987|NCT01029704|3899559|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4076988|NCT01029704|3899560|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4076989|NCT01029704|3899561|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4076990|NCT01029704|3899556|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
4076991|NCT01029704|3899557|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4076992|NCT01029704|3899558|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4076993|NCT01029704|3899559|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4076994|NCT01029704|3899560|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4076995|NCT01029704|3899561|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4076996|NCT01029704|3899556|B6||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4076997|NCT01029704|3899557|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4076998|NCT01029704|3899558|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4076999|NCT01029704|3899559|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4077000|NCT01029704|3899560|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4077001|NCT01029704|3899561|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4077002|NCT01029704|3899556|B6||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4077003|NCT01029704|3899557|B5||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4077004|NCT01029704|3899558|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4077005|NCT01029704|3899559|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4077006|NCT01029704|3899560|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4077007|NCT01029704|3899561|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4077008|NCT01029704|3899556|B6|||Age||years|Mean|57.1|57.1|Standard Deviation|7.5|7.5|||
4077009|NCT01029704|3899557|B5|||Age||years|Mean|54.7|54.7|Standard Deviation|6.7|6.7|||
4077010|NCT01029704|3899558|B4|||Age||years|Mean|59|59.0|Standard Deviation|7.1|7.1|||
4077011|NCT01029704|3899559|B3|||Age||years|Mean|54.9|54.9|Standard Deviation|9|9.0|||
4077012|NCT01029704|3899560|B2|||Age||years|Mean|57.8|57.8|Standard Deviation|6.9|6.9|||
4077013|NCT01029704|3899561|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|7.3|7.3|||
4077014|NCT01029691|3899592|B4|||sleep study apnea hypopnea index (AHI)|Number of respiratory events per hour of sleep|events per hour|Mean|12.4|12.4|Standard Deviation|24.0|24.0|||
4077015|NCT01029691|3899593|B3|||sleep study apnea hypopnea index (AHI)|Number of respiratory events per hour of sleep|events per hour|Mean|NA||Standard Deviation|NA||||The standard of care arm did not undergo a sleep study
4077016|NCT01029691|3899594|B2|||sleep study apnea hypopnea index (AHI)|Number of respiratory events per hour of sleep|events per hour|Mean|4.2|4.2|Standard Deviation|6.0|6.0|||
4077017|NCT01029691|3899595|B1|||sleep study apnea hypopnea index (AHI)|Number of respiratory events per hour of sleep|events per hour|Mean|18.9|18.9|Standard Deviation|30.6|30.6|||
4077018|NCT01029691|3899592|B4|Diastolic||Nocturnal blood pressure||mmHg|Mean|69.3|69.3|Standard Deviation|8.2|8.2|||
4077019|NCT01029691|3899593|B3|Diastolic||Nocturnal blood pressure||mmHg|Mean|NA||Standard Deviation|NA||||Standard of care group did not have nocturnal blood pressure measures
4077020|NCT01029691|3899594|B2|Diastolic||Nocturnal blood pressure||mmHg|Mean|68.8|68.8|Standard Deviation|8.3|8.3|||
4077021|NCT01029691|3899595|B1|Diastolic||Nocturnal blood pressure||mmHg|Mean|69.7|69.7|Standard Deviation|8.0|8.0|||
4077022|NCT01029691|3899592|B4|Systolic||Nocturnal blood pressure||mmHg|Mean|125.8|125.8|Standard Deviation|9.3|9.3|||
4077023|NCT01029691|3899593|B3|Systolic||Nocturnal blood pressure||mmHg|Mean|NA||Standard Deviation|NA||||Standard of care group did not have nocturnal blood pressure measures
4077024|NCT01029691|3899594|B2|Systolic||Nocturnal blood pressure||mmHg|Mean|124.5|124.5|Standard Deviation|8.9|8.9|||
4077025|NCT01029691|3899595|B1|Systolic||Nocturnal blood pressure||mmHg|Mean|126.7|126.7|Standard Deviation|9.5|9.5|||
4077026|NCT01029691|3899592|B4|United States||Region of Enrollment||participants|Number|113|113.0||||||
4077027|NCT01029691|3899593|B3|United States||Region of Enrollment||participants|Number|77|77.0||||||
4077028|NCT01029691|3899594|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4077029|NCT01029691|3899595|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4077030|NCT01029691|3899592|B4|Mixed Race||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4077031|NCT01029691|3899593|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4077032|NCT01029691|3899594|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4077033|NCT01029691|3899595|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4077034|NCT01029691|3899592|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4077035|NCT01029691|3899593|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4077036|NCT01029691|3899594|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4077037|NCT01029691|3899595|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4077038|NCT01029691|3899592|B4|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|72|72.0||||||
4077039|NCT01029691|3899593|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|52|52.0||||||
4077040|NCT01029691|3899594|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4077041|NCT01029691|3899595|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4077042|NCT01029691|3899592|B4|African American||Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
4077043|NCT01029691|3899593|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
4077044|NCT01029691|3899594|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4077045|NCT01029691|3899595|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4077046|NCT01029691|3899592|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4077047|NCT01029691|3899593|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4077048|NCT01029691|3899594|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4077049|NCT01029691|3899595|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4077050|NCT01029691|3899592|B4||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4077051|NCT01029691|3899593|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4077052|NCT01029691|3899594|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4077053|NCT01029691|3899595|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4077054|NCT01029691|3899592|B4|||Age||Years|Mean|31.8|31.8|Standard Deviation|6.1|6.1|||
4077055|NCT01029691|3899593|B3|||Age||Years|Mean|31.1|31.1|Standard Deviation|6.6|6.6|||
4077056|NCT01029691|3899594|B2|||Age||Years|Mean|32.3|32.3|Standard Deviation|3.8|3.8|||
4077057|NCT01029691|3899595|B1|||Age||Years|Mean|34.3|34.3|Standard Deviation|4.8|4.8|||
4077058|NCT01029652|3899620|B3||Male|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4077059|NCT01029652|3899621|B2||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4077060|NCT01029652|3899622|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4077061|NCT01029652|3899620|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4077062|NCT01029652|3899621|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4077063|NCT01029652|3899622|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4077064|NCT01029652|3899620|B3|≥ 75 years||Age, Customized||participants|Number|7|7.0||||||
4077065|NCT01029652|3899621|B2|≥ 75 years||Age, Customized||participants|Number|2|2.0||||||
4077066|NCT01029652|3899622|B1|≥ 75 years||Age, Customized||participants|Number|5|5.0||||||
4077067|NCT01029652|3899620|B3|≥ 65 - 74 years||Age, Customized||participants|Number|37|37.0||||||
4077068|NCT01029652|3899621|B2|≥ 65 - 74 years||Age, Customized||participants|Number|21|21.0||||||
4077069|NCT01029652|3899622|B1|≥ 65 - 74 years||Age, Customized||participants|Number|16|16.0||||||
4077070|NCT01029652|3899620|B3|< 65 years||Age, Customized||participants|Number|184|184.0||||||
4077071|NCT01029652|3899621|B2|< 65 years||Age, Customized||participants|Number|92|92.0||||||
4077072|NCT01029652|3899622|B1|< 65 years||Age, Customized||participants|Number|92|92.0||||||
4077073|NCT01029652|3899620|B3|||Age|Two patients randomized to canakinumab were not included in the data set (safety set) used to calculate demographic data as they did not receive any study medication and were discontinued from the study on the day of randomization.|years|Mean|54.3|54.3|Standard Deviation|10.93|10.93|||
4077074|NCT01029652|3899621|B2|||Age|Two patients randomized to canakinumab were not included in the data set (safety set) used to calculate demographic data as they did not receive any study medication and were discontinued from the study on the day of randomization.|years|Mean|54.6|54.6|Standard Deviation|10.71|10.71|||
4077075|NCT01029652|3899622|B1|||Age|Two patients randomized to canakinumab were not included in the data set (safety set) used to calculate demographic data as they did not receive any study medication and were discontinued from the study on the day of randomization.|years|Mean|54|54.0|Standard Deviation|11.18|11.18|||
4077076|NCT01029535|3899701|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4077077|NCT01029535|3899701|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4077078|NCT01029535|3899701|B1|||Age||years|Mean|46.7|46.7|Full Range|||29.0|63.0|
4077079|NCT01029535|3899701|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4077080|NCT01029535|3899701|B1||Between 18 and 65 years|Age||Participants|Count of Participants|103|103.0||||||
4077081|NCT01029535|3899701|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4077082|NCT01029405|3899726|B5||Male|Gender||Participants|Count of Participants|127|127.0||||||
4077083|NCT01029405|3899727|B4||Male|Gender||Participants|Count of Participants|33|33.0||||||
4077084|NCT01029405|3899728|B3||Male|Gender||Participants|Count of Participants|31|31.0||||||
4077085|NCT01029405|3899729|B2||Male|Gender||Participants|Count of Participants|33|33.0||||||
4077086|NCT01029405|3899730|B1||Male|Gender||Participants|Count of Participants|30|30.0||||||
4077087|NCT01029405|3899726|B5||Female|Gender||Participants|Count of Participants|18|18.0||||||
4077088|NCT01029405|3899727|B4||Female|Gender||Participants|Count of Participants|4|4.0||||||
4077089|NCT01029405|3899728|B3||Female|Gender||Participants|Count of Participants|4|4.0||||||
4077090|NCT01029405|3899729|B2||Female|Gender||Participants|Count of Participants|4|4.0||||||
4077091|NCT01029405|3899730|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
4077092|NCT01029405|3899726|B5||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4077093|NCT01029405|3899727|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4077094|NCT01029405|3899728|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4077095|NCT01029405|3899729|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4077096|NCT01029405|3899730|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4077097|NCT01029405|3899726|B5||Between 18 and 65 years|Age||Participants|Count of Participants|134|134.0||||||
4077098|NCT01029405|3899727|B4||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4077099|NCT01029405|3899728|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4077100|NCT01029405|3899729|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4077101|NCT01029405|3899730|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4077102|NCT01029405|3899726|B5||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4077103|NCT01029405|3899727|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4077104|NCT01029405|3899728|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4077105|NCT01029405|3899729|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4077106|NCT01029405|3899730|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4077107|NCT01029392|3899743|B3|United States||Region of Enrollment||participants|Number|75|75.0||||||
4077108|NCT01029392|3899744|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
4077109|NCT01029392|3899745|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4077110|NCT01029392|3899743|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4077111|NCT01029392|3899744|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4077112|NCT01029392|3899745|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4077113|NCT01029392|3899743|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4077114|NCT01029392|3899744|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4077115|NCT01029392|3899745|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077116|NCT01029392|3899743|B3||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4077117|NCT01029392|3899744|B2||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4077118|NCT01029392|3899745|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4077119|NCT01029392|3899743|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4077120|NCT01029392|3899744|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4077121|NCT01029392|3899745|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4077122|NCT01029392|3899743|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077123|NCT01029392|3899744|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077124|NCT01029392|3899745|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077125|NCT01029392|3899743|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4077126|NCT01029392|3899744|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4077127|NCT01029392|3899745|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4077128|NCT01029392|3899743|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077129|NCT01029392|3899744|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077130|NCT01029392|3899745|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077131|NCT01029392|3899743|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4077132|NCT01029392|3899744|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4077133|NCT01029392|3899745|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4077134|NCT01029392|3899743|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4077135|NCT01029392|3899744|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4077136|NCT01029392|3899745|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4077137|NCT01029392|3899743|B3|||Age||years|Mean|9.95|9.95|Standard Deviation|4.0|4.0|||
4077138|NCT01029392|3899744|B2|||Age||years|Mean|8.9|8.9|Standard Deviation|4.1|4.1|||
4077139|NCT01029392|3899745|B1|||Age||years|Mean|10.4|10.4|Standard Deviation|4.2|4.2|||
4077140|NCT01029392|3899743|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4077141|NCT01029392|3899744|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4077142|NCT01029392|3899745|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4077143|NCT01029392|3899743|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4077144|NCT01029392|3899744|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4077145|NCT01029392|3899745|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4077146|NCT01029392|3899743|B3||<=18 years|Age||Participants|Count of Participants|44|44.0||||||
4077147|NCT01029392|3899744|B2||<=18 years|Age||Participants|Count of Participants|27|27.0||||||
4077148|NCT01029392|3899745|B1||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
4077149|NCT01029366|3899754|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077150|NCT01029366|3899755|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077151|NCT01029366|3899756|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077152|NCT01029366|3899754|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077153|NCT01029366|3899755|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077154|NCT01029366|3899756|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077155|NCT01029366|3899754|B3||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4077156|NCT01029366|3899755|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4077157|NCT01029366|3899756|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4077158|NCT01029366|3899754|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4077159|NCT01029366|3899755|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4077160|NCT01029366|3899756|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077161|NCT01029366|3899754|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077162|NCT01029366|3899755|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077163|NCT01029366|3899756|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077164|NCT01029366|3899754|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077165|NCT01029366|3899755|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077166|NCT01029366|3899756|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077167|NCT01029366|3899754|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077168|NCT01029366|3899755|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077169|NCT01029366|3899756|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077170|NCT01029366|3899754|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077171|NCT01029366|3899755|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077172|NCT01029366|3899756|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077173|NCT01029366|3899754|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4077174|NCT01029366|3899755|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4077175|NCT01029366|3899756|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4077176|NCT01029366|3899754|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4077177|NCT01029366|3899755|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4077178|NCT01029366|3899756|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077179|NCT01029366|3899754|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4077180|NCT01029366|3899755|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4077181|NCT01029366|3899756|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4077182|NCT01029366|3899754|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4077183|NCT01029366|3899755|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4077184|NCT01029366|3899756|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4077185|NCT01029366|3899754|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4077186|NCT01029366|3899755|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4077187|NCT01029366|3899756|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4077188|NCT01029366|3899754|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4077189|NCT01029366|3899755|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4077190|NCT01029366|3899756|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4077191|NCT01029366|3899754|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4077192|NCT01029366|3899755|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4077193|NCT01029366|3899756|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4077194|NCT01029340|3899764|B6|Prophylaxis||Most recent treatment before enrolment in the study|Parts A, B and C all based on safety analysis set|Participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4077195|NCT01029340|3899765|B5|Prophylaxis||Most recent treatment before enrolment in the study|Parts A, B and C all based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077196|NCT01029340|3899766|B4|Prophylaxis||Most recent treatment before enrolment in the study|Parts A, B and C all based on safety analysis set|Participants|Number|24|24.0||||||
4077197|NCT01029340|3899767|B3|Prophylaxis||Most recent treatment before enrolment in the study|Parts A, B and C all based on safety analysis set|Participants|Number|26|26.0||||||
4077198|NCT01029340|3899768|B2|Prophylaxis||Most recent treatment before enrolment in the study|Parts A, B and C all based on safety analysis set|Participants|Number|11|11.0||||||
4077199|NCT01029340|3899769|B1|Prophylaxis||Most recent treatment before enrolment in the study|Parts A, B and C all based on safety analysis set|Participants|Number|10|10.0||||||
4077200|NCT01029340|3899764|B6|On-demand||Most recent treatment before enrolment in the study|Parts A, B and C all based on safety analysis set|Participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4077201|NCT01029340|3899765|B5|On-demand||Most recent treatment before enrolment in the study|Parts A, B and C all based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077202|NCT01029340|3899766|B4|On-demand||Most recent treatment before enrolment in the study|Parts A, B and C all based on safety analysis set|Participants|Number|8|8.0||||||
4077203|NCT01029340|3899767|B3|On-demand||Most recent treatment before enrolment in the study|Parts A, B and C all based on safety analysis set|Participants|Number|4|4.0||||||
4077204|NCT01029340|3899768|B2|On-demand||Most recent treatment before enrolment in the study|Parts A, B and C all based on safety analysis set|Participants|Number|3|3.0||||||
4077205|NCT01029340|3899769|B1|On-demand||Most recent treatment before enrolment in the study|Parts A, B and C all based on safety analysis set|Participants|Number|4|4.0||||||
4077206|NCT01029340|3899764|B6|Part C - Male||Sex/Gender, Customized|Part A based on PK analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4077207|NCT01029340|3899765|B5|Part C - Male||Sex/Gender, Customized|Part A based on PK analysis set; Parts B and C based on safety analysis set|Participants|Number|5|5.0||||||
4077208|NCT01029340|3899766|B4|Part C - Male||Sex/Gender, Customized|Part A based on PK analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077209|NCT01029340|3899767|B3|Part C - Male||Sex/Gender, Customized|Part A based on PK analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077210|NCT01029340|3899768|B2|Part C - Male||Sex/Gender, Customized|Part A based on PK analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077211|NCT01029340|3899769|B1|Part C - Male||Sex/Gender, Customized|Part A based on PK analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077212|NCT01029340|3899764|B6|Part C - Female||Sex/Gender, Customized|Part A based on PK analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4077213|NCT01029340|3899765|B5|Part C - Female||Sex/Gender, Customized|Part A based on PK analysis set; Parts B and C based on safety analysis set|Participants|Number|0|0.0||||||
4077214|NCT01029340|3899766|B4|Part C - Female||Sex/Gender, Customized|Part A based on PK analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077354|NCT01028911|3899871|B2|45 to 64 years||Age, Customized||participants|Number|0|0.0||||||
4077215|NCT01029340|3899767|B3|Part C - Female||Sex/Gender, Customized|Part A based on PK analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077216|NCT01029340|3899768|B2|Part C - Female||Sex/Gender, Customized|Part A based on PK analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077217|NCT01029340|3899769|B1|Part C - Female||Sex/Gender, Customized|Part A based on PK analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077218|NCT01029340|3899764|B6|Part B - Male||Sex/Gender, Customized|Part A based on PK analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4077219|NCT01029340|3899765|B5|Part B - Male||Sex/Gender, Customized|Part A based on PK analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077220|NCT01029340|3899766|B4|Part B - Male||Sex/Gender, Customized|Part A based on PK analysis set; Parts B and C based on safety analysis set|Participants|Number|32|32.0||||||
4077221|NCT01029340|3899767|B3|Part B - Male||Sex/Gender, Customized|Part A based on PK analysis set; Parts B and C based on safety analysis set|Participants|Number|30|30.0||||||
4077222|NCT01029340|3899768|B2|Part B - Male||Sex/Gender, Customized|Part A based on PK analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077223|NCT01029340|3899769|B1|Part B - Male||Sex/Gender, Customized|Part A based on PK analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077224|NCT01029340|3899764|B6|Part B - Female||Sex/Gender, Customized|Part A based on PK analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4077225|NCT01029340|3899765|B5|Part B - Female||Sex/Gender, Customized|Part A based on PK analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077226|NCT01029340|3899766|B4|Part B - Female||Sex/Gender, Customized|Part A based on PK analysis set; Parts B and C based on safety analysis set|Participants|Number|0|0.0||||||
4077227|NCT01029340|3899767|B3|Part B - Female||Sex/Gender, Customized|Part A based on PK analysis set; Parts B and C based on safety analysis set|Participants|Number|0|0.0||||||
4077228|NCT01029340|3899768|B2|Part B - Female||Sex/Gender, Customized|Part A based on PK analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077229|NCT01029340|3899769|B1|Part B - Female||Sex/Gender, Customized|Part A based on PK analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077230|NCT01029340|3899764|B6|Part A - Male||Sex/Gender, Customized|Part A based on PK analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4077231|NCT01029340|3899765|B5|Part A - Male||Sex/Gender, Customized|Part A based on PK analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077232|NCT01029340|3899766|B4|Part A - Male||Sex/Gender, Customized|Part A based on PK analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077233|NCT01029340|3899767|B3|Part A - Male||Sex/Gender, Customized|Part A based on PK analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077234|NCT01029340|3899768|B2|Part A - Male||Sex/Gender, Customized|Part A based on PK analysis set; Parts B and C based on safety analysis set|Participants|Number|13|13.0||||||
4077235|NCT01029340|3899769|B1|Part A - Male||Sex/Gender, Customized|Part A based on PK analysis set; Parts B and C based on safety analysis set|Participants|Number|13|13.0||||||
4077236|NCT01029340|3899764|B6|Part A - Female||Sex/Gender, Customized|Part A based on PK analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4077237|NCT01029340|3899765|B5|Part A - Female||Sex/Gender, Customized|Part A based on PK analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077238|NCT01029340|3899766|B4|Part A - Female||Sex/Gender, Customized|Part A based on PK analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077239|NCT01029340|3899767|B3|Part A - Female||Sex/Gender, Customized|Part A based on PK analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077240|NCT01029340|3899768|B2|Part A - Female||Sex/Gender, Customized|Part A based on PK analysis set; Parts B and C based on safety analysis set|Participants|Number|0|0.0||||||
4077241|NCT01029340|3899769|B1|Part A - Female||Sex/Gender, Customized|Part A based on PK analysis set; Parts B and C based on safety analysis set|Participants|Number|0|0.0||||||
4077242|NCT01029340|3899764|B6|Part C =/> 18 years||Age, Customized|Part A based on pharmacokinetic (PK) analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4077243|NCT01029340|3899765|B5|Part C =/> 18 years||Age, Customized|Part A based on pharmacokinetic (PK) analysis set; Parts B and C based on safety analysis set|Participants|Number|5|5.0||||||
4077244|NCT01029340|3899766|B4|Part C =/> 18 years||Age, Customized|Part A based on pharmacokinetic (PK) analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077245|NCT01029340|3899767|B3|Part C =/> 18 years||Age, Customized|Part A based on pharmacokinetic (PK) analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077246|NCT01029340|3899768|B2|Part C =/> 18 years||Age, Customized|Part A based on pharmacokinetic (PK) analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077247|NCT01029340|3899769|B1|Part C =/> 18 years||Age, Customized|Part A based on pharmacokinetic (PK) analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077248|NCT01029340|3899764|B6|Part C < 18 years||Age, Customized|Part A based on pharmacokinetic (PK) analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4077249|NCT01029340|3899765|B5|Part C < 18 years||Age, Customized|Part A based on pharmacokinetic (PK) analysis set; Parts B and C based on safety analysis set|Participants|Number|0|0.0||||||
4077250|NCT01029340|3899766|B4|Part C < 18 years||Age, Customized|Part A based on pharmacokinetic (PK) analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077251|NCT01029340|3899767|B3|Part C < 18 years||Age, Customized|Part A based on pharmacokinetic (PK) analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077252|NCT01029340|3899768|B2|Part C < 18 years||Age, Customized|Part A based on pharmacokinetic (PK) analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077253|NCT01029340|3899769|B1|Part C < 18 years||Age, Customized|Part A based on pharmacokinetic (PK) analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077254|NCT01029340|3899764|B6|Part B =/> 18 years||Age, Customized|Part A based on pharmacokinetic (PK) analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4077255|NCT01029340|3899765|B5|Part B =/> 18 years||Age, Customized|Part A based on pharmacokinetic (PK) analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077256|NCT01029340|3899766|B4|Part B =/> 18 years||Age, Customized|Part A based on pharmacokinetic (PK) analysis set; Parts B and C based on safety analysis set|Participants|Number|27|27.0||||||
4077257|NCT01029340|3899767|B3|Part B =/> 18 years||Age, Customized|Part A based on pharmacokinetic (PK) analysis set; Parts B and C based on safety analysis set|Participants|Number|25|25.0||||||
4077258|NCT01029340|3899768|B2|Part B =/> 18 years||Age, Customized|Part A based on pharmacokinetic (PK) analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077259|NCT01029340|3899769|B1|Part B =/> 18 years||Age, Customized|Part A based on pharmacokinetic (PK) analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077260|NCT01029340|3899764|B6|Part B < 18 years||Age, Customized|Part A based on pharmacokinetic (PK) analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4077261|NCT01029340|3899765|B5|Part B < 18 years||Age, Customized|Part A based on pharmacokinetic (PK) analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077262|NCT01029340|3899766|B4|Part B < 18 years||Age, Customized|Part A based on pharmacokinetic (PK) analysis set; Parts B and C based on safety analysis set|Participants|Number|5|5.0||||||
4077263|NCT01029340|3899767|B3|Part B < 18 years||Age, Customized|Part A based on pharmacokinetic (PK) analysis set; Parts B and C based on safety analysis set|Participants|Number|5|5.0||||||
4077264|NCT01029340|3899768|B2|Part B < 18 years||Age, Customized|Part A based on pharmacokinetic (PK) analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077265|NCT01029340|3899769|B1|Part B < 18 years||Age, Customized|Part A based on pharmacokinetic (PK) analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077266|NCT01029340|3899764|B6|Part A =/> 18 years||Age, Customized|Part A based on pharmacokinetic (PK) analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4077267|NCT01029340|3899765|B5|Part A =/> 18 years||Age, Customized|Part A based on pharmacokinetic (PK) analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077268|NCT01029340|3899766|B4|Part A =/> 18 years||Age, Customized|Part A based on pharmacokinetic (PK) analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077269|NCT01029340|3899767|B3|Part A =/> 18 years||Age, Customized|Part A based on pharmacokinetic (PK) analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077270|NCT01029340|3899768|B2|Part A =/> 18 years||Age, Customized|Part A based on pharmacokinetic (PK) analysis set; Parts B and C based on safety analysis set|Participants|Number|9|9.0||||||
4077271|NCT01029340|3899769|B1|Part A =/> 18 years||Age, Customized|Part A based on pharmacokinetic (PK) analysis set; Parts B and C based on safety analysis set|Participants|Number|12|12.0||||||
4077272|NCT01029340|3899764|B6|Part A < 18 years||Age, Customized|Part A based on pharmacokinetic (PK) analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4077273|NCT01029340|3899765|B5|Part A < 18 years||Age, Customized|Part A based on pharmacokinetic (PK) analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077274|NCT01029340|3899766|B4|Part A < 18 years||Age, Customized|Part A based on pharmacokinetic (PK) analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077355|NCT01028911|3899872|B1|45 to 64 years||Age, Customized||participants|Number|1|1.0||||||
4077275|NCT01029340|3899767|B3|Part A < 18 years||Age, Customized|Part A based on pharmacokinetic (PK) analysis set; Parts B and C based on safety analysis set|Participants|Number|NA|||||||Data is not available because participants did not participate in this phase.
4077276|NCT01029340|3899768|B2|Part A < 18 years||Age, Customized|Part A based on pharmacokinetic (PK) analysis set; Parts B and C based on safety analysis set|Participants|Number|4|4.0||||||
4077277|NCT01029340|3899769|B1|Part A < 18 years||Age, Customized|Part A based on pharmacokinetic (PK) analysis set; Parts B and C based on safety analysis set|Participants|Number|1|1.0||||||
4077278|NCT01029262|3899803|B3|||Gene Expression Signature|A prespecified subgroup of participants with an erythroid differentiation gene expression signature predictive of lenalidomide response|participants|Number|17|17.0||||||
4077279|NCT01029262|3899804|B2|||Gene Expression Signature|A prespecified subgroup of participants with an erythroid differentiation gene expression signature predictive of lenalidomide response|participants|Number|14|14.0||||||
4077280|NCT01029262|3899805|B1|||Gene Expression Signature|A prespecified subgroup of participants with an erythroid differentiation gene expression signature predictive of lenalidomide response|participants|Number|3|3.0||||||
4077281|NCT01029262|3899803|B3|||Hemoglobin||g/dL|Mean|8.7|8.7|Standard Deviation|1.28|1.28|||
4077282|NCT01029262|3899804|B2|||Hemoglobin||g/dL|Mean|8.7|8.7|Standard Deviation|1.23|1.23|||
4077283|NCT01029262|3899805|B1|||Hemoglobin||g/dL|Mean|8.7|8.7|Standard Deviation|1.37|1.37|||
4077284|NCT01029262|3899803|B3|No||Prior Erythropoiesis-stimulating agent (ESA) Treatment|Erythropoiesis-stimulating agents (ESA) are similar to the cytokine (erythropoietin) that stimulates red blood cell production (erythropoieisis). ESAs, structurally and biologically, are similar to naturally occurring protein erythropoietin. ESAs are used to maintain hemoglobin at the lowest level that both minimizes transfusions and best meets a person's needs|participants|Number|51|51.0||||||
4077285|NCT01029262|3899804|B2|No||Prior Erythropoiesis-stimulating agent (ESA) Treatment|Erythropoiesis-stimulating agents (ESA) are similar to the cytokine (erythropoietin) that stimulates red blood cell production (erythropoieisis). ESAs, structurally and biologically, are similar to naturally occurring protein erythropoietin. ESAs are used to maintain hemoglobin at the lowest level that both minimizes transfusions and best meets a person's needs|participants|Number|35|35.0||||||
4077286|NCT01029262|3899805|B1|No||Prior Erythropoiesis-stimulating agent (ESA) Treatment|Erythropoiesis-stimulating agents (ESA) are similar to the cytokine (erythropoietin) that stimulates red blood cell production (erythropoieisis). ESAs, structurally and biologically, are similar to naturally occurring protein erythropoietin. ESAs are used to maintain hemoglobin at the lowest level that both minimizes transfusions and best meets a person's needs|participants|Number|16|16.0||||||
4077287|NCT01029262|3899803|B3|Yes||Prior Erythropoiesis-stimulating agent (ESA) Treatment|Erythropoiesis-stimulating agents (ESA) are similar to the cytokine (erythropoietin) that stimulates red blood cell production (erythropoieisis). ESAs, structurally and biologically, are similar to naturally occurring protein erythropoietin. ESAs are used to maintain hemoglobin at the lowest level that both minimizes transfusions and best meets a person's needs|participants|Number|188|188.0||||||
4077288|NCT01029262|3899804|B2|Yes||Prior Erythropoiesis-stimulating agent (ESA) Treatment|Erythropoiesis-stimulating agents (ESA) are similar to the cytokine (erythropoietin) that stimulates red blood cell production (erythropoieisis). ESAs, structurally and biologically, are similar to naturally occurring protein erythropoietin. ESAs are used to maintain hemoglobin at the lowest level that both minimizes transfusions and best meets a person's needs|participants|Number|125|125.0||||||
4077289|NCT01029262|3899805|B1|Yes||Prior Erythropoiesis-stimulating agent (ESA) Treatment|Erythropoiesis-stimulating agents (ESA) are similar to the cytokine (erythropoietin) that stimulates red blood cell production (erythropoieisis). ESAs, structurally and biologically, are similar to naturally occurring protein erythropoietin. ESAs are used to maintain hemoglobin at the lowest level that both minimizes transfusions and best meets a person's needs|participants|Number|63|63.0||||||
4077290|NCT01029262|3899803|B3|Refractory anemia with excess blasts-1 (RAEB-1)||World Health Organization Classification 2008 of MDS by Central Review|The World Health Organization (WHO) 2008 classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|39|39.0||||||
4077291|NCT01029262|3899804|B2|Refractory anemia with excess blasts-1 (RAEB-1)||World Health Organization Classification 2008 of MDS by Central Review|The World Health Organization (WHO) 2008 classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|27|27.0||||||
4077292|NCT01029262|3899805|B1|Refractory anemia with excess blasts-1 (RAEB-1)||World Health Organization Classification 2008 of MDS by Central Review|The World Health Organization (WHO) 2008 classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|12|12.0||||||
4077293|NCT01029262|3899803|B3|Refractory cytopenia multilineage dysplasia (RCMD)||World Health Organization Classification 2008 of MDS by Central Review|The World Health Organization (WHO) 2008 classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|174|174.0||||||
4077294|NCT01029262|3899804|B2|Refractory cytopenia multilineage dysplasia (RCMD)||World Health Organization Classification 2008 of MDS by Central Review|The World Health Organization (WHO) 2008 classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|115|115.0||||||
4077356|NCT01028820|3899938|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077357|NCT01028820|3899938|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077358|NCT01028820|3899938|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4077295|NCT01029262|3899805|B1|Refractory cytopenia multilineage dysplasia (RCMD)||World Health Organization Classification 2008 of MDS by Central Review|The World Health Organization (WHO) 2008 classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|59|59.0||||||
4077296|NCT01029262|3899803|B3|RA with ringed sideroblasts (RARS)||World Health Organization Classification 2008 of MDS by Central Review|The World Health Organization (WHO) 2008 classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|19|19.0||||||
4077297|NCT01029262|3899804|B2|RA with ringed sideroblasts (RARS)||World Health Organization Classification 2008 of MDS by Central Review|The World Health Organization (WHO) 2008 classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|12|12.0||||||
4077298|NCT01029262|3899805|B1|RA with ringed sideroblasts (RARS)||World Health Organization Classification 2008 of MDS by Central Review|The World Health Organization (WHO) 2008 classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|7|7.0||||||
4077299|NCT01029262|3899803|B3|Refractory cytopenia unilineage dysplasia (RCUD)||World Health Organization Classification 2008 of MDS by Central Review|The World Health Organization (WHO) 2008 classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|5|5.0||||||
4077300|NCT01029262|3899804|B2|Refractory cytopenia unilineage dysplasia (RCUD)||World Health Organization Classification 2008 of MDS by Central Review|The World Health Organization (WHO) 2008 classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|5|5.0||||||
4077301|NCT01029262|3899805|B1|Refractory cytopenia unilineage dysplasia (RCUD)||World Health Organization Classification 2008 of MDS by Central Review|The World Health Organization (WHO) 2008 classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|0|0.0||||||
4077302|NCT01029262|3899803|B3|Refractory anemia (RA)||World Health Organization Classification 2008 of MDS by Central Review|The World Health Organization (WHO) 2008 classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|2|2.0||||||
4077303|NCT01029262|3899804|B2|Refractory anemia (RA)||World Health Organization Classification 2008 of MDS by Central Review|The World Health Organization (WHO) 2008 classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|1|1.0||||||
4077304|NCT01029262|3899805|B1|Refractory anemia (RA)||World Health Organization Classification 2008 of MDS by Central Review|The World Health Organization (WHO) 2008 classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|1|1.0||||||
4077305|NCT01029262|3899803|B3|Intermediate 1||International Prognostic Scoring System (IPSS) Investigator determined|The Myelodysplastic Syndrome (MDS) IPSS score assesses the severity of MDS based on 3 prognostic factors each assigned a score: the percentage of bone marrow blasts, chromosome changes in the marrow cells (karyotype) and the presence of one or more low blood cell counts (cytopenias). The IPSS score is the sum of the bone marrow blast + karyotype + cytopenia score and ranges from 0 (low risk) to 3.5 (high risk). Prognosis is categorized as Low risk (score = 0), Intermediate-1 (score 0.5 to 1.0), Intermediate-2 (score 1.5 to 2.0) or High risk (score ≥ 2.5).|participants|Number|124|124.0||||||
4077306|NCT01029262|3899804|B2|Intermediate 1||International Prognostic Scoring System (IPSS) Investigator determined|The Myelodysplastic Syndrome (MDS) IPSS score assesses the severity of MDS based on 3 prognostic factors each assigned a score: the percentage of bone marrow blasts, chromosome changes in the marrow cells (karyotype) and the presence of one or more low blood cell counts (cytopenias). The IPSS score is the sum of the bone marrow blast + karyotype + cytopenia score and ranges from 0 (low risk) to 3.5 (high risk). Prognosis is categorized as Low risk (score = 0), Intermediate-1 (score 0.5 to 1.0), Intermediate-2 (score 1.5 to 2.0) or High risk (score ≥ 2.5).|participants|Number|75|75.0||||||
4077307|NCT01029262|3899805|B1|Intermediate 1||International Prognostic Scoring System (IPSS) Investigator determined|The Myelodysplastic Syndrome (MDS) IPSS score assesses the severity of MDS based on 3 prognostic factors each assigned a score: the percentage of bone marrow blasts, chromosome changes in the marrow cells (karyotype) and the presence of one or more low blood cell counts (cytopenias). The IPSS score is the sum of the bone marrow blast + karyotype + cytopenia score and ranges from 0 (low risk) to 3.5 (high risk). Prognosis is categorized as Low risk (score = 0), Intermediate-1 (score 0.5 to 1.0), Intermediate-2 (score 1.5 to 2.0) or High risk (score ≥ 2.5).|participants|Number|49|49.0||||||
4077308|NCT01029262|3899803|B3|Low||International Prognostic Scoring System (IPSS) Investigator determined|The Myelodysplastic Syndrome (MDS) IPSS score assesses the severity of MDS based on 3 prognostic factors each assigned a score: the percentage of bone marrow blasts, chromosome changes in the marrow cells (karyotype) and the presence of one or more low blood cell counts (cytopenias). The IPSS score is the sum of the bone marrow blast + karyotype + cytopenia score and ranges from 0 (low risk) to 3.5 (high risk). Prognosis is categorized as Low risk (score = 0), Intermediate-1 (score 0.5 to 1.0), Intermediate-2 (score 1.5 to 2.0) or High risk (score ≥ 2.5).|participants|Number|115|115.0||||||
4077309|NCT01029262|3899804|B2|Low||International Prognostic Scoring System (IPSS) Investigator determined|The Myelodysplastic Syndrome (MDS) IPSS score assesses the severity of MDS based on 3 prognostic factors each assigned a score: the percentage of bone marrow blasts, chromosome changes in the marrow cells (karyotype) and the presence of one or more low blood cell counts (cytopenias). The IPSS score is the sum of the bone marrow blast + karyotype + cytopenia score and ranges from 0 (low risk) to 3.5 (high risk). Prognosis is categorized as Low risk (score = 0), Intermediate-1 (score 0.5 to 1.0), Intermediate-2 (score 1.5 to 2.0) or High risk (score ≥ 2.5).|participants|Number|85|85.0||||||
4077310|NCT01029262|3899805|B1|Low||International Prognostic Scoring System (IPSS) Investigator determined|The Myelodysplastic Syndrome (MDS) IPSS score assesses the severity of MDS based on 3 prognostic factors each assigned a score: the percentage of bone marrow blasts, chromosome changes in the marrow cells (karyotype) and the presence of one or more low blood cell counts (cytopenias). The IPSS score is the sum of the bone marrow blast + karyotype + cytopenia score and ranges from 0 (low risk) to 3.5 (high risk). Prognosis is categorized as Low risk (score = 0), Intermediate-1 (score 0.5 to 1.0), Intermediate-2 (score 1.5 to 2.0) or High risk (score ≥ 2.5).|participants|Number|30|30.0||||||
4077311|NCT01029262|3899803|B3|||Packed RBC (pRBC) transfusion burden|The baseline transfusion burden is the number of units over 112 days by the randomization divided by 4. RBC transfusion burden (units/28 days): as a continuous variable, average of 28 days RBC transfusion units is based on all transfusion units within 112 days by the randomization date|pRBC units|Mean|3.4|3.4|Standard Deviation|1.28|1.28|||
4077312|NCT01029262|3899804|B2|||Packed RBC (pRBC) transfusion burden|The baseline transfusion burden is the number of units over 112 days by the randomization divided by 4. RBC transfusion burden (units/28 days): as a continuous variable, average of 28 days RBC transfusion units is based on all transfusion units within 112 days by the randomization date|pRBC units|Mean|3.4|3.4|Standard Deviation|1.23|1.23|||
4077313|NCT01029262|3899805|B1|||Packed RBC (pRBC) transfusion burden|The baseline transfusion burden is the number of units over 112 days by the randomization divided by 4. RBC transfusion burden (units/28 days): as a continuous variable, average of 28 days RBC transfusion units is based on all transfusion units within 112 days by the randomization date|pRBC units|Mean|3.4|3.4|Standard Deviation|1.37|1.37|||
4077314|NCT01029262|3899803|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4077315|NCT01029262|3899804|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4077316|NCT01029262|3899805|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4077317|NCT01029262|3899803|B3|Other: Race Not disclosed||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4077318|NCT01029262|3899804|B2|Other: Race Not disclosed||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4077319|NCT01029262|3899805|B1|Other: Race Not disclosed||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4077320|NCT01029262|3899803|B3|Japanese||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4077321|NCT01029262|3899804|B2|Japanese||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4077322|NCT01029262|3899805|B1|Japanese||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4077323|NCT01029262|3899803|B3|White||Race/Ethnicity, Customized||participants|Number|202|202.0||||||
4077324|NCT01029262|3899804|B2|White||Race/Ethnicity, Customized||participants|Number|133|133.0||||||
4077325|NCT01029262|3899805|B1|White||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
4077326|NCT01029262|3899803|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4077327|NCT01029262|3899804|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4077328|NCT01029262|3899805|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4077329|NCT01029262|3899803|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4077330|NCT01029262|3899804|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4077331|NCT01029262|3899805|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4077332|NCT01029262|3899803|B3||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4077333|NCT01029262|3899804|B2||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4077334|NCT01029262|3899805|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4077335|NCT01029262|3899803|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4077336|NCT01029262|3899804|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4077337|NCT01029262|3899805|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4077338|NCT01029262|3899803|B3|||Age||years|Mean|69.6|69.6|Standard Deviation|8.21|8.21|||
4077339|NCT01029262|3899804|B2|||Age||years|Mean|70.0|70.0|Standard Deviation|8.19|8.19|||
4077340|NCT01029262|3899805|B1|||Age||years|Mean|68.9|68.9|Standard Deviation|8.26|8.26|||
4077341|NCT01029054|3899862|B1||Male|Gender||Participants|Count of Participants|39|39.0||||||
4077342|NCT01029054|3899862|B1||Female|Gender||Participants|Count of Participants|14|14.0||||||
4077343|NCT01029054|3899862|B1|||Age||years|Median|59|59.0|Full Range|||35.0|81.0|
4077344|NCT01028911|3899870|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4077345|NCT01028911|3899871|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4077346|NCT01028911|3899872|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4077347|NCT01028911|3899870|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4077348|NCT01028911|3899871|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4077349|NCT01028911|3899872|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4077350|NCT01028911|3899870|B3|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|8|8.0||||||
4077351|NCT01028911|3899871|B2|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|2|2.0||||||
4077352|NCT01028911|3899872|B1|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|6|6.0||||||
4077353|NCT01028911|3899870|B3|45 to 64 years||Age, Customized||participants|Number|1|1.0||||||
4077359|NCT01028820|3899938|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4077360|NCT01028820|3899938|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077361|NCT01028820|3899938|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4077362|NCT01028820|3899938|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077363|NCT01028820|3899938|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4077364|NCT01028820|3899938|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4077365|NCT01028820|3899938|B1|||Age||years|Mean|20.31|20.31|Standard Deviation|5.1|5.1|||
4077366|NCT01028677|3899945|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4077367|NCT01028677|3899946|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4077368|NCT01028677|3899947|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4077369|NCT01028677|3899945|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4077370|NCT01028677|3899946|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4077371|NCT01028677|3899947|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4077372|NCT01028677|3899945|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4077373|NCT01028677|3899946|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4077374|NCT01028677|3899947|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4077375|NCT01028677|3899945|B3|||Age||years|Mean|37.50|37.5|Standard Deviation|7.87|7.87|||
4077376|NCT01028677|3899946|B2|||Age||years|Mean|35.67|35.67|Standard Deviation|9.00|9.0|||
4077377|NCT01028677|3899947|B1|||Age||years|Mean|38.88|38.88|Standard Deviation|7.22|7.22|||
4077378|NCT01028651|3899964|B1|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4077379|NCT01028651|3899964|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077380|NCT01028651|3899964|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077381|NCT01028651|3899964|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4077382|NCT01028651|3899964|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077383|NCT01028651|3899964|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077384|NCT01028651|3899964|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077385|NCT01028651|3899964|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077386|NCT01028651|3899964|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077387|NCT01028651|3899964|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4077388|NCT01028651|3899964|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4077389|NCT01028651|3899964|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
4077390|NCT01028651|3899964|B1||Female|Gender||Participants|Count of Participants|8|8.0||||||
4077391|NCT01028651|3899964|B1|||Age||Years|Mean|55.8|55.8|Standard Deviation|8.00|8.0|||
4077392|NCT01028391|3899985|B3|||Hemoglobin A1c (HbA1c)|"These data reflect the baseline measurement at the beginning of the 24-~week base study. The number of patients with data for HbA1c at this time point were N=163 (sitagliptin+pioglitazone),~N=151 (pioglitazone), and N=314 (total)."|Percent|Mean|9.4|9.4|Standard Deviation|1.2|1.2|||
4077393|NCT01028391|3899986|B2|||Hemoglobin A1c (HbA1c)|"These data reflect the baseline measurement at the beginning of the 24-~week base study. The number of patients with data for HbA1c at this time point were N=163 (sitagliptin+pioglitazone),~N=151 (pioglitazone), and N=314 (total)."|Percent|Mean|9.4|9.4|Standard Deviation|1.2|1.2|||
4077394|NCT01028391|3899987|B1|||Hemoglobin A1c (HbA1c)|"These data reflect the baseline measurement at the beginning of the 24-~week base study. The number of patients with data for HbA1c at this time point were N=163 (sitagliptin+pioglitazone),~N=151 (pioglitazone), and N=314 (total)."|Percent|Mean|9.4|9.4|Standard Deviation|1.2|1.2|||
4077395|NCT01028391|3899985|B3|Other||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4077396|NCT01028391|3899986|B2|Other||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4077397|NCT01028391|3899987|B1|Other||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4077398|NCT01028391|3899985|B3|Asian||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
4077399|NCT01028391|3899986|B2|Asian||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4077400|NCT01028391|3899987|B1|Asian||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4077401|NCT01028391|3899985|B3|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4077402|NCT01028391|3899986|B2|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4077403|NCT01028391|3899987|B1|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4077404|NCT01028391|3899985|B3|White||Race/Ethnicity, Customized||participants|Number|178|178.0||||||
4077405|NCT01028391|3899986|B2|White||Race/Ethnicity, Customized||participants|Number|85|85.0||||||
4077406|NCT01028391|3899987|B1|White||Race/Ethnicity, Customized||participants|Number|93|93.0||||||
4077407|NCT01028391|3899985|B3||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4077408|NCT01028391|3899986|B2||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4077409|NCT01028391|3899987|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4077410|NCT01028391|3899985|B3||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4077411|NCT01028391|3899986|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4077412|NCT01028391|3899987|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4077413|NCT01028391|3899985|B3|||Age|These data reflect the patients' ages at the beginning of the 24-week base study|years|Mean|51.8|51.8|Standard Deviation|10.7|10.7|||
4077414|NCT01028391|3899986|B2|||Age|These data reflect the patients' ages at the beginning of the 24-week base study|years|Mean|52.3|52.3|Standard Deviation|11.5|11.5|||
4077415|NCT01028391|3899987|B1|||Age|These data reflect the patients' ages at the beginning of the 24-week base study|years|Mean|51.4|51.4|Standard Deviation|10.0|10.0|||
4077416|NCT01028378|3899996|B1|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4077417|NCT01028378|3899996|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4077418|NCT01028378|3899996|B1|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4077419|NCT01028378|3899996|B1|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4077420|NCT01028378|3899996|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|157|157.0||||||
4077421|NCT01028378|3899996|B1||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4077422|NCT01028378|3899996|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4077423|NCT01028378|3899996|B1|||Age||years|Mean|34|34.0|Standard Deviation|9.3|9.3|||
4077424|NCT01028352|3900008|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4077425|NCT01028352|3900008|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4077426|NCT01028352|3900008|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4077427|NCT01028352|3900008|B1|||Age||years|Mean|56|56.0|Standard Deviation|.9|0.9|||
4077428|NCT01028352|3900008|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4077429|NCT01028352|3900008|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4077430|NCT01028352|3900008|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4077431|NCT01028300|3900013|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4077432|NCT01028300|3900013|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4077433|NCT01028300|3900013|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4077434|NCT01028300|3900013|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4077435|NCT01028300|3900013|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4077436|NCT01028300|3900013|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4077437|NCT01028222|3900020|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4077438|NCT01028222|3900021|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4077439|NCT01028222|3900022|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4077440|NCT01028222|3900020|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4077441|NCT01028222|3900021|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4077442|NCT01028222|3900022|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4077443|NCT01028222|3900020|B3|||Age||Years|Mean|66.8|66.8|Standard Deviation|12.69|12.69|||
4077444|NCT01028222|3900021|B2|||Age||Years|Mean|68.8|68.8|Standard Deviation|12.99|12.99|||
4077445|NCT01028222|3900022|B1|||Age||Years|Mean|64.7|64.7|Standard Deviation|12.39|12.39|||
4077446|NCT01028131|3900044|B5|United States||Region of Enrollment||participants|Number|110|110.0||||||
4077447|NCT01028131|3900045|B4|United States||Region of Enrollment||participants|Number|30|30.0||||||
4077448|NCT01028131|3900046|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
4077449|NCT01028131|3900047|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4077450|NCT01028131|3900048|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4077451|NCT01028131|3900044|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4077452|NCT01028131|3900045|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4077453|NCT01028131|3900046|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4077454|NCT01028131|3900047|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4077455|NCT01028131|3900048|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4077456|NCT01028131|3900044|B5||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4077457|NCT01028131|3900045|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4077458|NCT01028131|3900046|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4077459|NCT01028131|3900047|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4077460|NCT01028131|3900048|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4077461|NCT01028131|3900044|B5|||Age||years|Mean|27.9|27.9|Standard Deviation|6.4|6.4|||
4077462|NCT01028131|3900045|B4|||Age||years|Mean|27.7|27.7|Standard Deviation|6.1|6.1|||
4077463|NCT01028131|3900046|B3|||Age||years|Mean|29.3|29.3|Standard Deviation|6.7|6.7|||
4077464|NCT01028131|3900047|B2|||Age||years|Mean|25.8|25.8|Standard Deviation|4.8|4.8|||
4077465|NCT01028131|3900048|B1|||Age||years|Mean|28.5|28.5|Standard Deviation|7.5|7.5|||
4077466|NCT01028131|3900044|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4077467|NCT01028131|3900045|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4077468|NCT01028131|3900046|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4077469|NCT01028131|3900047|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4077470|NCT01028131|3900048|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4077471|NCT01028131|3900044|B5||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
4077472|NCT01028131|3900045|B4||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4077473|NCT01028131|3900046|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4077474|NCT01028131|3900047|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4077475|NCT01028131|3900048|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4077476|NCT01028131|3900044|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4077477|NCT01028131|3900045|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4077478|NCT01028131|3900046|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4077479|NCT01028131|3900047|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4077480|NCT01028131|3900048|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4077481|NCT01028053|3900065|B1|United Kingdom||Region of Enrollment||participants|Number|80|80.0||||||
4077482|NCT01028053|3900065|B1|Sweden||Region of Enrollment||participants|Number|7|7.0||||||
4077483|NCT01028053|3900065|B1|Finland||Region of Enrollment||participants|Number|15|15.0||||||
4077484|NCT01028053|3900065|B1|Denmark||Region of Enrollment||participants|Number|8|8.0||||||
4077485|NCT01028053|3900065|B1|Belgium||Region of Enrollment||participants|Number|13|13.0||||||
4077486|NCT01028053|3900065|B1|United States||Region of Enrollment||participants|Number|109|109.0||||||
4077487|NCT01028053|3900065|B1||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4077488|NCT01028053|3900065|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4077489|NCT01028053|3900065|B1||>=65 years|Age||Participants|Count of Participants|169|169.0||||||
4077490|NCT01028053|3900065|B1||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4077491|NCT01028053|3900065|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4077492|NCT01028053|3900065|B1|||Age||years|Mean|71.1|71.1|Standard Deviation|8.62|8.62|||
4077493|NCT01028027|3900071|B3|Singapore||Region of Enrollment||participants|Number|357|357.0||||||
4077494|NCT01028027|3900072|B2|Singapore||Region of Enrollment||participants|Number|177|177.0||||||
4077495|NCT01028027|3900073|B1|Singapore||Region of Enrollment||participants|Number|180|180.0||||||
4077496|NCT01028027|3900071|B3||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4077497|NCT01028027|3900072|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4077498|NCT01028027|3900073|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4077499|NCT01028027|3900071|B3||Female|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
4077500|NCT01028027|3900072|B2||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4077501|NCT01028027|3900073|B1||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4077502|NCT01028027|3900071|B3|||Age||Years|Mean|41.26|41.26|Standard Deviation|13.57|13.57|||
4077503|NCT01028027|3900072|B2|||Age||Years|Mean|41.72|41.72|Standard Deviation|13.54|13.54|||
4077504|NCT01028027|3900073|B1|||Age||Years|Mean|40.8|40.8|Standard Deviation|13.63|13.63|||
4077505|NCT01028014|3900090|B7|United States||Region of Enrollment||participants|Number|56|56.0||||||
4077506|NCT01028014|3900091|B6|United States||Region of Enrollment||participants|Number|6|6.0||||||
4077507|NCT01028014|3900092|B5|United States||Region of Enrollment||participants|Number|10|10.0||||||
4077508|NCT01028014|3900093|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
4077509|NCT01028014|3900094|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4077510|NCT01028014|3900095|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4077511|NCT01028014|3900096|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4077512|NCT01028014|3900090|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4077513|NCT01028014|3900091|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4077514|NCT01028014|3900092|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4077515|NCT01028014|3900093|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4077516|NCT01028014|3900094|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4077517|NCT01028014|3900095|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4077518|NCT01028014|3900096|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4077519|NCT01028014|3900090|B7||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4077520|NCT01028014|3900091|B6||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4077521|NCT01028014|3900092|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4077522|NCT01028014|3900093|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4077523|NCT01028014|3900094|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4077524|NCT01028014|3900095|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4077525|NCT01028014|3900096|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4077526|NCT01028014|3900090|B7|||Age||years|Mean|34.3|34.3|Full Range|||19.0|57.0|
4077527|NCT01028014|3900091|B6|||Age||years|Mean|28.7|28.7|Full Range|||21.0|35.0|
4077528|NCT01028014|3900092|B5|||Age||years|Mean|38|38.0|Full Range|||24.0|53.0|
4077529|NCT01028014|3900093|B4|||Age||years|Mean|33.1|33.1|Full Range|||21.0|50.0|
4077530|NCT01028014|3900094|B3|||Age||years|Mean|35.5|35.5|Full Range|||21.0|49.0|
4077531|NCT01028014|3900095|B2|||Age||years|Mean|31.6|31.6|Full Range|||21.0|35.0|
4077532|NCT01028014|3900096|B1|||Age||years|Mean|36.6|36.6|Full Range|||24.0|49.0|
4077533|NCT01028014|3900090|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4077534|NCT01028014|3900091|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4077535|NCT01028014|3900092|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4077536|NCT01028014|3900093|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4077537|NCT01028014|3900094|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4077538|NCT01028014|3900095|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4077539|NCT01028014|3900096|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4077540|NCT01028014|3900090|B7||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4077541|NCT01028014|3900091|B6||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4077542|NCT01028014|3900092|B5||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4077543|NCT01028014|3900093|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4077544|NCT01028014|3900094|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4077545|NCT01028014|3900095|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4077546|NCT01028014|3900096|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4077547|NCT01028014|3900090|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4077548|NCT01028014|3900091|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4077549|NCT01028014|3900092|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4077550|NCT01028014|3900093|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4077551|NCT01028014|3900094|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4077552|NCT01028014|3900095|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4077553|NCT01028014|3900096|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4077554|NCT01027910|3900127|B3||Male|Gender||Participants|Count of Participants|12|12.0||||||
4077555|NCT01027910|3900128|B2||Male|Gender||Participants|Count of Participants|7|7.0||||||
4077556|NCT01027910|3900129|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
4077557|NCT01027910|3900127|B3||Female|Gender||Participants|Count of Participants|8|8.0||||||
4077558|NCT01027910|3900128|B2||Female|Gender||Participants|Count of Participants|7|7.0||||||
4077559|NCT01027910|3900129|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
4077560|NCT01027910|3900127|B3|||Age||years|Mean|54|54.0|Standard Deviation|14|14.0|||
4077561|NCT01027910|3900128|B2|||Age||years|Mean|56|56.0|Standard Deviation|14|14.0|||
4077562|NCT01027910|3900129|B1|||Age||years|Mean|52|52.0|Standard Deviation|14|14.0|||
4077563|NCT01027897|3900142|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4077564|NCT01027897|3900142|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4077565|NCT01027897|3900142|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4077566|NCT01027897|3900142|B1|||Age||years|Mean|43.6|43.6|Standard Deviation|15|15.0|||
4077567|NCT01027897|3900142|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4077568|NCT01027897|3900142|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4077569|NCT01027897|3900142|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4077570|NCT01027884|3900148|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4077571|NCT01027884|3900149|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4077572|NCT01027884|3900150|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4077573|NCT01027884|3900148|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4077574|NCT01027884|3900149|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4077575|NCT01027884|3900150|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4077576|NCT01027884|3900148|B3|||Age||years|Mean|14.3|14.3|Standard Deviation|2.7|2.7|||
4077577|NCT01027884|3900149|B2|||Age||years|Mean|13.5|13.5|Standard Deviation|2.7|2.7|||
4077578|NCT01027884|3900150|B1|||Age||years|Mean|15|15.0|Standard Deviation|2.5|2.5|||
4077579|NCT01027871|3900165|B4|Russia||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
4077580|NCT01027871|3900166|B3|Russia||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4077581|NCT01027871|3900167|B2|Russia||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4077582|NCT01027871|3900168|B1|Russia||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4077583|NCT01027871|3900165|B4|Australia||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
4077584|NCT01027871|3900166|B3|Australia||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4077585|NCT01027871|3900167|B2|Australia||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4077586|NCT01027871|3900168|B1|Australia||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4077587|NCT01027871|3900165|B4|Romania||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
4077588|NCT01027871|3900166|B3|Romania||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4077589|NCT01027871|3900167|B2|Romania||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4077590|NCT01027871|3900168|B1|Romania||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4077591|NCT01027871|3900165|B4|Spain||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
4077592|NCT01027871|3900166|B3|Spain||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4077593|NCT01027871|3900167|B2|Spain||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4077594|NCT01027871|3900168|B1|Spain||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4077595|NCT01027871|3900165|B4|Poland||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4077596|NCT01027871|3900166|B3|Poland||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4077597|NCT01027871|3900167|B2|Poland||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4077598|NCT01027871|3900168|B1|Poland||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4077599|NCT01027871|3900165|B4|Puerto Rico||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
4077600|NCT01027871|3900166|B3|Puerto Rico||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4077601|NCT01027871|3900167|B2|Puerto Rico||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4077602|NCT01027871|3900168|B1|Puerto Rico||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4077603|NCT01027871|3900165|B4|Hungary||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4077604|NCT01027871|3900166|B3|Hungary||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4077605|NCT01027871|3900167|B2|Hungary||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4077606|NCT01027871|3900168|B1|Hungary||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4077607|NCT01027871|3900165|B4|United States||Region of Enrollment||Participants|Count of Participants|91|91.0||||||
4077608|NCT01027871|3900166|B3|United States||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
4077609|NCT01027871|3900167|B2|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
4077610|NCT01027871|3900168|B1|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4077611|NCT01027871|3900165|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|87|87.0||||||
4077612|NCT01027871|3900166|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4077613|NCT01027871|3900167|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4077614|NCT01027871|3900168|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|87|87.0||||||
4077615|NCT01027871|3900165|B4|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4077616|NCT01027871|3900166|B3|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4077617|NCT01027871|3900167|B2|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4077618|NCT01027871|3900168|B1|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4077619|NCT01027871|3900165|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4077620|NCT01027871|3900166|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4077621|NCT01027871|3900167|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4077622|NCT01027871|3900168|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4077623|NCT01027871|3900165|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4077624|NCT01027871|3900166|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4077625|NCT01027871|3900167|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4077626|NCT01027871|3900168|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4077627|NCT01027871|3900165|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4077628|NCT01027871|3900166|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4077629|NCT01027871|3900167|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4077630|NCT01027871|3900168|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4077631|NCT01027871|3900165|B4||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4077632|NCT01027871|3900166|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4077633|NCT01027871|3900167|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4077634|NCT01027871|3900168|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4077635|NCT01027871|3900165|B4||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4077636|NCT01027871|3900166|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4077637|NCT01027871|3900167|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4077638|NCT01027871|3900168|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4077639|NCT01027871|3900165|B4|||Age||years|Mean|59.49|59.49|Standard Deviation|9.14|9.14|||
4077640|NCT01027871|3900166|B3|||Age||years|Mean|59.23|59.23|Standard Deviation|9.28|9.28|||
4077641|NCT01027871|3900167|B2|||Age||years|Mean|58.57|58.57|Standard Deviation|9.99|9.99|||
4077642|NCT01027871|3900168|B1|||Age||years|Mean|60.74|60.74|Standard Deviation|7.94|7.94|||
4077643|NCT01027819|3900227|B3|Korea, Republic of||Region of Enrollment||participants|Number|80|80.0||||||
4077644|NCT01027819|3900228|B2|Korea, Republic of||Region of Enrollment||participants|Number|40|40.0||||||
4077645|NCT01027819|3900229|B1|Korea, Republic of||Region of Enrollment||participants|Number|40|40.0||||||
4077646|NCT01027819|3900227|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4077647|NCT01027819|3900228|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4077648|NCT01027819|3900229|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4077649|NCT01027819|3900227|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4077650|NCT01027819|3900228|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4077651|NCT01027819|3900229|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4077652|NCT01027819|3900227|B3|||Age||years|Mean|67.24|67.24|Standard Deviation|5.81|5.81|||
4077653|NCT01027819|3900228|B2|||Age||years|Mean|66.08|66.08|Standard Deviation|5.55|5.55|||
4077654|NCT01027819|3900229|B1|||Age||years|Mean|68.36|68.36|Standard Deviation|5.61|5.61|||
4077655|NCT01027819|3900227|B3||>=65 years|Age||Participants|Count of Participants|54|54.0||||||
4077656|NCT01027819|3900228|B2||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4077657|NCT01027819|3900229|B1||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4077658|NCT01027819|3900227|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4077659|NCT01027819|3900228|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4077660|NCT01027819|3900229|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4077661|NCT01027819|3900227|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4077662|NCT01027819|3900228|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4077663|NCT01027819|3900229|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4077664|NCT01027780|3900236|B3|United States||Region of Enrollment||participants|Number|208|208.0||||||
4077665|NCT01027780|3900237|B2|United States||Region of Enrollment||participants|Number|103|103.0||||||
4077666|NCT01027780|3900238|B1|United States||Region of Enrollment||participants|Number|105|105.0||||||
4077667|NCT01027780|3900236|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4077668|NCT01027780|3900237|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4077669|NCT01027780|3900238|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4077670|NCT01027780|3900236|B3||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4077671|NCT01027780|3900237|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4077672|NCT01027780|3900238|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4077673|NCT01027780|3900236|B3|||Age||years|Mean|73.02|73.02|Standard Deviation|6.7|6.7|||
4077674|NCT01027780|3900237|B2|||Age||years|Mean|73.6|73.6|Standard Deviation|6.7|6.7|||
4077675|NCT01027780|3900238|B1|||Age||years|Mean|72.3|72.3|Standard Deviation|6.7|6.7|||
4077676|NCT01027780|3900236|B3||>=65 years|Age||Participants|Count of Participants|205|205.0||||||
4077677|NCT01027780|3900237|B2||>=65 years|Age||Participants|Count of Participants|102|102.0||||||
4077678|NCT01027780|3900238|B1||>=65 years|Age||Participants|Count of Participants|103|103.0||||||
4077679|NCT01027780|3900236|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4077680|NCT01027780|3900237|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4077681|NCT01027780|3900238|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4077682|NCT01027780|3900236|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4077683|NCT01027780|3900237|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4077684|NCT01027780|3900238|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4077685|NCT01027702|3900249|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4077686|NCT01027702|3900249|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4077687|NCT01027702|3900249|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
4077688|NCT01027702|3900249|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4077689|NCT01027702|3900249|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4077690|NCT01027702|3900249|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4077691|NCT01027702|3900249|B1|> 18 years||Age, Customized||participants|Number|4|4.0||||||
4077692|NCT01027702|3900249|B1|16-18 years||Age, Customized||participants|Number|6|6.0||||||
4077693|NCT01027702|3900249|B1|14-16 years||Age, Customized||participants|Number|3|3.0||||||
4077694|NCT01027702|3900249|B1|12-14 years||Age, Customized||participants|Number|4|4.0||||||
4077695|NCT01027702|3900249|B1|10-12 years||Age, Customized||participants|Number|4|4.0||||||
4077696|NCT01027702|3900249|B1|8-10 years||Age, Customized||participants|Number|3|3.0||||||
4077697|NCT01027702|3900249|B1|6-8 years||Age, Customized||participants|Number|3|3.0||||||
4077698|NCT01027702|3900249|B1|4-6 years||Age, Customized||participants|Number|3|3.0||||||
4077699|NCT01027702|3900249|B1|2-4 years||Age, Customized||participants|Number|3|3.0||||||
4077700|NCT01027702|3900249|B1|1-2 years||Age, Customized||participants|Number|3|3.0||||||
4077701|NCT01027702|3900249|B1|< 1 year||Age, Customized||participants|Number|2|2.0||||||
4077702|NCT01027650|3900273|B9||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4077703|NCT01027650|3900274|B8||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4077704|NCT01027650|3900275|B7||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4077705|NCT01027650|3900276|B6||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4077706|NCT01027650|3900277|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4077707|NCT01027650|3900278|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4077708|NCT01027650|3900279|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4077709|NCT01027650|3900280|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4077710|NCT01027650|3900281|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4077711|NCT01027650|3900273|B9||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4077712|NCT01027650|3900274|B8||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4077713|NCT01027650|3900275|B7||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4077714|NCT01027650|3900276|B6||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4077715|NCT01027650|3900277|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4077716|NCT01027650|3900278|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4077717|NCT01027650|3900279|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4077718|NCT01027650|3900280|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4077719|NCT01027650|3900281|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4077720|NCT01027650|3900273|B9|>65 years||Age, Customized||Participants|Number|62|62.0||||||
4077721|NCT01027650|3900274|B8|>65 years||Age, Customized||Participants|Number|12|12.0||||||
4077722|NCT01027650|3900275|B7|>65 years||Age, Customized||Participants|Number|11|11.0||||||
4077723|NCT01027650|3900276|B6|>65 years||Age, Customized||Participants|Number|13|13.0||||||
4077724|NCT01027650|3900277|B5|>65 years||Age, Customized||Participants|Number|17|17.0||||||
4077725|NCT01027650|3900278|B4|>65 years||Age, Customized||Participants|Number|3|3.0||||||
4077726|NCT01027650|3900279|B3|>65 years||Age, Customized||Participants|Number|2|2.0||||||
4077727|NCT01027650|3900280|B2|>65 years||Age, Customized||Participants|Number|2|2.0||||||
4077728|NCT01027650|3900281|B1|>65 years||Age, Customized||Participants|Number|2|2.0||||||
4077729|NCT01027650|3900273|B9|Between 45 and 65 years||Age, Customized||Participants|Number|49|49.0||||||
4077730|NCT01027650|3900274|B8|Between 45 and 65 years||Age, Customized||Participants|Number|9|9.0||||||
4077731|NCT01027650|3900275|B7|Between 45 and 65 years||Age, Customized||Participants|Number|11|11.0||||||
4077732|NCT01027650|3900276|B6|Between 45 and 65 years||Age, Customized||Participants|Number|10|10.0||||||
4077733|NCT01027650|3900277|B5|Between 45 and 65 years||Age, Customized||Participants|Number|8|8.0||||||
4077734|NCT01027650|3900278|B4|Between 45 and 65 years||Age, Customized||Participants|Number|0|0.0||||||
4077735|NCT01027650|3900279|B3|Between 45 and 65 years||Age, Customized||Participants|Number|4|4.0||||||
4077736|NCT01027650|3900280|B2|Between 45 and 65 years||Age, Customized||Participants|Number|4|4.0||||||
4077737|NCT01027650|3900281|B1|Between 45 and 65 years||Age, Customized||Participants|Number|3|3.0||||||
4077738|NCT01027650|3900273|B9|<45 years||Age, Customized||Participants|Number|10|10.0||||||
4077739|NCT01027650|3900274|B8|<45 years||Age, Customized||Participants|Number|3|3.0||||||
4077740|NCT01027650|3900275|B7|<45 years||Age, Customized||Participants|Number|3|3.0||||||
4077741|NCT01027650|3900276|B6|<45 years||Age, Customized||Participants|Number|3|3.0||||||
4077742|NCT01027650|3900277|B5|<45 years||Age, Customized||Participants|Number|0|0.0||||||
4077743|NCT01027650|3900278|B4|<45 years||Age, Customized||Participants|Number|0|0.0||||||
4077744|NCT01027650|3900279|B3|<45 years||Age, Customized||Participants|Number|0|0.0||||||
4077745|NCT01027650|3900280|B2|<45 years||Age, Customized||Participants|Number|0|0.0||||||
4077746|NCT01027650|3900281|B1|<45 years||Age, Customized||Participants|Number|1|1.0||||||
4077747|NCT01027598|3900330|B3|United States||Region of Enrollment|Includes all treated patients|participants|Number|201|201.0||||||
4077748|NCT01027598|3900331|B2|United States||Region of Enrollment|Includes all treated patients|participants|Number|67|67.0||||||
4077749|NCT01027598|3900332|B1|United States||Region of Enrollment|Includes all treated patients|participants|Number|134|134.0||||||
4077750|NCT01027598|3900330|B3||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4077751|NCT01027598|3900331|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4077752|NCT01027598|3900332|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4077753|NCT01027598|3900330|B3||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4077754|NCT01027598|3900331|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4077755|NCT01027598|3900332|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4077756|NCT01027598|3900330|B3|||Age||years|Median|67|67.0|Full Range|||35.0|88.0|
4077757|NCT01027598|3900331|B2|||Age||years|Median|67|67.0|Full Range|||48.0|85.0|
4077758|NCT01027598|3900332|B1|||Age||years|Median|66|66.0|Full Range|||35.0|88.0|
4077759|NCT01027559|3900343|B4|United States||Region of Enrollment||participants|Number|91|91.0||||||
4077760|NCT01027559|3900344|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
4077761|NCT01027559|3900345|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
4077762|NCT01027559|3900346|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4077763|NCT01027559|3900343|B4|Male||Sex/Gender, Customized||participants|Number|19|19.0||||||
4077764|NCT01027559|3900344|B3|Male||Sex/Gender, Customized||participants|Number|5|5.0||||||
4077765|NCT01027559|3900345|B2|Male||Sex/Gender, Customized||participants|Number|5|5.0||||||
4077766|NCT01027559|3900346|B1|Male||Sex/Gender, Customized||participants|Number|7|7.0||||||
4077767|NCT01027559|3900343|B4|Female||Sex/Gender, Customized||participants|Number|77|77.0||||||
4077768|NCT01027559|3900344|B3|Female||Sex/Gender, Customized||participants|Number|28|28.0||||||
4077769|NCT01027559|3900345|B2|Female||Sex/Gender, Customized||participants|Number|26|26.0||||||
4077770|NCT01027559|3900346|B1|Female||Sex/Gender, Customized||participants|Number|19|19.0||||||
4077771|NCT01027559|3900343|B4|||Age||years|Mean|32.16|32.16|Full Range|||18.0|49.0|
4077772|NCT01027559|3900344|B3|||Age||years|Mean|31.64|31.64|Full Range|||18.0|48.0|
4077773|NCT01027559|3900345|B2|||Age||years|Mean|33.29|33.29|Full Range|||19.0|49.0|
4077774|NCT01027559|3900346|B1|||Age||years|Mean|31.54|31.54|Full Range|||18.0|48.0|
4077775|NCT01027468|3900358|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4077776|NCT01027468|3900358|B1||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4077777|NCT01027468|3900358|B1|||Age, Customized||years|Mean|77.24|77.24|Standard Deviation|10.56|10.56|||
4077778|NCT01027416|3900362|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4077779|NCT01027416|3900363|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4077780|NCT01027416|3900364|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4077781|NCT01027416|3900362|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077782|NCT01027416|3900363|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077783|NCT01027416|3900364|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077784|NCT01027416|3900362|B3||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4077785|NCT01027416|3900363|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4077786|NCT01027416|3900364|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4077787|NCT01027416|3900362|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4077788|NCT01027416|3900363|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4077789|NCT01027416|3900364|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4077790|NCT01027416|3900362|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077791|NCT01027416|3900363|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077792|NCT01027416|3900364|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077793|NCT01027416|3900362|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077794|NCT01027416|3900363|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077795|NCT01027416|3900364|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077796|NCT01027416|3900362|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077797|NCT01027416|3900363|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077798|NCT01027416|3900364|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077799|NCT01027416|3900362|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4077800|NCT01027416|3900363|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4077801|NCT01027416|3900364|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4077802|NCT01027416|3900362|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4077803|NCT01027416|3900363|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4077804|NCT01027416|3900364|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4077805|NCT01027416|3900362|B3|||Age||years|Mean|57.0|57.0|Standard Deviation|11.7|11.7|||
4077806|NCT01027416|3900363|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|12.4|12.4|||
4077807|NCT01027416|3900364|B1|||Age||years|Mean|55.7|55.7|Standard Deviation|11.1|11.1|||
4077808|NCT01027416|3900362|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4077809|NCT01027416|3900363|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4077810|NCT01027416|3900364|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4077811|NCT01027416|3900362|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4077812|NCT01027416|3900363|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4077813|NCT01027416|3900364|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4077814|NCT01027416|3900362|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4077815|NCT01027416|3900363|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4077816|NCT01027416|3900364|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4077817|NCT01027364|3900373|B5||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4077818|NCT01027364|3900374|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4077819|NCT01027364|3900375|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4077820|NCT01027364|3900376|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4077821|NCT01027364|3900377|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4077822|NCT01027364|3900373|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4077823|NCT01027364|3900374|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4077824|NCT01027364|3900375|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4077825|NCT01027364|3900376|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4077826|NCT01027364|3900377|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4077827|NCT01027364|3900373|B5|||Age|The 4 participants represented in the Perioperative Management arm includes participants who were enrolled in this arm only. A total of 12 participants underwent 14 major surgeries in this study, and 8 participants either joined this arm from another arm, or who started this arm, then joined another arm (see Participant Flow milestones for details).|years|Median|30.0|30.0|Full Range|||12.0|71.0|
4077828|NCT01027364|3900374|B4|||Age|The 4 participants represented in the Perioperative Management arm includes participants who were enrolled in this arm only. A total of 12 participants underwent 14 major surgeries in this study, and 8 participants either joined this arm from another arm, or who started this arm, then joined another arm (see Participant Flow milestones for details).|years|Median|40.5|40.5|Full Range|||30.0|61.0|
4077829|NCT01027364|3900375|B3|||Age|The 4 participants represented in the Perioperative Management arm includes participants who were enrolled in this arm only. A total of 12 participants underwent 14 major surgeries in this study, and 8 participants either joined this arm from another arm, or who started this arm, then joined another arm (see Participant Flow milestones for details).|years|Median|36.0|36.0|Full Range|||14.0|64.0|
4077830|NCT01027364|3900376|B2|||Age|The 4 participants represented in the Perioperative Management arm includes participants who were enrolled in this arm only. A total of 12 participants underwent 14 major surgeries in this study, and 8 participants either joined this arm from another arm, or who started this arm, then joined another arm (see Participant Flow milestones for details).|years|Median|33.0|33.0|Full Range|||12.0|62.0|
4077891|NCT01027195|3900603|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4077892|NCT01027195|3900604|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4077831|NCT01027364|3900377|B1|||Age|The 4 participants represented in the Perioperative Management arm includes participants who were enrolled in this arm only. A total of 12 participants underwent 14 major surgeries in this study, and 8 participants either joined this arm from another arm, or who started this arm, then joined another arm (see Participant Flow milestones for details).|years|Median|28.0|28.0|Full Range|||12.0|71.0|
4077832|NCT01027351|3900469|B7|United Kingdom||Region of Enrollment||Subjects|Number|163|163.0||||||
4077833|NCT01027351|3900470|B6|United Kingdom||Region of Enrollment||Subjects|Number|50|50.0||||||
4077834|NCT01027351|3900471|B5|United Kingdom||Region of Enrollment||Subjects|Number|43|43.0||||||
4077835|NCT01027351|3900472|B4|United Kingdom||Region of Enrollment||Subjects|Number|8|8.0||||||
4077836|NCT01027351|3900473|B3|United Kingdom||Region of Enrollment||Subjects|Number|14|14.0||||||
4077837|NCT01027351|3900474|B2|United Kingdom||Region of Enrollment||Subjects|Number|19|19.0||||||
4077838|NCT01027351|3900475|B1|United Kingdom||Region of Enrollment||Subjects|Number|29|29.0||||||
4077839|NCT01027351|3900469|B7||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4077840|NCT01027351|3900470|B6||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4077841|NCT01027351|3900471|B5||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4077842|NCT01027351|3900472|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4077843|NCT01027351|3900473|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4077844|NCT01027351|3900474|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4077845|NCT01027351|3900475|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4077846|NCT01027351|3900469|B7||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4077847|NCT01027351|3900470|B6||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4077848|NCT01027351|3900471|B5||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4077849|NCT01027351|3900472|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4077850|NCT01027351|3900473|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4077851|NCT01027351|3900474|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4077852|NCT01027351|3900475|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4077853|NCT01027351|3900469|B7|||Age||months|Mean|47.6|47.6|Standard Deviation|9.2|9.2|||
4077854|NCT01027351|3900470|B6|||Age||months|Mean|61.3|61.3|Standard Deviation|0.9|0.9|||
4077855|NCT01027351|3900471|B5|||Age||months|Mean|41.8|41.8|Standard Deviation|1.7|1.7|||
4077856|NCT01027351|3900472|B4|||Age||months|Mean|40.4|40.4|Standard Deviation|0.7|0.7|||
4077857|NCT01027351|3900473|B3|||Age||months|Mean|41.4|41.4|Standard Deviation|1.5|1.5|||
4077858|NCT01027351|3900474|B2|||Age||months|Mean|41.8|41.8|Standard Deviation|1.4|1.4|||
4077859|NCT01027351|3900475|B1|||Age||months|Mean|41.4|41.4|Standard Deviation|1.5|1.5|||
4077860|NCT01027286|3900562|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4077861|NCT01027286|3900563|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4077862|NCT01027286|3900564|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4077863|NCT01027286|3900562|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4077864|NCT01027286|3900563|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4077865|NCT01027286|3900564|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4077866|NCT01027286|3900562|B3|||Age||years|Mean|64.0|64.0|Standard Deviation|8.7|8.7|||
4077867|NCT01027286|3900563|B2|||Age||years|Mean|62.4|62.4|Standard Deviation|8.8|8.8|||
4077868|NCT01027286|3900564|B1|||Age||years|Mean|66.3|66.3|Standard Deviation|8.2|8.2|||
4077869|NCT01027273|3900583|B3|||Years since stroke||years|Mean|1.8|1.8|Standard Deviation|1.5|1.5|||
4077870|NCT01027273|3900584|B2|||Years since stroke||years|Mean|1.8|1.8|Standard Deviation|1.5|1.5|||
4077871|NCT01027273|3900585|B1|||Years since stroke||years|Mean|1.8|1.8|Standard Deviation|1.4|1.4|||
4077872|NCT01027273|3900583|B3||Male|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
4077873|NCT01027273|3900584|B2||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4077874|NCT01027273|3900585|B1||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4077875|NCT01027273|3900583|B3||Female|Sex: Female, Male||Participants|Count of Participants|357|357.0||||||
4077876|NCT01027273|3900584|B2||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4077877|NCT01027273|3900585|B1||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4077878|NCT01027273|3900583|B3|||Age||years|Mean|63|63.0|Standard Deviation|11|11.0|||
4077879|NCT01027273|3900584|B2|||Age||years|Mean|64|64.0|Standard Deviation|11|11.0|||
4077880|NCT01027273|3900585|B1|||Age||years|Mean|63|63.0|Standard Deviation|11|11.0|||
4077881|NCT01027195|3900602|B3|||Baseline Hemoglobin||g/dL|Mean|14.4|14.4|Standard Deviation|1.3|1.3|||
4077882|NCT01027195|3900603|B2|||Baseline Hemoglobin||g/dL|Mean|14.2|14.2|Standard Deviation|1.2|1.2|||
4077883|NCT01027195|3900604|B1|||Baseline Hemoglobin||g/dL|Mean|14.6|14.6|Standard Deviation|1.3|1.3|||
4077884|NCT01027195|3900602|B3|Males||Body-Mass Index||kg/m2|Mean|29.9|29.9|Standard Deviation|4.9|4.9|||
4077885|NCT01027195|3900603|B2|Males||Body-Mass Index||kg/m2|Mean|30.4|30.4|Standard Deviation|5.1|5.1|||
4077886|NCT01027195|3900604|B1|Males||Body-Mass Index||kg/m2|Mean|29.4|29.4|Standard Deviation|4.7|4.7|||
4077887|NCT01027195|3900602|B3|Females||Body-Mass Index||kg/m2|Mean|28.9|28.9|Standard Deviation|6.6|6.6|||
4077888|NCT01027195|3900603|B2|Females||Body-Mass Index||kg/m2|Mean|29.2|29.2|Standard Deviation|6.1|6.1|||
4077889|NCT01027195|3900604|B1|Females||Body-Mass Index||kg/m2|Mean|28.6|28.6|Standard Deviation|7.1|7.1|||
4077890|NCT01027195|3900602|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4077893|NCT01027195|3900602|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4077894|NCT01027195|3900603|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4077895|NCT01027195|3900604|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4077896|NCT01027195|3900602|B3|||Age||years|Mean|55.5|55.5|Standard Deviation|11.0|11.0|||
4077897|NCT01027195|3900603|B2|||Age||years|Mean|55.7|55.7|Standard Deviation|11.0|11.0|||
4077898|NCT01027195|3900604|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|10.9|10.9|||
4077899|NCT01027000|3900625|B1|Not reported||Disease stage|"Early Disease: Participants must have received ≥2 cycles of induction therapy & have nodes ≤ 5 cm with one or more of the following: FISH deletion 17p, FISH del 11q, failure to achieve a partial response with initial chemotherapy with no progression, or have a 17p deletion by FISH at the time of first progression~Advanced Disease: Participants must have stable disease or better to their most recent chemotherapy & have nodes ≤ 5 cm with one or more of the following:~FISH deletion 17p, first progression < 24 months after completing therapy, or a subsequent progression"|participants|Number|4|4.0||||||
4077900|NCT01027000|3900625|B1|Advanced Disease||Disease stage|"Early Disease: Participants must have received ≥2 cycles of induction therapy & have nodes ≤ 5 cm with one or more of the following: FISH deletion 17p, FISH del 11q, failure to achieve a partial response with initial chemotherapy with no progression, or have a 17p deletion by FISH at the time of first progression~Advanced Disease: Participants must have stable disease or better to their most recent chemotherapy & have nodes ≤ 5 cm with one or more of the following:~FISH deletion 17p, first progression < 24 months after completing therapy, or a subsequent progression"|participants|Number|50|50.0||||||
4077901|NCT01027000|3900625|B1|Early Disease||Disease stage|"Early Disease: Participants must have received ≥2 cycles of induction therapy & have nodes ≤ 5 cm with one or more of the following: FISH deletion 17p, FISH del 11q, failure to achieve a partial response with initial chemotherapy with no progression, or have a 17p deletion by FISH at the time of first progression~Advanced Disease: Participants must have stable disease or better to their most recent chemotherapy & have nodes ≤ 5 cm with one or more of the following:~FISH deletion 17p, first progression < 24 months after completing therapy, or a subsequent progression"|participants|Number|14|14.0||||||
4077902|NCT01027000|3900625|B1|United States||Region of Enrollment||participants|Number|68|68.0||||||
4077903|NCT01027000|3900625|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4077904|NCT01027000|3900625|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077905|NCT01027000|3900625|B1||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4077906|NCT01027000|3900625|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4077907|NCT01027000|3900625|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077908|NCT01027000|3900625|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077909|NCT01027000|3900625|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4077910|NCT01027000|3900625|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4077911|NCT01027000|3900625|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4077912|NCT01027000|3900625|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4077913|NCT01027000|3900625|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4077914|NCT01027000|3900625|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4077915|NCT01027000|3900625|B1|||Age||years|Median|56|56.0|Full Range|||26.0|70.0|
4077916|NCT01026974|3900629|B5||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4077917|NCT01026974|3900630|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4077918|NCT01026974|3900631|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4077919|NCT01026974|3900632|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4077920|NCT01026974|3900633|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4077921|NCT01026974|3900629|B5||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4077922|NCT01026974|3900630|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4077923|NCT01026974|3900631|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4077924|NCT01026974|3900632|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4077925|NCT01026974|3900633|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4077926|NCT01026974|3900629|B5|||Age||months|Mean|50.0|50.0|Standard Deviation|9.5|9.5|||
4077927|NCT01026974|3900630|B4|||Age||months|Mean|61.3|61.3|Standard Deviation|0.7|0.7|||
4077928|NCT01026974|3900631|B3|||Age||months|Mean|41.7|41.7|Standard Deviation|1.7|1.7|||
4077929|NCT01026974|3900632|B2|||Age||months|Mean|43.1|43.1|Standard Deviation|0.9|0.9|||
4077930|NCT01026974|3900633|B1|||Age||months|Mean|42.8|42.8|Standard Deviation|1.1|1.1|||
4077931|NCT01026948|3900693|B1|United Kingdom||Region of Enrollment||participants|Number|70|70.0||||||
4077932|NCT01026948|3900693|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4077933|NCT01026948|3900693|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4077934|NCT01026948|3900693|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4077935|NCT01026948|3900693|B1||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4077936|NCT01026948|3900693|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4077937|NCT01026909|3900698|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4077938|NCT01026909|3900699|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4077939|NCT01026909|3900700|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4077940|NCT01026909|3900698|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4077941|NCT01026909|3900699|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4077942|NCT01026909|3900700|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4077943|NCT01026909|3900698|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4077944|NCT01026909|3900699|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4077945|NCT01026909|3900700|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4077946|NCT01026909|3900698|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4077947|NCT01026909|3900699|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4077948|NCT01026909|3900700|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4077949|NCT01026909|3900698|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4077950|NCT01026909|3900699|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4077951|NCT01026909|3900700|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4077952|NCT01026909|3900698|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4077953|NCT01026909|3900699|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4077954|NCT01026909|3900700|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4077955|NCT01026909|3900698|B3|||Age||years|Mean|7.33|7.33|Standard Deviation|2.08|2.08|||
4077956|NCT01026909|3900699|B2|||Age||years|Mean|7.33|7.33|Standard Deviation|2.08|2.08|||
4077957|NCT01026909|3900700|B1|||Age||years|Mean|9|9.0|Standard Deviation|0|0.0|||
4077958|NCT01026844|3900709|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
4077959|NCT01026844|3900710|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4077960|NCT01026844|3900711|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4077961|NCT01026844|3900709|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4077962|NCT01026844|3900710|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4077963|NCT01026844|3900711|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4077964|NCT01026844|3900709|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4077965|NCT01026844|3900710|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4077966|NCT01026844|3900711|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4077967|NCT01026844|3900709|B3|||Age||years|Median|64|64.0|Full Range|||27.0|76.0|
4077968|NCT01026844|3900710|B2|||Age||years|Median|61|61.0|Full Range|||48.0|76.0|
4077969|NCT01026844|3900711|B1|||Age||years|Median|65|65.0|Full Range|||27.0|73.0|
4077970|NCT01026844|3900709|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4077971|NCT01026844|3900710|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4077972|NCT01026844|3900711|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4077973|NCT01026844|3900709|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4077974|NCT01026844|3900710|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4077975|NCT01026844|3900711|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4077976|NCT01026844|3900709|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4077977|NCT01026844|3900710|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4077978|NCT01026844|3900711|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4077979|NCT01026831|3900724|B3||Male|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
4077980|NCT01026831|3900725|B2||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4077981|NCT01026831|3900726|B1||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4077982|NCT01026831|3900724|B3||Female|Sex: Female, Male||Participants|Count of Participants|375|375.0||||||
4077983|NCT01026831|3900725|B2||Female|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4077984|NCT01026831|3900726|B1||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4077985|NCT01026831|3900724|B3|||Age||years|Mean|63.3|63.3|Standard Deviation|11.6|11.6|||
4077986|NCT01026831|3900725|B2|||Age||years|Mean|63.3|63.3|Standard Deviation|11.6|11.6|||
4077987|NCT01026831|3900726|B1|||Age||years|Mean|63.3|63.3|Standard Deviation|11.7|11.7|||
4077988|NCT01026818|3900735|B4|Italy||Region of Enrollment||participants|Number|73|73.0||||||
4077989|NCT01026818|3900736|B3|Italy||Region of Enrollment||participants|Number|24|24.0||||||
4077990|NCT01026818|3900737|B2|Italy||Region of Enrollment||participants|Number|24|24.0||||||
4077991|NCT01026818|3900738|B1|Italy||Region of Enrollment||participants|Number|25|25.0||||||
4077992|NCT01026818|3900735|B4|Switzerland||Region of Enrollment||participants|Number|3|3.0||||||
4077993|NCT01026818|3900736|B3|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4077994|NCT01026818|3900737|B2|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4077995|NCT01026818|3900738|B1|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4077996|NCT01026818|3900735|B4|United Kingdom||Region of Enrollment||participants|Number|23|23.0||||||
4077997|NCT01026818|3900736|B3|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
4077998|NCT01026818|3900737|B2|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
4077999|NCT01026818|3900738|B1|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
4078000|NCT01026818|3900735|B4|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
4078001|NCT01026818|3900736|B3|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4078002|NCT01026818|3900737|B2|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
4078003|NCT01026818|3900738|B1|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4078004|NCT01026818|3900735|B4|Germany||Region of Enrollment||participants|Number|78|78.0||||||
4078005|NCT01026818|3900736|B3|Germany||Region of Enrollment||participants|Number|27|27.0||||||
4078006|NCT01026818|3900737|B2|Germany||Region of Enrollment||participants|Number|25|25.0||||||
4078007|NCT01026818|3900738|B1|Germany||Region of Enrollment||participants|Number|26|26.0||||||
4078008|NCT01026818|3900735|B4|Spain||Region of Enrollment||participants|Number|116|116.0||||||
4078009|NCT01026818|3900736|B3|Spain||Region of Enrollment||participants|Number|39|39.0||||||
4078010|NCT01026818|3900737|B2|Spain||Region of Enrollment||participants|Number|39|39.0||||||
4078011|NCT01026818|3900738|B1|Spain||Region of Enrollment||participants|Number|38|38.0||||||
4078012|NCT01026818|3900735|B4|Poland||Region of Enrollment||participants|Number|27|27.0||||||
4078013|NCT01026818|3900736|B3|Poland||Region of Enrollment||participants|Number|8|8.0||||||
4078014|NCT01026818|3900737|B2|Poland||Region of Enrollment||participants|Number|9|9.0||||||
4078015|NCT01026818|3900738|B1|Poland||Region of Enrollment||participants|Number|10|10.0||||||
4078016|NCT01026818|3900735|B4|Belgium||Region of Enrollment||participants|Number|24|24.0||||||
4078017|NCT01026818|3900736|B3|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
4078018|NCT01026818|3900737|B2|Belgium||Region of Enrollment||participants|Number|9|9.0||||||
4078019|NCT01026818|3900738|B1|Belgium||Region of Enrollment||participants|Number|7|7.0||||||
4078020|NCT01026818|3900735|B4|Canada||Region of Enrollment||participants|Number|38|38.0||||||
4078021|NCT01026818|3900736|B3|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4078022|NCT01026818|3900737|B2|Canada||Region of Enrollment||participants|Number|13|13.0||||||
4078023|NCT01026818|3900738|B1|Canada||Region of Enrollment||participants|Number|13|13.0||||||
4078024|NCT01026818|3900735|B4|France||Region of Enrollment||participants|Number|38|38.0||||||
4078025|NCT01026818|3900736|B3|France||Region of Enrollment||participants|Number|13|13.0||||||
4078026|NCT01026818|3900737|B2|France||Region of Enrollment||participants|Number|13|13.0||||||
4078027|NCT01026818|3900738|B1|France||Region of Enrollment||participants|Number|12|12.0||||||
4078028|NCT01026818|3900735|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4078029|NCT01026818|3900736|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4078030|NCT01026818|3900737|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4078031|NCT01026818|3900738|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4078032|NCT01026818|3900735|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4078033|NCT01026818|3900736|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4078034|NCT01026818|3900737|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4078035|NCT01026818|3900738|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4078036|NCT01026818|3900735|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4078037|NCT01026818|3900736|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4078038|NCT01026818|3900737|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4078039|NCT01026818|3900738|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4078040|NCT01026818|3900735|B4|White||Race/Ethnicity, Customized||participants|Number|416|416.0||||||
4078041|NCT01026818|3900736|B3|White||Race/Ethnicity, Customized||participants|Number|138|138.0||||||
4078042|NCT01026818|3900737|B2|White||Race/Ethnicity, Customized||participants|Number|141|141.0||||||
4078043|NCT01026818|3900738|B1|White||Race/Ethnicity, Customized||participants|Number|137|137.0||||||
4078044|NCT01026818|3900735|B4||Male|Sex: Female, Male||Participants|Count of Participants|423|423.0||||||
4078045|NCT01026818|3900736|B3||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4078046|NCT01026818|3900737|B2||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4078047|NCT01026818|3900738|B1||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4078048|NCT01026818|3900735|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4078049|NCT01026818|3900736|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4078050|NCT01026818|3900737|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4078051|NCT01026818|3900738|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4078052|NCT01026818|3900735|B4|||Age||years|Mean|57.9|57.9|Standard Deviation|5.58|5.58|||
4078053|NCT01026818|3900736|B3|||Age||years|Mean|57.6|57.6|Standard Deviation|5.69|5.69|||
4078054|NCT01026818|3900737|B2|||Age||years|Mean|57.5|57.5|Standard Deviation|5.91|5.91|||
4078055|NCT01026818|3900738|B1|||Age||years|Mean|58.6|58.6|Standard Deviation|5.07|5.07|||
4078056|NCT01026805|3900819|B1|||size of fibroid or polyp|measure size of pathology pre-treament via ultrasound or hysteroscopic exam|mm|Mean|16.3|16.3|Full Range|||5.0|50.0|
4078057|NCT01026805|3900819|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4078058|NCT01026805|3900819|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4078059|NCT01026805|3900819|B1|||Age||years|Mean|40.5|40.5|Standard Deviation|8.2|8.2|||
4078060|NCT01026805|3900819|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4078061|NCT01026805|3900819|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4078062|NCT01026805|3900819|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4078063|NCT01026792|3900829|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4078064|NCT01026792|3900829|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4078065|NCT01026792|3900829|B1|||Age||years|Median|50|50.0|Full Range|||26.0|77.0|
4078066|NCT01026493|3900833|B9||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4078067|NCT01026493|3900834|B8||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4078068|NCT01026493|3900835|B7||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4078069|NCT01026493|3900836|B6||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4078070|NCT01026493|3900837|B5||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4078071|NCT01026493|3900838|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4078072|NCT01026493|3900839|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4078073|NCT01026493|3900840|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4078074|NCT01026493|3900841|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4078075|NCT01026493|3900833|B9||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4078076|NCT01026493|3900834|B8||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4078077|NCT01026493|3900835|B7||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4078078|NCT01026493|3900836|B6||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4078079|NCT01026493|3900837|B5||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4078080|NCT01026493|3900838|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4078081|NCT01026493|3900839|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4078082|NCT01026493|3900840|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4078083|NCT01026493|3900841|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4078084|NCT01026493|3900833|B9|||Age||years|Median|56|56.0|Full Range|||18.0|81.0|
4078085|NCT01026493|3900834|B8|||Age||years|Median|57|57.0|Full Range|||38.0|77.0|
4078086|NCT01026493|3900835|B7|||Age||years|Median|56|56.0|Full Range|||20.0|70.0|
4078087|NCT01026493|3900836|B6|||Age||years|Median|56|56.0|Full Range|||20.0|81.0|
4078088|NCT01026493|3900837|B5|||Age||years|Median|56|56.0|Full Range|||21.0|77.0|
4078089|NCT01026493|3900838|B4|||Age||years|Median|41|41.0|Full Range|||20.0|81.0|
4078090|NCT01026493|3900839|B3|||Age||years|Median|53|53.0|Full Range|||18.0|67.0|
4078091|NCT01026493|3900840|B2|||Age||years|Median|51|51.0|Full Range|||48.0|63.0|
4078092|NCT01026493|3900841|B1|||Age||years|Median|48|48.0|Full Range|||20.0|63.0|
4078093|NCT01026454|3900874|B3|||Plasma HIV-1 RNA Level at Enrollment||log10 copies/mL|Mean|4.07|4.07|Standard Deviation|0.75|0.75|||
4078094|NCT01026454|3900875|B2|||Plasma HIV-1 RNA Level at Enrollment||log10 copies/mL|Mean|4.08|4.08|Standard Deviation|0.85|0.85|||
4078095|NCT01026454|3900876|B1|||Plasma HIV-1 RNA Level at Enrollment||log10 copies/mL|Mean|4.05|4.05|Standard Deviation|0.72|0.72|||
4078096|NCT01026454|3900874|B3|Kenya||Region of Enrollment||participants|Number|32|32.0||||||
4078097|NCT01026454|3900875|B2|Kenya||Region of Enrollment||participants|Number|14|14.0||||||
4078098|NCT01026454|3900876|B1|Kenya||Region of Enrollment||participants|Number|18|18.0||||||
4078099|NCT01026454|3900874|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4078100|NCT01026454|3900875|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4078101|NCT01026454|3900876|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4078102|NCT01026454|3900874|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4078103|NCT01026454|3900875|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4078104|NCT01026454|3900876|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4078105|NCT01026454|3900874|B3|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4078106|NCT01026454|3900875|B2|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4078107|NCT01026454|3900876|B1|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4078108|NCT01026454|3900874|B3|Between 18 and 65 years||Age, Customized||participants|Number|32|32.0||||||
4078109|NCT01026454|3900875|B2|Between 18 and 65 years||Age, Customized||participants|Number|14|14.0||||||
4078110|NCT01026454|3900876|B1|Between 18 and 65 years||Age, Customized||participants|Number|18|18.0||||||
4078111|NCT01026454|3900874|B3|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4078112|NCT01026454|3900875|B2|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4078113|NCT01026454|3900876|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4078114|NCT01026402|3900883|B18||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4078115|NCT01026402|3900884|B17||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4078116|NCT01026402|3900885|B16||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4078117|NCT01026402|3900886|B15||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4078118|NCT01026402|3900887|B14||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4078119|NCT01026402|3900888|B13||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4078120|NCT01026402|3900889|B12||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4078121|NCT01026402|3900890|B11||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4078122|NCT01026402|3900891|B10||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4078123|NCT01026402|3900892|B9||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4078124|NCT01026402|3900893|B8||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4078125|NCT01026402|3900894|B7||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4078126|NCT01026402|3900895|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4078127|NCT01026402|3900896|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4078128|NCT01026402|3900897|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4078129|NCT01026402|3900898|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4078130|NCT01026402|3900899|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4078131|NCT01026402|3900900|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4078132|NCT01026402|3900883|B18||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4078133|NCT01026402|3900884|B17||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4078134|NCT01026402|3900885|B16||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4078135|NCT01026402|3900886|B15||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4078136|NCT01026402|3900887|B14||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4078137|NCT01026402|3900888|B13||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4078138|NCT01026402|3900889|B12||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4078139|NCT01026402|3900890|B11||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4078140|NCT01026402|3900891|B10||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4078141|NCT01026402|3900892|B9||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4078142|NCT01026402|3900893|B8||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4078143|NCT01026402|3900894|B7||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4078144|NCT01026402|3900895|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4078145|NCT01026402|3900896|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4078146|NCT01026402|3900897|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4078147|NCT01026402|3900898|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4078148|NCT01026402|3900899|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4078149|NCT01026402|3900900|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4078150|NCT01026402|3900883|B18|||Age||Years|Mean|56.9|56.9|Standard Deviation|12.3|12.3|||
4078151|NCT01026402|3900884|B17|||Age||Years|Mean|50.0|50.0|Standard Deviation|8.2|8.2|||
4078152|NCT01026402|3900885|B16|||Age||Years|Mean|47.4|47.4|Standard Deviation|14.8|14.8|||
4078153|NCT01026402|3900886|B15|||Age||Years|Mean|42.7|42.7|Standard Deviation|9.0|9.0|||
4078154|NCT01026402|3900887|B14|||Age||Years|Mean|54.2|54.2|Standard Deviation|14.2|14.2|||
4078155|NCT01026402|3900888|B13|||Age||Years|Mean|53.8|53.8|Standard Deviation|9.9|9.9|||
4078156|NCT01026402|3900889|B12|||Age||Years|Mean|57.6|57.6|Standard Deviation|5.4|5.4|||
4078157|NCT01026402|3900890|B11|||Age||Years|Mean|67.3|67.3|Standard Deviation|7.9|7.9|||
4078158|NCT01026402|3900891|B10|||Age||Years|Mean|59.0|59.0|Standard Deviation|18.7|18.7|||
4078159|NCT01026402|3900892|B9|||Age||Years|Mean|65.6|65.6|Standard Deviation|9.8|9.8|||
4078160|NCT01026402|3900893|B8|||Age||Years|Mean|51.3|51.3|Standard Deviation|18.9|18.9|||
4078161|NCT01026402|3900894|B7|||Age||Years|Mean|59.4|59.4|Standard Deviation|11.0|11.0|||
4078162|NCT01026402|3900895|B6|||Age||Years|Mean|50.0|50.0|Standard Deviation|16.1|16.1|||
4078163|NCT01026402|3900896|B5|||Age||Years|Mean|51.7|51.7|Standard Deviation|11.5|11.5|||
4078164|NCT01026402|3900897|B4|||Age||Years|Mean|58.6|58.6|Standard Deviation|14.2|14.2|||
4078165|NCT01026402|3900898|B3|||Age||Years|Mean|57.2|57.2|Standard Deviation|10.3|10.3|||
4078166|NCT01026402|3900899|B2|||Age||Years|Mean|58.3|58.3|Standard Deviation|14.1|14.1|||
4078167|NCT01026402|3900900|B1|||Age||Years|Mean|59.2|59.2|Standard Deviation|15.8|15.8|||
4078168|NCT01026389|3901224|B3|Spain||Region of Enrollment||participants|Number|67|67.0||||||
4078169|NCT01026389|3901225|B2|Spain||Region of Enrollment||participants|Number|32|32.0||||||
4078170|NCT01026389|3901226|B1|Spain||Region of Enrollment||participants|Number|35|35.0||||||
4078171|NCT01026389|3901224|B3|Italy||Region of Enrollment||participants|Number|32|32.0||||||
4078172|NCT01026389|3901225|B2|Italy||Region of Enrollment||participants|Number|16|16.0||||||
4078173|NCT01026389|3901226|B1|Italy||Region of Enrollment||participants|Number|16|16.0||||||
4078174|NCT01026389|3901224|B3|Germany||Region of Enrollment||participants|Number|14|14.0||||||
4078175|NCT01026389|3901225|B2|Germany||Region of Enrollment||participants|Number|7|7.0||||||
4078176|NCT01026389|3901226|B1|Germany||Region of Enrollment||participants|Number|7|7.0||||||
4078177|NCT01026389|3901224|B3|France||Region of Enrollment||participants|Number|36|36.0||||||
4078178|NCT01026389|3901225|B2|France||Region of Enrollment||participants|Number|20|20.0||||||
4078179|NCT01026389|3901226|B1|France||Region of Enrollment||participants|Number|16|16.0||||||
4078180|NCT01026389|3901224|B3|Austria||Region of Enrollment||participants|Number|37|37.0||||||
4078181|NCT01026389|3901225|B2|Austria||Region of Enrollment||participants|Number|18|18.0||||||
4078182|NCT01026389|3901226|B1|Austria||Region of Enrollment||participants|Number|19|19.0||||||
4078183|NCT01026389|3901224|B3||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4078184|NCT01026389|3901225|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4078185|NCT01026389|3901226|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4078186|NCT01026389|3901224|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4078187|NCT01026389|3901225|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4078188|NCT01026389|3901226|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4078189|NCT01026389|3901224|B3|||Age||years|Mean|66.7|66.7|Standard Deviation|10.4|10.4|||
4078190|NCT01026389|3901225|B2|||Age||years|Mean|66.8|66.8|Standard Deviation|10.6|10.6|||
4078191|NCT01026389|3901226|B1|||Age||years|Mean|66.5|66.5|Standard Deviation|10.2|10.2|||
4078192|NCT01026389|3901224|B3||>=65 years|Age||Participants|Count of Participants|90|90.0||||||
4078193|NCT01026389|3901225|B2||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
4078194|NCT01026389|3901226|B1||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
4078195|NCT01026389|3901224|B3||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
4078196|NCT01026389|3901225|B2||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4078197|NCT01026389|3901226|B1||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4078198|NCT01026389|3901224|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4078199|NCT01026389|3901225|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4078200|NCT01026389|3901226|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4078201|NCT01026324|3901239|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4078202|NCT01026324|3901240|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4078203|NCT01026324|3901241|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4078204|NCT01026324|3901242|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4078205|NCT01026324|3901239|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4078206|NCT01026324|3901240|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4078207|NCT01026324|3901241|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4078208|NCT01026324|3901242|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4078209|NCT01026324|3901239|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4078210|NCT01026324|3901240|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4078211|NCT01026324|3901241|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4078212|NCT01026324|3901242|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4078213|NCT01026324|3901239|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4078214|NCT01026324|3901240|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4078215|NCT01026324|3901241|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4078216|NCT01026324|3901242|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4078217|NCT01026324|3901239|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4078218|NCT01026324|3901240|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4078219|NCT01026324|3901241|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4078220|NCT01026324|3901242|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4078221|NCT01026220|3901254|B1|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
4078222|NCT01026220|3901254|B1|Australia||Region of Enrollment||participants|Number|3|3.0||||||
4078223|NCT01026220|3901254|B1|United States||Region of Enrollment||participants|Number|143|143.0||||||
4078224|NCT01026220|3901254|B1|Canada||Region of Enrollment||participants|Number|19|19.0||||||
4078225|NCT01026220|3901254|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4078226|NCT01026220|3901254|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4078227|NCT01026220|3901254|B1||White|Race (NIH/OMB)||Participants|Count of Participants|112|112.0||||||
4078228|NCT01026220|3901254|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4078229|NCT01026220|3901254|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4078230|NCT01026220|3901254|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4078231|NCT01026220|3901254|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4078232|NCT01026220|3901254|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4078233|NCT01026220|3901254|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
4078234|NCT01026220|3901254|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4078235|NCT01026220|3901254|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4078236|NCT01026220|3901254|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4078237|NCT01026220|3901254|B1|||Age||years|Median|15|15.0|Full Range|||5.0|21.0|
4078238|NCT01026220|3901254|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4078239|NCT01026220|3901254|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4078240|NCT01026220|3901254|B1||<=18 years|Age||Participants|Count of Participants|156|156.0||||||
4078241|NCT01026194|3901278|B3||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4078242|NCT01026194|3901279|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4078243|NCT01026194|3901280|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4078244|NCT01026194|3901278|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4078245|NCT01026194|3901279|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4078246|NCT01026194|3901280|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4078247|NCT01026194|3901278|B3|||Age||years|Mean|60.4|60.4|Standard Deviation|9.3|9.3|||
4078248|NCT01026194|3901279|B2|||Age||years|Mean|59.7|59.7|Standard Deviation|9.7|9.7|||
4078249|NCT01026194|3901280|B1|||Age||years|Mean|61.1|61.1|Standard Deviation|8.9|8.9|||
4078250|NCT01026181|3901295|B4|race|other race|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4078251|NCT01026181|3901296|B3|race|other race|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4078252|NCT01026181|3901297|B2|race|other race|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4078253|NCT01026181|3901298|B1|race|other race|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4078318|NCT01026142|3901311|B3|United Kingdom||Region of Enrollment||participants|Number|35|35.0||||||
4078254|NCT01026181|3901295|B4|race|white race|Race/Ethnicity, Customized||Participants|Count of Participants|141|141.0||||||
4078255|NCT01026181|3901296|B3|race|white race|Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
4078256|NCT01026181|3901297|B2|race|white race|Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
4078257|NCT01026181|3901298|B1|race|white race|Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
4078258|NCT01026181|3901295|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4078259|NCT01026181|3901296|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4078260|NCT01026181|3901297|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4078261|NCT01026181|3901298|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4078262|NCT01026181|3901295|B4||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4078263|NCT01026181|3901296|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4078264|NCT01026181|3901297|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4078265|NCT01026181|3901298|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4078266|NCT01026181|3901295|B4|||Age||years|Mean|43.5|43.5|Standard Deviation|9.5|9.5|||
4078267|NCT01026181|3901296|B3|||Age||years|Mean|43.1|43.1|Standard Deviation|10.3|10.3|||
4078268|NCT01026181|3901297|B2|||Age||years|Mean|41.9|41.9|Standard Deviation|8.4|8.4|||
4078269|NCT01026181|3901298|B1|||Age||years|Mean|45.4|45.4|Standard Deviation|9.6|9.6|||
4078270|NCT01026142|3901311|B3|Croatia||Region of Enrollment||participants|Number|7|7.0||||||
4078271|NCT01026142|3901312|B2|Croatia||Region of Enrollment||participants|Number|3|3.0||||||
4078272|NCT01026142|3901313|B1|Croatia||Region of Enrollment||participants|Number|4|4.0||||||
4078273|NCT01026142|3901311|B3|Germany||Region of Enrollment||participants|Number|34|34.0||||||
4078274|NCT01026142|3901312|B2|Germany||Region of Enrollment||participants|Number|11|11.0||||||
4078275|NCT01026142|3901313|B1|Germany||Region of Enrollment||participants|Number|23|23.0||||||
4078276|NCT01026142|3901311|B3|Peru||Region of Enrollment||participants|Number|15|15.0||||||
4078277|NCT01026142|3901312|B2|Peru||Region of Enrollment||participants|Number|8|8.0||||||
4078278|NCT01026142|3901313|B1|Peru||Region of Enrollment||participants|Number|7|7.0||||||
4078279|NCT01026142|3901311|B3|France||Region of Enrollment||participants|Number|31|31.0||||||
4078280|NCT01026142|3901312|B2|France||Region of Enrollment||participants|Number|12|12.0||||||
4078281|NCT01026142|3901313|B1|France||Region of Enrollment||participants|Number|19|19.0||||||
4078282|NCT01026142|3901311|B3|Mexico||Region of Enrollment||participants|Number|1|1.0||||||
4078283|NCT01026142|3901312|B2|Mexico||Region of Enrollment||participants|Number|0|0.0||||||
4078284|NCT01026142|3901313|B1|Mexico||Region of Enrollment||participants|Number|1|1.0||||||
4078285|NCT01026142|3901311|B3|Italy||Region of Enrollment||participants|Number|34|34.0||||||
4078286|NCT01026142|3901312|B2|Italy||Region of Enrollment||participants|Number|18|18.0||||||
4078287|NCT01026142|3901313|B1|Italy||Region of Enrollment||participants|Number|16|16.0||||||
4078288|NCT01026142|3901311|B3|Korea, Republic of||Region of Enrollment||participants|Number|38|38.0||||||
4078289|NCT01026142|3901312|B2|Korea, Republic of||Region of Enrollment||participants|Number|24|24.0||||||
4078290|NCT01026142|3901313|B1|Korea, Republic of||Region of Enrollment||participants|Number|14|14.0||||||
4078291|NCT01026142|3901311|B3|Brazil||Region of Enrollment||participants|Number|13|13.0||||||
4078292|NCT01026142|3901312|B2|Brazil||Region of Enrollment||participants|Number|6|6.0||||||
4078293|NCT01026142|3901313|B1|Brazil||Region of Enrollment||participants|Number|7|7.0||||||
4078294|NCT01026142|3901311|B3|Poland||Region of Enrollment||participants|Number|12|12.0||||||
4078295|NCT01026142|3901312|B2|Poland||Region of Enrollment||participants|Number|6|6.0||||||
4078296|NCT01026142|3901313|B1|Poland||Region of Enrollment||participants|Number|6|6.0||||||
4078297|NCT01026142|3901311|B3|Belgium||Region of Enrollment||participants|Number|23|23.0||||||
4078298|NCT01026142|3901312|B2|Belgium||Region of Enrollment||participants|Number|11|11.0||||||
4078299|NCT01026142|3901313|B1|Belgium||Region of Enrollment||participants|Number|12|12.0||||||
4078300|NCT01026142|3901311|B3|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
4078301|NCT01026142|3901312|B2|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
4078302|NCT01026142|3901313|B1|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4078303|NCT01026142|3901311|B3|Austria||Region of Enrollment||participants|Number|5|5.0||||||
4078304|NCT01026142|3901312|B2|Austria||Region of Enrollment||participants|Number|3|3.0||||||
4078305|NCT01026142|3901313|B1|Austria||Region of Enrollment||participants|Number|2|2.0||||||
4078306|NCT01026142|3901311|B3|Czech Republic||Region of Enrollment||participants|Number|22|22.0||||||
4078307|NCT01026142|3901312|B2|Czech Republic||Region of Enrollment||participants|Number|10|10.0||||||
4078308|NCT01026142|3901313|B1|Czech Republic||Region of Enrollment||participants|Number|12|12.0||||||
4078309|NCT01026142|3901311|B3|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4078310|NCT01026142|3901312|B2|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4078311|NCT01026142|3901313|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4078312|NCT01026142|3901311|B3|Spain||Region of Enrollment||participants|Number|70|70.0||||||
4078313|NCT01026142|3901312|B2|Spain||Region of Enrollment||participants|Number|31|31.0||||||
4078314|NCT01026142|3901313|B1|Spain||Region of Enrollment||participants|Number|39|39.0||||||
4078315|NCT01026142|3901311|B3|Thailand||Region of Enrollment||participants|Number|5|5.0||||||
4078316|NCT01026142|3901312|B2|Thailand||Region of Enrollment||participants|Number|5|5.0||||||
4078317|NCT01026142|3901313|B1|Thailand||Region of Enrollment||participants|Number|0|0.0||||||
4078319|NCT01026142|3901312|B2|United Kingdom||Region of Enrollment||participants|Number|17|17.0||||||
4078320|NCT01026142|3901313|B1|United Kingdom||Region of Enrollment||participants|Number|18|18.0||||||
4078321|NCT01026142|3901311|B3|Hong Kong||Region of Enrollment||participants|Number|16|16.0||||||
4078322|NCT01026142|3901312|B2|Hong Kong||Region of Enrollment||participants|Number|11|11.0||||||
4078323|NCT01026142|3901313|B1|Hong Kong||Region of Enrollment||participants|Number|5|5.0||||||
4078324|NCT01026142|3901311|B3|Hungary||Region of Enrollment||participants|Number|42|42.0||||||
4078325|NCT01026142|3901312|B2|Hungary||Region of Enrollment||participants|Number|29|29.0||||||
4078326|NCT01026142|3901313|B1|Hungary||Region of Enrollment||participants|Number|13|13.0||||||
4078327|NCT01026142|3901311|B3|Romania||Region of Enrollment||participants|Number|14|14.0||||||
4078328|NCT01026142|3901312|B2|Romania||Region of Enrollment||participants|Number|8|8.0||||||
4078329|NCT01026142|3901313|B1|Romania||Region of Enrollment||participants|Number|6|6.0||||||
4078330|NCT01026142|3901311|B3|Argentina||Region of Enrollment||participants|Number|7|7.0||||||
4078331|NCT01026142|3901312|B2|Argentina||Region of Enrollment||participants|Number|4|4.0||||||
4078332|NCT01026142|3901313|B1|Argentina||Region of Enrollment||participants|Number|3|3.0||||||
4078333|NCT01026142|3901311|B3|Russian Federation||Region of Enrollment||participants|Number|11|11.0||||||
4078334|NCT01026142|3901312|B2|Russian Federation||Region of Enrollment||participants|Number|3|3.0||||||
4078335|NCT01026142|3901313|B1|Russian Federation||Region of Enrollment||participants|Number|8|8.0||||||
4078336|NCT01026142|3901311|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4078337|NCT01026142|3901312|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4078338|NCT01026142|3901313|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4078339|NCT01026142|3901311|B3||Female|Sex: Female, Male||Participants|Count of Participants|446|446.0||||||
4078340|NCT01026142|3901312|B2||Female|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
4078341|NCT01026142|3901313|B1||Female|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4078342|NCT01026142|3901311|B3|||Age||years|Mean|54.0|54.0|Standard Deviation|10.72|10.72|||
4078343|NCT01026142|3901312|B2|||Age||years|Mean|53.0|53.0|Standard Deviation|11.21|11.21|||
4078344|NCT01026142|3901313|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|10.10|10.1|||
4078345|NCT01026103|3901336|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4078346|NCT01026103|3901336|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4078347|NCT01026103|3901336|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4078348|NCT01026103|3901336|B1|||Age||years|Mean|42.2|42.2|Standard Deviation|11.3|11.3|||
4078349|NCT01026038|3901343|B4||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4078350|NCT01026038|3901344|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4078351|NCT01026038|3901345|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4078352|NCT01026038|3901346|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4078353|NCT01026038|3901343|B4||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4078354|NCT01026038|3901344|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4078355|NCT01026038|3901345|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4078356|NCT01026038|3901346|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4078357|NCT01026038|3901343|B4|||Age||Years|Mean|3.4|3.4|Standard Deviation|0.25|0.25|||
4078358|NCT01026038|3901344|B3|||Age||Years|Mean|3.5|3.5|Standard Deviation|0.25|0.25|||
4078359|NCT01026038|3901345|B2|||Age||Years|Mean|3.4|3.4|Standard Deviation|0.24|0.24|||
4078360|NCT01026038|3901346|B1|||Age||Years|Mean|3.4|3.4|Standard Deviation|0.25|0.25|||
4078361|NCT01026012|3901383|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4078362|NCT01026012|3901383|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4078363|NCT01026012|3901383|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4078364|NCT01026012|3901383|B1|||Age||years|Mean|65.9|65.9|Standard Deviation|1|1.0|||
4078365|NCT01026012|3901383|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4078366|NCT01026012|3901383|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4078367|NCT01026012|3901383|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4078368|NCT01025843|3901387|B11||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4078369|NCT01025843|3901388|B10||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4078370|NCT01025843|3901389|B9||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4078371|NCT01025843|3901390|B8||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4078372|NCT01025843|3901391|B7||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4078373|NCT01025843|3901392|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4078374|NCT01025843|3901393|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4078375|NCT01025843|3901394|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4078376|NCT01025843|3901395|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4078377|NCT01025843|3901396|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4078378|NCT01025843|3901397|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4078379|NCT01025843|3901387|B11||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4078380|NCT01025843|3901388|B10||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4078381|NCT01025843|3901389|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4078382|NCT01025843|3901390|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4078383|NCT01025843|3901391|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4078384|NCT01025843|3901392|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4078385|NCT01025843|3901393|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4078386|NCT01025843|3901394|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4078387|NCT01025843|3901395|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4078388|NCT01025843|3901396|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4078389|NCT01025843|3901397|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4078390|NCT01025843|3901387|B11|||Age||Years|Median|45.5|45.5|Full Range|||21.0|50.0|
4078391|NCT01025843|3901388|B10|||Age||Years|Median|39.0|39.0|Full Range|||38.0|40.0|
4078392|NCT01025843|3901389|B9|||Age||Years|Median|45.0|45.0|Full Range|||42.0|48.0|
4078393|NCT01025843|3901390|B8|||Age||Years|Median|46.5|46.5|Full Range|||44.0|49.0|
4078394|NCT01025843|3901391|B7|||Age||Years|Median|48.0|48.0|Full Range|||46.0|50.0|
4078395|NCT01025843|3901392|B6|||Age||Years|Median|44.5|44.5|Full Range|||40.0|49.0|
4078396|NCT01025843|3901393|B5|||Age||Years|Median|37.5|37.5|Full Range|||36.0|39.0|
4078397|NCT01025843|3901394|B4|||Age||Years|Median|35.0|35.0|Full Range|||21.0|49.0|
4078398|NCT01025843|3901395|B3|||Age||Years|Median|46.0|46.0|Full Range|||45.0|47.0|
4078399|NCT01025843|3901396|B2|||Age||Years|Median|38.5|38.5|Full Range|||29.0|48.0|
4078400|NCT01025843|3901397|B1|||Age||Years|Median|46.5|46.5|Full Range|||46.0|47.0|
4078401|NCT01025830|3901480|B1|||Weight||kg|Mean|68.3|68.3|Standard Deviation|6.6|6.6|||
4078402|NCT01025830|3901480|B1|||Body Mass Index||kg/m2|Mean|25.1|25.1|Standard Deviation|3.4|3.4|||
4078403|NCT01025830|3901480|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4078404|NCT01025830|3901480|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4078405|NCT01025830|3901480|B1|||Age||years|Mean|37.4|37.4|Standard Deviation|6.0|6.0|||
4078406|NCT01025830|3901480|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4078407|NCT01025830|3901480|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4078408|NCT01025830|3901480|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4078409|NCT01025817|3901498|B3|No||Diabetic status at randomization|62 Insulin dependent + 49 Non-insulin dependent = 111 participants who were diabetic at randomization.|Participants|Number|404|404.0||||||
4078410|NCT01025817|3901499|B2|No||Diabetic status at randomization|62 Insulin dependent + 49 Non-insulin dependent = 111 participants who were diabetic at randomization.|Participants|Number|209|209.0||||||
4078411|NCT01025817|3901500|B1|No||Diabetic status at randomization|62 Insulin dependent + 49 Non-insulin dependent = 111 participants who were diabetic at randomization.|Participants|Number|195|195.0||||||
4078412|NCT01025817|3901498|B3|Yes||Diabetic status at randomization|62 Insulin dependent + 49 Non-insulin dependent = 111 participants who were diabetic at randomization.|Participants|Number|206|206.0||||||
4078413|NCT01025817|3901499|B2|Yes||Diabetic status at randomization|62 Insulin dependent + 49 Non-insulin dependent = 111 participants who were diabetic at randomization.|Participants|Number|95|95.0||||||
4078414|NCT01025817|3901500|B1|Yes||Diabetic status at randomization|62 Insulin dependent + 49 Non-insulin dependent = 111 participants who were diabetic at randomization.|Participants|Number|111|111.0||||||
4078415|NCT01025817|3901498|B3|||BMI|Body Mass Index|kg/m˄2|Mean|28.0|28.0|Standard Deviation|5.35|5.35|||
4078416|NCT01025817|3901499|B2|||BMI|Body Mass Index|kg/m˄2|Mean|28.3|28.3|Standard Deviation|5.13|5.13|||
4078417|NCT01025817|3901500|B1|||BMI|Body Mass Index|kg/m˄2|Mean|27.7|27.7|Standard Deviation|5.55|5.55|||
4078418|NCT01025817|3901498|B3|Other||Race/Ethnicity, Customized||Participants|Number|33|33.0||||||
4078419|NCT01025817|3901499|B2|Other||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4078420|NCT01025817|3901500|B1|Other||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4078421|NCT01025817|3901498|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|397|397.0||||||
4078422|NCT01025817|3901499|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|201|201.0||||||
4078423|NCT01025817|3901500|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|196|196.0||||||
4078424|NCT01025817|3901498|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|144|144.0||||||
4078425|NCT01025817|3901499|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|74|74.0||||||
4078426|NCT01025817|3901500|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|70|70.0||||||
4078427|NCT01025817|3901498|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4078428|NCT01025817|3901499|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4078429|NCT01025817|3901500|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4078430|NCT01025817|3901498|B3|Asian||Race/Ethnicity, Customized||Participants|Number|28|28.0||||||
4078431|NCT01025817|3901499|B2|Asian||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4078432|NCT01025817|3901500|B1|Asian||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4078433|NCT01025817|3901498|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4078434|NCT01025817|3901499|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4078435|NCT01025817|3901500|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4078436|NCT01025817|3901498|B3||Male|Sex: Female, Male||Participants|Count of Participants|407|407.0||||||
4078437|NCT01025817|3901499|B2||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4078438|NCT01025817|3901500|B1||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4078439|NCT01025817|3901498|B3||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4078440|NCT01025817|3901499|B2||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4078441|NCT01025817|3901500|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4078442|NCT01025817|3901498|B3|||Age||Years|Mean|49.2|49.2|Standard Deviation|13.14|13.14|||
4078443|NCT01025817|3901499|B2|||Age||Years|Mean|48.4|48.4|Standard Deviation|12.91|12.91|||
4078444|NCT01025817|3901500|B1|||Age||Years|Mean|50.00|50.0|Standard Deviation|13.34|13.34|||
4078445|NCT01025752|3901519|B3|United States||Region of Enrollment||Participants|Count of Participants|125|125.0||||||
4078446|NCT01025752|3901520|B2|United States||Region of Enrollment||Participants|Count of Participants|63|63.0||||||
4078447|NCT01025752|3901521|B1|United States||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
4078448|NCT01025752|3901519|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4078449|NCT01025752|3901520|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4078450|NCT01025752|3901521|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4078451|NCT01025752|3901519|B3|White, not Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|80|80.0||||||
4078452|NCT01025752|3901520|B2|White, not Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
4078453|NCT01025752|3901521|B1|White, not Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
4078454|NCT01025752|3901519|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4078455|NCT01025752|3901520|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4078456|NCT01025752|3901521|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4078457|NCT01025752|3901519|B3|Balck, not Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
4078458|NCT01025752|3901520|B2|Balck, not Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
4078459|NCT01025752|3901521|B1|Balck, not Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4078460|NCT01025752|3901519|B3||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4078461|NCT01025752|3901520|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4078462|NCT01025752|3901521|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4078463|NCT01025752|3901519|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4078464|NCT01025752|3901520|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4078465|NCT01025752|3901521|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4078466|NCT01025752|3901519|B3|||Age||years|Mean|57.9|57.9|Standard Deviation|11.6|11.6|||
4078467|NCT01025752|3901520|B2|||Age||years|Mean|56.7|56.7|Standard Deviation|11.5|11.5|||
4078468|NCT01025752|3901521|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|11.8|11.8|||
4078469|NCT01025635|3901540|B3|||Number of inflammatory lesions per participant at Baseline||Inflammatory lesions|Mean|21.0|21.0|Standard Deviation|9.38|9.38|||
4078470|NCT01025635|3901541|B2|||Number of inflammatory lesions per participant at Baseline||Inflammatory lesions|Mean|20.4|20.4|Standard Deviation|8.83|8.83|||
4078471|NCT01025635|3901542|B1|||Number of inflammatory lesions per participant at Baseline||Inflammatory lesions|Mean|21.6|21.6|Standard Deviation|9.91|9.91|||
4078472|NCT01025635|3901540|B3|||Investigator’s Global Assessment (IGA) score at Baseline|IGA categories: 0 - Clear; 1 - Minimal; 2 - Mild; 4 - Moderate; 6 - Severe / Therapeutic success is defined as an IGA score of clear or minimal (0 to 1).|Scores on a scale|Mean|4.2|4.2|Standard Deviation|0.60|0.6|||
4078473|NCT01025635|3901541|B2|||Investigator’s Global Assessment (IGA) score at Baseline|IGA categories: 0 - Clear; 1 - Minimal; 2 - Mild; 4 - Moderate; 6 - Severe / Therapeutic success is defined as an IGA score of clear or minimal (0 to 1).|Scores on a scale|Mean|4.1|4.1|Standard Deviation|0.51|0.51|||
4078474|NCT01025635|3901542|B1|||Investigator’s Global Assessment (IGA) score at Baseline|IGA categories: 0 - Clear; 1 - Minimal; 2 - Mild; 4 - Moderate; 6 - Severe / Therapeutic success is defined as an IGA score of clear or minimal (0 to 1).|Scores on a scale|Mean|4.3|4.3|Standard Deviation|0.68|0.68|||
4078475|NCT01025635|3901540|B3|||Previous duration of rosacea||Months|Mean|123.8|123.8|Standard Deviation|108.53|108.53|||
4078476|NCT01025635|3901541|B2|||Previous duration of rosacea||Months|Mean|126.3|126.3|Standard Deviation|103.81|103.81|||
4078477|NCT01025635|3901542|B1|||Previous duration of rosacea||Months|Mean|121.4|121.4|Standard Deviation|113.38|113.38|||
4078478|NCT01025635|3901540|B3||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4078479|NCT01025635|3901541|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4078480|NCT01025635|3901542|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4078481|NCT01025635|3901540|B3||Female|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
4078482|NCT01025635|3901541|B2||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4078483|NCT01025635|3901542|B1||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4078484|NCT01025635|3901540|B3|||Age||Years|Mean|48.5|48.5|Standard Deviation|11.93|11.93|||
4078485|NCT01025635|3901541|B2|||Age||Years|Mean|48.9|48.9|Standard Deviation|11.65|11.65|||
4078486|NCT01025635|3901542|B1|||Age||Years|Mean|48.1|48.1|Standard Deviation|12.23|12.23|||
4078487|NCT01025492|3901555|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4078488|NCT01025492|3901555|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4078489|NCT01025492|3901555|B1|||Age||years|Mean|59.5|59.5|Standard Deviation|10.3|10.3|||
4078490|NCT01025453|3901559|B1|United States||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
4078491|NCT01025453|3901559|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4078492|NCT01025453|3901559|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4078493|NCT01025453|3901559|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4078494|NCT01025453|3901559|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4078495|NCT01025453|3901559|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4078496|NCT01025453|3901559|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4078497|NCT01025453|3901559|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4078498|NCT01025453|3901559|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4078499|NCT01025453|3901559|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4078500|NCT01025453|3901559|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4078501|NCT01025453|3901559|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4078502|NCT01025453|3901559|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4078503|NCT01025453|3901559|B1|||Age||years|Median|64|64.0|Full Range|||30.0|81.0|
4078504|NCT01025336|3901566|B6||Male|Sex: Female, Male||Participants|Count of Participants|430|430.0||||||
4078505|NCT01025336|3901567|B5||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4078506|NCT01025336|3901568|B4||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4078507|NCT01025336|3901569|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4078508|NCT01025336|3901570|B2||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4078509|NCT01025336|3901571|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4078510|NCT01025336|3901566|B6||Female|Sex: Female, Male||Participants|Count of Participants|532|532.0||||||
4078511|NCT01025336|3901567|B5||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4078512|NCT01025336|3901568|B4||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4078513|NCT01025336|3901569|B3||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4078514|NCT01025336|3901570|B2||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4078515|NCT01025336|3901571|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4078516|NCT01025336|3901566|B6|||Age||Years|Mean|70.5|70.5|Standard Deviation|7.6|7.6|||
4078517|NCT01025336|3901567|B5|||Age||Years|Mean|77.8|77.8|Standard Deviation|4.1|4.1|||
4078518|NCT01025336|3901568|B4|||Age||Years|Mean|78.3|78.3|Standard Deviation|4.5|4.5|||
4078519|NCT01025336|3901569|B3|||Age||Years|Mean|64.2|64.2|Standard Deviation|1.4|1.4|||
4078520|NCT01025336|3901570|B2|||Age||Years|Mean|64.1|64.1|Standard Deviation|1.4|1.4|||
4078521|NCT01025336|3901571|B1|||Age||Years|Mean|64.0|64.0|Standard Deviation|1.4|1.4|||
4078522|NCT01025284|3901627|B4|South Korea||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
4078523|NCT01025284|3901628|B3|South Korea||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4078524|NCT01025284|3901629|B2|South Korea||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4078525|NCT01025284|3901630|B1|South Korea||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4078526|NCT01025284|3901627|B4|Romania||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4078527|NCT01025284|3901628|B3|Romania||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4078528|NCT01025284|3901629|B2|Romania||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4078529|NCT01025284|3901630|B1|Romania||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4078530|NCT01025284|3901627|B4|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
4078531|NCT01025284|3901628|B3|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4078532|NCT01025284|3901629|B2|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4078533|NCT01025284|3901630|B1|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
4078534|NCT01025284|3901627|B4|White||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4078535|NCT01025284|3901628|B3|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4078536|NCT01025284|3901629|B2|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4078537|NCT01025284|3901630|B1|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4078538|NCT01025284|3901627|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4078539|NCT01025284|3901628|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4078540|NCT01025284|3901629|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4078541|NCT01025284|3901630|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4078542|NCT01025284|3901627|B4|Asian||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4078543|NCT01025284|3901628|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4078544|NCT01025284|3901629|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4078545|NCT01025284|3901630|B1|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4078546|NCT01025284|3901627|B4||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4078547|NCT01025284|3901628|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4078548|NCT01025284|3901629|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4078549|NCT01025284|3901630|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4078550|NCT01025284|3901627|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4078551|NCT01025284|3901628|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4078552|NCT01025284|3901629|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4078553|NCT01025284|3901630|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4078554|NCT01025284|3901627|B4|||Age||years|Mean|64.26|64.26|Standard Deviation|7.2|7.2|||
4078555|NCT01025284|3901628|B3|||Age||years|Mean|63.40|63.4|Standard Deviation|9.1|9.1|||
4078556|NCT01025284|3901629|B2|||Age||years|Mean|63.33|63.33|Standard Deviation|8.4|8.4|||
4078557|NCT01025284|3901630|B1|||Age||years|Mean|64.88|64.88|Standard Deviation|6.3|6.3|||
4078558|NCT01025271|3901650|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4078559|NCT01025271|3901650|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4078560|NCT01025271|3901650|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4078561|NCT01025271|3901650|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4078562|NCT01025271|3901650|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4078563|NCT01025271|3901650|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4078564|NCT01025232|3901655|B3|United States||Region of Enrollment||participants|Number|88|88.0||||||
4078565|NCT01025232|3901656|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
4078566|NCT01025232|3901657|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4078567|NCT01025232|3901655|B3||Male|Gender||Participants|Count of Participants|42|42.0||||||
4078568|NCT01025232|3901656|B2||Male|Gender||Participants|Count of Participants|21|21.0||||||
4078569|NCT01025232|3901657|B1||Male|Gender||Participants|Count of Participants|21|21.0||||||
4078570|NCT01025232|3901655|B3||Female|Gender||Participants|Count of Participants|46|46.0||||||
4078571|NCT01025232|3901656|B2||Female|Gender||Participants|Count of Participants|21|21.0||||||
4078572|NCT01025232|3901657|B1||Female|Gender||Participants|Count of Participants|25|25.0||||||
4078573|NCT01025232|3901655|B3|||Age||years|Mean|76.1|76.1|Full Range|||53.0|93.0|
4078574|NCT01025232|3901656|B2|||Age||years|Mean|77|77.0|Full Range|||53.0|87.0|
4078575|NCT01025232|3901657|B1|||Age||years|Mean|76|76.0|Full Range|||60.0|93.0|
4078576|NCT01025232|3901655|B3||>=65 years|Age||Participants|Count of Participants|83|83.0||||||
4078577|NCT01025232|3901656|B2||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4078578|NCT01025232|3901657|B1||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
4078579|NCT01025232|3901655|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4078580|NCT01025232|3901656|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4078581|NCT01025232|3901657|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4078582|NCT01025232|3901655|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4078583|NCT01025232|3901656|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4078584|NCT01025232|3901657|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4078585|NCT01025193|3901676|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4078586|NCT01025193|3901676|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4078587|NCT01025193|3901676|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4078588|NCT01025193|3901676|B1|||Age||years|Mean|41|41.0|Standard Deviation|26|26.0|||
4078589|NCT01025193|3901676|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4078590|NCT01025193|3901676|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4078591|NCT01025193|3901676|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4078592|NCT01025154|3901686|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
4078593|NCT01025154|3901686|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4078594|NCT01025154|3901686|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4078595|NCT01025154|3901686|B1|||Age||years|Median|48|48.0|Full Range|||19.0|60.0|
4078596|NCT01025076|3901691|B1|||Pre-operative weight||Kg|Mean|119.5|119.5|Standard Deviation|25.9|25.9|||
4078597|NCT01025076|3901691|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4078598|NCT01025076|3901691|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4078599|NCT01025076|3901691|B1|||Age||years|Mean|46.4|46.4|Standard Deviation|6.7|6.7|||
4078600|NCT01025037|3901695|B1|||BMI||kg/m^2|Mean|32|32.0|Standard Deviation|6.8|6.8|||
4078601|NCT01025037|3901695|B1|||Weight||kg|Mean|94.9|94.9|Standard Deviation|24.9|24.9|||
4078602|NCT01025037|3901695|B1|||Height||cm|Mean|171.5|171.5|Standard Deviation|11.3|11.3|||
4078603|NCT01025037|3901695|B1|United States||Region of Enrollment||participants|Number|61|61.0||||||
4078604|NCT01025037|3901695|B1|White||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
4078605|NCT01025037|3901695|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4078606|NCT01025037|3901695|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4078607|NCT01025037|3901695|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4078608|NCT01025037|3901695|B1|||Age||years|Mean|56.4|56.4|Standard Deviation|6.5|6.5|||
4078609|NCT01024972|3901704|B3|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4078610|NCT01024972|3901705|B2|African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4078611|NCT01024972|3901706|B1|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4078612|NCT01024972|3901704|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4078613|NCT01024972|3901705|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4078614|NCT01024972|3901706|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4078615|NCT01024972|3901704|B3|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4078616|NCT01024972|3901705|B2|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4078617|NCT01024972|3901706|B1|White||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4078618|NCT01024972|3901704|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4078619|NCT01024972|3901705|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4078620|NCT01024972|3901706|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4078621|NCT01024972|3901704|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4078622|NCT01024972|3901705|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4078623|NCT01024972|3901706|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4078624|NCT01024972|3901704|B3|||Age||years|Mean|54|54.0|Standard Deviation|12|12.0|||
4078625|NCT01024972|3901705|B2|||Age||years|Mean|52|52.0|Standard Deviation|11|11.0|||
4078626|NCT01024972|3901706|B1|||Age||years|Mean|56|56.0|Standard Deviation|12|12.0|||
4078627|NCT01024959|3901717|B1|United States||Region of Enrollment||participants|Number|495|495.0||||||
4078628|NCT01024959|3901717|B1||Male|Sex: Female, Male||Participants|Count of Participants|495|495.0||||||
4078629|NCT01024959|3901717|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4078630|NCT01024959|3901717|B1|||Age||years|Mean|66.7|66.7|Standard Deviation|8.3|8.3|||
4078631|NCT01024946|3901726|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4078632|NCT01024946|3901726|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4078633|NCT01024946|3901726|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4078634|NCT01024946|3901726|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4078635|NCT01024946|3901726|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4078636|NCT01024855|3901730|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4078637|NCT01024855|3901730|B1|Unknown||Sex/Gender, Customized|Study was performed in-house and strict confidentiality is required. Per Abbott In-House Study procedures, subject numbers and initials were used as identification. Limited access was given to data files to ensure confidentiality. Therefore, no gender data was collected for this study as it might reveal subjects identity to data entry personnel.|participants|Number|30|30.0||||||
4078638|NCT01024855|3901730|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4078639|NCT01024855|3901730|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4078640|NCT01024855|3901730|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4078641|NCT01024751|3901735|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4078642|NCT01024751|3901736|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4078643|NCT01024751|3901737|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4078644|NCT01024751|3901735|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4078645|NCT01024751|3901736|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4078646|NCT01024751|3901737|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4078647|NCT01024751|3901735|B3||White|Race (NIH/OMB)||Participants|Count of Participants|257|257.0||||||
4078648|NCT01024751|3901736|B2||White|Race (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
4078649|NCT01024751|3901737|B1||White|Race (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
4078650|NCT01024751|3901735|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4078651|NCT01024751|3901736|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4078652|NCT01024751|3901737|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4078653|NCT01024751|3901735|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4078654|NCT01024751|3901736|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4078655|NCT01024751|3901737|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4078656|NCT01024751|3901735|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4078657|NCT01024751|3901736|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4078658|NCT01024751|3901737|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4078659|NCT01024751|3901735|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4078660|NCT01024751|3901736|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4078661|NCT01024751|3901737|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4078662|NCT01024751|3901735|B3||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4078663|NCT01024751|3901736|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4078664|NCT01024751|3901737|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4078665|NCT01024751|3901735|B3||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4078666|NCT01024751|3901736|B2||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4078667|NCT01024751|3901737|B1||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4078668|NCT01024751|3901735|B3|Between 18 and 70 years||Age, Customized||participants|Number|305|305.0||||||
4078669|NCT01024751|3901736|B2|Between 18 and 70 years||Age, Customized||participants|Number|152|152.0||||||
4078670|NCT01024751|3901737|B1|Between 18 and 70 years||Age, Customized||participants|Number|153|153.0||||||
4078671|NCT01024738|3901746|B4|United States||Region of Enrollment||participants|Number|22|22.0||||||
4078672|NCT01024738|3901747|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4078673|NCT01024738|3901748|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4078674|NCT01024738|3901749|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4078675|NCT01024738|3901746|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4078676|NCT01024738|3901747|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4078677|NCT01024738|3901748|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4078678|NCT01024738|3901749|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4078679|NCT01024738|3901746|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4078680|NCT01024738|3901747|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4078681|NCT01024738|3901748|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4078682|NCT01024738|3901749|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4078683|NCT01024738|3901746|B4|||Age||years|Mean|50.43|50.43|Standard Deviation|8.86|8.86|||
4078684|NCT01024738|3901747|B3|||Age||years|Mean|56.6|56.6|Standard Deviation|5.5|5.5|||
4078685|NCT01024738|3901748|B2|||Age||years|Mean|50.5|50.5|Standard Deviation|6.5|6.5|||
4078686|NCT01024738|3901749|B1|||Age||years|Mean|44.2|44.2|Standard Deviation|10.23|10.23|||
4078687|NCT01024738|3901746|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4078688|NCT01024738|3901747|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4078689|NCT01024738|3901748|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4078690|NCT01024738|3901749|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4078691|NCT01024738|3901746|B4||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4078692|NCT01024738|3901747|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4078693|NCT01024738|3901748|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4078694|NCT01024738|3901749|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4078695|NCT01024738|3901746|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4078696|NCT01024738|3901747|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4078697|NCT01024738|3901748|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4078698|NCT01024738|3901749|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4078699|NCT01024608|3901759|B3|White||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|284|284.0||||||
4078700|NCT01024608|3901760|B2|White||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|142|142.0||||||
4078701|NCT01024608|3901761|B1|White||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|142|142.0||||||
4078702|NCT01024608|3901759|B3|Black or African American||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|49|49.0||||||
4078703|NCT01024608|3901760|B2|Black or African American||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|26|26.0||||||
4078704|NCT01024608|3901761|B1|Black or African American||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|23|23.0||||||
4078705|NCT01024608|3901759|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|1|1.0||||||
4078706|NCT01024608|3901760|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|1|1.0||||||
4078707|NCT01024608|3901761|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|0|0.0||||||
4078708|NCT01024608|3901759|B3|Asian||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|6|6.0||||||
4078709|NCT01024608|3901760|B2|Asian||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|3|3.0||||||
4078710|NCT01024608|3901761|B1|Asian||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|3|3.0||||||
4078711|NCT01024608|3901759|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|2|2.0||||||
4078712|NCT01024608|3901760|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|1|1.0||||||
4078713|NCT01024608|3901761|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|1|1.0||||||
4078714|NCT01024608|3901759|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4078715|NCT01024608|3901760|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4078716|NCT01024608|3901761|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4078717|NCT01024608|3901759|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|237|237.0||||||
4078718|NCT01024608|3901760|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
4078719|NCT01024608|3901761|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
4078720|NCT01024608|3901759|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
4078721|NCT01024608|3901760|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4078722|NCT01024608|3901761|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4078723|NCT01024608|3901759|B3||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4078724|NCT01024608|3901760|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4078725|NCT01024608|3901761|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4078726|NCT01024608|3901759|B3||Female|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4078727|NCT01024608|3901760|B2||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4078728|NCT01024608|3901761|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4078729|NCT01024608|3901759|B3|||Age|Demographic data are provided for the Intent to Treat population.|years|Mean|38.6|38.6|Standard Deviation|13.3|13.3|||
4078730|NCT01024608|3901760|B2|||Age|Demographic data are provided for the Intent to Treat population.|years|Mean|38.0|38.0|Standard Deviation|13.3|13.3|||
4078731|NCT01024608|3901761|B1|||Age|Demographic data are provided for the Intent to Treat population.|years|Mean|39.3|39.3|Standard Deviation|13.4|13.4|||
4078732|NCT01024465|3901774|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4078733|NCT01024465|3901774|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4078734|NCT01024465|3901774|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4078735|NCT01024465|3901774|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4078736|NCT01024465|3901774|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4078737|NCT01024465|3901774|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4078738|NCT01024465|3901774|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4078739|NCT01024465|3901774|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4078740|NCT01024465|3901774|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4078741|NCT01024465|3901774|B1|||Age||years|Mean|39.7|39.7|Standard Deviation|11.2|11.2|||
4078742|NCT01024387|3901778|B1|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
4078743|NCT01024387|3901778|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4078744|NCT01024387|3901778|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4078745|NCT01024387|3901778|B1|||Age||years|Median|61|61.0|Full Range|||30.0|82.0|
4078746|NCT01024335|3901786|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4078747|NCT01024335|3901787|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4078748|NCT01024335|3901788|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4078749|NCT01024335|3901786|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4078750|NCT01024335|3901787|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4078751|NCT01024335|3901788|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4078752|NCT01024335|3901786|B3|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4078753|NCT01024335|3901787|B2|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4078754|NCT01024335|3901788|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4078755|NCT01024335|3901786|B3|White||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4078756|NCT01024335|3901787|B2|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4078757|NCT01024335|3901788|B1|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4078758|NCT01024335|3901786|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4078759|NCT01024335|3901787|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4078760|NCT01024335|3901788|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4078761|NCT01024335|3901786|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4078762|NCT01024335|3901787|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4078763|NCT01024335|3901788|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4078764|NCT01024335|3901786|B3|||Age||years|Mean|38.1|38.1|Standard Deviation|11.3|11.3|||
4078765|NCT01024335|3901787|B2|||Age||years|Mean|38.5|38.5|Standard Deviation|11.6|11.6|||
4078766|NCT01024335|3901788|B1|||Age||years|Mean|37.3|37.3|Standard Deviation|11.1|11.1|||
4078767|NCT01024309|3901797|B3|United States||Region of Enrollment||participants|Number|66|66.0||||||
4078768|NCT01024309|3901798|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
4078769|NCT01024309|3901799|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4078770|NCT01024309|3901797|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4078771|NCT01024309|3901798|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4078772|NCT01024309|3901799|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4078773|NCT01024309|3901797|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4078774|NCT01024309|3901798|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4078775|NCT01024309|3901799|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4078776|NCT01024309|3901797|B3|||Age||years|Mean|63.8|63.8|Standard Deviation|9.0|9.0|||
4078777|NCT01024309|3901798|B2|||Age||years|Mean|63.4|63.4|Standard Deviation|8.6|8.6|||
4078778|NCT01024309|3901799|B1|||Age||years|Mean|64.2|64.2|Standard Deviation|9.4|9.4|||
4078779|NCT01024309|3901797|B3||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4078780|NCT01024309|3901798|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4078781|NCT01024309|3901799|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4078782|NCT01024309|3901797|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4078783|NCT01024309|3901798|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4078784|NCT01024309|3901799|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4078785|NCT01024309|3901797|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4078786|NCT01024309|3901798|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4078787|NCT01024309|3901799|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4078788|NCT01024296|3901822|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4078789|NCT01024296|3901822|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4078790|NCT01024296|3901822|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4078791|NCT01024296|3901822|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4078792|NCT01024296|3901822|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4078793|NCT01024244|3901827|B6|||Percentage of Glycosylated Fraction of Hemoglobin A1c|HbA1c: hemoglobin A1c, glycosylated fraction of hemoglobin A (%)|percentage of glycosylated hemoglobin|Mean|7.86|7.86|Standard Deviation|0.69|0.69|||
4078794|NCT01024244|3901828|B5|||Percentage of Glycosylated Fraction of Hemoglobin A1c|HbA1c: hemoglobin A1c, glycosylated fraction of hemoglobin A (%)|percentage of glycosylated hemoglobin|Mean|7.79|7.79|Standard Deviation|0.83|0.83|||
4078795|NCT01024244|3901829|B4|||Percentage of Glycosylated Fraction of Hemoglobin A1c|HbA1c: hemoglobin A1c, glycosylated fraction of hemoglobin A (%)|percentage of glycosylated hemoglobin|Mean|7.88|7.88|Standard Deviation|0.74|0.74|||
4078796|NCT01024244|3901830|B3|||Percentage of Glycosylated Fraction of Hemoglobin A1c|HbA1c: hemoglobin A1c, glycosylated fraction of hemoglobin A (%)|percentage of glycosylated hemoglobin|Mean|7.89|7.89|Standard Deviation|0.45|0.45|||
4078797|NCT01024244|3901831|B2|||Percentage of Glycosylated Fraction of Hemoglobin A1c|HbA1c: hemoglobin A1c, glycosylated fraction of hemoglobin A (%)|percentage of glycosylated hemoglobin|Mean|7.48|7.48|Standard Deviation|0.71|0.71|||
4078798|NCT01024244|3901832|B1|||Percentage of Glycosylated Fraction of Hemoglobin A1c|HbA1c: hemoglobin A1c, glycosylated fraction of hemoglobin A (%)|percentage of glycosylated hemoglobin|Mean|8.10|8.1|Standard Deviation|0.63|0.63|||
4078799|NCT01024244|3901827|B6|||Duration of Diabetes in Years||years|Mean|5.25|5.25|Standard Deviation|4.18|4.18|||
4078800|NCT01024244|3901828|B5|||Duration of Diabetes in Years||years|Mean|5.78|5.78|Standard Deviation|4.15|4.15|||
4078801|NCT01024244|3901829|B4|||Duration of Diabetes in Years||years|Mean|5.12|5.12|Standard Deviation|3.34|3.34|||
4078802|NCT01024244|3901830|B3|||Duration of Diabetes in Years||years|Mean|5.54|5.54|Standard Deviation|4.43|4.43|||
4078803|NCT01024244|3901831|B2|||Duration of Diabetes in Years||years|Mean|3.55|3.55|Standard Deviation|4.87|4.87|||
4078804|NCT01024244|3901832|B1|||Duration of Diabetes in Years||years|Mean|5.71|5.71|Standard Deviation|4.26|4.26|||
4078805|NCT01024244|3901827|B6|United States||Region of Enrollment||participants|Number|11|11.0||||||
4078806|NCT01024244|3901828|B5|United States||Region of Enrollment||participants|Number|3|3.0||||||
4078807|NCT01024244|3901829|B4|United States||Region of Enrollment||participants|Number|1|1.0||||||
4078808|NCT01024244|3901830|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4078809|NCT01024244|3901831|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4078810|NCT01024244|3901832|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4078811|NCT01024244|3901827|B6|Spain||Region of Enrollment||participants|Number|31|31.0||||||
4078812|NCT01024244|3901828|B5|Spain||Region of Enrollment||participants|Number|5|5.0||||||
4078813|NCT01024244|3901829|B4|Spain||Region of Enrollment||participants|Number|5|5.0||||||
4078814|NCT01024244|3901830|B3|Spain||Region of Enrollment||participants|Number|6|6.0||||||
4078815|NCT01024244|3901831|B2|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4078816|NCT01024244|3901832|B1|Spain||Region of Enrollment||participants|Number|11|11.0||||||
4078817|NCT01024244|3901827|B6|Russian Federation||Region of Enrollment||participants|Number|21|21.0||||||
4078818|NCT01024244|3901828|B5|Russian Federation||Region of Enrollment||participants|Number|3|3.0||||||
4078819|NCT01024244|3901829|B4|Russian Federation||Region of Enrollment||participants|Number|4|4.0||||||
4078820|NCT01024244|3901830|B3|Russian Federation||Region of Enrollment||participants|Number|7|7.0||||||
4078821|NCT01024244|3901831|B2|Russian Federation||Region of Enrollment||participants|Number|3|3.0||||||
4078822|NCT01024244|3901832|B1|Russian Federation||Region of Enrollment||participants|Number|4|4.0||||||
4078823|NCT01024244|3901827|B6|Puerto Rico||Region of Enrollment||participants|Number|7|7.0||||||
4078824|NCT01024244|3901828|B5|Puerto Rico||Region of Enrollment||participants|Number|0|0.0||||||
4078825|NCT01024244|3901829|B4|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
4078826|NCT01024244|3901830|B3|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
4078827|NCT01024244|3901831|B2|Puerto Rico||Region of Enrollment||participants|Number|2|2.0||||||
4078828|NCT01024244|3901832|B1|Puerto Rico||Region of Enrollment||participants|Number|3|3.0||||||
4078829|NCT01024244|3901827|B6|Australia||Region of Enrollment||participants|Number|8|8.0||||||
4078830|NCT01024244|3901828|B5|Australia||Region of Enrollment||participants|Number|4|4.0||||||
4078831|NCT01024244|3901829|B4|Australia||Region of Enrollment||participants|Number|3|3.0||||||
4078832|NCT01024244|3901830|B3|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4078833|NCT01024244|3901831|B2|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4078834|NCT01024244|3901832|B1|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4078835|NCT01024244|3901827|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4078836|NCT01024244|3901828|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4078837|NCT01024244|3901829|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4078838|NCT01024244|3901830|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4078839|NCT01024244|3901831|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4078840|NCT01024244|3901832|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4078841|NCT01024244|3901827|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4078842|NCT01024244|3901828|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4078843|NCT01024244|3901829|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4078844|NCT01024244|3901830|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4078845|NCT01024244|3901831|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4078846|NCT01024244|3901832|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4078847|NCT01024244|3901827|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4078848|NCT01024244|3901828|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4078849|NCT01024244|3901829|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4078850|NCT01024244|3901830|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4078851|NCT01024244|3901831|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4078852|NCT01024244|3901832|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4078853|NCT01024244|3901827|B6||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4078854|NCT01024244|3901828|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4078855|NCT01024244|3901829|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4078856|NCT01024244|3901830|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4078857|NCT01024244|3901831|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4078858|NCT01024244|3901832|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4078859|NCT01024244|3901827|B6||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4078860|NCT01024244|3901828|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4078861|NCT01024244|3901829|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4078862|NCT01024244|3901830|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4078863|NCT01024244|3901831|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4078864|NCT01024244|3901832|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4078865|NCT01024244|3901827|B6|||Age||years|Mean|57.62|57.62|Standard Deviation|7.81|7.81|||
4078866|NCT01024244|3901828|B5|||Age||years|Mean|59.25|59.25|Standard Deviation|5.83|5.83|||
4078867|NCT01024244|3901829|B4|||Age||years|Mean|59.94|59.94|Standard Deviation|10.88|10.88|||
4078868|NCT01024244|3901830|B3|||Age||years|Mean|56.55|56.55|Standard Deviation|7.53|7.53|||
4078869|NCT01024244|3901831|B2|||Age||years|Mean|55.94|55.94|Standard Deviation|6.66|6.66|||
4078870|NCT01024244|3901832|B1|||Age||years|Mean|56.69|56.69|Standard Deviation|7.60|7.6|||
4078871|NCT01024036|3901948|B3|UNITED STATES||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4078872|NCT01024036|3901949|B2|UNITED STATES||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4078873|NCT01024036|3901950|B1|UNITED STATES||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4078874|NCT01024036|3901948|B3|UNITED KINGDOM||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4078875|NCT01024036|3901949|B2|UNITED KINGDOM||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4078876|NCT01024036|3901950|B1|UNITED KINGDOM||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4078877|NCT01024036|3901948|B3|TAIWAN||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4078878|NCT01024036|3901949|B2|TAIWAN||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4078879|NCT01024036|3901950|B1|TAIWAN||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4078880|NCT01024036|3901948|B3|SPAIN||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4078881|NCT01024036|3901949|B2|SPAIN||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4078882|NCT01024036|3901950|B1|SPAIN||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4078883|NCT01024036|3901948|B3|SOUTH KOREA||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4078884|NCT01024036|3901949|B2|SOUTH KOREA||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4078885|NCT01024036|3901950|B1|SOUTH KOREA||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4078886|NCT01024036|3901948|B3|SINGAPORE||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4078887|NCT01024036|3901949|B2|SINGAPORE||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4078888|NCT01024036|3901950|B1|SINGAPORE||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4078889|NCT01024036|3901948|B3|RUSSIAN FEDERATION||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4078890|NCT01024036|3901949|B2|RUSSIAN FEDERATION||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4078891|NCT01024036|3901950|B1|RUSSIAN FEDERATION||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4078892|NCT01024036|3901948|B3|NORWAY||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4078893|NCT01024036|3901949|B2|NORWAY||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4078894|NCT01024036|3901950|B1|NORWAY||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4078895|NCT01024036|3901948|B3|NEW ZEALAND||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4078896|NCT01024036|3901949|B2|NEW ZEALAND||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4078897|NCT01024036|3901950|B1|NEW ZEALAND||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4078898|NCT01024036|3901948|B3|ISRAEL||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4078899|NCT01024036|3901949|B2|ISRAEL||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4078900|NCT01024036|3901950|B1|ISRAEL||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4078901|NCT01024036|3901948|B3|HONG KONG||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4078902|NCT01024036|3901949|B2|HONG KONG||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4078903|NCT01024036|3901950|B1|HONG KONG||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4078904|NCT01024036|3901948|B3|GERMANY||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4078905|NCT01024036|3901949|B2|GERMANY||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4078906|NCT01024036|3901950|B1|GERMANY||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4078907|NCT01024036|3901948|B3|FRANCE||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4078908|NCT01024036|3901949|B2|FRANCE||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4078909|NCT01024036|3901950|B1|FRANCE||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4078910|NCT01024036|3901948|B3|EGYPT||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4078911|NCT01024036|3901949|B2|EGYPT||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4078912|NCT01024036|3901950|B1|EGYPT||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4078913|NCT01024036|3901948|B3|CHINA||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4078914|NCT01024036|3901949|B2|CHINA||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4078915|NCT01024036|3901950|B1|CHINA||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4078916|NCT01024036|3901948|B3|CANADA||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4078917|NCT01024036|3901949|B2|CANADA||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4078918|NCT01024036|3901950|B1|CANADA||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4078919|NCT01024036|3901948|B3|BRAZIL||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4078920|NCT01024036|3901949|B2|BRAZIL||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4078921|NCT01024036|3901950|B1|BRAZIL||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4078922|NCT01024036|3901948|B3|BELGIUM||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4078923|NCT01024036|3901949|B2|BELGIUM||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4078924|NCT01024036|3901950|B1|BELGIUM||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4078925|NCT01024036|3901948|B3|AUSTRALIA||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4078926|NCT01024036|3901949|B2|AUSTRALIA||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4078927|NCT01024036|3901950|B1|AUSTRALIA||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4078928|NCT01024036|3901948|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4078929|NCT01024036|3901949|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4078930|NCT01024036|3901950|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4078931|NCT01024036|3901948|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4078932|NCT01024036|3901949|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4078933|NCT01024036|3901950|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4078934|NCT01024036|3901948|B3|||Age||years|Mean|45.5|45.5|Standard Deviation|13.35|13.35|||
4078935|NCT01024036|3901949|B2|||Age||years|Mean|44.4|44.4|Standard Deviation|13.32|13.32|||
4078936|NCT01024036|3901950|B1|||Age||years|Mean|47.7|47.7|Standard Deviation|13.4|13.4|||
4078937|NCT01024010|3901982|B3|United States||Region of Enrollment||participants|Number|82|82.0||||||
4078938|NCT01024010|3901983|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
4078939|NCT01024010|3901984|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4078940|NCT01024010|3901982|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4078941|NCT01024010|3901983|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4078942|NCT01024010|3901984|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4078943|NCT01024010|3901982|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4078944|NCT01024010|3901983|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4078945|NCT01024010|3901984|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4078946|NCT01024010|3901982|B3|||Age||years|Median|63|63.0|Full Range|||40.0|79.0|
4078947|NCT01024010|3901983|B2|||Age||years|Median|59|59.0|Full Range|||40.0|79.0|
4078948|NCT01024010|3901984|B1|||Age||years|Median|65|65.0|Full Range|||50.0|83.0|
4078949|NCT01023958|3901998|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4078950|NCT01023958|3901998|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4078951|NCT01023958|3901998|B1|||Age||Years|Mean|69.0|69.0|Standard Deviation|7.4|7.4|||
4078952|NCT01023841|3902025|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4078953|NCT01023841|3902026|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4078954|NCT01023841|3902027|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4078955|NCT01023841|3902025|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4078956|NCT01023841|3902026|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4078957|NCT01023841|3902027|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4078958|NCT01023841|3902025|B3|12-17 years||Age, Customized||participants|Number|62|62.0||||||
4078959|NCT01023841|3902026|B2|12-17 years||Age, Customized||participants|Number|20|20.0||||||
4078960|NCT01023841|3902027|B1|12-17 years||Age, Customized||participants|Number|42|42.0||||||
4078961|NCT01023841|3902025|B3|5-11 years||Age, Customized||participants|Number|9|9.0||||||
4078962|NCT01023841|3902026|B2|5-11 years||Age, Customized||participants|Number|3|3.0||||||
4078963|NCT01023841|3902027|B1|5-11 years||Age, Customized||participants|Number|6|6.0||||||
4078964|NCT01023815|3902042|B5|Missing||Result of HCG pregnancy screen - Negative||Participants|Number|81|81.0||||||
4078965|NCT01023815|3902043|B4|Missing||Result of HCG pregnancy screen - Negative||Participants|Number|16|16.0||||||
4078966|NCT01023815|3902044|B3|Missing||Result of HCG pregnancy screen - Negative||Participants|Number|10|10.0||||||
4078967|NCT01023815|3902045|B2|Missing||Result of HCG pregnancy screen - Negative||Participants|Number|9|9.0||||||
4078968|NCT01023815|3902046|B1|Missing||Result of HCG pregnancy screen - Negative||Participants|Number|46|46.0||||||
4078969|NCT01023815|3902042|B5|Negative||Result of HCG pregnancy screen - Negative||Participants|Number|32|32.0||||||
4078970|NCT01023815|3902043|B4|Negative||Result of HCG pregnancy screen - Negative||Participants|Number|4|4.0||||||
4078971|NCT01023815|3902044|B3|Negative||Result of HCG pregnancy screen - Negative||Participants|Number|12|12.0||||||
4078972|NCT01023815|3902045|B2|Negative||Result of HCG pregnancy screen - Negative||Participants|Number|6|6.0||||||
4078973|NCT01023815|3902046|B1|Negative||Result of HCG pregnancy screen - Negative||Participants|Number|10|10.0||||||
4078974|NCT01023815|3902042|B5|Postmenopausal||Female reproductive status||Participants|Number|74|74.0||||||
4078975|NCT01023815|3902043|B4|Postmenopausal||Female reproductive status||Participants|Number|16|16.0||||||
4078976|NCT01023815|3902044|B3|Postmenopausal||Female reproductive status||Participants|Number|8|8.0||||||
4078977|NCT01023815|3902045|B2|Postmenopausal||Female reproductive status||Participants|Number|7|7.0||||||
4078978|NCT01023815|3902046|B1|Postmenopausal||Female reproductive status||Participants|Number|43|43.0||||||
4078979|NCT01023815|3902042|B5|Surgically sterilised||Female reproductive status||Participants|Number|4|4.0||||||
4078980|NCT01023815|3902043|B4|Surgically sterilised||Female reproductive status||Participants|Number|0|0.0||||||
4078981|NCT01023815|3902044|B3|Surgically sterilised||Female reproductive status||Participants|Number|2|2.0||||||
4078982|NCT01023815|3902045|B2|Surgically sterilised||Female reproductive status||Participants|Number|0|0.0||||||
4078983|NCT01023815|3902046|B1|Surgically sterilised||Female reproductive status||Participants|Number|2|2.0||||||
4078984|NCT01023815|3902042|B5|Childbearing potential with contraceptive protecti||Female reproductive status||Participants|Number|35|35.0||||||
4078985|NCT01023815|3902043|B4|Childbearing potential with contraceptive protecti||Female reproductive status||Participants|Number|4|4.0||||||
4078986|NCT01023815|3902044|B3|Childbearing potential with contraceptive protecti||Female reproductive status||Participants|Number|12|12.0||||||
4078987|NCT01023815|3902045|B2|Childbearing potential with contraceptive protecti||Female reproductive status||Participants|Number|8|8.0||||||
4078988|NCT01023815|3902046|B1|Childbearing potential with contraceptive protecti||Female reproductive status||Participants|Number|11|11.0||||||
4078989|NCT01023815|3902042|B5|||BMI||kg/m^2|Mean|24.4|24.4|Standard Deviation|3.4|3.4|||
4078990|NCT01023815|3902043|B4|||BMI||kg/m^2|Mean|24.2|24.2|Standard Deviation|3.6|3.6|||
4078991|NCT01023815|3902044|B3|||BMI||kg/m^2|Mean|24.1|24.1|Standard Deviation|3.3|3.3|||
4078992|NCT01023815|3902045|B2|||BMI||kg/m^2|Mean|24.9|24.9|Standard Deviation|3.6|3.6|||
4078993|NCT01023815|3902046|B1|||BMI||kg/m^2|Mean|24.6|24.6|Standard Deviation|3.4|3.4|||
4078994|NCT01023815|3902042|B5|Missing||Smoking Status||Participants|Number|32|32.0||||||
4078995|NCT01023815|3902043|B4|Missing||Smoking Status||Participants|Number|13|13.0||||||
4078996|NCT01023815|3902044|B3|Missing||Smoking Status||Participants|Number|8|8.0||||||
4078997|NCT01023815|3902045|B2|Missing||Smoking Status||Participants|Number|2|2.0||||||
4078998|NCT01023815|3902046|B1|Missing||Smoking Status||Participants|Number|9|9.0||||||
4078999|NCT01023815|3902042|B5|Yes||Smoking Status||Participants|Number|22|22.0||||||
4079000|NCT01023815|3902043|B4|Yes||Smoking Status||Participants|Number|2|2.0||||||
4079001|NCT01023815|3902044|B3|Yes||Smoking Status||Participants|Number|2|2.0||||||
4079002|NCT01023815|3902045|B2|Yes||Smoking Status||Participants|Number|2|2.0||||||
4079003|NCT01023815|3902046|B1|Yes||Smoking Status||Participants|Number|16|16.0||||||
4079004|NCT01023815|3902042|B5|No||Smoking Status||Participants|Number|274|274.0||||||
4079005|NCT01023815|3902043|B4|No||Smoking Status||Participants|Number|56|56.0||||||
4079006|NCT01023815|3902044|B3|No||Smoking Status||Participants|Number|58|58.0||||||
4079007|NCT01023815|3902045|B2|No||Smoking Status||Participants|Number|41|41.0||||||
4079008|NCT01023815|3902046|B1|No||Smoking Status||Participants|Number|119|119.0||||||
4079009|NCT01023815|3902042|B5|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4079010|NCT01023815|3902043|B4|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4079011|NCT01023815|3902044|B3|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4079012|NCT01023815|3902045|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4079013|NCT01023815|3902046|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4079014|NCT01023815|3902042|B5|Oriental||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4079015|NCT01023815|3902043|B4|Oriental||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4079016|NCT01023815|3902044|B3|Oriental||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4079017|NCT01023815|3902045|B2|Oriental||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4079018|NCT01023815|3902046|B1|Oriental||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4079019|NCT01023815|3902042|B5|Black||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4079020|NCT01023815|3902043|B4|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4079021|NCT01023815|3902044|B3|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4079022|NCT01023815|3902045|B2|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4079023|NCT01023815|3902046|B1|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4079024|NCT01023815|3902042|B5|Caucasian||Race/Ethnicity, Customized||Participants|Number|318|318.0||||||
4079025|NCT01023815|3902043|B4|Caucasian||Race/Ethnicity, Customized||Participants|Number|67|67.0||||||
4079026|NCT01023815|3902044|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|68|68.0||||||
4079027|NCT01023815|3902045|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|44|44.0||||||
4079028|NCT01023815|3902046|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|139|139.0||||||
4079029|NCT01023815|3902042|B5||Male|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
4079030|NCT01023815|3902043|B4||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4079031|NCT01023815|3902044|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4079032|NCT01023815|3902045|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4079033|NCT01023815|3902046|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4079034|NCT01023815|3902042|B5||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4079035|NCT01023815|3902043|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4079036|NCT01023815|3902044|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4079037|NCT01023815|3902045|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4079038|NCT01023815|3902046|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4079039|NCT01023815|3902042|B5|||Age||years|Mean|50.3|50.3|Standard Deviation|12.3|12.3|||
4079040|NCT01023815|3902043|B4|||Age||years|Mean|49.2|49.2|Standard Deviation|13.0|13.0|||
4079041|NCT01023815|3902044|B3|||Age||years|Mean|48.5|48.5|Standard Deviation|11.6|11.6|||
4079042|NCT01023815|3902045|B2|||Age||years|Mean|46.6|46.6|Standard Deviation|13.7|13.7|||
4079043|NCT01023815|3902046|B1|||Age||years|Mean|52.9|52.9|Standard Deviation|11.5|11.5|||
4079044|NCT01023789|3902068|B1|Germany||Region of Enrollment||participants|Number|29|29.0||||||
4079045|NCT01023789|3902068|B1|Australia||Region of Enrollment||participants|Number|62|62.0||||||
4079046|NCT01023789|3902068|B1|Israel||Region of Enrollment||participants|Number|13|13.0||||||
4079047|NCT01023789|3902068|B1|South Africa||Region of Enrollment||participants|Number|4|4.0||||||
4079048|NCT01023789|3902068|B1|Italy||Region of Enrollment||participants|Number|21|21.0||||||
4079049|NCT01023789|3902068|B1|Denmark||Region of Enrollment||participants|Number|15|15.0||||||
4079050|NCT01023789|3902068|B1|Taiwan||Region of Enrollment||participants|Number|74|74.0||||||
4079051|NCT01023789|3902068|B1|Belgium||Region of Enrollment||participants|Number|21|21.0||||||
4079052|NCT01023789|3902068|B1|Canada||Region of Enrollment||participants|Number|27|27.0||||||
4079053|NCT01023789|3902068|B1|New Zealand||Region of Enrollment||participants|Number|23|23.0||||||
4079054|NCT01023789|3902068|B1|Spain||Region of Enrollment||participants|Number|13|13.0||||||
4079055|NCT01023789|3902068|B1|India||Region of Enrollment||participants|Number|100|100.0||||||
4079056|NCT01023789|3902068|B1|Switzerland||Region of Enrollment||participants|Number|13|13.0||||||
4079057|NCT01023789|3902068|B1|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
4079058|NCT01023789|3902068|B1|Japan||Region of Enrollment||participants|Number|40|40.0||||||
4079059|NCT01023789|3902068|B1|Argentina||Region of Enrollment||participants|Number|20|20.0||||||
4079060|NCT01023789|3902068|B1|France||Region of Enrollment||participants|Number|57|57.0||||||
4079061|NCT01023789|3902068|B1|Poland||Region of Enrollment||participants|Number|13|13.0||||||
4079062|NCT01023789|3902068|B1|Brazil||Region of Enrollment||participants|Number|97|97.0||||||
4079063|NCT01023789|3902068|B1|Hong Kong||Region of Enrollment||participants|Number|21|21.0||||||
4079064|NCT01023789|3902068|B1|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
4079065|NCT01023789|3902068|B1|Netherlands||Region of Enrollment||participants|Number|67|67.0||||||
4079066|NCT01023789|3902068|B1|Austria||Region of Enrollment||participants|Number|24|24.0||||||
4079067|NCT01023789|3902068|B1|Malaysia||Region of Enrollment||participants|Number|23|23.0||||||
4079068|NCT01023789|3902068|B1|Singapore||Region of Enrollment||participants|Number|20|20.0||||||
4079069|NCT01023789|3902068|B1||Male|Sex: Female, Male||Participants|Count of Participants|603|603.0||||||
4079070|NCT01023789|3902068|B1||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4079071|NCT01023789|3902068|B1|||Age||years|Mean|61.12|61.12|Standard Deviation|10.75|10.75|||
4079072|NCT01023776|3902135|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4079073|NCT01023776|3902135|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4079074|NCT01023776|3902135|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4079075|NCT01023776|3902135|B1|||Age||years|Mean|26.8|26.8|Standard Deviation|3.41|3.41|||
4079076|NCT01023776|3902135|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4079077|NCT01023776|3902135|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4079078|NCT01023776|3902135|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4079079|NCT01023724|3902140|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4079080|NCT01023724|3902141|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4079081|NCT01023724|3902142|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4079082|NCT01023724|3902140|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4079083|NCT01023724|3902141|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4079084|NCT01023724|3902142|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4079085|NCT01023724|3902140|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4079086|NCT01023724|3902141|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4079087|NCT01023724|3902142|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4079088|NCT01023724|3902140|B3|||Age||years|Mean|71|71.0|Standard Deviation|9|9.0|||
4079089|NCT01023724|3902141|B2|||Age||years|Mean|72|72.0|Standard Deviation|9|9.0|||
4079090|NCT01023724|3902142|B1|||Age||years|Mean|70|70.0|Standard Deviation|8|8.0|||
4079091|NCT01023724|3902140|B3||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
4079092|NCT01023724|3902141|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4079093|NCT01023724|3902142|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4079094|NCT01023724|3902140|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4079095|NCT01023724|3902141|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4079096|NCT01023724|3902142|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4079097|NCT01023724|3902140|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4079098|NCT01023724|3902141|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4079099|NCT01023724|3902142|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4079100|NCT01023711|3902149|B1|United States||Region of Enrollment||participants|Number|107|107.0||||||
4079101|NCT01023711|3902149|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4079102|NCT01023711|3902149|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4079103|NCT01023711|3902149|B1|||Age||years|Mean|54.19626|54.19626|Standard Deviation|21.47638|21.47638|||
4079104|NCT01023711|3902149|B1||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
4079105|NCT01023711|3902149|B1||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4079106|NCT01023711|3902149|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4079107|NCT01023672|3902154|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4079108|NCT01023672|3902154|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4079109|NCT01023672|3902154|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4079110|NCT01023672|3902154|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4079111|NCT01023672|3902154|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4079112|NCT01023672|3902154|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4079113|NCT01023659|3902158|B4|||History of drug or alcohol problem|Self report history of alcohol or drug problem|Participants|Count of Participants|122|122.0||||||
4079114|NCT01023659|3902159|B3|||History of drug or alcohol problem|Self report history of alcohol or drug problem|Participants|Count of Participants|27|27.0||||||
4079115|NCT01023659|3902160|B2|||History of drug or alcohol problem|Self report history of alcohol or drug problem|Participants|Count of Participants|55|55.0||||||
4079116|NCT01023659|3902161|B1|||History of drug or alcohol problem|Self report history of alcohol or drug problem|Participants|Count of Participants|40|40.0||||||
4079117|NCT01023659|3902158|B4|||Lives with other smoker(s)|Yes- lives with other smokers|Participants|Count of Participants|498|498.0||||||
4079118|NCT01023659|3902159|B3|||Lives with other smoker(s)|Yes- lives with other smokers|Participants|Count of Participants|139|139.0||||||
4079119|NCT01023659|3902160|B2|||Lives with other smoker(s)|Yes- lives with other smokers|Participants|Count of Participants|219|219.0||||||
4079120|NCT01023659|3902161|B1|||Lives with other smoker(s)|Yes- lives with other smokers|Participants|Count of Participants|140|140.0||||||
4079121|NCT01023659|3902158|B4|||Participants who report all or most of my friends smoke|self report: Proportion of friends that smoke - all or most of my friends smoke|Participants|Count of Participants|344|344.0||||||
4079122|NCT01023659|3902159|B3|||Participants who report all or most of my friends smoke|self report: Proportion of friends that smoke - all or most of my friends smoke|Participants|Count of Participants|84|84.0||||||
4079123|NCT01023659|3902160|B2|||Participants who report all or most of my friends smoke|self report: Proportion of friends that smoke - all or most of my friends smoke|Participants|Count of Participants|180|180.0||||||
4079124|NCT01023659|3902161|B1|||Participants who report all or most of my friends smoke|self report: Proportion of friends that smoke - all or most of my friends smoke|Participants|Count of Participants|80|80.0||||||
4079125|NCT01023659|3902158|B4||1 week or more|# participants with longest period of abstinence from smoking- less than 1 week|# participants who report longest period of abstinence from smoking of less than 1 week|Participants|Count of Participants|623|623.0||||||
4079126|NCT01023659|3902159|B3||1 week or more|# participants with longest period of abstinence from smoking- less than 1 week|# participants who report longest period of abstinence from smoking of less than 1 week|Participants|Count of Participants|190|190.0||||||
4079127|NCT01023659|3902160|B2||1 week or more|# participants with longest period of abstinence from smoking- less than 1 week|# participants who report longest period of abstinence from smoking of less than 1 week|Participants|Count of Participants|250|250.0||||||
4079128|NCT01023659|3902161|B1||1 week or more|# participants with longest period of abstinence from smoking- less than 1 week|# participants who report longest period of abstinence from smoking of less than 1 week|Participants|Count of Participants|183|183.0||||||
4079129|NCT01023659|3902158|B4||less than 1 week|# participants with longest period of abstinence from smoking- less than 1 week|# participants who report longest period of abstinence from smoking of less than 1 week|Participants|Count of Participants|264|264.0||||||
4079130|NCT01023659|3902159|B3||less than 1 week|# participants with longest period of abstinence from smoking- less than 1 week|# participants who report longest period of abstinence from smoking of less than 1 week|Participants|Count of Participants|74|74.0||||||
4079131|NCT01023659|3902160|B2||less than 1 week|# participants with longest period of abstinence from smoking- less than 1 week|# participants who report longest period of abstinence from smoking of less than 1 week|Participants|Count of Participants|115|115.0||||||
4079132|NCT01023659|3902161|B1||less than 1 week|# participants with longest period of abstinence from smoking- less than 1 week|# participants who report longest period of abstinence from smoking of less than 1 week|Participants|Count of Participants|75|75.0||||||
4079133|NCT01023659|3902158|B4|||# Participants who report previous use of smoking cessation medication|# participants who report previous use of medication for smoking cessation|Participants|Count of Participants|470|470.0||||||
4079134|NCT01023659|3902159|B3|||# Participants who report previous use of smoking cessation medication|# participants who report previous use of medication for smoking cessation|Participants|Count of Participants|142|142.0||||||
4079135|NCT01023659|3902160|B2|||# Participants who report previous use of smoking cessation medication|# participants who report previous use of medication for smoking cessation|Participants|Count of Participants|186|186.0||||||
4079136|NCT01023659|3902161|B1|||# Participants who report previous use of smoking cessation medication|# participants who report previous use of medication for smoking cessation|Participants|Count of Participants|142|142.0||||||
4079137|NCT01023659|3902158|B4|||Confidence in Quitting|10 point scale from: 1- Very little confidence quitting ...to.. 10-Very confident in quitting|units on a scale|Mean|7.7|7.7|Standard Deviation|2.1|2.1|||
4079138|NCT01023659|3902159|B3|||Confidence in Quitting|10 point scale from: 1- Very little confidence quitting ...to.. 10-Very confident in quitting|units on a scale|Mean|7.8|7.8|Standard Deviation|2.0|2.0|||
4079139|NCT01023659|3902160|B2|||Confidence in Quitting|10 point scale from: 1- Very little confidence quitting ...to.. 10-Very confident in quitting|units on a scale|Mean|7.5|7.5|Standard Deviation|2.1|2.1|||
4079140|NCT01023659|3902161|B1|||Confidence in Quitting|10 point scale from: 1- Very little confidence quitting ...to.. 10-Very confident in quitting|units on a scale|Mean|7.8|7.8|Standard Deviation|2.2|2.2|||
4079141|NCT01023659|3902158|B4|||# participants with less than 3 quit attempts||Participants|Count of Participants|478|478.0||||||
4079142|NCT01023659|3902159|B3|||# participants with less than 3 quit attempts||Participants|Count of Participants|118|118.0||||||
4079143|NCT01023659|3902160|B2|||# participants with less than 3 quit attempts||Participants|Count of Participants|220|220.0||||||
4079144|NCT01023659|3902161|B1|||# participants with less than 3 quit attempts||Participants|Count of Participants|140|140.0||||||
4079145|NCT01023659|3902158|B4|||Years since started smoking daily|Mean (SD) years since started smoking daily|years|Mean|27.5|27.5|Standard Deviation|12.2|12.2|||
4079146|NCT01023659|3902159|B3|||Years since started smoking daily|Mean (SD) years since started smoking daily|years|Mean|30.0|30.0|Standard Deviation|12.7|12.7|||
4079147|NCT01023659|3902160|B2|||Years since started smoking daily|Mean (SD) years since started smoking daily|years|Mean|24.2|24.2|Standard Deviation|12.0|12.0|||
4079148|NCT01023659|3902161|B1|||Years since started smoking daily|Mean (SD) years since started smoking daily|years|Mean|29.7|29.7|Standard Deviation|12.1|12.1|||
4079149|NCT01023659|3902158|B4|||# participants who smoke first morning cigarette within 5 minutes|# participants who report smoking first morning cigarette within 5 minutes after waking-up.|Participants|Count of Participants|426|426.0||||||
4079150|NCT01023659|3902159|B3|||# participants who smoke first morning cigarette within 5 minutes|# participants who report smoking first morning cigarette within 5 minutes after waking-up.|Participants|Count of Participants|118|118.0||||||
4079151|NCT01023659|3902160|B2|||# participants who smoke first morning cigarette within 5 minutes|# participants who report smoking first morning cigarette within 5 minutes after waking-up.|Participants|Count of Participants|186|186.0||||||
4079152|NCT01023659|3902161|B1|||# participants who smoke first morning cigarette within 5 minutes|# participants who report smoking first morning cigarette within 5 minutes after waking-up.|Participants|Count of Participants|122|122.0||||||
4079153|NCT01023659|3902158|B4|30 + cpd||# cigarettes smoked per day|# participants in cpd smoking category|participants|Number|131|131.0||||||
4079154|NCT01023659|3902159|B3|30 + cpd||# cigarettes smoked per day|# participants in cpd smoking category|participants|Number|39|39.0||||||
4079155|NCT01023659|3902160|B2|30 + cpd||# cigarettes smoked per day|# participants in cpd smoking category|participants|Number|48|48.0||||||
4079156|NCT01023659|3902161|B1|30 + cpd||# cigarettes smoked per day|# participants in cpd smoking category|participants|Number|44|44.0||||||
4079157|NCT01023659|3902158|B4|20-29 cpd||# cigarettes smoked per day|# participants in cpd smoking category|participants|Number|457|457.0||||||
4079158|NCT01023659|3902159|B3|20-29 cpd||# cigarettes smoked per day|# participants in cpd smoking category|participants|Number|138|138.0||||||
4079159|NCT01023659|3902160|B2|20-29 cpd||# cigarettes smoked per day|# participants in cpd smoking category|participants|Number|186|186.0||||||
4079160|NCT01023659|3902161|B1|20-29 cpd||# cigarettes smoked per day|# participants in cpd smoking category|participants|Number|133|133.0||||||
4079161|NCT01023659|3902158|B4|10-19 cpd||# cigarettes smoked per day|# participants in cpd smoking category|participants|Number|299|299.0||||||
4079162|NCT01023659|3902159|B3|10-19 cpd||# cigarettes smoked per day|# participants in cpd smoking category|participants|Number|87|87.0||||||
4079163|NCT01023659|3902160|B2|10-19 cpd||# cigarettes smoked per day|# participants in cpd smoking category|participants|Number|131|131.0||||||
4079164|NCT01023659|3902161|B1|10-19 cpd||# cigarettes smoked per day|# participants in cpd smoking category|participants|Number|81|81.0||||||
4079165|NCT01023659|3902158|B4|||# Participants currently employed|Number of participants who report being employed|Participants|Count of Participants|472|472.0||||||
4079166|NCT01023659|3902159|B3|||# Participants currently employed|Number of participants who report being employed|Participants|Count of Participants|138|138.0||||||
4079167|NCT01023659|3902160|B2|||# Participants currently employed|Number of participants who report being employed|Participants|Count of Participants|198|198.0||||||
4079168|NCT01023659|3902161|B1|||# Participants currently employed|Number of participants who report being employed|Participants|Count of Participants|136|136.0||||||
4079169|NCT01023659|3902158|B4|||Annual household income:$20,000 or less|number participants with annual income equal or less than $20,000|Participants|Count of Participants|373|373.0||||||
4079170|NCT01023659|3902159|B3|||Annual household income:$20,000 or less|number participants with annual income equal or less than $20,000|Participants|Count of Participants|93|93.0||||||
4079171|NCT01023659|3902160|B2|||Annual household income:$20,000 or less|number participants with annual income equal or less than $20,000|Participants|Count of Participants|164|164.0||||||
4079172|NCT01023659|3902161|B1|||Annual household income:$20,000 or less|number participants with annual income equal or less than $20,000|Participants|Count of Participants|116|116.0||||||
4079173|NCT01023659|3902158|B4|||Education level- less than high school diploma|Number of participants with less than high school diploma|Participants|Count of Participants|211|211.0||||||
4079174|NCT01023659|3902159|B3|||Education level- less than high school diploma|Number of participants with less than high school diploma|Participants|Count of Participants|58|58.0||||||
4079175|NCT01023659|3902160|B2|||Education level- less than high school diploma|Number of participants with less than high school diploma|Participants|Count of Participants|94|94.0||||||
4079176|NCT01023659|3902161|B1|||Education level- less than high school diploma|Number of participants with less than high school diploma|Participants|Count of Participants|59|59.0||||||
4079177|NCT01023659|3902158|B4|Canada||Region of Enrollment||participants|Number|887|887.0||||||
4079178|NCT01023659|3902159|B3|Canada||Region of Enrollment||participants|Number|264|264.0||||||
4079179|NCT01023659|3902160|B2|Canada||Region of Enrollment||participants|Number|365|365.0||||||
4079180|NCT01023659|3902161|B1|Canada||Region of Enrollment||participants|Number|258|258.0||||||
4079181|NCT01023659|3902158|B4||Male|Sex: Female, Male||Participants|Count of Participants|384|384.0||||||
4079182|NCT01023659|3902159|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4079183|NCT01023659|3902160|B2||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4079184|NCT01023659|3902161|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4079185|NCT01023659|3902158|B4||Female|Sex: Female, Male||Participants|Count of Participants|503|503.0||||||
4079186|NCT01023659|3902159|B3||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4079187|NCT01023659|3902160|B2||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4079188|NCT01023659|3902161|B1||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4079189|NCT01023659|3902158|B4|||Age||years|Mean|41.9|41.9|Standard Deviation|12.3|12.3|||
4079190|NCT01023659|3902159|B3|||Age||years|Mean|44.0|44.0|Standard Deviation|12.8|12.8|||
4079191|NCT01023659|3902160|B2|||Age||years|Mean|38.6|38.6|Standard Deviation|12.0|12.0|||
4079192|NCT01023659|3902161|B1|||Age||years|Mean|44.4|44.4|Standard Deviation|12.2|12.2|||
4079193|NCT01023581|3902172|B8|>8.5%||Baseline HbA1c|The count for baseline HbA1c category is based on HbA1c value used in randomization for stratification.|participants|Number|319|319.0||||||
4079194|NCT01023581|3902173|B7|>8.5%||Baseline HbA1c|The count for baseline HbA1c category is based on HbA1c value used in randomization for stratification.|participants|Number|47|47.0||||||
4079195|NCT01023581|3902174|B6|>8.5%||Baseline HbA1c|The count for baseline HbA1c category is based on HbA1c value used in randomization for stratification.|participants|Number|45|45.0||||||
4079196|NCT01023581|3902175|B5|>8.5%||Baseline HbA1c|The count for baseline HbA1c category is based on HbA1c value used in randomization for stratification.|participants|Number|45|45.0||||||
4079197|NCT01023581|3902176|B4|>8.5%||Baseline HbA1c|The count for baseline HbA1c category is based on HbA1c value used in randomization for stratification.|participants|Number|47|47.0||||||
4079198|NCT01023581|3902177|B3|>8.5%||Baseline HbA1c|The count for baseline HbA1c category is based on HbA1c value used in randomization for stratification.|participants|Number|46|46.0||||||
4079199|NCT01023581|3902178|B2|>8.5%||Baseline HbA1c|The count for baseline HbA1c category is based on HbA1c value used in randomization for stratification.|participants|Number|45|45.0||||||
4079200|NCT01023581|3902179|B1|>8.5%||Baseline HbA1c|The count for baseline HbA1c category is based on HbA1c value used in randomization for stratification.|participants|Number|44|44.0||||||
4079201|NCT01023581|3902172|B8|≤8.5%||Baseline HbA1c|The count for baseline HbA1c category is based on HbA1c value used in randomization for stratification.|participants|Number|465|465.0||||||
4079202|NCT01023581|3902173|B7|≤8.5%||Baseline HbA1c|The count for baseline HbA1c category is based on HbA1c value used in randomization for stratification.|participants|Number|67|67.0||||||
4079203|NCT01023581|3902174|B6|≤8.5%||Baseline HbA1c|The count for baseline HbA1c category is based on HbA1c value used in randomization for stratification.|participants|Number|66|66.0||||||
4079204|NCT01023581|3902175|B5|≤8.5%||Baseline HbA1c|The count for baseline HbA1c category is based on HbA1c value used in randomization for stratification.|participants|Number|66|66.0||||||
4079205|NCT01023581|3902176|B4|≤8.5%||Baseline HbA1c|The count for baseline HbA1c category is based on HbA1c value used in randomization for stratification.|participants|Number|67|67.0||||||
4079206|NCT01023581|3902177|B3|≤8.5%||Baseline HbA1c|The count for baseline HbA1c category is based on HbA1c value used in randomization for stratification.|participants|Number|67|67.0||||||
4079207|NCT01023581|3902178|B2|≤8.5%||Baseline HbA1c|The count for baseline HbA1c category is based on HbA1c value used in randomization for stratification.|participants|Number|67|67.0||||||
4079208|NCT01023581|3902179|B1|≤8.5%||Baseline HbA1c|The count for baseline HbA1c category is based on HbA1c value used in randomization for stratification.|participants|Number|65|65.0||||||
4079209|NCT01023581|3902172|B8|||Diabetes Duration||years|Mean|4.01|4.01|Standard Deviation|4.563|4.563|||
4079210|NCT01023581|3902173|B7|||Diabetes Duration||years|Mean|4.22|4.22|Standard Deviation|4.972|4.972|||
4079211|NCT01023581|3902174|B6|||Diabetes Duration||years|Mean|4.13|4.13|Standard Deviation|4.777|4.777|||
4079212|NCT01023581|3902175|B5|||Diabetes Duration||years|Mean|4.08|4.08|Standard Deviation|4.587|4.587|||
4079213|NCT01023581|3902176|B4|||Diabetes Duration||years|Mean|3.78|3.78|Standard Deviation|3.904|3.904|||
4079214|NCT01023581|3902177|B3|||Diabetes Duration||years|Mean|3.97|3.97|Standard Deviation|4.800|4.8|||
4079215|NCT01023581|3902178|B2|||Diabetes Duration||years|Mean|3.65|3.65|Standard Deviation|4.119|4.119|||
4079216|NCT01023581|3902179|B1|||Diabetes Duration||years|Mean|4.25|4.25|Standard Deviation|4.778|4.778|||
4079217|NCT01023581|3902172|B8|||Body Mass Index (BMI)||kg/m^2|Mean|30.71|30.71|Standard Deviation|5.173|5.173|||
4079218|NCT01023581|3902173|B7|||Body Mass Index (BMI)||kg/m^2|Mean|31.04|31.04|Standard Deviation|5.375|5.375|||
4079219|NCT01023581|3902174|B6|||Body Mass Index (BMI)||kg/m^2|Mean|30.92|30.92|Standard Deviation|5.353|5.353|||
4079220|NCT01023581|3902175|B5|||Body Mass Index (BMI)||kg/m^2|Mean|30.51|30.51|Standard Deviation|5.043|5.043|||
4079221|NCT01023581|3902176|B4|||Body Mass Index (BMI)||kg/m^2|Mean|30.19|30.19|Standard Deviation|4.842|4.842|||
4079222|NCT01023581|3902177|B3|||Body Mass Index (BMI)||kg/m^2|Mean|30.36|30.36|Standard Deviation|5.159|5.159|||
4079223|NCT01023581|3902178|B2|||Body Mass Index (BMI)||kg/m^2|Mean|30.81|30.81|Standard Deviation|5.219|5.219|||
4079224|NCT01023581|3902179|B1|||Body Mass Index (BMI)||kg/m^2|Mean|31.15|31.15|Standard Deviation|5.269|5.269|||
4079225|NCT01023581|3902172|B8|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4079226|NCT01023581|3902173|B7|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4079227|NCT01023581|3902174|B6|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4079228|NCT01023581|3902175|B5|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4079229|NCT01023581|3902176|B4|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4079230|NCT01023581|3902177|B3|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4079231|NCT01023581|3902178|B2|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4079232|NCT01023581|3902179|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4079233|NCT01023581|3902172|B8|White||Race/Ethnicity, Customized||participants|Number|561|561.0||||||
4079234|NCT01023581|3902173|B7|White||Race/Ethnicity, Customized||participants|Number|78|78.0||||||
4079235|NCT01023581|3902174|B6|White||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
4079236|NCT01023581|3902175|B5|White||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
4079237|NCT01023581|3902176|B4|White||Race/Ethnicity, Customized||participants|Number|85|85.0||||||
4079238|NCT01023581|3902177|B3|White||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
4079239|NCT01023581|3902178|B2|White||Race/Ethnicity, Customized||participants|Number|84|84.0||||||
4079240|NCT01023581|3902179|B1|White||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
4079241|NCT01023581|3902172|B8|Black or African American||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4079242|NCT01023581|3902173|B7|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4079243|NCT01023581|3902174|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4079244|NCT01023581|3902175|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4079245|NCT01023581|3902176|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4079246|NCT01023581|3902177|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4079247|NCT01023581|3902178|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4079248|NCT01023581|3902179|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4079249|NCT01023581|3902172|B8|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4079250|NCT01023581|3902173|B7|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4079251|NCT01023581|3902174|B6|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4079252|NCT01023581|3902175|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4079253|NCT01023581|3902176|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4079254|NCT01023581|3902177|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4079255|NCT01023581|3902178|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4079256|NCT01023581|3902179|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4079257|NCT01023581|3902172|B8|Asian||Race/Ethnicity, Customized||participants|Number|143|143.0||||||
4079258|NCT01023581|3902173|B7|Asian||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4079259|NCT01023581|3902174|B6|Asian||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4079260|NCT01023581|3902175|B5|Asian||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4079261|NCT01023581|3902176|B4|Asian||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4079262|NCT01023581|3902177|B3|Asian||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4079263|NCT01023581|3902178|B2|Asian||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4079264|NCT01023581|3902179|B1|Asian||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4079265|NCT01023581|3902172|B8|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4079266|NCT01023581|3902173|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4079267|NCT01023581|3902174|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4079268|NCT01023581|3902175|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4079269|NCT01023581|3902176|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4079270|NCT01023581|3902177|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4079271|NCT01023581|3902178|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4079272|NCT01023581|3902179|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4079273|NCT01023581|3902172|B8|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|482|482.0||||||
4079274|NCT01023581|3902173|B7|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|75|75.0||||||
4079275|NCT01023581|3902174|B6|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
4079276|NCT01023581|3902175|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
4079277|NCT01023581|3902176|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
4079278|NCT01023581|3902177|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
4079279|NCT01023581|3902178|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
4079280|NCT01023581|3902179|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|64|64.0||||||
4079281|NCT01023581|3902172|B8|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|302|302.0||||||
4079282|NCT01023581|3902173|B7|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4079283|NCT01023581|3902174|B6|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4079284|NCT01023581|3902175|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4079285|NCT01023581|3902176|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4079286|NCT01023581|3902177|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4079287|NCT01023581|3902178|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4079288|NCT01023581|3902179|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4079289|NCT01023581|3902172|B8||Male|Sex: Female, Male||Participants|Count of Participants|374|374.0||||||
4079290|NCT01023581|3902173|B7||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4079291|NCT01023581|3902174|B6||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4079292|NCT01023581|3902175|B5||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4079293|NCT01023581|3902176|B4||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4079294|NCT01023581|3902177|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4079295|NCT01023581|3902178|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4079296|NCT01023581|3902179|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4079297|NCT01023581|3902172|B8||Female|Sex: Female, Male||Participants|Count of Participants|410|410.0||||||
4079298|NCT01023581|3902173|B7||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4079299|NCT01023581|3902174|B6||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4079300|NCT01023581|3902175|B5||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4079301|NCT01023581|3902176|B4||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4079302|NCT01023581|3902177|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4079303|NCT01023581|3902178|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4079304|NCT01023581|3902179|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4079305|NCT01023581|3902172|B8|≥65 years||Age, Customized||participants|Number|109|109.0||||||
4079306|NCT01023581|3902173|B7|≥65 years||Age, Customized||participants|Number|18|18.0||||||
4079307|NCT01023581|3902174|B6|≥65 years||Age, Customized||participants|Number|20|20.0||||||
4079308|NCT01023581|3902175|B5|≥65 years||Age, Customized||participants|Number|17|17.0||||||
4079309|NCT01023581|3902176|B4|≥65 years||Age, Customized||participants|Number|19|19.0||||||
4079310|NCT01023581|3902177|B3|≥65 years||Age, Customized||participants|Number|17|17.0||||||
4079311|NCT01023581|3902178|B2|≥65 years||Age, Customized||participants|Number|9|9.0||||||
4079312|NCT01023581|3902179|B1|≥65 years||Age, Customized||participants|Number|9|9.0||||||
4079313|NCT01023581|3902172|B8|<65 years||Age, Customized||participants|Number|675|675.0||||||
4079314|NCT01023581|3902173|B7|<65 years||Age, Customized||participants|Number|96|96.0||||||
4079315|NCT01023581|3902174|B6|<65 years||Age, Customized||participants|Number|91|91.0||||||
4079316|NCT01023581|3902175|B5|<65 years||Age, Customized||participants|Number|94|94.0||||||
4079317|NCT01023581|3902176|B4|<65 years||Age, Customized||participants|Number|95|95.0||||||
4079318|NCT01023581|3902177|B3|<65 years||Age, Customized||participants|Number|96|96.0||||||
4079319|NCT01023581|3902178|B2|<65 years||Age, Customized||participants|Number|103|103.0||||||
4079320|NCT01023581|3902179|B1|<65 years||Age, Customized||participants|Number|100|100.0||||||
4079321|NCT01023581|3902172|B8|||Age||years|Mean|53.5|53.5|Standard Deviation|10.33|10.33|||
4079322|NCT01023581|3902173|B7|||Age||years|Mean|54.6|54.6|Standard Deviation|10.42|10.42|||
4079323|NCT01023581|3902174|B6|||Age||years|Mean|53.7|53.7|Standard Deviation|11.59|11.59|||
4079324|NCT01023581|3902175|B5|||Age||years|Mean|52.6|52.6|Standard Deviation|11.30|11.3|||
4079325|NCT01023581|3902176|B4|||Age||years|Mean|54.6|54.6|Standard Deviation|10.20|10.2|||
4079326|NCT01023581|3902177|B3|||Age||years|Mean|53.7|53.7|Standard Deviation|9.70|9.7|||
4079327|NCT01023581|3902178|B2|||Age||years|Mean|52.6|52.6|Standard Deviation|9.38|9.38|||
4079328|NCT01023581|3902179|B1|||Age||years|Mean|53.1|53.1|Standard Deviation|9.60|9.6|||
4079329|NCT01023568|3902215|B4|III: A patient with severe systemic disease||ASA physical status||participants|Number|4|4.0||||||
4079330|NCT01023568|3902216|B3|III: A patient with severe systemic disease||ASA physical status||participants|Number|1|1.0||||||
4079331|NCT01023568|3902217|B2|III: A patient with severe systemic disease||ASA physical status||participants|Number|1|1.0||||||
4079332|NCT01023568|3902218|B1|III: A patient with severe systemic disease||ASA physical status||participants|Number|2|2.0||||||
4079333|NCT01023568|3902215|B4|II: A patient with mild systemic disease||ASA physical status||participants|Number|72|72.0||||||
4079334|NCT01023568|3902216|B3|II: A patient with mild systemic disease||ASA physical status||participants|Number|25|25.0||||||
4079448|NCT01023256|3902353|B4|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
4079335|NCT01023568|3902217|B2|II: A patient with mild systemic disease||ASA physical status||participants|Number|23|23.0||||||
4079336|NCT01023568|3902218|B1|II: A patient with mild systemic disease||ASA physical status||participants|Number|24|24.0||||||
4079337|NCT01023568|3902215|B4|I: A normal healthy patient||ASA physical status||participants|Number|58|58.0||||||
4079338|NCT01023568|3902216|B3|I: A normal healthy patient||ASA physical status||participants|Number|19|19.0||||||
4079339|NCT01023568|3902217|B2|I: A normal healthy patient||ASA physical status||participants|Number|20|20.0||||||
4079340|NCT01023568|3902218|B1|I: A normal healthy patient||ASA physical status||participants|Number|19|19.0||||||
4079341|NCT01023568|3902215|B4|||Body mass index||kg/m2|Median|16.5|16.5|Inter-Quartile Range|||15.4|18.8|
4079342|NCT01023568|3902216|B3|||Body mass index||kg/m2|Median|16|16.0|Inter-Quartile Range|||16.0|18.0|
4079343|NCT01023568|3902217|B2|||Body mass index||kg/m2|Median|16|16.0|Inter-Quartile Range|||15.0|18.0|
4079344|NCT01023568|3902218|B1|||Body mass index||kg/m2|Median|17|17.0|Inter-Quartile Range|||15.0|19.0|
4079345|NCT01023568|3902215|B4||Male|Gender||Participants|Count of Participants|93|93.0||||||
4079346|NCT01023568|3902216|B3||Male|Gender||Participants|Count of Participants|31|31.0||||||
4079347|NCT01023568|3902217|B2||Male|Gender||Participants|Count of Participants|33|33.0||||||
4079348|NCT01023568|3902218|B1||Male|Gender||Participants|Count of Participants|29|29.0||||||
4079349|NCT01023568|3902215|B4||Female|Gender||Participants|Count of Participants|41|41.0||||||
4079350|NCT01023568|3902216|B3||Female|Gender||Participants|Count of Participants|14|14.0||||||
4079351|NCT01023568|3902217|B2||Female|Gender||Participants|Count of Participants|11|11.0||||||
4079352|NCT01023568|3902218|B1||Female|Gender||Participants|Count of Participants|16|16.0||||||
4079353|NCT01023568|3902215|B4|||Age||years|Mean|4.6|4.6|Standard Deviation|2.8|2.8|||
4079354|NCT01023568|3902216|B3|||Age||years|Mean|5.2|5.2|Standard Deviation|2.8|2.8|||
4079355|NCT01023568|3902217|B2|||Age||years|Mean|4.6|4.6|Standard Deviation|2.7|2.7|||
4079356|NCT01023568|3902218|B1|||Age||years|Mean|4.0|4.0|Standard Deviation|2.8|2.8|||
4079357|NCT01023516|3902240|B3||Male|Sex: Female, Male||Participants|Count of Participants|454|454.0||||||
4079358|NCT01023516|3902241|B2||Male|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
4079359|NCT01023516|3902242|B1||Male|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
4079360|NCT01023516|3902240|B3||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4079361|NCT01023516|3902241|B2||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4079362|NCT01023516|3902242|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4079363|NCT01023516|3902240|B3|||Age||Years|Median|61.5|61.5|Full Range|||41.0|80.0|
4079364|NCT01023516|3902241|B2|||Age||Years|Median|61|61.0|Full Range|||41.0|79.0|
4079365|NCT01023516|3902242|B1|||Age||Years|Median|62|62.0|Full Range|||42.0|80.0|
4079366|NCT01023308|3902323|B3|Other||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4079367|NCT01023308|3902324|B2|Other||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4079368|NCT01023308|3902325|B1|Other||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4079369|NCT01023308|3902323|B3|Black||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4079370|NCT01023308|3902324|B2|Black||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4079371|NCT01023308|3902325|B1|Black||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4079372|NCT01023308|3902323|B3|Asian||Race/Ethnicity, Customized||Participants|Number|232|232.0||||||
4079373|NCT01023308|3902324|B2|Asian||Race/Ethnicity, Customized||Participants|Number|104|104.0||||||
4079374|NCT01023308|3902325|B1|Asian||Race/Ethnicity, Customized||Participants|Number|128|128.0||||||
4079375|NCT01023308|3902323|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|499|499.0||||||
4079376|NCT01023308|3902324|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|250|250.0||||||
4079377|NCT01023308|3902325|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|249|249.0||||||
4079378|NCT01023308|3902323|B3||Male|Gender||Participants|Count of Participants|407|407.0||||||
4079379|NCT01023308|3902324|B2||Male|Gender||Participants|Count of Participants|205|205.0||||||
4079380|NCT01023308|3902325|B1||Male|Gender||Participants|Count of Participants|202|202.0||||||
4079381|NCT01023308|3902323|B3||Female|Gender||Participants|Count of Participants|361|361.0||||||
4079382|NCT01023308|3902324|B2||Female|Gender||Participants|Count of Participants|176|176.0||||||
4079383|NCT01023308|3902325|B1||Female|Gender||Participants|Count of Participants|185|185.0||||||
4079384|NCT01023308|3902323|B3|||Age||years|Mean|62.1|62.1|Standard Deviation|9.38|9.38|||
4079385|NCT01023308|3902324|B2|||Age||years|Mean|61.8|61.8|Standard Deviation|9.43|9.43|||
4079386|NCT01023308|3902325|B1|||Age||years|Mean|62.4|62.4|Standard Deviation|9.34|9.34|||
4079387|NCT01023256|3902352|B5|Not treated with concomitant non-biologic DMARDs||Concomitant medication with non-biologic disease-modifying antirheumatic drugs (DMARDs)|Concomitant medication with non-biologic disease-modifying antirheumatic drugs at baseline|participants|Number|10|10.0||||||
4079388|NCT01023256|3902353|B4|Not treated with concomitant non-biologic DMARDs||Concomitant medication with non-biologic disease-modifying antirheumatic drugs (DMARDs)|Concomitant medication with non-biologic disease-modifying antirheumatic drugs at baseline|participants|Number|1|1.0||||||
4079389|NCT01023256|3902354|B3|Not treated with concomitant non-biologic DMARDs||Concomitant medication with non-biologic disease-modifying antirheumatic drugs (DMARDs)|Concomitant medication with non-biologic disease-modifying antirheumatic drugs at baseline|participants|Number|2|2.0||||||
4079390|NCT01023256|3902355|B2|Not treated with concomitant non-biologic DMARDs||Concomitant medication with non-biologic disease-modifying antirheumatic drugs (DMARDs)|Concomitant medication with non-biologic disease-modifying antirheumatic drugs at baseline|participants|Number|5|5.0||||||
4079449|NCT01023256|3902354|B3|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4079391|NCT01023256|3902356|B1|Not treated with concomitant non-biologic DMARDs||Concomitant medication with non-biologic disease-modifying antirheumatic drugs (DMARDs)|Concomitant medication with non-biologic disease-modifying antirheumatic drugs at baseline|participants|Number|2|2.0||||||
4079392|NCT01023256|3902352|B5|Treated with concomitant non-biologic DMARDs||Concomitant medication with non-biologic disease-modifying antirheumatic drugs (DMARDs)|Concomitant medication with non-biologic disease-modifying antirheumatic drugs at baseline|participants|Number|86|86.0||||||
4079393|NCT01023256|3902353|B4|Treated with concomitant non-biologic DMARDs||Concomitant medication with non-biologic disease-modifying antirheumatic drugs (DMARDs)|Concomitant medication with non-biologic disease-modifying antirheumatic drugs at baseline|participants|Number|26|26.0||||||
4079394|NCT01023256|3902354|B3|Treated with concomitant non-biologic DMARDs||Concomitant medication with non-biologic disease-modifying antirheumatic drugs (DMARDs)|Concomitant medication with non-biologic disease-modifying antirheumatic drugs at baseline|participants|Number|21|21.0||||||
4079395|NCT01023256|3902355|B2|Treated with concomitant non-biologic DMARDs||Concomitant medication with non-biologic disease-modifying antirheumatic drugs (DMARDs)|Concomitant medication with non-biologic disease-modifying antirheumatic drugs at baseline|participants|Number|17|17.0||||||
4079396|NCT01023256|3902356|B1|Treated with concomitant non-biologic DMARDs||Concomitant medication with non-biologic disease-modifying antirheumatic drugs (DMARDs)|Concomitant medication with non-biologic disease-modifying antirheumatic drugs at baseline|participants|Number|22|22.0||||||
4079397|NCT01023256|3902352|B5|Not treated with prior TNF inhibitors||Prior medication with tumor necrosis factor (TNF) inhibitors|Medication with tumour necrosis factor inhibitors in the 3 months prior to screening|participants|Number|93|93.0||||||
4079398|NCT01023256|3902353|B4|Not treated with prior TNF inhibitors||Prior medication with tumor necrosis factor (TNF) inhibitors|Medication with tumour necrosis factor inhibitors in the 3 months prior to screening|participants|Number|25|25.0||||||
4079399|NCT01023256|3902354|B3|Not treated with prior TNF inhibitors||Prior medication with tumor necrosis factor (TNF) inhibitors|Medication with tumour necrosis factor inhibitors in the 3 months prior to screening|participants|Number|23|23.0||||||
4079400|NCT01023256|3902355|B2|Not treated with prior TNF inhibitors||Prior medication with tumor necrosis factor (TNF) inhibitors|Medication with tumour necrosis factor inhibitors in the 3 months prior to screening|participants|Number|22|22.0||||||
4079401|NCT01023256|3902356|B1|Not treated with prior TNF inhibitors||Prior medication with tumor necrosis factor (TNF) inhibitors|Medication with tumour necrosis factor inhibitors in the 3 months prior to screening|participants|Number|23|23.0||||||
4079402|NCT01023256|3902352|B5|Treated with prior TNF inhibitors||Prior medication with tumor necrosis factor (TNF) inhibitors|Medication with tumour necrosis factor inhibitors in the 3 months prior to screening|participants|Number|3|3.0||||||
4079403|NCT01023256|3902353|B4|Treated with prior TNF inhibitors||Prior medication with tumor necrosis factor (TNF) inhibitors|Medication with tumour necrosis factor inhibitors in the 3 months prior to screening|participants|Number|2|2.0||||||
4079404|NCT01023256|3902354|B3|Treated with prior TNF inhibitors||Prior medication with tumor necrosis factor (TNF) inhibitors|Medication with tumour necrosis factor inhibitors in the 3 months prior to screening|participants|Number|0|0.0||||||
4079405|NCT01023256|3902355|B2|Treated with prior TNF inhibitors||Prior medication with tumor necrosis factor (TNF) inhibitors|Medication with tumour necrosis factor inhibitors in the 3 months prior to screening|participants|Number|0|0.0||||||
4079406|NCT01023256|3902356|B1|Treated with prior TNF inhibitors||Prior medication with tumor necrosis factor (TNF) inhibitors|Medication with tumour necrosis factor inhibitors in the 3 months prior to screening|participants|Number|1|1.0||||||
4079407|NCT01023256|3902352|B5|Not treated with prior non-biologic DMARDs||Prior medication with non-biologic disease-modifying antirheumatic drugs (DMARDs)|Medication with non-biologic disease-modifying drugs in the 3 months prior to screening|participants|Number|22|22.0||||||
4079408|NCT01023256|3902353|B4|Not treated with prior non-biologic DMARDs||Prior medication with non-biologic disease-modifying antirheumatic drugs (DMARDs)|Medication with non-biologic disease-modifying drugs in the 3 months prior to screening|participants|Number|6|6.0||||||
4079409|NCT01023256|3902354|B3|Not treated with prior non-biologic DMARDs||Prior medication with non-biologic disease-modifying antirheumatic drugs (DMARDs)|Medication with non-biologic disease-modifying drugs in the 3 months prior to screening|participants|Number|3|3.0||||||
4079410|NCT01023256|3902355|B2|Not treated with prior non-biologic DMARDs||Prior medication with non-biologic disease-modifying antirheumatic drugs (DMARDs)|Medication with non-biologic disease-modifying drugs in the 3 months prior to screening|participants|Number|7|7.0||||||
4079411|NCT01023256|3902356|B1|Not treated with prior non-biologic DMARDs||Prior medication with non-biologic disease-modifying antirheumatic drugs (DMARDs)|Medication with non-biologic disease-modifying drugs in the 3 months prior to screening|participants|Number|6|6.0||||||
4079412|NCT01023256|3902352|B5|Treated with prior non-biologic DMARDs||Prior medication with non-biologic disease-modifying antirheumatic drugs (DMARDs)|Medication with non-biologic disease-modifying drugs in the 3 months prior to screening|participants|Number|74|74.0||||||
4079413|NCT01023256|3902353|B4|Treated with prior non-biologic DMARDs||Prior medication with non-biologic disease-modifying antirheumatic drugs (DMARDs)|Medication with non-biologic disease-modifying drugs in the 3 months prior to screening|participants|Number|21|21.0||||||
4079414|NCT01023256|3902354|B3|Treated with prior non-biologic DMARDs||Prior medication with non-biologic disease-modifying antirheumatic drugs (DMARDs)|Medication with non-biologic disease-modifying drugs in the 3 months prior to screening|participants|Number|20|20.0||||||
4079415|NCT01023256|3902355|B2|Treated with prior non-biologic DMARDs||Prior medication with non-biologic disease-modifying antirheumatic drugs (DMARDs)|Medication with non-biologic disease-modifying drugs in the 3 months prior to screening|participants|Number|15|15.0||||||
4079416|NCT01023256|3902356|B1|Treated with prior non-biologic DMARDs||Prior medication with non-biologic disease-modifying antirheumatic drugs (DMARDs)|Medication with non-biologic disease-modifying drugs in the 3 months prior to screening|participants|Number|18|18.0||||||
4079417|NCT01023256|3902352|B5|Missing||Rheumatoid factor (RF) status|Defined as RF levels >13.9 IU/mL. One patient in the MOR103 1.0 mg/kg group and one patient in the pooled placebo group had missing data.|participants|Number|2|2.0||||||
4079450|NCT01023256|3902355|B2|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4079418|NCT01023256|3902353|B4|Missing||Rheumatoid factor (RF) status|Defined as RF levels >13.9 IU/mL. One patient in the MOR103 1.0 mg/kg group and one patient in the pooled placebo group had missing data.|participants|Number|1|1.0||||||
4079419|NCT01023256|3902354|B3|Missing||Rheumatoid factor (RF) status|Defined as RF levels >13.9 IU/mL. One patient in the MOR103 1.0 mg/kg group and one patient in the pooled placebo group had missing data.|participants|Number|0|0.0||||||
4079420|NCT01023256|3902355|B2|Missing||Rheumatoid factor (RF) status|Defined as RF levels >13.9 IU/mL. One patient in the MOR103 1.0 mg/kg group and one patient in the pooled placebo group had missing data.|participants|Number|1|1.0||||||
4079421|NCT01023256|3902356|B1|Missing||Rheumatoid factor (RF) status|Defined as RF levels >13.9 IU/mL. One patient in the MOR103 1.0 mg/kg group and one patient in the pooled placebo group had missing data.|participants|Number|0|0.0||||||
4079422|NCT01023256|3902352|B5|RF negative||Rheumatoid factor (RF) status|Defined as RF levels >13.9 IU/mL. One patient in the MOR103 1.0 mg/kg group and one patient in the pooled placebo group had missing data.|participants|Number|10|10.0||||||
4079423|NCT01023256|3902353|B4|RF negative||Rheumatoid factor (RF) status|Defined as RF levels >13.9 IU/mL. One patient in the MOR103 1.0 mg/kg group and one patient in the pooled placebo group had missing data.|participants|Number|1|1.0||||||
4079424|NCT01023256|3902354|B3|RF negative||Rheumatoid factor (RF) status|Defined as RF levels >13.9 IU/mL. One patient in the MOR103 1.0 mg/kg group and one patient in the pooled placebo group had missing data.|participants|Number|4|4.0||||||
4079425|NCT01023256|3902355|B2|RF negative||Rheumatoid factor (RF) status|Defined as RF levels >13.9 IU/mL. One patient in the MOR103 1.0 mg/kg group and one patient in the pooled placebo group had missing data.|participants|Number|2|2.0||||||
4079426|NCT01023256|3902356|B1|RF negative||Rheumatoid factor (RF) status|Defined as RF levels >13.9 IU/mL. One patient in the MOR103 1.0 mg/kg group and one patient in the pooled placebo group had missing data.|participants|Number|3|3.0||||||
4079427|NCT01023256|3902352|B5|RF positive||Rheumatoid factor (RF) status|Defined as RF levels >13.9 IU/mL. One patient in the MOR103 1.0 mg/kg group and one patient in the pooled placebo group had missing data.|participants|Number|84|84.0||||||
4079428|NCT01023256|3902353|B4|RF positive||Rheumatoid factor (RF) status|Defined as RF levels >13.9 IU/mL. One patient in the MOR103 1.0 mg/kg group and one patient in the pooled placebo group had missing data.|participants|Number|25|25.0||||||
4079429|NCT01023256|3902354|B3|RF positive||Rheumatoid factor (RF) status|Defined as RF levels >13.9 IU/mL. One patient in the MOR103 1.0 mg/kg group and one patient in the pooled placebo group had missing data.|participants|Number|19|19.0||||||
4079430|NCT01023256|3902355|B2|RF positive||Rheumatoid factor (RF) status|Defined as RF levels >13.9 IU/mL. One patient in the MOR103 1.0 mg/kg group and one patient in the pooled placebo group had missing data.|participants|Number|19|19.0||||||
4079431|NCT01023256|3902356|B1|RF positive||Rheumatoid factor (RF) status|Defined as RF levels >13.9 IU/mL. One patient in the MOR103 1.0 mg/kg group and one patient in the pooled placebo group had missing data.|participants|Number|21|21.0||||||
4079432|NCT01023256|3902352|B5|||Disease Activity Score based on 28 joints and erythrocyte sedimentation rate (DAS28-ESR)|The Disease Activity Score is a measure of overall disease activity and was calculated using 28 joints (DAS28) and the erythrocyte sedimentation rate (ESR) as the acute phase reactant (0 = no disease activity; 9.3 = maximal disease activity). In the MOR103 1.0 mg/kg group, one patient had missing data so the mean was calculated on 21 patients.|units on a scale|Mean|4.86|4.86|Standard Deviation|0.50|0.5|||
4079433|NCT01023256|3902353|B4|||Disease Activity Score based on 28 joints and erythrocyte sedimentation rate (DAS28-ESR)|The Disease Activity Score is a measure of overall disease activity and was calculated using 28 joints (DAS28) and the erythrocyte sedimentation rate (ESR) as the acute phase reactant (0 = no disease activity; 9.3 = maximal disease activity). In the MOR103 1.0 mg/kg group, one patient had missing data so the mean was calculated on 21 patients.|units on a scale|Mean|4.88|4.88|Standard Deviation|0.41|0.41|||
4079434|NCT01023256|3902354|B3|||Disease Activity Score based on 28 joints and erythrocyte sedimentation rate (DAS28-ESR)|The Disease Activity Score is a measure of overall disease activity and was calculated using 28 joints (DAS28) and the erythrocyte sedimentation rate (ESR) as the acute phase reactant (0 = no disease activity; 9.3 = maximal disease activity). In the MOR103 1.0 mg/kg group, one patient had missing data so the mean was calculated on 21 patients.|units on a scale|Mean|4.87|4.87|Standard Deviation|0.38|0.38|||
4079435|NCT01023256|3902355|B2|||Disease Activity Score based on 28 joints and erythrocyte sedimentation rate (DAS28-ESR)|The Disease Activity Score is a measure of overall disease activity and was calculated using 28 joints (DAS28) and the erythrocyte sedimentation rate (ESR) as the acute phase reactant (0 = no disease activity; 9.3 = maximal disease activity). In the MOR103 1.0 mg/kg group, one patient had missing data so the mean was calculated on 21 patients.|units on a scale|Mean|4.78|4.78|Standard Deviation|0.66|0.66|||
4079436|NCT01023256|3902356|B1|||Disease Activity Score based on 28 joints and erythrocyte sedimentation rate (DAS28-ESR)|The Disease Activity Score is a measure of overall disease activity and was calculated using 28 joints (DAS28) and the erythrocyte sedimentation rate (ESR) as the acute phase reactant (0 = no disease activity; 9.3 = maximal disease activity). In the MOR103 1.0 mg/kg group, one patient had missing data so the mean was calculated on 21 patients.|units on a scale|Mean|4.88|4.88|Standard Deviation|0.54|0.54|||
4079437|NCT01023256|3902352|B5|||Body mass index||kg/m2|Mean|26.1|26.1|Standard Deviation|4.1|4.1|||
4079438|NCT01023256|3902353|B4|||Body mass index||kg/m2|Mean|26.3|26.3|Standard Deviation|3.5|3.5|||
4079439|NCT01023256|3902354|B3|||Body mass index||kg/m2|Mean|25.7|25.7|Standard Deviation|4.7|4.7|||
4079440|NCT01023256|3902355|B2|||Body mass index||kg/m2|Mean|26.1|26.1|Standard Deviation|4.6|4.6|||
4079441|NCT01023256|3902356|B1|||Body mass index||kg/m2|Mean|26.3|26.3|Standard Deviation|3.6|3.6|||
4079442|NCT01023256|3902352|B5|Germany||Region of Enrollment||participants|Number|17|17.0||||||
4079443|NCT01023256|3902353|B4|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4079444|NCT01023256|3902354|B3|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4079445|NCT01023256|3902355|B2|Germany||Region of Enrollment||participants|Number|7|7.0||||||
4079446|NCT01023256|3902356|B1|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4079447|NCT01023256|3902352|B5|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
4079451|NCT01023256|3902356|B1|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4079452|NCT01023256|3902352|B5|Bulgaria||Region of Enrollment||participants|Number|29|29.0||||||
4079453|NCT01023256|3902353|B4|Bulgaria||Region of Enrollment||participants|Number|6|6.0||||||
4079454|NCT01023256|3902354|B3|Bulgaria||Region of Enrollment||participants|Number|4|4.0||||||
4079455|NCT01023256|3902355|B2|Bulgaria||Region of Enrollment||participants|Number|7|7.0||||||
4079456|NCT01023256|3902356|B1|Bulgaria||Region of Enrollment||participants|Number|12|12.0||||||
4079457|NCT01023256|3902352|B5|Ukraine||Region of Enrollment||participants|Number|24|24.0||||||
4079458|NCT01023256|3902353|B4|Ukraine||Region of Enrollment||participants|Number|7|7.0||||||
4079459|NCT01023256|3902354|B3|Ukraine||Region of Enrollment||participants|Number|13|13.0||||||
4079460|NCT01023256|3902355|B2|Ukraine||Region of Enrollment||participants|Number|4|4.0||||||
4079461|NCT01023256|3902356|B1|Ukraine||Region of Enrollment||participants|Number|0|0.0||||||
4079462|NCT01023256|3902352|B5|Poland||Region of Enrollment||participants|Number|23|23.0||||||
4079463|NCT01023256|3902353|B4|Poland||Region of Enrollment||participants|Number|8|8.0||||||
4079464|NCT01023256|3902354|B3|Poland||Region of Enrollment||participants|Number|3|3.0||||||
4079465|NCT01023256|3902355|B2|Poland||Region of Enrollment||participants|Number|4|4.0||||||
4079466|NCT01023256|3902356|B1|Poland||Region of Enrollment||participants|Number|8|8.0||||||
4079467|NCT01023256|3902352|B5||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4079468|NCT01023256|3902353|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4079469|NCT01023256|3902354|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4079470|NCT01023256|3902355|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4079471|NCT01023256|3902356|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4079472|NCT01023256|3902352|B5||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4079473|NCT01023256|3902353|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4079474|NCT01023256|3902354|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4079475|NCT01023256|3902355|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4079476|NCT01023256|3902356|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4079477|NCT01023256|3902352|B5|||Age||years|Mean|53.4|53.4|Standard Deviation|11.3|11.3|||
4079478|NCT01023256|3902353|B4|||Age||years|Mean|53.8|53.8|Standard Deviation|12.7|12.7|||
4079479|NCT01023256|3902354|B3|||Age||years|Mean|53.0|53.0|Standard Deviation|9.9|9.9|||
4079480|NCT01023256|3902355|B2|||Age||years|Mean|49.0|49.0|Standard Deviation|12.7|12.7|||
4079481|NCT01023256|3902356|B1|||Age||years|Mean|57.4|57.4|Standard Deviation|8.3|8.3|||
4079482|NCT01023217|3902399|B3|||Multiple-Drug-Refractory Chronic Hepatitis B Virus Patients||participants|Number|90|90.0||||||
4079483|NCT01023217|3902400|B2|||Multiple-Drug-Refractory Chronic Hepatitis B Virus Patients||participants|Number|45|45.0||||||
4079484|NCT01023217|3902401|B1|||Multiple-Drug-Refractory Chronic Hepatitis B Virus Patients||participants|Number|45|45.0||||||
4079485|NCT01023217|3902399|B3|Korea, Republic of||Region of Enrollment||participants|Number|90|90.0||||||
4079486|NCT01023217|3902400|B2|Korea, Republic of||Region of Enrollment||participants|Number|45|45.0||||||
4079487|NCT01023217|3902401|B1|Korea, Republic of||Region of Enrollment||participants|Number|45|45.0||||||
4079488|NCT01023217|3902399|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4079489|NCT01023217|3902400|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4079490|NCT01023217|3902401|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4079491|NCT01023217|3902399|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079492|NCT01023217|3902400|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079493|NCT01023217|3902401|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079494|NCT01023217|3902399|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079495|NCT01023217|3902400|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079496|NCT01023217|3902401|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079497|NCT01023217|3902399|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079498|NCT01023217|3902400|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079499|NCT01023217|3902401|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079500|NCT01023217|3902399|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079501|NCT01023217|3902400|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079502|NCT01023217|3902401|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079503|NCT01023217|3902399|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079504|NCT01023217|3902400|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079505|NCT01023217|3902401|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079506|NCT01023217|3902399|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079507|NCT01023217|3902400|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079508|NCT01023217|3902401|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079509|NCT01023217|3902399|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079510|NCT01023217|3902400|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079511|NCT01023217|3902401|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079512|NCT01023217|3902399|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4079513|NCT01023217|3902400|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4079514|NCT01023217|3902401|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4079515|NCT01023217|3902399|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079516|NCT01023217|3902400|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079517|NCT01023217|3902401|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079518|NCT01023217|3902399|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4079519|NCT01023217|3902400|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4079520|NCT01023217|3902401|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4079521|NCT01023217|3902399|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4079522|NCT01023217|3902400|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4079523|NCT01023217|3902401|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4079524|NCT01023217|3902399|B3|||Age||years|Mean|47|47.0|Standard Deviation|11|11.0|||
4079525|NCT01023217|3902400|B2|||Age||years|Mean|49|49.0|Standard Deviation|11|11.0|||
4079526|NCT01023217|3902401|B1|||Age||years|Mean|45|45.0|Standard Deviation|11|11.0|||
4079527|NCT01023178|3902408|B4|||Luteinizing Hormone (LH)||mIU/mL|Mean|18|18.0|Full Range|||0.009|86.0|
4079528|NCT01023178|3902409|B3|||Luteinizing Hormone (LH)||mIU/mL|Mean|13|13.0|Full Range|||0.041|26.0|
4079529|NCT01023178|3902410|B2|||Luteinizing Hormone (LH)||mIU/mL|Mean|26|26.0|Full Range|||0.009|86.0|
4079530|NCT01023178|3902411|B1|||Luteinizing Hormone (LH)||mIU/mL|Mean|14|14.0|Full Range|||0.15|26.0|
4079531|NCT01023178|3902408|B4|||Follicle Stimulating Hormone (FSH)||mIU/mL|Mean|78|78.0|Full Range|||0.027|197.0|
4079532|NCT01023178|3902409|B3|||Follicle Stimulating Hormone (FSH)||mIU/mL|Mean|71|71.0|Full Range|||0.656|144.0|
4079533|NCT01023178|3902410|B2|||Follicle Stimulating Hormone (FSH)||mIU/mL|Mean|86|86.0|Full Range|||0.027|197.0|
4079534|NCT01023178|3902411|B1|||Follicle Stimulating Hormone (FSH)||mIU/mL|Mean|76|76.0|Full Range|||1.5|144.0|
4079535|NCT01023178|3902408|B4|Female||Sex/Gender, Customized||participants|Number|20|20.0||||||
4079536|NCT01023178|3902409|B3|Female||Sex/Gender, Customized||participants|Number|7|7.0||||||
4079537|NCT01023178|3902410|B2|Female||Sex/Gender, Customized||participants|Number|8|8.0||||||
4079538|NCT01023178|3902411|B1|Female||Sex/Gender, Customized||participants|Number|5|5.0||||||
4079539|NCT01023178|3902408|B4|||Age||years|Mean|14.2|14.2|Standard Deviation|0.6|0.6|||
4079540|NCT01023178|3902409|B3|||Age||years|Mean|14.5|14.5|Standard Deviation|0.6|0.6|||
4079541|NCT01023178|3902410|B2|||Age||years|Mean|13.8|13.8|Standard Deviation|0.4|0.4|||
4079542|NCT01023178|3902411|B1|||Age||years|Mean|14.2|14.2|Standard Deviation|0.5|0.5|||
4079543|NCT01023074|3902421|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4079544|NCT01023074|3902422|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4079545|NCT01023074|3902423|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4079546|NCT01023074|3902424|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4079547|NCT01023074|3902421|B4||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4079548|NCT01023074|3902422|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4079549|NCT01023074|3902423|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4079550|NCT01023074|3902424|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4079551|NCT01023074|3902421|B4|||Age||years|Mean|47.85|47.85|Standard Deviation|11.1|11.1|||
4079552|NCT01023074|3902422|B3|||Age||years|Mean|53.0|53.0|Standard Deviation|10|10.0|||
4079553|NCT01023074|3902423|B2|||Age||years|Mean|52.0|52.0|Standard Deviation|9.6|9.6|||
4079554|NCT01023074|3902424|B1|||Age||years|Mean|43.2|43.2|Standard Deviation|12.5|12.5|||
4079555|NCT01023061|3902440|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4079556|NCT01023061|3902440|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4079557|NCT01023061|3902440|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4079558|NCT01023061|3902440|B1|||Age||years|Median|61|61.0|Standard Deviation|9.1|9.1|||
4079559|NCT01023035|3902446|B4||Male|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
4079560|NCT01023035|3902447|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4079561|NCT01023035|3902448|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4079562|NCT01023035|3902449|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4079563|NCT01023035|3902446|B4||Female|Sex: Female, Male||Participants|Count of Participants|434|434.0||||||
4079564|NCT01023035|3902447|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4079565|NCT01023035|3902448|B2||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4079566|NCT01023035|3902449|B1||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4079567|NCT01023035|3902446|B4|||Age||years|Mean|49.3|49.3|Standard Deviation|10.1|10.1|||
4079568|NCT01023035|3902447|B3|||Age||years|Mean|47.5|47.5|Standard Deviation|10.1|10.1|||
4079569|NCT01023035|3902448|B2|||Age||years|Mean|49.7|49.7|Standard Deviation|9.7|9.7|||
4079570|NCT01023035|3902449|B1|||Age||years|Mean|50.2|50.2|Standard Deviation|9.9|9.9|||
4079571|NCT01023022|3902461|B1|Poland||Region of Enrollment||participants|Number|176|176.0||||||
4079572|NCT01023022|3902461|B1||Male|Gender||Participants|Count of Participants|147|147.0||||||
4079573|NCT01023022|3902461|B1||Female|Gender||Participants|Count of Participants|29|29.0||||||
4079574|NCT01023022|3902461|B1||>=65 years|Age||Participants|Count of Participants|73|73.0||||||
4079575|NCT01023022|3902461|B1||Between 18 and 65 years|Age||Participants|Count of Participants|103|103.0||||||
4079576|NCT01023022|3902461|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4079577|NCT01023022|3902461|B1|||Age||years|Mean|61|61.0|Standard Deviation|13|13.0|||
4079578|NCT01022996|3902467|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4079579|NCT01022996|3902467|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4079580|NCT01022996|3902467|B1|||Age||years|Mean|36.33|36.33|Standard Deviation|14.101|14.101|||
4079581|NCT01022853|3902476|B6||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4079582|NCT01022853|3902477|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4079583|NCT01022853|3902478|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4079584|NCT01022853|3902479|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4079585|NCT01022853|3902480|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4079586|NCT01022853|3902481|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4079587|NCT01022853|3902476|B6||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4079588|NCT01022853|3902477|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4079589|NCT01022853|3902478|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4079590|NCT01022853|3902479|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4079591|NCT01022853|3902480|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4079592|NCT01022853|3902481|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4079593|NCT01022853|3902476|B6|||Age||years|Mean|56.3|56.3|Standard Deviation|9.6|9.6|||
4079594|NCT01022853|3902477|B5|||Age||years|Mean|59.0|59.0|Standard Deviation|5.7|5.7|||
4079595|NCT01022853|3902478|B4|||Age||years|Mean|53.1|53.1|Standard Deviation|12.9|12.9|||
4079596|NCT01022853|3902479|B3|||Age||years|Mean|57.5|57.5|Standard Deviation|8.8|8.8|||
4079597|NCT01022853|3902480|B2|||Age||years|Mean|60.0|60.0|Standard Deviation|7.1|7.1|||
4079598|NCT01022853|3902481|B1|||Age||years|Mean|53.0|53.0|Standard Deviation|9.2|9.2|||
4079599|NCT01022762|3902562|B3|||Duration of diagnosed diabetes||years|Mean|0.91|0.91|Standard Deviation|1.89|1.89|||
4079600|NCT01022762|3902563|B2|||Duration of diagnosed diabetes||years|Mean|0.79|0.79|Standard Deviation|1.82|1.82|||
4079601|NCT01022762|3902564|B1|||Duration of diagnosed diabetes||years|Mean|1.02|1.02|Standard Deviation|1.95|1.95|||
4079602|NCT01022762|3902562|B3|||Body Mass Index (BMI)||kg/m^2|Mean|25.53|25.53|Standard Deviation|3.00|3.0|||
4079603|NCT01022762|3902563|B2|||Body Mass Index (BMI)||kg/m^2|Mean|25.37|25.37|Standard Deviation|3.01|3.01|||
4079604|NCT01022762|3902564|B1|||Body Mass Index (BMI)||kg/m^2|Mean|25.69|25.69|Standard Deviation|3.00|3.0|||
4079605|NCT01022762|3902562|B3|||Weight||kg|Mean|68.6|68.6|Standard Deviation|11.4|11.4|||
4079606|NCT01022762|3902563|B2|||Weight||kg|Mean|68.4|68.4|Standard Deviation|11.2|11.2|||
4079607|NCT01022762|3902564|B1|||Weight||kg|Mean|68.7|68.7|Standard Deviation|11.6|11.6|||
4079608|NCT01022762|3902562|B3|||Height||cm|Mean|163.5|163.5|Standard Deviation|8.7|8.7|||
4079609|NCT01022762|3902563|B2|||Height||cm|Mean|163.9|163.9|Standard Deviation|8.4|8.4|||
4079610|NCT01022762|3902564|B1|||Height||cm|Mean|163.2|163.2|Standard Deviation|8.9|8.9|||
4079611|NCT01022762|3902562|B3|China||Region of Enrollment||participants|Number|435|435.0||||||
4079612|NCT01022762|3902563|B2|China||Region of Enrollment||participants|Number|218|218.0||||||
4079613|NCT01022762|3902564|B1|China||Region of Enrollment||participants|Number|217|217.0||||||
4079614|NCT01022762|3902562|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079615|NCT01022762|3902563|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079616|NCT01022762|3902564|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079617|NCT01022762|3902562|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079618|NCT01022762|3902563|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079619|NCT01022762|3902564|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079620|NCT01022762|3902562|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079621|NCT01022762|3902563|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079622|NCT01022762|3902564|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079623|NCT01022762|3902562|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079624|NCT01022762|3902563|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079625|NCT01022762|3902564|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079626|NCT01022762|3902562|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079627|NCT01022762|3902563|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079628|NCT01022762|3902564|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079629|NCT01022762|3902562|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|435|435.0||||||
4079630|NCT01022762|3902563|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|218|218.0||||||
4079631|NCT01022762|3902564|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|217|217.0||||||
4079632|NCT01022762|3902562|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079633|NCT01022762|3902563|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079634|NCT01022762|3902564|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079635|NCT01022762|3902562|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079636|NCT01022762|3902563|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079637|NCT01022762|3902564|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079638|NCT01022762|3902562|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|435|435.0||||||
4079639|NCT01022762|3902563|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|218|218.0||||||
4079640|NCT01022762|3902564|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|217|217.0||||||
4079641|NCT01022762|3902562|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079642|NCT01022762|3902563|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079643|NCT01022762|3902564|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079644|NCT01022762|3902562|B3||Male|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
4079645|NCT01022762|3902563|B2||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4079646|NCT01022762|3902564|B1||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4079647|NCT01022762|3902562|B3||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4079648|NCT01022762|3902563|B2||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4079649|NCT01022762|3902564|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4079650|NCT01022762|3902562|B3|||Age||years|Mean|53.8|53.8|Standard Deviation|9.9|9.9|||
4079651|NCT01022762|3902563|B2|||Age||years|Mean|53.5|53.5|Standard Deviation|9.9|9.9|||
4079652|NCT01022762|3902564|B1|||Age||years|Mean|54.1|54.1|Standard Deviation|10.0|10.0|||
4079653|NCT01022567|3902591|B3|Finland||Region of Enrollment||participants|Number|530|530.0||||||
4079654|NCT01022567|3902592|B2|Finland||Region of Enrollment||participants|Number|257|257.0||||||
4079655|NCT01022567|3902593|B1|Finland||Region of Enrollment||participants|Number|273|273.0||||||
4079656|NCT01022567|3902591|B3|Male||Sex/Gender, Customized||participants|Number|329|329.0||||||
4079657|NCT01022567|3902592|B2|Male||Sex/Gender, Customized||participants|Number|155|155.0||||||
4079658|NCT01022567|3902593|B1|Male||Sex/Gender, Customized||participants|Number|174|174.0||||||
4079659|NCT01022567|3902591|B3|Female||Sex/Gender, Customized||participants|Number|201|201.0||||||
4079660|NCT01022567|3902592|B2|Female||Sex/Gender, Customized||participants|Number|102|102.0||||||
4079661|NCT01022567|3902593|B1|Female||Sex/Gender, Customized||participants|Number|99|99.0||||||
4079662|NCT01022567|3902591|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4079663|NCT01022567|3902592|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4079664|NCT01022567|3902593|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4079665|NCT01022567|3902591|B3||Between 18 and 65 years|Age||Participants|Count of Participants|530|530.0||||||
4079666|NCT01022567|3902592|B2||Between 18 and 65 years|Age||Participants|Count of Participants|257|257.0||||||
4079667|NCT01022567|3902593|B1||Between 18 and 65 years|Age||Participants|Count of Participants|273|273.0||||||
4079668|NCT01022567|3902591|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4079669|NCT01022567|3902592|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4079670|NCT01022567|3902593|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4079671|NCT01022502|3902600|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4079672|NCT01022502|3902600|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4079673|NCT01022502|3902600|B1|||Age||years|Mean|42.8|42.8|Standard Deviation|12.7|12.7|||
4079674|NCT01022424|3902614|B1|Japan||Region of Enrollment||participants|Number|13|13.0||||||
4079675|NCT01022424|3902614|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4079676|NCT01022424|3902614|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4079677|NCT01022424|3902614|B1|||Age||years|Mean|45.6|45.6|Standard Deviation|9.2|9.2|||
4079678|NCT01022424|3902614|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4079679|NCT01022424|3902614|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4079680|NCT01022424|3902614|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4079681|NCT01022398|3902627|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4079682|NCT01022398|3902628|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4079683|NCT01022398|3902629|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4079684|NCT01022398|3902627|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4079685|NCT01022398|3902628|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4079686|NCT01022398|3902629|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4079687|NCT01022398|3902627|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4079688|NCT01022398|3902628|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4079689|NCT01022398|3902629|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4079690|NCT01022398|3902627|B3|||Age||years|Mean|52.75|52.75|Standard Deviation|10.4|10.4|||
4079691|NCT01022398|3902628|B2|||Age||years|Mean|56.5|56.5|Standard Deviation|16.2|16.2|||
4079692|NCT01022398|3902629|B1|||Age||years|Mean|49|49.0|Standard Deviation|1.4|1.4|||
4079693|NCT01022398|3902627|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4079694|NCT01022398|3902628|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4079695|NCT01022398|3902629|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4079696|NCT01022398|3902627|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4079697|NCT01022398|3902628|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4079698|NCT01022398|3902629|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4079699|NCT01022398|3902627|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4079700|NCT01022398|3902628|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4079701|NCT01022398|3902629|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4079702|NCT01022307|3902635|B3|United States||Region of Enrollment||participants|Number|208|208.0||||||
4079703|NCT01022307|3902636|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4079704|NCT01022307|3902637|B1|United States||Region of Enrollment||participants|Number|184|184.0||||||
4079705|NCT01022307|3902635|B3|Male||Gender||participants|Number|121|121.0||||||
4079706|NCT01022307|3902636|B2|Male||Gender||participants|Number|23|23.0||||||
4079707|NCT01022307|3902637|B1|Male||Gender||participants|Number|98|98.0||||||
4079708|NCT01022307|3902635|B3|Female||Gender||participants|Number|83|83.0||||||
4079709|NCT01022307|3902636|B2|Female||Gender||participants|Number|1|1.0||||||
4079710|NCT01022307|3902637|B1|Female||Gender||participants|Number|82|82.0||||||
4079711|NCT01022307|3902635|B3|||Age||years|Mean|39.2|39.2|Standard Deviation|25.8|25.8|||
4079712|NCT01022307|3902636|B2|||Age||years|Mean|36.16|36.16|Standard Deviation|29.0|29.0|||
4079713|NCT01022307|3902637|B1|||Age||years|Mean|40.03|40.03|Standard Deviation|24.2|24.2|||
4079714|NCT01022307|3902635|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4079715|NCT01022307|3902636|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4079716|NCT01022307|3902637|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4079717|NCT01022307|3902635|B3||Between 18 and 65 years|Age||Participants|Count of Participants|208|208.0||||||
4079718|NCT01022307|3902636|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4079719|NCT01022307|3902637|B1||Between 18 and 65 years|Age||Participants|Count of Participants|184|184.0||||||
4079720|NCT01022307|3902635|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4079721|NCT01022307|3902636|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4079722|NCT01022307|3902637|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4079723|NCT01022242|3902644|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4079724|NCT01022242|3902645|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4079725|NCT01022242|3902646|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4079726|NCT01022242|3902644|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4079727|NCT01022242|3902645|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4079728|NCT01022242|3902646|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079729|NCT01022242|3902644|B3||White|Race (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
4079730|NCT01022242|3902645|B2||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4079731|NCT01022242|3902646|B1||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4079732|NCT01022242|3902644|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4079733|NCT01022242|3902645|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4079734|NCT01022242|3902646|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4079735|NCT01022242|3902644|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079736|NCT01022242|3902645|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079737|NCT01022242|3902646|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079738|NCT01022242|3902644|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4079739|NCT01022242|3902645|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079740|NCT01022242|3902646|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4079741|NCT01022242|3902644|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079742|NCT01022242|3902645|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079743|NCT01022242|3902646|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079744|NCT01022242|3902644|B3||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4079745|NCT01022242|3902645|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4079746|NCT01022242|3902646|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4079747|NCT01022242|3902644|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4079748|NCT01022242|3902645|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4079749|NCT01022242|3902646|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4079750|NCT01022242|3902644|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4079751|NCT01022242|3902645|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4079752|NCT01022242|3902646|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4079753|NCT01022242|3902644|B3||Between 18 and 65 years|Age||Participants|Count of Participants|126|126.0||||||
4079754|NCT01022242|3902645|B2||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4079755|NCT01022242|3902646|B1||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4079756|NCT01022242|3902644|B3||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4079757|NCT01022242|3902645|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4079758|NCT01022242|3902646|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4079759|NCT01022203|3902653|B3|United States||Region of Enrollment||participants|Number|114|114.0||||||
4079760|NCT01022203|3902654|B2|United States||Region of Enrollment||participants|Number|56|56.0||||||
4079761|NCT01022203|3902655|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
4079762|NCT01022203|3902653|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079763|NCT01022203|3902654|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079764|NCT01022203|3902655|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079765|NCT01022203|3902653|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|112|112.0||||||
4079766|NCT01022203|3902654|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4079767|NCT01022203|3902655|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4079768|NCT01022203|3902653|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4079769|NCT01022203|3902654|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079770|NCT01022203|3902655|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4079771|NCT01022203|3902653|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4079772|NCT01022203|3902654|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4079773|NCT01022203|3902655|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4079774|NCT01022203|3902653|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4079775|NCT01022203|3902654|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4079776|NCT01022203|3902655|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4079777|NCT01022203|3902653|B3|Partners Age||Age||years|Mean|32.21|32.21|Standard Deviation|7.72|7.72|||
4079778|NCT01022203|3902654|B2|Partners Age||Age||years|Mean|32.17|32.17|Standard Deviation|7.68|7.68|||
4079779|NCT01022203|3902655|B1|Partners Age||Age||years|Mean|32.25|32.25|Standard Deviation|7.89|7.89|||
4079780|NCT01022203|3902653|B3|Veterans Age||Age||years|Mean|33.12|33.12|Standard Deviation|6.56|6.56|||
4079781|NCT01022203|3902654|B2|Veterans Age||Age||years|Mean|32.55|32.55|Standard Deviation|6.16|6.16|||
4079782|NCT01022203|3902655|B1|Veterans Age||Age||years|Mean|33.71|33.71|Standard Deviation|7.01|7.01|||
4079783|NCT01022203|3902653|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4079784|NCT01022203|3902654|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4079785|NCT01022203|3902655|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4079786|NCT01022203|3902653|B3||Between 18 and 65 years|Age||Participants|Count of Participants|114|114.0||||||
4079787|NCT01022203|3902654|B2||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4079788|NCT01022203|3902655|B1||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4079789|NCT01022203|3902653|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4079790|NCT01022203|3902654|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4079791|NCT01022203|3902655|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4079792|NCT01022190|3902666|B1|Netherlands||Region of Enrollment||participants|Number|42|42.0||||||
4079793|NCT01022190|3902666|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4079794|NCT01022190|3902666|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4079795|NCT01022190|3902666|B1|||Age||years|Mean|54.2|54.2|Standard Deviation|15.8|15.8|||
4079796|NCT01022190|3902666|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4079797|NCT01022190|3902666|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4079798|NCT01022190|3902666|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4079799|NCT01022112|3902670|B6||Male|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
4079800|NCT01022112|3902671|B5||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4079801|NCT01022112|3902672|B4||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4079802|NCT01022112|3902673|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4079803|NCT01022112|3902674|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4079804|NCT01022112|3902675|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4079805|NCT01022112|3902670|B6||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4079806|NCT01022112|3902671|B5||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4079807|NCT01022112|3902672|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4079808|NCT01022112|3902673|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4079809|NCT01022112|3902674|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4079810|NCT01022112|3902675|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4079811|NCT01022112|3902670|B6|||Age||years|Mean|57.4|57.4|Standard Deviation|10.6|10.6|||
4079812|NCT01022112|3902671|B5|||Age||years|Mean|57.7|57.7|Standard Deviation|11.0|11.0|||
4079813|NCT01022112|3902672|B4|||Age||years|Mean|57.1|57.1|Standard Deviation|10.1|10.1|||
4079814|NCT01022112|3902673|B3|||Age||years|Mean|57|57.0|Standard Deviation|10.6|10.6|||
4079815|NCT01022112|3902674|B2|||Age||years|Mean|57.7|57.7|Standard Deviation|10.5|10.5|||
4079816|NCT01022112|3902675|B1|||Age||years|Mean|57.4|57.4|Standard Deviation|10.8|10.8|||
4079817|NCT01022073|3902691|B3|||Years on Parkinson's Disease medications||years|Mean|10.8|10.8|Standard Deviation|4.7|4.7|||
4079818|NCT01022073|3902692|B2|||Years on Parkinson's Disease medications||years|Mean|10.6|10.6|Standard Deviation|4.7|4.7|||
4079819|NCT01022073|3902693|B1|||Years on Parkinson's Disease medications||years|Mean|11.0|11.0|Standard Deviation|4.7|4.7|||
4079820|NCT01022073|3902691|B3|||Years since Parkinson's Disease diagnosis||years|Mean|11.4|11.4|Standard Deviation|4.9|4.9|||
4079821|NCT01022073|3902692|B2|||Years since Parkinson's Disease diagnosis||years|Mean|11.4|11.4|Standard Deviation|5.2|5.2|||
4079822|NCT01022073|3902693|B1|||Years since Parkinson's Disease diagnosis||years|Mean|11.4|11.4|Standard Deviation|4.7|4.7|||
4079823|NCT01022073|3902691|B3|no||Family history of Parkinson's Disease||participants|Number|117|117.0||||||
4079824|NCT01022073|3902692|B2|no||Family history of Parkinson's Disease||participants|Number|50|50.0||||||
4079825|NCT01022073|3902693|B1|no||Family history of Parkinson's Disease||participants|Number|67|67.0||||||
4079826|NCT01022073|3902691|B3|yes||Family history of Parkinson's Disease||participants|Number|39|39.0||||||
4079827|NCT01022073|3902692|B2|yes||Family history of Parkinson's Disease||participants|Number|20|20.0||||||
4079828|NCT01022073|3902693|B1|yes||Family history of Parkinson's Disease||participants|Number|19|19.0||||||
4079829|NCT01022073|3902691|B3|Nursing||Living with Family||participants|Number|1|1.0||||||
4079830|NCT01022073|3902692|B2|Nursing||Living with Family||participants|Number|1|1.0||||||
4079831|NCT01022073|3902693|B1|Nursing||Living with Family||participants|Number|0|0.0||||||
4079832|NCT01022073|3902691|B3|With Non-Family||Living with Family||participants|Number|8|8.0||||||
4079833|NCT01022073|3902692|B2|With Non-Family||Living with Family||participants|Number|3|3.0||||||
4079834|NCT01022073|3902693|B1|With Non-Family||Living with Family||participants|Number|5|5.0||||||
4079835|NCT01022073|3902691|B3|With Family||Living with Family||participants|Number|132|132.0||||||
4079836|NCT01022073|3902692|B2|With Family||Living with Family||participants|Number|57|57.0||||||
4079837|NCT01022073|3902693|B1|With Family||Living with Family||participants|Number|75|75.0||||||
4079838|NCT01022073|3902691|B3|Alone||Living with Family||participants|Number|15|15.0||||||
4079839|NCT01022073|3902692|B2|Alone||Living with Family||participants|Number|9|9.0||||||
4079840|NCT01022073|3902693|B1|Alone||Living with Family||participants|Number|6|6.0||||||
4079841|NCT01022073|3902691|B3|Divorced||Married Status||participants|Number|35|35.0||||||
4079842|NCT01022073|3902692|B2|Divorced||Married Status||participants|Number|19|19.0||||||
4079843|NCT01022073|3902693|B1|Divorced||Married Status||participants|Number|16|16.0||||||
4079844|NCT01022073|3902691|B3|Seperated||Married Status||participants|Number|1|1.0||||||
4079845|NCT01022073|3902692|B2|Seperated||Married Status||participants|Number|0|0.0||||||
4079846|NCT01022073|3902693|B1|Seperated||Married Status||participants|Number|1|1.0||||||
4079847|NCT01022073|3902691|B3|Single/Never Married||Married Status||participants|Number|6|6.0||||||
4079848|NCT01022073|3902692|B2|Single/Never Married||Married Status||participants|Number|2|2.0||||||
4079849|NCT01022073|3902693|B1|Single/Never Married||Married Status||participants|Number|4|4.0||||||
4079850|NCT01022073|3902691|B3|Married||Married Status||participants|Number|114|114.0||||||
4079851|NCT01022073|3902692|B2|Married||Married Status||participants|Number|49|49.0||||||
4079852|NCT01022073|3902693|B1|Married||Married Status||participants|Number|65|65.0||||||
4079853|NCT01022073|3902691|B3|United States||Region of Enrollment||participants|Number|156|156.0||||||
4079854|NCT01022073|3902692|B2|United States||Region of Enrollment||participants|Number|70|70.0||||||
4079855|NCT01022073|3902693|B1|United States||Region of Enrollment||participants|Number|86|86.0||||||
4079856|NCT01022073|3902691|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079857|NCT01022073|3902692|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079858|NCT01022073|3902693|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079859|NCT01022073|3902691|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079860|NCT01022073|3902692|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079861|NCT01022073|3902693|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079862|NCT01022073|3902691|B3||White|Race (NIH/OMB)||Participants|Count of Participants|150|150.0||||||
4079863|NCT01022073|3902692|B2||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4079864|NCT01022073|3902693|B1||White|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
4079865|NCT01022073|3902691|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4079866|NCT01022073|3902692|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4079867|NCT01022073|3902693|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079868|NCT01022073|3902691|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079869|NCT01022073|3902692|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079870|NCT01022073|3902693|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079871|NCT01022073|3902691|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4079872|NCT01022073|3902692|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4079873|NCT01022073|3902693|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4079874|NCT01022073|3902691|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4079875|NCT01022073|3902692|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079876|NCT01022073|3902693|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4079877|NCT01022073|3902691|B3||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4079878|NCT01022073|3902692|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4079879|NCT01022073|3902693|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4079880|NCT01022073|3902691|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4079881|NCT01022073|3902692|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4079882|NCT01022073|3902693|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4079883|NCT01022073|3902691|B3|||Age||years|Mean|59.1|59.1|Standard Deviation|8.2|8.2|||
4079884|NCT01022073|3902692|B2|||Age||years|Mean|58.6|58.6|Standard Deviation|7.9|7.9|||
4079885|NCT01022073|3902693|B1|||Age||years|Mean|59.5|59.5|Standard Deviation|8.4|8.4|||
4079886|NCT01021956|3902700|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079887|NCT01021956|3902701|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079888|NCT01021956|3902702|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079889|NCT01021956|3902703|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079890|NCT01021956|3902704|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079891|NCT01021956|3902700|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4079892|NCT01021956|3902701|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4079893|NCT01021956|3902702|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4079894|NCT01021956|3902703|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4079895|NCT01021956|3902704|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4079896|NCT01021956|3902700|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4079897|NCT01021956|3902701|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079898|NCT01021956|3902702|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079899|NCT01021956|3902703|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4079900|NCT01021956|3902704|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4079901|NCT01021956|3902700|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4079902|NCT01021956|3902701|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4079903|NCT01021956|3902702|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4079904|NCT01021956|3902703|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4079905|NCT01021956|3902704|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4079906|NCT01021956|3902700|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4079907|NCT01021956|3902701|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4079908|NCT01021956|3902702|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4079909|NCT01021956|3902703|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4079910|NCT01021956|3902704|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4079911|NCT01021956|3902700|B5|||Age||years|Mean|77.60|77.6|Standard Deviation|7.78|7.78|||
4079912|NCT01021956|3902701|B4|||Age||years|Mean|87.00|87.0|Standard Deviation|0|0.0|||
4079913|NCT01021956|3902702|B3|||Age||years|Mean|81.00|81.0|Standard Deviation|6.08|6.08|||
4079914|NCT01021956|3902703|B2|||Age||years|Mean|78.3|78.3|Standard Deviation|6.11|6.11|||
4079915|NCT01021956|3902704|B1|||Age||years|Mean|70.30|70.3|Standard Deviation|7.51|7.51|||
4079916|NCT01021878|3902726|B3|||HOMA index||IR score|Mean|1.95|1.95|Standard Deviation|1.05|1.05|||
4079917|NCT01021878|3902727|B2|||HOMA index||IR score|Mean|1.77|1.77|Standard Deviation|1.00|1.0|||
4079918|NCT01021878|3902728|B1|||HOMA index||IR score|Mean|2.10|2.1|Standard Deviation|1.10|1.1|||
4079919|NCT01021878|3902726|B3|Brazil||Region of Enrollment||participants|Number|60|60.0||||||
4079920|NCT01021878|3902727|B2|Brazil||Region of Enrollment||participants|Number|27|27.0||||||
4079921|NCT01021878|3902728|B1|Brazil||Region of Enrollment||participants|Number|33|33.0||||||
4079922|NCT01021878|3902726|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4079923|NCT01021878|3902727|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4079924|NCT01021878|3902728|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4079925|NCT01021878|3902726|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4079926|NCT01021878|3902727|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4079927|NCT01021878|3902728|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4079928|NCT01021878|3902726|B3|||Age||years|Median|52.1|52.1|Standard Deviation|16.45|16.45|||
4079929|NCT01021878|3902727|B2|||Age||years|Median|54.1|54.1|Standard Deviation|17.4|17.4|||
4079930|NCT01021878|3902728|B1|||Age||years|Median|50.1|50.1|Standard Deviation|15.5|15.5|||
4079931|NCT01021852|3902743|B9||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4079932|NCT01021852|3902744|B8||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4079933|NCT01021852|3902745|B7||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4079934|NCT01021852|3902746|B6||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4079935|NCT01021852|3902747|B5||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4079936|NCT01021852|3902748|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4079937|NCT01021852|3902749|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4079938|NCT01021852|3902750|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4079939|NCT01021852|3902751|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4079940|NCT01021852|3902743|B9||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4079941|NCT01021852|3902744|B8||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4079942|NCT01021852|3902745|B7||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4079943|NCT01021852|3902746|B6||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4079944|NCT01021852|3902747|B5||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4079945|NCT01021852|3902748|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4079946|NCT01021852|3902749|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4079947|NCT01021852|3902750|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4079948|NCT01021852|3902751|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4079949|NCT01021852|3902743|B9|||Age||years|Mean|46.8|46.8|Standard Deviation|11.0|11.0|||
4079950|NCT01021852|3902744|B8|||Age||years|Mean|47.0|47.0|Standard Deviation|12.3|12.3|||
4079951|NCT01021852|3902745|B7|||Age||years|Mean|49.8|49.8|Standard Deviation|9.8|9.8|||
4079952|NCT01021852|3902746|B6|||Age||years|Mean|45.2|45.2|Standard Deviation|11.0|11.0|||
4079953|NCT01021852|3902747|B5|||Age||years|Mean|45.4|45.4|Standard Deviation|9.9|9.9|||
4079954|NCT01021852|3902748|B4|||Age||years|Mean|47.6|47.6|Standard Deviation|10.4|10.4|||
4079955|NCT01021852|3902749|B3|||Age||years|Mean|44.7|44.7|Standard Deviation|10.7|10.7|||
4079956|NCT01021852|3902750|B2|||Age||years|Mean|47.9|47.9|Standard Deviation|11.7|11.7|||
4079957|NCT01021852|3902751|B1|||Age||years|Mean|46.9|46.9|Standard Deviation|11.9|11.9|||
4079958|NCT01021813|3902792|B3|||Mean Subjective Time to Sleep Onset in minutes (sTSOm)|"The baseline sTSOm was defined as the participant’s reported time that he or she required to fall asleep (measured in minutes), calculated as the mean of the last 7 (non-missing) daily e-diary values obtained during the placebo run-in phase.~(n=517, n=254)"|minutes|Mean|65.6|65.6|Standard Deviation|62.7|62.7|||
4079959|NCT01021813|3902793|B2|||Mean Subjective Time to Sleep Onset in minutes (sTSOm)|"The baseline sTSOm was defined as the participant’s reported time that he or she required to fall asleep (measured in minutes), calculated as the mean of the last 7 (non-missing) daily e-diary values obtained during the placebo run-in phase.~(n=517, n=254)"|minutes|Mean|65.0|65.0|Standard Deviation|60.6|60.6|||
4079960|NCT01021813|3902794|B1|||Mean Subjective Time to Sleep Onset in minutes (sTSOm)|"The baseline sTSOm was defined as the participant’s reported time that he or she required to fall asleep (measured in minutes), calculated as the mean of the last 7 (non-missing) daily e-diary values obtained during the placebo run-in phase.~(n=517, n=254)"|minutes|Mean|65.9|65.9|Standard Deviation|63.8|63.8|||
4079961|NCT01021813|3902792|B3|||Mean Subjective Total Sleep Time (sTSTm)|"The baseline sTSTm was defined as the participant’s reported total amount of time spent asleep before waking for the day (measured in minutes), calculated as the mean of the last 7 (non-missing) daily e-diary values obtained during the placebo run-in phase.~(n=517, n=254)"|minutes|Mean|323.5|323.5|Standard Deviation|77.3|77.3|||
4079962|NCT01021813|3902793|B2|||Mean Subjective Total Sleep Time (sTSTm)|"The baseline sTSTm was defined as the participant’s reported total amount of time spent asleep before waking for the day (measured in minutes), calculated as the mean of the last 7 (non-missing) daily e-diary values obtained during the placebo run-in phase.~(n=517, n=254)"|minutes|Mean|329.9|329.9|Standard Deviation|79.4|79.4|||
4079963|NCT01021813|3902794|B1|||Mean Subjective Total Sleep Time (sTSTm)|"The baseline sTSTm was defined as the participant’s reported total amount of time spent asleep before waking for the day (measured in minutes), calculated as the mean of the last 7 (non-missing) daily e-diary values obtained during the placebo run-in phase.~(n=517, n=254)"|minutes|Mean|320.4|320.4|Standard Deviation|76.1|76.1|||
4079964|NCT01021813|3902792|B3||Male|Sex: Female, Male||Participants|Count of Participants|343|343.0||||||
4079965|NCT01021813|3902793|B2||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4079966|NCT01021813|3902794|B1||Male|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
4079967|NCT01021813|3902792|B3||Female|Sex: Female, Male||Participants|Count of Participants|436|436.0||||||
4079968|NCT01021813|3902793|B2||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4079969|NCT01021813|3902794|B1||Female|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
4079970|NCT01021813|3902792|B3|||Age||years|Mean|61.5|61.5|Standard Deviation|14.5|14.5|||
4079971|NCT01021813|3902793|B2|||Age||years|Mean|62.0|62.0|Standard Deviation|14.6|14.6|||
4079972|NCT01021813|3902794|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|14.5|14.5|||
4079973|NCT01021761|3902837|B4|United States||Region of Enrollment||participants|Number|126|126.0||||||
4079974|NCT01021761|3902838|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4079975|NCT01021761|3902839|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
4079976|NCT01021761|3902840|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4079977|NCT01021761|3902837|B4||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4079978|NCT01021761|3902838|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4079979|NCT01021761|3902839|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4079980|NCT01021761|3902840|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4079981|NCT01021761|3902837|B4||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4079982|NCT01021761|3902838|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4079983|NCT01021761|3902839|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4079984|NCT01021761|3902840|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4079985|NCT01021761|3902837|B4|||Age||years|Mean|74|74.0|Standard Deviation|29|29.0|||
4079986|NCT01021761|3902838|B3|||Age||years|Mean|75|75.0|Standard Deviation|30|30.0|||
4079987|NCT01021761|3902839|B2|||Age||years|Mean|74|74.0|Standard Deviation|29|29.0|||
4079988|NCT01021761|3902840|B1|||Age||years|Mean|72|72.0|Standard Deviation|31|31.0|||
4079989|NCT01021761|3902837|B4||>=65 years|Age||Participants|Count of Participants|72|72.0||||||
4079990|NCT01021761|3902838|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4079991|NCT01021761|3902839|B2||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4079992|NCT01021761|3902840|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4079993|NCT01021761|3902837|B4||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4079994|NCT01021761|3902838|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4079995|NCT01021761|3902839|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4079996|NCT01021761|3902840|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4079997|NCT01021761|3902837|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4079998|NCT01021761|3902838|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4079999|NCT01021761|3902839|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4080000|NCT01021761|3902840|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4080001|NCT01021748|3902850|B10||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4080002|NCT01021748|3902851|B9||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4080003|NCT01021748|3902852|B8||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4080004|NCT01021748|3902853|B7||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4080005|NCT01021748|3902854|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4080006|NCT01021748|3902855|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4080007|NCT01021748|3902856|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4080008|NCT01021748|3902857|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4080009|NCT01021748|3902858|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4080010|NCT01021748|3902859|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4080011|NCT01021748|3902850|B10||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4080012|NCT01021748|3902851|B9||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4080013|NCT01021748|3902852|B8||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4080014|NCT01021748|3902853|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4080015|NCT01021748|3902854|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4080016|NCT01021748|3902855|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4080017|NCT01021748|3902856|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4080018|NCT01021748|3902857|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4080019|NCT01021748|3902858|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4080020|NCT01021748|3902859|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4080021|NCT01021748|3902850|B10|||Age||Years|Mean|56.8|56.8|Standard Deviation|11.1|11.1|||
4080022|NCT01021748|3902851|B9|||Age||Years|Mean|64.7|64.7|Standard Deviation|9.4|9.4|||
4080023|NCT01021748|3902852|B8|||Age||Years|Mean|54.3|54.3|Standard Deviation|15.3|15.3|||
4080024|NCT01021748|3902853|B7|||Age||Years|Mean|63.0|63.0|Standard Deviation|6.2|6.2|||
4080025|NCT01021748|3902854|B6|||Age||Years|Mean|44.3|44.3|Standard Deviation|8.0|8.0|||
4080026|NCT01021748|3902855|B5|||Age||Years|Mean|56.1|56.1|Standard Deviation|12.5|12.5|||
4080027|NCT01021748|3902856|B4|||Age||Years|Mean|56.6|56.6|Standard Deviation|7.3|7.3|||
4080028|NCT01021748|3902857|B3|||Age||Years|Mean|48.9|48.9|Standard Deviation|8.6|8.6|||
4080029|NCT01021748|3902858|B2|||Age||Years|Mean|50.0|50.0|Standard Deviation|5.9|5.9|||
4080030|NCT01021748|3902859|B1|||Age||Years|Mean|55.0|55.0|Standard Deviation|8.0|8.0|||
4080031|NCT01021683|3902914|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4080032|NCT01021683|3902914|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4080033|NCT01021683|3902914|B1|||Age||Years|Mean|52.2|52.2|Standard Deviation|15.0|15.0|||
4080034|NCT01021618|3902926|B3|Other||Indication for Stress Testing|Clinical indication for referral to the nuclear laboratory for stress testing, from the referring clinician|participants|Number|7|7.0||||||
4080035|NCT01021618|3902927|B2|Other||Indication for Stress Testing|Clinical indication for referral to the nuclear laboratory for stress testing, from the referring clinician|participants|Number|6|6.0||||||
4080036|NCT01021618|3902928|B1|Other||Indication for Stress Testing|Clinical indication for referral to the nuclear laboratory for stress testing, from the referring clinician|participants|Number|1|1.0||||||
4080037|NCT01021618|3902926|B3|Syncope or Near-Syncope||Indication for Stress Testing|Clinical indication for referral to the nuclear laboratory for stress testing, from the referring clinician|participants|Number|6|6.0||||||
4080038|NCT01021618|3902927|B2|Syncope or Near-Syncope||Indication for Stress Testing|Clinical indication for referral to the nuclear laboratory for stress testing, from the referring clinician|participants|Number|4|4.0||||||
4080039|NCT01021618|3902928|B1|Syncope or Near-Syncope||Indication for Stress Testing|Clinical indication for referral to the nuclear laboratory for stress testing, from the referring clinician|participants|Number|2|2.0||||||
4080040|NCT01021618|3902926|B3|Arrhythmia||Indication for Stress Testing|Clinical indication for referral to the nuclear laboratory for stress testing, from the referring clinician|participants|Number|8|8.0||||||
4080041|NCT01021618|3902927|B2|Arrhythmia||Indication for Stress Testing|Clinical indication for referral to the nuclear laboratory for stress testing, from the referring clinician|participants|Number|7|7.0||||||
4080042|NCT01021618|3902928|B1|Arrhythmia||Indication for Stress Testing|Clinical indication for referral to the nuclear laboratory for stress testing, from the referring clinician|participants|Number|1|1.0||||||
4080043|NCT01021618|3902926|B3|Dyspnea||Indication for Stress Testing|Clinical indication for referral to the nuclear laboratory for stress testing, from the referring clinician|participants|Number|12|12.0||||||
4080044|NCT01021618|3902927|B2|Dyspnea||Indication for Stress Testing|Clinical indication for referral to the nuclear laboratory for stress testing, from the referring clinician|participants|Number|8|8.0||||||
4080045|NCT01021618|3902928|B1|Dyspnea||Indication for Stress Testing|Clinical indication for referral to the nuclear laboratory for stress testing, from the referring clinician|participants|Number|4|4.0||||||
4080046|NCT01021618|3902926|B3|Chest Pain||Indication for Stress Testing|Clinical indication for referral to the nuclear laboratory for stress testing, from the referring clinician|participants|Number|107|107.0||||||
4080047|NCT01021618|3902927|B2|Chest Pain||Indication for Stress Testing|Clinical indication for referral to the nuclear laboratory for stress testing, from the referring clinician|participants|Number|71|71.0||||||
4080048|NCT01021618|3902928|B1|Chest Pain||Indication for Stress Testing|Clinical indication for referral to the nuclear laboratory for stress testing, from the referring clinician|participants|Number|36|36.0||||||
4080049|NCT01021618|3902926|B3|No known coronary disease||Known Coronary Artery Disease|History of either myocardial infarction or coronary revascularization|participants|Number|96|96.0||||||
4080050|NCT01021618|3902927|B2|No known coronary disease||Known Coronary Artery Disease|History of either myocardial infarction or coronary revascularization|participants|Number|67|67.0||||||
4080051|NCT01021618|3902928|B1|No known coronary disease||Known Coronary Artery Disease|History of either myocardial infarction or coronary revascularization|participants|Number|29|29.0||||||
4080052|NCT01021618|3902926|B3|Any known coronary disease||Known Coronary Artery Disease|History of either myocardial infarction or coronary revascularization|participants|Number|44|44.0||||||
4080053|NCT01021618|3902927|B2|Any known coronary disease||Known Coronary Artery Disease|History of either myocardial infarction or coronary revascularization|participants|Number|29|29.0||||||
4080054|NCT01021618|3902928|B1|Any known coronary disease||Known Coronary Artery Disease|History of either myocardial infarction or coronary revascularization|participants|Number|15|15.0||||||
4080055|NCT01021618|3902926|B3|Other||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4080056|NCT01021618|3902927|B2|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4080057|NCT01021618|3902928|B1|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4080058|NCT01021618|3902926|B3|Black||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
4080059|NCT01021618|3902927|B2|Black||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4080060|NCT01021618|3902928|B1|Black||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4080061|NCT01021618|3902926|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
4080062|NCT01021618|3902927|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
4080063|NCT01021618|3902928|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4080064|NCT01021618|3902926|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|71|71.0||||||
4080065|NCT01021618|3902927|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|50|50.0||||||
4080066|NCT01021618|3902928|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
4080067|NCT01021618|3902926|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4080068|NCT01021618|3902927|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4080069|NCT01021618|3902928|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4080070|NCT01021618|3902926|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4080071|NCT01021618|3902927|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4080072|NCT01021618|3902928|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4080073|NCT01021618|3902926|B3|||Age||years|Mean|62|62.0|Standard Deviation|12|12.0|||
4080074|NCT01021618|3902927|B2|||Age||years|Mean|63|63.0|Standard Deviation|11|11.0|||
4080075|NCT01021618|3902928|B1|||Age||years|Mean|59|59.0|Standard Deviation|13|13.0|||
4080076|NCT01021553|3902937|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080077|NCT01021553|3902938|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080078|NCT01021553|3902939|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080079|NCT01021553|3902940|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080080|NCT01021553|3902937|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4080081|NCT01021553|3902938|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4080082|NCT01021553|3902939|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080083|NCT01021553|3902940|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080084|NCT01021553|3902937|B4||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4080085|NCT01021553|3902938|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4080086|NCT01021553|3902939|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4080087|NCT01021553|3902940|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4080088|NCT01021553|3902937|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4080089|NCT01021553|3902938|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4080090|NCT01021553|3902939|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4080091|NCT01021553|3902940|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4080092|NCT01021553|3902937|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4080093|NCT01021553|3902938|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4080094|NCT01021553|3902939|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080095|NCT01021553|3902940|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080096|NCT01021553|3902937|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4080097|NCT01021553|3902938|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4080098|NCT01021553|3902939|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080099|NCT01021553|3902940|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4080100|NCT01021553|3902937|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080101|NCT01021553|3902938|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080102|NCT01021553|3902939|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080103|NCT01021553|3902940|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080104|NCT01021553|3902937|B4||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4080105|NCT01021553|3902938|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4080106|NCT01021553|3902939|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4080107|NCT01021553|3902940|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4080108|NCT01021553|3902937|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4080109|NCT01021553|3902938|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4080110|NCT01021553|3902939|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4080111|NCT01021553|3902940|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4080112|NCT01021553|3902937|B4|||Age||Years|Mean|36.7|36.7|Standard Deviation|9.31|9.31|||
4080113|NCT01021553|3902938|B3|||Age||Years|Mean|34.0|34.0|Standard Deviation|9.00|9.0|||
4080114|NCT01021553|3902939|B2|||Age||Years|Mean|37.9|37.9|Standard Deviation|9.85|9.85|||
4080115|NCT01021553|3902940|B1|||Age||Years|Mean|38.4|38.4|Standard Deviation|8.90|8.9|||
4080116|NCT01021423|3902994|B3|Partial response||Response of Mantle Cell Lymphoma (MCL) to chemotherapy at enrollment|Participants' response to first-line chemotherapy. Response evaluation was as defined by 2007 Revised Response Criteria for Malignant Lymphoma (Cheson 2007). Complete response (CR) is defined as the complete disappearance of all detectable clinical and radiographic evidence of disease and the disappearance of all disease-related symptoms if present before therapy. Partial response (PR) is defined as the regression of measurable disease and no appearance of new sites of disease. For full definitions, please refer to the 2007 Revised Response Criteria for Malignant Lymphoma (Cheson 2007).|participants|Number|5|5.0||||||
4080117|NCT01021423|3902995|B2|Partial response||Response of Mantle Cell Lymphoma (MCL) to chemotherapy at enrollment|Participants' response to first-line chemotherapy. Response evaluation was as defined by 2007 Revised Response Criteria for Malignant Lymphoma (Cheson 2007). Complete response (CR) is defined as the complete disappearance of all detectable clinical and radiographic evidence of disease and the disappearance of all disease-related symptoms if present before therapy. Partial response (PR) is defined as the regression of measurable disease and no appearance of new sites of disease. For full definitions, please refer to the 2007 Revised Response Criteria for Malignant Lymphoma (Cheson 2007).|participants|Number|4|4.0||||||
4080118|NCT01021423|3902996|B1|Partial response||Response of Mantle Cell Lymphoma (MCL) to chemotherapy at enrollment|Participants' response to first-line chemotherapy. Response evaluation was as defined by 2007 Revised Response Criteria for Malignant Lymphoma (Cheson 2007). Complete response (CR) is defined as the complete disappearance of all detectable clinical and radiographic evidence of disease and the disappearance of all disease-related symptoms if present before therapy. Partial response (PR) is defined as the regression of measurable disease and no appearance of new sites of disease. For full definitions, please refer to the 2007 Revised Response Criteria for Malignant Lymphoma (Cheson 2007).|participants|Number|1|1.0||||||
4080119|NCT01021423|3902994|B3|Complete response||Response of Mantle Cell Lymphoma (MCL) to chemotherapy at enrollment|Participants' response to first-line chemotherapy. Response evaluation was as defined by 2007 Revised Response Criteria for Malignant Lymphoma (Cheson 2007). Complete response (CR) is defined as the complete disappearance of all detectable clinical and radiographic evidence of disease and the disappearance of all disease-related symptoms if present before therapy. Partial response (PR) is defined as the regression of measurable disease and no appearance of new sites of disease. For full definitions, please refer to the 2007 Revised Response Criteria for Malignant Lymphoma (Cheson 2007).|participants|Number|4|4.0||||||
4080120|NCT01021423|3902995|B2|Complete response||Response of Mantle Cell Lymphoma (MCL) to chemotherapy at enrollment|Participants' response to first-line chemotherapy. Response evaluation was as defined by 2007 Revised Response Criteria for Malignant Lymphoma (Cheson 2007). Complete response (CR) is defined as the complete disappearance of all detectable clinical and radiographic evidence of disease and the disappearance of all disease-related symptoms if present before therapy. Partial response (PR) is defined as the regression of measurable disease and no appearance of new sites of disease. For full definitions, please refer to the 2007 Revised Response Criteria for Malignant Lymphoma (Cheson 2007).|participants|Number|1|1.0||||||
4080159|NCT01021332|3903013|B1|||Urgency incontinence episodes /24 hour|FAS population. An urgency incontinence episode is defined as an episode with any involuntary leakage of urine accompanied by or immediately preceded by urgency. The mean number of urgency incontinence episodes with PPIUS grade 3 (Severe urgency) or 4 (Urgency incontinence) per 24 hours was calculated from data recorded by the participant in the micturition diary for the 3 days preceding each clinic visit.|urgency incontinence episodes|Mean|1.74|1.74|Standard Deviation|1.97|1.97|||
4080196|NCT01021306|3903051|B1|||Age||years|Mean|31.7|31.7|Standard Deviation|7.9|7.9|||
4080121|NCT01021423|3902996|B1|Complete response||Response of Mantle Cell Lymphoma (MCL) to chemotherapy at enrollment|Participants' response to first-line chemotherapy. Response evaluation was as defined by 2007 Revised Response Criteria for Malignant Lymphoma (Cheson 2007). Complete response (CR) is defined as the complete disappearance of all detectable clinical and radiographic evidence of disease and the disappearance of all disease-related symptoms if present before therapy. Partial response (PR) is defined as the regression of measurable disease and no appearance of new sites of disease. For full definitions, please refer to the 2007 Revised Response Criteria for Malignant Lymphoma (Cheson 2007).|participants|Number|3|3.0||||||
4080122|NCT01021423|3902994|B3|Status = 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Category 0 = Fully active, able to carry on all pre-diseases performance without restriction; Category 1 = restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (e.g. light housework, office work).|participants|Number|2|2.0||||||
4080123|NCT01021423|3902995|B2|Status = 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Category 0 = Fully active, able to carry on all pre-diseases performance without restriction; Category 1 = restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (e.g. light housework, office work).|participants|Number|2|2.0||||||
4080124|NCT01021423|3902996|B1|Status = 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Category 0 = Fully active, able to carry on all pre-diseases performance without restriction; Category 1 = restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (e.g. light housework, office work).|participants|Number|0|0.0||||||
4080125|NCT01021423|3902994|B3|Status = 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Category 0 = Fully active, able to carry on all pre-diseases performance without restriction; Category 1 = restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (e.g. light housework, office work).|participants|Number|7|7.0||||||
4080126|NCT01021423|3902995|B2|Status = 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Category 0 = Fully active, able to carry on all pre-diseases performance without restriction; Category 1 = restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (e.g. light housework, office work).|participants|Number|3|3.0||||||
4080127|NCT01021423|3902996|B1|Status = 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Category 0 = Fully active, able to carry on all pre-diseases performance without restriction; Category 1 = restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (e.g. light housework, office work).|participants|Number|4|4.0||||||
4080128|NCT01021423|3902994|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080129|NCT01021423|3902995|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080130|NCT01021423|3902996|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080131|NCT01021423|3902994|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080132|NCT01021423|3902995|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080133|NCT01021423|3902996|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080134|NCT01021423|3902994|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4080135|NCT01021423|3902995|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4080136|NCT01021423|3902996|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4080137|NCT01021423|3902994|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080138|NCT01021423|3902995|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080139|NCT01021423|3902996|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080140|NCT01021423|3902994|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080141|NCT01021423|3902995|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080142|NCT01021423|3902996|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080143|NCT01021423|3902994|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080144|NCT01021423|3902995|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080145|NCT01021423|3902996|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080146|NCT01021423|3902994|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080147|NCT01021423|3902995|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080148|NCT01021423|3902996|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080149|NCT01021423|3902994|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4080150|NCT01021423|3902995|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4080151|NCT01021423|3902996|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4080152|NCT01021423|3902994|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4080153|NCT01021423|3902995|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4080154|NCT01021423|3902996|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4080155|NCT01021423|3902994|B3|||Age||years|Mean|75.1|75.1|Standard Deviation|6.17|6.17|||
4080156|NCT01021423|3902995|B2|||Age||years|Mean|73.0|73.0|Standard Deviation|6.89|6.89|||
4080157|NCT01021423|3902996|B1|||Age||years|Mean|77.8|77.8|Standard Deviation|4.65|4.65|||
4080158|NCT01021332|3903013|B1|||Nocturia episodes/ 24 hour|FAS population. A nocturia episode is defined as waking up at night to void (i.e., any voiding associated with sleep disturbance between the time the participant goes to bed with the intention to sleep until the time the patient gets up in the morning with the intention to stay awake). The mean number of nocturia episodes per 24 hours was calculated from data recorded by the participant in the micturition diary for the 3 days preceding each clinic visit.|nocturia episodes|Mean|2.40|2.4|Standard Deviation|1.26|1.26|||
4080160|NCT01021332|3903013|B1|||Incontinence episodes/24 hour|FAS population. An incontinence episode is defined as an episode with any involuntary loss of urine. The mean number of incontinence episodes per 24 hours was calculated from data recorded by the participant in the micturition diary for the 3 days preceding each clinic visit.|incontinence episodes|Mean|1.77|1.77|Standard Deviation|2.04|2.04|||
4080161|NCT01021332|3903013|B1|||Volume voided/micturition|FAS population. A micturition is any voluntary urination, excluding episodes of incontinence only. The mean volume voided per micturition was calculated from data recorded by the participant in the micturition diary for the 3 days preceding each clinic visit.|ml|Mean|162.81|162.81|Standard Deviation|47.57|47.57|||
4080162|NCT01021332|3903013|B1|||Micturitions/24 hour|FAS population. A micturition is any voluntary urination, excluding episodes of incontinence only. The mean number of micturitions per 24 hours was calculated from data recorded by the participant in the micturition diary for the 3 days preceding each clinic visit.|micturitions|Mean|11.44|11.44|Standard Deviation|2.61|2.61|||
4080163|NCT01021332|3903013|B1|||Total Urgency Frequency Score (TUFS) (previous known as Total Urgency Score (TUS)|FAS population.The Participant Perception of the Intensity of Urgency Scale (PPIUS) is a validated scale completed as part of the micturition diary. For each micturition and/or incontinence episode, the participant rated the degree of associated urgency according to the following 5-point categorical scale: 0.No urgency; 1.Mild urgency; 2.Moderate urgency; 3.Severe urgency; 4.Urgency incontinence. TUFS/TUS was the sum of the PPIUS gradings from the 3-day diary divided by the number of days on which urgency grading was recorded.|units on a scale|Mean|27.18|27.18|Standard Deviation|8.59|8.59|||
4080164|NCT01021332|3903013|B1|||IPSS Quality of Life Score(Qol) score|FAS population excluding 5 patients with invalid questionnaires. The QoL assessment was a single question asking the participant how he would feel about tolerating his current level of symptoms for the rest of his life. The answers ranged from 0 to 6 (delighted to terrible).|units on a scale|Mean|4.1|4.1|Standard Deviation|1.09|1.09|||
4080165|NCT01021332|3903013|B1|||Total International Prostate Symptom Score (IPSS) storage score|"FAS population excluding 5 patients with invalid questionnaires.The IPSS is a validated global questionnaire to assess the degree of bother from urinary symptoms based on answers to 7 questions. Each question is assigned points from 0 to 5 indicating increasing severity of the particular symptom. The storage symptom score is the sum of the responses to 3 storage questions (frequency, urgency and nocturia) and ranges from 0 to 15 (mildly symptomatic to severely symptomatic)."|units on a scale|Mean|8.9|8.9|Standard Deviation|2.37|2.37|||
4080166|NCT01021332|3903013|B1|||Total International Prostate Symptom Score (IPSS) voiding score|"FAS population excluding 5 patients with invalid questionnaires. The IPSS is a validated global questionnaire to assess the degree of bother from urinary symptoms based on answers to 7 questions. Each question is assigned points from 0 to 5 indicating increasing severity of the particular symptom. The voiding score is the sum of the responses to 4 voiding questions (incomplete emptying of the bladder, intermittency, weak stream, hesitancy) and ranges from 0 to 20 (mildly symptomatic to severely symptomatic)."|units on a scale|Mean|9.8|9.8|Standard Deviation|3.58|3.58|||
4080167|NCT01021332|3903013|B1|||Total International Prostate Symptom Score (IPSS)|"FAS population excluding 5 patients with invalid questionnaires. The IPSS is a validated global questionnaire to assess the degree of bother from urinary symptoms, based on answers to 7questions concerning urinary symptoms:~Incomplete emptying of the bladder~Intermittency~Weak stream~Hesitancy~Frequency~Urgency~Nocturia Each question is assigned points from 0 to 5 indicating increasing severity of the symptom. Total score can range from 0 to 35 (mildly symptomatic to severely symptomatic)."|units on a scale|Mean|18.7|18.7|Standard Deviation|4.41|4.41|||
4080168|NCT01021332|3903013|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4080169|NCT01021332|3903013|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4080170|NCT01021332|3903013|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4080171|NCT01021332|3903013|B1|White||Race/Ethnicity, Customized||participants|Number|1060|1060.0||||||
4080172|NCT01021332|3903013|B1|Female||Sex/Gender, Customized||participants|Number|0|0.0||||||
4080173|NCT01021332|3903013|B1|Male||Sex/Gender, Customized||participants|Number|1066|1066.0||||||
4080174|NCT01021332|3903013|B1|> 75 years||Age, Customized||participants|Number|109|109.0||||||
4080175|NCT01021332|3903013|B1|>65 and < 75 years||Age, Customized||participants|Number|417|417.0||||||
4080176|NCT01021332|3903013|B1|<65 years||Age, Customized||participants|Number|540|540.0||||||
4080177|NCT01021306|3903047|B5|United States||Region of Enrollment||participants|Number|80|80.0||||||
4080178|NCT01021306|3903048|B4|United States||Region of Enrollment||participants|Number|21|21.0||||||
4080179|NCT01021306|3903049|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4080180|NCT01021306|3903050|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4080181|NCT01021306|3903051|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4080182|NCT01021306|3903047|B5||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4080183|NCT01021306|3903048|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4080184|NCT01021306|3903049|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4080185|NCT01021306|3903050|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4080186|NCT01021306|3903051|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4080187|NCT01021306|3903047|B5||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4080188|NCT01021306|3903048|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4080189|NCT01021306|3903049|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4080190|NCT01021306|3903050|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4080191|NCT01021306|3903051|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4080192|NCT01021306|3903047|B5|||Age||years|Mean|35.0|35.0|Standard Deviation|11.7|11.7|||
4080193|NCT01021306|3903048|B4|||Age||years|Mean|38.0|38.0|Standard Deviation|12.7|12.7|||
4080194|NCT01021306|3903049|B3|||Age||years|Mean|33.1|33.1|Standard Deviation|11.4|11.4|||
4080195|NCT01021306|3903050|B2|||Age||years|Mean|36.9|36.9|Standard Deviation|13.5|13.5|||
4080197|NCT01021293|3903072|B3|Asian-Chinese heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1100|1100.0||||||
4080198|NCT01021293|3903073|B2|Asian-Chinese heritage||Race/Ethnicity, Customized||Participants|Count of Participants|550|550.0||||||
4080199|NCT01021293|3903074|B1|Asian-Chinese heritage||Race/Ethnicity, Customized||Participants|Count of Participants|550|550.0||||||
4080200|NCT01021293|3903072|B3||Male|Sex: Female, Male||Participants|Count of Participants|573|573.0||||||
4080201|NCT01021293|3903073|B2||Male|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
4080202|NCT01021293|3903074|B1||Male|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
4080203|NCT01021293|3903072|B3||Female|Sex: Female, Male||Participants|Count of Participants|527|527.0||||||
4080204|NCT01021293|3903073|B2||Female|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
4080205|NCT01021293|3903074|B1||Female|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
4080206|NCT01021293|3903072|B3|||Age||Weeks|Mean|10.05|10.05|Standard Deviation|1.17|1.17|||
4080207|NCT01021293|3903073|B2|||Age||Weeks|Mean|10.1|10.1|Standard Deviation|1.18|1.18|||
4080208|NCT01021293|3903074|B1|||Age||Weeks|Mean|10|10.0|Standard Deviation|1.16|1.16|||
4080209|NCT01021215|3903092|B3|||Age, Continuous, Compliant Participants|Baseline measure includes the 70 compliant study participants only.|years|Mean|43.6|43.6|Standard Deviation|9.1|9.1|||
4080210|NCT01021215|3903093|B2|||Age, Continuous, Compliant Participants|Baseline measure includes the 70 compliant study participants only.|years|Mean|43.1|43.1|Standard Deviation|7.6|7.6|||
4080211|NCT01021215|3903094|B1|||Age, Continuous, Compliant Participants|Baseline measure includes the 70 compliant study participants only.|years|Mean|43.8|43.8|Standard Deviation|9.6|9.6|||
4080212|NCT01021215|3903092|B3|Unknown or Not Reported||Race, Compliant Participants|Baseline measure includes the 70 compliant study participants only.|participants|Number|0|0.0||||||
4080213|NCT01021215|3903093|B2|Unknown or Not Reported||Race, Compliant Participants|Baseline measure includes the 70 compliant study participants only.|participants|Number|0|0.0||||||
4080214|NCT01021215|3903094|B1|Unknown or Not Reported||Race, Compliant Participants|Baseline measure includes the 70 compliant study participants only.|participants|Number|0|0.0||||||
4080215|NCT01021215|3903092|B3|White||Race, Compliant Participants|Baseline measure includes the 70 compliant study participants only.|participants|Number|33|33.0||||||
4080216|NCT01021215|3903093|B2|White||Race, Compliant Participants|Baseline measure includes the 70 compliant study participants only.|participants|Number|9|9.0||||||
4080217|NCT01021215|3903094|B1|White||Race, Compliant Participants|Baseline measure includes the 70 compliant study participants only.|participants|Number|24|24.0||||||
4080218|NCT01021215|3903092|B3|Black or African American||Race, Compliant Participants|Baseline measure includes the 70 compliant study participants only.|participants|Number|35|35.0||||||
4080219|NCT01021215|3903093|B2|Black or African American||Race, Compliant Participants|Baseline measure includes the 70 compliant study participants only.|participants|Number|7|7.0||||||
4080220|NCT01021215|3903094|B1|Black or African American||Race, Compliant Participants|Baseline measure includes the 70 compliant study participants only.|participants|Number|28|28.0||||||
4080221|NCT01021215|3903092|B3|Native Hawaiian or Other Pacific Islander||Race, Compliant Participants|Baseline measure includes the 70 compliant study participants only.|participants|Number|0|0.0||||||
4080222|NCT01021215|3903093|B2|Native Hawaiian or Other Pacific Islander||Race, Compliant Participants|Baseline measure includes the 70 compliant study participants only.|participants|Number|0|0.0||||||
4080223|NCT01021215|3903094|B1|Native Hawaiian or Other Pacific Islander||Race, Compliant Participants|Baseline measure includes the 70 compliant study participants only.|participants|Number|0|0.0||||||
4080224|NCT01021215|3903092|B3|Asian||Race, Compliant Participants|Baseline measure includes the 70 compliant study participants only.|participants|Number|2|2.0||||||
4080225|NCT01021215|3903093|B2|Asian||Race, Compliant Participants|Baseline measure includes the 70 compliant study participants only.|participants|Number|2|2.0||||||
4080226|NCT01021215|3903094|B1|Asian||Race, Compliant Participants|Baseline measure includes the 70 compliant study participants only.|participants|Number|0|0.0||||||
4080227|NCT01021215|3903092|B3|American Indian or Alaska Native||Race, Compliant Participants|Baseline measure includes the 70 compliant study participants only.|participants|Number|0|0.0||||||
4080228|NCT01021215|3903093|B2|American Indian or Alaska Native||Race, Compliant Participants|Baseline measure includes the 70 compliant study participants only.|participants|Number|0|0.0||||||
4080229|NCT01021215|3903094|B1|American Indian or Alaska Native||Race, Compliant Participants|Baseline measure includes the 70 compliant study participants only.|participants|Number|0|0.0||||||
4080230|NCT01021215|3903092|B3|Male||Gender, Male/Female: Compliant Participants|Measure includes the 70 compliant study participants only.|participants|Number|43|43.0||||||
4080231|NCT01021215|3903093|B2|Male||Gender, Male/Female: Compliant Participants|Measure includes the 70 compliant study participants only.|participants|Number|10|10.0||||||
4080232|NCT01021215|3903094|B1|Male||Gender, Male/Female: Compliant Participants|Measure includes the 70 compliant study participants only.|participants|Number|33|33.0||||||
4080233|NCT01021215|3903092|B3|Female||Gender, Male/Female: Compliant Participants|Measure includes the 70 compliant study participants only.|participants|Number|27|27.0||||||
4080234|NCT01021215|3903093|B2|Female||Gender, Male/Female: Compliant Participants|Measure includes the 70 compliant study participants only.|participants|Number|8|8.0||||||
4080235|NCT01021215|3903094|B1|Female||Gender, Male/Female: Compliant Participants|Measure includes the 70 compliant study participants only.|participants|Number|19|19.0||||||
4080236|NCT01021215|3903092|B3|||Baseline LTE4 (pg/mg CR)|Leukotriene E4 (LTE4) levels via creatinine (Cr) in the urine measured by a chemical assay. Baseline measure includes the 70 compliant study participants only.|pg/mg CR|Median|102.5|102.5|Full Range|||4.0|268.0|
4080237|NCT01021215|3903093|B2|||Baseline LTE4 (pg/mg CR)|Leukotriene E4 (LTE4) levels via creatinine (Cr) in the urine measured by a chemical assay. Baseline measure includes the 70 compliant study participants only.|pg/mg CR|Median|86.5|86.5|Full Range|||37.0|250.0|
4080289|NCT01021020|3903110|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4080238|NCT01021215|3903094|B1|||Baseline LTE4 (pg/mg CR)|Leukotriene E4 (LTE4) levels via creatinine (Cr) in the urine measured by a chemical assay. Baseline measure includes the 70 compliant study participants only.|pg/mg CR|Median|107|107.0|Full Range|||4.0|268.0|
4080239|NCT01021215|3903092|B3|||Baseline PGE-M (ng/mg Cr)|Prostaglandin E metabolite (PGE-M) levels via creatinine (Cr) in the urine measured by a chemical assay. Baseline measure includes the 70 compliant study participants only.|ng/mg Cr|Median|12.6|12.6|Full Range|||1.4|50.4|
4080240|NCT01021215|3903093|B2|||Baseline PGE-M (ng/mg Cr)|Prostaglandin E metabolite (PGE-M) levels via creatinine (Cr) in the urine measured by a chemical assay. Baseline measure includes the 70 compliant study participants only.|ng/mg Cr|Median|10.2|10.2|Full Range|||2.3|35.1|
4080241|NCT01021215|3903094|B1|||Baseline PGE-M (ng/mg Cr)|Prostaglandin E metabolite (PGE-M) levels via creatinine (Cr) in the urine measured by a chemical assay. Baseline measure includes the 70 compliant study participants only.|ng/mg Cr|Median|12.8|12.8|Full Range|||1.4|50.4|
4080242|NCT01021215|3903092|B3|||Smoking (Packs per Year)|Number of cigarette packs smoked annually; Measure includes the 70 compliant participants only.|cigarette packs|Median|19.5|19.5|Full Range|||10.0|68.0|
4080243|NCT01021215|3903093|B2|||Smoking (Packs per Year)|Number of cigarette packs smoked annually; Measure includes the 70 compliant participants only.|cigarette packs|Median|19.5|19.5|Full Range|||10.0|40.0|
4080244|NCT01021215|3903094|B1|||Smoking (Packs per Year)|Number of cigarette packs smoked annually; Measure includes the 70 compliant participants only.|cigarette packs|Median|19.5|19.5|Full Range|||10.0|68.0|
4080245|NCT01021215|3903092|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
4080246|NCT01021215|3903093|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4080247|NCT01021215|3903094|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4080248|NCT01021215|3903092|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4080249|NCT01021215|3903093|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4080250|NCT01021215|3903094|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4080251|NCT01021215|3903092|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080252|NCT01021215|3903093|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080253|NCT01021215|3903094|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080254|NCT01021215|3903092|B3||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4080255|NCT01021215|3903093|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4080256|NCT01021215|3903094|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4080257|NCT01021215|3903092|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4080258|NCT01021215|3903093|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4080259|NCT01021215|3903094|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4080260|NCT01021215|3903092|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080261|NCT01021215|3903093|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080262|NCT01021215|3903094|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080263|NCT01021215|3903092|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4080264|NCT01021215|3903093|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4080265|NCT01021215|3903094|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080266|NCT01021215|3903092|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080267|NCT01021215|3903093|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080268|NCT01021215|3903094|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080269|NCT01021215|3903092|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4080270|NCT01021215|3903093|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4080271|NCT01021215|3903094|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4080272|NCT01021215|3903092|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4080273|NCT01021215|3903093|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4080274|NCT01021215|3903094|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4080275|NCT01021215|3903092|B3|||Age||years|Median|43|43.0|Full Range|||25.0|64.0|
4080276|NCT01021215|3903093|B2|||Age||years|Median|43|43.0|Full Range|||30.0|54.0|
4080277|NCT01021215|3903094|B1|||Age||years|Median|45|45.0|Full Range|||25.0|64.0|
4080278|NCT01021111|3903105|B1|||Thigh coronal angular velocity||degrees/second|Mean|67.7|67.7|Standard Deviation|49.7|49.7|||
4080279|NCT01021111|3903105|B1|||Trunk lean||degrees|Mean|23.6|23.6|Standard Deviation|8.0|8.0|||
4080280|NCT01021111|3903105|B1|||Knee Flexion Angle||degrees|Mean|88.8|88.8|Standard Deviation|8.0|8.0|||
4080281|NCT01021111|3903105|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4080282|NCT01021111|3903105|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4080283|NCT01021111|3903105|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4080284|NCT01021111|3903105|B1|||Age||years|Mean|27.5|27.5|Standard Deviation|2.3|2.3|||
4080285|NCT01021020|3903110|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4080286|NCT01021020|3903110|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4080287|NCT01021020|3903110|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080288|NCT01021020|3903110|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4080290|NCT01021020|3903110|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080291|NCT01021020|3903110|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080292|NCT01021020|3903110|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4080293|NCT01021020|3903110|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4080294|NCT01021020|3903110|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4080295|NCT01021020|3903110|B1|||Age||years|Mean|23.7|23.7|Standard Deviation|5.7|5.7|||
4080296|NCT01021020|3903110|B1||>=65 years|Age|age range: >=18 and <=45 years old|Participants|Count of Participants|0|0.0||||||
4080297|NCT01021020|3903110|B1||Between 18 and 65 years|Age|age range: >=18 and <=45 years old|Participants|Count of Participants|28|28.0||||||
4080298|NCT01021020|3903110|B1||<=18 years|Age|age range: >=18 and <=45 years old|Participants|Count of Participants|0|0.0||||||
4080299|NCT01021007|3903124|B3|United States||Region of Enrollment||participants|Number|73|73.0||||||
4080300|NCT01021007|3903125|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4080301|NCT01021007|3903126|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4080302|NCT01021007|3903124|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4080303|NCT01021007|3903125|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4080304|NCT01021007|3903126|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4080305|NCT01021007|3903124|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4080306|NCT01021007|3903125|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4080307|NCT01021007|3903126|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4080308|NCT01021007|3903124|B3|||Age||years|Mean|37.2|37.2|Standard Deviation|9.6|9.6|||
4080309|NCT01021007|3903125|B2|||Age||years|Mean|36.6|36.6|Standard Deviation|10.9|10.9|||
4080310|NCT01021007|3903126|B1|||Age||years|Mean|37.8|37.8|Standard Deviation|8.3|8.3|||
4080311|NCT01021007|3903124|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4080312|NCT01021007|3903125|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4080313|NCT01021007|3903126|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4080314|NCT01021007|3903124|B3||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4080315|NCT01021007|3903125|B2||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4080316|NCT01021007|3903126|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4080317|NCT01021007|3903124|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4080318|NCT01021007|3903125|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4080319|NCT01021007|3903126|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4080320|NCT01020981|3903137|B3|Unknown||Sex/Gender, Customized||participants|Number|22|22.0||||||
4080321|NCT01020981|3903138|B2|Unknown||Sex/Gender, Customized||participants|Number|4|4.0||||||
4080322|NCT01020981|3903139|B1|Unknown||Sex/Gender, Customized||participants|Number|18|18.0||||||
4080323|NCT01020981|3903137|B3|Female||Sex/Gender, Customized||participants|Number|13|13.0||||||
4080324|NCT01020981|3903138|B2|Female||Sex/Gender, Customized||participants|Number|10|10.0||||||
4080325|NCT01020981|3903139|B1|Female||Sex/Gender, Customized||participants|Number|3|3.0||||||
4080326|NCT01020981|3903137|B3|Male||Sex/Gender, Customized||participants|Number|106|106.0||||||
4080327|NCT01020981|3903138|B2|Male||Sex/Gender, Customized||participants|Number|46|46.0||||||
4080328|NCT01020981|3903139|B1|Male||Sex/Gender, Customized||participants|Number|60|60.0||||||
4080329|NCT01020981|3903137|B3|Unknown||Age, Customized||participants|Number|17|17.0||||||
4080330|NCT01020981|3903138|B2|Unknown||Age, Customized||participants|Number|0|0.0||||||
4080331|NCT01020981|3903139|B1|Unknown||Age, Customized||participants|Number|17|17.0||||||
4080332|NCT01020981|3903137|B3|>50 yrs||Age, Customized||participants|Number|18|18.0||||||
4080333|NCT01020981|3903138|B2|>50 yrs||Age, Customized||participants|Number|15|15.0||||||
4080334|NCT01020981|3903139|B1|>50 yrs||Age, Customized||participants|Number|3|3.0||||||
4080335|NCT01020981|3903137|B3|41-50 yrs||Age, Customized||participants|Number|46|46.0||||||
4080336|NCT01020981|3903138|B2|41-50 yrs||Age, Customized||participants|Number|28|28.0||||||
4080337|NCT01020981|3903139|B1|41-50 yrs||Age, Customized||participants|Number|18|18.0||||||
4080338|NCT01020981|3903137|B3|31-40 yrs||Age, Customized||participants|Number|23|23.0||||||
4080339|NCT01020981|3903138|B2|31-40 yrs||Age, Customized||participants|Number|8|8.0||||||
4080340|NCT01020981|3903139|B1|31-40 yrs||Age, Customized||participants|Number|15|15.0||||||
4080341|NCT01020981|3903137|B3|22-30 yrs||Age, Customized||participants|Number|32|32.0||||||
4080342|NCT01020981|3903138|B2|22-30 yrs||Age, Customized||participants|Number|9|9.0||||||
4080343|NCT01020981|3903139|B1|22-30 yrs||Age, Customized||participants|Number|23|23.0||||||
4080344|NCT01020981|3903137|B3|18-21 yrs||Age, Customized||participants|Number|5|5.0||||||
4080345|NCT01020981|3903138|B2|18-21 yrs||Age, Customized||participants|Number|0|0.0||||||
4080346|NCT01020981|3903139|B1|18-21 yrs||Age, Customized||participants|Number|5|5.0||||||
4080347|NCT01020877|3903159|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
4080348|NCT01020877|3903160|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4080349|NCT01020877|3903161|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4080350|NCT01020877|3903159|B3|More Than One||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4080351|NCT01020877|3903160|B2|More Than One||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4080352|NCT01020877|3903161|B1|More Than One||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4080353|NCT01020877|3903159|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4080354|NCT01020877|3903160|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4080355|NCT01020877|3903161|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4080356|NCT01020877|3903159|B3|Black||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4080357|NCT01020877|3903160|B2|Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4080358|NCT01020877|3903161|B1|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4080359|NCT01020877|3903159|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4080360|NCT01020877|3903160|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4080361|NCT01020877|3903161|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4080362|NCT01020877|3903159|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4080363|NCT01020877|3903160|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4080364|NCT01020877|3903161|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4080365|NCT01020877|3903159|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4080366|NCT01020877|3903160|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4080367|NCT01020877|3903161|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4080368|NCT01020877|3903159|B3||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4080369|NCT01020877|3903160|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4080370|NCT01020877|3903161|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4080371|NCT01020877|3903159|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4080372|NCT01020877|3903160|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4080373|NCT01020877|3903161|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4080374|NCT01020838|3903172|B1|Healthy negative control||Baseline clinical diagnosis||participants|Number|11|11.0||||||
4080375|NCT01020838|3903172|B1|Healthy volunteers||Baseline clinical diagnosis||participants|Number|32|32.0||||||
4080376|NCT01020838|3903172|B1|Other dementia subject||Baseline clinical diagnosis||participants|Number|31|31.0||||||
4080377|NCT01020838|3903172|B1|Dementia with Lewy bodies||Baseline clinical diagnosis||participants|Number|5|5.0||||||
4080378|NCT01020838|3903172|B1|Alzheimer's Disease||Baseline clinical diagnosis||participants|Number|137|137.0||||||
4080379|NCT01020838|3903172|B1|||Height||cm|Mean|164.70|164.7|Standard Deviation|12.34|12.34|||
4080380|NCT01020838|3903172|B1|||Body weight||kg|Mean|64.95|64.95|Standard Deviation|18.44|18.44|||
4080381|NCT01020838|3903172|B1|||BMI (kg/m^2)||kg/m^2|Mean|23.617|23.617|Standard Deviation|5.213|5.213|||
4080382|NCT01020838|3903172|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080383|NCT01020838|3903172|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080384|NCT01020838|3903172|B1||White|Race (NIH/OMB)||Participants|Count of Participants|159|159.0||||||
4080385|NCT01020838|3903172|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4080386|NCT01020838|3903172|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080387|NCT01020838|3903172|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4080388|NCT01020838|3903172|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080389|NCT01020838|3903172|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080390|NCT01020838|3903172|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|213|213.0||||||
4080391|NCT01020838|3903172|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4080392|NCT01020838|3903172|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4080393|NCT01020838|3903172|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4080394|NCT01020838|3903172|B1|||Age||years|Mean|74.4|74.4|Standard Deviation|15.4|15.4|||
4080395|NCT01020812|3903187|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4080396|NCT01020812|3903187|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4080397|NCT01020812|3903187|B1|||Age||years|Mean|67.1|67.1|Standard Deviation|11.8|11.8|||
4080398|NCT01020799|3903194|B4|||Hamilton Rating Scale for Depression (HAM-D) total score at baseline|HAM-D total score, sum of 17 item scores (each on a 0 to 2 or 0 to 4 scale), assesses the severity of depressive symptoms on a continuous scale from 0 (the best) to 52 (the worst). [observed cases, Mixed Model Repeated Measurement (MMRM), Full Analysis Set (FAS)]|scores on a scale|Mean|24.43|24.43|Standard Deviation|2.83|2.83|||
4080399|NCT01020799|3903195|B3|||Hamilton Rating Scale for Depression (HAM-D) total score at baseline|HAM-D total score, sum of 17 item scores (each on a 0 to 2 or 0 to 4 scale), assesses the severity of depressive symptoms on a continuous scale from 0 (the best) to 52 (the worst). [observed cases, Mixed Model Repeated Measurement (MMRM), Full Analysis Set (FAS)]|scores on a scale|Mean|24.4|24.4|Standard Deviation|2.8|2.8|||
4080400|NCT01020799|3903196|B2|||Hamilton Rating Scale for Depression (HAM-D) total score at baseline|HAM-D total score, sum of 17 item scores (each on a 0 to 2 or 0 to 4 scale), assesses the severity of depressive symptoms on a continuous scale from 0 (the best) to 52 (the worst). [observed cases, Mixed Model Repeated Measurement (MMRM), Full Analysis Set (FAS)]|scores on a scale|Mean|24.6|24.6|Standard Deviation|2.8|2.8|||
4080401|NCT01020799|3903197|B1|||Hamilton Rating Scale for Depression (HAM-D) total score at baseline|HAM-D total score, sum of 17 item scores (each on a 0 to 2 or 0 to 4 scale), assesses the severity of depressive symptoms on a continuous scale from 0 (the best) to 52 (the worst). [observed cases, Mixed Model Repeated Measurement (MMRM), Full Analysis Set (FAS)]|scores on a scale|Mean|24.3|24.3|Standard Deviation|2.9|2.9|||
4080478|NCT01020773|3903234|B3||<=18 years|Age||Participants|Count of Participants|1.0|1.0||||||
4080402|NCT01020799|3903194|B4|||Montgomery-Åsberg Depression Rating Scale (MADRS) total score at baseline|MADRS total score, sum of 10 item scores (each on a 0 (best value) to 6 (worst value)scale), assesses the severity of depressive symptoms on a continuous scale from 0 (the best) to 60 (the worst). [observed cases, Mixed Model Repeated Measurement (MMRM), Full Analysis Set (FAS)]|scores on a scale|Mean|31.03|31.03|Standard Deviation|4.03|4.03|||
4080403|NCT01020799|3903195|B3|||Montgomery-Åsberg Depression Rating Scale (MADRS) total score at baseline|MADRS total score, sum of 10 item scores (each on a 0 (best value) to 6 (worst value)scale), assesses the severity of depressive symptoms on a continuous scale from 0 (the best) to 60 (the worst). [observed cases, Mixed Model Repeated Measurement (MMRM), Full Analysis Set (FAS)]|scores on a scale|Mean|30.8|30.8|Standard Deviation|4.0|4.0|||
4080404|NCT01020799|3903196|B2|||Montgomery-Åsberg Depression Rating Scale (MADRS) total score at baseline|MADRS total score, sum of 10 item scores (each on a 0 (best value) to 6 (worst value)scale), assesses the severity of depressive symptoms on a continuous scale from 0 (the best) to 60 (the worst). [observed cases, Mixed Model Repeated Measurement (MMRM), Full Analysis Set (FAS)]|scores on a scale|Mean|31.4|31.4|Standard Deviation|4.2|4.2|||
4080405|NCT01020799|3903197|B1|||Montgomery-Åsberg Depression Rating Scale (MADRS) total score at baseline|MADRS total score, sum of 10 item scores (each on a 0 (best value) to 6 (worst value)scale), assesses the severity of depressive symptoms on a continuous scale from 0 (the best) to 60 (the worst). [observed cases, Mixed Model Repeated Measurement (MMRM), Full Analysis Set (FAS)]|scores on a scale|Mean|30.9|30.9|Standard Deviation|3.9|3.9|||
4080406|NCT01020799|3903194|B4|Other||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4080407|NCT01020799|3903195|B3|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4080408|NCT01020799|3903196|B2|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4080409|NCT01020799|3903197|B1|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4080410|NCT01020799|3903194|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4080411|NCT01020799|3903195|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4080412|NCT01020799|3903196|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4080413|NCT01020799|3903197|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4080414|NCT01020799|3903194|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4080415|NCT01020799|3903195|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4080416|NCT01020799|3903196|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4080417|NCT01020799|3903197|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4080418|NCT01020799|3903194|B4|Asian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4080419|NCT01020799|3903195|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4080420|NCT01020799|3903196|B2|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4080421|NCT01020799|3903197|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4080422|NCT01020799|3903194|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|77|77.0||||||
4080423|NCT01020799|3903195|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4080424|NCT01020799|3903196|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
4080425|NCT01020799|3903197|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
4080426|NCT01020799|3903194|B4|White||Race/Ethnicity, Customized||Participants|Number|156|156.0||||||
4080427|NCT01020799|3903195|B3|White||Race/Ethnicity, Customized||Participants|Number|34|34.0||||||
4080428|NCT01020799|3903196|B2|White||Race/Ethnicity, Customized||Participants|Number|56|56.0||||||
4080429|NCT01020799|3903197|B1|White||Race/Ethnicity, Customized||Participants|Number|66|66.0||||||
4080430|NCT01020799|3903194|B4||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4080431|NCT01020799|3903195|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4080432|NCT01020799|3903196|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4080433|NCT01020799|3903197|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4080434|NCT01020799|3903194|B4||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4080435|NCT01020799|3903195|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4080436|NCT01020799|3903196|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4080437|NCT01020799|3903197|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4080438|NCT01020799|3903194|B4|||Age||Years|Mean|39.09|39.09|Standard Deviation|10.98|10.98|||
4080439|NCT01020799|3903195|B3|||Age||Years|Mean|36.22|36.22|Standard Deviation|11.29|11.29|||
4080440|NCT01020799|3903196|B2|||Age||Years|Mean|41.77|41.77|Standard Deviation|10.02|10.02|||
4080441|NCT01020799|3903197|B1|||Age||Years|Mean|39.29|39.29|Standard Deviation|11.63|11.63|||
4080442|NCT01020786|3903222|B1|1 - Ambulatory, Restricted Strenuous Activity||Percentage of Participants in Each Eastern Cooperative Oncology Group (ECOG) Status|"ECOG Performance Status (PS). Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).~0 - Fully Active~- Ambulatory, Restricted Strenuous Activity~- Ambulatory, No Work Activities~- Partially Confined to Bed, Limited Self Care~- Completely Disabled~- Death"|percentage of participants|Number|66.1|66.1||||||
4080443|NCT01020786|3903222|B1|0 - Fully Active||Percentage of Participants in Each Eastern Cooperative Oncology Group (ECOG) Status|"ECOG Performance Status (PS). Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).~0 - Fully Active~- Ambulatory, Restricted Strenuous Activity~- Ambulatory, No Work Activities~- Partially Confined to Bed, Limited Self Care~- Completely Disabled~- Death"|percentage of participants|Number|33.9|33.9||||||
4080479|NCT01020773|3903235|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4080444|NCT01020786|3903222|B1|Not Done||Percentage of Participants in Each Epidermal Growth Factor Receptor (EGFR) Mutation Status Category|Percentage of participants in each EGFR mutation status category.|percentage of participants|Number|17.4|17.4||||||
4080445|NCT01020786|3903222|B1|Unknown||Percentage of Participants in Each Epidermal Growth Factor Receptor (EGFR) Mutation Status Category|Percentage of participants in each EGFR mutation status category.|percentage of participants|Number|2.8|2.8||||||
4080446|NCT01020786|3903222|B1|Negative||Percentage of Participants in Each Epidermal Growth Factor Receptor (EGFR) Mutation Status Category|Percentage of participants in each EGFR mutation status category.|percentage of participants|Number|57.8|57.8||||||
4080447|NCT01020786|3903222|B1|Positive||Percentage of Participants in Each Epidermal Growth Factor Receptor (EGFR) Mutation Status Category|Percentage of participants in each EGFR mutation status category.|percentage of participants|Number|22.0|22.0||||||
4080448|NCT01020786|3903222|B1|Other||Percentage of Participants in Each Disease Stage|Percentage of participants in each disease stage category. Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body. Stage IIIB - cancer spread to opposite side of chest, more than 1 tumor within same lobe of lung; Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver. All of the percentages do not add up to 100% because of rounding.|percentage of participants|Number|3.7|3.7||||||
4080449|NCT01020786|3903222|B1|Stage IV||Percentage of Participants in Each Disease Stage|Percentage of participants in each disease stage category. Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body. Stage IIIB - cancer spread to opposite side of chest, more than 1 tumor within same lobe of lung; Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver. All of the percentages do not add up to 100% because of rounding.|percentage of participants|Number|66.1|66.1||||||
4080450|NCT01020786|3903222|B1|Stage IIIb||Percentage of Participants in Each Disease Stage|Percentage of participants in each disease stage category. Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body. Stage IIIB - cancer spread to opposite side of chest, more than 1 tumor within same lobe of lung; Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver. All of the percentages do not add up to 100% because of rounding.|percentage of participants|Number|30.3|30.3||||||
4080451|NCT01020786|3903222|B1|Carcinoma, Non-small Cell, Lung Not Otherwise S||Percentage of Participants in Each Histology Category|Percentage of participants in each of the following categories: adenocarcinoma, large cell lung carcinoma, and carcinoma, non-small cell, lung not otherwise specified (NOS).|percentage of participants|Number|0|0.0||||||
4080452|NCT01020786|3903222|B1|Large Cell Lung Carcinoma||Percentage of Participants in Each Histology Category|Percentage of participants in each of the following categories: adenocarcinoma, large cell lung carcinoma, and carcinoma, non-small cell, lung not otherwise specified (NOS).|percentage of participants|Number|2.8|2.8||||||
4080453|NCT01020786|3903222|B1|Adenocarcinoma Lung||Percentage of Participants in Each Histology Category|Percentage of participants in each of the following categories: adenocarcinoma, large cell lung carcinoma, and carcinoma, non-small cell, lung not otherwise specified (NOS).|percentage of participants|Number|97.2|97.2||||||
4080454|NCT01020786|3903222|B1|Unknown||Percentage of Participants in Each Smoking Status Category at Study Entry|Percentage of participants in each category for smoking status. All of the percentages do not add up to 100% because of rounding.|percentage of participants|Number|0.0|0.0||||||
4080455|NCT01020786|3903222|B1|Never Smoker||Percentage of Participants in Each Smoking Status Category at Study Entry|Percentage of participants in each category for smoking status. All of the percentages do not add up to 100% because of rounding.|percentage of participants|Number|30.3|30.3||||||
4080456|NCT01020786|3903222|B1|Former Smoker||Percentage of Participants in Each Smoking Status Category at Study Entry|Percentage of participants in each category for smoking status. All of the percentages do not add up to 100% because of rounding.|percentage of participants|Number|61.5|61.5||||||
4080457|NCT01020786|3903222|B1|Current Smoker||Percentage of Participants in Each Smoking Status Category at Study Entry|Percentage of participants in each category for smoking status. All of the percentages do not add up to 100% because of rounding.|percentage of participants|Number|8.3|8.3||||||
4080458|NCT01020786|3903222|B1|Japan||Region of Enrollment||participants|Number|109|109.0||||||
4080459|NCT01020786|3903222|B1|Japanese||Race/Ethnicity, Customized||participants|Number|109|109.0||||||
4080460|NCT01020786|3903222|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4080461|NCT01020786|3903222|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4080462|NCT01020786|3903222|B1|||Age||years|Mean|63.35|63.35|Standard Deviation|8.692|8.692|||
4080463|NCT01020773|3903234|B3||Male|Sex: Female, Male||Participants|Count of Participants|42.0|42.0||||||
4080464|NCT01020773|3903235|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4080465|NCT01020773|3903236|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4080466|NCT01020773|3903234|B3||Female|Sex: Female, Male||Participants|Count of Participants|25.0|25.0||||||
4080467|NCT01020773|3903235|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4080468|NCT01020773|3903236|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4080469|NCT01020773|3903234|B3|||Age||years|Mean|57.9|57.9|Standard Deviation|17.1|17.1|||
4080470|NCT01020773|3903235|B2|||Age||years|Mean|56.7|56.7|Standard Deviation|18.0|18.0|||
4080471|NCT01020773|3903236|B1|||Age||years|Mean|58.9|58.9|Standard Deviation|16.3|16.3|||
4080472|NCT01020773|3903234|B3||>=65 years|Age||Participants|Count of Participants|28.0|28.0||||||
4080473|NCT01020773|3903235|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4080474|NCT01020773|3903236|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4080475|NCT01020773|3903234|B3||Between 18 and 65 years|Age||Participants|Count of Participants|38.0|38.0||||||
4080476|NCT01020773|3903235|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4080477|NCT01020773|3903236|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4080480|NCT01020773|3903236|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4080481|NCT01020747|3903243|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4080482|NCT01020747|3903243|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4080483|NCT01020747|3903243|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4080484|NCT01020747|3903243|B1|||Age||years|Mean|47.5|47.5|Standard Deviation|8.6|8.6|||
4080485|NCT01020747|3903243|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4080486|NCT01020747|3903243|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4080487|NCT01020747|3903243|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4080488|NCT01020591|3903248|B3|Canada||Region of Enrollment||participants|Number|30|30.0||||||
4080489|NCT01020591|3903249|B2|Canada||Region of Enrollment||participants|Number|15|15.0||||||
4080490|NCT01020591|3903250|B1|Canada||Region of Enrollment||participants|Number|15|15.0||||||
4080491|NCT01020591|3903248|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4080492|NCT01020591|3903249|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4080493|NCT01020591|3903250|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4080494|NCT01020591|3903248|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4080495|NCT01020591|3903249|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4080496|NCT01020591|3903250|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4080497|NCT01020591|3903248|B3|||Age||years|Mean|63.47|63.47|Standard Deviation|8.80|8.8|||
4080498|NCT01020591|3903249|B2|||Age||years|Mean|63.20|63.2|Standard Deviation|7.97|7.97|||
4080499|NCT01020591|3903250|B1|||Age||years|Mean|63.73|63.73|Standard Deviation|9.63|9.63|||
4080500|NCT01020591|3903248|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4080501|NCT01020591|3903249|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4080502|NCT01020591|3903250|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4080503|NCT01020591|3903248|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4080504|NCT01020591|3903249|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4080505|NCT01020591|3903250|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4080506|NCT01020591|3903248|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4080507|NCT01020591|3903249|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4080508|NCT01020591|3903250|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4080509|NCT01020526|3903259|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4080510|NCT01020526|3903259|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4080511|NCT01020526|3903259|B1|||Age||Years|Mean|14.8|14.8|Standard Deviation|1.4|1.4|||
4080512|NCT01020474|3903263|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4080513|NCT01020474|3903264|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4080514|NCT01020474|3903265|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4080515|NCT01020474|3903263|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4080516|NCT01020474|3903264|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4080517|NCT01020474|3903265|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4080518|NCT01020474|3903263|B3|||Age||years|Mean|14.7|14.7|Standard Deviation|1.2|1.2|||
4080519|NCT01020474|3903264|B2|||Age||years|Mean|14.7|14.7|Standard Deviation|1.2|1.2|||
4080520|NCT01020474|3903265|B1|||Age||years|Mean|14.6|14.6|Standard Deviation|1.2|1.2|||
4080521|NCT01020448|3903286|B1|Missing - No sample analysis done||PCA-3 Score|"PCA-3 score = (mRNA PCA3/mRNA PSA)x1000~Non-assessable = Associated PSA mRNA <7500 copies/mL~≤BLQ = PCA-3 mRNA is below the concentration of the calibrator and associated PSA mRNA >7500 copies/mL~<35 = PCA-3 mRNA above BLQ and less than 35~≥35 = PCA-3 mRNA greater or equal to 35"|participants|Number|3|3.0||||||
4080522|NCT01020448|3903286|B1|≥35||PCA-3 Score|"PCA-3 score = (mRNA PCA3/mRNA PSA)x1000~Non-assessable = Associated PSA mRNA <7500 copies/mL~≤BLQ = PCA-3 mRNA is below the concentration of the calibrator and associated PSA mRNA >7500 copies/mL~<35 = PCA-3 mRNA above BLQ and less than 35~≥35 = PCA-3 mRNA greater or equal to 35"|participants|Number|179|179.0||||||
4080523|NCT01020448|3903286|B1|<35||PCA-3 Score|"PCA-3 score = (mRNA PCA3/mRNA PSA)x1000~Non-assessable = Associated PSA mRNA <7500 copies/mL~≤BLQ = PCA-3 mRNA is below the concentration of the calibrator and associated PSA mRNA >7500 copies/mL~<35 = PCA-3 mRNA above BLQ and less than 35~≥35 = PCA-3 mRNA greater or equal to 35"|participants|Number|89|89.0||||||
4080524|NCT01020448|3903286|B1|≤BLQ||PCA-3 Score|"PCA-3 score = (mRNA PCA3/mRNA PSA)x1000~Non-assessable = Associated PSA mRNA <7500 copies/mL~≤BLQ = PCA-3 mRNA is below the concentration of the calibrator and associated PSA mRNA >7500 copies/mL~<35 = PCA-3 mRNA above BLQ and less than 35~≥35 = PCA-3 mRNA greater or equal to 35"|participants|Number|15|15.0||||||
4080525|NCT01020448|3903286|B1|Non-assessable||PCA-3 Score|"PCA-3 score = (mRNA PCA3/mRNA PSA)x1000~Non-assessable = Associated PSA mRNA <7500 copies/mL~≤BLQ = PCA-3 mRNA is below the concentration of the calibrator and associated PSA mRNA >7500 copies/mL~<35 = PCA-3 mRNA above BLQ and less than 35~≥35 = PCA-3 mRNA greater or equal to 35"|participants|Number|39|39.0||||||
4080526|NCT01020448|3903286|B1|||BMI||kg/m²|Mean|26.79|26.79|Standard Deviation|4.23|4.23|||
4080527|NCT01020448|3903286|B1|||Weight||KG|Mean|79.6|79.6|Standard Deviation|13.4|13.4|||
4080528|NCT01020448|3903286|B1|||Height||Cm|Mean|172.3|172.3|Standard Deviation|6.5|6.5|||
4080529|NCT01020448|3903286|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4080530|NCT01020448|3903286|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080531|NCT01020448|3903286|B1||White|Race (NIH/OMB)||Participants|Count of Participants|307|307.0||||||
4080532|NCT01020448|3903286|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4080533|NCT01020448|3903286|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080534|NCT01020448|3903286|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4080535|NCT01020448|3903286|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080536|NCT01020448|3903286|B1||Male|Sex: Female, Male||Participants|Count of Participants|325|325.0||||||
4080537|NCT01020448|3903286|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4080538|NCT01020448|3903286|B1|||Age||years|Mean|72.6|72.6|Standard Deviation|8.4|8.4|||
4080539|NCT01020435|3903295|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4080540|NCT01020435|3903296|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4080541|NCT01020435|3903297|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4080542|NCT01020435|3903295|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4080543|NCT01020435|3903296|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4080544|NCT01020435|3903297|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4080545|NCT01020435|3903295|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
4080546|NCT01020435|3903296|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
4080547|NCT01020435|3903297|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
4080548|NCT01020435|3903295|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4080549|NCT01020435|3903296|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4080550|NCT01020435|3903297|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4080551|NCT01020435|3903295|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4080552|NCT01020435|3903296|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4080553|NCT01020435|3903297|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4080554|NCT01020435|3903295|B3|||Age||years|Mean|56.2|56.2|Standard Deviation|10.6|10.6|||
4080555|NCT01020435|3903296|B2|||Age||years|Mean|54.9|54.9|Standard Deviation|12.1|12.1|||
4080556|NCT01020435|3903297|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|8.5|8.5|||
4080557|NCT01020305|3903306|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080558|NCT01020305|3903306|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080559|NCT01020305|3903306|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4080560|NCT01020305|3903306|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080561|NCT01020305|3903306|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080562|NCT01020305|3903306|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4080563|NCT01020305|3903306|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080564|NCT01020305|3903306|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080565|NCT01020305|3903306|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4080566|NCT01020305|3903306|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4080567|NCT01020305|3903306|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4080568|NCT01020305|3903306|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4080569|NCT01020305|3903306|B1|||Age||years|Median|73|73.0|Full Range|||64.0|77.0|
4080570|NCT01020123|3903310|B8||Male|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
4080571|NCT01020123|3903311|B7||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4080572|NCT01020123|3903312|B6||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4080573|NCT01020123|3903313|B5||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4080574|NCT01020123|3903314|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4080575|NCT01020123|3903315|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4080576|NCT01020123|3903316|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4080577|NCT01020123|3903317|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4080578|NCT01020123|3903310|B8||Female|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
4080579|NCT01020123|3903311|B7||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4080580|NCT01020123|3903312|B6||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4080581|NCT01020123|3903313|B5||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4080582|NCT01020123|3903314|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4080583|NCT01020123|3903315|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4080584|NCT01020123|3903316|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4080585|NCT01020123|3903317|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4080586|NCT01020123|3903310|B8|||Age||Year|Mean|56|56.0|Full Range|||20.0|81.0|
4080587|NCT01020123|3903311|B7|||Age||Year|Mean|53.1|53.1|Full Range|||20.0|69.0|
4080588|NCT01020123|3903312|B6|||Age||Year|Mean|57.1|57.1|Full Range|||36.0|78.0|
4080589|NCT01020123|3903313|B5|||Age||Year|Mean|56.9|56.9|Full Range|||30.0|75.0|
4080590|NCT01020123|3903314|B4|||Age||Year|Mean|57.4|57.4|Full Range|||35.0|80.0|
4080591|NCT01020123|3903315|B3|||Age||Year|Mean|54.4|54.4|Full Range|||23.0|77.0|
4080592|NCT01020123|3903316|B2|||Age||Year|Mean|57.1|57.1|Full Range|||32.0|80.0|
4080593|NCT01020123|3903317|B1|||Age||Year|Mean|57.1|57.1|Full Range|||34.0|81.0|
4080594|NCT01020019|3903516|B3|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4080595|NCT01020019|3903517|B2|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4080596|NCT01020019|3903518|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4080597|NCT01020019|3903516|B3|White||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4080598|NCT01020019|3903517|B2|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4080599|NCT01020019|3903518|B1|White||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4080600|NCT01020019|3903516|B3|Black||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4080601|NCT01020019|3903517|B2|Black||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4080602|NCT01020019|3903518|B1|Black||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4080603|NCT01020019|3903516|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4080604|NCT01020019|3903517|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4080605|NCT01020019|3903518|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4080606|NCT01020019|3903516|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4080607|NCT01020019|3903517|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4080608|NCT01020019|3903518|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4080609|NCT01020019|3903516|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4080610|NCT01020019|3903517|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4080611|NCT01020019|3903518|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4080612|NCT01020019|3903516|B3|||Age||years|Mean|35.2|35.2|Standard Deviation|10.9|10.9|||
4080613|NCT01020019|3903517|B2|||Age||years|Mean|34.8|34.8|Standard Deviation|11.2|11.2|||
4080614|NCT01020019|3903518|B1|||Age||years|Mean|35.4|35.4|Standard Deviation|10.8|10.8|||
4080615|NCT01020006|3903525|B4|United States||Region of Enrollment||participants|Number|42|42.0||||||
4080616|NCT01020006|3903526|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4080617|NCT01020006|3903527|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4080618|NCT01020006|3903528|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4080619|NCT01020006|3903525|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4080620|NCT01020006|3903526|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4080621|NCT01020006|3903527|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4080622|NCT01020006|3903528|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4080623|NCT01020006|3903525|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4080624|NCT01020006|3903526|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4080625|NCT01020006|3903527|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4080626|NCT01020006|3903528|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4080627|NCT01020006|3903525|B4||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4080628|NCT01020006|3903526|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4080629|NCT01020006|3903527|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4080630|NCT01020006|3903528|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4080631|NCT01020006|3903525|B4||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4080632|NCT01020006|3903526|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4080633|NCT01020006|3903527|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4080634|NCT01020006|3903528|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4080635|NCT01020006|3903525|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4080636|NCT01020006|3903526|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4080637|NCT01020006|3903527|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4080638|NCT01020006|3903528|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4080639|NCT01019928|3903547|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4080640|NCT01019928|3903548|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4080641|NCT01019928|3903549|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4080642|NCT01019928|3903547|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4080643|NCT01019928|3903548|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4080644|NCT01019928|3903549|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4080645|NCT01019928|3903547|B3|Age (years)||Age||years|Mean|54.8|54.8|Standard Deviation|16.2|16.2|||
4080646|NCT01019928|3903548|B2|Age (years)||Age||years|Mean|54.7|54.7|Standard Deviation|17.4|17.4|||
4080647|NCT01019928|3903549|B1|Age (years)||Age||years|Mean|54.9|54.9|Standard Deviation|15.0|15.0|||
4080648|NCT01019707|3903590|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4080649|NCT01019707|3903590|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4080650|NCT01019707|3903590|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4080651|NCT01019707|3903590|B1|||Age||years|Mean|37|37.0|Standard Deviation|4.1|4.1|||
4080652|NCT01019707|3903590|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4080653|NCT01019707|3903590|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4080654|NCT01019707|3903590|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4080655|NCT01019694|3903601|B4|||Chronic Obstructive Pulmonary Disease (COPD) Duration||years|Mean|7.6|7.6|Standard Deviation|6.2|6.2|||
4080656|NCT01019694|3903602|B3|||Chronic Obstructive Pulmonary Disease (COPD) Duration||years|Mean|7.5|7.5|Standard Deviation|5.8|5.8|||
4080657|NCT01019694|3903603|B2|||Chronic Obstructive Pulmonary Disease (COPD) Duration||years|Mean|7.3|7.3|Standard Deviation|6.1|6.1|||
4080658|NCT01019694|3903604|B1|||Chronic Obstructive Pulmonary Disease (COPD) Duration||years|Mean|8.1|8.1|Standard Deviation|6.7|6.7|||
4080659|NCT01019694|3903601|B4|||Smoking History (pack years)||pack years|Mean|54.3|54.3|Standard Deviation|26.6|26.6|||
4080660|NCT01019694|3903602|B3|||Smoking History (pack years)||pack years|Mean|55.6|55.6|Standard Deviation|25.4|25.4|||
4080661|NCT01019694|3903603|B2|||Smoking History (pack years)||pack years|Mean|53.6|53.6|Standard Deviation|29.7|29.7|||
4080662|NCT01019694|3903604|B1|||Smoking History (pack years)||pack years|Mean|53.6|53.6|Standard Deviation|24.5|24.5|||
4080663|NCT01019694|3903601|B4|Currently smokes||Smoking History||participants|Number|242|242.0||||||
4080664|NCT01019694|3903602|B3|Currently smokes||Smoking History||participants|Number|75|75.0||||||
4080665|NCT01019694|3903603|B2|Currently smokes||Smoking History||participants|Number|93|93.0||||||
4080666|NCT01019694|3903604|B1|Currently smokes||Smoking History||participants|Number|74|74.0||||||
4080667|NCT01019694|3903601|B4|Ex-smoker||Smoking History||participants|Number|223|223.0||||||
4080668|NCT01019694|3903602|B3|Ex-smoker||Smoking History||participants|Number|79|79.0||||||
4080669|NCT01019694|3903603|B2|Ex-smoker||Smoking History||participants|Number|61|61.0||||||
4080670|NCT01019694|3903604|B1|Ex-smoker||Smoking History||participants|Number|83|83.0||||||
4080671|NCT01019694|3903601|B4|||Height||centimeters|Mean|170.8|170.8|Standard Deviation|10.1|10.1|||
4080672|NCT01019694|3903602|B3|||Height||centimeters|Mean|171.1|171.1|Standard Deviation|10.4|10.4|||
4080673|NCT01019694|3903603|B2|||Height||centimeters|Mean|170.6|170.6|Standard Deviation|10.4|10.4|||
4080674|NCT01019694|3903604|B1|||Height||centimeters|Mean|170.6|170.6|Standard Deviation|9.6|9.6|||
4080675|NCT01019694|3903601|B4|White||Race/Ethnicity, Customized||participants|Number|435|435.0||||||
4080676|NCT01019694|3903602|B3|White||Race/Ethnicity, Customized||participants|Number|144|144.0||||||
4080677|NCT01019694|3903603|B2|White||Race/Ethnicity, Customized||participants|Number|143|143.0||||||
4080678|NCT01019694|3903604|B1|White||Race/Ethnicity, Customized||participants|Number|148|148.0||||||
4080679|NCT01019694|3903601|B4|Black / African American||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4080680|NCT01019694|3903602|B3|Black / African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4080681|NCT01019694|3903603|B2|Black / African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4080682|NCT01019694|3903604|B1|Black / African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4080683|NCT01019694|3903601|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4080684|NCT01019694|3903602|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4080685|NCT01019694|3903603|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4080686|NCT01019694|3903604|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4080687|NCT01019694|3903601|B4||Male|Sex: Female, Male||Participants|Count of Participants|273|273.0||||||
4080688|NCT01019694|3903602|B3||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4080689|NCT01019694|3903603|B2||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4080690|NCT01019694|3903604|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4080691|NCT01019694|3903601|B4||Female|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4080692|NCT01019694|3903602|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4080693|NCT01019694|3903603|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4080694|NCT01019694|3903604|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4080695|NCT01019694|3903601|B4|>= 75 years||Age, Customized||participants|Number|46|46.0||||||
4080696|NCT01019694|3903602|B3|>= 75 years||Age, Customized||participants|Number|14|14.0||||||
4080697|NCT01019694|3903603|B2|>= 75 years||Age, Customized||participants|Number|16|16.0||||||
4080698|NCT01019694|3903604|B1|>= 75 years||Age, Customized||participants|Number|16|16.0||||||
4080699|NCT01019694|3903601|B4|>= 65 to < 75 years||Age, Customized||participants|Number|156|156.0||||||
4080700|NCT01019694|3903602|B3|>= 65 to < 75 years||Age, Customized||participants|Number|58|58.0||||||
4080701|NCT01019694|3903603|B2|>= 65 to < 75 years||Age, Customized||participants|Number|47|47.0||||||
4080702|NCT01019694|3903604|B1|>= 65 to < 75 years||Age, Customized||participants|Number|51|51.0||||||
4080703|NCT01019694|3903601|B4|>= 40 to < 65 years||Age, Customized||participants|Number|263|263.0||||||
4080704|NCT01019694|3903602|B3|>= 40 to < 65 years||Age, Customized||participants|Number|82|82.0||||||
4080705|NCT01019694|3903603|B2|>= 40 to < 65 years||Age, Customized||participants|Number|91|91.0||||||
4080706|NCT01019694|3903604|B1|>= 40 to < 65 years||Age, Customized||participants|Number|90|90.0||||||
4080707|NCT01019694|3903601|B4|||Age||years|Mean|62.9|62.9|Standard Deviation|8.8|8.8|||
4080708|NCT01019694|3903602|B3|||Age||years|Mean|63.0|63.0|Standard Deviation|9.3|9.3|||
4080709|NCT01019694|3903603|B2|||Age||years|Mean|62.6|62.6|Standard Deviation|8.9|8.9|||
4080710|NCT01019694|3903604|B1|||Age||years|Mean|63.0|63.0|Standard Deviation|8.2|8.2|||
4080711|NCT01019486|3903728|B4|United States||Region of Enrollment||participants|Number|23|23.0||||||
4080712|NCT01019486|3903729|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4080713|NCT01019486|3903730|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4080714|NCT01019486|3903731|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4080715|NCT01019486|3903728|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4080716|NCT01019486|3903729|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4080717|NCT01019486|3903730|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4080718|NCT01019486|3903731|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4080719|NCT01019486|3903728|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4080720|NCT01019486|3903729|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4080721|NCT01019486|3903730|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4080722|NCT01019486|3903731|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4080723|NCT01019486|3903728|B4|||Age||years|Mean|59.8|59.8|Standard Deviation|8.2|8.2|||
4080724|NCT01019486|3903729|B3|||Age||years|Mean|57.3|57.3|Standard Deviation|5.2|5.2|||
4080725|NCT01019486|3903730|B2|||Age||years|Mean|59.3|59.3|Standard Deviation|10.1|10.1|||
4080726|NCT01019486|3903731|B1|||Age||years|Mean|62.0|62.0|Standard Deviation|1.6|1.6|||
4080727|NCT01019486|3903728|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4080728|NCT01019486|3903729|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4080729|NCT01019486|3903730|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4080730|NCT01019486|3903731|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4080731|NCT01019486|3903728|B4||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4080732|NCT01019486|3903729|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4080733|NCT01019486|3903730|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4080734|NCT01019486|3903731|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4080735|NCT01019486|3903728|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4080736|NCT01019486|3903729|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4080737|NCT01019486|3903730|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4080738|NCT01019486|3903731|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4080739|NCT01019369|3903745|B3|United States||Region of Enrollment||participants|Number|132|132.0||||||
4080740|NCT01019369|3903746|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
4080741|NCT01019369|3903747|B1|United States||Region of Enrollment||participants|Number|86|86.0||||||
4080742|NCT01019369|3903745|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4080743|NCT01019369|3903746|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4080744|NCT01019369|3903747|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4080745|NCT01019369|3903745|B3||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4080746|NCT01019369|3903746|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4080747|NCT01019369|3903747|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4080748|NCT01019369|3903745|B3|||Age||years|Mean|26.03|26.03|Standard Deviation|6.2|6.2|||
4080749|NCT01019369|3903746|B2|||Age||years|Mean|26.1|26.1|Standard Deviation|6.3|6.3|||
4080750|NCT01019369|3903747|B1|||Age||years|Mean|26|26.0|Standard Deviation|6.1|6.1|||
4080751|NCT01019317|3903756|B1|United States||Region of Enrollment||participants|Number|151|151.0||||||
4080752|NCT01019317|3903756|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4080753|NCT01019317|3903756|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4080754|NCT01019317|3903756|B1|||Age||years|Median|63|63.0|Full Range|||20.0|85.0|
4080755|NCT01019252|3903760|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4080756|NCT01019252|3903761|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4080757|NCT01019252|3903762|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4080758|NCT01019252|3903760|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4080759|NCT01019252|3903761|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4080760|NCT01019252|3903762|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4080761|NCT01019252|3903760|B3|||Age||years|Mean|15.13|15.13|Standard Deviation|1.05|1.05|||
4080762|NCT01019252|3903761|B2|||Age||years|Mean|15.09|15.09|Standard Deviation|1.11|1.11|||
4080763|NCT01019252|3903762|B1|||Age||years|Mean|15.17|15.17|Standard Deviation|1.01|1.01|||
4080764|NCT01019135|3903773|B4|Canada||Region of Enrollment||participants|Number|169|169.0||||||
4080765|NCT01019135|3903774|B3|Canada||Region of Enrollment||participants|Number|55|55.0||||||
4080766|NCT01019135|3903775|B2|Canada||Region of Enrollment||participants|Number|59|59.0||||||
4080767|NCT01019135|3903776|B1|Canada||Region of Enrollment||participants|Number|55|55.0||||||
4080768|NCT01019135|3903773|B4|Other||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
4080769|NCT01019135|3903774|B3|Other||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4080770|NCT01019135|3903775|B2|Other||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4080771|NCT01019135|3903776|B1|Other||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4080772|NCT01019135|3903773|B4|White||Race/Ethnicity, Customized||participants|Number|90|90.0||||||
4080773|NCT01019135|3903774|B3|White||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4080774|NCT01019135|3903775|B2|White||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4080775|NCT01019135|3903776|B1|White||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4080776|NCT01019135|3903773|B4|Females||Sex/Gender, Customized||participants|Number|169|169.0||||||
4080777|NCT01019135|3903774|B3|Females||Sex/Gender, Customized||participants|Number|55|55.0||||||
4080778|NCT01019135|3903775|B2|Females||Sex/Gender, Customized||participants|Number|59|59.0||||||
4080779|NCT01019135|3903776|B1|Females||Sex/Gender, Customized||participants|Number|55|55.0||||||
4080780|NCT01019135|3903773|B4|||Age||years|Mean|63.64|63.64|Standard Deviation|10.42|10.42|||
4080781|NCT01019135|3903774|B3|||Age||years|Mean|63.13|63.13|Standard Deviation|10.94|10.94|||
4080782|NCT01019135|3903775|B2|||Age||years|Mean|61.56|61.56|Standard Deviation|9.73|9.73|||
4080783|NCT01019135|3903776|B1|||Age||years|Mean|66.22|66.22|Standard Deviation|10.21|10.21|||
4080784|NCT01018992|3903804|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4080785|NCT01018992|3903805|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4080786|NCT01018992|3903806|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4080787|NCT01018992|3903804|B3||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4080788|NCT01018992|3903805|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4080789|NCT01018992|3903806|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4080790|NCT01018992|3903804|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4080791|NCT01018992|3903805|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4080792|NCT01018992|3903806|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4080793|NCT01018992|3903804|B3||Between 18 and 65 years|Age||Participants|Count of Participants|128|128.0||||||
4080794|NCT01018992|3903805|B2||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4080795|NCT01018992|3903806|B1||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4080796|NCT01018992|3903804|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4080797|NCT01018992|3903805|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4080798|NCT01018992|3903806|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4080799|NCT01018979|3903819|B3|Hodgkin disease||Diagnosis||participants|Number|2|2.0||||||
4080800|NCT01018979|3903820|B2|Hodgkin disease||Diagnosis||participants|Number|1|1.0||||||
4080801|NCT01018979|3903821|B1|Hodgkin disease||Diagnosis||participants|Number|1|1.0||||||
4080802|NCT01018979|3903819|B3|Non-Hodgkin lymphoma||Diagnosis||participants|Number|10|10.0||||||
4080803|NCT01018979|3903820|B2|Non-Hodgkin lymphoma||Diagnosis||participants|Number|7|7.0||||||
4080804|NCT01018979|3903821|B1|Non-Hodgkin lymphoma||Diagnosis||participants|Number|3|3.0||||||
4080805|NCT01018979|3903819|B3|Multiple myeloma||Diagnosis||participants|Number|7|7.0||||||
4080806|NCT01018979|3903820|B2|Multiple myeloma||Diagnosis||participants|Number|4|4.0||||||
4080807|NCT01018979|3903821|B1|Multiple myeloma||Diagnosis||participants|Number|3|3.0||||||
4080808|NCT01018979|3903819|B3|||Body Mass Index||kilogram/ meter^2|Mean|24.4|24.4|Standard Deviation|4.2|4.2|||
4080809|NCT01018979|3903820|B2|||Body Mass Index||kilogram/ meter^2|Mean|24.0|24.0|Standard Deviation|3.0|3.0|||
4080810|NCT01018979|3903821|B1|||Body Mass Index||kilogram/ meter^2|Mean|25.1|25.1|Standard Deviation|6.0|6.0|||
4080811|NCT01018979|3903819|B3|||Weight||kilogram|Mean|63.1|63.1|Standard Deviation|15.9|15.9|||
4080812|NCT01018979|3903820|B2|||Weight||kilogram|Mean|60.6|60.6|Standard Deviation|10.2|10.2|||
4080813|NCT01018979|3903821|B1|||Weight||kilogram|Mean|67.3|67.3|Standard Deviation|23.1|23.1|||
4080814|NCT01018979|3903819|B3|||Height||centimeters|Mean|160.2|160.2|Standard Deviation|9.1|9.1|||
4080815|NCT01018979|3903820|B2|||Height||centimeters|Mean|158.7|158.7|Standard Deviation|8.6|8.6|||
4080816|NCT01018979|3903821|B1|||Height||centimeters|Mean|162.7|162.7|Standard Deviation|10.1|10.1|||
4080817|NCT01018979|3903819|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4080818|NCT01018979|3903820|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4080819|NCT01018979|3903821|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4080820|NCT01018979|3903819|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4080821|NCT01018979|3903820|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4080822|NCT01018979|3903821|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4080823|NCT01018979|3903819|B3|||Age||years|Mean|50.5|50.5|Standard Deviation|11.8|11.8|||
4080824|NCT01018979|3903820|B2|||Age||years|Mean|52.4|52.4|Standard Deviation|9.3|9.3|||
4080825|NCT01018979|3903821|B1|||Age||years|Mean|47.3|47.3|Standard Deviation|15.5|15.5|||
4080826|NCT01018953|3903852|B1|N/A - Not applicable||Post-menopausal status||participants|Number|2|2.0||||||
4080827|NCT01018953|3903852|B1|No||Post-menopausal status||participants|Number|0|0.0||||||
4080828|NCT01018953|3903852|B1|Yes||Post-menopausal status||participants|Number|6|6.0||||||
4080829|NCT01018953|3903852|B1|Nondiabetic||Diabetic status||participants|Number|8|8.0||||||
4080830|NCT01018953|3903852|B1|Diabetic||Diabetic status||participants|Number|0|0.0||||||
4080831|NCT01018953|3903852|B1|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4080832|NCT01018953|3903852|B1|Finland||Region of Enrollment||participants|Number|1|1.0||||||
4080833|NCT01018953|3903852|B1|Ireland||Region of Enrollment||participants|Number|1|1.0||||||
4080834|NCT01018953|3903852|B1|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4080835|NCT01018953|3903852|B1|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4080836|NCT01018953|3903852|B1|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4080837|NCT01018953|3903852|B1|Russian Federation||Region of Enrollment||participants|Number|1|1.0||||||
4080838|NCT01018953|3903852|B1|Caucasian/ White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4080839|NCT01018953|3903852|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4080840|NCT01018953|3903852|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4080841|NCT01018953|3903852|B1|Between 18 and 75 years||Age, Customized||participants|Number|8|8.0||||||
4080842|NCT01018953|3903852|B1|||Age||years|Mean|62.1|62.1|Standard Deviation|6.88|6.88|||
4080843|NCT01018862|3903862|B4|United States||Region of Enrollment||participants|Number|489|489.0||||||
4080844|NCT01018862|3903863|B3|United States||Region of Enrollment||participants|Number|162|162.0||||||
4080845|NCT01018862|3903864|B2|United States||Region of Enrollment||participants|Number|166|166.0||||||
4080846|NCT01018862|3903865|B1|United States||Region of Enrollment||participants|Number|161|161.0||||||
4080847|NCT01018862|3903862|B4||Male|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
4080848|NCT01018862|3903863|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4080849|NCT01018862|3903864|B2||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4080850|NCT01018862|3903865|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4080851|NCT01018862|3903862|B4||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4080852|NCT01018862|3903863|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4080853|NCT01018862|3903864|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4080854|NCT01018862|3903865|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4080855|NCT01018862|3903862|B4|||Age||years|Mean|8.8|8.8|Standard Deviation|2.7|2.7|||
4080856|NCT01018862|3903863|B3|||Age||years|Mean|8.7|8.7|Standard Deviation|2.8|2.8|||
4080857|NCT01018862|3903864|B2|||Age||years|Mean|8.8|8.8|Standard Deviation|2.7|2.7|||
4080858|NCT01018862|3903865|B1|||Age||years|Mean|8.8|8.8|Standard Deviation|2.6|2.6|||
4080859|NCT01018862|3903862|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4080860|NCT01018862|3903863|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4080861|NCT01018862|3903864|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4080862|NCT01018862|3903865|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4080863|NCT01018862|3903862|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4080864|NCT01018862|3903863|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4080865|NCT01018862|3903864|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4080866|NCT01018862|3903865|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4080867|NCT01018862|3903862|B4||<=18 years|Age||Participants|Count of Participants|489|489.0||||||
4080868|NCT01018862|3903863|B3||<=18 years|Age||Participants|Count of Participants|162|162.0||||||
4080869|NCT01018862|3903864|B2||<=18 years|Age||Participants|Count of Participants|166|166.0||||||
4080870|NCT01018862|3903865|B1||<=18 years|Age||Participants|Count of Participants|161|161.0||||||
4080871|NCT01018810|3903884|B6|United States||Region of Enrollment||participants|Number|8|8.0||||||
4080872|NCT01018810|3903885|B5|United States||Region of Enrollment||participants|Number|1|1.0||||||
4080873|NCT01018810|3903886|B4|United States||Region of Enrollment||participants|Number|1|1.0||||||
4080874|NCT01018810|3903887|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4080875|NCT01018810|3903888|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4080876|NCT01018810|3903889|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4080877|NCT01018810|3903884|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080878|NCT01018810|3903885|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080879|NCT01018810|3903886|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080880|NCT01018810|3903887|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080881|NCT01018810|3903888|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080882|NCT01018810|3903889|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080883|NCT01018810|3903884|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080884|NCT01018810|3903885|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080885|NCT01018810|3903886|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080886|NCT01018810|3903887|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080887|NCT01018810|3903888|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080888|NCT01018810|3903889|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080889|NCT01018810|3903884|B6||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4080890|NCT01018810|3903885|B5||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4080891|NCT01018810|3903886|B4||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4080892|NCT01018810|3903887|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4080893|NCT01018810|3903888|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4080894|NCT01018810|3903889|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4080895|NCT01018810|3903884|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080896|NCT01018810|3903885|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080897|NCT01018810|3903886|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080898|NCT01018810|3903887|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080899|NCT01018810|3903888|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080900|NCT01018810|3903889|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080901|NCT01018810|3903884|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080902|NCT01018810|3903885|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080903|NCT01018810|3903886|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080904|NCT01018810|3903887|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080905|NCT01018810|3903888|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080906|NCT01018810|3903889|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080907|NCT01018810|3903884|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080908|NCT01018810|3903885|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080909|NCT01018810|3903886|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080910|NCT01018810|3903887|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080911|NCT01018810|3903888|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080912|NCT01018810|3903889|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080913|NCT01018810|3903884|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080914|NCT01018810|3903885|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080915|NCT01018810|3903886|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080916|NCT01018810|3903887|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080917|NCT01018810|3903888|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080918|NCT01018810|3903889|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080919|NCT01018810|3903884|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080920|NCT01018810|3903885|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080921|NCT01018810|3903886|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080922|NCT01018810|3903887|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080923|NCT01018810|3903888|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080924|NCT01018810|3903889|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080925|NCT01018810|3903884|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4080926|NCT01018810|3903885|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4080927|NCT01018810|3903886|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4080928|NCT01018810|3903887|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4080929|NCT01018810|3903888|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4080930|NCT01018810|3903889|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4080931|NCT01018810|3903884|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080932|NCT01018810|3903885|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080933|NCT01018810|3903886|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080934|NCT01018810|3903887|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080935|NCT01018810|3903888|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080936|NCT01018810|3903889|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4080937|NCT01018810|3903884|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4080938|NCT01018810|3903885|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4080939|NCT01018810|3903886|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4080940|NCT01018810|3903887|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4080941|NCT01018810|3903888|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4080942|NCT01018810|3903889|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4080943|NCT01018810|3903884|B6||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4080944|NCT01018810|3903885|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4080945|NCT01018810|3903886|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4080946|NCT01018810|3903887|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4080947|NCT01018810|3903888|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4080948|NCT01018810|3903889|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4080949|NCT01018810|3903884|B6||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4080950|NCT01018810|3903885|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4080951|NCT01018810|3903886|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4080952|NCT01018810|3903887|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4080953|NCT01018810|3903888|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4080954|NCT01018810|3903889|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4080955|NCT01018810|3903884|B6||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4080956|NCT01018810|3903885|B5||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4080957|NCT01018810|3903886|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4080958|NCT01018810|3903887|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4080959|NCT01018810|3903888|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4080960|NCT01018810|3903889|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4080961|NCT01018810|3903884|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4080962|NCT01018810|3903885|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4080963|NCT01018810|3903886|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4080964|NCT01018810|3903887|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4080965|NCT01018810|3903888|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4080966|NCT01018810|3903889|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4080967|NCT01018732|3903950|B4||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4080968|NCT01018732|3903951|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4080969|NCT01018732|3903952|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4080970|NCT01018732|3903953|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4080971|NCT01018732|3903950|B4||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4080972|NCT01018732|3903951|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4080973|NCT01018732|3903952|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4080974|NCT01018732|3903953|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4080975|NCT01018732|3903950|B4|||Age||years|Mean|19.5|19.5|Standard Deviation|2.1|2.1|||
4080976|NCT01018732|3903951|B3|||Age||years|Mean|20.5|20.5|Standard Deviation|2.3|2.3|||
4080977|NCT01018732|3903952|B2|||Age||years|Mean|19.2|19.2|Standard Deviation|2.0|2.0|||
4080978|NCT01018732|3903953|B1|||Age||years|Mean|18.8|18.8|Standard Deviation|1.9|1.9|||
4080979|NCT01018680|3903987|B3|||Duration of Osteoarthritis (OA) Pain||years|Mean|9.49|9.49|Standard Deviation|8.90|8.9|||
4080980|NCT01018680|3903988|B2|||Duration of Osteoarthritis (OA) Pain||years|Mean|9.79|9.79|Standard Deviation|8.88|8.88|||
4080981|NCT01018680|3903989|B1|||Duration of Osteoarthritis (OA) Pain||years|Mean|9.19|9.19|Standard Deviation|8.92|8.92|||
4080982|NCT01018680|3903987|B3|||Western Ontario and McMaster Universities Index of Osteoarthritis Physical Function Score|The Western Ontario and McMaster Universities Index of Osteoarthritis Physical Function Score (WOMAC; Bellamy et al. 1988) is a self-administered, participant-centered health status questionnaire used to capture the elements of pain, stiffness, and physical disability in participants with osteoarthritis (OA) of the knee and/or hip. The physical function index has 17 questions. Each question uses a 5-point numeric rating scale ranging from 0 (no difficulty) to 4 (extreme difficulty). Physical function scores range from 0 to 68, where higher scores indicate greater impairment.|units on a scale|Mean|37.45|37.45|Standard Deviation|9.74|9.74|||
4080983|NCT01018680|3903988|B2|||Western Ontario and McMaster Universities Index of Osteoarthritis Physical Function Score|The Western Ontario and McMaster Universities Index of Osteoarthritis Physical Function Score (WOMAC; Bellamy et al. 1988) is a self-administered, participant-centered health status questionnaire used to capture the elements of pain, stiffness, and physical disability in participants with osteoarthritis (OA) of the knee and/or hip. The physical function index has 17 questions. Each question uses a 5-point numeric rating scale ranging from 0 (no difficulty) to 4 (extreme difficulty). Physical function scores range from 0 to 68, where higher scores indicate greater impairment.|units on a scale|Mean|37.40|37.4|Standard Deviation|10.10|10.1|||
4080984|NCT01018680|3903989|B1|||Western Ontario and McMaster Universities Index of Osteoarthritis Physical Function Score|The Western Ontario and McMaster Universities Index of Osteoarthritis Physical Function Score (WOMAC; Bellamy et al. 1988) is a self-administered, participant-centered health status questionnaire used to capture the elements of pain, stiffness, and physical disability in participants with osteoarthritis (OA) of the knee and/or hip. The physical function index has 17 questions. Each question uses a 5-point numeric rating scale ranging from 0 (no difficulty) to 4 (extreme difficulty). Physical function scores range from 0 to 68, where higher scores indicate greater impairment.|units on a scale|Mean|37.51|37.51|Standard Deviation|9.39|9.39|||
4080985|NCT01018680|3903987|B3|||Patient Global Assessment of Illness (PGAI)|The PGAI is a participant-rated measure of the severity of osteoarthritis (OA) of the knee the participant has experienced in the past week as indicated on an 11-point numeric rating scale, with scores ranging from 0 to 10, where greater numbers reflect greater severity.|units on a scale|Mean|6.94|6.94|Standard Deviation|1.49|1.49|||
4080986|NCT01018680|3903988|B2|||Patient Global Assessment of Illness (PGAI)|The PGAI is a participant-rated measure of the severity of osteoarthritis (OA) of the knee the participant has experienced in the past week as indicated on an 11-point numeric rating scale, with scores ranging from 0 to 10, where greater numbers reflect greater severity.|units on a scale|Mean|6.93|6.93|Standard Deviation|1.49|1.49|||
4080987|NCT01018680|3903989|B1|||Patient Global Assessment of Illness (PGAI)|The PGAI is a participant-rated measure of the severity of osteoarthritis (OA) of the knee the participant has experienced in the past week as indicated on an 11-point numeric rating scale, with scores ranging from 0 to 10, where greater numbers reflect greater severity.|units on a scale|Mean|6.95|6.95|Standard Deviation|1.50|1.5|||
4080988|NCT01018680|3903987|B3|||Brief Pain Inventory-Severity (BPI-S) Average Pain|The BPI-S is a self-reported scale measuring severity of pain. Severity score ranges from 0 (no pain) to 10 (severe pain) assessing average pain in past 24 hours.|units on a scale|Mean|6.16|6.16|Standard Deviation|1.54|1.54|||
4080989|NCT01018680|3903988|B2|||Brief Pain Inventory-Severity (BPI-S) Average Pain|The BPI-S is a self-reported scale measuring severity of pain. Severity score ranges from 0 (no pain) to 10 (severe pain) assessing average pain in past 24 hours.|units on a scale|Mean|6.09|6.09|Standard Deviation|1.58|1.58|||
4080990|NCT01018680|3903989|B1|||Brief Pain Inventory-Severity (BPI-S) Average Pain|The BPI-S is a self-reported scale measuring severity of pain. Severity score ranges from 0 (no pain) to 10 (severe pain) assessing average pain in past 24 hours.|units on a scale|Mean|6.24|6.24|Standard Deviation|1.51|1.51|||
4080991|NCT01018680|3903987|B3|||Weekly 24-Hour Average Pain Rating|"The weekly 24-hour average pain rating was calculated from the participant's daily 24-hour average pain ratings made on an 11-point numeric rating scale, with scores from 0 (indicating no pain) to 10 (indicating the worst possible pain) from the week ending at the day of randomization."|units on a scale|Mean|6.32|6.32|Standard Deviation|1.41|1.41|||
4080992|NCT01018680|3903988|B2|||Weekly 24-Hour Average Pain Rating|"The weekly 24-hour average pain rating was calculated from the participant's daily 24-hour average pain ratings made on an 11-point numeric rating scale, with scores from 0 (indicating no pain) to 10 (indicating the worst possible pain) from the week ending at the day of randomization."|units on a scale|Mean|6.27|6.27|Standard Deviation|1.41|1.41|||
4080993|NCT01018680|3903989|B1|||Weekly 24-Hour Average Pain Rating|"The weekly 24-hour average pain rating was calculated from the participant's daily 24-hour average pain ratings made on an 11-point numeric rating scale, with scores from 0 (indicating no pain) to 10 (indicating the worst possible pain) from the week ending at the day of randomization."|units on a scale|Mean|6.36|6.36|Standard Deviation|1.41|1.41|||
4080994|NCT01018680|3903987|B3|||Weight||kilograms (kg)|Mean|90.59|90.59|Standard Deviation|17.80|17.8|||
4080995|NCT01018680|3903988|B2|||Weight||kilograms (kg)|Mean|90.41|90.41|Standard Deviation|18.13|18.13|||
4080996|NCT01018680|3903989|B1|||Weight||kilograms (kg)|Mean|90.78|90.78|Standard Deviation|17.49|17.49|||
4080997|NCT01018680|3903987|B3|United States||Region of Enrollment||participants|Number|524|524.0||||||
4080998|NCT01018680|3903988|B2|United States||Region of Enrollment||participants|Number|264|264.0||||||
4080999|NCT01018680|3903989|B1|United States||Region of Enrollment||participants|Number|260|260.0||||||
4081000|NCT01018680|3903987|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4081001|NCT01018680|3903988|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081002|NCT01018680|3903989|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4081003|NCT01018680|3903987|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4081004|NCT01018680|3903988|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4081005|NCT01018680|3903989|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4081006|NCT01018680|3903987|B3||White|Race (NIH/OMB)||Participants|Count of Participants|424|424.0||||||
4081007|NCT01018680|3903988|B2||White|Race (NIH/OMB)||Participants|Count of Participants|218|218.0||||||
4081008|NCT01018680|3903989|B1||White|Race (NIH/OMB)||Participants|Count of Participants|206|206.0||||||
4081009|NCT01018680|3903987|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
4081010|NCT01018680|3903988|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4081011|NCT01018680|3903989|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4081012|NCT01018680|3903987|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081013|NCT01018680|3903988|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081014|NCT01018680|3903989|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081015|NCT01018680|3903987|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4081016|NCT01018680|3903988|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4081017|NCT01018680|3903989|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4081018|NCT01018680|3903987|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4081019|NCT01018680|3903988|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4081020|NCT01018680|3903989|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4081021|NCT01018680|3903987|B3||Male|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
4081022|NCT01018680|3903988|B2||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4081023|NCT01018680|3903989|B1||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4081024|NCT01018680|3903987|B3||Female|Sex: Female, Male||Participants|Count of Participants|299|299.0||||||
4081025|NCT01018680|3903988|B2||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4081026|NCT01018680|3903989|B1||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4081027|NCT01018680|3903987|B3|||Age||years|Mean|60.98|60.98|Standard Deviation|9.22|9.22|||
4081028|NCT01018680|3903988|B2|||Age||years|Mean|61.63|61.63|Standard Deviation|9.24|9.24|||
4081029|NCT01018680|3903989|B1|||Age||years|Mean|60.32|60.32|Standard Deviation|9.17|9.17|||
4081030|NCT01020487|3904030|B4||Missing|Chronic Kidney Disease Stage|Stage 3: estimated glomerular filtration rate (eGFR) 30 to 59 mL/min/1.73 m²; Stage 4: eGFR 15 to 29 mL/min/1.73 m², not requiring dialysis|Participants|Count of Participants|1|1.0||||||
4081031|NCT01020487|3904031|B3||Missing|Chronic Kidney Disease Stage|Stage 3: estimated glomerular filtration rate (eGFR) 30 to 59 mL/min/1.73 m²; Stage 4: eGFR 15 to 29 mL/min/1.73 m², not requiring dialysis|Participants|Count of Participants|1|1.0||||||
4081032|NCT01020487|3904032|B2||Missing|Chronic Kidney Disease Stage|Stage 3: estimated glomerular filtration rate (eGFR) 30 to 59 mL/min/1.73 m²; Stage 4: eGFR 15 to 29 mL/min/1.73 m², not requiring dialysis|Participants|Count of Participants|0|0.0||||||
4081033|NCT01020487|3904033|B1||Missing|Chronic Kidney Disease Stage|Stage 3: estimated glomerular filtration rate (eGFR) 30 to 59 mL/min/1.73 m²; Stage 4: eGFR 15 to 29 mL/min/1.73 m², not requiring dialysis|Participants|Count of Participants|0|0.0||||||
4081034|NCT01020487|3904030|B4||Stage 4|Chronic Kidney Disease Stage|Stage 3: estimated glomerular filtration rate (eGFR) 30 to 59 mL/min/1.73 m²; Stage 4: eGFR 15 to 29 mL/min/1.73 m², not requiring dialysis|Participants|Count of Participants|21|21.0||||||
4081173|NCT01018420|3904231|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081179|NCT01018420|3904231|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4081035|NCT01020487|3904031|B3||Stage 4|Chronic Kidney Disease Stage|Stage 3: estimated glomerular filtration rate (eGFR) 30 to 59 mL/min/1.73 m²; Stage 4: eGFR 15 to 29 mL/min/1.73 m², not requiring dialysis|Participants|Count of Participants|8|8.0||||||
4081036|NCT01020487|3904032|B2||Stage 4|Chronic Kidney Disease Stage|Stage 3: estimated glomerular filtration rate (eGFR) 30 to 59 mL/min/1.73 m²; Stage 4: eGFR 15 to 29 mL/min/1.73 m², not requiring dialysis|Participants|Count of Participants|7|7.0||||||
4081037|NCT01020487|3904033|B1||Stage 4|Chronic Kidney Disease Stage|Stage 3: estimated glomerular filtration rate (eGFR) 30 to 59 mL/min/1.73 m²; Stage 4: eGFR 15 to 29 mL/min/1.73 m², not requiring dialysis|Participants|Count of Participants|6|6.0||||||
4081038|NCT01020487|3904030|B4||Stage 3|Chronic Kidney Disease Stage|Stage 3: estimated glomerular filtration rate (eGFR) 30 to 59 mL/min/1.73 m²; Stage 4: eGFR 15 to 29 mL/min/1.73 m², not requiring dialysis|Participants|Count of Participants|27|27.0||||||
4081039|NCT01020487|3904031|B3||Stage 3|Chronic Kidney Disease Stage|Stage 3: estimated glomerular filtration rate (eGFR) 30 to 59 mL/min/1.73 m²; Stage 4: eGFR 15 to 29 mL/min/1.73 m², not requiring dialysis|Participants|Count of Participants|10|10.0||||||
4081040|NCT01020487|3904032|B2||Stage 3|Chronic Kidney Disease Stage|Stage 3: estimated glomerular filtration rate (eGFR) 30 to 59 mL/min/1.73 m²; Stage 4: eGFR 15 to 29 mL/min/1.73 m², not requiring dialysis|Participants|Count of Participants|11|11.0||||||
4081041|NCT01020487|3904033|B1||Stage 3|Chronic Kidney Disease Stage|Stage 3: estimated glomerular filtration rate (eGFR) 30 to 59 mL/min/1.73 m²; Stage 4: eGFR 15 to 29 mL/min/1.73 m², not requiring dialysis|Participants|Count of Participants|6|6.0||||||
4081042|NCT01020487|3904030|B4||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4081043|NCT01020487|3904031|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4081044|NCT01020487|3904032|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4081045|NCT01020487|3904033|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4081046|NCT01020487|3904030|B4||Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4081047|NCT01020487|3904031|B3||Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4081048|NCT01020487|3904032|B2||Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4081049|NCT01020487|3904033|B1||Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4081050|NCT01020487|3904030|B4||American Indian/Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4081051|NCT01020487|3904031|B3||American Indian/Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4081052|NCT01020487|3904032|B2||American Indian/Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4081053|NCT01020487|3904033|B1||American Indian/Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4081054|NCT01020487|3904030|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4081055|NCT01020487|3904031|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4081056|NCT01020487|3904032|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4081057|NCT01020487|3904033|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4081058|NCT01020487|3904030|B4||Black|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4081059|NCT01020487|3904031|B3||Black|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4081060|NCT01020487|3904032|B2||Black|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4081061|NCT01020487|3904033|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4081062|NCT01020487|3904030|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
4081063|NCT01020487|3904031|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4081064|NCT01020487|3904032|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4081065|NCT01020487|3904033|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4081066|NCT01020487|3904030|B4||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4081067|NCT01020487|3904031|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4081068|NCT01020487|3904032|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4081069|NCT01020487|3904033|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4081070|NCT01020487|3904030|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4081071|NCT01020487|3904031|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4081072|NCT01020487|3904032|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4081073|NCT01020487|3904033|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4081074|NCT01020487|3904030|B4|Part 2||Age||years|Mean|13.6|13.6|Standard Deviation|1.78|1.78|||
4081075|NCT01020487|3904031|B3|Part 2||Age||years|Mean|13.9|13.9|Standard Deviation|1.81|1.81|||
4081076|NCT01020487|3904032|B2|Part 2||Age||years|Mean|13.3|13.3|Standard Deviation|1.75|1.75|||
4081077|NCT01020487|3904030|B4|Part 1||Age||years|Mean|13.5|13.5|Standard Deviation|1.98|1.98|||
4081078|NCT01020487|3904033|B1|Part 1||Age||years|Mean|13.5|13.5|Standard Deviation|1.98|1.98|||
4081079|NCT01018511|3904056|B5|||Nocturia episodes/24 hours|"FAS population. The number of participants was 306; 287; 302; 291 per treatment arm, respectively.~A nocturia episode is defined as waking up at night to void (i.e., any voiding associated with sleep disturbance between the time the participant goes to bed with the intention to sleep until the time the patient gets up in the morning with the intention to stay awake). The mean number of nocturia episodes per 24 hours was calculated from data recorded by the participant in the micturition diary for the 3 days preceding each clinic visit."|nocturia episodes|Mean|2.42|2.42|Standard Deviation|1.27|1.27|||
4081080|NCT01018511|3904057|B4|||Nocturia episodes/24 hours|"FAS population. The number of participants was 306; 287; 302; 291 per treatment arm, respectively.~A nocturia episode is defined as waking up at night to void (i.e., any voiding associated with sleep disturbance between the time the participant goes to bed with the intention to sleep until the time the patient gets up in the morning with the intention to stay awake). The mean number of nocturia episodes per 24 hours was calculated from data recorded by the participant in the micturition diary for the 3 days preceding each clinic visit."|nocturia episodes|Mean|2.41|2.41|Standard Deviation|1.26|1.26|||
4081081|NCT01018511|3904058|B3|||Nocturia episodes/24 hours|"FAS population. The number of participants was 306; 287; 302; 291 per treatment arm, respectively.~A nocturia episode is defined as waking up at night to void (i.e., any voiding associated with sleep disturbance between the time the participant goes to bed with the intention to sleep until the time the patient gets up in the morning with the intention to stay awake). The mean number of nocturia episodes per 24 hours was calculated from data recorded by the participant in the micturition diary for the 3 days preceding each clinic visit."|nocturia episodes|Mean|2.37|2.37|Standard Deviation|1.19|1.19|||
4081082|NCT01018511|3904059|B2|||Nocturia episodes/24 hours|"FAS population. The number of participants was 306; 287; 302; 291 per treatment arm, respectively.~A nocturia episode is defined as waking up at night to void (i.e., any voiding associated with sleep disturbance between the time the participant goes to bed with the intention to sleep until the time the patient gets up in the morning with the intention to stay awake). The mean number of nocturia episodes per 24 hours was calculated from data recorded by the participant in the micturition diary for the 3 days preceding each clinic visit."|nocturia episodes|Mean|2.50|2.5|Standard Deviation|1.31|1.31|||
4081083|NCT01018511|3904060|B1|||Nocturia episodes/24 hours|"FAS population. The number of participants was 306; 287; 302; 291 per treatment arm, respectively.~A nocturia episode is defined as waking up at night to void (i.e., any voiding associated with sleep disturbance between the time the participant goes to bed with the intention to sleep until the time the patient gets up in the morning with the intention to stay awake). The mean number of nocturia episodes per 24 hours was calculated from data recorded by the participant in the micturition diary for the 3 days preceding each clinic visit."|nocturia episodes|Mean|2.41|2.41|Standard Deviation|1.31|1.31|||
4081084|NCT01018511|3904056|B5|||Urgency incontinence episodes/24 hours|"FAS population. The number of participants was 86; 59; 69; 80 per treatment arm, respectively.~An urgency incontinence episode is defined as an episode with any involuntary leakage of urine accompanied by or immediately preceded by urgency. The mean number of urgency incontinence episodes with PPIUS grade 3 (Severe urgency) or 4 (Urgency incontinence) per 24 hours was calculated from data recorded by the participant in the micturition diary for the 3 days preceding each clinic visit."|urgency incontinence episodes|Mean|1.70|1.7|Standard Deviation|1.89|1.89|||
4081085|NCT01018511|3904057|B4|||Urgency incontinence episodes/24 hours|"FAS population. The number of participants was 86; 59; 69; 80 per treatment arm, respectively.~An urgency incontinence episode is defined as an episode with any involuntary leakage of urine accompanied by or immediately preceded by urgency. The mean number of urgency incontinence episodes with PPIUS grade 3 (Severe urgency) or 4 (Urgency incontinence) per 24 hours was calculated from data recorded by the participant in the micturition diary for the 3 days preceding each clinic visit."|urgency incontinence episodes|Mean|1.60|1.6|Standard Deviation|2.24|2.24|||
4081086|NCT01018511|3904058|B3|||Urgency incontinence episodes/24 hours|"FAS population. The number of participants was 86; 59; 69; 80 per treatment arm, respectively.~An urgency incontinence episode is defined as an episode with any involuntary leakage of urine accompanied by or immediately preceded by urgency. The mean number of urgency incontinence episodes with PPIUS grade 3 (Severe urgency) or 4 (Urgency incontinence) per 24 hours was calculated from data recorded by the participant in the micturition diary for the 3 days preceding each clinic visit."|urgency incontinence episodes|Mean|1.71|1.71|Standard Deviation|1.59|1.59|||
4081087|NCT01018511|3904059|B2|||Urgency incontinence episodes/24 hours|"FAS population. The number of participants was 86; 59; 69; 80 per treatment arm, respectively.~An urgency incontinence episode is defined as an episode with any involuntary leakage of urine accompanied by or immediately preceded by urgency. The mean number of urgency incontinence episodes with PPIUS grade 3 (Severe urgency) or 4 (Urgency incontinence) per 24 hours was calculated from data recorded by the participant in the micturition diary for the 3 days preceding each clinic visit."|urgency incontinence episodes|Mean|1.90|1.9|Standard Deviation|1.75|1.75|||
4081088|NCT01018511|3904060|B1|||Urgency incontinence episodes/24 hours|"FAS population. The number of participants was 86; 59; 69; 80 per treatment arm, respectively.~An urgency incontinence episode is defined as an episode with any involuntary leakage of urine accompanied by or immediately preceded by urgency. The mean number of urgency incontinence episodes with PPIUS grade 3 (Severe urgency) or 4 (Urgency incontinence) per 24 hours was calculated from data recorded by the participant in the micturition diary for the 3 days preceding each clinic visit."|urgency incontinence episodes|Mean|1.62|1.62|Standard Deviation|1.86|1.86|||
4081089|NCT01018511|3904056|B5|||Incontinence episodes/24 hours|"FAS population. The number of participants was 89; 66; 77; 86 per treatment arm, respectively.~An incontinence episode is defined as an episode with any involuntary loss of urine. The mean number of incontinence episodes per 24 hours was calculated from data recorded by the participant in the micturition diary for the 3 days preceding each clinic visit."|incontinence episodes|Mean|1.73|1.73|Standard Deviation|2.03|2.03|||
4081090|NCT01018511|3904057|B4|||Incontinence episodes/24 hours|"FAS population. The number of participants was 89; 66; 77; 86 per treatment arm, respectively.~An incontinence episode is defined as an episode with any involuntary loss of urine. The mean number of incontinence episodes per 24 hours was calculated from data recorded by the participant in the micturition diary for the 3 days preceding each clinic visit."|incontinence episodes|Mean|1.60|1.6|Standard Deviation|2.23|2.23|||
4081091|NCT01018511|3904058|B3|||Incontinence episodes/24 hours|"FAS population. The number of participants was 89; 66; 77; 86 per treatment arm, respectively.~An incontinence episode is defined as an episode with any involuntary loss of urine. The mean number of incontinence episodes per 24 hours was calculated from data recorded by the participant in the micturition diary for the 3 days preceding each clinic visit."|incontinence episodes|Mean|1.70|1.7|Standard Deviation|1.74|1.74|||
4081174|NCT01018420|3904232|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081175|NCT01018420|3904230|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0.0|0.0||||||
4081092|NCT01018511|3904059|B2|||Incontinence episodes/24 hours|"FAS population. The number of participants was 89; 66; 77; 86 per treatment arm, respectively.~An incontinence episode is defined as an episode with any involuntary loss of urine. The mean number of incontinence episodes per 24 hours was calculated from data recorded by the participant in the micturition diary for the 3 days preceding each clinic visit."|incontinence episodes|Mean|1.82|1.82|Standard Deviation|1.73|1.73|||
4081093|NCT01018511|3904060|B1|||Incontinence episodes/24 hours|"FAS population. The number of participants was 89; 66; 77; 86 per treatment arm, respectively.~An incontinence episode is defined as an episode with any involuntary loss of urine. The mean number of incontinence episodes per 24 hours was calculated from data recorded by the participant in the micturition diary for the 3 days preceding each clinic visit."|incontinence episodes|Mean|1.79|1.79|Standard Deviation|2.27|2.27|||
4081094|NCT01018511|3904056|B5|||Urgency episodes/24 hours|"FAS population. The number of participants was 319; 299; 314; 302 per treatment arm, respectively.~An urgency episode is defined as an episode of strong desire to void accompanied by fear of leakage or pain. The mean number of urgency episodes with PPIUS grade 3 (Severe urgency) or 4 (Urgency incontinence) per 24 hours was calculated from data recorded by the participant in the micturition diary for the 3 days preceding each clinic visit."|urgency episodes|Mean|5.36|5.36|Standard Deviation|3.21|3.21|||
4081095|NCT01018511|3904057|B4|||Urgency episodes/24 hours|"FAS population. The number of participants was 319; 299; 314; 302 per treatment arm, respectively.~An urgency episode is defined as an episode of strong desire to void accompanied by fear of leakage or pain. The mean number of urgency episodes with PPIUS grade 3 (Severe urgency) or 4 (Urgency incontinence) per 24 hours was calculated from data recorded by the participant in the micturition diary for the 3 days preceding each clinic visit."|urgency episodes|Mean|5.18|5.18|Standard Deviation|3.09|3.09|||
4081096|NCT01018511|3904058|B3|||Urgency episodes/24 hours|"FAS population. The number of participants was 319; 299; 314; 302 per treatment arm, respectively.~An urgency episode is defined as an episode of strong desire to void accompanied by fear of leakage or pain. The mean number of urgency episodes with PPIUS grade 3 (Severe urgency) or 4 (Urgency incontinence) per 24 hours was calculated from data recorded by the participant in the micturition diary for the 3 days preceding each clinic visit."|urgency episodes|Mean|5.28|5.28|Standard Deviation|3.22|3.22|||
4081097|NCT01018511|3904059|B2|||Urgency episodes/24 hours|"FAS population. The number of participants was 319; 299; 314; 302 per treatment arm, respectively.~An urgency episode is defined as an episode of strong desire to void accompanied by fear of leakage or pain. The mean number of urgency episodes with PPIUS grade 3 (Severe urgency) or 4 (Urgency incontinence) per 24 hours was calculated from data recorded by the participant in the micturition diary for the 3 days preceding each clinic visit."|urgency episodes|Mean|5.51|5.51|Standard Deviation|3.27|3.27|||
4081098|NCT01018511|3904060|B1|||Urgency episodes/24 hours|"FAS population. The number of participants was 319; 299; 314; 302 per treatment arm, respectively.~An urgency episode is defined as an episode of strong desire to void accompanied by fear of leakage or pain. The mean number of urgency episodes with PPIUS grade 3 (Severe urgency) or 4 (Urgency incontinence) per 24 hours was calculated from data recorded by the participant in the micturition diary for the 3 days preceding each clinic visit."|urgency episodes|Mean|5.47|5.47|Standard Deviation|3.26|3.26|||
4081099|NCT01018511|3904056|B5|||Volume voided/micturition|"FAS population. The number of participants was 319; 299; 314; 302 per treatment arm, respectively.~A micturition is any voluntary urination, excluding episodes of incontinence only. The mean volume voided per micturition was calculated from data recorded by the participant in the micturition diary for the 3 days preceding each clinic visit."|mL|Mean|161.82|161.82|Standard Deviation|48.14|48.14|||
4081100|NCT01018511|3904057|B4|||Volume voided/micturition|"FAS population. The number of participants was 319; 299; 314; 302 per treatment arm, respectively.~A micturition is any voluntary urination, excluding episodes of incontinence only. The mean volume voided per micturition was calculated from data recorded by the participant in the micturition diary for the 3 days preceding each clinic visit."|mL|Mean|167.35|167.35|Standard Deviation|50.32|50.32|||
4081101|NCT01018511|3904058|B3|||Volume voided/micturition|"FAS population. The number of participants was 319; 299; 314; 302 per treatment arm, respectively.~A micturition is any voluntary urination, excluding episodes of incontinence only. The mean volume voided per micturition was calculated from data recorded by the participant in the micturition diary for the 3 days preceding each clinic visit."|mL|Mean|160.74|160.74|Standard Deviation|47.60|47.6|||
4081102|NCT01018511|3904059|B2|||Volume voided/micturition|"FAS population. The number of participants was 319; 299; 314; 302 per treatment arm, respectively.~A micturition is any voluntary urination, excluding episodes of incontinence only. The mean volume voided per micturition was calculated from data recorded by the participant in the micturition diary for the 3 days preceding each clinic visit."|mL|Mean|158.80|158.8|Standard Deviation|47.21|47.21|||
4081103|NCT01018511|3904060|B1|||Volume voided/micturition|"FAS population. The number of participants was 319; 299; 314; 302 per treatment arm, respectively.~A micturition is any voluntary urination, excluding episodes of incontinence only. The mean volume voided per micturition was calculated from data recorded by the participant in the micturition diary for the 3 days preceding each clinic visit."|mL|Mean|160.49|160.49|Standard Deviation|47.24|47.24|||
4081104|NCT01018511|3904056|B5|||Micturitions/24 hours|"FAS population. The number of participants was 319; 299; 314; 302 per treatment arm, respectively.~A micturition is any voluntary urination, excluding episodes of incontinence only. The mean number of micturitions per 24 hours was calculated from data recorded by the participant in the micturition diary for the 3 days preceding each clinic visit."|micturitions|Mean|11.44|11.44|Standard Deviation|2.64|2.64|||
4081105|NCT01018511|3904057|B4|||Micturitions/24 hours|"FAS population. The number of participants was 319; 299; 314; 302 per treatment arm, respectively.~A micturition is any voluntary urination, excluding episodes of incontinence only. The mean number of micturitions per 24 hours was calculated from data recorded by the participant in the micturition diary for the 3 days preceding each clinic visit."|micturitions|Mean|11.23|11.23|Standard Deviation|2.56|2.56|||
4081106|NCT01018511|3904058|B3|||Micturitions/24 hours|"FAS population. The number of participants was 319; 299; 314; 302 per treatment arm, respectively.~A micturition is any voluntary urination, excluding episodes of incontinence only. The mean number of micturitions per 24 hours was calculated from data recorded by the participant in the micturition diary for the 3 days preceding each clinic visit."|micturitions|Mean|11.48|11.48|Standard Deviation|2.61|2.61|||
4081180|NCT01018420|3904232|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4081107|NCT01018511|3904059|B2|||Micturitions/24 hours|"FAS population. The number of participants was 319; 299; 314; 302 per treatment arm, respectively.~A micturition is any voluntary urination, excluding episodes of incontinence only. The mean number of micturitions per 24 hours was calculated from data recorded by the participant in the micturition diary for the 3 days preceding each clinic visit."|micturitions|Mean|11.68|11.68|Standard Deviation|2.86|2.86|||
4081108|NCT01018511|3904060|B1|||Micturitions/24 hours|"FAS population. The number of participants was 319; 299; 314; 302 per treatment arm, respectively.~A micturition is any voluntary urination, excluding episodes of incontinence only. The mean number of micturitions per 24 hours was calculated from data recorded by the participant in the micturition diary for the 3 days preceding each clinic visit."|micturitions|Mean|11.37|11.37|Standard Deviation|2.52|2.52|||
4081109|NCT01018511|3904056|B5|||Total Urgency Frequency Score (TUFS) (previously known as Total Urgency Score ([TUS])|FAS population.The number of participants was 318; 299; 314; 302 per arm, respectively.The Patient Perception of the Intensity of Urgency Scale (PPIUS) is a validated scale completed as part of the micturition diary. For each micturition and/or incontinence episode, the participant rated the degree of associated urgency according to the following 5-point categorical scale: 0.No urgency; 1.Mild urgency; 2.Moderate urgency; 3.Severe urgency; 4.Urgency incontinence. TUFS/TUS was the sum of the PPIUS gradings from the 3-day diary divided by the number of days on which urgency grading was recorded.|units on a scale|Mean|27.09|27.09|Standard Deviation|8.71|8.71|||
4081110|NCT01018511|3904057|B4|||Total Urgency Frequency Score (TUFS) (previously known as Total Urgency Score ([TUS])|FAS population.The number of participants was 318; 299; 314; 302 per arm, respectively.The Patient Perception of the Intensity of Urgency Scale (PPIUS) is a validated scale completed as part of the micturition diary. For each micturition and/or incontinence episode, the participant rated the degree of associated urgency according to the following 5-point categorical scale: 0.No urgency; 1.Mild urgency; 2.Moderate urgency; 3.Severe urgency; 4.Urgency incontinence. TUFS/TUS was the sum of the PPIUS gradings from the 3-day diary divided by the number of days on which urgency grading was recorded.|units on a scale|Mean|26.39|26.39|Standard Deviation|8.34|8.34|||
4081111|NCT01018511|3904058|B3|||Total Urgency Frequency Score (TUFS) (previously known as Total Urgency Score ([TUS])|FAS population.The number of participants was 318; 299; 314; 302 per arm, respectively.The Patient Perception of the Intensity of Urgency Scale (PPIUS) is a validated scale completed as part of the micturition diary. For each micturition and/or incontinence episode, the participant rated the degree of associated urgency according to the following 5-point categorical scale: 0.No urgency; 1.Mild urgency; 2.Moderate urgency; 3.Severe urgency; 4.Urgency incontinence. TUFS/TUS was the sum of the PPIUS gradings from the 3-day diary divided by the number of days on which urgency grading was recorded.|units on a scale|Mean|26.97|26.97|Standard Deviation|8.66|8.66|||
4081112|NCT01018511|3904059|B2|||Total Urgency Frequency Score (TUFS) (previously known as Total Urgency Score ([TUS])|FAS population.The number of participants was 318; 299; 314; 302 per arm, respectively.The Patient Perception of the Intensity of Urgency Scale (PPIUS) is a validated scale completed as part of the micturition diary. For each micturition and/or incontinence episode, the participant rated the degree of associated urgency according to the following 5-point categorical scale: 0.No urgency; 1.Mild urgency; 2.Moderate urgency; 3.Severe urgency; 4.Urgency incontinence. TUFS/TUS was the sum of the PPIUS gradings from the 3-day diary divided by the number of days on which urgency grading was recorded.|units on a scale|Mean|27.85|27.85|Standard Deviation|9.02|9.02|||
4081113|NCT01018511|3904060|B1|||Total Urgency Frequency Score (TUFS) (previously known as Total Urgency Score ([TUS])|FAS population.The number of participants was 318; 299; 314; 302 per arm, respectively.The Patient Perception of the Intensity of Urgency Scale (PPIUS) is a validated scale completed as part of the micturition diary. For each micturition and/or incontinence episode, the participant rated the degree of associated urgency according to the following 5-point categorical scale: 0.No urgency; 1.Mild urgency; 2.Moderate urgency; 3.Severe urgency; 4.Urgency incontinence. TUFS/TUS was the sum of the PPIUS gradings from the 3-day diary divided by the number of days on which urgency grading was recorded.|units on a scale|Mean|27.15|27.15|Standard Deviation|8.80|8.8|||
4081114|NCT01018511|3904056|B5|||IPSS Quality of Life (QoL) score|"FAS population excluding 5 patients with invalid questionnaires. The number of participants was 318; 297; 313; 301 per treatment arm, respectively.~The QoL assessment was a single question asking the participant how he would feel about tolerating his current level of symptoms for the rest of his life. The answers ranged from 0 to 6 (delighted to terrible)."|units on a scale|Mean|4.1|4.1|Standard Deviation|1.11|1.11|||
4081115|NCT01018511|3904057|B4|||IPSS Quality of Life (QoL) score|"FAS population excluding 5 patients with invalid questionnaires. The number of participants was 318; 297; 313; 301 per treatment arm, respectively.~The QoL assessment was a single question asking the participant how he would feel about tolerating his current level of symptoms for the rest of his life. The answers ranged from 0 to 6 (delighted to terrible)."|units on a scale|Mean|4.1|4.1|Standard Deviation|1.08|1.08|||
4081116|NCT01018511|3904058|B3|||IPSS Quality of Life (QoL) score|"FAS population excluding 5 patients with invalid questionnaires. The number of participants was 318; 297; 313; 301 per treatment arm, respectively.~The QoL assessment was a single question asking the participant how he would feel about tolerating his current level of symptoms for the rest of his life. The answers ranged from 0 to 6 (delighted to terrible)."|units on a scale|Mean|4.0|4.0|Standard Deviation|1.15|1.15|||
4081117|NCT01018511|3904059|B2|||IPSS Quality of Life (QoL) score|"FAS population excluding 5 patients with invalid questionnaires. The number of participants was 318; 297; 313; 301 per treatment arm, respectively.~The QoL assessment was a single question asking the participant how he would feel about tolerating his current level of symptoms for the rest of his life. The answers ranged from 0 to 6 (delighted to terrible)."|units on a scale|Mean|4.1|4.1|Standard Deviation|1.07|1.07|||
4081118|NCT01018511|3904060|B1|||IPSS Quality of Life (QoL) score|"FAS population excluding 5 patients with invalid questionnaires. The number of participants was 318; 297; 313; 301 per treatment arm, respectively.~The QoL assessment was a single question asking the participant how he would feel about tolerating his current level of symptoms for the rest of his life. The answers ranged from 0 to 6 (delighted to terrible)."|units on a scale|Mean|4.1|4.1|Standard Deviation|1.12|1.12|||
4081176|NCT01018420|3904231|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081177|NCT01018420|3904232|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081178|NCT01018420|3904230|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16.0|16.0||||||
4081119|NCT01018511|3904056|B5|||IPSS storage score|"FAS population excluding 5 patients with invalid questionnaires. The number of participants was 318; 297; 311; 301 per treatment arm, respectively.~The IPSS is a validated global questionnaire to assess the degree of bother from urinary symptoms based on answers to 7 questions. Each question is assigned points from 0 to 5 indicating increasing severity of the particular symptom. The storage symptom score is the sum of the responses to 3 storage questions (frequency, urgency and nocturia) and ranges from 0 to 15 (mildly symptomatic to severely symptomatic)."|units on a scale|Mean|8.8|8.8|Standard Deviation|2.38|2.38|||
4081120|NCT01018511|3904057|B4|||IPSS storage score|"FAS population excluding 5 patients with invalid questionnaires. The number of participants was 318; 297; 311; 301 per treatment arm, respectively.~The IPSS is a validated global questionnaire to assess the degree of bother from urinary symptoms based on answers to 7 questions. Each question is assigned points from 0 to 5 indicating increasing severity of the particular symptom. The storage symptom score is the sum of the responses to 3 storage questions (frequency, urgency and nocturia) and ranges from 0 to 15 (mildly symptomatic to severely symptomatic)."|units on a scale|Mean|8.8|8.8|Standard Deviation|2.36|2.36|||
4081121|NCT01018511|3904058|B3|||IPSS storage score|"FAS population excluding 5 patients with invalid questionnaires. The number of participants was 318; 297; 311; 301 per treatment arm, respectively.~The IPSS is a validated global questionnaire to assess the degree of bother from urinary symptoms based on answers to 7 questions. Each question is assigned points from 0 to 5 indicating increasing severity of the particular symptom. The storage symptom score is the sum of the responses to 3 storage questions (frequency, urgency and nocturia) and ranges from 0 to 15 (mildly symptomatic to severely symptomatic)."|units on a scale|Mean|8.6|8.6|Standard Deviation|2.39|2.39|||
4081122|NCT01018511|3904059|B2|||IPSS storage score|"FAS population excluding 5 patients with invalid questionnaires. The number of participants was 318; 297; 311; 301 per treatment arm, respectively.~The IPSS is a validated global questionnaire to assess the degree of bother from urinary symptoms based on answers to 7 questions. Each question is assigned points from 0 to 5 indicating increasing severity of the particular symptom. The storage symptom score is the sum of the responses to 3 storage questions (frequency, urgency and nocturia) and ranges from 0 to 15 (mildly symptomatic to severely symptomatic)."|units on a scale|Mean|8.9|8.9|Standard Deviation|2.33|2.33|||
4081123|NCT01018511|3904060|B1|||IPSS storage score|"FAS population excluding 5 patients with invalid questionnaires. The number of participants was 318; 297; 311; 301 per treatment arm, respectively.~The IPSS is a validated global questionnaire to assess the degree of bother from urinary symptoms based on answers to 7 questions. Each question is assigned points from 0 to 5 indicating increasing severity of the particular symptom. The storage symptom score is the sum of the responses to 3 storage questions (frequency, urgency and nocturia) and ranges from 0 to 15 (mildly symptomatic to severely symptomatic)."|units on a scale|Mean|9.0|9.0|Standard Deviation|2.42|2.42|||
4081124|NCT01018511|3904056|B5|||IPSS voiding score|"FAS population excluding 5 patients with invalid questionnaires. The number of participants was 318; 297; 312; 299 per treatment arm, respectively.~The IPSS is a validated global questionnaire to assess the degree of “bother” from urinary symptoms based on answers to 7 questions. Each question is assigned points from 0 to 5 indicating increasing severity of the particular symptom. The voiding score is the sum of the responses to 4 voiding questions (incomplete emptying of the bladder, intermittency, weak stream, hesitancy) and ranges from 0 to 20 (mildly symptomatic to severely symptomatic)."|units on a scale|Mean|9.8|9.8|Standard Deviation|3.60|3.6|||
4081125|NCT01018511|3904057|B4|||IPSS voiding score|"FAS population excluding 5 patients with invalid questionnaires. The number of participants was 318; 297; 312; 299 per treatment arm, respectively.~The IPSS is a validated global questionnaire to assess the degree of “bother” from urinary symptoms based on answers to 7 questions. Each question is assigned points from 0 to 5 indicating increasing severity of the particular symptom. The voiding score is the sum of the responses to 4 voiding questions (incomplete emptying of the bladder, intermittency, weak stream, hesitancy) and ranges from 0 to 20 (mildly symptomatic to severely symptomatic)."|units on a scale|Mean|9.7|9.7|Standard Deviation|3.63|3.63|||
4081126|NCT01018511|3904058|B3|||IPSS voiding score|"FAS population excluding 5 patients with invalid questionnaires. The number of participants was 318; 297; 312; 299 per treatment arm, respectively.~The IPSS is a validated global questionnaire to assess the degree of “bother” from urinary symptoms based on answers to 7 questions. Each question is assigned points from 0 to 5 indicating increasing severity of the particular symptom. The voiding score is the sum of the responses to 4 voiding questions (incomplete emptying of the bladder, intermittency, weak stream, hesitancy) and ranges from 0 to 20 (mildly symptomatic to severely symptomatic)."|units on a scale|Mean|9.7|9.7|Standard Deviation|3.61|3.61|||
4081127|NCT01018511|3904059|B2|||IPSS voiding score|"FAS population excluding 5 patients with invalid questionnaires. The number of participants was 318; 297; 312; 299 per treatment arm, respectively.~The IPSS is a validated global questionnaire to assess the degree of “bother” from urinary symptoms based on answers to 7 questions. Each question is assigned points from 0 to 5 indicating increasing severity of the particular symptom. The voiding score is the sum of the responses to 4 voiding questions (incomplete emptying of the bladder, intermittency, weak stream, hesitancy) and ranges from 0 to 20 (mildly symptomatic to severely symptomatic)."|units on a scale|Mean|9.8|9.8|Standard Deviation|3.63|3.63|||
4081128|NCT01018511|3904060|B1|||IPSS voiding score|"FAS population excluding 5 patients with invalid questionnaires. The number of participants was 318; 297; 312; 299 per treatment arm, respectively.~The IPSS is a validated global questionnaire to assess the degree of “bother” from urinary symptoms based on answers to 7 questions. Each question is assigned points from 0 to 5 indicating increasing severity of the particular symptom. The voiding score is the sum of the responses to 4 voiding questions (incomplete emptying of the bladder, intermittency, weak stream, hesitancy) and ranges from 0 to 20 (mildly symptomatic to severely symptomatic)."|units on a scale|Mean|10.0|10.0|Standard Deviation|3.53|3.53|||
4081129|NCT01018511|3904056|B5|||Total International Prostate Symptom Score (IPSS)|"FAS population excluding 5 patients with invalid questionnaires. The number of participants was 318; 297; 311; 299 per treatment arm, respectively. The IPSS is a validated global questionnaire to assess the degree of “bother” from urinary symptoms, based on answers to 7 questions concerning urinary symptoms:~Incomplete emptying of the bladder~Intermittency~Weak stream~Hesitancy~Frequency~Urgency~Nocturia~Each question is assigned points from 0 to 5 indicating increasing severity of the symptom. Total score can range from 0 to 35 (mildly symptomatic to severely symptomatic)."|units on a scale|Mean|18.6|18.6|Standard Deviation|4.44|4.44|||
4081130|NCT01018511|3904057|B4|||Total International Prostate Symptom Score (IPSS)|"FAS population excluding 5 patients with invalid questionnaires. The number of participants was 318; 297; 311; 299 per treatment arm, respectively. The IPSS is a validated global questionnaire to assess the degree of “bother” from urinary symptoms, based on answers to 7 questions concerning urinary symptoms:~Incomplete emptying of the bladder~Intermittency~Weak stream~Hesitancy~Frequency~Urgency~Nocturia~Each question is assigned points from 0 to 5 indicating increasing severity of the symptom. Total score can range from 0 to 35 (mildly symptomatic to severely symptomatic)."|units on a scale|Mean|18.6|18.6|Standard Deviation|4.31|4.31|||
4081131|NCT01018511|3904058|B3|||Total International Prostate Symptom Score (IPSS)|"FAS population excluding 5 patients with invalid questionnaires. The number of participants was 318; 297; 311; 299 per treatment arm, respectively. The IPSS is a validated global questionnaire to assess the degree of “bother” from urinary symptoms, based on answers to 7 questions concerning urinary symptoms:~Incomplete emptying of the bladder~Intermittency~Weak stream~Hesitancy~Frequency~Urgency~Nocturia~Each question is assigned points from 0 to 5 indicating increasing severity of the symptom. Total score can range from 0 to 35 (mildly symptomatic to severely symptomatic)."|units on a scale|Mean|18.3|18.3|Standard Deviation|4.31|4.31|||
4081132|NCT01018511|3904059|B2|||Total International Prostate Symptom Score (IPSS)|"FAS population excluding 5 patients with invalid questionnaires. The number of participants was 318; 297; 311; 299 per treatment arm, respectively. The IPSS is a validated global questionnaire to assess the degree of “bother” from urinary symptoms, based on answers to 7 questions concerning urinary symptoms:~Incomplete emptying of the bladder~Intermittency~Weak stream~Hesitancy~Frequency~Urgency~Nocturia~Each question is assigned points from 0 to 5 indicating increasing severity of the symptom. Total score can range from 0 to 35 (mildly symptomatic to severely symptomatic)."|units on a scale|Mean|18.7|18.7|Standard Deviation|4.63|4.63|||
4081133|NCT01018511|3904060|B1|||Total International Prostate Symptom Score (IPSS)|"FAS population excluding 5 patients with invalid questionnaires. The number of participants was 318; 297; 311; 299 per treatment arm, respectively. The IPSS is a validated global questionnaire to assess the degree of “bother” from urinary symptoms, based on answers to 7 questions concerning urinary symptoms:~Incomplete emptying of the bladder~Intermittency~Weak stream~Hesitancy~Frequency~Urgency~Nocturia~Each question is assigned points from 0 to 5 indicating increasing severity of the symptom. Total score can range from 0 to 35 (mildly symptomatic to severely symptomatic)."|units on a scale|Mean|19.0|19.0|Standard Deviation|4.48|4.48|||
4081134|NCT01018511|3904056|B5|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4081135|NCT01018511|3904057|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4081136|NCT01018511|3904058|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4081137|NCT01018511|3904059|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4081138|NCT01018511|3904060|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4081139|NCT01018511|3904056|B5|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4081140|NCT01018511|3904057|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4081141|NCT01018511|3904058|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4081142|NCT01018511|3904059|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4081143|NCT01018511|3904060|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4081144|NCT01018511|3904056|B5|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4081145|NCT01018511|3904057|B4|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4081146|NCT01018511|3904058|B3|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4081147|NCT01018511|3904059|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4081148|NCT01018511|3904060|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4081149|NCT01018511|3904056|B5|White||Race/Ethnicity, Customized||participants|Number|1317|1317.0||||||
4081150|NCT01018511|3904057|B4|White||Race/Ethnicity, Customized||participants|Number|321|321.0||||||
4081151|NCT01018511|3904058|B3|White||Race/Ethnicity, Customized||participants|Number|334|334.0||||||
4081152|NCT01018511|3904059|B2|White||Race/Ethnicity, Customized||participants|Number|325|325.0||||||
4081153|NCT01018511|3904060|B1|White||Race/Ethnicity, Customized||participants|Number|337|337.0||||||
4081154|NCT01018511|3904056|B5||Male|Sex: Female, Male||Participants|Count of Participants|1328|1328.0||||||
4081155|NCT01018511|3904057|B4||Male|Sex: Female, Male||Participants|Count of Participants|324|324.0||||||
4081156|NCT01018511|3904058|B3||Male|Sex: Female, Male||Participants|Count of Participants|337|337.0||||||
4081157|NCT01018511|3904059|B2||Male|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
4081158|NCT01018511|3904060|B1||Male|Sex: Female, Male||Participants|Count of Participants|341|341.0||||||
4081159|NCT01018511|3904056|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4081160|NCT01018511|3904057|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4081161|NCT01018511|3904058|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4081162|NCT01018511|3904059|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4081163|NCT01018511|3904060|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4081164|NCT01018511|3904056|B5|||Age||years|Mean|65.4|65.4|Standard Deviation|8.13|8.13|||
4081165|NCT01018511|3904057|B4|||Age||years|Mean|65.5|65.5|Standard Deviation|7.71|7.71|||
4081166|NCT01018511|3904058|B3|||Age||years|Mean|65.3|65.3|Standard Deviation|8.39|8.39|||
4081167|NCT01018511|3904059|B2|||Age||years|Mean|65.1|65.1|Standard Deviation|7.98|7.98|||
4081168|NCT01018511|3904060|B1|||Age||years|Mean|65.6|65.6|Standard Deviation|8.41|8.41|||
4081169|NCT01018420|3904230|B3|United States||Region of Enrollment||participants|Number|18.0|18.0||||||
4081170|NCT01018420|3904231|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4081171|NCT01018420|3904232|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4081172|NCT01018420|3904230|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0.0|0.0||||||
4081181|NCT01018420|3904230|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1.0|1.0||||||
4081182|NCT01018420|3904231|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081183|NCT01018420|3904232|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4081184|NCT01018420|3904230|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0.0|0.0||||||
4081185|NCT01018420|3904231|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081186|NCT01018420|3904232|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081187|NCT01018420|3904230|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0.0|0.0||||||
4081188|NCT01018420|3904231|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081189|NCT01018420|3904232|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081190|NCT01018420|3904230|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1.0|1.0||||||
4081191|NCT01018420|3904231|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081192|NCT01018420|3904232|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4081193|NCT01018420|3904230|B3||Male|Sex: Female, Male||Participants|Count of Participants|10.0|10.0||||||
4081194|NCT01018420|3904231|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4081195|NCT01018420|3904232|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4081196|NCT01018420|3904230|B3||Female|Sex: Female, Male||Participants|Count of Participants|8.0|8.0||||||
4081197|NCT01018420|3904231|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4081198|NCT01018420|3904232|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4081199|NCT01018420|3904230|B3|||Age||years|Mean|28.7|28.7|Standard Deviation|10.0|10.0|||
4081200|NCT01018420|3904231|B2|||Age||years|Mean|21.3|21.3|Standard Deviation|0.6|0.6|||
4081201|NCT01018420|3904232|B1|||Age||years|Mean|30.1|30.1|Standard Deviation|10.4|10.4|||
4081202|NCT01018420|3904230|B3||>=65 years|Age|age range: >=18 and <=55|Participants|Count of Participants|0.0|0.0||||||
4081203|NCT01018420|3904231|B2||>=65 years|Age|age range: >=18 and <=55|Participants|Count of Participants|0|0.0||||||
4081204|NCT01018420|3904232|B1||>=65 years|Age|age range: >=18 and <=55|Participants|Count of Participants|0|0.0||||||
4081205|NCT01018420|3904230|B3||Between 18 and 65 years|Age|age range: >=18 and <=55|Participants|Count of Participants|18.0|18.0||||||
4081206|NCT01018420|3904231|B2||Between 18 and 65 years|Age|age range: >=18 and <=55|Participants|Count of Participants|3|3.0||||||
4081207|NCT01018420|3904232|B1||Between 18 and 65 years|Age|age range: >=18 and <=55|Participants|Count of Participants|15|15.0||||||
4081208|NCT01018420|3904230|B3||<=18 years|Age|age range: >=18 and <=55|Participants|Count of Participants|0.0|0.0||||||
4081209|NCT01018420|3904231|B2||<=18 years|Age|age range: >=18 and <=55|Participants|Count of Participants|0|0.0||||||
4081210|NCT01018420|3904232|B1||<=18 years|Age|age range: >=18 and <=55|Participants|Count of Participants|0|0.0||||||
4081211|NCT01018394|3904258|B3|||Baseline tobacco used per week|Amount of smokeless tobacco used upon study entry.|cans of smokeless tobacco|Mean|3.6|3.6|Standard Deviation|2.4|2.4|||
4081212|NCT01018394|3904259|B2|||Baseline tobacco used per week|Amount of smokeless tobacco used upon study entry.|cans of smokeless tobacco|Mean|4.0|4.0|Standard Deviation|2.7|2.7|||
4081213|NCT01018394|3904260|B1|||Baseline tobacco used per week|Amount of smokeless tobacco used upon study entry.|cans of smokeless tobacco|Mean|3.2|3.2|Standard Deviation|2.1|2.1|||
4081214|NCT01018394|3904258|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4081215|NCT01018394|3904259|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4081216|NCT01018394|3904260|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4081217|NCT01018394|3904258|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4081218|NCT01018394|3904259|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4081219|NCT01018394|3904260|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4081220|NCT01018394|3904258|B3|||Age||years|Mean|37.6|37.6|Standard Deviation|14.3|14.3|||
4081221|NCT01018394|3904259|B2|||Age||years|Mean|37.5|37.5|Standard Deviation|12.5|12.5|||
4081222|NCT01018394|3904260|B1|||Age||years|Mean|37.8|37.8|Standard Deviation|15.9|15.9|||
4081223|NCT01018394|3904258|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4081224|NCT01018394|3904259|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4081225|NCT01018394|3904260|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4081226|NCT01018394|3904258|B3||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4081227|NCT01018394|3904259|B2||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4081228|NCT01018394|3904260|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4081229|NCT01018394|3904258|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4081230|NCT01018394|3904259|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4081231|NCT01018394|3904260|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4081232|NCT01018264|3904269|B3|Severe Urgency||Patient Perception of Intensity of Urgency Scale (PPIUS)|The PPIUS is a scale to assess patient's perception of their level of urgency. Mild urgency = better outcome; Severe urgency = worse outcome.|participants|Number|9|9.0||||||
4081233|NCT01018264|3904270|B2|Severe Urgency||Patient Perception of Intensity of Urgency Scale (PPIUS)|The PPIUS is a scale to assess patient's perception of their level of urgency. Mild urgency = better outcome; Severe urgency = worse outcome.|participants|Number|6|6.0||||||
4081316|NCT01018264|3904269|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4081234|NCT01018264|3904271|B1|Severe Urgency||Patient Perception of Intensity of Urgency Scale (PPIUS)|The PPIUS is a scale to assess patient's perception of their level of urgency. Mild urgency = better outcome; Severe urgency = worse outcome.|participants|Number|3|3.0||||||
4081235|NCT01018264|3904269|B3|Moderate-Severe||Patient Perception of Intensity of Urgency Scale (PPIUS)|The PPIUS is a scale to assess patient's perception of their level of urgency. Mild urgency = better outcome; Severe urgency = worse outcome.|participants|Number|1|1.0||||||
4081236|NCT01018264|3904270|B2|Moderate-Severe||Patient Perception of Intensity of Urgency Scale (PPIUS)|The PPIUS is a scale to assess patient's perception of their level of urgency. Mild urgency = better outcome; Severe urgency = worse outcome.|participants|Number|1|1.0||||||
4081237|NCT01018264|3904271|B1|Moderate-Severe||Patient Perception of Intensity of Urgency Scale (PPIUS)|The PPIUS is a scale to assess patient's perception of their level of urgency. Mild urgency = better outcome; Severe urgency = worse outcome.|participants|Number|0|0.0||||||
4081238|NCT01018264|3904269|B3|Moderate Urgency||Patient Perception of Intensity of Urgency Scale (PPIUS)|The PPIUS is a scale to assess patient's perception of their level of urgency. Mild urgency = better outcome; Severe urgency = worse outcome.|participants|Number|9|9.0||||||
4081239|NCT01018264|3904270|B2|Moderate Urgency||Patient Perception of Intensity of Urgency Scale (PPIUS)|The PPIUS is a scale to assess patient's perception of their level of urgency. Mild urgency = better outcome; Severe urgency = worse outcome.|participants|Number|5|5.0||||||
4081240|NCT01018264|3904271|B1|Moderate Urgency||Patient Perception of Intensity of Urgency Scale (PPIUS)|The PPIUS is a scale to assess patient's perception of their level of urgency. Mild urgency = better outcome; Severe urgency = worse outcome.|participants|Number|4|4.0||||||
4081241|NCT01018264|3904269|B3|Mild Urgency||Patient Perception of Intensity of Urgency Scale (PPIUS)|The PPIUS is a scale to assess patient's perception of their level of urgency. Mild urgency = better outcome; Severe urgency = worse outcome.|participants|Number|4|4.0||||||
4081242|NCT01018264|3904270|B2|Mild Urgency||Patient Perception of Intensity of Urgency Scale (PPIUS)|The PPIUS is a scale to assess patient's perception of their level of urgency. Mild urgency = better outcome; Severe urgency = worse outcome.|participants|Number|1|1.0||||||
4081243|NCT01018264|3904271|B1|Mild Urgency||Patient Perception of Intensity of Urgency Scale (PPIUS)|The PPIUS is a scale to assess patient's perception of their level of urgency. Mild urgency = better outcome; Severe urgency = worse outcome.|participants|Number|3|3.0||||||
4081244|NCT01018264|3904269|B3|Causes me many severe problems||Patient perception of Bladder Condition (PBC/PPBC)|The PBC/PPBC is a single-item global measure for patients with overactive bladder.|participants|Number|2|2.0||||||
4081245|NCT01018264|3904270|B2|Causes me many severe problems||Patient perception of Bladder Condition (PBC/PPBC)|The PBC/PPBC is a single-item global measure for patients with overactive bladder.|participants|Number|1|1.0||||||
4081246|NCT01018264|3904271|B1|Causes me many severe problems||Patient perception of Bladder Condition (PBC/PPBC)|The PBC/PPBC is a single-item global measure for patients with overactive bladder.|participants|Number|1|1.0||||||
4081247|NCT01018264|3904269|B3|Causes me severe problems||Patient perception of Bladder Condition (PBC/PPBC)|The PBC/PPBC is a single-item global measure for patients with overactive bladder.|participants|Number|11|11.0||||||
4081248|NCT01018264|3904270|B2|Causes me severe problems||Patient perception of Bladder Condition (PBC/PPBC)|The PBC/PPBC is a single-item global measure for patients with overactive bladder.|participants|Number|7|7.0||||||
4081249|NCT01018264|3904271|B1|Causes me severe problems||Patient perception of Bladder Condition (PBC/PPBC)|The PBC/PPBC is a single-item global measure for patients with overactive bladder.|participants|Number|4|4.0||||||
4081250|NCT01018264|3904269|B3|Causes me (some) moderate problems||Patient perception of Bladder Condition (PBC/PPBC)|The PBC/PPBC is a single-item global measure for patients with overactive bladder.|participants|Number|10|10.0||||||
4081251|NCT01018264|3904270|B2|Causes me (some) moderate problems||Patient perception of Bladder Condition (PBC/PPBC)|The PBC/PPBC is a single-item global measure for patients with overactive bladder.|participants|Number|5|5.0||||||
4081252|NCT01018264|3904271|B1|Causes me (some) moderate problems||Patient perception of Bladder Condition (PBC/PPBC)|The PBC/PPBC is a single-item global measure for patients with overactive bladder.|participants|Number|5|5.0||||||
4081253|NCT01018264|3904269|B3|||Bladder diary: # nocturia episodes|This is the mean number of nocturia episodes as recorded on a 3-day bladder diary.|Number of nocturia episodes per 24 hours|Mean|2.04|2.04|Standard Deviation|1.36|1.36|||
4081254|NCT01018264|3904270|B2|||Bladder diary: # nocturia episodes|This is the mean number of nocturia episodes as recorded on a 3-day bladder diary.|Number of nocturia episodes per 24 hours|Mean|1.90|1.9|Standard Deviation|1.09|1.09|||
4081255|NCT01018264|3904271|B1|||Bladder diary: # nocturia episodes|This is the mean number of nocturia episodes as recorded on a 3-day bladder diary.|Number of nocturia episodes per 24 hours|Mean|2.23|2.23|Standard Deviation|1.69|1.69|||
4081256|NCT01018264|3904269|B3|||Bladder diary: # leaks|This is the mean number of leaks as recorded on a 3-day bladder diary.|Number of leaks per 24-hour period|Mean|1.55|1.55|Standard Deviation|1.82|1.82|||
4081257|NCT01018264|3904270|B2|||Bladder diary: # leaks|This is the mean number of leaks as recorded on a 3-day bladder diary.|Number of leaks per 24-hour period|Mean|1.72|1.72|Standard Deviation|1.23|1.23|||
4081258|NCT01018264|3904271|B1|||Bladder diary: # leaks|This is the mean number of leaks as recorded on a 3-day bladder diary.|Number of leaks per 24-hour period|Mean|1.33|1.33|Standard Deviation|2.45|2.45|||
4081259|NCT01018264|3904269|B3|||Bladder diary: # micturations|This is the mean number of micturations per 24 hour period as recorded on a 3-day bladder diary|Micturation episodes per 24 hour period|Mean|9.14|9.14|Standard Deviation|2.83|2.83|||
4081260|NCT01018264|3904270|B2|||Bladder diary: # micturations|This is the mean number of micturations per 24 hour period as recorded on a 3-day bladder diary|Micturation episodes per 24 hour period|Mean|9.23|9.23|Standard Deviation|3.31|3.31|||
4081261|NCT01018264|3904271|B1|||Bladder diary: # micturations|This is the mean number of micturations per 24 hour period as recorded on a 3-day bladder diary|Micturation episodes per 24 hour period|Mean|9.03|9.03|Standard Deviation|2.21|2.21|||
4081262|NCT01018264|3904269|B3|||Incontinence Quality of Life scale (IQOL)|The Incontinence Quality of Life scale has a possible range of 22 (worst outcome) to 110 (best outcome) total points.|units on a scale|Mean|76.83|76.83|Standard Deviation|18.96|18.96|||
4081263|NCT01018264|3904270|B2|||Incontinence Quality of Life scale (IQOL)|The Incontinence Quality of Life scale has a possible range of 22 (worst outcome) to 110 (best outcome) total points.|units on a scale|Mean|75.92|75.92|Standard Deviation|18.87|18.87|||
4081264|NCT01018264|3904271|B1|||Incontinence Quality of Life scale (IQOL)|The Incontinence Quality of Life scale has a possible range of 22 (worst outcome) to 110 (best outcome) total points.|units on a scale|Mean|78.00|78.0|Standard Deviation|20.03|20.03|||
4081265|NCT01018264|3904269|B3|Stage 3||Hoehn & Yahr stage|Stage 1: Unilateral disease. (Better outcome) Stage 1.5: Unilateral plus axial involvement. Stage 2: Bilateral disease, without impairment of balance. Stage 2.5: Mild bilateral disease, with recovery on pull test. Stage 3: Mild to moderate bilateral disease; some postural instability; physically independent. (Worst Outcome)|participants|Number|4|4.0||||||
4081266|NCT01018264|3904270|B2|Stage 3||Hoehn & Yahr stage|Stage 1: Unilateral disease. (Better outcome) Stage 1.5: Unilateral plus axial involvement. Stage 2: Bilateral disease, without impairment of balance. Stage 2.5: Mild bilateral disease, with recovery on pull test. Stage 3: Mild to moderate bilateral disease; some postural instability; physically independent. (Worst Outcome)|participants|Number|3|3.0||||||
4081267|NCT01018264|3904271|B1|Stage 3||Hoehn & Yahr stage|Stage 1: Unilateral disease. (Better outcome) Stage 1.5: Unilateral plus axial involvement. Stage 2: Bilateral disease, without impairment of balance. Stage 2.5: Mild bilateral disease, with recovery on pull test. Stage 3: Mild to moderate bilateral disease; some postural instability; physically independent. (Worst Outcome)|participants|Number|1|1.0||||||
4081268|NCT01018264|3904269|B3|Stage 2.5||Hoehn & Yahr stage|Stage 1: Unilateral disease. (Better outcome) Stage 1.5: Unilateral plus axial involvement. Stage 2: Bilateral disease, without impairment of balance. Stage 2.5: Mild bilateral disease, with recovery on pull test. Stage 3: Mild to moderate bilateral disease; some postural instability; physically independent. (Worst Outcome)|participants|Number|13|13.0||||||
4081269|NCT01018264|3904270|B2|Stage 2.5||Hoehn & Yahr stage|Stage 1: Unilateral disease. (Better outcome) Stage 1.5: Unilateral plus axial involvement. Stage 2: Bilateral disease, without impairment of balance. Stage 2.5: Mild bilateral disease, with recovery on pull test. Stage 3: Mild to moderate bilateral disease; some postural instability; physically independent. (Worst Outcome)|participants|Number|7|7.0||||||
4081270|NCT01018264|3904271|B1|Stage 2.5||Hoehn & Yahr stage|Stage 1: Unilateral disease. (Better outcome) Stage 1.5: Unilateral plus axial involvement. Stage 2: Bilateral disease, without impairment of balance. Stage 2.5: Mild bilateral disease, with recovery on pull test. Stage 3: Mild to moderate bilateral disease; some postural instability; physically independent. (Worst Outcome)|participants|Number|6|6.0||||||
4081271|NCT01018264|3904269|B3|Stage 2||Hoehn & Yahr stage|Stage 1: Unilateral disease. (Better outcome) Stage 1.5: Unilateral plus axial involvement. Stage 2: Bilateral disease, without impairment of balance. Stage 2.5: Mild bilateral disease, with recovery on pull test. Stage 3: Mild to moderate bilateral disease; some postural instability; physically independent. (Worst Outcome)|participants|Number|3|3.0||||||
4081272|NCT01018264|3904270|B2|Stage 2||Hoehn & Yahr stage|Stage 1: Unilateral disease. (Better outcome) Stage 1.5: Unilateral plus axial involvement. Stage 2: Bilateral disease, without impairment of balance. Stage 2.5: Mild bilateral disease, with recovery on pull test. Stage 3: Mild to moderate bilateral disease; some postural instability; physically independent. (Worst Outcome)|participants|Number|2|2.0||||||
4081273|NCT01018264|3904271|B1|Stage 2||Hoehn & Yahr stage|Stage 1: Unilateral disease. (Better outcome) Stage 1.5: Unilateral plus axial involvement. Stage 2: Bilateral disease, without impairment of balance. Stage 2.5: Mild bilateral disease, with recovery on pull test. Stage 3: Mild to moderate bilateral disease; some postural instability; physically independent. (Worst Outcome)|participants|Number|1|1.0||||||
4081274|NCT01018264|3904269|B3|Stage 1.5||Hoehn & Yahr stage|Stage 1: Unilateral disease. (Better outcome) Stage 1.5: Unilateral plus axial involvement. Stage 2: Bilateral disease, without impairment of balance. Stage 2.5: Mild bilateral disease, with recovery on pull test. Stage 3: Mild to moderate bilateral disease; some postural instability; physically independent. (Worst Outcome)|participants|Number|2|2.0||||||
4081275|NCT01018264|3904270|B2|Stage 1.5||Hoehn & Yahr stage|Stage 1: Unilateral disease. (Better outcome) Stage 1.5: Unilateral plus axial involvement. Stage 2: Bilateral disease, without impairment of balance. Stage 2.5: Mild bilateral disease, with recovery on pull test. Stage 3: Mild to moderate bilateral disease; some postural instability; physically independent. (Worst Outcome)|participants|Number|1|1.0||||||
4081276|NCT01018264|3904271|B1|Stage 1.5||Hoehn & Yahr stage|Stage 1: Unilateral disease. (Better outcome) Stage 1.5: Unilateral plus axial involvement. Stage 2: Bilateral disease, without impairment of balance. Stage 2.5: Mild bilateral disease, with recovery on pull test. Stage 3: Mild to moderate bilateral disease; some postural instability; physically independent. (Worst Outcome)|participants|Number|1|1.0||||||
4081277|NCT01018264|3904269|B3|Stage 1||Hoehn & Yahr stage|Stage 1: Unilateral disease. (Better outcome) Stage 1.5: Unilateral plus axial involvement. Stage 2: Bilateral disease, without impairment of balance. Stage 2.5: Mild bilateral disease, with recovery on pull test. Stage 3: Mild to moderate bilateral disease; some postural instability; physically independent. (Worst Outcome)|participants|Number|1|1.0||||||
4081278|NCT01018264|3904270|B2|Stage 1||Hoehn & Yahr stage|Stage 1: Unilateral disease. (Better outcome) Stage 1.5: Unilateral plus axial involvement. Stage 2: Bilateral disease, without impairment of balance. Stage 2.5: Mild bilateral disease, with recovery on pull test. Stage 3: Mild to moderate bilateral disease; some postural instability; physically independent. (Worst Outcome)|participants|Number|0|0.0||||||
4081279|NCT01018264|3904271|B1|Stage 1||Hoehn & Yahr stage|Stage 1: Unilateral disease. (Better outcome) Stage 1.5: Unilateral plus axial involvement. Stage 2: Bilateral disease, without impairment of balance. Stage 2.5: Mild bilateral disease, with recovery on pull test. Stage 3: Mild to moderate bilateral disease; some postural instability; physically independent. (Worst Outcome)|participants|Number|1|1.0||||||
4081280|NCT01018264|3904269|B3|||Parkinson's Disease Quality of Life (PDQOL) total score|Parkinson's disease quality of life scale has a possible point range from 37 (worst outcome) to 185 (best outcome).|units on a scale|Mean|119.13|119.13|Standard Deviation|15.65|15.65|||
4081281|NCT01018264|3904270|B2|||Parkinson's Disease Quality of Life (PDQOL) total score|Parkinson's disease quality of life scale has a possible point range from 37 (worst outcome) to 185 (best outcome).|units on a scale|Mean|115.31|115.31|Standard Deviation|10.68|10.68|||
4081317|NCT01018264|3904270|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4081282|NCT01018264|3904271|B1|||Parkinson's Disease Quality of Life (PDQOL) total score|Parkinson's disease quality of life scale has a possible point range from 37 (worst outcome) to 185 (best outcome).|units on a scale|Mean|124.10|124.1|Standard Deviation|19.96|19.96|||
4081283|NCT01018264|3904269|B3|||Unified Parkinson's Disease Rating Scale (UPDRS) Total score|The UPDRS is a rating tool to follow the longitudinal course of Parkinson's Disease. It is made up of: Part 1- Mentation, Behavior, and Mood; Part 2- Activities of Daily Living (ADL); Part 3 - Motor function; and Part IV - Complications. These are evaluated by interview. Some sections require multiple grades assigned to each extremity. A total of 199 points are possible. 199 represents the worst (total disability), 0 =no disability. To get the total score you sum up each subsection score.|units on a scale|Mean|24.61|24.61|Standard Deviation|10.78|10.78|||
4081284|NCT01018264|3904270|B2|||Unified Parkinson's Disease Rating Scale (UPDRS) Total score|The UPDRS is a rating tool to follow the longitudinal course of Parkinson's Disease. It is made up of: Part 1- Mentation, Behavior, and Mood; Part 2- Activities of Daily Living (ADL); Part 3 - Motor function; and Part IV - Complications. These are evaluated by interview. Some sections require multiple grades assigned to each extremity. A total of 199 points are possible. 199 represents the worst (total disability), 0 =no disability. To get the total score you sum up each subsection score.|units on a scale|Mean|25.08|25.08|Standard Deviation|11.93|11.93|||
4081285|NCT01018264|3904271|B1|||Unified Parkinson's Disease Rating Scale (UPDRS) Total score|The UPDRS is a rating tool to follow the longitudinal course of Parkinson's Disease. It is made up of: Part 1- Mentation, Behavior, and Mood; Part 2- Activities of Daily Living (ADL); Part 3 - Motor function; and Part IV - Complications. These are evaluated by interview. Some sections require multiple grades assigned to each extremity. A total of 199 points are possible. 199 represents the worst (total disability), 0 =no disability. To get the total score you sum up each subsection score.|units on a scale|Mean|24.00|24.0|Standard Deviation|9.67|9.67|||
4081286|NCT01018264|3904269|B3|||Unified Parkinson's Disease Rating Scale (UPDRS) Motor subsection (Part III)|This is part III of the UPDRS scale. It measures motor function in PD patients. Scores range from 0 to 108, with a score of 0 being a better outcome and 108 being a worse outcome.|points|Mean|13.78|13.78|Standard Deviation|4.86|4.86|||
4081287|NCT01018264|3904270|B2|||Unified Parkinson's Disease Rating Scale (UPDRS) Motor subsection (Part III)|This is part III of the UPDRS scale. It measures motor function in PD patients. Scores range from 0 to 108, with a score of 0 being a better outcome and 108 being a worse outcome.|points|Mean|14.69|14.69|Standard Deviation|5.19|5.19|||
4081288|NCT01018264|3904271|B1|||Unified Parkinson's Disease Rating Scale (UPDRS) Motor subsection (Part III)|This is part III of the UPDRS scale. It measures motor function in PD patients. Scores range from 0 to 108, with a score of 0 being a better outcome and 108 being a worse outcome.|points|Mean|12.60|12.6|Standard Deviation|4.38|4.38|||
4081289|NCT01018264|3904269|B3|||Unified Parkinson's Disease Rating Scale (UPDRS) ADL subsection (mean)|This subscale of the UPDRS measures activities of daily living. Points can range from 0-52 with 0 being better outcomes and 52 being a worse outcome.|units on a scale|Mean|10.48|10.48|Standard Deviation|5.01|5.01|||
4081290|NCT01018264|3904270|B2|||Unified Parkinson's Disease Rating Scale (UPDRS) ADL subsection (mean)|This subscale of the UPDRS measures activities of daily living. Points can range from 0-52 with 0 being better outcomes and 52 being a worse outcome.|units on a scale|Mean|11.23|11.23|Standard Deviation|4.76|4.76|||
4081291|NCT01018264|3904271|B1|||Unified Parkinson's Disease Rating Scale (UPDRS) ADL subsection (mean)|This subscale of the UPDRS measures activities of daily living. Points can range from 0-52 with 0 being better outcomes and 52 being a worse outcome.|units on a scale|Mean|9.50|9.5|Standard Deviation|5.40|5.4|||
4081292|NCT01018264|3904269|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4081293|NCT01018264|3904270|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4081294|NCT01018264|3904271|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4081295|NCT01018264|3904269|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081296|NCT01018264|3904270|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081297|NCT01018264|3904271|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081298|NCT01018264|3904269|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4081299|NCT01018264|3904270|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4081300|NCT01018264|3904271|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4081301|NCT01018264|3904269|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4081302|NCT01018264|3904270|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4081303|NCT01018264|3904271|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4081304|NCT01018264|3904269|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4081305|NCT01018264|3904270|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4081306|NCT01018264|3904271|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081307|NCT01018264|3904269|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081308|NCT01018264|3904270|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081309|NCT01018264|3904271|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081310|NCT01018264|3904269|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081311|NCT01018264|3904270|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081312|NCT01018264|3904271|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081313|NCT01018264|3904269|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081314|NCT01018264|3904270|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081315|NCT01018264|3904271|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081318|NCT01018264|3904271|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4081319|NCT01018264|3904269|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4081320|NCT01018264|3904270|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4081321|NCT01018264|3904271|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4081322|NCT01018264|3904269|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4081323|NCT01018264|3904270|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4081324|NCT01018264|3904271|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4081325|NCT01018264|3904269|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4081326|NCT01018264|3904270|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4081327|NCT01018264|3904271|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4081328|NCT01018264|3904269|B3|Age (years)||Age, Customized||years|Mean|66.96|66.96|Standard Deviation|8.04|8.04|||
4081329|NCT01018264|3904270|B2|Age (years)||Age, Customized||years|Mean|66.5|66.5|Standard Deviation|9.3|9.3|||
4081330|NCT01018264|3904271|B1|Age (years)||Age, Customized||years|Mean|67.6|67.6|Standard Deviation|6.6|6.6|||
4081331|NCT01018186|3904286|B4|Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4081332|NCT01018186|3904287|B3|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4081333|NCT01018186|3904288|B2|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4081334|NCT01018186|3904289|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4081335|NCT01018186|3904286|B4|White - Mixed Race||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4081336|NCT01018186|3904287|B3|White - Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4081337|NCT01018186|3904288|B2|White - Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4081338|NCT01018186|3904289|B1|White - Mixed Race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4081339|NCT01018186|3904286|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|329|329.0||||||
4081340|NCT01018186|3904287|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
4081341|NCT01018186|3904288|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|132|132.0||||||
4081342|NCT01018186|3904289|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|129|129.0||||||
4081343|NCT01018186|3904286|B4|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4081344|NCT01018186|3904287|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4081345|NCT01018186|3904288|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4081346|NCT01018186|3904289|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4081347|NCT01018186|3904286|B4|Asian - Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4081348|NCT01018186|3904287|B3|Asian - Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4081349|NCT01018186|3904288|B2|Asian - Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4081350|NCT01018186|3904289|B1|Asian - Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4081351|NCT01018186|3904286|B4|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|125|125.0||||||
4081352|NCT01018186|3904287|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4081353|NCT01018186|3904288|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4081354|NCT01018186|3904289|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
4081355|NCT01018186|3904286|B4|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4081356|NCT01018186|3904287|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4081357|NCT01018186|3904288|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4081358|NCT01018186|3904289|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4081359|NCT01018186|3904286|B4|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4081360|NCT01018186|3904287|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4081361|NCT01018186|3904288|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4081362|NCT01018186|3904289|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4081363|NCT01018186|3904286|B4||Male|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4081364|NCT01018186|3904287|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4081365|NCT01018186|3904288|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4081366|NCT01018186|3904289|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4081367|NCT01018186|3904286|B4||Female|Sex: Female, Male||Participants|Count of Participants|316|316.0||||||
4081368|NCT01018186|3904287|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4081369|NCT01018186|3904288|B2||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4081370|NCT01018186|3904289|B1||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4081371|NCT01018186|3904286|B4|||Age||Years|Mean|39.0|39.0|Standard Deviation|15.77|15.77|||
4081372|NCT01018186|3904287|B3|||Age||Years|Mean|38.6|38.6|Standard Deviation|15.97|15.97|||
4081373|NCT01018186|3904288|B2|||Age||Years|Mean|38.5|38.5|Standard Deviation|15.64|15.64|||
4081374|NCT01018186|3904289|B1|||Age||Years|Mean|39.7|39.7|Standard Deviation|15.85|15.85|||
4081375|NCT01018134|3904378|B7|United States||Region of Enrollment||participants|Number|150|150.0||||||
4081376|NCT01018134|3904379|B6|United States||Region of Enrollment||participants|Number|15|15.0||||||
4081377|NCT01018134|3904380|B5|United States||Region of Enrollment||participants|Number|15|15.0||||||
4081378|NCT01018134|3904381|B4|United States||Region of Enrollment||participants|Number|29|29.0||||||
4081379|NCT01018134|3904382|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4081380|NCT01018134|3904383|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
4081381|NCT01018134|3904384|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4081382|NCT01018134|3904378|B7||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4081383|NCT01018134|3904379|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4081384|NCT01018134|3904380|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4081385|NCT01018134|3904381|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4081386|NCT01018134|3904382|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4081387|NCT01018134|3904383|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4081388|NCT01018134|3904384|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4081389|NCT01018134|3904378|B7||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4081390|NCT01018134|3904379|B6||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4081391|NCT01018134|3904380|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4081392|NCT01018134|3904381|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4081393|NCT01018134|3904382|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4081394|NCT01018134|3904383|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4081395|NCT01018134|3904384|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4081396|NCT01018134|3904378|B7|||Age||years|Mean|50.66|50.66|Standard Deviation|13.61|13.61|||
4081397|NCT01018134|3904379|B6|||Age||years|Mean|49.60|49.6|Standard Deviation|13.30|13.3|||
4081398|NCT01018134|3904380|B5|||Age||years|Mean|53.53|53.53|Standard Deviation|12.92|12.92|||
4081399|NCT01018134|3904381|B4|||Age||years|Mean|50.62|50.62|Standard Deviation|14.54|14.54|||
4081400|NCT01018134|3904382|B3|||Age||years|Mean|51.60|51.6|Standard Deviation|12.67|12.67|||
4081401|NCT01018134|3904383|B2|||Age||years|Mean|45.06|45.06|Standard Deviation|13.04|13.04|||
4081402|NCT01018134|3904384|B1|||Age||years|Mean|53.60|53.6|Standard Deviation|15.21|15.21|||
4081403|NCT01018095|3904427|B3|United States||Region of Enrollment||participants|Number|270|270.0||||||
4081404|NCT01018095|3904428|B2|United States||Region of Enrollment||participants|Number|135|135.0||||||
4081405|NCT01018095|3904429|B1|United States||Region of Enrollment||participants|Number|135|135.0||||||
4081406|NCT01018095|3904427|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
4081407|NCT01018095|3904428|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
4081408|NCT01018095|3904429|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4081409|NCT01018095|3904427|B3||Female|Gender||Participants|Count of Participants|270|270.0||||||
4081410|NCT01018095|3904428|B2||Female|Gender||Participants|Count of Participants|135|135.0||||||
4081411|NCT01018095|3904429|B1||Female|Gender||Participants|Count of Participants|135|135.0||||||
4081412|NCT01018095|3904427|B3|||Age||years|Mean|40.1|40.1|Standard Deviation|9.4|9.4|||
4081413|NCT01018095|3904428|B2|||Age||years|Mean|40.7|40.7|Standard Deviation|9.4|9.4|||
4081414|NCT01018095|3904429|B1|||Age||years|Mean|39.5|39.5|Standard Deviation|9.3|9.3|||
4081415|NCT01018095|3904427|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4081416|NCT01018095|3904428|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4081417|NCT01018095|3904429|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4081418|NCT01018095|3904427|B3||Between 18 and 65 years|Age||Participants|Count of Participants|269|269.0||||||
4081419|NCT01018095|3904428|B2||Between 18 and 65 years|Age||Participants|Count of Participants|134|134.0||||||
4081420|NCT01018095|3904429|B1||Between 18 and 65 years|Age||Participants|Count of Participants|135|135.0||||||
4081421|NCT01018095|3904427|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4081422|NCT01018095|3904428|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4081423|NCT01018095|3904429|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4081424|NCT01018056|3904438|B4|United States||Region of Enrollment||participants|Number|24|24.0||||||
4081425|NCT01018056|3904439|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4081426|NCT01018056|3904440|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4081427|NCT01018056|3904441|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4081428|NCT01018056|3904438|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4081429|NCT01018056|3904439|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4081430|NCT01018056|3904440|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4081431|NCT01018056|3904441|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4081432|NCT01018056|3904438|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4081433|NCT01018056|3904439|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4081434|NCT01018056|3904440|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4081435|NCT01018056|3904441|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4081436|NCT01018056|3904438|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4081437|NCT01018056|3904439|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4081438|NCT01018056|3904440|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4081439|NCT01018056|3904441|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4081440|NCT01018056|3904438|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4081441|NCT01018056|3904439|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4081442|NCT01018056|3904440|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4081443|NCT01018056|3904441|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4081444|NCT01018056|3904438|B4||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
4081445|NCT01018056|3904439|B3||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4081446|NCT01018056|3904440|B2||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4081447|NCT01018056|3904441|B1||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4081448|NCT01018056|3904438|B4|||Age||years|Mean|13.5|13.5|Standard Deviation|2.58|2.58|||
4081449|NCT01018056|3904439|B3|||Age||years|Mean|12.6|12.6|Standard Deviation|2.76|2.76|||
4081450|NCT01018056|3904440|B2|||Age||years|Mean|13.1|13.1|Standard Deviation|1.98|1.98|||
4081451|NCT01018056|3904441|B1|||Age||years|Mean|14.4|14.4|Standard Deviation|3.04|3.04|||
4081452|NCT01018030|3904490|B4|Other (Other than White and Black)||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4081453|NCT01018030|3904491|B3|Other (Other than White and Black)||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4081454|NCT01018030|3904492|B2|Other (Other than White and Black)||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4081455|NCT01018030|3904493|B1|Other (Other than White and Black)||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4081456|NCT01018030|3904490|B4|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4081457|NCT01018030|3904491|B3|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4081458|NCT01018030|3904492|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4081459|NCT01018030|3904493|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4081460|NCT01018030|3904490|B4|White||Race/Ethnicity, Customized||participants|Number|716|716.0||||||
4081461|NCT01018030|3904491|B3|White||Race/Ethnicity, Customized||participants|Number|244|244.0||||||
4081462|NCT01018030|3904492|B2|White||Race/Ethnicity, Customized||participants|Number|234|234.0||||||
4081463|NCT01018030|3904493|B1|White||Race/Ethnicity, Customized||participants|Number|238|238.0||||||
4081464|NCT01018030|3904490|B4||Male|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
4081465|NCT01018030|3904491|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4081466|NCT01018030|3904492|B2||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4081467|NCT01018030|3904493|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4081468|NCT01018030|3904490|B4||Female|Sex: Female, Male||Participants|Count of Participants|460|460.0||||||
4081469|NCT01018030|3904491|B3||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4081470|NCT01018030|3904492|B2||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4081471|NCT01018030|3904493|B1||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4081472|NCT01018030|3904490|B4|||Age|Baseline Characteristics were collected in the Intent-to-Treat Population, comprised of all participants who were randomized and received at least one dose of double-blind study drug. One participant in the placebo group and three participants in the FFNS 110 mcg QD group did not receive any study treatment.|Years|Mean|39.3|39.3|Standard Deviation|15.48|15.48|||
4081473|NCT01018030|3904491|B3|||Age|Baseline Characteristics were collected in the Intent-to-Treat Population, comprised of all participants who were randomized and received at least one dose of double-blind study drug. One participant in the placebo group and three participants in the FFNS 110 mcg QD group did not receive any study treatment.|Years|Mean|39.0|39.0|Standard Deviation|16.02|16.02|||
4081474|NCT01018030|3904492|B2|||Age|Baseline Characteristics were collected in the Intent-to-Treat Population, comprised of all participants who were randomized and received at least one dose of double-blind study drug. One participant in the placebo group and three participants in the FFNS 110 mcg QD group did not receive any study treatment.|Years|Mean|39.7|39.7|Standard Deviation|15.64|15.64|||
4081475|NCT01018030|3904493|B1|||Age|Baseline Characteristics were collected in the Intent-to-Treat Population, comprised of all participants who were randomized and received at least one dose of double-blind study drug. One participant in the placebo group and three participants in the FFNS 110 mcg QD group did not receive any study treatment.|Years|Mean|39.1|39.1|Standard Deviation|14.81|14.81|||
4081476|NCT01017952|3904542|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|64|64.0||||||
4081477|NCT01017952|3904543|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4081478|NCT01017952|3904544|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4081479|NCT01017952|3904545|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4081480|NCT01017952|3904546|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4081481|NCT01017952|3904542|B5|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4081482|NCT01017952|3904543|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4081483|NCT01017952|3904544|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4081484|NCT01017952|3904545|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4081485|NCT01017952|3904546|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4081486|NCT01017952|3904542|B5|Asian & White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4081487|NCT01017952|3904543|B4|Asian & White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4081488|NCT01017952|3904544|B3|Asian & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4081489|NCT01017952|3904545|B2|Asian & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4081490|NCT01017952|3904546|B1|Asian & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4081491|NCT01017952|3904542|B5|American Indian or Alaska Native & White||Race/Ethnicity, Customized||participants|Number|80|80.0||||||
4081492|NCT01017952|3904543|B4|American Indian or Alaska Native & White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4081493|NCT01017952|3904544|B3|American Indian or Alaska Native & White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4081494|NCT01017952|3904545|B2|American Indian or Alaska Native & White||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4081495|NCT01017952|3904546|B1|American Indian or Alaska Native & White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4081496|NCT01017952|3904542|B5|African American/African Heritage & White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4081497|NCT01017952|3904543|B4|African American/African Heritage & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4081498|NCT01017952|3904544|B3|African American/African Heritage & White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4081499|NCT01017952|3904545|B2|African American/African Heritage & White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4081500|NCT01017952|3904546|B1|African American/African Heritage & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4081501|NCT01017952|3904542|B5|Asian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4081502|NCT01017952|3904543|B4|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4081503|NCT01017952|3904544|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4081504|NCT01017952|3904545|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4081505|NCT01017952|3904546|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4081506|NCT01017952|3904542|B5|African American/ African Heritage||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4081507|NCT01017952|3904543|B4|African American/ African Heritage||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4081508|NCT01017952|3904544|B3|African American/ African Heritage||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4081509|NCT01017952|3904545|B2|African American/ African Heritage||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4081510|NCT01017952|3904546|B1|African American/ African Heritage||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4081511|NCT01017952|3904542|B5|White||Race/Ethnicity, Customized||participants|Number|1431|1431.0||||||
4081512|NCT01017952|3904543|B4|White||Race/Ethnicity, Customized||participants|Number|359|359.0||||||
4081513|NCT01017952|3904544|B3|White||Race/Ethnicity, Customized||participants|Number|353|353.0||||||
4081514|NCT01017952|3904545|B2|White||Race/Ethnicity, Customized||participants|Number|359|359.0||||||
4081515|NCT01017952|3904546|B1|White||Race/Ethnicity, Customized||participants|Number|360|360.0||||||
4081516|NCT01017952|3904542|B5||Male|Sex: Female, Male||Participants|Count of Participants|906|906.0||||||
4081517|NCT01017952|3904543|B4||Male|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4081518|NCT01017952|3904544|B3||Male|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4081519|NCT01017952|3904545|B2||Male|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
4081520|NCT01017952|3904546|B1||Male|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4081521|NCT01017952|3904542|B5||Female|Sex: Female, Male||Participants|Count of Participants|727|727.0||||||
4081522|NCT01017952|3904543|B4||Female|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4081523|NCT01017952|3904544|B3||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4081524|NCT01017952|3904545|B2||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4081525|NCT01017952|3904546|B1||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4081526|NCT01017952|3904542|B5|||Age||Years|Mean|63.7|63.7|Standard Deviation|9.24|9.24|||
4081527|NCT01017952|3904543|B4|||Age||Years|Mean|63.5|63.5|Standard Deviation|8.84|8.84|||
4081528|NCT01017952|3904544|B3|||Age||Years|Mean|64.0|64.0|Standard Deviation|9.28|9.28|||
4081529|NCT01017952|3904545|B2|||Age||Years|Mean|63.7|63.7|Standard Deviation|9.56|9.56|||
4081530|NCT01017952|3904546|B1|||Age||Years|Mean|63.6|63.6|Standard Deviation|9.29|9.29|||
4081531|NCT01017874|3904572|B3|Korea, Republic of||Region of Enrollment||participants|Number|114|114.0||||||
4081532|NCT01017874|3904573|B2|Korea, Republic of||Region of Enrollment||participants|Number|60|60.0||||||
4081533|NCT01017874|3904574|B1|Korea, Republic of||Region of Enrollment||participants|Number|54|54.0||||||
4081534|NCT01017874|3904572|B3|Singapore||Region of Enrollment||participants|Number|2|2.0||||||
4081535|NCT01017874|3904573|B2|Singapore||Region of Enrollment||participants|Number|1|1.0||||||
4081536|NCT01017874|3904574|B1|Singapore||Region of Enrollment||participants|Number|1|1.0||||||
4081537|NCT01017874|3904572|B3|Thailand||Region of Enrollment||participants|Number|43|43.0||||||
4081538|NCT01017874|3904573|B2|Thailand||Region of Enrollment||participants|Number|22|22.0||||||
4081539|NCT01017874|3904574|B1|Thailand||Region of Enrollment||participants|Number|21|21.0||||||
4081540|NCT01017874|3904572|B3|Taiwan||Region of Enrollment||participants|Number|67|67.0||||||
4081541|NCT01017874|3904573|B2|Taiwan||Region of Enrollment||participants|Number|28|28.0||||||
4081542|NCT01017874|3904574|B1|Taiwan||Region of Enrollment||participants|Number|39|39.0||||||
4081543|NCT01017874|3904572|B3|Hong Kong||Region of Enrollment||participants|Number|10|10.0||||||
4081544|NCT01017874|3904573|B2|Hong Kong||Region of Enrollment||participants|Number|7|7.0||||||
4081545|NCT01017874|3904574|B1|Hong Kong||Region of Enrollment||participants|Number|3|3.0||||||
4081546|NCT01017874|3904572|B3|Asian||Race/Ethnicity, Customized||participant|Number|236|236.0||||||
4081547|NCT01017874|3904573|B2|Asian||Race/Ethnicity, Customized||participant|Number|118|118.0||||||
4081548|NCT01017874|3904574|B1|Asian||Race/Ethnicity, Customized||participant|Number|118|118.0||||||
4081549|NCT01017874|3904572|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4081550|NCT01017874|3904573|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4081551|NCT01017874|3904574|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4081552|NCT01017874|3904572|B3||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4081553|NCT01017874|3904573|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4081554|NCT01017874|3904574|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4081555|NCT01017874|3904572|B3|||Age||years|Mean|58.95|58.95|Standard Deviation|10.686|10.686|||
4081556|NCT01017874|3904573|B2|||Age||years|Mean|59.36|59.36|Standard Deviation|10.672|10.672|||
4081557|NCT01017874|3904574|B1|||Age||years|Mean|58.53|58.53|Standard Deviation|10.730|10.73|||
4081558|NCT01017731|3904593|B1|Non-Hispanic or Latino||Ethnicity||participants|Number|62|62.0||||||
4081559|NCT01017731|3904593|B1|Hispanic or Latino||Ethnicity||participants|Number|4|4.0||||||
4081560|NCT01017731|3904593|B1|United States||Region of Enrollment||participants|Number|66|66.0||||||
4081561|NCT01017731|3904593|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4081562|NCT01017731|3904593|B1|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4081563|NCT01017731|3904593|B1|White||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
4081564|NCT01017731|3904593|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4081565|NCT01017731|3904593|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4081566|NCT01017731|3904593|B1|>=65 years||Age, Customized||participants|Number|26|26.0||||||
4081567|NCT01017731|3904593|B1|Between 18 and 65 years||Age, Customized||participants|Number|40|40.0||||||
4081568|NCT01017653|3904610|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4081569|NCT01017653|3904610|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4081570|NCT01017653|3904610|B1|||Age||years|Mean|48.73|48.73|Standard Deviation|14.58|14.58|||
4081571|NCT01017601|3904620|B3||Previously treated|Enrolling Group||Participants|Count of Participants|43|43.0||||||
4081572|NCT01017601|3904621|B2||Previously treated|Enrolling Group||Participants|Count of Participants|20|20.0||||||
4081573|NCT01017601|3904622|B1||Previously treated|Enrolling Group||Participants|Count of Participants|23|23.0||||||
4081574|NCT01017601|3904620|B3||Previously untreated|Enrolling Group||Participants|Count of Participants|7|7.0||||||
4081575|NCT01017601|3904621|B2||Previously untreated|Enrolling Group||Participants|Count of Participants|4|4.0||||||
4081576|NCT01017601|3904622|B1||Previously untreated|Enrolling Group||Participants|Count of Participants|3|3.0||||||
4081577|NCT01017601|3904620|B3||No|Prior Radiation Therapy||Participants|Count of Participants|33|33.0||||||
4081578|NCT01017601|3904621|B2||No|Prior Radiation Therapy||Participants|Count of Participants|15|15.0||||||
4081579|NCT01017601|3904622|B1||No|Prior Radiation Therapy||Participants|Count of Participants|18|18.0||||||
4081580|NCT01017601|3904620|B3||Yes|Prior Radiation Therapy||Participants|Count of Participants|17|17.0||||||
4081581|NCT01017601|3904621|B2||Yes|Prior Radiation Therapy||Participants|Count of Participants|9|9.0||||||
4081582|NCT01017601|3904622|B1||Yes|Prior Radiation Therapy||Participants|Count of Participants|8|8.0||||||
4081583|NCT01017601|3904620|B3||Unknown|Time between Completion of Chemo to Randomization||Participants|Count of Participants|1|1.0||||||
4081584|NCT01017601|3904621|B2||Unknown|Time between Completion of Chemo to Randomization||Participants|Count of Participants|1|1.0||||||
4081585|NCT01017601|3904622|B1||Unknown|Time between Completion of Chemo to Randomization||Participants|Count of Participants|0|0.0||||||
4081586|NCT01017601|3904620|B3||3 months|Time between Completion of Chemo to Randomization||Participants|Count of Participants|10|10.0||||||
4081587|NCT01017601|3904621|B2||3 months|Time between Completion of Chemo to Randomization||Participants|Count of Participants|4|4.0||||||
4081588|NCT01017601|3904622|B1||3 months|Time between Completion of Chemo to Randomization||Participants|Count of Participants|6|6.0||||||
4081589|NCT01017601|3904620|B3||2 months|Time between Completion of Chemo to Randomization||Participants|Count of Participants|20|20.0||||||
4081590|NCT01017601|3904621|B2||2 months|Time between Completion of Chemo to Randomization||Participants|Count of Participants|10|10.0||||||
4081591|NCT01017601|3904622|B1||2 months|Time between Completion of Chemo to Randomization||Participants|Count of Participants|10|10.0||||||
4081592|NCT01017601|3904620|B3||1 month|Time between Completion of Chemo to Randomization||Participants|Count of Participants|19|19.0||||||
4081593|NCT01017601|3904621|B2||1 month|Time between Completion of Chemo to Randomization||Participants|Count of Participants|9|9.0||||||
4081594|NCT01017601|3904622|B1||1 month|Time between Completion of Chemo to Randomization||Participants|Count of Participants|10|10.0||||||
4081595|NCT01017601|3904620|B3||Former Smoker|Cigarette History||Participants|Count of Participants|37|37.0||||||
4081596|NCT01017601|3904621|B2||Former Smoker|Cigarette History||Participants|Count of Participants|18|18.0||||||
4081597|NCT01017601|3904622|B1||Former Smoker|Cigarette History||Participants|Count of Participants|19|19.0||||||
4081598|NCT01017601|3904620|B3||Current Smoker|Cigarette History||Participants|Count of Participants|11|11.0||||||
4081599|NCT01017601|3904621|B2||Current Smoker|Cigarette History||Participants|Count of Participants|4|4.0||||||
4081600|NCT01017601|3904622|B1||Current Smoker|Cigarette History||Participants|Count of Participants|7|7.0||||||
4081601|NCT01017601|3904620|B3||Never Smoked|Cigarette History||Participants|Count of Participants|2|2.0||||||
4081602|NCT01017601|3904621|B2||Never Smoked|Cigarette History||Participants|Count of Participants|2|2.0||||||
4081603|NCT01017601|3904622|B1||Never Smoked|Cigarette History||Participants|Count of Participants|0|0.0||||||
4081604|NCT01017601|3904620|B3||Complete Response (CR)|Prior Response to Chemo||Participants|Count of Participants|14|14.0||||||
4081605|NCT01017601|3904621|B2||Complete Response (CR)|Prior Response to Chemo||Participants|Count of Participants|7|7.0||||||
4081606|NCT01017601|3904622|B1||Complete Response (CR)|Prior Response to Chemo||Participants|Count of Participants|7|7.0||||||
4081607|NCT01017601|3904620|B3||Partial Response (PR)|Prior Response to Chemo||Participants|Count of Participants|27|27.0||||||
4081608|NCT01017601|3904621|B2||Partial Response (PR)|Prior Response to Chemo||Participants|Count of Participants|12|12.0||||||
4081609|NCT01017601|3904622|B1||Partial Response (PR)|Prior Response to Chemo||Participants|Count of Participants|15|15.0||||||
4081610|NCT01017601|3904620|B3||Stable Disease (SD)|Prior Response to Chemo||Participants|Count of Participants|9|9.0||||||
4081611|NCT01017601|3904621|B2||Stable Disease (SD)|Prior Response to Chemo||Participants|Count of Participants|5|5.0||||||
4081612|NCT01017601|3904622|B1||Stable Disease (SD)|Prior Response to Chemo||Participants|Count of Participants|4|4.0||||||
4081613|NCT01017601|3904620|B3||1=Symptomatic and fully ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|35|35.0||||||
4081614|NCT01017601|3904621|B2||1=Symptomatic and fully ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|17|17.0||||||
4081615|NCT01017601|3904622|B1||1=Symptomatic and fully ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|18|18.0||||||
4081616|NCT01017601|3904620|B3||0=Asymptomatic and fully active|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|15|15.0||||||
4081617|NCT01017601|3904621|B2||0=Asymptomatic and fully active|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|7|7.0||||||
4081618|NCT01017601|3904622|B1||0=Asymptomatic and fully active|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|8|8.0||||||
4081619|NCT01017601|3904620|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4081620|NCT01017601|3904621|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4081621|NCT01017601|3904622|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4081622|NCT01017601|3904620|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4081623|NCT01017601|3904621|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081624|NCT01017601|3904622|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4081625|NCT01017601|3904620|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4081626|NCT01017601|3904621|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4081627|NCT01017601|3904622|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4081628|NCT01017601|3904620|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081629|NCT01017601|3904621|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081630|NCT01017601|3904622|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081631|NCT01017601|3904620|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4081632|NCT01017601|3904621|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4081633|NCT01017601|3904622|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4081634|NCT01017601|3904620|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4081635|NCT01017601|3904621|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4081636|NCT01017601|3904622|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4081637|NCT01017601|3904620|B3|||Age||years|Median|63|63.0|Full Range|||44.0|82.0|
4081638|NCT01017601|3904621|B2|||Age||years|Median|60|60.0|Full Range|||50.0|82.0|
4081639|NCT01017601|3904622|B1|||Age||years|Median|67|67.0|Full Range|||44.0|81.0|
4081640|NCT01017575|3904645|B6||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4081641|NCT01017575|3904646|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4081642|NCT01017575|3904647|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4081643|NCT01017575|3904648|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4081644|NCT01017575|3904649|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4081645|NCT01017575|3904650|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4081646|NCT01017575|3904645|B6||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4081647|NCT01017575|3904646|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4081648|NCT01017575|3904647|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4081649|NCT01017575|3904648|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4081650|NCT01017575|3904649|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4081651|NCT01017575|3904650|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4081652|NCT01017575|3904645|B6|>=65 years||Age, Customized||participants|Number|7|7.0||||||
4081653|NCT01017575|3904646|B5|>=65 years||Age, Customized||participants|Number|1|1.0||||||
4081654|NCT01017575|3904647|B4|>=65 years||Age, Customized||participants|Number|2|2.0||||||
4081655|NCT01017575|3904648|B3|>=65 years||Age, Customized||participants|Number|2|2.0||||||
4081656|NCT01017575|3904649|B2|>=65 years||Age, Customized||participants|Number|1|1.0||||||
4081657|NCT01017575|3904650|B1|>=65 years||Age, Customized||participants|Number|1|1.0||||||
4081658|NCT01017575|3904645|B6|<65 years||Age, Customized||participants|Number|35|35.0||||||
4081659|NCT01017575|3904646|B5|<65 years||Age, Customized||participants|Number|8|8.0||||||
4081660|NCT01017575|3904647|B4|<65 years||Age, Customized||participants|Number|6|6.0||||||
4081661|NCT01017575|3904648|B3|<65 years||Age, Customized||participants|Number|6|6.0||||||
4081662|NCT01017575|3904649|B2|<65 years||Age, Customized||participants|Number|8|8.0||||||
4081663|NCT01017575|3904650|B1|<65 years||Age, Customized||participants|Number|7|7.0||||||
4081664|NCT01017549|3904691|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4081665|NCT01017549|3904691|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4081666|NCT01017549|3904691|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4081667|NCT01017549|3904691|B1|>=50 years||Age, Customized||participants|Number|42|42.0||||||
4081668|NCT01017549|3904691|B1|Between 18 and 50 years||Age, Customized||participants|Number|2|2.0||||||
4081669|NCT01017549|3904691|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4081670|NCT01017549|3904691|B1|||Age||years|Mean|64|64.0|Standard Deviation|8.24|8.24|||
4081671|NCT01017536|3904696|B3|South Africa||Region of Enrollment||participants|Number|26|26.0||||||
4081672|NCT01017536|3904697|B2|South Africa||Region of Enrollment||participants|Number|13|13.0||||||
4081673|NCT01017536|3904698|B1|South Africa||Region of Enrollment||participants|Number|13|13.0||||||
4081674|NCT01017536|3904696|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4081675|NCT01017536|3904697|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4081676|NCT01017536|3904698|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4081677|NCT01017536|3904696|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4081678|NCT01017536|3904697|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4081679|NCT01017536|3904698|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4081680|NCT01017536|3904696|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4081681|NCT01017536|3904697|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4081682|NCT01017536|3904698|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4081683|NCT01017536|3904696|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4081684|NCT01017536|3904697|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4081685|NCT01017536|3904698|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4081686|NCT01017536|3904696|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4081687|NCT01017536|3904697|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4081688|NCT01017536|3904698|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4081689|NCT01017536|3904696|B3|||Age||years|Mean|30.7|30.7|Standard Deviation|6.07|6.07|||
4081690|NCT01017536|3904697|B2|||Age||years|Mean|30.5|30.5|Standard Deviation|5.88|5.88|||
4081691|NCT01017536|3904698|B1|||Age||years|Mean|30.8|30.8|Standard Deviation|6.49|6.49|||
4081692|NCT01017497|3904709|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4081693|NCT01017497|3904709|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4081694|NCT01017497|3904709|B1|||Age||years|Median|61|61.0|Full Range|||26.0|87.0|
4081695|NCT01017263|3904722|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4081696|NCT01017263|3904722|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4081697|NCT01017263|3904722|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4081698|NCT01017263|3904722|B1|||Age||years|Mean|10.92|10.92|Standard Deviation|2.73|2.73|||
4081699|NCT01017263|3904722|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4081700|NCT01017263|3904722|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4081701|NCT01017263|3904722|B1||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4081702|NCT01017250|3904726|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4081703|NCT01017250|3904726|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4081704|NCT01017250|3904726|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4081705|NCT01017250|3904726|B1|||Age||years|Mean|50.27|50.27|Standard Deviation|11.3|11.3|||
4081706|NCT01017250|3904726|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4081707|NCT01017250|3904726|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4081708|NCT01017250|3904726|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4081709|NCT01017237|3904746|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4081710|NCT01017237|3904747|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4081711|NCT01017237|3904748|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4081712|NCT01017237|3904746|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4081713|NCT01017237|3904747|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4081714|NCT01017237|3904748|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4081715|NCT01017237|3904746|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4081716|NCT01017237|3904747|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4081717|NCT01017237|3904748|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4081718|NCT01017237|3904746|B3|||Age||years|Mean|19|19.0|Standard Deviation|3.8|3.8|||
4081719|NCT01017237|3904747|B2|||Age||years|Mean|20|20.0|Standard Deviation|4.1|4.1|||
4081720|NCT01017237|3904748|B1|||Age||years|Mean|19|19.0|Standard Deviation|3.6|3.6|||
4081721|NCT01017146|3904801|B3|Mixed Race||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Analysis Set, consisting of all randomized participants who were dispensed study product. One participant was randomized to the tazarotene foam group, but discontinued due to pregnancy and did not receive study product.|participants|Number|17|17.0||||||
4081722|NCT01017146|3904802|B2|Mixed Race||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Analysis Set, consisting of all randomized participants who were dispensed study product. One participant was randomized to the tazarotene foam group, but discontinued due to pregnancy and did not receive study product.|participants|Number|7|7.0||||||
4081723|NCT01017146|3904803|B1|Mixed Race||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Analysis Set, consisting of all randomized participants who were dispensed study product. One participant was randomized to the tazarotene foam group, but discontinued due to pregnancy and did not receive study product.|participants|Number|10|10.0||||||
4081724|NCT01017146|3904801|B3|White||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Analysis Set, consisting of all randomized participants who were dispensed study product. One participant was randomized to the tazarotene foam group, but discontinued due to pregnancy and did not receive study product.|participants|Number|592|592.0||||||
4081725|NCT01017146|3904802|B2|White||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Analysis Set, consisting of all randomized participants who were dispensed study product. One participant was randomized to the tazarotene foam group, but discontinued due to pregnancy and did not receive study product.|participants|Number|307|307.0||||||
4081726|NCT01017146|3904803|B1|White||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Analysis Set, consisting of all randomized participants who were dispensed study product. One participant was randomized to the tazarotene foam group, but discontinued due to pregnancy and did not receive study product.|participants|Number|285|285.0||||||
4081727|NCT01017146|3904801|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Analysis Set, consisting of all randomized participants who were dispensed study product. One participant was randomized to the tazarotene foam group, but discontinued due to pregnancy and did not receive study product.|participants|Number|1|1.0||||||
4081728|NCT01017146|3904802|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Analysis Set, consisting of all randomized participants who were dispensed study product. One participant was randomized to the tazarotene foam group, but discontinued due to pregnancy and did not receive study product.|participants|Number|1|1.0||||||
4081729|NCT01017146|3904803|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Analysis Set, consisting of all randomized participants who were dispensed study product. One participant was randomized to the tazarotene foam group, but discontinued due to pregnancy and did not receive study product.|participants|Number|0|0.0||||||
4081730|NCT01017146|3904801|B3|Black||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Analysis Set, consisting of all randomized participants who were dispensed study product. One participant was randomized to the tazarotene foam group, but discontinued due to pregnancy and did not receive study product.|participants|Number|103|103.0||||||
4081731|NCT01017146|3904802|B2|Black||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Analysis Set, consisting of all randomized participants who were dispensed study product. One participant was randomized to the tazarotene foam group, but discontinued due to pregnancy and did not receive study product.|participants|Number|50|50.0||||||
4081732|NCT01017146|3904803|B1|Black||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Analysis Set, consisting of all randomized participants who were dispensed study product. One participant was randomized to the tazarotene foam group, but discontinued due to pregnancy and did not receive study product.|participants|Number|53|53.0||||||
4081733|NCT01017146|3904801|B3|Asian||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Analysis Set, consisting of all randomized participants who were dispensed study product. One participant was randomized to the tazarotene foam group, but discontinued due to pregnancy and did not receive study product.|participants|Number|15|15.0||||||
4081734|NCT01017146|3904802|B2|Asian||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Analysis Set, consisting of all randomized participants who were dispensed study product. One participant was randomized to the tazarotene foam group, but discontinued due to pregnancy and did not receive study product.|participants|Number|4|4.0||||||
4081735|NCT01017146|3904803|B1|Asian||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Analysis Set, consisting of all randomized participants who were dispensed study product. One participant was randomized to the tazarotene foam group, but discontinued due to pregnancy and did not receive study product.|participants|Number|11|11.0||||||
4081736|NCT01017146|3904801|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Analysis Set, consisting of all randomized participants who were dispensed study product. One participant was randomized to the tazarotene foam group, but discontinued due to pregnancy and did not receive study product.|participants|Number|15|15.0||||||
4081737|NCT01017146|3904802|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Analysis Set, consisting of all randomized participants who were dispensed study product. One participant was randomized to the tazarotene foam group, but discontinued due to pregnancy and did not receive study product.|participants|Number|3|3.0||||||
4081738|NCT01017146|3904803|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Analysis Set, consisting of all randomized participants who were dispensed study product. One participant was randomized to the tazarotene foam group, but discontinued due to pregnancy and did not receive study product.|participants|Number|12|12.0||||||
4081739|NCT01017146|3904801|B3||Male|Gender|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Analysis Set, consisting of all randomized participants who were dispensed study product. One participant was randomized to the tazarotene foam group, but discontinued due to pregnancy and did not receive study product.|Participants|Count of Participants|369|369.0||||||
4081843|NCT01016964|3904968|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4081740|NCT01017146|3904802|B2||Male|Gender|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Analysis Set, consisting of all randomized participants who were dispensed study product. One participant was randomized to the tazarotene foam group, but discontinued due to pregnancy and did not receive study product.|Participants|Count of Participants|180|180.0||||||
4081741|NCT01017146|3904803|B1||Male|Gender|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Analysis Set, consisting of all randomized participants who were dispensed study product. One participant was randomized to the tazarotene foam group, but discontinued due to pregnancy and did not receive study product.|Participants|Count of Participants|189|189.0||||||
4081742|NCT01017146|3904801|B3||Female|Gender|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Analysis Set, consisting of all randomized participants who were dispensed study product. One participant was randomized to the tazarotene foam group, but discontinued due to pregnancy and did not receive study product.|Participants|Count of Participants|374|374.0||||||
4081743|NCT01017146|3904802|B2||Female|Gender|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Analysis Set, consisting of all randomized participants who were dispensed study product. One participant was randomized to the tazarotene foam group, but discontinued due to pregnancy and did not receive study product.|Participants|Count of Participants|192|192.0||||||
4081744|NCT01017146|3904803|B1||Female|Gender|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Analysis Set, consisting of all randomized participants who were dispensed study product. One participant was randomized to the tazarotene foam group, but discontinued due to pregnancy and did not receive study product.|Participants|Count of Participants|182|182.0||||||
4081745|NCT01017146|3904801|B3|Years||Age|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Analysis Set, consisting of all randomized participants who were dispensed study product. One participant was randomized to the tazarotene foam group, but discontinued due to pregnancy and did not receive study product.|Years|Mean|18.4|18.4|Standard Deviation|6.1|6.1|||
4081746|NCT01017146|3904802|B2|Years||Age|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Analysis Set, consisting of all randomized participants who were dispensed study product. One participant was randomized to the tazarotene foam group, but discontinued due to pregnancy and did not receive study product.|Years|Mean|18.6|18.6|Standard Deviation|6.4|6.4|||
4081747|NCT01017146|3904803|B1|Years||Age|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Analysis Set, consisting of all randomized participants who were dispensed study product. One participant was randomized to the tazarotene foam group, but discontinued due to pregnancy and did not receive study product.|Years|Mean|18.2|18.2|Standard Deviation|5.7|5.7|||
4081748|NCT01017120|3904840|B3|Mixed Race||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4081749|NCT01017120|3904841|B2|Mixed Race||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4081750|NCT01017120|3904842|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4081751|NCT01017120|3904840|B3|White||Race/Ethnicity, Customized||participants|Number|558|558.0||||||
4081752|NCT01017120|3904841|B2|White||Race/Ethnicity, Customized||participants|Number|280|280.0||||||
4081753|NCT01017120|3904842|B1|White||Race/Ethnicity, Customized||participants|Number|278|278.0||||||
4081754|NCT01017120|3904840|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4081755|NCT01017120|3904841|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4081756|NCT01017120|3904842|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4081757|NCT01017120|3904840|B3|Black||Race/Ethnicity, Customized||participants|Number|117|117.0||||||
4081758|NCT01017120|3904841|B2|Black||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
4081759|NCT01017120|3904842|B1|Black||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
4081760|NCT01017120|3904840|B3|Asian||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4081761|NCT01017120|3904841|B2|Asian||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4081762|NCT01017120|3904842|B1|Asian||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4081763|NCT01017120|3904840|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4081764|NCT01017120|3904841|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4081765|NCT01017120|3904842|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4081766|NCT01017120|3904840|B3||Male|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
4081767|NCT01017120|3904841|B2||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4081768|NCT01017120|3904842|B1||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4081769|NCT01017120|3904840|B3||Female|Sex: Female, Male||Participants|Count of Participants|382|382.0||||||
4081770|NCT01017120|3904841|B2||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4081771|NCT01017120|3904842|B1||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4081772|NCT01017120|3904840|B3|||Age||Years|Mean|19.2|19.2|Standard Deviation|6.6|6.6|||
4081773|NCT01017120|3904841|B2|||Age||Years|Mean|19.2|19.2|Standard Deviation|6.8|6.8|||
4081774|NCT01017120|3904842|B1|||Age||Years|Mean|19.2|19.2|Standard Deviation|6.5|6.5|||
4081775|NCT01017042|3904891|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4081776|NCT01017042|3904891|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4081777|NCT01017042|3904891|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4081778|NCT01017042|3904891|B1|||Age||years|Mean|28.9|28.9|Standard Deviation|8.4|8.4|||
4081779|NCT01017042|3904891|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4081780|NCT01017042|3904891|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4081781|NCT01017042|3904891|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4081844|NCT01016964|3904969|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4081782|NCT01017029|3904902|B3|||Calculated BMI|Body Mass Index (BMI) Body mass divided by the square of their height.|kg/m2*|Mean|24.95|24.95|Standard Deviation|3.52|3.52|||
4081783|NCT01017029|3904903|B2|||Calculated BMI|Body Mass Index (BMI) Body mass divided by the square of their height.|kg/m2*|Mean|24.48|24.48|Standard Deviation|3.33|3.33|||
4081784|NCT01017029|3904904|B1|||Calculated BMI|Body Mass Index (BMI) Body mass divided by the square of their height.|kg/m2*|Mean|25.44|25.44|Standard Deviation|3.65|3.65|||
4081785|NCT01017029|3904902|B3|||Height||centimeters|Mean|170.44|170.44|Standard Deviation|7.85|7.85|||
4081786|NCT01017029|3904903|B2|||Height||centimeters|Mean|170.10|170.1|Standard Deviation|8.03|8.03|||
4081787|NCT01017029|3904904|B1|||Height||centimeters|Mean|170.80|170.8|Standard Deviation|7.69|7.69|||
4081788|NCT01017029|3904902|B3|||Weight||kilograms|Mean|72.76|72.76|Standard Deviation|12.70|12.7|||
4081789|NCT01017029|3904903|B2|||Weight||kilograms|Mean|71.18|71.18|Standard Deviation|12.75|12.75|||
4081790|NCT01017029|3904904|B1|||Weight||kilograms|Mean|74.38|74.38|Standard Deviation|12.50|12.5|||
4081791|NCT01017029|3904902|B3|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4081792|NCT01017029|3904903|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4081793|NCT01017029|3904904|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4081794|NCT01017029|3904902|B3|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4081795|NCT01017029|3904903|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4081796|NCT01017029|3904904|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4081797|NCT01017029|3904902|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|176|176.0||||||
4081798|NCT01017029|3904903|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|88|88.0||||||
4081799|NCT01017029|3904904|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|88|88.0||||||
4081800|NCT01017029|3904902|B3||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4081801|NCT01017029|3904903|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4081802|NCT01017029|3904904|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4081803|NCT01017029|3904902|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4081804|NCT01017029|3904903|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4081805|NCT01017029|3904904|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4081806|NCT01017029|3904902|B3|||Age||years|Mean|52.82|52.82|Standard Deviation|10.14|10.14|||
4081807|NCT01017029|3904903|B2|||Age||years|Mean|52.95|52.95|Standard Deviation|10.19|10.19|||
4081808|NCT01017029|3904904|B1|||Age||years|Mean|52.69|52.69|Standard Deviation|10.15|10.15|||
4081809|NCT01017003|3904921|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4081810|NCT01017003|3904921|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4081811|NCT01017003|3904921|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4081812|NCT01017003|3904921|B1|||Age||years|Mean|25.5|25.5|Full Range|||19.0|38.0|
4081813|NCT01017003|3904921|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4081814|NCT01017003|3904921|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4081815|NCT01017003|3904921|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4081816|NCT01016977|3904931|B3|Multiracial (Black, White)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4081817|NCT01016977|3904932|B2|Multiracial (Black, White)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4081818|NCT01016977|3904933|B1|Multiracial (Black, White)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4081819|NCT01016977|3904931|B3|Biracial, India, Black, and Phillipino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4081820|NCT01016977|3904932|B2|Biracial, India, Black, and Phillipino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4081821|NCT01016977|3904933|B1|Biracial, India, Black, and Phillipino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4081822|NCT01016977|3904931|B3|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4081823|NCT01016977|3904932|B2|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4081824|NCT01016977|3904933|B1|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4081825|NCT01016977|3904931|B3|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4081826|NCT01016977|3904932|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4081827|NCT01016977|3904933|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4081828|NCT01016977|3904931|B3|Asian||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4081829|NCT01016977|3904932|B2|Asian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4081830|NCT01016977|3904933|B1|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4081831|NCT01016977|3904931|B3||Male|Gender||Participants|Count of Participants|18|18.0||||||
4081832|NCT01016977|3904932|B2||Male|Gender||Participants|Count of Participants|11|11.0||||||
4081833|NCT01016977|3904933|B1||Male|Gender||Participants|Count of Participants|7|7.0||||||
4081834|NCT01016977|3904931|B3||Female|Gender||Participants|Count of Participants|22|22.0||||||
4081835|NCT01016977|3904932|B2||Female|Gender||Participants|Count of Participants|9|9.0||||||
4081836|NCT01016977|3904933|B1||Female|Gender||Participants|Count of Participants|13|13.0||||||
4081837|NCT01016977|3904931|B3|||Age||Years|Mean|21.9|21.9|Standard Deviation|8.3|8.3|||
4081838|NCT01016977|3904932|B2|||Age||Years|Mean|22.6|22.6|Standard Deviation|7.8|7.8|||
4081839|NCT01016977|3904933|B1|||Age||Years|Mean|21.2|21.2|Standard Deviation|9.0|9.0|||
4081840|NCT01016964|3904968|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4081841|NCT01016964|3904969|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4081842|NCT01016964|3904970|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4081845|NCT01016964|3904970|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4081846|NCT01016964|3904968|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4081847|NCT01016964|3904969|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4081848|NCT01016964|3904970|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4081849|NCT01016964|3904968|B3||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4081850|NCT01016964|3904969|B2||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4081851|NCT01016964|3904970|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4081852|NCT01016964|3904968|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4081853|NCT01016964|3904969|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4081854|NCT01016964|3904970|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4081855|NCT01016938|3904977|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4081856|NCT01016938|3904977|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4081857|NCT01016938|3904977|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4081858|NCT01016938|3904977|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4081859|NCT01016938|3904977|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4081860|NCT01016938|3904977|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4081861|NCT01016912|3904982|B6||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4081862|NCT01016912|3904983|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4081863|NCT01016912|3904984|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4081864|NCT01016912|3904985|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4081865|NCT01016912|3904986|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4081866|NCT01016912|3904987|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4081867|NCT01016912|3904982|B6||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4081868|NCT01016912|3904983|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4081869|NCT01016912|3904984|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4081870|NCT01016912|3904985|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4081871|NCT01016912|3904986|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4081872|NCT01016912|3904987|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4081873|NCT01016912|3904982|B6|||Age||years|Mean|54.2|54.2|Standard Deviation|10.46|10.46|||
4081874|NCT01016912|3904983|B5|||Age||years|Mean|58.8|58.8|Standard Deviation|9.46|9.46|||
4081875|NCT01016912|3904984|B4|||Age||years|Mean|57.4|57.4|Standard Deviation|6.11|6.11|||
4081876|NCT01016912|3904985|B3|||Age||years|Mean|53.2|53.2|Standard Deviation|9.96|9.96|||
4081877|NCT01016912|3904986|B2|||Age||years|Mean|49.1|49.1|Standard Deviation|15.09|15.09|||
4081878|NCT01016912|3904987|B1|||Age||years|Mean|52.6|52.6|Standard Deviation|8.78|8.78|||
4081879|NCT01016873|3905033|B4|Italy||Region of Enrollment||participants|Number|6|6.0||||||
4081880|NCT01016873|3905034|B3|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4081881|NCT01016873|3905035|B2|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4081882|NCT01016873|3905036|B1|Italy||Region of Enrollment||participants|Number|3|3.0||||||
4081883|NCT01016873|3905033|B4|United Kingdom||Region of Enrollment||participants|Number|49|49.0||||||
4081884|NCT01016873|3905034|B3|United Kingdom||Region of Enrollment||participants|Number|17|17.0||||||
4081885|NCT01016873|3905035|B2|United Kingdom||Region of Enrollment||participants|Number|18|18.0||||||
4081886|NCT01016873|3905036|B1|United Kingdom||Region of Enrollment||participants|Number|14|14.0||||||
4081887|NCT01016873|3905033|B4|Germany||Region of Enrollment||participants|Number|23|23.0||||||
4081888|NCT01016873|3905034|B3|Germany||Region of Enrollment||participants|Number|10|10.0||||||
4081889|NCT01016873|3905035|B2|Germany||Region of Enrollment||participants|Number|7|7.0||||||
4081890|NCT01016873|3905036|B1|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4081891|NCT01016873|3905033|B4|Austria||Region of Enrollment||participants|Number|28|28.0||||||
4081892|NCT01016873|3905034|B3|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4081893|NCT01016873|3905035|B2|Austria||Region of Enrollment||participants|Number|20|20.0||||||
4081894|NCT01016873|3905036|B1|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4081895|NCT01016873|3905033|B4|Czech Republic||Region of Enrollment||participants|Number|124|124.0||||||
4081896|NCT01016873|3905034|B3|Czech Republic||Region of Enrollment||participants|Number|47|47.0||||||
4081897|NCT01016873|3905035|B2|Czech Republic||Region of Enrollment||participants|Number|29|29.0||||||
4081898|NCT01016873|3905036|B1|Czech Republic||Region of Enrollment||participants|Number|48|48.0||||||
4081899|NCT01016873|3905033|B4||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4081900|NCT01016873|3905034|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4081901|NCT01016873|3905035|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4081902|NCT01016873|3905036|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4081903|NCT01016873|3905033|B4||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4081904|NCT01016873|3905034|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4081905|NCT01016873|3905035|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4081906|NCT01016873|3905036|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4081907|NCT01016873|3905033|B4|Age||Age, Customized||years|Mean|73.52|73.52|Standard Deviation|7.51|7.51|||
4081908|NCT01016873|3905034|B3|Age||Age, Customized||years|Mean|73.45|73.45|Standard Deviation|7.14|7.14|||
4081909|NCT01016873|3905035|B2|Age||Age, Customized||years|Mean|73.77|73.77|Standard Deviation|8.26|8.26|||
4081910|NCT01016873|3905036|B1|Age||Age, Customized||years|Mean|73.35|73.35|Standard Deviation|7.18|7.18|||
4081911|NCT01016847|3905067|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4081912|NCT01016847|3905068|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4081913|NCT01016847|3905069|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4081914|NCT01016847|3905067|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081915|NCT01016847|3905068|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081916|NCT01016847|3905069|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081917|NCT01016847|3905067|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081918|NCT01016847|3905068|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081919|NCT01016847|3905069|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081920|NCT01016847|3905067|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4081921|NCT01016847|3905068|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4081922|NCT01016847|3905069|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4081923|NCT01016847|3905067|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4081924|NCT01016847|3905068|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4081925|NCT01016847|3905069|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081926|NCT01016847|3905067|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081927|NCT01016847|3905068|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081928|NCT01016847|3905069|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081929|NCT01016847|3905067|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081930|NCT01016847|3905068|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081931|NCT01016847|3905069|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081932|NCT01016847|3905067|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081933|NCT01016847|3905068|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081934|NCT01016847|3905069|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4081935|NCT01016847|3905067|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4081936|NCT01016847|3905068|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4081937|NCT01016847|3905069|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4081938|NCT01016847|3905067|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4081939|NCT01016847|3905068|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4081940|NCT01016847|3905069|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4081941|NCT01016847|3905067|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4081942|NCT01016847|3905068|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4081943|NCT01016847|3905069|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4081944|NCT01016847|3905067|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4081945|NCT01016847|3905068|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4081946|NCT01016847|3905069|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4081947|NCT01016847|3905067|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4081948|NCT01016847|3905068|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4081949|NCT01016847|3905069|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4081950|NCT01016834|3905086|B1|United States||Region of Enrollment||participants|Number|242|242.0||||||
4081951|NCT01016834|3905086|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4081952|NCT01016834|3905086|B1||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4081953|NCT01016834|3905086|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4081954|NCT01016834|3905086|B1||Between 18 and 65 years|Age||Participants|Count of Participants|242|242.0||||||
4081955|NCT01016834|3905086|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4081956|NCT01016691|3905092|B4|United States||Region of Enrollment||participants|Number|47|47.0||||||
4081957|NCT01016691|3905093|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4081958|NCT01016691|3905094|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4081959|NCT01016691|3905095|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4081960|NCT01016691|3905092|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4081961|NCT01016691|3905093|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4081962|NCT01016691|3905094|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4081963|NCT01016691|3905095|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4081964|NCT01016691|3905092|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4081965|NCT01016691|3905093|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4081966|NCT01016691|3905094|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4081967|NCT01016691|3905095|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4081968|NCT01016691|3905092|B4|||Age||years|Mean|63.4|63.4|Standard Deviation|8.68|8.68|||
4081969|NCT01016691|3905093|B3|||Age||years|Mean|63.1|63.1|Standard Deviation|9.07|9.07|||
4081970|NCT01016691|3905094|B2|||Age||years|Mean|66.3|66.3|Standard Deviation|11.37|11.37|||
4081971|NCT01016691|3905095|B1|||Age||years|Mean|61.8|61.8|Standard Deviation|9.78|9.78|||
4081972|NCT01016678|3905105|B1|United States||Region of Enrollment||participants|Number|104|104.0||||||
4081973|NCT01016678|3905105|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4081974|NCT01016678|3905105|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4081975|NCT01016678|3905105|B1|||Age||years|Mean|14.8|14.8|Full Range|||12.0|17.0|
4081976|NCT01016678|3905105|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4081977|NCT01016678|3905105|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4081978|NCT01016678|3905105|B1||<=18 years|Age||Participants|Count of Participants|104|104.0||||||
4081979|NCT01016652|3905129|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4081980|NCT01016652|3905130|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4081981|NCT01016652|3905131|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4081982|NCT01016652|3905129|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4081983|NCT01016652|3905130|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4081984|NCT01016652|3905131|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4081985|NCT01016652|3905129|B3|||Age|Mean age was the same for both groups.|years|Mean|42.3|42.3|Standard Deviation|3.4|3.4|||
4081986|NCT01016652|3905130|B2|||Age|Mean age was the same for both groups.|years|Mean|42.3|42.3|Standard Deviation|3.4|3.4|||
4081987|NCT01016652|3905131|B1|||Age|Mean age was the same for both groups.|years|Mean|42.3|42.3|Standard Deviation|3.4|3.4|||
4081988|NCT01016652|3905129|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4081989|NCT01016652|3905130|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4081990|NCT01016652|3905131|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4081991|NCT01016652|3905129|B3||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4081992|NCT01016652|3905130|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4081993|NCT01016652|3905131|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4081994|NCT01016652|3905129|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4081995|NCT01016652|3905130|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4081996|NCT01016652|3905131|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4081997|NCT01016600|3905148|B5|United States||Region of Enrollment||participants|Number|31|31.0||||||
4081998|NCT01016600|3905149|B4|United States||Region of Enrollment||participants|Number|12|12.0||||||
4081999|NCT01016600|3905150|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4082000|NCT01016600|3905151|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4082001|NCT01016600|3905152|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4082002|NCT01016600|3905148|B5||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4082003|NCT01016600|3905149|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4082004|NCT01016600|3905150|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4082005|NCT01016600|3905151|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4082006|NCT01016600|3905152|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4082007|NCT01016600|3905148|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4082008|NCT01016600|3905149|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4082009|NCT01016600|3905150|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4082010|NCT01016600|3905151|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4082011|NCT01016600|3905152|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4082012|NCT01016600|3905148|B5|||Age||years|Median|72|72.0|Full Range|||63.0|88.0|
4082013|NCT01016600|3905149|B4|||Age||years|Median|72|72.0|Full Range|||65.0|88.0|
4082014|NCT01016600|3905150|B3|||Age||years|Median|75.5|75.5|Full Range|||65.0|81.0|
4082015|NCT01016600|3905151|B2|||Age||years|Median|67.5|67.5|Full Range|||63.0|77.0|
4082016|NCT01016600|3905152|B1|||Age||years|Median|70|70.0|Full Range|||64.0|74.0|
4082017|NCT01016483|3905218|B5||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4082018|NCT01016483|3905219|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4082019|NCT01016483|3905220|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4082020|NCT01016483|3905221|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4082021|NCT01016483|3905222|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4082022|NCT01016483|3905218|B5||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4082023|NCT01016483|3905219|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4082024|NCT01016483|3905220|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4082025|NCT01016483|3905221|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4082026|NCT01016483|3905222|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4082027|NCT01016483|3905218|B5||>=65 years|Age||Participants|Count of Participants|53|53.0||||||
4082028|NCT01016483|3905219|B4||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4082029|NCT01016483|3905220|B3||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4082030|NCT01016483|3905221|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4082031|NCT01016483|3905222|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4082032|NCT01016483|3905218|B5||Between 18 and 65 years|Age||Participants|Count of Participants|88|88.0||||||
4082033|NCT01016483|3905219|B4||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4082034|NCT01016483|3905220|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4082035|NCT01016483|3905221|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4082036|NCT01016483|3905222|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4082037|NCT01016483|3905218|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4082038|NCT01016483|3905219|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4082039|NCT01016483|3905220|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4082040|NCT01016483|3905221|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4082041|NCT01016483|3905222|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4082042|NCT01016353|3905331|B3|United States||Region of Enrollment||Participants|Count of Participants|280|280.0||||||
4082043|NCT01016353|3905332|B2|United States||Region of Enrollment||Participants|Count of Participants|102|102.0||||||
4082044|NCT01016353|3905333|B1|United States||Region of Enrollment||Participants|Count of Participants|178|178.0||||||
4082045|NCT01016353|3905331|B3|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|128|128.0||||||
4082046|NCT01016353|3905332|B2|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
4082047|NCT01016353|3905333|B1|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|81|81.0||||||
4082048|NCT01016353|3905331|B3|Race/Ethnicity|Native Hawaiian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4082049|NCT01016353|3905332|B2|Race/Ethnicity|Native Hawaiian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4082050|NCT01016353|3905333|B1|Race/Ethnicity|Native Hawaiian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4082051|NCT01016353|3905331|B3|Race/Ethnicity|Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
4082052|NCT01016353|3905332|B2|Race/Ethnicity|Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4082053|NCT01016353|3905333|B1|Race/Ethnicity|Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
4082054|NCT01016353|3905331|B3|Race/Ethnicity|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|94|94.0||||||
4082055|NCT01016353|3905332|B2|Race/Ethnicity|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
4082056|NCT01016353|3905333|B1|Race/Ethnicity|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|54|54.0||||||
4082057|NCT01016353|3905331|B3|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4082058|NCT01016353|3905332|B2|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4082059|NCT01016353|3905333|B1|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4082060|NCT01016353|3905331|B3|Race/Ethnicity|American Indian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4082061|NCT01016353|3905332|B2|Race/Ethnicity|American Indian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4082062|NCT01016353|3905333|B1|Race/Ethnicity|American Indian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4082063|NCT01016353|3905331|B3||Male|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4082064|NCT01016353|3905332|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4082065|NCT01016353|3905333|B1||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4082066|NCT01016353|3905331|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4082067|NCT01016353|3905332|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4082068|NCT01016353|3905333|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4082069|NCT01016353|3905331|B3|||Age||years|Mean|40|40.0|Standard Deviation|16|16.0|||
4082070|NCT01016353|3905332|B2|||Age||years|Mean|39|39.0|Standard Deviation|16|16.0|||
4082071|NCT01016353|3905333|B1|||Age||years|Mean|40|40.0|Standard Deviation|17|17.0|||
4082072|NCT01016132|3905340|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4082073|NCT01016132|3905340|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4082074|NCT01016132|3905340|B1|||Age||years|Mean|33.5|33.5|Standard Deviation|10.9|10.9|||
4082075|NCT01016106|3905344|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
4082076|NCT01016106|3905345|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4082077|NCT01016106|3905346|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4082078|NCT01016106|3905344|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4082079|NCT01016106|3905345|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4082080|NCT01016106|3905346|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4082081|NCT01016106|3905344|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4082082|NCT01016106|3905345|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4082083|NCT01016106|3905346|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4082084|NCT01016106|3905344|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4082085|NCT01016106|3905345|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4082086|NCT01016106|3905346|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4082087|NCT01016106|3905344|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4082088|NCT01016106|3905345|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4082089|NCT01016106|3905346|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4082090|NCT01016106|3905344|B3||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
4082091|NCT01016106|3905345|B2||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
4082092|NCT01016106|3905346|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4082093|NCT01016067|3905353|B3|||Weight||lbs.|Mean|182.7|182.7|Standard Deviation|45.46|45.46|||
4082094|NCT01016067|3905354|B2|||Weight||lbs.|Mean|186.3|186.3|Standard Deviation|42.74|42.74|||
4082095|NCT01016067|3905355|B1|||Weight||lbs.|Mean|178.9|178.9|Standard Deviation|50.07|50.07|||
4082096|NCT01016067|3905353|B3|||Height||Inches|Mean|68.8|68.8|Standard Deviation|3.98|3.98|||
4082097|NCT01016067|3905354|B2|||Height||Inches|Mean|68.6|68.6|Standard Deviation|4.56|4.56|||
4082098|NCT01016067|3905355|B1|||Height||Inches|Mean|69.0|69.0|Standard Deviation|3.44|3.44|||
4082099|NCT01016067|3905353|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082100|NCT01016067|3905354|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082101|NCT01016067|3905355|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082102|NCT01016067|3905353|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082103|NCT01016067|3905354|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082104|NCT01016067|3905355|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082105|NCT01016067|3905353|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082106|NCT01016067|3905354|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082107|NCT01016067|3905355|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082108|NCT01016067|3905353|B3|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4082109|NCT01016067|3905354|B2|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4082110|NCT01016067|3905355|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082111|NCT01016067|3905353|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4082112|NCT01016067|3905354|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4082113|NCT01016067|3905355|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4082114|NCT01016067|3905353|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4082115|NCT01016067|3905354|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4082116|NCT01016067|3905355|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4082117|NCT01016067|3905353|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4082118|NCT01016067|3905354|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4082119|NCT01016067|3905355|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4082120|NCT01016067|3905353|B3|||Age||years|Mean|42.5|42.5|Standard Deviation|11.20|11.2|||
4082121|NCT01016067|3905354|B2|||Age||years|Mean|37.7|37.7|Standard Deviation|8.47|8.47|||
4082122|NCT01016067|3905355|B1|||Age||years|Mean|47.8|47.8|Standard Deviation|11.76|11.76|||
4082123|NCT01016015|3905374|B1|United States||Region of Enrollment||participants|Number|178|178.0||||||
4082124|NCT01016015|3905374|B1||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4082125|NCT01016015|3905374|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4082126|NCT01016015|3905374|B1||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4082127|NCT01016015|3905374|B1||Between 18 and 65 years|Age||Participants|Count of Participants|144|144.0||||||
4082128|NCT01016015|3905374|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4082129|NCT01015976|3905378|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4082130|NCT01015976|3905378|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4082131|NCT01015976|3905378|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4082132|NCT01015976|3905378|B1|||Age||years|Mean|46.6|46.6|Standard Deviation|10.6|10.6|||
4082133|NCT01015976|3905378|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4082134|NCT01015976|3905378|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4082135|NCT01015976|3905378|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4082136|NCT01015833|3905383|B3|United States||Region of Enrollment||Participants|Count of Participants|295|295.0||||||
4082137|NCT01015833|3905384|B2|United States||Region of Enrollment||Participants|Count of Participants|147|147.0||||||
4082138|NCT01015833|3905385|B1|United States||Region of Enrollment||Participants|Count of Participants|148|148.0||||||
4082139|NCT01015833|3905383|B3|Canada||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
4082140|NCT01015833|3905384|B2|Canada||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
4082141|NCT01015833|3905385|B1|Canada||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
4082142|NCT01015833|3905383|B3||Male|Sex: Female, Male||Participants|Count of Participants|306|306.0||||||
4082143|NCT01015833|3905384|B2||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4082144|NCT01015833|3905385|B1||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4082145|NCT01015833|3905383|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4082146|NCT01015833|3905384|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4082147|NCT01015833|3905385|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4082148|NCT01015833|3905383|B3|||Age||years|Median|62|62.0|Full Range|||22.0|85.0|
4082149|NCT01015833|3905384|B2|||Age||years|Median|62|62.0|Full Range|||31.0|85.0|
4082150|NCT01015833|3905385|B1|||Age||years|Median|62|62.0|Full Range|||22.0|81.0|
4082151|NCT01015820|3905400|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
4082152|NCT01015820|3905401|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4082153|NCT01015820|3905402|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4082154|NCT01015820|3905400|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4082155|NCT01015820|3905401|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4082156|NCT01015820|3905402|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4082157|NCT01015820|3905400|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4082158|NCT01015820|3905401|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4082159|NCT01015820|3905402|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4082160|NCT01015820|3905400|B3|||Age||years|Mean|67|67.0|Standard Deviation|12|12.0|||
4082161|NCT01015820|3905401|B2|||Age||years|Mean|63|63.0|Standard Deviation|11|11.0|||
4082162|NCT01015820|3905402|B1|||Age||years|Mean|72|72.0|Standard Deviation|10|10.0|||
4082163|NCT01015807|3905411|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4082164|NCT01015807|3905412|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4082165|NCT01015807|3905413|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4082166|NCT01015807|3905414|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4082167|NCT01015807|3905411|B4||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4082168|NCT01015807|3905412|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4082169|NCT01015807|3905413|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4082170|NCT01015807|3905414|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4082171|NCT01015807|3905411|B4|||Age||years|Mean|30|30.0|Standard Deviation|5.5|5.5|||
4082172|NCT01015807|3905412|B3|||Age||years|Mean|29.5|29.5|Standard Deviation|6.7|6.7|||
4082173|NCT01015807|3905413|B2|||Age||years|Mean|31.8|31.8|Standard Deviation|4.5|4.5|||
4082174|NCT01015807|3905414|B1|||Age||years|Mean|30.5|30.5|Standard Deviation|6.7|6.7|||
4082175|NCT01015781|3905424|B3|United States||Region of Enrollment||participants|Number|300|300.0||||||
4082176|NCT01015781|3905425|B2|United States||Region of Enrollment||participants|Number|150|150.0||||||
4082177|NCT01015781|3905426|B1|United States||Region of Enrollment||participants|Number|150|150.0||||||
4082178|NCT01015781|3905424|B3||Male|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
4082179|NCT01015781|3905425|B2||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4082180|NCT01015781|3905426|B1||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4082181|NCT01015781|3905424|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4082182|NCT01015781|3905425|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4082183|NCT01015781|3905426|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4082184|NCT01015781|3905424|B3|||Age||years|Mean|57.89|57.89|Standard Deviation|12.99|12.99|||
4082185|NCT01015781|3905425|B2|||Age||years|Mean|58.05|58.05|Standard Deviation|12.05|12.05|||
4082186|NCT01015781|3905426|B1|||Age||years|Mean|57.72|57.72|Standard Deviation|13.92|13.92|||
4082187|NCT01015703|3905433|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082188|NCT01015703|3905434|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082189|NCT01015703|3905435|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082190|NCT01015703|3905436|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082191|NCT01015703|3905437|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082192|NCT01015703|3905438|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082193|NCT01015703|3905433|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082194|NCT01015703|3905434|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082195|NCT01015703|3905435|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082196|NCT01015703|3905436|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082197|NCT01015703|3905437|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082198|NCT01015703|3905438|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082199|NCT01015703|3905433|B6||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4082200|NCT01015703|3905434|B5||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4082201|NCT01015703|3905435|B4||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4082202|NCT01015703|3905436|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4082203|NCT01015703|3905437|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4082204|NCT01015703|3905438|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4082205|NCT01015703|3905433|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4082206|NCT01015703|3905434|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4082207|NCT01015703|3905435|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082208|NCT01015703|3905436|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082209|NCT01015703|3905437|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4082210|NCT01015703|3905438|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4082211|NCT01015703|3905433|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082212|NCT01015703|3905434|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082213|NCT01015703|3905435|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082214|NCT01015703|3905436|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082215|NCT01015703|3905437|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082216|NCT01015703|3905438|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082217|NCT01015703|3905433|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4082218|NCT01015703|3905434|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082219|NCT01015703|3905435|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082220|NCT01015703|3905436|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082221|NCT01015703|3905437|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082222|NCT01015703|3905438|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4082223|NCT01015703|3905433|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082224|NCT01015703|3905434|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082225|NCT01015703|3905435|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082226|NCT01015703|3905436|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082227|NCT01015703|3905437|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082228|NCT01015703|3905438|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082229|NCT01015703|3905433|B6||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4082230|NCT01015703|3905434|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4082231|NCT01015703|3905435|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4082232|NCT01015703|3905436|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4082233|NCT01015703|3905437|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4082234|NCT01015703|3905438|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4082235|NCT01015703|3905433|B6||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4082236|NCT01015703|3905434|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4082237|NCT01015703|3905435|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4082238|NCT01015703|3905436|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4082239|NCT01015703|3905437|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4082240|NCT01015703|3905438|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4082241|NCT01015703|3905433|B6|||Age||years|Mean|42|42.0|Standard Deviation|10|10.0|||
4082242|NCT01015703|3905434|B5|||Age||years|Mean|36|36.0|Standard Deviation|9|9.0|||
4082243|NCT01015703|3905435|B4|||Age||years|Mean|44|44.0|Standard Deviation|15|15.0|||
4082244|NCT01015703|3905436|B3|||Age||years|Mean|49|49.0|Standard Deviation|9|9.0|||
4082245|NCT01015703|3905437|B2|||Age||years|Mean|46|46.0|Standard Deviation|11|11.0|||
4082246|NCT01015703|3905438|B1|||Age||years|Mean|41|41.0|Standard Deviation|11|11.0|||
4082247|NCT01015677|3905454|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4082248|NCT01015677|3905455|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4082249|NCT01015677|3905456|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4082250|NCT01015677|3905457|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4082251|NCT01015677|3905454|B4||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4082252|NCT01015677|3905455|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4082253|NCT01015677|3905456|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4082254|NCT01015677|3905457|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4082255|NCT01015677|3905454|B4|||Age||Years|Mean|52.5|52.5|Standard Deviation|4.0|4.0|||
4082256|NCT01015677|3905455|B3|||Age||Years|Mean|52.2|52.2|Standard Deviation|4.2|4.2|||
4082257|NCT01015677|3905456|B2|||Age||Years|Mean|53.2|53.2|Standard Deviation|3.9|3.9|||
4082258|NCT01015677|3905457|B1|||Age||Years|Mean|52.1|52.1|Standard Deviation|3.9|3.9|||
4082259|NCT01015638|3905479|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4082260|NCT01015638|3905480|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4082261|NCT01015638|3905481|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4082262|NCT01015638|3905479|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4082263|NCT01015638|3905480|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4082264|NCT01015638|3905481|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4082265|NCT01015638|3905479|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4082266|NCT01015638|3905480|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4082267|NCT01015638|3905481|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4082268|NCT01015638|3905479|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4082269|NCT01015638|3905480|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4082270|NCT01015638|3905481|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4082271|NCT01015638|3905479|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4082272|NCT01015638|3905480|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4082273|NCT01015638|3905481|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4082274|NCT01015638|3905479|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4082275|NCT01015638|3905480|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4082276|NCT01015638|3905481|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4082277|NCT01015612|3905510|B1|Australia||Region of Enrollment||participants|Number|523|523.0||||||
4082278|NCT01015612|3905510|B1|New Zealand||Region of Enrollment||participants|Number|111|111.0||||||
4082279|NCT01015612|3905510|B1||Male|Sex: Female, Male||Participants|Count of Participants|353|353.0||||||
4082280|NCT01015612|3905510|B1||Female|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
4082281|NCT01015612|3905510|B1|||Age||years|Mean|84.1|84.1|Standard Deviation|5.6|5.6|||
4082282|NCT01015560|3905520|B1|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4082283|NCT01015560|3905520|B1|White||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4082284|NCT01015560|3905520|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4082285|NCT01015560|3905520|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4082286|NCT01015560|3905520|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4082287|NCT01015560|3905520|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4082288|NCT01015560|3905520|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4082289|NCT01015560|3905520|B1|||Age||years|Median|65|65.0|Full Range|||38.0|89.0|
4082290|NCT01015534|3905524|B3|Mexico||Region of Enrollment||participants|Number|55|55.0||||||
4082291|NCT01015534|3905525|B2|Mexico||Region of Enrollment||participants|Number|27|27.0||||||
4082292|NCT01015534|3905526|B1|Mexico||Region of Enrollment||participants|Number|28|28.0||||||
4082293|NCT01015534|3905524|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4082294|NCT01015534|3905525|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4082295|NCT01015534|3905526|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4082296|NCT01015534|3905524|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4082297|NCT01015534|3905525|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4082298|NCT01015534|3905526|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4082299|NCT01015534|3905524|B3|||Age||years|Mean|51.7|51.7|Standard Deviation|13.55|13.55|||
4082300|NCT01015534|3905525|B2|||Age||years|Mean|53.8|53.8|Standard Deviation|13.7|13.7|||
4082301|NCT01015534|3905526|B1|||Age||years|Mean|49.5|49.5|Standard Deviation|13.4|13.4|||
4082302|NCT01015534|3905524|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4082303|NCT01015534|3905525|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4082304|NCT01015534|3905526|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4082305|NCT01015534|3905524|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4082306|NCT01015534|3905525|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4082307|NCT01015534|3905526|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4082308|NCT01015534|3905524|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4082309|NCT01015534|3905525|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4082310|NCT01015534|3905526|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4082311|NCT01015443|3905539|B3||Male|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
4082312|NCT01015443|3905540|B2||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4082313|NCT01015443|3905541|B1||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4082314|NCT01015443|3905539|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4082315|NCT01015443|3905540|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4082316|NCT01015443|3905541|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4082317|NCT01015443|3905539|B3|||Age||Years|Mean|57.4|57.4|Standard Deviation|9.06|9.06|||
4082318|NCT01015443|3905540|B2|||Age||Years|Mean|59.3|59.3|Standard Deviation|9.08|9.08|||
4082319|NCT01015443|3905541|B1|||Age||Years|Mean|56.5|56.5|Standard Deviation|8.93|8.93|||
4082320|NCT01015326|3905558|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4082321|NCT01015326|3905559|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4082322|NCT01015326|3905560|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4082323|NCT01015326|3905558|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4082324|NCT01015326|3905559|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4082325|NCT01015326|3905560|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4082326|NCT01015326|3905558|B3|||Age||years|Mean|50.3|50.3|Full Range|||25.0|76.0|
4082327|NCT01015326|3905559|B2|||Age||years|Mean|57.0|57.0|Full Range|||34.0|76.0|
4082328|NCT01015326|3905560|B1|||Age||years|Mean|39.2|39.2|Full Range|||25.0|52.0|
4082329|NCT01015287|3905567|B3||Male|Sex: Female, Male||Participants|Count of Participants|2923|2923.0||||||
4082330|NCT01015287|3905568|B2||Male|Sex: Female, Male||Participants|Count of Participants|1485|1485.0||||||
4082331|NCT01015287|3905569|B1||Male|Sex: Female, Male||Participants|Count of Participants|1438|1438.0||||||
4082332|NCT01015287|3905567|B3||Female|Sex: Female, Male||Participants|Count of Participants|1110|1110.0||||||
4082333|NCT01015287|3905568|B2||Female|Sex: Female, Male||Participants|Count of Participants|552|552.0||||||
4082334|NCT01015287|3905569|B1||Female|Sex: Female, Male||Participants|Count of Participants|558|558.0||||||
4082335|NCT01015287|3905567|B3|||Age||years|Mean|63.69|63.69|Standard Deviation|11.254|11.254|||
4082336|NCT01015287|3905568|B2|||Age||years|Mean|63.80|63.8|Standard Deviation|11.270|11.27|||
4082337|NCT01015287|3905569|B1|||Age||years|Mean|63.59|63.59|Standard Deviation|11.239|11.239|||
4082338|NCT01015170|3905596|B1|Yes||Ever had a psychiatric diagnosis||participants|Number|145|145.0||||||
4082339|NCT01015170|3905596|B1|No||Ever had a psychiatric diagnosis||participants|Number|309|309.0||||||
4082340|NCT01015170|3905596|B1|||Confidence in quitting smoking|"Confidence in quitting smoking~1- very little confidence 10- very confident"|units on a scale|Mean|7.6|7.6|Standard Deviation|2.0|2.0|||
4082341|NCT01015170|3905596|B1|||Importance of quitting smoking|"scale of importance of quitting (1 to 10)~1 - least important 10- most important"|units on a scale|Mean|9.2|9.2|Standard Deviation|1.3|1.3|||
4082342|NCT01015170|3905596|B1|missing||# quit attempts in the past||participants|Number|48|48.0||||||
4082343|NCT01015170|3905596|B1|3 or more quit attempts||# quit attempts in the past||participants|Number|225|225.0||||||
4082344|NCT01015170|3905596|B1|0 - 2 quit attempts||# quit attempts in the past||participants|Number|181|181.0||||||
4082345|NCT01015170|3905596|B1|missing||Time to first morning cigarette||participants|Number|4|4.0||||||
4082346|NCT01015170|3905596|B1|more than 15 minutes||Time to first morning cigarette||participants|Number|144|144.0||||||
4082347|NCT01015170|3905596|B1|15 minutes or less||Time to first morning cigarette||participants|Number|306|306.0||||||
4082348|NCT01015170|3905596|B1|||Age smoked daily||years|Mean|16.4|16.4|Standard Deviation|4.3|4.3|||
4082349|NCT01015170|3905596|B1|||Age first smoked||years|Mean|14.1|14.1|Standard Deviation|3.7|3.7|||
4082350|NCT01015170|3905596|B1|||Cigarettes per day (cpd)|# cigarettes smoked per day|# cigarettes smoked per day|Mean|20.5|20.5|Standard Deviation|9.0|9.0|||
4082351|NCT01015170|3905596|B1|missing||Income category||participants|Number|87|87.0||||||
4082352|NCT01015170|3905596|B1|more than $40,000||Income category||participants|Number|106|106.0||||||
4082353|NCT01015170|3905596|B1|up to $40,000||Income category||participants|Number|261|261.0||||||
4082354|NCT01015170|3905596|B1|missing||Employment||participants|Number|4|4.0||||||
4082355|NCT01015170|3905596|B1|Not employed||Employment||participants|Number|229|229.0||||||
4082356|NCT01015170|3905596|B1|Employed||Employment||participants|Number|221|221.0||||||
4082357|NCT01015170|3905596|B1|missing||Education level attained|highest level of education attained|participants|Number|9|9.0||||||
4082358|NCT01015170|3905596|B1|Post secondary||Education level attained|highest level of education attained|participants|Number|207|207.0||||||
4082359|NCT01015170|3905596|B1|up to highschool||Education level attained|highest level of education attained|participants|Number|238|238.0||||||
4082360|NCT01015170|3905596|B1||Male|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4082361|NCT01015170|3905596|B1||Female|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
4082362|NCT01015170|3905596|B1|||Age||years|Mean|47.5|47.5|Standard Deviation|13.2|13.2|||
4082363|NCT01015170|3905596|B1||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4082364|NCT01015170|3905596|B1||Between 18 and 65 years|Age||Participants|Count of Participants|415|415.0||||||
4082365|NCT01015170|3905596|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4082366|NCT01015131|3905602|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4082367|NCT01015131|3905602|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4082368|NCT01015131|3905602|B1|||Age||years|Mean|50.0|50.0|Standard Deviation|9.0|9.0|||
4082369|NCT01015118|3905616|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4082370|NCT01015118|3905617|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4082371|NCT01015118|3905618|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4082372|NCT01015118|3905616|B3||Female|Sex: Female, Male||Participants|Count of Participants|1366|1366.0||||||
4082373|NCT01015118|3905617|B2||Female|Sex: Female, Male||Participants|Count of Participants|455|455.0||||||
4082374|NCT01015118|3905618|B1||Female|Sex: Female, Male||Participants|Count of Participants|911|911.0||||||
4082375|NCT01015118|3905616|B3|||Age||Years|Mean|57.3|57.3|Standard Deviation|11.1|11.1|||
4082376|NCT01015118|3905617|B2|||Age||Years|Mean|56.9|56.9|Standard Deviation|11.1|11.1|||
4082377|NCT01015118|3905618|B1|||Age||Years|Mean|57.5|57.5|Standard Deviation|11.0|11.0|||
4082378|NCT01014988|3905641|B7|Mixed Race||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4082379|NCT01014988|3905642|B6|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082380|NCT01014988|3905643|B5|Mixed Race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4082381|NCT01014988|3905644|B4|Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4082382|NCT01014988|3905645|B3|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082383|NCT01014988|3905646|B2|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082384|NCT01014988|3905647|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082385|NCT01014988|3905641|B7|Unknown||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4082386|NCT01014988|3905642|B6|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082387|NCT01014988|3905643|B5|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4082388|NCT01014988|3905644|B4|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082389|NCT01014988|3905645|B3|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082390|NCT01014988|3905646|B2|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082391|NCT01014988|3905647|B1|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4082392|NCT01014988|3905641|B7|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|145|145.0||||||
4082393|NCT01014988|3905642|B6|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4082394|NCT01014988|3905643|B5|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4082395|NCT01014988|3905644|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4082396|NCT01014988|3905645|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4082397|NCT01014988|3905646|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4082398|NCT01014988|3905647|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|97|97.0||||||
4082399|NCT01014988|3905641|B7|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4082400|NCT01014988|3905642|B6|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082401|NCT01014988|3905643|B5|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4082402|NCT01014988|3905644|B4|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4082403|NCT01014988|3905645|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082404|NCT01014988|3905646|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082405|NCT01014988|3905647|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4082406|NCT01014988|3905641|B7|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4082407|NCT01014988|3905642|B6|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082408|NCT01014988|3905643|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4082409|NCT01014988|3905644|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082410|NCT01014988|3905645|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082411|NCT01014988|3905646|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082412|NCT01014988|3905647|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082413|NCT01014988|3905641|B7|Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4082414|NCT01014988|3905642|B6|Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082415|NCT01014988|3905643|B5|Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082416|NCT01014988|3905644|B4|Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4082417|NCT01014988|3905645|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082418|NCT01014988|3905646|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4082419|NCT01014988|3905647|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082420|NCT01014988|3905641|B7|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4082421|NCT01014988|3905642|B6|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082422|NCT01014988|3905643|B5|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082423|NCT01014988|3905644|B4|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082424|NCT01014988|3905645|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082425|NCT01014988|3905646|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082426|NCT01014988|3905647|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4082427|NCT01014988|3905641|B7|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4082428|NCT01014988|3905642|B6|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082429|NCT01014988|3905643|B5|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082430|NCT01014988|3905644|B4|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082431|NCT01014988|3905645|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082432|NCT01014988|3905646|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082433|NCT01014988|3905647|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4082434|NCT01014988|3905641|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4082435|NCT01014988|3905642|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082436|NCT01014988|3905643|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082437|NCT01014988|3905644|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082438|NCT01014988|3905645|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082439|NCT01014988|3905646|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4082440|NCT01014988|3905647|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4082441|NCT01014988|3905641|B7|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4082569|NCT01014741|3906348|B1|no||Current anti-arrhythmic drug use||participants|Number|66|66.0||||||
4082442|NCT01014988|3905642|B6|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4082443|NCT01014988|3905643|B5|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4082444|NCT01014988|3905644|B4|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4082445|NCT01014988|3905645|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4082446|NCT01014988|3905646|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4082447|NCT01014988|3905647|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4082448|NCT01014988|3905641|B7||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4082449|NCT01014988|3905642|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4082450|NCT01014988|3905643|B5||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4082451|NCT01014988|3905644|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4082452|NCT01014988|3905645|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4082453|NCT01014988|3905646|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4082454|NCT01014988|3905647|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4082455|NCT01014988|3905641|B7||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4082456|NCT01014988|3905642|B6||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4082457|NCT01014988|3905643|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4082458|NCT01014988|3905644|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4082459|NCT01014988|3905645|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4082460|NCT01014988|3905646|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4082461|NCT01014988|3905647|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4082462|NCT01014988|3905641|B7|||Age||Years|Mean|33.81|33.81|Standard Deviation|23.796|23.796|||
4082463|NCT01014988|3905642|B6|||Age||Years|Mean|15.36|15.36|Standard Deviation|1.151|1.151|||
4082464|NCT01014988|3905643|B5|||Age||Years|Mean|8.67|8.67|Standard Deviation|1.861|1.861|||
4082465|NCT01014988|3905644|B4|||Age||Years|Mean|3.74|3.74|Standard Deviation|1.201|1.201|||
4082466|NCT01014988|3905645|B3|||Age||Years|Mean|1.33|1.33|Standard Deviation|0.220|0.22|||
4082467|NCT01014988|3905646|B2|||Age||Years|Mean|0.76|0.76|Standard Deviation|0.127|0.127|||
4082468|NCT01014988|3905647|B1|||Age||Years|Mean|48.30|48.3|Standard Deviation|16.19|16.19|||
4082469|NCT01014975|3905824|B1|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4082470|NCT01014975|3905824|B1|Australia||Region of Enrollment||participants|Number|5|5.0||||||
4082471|NCT01014975|3905824|B1|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4082472|NCT01014975|3905824|B1|Spain||Region of Enrollment||participants|Number|8|8.0||||||
4082473|NCT01014975|3905824|B1|Slovakia||Region of Enrollment||participants|Number|5|5.0||||||
4082474|NCT01014975|3905824|B1|France||Region of Enrollment||participants|Number|7|7.0||||||
4082475|NCT01014975|3905824|B1|Serbia||Region of Enrollment||participants|Number|10|10.0||||||
4082476|NCT01014975|3905824|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4082477|NCT01014975|3905824|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4082478|NCT01014975|3905824|B1|||Age||years|Mean|73.1|73.1|Standard Deviation|9.38|9.38|||
4082479|NCT01014975|3905824|B1||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4082480|NCT01014975|3905824|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4082481|NCT01014975|3905824|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4082482|NCT01014936|3905834|B4||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4082483|NCT01014936|3905835|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4082484|NCT01014936|3905836|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4082485|NCT01014936|3905837|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4082486|NCT01014936|3905834|B4||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4082487|NCT01014936|3905835|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4082488|NCT01014936|3905836|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4082489|NCT01014936|3905837|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4082490|NCT01014936|3905834|B4|||Age||years|Mean|58.32|58.32|Standard Deviation|14.050|14.05|||
4082491|NCT01014936|3905835|B3|||Age||years|Mean|56.49|56.49|Standard Deviation|13.986|13.986|||
4082492|NCT01014936|3905836|B2|||Age||years|Mean|59.29|59.29|Standard Deviation|14.656|14.656|||
4082493|NCT01014936|3905837|B1|||Age||years|Mean|59.97|59.97|Standard Deviation|13.496|13.496|||
4082494|NCT01014910|3906329|B3|||Receipt of oral corticosteroids before admission||participants|Number|16|16.0||||||
4082495|NCT01014910|3906330|B2|||Receipt of oral corticosteroids before admission||participants|Number|12|12.0||||||
4082496|NCT01014910|3906331|B1|||Receipt of oral corticosteroids before admission||participants|Number|4|4.0||||||
4082497|NCT01014910|3906329|B3|||Receipt of antibiotics prior to admission||participants|Number|31|31.0||||||
4082498|NCT01014910|3906330|B2|||Receipt of antibiotics prior to admission||participants|Number|21|21.0||||||
4082499|NCT01014910|3906331|B1|||Receipt of antibiotics prior to admission||participants|Number|10|10.0||||||
4082500|NCT01014910|3906329|B3|||Receipt of bronchodilators prior to admission||participants|Number|121|121.0||||||
4082501|NCT01014910|3906330|B2|||Receipt of bronchodilators prior to admission||participants|Number|63|63.0||||||
4082502|NCT01014910|3906331|B1|||Receipt of bronchodilators prior to admission||participants|Number|58|58.0||||||
4082503|NCT01014910|3906329|B3|||Day-care exposure|Includes patients with a sibling in daycare|participants|Number|23|23.0||||||
4082504|NCT01014910|3906330|B2|||Day-care exposure|Includes patients with a sibling in daycare|participants|Number|15|15.0||||||
4082505|NCT01014910|3906331|B1|||Day-care exposure|Includes patients with a sibling in daycare|participants|Number|8|8.0||||||
4082506|NCT01014910|3906329|B3|||Family history of asthma/reactive airway disease||participants|Number|75|75.0||||||
4082507|NCT01014910|3906330|B2|||Family history of asthma/reactive airway disease||participants|Number|45|45.0||||||
4082508|NCT01014910|3906331|B1|||Family history of asthma/reactive airway disease||participants|Number|30|30.0||||||
4082509|NCT01014910|3906329|B3|||History of tobacco exposure||participants|Number|39|39.0||||||
4082510|NCT01014910|3906330|B2|||History of tobacco exposure||participants|Number|22|22.0||||||
4082511|NCT01014910|3906331|B1|||History of tobacco exposure||participants|Number|17|17.0||||||
4082512|NCT01014910|3906329|B3|||Seizure||participants|Number|0|0.0||||||
4082513|NCT01014910|3906330|B2|||Seizure||participants|Number|0|0.0||||||
4082514|NCT01014910|3906331|B1|||Seizure||participants|Number|0|0.0||||||
4082515|NCT01014910|3906329|B3|||Lethargy||participants|Number|23|23.0||||||
4082516|NCT01014910|3906330|B2|||Lethargy||participants|Number|11|11.0||||||
4082517|NCT01014910|3906331|B1|||Lethargy||participants|Number|12|12.0||||||
4082518|NCT01014910|3906329|B3|||Irritability||participants|Number|56|56.0||||||
4082519|NCT01014910|3906330|B2|||Irritability||participants|Number|27|27.0||||||
4082520|NCT01014910|3906331|B1|||Irritability||participants|Number|29|29.0||||||
4082521|NCT01014910|3906329|B3|||Rash||participants|Number|20|20.0||||||
4082522|NCT01014910|3906330|B2|||Rash||participants|Number|14|14.0||||||
4082523|NCT01014910|3906331|B1|||Rash||participants|Number|6|6.0||||||
4082524|NCT01014910|3906329|B3|||Diarrhea||participants|Number|28|28.0||||||
4082525|NCT01014910|3906330|B2|||Diarrhea||participants|Number|14|14.0||||||
4082526|NCT01014910|3906331|B1|||Diarrhea||participants|Number|14|14.0||||||
4082527|NCT01014910|3906329|B3|||Vomiting||participants|Number|72|72.0||||||
4082528|NCT01014910|3906330|B2|||Vomiting||participants|Number|40|40.0||||||
4082529|NCT01014910|3906331|B1|||Vomiting||participants|Number|32|32.0||||||
4082530|NCT01014910|3906329|B3|||Decreased oral intake||participants|Number|105|105.0||||||
4082531|NCT01014910|3906330|B2|||Decreased oral intake||participants|Number|54|54.0||||||
4082532|NCT01014910|3906331|B1|||Decreased oral intake||participants|Number|51|51.0||||||
4082533|NCT01014910|3906329|B3|||Presence of rhonorrhea||participants|Number|154|154.0||||||
4082534|NCT01014910|3906330|B2|||Presence of rhonorrhea||participants|Number|77|77.0||||||
4082535|NCT01014910|3906331|B1|||Presence of rhonorrhea||participants|Number|77|77.0||||||
4082536|NCT01014910|3906329|B3|United States||Region of Enrollment||participants|Number|161|161.0||||||
4082537|NCT01014910|3906330|B2|United States||Region of Enrollment||participants|Number|81|81.0||||||
4082538|NCT01014910|3906331|B1|United States||Region of Enrollment||participants|Number|80|80.0||||||
4082539|NCT01014910|3906329|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4082540|NCT01014910|3906330|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4082541|NCT01014910|3906331|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4082542|NCT01014910|3906329|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4082543|NCT01014910|3906330|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4082544|NCT01014910|3906331|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4082545|NCT01014910|3906329|B3|||Age||years|Median|0.25|0.25|Inter-Quartile Range|||0.13|0.52|
4082546|NCT01014910|3906330|B2|||Age||years|Median|0.30|0.3|Inter-Quartile Range|||0.15|0.64|
4082547|NCT01014910|3906331|B1|||Age||years|Median|0.22|0.22|Inter-Quartile Range|||0.13|0.44|
4082548|NCT01014871|3906340|B1|Germany||Region of Enrollment||participants|Number|30|30.0||||||
4082549|NCT01014871|3906340|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4082550|NCT01014871|3906340|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4082551|NCT01014871|3906340|B1|||Age||years|Mean|46.4|46.4|Standard Deviation|8.3|8.3|||
4082552|NCT01014871|3906340|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4082553|NCT01014871|3906340|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4082554|NCT01014871|3906340|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4082555|NCT01014741|3906346|B3|no||Current amiodarone use||participants|Number|184|184.0||||||
4082556|NCT01014741|3906347|B2|no||Current amiodarone use||participants|Number|85|85.0||||||
4082557|NCT01014741|3906348|B1|no||Current amiodarone use||participants|Number|99|99.0||||||
4082558|NCT01014741|3906346|B3|yes||Current amiodarone use||participants|Number|16|16.0||||||
4082559|NCT01014741|3906347|B2|yes||Current amiodarone use||participants|Number|10|10.0||||||
4082560|NCT01014741|3906348|B1|yes||Current amiodarone use||participants|Number|6|6.0||||||
4082561|NCT01014741|3906346|B3|no||Prior anti-arrhythmic drug use||participants|Number|127|127.0||||||
4082562|NCT01014741|3906347|B2|no||Prior anti-arrhythmic drug use||participants|Number|59|59.0||||||
4082563|NCT01014741|3906348|B1|no||Prior anti-arrhythmic drug use||participants|Number|68|68.0||||||
4082564|NCT01014741|3906346|B3|yes||Prior anti-arrhythmic drug use||participants|Number|73|73.0||||||
4082565|NCT01014741|3906347|B2|yes||Prior anti-arrhythmic drug use||participants|Number|36|36.0||||||
4082566|NCT01014741|3906348|B1|yes||Prior anti-arrhythmic drug use||participants|Number|37|37.0||||||
4082567|NCT01014741|3906346|B3|no||Current anti-arrhythmic drug use||participants|Number|126|126.0||||||
4082568|NCT01014741|3906347|B2|no||Current anti-arrhythmic drug use||participants|Number|60|60.0||||||
4082570|NCT01014741|3906346|B3|yes||Current anti-arrhythmic drug use||participants|Number|74|74.0||||||
4082571|NCT01014741|3906347|B2|yes||Current anti-arrhythmic drug use||participants|Number|35|35.0||||||
4082572|NCT01014741|3906348|B1|yes||Current anti-arrhythmic drug use||participants|Number|39|39.0||||||
4082573|NCT01014741|3906346|B3|no||Current B-blocker use||participants|Number|90|90.0||||||
4082574|NCT01014741|3906347|B2|no||Current B-blocker use||participants|Number|45|45.0||||||
4082575|NCT01014741|3906348|B1|no||Current B-blocker use||participants|Number|45|45.0||||||
4082576|NCT01014741|3906346|B3|yes||Current B-blocker use||participants|Number|110|110.0||||||
4082577|NCT01014741|3906347|B2|yes||Current B-blocker use||participants|Number|50|50.0||||||
4082578|NCT01014741|3906348|B1|yes||Current B-blocker use||participants|Number|60|60.0||||||
4082579|NCT01014741|3906346|B3|no||ACE inhibitor/ARB use|ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker.|participants|Number|120|120.0||||||
4082580|NCT01014741|3906347|B2|no||ACE inhibitor/ARB use|ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker.|participants|Number|56|56.0||||||
4082581|NCT01014741|3906348|B1|no||ACE inhibitor/ARB use|ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker.|participants|Number|64|64.0||||||
4082582|NCT01014741|3906346|B3|yes||ACE inhibitor/ARB use|ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker.|participants|Number|80|80.0||||||
4082583|NCT01014741|3906347|B2|yes||ACE inhibitor/ARB use|ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker.|participants|Number|39|39.0||||||
4082584|NCT01014741|3906348|B1|yes||ACE inhibitor/ARB use|ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker.|participants|Number|41|41.0||||||
4082585|NCT01014741|3906346|B3|no||Statin use||participants|Number|128|128.0||||||
4082586|NCT01014741|3906347|B2|no||Statin use||participants|Number|58|58.0||||||
4082587|NCT01014741|3906348|B1|no||Statin use||participants|Number|70|70.0||||||
4082588|NCT01014741|3906346|B3|yes||Statin use||participants|Number|72|72.0||||||
4082589|NCT01014741|3906347|B2|yes||Statin use||participants|Number|37|37.0||||||
4082590|NCT01014741|3906348|B1|yes||Statin use||participants|Number|35|35.0||||||
4082591|NCT01014741|3906346|B3|no||Prior cardioversion||participants|Number|45|45.0||||||
4082592|NCT01014741|3906347|B2|no||Prior cardioversion||participants|Number|24|24.0||||||
4082593|NCT01014741|3906348|B1|no||Prior cardioversion||participants|Number|21|21.0||||||
4082594|NCT01014741|3906346|B3|yes||Prior cardioversion||participants|Number|155|155.0||||||
4082595|NCT01014741|3906347|B2|yes||Prior cardioversion||participants|Number|71|71.0||||||
4082596|NCT01014741|3906348|B1|yes||Prior cardioversion||participants|Number|84|84.0||||||
4082597|NCT01014741|3906346|B3|no||Prior hospitalization for AF||participants|Number|134|134.0||||||
4082598|NCT01014741|3906347|B2|no||Prior hospitalization for AF||participants|Number|63|63.0||||||
4082599|NCT01014741|3906348|B1|no||Prior hospitalization for AF||participants|Number|71|71.0||||||
4082600|NCT01014741|3906346|B3|yes||Prior hospitalization for AF||participants|Number|66|66.0||||||
4082601|NCT01014741|3906347|B2|yes||Prior hospitalization for AF||participants|Number|32|32.0||||||
4082602|NCT01014741|3906348|B1|yes||Prior hospitalization for AF||participants|Number|34|34.0||||||
4082603|NCT01014741|3906346|B3|no||Long-lasting AF||participants|Number|162|162.0||||||
4082604|NCT01014741|3906347|B2|no||Long-lasting AF||participants|Number|73|73.0||||||
4082605|NCT01014741|3906348|B1|no||Long-lasting AF||participants|Number|89|89.0||||||
4082606|NCT01014741|3906346|B3|yes||Long-lasting AF||participants|Number|38|38.0||||||
4082607|NCT01014741|3906347|B2|yes||Long-lasting AF||participants|Number|22|22.0||||||
4082608|NCT01014741|3906348|B1|yes||Long-lasting AF||participants|Number|16|16.0||||||
4082609|NCT01014741|3906346|B3|||Duration of longest AF episode||month|Median|11.5|11.5|Standard Deviation|22.5|22.5|||
4082610|NCT01014741|3906347|B2|||Duration of longest AF episode||month|Median|12|12.0|Standard Deviation|23|23.0|||
4082611|NCT01014741|3906348|B1|||Duration of longest AF episode||month|Median|11|11.0|Standard Deviation|22|22.0|||
4082612|NCT01014741|3906346|B3|||Duration of current AF episode||months|Mean|9.5|9.5|Standard Deviation|21.5|21.5|||
4082613|NCT01014741|3906347|B2|||Duration of current AF episode||months|Mean|10|10.0|Standard Deviation|22|22.0|||
4082614|NCT01014741|3906348|B1|||Duration of current AF episode||months|Mean|9|9.0|Standard Deviation|21|21.0|||
4082615|NCT01014741|3906346|B3|||CHA2DS2VASc score|CHA2DS2VASc Score calculates stroke risk for patients with atrial fibrillation. As CHA2DS2-VASc score increased, rate of thromboembolic event (TE) within 1 year in non-anticoagulated patients with non-valvular AF increased as well. Score of 0 to be low risk for TE events (none seen in cohort at one year), score of 1 intermediate risk (0.6% rate at 1 year), and greater than 1 high risk (3% rate at 1 year).|units on a scale|Mean|1.5|1.5|Standard Deviation|1.3|1.3|||
4082616|NCT01014741|3906347|B2|||CHA2DS2VASc score|CHA2DS2VASc Score calculates stroke risk for patients with atrial fibrillation. As CHA2DS2-VASc score increased, rate of thromboembolic event (TE) within 1 year in non-anticoagulated patients with non-valvular AF increased as well. Score of 0 to be low risk for TE events (none seen in cohort at one year), score of 1 intermediate risk (0.6% rate at 1 year), and greater than 1 high risk (3% rate at 1 year).|units on a scale|Mean|1.4|1.4|Standard Deviation|1.3|1.3|||
4082617|NCT01014741|3906348|B1|||CHA2DS2VASc score|CHA2DS2VASc Score calculates stroke risk for patients with atrial fibrillation. As CHA2DS2-VASc score increased, rate of thromboembolic event (TE) within 1 year in non-anticoagulated patients with non-valvular AF increased as well. Score of 0 to be low risk for TE events (none seen in cohort at one year), score of 1 intermediate risk (0.6% rate at 1 year), and greater than 1 high risk (3% rate at 1 year).|units on a scale|Mean|1.6|1.6|Standard Deviation|1.3|1.3|||
4082618|NCT01014741|3906346|B3|no||Congestive heart failure||participants|Number|177|177.0||||||
4082619|NCT01014741|3906347|B2|no||Congestive heart failure||participants|Number|88|88.0||||||
4082620|NCT01014741|3906348|B1|no||Congestive heart failure||participants|Number|89|89.0||||||
4082621|NCT01014741|3906346|B3|yes||Congestive heart failure||participants|Number|23|23.0||||||
4082622|NCT01014741|3906347|B2|yes||Congestive heart failure||participants|Number|7|7.0||||||
4082623|NCT01014741|3906348|B1|yes||Congestive heart failure||participants|Number|16|16.0||||||
4082624|NCT01014741|3906346|B3|no||Stroke or transient ischaemic attack||participants|Number|189|189.0||||||
4082625|NCT01014741|3906347|B2|no||Stroke or transient ischaemic attack||participants|Number|89|89.0||||||
4082626|NCT01014741|3906348|B1|no||Stroke or transient ischaemic attack||participants|Number|100|100.0||||||
4082627|NCT01014741|3906346|B3|yes||Stroke or transient ischaemic attack||participants|Number|11|11.0||||||
4082628|NCT01014741|3906347|B2|yes||Stroke or transient ischaemic attack||participants|Number|6|6.0||||||
4082629|NCT01014741|3906348|B1|yes||Stroke or transient ischaemic attack||participants|Number|5|5.0||||||
4082630|NCT01014741|3906346|B3|no||Coronary artery disease||participants|Number|170|170.0||||||
4082631|NCT01014741|3906347|B2|no||Coronary artery disease||participants|Number|85|85.0||||||
4082632|NCT01014741|3906348|B1|no||Coronary artery disease||participants|Number|85|85.0||||||
4082633|NCT01014741|3906346|B3|yes||Coronary artery disease||participants|Number|30|30.0||||||
4082634|NCT01014741|3906347|B2|yes||Coronary artery disease||participants|Number|10|10.0||||||
4082635|NCT01014741|3906348|B1|yes||Coronary artery disease||participants|Number|20|20.0||||||
4082636|NCT01014741|3906346|B3|no||Diabetes||participants|Number|168|168.0||||||
4082637|NCT01014741|3906347|B2|no||Diabetes||participants|Number|78|78.0||||||
4082638|NCT01014741|3906348|B1|no||Diabetes||participants|Number|90|90.0||||||
4082639|NCT01014741|3906346|B3|yes||Diabetes||participants|Number|32|32.0||||||
4082640|NCT01014741|3906347|B2|yes||Diabetes||participants|Number|17|17.0||||||
4082641|NCT01014741|3906348|B1|yes||Diabetes||participants|Number|15|15.0||||||
4082642|NCT01014741|3906346|B3|no||Hypertension||participants|Number|84|84.0||||||
4082643|NCT01014741|3906347|B2|no||Hypertension||participants|Number|37|37.0||||||
4082644|NCT01014741|3906348|B1|no||Hypertension||participants|Number|47|47.0||||||
4082645|NCT01014741|3906346|B3|yes||Hypertension||participants|Number|116|116.0||||||
4082646|NCT01014741|3906347|B2|yes||Hypertension||participants|Number|58|58.0||||||
4082647|NCT01014741|3906348|B1|yes||Hypertension||participants|Number|58|58.0||||||
4082648|NCT01014741|3906346|B3|||Left atrial diameter||mm|Mean|46.5|46.5|Standard Deviation|7.5|7.5|||
4082649|NCT01014741|3906347|B2|||Left atrial diameter||mm|Mean|46|46.0|Standard Deviation|8|8.0|||
4082650|NCT01014741|3906348|B1|||Left atrial diameter||mm|Mean|47|47.0|Standard Deviation|7|7.0|||
4082651|NCT01014741|3906346|B3|||Ejection Fraction||percent|Mean|54.5|54.5|Standard Deviation|8|8.0|||
4082652|NCT01014741|3906347|B2|||Ejection Fraction||percent|Mean|55|55.0|Standard Deviation|8|8.0|||
4082653|NCT01014741|3906348|B1|||Ejection Fraction||percent|Mean|54|54.0|Standard Deviation|8|8.0|||
4082654|NCT01014741|3906346|B3||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4082655|NCT01014741|3906347|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4082656|NCT01014741|3906348|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4082657|NCT01014741|3906346|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4082658|NCT01014741|3906347|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4082659|NCT01014741|3906348|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4082660|NCT01014741|3906346|B3|||Age||years|Mean|60|60.0|Standard Deviation|10.5|10.5|||
4082661|NCT01014741|3906347|B2|||Age||years|Mean|60|60.0|Standard Deviation|9|9.0|||
4082662|NCT01014741|3906348|B1|||Age||years|Mean|60|60.0|Standard Deviation|12|12.0|||
4082663|NCT01014728|3906361|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4082664|NCT01014728|3906362|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4082665|NCT01014728|3906363|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4082666|NCT01014728|3906361|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4082667|NCT01014728|3906362|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4082668|NCT01014728|3906363|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4082669|NCT01014728|3906361|B3|||Age||years|Mean|42.3|42.3|Standard Deviation|16.5|16.5|||
4082670|NCT01014728|3906362|B2|||Age||years|Mean|43.4|43.4|Standard Deviation|16.6|16.6|||
4082671|NCT01014728|3906363|B1|||Age||years|Mean|41.3|41.3|Standard Deviation|16.9|16.9|||
4082672|NCT01014689|3906374|B3|Sweden||Region of Enrollment||participants|Number|33|33.0||||||
4082673|NCT01014689|3906375|B2|Sweden||Region of Enrollment||participants|Number|15|15.0||||||
4082674|NCT01014689|3906376|B1|Sweden||Region of Enrollment||participants|Number|18|18.0||||||
4082675|NCT01014689|3906374|B3|Italy||Region of Enrollment||participants|Number|28|28.0||||||
4082676|NCT01014689|3906375|B2|Italy||Region of Enrollment||participants|Number|14|14.0||||||
4082677|NCT01014689|3906376|B1|Italy||Region of Enrollment||participants|Number|14|14.0||||||
4082678|NCT01014689|3906374|B3|Germany||Region of Enrollment||participants|Number|35|35.0||||||
4082679|NCT01014689|3906375|B2|Germany||Region of Enrollment||participants|Number|17|17.0||||||
4082680|NCT01014689|3906376|B1|Germany||Region of Enrollment||participants|Number|18|18.0||||||
4082681|NCT01014689|3906374|B3|Australia||Region of Enrollment||participants|Number|33|33.0||||||
4082682|NCT01014689|3906375|B2|Australia||Region of Enrollment||participants|Number|18|18.0||||||
4082683|NCT01014689|3906376|B1|Australia||Region of Enrollment||participants|Number|15|15.0||||||
4082684|NCT01014689|3906374|B3|Belgium||Region of Enrollment||participants|Number|27|27.0||||||
4082685|NCT01014689|3906375|B2|Belgium||Region of Enrollment||participants|Number|13|13.0||||||
4082686|NCT01014689|3906376|B1|Belgium||Region of Enrollment||participants|Number|14|14.0||||||
4082687|NCT01014689|3906374|B3|Poland||Region of Enrollment||participants|Number|32|32.0||||||
4082688|NCT01014689|3906375|B2|Poland||Region of Enrollment||participants|Number|16|16.0||||||
4082689|NCT01014689|3906376|B1|Poland||Region of Enrollment||participants|Number|16|16.0||||||
4082690|NCT01014689|3906374|B3|Brazil||Region of Enrollment||participants|Number|35|35.0||||||
4082691|NCT01014689|3906375|B2|Brazil||Region of Enrollment||participants|Number|17|17.0||||||
4082692|NCT01014689|3906376|B1|Brazil||Region of Enrollment||participants|Number|18|18.0||||||
4082693|NCT01014689|3906374|B3|Mexico||Region of Enrollment||participants|Number|104|104.0||||||
4082694|NCT01014689|3906375|B2|Mexico||Region of Enrollment||participants|Number|52|52.0||||||
4082695|NCT01014689|3906376|B1|Mexico||Region of Enrollment||participants|Number|52|52.0||||||
4082696|NCT01014689|3906374|B3|France||Region of Enrollment||participants|Number|51|51.0||||||
4082697|NCT01014689|3906375|B2|France||Region of Enrollment||participants|Number|25|25.0||||||
4082698|NCT01014689|3906376|B1|France||Region of Enrollment||participants|Number|26|26.0||||||
4082699|NCT01014689|3906374|B3||Male|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4082700|NCT01014689|3906375|B2||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4082701|NCT01014689|3906376|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4082702|NCT01014689|3906374|B3||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4082703|NCT01014689|3906375|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4082704|NCT01014689|3906376|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4082705|NCT01014689|3906374|B3|||Age||years|Mean|18.9|18.9|Standard Deviation|4.6|4.6|||
4082706|NCT01014689|3906375|B2|||Age||years|Mean|19.1|19.1|Standard Deviation|4.6|4.6|||
4082707|NCT01014689|3906376|B1|||Age||years|Mean|18.6|18.6|Standard Deviation|4.7|4.7|||
4082708|NCT01014689|3906374|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4082709|NCT01014689|3906375|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4082710|NCT01014689|3906376|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4082711|NCT01014689|3906374|B3||Between 18 and 65 years|Age||Participants|Count of Participants|163|163.0||||||
4082712|NCT01014689|3906375|B2||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
4082713|NCT01014689|3906376|B1||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
4082714|NCT01014689|3906374|B3||<=18 years|Age||Participants|Count of Participants|215|215.0||||||
4082715|NCT01014689|3906375|B2||<=18 years|Age||Participants|Count of Participants|102|102.0||||||
4082716|NCT01014689|3906376|B1||<=18 years|Age||Participants|Count of Participants|113|113.0||||||
4082717|NCT01014624|3906385|B3|Has diabetes||Diabetes status||participants|Number|22|22.0||0|0.0|0.0|0.0|
4082718|NCT01014624|3906386|B2|Has diabetes||Diabetes status||participants|Number|11|11.0||0|0.0|0.0|0.0|
4082719|NCT01014624|3906387|B1|Has diabetes||Diabetes status||participants|Number|11|11.0||0|0.0|0.0|0.0|
4082720|NCT01014624|3906385|B3|Does not have diabetes||Diabetes status||participants|Number|34|34.0||0|0.0|0.0|0.0|
4082721|NCT01014624|3906386|B2|Does not have diabetes||Diabetes status||participants|Number|16|16.0||0|0.0|0.0|0.0|
4082722|NCT01014624|3906387|B1|Does not have diabetes||Diabetes status||participants|Number|18|18.0||0|0.0|0.0|0.0|
4082723|NCT01014624|3906385|B3|Formerly used alcohol||Alcohol Use||participants|Number|11|11.0||0|0.0|0.0|0.0|
4082724|NCT01014624|3906386|B2|Formerly used alcohol||Alcohol Use||participants|Number|4|4.0||0|0.0|0.0|0.0|
4082725|NCT01014624|3906387|B1|Formerly used alcohol||Alcohol Use||participants|Number|7|7.0||0|0.0|0.0|0.0|
4082726|NCT01014624|3906385|B3|Currently use alcohol||Alcohol Use||participants|Number|37|37.0||0|0.0|0.0|0.0|
4082727|NCT01014624|3906386|B2|Currently use alcohol||Alcohol Use||participants|Number|18|18.0||0|0.0|0.0|0.0|
4082728|NCT01014624|3906387|B1|Currently use alcohol||Alcohol Use||participants|Number|19|19.0||0|0.0|0.0|0.0|
4082729|NCT01014624|3906385|B3|Never used alcohol||Alcohol Use||participants|Number|8|8.0||0|0.0|0.0|0.0|
4082730|NCT01014624|3906386|B2|Never used alcohol||Alcohol Use||participants|Number|5|5.0||0|0.0|0.0|0.0|
4082731|NCT01014624|3906387|B1|Never used alcohol||Alcohol Use||participants|Number|3|3.0||0|0.0|0.0|0.0|
4082732|NCT01014624|3906385|B3|Formerly Smoked||Smoking Status||participants|Number|23|23.0||0|0.0|0.0|0.0|
4082733|NCT01014624|3906386|B2|Formerly Smoked||Smoking Status||participants|Number|11|11.0||0|0.0|0.0|0.0|
4082734|NCT01014624|3906387|B1|Formerly Smoked||Smoking Status||participants|Number|12|12.0||0|0.0|0.0|0.0|
4082735|NCT01014624|3906385|B3|Currently Smoke||Smoking Status||participants|Number|16|16.0||0|0.0|0.0|0.0|
4082736|NCT01014624|3906386|B2|Currently Smoke||Smoking Status||participants|Number|6|6.0||0|0.0|0.0|0.0|
4082737|NCT01014624|3906387|B1|Currently Smoke||Smoking Status||participants|Number|10|10.0||0|0.0|0.0|0.0|
4082738|NCT01014624|3906385|B3|Never smoked||Smoking Status||participants|Number|17|17.0||0|0.0|0.0|0.0|
4082739|NCT01014624|3906386|B2|Never smoked||Smoking Status||participants|Number|10|10.0||0|0.0|0.0|0.0|
4082740|NCT01014624|3906387|B1|Never smoked||Smoking Status||participants|Number|7|7.0||0|0.0|0.0|0.0|
4082741|NCT01014624|3906385|B3|||Body Mass Index||kg/m^2|Mean|31.2|31.2|Standard Deviation|4.76|4.76|0.0|0.0|
4082742|NCT01014624|3906386|B2|||Body Mass Index||kg/m^2|Mean|30.3|30.3|Standard Deviation|5.34|5.34|0.0|0.0|
4082743|NCT01014624|3906387|B1|||Body Mass Index||kg/m^2|Mean|32.0|32.0|Standard Deviation|4.07|4.07|0.0|0.0|
4082744|NCT01014624|3906385|B3|Non Hispanic or Latino||Ethnicity||participants|Number|55|55.0||0|0.0|0.0|0.0|
4082745|NCT01014624|3906386|B2|Non Hispanic or Latino||Ethnicity||participants|Number|27|27.0||0|0.0|0.0|0.0|
4082746|NCT01014624|3906387|B1|Non Hispanic or Latino||Ethnicity||participants|Number|28|28.0||0|0.0|0.0|0.0|
4082747|NCT01014624|3906385|B3|Hispanic or Latino||Ethnicity||participants|Number|1|1.0||0|0.0|0.0|0.0|
4082748|NCT01014624|3906386|B2|Hispanic or Latino||Ethnicity||participants|Number|0|0.0||0|0.0|0.0|0.0|
4082749|NCT01014624|3906387|B1|Hispanic or Latino||Ethnicity||participants|Number|1|1.0||0|0.0|0.0|0.0|
4082750|NCT01014624|3906385|B3|||Height||cm|Mean|173.8|173.8|Standard Deviation|8.52|8.52|0.0|0.0|
4082751|NCT01014624|3906386|B2|||Height||cm|Mean|173.5|173.5|Standard Deviation|9.00|9.0|0.0|0.0|
4082752|NCT01014624|3906387|B1|||Height||cm|Mean|174.1|174.1|Standard Deviation|8.20|8.2|0.0|0.0|
4082753|NCT01014624|3906385|B3|||weight||kg|Mean|94.1|94.1|Standard Deviation|15.02|15.02|0.0|0.0|
4082754|NCT01014624|3906386|B2|||weight||kg|Mean|90.8|90.8|Standard Deviation|14.41|14.41|0.0|0.0|
4082755|NCT01014624|3906387|B1|||weight||kg|Mean|97.3|97.3|Standard Deviation|15.13|15.13|0.0|0.0|
4082756|NCT01014624|3906385|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||0|0.0|0.0|0.0|
4082757|NCT01014624|3906386|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4082758|NCT01014624|3906387|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||0|0.0|0.0|0.0|
4082759|NCT01014624|3906385|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4082760|NCT01014624|3906386|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4082761|NCT01014624|3906387|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4082762|NCT01014624|3906385|B3||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||0|0.0|0.0|0.0|
4082763|NCT01014624|3906386|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||0|0.0|0.0|0.0|
4082764|NCT01014624|3906387|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||0|0.0|0.0|0.0|
4082765|NCT01014624|3906385|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||0|0.0|0.0|0.0|
4082766|NCT01014624|3906386|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||0|0.0|0.0|0.0|
4082767|NCT01014624|3906387|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||0|0.0|0.0|0.0|
4082768|NCT01014624|3906385|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4082769|NCT01014624|3906386|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4082770|NCT01014624|3906387|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4082771|NCT01014624|3906385|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4082772|NCT01014624|3906386|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4082773|NCT01014624|3906387|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4082774|NCT01014624|3906385|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||0|0.0|0.0|0.0|
4082775|NCT01014624|3906386|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4082776|NCT01014624|3906387|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||0|0.0|0.0|0.0|
4082777|NCT01014624|3906385|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4082778|NCT01014624|3906386|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4082779|NCT01014624|3906387|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4082780|NCT01014624|3906385|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||0|0.0|0.0|0.0|
4082781|NCT01014624|3906386|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||0|0.0|0.0|0.0|
4082782|NCT01014624|3906387|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||0|0.0|0.0|0.0|
4082783|NCT01014624|3906385|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||0|0.0|0.0|0.0|
4082784|NCT01014624|3906386|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4082785|NCT01014624|3906387|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||0|0.0|0.0|0.0|
4082786|NCT01014624|3906385|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||0|0.0|0.0|0.0|
4082787|NCT01014624|3906386|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||0|0.0|0.0|0.0|
4082788|NCT01014624|3906387|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||0|0.0|0.0|0.0|
4082789|NCT01014624|3906385|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||0|0.0|0.0|0.0|
4082790|NCT01014624|3906386|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||0|0.0|0.0|0.0|
4082791|NCT01014624|3906387|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||0|0.0|0.0|0.0|
4082792|NCT01014624|3906385|B3|||Age||Years|Mean|59.80|59.8|Standard Deviation|8.56|8.56|0.0|0.0|
4082793|NCT01014624|3906386|B2|||Age||Years|Mean|62.3|62.3|Standard Deviation|8.10|8.1|0.0|0.0|
4082794|NCT01014624|3906387|B1|||Age||Years|Mean|57.5|57.5|Standard Deviation|8.45|8.45|0.0|0.0|
4082795|NCT01014585|3906408|B5|United States||Region of Enrollment||participants|Number|338|338.0||||||
4082796|NCT01014585|3906409|B4|United States||Region of Enrollment||participants|Number|128|128.0||||||
4082797|NCT01014585|3906410|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4082798|NCT01014585|3906411|B2|United States||Region of Enrollment||participants|Number|100|100.0||||||
4082799|NCT01014585|3906412|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4082800|NCT01014585|3906408|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4082801|NCT01014585|3906409|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4082802|NCT01014585|3906410|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4082803|NCT01014585|3906411|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4082804|NCT01014585|3906412|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4082805|NCT01014585|3906408|B5||Female|Sex: Female, Male||Participants|Count of Participants|325|325.0||||||
4082806|NCT01014585|3906409|B4||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4082807|NCT01014585|3906410|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4082808|NCT01014585|3906411|B2||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4082809|NCT01014585|3906412|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4082810|NCT01014585|3906408|B5|>=60 years||Age, Customized||Years|Number|102|102.0||||||
4082811|NCT01014585|3906409|B4|>=60 years||Age, Customized||Years|Number|42|42.0||||||
4082812|NCT01014585|3906410|B3|>=60 years||Age, Customized||Years|Number|22|22.0||||||
4082813|NCT01014585|3906411|B2|>=60 years||Age, Customized||Years|Number|27|27.0||||||
4082814|NCT01014585|3906412|B1|>=60 years||Age, Customized||Years|Number|11|11.0||||||
4082815|NCT01014585|3906408|B5|Between 20 and 60 years||Age, Customized||Years|Number|236|236.0||||||
4082816|NCT01014585|3906409|B4|Between 20 and 60 years||Age, Customized||Years|Number|86|86.0||||||
4082817|NCT01014585|3906410|B3|Between 20 and 60 years||Age, Customized||Years|Number|38|38.0||||||
4082818|NCT01014585|3906411|B2|Between 20 and 60 years||Age, Customized||Years|Number|73|73.0||||||
4082819|NCT01014585|3906412|B1|Between 20 and 60 years||Age, Customized||Years|Number|39|39.0||||||
4082820|NCT01014585|3906408|B5|||Age||years|Mean|54.6|54.6|Standard Deviation|9.2|9.2|||
4082821|NCT01014585|3906409|B4|||Age||years|Mean|54.8|54.8|Standard Deviation|9.4|9.4|||
4082822|NCT01014585|3906410|B3|||Age||years|Mean|54.7|54.7|Standard Deviation|9.6|9.6|||
4082823|NCT01014585|3906411|B2|||Age||years|Mean|54.5|54.5|Standard Deviation|9.3|9.3|||
4082824|NCT01014585|3906412|B1|||Age||years|Mean|54.0|54.0|Standard Deviation|8.3|8.3|||
4082825|NCT01014533|3906433|B3|United States||Region of Enrollment||Participants|Count of Participants|59|59.0||||||
4082826|NCT01014533|3906434|B2|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4082827|NCT01014533|3906435|B1|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
4082828|NCT01014533|3906433|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4082829|NCT01014533|3906434|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4082830|NCT01014533|3906435|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4082831|NCT01014533|3906433|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4082832|NCT01014533|3906434|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4082833|NCT01014533|3906435|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4082834|NCT01014533|3906433|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
4082835|NCT01014533|3906434|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
4082836|NCT01014533|3906435|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
4082837|NCT01014533|3906433|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4082838|NCT01014533|3906434|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4082839|NCT01014533|3906435|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4082840|NCT01014533|3906433|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082841|NCT01014533|3906434|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082842|NCT01014533|3906435|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082843|NCT01014533|3906433|B3||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4082844|NCT01014533|3906434|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4082845|NCT01014533|3906435|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4082846|NCT01014533|3906433|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4082847|NCT01014533|3906434|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4082848|NCT01014533|3906435|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4082849|NCT01014533|3906433|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082850|NCT01014533|3906434|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082851|NCT01014533|3906435|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082852|NCT01014533|3906433|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082853|NCT01014533|3906434|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082854|NCT01014533|3906435|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082855|NCT01014533|3906433|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082856|NCT01014533|3906434|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082857|NCT01014533|3906435|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082858|NCT01014533|3906433|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082859|NCT01014533|3906434|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082860|NCT01014533|3906435|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4082861|NCT01014533|3906433|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4082862|NCT01014533|3906434|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4082863|NCT01014533|3906435|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4082864|NCT01014533|3906433|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4082865|NCT01014533|3906434|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4082866|NCT01014533|3906435|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4082867|NCT01014533|3906433|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4082868|NCT01014533|3906434|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4082869|NCT01014533|3906435|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4082870|NCT01014533|3906433|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4082871|NCT01014533|3906434|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4082872|NCT01014533|3906435|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4082873|NCT01014533|3906433|B3|||Age||years|Mean|36.0|36.0|Standard Deviation|10.8|10.8|||
4082874|NCT01014533|3906434|B2|||Age||years|Mean|37.0|37.0|Standard Deviation|8.9|8.9|||
4082875|NCT01014533|3906435|B1|||Age||years|Mean|34.9|34.9|Standard Deviation|12.5|12.5|||
4082876|NCT01014455|3906446|B3|United States||Region of Enrollment||participants|Number|169|169.0||||||
4082877|NCT01014455|3906447|B2|United States||Region of Enrollment||participants|Number|87|87.0||||||
4082878|NCT01014455|3906448|B1|United States||Region of Enrollment||participants|Number|82|82.0||||||
4082879|NCT01014455|3906446|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4082880|NCT01014455|3906447|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4082881|NCT01014455|3906448|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4082882|NCT01014455|3906446|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4082883|NCT01014455|3906447|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4082884|NCT01014455|3906448|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4082885|NCT01014455|3906446|B3|||Age||years|Mean|53|53.0|Standard Deviation|12|12.0|||
4082886|NCT01014455|3906447|B2|||Age||years|Mean|53|53.0|Standard Deviation|12|12.0|||
4082887|NCT01014455|3906448|B1|||Age||years|Mean|53|53.0|Standard Deviation|12|12.0|||
4082888|NCT01014455|3906446|B3||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
4082889|NCT01014455|3906447|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4082890|NCT01014455|3906448|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4082891|NCT01014455|3906446|B3||Between 18 and 65 years|Age||Participants|Count of Participants|136|136.0||||||
4082892|NCT01014455|3906447|B2||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4082893|NCT01014455|3906448|B1||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4082894|NCT01014455|3906446|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4082895|NCT01014455|3906447|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4082896|NCT01014455|3906448|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4082897|NCT01014442|3906455|B3||Male|Gender||Participants|Count of Participants|41|41.0||||||
4082898|NCT01014442|3906456|B2||Male|Gender||Participants|Count of Participants|21|21.0||||||
4082899|NCT01014442|3906457|B1||Male|Gender||Participants|Count of Participants|20|20.0||||||
4082900|NCT01014442|3906455|B3||Female|Gender||Participants|Count of Participants|27|27.0||||||
4082901|NCT01014442|3906456|B2||Female|Gender||Participants|Count of Participants|14|14.0||||||
4082902|NCT01014442|3906457|B1||Female|Gender||Participants|Count of Participants|13|13.0||||||
4082903|NCT01014442|3906455|B3|||Age||years|Mean|43.1|43.1|Standard Deviation|13.86|13.86|||
4082904|NCT01014442|3906456|B2|||Age||years|Mean|54.3|54.3|Standard Deviation|7.93|7.93|||
4082905|NCT01014442|3906457|B1|||Age||years|Mean|31.3|31.3|Standard Deviation|7.42|7.42|||
4082906|NCT01014351|3906570|B1|United States||Region of Enrollment||participants|Number|70|70.0||||||
4082907|NCT01014351|3906570|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4082908|NCT01014351|3906570|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4082909|NCT01014351|3906570|B1||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4082910|NCT01014351|3906570|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4082911|NCT01014351|3906570|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4082912|NCT01014351|3906570|B1|||Age||years|Median|63|63.0|Full Range|||29.0|82.0|
4082913|NCT01014208|3906576|B3|Early relapsers/Refractory||Number of participants in the indicated categories per best response to first-line treatment|Late relapsers are those participants with a complete response (CR: complete disappearance of all detectable clinical evidence of disease/disease-related symptoms) following first line treatment which lasts >12 months from diagnosis. Early relapsers/refractory are those participants with a CR <= 12 months, PR (>=50% decrease from Baseline in the sum of the product of the diameters of target lesions), SD (failure to attain CR or PR; no fulfillment of PD), or PD (disease that has grown or spread) after first-line treatment.|Participants|Number|316|316.0||||||
4082914|NCT01014208|3906577|B2|Early relapsers/Refractory||Number of participants in the indicated categories per best response to first-line treatment|Late relapsers are those participants with a complete response (CR: complete disappearance of all detectable clinical evidence of disease/disease-related symptoms) following first line treatment which lasts >12 months from diagnosis. Early relapsers/refractory are those participants with a CR <= 12 months, PR (>=50% decrease from Baseline in the sum of the product of the diameters of target lesions), SD (failure to attain CR or PR; no fulfillment of PD), or PD (disease that has grown or spread) after first-line treatment.|Participants|Number|159|159.0||||||
4082934|NCT01014208|3906576|B3|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4082935|NCT01014208|3906577|B2|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4082936|NCT01014208|3906578|B1|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4082937|NCT01014208|3906576|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4082915|NCT01014208|3906578|B1|Early relapsers/Refractory||Number of participants in the indicated categories per best response to first-line treatment|Late relapsers are those participants with a complete response (CR: complete disappearance of all detectable clinical evidence of disease/disease-related symptoms) following first line treatment which lasts >12 months from diagnosis. Early relapsers/refractory are those participants with a CR <= 12 months, PR (>=50% decrease from Baseline in the sum of the product of the diameters of target lesions), SD (failure to attain CR or PR; no fulfillment of PD), or PD (disease that has grown or spread) after first-line treatment.|Participants|Number|157|157.0||||||
4082916|NCT01014208|3906576|B3|Late relapsers||Number of participants in the indicated categories per best response to first-line treatment|Late relapsers are those participants with a complete response (CR: complete disappearance of all detectable clinical evidence of disease/disease-related symptoms) following first line treatment which lasts >12 months from diagnosis. Early relapsers/refractory are those participants with a CR <= 12 months, PR (>=50% decrease from Baseline in the sum of the product of the diameters of target lesions), SD (failure to attain CR or PR; no fulfillment of PD), or PD (disease that has grown or spread) after first-line treatment.|Participants|Number|129|129.0||||||
4082917|NCT01014208|3906577|B2|Late relapsers||Number of participants in the indicated categories per best response to first-line treatment|Late relapsers are those participants with a complete response (CR: complete disappearance of all detectable clinical evidence of disease/disease-related symptoms) following first line treatment which lasts >12 months from diagnosis. Early relapsers/refractory are those participants with a CR <= 12 months, PR (>=50% decrease from Baseline in the sum of the product of the diameters of target lesions), SD (failure to attain CR or PR; no fulfillment of PD), or PD (disease that has grown or spread) after first-line treatment.|Participants|Number|63|63.0||||||
4082918|NCT01014208|3906578|B1|Late relapsers||Number of participants in the indicated categories per best response to first-line treatment|Late relapsers are those participants with a complete response (CR: complete disappearance of all detectable clinical evidence of disease/disease-related symptoms) following first line treatment which lasts >12 months from diagnosis. Early relapsers/refractory are those participants with a CR <= 12 months, PR (>=50% decrease from Baseline in the sum of the product of the diameters of target lesions), SD (failure to attain CR or PR; no fulfillment of PD), or PD (disease that has grown or spread) after first-line treatment.|Participants|Number|66|66.0||||||
4082919|NCT01014208|3906576|B3|2 or 3||Number of participants with the indicated SaaIPI scores|The secondary age adjusted international prognostic index (SaaIPI) is assessed according to the absence or presence of 3 risk factors (RFs) at the start of Screening: Eastern Cooperative Oncology Group performance status greater than 1, lactate dehydrogenase level greater than the upper level of normal, and Ann Arbor stage II or IV disease. The presence of 0, 1, or more than 1 RFs corresponds to a SaaIPI score reflecting low, intermediate, and high risk of disease progression.|Participants|Number|176|176.0||||||
4082920|NCT01014208|3906577|B2|2 or 3||Number of participants with the indicated SaaIPI scores|The secondary age adjusted international prognostic index (SaaIPI) is assessed according to the absence or presence of 3 risk factors (RFs) at the start of Screening: Eastern Cooperative Oncology Group performance status greater than 1, lactate dehydrogenase level greater than the upper level of normal, and Ann Arbor stage II or IV disease. The presence of 0, 1, or more than 1 RFs corresponds to a SaaIPI score reflecting low, intermediate, and high risk of disease progression.|Participants|Number|89|89.0||||||
4082921|NCT01014208|3906578|B1|2 or 3||Number of participants with the indicated SaaIPI scores|The secondary age adjusted international prognostic index (SaaIPI) is assessed according to the absence or presence of 3 risk factors (RFs) at the start of Screening: Eastern Cooperative Oncology Group performance status greater than 1, lactate dehydrogenase level greater than the upper level of normal, and Ann Arbor stage II or IV disease. The presence of 0, 1, or more than 1 RFs corresponds to a SaaIPI score reflecting low, intermediate, and high risk of disease progression.|Participants|Number|87|87.0||||||
4082922|NCT01014208|3906576|B3|0 or 1||Number of participants with the indicated SaaIPI scores|The secondary age adjusted international prognostic index (SaaIPI) is assessed according to the absence or presence of 3 risk factors (RFs) at the start of Screening: Eastern Cooperative Oncology Group performance status greater than 1, lactate dehydrogenase level greater than the upper level of normal, and Ann Arbor stage II or IV disease. The presence of 0, 1, or more than 1 RFs corresponds to a SaaIPI score reflecting low, intermediate, and high risk of disease progression.|Participants|Number|269|269.0||||||
4082923|NCT01014208|3906577|B2|0 or 1||Number of participants with the indicated SaaIPI scores|The secondary age adjusted international prognostic index (SaaIPI) is assessed according to the absence or presence of 3 risk factors (RFs) at the start of Screening: Eastern Cooperative Oncology Group performance status greater than 1, lactate dehydrogenase level greater than the upper level of normal, and Ann Arbor stage II or IV disease. The presence of 0, 1, or more than 1 RFs corresponds to a SaaIPI score reflecting low, intermediate, and high risk of disease progression.|Participants|Number|133|133.0||||||
4082924|NCT01014208|3906578|B1|0 or 1||Number of participants with the indicated SaaIPI scores|The secondary age adjusted international prognostic index (SaaIPI) is assessed according to the absence or presence of 3 risk factors (RFs) at the start of Screening: Eastern Cooperative Oncology Group performance status greater than 1, lactate dehydrogenase level greater than the upper level of normal, and Ann Arbor stage II or IV disease. The presence of 0, 1, or more than 1 RFs corresponds to a SaaIPI score reflecting low, intermediate, and high risk of disease progression.|Participants|Number|136|136.0||||||
4082925|NCT01014208|3906576|B3|Missing||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4082926|NCT01014208|3906577|B2|Missing||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4082927|NCT01014208|3906578|B1|Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4082928|NCT01014208|3906576|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|319|319.0||||||
4082929|NCT01014208|3906577|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|151|151.0||||||
4082930|NCT01014208|3906578|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|168|168.0||||||
4082931|NCT01014208|3906576|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4082932|NCT01014208|3906577|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4082933|NCT01014208|3906578|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4082938|NCT01014208|3906577|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4082939|NCT01014208|3906578|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4082940|NCT01014208|3906576|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|41|41.0||||||
4082941|NCT01014208|3906577|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4082942|NCT01014208|3906578|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4082943|NCT01014208|3906576|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|55|55.0||||||
4082944|NCT01014208|3906577|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|31|31.0||||||
4082945|NCT01014208|3906578|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
4082946|NCT01014208|3906576|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4082947|NCT01014208|3906577|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4082948|NCT01014208|3906578|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4082949|NCT01014208|3906576|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4082950|NCT01014208|3906577|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4082951|NCT01014208|3906578|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4082952|NCT01014208|3906576|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4082953|NCT01014208|3906577|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4082954|NCT01014208|3906578|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4082955|NCT01014208|3906576|B3||Male|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
4082956|NCT01014208|3906577|B2||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4082957|NCT01014208|3906578|B1||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4082958|NCT01014208|3906576|B3||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4082959|NCT01014208|3906577|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4082960|NCT01014208|3906578|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4082961|NCT01014208|3906576|B3|||Age||Years|Mean|54.3|54.3|Standard Deviation|11.55|11.55|||
4082962|NCT01014208|3906577|B2|||Age||Years|Mean|55.2|55.2|Standard Deviation|10.80|10.8|||
4082963|NCT01014208|3906578|B1|||Age||Years|Mean|53.4|53.4|Standard Deviation|12.22|12.22|||
4082964|NCT01014169|3906605|B3|Patients Seen By Nurse Practitioner # 3||Nurse Practitioner||participants|Number|12|12.0||||||
4082965|NCT01014169|3906606|B2|Patients Seen By Nurse Practitioner # 3||Nurse Practitioner||participants|Number|5|5.0||||||
4082966|NCT01014169|3906607|B1|Patients Seen By Nurse Practitioner # 3||Nurse Practitioner||participants|Number|7|7.0||||||
4082967|NCT01014169|3906605|B3|Patients Seen By Nurse Practitioner # 2||Nurse Practitioner||participants|Number|43|43.0||||||
4082968|NCT01014169|3906606|B2|Patients Seen By Nurse Practitioner # 2||Nurse Practitioner||participants|Number|22|22.0||||||
4082969|NCT01014169|3906607|B1|Patients Seen By Nurse Practitioner # 2||Nurse Practitioner||participants|Number|21|21.0||||||
4082970|NCT01014169|3906605|B3|Patients Seen By Nurse Practitioner # 1||Nurse Practitioner||participants|Number|71|71.0||||||
4082971|NCT01014169|3906606|B2|Patients Seen By Nurse Practitioner # 1||Nurse Practitioner||participants|Number|34|34.0||||||
4082972|NCT01014169|3906607|B1|Patients Seen By Nurse Practitioner # 1||Nurse Practitioner||participants|Number|37|37.0||||||
4082973|NCT01014169|3906605|B3|Other adult||Other Adults in the Home||participants|Number|4|4.0||||||
4082974|NCT01014169|3906606|B2|Other adult||Other Adults in the Home||participants|Number|2|2.0||||||
4082975|NCT01014169|3906607|B1|Other adult||Other Adults in the Home||participants|Number|2|2.0||||||
4082976|NCT01014169|3906605|B3|Baby's uncles or aunts||Other Adults in the Home||participants|Number|28|28.0||||||
4082977|NCT01014169|3906606|B2|Baby's uncles or aunts||Other Adults in the Home||participants|Number|11|11.0||||||
4082978|NCT01014169|3906607|B1|Baby's uncles or aunts||Other Adults in the Home||participants|Number|17|17.0||||||
4082979|NCT01014169|3906605|B3|Baby's grandfather||Other Adults in the Home||participants|Number|10|10.0||||||
4082980|NCT01014169|3906606|B2|Baby's grandfather||Other Adults in the Home||participants|Number|4|4.0||||||
4082981|NCT01014169|3906607|B1|Baby's grandfather||Other Adults in the Home||participants|Number|6|6.0||||||
4082982|NCT01014169|3906605|B3|Baby's grandmother||Other Adults in the Home||participants|Number|22|22.0||||||
4082983|NCT01014169|3906606|B2|Baby's grandmother||Other Adults in the Home||participants|Number|12|12.0||||||
4082984|NCT01014169|3906607|B1|Baby's grandmother||Other Adults in the Home||participants|Number|10|10.0||||||
4082985|NCT01014169|3906605|B3|Spouse/partner||Other Adults in the Home||participants|Number|87|87.0||||||
4082986|NCT01014169|3906606|B2|Spouse/partner||Other Adults in the Home||participants|Number|44|44.0||||||
4082987|NCT01014169|3906607|B1|Spouse/partner||Other Adults in the Home||participants|Number|43|43.0||||||
4082988|NCT01014169|3906605|B3|No other adult in home||Other Adults in the Home||participants|Number|17|17.0||||||
4082989|NCT01014169|3906606|B2|No other adult in home||Other Adults in the Home||participants|Number|8|8.0||||||
4082990|NCT01014169|3906607|B1|No other adult in home||Other Adults in the Home||participants|Number|9|9.0||||||
4082991|NCT01014169|3906605|B3|No||Attended Childbirth Classes||participants|Number|104|104.0||||||
4082992|NCT01014169|3906606|B2|No||Attended Childbirth Classes||participants|Number|49|49.0||||||
4082993|NCT01014169|3906607|B1|No||Attended Childbirth Classes||participants|Number|55|55.0||||||
4082994|NCT01014169|3906605|B3|Yes||Attended Childbirth Classes||participants|Number|22|22.0||||||
4082995|NCT01014169|3906606|B2|Yes||Attended Childbirth Classes||participants|Number|12|12.0||||||
4082996|NCT01014169|3906607|B1|Yes||Attended Childbirth Classes||participants|Number|10|10.0||||||
4082997|NCT01014169|3906605|B3|No||Received prenatal care||participants|Number|0|0.0||||||
4082998|NCT01014169|3906606|B2|No||Received prenatal care||participants|Number|0|0.0||||||
4082999|NCT01014169|3906607|B1|No||Received prenatal care||participants|Number|0|0.0||||||
4083000|NCT01014169|3906605|B3|Yes||Received prenatal care||participants|Number|126|126.0||||||
4083001|NCT01014169|3906606|B2|Yes||Received prenatal care||participants|Number|61|61.0||||||
4083002|NCT01014169|3906607|B1|Yes||Received prenatal care||participants|Number|65|65.0||||||
4083003|NCT01014169|3906605|B3|Graduate/professional degree||Highest Education Level||participants|Number|9|9.0||||||
4083004|NCT01014169|3906606|B2|Graduate/professional degree||Highest Education Level||participants|Number|5|5.0||||||
4083005|NCT01014169|3906607|B1|Graduate/professional degree||Highest Education Level||participants|Number|4|4.0||||||
4083006|NCT01014169|3906605|B3|Bachelors degree||Highest Education Level||participants|Number|14|14.0||||||
4083007|NCT01014169|3906606|B2|Bachelors degree||Highest Education Level||participants|Number|7|7.0||||||
4083008|NCT01014169|3906607|B1|Bachelors degree||Highest Education Level||participants|Number|7|7.0||||||
4083009|NCT01014169|3906605|B3|Associates degree||Highest Education Level||participants|Number|6|6.0||||||
4083010|NCT01014169|3906606|B2|Associates degree||Highest Education Level||participants|Number|1|1.0||||||
4083011|NCT01014169|3906607|B1|Associates degree||Highest Education Level||participants|Number|5|5.0||||||
4083012|NCT01014169|3906605|B3|Some college||Highest Education Level||participants|Number|20|20.0||||||
4083013|NCT01014169|3906606|B2|Some college||Highest Education Level||participants|Number|11|11.0||||||
4083014|NCT01014169|3906607|B1|Some college||Highest Education Level||participants|Number|9|9.0||||||
4083015|NCT01014169|3906605|B3|Vocational/trade school||Highest Education Level||participants|Number|3|3.0||||||
4083016|NCT01014169|3906606|B2|Vocational/trade school||Highest Education Level||participants|Number|2|2.0||||||
4083017|NCT01014169|3906607|B1|Vocational/trade school||Highest Education Level||participants|Number|1|1.0||||||
4083018|NCT01014169|3906605|B3|High school graduate||Highest Education Level||participants|Number|36|36.0||||||
4083019|NCT01014169|3906606|B2|High school graduate||Highest Education Level||participants|Number|21|21.0||||||
4083020|NCT01014169|3906607|B1|High school graduate||Highest Education Level||participants|Number|15|15.0||||||
4083021|NCT01014169|3906605|B3|Less than/some high school||Highest Education Level||participants|Number|38|38.0||||||
4083022|NCT01014169|3906606|B2|Less than/some high school||Highest Education Level||participants|Number|14|14.0||||||
4083023|NCT01014169|3906607|B1|Less than/some high school||Highest Education Level||participants|Number|24|24.0||||||
4083024|NCT01014169|3906605|B3|None||Type of Insurance||participants|Number|2|2.0||||||
4083025|NCT01014169|3906606|B2|None||Type of Insurance||participants|Number|1|1.0||||||
4083026|NCT01014169|3906607|B1|None||Type of Insurance||participants|Number|1|1.0||||||
4083027|NCT01014169|3906605|B3|Private||Type of Insurance||participants|Number|18|18.0||||||
4083028|NCT01014169|3906606|B2|Private||Type of Insurance||participants|Number|11|11.0||||||
4083029|NCT01014169|3906607|B1|Private||Type of Insurance||participants|Number|7|7.0||||||
4083030|NCT01014169|3906605|B3|Free Care||Type of Insurance||participants|Number|8|8.0||||||
4083031|NCT01014169|3906606|B2|Free Care||Type of Insurance||participants|Number|3|3.0||||||
4083032|NCT01014169|3906607|B1|Free Care||Type of Insurance||participants|Number|5|5.0||||||
4083033|NCT01014169|3906605|B3|Medicaid||Type of Insurance||participants|Number|98|98.0||||||
4083034|NCT01014169|3906606|B2|Medicaid||Type of Insurance||participants|Number|46|46.0||||||
4083035|NCT01014169|3906607|B1|Medicaid||Type of Insurance||participants|Number|52|52.0||||||
4083036|NCT01014169|3906605|B3|Cesarean section||Type of delivery||participants|Number|34|34.0||||||
4083037|NCT01014169|3906606|B2|Cesarean section||Type of delivery||participants|Number|15|15.0||||||
4083038|NCT01014169|3906607|B1|Cesarean section||Type of delivery||participants|Number|19|19.0||||||
4083039|NCT01014169|3906605|B3|Vaginal||Type of delivery||participants|Number|92|92.0||||||
4083040|NCT01014169|3906606|B2|Vaginal||Type of delivery||participants|Number|46|46.0||||||
4083041|NCT01014169|3906607|B1|Vaginal||Type of delivery||participants|Number|46|46.0||||||
4083042|NCT01014169|3906605|B3|||Number of Children||Children|Median|2|2.0|Inter-Quartile Range|||2.0|2.0|
4083043|NCT01014169|3906606|B2|||Number of Children||Children|Median|2|2.0|Inter-Quartile Range|||1.0|2.0|
4083044|NCT01014169|3906607|B1|||Number of Children||Children|Median|2|2.0|Inter-Quartile Range|||2.0|2.0|
4083045|NCT01014169|3906605|B3|||Number of pregnancies||Pregnancies|Median|2|2.0|Inter-Quartile Range|||2.0|2.0|
4083046|NCT01014169|3906606|B2|||Number of pregnancies||Pregnancies|Median|2|2.0|Inter-Quartile Range|||2.0|2.0|
4083047|NCT01014169|3906607|B1|||Number of pregnancies||Pregnancies|Median|2|2.0|Inter-Quartile Range|||2.0|2.0|
4083048|NCT01014169|3906605|B3|Spanish||Language||participants|Number|53|53.0||||||
4083049|NCT01014169|3906606|B2|Spanish||Language||participants|Number|25|25.0||||||
4083050|NCT01014169|3906607|B1|Spanish||Language||participants|Number|28|28.0||||||
4083051|NCT01014169|3906605|B3|English||Language||participants|Number|73|73.0||||||
4083052|NCT01014169|3906606|B2|English||Language||participants|Number|36|36.0||||||
4083053|NCT01014169|3906607|B1|English||Language||participants|Number|37|37.0||||||
4083054|NCT01014169|3906605|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083055|NCT01014169|3906606|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083056|NCT01014169|3906607|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083057|NCT01014169|3906605|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4083058|NCT01014169|3906606|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4083059|NCT01014169|3906607|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4083060|NCT01014169|3906605|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4083061|NCT01014169|3906606|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4083062|NCT01014169|3906607|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4083063|NCT01014169|3906605|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4083064|NCT01014169|3906606|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4083065|NCT01014169|3906607|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4083066|NCT01014169|3906605|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083067|NCT01014169|3906606|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083068|NCT01014169|3906607|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083069|NCT01014169|3906605|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4083070|NCT01014169|3906606|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4083071|NCT01014169|3906607|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4083072|NCT01014169|3906605|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083073|NCT01014169|3906606|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083074|NCT01014169|3906607|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083075|NCT01014169|3906605|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083076|NCT01014169|3906606|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083077|NCT01014169|3906607|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083078|NCT01014169|3906605|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4083079|NCT01014169|3906606|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4083080|NCT01014169|3906607|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4083081|NCT01014169|3906605|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4083082|NCT01014169|3906606|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4083083|NCT01014169|3906607|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4083084|NCT01014169|3906605|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4083085|NCT01014169|3906606|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4083086|NCT01014169|3906607|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4083087|NCT01014169|3906605|B3||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4083088|NCT01014169|3906606|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4083089|NCT01014169|3906607|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4083090|NCT01014169|3906605|B3|||Age||years|Mean|28.3|28.3|Standard Deviation|6.4|6.4|||
4083091|NCT01014169|3906606|B2|||Age||years|Mean|28.9|28.9|Standard Deviation|6.4|6.4|||
4083092|NCT01014169|3906607|B1|||Age||years|Mean|27.8|27.8|Standard Deviation|6.5|6.5|||
4083093|NCT01014143|3906618|B4|United States||Region of Enrollment||participants|Number|28|28.0||||||
4083094|NCT01014143|3906619|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4083095|NCT01014143|3906620|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4083096|NCT01014143|3906621|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4083097|NCT01014143|3906618|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4083098|NCT01014143|3906619|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4083099|NCT01014143|3906620|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4083100|NCT01014143|3906621|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4083101|NCT01014143|3906618|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4083102|NCT01014143|3906619|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4083103|NCT01014143|3906620|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4083104|NCT01014143|3906621|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4083105|NCT01014143|3906618|B4|||Age||years|Mean|44.5|44.5|Standard Deviation|11.7|11.7|||
4083106|NCT01014143|3906619|B3|||Age||years|Mean|47.2|47.2|Standard Deviation|9.6|9.6|||
4083107|NCT01014143|3906620|B2|||Age||years|Mean|39|39.0|Standard Deviation|9.2|9.2|||
4083108|NCT01014143|3906621|B1|||Age||years|Mean|47.6|47.6|Standard Deviation|15.1|15.1|||
4083109|NCT01014143|3906618|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4083110|NCT01014143|3906619|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4083111|NCT01014143|3906620|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4083112|NCT01014143|3906621|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4083113|NCT01014143|3906618|B4||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4083114|NCT01014143|3906619|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4083115|NCT01014143|3906620|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4083116|NCT01014143|3906621|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4083117|NCT01014143|3906618|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4083118|NCT01014143|3906619|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4083119|NCT01014143|3906620|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4083120|NCT01014143|3906621|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4083121|NCT01014091|3906631|B7||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4083122|NCT01014091|3906632|B6||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4083123|NCT01014091|3906633|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4083124|NCT01014091|3906634|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4083125|NCT01014091|3906635|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4083126|NCT01014091|3906636|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4083127|NCT01014091|3906637|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4083128|NCT01014091|3906631|B7||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4083129|NCT01014091|3906632|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4083130|NCT01014091|3906633|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4083131|NCT01014091|3906634|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4083132|NCT01014091|3906635|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4083133|NCT01014091|3906636|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4083134|NCT01014091|3906637|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4083135|NCT01014091|3906631|B7|||Age||Years|Mean|6.36|6.36|Standard Deviation|1.90|1.9|||
4083136|NCT01014091|3906632|B6|||Age||Years|Mean|7.6|7.6|Standard Deviation|0.9|0.9|||
4083137|NCT01014091|3906633|B5|||Age||Years|Mean|3.8|3.8|Standard Deviation|0.98|0.98|||
4083138|NCT01014091|3906634|B4|||Age||Years|Mean|7.3|7.3|Standard Deviation|0.9|0.9|||
4083139|NCT01014091|3906635|B3|||Age||Years|Mean|3.8|3.8|Standard Deviation|0.84|0.84|||
4083140|NCT01014091|3906636|B2|||Age||Years|Mean|7.5|7.5|Standard Deviation|1.2|1.2|||
4083141|NCT01014091|3906637|B1|||Age||Years|Mean|4.1|4.1|Standard Deviation|0.9|0.9|||
4083142|NCT01014013|3906716|B3|||Duration of Symptoms(Days)|The duration of clinical symptoms prior to study entry|Days|Mean|4.4|4.4|Standard Deviation|5.6|5.6|||
4083143|NCT01014013|3906717|B2|||Duration of Symptoms(Days)|The duration of clinical symptoms prior to study entry|Days|Mean|4.7|4.7|Standard Deviation|6.4|6.4|||
4083144|NCT01014013|3906718|B1|||Duration of Symptoms(Days)|The duration of clinical symptoms prior to study entry|Days|Mean|4.1|4.1|Standard Deviation|4.6|4.6|||
4083145|NCT01014013|3906716|B3|Other complicated urinary tract infection||Stratum|Patients have enrolled who have complicated urinary tract infection with or without acute pyelonephritis|participants|Number|61|61.0||||||
4083146|NCT01014013|3906717|B2|Other complicated urinary tract infection||Stratum|Patients have enrolled who have complicated urinary tract infection with or without acute pyelonephritis|participants|Number|29|29.0||||||
4083147|NCT01014013|3906718|B1|Other complicated urinary tract infection||Stratum|Patients have enrolled who have complicated urinary tract infection with or without acute pyelonephritis|participants|Number|32|32.0||||||
4083148|NCT01014013|3906716|B3|Acute pyelonephritis||Stratum|Patients have enrolled who have complicated urinary tract infection with or without acute pyelonephritis|participants|Number|210|210.0||||||
4083149|NCT01014013|3906717|B2|Acute pyelonephritis||Stratum|Patients have enrolled who have complicated urinary tract infection with or without acute pyelonephritis|participants|Number|107|107.0||||||
4083150|NCT01014013|3906718|B1|Acute pyelonephritis||Stratum|Patients have enrolled who have complicated urinary tract infection with or without acute pyelonephritis|participants|Number|103|103.0||||||
4083151|NCT01014013|3906716|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4083152|NCT01014013|3906717|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4083153|NCT01014013|3906718|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4083154|NCT01014013|3906716|B3||Female|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4083155|NCT01014013|3906717|B2||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4083156|NCT01014013|3906718|B1||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4083157|NCT01014013|3906716|B3|||Age||years|Mean|55.9|55.9|Standard Deviation|18.5|18.5|||
4083158|NCT01014013|3906717|B2|||Age||years|Mean|56.5|56.5|Standard Deviation|17.6|17.6|||
4083159|NCT01014013|3906718|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|19.5|19.5|||
4083160|NCT01013961|3906729|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4083161|NCT01013961|3906730|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4083162|NCT01013961|3906731|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4083163|NCT01013961|3906729|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4083164|NCT01013961|3906730|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4083165|NCT01013961|3906731|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4083166|NCT01013961|3906729|B3|||Age||years|Median|76|76.0|Full Range|||67.0|92.0|
4083167|NCT01013961|3906730|B2|||Age||years|Median|76|76.0|Full Range|||72.0|83.0|
4083168|NCT01013961|3906731|B1|||Age||years|Median|77|77.0|Full Range|||67.0|92.0|
4083169|NCT01013883|3906748|B3|United Kingdom||Region of Enrollment||participants|Number|509|509.0||||||
4083170|NCT01013883|3906749|B2|United Kingdom||Region of Enrollment||participants|Number|241|241.0||||||
4083171|NCT01013883|3906750|B1|United Kingdom||Region of Enrollment||participants|Number|268|268.0||||||
4083172|NCT01013883|3906748|B3||Male|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
4083173|NCT01013883|3906749|B2||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4083174|NCT01013883|3906750|B1||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4083175|NCT01013883|3906748|B3||Female|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
4083176|NCT01013883|3906749|B2||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4083177|NCT01013883|3906750|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4083178|NCT01013883|3906748|B3|||Age||years|Mean|76|76.0|Standard Deviation|10|10.0|||
4083179|NCT01013883|3906749|B2|||Age||years|Mean|78|78.0|Standard Deviation|8|8.0|||
4083180|NCT01013883|3906750|B1|||Age||years|Mean|74|74.0|Standard Deviation|10|10.0|||
4083181|NCT01013883|3906748|B3||>=65 years|Age||Participants|Count of Participants|439|439.0||||||
4083182|NCT01013883|3906749|B2||>=65 years|Age||Participants|Count of Participants|220|220.0||||||
4083183|NCT01013883|3906750|B1||>=65 years|Age||Participants|Count of Participants|219|219.0||||||
4083184|NCT01013883|3906748|B3||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4083185|NCT01013883|3906749|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4083186|NCT01013883|3906750|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4083187|NCT01013883|3906748|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4083188|NCT01013883|3906749|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4083189|NCT01013883|3906750|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4083190|NCT01013870|3906761|B3|||Injury Severity Score|ISS is a score that describes the overall injury severity and was determined at presentation to the hospital. There are 9 body regions where the injury severity is assessed on a scale from 1-6, with a higher score indicating a more severe injury. Is all body region scores are < 6, then the ISS is calculated by summing the square of the 3 highest region scores. If any of the body region scores is 6 (unsurvivable) then the ISS is set to 75. The ISS score ranges from 1-75.|units on a scale|Mean|3.6|3.6|Standard Deviation|1.9|1.9|||
4083191|NCT01013870|3906762|B2|||Injury Severity Score|ISS is a score that describes the overall injury severity and was determined at presentation to the hospital. There are 9 body regions where the injury severity is assessed on a scale from 1-6, with a higher score indicating a more severe injury. Is all body region scores are < 6, then the ISS is calculated by summing the square of the 3 highest region scores. If any of the body region scores is 6 (unsurvivable) then the ISS is set to 75. The ISS score ranges from 1-75.|units on a scale|Mean|3.5|3.5|Standard Deviation|1.9|1.9|||
4083192|NCT01013870|3906763|B1|||Injury Severity Score|ISS is a score that describes the overall injury severity and was determined at presentation to the hospital. There are 9 body regions where the injury severity is assessed on a scale from 1-6, with a higher score indicating a more severe injury. Is all body region scores are < 6, then the ISS is calculated by summing the square of the 3 highest region scores. If any of the body region scores is 6 (unsurvivable) then the ISS is set to 75. The ISS score ranges from 1-75.|units on a scale|Mean|3.6|3.6|Standard Deviation|2.0|2.0|||
4083193|NCT01013870|3906761|B3|2||Head Abbreviated Injury Score|The head component of the Abbreviated Injury Score describes the severity of a head injury. The score ranges from 1-6, with a higher score indicating a more severe injury. Patients were excluded from this study if any component AIS was greater than 2.|participants|Number|20|20.0||||||
4083194|NCT01013870|3906762|B2|2||Head Abbreviated Injury Score|The head component of the Abbreviated Injury Score describes the severity of a head injury. The score ranges from 1-6, with a higher score indicating a more severe injury. Patients were excluded from this study if any component AIS was greater than 2.|participants|Number|8|8.0||||||
4083195|NCT01013870|3906763|B1|2||Head Abbreviated Injury Score|The head component of the Abbreviated Injury Score describes the severity of a head injury. The score ranges from 1-6, with a higher score indicating a more severe injury. Patients were excluded from this study if any component AIS was greater than 2.|participants|Number|12|12.0||||||
4083196|NCT01013870|3906761|B3|1||Head Abbreviated Injury Score|The head component of the Abbreviated Injury Score describes the severity of a head injury. The score ranges from 1-6, with a higher score indicating a more severe injury. Patients were excluded from this study if any component AIS was greater than 2.|participants|Number|32|32.0||||||
4083197|NCT01013870|3906762|B2|1||Head Abbreviated Injury Score|The head component of the Abbreviated Injury Score describes the severity of a head injury. The score ranges from 1-6, with a higher score indicating a more severe injury. Patients were excluded from this study if any component AIS was greater than 2.|participants|Number|16|16.0||||||
4083198|NCT01013870|3906763|B1|1||Head Abbreviated Injury Score|The head component of the Abbreviated Injury Score describes the severity of a head injury. The score ranges from 1-6, with a higher score indicating a more severe injury. Patients were excluded from this study if any component AIS was greater than 2.|participants|Number|16|16.0||||||
4083199|NCT01013870|3906761|B3|14||Glasgow Coma Scale Score|GCS was obtained in the emergency room on presentation as an assessment of neurological status. The score has 3 components: eye opening (1-4), verbal response (1-5), and motor response (1-6). The components are summed for a score that ranges from 3-15. Normal GCS is 15, less than 15 indicates some abnormality.|participants|Number|2|2.0||||||
4083200|NCT01013870|3906762|B2|14||Glasgow Coma Scale Score|GCS was obtained in the emergency room on presentation as an assessment of neurological status. The score has 3 components: eye opening (1-4), verbal response (1-5), and motor response (1-6). The components are summed for a score that ranges from 3-15. Normal GCS is 15, less than 15 indicates some abnormality.|participants|Number|1|1.0||||||
4083201|NCT01013870|3906763|B1|14||Glasgow Coma Scale Score|GCS was obtained in the emergency room on presentation as an assessment of neurological status. The score has 3 components: eye opening (1-4), verbal response (1-5), and motor response (1-6). The components are summed for a score that ranges from 3-15. Normal GCS is 15, less than 15 indicates some abnormality.|participants|Number|1|1.0||||||
4083238|NCT01013870|3906761|B3|English||Primary Language||participants|Number|48|48.0||||||
4083239|NCT01013870|3906762|B2|English||Primary Language||participants|Number|21|21.0||||||
4083240|NCT01013870|3906763|B1|English||Primary Language||participants|Number|27|27.0||||||
4083202|NCT01013870|3906761|B3|15||Glasgow Coma Scale Score|GCS was obtained in the emergency room on presentation as an assessment of neurological status. The score has 3 components: eye opening (1-4), verbal response (1-5), and motor response (1-6). The components are summed for a score that ranges from 3-15. Normal GCS is 15, less than 15 indicates some abnormality.|participants|Number|50|50.0||||||
4083203|NCT01013870|3906762|B2|15||Glasgow Coma Scale Score|GCS was obtained in the emergency room on presentation as an assessment of neurological status. The score has 3 components: eye opening (1-4), verbal response (1-5), and motor response (1-6). The components are summed for a score that ranges from 3-15. Normal GCS is 15, less than 15 indicates some abnormality.|participants|Number|23|23.0||||||
4083204|NCT01013870|3906763|B1|15||Glasgow Coma Scale Score|GCS was obtained in the emergency room on presentation as an assessment of neurological status. The score has 3 components: eye opening (1-4), verbal response (1-5), and motor response (1-6). The components are summed for a score that ranges from 3-15. Normal GCS is 15, less than 15 indicates some abnormality.|participants|Number|27|27.0||||||
4083205|NCT01013870|3906761|B3|<100||Galveston Orientation and Amnesia Test Score|The GOAT assesses the duration of post-traumatic amnesia and was assessed on presentation to the hospital. It includes 10 items on recovery of orientation to person, place, and time and the maximum score is 100. (Levin, H., O'Donnell, V., and Grossman, R. [1979]. The Galveston Orientation and Amnesia Test. A practical scale to assess cognition after head injury. J Nerv Ment Dis 167[11], 675-684.). Categories used were normal (=100) or some abnormality (<100).|participants|Number|6|6.0||||||
4083206|NCT01013870|3906762|B2|<100||Galveston Orientation and Amnesia Test Score|The GOAT assesses the duration of post-traumatic amnesia and was assessed on presentation to the hospital. It includes 10 items on recovery of orientation to person, place, and time and the maximum score is 100. (Levin, H., O'Donnell, V., and Grossman, R. [1979]. The Galveston Orientation and Amnesia Test. A practical scale to assess cognition after head injury. J Nerv Ment Dis 167[11], 675-684.). Categories used were normal (=100) or some abnormality (<100).|participants|Number|1|1.0||||||
4083207|NCT01013870|3906763|B1|<100||Galveston Orientation and Amnesia Test Score|The GOAT assesses the duration of post-traumatic amnesia and was assessed on presentation to the hospital. It includes 10 items on recovery of orientation to person, place, and time and the maximum score is 100. (Levin, H., O'Donnell, V., and Grossman, R. [1979]. The Galveston Orientation and Amnesia Test. A practical scale to assess cognition after head injury. J Nerv Ment Dis 167[11], 675-684.). Categories used were normal (=100) or some abnormality (<100).|participants|Number|5|5.0||||||
4083208|NCT01013870|3906761|B3|=100||Galveston Orientation and Amnesia Test Score|The GOAT assesses the duration of post-traumatic amnesia and was assessed on presentation to the hospital. It includes 10 items on recovery of orientation to person, place, and time and the maximum score is 100. (Levin, H., O'Donnell, V., and Grossman, R. [1979]. The Galveston Orientation and Amnesia Test. A practical scale to assess cognition after head injury. J Nerv Ment Dis 167[11], 675-684.). Categories used were normal (=100) or some abnormality (<100).|participants|Number|46|46.0||||||
4083209|NCT01013870|3906762|B2|=100||Galveston Orientation and Amnesia Test Score|The GOAT assesses the duration of post-traumatic amnesia and was assessed on presentation to the hospital. It includes 10 items on recovery of orientation to person, place, and time and the maximum score is 100. (Levin, H., O'Donnell, V., and Grossman, R. [1979]. The Galveston Orientation and Amnesia Test. A practical scale to assess cognition after head injury. J Nerv Ment Dis 167[11], 675-684.). Categories used were normal (=100) or some abnormality (<100).|participants|Number|23|23.0||||||
4083210|NCT01013870|3906763|B1|=100||Galveston Orientation and Amnesia Test Score|The GOAT assesses the duration of post-traumatic amnesia and was assessed on presentation to the hospital. It includes 10 items on recovery of orientation to person, place, and time and the maximum score is 100. (Levin, H., O'Donnell, V., and Grossman, R. [1979]. The Galveston Orientation and Amnesia Test. A practical scale to assess cognition after head injury. J Nerv Ment Dis 167[11], 675-684.). Categories used were normal (=100) or some abnormality (<100).|participants|Number|23|23.0||||||
4083211|NCT01013870|3906761|B3|unknown||Education||participants|Number|1|1.0||||||
4083212|NCT01013870|3906762|B2|unknown||Education||participants|Number|1|1.0||||||
4083213|NCT01013870|3906763|B1|unknown||Education||participants|Number|0|0.0||||||
4083214|NCT01013870|3906761|B3|vocational||Education||participants|Number|2|2.0||||||
4083215|NCT01013870|3906762|B2|vocational||Education||participants|Number|0|0.0||||||
4083216|NCT01013870|3906763|B1|vocational||Education||participants|Number|2|2.0||||||
4083217|NCT01013870|3906761|B3|post-graduate||Education||participants|Number|1|1.0||||||
4083218|NCT01013870|3906762|B2|post-graduate||Education||participants|Number|1|1.0||||||
4083219|NCT01013870|3906763|B1|post-graduate||Education||participants|Number|0|0.0||||||
4083220|NCT01013870|3906761|B3|college graduate||Education||participants|Number|7|7.0||||||
4083221|NCT01013870|3906762|B2|college graduate||Education||participants|Number|3|3.0||||||
4083222|NCT01013870|3906763|B1|college graduate||Education||participants|Number|4|4.0||||||
4083223|NCT01013870|3906761|B3|some college||Education||participants|Number|18|18.0||||||
4083224|NCT01013870|3906762|B2|some college||Education||participants|Number|6|6.0||||||
4083225|NCT01013870|3906763|B1|some college||Education||participants|Number|12|12.0||||||
4083226|NCT01013870|3906761|B3|high school graduate||Education||participants|Number|16|16.0||||||
4083227|NCT01013870|3906762|B2|high school graduate||Education||participants|Number|8|8.0||||||
4083228|NCT01013870|3906763|B1|high school graduate||Education||participants|Number|8|8.0||||||
4083229|NCT01013870|3906761|B3|some high school||Education||participants|Number|5|5.0||||||
4083230|NCT01013870|3906762|B2|some high school||Education||participants|Number|4|4.0||||||
4083231|NCT01013870|3906763|B1|some high school||Education||participants|Number|1|1.0||||||
4083232|NCT01013870|3906761|B3|1-8 years||Education||participants|Number|2|2.0||||||
4083233|NCT01013870|3906762|B2|1-8 years||Education||participants|Number|1|1.0||||||
4083234|NCT01013870|3906763|B1|1-8 years||Education||participants|Number|1|1.0||||||
4083235|NCT01013870|3906761|B3|Spanish||Primary Language||participants|Number|4|4.0||||||
4083236|NCT01013870|3906762|B2|Spanish||Primary Language||participants|Number|3|3.0||||||
4083237|NCT01013870|3906763|B1|Spanish||Primary Language||participants|Number|1|1.0||||||
4083241|NCT01013870|3906761|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4083242|NCT01013870|3906762|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4083243|NCT01013870|3906763|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083244|NCT01013870|3906761|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083245|NCT01013870|3906762|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083246|NCT01013870|3906763|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083247|NCT01013870|3906761|B3||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4083248|NCT01013870|3906762|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4083249|NCT01013870|3906763|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4083250|NCT01013870|3906761|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4083251|NCT01013870|3906762|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4083252|NCT01013870|3906763|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4083253|NCT01013870|3906761|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083254|NCT01013870|3906762|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083255|NCT01013870|3906763|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083256|NCT01013870|3906761|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083257|NCT01013870|3906762|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083258|NCT01013870|3906763|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083259|NCT01013870|3906761|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083260|NCT01013870|3906762|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083261|NCT01013870|3906763|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083262|NCT01013870|3906761|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083263|NCT01013870|3906762|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083264|NCT01013870|3906763|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083265|NCT01013870|3906761|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4083266|NCT01013870|3906762|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4083267|NCT01013870|3906763|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4083268|NCT01013870|3906761|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4083269|NCT01013870|3906762|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4083270|NCT01013870|3906763|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4083271|NCT01013870|3906761|B3||Male|Gender||Participants|Count of Participants|35|35.0||||||
4083272|NCT01013870|3906762|B2||Male|Gender||Participants|Count of Participants|17|17.0||||||
4083273|NCT01013870|3906763|B1||Male|Gender||Participants|Count of Participants|18|18.0||||||
4083274|NCT01013870|3906761|B3||Female|Gender||Participants|Count of Participants|17|17.0||||||
4083275|NCT01013870|3906762|B2||Female|Gender||Participants|Count of Participants|7|7.0||||||
4083276|NCT01013870|3906763|B1||Female|Gender||Participants|Count of Participants|10|10.0||||||
4083277|NCT01013870|3906761|B3|||Age||years|Mean|29.5|29.5|Standard Deviation|9.3|9.3|||
4083278|NCT01013870|3906762|B2|||Age||years|Mean|29.9|29.9|Standard Deviation|9.9|9.9|||
4083279|NCT01013870|3906763|B1|||Age||years|Mean|29.1|29.1|Standard Deviation|9.0|9.0|||
4083280|NCT01013844|3906786|B3|United States||Region of Enrollment||participants|Number|130|130.0||||||
4083281|NCT01013844|3906787|B2|United States||Region of Enrollment||participants|Number|65|65.0||||||
4083282|NCT01013844|3906788|B1|United States||Region of Enrollment||participants|Number|65|65.0||||||
4083283|NCT01013844|3906786|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4083284|NCT01013844|3906787|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4083285|NCT01013844|3906788|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4083286|NCT01013844|3906786|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4083287|NCT01013844|3906787|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4083288|NCT01013844|3906788|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4083289|NCT01013844|3906786|B3|>=70 years||Age, Customized||participants|Number|15|15.0||||||
4083290|NCT01013844|3906787|B2|>=70 years||Age, Customized||participants|Number|4|4.0||||||
4083291|NCT01013844|3906788|B1|>=70 years||Age, Customized||participants|Number|11|11.0||||||
4083292|NCT01013844|3906786|B3|Between 18 and 69 years||Age, Customized||participants|Number|115|115.0||||||
4083293|NCT01013844|3906787|B2|Between 18 and 69 years||Age, Customized||participants|Number|61|61.0||||||
4083294|NCT01013844|3906788|B1|Between 18 and 69 years||Age, Customized||participants|Number|54|54.0||||||
4083295|NCT01013844|3906786|B3|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4083296|NCT01013844|3906787|B2|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4083297|NCT01013844|3906788|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4083298|NCT01013792|3906811|B3|>5 years||Diabetic foot ulcer age||participants|Number|2|2.0||||||
4083299|NCT01013792|3906812|B2|>5 years||Diabetic foot ulcer age||participants|Number|0|0.0||||||
4083300|NCT01013792|3906813|B1|>5 years||Diabetic foot ulcer age||participants|Number|2|2.0||||||
4083301|NCT01013792|3906811|B3|>1-5 years||Diabetic foot ulcer age||participants|Number|14|14.0||||||
4083302|NCT01013792|3906812|B2|>1-5 years||Diabetic foot ulcer age||participants|Number|10|10.0||||||
4083303|NCT01013792|3906813|B1|>1-5 years||Diabetic foot ulcer age||participants|Number|4|4.0||||||
4083304|NCT01013792|3906811|B3|27-52 weeks||Diabetic foot ulcer age||participants|Number|2|2.0||||||
4083305|NCT01013792|3906812|B2|27-52 weeks||Diabetic foot ulcer age||participants|Number|1|1.0||||||
4083306|NCT01013792|3906813|B1|27-52 weeks||Diabetic foot ulcer age||participants|Number|1|1.0||||||
4083307|NCT01013792|3906811|B3|13-26 weeks||Diabetic foot ulcer age||participants|Number|6|6.0||||||
4083308|NCT01013792|3906812|B2|13-26 weeks||Diabetic foot ulcer age||participants|Number|2|2.0||||||
4083309|NCT01013792|3906813|B1|13-26 weeks||Diabetic foot ulcer age||participants|Number|4|4.0||||||
4083310|NCT01013792|3906811|B3|4-12 weeks||Diabetic foot ulcer age||participants|Number|6|6.0||||||
4083311|NCT01013792|3906812|B2|4-12 weeks||Diabetic foot ulcer age||participants|Number|3|3.0||||||
4083312|NCT01013792|3906813|B1|4-12 weeks||Diabetic foot ulcer age||participants|Number|3|3.0||||||
4083313|NCT01013792|3906811|B3|||Diabetic foot ulcer area||cm2|Median|2.8|2.8|Full Range|||1.1|14.6|
4083314|NCT01013792|3906812|B2|||Diabetic foot ulcer area||cm2|Median|2.8|2.8|Full Range|||1.1|14.6|
4083315|NCT01013792|3906813|B1|||Diabetic foot ulcer area||cm2|Median|3.1|3.1|Full Range|||1.3|11.3|
4083316|NCT01013792|3906811|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4083317|NCT01013792|3906812|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4083318|NCT01013792|3906813|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4083319|NCT01013792|3906811|B3|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4083320|NCT01013792|3906812|B2|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4083321|NCT01013792|3906813|B1|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4083322|NCT01013792|3906811|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4083323|NCT01013792|3906812|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4083324|NCT01013792|3906813|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4083325|NCT01013792|3906811|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4083326|NCT01013792|3906812|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4083327|NCT01013792|3906813|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4083328|NCT01013792|3906811|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4083329|NCT01013792|3906812|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4083330|NCT01013792|3906813|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4083331|NCT01013792|3906811|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4083332|NCT01013792|3906812|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4083333|NCT01013792|3906813|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4083334|NCT01013792|3906811|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4083335|NCT01013792|3906812|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4083336|NCT01013792|3906813|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4083337|NCT01013792|3906811|B3|||Age||years|Mean|56.9|56.9|Standard Deviation|9.71|9.71|||
4083338|NCT01013792|3906812|B2|||Age||years|Mean|54.1|54.1|Standard Deviation|11.01|11.01|||
4083339|NCT01013792|3906813|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|7.06|7.06|||
4083340|NCT01013753|3906820|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4083341|NCT01013753|3906820|B1||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4083342|NCT01013753|3906820|B1|||Age||years|Mean|45.0|45.0|Standard Deviation|11.8|11.8|||
4083343|NCT01013740|3907014|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4083344|NCT01013740|3907015|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4083345|NCT01013740|3907016|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4083346|NCT01013740|3907014|B3|Native Hawaiian or other Pacific Islander & White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4083347|NCT01013740|3907015|B2|Native Hawaiian or other Pacific Islander & White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4083348|NCT01013740|3907016|B1|Native Hawaiian or other Pacific Islander & White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4083349|NCT01013740|3907014|B3|White||Race/Ethnicity, Customized||Participants|Number|110|110.0||||||
4083350|NCT01013740|3907015|B2|White||Race/Ethnicity, Customized||Participants|Number|74|74.0||||||
4083351|NCT01013740|3907016|B1|White||Race/Ethnicity, Customized||Participants|Number|36|36.0||||||
4083352|NCT01013740|3907014|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4083353|NCT01013740|3907015|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4083354|NCT01013740|3907016|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4083355|NCT01013740|3907014|B3||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4083356|NCT01013740|3907015|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4083357|NCT01013740|3907016|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4083358|NCT01013740|3907014|B3|||Age||Years|Mean|57.6|57.6|Standard Deviation|10.41|10.41|||
4083359|NCT01013740|3907015|B2|||Age||Years|Mean|57.7|57.7|Standard Deviation|10.23|10.23|||
4083360|NCT01013740|3907016|B1|||Age||Years|Mean|57.5|57.5|Standard Deviation|10.90|10.9|||
4083361|NCT01013701|3907041|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4083362|NCT01013701|3907041|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4083363|NCT01013701|3907041|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4083364|NCT01013701|3907041|B1|>=18, <=70, years||Age, Customized||Participants|Count of Participants|7|7.0||||||
4083365|NCT01013597|3907048|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4083366|NCT01013597|3907048|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083367|NCT01013597|3907048|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083368|NCT01013597|3907048|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4083369|NCT01013597|3907048|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4083370|NCT01013597|3907048|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083371|NCT01013597|3907048|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083372|NCT01013597|3907048|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083373|NCT01013597|3907048|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083374|NCT01013597|3907048|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4083375|NCT01013597|3907048|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083376|NCT01013597|3907048|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4083377|NCT01013597|3907048|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4083378|NCT01013597|3907048|B1|70-79 years||Age, Customized||participants|Number|2|2.0||||||
4083379|NCT01013597|3907048|B1|60-69 years||Age, Customized||participants|Number|6|6.0||||||
4083380|NCT01013597|3907048|B1|50-59 years||Age, Customized||participants|Number|2|2.0||||||
4083381|NCT01013597|3907048|B1|40-49 years||Age, Customized||participants|Number|2|2.0||||||
4083382|NCT01013597|3907048|B1|30-39 years||Age, Customized||participants|Number|1|1.0||||||
4083383|NCT01013207|3907058|B1|Australia||Region of Enrollment||participants|Number|50|50.0||||||
4083384|NCT01013207|3907058|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4083385|NCT01013207|3907058|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4083386|NCT01013207|3907058|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4083387|NCT01013207|3907058|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4083388|NCT01013207|3907058|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4083389|NCT01013194|3907063|B3|Italy||Region of Enrollment||participants|Number|25|25.0||||||
4083390|NCT01013194|3907064|B2|Italy||Region of Enrollment||participants|Number|16|16.0||||||
4083391|NCT01013194|3907065|B1|Italy||Region of Enrollment||participants|Number|9|9.0||||||
4083392|NCT01013194|3907063|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4083393|NCT01013194|3907064|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4083394|NCT01013194|3907065|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4083395|NCT01013194|3907063|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4083396|NCT01013194|3907064|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4083397|NCT01013194|3907065|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4083398|NCT01013194|3907063|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4083399|NCT01013194|3907064|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4083400|NCT01013194|3907065|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4083401|NCT01013194|3907063|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4083402|NCT01013194|3907064|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4083403|NCT01013194|3907065|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4083404|NCT01013194|3907063|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4083405|NCT01013194|3907064|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4083406|NCT01013194|3907065|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4083407|NCT01012999|3907076|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4083408|NCT01012999|3907076|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4083409|NCT01012999|3907076|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4083410|NCT01012999|3907076|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4083411|NCT01012999|3907076|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4083412|NCT01012999|3907076|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4083413|NCT01012973|3907080|B3|Unknown or Not Reported||Race||Participants|Number|7|7.0||||||
4083414|NCT01012973|3907081|B2|Unknown or Not Reported||Race||Participants|Number|4|4.0||||||
4083415|NCT01012973|3907082|B1|Unknown or Not Reported||Race||Participants|Number|3|3.0||||||
4083416|NCT01012973|3907080|B3|White||Race||Participants|Number|124|124.0||||||
4083417|NCT01012973|3907081|B2|White||Race||Participants|Number|49|49.0||||||
4083418|NCT01012973|3907082|B1|White||Race||Participants|Number|75|75.0||||||
4083419|NCT01012973|3907080|B3|Asian||Race||Participants|Number|41|41.0||||||
4083420|NCT01012973|3907081|B2|Asian||Race||Participants|Number|15|15.0||||||
4083421|NCT01012973|3907082|B1|Asian||Race||Participants|Number|26|26.0||||||
4083422|NCT01012973|3907080|B3|||European questionnaire 5 dimensions (EQ-5D) total score|The EQ-5D total score ranges from -0.594 to 1.000 with -0.594 being the worst.|score on a scale|Mean|0.87|0.87|Standard Deviation|0.15|0.15|||
4083423|NCT01012973|3907081|B2|||European questionnaire 5 dimensions (EQ-5D) total score|The EQ-5D total score ranges from -0.594 to 1.000 with -0.594 being the worst.|score on a scale|Mean|0.86|0.86|Standard Deviation|0.16|0.16|||
4083424|NCT01012973|3907082|B1|||European questionnaire 5 dimensions (EQ-5D) total score|The EQ-5D total score ranges from -0.594 to 1.000 with -0.594 being the worst.|score on a scale|Mean|0.87|0.87|Standard Deviation|0.15|0.15|||
4083425|NCT01012973|3907080|B3|||Baseline National Eye Institute 25-item Visual Function Questionnaire (NEI VFQ-25) total score|The NEI VFQ-25 total score ranges from 0-100 with a score of 0 being the worst outcome and 100 being the best outcome. The NEI VFQ questionnaire is organized as a collection of subscales which are all scored from 0-100. To reach the overall composite score, each sub-scale score is averaged in order to give each sub-scale equal weight.|scores on a scale|Mean|79.38|79.38|Standard Deviation|13.40|13.4|||
4083426|NCT01012973|3907081|B2|||Baseline National Eye Institute 25-item Visual Function Questionnaire (NEI VFQ-25) total score|The NEI VFQ-25 total score ranges from 0-100 with a score of 0 being the worst outcome and 100 being the best outcome. The NEI VFQ questionnaire is organized as a collection of subscales which are all scored from 0-100. To reach the overall composite score, each sub-scale score is averaged in order to give each sub-scale equal weight.|scores on a scale|Mean|78.94|78.94|Standard Deviation|14.00|14.0|||
4083427|NCT01012973|3907082|B1|||Baseline National Eye Institute 25-item Visual Function Questionnaire (NEI VFQ-25) total score|The NEI VFQ-25 total score ranges from 0-100 with a score of 0 being the worst outcome and 100 being the best outcome. The NEI VFQ questionnaire is organized as a collection of subscales which are all scored from 0-100. To reach the overall composite score, each sub-scale score is averaged in order to give each sub-scale equal weight.|scores on a scale|Mean|79.66|79.66|Standard Deviation|13.06|13.06|||
4083428|NCT01012973|3907080|B3|Missing||Number of participants with time since Central retinal vein occlusion (CRVO) diagnosis||Participants|Number|2|2.0||||||
4083429|NCT01012973|3907081|B2|Missing||Number of participants with time since Central retinal vein occlusion (CRVO) diagnosis||Participants|Number|0|0.0||||||
4083430|NCT01012973|3907082|B1|Missing||Number of participants with time since Central retinal vein occlusion (CRVO) diagnosis||Participants|Number|2|2.0||||||
4083431|NCT01012973|3907080|B3|< 2 months||Number of participants with time since Central retinal vein occlusion (CRVO) diagnosis||Participants|Number|91|91.0||||||
4083432|NCT01012973|3907081|B2|< 2 months||Number of participants with time since Central retinal vein occlusion (CRVO) diagnosis||Participants|Number|35|35.0||||||
4083433|NCT01012973|3907082|B1|< 2 months||Number of participants with time since Central retinal vein occlusion (CRVO) diagnosis||Participants|Number|56|56.0||||||
4083434|NCT01012973|3907080|B3|>= 2 months||Number of participants with time since Central retinal vein occlusion (CRVO) diagnosis||Participants|Number|79|79.0||||||
4083435|NCT01012973|3907081|B2|>= 2 months||Number of participants with time since Central retinal vein occlusion (CRVO) diagnosis||Participants|Number|33|33.0||||||
4083436|NCT01012973|3907082|B1|>= 2 months||Number of participants with time since Central retinal vein occlusion (CRVO) diagnosis||Participants|Number|46|46.0||||||
4083437|NCT01012973|3907080|B3|||Baseline intraocular pressure||mm Hg|Mean|14.9|14.9|Standard Deviation|2.8|2.8|||
4083438|NCT01012973|3907081|B2|||Baseline intraocular pressure||mm Hg|Mean|14.4|14.4|Standard Deviation|2.7|2.7|||
4083439|NCT01012973|3907082|B1|||Baseline intraocular pressure||mm Hg|Mean|15.2|15.2|Standard Deviation|2.8|2.8|||
4083440|NCT01012973|3907080|B3|||Baseline Retinal Thickness by Optical Coherence Tomography (OCT)||microns|Mean|665.34|665.34|Standard Deviation|230.33|230.33|||
4083441|NCT01012973|3907081|B2|||Baseline Retinal Thickness by Optical Coherence Tomography (OCT)||microns|Mean|638.66|638.66|Standard Deviation|224.69|224.69|||
4083442|NCT01012973|3907082|B1|||Baseline Retinal Thickness by Optical Coherence Tomography (OCT)||microns|Mean|682.78|682.78|Standard Deviation|233.36|233.36|||
4083443|NCT01012973|3907080|B3|Indeterminate||Number of participants with baseline retinal perfusion|Retinal perfusion defined as less than 10 disc areas of capillary nonperfusion using fluorescein angiography (FA)|Participants|Number|14|14.0||||||
4083444|NCT01012973|3907081|B2|Indeterminate||Number of participants with baseline retinal perfusion|Retinal perfusion defined as less than 10 disc areas of capillary nonperfusion using fluorescein angiography (FA)|Participants|Number|7|7.0||||||
4083445|NCT01012973|3907082|B1|Indeterminate||Number of participants with baseline retinal perfusion|Retinal perfusion defined as less than 10 disc areas of capillary nonperfusion using fluorescein angiography (FA)|Participants|Number|7|7.0||||||
4083446|NCT01012973|3907080|B3|Nonperfused||Number of participants with baseline retinal perfusion|Retinal perfusion defined as less than 10 disc areas of capillary nonperfusion using fluorescein angiography (FA)|Participants|Number|14|14.0||||||
4083447|NCT01012973|3907081|B2|Nonperfused||Number of participants with baseline retinal perfusion|Retinal perfusion defined as less than 10 disc areas of capillary nonperfusion using fluorescein angiography (FA)|Participants|Number|7|7.0||||||
4083448|NCT01012973|3907082|B1|Nonperfused||Number of participants with baseline retinal perfusion|Retinal perfusion defined as less than 10 disc areas of capillary nonperfusion using fluorescein angiography (FA)|Participants|Number|7|7.0||||||
4083449|NCT01012973|3907080|B3|Perfused||Number of participants with baseline retinal perfusion|Retinal perfusion defined as less than 10 disc areas of capillary nonperfusion using fluorescein angiography (FA)|Participants|Number|144|144.0||||||
4083450|NCT01012973|3907081|B2|Perfused||Number of participants with baseline retinal perfusion|Retinal perfusion defined as less than 10 disc areas of capillary nonperfusion using fluorescein angiography (FA)|Participants|Number|54|54.0||||||
4083451|NCT01012973|3907082|B1|Perfused||Number of participants with baseline retinal perfusion|Retinal perfusion defined as less than 10 disc areas of capillary nonperfusion using fluorescein angiography (FA)|Participants|Number|90|90.0||||||
4083504|NCT01012947|3907104|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4083505|NCT01012947|3907105|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4083506|NCT01012947|3907106|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4083452|NCT01012973|3907080|B3|||Baseline Best Corrected Visual Acuity (BCVA) letter scores|Infiormation retrieved from all baseline participants. Only participants with a ETDRS (Early Treatment Diabetic Retinopathy Study) Best Corrected Visual Acuity letter score of 73 to 25 (= Acuity of 20/40 to 20/320) in the study eye at 4 meters were included; a higher score represents better functioning.|Letters correctly read|Mean|52.5|52.5|Standard Deviation|15.6|15.6|||
4083453|NCT01012973|3907081|B2|||Baseline Best Corrected Visual Acuity (BCVA) letter scores|Infiormation retrieved from all baseline participants. Only participants with a ETDRS (Early Treatment Diabetic Retinopathy Study) Best Corrected Visual Acuity letter score of 73 to 25 (= Acuity of 20/40 to 20/320) in the study eye at 4 meters were included; a higher score represents better functioning.|Letters correctly read|Mean|50.9|50.9|Standard Deviation|15.4|15.4|||
4083454|NCT01012973|3907082|B1|||Baseline Best Corrected Visual Acuity (BCVA) letter scores|Infiormation retrieved from all baseline participants. Only participants with a ETDRS (Early Treatment Diabetic Retinopathy Study) Best Corrected Visual Acuity letter score of 73 to 25 (= Acuity of 20/40 to 20/320) in the study eye at 4 meters were included; a higher score represents better functioning.|Letters correctly read|Mean|53.5|53.5|Standard Deviation|15.7|15.7|||
4083455|NCT01012973|3907080|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4083456|NCT01012973|3907081|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4083457|NCT01012973|3907082|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083458|NCT01012973|3907080|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|166|166.0||||||
4083459|NCT01012973|3907081|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4083460|NCT01012973|3907082|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
4083461|NCT01012973|3907080|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4083462|NCT01012973|3907081|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4083463|NCT01012973|3907082|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4083464|NCT01012973|3907080|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4083465|NCT01012973|3907081|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4083466|NCT01012973|3907082|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4083467|NCT01012973|3907080|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4083468|NCT01012973|3907081|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4083469|NCT01012973|3907082|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4083470|NCT01012973|3907080|B3|||Age||Years|Mean|61.5|61.5|Standard Deviation|12.8|12.8|||
4083471|NCT01012973|3907081|B2|||Age||Years|Mean|63.8|63.8|Standard Deviation|13.3|13.3|||
4083472|NCT01012973|3907082|B1|||Age||Years|Mean|60.0|60.0|Standard Deviation|12.3|12.3|||
4083473|NCT01012947|3907103|B6|Korea, Republic of||Region of Enrollment||participants|Number|1115|1115.0||||||
4083474|NCT01012947|3907104|B5|Korea, Republic of||Region of Enrollment||participants|Number|236|236.0||||||
4083475|NCT01012947|3907105|B4|Korea, Republic of||Region of Enrollment||participants|Number|211|211.0||||||
4083476|NCT01012947|3907106|B3|Korea, Republic of||Region of Enrollment||participants|Number|241|241.0||||||
4083477|NCT01012947|3907107|B2|Korea, Republic of||Region of Enrollment||participants|Number|215|215.0||||||
4083478|NCT01012947|3907108|B1|Korea, Republic of||Region of Enrollment||participants|Number|212|212.0||||||
4083479|NCT01012947|3907103|B6||Male|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
4083480|NCT01012947|3907104|B5||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4083481|NCT01012947|3907105|B4||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4083482|NCT01012947|3907106|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4083483|NCT01012947|3907107|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4083484|NCT01012947|3907108|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4083485|NCT01012947|3907103|B6||Female|Sex: Female, Male||Participants|Count of Participants|861|861.0||||||
4083486|NCT01012947|3907104|B5||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4083487|NCT01012947|3907105|B4||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4083488|NCT01012947|3907106|B3||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4083489|NCT01012947|3907107|B2||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4083490|NCT01012947|3907108|B1||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4083491|NCT01012947|3907103|B6|||Age||years|Mean|77.1|77.1|Standard Deviation|2.5|2.5|||
4083492|NCT01012947|3907104|B5|||Age||years|Mean|76.7|76.7|Standard Deviation|2.1|2.1|||
4083493|NCT01012947|3907105|B4|||Age||years|Mean|77.9|77.9|Standard Deviation|3.7|3.7|||
4083494|NCT01012947|3907106|B3|||Age||years|Mean|77.3|77.3|Standard Deviation|1.7|1.7|||
4083495|NCT01012947|3907107|B2|||Age||years|Mean|76.5|76.5|Standard Deviation|2.9|2.9|||
4083496|NCT01012947|3907108|B1|||Age||years|Mean|77.5|77.5|Standard Deviation|1.9|1.9|||
4083497|NCT01012947|3907103|B6||>=65 years|Age||Participants|Count of Participants|1115|1115.0||||||
4083498|NCT01012947|3907104|B5||>=65 years|Age||Participants|Count of Participants|236|236.0||||||
4083499|NCT01012947|3907105|B4||>=65 years|Age||Participants|Count of Participants|211|211.0||||||
4083500|NCT01012947|3907106|B3||>=65 years|Age||Participants|Count of Participants|241|241.0||||||
4083501|NCT01012947|3907107|B2||>=65 years|Age||Participants|Count of Participants|215|215.0||||||
4083502|NCT01012947|3907108|B1||>=65 years|Age||Participants|Count of Participants|212|212.0||||||
4083503|NCT01012947|3907103|B6||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4083507|NCT01012947|3907107|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4083508|NCT01012947|3907108|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4083509|NCT01012947|3907103|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4083510|NCT01012947|3907104|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4083511|NCT01012947|3907105|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4083512|NCT01012947|3907106|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4083513|NCT01012947|3907107|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4083514|NCT01012947|3907108|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4083515|NCT01012921|3907124|B3|Spain||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4083516|NCT01012921|3907125|B2|Spain||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4083517|NCT01012921|3907126|B1|Spain||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4083518|NCT01012921|3907124|B3|Germany||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
4083519|NCT01012921|3907125|B2|Germany||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4083520|NCT01012921|3907126|B1|Germany||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4083521|NCT01012921|3907124|B3|Switzerland||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4083522|NCT01012921|3907125|B2|Switzerland||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4083523|NCT01012921|3907126|B1|Switzerland||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4083524|NCT01012921|3907124|B3|Italy||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4083525|NCT01012921|3907125|B2|Italy||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4083526|NCT01012921|3907126|B1|Italy||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4083527|NCT01012921|3907124|B3|Belgium||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4083528|NCT01012921|3907125|B2|Belgium||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4083529|NCT01012921|3907126|B1|Belgium||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4083530|NCT01012921|3907124|B3|Sweden||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4083531|NCT01012921|3907125|B2|Sweden||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4083532|NCT01012921|3907126|B1|Sweden||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4083533|NCT01012921|3907124|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083534|NCT01012921|3907125|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083535|NCT01012921|3907126|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083536|NCT01012921|3907124|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083537|NCT01012921|3907125|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083538|NCT01012921|3907126|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083539|NCT01012921|3907124|B3||White|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
4083540|NCT01012921|3907125|B2||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4083541|NCT01012921|3907126|B1||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4083542|NCT01012921|3907124|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083543|NCT01012921|3907125|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083544|NCT01012921|3907126|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083545|NCT01012921|3907124|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083546|NCT01012921|3907125|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083547|NCT01012921|3907126|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083548|NCT01012921|3907124|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4083549|NCT01012921|3907125|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083550|NCT01012921|3907126|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4083551|NCT01012921|3907124|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083552|NCT01012921|3907125|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083553|NCT01012921|3907126|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083554|NCT01012921|3907124|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4083555|NCT01012921|3907125|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4083556|NCT01012921|3907126|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4083557|NCT01012921|3907124|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4083558|NCT01012921|3907125|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4083559|NCT01012921|3907126|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4083560|NCT01012921|3907124|B3|||Age||years|Mean|49.8|49.8|Standard Deviation|14.3|14.3|||
4083561|NCT01012921|3907125|B2|||Age||years|Mean|50.6|50.6|Standard Deviation|14.0|14.0|||
4083562|NCT01012921|3907126|B1|||Age||years|Mean|49.1|49.1|Standard Deviation|14.7|14.7|||
4083563|NCT01012765|3907133|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4083564|NCT01012765|3907133|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4083565|NCT01012765|3907133|B1|||Age||years|Mean|61.4|61.4|Standard Deviation|8.9|8.9|||
4083566|NCT01012739|3907167|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4083567|NCT01012739|3907167|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4083568|NCT01012739|3907167|B1|||Age||years|Mean|42.6|42.6|Standard Deviation|11.42|11.42|||
4083569|NCT01012713|3907198|B1|||Psoriasis Area and Severity Index|Psoriasis Area and Severity Index measures the severity of psoriasis on a scale of 0 (no evidence of psoriasis) to 72 (worst possible psoriasis). The score is based on the redness, scaling, thickness and amount of body surface area affected by psoriasis.|units on a scale|Mean|12.7|12.7|Standard Deviation|3.5|3.5|||
4083570|NCT01012713|3907198|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4083571|NCT01012713|3907198|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4083572|NCT01012713|3907198|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4083573|NCT01012713|3907198|B1|||Age||years|Mean|42.6|42.6|Standard Deviation|14.1|14.1|||
4083574|NCT01012674|3907204|B1|Chile||Region of Enrollment||participants|Number|22|22.0||||||
4083575|NCT01012674|3907204|B1|Korea, Republic of||Region of Enrollment||participants|Number|30|30.0||||||
4083576|NCT01012674|3907204|B1|Mexico||Region of Enrollment||participants|Number|25|25.0||||||
4083577|NCT01012674|3907204|B1|South Africa||Region of Enrollment||participants|Number|22|22.0||||||
4083578|NCT01012674|3907204|B1|Argentina||Region of Enrollment||participants|Number|44|44.0||||||
4083579|NCT01012674|3907204|B1|United States||Region of Enrollment||participants|Number|68|68.0||||||
4083580|NCT01012674|3907204|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4083581|NCT01012674|3907204|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4083582|NCT01012674|3907204|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|12.7|12.7|||
4083583|NCT01012674|3907204|B1||>=65 years|Age||Participants|Count of Participants|101|101.0||||||
4083584|NCT01012674|3907204|B1||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
4083585|NCT01012674|3907204|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4083586|NCT01012661|3907216|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4083587|NCT01012661|3907216|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4083588|NCT01012661|3907216|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4083589|NCT01012661|3907216|B1|||Age||years|Mean|53|53.0|Standard Deviation|10.1|10.1|||
4083590|NCT01012661|3907216|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4083591|NCT01012661|3907216|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4083592|NCT01012661|3907216|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4083593|NCT01012622|3907224|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4083594|NCT01012622|3907224|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4083595|NCT01012622|3907224|B1|||Age||years|Mean|8.4|8.4|Standard Deviation|1.5|1.5|||
4083596|NCT01012492|3907243|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4083597|NCT01012492|3907243|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4083598|NCT01012492|3907243|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4083599|NCT01012492|3907243|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4083600|NCT01012492|3907243|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4083601|NCT01012492|3907243|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4083602|NCT01012492|3907243|B1|||Age||years|Mean|44.5|44.5|Standard Deviation|27|27.0|||
4083603|NCT01012440|3907248|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4083604|NCT01012440|3907248|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4083605|NCT01012440|3907248|B1|||Age||years|Mean|50.8|50.8|Standard Deviation|6.98|6.98|||
4083606|NCT01012414|3907252|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083607|NCT01012414|3907252|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083608|NCT01012414|3907252|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4083609|NCT01012414|3907252|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4083610|NCT01012414|3907252|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083611|NCT01012414|3907252|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083612|NCT01012414|3907252|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083613|NCT01012414|3907252|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083614|NCT01012414|3907252|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4083615|NCT01012414|3907252|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4083616|NCT01012414|3907252|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4083617|NCT01012414|3907252|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4083618|NCT01012414|3907252|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4083619|NCT01012414|3907252|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4083620|NCT01012414|3907252|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4083621|NCT01012388|3907259|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
4083622|NCT01012388|3907259|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4083623|NCT01012388|3907259|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4083624|NCT01012388|3907259|B1|||Age||years|Mean|52|52.0|Standard Deviation|11.1|11.1|||
4083625|NCT01012388|3907259|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4083626|NCT01012388|3907259|B1||Between 18 and 65 years|Age||Participants|Count of Participants|88|88.0||||||
4083627|NCT01012388|3907259|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4083628|NCT01012362|3907264|B6||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4083629|NCT01012362|3907265|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4083630|NCT01012362|3907266|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4083631|NCT01012362|3907267|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4083632|NCT01012362|3907268|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4083633|NCT01012362|3907269|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4083634|NCT01012362|3907264|B6||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4083635|NCT01012362|3907265|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4083636|NCT01012362|3907266|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4083637|NCT01012362|3907267|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4083638|NCT01012362|3907268|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4083639|NCT01012362|3907269|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4083640|NCT01012362|3907264|B6||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4083641|NCT01012362|3907265|B5||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4083642|NCT01012362|3907266|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4083643|NCT01012362|3907267|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4083644|NCT01012362|3907268|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4083645|NCT01012362|3907269|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4083646|NCT01012362|3907264|B6||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4083647|NCT01012362|3907265|B5||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4083648|NCT01012362|3907266|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4083649|NCT01012362|3907267|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4083650|NCT01012362|3907268|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4083651|NCT01012362|3907269|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4083652|NCT01012362|3907264|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4083653|NCT01012362|3907265|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4083654|NCT01012362|3907266|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4083655|NCT01012362|3907267|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4083656|NCT01012362|3907268|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4083657|NCT01012362|3907269|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4083658|NCT01012336|3907289|B1|Korea, Republic of||Region of Enrollment||participants|Number|85|85.0||||||
4083659|NCT01012336|3907289|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4083660|NCT01012336|3907289|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4083661|NCT01012336|3907289|B1|||Age||years|Mean|54.9|54.9|Standard Deviation|12.1|12.1|||
4083662|NCT01012336|3907289|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4083663|NCT01012336|3907289|B1||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
4083664|NCT01012336|3907289|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4083665|NCT01012323|3907293|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4083666|NCT01012323|3907293|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4083667|NCT01012323|3907293|B1|||Age||Years|Mean|26.8|26.8|Standard Deviation|19.25|19.25|||
4083668|NCT01012297|3907315|B3||Unknown|Cell Type||Participants|Count of Participants|1|1.0||||||
4083669|NCT01012297|3907316|B2||Unknown|Cell Type||Participants|Count of Participants|0|0.0||||||
4083670|NCT01012297|3907317|B1||Unknown|Cell Type||Participants|Count of Participants|1|1.0||||||
4083671|NCT01012297|3907315|B3||Carcinsarcoma|Cell Type||Participants|Count of Participants|1|1.0||||||
4083672|NCT01012297|3907316|B2||Carcinsarcoma|Cell Type||Participants|Count of Participants|1|1.0||||||
4083673|NCT01012297|3907317|B1||Carcinsarcoma|Cell Type||Participants|Count of Participants|0|0.0||||||
4083674|NCT01012297|3907315|B3||Sarcoma, Unsp.|Cell Type||Participants|Count of Participants|1|1.0||||||
4083675|NCT01012297|3907316|B2||Sarcoma, Unsp.|Cell Type||Participants|Count of Participants|0|0.0||||||
4083676|NCT01012297|3907317|B1||Sarcoma, Unsp.|Cell Type||Participants|Count of Participants|1|1.0||||||
4083677|NCT01012297|3907315|B3||Leiomyosarcoma|Cell Type||Participants|Count of Participants|104|104.0||||||
4083678|NCT01012297|3907316|B2||Leiomyosarcoma|Cell Type||Participants|Count of Participants|52|52.0||||||
4083679|NCT01012297|3907317|B1||Leiomyosarcoma|Cell Type||Participants|Count of Participants|52|52.0||||||
4083680|NCT01012297|3907315|B3|unknown||FIGO Stage|FIGO Stage describes disease burden at time of surgery. Stage 1 indicates the cancer has not spread beyond the uterus. Stage 4 indicates cancer metastasis in distant organs.|Participants|Count of Participants|12|12.0||||||
4083681|NCT01012297|3907316|B2|unknown||FIGO Stage|FIGO Stage describes disease burden at time of surgery. Stage 1 indicates the cancer has not spread beyond the uterus. Stage 4 indicates cancer metastasis in distant organs.|Participants|Count of Participants|7|7.0||||||
4083682|NCT01012297|3907317|B1|unknown||FIGO Stage|FIGO Stage describes disease burden at time of surgery. Stage 1 indicates the cancer has not spread beyond the uterus. Stage 4 indicates cancer metastasis in distant organs.|Participants|Count of Participants|5|5.0||||||
4083683|NCT01012297|3907315|B3|4||FIGO Stage|FIGO Stage describes disease burden at time of surgery. Stage 1 indicates the cancer has not spread beyond the uterus. Stage 4 indicates cancer metastasis in distant organs.|Participants|Count of Participants|52|52.0||||||
4083684|NCT01012297|3907316|B2|4||FIGO Stage|FIGO Stage describes disease burden at time of surgery. Stage 1 indicates the cancer has not spread beyond the uterus. Stage 4 indicates cancer metastasis in distant organs.|Participants|Count of Participants|30|30.0||||||
4083685|NCT01012297|3907317|B1|4||FIGO Stage|FIGO Stage describes disease burden at time of surgery. Stage 1 indicates the cancer has not spread beyond the uterus. Stage 4 indicates cancer metastasis in distant organs.|Participants|Count of Participants|22|22.0||||||
4083686|NCT01012297|3907315|B3|3||FIGO Stage|FIGO Stage describes disease burden at time of surgery. Stage 1 indicates the cancer has not spread beyond the uterus. Stage 4 indicates cancer metastasis in distant organs.|Participants|Count of Participants|8|8.0||||||
4083687|NCT01012297|3907316|B2|3||FIGO Stage|FIGO Stage describes disease burden at time of surgery. Stage 1 indicates the cancer has not spread beyond the uterus. Stage 4 indicates cancer metastasis in distant organs.|Participants|Count of Participants|5|5.0||||||
4083688|NCT01012297|3907317|B1|3||FIGO Stage|FIGO Stage describes disease burden at time of surgery. Stage 1 indicates the cancer has not spread beyond the uterus. Stage 4 indicates cancer metastasis in distant organs.|Participants|Count of Participants|3|3.0||||||
4083689|NCT01012297|3907315|B3|2||FIGO Stage|FIGO Stage describes disease burden at time of surgery. Stage 1 indicates the cancer has not spread beyond the uterus. Stage 4 indicates cancer metastasis in distant organs.|Participants|Count of Participants|4|4.0||||||
4083690|NCT01012297|3907316|B2|2||FIGO Stage|FIGO Stage describes disease burden at time of surgery. Stage 1 indicates the cancer has not spread beyond the uterus. Stage 4 indicates cancer metastasis in distant organs.|Participants|Count of Participants|0|0.0||||||
4083691|NCT01012297|3907317|B1|2||FIGO Stage|FIGO Stage describes disease burden at time of surgery. Stage 1 indicates the cancer has not spread beyond the uterus. Stage 4 indicates cancer metastasis in distant organs.|Participants|Count of Participants|4|4.0||||||
4083692|NCT01012297|3907315|B3|1||FIGO Stage|FIGO Stage describes disease burden at time of surgery. Stage 1 indicates the cancer has not spread beyond the uterus. Stage 4 indicates cancer metastasis in distant organs.|Participants|Count of Participants|31|31.0||||||
4083693|NCT01012297|3907316|B2|1||FIGO Stage|FIGO Stage describes disease burden at time of surgery. Stage 1 indicates the cancer has not spread beyond the uterus. Stage 4 indicates cancer metastasis in distant organs.|Participants|Count of Participants|11|11.0||||||
4083694|NCT01012297|3907317|B1|1||FIGO Stage|FIGO Stage describes disease burden at time of surgery. Stage 1 indicates the cancer has not spread beyond the uterus. Stage 4 indicates cancer metastasis in distant organs.|Participants|Count of Participants|20|20.0||||||
4083695|NCT01012297|3907315|B3|2: Symptomatic, in bed < 50% of time||Performance Status||Participants|Count of Participants|2|2.0||||||
4083696|NCT01012297|3907316|B2|2: Symptomatic, in bed < 50% of time||Performance Status||Participants|Count of Participants|1|1.0||||||
4083697|NCT01012297|3907317|B1|2: Symptomatic, in bed < 50% of time||Performance Status||Participants|Count of Participants|1|1.0||||||
4083698|NCT01012297|3907315|B3|1: Symptomatic, fully ambulatory||Performance Status||Participants|Count of Participants|26|26.0||||||
4083699|NCT01012297|3907316|B2|1: Symptomatic, fully ambulatory||Performance Status||Participants|Count of Participants|11|11.0||||||
4083700|NCT01012297|3907317|B1|1: Symptomatic, fully ambulatory||Performance Status||Participants|Count of Participants|15|15.0||||||
4083701|NCT01012297|3907315|B3|0: Asymptomatic||Performance Status||Participants|Count of Participants|79|79.0||||||
4083702|NCT01012297|3907316|B2|0: Asymptomatic||Performance Status||Participants|Count of Participants|41|41.0||||||
4083703|NCT01012297|3907317|B1|0: Asymptomatic||Performance Status||Participants|Count of Participants|38|38.0||||||
4083704|NCT01012297|3907315|B3|No||Prior whole pelvic radiation||Participants|Count of Participants|85|85.0||||||
4083705|NCT01012297|3907316|B2|No||Prior whole pelvic radiation||Participants|Count of Participants|42|42.0||||||
4083706|NCT01012297|3907317|B1|No||Prior whole pelvic radiation||Participants|Count of Participants|43|43.0||||||
4083707|NCT01012297|3907315|B3|Yes||Prior whole pelvic radiation||Participants|Count of Participants|22|22.0||||||
4083708|NCT01012297|3907316|B2|Yes||Prior whole pelvic radiation||Participants|Count of Participants|11|11.0||||||
4083709|NCT01012297|3907317|B1|Yes||Prior whole pelvic radiation||Participants|Count of Participants|11|11.0||||||
4083710|NCT01012297|3907315|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4083711|NCT01012297|3907316|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4083712|NCT01012297|3907317|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4083713|NCT01012297|3907315|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083714|NCT01012297|3907316|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083715|NCT01012297|3907317|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083716|NCT01012297|3907315|B3||White|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
4083717|NCT01012297|3907316|B2||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4083718|NCT01012297|3907317|B1||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4083719|NCT01012297|3907315|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4083720|NCT01012297|3907316|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4083721|NCT01012297|3907317|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4083722|NCT01012297|3907315|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083723|NCT01012297|3907316|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083724|NCT01012297|3907317|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083725|NCT01012297|3907315|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4083726|NCT01012297|3907316|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4083727|NCT01012297|3907317|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4083728|NCT01012297|3907315|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4083729|NCT01012297|3907316|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4083730|NCT01012297|3907317|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4083731|NCT01012297|3907315|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4083732|NCT01012297|3907316|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4083733|NCT01012297|3907317|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4083734|NCT01012297|3907315|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
4083735|NCT01012297|3907316|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4083736|NCT01012297|3907317|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4083737|NCT01012297|3907315|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4083738|NCT01012297|3907316|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4083739|NCT01012297|3907317|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4083740|NCT01012297|3907315|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4083741|NCT01012297|3907316|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4083742|NCT01012297|3907317|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4083743|NCT01012297|3907315|B3||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4083744|NCT01012297|3907316|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4083745|NCT01012297|3907317|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4083746|NCT01012297|3907315|B3|Age Groups|60-69 years|Age, Customized||Participants|Count of Participants|31|31.0||||||
4083747|NCT01012297|3907316|B2|Age Groups|60-69 years|Age, Customized||Participants|Count of Participants|12|12.0||||||
4083748|NCT01012297|3907317|B1|Age Groups|60-69 years|Age, Customized||Participants|Count of Participants|19|19.0||||||
4083749|NCT01012297|3907315|B3|Age Groups|50-59 years|Age, Customized||Participants|Count of Participants|49|49.0||||||
4083750|NCT01012297|3907316|B2|Age Groups|50-59 years|Age, Customized||Participants|Count of Participants|25|25.0||||||
4083751|NCT01012297|3907317|B1|Age Groups|50-59 years|Age, Customized||Participants|Count of Participants|24|24.0||||||
4083752|NCT01012297|3907315|B3|Age Groups|40-49 years|Age, Customized||Participants|Count of Participants|23|23.0||||||
4083753|NCT01012297|3907316|B2|Age Groups|40-49 years|Age, Customized||Participants|Count of Participants|12|12.0||||||
4083754|NCT01012297|3907317|B1|Age Groups|40-49 years|Age, Customized||Participants|Count of Participants|11|11.0||||||
4083755|NCT01012297|3907315|B3|Age Groups|30-39 years|Age, Customized||Participants|Count of Participants|3|3.0||||||
4083756|NCT01012297|3907316|B2|Age Groups|30-39 years|Age, Customized||Participants|Count of Participants|3|3.0||||||
4083757|NCT01012297|3907317|B1|Age Groups|30-39 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
4083758|NCT01012297|3907315|B3|Age Groups|20-29 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
4083759|NCT01012297|3907316|B2|Age Groups|20-29 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
4083760|NCT01012297|3907317|B1|Age Groups|20-29 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
4083761|NCT01012297|3907315|B3|||Age||years|Mean|55.7|55.7|Standard Deviation|8.6|8.6|||
4083762|NCT01012297|3907316|B2|||Age||years|Mean|54.0|54.0|Standard Deviation|8.7|8.7|||
4083763|NCT01012297|3907317|B1|||Age||years|Mean|57.5|57.5|Standard Deviation|8.1|8.1|||
4083764|NCT01012258|3907330|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4083765|NCT01012258|3907330|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4083766|NCT01012258|3907330|B1|>=65 years||Age, Customized||participants|Number|14|14.0||||||
4083767|NCT01012258|3907330|B1|<65 years||Age, Customized||participants|Number|52|52.0||||||
4083768|NCT01012258|3907330|B1|||Age||years|Mean|55.8|55.8|Standard Deviation|9.5|9.5|||
4083769|NCT01012245|3907336|B5|||Duration of glaucoma disease at baseline|Duration in years for glaucoma disease present at baseline visit.|years|Mean|5.9|5.9|Standard Deviation|6.2|6.2|||
4083770|NCT01012245|3907337|B4|||Duration of glaucoma disease at baseline|Duration in years for glaucoma disease present at baseline visit.|years|Mean|6.6|6.6|Standard Deviation|6.8|6.8|||
4083771|NCT01012245|3907338|B3|||Duration of glaucoma disease at baseline|Duration in years for glaucoma disease present at baseline visit.|years|Mean|6.6|6.6|Standard Deviation|6.1|6.1|||
4083772|NCT01012245|3907339|B2|||Duration of glaucoma disease at baseline|Duration in years for glaucoma disease present at baseline visit.|years|Mean|6.0|6.0|Standard Deviation|5.9|5.9|||
4083773|NCT01012245|3907340|B1|||Duration of glaucoma disease at baseline|Duration in years for glaucoma disease present at baseline visit.|years|Mean|5.1|5.1|Standard Deviation|5.6|5.6|||
4083774|NCT01012245|3907336|B5|Missing values OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|165|165.0||||||
4083775|NCT01012245|3907337|B4|Missing values OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|87|87.0||||||
4083776|NCT01012245|3907338|B3|Missing values OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|1|1.0||||||
4083777|NCT01012245|3907339|B2|Missing values OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|0|0.0||||||
4083778|NCT01012245|3907340|B1|Missing values OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|77|77.0||||||
4083779|NCT01012245|3907336|B5|Missing values OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|189|189.0||||||
4083780|NCT01012245|3907337|B4|Missing values OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|101|101.0||||||
4083781|NCT01012245|3907338|B3|Missing values OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|1|1.0||||||
4083782|NCT01012245|3907339|B2|Missing values OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|0|0.0||||||
4083783|NCT01012245|3907340|B1|Missing values OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|87|87.0||||||
4083784|NCT01012245|3907336|B5|No glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|539|539.0||||||
4083785|NCT01012245|3907337|B4|No glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|259|259.0||||||
4083786|NCT01012245|3907338|B3|No glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|13|13.0||||||
4083787|NCT01012245|3907339|B2|No glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|37|37.0||||||
4083788|NCT01012245|3907340|B1|No glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|230|230.0||||||
4083789|NCT01012245|3907336|B5|No glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|581|581.0||||||
4083790|NCT01012245|3907337|B4|No glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|267|267.0||||||
4083791|NCT01012245|3907338|B3|No glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|14|14.0||||||
4083792|NCT01012245|3907339|B2|No glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|38|38.0||||||
4083793|NCT01012245|3907340|B1|No glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|262|262.0||||||
4083794|NCT01012245|3907336|B5|Other glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|673|673.0||||||
4083795|NCT01012245|3907337|B4|Other glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|363|363.0||||||
4083796|NCT01012245|3907338|B3|Other glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|2|2.0||||||
4084042|NCT01012245|3907339|B2||Male|Sex: Female, Male||Participants|Count of Participants|783|783.0||||||
4084043|NCT01012245|3907340|B1||Male|Sex: Female, Male||Participants|Count of Participants|5850|5850.0||||||
4083797|NCT01012245|3907339|B2|Other glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|21|21.0||||||
4083798|NCT01012245|3907340|B1|Other glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|287|287.0||||||
4083799|NCT01012245|3907336|B5|Other glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|667|667.0||||||
4083800|NCT01012245|3907337|B4|Other glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|365|365.0||||||
4083801|NCT01012245|3907338|B3|Other glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|3|3.0||||||
4083802|NCT01012245|3907339|B2|Other glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|16|16.0||||||
4083803|NCT01012245|3907340|B1|Other glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|283|283.0||||||
4083804|NCT01012245|3907336|B5|Ocular hypertension OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|1564|1564.0||||||
4083805|NCT01012245|3907337|B4|Ocular hypertension OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|468|468.0||||||
4083806|NCT01012245|3907338|B3|Ocular hypertension OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|46|46.0||||||
4083807|NCT01012245|3907339|B2|Ocular hypertension OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|63|63.0||||||
4083808|NCT01012245|3907340|B1|Ocular hypertension OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|987|987.0||||||
4083809|NCT01012245|3907336|B5|Ocular hypertension OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|1559|1559.0||||||
4083810|NCT01012245|3907337|B4|Ocular hypertension OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|467|467.0||||||
4083811|NCT01012245|3907338|B3|Ocular hypertension OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|45|45.0||||||
4083812|NCT01012245|3907339|B2|Ocular hypertension OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|60|60.0||||||
4083813|NCT01012245|3907340|B1|Ocular hypertension OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|987|987.0||||||
4083814|NCT01012245|3907336|B5|Acute angle closure OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|23|23.0||||||
4083815|NCT01012245|3907337|B4|Acute angle closure OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|9|9.0||||||
4083816|NCT01012245|3907338|B3|Acute angle closure OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|0|0.0||||||
4083817|NCT01012245|3907339|B2|Acute angle closure OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|4|4.0||||||
4084044|NCT01012245|3907336|B5||Female|Sex: Female, Male||Participants|Count of Participants|16613|16613.0||||||
4083818|NCT01012245|3907340|B1|Acute angle closure OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|10|10.0||||||
4083819|NCT01012245|3907336|B5|Acute angle closure OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|25|25.0||||||
4083820|NCT01012245|3907337|B4|Acute angle closure OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|11|11.0||||||
4083821|NCT01012245|3907338|B3|Acute angle closure OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|0|0.0||||||
4083822|NCT01012245|3907339|B2|Acute angle closure OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|3|3.0||||||
4083823|NCT01012245|3907340|B1|Acute angle closure OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|11|11.0||||||
4083824|NCT01012245|3907336|B5|Other secondary glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|446|446.0||||||
4083825|NCT01012245|3907337|B4|Other secondary glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|262|262.0||||||
4083826|NCT01012245|3907338|B3|Other secondary glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|16|16.0||||||
4083827|NCT01012245|3907339|B2|Other secondary glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|10|10.0||||||
4083828|NCT01012245|3907340|B1|Other secondary glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|158|158.0||||||
4083829|NCT01012245|3907336|B5|Other secondary glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|426|426.0||||||
4083830|NCT01012245|3907337|B4|Other secondary glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|242|242.0||||||
4083831|NCT01012245|3907338|B3|Other secondary glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|18|18.0||||||
4083832|NCT01012245|3907339|B2|Other secondary glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|14|14.0||||||
4083833|NCT01012245|3907340|B1|Other secondary glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|152|152.0||||||
4083834|NCT01012245|3907336|B5|Neovascular glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|114|114.0||||||
4083835|NCT01012245|3907337|B4|Neovascular glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|73|73.0||||||
4083836|NCT01012245|3907338|B3|Neovascular glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|5|5.0||||||
4083837|NCT01012245|3907339|B2|Neovascular glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|6|6.0||||||
4083838|NCT01012245|3907340|B1|Neovascular glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|30|30.0||||||
4084050|NCT01012245|3907337|B4|||Age||years|Mean|66.9|66.9|Standard Deviation|13.3|13.3|||
4083839|NCT01012245|3907336|B5|Neovascular glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|128|128.0||||||
4083840|NCT01012245|3907337|B4|Neovascular glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|93|93.0||||||
4083841|NCT01012245|3907338|B3|Neovascular glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|5|5.0||||||
4083842|NCT01012245|3907339|B2|Neovascular glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|3|3.0||||||
4083843|NCT01012245|3907340|B1|Neovascular glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|27|27.0||||||
4083844|NCT01012245|3907336|B5|Pigment dispersion glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|309|309.0||||||
4083845|NCT01012245|3907337|B4|Pigment dispersion glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|150|150.0||||||
4083846|NCT01012245|3907338|B3|Pigment dispersion glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|9|9.0||||||
4083847|NCT01012245|3907339|B2|Pigment dispersion glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|13|13.0||||||
4083848|NCT01012245|3907340|B1|Pigment dispersion glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|137|137.0||||||
4083849|NCT01012245|3907336|B5|Pigment dispersion glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|311|311.0||||||
4083850|NCT01012245|3907337|B4|Pigment dispersion glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|155|155.0||||||
4083851|NCT01012245|3907338|B3|Pigment dispersion glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|8|8.0||||||
4083852|NCT01012245|3907339|B2|Pigment dispersion glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|13|13.0||||||
4083853|NCT01012245|3907340|B1|Pigment dispersion glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|135|135.0||||||
4083854|NCT01012245|3907336|B5|Exfoliation glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|777|777.0||||||
4083855|NCT01012245|3907337|B4|Exfoliation glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|390|390.0||||||
4083856|NCT01012245|3907338|B3|Exfoliation glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|16|16.0||||||
4083857|NCT01012245|3907339|B2|Exfoliation glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|36|36.0||||||
4083858|NCT01012245|3907340|B1|Exfoliation glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|335|335.0||||||
4083859|NCT01012245|3907336|B5|Exfoliation glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|776|776.0||||||
4083860|NCT01012245|3907337|B4|Exfoliation glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|381|381.0||||||
4083861|NCT01012245|3907338|B3|Exfoliation glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|15|15.0||||||
4083862|NCT01012245|3907339|B2|Exfoliation glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|41|41.0||||||
4083863|NCT01012245|3907340|B1|Exfoliation glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|339|339.0||||||
4083864|NCT01012245|3907336|B5|Congenital glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|88|88.0||||||
4083865|NCT01012245|3907337|B4|Congenital glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|55|55.0||||||
4083866|NCT01012245|3907338|B3|Congenital glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|1|1.0||||||
4083867|NCT01012245|3907339|B2|Congenital glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|8|8.0||||||
4083868|NCT01012245|3907340|B1|Congenital glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|24|24.0||||||
4083869|NCT01012245|3907336|B5|Congenital glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|91|91.0||||||
4083870|NCT01012245|3907337|B4|Congenital glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|58|58.0||||||
4083871|NCT01012245|3907338|B3|Congenital glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|0|0.0||||||
4083872|NCT01012245|3907339|B2|Congenital glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|7|7.0||||||
4083873|NCT01012245|3907340|B1|Congenital glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|26|26.0||||||
4083874|NCT01012245|3907336|B5|Chronic narrow-angle glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|1372|1372.0||||||
4083875|NCT01012245|3907337|B4|Chronic narrow-angle glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|804|804.0||||||
4083876|NCT01012245|3907338|B3|Chronic narrow-angle glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|22|22.0||||||
4083877|NCT01012245|3907339|B2|Chronic narrow-angle glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|43|43.0||||||
4083878|NCT01012245|3907340|B1|Chronic narrow-angle glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|503|503.0||||||
4083879|NCT01012245|3907336|B5|Chronic narrow-angle glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|1365|1365.0||||||
4083880|NCT01012245|3907337|B4|Chronic narrow-angle glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|804|804.0||||||
4084051|NCT01012245|3907338|B3|||Age||years|Mean|66.5|66.5|Standard Deviation|12.7|12.7|||
4083881|NCT01012245|3907338|B3|Chronic narrow-angle glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|22|22.0||||||
4083882|NCT01012245|3907339|B2|Chronic narrow-angle glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|43|43.0||||||
4083883|NCT01012245|3907340|B1|Chronic narrow-angle glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|496|496.0||||||
4083884|NCT01012245|3907336|B5|Normal tension glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|1447|1447.0||||||
4083885|NCT01012245|3907337|B4|Normal tension glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|507|507.0||||||
4083886|NCT01012245|3907338|B3|Normal tension glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|53|53.0||||||
4083887|NCT01012245|3907339|B2|Normal tension glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|53|53.0||||||
4083888|NCT01012245|3907340|B1|Normal tension glaucoma OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|834|834.0||||||
4083889|NCT01012245|3907336|B5|Normal tension glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|1410|1410.0||||||
4083890|NCT01012245|3907337|B4|Normal tension glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|486|486.0||||||
4083891|NCT01012245|3907338|B3|Normal tension glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|55|55.0||||||
4083892|NCT01012245|3907339|B2|Normal tension glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|51|51.0||||||
4083893|NCT01012245|3907340|B1|Normal tension glaucoma OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|818|818.0||||||
4083894|NCT01012245|3907336|B5|Glaucoma chronicum simplex OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|21295|21295.0||||||
4083895|NCT01012245|3907337|B4|Glaucoma chronicum simplex OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|9269|9269.0||||||
4083896|NCT01012245|3907338|B3|Glaucoma chronicum simplex OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|562|562.0||||||
4083897|NCT01012245|3907339|B2|Glaucoma chronicum simplex OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|1590|1590.0||||||
4083898|NCT01012245|3907340|B1|Glaucoma chronicum simplex OS||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|9874|9874.0||||||
4083899|NCT01012245|3907336|B5|Glaucoma chronicum simplex OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|21284|21284.0||||||
4083900|NCT01012245|3907337|B4|Glaucoma chronicum simplex OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|9266|9266.0||||||
4083901|NCT01012245|3907338|B3|Glaucoma chronicum simplex OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|560|560.0||||||
4083902|NCT01012245|3907339|B2|Glaucoma chronicum simplex OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|1595|1595.0||||||
4083903|NCT01012245|3907340|B1|Glaucoma chronicum simplex OD||Glaucoma diagnosis at baseline|Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|9863|9863.0||||||
4083904|NCT01012245|3907336|B5|Missing values||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|2061|2061.0||||||
4083905|NCT01012245|3907337|B4|Missing values||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|1108|1108.0||||||
4083906|NCT01012245|3907338|B3|Missing values||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|0|0.0||||||
4083907|NCT01012245|3907339|B2|Missing values||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|0|0.0||||||
4083908|NCT01012245|3907340|B1|Missing values||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|953|953.0||||||
4083909|NCT01012245|3907336|B5|Other disease||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|3873|3873.0||||||
4083910|NCT01012245|3907337|B4|Other disease||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|1902|1902.0||||||
4083911|NCT01012245|3907338|B3|Other disease||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|75|75.0||||||
4083912|NCT01012245|3907339|B2|Other disease||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|200|200.0||||||
4083913|NCT01012245|3907340|B1|Other disease||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|1696|1696.0||||||
4083914|NCT01012245|3907336|B5|Hypertension||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|5190|5190.0||||||
4083915|NCT01012245|3907337|B4|Hypertension||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|2288|2288.0||||||
4083916|NCT01012245|3907338|B3|Hypertension||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|192|192.0||||||
4083917|NCT01012245|3907339|B2|Hypertension||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|453|453.0||||||
4083918|NCT01012245|3907340|B1|Hypertension||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|2257|2257.0||||||
4083919|NCT01012245|3907336|B5|Hypotension||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|734|734.0||||||
4083920|NCT01012245|3907337|B4|Hypotension||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|288|288.0||||||
4083921|NCT01012245|3907338|B3|Hypotension||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|24|24.0||||||
4083922|NCT01012245|3907339|B2|Hypotension||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|75|75.0||||||
4084045|NCT01012245|3907337|B4||Female|Sex: Female, Male||Participants|Count of Participants|7493|7493.0||||||
4084046|NCT01012245|3907338|B3||Female|Sex: Female, Male||Participants|Count of Participants|383|383.0||||||
4083923|NCT01012245|3907340|B1|Hypotension||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|347|347.0||||||
4083924|NCT01012245|3907336|B5|Cardiac insufficiency||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|2193|2193.0||||||
4083925|NCT01012245|3907337|B4|Cardiac insufficiency||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|1118|1118.0||||||
4083926|NCT01012245|3907338|B3|Cardiac insufficiency||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|48|48.0||||||
4083927|NCT01012245|3907339|B2|Cardiac insufficiency||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|136|136.0||||||
4083928|NCT01012245|3907340|B1|Cardiac insufficiency||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|891|891.0||||||
4083929|NCT01012245|3907336|B5|Asthma||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|1063|1063.0||||||
4083930|NCT01012245|3907337|B4|Asthma||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|484|484.0||||||
4083931|NCT01012245|3907338|B3|Asthma||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|4|4.0||||||
4083932|NCT01012245|3907339|B2|Asthma||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|43|43.0||||||
4083933|NCT01012245|3907340|B1|Asthma||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|532|532.0||||||
4083934|NCT01012245|3907336|B5|Diabetes mellitus||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|3741|3741.0||||||
4083935|NCT01012245|3907337|B4|Diabetes mellitus||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|1743|1743.0||||||
4083936|NCT01012245|3907338|B3|Diabetes mellitus||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|107|107.0||||||
4083937|NCT01012245|3907339|B2|Diabetes mellitus||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|247|247.0||||||
4083938|NCT01012245|3907340|B1|Diabetes mellitus||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|1644|1644.0||||||
4083939|NCT01012245|3907336|B5|At least 1 concomitant disease||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|12681|12681.0||||||
4083940|NCT01012245|3907337|B4|At least 1 concomitant disease||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|5854|5854.0||||||
4083941|NCT01012245|3907338|B3|At least 1 concomitant disease||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|350|350.0||||||
4083942|NCT01012245|3907339|B2|At least 1 concomitant disease||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|839|839.0||||||
4083943|NCT01012245|3907340|B1|At least 1 concomitant disease||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|5638|5638.0||||||
4084047|NCT01012245|3907339|B2||Female|Sex: Female, Male||Participants|Count of Participants|1101|1101.0||||||
4083944|NCT01012245|3907336|B5|No concomitant diseases||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|14070|14070.0||||||
4083945|NCT01012245|3907337|B4|No concomitant diseases||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|5734|5734.0||||||
4083946|NCT01012245|3907338|B3|No concomitant diseases||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|396|396.0||||||
4083947|NCT01012245|3907339|B2|No concomitant diseases||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|1045|1045.0||||||
4083948|NCT01012245|3907340|B1|No concomitant diseases||Concomitant systemic diseases at baseline|Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.|participants|Number|6895|6895.0||||||
4083949|NCT01012245|3907336|B5|Missing values OS||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|2090|2090.0||||||
4083950|NCT01012245|3907337|B4|Missing values OS||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|1101|1101.0||||||
4083951|NCT01012245|3907338|B3|Missing values OS||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|0|0.0||||||
4083952|NCT01012245|3907339|B2|Missing values OS||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|0|0.0||||||
4083953|NCT01012245|3907340|B1|Missing values OS||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|989|989.0||||||
4083954|NCT01012245|3907336|B5|Missing values OD||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|2072|2072.0||||||
4083955|NCT01012245|3907337|B4|Missing values OD||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|1098|1098.0||||||
4083956|NCT01012245|3907338|B3|Missing values OD||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|0|0.0||||||
4083957|NCT01012245|3907339|B2|Missing values OD||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|0|0.0||||||
4083958|NCT01012245|3907340|B1|Missing values OD||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|974|974.0||||||
4083959|NCT01012245|3907336|B5|Other disease OS||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|5330|5330.0||||||
4083960|NCT01012245|3907337|B4|Other disease OS||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|2633|2633.0||||||
4083961|NCT01012245|3907338|B3|Other disease OS||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|143|143.0||||||
4083962|NCT01012245|3907339|B2|Other disease OS||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|285|285.0||||||
4083963|NCT01012245|3907340|B1|Other disease OS||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|2269|2269.0||||||
4083964|NCT01012245|3907336|B5|Other disease OD||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|5315|5315.0||||||
4083965|NCT01012245|3907337|B4|Other disease OD||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|2639|2639.0||||||
4083966|NCT01012245|3907338|B3|Other disease OD||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|147|147.0||||||
4083967|NCT01012245|3907339|B2|Other disease OD||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|280|280.0||||||
4083968|NCT01012245|3907340|B1|Other disease OD||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|2249|2249.0||||||
4083969|NCT01012245|3907336|B5|Cataract OS||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|5479|5479.0||||||
4083970|NCT01012245|3907337|B4|Cataract OS||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|2587|2587.0||||||
4083971|NCT01012245|3907338|B3|Cataract OS||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|220|220.0||||||
4083972|NCT01012245|3907339|B2|Cataract OS||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|370|370.0||||||
4083973|NCT01012245|3907340|B1|Cataract OS||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|2302|2302.0||||||
4083974|NCT01012245|3907336|B5|Cataract OD||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|5418|5418.0||||||
4083975|NCT01012245|3907337|B4|Cataract OD||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|2542|2542.0||||||
4083976|NCT01012245|3907338|B3|Cataract OD||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|209|209.0||||||
4083977|NCT01012245|3907339|B2|Cataract OD||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|370|370.0||||||
4083978|NCT01012245|3907340|B1|Cataract OD||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|2297|2297.0||||||
4083979|NCT01012245|3907336|B5|Status post laser surgery for glaucoma OS||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|1818|1818.0||||||
4083980|NCT01012245|3907337|B4|Status post laser surgery for glaucoma OS||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|1061|1061.0||||||
4083981|NCT01012245|3907338|B3|Status post laser surgery for glaucoma OS||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|64|64.0||||||
4083982|NCT01012245|3907339|B2|Status post laser surgery for glaucoma OS||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|56|56.0||||||
4084048|NCT01012245|3907340|B1||Female|Sex: Female, Male||Participants|Count of Participants|7636|7636.0||||||
4084049|NCT01012245|3907336|B5|||Age||years|Mean|65.9|65.9|Standard Deviation|13.3|13.3|||
4083983|NCT01012245|3907340|B1|Status post laser surgery for glaucoma OS||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|637|637.0||||||
4083984|NCT01012245|3907336|B5|Status post laser surgery for glaucoma OD||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|1836|1836.0||||||
4083985|NCT01012245|3907337|B4|Status post laser surgery for glaucoma OD||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|1070|1070.0||||||
4083986|NCT01012245|3907338|B3|Status post laser surgery for glaucoma OD||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|54|54.0||||||
4083987|NCT01012245|3907339|B2|Status post laser surgery for glaucoma OD||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|56|56.0||||||
4083988|NCT01012245|3907340|B1|Status post laser surgery for glaucoma OD||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|656|656.0||||||
4083989|NCT01012245|3907336|B5|Status post glaucoma surgery OS||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|3312|3312.0||||||
4083990|NCT01012245|3907337|B4|Status post glaucoma surgery OS||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|1729|1729.0||||||
4083991|NCT01012245|3907338|B3|Status post glaucoma surgery OS||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|107|107.0||||||
4083992|NCT01012245|3907339|B2|Status post glaucoma surgery OS||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|184|184.0||||||
4083993|NCT01012245|3907340|B1|Status post glaucoma surgery OS||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|1292|1292.0||||||
4083994|NCT01012245|3907336|B5|Status post glaucoma surgery OD||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|3373|3373.0||||||
4083995|NCT01012245|3907337|B4|Status post glaucoma surgery OD||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|1799|1799.0||||||
4083996|NCT01012245|3907338|B3|Status post glaucoma surgery OD||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|109|109.0||||||
4083997|NCT01012245|3907339|B2|Status post glaucoma surgery OD||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|189|189.0||||||
4083998|NCT01012245|3907340|B1|Status post glaucoma surgery OD||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|1276|1276.0||||||
4083999|NCT01012245|3907336|B5|Status post cataract surgery OS||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|1149|1149.0||||||
4084000|NCT01012245|3907337|B4|Status post cataract surgery OS||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|752|752.0||||||
4084001|NCT01012245|3907338|B3|Status post cataract surgery OS||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|19|19.0||||||
4084002|NCT01012245|3907339|B2|Status post cataract surgery OS||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|40|40.0||||||
4084003|NCT01012245|3907340|B1|Status post cataract surgery OS||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|338|338.0||||||
4084004|NCT01012245|3907336|B5|Status post cataract surgery OD||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|1100|1100.0||||||
4084005|NCT01012245|3907337|B4|Status post cataract surgery OD||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|731|731.0||||||
4084006|NCT01012245|3907338|B3|Status post cataract surgery OD||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|21|21.0||||||
4084007|NCT01012245|3907339|B2|Status post cataract surgery OD||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|39|39.0||||||
4084008|NCT01012245|3907340|B1|Status post cataract surgery OD||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|309|309.0||||||
4084009|NCT01012245|3907336|B5|At least 1 concomitant disease OS||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|13156|13156.0||||||
4084010|NCT01012245|3907337|B4|At least 1 concomitant disease OS||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|6492|6492.0||||||
4084011|NCT01012245|3907338|B3|At least 1 concomitant disease OS||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|424|424.0||||||
4084012|NCT01012245|3907339|B2|At least 1 concomitant disease OS||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|780|780.0||||||
4084013|NCT01012245|3907340|B1|At least 1 concomitant disease OS||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|5460|5460.0||||||
4084014|NCT01012245|3907336|B5|At least 1 concomitant disease OD||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|13116|13116.0||||||
4084015|NCT01012245|3907337|B4|At least 1 concomitant disease OD||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|6488|6488.0||||||
4084016|NCT01012245|3907338|B3|At least 1 concomitant disease OD||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|416|416.0||||||
4084017|NCT01012245|3907339|B2|At least 1 concomitant disease OD||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|786|786.0||||||
4084018|NCT01012245|3907340|B1|At least 1 concomitant disease OD||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|5426|5426.0||||||
4084019|NCT01012245|3907336|B5|No concomitant diseases OS||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|12862|12862.0||||||
4084020|NCT01012245|3907337|B4|No concomitant diseases OS||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|4757|4757.0||||||
4084021|NCT01012245|3907338|B3|No concomitant diseases OS||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|308|308.0||||||
4084022|NCT01012245|3907339|B2|No concomitant diseases OS||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|1067|1067.0||||||
4084023|NCT01012245|3907340|B1|No concomitant diseases OS||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|6730|6730.0||||||
4084024|NCT01012245|3907336|B5|No concomitant diseases OD||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|12854|12854.0||||||
4084025|NCT01012245|3907337|B4|No concomitant diseases OD||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|4742|4742.0||||||
4084026|NCT01012245|3907338|B3|No concomitant diseases OD||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|315|315.0||||||
4084027|NCT01012245|3907339|B2|No concomitant diseases OD||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|1060|1060.0||||||
4084028|NCT01012245|3907340|B1|No concomitant diseases OD||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|6737|6737.0||||||
4084029|NCT01012245|3907336|B5|Concomitant ocular disease (left eye [OS])||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|28108|28108.0||||||
4084030|NCT01012245|3907337|B4|Concomitant ocular disease (left eye [OS])||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|12350|12350.0||||||
4084031|NCT01012245|3907338|B3|Concomitant ocular disease (left eye [OS])||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|732|732.0||||||
4084032|NCT01012245|3907339|B2|Concomitant ocular disease (left eye [OS])||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|1847|1847.0||||||
4084033|NCT01012245|3907340|B1|Concomitant ocular disease (left eye [OS])||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|13179|13179.0||||||
4084034|NCT01012245|3907336|B5|Concomitant ocular disease (right eye [OD])||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|28042|28042.0||||||
4084035|NCT01012245|3907337|B4|Concomitant ocular disease (right eye [OD])||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|12328|12328.0||||||
4084036|NCT01012245|3907338|B3|Concomitant ocular disease (right eye [OD])||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|731|731.0||||||
4084037|NCT01012245|3907339|B2|Concomitant ocular disease (right eye [OD])||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|1846|1846.0||||||
4084038|NCT01012245|3907340|B1|Concomitant ocular disease (right eye [OD])||Concomitant ocular diseases at baseline|Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.|participants|Number|13137|13137.0||||||
4084039|NCT01012245|3907336|B5||Male|Sex: Female, Male||Participants|Count of Participants|12199|12199.0||||||
4084040|NCT01012245|3907337|B4||Male|Sex: Female, Male||Participants|Count of Participants|5203|5203.0||||||
4084041|NCT01012245|3907338|B3||Male|Sex: Female, Male||Participants|Count of Participants|363|363.0||||||
4084052|NCT01012245|3907339|B2|||Age||years|Mean|65.3|65.3|Standard Deviation|12.7|12.7|||
4084053|NCT01012245|3907340|B1|||Age||years|Mean|64.9|64.9|Standard Deviation|13.4|13.4|||
4084054|NCT01012219|3907377|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4084055|NCT01012219|3907377|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4084056|NCT01012219|3907377|B1|||Age||years|Mean|55.0|55.0|Full Range|||24.0|74.0|
4084057|NCT01012167|3907384|B4|United States||Region of Enrollment||participants|Number|56|56.0||||||
4084058|NCT01012167|3907385|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4084059|NCT01012167|3907386|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4084060|NCT01012167|3907387|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4084061|NCT01012167|3907384|B4||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4084062|NCT01012167|3907385|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4084063|NCT01012167|3907386|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4084064|NCT01012167|3907387|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4084065|NCT01012167|3907384|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4084066|NCT01012167|3907385|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4084067|NCT01012167|3907386|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4084068|NCT01012167|3907387|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4084069|NCT01012167|3907384|B4|||Age||years|Mean|44.9|44.9|Standard Deviation|11.8|11.8|||
4084070|NCT01012167|3907385|B3|||Age||years|Mean|42.2|42.2|Standard Deviation|11.7|11.7|||
4084071|NCT01012167|3907386|B2|||Age||years|Mean|45.8|45.8|Standard Deviation|12.4|12.4|||
4084072|NCT01012167|3907387|B1|||Age||years|Mean|47.4|47.4|Standard Deviation|11.2|11.2|||
4084073|NCT01012167|3907384|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4084074|NCT01012167|3907385|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4084075|NCT01012167|3907386|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4084076|NCT01012167|3907387|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4084077|NCT01012167|3907384|B4||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4084078|NCT01012167|3907385|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4084079|NCT01012167|3907386|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4084080|NCT01012167|3907387|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4084081|NCT01012167|3907384|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084082|NCT01012167|3907385|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084083|NCT01012167|3907386|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084084|NCT01012167|3907387|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084085|NCT01012089|3907643|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4084086|NCT01012089|3907644|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4084087|NCT01012089|3907645|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4084088|NCT01012089|3907643|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4084089|NCT01012089|3907644|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4084090|NCT01012089|3907645|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4084091|NCT01012089|3907643|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4084092|NCT01012089|3907644|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4084093|NCT01012089|3907645|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4084094|NCT01012089|3907643|B3|||Age||years|Mean|14.5|14.5|Full Range|||12.0|17.0|
4084095|NCT01012089|3907644|B2|||Age||years|Mean|13.7|13.7|Full Range|||12.0|15.0|
4084096|NCT01012089|3907645|B1|||Age||years|Mean|15.3|15.3|Full Range|||14.0|17.0|
4084097|NCT01012089|3907643|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4084098|NCT01012089|3907644|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4084099|NCT01012089|3907645|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4084100|NCT01012089|3907643|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4084101|NCT01012089|3907644|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4084102|NCT01012089|3907645|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4084103|NCT01012089|3907643|B3||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4084104|NCT01012089|3907644|B2||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4084105|NCT01012089|3907645|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4084106|NCT01012037|3907665|B4|||Fasting blood plasma glucose (FPG)|Baseline FPG was determined for the Full Analysis Set (where FPG values were also available) with 41 patients treated with Placebo, 209 patients treated with Linagliptin 2.5 bid and 216 patients treated with Linagliptin 5mg qd (466 in total).|mg/dL|Mean|165.1|165.1|Standard Deviation|38.6|38.6|||
4084107|NCT01012037|3907666|B3|||Fasting blood plasma glucose (FPG)|Baseline FPG was determined for the Full Analysis Set (where FPG values were also available) with 41 patients treated with Placebo, 209 patients treated with Linagliptin 2.5 bid and 216 patients treated with Linagliptin 5mg qd (466 in total).|mg/dL|Mean|165.8|165.8|Standard Deviation|35.1|35.1|||
4084108|NCT01012037|3907667|B2|||Fasting blood plasma glucose (FPG)|Baseline FPG was determined for the Full Analysis Set (where FPG values were also available) with 41 patients treated with Placebo, 209 patients treated with Linagliptin 2.5 bid and 216 patients treated with Linagliptin 5mg qd (466 in total).|mg/dL|Mean|164.1|164.1|Standard Deviation|41.8|41.8|||
4084109|NCT01012037|3907668|B1|||Fasting blood plasma glucose (FPG)|Baseline FPG was determined for the Full Analysis Set (where FPG values were also available) with 41 patients treated with Placebo, 209 patients treated with Linagliptin 2.5 bid and 216 patients treated with Linagliptin 5mg qd (466 in total).|mg/dL|Mean|166.2|166.2|Standard Deviation|40.3|40.3|||
4084110|NCT01012037|3907665|B4|||Glycosylated hemoglobin (HbA1c)|Baseline HbA1c was determined for the Full Analysis Set with 43 patients treated with Placebo, 214 patients treated with Linagliptin 2.5 bid and 221 patients treated with Linagliptin 5mg qd (478 in total).|percent|Mean|7.97|7.97|Standard Deviation|0.75|0.75|||
4084111|NCT01012037|3907666|B3|||Glycosylated hemoglobin (HbA1c)|Baseline HbA1c was determined for the Full Analysis Set with 43 patients treated with Placebo, 214 patients treated with Linagliptin 2.5 bid and 221 patients treated with Linagliptin 5mg qd (478 in total).|percent|Mean|7.98|7.98|Standard Deviation|0.72|0.72|||
4084112|NCT01012037|3907667|B2|||Glycosylated hemoglobin (HbA1c)|Baseline HbA1c was determined for the Full Analysis Set with 43 patients treated with Placebo, 214 patients treated with Linagliptin 2.5 bid and 221 patients treated with Linagliptin 5mg qd (478 in total).|percent|Mean|7.96|7.96|Standard Deviation|0.78|0.78|||
4084113|NCT01012037|3907668|B1|||Glycosylated hemoglobin (HbA1c)|Baseline HbA1c was determined for the Full Analysis Set with 43 patients treated with Placebo, 214 patients treated with Linagliptin 2.5 bid and 221 patients treated with Linagliptin 5mg qd (478 in total).|percent|Mean|7.92|7.92|Standard Deviation|0.74|0.74|||
4084114|NCT01012037|3907665|B4|||Body Mass Index (BMI) continuous||kg/m^2|Mean|29.57|29.57|Standard Deviation|5.13|5.13|||
4084115|NCT01012037|3907666|B3|||Body Mass Index (BMI) continuous||kg/m^2|Mean|29.55|29.55|Standard Deviation|4.95|4.95|||
4084116|NCT01012037|3907667|B2|||Body Mass Index (BMI) continuous||kg/m^2|Mean|29.77|29.77|Standard Deviation|5.23|5.23|||
4084117|NCT01012037|3907668|B1|||Body Mass Index (BMI) continuous||kg/m^2|Mean|28.65|28.65|Standard Deviation|5.53|5.53|||
4084118|NCT01012037|3907665|B4||Male|Sex: Female, Male||Participants|Count of Participants|280|280.0||||||
4084119|NCT01012037|3907666|B3||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4084120|NCT01012037|3907667|B2||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4084121|NCT01012037|3907668|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4084122|NCT01012037|3907665|B4||Female|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4084123|NCT01012037|3907666|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4084124|NCT01012037|3907667|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4084125|NCT01012037|3907668|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4084126|NCT01012037|3907665|B4|||Age||Years|Mean|58.6|58.6|Standard Deviation|10.3|10.3|||
4084127|NCT01012037|3907666|B3|||Age||Years|Mean|58.4|58.4|Standard Deviation|10.6|10.6|||
4084128|NCT01012037|3907667|B2|||Age||Years|Mean|58.7|58.7|Standard Deviation|9.9|9.9|||
4084129|NCT01012037|3907668|B1|||Age||Years|Mean|59.9|59.9|Standard Deviation|10.7|10.7|||
4084130|NCT01011946|3907705|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4084131|NCT01011946|3907705|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4084132|NCT01011946|3907705|B1|||Age||years|Mean|57.4|57.4|Standard Deviation|10.9|10.9|||
4084133|NCT01011933|3907709|B1|Serous adenocarcinoma||Cell Type||participants|Number|8|8.0||||||
4084134|NCT01011933|3907709|B1|Mixed epithelial carcinoma||Cell Type||participants|Number|10|10.0||||||
4084135|NCT01011933|3907709|B1|Endometrioid adenocarcinoma||Cell Type||participants|Number|31|31.0||||||
4084136|NCT01011933|3907709|B1|Clear cell carcinoma||Cell Type||participants|Number|1|1.0||||||
4084137|NCT01011933|3907709|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4084138|NCT01011933|3907709|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4084139|NCT01011933|3907709|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4084140|NCT01011933|3907709|B1|80-89 years||Age, Customized||participants|Number|2|2.0||||||
4084141|NCT01011933|3907709|B1|70-79 years||Age, Customized||participants|Number|11|11.0||||||
4084142|NCT01011933|3907709|B1|60-69 years||Age, Customized||participants|Number|18|18.0||||||
4084143|NCT01011933|3907709|B1|50-59 years||Age, Customized||participants|Number|15|15.0||||||
4084144|NCT01011933|3907709|B1|40-49 years||Age, Customized||participants|Number|4|4.0||||||
4084145|NCT01011933|3907709|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|9.7|9.7|||
4084146|NCT01011907|3907724|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
4084147|NCT01011907|3907725|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4084148|NCT01011907|3907726|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4084149|NCT01011907|3907724|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4084150|NCT01011907|3907725|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4084151|NCT01011907|3907726|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4084152|NCT01011907|3907724|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4084153|NCT01011907|3907725|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4084154|NCT01011907|3907726|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4084155|NCT01011907|3907724|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4084156|NCT01011907|3907725|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4084157|NCT01011907|3907726|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4084158|NCT01011907|3907724|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4084159|NCT01011907|3907725|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4084160|NCT01011907|3907726|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4084161|NCT01011907|3907724|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084162|NCT01011907|3907725|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084163|NCT01011907|3907726|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084164|NCT01011894|3907737|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084165|NCT01011894|3907737|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084166|NCT01011894|3907737|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4084167|NCT01011894|3907737|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4084168|NCT01011894|3907737|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084169|NCT01011894|3907737|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084170|NCT01011894|3907737|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084171|NCT01011894|3907737|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4084172|NCT01011894|3907737|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4084173|NCT01011894|3907737|B1||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4084174|NCT01011894|3907737|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4084175|NCT01011894|3907737|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084176|NCT01011868|3907741|B4||Male|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
4084177|NCT01011868|3907742|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4084178|NCT01011868|3907743|B2||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4084179|NCT01011868|3907744|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4084180|NCT01011868|3907741|B4||Female|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4084181|NCT01011868|3907742|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4084182|NCT01011868|3907743|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4084183|NCT01011868|3907744|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4084184|NCT01011868|3907741|B4|||Age||years|Mean|58.8|58.8|Standard Deviation|9.9|9.9|||
4084185|NCT01011868|3907742|B3|||Age||years|Mean|59.9|59.9|Standard Deviation|10.5|10.5|||
4084186|NCT01011868|3907743|B2|||Age||years|Mean|58.6|58.6|Standard Deviation|9.8|9.8|||
4084187|NCT01011868|3907744|B1|||Age||years|Mean|58.1|58.1|Standard Deviation|9.4|9.4|||
4084188|NCT01011829|3907781|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4084189|NCT01011829|3907782|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4084190|NCT01011829|3907783|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4084191|NCT01011829|3907781|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4084192|NCT01011829|3907782|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4084193|NCT01011829|3907783|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4084194|NCT01011829|3907781|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4084195|NCT01011829|3907782|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4084196|NCT01011829|3907783|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4084197|NCT01011829|3907781|B3|||Age||years|Mean|36.1|36.1|Standard Deviation|10.2|10.2|||
4084198|NCT01011829|3907782|B2|||Age||years|Mean|35.1|35.1|Standard Deviation|10.5|10.5|||
4084199|NCT01011829|3907783|B1|||Age||years|Mean|37.1|37.1|Standard Deviation|10.4|10.4|||
4084200|NCT01011829|3907781|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4084201|NCT01011829|3907782|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4084202|NCT01011829|3907783|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4084203|NCT01011829|3907781|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4084204|NCT01011829|3907782|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4084205|NCT01011829|3907783|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4084206|NCT01011829|3907781|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084207|NCT01011829|3907782|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084208|NCT01011829|3907783|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084209|NCT01011816|3907792|B3|||Injection Volume||ml|Mean|2.9|2.9|Standard Deviation|0.9|0.9|||
4084210|NCT01011816|3907793|B2|||Injection Volume||ml|Mean|3.3|3.3|Standard Deviation|0.8|0.8|||
4084211|NCT01011816|3907794|B1|||Injection Volume||ml|Mean|2.8|2.8|Standard Deviation|0.9|0.9|||
4084212|NCT01011816|3907792|B3|||Maximum Injection Pressure|n=163 BIOSTAT BIOLOGX n=55 Saline|psi|Mean|74.6|74.6|Standard Deviation|31.9|31.9|||
4084213|NCT01011816|3907793|B2|||Maximum Injection Pressure|n=163 BIOSTAT BIOLOGX n=55 Saline|psi|Mean|49.7|49.7|Standard Deviation|25.7|25.7|||
4084214|NCT01011816|3907794|B1|||Maximum Injection Pressure|n=163 BIOSTAT BIOLOGX n=55 Saline|psi|Mean|83.0|83.0|Standard Deviation|29.3|29.3|||
4084215|NCT01011816|3907792|B3|Other [investigator discretion; saline backflow]||Reason for Stopping Injection||participants|Number|4|4.0||||||
4084216|NCT01011816|3907793|B2|Other [investigator discretion; saline backflow]||Reason for Stopping Injection||participants|Number|3|3.0||||||
4084217|NCT01011816|3907794|B1|Other [investigator discretion; saline backflow]||Reason for Stopping Injection||participants|Number|1|1.0||||||
4084218|NCT01011816|3907792|B3|Total Available Volume Delivered||Reason for Stopping Injection||participants|Number|113|113.0||||||
4084219|NCT01011816|3907793|B2|Total Available Volume Delivered||Reason for Stopping Injection||participants|Number|45|45.0||||||
4084220|NCT01011816|3907794|B1|Total Available Volume Delivered||Reason for Stopping Injection||participants|Number|68|68.0||||||
4084221|NCT01011816|3907792|B3|Maximum Pressure Reached||Reason for Stopping Injection||participants|Number|97|97.0||||||
4084222|NCT01011816|3907793|B2|Maximum Pressure Reached||Reason for Stopping Injection||participants|Number|6|6.0||||||
4084223|NCT01011816|3907794|B1|Maximum Pressure Reached||Reason for Stopping Injection||participants|Number|91|91.0||||||
4084224|NCT01011816|3907792|B3|Subject Discomfort||Reason for Stopping Injection||participants|Number|6|6.0||||||
4084225|NCT01011816|3907793|B2|Subject Discomfort||Reason for Stopping Injection||participants|Number|2|2.0||||||
4084226|NCT01011816|3907794|B1|Subject Discomfort||Reason for Stopping Injection||participants|Number|4|4.0||||||
4084227|NCT01011816|3907792|B3|L5/S1||Lumbar Level Treated||participants|Number|141|141.0||||||
4084228|NCT01011816|3907793|B2|L5/S1||Lumbar Level Treated||participants|Number|37|37.0||||||
4084229|NCT01011816|3907794|B1|L5/S1||Lumbar Level Treated||participants|Number|104|104.0||||||
4084230|NCT01011816|3907792|B3|L4/L5||Lumbar Level Treated||participants|Number|59|59.0||||||
4084231|NCT01011816|3907793|B2|L4/L5||Lumbar Level Treated||participants|Number|11|11.0||||||
4084232|NCT01011816|3907794|B1|L4/L5||Lumbar Level Treated||participants|Number|48|48.0||||||
4084233|NCT01011816|3907792|B3|L3/L4||Lumbar Level Treated||participants|Number|20|20.0||||||
4084234|NCT01011816|3907793|B2|L3/L4||Lumbar Level Treated||participants|Number|8|8.0||||||
4084235|NCT01011816|3907794|B1|L3/L4||Lumbar Level Treated||participants|Number|12|12.0||||||
4084236|NCT01011816|3907792|B3|No||Baseline Opioid Medication for Back Pain||participants|Number|74|74.0||||||
4084237|NCT01011816|3907793|B2|No||Baseline Opioid Medication for Back Pain||participants|Number|19|19.0||||||
4084238|NCT01011816|3907794|B1|No||Baseline Opioid Medication for Back Pain||participants|Number|55|55.0||||||
4084239|NCT01011816|3907792|B3|Yes||Baseline Opioid Medication for Back Pain||participants|Number|146|146.0||||||
4084240|NCT01011816|3907793|B2|Yes||Baseline Opioid Medication for Back Pain||participants|Number|37|37.0||||||
4084241|NCT01011816|3907794|B1|Yes||Baseline Opioid Medication for Back Pain||participants|Number|109|109.0||||||
4084242|NCT01011816|3907792|B3|>=4years||History Left Leg Pain||participants|Number|26|26.0||||||
4084243|NCT01011816|3907793|B2|>=4years||History Left Leg Pain||participants|Number|7|7.0||||||
4084244|NCT01011816|3907794|B1|>=4years||History Left Leg Pain||participants|Number|19|19.0||||||
4084245|NCT01011816|3907792|B3|3 - <4 years||History Left Leg Pain||participants|Number|4|4.0||||||
4084246|NCT01011816|3907793|B2|3 - <4 years||History Left Leg Pain||participants|Number|1|1.0||||||
4084247|NCT01011816|3907794|B1|3 - <4 years||History Left Leg Pain||participants|Number|3|3.0||||||
4084248|NCT01011816|3907792|B3|2 - <3 years||History Left Leg Pain||participants|Number|21|21.0||||||
4084249|NCT01011816|3907793|B2|2 - <3 years||History Left Leg Pain||participants|Number|7|7.0||||||
4084250|NCT01011816|3907794|B1|2 - <3 years||History Left Leg Pain||participants|Number|14|14.0||||||
4084251|NCT01011816|3907792|B3|1 - <2 years||History Left Leg Pain||participants|Number|9|9.0||||||
4084252|NCT01011816|3907793|B2|1 - <2 years||History Left Leg Pain||participants|Number|2|2.0||||||
4084253|NCT01011816|3907794|B1|1 - <2 years||History Left Leg Pain||participants|Number|7|7.0||||||
4084254|NCT01011816|3907792|B3|<1 year||History Left Leg Pain||participants|Number|17|17.0||||||
4084255|NCT01011816|3907793|B2|<1 year||History Left Leg Pain||participants|Number|6|6.0||||||
4084256|NCT01011816|3907794|B1|<1 year||History Left Leg Pain||participants|Number|11|11.0||||||
4084257|NCT01011816|3907792|B3|None||History Left Leg Pain||participants|Number|143|143.0||||||
4084258|NCT01011816|3907793|B2|None||History Left Leg Pain||participants|Number|33|33.0||||||
4084259|NCT01011816|3907794|B1|None||History Left Leg Pain||participants|Number|110|110.0||||||
4084260|NCT01011816|3907792|B3|>=4 years||History Right Leg Pain||participants|Number|20|20.0||||||
4084261|NCT01011816|3907793|B2|>=4 years||History Right Leg Pain||participants|Number|6|6.0||||||
4084262|NCT01011816|3907794|B1|>=4 years||History Right Leg Pain||participants|Number|14|14.0||||||
4084263|NCT01011816|3907792|B3|3 - <4 years||History Right Leg Pain||participants|Number|2|2.0||||||
4084264|NCT01011816|3907793|B2|3 - <4 years||History Right Leg Pain||participants|Number|0|0.0||||||
4084265|NCT01011816|3907794|B1|3 - <4 years||History Right Leg Pain||participants|Number|2|2.0||||||
4084266|NCT01011816|3907792|B3|2 - <3 years||History Right Leg Pain||participants|Number|16|16.0||||||
4084267|NCT01011816|3907793|B2|2 - <3 years||History Right Leg Pain||participants|Number|5|5.0||||||
4084268|NCT01011816|3907794|B1|2 - <3 years||History Right Leg Pain||participants|Number|11|11.0||||||
4084269|NCT01011816|3907792|B3|1 - <2 years||History Right Leg Pain||participants|Number|13|13.0||||||
4084270|NCT01011816|3907793|B2|1 - <2 years||History Right Leg Pain||participants|Number|2|2.0||||||
4084271|NCT01011816|3907794|B1|1 - <2 years||History Right Leg Pain||participants|Number|11|11.0||||||
4084272|NCT01011816|3907792|B3|<1 year||History Right Leg Pain||participants|Number|11|11.0||||||
4084273|NCT01011816|3907793|B2|<1 year||History Right Leg Pain||participants|Number|3|3.0||||||
4084274|NCT01011816|3907794|B1|<1 year||History Right Leg Pain||participants|Number|8|8.0||||||
4084275|NCT01011816|3907792|B3|None||History Right Leg Pain||participants|Number|158|158.0||||||
4084276|NCT01011816|3907793|B2|None||History Right Leg Pain||participants|Number|40|40.0||||||
4084277|NCT01011816|3907794|B1|None||History Right Leg Pain||participants|Number|118|118.0||||||
4084278|NCT01011816|3907792|B3|>=20 years||History Low Back Pain||participants|Number|16|16.0||||||
4084279|NCT01011816|3907793|B2|>=20 years||History Low Back Pain||participants|Number|8|8.0||||||
4084280|NCT01011816|3907794|B1|>=20 years||History Low Back Pain||participants|Number|8|8.0||||||
4084281|NCT01011816|3907792|B3|10 - <20 years||History Low Back Pain||participants|Number|44|44.0||||||
4084282|NCT01011816|3907793|B2|10 - <20 years||History Low Back Pain||participants|Number|12|12.0||||||
4084283|NCT01011816|3907794|B1|10 - <20 years||History Low Back Pain||participants|Number|32|32.0||||||
4084284|NCT01011816|3907792|B3|5 - <10 years||History Low Back Pain||participants|Number|50|50.0||||||
4084285|NCT01011816|3907793|B2|5 - <10 years||History Low Back Pain||participants|Number|9|9.0||||||
4084286|NCT01011816|3907794|B1|5 - <10 years||History Low Back Pain||participants|Number|41|41.0||||||
4084287|NCT01011816|3907792|B3|1 - <5 years||History Low Back Pain||participants|Number|100|100.0||||||
4084288|NCT01011816|3907793|B2|1 - <5 years||History Low Back Pain||participants|Number|24|24.0||||||
4084289|NCT01011816|3907794|B1|1 - <5 years||History Low Back Pain||participants|Number|76|76.0||||||
4084290|NCT01011816|3907792|B3|0.5 - 1 year||History Low Back Pain||participants|Number|10|10.0||||||
4084291|NCT01011816|3907793|B2|0.5 - 1 year||History Low Back Pain||participants|Number|3|3.0||||||
4084292|NCT01011816|3907794|B1|0.5 - 1 year||History Low Back Pain||participants|Number|7|7.0||||||
4084293|NCT01011816|3907792|B3|Cervical||Previous Back Surgery||participants|Number|4|4.0||||||
4084294|NCT01011816|3907793|B2|Cervical||Previous Back Surgery||participants|Number|1|1.0||||||
4084295|NCT01011816|3907794|B1|Cervical||Previous Back Surgery||participants|Number|3|3.0||||||
4084296|NCT01011816|3907792|B3|None||Previous Back Surgery||participants|Number|216|216.0||||||
4084297|NCT01011816|3907793|B2|None||Previous Back Surgery||participants|Number|55|55.0||||||
4084298|NCT01011816|3907794|B1|None||Previous Back Surgery||participants|Number|161|161.0||||||
4084299|NCT01011816|3907792|B3|Current||Smoking Status||participants|Number|44|44.0||||||
4084300|NCT01011816|3907793|B2|Current||Smoking Status||participants|Number|16|16.0||||||
4084301|NCT01011816|3907794|B1|Current||Smoking Status||participants|Number|28|28.0||||||
4084302|NCT01011816|3907792|B3|Previous||Smoking Status||participants|Number|65|65.0||||||
4084303|NCT01011816|3907793|B2|Previous||Smoking Status||participants|Number|19|19.0||||||
4084304|NCT01011816|3907794|B1|Previous||Smoking Status||participants|Number|46|46.0||||||
4084305|NCT01011816|3907792|B3|Never||Smoking Status||participants|Number|111|111.0||||||
4084306|NCT01011816|3907793|B2|Never||Smoking Status||participants|Number|21|21.0||||||
4084307|NCT01011816|3907794|B1|Never||Smoking Status||participants|Number|90|90.0||||||
4084308|NCT01011816|3907792|B3|No Response||Currently Employed||participants|Number|3|3.0||||||
4084309|NCT01011816|3907793|B2|No Response||Currently Employed||participants|Number|0|0.0||||||
4084310|NCT01011816|3907794|B1|No Response||Currently Employed||participants|Number|3|3.0||||||
4084311|NCT01011816|3907792|B3|No||Currently Employed||participants|Number|87|87.0||||||
4084312|NCT01011816|3907793|B2|No||Currently Employed||participants|Number|22|22.0||||||
4084313|NCT01011816|3907794|B1|No||Currently Employed||participants|Number|65|65.0||||||
4084314|NCT01011816|3907792|B3|Yes||Currently Employed||participants|Number|130|130.0||||||
4084315|NCT01011816|3907793|B2|Yes||Currently Employed||participants|Number|34|34.0||||||
4084316|NCT01011816|3907794|B1|Yes||Currently Employed||participants|Number|96|96.0||||||
4084317|NCT01011816|3907792|B3|||BMI||kg/m^2|Mean|27.9|27.9|Standard Deviation|5.9|5.9|||
4084318|NCT01011816|3907793|B2|||BMI||kg/m^2|Mean|27.5|27.5|Standard Deviation|5.6|5.6|||
4084319|NCT01011816|3907794|B1|||BMI||kg/m^2|Mean|28.0|28.0|Standard Deviation|6.1|6.1|||
4084320|NCT01011816|3907792|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084321|NCT01011816|3907793|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084322|NCT01011816|3907794|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084323|NCT01011816|3907792|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4084324|NCT01011816|3907793|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4084325|NCT01011816|3907794|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4084326|NCT01011816|3907792|B3||White|Race (NIH/OMB)||Participants|Count of Participants|199|199.0||||||
4084327|NCT01011816|3907793|B2||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4084328|NCT01011816|3907794|B1||White|Race (NIH/OMB)||Participants|Count of Participants|147|147.0||||||
4084329|NCT01011816|3907792|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4084330|NCT01011816|3907793|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4084331|NCT01011816|3907794|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4084332|NCT01011816|3907792|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084333|NCT01011816|3907793|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084334|NCT01011816|3907794|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084335|NCT01011816|3907792|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4084336|NCT01011816|3907793|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4084337|NCT01011816|3907794|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084338|NCT01011816|3907792|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084339|NCT01011816|3907793|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084340|NCT01011816|3907794|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084341|NCT01011816|3907792|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084342|NCT01011816|3907793|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084404|NCT01011673|3907848|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084343|NCT01011816|3907794|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084344|NCT01011816|3907792|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|207|207.0||||||
4084345|NCT01011816|3907793|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4084346|NCT01011816|3907794|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|156|156.0||||||
4084347|NCT01011816|3907792|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4084348|NCT01011816|3907793|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4084349|NCT01011816|3907794|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4084350|NCT01011816|3907792|B3||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4084351|NCT01011816|3907793|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4084352|NCT01011816|3907794|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4084353|NCT01011816|3907792|B3||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4084354|NCT01011816|3907793|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4084355|NCT01011816|3907794|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4084356|NCT01011816|3907792|B3|≥60 years||Age, Customized||participants|Number|9|9.0||||||
4084357|NCT01011816|3907793|B2|≥60 years||Age, Customized||participants|Number|4|4.0||||||
4084358|NCT01011816|3907794|B1|≥60 years||Age, Customized||participants|Number|5|5.0||||||
4084359|NCT01011816|3907792|B3|≥50-≤59 years||Age, Customized||participants|Number|37|37.0||||||
4084360|NCT01011816|3907793|B2|≥50-≤59 years||Age, Customized||participants|Number|9|9.0||||||
4084361|NCT01011816|3907794|B1|≥50-≤59 years||Age, Customized||participants|Number|28|28.0||||||
4084362|NCT01011816|3907792|B3|≥40-≤49 years||Age, Customized||participants|Number|71|71.0||||||
4084363|NCT01011816|3907793|B2|≥40-≤49 years||Age, Customized||participants|Number|20|20.0||||||
4084364|NCT01011816|3907794|B1|≥40-≤49 years||Age, Customized||participants|Number|51|51.0||||||
4084365|NCT01011816|3907792|B3|≥30-≤39 years||Age, Customized||participants|Number|62|62.0||||||
4084366|NCT01011816|3907793|B2|≥30-≤39 years||Age, Customized||participants|Number|12|12.0||||||
4084367|NCT01011816|3907794|B1|≥30-≤39 years||Age, Customized||participants|Number|50|50.0||||||
4084368|NCT01011816|3907792|B3|≥18-≤29 years||Age, Customized||participants|Number|41|41.0||||||
4084369|NCT01011816|3907793|B2|≥18-≤29 years||Age, Customized||participants|Number|11|11.0||||||
4084370|NCT01011816|3907794|B1|≥18-≤29 years||Age, Customized||participants|Number|30|30.0||||||
4084371|NCT01011816|3907792|B3|||Age||years|Mean|40.2|40.2|Standard Deviation|10.9|10.9|||
4084372|NCT01011816|3907793|B2|||Age||years|Mean|41.9|41.9|Standard Deviation|11.4|11.4|||
4084373|NCT01011816|3907794|B1|||Age||years|Mean|39.7|39.7|Standard Deviation|10.7|10.7|||
4084374|NCT01011738|3907805|B4||Male|Sex: Female, Male||Participants|Count of Participants|1302|1302.0||||||
4084375|NCT01011738|3907806|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4084376|NCT01011738|3907807|B2||Male|Sex: Female, Male||Participants|Count of Participants|659|659.0||||||
4084377|NCT01011738|3907808|B1||Male|Sex: Female, Male||Participants|Count of Participants|606|606.0||||||
4084378|NCT01011738|3907805|B4||Female|Sex: Female, Male||Participants|Count of Participants|499|499.0||||||
4084379|NCT01011738|3907806|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4084380|NCT01011738|3907807|B2||Female|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
4084381|NCT01011738|3907808|B1||Female|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
4084382|NCT01011738|3907805|B4|||Age||Years|Mean|34.6|34.6|Standard Deviation|10.67|10.67|||
4084383|NCT01011738|3907806|B3|||Age||Years|Mean|38.6|38.6|Standard Deviation|12.69|12.69|||
4084384|NCT01011738|3907807|B2|||Age||Years|Mean|37.8|37.8|Standard Deviation|10.81|10.81|||
4084385|NCT01011738|3907808|B1|||Age||Years|Mean|31.1|31.1|Standard Deviation|9.37|9.37|||
4084386|NCT01011673|3907848|B3|United States||Region of Enrollment||participants|Number|120|120.0||||||
4084387|NCT01011673|3907849|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
4084388|NCT01011673|3907850|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4084389|NCT01011673|3907848|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4084390|NCT01011673|3907849|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4084391|NCT01011673|3907850|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4084392|NCT01011673|3907848|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4084393|NCT01011673|3907849|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4084394|NCT01011673|3907850|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4084395|NCT01011673|3907848|B3|||Age||years|Mean|38|38.0|Standard Deviation|11|11.0|||
4084396|NCT01011673|3907849|B2|||Age||years|Mean|39|39.0|Standard Deviation|12|12.0|||
4084397|NCT01011673|3907850|B1|||Age||years|Mean|37|37.0|Standard Deviation|10|10.0|||
4084398|NCT01011673|3907848|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4084399|NCT01011673|3907849|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4084400|NCT01011673|3907850|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4084401|NCT01011673|3907848|B3||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
4084402|NCT01011673|3907849|B2||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4084403|NCT01011673|3907850|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4084405|NCT01011673|3907849|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084406|NCT01011673|3907850|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084407|NCT01011634|3907859|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4084408|NCT01011634|3907860|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4084409|NCT01011634|3907861|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4084410|NCT01011634|3907859|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4084411|NCT01011634|3907860|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4084412|NCT01011634|3907861|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4084413|NCT01011634|3907859|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4084414|NCT01011634|3907860|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4084415|NCT01011634|3907861|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4084416|NCT01011634|3907859|B3|>= 18 years old||Age, Customized|no baseline measurement as study stopped for low enrollment|participants|Number|18|18.0||||||
4084417|NCT01011634|3907860|B2|>= 18 years old||Age, Customized|no baseline measurement as study stopped for low enrollment|participants|Number|9|9.0||||||
4084418|NCT01011634|3907861|B1|>= 18 years old||Age, Customized|no baseline measurement as study stopped for low enrollment|participants|Number|9|9.0||||||
4084419|NCT01011556|3907870|B5|Romania||Region of Enrollment||participants|Number|30|30.0||||||
4084420|NCT01011556|3907871|B4|Romania||Region of Enrollment||participants|Number|11|11.0||||||
4084421|NCT01011556|3907872|B3|Romania||Region of Enrollment||participants|Number|4|4.0||||||
4084422|NCT01011556|3907873|B2|Romania||Region of Enrollment||participants|Number|7|7.0||||||
4084423|NCT01011556|3907874|B1|Romania||Region of Enrollment||participants|Number|8|8.0||||||
4084424|NCT01011556|3907870|B5|Argentina||Region of Enrollment||participants|Number|68|68.0||||||
4084425|NCT01011556|3907871|B4|Argentina||Region of Enrollment||participants|Number|18|18.0||||||
4084426|NCT01011556|3907872|B3|Argentina||Region of Enrollment||participants|Number|16|16.0||||||
4084427|NCT01011556|3907873|B2|Argentina||Region of Enrollment||participants|Number|17|17.0||||||
4084428|NCT01011556|3907874|B1|Argentina||Region of Enrollment||participants|Number|17|17.0||||||
4084429|NCT01011556|3907870|B5|Mexico||Region of Enrollment||participants|Number|24|24.0||||||
4084430|NCT01011556|3907871|B4|Mexico||Region of Enrollment||participants|Number|6|6.0||||||
4084431|NCT01011556|3907872|B3|Mexico||Region of Enrollment||participants|Number|5|5.0||||||
4084432|NCT01011556|3907873|B2|Mexico||Region of Enrollment||participants|Number|6|6.0||||||
4084433|NCT01011556|3907874|B1|Mexico||Region of Enrollment||participants|Number|7|7.0||||||
4084434|NCT01011556|3907870|B5|Hungary||Region of Enrollment||participants|Number|94|94.0||||||
4084435|NCT01011556|3907871|B4|Hungary||Region of Enrollment||participants|Number|25|25.0||||||
4084436|NCT01011556|3907872|B3|Hungary||Region of Enrollment||participants|Number|23|23.0||||||
4084437|NCT01011556|3907873|B2|Hungary||Region of Enrollment||participants|Number|25|25.0||||||
4084438|NCT01011556|3907874|B1|Hungary||Region of Enrollment||participants|Number|21|21.0||||||
4084439|NCT01011556|3907870|B5|Estonia||Region of Enrollment||participants|Number|15|15.0||||||
4084440|NCT01011556|3907871|B4|Estonia||Region of Enrollment||participants|Number|4|4.0||||||
4084441|NCT01011556|3907872|B3|Estonia||Region of Enrollment||participants|Number|6|6.0||||||
4084442|NCT01011556|3907873|B2|Estonia||Region of Enrollment||participants|Number|1|1.0||||||
4084443|NCT01011556|3907874|B1|Estonia||Region of Enrollment||participants|Number|4|4.0||||||
4084444|NCT01011556|3907870|B5|Spaniard||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4084445|NCT01011556|3907871|B4|Spaniard||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4084446|NCT01011556|3907872|B3|Spaniard||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4084447|NCT01011556|3907873|B2|Spaniard||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4084448|NCT01011556|3907874|B1|Spaniard||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4084449|NCT01011556|3907870|B5|South American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4084450|NCT01011556|3907871|B4|South American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4084451|NCT01011556|3907872|B3|South American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4084452|NCT01011556|3907873|B2|South American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4084453|NCT01011556|3907874|B1|South American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4084454|NCT01011556|3907870|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|137|137.0||||||
4084455|NCT01011556|3907871|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4084456|NCT01011556|3907872|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4084457|NCT01011556|3907873|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4084458|NCT01011556|3907874|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4084459|NCT01011556|3907870|B5|Mexican||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4084460|NCT01011556|3907871|B4|Mexican||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4084461|NCT01011556|3907872|B3|Mexican||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4084462|NCT01011556|3907873|B2|Mexican||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4084463|NCT01011556|3907874|B1|Mexican||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4084464|NCT01011556|3907870|B5|Latin American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4084465|NCT01011556|3907871|B4|Latin American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4084466|NCT01011556|3907872|B3|Latin American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4084467|NCT01011556|3907873|B2|Latin American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4084468|NCT01011556|3907874|B1|Latin American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4084469|NCT01011556|3907870|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
4084470|NCT01011556|3907871|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4084471|NCT01011556|3907872|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4084472|NCT01011556|3907873|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4084473|NCT01011556|3907874|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4084474|NCT01011556|3907870|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4084475|NCT01011556|3907871|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4084476|NCT01011556|3907872|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4084477|NCT01011556|3907873|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4084478|NCT01011556|3907874|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4084479|NCT01011556|3907870|B5||Female|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
4084480|NCT01011556|3907871|B4||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4084481|NCT01011556|3907872|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4084482|NCT01011556|3907873|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4084483|NCT01011556|3907874|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4084484|NCT01011556|3907870|B5|||Age||years|Mean|65.4|65.4|Standard Deviation|7.8|7.8|||
4084485|NCT01011556|3907871|B4|||Age||years|Mean|65.1|65.1|Standard Deviation|7.2|7.2|||
4084486|NCT01011556|3907872|B3|||Age||years|Mean|67.6|67.6|Standard Deviation|8.4|8.4|||
4084487|NCT01011556|3907873|B2|||Age||years|Mean|65.0|65.0|Standard Deviation|8.3|8.3|||
4084488|NCT01011556|3907874|B1|||Age||years|Mean|63.9|63.9|Standard Deviation|7.2|7.2|||
4084489|NCT01011465|3907947|B9|United States||Region of Enrollment||participants|Number|270|270.0||||||
4084490|NCT01011465|3907948|B8|United States||Region of Enrollment||participants|Number|32|32.0||||||
4084491|NCT01011465|3907949|B7|United States||Region of Enrollment||participants|Number|52|52.0||||||
4084492|NCT01011465|3907950|B6|United States||Region of Enrollment||participants|Number|29|29.0||||||
4084493|NCT01011465|3907951|B5|United States||Region of Enrollment||participants|Number|47|47.0||||||
4084494|NCT01011465|3907952|B4|United States||Region of Enrollment||participants|Number|18|18.0||||||
4084495|NCT01011465|3907953|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4084496|NCT01011465|3907954|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4084497|NCT01011465|3907955|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4084498|NCT01011465|3907947|B9||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4084499|NCT01011465|3907948|B8||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4084500|NCT01011465|3907949|B7||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4084501|NCT01011465|3907950|B6||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4084502|NCT01011465|3907951|B5||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4084503|NCT01011465|3907952|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4084504|NCT01011465|3907953|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4084505|NCT01011465|3907954|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4084506|NCT01011465|3907955|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4084507|NCT01011465|3907947|B9||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4084508|NCT01011465|3907948|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4084509|NCT01011465|3907949|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4084510|NCT01011465|3907950|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4084511|NCT01011465|3907951|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4084512|NCT01011465|3907952|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4084513|NCT01011465|3907953|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4084514|NCT01011465|3907954|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4084515|NCT01011465|3907955|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4084516|NCT01011465|3907947|B9|||Age||years|Mean|33.2|33.2|Standard Deviation|11.0|11.0|||
4084517|NCT01011465|3907948|B8|||Age||years|Mean|32.4|32.4|Standard Deviation|9.7|9.7|||
4084518|NCT01011465|3907949|B7|||Age||years|Mean|36.0|36.0|Standard Deviation|12.1|12.1|||
4084519|NCT01011465|3907950|B6|||Age||years|Mean|28.4|28.4|Standard Deviation|9.0|9.0|||
4084520|NCT01011465|3907951|B5|||Age||years|Mean|34.8|34.8|Standard Deviation|11.8|11.8|||
4084521|NCT01011465|3907952|B4|||Age||years|Mean|33.7|33.7|Standard Deviation|13.2|13.2|||
4084522|NCT01011465|3907953|B3|||Age||years|Mean|34.3|34.3|Standard Deviation|10.7|10.7|||
4084523|NCT01011465|3907954|B2|||Age||years|Mean|28.7|28.7|Standard Deviation|6.2|6.2|||
4084524|NCT01011465|3907955|B1|||Age||years|Mean|32.9|32.9|Standard Deviation|11.2|11.2|||
4084525|NCT01011465|3907947|B9||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4084526|NCT01011465|3907948|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4084527|NCT01011465|3907949|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4084528|NCT01011465|3907950|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4084529|NCT01011465|3907951|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4084530|NCT01011465|3907952|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4084531|NCT01011465|3907953|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4084532|NCT01011465|3907954|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4084533|NCT01011465|3907955|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4084534|NCT01011465|3907947|B9||Between 18 and 65 years|Age||Participants|Count of Participants|270|270.0||||||
4084535|NCT01011465|3907948|B8||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4084536|NCT01011465|3907949|B7||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4084537|NCT01011465|3907950|B6||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4084538|NCT01011465|3907951|B5||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4084539|NCT01011465|3907952|B4||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4084540|NCT01011465|3907953|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4084541|NCT01011465|3907954|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4084542|NCT01011465|3907955|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4084543|NCT01011465|3907947|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084544|NCT01011465|3907948|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084545|NCT01011465|3907949|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084546|NCT01011465|3907950|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084547|NCT01011465|3907951|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084548|NCT01011465|3907952|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084549|NCT01011465|3907953|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084550|NCT01011465|3907954|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084551|NCT01011465|3907955|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084552|NCT01011439|3907990|B1|Not Listed||Masaoka clinical staging at study entry|Staging used to evaluate invasiveness of the tumor.|Participants|Count of Participants|7|7.0||||||
4084553|NCT01011439|3907990|B1|Stage IVB:hematogeneous or lymphatic dissemination||Masaoka clinical staging at study entry|Staging used to evaluate invasiveness of the tumor.|Participants|Count of Participants|51|51.0||||||
4084554|NCT01011439|3907990|B1|Stage IV A: pleural or pericardial dissemination||Masaoka clinical staging at study entry|Staging used to evaluate invasiveness of the tumor.|Participants|Count of Participants|13|13.0||||||
4084555|NCT01011439|3907990|B1|Stage III: macroscopic invasion neighboring organs||Masaoka clinical staging at study entry|Staging used to evaluate invasiveness of the tumor.|Participants|Count of Participants|1|1.0||||||
4084556|NCT01011439|3907990|B1|Stage II: thymoma invades beyond the capsule||Masaoka clinical staging at study entry|Staging used to evaluate invasiveness of the tumor.|Participants|Count of Participants|0|0.0||||||
4084557|NCT01011439|3907990|B1|Stage I: grossly and microscopically encapsulated||Masaoka clinical staging at study entry|Staging used to evaluate invasiveness of the tumor.|Participants|Count of Participants|0|0.0||||||
4084558|NCT01011439|3907990|B1|Metastatic||Tumor extent at study entry||Participants|Count of Participants|71|71.0||||||
4084559|NCT01011439|3907990|B1|Locally advanced||Tumor extent at study entry||Participants|Count of Participants|1|1.0||||||
4084560|NCT01011439|3907990|B1|C - Thymic Carcinoma||WHO - Classification||Participants|Count of Participants|52|52.0||||||
4084561|NCT01011439|3907990|B1|B3 - Well differantiated thymic carcinoma||WHO - Classification||Participants|Count of Participants|20|20.0||||||
4084562|NCT01011439|3907990|B1|France||Region of Enrollment||participants|Number|23|23.0||||||
4084563|NCT01011439|3907990|B1|Italy||Region of Enrollment||participants|Number|36|36.0||||||
4084564|NCT01011439|3907990|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4084565|NCT01011439|3907990|B1|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4084566|NCT01011439|3907990|B1|Not allowed to ask per local regulation||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4084567|NCT01011439|3907990|B1|Not Listed||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4084568|NCT01011439|3907990|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4084569|NCT01011439|3907990|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4084570|NCT01011439|3907990|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
4084571|NCT01011439|3907990|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4084572|NCT01011439|3907990|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4084573|NCT01011439|3907990|B1|||Age||years|Mean|53.2|53.2|Standard Deviation|13.3|13.3|||
4084574|NCT01011439|3907990|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4084575|NCT01011439|3907990|B1||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4084576|NCT01011439|3907990|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084577|NCT01011387|3908000|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4084578|NCT01011387|3908000|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4084579|NCT01011387|3908000|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4084580|NCT01011387|3908000|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4084581|NCT01011387|3908000|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084582|NCT01011335|3908004|B5|All Other||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4084583|NCT01011335|3908005|B4|All Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4084584|NCT01011335|3908006|B3|All Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4084585|NCT01011335|3908007|B2|All Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4084586|NCT01011335|3908008|B1|All Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4084587|NCT01011335|3908004|B5|Black||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4084588|NCT01011335|3908005|B4|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4084589|NCT01011335|3908006|B3|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4084590|NCT01011335|3908007|B2|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4084591|NCT01011335|3908008|B1|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4084592|NCT01011335|3908004|B5|White||Race/Ethnicity, Customized||participants|Number|132|132.0||||||
4084593|NCT01011335|3908005|B4|White||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4084594|NCT01011335|3908006|B3|White||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4084595|NCT01011335|3908007|B2|White||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4084596|NCT01011335|3908008|B1|White||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4084597|NCT01011335|3908004|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084598|NCT01011335|3908005|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084599|NCT01011335|3908006|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084600|NCT01011335|3908007|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084601|NCT01011335|3908008|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084602|NCT01011335|3908004|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|149|149.0||||||
4084603|NCT01011335|3908005|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4084604|NCT01011335|3908006|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4084605|NCT01011335|3908007|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4084606|NCT01011335|3908008|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4084607|NCT01011335|3908004|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4084608|NCT01011335|3908005|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4084609|NCT01011335|3908006|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4084610|NCT01011335|3908007|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4084611|NCT01011335|3908008|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4084612|NCT01011335|3908004|B5||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4084613|NCT01011335|3908005|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4084614|NCT01011335|3908006|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4084615|NCT01011335|3908007|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4084616|NCT01011335|3908008|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4084617|NCT01011335|3908004|B5||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4084618|NCT01011335|3908005|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4084619|NCT01011335|3908006|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4084620|NCT01011335|3908007|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4084621|NCT01011335|3908008|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4084622|NCT01011335|3908004|B5|||Age||years|Mean|32.1|32.1|Standard Deviation|9.3|9.3|||
4084623|NCT01011335|3908005|B4|||Age||years|Mean|32.9|32.9|Standard Deviation|10.2|10.2|||
4084624|NCT01011335|3908006|B3|||Age||years|Mean|32.0|32.0|Standard Deviation|8.6|8.6|||
4084625|NCT01011335|3908007|B2|||Age||years|Mean|31.1|31.1|Standard Deviation|8.6|8.6|||
4084626|NCT01011335|3908008|B1|||Age||years|Mean|32.5|32.5|Standard Deviation|10.0|10.0|||
4084627|NCT01011309|3908057|B4|Peru||Region of Enrollment||participants|Number|45|45.0||||||
4084628|NCT01011309|3908058|B3|Peru||Region of Enrollment||participants|Number|21|21.0||||||
4084629|NCT01011309|3908059|B2|Peru||Region of Enrollment||participants|Number|10|10.0||||||
4084630|NCT01011309|3908060|B1|Peru||Region of Enrollment||participants|Number|14|14.0||||||
4084631|NCT01011309|3908057|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4084632|NCT01011309|3908058|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4084633|NCT01011309|3908059|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4084634|NCT01011309|3908060|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4084635|NCT01011309|3908057|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4084636|NCT01011309|3908058|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4084637|NCT01011309|3908059|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4084638|NCT01011309|3908060|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4084639|NCT01011309|3908057|B4|||Age||years|Mean|38.0|38.0|Standard Deviation|14.0|14.0|||
4084640|NCT01011309|3908058|B3|||Age||years|Mean|40.2|40.2|Standard Deviation|16.0|16.0|||
4084641|NCT01011309|3908059|B2|||Age||years|Mean|32.7|32.7|Standard Deviation|6.8|6.8|||
4084642|NCT01011309|3908060|B1|||Age||years|Mean|38.3|38.3|Standard Deviation|14.2|14.2|||
4084643|NCT01011309|3908057|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4084644|NCT01011309|3908058|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4084645|NCT01011309|3908059|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4084646|NCT01011309|3908060|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4084647|NCT01011309|3908057|B4||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4084648|NCT01011309|3908058|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4084649|NCT01011309|3908059|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4084650|NCT01011309|3908060|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4084651|NCT01011309|3908057|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084652|NCT01011309|3908058|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084653|NCT01011309|3908059|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084654|NCT01011309|3908060|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084655|NCT01011283|3908076|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084656|NCT01011283|3908077|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084657|NCT01011283|3908078|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084658|NCT01011283|3908076|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084659|NCT01011283|3908077|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084660|NCT01011283|3908078|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084661|NCT01011283|3908076|B3||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4084662|NCT01011283|3908077|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4084663|NCT01011283|3908078|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4084664|NCT01011283|3908076|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4084665|NCT01011283|3908077|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4084666|NCT01011283|3908078|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084667|NCT01011283|3908076|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084668|NCT01011283|3908077|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084669|NCT01011283|3908078|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084670|NCT01011283|3908076|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084671|NCT01011283|3908077|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084672|NCT01011283|3908078|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084673|NCT01011283|3908076|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084674|NCT01011283|3908077|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084675|NCT01011283|3908078|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084676|NCT01011283|3908076|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084677|NCT01011283|3908077|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084678|NCT01011283|3908078|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084679|NCT01011283|3908076|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4084680|NCT01011283|3908077|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4084681|NCT01011283|3908078|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4084682|NCT01011283|3908076|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4084683|NCT01011283|3908077|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4084684|NCT01011283|3908078|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084685|NCT01011283|3908076|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4084686|NCT01011283|3908077|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4084687|NCT01011283|3908078|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4084688|NCT01011283|3908076|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4084689|NCT01011283|3908077|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4084690|NCT01011283|3908078|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4084691|NCT01011283|3908076|B3|||Age||years|Mean|72.3|72.3|Standard Deviation|10.35|10.35|||
4084692|NCT01011283|3908077|B2|||Age||years|Mean|70.8|70.8|Standard Deviation|9.13|9.13|||
4084693|NCT01011283|3908078|B1|||Age||years|Mean|73.8|73.8|Standard Deviation|11.60|11.6|||
4084694|NCT01011218|3908087|B5|United States||Region of Enrollment||participants|Number|70|70.0||||||
4084695|NCT01011218|3908088|B4|United States||Region of Enrollment||participants|Number|26|26.0||||||
4084696|NCT01011218|3908089|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4084697|NCT01011218|3908090|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4084698|NCT01011218|3908091|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4084699|NCT01011218|3908087|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084700|NCT01011218|3908088|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084701|NCT01011218|3908089|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084702|NCT01011218|3908090|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084703|NCT01011218|3908091|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084704|NCT01011218|3908087|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4084705|NCT01011218|3908088|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4084706|NCT01011218|3908089|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4084707|NCT01011218|3908090|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4084708|NCT01011218|3908091|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4084709|NCT01011218|3908087|B5||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4084710|NCT01011218|3908088|B4||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4084711|NCT01011218|3908089|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4084712|NCT01011218|3908090|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4084713|NCT01011218|3908091|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4084714|NCT01011218|3908087|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4084715|NCT01011218|3908088|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4084716|NCT01011218|3908089|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4084717|NCT01011218|3908090|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084718|NCT01011218|3908091|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084719|NCT01011218|3908087|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4084720|NCT01011218|3908088|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084721|NCT01011218|3908089|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4084722|NCT01011218|3908090|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084723|NCT01011218|3908091|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084724|NCT01011218|3908087|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4084725|NCT01011218|3908088|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4084726|NCT01011218|3908089|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4084727|NCT01011218|3908090|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084728|NCT01011218|3908091|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084729|NCT01011218|3908087|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4084730|NCT01011218|3908088|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4084731|NCT01011218|3908089|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084732|NCT01011218|3908090|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084733|NCT01011218|3908091|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084734|NCT01011218|3908087|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4084735|NCT01011218|3908088|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4084736|NCT01011218|3908089|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4084737|NCT01011218|3908090|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4084738|NCT01011218|3908091|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4084739|NCT01011218|3908087|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4084740|NCT01011218|3908088|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4084741|NCT01011218|3908089|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4084742|NCT01011218|3908090|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4084743|NCT01011218|3908091|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4084744|NCT01011218|3908087|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4084745|NCT01011218|3908088|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4084746|NCT01011218|3908089|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4084747|NCT01011218|3908090|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4084748|NCT01011218|3908091|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4084749|NCT01011218|3908087|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4084750|NCT01011218|3908088|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4084751|NCT01011218|3908089|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4084752|NCT01011218|3908090|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4084753|NCT01011218|3908091|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4084754|NCT01011218|3908087|B5||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4084755|NCT01011218|3908088|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4084756|NCT01011218|3908089|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4084757|NCT01011218|3908090|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4084758|NCT01011218|3908091|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4084759|NCT01011218|3908087|B5|||Age||years|Mean|50.1|50.1|Standard Deviation|9.0|9.0|||
4084760|NCT01011218|3908088|B4|||Age||years|Mean|50.3|50.3|Standard Deviation|8.6|8.6|||
4084761|NCT01011218|3908089|B3|||Age||years|Mean|51.5|51.5|Standard Deviation|9.0|9.0|||
4084762|NCT01011218|3908090|B2|||Age||years|Mean|46.7|46.7|Standard Deviation|9.2|9.2|||
4084763|NCT01011218|3908091|B1|||Age||years|Mean|49.1|49.1|Standard Deviation|10.5|10.5|||
4084764|NCT01011218|3908087|B5||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4084765|NCT01011218|3908088|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4084766|NCT01011218|3908089|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4084767|NCT01011218|3908090|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4084768|NCT01011218|3908091|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4084769|NCT01011218|3908087|B5||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4084770|NCT01011218|3908088|B4||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4084771|NCT01011218|3908089|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4084772|NCT01011218|3908090|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4084773|NCT01011218|3908091|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4084774|NCT01011218|3908087|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084775|NCT01011218|3908088|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084776|NCT01011218|3908089|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084777|NCT01011218|3908090|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084778|NCT01011218|3908091|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084779|NCT01011179|3908116|B3|Canada||Region of Enrollment||participants|Number|46|46.0||||||
4084780|NCT01011179|3908117|B2|Canada||Region of Enrollment||participants|Number|22|22.0||||||
4084781|NCT01011179|3908118|B1|Canada||Region of Enrollment||participants|Number|24|24.0||||||
4084782|NCT01011179|3908116|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4084783|NCT01011179|3908117|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4084784|NCT01011179|3908118|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4084785|NCT01011179|3908116|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4084786|NCT01011179|3908117|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4084787|NCT01011179|3908118|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4084788|NCT01011179|3908116|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4084789|NCT01011179|3908117|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4084790|NCT01011179|3908118|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4084791|NCT01011179|3908116|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4084792|NCT01011179|3908117|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4084793|NCT01011179|3908118|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4084794|NCT01011179|3908116|B3||<=18 years|Age||Participants|Count of Participants|46|46.0||||||
4084795|NCT01011179|3908117|B2||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
4084796|NCT01011179|3908118|B1||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
4084797|NCT01011153|3908125|B4|United States||Region of Enrollment||participants|Number|183|183.0||||||
4084798|NCT01011153|3908126|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
4084799|NCT01011153|3908127|B2|United States||Region of Enrollment||participants|Number|75|75.0||||||
4084800|NCT01011153|3908128|B1|United States||Region of Enrollment||participants|Number|54|54.0||||||
4084801|NCT01011153|3908125|B4|Unknown||Sex/Gender, Customized||participants|Number|15|15.0||||||
4084802|NCT01011153|3908126|B3|Unknown||Sex/Gender, Customized||participants|Number|5|5.0||||||
4084803|NCT01011153|3908127|B2|Unknown||Sex/Gender, Customized||participants|Number|4|4.0||||||
4084804|NCT01011153|3908128|B1|Unknown||Sex/Gender, Customized||participants|Number|6|6.0||||||
4084805|NCT01011153|3908125|B4|Male||Sex/Gender, Customized||participants|Number|93|93.0||||||
4084806|NCT01011153|3908126|B3|Male||Sex/Gender, Customized||participants|Number|26|26.0||||||
4084807|NCT01011153|3908127|B2|Male||Sex/Gender, Customized||participants|Number|35|35.0||||||
4084808|NCT01011153|3908128|B1|Male||Sex/Gender, Customized||participants|Number|32|32.0||||||
4084809|NCT01011153|3908125|B4|Female||Sex/Gender, Customized||participants|Number|75|75.0||||||
4084810|NCT01011153|3908126|B3|Female||Sex/Gender, Customized||participants|Number|23|23.0||||||
4084811|NCT01011153|3908127|B2|Female||Sex/Gender, Customized||participants|Number|36|36.0||||||
4084812|NCT01011153|3908128|B1|Female||Sex/Gender, Customized||participants|Number|16|16.0||||||
4084813|NCT01011153|3908125|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4084814|NCT01011153|3908126|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4084815|NCT01011153|3908127|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4084816|NCT01011153|3908128|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4084817|NCT01011153|3908125|B4||Between 18 and 65 years|Age||Participants|Count of Participants|183|183.0||||||
4084818|NCT01011153|3908126|B3||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4084819|NCT01011153|3908127|B2||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4084820|NCT01011153|3908128|B1||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4084821|NCT01011153|3908125|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084822|NCT01011153|3908126|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084823|NCT01011153|3908127|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084824|NCT01011153|3908128|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084825|NCT01011075|3908148|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4084826|NCT01011075|3908148|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4084827|NCT01011075|3908148|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4084828|NCT01011075|3908148|B1|||Age||years|Mean|74.5|74.5|Standard Deviation|4.6|4.6|||
4084829|NCT01011075|3908148|B1||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
4084830|NCT01011075|3908148|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4084831|NCT01011075|3908148|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084832|NCT01011049|3908155|B5|United States||Region of Enrollment||Participants|Number|1248|1248.0||||||
4084833|NCT01011049|3908156|B4|United States||Region of Enrollment||Participants|Number|246|246.0||||||
4084834|NCT01011049|3908157|B3|United States||Region of Enrollment||Participants|Number|243|243.0||||||
4084835|NCT01011049|3908158|B2|United States||Region of Enrollment||Participants|Number|252|252.0||||||
4084836|NCT01011049|3908159|B1|United States||Region of Enrollment||Participants|Number|507|507.0||||||
4084837|NCT01011049|3908155|B5||Male|Sex: Female, Male||Participants|Count of Participants|450|450.0||||||
4084838|NCT01011049|3908156|B4||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4084839|NCT01011049|3908157|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4084840|NCT01011049|3908158|B2||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4084841|NCT01011049|3908159|B1||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4084842|NCT01011049|3908155|B5||Female|Sex: Female, Male||Participants|Count of Participants|798|798.0||||||
4084843|NCT01011049|3908156|B4||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4084844|NCT01011049|3908157|B3||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4084845|NCT01011049|3908158|B2||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4084846|NCT01011049|3908159|B1||Female|Sex: Female, Male||Participants|Count of Participants|324|324.0||||||
4084847|NCT01011049|3908155|B5|||Age||Years|Mean|45|45.0|Standard Deviation|13|13.0|||
4084848|NCT01011049|3908156|B4|||Age||Years|Mean|43.7|43.7|Standard Deviation|12.78|12.78|||
4084849|NCT01011049|3908157|B3|||Age||Years|Mean|45.8|45.8|Standard Deviation|12.74|12.74|||
4084850|NCT01011049|3908158|B2|||Age||Years|Mean|44.8|44.8|Standard Deviation|13.26|13.26|||
4084851|NCT01011049|3908159|B1|||Age||Years|Mean|45.2|45.2|Standard Deviation|13.10|13.1|||
4084852|NCT01011049|3908155|B5||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4084853|NCT01011049|3908156|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4084854|NCT01011049|3908157|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4084855|NCT01011049|3908158|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4084856|NCT01011049|3908159|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4084857|NCT01011049|3908155|B5||Between 18 and 65 years|Age||Participants|Count of Participants|1247|1247.0||||||
4084858|NCT01011049|3908156|B4||Between 18 and 65 years|Age||Participants|Count of Participants|246|246.0||||||
4084859|NCT01011049|3908157|B3||Between 18 and 65 years|Age||Participants|Count of Participants|242|242.0||||||
4084860|NCT01011049|3908158|B2||Between 18 and 65 years|Age||Participants|Count of Participants|252|252.0||||||
4084861|NCT01011049|3908159|B1||Between 18 and 65 years|Age||Participants|Count of Participants|507|507.0||||||
4084862|NCT01011049|3908155|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084863|NCT01011049|3908156|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084864|NCT01011049|3908157|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084865|NCT01011049|3908158|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084866|NCT01011049|3908159|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084867|NCT01010984|3908184|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084868|NCT01010984|3908184|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084869|NCT01010984|3908184|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4084870|NCT01010984|3908184|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084871|NCT01010984|3908184|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084872|NCT01010984|3908184|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084873|NCT01010984|3908184|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084874|NCT01010984|3908184|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4084875|NCT01010984|3908184|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4084876|NCT01010984|3908184|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4084877|NCT01010984|3908184|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4084878|NCT01010984|3908184|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4084960|NCT01010971|3908190|B3|AM and PM nasal itching||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.15|2.15|Standard Deviation|0.66|0.66|||
4084879|NCT01010971|3908189|B4|||Baseline Rhinoconjunctivitis Quality of Life Questionnaire [RQLQ(S)] ≥3.0|RQLQ(S) in subjects with baseline RQLQ[S] score ≥3.0. RQLQ(S) consists of 28 questions, each question measured on a scale of 0-6 where a higher score indicates poor quality of life. Domains: Activities (questions 1-3), Sleep (questions 4-6), Non-Nose/Eye Symptoms (questions 7-13), Practical Problems (questions 14-16), Nasal Symptoms (questions 17-20), Eye Symptoms (questions 21-24), and Emotional (questions 25-28). The overall RQLQ(S) score was calculated as the average of the mean domain scores.|units on a scale|Mean|4.36|4.36|Standard Deviation|0.82|0.82|||
4084880|NCT01010971|3908190|B3|||Baseline Rhinoconjunctivitis Quality of Life Questionnaire [RQLQ(S)] ≥3.0|RQLQ(S) in subjects with baseline RQLQ[S] score ≥3.0. RQLQ(S) consists of 28 questions, each question measured on a scale of 0-6 where a higher score indicates poor quality of life. Domains: Activities (questions 1-3), Sleep (questions 4-6), Non-Nose/Eye Symptoms (questions 7-13), Practical Problems (questions 14-16), Nasal Symptoms (questions 17-20), Eye Symptoms (questions 21-24), and Emotional (questions 25-28). The overall RQLQ(S) score was calculated as the average of the mean domain scores.|units on a scale|Mean|4.36|4.36|Standard Deviation|0.78|0.78|||
4084881|NCT01010971|3908191|B2|||Baseline Rhinoconjunctivitis Quality of Life Questionnaire [RQLQ(S)] ≥3.0|RQLQ(S) in subjects with baseline RQLQ[S] score ≥3.0. RQLQ(S) consists of 28 questions, each question measured on a scale of 0-6 where a higher score indicates poor quality of life. Domains: Activities (questions 1-3), Sleep (questions 4-6), Non-Nose/Eye Symptoms (questions 7-13), Practical Problems (questions 14-16), Nasal Symptoms (questions 17-20), Eye Symptoms (questions 21-24), and Emotional (questions 25-28). The overall RQLQ(S) score was calculated as the average of the mean domain scores.|units on a scale|Mean|4.42|4.42|Standard Deviation|0.87|0.87|||
4084882|NCT01010971|3908192|B1|||Baseline Rhinoconjunctivitis Quality of Life Questionnaire [RQLQ(S)] ≥3.0|RQLQ(S) in subjects with baseline RQLQ[S] score ≥3.0. RQLQ(S) consists of 28 questions, each question measured on a scale of 0-6 where a higher score indicates poor quality of life. Domains: Activities (questions 1-3), Sleep (questions 4-6), Non-Nose/Eye Symptoms (questions 7-13), Practical Problems (questions 14-16), Nasal Symptoms (questions 17-20), Eye Symptoms (questions 21-24), and Emotional (questions 25-28). The overall RQLQ(S) score was calculated as the average of the mean domain scores.|units on a scale|Mean|4.30|4.3|Standard Deviation|0.80|0.8|||
4084883|NCT01010971|3908189|B4|AM and PM tearing eyes||Baseline Individual Instantaneous Ocular Symptom Score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.26|2.26|Standard Deviation|0.48|0.48|||
4084884|NCT01010971|3908190|B3|AM and PM tearing eyes||Baseline Individual Instantaneous Ocular Symptom Score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.26|2.26|Standard Deviation|0.42|0.42|||
4084885|NCT01010971|3908191|B2|AM and PM tearing eyes||Baseline Individual Instantaneous Ocular Symptom Score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.28|2.28|Standard Deviation|0.50|0.5|||
4084886|NCT01010971|3908192|B1|AM and PM tearing eyes||Baseline Individual Instantaneous Ocular Symptom Score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.23|2.23|Standard Deviation|0.50|0.5|||
4084887|NCT01010971|3908189|B4|AM and PM redness of eyes||Baseline Individual Instantaneous Ocular Symptom Score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.29|2.29|Standard Deviation|0.54|0.54|||
4084888|NCT01010971|3908190|B3|AM and PM redness of eyes||Baseline Individual Instantaneous Ocular Symptom Score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.29|2.29|Standard Deviation|0.50|0.5|||
4085110|NCT01010971|3908192|B1|Native Hawaiin or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4085111|NCT01010971|3908189|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4085112|NCT01010971|3908190|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4084889|NCT01010971|3908191|B2|AM and PM redness of eyes||Baseline Individual Instantaneous Ocular Symptom Score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.26|2.26|Standard Deviation|0.58|0.58|||
4084890|NCT01010971|3908192|B1|AM and PM redness of eyes||Baseline Individual Instantaneous Ocular Symptom Score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.32|2.32|Standard Deviation|0.54|0.54|||
4084891|NCT01010971|3908189|B4|AM and PM itching eyes||Baseline Individual Instantaneous Ocular Symptom Score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.43|2.43|Standard Deviation|0.43|0.43|||
4084892|NCT01010971|3908190|B3|AM and PM itching eyes||Baseline Individual Instantaneous Ocular Symptom Score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.43|2.43|Standard Deviation|0.44|0.44|||
4084893|NCT01010971|3908191|B2|AM and PM itching eyes||Baseline Individual Instantaneous Ocular Symptom Score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.43|2.43|Standard Deviation|0.44|0.44|||
4084894|NCT01010971|3908192|B1|AM and PM itching eyes||Baseline Individual Instantaneous Ocular Symptom Score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.44|2.44|Standard Deviation|0.42|0.42|||
4084895|NCT01010971|3908189|B4|PM tearing eyes||Baseline Individual Instantaneous Ocular Symptom Score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.22|2.22|Standard Deviation|0.54|0.54|||
4084896|NCT01010971|3908190|B3|PM tearing eyes||Baseline Individual Instantaneous Ocular Symptom Score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.22|2.22|Standard Deviation|0.48|0.48|||
4084897|NCT01010971|3908191|B2|PM tearing eyes||Baseline Individual Instantaneous Ocular Symptom Score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.25|2.25|Standard Deviation|0.56|0.56|||
4084898|NCT01010971|3908192|B1|PM tearing eyes||Baseline Individual Instantaneous Ocular Symptom Score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.19|2.19|Standard Deviation|0.57|0.57|||
4085113|NCT01010971|3908191|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4084899|NCT01010971|3908189|B4|PM redness of eyes||Baseline Individual Instantaneous Ocular Symptom Score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.27|2.27|Standard Deviation|0.58|0.58|||
4084900|NCT01010971|3908190|B3|PM redness of eyes||Baseline Individual Instantaneous Ocular Symptom Score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.28|2.28|Standard Deviation|0.54|0.54|||
4084901|NCT01010971|3908191|B2|PM redness of eyes||Baseline Individual Instantaneous Ocular Symptom Score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.24|2.24|Standard Deviation|0.62|0.62|||
4084902|NCT01010971|3908192|B1|PM redness of eyes||Baseline Individual Instantaneous Ocular Symptom Score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.30|2.3|Standard Deviation|0.58|0.58|||
4084903|NCT01010971|3908189|B4|PM itching eyes||Baseline Individual Instantaneous Ocular Symptom Score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.41|2.41|Standard Deviation|0.47|0.47|||
4084904|NCT01010971|3908190|B3|PM itching eyes||Baseline Individual Instantaneous Ocular Symptom Score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.41|2.41|Standard Deviation|0.47|0.47|||
4084905|NCT01010971|3908191|B2|PM itching eyes||Baseline Individual Instantaneous Ocular Symptom Score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.40|2.4|Standard Deviation|0.50|0.5|||
4084906|NCT01010971|3908192|B1|PM itching eyes||Baseline Individual Instantaneous Ocular Symptom Score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.41|2.41|Standard Deviation|0.46|0.46|||
4084907|NCT01010971|3908189|B4|AM tearing eyes||Baseline Individual Instantaneous Ocular Symptom Score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.29|2.29|Standard Deviation|0.49|0.49|||
4084908|NCT01010971|3908190|B3|AM tearing eyes||Baseline Individual Instantaneous Ocular Symptom Score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.29|2.29|Standard Deviation|0.45|0.45|||
4085114|NCT01010971|3908192|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4084909|NCT01010971|3908191|B2|AM tearing eyes||Baseline Individual Instantaneous Ocular Symptom Score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.32|2.32|Standard Deviation|0.52|0.52|||
4084910|NCT01010971|3908192|B1|AM tearing eyes||Baseline Individual Instantaneous Ocular Symptom Score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.26|2.26|Standard Deviation|0.50|0.5|||
4084911|NCT01010971|3908189|B4|AM redness of eyes||Baseline Individual Instantaneous Ocular Symptom Score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.31|2.31|Standard Deviation|0.56|0.56|||
4084912|NCT01010971|3908190|B3|AM redness of eyes||Baseline Individual Instantaneous Ocular Symptom Score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.31|2.31|Standard Deviation|0.52|0.52|||
4084913|NCT01010971|3908191|B2|AM redness of eyes||Baseline Individual Instantaneous Ocular Symptom Score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.29|2.29|Standard Deviation|0.60|0.6|||
4084914|NCT01010971|3908192|B1|AM redness of eyes||Baseline Individual Instantaneous Ocular Symptom Score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.34|2.34|Standard Deviation|0.56|0.56|||
4084915|NCT01010971|3908189|B4|AM itching eyes||Baseline Individual Instantaneous Ocular Symptom Score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.46|2.46|Standard Deviation|0.44|0.44|||
4084916|NCT01010971|3908190|B3|AM itching eyes||Baseline Individual Instantaneous Ocular Symptom Score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.45|2.45|Standard Deviation|0.47|0.47|||
4084917|NCT01010971|3908191|B2|AM itching eyes||Baseline Individual Instantaneous Ocular Symptom Score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.47|2.47|Standard Deviation|0.44|0.44|||
4084918|NCT01010971|3908192|B1|AM itching eyes||Baseline Individual Instantaneous Ocular Symptom Score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.47|2.47|Standard Deviation|0.43|0.43|||
4085115|NCT01010971|3908189|B4|Asian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4085116|NCT01010971|3908190|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4084919|NCT01010971|3908189|B4|AM and PM tearing eyes||Baseline Individual Reflective Ocular Symptom Score (rOSS) in Subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms.)Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.30|2.3|Standard Deviation|0.49|0.49|||
4084920|NCT01010971|3908190|B3|AM and PM tearing eyes||Baseline Individual Reflective Ocular Symptom Score (rOSS) in Subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms.)Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.27|2.27|Standard Deviation|0.48|0.48|||
4084921|NCT01010971|3908191|B2|AM and PM tearing eyes||Baseline Individual Reflective Ocular Symptom Score (rOSS) in Subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms.)Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.35|2.35|Standard Deviation|0.49|0.49|||
4084922|NCT01010971|3908192|B1|AM and PM tearing eyes||Baseline Individual Reflective Ocular Symptom Score (rOSS) in Subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms.)Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.27|2.27|Standard Deviation|0.49|0.49|||
4084923|NCT01010971|3908189|B4|AM and PM redness of eyes||Baseline Individual Reflective Ocular Symptom Score (rOSS) in Subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms.)Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.27|2.27|Standard Deviation|0.59|0.59|||
4084924|NCT01010971|3908190|B3|AM and PM redness of eyes||Baseline Individual Reflective Ocular Symptom Score (rOSS) in Subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms.)Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.24|2.24|Standard Deviation|0.59|0.59|||
4084925|NCT01010971|3908191|B2|AM and PM redness of eyes||Baseline Individual Reflective Ocular Symptom Score (rOSS) in Subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms.)Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.27|2.27|Standard Deviation|0.62|0.62|||
4084926|NCT01010971|3908192|B1|AM and PM redness of eyes||Baseline Individual Reflective Ocular Symptom Score (rOSS) in Subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms.)Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.29|2.29|Standard Deviation|0.55|0.55|||
4084927|NCT01010971|3908189|B4|AM and PM itching eyes||Baseline Individual Reflective Ocular Symptom Score (rOSS) in Subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms.)Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.48|2.48|Standard Deviation|0.43|0.43|||
4084928|NCT01010971|3908190|B3|AM and PM itching eyes||Baseline Individual Reflective Ocular Symptom Score (rOSS) in Subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms.)Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.46|2.46|Standard Deviation|0.44|0.44|||
4085117|NCT01010971|3908191|B2|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4085118|NCT01010971|3908192|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4084929|NCT01010971|3908191|B2|AM and PM itching eyes||Baseline Individual Reflective Ocular Symptom Score (rOSS) in Subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms.)Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.51|2.51|Standard Deviation|0.43|0.43|||
4084930|NCT01010971|3908192|B1|AM and PM itching eyes||Baseline Individual Reflective Ocular Symptom Score (rOSS) in Subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms.)Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.48|2.48|Standard Deviation|0.43|0.43|||
4084931|NCT01010971|3908189|B4|PM tearing eyes||Baseline Individual Reflective Ocular Symptom Score (rOSS) in Subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms.)Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.28|2.28|Standard Deviation|0.53|0.53|||
4084932|NCT01010971|3908190|B3|PM tearing eyes||Baseline Individual Reflective Ocular Symptom Score (rOSS) in Subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms.)Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.25|2.25|Standard Deviation|0.51|0.51|||
4084933|NCT01010971|3908191|B2|PM tearing eyes||Baseline Individual Reflective Ocular Symptom Score (rOSS) in Subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms.)Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.34|2.34|Standard Deviation|0.52|0.52|||
4084934|NCT01010971|3908192|B1|PM tearing eyes||Baseline Individual Reflective Ocular Symptom Score (rOSS) in Subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms.)Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.25|2.25|Standard Deviation|0.56|0.56|||
4084935|NCT01010971|3908189|B4|PM redness of eyes||Baseline Individual Reflective Ocular Symptom Score (rOSS) in Subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms.)Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.26|2.26|Standard Deviation|0.62|0.62|||
4084936|NCT01010971|3908190|B3|PM redness of eyes||Baseline Individual Reflective Ocular Symptom Score (rOSS) in Subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms.)Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.24|2.24|Standard Deviation|0.62|0.62|||
4084937|NCT01010971|3908191|B2|PM redness of eyes||Baseline Individual Reflective Ocular Symptom Score (rOSS) in Subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms.)Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.26|2.26|Standard Deviation|0.65|0.65|||
4084938|NCT01010971|3908192|B1|PM redness of eyes||Baseline Individual Reflective Ocular Symptom Score (rOSS) in Subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms.)Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.28|2.28|Standard Deviation|0.58|0.58|||
4085119|NCT01010971|3908189|B4|Black/African American||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
4085120|NCT01010971|3908190|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4084939|NCT01010971|3908189|B4|PM itching eyes||Baseline Individual Reflective Ocular Symptom Score (rOSS) in Subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms.)Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.47|2.47|Standard Deviation|0.47|0.47|||
4084940|NCT01010971|3908190|B3|PM itching eyes||Baseline Individual Reflective Ocular Symptom Score (rOSS) in Subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms.)Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.45|2.45|Standard Deviation|0.48|0.48|||
4084941|NCT01010971|3908191|B2|PM itching eyes||Baseline Individual Reflective Ocular Symptom Score (rOSS) in Subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms.)Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.50|2.5|Standard Deviation|0.47|0.47|||
4084942|NCT01010971|3908192|B1|PM itching eyes||Baseline Individual Reflective Ocular Symptom Score (rOSS) in Subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms.)Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.47|2.47|Standard Deviation|0.45|0.45|||
4084943|NCT01010971|3908189|B4|AM tearing eyes||Baseline Individual Reflective Ocular Symptom Score (rOSS) in Subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms.)Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.31|2.31|Standard Deviation|0.50|0.5|||
4084944|NCT01010971|3908190|B3|AM tearing eyes||Baseline Individual Reflective Ocular Symptom Score (rOSS) in Subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms.)Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.28|2.28|Standard Deviation|0.50|0.5|||
4084945|NCT01010971|3908191|B2|AM tearing eyes||Baseline Individual Reflective Ocular Symptom Score (rOSS) in Subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms.)Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.37|2.37|Standard Deviation|0.51|0.51|||
4084946|NCT01010971|3908192|B1|AM tearing eyes||Baseline Individual Reflective Ocular Symptom Score (rOSS) in Subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms.)Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.30|2.3|Standard Deviation|0.48|0.48|||
4084947|NCT01010971|3908189|B4|AM redness of eyes||Baseline Individual Reflective Ocular Symptom Score (rOSS) in Subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms.)Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.28|2.28|Standard Deviation|0.60|0.6|||
4084948|NCT01010971|3908190|B3|AM redness of eyes||Baseline Individual Reflective Ocular Symptom Score (rOSS) in Subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms.)Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.24|2.24|Standard Deviation|0.60|0.6|||
4085121|NCT01010971|3908191|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4085122|NCT01010971|3908192|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4084949|NCT01010971|3908191|B2|AM redness of eyes||Baseline Individual Reflective Ocular Symptom Score (rOSS) in Subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms.)Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.28|2.28|Standard Deviation|0.62|0.62|||
4084950|NCT01010971|3908192|B1|AM redness of eyes||Baseline Individual Reflective Ocular Symptom Score (rOSS) in Subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms.)Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.31|2.31|Standard Deviation|0.57|0.57|||
4084951|NCT01010971|3908189|B4|AM itching eyes||Baseline Individual Reflective Ocular Symptom Score (rOSS) in Subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms.)Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.49|2.49|Standard Deviation|0.43|0.43|||
4084952|NCT01010971|3908190|B3|AM itching eyes||Baseline Individual Reflective Ocular Symptom Score (rOSS) in Subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms.)Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.48|2.48|Standard Deviation|0.44|0.44|||
4084953|NCT01010971|3908191|B2|AM itching eyes||Baseline Individual Reflective Ocular Symptom Score (rOSS) in Subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms.)Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.52|2.52|Standard Deviation|0.43|0.43|||
4084954|NCT01010971|3908192|B1|AM itching eyes||Baseline Individual Reflective Ocular Symptom Score (rOSS) in Subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms.)Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.49|2.49|Standard Deviation|0.44|0.44|||
4084955|NCT01010971|3908189|B4|AM and PM nasal congestion||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.42|2.42|Standard Deviation|0.50|0.5|||
4084956|NCT01010971|3908190|B3|AM and PM nasal congestion||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.41|2.41|Standard Deviation|0.51|0.51|||
4084957|NCT01010971|3908191|B2|AM and PM nasal congestion||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.42|2.42|Standard Deviation|0.51|0.51|||
4084958|NCT01010971|3908192|B1|AM and PM nasal congestion||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.43|2.43|Standard Deviation|0.48|0.48|||
4084959|NCT01010971|3908189|B4|AM and PM nasal itching||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.17|2.17|Standard Deviation|0.64|0.64|||
4085123|NCT01010971|3908189|B4|White/Caucasian||Race/Ethnicity, Customized||participants|Number|589|589.0||||||
4084961|NCT01010971|3908191|B2|AM and PM nasal itching||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.20|2.2|Standard Deviation|0.61|0.61|||
4084962|NCT01010971|3908192|B1|AM and PM nasal itching||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.18|2.18|Standard Deviation|0.65|0.65|||
4084963|NCT01010971|3908189|B4|AM and PM runny nose||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.24|2.24|Standard Deviation|0.62|0.62|||
4084964|NCT01010971|3908190|B3|AM and PM runny nose||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.23|2.23|Standard Deviation|0.64|0.64|||
4084965|NCT01010971|3908191|B2|AM and PM runny nose||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.22|2.22|Standard Deviation|0.62|0.62|||
4084966|NCT01010971|3908192|B1|AM and PM runny nose||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.27|2.27|Standard Deviation|0.60|0.6|||
4084967|NCT01010971|3908189|B4|AM and PM sneezing||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|1.76|1.76|Standard Deviation|0.84|0.84|||
4084968|NCT01010971|3908190|B3|AM and PM sneezing||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|1.75|1.75|Standard Deviation|0.86|0.86|||
4084969|NCT01010971|3908191|B2|AM and PM sneezing||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|1.77|1.77|Standard Deviation|0.86|0.86|||
4084970|NCT01010971|3908192|B1|AM and PM sneezing||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|1.76|1.76|Standard Deviation|0.81|0.81|||
4084971|NCT01010971|3908189|B4|PM nasal congestion||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.35|2.35|Standard Deviation|0.55|0.55|||
4084972|NCT01010971|3908190|B3|PM nasal congestion||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.34|2.34|Standard Deviation|0.55|0.55|||
4085124|NCT01010971|3908190|B3|White/Caucasian||Race/Ethnicity, Customized||participants|Number|191|191.0||||||
4085125|NCT01010971|3908191|B2|White/Caucasian||Race/Ethnicity, Customized||participants|Number|191|191.0||||||
4084973|NCT01010971|3908191|B2|PM nasal congestion||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.36|2.36|Standard Deviation|0.57|0.57|||
4084974|NCT01010971|3908192|B1|PM nasal congestion||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.36|2.36|Standard Deviation|0.54|0.54|||
4084975|NCT01010971|3908189|B4|PM nasal itching||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.13|2.13|Standard Deviation|0.67|0.67|||
4084976|NCT01010971|3908190|B3|PM nasal itching||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.10|2.1|Standard Deviation|0.69|0.69|||
4084977|NCT01010971|3908191|B2|PM nasal itching||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.17|2.17|Standard Deviation|0.66|0.66|||
4084978|NCT01010971|3908192|B1|PM nasal itching||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.13|2.13|Standard Deviation|0.68|0.68|||
4084979|NCT01010971|3908189|B4|PM runny nose||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.19|2.19|Standard Deviation|0.68|0.68|||
4084980|NCT01010971|3908190|B3|PM runny nose||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.16|2.16|Standard Deviation|0.70|0.7|||
4084981|NCT01010971|3908191|B2|PM runny nose||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.18|2.18|Standard Deviation|0.69|0.69|||
4084982|NCT01010971|3908192|B1|PM runny nose||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.22|2.22|Standard Deviation|0.65|0.65|||
4084983|NCT01010971|3908189|B4|PM sneezing||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|1.78|1.78|Standard Deviation|0.86|0.86|||
4084984|NCT01010971|3908190|B3|PM sneezing||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|1.77|1.77|Standard Deviation|0.88|0.88|||
4085126|NCT01010971|3908192|B1|White/Caucasian||Race/Ethnicity, Customized||participants|Number|207|207.0||||||
4085127|NCT01010971|3908189|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085146|NCT01010971|3908192|B1||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4084985|NCT01010971|3908191|B2|PM sneezing||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|1.79|1.79|Standard Deviation|0.89|0.89|||
4084986|NCT01010971|3908192|B1|PM sneezing||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|1.79|1.79|Standard Deviation|0.82|0.82|||
4084987|NCT01010971|3908189|B4|AM nasal congestion||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.48|2.48|Standard Deviation|0.50|0.5|||
4084988|NCT01010971|3908190|B3|AM nasal congestion||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.47|2.47|Standard Deviation|0.53|0.53|||
4084989|NCT01010971|3908191|B2|AM nasal congestion||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.48|2.48|Standard Deviation|0.51|0.51|||
4084990|NCT01010971|3908192|B1|AM nasal congestion||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.50|2.5|Standard Deviation|0.47|0.47|||
4084991|NCT01010971|3908189|B4|AM nasal itching||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.22|2.22|Standard Deviation|0.66|0.66|||
4084992|NCT01010971|3908190|B3|AM nasal itching||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.20|2.2|Standard Deviation|0.68|0.68|||
4084993|NCT01010971|3908191|B2|AM nasal itching||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.23|2.23|Standard Deviation|0.64|0.64|||
4084994|NCT01010971|3908192|B1|AM nasal itching||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.22|2.22|Standard Deviation|0.66|0.66|||
4084995|NCT01010971|3908189|B4|AM runny nose||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.29|2.29|Standard Deviation|0.62|0.62|||
4084996|NCT01010971|3908190|B3|AM runny nose||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.29|2.29|Standard Deviation|0.64|0.64|||
4085128|NCT01010971|3908190|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085129|NCT01010971|3908191|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4084997|NCT01010971|3908191|B2|AM runny nose||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.26|2.26|Standard Deviation|0.64|0.64|||
4084998|NCT01010971|3908192|B1|AM runny nose||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.32|2.32|Standard Deviation|0.58|0.58|||
4084999|NCT01010971|3908189|B4|AM sneezing||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|1.74|1.74|Standard Deviation|0.88|0.88|||
4085000|NCT01010971|3908190|B3|AM sneezing||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|1.73|1.73|Standard Deviation|0.88|0.88|||
4085001|NCT01010971|3908191|B2|AM sneezing||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|1.75|1.75|Standard Deviation|0.91|0.91|||
4085002|NCT01010971|3908192|B1|AM sneezing||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|1.73|1.73|Standard Deviation|0.84|0.84|||
4085003|NCT01010971|3908189|B4|AM and PM nasal congestion||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.52|2.52|Standard Deviation|0.45|0.45|||
4085004|NCT01010971|3908190|B3|AM and PM nasal congestion||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.52|2.52|Standard Deviation|0.45|0.45|||
4085005|NCT01010971|3908191|B2|AM and PM nasal congestion||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.52|2.52|Standard Deviation|0.47|0.47|||
4085006|NCT01010971|3908192|B1|AM and PM nasal congestion||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.52|2.52|Standard Deviation|0.43|0.43|||
4085007|NCT01010971|3908189|B4|AM and PM nasal itching||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.30|2.3|Standard Deviation|0.57|0.57|||
4085008|NCT01010971|3908190|B3|AM and PM nasal itching||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.29|2.29|Standard Deviation|0.57|0.57|||
4085130|NCT01010971|3908192|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085131|NCT01010971|3908189|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|384|384.0||57.2|57.2|||
4085132|NCT01010971|3908190|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|120|120.0||54.5|54.5|||
4085009|NCT01010971|3908191|B2|AM and PM nasal itching||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.34|2.34|Standard Deviation|0.55|0.55|||
4085010|NCT01010971|3908192|B1|AM and PM nasal itching||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.28|2.28|Standard Deviation|0.59|0.59|||
4085011|NCT01010971|3908189|B4|AM and PM runny nose||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.39|2.39|Standard Deviation|0.55|0.55|||
4085012|NCT01010971|3908190|B3|AM and PM runny nose||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.39|2.39|Standard Deviation|0.55|0.55|||
4085013|NCT01010971|3908191|B2|AM and PM runny nose||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.38|2.38|Standard Deviation|0.57|0.57|||
4085014|NCT01010971|3908192|B1|AM and PM runny nose||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.41|2.41|Standard Deviation|0.54|0.54|||
4085015|NCT01010971|3908189|B4|AM and PM sneezing||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.08|2.08|Standard Deviation|0.68|0.68|||
4085016|NCT01010971|3908190|B3|AM and PM sneezing||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.08|2.08|Standard Deviation|0.67|0.67|||
4085017|NCT01010971|3908191|B2|AM and PM sneezing||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.10|2.1|Standard Deviation|0.72|0.72|||
4085018|NCT01010971|3908192|B1|AM and PM sneezing||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.05|2.05|Standard Deviation|0.66|0.66|||
4085019|NCT01010971|3908189|B4|PM nasal congestion||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.48|2.48|Standard Deviation|0.50|0.5|||
4085020|NCT01010971|3908190|B3|PM nasal congestion||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.48|2.48|Standard Deviation|0.50|0.5|||
4085021|NCT01010971|3908191|B2|PM nasal congestion||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.47|2.47|Standard Deviation|0.52|0.52|||
4085133|NCT01010971|3908191|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|137|137.0||60.6|60.6|||
4085022|NCT01010971|3908192|B1|PM nasal congestion||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.47|2.47|Standard Deviation|0.49|0.49|||
4085023|NCT01010971|3908189|B4|PM nasal itching||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.28|2.28|Standard Deviation|0.60|0.6|||
4085024|NCT01010971|3908190|B3|PM nasal itching||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.27|2.27|Standard Deviation|0.60|0.6|||
4085025|NCT01010971|3908191|B2|PM nasal itching||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.30|2.3|Standard Deviation|0.60|0.6|||
4085026|NCT01010971|3908192|B1|PM nasal itching||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.27|2.27|Standard Deviation|0.62|0.62|||
4085027|NCT01010971|3908189|B4|PM runny nose||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.36|2.36|Standard Deviation|0.60|0.6|||
4085028|NCT01010971|3908190|B3|PM runny nose||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.35|2.35|Standard Deviation|0.59|0.59|||
4085029|NCT01010971|3908191|B2|PM runny nose||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.34|2.34|Standard Deviation|0.63|0.63|||
4085030|NCT01010971|3908192|B1|PM runny nose||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.40|2.4|Standard Deviation|0.59|0.59|||
4085031|NCT01010971|3908189|B4|PM sneezing||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.09|2.09|Standard Deviation|0.71|0.71|||
4085032|NCT01010971|3908190|B3|PM sneezing||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.10|2.1|Standard Deviation|0.69|0.69|||
4085033|NCT01010971|3908191|B2|PM sneezing||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.10|2.1|Standard Deviation|0.75|0.75|||
4085034|NCT01010971|3908192|B1|PM sneezing||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.06|2.06|Standard Deviation|0.68|0.68|||
4085134|NCT01010971|3908192|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|127|127.0||56.4|56.4|||
4085035|NCT01010971|3908189|B4|AM nasal congestion||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.56|2.56|Standard Deviation|0.44|0.44|||
4085036|NCT01010971|3908190|B3|AM nasal congestion||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.55|2.55|Standard Deviation|0.45|0.45|||
4085037|NCT01010971|3908191|B2|AM nasal congestion||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.56|2.56|Standard Deviation|0.46|0.46|||
4085038|NCT01010971|3908192|B1|AM nasal congestion||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.57|2.57|Standard Deviation|0.41|0.41|||
4085039|NCT01010971|3908189|B4|AM nasal itching||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.33|2.33|Standard Deviation|0.58|0.58|||
4085040|NCT01010971|3908190|B3|AM nasal itching||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.31|2.31|Standard Deviation|0.59|0.59|||
4085041|NCT01010971|3908191|B2|AM nasal itching||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.38|2.38|Standard Deviation|0.54|0.54|||
4085042|NCT01010971|3908192|B1|AM nasal itching||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.29|2.29|Standard Deviation|0.59|0.59|||
4085043|NCT01010971|3908189|B4|AM runny nose||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.43|2.43|Standard Deviation|0.55|0.55|||
4085044|NCT01010971|3908190|B3|AM runny nose||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.42|2.42|Standard Deviation|0.55|0.55|||
4085045|NCT01010971|3908191|B2|AM runny nose||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.43|2.43|Standard Deviation|0.57|0.57|||
4085046|NCT01010971|3908192|B1|AM runny nose||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.43|2.43|Standard Deviation|0.54|0.54|||
4085047|NCT01010971|3908189|B4|AM sneezing||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.07|2.07|Standard Deviation|0.72|0.72|||
4085135|NCT01010971|3908189|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|287|287.0||42.8|42.8|||
4085048|NCT01010971|3908190|B3|AM sneezing||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.06|2.06|Standard Deviation|0.70|0.7|||
4085049|NCT01010971|3908191|B2|AM sneezing||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.10|2.1|Standard Deviation|0.74|0.74|||
4085050|NCT01010971|3908192|B1|AM sneezing||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|unit on a scale|Mean|2.04|2.04|Standard Deviation|0.71|0.71|||
4085051|NCT01010971|3908189|B4|AM and PM||Baseline Instantaneous Total Ocular Symtom Score (iTOSS) in Subjects with iTOSS ≥5.0|"TOSS is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TOSS symptom scores assess symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|6.98|6.98|Standard Deviation|1.17|1.17|||
4085052|NCT01010971|3908190|B3|AM and PM||Baseline Instantaneous Total Ocular Symtom Score (iTOSS) in Subjects with iTOSS ≥5.0|"TOSS is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TOSS symptom scores assess symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|6.99|6.99|Standard Deviation|1.07|1.07|||
4085053|NCT01010971|3908191|B2|AM and PM||Baseline Instantaneous Total Ocular Symtom Score (iTOSS) in Subjects with iTOSS ≥5.0|"TOSS is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TOSS symptom scores assess symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|6.97|6.97|Standard Deviation|1.24|1.24|||
4085054|NCT01010971|3908192|B1|AM and PM||Baseline Instantaneous Total Ocular Symtom Score (iTOSS) in Subjects with iTOSS ≥5.0|"TOSS is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TOSS symptom scores assess symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|6.99|6.99|Standard Deviation|1.21|1.21|||
4085055|NCT01010971|3908189|B4|PM||Baseline Instantaneous Total Ocular Symtom Score (iTOSS) in Subjects with iTOSS ≥5.0|"TOSS is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TOSS symptom scores assess symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|6.90|6.9|Standard Deviation|1.31|1.31|||
4085056|NCT01010971|3908190|B3|PM||Baseline Instantaneous Total Ocular Symtom Score (iTOSS) in Subjects with iTOSS ≥5.0|"TOSS is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TOSS symptom scores assess symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|6.92|6.92|Standard Deviation|1.20|1.2|||
4085057|NCT01010971|3908191|B2|PM||Baseline Instantaneous Total Ocular Symtom Score (iTOSS) in Subjects with iTOSS ≥5.0|"TOSS is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TOSS symptom scores assess symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|6.88|6.88|Standard Deviation|1.39|1.39|||
4085058|NCT01010971|3908192|B1|PM||Baseline Instantaneous Total Ocular Symtom Score (iTOSS) in Subjects with iTOSS ≥5.0|"TOSS is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TOSS symptom scores assess symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|6.90|6.9|Standard Deviation|1.35|1.35|||
4085136|NCT01010971|3908190|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|100|100.0||45.5|45.5|||
4085059|NCT01010971|3908189|B4|AM||Baseline Instantaneous Total Ocular Symtom Score (iTOSS) in Subjects with iTOSS ≥5.0|"TOSS is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TOSS symptom scores assess symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|7.06|7.06|Standard Deviation|1.20|1.2|||
4085060|NCT01010971|3908190|B3|AM||Baseline Instantaneous Total Ocular Symtom Score (iTOSS) in Subjects with iTOSS ≥5.0|"TOSS is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TOSS symptom scores assess symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|7.05|7.05|Standard Deviation|1.14|1.14|||
4085061|NCT01010971|3908191|B2|AM||Baseline Instantaneous Total Ocular Symtom Score (iTOSS) in Subjects with iTOSS ≥5.0|"TOSS is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TOSS symptom scores assess symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|7.07|7.07|Standard Deviation|1.26|1.26|||
4085062|NCT01010971|3908192|B1|AM||Baseline Instantaneous Total Ocular Symtom Score (iTOSS) in Subjects with iTOSS ≥5.0|"TOSS is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TOSS symptom scores assess symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|7.07|7.07|Standard Deviation|1.20|1.2|||
4085063|NCT01010971|3908189|B4|AM and PM||Baseline Baseline Reflective Ocular Symptom Score (rTOSS) in Subjects with rTOSS ≥5.0|"TOSS is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TOSS symptom scores assess symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|7.05|7.05|Standard Deviation|1.20|1.2|||
4085064|NCT01010971|3908190|B3|AM and PM||Baseline Baseline Reflective Ocular Symptom Score (rTOSS) in Subjects with rTOSS ≥5.0|"TOSS is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TOSS symptom scores assess symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|6.97|6.97|Standard Deviation|1.19|1.19|||
4085065|NCT01010971|3908191|B2|AM and PM||Baseline Baseline Reflective Ocular Symptom Score (rTOSS) in Subjects with rTOSS ≥5.0|"TOSS is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TOSS symptom scores assess symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|7.13|7.13|Standard Deviation|1.19|1.19|||
4085066|NCT01010971|3908192|B1|AM and PM||Baseline Baseline Reflective Ocular Symptom Score (rTOSS) in Subjects with rTOSS ≥5.0|"TOSS is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TOSS symptom scores assess symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|7.04|7.04|Standard Deviation|1.22|1.22|||
4085067|NCT01010971|3908189|B4|PM||Baseline Baseline Reflective Ocular Symptom Score (rTOSS) in Subjects with rTOSS ≥5.0|"TOSS is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TOSS symptom scores assess symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|7.01|7.01|Standard Deviation|1.28|1.28|||
4085068|NCT01010971|3908190|B3|PM||Baseline Baseline Reflective Ocular Symptom Score (rTOSS) in Subjects with rTOSS ≥5.0|"TOSS is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TOSS symptom scores assess symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|6.94|6.94|Standard Deviation|1.30|1.3|||
4085137|NCT01010971|3908191|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|89|89.0||39.4|39.4|||
4085138|NCT01010971|3908192|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|98|98.0||43.6|43.6|||
4085139|NCT01010971|3908189|B4||Male|Sex: Female, Male||Participants|Count of Participants|273|273.0||||||
4085140|NCT01010971|3908190|B3||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4085069|NCT01010971|3908191|B2|PM||Baseline Baseline Reflective Ocular Symptom Score (rTOSS) in Subjects with rTOSS ≥5.0|"TOSS is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TOSS symptom scores assess symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|7.10|7.1|Standard Deviation|1.25|1.25|||
4085070|NCT01010971|3908192|B1|PM||Baseline Baseline Reflective Ocular Symptom Score (rTOSS) in Subjects with rTOSS ≥5.0|"TOSS is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TOSS symptom scores assess symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|7.00|7.0|Standard Deviation|1.30|1.3|||
4085071|NCT01010971|3908189|B4|AM||Baseline Baseline Reflective Ocular Symptom Score (rTOSS) in Subjects with rTOSS ≥5.0|"TOSS is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TOSS symptom scores assess symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|7.09|7.09|Standard Deviation|1.23|1.23|||
4085072|NCT01010971|3908190|B3|AM||Baseline Baseline Reflective Ocular Symptom Score (rTOSS) in Subjects with rTOSS ≥5.0|"TOSS is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TOSS symptom scores assess symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|6.99|6.99|Standard Deviation|1.21|1.21|||
4085073|NCT01010971|3908191|B2|AM||Baseline Baseline Reflective Ocular Symptom Score (rTOSS) in Subjects with rTOSS ≥5.0|"TOSS is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TOSS symptom scores assess symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|7.17|7.17|Standard Deviation|1.24|1.24|||
4085074|NCT01010971|3908192|B1|AM||Baseline Baseline Reflective Ocular Symptom Score (rTOSS) in Subjects with rTOSS ≥5.0|"TOSS is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TOSS symptom scores assess symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|7.09|7.09|Standard Deviation|1.24|1.24|||
4085075|NCT01010971|3908189|B4|AM and PM||Baseline Instantaneous Total Nasal Symptom Score (iTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|8.59|8.59|Standard Deviation|2.16|2.16|||
4085076|NCT01010971|3908190|B3|AM and PM||Baseline Instantaneous Total Nasal Symptom Score (iTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|8.53|8.53|Standard Deviation|2.21|2.21|||
4085077|NCT01010971|3908191|B2|AM and PM||Baseline Instantaneous Total Nasal Symptom Score (iTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|8.60|8.6|Standard Deviation|2.15|2.15|||
4085078|NCT01010971|3908192|B1|AM and PM||Baseline Instantaneous Total Nasal Symptom Score (iTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|8.64|8.64|Standard Deviation|2.14|2.14|||
4085141|NCT01010971|3908191|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4085142|NCT01010971|3908192|B1||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4085143|NCT01010971|3908189|B4||Female|Sex: Female, Male||Participants|Count of Participants|398|398.0||||||
4085144|NCT01010971|3908190|B3||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4085145|NCT01010971|3908191|B2||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4085079|NCT01010971|3908189|B4|PM||Baseline Instantaneous Total Nasal Symptom Score (iTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|8.45|8.45|Standard Deviation|2.34|2.34|||
4085080|NCT01010971|3908190|B3|PM||Baseline Instantaneous Total Nasal Symptom Score (iTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|8.36|8.36|Standard Deviation|2.38|2.38|||
4085081|NCT01010971|3908191|B2|PM||Baseline Instantaneous Total Nasal Symptom Score (iTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|8.49|8.49|Standard Deviation|2.35|2.35|||
4085082|NCT01010971|3908192|B1|PM||Baseline Instantaneous Total Nasal Symptom Score (iTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|8.51|8.51|Standard Deviation|2.29|2.29|||
4085083|NCT01010971|3908189|B4|AM||Baseline Instantaneous Total Nasal Symptom Score (iTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|8.73|8.73|Standard Deviation|2.15|2.15|||
4085084|NCT01010971|3908190|B3|AM||Baseline Instantaneous Total Nasal Symptom Score (iTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|8.69|8.69|Standard Deviation|2.19|2.19|||
4085085|NCT01010971|3908191|B2|AM||Baseline Instantaneous Total Nasal Symptom Score (iTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|8.73|8.73|Standard Deviation|2.18|2.18|||
4085086|NCT01010971|3908192|B1|AM||Baseline Instantaneous Total Nasal Symptom Score (iTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|8.77|8.77|Standard Deviation|2.10|2.1|||
4085087|NCT01010971|3908189|B4|AM and PM||Baseline Reflective Total Nasal Symptom Score (rTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|9.29|9.29|Standard Deviation|1.82|1.82|||
4085088|NCT01010971|3908190|B3|AM and PM||Baseline Reflective Total Nasal Symptom Score (rTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|9.28|9.28|Standard Deviation|1.77|1.77|||
4085089|NCT01010971|3908191|B2|AM and PM||Baseline Reflective Total Nasal Symptom Score (rTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|9.34|9.34|Standard Deviation|1.88|1.88|||
4085090|NCT01010971|3908192|B1|AM and PM||Baseline Reflective Total Nasal Symptom Score (rTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|9.26|9.26|Standard Deviation|1.80|1.8|||
4085091|NCT01010971|3908189|B4|PM||Baseline Reflective Total Nasal Symptom Score (rTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|9.21|9.21|Standard Deviation|2.00|2.0|||
4085092|NCT01010971|3908190|B3|PM||Baseline Reflective Total Nasal Symptom Score (rTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|9.21|9.21|Standard Deviation|1.92|1.92|||
4085093|NCT01010971|3908191|B2|PM||Baseline Reflective Total Nasal Symptom Score (rTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|9.21|9.21|Standard Deviation|2.11|2.11|||
4085094|NCT01010971|3908192|B1|PM||Baseline Reflective Total Nasal Symptom Score (rTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|9.20|9.2|Standard Deviation|1.97|1.97|||
4085095|NCT01010971|3908189|B4|AM||Baseline Reflective Total Nasal Symptom Score (rTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|9.38|9.38|Standard Deviation|1.78|1.78|||
4085096|NCT01010971|3908190|B3|AM||Baseline Reflective Total Nasal Symptom Score (rTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|9.34|9.34|Standard Deviation|1.76|1.76|||
4085097|NCT01010971|3908191|B2|AM||Baseline Reflective Total Nasal Symptom Score (rTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|9.47|9.47|Standard Deviation|1.80|1.8|||
4085098|NCT01010971|3908192|B1|AM||Baseline Reflective Total Nasal Symptom Score (rTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|9.33|9.33|Standard Deviation|1.78|1.78|||
4085099|NCT01010971|3908189|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4085100|NCT01010971|3908190|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4085101|NCT01010971|3908191|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4085102|NCT01010971|3908192|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4085103|NCT01010971|3908189|B4|Multiple||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4085104|NCT01010971|3908190|B3|Multiple||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4085105|NCT01010971|3908191|B2|Multiple||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4085106|NCT01010971|3908192|B1|Multiple||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4085107|NCT01010971|3908189|B4|Native Hawaiin or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4085108|NCT01010971|3908190|B3|Native Hawaiin or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4085109|NCT01010971|3908191|B2|Native Hawaiin or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4085147|NCT01010971|3908189|B4|||Age||years|Mean|40.4|40.4|Standard Deviation|14.2|14.2|||
4085148|NCT01010971|3908190|B3|||Age||years|Mean|41.0|41.0|Standard Deviation|13.5|13.5|||
4085149|NCT01010971|3908191|B2|||Age||years|Mean|39.8|39.8|Standard Deviation|14.7|14.7|||
4085150|NCT01010971|3908192|B1|||Age||years|Mean|40.4|40.4|Standard Deviation|14.4|14.4|||
4085151|NCT01010971|3908189|B4||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4085152|NCT01010971|3908190|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4085153|NCT01010971|3908191|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4085154|NCT01010971|3908192|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4085155|NCT01010971|3908189|B4||Between 18 and 65 years|Age||Participants|Count of Participants|594|594.0||||||
4085156|NCT01010971|3908190|B3||Between 18 and 65 years|Age||Participants|Count of Participants|202|202.0||||||
4085157|NCT01010971|3908191|B2||Between 18 and 65 years|Age||Participants|Count of Participants|194|194.0||||||
4085158|NCT01010971|3908192|B1||Between 18 and 65 years|Age||Participants|Count of Participants|198|198.0||||||
4085159|NCT01010971|3908189|B4||<=18 years|Age||Participants|Count of Participants|51|51.0||||||
4085160|NCT01010971|3908190|B3||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4085161|NCT01010971|3908191|B2||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
4085162|NCT01010971|3908192|B1||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
4085163|NCT01010932|3908279|B1|Chile||Region of Enrollment||participants|Number|1|1.0||||||
4085164|NCT01010932|3908279|B1|Korea, Republic of||Region of Enrollment||participants|Number|39|39.0||||||
4085165|NCT01010932|3908279|B1|Mexico||Region of Enrollment||participants|Number|18|18.0||||||
4085166|NCT01010932|3908279|B1|Argentina||Region of Enrollment||participants|Number|48|48.0||||||
4085167|NCT01010932|3908279|B1|Colombia||Region of Enrollment||participants|Number|35|35.0||||||
4085168|NCT01010932|3908279|B1|United States||Region of Enrollment||participants|Number|81|81.0||||||
4085169|NCT01010932|3908279|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4085170|NCT01010932|3908279|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4085171|NCT01010932|3908279|B1|||Age||years|Mean|64.8|64.8|Standard Deviation|11.9|11.9|||
4085172|NCT01010932|3908279|B1||>=65 years|Age||Participants|Count of Participants|114|114.0||||||
4085173|NCT01010932|3908279|B1||Between 18 and 65 years|Age||Participants|Count of Participants|108|108.0||||||
4085174|NCT01010932|3908279|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4085175|NCT01010906|3908291|B7||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4085176|NCT01010906|3908292|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4085177|NCT01010906|3908293|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4085178|NCT01010906|3908294|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4085179|NCT01010906|3908295|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4085180|NCT01010906|3908296|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4085181|NCT01010906|3908297|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4085182|NCT01010906|3908291|B7||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4085183|NCT01010906|3908292|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4085184|NCT01010906|3908293|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4085185|NCT01010906|3908294|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4085186|NCT01010906|3908295|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4085187|NCT01010906|3908296|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4085188|NCT01010906|3908297|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4085189|NCT01010906|3908291|B7|||Age||Years|Mean|52.3|52.3|Standard Deviation|5.49|5.49|||
4085190|NCT01010906|3908292|B6|||Age||Years|Mean|52.6|52.6|Standard Deviation|7.04|7.04|||
4085191|NCT01010906|3908293|B5|||Age||Years|Mean|53.4|53.4|Standard Deviation|6.08|6.08|||
4085192|NCT01010906|3908294|B4|||Age||Years|Mean|53.3|53.3|Standard Deviation|4.90|4.9|||
4085193|NCT01010906|3908295|B3|||Age||Years|Mean|52.1|52.1|Standard Deviation|6.51|6.51|||
4085194|NCT01010906|3908296|B2|||Age||Years|Mean|52.1|52.1|Standard Deviation|3.54|3.54|||
4085195|NCT01010906|3908297|B1|||Age||Years|Mean|50.3|50.3|Standard Deviation|5.03|5.03|||
4085196|NCT01010867|3908322|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4085197|NCT01010867|3908322|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085198|NCT01010867|3908322|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085199|NCT01010867|3908322|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4085200|NCT01010867|3908322|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4085201|NCT01010867|3908322|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085202|NCT01010867|3908322|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4085203|NCT01010867|3908322|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085204|NCT01010867|3908322|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4085205|NCT01010867|3908322|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4085206|NCT01010867|3908322|B1|||Age||years|Mean|7.8|7.8|Standard Deviation|4.7|4.7|||
4085207|NCT01010854|3908329|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4085208|NCT01010854|3908329|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4085209|NCT01010854|3908329|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4085210|NCT01010854|3908329|B1|||Age||years|Median|56|56.0|Full Range|||50.0|73.0|
4085211|NCT01010776|3908334|B1|||Pittsburg Sleep Quality Index (PSQI)|The PSQI evaluates sleep behavior by means of 7 components: sleep quality, sleep latency, sleep duration, usual sleep efficiency, sleep disorders, use of sleep medication and daytime dysfunction. The sum of the 7 component scores produces a global score of subjective sleep quality that varies from 0 to 21, with higher scores indicating worse sleep quality.|Units on a scale|Mean|6.7|6.7|Standard Deviation|4.1|4.1|||
4085212|NCT01010776|3908334|B1|||Personal and Social Performance (PSP) Scale Score|The PSP assesses the degree of a participant’s dysfunction within 4 domains of behavior: socially useful activities, personal and social relationships, self-care, and disturbing and aggressive behavior. The score ranges from 1 to 100, divided into 10 equal intervals to rate the degree of difficulty (i, absent to vi, very severe) in each of the 4 domains. Based on the four domains there will be one total score. Participants with a score of 71 to 100 have a mild degree of difficulty; from 31 to 70, varying degrees of disability; =< 30, functioning so poorly as to require intensive supervision.|Units on a scale|Mean|44.39|44.39|Standard Deviation|13.11|13.11|||
4085213|NCT01010776|3908334|B1|Negative PANSS Subscale Score||Positive and Negative PANSS Subscales Score|The PANSS positive subscale assesses 7 positive-symptoms of schizophrenia. Positive symptoms refer to an excess or distortion of normal functions. The symptoms are rated on a 7-point scale, with a range of 7 (absent) to 49 (extreme psychopathology). The PANSS negative subscale assesses seven negative-symptoms of schizophrenia. Negative symptoms represent a diminution or loss of normal functions. The symptoms are rated on a 7-point scale, with a range of 7 (absent) to 49 (extreme psychopathology).|Units on a scale|Mean|19.76|19.76|Standard Deviation|5.79|5.79|||
4085214|NCT01010776|3908334|B1|Positive PANSS Subscale Score||Positive and Negative PANSS Subscales Score|The PANSS positive subscale assesses 7 positive-symptoms of schizophrenia. Positive symptoms refer to an excess or distortion of normal functions. The symptoms are rated on a 7-point scale, with a range of 7 (absent) to 49 (extreme psychopathology). The PANSS negative subscale assesses seven negative-symptoms of schizophrenia. Negative symptoms represent a diminution or loss of normal functions. The symptoms are rated on a 7-point scale, with a range of 7 (absent) to 49 (extreme psychopathology).|Units on a scale|Mean|27.37|27.37|Standard Deviation|6.48|6.48|||
4085215|NCT01010776|3908334|B1|||Positive and Negative Syndrome Scale (PANSS) Total Score|The PANSS is a 30-item scale designed to assess various symptoms of schizophrenia including delusions, grandiosity, blunted affect, poor attention, and poor impulse control. The 30 symptoms are rated on a 7-point scale that ranges from 1 (absent) to 7 (extreme psychopathology). The PANSS total score consists of the sum of all 30 PANSS items and ranges from 30 to 210. Higher scores indicate worsening.|Units on a scale|Mean|94.49|94.49|Standard Deviation|12.38|12.38|||
4085216|NCT01010776|3908334|B1|Brown||Race/Ethnicity, Customized||Participants|Number|34|34.0||||||
4085217|NCT01010776|3908334|B1|Mulatto||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4085218|NCT01010776|3908334|B1|Oriental||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4085219|NCT01010776|3908334|B1|Black||Race/Ethnicity, Customized||Participants|Number|52|52.0||||||
4085220|NCT01010776|3908334|B1|White/Caucasian||Race/Ethnicity, Customized||Participants|Number|120|120.0||||||
4085221|NCT01010776|3908334|B1||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4085222|NCT01010776|3908334|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4085223|NCT01010776|3908334|B1|61-69 years||Age, Customized||Participants|Number|1|1.0||||||
4085224|NCT01010776|3908334|B1|50-60 years||Age, Customized||Participants|Number|35|35.0||||||
4085225|NCT01010776|3908334|B1|40-49 years||Age, Customized||Participants|Number|67|67.0||||||
4085226|NCT01010776|3908334|B1|30-39 years||Age, Customized||Participants|Number|51|51.0||||||
4085227|NCT01010776|3908334|B1|22-29 years||Age, Customized||Participants|Number|50|50.0||||||
4085228|NCT01010776|3908334|B1|18-21 years||Age, Customized||Participants|Number|14|14.0||||||
4085229|NCT01010776|3908334|B1|||Age||Years|Mean|37.87|37.87|Standard Deviation|11.01|11.01|||
4085230|NCT01010750|3908356|B7|United States||Region of Enrollment||participants|Number|18|18.0||||||
4085231|NCT01010750|3908357|B6|United States||Region of Enrollment||participants|Number|3|3.0||||||
4085232|NCT01010750|3908358|B5|United States||Region of Enrollment||participants|Number|2|2.0||||||
4085233|NCT01010750|3908359|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
4085234|NCT01010750|3908360|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4085235|NCT01010750|3908361|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4085236|NCT01010750|3908362|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4085237|NCT01010750|3908356|B7||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4085238|NCT01010750|3908357|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4085239|NCT01010750|3908358|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4085240|NCT01010750|3908359|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4085241|NCT01010750|3908360|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4085242|NCT01010750|3908361|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4085243|NCT01010750|3908362|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4085244|NCT01010750|3908356|B7||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4085245|NCT01010750|3908357|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4085246|NCT01010750|3908358|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4085247|NCT01010750|3908359|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4085248|NCT01010750|3908360|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4085249|NCT01010750|3908361|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4085250|NCT01010750|3908362|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4085251|NCT01010750|3908356|B7|>=56 years||Age, Customized||participants|Number|0|0.0||||||
4085252|NCT01010750|3908357|B6|>=56 years||Age, Customized||participants|Number|0|0.0||||||
4085253|NCT01010750|3908358|B5|>=56 years||Age, Customized||participants|Number|0|0.0||||||
4085254|NCT01010750|3908359|B4|>=56 years||Age, Customized||participants|Number|0|0.0||||||
4085255|NCT01010750|3908360|B3|>=56 years||Age, Customized||participants|Number|0|0.0||||||
4085256|NCT01010750|3908361|B2|>=56 years||Age, Customized||participants|Number|0|0.0||||||
4085257|NCT01010750|3908362|B1|>=56 years||Age, Customized||participants|Number|0|0.0||||||
4085258|NCT01010750|3908356|B7|Between 18 and 55 years||Age, Customized||participants|Number|18|18.0||||||
4085259|NCT01010750|3908357|B6|Between 18 and 55 years||Age, Customized||participants|Number|3|3.0||||||
4085260|NCT01010750|3908358|B5|Between 18 and 55 years||Age, Customized||participants|Number|2|2.0||||||
4085261|NCT01010750|3908359|B4|Between 18 and 55 years||Age, Customized||participants|Number|3|3.0||||||
4085262|NCT01010750|3908360|B3|Between 18 and 55 years||Age, Customized||participants|Number|3|3.0||||||
4085263|NCT01010750|3908361|B2|Between 18 and 55 years||Age, Customized||participants|Number|4|4.0||||||
4085264|NCT01010750|3908362|B1|Between 18 and 55 years||Age, Customized||participants|Number|3|3.0||||||
4085265|NCT01010750|3908356|B7|<18 years||Age, Customized||participants|Number|0|0.0||||||
4085266|NCT01010750|3908357|B6|<18 years||Age, Customized||participants|Number|0|0.0||||||
4085267|NCT01010750|3908358|B5|<18 years||Age, Customized||participants|Number|0|0.0||||||
4085268|NCT01010750|3908359|B4|<18 years||Age, Customized||participants|Number|0|0.0||||||
4085269|NCT01010750|3908360|B3|<18 years||Age, Customized||participants|Number|0|0.0||||||
4085270|NCT01010750|3908361|B2|<18 years||Age, Customized||participants|Number|0|0.0||||||
4085271|NCT01010750|3908362|B1|<18 years||Age, Customized||participants|Number|0|0.0||||||
4085272|NCT01010750|3908356|B7|||Age||years|Mean|30.8|30.8|Standard Deviation|10.75|10.75|||
4085273|NCT01010750|3908357|B6|||Age||years|Mean|30.0|30.0|Standard Deviation|11.36|11.36|||
4085274|NCT01010750|3908358|B5|||Age||years|Mean|53.0|53.0|Standard Deviation|0.00|0.0|||
4085275|NCT01010750|3908359|B4|||Age||years|Mean|31.3|31.3|Standard Deviation|11.37|11.37|||
4085276|NCT01010750|3908360|B3|||Age||years|Mean|30.3|30.3|Standard Deviation|6.11|6.11|||
4085277|NCT01010750|3908361|B2|||Age||years|Mean|24.8|24.8|Standard Deviation|6.70|6.7|||
4085278|NCT01010750|3908362|B1|||Age||years|Mean|25.0|25.0|Standard Deviation|1.00|1.0|||
4085279|NCT01010633|3908390|B3|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4085280|NCT01010633|3908391|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4085281|NCT01010633|3908392|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4085282|NCT01010633|3908390|B3|White||Race/Ethnicity, Customized||participants|Number|358|358.0||||||
4085283|NCT01010633|3908391|B2|White||Race/Ethnicity, Customized||participants|Number|182|182.0||||||
4085284|NCT01010633|3908392|B1|White||Race/Ethnicity, Customized||participants|Number|176|176.0||||||
4085285|NCT01010633|3908390|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4085286|NCT01010633|3908391|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4085287|NCT01010633|3908392|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4085288|NCT01010633|3908390|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4085289|NCT01010633|3908391|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4085290|NCT01010633|3908392|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4085291|NCT01010633|3908390|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4085292|NCT01010633|3908391|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4085293|NCT01010633|3908392|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4085294|NCT01010633|3908390|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4085295|NCT01010633|3908391|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4085296|NCT01010633|3908392|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4085297|NCT01010633|3908390|B3||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4085298|NCT01010633|3908391|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4085299|NCT01010633|3908392|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4085300|NCT01010633|3908390|B3||Female|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
4085301|NCT01010633|3908391|B2||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4085302|NCT01010633|3908392|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4085303|NCT01010633|3908390|B3|||Age||years|Mean|69.1|69.1|Standard Deviation|9.27|9.27|||
4085304|NCT01010633|3908391|B2|||Age||years|Mean|69.0|69.0|Standard Deviation|9.80|9.8|||
4085305|NCT01010633|3908392|B1|||Age||years|Mean|69.3|69.3|Standard Deviation|8.73|8.73|||
4085306|NCT01010568|3908403|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4085307|NCT01010568|3908403|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4085308|NCT01010568|3908403|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4085309|NCT01010568|3908403|B1|||Age||years|Median|63|63.0|Full Range|||52.0|80.0|
4085310|NCT01010568|3908403|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4085311|NCT01010568|3908403|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4085312|NCT01010568|3908403|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4085313|NCT01010555|3908409|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4085314|NCT01010555|3908409|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4085315|NCT01010555|3908409|B1|||Age||years|Median|20.0|20.0|Full Range|||18.0|56.0|
4085316|NCT01010503|3908420|B1|||Erythrocyte Sedimentation Rate (ESR)|ESR was measured in millimeters per hour (mm/hr)|mm/hr|Mean|55.81|55.81|Standard Deviation|25.05|25.05|||
4085317|NCT01010503|3908420|B1|||C-Reactive Protein (CRP)|CRP was measured in milligrams per liter (mg/L)|mg/L|Mean|17.84|17.84|Standard Deviation|21.30|21.3|||
4085318|NCT01010503|3908420|B1|Class IV||Functional Class of Disease|Classification of global functional status in RA is as follows: Class I: completely able to perform usual activities of daily living (self-care, vocational, and avocational); Class II: able to perform usual self-care and vocational activities, but limited in avocational activities; Class III: able to perform usual self-care activities, but limited in vocational and avocational activities; and Class IV: limited in ability to perform usual self-care, vocational, and avocational activities.|participants|Number|0|0.0||||||
4085319|NCT01010503|3908420|B1|Class III||Functional Class of Disease|Classification of global functional status in RA is as follows: Class I: completely able to perform usual activities of daily living (self-care, vocational, and avocational); Class II: able to perform usual self-care and vocational activities, but limited in avocational activities; Class III: able to perform usual self-care activities, but limited in vocational and avocational activities; and Class IV: limited in ability to perform usual self-care, vocational, and avocational activities.|participants|Number|22|22.0||||||
4085320|NCT01010503|3908420|B1|Class II||Functional Class of Disease|Classification of global functional status in RA is as follows: Class I: completely able to perform usual activities of daily living (self-care, vocational, and avocational); Class II: able to perform usual self-care and vocational activities, but limited in avocational activities; Class III: able to perform usual self-care activities, but limited in vocational and avocational activities; and Class IV: limited in ability to perform usual self-care, vocational, and avocational activities.|participants|Number|10|10.0||||||
4085321|NCT01010503|3908420|B1|Class I||Functional Class of Disease|Classification of global functional status in RA is as follows: Class I: completely able to perform usual activities of daily living (self-care, vocational, and avocational); Class II: able to perform usual self-care and vocational activities, but limited in avocational activities; Class III: able to perform usual self-care activities, but limited in vocational and avocational activities; and Class IV: limited in ability to perform usual self-care, vocational, and avocational activities.|participants|Number|0|0.0||||||
4085322|NCT01010503|3908420|B1|Phase/Stage IV||Disease Phase/Stage|Disease stages/phases of rheumatoid arthritis (RA): Stage I represents synovitis: synovial membrane becomes hyperemic and edematous; joint effusions with high cell count; x-rays will as yet show no destructive changes, but soft tissue swelling or osteoporosis may be seen; Stage II: inflamed synovial tissue now proliferates and begins to grow into joint cavity across articular cartilage, which it gradually destroys; Stage III: pannus of synovium; eroded articular cartilage and exposed subchondral bone x-rays will show extensive cartilage loss; Stage IV represents end-stage disease.|participants|Number|4|4.0||||||
4085323|NCT01010503|3908420|B1|Phase/Stage III||Disease Phase/Stage|Disease stages/phases of rheumatoid arthritis (RA): Stage I represents synovitis: synovial membrane becomes hyperemic and edematous; joint effusions with high cell count; x-rays will as yet show no destructive changes, but soft tissue swelling or osteoporosis may be seen; Stage II: inflamed synovial tissue now proliferates and begins to grow into joint cavity across articular cartilage, which it gradually destroys; Stage III: pannus of synovium; eroded articular cartilage and exposed subchondral bone x-rays will show extensive cartilage loss; Stage IV represents end-stage disease.|participants|Number|12|12.0||||||
4085324|NCT01010503|3908420|B1|Phase/Stage II||Disease Phase/Stage|Disease stages/phases of rheumatoid arthritis (RA): Stage I represents synovitis: synovial membrane becomes hyperemic and edematous; joint effusions with high cell count; x-rays will as yet show no destructive changes, but soft tissue swelling or osteoporosis may be seen; Stage II: inflamed synovial tissue now proliferates and begins to grow into joint cavity across articular cartilage, which it gradually destroys; Stage III: pannus of synovium; eroded articular cartilage and exposed subchondral bone x-rays will show extensive cartilage loss; Stage IV represents end-stage disease.|participants|Number|12|12.0||||||
4085325|NCT01010503|3908420|B1|Phase/Stage I||Disease Phase/Stage|Disease stages/phases of rheumatoid arthritis (RA): Stage I represents synovitis: synovial membrane becomes hyperemic and edematous; joint effusions with high cell count; x-rays will as yet show no destructive changes, but soft tissue swelling or osteoporosis may be seen; Stage II: inflamed synovial tissue now proliferates and begins to grow into joint cavity across articular cartilage, which it gradually destroys; Stage III: pannus of synovium; eroded articular cartilage and exposed subchondral bone x-rays will show extensive cartilage loss; Stage IV represents end-stage disease.|participants|Number|4|4.0||||||
4085326|NCT01010503|3908420|B1|||Disease Duration||years|Mean|11.97|11.97|Standard Deviation|10.55|10.55|||
4085327|NCT01010503|3908420|B1|Slovakia||Region of Enrollment||participants|Number|32|32.0||||||
4085328|NCT01010503|3908420|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085329|NCT01010503|3908420|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085330|NCT01010503|3908420|B1||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4085331|NCT01010503|3908420|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085332|NCT01010503|3908420|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085333|NCT01010503|3908420|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085334|NCT01010503|3908420|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085335|NCT01010503|3908420|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4085336|NCT01010503|3908420|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4085337|NCT01010503|3908420|B1|||Age||years|Mean|52.38|52.38|Standard Deviation|12.05|12.05|||
4085338|NCT01010477|3908438|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4085339|NCT01010477|3908439|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4085340|NCT01010477|3908440|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4085341|NCT01010477|3908438|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085342|NCT01010477|3908439|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085343|NCT01010477|3908440|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085344|NCT01010477|3908438|B3||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4085345|NCT01010477|3908439|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4085346|NCT01010477|3908440|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4085347|NCT01010477|3908438|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4085348|NCT01010477|3908439|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4085349|NCT01010477|3908440|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4085350|NCT01010477|3908438|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085351|NCT01010477|3908439|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085352|NCT01010477|3908440|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085353|NCT01010477|3908438|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085354|NCT01010477|3908439|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085355|NCT01010477|3908440|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085356|NCT01010477|3908438|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085357|NCT01010477|3908439|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085358|NCT01010477|3908440|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085359|NCT01010477|3908438|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4085360|NCT01010477|3908439|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4085361|NCT01010477|3908440|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4085362|NCT01010477|3908438|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4085363|NCT01010477|3908439|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4085364|NCT01010477|3908440|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4085365|NCT01010477|3908438|B3|||Age||years|Mean|45.3|45.3|Standard Deviation|12.0|12.0|||
4085366|NCT01010477|3908439|B2|||Age||years|Mean|48.4|48.4|Standard Deviation|10.5|10.5|||
4085367|NCT01010477|3908440|B1|||Age||years|Mean|42.4|42.4|Standard Deviation|12.8|12.8|||
4085368|NCT01010399|3908447|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4085369|NCT01010399|3908447|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4085370|NCT01010399|3908447|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4085371|NCT01010399|3908447|B1|||Age||years|Mean|48.3|48.3|Standard Deviation|6.9|6.9|||
4085372|NCT01010399|3908447|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4085373|NCT01010399|3908447|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4085374|NCT01010399|3908447|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4085375|NCT01010282|3908452|B4||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4085376|NCT01010282|3908453|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4085377|NCT01010282|3908454|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4085378|NCT01010282|3908455|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4085379|NCT01010282|3908452|B4||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4085380|NCT01010282|3908453|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4085381|NCT01010282|3908454|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4085382|NCT01010282|3908455|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4085383|NCT01010282|3908452|B4|>40 years||Age, Customized||participants|Number|243|243.0||||||
4085384|NCT01010282|3908453|B3|>40 years||Age, Customized||participants|Number|81|81.0||||||
4085385|NCT01010282|3908454|B2|>40 years||Age, Customized||participants|Number|77|77.0||||||
4085386|NCT01010282|3908455|B1|>40 years||Age, Customized||participants|Number|85|85.0||||||
4085387|NCT01010282|3908452|B4|between 30 and 40 years||Age, Customized||participants|Number|26|26.0||||||
4085388|NCT01010282|3908453|B3|between 30 and 40 years||Age, Customized||participants|Number|11|11.0||||||
4085389|NCT01010282|3908454|B2|between 30 and 40 years||Age, Customized||participants|Number|9|9.0||||||
4085390|NCT01010282|3908455|B1|between 30 and 40 years||Age, Customized||participants|Number|6|6.0||||||
4085391|NCT01010282|3908452|B4|<30 years||Age, Customized||participants|Number|19|19.0||||||
4085392|NCT01010282|3908453|B3|<30 years||Age, Customized||participants|Number|4|4.0||||||
4085393|NCT01010282|3908454|B2|<30 years||Age, Customized||participants|Number|9|9.0||||||
4085394|NCT01010282|3908455|B1|<30 years||Age, Customized||participants|Number|6|6.0||||||
4085395|NCT01010230|3908477|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4085396|NCT01010230|3908478|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4085397|NCT01010230|3908479|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4085398|NCT01010230|3908477|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4085399|NCT01010230|3908478|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4085400|NCT01010230|3908479|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4085401|NCT01010230|3908477|B3|||Age||years|Mean|13.5|13.5|Standard Deviation|2.8|2.8|||
4085402|NCT01010230|3908478|B2|||Age||years|Mean|13.5|13.5|Standard Deviation|2.8|2.8|||
4085403|NCT01010230|3908479|B1|||Age||years|Mean|13.4|13.4|Standard Deviation|2.7|2.7|||
4085404|NCT01010204|3908510|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085405|NCT01010204|3908511|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085406|NCT01010204|3908512|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085407|NCT01010204|3908510|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085408|NCT01010204|3908511|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085409|NCT01010204|3908512|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085410|NCT01010204|3908510|B3||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4085411|NCT01010204|3908511|B2||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4085412|NCT01010204|3908512|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4085413|NCT01010204|3908510|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4085414|NCT01010204|3908511|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4085415|NCT01010204|3908512|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4085416|NCT01010204|3908510|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085417|NCT01010204|3908511|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085418|NCT01010204|3908512|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085419|NCT01010204|3908510|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085420|NCT01010204|3908511|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085421|NCT01010204|3908512|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085422|NCT01010204|3908510|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085423|NCT01010204|3908511|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085424|NCT01010204|3908512|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085425|NCT01010204|3908510|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4085426|NCT01010204|3908511|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4085427|NCT01010204|3908512|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4085428|NCT01010204|3908510|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4085429|NCT01010204|3908511|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4085430|NCT01010204|3908512|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4085431|NCT01010204|3908510|B3|||Age||years|Mean|45.95|45.95|Standard Deviation|9.40|9.4|||
4085432|NCT01010204|3908511|B2|||Age||years|Mean|46.2|46.2|Standard Deviation|8.5|8.5|||
4085433|NCT01010204|3908512|B1|||Age||years|Mean|45.7|45.7|Standard Deviation|10.3|10.3|||
4085434|NCT01010061|3908523|B3||Male|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
4085435|NCT01010061|3908524|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4085436|NCT01010061|3908525|B1||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4085437|NCT01010061|3908523|B3||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4085438|NCT01010061|3908524|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4085439|NCT01010061|3908525|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4085440|NCT01010061|3908523|B3|>=65 years||Age, Customized||participants|Number|288|288.0||||||
4085441|NCT01010061|3908524|B2|>=65 years||Age, Customized||participants|Number|92|92.0||||||
4085442|NCT01010061|3908525|B1|>=65 years||Age, Customized||participants|Number|196|196.0||||||
4085443|NCT01010061|3908523|B3|<65 years||Age, Customized||participants|Number|68|68.0||||||
4085444|NCT01010061|3908524|B2|<65 years||Age, Customized||participants|Number|26|26.0||||||
4085445|NCT01010061|3908525|B1|<65 years||Age, Customized||participants|Number|42|42.0||||||
4085446|NCT01010009|3908558|B4|United Kingdom||Region of Enrollment||participants|Number|24|24.0||||||
4085447|NCT01010009|3908559|B3|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
4085448|NCT01010009|3908560|B2|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
4085449|NCT01010009|3908561|B1|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
4085450|NCT01010009|3908558|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4085451|NCT01010009|3908559|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4085452|NCT01010009|3908560|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4085453|NCT01010009|3908561|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4085454|NCT01010009|3908558|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4085455|NCT01010009|3908559|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4085456|NCT01010009|3908560|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4085457|NCT01010009|3908561|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4085458|NCT01010009|3908558|B4|||Age||years|Mean|20|20.0|Standard Deviation|2|2.0|||
4085459|NCT01010009|3908559|B3|||Age||years|Mean|20|20.0|Standard Deviation|2|2.0|||
4085460|NCT01010009|3908560|B2|||Age||years|Mean|21.3|21.3|Standard Deviation|1.8|1.8|||
4085461|NCT01010009|3908561|B1|||Age||years|Mean|19.2|19.2|Standard Deviation|2.2|2.2|||
4085462|NCT01010009|3908558|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4085463|NCT01010009|3908559|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4085464|NCT01010009|3908560|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4085465|NCT01010009|3908561|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4085466|NCT01010009|3908558|B4||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4085467|NCT01010009|3908559|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4085468|NCT01010009|3908560|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4085469|NCT01010009|3908561|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4085470|NCT01010009|3908558|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4085471|NCT01010009|3908559|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4085472|NCT01010009|3908560|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4085473|NCT01010009|3908561|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4085474|NCT01009983|3908577|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4085475|NCT01009983|3908577|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085476|NCT01009983|3908577|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4085477|NCT01009983|3908577|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085478|NCT01009983|3908577|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085479|NCT01009983|3908577|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085480|NCT01009983|3908577|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4085481|NCT01009983|3908577|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4085482|NCT01009983|3908577|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085483|NCT01009983|3908577|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085484|NCT01009983|3908577|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085485|NCT01009983|3908577|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4085486|NCT01009983|3908577|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4085487|NCT01009983|3908577|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4085488|NCT01009983|3908577|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4085489|NCT01009983|3908577|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4085490|NCT01009983|3908577|B1|||Age||years|Mean|54.5|54.5|Standard Deviation|10.1|10.1|||
4085491|NCT01009931|3908584|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4085492|NCT01009931|3908584|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085493|NCT01009931|3908584|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085494|NCT01009931|3908584|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4085495|NCT01009931|3908584|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085496|NCT01009931|3908584|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085497|NCT01009931|3908584|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085498|NCT01009931|3908584|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085499|NCT01009931|3908584|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085500|NCT01009931|3908584|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4085501|NCT01009931|3908584|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085502|NCT01009931|3908584|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4085503|NCT01009931|3908584|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4085504|NCT01009931|3908584|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4085505|NCT01009931|3908584|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4085506|NCT01009931|3908584|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4085507|NCT01009840|3908590|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4085508|NCT01009840|3908590|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4085509|NCT01009840|3908590|B1|||Age||years|Mean|59.1|59.1|Standard Deviation|6.9|6.9|||
4085510|NCT01009762|3908603|B3|||Viral load >10^3/mm^3 plasma|Numbers of participants with Viral Load in plasma above 1000 copies per ml|participants|Number|11|11.0||||||
4085511|NCT01009762|3908604|B2|||Viral load >10^3/mm^3 plasma|Numbers of participants with Viral Load in plasma above 1000 copies per ml|participants|Number|10|10.0||||||
4085512|NCT01009762|3908605|B1|||Viral load >10^3/mm^3 plasma|Numbers of participants with Viral Load in plasma above 1000 copies per ml|participants|Number|1|1.0||||||
4085513|NCT01009762|3908603|B3|||Absence of T cell reaction to all vaccine peptides||participants|Number|11|11.0||||||
4085514|NCT01009762|3908604|B2|||Absence of T cell reaction to all vaccine peptides||participants|Number|10|10.0||||||
4085515|NCT01009762|3908605|B1|||Absence of T cell reaction to all vaccine peptides||participants|Number|1|1.0||||||
4085516|NCT01009762|3908603|B3|||Clusters of Differentiation 4 (CD4) T-cells >400 cells/mm^3||participants|Number|11|11.0||||||
4085517|NCT01009762|3908604|B2|||Clusters of Differentiation 4 (CD4) T-cells >400 cells/mm^3||participants|Number|10|10.0||||||
4085518|NCT01009762|3908605|B1|||Clusters of Differentiation 4 (CD4) T-cells >400 cells/mm^3||participants|Number|1|1.0||||||
4085519|NCT01009762|3908603|B3|Denmark||Region of Enrollment||participants|Number|11|11.0||||||
4085520|NCT01009762|3908604|B2|Denmark||Region of Enrollment||participants|Number|10|10.0||||||
4085521|NCT01009762|3908605|B1|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
4085522|NCT01009762|3908603|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4085523|NCT01009762|3908604|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4085524|NCT01009762|3908605|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4085525|NCT01009762|3908603|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4085526|NCT01009762|3908604|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4085527|NCT01009762|3908605|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4085528|NCT01009762|3908603|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4085529|NCT01009762|3908604|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4085530|NCT01009762|3908605|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4085531|NCT01009762|3908603|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4085532|NCT01009762|3908604|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4085533|NCT01009762|3908605|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4085534|NCT01009762|3908603|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4085535|NCT01009762|3908604|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4085536|NCT01009762|3908605|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4085537|NCT01009645|3908616|B5|United States||Region of Enrollment||participants|Number|125|125.0||||||
4085538|NCT01009645|3908617|B4|United States||Region of Enrollment||participants|Number|31|31.0||||||
4085539|NCT01009645|3908618|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4085540|NCT01009645|3908619|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
4085541|NCT01009645|3908620|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4085542|NCT01009645|3908616|B5||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4085543|NCT01009645|3908617|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4085544|NCT01009645|3908618|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4085545|NCT01009645|3908619|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4085546|NCT01009645|3908620|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4085547|NCT01009645|3908616|B5||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4085548|NCT01009645|3908617|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4085549|NCT01009645|3908618|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4085550|NCT01009645|3908619|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4085551|NCT01009645|3908620|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4085552|NCT01009645|3908616|B5|||Age||years|Mean|63.16|63.16|Standard Deviation|9.43|9.43|||
4085553|NCT01009645|3908617|B4|||Age||years|Mean|65.35|65.35|Standard Deviation|8.40|8.4|||
4085554|NCT01009645|3908618|B3|||Age||years|Mean|63.34|63.34|Standard Deviation|9.64|9.64|||
4085555|NCT01009645|3908619|B2|||Age||years|Mean|61.13|61.13|Standard Deviation|7.46|7.46|||
4085556|NCT01009645|3908620|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|11.27|11.27|||
4085557|NCT01009645|3908616|B5||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4085558|NCT01009645|3908617|B4||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4085559|NCT01009645|3908618|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4085560|NCT01009645|3908619|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4085561|NCT01009645|3908620|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4085562|NCT01009645|3908616|B5||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
4085563|NCT01009645|3908617|B4||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4085564|NCT01009645|3908618|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4085565|NCT01009645|3908619|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4085566|NCT01009645|3908620|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4085567|NCT01009645|3908616|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4085568|NCT01009645|3908617|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4085569|NCT01009645|3908618|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4085570|NCT01009645|3908619|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4085571|NCT01009645|3908620|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4085572|NCT01009619|3908637|B3|Belgium||Region of Enrollment||participants|Number|83|83.0||||||
4085573|NCT01009619|3908638|B2|Belgium||Region of Enrollment||participants|Number|43|43.0||||||
4085574|NCT01009619|3908639|B1|Belgium||Region of Enrollment||participants|Number|40|40.0||||||
4085575|NCT01009619|3908637|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4085576|NCT01009619|3908638|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4085577|NCT01009619|3908639|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4085578|NCT01009619|3908637|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4085579|NCT01009619|3908638|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4085580|NCT01009619|3908639|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4085581|NCT01009619|3908637|B3|||Age||years|Mean|51.1|51.1|Standard Deviation|0|0.0|||
4085582|NCT01009619|3908638|B2|||Age||years|Mean|50.9|50.9|Standard Deviation|0|0.0|||
4085583|NCT01009619|3908639|B1|||Age||years|Mean|51.2|51.2|Standard Deviation|0|0.0|||
4085584|NCT01009619|3908637|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4085585|NCT01009619|3908638|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4085586|NCT01009619|3908639|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4085587|NCT01009619|3908637|B3||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4085588|NCT01009619|3908638|B2||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4085589|NCT01009619|3908639|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4085590|NCT01009619|3908637|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4085591|NCT01009619|3908638|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4085592|NCT01009619|3908639|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4085593|NCT01009580|3908658|B3|||Fasting plasma glucose (FPG)||mmol/L|Mean|8.7|8.7|Standard Deviation|2.8|2.8|||
4085594|NCT01009580|3908659|B2|||Fasting plasma glucose (FPG)||mmol/L|Mean|8.6|8.6|Standard Deviation|2.6|2.6|||
4085595|NCT01009580|3908660|B1|||Fasting plasma glucose (FPG)||mmol/L|Mean|8.9|8.9|Standard Deviation|2.9|2.9|||
4085596|NCT01009580|3908658|B3|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.4|8.4|Standard Deviation|0.8|0.8|||
4085597|NCT01009580|3908659|B2|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.4|8.4|Standard Deviation|0.9|0.9|||
4085598|NCT01009580|3908660|B1|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.3|8.3|Standard Deviation|0.8|0.8|||
4085599|NCT01009580|3908658|B3||Male|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
4085600|NCT01009580|3908659|B2||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4085601|NCT01009580|3908660|B1||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4085602|NCT01009580|3908658|B3||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4085603|NCT01009580|3908659|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4085604|NCT01009580|3908660|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4085605|NCT01009580|3908658|B3|||Age||years|Mean|58.7|58.7|Standard Deviation|9.8|9.8|||
4085606|NCT01009580|3908659|B2|||Age||years|Mean|58.8|58.8|Standard Deviation|9.8|9.8|||
4085607|NCT01009580|3908660|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|9.9|9.9|||
4085608|NCT01009554|3908673|B3|USA||Region of Enrollment||participants|Number|96|96.0||||||
4085609|NCT01009554|3908674|B2|USA||Region of Enrollment||participants|Number|48|48.0||||||
4085610|NCT01009554|3908675|B1|USA||Region of Enrollment||participants|Number|48|48.0||||||
4085611|NCT01009554|3908673|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4085612|NCT01009554|3908674|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4085613|NCT01009554|3908675|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4085614|NCT01009554|3908673|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4085615|NCT01009554|3908674|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4085616|NCT01009554|3908675|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4085617|NCT01009554|3908673|B3|||Age||years|Mean|48.7|48.7|Standard Deviation|9.08|9.08|||
4085618|NCT01009554|3908674|B2|||Age||years|Mean|49.8|49.8|Standard Deviation|8.08|8.08|||
4085619|NCT01009554|3908675|B1|||Age||years|Mean|47.6|47.6|Standard Deviation|9.96|9.96|||
4085620|NCT01009515|3908808|B1|Immune Vaccines||Previous Therapy||participants|Number|2|2.0||||||
4085621|NCT01009515|3908808|B1|Interferon||Previous Therapy||participants|Number|5|5.0||||||
4085622|NCT01009515|3908808|B1|Chemotherapy||Previous Therapy||participants|Number|4|4.0||||||
4085623|NCT01009515|3908808|B1|Radiation||Previous Therapy||participants|Number|8|8.0||||||
4085624|NCT01009515|3908808|B1|Surgery||Previous Therapy||participants|Number|16|16.0||||||
4085625|NCT01009515|3908808|B1|Regional Lymph Nodes||Site of Metastasis||participants|Number|10|10.0||||||
4085626|NCT01009515|3908808|B1|Other visceral organs||Site of Metastasis||participants|Number|12|12.0||||||
4085627|NCT01009515|3908808|B1|Lung||Site of Metastasis||participants|Number|14|14.0||||||
4085628|NCT01009515|3908808|B1|Liver||Site of Metastasis||participants|Number|7|7.0||||||
4085629|NCT01009515|3908808|B1|Bone||Site of Metastasis||participants|Number|8|8.0||||||
4085630|NCT01009515|3908808|B1|Brain||Site of Metastasis||participants|Number|1|1.0||||||
4085631|NCT01009515|3908808|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4085632|NCT01009515|3908808|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4085633|NCT01009515|3908808|B1|White Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4085634|NCT01009515|3908808|B1|White non-Hispanic||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4085635|NCT01009515|3908808|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4085636|NCT01009515|3908808|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4085637|NCT01009515|3908808|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4085638|NCT01009515|3908808|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4085639|NCT01009515|3908808|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4085640|NCT01009463|3908815|B5|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4085641|NCT01009463|3908816|B4|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4085642|NCT01009463|3908817|B3|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4085643|NCT01009463|3908818|B2|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4085644|NCT01009463|3908819|B1|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4085645|NCT01009463|3908815|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4085646|NCT01009463|3908816|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4085647|NCT01009463|3908817|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4085648|NCT01009463|3908818|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4085649|NCT01009463|3908819|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4085650|NCT01009463|3908815|B5|Asian & White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4085651|NCT01009463|3908816|B4|Asian & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4085652|NCT01009463|3908817|B3|Asian & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4085653|NCT01009463|3908818|B2|Asian & White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4085654|NCT01009463|3908819|B1|Asian & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4085655|NCT01009463|3908815|B5|American Indian or Alaska Native & White||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
4085656|NCT01009463|3908816|B4|American Indian or Alaska Native & White||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4085657|NCT01009463|3908817|B3|American Indian or Alaska Native & White||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4085658|NCT01009463|3908818|B2|American Indian or Alaska Native & White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4085659|NCT01009463|3908819|B1|American Indian or Alaska Native & White||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4085660|NCT01009463|3908815|B5|Asian||Race/Ethnicity, Customized||participants|Number|154|154.0||||||
4085661|NCT01009463|3908816|B4|Asian||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4085662|NCT01009463|3908817|B3|Asian||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4085663|NCT01009463|3908818|B2|Asian||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4085664|NCT01009463|3908819|B1|Asian||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4085665|NCT01009463|3908815|B5|African American/ African Heritage||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4085666|NCT01009463|3908816|B4|African American/ African Heritage||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4085667|NCT01009463|3908817|B3|African American/ African Heritage||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4085668|NCT01009463|3908818|B2|African American/ African Heritage||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4085669|NCT01009463|3908819|B1|African American/ African Heritage||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4085670|NCT01009463|3908815|B5|White||Race/Ethnicity, Customized||participants|Number|1321|1321.0||||||
4085671|NCT01009463|3908816|B4|White||Race/Ethnicity, Customized||participants|Number|324|324.0||||||
4085672|NCT01009463|3908817|B3|White||Race/Ethnicity, Customized||participants|Number|332|332.0||||||
4085673|NCT01009463|3908818|B2|White||Race/Ethnicity, Customized||participants|Number|334|334.0||||||
4085674|NCT01009463|3908819|B1|White||Race/Ethnicity, Customized||participants|Number|331|331.0||||||
4085675|NCT01009463|3908815|B5||Male|Sex: Female, Male||Participants|Count of Participants|964|964.0||||||
4085676|NCT01009463|3908816|B4||Male|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
4085677|NCT01009463|3908817|B3||Male|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
4085678|NCT01009463|3908818|B2||Male|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4085679|NCT01009463|3908819|B1||Male|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
4085680|NCT01009463|3908815|B5||Female|Sex: Female, Male||Participants|Count of Participants|658|658.0||||||
4085681|NCT01009463|3908816|B4||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4085682|NCT01009463|3908817|B3||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4085683|NCT01009463|3908818|B2||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4085684|NCT01009463|3908819|B1||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4085685|NCT01009463|3908815|B5|||Age||Years|Mean|63.6|63.6|Standard Deviation|9.21|9.21|||
4085686|NCT01009463|3908816|B4|||Age||Years|Mean|63.8|63.8|Standard Deviation|9.30|9.3|||
4085687|NCT01009463|3908817|B3|||Age||Years|Mean|63.6|63.6|Standard Deviation|9.06|9.06|||
4085688|NCT01009463|3908818|B2|||Age||Years|Mean|63.6|63.6|Standard Deviation|9.06|9.06|||
4085689|NCT01009463|3908819|B1|||Age||Years|Mean|63.6|63.6|Standard Deviation|9.43|9.43|||
4085690|NCT01009346|3908845|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4085691|NCT01009346|3908845|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4085692|NCT01009346|3908845|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4085693|NCT01009346|3908845|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4085694|NCT01009346|3908845|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4085695|NCT01009346|3908845|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4085696|NCT01009346|3908845|B1|||Age||years|Mean|65.77778|65.77778|Standard Deviation|12.71591|12.71591|||
4085697|NCT01009333|3908850|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4085698|NCT01009333|3908850|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4085699|NCT01009333|3908850|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4085700|NCT01009333|3908850|B1|||Age||years|Mean|61.9|61.9|Standard Deviation|6.9|6.9|||
4085701|NCT01009333|3908850|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4085702|NCT01009333|3908850|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4085703|NCT01009333|3908850|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4085704|NCT01009203|3908869|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4085705|NCT01009203|3908869|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4085706|NCT01009203|3908869|B1|||Age||years|Median|61.5|61.5|Full Range|||45.0|87.0|
4085707|NCT01009138|3908876|B3|||BMI (kg/m2)||kg/m2|Mean|29|29.0|Standard Deviation|7|7.0|||
4085708|NCT01009138|3908877|B2|||BMI (kg/m2)||kg/m2|Mean|28|28.0|Standard Deviation|6|6.0|||
4085709|NCT01009138|3908878|B1|||BMI (kg/m2)||kg/m2|Mean|30|30.0|Standard Deviation|8|8.0|||
4085710|NCT01009138|3908876|B3|||HbA1c (%-points)||%-points|Mean|8.9|8.9|Standard Deviation|1.8|1.8|||
4085711|NCT01009138|3908877|B2|||HbA1c (%-points)||%-points|Mean|8.9|8.9|Standard Deviation|1.8|1.8|||
4085712|NCT01009138|3908878|B1|||HbA1c (%-points)||%-points|Mean|8.9|8.9|Standard Deviation|1.8|1.8|||
4085713|NCT01009138|3908876|B3|||Diabetes duration||years|Mean|14|14.0|Standard Deviation|11|11.0|||
4085714|NCT01009138|3908877|B2|||Diabetes duration||years|Mean|14|14.0|Standard Deviation|11|11.0|||
4085715|NCT01009138|3908878|B1|||Diabetes duration||years|Mean|14|14.0|Standard Deviation|10|10.0|||
4085716|NCT01009138|3908876|B3|||Type 1 diabetes||participants|Number|141|141.0||||||
4085717|NCT01009138|3908877|B2|||Type 1 diabetes||participants|Number|78|78.0||||||
4085718|NCT01009138|3908878|B1|||Type 1 diabetes||participants|Number|63|63.0||||||
4085719|NCT01009138|3908876|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4085720|NCT01009138|3908877|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4085721|NCT01009138|3908878|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4085722|NCT01009138|3908876|B3||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4085723|NCT01009138|3908877|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4085724|NCT01009138|3908878|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4085725|NCT01009138|3908876|B3|||Age||years|Mean|43|43.0|Standard Deviation|13|13.0|||
4085726|NCT01009138|3908877|B2|||Age||years|Mean|43|43.0|Standard Deviation|14|14.0|||
4085727|NCT01009138|3908878|B1|||Age||years|Mean|43|43.0|Standard Deviation|15|15.0|||
4085728|NCT01009099|3908907|B3|||Time on treadmill constant workrate test||minutes walked|Mean|6.9|6.9|Standard Deviation|2.4|2.4|||
4085729|NCT01009099|3908908|B2|||Time on treadmill constant workrate test||minutes walked|Mean|6.9|6.9|Standard Deviation|2.3|2.3|||
4085730|NCT01009099|3908909|B1|||Time on treadmill constant workrate test||minutes walked|Mean|6.8|6.8|Standard Deviation|2.5|2.5|||
4085731|NCT01009099|3908907|B3|||Peak oxygen uptake||VO2 mL/kg/min|Mean|16.1|16.1|Standard Deviation|3.6|3.6|||
4085732|NCT01009099|3908908|B2|||Peak oxygen uptake||VO2 mL/kg/min|Mean|16.6|16.6|Standard Deviation|3.3|3.3|||
4085733|NCT01009099|3908909|B1|||Peak oxygen uptake||VO2 mL/kg/min|Mean|15.7|15.7|Standard Deviation|3.9|3.9|||
4085734|NCT01009099|3908907|B3|||RV/TLC||percent predicted|Mean|169.7|169.7|Standard Deviation|28.4|28.4|||
4085735|NCT01009099|3908908|B2|||RV/TLC||percent predicted|Mean|168.2|168.2|Standard Deviation|26.6|26.6|||
4085736|NCT01009099|3908909|B1|||RV/TLC||percent predicted|Mean|171.3|171.3|Standard Deviation|30.3|30.3|||
4085737|NCT01009099|3908907|B3|||FEV1/FVC||percent|Mean|45.8|45.8|Standard Deviation|12.7|12.7|||
4085738|NCT01009099|3908908|B2|||FEV1/FVC||percent|Mean|45.1|45.1|Standard Deviation|12.1|12.1|||
4085739|NCT01009099|3908909|B1|||FEV1/FVC||percent|Mean|46.6|46.6|Standard Deviation|13.3|13.3|||
4085740|NCT01009099|3908907|B3|||FEV1||percent predicted|Mean|43.8|43.8|Standard Deviation|14.3|14.3|||
4085741|NCT01009099|3908908|B2|||FEV1||percent predicted|Mean|44.0|44.0|Standard Deviation|13.9|13.9|||
4085742|NCT01009099|3908909|B1|||FEV1||percent predicted|Mean|43.7|43.7|Standard Deviation|14.9|14.9|||
4085743|NCT01009099|3908907|B3|||Body Mass Index||kg/m2|Mean|29.7|29.7|Standard Deviation|6.5|6.5|||
4085744|NCT01009099|3908908|B2|||Body Mass Index||kg/m2|Mean|29.3|29.3|Standard Deviation|6.2|6.2|||
4085745|NCT01009099|3908909|B1|||Body Mass Index||kg/m2|Mean|30.0|30.0|Standard Deviation|6.7|6.7|||
4085746|NCT01009099|3908907|B3|United States||Region of Enrollment||participants|Number|119|119.0||||||
4085747|NCT01009099|3908908|B2|United States||Region of Enrollment||participants|Number|61|61.0||||||
4085748|NCT01009099|3908909|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
4085749|NCT01009099|3908907|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085750|NCT01009099|3908908|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085751|NCT01009099|3908909|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085752|NCT01009099|3908907|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085753|NCT01009099|3908908|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085754|NCT01009099|3908909|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085755|NCT01009099|3908907|B3||White|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
4085756|NCT01009099|3908908|B2||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4085757|NCT01009099|3908909|B1||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4085758|NCT01009099|3908907|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4085759|NCT01009099|3908908|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4085760|NCT01009099|3908909|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4085761|NCT01009099|3908907|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085762|NCT01009099|3908908|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085763|NCT01009099|3908909|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085764|NCT01009099|3908907|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085765|NCT01009099|3908908|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085766|NCT01009099|3908909|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085767|NCT01009099|3908907|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085768|NCT01009099|3908908|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085769|NCT01009099|3908909|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085770|NCT01009099|3908907|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085771|NCT01009099|3908908|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085772|NCT01009099|3908909|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085773|NCT01009099|3908907|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|118|118.0||||||
4085774|NCT01009099|3908908|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4085775|NCT01009099|3908909|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4085776|NCT01009099|3908907|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4085777|NCT01009099|3908908|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085778|NCT01009099|3908909|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4085779|NCT01009099|3908907|B3||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4085780|NCT01009099|3908908|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4085781|NCT01009099|3908909|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4085782|NCT01009099|3908907|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4085783|NCT01009099|3908908|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4085784|NCT01009099|3908909|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4085785|NCT01009099|3908907|B3|||Age||years|Mean|66.0|66.0|Standard Deviation|8.0|8.0|||
4085786|NCT01009099|3908908|B2|||Age||years|Mean|66.3|66.3|Standard Deviation|8.1|8.1|||
4085787|NCT01009099|3908909|B1|||Age||years|Mean|65.8|65.8|Standard Deviation|7.9|7.9|||
4085788|NCT01009086|3908916|B4||Male|Sex: Female, Male||Participants|Count of Participants|330|330.0||||||
4085789|NCT01009086|3908917|B3||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4085790|NCT01009086|3908918|B2||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4085791|NCT01009086|3908919|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4085792|NCT01009086|3908916|B4||Female|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
4085793|NCT01009086|3908917|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4085794|NCT01009086|3908918|B2||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4085795|NCT01009086|3908919|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4085796|NCT01009086|3908916|B4|||Age||years|Mean|47.1|47.1|Standard Deviation|12.21|12.21|||
4085797|NCT01009086|3908917|B3|||Age||years|Mean|46.8|46.8|Standard Deviation|11.75|11.75|||
4085798|NCT01009086|3908918|B2|||Age||years|Mean|47.1|47.1|Standard Deviation|12.64|12.64|||
4085799|NCT01009086|3908919|B1|||Age||years|Mean|47.4|47.4|Standard Deviation|12.29|12.29|||
4085800|NCT01009060|3908954|B3|Mixed Race||Race/Ethnicity, Customized||Number|Number|2|2.0||||||
4085801|NCT01009060|3908955|B2|Mixed Race||Race/Ethnicity, Customized||Number|Number|2|2.0||||||
4085802|NCT01009060|3908956|B1|Mixed Race||Race/Ethnicity, Customized||Number|Number|0|0.0||||||
4085803|NCT01009060|3908954|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Number|Number|21|21.0||||||
4085804|NCT01009060|3908955|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Number|Number|8|8.0||||||
4085805|NCT01009060|3908956|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Number|Number|13|13.0||||||
4085806|NCT01009060|3908954|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Number|Number|1|1.0||||||
4085807|NCT01009060|3908955|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Number|Number|1|1.0||||||
4085808|NCT01009060|3908956|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Number|Number|0|0.0||||||
4085809|NCT01009060|3908954|B3|African American/African Heritage||Race/Ethnicity, Customized||Number|Number|22|22.0||||||
4085810|NCT01009060|3908955|B2|African American/African Heritage||Race/Ethnicity, Customized||Number|Number|11|11.0||||||
4085811|NCT01009060|3908956|B1|African American/African Heritage||Race/Ethnicity, Customized||Number|Number|11|11.0||||||
4085812|NCT01009060|3908954|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4085813|NCT01009060|3908955|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4085814|NCT01009060|3908956|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4085815|NCT01009060|3908954|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4085816|NCT01009060|3908955|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4085817|NCT01009060|3908956|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4085818|NCT01009060|3908954|B3|||Age||Years|Mean|39.2|39.2|Standard Deviation|11.30|11.3|||
4085819|NCT01009060|3908955|B2|||Age||Years|Mean|38.2|38.2|Standard Deviation|13.10|13.1|||
4085820|NCT01009060|3908956|B1|||Age||Years|Mean|40.1|40.1|Standard Deviation|9.54|9.54|||
4085858|NCT01008943|3909046|B1|||Age||years|Mean|61|61.0|Standard Deviation|2|2.0|||
4085821|NCT01009047|3908993|B3||Male|Sex: Female, Male|Number of participants analyzed for this Baseline characteristic is intent to treat (ITT) population which included all randomly assigned participants who received at least 1 dose of double-blind study drug, had both a Baseline measurement and at least 1 Post-Baseline measurement in the double-blind phase. Last observation carried forward (LOCF) method was used.|Participants|Count of Participants|149|149.0||||||
4085822|NCT01009047|3908994|B2||Male|Sex: Female, Male|Number of participants analyzed for this Baseline characteristic is intent to treat (ITT) population which included all randomly assigned participants who received at least 1 dose of double-blind study drug, had both a Baseline measurement and at least 1 Post-Baseline measurement in the double-blind phase. Last observation carried forward (LOCF) method was used.|Participants|Count of Participants|76|76.0||||||
4085823|NCT01009047|3908995|B1||Male|Sex: Female, Male|Number of participants analyzed for this Baseline characteristic is intent to treat (ITT) population which included all randomly assigned participants who received at least 1 dose of double-blind study drug, had both a Baseline measurement and at least 1 Post-Baseline measurement in the double-blind phase. Last observation carried forward (LOCF) method was used.|Participants|Count of Participants|73|73.0||||||
4085824|NCT01009047|3908993|B3||Female|Sex: Female, Male|Number of participants analyzed for this Baseline characteristic is intent to treat (ITT) population which included all randomly assigned participants who received at least 1 dose of double-blind study drug, had both a Baseline measurement and at least 1 Post-Baseline measurement in the double-blind phase. Last observation carried forward (LOCF) method was used.|Participants|Count of Participants|77|77.0||||||
4085825|NCT01009047|3908994|B2||Female|Sex: Female, Male|Number of participants analyzed for this Baseline characteristic is intent to treat (ITT) population which included all randomly assigned participants who received at least 1 dose of double-blind study drug, had both a Baseline measurement and at least 1 Post-Baseline measurement in the double-blind phase. Last observation carried forward (LOCF) method was used.|Participants|Count of Participants|38|38.0||||||
4085826|NCT01009047|3908995|B1||Female|Sex: Female, Male|Number of participants analyzed for this Baseline characteristic is intent to treat (ITT) population which included all randomly assigned participants who received at least 1 dose of double-blind study drug, had both a Baseline measurement and at least 1 Post-Baseline measurement in the double-blind phase. Last observation carried forward (LOCF) method was used.|Participants|Count of Participants|39|39.0||||||
4085827|NCT01009047|3908993|B3|||Age|Number of participants analyzed for this Baseline characteristic is intent to treat (ITT) population which included all randomly assigned participants who received at least 1 dose of double-blind study drug, had both a Baseline measurement and at least 1 Post-Baseline measurement in the double-blind phase. Last observation carried forward (LOCF) method was used.|Years|Mean|15.3|15.3|Standard Deviation|1.46|1.46|||
4085828|NCT01009047|3908994|B2|||Age|Number of participants analyzed for this Baseline characteristic is intent to treat (ITT) population which included all randomly assigned participants who received at least 1 dose of double-blind study drug, had both a Baseline measurement and at least 1 Post-Baseline measurement in the double-blind phase. Last observation carried forward (LOCF) method was used.|Years|Mean|15.4|15.4|Standard Deviation|1.45|1.45|||
4085829|NCT01009047|3908995|B1|||Age|Number of participants analyzed for this Baseline characteristic is intent to treat (ITT) population which included all randomly assigned participants who received at least 1 dose of double-blind study drug, had both a Baseline measurement and at least 1 Post-Baseline measurement in the double-blind phase. Last observation carried forward (LOCF) method was used.|Years|Mean|15.3|15.3|Standard Deviation|1.46|1.46|||
4085830|NCT01009034|3909018|B1|Canada||Region of Enrollment||participants|Number|14|14.0||||||
4085831|NCT01009034|3909018|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4085832|NCT01009034|3909018|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4085833|NCT01009034|3909018|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4085834|NCT01009034|3909018|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4085835|NCT01009034|3909018|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4085836|NCT01009034|3909018|B1|||Age||years|Median|51|51.0|Inter-Quartile Range|||46.0|57.0|
4085837|NCT01008995|3909024|B3|China||Region of Enrollment||participants|Number|322|322.0||||||
4085838|NCT01008995|3909025|B2|China||Region of Enrollment||participants|Number|160|160.0||||||
4085839|NCT01008995|3909026|B1|China||Region of Enrollment||participants|Number|162|162.0||||||
4085840|NCT01008995|3909024|B3||Male|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
4085841|NCT01008995|3909025|B2||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4085842|NCT01008995|3909026|B1||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4085843|NCT01008995|3909024|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4085844|NCT01008995|3909025|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4085845|NCT01008995|3909026|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4085846|NCT01008995|3909024|B3|||Age||years|Mean|39.7|39.7|Standard Deviation|12.28|12.28|||
4085847|NCT01008995|3909025|B2|||Age||years|Mean|40.1|40.1|Standard Deviation|12.36|12.36|||
4085848|NCT01008995|3909026|B1|||Age||years|Mean|39.2|39.2|Standard Deviation|12.21|12.21|||
4085849|NCT01008969|3909041|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4085850|NCT01008969|3909041|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4085851|NCT01008969|3909041|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4085852|NCT01008969|3909041|B1|||Age||years|Mean|71.5|71.5|Standard Deviation|8.34|8.34|||
4085853|NCT01008969|3909041|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4085854|NCT01008969|3909041|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4085855|NCT01008969|3909041|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4085856|NCT01008943|3909046|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4085857|NCT01008943|3909046|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4085859|NCT01008904|3909053|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4085860|NCT01008904|3909053|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4085861|NCT01008904|3909053|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4085862|NCT01008904|3909053|B1|||Age||years|Mean|53.5|53.5|Standard Deviation|3.7|3.7|||
4085863|NCT01008904|3909053|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4085864|NCT01008904|3909053|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4085865|NCT01008904|3909053|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4085866|NCT01008722|3909058|B3|United States||Region of Enrollment||participants|Number|107|107.0||||||
4085867|NCT01008722|3909059|B2|United States||Region of Enrollment||participants|Number|71|71.0||||||
4085868|NCT01008722|3909060|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4085869|NCT01008722|3909058|B3||Male|Gender||Participants|Count of Participants|102|102.0||||||
4085870|NCT01008722|3909059|B2||Male|Gender||Participants|Count of Participants|68|68.0||||||
4085871|NCT01008722|3909060|B1||Male|Gender||Participants|Count of Participants|34|34.0||||||
4085872|NCT01008722|3909058|B3||Female|Gender||Participants|Count of Participants|5|5.0||||||
4085873|NCT01008722|3909059|B2||Female|Gender||Participants|Count of Participants|3|3.0||||||
4085874|NCT01008722|3909060|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
4085875|NCT01008722|3909058|B3|||Age||years|Mean|62|62.0|Standard Deviation|8|8.0|||
4085876|NCT01008722|3909059|B2|||Age||years|Mean|61|61.0|Standard Deviation|8|8.0|||
4085877|NCT01008722|3909060|B1|||Age||years|Mean|63|63.0|Standard Deviation|9|9.0|||
4085878|NCT01008722|3909058|B3||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4085879|NCT01008722|3909059|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4085880|NCT01008722|3909060|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4085881|NCT01008722|3909058|B3||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
4085882|NCT01008722|3909059|B2||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4085883|NCT01008722|3909060|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4085884|NCT01008722|3909058|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4085885|NCT01008722|3909059|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4085886|NCT01008722|3909060|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4085887|NCT01008696|3909069|B3||Male|Sex: Female, Male|Gender is measured for the FAS popluation. It included participants who received study medication at least once and had follow-up data that could be used after Baseline among participants who met eligibilitycriteria. Last observation carried forward (LOCF) was used.|Participants|Count of Participants|144|144.0||||||
4085888|NCT01008696|3909070|B2||Male|Sex: Female, Male|Gender is measured for the FAS popluation. It included participants who received study medication at least once and had follow-up data that could be used after Baseline among participants who met eligibilitycriteria. Last observation carried forward (LOCF) was used.|Participants|Count of Participants|69|69.0||||||
4085889|NCT01008696|3909071|B1||Male|Sex: Female, Male|Gender is measured for the FAS popluation. It included participants who received study medication at least once and had follow-up data that could be used after Baseline among participants who met eligibilitycriteria. Last observation carried forward (LOCF) was used.|Participants|Count of Participants|75|75.0||||||
4085890|NCT01008696|3909069|B3||Female|Sex: Female, Male|Gender is measured for the FAS popluation. It included participants who received study medication at least once and had follow-up data that could be used after Baseline among participants who met eligibilitycriteria. Last observation carried forward (LOCF) was used.|Participants|Count of Participants|34|34.0||||||
4085891|NCT01008696|3909070|B2||Female|Sex: Female, Male|Gender is measured for the FAS popluation. It included participants who received study medication at least once and had follow-up data that could be used after Baseline among participants who met eligibilitycriteria. Last observation carried forward (LOCF) was used.|Participants|Count of Participants|22|22.0||||||
4085892|NCT01008696|3909071|B1||Female|Sex: Female, Male|Gender is measured for the FAS popluation. It included participants who received study medication at least once and had follow-up data that could be used after Baseline among participants who met eligibilitycriteria. Last observation carried forward (LOCF) was used.|Participants|Count of Participants|12|12.0||||||
4085893|NCT01008696|3909069|B3|||Age|Age continuous was measured for full analysis set (FAS) population. It included participants who received study medication at least once and had follow-up data that could be used after Baseline among participants who met eligibilitycriteria. Last observation carried forward (LOCF) was used.|Years|Mean|49.72|49.72|Standard Deviation|12.17|12.17|||
4085894|NCT01008696|3909070|B2|||Age|Age continuous was measured for full analysis set (FAS) population. It included participants who received study medication at least once and had follow-up data that could be used after Baseline among participants who met eligibilitycriteria. Last observation carried forward (LOCF) was used.|Years|Mean|49.74|49.74|Standard Deviation|12.65|12.65|||
4085895|NCT01008696|3909071|B1|||Age|Age continuous was measured for full analysis set (FAS) population. It included participants who received study medication at least once and had follow-up data that could be used after Baseline among participants who met eligibilitycriteria. Last observation carried forward (LOCF) was used.|Years|Mean|49.70|49.7|Standard Deviation|11.72|11.72|||
4085896|NCT01008618|3909082|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4085897|NCT01008618|3909082|B1||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4085898|NCT01008618|3909082|B1|||Age||Years|Mean|66.8|66.8|Standard Deviation|13.09|13.09|||
4085899|NCT01008605|3909109|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4085900|NCT01008605|3909109|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4085901|NCT01008605|3909109|B1|>= 65 years||Age, Customized||participants|Number|6|6.0||||||
4085902|NCT01008605|3909109|B1|Between 45 and 64 years||Age, Customized||participants|Number|31|31.0||||||
4085903|NCT01008605|3909109|B1|Between 18 and 44 years||Age, Customized||participants|Number|11|11.0||||||
4085904|NCT01008605|3909109|B1|||Age||years|Mean|51.6|51.6|Standard Deviation|8.5|8.5|||
4085905|NCT01008553|3909133|B1||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4085906|NCT01008553|3909133|B1||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4085907|NCT01008553|3909133|B1|||Age||Years|Mean|66.5|66.5|Standard Deviation|13.89|13.89|||
4085908|NCT01008475|3909160|B8||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4085909|NCT01008475|3909161|B7||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4085910|NCT01008475|3909162|B6||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4085911|NCT01008475|3909163|B5||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4085912|NCT01008475|3909164|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4085913|NCT01008475|3909165|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4085914|NCT01008475|3909166|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4085915|NCT01008475|3909167|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4085916|NCT01008475|3909160|B8||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4085917|NCT01008475|3909161|B7||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4085918|NCT01008475|3909162|B6||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4085919|NCT01008475|3909163|B5||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4085920|NCT01008475|3909164|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4085921|NCT01008475|3909165|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4085922|NCT01008475|3909166|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4085923|NCT01008475|3909167|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4085924|NCT01008475|3909160|B8|||Age||Years|Mean|58.5|58.5|Standard Deviation|11.49|11.49|||
4085925|NCT01008475|3909161|B7|||Age||Years|Mean|59.9|59.9|Standard Deviation|10.63|10.63|||
4085926|NCT01008475|3909162|B6|||Age||Years|Mean|58.9|58.9|Standard Deviation|12.18|12.18|||
4085927|NCT01008475|3909163|B5|||Age||Years|Mean|56.2|56.2|Standard Deviation|12.11|12.11|||
4085928|NCT01008475|3909164|B4|||Age||Years|Mean|63.0|63.0|Standard Deviation|7.2|7.2|||
4085929|NCT01008475|3909165|B3|||Age||Years|Mean|60.4|60.4|Standard Deviation|6.2|6.2|||
4085930|NCT01008475|3909166|B2|||Age||Years|Mean|57.7|57.7|Standard Deviation|11.2|11.2|||
4085931|NCT01008475|3909167|B1|||Age||Years|Mean|62.3|62.3|Standard Deviation|11.5|11.5|||
4085932|NCT01008449|3909201|B3|United States||Region of Enrollment||participants|Number|350|350.0||||||
4085933|NCT01008449|3909202|B2|United States||Region of Enrollment||participants|Number|179|179.0||||||
4085934|NCT01008449|3909203|B1|United States||Region of Enrollment||participants|Number|171|171.0||||||
4085935|NCT01008449|3909201|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4085936|NCT01008449|3909202|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4085937|NCT01008449|3909203|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4085938|NCT01008449|3909201|B3||Female|Sex: Female, Male||Participants|Count of Participants|350|350.0||||||
4085939|NCT01008449|3909202|B2||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4085940|NCT01008449|3909203|B1||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4085941|NCT01008449|3909201|B3|||Age||years|Mean|26.8|26.8|Standard Deviation|6.0|6.0|||
4085942|NCT01008449|3909202|B2|||Age||years|Mean|26.7|26.7|Standard Deviation|6.1|6.1|||
4085943|NCT01008449|3909203|B1|||Age||years|Mean|26.9|26.9|Standard Deviation|5.9|5.9|||
4085944|NCT01008319|3909224|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085945|NCT01008319|3909225|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085946|NCT01008319|3909226|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085947|NCT01008319|3909224|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085948|NCT01008319|3909225|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085949|NCT01008319|3909226|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085950|NCT01008319|3909224|B3||White|Race (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
4085951|NCT01008319|3909225|B2||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4085952|NCT01008319|3909226|B1||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4085953|NCT01008319|3909224|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4085954|NCT01008319|3909225|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4085955|NCT01008319|3909226|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4085956|NCT01008319|3909224|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085957|NCT01008319|3909225|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085958|NCT01008319|3909226|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085959|NCT01008319|3909224|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4085960|NCT01008319|3909225|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4085961|NCT01008319|3909226|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4085962|NCT01008319|3909224|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4085963|NCT01008319|3909225|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085964|NCT01008319|3909226|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4085965|NCT01008319|3909224|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4085966|NCT01008319|3909225|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4085967|NCT01008319|3909226|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4085968|NCT01008319|3909224|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4085969|NCT01008319|3909225|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4085970|NCT01008319|3909226|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4085971|NCT01008319|3909224|B3|||Age||years|Mean|28.65|28.65|Standard Deviation|4.45|4.45|||
4085972|NCT01008319|3909225|B2|||Age||years|Mean|29.37|29.37|Standard Deviation|3.96|3.96|||
4085973|NCT01008319|3909226|B1|||Age||years|Mean|27.88|27.88|Standard Deviation|4.95|4.95|||
4085974|NCT01008280|3909237|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4085975|NCT01008280|3909238|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4085976|NCT01008280|3909239|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4085977|NCT01008280|3909237|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085978|NCT01008280|3909238|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085979|NCT01008280|3909239|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085980|NCT01008280|3909237|B3||White|Race (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
4085981|NCT01008280|3909238|B2||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4085982|NCT01008280|3909239|B1||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4085983|NCT01008280|3909237|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4085984|NCT01008280|3909238|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4085985|NCT01008280|3909239|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4085986|NCT01008280|3909237|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4085987|NCT01008280|3909238|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4085988|NCT01008280|3909239|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4085989|NCT01008280|3909237|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085990|NCT01008280|3909238|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085991|NCT01008280|3909239|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4085992|NCT01008280|3909237|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4085993|NCT01008280|3909238|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4085994|NCT01008280|3909239|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4085995|NCT01008280|3909237|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4085996|NCT01008280|3909238|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4085997|NCT01008280|3909239|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4085998|NCT01008280|3909237|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
4085999|NCT01008280|3909238|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
4086000|NCT01008280|3909239|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4086001|NCT01008280|3909237|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4086002|NCT01008280|3909238|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4086003|NCT01008280|3909239|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4086004|NCT01008280|3909237|B3||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4086005|NCT01008280|3909238|B2||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4086006|NCT01008280|3909239|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4086007|NCT01008280|3909237|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4086008|NCT01008280|3909238|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4086009|NCT01008280|3909239|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4086010|NCT01008280|3909237|B3|||Age||Years|Mean|56.6|56.6|Standard Deviation|1.3|1.3|||
4086011|NCT01008280|3909238|B2|||Age||Years|Mean|57.5|57.5|Standard Deviation|6.9|6.9|||
4086012|NCT01008280|3909239|B1|||Age||Years|Mean|55.7|55.7|Standard Deviation|7.1|7.1|||
4086013|NCT01008150|3909250|B5|White/American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4086014|NCT01008150|3909251|B4|White/American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4086015|NCT01008150|3909252|B3|White/American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4086016|NCT01008150|3909253|B2|White/American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4086017|NCT01008150|3909254|B1|White/American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4086018|NCT01008150|3909250|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4086019|NCT01008150|3909251|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4086020|NCT01008150|3909252|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4086021|NCT01008150|3909253|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4086022|NCT01008150|3909254|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4086023|NCT01008150|3909250|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4086024|NCT01008150|3909251|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4086025|NCT01008150|3909252|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4086026|NCT01008150|3909253|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4086027|NCT01008150|3909254|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4086028|NCT01008150|3909250|B5|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4086029|NCT01008150|3909251|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4086030|NCT01008150|3909252|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4086031|NCT01008150|3909253|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4086032|NCT01008150|3909254|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4086033|NCT01008150|3909250|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|116|116.0||||||
4086034|NCT01008150|3909251|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4086035|NCT01008150|3909252|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
4086036|NCT01008150|3909253|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
4086037|NCT01008150|3909254|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
4086038|NCT01008150|3909250|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4086039|NCT01008150|3909251|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4086040|NCT01008150|3909252|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086041|NCT01008150|3909253|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086042|NCT01008150|3909254|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4086043|NCT01008150|3909250|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
4086044|NCT01008150|3909251|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4086045|NCT01008150|3909252|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4086046|NCT01008150|3909253|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4086047|NCT01008150|3909254|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4086048|NCT01008150|3909250|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4086049|NCT01008150|3909251|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4086050|NCT01008150|3909252|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4086051|NCT01008150|3909253|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4086052|NCT01008150|3909254|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4086053|NCT01008150|3909250|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4086054|NCT01008150|3909251|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4086055|NCT01008150|3909252|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4086056|NCT01008150|3909253|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4086057|NCT01008150|3909254|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4086058|NCT01008150|3909250|B5||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4086059|NCT01008150|3909251|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4086060|NCT01008150|3909252|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4086061|NCT01008150|3909253|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4086062|NCT01008150|3909254|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4086063|NCT01008150|3909250|B5|||Age||years|Mean|51.6|51.6|Standard Deviation|10.86|10.86|||
4086064|NCT01008150|3909251|B4|||Age||years|Mean|48.7|48.7|Standard Deviation|11.94|11.94|||
4086065|NCT01008150|3909252|B3|||Age||years|Mean|50.9|50.9|Standard Deviation|12.68|12.68|||
4086066|NCT01008150|3909253|B2|||Age||years|Mean|53.7|53.7|Standard Deviation|9.87|9.87|||
4086067|NCT01008150|3909254|B1|||Age||years|Mean|50.1|50.1|Standard Deviation|9.70|9.7|||
4086068|NCT01007916|3909287|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4086069|NCT01007916|3909287|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4086070|NCT01007916|3909287|B1|||Age||years|Mean|30.4|30.4|Standard Deviation|10.2|10.2|||
4086071|NCT01007942|3909294|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4086072|NCT01007942|3909295|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4086073|NCT01007942|3909296|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4086074|NCT01007942|3909294|B3||Female|Sex: Female, Male||Participants|Count of Participants|569|569.0||||||
4086075|NCT01007942|3909295|B2||Female|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
4086076|NCT01007942|3909296|B1||Female|Sex: Female, Male||Participants|Count of Participants|284|284.0||||||
4086077|NCT01007942|3909294|B3|||Age||years|Mean|53.8|53.8|Standard Deviation|10.99|10.99|||
4086078|NCT01007942|3909295|B2|||Age||years|Mean|53.4|53.4|Standard Deviation|11.00|11.0|||
4086079|NCT01007942|3909296|B1|||Age||years|Mean|54.3|54.3|Standard Deviation|10.98|10.98|||
4086080|NCT01007838|3909319|B5|United Kingdom||Region of Enrollment||participants|Number|32|32.0||||||
4086081|NCT01007838|3909320|B4|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4086082|NCT01007838|3909321|B3|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4086083|NCT01007838|3909322|B2|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
4086084|NCT01007838|3909323|B1|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
4086085|NCT01007838|3909319|B5||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4086086|NCT01007838|3909320|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4086087|NCT01007838|3909321|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4086088|NCT01007838|3909322|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4086089|NCT01007838|3909323|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4086090|NCT01007838|3909319|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4086091|NCT01007838|3909320|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4086092|NCT01007838|3909321|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4086093|NCT01007838|3909322|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4086094|NCT01007838|3909323|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4086095|NCT01007838|3909319|B5|||Age||years|Mean|51|51.0|Standard Deviation|17|17.0|||
4086096|NCT01007838|3909320|B4|||Age||years|Mean|40|40.0|Standard Deviation|17|17.0|||
4086097|NCT01007838|3909321|B3|||Age||years|Mean|51|51.0|Standard Deviation|13|13.0|||
4086098|NCT01007838|3909322|B2|||Age||years|Mean|67|67.0|Standard Deviation|16|16.0|||
4086099|NCT01007838|3909323|B1|||Age||years|Mean|48|48.0|Standard Deviation|18|18.0|||
4086100|NCT01007838|3909319|B5||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4086101|NCT01007838|3909320|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4086102|NCT01007838|3909321|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4086103|NCT01007838|3909322|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4086104|NCT01007838|3909323|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4086105|NCT01007838|3909319|B5||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4086106|NCT01007838|3909320|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4086107|NCT01007838|3909321|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4086108|NCT01007838|3909322|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4086109|NCT01007838|3909323|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4086110|NCT01007838|3909319|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4086111|NCT01007838|3909320|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4086112|NCT01007838|3909321|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4086113|NCT01007838|3909322|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4086114|NCT01007838|3909323|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4086115|NCT01007812|3909336|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4086116|NCT01007812|3909336|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4086117|NCT01007812|3909336|B1|||Age||years|Mean|33.4|33.4|Standard Deviation|11.2|11.2|||
4086118|NCT01007656|3909343|B1|||r-glutamyl transpeptidase (r-GT)|Subjects would fast for 8 hours prior to study product administration at 7:30 in the morning. Blood would be sampled from an antecubital vein of the forearm for the laboratory measurement. Qualified medical personnel would attend the whole study. No smoking, alcohol and caffeine consumption would be permitted for at least 48 hours before and during the study.|U/L|Mean|14.90|14.9|Standard Deviation|6.85|6.85|||
4086119|NCT01007656|3909343|B1|||Globulin|Globulin proteins include enzymes, antibodies and more than 500 other proteins. Subjects fasted for 8 hours prior to study product administration at 7:30 am in the morning. Blood would be sampled from an antecubital vein of the forearm for the laboratory measurement at 7:30 in the morning. Qualified medical personnel would attend the whole study. No smoking, alcohol and caffeine consumption would be permitted for at least 48 hours before and during the study.|g/dL|Mean|2.41|2.41|Standard Deviation|0.32|0.32|||
4086120|NCT01007656|3909343|B1|||Creatinine|Subjects fasted for 8 hours prior to study product administration at 7:30 in the morning. Blood would be sampled from an antecubital vein of the forearm for the laboratory measurement at 7:30 am. Qualified medical personnel would attend the whole study. No smoking, alcohol and caffeine consumption would be permitted for at least 48 hours before and during the study.|mg/dL|Mean|0.78|0.78|Standard Deviation|0.15|0.15|||
4086121|NCT01007656|3909343|B1|||Cholesterol|Subjects fasted for 8 hours prior to study product administration at 7:30 in the morning. Blood would be sampled from an antecubital vein of the forearm for the laboratory measurement at 7:30 in the morning. Qualified medical personnel would attend the whole study. No smoking, alcohol and caffeine consumption would be permitted for at least 48 hours before and during the study.|mg/dL|Mean|169.10|169.1|Standard Deviation|27.05|27.05|||
4086122|NCT01007656|3909343|B1|||BUN|Subjects fasted for 8 hours prior to study product administration at 7:30 in the morning. Blood would be sampled from an antecubital vein of the forearm for the laboratory measurement at 7:30 am. Qualified medical personnel would attend the whole study. No smoking, alcohol and caffeine consumption would be permitted for at least 48 hours before and during the study.|mg/dL|Mean|10.70|10.7|Standard Deviation|2.53|2.53|||
4086123|NCT01007656|3909343|B1|||Total bilirubin|Total bilirubin is referred to the sum of direct bilirubin and indirect bilirubin. Direct bilirubin is water- soluble form, made by the liver. Indirect bilirubin is not soluble in water due to the intramolecular hydrogen bond. Indirect bilirubin circulates in plasma. Total bilirubin test can be used to check liver function and haemolytic disease. Blood would be sampled from an antecubital vein of the forearm for the laboratory measurement at 7:30 in the morning. No smoking, alcohol and caffeine consumption would be permitted for at least 48 hours before and during the study.|mg/dL|Mean|0.80|0.8|Standard Deviation|0.28|0.28|||
4086124|NCT01007656|3909343|B1|||Direct bilirubin|Bilirubin is brownish yellow substance found in bile. It's produced when the liver breaks down old red blood cells. Bilirubin circulates in the bloodstream in two forms: indirect and direct bilirubin. Direct bilirubin is made by the liver from indirect form. This test can be used to check the liver function. Subjects would fast for 8 hours prior to study product administration at 7:30 in the morning. Blood would be sampled from an antecubital vein of the forearm for the laboratory measurement.|mg/dL|Mean|0.16|0.16|Standard Deviation|0.06|0.06|||
4086125|NCT01007656|3909343|B1|||Alkaline phosphatase|Subjects would fast for 8 hours prior to study product administration at 7:30 in the morning. Blood would be sampled from an antecubital vein of the forearm for the laboratory measurement at 7:30 in the morning. Qualified medical personnel would attend the whole study. No smoking, alcohol and caffeine consumption would be permitted for at least 48 hours before and during the study.|U/L|Mean|52.06|52.06|Standard Deviation|13.18|13.18|||
4086126|NCT01007656|3909343|B1|||Albumin|Subjects would fast for 8 hours prior to study product administration at 7:30 in the morning. Blood would be sampled from an antecubital vein of the forearm for the laboratory measurement at 7:30 in the morning. Qualified medical personnel would attend the whole study. No smoking, alcohol and caffeine consumption would be permitted for at least 48 hours before and during the study.|g/dL|Mean|4.47|4.47|Standard Deviation|0.16|0.16|||
4086127|NCT01007656|3909343|B1|||Uric acid|Subjects would fast for 8 hours prior to study product administration at 7:30 in the morning. Blood would be sampled from an antecubital vein of the forearm for the laboratory measurement at 7:30 in the morning.|mg/dL|Mean|5.79|5.79|Standard Deviation|1.13|1.13|||
4086128|NCT01007656|3909343|B1|||Total protein|The total protein test measures the total amount of two classes of proteins in the blood, albumin and globulin. Blood would be sampled from an antecubital vein of the forearm for the laboratory measurement at 7:30 am. Qualified medical personnel would attend the whole study. No smoking, alcohol and caffeine consumption would be permitted for at least 48 hours before and during the study.|g/dL|Mean|6.88|6.88|Standard Deviation|0.32|0.32|||
4086129|NCT01007656|3909343|B1|||Triglycerides (TG)|Subjects would fast for 8 hours prior to study product administration at 7:30 in the morning. Blood would be sampled from an antecubital vein of the forearm for the laboratory measurement at 7:30 in the morning. Qualified medical personnel will attend the whole study. No smoking, alcohol and caffeine consumption would be permitted for at least 48 hours before and during the study.|mg/dL|Mean|75.19|75.19|Standard Deviation|35.16|35.16|||
4086130|NCT01007656|3909343|B1|||Serum glutamic pyruvate transaminase, SGPT (ALT)|Subjects would fast for 8 hours prior to study product administration at 7:30 in the morning. Blood would be sampled from an antecubital vein of the forearm for the laboratory measurement. Qualified medical personnel would attend the whole study. No smoking, alcohol and caffeine consumption would be permitted for at least 48 hours before and during the study.|U/L|Mean|17.32|17.32|Standard Deviation|9.03|9.03|||
4086131|NCT01007656|3909343|B1|||Serum glutamic oxaloacetic transaminase SGOT (AST)|Blood was sampled from an antecubital vein of the forearm for the laboratory measurement at 07:30 in the morning. Qualified medical personnel will attend the whole study. No smoking, alcohol and caffeine consumption will be permitted for at least 48 hours before and during the study.|U/L|Mean|16.74|16.74|Standard Deviation|3.95|3.95|||
4086132|NCT01007656|3909343|B1|Taiwan||Region of Enrollment||participants|Number|31|31.0||||||
4086133|NCT01007656|3909343|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4086134|NCT01007656|3909343|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4086135|NCT01007656|3909343|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4086136|NCT01007656|3909343|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4086137|NCT01007656|3909343|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4086138|NCT01007643|3909361|B3|Canada||Region of Enrollment||participants|Number|22|22.0||||||
4086139|NCT01007643|3909362|B2|Canada||Region of Enrollment||participants|Number|14|14.0||||||
4086140|NCT01007643|3909363|B1|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4086141|NCT01007643|3909361|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4086142|NCT01007643|3909362|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4086143|NCT01007643|3909363|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4086144|NCT01007643|3909361|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4086145|NCT01007643|3909362|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4086146|NCT01007643|3909363|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4086147|NCT01007643|3909361|B3|||Age||years|Mean|13.2|13.2|Standard Deviation|1.5|1.5|||
4086148|NCT01007643|3909362|B2|||Age||years|Mean|13.5|13.5|Standard Deviation|1.5|1.5|||
4086149|NCT01007643|3909363|B1|||Age||years|Mean|12.6|12.6|Standard Deviation|1.5|1.5|||
4086150|NCT01007643|3909361|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4086151|NCT01007643|3909362|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4086152|NCT01007643|3909363|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4086153|NCT01007643|3909361|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4086154|NCT01007643|3909362|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4086155|NCT01007643|3909363|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4086156|NCT01007643|3909361|B3||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
4086157|NCT01007643|3909362|B2||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4086158|NCT01007643|3909363|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4086159|NCT01007552|3909370|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4086160|NCT01007552|3909370|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4086161|NCT01007552|3909370|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|12.2|12.2|||
4086162|NCT01007552|3909370|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4086163|NCT01007552|3909370|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4086164|NCT01007552|3909370|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4086165|NCT01007435|3909380|B5||Male|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
4086166|NCT01007435|3909381|B4||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4086167|NCT01007435|3909382|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4086168|NCT01007435|3909383|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4086169|NCT01007435|3909384|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4086170|NCT01007435|3909380|B5||Female|Sex: Female, Male||Participants|Count of Participants|904|904.0||||||
4086171|NCT01007435|3909381|B4||Female|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
4086172|NCT01007435|3909382|B3||Female|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
4086173|NCT01007435|3909383|B2||Female|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
4086174|NCT01007435|3909384|B1||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4086175|NCT01007435|3909380|B5|||Age||years|Mean|50.1|50.1|Standard Deviation|13.47|13.47|||
4086176|NCT01007435|3909381|B4|||Age||years|Mean|49.9|49.9|Standard Deviation|13.22|13.22|||
4086177|NCT01007435|3909382|B3|||Age||years|Mean|49.5|49.5|Standard Deviation|13.70|13.7|||
4086178|NCT01007435|3909383|B2|||Age||years|Mean|51.2|51.2|Standard Deviation|13.84|13.84|||
4086179|NCT01007435|3909384|B1|||Age||years|Mean|49.6|49.6|Standard Deviation|13.10|13.1|||
4086180|NCT01007396|3909429|B1|Korea, Republic of||Region of Enrollment||participants|Number|322|322.0||||||
4086181|NCT01007396|3909429|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4086182|NCT01007396|3909429|B1||Female|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
4086183|NCT01007396|3909429|B1|||Age||years|Median|24|24.0|Inter-Quartile Range|||22.0|25.0|
4086184|NCT01007253|3909434|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4086185|NCT01007253|3909434|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4086186|NCT01007253|3909434|B1|||Age||years|Mean|31.1|31.1|Standard Deviation|6.89|6.89|||
4086187|NCT01007149|3909467|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4086188|NCT01007149|3909468|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4086189|NCT01007149|3909469|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4086190|NCT01007149|3909467|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4086191|NCT01007149|3909468|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4086192|NCT01007149|3909469|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4086193|NCT01007149|3909467|B3|||Age||years|Mean|54.8|54.8|Standard Deviation|11.23|11.23|||
4086194|NCT01007149|3909468|B2|||Age||years|Mean|54.6|54.6|Standard Deviation|12.78|12.78|||
4086195|NCT01007149|3909469|B1|||Age||years|Mean|55.0|55.0|Standard Deviation|9.67|9.67|||
4086196|NCT01007123|3909492|B5|United States||Region of Enrollment||participants|Number|190|190.0||||||
4086197|NCT01007123|3909493|B4|United States||Region of Enrollment||participants|Number|47|47.0||||||
4086198|NCT01007123|3909494|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
4086199|NCT01007123|3909495|B2|United States||Region of Enrollment||participants|Number|47|47.0||||||
4086200|NCT01007123|3909496|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4086201|NCT01007123|3909492|B5||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4086202|NCT01007123|3909493|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4086203|NCT01007123|3909494|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4086204|NCT01007123|3909495|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4086205|NCT01007123|3909496|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4086206|NCT01007123|3909492|B5||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4086207|NCT01007123|3909493|B4||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4086208|NCT01007123|3909494|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4086209|NCT01007123|3909495|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4086210|NCT01007123|3909496|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4086211|NCT01007123|3909492|B5|||Age||years|Mean|48|48.0|Standard Deviation|12|12.0|||
4086212|NCT01007123|3909493|B4|||Age||years|Mean|50|50.0|Standard Deviation|13|13.0|||
4086213|NCT01007123|3909494|B3|||Age||years|Mean|46|46.0|Standard Deviation|13|13.0|||
4086214|NCT01007123|3909495|B2|||Age||years|Mean|48|48.0|Standard Deviation|11|11.0|||
4086215|NCT01007123|3909496|B1|||Age||years|Mean|48|48.0|Standard Deviation|13|13.0|||
4086216|NCT01007123|3909492|B5||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4086217|NCT01007123|3909493|B4||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4086218|NCT01007123|3909494|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4086219|NCT01007123|3909495|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4086220|NCT01007123|3909496|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4086221|NCT01007123|3909492|B5||Between 18 and 65 years|Age||Participants|Count of Participants|174|174.0||||||
4086222|NCT01007123|3909493|B4||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4086223|NCT01007123|3909494|B3||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4086224|NCT01007123|3909495|B2||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4086225|NCT01007123|3909496|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4086226|NCT01007123|3909492|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4086227|NCT01007123|3909493|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4086228|NCT01007123|3909494|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4086229|NCT01007123|3909495|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4086230|NCT01007123|3909496|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4086231|NCT01007110|3909528|B3|||Gestational Age (GA)||Weeks|Mean|14.4|14.4|Standard Deviation|3.88|3.88|||
4086232|NCT01007110|3909529|B2|||Gestational Age (GA)||Weeks|Mean|13.6|13.6|Standard Deviation|4.1|4.1|||
4086233|NCT01007110|3909530|B1|||Gestational Age (GA)||Weeks|Mean|15.2|15.2|Standard Deviation|3.7|3.7|||
4086234|NCT01007110|3909528|B3|||Education||Years|Mean|14|14.0|Standard Deviation|2.89|2.89|||
4086235|NCT01007110|3909529|B2|||Education||Years|Mean|14.0|14.0|Standard Deviation|3.1|3.1|||
4086236|NCT01007110|3909530|B1|||Education||Years|Mean|13.9|13.9|Standard Deviation|2.7|2.7|||
4086237|NCT01007110|3909528|B3|||Enrollment BMI||kg/m^2|Mean|27.9|27.9|Standard Deviation|6.21|6.21|||
4086238|NCT01007110|3909529|B2|||Enrollment BMI||kg/m^2|Mean|26.8|26.8|Standard Deviation|5.5|5.5|||
4086239|NCT01007110|3909530|B1|||Enrollment BMI||kg/m^2|Mean|29.0|29.0|Standard Deviation|7.0|7.0|||
4086240|NCT01007110|3909528|B3|United States||Region of Enrollment||participants|Number|67|67.0||||||
4086241|NCT01007110|3909529|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
4086242|NCT01007110|3909530|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4086243|NCT01007110|3909528|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4086244|NCT01007110|3909529|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4086245|NCT01007110|3909530|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4086246|NCT01007110|3909528|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4086247|NCT01007110|3909529|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4086248|NCT01007110|3909530|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4086249|NCT01007110|3909528|B3|||Age||years|Mean|25.5|25.5|Standard Deviation|4.51|4.51|||
4086250|NCT01007110|3909529|B2|||Age||years|Mean|25.5|25.5|Standard Deviation|4.3|4.3|||
4086251|NCT01007110|3909530|B1|||Age||years|Mean|25.6|25.6|Standard Deviation|4.8|4.8|||
4086252|NCT01007071|3909545|B3|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4086253|NCT01007071|3909546|B2|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4086254|NCT01007071|3909547|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4086255|NCT01007071|3909545|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4086256|NCT01007071|3909546|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4086257|NCT01007071|3909547|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4086258|NCT01007071|3909545|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4086259|NCT01007071|3909546|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4086260|NCT01007071|3909547|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4086261|NCT01007071|3909545|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4086262|NCT01007071|3909546|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4086263|NCT01007071|3909547|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4086264|NCT01007071|3909545|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4086265|NCT01007071|3909546|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4086266|NCT01007071|3909547|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4086267|NCT01007071|3909545|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4086268|NCT01007071|3909546|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4086269|NCT01007071|3909547|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4086270|NCT01007071|3909545|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4086271|NCT01007071|3909546|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4086272|NCT01007071|3909547|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4086273|NCT01007071|3909545|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4086274|NCT01007071|3909546|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4086275|NCT01007071|3909547|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4086276|NCT01007071|3909545|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4086277|NCT01007071|3909546|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4086278|NCT01007071|3909547|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4086279|NCT01006980|3909556|B3||Male|Sex: Female, Male||Participants|Count of Participants|381|381.0||||||
4086280|NCT01006980|3909557|B2||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4086281|NCT01006980|3909558|B1||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4086282|NCT01006980|3909556|B3||Female|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
4086283|NCT01006980|3909557|B2||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4086284|NCT01006980|3909558|B1||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4086285|NCT01006980|3909556|B3|>=65 years||Age, Customized||participants|Number|161|161.0||||||
4086286|NCT01006980|3909557|B2|>=65 years||Age, Customized||participants|Number|68|68.0||||||
4086287|NCT01006980|3909558|B1|>=65 years||Age, Customized||participants|Number|93|93.0||||||
4086288|NCT01006980|3909556|B3|< 65 years||Age, Customized||participants|Number|514|514.0||||||
4086289|NCT01006980|3909557|B2|< 65 years||Age, Customized||participants|Number|270|270.0||||||
4086290|NCT01006980|3909558|B1|< 65 years||Age, Customized||participants|Number|244|244.0||||||
4086291|NCT01006967|3909579|B3|||Fall in Past Year||Participants|Count of Participants|348|348.0||||||
4086292|NCT01006967|3909580|B2|||Fall in Past Year||Participants|Count of Participants|169|169.0||||||
4086293|NCT01006967|3909581|B1|||Fall in Past Year||Participants|Count of Participants|179|179.0||||||
4086294|NCT01006967|3909579|B3|||Fall in past 3 months||Participants|Count of Participants|266|266.0||||||
4086295|NCT01006967|3909580|B2|||Fall in past 3 months||Participants|Count of Participants|130|130.0||||||
4086296|NCT01006967|3909581|B1|||Fall in past 3 months||Participants|Count of Participants|136|136.0||||||
4086297|NCT01006967|3909579|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4086298|NCT01006967|3909579|B3||Male|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
4086299|NCT01006967|3909580|B2||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4086300|NCT01006967|3909581|B1||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4086301|NCT01006967|3909579|B3||Female|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
4086302|NCT01006967|3909580|B2||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4086303|NCT01006967|3909581|B1||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4086304|NCT01006967|3909579|B3|||Age||years|Mean|78|78.0|Full Range|||65.0|96.0|
4086305|NCT01006967|3909580|B2|||Age||years|Mean|78|78.0|Full Range|||65.0|95.0|
4086306|NCT01006967|3909581|B1|||Age||years|Mean|78|78.0|Full Range|||65.0|96.0|
4086307|NCT01006889|3909598|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4086308|NCT01006889|3909598|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4086309|NCT01006889|3909598|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4086310|NCT01006889|3909598|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4086311|NCT01006889|3909598|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4086312|NCT01006889|3909598|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4086313|NCT01006707|3909609|B1|||Height||centimeters|Mean|177.9|177.9|Standard Deviation|4.8|4.8|||
4086314|NCT01006707|3909609|B1|||Weight||kilograms|Mean|74.33|74.33|Standard Deviation|4.4|4.4|||
4086315|NCT01006707|3909609|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4086316|NCT01006707|3909609|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4086317|NCT01006707|3909609|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4086318|NCT01006707|3909609|B1|||Age||years|Mean|27.1|27.1|Standard Deviation|4.3|4.3|||
4086319|NCT01006655|3909622|B3|Israel||Region of Enrollment||participants|Number|21|21.0||||||
4086320|NCT01006655|3909623|B2|Israel||Region of Enrollment||participants|Number|10|10.0||||||
4086321|NCT01006655|3909624|B1|Israel||Region of Enrollment||participants|Number|11|11.0||||||
4086322|NCT01006655|3909622|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4086323|NCT01006655|3909623|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4086324|NCT01006655|3909624|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4086325|NCT01006655|3909622|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4086326|NCT01006655|3909623|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4086327|NCT01006655|3909624|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4086328|NCT01006655|3909622|B3|||Age||years|Mean|4.95|4.95|Standard Deviation|1.05|1.05|||
4086329|NCT01006655|3909623|B2|||Age||years|Mean|5.05|5.05|Standard Deviation|1.05|1.05|||
4086330|NCT01006655|3909624|B1|||Age||years|Mean|4.94|4.94|Standard Deviation|1.08|1.08|||
4086331|NCT01006655|3909622|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4086332|NCT01006655|3909623|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4086333|NCT01006655|3909624|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4086334|NCT01006655|3909622|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4086335|NCT01006655|3909623|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4086336|NCT01006655|3909624|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4086337|NCT01006655|3909622|B3||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
4086338|NCT01006655|3909623|B2||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4086339|NCT01006655|3909624|B1||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4086340|NCT01006629|3909631|B1|No||Infants <= 24 months of age at enrollment and with HSCHD||participants|Number|70|70.0||||||
4086341|NCT01006629|3909631|B1|Yes||Infants <= 24 months of age at enrollment and with HSCHD||participants|Number|30|30.0||||||
4086342|NCT01006629|3909631|B1|No||Infants <= 24 months of age at enrollment and with a diagnosis of BPD||participants|Number|54|54.0||||||
4086343|NCT01006629|3909631|B1|Yes||Infants <= 24 months of age at enrollment and with a diagnosis of BPD||participants|Number|46|46.0||||||
4086344|NCT01006629|3909631|B1|No||Infants born <= 35 weeks gestational age and <= 6 months of age at enrollment||participants|Number|67|67.0||||||
4086345|NCT01006629|3909631|B1|Yes||Infants born <= 35 weeks gestational age and <= 6 months of age at enrollment||participants|Number|33|33.0||||||
4086346|NCT01006629|3909631|B1|Greater than 35 weeks gestational age||Gestational Age, categorical||participants|Number|33|33.0||||||
4086347|NCT01006629|3909631|B1|Between 33 and 35 weeks gestational age||Gestational Age, categorical||participants|Number|22|22.0||||||
4086348|NCT01006629|3909631|B1|Between 29 and 32 weeks gestational age||Gestational Age, categorical||participants|Number|22|22.0||||||
4086349|NCT01006629|3909631|B1|Less than 29 weeks gestational age||Gestational Age, categorical||participants|Number|23|23.0||||||
4086350|NCT01006629|3909631|B1|||Gestational Age|Gestational age is defined as the time from mother's last menstrual period until birth.|weeks|Mean|33.4|33.4|Standard Deviation|5.1|5.1|||
4086351|NCT01006629|3909631|B1|Russian Federation||Region of Enrollment||participants|Number|100|100.0||||||
4086352|NCT01006629|3909631|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4086353|NCT01006629|3909631|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4086354|NCT01006629|3909631|B1|Between 22 and 24 months||Age, Customized||participants|Number|4|4.0||||||
4086355|NCT01006629|3909631|B1|Between 19 and 21 months||Age, Customized||participants|Number|5|5.0||||||
4086356|NCT01006629|3909631|B1|Between 16 and 18 months||Age, Customized||participants|Number|10|10.0||||||
4086357|NCT01006629|3909631|B1|Between 13 and 15 months||Age, Customized||participants|Number|8|8.0||||||
4086358|NCT01006629|3909631|B1|Between 10 and 12 months||Age, Customized||participants|Number|7|7.0||||||
4086359|NCT01006629|3909631|B1|Between 7 and 9 months||Age, Customized||participants|Number|14|14.0||||||
4086360|NCT01006629|3909631|B1|Between 4 and 6 months||Age, Customized||participants|Number|24|24.0||||||
4086361|NCT01006629|3909631|B1|Between 0 and 3 months||Age, Customized||participants|Number|28|28.0||||||
4086362|NCT01006629|3909631|B1|||Age||months|Mean|8.2|8.2|Standard Deviation|6.3|6.3|||
4086363|NCT01006616|3909642|B5||Male|Sex: Female, Male||Participants|Count of Participants|438|438.0||||||
4086364|NCT01006616|3909643|B4||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4086365|NCT01006616|3909644|B3||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4086366|NCT01006616|3909645|B2||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4086367|NCT01006616|3909646|B1||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4086368|NCT01006616|3909642|B5||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4086369|NCT01006616|3909643|B4||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4086370|NCT01006616|3909644|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4086371|NCT01006616|3909645|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4086372|NCT01006616|3909646|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4086373|NCT01006616|3909642|B5|||Age||Years|Mean|62.9|62.9|Standard Deviation|7.3|7.3|||
4086374|NCT01006616|3909643|B4|||Age||Years|Mean|63.3|63.3|Standard Deviation|7.2|7.2|||
4086375|NCT01006616|3909644|B3|||Age||Years|Mean|61.3|61.3|Standard Deviation|7.5|7.5|||
4086376|NCT01006616|3909645|B2|||Age||Years|Mean|63.2|63.2|Standard Deviation|7.4|7.4|||
4086377|NCT01006616|3909646|B1|||Age||Years|Mean|63.7|63.7|Standard Deviation|6.9|6.9|||
4086378|NCT01006603|3909783|B3|Sweden||Region of Enrollment||participants|Number|128|128.0||||||
4086379|NCT01006603|3909784|B2|Sweden||Region of Enrollment||participants|Number|62|62.0||||||
4086380|NCT01006603|3909785|B1|Sweden||Region of Enrollment||participants|Number|66|66.0||||||
4086381|NCT01006603|3909783|B3|Norway||Region of Enrollment||participants|Number|106|106.0||||||
4086382|NCT01006603|3909784|B2|Norway||Region of Enrollment||participants|Number|59|59.0||||||
4086383|NCT01006603|3909785|B1|Norway||Region of Enrollment||participants|Number|47|47.0||||||
4086384|NCT01006603|3909783|B3|Germany||Region of Enrollment||participants|Number|99|99.0||||||
4086385|NCT01006603|3909784|B2|Germany||Region of Enrollment||participants|Number|55|55.0||||||
4086386|NCT01006603|3909785|B1|Germany||Region of Enrollment||participants|Number|44|44.0||||||
4086387|NCT01006603|3909783|B3|Denmark||Region of Enrollment||participants|Number|33|33.0||||||
4086388|NCT01006603|3909784|B2|Denmark||Region of Enrollment||participants|Number|17|17.0||||||
4086389|NCT01006603|3909785|B1|Denmark||Region of Enrollment||participants|Number|16|16.0||||||
4086390|NCT01006603|3909783|B3|Mexico||Region of Enrollment||participants|Number|17|17.0||||||
4086391|NCT01006603|3909784|B2|Mexico||Region of Enrollment||participants|Number|7|7.0||||||
4086392|NCT01006603|3909785|B1|Mexico||Region of Enrollment||participants|Number|10|10.0||||||
4086393|NCT01006603|3909783|B3|Hungary||Region of Enrollment||participants|Number|18|18.0||||||
4086394|NCT01006603|3909784|B2|Hungary||Region of Enrollment||participants|Number|9|9.0||||||
4086395|NCT01006603|3909785|B1|Hungary||Region of Enrollment||participants|Number|9|9.0||||||
4086396|NCT01006603|3909783|B3|France||Region of Enrollment||participants|Number|24|24.0||||||
4086397|NCT01006603|3909784|B2|France||Region of Enrollment||participants|Number|13|13.0||||||
4086398|NCT01006603|3909785|B1|France||Region of Enrollment||participants|Number|11|11.0||||||
4086399|NCT01006603|3909783|B3|Italy||Region of Enrollment||participants|Number|24|24.0||||||
4086400|NCT01006603|3909784|B2|Italy||Region of Enrollment||participants|Number|12|12.0||||||
4086401|NCT01006603|3909785|B1|Italy||Region of Enrollment||participants|Number|12|12.0||||||
4086402|NCT01006603|3909783|B3|United Kingdom||Region of Enrollment||participants|Number|88|88.0||||||
4086403|NCT01006603|3909784|B2|United Kingdom||Region of Enrollment||participants|Number|49|49.0||||||
4086404|NCT01006603|3909785|B1|United Kingdom||Region of Enrollment||participants|Number|39|39.0||||||
4086405|NCT01006603|3909783|B3|Austria||Region of Enrollment||participants|Number|45|45.0||||||
4086406|NCT01006603|3909784|B2|Austria||Region of Enrollment||participants|Number|15|15.0||||||
4086407|NCT01006603|3909785|B1|Austria||Region of Enrollment||participants|Number|30|30.0||||||
4086408|NCT01006603|3909783|B3|Spain||Region of Enrollment||participants|Number|56|56.0||||||
4086409|NCT01006603|3909784|B2|Spain||Region of Enrollment||participants|Number|25|25.0||||||
4086410|NCT01006603|3909785|B1|Spain||Region of Enrollment||participants|Number|31|31.0||||||
4086411|NCT01006603|3909783|B3|Finland||Region of Enrollment||participants|Number|43|43.0||||||
4086412|NCT01006603|3909784|B2|Finland||Region of Enrollment||participants|Number|19|19.0||||||
4086413|NCT01006603|3909785|B1|Finland||Region of Enrollment||participants|Number|24|24.0||||||
4086414|NCT01006603|3909783|B3|Greece||Region of Enrollment||participants|Number|39|39.0||||||
4086415|NCT01006603|3909784|B2|Greece||Region of Enrollment||participants|Number|18|18.0||||||
4086416|NCT01006603|3909785|B1|Greece||Region of Enrollment||participants|Number|21|21.0||||||
4086417|NCT01006603|3909783|B3||Male|Sex: Female, Male||Participants|Count of Participants|445|445.0||||||
4086418|NCT01006603|3909784|B2||Male|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
4086419|NCT01006603|3909785|B1||Male|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
4086420|NCT01006603|3909783|B3||Female|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4086421|NCT01006603|3909784|B2||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4086422|NCT01006603|3909785|B1||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4086423|NCT01006603|3909783|B3|||Age||years|Mean|72.6|72.6|Standard Deviation|5.58|5.58|||
4086424|NCT01006603|3909784|B2|||Age||years|Mean|72.7|72.7|Standard Deviation|5.44|5.44|||
4086425|NCT01006603|3909785|B1|||Age||years|Mean|72.5|72.5|Standard Deviation|5.72|5.72|||
4086426|NCT01006603|3909783|B3||>=65 years|Age||Participants|Count of Participants|720|720.0||||||
4086427|NCT01006603|3909784|B2||>=65 years|Age||Participants|Count of Participants|360|360.0||||||
4086428|NCT01006603|3909785|B1||>=65 years|Age||Participants|Count of Participants|360|360.0||||||
4086429|NCT01006603|3909783|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4086430|NCT01006603|3909784|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4086431|NCT01006603|3909785|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4086432|NCT01006603|3909783|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4086433|NCT01006603|3909784|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4086434|NCT01006603|3909785|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4086435|NCT01006590|3909804|B3||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4086436|NCT01006590|3909805|B2||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4086437|NCT01006590|3909806|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4086438|NCT01006590|3909804|B3||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4086439|NCT01006590|3909805|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4086440|NCT01006590|3909806|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4086441|NCT01006590|3909804|B3|||Age||Years|Mean|58.7|58.7|Standard Deviation|10.58|10.58|||
4086442|NCT01006590|3909805|B2|||Age||Years|Mean|58.6|58.6|Standard Deviation|9.79|9.79|||
4086443|NCT01006590|3909806|B1|||Age||Years|Mean|58.7|58.7|Standard Deviation|11.31|11.31|||
4086444|NCT01006356|3909823|B1||Male|Sex: Female, Male|Gender was measured for ITT analysis population which was defined as participants who received at least 1 dose of study drug and had available data in the dosing frequency of short-acting narcotic analgesics for treating breakthrough pain at Visit 3 (Day 8).|Participants|Count of Participants|69|69.0||||||
4086445|NCT01006356|3909823|B1||Female|Sex: Female, Male|Gender was measured for ITT analysis population which was defined as participants who received at least 1 dose of study drug and had available data in the dosing frequency of short-acting narcotic analgesics for treating breakthrough pain at Visit 3 (Day 8).|Participants|Count of Participants|37|37.0||||||
4086446|NCT01006356|3909823|B1|||Age|Age Continuous was measured for intent-to-treat (ITT) analysis population which was defined as participants who received at least 1 dose of study drug and had available data in the dosing frequency of short-acting narcotic analgesics for treating breakthrough pain at Visit 3 (Day 8).|Years|Mean|57.94|57.94|Standard Deviation|11.27|11.27|||
4086447|NCT01006291|3909835|B4|||Fasting plasma glucose (FPG)||mmol/L|Mean|8.9|8.9|Standard Deviation|2.7|2.7|||
4086448|NCT01006291|3909836|B3|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.0|9.0|Standard Deviation|2.8|2.8|||
4086449|NCT01006291|3909837|B2|||Fasting plasma glucose (FPG)||mmol/L|Mean|8.8|8.8|Standard Deviation|2.8|2.8|||
4086450|NCT01006291|3909838|B1|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.0|9.0|Standard Deviation|2.6|2.6|||
4086451|NCT01006291|3909835|B4|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.4|8.4|Standard Deviation|0.9|0.9|||
4086452|NCT01006291|3909836|B3|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.4|8.4|Standard Deviation|0.9|0.9|||
4086453|NCT01006291|3909837|B2|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.4|8.4|Standard Deviation|0.9|0.9|||
4086454|NCT01006291|3909838|B1|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.5|8.5|Standard Deviation|1.0|1.0|||
4086455|NCT01006291|3909835|B4||Male|Gender||Participants|Count of Participants|370|370.0||||||
4086456|NCT01006291|3909836|B3||Male|Gender||Participants|Count of Participants|111|111.0||||||
4086457|NCT01006291|3909837|B2||Male|Gender||Participants|Count of Participants|124|124.0||||||
4086458|NCT01006291|3909838|B1||Male|Gender||Participants|Count of Participants|135|135.0||||||
4086459|NCT01006291|3909835|B4||Female|Gender||Participants|Count of Participants|317|317.0||||||
4086460|NCT01006291|3909836|B3||Female|Gender||Participants|Count of Participants|119|119.0||||||
4086461|NCT01006291|3909837|B2||Female|Gender||Participants|Count of Participants|104|104.0||||||
4086462|NCT01006291|3909838|B1||Female|Gender||Participants|Count of Participants|94|94.0||||||
4086463|NCT01006291|3909835|B4|||Age||years|Mean|56.4|56.4|Standard Deviation|9.6|9.6|||
4086464|NCT01006291|3909836|B3|||Age||years|Mean|56.7|56.7|Standard Deviation|8.8|8.8|||
4086465|NCT01006291|3909837|B2|||Age||years|Mean|56.5|56.5|Standard Deviation|9.6|9.6|||
4086466|NCT01006291|3909838|B1|||Age||years|Mean|56.2|56.2|Standard Deviation|10.3|10.3|||
4086467|NCT01006252|3909857|B3|South Korea||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4086468|NCT01006252|3909858|B2|South Korea||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4086469|NCT01006252|3909859|B1|South Korea||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4086470|NCT01006252|3909857|B3|Sweden||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4086471|NCT01006252|3909858|B2|Sweden||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4086472|NCT01006252|3909859|B1|Sweden||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4086473|NCT01006252|3909857|B3|Germany||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
4086474|NCT01006252|3909858|B2|Germany||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
4086475|NCT01006252|3909859|B1|Germany||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
4086476|NCT01006252|3909857|B3|Norway||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4086477|NCT01006252|3909858|B2|Norway||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4086478|NCT01006252|3909859|B1|Norway||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4086479|NCT01006252|3909857|B3|Australia||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4086480|NCT01006252|3909858|B2|Australia||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4086481|NCT01006252|3909859|B1|Australia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4086482|NCT01006252|3909857|B3|Belgium||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4086483|NCT01006252|3909858|B2|Belgium||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4086484|NCT01006252|3909859|B1|Belgium||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4086485|NCT01006252|3909857|B3|Poland||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4086486|NCT01006252|3909858|B2|Poland||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4086487|NCT01006252|3909859|B1|Poland||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4086488|NCT01006252|3909857|B3|Canada||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4086489|NCT01006252|3909858|B2|Canada||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4086490|NCT01006252|3909859|B1|Canada||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4086491|NCT01006252|3909857|B3|France||Region of Enrollment||Participants|Count of Participants|58|58.0||||||
4086492|NCT01006252|3909858|B2|France||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
4086493|NCT01006252|3909859|B1|France||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
4086494|NCT01006252|3909857|B3|Italy||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4086495|NCT01006252|3909858|B2|Italy||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4086496|NCT01006252|3909859|B1|Italy||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4086497|NCT01006252|3909857|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4086498|NCT01006252|3909858|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4086499|NCT01006252|3909859|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4086500|NCT01006252|3909857|B3|Israel||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4086501|NCT01006252|3909858|B2|Israel||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4086502|NCT01006252|3909859|B1|Israel||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4086503|NCT01006252|3909857|B3|Austria||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4086504|NCT01006252|3909858|B2|Austria||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4086505|NCT01006252|3909859|B1|Austria||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4086506|NCT01006252|3909857|B3|Spain||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4086507|NCT01006252|3909858|B2|Spain||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4086508|NCT01006252|3909859|B1|Spain||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4086509|NCT01006252|3909857|B3|Finland||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4086510|NCT01006252|3909858|B2|Finland||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4086511|NCT01006252|3909859|B1|Finland||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4086512|NCT01006252|3909857|B3|United States||Region of Enrollment||Participants|Count of Participants|90|90.0||||||
4086513|NCT01006252|3909858|B2|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
4086514|NCT01006252|3909859|B1|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
4086515|NCT01006252|3909857|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4086516|NCT01006252|3909858|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4086575|NCT01005901|3909977|B3||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4086517|NCT01006252|3909859|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086518|NCT01006252|3909857|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086519|NCT01006252|3909858|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086520|NCT01006252|3909859|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086521|NCT01006252|3909857|B3||White|Race (NIH/OMB)||Participants|Count of Participants|320|320.0||||||
4086522|NCT01006252|3909858|B2||White|Race (NIH/OMB)||Participants|Count of Participants|162|162.0||||||
4086523|NCT01006252|3909859|B1||White|Race (NIH/OMB)||Participants|Count of Participants|158|158.0||||||
4086524|NCT01006252|3909857|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086525|NCT01006252|3909858|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086526|NCT01006252|3909859|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086527|NCT01006252|3909857|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086528|NCT01006252|3909858|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086529|NCT01006252|3909859|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086530|NCT01006252|3909857|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4086531|NCT01006252|3909858|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4086532|NCT01006252|3909859|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4086533|NCT01006252|3909857|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086534|NCT01006252|3909858|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086535|NCT01006252|3909859|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086536|NCT01006252|3909857|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|172|172.0||||||
4086537|NCT01006252|3909858|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
4086538|NCT01006252|3909859|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
4086539|NCT01006252|3909857|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|159|159.0||||||
4086540|NCT01006252|3909858|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4086541|NCT01006252|3909859|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
4086542|NCT01006252|3909857|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4086543|NCT01006252|3909858|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4086544|NCT01006252|3909859|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4086545|NCT01006252|3909857|B3||Male|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4086546|NCT01006252|3909858|B2||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4086547|NCT01006252|3909859|B1||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4086548|NCT01006252|3909857|B3||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4086549|NCT01006252|3909858|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4086550|NCT01006252|3909859|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4086551|NCT01006252|3909857|B3|||Age||years|Mean|58.87|58.87|Standard Deviation|13.31|13.31|||
4086552|NCT01006252|3909858|B2|||Age||years|Mean|59.44|59.44|Standard Deviation|13.43|13.43|||
4086553|NCT01006252|3909859|B1|||Age||years|Mean|58.30|58.3|Standard Deviation|13.20|13.2|||
4086554|NCT01006135|3909890|B1|Missing||Sex/Gender, Customized||Participants|Number|28|28.0||||||
4086555|NCT01006135|3909890|B1|Female||Sex/Gender, Customized||Participants|Number|1391|1391.0||||||
4086556|NCT01006135|3909890|B1|Male||Sex/Gender, Customized||Participants|Number|3433|3433.0||||||
4086557|NCT01006135|3909890|B1|||Age|There were only 4779 patients with a non-missing age.|Years|Mean|62.6|62.6|Standard Deviation|9.8|9.8|||
4086558|NCT01006122|3909897|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4086559|NCT01006122|3909897|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4086560|NCT01006122|3909897|B1|||Age||years|Mean|32.1|32.1|Standard Deviation|10.3|10.3|||
4086561|NCT01005966|3909949|B1|United States||Region of Enrollment||participants|Number|65|65.0||||||
4086562|NCT01005966|3909949|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4086563|NCT01005966|3909949|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4086564|NCT01005966|3909949|B1|||Age||years|Mean|67.0|67.0|Standard Deviation|9.97|9.97|||
4086565|NCT01005914|3909973|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4086566|NCT01005914|3909973|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4086567|NCT01005914|3909973|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4086568|NCT01005914|3909973|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4086569|NCT01005914|3909973|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4086570|NCT01005914|3909973|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4086571|NCT01005914|3909973|B1|||Age||years|Mean|42.9|42.9|Full Range|||22.0|60.0|
4086572|NCT01005901|3909977|B3||Male|Sex: Female, Male||Participants|Count of Participants|669|669.0||||||
4086573|NCT01005901|3909978|B2||Male|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
4086574|NCT01005901|3909979|B1||Male|Sex: Female, Male||Participants|Count of Participants|454|454.0||||||
4086576|NCT01005901|3909978|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4086577|NCT01005901|3909979|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4086578|NCT01005901|3909977|B3|>=75 years||Age, Customized|All baseline measures are based on safety population.|participants|Number|108|108.0||||||
4086579|NCT01005901|3909978|B2|>=75 years||Age, Customized|All baseline measures are based on safety population.|participants|Number|35|35.0||||||
4086580|NCT01005901|3909979|B1|>=75 years||Age, Customized|All baseline measures are based on safety population.|participants|Number|73|73.0||||||
4086581|NCT01005901|3909977|B3|65 to <75 years||Age, Customized|All baseline measures are based on safety population.|participants|Number|297|297.0||||||
4086582|NCT01005901|3909978|B2|65 to <75 years||Age, Customized|All baseline measures are based on safety population.|participants|Number|98|98.0||||||
4086583|NCT01005901|3909979|B1|65 to <75 years||Age, Customized|All baseline measures are based on safety population.|participants|Number|199|199.0||||||
4086584|NCT01005901|3909977|B3|<65 years||Age, Customized|All baseline measures are based on safety population.|participants|Number|412|412.0||||||
4086585|NCT01005901|3909978|B2|<65 years||Age, Customized|All baseline measures are based on safety population.|participants|Number|134|134.0||||||
4086586|NCT01005901|3909979|B1|<65 years||Age, Customized|All baseline measures are based on safety population.|participants|Number|278|278.0||||||
4086587|NCT01005888|3910018|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4086588|NCT01005888|3910019|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4086589|NCT01005888|3910020|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4086590|NCT01005888|3910021|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4086591|NCT01005888|3910022|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4086592|NCT01005888|3910018|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4086593|NCT01005888|3910019|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4086594|NCT01005888|3910020|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4086595|NCT01005888|3910021|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4086596|NCT01005888|3910022|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4086597|NCT01005888|3910018|B5||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4086598|NCT01005888|3910019|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4086599|NCT01005888|3910020|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4086600|NCT01005888|3910021|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4086601|NCT01005888|3910022|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4086602|NCT01005888|3910018|B5||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4086603|NCT01005888|3910019|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4086604|NCT01005888|3910020|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4086605|NCT01005888|3910021|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4086606|NCT01005888|3910022|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4086607|NCT01005888|3910018|B5||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4086608|NCT01005888|3910019|B4||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4086609|NCT01005888|3910020|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4086610|NCT01005888|3910021|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4086611|NCT01005888|3910022|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4086612|NCT01005875|3910043|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4086613|NCT01005875|3910043|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4086614|NCT01005875|3910043|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4086615|NCT01005875|3910043|B1|||Age||years|Mean|60|60.0|Full Range|||50.0|77.0|
4086616|NCT01005810|3910051|B3|United States||Region of Enrollment||Participants|Count of Participants|116|116.0||||||
4086617|NCT01005810|3910052|B2|United States||Region of Enrollment||Participants|Count of Participants|58|58.0||||||
4086618|NCT01005810|3910053|B1|United States||Region of Enrollment||Participants|Count of Participants|58|58.0||||||
4086619|NCT01005810|3910051|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4086620|NCT01005810|3910052|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4086621|NCT01005810|3910053|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4086622|NCT01005810|3910051|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4086623|NCT01005810|3910052|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4086624|NCT01005810|3910053|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4086625|NCT01005810|3910051|B3|||Age||years|Mean|18.9|18.9|Standard Deviation|1.5|1.5|||
4086626|NCT01005810|3910052|B2|||Age||years|Mean|18.8|18.8|Standard Deviation|1.5|1.5|||
4086627|NCT01005810|3910053|B1|||Age||years|Mean|18.9|18.9|Standard Deviation|1.5|1.5|||
4086628|NCT01005810|3910051|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4086629|NCT01005810|3910052|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4086630|NCT01005810|3910053|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4086631|NCT01005810|3910051|B3||Between 18 and 65 years|Age||Participants|Count of Participants|98|98.0||||||
4086632|NCT01005810|3910052|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4086633|NCT01005810|3910053|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4086634|NCT01005810|3910051|B3||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
4086635|NCT01005810|3910052|B2||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4086636|NCT01005810|3910053|B1||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4086637|NCT01005745|3910060|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4086638|NCT01005745|3910060|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4086639|NCT01005745|3910060|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4086640|NCT01005745|3910060|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4086641|NCT01005745|3910060|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4086642|NCT01005745|3910060|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4086643|NCT01005745|3910060|B1|||Age||years|Median|46.5|46.5|Full Range|||25.0|68.0|
4086644|NCT01005732|3910065|B1|United States||Region of Enrollment||participants|Number|54|54.0||||||
4086645|NCT01005732|3910065|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4086646|NCT01005732|3910065|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4086647|NCT01005732|3910065|B1|31-59 years||Age, Customized||participants|Number|34|34.0||||||
4086648|NCT01005732|3910065|B1|15-30 years||Age, Customized||participants|Number|17|17.0||||||
4086649|NCT01005732|3910065|B1|7-14 years||Age, Customized||participants|Number|3|3.0||||||
4086650|NCT01005732|3910065|B1|||Age||years|Mean|36|36.0|Standard Deviation|14|14.0|||
4086651|NCT01005719|3910081|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4086652|NCT01005719|3910081|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4086653|NCT01005719|3910081|B1|||Age||years|Mean|27.6|27.6|Standard Deviation|7.12|7.12|||
4086654|NCT01005706|3910142|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4086655|NCT01005706|3910143|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4086656|NCT01005706|3910144|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4086657|NCT01005706|3910142|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4086658|NCT01005706|3910143|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4086659|NCT01005706|3910144|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4086660|NCT01005706|3910142|B3|||Age||years|Mean|52|52.0|Standard Deviation|13|13.0|||
4086661|NCT01005706|3910143|B2|||Age||years|Mean|54|54.0|Standard Deviation|11|11.0|||
4086662|NCT01005706|3910144|B1|||Age||years|Mean|51|51.0|Standard Deviation|14|14.0|||
4086663|NCT01005680|3910151|B3|China||Region of Enrollment||participants|Number|256|256.0||||||
4086664|NCT01005680|3910152|B2|China||Region of Enrollment||participants|Number|130|130.0||||||
4086665|NCT01005680|3910153|B1|China||Region of Enrollment||participants|Number|126|126.0||||||
4086666|NCT01005680|3910151|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086667|NCT01005680|3910152|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086668|NCT01005680|3910153|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086669|NCT01005680|3910151|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086670|NCT01005680|3910152|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086671|NCT01005680|3910153|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086672|NCT01005680|3910151|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086673|NCT01005680|3910152|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086674|NCT01005680|3910153|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086675|NCT01005680|3910151|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086676|NCT01005680|3910152|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086677|NCT01005680|3910153|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086678|NCT01005680|3910151|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086679|NCT01005680|3910152|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086680|NCT01005680|3910153|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086681|NCT01005680|3910151|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|256|256.0||||||
4086682|NCT01005680|3910152|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
4086683|NCT01005680|3910153|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
4086684|NCT01005680|3910151|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086685|NCT01005680|3910152|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086686|NCT01005680|3910153|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086687|NCT01005680|3910151|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086688|NCT01005680|3910152|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086689|NCT01005680|3910153|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086690|NCT01005680|3910151|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|256|256.0||||||
4086691|NCT01005680|3910152|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
4086692|NCT01005680|3910153|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
4086693|NCT01005680|3910151|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086809|NCT01005355|3910229|B2|Japan||Region of Enrollment||participants|Number|6|6.0||||||
4086694|NCT01005680|3910152|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086695|NCT01005680|3910153|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086696|NCT01005680|3910151|B3||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4086697|NCT01005680|3910152|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4086698|NCT01005680|3910153|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4086699|NCT01005680|3910151|B3||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4086700|NCT01005680|3910152|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4086701|NCT01005680|3910153|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4086702|NCT01005680|3910151|B3|||Age||years|Mean|56.1|56.1|Standard Deviation|10.29|10.29|||
4086703|NCT01005680|3910152|B2|||Age||years|Mean|55.7|55.7|Standard Deviation|9.95|9.95|||
4086704|NCT01005680|3910153|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|10.65|10.65|||
4086705|NCT01005602|3910176|B3|||Estimated Glomerular Filtration Rate||ml/min/1.73m^2|Mean|65|65.0|Standard Deviation|23|23.0|||
4086706|NCT01005602|3910177|B2|||Estimated Glomerular Filtration Rate||ml/min/1.73m^2|Mean|59|59.0|Standard Deviation|23|23.0|||
4086707|NCT01005602|3910178|B1|||Estimated Glomerular Filtration Rate||ml/min/1.73m^2|Mean|71|71.0|Standard Deviation|22|22.0|||
4086708|NCT01005602|3910176|B3|||Creatinine clearance||ml/min|Mean|58|58.0|Standard Deviation|25|25.0|||
4086709|NCT01005602|3910177|B2|||Creatinine clearance||ml/min|Mean|51|51.0|Standard Deviation|22|22.0|||
4086710|NCT01005602|3910178|B1|||Creatinine clearance||ml/min|Mean|66|66.0|Standard Deviation|10|10.0|||
4086711|NCT01005602|3910176|B3|||Body Mass Index||kg/m^2|Mean|31.6|31.6|Standard Deviation|9.8|9.8|||
4086712|NCT01005602|3910177|B2|||Body Mass Index||kg/m^2|Mean|29.9|29.9|Standard Deviation|8.9|8.9|||
4086713|NCT01005602|3910178|B1|||Body Mass Index||kg/m^2|Mean|33.2|33.2|Standard Deviation|10.4|10.4|||
4086714|NCT01005602|3910176|B3|||Total body weight||kg|Mean|92|92.0|Standard Deviation|32|32.0|||
4086715|NCT01005602|3910177|B2|||Total body weight||kg|Mean|85|85.0|Standard Deviation|27|27.0|||
4086716|NCT01005602|3910178|B1|||Total body weight||kg|Mean|100|100.0|Standard Deviation|34|34.0|||
4086717|NCT01005602|3910176|B3|||Ideal body weight|Ideal body weight (IBW) as determined by the method of Devine. (Devine BJ. Drug Intell Clin Pharm 1974;8:650-5.)|kg|Mean|65|65.0|Standard Deviation|11|11.0|||
4086718|NCT01005602|3910177|B2|||Ideal body weight|Ideal body weight (IBW) as determined by the method of Devine. (Devine BJ. Drug Intell Clin Pharm 1974;8:650-5.)|kg|Mean|62|62.0|Standard Deviation|11|11.0|||
4086719|NCT01005602|3910178|B1|||Ideal body weight|Ideal body weight (IBW) as determined by the method of Devine. (Devine BJ. Drug Intell Clin Pharm 1974;8:650-5.)|kg|Mean|67|67.0|Standard Deviation|10|10.0|||
4086720|NCT01005602|3910176|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4086721|NCT01005602|3910177|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4086722|NCT01005602|3910178|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4086723|NCT01005602|3910176|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086724|NCT01005602|3910177|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086725|NCT01005602|3910178|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086726|NCT01005602|3910176|B3||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4086727|NCT01005602|3910177|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4086728|NCT01005602|3910178|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4086729|NCT01005602|3910176|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4086730|NCT01005602|3910177|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4086731|NCT01005602|3910178|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4086732|NCT01005602|3910176|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086733|NCT01005602|3910177|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086734|NCT01005602|3910178|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086735|NCT01005602|3910176|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086736|NCT01005602|3910177|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086737|NCT01005602|3910178|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086738|NCT01005602|3910176|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086739|NCT01005602|3910177|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086740|NCT01005602|3910178|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4086741|NCT01005602|3910176|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4086742|NCT01005602|3910177|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4086743|NCT01005602|3910178|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4086744|NCT01005602|3910176|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4086745|NCT01005602|3910177|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4086746|NCT01005602|3910178|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4086747|NCT01005602|3910176|B3|||Age||years|Mean|60|60.0|Standard Deviation|15|15.0|||
4086748|NCT01005602|3910177|B2|||Age||years|Mean|63|63.0|Standard Deviation|15|15.0|||
4086749|NCT01005602|3910178|B1|||Age||years|Mean|58|58.0|Standard Deviation|15|15.0|||
4086750|NCT01005576|3910199|B1|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
4086751|NCT01005576|3910199|B1|Race/Ethnicity|More than 1 race reported|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4086752|NCT01005576|3910199|B1|Race/Ethnicity|Vietnamese|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4086753|NCT01005576|3910199|B1|Race/Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4086754|NCT01005576|3910199|B1|Race/Ethnicity|Pakistani|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4086755|NCT01005576|3910199|B1|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4086756|NCT01005576|3910199|B1|Race/Ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4086757|NCT01005576|3910199|B1|Race/Ethnicity|Middle Eastern|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4086758|NCT01005576|3910199|B1|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4086759|NCT01005576|3910199|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4086760|NCT01005576|3910199|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4086761|NCT01005576|3910199|B1|||Age||years|Median|10|10.0|Full Range|||1.8|17.0|
4086762|NCT01005459|3910207|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
4086763|NCT01005459|3910208|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4086764|NCT01005459|3910209|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4086765|NCT01005459|3910207|B3|other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4086766|NCT01005459|3910208|B2|other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4086767|NCT01005459|3910209|B1|other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4086768|NCT01005459|3910207|B3|hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4086769|NCT01005459|3910208|B2|hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4086770|NCT01005459|3910209|B1|hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4086771|NCT01005459|3910207|B3|african american||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4086772|NCT01005459|3910208|B2|african american||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4086773|NCT01005459|3910209|B1|african american||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4086774|NCT01005459|3910207|B3|white||Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
4086775|NCT01005459|3910208|B2|white||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4086776|NCT01005459|3910209|B1|white||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
4086777|NCT01005459|3910207|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4086778|NCT01005459|3910208|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4086779|NCT01005459|3910209|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4086780|NCT01005459|3910207|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4086781|NCT01005459|3910208|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4086782|NCT01005459|3910209|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4086783|NCT01005459|3910207|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4086784|NCT01005459|3910208|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4086785|NCT01005459|3910209|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4086786|NCT01005459|3910207|B3||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4086787|NCT01005459|3910208|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4086788|NCT01005459|3910209|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4086789|NCT01005459|3910207|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4086790|NCT01005459|3910208|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4086791|NCT01005459|3910209|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4086792|NCT01005407|3910216|B3|United States||Region of Enrollment||Participants|Count of Participants|2253|2253.0||||||
4086793|NCT01005407|3910217|B2|United States||Region of Enrollment||Participants|Count of Participants|436|436.0||||||
4086794|NCT01005407|3910218|B1|United States||Region of Enrollment||Participants|Count of Participants|1817|1817.0||||||
4086795|NCT01005407|3910216|B3|Canada||Region of Enrollment||Participants|Count of Participants|196|196.0||||||
4086796|NCT01005407|3910217|B2|Canada||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
4086797|NCT01005407|3910218|B1|Canada||Region of Enrollment||Participants|Count of Participants|151|151.0||||||
4086798|NCT01005407|3910216|B3||Male|Sex: Female, Male||Participants|Count of Participants|1179|1179.0||||||
4086799|NCT01005407|3910217|B2||Male|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
4086800|NCT01005407|3910218|B1||Male|Sex: Female, Male||Participants|Count of Participants|943|943.0||||||
4086801|NCT01005407|3910216|B3||Female|Sex: Female, Male||Participants|Count of Participants|1270|1270.0||||||
4086802|NCT01005407|3910217|B2||Female|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4086803|NCT01005407|3910218|B1||Female|Sex: Female, Male||Participants|Count of Participants|1025|1025.0||||||
4086804|NCT01005407|3910216|B3|≥ 40 to ≤ 70 years||Age, Customized||Participants|Count of Participants|2449|2449.0||||||
4086805|NCT01005407|3910217|B2|≥ 40 to ≤ 70 years||Age, Customized||Participants|Count of Participants|481|481.0||||||
4086806|NCT01005407|3910218|B1|≥ 40 to ≤ 70 years||Age, Customized||Participants|Count of Participants|1968|1968.0||||||
4086807|NCT01005355|3910227|B4|Japan||Region of Enrollment||participants|Number|15|15.0||||||
4086808|NCT01005355|3910228|B3|Japan||Region of Enrollment||participants|Number|6|6.0||||||
4086810|NCT01005355|3910230|B1|Japan||Region of Enrollment||participants|Number|3|3.0||||||
4086811|NCT01005355|3910227|B4|Asian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4086812|NCT01005355|3910228|B3|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4086813|NCT01005355|3910229|B2|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4086814|NCT01005355|3910230|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4086815|NCT01005355|3910227|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4086816|NCT01005355|3910228|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4086817|NCT01005355|3910229|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4086818|NCT01005355|3910230|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4086819|NCT01005355|3910227|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4086820|NCT01005355|3910228|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4086821|NCT01005355|3910229|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4086822|NCT01005355|3910230|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4086823|NCT01005355|3910227|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4086824|NCT01005355|3910228|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4086825|NCT01005355|3910229|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4086826|NCT01005355|3910230|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4086827|NCT01005355|3910227|B4||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4086828|NCT01005355|3910228|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4086829|NCT01005355|3910229|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4086830|NCT01005355|3910230|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4086831|NCT01005355|3910227|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4086832|NCT01005355|3910228|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4086833|NCT01005355|3910229|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4086834|NCT01005355|3910230|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4086835|NCT01005329|3910267|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4086836|NCT01005329|3910267|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4086837|NCT01005329|3910267|B1|||Age||years|Median|59|59.0|Full Range|||34.0|80.0|
4086838|NCT01005316|3910277|B4|United States||Region of Enrollment||participants|Number|209|209.0||||||
4086839|NCT01005316|3910278|B3|United States||Region of Enrollment||participants|Number|109|109.0||||||
4086840|NCT01005316|3910279|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4086841|NCT01005316|3910280|B1|United States||Region of Enrollment||participants|Number|85|85.0||||||
4086842|NCT01005316|3910277|B4|Canada||Region of Enrollment||participants|Number|31|31.0||||||
4086843|NCT01005316|3910278|B3|Canada||Region of Enrollment||participants|Number|18|18.0||||||
4086844|NCT01005316|3910279|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4086845|NCT01005316|3910280|B1|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4086846|NCT01005316|3910277|B4||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4086847|NCT01005316|3910278|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4086848|NCT01005316|3910279|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4086849|NCT01005316|3910280|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4086850|NCT01005316|3910277|B4||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4086851|NCT01005316|3910278|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4086852|NCT01005316|3910279|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4086853|NCT01005316|3910280|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4086854|NCT01005316|3910277|B4|||Age||years|Mean|7.2|7.2|Standard Deviation|6.5|6.5|||
4086855|NCT01005316|3910278|B3|||Age||years|Mean|7.4|7.4|Standard Deviation|6.3|6.3|||
4086856|NCT01005316|3910279|B2|||Age||years|Mean|7.8|7.8|Standard Deviation|6.7|6.7|||
4086857|NCT01005316|3910280|B1|||Age||years|Mean|6.9|6.9|Standard Deviation|6.8|6.8|||
4086858|NCT01005316|3910277|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4086859|NCT01005316|3910278|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4086860|NCT01005316|3910279|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4086861|NCT01005316|3910280|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4086862|NCT01005316|3910277|B4||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4086863|NCT01005316|3910278|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4086864|NCT01005316|3910279|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4086865|NCT01005316|3910280|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4086866|NCT01005316|3910277|B4||<=18 years|Age||Participants|Count of Participants|233|233.0||||||
4086867|NCT01005316|3910278|B3||<=18 years|Age||Participants|Count of Participants|124|124.0||||||
4086868|NCT01005316|3910279|B2||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4086869|NCT01005316|3910280|B1||<=18 years|Age||Participants|Count of Participants|93|93.0||||||
4086870|NCT01005290|3910335|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4086871|NCT01005290|3910335|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4086872|NCT01005290|3910335|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4086873|NCT01005290|3910335|B1|||Age||years|Mean|39.8|39.8|Standard Deviation|11.71|11.71|||
4086874|NCT01005251|3910345|B6||Male|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
4086875|NCT01005251|3910346|B5||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4086876|NCT01005251|3910347|B4||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4086877|NCT01005251|3910348|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4086878|NCT01005251|3910349|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4086879|NCT01005251|3910350|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4086880|NCT01005251|3910345|B6||Female|Sex: Female, Male||Participants|Count of Participants|376|376.0||||||
4086881|NCT01005251|3910346|B5||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4086882|NCT01005251|3910347|B4||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4086883|NCT01005251|3910348|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4086884|NCT01005251|3910349|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4086885|NCT01005251|3910350|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4086886|NCT01005251|3910345|B6|||Age||years|Mean|47.7|47.7|Standard Deviation|12.4|12.4|||
4086887|NCT01005251|3910346|B5|||Age||years|Mean|48.3|48.3|Standard Deviation|12.0|12.0|||
4086888|NCT01005251|3910347|B4|||Age||years|Mean|48.5|48.5|Standard Deviation|12.1|12.1|||
4086889|NCT01005251|3910348|B3|||Age||years|Mean|48.0|48.0|Standard Deviation|12.3|12.3|||
4086890|NCT01005251|3910349|B2|||Age||years|Mean|46.1|46.1|Standard Deviation|13.5|13.5|||
4086891|NCT01005251|3910350|B1|||Age||years|Mean|47.4|47.4|Standard Deviation|12.3|12.3|||
4086892|NCT01004991|3910371|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4086893|NCT01004991|3910371|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4086894|NCT01004991|3910371|B1|||Age||years|Median|65|65.0|Full Range|||43.0|83.0|
4086895|NCT01004939|3910375|B1|Other||Number of participants with the indicated reason for the end of LMWH administration|It is possible for one participant to have multiple responses.|participants|Number|19|19.0||||||
4086896|NCT01004939|3910375|B1|Allergy to heparin||Number of participants with the indicated reason for the end of LMWH administration|It is possible for one participant to have multiple responses.|participants|Number|39|39.0||||||
4086897|NCT01004939|3910375|B1|Thrombocytopenia||Number of participants with the indicated reason for the end of LMWH administration|It is possible for one participant to have multiple responses.|participants|Number|7|7.0||||||
4086898|NCT01004939|3910375|B1|Change to another antithrombotic agent||Number of participants with the indicated reason for the end of LMWH administration|It is possible for one participant to have multiple responses.|participants|Number|44|44.0||||||
4086899|NCT01004939|3910375|B1|End of thromboembolism prophylaxis/therapy||Number of participants with the indicated reason for the end of LMWH administration|It is possible for one participant to have multiple responses.|participants|Number|3|3.0||||||
4086900|NCT01004939|3910375|B1|Missing||Number of participants with the indicated reason for the end of LMWH administration|It is possible for one participant to have multiple responses.|participants|Number|44|44.0||||||
4086901|NCT01004939|3910375|B1|Total||Number of participants with the indicated reason for the end of LMWH administration|It is possible for one participant to have multiple responses.|participants|Number|120|120.0||||||
4086902|NCT01004939|3910375|B1|||Duration of LMWH administration||days|Median|54|54.0|Full Range|||4.0|1205.0|
4086903|NCT01004939|3910375|B1|Reviparin||Number of participants receiving the indicated type of low-molecular-weight heparin (LMWH)|It is possible for one participant to have multiple responses.|participants|Number|0|0.0||||||
4086904|NCT01004939|3910375|B1|Tinzaparin||Number of participants receiving the indicated type of low-molecular-weight heparin (LMWH)|It is possible for one participant to have multiple responses.|participants|Number|0|0.0||||||
4086905|NCT01004939|3910375|B1|Certoparin||Number of participants receiving the indicated type of low-molecular-weight heparin (LMWH)|It is possible for one participant to have multiple responses.|participants|Number|1|1.0||||||
4086906|NCT01004939|3910375|B1|Dalteparin||Number of participants receiving the indicated type of low-molecular-weight heparin (LMWH)|It is possible for one participant to have multiple responses.|participants|Number|35|35.0||||||
4086907|NCT01004939|3910375|B1|Nadroparin||Number of participants receiving the indicated type of low-molecular-weight heparin (LMWH)|It is possible for one participant to have multiple responses.|participants|Number|21|21.0||||||
4086908|NCT01004939|3910375|B1|Enoxaparin||Number of participants receiving the indicated type of low-molecular-weight heparin (LMWH)|It is possible for one participant to have multiple responses.|participants|Number|28|28.0||||||
4086909|NCT01004939|3910375|B1|Missing||Number of participants receiving the indicated type of low-molecular-weight heparin (LMWH)|It is possible for one participant to have multiple responses.|participants|Number|45|45.0||||||
4086910|NCT01004939|3910375|B1|Total||Number of participants receiving the indicated type of low-molecular-weight heparin (LMWH)|It is possible for one participant to have multiple responses.|participants|Number|120|120.0||||||
4086911|NCT01004939|3910375|B1|Allergy to heparin||Number of participants with the indicated reason for the end of UFH administration|It is possible for one participant to have multiple responses.|participants|Number|2|2.0||||||
4086912|NCT01004939|3910375|B1|Thrombocytopenia||Number of participants with the indicated reason for the end of UFH administration|It is possible for one participant to have multiple responses.|participants|Number|0|0.0||||||
4086913|NCT01004939|3910375|B1|Change to another antithrombotic agent||Number of participants with the indicated reason for the end of UFH administration|It is possible for one participant to have multiple responses.|participants|Number|0|0.0||||||
4086914|NCT01004939|3910375|B1|End of thromboembolism prophylaxis/therapy||Number of participants with the indicated reason for the end of UFH administration|It is possible for one participant to have multiple responses.|participants|Number|1|1.0||||||
4086915|NCT01004939|3910375|B1|||Duration of UFH administration||days|Median|32|32.0|Full Range|||7.0|102.0|
4086916|NCT01004939|3910375|B1|Received UFH||Number of participants who did and did not receive UFH|Unfractionated heparin (UFH) is an anticoagulant.|participants|Number|3|3.0||||||
4086917|NCT01004939|3910375|B1|Did not receive UFH||Number of participants who did and did not receive UFH|Unfractionated heparin (UFH) is an anticoagulant.|participants|Number|117|117.0||||||
4086918|NCT01004939|3910375|B1|With VTE in anamnesis||Number of participants with thrombophilia accompanied by venous thromboembolism (VTE) in anamnesis|Thrombophilia is a genetic disorder of blood coagulation that increases the risk of thrombosis.|participants|Number|22|22.0||||||
4086919|NCT01004939|3910375|B1|Without VTE in anamnesis||Number of participants with thrombophilia accompanied by venous thromboembolism (VTE) in anamnesis|Thrombophilia is a genetic disorder of blood coagulation that increases the risk of thrombosis.|participants|Number|58|58.0||||||
4086920|NCT01004939|3910375|B1|Missing||Number of participants with thrombophilia accompanied by venous thromboembolism (VTE) in anamnesis|Thrombophilia is a genetic disorder of blood coagulation that increases the risk of thrombosis.|participants|Number|2|2.0||||||
4086921|NCT01004939|3910375|B1|Total||Number of participants with thrombophilia accompanied by venous thromboembolism (VTE) in anamnesis|Thrombophilia is a genetic disorder of blood coagulation that increases the risk of thrombosis.|participants|Number|82|82.0||||||
4086922|NCT01004939|3910375|B1|Acute VTE during pregnancy||Number of participants receiving thromboembolic prophylaxis for the given indications|It is possible for one participant to undergo multiple types of treatment for multiple indications. VTE, venous thromboembolis.|participants|Number|1|1.0||||||
4086923|NCT01004939|3910375|B1|Antithrombine deficiency||Number of participants receiving thromboembolic prophylaxis for the given indications|It is possible for one participant to undergo multiple types of treatment for multiple indications. VTE, venous thromboembolis.|participants|Number|3|3.0||||||
4086924|NCT01004939|3910375|B1|Antiphospholipid syndrome||Number of participants receiving thromboembolic prophylaxis for the given indications|It is possible for one participant to undergo multiple types of treatment for multiple indications. VTE, venous thromboembolis.|participants|Number|14|14.0||||||
4086925|NCT01004939|3910375|B1|Long-time anticoagulation with oral anticoagulants||Number of participants receiving thromboembolic prophylaxis for the given indications|It is possible for one participant to undergo multiple types of treatment for multiple indications. VTE, venous thromboembolis.|participants|Number|4|4.0||||||
4086926|NCT01004939|3910375|B1|Women with >=2 risk factors||Number of participants receiving thromboembolic prophylaxis for the given indications|It is possible for one participant to undergo multiple types of treatment for multiple indications. VTE, venous thromboembolis.|participants|Number|9|9.0||||||
4086927|NCT01004939|3910375|B1|VTE in anamnesis||Number of participants receiving thromboembolic prophylaxis for the given indications|It is possible for one participant to undergo multiple types of treatment for multiple indications. VTE, venous thromboembolis.|participants|Number|33|33.0||||||
4086928|NCT01004939|3910375|B1|Thrombophilia||Number of participants receiving thromboembolic prophylaxis for the given indications|It is possible for one participant to undergo multiple types of treatment for multiple indications. VTE, venous thromboembolis.|participants|Number|82|82.0||||||
4086929|NCT01004939|3910375|B1|Alternative anticoagulation at heart valve||Number of participants receiving therapeutic treatment for the given indications|It is possible for one participant to undergo multiple types of therapeutic treatment for multiple indications.|participants|Number|1|1.0||||||
4086930|NCT01004939|3910375|B1|Alternative anticoagulation at atrial fibrilation||Number of participants receiving therapeutic treatment for the given indications|It is possible for one participant to undergo multiple types of therapeutic treatment for multiple indications.|participants|Number|0|0.0||||||
4086931|NCT01004939|3910375|B1|Acute coronary syndrome||Number of participants receiving therapeutic treatment for the given indications|It is possible for one participant to undergo multiple types of therapeutic treatment for multiple indications.|participants|Number|0|0.0||||||
4086932|NCT01004939|3910375|B1|Peripheral arterial disease||Number of participants receiving therapeutic treatment for the given indications|It is possible for one participant to undergo multiple types of therapeutic treatment for multiple indications.|participants|Number|0|0.0||||||
4086933|NCT01004939|3910375|B1|Therapy: pulmonary embolism||Number of participants receiving therapeutic treatment for the given indications|It is possible for one participant to undergo multiple types of therapeutic treatment for multiple indications.|participants|Number|3|3.0||||||
4086934|NCT01004939|3910375|B1|Therapy: deep vein thrombosis||Number of participants receiving therapeutic treatment for the given indications|It is possible for one participant to undergo multiple types of therapeutic treatment for multiple indications.|participants|Number|7|7.0||||||
4086935|NCT01004939|3910375|B1|Data missing||Number of participants receiving therapeutic treatment for the given indications|It is possible for one participant to undergo multiple types of therapeutic treatment for multiple indications.|participants|Number|1|1.0||||||
4086936|NCT01004939|3910375|B1|Prophylaxis: internal medicine||Number of participants receiving the indicated type of prophylactic treatment|A prophylactic treatment is one that is designed and used to prevent a disease from occurring. Prophylaxis for thromboembolic risk is treatment for dispositional thromboembolic risk factors. It is possible for one participant to undergo multiple types of prophylactic treatment.|participants|Number|31|31.0||||||
4086937|NCT01004939|3910375|B1|Prophylaxis: surgery||Number of participants receiving the indicated type of prophylactic treatment|A prophylactic treatment is one that is designed and used to prevent a disease from occurring. Prophylaxis for thromboembolic risk is treatment for dispositional thromboembolic risk factors. It is possible for one participant to undergo multiple types of prophylactic treatment.|participants|Number|5|5.0||||||
4086938|NCT01004939|3910375|B1|Prophylaxis: thromboembolic risk||Number of participants receiving the indicated type of prophylactic treatment|A prophylactic treatment is one that is designed and used to prevent a disease from occurring. Prophylaxis for thromboembolic risk is treatment for dispositional thromboembolic risk factors. It is possible for one participant to undergo multiple types of prophylactic treatment.|participants|Number|99|99.0||||||
4086939|NCT01004939|3910375|B1|Therapy||Number of participants undergoing either prophylaxis or therapy|The number of participants receiving either antithrombotic prophylaxis (designed and used to prevent a disease from occurring) or therapy of acute venous thromboembolism was measured. It is possible for a participant to have multiple responses.|participants|Number|11|11.0||||||
4086940|NCT01004939|3910375|B1|Prophylaxis||Number of participants undergoing either prophylaxis or therapy|The number of participants receiving either antithrombotic prophylaxis (designed and used to prevent a disease from occurring) or therapy of acute venous thromboembolism was measured. It is possible for a participant to have multiple responses.|participants|Number|111|111.0||||||
4086941|NCT01004939|3910375|B1|Missing data||Number of participants with the indicated number of former abortions|Data were collected from only those participants who gave a response of “Yes” to the question of “Did you have former abortions.”|participants|Number|3|3.0||||||
4086942|NCT01004939|3910375|B1|6||Number of participants with the indicated number of former abortions|Data were collected from only those participants who gave a response of “Yes” to the question of “Did you have former abortions.”|participants|Number|1|1.0||||||
4086943|NCT01004939|3910375|B1|4||Number of participants with the indicated number of former abortions|Data were collected from only those participants who gave a response of “Yes” to the question of “Did you have former abortions.”|participants|Number|2|2.0||||||
4086944|NCT01004939|3910375|B1|3||Number of participants with the indicated number of former abortions|Data were collected from only those participants who gave a response of “Yes” to the question of “Did you have former abortions.”|participants|Number|2|2.0||||||
4086945|NCT01004939|3910375|B1|2||Number of participants with the indicated number of former abortions|Data were collected from only those participants who gave a response of “Yes” to the question of “Did you have former abortions.”|participants|Number|16|16.0||||||
4086946|NCT01004939|3910375|B1|1||Number of participants with the indicated number of former abortions|Data were collected from only those participants who gave a response of “Yes” to the question of “Did you have former abortions.”|participants|Number|27|27.0||||||
4086947|NCT01004939|3910375|B1|Total||Number of participants with the indicated number of former abortions|Data were collected from only those participants who gave a response of “Yes” to the question of “Did you have former abortions.”|participants|Number|51|51.0||||||
4086948|NCT01004939|3910375|B1|Missing data||Number of participants who indicated that they did or did not have former abortions|Participants were asked to respond “Yes” or “No” to the question: “Did you have former abortions.” Only those participants who reported a former pregnancy responded to this question.|participants|Number|2|2.0||||||
4086949|NCT01004939|3910375|B1|No||Number of participants who indicated that they did or did not have former abortions|Participants were asked to respond “Yes” or “No” to the question: “Did you have former abortions.” Only those participants who reported a former pregnancy responded to this question.|participants|Number|51|51.0||||||
4086950|NCT01004939|3910375|B1|Yes||Number of participants who indicated that they did or did not have former abortions|Participants were asked to respond “Yes” or “No” to the question: “Did you have former abortions.” Only those participants who reported a former pregnancy responded to this question.|participants|Number|32|32.0||||||
4086951|NCT01004939|3910375|B1|Total||Number of participants who indicated that they did or did not have former abortions|Participants were asked to respond “Yes” or “No” to the question: “Did you have former abortions.” Only those participants who reported a former pregnancy responded to this question.|participants|Number|85|85.0||||||
4086952|NCT01004939|3910375|B1|Children with abnormalities||Number of participants with the indicated type of former birth|It is possible for a participant to have more than one type of former birth. It is possible for a participant to have multiple responses.|participants|Number|1|1.0||||||
4086953|NCT01004939|3910375|B1|Healthy children||Number of participants with the indicated type of former birth|It is possible for a participant to have more than one type of former birth. It is possible for a participant to have multiple responses.|participants|Number|51|51.0||||||
4086954|NCT01004939|3910375|B1|Live births||Number of participants with the indicated type of former birth|It is possible for a participant to have more than one type of former birth. It is possible for a participant to have multiple responses.|participants|Number|56|56.0||||||
4086955|NCT01004939|3910375|B1|Still births||Number of participants with the indicated type of former birth|It is possible for a participant to have more than one type of former birth. It is possible for a participant to have multiple responses.|participants|Number|6|6.0||||||
4086956|NCT01004939|3910375|B1|All former births||Number of participants with the indicated type of former birth|It is possible for a participant to have more than one type of former birth. It is possible for a participant to have multiple responses.|participants|Number|61|61.0||||||
4086957|NCT01004939|3910375|B1|Missing data||Number of participants with the indicated type of former birth|It is possible for a participant to have more than one type of former birth. It is possible for a participant to have multiple responses.|participants|Number|59|59.0||||||
4086958|NCT01004939|3910375|B1|10||Number of participants with the indicated number of former pregnancies||participants|Number|1|1.0||||||
4086959|NCT01004939|3910375|B1|6||Number of participants with the indicated number of former pregnancies||participants|Number|1|1.0||||||
4086960|NCT01004939|3910375|B1|5||Number of participants with the indicated number of former pregnancies||participants|Number|2|2.0||||||
4086961|NCT01004939|3910375|B1|4||Number of participants with the indicated number of former pregnancies||participants|Number|3|3.0||||||
4086962|NCT01004939|3910375|B1|3||Number of participants with the indicated number of former pregnancies||participants|Number|15|15.0||||||
4086963|NCT01004939|3910375|B1|2||Number of participants with the indicated number of former pregnancies||participants|Number|19|19.0||||||
4086964|NCT01004939|3910375|B1|1||Number of participants with the indicated number of former pregnancies||participants|Number|43|43.0||||||
4086965|NCT01004939|3910375|B1|0||Number of participants with the indicated number of former pregnancies||participants|Number|35|35.0||||||
4086966|NCT01004939|3910375|B1|Missing||Number of participants with the indicated number of former pregnancies||participants|Number|1|1.0||||||
4086967|NCT01004939|3910375|B1|Other||Number of participants with the indicated risk factors for venous thromboembolism|It is possible for a participant to have more than one of the indicated risk factors.|participants|Number|5|5.0||||||
4086968|NCT01004939|3910375|B1|Hypertonia||Number of participants with the indicated risk factors for venous thromboembolism|It is possible for a participant to have more than one of the indicated risk factors.|participants|Number|5|5.0||||||
4087037|NCT01004848|3910425|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4086969|NCT01004939|3910375|B1|Hypercholesteremia||Number of participants with the indicated risk factors for venous thromboembolism|It is possible for a participant to have more than one of the indicated risk factors.|participants|Number|3|3.0||||||
4086970|NCT01004939|3910375|B1|Diabetes mellitus||Number of participants with the indicated risk factors for venous thromboembolism|It is possible for a participant to have more than one of the indicated risk factors.|participants|Number|2|2.0||||||
4086971|NCT01004939|3910375|B1|Immobilization||Number of participants with the indicated risk factors for venous thromboembolism|It is possible for a participant to have more than one of the indicated risk factors.|participants|Number|5|5.0||||||
4086972|NCT01004939|3910375|B1|Serious systemic infection||Number of participants with the indicated risk factors for venous thromboembolism|It is possible for a participant to have more than one of the indicated risk factors.|participants|Number|3|3.0||||||
4086973|NCT01004939|3910375|B1|Chronic inflammatory disease||Number of participants with the indicated risk factors for venous thromboembolism|It is possible for a participant to have more than one of the indicated risk factors.|participants|Number|3|3.0||||||
4086974|NCT01004939|3910375|B1|Drug abuse||Number of participants with the indicated risk factors for venous thromboembolism|It is possible for a participant to have more than one of the indicated risk factors.|participants|Number|1|1.0||||||
4086975|NCT01004939|3910375|B1|Alcohol||Number of participants with the indicated risk factors for venous thromboembolism|It is possible for a participant to have more than one of the indicated risk factors.|participants|Number|1|1.0||||||
4086976|NCT01004939|3910375|B1|Smoking||Number of participants with the indicated risk factors for venous thromboembolism|It is possible for a participant to have more than one of the indicated risk factors.|participants|Number|11|11.0||||||
4086977|NCT01004939|3910375|B1|Adiposity (BMI>=30)||Number of participants with the indicated risk factors for venous thromboembolism|It is possible for a participant to have more than one of the indicated risk factors.|participants|Number|12|12.0||||||
4086978|NCT01004939|3910375|B1|Malignant underlying disease||Number of participants with the indicated risk factors for venous thromboembolism|It is possible for a participant to have more than one of the indicated risk factors.|participants|Number|3|3.0||||||
4086979|NCT01004939|3910375|B1|Other supportive gynaecological treatments||Number of participants with the indicated risk factors for venous thromboembolism|It is possible for a participant to have more than one of the indicated risk factors.|participants|Number|8|8.0||||||
4086980|NCT01004939|3910375|B1|Hormonotherapy in in-vitro fertilization||Number of participants with the indicated risk factors for venous thromboembolism|It is possible for a participant to have more than one of the indicated risk factors.|participants|Number|10|10.0||||||
4086981|NCT01004939|3910375|B1|Previous oral contraception||Number of participants with the indicated risk factors for venous thromboembolism|It is possible for a participant to have more than one of the indicated risk factors.|participants|Number|11|11.0||||||
4086982|NCT01004939|3910375|B1|None||Number of participants with the indicated risk factors for venous thromboembolism|It is possible for a participant to have more than one of the indicated risk factors.|participants|Number|75|75.0||||||
4086983|NCT01004939|3910375|B1|Other||Number of participants with known thrombophilia|Thrombophilic defects, important dispositional risk factors, are reported. It is possible for a participant to have multiple responses. Thrombophilia is a genetic disorder of blood coagulation that increases the risk of thrombosis.|participants|Number|46|46.0||||||
4086984|NCT01004939|3910375|B1|Factor VII C46T||Number of participants with known thrombophilia|Thrombophilic defects, important dispositional risk factors, are reported. It is possible for a participant to have multiple responses. Thrombophilia is a genetic disorder of blood coagulation that increases the risk of thrombosis.|participants|Number|18|18.0||||||
4086985|NCT01004939|3910375|B1|Factor VII activating protease (FSAP)||Number of participants with known thrombophilia|Thrombophilic defects, important dispositional risk factors, are reported. It is possible for a participant to have multiple responses. Thrombophilia is a genetic disorder of blood coagulation that increases the risk of thrombosis.|participants|Number|6|6.0||||||
4086986|NCT01004939|3910375|B1|Persistant factor VIII increase||Number of participants with known thrombophilia|Thrombophilic defects, important dispositional risk factors, are reported. It is possible for a participant to have multiple responses. Thrombophilia is a genetic disorder of blood coagulation that increases the risk of thrombosis.|participants|Number|4|4.0||||||
4086987|NCT01004939|3910375|B1|Antiphospholipid syndrome||Number of participants with known thrombophilia|Thrombophilic defects, important dispositional risk factors, are reported. It is possible for a participant to have multiple responses. Thrombophilia is a genetic disorder of blood coagulation that increases the risk of thrombosis.|participants|Number|15|15.0||||||
4086988|NCT01004939|3910375|B1|Prothombin mutation homozygous||Number of participants with known thrombophilia|Thrombophilic defects, important dispositional risk factors, are reported. It is possible for a participant to have multiple responses. Thrombophilia is a genetic disorder of blood coagulation that increases the risk of thrombosis.|participants|Number|0|0.0||||||
4086989|NCT01004939|3910375|B1|Prothrombin mutation heterozygous||Number of participants with known thrombophilia|Thrombophilic defects, important dispositional risk factors, are reported. It is possible for a participant to have multiple responses. Thrombophilia is a genetic disorder of blood coagulation that increases the risk of thrombosis.|participants|Number|13|13.0||||||
4086990|NCT01004939|3910375|B1|Factor V Leiden mutation homozygous||Number of participants with known thrombophilia|Thrombophilic defects, important dispositional risk factors, are reported. It is possible for a participant to have multiple responses. Thrombophilia is a genetic disorder of blood coagulation that increases the risk of thrombosis.|participants|Number|0|0.0||||||
4086991|NCT01004939|3910375|B1|Factor V Leiden mutation heterozygous||Number of participants with known thrombophilia|Thrombophilic defects, important dispositional risk factors, are reported. It is possible for a participant to have multiple responses. Thrombophilia is a genetic disorder of blood coagulation that increases the risk of thrombosis.|participants|Number|13|13.0||||||
4086992|NCT01004939|3910375|B1|Antithrombin deficiency||Number of participants with known thrombophilia|Thrombophilic defects, important dispositional risk factors, are reported. It is possible for a participant to have multiple responses. Thrombophilia is a genetic disorder of blood coagulation that increases the risk of thrombosis.|participants|Number|2|2.0||||||
4087036|NCT01004848|3910427|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|153|153.0||||||
4086993|NCT01004939|3910375|B1|Protein S deficiency||Number of participants with known thrombophilia|Thrombophilic defects, important dispositional risk factors, are reported. It is possible for a participant to have multiple responses. Thrombophilia is a genetic disorder of blood coagulation that increases the risk of thrombosis.|participants|Number|10|10.0||||||
4086994|NCT01004939|3910375|B1|Protein C deficiency||Number of participants with known thrombophilia|Thrombophilic defects, important dispositional risk factors, are reported. It is possible for a participant to have multiple responses. Thrombophilia is a genetic disorder of blood coagulation that increases the risk of thrombosis.|participants|Number|5|5.0||||||
4086995|NCT01004939|3910375|B1|None||Number of participants with known thrombophilia|Thrombophilic defects, important dispositional risk factors, are reported. It is possible for a participant to have multiple responses. Thrombophilia is a genetic disorder of blood coagulation that increases the risk of thrombosis.|participants|Number|20|20.0||||||
4086996|NCT01004939|3910375|B1|Both arterial and venous||Number of participants with the indicated anamnestic thromboembolisms|Known anamnestic (experienced in the past) arterial and venous thromboembolisms, important dispositional risk factors, are reported. A thromboembolism is a clot in the blood that forms and blocks a blood vessel.|participants|Number|2|2.0||||||
4086997|NCT01004939|3910375|B1|Venous only||Number of participants with the indicated anamnestic thromboembolisms|Known anamnestic (experienced in the past) arterial and venous thromboembolisms, important dispositional risk factors, are reported. A thromboembolism is a clot in the blood that forms and blocks a blood vessel.|participants|Number|39|39.0||||||
4086998|NCT01004939|3910375|B1|Arterial only||Number of participants with the indicated anamnestic thromboembolisms|Known anamnestic (experienced in the past) arterial and venous thromboembolisms, important dispositional risk factors, are reported. A thromboembolism is a clot in the blood that forms and blocks a blood vessel.|participants|Number|0|0.0||||||
4086999|NCT01004939|3910375|B1|None||Number of participants with the indicated anamnestic thromboembolisms|Known anamnestic (experienced in the past) arterial and venous thromboembolisms, important dispositional risk factors, are reported. A thromboembolism is a clot in the blood that forms and blocks a blood vessel.|participants|Number|79|79.0||||||
4087000|NCT01004939|3910375|B1|||Body Mass Index (BMI)|BMI is calculated as body weight in kilograms (kg) divided by body height in meters squared (m^2)|kilograms (kg)/meters squared (m^2)|Mean|26.5|26.5|Standard Deviation|6.2|6.2|||
4087001|NCT01004939|3910375|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4087002|NCT01004939|3910375|B1||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4087003|NCT01004939|3910375|B1|||Age||Years|Mean|31.5|31.5|Standard Deviation|5.4|5.4|||
4087004|NCT01004874|3910416|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4087005|NCT01004874|3910416|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4087006|NCT01004874|3910416|B1|||Age||years|Mean|53.7|53.7|Standard Deviation|9.6|9.6|||
4087007|NCT01004848|3910425|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|299|299.0||||||
4087008|NCT01004848|3910426|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
4087009|NCT01004848|3910427|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|155|155.0||||||
4087010|NCT01004848|3910425|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4087011|NCT01004848|3910426|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4087012|NCT01004848|3910427|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4087013|NCT01004848|3910425|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4087014|NCT01004848|3910426|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4087015|NCT01004848|3910427|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087016|NCT01004848|3910425|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
4087017|NCT01004848|3910426|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4087018|NCT01004848|3910427|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4087019|NCT01004848|3910425|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087020|NCT01004848|3910426|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087021|NCT01004848|3910427|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087022|NCT01004848|3910425|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4087023|NCT01004848|3910426|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4087024|NCT01004848|3910427|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087025|NCT01004848|3910425|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087026|NCT01004848|3910426|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087027|NCT01004848|3910427|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087028|NCT01004848|3910425|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4087029|NCT01004848|3910426|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4087030|NCT01004848|3910427|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4087031|NCT01004848|3910425|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
4087032|NCT01004848|3910426|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4087033|NCT01004848|3910427|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4087034|NCT01004848|3910425|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|294|294.0||||||
4087035|NCT01004848|3910426|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|141|141.0||||||
4087038|NCT01004848|3910426|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4087039|NCT01004848|3910427|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4087040|NCT01004848|3910425|B3||Female|Sex: Female, Male||Participants|Count of Participants|343|343.0||||||
4087041|NCT01004848|3910426|B2||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4087042|NCT01004848|3910427|B1||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4087043|NCT01004848|3910425|B3||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
4087044|NCT01004848|3910426|B2||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4087045|NCT01004848|3910427|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4087046|NCT01004848|3910425|B3||Between 18 and 65 years|Age||Participants|Count of Participants|356|356.0||||||
4087047|NCT01004848|3910426|B2||Between 18 and 65 years|Age||Participants|Count of Participants|170|170.0||||||
4087048|NCT01004848|3910427|B1||Between 18 and 65 years|Age||Participants|Count of Participants|186|186.0||||||
4087049|NCT01004848|3910425|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4087050|NCT01004848|3910426|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4087051|NCT01004848|3910427|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4087052|NCT01004822|3910458|B9||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4087053|NCT01004822|3910459|B8||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4087054|NCT01004822|3910460|B7||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4087055|NCT01004822|3910461|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4087056|NCT01004822|3910462|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4087057|NCT01004822|3910463|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4087058|NCT01004822|3910464|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4087059|NCT01004822|3910465|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4087060|NCT01004822|3910466|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4087061|NCT01004822|3910458|B9||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4087062|NCT01004822|3910459|B8||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4087063|NCT01004822|3910460|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4087064|NCT01004822|3910461|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4087065|NCT01004822|3910462|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4087066|NCT01004822|3910463|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4087067|NCT01004822|3910464|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4087068|NCT01004822|3910465|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4087069|NCT01004822|3910466|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4087070|NCT01004822|3910458|B9|||Age||years|Mean|60.4|60.4|Standard Deviation|8.84|8.84|||
4087071|NCT01004822|3910459|B8|||Age||years|Mean|60.6|60.6|Standard Deviation|10.60|10.6|||
4087072|NCT01004822|3910460|B7|||Age||years|Mean|58.0|58.0|Standard Deviation|7.75|7.75|||
4087073|NCT01004822|3910461|B6|||Age||years|Mean|55.5|55.5|Standard Deviation|10.66|10.66|||
4087074|NCT01004822|3910462|B5|||Age||years|Mean|66.0|66.0|Standard Deviation|9.13|9.13|||
4087075|NCT01004822|3910463|B4|||Age||years|Mean|58.8|58.8|Standard Deviation|6.90|6.9|||
4087076|NCT01004822|3910464|B3|||Age||years|Mean|64.7|64.7|Standard Deviation|2.52|2.52|||
4087077|NCT01004822|3910465|B2|||Age||years|Mean|55.0|55.0|Standard Deviation|11.27|11.27|||
4087078|NCT01004822|3910466|B1|||Age||years|Mean|66.0|66.0|Standard Deviation|8.54|8.54|||
4087079|NCT01004770|3910582|B6|United States||Region of Enrollment||participants|Number|50|50.0||||||
4087080|NCT01004770|3910583|B5|United States||Region of Enrollment||participants|Number|10|10.0||||||
4087081|NCT01004770|3910584|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
4087082|NCT01004770|3910585|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4087083|NCT01004770|3910586|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4087084|NCT01004770|3910587|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4087085|NCT01004770|3910582|B6||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4087086|NCT01004770|3910583|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4087087|NCT01004770|3910584|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4087088|NCT01004770|3910585|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4087089|NCT01004770|3910586|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4087090|NCT01004770|3910587|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4087091|NCT01004770|3910582|B6||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4087092|NCT01004770|3910583|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4087093|NCT01004770|3910584|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4087094|NCT01004770|3910585|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4087095|NCT01004770|3910586|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4087096|NCT01004770|3910587|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4087097|NCT01004770|3910582|B6|||Age||years|Mean|28.6|28.6|Standard Deviation|10.01|10.01|||
4087098|NCT01004770|3910583|B5|||Age||years|Mean|31.3|31.3|Standard Deviation|11.91|11.91|||
4087099|NCT01004770|3910584|B4|||Age||years|Mean|27.4|27.4|Standard Deviation|10.05|10.05|||
4087100|NCT01004770|3910585|B3|||Age||years|Mean|30.8|30.8|Standard Deviation|11.50|11.5|||
4087101|NCT01004770|3910586|B2|||Age||years|Mean|27.2|27.2|Standard Deviation|11.54|11.54|||
4087102|NCT01004770|3910587|B1|||Age||years|Mean|26.5|26.5|Standard Deviation|3.89|3.89|||
4087103|NCT01004770|3910582|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4087104|NCT01004770|3910583|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4087105|NCT01004770|3910584|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4087106|NCT01004770|3910585|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4087107|NCT01004770|3910586|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4087108|NCT01004770|3910587|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4087109|NCT01004770|3910582|B6||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4087110|NCT01004770|3910583|B5||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4087111|NCT01004770|3910584|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4087112|NCT01004770|3910585|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4087113|NCT01004770|3910586|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4087114|NCT01004770|3910587|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4087115|NCT01004770|3910582|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4087116|NCT01004770|3910583|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4087117|NCT01004770|3910584|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4087118|NCT01004770|3910585|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4087119|NCT01004770|3910586|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4087120|NCT01004770|3910587|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4087121|NCT01004705|3910623|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4087122|NCT01004705|3910623|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4087123|NCT01004705|3910623|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4087124|NCT01004705|3910623|B1|||Age||years|Mean|44.6|44.6|Standard Deviation|11.44|11.44|||
4087125|NCT01004614|3910634|B5||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4087126|NCT01004614|3910635|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4087127|NCT01004614|3910636|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4087128|NCT01004614|3910637|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4087129|NCT01004614|3910638|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4087130|NCT01004614|3910634|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4087131|NCT01004614|3910635|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4087132|NCT01004614|3910636|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4087133|NCT01004614|3910637|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4087134|NCT01004614|3910638|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4087135|NCT01004614|3910634|B5|||Age||years|Mean|33.1|33.1|Standard Deviation|10.7|10.7|||
4087136|NCT01004614|3910635|B4|||Age||years|Mean|37.8|37.8|Standard Deviation|12.1|12.1|||
4087137|NCT01004614|3910636|B3|||Age||years|Mean|37.3|37.3|Standard Deviation|9.0|9.0|||
4087138|NCT01004614|3910637|B2|||Age||years|Mean|32.4|32.4|Standard Deviation|11.1|11.1|||
4087139|NCT01004614|3910638|B1|||Age||years|Mean|33.8|33.8|Standard Deviation|10.7|10.7|||
4087140|NCT01004510|3910675|B1|||control of malignant pleural effusions in non small cell lung cancer||participants|Number|3|3.0||||||
4087141|NCT01004510|3910675|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4087142|NCT01004510|3910675|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4087143|NCT01004510|3910675|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4087144|NCT01004510|3910675|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4087145|NCT01004510|3910675|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4087146|NCT01004510|3910675|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4087147|NCT01004432|3910679|B1|United States||Region of Enrollment||participants|Number|349|349.0||||||
4087148|NCT01004432|3910679|B1|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
4087149|NCT01004432|3910679|B1|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
4087150|NCT01004432|3910679|B1|Italy||Region of Enrollment||participants|Number|12|12.0||||||
4087151|NCT01004432|3910679|B1|Greece||Region of Enrollment||participants|Number|8|8.0||||||
4087152|NCT01004432|3910679|B1|Germany||Region of Enrollment||participants|Number|7|7.0||||||
4087153|NCT01004432|3910679|B1|Canada||Region of Enrollment||participants|Number|37|37.0||||||
4087154|NCT01004432|3910679|B1|Belgium||Region of Enrollment||participants|Number|9|9.0||||||
4087155|NCT01004432|3910679|B1|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4087156|NCT01004432|3910679|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4087157|NCT01004432|3910679|B1||Female|Sex: Female, Male||Participants|Count of Participants|358|358.0||||||
4087158|NCT01004432|3910679|B1|||Age||years|Mean|55.7|55.7|Standard Deviation|11.52|11.52|||
4087159|NCT01004393|3910703|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4087160|NCT01004393|3910703|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4087161|NCT01004393|3910703|B1|||Age||years|Median|52|52.0|Full Range|||27.0|87.0|
4087162|NCT01004354|3910714|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4087163|NCT01004354|3910714|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4087164|NCT01004354|3910714|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4087165|NCT01004354|3910714|B1|||Age||years|Mean|16.6|16.6|Standard Deviation|1.65|1.65|||
4087166|NCT01004354|3910714|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4087167|NCT01004354|3910714|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4087168|NCT01004354|3910714|B1||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4087169|NCT01004263|3910726|B1||Male|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
4087170|NCT01004263|3910726|B1||Female|Sex: Female, Male||Participants|Count of Participants|372|372.0||||||
4087171|NCT01004263|3910726|B1|||Age||years|Mean|14.7|14.7|Standard Deviation|1.7|1.7|||
4087172|NCT01004250|3910734|B1|Current Smoker||Tobacco Use||Participant|Number|28|28.0||||||
4087173|NCT01004250|3910734|B1|Ex-Smoker||Tobacco Use||Participant|Number|66|66.0||||||
4087174|NCT01004250|3910734|B1|Never Smoked||Tobacco Use||Participant|Number|15|15.0||||||
4087175|NCT01004250|3910734|B1|Stage IV||Stage of Disease|"According to American Joint Committee on Cancer (AJCC) Cancer Staging Manual, sixth edition (2002), stage of disease means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body).~Stage IIIB - the cancer has spread to nearby tissue or spread to far away lymph nodes but not spread to other organs~Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver"|Participants|Number|99|99.0||||||
4087176|NCT01004250|3910734|B1|Stage IIIB||Stage of Disease|"According to American Joint Committee on Cancer (AJCC) Cancer Staging Manual, sixth edition (2002), stage of disease means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body).~Stage IIIB - the cancer has spread to nearby tissue or spread to far away lymph nodes but not spread to other organs~Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver"|Participants|Number|10|10.0||||||
4087177|NCT01004250|3910734|B1|Other||Initial Pathological Diagnosis|Non-Small Cell Lung Cancer (NSCLC)|Participants|Number|4|4.0||||||
4087178|NCT01004250|3910734|B1|Poorly Differentiated NSCLC||Initial Pathological Diagnosis|Non-Small Cell Lung Cancer (NSCLC)|Participants|Number|3|3.0||||||
4087179|NCT01004250|3910734|B1|Large Cell Lung Carcinoma||Initial Pathological Diagnosis|Non-Small Cell Lung Cancer (NSCLC)|Participants|Number|3|3.0||||||
4087180|NCT01004250|3910734|B1|Adenocarcinoma||Initial Pathological Diagnosis|Non-Small Cell Lung Cancer (NSCLC)|Participants|Number|99|99.0||||||
4087181|NCT01004250|3910734|B1|ECOG 1||ECOG Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death):~0 - Fully Active~- Ambulatory, Restricted Strenuous Activity~- Ambulatory, No Work Activities~- Partially Confined to Bed, Limited Self Care~- Completely Disabled~- Death"|Participants|Number|50|50.0||||||
4087182|NCT01004250|3910734|B1|ECOG 0||ECOG Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death):~0 - Fully Active~- Ambulatory, Restricted Strenuous Activity~- Ambulatory, No Work Activities~- Partially Confined to Bed, Limited Self Care~- Completely Disabled~- Death"|Participants|Number|59|59.0||||||
4087183|NCT01004250|3910734|B1|Sweden||Region of Enrollment||participants|Number|18|18.0||||||
4087184|NCT01004250|3910734|B1|Italy||Region of Enrollment||participants|Number|35|35.0||||||
4087185|NCT01004250|3910734|B1|Germany||Region of Enrollment||participants|Number|25|25.0||||||
4087186|NCT01004250|3910734|B1|Denmark||Region of Enrollment||participants|Number|19|19.0||||||
4087187|NCT01004250|3910734|B1|Spain||Region of Enrollment||participants|Number|12|12.0||||||
4087188|NCT01004250|3910734|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087189|NCT01004250|3910734|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087190|NCT01004250|3910734|B1||White|Race (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
4087191|NCT01004250|3910734|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4087192|NCT01004250|3910734|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087193|NCT01004250|3910734|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087194|NCT01004250|3910734|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087195|NCT01004250|3910734|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4087196|NCT01004250|3910734|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4087197|NCT01004250|3910734|B1|||Age||years|Mean|59.1|59.1|Standard Deviation|8.80|8.8|||
4087198|NCT01004185|3910744|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087199|NCT01004185|3910745|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087200|NCT01004185|3910746|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087201|NCT01004185|3910744|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4087202|NCT01004185|3910745|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4087203|NCT01004185|3910746|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087204|NCT01004185|3910744|B3||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4087205|NCT01004185|3910745|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4087206|NCT01004185|3910746|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4087207|NCT01004185|3910744|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4087208|NCT01004185|3910745|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4087209|NCT01004185|3910746|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4087210|NCT01004185|3910744|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087211|NCT01004185|3910745|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087212|NCT01004185|3910746|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087213|NCT01004185|3910744|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4087214|NCT01004185|3910745|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087215|NCT01004185|3910746|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4087216|NCT01004185|3910744|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087217|NCT01004185|3910745|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087218|NCT01004185|3910746|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087219|NCT01004185|3910744|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087220|NCT01004185|3910745|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087221|NCT01004185|3910746|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087222|NCT01004185|3910744|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4087223|NCT01004185|3910745|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4087224|NCT01004185|3910746|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4087225|NCT01004185|3910744|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4087226|NCT01004185|3910745|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4087227|NCT01004185|3910746|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4087228|NCT01004185|3910744|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4087229|NCT01004185|3910745|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4087230|NCT01004185|3910746|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4087231|NCT01004185|3910744|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4087232|NCT01004185|3910745|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4087233|NCT01004185|3910746|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4087234|NCT01004185|3910744|B3|9-17 years||Age, Customized||participants|Number|38|38.0||||||
4087235|NCT01004185|3910745|B2|9-17 years||Age, Customized||participants|Number|20|20.0||||||
4087236|NCT01004185|3910746|B1|9-17 years||Age, Customized||participants|Number|18|18.0||||||
4087237|NCT01004185|3910744|B3|5-8 years||Age, Customized||participants|Number|1|1.0||||||
4087238|NCT01004185|3910745|B2|5-8 years||Age, Customized||participants|Number|0|0.0||||||
4087239|NCT01004185|3910746|B1|5-8 years||Age, Customized||participants|Number|1|1.0||||||
4087240|NCT01004185|3910744|B3|||Age||years|Mean|13.1|13.1|Standard Deviation|2.3|2.3|||
4087241|NCT01004185|3910745|B2|||Age||years|Mean|13.2|13.2|Standard Deviation|2.1|2.1|||
4087242|NCT01004185|3910746|B1|||Age||years|Mean|13.1|13.1|Standard Deviation|2.5|2.5|||
4087243|NCT01004172|3910755|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4087244|NCT01004172|3910755|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4087245|NCT01004172|3910755|B1|Black or African-American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4087246|NCT01004172|3910755|B1|White||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4087247|NCT01004172|3910755|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087248|NCT01004172|3910755|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4087249|NCT01004172|3910755|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4087250|NCT01004172|3910755|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4087251|NCT01004172|3910755|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4087252|NCT01004172|3910755|B1|||Age, Customized||years|Median|48|48.0|Full Range|||31.0|62.0|
4087253|NCT01004159|3910763|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4087254|NCT01004159|3910763|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4087255|NCT01004159|3910763|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4087256|NCT01004159|3910763|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4087257|NCT01004159|3910763|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4087258|NCT01004159|3910763|B1|||Age||years|Mean|64.6|64.6|Standard Deviation|10.7|10.7|||
4087259|NCT01004146|3910768|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
4087260|NCT01004146|3910769|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4087261|NCT01004146|3910770|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4087262|NCT01004146|3910768|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4087263|NCT01004146|3910769|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4087264|NCT01004146|3910770|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4087265|NCT01004146|3910768|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4087266|NCT01004146|3910769|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4087267|NCT01004146|3910770|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4087268|NCT01004146|3910768|B3|||Age||years|Mean|45.1|45.1|Standard Deviation|12.2|12.2|||
4087269|NCT01004146|3910769|B2|||Age||years|Mean|45.2|45.2|Standard Deviation|12.3|12.3|||
4087270|NCT01004146|3910770|B1|||Age||years|Mean|45.0|45.0|Standard Deviation|12.4|12.4|||
4087271|NCT01004146|3910768|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4087272|NCT01004146|3910769|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4087273|NCT01004146|3910770|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4087274|NCT01004146|3910768|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4087275|NCT01004146|3910769|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4087276|NCT01004146|3910770|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4087277|NCT01004146|3910768|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4087278|NCT01004146|3910769|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4087279|NCT01004146|3910770|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4087280|NCT01004107|3910777|B3|Left||Hand Dominance||participants|Number|9|9.0||||||
4087281|NCT01004107|3910778|B2|Left||Hand Dominance||participants|Number|1|1.0||||||
4087282|NCT01004107|3910779|B1|Left||Hand Dominance||participants|Number|8|8.0||||||
4087283|NCT01004107|3910777|B3|Right||Hand Dominance||participants|Number|92|92.0||||||
4087284|NCT01004107|3910778|B2|Right||Hand Dominance||participants|Number|24|24.0||||||
4087285|NCT01004107|3910779|B1|Right||Hand Dominance||participants|Number|68|68.0||||||
4087286|NCT01004107|3910777|B3|VI: never burns, tans profusely||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|0|0.0||||||
4087287|NCT01004107|3910778|B2|VI: never burns, tans profusely||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|0|0.0||||||
4087288|NCT01004107|3910779|B1|VI: never burns, tans profusely||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|0|0.0||||||
4087289|NCT01004107|3910777|B3|V: rarely burns, tans profusely||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|0|0.0||||||
4087290|NCT01004107|3910778|B2|V: rarely burns, tans profusely||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|0|0.0||||||
4087291|NCT01004107|3910779|B1|V: rarely burns, tans profusely||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|0|0.0||||||
4087292|NCT01004107|3910777|B3|IV: burns minimally, tans moderately & easily||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|0|0.0||||||
4087293|NCT01004107|3910778|B2|IV: burns minimally, tans moderately & easily||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|0|0.0||||||
4087294|NCT01004107|3910779|B1|IV: burns minimally, tans moderately & easily||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|0|0.0||||||
4087295|NCT01004107|3910777|B3|III: burns moderately, tans moderately & uniformly||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|3|3.0||||||
4087296|NCT01004107|3910778|B2|III: burns moderately, tans moderately & uniformly||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|1|1.0||||||
4087337|NCT01004003|3910864|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4087338|NCT01004003|3910865|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4087339|NCT01004003|3910856|B10|||Age||Years|Mean|64.2|64.2|Standard Deviation|10.5|10.5|||
4087297|NCT01004107|3910779|B1|III: burns moderately, tans moderately & uniformly||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|2|2.0||||||
4087298|NCT01004107|3910777|B3|II: burns easily, tans minimally with difficulty||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|97|97.0||||||
4087299|NCT01004107|3910778|B2|II: burns easily, tans minimally with difficulty||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|24|24.0||||||
4087300|NCT01004107|3910779|B1|II: burns easily, tans minimally with difficulty||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|73|73.0||||||
4087301|NCT01004107|3910777|B3|I: burns easily, never tans||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|1|1.0||||||
4087302|NCT01004107|3910778|B2|I: burns easily, never tans||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|0|0.0||||||
4087303|NCT01004107|3910779|B1|I: burns easily, never tans||Fitzpatrick Skin Type|"The Fitzpatrick Skin Types (FST) represent a standard classification of skin color based on one's response to sun exposure (i.e., burns or tans), rather than defined by race or ethnicity.~All FST were eligible for participation in the current study.~See full FST descriptions in Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol. 2004 Feb;122(2):xxx-xxxi."|participants|Number|1|1.0||||||
4087304|NCT01004107|3910777|B3|Non-Caucasian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4087305|NCT01004107|3910778|B2|Non-Caucasian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4087306|NCT01004107|3910779|B1|Non-Caucasian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4087307|NCT01004107|3910777|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|101|101.0||||||
4087308|NCT01004107|3910778|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4087309|NCT01004107|3910779|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
4087310|NCT01004107|3910777|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4087311|NCT01004107|3910778|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4087312|NCT01004107|3910779|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4087313|NCT01004107|3910777|B3||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4087314|NCT01004107|3910778|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4087315|NCT01004107|3910779|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4087316|NCT01004107|3910777|B3|||Age||years|Mean|57.3|57.3|Standard Deviation|8.6|8.6|||
4087317|NCT01004107|3910778|B2|||Age||years|Mean|56.9|56.9|Standard Deviation|9.0|9.0|||
4087318|NCT01004107|3910779|B1|||Age||years|Mean|57.4|57.4|Standard Deviation|8.5|8.5|||
4087319|NCT01004003|3910856|B10||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4087320|NCT01004003|3910857|B9||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4087321|NCT01004003|3910858|B8||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4087322|NCT01004003|3910859|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4087323|NCT01004003|3910860|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4087324|NCT01004003|3910861|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4087325|NCT01004003|3910862|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4087326|NCT01004003|3910863|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4087327|NCT01004003|3910864|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4087328|NCT01004003|3910865|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4087329|NCT01004003|3910856|B10||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4087330|NCT01004003|3910857|B9||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4087331|NCT01004003|3910858|B8||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4087332|NCT01004003|3910859|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4087333|NCT01004003|3910860|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4087334|NCT01004003|3910861|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4087335|NCT01004003|3910862|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4087336|NCT01004003|3910863|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4087340|NCT01004003|3910857|B9|||Age||Years|Mean|63.1|63.1|Standard Deviation|11.8|11.8|||
4087341|NCT01004003|3910858|B8|||Age||Years|Mean|65.4|65.4|Standard Deviation|10.0|10.0|||
4087342|NCT01004003|3910859|B7|||Age||Years|Mean|57.0|57.0|Standard Deviation|11.0|11.0|||
4087343|NCT01004003|3910860|B6|||Age||Years|Mean|59.3|59.3|Standard Deviation|13.9|13.9|||
4087344|NCT01004003|3910861|B5|||Age||Years|Mean|56.3|56.3|Standard Deviation|6.4|6.4|||
4087345|NCT01004003|3910862|B4|||Age||Years|Mean|72.3|72.3|Standard Deviation|11.7|11.7|||
4087346|NCT01004003|3910863|B3|||Age||Years|Mean|66.5|66.5|Standard Deviation|4.0|4.0|||
4087347|NCT01004003|3910864|B2|||Age||Years|Mean|65.0|65.0|Standard Deviation|7.8|7.8|||
4087348|NCT01004003|3910865|B1|||Age||Years|Mean|69.7|69.7|Standard Deviation|6.8|6.8|||
4087349|NCT01003990|3910901|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|275|275.0||||||
4087350|NCT01003990|3910902|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|58|58.0||||||
4087351|NCT01003990|3910903|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|82|82.0||||||
4087352|NCT01003990|3910904|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|135|135.0||||||
4087353|NCT01003990|3910901|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|84|84.0||||||
4087354|NCT01003990|3910902|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
4087355|NCT01003990|3910903|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4087356|NCT01003990|3910904|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|53|53.0||||||
4087357|NCT01003990|3910901|B4|American Indian/Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4087358|NCT01003990|3910902|B3|American Indian/Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4087359|NCT01003990|3910903|B2|American Indian/Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4087360|NCT01003990|3910904|B1|American Indian/Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4087361|NCT01003990|3910901|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|139|139.0||||||
4087362|NCT01003990|3910902|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4087363|NCT01003990|3910903|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
4087364|NCT01003990|3910904|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|112|112.0||||||
4087365|NCT01003990|3910901|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|210|210.0||||||
4087366|NCT01003990|3910902|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
4087367|NCT01003990|3910903|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
4087368|NCT01003990|3910904|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|158|158.0||||||
4087369|NCT01003990|3910901|B4||Male|Sex: Female, Male||Participants|Count of Participants|453|453.0||||||
4087370|NCT01003990|3910902|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4087371|NCT01003990|3910903|B2||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4087372|NCT01003990|3910904|B1||Male|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
4087373|NCT01003990|3910901|B4||Female|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
4087374|NCT01003990|3910902|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4087375|NCT01003990|3910903|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4087376|NCT01003990|3910904|B1||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4087377|NCT01003990|3910901|B4|||Age||years|Mean|36.6|36.6|Standard Deviation|9.12|9.12|||
4087378|NCT01003990|3910902|B3|||Age||years|Mean|37.6|37.6|Standard Deviation|10.16|10.16|||
4087379|NCT01003990|3910903|B2|||Age||years|Mean|35.9|35.9|Standard Deviation|8.81|8.81|||
4087380|NCT01003990|3910904|B1|||Age||years|Mean|36.6|36.6|Standard Deviation|9.00|9.0|||
4087381|NCT01003938|3910914|B1|8 regimens||Prior regimens||participants|Number|1|1.0||||||
4087382|NCT01003938|3910914|B1|7 regimens||Prior regimens||participants|Number|1|1.0||||||
4087383|NCT01003938|3910914|B1|5 regimens||Prior regimens||participants|Number|3|3.0||||||
4087384|NCT01003938|3910914|B1|4 regimens||Prior regimens||participants|Number|1|1.0||||||
4087385|NCT01003938|3910914|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4087386|NCT01003938|3910914|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4087387|NCT01003938|3910914|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4087388|NCT01003938|3910914|B1|||Age||years|Median|65|65.0|Full Range|||61.0|75.0|
4087389|NCT01003938|3910914|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4087390|NCT01003938|3910914|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4087391|NCT01003938|3910914|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4087392|NCT01003899|3910923|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4087393|NCT01003899|3910923|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4087394|NCT01003899|3910923|B1|||Age||years|Mean|57.9|57.9|Standard Deviation|7.1|7.1|||
4087395|NCT01003886|3910932|B1|||Diastolic BP|N=900 for the parameter analyzed.|mmHg|Mean|80.50|80.5|Standard Deviation|9.35|9.35|||
4087396|NCT01003886|3910932|B1|||Systolic blood pressure (BP)|N=900 for the parameter analyzed.|Millimeters of mercury (mmHg)|Mean|127.80|127.8|Standard Deviation|15.18|15.18|||
4087397|NCT01003886|3910932|B1||Male|Sex: Female, Male||Participants|Count of Participants|989|989.0||||||
4087398|NCT01003886|3910932|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4087399|NCT01003886|3910932|B1|||Age||Years|Mean|62.50|62.5|Standard Deviation|10.10|10.1|||
4087400|NCT01003639|3910941|B3|Mental||SF-36 component summary score|Generic health-related quality of life was assessed with the 36-Item Short Form Health Survey - SF-36 consists of eight scaled scores (vitality, physical functioning bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning, and mental health) : with weighted sums 0-100 (higher scores indicate better quality of life)|units on a scale|Mean|45.8|45.8|Standard Deviation|9.0|9.0|||
4087401|NCT01003639|3910942|B2|Mental||SF-36 component summary score|Generic health-related quality of life was assessed with the 36-Item Short Form Health Survey - SF-36 consists of eight scaled scores (vitality, physical functioning bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning, and mental health) : with weighted sums 0-100 (higher scores indicate better quality of life)|units on a scale|Mean|46.3|46.3|Standard Deviation|8.2|8.2|||
4087402|NCT01003639|3910943|B1|Mental||SF-36 component summary score|Generic health-related quality of life was assessed with the 36-Item Short Form Health Survey - SF-36 consists of eight scaled scores (vitality, physical functioning bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning, and mental health) : with weighted sums 0-100 (higher scores indicate better quality of life)|units on a scale|Mean|45.2|45.2|Standard Deviation|9.8|9.8|||
4087403|NCT01003639|3910941|B3|Physical||SF-36 component summary score|Generic health-related quality of life was assessed with the 36-Item Short Form Health Survey - SF-36 consists of eight scaled scores (vitality, physical functioning bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning, and mental health) : with weighted sums 0-100 (higher scores indicate better quality of life)|units on a scale|Mean|45.8|45.8|Standard Deviation|9.0|9.0|||
4087404|NCT01003639|3910942|B2|Physical||SF-36 component summary score|Generic health-related quality of life was assessed with the 36-Item Short Form Health Survey - SF-36 consists of eight scaled scores (vitality, physical functioning bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning, and mental health) : with weighted sums 0-100 (higher scores indicate better quality of life)|units on a scale|Mean|46.3|46.3|Standard Deviation|8.2|8.2|||
4087405|NCT01003639|3910943|B1|Physical||SF-36 component summary score|Generic health-related quality of life was assessed with the 36-Item Short Form Health Survey - SF-36 consists of eight scaled scores (vitality, physical functioning bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning, and mental health) : with weighted sums 0-100 (higher scores indicate better quality of life)|units on a scale|Mean|45.4|45.4|Standard Deviation|9.8|9.8|||
4087406|NCT01003639|3910941|B3|||CSF pressure|cerebrospinal fluid|mm H2O|Mean|343.5|343.5|Standard Deviation|86.9|86.9|||
4087407|NCT01003639|3910942|B2|||CSF pressure|cerebrospinal fluid|mm H2O|Mean|342.0|342.0|Standard Deviation|70.7|70.7|||
4087408|NCT01003639|3910943|B1|||CSF pressure|cerebrospinal fluid|mm H2O|Mean|348.9|348.9|Standard Deviation|94.1|94.1|||
4087409|NCT01003639|3910941|B3|||HIT-6 total score|"6-Item Headache Impact Test.~HIT-6 total score: 36-78 (higher scores indicate greater headache severity)"|units on a scale|Mean|59.7|59.7|Standard Deviation|9.0|9.0|||
4087410|NCT01003639|3910942|B2|||HIT-6 total score|"6-Item Headache Impact Test.~HIT-6 total score: 36-78 (higher scores indicate greater headache severity)"|units on a scale|Mean|59.1|59.1|Standard Deviation|9.3|9.3|||
4087411|NCT01003639|3910943|B1|||HIT-6 total score|"6-Item Headache Impact Test.~HIT-6 total score: 36-78 (higher scores indicate greater headache severity)"|units on a scale|Mean|60.3|60.3|Standard Deviation|8.7|8.7|||
4087412|NCT01003639|3910941|B3|Fellow eye 5||Papilledema grade (fundus photography) Fellow eye|Frisén papilledema grade is an ordinal scale that uses ocular fundus features to rate the severity of papilledema; grade 0 indicates no features of papilledema and grade 5 indicates severe papilledema.|participants|Number|2|2.0||||||
4087413|NCT01003639|3910942|B2|Fellow eye 5||Papilledema grade (fundus photography) Fellow eye|Frisén papilledema grade is an ordinal scale that uses ocular fundus features to rate the severity of papilledema; grade 0 indicates no features of papilledema and grade 5 indicates severe papilledema.|participants|Number|2|2.0||||||
4087414|NCT01003639|3910943|B1|Fellow eye 5||Papilledema grade (fundus photography) Fellow eye|Frisén papilledema grade is an ordinal scale that uses ocular fundus features to rate the severity of papilledema; grade 0 indicates no features of papilledema and grade 5 indicates severe papilledema.|participants|Number|0|0.0||||||
4087415|NCT01003639|3910941|B3|Fellow eye 4||Papilledema grade (fundus photography) Fellow eye|Frisén papilledema grade is an ordinal scale that uses ocular fundus features to rate the severity of papilledema; grade 0 indicates no features of papilledema and grade 5 indicates severe papilledema.|participants|Number|33|33.0||||||
4087416|NCT01003639|3910942|B2|Fellow eye 4||Papilledema grade (fundus photography) Fellow eye|Frisén papilledema grade is an ordinal scale that uses ocular fundus features to rate the severity of papilledema; grade 0 indicates no features of papilledema and grade 5 indicates severe papilledema.|participants|Number|14|14.0||||||
4087417|NCT01003639|3910943|B1|Fellow eye 4||Papilledema grade (fundus photography) Fellow eye|Frisén papilledema grade is an ordinal scale that uses ocular fundus features to rate the severity of papilledema; grade 0 indicates no features of papilledema and grade 5 indicates severe papilledema.|participants|Number|19|19.0||||||
4087418|NCT01003639|3910941|B3|Fellow eye 3||Papilledema grade (fundus photography) Fellow eye|Frisén papilledema grade is an ordinal scale that uses ocular fundus features to rate the severity of papilledema; grade 0 indicates no features of papilledema and grade 5 indicates severe papilledema.|participants|Number|40|40.0||||||
4087419|NCT01003639|3910942|B2|Fellow eye 3||Papilledema grade (fundus photography) Fellow eye|Frisén papilledema grade is an ordinal scale that uses ocular fundus features to rate the severity of papilledema; grade 0 indicates no features of papilledema and grade 5 indicates severe papilledema.|participants|Number|21|21.0||||||
4087420|NCT01003639|3910943|B1|Fellow eye 3||Papilledema grade (fundus photography) Fellow eye|Frisén papilledema grade is an ordinal scale that uses ocular fundus features to rate the severity of papilledema; grade 0 indicates no features of papilledema and grade 5 indicates severe papilledema.|participants|Number|19|19.0||||||
4087498|NCT01003639|3910943|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4087421|NCT01003639|3910941|B3|Fellow eye 2||Papilledema grade (fundus photography) Fellow eye|Frisén papilledema grade is an ordinal scale that uses ocular fundus features to rate the severity of papilledema; grade 0 indicates no features of papilledema and grade 5 indicates severe papilledema.|participants|Number|61|61.0||||||
4087422|NCT01003639|3910942|B2|Fellow eye 2||Papilledema grade (fundus photography) Fellow eye|Frisén papilledema grade is an ordinal scale that uses ocular fundus features to rate the severity of papilledema; grade 0 indicates no features of papilledema and grade 5 indicates severe papilledema.|participants|Number|28|28.0||||||
4087423|NCT01003639|3910943|B1|Fellow eye 2||Papilledema grade (fundus photography) Fellow eye|Frisén papilledema grade is an ordinal scale that uses ocular fundus features to rate the severity of papilledema; grade 0 indicates no features of papilledema and grade 5 indicates severe papilledema.|participants|Number|33|33.0||||||
4087424|NCT01003639|3910941|B3|Fellow eye 1||Papilledema grade (fundus photography) Fellow eye|Frisén papilledema grade is an ordinal scale that uses ocular fundus features to rate the severity of papilledema; grade 0 indicates no features of papilledema and grade 5 indicates severe papilledema.|participants|Number|29|29.0||||||
4087425|NCT01003639|3910942|B2|Fellow eye 1||Papilledema grade (fundus photography) Fellow eye|Frisén papilledema grade is an ordinal scale that uses ocular fundus features to rate the severity of papilledema; grade 0 indicates no features of papilledema and grade 5 indicates severe papilledema.|participants|Number|14|14.0||||||
4087426|NCT01003639|3910943|B1|Fellow eye 1||Papilledema grade (fundus photography) Fellow eye|Frisén papilledema grade is an ordinal scale that uses ocular fundus features to rate the severity of papilledema; grade 0 indicates no features of papilledema and grade 5 indicates severe papilledema.|participants|Number|15|15.0||||||
4087427|NCT01003639|3910941|B3|Study eye 5||Papilledema grade (fundus photography) Study Eye|Frisén papilledema grade is an ordinal scale that uses ocular fundus features to rate the severity of papilledema; grade 0 indicates no features of papilledema and grade 5 indicates severe papilledema.|participants|Number|5|5.0||||||
4087428|NCT01003639|3910942|B2|Study eye 5||Papilledema grade (fundus photography) Study Eye|Frisén papilledema grade is an ordinal scale that uses ocular fundus features to rate the severity of papilledema; grade 0 indicates no features of papilledema and grade 5 indicates severe papilledema.|participants|Number|3|3.0||||||
4087429|NCT01003639|3910943|B1|Study eye 5||Papilledema grade (fundus photography) Study Eye|Frisén papilledema grade is an ordinal scale that uses ocular fundus features to rate the severity of papilledema; grade 0 indicates no features of papilledema and grade 5 indicates severe papilledema.|participants|Number|2|2.0||||||
4087430|NCT01003639|3910941|B3|Study eye 4||Papilledema grade (fundus photography) Study Eye|Frisén papilledema grade is an ordinal scale that uses ocular fundus features to rate the severity of papilledema; grade 0 indicates no features of papilledema and grade 5 indicates severe papilledema.|participants|Number|45|45.0||||||
4087431|NCT01003639|3910942|B2|Study eye 4||Papilledema grade (fundus photography) Study Eye|Frisén papilledema grade is an ordinal scale that uses ocular fundus features to rate the severity of papilledema; grade 0 indicates no features of papilledema and grade 5 indicates severe papilledema.|participants|Number|21|21.0||||||
4087432|NCT01003639|3910943|B1|Study eye 4||Papilledema grade (fundus photography) Study Eye|Frisén papilledema grade is an ordinal scale that uses ocular fundus features to rate the severity of papilledema; grade 0 indicates no features of papilledema and grade 5 indicates severe papilledema.|participants|Number|24|24.0||||||
4087433|NCT01003639|3910941|B3|Study eye 3||Papilledema grade (fundus photography) Study Eye|Frisén papilledema grade is an ordinal scale that uses ocular fundus features to rate the severity of papilledema; grade 0 indicates no features of papilledema and grade 5 indicates severe papilledema.|participants|Number|40|40.0||||||
4087434|NCT01003639|3910942|B2|Study eye 3||Papilledema grade (fundus photography) Study Eye|Frisén papilledema grade is an ordinal scale that uses ocular fundus features to rate the severity of papilledema; grade 0 indicates no features of papilledema and grade 5 indicates severe papilledema.|participants|Number|20|20.0||||||
4087435|NCT01003639|3910943|B1|Study eye 3||Papilledema grade (fundus photography) Study Eye|Frisén papilledema grade is an ordinal scale that uses ocular fundus features to rate the severity of papilledema; grade 0 indicates no features of papilledema and grade 5 indicates severe papilledema.|participants|Number|20|20.0||||||
4087436|NCT01003639|3910941|B3|Study eye 2||Papilledema grade (fundus photography) Study Eye|Frisén papilledema grade is an ordinal scale that uses ocular fundus features to rate the severity of papilledema; grade 0 indicates no features of papilledema and grade 5 indicates severe papilledema.|participants|Number|55|55.0||||||
4087437|NCT01003639|3910942|B2|Study eye 2||Papilledema grade (fundus photography) Study Eye|Frisén papilledema grade is an ordinal scale that uses ocular fundus features to rate the severity of papilledema; grade 0 indicates no features of papilledema and grade 5 indicates severe papilledema.|participants|Number|23|23.0||||||
4087438|NCT01003639|3910943|B1|Study eye 2||Papilledema grade (fundus photography) Study Eye|Frisén papilledema grade is an ordinal scale that uses ocular fundus features to rate the severity of papilledema; grade 0 indicates no features of papilledema and grade 5 indicates severe papilledema.|participants|Number|32|32.0||||||
4087439|NCT01003639|3910941|B3|Study eye 1||Papilledema grade (fundus photography) Study Eye|Frisén papilledema grade is an ordinal scale that uses ocular fundus features to rate the severity of papilledema; grade 0 indicates no features of papilledema and grade 5 indicates severe papilledema.|participants|Number|20|20.0||||||
4087440|NCT01003639|3910942|B2|Study eye 1||Papilledema grade (fundus photography) Study Eye|Frisén papilledema grade is an ordinal scale that uses ocular fundus features to rate the severity of papilledema; grade 0 indicates no features of papilledema and grade 5 indicates severe papilledema.|participants|Number|12|12.0||||||
4087441|NCT01003639|3910943|B1|Study eye 1||Papilledema grade (fundus photography) Study Eye|Frisén papilledema grade is an ordinal scale that uses ocular fundus features to rate the severity of papilledema; grade 0 indicates no features of papilledema and grade 5 indicates severe papilledema.|participants|Number|8|8.0||||||
4087442|NCT01003639|3910941|B3|Fellow eye||Perimetric mean deviation|Perimetric mean deviation is a measure of global visual field loss (mean deviation from age-corrected normal values), with a range of 2 to −32 dB; larger negative values indicate greater vision loss.|dB|Mean|-2.3|-2.3|Standard Deviation|1.1|1.1|||
4087499|NCT01003639|3910941|B3||White|Race (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
4087443|NCT01003639|3910942|B2|Fellow eye||Perimetric mean deviation|Perimetric mean deviation is a measure of global visual field loss (mean deviation from age-corrected normal values), with a range of 2 to −32 dB; larger negative values indicate greater vision loss.|dB|Mean|-2.3|-2.3|Standard Deviation|1.1|1.1|||
4087444|NCT01003639|3910943|B1|Fellow eye||Perimetric mean deviation|Perimetric mean deviation is a measure of global visual field loss (mean deviation from age-corrected normal values), with a range of 2 to −32 dB; larger negative values indicate greater vision loss.|dB|Mean|-2.3|-2.3|Standard Deviation|1.1|1.1|||
4087445|NCT01003639|3910941|B3|Study eye||Perimetric mean deviation|Perimetric mean deviation is a measure of global visual field loss (mean deviation from age-corrected normal values), with a range of 2 to −32 dB; larger negative values indicate greater vision loss.|dB|Mean|-3.5|-3.5|Standard Deviation|1.1|1.1|||
4087446|NCT01003639|3910942|B2|Study eye||Perimetric mean deviation|Perimetric mean deviation is a measure of global visual field loss (mean deviation from age-corrected normal values), with a range of 2 to −32 dB; larger negative values indicate greater vision loss.|dB|Mean|-3.5|-3.5|Standard Deviation|1.1|1.1|||
4087447|NCT01003639|3910943|B1|Study eye||Perimetric mean deviation|Perimetric mean deviation is a measure of global visual field loss (mean deviation from age-corrected normal values), with a range of 2 to −32 dB; larger negative values indicate greater vision loss.|dB|Mean|-3.5|-3.5|Standard Deviation|1.2|1.2|||
4087448|NCT01003639|3910941|B3|No||Pulsatile tinnitus||participants|Number|79|79.0||||||
4087449|NCT01003639|3910942|B2|No||Pulsatile tinnitus||participants|Number|38|38.0||||||
4087450|NCT01003639|3910943|B1|No||Pulsatile tinnitus||participants|Number|41|41.0||||||
4087451|NCT01003639|3910941|B3|Yes||Pulsatile tinnitus||participants|Number|86|86.0||||||
4087452|NCT01003639|3910942|B2|Yes||Pulsatile tinnitus||participants|Number|41|41.0||||||
4087453|NCT01003639|3910943|B1|Yes||Pulsatile tinnitus||participants|Number|45|45.0||||||
4087454|NCT01003639|3910941|B3|No||Headache||participants|Number|26|26.0||||||
4087455|NCT01003639|3910942|B2|No||Headache||participants|Number|10|10.0||||||
4087456|NCT01003639|3910943|B1|No||Headache||participants|Number|16|16.0||||||
4087457|NCT01003639|3910941|B3|Yes||Headache||participants|Number|139|139.0||||||
4087458|NCT01003639|3910942|B2|Yes||Headache||participants|Number|69|69.0||||||
4087459|NCT01003639|3910943|B1|Yes||Headache||participants|Number|70|70.0||||||
4087460|NCT01003639|3910941|B3|No||Photophobia||participants|Number|86|86.0||||||
4087461|NCT01003639|3910942|B2|No||Photophobia||participants|Number|42|42.0||||||
4087462|NCT01003639|3910943|B1|No||Photophobia||participants|Number|44|44.0||||||
4087463|NCT01003639|3910941|B3|Yes||Photophobia||participants|Number|79|79.0||||||
4087464|NCT01003639|3910942|B2|Yes||Photophobia||participants|Number|37|37.0||||||
4087465|NCT01003639|3910943|B1|Yes||Photophobia||participants|Number|42|42.0||||||
4087466|NCT01003639|3910941|B3|No||Constant visual loss||participants|Number|112|112.0||||||
4087467|NCT01003639|3910942|B2|No||Constant visual loss||participants|Number|51|51.0||||||
4087468|NCT01003639|3910943|B1|No||Constant visual loss||participants|Number|61|61.0||||||
4087469|NCT01003639|3910941|B3|Yes||Constant visual loss||participants|Number|53|53.0||||||
4087470|NCT01003639|3910942|B2|Yes||Constant visual loss||participants|Number|28|28.0||||||
4087471|NCT01003639|3910943|B1|Yes||Constant visual loss||participants|Number|25|25.0||||||
4087472|NCT01003639|3910941|B3|No||Diplopia||participants|Number|129|129.0||||||
4087473|NCT01003639|3910942|B2|No||Diplopia||participants|Number|63|63.0||||||
4087474|NCT01003639|3910943|B1|No||Diplopia||participants|Number|66|66.0||||||
4087475|NCT01003639|3910941|B3|Yes||Diplopia||participants|Number|36|36.0||||||
4087476|NCT01003639|3910942|B2|Yes||Diplopia||participants|Number|16|16.0||||||
4087477|NCT01003639|3910943|B1|Yes||Diplopia||participants|Number|20|20.0||||||
4087478|NCT01003639|3910941|B3|No||Transient visual obscurations||participants|Number|53|53.0||||||
4087479|NCT01003639|3910942|B2|No||Transient visual obscurations||participants|Number|22|22.0||||||
4087480|NCT01003639|3910943|B1|No||Transient visual obscurations||participants|Number|31|31.0||||||
4087481|NCT01003639|3910941|B3|yes||Transient visual obscurations||participants|Number|112|112.0||||||
4087482|NCT01003639|3910942|B2|yes||Transient visual obscurations||participants|Number|57|57.0||||||
4087483|NCT01003639|3910943|B1|yes||Transient visual obscurations||participants|Number|55|55.0||||||
4087484|NCT01003639|3910941|B3|||Weight change in the past 6 mo||kg|Mean|9.8|9.8|Standard Deviation|16.7|16.7|||
4087485|NCT01003639|3910942|B2|||Weight change in the past 6 mo||kg|Mean|8.8|8.8|Standard Deviation|16.9|16.9|||
4087486|NCT01003639|3910943|B1|||Weight change in the past 6 mo||kg|Mean|10.7|10.7|Standard Deviation|16.7|16.7|||
4087487|NCT01003639|3910941|B3|||Body mass index|Body mass index is calculated as weight in kilograms divided by height in meters squared.|Kg/m^2|Mean|39.9|39.9|Standard Deviation|8.3|8.3|||
4087488|NCT01003639|3910942|B2|||Body mass index|Body mass index is calculated as weight in kilograms divided by height in meters squared.|Kg/m^2|Mean|39.9|39.9|Standard Deviation|8.1|8.1|||
4087489|NCT01003639|3910943|B1|||Body mass index|Body mass index is calculated as weight in kilograms divided by height in meters squared.|Kg/m^2|Mean|40.0|40.0|Standard Deviation|8.5|8.5|||
4087490|NCT01003639|3910941|B3|||Weight||kg|Mean|107.7|107.7|Standard Deviation|25.0|25.0|||
4087491|NCT01003639|3910942|B2|||Weight||kg|Mean|107.3|107.3|Standard Deviation|24.5|24.5|||
4087492|NCT01003639|3910943|B1|||Weight||kg|Mean|108.1|108.1|Standard Deviation|25.6|25.6|||
4087493|NCT01003639|3910941|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4087494|NCT01003639|3910942|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4087495|NCT01003639|3910943|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4087496|NCT01003639|3910941|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4087497|NCT01003639|3910942|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4087500|NCT01003639|3910942|B2||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4087501|NCT01003639|3910943|B1||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4087502|NCT01003639|3910941|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4087503|NCT01003639|3910942|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4087504|NCT01003639|3910943|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4087505|NCT01003639|3910941|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087506|NCT01003639|3910942|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087507|NCT01003639|3910943|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087508|NCT01003639|3910941|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087509|NCT01003639|3910942|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087510|NCT01003639|3910943|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087511|NCT01003639|3910941|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087512|NCT01003639|3910942|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087513|NCT01003639|3910943|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087514|NCT01003639|3910941|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4087515|NCT01003639|3910942|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4087516|NCT01003639|3910943|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4087517|NCT01003639|3910941|B3||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4087518|NCT01003639|3910942|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4087519|NCT01003639|3910943|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4087520|NCT01003639|3910941|B3|||Age||years|Mean|29.0|29.0|Standard Deviation|7.4|7.4|||
4087521|NCT01003639|3910942|B2|||Age||years|Mean|30.0|30.0|Standard Deviation|8.0|8.0|||
4087522|NCT01003639|3910943|B1|||Age||years|Mean|28.2|28.2|Standard Deviation|6.9|6.9|||
4087523|NCT01003301|3910956|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4087524|NCT01003301|3910957|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4087525|NCT01003301|3910958|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4087526|NCT01003301|3910956|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4087527|NCT01003301|3910957|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4087528|NCT01003301|3910958|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4087529|NCT01003301|3910956|B3|||Age||years|Mean|24|24.0|Full Range|||18.0|35.0|
4087530|NCT01003301|3910957|B2|||Age||years|Mean|25.1|25.1|Full Range|||18.0|35.0|
4087531|NCT01003301|3910958|B1|||Age||years|Mean|23.7|23.7|Full Range|||19.0|30.0|
4087532|NCT01003288|3910965|B3|Norway||Region of Enrollment||participants|Number|255|255.0||||||
4087533|NCT01003288|3910966|B2|Norway||Region of Enrollment||participants|Number|4|4.0||||||
4087534|NCT01003288|3910967|B1|Norway||Region of Enrollment||participants|Number|251|251.0||||||
4087535|NCT01003288|3910965|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4087536|NCT01003288|3910966|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4087537|NCT01003288|3910967|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4087538|NCT01003288|3910965|B3||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4087539|NCT01003288|3910966|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4087540|NCT01003288|3910967|B1||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4087541|NCT01003288|3910965|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4087542|NCT01003288|3910966|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4087543|NCT01003288|3910967|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4087544|NCT01003288|3910965|B3||Between 18 and 65 years|Age||Participants|Count of Participants|255|255.0||||||
4087545|NCT01003288|3910966|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4087546|NCT01003288|3910967|B1||Between 18 and 65 years|Age||Participants|Count of Participants|251|251.0||||||
4087547|NCT01003288|3910965|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4087548|NCT01003288|3910966|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4087549|NCT01003288|3910967|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4087550|NCT01003275|3910972|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4087551|NCT01003275|3910973|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4087552|NCT01003275|3910974|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4087553|NCT01003275|3910972|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4087554|NCT01003275|3910973|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4087555|NCT01003275|3910974|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4087556|NCT01003275|3910972|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4087557|NCT01003275|3910973|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4087558|NCT01003275|3910974|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4087559|NCT01003275|3910972|B3|||Age||years|Mean|65.8|65.8|Standard Deviation|11.6|11.6|||
4087560|NCT01003275|3910973|B2|||Age||years|Mean|65.5|65.5|Standard Deviation|13.1|13.1|||
4087561|NCT01003275|3910974|B1|||Age||years|Mean|66|66.0|Standard Deviation|10.4|10.4|||
4087562|NCT01003249|3910981|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4087563|NCT01003249|3910981|B1|Unknown||Sex/Gender, Customized||Participants|Count of Participants|7|7.0||||||
4087564|NCT01003249|3910981|B1|Male||Sex/Gender, Customized||Participants|Count of Participants|2|2.0||||||
4087565|NCT01003249|3910981|B1|Female||Sex/Gender, Customized||Participants|Count of Participants|3|3.0||||||
4087566|NCT01003249|3910981|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4087567|NCT01003249|3910981|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4087568|NCT01003249|3910981|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4087569|NCT01003210|3910998|B3|United States||Region of Enrollment||participants|Number|210|210.0||||||
4087570|NCT01003210|3910999|B2|United States||Region of Enrollment||participants|Number|105|105.0||||||
4087571|NCT01003210|3911000|B1|United States||Region of Enrollment||participants|Number|105|105.0||||||
4087572|NCT01003210|3910998|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4087573|NCT01003210|3910999|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4087574|NCT01003210|3911000|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4087575|NCT01003210|3910998|B3||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4087576|NCT01003210|3910999|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4087577|NCT01003210|3911000|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4087578|NCT01003210|3910998|B3|||Age||years|Mean|4.1|4.1|Standard Deviation|2.7|2.7|||
4087579|NCT01003210|3910999|B2|||Age||years|Mean|4.2|4.2|Standard Deviation|2.6|2.6|||
4087580|NCT01003210|3911000|B1|||Age||years|Mean|3.9|3.9|Standard Deviation|2.8|2.8|||
4087581|NCT01003210|3910998|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4087582|NCT01003210|3910999|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4087583|NCT01003210|3911000|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4087584|NCT01003210|3910998|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4087585|NCT01003210|3910999|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4087586|NCT01003210|3911000|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4087587|NCT01003210|3910998|B3||<=18 years|Age||Participants|Count of Participants|210|210.0||||||
4087588|NCT01003210|3910999|B2||<=18 years|Age||Participants|Count of Participants|105|105.0||||||
4087589|NCT01003210|3911000|B1||<=18 years|Age||Participants|Count of Participants|105|105.0||||||
4087590|NCT01003184|3911011|B3|||Weight||Kilograms|Mean|97.3|97.3|Standard Deviation|16.42|16.42|||
4087591|NCT01003184|3911012|B2|||Weight||Kilograms|Mean|97.9|97.9|Standard Deviation|15.82|15.82|||
4087592|NCT01003184|3911013|B1|||Weight||Kilograms|Mean|96.7|96.7|Standard Deviation|17.03|17.03|||
4087593|NCT01003184|3911011|B3|||HbA1c|At visit 3 (week 0).|Percentage of total hemoglobin|Mean|8.4|8.4|Standard Deviation|0.86|0.86|||
4087594|NCT01003184|3911012|B2|||HbA1c|At visit 3 (week 0).|Percentage of total hemoglobin|Mean|8.4|8.4|Standard Deviation|0.88|0.88|||
4087595|NCT01003184|3911013|B1|||HbA1c|At visit 3 (week 0).|Percentage of total hemoglobin|Mean|8.4|8.4|Standard Deviation|0.85|0.85|||
4087596|NCT01003184|3911011|B3||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4087597|NCT01003184|3911012|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4087598|NCT01003184|3911013|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4087599|NCT01003184|3911011|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4087600|NCT01003184|3911012|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4087601|NCT01003184|3911013|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4087602|NCT01003184|3911011|B3|||Age||years|Mean|58.5|58.5|Standard Deviation|9.68|9.68|||
4087603|NCT01003184|3911012|B2|||Age||years|Mean|57.8|57.8|Standard Deviation|9.48|9.48|||
4087604|NCT01003184|3911013|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|9.86|9.86|||
4087605|NCT01003184|3911011|B3||>=65 years|Age||Participants|Count of Participants|64|64.0||||||
4087606|NCT01003184|3911012|B2||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4087607|NCT01003184|3911013|B1||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
4087608|NCT01003184|3911011|B3||Between 18 and 65 years|Age||Participants|Count of Participants|152|152.0||||||
4087609|NCT01003184|3911012|B2||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
4087610|NCT01003184|3911013|B1||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
4087611|NCT01003184|3911011|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4087612|NCT01003184|3911012|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4087613|NCT01003184|3911013|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4087614|NCT01003106|3911046|B5||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4087615|NCT01003106|3911047|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4087616|NCT01003106|3911048|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4087617|NCT01003106|3911049|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4087618|NCT01003106|3911050|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4087619|NCT01003106|3911046|B5||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4087620|NCT01003106|3911047|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4087621|NCT01003106|3911048|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4087622|NCT01003106|3911049|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4087623|NCT01003106|3911050|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4087624|NCT01003106|3911046|B5|||Age||years|Mean|64.7|64.7|Standard Deviation|2.5|2.5|||
4087625|NCT01003106|3911047|B4|||Age||years|Mean|64.4|64.4|Standard Deviation|2.9|2.9|||
4087626|NCT01003106|3911048|B3|||Age||years|Mean|59.0|59.0|Standard Deviation|2.9|2.9|||
4087627|NCT01003106|3911049|B2|||Age||years|Mean|69.3|69.3|Standard Deviation|1.8|1.8|||
4087628|NCT01003106|3911050|B1|||Age||years|Mean|66.6|66.6|Standard Deviation|2.2|2.2|||
4087629|NCT01003080|3911079|B3|United States||Region of Enrollment||participants|Number|111|111.0||||||
4087630|NCT01003080|3911080|B2|United States||Region of Enrollment||participants|Number|61|61.0||||||
4087631|NCT01003080|3911081|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4087632|NCT01003080|3911079|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4087633|NCT01003080|3911080|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4087634|NCT01003080|3911081|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4087635|NCT01003080|3911079|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4087636|NCT01003080|3911080|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4087637|NCT01003080|3911081|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4087638|NCT01003080|3911079|B3|||Age||years|Mean|66|66.0|Standard Deviation|9.96|9.96|||
4087639|NCT01003080|3911080|B2|||Age||years|Mean|66.3|66.3|Standard Deviation|9.6|9.6|||
4087640|NCT01003080|3911081|B1|||Age||years|Mean|64.9|64.9|Standard Deviation|10.4|10.4|||
4087641|NCT01003080|3911079|B3||>=65 years|Age||Participants|Count of Participants|58|58.0||||||
4087642|NCT01003080|3911080|B2||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
4087643|NCT01003080|3911081|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4087644|NCT01003080|3911079|B3||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4087645|NCT01003080|3911080|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4087646|NCT01003080|3911081|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4087647|NCT01003080|3911079|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4087648|NCT01003080|3911080|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4087649|NCT01003080|3911081|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4087650|NCT01003067|3911088|B3|Switzerland||Region of Enrollment||participants|Number|267|267.0||||||
4087651|NCT01003067|3911089|B2|Switzerland||Region of Enrollment||participants|Number|131|131.0||||||
4087652|NCT01003067|3911090|B1|Switzerland||Region of Enrollment||participants|Number|136|136.0||||||
4087653|NCT01003067|3911088|B3||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4087654|NCT01003067|3911089|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4087655|NCT01003067|3911090|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4087656|NCT01003067|3911088|B3||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4087657|NCT01003067|3911089|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4087658|NCT01003067|3911090|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4087659|NCT01003067|3911088|B3|||Age, Customized||years|Mean|64.5|64.5|Standard Deviation|2|2.0|||
4087660|NCT01003067|3911089|B2|||Age, Customized||years|Mean|64.1|64.1|Standard Deviation|2.3|2.3|||
4087661|NCT01003067|3911090|B1|||Age, Customized||years|Mean|65.1|65.1|Standard Deviation|2|2.0|||
4087662|NCT01002989|3911097|B1|||Mean Watch BP Office ABI||ratio|Mean|1.11|1.11|Standard Deviation|0.17|0.17|||
4087663|NCT01002989|3911097|B1|||Watch BP Office minus Doppler Ankle-Brachial Index (ABI) difference||ratio|Mean|0.03|0.03|Standard Deviation|0.11|0.11|||
4087664|NCT01002989|3911097|B1|||Mean Doppler ABI||ratio|Mean|1.08|1.08|Standard Deviation|0.17|0.17|||
4087665|NCT01002989|3911097|B1|Greece||Region of Enrollment||participants|Number|98|98.0||||||
4087666|NCT01002989|3911097|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4087667|NCT01002989|3911097|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4087668|NCT01002989|3911097|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|11.1|11.1|||
4087669|NCT01002989|3911097|B1||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
4087670|NCT01002989|3911097|B1||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4087671|NCT01002989|3911097|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4087672|NCT01002742|3911104|B3|Bilirubin >15 mg/dL||Liver Abnormalities at Diagnosis||participants|Number|1|1.0||||||
4087673|NCT01002742|3911105|B2|Bilirubin >15 mg/dL||Liver Abnormalities at Diagnosis||participants|Number|1|1.0||||||
4087674|NCT01002742|3911106|B1|Bilirubin >15 mg/dL||Liver Abnormalities at Diagnosis||participants|Number|0|0.0||||||
4087675|NCT01002742|3911104|B3|Bilirubin 6.1-15 mg/dL||Liver Abnormalities at Diagnosis||participants|Number|2|2.0||||||
4087676|NCT01002742|3911105|B2|Bilirubin 6.1-15 mg/dL||Liver Abnormalities at Diagnosis||participants|Number|2|2.0||||||
4087677|NCT01002742|3911106|B1|Bilirubin 6.1-15 mg/dL||Liver Abnormalities at Diagnosis||participants|Number|0|0.0||||||
4087678|NCT01002742|3911104|B3|Bilirubin 3.1-6 mg/dL||Liver Abnormalities at Diagnosis||participants|Number|10|10.0||||||
4087679|NCT01002742|3911105|B2|Bilirubin 3.1-6 mg/dL||Liver Abnormalities at Diagnosis||participants|Number|6|6.0||||||
4087680|NCT01002742|3911106|B1|Bilirubin 3.1-6 mg/dL||Liver Abnormalities at Diagnosis||participants|Number|4|4.0||||||
4087681|NCT01002742|3911104|B3|Bilirubin 2-3 mg/dL||Liver Abnormalities at Diagnosis||participants|Number|6|6.0||||||
4087868|NCT01002547|3911165|B1|||Plasma ALT||U/L|Mean|53|53.0|Standard Deviation|33|33.0|||
4087682|NCT01002742|3911105|B2|Bilirubin 2-3 mg/dL||Liver Abnormalities at Diagnosis||participants|Number|1|1.0||||||
4087683|NCT01002742|3911106|B1|Bilirubin 2-3 mg/dL||Liver Abnormalities at Diagnosis||participants|Number|5|5.0||||||
4087684|NCT01002742|3911104|B3|Bilirubin <2 mg/dL||Liver Abnormalities at Diagnosis||participants|Number|216|216.0||||||
4087685|NCT01002742|3911105|B2|Bilirubin <2 mg/dL||Liver Abnormalities at Diagnosis||participants|Number|106|106.0||||||
4087686|NCT01002742|3911106|B1|Bilirubin <2 mg/dL||Liver Abnormalities at Diagnosis||participants|Number|110|110.0||||||
4087687|NCT01002742|3911104|B3|Stool with Frank Blood or Melena||Lower GI Abnormalities at Diagnosis||participants|Number|2|2.0||||||
4087688|NCT01002742|3911105|B2|Stool with Frank Blood or Melena||Lower GI Abnormalities at Diagnosis||participants|Number|2|2.0||||||
4087689|NCT01002742|3911106|B1|Stool with Frank Blood or Melena||Lower GI Abnormalities at Diagnosis||participants|Number|0|0.0||||||
4087690|NCT01002742|3911104|B3|Diarrhea >1500 mL/day||Lower GI Abnormalities at Diagnosis||participants|Number|18|18.0||||||
4087691|NCT01002742|3911105|B2|Diarrhea >1500 mL/day||Lower GI Abnormalities at Diagnosis||participants|Number|7|7.0||||||
4087692|NCT01002742|3911106|B1|Diarrhea >1500 mL/day||Lower GI Abnormalities at Diagnosis||participants|Number|11|11.0||||||
4087693|NCT01002742|3911104|B3|Diarrhea >1000 but ≤ 1500 mL/day||Lower GI Abnormalities at Diagnosis||participants|Number|17|17.0||||||
4087694|NCT01002742|3911105|B2|Diarrhea >1000 but ≤ 1500 mL/day||Lower GI Abnormalities at Diagnosis||participants|Number|8|8.0||||||
4087695|NCT01002742|3911106|B1|Diarrhea >1000 but ≤ 1500 mL/day||Lower GI Abnormalities at Diagnosis||participants|Number|9|9.0||||||
4087696|NCT01002742|3911104|B3|Diarrhea >500 but ≤ 1000 mL/day||Lower GI Abnormalities at Diagnosis||participants|Number|35|35.0||||||
4087697|NCT01002742|3911105|B2|Diarrhea >500 but ≤ 1000 mL/day||Lower GI Abnormalities at Diagnosis||participants|Number|21|21.0||||||
4087698|NCT01002742|3911106|B1|Diarrhea >500 but ≤ 1000 mL/day||Lower GI Abnormalities at Diagnosis||participants|Number|14|14.0||||||
4087699|NCT01002742|3911104|B3|Diarrhea Less ≤ 500 mL/day||Lower GI Abnormalities at Diagnosis||participants|Number|40|40.0||||||
4087700|NCT01002742|3911105|B2|Diarrhea Less ≤ 500 mL/day||Lower GI Abnormalities at Diagnosis||participants|Number|21|21.0||||||
4087701|NCT01002742|3911106|B1|Diarrhea Less ≤ 500 mL/day||Lower GI Abnormalities at Diagnosis||participants|Number|19|19.0||||||
4087702|NCT01002742|3911104|B3|No Diarrhea||Lower GI Abnormalities at Diagnosis||participants|Number|123|123.0||||||
4087703|NCT01002742|3911105|B2|No Diarrhea||Lower GI Abnormalities at Diagnosis||participants|Number|57|57.0||||||
4087704|NCT01002742|3911106|B1|No Diarrhea||Lower GI Abnormalities at Diagnosis||participants|Number|66|66.0||||||
4087705|NCT01002742|3911104|B3|Persistent Nausea, Vomiting or Anorexia||Upper GI Abnormalities at Diagnosis||participants|Number|68|68.0||||||
4087706|NCT01002742|3911105|B2|Persistent Nausea, Vomiting or Anorexia||Upper GI Abnormalities at Diagnosis||participants|Number|31|31.0||||||
4087707|NCT01002742|3911106|B1|Persistent Nausea, Vomiting or Anorexia||Upper GI Abnormalities at Diagnosis||participants|Number|37|37.0||||||
4087708|NCT01002742|3911104|B3|No Protracted Nausea and Vomiting||Upper GI Abnormalities at Diagnosis||participants|Number|167|167.0||||||
4087709|NCT01002742|3911105|B2|No Protracted Nausea and Vomiting||Upper GI Abnormalities at Diagnosis||participants|Number|85|85.0||||||
4087710|NCT01002742|3911106|B1|No Protracted Nausea and Vomiting||Upper GI Abnormalities at Diagnosis||participants|Number|82|82.0||||||
4087711|NCT01002742|3911104|B3|Erythroderma and Bullae Formation/Desquamation||Cutaneous involvement at onset||participants|Number|5|5.0||||||
4087712|NCT01002742|3911105|B2|Erythroderma and Bullae Formation/Desquamation||Cutaneous involvement at onset||participants|Number|1|1.0||||||
4087713|NCT01002742|3911106|B1|Erythroderma and Bullae Formation/Desquamation||Cutaneous involvement at onset||participants|Number|4|4.0||||||
4087714|NCT01002742|3911104|B3|Generalized Erythroderma||Cutaneous involvement at onset||participants|Number|90|90.0||||||
4087715|NCT01002742|3911105|B2|Generalized Erythroderma||Cutaneous involvement at onset||participants|Number|46|46.0||||||
4087716|NCT01002742|3911106|B1|Generalized Erythroderma||Cutaneous involvement at onset||participants|Number|44|44.0||||||
4087717|NCT01002742|3911104|B3|Maculopapular Rash, 25-50% of Body Surface||Cutaneous involvement at onset||participants|Number|48|48.0||||||
4087718|NCT01002742|3911105|B2|Maculopapular Rash, 25-50% of Body Surface||Cutaneous involvement at onset||participants|Number|27|27.0||||||
4087719|NCT01002742|3911106|B1|Maculopapular Rash, 25-50% of Body Surface||Cutaneous involvement at onset||participants|Number|21|21.0||||||
4087720|NCT01002742|3911104|B3|Maculopapular Rash, <25% of Body Surface||Cutaneous involvement at onset||participants|Number|25|25.0||||||
4087721|NCT01002742|3911105|B2|Maculopapular Rash, <25% of Body Surface||Cutaneous involvement at onset||participants|Number|11|11.0||||||
4087722|NCT01002742|3911106|B1|Maculopapular Rash, <25% of Body Surface||Cutaneous involvement at onset||participants|Number|14|14.0||||||
4087723|NCT01002742|3911104|B3|No Rash||Cutaneous involvement at onset||participants|Number|67|67.0||||||
4087724|NCT01002742|3911105|B2|No Rash||Cutaneous involvement at onset||participants|Number|31|31.0||||||
4087725|NCT01002742|3911106|B1|No Rash||Cutaneous involvement at onset||participants|Number|36|36.0||||||
4087726|NCT01002742|3911104|B3|Grade IV||Grade of acute Graft-Vs-Host-Disease (GVHD) at Diagnosis|Participants are graded on a scale of 1 to 4 according to their symptoms and organs involved, where 4 represents a worse grade.|participants|Number|14|14.0||||||
4087727|NCT01002742|3911105|B2|Grade IV||Grade of acute Graft-Vs-Host-Disease (GVHD) at Diagnosis|Participants are graded on a scale of 1 to 4 according to their symptoms and organs involved, where 4 represents a worse grade.|participants|Number|7|7.0||||||
4087728|NCT01002742|3911106|B1|Grade IV||Grade of acute Graft-Vs-Host-Disease (GVHD) at Diagnosis|Participants are graded on a scale of 1 to 4 according to their symptoms and organs involved, where 4 represents a worse grade.|participants|Number|7|7.0||||||
4087729|NCT01002742|3911104|B3|Grade III||Grade of acute Graft-Vs-Host-Disease (GVHD) at Diagnosis|Participants are graded on a scale of 1 to 4 according to their symptoms and organs involved, where 4 represents a worse grade.|participants|Number|64|64.0||||||
4087730|NCT01002742|3911105|B2|Grade III||Grade of acute Graft-Vs-Host-Disease (GVHD) at Diagnosis|Participants are graded on a scale of 1 to 4 according to their symptoms and organs involved, where 4 represents a worse grade.|participants|Number|30|30.0||||||
4087731|NCT01002742|3911106|B1|Grade III||Grade of acute Graft-Vs-Host-Disease (GVHD) at Diagnosis|Participants are graded on a scale of 1 to 4 according to their symptoms and organs involved, where 4 represents a worse grade.|participants|Number|34|34.0||||||
4087732|NCT01002742|3911104|B3|Grade II||Grade of acute Graft-Vs-Host-Disease (GVHD) at Diagnosis|Participants are graded on a scale of 1 to 4 according to their symptoms and organs involved, where 4 represents a worse grade.|participants|Number|130|130.0||||||
4087733|NCT01002742|3911105|B2|Grade II||Grade of acute Graft-Vs-Host-Disease (GVHD) at Diagnosis|Participants are graded on a scale of 1 to 4 according to their symptoms and organs involved, where 4 represents a worse grade.|participants|Number|68|68.0||||||
4087734|NCT01002742|3911106|B1|Grade II||Grade of acute Graft-Vs-Host-Disease (GVHD) at Diagnosis|Participants are graded on a scale of 1 to 4 according to their symptoms and organs involved, where 4 represents a worse grade.|participants|Number|62|62.0||||||
4087735|NCT01002742|3911104|B3|Grade I||Grade of acute Graft-Vs-Host-Disease (GVHD) at Diagnosis|Participants are graded on a scale of 1 to 4 according to their symptoms and organs involved, where 4 represents a worse grade.|participants|Number|27|27.0||||||
4087736|NCT01002742|3911105|B2|Grade I||Grade of acute Graft-Vs-Host-Disease (GVHD) at Diagnosis|Participants are graded on a scale of 1 to 4 according to their symptoms and organs involved, where 4 represents a worse grade.|participants|Number|11|11.0||||||
4087737|NCT01002742|3911106|B1|Grade I||Grade of acute Graft-Vs-Host-Disease (GVHD) at Diagnosis|Participants are graded on a scale of 1 to 4 according to their symptoms and organs involved, where 4 represents a worse grade.|participants|Number|16|16.0||||||
4087738|NCT01002742|3911104|B3|||Myeloablative Conditioning|Not all participants received Myeloablative Conditioning.|participants|Number|148|148.0||||||
4087739|NCT01002742|3911105|B2|||Myeloablative Conditioning|Not all participants received Myeloablative Conditioning.|participants|Number|74|74.0||||||
4087740|NCT01002742|3911106|B1|||Myeloablative Conditioning|Not all participants received Myeloablative Conditioning.|participants|Number|74|74.0||||||
4087741|NCT01002742|3911104|B3|Cord blood||Graft Source||participants|Number|3|3.0||||||
4087742|NCT01002742|3911105|B2|Cord blood||Graft Source||participants|Number|2|2.0||||||
4087743|NCT01002742|3911106|B1|Cord blood||Graft Source||participants|Number|1|1.0||||||
4087744|NCT01002742|3911104|B3|Peripheral blood stem cell||Graft Source||participants|Number|193|193.0||||||
4087745|NCT01002742|3911105|B2|Peripheral blood stem cell||Graft Source||participants|Number|91|91.0||||||
4087746|NCT01002742|3911106|B1|Peripheral blood stem cell||Graft Source||participants|Number|102|102.0||||||
4087747|NCT01002742|3911104|B3|Bone marrow||Graft Source||participants|Number|39|39.0||||||
4087748|NCT01002742|3911105|B2|Bone marrow||Graft Source||participants|Number|23|23.0||||||
4087749|NCT01002742|3911106|B1|Bone marrow||Graft Source||participants|Number|16|16.0||||||
4087750|NCT01002742|3911104|B3|||Unrelated Donor|Not all participants were matched with an unrelated donor.|participants|Number|138|138.0||||||
4087751|NCT01002742|3911105|B2|||Unrelated Donor|Not all participants were matched with an unrelated donor.|participants|Number|66|66.0||||||
4087752|NCT01002742|3911106|B1|||Unrelated Donor|Not all participants were matched with an unrelated donor.|participants|Number|72|72.0||||||
4087753|NCT01002742|3911104|B3|Other||Primary Disease||participants|Number|38|38.0||||||
4087754|NCT01002742|3911105|B2|Other||Primary Disease||participants|Number|19|19.0||||||
4087755|NCT01002742|3911106|B1|Other||Primary Disease||participants|Number|19|19.0||||||
4087756|NCT01002742|3911104|B3|Lymphoma||Primary Disease||participants|Number|34|34.0||||||
4087757|NCT01002742|3911105|B2|Lymphoma||Primary Disease||participants|Number|17|17.0||||||
4087758|NCT01002742|3911106|B1|Lymphoma||Primary Disease||participants|Number|17|17.0||||||
4087759|NCT01002742|3911104|B3|Myelodysplastic syndrome||Primary Disease||participants|Number|37|37.0||||||
4087760|NCT01002742|3911105|B2|Myelodysplastic syndrome||Primary Disease||participants|Number|20|20.0||||||
4087761|NCT01002742|3911106|B1|Myelodysplastic syndrome||Primary Disease||participants|Number|17|17.0||||||
4087762|NCT01002742|3911104|B3|Chronic myeloid leukemia||Primary Disease||participants|Number|8|8.0||||||
4087763|NCT01002742|3911105|B2|Chronic myeloid leukemia||Primary Disease||participants|Number|3|3.0||||||
4087764|NCT01002742|3911106|B1|Chronic myeloid leukemia||Primary Disease||participants|Number|5|5.0||||||
4087765|NCT01002742|3911104|B3|Acute lymphoblastic leukemia||Primary Disease||participants|Number|30|30.0||||||
4087766|NCT01002742|3911105|B2|Acute lymphoblastic leukemia||Primary Disease||participants|Number|16|16.0||||||
4087767|NCT01002742|3911106|B1|Acute lymphoblastic leukemia||Primary Disease||participants|Number|14|14.0||||||
4087768|NCT01002742|3911104|B3|Acute myeloid leukemia||Primary Disease||participants|Number|88|88.0||||||
4087769|NCT01002742|3911105|B2|Acute myeloid leukemia||Primary Disease||participants|Number|41|41.0||||||
4087770|NCT01002742|3911106|B1|Acute myeloid leukemia||Primary Disease||participants|Number|47|47.0||||||
4087771|NCT01002742|3911104|B3||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4087772|NCT01002742|3911105|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4087773|NCT01002742|3911106|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4087774|NCT01002742|3911104|B3||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4087775|NCT01002742|3911105|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4087776|NCT01002742|3911106|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4087777|NCT01002742|3911104|B3|Median Age||Age, Customized||years|Median|53.8|53.8|Full Range|||9.1|76.3|
4087778|NCT01002742|3911105|B2|Median Age||Age, Customized||years|Median|54|54.0|Full Range|||9.1|76.36|
4087779|NCT01002742|3911106|B1|Median Age||Age, Customized||years|Median|52.9|52.9|Full Range|||9.1|76.3|
4087780|NCT01002573|3911141|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4087781|NCT01002573|3911142|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4087782|NCT01002573|3911143|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087783|NCT01002573|3911141|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087784|NCT01002573|3911142|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087785|NCT01002573|3911143|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087786|NCT01002573|3911141|B3||White|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
4087787|NCT01002573|3911142|B2||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4087788|NCT01002573|3911143|B1||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4087789|NCT01002573|3911141|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4087790|NCT01002573|3911142|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4087791|NCT01002573|3911143|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4087792|NCT01002573|3911141|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087793|NCT01002573|3911142|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087794|NCT01002573|3911143|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087795|NCT01002573|3911141|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087796|NCT01002573|3911142|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087797|NCT01002573|3911143|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087798|NCT01002573|3911141|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4087799|NCT01002573|3911142|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4087800|NCT01002573|3911143|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087801|NCT01002573|3911141|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087802|NCT01002573|3911142|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087803|NCT01002573|3911143|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4087804|NCT01002573|3911141|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4087805|NCT01002573|3911142|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4087806|NCT01002573|3911143|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4087807|NCT01002573|3911141|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4087808|NCT01002573|3911142|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4087809|NCT01002573|3911143|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4087810|NCT01002573|3911141|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4087811|NCT01002573|3911142|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4087812|NCT01002573|3911143|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4087813|NCT01002573|3911141|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4087814|NCT01002573|3911142|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4087815|NCT01002573|3911143|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4087816|NCT01002573|3911141|B3|6 years to 16 years||Age, Customized||participants|Number|53|53.0||||||
4087817|NCT01002573|3911142|B2|6 years to 16 years||Age, Customized||participants|Number|25|25.0||||||
4087818|NCT01002573|3911143|B1|6 years to 16 years||Age, Customized||participants|Number|28|28.0||||||
4087819|NCT01002573|3911141|B3|2 years to 6 years||Age, Customized||participants|Number|27|27.0||||||
4087820|NCT01002573|3911142|B2|2 years to 6 years||Age, Customized||participants|Number|14|14.0||||||
4087821|NCT01002573|3911143|B1|2 years to 6 years||Age, Customized||participants|Number|13|13.0||||||
4087822|NCT01002573|3911141|B3|6 months to 2 years||Age, Customized||participants|Number|20|20.0||||||
4087823|NCT01002573|3911142|B2|6 months to 2 years||Age, Customized||participants|Number|14|14.0||||||
4087824|NCT01002573|3911143|B1|6 months to 2 years||Age, Customized||participants|Number|6|6.0||||||
4087825|NCT01002547|3911162|B4|||Fibrosis|Fibrosis stage, range 0-4, where: 0 = None; 1 = Perisinusoidal or periportal; 2 = Perisinusoidal and portal/periportal; 3 = Bridging fibrosis, 4 = Cirrhosis.|units on a scale|Mean|1.5|1.5|Standard Deviation|1.1|1.1|||
4087826|NCT01002547|3911163|B3|||Fibrosis|Fibrosis stage, range 0-4, where: 0 = None; 1 = Perisinusoidal or periportal; 2 = Perisinusoidal and portal/periportal; 3 = Bridging fibrosis, 4 = Cirrhosis.|units on a scale|Mean|1.4|1.4|Standard Deviation|1.1|1.1|||
4087827|NCT01002547|3911164|B2|||Fibrosis|Fibrosis stage, range 0-4, where: 0 = None; 1 = Perisinusoidal or periportal; 2 = Perisinusoidal and portal/periportal; 3 = Bridging fibrosis, 4 = Cirrhosis.|units on a scale|Mean|1.6|1.6|Standard Deviation|1.2|1.2|||
4087828|NCT01002547|3911165|B1|||Fibrosis|Fibrosis stage, range 0-4, where: 0 = None; 1 = Perisinusoidal or periportal; 2 = Perisinusoidal and portal/periportal; 3 = Bridging fibrosis, 4 = Cirrhosis.|units on a scale|Mean|1.5|1.5|Standard Deviation|1.0|1.0|||
4087829|NCT01002547|3911162|B4|||Hepatocyte ballooning|Hepatocyte Ballooning, range 0-2, where: 0 = None; 1 = Few balloon cells; 2 = Many cells/prominent ballooning.|units on a scale|Mean|0.8|0.8|Standard Deviation|0.7|0.7|||
4087830|NCT01002547|3911163|B3|||Hepatocyte ballooning|Hepatocyte Ballooning, range 0-2, where: 0 = None; 1 = Few balloon cells; 2 = Many cells/prominent ballooning.|units on a scale|Mean|0.7|0.7|Standard Deviation|0.6|0.6|||
4087869|NCT01002547|3911162|B4|||Plasma AST||U/L|Mean|37|37.0|Standard Deviation|21|21.0|||
4087831|NCT01002547|3911164|B2|||Hepatocyte ballooning|Hepatocyte Ballooning, range 0-2, where: 0 = None; 1 = Few balloon cells; 2 = Many cells/prominent ballooning.|units on a scale|Mean|0.9|0.9|Standard Deviation|0.8|0.8|||
4087832|NCT01002547|3911165|B1|||Hepatocyte ballooning|Hepatocyte Ballooning, range 0-2, where: 0 = None; 1 = Few balloon cells; 2 = Many cells/prominent ballooning.|units on a scale|Mean|0.9|0.9|Standard Deviation|0.8|0.8|||
4087833|NCT01002547|3911162|B4|||Inflammation|Lobular Inflammation, range 0-3, where: 0 = No foci 1 = <2 foci/200x; 2 = 2-4 foci/200x, 3 = >4 foci/200x.|units on a scale|Mean|1.4|1.4|Standard Deviation|0.6|0.6|||
4087834|NCT01002547|3911163|B3|||Inflammation|Lobular Inflammation, range 0-3, where: 0 = No foci 1 = <2 foci/200x; 2 = 2-4 foci/200x, 3 = >4 foci/200x.|units on a scale|Mean|1.4|1.4|Standard Deviation|0.5|0.5|||
4087835|NCT01002547|3911164|B2|||Inflammation|Lobular Inflammation, range 0-3, where: 0 = No foci 1 = <2 foci/200x; 2 = 2-4 foci/200x, 3 = >4 foci/200x.|units on a scale|Mean|1.3|1.3|Standard Deviation|0.5|0.5|||
4087836|NCT01002547|3911165|B1|||Inflammation|Lobular Inflammation, range 0-3, where: 0 = No foci 1 = <2 foci/200x; 2 = 2-4 foci/200x, 3 = >4 foci/200x.|units on a scale|Mean|1.6|1.6|Standard Deviation|0.6|0.6|||
4087837|NCT01002547|3911162|B4|||Steatosis|Steatosis range 0-3, where: 0 = <5% fat; 1 = 5-33% fat; 2 = >33-66% fat; 3 = >66% fat.|units on a scale|Mean|1.7|1.7|Standard Deviation|0.7|0.7|||
4087838|NCT01002547|3911163|B3|||Steatosis|Steatosis range 0-3, where: 0 = <5% fat; 1 = 5-33% fat; 2 = >33-66% fat; 3 = >66% fat.|units on a scale|Mean|1.6|1.6|Standard Deviation|0.8|0.8|||
4087839|NCT01002547|3911164|B2|||Steatosis|Steatosis range 0-3, where: 0 = <5% fat; 1 = 5-33% fat; 2 = >33-66% fat; 3 = >66% fat.|units on a scale|Mean|1.7|1.7|Standard Deviation|0.8|0.8|||
4087840|NCT01002547|3911165|B1|||Steatosis|Steatosis range 0-3, where: 0 = <5% fat; 1 = 5-33% fat; 2 = >33-66% fat; 3 = >66% fat.|units on a scale|Mean|1.8|1.8|Standard Deviation|0.7|0.7|||
4087841|NCT01002547|3911162|B4|||NAFLD activity score|"Calculated as the sum of steatosis grade (0 to 3), inflammation grade (0 to 3), and ballooning grade (0 to 2). Therefore, this score ranges from 0 to 8.~Steatosis: 0 = <5% fat; 1 = 5-33% fat; 2 = >33-66% fat; 3 = >66% fat.~Lobular Inflammation: 0 = No foci 1 = <2 foci/200x; 2 = 2-4 foci/200x, 3 = >4 foci/200x.~Hepatocyte Ballooning: 0 = None; 1 = Few balloon cells; 2 = Many cells/prominent ballooning.~Fibrosis stage: 0 = None; 1 = Perisinusoidal or periportal; 2 = Perisinusoidal and portal/periportal; 3 = Bridging fibrosis, 4 = Cirrhosis."|units on a scale|Mean|4.0|4.0|Standard Deviation|1.5|1.5|||
4087842|NCT01002547|3911163|B3|||NAFLD activity score|"Calculated as the sum of steatosis grade (0 to 3), inflammation grade (0 to 3), and ballooning grade (0 to 2). Therefore, this score ranges from 0 to 8.~Steatosis: 0 = <5% fat; 1 = 5-33% fat; 2 = >33-66% fat; 3 = >66% fat.~Lobular Inflammation: 0 = No foci 1 = <2 foci/200x; 2 = 2-4 foci/200x, 3 = >4 foci/200x.~Hepatocyte Ballooning: 0 = None; 1 = Few balloon cells; 2 = Many cells/prominent ballooning.~Fibrosis stage: 0 = None; 1 = Perisinusoidal or periportal; 2 = Perisinusoidal and portal/periportal; 3 = Bridging fibrosis, 4 = Cirrhosis."|units on a scale|Mean|3.7|3.7|Standard Deviation|1.3|1.3|||
4087843|NCT01002547|3911164|B2|||NAFLD activity score|"Calculated as the sum of steatosis grade (0 to 3), inflammation grade (0 to 3), and ballooning grade (0 to 2). Therefore, this score ranges from 0 to 8.~Steatosis: 0 = <5% fat; 1 = 5-33% fat; 2 = >33-66% fat; 3 = >66% fat.~Lobular Inflammation: 0 = No foci 1 = <2 foci/200x; 2 = 2-4 foci/200x, 3 = >4 foci/200x.~Hepatocyte Ballooning: 0 = None; 1 = Few balloon cells; 2 = Many cells/prominent ballooning.~Fibrosis stage: 0 = None; 1 = Perisinusoidal or periportal; 2 = Perisinusoidal and portal/periportal; 3 = Bridging fibrosis, 4 = Cirrhosis."|units on a scale|Mean|3.9|3.9|Standard Deviation|1.6|1.6|||
4087844|NCT01002547|3911165|B1|||NAFLD activity score|"Calculated as the sum of steatosis grade (0 to 3), inflammation grade (0 to 3), and ballooning grade (0 to 2). Therefore, this score ranges from 0 to 8.~Steatosis: 0 = <5% fat; 1 = 5-33% fat; 2 = >33-66% fat; 3 = >66% fat.~Lobular Inflammation: 0 = No foci 1 = <2 foci/200x; 2 = 2-4 foci/200x, 3 = >4 foci/200x.~Hepatocyte Ballooning: 0 = None; 1 = Few balloon cells; 2 = Many cells/prominent ballooning.~Fibrosis stage: 0 = None; 1 = Perisinusoidal or periportal; 2 = Perisinusoidal and portal/periportal; 3 = Bridging fibrosis, 4 = Cirrhosis."|units on a scale|Mean|4.2|4.2|Standard Deviation|1.6|1.6|||
4087845|NCT01002547|3911162|B4|||Statin use||Participants|Count of Participants|80|80.0||||||
4087846|NCT01002547|3911163|B3|||Statin use||Participants|Count of Participants|29|29.0||||||
4087847|NCT01002547|3911164|B2|||Statin use||Participants|Count of Participants|26|26.0||||||
4087848|NCT01002547|3911165|B1|||Statin use||Participants|Count of Participants|25|25.0||||||
4087849|NCT01002547|3911162|B4|||Triglycerides||mg/dl|Median|158|158.0|Inter-Quartile Range|||116.0|243.0|
4087850|NCT01002547|3911163|B3|||Triglycerides||mg/dl|Median|163|163.0|Inter-Quartile Range|||108.0|274.0|
4087851|NCT01002547|3911164|B2|||Triglycerides||mg/dl|Median|156|156.0|Inter-Quartile Range|||126.0|210.0|
4087852|NCT01002547|3911165|B1|||Triglycerides||mg/dl|Median|154|154.0|Inter-Quartile Range|||117.0|255.0|
4087853|NCT01002547|3911162|B4|||HDL-cholesterol||mg/dl|Mean|38|38.0|Standard Deviation|9|9.0|||
4087854|NCT01002547|3911163|B3|||HDL-cholesterol||mg/dl|Mean|38|38.0|Standard Deviation|10|10.0|||
4087855|NCT01002547|3911164|B2|||HDL-cholesterol||mg/dl|Mean|39|39.0|Standard Deviation|9|9.0|||
4087856|NCT01002547|3911165|B1|||HDL-cholesterol||mg/dl|Mean|39|39.0|Standard Deviation|10|10.0|||
4087857|NCT01002547|3911162|B4|||LDL-cholesterol||mg/dl|Mean|94|94.0|Standard Deviation|39|39.0|||
4087858|NCT01002547|3911163|B3|||LDL-cholesterol||mg/dl|Mean|91|91.0|Standard Deviation|44|44.0|||
4087859|NCT01002547|3911164|B2|||LDL-cholesterol||mg/dl|Mean|98|98.0|Standard Deviation|39|39.0|||
4087860|NCT01002547|3911165|B1|||LDL-cholesterol||mg/dl|Mean|94|94.0|Standard Deviation|33|33.0|||
4087861|NCT01002547|3911162|B4|||Total cholesterol||mg/dl|Mean|172|172.0|Standard Deviation|46|46.0|||
4087862|NCT01002547|3911163|B3|||Total cholesterol||mg/dl|Mean|170|170.0|Standard Deviation|53|53.0|||
4087863|NCT01002547|3911164|B2|||Total cholesterol||mg/dl|Mean|174|174.0|Standard Deviation|44|44.0|||
4087864|NCT01002547|3911165|B1|||Total cholesterol||mg/dl|Mean|171|171.0|Standard Deviation|40|40.0|||
4087865|NCT01002547|3911162|B4|||Plasma ALT||U/L|Mean|49|49.0|Standard Deviation|31|31.0|||
4087866|NCT01002547|3911163|B3|||Plasma ALT||U/L|Mean|40|40.0|Standard Deviation|25|25.0|||
4087867|NCT01002547|3911164|B2|||Plasma ALT||U/L|Mean|53|53.0|Standard Deviation|32|32.0|||
4087870|NCT01002547|3911163|B3|||Plasma AST||U/L|Mean|32|32.0|Standard Deviation|18|18.0|||
4087871|NCT01002547|3911164|B2|||Plasma AST||U/L|Mean|41|41.0|Standard Deviation|22|22.0|||
4087872|NCT01002547|3911165|B1|||Plasma AST||U/L|Mean|40|40.0|Standard Deviation|23|23.0|||
4087873|NCT01002547|3911162|B4|||Intrahepatic triglyceride content||percentage|Mean|12.2|12.2|Standard Deviation|7.0|7.0|||
4087874|NCT01002547|3911163|B3|||Intrahepatic triglyceride content||percentage|Mean|13.8|13.8|Standard Deviation|8.4|8.4|||
4087875|NCT01002547|3911164|B2|||Intrahepatic triglyceride content||percentage|Mean|11.7|11.7|Standard Deviation|5.7|5.7|||
4087876|NCT01002547|3911165|B1|||Intrahepatic triglyceride content||percentage|Mean|10.5|10.5|Standard Deviation|5.8|5.8|||
4087877|NCT01002547|3911162|B4|||Fasting free fatty acids||umol/ml|Mean|0.40|0.4|Standard Deviation|0.14|0.14|||
4087878|NCT01002547|3911163|B3|||Fasting free fatty acids||umol/ml|Mean|0.41|0.41|Standard Deviation|0.15|0.15|||
4087879|NCT01002547|3911164|B2|||Fasting free fatty acids||umol/ml|Mean|0.39|0.39|Standard Deviation|0.14|0.14|||
4087880|NCT01002547|3911165|B1|||Fasting free fatty acids||umol/ml|Mean|0.41|0.41|Standard Deviation|0.15|0.15|||
4087881|NCT01002547|3911162|B4|||Fasting plasma insulin||uU/mL|Mean|18|18.0|Standard Deviation|13|13.0|||
4087882|NCT01002547|3911163|B3|||Fasting plasma insulin||uU/mL|Mean|16|16.0|Standard Deviation|10|10.0|||
4087883|NCT01002547|3911164|B2|||Fasting plasma insulin||uU/mL|Mean|22|22.0|Standard Deviation|14|14.0|||
4087884|NCT01002547|3911165|B1|||Fasting plasma insulin||uU/mL|Mean|18|18.0|Standard Deviation|13|13.0|||
4087885|NCT01002547|3911162|B4|Insulin||Use of glucose-lowering medications||Participants|Count of Participants|28|28.0||||||
4087886|NCT01002547|3911163|B3|Insulin||Use of glucose-lowering medications||Participants|Count of Participants|10|10.0||||||
4087887|NCT01002547|3911164|B2|Insulin||Use of glucose-lowering medications||Participants|Count of Participants|10|10.0||||||
4087888|NCT01002547|3911165|B1|Insulin||Use of glucose-lowering medications||Participants|Count of Participants|8|8.0||||||
4087889|NCT01002547|3911162|B4|Sulfonylurea||Use of glucose-lowering medications||Participants|Count of Participants|42|42.0||||||
4087890|NCT01002547|3911163|B3|Sulfonylurea||Use of glucose-lowering medications||Participants|Count of Participants|14|14.0||||||
4087891|NCT01002547|3911164|B2|Sulfonylurea||Use of glucose-lowering medications||Participants|Count of Participants|15|15.0||||||
4087892|NCT01002547|3911165|B1|Sulfonylurea||Use of glucose-lowering medications||Participants|Count of Participants|13|13.0||||||
4087893|NCT01002547|3911162|B4|Metformin||Use of glucose-lowering medications||Participants|Count of Participants|85|85.0||||||
4087894|NCT01002547|3911163|B3|Metformin||Use of glucose-lowering medications||Participants|Count of Participants|29|29.0||||||
4087895|NCT01002547|3911164|B2|Metformin||Use of glucose-lowering medications||Participants|Count of Participants|29|29.0||||||
4087896|NCT01002547|3911165|B1|Metformin||Use of glucose-lowering medications||Participants|Count of Participants|27|27.0||||||
4087897|NCT01002547|3911162|B4|||Hemoglobin A1c||percentage|Mean|7.3|7.3|Standard Deviation|1.2|1.2|||
4087898|NCT01002547|3911163|B3|||Hemoglobin A1c||percentage|Mean|7.3|7.3|Standard Deviation|1.1|1.1|||
4087899|NCT01002547|3911164|B2|||Hemoglobin A1c||percentage|Mean|7.5|7.5|Standard Deviation|1.3|1.3|||
4087900|NCT01002547|3911165|B1|||Hemoglobin A1c||percentage|Mean|7.2|7.2|Standard Deviation|1.2|1.2|||
4087901|NCT01002547|3911162|B4|||Fasting plasma glucose||mg/dl|Mean|152|152.0|Standard Deviation|44|44.0|||
4087902|NCT01002547|3911163|B3|||Fasting plasma glucose||mg/dl|Mean|144|144.0|Standard Deviation|43|43.0|||
4087903|NCT01002547|3911164|B2|||Fasting plasma glucose||mg/dl|Mean|158|158.0|Standard Deviation|41|41.0|||
4087904|NCT01002547|3911165|B1|||Fasting plasma glucose||mg/dl|Mean|153|153.0|Standard Deviation|37|37.0|||
4087905|NCT01002547|3911162|B4|||Total body fat||percentage|Mean|37|37.0|Standard Deviation|6|6.0|||
4087906|NCT01002547|3911163|B3|||Total body fat||percentage|Mean|38|38.0|Standard Deviation|6|6.0|||
4087907|NCT01002547|3911164|B2|||Total body fat||percentage|Mean|37|37.0|Standard Deviation|6|6.0|||
4087908|NCT01002547|3911165|B1|||Total body fat||percentage|Mean|36|36.0|Standard Deviation|5|5.0|||
4087909|NCT01002547|3911162|B4|||Body mass index||kg/m2|Mean|34.5|34.5|Standard Deviation|4.2|4.2|||
4087910|NCT01002547|3911163|B3|||Body mass index||kg/m2|Mean|35.2|35.2|Standard Deviation|4.3|4.3|||
4087911|NCT01002547|3911164|B2|||Body mass index||kg/m2|Mean|33.8|33.8|Standard Deviation|4.6|4.6|||
4087912|NCT01002547|3911165|B1|||Body mass index||kg/m2|Mean|33.6|33.6|Standard Deviation|4.0|4.0|||
4087913|NCT01002547|3911162|B4|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
4087914|NCT01002547|3911163|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4087915|NCT01002547|3911164|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4087916|NCT01002547|3911165|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4087917|NCT01002547|3911162|B4|African American||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4087918|NCT01002547|3911163|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4087919|NCT01002547|3911164|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4087920|NCT01002547|3911165|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4087921|NCT01002547|3911162|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|76|76.0||||||
4087922|NCT01002547|3911163|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
4087923|NCT01002547|3911164|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
4087924|NCT01002547|3911165|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
4087925|NCT01002547|3911162|B4||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4087926|NCT01002547|3911163|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4087927|NCT01002547|3911164|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4087928|NCT01002547|3911165|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4087929|NCT01002547|3911162|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4087930|NCT01002547|3911163|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4087931|NCT01002547|3911164|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4087932|NCT01002547|3911165|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4087933|NCT01002547|3911162|B4|||Age||years|Mean|59|59.0|Standard Deviation|9|9.0|||
4087934|NCT01002547|3911163|B3|||Age||years|Mean|60|60.0|Standard Deviation|6|6.0|||
4087935|NCT01002547|3911164|B2|||Age||years|Mean|60|60.0|Standard Deviation|9|9.0|||
4087936|NCT01002547|3911165|B1|||Age||years|Mean|57|57.0|Standard Deviation|11|11.0|||
4087937|NCT01002482|3911223|B3|France||Region of Enrollment||participants|Number|2648|2648.0||||||
4087938|NCT01002482|3911224|B2|France||Region of Enrollment||participants|Number|1312|1312.0||||||
4087939|NCT01002482|3911225|B1|France||Region of Enrollment||participants|Number|1336|1336.0||||||
4087940|NCT01002482|3911223|B3||Male|Sex: Female, Male||Participants|Count of Participants|1706|1706.0||||||
4087941|NCT01002482|3911224|B2||Male|Sex: Female, Male||Participants|Count of Participants|844|844.0||||||
4087942|NCT01002482|3911225|B1||Male|Sex: Female, Male||Participants|Count of Participants|862|862.0||||||
4087943|NCT01002482|3911223|B3||Female|Sex: Female, Male||Participants|Count of Participants|942|942.0||||||
4087944|NCT01002482|3911224|B2||Female|Sex: Female, Male||Participants|Count of Participants|468|468.0||||||
4087945|NCT01002482|3911225|B1||Female|Sex: Female, Male||Participants|Count of Participants|474|474.0||||||
4087946|NCT01002482|3911223|B3|||Age||years|Mean|61.5|61.5|Standard Deviation|16.2|16.2|||
4087947|NCT01002482|3911224|B2|||Age||years|Mean|61.6|61.6|Standard Deviation|16.2|16.2|||
4087948|NCT01002482|3911225|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|16.2|16.2|||
4087949|NCT01002482|3911223|B3||>=65 years|Age||Participants|Count of Participants|1206|1206.0||||||
4087950|NCT01002482|3911224|B2||>=65 years|Age||Participants|Count of Participants|590|590.0||||||
4087951|NCT01002482|3911225|B1||>=65 years|Age||Participants|Count of Participants|616|616.0||||||
4087952|NCT01002482|3911223|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1442|1442.0||||||
4087953|NCT01002482|3911224|B2||Between 18 and 65 years|Age||Participants|Count of Participants|722|722.0||||||
4087954|NCT01002482|3911225|B1||Between 18 and 65 years|Age||Participants|Count of Participants|720|720.0||||||
4087955|NCT01002482|3911223|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4087956|NCT01002482|3911224|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4087957|NCT01002482|3911225|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4087958|NCT01002456|3911246|B3|United States||Region of Enrollment||patients|Number|220|220.0||||||
4087959|NCT01002456|3911247|B2|United States||Region of Enrollment||patients|Number|122|122.0||||||
4087960|NCT01002456|3911248|B1|United States||Region of Enrollment||patients|Number|98|98.0||||||
4087961|NCT01002456|3911246|B3||Male|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
4087962|NCT01002456|3911247|B2||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4087963|NCT01002456|3911248|B1||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4087964|NCT01002456|3911246|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4087965|NCT01002456|3911247|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4087966|NCT01002456|3911248|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4087967|NCT01002456|3911246|B3|||Age||years|Mean|71|71.0|Standard Deviation|11.3|11.3|||
4087968|NCT01002456|3911247|B2|||Age||years|Mean|71|71.0|Standard Deviation|11.0|11.0|||
4087969|NCT01002456|3911248|B1|||Age||years|Mean|70|70.0|Standard Deviation|11.5|11.5|||
4087970|NCT01002339|3911257|B4|Not available||Anti-HLA lymphocytotoxic antibodies against <25% a reference panel||participants|Number|3|3.0||||||
4087971|NCT01002339|3911258|B3|Not available||Anti-HLA lymphocytotoxic antibodies against <25% a reference panel||participants|Number|1|1.0||||||
4087972|NCT01002339|3911259|B2|Not available||Anti-HLA lymphocytotoxic antibodies against <25% a reference panel||participants|Number|2|2.0||||||
4087973|NCT01002339|3911260|B1|Not available||Anti-HLA lymphocytotoxic antibodies against <25% a reference panel||participants|Number|0|0.0||||||
4087974|NCT01002339|3911257|B4|No Antibodies||Anti-HLA lymphocytotoxic antibodies against <25% a reference panel||participants|Number|121|121.0||||||
4087975|NCT01002339|3911258|B3|No Antibodies||Anti-HLA lymphocytotoxic antibodies against <25% a reference panel||participants|Number|40|40.0||||||
4087976|NCT01002339|3911259|B2|No Antibodies||Anti-HLA lymphocytotoxic antibodies against <25% a reference panel||participants|Number|40|40.0||||||
4087977|NCT01002339|3911260|B1|No Antibodies||Anti-HLA lymphocytotoxic antibodies against <25% a reference panel||participants|Number|41|41.0||||||
4087978|NCT01002339|3911257|B4|Yes||Anti-HLA lymphocytotoxic antibodies against <25% a reference panel||participants|Number|4|4.0||||||
4087979|NCT01002339|3911258|B3|Yes||Anti-HLA lymphocytotoxic antibodies against <25% a reference panel||participants|Number|1|1.0||||||
4087980|NCT01002339|3911259|B2|Yes||Anti-HLA lymphocytotoxic antibodies against <25% a reference panel||participants|Number|0|0.0||||||
4087981|NCT01002339|3911260|B1|Yes||Anti-HLA lymphocytotoxic antibodies against <25% a reference panel||participants|Number|3|3.0||||||
4087982|NCT01002339|3911257|B4|||Human leucocyte antigens (HLA) class I (A, B) and class II (DR) incompatibilities||number of incompatibilities|Mean|3.93|3.93|Standard Deviation|1.10|1.1|||
4087983|NCT01002339|3911258|B3|||Human leucocyte antigens (HLA) class I (A, B) and class II (DR) incompatibilities||number of incompatibilities|Mean|4.24|4.24|Standard Deviation|1.10|1.1|||
4087984|NCT01002339|3911259|B2|||Human leucocyte antigens (HLA) class I (A, B) and class II (DR) incompatibilities||number of incompatibilities|Mean|4.00|4.0|Standard Deviation|0.87|0.87|||
4087985|NCT01002339|3911260|B1|||Human leucocyte antigens (HLA) class I (A, B) and class II (DR) incompatibilities||number of incompatibilities|Mean|3.55|3.55|Standard Deviation|1.17|1.17|||
4087986|NCT01002339|3911257|B4|||Donor creatinine levels||mg/dl|Mean|0.83|0.83|Standard Deviation|0.32|0.32|||
4087987|NCT01002339|3911258|B3|||Donor creatinine levels||mg/dl|Mean|0.87|0.87|Standard Deviation|0.29|0.29|||
4087988|NCT01002339|3911259|B2|||Donor creatinine levels||mg/dl|Mean|0.83|0.83|Standard Deviation|0.40|0.4|||
4087989|NCT01002339|3911260|B1|||Donor creatinine levels||mg/dl|Mean|0.80|0.8|Standard Deviation|0.28|0.28|||
4087990|NCT01002339|3911257|B4|||Age of the donor||years|Mean|62.20|62.2|Standard Deviation|9.75|9.75|||
4087991|NCT01002339|3911258|B3|||Age of the donor||years|Mean|61.62|61.62|Standard Deviation|10.02|10.02|||
4087992|NCT01002339|3911259|B2|||Age of the donor||years|Mean|62.88|62.88|Standard Deviation|8.92|8.92|||
4087993|NCT01002339|3911260|B1|||Age of the donor||years|Mean|62.11|62.11|Standard Deviation|10.43|10.43|||
4087994|NCT01002339|3911257|B4|||Cold ischemia time||hours|Mean|17.41|17.41|Standard Deviation|5.75|5.75|||
4087995|NCT01002339|3911258|B3|||Cold ischemia time||hours|Mean|17.26|17.26|Standard Deviation|6.36|6.36|||
4087996|NCT01002339|3911259|B2|||Cold ischemia time||hours|Mean|18.15|18.15|Standard Deviation|5.40|5.4|||
4087997|NCT01002339|3911260|B1|||Cold ischemia time||hours|Mean|16.83|16.83|Standard Deviation|5.52|5.52|||
4087998|NCT01002339|3911257|B4|||Transfusions||average number of transfusions/patient|Mean|0.78|0.78|Standard Deviation|1.99|1.99|||
4087999|NCT01002339|3911258|B3|||Transfusions||average number of transfusions/patient|Mean|0.83|0.83|Standard Deviation|2.12|2.12|||
4088000|NCT01002339|3911259|B2|||Transfusions||average number of transfusions/patient|Mean|0.85|0.85|Standard Deviation|2.50|2.5|||
4088001|NCT01002339|3911260|B1|||Transfusions||average number of transfusions/patient|Mean|0.66|0.66|Standard Deviation|1.27|1.27|||
4088002|NCT01002339|3911257|B4|||Fasting blood glucose level||mg/dl|Mean|93.85|93.85|Standard Deviation|13.96|13.96|||
4088003|NCT01002339|3911258|B3|||Fasting blood glucose level||mg/dl|Mean|91.90|91.9|Standard Deviation|13.93|13.93|||
4088004|NCT01002339|3911259|B2|||Fasting blood glucose level||mg/dl|Mean|97.74|97.74|Standard Deviation|14.29|14.29|||
4088005|NCT01002339|3911260|B1|||Fasting blood glucose level||mg/dl|Mean|91.91|91.91|Standard Deviation|13.16|13.16|||
4088006|NCT01002339|3911257|B4|||LDL-c||mg/dl|Mean|97.65|97.65|Standard Deviation|36.79|36.79|||
4088007|NCT01002339|3911258|B3|||LDL-c||mg/dl|Mean|103.81|103.81|Standard Deviation|36.03|36.03|||
4088008|NCT01002339|3911259|B2|||LDL-c||mg/dl|Mean|90.00|90.0|Standard Deviation|37.53|37.53|||
4088009|NCT01002339|3911260|B1|||LDL-c||mg/dl|Mean|98.45|98.45|Standard Deviation|36.61|36.61|||
4088010|NCT01002339|3911257|B4|||HDL-c||mg/dl|Mean|41.85|41.85|Standard Deviation|13.92|13.92|||
4088011|NCT01002339|3911258|B3|||HDL-c||mg/dl|Mean|42.21|42.21|Standard Deviation|15.27|15.27|||
4088012|NCT01002339|3911259|B2|||HDL-c||mg/dl|Mean|42.50|42.5|Standard Deviation|12.07|12.07|||
4088013|NCT01002339|3911260|B1|||HDL-c||mg/dl|Mean|40.95|40.95|Standard Deviation|14.37|14.37|||
4088014|NCT01002339|3911257|B4|||Total cholesterol||mg/dl|Mean|169.40|169.4|Standard Deviation|43.78|43.78|||
4088015|NCT01002339|3911258|B3|||Total cholesterol||mg/dl|Mean|179.37|179.37|Standard Deviation|42.47|42.47|||
4088016|NCT01002339|3911259|B2|||Total cholesterol||mg/dl|Mean|162.82|162.82|Standard Deviation|39.29|39.29|||
4088017|NCT01002339|3911260|B1|||Total cholesterol||mg/dl|Mean|165.86|165.86|Standard Deviation|47.99|47.99|||
4088018|NCT01002339|3911257|B4|||Triglycerides levels||mg/dl|Mean|197.60|197.6|Standard Deviation|105.83|105.83|||
4088019|NCT01002339|3911258|B3|||Triglycerides levels||mg/dl|Mean|209.69|209.69|Standard Deviation|109.01|109.01|||
4088020|NCT01002339|3911259|B2|||Triglycerides levels||mg/dl|Mean|199.31|199.31|Standard Deviation|91.99|91.99|||
4088021|NCT01002339|3911260|B1|||Triglycerides levels||mg/dl|Mean|184.26|184.26|Standard Deviation|114.93|114.93|||
4088022|NCT01002339|3911257|B4|||Glycated hemoglobin||percentage|Mean|5.31|5.31|Standard Deviation|0.43|0.43|||
4088023|NCT01002339|3911258|B3|||Glycated hemoglobin||percentage|Mean|5.31|5.31|Standard Deviation|0.43|0.43|||
4088024|NCT01002339|3911259|B2|||Glycated hemoglobin||percentage|Mean|5.37|5.37|Standard Deviation|0.32|0.32|||
4088025|NCT01002339|3911260|B1|||Glycated hemoglobin||percentage|Mean|5.27|5.27|Standard Deviation|0.51|0.51|||
4088026|NCT01002339|3911257|B4|||Time in dialysis||months|Mean|33.22|33.22|Standard Deviation|26.82|26.82|||
4088027|NCT01002339|3911258|B3|||Time in dialysis||months|Mean|32.95|32.95|Standard Deviation|26.16|26.16|||
4088028|NCT01002339|3911259|B2|||Time in dialysis||months|Mean|28.61|28.61|Standard Deviation|23.61|23.61|||
4088029|NCT01002339|3911260|B1|||Time in dialysis||months|Mean|37.86|37.86|Standard Deviation|29.97|29.97|||
4088030|NCT01002339|3911257|B4|||Body Mass Index (BMI)||kg/m^2|Mean|27.57|27.57|Standard Deviation|3.84|3.84|||
4088031|NCT01002339|3911258|B3|||Body Mass Index (BMI)||kg/m^2|Mean|27.94|27.94|Standard Deviation|4.08|4.08|||
4088032|NCT01002339|3911259|B2|||Body Mass Index (BMI)||kg/m^2|Mean|27.87|27.87|Standard Deviation|3.72|3.72|||
4088033|NCT01002339|3911260|B1|||Body Mass Index (BMI)||kg/m^2|Mean|26.95|26.95|Standard Deviation|3.71|3.71|||
4088034|NCT01002339|3911257|B4|Not available||Familiar history of diabetes (N)||participants|Number|18|18.0||||||
4088035|NCT01002339|3911258|B3|Not available||Familiar history of diabetes (N)||participants|Number|3|3.0||||||
4088036|NCT01002339|3911259|B2|Not available||Familiar history of diabetes (N)||participants|Number|9|9.0||||||
4088037|NCT01002339|3911260|B1|Not available||Familiar history of diabetes (N)||participants|Number|6|6.0||||||
4088038|NCT01002339|3911257|B4|No||Familiar history of diabetes (N)||participants|Number|94|94.0||||||
4088039|NCT01002339|3911258|B3|No||Familiar history of diabetes (N)||participants|Number|30|30.0||||||
4088040|NCT01002339|3911259|B2|No||Familiar history of diabetes (N)||participants|Number|29|29.0||||||
4088041|NCT01002339|3911260|B1|No||Familiar history of diabetes (N)||participants|Number|35|35.0||||||
4088042|NCT01002339|3911257|B4|Yes||Familiar history of diabetes (N)||participants|Number|16|16.0||||||
4088043|NCT01002339|3911258|B3|Yes||Familiar history of diabetes (N)||participants|Number|9|9.0||||||
4088044|NCT01002339|3911259|B2|Yes||Familiar history of diabetes (N)||participants|Number|4|4.0||||||
4088045|NCT01002339|3911260|B1|Yes||Familiar history of diabetes (N)||participants|Number|3|3.0||||||
4088046|NCT01002339|3911257|B4|Spain||Region of Enrollment||participants|Number|128|128.0||||||
4088047|NCT01002339|3911258|B3|Spain||Region of Enrollment||participants|Number|42|42.0||||||
4088048|NCT01002339|3911259|B2|Spain||Region of Enrollment||participants|Number|42|42.0||||||
4088049|NCT01002339|3911260|B1|Spain||Region of Enrollment||participants|Number|44|44.0||||||
4088050|NCT01002339|3911257|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088051|NCT01002339|3911258|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088052|NCT01002339|3911259|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088053|NCT01002339|3911260|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088054|NCT01002339|3911257|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088055|NCT01002339|3911258|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088056|NCT01002339|3911259|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088057|NCT01002339|3911260|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088058|NCT01002339|3911257|B4||White|Race (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
4088059|NCT01002339|3911258|B3||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4088060|NCT01002339|3911259|B2||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4088061|NCT01002339|3911260|B1||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4088062|NCT01002339|3911257|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088063|NCT01002339|3911258|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088064|NCT01002339|3911259|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088065|NCT01002339|3911260|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088066|NCT01002339|3911257|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088067|NCT01002339|3911258|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088068|NCT01002339|3911259|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088069|NCT01002339|3911260|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088070|NCT01002339|3911257|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088071|NCT01002339|3911258|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088072|NCT01002339|3911259|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088073|NCT01002339|3911260|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088074|NCT01002339|3911257|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088075|NCT01002339|3911258|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088076|NCT01002339|3911259|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088077|NCT01002339|3911260|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088078|NCT01002339|3911257|B4||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4088079|NCT01002339|3911258|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4088080|NCT01002339|3911259|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4088081|NCT01002339|3911260|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4088082|NCT01002339|3911257|B4||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4088083|NCT01002339|3911258|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4088084|NCT01002339|3911259|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4088085|NCT01002339|3911260|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4088086|NCT01002339|3911257|B4|||Age||years|Mean|61.0|61.0|Standard Deviation|7.7|7.7|||
4088087|NCT01002339|3911258|B3|||Age||years|Mean|60.2|60.2|Standard Deviation|8.3|8.3|||
4088088|NCT01002339|3911259|B2|||Age||years|Mean|61.6|61.6|Standard Deviation|7.3|7.3|||
4088089|NCT01002339|3911260|B1|||Age||years|Mean|61.2|61.2|Standard Deviation|7.6|7.6|||
4088090|NCT01002287|3911315|B3|Poland||Region of Enrollment||participants|Number|6|6.0||||||
4088091|NCT01002287|3911316|B2|Poland||Region of Enrollment||participants|Number|1|1.0||||||
4088092|NCT01002287|3911317|B1|Poland||Region of Enrollment||participants|Number|5|5.0||||||
4088093|NCT01002287|3911315|B3|Czech Republic||Region of Enrollment||participants|Number|5|5.0||||||
4088094|NCT01002287|3911316|B2|Czech Republic||Region of Enrollment||participants|Number|2|2.0||||||
4088095|NCT01002287|3911317|B1|Czech Republic||Region of Enrollment||participants|Number|3|3.0||||||
4088096|NCT01002287|3911315|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4088097|NCT01002287|3911316|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4088098|NCT01002287|3911317|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4088099|NCT01002287|3911315|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4088100|NCT01002287|3911316|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4088101|NCT01002287|3911317|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4088102|NCT01002287|3911315|B3|||Age||years|Mean|45.5|45.5|Standard Deviation|14.7|14.7|||
4088103|NCT01002287|3911316|B2|||Age||years|Mean|37.7|37.7|Standard Deviation|19.8|19.8|||
4088104|NCT01002287|3911317|B1|||Age||years|Mean|48.5|48.5|Standard Deviation|12.6|12.6|||
4088105|NCT01002287|3911315|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4088106|NCT01002287|3911316|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4088107|NCT01002287|3911317|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4088108|NCT01002287|3911315|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4088109|NCT01002287|3911316|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4088110|NCT01002287|3911317|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4088111|NCT01002287|3911315|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4088112|NCT01002287|3911316|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4088113|NCT01002287|3911317|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4088114|NCT01002118|3911330|B1|||Holter monitor||Participants|Count of Participants|1|1.0||||||
4088115|NCT01002118|3911330|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4088116|NCT01002118|3911330|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4088117|NCT01002118|3911330|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4088118|NCT01002118|3911330|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4088119|NCT01002118|3911330|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4088120|NCT01002105|3911336|B3|||Alcohol intake in last six months||grams 40% alcohol/drinking day|Mean|797.3|797.3|Standard Deviation|150.25|150.25|||
4088121|NCT01002105|3911337|B2|||Alcohol intake in last six months||grams 40% alcohol/drinking day|Mean|831|831.0|Standard Deviation|151.0|151.0|||
4088122|NCT01002105|3911338|B1|||Alcohol intake in last six months||grams 40% alcohol/drinking day|Mean|763.6|763.6|Standard Deviation|149.5|149.5|||
4088123|NCT01002105|3911336|B3|Israel||Region of Enrollment||participants|Number|64|64.0||||||
4088124|NCT01002105|3911337|B2|Israel||Region of Enrollment||participants|Number|32|32.0||||||
4088125|NCT01002105|3911338|B1|Israel||Region of Enrollment||participants|Number|32|32.0||||||
4088126|NCT01002105|3911336|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088127|NCT01002105|3911337|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088128|NCT01002105|3911338|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088129|NCT01002105|3911336|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088130|NCT01002105|3911337|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088131|NCT01002105|3911338|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088132|NCT01002105|3911336|B3||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4088133|NCT01002105|3911337|B2||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4088134|NCT01002105|3911338|B1||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4088135|NCT01002105|3911336|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088136|NCT01002105|3911337|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088137|NCT01002105|3911338|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088138|NCT01002105|3911336|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088139|NCT01002105|3911337|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088140|NCT01002105|3911338|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088141|NCT01002105|3911336|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088142|NCT01002105|3911337|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088143|NCT01002105|3911338|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088144|NCT01002105|3911336|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088145|NCT01002105|3911337|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088146|NCT01002105|3911338|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088147|NCT01002105|3911336|B3||Male|Gender||Participants|Count of Participants|48|48.0||||||
4088148|NCT01002105|3911337|B2||Male|Gender||Participants|Count of Participants|24|24.0||||||
4088149|NCT01002105|3911338|B1||Male|Gender||Participants|Count of Participants|24|24.0||||||
4088150|NCT01002105|3911336|B3||Female|Gender||Participants|Count of Participants|16|16.0||||||
4088151|NCT01002105|3911337|B2||Female|Gender||Participants|Count of Participants|8|8.0||||||
4088152|NCT01002105|3911338|B1||Female|Gender||Participants|Count of Participants|8|8.0||||||
4088153|NCT01002105|3911336|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4088154|NCT01002105|3911337|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4088155|NCT01002105|3911338|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4088156|NCT01002105|3911336|B3||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4088157|NCT01002105|3911337|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4088158|NCT01002105|3911338|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4088159|NCT01002105|3911336|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4088160|NCT01002105|3911337|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4088161|NCT01002105|3911338|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4088162|NCT01001988|3911355|B1|Thailand||Region of Enrollment||participants|Number|356|356.0||||||
4088163|NCT01001988|3911355|B1|Philippines||Region of Enrollment||participants|Number|229|229.0||||||
4088164|NCT01001988|3911355|B1||Male|Sex: Female, Male||Participants|Count of Participants|313|313.0||||||
4088165|NCT01001988|3911355|B1||Female|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
4088166|NCT01001988|3911355|B1|||Age||months|Mean|26.2|26.2|Standard Deviation|1.86|1.86|||
4088167|NCT01001988|3911355|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4088168|NCT01001988|3911355|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4088169|NCT01001988|3911355|B1||<=18 years|Age||Participants|Count of Participants|585|585.0||||||
4088170|NCT01001975|3911360|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4088171|NCT01001975|3911361|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4088172|NCT01001975|3911362|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4088173|NCT01001975|3911360|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4088174|NCT01001975|3911361|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4088175|NCT01001975|3911362|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4088176|NCT01001975|3911360|B3|||Age||years|Mean|40.3|40.3|Standard Deviation|11.2|11.2|||
4088177|NCT01001975|3911361|B2|||Age||years|Mean|38|38.0|Standard Deviation|12.6|12.6|||
4088178|NCT01001975|3911362|B1|||Age||years|Mean|42.6|42.6|Standard Deviation|9.8|9.8|||
4088179|NCT01001832|3911371|B3|||Methotrexate dose|The methotrexate dose is the calculated weekly total dose in the week ending at the first dose date of the Short-term Period.|mg/week|Mean|7.3|7.3|Standard Deviation|0.9|0.9|||
4088180|NCT01001832|3911372|B2|||Methotrexate dose|The methotrexate dose is the calculated weekly total dose in the week ending at the first dose date of the Short-term Period.|mg/week|Mean|7.3|7.3|Standard Deviation|1.0|1.0|||
4088181|NCT01001832|3911373|B1|||Methotrexate dose|The methotrexate dose is the calculated weekly total dose in the week ending at the first dose date of the Short-term Period.|mg/week|Mean|7.3|7.3|Standard Deviation|1.0|1.0|||
4088182|NCT01001832|3911371|B3|||HAQ Score|The Health Assessment Questionnaire(HAQ) Disability Index (DI) assesses patients' functional ability by rating their abilities over the previous week. At least 2 questions are asked from each of 8 categories: dressing and grooming, hygiene, arising, reach, eating, grip, walking, and common daily activities. Patients rate difficulty performing specific tasks: 0=without difficulty, 1=with some difficulty, 2=with much difficulty, and 3=unable to do. The sum of the categories score (the highest scored item in the category) is divided by the number of categories answered, yielding a score from 0-3.|Units on a scale|Mean|1.30|1.3|Standard Deviation|0.66|0.66|||
4088183|NCT01001832|3911372|B2|||HAQ Score|The Health Assessment Questionnaire(HAQ) Disability Index (DI) assesses patients' functional ability by rating their abilities over the previous week. At least 2 questions are asked from each of 8 categories: dressing and grooming, hygiene, arising, reach, eating, grip, walking, and common daily activities. Patients rate difficulty performing specific tasks: 0=without difficulty, 1=with some difficulty, 2=with much difficulty, and 3=unable to do. The sum of the categories score (the highest scored item in the category) is divided by the number of categories answered, yielding a score from 0-3.|Units on a scale|Mean|1.32|1.32|Standard Deviation|0.64|0.64|||
4088184|NCT01001832|3911373|B1|||HAQ Score|The Health Assessment Questionnaire(HAQ) Disability Index (DI) assesses patients' functional ability by rating their abilities over the previous week. At least 2 questions are asked from each of 8 categories: dressing and grooming, hygiene, arising, reach, eating, grip, walking, and common daily activities. Patients rate difficulty performing specific tasks: 0=without difficulty, 1=with some difficulty, 2=with much difficulty, and 3=unable to do. The sum of the categories score (the highest scored item in the category) is divided by the number of categories answered, yielding a score from 0-3.|Units on a scale|Mean|1.28|1.28|Standard Deviation|0.690|0.69|||
4088185|NCT01001832|3911371|B3|||DAS28-CRP|The Disease Activity Score 28 using C-Reactive Protein (DAS28-CRP) is a measure of disease activity in rheumatoid arthritis (RA) and assesses the 28 joints RA commonly affects; the score includes the number of tender and swollen joints (out of 28), CRP level (a measure of inflammation in the blood), and the patient’s global assessment of health (ranging from very good to very bad). These measures are then fed into a complex mathematical formula to produce the overall DAS (greater than 5.1 implies active disease; less than 3.2, well controlled disease; and less than 2.6, remission.)|Units on a scale|Mean|5.79|5.79|Standard Deviation|0.89|0.89|||
4088186|NCT01001832|3911372|B2|||DAS28-CRP|The Disease Activity Score 28 using C-Reactive Protein (DAS28-CRP) is a measure of disease activity in rheumatoid arthritis (RA) and assesses the 28 joints RA commonly affects; the score includes the number of tender and swollen joints (out of 28), CRP level (a measure of inflammation in the blood), and the patient’s global assessment of health (ranging from very good to very bad). These measures are then fed into a complex mathematical formula to produce the overall DAS (greater than 5.1 implies active disease; less than 3.2, well controlled disease; and less than 2.6, remission.)|Units on a scale|Mean|5.95|5.95|Standard Deviation|0.91|0.91|||
4088187|NCT01001832|3911373|B1|||DAS28-CRP|The Disease Activity Score 28 using C-Reactive Protein (DAS28-CRP) is a measure of disease activity in rheumatoid arthritis (RA) and assesses the 28 joints RA commonly affects; the score includes the number of tender and swollen joints (out of 28), CRP level (a measure of inflammation in the blood), and the patient’s global assessment of health (ranging from very good to very bad). These measures are then fed into a complex mathematical formula to produce the overall DAS (greater than 5.1 implies active disease; less than 3.2, well controlled disease; and less than 2.6, remission.)|Units on a scale|Mean|5.62|5.62|Standard Deviation|0.84|0.84|||
4088188|NCT01001832|3911371|B3|||Swollen Joint Count|the number of the participants' joints that the investigator observes is swollen.|Number of joints|Mean|17.0|17.0|Standard Deviation|7.1|7.1|||
4088189|NCT01001832|3911372|B2|||Swollen Joint Count|the number of the participants' joints that the investigator observes is swollen.|Number of joints|Mean|17.6|17.6|Standard Deviation|7.2|7.2|||
4088190|NCT01001832|3911373|B1|||Swollen Joint Count|the number of the participants' joints that the investigator observes is swollen.|Number of joints|Mean|16.4|16.4|Standard Deviation|7.0|7.0|||
4088191|NCT01001832|3911371|B3|||Tender Joint Count|The number of joints the participant finds painful (tender) is counted by the investigator.|Number of joints|Mean|21.6|21.6|Standard Deviation|9.6|9.6|||
4088192|NCT01001832|3911372|B2|||Tender Joint Count|The number of joints the participant finds painful (tender) is counted by the investigator.|Number of joints|Mean|22.3|22.3|Standard Deviation|9.9|9.9|||
4088193|NCT01001832|3911373|B1|||Tender Joint Count|The number of joints the participant finds painful (tender) is counted by the investigator.|Number of joints|Mean|20.9|20.9|Standard Deviation|9.3|9.3|||
4088194|NCT01001832|3911371|B3|>10 years||Duration of Disease Category||Participants|Number|29|29.0||24.6|24.6|||
4088195|NCT01001832|3911372|B2|>10 years||Duration of Disease Category||Participants|Number|12|12.0||20.3|20.3|||
4088196|NCT01001832|3911373|B1|>10 years||Duration of Disease Category||Participants|Number|17|17.0||28.8|28.8|||
4088197|NCT01001832|3911371|B3|>5 to <= 10 years||Duration of Disease Category||Participants|Number|16|16.0||13.6|13.6|||
4088198|NCT01001832|3911372|B2|>5 to <= 10 years||Duration of Disease Category||Participants|Number|6|6.0||10.2|10.2|||
4088199|NCT01001832|3911373|B1|>5 to <= 10 years||Duration of Disease Category||Participants|Number|10|10.0||16.9|16.9|||
4088200|NCT01001832|3911371|B3|>2 to <= 5 years||Duration of Disease Category||Participants|Number|18|18.0||15.3|15.3|||
4088201|NCT01001832|3911372|B2|>2 to <= 5 years||Duration of Disease Category||Participants|Number|11|11.0||18.6|18.6|||
4088202|NCT01001832|3911373|B1|>2 to <= 5 years||Duration of Disease Category||Participants|Number|7|7.0||11.9|11.9|||
4088203|NCT01001832|3911371|B3|<= 2 years||Duration of Disease Category||Participants|Number|55|55.0||46.6|46.6|||
4088204|NCT01001832|3911372|B2|<= 2 years||Duration of Disease Category||Participants|Number|30|30.0||50.8|50.8|||
4088205|NCT01001832|3911373|B1|<= 2 years||Duration of Disease Category||Participants|Number|25|25.0||42.4|42.4|||
4088206|NCT01001832|3911371|B3|||Duration of Disease||Years|Mean|6.4|6.4|Standard Deviation|8.3|8.3|||
4088207|NCT01001832|3911372|B2|||Duration of Disease||Years|Mean|5.3|5.3|Standard Deviation|7.3|7.3|||
4088208|NCT01001832|3911373|B1|||Duration of Disease||Years|Mean|7.5|7.5|Standard Deviation|9.2|9.2|||
4088209|NCT01001832|3911371|B3|Asian (not Japanese)||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4088210|NCT01001832|3911372|B2|Asian (not Japanese)||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4088211|NCT01001832|3911373|B1|Asian (not Japanese)||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4088212|NCT01001832|3911371|B3|Japanese||Race/Ethnicity, Customized||Participants|Number|117|117.0||||||
4088213|NCT01001832|3911372|B2|Japanese||Race/Ethnicity, Customized||Participants|Number|59|59.0||||||
4088214|NCT01001832|3911373|B1|Japanese||Race/Ethnicity, Customized||Participants|Number|58|58.0||||||
4088215|NCT01001832|3911371|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4088216|NCT01001832|3911372|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4088217|NCT01001832|3911373|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4088218|NCT01001832|3911371|B3||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4088219|NCT01001832|3911372|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4088220|NCT01001832|3911373|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4088221|NCT01001832|3911371|B3|||Age||Years|Mean|55.6|55.6|Standard Deviation|12.9|12.9|||
4088222|NCT01001832|3911372|B2|||Age||Years|Mean|55.2|55.2|Standard Deviation|13.6|13.6|||
4088223|NCT01001832|3911373|B1|||Age||Years|Mean|56.1|56.1|Standard Deviation|12.3|12.3|||
4088224|NCT01001806|3911417|B4|United States||Region of Enrollment||participants|Number|126|126.0||||||
4088225|NCT01001806|3911418|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4088226|NCT01001806|3911419|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
4088227|NCT01001806|3911420|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4088228|NCT01001806|3911417|B4||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4088229|NCT01001806|3911418|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4088230|NCT01001806|3911419|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4088231|NCT01001806|3911420|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4088232|NCT01001806|3911417|B4||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4088233|NCT01001806|3911418|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4088234|NCT01001806|3911419|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4088235|NCT01001806|3911420|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4088236|NCT01001806|3911417|B4|||Age||years|Mean|74|74.0|Standard Deviation|29|29.0|||
4088237|NCT01001806|3911418|B3|||Age||years|Mean|74|74.0|Standard Deviation|29|29.0|||
4088238|NCT01001806|3911419|B2|||Age||years|Mean|72|72.0|Standard Deviation|31|31.0|||
4088239|NCT01001806|3911420|B1|||Age||years|Mean|75|75.0|Standard Deviation|30|30.0|||
4088240|NCT01001806|3911417|B4||>=65 years|Age||Participants|Count of Participants|72|72.0||||||
4088241|NCT01001806|3911418|B3||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4088242|NCT01001806|3911419|B2||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4088243|NCT01001806|3911420|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4088244|NCT01001806|3911417|B4||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4088245|NCT01001806|3911418|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4088246|NCT01001806|3911419|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4088247|NCT01001806|3911420|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4088248|NCT01001806|3911417|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4088249|NCT01001806|3911418|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4088250|NCT01001806|3911419|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4088251|NCT01001806|3911420|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4088252|NCT01001767|3911430|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
4088253|NCT01001767|3911431|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4088254|NCT01001767|3911432|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4088255|NCT01001767|3911430|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4088256|NCT01001767|3911431|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4088257|NCT01001767|3911432|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4088258|NCT01001767|3911430|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4088259|NCT01001767|3911431|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4088260|NCT01001767|3911432|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4088261|NCT01001767|3911430|B3|||Age||years|Median|51|51.0|Inter-Quartile Range|||48.0|53.0|
4088262|NCT01001767|3911431|B2|||Age||years|Median|51|51.0|Inter-Quartile Range|||49.0|54.0|
4088263|NCT01001767|3911432|B1|||Age||years|Median|51|51.0|Inter-Quartile Range|||47.0|53.0|
4088264|NCT01001767|3911430|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4088265|NCT01001767|3911431|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4088266|NCT01001767|3911432|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4088267|NCT01001767|3911430|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4088268|NCT01001767|3911431|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4088269|NCT01001767|3911432|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4088270|NCT01001767|3911430|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4088271|NCT01001767|3911431|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4088272|NCT01001767|3911432|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4088273|NCT01001702|3911439|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4088274|NCT01001702|3911439|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4088275|NCT01001702|3911439|B1|||Age||years|Mean|16.29|16.29|Standard Deviation|1.36|1.36|||
4088276|NCT01001572|3911450|B3||Male|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
4088277|NCT01001572|3911451|B2||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4088278|NCT01001572|3911452|B1||Male|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4088279|NCT01001572|3911450|B3||Female|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
4088280|NCT01001572|3911451|B2||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4088281|NCT01001572|3911452|B1||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4088282|NCT01001572|3911450|B3|||Age|Baseline Measures were based on the Full Analysis Set that excludes 3 participants for having no post-baseline efficacy assessment.|years|Mean|53.0|53.0|Standard Deviation|9.43|9.43|||
4088283|NCT01001572|3911451|B2|||Age|Baseline Measures were based on the Full Analysis Set that excludes 3 participants for having no post-baseline efficacy assessment.|years|Mean|53.1|53.1|Standard Deviation|9.41|9.41|||
4088284|NCT01001572|3911452|B1|||Age|Baseline Measures were based on the Full Analysis Set that excludes 3 participants for having no post-baseline efficacy assessment.|years|Mean|52.9|52.9|Standard Deviation|9.47|9.47|||
4088285|NCT01001559|3911468|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4088286|NCT01001559|3911469|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4088287|NCT01001559|3911470|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4088288|NCT01001559|3911468|B3||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4088289|NCT01001559|3911469|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4088290|NCT01001559|3911470|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4088291|NCT01001559|3911468|B3|||Age||years|Mean|43.0|43.0|Standard Deviation|11.9|11.9|||
4088292|NCT01001559|3911469|B2|||Age||years|Mean|41.4|41.4|Standard Deviation|11.7|11.7|||
4088293|NCT01001559|3911470|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|11.9|11.9|||
4088294|NCT01001546|3911483|B3|United States||Region of Enrollment||participants|Number|413|413.0||||||
4088295|NCT01001546|3911484|B2|United States||Region of Enrollment||participants|Number|207|207.0||||||
4088296|NCT01001546|3911485|B1|United States||Region of Enrollment||participants|Number|206|206.0||||||
4088297|NCT01001546|3911483|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088298|NCT01001546|3911484|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088299|NCT01001546|3911485|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088300|NCT01001546|3911483|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4088301|NCT01001546|3911484|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4088302|NCT01001546|3911485|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4088303|NCT01001546|3911483|B3||White|Race (NIH/OMB)||Participants|Count of Participants|209|209.0||||||
4088304|NCT01001546|3911484|B2||White|Race (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
4088305|NCT01001546|3911485|B1||White|Race (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
4088306|NCT01001546|3911483|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|162|162.0||||||
4088307|NCT01001546|3911484|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4088308|NCT01001546|3911485|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
4088309|NCT01001546|3911483|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4088310|NCT01001546|3911484|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4088311|NCT01001546|3911485|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4088312|NCT01001546|3911483|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4088313|NCT01001546|3911484|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088314|NCT01001546|3911485|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4088315|NCT01001546|3911483|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4088316|NCT01001546|3911484|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4088317|NCT01001546|3911485|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4088318|NCT01001546|3911483|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4088319|NCT01001546|3911484|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4088320|NCT01001546|3911485|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4088321|NCT01001546|3911483|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|393|393.0||||||
4088322|NCT01001546|3911484|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|199|199.0||||||
4088323|NCT01001546|3911485|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|194|194.0||||||
4088324|NCT01001546|3911483|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4088325|NCT01001546|3911484|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4088326|NCT01001546|3911485|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4088327|NCT01001546|3911483|B3||Male|Sex: Female, Male||Participants|Count of Participants|349|349.0||||||
4088328|NCT01001546|3911484|B2||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4088329|NCT01001546|3911485|B1||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4088330|NCT01001546|3911483|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4088331|NCT01001546|3911484|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4088332|NCT01001546|3911485|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4088333|NCT01001546|3911483|B3|||Age||years|Mean|43.1|43.1|Standard Deviation|14.0|14.0|||
4088334|NCT01001546|3911484|B2|||Age||years|Mean|42.9|42.9|Standard Deviation|14.4|14.4|||
4088335|NCT01001546|3911485|B1|||Age||years|Mean|43.4|43.4|Standard Deviation|13.7|13.7|||
4088336|NCT01001520|3911492|B1|||Number of years smoked|During the medical screening visit, subjects were asked to self-report the number of years they have been a regular smoker (defined as smoking at least one cigarette per day).|years|Mean|21.8|21.8|Standard Deviation|13.7|13.7|||
4088337|NCT01001520|3911492|B1|||Cigarettes smoked per day|During the medical screening visit, subjects were asked to self-report the number of cigarettes they smoked on an average day.|Cigarettes smoked per day|Mean|17.1|17.1|Standard Deviation|4.9|4.9|||
4088338|NCT01001520|3911492|B1|||Nicotine Dependence|Determined by the Fagerstrom Test for Nicotine Dependence (FTND). The FTND is a 6-item, self-report measure of nicotine dependence derived from the Fagerstrom Tolerance Questionnaire. Scores range from 0-10; higher FTND scores indicate greater difficulty in quitting smoking. All subjects completed the FTND during the medical screening visit.|Scores on a scale|Mean|4.8|4.8|Standard Deviation|1.5|1.5|||
4088339|NCT01001520|3911492|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4088340|NCT01001520|3911492|B1|More than one race||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4088341|NCT01001520|3911492|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
4088342|NCT01001520|3911492|B1|African American||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4088343|NCT01001520|3911492|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4088344|NCT01001520|3911492|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4088345|NCT01001520|3911492|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4088346|NCT01001520|3911492|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4088347|NCT01001520|3911492|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4088348|NCT01001520|3911492|B1|||Age||Years|Mean|38.3|38.3|Standard Deviation|12.2|12.2|||
4088349|NCT01001494|3911517|B4|Germany||Region of Enrollment||participants|Number|168|168.0||||||
4088350|NCT01001494|3911518|B3|Germany||Region of Enrollment||participants|Number|56|56.0||||||
4088351|NCT01001494|3911519|B2|Germany||Region of Enrollment||participants|Number|57|57.0||||||
4088352|NCT01001494|3911520|B1|Germany||Region of Enrollment||participants|Number|55|55.0||||||
4088353|NCT01001494|3911517|B4|South Africa||Region of Enrollment||participants|Number|141|141.0||||||
4088354|NCT01001494|3911518|B3|South Africa||Region of Enrollment||participants|Number|48|48.0||||||
4088355|NCT01001494|3911519|B2|South Africa||Region of Enrollment||participants|Number|47|47.0||||||
4088356|NCT01001494|3911520|B1|South Africa||Region of Enrollment||participants|Number|46|46.0||||||
4088357|NCT01001494|3911517|B4|Poland||Region of Enrollment||participants|Number|230|230.0||||||
4088358|NCT01001494|3911518|B3|Poland||Region of Enrollment||participants|Number|77|77.0||||||
4088359|NCT01001494|3911519|B2|Poland||Region of Enrollment||participants|Number|74|74.0||||||
4088360|NCT01001494|3911520|B1|Poland||Region of Enrollment||participants|Number|79|79.0||||||
4088361|NCT01001494|3911517|B4|Czech Republic||Region of Enrollment||participants|Number|61|61.0||||||
4088362|NCT01001494|3911518|B3|Czech Republic||Region of Enrollment||participants|Number|19|19.0||||||
4088363|NCT01001494|3911519|B2|Czech Republic||Region of Enrollment||participants|Number|20|20.0||||||
4088364|NCT01001494|3911520|B1|Czech Republic||Region of Enrollment||participants|Number|22|22.0||||||
4088365|NCT01001494|3911517|B4|Hungary||Region of Enrollment||participants|Number|97|97.0||||||
4088366|NCT01001494|3911518|B3|Hungary||Region of Enrollment||participants|Number|32|32.0||||||
4088367|NCT01001494|3911519|B2|Hungary||Region of Enrollment||participants|Number|30|30.0||||||
4088368|NCT01001494|3911520|B1|Hungary||Region of Enrollment||participants|Number|35|35.0||||||
4088369|NCT01001494|3911517|B4|France||Region of Enrollment||participants|Number|24|24.0||||||
4088370|NCT01001494|3911518|B3|France||Region of Enrollment||participants|Number|8|8.0||||||
4088371|NCT01001494|3911519|B2|France||Region of Enrollment||participants|Number|8|8.0||||||
4088372|NCT01001494|3911520|B1|France||Region of Enrollment||participants|Number|8|8.0||||||
4088373|NCT01001494|3911517|B4|Italy||Region of Enrollment||participants|Number|8|8.0||||||
4088374|NCT01001494|3911518|B3|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4088375|NCT01001494|3911519|B2|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4088376|NCT01001494|3911520|B1|Italy||Region of Enrollment||participants|Number|4|4.0||||||
4088377|NCT01001494|3911517|B4|Russian Federation||Region of Enrollment||participants|Number|45|45.0||||||
4088378|NCT01001494|3911518|B3|Russian Federation||Region of Enrollment||participants|Number|15|15.0||||||
4088379|NCT01001494|3911519|B2|Russian Federation||Region of Enrollment||participants|Number|16|16.0||||||
4088380|NCT01001494|3911520|B1|Russian Federation||Region of Enrollment||participants|Number|14|14.0||||||
4088381|NCT01001494|3911517|B4|Ukraine||Region of Enrollment||participants|Number|27|27.0||||||
4088382|NCT01001494|3911518|B3|Ukraine||Region of Enrollment||participants|Number|11|11.0||||||
4088383|NCT01001494|3911519|B2|Ukraine||Region of Enrollment||participants|Number|8|8.0||||||
4088384|NCT01001494|3911520|B1|Ukraine||Region of Enrollment||participants|Number|8|8.0||||||
4088385|NCT01001494|3911517|B4|Spain||Region of Enrollment||participants|Number|18|18.0||||||
4088386|NCT01001494|3911518|B3|Spain||Region of Enrollment||participants|Number|5|5.0||||||
4088387|NCT01001494|3911519|B2|Spain||Region of Enrollment||participants|Number|7|7.0||||||
4088388|NCT01001494|3911520|B1|Spain||Region of Enrollment||participants|Number|6|6.0||||||
4088389|NCT01001494|3911517|B4||Male|Gender||Participants|Count of Participants|552|552.0||||||
4088390|NCT01001494|3911518|B3||Male|Gender||Participants|Count of Participants|189|189.0||||||
4088391|NCT01001494|3911519|B2||Male|Gender||Participants|Count of Participants|182|182.0||||||
4088392|NCT01001494|3911520|B1||Male|Gender||Participants|Count of Participants|181|181.0||||||
4088393|NCT01001494|3911517|B4||Female|Gender||Participants|Count of Participants|267|267.0||||||
4088394|NCT01001494|3911518|B3||Female|Gender||Participants|Count of Participants|84|84.0||||||
4088395|NCT01001494|3911519|B2||Female|Gender||Participants|Count of Participants|87|87.0||||||
4088396|NCT01001494|3911520|B1||Female|Gender||Participants|Count of Participants|96|96.0||||||
4088397|NCT01001494|3911517|B4|||Age||years|Mean|62.4|62.4|Standard Deviation|8.0|8.0|||
4088398|NCT01001494|3911518|B3|||Age||years|Mean|62.0|62.0|Standard Deviation|8.0|8.0|||
4088399|NCT01001494|3911519|B2|||Age||years|Mean|62.9|62.9|Standard Deviation|8.4|8.4|||
4088400|NCT01001494|3911520|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|7.8|7.8|||
4088401|NCT01001494|3911517|B4||>=65 years|Age||Participants|Count of Participants|310|310.0||||||
4088402|NCT01001494|3911518|B3||>=65 years|Age||Participants|Count of Participants|94|94.0||||||
4088403|NCT01001494|3911519|B2||>=65 years|Age||Participants|Count of Participants|108|108.0||||||
4088404|NCT01001494|3911520|B1||>=65 years|Age||Participants|Count of Participants|108|108.0||||||
4088405|NCT01001494|3911517|B4||Between 18 and 65 years|Age||Participants|Count of Participants|509|509.0||||||
4088406|NCT01001494|3911518|B3||Between 18 and 65 years|Age||Participants|Count of Participants|179|179.0||||||
4088407|NCT01001494|3911519|B2||Between 18 and 65 years|Age||Participants|Count of Participants|161|161.0||||||
4088408|NCT01001494|3911520|B1||Between 18 and 65 years|Age||Participants|Count of Participants|169|169.0||||||
4088409|NCT01001494|3911517|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4088410|NCT01001494|3911518|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4088411|NCT01001494|3911519|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4088412|NCT01001494|3911520|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4088413|NCT01001442|3911542|B9|United States||Region of Enrollment||participants|Number|34|34.0||||||
4088414|NCT01001442|3911543|B8|United States||Region of Enrollment||participants|Number|4|4.0||||||
4088415|NCT01001442|3911544|B7|United States||Region of Enrollment||participants|Number|10|10.0||||||
4088416|NCT01001442|3911545|B6|United States||Region of Enrollment||participants|Number|3|3.0||||||
4088417|NCT01001442|3911546|B5|United States||Region of Enrollment||participants|Number|3|3.0||||||
4088418|NCT01001442|3911547|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
4088419|NCT01001442|3911548|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4088420|NCT01001442|3911549|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4088421|NCT01001442|3911550|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4088422|NCT01001442|3911542|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4088423|NCT01001442|3911543|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088424|NCT01001442|3911544|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088425|NCT01001442|3911545|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088426|NCT01001442|3911546|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088427|NCT01001442|3911547|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088428|NCT01001442|3911548|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4088429|NCT01001442|3911549|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088430|NCT01001442|3911550|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088431|NCT01001442|3911542|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088432|NCT01001442|3911543|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088433|NCT01001442|3911544|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088434|NCT01001442|3911545|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088435|NCT01001442|3911546|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088436|NCT01001442|3911547|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088437|NCT01001442|3911548|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088438|NCT01001442|3911549|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088439|NCT01001442|3911550|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088440|NCT01001442|3911542|B9||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4088441|NCT01001442|3911543|B8||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4088442|NCT01001442|3911544|B7||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4088443|NCT01001442|3911545|B6||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4088444|NCT01001442|3911546|B5||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4088445|NCT01001442|3911547|B4||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4088446|NCT01001442|3911548|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4088447|NCT01001442|3911549|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4088448|NCT01001442|3911550|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4088449|NCT01001442|3911542|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4088450|NCT01001442|3911543|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4088451|NCT01001442|3911544|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4088452|NCT01001442|3911545|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4088453|NCT01001442|3911546|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4088454|NCT01001442|3911547|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088455|NCT01001442|3911548|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088456|NCT01001442|3911549|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088457|NCT01001442|3911550|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088458|NCT01001442|3911542|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088459|NCT01001442|3911543|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088460|NCT01001442|3911544|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088461|NCT01001442|3911545|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088462|NCT01001442|3911546|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088463|NCT01001442|3911547|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088464|NCT01001442|3911548|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088465|NCT01001442|3911549|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088466|NCT01001442|3911550|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088467|NCT01001442|3911542|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088468|NCT01001442|3911543|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088469|NCT01001442|3911544|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088470|NCT01001442|3911545|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088471|NCT01001442|3911546|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088472|NCT01001442|3911547|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088473|NCT01001442|3911548|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088474|NCT01001442|3911549|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088475|NCT01001442|3911550|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088476|NCT01001442|3911542|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088477|NCT01001442|3911543|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088478|NCT01001442|3911544|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088479|NCT01001442|3911545|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088480|NCT01001442|3911546|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088481|NCT01001442|3911547|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088482|NCT01001442|3911548|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088483|NCT01001442|3911549|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088484|NCT01001442|3911550|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088485|NCT01001442|3911542|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4088486|NCT01001442|3911543|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088487|NCT01001442|3911544|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088488|NCT01001442|3911545|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088489|NCT01001442|3911546|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088490|NCT01001442|3911547|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088491|NCT01001442|3911548|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4088492|NCT01001442|3911549|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088493|NCT01001442|3911550|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088494|NCT01001442|3911542|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4088495|NCT01001442|3911543|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4088496|NCT01001442|3911544|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4088497|NCT01001442|3911545|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4088498|NCT01001442|3911546|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4088499|NCT01001442|3911547|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4088500|NCT01001442|3911548|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4088501|NCT01001442|3911549|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4088502|NCT01001442|3911550|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4088503|NCT01001442|3911542|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4088504|NCT01001442|3911543|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4088505|NCT01001442|3911544|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4088506|NCT01001442|3911545|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088507|NCT01001442|3911546|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088508|NCT01001442|3911547|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088509|NCT01001442|3911548|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088510|NCT01001442|3911549|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088511|NCT01001442|3911550|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088512|NCT01001442|3911542|B9||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4088513|NCT01001442|3911543|B8||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4088514|NCT01001442|3911544|B7||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4088515|NCT01001442|3911545|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4088516|NCT01001442|3911546|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4088517|NCT01001442|3911547|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4088518|NCT01001442|3911548|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4088519|NCT01001442|3911549|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4088520|NCT01001442|3911550|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4088521|NCT01001442|3911542|B9||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4088522|NCT01001442|3911543|B8||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4088523|NCT01001442|3911544|B7||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4088524|NCT01001442|3911545|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4088525|NCT01001442|3911546|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4088526|NCT01001442|3911547|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4088527|NCT01001442|3911548|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4088528|NCT01001442|3911549|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4088529|NCT01001442|3911550|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4088530|NCT01001442|3911542|B9|||Age||years|Mean|63.5|63.5|Standard Deviation|9.63|9.63|||
4088531|NCT01001442|3911543|B8|||Age||years|Mean|61.5|61.5|Standard Deviation|9.98|9.98|||
4088532|NCT01001442|3911544|B7|||Age||years|Mean|66.8|66.8|Standard Deviation|8.80|8.8|||
4088533|NCT01001442|3911545|B6|||Age||years|Mean|55.3|55.3|Standard Deviation|5.03|5.03|||
4088534|NCT01001442|3911546|B5|||Age||years|Mean|64.3|64.3|Standard Deviation|8.02|8.02|||
4088535|NCT01001442|3911547|B4|||Age||years|Mean|60.7|60.7|Standard Deviation|4.51|4.51|||
4088536|NCT01001442|3911548|B3|||Age||years|Mean|64.3|64.3|Standard Deviation|9.39|9.39|||
4088537|NCT01001442|3911549|B2|||Age||years|Mean|55.3|55.3|Standard Deviation|7.64|7.64|||
4088538|NCT01001442|3911550|B1|||Age||years|Mean|70.3|70.3|Standard Deviation|15.56|15.56|||
4088539|NCT01001442|3911542|B9||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4088540|NCT01001442|3911543|B8||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4088541|NCT01001442|3911544|B7||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4088542|NCT01001442|3911545|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4088543|NCT01001442|3911546|B5||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4088544|NCT01001442|3911547|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4088545|NCT01001442|3911548|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4088546|NCT01001442|3911549|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4088547|NCT01001442|3911550|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4088548|NCT01001442|3911542|B9||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4088549|NCT01001442|3911543|B8||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4088550|NCT01001442|3911544|B7||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4088551|NCT01001442|3911545|B6||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4088552|NCT01001442|3911546|B5||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4088553|NCT01001442|3911547|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4088554|NCT01001442|3911548|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4088555|NCT01001442|3911549|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4088556|NCT01001442|3911550|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4088557|NCT01001442|3911542|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4088558|NCT01001442|3911543|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4088559|NCT01001442|3911544|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4088560|NCT01001442|3911545|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4088561|NCT01001442|3911546|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4088562|NCT01001442|3911547|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4088563|NCT01001442|3911548|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4088564|NCT01001442|3911549|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4088565|NCT01001442|3911550|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4088566|NCT01001429|3911605|B3|||total participants||participants|Number|76|76.0||||||
4088567|NCT01001429|3911606|B2|||total participants||participants|Number|37|37.0||||||
4088568|NCT01001429|3911607|B1|||total participants||participants|Number|39|39.0||||||
4088569|NCT01001429|3911605|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4088570|NCT01001429|3911606|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4088571|NCT01001429|3911607|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4088572|NCT01001429|3911605|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4088573|NCT01001429|3911606|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4088574|NCT01001429|3911607|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4088575|NCT01001429|3911605|B3|||Age||years|Mean|46|46.0|Inter-Quartile Range|||40.0|61.2|
4088576|NCT01001429|3911606|B2|||Age||years|Mean|52|52.0|Inter-Quartile Range|||42.8|61.2|
4088577|NCT01001429|3911607|B1|||Age||years|Mean|40|40.0|Inter-Quartile Range|||40.0|60.0|
4088578|NCT01001403|3911638|B3|Korea, Republic of||Region of Enrollment||participants|Number|62|62.0||||||
4088579|NCT01001403|3911639|B2|Korea, Republic of||Region of Enrollment||participants|Number|31|31.0||||||
4088580|NCT01001403|3911640|B1|Korea, Republic of||Region of Enrollment||participants|Number|31|31.0||||||
4088581|NCT01001403|3911638|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4088582|NCT01001403|3911639|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4088583|NCT01001403|3911640|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4088584|NCT01001403|3911638|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4088585|NCT01001403|3911639|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4088586|NCT01001403|3911640|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4088587|NCT01001403|3911638|B3|||Age||years|Mean|52|52.0|Standard Deviation|11|11.0|||
4088588|NCT01001403|3911639|B2|||Age||years|Mean|52|52.0|Standard Deviation|11|11.0|||
4088589|NCT01001403|3911640|B1|||Age||years|Mean|51|51.0|Standard Deviation|10|10.0|||
4088590|NCT01001403|3911638|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4088591|NCT01001403|3911639|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4088592|NCT01001403|3911640|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4088593|NCT01001403|3911638|B3||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4088594|NCT01001403|3911639|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4088595|NCT01001403|3911640|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4088596|NCT01001403|3911638|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4088597|NCT01001403|3911639|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4088598|NCT01001403|3911640|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4088599|NCT01001390|3911647|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4088600|NCT01001390|3911647|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4088601|NCT01001390|3911647|B1|> 18 years||Age, Customized||participants|Number|0|0.0||||||
4088602|NCT01001390|3911647|B1|6-18 years||Age, Customized||participants|Number|2|2.0||||||
4088603|NCT01001390|3911647|B1|< 6 years||Age, Customized||participants|Number|0|0.0||||||
4088604|NCT01001377|3911654|B3|Grade 2||Eastern Cooperative Oncology Group (ECOG) performance status|"0 = Fully active, able to carry on all pre-disease performance without restriction.~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, ie, light housework or office work.~= Ambulatory and capable of all self-care but unable to carry out any work. activities. Up and about > 50% of waking hours.~= Capable of only limited self-care, confined to a bed or chair > 50% of waking hours.~= Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.~= Dead."|participants|Number|82|82.0||||||
4088605|NCT01001377|3911655|B2|Grade 2||Eastern Cooperative Oncology Group (ECOG) performance status|"0 = Fully active, able to carry on all pre-disease performance without restriction.~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, ie, light housework or office work.~= Ambulatory and capable of all self-care but unable to carry out any work. activities. Up and about > 50% of waking hours.~= Capable of only limited self-care, confined to a bed or chair > 50% of waking hours.~= Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.~= Dead."|participants|Number|42|42.0||||||
4088606|NCT01001377|3911656|B1|Grade 2||Eastern Cooperative Oncology Group (ECOG) performance status|"0 = Fully active, able to carry on all pre-disease performance without restriction.~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, ie, light housework or office work.~= Ambulatory and capable of all self-care but unable to carry out any work. activities. Up and about > 50% of waking hours.~= Capable of only limited self-care, confined to a bed or chair > 50% of waking hours.~= Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.~= Dead."|participants|Number|40|40.0||||||
4088607|NCT01001377|3911654|B3|Grade 1||Eastern Cooperative Oncology Group (ECOG) performance status|"0 = Fully active, able to carry on all pre-disease performance without restriction.~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, ie, light housework or office work.~= Ambulatory and capable of all self-care but unable to carry out any work. activities. Up and about > 50% of waking hours.~= Capable of only limited self-care, confined to a bed or chair > 50% of waking hours.~= Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.~= Dead."|participants|Number|608|608.0||||||
4088608|NCT01001377|3911655|B2|Grade 1||Eastern Cooperative Oncology Group (ECOG) performance status|"0 = Fully active, able to carry on all pre-disease performance without restriction.~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, ie, light housework or office work.~= Ambulatory and capable of all self-care but unable to carry out any work. activities. Up and about > 50% of waking hours.~= Capable of only limited self-care, confined to a bed or chair > 50% of waking hours.~= Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.~= Dead."|participants|Number|309|309.0||||||
4088609|NCT01001377|3911656|B1|Grade 1||Eastern Cooperative Oncology Group (ECOG) performance status|"0 = Fully active, able to carry on all pre-disease performance without restriction.~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, ie, light housework or office work.~= Ambulatory and capable of all self-care but unable to carry out any work. activities. Up and about > 50% of waking hours.~= Capable of only limited self-care, confined to a bed or chair > 50% of waking hours.~= Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.~= Dead."|participants|Number|299|299.0||||||
4088610|NCT01001377|3911654|B3|Grade 0||Eastern Cooperative Oncology Group (ECOG) performance status|"0 = Fully active, able to carry on all pre-disease performance without restriction.~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, ie, light housework or office work.~= Ambulatory and capable of all self-care but unable to carry out any work. activities. Up and about > 50% of waking hours.~= Capable of only limited self-care, confined to a bed or chair > 50% of waking hours.~= Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.~= Dead."|participants|Number|320|320.0||||||
4088611|NCT01001377|3911655|B2|Grade 0||Eastern Cooperative Oncology Group (ECOG) performance status|"0 = Fully active, able to carry on all pre-disease performance without restriction.~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, ie, light housework or office work.~= Ambulatory and capable of all self-care but unable to carry out any work. activities. Up and about > 50% of waking hours.~= Capable of only limited self-care, confined to a bed or chair > 50% of waking hours.~= Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.~= Dead."|participants|Number|155|155.0||||||
4088612|NCT01001377|3911656|B1|Grade 0||Eastern Cooperative Oncology Group (ECOG) performance status|"0 = Fully active, able to carry on all pre-disease performance without restriction.~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, ie, light housework or office work.~= Ambulatory and capable of all self-care but unable to carry out any work. activities. Up and about > 50% of waking hours.~= Capable of only limited self-care, confined to a bed or chair > 50% of waking hours.~= Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.~= Dead."|participants|Number|165|165.0||||||
4088613|NCT01001377|3911654|B3|Rest of World||Geographic region|Stratification factor. Rest of world includes South America, Asia and South Africa|participants|Number|694|694.0||||||
4088614|NCT01001377|3911655|B2|Rest of World||Geographic region|Stratification factor. Rest of world includes South America, Asia and South Africa|participants|Number|348|348.0||||||
4088615|NCT01001377|3911656|B1|Rest of World||Geographic region|Stratification factor. Rest of world includes South America, Asia and South Africa|participants|Number|346|346.0||||||
4088616|NCT01001377|3911654|B3|North America, Western Europe and Australia||Geographic region|Stratification factor. Rest of world includes South America, Asia and South Africa|participants|Number|316|316.0||||||
4088617|NCT01001377|3911655|B2|North America, Western Europe and Australia||Geographic region|Stratification factor. Rest of world includes South America, Asia and South Africa|participants|Number|158|158.0||||||
4088618|NCT01001377|3911656|B1|North America, Western Europe and Australia||Geographic region|Stratification factor. Rest of world includes South America, Asia and South Africa|participants|Number|158|158.0||||||
4088619|NCT01001377|3911654|B3|White or Caucasian||Race/Ethnicity, Customized||participants|Number|530|530.0||||||
4088620|NCT01001377|3911655|B2|White or Caucasian||Race/Ethnicity, Customized||participants|Number|270|270.0||||||
4088621|NCT01001377|3911656|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|260|260.0||||||
4088622|NCT01001377|3911654|B3|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4088623|NCT01001377|3911655|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4088624|NCT01001377|3911656|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4088625|NCT01001377|3911654|B3|Japanese||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4088626|NCT01001377|3911655|B2|Japanese||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4088627|NCT01001377|3911656|B1|Japanese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4088628|NCT01001377|3911654|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4088629|NCT01001377|3911655|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4088630|NCT01001377|3911656|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4088631|NCT01001377|3911654|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4088632|NCT01001377|3911655|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4088633|NCT01001377|3911656|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4088634|NCT01001377|3911654|B3|Asian||Race/Ethnicity, Customized||participants|Number|455|455.0||||||
4088635|NCT01001377|3911655|B2|Asian||Race/Ethnicity, Customized||participants|Number|225|225.0||||||
4088636|NCT01001377|3911656|B1|Asian||Race/Ethnicity, Customized||participants|Number|230|230.0||||||
4088637|NCT01001377|3911654|B3||Male|Sex: Female, Male||Participants|Count of Participants|640|640.0||||||
4088638|NCT01001377|3911655|B2||Male|Sex: Female, Male||Participants|Count of Participants|319|319.0||||||
4088639|NCT01001377|3911656|B1||Male|Sex: Female, Male||Participants|Count of Participants|321|321.0||||||
4088640|NCT01001377|3911654|B3||Female|Sex: Female, Male||Participants|Count of Participants|370|370.0||||||
4088641|NCT01001377|3911655|B2||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4088642|NCT01001377|3911656|B1||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4088643|NCT01001377|3911654|B3|||Age||years|Mean|59.9|59.9|Standard Deviation|11.1|11.1|||
4088644|NCT01001377|3911655|B2|||Age||years|Mean|59.6|59.6|Standard Deviation|10.9|10.9|||
4088645|NCT01001377|3911656|B1|||Age||years|Mean|60.2|60.2|Standard Deviation|11.2|11.2|||
4088646|NCT01001325|3911685|B3|Canada||Region of Enrollment||participants|Number|468|468.0||||||
4088647|NCT01001325|3911686|B2|Canada||Region of Enrollment||participants|Number|234|234.0||||||
4088648|NCT01001325|3911687|B1|Canada||Region of Enrollment||participants|Number|234|234.0||||||
4088649|NCT01001325|3911685|B3||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4088650|NCT01001325|3911686|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4088651|NCT01001325|3911687|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4088652|NCT01001325|3911685|B3||Female|Sex: Female, Male||Participants|Count of Participants|305|305.0||||||
4088653|NCT01001325|3911686|B2||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4088654|NCT01001325|3911687|B1||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4088655|NCT01001325|3911685|B3|||Age||years|Mean|36.3|36.3|Standard Deviation|12.5|12.5|||
4088656|NCT01001325|3911686|B2|||Age||years|Mean|35.7|35.7|Standard Deviation|12.5|12.5|||
4088657|NCT01001325|3911687|B1|||Age||years|Mean|36.8|36.8|Standard Deviation|12.6|12.6|||
4088658|NCT01001325|3911685|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4088659|NCT01001325|3911686|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4088660|NCT01001325|3911687|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4088661|NCT01001325|3911685|B3||Between 18 and 65 years|Age||Participants|Count of Participants|467|467.0||||||
4088662|NCT01001325|3911686|B2||Between 18 and 65 years|Age||Participants|Count of Participants|234|234.0||||||
4088663|NCT01001325|3911687|B1||Between 18 and 65 years|Age||Participants|Count of Participants|233|233.0||||||
4088664|NCT01001325|3911685|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4088665|NCT01001325|3911686|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4088666|NCT01001325|3911687|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4088667|NCT01001299|3911694|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4088668|NCT01001299|3911694|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4088669|NCT01001299|3911694|B1|||Age||years|Mean|52.0|52.0|Standard Deviation|13.73|13.73|||
4088670|NCT01001234|3911718|B6||Male|Sex: Female, Male|Includes only participants who took study drug|Participants|Count of Participants|427|427.0||||||
4088671|NCT01001234|3911719|B5||Male|Sex: Female, Male|Includes only participants who took study drug|Participants|Count of Participants|20|20.0||||||
4088672|NCT01001234|3911720|B4||Male|Sex: Female, Male|Includes only participants who took study drug|Participants|Count of Participants|167|167.0||||||
4088673|NCT01001234|3911721|B3||Male|Sex: Female, Male|Includes only participants who took study drug|Participants|Count of Participants|173|173.0||||||
4088674|NCT01001234|3911722|B2||Male|Sex: Female, Male|Includes only participants who took study drug|Participants|Count of Participants|4|4.0||||||
4088675|NCT01001234|3911723|B1||Male|Sex: Female, Male|Includes only participants who took study drug|Participants|Count of Participants|63|63.0||||||
4088676|NCT01001234|3911718|B6||Female|Sex: Female, Male|Includes only participants who took study drug|Participants|Count of Participants|550|550.0||||||
4088677|NCT01001234|3911719|B5||Female|Sex: Female, Male|Includes only participants who took study drug|Participants|Count of Participants|20|20.0||||||
4088678|NCT01001234|3911720|B4||Female|Sex: Female, Male|Includes only participants who took study drug|Participants|Count of Participants|238|238.0||||||
4088679|NCT01001234|3911721|B3||Female|Sex: Female, Male|Includes only participants who took study drug|Participants|Count of Participants|227|227.0||||||
4088680|NCT01001234|3911722|B2||Female|Sex: Female, Male|Includes only participants who took study drug|Participants|Count of Participants|4|4.0||||||
4088681|NCT01001234|3911723|B1||Female|Sex: Female, Male|Includes only participants who took study drug|Participants|Count of Participants|61|61.0||||||
4088682|NCT01001234|3911718|B6|||Age|Includes only participants who took study drug|years|Mean|13.0|13.0|Standard Deviation|2.9|2.9|||
4088683|NCT01001234|3911719|B5|||Age|Includes only participants who took study drug|years|Mean|13.1|13.1|Standard Deviation|3.4|3.4|||
4088684|NCT01001234|3911720|B4|||Age|Includes only participants who took study drug|years|Mean|13.1|13.1|Standard Deviation|2.9|2.9|||
4088685|NCT01001234|3911721|B3|||Age|Includes only participants who took study drug|years|Mean|13.0|13.0|Standard Deviation|2.9|2.9|||
4088686|NCT01001234|3911722|B2|||Age|Includes only participants who took study drug|years|Mean|13.4|13.4|Standard Deviation|2.1|2.1|||
4088687|NCT01001234|3911723|B1|||Age|Includes only participants who took study drug|years|Mean|12.7|12.7|Standard Deviation|2.9|2.9|||
4088688|NCT01001221|3911739|B5|||Number of Organs Involved||organs|Mean|2.9|2.9|Standard Deviation|1.2|1.2|||
4088689|NCT01001221|3911740|B4|||Number of Organs Involved||organs|Mean|2.0|2.0|Standard Deviation|0.6|0.6|||
4088690|NCT01001221|3911741|B3|||Number of Organs Involved||organs|Mean|3.3|3.3|Standard Deviation|0.6|0.6|||
4088691|NCT01001221|3911742|B2|||Number of Organs Involved||organs|Mean|2.6|2.6|Standard Deviation|0.5|0.5|||
4088692|NCT01001221|3911743|B1|||Number of Organs Involved||organs|Mean|4.0|4.0|Standard Deviation|1.6|1.6|||
4088693|NCT01001221|3911739|B5|Unknown||Stage at Diagnosis|"Cancer staging is on a scale of I-IV with higher numbers indicating an increase in progression of the disease.~Stage I: cancers are localized to one part of the body. Stage II: cancers are early locally advanced. Stage III: cancers are late locally advanced. Stage IV: cancers have often metastasized, or spread to other organs or throughout the body."|participants|Number|7|7.0||||||
4088694|NCT01001221|3911740|B4|Unknown||Stage at Diagnosis|"Cancer staging is on a scale of I-IV with higher numbers indicating an increase in progression of the disease.~Stage I: cancers are localized to one part of the body. Stage II: cancers are early locally advanced. Stage III: cancers are late locally advanced. Stage IV: cancers have often metastasized, or spread to other organs or throughout the body."|participants|Number|3|3.0||||||
4088695|NCT01001221|3911741|B3|Unknown||Stage at Diagnosis|"Cancer staging is on a scale of I-IV with higher numbers indicating an increase in progression of the disease.~Stage I: cancers are localized to one part of the body. Stage II: cancers are early locally advanced. Stage III: cancers are late locally advanced. Stage IV: cancers have often metastasized, or spread to other organs or throughout the body."|participants|Number|3|3.0||||||
4088696|NCT01001221|3911742|B2|Unknown||Stage at Diagnosis|"Cancer staging is on a scale of I-IV with higher numbers indicating an increase in progression of the disease.~Stage I: cancers are localized to one part of the body. Stage II: cancers are early locally advanced. Stage III: cancers are late locally advanced. Stage IV: cancers have often metastasized, or spread to other organs or throughout the body."|participants|Number|1|1.0||||||
4088697|NCT01001221|3911743|B1|Unknown||Stage at Diagnosis|"Cancer staging is on a scale of I-IV with higher numbers indicating an increase in progression of the disease.~Stage I: cancers are localized to one part of the body. Stage II: cancers are early locally advanced. Stage III: cancers are late locally advanced. Stage IV: cancers have often metastasized, or spread to other organs or throughout the body."|participants|Number|0|0.0||||||
4088698|NCT01001221|3911739|B5|Stage IV||Stage at Diagnosis|"Cancer staging is on a scale of I-IV with higher numbers indicating an increase in progression of the disease.~Stage I: cancers are localized to one part of the body. Stage II: cancers are early locally advanced. Stage III: cancers are late locally advanced. Stage IV: cancers have often metastasized, or spread to other organs or throughout the body."|participants|Number|7|7.0||||||
4088699|NCT01001221|3911740|B4|Stage IV||Stage at Diagnosis|"Cancer staging is on a scale of I-IV with higher numbers indicating an increase in progression of the disease.~Stage I: cancers are localized to one part of the body. Stage II: cancers are early locally advanced. Stage III: cancers are late locally advanced. Stage IV: cancers have often metastasized, or spread to other organs or throughout the body."|participants|Number|2|2.0||||||
4088700|NCT01001221|3911741|B3|Stage IV||Stage at Diagnosis|"Cancer staging is on a scale of I-IV with higher numbers indicating an increase in progression of the disease.~Stage I: cancers are localized to one part of the body. Stage II: cancers are early locally advanced. Stage III: cancers are late locally advanced. Stage IV: cancers have often metastasized, or spread to other organs or throughout the body."|participants|Number|0|0.0||||||
4088701|NCT01001221|3911742|B2|Stage IV||Stage at Diagnosis|"Cancer staging is on a scale of I-IV with higher numbers indicating an increase in progression of the disease.~Stage I: cancers are localized to one part of the body. Stage II: cancers are early locally advanced. Stage III: cancers are late locally advanced. Stage IV: cancers have often metastasized, or spread to other organs or throughout the body."|participants|Number|0|0.0||||||
4088702|NCT01001221|3911743|B1|Stage IV||Stage at Diagnosis|"Cancer staging is on a scale of I-IV with higher numbers indicating an increase in progression of the disease.~Stage I: cancers are localized to one part of the body. Stage II: cancers are early locally advanced. Stage III: cancers are late locally advanced. Stage IV: cancers have often metastasized, or spread to other organs or throughout the body."|participants|Number|5|5.0||||||
4088726|NCT01001221|3911742|B2|Squamous cell carcinoma||Histological Type||participants|Number|1|1.0||||||
4088727|NCT01001221|3911743|B1|Squamous cell carcinoma||Histological Type||participants|Number|0|0.0||||||
4088728|NCT01001221|3911739|B5|Adenocarcinoma||Histological Type||participants|Number|8|8.0||||||
4088703|NCT01001221|3911739|B5|Stage III||Stage at Diagnosis|"Cancer staging is on a scale of I-IV with higher numbers indicating an increase in progression of the disease.~Stage I: cancers are localized to one part of the body. Stage II: cancers are early locally advanced. Stage III: cancers are late locally advanced. Stage IV: cancers have often metastasized, or spread to other organs or throughout the body."|participants|Number|4|4.0||||||
4088704|NCT01001221|3911740|B4|Stage III||Stage at Diagnosis|"Cancer staging is on a scale of I-IV with higher numbers indicating an increase in progression of the disease.~Stage I: cancers are localized to one part of the body. Stage II: cancers are early locally advanced. Stage III: cancers are late locally advanced. Stage IV: cancers have often metastasized, or spread to other organs or throughout the body."|participants|Number|1|1.0||||||
4088705|NCT01001221|3911741|B3|Stage III||Stage at Diagnosis|"Cancer staging is on a scale of I-IV with higher numbers indicating an increase in progression of the disease.~Stage I: cancers are localized to one part of the body. Stage II: cancers are early locally advanced. Stage III: cancers are late locally advanced. Stage IV: cancers have often metastasized, or spread to other organs or throughout the body."|participants|Number|0|0.0||||||
4088706|NCT01001221|3911742|B2|Stage III||Stage at Diagnosis|"Cancer staging is on a scale of I-IV with higher numbers indicating an increase in progression of the disease.~Stage I: cancers are localized to one part of the body. Stage II: cancers are early locally advanced. Stage III: cancers are late locally advanced. Stage IV: cancers have often metastasized, or spread to other organs or throughout the body."|participants|Number|3|3.0||||||
4088707|NCT01001221|3911743|B1|Stage III||Stage at Diagnosis|"Cancer staging is on a scale of I-IV with higher numbers indicating an increase in progression of the disease.~Stage I: cancers are localized to one part of the body. Stage II: cancers are early locally advanced. Stage III: cancers are late locally advanced. Stage IV: cancers have often metastasized, or spread to other organs or throughout the body."|participants|Number|0|0.0||||||
4088708|NCT01001221|3911739|B5|Stage II||Stage at Diagnosis|"Cancer staging is on a scale of I-IV with higher numbers indicating an increase in progression of the disease.~Stage I: cancers are localized to one part of the body. Stage II: cancers are early locally advanced. Stage III: cancers are late locally advanced. Stage IV: cancers have often metastasized, or spread to other organs or throughout the body."|participants|Number|1|1.0||||||
4088709|NCT01001221|3911740|B4|Stage II||Stage at Diagnosis|"Cancer staging is on a scale of I-IV with higher numbers indicating an increase in progression of the disease.~Stage I: cancers are localized to one part of the body. Stage II: cancers are early locally advanced. Stage III: cancers are late locally advanced. Stage IV: cancers have often metastasized, or spread to other organs or throughout the body."|participants|Number|0|0.0||||||
4088710|NCT01001221|3911741|B3|Stage II||Stage at Diagnosis|"Cancer staging is on a scale of I-IV with higher numbers indicating an increase in progression of the disease.~Stage I: cancers are localized to one part of the body. Stage II: cancers are early locally advanced. Stage III: cancers are late locally advanced. Stage IV: cancers have often metastasized, or spread to other organs or throughout the body."|participants|Number|0|0.0||||||
4088711|NCT01001221|3911742|B2|Stage II||Stage at Diagnosis|"Cancer staging is on a scale of I-IV with higher numbers indicating an increase in progression of the disease.~Stage I: cancers are localized to one part of the body. Stage II: cancers are early locally advanced. Stage III: cancers are late locally advanced. Stage IV: cancers have often metastasized, or spread to other organs or throughout the body."|participants|Number|1|1.0||||||
4088712|NCT01001221|3911743|B1|Stage II||Stage at Diagnosis|"Cancer staging is on a scale of I-IV with higher numbers indicating an increase in progression of the disease.~Stage I: cancers are localized to one part of the body. Stage II: cancers are early locally advanced. Stage III: cancers are late locally advanced. Stage IV: cancers have often metastasized, or spread to other organs or throughout the body."|participants|Number|0|0.0||||||
4088713|NCT01001221|3911739|B5|Stage I||Stage at Diagnosis|"Cancer staging is on a scale of I-IV with higher numbers indicating an increase in progression of the disease.~Stage I: cancers are localized to one part of the body. Stage II: cancers are early locally advanced. Stage III: cancers are late locally advanced. Stage IV: cancers have often metastasized, or spread to other organs or throughout the body."|participants|Number|0|0.0||||||
4088714|NCT01001221|3911740|B4|Stage I||Stage at Diagnosis|"Cancer staging is on a scale of I-IV with higher numbers indicating an increase in progression of the disease.~Stage I: cancers are localized to one part of the body. Stage II: cancers are early locally advanced. Stage III: cancers are late locally advanced. Stage IV: cancers have often metastasized, or spread to other organs or throughout the body."|participants|Number|0|0.0||||||
4088715|NCT01001221|3911741|B3|Stage I||Stage at Diagnosis|"Cancer staging is on a scale of I-IV with higher numbers indicating an increase in progression of the disease.~Stage I: cancers are localized to one part of the body. Stage II: cancers are early locally advanced. Stage III: cancers are late locally advanced. Stage IV: cancers have often metastasized, or spread to other organs or throughout the body."|participants|Number|0|0.0||||||
4088716|NCT01001221|3911742|B2|Stage I||Stage at Diagnosis|"Cancer staging is on a scale of I-IV with higher numbers indicating an increase in progression of the disease.~Stage I: cancers are localized to one part of the body. Stage II: cancers are early locally advanced. Stage III: cancers are late locally advanced. Stage IV: cancers have often metastasized, or spread to other organs or throughout the body."|participants|Number|0|0.0||||||
4088717|NCT01001221|3911743|B1|Stage I||Stage at Diagnosis|"Cancer staging is on a scale of I-IV with higher numbers indicating an increase in progression of the disease.~Stage I: cancers are localized to one part of the body. Stage II: cancers are early locally advanced. Stage III: cancers are late locally advanced. Stage IV: cancers have often metastasized, or spread to other organs or throughout the body."|participants|Number|0|0.0||||||
4088718|NCT01001221|3911739|B5|Other||Histological Type||participants|Number|10|10.0||||||
4088719|NCT01001221|3911740|B4|Other||Histological Type||participants|Number|4|4.0||||||
4088720|NCT01001221|3911741|B3|Other||Histological Type||participants|Number|3|3.0||||||
4088721|NCT01001221|3911742|B2|Other||Histological Type||participants|Number|0|0.0||||||
4088722|NCT01001221|3911743|B1|Other||Histological Type||participants|Number|3|3.0||||||
4088723|NCT01001221|3911739|B5|Squamous cell carcinoma||Histological Type||participants|Number|1|1.0||||||
4088724|NCT01001221|3911740|B4|Squamous cell carcinoma||Histological Type||participants|Number|0|0.0||||||
4088725|NCT01001221|3911741|B3|Squamous cell carcinoma||Histological Type||participants|Number|0|0.0||||||
4088729|NCT01001221|3911740|B4|Adenocarcinoma||Histological Type||participants|Number|2|2.0||||||
4088730|NCT01001221|3911741|B3|Adenocarcinoma||Histological Type||participants|Number|0|0.0||||||
4088731|NCT01001221|3911742|B2|Adenocarcinoma||Histological Type||participants|Number|4|4.0||||||
4088732|NCT01001221|3911743|B1|Adenocarcinoma||Histological Type||participants|Number|2|2.0||||||
4088733|NCT01001221|3911739|B5|Skin||Primary Tumor Site||participants|Number|1|1.0||||||
4088734|NCT01001221|3911740|B4|Skin||Primary Tumor Site||participants|Number|1|1.0||||||
4088735|NCT01001221|3911741|B3|Skin||Primary Tumor Site||participants|Number|0|0.0||||||
4088736|NCT01001221|3911742|B2|Skin||Primary Tumor Site||participants|Number|0|0.0||||||
4088737|NCT01001221|3911743|B1|Skin||Primary Tumor Site||participants|Number|0|0.0||||||
4088738|NCT01001221|3911739|B5|Prostate||Primary Tumor Site||participants|Number|2|2.0||||||
4088739|NCT01001221|3911740|B4|Prostate||Primary Tumor Site||participants|Number|0|0.0||||||
4088740|NCT01001221|3911741|B3|Prostate||Primary Tumor Site||participants|Number|0|0.0||||||
4088741|NCT01001221|3911742|B2|Prostate||Primary Tumor Site||participants|Number|0|0.0||||||
4088742|NCT01001221|3911743|B1|Prostate||Primary Tumor Site||participants|Number|2|2.0||||||
4088743|NCT01001221|3911739|B5|Pelvis||Primary Tumor Site||participants|Number|1|1.0||||||
4088744|NCT01001221|3911740|B4|Pelvis||Primary Tumor Site||participants|Number|1|1.0||||||
4088745|NCT01001221|3911741|B3|Pelvis||Primary Tumor Site||participants|Number|0|0.0||||||
4088746|NCT01001221|3911742|B2|Pelvis||Primary Tumor Site||participants|Number|0|0.0||||||
4088747|NCT01001221|3911743|B1|Pelvis||Primary Tumor Site||participants|Number|0|0.0||||||
4088748|NCT01001221|3911739|B5|Pancreas||Primary Tumor Site||participants|Number|3|3.0||||||
4088749|NCT01001221|3911740|B4|Pancreas||Primary Tumor Site||participants|Number|1|1.0||||||
4088750|NCT01001221|3911741|B3|Pancreas||Primary Tumor Site||participants|Number|0|0.0||||||
4088751|NCT01001221|3911742|B2|Pancreas||Primary Tumor Site||participants|Number|1|1.0||||||
4088752|NCT01001221|3911743|B1|Pancreas||Primary Tumor Site||participants|Number|1|1.0||||||
4088753|NCT01001221|3911739|B5|Ovaries||Primary Tumor Site||participants|Number|1|1.0||||||
4088754|NCT01001221|3911740|B4|Ovaries||Primary Tumor Site||participants|Number|1|1.0||||||
4088755|NCT01001221|3911741|B3|Ovaries||Primary Tumor Site||participants|Number|0|0.0||||||
4088756|NCT01001221|3911742|B2|Ovaries||Primary Tumor Site||participants|Number|0|0.0||||||
4088757|NCT01001221|3911743|B1|Ovaries||Primary Tumor Site||participants|Number|0|0.0||||||
4088758|NCT01001221|3911739|B5|Other||Primary Tumor Site||participants|Number|1|1.0||||||
4088759|NCT01001221|3911740|B4|Other||Primary Tumor Site||participants|Number|0|0.0||||||
4088760|NCT01001221|3911741|B3|Other||Primary Tumor Site||participants|Number|0|0.0||||||
4088761|NCT01001221|3911742|B2|Other||Primary Tumor Site||participants|Number|1|1.0||||||
4088762|NCT01001221|3911743|B1|Other||Primary Tumor Site||participants|Number|0|0.0||||||
4088763|NCT01001221|3911739|B5|Muscle/soft tissue||Primary Tumor Site||participants|Number|1|1.0||||||
4088764|NCT01001221|3911740|B4|Muscle/soft tissue||Primary Tumor Site||participants|Number|1|1.0||||||
4088765|NCT01001221|3911741|B3|Muscle/soft tissue||Primary Tumor Site||participants|Number|0|0.0||||||
4088766|NCT01001221|3911742|B2|Muscle/soft tissue||Primary Tumor Site||participants|Number|0|0.0||||||
4088767|NCT01001221|3911743|B1|Muscle/soft tissue||Primary Tumor Site||participants|Number|0|0.0||||||
4088768|NCT01001221|3911739|B5|Lung||Primary Tumor Site||participants|Number|4|4.0||||||
4088769|NCT01001221|3911740|B4|Lung||Primary Tumor Site||participants|Number|0|0.0||||||
4088770|NCT01001221|3911741|B3|Lung||Primary Tumor Site||participants|Number|1|1.0||||||
4088771|NCT01001221|3911742|B2|Lung||Primary Tumor Site||participants|Number|1|1.0||||||
4088772|NCT01001221|3911743|B1|Lung||Primary Tumor Site||participants|Number|2|2.0||||||
4088773|NCT01001221|3911739|B5|Head/neck||Primary Tumor Site||participants|Number|2|2.0||||||
4088774|NCT01001221|3911740|B4|Head/neck||Primary Tumor Site||participants|Number|0|0.0||||||
4088775|NCT01001221|3911741|B3|Head/neck||Primary Tumor Site||participants|Number|1|1.0||||||
4088776|NCT01001221|3911742|B2|Head/neck||Primary Tumor Site||participants|Number|1|1.0||||||
4088777|NCT01001221|3911743|B1|Head/neck||Primary Tumor Site||participants|Number|0|0.0||||||
4088778|NCT01001221|3911739|B5|Colon||Primary Tumor Site||participants|Number|1|1.0||||||
4088779|NCT01001221|3911740|B4|Colon||Primary Tumor Site||participants|Number|0|0.0||||||
4088780|NCT01001221|3911741|B3|Colon||Primary Tumor Site||participants|Number|0|0.0||||||
4088781|NCT01001221|3911742|B2|Colon||Primary Tumor Site||participants|Number|1|1.0||||||
4088782|NCT01001221|3911743|B1|Colon||Primary Tumor Site||participants|Number|0|0.0||||||
4088783|NCT01001221|3911739|B5|Bladder||Primary Tumor Site||participants|Number|2|2.0||||||
4088784|NCT01001221|3911740|B4|Bladder||Primary Tumor Site||participants|Number|1|1.0||||||
4088785|NCT01001221|3911741|B3|Bladder||Primary Tumor Site||participants|Number|1|1.0||||||
4088786|NCT01001221|3911742|B2|Bladder||Primary Tumor Site||participants|Number|0|0.0||||||
4088787|NCT01001221|3911743|B1|Bladder||Primary Tumor Site||participants|Number|0|0.0||||||
4088788|NCT01001221|3911739|B5|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG criteria:~0: Fully active~1: Ambulatory, carry out work of a light or sedentary nature~2: Ambulatory, capable of all selfcare~3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours~4: Completely disabled, no selfcare, totally confined to bed or chair~5: Dead"|participants|Number|0|0.0||||||
4088789|NCT01001221|3911740|B4|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG criteria:~0: Fully active~1: Ambulatory, carry out work of a light or sedentary nature~2: Ambulatory, capable of all selfcare~3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours~4: Completely disabled, no selfcare, totally confined to bed or chair~5: Dead"|participants|Number|0|0.0||||||
4088820|NCT01001221|3911741|B3|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4088790|NCT01001221|3911741|B3|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG criteria:~0: Fully active~1: Ambulatory, carry out work of a light or sedentary nature~2: Ambulatory, capable of all selfcare~3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours~4: Completely disabled, no selfcare, totally confined to bed or chair~5: Dead"|participants|Number|0|0.0||||||
4088791|NCT01001221|3911742|B2|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG criteria:~0: Fully active~1: Ambulatory, carry out work of a light or sedentary nature~2: Ambulatory, capable of all selfcare~3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours~4: Completely disabled, no selfcare, totally confined to bed or chair~5: Dead"|participants|Number|0|0.0||||||
4088792|NCT01001221|3911743|B1|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG criteria:~0: Fully active~1: Ambulatory, carry out work of a light or sedentary nature~2: Ambulatory, capable of all selfcare~3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours~4: Completely disabled, no selfcare, totally confined to bed or chair~5: Dead"|participants|Number|0|0.0||||||
4088793|NCT01001221|3911739|B5|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG criteria:~0: Fully active~1: Ambulatory, carry out work of a light or sedentary nature~2: Ambulatory, capable of all selfcare~3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours~4: Completely disabled, no selfcare, totally confined to bed or chair~5: Dead"|participants|Number|15|15.0||||||
4088794|NCT01001221|3911740|B4|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG criteria:~0: Fully active~1: Ambulatory, carry out work of a light or sedentary nature~2: Ambulatory, capable of all selfcare~3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours~4: Completely disabled, no selfcare, totally confined to bed or chair~5: Dead"|participants|Number|5|5.0||||||
4088795|NCT01001221|3911741|B3|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG criteria:~0: Fully active~1: Ambulatory, carry out work of a light or sedentary nature~2: Ambulatory, capable of all selfcare~3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours~4: Completely disabled, no selfcare, totally confined to bed or chair~5: Dead"|participants|Number|2|2.0||||||
4088796|NCT01001221|3911742|B2|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG criteria:~0: Fully active~1: Ambulatory, carry out work of a light or sedentary nature~2: Ambulatory, capable of all selfcare~3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours~4: Completely disabled, no selfcare, totally confined to bed or chair~5: Dead"|participants|Number|3|3.0||||||
4088797|NCT01001221|3911743|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG criteria:~0: Fully active~1: Ambulatory, carry out work of a light or sedentary nature~2: Ambulatory, capable of all selfcare~3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours~4: Completely disabled, no selfcare, totally confined to bed or chair~5: Dead"|participants|Number|5|5.0||||||
4088798|NCT01001221|3911739|B5|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG criteria:~0: Fully active~1: Ambulatory, carry out work of a light or sedentary nature~2: Ambulatory, capable of all selfcare~3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours~4: Completely disabled, no selfcare, totally confined to bed or chair~5: Dead"|participants|Number|4|4.0||||||
4088799|NCT01001221|3911740|B4|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG criteria:~0: Fully active~1: Ambulatory, carry out work of a light or sedentary nature~2: Ambulatory, capable of all selfcare~3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours~4: Completely disabled, no selfcare, totally confined to bed or chair~5: Dead"|participants|Number|1|1.0||||||
4088800|NCT01001221|3911741|B3|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG criteria:~0: Fully active~1: Ambulatory, carry out work of a light or sedentary nature~2: Ambulatory, capable of all selfcare~3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours~4: Completely disabled, no selfcare, totally confined to bed or chair~5: Dead"|participants|Number|1|1.0||||||
4088801|NCT01001221|3911742|B2|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG criteria:~0: Fully active~1: Ambulatory, carry out work of a light or sedentary nature~2: Ambulatory, capable of all selfcare~3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours~4: Completely disabled, no selfcare, totally confined to bed or chair~5: Dead"|participants|Number|2|2.0||||||
4088802|NCT01001221|3911743|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG criteria:~0: Fully active~1: Ambulatory, carry out work of a light or sedentary nature~2: Ambulatory, capable of all selfcare~3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours~4: Completely disabled, no selfcare, totally confined to bed or chair~5: Dead"|participants|Number|0|0.0||||||
4088803|NCT01001221|3911739|B5|||Body Surface Area||m^2|Mean|1.87|1.87|Standard Deviation|0.24|0.24|||
4088804|NCT01001221|3911740|B4|||Body Surface Area||m^2|Mean|1.84|1.84|Standard Deviation|0.12|0.12|||
4088805|NCT01001221|3911741|B3|||Body Surface Area||m^2|Mean|1.98|1.98|Standard Deviation|0.42|0.42|||
4088806|NCT01001221|3911742|B2|||Body Surface Area||m^2|Mean|1.82|1.82|Standard Deviation|0.21|0.21|||
4088807|NCT01001221|3911743|B1|||Body Surface Area||m^2|Mean|1.87|1.87|Standard Deviation|0.32|0.32|||
4088808|NCT01001221|3911739|B5|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4088809|NCT01001221|3911740|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4088810|NCT01001221|3911741|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4088811|NCT01001221|3911742|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4088812|NCT01001221|3911743|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4088813|NCT01001221|3911739|B5|Caucasian/White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4088814|NCT01001221|3911740|B4|Caucasian/White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4088815|NCT01001221|3911741|B3|Caucasian/White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4088816|NCT01001221|3911742|B2|Caucasian/White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4088817|NCT01001221|3911743|B1|Caucasian/White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4088818|NCT01001221|3911739|B5|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4088819|NCT01001221|3911740|B4|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4088821|NCT01001221|3911742|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4088822|NCT01001221|3911743|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4088823|NCT01001221|3911739|B5|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4088824|NCT01001221|3911740|B4|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4088825|NCT01001221|3911741|B3|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4088826|NCT01001221|3911742|B2|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4088827|NCT01001221|3911743|B1|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4088828|NCT01001221|3911739|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4088829|NCT01001221|3911740|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4088830|NCT01001221|3911741|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4088831|NCT01001221|3911742|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4088832|NCT01001221|3911743|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4088833|NCT01001221|3911739|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4088834|NCT01001221|3911740|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4088835|NCT01001221|3911741|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4088836|NCT01001221|3911742|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4088837|NCT01001221|3911743|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4088838|NCT01001221|3911739|B5|||Age||years|Mean|57.7|57.7|Standard Deviation|11.5|11.5|||
4088839|NCT01001221|3911740|B4|||Age||years|Mean|56.3|56.3|Standard Deviation|16.1|16.1|||
4088840|NCT01001221|3911741|B3|||Age||years|Mean|53.0|53.0|Standard Deviation|14.8|14.8|||
4088841|NCT01001221|3911742|B2|||Age||years|Mean|59.2|59.2|Standard Deviation|9.2|9.2|||
4088842|NCT01001221|3911743|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|6.6|6.6|||
4088843|NCT01001208|3911920|B3|No||Prior Anti-tumor Necrosis Factor (TNF) Exposure||participants|Number|388|388.0||||||
4088844|NCT01001208|3911921|B2|No||Prior Anti-tumor Necrosis Factor (TNF) Exposure||participants|Number|191|191.0||||||
4088845|NCT01001208|3911922|B1|No||Prior Anti-tumor Necrosis Factor (TNF) Exposure||participants|Number|197|197.0||||||
4088846|NCT01001208|3911920|B3|Yes||Prior Anti-tumor Necrosis Factor (TNF) Exposure||participants|Number|90|90.0||||||
4088847|NCT01001208|3911921|B2|Yes||Prior Anti-tumor Necrosis Factor (TNF) Exposure||participants|Number|48|48.0||||||
4088848|NCT01001208|3911922|B1|Yes||Prior Anti-tumor Necrosis Factor (TNF) Exposure||participants|Number|42|42.0||||||
4088849|NCT01001208|3911920|B3|>35 kg/m^2||Body Mass Index Group||participants|Number|133|133.0||||||
4088850|NCT01001208|3911921|B2|>35 kg/m^2||Body Mass Index Group||participants|Number|66|66.0||||||
4088851|NCT01001208|3911922|B1|>35 kg/m^2||Body Mass Index Group||participants|Number|67|67.0||||||
4088852|NCT01001208|3911920|B3|<=35 kg/m^2||Body Mass Index Group||participants|Number|345|345.0||||||
4088853|NCT01001208|3911921|B2|<=35 kg/m^2||Body Mass Index Group||participants|Number|173|173.0||||||
4088854|NCT01001208|3911922|B1|<=35 kg/m^2||Body Mass Index Group||participants|Number|172|172.0||||||
4088855|NCT01001208|3911920|B3|||Percent of Body Surface Area (BSA) Involved in Psoriasis||Percentage of BSA|Mean|24.33|24.33|Standard Deviation|14.82|14.82|||
4088856|NCT01001208|3911921|B2|||Percent of Body Surface Area (BSA) Involved in Psoriasis||Percentage of BSA|Mean|24.23|24.23|Standard Deviation|13.64|13.64|||
4088857|NCT01001208|3911922|B1|||Percent of Body Surface Area (BSA) Involved in Psoriasis||Percentage of BSA|Mean|24.43|24.43|Standard Deviation|15.94|15.94|||
4088858|NCT01001208|3911920|B3|||Psoriasis Area and Severity Index (PASI) Score|Psoriasis Area and Severity Index (PASI) Score incorporates measures of erythema, desquamation, infiltration, and affected body surface area. Involvement and severity of psoriasis was scored by physicians using a scale of 0 to 72, where 0 = no psoriasis and 72 = severe disease.|Units on a scale|Mean|18.29|18.29|Standard Deviation|7.42|7.42|||
4088859|NCT01001208|3911921|B2|||Psoriasis Area and Severity Index (PASI) Score|Psoriasis Area and Severity Index (PASI) Score incorporates measures of erythema, desquamation, infiltration, and affected body surface area. Involvement and severity of psoriasis was scored by physicians using a scale of 0 to 72, where 0 = no psoriasis and 72 = severe disease.|Units on a scale|Mean|18.34|18.34|Standard Deviation|6.62|6.62|||
4088860|NCT01001208|3911922|B1|||Psoriasis Area and Severity Index (PASI) Score|Psoriasis Area and Severity Index (PASI) Score incorporates measures of erythema, desquamation, infiltration, and affected body surface area. Involvement and severity of psoriasis was scored by physicians using a scale of 0 to 72, where 0 = no psoriasis and 72 = severe disease.|Units on a scale|Mean|18.24|18.24|Standard Deviation|8.15|8.15|||
4088861|NCT01001208|3911920|B3|Aborigine||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4088862|NCT01001208|3911921|B2|Aborigine||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4088863|NCT01001208|3911922|B1|Aborigine||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4088864|NCT01001208|3911920|B3|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4088865|NCT01001208|3911921|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4088866|NCT01001208|3911922|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4088867|NCT01001208|3911920|B3|Japanese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4088868|NCT01001208|3911921|B2|Japanese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4088869|NCT01001208|3911922|B1|Japanese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4088870|NCT01001208|3911920|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
4088871|NCT01001208|3911921|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4088872|NCT01001208|3911922|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4088873|NCT01001208|3911920|B3|White||Race/Ethnicity, Customized||participants|Number|356|356.0||||||
4088874|NCT01001208|3911921|B2|White||Race/Ethnicity, Customized||participants|Number|177|177.0||||||
4088875|NCT01001208|3911922|B1|White||Race/Ethnicity, Customized||participants|Number|179|179.0||||||
4088876|NCT01001208|3911920|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4088877|NCT01001208|3911921|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4088878|NCT01001208|3911922|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4088879|NCT01001208|3911920|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4088880|NCT01001208|3911921|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4088881|NCT01001208|3911922|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4088882|NCT01001208|3911920|B3|Asian||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4088883|NCT01001208|3911921|B2|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4088884|NCT01001208|3911922|B1|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4088885|NCT01001208|3911920|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4088886|NCT01001208|3911921|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4088887|NCT01001208|3911922|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4088888|NCT01001208|3911920|B3||Male|Sex: Female, Male||Participants|Count of Participants|320|320.0||||||
4088889|NCT01001208|3911921|B2||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4088890|NCT01001208|3911922|B1||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4088891|NCT01001208|3911920|B3||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4088892|NCT01001208|3911921|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4088893|NCT01001208|3911922|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4088894|NCT01001208|3911920|B3|||Age||years|Mean|44.11|44.11|Standard Deviation|12.96|12.96|||
4088895|NCT01001208|3911921|B2|||Age||years|Mean|45.23|45.23|Standard Deviation|12.79|12.79|||
4088896|NCT01001208|3911922|B1|||Age||years|Mean|42.99|42.99|Standard Deviation|13.06|13.06|||
4088897|NCT01001195|3911947|B5||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4088898|NCT01001195|3911948|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4088899|NCT01001195|3911949|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4088900|NCT01001195|3911950|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4088901|NCT01001195|3911951|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4088902|NCT01001195|3911947|B5||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4088903|NCT01001195|3911948|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4088904|NCT01001195|3911949|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4088905|NCT01001195|3911950|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4088906|NCT01001195|3911951|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4088907|NCT01001195|3911947|B5|>65 years||Age, Customized||Participants|Number|73|73.0||||||
4088908|NCT01001195|3911948|B4|>65 years||Age, Customized||Participants|Number|20|20.0||||||
4088909|NCT01001195|3911949|B3|>65 years||Age, Customized||Participants|Number|21|21.0||||||
4088910|NCT01001195|3911950|B2|>65 years||Age, Customized||Participants|Number|16|16.0||||||
4088911|NCT01001195|3911951|B1|>65 years||Age, Customized||Participants|Number|16|16.0||||||
4088912|NCT01001195|3911947|B5|45 to 65 years||Age, Customized||Participants|Number|88|88.0||||||
4088913|NCT01001195|3911948|B4|45 to 65 years||Age, Customized||Participants|Number|21|21.0||||||
4088914|NCT01001195|3911949|B3|45 to 65 years||Age, Customized||Participants|Number|21|21.0||||||
4088915|NCT01001195|3911950|B2|45 to 65 years||Age, Customized||Participants|Number|24|24.0||||||
4088916|NCT01001195|3911951|B1|45 to 65 years||Age, Customized||Participants|Number|22|22.0||||||
4088917|NCT01001195|3911947|B5|<45 years||Age, Customized||Participants|Number|4|4.0||||||
4088918|NCT01001195|3911948|B4|<45 years||Age, Customized||Participants|Number|0|0.0||||||
4088919|NCT01001195|3911949|B3|<45 years||Age, Customized||Participants|Number|2|2.0||||||
4088920|NCT01001195|3911950|B2|<45 years||Age, Customized||Participants|Number|1|1.0||||||
4088921|NCT01001195|3911951|B1|<45 years||Age, Customized||Participants|Number|1|1.0||||||
4088922|NCT01001169|3911964|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4088923|NCT01001169|3911965|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4088924|NCT01001169|3911966|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4088925|NCT01001169|3911964|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4088926|NCT01001169|3911965|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4088927|NCT01001169|3911966|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4088928|NCT01001169|3911964|B3|||Age||Months|Mean|106.00|106.0|Standard Deviation|64.78|64.78|||
4088929|NCT01001169|3911965|B2|||Age||Months|Mean|163.00|163.0|Standard Deviation|32.41|32.41|||
4088930|NCT01001169|3911966|B1|||Age||Months|Mean|49.00|49.0|Standard Deviation|27.66|27.66|||
4088931|NCT01001104|3912071|B5|||Fasting Blood Glucose (FBG)||milligrams per deciliter (mg/dL)|Mean|156.45|156.45|Standard Deviation|31.26|31.26|||
4088932|NCT01001104|3912072|B4|||Fasting Blood Glucose (FBG)||milligrams per deciliter (mg/dL)|Mean|159.65|159.65|Standard Deviation|33.29|33.29|||
4088933|NCT01001104|3912073|B3|||Fasting Blood Glucose (FBG)||milligrams per deciliter (mg/dL)|Mean|158.75|158.75|Standard Deviation|35.62|35.62|||
4088934|NCT01001104|3912074|B2|||Fasting Blood Glucose (FBG)||milligrams per deciliter (mg/dL)|Mean|150.95|150.95|Standard Deviation|29.31|29.31|||
4088935|NCT01001104|3912075|B1|||Fasting Blood Glucose (FBG)||milligrams per deciliter (mg/dL)|Mean|156.51|156.51|Standard Deviation|26.43|26.43|||
4088936|NCT01001104|3912071|B5|||Percentage of Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|8.00|8.0|Standard Deviation|0.64|0.64|||
4088937|NCT01001104|3912072|B4|||Percentage of Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|7.98|7.98|Standard Deviation|0.64|0.64|||
4088938|NCT01001104|3912073|B3|||Percentage of Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|8.05|8.05|Standard Deviation|0.66|0.66|||
4088939|NCT01001104|3912074|B2|||Percentage of Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|7.98|7.98|Standard Deviation|0.66|0.66|||
4088940|NCT01001104|3912075|B1|||Percentage of Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|8.01|8.01|Standard Deviation|0.63|0.63|||
4088941|NCT01001104|3912071|B5|Japan||Region of Enrollment||participants|Number|145|145.0||||||
4088942|NCT01001104|3912072|B4|Japan||Region of Enrollment||participants|Number|37|37.0||||||
4088943|NCT01001104|3912073|B3|Japan||Region of Enrollment||participants|Number|36|36.0||||||
4088944|NCT01001104|3912074|B2|Japan||Region of Enrollment||participants|Number|37|37.0||||||
4088945|NCT01001104|3912075|B1|Japan||Region of Enrollment||participants|Number|35|35.0||||||
4088946|NCT01001104|3912071|B5|Japanese||Race/Ethnicity, Customized||participants|Number|145|145.0||||||
4088947|NCT01001104|3912072|B4|Japanese||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4088948|NCT01001104|3912073|B3|Japanese||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4088949|NCT01001104|3912074|B2|Japanese||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4088950|NCT01001104|3912075|B1|Japanese||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4088951|NCT01001104|3912071|B5||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4088952|NCT01001104|3912072|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4088953|NCT01001104|3912073|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4088954|NCT01001104|3912074|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4088955|NCT01001104|3912075|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4088956|NCT01001104|3912071|B5||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4088957|NCT01001104|3912072|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4088958|NCT01001104|3912073|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4088959|NCT01001104|3912074|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4088960|NCT01001104|3912075|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4088961|NCT01001104|3912071|B5|||Age||years|Mean|52.17|52.17|Standard Deviation|8.82|8.82|||
4088962|NCT01001104|3912072|B4|||Age||years|Mean|51.70|51.7|Standard Deviation|9.67|9.67|||
4088963|NCT01001104|3912073|B3|||Age||years|Mean|52.26|52.26|Standard Deviation|8.82|8.82|||
4088964|NCT01001104|3912074|B2|||Age||years|Mean|52.50|52.5|Standard Deviation|9.17|9.17|||
4088965|NCT01001104|3912075|B1|||Age||years|Mean|52.23|52.23|Standard Deviation|7.80|7.8|||
4088966|NCT01001078|3912123|B3|||Height||meters|Mean|1.68|1.68|Standard Deviation|0.095|0.095|||
4088967|NCT01001078|3912124|B2|||Height||meters|Mean|1.67|1.67|Standard Deviation|0.10|0.1|||
4088968|NCT01001078|3912125|B1|||Height||meters|Mean|1.68|1.68|Standard Deviation|0.09|0.09|||
4088969|NCT01001078|3912123|B3|||BMI||kg/m^2|Mean|26|26.0|Standard Deviation|4|4.0|||
4088970|NCT01001078|3912124|B2|||BMI||kg/m^2|Mean|26|26.0|Standard Deviation|4|4.0|||
4088971|NCT01001078|3912125|B1|||BMI||kg/m^2|Mean|26|26.0|Standard Deviation|4|4.0|||
4088972|NCT01001078|3912123|B3|||Weight||kilograms|Mean|71.5|71.5|Standard Deviation|12|12.0|||
4088973|NCT01001078|3912124|B2|||Weight||kilograms|Mean|71|71.0|Standard Deviation|13|13.0|||
4088974|NCT01001078|3912125|B1|||Weight||kilograms|Mean|72|72.0|Standard Deviation|11|11.0|||
4088975|NCT01001078|3912123|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4088976|NCT01001078|3912124|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4088977|NCT01001078|3912125|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4088978|NCT01001078|3912123|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4088979|NCT01001078|3912124|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4088980|NCT01001078|3912125|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4088981|NCT01001078|3912123|B3|||Age||years|Mean|50|50.0|Standard Deviation|17|17.0|||
4088982|NCT01001078|3912124|B2|||Age||years|Mean|50|50.0|Standard Deviation|18|18.0|||
4088983|NCT01001078|3912125|B1|||Age||years|Mean|50|50.0|Standard Deviation|16|16.0|||
4088984|NCT01001052|3912142|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4088985|NCT01001052|3912142|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4088986|NCT01001052|3912142|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088987|NCT01001052|3912142|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4088988|NCT01001052|3912142|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4088989|NCT01001052|3912142|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088990|NCT01001052|3912142|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088991|NCT01001052|3912142|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4088992|NCT01001052|3912142|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4088993|NCT01001052|3912142|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4088994|NCT01001052|3912142|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4088995|NCT01001052|3912142|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4088996|NCT01001052|3912142|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4088997|NCT01001052|3912142|B1|||Age||years|Mean|42.32|42.32|Standard Deviation|19.44|19.44|||
4088998|NCT01001052|3912142|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4088999|NCT01001052|3912142|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4089000|NCT01001052|3912142|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4089001|NCT01000987|3912153|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4089002|NCT01000987|3912154|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4089003|NCT01000987|3912155|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4089004|NCT01000987|3912156|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4089005|NCT01000987|3912153|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4089006|NCT01000987|3912154|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4089007|NCT01000987|3912155|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4089008|NCT01000987|3912156|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4089009|NCT01000987|3912153|B4|||Age||years|Mean|34.6|34.6|Standard Deviation|9.96|9.96|||
4089010|NCT01000987|3912154|B3|||Age||years|Mean|35.3|35.3|Standard Deviation|9.47|9.47|||
4089011|NCT01000987|3912155|B2|||Age||years|Mean|34.4|34.4|Standard Deviation|12.6|12.6|||
4089012|NCT01000987|3912156|B1|||Age||years|Mean|33.9|33.9|Standard Deviation|7.29|7.29|||
4089013|NCT01000974|3912166|B4||Male|Sex: Female, Male||Participants|Count of Participants|2050|2050.0||||||
4089014|NCT01000974|3912167|B3||Male|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
4089015|NCT01000974|3912168|B2||Male|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
4089016|NCT01000974|3912169|B1||Male|Sex: Female, Male||Participants|Count of Participants|1539|1539.0||||||
4089017|NCT01000974|3912166|B4||Female|Sex: Female, Male||Participants|Count of Participants|1953|1953.0||||||
4089018|NCT01000974|3912167|B3||Female|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
4089019|NCT01000974|3912168|B2||Female|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
4089020|NCT01000974|3912169|B1||Female|Sex: Female, Male||Participants|Count of Participants|1424|1424.0||||||
4089021|NCT01000974|3912166|B4|||Age||Weeks|Mean|8.61|8.61|Standard Deviation|1.09|1.09|||
4089022|NCT01000974|3912167|B3|||Age||Weeks|Mean|8.7|8.7|Standard Deviation|1.12|1.12|||
4089023|NCT01000974|3912168|B2|||Age||Weeks|Mean|8.6|8.6|Standard Deviation|1.13|1.13|||
4089024|NCT01000974|3912169|B1|||Age||Weeks|Mean|8.6|8.6|Standard Deviation|1.08|1.08|||
4089025|NCT01000961|3912278|B1|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
4089026|NCT01000961|3912278|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4089027|NCT01000961|3912278|B1|France||Region of Enrollment||participants|Number|13|13.0||||||
4089028|NCT01000961|3912278|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4089029|NCT01000961|3912278|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4089030|NCT01000961|3912278|B1|||Age||years|Mean|11.9|11.9|Standard Deviation|4.33|4.33|||
4089031|NCT01000961|3912278|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4089032|NCT01000961|3912278|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4089033|NCT01000961|3912278|B1||<=18 years|Age||Participants|Count of Participants|36|36.0||||||
4089034|NCT01000818|3912291|B1|||Weight||Kilograms|Mean|85.7|85.7|Full Range|||60.6|141.0|
4089035|NCT01000818|3912291|B1|||Height||Centimeters|Mean|176.6|176.6|Full Range|||161.0|188.0|
4089036|NCT01000818|3912291|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4089037|NCT01000818|3912291|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4089038|NCT01000818|3912291|B1|||Age||years|Mean|49.3|49.3|Full Range|||37.0|59.0|
4089039|NCT01000805|3912300|B3|||Number of Previous Major Depressive Disorder (MDD) Episodes||number of previous episodes|Mean|3.60|3.6|Standard Deviation|4.45|4.45|||
4089040|NCT01000805|3912301|B2|||Number of Previous Major Depressive Disorder (MDD) Episodes||number of previous episodes|Mean|3.67|3.67|Standard Deviation|4.88|4.88|||
4089041|NCT01000805|3912302|B1|||Number of Previous Major Depressive Disorder (MDD) Episodes||number of previous episodes|Mean|3.52|3.52|Standard Deviation|3.98|3.98|||
4089042|NCT01000805|3912300|B3|||Sheehan Disability Scale -Total Score (SDS Total), N=262,265,527|The SDS is completed by the participant and is used to assess the effect of the participant's symptoms on their work/social/family life. Total scores range from 0 to 30 with higher values indicating greater disruption in the participant's work/social/family life.|units on a scale|Mean|19.27|19.27|Standard Deviation|5.92|5.92|||
4089043|NCT01000805|3912301|B2|||Sheehan Disability Scale -Total Score (SDS Total), N=262,265,527|The SDS is completed by the participant and is used to assess the effect of the participant's symptoms on their work/social/family life. Total scores range from 0 to 30 with higher values indicating greater disruption in the participant's work/social/family life.|units on a scale|Mean|19.38|19.38|Standard Deviation|5.84|5.84|||
4089044|NCT01000805|3912302|B1|||Sheehan Disability Scale -Total Score (SDS Total), N=262,265,527|The SDS is completed by the participant and is used to assess the effect of the participant's symptoms on their work/social/family life. Total scores range from 0 to 30 with higher values indicating greater disruption in the participant's work/social/family life.|units on a scale|Mean|19.16|19.16|Standard Deviation|6.00|6.0|||
4089098|NCT01000805|3912302|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4089045|NCT01000805|3912300|B3|||Sheehan Disability Scale-Item 3 (SDS-Item 3), N=262,265,527|The SDS is completed by the participant and Item 3 is used to assess the effect of the participant's symptoms on their family life/home responsibilities. Scores range from 0 to 10 with higher values indicating greater disruption in the participant's family life/home responsibilities.|units on a scale|Mean|6.44|6.44|Standard Deviation|2.13|2.13|||
4089046|NCT01000805|3912301|B2|||Sheehan Disability Scale-Item 3 (SDS-Item 3), N=262,265,527|The SDS is completed by the participant and Item 3 is used to assess the effect of the participant's symptoms on their family life/home responsibilities. Scores range from 0 to 10 with higher values indicating greater disruption in the participant's family life/home responsibilities.|units on a scale|Mean|6.45|6.45|Standard Deviation|2.06|2.06|||
4089047|NCT01000805|3912302|B1|||Sheehan Disability Scale-Item 3 (SDS-Item 3), N=262,265,527|The SDS is completed by the participant and Item 3 is used to assess the effect of the participant's symptoms on their family life/home responsibilities. Scores range from 0 to 10 with higher values indicating greater disruption in the participant's family life/home responsibilities.|units on a scale|Mean|6.42|6.42|Standard Deviation|2.21|2.21|||
4089048|NCT01000805|3912300|B3|||Sheehan Disability Scale-Item 2 (SDS-Item 2), N=262,265,527|The SDS is completed by the participant and Item 2 is used to assess the effect of the participant's symptoms on their social life/leisure activities. Scores range from 0 to 10 with higher values indicating greater disruption in the patient's social life.|units on a scale|Mean|6.46|6.46|Standard Deviation|2.21|2.21|||
4089049|NCT01000805|3912301|B2|||Sheehan Disability Scale-Item 2 (SDS-Item 2), N=262,265,527|The SDS is completed by the participant and Item 2 is used to assess the effect of the participant's symptoms on their social life/leisure activities. Scores range from 0 to 10 with higher values indicating greater disruption in the patient's social life.|units on a scale|Mean|6.50|6.5|Standard Deviation|2.15|2.15|||
4089050|NCT01000805|3912302|B1|||Sheehan Disability Scale-Item 2 (SDS-Item 2), N=262,265,527|The SDS is completed by the participant and Item 2 is used to assess the effect of the participant's symptoms on their social life/leisure activities. Scores range from 0 to 10 with higher values indicating greater disruption in the patient's social life.|units on a scale|Mean|6.43|6.43|Standard Deviation|2.27|2.27|||
4089051|NCT01000805|3912300|B3|||Sheehan Disability Scale-Item 1 (SDS-Item 1), N=196,200,396|The SDS is completed by the participant and Item 1 is used to assess the effect of the participant's symptoms on their work/school schedule. Scores range from 0 to 10 with higher values indicating greater disruption in the participant's work/school life.|units on a scale|Mean|6.23|6.23|Standard Deviation|2.22|2.22|||
4089052|NCT01000805|3912301|B2|||Sheehan Disability Scale-Item 1 (SDS-Item 1), N=196,200,396|The SDS is completed by the participant and Item 1 is used to assess the effect of the participant's symptoms on their work/school schedule. Scores range from 0 to 10 with higher values indicating greater disruption in the participant's work/school life.|units on a scale|Mean|6.23|6.23|Standard Deviation|2.15|2.15|||
4089053|NCT01000805|3912302|B1|||Sheehan Disability Scale-Item 1 (SDS-Item 1), N=196,200,396|The SDS is completed by the participant and Item 1 is used to assess the effect of the participant's symptoms on their work/school schedule. Scores range from 0 to 10 with higher values indicating greater disruption in the participant's work/school life.|units on a scale|Mean|6.24|6.24|Standard Deviation|2.30|2.3|||
4089054|NCT01000805|3912300|B3|||Montgomery Asberg Depression Rating Scale (MADRS) Total Score|The MADRS is a rating scale for severity of depressive mood symptoms. The MADRS has a 10-item checklist. Items are rated on a scale of 0-6, for a total score range of 0 (low severity of depressive symptoms) to 60 (high severity of depressive symptoms).|units on a scale|Mean|30.15|30.15|Standard Deviation|5.09|5.09|||
4089055|NCT01000805|3912301|B2|||Montgomery Asberg Depression Rating Scale (MADRS) Total Score|The MADRS is a rating scale for severity of depressive mood symptoms. The MADRS has a 10-item checklist. Items are rated on a scale of 0-6, for a total score range of 0 (low severity of depressive symptoms) to 60 (high severity of depressive symptoms).|units on a scale|Mean|30.39|30.39|Standard Deviation|5.25|5.25|||
4089056|NCT01000805|3912302|B1|||Montgomery Asberg Depression Rating Scale (MADRS) Total Score|The MADRS is a rating scale for severity of depressive mood symptoms. The MADRS has a 10-item checklist. Items are rated on a scale of 0-6, for a total score range of 0 (low severity of depressive symptoms) to 60 (high severity of depressive symptoms).|units on a scale|Mean|29.91|29.91|Standard Deviation|4.92|4.92|||
4089057|NCT01000805|3912300|B3|||Clinical Global Impressions of Severity Scale (CGI-S)|The CGI-S measures severity of illness at the time of assessment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|4.58|4.58|Standard Deviation|0.63|0.63|||
4089058|NCT01000805|3912301|B2|||Clinical Global Impressions of Severity Scale (CGI-S)|The CGI-S measures severity of illness at the time of assessment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|4.58|4.58|Standard Deviation|0.63|0.63|||
4089059|NCT01000805|3912302|B1|||Clinical Global Impressions of Severity Scale (CGI-S)|The CGI-S measures severity of illness at the time of assessment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|4.58|4.58|Standard Deviation|0.63|0.63|||
4089060|NCT01000805|3912300|B3|||Brief Pain Inventory - Interference (BPI-I)|The BPI-I scores range from 0 (does not interfere) to 10 (completely interferes). There are 7 questions assessing the interference of pain in the past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|5.66|5.66|Standard Deviation|2.16|2.16|||
4089061|NCT01000805|3912301|B2|||Brief Pain Inventory - Interference (BPI-I)|The BPI-I scores range from 0 (does not interfere) to 10 (completely interferes). There are 7 questions assessing the interference of pain in the past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|5.67|5.67|Standard Deviation|2.11|2.11|||
4089062|NCT01000805|3912302|B1|||Brief Pain Inventory - Interference (BPI-I)|The BPI-I scores range from 0 (does not interfere) to 10 (completely interferes). There are 7 questions assessing the interference of pain in the past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.|units on a scale|Mean|5.65|5.65|Standard Deviation|2.20|2.2|||
4089099|NCT01000805|3912300|B3||White|Race (NIH/OMB)||Participants|Count of Participants|435|435.0||||||
4089063|NCT01000805|3912300|B3|||Brief Pain Inventory Severity: Pain Right Now Score (BPI-S: Pain Right Now)|The BPI-S: Pain Right Now is a self-reported scale that measures the severity of pain based on the pain right now. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|5.32|5.32|Standard Deviation|2.24|2.24|||
4089064|NCT01000805|3912301|B2|||Brief Pain Inventory Severity: Pain Right Now Score (BPI-S: Pain Right Now)|The BPI-S: Pain Right Now is a self-reported scale that measures the severity of pain based on the pain right now. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|5.34|5.34|Standard Deviation|2.10|2.1|||
4089065|NCT01000805|3912302|B1|||Brief Pain Inventory Severity: Pain Right Now Score (BPI-S: Pain Right Now)|The BPI-S: Pain Right Now is a self-reported scale that measures the severity of pain based on the pain right now. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|5.29|5.29|Standard Deviation|2.37|2.37|||
4089066|NCT01000805|3912300|B3|||Brief Pain Inventory Severity: Average Pain Score (BPI-S: Average Pain)|The BPI-S: Average Pain is a self-reported scale that measures the severity of pain based on the average pain experienced over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|5.63|5.63|Standard Deviation|1.68|1.68|||
4089067|NCT01000805|3912301|B2|||Brief Pain Inventory Severity: Average Pain Score (BPI-S: Average Pain)|The BPI-S: Average Pain is a self-reported scale that measures the severity of pain based on the average pain experienced over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|5.58|5.58|Standard Deviation|1.67|1.67|||
4089068|NCT01000805|3912302|B1|||Brief Pain Inventory Severity: Average Pain Score (BPI-S: Average Pain)|The BPI-S: Average Pain is a self-reported scale that measures the severity of pain based on the average pain experienced over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|5.68|5.68|Standard Deviation|1.69|1.69|||
4089069|NCT01000805|3912300|B3|||Brief Pain Inventory Severity: Least Pain Score (BPI-S: Least Pain)|The BPI-S: Least Pain is a self-reported scale that measures the severity of pain based on the least pain experienced over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|4.19|4.19|Standard Deviation|2.19|2.19|||
4089070|NCT01000805|3912301|B2|||Brief Pain Inventory Severity: Least Pain Score (BPI-S: Least Pain)|The BPI-S: Least Pain is a self-reported scale that measures the severity of pain based on the least pain experienced over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|4.11|4.11|Standard Deviation|2.22|2.22|||
4089071|NCT01000805|3912302|B1|||Brief Pain Inventory Severity: Least Pain Score (BPI-S: Least Pain)|The BPI-S: Least Pain is a self-reported scale that measures the severity of pain based on the least pain experienced over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|4.27|4.27|Standard Deviation|2.17|2.17|||
4089072|NCT01000805|3912300|B3|||Brief Pain Inventory Severity: Worst Pain Score (BPI-S: Worst Pain)|The BPI-S: Worst Pain is a self-reported scale that measures the severity of pain based on the worst pain experienced over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|6.89|6.89|Standard Deviation|1.67|1.67|||
4089073|NCT01000805|3912301|B2|||Brief Pain Inventory Severity: Worst Pain Score (BPI-S: Worst Pain)|The BPI-S: Worst Pain is a self-reported scale that measures the severity of pain based on the worst pain experienced over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|6.86|6.86|Standard Deviation|1.70|1.7|||
4089074|NCT01000805|3912302|B1|||Brief Pain Inventory Severity: Worst Pain Score (BPI-S: Worst Pain)|The BPI-S: Worst Pain is a self-reported scale that measures the severity of pain based on the worst pain experienced over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|6.93|6.93|Standard Deviation|1.65|1.65|||
4089075|NCT01000805|3912300|B3|United States||Region of Enrollment||participants|Number|290|290.0||||||
4089076|NCT01000805|3912301|B2|United States||Region of Enrollment||participants|Number|145|145.0||||||
4089077|NCT01000805|3912302|B1|United States||Region of Enrollment||participants|Number|145|145.0||||||
4089078|NCT01000805|3912300|B3|Sweden||Region of Enrollment||participants|Number|44|44.0||||||
4089079|NCT01000805|3912301|B2|Sweden||Region of Enrollment||participants|Number|22|22.0||||||
4089080|NCT01000805|3912302|B1|Sweden||Region of Enrollment||participants|Number|22|22.0||||||
4089081|NCT01000805|3912300|B3|Romania||Region of Enrollment||participants|Number|26|26.0||||||
4089082|NCT01000805|3912301|B2|Romania||Region of Enrollment||participants|Number|15|15.0||||||
4089083|NCT01000805|3912302|B1|Romania||Region of Enrollment||participants|Number|11|11.0||||||
4089084|NCT01000805|3912300|B3|Puerto Rico||Region of Enrollment||participants|Number|72|72.0||||||
4089085|NCT01000805|3912301|B2|Puerto Rico||Region of Enrollment||participants|Number|35|35.0||||||
4089086|NCT01000805|3912302|B1|Puerto Rico||Region of Enrollment||participants|Number|37|37.0||||||
4089087|NCT01000805|3912300|B3|France||Region of Enrollment||participants|Number|62|62.0||||||
4089088|NCT01000805|3912301|B2|France||Region of Enrollment||participants|Number|33|33.0||||||
4089089|NCT01000805|3912302|B1|France||Region of Enrollment||participants|Number|29|29.0||||||
4089090|NCT01000805|3912300|B3|Germany||Region of Enrollment||participants|Number|34|34.0||||||
4089091|NCT01000805|3912301|B2|Germany||Region of Enrollment||participants|Number|16|16.0||||||
4089092|NCT01000805|3912302|B1|Germany||Region of Enrollment||participants|Number|18|18.0||||||
4089093|NCT01000805|3912300|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089094|NCT01000805|3912301|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089095|NCT01000805|3912302|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089096|NCT01000805|3912300|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4089097|NCT01000805|3912301|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4089100|NCT01000805|3912301|B2||White|Race (NIH/OMB)||Participants|Count of Participants|213|213.0||||||
4089101|NCT01000805|3912302|B1||White|Race (NIH/OMB)||Participants|Count of Participants|222|222.0||||||
4089102|NCT01000805|3912300|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
4089103|NCT01000805|3912301|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4089104|NCT01000805|3912302|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4089105|NCT01000805|3912300|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089106|NCT01000805|3912301|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089107|NCT01000805|3912302|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089108|NCT01000805|3912300|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4089109|NCT01000805|3912301|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4089110|NCT01000805|3912302|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4089111|NCT01000805|3912300|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4089112|NCT01000805|3912301|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4089113|NCT01000805|3912302|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4089114|NCT01000805|3912300|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089115|NCT01000805|3912301|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089116|NCT01000805|3912302|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089117|NCT01000805|3912300|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|397|397.0||||||
4089118|NCT01000805|3912301|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|203|203.0||||||
4089119|NCT01000805|3912302|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|194|194.0||||||
4089120|NCT01000805|3912300|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
4089121|NCT01000805|3912301|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4089122|NCT01000805|3912302|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4089123|NCT01000805|3912300|B3||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4089124|NCT01000805|3912301|B2||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4089125|NCT01000805|3912302|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4089126|NCT01000805|3912300|B3||Female|Sex: Female, Male||Participants|Count of Participants|364|364.0||||||
4089127|NCT01000805|3912301|B2||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4089128|NCT01000805|3912302|B1||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4089129|NCT01000805|3912300|B3|||Age||years|Mean|45.94|45.94|Standard Deviation|13.05|13.05|||
4089130|NCT01000805|3912301|B2|||Age||years|Mean|45.73|45.73|Standard Deviation|12.85|12.85|||
4089131|NCT01000805|3912302|B1|||Age||years|Mean|46.15|46.15|Standard Deviation|13.27|13.27|||
4089132|NCT01000727|3912335|B3|White - Mixed Race||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4089133|NCT01000727|3912336|B2|White - Mixed Race||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4089134|NCT01000727|3912337|B1|White - Mixed Race||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4089135|NCT01000727|3912335|B3|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4089136|NCT01000727|3912336|B2|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4089137|NCT01000727|3912337|B1|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4089138|NCT01000727|3912335|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4089139|NCT01000727|3912336|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4089140|NCT01000727|3912337|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4089141|NCT01000727|3912335|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|95|95.0||||||
4089142|NCT01000727|3912336|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|52|52.0||||||
4089143|NCT01000727|3912337|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|43|43.0||||||
4089144|NCT01000727|3912335|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|108|108.0||||||
4089145|NCT01000727|3912336|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|52|52.0||||||
4089146|NCT01000727|3912337|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|56|56.0||||||
4089147|NCT01000727|3912335|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|218|218.0||||||
4089148|NCT01000727|3912336|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|109|109.0||||||
4089149|NCT01000727|3912337|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|109|109.0||||||
4089150|NCT01000727|3912335|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|239|239.0||||||
4089151|NCT01000727|3912336|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|116|116.0||||||
4089152|NCT01000727|3912337|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|123|123.0||||||
4089153|NCT01000727|3912335|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|257|257.0||||||
4089154|NCT01000727|3912336|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|119|119.0||||||
4089360|NCT01000493|3912519|B3||White|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4089155|NCT01000727|3912337|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|138|138.0||||||
4089156|NCT01000727|3912335|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|315|315.0||||||
4089157|NCT01000727|3912336|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|155|155.0||||||
4089158|NCT01000727|3912337|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|160|160.0||||||
4089159|NCT01000727|3912335|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|411|411.0||||||
4089160|NCT01000727|3912336|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|211|211.0||||||
4089161|NCT01000727|3912337|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|200|200.0||||||
4089162|NCT01000727|3912335|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|700|700.0||||||
4089163|NCT01000727|3912336|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|349|349.0||||||
4089164|NCT01000727|3912337|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|351|351.0||||||
4089165|NCT01000727|3912335|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|10660|10660.0||||||
4089166|NCT01000727|3912336|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|5331|5331.0||||||
4089167|NCT01000727|3912337|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|5329|5329.0||||||
4089168|NCT01000727|3912335|B3||Male|Sex: Female, Male||Participants|Count of Participants|9700|9700.0||||||
4089169|NCT01000727|3912336|B2||Male|Sex: Female, Male||Participants|Count of Participants|4847|4847.0||||||
4089170|NCT01000727|3912337|B1||Male|Sex: Female, Male||Participants|Count of Participants|4853|4853.0||||||
4089171|NCT01000727|3912335|B3||Female|Sex: Female, Male||Participants|Count of Participants|3326|3326.0||||||
4089172|NCT01000727|3912336|B2||Female|Sex: Female, Male||Participants|Count of Participants|1657|1657.0||||||
4089173|NCT01000727|3912337|B1||Female|Sex: Female, Male||Participants|Count of Participants|1669|1669.0||||||
4089174|NCT01000727|3912335|B3|||Age||Years|Mean|64.2|64.2|Standard Deviation|9.51|9.51|||
4089175|NCT01000727|3912336|B2|||Age||Years|Mean|64.1|64.1|Standard Deviation|9.52|9.52|||
4089176|NCT01000727|3912337|B1|||Age||Years|Mean|64.3|64.3|Standard Deviation|9.50|9.5|||
4089177|NCT01000662|3912366|B3|United States||Region of Enrollment||participants|Number|412|412.0||||||
4089178|NCT01000662|3912367|B2|United States||Region of Enrollment||participants|Number|206|206.0||||||
4089179|NCT01000662|3912368|B1|United States||Region of Enrollment||participants|Number|206|206.0||||||
4089180|NCT01000662|3912366|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4089181|NCT01000662|3912367|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4089182|NCT01000662|3912368|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4089183|NCT01000662|3912366|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089184|NCT01000662|3912367|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089185|NCT01000662|3912368|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089186|NCT01000662|3912366|B3||White|Race (NIH/OMB)||Participants|Count of Participants|308|308.0||||||
4089187|NCT01000662|3912367|B2||White|Race (NIH/OMB)||Participants|Count of Participants|150|150.0||||||
4089188|NCT01000662|3912368|B1||White|Race (NIH/OMB)||Participants|Count of Participants|158|158.0||||||
4089189|NCT01000662|3912366|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4089190|NCT01000662|3912367|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4089191|NCT01000662|3912368|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4089192|NCT01000662|3912366|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4089193|NCT01000662|3912367|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089194|NCT01000662|3912368|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4089195|NCT01000662|3912366|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4089196|NCT01000662|3912367|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4089197|NCT01000662|3912368|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4089198|NCT01000662|3912366|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4089199|NCT01000662|3912367|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089200|NCT01000662|3912368|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4089201|NCT01000662|3912366|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4089202|NCT01000662|3912367|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4089203|NCT01000662|3912368|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4089204|NCT01000662|3912366|B3||Female|Sex: Female, Male||Participants|Count of Participants|412|412.0||||||
4089205|NCT01000662|3912367|B2||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
4089206|NCT01000662|3912368|B1||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
4089207|NCT01000662|3912366|B3||>=65 years|Age||Participants|Count of Participants|89|89.0||||||
4089208|NCT01000662|3912367|B2||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4089209|NCT01000662|3912368|B1||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
4089210|NCT01000662|3912366|B3||Between 18 and 65 years|Age||Participants|Count of Participants|323|323.0||||||
4089211|NCT01000662|3912367|B2||Between 18 and 65 years|Age||Participants|Count of Participants|168|168.0||||||
4089212|NCT01000662|3912368|B1||Between 18 and 65 years|Age||Participants|Count of Participants|155|155.0||||||
4089213|NCT01000662|3912366|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4089214|NCT01000662|3912367|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4089215|NCT01000662|3912368|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4089216|NCT01000649|3912375|B5|||Sequential Organ Failure Assessment (SOFA) Score|"The SOFA score, is used to track a patient’s status during the stay in an intensive care unit. This scoring system is used to determine the extent of a person’s organ function or rate of failure. The scoring system comprise of scores for six different system: Respiratory System; Nervous System; Cardiovascular System; Liver; Coagulation; and Renal System. Score for each system ranges from 0-4 (0=normal, 4=worst)..~Total SOFA score is a sum of the individual system score and range from 0 to 24, 0 being the better and 24 being the worst patient status."|Score on a scale|Mean|10.5|10.5|Standard Deviation|3.31|3.31|||
4089217|NCT01000649|3912376|B4|||Sequential Organ Failure Assessment (SOFA) Score|"The SOFA score, is used to track a patient’s status during the stay in an intensive care unit. This scoring system is used to determine the extent of a person’s organ function or rate of failure. The scoring system comprise of scores for six different system: Respiratory System; Nervous System; Cardiovascular System; Liver; Coagulation; and Renal System. Score for each system ranges from 0-4 (0=normal, 4=worst)..~Total SOFA score is a sum of the individual system score and range from 0 to 24, 0 being the better and 24 being the worst patient status."|Score on a scale|Mean|10.4|10.4|Standard Deviation|3.46|3.46|||
4089218|NCT01000649|3912377|B3|||Sequential Organ Failure Assessment (SOFA) Score|"The SOFA score, is used to track a patient’s status during the stay in an intensive care unit. This scoring system is used to determine the extent of a person’s organ function or rate of failure. The scoring system comprise of scores for six different system: Respiratory System; Nervous System; Cardiovascular System; Liver; Coagulation; and Renal System. Score for each system ranges from 0-4 (0=normal, 4=worst)..~Total SOFA score is a sum of the individual system score and range from 0 to 24, 0 being the better and 24 being the worst patient status."|Score on a scale|Mean|12|12.0|Standard Deviation|0|0.0|||
4089219|NCT01000649|3912378|B2|||Sequential Organ Failure Assessment (SOFA) Score|"The SOFA score, is used to track a patient’s status during the stay in an intensive care unit. This scoring system is used to determine the extent of a person’s organ function or rate of failure. The scoring system comprise of scores for six different system: Respiratory System; Nervous System; Cardiovascular System; Liver; Coagulation; and Renal System. Score for each system ranges from 0-4 (0=normal, 4=worst)..~Total SOFA score is a sum of the individual system score and range from 0 to 24, 0 being the better and 24 being the worst patient status."|Score on a scale|Mean|11.2|11.2|Standard Deviation|3.73|3.73|||
4089220|NCT01000649|3912379|B1|||Sequential Organ Failure Assessment (SOFA) Score|"The SOFA score, is used to track a patient’s status during the stay in an intensive care unit. This scoring system is used to determine the extent of a person’s organ function or rate of failure. The scoring system comprise of scores for six different system: Respiratory System; Nervous System; Cardiovascular System; Liver; Coagulation; and Renal System. Score for each system ranges from 0-4 (0=normal, 4=worst)..~Total SOFA score is a sum of the individual system score and range from 0 to 24, 0 being the better and 24 being the worst patient status."|Score on a scale|Mean|9.3|9.3|Standard Deviation|2.16|2.16|||
4089221|NCT01000649|3912375|B5|||Weight||Kilogram|Mean|77.8|77.8|Standard Deviation|22.2|22.2|||
4089222|NCT01000649|3912376|B4|||Weight||Kilogram|Mean|75.1|75.1|Standard Deviation|15.3|15.3|||
4089223|NCT01000649|3912377|B3|||Weight||Kilogram|Mean|77.5|77.5|Standard Deviation|17.7|17.7|||
4089224|NCT01000649|3912378|B2|||Weight||Kilogram|Mean|87.6|87.6|Standard Deviation|28.6|28.6|||
4089225|NCT01000649|3912379|B1|||Weight||Kilogram|Mean|64.8|64.8|Standard Deviation|14.3|14.3|||
4089226|NCT01000649|3912375|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089227|NCT01000649|3912376|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089228|NCT01000649|3912377|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089229|NCT01000649|3912378|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089230|NCT01000649|3912379|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089231|NCT01000649|3912375|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089232|NCT01000649|3912376|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089233|NCT01000649|3912377|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089234|NCT01000649|3912378|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089235|NCT01000649|3912379|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089236|NCT01000649|3912375|B5||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4089237|NCT01000649|3912376|B4||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4089238|NCT01000649|3912377|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4089239|NCT01000649|3912378|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4089240|NCT01000649|3912379|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4089241|NCT01000649|3912375|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4089242|NCT01000649|3912376|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4089243|NCT01000649|3912377|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089244|NCT01000649|3912378|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4089245|NCT01000649|3912379|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089246|NCT01000649|3912375|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089247|NCT01000649|3912376|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089248|NCT01000649|3912377|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089249|NCT01000649|3912378|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089250|NCT01000649|3912379|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089251|NCT01000649|3912375|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089252|NCT01000649|3912376|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089253|NCT01000649|3912377|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089254|NCT01000649|3912378|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089255|NCT01000649|3912379|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089256|NCT01000649|3912375|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089257|NCT01000649|3912376|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089258|NCT01000649|3912377|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089259|NCT01000649|3912378|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089260|NCT01000649|3912379|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089261|NCT01000649|3912375|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089262|NCT01000649|3912376|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089263|NCT01000649|3912377|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089264|NCT01000649|3912378|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089265|NCT01000649|3912379|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089266|NCT01000649|3912375|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4089267|NCT01000649|3912376|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4089268|NCT01000649|3912377|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4089269|NCT01000649|3912378|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4089270|NCT01000649|3912379|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4089271|NCT01000649|3912375|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4089272|NCT01000649|3912376|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4089273|NCT01000649|3912377|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089274|NCT01000649|3912378|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089275|NCT01000649|3912379|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089276|NCT01000649|3912375|B5||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4089277|NCT01000649|3912376|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4089278|NCT01000649|3912377|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4089279|NCT01000649|3912378|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4089280|NCT01000649|3912379|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4089281|NCT01000649|3912375|B5||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4089282|NCT01000649|3912376|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4089283|NCT01000649|3912377|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4089284|NCT01000649|3912378|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4089285|NCT01000649|3912379|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4089286|NCT01000649|3912375|B5|||Age||years|Mean|60.4|60.4|Standard Deviation|17.1|17.1|||
4089287|NCT01000649|3912376|B4|||Age||years|Mean|63.2|63.2|Standard Deviation|18|18.0|||
4089288|NCT01000649|3912377|B3|||Age||years|Mean|69|69.0|Standard Deviation|12.7|12.7|||
4089289|NCT01000649|3912378|B2|||Age||years|Mean|57.1|57.1|Standard Deviation|15.4|15.4|||
4089290|NCT01000649|3912379|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|19.6|19.6|||
4089291|NCT01000610|3912463|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4089292|NCT01000610|3912463|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4089293|NCT01000610|3912463|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|7.91|7.91|||
4089294|NCT01000506|3912470|B5|Mixed Race||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4089295|NCT01000506|3912471|B4|Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4089296|NCT01000506|3912472|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4089297|NCT01000506|3912473|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4089298|NCT01000506|3912474|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4089299|NCT01000506|3912470|B5|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|547|547.0||||||
4089300|NCT01000506|3912471|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|139|139.0||||||
4089301|NCT01000506|3912472|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|133|133.0||||||
4089302|NCT01000506|3912473|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|138|138.0||||||
4089303|NCT01000506|3912474|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|137|137.0||||||
4089304|NCT01000506|3912470|B5|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4089305|NCT01000506|3912471|B4|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4089306|NCT01000506|3912472|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4089307|NCT01000506|3912473|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4089308|NCT01000506|3912474|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4089309|NCT01000506|3912470|B5|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4089310|NCT01000506|3912471|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4089311|NCT01000506|3912472|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4089312|NCT01000506|3912473|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4089313|NCT01000506|3912474|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4089314|NCT01000506|3912470|B5|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4089315|NCT01000506|3912471|B4|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4089316|NCT01000506|3912472|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4089317|NCT01000506|3912473|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4089318|NCT01000506|3912474|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4089319|NCT01000506|3912470|B5|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|26|26.0||||||
4089320|NCT01000506|3912471|B4|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4089321|NCT01000506|3912472|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4089322|NCT01000506|3912473|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4089323|NCT01000506|3912474|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4089324|NCT01000506|3912470|B5|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4089325|NCT01000506|3912471|B4|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4089326|NCT01000506|3912472|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4089327|NCT01000506|3912473|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4089328|NCT01000506|3912474|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4089329|NCT01000506|3912470|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4089330|NCT01000506|3912471|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4089331|NCT01000506|3912472|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4089332|NCT01000506|3912473|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4089333|NCT01000506|3912474|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4089334|NCT01000506|3912470|B5|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
4089335|NCT01000506|3912471|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4089336|NCT01000506|3912472|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4089337|NCT01000506|3912473|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4089338|NCT01000506|3912474|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4089339|NCT01000506|3912470|B5||Male|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4089340|NCT01000506|3912471|B4||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4089341|NCT01000506|3912472|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4089342|NCT01000506|3912473|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4089343|NCT01000506|3912474|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4089344|NCT01000506|3912470|B5||Female|Sex: Female, Male||Participants|Count of Participants|387|387.0||||||
4089345|NCT01000506|3912471|B4||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4089346|NCT01000506|3912472|B3||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4089347|NCT01000506|3912473|B2||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4089348|NCT01000506|3912474|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4089349|NCT01000506|3912470|B5|||Age||Years|Mean|48.6|48.6|Standard Deviation|11.28|11.28|||
4089350|NCT01000506|3912471|B4|||Age||Years|Mean|48.6|48.6|Standard Deviation|11.06|11.06|||
4089351|NCT01000506|3912472|B3|||Age||Years|Mean|49.4|49.4|Standard Deviation|11.63|11.63|||
4089352|NCT01000506|3912473|B2|||Age||Years|Mean|50.2|50.2|Standard Deviation|10.84|10.84|||
4089353|NCT01000506|3912474|B1|||Age||Years|Mean|46.4|46.4|Standard Deviation|11.33|11.33|||
4089354|NCT01000493|3912519|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089355|NCT01000493|3912520|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089356|NCT01000493|3912521|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089357|NCT01000493|3912519|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4089358|NCT01000493|3912520|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4089359|NCT01000493|3912521|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4089361|NCT01000493|3912520|B2||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4089362|NCT01000493|3912521|B1||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4089363|NCT01000493|3912519|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4089364|NCT01000493|3912520|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4089365|NCT01000493|3912521|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4089366|NCT01000493|3912519|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089367|NCT01000493|3912520|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089368|NCT01000493|3912521|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089369|NCT01000493|3912519|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4089370|NCT01000493|3912520|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089371|NCT01000493|3912521|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4089372|NCT01000493|3912519|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4089373|NCT01000493|3912520|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089374|NCT01000493|3912521|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4089375|NCT01000493|3912519|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4089376|NCT01000493|3912520|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4089377|NCT01000493|3912521|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4089378|NCT01000493|3912519|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4089379|NCT01000493|3912520|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4089380|NCT01000493|3912521|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4089381|NCT01000493|3912519|B3|||Age||Years|Mean|36.7|36.7|Standard Deviation|11.59|11.59|||
4089382|NCT01000493|3912520|B2|||Age||Years|Mean|37.0|37.0|Standard Deviation|12.24|12.24|||
4089383|NCT01000493|3912521|B1|||Age||Years|Mean|36.3|36.3|Standard Deviation|10.88|10.88|||
4089384|NCT01000480|3912572|B1|Current use of tobacco||Current Tobacco Use||participants|Number|28|28.0||||||
4089385|NCT01000480|3912572|B1|Former user of tobacco||Current Tobacco Use||participants|Number|55|55.0||||||
4089386|NCT01000480|3912572|B1|Never used tobacco||Current Tobacco Use||participants|Number|7|7.0||||||
4089387|NCT01000480|3912572|B1|Carcinoma (non-small cell, poorly differentiated)||Initial pathological diagnosis|The number of participants with an initial pathological diagnosis of Adenocarcinoma (lung), Carcinoma (large cell, lung), Carcinoma [non-small cell, lung, not otherwise specified (NOS)], Carcinoma (non-small cell, lung, poorly differentiated).|participants|Number|1|1.0||||||
4089388|NCT01000480|3912572|B1|Carcinoma (non-small cell, lung, NOS)||Initial pathological diagnosis|The number of participants with an initial pathological diagnosis of Adenocarcinoma (lung), Carcinoma (large cell, lung), Carcinoma [non-small cell, lung, not otherwise specified (NOS)], Carcinoma (non-small cell, lung, poorly differentiated).|participants|Number|1|1.0||||||
4089389|NCT01000480|3912572|B1|Carcinoma (large cell, lung)||Initial pathological diagnosis|The number of participants with an initial pathological diagnosis of Adenocarcinoma (lung), Carcinoma (large cell, lung), Carcinoma [non-small cell, lung, not otherwise specified (NOS)], Carcinoma (non-small cell, lung, poorly differentiated).|participants|Number|7|7.0||||||
4089390|NCT01000480|3912572|B1|Adenocarcinoma (lung)||Initial pathological diagnosis|The number of participants with an initial pathological diagnosis of Adenocarcinoma (lung), Carcinoma (large cell, lung), Carcinoma [non-small cell, lung, not otherwise specified (NOS)], Carcinoma (non-small cell, lung, poorly differentiated).|participants|Number|81|81.0||||||
4089391|NCT01000480|3912572|B1|ECOG PS=2||Eastern Cooperative Oncology Group (ECOG) performance status (PS)|ECOG PS classified participants according to their functional impairment. Scores ranged from 0 (Fully Active) to 5 (Death). 0=Fully Active; 1=Ambulatory, Restricted Strenuous Activity; 2=Ambulatory, No Work Activities; 3=Partially Confined to Bed, Limited Self Care; 4=Completely Disabled; and 5=Death.|participants|Number|0|0.0||||||
4089392|NCT01000480|3912572|B1|ECOG PS=1||Eastern Cooperative Oncology Group (ECOG) performance status (PS)|ECOG PS classified participants according to their functional impairment. Scores ranged from 0 (Fully Active) to 5 (Death). 0=Fully Active; 1=Ambulatory, Restricted Strenuous Activity; 2=Ambulatory, No Work Activities; 3=Partially Confined to Bed, Limited Self Care; 4=Completely Disabled; and 5=Death.|participants|Number|31|31.0||||||
4089393|NCT01000480|3912572|B1|ECOG PS=0||Eastern Cooperative Oncology Group (ECOG) performance status (PS)|ECOG PS classified participants according to their functional impairment. Scores ranged from 0 (Fully Active) to 5 (Death). 0=Fully Active; 1=Ambulatory, Restricted Strenuous Activity; 2=Ambulatory, No Work Activities; 3=Partially Confined to Bed, Limited Self Care; 4=Completely Disabled; and 5=Death.|participants|Number|59|59.0||||||
4089394|NCT01000480|3912572|B1|Stage IV||Stage of Disease|Classification based on American Joint Committee on Cancer (AJCC) Staging System for lung cancer (sixth edition, 2002). Disease stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIA is a locally advanced cancer that spread to lymph nodes within the chest area. Stage IIIB is a locally advanced cancer that spread to nearby tissue or far away lymph nodes, or has fluid, containing cancer cells, built up between the layers lining the lungs.|participants|Number|2|2.0||||||
4089395|NCT01000480|3912572|B1|Stage IIIB||Stage of Disease|Classification based on American Joint Committee on Cancer (AJCC) Staging System for lung cancer (sixth edition, 2002). Disease stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIA is a locally advanced cancer that spread to lymph nodes within the chest area. Stage IIIB is a locally advanced cancer that spread to nearby tissue or far away lymph nodes, or has fluid, containing cancer cells, built up between the layers lining the lungs.|participants|Number|56|56.0||||||
4089453|NCT01000337|3912589|B3||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
4089396|NCT01000480|3912572|B1|Stage IIIA||Stage of Disease|Classification based on American Joint Committee on Cancer (AJCC) Staging System for lung cancer (sixth edition, 2002). Disease stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIA is a locally advanced cancer that spread to lymph nodes within the chest area. Stage IIIB is a locally advanced cancer that spread to nearby tissue or far away lymph nodes, or has fluid, containing cancer cells, built up between the layers lining the lungs.|participants|Number|32|32.0||||||
4089397|NCT01000480|3912572|B1|Italy||Region of Enrollment||participants|Number|22|22.0||||||
4089398|NCT01000480|3912572|B1|Germany||Region of Enrollment||participants|Number|42|42.0||||||
4089399|NCT01000480|3912572|B1|Spain||Region of Enrollment||participants|Number|17|17.0||||||
4089400|NCT01000480|3912572|B1|France||Region of Enrollment||participants|Number|9|9.0||||||
4089401|NCT01000480|3912572|B1|White||Race/Ethnicity, Customized||participants|Number|90|90.0||||||
4089402|NCT01000480|3912572|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4089403|NCT01000480|3912572|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4089404|NCT01000480|3912572|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|8.15|8.15|||
4089405|NCT01000376|3912578|B3|Netherlands||Region of Enrollment||participants|Number|12|12.0||||||
4089406|NCT01000376|3912579|B2|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
4089407|NCT01000376|3912580|B1|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
4089408|NCT01000376|3912578|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089409|NCT01000376|3912579|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089410|NCT01000376|3912580|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089411|NCT01000376|3912578|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089412|NCT01000376|3912579|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089413|NCT01000376|3912580|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089414|NCT01000376|3912578|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4089415|NCT01000376|3912579|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4089416|NCT01000376|3912580|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4089417|NCT01000376|3912578|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089418|NCT01000376|3912579|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089419|NCT01000376|3912580|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089420|NCT01000376|3912578|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089421|NCT01000376|3912579|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089422|NCT01000376|3912580|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089423|NCT01000376|3912578|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089424|NCT01000376|3912579|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089425|NCT01000376|3912580|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089426|NCT01000376|3912578|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089427|NCT01000376|3912579|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089428|NCT01000376|3912580|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089429|NCT01000376|3912578|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4089430|NCT01000376|3912579|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4089431|NCT01000376|3912580|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4089432|NCT01000376|3912578|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4089433|NCT01000376|3912579|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4089434|NCT01000376|3912580|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4089435|NCT01000376|3912578|B3|||Age||years|Mean|60.4|60.4|Standard Deviation|8.7|8.7|||
4089436|NCT01000376|3912579|B2|||Age||years|Mean|62.5|62.5|Standard Deviation|5.5|5.5|||
4089437|NCT01000376|3912580|B1|||Age||years|Mean|58.3|58.3|Standard Deviation|11.22|11.22|||
4089438|NCT01000337|3912589|B3|Greece||Region of Enrollment||participants|Number|67|67.0||||||
4089439|NCT01000337|3912590|B2|Greece||Region of Enrollment||participants|Number|33|33.0||||||
4089440|NCT01000337|3912591|B1|Greece||Region of Enrollment||participants|Number|34|34.0||||||
4089441|NCT01000337|3912589|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4089442|NCT01000337|3912590|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4089443|NCT01000337|3912591|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4089444|NCT01000337|3912589|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4089445|NCT01000337|3912590|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4089446|NCT01000337|3912591|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4089447|NCT01000337|3912589|B3|||Age||years|Mean|51.1|51.1|Standard Deviation|10.7|10.7|||
4089448|NCT01000337|3912590|B2|||Age||years|Mean|48.30|48.3|Standard Deviation|10.81|10.81|||
4089449|NCT01000337|3912591|B1|||Age||years|Mean|53.93|53.93|Standard Deviation|10.19|10.19|||
4089450|NCT01000337|3912589|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4089451|NCT01000337|3912590|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4089452|NCT01000337|3912591|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4089454|NCT01000337|3912590|B2||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4089455|NCT01000337|3912591|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4089456|NCT01000337|3912589|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4089457|NCT01000337|3912590|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4089458|NCT01000337|3912591|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4089459|NCT01000324|3912598|B1||Male|Sex: Female, Male|The baseline measure data here corresponds to Year 20|Participants|Count of Participants|5|5.0||||||
4089460|NCT01000324|3912598|B1||Female|Sex: Female, Male|The baseline measure data here corresponds to Year 20|Participants|Count of Participants|23|23.0||||||
4089461|NCT01000324|3912598|B1||Male|Sex: Female, Male|The baseline measure data here corresponds to Year 19|Participants|Count of Participants|7|7.0||||||
4089462|NCT01000324|3912598|B1||Female|Sex: Female, Male|The baseline measure data here corresponds to Year 19|Participants|Count of Participants|21|21.0||||||
4089463|NCT01000324|3912598|B1||Male|Sex: Female, Male|The baseline measure data here corresponds to Year 18|Participants|Count of Participants|7|7.0||||||
4089464|NCT01000324|3912598|B1||Female|Sex: Female, Male|The baseline measure data here corresponds to Year 18|Participants|Count of Participants|22|22.0||||||
4089465|NCT01000324|3912598|B1||Male|Sex: Female, Male|The baseline measure data here corresponds to Year 17|Participants|Count of Participants|7|7.0||||||
4089466|NCT01000324|3912598|B1||Female|Sex: Female, Male|The baseline measure data here corresponds to Year 17|Participants|Count of Participants|25|25.0||||||
4089467|NCT01000324|3912598|B1||Male|Sex: Female, Male|The baseline measure data here corresponds to Year 16|Participants|Count of Participants|11|11.0||||||
4089468|NCT01000324|3912598|B1||Female|Sex: Female, Male|The baseline measure data here corresponds to Year 16|Participants|Count of Participants|29|29.0||||||
4089469|NCT01000324|3912598|B1|||Age|The baseline measure data here corresponds to Year 20|Years|Mean|39.6|39.6|Standard Deviation|1.4|1.4|||
4089470|NCT01000324|3912598|B1|||Age|The baseline measure data here corresponds to Year 19|Years|Mean|38.8|38.8|Standard Deviation|3.31|3.31|||
4089471|NCT01000324|3912598|B1|||Age|The baseline measure data here corresponds to Year 18|Years|Mean|37.7|37.7|Standard Deviation|3.25|3.25|||
4089472|NCT01000324|3912598|B1|||Age|The baseline measure data here corresponds to Year 17|Years|Mean|36.3|36.3|Standard Deviation|1.52|1.52|||
4089473|NCT01000324|3912598|B1|||Age|The baseline measure data here corresponds to Year 16|Years|Mean|35.5|35.5|Standard Deviation|2.87|2.87|||
4089474|NCT01000311|3912608|B3||Male|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
4089475|NCT01000311|3912609|B2||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4089476|NCT01000311|3912610|B1||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4089477|NCT01000311|3912608|B3||Female|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
4089478|NCT01000311|3912609|B2||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4089479|NCT01000311|3912610|B1||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4089480|NCT01000311|3912608|B3|||Age||Days|Mean|65.1|65.1|Standard Deviation|7.0|7.0|||
4089481|NCT01000311|3912609|B2|||Age||Days|Mean|65.4|65.4|Standard Deviation|7.4|7.4|||
4089482|NCT01000311|3912610|B1|||Age||Days|Mean|64.7|64.7|Standard Deviation|6.5|6.5|||
4089483|NCT01000285|3912639|B3|Bahamas||Birthplace||participants|Number|1|1.0||||||
4089484|NCT01000285|3912640|B2|Bahamas||Birthplace||participants|Number|0|0.0||||||
4089485|NCT01000285|3912641|B1|Bahamas||Birthplace||participants|Number|1|1.0||||||
4089486|NCT01000285|3912639|B3|Virgin Islands||Birthplace||participants|Number|1|1.0||||||
4089487|NCT01000285|3912640|B2|Virgin Islands||Birthplace||participants|Number|1|1.0||||||
4089488|NCT01000285|3912641|B1|Virgin Islands||Birthplace||participants|Number|0|0.0||||||
4089489|NCT01000285|3912639|B3|USA||Birthplace||participants|Number|3|3.0||||||
4089490|NCT01000285|3912640|B2|USA||Birthplace||participants|Number|2|2.0||||||
4089491|NCT01000285|3912641|B1|USA||Birthplace||participants|Number|1|1.0||||||
4089492|NCT01000285|3912639|B3|Jamaica||Birthplace||participants|Number|8|8.0||||||
4089493|NCT01000285|3912640|B2|Jamaica||Birthplace||participants|Number|5|5.0||||||
4089494|NCT01000285|3912641|B1|Jamaica||Birthplace||participants|Number|3|3.0||||||
4089495|NCT01000285|3912639|B3|Haiti||Birthplace||participants|Number|3|3.0||||||
4089496|NCT01000285|3912640|B2|Haiti||Birthplace||participants|Number|3|3.0||||||
4089497|NCT01000285|3912641|B1|Haiti||Birthplace||participants|Number|0|0.0||||||
4089498|NCT01000285|3912639|B3|Dominican Republic||Birthplace||participants|Number|1|1.0||||||
4089499|NCT01000285|3912640|B2|Dominican Republic||Birthplace||participants|Number|0|0.0||||||
4089500|NCT01000285|3912641|B1|Dominican Republic||Birthplace||participants|Number|1|1.0||||||
4089501|NCT01000285|3912639|B3|Antigua||Birthplace||participants|Number|1|1.0||||||
4089502|NCT01000285|3912640|B2|Antigua||Birthplace||participants|Number|1|1.0||||||
4089503|NCT01000285|3912641|B1|Antigua||Birthplace||participants|Number|0|0.0||||||
4089504|NCT01000285|3912639|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4089505|NCT01000285|3912640|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4089506|NCT01000285|3912641|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4089507|NCT01000285|3912639|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4089508|NCT01000285|3912640|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4089509|NCT01000285|3912641|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4089510|NCT01000285|3912639|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4089511|NCT01000285|3912640|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4089512|NCT01000285|3912641|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4089513|NCT01000285|3912639|B3|||Age||years|Median|52|52.0|Full Range|||36.0|76.0|
4089514|NCT01000285|3912640|B2|||Age||years|Median|56|56.0|Full Range|||36.0|76.0|
4089515|NCT01000285|3912641|B1|||Age||years|Median|51.5|51.5|Full Range|||38.0|70.0|
4089516|NCT01000155|3912661|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4089517|NCT01000155|3912661|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4089518|NCT01000155|3912661|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4089519|NCT01000155|3912661|B1|||Age||years|Median|37|37.0|Full Range|||21.0|44.0|
4089520|NCT01000064|3912667|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4089521|NCT01000064|3912667|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4089522|NCT01000064|3912667|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4089523|NCT01000064|3912667|B1|||Age||years|Mean|28.85|28.85|Standard Deviation|8.61|8.61|||
4089524|NCT01000064|3912667|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4089525|NCT01000064|3912667|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4089526|NCT01000064|3912667|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4089527|NCT01000025|3912689|B3|Argentina||Region of Enrollment||participants|Number|10|10.0||||||
4089528|NCT01000025|3912690|B2|Argentina||Region of Enrollment||participants|Number|3|3.0||||||
4089529|NCT01000025|3912691|B1|Argentina||Region of Enrollment||participants|Number|7|7.0||||||
4089530|NCT01000025|3912689|B3|Korea, Republic of||Region of Enrollment||participants|Number|71|71.0||||||
4089531|NCT01000025|3912690|B2|Korea, Republic of||Region of Enrollment||participants|Number|24|24.0||||||
4089532|NCT01000025|3912691|B1|Korea, Republic of||Region of Enrollment||participants|Number|47|47.0||||||
4089533|NCT01000025|3912689|B3|Italy||Region of Enrollment||participants|Number|111|111.0||||||
4089534|NCT01000025|3912690|B2|Italy||Region of Enrollment||participants|Number|34|34.0||||||
4089535|NCT01000025|3912691|B1|Italy||Region of Enrollment||participants|Number|77|77.0||||||
4089536|NCT01000025|3912689|B3|New Zealand||Region of Enrollment||participants|Number|11|11.0||||||
4089537|NCT01000025|3912690|B2|New Zealand||Region of Enrollment||participants|Number|4|4.0||||||
4089538|NCT01000025|3912691|B1|New Zealand||Region of Enrollment||participants|Number|7|7.0||||||
4089539|NCT01000025|3912689|B3|Australia||Region of Enrollment||participants|Number|77|77.0||||||
4089540|NCT01000025|3912690|B2|Australia||Region of Enrollment||participants|Number|27|27.0||||||
4089541|NCT01000025|3912691|B1|Australia||Region of Enrollment||participants|Number|50|50.0||||||
4089542|NCT01000025|3912689|B3|Peru||Region of Enrollment||participants|Number|1|1.0||||||
4089543|NCT01000025|3912690|B2|Peru||Region of Enrollment||participants|Number|1|1.0||||||
4089544|NCT01000025|3912691|B1|Peru||Region of Enrollment||participants|Number|0|0.0||||||
4089545|NCT01000025|3912689|B3|Brazil||Region of Enrollment||participants|Number|39|39.0||||||
4089546|NCT01000025|3912690|B2|Brazil||Region of Enrollment||participants|Number|14|14.0||||||
4089547|NCT01000025|3912691|B1|Brazil||Region of Enrollment||participants|Number|25|25.0||||||
4089548|NCT01000025|3912689|B3|Thailand||Region of Enrollment||participants|Number|42|42.0||||||
4089549|NCT01000025|3912690|B2|Thailand||Region of Enrollment||participants|Number|14|14.0||||||
4089550|NCT01000025|3912691|B1|Thailand||Region of Enrollment||participants|Number|28|28.0||||||
4089551|NCT01000025|3912689|B3|Canada||Region of Enrollment||participants|Number|308|308.0||||||
4089552|NCT01000025|3912690|B2|Canada||Region of Enrollment||participants|Number|101|101.0||||||
4089553|NCT01000025|3912691|B1|Canada||Region of Enrollment||participants|Number|207|207.0||||||
4089554|NCT01000025|3912689|B3|Taiwan||Region of Enrollment||participants|Number|17|17.0||||||
4089555|NCT01000025|3912690|B2|Taiwan||Region of Enrollment||participants|Number|6|6.0||||||
4089556|NCT01000025|3912691|B1|Taiwan||Region of Enrollment||participants|Number|11|11.0||||||
4089557|NCT01000025|3912689|B3|Philippines||Region of Enrollment||participants|Number|31|31.0||||||
4089558|NCT01000025|3912690|B2|Philippines||Region of Enrollment||participants|Number|11|11.0||||||
4089559|NCT01000025|3912691|B1|Philippines||Region of Enrollment||participants|Number|20|20.0||||||
4089560|NCT01000025|3912689|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4089561|NCT01000025|3912690|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4089562|NCT01000025|3912691|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4089563|NCT01000025|3912689|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4089564|NCT01000025|3912690|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4089565|NCT01000025|3912691|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4089566|NCT01000025|3912689|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089567|NCT01000025|3912690|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089568|NCT01000025|3912691|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089569|NCT01000025|3912689|B3||White|Race (NIH/OMB)||Participants|Count of Participants|432|432.0||||||
4089570|NCT01000025|3912690|B2||White|Race (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
4089571|NCT01000025|3912691|B1||White|Race (NIH/OMB)||Participants|Count of Participants|288|288.0||||||
4089572|NCT01000025|3912689|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4089573|NCT01000025|3912690|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4089574|NCT01000025|3912691|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4089575|NCT01000025|3912689|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4089576|NCT01000025|3912690|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089577|NCT01000025|3912691|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4089578|NCT01000025|3912689|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|259|259.0||||||
4089579|NCT01000025|3912690|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
4089580|NCT01000025|3912691|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|172|172.0||||||
4089581|NCT01000025|3912689|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4089582|NCT01000025|3912690|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089583|NCT01000025|3912691|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4089584|NCT01000025|3912689|B3||Male|Sex: Female, Male||Participants|Count of Participants|364|364.0||||||
4089585|NCT01000025|3912690|B2||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4089586|NCT01000025|3912691|B1||Male|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
4089587|NCT01000025|3912689|B3||Female|Sex: Female, Male||Participants|Count of Participants|356|356.0||||||
4089588|NCT01000025|3912690|B2||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4089589|NCT01000025|3912691|B1||Female|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
4089590|NCT01000025|3912689|B3|||Age||years|Median|64|64.0|Full Range|||32.0|90.0|
4089591|NCT01000025|3912690|B2|||Age||years|Median|65.5|65.5|Full Range|||34.0|90.0|
4089592|NCT01000025|3912691|B1|||Age||years|Median|63.5|63.5|Full Range|||32.0|86.0|
4089593|NCT00999921|3912708|B3|India||Region of Enrollment||participants|Number|256|256.0||||||
4089594|NCT00999921|3912709|B2|India||Region of Enrollment||participants|Number|129|129.0||||||
4089595|NCT00999921|3912710|B1|India||Region of Enrollment||participants|Number|127|127.0||||||
4089596|NCT00999921|3912708|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4089597|NCT00999921|3912709|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4089598|NCT00999921|3912710|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4089599|NCT00999921|3912708|B3||Female|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
4089600|NCT00999921|3912709|B2||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4089601|NCT00999921|3912710|B1||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4089602|NCT00999921|3912708|B3|||Age||years|Mean|25.27|25.27|Standard Deviation|4.0|4.0|||
4089603|NCT00999921|3912709|B2|||Age||years|Mean|25.16|25.16|Standard Deviation|3.8|3.8|||
4089604|NCT00999921|3912710|B1|||Age||years|Mean|25.38|25.38|Standard Deviation|4.2|4.2|||
4089605|NCT00999921|3912708|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4089606|NCT00999921|3912709|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4089607|NCT00999921|3912710|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4089608|NCT00999921|3912708|B3||Between 18 and 65 years|Age||Participants|Count of Participants|251|251.0||||||
4089609|NCT00999921|3912709|B2||Between 18 and 65 years|Age||Participants|Count of Participants|127|127.0||||||
4089610|NCT00999921|3912710|B1||Between 18 and 65 years|Age||Participants|Count of Participants|124|124.0||||||
4089611|NCT00999921|3912708|B3||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4089612|NCT00999921|3912709|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4089613|NCT00999921|3912710|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4089614|NCT00999908|3912721|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4089615|NCT00999908|3912721|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4089616|NCT00999908|3912721|B1|||Age||years|Mean|69.3|69.3|Standard Deviation|9.2|9.2|||
4089617|NCT00999830|3912737|B3|France||Region of Enrollment||participants|Number|27|27.0||||||
4089618|NCT00999830|3912738|B2|France||Region of Enrollment||participants|Number|13|13.0||||||
4089619|NCT00999830|3912739|B1|France||Region of Enrollment||participants|Number|14|14.0||||||
4089620|NCT00999830|3912737|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4089621|NCT00999830|3912738|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4089622|NCT00999830|3912739|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4089623|NCT00999830|3912737|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4089624|NCT00999830|3912738|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4089625|NCT00999830|3912739|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4089626|NCT00999830|3912737|B3|||Age||years|Mean|57.3|57.3|Standard Deviation|8.1|8.1|||
4089627|NCT00999830|3912738|B2|||Age||years|Mean|55.9|55.9|Standard Deviation|10.2|10.2|||
4089628|NCT00999830|3912739|B1|||Age||years|Mean|58.6|58.6|Standard Deviation|5.6|5.6|||
4089629|NCT00999830|3912737|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4089630|NCT00999830|3912738|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4089631|NCT00999830|3912739|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4089632|NCT00999830|3912737|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4089633|NCT00999830|3912738|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4089634|NCT00999830|3912739|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4089635|NCT00999830|3912737|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4089636|NCT00999830|3912738|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4089637|NCT00999830|3912739|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4089638|NCT00999804|3912750|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4089639|NCT00999804|3912751|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089640|NCT00999804|3912752|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4089641|NCT00999804|3912750|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4089642|NCT00999804|3912751|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089643|NCT00999804|3912752|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4089644|NCT00999804|3912750|B3||White|Race (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
4089645|NCT00999804|3912751|B2||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4089646|NCT00999804|3912752|B1||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4089647|NCT00999804|3912750|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4089648|NCT00999804|3912751|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4089649|NCT00999804|3912752|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4089650|NCT00999804|3912750|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4089651|NCT00999804|3912751|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089652|NCT00999804|3912752|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4089653|NCT00999804|3912750|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4089654|NCT00999804|3912751|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4089655|NCT00999804|3912752|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4089656|NCT00999804|3912750|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089657|NCT00999804|3912751|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089658|NCT00999804|3912752|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089659|NCT00999804|3912750|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4089660|NCT00999804|3912751|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4089661|NCT00999804|3912752|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4089662|NCT00999804|3912750|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
4089663|NCT00999804|3912751|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4089664|NCT00999804|3912752|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
4089665|NCT00999804|3912750|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4089666|NCT00999804|3912751|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4089667|NCT00999804|3912752|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4089668|NCT00999804|3912750|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4089669|NCT00999804|3912751|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4089670|NCT00999804|3912752|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4089671|NCT00999804|3912750|B3||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4089672|NCT00999804|3912751|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4089673|NCT00999804|3912752|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4089674|NCT00999804|3912750|B3|||Age||years|Median|52|52.0|Full Range|||23.0|88.0|
4089675|NCT00999804|3912751|B2|||Age||years|Median|57|57.0|Full Range|||38.0|88.0|
4089676|NCT00999804|3912752|B1|||Age||years|Median|50|50.0|Full Range|||23.0|80.0|
4089677|NCT00999713|3912765|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4089678|NCT00999713|3912766|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4089679|NCT00999713|3912767|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4089680|NCT00999713|3912765|B3|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4089681|NCT00999713|3912766|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4089682|NCT00999713|3912767|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4089683|NCT00999713|3912765|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4089684|NCT00999713|3912766|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4089685|NCT00999713|3912767|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4089686|NCT00999713|3912765|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4089687|NCT00999713|3912766|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089688|NCT00999713|3912767|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4089689|NCT00999713|3912765|B3||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4089690|NCT00999713|3912766|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4089691|NCT00999713|3912767|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4089692|NCT00999713|3912765|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4089693|NCT00999713|3912766|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4089694|NCT00999713|3912767|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4089695|NCT00999713|3912765|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089696|NCT00999713|3912766|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089697|NCT00999713|3912767|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089698|NCT00999713|3912765|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089699|NCT00999713|3912766|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089700|NCT00999713|3912767|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089701|NCT00999713|3912765|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4089702|NCT00999713|3912766|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089703|NCT00999713|3912767|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4089704|NCT00999713|3912765|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4089705|NCT00999713|3912766|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4089706|NCT00999713|3912767|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4089707|NCT00999713|3912765|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4089708|NCT00999713|3912766|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4089709|NCT00999713|3912767|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4089710|NCT00999713|3912765|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4089711|NCT00999713|3912766|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4089712|NCT00999713|3912767|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4089713|NCT00999713|3912765|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4089714|NCT00999713|3912766|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4089715|NCT00999713|3912767|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4089716|NCT00999713|3912765|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4089717|NCT00999713|3912766|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4089718|NCT00999713|3912767|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4089719|NCT00999713|3912765|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4089720|NCT00999713|3912766|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4089721|NCT00999713|3912767|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4089722|NCT00999713|3912765|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4089723|NCT00999713|3912766|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4089724|NCT00999713|3912767|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4089725|NCT00999713|3912765|B3||<=18 years|Age||Participants|Count of Participants|39|39.0||||||
4089726|NCT00999713|3912766|B2||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4089727|NCT00999713|3912767|B1||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
4089728|NCT00999687|3912782|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4089729|NCT00999687|3912782|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4089730|NCT00999687|3912782|B1|||Age||years|Mean|40.7|40.7|Standard Deviation|12.6|12.6|||
4089731|NCT00999661|3912789|B1|United States||Region of Enrollment||participants|Number|231|231.0||||||
4089732|NCT00999661|3912789|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4089733|NCT00999661|3912789|B1||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4089734|NCT00999661|3912789|B1|||Age||years|Mean|46.4|46.4|Standard Deviation|12.05|12.05|||
4089735|NCT00999661|3912789|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4089736|NCT00999661|3912789|B1||Between 18 and 65 years|Age||Participants|Count of Participants|214|214.0||||||
4089737|NCT00999661|3912789|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4089738|NCT00999609|3912795|B3||Lowest passing light level of ≥ 125 lux|Multi-luminance Mobility Test (MLMT), bilateral, passing at a lux level of < 125 or ≥ 125 lux|The multi-luminance mobility test (MLMT) measures changes in functional vision, based on the ability to navigate a course accurately and at a reasonable pace at different levels of environmental illumination. The MLMT was assessed at 1 or more of 7 light levels ranging from 400 lux (a brightly lit office) to 1 lux (a moonless summer night). At baseline, stratification was based on the lowest passing light level (less than or equal to 125 lux or greater than 125 lux).|Participants|Count of Participants|15|15.0||||||
4089739|NCT00999609|3912796|B2||Lowest passing light level of ≥ 125 lux|Multi-luminance Mobility Test (MLMT), bilateral, passing at a lux level of < 125 or ≥ 125 lux|The multi-luminance mobility test (MLMT) measures changes in functional vision, based on the ability to navigate a course accurately and at a reasonable pace at different levels of environmental illumination. The MLMT was assessed at 1 or more of 7 light levels ranging from 400 lux (a brightly lit office) to 1 lux (a moonless summer night). At baseline, stratification was based on the lowest passing light level (less than or equal to 125 lux or greater than 125 lux).|Participants|Count of Participants|6|6.0||||||
4089740|NCT00999609|3912797|B1||Lowest passing light level of ≥ 125 lux|Multi-luminance Mobility Test (MLMT), bilateral, passing at a lux level of < 125 or ≥ 125 lux|The multi-luminance mobility test (MLMT) measures changes in functional vision, based on the ability to navigate a course accurately and at a reasonable pace at different levels of environmental illumination. The MLMT was assessed at 1 or more of 7 light levels ranging from 400 lux (a brightly lit office) to 1 lux (a moonless summer night). At baseline, stratification was based on the lowest passing light level (less than or equal to 125 lux or greater than 125 lux).|Participants|Count of Participants|9|9.0||||||
4089741|NCT00999609|3912795|B3||Lowest passing light level of < 125 lux|Multi-luminance Mobility Test (MLMT), bilateral, passing at a lux level of < 125 or ≥ 125 lux|The multi-luminance mobility test (MLMT) measures changes in functional vision, based on the ability to navigate a course accurately and at a reasonable pace at different levels of environmental illumination. The MLMT was assessed at 1 or more of 7 light levels ranging from 400 lux (a brightly lit office) to 1 lux (a moonless summer night). At baseline, stratification was based on the lowest passing light level (less than or equal to 125 lux or greater than 125 lux).|Participants|Count of Participants|16|16.0||||||
4089742|NCT00999609|3912796|B2||Lowest passing light level of < 125 lux|Multi-luminance Mobility Test (MLMT), bilateral, passing at a lux level of < 125 or ≥ 125 lux|The multi-luminance mobility test (MLMT) measures changes in functional vision, based on the ability to navigate a course accurately and at a reasonable pace at different levels of environmental illumination. The MLMT was assessed at 1 or more of 7 light levels ranging from 400 lux (a brightly lit office) to 1 lux (a moonless summer night). At baseline, stratification was based on the lowest passing light level (less than or equal to 125 lux or greater than 125 lux).|Participants|Count of Participants|4|4.0||||||
4089743|NCT00999609|3912797|B1||Lowest passing light level of < 125 lux|Multi-luminance Mobility Test (MLMT), bilateral, passing at a lux level of < 125 or ≥ 125 lux|The multi-luminance mobility test (MLMT) measures changes in functional vision, based on the ability to navigate a course accurately and at a reasonable pace at different levels of environmental illumination. The MLMT was assessed at 1 or more of 7 light levels ranging from 400 lux (a brightly lit office) to 1 lux (a moonless summer night). At baseline, stratification was based on the lowest passing light level (less than or equal to 125 lux or greater than 125 lux).|Participants|Count of Participants|12|12.0||||||
4089744|NCT00999609|3912795|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089745|NCT00999609|3912796|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089746|NCT00999609|3912797|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089747|NCT00999609|3912795|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089748|NCT00999609|3912796|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089749|NCT00999609|3912797|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089750|NCT00999609|3912795|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4089751|NCT00999609|3912796|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4089752|NCT00999609|3912797|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4089753|NCT00999609|3912795|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4089754|NCT00999609|3912796|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089755|NCT00999609|3912797|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4089756|NCT00999609|3912795|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089757|NCT00999609|3912796|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089758|NCT00999609|3912797|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089759|NCT00999609|3912795|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4089760|NCT00999609|3912796|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4089761|NCT00999609|3912797|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4089762|NCT00999609|3912795|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4089763|NCT00999609|3912796|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4089764|NCT00999609|3912797|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4089765|NCT00999609|3912795|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089766|NCT00999609|3912796|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089767|NCT00999609|3912797|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089768|NCT00999609|3912795|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4089769|NCT00999609|3912796|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4089770|NCT00999609|3912797|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4089771|NCT00999609|3912795|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4089772|NCT00999609|3912796|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4089773|NCT00999609|3912797|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4089774|NCT00999609|3912795|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4089775|NCT00999609|3912796|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4089776|NCT00999609|3912797|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4089777|NCT00999609|3912795|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4089778|NCT00999609|3912796|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4089779|NCT00999609|3912797|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4089780|NCT00999609|3912795|B3|Age Group|≥10 years old|Age, Customized||Participants|Count of Participants|18|18.0||||||
4089781|NCT00999609|3912796|B2|Age Group|≥10 years old|Age, Customized||Participants|Count of Participants|6|6.0||||||
4089782|NCT00999609|3912797|B1|Age Group|≥10 years old|Age, Customized||Participants|Count of Participants|12|12.0||||||
4089783|NCT00999609|3912795|B3|Age Group|<10 years old|Age, Customized||Participants|Count of Participants|13|13.0||||||
4089784|NCT00999609|3912796|B2|Age Group|<10 years old|Age, Customized||Participants|Count of Participants|4|4.0||||||
4089785|NCT00999609|3912797|B1|Age Group|<10 years old|Age, Customized||Participants|Count of Participants|9|9.0||||||
4089786|NCT00999609|3912795|B3|||Age||years|Mean|15.1|15.1|Standard Deviation|10.9|10.9|||
4089787|NCT00999609|3912796|B2|||Age||years|Mean|15.9|15.9|Standard Deviation|9.5|9.5|||
4089788|NCT00999609|3912797|B1|||Age||years|Mean|14.7|14.7|Standard Deviation|11.8|11.8|||
4089789|NCT00999596|3912810|B1|Germany||Region of Enrollment||participants|Number|3|3.0||||||
4089790|NCT00999596|3912810|B1|United States||Region of Enrollment||participants|Number|104|104.0||||||
4089791|NCT00999596|3912810|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4089792|NCT00999596|3912810|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4089793|NCT00999596|3912810|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4089794|NCT00999596|3912810|B1||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
4089795|NCT00999596|3912810|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4089796|NCT00999544|3912815|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4089797|NCT00999544|3912815|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4089798|NCT00999544|3912815|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4089799|NCT00999544|3912815|B1|||Age||years|Mean|32.3|32.3|Standard Deviation|3|3.0|||
4089800|NCT00999544|3912815|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4089801|NCT00999544|3912815|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4089802|NCT00999544|3912815|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4089803|NCT00999466|3912848|B4||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4089804|NCT00999466|3912849|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4089805|NCT00999466|3912850|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4089806|NCT00999466|3912851|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4089807|NCT00999466|3912848|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4089808|NCT00999466|3912849|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4089809|NCT00999466|3912850|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4089810|NCT00999466|3912851|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4089811|NCT00999466|3912848|B4|||Age||Years|Mean|33.9|33.9|Full Range|||19.0|51.0|
4089812|NCT00999466|3912849|B3|||Age||Years|Mean|32.3|32.3|Full Range|||21.0|50.0|
4089813|NCT00999466|3912850|B2|||Age||Years|Mean|33.0|33.0|Full Range|||19.0|51.0|
4089814|NCT00999466|3912851|B1|||Age||Years|Mean|36.3|36.3|Full Range|||23.0|47.0|
4089815|NCT00999167|3913128|B3|Ukraine||Region of Enrollment||participants|Number|40|40.0||||||
4089816|NCT00999167|3913129|B2|Ukraine||Region of Enrollment||participants|Number|20|20.0||||||
4089817|NCT00999167|3913130|B1|Ukraine||Region of Enrollment||participants|Number|20|20.0||||||
4089818|NCT00999167|3913128|B3|Russian Federation||Region of Enrollment||participants|Number|50|50.0||||||
4089819|NCT00999167|3913129|B2|Russian Federation||Region of Enrollment||participants|Number|24|24.0||||||
4089820|NCT00999167|3913130|B1|Russian Federation||Region of Enrollment||participants|Number|26|26.0||||||
4089821|NCT00999167|3913128|B3|United States||Region of Enrollment||participants|Number|88|88.0||||||
4089822|NCT00999167|3913129|B2|United States||Region of Enrollment||participants|Number|44|44.0||||||
4089823|NCT00999167|3913130|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4089824|NCT00999167|3913128|B3||Male|Gender||Participants|Count of Participants|104|104.0||||||
4089825|NCT00999167|3913129|B2||Male|Gender||Participants|Count of Participants|59|59.0||||||
4089826|NCT00999167|3913130|B1||Male|Gender||Participants|Count of Participants|45|45.0||||||
4089827|NCT00999167|3913128|B3||Female|Gender||Participants|Count of Participants|74|74.0||||||
4089828|NCT00999167|3913129|B2||Female|Gender||Participants|Count of Participants|29|29.0||||||
4089829|NCT00999167|3913130|B1||Female|Gender||Participants|Count of Participants|45|45.0||||||
4089830|NCT00999167|3913128|B3|||Age||years|Mean|54.6|54.6|Standard Deviation|8.85|8.85|||
4089831|NCT00999167|3913129|B2|||Age||years|Mean|55.4|55.4|Standard Deviation|8.85|8.85|||
4089832|NCT00999167|3913130|B1|||Age||years|Mean|53.8|53.8|Standard Deviation|8.94|8.94|||
4089833|NCT00999167|3913128|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4089834|NCT00999167|3913129|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4089835|NCT00999167|3913130|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4089836|NCT00999167|3913128|B3||Between 18 and 65 years|Age||Participants|Count of Participants|163|163.0||||||
4089837|NCT00999167|3913129|B2||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
4089838|NCT00999167|3913130|B1||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
4089839|NCT00999167|3913128|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4089840|NCT00999167|3913129|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4089841|NCT00999167|3913130|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4089842|NCT00999141|3913146|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
4089843|NCT00999141|3913146|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4089844|NCT00999141|3913146|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4089845|NCT00999141|3913146|B1|||Age||years|Mean|54.4|54.4|Standard Deviation|7.4|7.4|||
4089846|NCT00999102|3913228|B1|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
4089847|NCT00999102|3913228|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4089848|NCT00999102|3913228|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4089849|NCT00999102|3913228|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|13.4|13.4|||
4089850|NCT00999102|3913228|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4089851|NCT00999102|3913228|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4089852|NCT00999102|3913228|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4089853|NCT00999037|3913243|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4089854|NCT00999037|3913244|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4089855|NCT00999037|3913245|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4089856|NCT00999037|3913243|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4089857|NCT00999037|3913244|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4089858|NCT00999037|3913245|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4089859|NCT00999037|3913243|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4089860|NCT00999037|3913244|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4089861|NCT00999037|3913245|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4089862|NCT00999037|3913243|B3|||Age||years|Mean|14.3|14.3|Standard Deviation|4.0|4.0|||
4089863|NCT00999037|3913244|B2|||Age||years|Mean|15.4|15.4|Standard Deviation|4.6|4.6|||
4089864|NCT00999037|3913245|B1|||Age||years|Mean|13.3|13.3|Standard Deviation|3.2|3.2|||
4089865|NCT00999037|3913243|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4089866|NCT00999037|3913244|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4089867|NCT00999037|3913245|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4089868|NCT00999037|3913243|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4089869|NCT00999037|3913244|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4089870|NCT00999037|3913245|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4089871|NCT00999037|3913243|B3||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4089872|NCT00999037|3913244|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4089873|NCT00999037|3913245|B1||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4089874|NCT00998985|3913256|B15||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4089875|NCT00998985|3913257|B14||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4089876|NCT00998985|3913258|B13||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4089877|NCT00998985|3913259|B12||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4089878|NCT00998985|3913260|B11||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4089879|NCT00998985|3913261|B10||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4089880|NCT00998985|3913262|B9||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4089881|NCT00998985|3913263|B8||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4089882|NCT00998985|3913264|B7||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4089883|NCT00998985|3913265|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4089884|NCT00998985|3913266|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4089885|NCT00998985|3913267|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4089886|NCT00998985|3913268|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4089887|NCT00998985|3913269|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4089888|NCT00998985|3913270|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4089889|NCT00998985|3913256|B15||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4089890|NCT00998985|3913257|B14||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4089891|NCT00998985|3913258|B13||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4089892|NCT00998985|3913259|B12||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4089893|NCT00998985|3913260|B11||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4089894|NCT00998985|3913261|B10||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4089895|NCT00998985|3913262|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4089896|NCT00998985|3913263|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4089897|NCT00998985|3913264|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4089898|NCT00998985|3913265|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4089899|NCT00998985|3913266|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4089900|NCT00998985|3913267|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4089901|NCT00998985|3913268|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4089902|NCT00998985|3913269|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4089903|NCT00998985|3913270|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4089904|NCT00998985|3913256|B15|||Age||Years|Mean|44.7|44.7|Standard Deviation|11.5|11.5|||
4089905|NCT00998985|3913257|B14|||Age||Years|Mean|45.6|45.6|Standard Deviation|11.5|11.5|||
4089906|NCT00998985|3913258|B13|||Age||Years|Mean|48.4|48.4|Standard Deviation|13.1|13.1|||
4089907|NCT00998985|3913259|B12|||Age||Years|Mean|55.8|55.8|Standard Deviation|5.4|5.4|||
4089908|NCT00998985|3913260|B11|||Age||Years|Mean|31.4|31.4|Standard Deviation|6.3|6.3|||
4089909|NCT00998985|3913261|B10|||Age||Years|Mean|40.0|40.0|Standard Deviation|10.2|10.2|||
4089910|NCT00998985|3913262|B9|||Age||Years|Mean|36.8|36.8|Standard Deviation|6.0|6.0|||
4089911|NCT00998985|3913263|B8|||Age||Years|Mean|48.4|48.4|Standard Deviation|5.9|5.9|||
4089912|NCT00998985|3913264|B7|||Age||Years|Mean|51.0|51.0|Standard Deviation|16.2|16.2|||
4089913|NCT00998985|3913265|B6|||Age||Years|Mean|46.2|46.2|Standard Deviation|10.8|10.8|||
4089914|NCT00998985|3913266|B5|||Age||Years|Mean|38.0|38.0|Standard Deviation|13.1|13.1|||
4089915|NCT00998985|3913267|B4|||Age||Years|Mean|42.8|42.8|Standard Deviation|14.4|14.4|||
4089916|NCT00998985|3913268|B3|||Age||Years|Mean|46.7|46.7|Standard Deviation|9.7|9.7|||
4089917|NCT00998985|3913269|B2|||Age||Years|Mean|47.2|47.2|Standard Deviation|12.2|12.2|||
4089918|NCT00998985|3913270|B1|||Age||Years|Mean|42.4|42.4|Standard Deviation|12.8|12.8|||
4089919|NCT00998881|3913349|B3||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4089920|NCT00998881|3913350|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4089921|NCT00998881|3913351|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4089922|NCT00998881|3913349|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4089923|NCT00998881|3913350|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4089924|NCT00998881|3913351|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4089925|NCT00998881|3913349|B3|||Age||years|Mean|58.9|58.9|Standard Deviation|10.0|10.0|||
4089926|NCT00998881|3913350|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|10.0|10.0|||
4089927|NCT00998881|3913351|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|10.1|10.1|||
4089928|NCT00998868|3913364|B1|Korea, Republic of||Region of Enrollment||participants|Number|51|51.0||||||
4089929|NCT00998868|3913364|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4089930|NCT00998868|3913364|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4089931|NCT00998868|3913364|B1|||Age||years|Mean|63.37|63.37|Standard Deviation|10.765|10.765|||
4089932|NCT00998868|3913364|B1||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4089933|NCT00998868|3913364|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4089934|NCT00998868|3913364|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4089935|NCT00998790|3913371|B1|||Duration of Incontinence Symptoms||years|Mean|41.8|41.8|Standard Deviation|28.7|28.7|||
4089936|NCT00998790|3913371|B1|Spain||Region of Enrollment||participants|Number|6|6.0||||||
4089937|NCT00998790|3913371|B1|Germany||Region of Enrollment||participants|Number|14|14.0||||||
4089938|NCT00998790|3913371|B1|France||Region of Enrollment||participants|Number|63|63.0||||||
4089939|NCT00998790|3913371|B1|Belgium||Region of Enrollment||participants|Number|31|31.0||||||
4089940|NCT00998790|3913371|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089941|NCT00998790|3913371|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|114|114.0||||||
4089942|NCT00998790|3913371|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4089943|NCT00998790|3913371|B1||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4089944|NCT00998790|3913371|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4089945|NCT00998790|3913371|B1|||Age, Customized||years|Mean|66.4|66.4|Standard Deviation|6.7|6.7|||
4089946|NCT00998764|3913379|B3||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4089947|NCT00998764|3913380|B2||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4089948|NCT00998764|3913381|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4089949|NCT00998764|3913379|B3||Female|Sex: Female, Male||Participants|Count of Participants|321|321.0||||||
4089950|NCT00998764|3913380|B2||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4089951|NCT00998764|3913381|B1||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4089952|NCT00998764|3913379|B3|>= 65 years||Age, Customized||Participants|Number|404|404.0||||||
4089953|NCT00998764|3913380|B2|>= 65 years||Age, Customized||Participants|Number|233|233.0||||||
4089954|NCT00998764|3913381|B1|>= 65 years||Age, Customized||Participants|Number|171|171.0||||||
4089955|NCT00998764|3913379|B3|< 65 years||Age, Customized||Participants|Number|86|86.0||||||
4089956|NCT00998764|3913380|B2|< 65 years||Age, Customized||Participants|Number|42|42.0||||||
4089957|NCT00998764|3913381|B1|< 65 years||Age, Customized||Participants|Number|44|44.0||||||
4089958|NCT00998764|3913379|B3|||Age||Years|Mean|71.8|71.8|Standard Deviation|7.77|7.77|||
4089959|NCT00998764|3913380|B2|||Age||Years|Mean|72.1|72.1|Standard Deviation|7.47|7.47|||
4089960|NCT00998764|3913381|B1|||Age||Years|Mean|71.4|71.4|Standard Deviation|8.14|8.14|||
4089961|NCT00998660|3913416|B4|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4089962|NCT00998660|3913417|B3|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4089963|NCT00998660|3913418|B2|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4089964|NCT00998660|3913419|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4089965|NCT00998660|3913416|B4|Germany||Region of Enrollment||participants|Number|17|17.0||||||
4089966|NCT00998660|3913417|B3|Germany||Region of Enrollment||participants|Number|10|10.0||||||
4089967|NCT00998660|3913418|B2|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4089968|NCT00998660|3913419|B1|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4089969|NCT00998660|3913416|B4|Austria||Region of Enrollment||participants|Number|9|9.0||||||
4089970|NCT00998660|3913417|B3|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4089971|NCT00998660|3913418|B2|Austria||Region of Enrollment||participants|Number|0|0.0||||||
4089972|NCT00998660|3913419|B1|Austria||Region of Enrollment||participants|Number|5|5.0||||||
4089973|NCT00998660|3913416|B4|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4089974|NCT00998660|3913417|B3|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4089975|NCT00998660|3913418|B2|Spain||Region of Enrollment||participants|Number|0|0.0||||||
4089976|NCT00998660|3913419|B1|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4089977|NCT00998660|3913416|B4|France||Region of Enrollment||participants|Number|15|15.0||||||
4089978|NCT00998660|3913417|B3|France||Region of Enrollment||participants|Number|0|0.0||||||
4089979|NCT00998660|3913418|B2|France||Region of Enrollment||participants|Number|0|0.0||||||
4089980|NCT00998660|3913419|B1|France||Region of Enrollment||participants|Number|15|15.0||||||
4089981|NCT00998660|3913416|B4|United States||Region of Enrollment||participants|Number|45|45.0||||||
4089982|NCT00998660|3913417|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
4089983|NCT00998660|3913418|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4089984|NCT00998660|3913419|B1|United States||Region of Enrollment||participants|Number|0|0.0||||||
4089985|NCT00998660|3913416|B4||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4089986|NCT00998660|3913417|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4089987|NCT00998660|3913418|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4089988|NCT00998660|3913419|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4089989|NCT00998660|3913416|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4089990|NCT00998660|3913417|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4089991|NCT00998660|3913418|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4089992|NCT00998660|3913419|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4089993|NCT00998660|3913416|B4|||Age||years|Mean|54.4|54.4|Full Range|||11.0|82.0|
4089994|NCT00998660|3913417|B3|||Age||years|Mean|59.6|59.6|Full Range|||39.0|79.0|
4089995|NCT00998660|3913418|B2|||Age||years|Mean|64.5|64.5|Full Range|||39.0|79.0|
4089996|NCT00998660|3913419|B1|||Age||years|Mean|40.4|40.4|Full Range|||11.0|82.0|
4089997|NCT00998582|3913423|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
4089998|NCT00998582|3913424|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4089999|NCT00998582|3913425|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4090000|NCT00998582|3913423|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4090001|NCT00998582|3913424|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4090002|NCT00998582|3913425|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4090003|NCT00998582|3913423|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4090004|NCT00998582|3913424|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4090005|NCT00998582|3913425|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4090006|NCT00998582|3913423|B3|||Age||years|Mean|46|46.0|Standard Deviation|8|8.0|||
4090007|NCT00998582|3913424|B2|||Age||years|Mean|43|43.0|Standard Deviation|9|9.0|||
4090008|NCT00998582|3913425|B1|||Age||years|Mean|47|47.0|Standard Deviation|7|7.0|||
4090009|NCT00998582|3913423|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4090010|NCT00998582|3913424|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4090011|NCT00998582|3913425|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4090012|NCT00998582|3913423|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4090013|NCT00998582|3913424|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4090014|NCT00998582|3913425|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4090015|NCT00998582|3913423|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090016|NCT00998582|3913424|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090017|NCT00998582|3913425|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090018|NCT00998517|3913434|B4|Malawi||Region of Enrollment||participants|Number|2712|2712.0||||||
4090019|NCT00998517|3913435|B3|Malawi||Region of Enrollment||participants|Number|918|918.0||||||
4090020|NCT00998517|3913436|B2|Malawi||Region of Enrollment||participants|Number|906|906.0||||||
4090021|NCT00998517|3913437|B1|Malawi||Region of Enrollment||participants|Number|888|888.0||||||
4090022|NCT00998517|3913434|B4||Male|Sex: Female, Male||Participants|Count of Participants|1028|1028.0||||||
4090023|NCT00998517|3913435|B3||Male|Sex: Female, Male||Participants|Count of Participants|335|335.0||||||
4090024|NCT00998517|3913436|B2||Male|Sex: Female, Male||Participants|Count of Participants|344|344.0||||||
4090025|NCT00998517|3913437|B1||Male|Sex: Female, Male||Participants|Count of Participants|349|349.0||||||
4090026|NCT00998517|3913434|B4||Female|Sex: Female, Male||Participants|Count of Participants|1684|1684.0||||||
4090027|NCT00998517|3913435|B3||Female|Sex: Female, Male||Participants|Count of Participants|583|583.0||||||
4090028|NCT00998517|3913436|B2||Female|Sex: Female, Male||Participants|Count of Participants|562|562.0||||||
4090029|NCT00998517|3913437|B1||Female|Sex: Female, Male||Participants|Count of Participants|539|539.0||||||
4090030|NCT00998517|3913434|B4|||Age||years|Mean|1.62|1.62|Standard Deviation|0.91|0.91|||
4090031|NCT00998517|3913435|B3|||Age||years|Mean|1.61|1.61|Standard Deviation|0.92|0.92|||
4090032|NCT00998517|3913436|B2|||Age||years|Mean|1.63|1.63|Standard Deviation|0.9|0.9|||
4090033|NCT00998517|3913437|B1|||Age||years|Mean|1.63|1.63|Standard Deviation|0.92|0.92|||
4090034|NCT00998517|3913434|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4090035|NCT00998517|3913435|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4090036|NCT00998517|3913436|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4090037|NCT00998517|3913437|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4090038|NCT00998517|3913434|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4090039|NCT00998517|3913435|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4090040|NCT00998517|3913436|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4090041|NCT00998517|3913437|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4090042|NCT00998517|3913434|B4||<=18 years|Age||Participants|Count of Participants|2712|2712.0||||||
4090043|NCT00998517|3913435|B3||<=18 years|Age||Participants|Count of Participants|918|918.0||||||
4090044|NCT00998517|3913436|B2||<=18 years|Age||Participants|Count of Participants|906|906.0||||||
4090045|NCT00998517|3913437|B1||<=18 years|Age||Participants|Count of Participants|888|888.0||||||
4090046|NCT00998426|3913465|B1|||adult OLT recipients|This is a nonrandomized, prospective study evaluating patients receiving maintenance HBIG therapy over 3 months post liver transplantation. Blood glucose levels in each subject were analyzed by GSPOC and GNSPOC devices at specific times around HBIG administration|participants|Number|5|5.0||||||
4090047|NCT00998426|3913465|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4090048|NCT00998426|3913465|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4090049|NCT00998426|3913465|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4090050|NCT00998426|3913465|B1|||Age||years|Mean|48|48.0|Standard Deviation|8|8.0|||
4090051|NCT00998426|3913465|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4090052|NCT00998426|3913465|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4090053|NCT00998426|3913465|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090054|NCT00998374|3913470|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
4090055|NCT00998374|3913471|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4090056|NCT00998374|3913472|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4090057|NCT00998374|3913470|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4090058|NCT00998374|3913471|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4090059|NCT00998374|3913472|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4090060|NCT00998374|3913470|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4090061|NCT00998374|3913471|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4090062|NCT00998374|3913472|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4090063|NCT00998374|3913470|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4090064|NCT00998374|3913471|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4090065|NCT00998374|3913472|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4090066|NCT00998374|3913470|B3||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4090067|NCT00998374|3913471|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4090068|NCT00998374|3913472|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4090069|NCT00998374|3913470|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090070|NCT00998374|3913471|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090071|NCT00998374|3913472|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090072|NCT00998335|3913485|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4090073|NCT00998335|3913486|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4090074|NCT00998335|3913487|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4090075|NCT00998335|3913485|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4090076|NCT00998335|3913486|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4090077|NCT00998335|3913487|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4090078|NCT00998335|3913485|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4090079|NCT00998335|3913486|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4090080|NCT00998335|3913487|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4090081|NCT00998335|3913485|B3|||Age||years|Mean|57|57.0|Standard Deviation|9|9.0|||
4090082|NCT00998335|3913486|B2|||Age||years|Mean|59|59.0|Standard Deviation|8|8.0|||
4090083|NCT00998335|3913487|B1|||Age||years|Mean|50|50.0|Standard Deviation|8|8.0|||
4090084|NCT00998335|3913485|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4090085|NCT00998335|3913486|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4090086|NCT00998335|3913487|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4090087|NCT00998335|3913485|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4090088|NCT00998335|3913486|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4090089|NCT00998335|3913487|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4090090|NCT00998335|3913485|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090091|NCT00998335|3913486|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090092|NCT00998335|3913487|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090093|NCT00998309|3913516|B1|Others||Type of Infection|The physician in charge of the survey made the diagnosis of type of infection based on symptoms.|participants|Number|12|12.0||||||
4090094|NCT00998309|3913516|B1|Dental and Oral Surgery Infection||Type of Infection|The physician in charge of the survey made the diagnosis of type of infection based on symptoms.|participants|Number|183|183.0||||||
4090156|NCT00998023|3913675|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4090095|NCT00998309|3913516|B1|Sexual Transmitted Infection||Type of Infection|The physician in charge of the survey made the diagnosis of type of infection based on symptoms.|participants|Number|199|199.0||||||
4090096|NCT00998309|3913516|B1|Skin and Soft Tissue Infection||Type of Infection|The physician in charge of the survey made the diagnosis of type of infection based on symptoms.|participants|Number|104|104.0||||||
4090097|NCT00998309|3913516|B1||Male|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
4090098|NCT00998309|3913516|B1||Female|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4090099|NCT00998309|3913516|B1|||Age, Customized||years|Mean|39.9|39.9|Standard Deviation|15.6|15.6|||
4090100|NCT00998296|3913572|B12||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4090101|NCT00998296|3913573|B11||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4090102|NCT00998296|3913574|B10||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4090103|NCT00998296|3913575|B9||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4090104|NCT00998296|3913576|B8||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4090105|NCT00998296|3913577|B7||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4090106|NCT00998296|3913578|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4090107|NCT00998296|3913579|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4090108|NCT00998296|3913580|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4090109|NCT00998296|3913581|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4090110|NCT00998296|3913582|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4090111|NCT00998296|3913583|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4090112|NCT00998296|3913572|B12||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4090113|NCT00998296|3913573|B11||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4090114|NCT00998296|3913574|B10||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4090115|NCT00998296|3913575|B9||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4090116|NCT00998296|3913576|B8||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4090117|NCT00998296|3913577|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4090118|NCT00998296|3913578|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4090119|NCT00998296|3913579|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4090120|NCT00998296|3913580|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4090121|NCT00998296|3913581|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4090122|NCT00998296|3913582|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4090123|NCT00998296|3913583|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4090124|NCT00998296|3913572|B12|||Age||years|Mean|56.0|56.0|Standard Deviation|9.7|9.7|||
4090125|NCT00998296|3913573|B11|||Age||years|Mean|58.1|58.1|Standard Deviation|6.8|6.8|||
4090126|NCT00998296|3913574|B10|||Age||years|Mean|58.1|58.1|Standard Deviation|10.9|10.9|||
4090127|NCT00998296|3913575|B9|||Age||years|Mean|63.3|63.3|Standard Deviation|10.3|10.3|||
4090128|NCT00998296|3913576|B8|||Age||years|Mean|52.2|52.2|Standard Deviation|6.0|6.0|||
4090129|NCT00998296|3913577|B7|||Age||years|Mean|64.9|64.9|Standard Deviation|3.5|3.5|||
4090130|NCT00998296|3913578|B6|||Age||years|Mean|44.3|44.3|Standard Deviation|8.1|8.1|||
4090131|NCT00998296|3913579|B5|||Age||years|Mean|51.5|51.5|Standard Deviation|9.7|9.7|||
4090132|NCT00998296|3913580|B4|||Age||years|Mean|53.3|53.3|Standard Deviation|11.0|11.0|||
4090133|NCT00998296|3913581|B3|||Age||years|Mean|46.7|46.7|Standard Deviation|4.9|4.9|||
4090134|NCT00998296|3913582|B2|||Age||years|Mean|51.7|51.7|Standard Deviation|1.5|1.5|||
4090135|NCT00998296|3913583|B1|||Age||years|Mean|53.7|53.7|Standard Deviation|8.1|8.1|||
4090136|NCT00998205|3913660|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4090137|NCT00998205|3913660|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4090138|NCT00998205|3913660|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4090139|NCT00998205|3913660|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4090140|NCT00998205|3913660|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4090141|NCT00998205|3913660|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090142|NCT00998049|3913665|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4090143|NCT00998049|3913665|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4090144|NCT00998049|3913665|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4090145|NCT00998049|3913665|B1|||Age||years|Median|60|60.0|Full Range|||28.0|73.0|
4090146|NCT00998023|3913674|B3|United States||Region of Enrollment||participants|Number|64|64.0||||||
4090147|NCT00998023|3913675|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
4090148|NCT00998023|3913676|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4090149|NCT00998023|3913674|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4090150|NCT00998023|3913675|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4090151|NCT00998023|3913676|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4090152|NCT00998023|3913674|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4090153|NCT00998023|3913675|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4090154|NCT00998023|3913676|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4090155|NCT00998023|3913674|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4090157|NCT00998023|3913676|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4090158|NCT00998023|3913674|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4090159|NCT00998023|3913675|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4090160|NCT00998023|3913676|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4090161|NCT00998023|3913674|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090162|NCT00998023|3913675|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090163|NCT00998023|3913676|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090164|NCT00997984|3913685|B4|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4090165|NCT00997984|3913686|B3|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4090166|NCT00997984|3913687|B2|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4090167|NCT00997984|3913688|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4090168|NCT00997984|3913685|B4|United States||Region of Enrollment||participants|Number|324|324.0||||||
4090169|NCT00997984|3913686|B3|United States||Region of Enrollment||participants|Number|110|110.0||||||
4090170|NCT00997984|3913687|B2|United States||Region of Enrollment||participants|Number|104|104.0||||||
4090171|NCT00997984|3913688|B1|United States||Region of Enrollment||participants|Number|110|110.0||||||
4090172|NCT00997984|3913685|B4||Male|Sex: Female, Male|Based on the Full Analysis Set (FAS) defined as all subjects who had taken at least 1 dose of investigational product during the study. 340 subjects were randomized, but only 333 received at least 1 dose of investigational product.|Participants|Count of Participants|235|235.0||||||
4090173|NCT00997984|3913686|B3||Male|Sex: Female, Male|Based on the Full Analysis Set (FAS) defined as all subjects who had taken at least 1 dose of investigational product during the study. 340 subjects were randomized, but only 333 received at least 1 dose of investigational product.|Participants|Count of Participants|78|78.0||||||
4090174|NCT00997984|3913687|B2||Male|Sex: Female, Male|Based on the Full Analysis Set (FAS) defined as all subjects who had taken at least 1 dose of investigational product during the study. 340 subjects were randomized, but only 333 received at least 1 dose of investigational product.|Participants|Count of Participants|72|72.0||||||
4090175|NCT00997984|3913688|B1||Male|Sex: Female, Male|Based on the Full Analysis Set (FAS) defined as all subjects who had taken at least 1 dose of investigational product during the study. 340 subjects were randomized, but only 333 received at least 1 dose of investigational product.|Participants|Count of Participants|85|85.0||||||
4090176|NCT00997984|3913685|B4||Female|Sex: Female, Male|Based on the Full Analysis Set (FAS) defined as all subjects who had taken at least 1 dose of investigational product during the study. 340 subjects were randomized, but only 333 received at least 1 dose of investigational product.|Participants|Count of Participants|98|98.0||||||
4090177|NCT00997984|3913686|B3||Female|Sex: Female, Male|Based on the Full Analysis Set (FAS) defined as all subjects who had taken at least 1 dose of investigational product during the study. 340 subjects were randomized, but only 333 received at least 1 dose of investigational product.|Participants|Count of Participants|36|36.0||||||
4090178|NCT00997984|3913687|B2||Female|Sex: Female, Male|Based on the Full Analysis Set (FAS) defined as all subjects who had taken at least 1 dose of investigational product during the study. 340 subjects were randomized, but only 333 received at least 1 dose of investigational product.|Participants|Count of Participants|35|35.0||||||
4090179|NCT00997984|3913688|B1||Female|Sex: Female, Male|Based on the Full Analysis Set (FAS) defined as all subjects who had taken at least 1 dose of investigational product during the study. 340 subjects were randomized, but only 333 received at least 1 dose of investigational product.|Participants|Count of Participants|27|27.0||||||
4090180|NCT00997984|3913685|B4|6-12 years||Age, Customized|Based on the Full Analysis Set (FAS) defined as all subjects who had taken at least 1 dose of investigational product during the study. 340 subjects were randomized, but only 333 received at least 1 dose of investigational product.|participants|Number|333|333.0||||||
4090181|NCT00997984|3913686|B3|6-12 years||Age, Customized|Based on the Full Analysis Set (FAS) defined as all subjects who had taken at least 1 dose of investigational product during the study. 340 subjects were randomized, but only 333 received at least 1 dose of investigational product.|participants|Number|114|114.0||||||
4090182|NCT00997984|3913687|B2|6-12 years||Age, Customized|Based on the Full Analysis Set (FAS) defined as all subjects who had taken at least 1 dose of investigational product during the study. 340 subjects were randomized, but only 333 received at least 1 dose of investigational product.|participants|Number|107|107.0||||||
4090183|NCT00997984|3913688|B1|6-12 years||Age, Customized|Based on the Full Analysis Set (FAS) defined as all subjects who had taken at least 1 dose of investigational product during the study. 340 subjects were randomized, but only 333 received at least 1 dose of investigational product.|participants|Number|112|112.0||||||
4090184|NCT00997984|3913685|B4|||Age|Based on the Full Analysis Set (FAS) defined as all subjects who had taken at least 1 dose of investigational product during the study. 340 subjects were randomized, but only 333 received at least 1 dose of investigational product.|years|Mean|9.1|9.1|Standard Deviation|1.77|1.77|||
4090185|NCT00997984|3913686|B3|||Age|Based on the Full Analysis Set (FAS) defined as all subjects who had taken at least 1 dose of investigational product during the study. 340 subjects were randomized, but only 333 received at least 1 dose of investigational product.|years|Mean|9.3|9.3|Standard Deviation|1.76|1.76|||
4090186|NCT00997984|3913687|B2|||Age|Based on the Full Analysis Set (FAS) defined as all subjects who had taken at least 1 dose of investigational product during the study. 340 subjects were randomized, but only 333 received at least 1 dose of investigational product.|years|Mean|9.1|9.1|Standard Deviation|1.77|1.77|||
4090187|NCT00997984|3913688|B1|||Age|Based on the Full Analysis Set (FAS) defined as all subjects who had taken at least 1 dose of investigational product during the study. 340 subjects were randomized, but only 333 received at least 1 dose of investigational product.|years|Mean|8.9|8.9|Standard Deviation|1.78|1.78|||
4090188|NCT00997932|3913756|B1|Prior use of contraception|No|Previous contraceptive use, marital status, employment,||Participants|Count of Participants|0|0.0||||||
4090189|NCT00997932|3913756|B1|Prior use of contraception|Yes|Previous contraceptive use, marital status, employment,||Participants|Count of Participants|29|29.0||||||
4090190|NCT00997932|3913756|B1|Married or Cohabitating|No|Previous contraceptive use, marital status, employment,||Participants|Count of Participants|20|20.0||||||
4090191|NCT00997932|3913756|B1|Married or Cohabitating|Yes|Previous contraceptive use, marital status, employment,||Participants|Count of Participants|9|9.0||||||
4090192|NCT00997932|3913756|B1|Employed|No|Previous contraceptive use, marital status, employment,||Participants|Count of Participants|27|27.0||||||
4090193|NCT00997932|3913756|B1|Employed|Yes|Previous contraceptive use, marital status, employment,||Participants|Count of Participants|2|2.0||||||
4090194|NCT00997932|3913756|B1|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
4090195|NCT00997932|3913756|B1|Race|Other|Race/Ethnicity, Customized|Race White Black Other Hispanic ethnicity|Participants|Count of Participants|3|3.0||||||
4090196|NCT00997932|3913756|B1|Race|Black|Race/Ethnicity, Customized|Race White Black Other Hispanic ethnicity|Participants|Count of Participants|9|9.0||||||
4090197|NCT00997932|3913756|B1|Race|White|Race/Ethnicity, Customized|Race White Black Other Hispanic ethnicity|Participants|Count of Participants|17|17.0||||||
4090198|NCT00997932|3913756|B1||Male|Sex: Female, Male|females only because this was a female contraception study|Participants|Count of Participants|0|0.0||||||
4090199|NCT00997932|3913756|B1||Female|Sex: Female, Male|females only because this was a female contraception study|Participants|Count of Participants|29|29.0||||||
4090200|NCT00997932|3913756|B1|||Age||years|Median|23|23.0|Inter-Quartile Range|||21.0|29.0|
4090201|NCT00997672|3913761|B3|Italy||Region of Enrollment||participants|Number|9|9.0||||||
4090202|NCT00997672|3913762|B2|Italy||Region of Enrollment||participants|Number|5|5.0||||||
4090203|NCT00997672|3913763|B1|Italy||Region of Enrollment||participants|Number|4|4.0||||||
4090204|NCT00997672|3913761|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4090205|NCT00997672|3913762|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4090206|NCT00997672|3913763|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4090207|NCT00997672|3913761|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4090208|NCT00997672|3913762|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4090209|NCT00997672|3913763|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4090210|NCT00997672|3913761|B3|||Age||years|Mean|64|64.0|Standard Deviation|5|5.0|||
4090211|NCT00997672|3913762|B2|||Age||years|Mean|64|64.0|Standard Deviation|6|6.0|||
4090212|NCT00997672|3913763|B1|||Age||years|Mean|65|65.0|Standard Deviation|5|5.0|||
4090213|NCT00997672|3913761|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4090214|NCT00997672|3913762|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4090215|NCT00997672|3913763|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4090216|NCT00997672|3913761|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4090217|NCT00997672|3913762|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4090218|NCT00997672|3913763|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4090219|NCT00997672|3913761|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090220|NCT00997672|3913762|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090221|NCT00997672|3913763|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090222|NCT00997620|3913770|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4090223|NCT00997620|3913771|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4090224|NCT00997620|3913772|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4090225|NCT00997620|3913770|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4090226|NCT00997620|3913771|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4090227|NCT00997620|3913772|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4090228|NCT00997620|3913770|B3|||Age||years|Mean|37|37.0|Full Range|||18.0|55.0|
4090229|NCT00997620|3913771|B2|||Age||years|Mean|38|38.0|Full Range|||19.0|55.0|
4090230|NCT00997620|3913772|B1|||Age||years|Mean|36|36.0|Full Range|||18.0|55.0|
4090231|NCT00997594|3913789|B3|Japan||Region of Enrollment||participants|Number|18|18.0||||||
4090232|NCT00997594|3913790|B2|Japan||Region of Enrollment||participants|Number|9|9.0||||||
4090233|NCT00997594|3913791|B1|Japan||Region of Enrollment||participants|Number|9|9.0||||||
4090234|NCT00997594|3913789|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4090235|NCT00997594|3913790|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4090236|NCT00997594|3913791|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4090237|NCT00997594|3913789|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4090238|NCT00997594|3913790|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4090239|NCT00997594|3913791|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4090240|NCT00997594|3913789|B3|||Age||years|Mean|65|65.0|Standard Deviation|14|14.0|||
4090241|NCT00997594|3913790|B2|||Age||years|Mean|71|71.0|Standard Deviation|12|12.0|||
4090242|NCT00997594|3913791|B1|||Age||years|Mean|58|58.0|Standard Deviation|13|13.0|||
4090243|NCT00997594|3913789|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4090244|NCT00997594|3913790|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4090245|NCT00997594|3913791|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4090246|NCT00997594|3913789|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4090247|NCT00997594|3913790|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4090248|NCT00997594|3913791|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4090249|NCT00997594|3913789|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090250|NCT00997594|3913790|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090251|NCT00997594|3913791|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090252|NCT00997555|3913798|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
4090253|NCT00997555|3913799|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4090254|NCT00997555|3913800|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4090255|NCT00997555|3913798|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4090256|NCT00997555|3913799|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4090257|NCT00997555|3913800|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4090258|NCT00997555|3913798|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4090259|NCT00997555|3913799|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4090260|NCT00997555|3913800|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4090261|NCT00997555|3913798|B3|||Age||years|Mean|42|42.0|Standard Deviation|9|9.0|||
4090262|NCT00997555|3913799|B2|||Age||years|Mean|35|35.0|Standard Deviation|8|8.0|||
4090263|NCT00997555|3913800|B1|||Age||years|Mean|51|51.0|Standard Deviation|11|11.0|||
4090264|NCT00997555|3913798|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4090265|NCT00997555|3913799|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4090266|NCT00997555|3913800|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4090267|NCT00997555|3913798|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4090268|NCT00997555|3913799|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4090269|NCT00997555|3913800|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4090270|NCT00997555|3913798|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090271|NCT00997555|3913799|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090272|NCT00997555|3913800|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090273|NCT00997516|3913817|B3|United States||Region of Enrollment||participants|Number|75|75.0||||||
4090274|NCT00997516|3913818|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
4090275|NCT00997516|3913819|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4090276|NCT00997516|3913817|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4090277|NCT00997516|3913818|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4090278|NCT00997516|3913819|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4090279|NCT00997516|3913817|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4090280|NCT00997516|3913818|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4090281|NCT00997516|3913819|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4090282|NCT00997516|3913817|B3|||Age||years|Mean|34|34.0|Standard Deviation|10|10.0|||
4090283|NCT00997516|3913818|B2|||Age||years|Mean|35|35.0|Standard Deviation|12|12.0|||
4090284|NCT00997516|3913819|B1|||Age||years|Mean|34|34.0|Standard Deviation|11|11.0|||
4090285|NCT00997503|3913848|B1|No||Thrombus Present (Post-Procedure)||lesions|Number|5588|5588.0||||||
4090286|NCT00997503|3913848|B1|Possibly||Thrombus Present (Post-Procedure)||lesions|Number|45|45.0||||||
4090287|NCT00997503|3913848|B1|Yes||Thrombus Present (Post-Procedure)||lesions|Number|27|27.0||||||
4090288|NCT00997503|3913848|B1|||Post-Procedure Target Lesion Percent Diameter Stenosis (%DS)||percentage of diameter stenosis|Mean|1.3|1.3|Standard Deviation|4.2|4.2|||
4090289|NCT00997503|3913848|B1|3||Post-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|"TIMI 0 No perfusion.~TIMI 1 Penetration with minimal perfusion. Contrast fails to opacify the entire bed distal to the stenosis of the duration of the cine run.~TIMI 2 Partial perfusion. Contrast opacifies the entire coronary bed distal to the stenosis. However, the rate of entry and/or clearance is slower in the coronary bed distal to the obstruction than in comparable areas not perfused by the dilated vessel.~TIMI 3 Complete perfusion. Filling and clearance of contrast equally rapid in the coronary bed distal to stenosis as in other coronary beds."|lesions|Number|5617|5617.0||||||
4090290|NCT00997503|3913848|B1|2||Post-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|"TIMI 0 No perfusion.~TIMI 1 Penetration with minimal perfusion. Contrast fails to opacify the entire bed distal to the stenosis of the duration of the cine run.~TIMI 2 Partial perfusion. Contrast opacifies the entire coronary bed distal to the stenosis. However, the rate of entry and/or clearance is slower in the coronary bed distal to the obstruction than in comparable areas not perfused by the dilated vessel.~TIMI 3 Complete perfusion. Filling and clearance of contrast equally rapid in the coronary bed distal to stenosis as in other coronary beds."|lesions|Number|42|42.0||||||
4090291|NCT00997503|3913848|B1|1||Post-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|"TIMI 0 No perfusion.~TIMI 1 Penetration with minimal perfusion. Contrast fails to opacify the entire bed distal to the stenosis of the duration of the cine run.~TIMI 2 Partial perfusion. Contrast opacifies the entire coronary bed distal to the stenosis. However, the rate of entry and/or clearance is slower in the coronary bed distal to the obstruction than in comparable areas not perfused by the dilated vessel.~TIMI 3 Complete perfusion. Filling and clearance of contrast equally rapid in the coronary bed distal to stenosis as in other coronary beds."|lesions|Number|1|1.0||||||
4090292|NCT00997503|3913848|B1|0||Post-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|"TIMI 0 No perfusion.~TIMI 1 Penetration with minimal perfusion. Contrast fails to opacify the entire bed distal to the stenosis of the duration of the cine run.~TIMI 2 Partial perfusion. Contrast opacifies the entire coronary bed distal to the stenosis. However, the rate of entry and/or clearance is slower in the coronary bed distal to the obstruction than in comparable areas not perfused by the dilated vessel.~TIMI 3 Complete perfusion. Filling and clearance of contrast equally rapid in the coronary bed distal to stenosis as in other coronary beds."|lesions|Number|0|0.0||||||
4090293|NCT00997503|3913848|B1|||Study Stents Implanted Per Patient||stents|Mean|1.5|1.5|Standard Deviation|0.8|0.8|||
4090294|NCT00997503|3913848|B1|||Number of Vessels Treated Per Patient||vessels|Mean|1.1|1.1|Standard Deviation|0.4|0.4|||
4090295|NCT00997503|3913848|B1|||Number of Lesions Treated Per Patient||lesions|Mean|1.3|1.3|Standard Deviation|0.7|0.7|||
4090296|NCT00997503|3913848|B1|||Pre-dilatation Performed||procedures|Number|3044|3044.0||||||
4090297|NCT00997503|3913848|B1|||Acute Coronary Syndrome (ACS) Present|"Subjects may have more than 1 procedure (enrollment and staged)~ACS is defined as ischemic symptoms occurring at rest and lasting 10 minutes or more and occurring within 72 hours before index procedure and either ST-segment deviation of 1 mm or more or elevated levels of a cardiac biomarker of necrosis (CK-MB or troponin T or I greater than the upper limit of normal. If CK-MB or troponin is not available, total CK >2 times upper limit of normal). Subjects with STEMI can be enrolled at any time, and will be classified as ACS and therefore complex, within 14 days after onset of symptoms."|procedures|Number|1194|1194.0||||||
4090298|NCT00997503|3913848|B1|Unknown||Thrombus Present (Pre-Procedure)||lesions|Number|69|69.0||||||
4090299|NCT00997503|3913848|B1|No||Thrombus Present (Pre-Procedure)||lesions|Number|4840|4840.0||||||
4090300|NCT00997503|3913848|B1|Possibly||Thrombus Present (Pre-Procedure)||lesions|Number|273|273.0||||||
4090301|NCT00997503|3913848|B1|Yes||Thrombus Present (Pre-Procedure)||lesions|Number|478|478.0||||||
4090302|NCT00997503|3913848|B1|Arterial or Vein Graft||Lesion Location (Vessel)||lesions|Number|167|167.0||||||
4090303|NCT00997503|3913848|B1|Left Main (LM) Coronary Artery||Lesion Location (Vessel)||lesions|Number|46|46.0||||||
4090304|NCT00997503|3913848|B1|Left Circumflex (LCX) Coronary Artery||Lesion Location (Vessel)||lesions|Number|1306|1306.0||||||
4090305|NCT00997503|3913848|B1|Left Anterior Descending (LAD) Coronary Artery||Lesion Location (Vessel)||lesions|Number|2198|2198.0||||||
4090306|NCT00997503|3913848|B1|Right Coronary Artery (RCA)||Lesion Location (Vessel)||lesions|Number|1943|1943.0||||||
4090307|NCT00997503|3913848|B1|Severe||Vessel Tortuosity||lesions|Number|56|56.0||||||
4090308|NCT00997503|3913848|B1|Moderate||Vessel Tortuosity||lesions|Number|431|431.0||||||
4090309|NCT00997503|3913848|B1|Mild||Vessel Tortuosity||lesions|Number|1261|1261.0||||||
4090310|NCT00997503|3913848|B1|None||Vessel Tortuosity||lesions|Number|3912|3912.0||||||
4090311|NCT00997503|3913848|B1|||Pre-Procedure Target Lesion Percent Diameter Stenosis (%DS)||percemt|Mean|85.3|85.3|Standard Deviation|11.7|11.7|||
4090312|NCT00997503|3913848|B1|Severe||Lesion Calcification|Readily apparent densities seen within the artery wall and site of lesion either as an X-ray absorbing mass or as an echogenic and shadow generating mass in IVUS imaging; these can be classified as little/none, moderate, or severe.|lesions|Number|150|150.0||||||
4090313|NCT00997503|3913848|B1|Moderate||Lesion Calcification|Readily apparent densities seen within the artery wall and site of lesion either as an X-ray absorbing mass or as an echogenic and shadow generating mass in IVUS imaging; these can be classified as little/none, moderate, or severe.|lesions|Number|482|482.0||||||
4090314|NCT00997503|3913848|B1|Mild||Lesion Calcification|Readily apparent densities seen within the artery wall and site of lesion either as an X-ray absorbing mass or as an echogenic and shadow generating mass in IVUS imaging; these can be classified as little/none, moderate, or severe.|lesions|Number|1398|1398.0||||||
4090315|NCT00997503|3913848|B1|None||Lesion Calcification|Readily apparent densities seen within the artery wall and site of lesion either as an X-ray absorbing mass or as an echogenic and shadow generating mass in IVUS imaging; these can be classified as little/none, moderate, or severe.|lesions|Number|3630|3630.0||||||
4090316|NCT00997503|3913848|B1|Type C||Lesion Classification: American College of Cardiology (ACC)/ American Heart Association (AHA)|Please note the reference section for further definition of the lesion classification.|lesions|Number|1068|1068.0||||||
4090317|NCT00997503|3913848|B1|Type B2||Lesion Classification: American College of Cardiology (ACC)/ American Heart Association (AHA)|Please note the reference section for further definition of the lesion classification.|lesions|Number|1162|1162.0||||||
4090318|NCT00997503|3913848|B1|Type B1||Lesion Classification: American College of Cardiology (ACC)/ American Heart Association (AHA)|Please note the reference section for further definition of the lesion classification.|lesions|Number|2298|2298.0||||||
4090319|NCT00997503|3913848|B1|Type A||Lesion Classification: American College of Cardiology (ACC)/ American Heart Association (AHA)|Please note the reference section for further definition of the lesion classification.|lesions|Number|1132|1132.0||||||
4090320|NCT00997503|3913848|B1|3||Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|"TIMI 0 No perfusion.~TIMI 1 Penetration with minimal perfusion. Contrast fails to opacify the entire bed distal to the stenosis of the duration of the cine run.~TIMI 2 Partial perfusion. Contrast opacifies the entire coronary bed distal to the stenosis. However, the rate of entry and/or clearance is slower in the coronary bed distal to the obstruction than in comparable areas not perfused by the dilated vessel.~TIMI 3 Complete perfusion. Filling and clearance of contrast equally rapid in the coronary bed distal to stenosis as in other coronary beds."|lesions|Number|4283|4283.0||||||
4090321|NCT00997503|3913848|B1|2||Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|"TIMI 0 No perfusion.~TIMI 1 Penetration with minimal perfusion. Contrast fails to opacify the entire bed distal to the stenosis of the duration of the cine run.~TIMI 2 Partial perfusion. Contrast opacifies the entire coronary bed distal to the stenosis. However, the rate of entry and/or clearance is slower in the coronary bed distal to the obstruction than in comparable areas not perfused by the dilated vessel.~TIMI 3 Complete perfusion. Filling and clearance of contrast equally rapid in the coronary bed distal to stenosis as in other coronary beds."|lesions|Number|679|679.0||||||
4090322|NCT00997503|3913848|B1|1||Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|"TIMI 0 No perfusion.~TIMI 1 Penetration with minimal perfusion. Contrast fails to opacify the entire bed distal to the stenosis of the duration of the cine run.~TIMI 2 Partial perfusion. Contrast opacifies the entire coronary bed distal to the stenosis. However, the rate of entry and/or clearance is slower in the coronary bed distal to the obstruction than in comparable areas not perfused by the dilated vessel.~TIMI 3 Complete perfusion. Filling and clearance of contrast equally rapid in the coronary bed distal to stenosis as in other coronary beds."|lesions|Number|197|197.0||||||
4090369|NCT00997503|3913848|B1||Female|Sex: Female, Male||Participants|Count of Participants|1161|1161.0||||||
4090323|NCT00997503|3913848|B1|0||Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|"TIMI 0 No perfusion.~TIMI 1 Penetration with minimal perfusion. Contrast fails to opacify the entire bed distal to the stenosis of the duration of the cine run.~TIMI 2 Partial perfusion. Contrast opacifies the entire coronary bed distal to the stenosis. However, the rate of entry and/or clearance is slower in the coronary bed distal to the obstruction than in comparable areas not perfused by the dilated vessel.~TIMI 3 Complete perfusion. Filling and clearance of contrast equally rapid in the coronary bed distal to stenosis as in other coronary beds."|lesions|Number|501|501.0||||||
4090324|NCT00997503|3913848|B1|||Lesion Length|Measured as distance from the proximal to the distal shoulder in the view that demonstrates the stenosis in its most elongated projection; lesion length is recorded as discrete (<10 mm), tubular (10-20 mm), and diffuse (>20 mm).|millimeters|Mean|16|16.0|Standard Deviation|9.5|9.5|||
4090325|NCT00997503|3913848|B1|||Reference Vessel Diameter (RVD)||millimeters|Mean|2.99|2.99|Standard Deviation|0.5|0.5|||
4090326|NCT00997503|3913848|B1|||Bifurcated Lesion|Lesion where a branch vessel of medium or large size originates.|lesions|Number|336|336.0||||||
4090327|NCT00997503|3913848|B1|||Post Brachytherapy||lesions|Number|5|5.0||||||
4090328|NCT00997503|3913848|B1|||Ostial Lesion|Lesions involving the origin of the coronary artery within the first 3 mm.|lesions|Number|216|216.0||||||
4090329|NCT00997503|3913848|B1|||Chronic Total Occlusion|Lesion that has been totally occluded for three or more months and with a documented TIMI flow of 0.|lesions|Number|70|70.0||||||
4090330|NCT00997503|3913848|B1|Restenotic Lesion (No Stent)||Restenosis||lesions|Number|31|31.0||||||
4090331|NCT00997503|3913848|B1|Restenosis - Bare Metal Stent (BMS)||Restenosis||lesions|Number|82|82.0||||||
4090332|NCT00997503|3913848|B1|Restenosis - Drug Eluting Stent (DES)||Restenosis||lesions|Number|168|168.0||||||
4090333|NCT00997503|3913848|B1|||Culprit Lesion for ST Elevation Myocardial Infarction (STEMI)||lesions|Number|386|386.0||||||
4090334|NCT00997503|3913848|B1|||De Novo Lesion|A coronary lesion not previously treated.|lesions|Number|5421|5421.0||||||
4090335|NCT00997503|3913848|B1|||History of Major Bleeding||participants|Number|32|32.0||||||
4090336|NCT00997503|3913848|B1|||History of Peripheral Vascular Disease||participants|Number|284|284.0||||||
4090337|NCT00997503|3913848|B1|||Current Renal Dysfunction||participants|Number|185|185.0||||||
4090338|NCT00997503|3913848|B1|||History of Stroke||participants|Number|4|4.0||||||
4090339|NCT00997503|3913848|B1|||History of Transient Ischemic Attack (TIA)||participants|Number|4|4.0||||||
4090340|NCT00997503|3913848|B1|||History of Left Main Disease||participants|Number|155|155.0||||||
4090341|NCT00997503|3913848|B1|||History of Multivessel Disease|The presence of a greater than 50% diameter stenosis in 2 or 3 major epicardial coronary vessels or bypassed branches.|participants|Number|1464|1464.0||||||
4090342|NCT00997503|3913848|B1|||Experiencing Cardiogenic Shock|A clinical state of hypoperfusion characterized by systolic pressure <80 mm Hg and/or central filling pressure >20 mm Hg, or cardiac index <1.8 liters/minute/m2 where there is evidence of insufficient end organ profusion. Shock is also considered present if intravenous inotropes and/or intra-aortic balloon pump are needed to maintain a systolic blood pressure >80 mm Hg and a cardiac index >1.8 liters/minute/ m2.|participants|Number|17|17.0||||||
4090343|NCT00997503|3913848|B1|||Current Myocardial Infarction (MI)||participants|Number|1040|1040.0||||||
4090344|NCT00997503|3913848|B1|||Current Silent Ischemia||participants|Number|310|310.0||||||
4090345|NCT00997503|3913848|B1|||Current Unstable Angina||participants|Number|1385|1385.0||||||
4090346|NCT00997503|3913848|B1|||Current Stable Angina|Canadian Cardiology Society Classification (CCSC)|participants|Number|1320|1320.0||||||
4090347|NCT00997503|3913848|B1|||History of Congestive Heart Failure (CHF)||participants|Number|254|254.0||||||
4090348|NCT00997503|3913848|B1|||History of Percutaneous Coronary Intervention (PCI)||participants|Number|1411|1411.0||||||
4090349|NCT00997503|3913848|B1|||History of Coronary Artery Bypass Graft (CABG)||participants|Number|559|559.0||||||
4090350|NCT00997503|3913848|B1|||History of Atrial Fibrillation||participants|Number|143|143.0||||||
4090351|NCT00997503|3913848|B1|||Family History of Coronary Artery Disease (CAD)||participants|Number|2466|2466.0||||||
4090352|NCT00997503|3913848|B1|||Diabetic (Medically Treated)||participants|Number|1289|1289.0||||||
4090353|NCT00997503|3913848|B1|||History of Hypertension Requiring Medication||participants|Number|3130|3130.0||||||
4090354|NCT00997503|3913848|B1|||History of Hyperlipidemia Requiring Medication||participants|Number|2950|2950.0||||||
4090355|NCT00997503|3913848|B1|Unknown||Smoking Status||participants|Number|89|89.0||||||
4090356|NCT00997503|3913848|B1|Never||Smoking Status||participants|Number|1387|1387.0||||||
4090357|NCT00997503|3913848|B1|Previous||Smoking Status||participants|Number|1451|1451.0||||||
4090358|NCT00997503|3913848|B1|Current||Smoking Status||participants|Number|1272|1272.0||||||
4090359|NCT00997503|3913848|B1|||Weight||kilograms|Mean|92.9|92.9|Standard Deviation|20.7|20.7|||
4090360|NCT00997503|3913848|B1|United States||Region of Enrollment||participants|Number|4199|4199.0||||||
4090361|NCT00997503|3913848|B1|Other||Race/Ethnicity, Customized|Some participants may be allocated to greater than one category.|participants|Number|43|43.0||||||
4090362|NCT00997503|3913848|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Some participants may be allocated to greater than one category.|participants|Number|16|16.0||||||
4090363|NCT00997503|3913848|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Some participants may be allocated to greater than one category.|participants|Number|8|8.0||||||
4090364|NCT00997503|3913848|B1|Black, or African Heritage||Race/Ethnicity, Customized|Some participants may be allocated to greater than one category.|participants|Number|323|323.0||||||
4090365|NCT00997503|3913848|B1|Asian||Race/Ethnicity, Customized|Some participants may be allocated to greater than one category.|participants|Number|23|23.0||||||
4090366|NCT00997503|3913848|B1|Caucasian||Race/Ethnicity, Customized|Some participants may be allocated to greater than one category.|participants|Number|3623|3623.0||||||
4090367|NCT00997503|3913848|B1|Hispanic or Latino||Race/Ethnicity, Customized|Some participants may be allocated to greater than one category.|participants|Number|181|181.0||||||
4090368|NCT00997503|3913848|B1||Male|Sex: Female, Male||Participants|Count of Participants|3038|3038.0||||||
4090370|NCT00997503|3913848|B1|||Age||years|Mean|59.8|59.8|Standard Deviation|9.8|9.8|||
4090371|NCT00997438|3913888|B4||Male|Gender||Participants|Count of Participants|21|21.0||||||
4090372|NCT00997438|3913889|B3||Male|Gender||Participants|Count of Participants|8|8.0||||||
4090373|NCT00997438|3913890|B2||Male|Gender||Participants|Count of Participants|7|7.0||||||
4090374|NCT00997438|3913891|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
4090375|NCT00997438|3913888|B4||Female|Gender||Participants|Count of Participants|36|36.0||||||
4090376|NCT00997438|3913889|B3||Female|Gender||Participants|Count of Participants|12|12.0||||||
4090377|NCT00997438|3913890|B2||Female|Gender||Participants|Count of Participants|14|14.0||||||
4090378|NCT00997438|3913891|B1||Female|Gender||Participants|Count of Participants|10|10.0||||||
4090379|NCT00997438|3913888|B4|||Age||years|Median|54|54.0|Full Range|||26.0|69.0|
4090380|NCT00997438|3913889|B3|||Age||years|Median|49.5|49.5|Full Range|||26.0|65.0|
4090381|NCT00997438|3913890|B2|||Age||years|Median|51|51.0|Full Range|||29.0|64.0|
4090382|NCT00997438|3913891|B1|||Age||years|Median|57.5|57.5|Full Range|||39.0|69.0|
4090383|NCT00997425|3913928|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090384|NCT00997425|3913928|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090385|NCT00997425|3913928|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4090386|NCT00997425|3913928|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4090387|NCT00997425|3913928|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090388|NCT00997425|3913928|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090389|NCT00997425|3913928|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4090390|NCT00997425|3913928|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4090391|NCT00997425|3913928|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4090392|NCT00997425|3913928|B1|||Age||years|Mean|79.9|79.9|Standard Deviation|7.89|7.89|||
4090393|NCT00997425|3913928|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4090394|NCT00997425|3913928|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4090395|NCT00997425|3913928|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090396|NCT00997386|3913933|B1|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4090397|NCT00997386|3913933|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090398|NCT00997386|3913933|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4090399|NCT00997386|3913933|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4090400|NCT00997386|3913933|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4090401|NCT00997386|3913933|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4090402|NCT00997386|3913933|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4090403|NCT00997386|3913933|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4090404|NCT00997386|3913933|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090405|NCT00997373|3913940|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4090406|NCT00997373|3913941|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4090407|NCT00997373|3913942|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4090408|NCT00997373|3913940|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090409|NCT00997373|3913941|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090410|NCT00997373|3913942|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090411|NCT00997373|3913940|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090412|NCT00997373|3913941|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090413|NCT00997373|3913942|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090414|NCT00997373|3913940|B3||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4090415|NCT00997373|3913941|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4090416|NCT00997373|3913942|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4090417|NCT00997373|3913940|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090418|NCT00997373|3913941|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090419|NCT00997373|3913942|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090420|NCT00997373|3913940|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090421|NCT00997373|3913941|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090422|NCT00997373|3913942|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090423|NCT00997373|3913940|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090424|NCT00997373|3913941|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090425|NCT00997373|3913942|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090426|NCT00997373|3913940|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4090427|NCT00997373|3913941|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4090428|NCT00997373|3913942|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090429|NCT00997373|3913940|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4090430|NCT00997373|3913941|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4090431|NCT00997373|3913942|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4090432|NCT00997373|3913940|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4090433|NCT00997373|3913941|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4090434|NCT00997373|3913942|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4090435|NCT00997373|3913940|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4090436|NCT00997373|3913941|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4090437|NCT00997373|3913942|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4090438|NCT00997373|3913940|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4090439|NCT00997373|3913941|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4090440|NCT00997373|3913942|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4090441|NCT00997373|3913940|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090442|NCT00997373|3913941|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090443|NCT00997373|3913942|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090444|NCT00997334|3913949|B1||Smoker|Smoking Status||Participants|Count of Participants|26|26.0||||||
4090445|NCT00997334|3913949|B1||Never-Smoker|Smoking Status||Participants|Count of Participants|34|34.0||||||
4090446|NCT00997334|3913949|B1|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
4090447|NCT00997334|3913949|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4090448|NCT00997334|3913949|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4090449|NCT00997334|3913949|B1|||Age||years|Median|60|60.0|Full Range|||34.0|90.0|
4090450|NCT00997321|3913956|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
4090451|NCT00997321|3913957|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
4090452|NCT00997321|3913958|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4090453|NCT00997321|3913956|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4090454|NCT00997321|3913957|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4090455|NCT00997321|3913958|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4090456|NCT00997321|3913956|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4090457|NCT00997321|3913957|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4090458|NCT00997321|3913958|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4090459|NCT00997321|3913956|B3|||Age||years|Mean|32|32.0|Standard Deviation|5|5.0|||
4090460|NCT00997321|3913957|B2|||Age||years|Mean|30|30.0|Standard Deviation|5|5.0|||
4090461|NCT00997321|3913958|B1|||Age||years|Mean|34|34.0|Standard Deviation|5|5.0|||
4090462|NCT00997321|3913956|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4090463|NCT00997321|3913957|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4090464|NCT00997321|3913958|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4090465|NCT00997321|3913956|B3||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4090466|NCT00997321|3913957|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4090467|NCT00997321|3913958|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4090468|NCT00997321|3913956|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090469|NCT00997321|3913957|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090470|NCT00997321|3913958|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090471|NCT00997243|3913971|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4090472|NCT00997243|3913971|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4090473|NCT00997243|3913971|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4090474|NCT00997243|3913971|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4090475|NCT00997243|3913971|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4090476|NCT00997243|3913971|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090477|NCT00997204|3913981|B3|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
4090478|NCT00997204|3913982|B2|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4090479|NCT00997204|3913983|B1|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4090480|NCT00997204|3913981|B3|Switzerland||Region of Enrollment||participants|Number|2|2.0||||||
4090481|NCT00997204|3913982|B2|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4090482|NCT00997204|3913983|B1|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4090483|NCT00997204|3913981|B3|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4090484|NCT00997204|3913982|B2|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4090485|NCT00997204|3913983|B1|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4090486|NCT00997204|3913981|B3|Germany||Region of Enrollment||participants|Number|14|14.0||||||
4090487|NCT00997204|3913982|B2|Germany||Region of Enrollment||participants|Number|5|5.0||||||
4090488|NCT00997204|3913983|B1|Germany||Region of Enrollment||participants|Number|9|9.0||||||
4090489|NCT00997204|3913981|B3|Israel||Region of Enrollment||participants|Number|15|15.0||||||
4090490|NCT00997204|3913982|B2|Israel||Region of Enrollment||participants|Number|0|0.0||||||
4090491|NCT00997204|3913983|B1|Israel||Region of Enrollment||participants|Number|15|15.0||||||
4090492|NCT00997204|3913981|B3|Austria||Region of Enrollment||participants|Number|14|14.0||||||
4090493|NCT00997204|3913982|B2|Austria||Region of Enrollment||participants|Number|5|5.0||||||
4090494|NCT00997204|3913983|B1|Austria||Region of Enrollment||participants|Number|9|9.0||||||
4090495|NCT00997204|3913981|B3|Denmark||Region of Enrollment||participants|Number|5|5.0||||||
4090496|NCT00997204|3913982|B2|Denmark||Region of Enrollment||participants|Number|0|0.0||||||
4090497|NCT00997204|3913983|B1|Denmark||Region of Enrollment||participants|Number|5|5.0||||||
4090498|NCT00997204|3913981|B3|Spain||Region of Enrollment||participants|Number|11|11.0||||||
4090499|NCT00997204|3913982|B2|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4090500|NCT00997204|3913983|B1|Spain||Region of Enrollment||participants|Number|9|9.0||||||
4090501|NCT00997204|3913981|B3|Argentina||Region of Enrollment||participants|Number|23|23.0||||||
4090502|NCT00997204|3913982|B2|Argentina||Region of Enrollment||participants|Number|5|5.0||||||
4090503|NCT00997204|3913983|B1|Argentina||Region of Enrollment||participants|Number|18|18.0||||||
4090504|NCT00997204|3913981|B3|France||Region of Enrollment||participants|Number|6|6.0||||||
4090505|NCT00997204|3913982|B2|France||Region of Enrollment||participants|Number|0|0.0||||||
4090506|NCT00997204|3913983|B1|France||Region of Enrollment||participants|Number|6|6.0||||||
4090507|NCT00997204|3913981|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4090508|NCT00997204|3913982|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4090509|NCT00997204|3913983|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4090510|NCT00997204|3913981|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4090511|NCT00997204|3913982|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4090512|NCT00997204|3913983|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4090513|NCT00997204|3913981|B3|||Age||years|Mean|41.58|41.58|Standard Deviation|13.98|13.98|||
4090514|NCT00997204|3913982|B2|||Age||years|Mean|44.68|44.68|Standard Deviation|16.53|16.53|||
4090515|NCT00997204|3913983|B1|||Age||years|Mean|40.607|40.607|Standard Deviation|13.044|13.044|||
4090516|NCT00997139|3913995|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4090517|NCT00997139|3913995|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4090518|NCT00997139|3913995|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4090519|NCT00997139|3913995|B1|||Age||years|Mean|39.3|39.3|Standard Deviation|10.9|10.9|||
4090520|NCT00997139|3913995|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4090521|NCT00997139|3913995|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4090522|NCT00997139|3913995|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090523|NCT00997126|3914001|B3||Male|Gender||Participants|Count of Participants|54|54.0||||||
4090524|NCT00997126|3914002|B2||Male|Gender||Participants|Count of Participants|29|29.0||||||
4090525|NCT00997126|3914003|B1||Male|Gender||Participants|Count of Participants|25|25.0||||||
4090526|NCT00997126|3914001|B3||Female|Gender||Participants|Count of Participants|54|54.0||||||
4090527|NCT00997126|3914002|B2||Female|Gender||Participants|Count of Participants|23|23.0||||||
4090528|NCT00997126|3914003|B1||Female|Gender||Participants|Count of Participants|31|31.0||||||
4090529|NCT00997126|3914001|B3|||Age||years|Median|34|34.0|Full Range|||18.0|82.0|
4090530|NCT00997126|3914002|B2|||Age||years|Median|32|32.0|Full Range|||18.0|82.0|
4090531|NCT00997126|3914003|B1|||Age||years|Median|36|36.0|Full Range|||18.0|64.0|
4090532|NCT00997113|3914018|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4090533|NCT00997113|3914019|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4090534|NCT00997113|3914020|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4090535|NCT00997113|3914018|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4090536|NCT00997113|3914019|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4090537|NCT00997113|3914020|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4090538|NCT00997113|3914018|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4090539|NCT00997113|3914019|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4090540|NCT00997113|3914020|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4090541|NCT00997113|3914018|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4090542|NCT00997113|3914019|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4090543|NCT00997113|3914020|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4090544|NCT00997113|3914018|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4090545|NCT00997113|3914019|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4090546|NCT00997113|3914020|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4090547|NCT00997113|3914018|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090548|NCT00997113|3914019|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090549|NCT00997113|3914020|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090550|NCT00997113|3914018|B3|||Age||years|Median|35|35.0|Full Range|||18.0|60.0|
4090551|NCT00997113|3914019|B2|||Age||years|Median|36|36.0|Full Range|||20.0|58.0|
4090552|NCT00997113|3914020|B1|||Age||years|Median|34|34.0|Full Range|||18.0|60.0|
4090553|NCT00997035|3914031|B3|||Weight (lbs)||lbs|Median|108|108.0|Inter-Quartile Range|||97.0|121.0|
4090554|NCT00997035|3914032|B2|||Weight (lbs)||lbs|Median|105|105.0|Inter-Quartile Range|||94.0|123.0|
4090555|NCT00997035|3914033|B1|||Weight (lbs)||lbs|Median|108|108.0|Inter-Quartile Range|||97.0|121.0|
4090556|NCT00997035|3914031|B3|India||Region of Enrollment||participants|Number|44|44.0||||||
4090557|NCT00997035|3914032|B2|India||Region of Enrollment||participants|Number|21|21.0||||||
4090558|NCT00997035|3914033|B1|India||Region of Enrollment||participants|Number|23|23.0||||||
4090559|NCT00997035|3914031|B3|Nepal||Region of Enrollment||participants|Number|196|196.0||||||
4090560|NCT00997035|3914032|B2|Nepal||Region of Enrollment||participants|Number|98|98.0||||||
4090561|NCT00997035|3914033|B1|Nepal||Region of Enrollment||participants|Number|98|98.0||||||
4090562|NCT00997035|3914031|B3||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4090563|NCT00997035|3914032|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4090564|NCT00997035|3914033|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4090565|NCT00997035|3914031|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4090566|NCT00997035|3914032|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4090567|NCT00997035|3914033|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4090568|NCT00997035|3914031|B3|||Age||years|Median|54|54.0|Inter-Quartile Range|||45.0|60.0|
4090569|NCT00997035|3914032|B2|||Age||years|Median|54|54.0|Inter-Quartile Range|||42.0|62.0|
4090570|NCT00997035|3914033|B1|||Age||years|Median|50|50.0|Inter-Quartile Range|||45.0|60.0|
4090571|NCT00997035|3914031|B3||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
4090572|NCT00997035|3914032|B2||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4090573|NCT00997035|3914033|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4090574|NCT00997035|3914031|B3||Between 18 and 65 years|Age||Participants|Count of Participants|191|191.0||||||
4090575|NCT00997035|3914032|B2||Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
4090576|NCT00997035|3914033|B1||Between 18 and 65 years|Age||Participants|Count of Participants|98|98.0||||||
4090577|NCT00997035|3914031|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090578|NCT00997035|3914032|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090579|NCT00997035|3914033|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090580|NCT00996996|3914054|B1|Asian||Race/Ethnicity, Customized|Baseline characteristics are summarized for the ITT-Exposed Population, comprised of all participants who were enrolled in the study and received at least one dose of study drug. A total of 77 participants were enrolled in the study; however, only 76 participants received study drug.|participants|Number|1|1.0||||||
4090581|NCT00996996|3914054|B1|Hispanic||Race/Ethnicity, Customized|Baseline characteristics are summarized for the ITT-Exposed Population, comprised of all participants who were enrolled in the study and received at least one dose of study drug. A total of 77 participants were enrolled in the study; however, only 76 participants received study drug.|participants|Number|1|1.0||||||
4090582|NCT00996996|3914054|B1|White||Race/Ethnicity, Customized|Baseline characteristics are summarized for the ITT-Exposed Population, comprised of all participants who were enrolled in the study and received at least one dose of study drug. A total of 77 participants were enrolled in the study; however, only 76 participants received study drug.|participants|Number|74|74.0||||||
4090583|NCT00996996|3914054|B1||Male|Gender|Baseline characteristics are summarized for the ITT-Exposed Population, comprised of all participants who were enrolled in the study and received at least one dose of study drug. A total of 77 participants were enrolled in the study; however, only 76 participants received study drug.|Participants|Count of Participants|41|41.0||||||
4090584|NCT00996996|3914054|B1||Female|Gender|Baseline characteristics are summarized for the ITT-Exposed Population, comprised of all participants who were enrolled in the study and received at least one dose of study drug. A total of 77 participants were enrolled in the study; however, only 76 participants received study drug.|Participants|Count of Participants|35|35.0||||||
4090585|NCT00996996|3914054|B1|||Age|Baseline characteristics are summarized for the Intent-to-Treat (ITT)-Exposed Population, comprised of all participants who were enrolled in the study and received at least one dose of study drug. A total of 77 participants were enrolled in the study; however, only 76 participants received study drug.|Years|Mean|48.1|48.1|Standard Deviation|9.9|9.9|||
4090586|NCT00996944|3914086|B3|||Duration of Dialysis||years|Mean|6.94|6.94|Standard Deviation|5.403|5.403|||
4090587|NCT00996944|3914087|B2|||Duration of Dialysis||years|Mean|6.08|6.08|Standard Deviation|5.274|5.274|||
4090588|NCT00996944|3914088|B1|||Duration of Dialysis||years|Mean|7.41|7.41|Standard Deviation|5.537|5.537|||
4090589|NCT00996944|3914086|B3|||Age at Onset of Restless Legs Syndrome||years|Mean|49.1|49.1|Standard Deviation|10.71|10.71|||
4090590|NCT00996944|3914087|B2|||Age at Onset of Restless Legs Syndrome||years|Mean|49.4|49.4|Standard Deviation|10.12|10.12|||
4090591|NCT00996944|3914088|B1|||Age at Onset of Restless Legs Syndrome||years|Mean|48.9|48.9|Standard Deviation|11.24|11.24|||
4090592|NCT00996944|3914086|B3|Not Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4090593|NCT00996944|3914087|B2|Not Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4090594|NCT00996944|3914088|B1|Not Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4090595|NCT00996944|3914086|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4090596|NCT00996944|3914087|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4090597|NCT00996944|3914088|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4090598|NCT00996944|3914086|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4090599|NCT00996944|3914087|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4090600|NCT00996944|3914088|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4090601|NCT00996944|3914086|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4090602|NCT00996944|3914087|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4090603|NCT00996944|3914088|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4090604|NCT00996944|3914086|B3|||Age||Years|Mean|53.6|53.6|Standard Deviation|11.06|11.06|||
4090605|NCT00996944|3914087|B2|||Age||Years|Mean|53.8|53.8|Standard Deviation|10.90|10.9|||
4090606|NCT00996944|3914088|B1|||Age||Years|Mean|53.5|53.5|Standard Deviation|11.39|11.39|||
4090607|NCT00996931|3914131|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4090608|NCT00996931|3914131|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4090609|NCT00996931|3914131|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4090610|NCT00996931|3914131|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4090611|NCT00996931|3914131|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4090612|NCT00996931|3914131|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4090613|NCT00996918|3914136|B6||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4090614|NCT00996918|3914137|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4090615|NCT00996918|3914138|B4||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4090616|NCT00996918|3914139|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4090617|NCT00996918|3914140|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4090618|NCT00996918|3914141|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4090619|NCT00996918|3914136|B6||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4090620|NCT00996918|3914137|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4090621|NCT00996918|3914138|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4090622|NCT00996918|3914139|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4090623|NCT00996918|3914140|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4090624|NCT00996918|3914141|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4090625|NCT00996918|3914136|B6|>= 65||Age, Customized||Number of participants|Number|128|128.0||||||
4090626|NCT00996918|3914137|B5|>= 65||Age, Customized||Number of participants|Number|3|3.0||||||
4090627|NCT00996918|3914138|B4|>= 65||Age, Customized||Number of participants|Number|36|36.0||||||
4090628|NCT00996918|3914139|B3|>= 65||Age, Customized||Number of participants|Number|21|21.0||||||
4090629|NCT00996918|3914140|B2|>= 65||Age, Customized||Number of participants|Number|47|47.0||||||
4090630|NCT00996918|3914141|B1|>= 65||Age, Customized||Number of participants|Number|21|21.0||||||
4090631|NCT00996918|3914136|B6|< 65||Age, Customized||Number of participants|Number|62|62.0||||||
4090632|NCT00996918|3914137|B5|< 65||Age, Customized||Number of participants|Number|1|1.0||||||
4090633|NCT00996918|3914138|B4|< 65||Age, Customized||Number of participants|Number|17|17.0||||||
4090634|NCT00996918|3914139|B3|< 65||Age, Customized||Number of participants|Number|12|12.0||||||
4090635|NCT00996918|3914140|B2|< 65||Age, Customized||Number of participants|Number|15|15.0||||||
4090636|NCT00996918|3914141|B1|< 65||Age, Customized||Number of participants|Number|17|17.0||||||
4090637|NCT00996918|3914136|B6|||Age||Years|Mean|70.4|70.4|Standard Deviation|9.08|9.08|||
4090638|NCT00996918|3914137|B5|||Age||Years|Mean|71.3|71.3|Standard Deviation|10.63|10.63|||
4090639|NCT00996918|3914138|B4|||Age||Years|Mean|70.6|70.6|Standard Deviation|9.13|9.13|||
4090640|NCT00996918|3914139|B3|||Age||Years|Mean|68.8|68.8|Standard Deviation|8.59|8.59|||
4090641|NCT00996918|3914140|B2|||Age||Years|Mean|71.9|71.9|Standard Deviation|8.83|8.83|||
4090642|NCT00996918|3914141|B1|||Age||Years|Mean|68.9|68.9|Standard Deviation|9.70|9.7|||
4090643|NCT00996892|3914189|B1||Male|Gender||Participants|Count of Participants|69|69.0||||||
4090644|NCT00996892|3914189|B1||Female|Gender||Participants|Count of Participants|109|109.0||||||
4090645|NCT00996892|3914189|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|12.0|12.0|||
4090646|NCT00996840|3914797|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4090647|NCT00996840|3914798|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4090648|NCT00996840|3914799|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4090649|NCT00996840|3914800|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4090650|NCT00996840|3914801|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090651|NCT00996840|3914802|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4090652|NCT00996840|3914797|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090653|NCT00996840|3914798|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090654|NCT00996840|3914799|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090655|NCT00996840|3914800|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090656|NCT00996840|3914801|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090657|NCT00996840|3914802|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090658|NCT00996840|3914797|B6||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4090659|NCT00996840|3914798|B5||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4090660|NCT00996840|3914799|B4||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4090661|NCT00996840|3914800|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4090662|NCT00996840|3914801|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4090663|NCT00996840|3914802|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4090664|NCT00996840|3914797|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4090665|NCT00996840|3914798|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4090666|NCT00996840|3914799|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4090667|NCT00996840|3914800|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4090668|NCT00996840|3914801|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090669|NCT00996840|3914802|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4090670|NCT00996840|3914797|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090671|NCT00996840|3914798|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090672|NCT00996840|3914799|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090673|NCT00996840|3914800|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090674|NCT00996840|3914801|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090675|NCT00996840|3914802|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090676|NCT00996840|3914797|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090677|NCT00996840|3914798|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090678|NCT00996840|3914799|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090679|NCT00996840|3914800|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090680|NCT00996840|3914801|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090681|NCT00996840|3914802|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090682|NCT00996840|3914797|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4090683|NCT00996840|3914798|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090684|NCT00996840|3914799|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4090685|NCT00996840|3914800|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090686|NCT00996840|3914801|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090687|NCT00996840|3914802|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4090688|NCT00996840|3914797|B6||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4090689|NCT00996840|3914798|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4090690|NCT00996840|3914799|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4090691|NCT00996840|3914800|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4090692|NCT00996840|3914801|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4090693|NCT00996840|3914802|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4090694|NCT00996840|3914797|B6||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4090695|NCT00996840|3914798|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4090696|NCT00996840|3914799|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4090697|NCT00996840|3914800|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4090698|NCT00996840|3914801|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4090699|NCT00996840|3914802|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4090700|NCT00996840|3914797|B6|||Age||Years|Mean|42.7|42.7|Standard Deviation|18.24|18.24|||
4090701|NCT00996840|3914798|B5|||Age||Years|Mean|46.1|46.1|Standard Deviation|21.80|21.8|||
4090702|NCT00996840|3914799|B4|||Age||Years|Mean|44.1|44.1|Standard Deviation|15.89|15.89|||
4090703|NCT00996840|3914800|B3|||Age||Years|Mean|34.5|34.5|Standard Deviation|15.61|15.61|||
4090704|NCT00996840|3914801|B2|||Age||Years|Mean|47.4|47.4|Standard Deviation|19.31|19.31|||
4090705|NCT00996840|3914802|B1|||Age||Years|Mean|41.2|41.2|Standard Deviation|17.70|17.7|||
4090706|NCT00996801|3914950|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4090707|NCT00996801|3914951|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4090708|NCT00996801|3914952|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4090709|NCT00996801|3914953|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4090710|NCT00996801|3914954|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4090711|NCT00996801|3914955|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4090712|NCT00996801|3914956|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4090713|NCT00996801|3914950|B7||Female|Sex: Female, Male||Participants|Count of Participants|526|526.0||||||
4090714|NCT00996801|3914951|B6||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4090715|NCT00996801|3914952|B5||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4090716|NCT00996801|3914953|B4||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4090717|NCT00996801|3914954|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4090718|NCT00996801|3914955|B2||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4090719|NCT00996801|3914956|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4090720|NCT00996801|3914950|B7|||Age||Years|Mean|67.5|67.5|Standard Deviation|7.6|7.6|||
4090721|NCT00996801|3914951|B6|||Age||Years|Mean|66.9|66.9|Standard Deviation|7.5|7.5|||
4090722|NCT00996801|3914952|B5|||Age||Years|Mean|68.1|68.1|Standard Deviation|7.4|7.4|||
4090723|NCT00996801|3914953|B4|||Age||Years|Mean|68.2|68.2|Standard Deviation|6.9|6.9|||
4090724|NCT00996801|3914954|B3|||Age||Years|Mean|67.3|67.3|Standard Deviation|7.1|7.1|||
4090725|NCT00996801|3914955|B2|||Age||Years|Mean|66.5|66.5|Standard Deviation|8.8|8.8|||
4090726|NCT00996801|3914956|B1|||Age||Years|Mean|67.8|67.8|Standard Deviation|7.8|7.8|||
4090727|NCT00996775|3915062|B3||Male|Gender||Participants|Count of Participants|147|147.0||||||
4090728|NCT00996775|3915063|B2||Male|Gender||Participants|Count of Participants|79|79.0||||||
4090729|NCT00996775|3915064|B1||Male|Gender||Participants|Count of Participants|68|68.0||||||
4090730|NCT00996775|3915062|B3||Female|Gender||Participants|Count of Participants|20|20.0||||||
4090731|NCT00996775|3915063|B2||Female|Gender||Participants|Count of Participants|10|10.0||||||
4090732|NCT00996775|3915064|B1||Female|Gender||Participants|Count of Participants|10|10.0||||||
4090733|NCT00996775|3915062|B3|||Age||years|Mean|59.0|59.0|Standard Deviation|15.0|15.0|||
4090734|NCT00996775|3915063|B2|||Age||years|Mean|60.8|60.8|Standard Deviation|14.1|14.1|||
4090735|NCT00996775|3915064|B1|||Age||years|Mean|57.7|57.7|Standard Deviation|15.9|15.9|||
4090736|NCT00996736|3915071|B3|India||Region of Enrollment||participants|Number|323|323.0||||||
4090737|NCT00996736|3915072|B2|India||Region of Enrollment||participants|Number|161|161.0||||||
4090738|NCT00996736|3915073|B1|India||Region of Enrollment||participants|Number|162|162.0||||||
4090739|NCT00996736|3915071|B3||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4090740|NCT00996736|3915072|B2||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4090741|NCT00996736|3915073|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4090742|NCT00996736|3915071|B3||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4090743|NCT00996736|3915072|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4090744|NCT00996736|3915073|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4090745|NCT00996736|3915071|B3|||Age||years|Median|47|47.0|Inter-Quartile Range|||39.0|56.0|
4090746|NCT00996736|3915072|B2|||Age||years|Median|45|45.0|Inter-Quartile Range|||38.0|55.0|
4090747|NCT00996736|3915073|B1|||Age||years|Median|48|48.0|Inter-Quartile Range|||39.0|58.0|
4090748|NCT00996658|3915092|B3|Drinks - investigator opinion/interfere with study||Alcohol status||participants|Number|0|0.0||||||
4090749|NCT00996658|3915093|B2|Drinks - investigator opinion/interfere with study||Alcohol status||participants|Number|0|0.0||||||
4090750|NCT00996658|3915094|B1|Drinks - investigator opinion/interfere with study||Alcohol status||participants|Number|0|0.0||||||
4090751|NCT00996658|3915092|B3|Drinks - no interference with study||Alcohol status||participants|Number|37|37.0||||||
4090752|NCT00996658|3915093|B2|Drinks - no interference with study||Alcohol status||participants|Number|27|27.0||||||
4090753|NCT00996658|3915094|B1|Drinks - no interference with study||Alcohol status||participants|Number|10|10.0||||||
4090754|NCT00996658|3915092|B3|Non drinker||Alcohol status||participants|Number|235|235.0||||||
4090755|NCT00996658|3915093|B2|Non drinker||Alcohol status||participants|Number|156|156.0||||||
4090756|NCT00996658|3915094|B1|Non drinker||Alcohol status||participants|Number|79|79.0||||||
4090757|NCT00996658|3915092|B3|Currently smokes||Smoking status||participants|Number|18|18.0||||||
4090758|NCT00996658|3915093|B2|Currently smokes||Smoking status||participants|Number|16|16.0||||||
4090759|NCT00996658|3915094|B1|Currently smokes||Smoking status||participants|Number|2|2.0||||||
4090760|NCT00996658|3915092|B3|Ex-smoker||Smoking status||participants|Number|28|28.0||||||
4090761|NCT00996658|3915093|B2|Ex-smoker||Smoking status||participants|Number|16|16.0||||||
4090762|NCT00996658|3915094|B1|Ex-smoker||Smoking status||participants|Number|12|12.0||||||
4090763|NCT00996658|3915092|B3|Never smoked||Smoking status||participants|Number|226|226.0||||||
4090764|NCT00996658|3915093|B2|Never smoked||Smoking status||participants|Number|151|151.0||||||
4090765|NCT00996658|3915094|B1|Never smoked||Smoking status||participants|Number|75|75.0||||||
4090766|NCT00996658|3915092|B3|||Waist circumference||centimeters|Mean|98.0|98.0|Standard Deviation|13.2|13.2|||
4090767|NCT00996658|3915093|B2|||Waist circumference||centimeters|Mean|98.1|98.1|Standard Deviation|13.1|13.1|||
4090768|NCT00996658|3915094|B1|||Waist circumference||centimeters|Mean|97.7|97.7|Standard Deviation|13.5|13.5|||
4090769|NCT00996658|3915092|B3|||Height||centimeters|Mean|161.6|161.6|Standard Deviation|11.2|11.2|||
4090770|NCT00996658|3915093|B2|||Height||centimeters|Mean|161.4|161.4|Standard Deviation|11.4|11.4|||
4090771|NCT00996658|3915094|B1|||Height||centimeters|Mean|162.0|162.0|Standard Deviation|11.0|11.0|||
4090772|NCT00996658|3915092|B3|>= 30 kilograms/square meter||Body Mass Index (BMI) categories||participants|Number|78|78.0||||||
4090773|NCT00996658|3915093|B2|>= 30 kilograms/square meter||Body Mass Index (BMI) categories||participants|Number|56|56.0||||||
4090774|NCT00996658|3915094|B1|>= 30 kilograms/square meter||Body Mass Index (BMI) categories||participants|Number|22|22.0||||||
4090775|NCT00996658|3915092|B3|>= 25 and < 30 kilograms/square meter||Body Mass Index (BMI) categories||participants|Number|114|114.0||||||
4090776|NCT00996658|3915093|B2|>= 25 and < 30 kilograms/square meter||Body Mass Index (BMI) categories||participants|Number|76|76.0||||||
4090777|NCT00996658|3915094|B1|>= 25 and < 30 kilograms/square meter||Body Mass Index (BMI) categories||participants|Number|38|38.0||||||
4090778|NCT00996658|3915092|B3|< 25 kilograms/square meter||Body Mass Index (BMI) categories||participants|Number|80|80.0||||||
4090779|NCT00996658|3915093|B2|< 25 kilograms/square meter||Body Mass Index (BMI) categories||participants|Number|51|51.0||||||
4090780|NCT00996658|3915094|B1|< 25 kilograms/square meter||Body Mass Index (BMI) categories||participants|Number|29|29.0||||||
4090781|NCT00996658|3915092|B3|||Body Mass Index (BMI)||kilograms per square meter|Mean|28.2|28.2|Standard Deviation|5.3|5.3|||
4090782|NCT00996658|3915093|B2|||Body Mass Index (BMI)||kilograms per square meter|Mean|28.2|28.2|Standard Deviation|5.2|5.2|||
4090783|NCT00996658|3915094|B1|||Body Mass Index (BMI)||kilograms per square meter|Mean|28.1|28.1|Standard Deviation|5.5|5.5|||
4090784|NCT00996658|3915092|B3|> 90 kilograms||Weight categories||participants|Number|52|52.0||||||
4090785|NCT00996658|3915093|B2|> 90 kilograms||Weight categories||participants|Number|36|36.0||||||
4090786|NCT00996658|3915094|B1|> 90 kilograms||Weight categories||participants|Number|16|16.0||||||
4090787|NCT00996658|3915092|B3|> 80 to 90 kilograms||Weight categories||participants|Number|28|28.0||||||
4090788|NCT00996658|3915093|B2|> 80 to 90 kilograms||Weight categories||participants|Number|18|18.0||||||
4090789|NCT00996658|3915094|B1|> 80 to 90 kilograms||Weight categories||participants|Number|10|10.0||||||
4090790|NCT00996658|3915092|B3|> 70 to 80 kilograms||Weight categories||participants|Number|49|49.0||||||
4090791|NCT00996658|3915093|B2|> 70 to 80 kilograms||Weight categories||participants|Number|32|32.0||||||
4090792|NCT00996658|3915094|B1|> 70 to 80 kilograms||Weight categories||participants|Number|17|17.0||||||
4090793|NCT00996658|3915092|B3|<= 70 kilograms||Weight categories||participants|Number|143|143.0||||||
4090794|NCT00996658|3915093|B2|<= 70 kilograms||Weight categories||participants|Number|97|97.0||||||
4090795|NCT00996658|3915094|B1|<= 70 kilograms||Weight categories||participants|Number|46|46.0||||||
4090796|NCT00996658|3915092|B3|||Weight||kilograms|Mean|74.4|74.4|Standard Deviation|20.2|20.2|||
4090797|NCT00996658|3915093|B2|||Weight||kilograms|Mean|74.4|74.4|Standard Deviation|20.4|20.4|||
4090798|NCT00996658|3915094|B1|||Weight||kilograms|Mean|74.4|74.4|Standard Deviation|19.8|19.8|||
4090799|NCT00996658|3915092|B3||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4090800|NCT00996658|3915093|B2||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4090801|NCT00996658|3915094|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4090802|NCT00996658|3915092|B3||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4090803|NCT00996658|3915093|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4090804|NCT00996658|3915094|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4090805|NCT00996658|3915092|B3|>= 75 years||Age, Customized||participants|Number|3|3.0||||||
4090806|NCT00996658|3915093|B2|>= 75 years||Age, Customized||participants|Number|1|1.0||||||
4090807|NCT00996658|3915094|B1|>= 75 years||Age, Customized||participants|Number|2|2.0||||||
4090808|NCT00996658|3915092|B3|65 to 74 years||Age, Customized||participants|Number|28|28.0||||||
4090809|NCT00996658|3915093|B2|65 to 74 years||Age, Customized||participants|Number|20|20.0||||||
4090810|NCT00996658|3915094|B1|65 to 74 years||Age, Customized||participants|Number|8|8.0||||||
4090811|NCT00996658|3915092|B3|< 65 years||Age, Customized||participants|Number|241|241.0||||||
4090812|NCT00996658|3915093|B2|< 65 years||Age, Customized||participants|Number|162|162.0||||||
4090813|NCT00996658|3915094|B1|< 65 years||Age, Customized||participants|Number|79|79.0||||||
4090814|NCT00996658|3915092|B3|||Age||years|Mean|53.8|53.8|Standard Deviation|9.3|9.3|||
4090815|NCT00996658|3915093|B2|||Age||years|Mean|53.1|53.1|Standard Deviation|9.7|9.7|||
4090816|NCT00996658|3915094|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|8.4|8.4|||
4090817|NCT00996632|3915121|B3|Italy||Region of Enrollment||participants|Number|94|94.0||||||
4090818|NCT00996632|3915122|B2|Italy||Region of Enrollment||participants|Number|56|56.0||||||
4090819|NCT00996632|3915123|B1|Italy||Region of Enrollment||participants|Number|38|38.0||||||
4090820|NCT00996632|3915121|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4090821|NCT00996632|3915122|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4090822|NCT00996632|3915123|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4090823|NCT00996632|3915121|B3||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4090824|NCT00996632|3915122|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4090825|NCT00996632|3915123|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4090826|NCT00996632|3915121|B3|||Age||years|Mean|64.7|64.7|Standard Deviation|12.4|12.4|||
4090827|NCT00996632|3915122|B2|||Age||years|Mean|65.0|65.0|Standard Deviation|12.5|12.5|||
4090828|NCT00996632|3915123|B1|||Age||years|Mean|64.6|64.6|Standard Deviation|12.3|12.3|||
4090829|NCT00996632|3915121|B3||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
4090830|NCT00996632|3915122|B2||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4090831|NCT00996632|3915123|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4090832|NCT00996632|3915121|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4090833|NCT00996632|3915122|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4090834|NCT00996632|3915123|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4090835|NCT00996632|3915121|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090836|NCT00996632|3915122|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090837|NCT00996632|3915123|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4090838|NCT00996606|3915132|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4090839|NCT00996606|3915132|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4090840|NCT00996606|3915132|B1|||Age||years|Mean|51.5|51.5|Standard Deviation|13.0|13.0|||
4090841|NCT00996593|3915226|B1|Black||Race/Ethnicity, Customized|Baseline characteristics are summarized for the Intent-to-Treat (ITT) Population, comprised of all participants who were enrolled into the study and received at least one dose of study drug.|participants|Number|3|3.0||||||
4090842|NCT00996593|3915226|B1|Asian||Race/Ethnicity, Customized|Baseline characteristics are summarized for the Intent-to-Treat (ITT) Population, comprised of all participants who were enrolled into the study and received at least one dose of study drug.|participants|Number|1|1.0||||||
4090964|NCT00996437|3915361|B3|Posterior Chamber Intraocular Lens||Lens Status (on clinical exam)||Participants|Number|66|66.0||||||
4090843|NCT00996593|3915226|B1|Hispanic||Race/Ethnicity, Customized|Baseline characteristics are summarized for the Intent-to-Treat (ITT) Population, comprised of all participants who were enrolled into the study and received at least one dose of study drug.|participants|Number|3|3.0||||||
4090844|NCT00996593|3915226|B1|White||Race/Ethnicity, Customized|Baseline characteristics are summarized for the Intent-to-Treat (ITT) Population, comprised of all participants who were enrolled into the study and received at least one dose of study drug.|participants|Number|33|33.0||||||
4090845|NCT00996593|3915226|B1||Male|Sex: Female, Male|Baseline characteristics are summarized for the Intent-to-Treat (ITT) Population, comprised of all participants who were enrolled into the study and received at least one dose of study drug.|Participants|Count of Participants|27|27.0||||||
4090846|NCT00996593|3915226|B1||Female|Sex: Female, Male|Baseline characteristics are summarized for the Intent-to-Treat (ITT) Population, comprised of all participants who were enrolled into the study and received at least one dose of study drug.|Participants|Count of Participants|13|13.0||||||
4090847|NCT00996593|3915226|B1|||Age|Baseline characteristics are summarized for the Intent-to-Treat (ITT) Population, comprised of all participants who were enrolled into the study and received at least one dose of study drug.|Years|Mean|57.0|57.0|Standard Deviation|11.8|11.8|||
4090848|NCT00996580|3915254|B1|Never Smoked||Smoking Status||participants|Number|2359|2359.0||||||
4090849|NCT00996580|3915254|B1|Former Smoker||Smoking Status||participants|Number|636|636.0||||||
4090850|NCT00996580|3915254|B1|Current Smoker||Smoking Status||participants|Number|602|602.0||||||
4090851|NCT00996580|3915254|B1|Prior User||Oral Contraceptive Use History||participants|Number|1408|1408.0||||||
4090852|NCT00996580|3915254|B1|New Start||Oral Contraceptive Use History||participants|Number|619|619.0||||||
4090853|NCT00996580|3915254|B1|Continuous user||Oral Contraceptive Use History||participants|Number|1570|1570.0||||||
4090854|NCT00996580|3915254|B1|||Heart Rate||beats/minute|Mean|74.6|74.6|Standard Deviation|10.0|10.0|||
4090855|NCT00996580|3915254|B1|||Diastolic Blood Pressure||mmHg|Mean|72.3|72.3|Standard Deviation|8.3|8.3|||
4090856|NCT00996580|3915254|B1|||Systolic Blood Pressure||mmHg|Mean|113.1|113.1|Standard Deviation|10.4|10.4|||
4090857|NCT00996580|3915254|B1|||Body Mass Index||kg/m^2|Mean|27.4|27.4|Standard Deviation|7.0|7.0|||
4090858|NCT00996580|3915254|B1|||Weight||pounds|Mean|162.5|162.5|Standard Deviation|43.2|43.2|||
4090859|NCT00996580|3915254|B1|||Height||inches|Mean|64.6|64.6|Standard Deviation|2.7|2.7|||
4090860|NCT00996580|3915254|B1|Other||Race/Ethnicity, Customized||participants|Number|71|71.0||||||
4090861|NCT00996580|3915254|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|404|404.0||||||
4090862|NCT00996580|3915254|B1|White||Race/Ethnicity, Customized||participants|Number|2324|2324.0||||||
4090863|NCT00996580|3915254|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|696|696.0||||||
4090864|NCT00996580|3915254|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4090865|NCT00996580|3915254|B1|Asian||Race/Ethnicity, Customized||participants|Number|78|78.0||||||
4090866|NCT00996580|3915254|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4090867|NCT00996580|3915254|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4090868|NCT00996580|3915254|B1||Female|Sex: Female, Male||Participants|Count of Participants|3597|3597.0||||||
4090869|NCT00996580|3915254|B1|||Age||years|Mean|27.4|27.4|Standard Deviation|7.0|7.0|||
4090870|NCT00996502|3915282|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4090871|NCT00996502|3915282|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4090872|NCT00996502|3915282|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4090873|NCT00996502|3915282|B1|18 years and older||Age, Customized||participants|Number|4|4.0||||||
4090874|NCT00996476|3915286|B6||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4090875|NCT00996476|3915287|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4090876|NCT00996476|3915288|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4090877|NCT00996476|3915289|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4090878|NCT00996476|3915290|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4090879|NCT00996476|3915291|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4090880|NCT00996476|3915286|B6||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4090881|NCT00996476|3915287|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4090882|NCT00996476|3915288|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4090883|NCT00996476|3915289|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4090884|NCT00996476|3915290|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4090885|NCT00996476|3915291|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4090886|NCT00996476|3915286|B6|||Age||years|Median|54|54.0|Full Range|||20.0|69.0|
4090887|NCT00996476|3915287|B5|||Age||years|Median|54|54.0|Full Range|||20.0|66.0|
4090888|NCT00996476|3915288|B4|||Age||years|Median|54|54.0|Full Range|||28.0|68.0|
4090889|NCT00996476|3915289|B3|||Age||years|Median|48|48.0|Full Range|||34.0|67.0|
4090890|NCT00996476|3915290|B2|||Age||years|Median|56|56.0|Full Range|||22.0|69.0|
4090891|NCT00996476|3915291|B1|||Age||years|Median|53|53.0|Full Range|||31.0|67.0|
4090892|NCT00996437|3915361|B3|Not Available||Anti-platelet aggregation and anti-coagulant drugs|The Ns represent concomitant medications reported throughout the study duration. Please notice that these might not be equal to the number of participants enrolled.|Participants|Number|71|71.0||||||
4090893|NCT00996437|3915362|B2|Not Available||Anti-platelet aggregation and anti-coagulant drugs|The Ns represent concomitant medications reported throughout the study duration. Please notice that these might not be equal to the number of participants enrolled.|Participants|Number|37|37.0||||||
4090894|NCT00996437|3915363|B1|Not Available||Anti-platelet aggregation and anti-coagulant drugs|The Ns represent concomitant medications reported throughout the study duration. Please notice that these might not be equal to the number of participants enrolled.|Participants|Number|34|34.0||||||
4090895|NCT00996437|3915361|B3|NSAIDs||Anti-platelet aggregation and anti-coagulant drugs|The Ns represent concomitant medications reported throughout the study duration. Please notice that these might not be equal to the number of participants enrolled.|Participants|Number|30|30.0||||||
4090896|NCT00996437|3915362|B2|NSAIDs||Anti-platelet aggregation and anti-coagulant drugs|The Ns represent concomitant medications reported throughout the study duration. Please notice that these might not be equal to the number of participants enrolled.|Participants|Number|15|15.0||||||
4090897|NCT00996437|3915363|B1|NSAIDs||Anti-platelet aggregation and anti-coagulant drugs|The Ns represent concomitant medications reported throughout the study duration. Please notice that these might not be equal to the number of participants enrolled.|Participants|Number|15|15.0||||||
4090898|NCT00996437|3915361|B3|Anti-coagulants||Anti-platelet aggregation and anti-coagulant drugs|The Ns represent concomitant medications reported throughout the study duration. Please notice that these might not be equal to the number of participants enrolled.|Participants|Number|13|13.0||||||
4090899|NCT00996437|3915362|B2|Anti-coagulants||Anti-platelet aggregation and anti-coagulant drugs|The Ns represent concomitant medications reported throughout the study duration. Please notice that these might not be equal to the number of participants enrolled.|Participants|Number|6|6.0||||||
4090900|NCT00996437|3915363|B1|Anti-coagulants||Anti-platelet aggregation and anti-coagulant drugs|The Ns represent concomitant medications reported throughout the study duration. Please notice that these might not be equal to the number of participants enrolled.|Participants|Number|7|7.0||||||
4090901|NCT00996437|3915361|B3|Other anti-platelet aggregation drugs||Anti-platelet aggregation and anti-coagulant drugs|The Ns represent concomitant medications reported throughout the study duration. Please notice that these might not be equal to the number of participants enrolled.|Participants|Number|40|40.0||||||
4090902|NCT00996437|3915362|B2|Other anti-platelet aggregation drugs||Anti-platelet aggregation and anti-coagulant drugs|The Ns represent concomitant medications reported throughout the study duration. Please notice that these might not be equal to the number of participants enrolled.|Participants|Number|21|21.0||||||
4090903|NCT00996437|3915363|B1|Other anti-platelet aggregation drugs||Anti-platelet aggregation and anti-coagulant drugs|The Ns represent concomitant medications reported throughout the study duration. Please notice that these might not be equal to the number of participants enrolled.|Participants|Number|19|19.0||||||
4090904|NCT00996437|3915361|B3|Aspirin||Anti-platelet aggregation and anti-coagulant drugs|The Ns represent concomitant medications reported throughout the study duration. Please notice that these might not be equal to the number of participants enrolled.|Participants|Number|107|107.0||||||
4090905|NCT00996437|3915362|B2|Aspirin||Anti-platelet aggregation and anti-coagulant drugs|The Ns represent concomitant medications reported throughout the study duration. Please notice that these might not be equal to the number of participants enrolled.|Participants|Number|57|57.0||||||
4090906|NCT00996437|3915363|B1|Aspirin||Anti-platelet aggregation and anti-coagulant drugs|The Ns represent concomitant medications reported throughout the study duration. Please notice that these might not be equal to the number of participants enrolled.|Participants|Number|50|50.0||||||
4090907|NCT00996437|3915361|B3|||Intraocular Pressure||mm Hg|Median|15|15.0|Inter-Quartile Range|||12.0|17.0|
4090908|NCT00996437|3915362|B2|||Intraocular Pressure||mm Hg|Median|14|14.0|Inter-Quartile Range|||12.0|17.0|
4090909|NCT00996437|3915363|B1|||Intraocular Pressure||mm Hg|Median|15|15.0|Inter-Quartile Range|||12.0|17.0|
4090910|NCT00996437|3915361|B3|No light perception||Electronic Early Treatment Diabetic Retinopathy Visual Acuity Score|Visual Acuity Electronic Early Treatment Study (E-ETDRS) visual acuity test (Letter Score [snellen equivalent]). Letter score and its snellen equivalent (categorical) are reported. Unit of measure is based on the E-ETDRS letter score scale, 0-97, where 0 = worst and 97 = best.|Participants|Number|0|0.0||||||
4090911|NCT00996437|3915362|B2|No light perception||Electronic Early Treatment Diabetic Retinopathy Visual Acuity Score|Visual Acuity Electronic Early Treatment Study (E-ETDRS) visual acuity test (Letter Score [snellen equivalent]). Letter score and its snellen equivalent (categorical) are reported. Unit of measure is based on the E-ETDRS letter score scale, 0-97, where 0 = worst and 97 = best.|Participants|Number|0|0.0||||||
4090912|NCT00996437|3915363|B1|No light perception||Electronic Early Treatment Diabetic Retinopathy Visual Acuity Score|Visual Acuity Electronic Early Treatment Study (E-ETDRS) visual acuity test (Letter Score [snellen equivalent]). Letter score and its snellen equivalent (categorical) are reported. Unit of measure is based on the E-ETDRS letter score scale, 0-97, where 0 = worst and 97 = best.|Participants|Number|0|0.0||||||
4090913|NCT00996437|3915361|B3|Light perception only||Electronic Early Treatment Diabetic Retinopathy Visual Acuity Score|Visual Acuity Electronic Early Treatment Study (E-ETDRS) visual acuity test (Letter Score [snellen equivalent]). Letter score and its snellen equivalent (categorical) are reported. Unit of measure is based on the E-ETDRS letter score scale, 0-97, where 0 = worst and 97 = best.|Participants|Number|11|11.0||||||
4090914|NCT00996437|3915362|B2|Light perception only||Electronic Early Treatment Diabetic Retinopathy Visual Acuity Score|Visual Acuity Electronic Early Treatment Study (E-ETDRS) visual acuity test (Letter Score [snellen equivalent]). Letter score and its snellen equivalent (categorical) are reported. Unit of measure is based on the E-ETDRS letter score scale, 0-97, where 0 = worst and 97 = best.|Participants|Number|6|6.0||||||
4090915|NCT00996437|3915363|B1|Light perception only||Electronic Early Treatment Diabetic Retinopathy Visual Acuity Score|Visual Acuity Electronic Early Treatment Study (E-ETDRS) visual acuity test (Letter Score [snellen equivalent]). Letter score and its snellen equivalent (categorical) are reported. Unit of measure is based on the E-ETDRS letter score scale, 0-97, where 0 = worst and 97 = best.|Participants|Number|5|5.0||||||
4090916|NCT00996437|3915361|B3|Hand motion only||Electronic Early Treatment Diabetic Retinopathy Visual Acuity Score|Visual Acuity Electronic Early Treatment Study (E-ETDRS) visual acuity test (Letter Score [snellen equivalent]). Letter score and its snellen equivalent (categorical) are reported. Unit of measure is based on the E-ETDRS letter score scale, 0-97, where 0 = worst and 97 = best.|Participants|Number|39|39.0||||||
4090965|NCT00996437|3915362|B2|Posterior Chamber Intraocular Lens||Lens Status (on clinical exam)||Participants|Number|38|38.0||||||
4090917|NCT00996437|3915362|B2|Hand motion only||Electronic Early Treatment Diabetic Retinopathy Visual Acuity Score|Visual Acuity Electronic Early Treatment Study (E-ETDRS) visual acuity test (Letter Score [snellen equivalent]). Letter score and its snellen equivalent (categorical) are reported. Unit of measure is based on the E-ETDRS letter score scale, 0-97, where 0 = worst and 97 = best.|Participants|Number|20|20.0||||||
4090918|NCT00996437|3915363|B1|Hand motion only||Electronic Early Treatment Diabetic Retinopathy Visual Acuity Score|Visual Acuity Electronic Early Treatment Study (E-ETDRS) visual acuity test (Letter Score [snellen equivalent]). Letter score and its snellen equivalent (categorical) are reported. Unit of measure is based on the E-ETDRS letter score scale, 0-97, where 0 = worst and 97 = best.|Participants|Number|19|19.0||||||
4090919|NCT00996437|3915361|B3|Counting fingers only||Electronic Early Treatment Diabetic Retinopathy Visual Acuity Score|Visual Acuity Electronic Early Treatment Study (E-ETDRS) visual acuity test (Letter Score [snellen equivalent]). Letter score and its snellen equivalent (categorical) are reported. Unit of measure is based on the E-ETDRS letter score scale, 0-97, where 0 = worst and 97 = best.|Participants|Number|27|27.0||||||
4090920|NCT00996437|3915362|B2|Counting fingers only||Electronic Early Treatment Diabetic Retinopathy Visual Acuity Score|Visual Acuity Electronic Early Treatment Study (E-ETDRS) visual acuity test (Letter Score [snellen equivalent]). Letter score and its snellen equivalent (categorical) are reported. Unit of measure is based on the E-ETDRS letter score scale, 0-97, where 0 = worst and 97 = best.|Participants|Number|15|15.0||||||
4090921|NCT00996437|3915363|B1|Counting fingers only||Electronic Early Treatment Diabetic Retinopathy Visual Acuity Score|Visual Acuity Electronic Early Treatment Study (E-ETDRS) visual acuity test (Letter Score [snellen equivalent]). Letter score and its snellen equivalent (categorical) are reported. Unit of measure is based on the E-ETDRS letter score scale, 0-97, where 0 = worst and 97 = best.|Participants|Number|12|12.0||||||
4090922|NCT00996437|3915361|B3|23 to 1 letter score - (20/400 to 20/800-3)||Electronic Early Treatment Diabetic Retinopathy Visual Acuity Score|Visual Acuity Electronic Early Treatment Study (E-ETDRS) visual acuity test (Letter Score [snellen equivalent]). Letter score and its snellen equivalent (categorical) are reported. Unit of measure is based on the E-ETDRS letter score scale, 0-97, where 0 = worst and 97 = best.|Participants|Number|37|37.0||||||
4090923|NCT00996437|3915362|B2|23 to 1 letter score - (20/400 to 20/800-3)||Electronic Early Treatment Diabetic Retinopathy Visual Acuity Score|Visual Acuity Electronic Early Treatment Study (E-ETDRS) visual acuity test (Letter Score [snellen equivalent]). Letter score and its snellen equivalent (categorical) are reported. Unit of measure is based on the E-ETDRS letter score scale, 0-97, where 0 = worst and 97 = best.|Participants|Number|18|18.0||||||
4090924|NCT00996437|3915363|B1|23 to 1 letter score - (20/400 to 20/800-3)||Electronic Early Treatment Diabetic Retinopathy Visual Acuity Score|Visual Acuity Electronic Early Treatment Study (E-ETDRS) visual acuity test (Letter Score [snellen equivalent]). Letter score and its snellen equivalent (categorical) are reported. Unit of measure is based on the E-ETDRS letter score scale, 0-97, where 0 = worst and 97 = best.|Participants|Number|19|19.0||||||
4090925|NCT00996437|3915361|B3|48 to 24 letter score - (20/125 to 20/320)||Electronic Early Treatment Diabetic Retinopathy Visual Acuity Score|Visual Acuity Electronic Early Treatment Study (E-ETDRS) visual acuity test (Letter Score [snellen equivalent]). Letter score and its snellen equivalent (categorical) are reported. Unit of measure is based on the E-ETDRS letter score scale, 0-97, where 0 = worst and 97 = best.|Participants|Number|55|55.0||||||
4090926|NCT00996437|3915362|B2|48 to 24 letter score - (20/125 to 20/320)||Electronic Early Treatment Diabetic Retinopathy Visual Acuity Score|Visual Acuity Electronic Early Treatment Study (E-ETDRS) visual acuity test (Letter Score [snellen equivalent]). Letter score and its snellen equivalent (categorical) are reported. Unit of measure is based on the E-ETDRS letter score scale, 0-97, where 0 = worst and 97 = best.|Participants|Number|37|37.0||||||
4090927|NCT00996437|3915363|B1|48 to 24 letter score - (20/125 to 20/320)||Electronic Early Treatment Diabetic Retinopathy Visual Acuity Score|Visual Acuity Electronic Early Treatment Study (E-ETDRS) visual acuity test (Letter Score [snellen equivalent]). Letter score and its snellen equivalent (categorical) are reported. Unit of measure is based on the E-ETDRS letter score scale, 0-97, where 0 = worst and 97 = best.|Participants|Number|18|18.0||||||
4090928|NCT00996437|3915361|B3|68 to 49 letter score - (20/50 to 20/100)||Electronic Early Treatment Diabetic Retinopathy Visual Acuity Score|Visual Acuity Electronic Early Treatment Study (E-ETDRS) visual acuity test (Letter Score [snellen equivalent]). Letter score and its snellen equivalent (categorical) are reported. Unit of measure is based on the E-ETDRS letter score scale, 0-97, where 0 = worst and 97 = best.|Participants|Number|51|51.0||||||
4090929|NCT00996437|3915362|B2|68 to 49 letter score - (20/50 to 20/100)||Electronic Early Treatment Diabetic Retinopathy Visual Acuity Score|Visual Acuity Electronic Early Treatment Study (E-ETDRS) visual acuity test (Letter Score [snellen equivalent]). Letter score and its snellen equivalent (categorical) are reported. Unit of measure is based on the E-ETDRS letter score scale, 0-97, where 0 = worst and 97 = best.|Participants|Number|19|19.0||||||
4090930|NCT00996437|3915363|B1|68 to 49 letter score - (20/50 to 20/100)||Electronic Early Treatment Diabetic Retinopathy Visual Acuity Score|Visual Acuity Electronic Early Treatment Study (E-ETDRS) visual acuity test (Letter Score [snellen equivalent]). Letter score and its snellen equivalent (categorical) are reported. Unit of measure is based on the E-ETDRS letter score scale, 0-97, where 0 = worst and 97 = best.|Participants|Number|32|32.0||||||
4090931|NCT00996437|3915361|B3|> 69 letter score - (20/40 or better)||Electronic Early Treatment Diabetic Retinopathy Visual Acuity Score|Visual Acuity Electronic Early Treatment Study (E-ETDRS) visual acuity test (Letter Score [snellen equivalent]). Letter score and its snellen equivalent (categorical) are reported. Unit of measure is based on the E-ETDRS letter score scale, 0-97, where 0 = worst and 97 = best.|Participants|Number|41|41.0||||||
4090932|NCT00996437|3915362|B2|> 69 letter score - (20/40 or better)||Electronic Early Treatment Diabetic Retinopathy Visual Acuity Score|Visual Acuity Electronic Early Treatment Study (E-ETDRS) visual acuity test (Letter Score [snellen equivalent]). Letter score and its snellen equivalent (categorical) are reported. Unit of measure is based on the E-ETDRS letter score scale, 0-97, where 0 = worst and 97 = best.|Participants|Number|21|21.0||||||
4090933|NCT00996437|3915363|B1|> 69 letter score - (20/40 or better)||Electronic Early Treatment Diabetic Retinopathy Visual Acuity Score|Visual Acuity Electronic Early Treatment Study (E-ETDRS) visual acuity test (Letter Score [snellen equivalent]). Letter score and its snellen equivalent (categorical) are reported. Unit of measure is based on the E-ETDRS letter score scale, 0-97, where 0 = worst and 97 = best.|Participants|Number|20|20.0||||||
4090934|NCT00996437|3915361|B3|||Median Electronic-Early Treatment Diabetic Retinopathy Visual Acuity (letter score)|Visual Acuity was measured with the Electronic Early Treatment Study (E-ETDRS) visual acuity test. Unit of measure is based on the E-ETDRS letter score scale, 0-97, where 0 = worst and 97 = best|Units on a scale|Median|31|31.0|Inter-Quartile Range|||0.0|61.0|
4090935|NCT00996437|3915362|B2|||Median Electronic-Early Treatment Diabetic Retinopathy Visual Acuity (letter score)|Visual Acuity was measured with the Electronic Early Treatment Study (E-ETDRS) visual acuity test. Unit of measure is based on the E-ETDRS letter score scale, 0-97, where 0 = worst and 97 = best|Units on a scale|Median|28|28.0|Inter-Quartile Range|||0.0|59.0|
4090936|NCT00996437|3915363|B1|||Median Electronic-Early Treatment Diabetic Retinopathy Visual Acuity (letter score)|Visual Acuity was measured with the Electronic Early Treatment Study (E-ETDRS) visual acuity test. Unit of measure is based on the E-ETDRS letter score scale, 0-97, where 0 = worst and 97 = best|Units on a scale|Median|34|34.0|Inter-Quartile Range|||0.0|61.0|
4090937|NCT00996437|3915361|B3|> 6 months||Duration of vitreous hemorrhage since first documented on clinical exam||Participants|Number|22|22.0||||||
4090938|NCT00996437|3915362|B2|> 6 months||Duration of vitreous hemorrhage since first documented on clinical exam||Participants|Number|11|11.0||||||
4090939|NCT00996437|3915363|B1|> 6 months||Duration of vitreous hemorrhage since first documented on clinical exam||Participants|Number|11|11.0||||||
4090940|NCT00996437|3915361|B3|4-6 months||Duration of vitreous hemorrhage since first documented on clinical exam||Participants|Number|18|18.0||||||
4090941|NCT00996437|3915362|B2|4-6 months||Duration of vitreous hemorrhage since first documented on clinical exam||Participants|Number|11|11.0||||||
4090942|NCT00996437|3915363|B1|4-6 months||Duration of vitreous hemorrhage since first documented on clinical exam||Participants|Number|7|7.0||||||
4090943|NCT00996437|3915361|B3|1-3 months||Duration of vitreous hemorrhage since first documented on clinical exam||Participants|Number|80|80.0||||||
4090944|NCT00996437|3915362|B2|1-3 months||Duration of vitreous hemorrhage since first documented on clinical exam||Participants|Number|39|39.0||||||
4090945|NCT00996437|3915363|B1|1-3 months||Duration of vitreous hemorrhage since first documented on clinical exam||Participants|Number|41|41.0||||||
4090946|NCT00996437|3915361|B3|< 1month||Duration of vitreous hemorrhage since first documented on clinical exam||Participants|Number|141|141.0||||||
4090947|NCT00996437|3915362|B2|< 1month||Duration of vitreous hemorrhage since first documented on clinical exam||Participants|Number|75|75.0||||||
4090948|NCT00996437|3915363|B1|< 1month||Duration of vitreous hemorrhage since first documented on clinical exam||Participants|Number|66|66.0||||||
4090949|NCT00996437|3915361|B3|No||Ultrasound completed to assess eligibility||Participants|Number|137|137.0||||||
4090950|NCT00996437|3915362|B2|No||Ultrasound completed to assess eligibility||Participants|Number|74|74.0||||||
4090951|NCT00996437|3915363|B1|No||Ultrasound completed to assess eligibility||Participants|Number|63|63.0||||||
4090952|NCT00996437|3915361|B3|Yes||Ultrasound completed to assess eligibility||Participants|Number|124|124.0||||||
4090953|NCT00996437|3915362|B2|Yes||Ultrasound completed to assess eligibility||Participants|Number|62|62.0||||||
4090954|NCT00996437|3915363|B1|Yes||Ultrasound completed to assess eligibility||Participants|Number|62|62.0||||||
4090955|NCT00996437|3915361|B3|Missing/not available||Optical coherence tomography signal strength|The Ns represent the total number of available baseline optical coherence tomography signal strengths data. Optical Coherence Tomography Signal strength is measured on a scale of 0-10 with 10 being the maximum signal strength, a greater signal strength indicates a better image.|Participants|Number|3|3.0||||||
4090956|NCT00996437|3915362|B2|Missing/not available||Optical coherence tomography signal strength|The Ns represent the total number of available baseline optical coherence tomography signal strengths data. Optical Coherence Tomography Signal strength is measured on a scale of 0-10 with 10 being the maximum signal strength, a greater signal strength indicates a better image.|Participants|Number|2|2.0||||||
4090957|NCT00996437|3915363|B1|Missing/not available||Optical coherence tomography signal strength|The Ns represent the total number of available baseline optical coherence tomography signal strengths data. Optical Coherence Tomography Signal strength is measured on a scale of 0-10 with 10 being the maximum signal strength, a greater signal strength indicates a better image.|Participants|Number|1|1.0||||||
4090958|NCT00996437|3915361|B3|> 0||Optical coherence tomography signal strength|The Ns represent the total number of available baseline optical coherence tomography signal strengths data. Optical Coherence Tomography Signal strength is measured on a scale of 0-10 with 10 being the maximum signal strength, a greater signal strength indicates a better image.|Participants|Number|88|88.0||||||
4090959|NCT00996437|3915362|B2|> 0||Optical coherence tomography signal strength|The Ns represent the total number of available baseline optical coherence tomography signal strengths data. Optical Coherence Tomography Signal strength is measured on a scale of 0-10 with 10 being the maximum signal strength, a greater signal strength indicates a better image.|Participants|Number|38|38.0||||||
4090960|NCT00996437|3915363|B1|> 0||Optical coherence tomography signal strength|The Ns represent the total number of available baseline optical coherence tomography signal strengths data. Optical Coherence Tomography Signal strength is measured on a scale of 0-10 with 10 being the maximum signal strength, a greater signal strength indicates a better image.|Participants|Number|50|50.0||||||
4090961|NCT00996437|3915361|B3|=0||Optical coherence tomography signal strength|The Ns represent the total number of available baseline optical coherence tomography signal strengths data. Optical Coherence Tomography Signal strength is measured on a scale of 0-10 with 10 being the maximum signal strength, a greater signal strength indicates a better image.|Participants|Number|170|170.0||||||
4090962|NCT00996437|3915362|B2|=0||Optical coherence tomography signal strength|The Ns represent the total number of available baseline optical coherence tomography signal strengths data. Optical Coherence Tomography Signal strength is measured on a scale of 0-10 with 10 being the maximum signal strength, a greater signal strength indicates a better image.|Participants|Number|96|96.0||||||
4090963|NCT00996437|3915363|B1|=0||Optical coherence tomography signal strength|The Ns represent the total number of available baseline optical coherence tomography signal strengths data. Optical Coherence Tomography Signal strength is measured on a scale of 0-10 with 10 being the maximum signal strength, a greater signal strength indicates a better image.|Participants|Number|74|74.0||||||
4090966|NCT00996437|3915363|B1|Posterior Chamber Intraocular Lens||Lens Status (on clinical exam)||Participants|Number|28|28.0||||||
4090967|NCT00996437|3915361|B3|Phakic||Lens Status (on clinical exam)||Participants|Number|195|195.0||||||
4090968|NCT00996437|3915362|B2|Phakic||Lens Status (on clinical exam)||Participants|Number|98|98.0||||||
4090969|NCT00996437|3915363|B1|Phakic||Lens Status (on clinical exam)||Participants|Number|97|97.0||||||
4090970|NCT00996437|3915361|B3|No||Prior treatment with anti-vascular endothelial growth factor drug for diabetic macular edema||Participants|Number|233|233.0||||||
4090971|NCT00996437|3915362|B2|No||Prior treatment with anti-vascular endothelial growth factor drug for diabetic macular edema||Participants|Number|118|118.0||||||
4090972|NCT00996437|3915363|B1|No||Prior treatment with anti-vascular endothelial growth factor drug for diabetic macular edema||Participants|Number|115|115.0||||||
4090973|NCT00996437|3915361|B3|Yes||Prior treatment with anti-vascular endothelial growth factor drug for diabetic macular edema||Participants|Number|28|28.0||||||
4090974|NCT00996437|3915362|B2|Yes||Prior treatment with anti-vascular endothelial growth factor drug for diabetic macular edema||Participants|Number|18|18.0||||||
4090975|NCT00996437|3915363|B1|Yes||Prior treatment with anti-vascular endothelial growth factor drug for diabetic macular edema||Participants|Number|10|10.0||||||
4090976|NCT00996437|3915361|B3|No||Prior Treatment for Diabetic Macular Edema||Participants|Number|151|151.0||||||
4090977|NCT00996437|3915362|B2|No||Prior Treatment for Diabetic Macular Edema||Participants|Number|79|79.0||||||
4090978|NCT00996437|3915363|B1|No||Prior Treatment for Diabetic Macular Edema||Participants|Number|72|72.0||||||
4090979|NCT00996437|3915361|B3|Yes||Prior Treatment for Diabetic Macular Edema||Participants|Number|110|110.0||||||
4090980|NCT00996437|3915362|B2|Yes||Prior Treatment for Diabetic Macular Edema||Participants|Number|57|57.0||||||
4090981|NCT00996437|3915363|B1|Yes||Prior Treatment for Diabetic Macular Edema||Participants|Number|53|53.0||||||
4090982|NCT00996437|3915361|B3|No||Prior panretinal photocoagulation||Participants|Number|121|121.0||||||
4090983|NCT00996437|3915362|B2|No||Prior panretinal photocoagulation||Participants|Number|58|58.0||||||
4090984|NCT00996437|3915363|B1|No||Prior panretinal photocoagulation||Participants|Number|63|63.0||||||
4090985|NCT00996437|3915361|B3|Yes||Prior panretinal photocoagulation||Participants|Number|140|140.0||||||
4090986|NCT00996437|3915362|B2|Yes||Prior panretinal photocoagulation||Participants|Number|78|78.0||||||
4090987|NCT00996437|3915363|B1|Yes||Prior panretinal photocoagulation||Participants|Number|62|62.0||||||
4090988|NCT00996437|3915361|B3|No||Pre-Existing Hypertension||Participants|Number|39|39.0||||||
4090989|NCT00996437|3915362|B2|No||Pre-Existing Hypertension||Participants|Number|19|19.0||||||
4090990|NCT00996437|3915363|B1|No||Pre-Existing Hypertension||Participants|Number|20|20.0||||||
4090991|NCT00996437|3915361|B3|Yes||Pre-Existing Hypertension||Participants|Number|222|222.0||||||
4090992|NCT00996437|3915362|B2|Yes||Pre-Existing Hypertension||Participants|Number|117|117.0||||||
4090993|NCT00996437|3915363|B1|Yes||Pre-Existing Hypertension||Participants|Number|105|105.0||||||
4090994|NCT00996437|3915361|B3|No||Pre-Existing Cardiovascular Conditions||Participants|Number|157|157.0||||||
4090995|NCT00996437|3915362|B2|No||Pre-Existing Cardiovascular Conditions||Participants|Number|76|76.0||||||
4090996|NCT00996437|3915363|B1|No||Pre-Existing Cardiovascular Conditions||Participants|Number|81|81.0||||||
4090997|NCT00996437|3915361|B3|Yes||Pre-Existing Cardiovascular Conditions||Participants|Number|104|104.0||||||
4090998|NCT00996437|3915362|B2|Yes||Pre-Existing Cardiovascular Conditions||Participants|Number|60|60.0||||||
4090999|NCT00996437|3915363|B1|Yes||Pre-Existing Cardiovascular Conditions||Participants|Number|44|44.0||||||
4091000|NCT00996437|3915361|B3|||Hemoglobin A1c||Percentage|Median|7.9|7.9|Inter-Quartile Range|||6.8|9.0|
4091001|NCT00996437|3915362|B2|||Hemoglobin A1c||Percentage|Median|8.0|8.0|Inter-Quartile Range|||6.9|9.3|
4091002|NCT00996437|3915363|B1|||Hemoglobin A1c||Percentage|Median|7.7|7.7|Inter-Quartile Range|||6.7|8.7|
4091003|NCT00996437|3915361|B3|||Duration of Diabetes (years)||Number|Median|20|20.0|Inter-Quartile Range|||13.0|27.0|
4091004|NCT00996437|3915362|B2|||Duration of Diabetes (years)||Number|Median|21|21.0|Inter-Quartile Range|||16.0|27.0|
4091005|NCT00996437|3915363|B1|||Duration of Diabetes (years)||Number|Median|19|19.0|Inter-Quartile Range|||12.0|28.0|
4091006|NCT00996437|3915361|B3|Uncertain||Diabetes Type||Participants|Number|9|9.0||||||
4091007|NCT00996437|3915362|B2|Uncertain||Diabetes Type||Participants|Number|6|6.0||||||
4091008|NCT00996437|3915363|B1|Uncertain||Diabetes Type||Participants|Number|3|3.0||||||
4091009|NCT00996437|3915361|B3|Type 2||Diabetes Type||Participants|Number|200|200.0||||||
4091010|NCT00996437|3915362|B2|Type 2||Diabetes Type||Participants|Number|99|99.0||||||
4091011|NCT00996437|3915363|B1|Type 2||Diabetes Type||Participants|Number|101|101.0||||||
4091012|NCT00996437|3915361|B3|Type1||Diabetes Type||Participants|Number|52|52.0||||||
4091013|NCT00996437|3915362|B2|Type1||Diabetes Type||Participants|Number|31|31.0||||||
4091014|NCT00996437|3915363|B1|Type1||Diabetes Type||Participants|Number|21|21.0||||||
4091015|NCT00996437|3915361|B3|Unknown/not reported||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4091016|NCT00996437|3915362|B2|Unknown/not reported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4091017|NCT00996437|3915363|B1|Unknown/not reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4091018|NCT00996437|3915361|B3|More than one race||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4091019|NCT00996437|3915362|B2|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4091020|NCT00996437|3915363|B1|More than one race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4091021|NCT00996437|3915361|B3|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4091022|NCT00996437|3915362|B2|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4091023|NCT00996437|3915363|B1|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4091024|NCT00996437|3915361|B3|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4091025|NCT00996437|3915362|B2|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4091026|NCT00996437|3915363|B1|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4091027|NCT00996437|3915361|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4091028|NCT00996437|3915362|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4091029|NCT00996437|3915363|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4091030|NCT00996437|3915361|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
4091031|NCT00996437|3915362|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4091032|NCT00996437|3915363|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4091033|NCT00996437|3915361|B3|African-American||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4091034|NCT00996437|3915362|B2|African-American||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4091035|NCT00996437|3915363|B1|African-American||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4091036|NCT00996437|3915361|B3|White||Race/Ethnicity, Customized||participants|Number|137|137.0||||||
4091037|NCT00996437|3915362|B2|White||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
4091038|NCT00996437|3915363|B1|White||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
4091039|NCT00996437|3915361|B3||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4091040|NCT00996437|3915362|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4091041|NCT00996437|3915363|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4091042|NCT00996437|3915361|B3||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4091043|NCT00996437|3915362|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4091044|NCT00996437|3915363|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4091045|NCT00996437|3915361|B3|||Age, Customized||years|Median|59|59.0|Inter-Quartile Range|||50.0|66.0|
4091046|NCT00996437|3915362|B2|||Age, Customized||years|Median|58|58.0|Inter-Quartile Range|||49.0|64.0|
4091047|NCT00996437|3915363|B1|||Age, Customized||years|Median|61|61.0|Inter-Quartile Range|||50.0|67.0|
4091048|NCT00996372|3915384|B3|Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4091049|NCT00996372|3915385|B2|Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4091050|NCT00996372|3915386|B1|Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4091051|NCT00996372|3915384|B3|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4091052|NCT00996372|3915385|B2|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4091053|NCT00996372|3915386|B1|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4091054|NCT00996372|3915384|B3|Asian Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4091055|NCT00996372|3915385|B2|Asian Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4091056|NCT00996372|3915386|B1|Asian Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4091057|NCT00996372|3915384|B3|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4091058|NCT00996372|3915385|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4091059|NCT00996372|3915386|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4091060|NCT00996372|3915384|B3|Black/African American Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4091061|NCT00996372|3915385|B2|Black/African American Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4091062|NCT00996372|3915386|B1|Black/African American Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4091063|NCT00996372|3915384|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
4091064|NCT00996372|3915385|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4091065|NCT00996372|3915386|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4091066|NCT00996372|3915384|B3|White Hispanic||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4091067|NCT00996372|3915385|B2|White Hispanic||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4091068|NCT00996372|3915386|B1|White Hispanic||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4091069|NCT00996372|3915384|B3|White||Race/Ethnicity, Customized||participants|Number|820|820.0||||||
4091070|NCT00996372|3915385|B2|White||Race/Ethnicity, Customized||participants|Number|422|422.0||||||
4091071|NCT00996372|3915386|B1|White||Race/Ethnicity, Customized||participants|Number|398|398.0||||||
4091072|NCT00996372|3915384|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4091073|NCT00996372|3915385|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4091074|NCT00996372|3915386|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4091075|NCT00996372|3915384|B3||Female|Sex: Female, Male||Participants|Count of Participants|949|949.0||||||
4091076|NCT00996372|3915385|B2||Female|Sex: Female, Male||Participants|Count of Participants|481|481.0||||||
4091077|NCT00996372|3915386|B1||Female|Sex: Female, Male||Participants|Count of Participants|468|468.0||||||
4091078|NCT00996372|3915384|B3|65 years and older||Age, Customized||participants|Number|45|45.0||||||
4091079|NCT00996372|3915385|B2|65 years and older||Age, Customized||participants|Number|25|25.0||||||
4091080|NCT00996372|3915386|B1|65 years and older||Age, Customized||participants|Number|20|20.0||||||
4091081|NCT00996372|3915384|B3|55-64||Age, Customized||participants|Number|485|485.0||||||
4091082|NCT00996372|3915385|B2|55-64||Age, Customized||participants|Number|237|237.0||||||
4091083|NCT00996372|3915386|B1|55-64||Age, Customized||participants|Number|248|248.0||||||
4091084|NCT00996372|3915384|B3|45-54 years||Age, Customized||participants|Number|405|405.0||||||
4091085|NCT00996372|3915385|B2|45-54 years||Age, Customized||participants|Number|213|213.0||||||
4091086|NCT00996372|3915386|B1|45-54 years||Age, Customized||participants|Number|192|192.0||||||
4091087|NCT00996372|3915384|B3|less than 45 years||Age, Customized||participants|Number|14|14.0||||||
4091088|NCT00996372|3915385|B2|less than 45 years||Age, Customized||participants|Number|6|6.0||||||
4091089|NCT00996372|3915386|B1|less than 45 years||Age, Customized||participants|Number|8|8.0||||||
4091090|NCT00996346|3915397|B4|United States||Region of Enrollment||participants|Number|17|17.0||||||
4091091|NCT00996346|3915398|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4091092|NCT00996346|3915399|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4091093|NCT00996346|3915400|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4091094|NCT00996346|3915397|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4091095|NCT00996346|3915398|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4091096|NCT00996346|3915399|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4091097|NCT00996346|3915400|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4091098|NCT00996346|3915397|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4091099|NCT00996346|3915398|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4091100|NCT00996346|3915399|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4091101|NCT00996346|3915400|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4091102|NCT00996346|3915397|B4|||Age||years|Median|56|56.0|Full Range|||25.0|72.0|
4091103|NCT00996346|3915398|B3|||Age||years|Median|56|56.0|Full Range|||56.0|64.0|
4091104|NCT00996346|3915399|B2|||Age||years|Median|47.5|47.5|Full Range|||25.0|72.0|
4091105|NCT00996346|3915400|B1|||Age||years|Median|60.5|60.5|Full Range|||48.0|69.0|
4091106|NCT00996333|3915409|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4091107|NCT00996333|3915409|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4091108|NCT00996333|3915409|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4091109|NCT00996333|3915409|B1||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4091110|NCT00996333|3915409|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4091111|NCT00996333|3915409|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091112|NCT00996333|3915409|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091113|NCT00996333|3915409|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091114|NCT00996333|3915409|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4091115|NCT00996333|3915409|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4091116|NCT00996333|3915409|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4091117|NCT00996333|3915409|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4091118|NCT00996333|3915409|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4091119|NCT00996333|3915409|B1|Unknown||Age, Customized||participants|Number|1|1.0||||||
4091120|NCT00996333|3915409|B1|Between 70 and 79 years||Age, Customized||participants|Number|3|3.0||||||
4091121|NCT00996333|3915409|B1|Between 60 and 69 years||Age, Customized||participants|Number|20|20.0||||||
4091122|NCT00996333|3915409|B1|Between 50 and 59 years||Age, Customized||participants|Number|16|16.0||||||
4091123|NCT00996333|3915409|B1|Between 40 and 49 years||Age, Customized||participants|Number|4|4.0||||||
4091124|NCT00996333|3915409|B1|Between 30 and 39 years||Age, Customized||participants|Number|2|2.0||||||
4091125|NCT00996307|3915415|B5||Male|Sex: Female, Male||Participants|Count of Participants|342|342.0||||||
4091126|NCT00996307|3915416|B4||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4091127|NCT00996307|3915417|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4091128|NCT00996307|3915418|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4091129|NCT00996307|3915419|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4091130|NCT00996307|3915415|B5||Female|Sex: Female, Male||Participants|Count of Participants|312|312.0||||||
4091131|NCT00996307|3915416|B4||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4091132|NCT00996307|3915417|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4091133|NCT00996307|3915418|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4091134|NCT00996307|3915419|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4091135|NCT00996307|3915415|B5|6 to <36 Months age||Age||Months|Mean|21.3|21.3|Standard Deviation|8.5|8.5|||
4091136|NCT00996307|3915416|B4|6 to <36 Months age||Age||Months|Mean|21.3|21.3|Standard Deviation|8.9|8.9|||
4091137|NCT00996307|3915417|B3|6 to <36 Months age||Age||Months|Mean|21.1|21.1|Standard Deviation|8.4|8.4|||
4091138|NCT00996307|3915418|B2|6 to <36 Months age||Age||Months|Mean|21.6|21.6|Standard Deviation|8.8|8.8|||
4091139|NCT00996307|3915419|B1|6 to <36 Months age||Age||Months|Mean|21.2|21.2|Standard Deviation|7.9|7.9|||
4091140|NCT00996281|3915480|B3|≥90 mmHg||Diastolic blood pressure||participants|Number|627|627.0||||||
4091141|NCT00996281|3915481|B2|≥90 mmHg||Diastolic blood pressure||participants|Number|316|316.0||||||
4091142|NCT00996281|3915482|B1|≥90 mmHg||Diastolic blood pressure||participants|Number|311|311.0||||||
4091143|NCT00996281|3915480|B3|< 90 mmHg||Diastolic blood pressure||participants|Number|210|210.0||||||
4091144|NCT00996281|3915481|B2|< 90 mmHg||Diastolic blood pressure||participants|Number|103|103.0||||||
4091145|NCT00996281|3915482|B1|< 90 mmHg||Diastolic blood pressure||participants|Number|107|107.0||||||
4091146|NCT00996281|3915480|B3|≥180 mm Hg||Systolic blood pressure||participants|Number|68|68.0||||||
4091147|NCT00996281|3915481|B2|≥180 mm Hg||Systolic blood pressure||participants|Number|33|33.0||||||
4091148|NCT00996281|3915482|B1|≥180 mm Hg||Systolic blood pressure||participants|Number|35|35.0||||||
4091149|NCT00996281|3915480|B3|≥160 - < 180 mmHg||Systolic blood pressure||participants|Number|767|767.0||||||
4091150|NCT00996281|3915481|B2|≥160 - < 180 mmHg||Systolic blood pressure||participants|Number|385|385.0||||||
4091151|NCT00996281|3915482|B1|≥160 - < 180 mmHg||Systolic blood pressure||participants|Number|382|382.0||||||
4091152|NCT00996281|3915480|B3|≥140 - < 160 mmHg||Systolic blood pressure||participants|Number|2|2.0||||||
4091153|NCT00996281|3915481|B2|≥140 - < 160 mmHg||Systolic blood pressure||participants|Number|1|1.0||||||
4091154|NCT00996281|3915482|B1|≥140 - < 160 mmHg||Systolic blood pressure||participants|Number|1|1.0||||||
4091155|NCT00996281|3915480|B3|No||Chronic Kidney Disease (CKD) status|Participants were considered to have CKD if their estimated glomerular filtration rate (GFR) was <60 mL/min/1.73 m^2 or urinary albumin:creatinine ratio (UACR) was >200 mg albumin/g creatinine at Screening.|participants|Number|727|727.0||||||
4091156|NCT00996281|3915481|B2|No||Chronic Kidney Disease (CKD) status|Participants were considered to have CKD if their estimated glomerular filtration rate (GFR) was <60 mL/min/1.73 m^2 or urinary albumin:creatinine ratio (UACR) was >200 mg albumin/g creatinine at Screening.|participants|Number|368|368.0||||||
4091157|NCT00996281|3915482|B1|No||Chronic Kidney Disease (CKD) status|Participants were considered to have CKD if their estimated glomerular filtration rate (GFR) was <60 mL/min/1.73 m^2 or urinary albumin:creatinine ratio (UACR) was >200 mg albumin/g creatinine at Screening.|participants|Number|359|359.0||||||
4091158|NCT00996281|3915480|B3|Yes||Chronic Kidney Disease (CKD) status|Participants were considered to have CKD if their estimated glomerular filtration rate (GFR) was <60 mL/min/1.73 m^2 or urinary albumin:creatinine ratio (UACR) was >200 mg albumin/g creatinine at Screening.|participants|Number|110|110.0||||||
4091159|NCT00996281|3915481|B2|Yes||Chronic Kidney Disease (CKD) status|Participants were considered to have CKD if their estimated glomerular filtration rate (GFR) was <60 mL/min/1.73 m^2 or urinary albumin:creatinine ratio (UACR) was >200 mg albumin/g creatinine at Screening.|participants|Number|51|51.0||||||
4091160|NCT00996281|3915482|B1|Yes||Chronic Kidney Disease (CKD) status|Participants were considered to have CKD if their estimated glomerular filtration rate (GFR) was <60 mL/min/1.73 m^2 or urinary albumin:creatinine ratio (UACR) was >200 mg albumin/g creatinine at Screening.|participants|Number|59|59.0||||||
4091161|NCT00996281|3915480|B3|Missing||Estimated glomerular filtration rate||participants|Number|3|3.0||||||
4091162|NCT00996281|3915481|B2|Missing||Estimated glomerular filtration rate||participants|Number|1|1.0||||||
4091163|NCT00996281|3915482|B1|Missing||Estimated glomerular filtration rate||participants|Number|2|2.0||||||
4091164|NCT00996281|3915480|B3|Normal: ≥90 ml/min/1.73 m^2||Estimated glomerular filtration rate||participants|Number|197|197.0||||||
4091165|NCT00996281|3915481|B2|Normal: ≥90 ml/min/1.73 m^2||Estimated glomerular filtration rate||participants|Number|110|110.0||||||
4091166|NCT00996281|3915482|B1|Normal: ≥90 ml/min/1.73 m^2||Estimated glomerular filtration rate||participants|Number|87|87.0||||||
4091167|NCT00996281|3915480|B3|Mild impairment: ≥60 and <90 ml/min/1.73 m^2||Estimated glomerular filtration rate||participants|Number|540|540.0||||||
4091168|NCT00996281|3915481|B2|Mild impairment: ≥60 and <90 ml/min/1.73 m^2||Estimated glomerular filtration rate||participants|Number|265|265.0||||||
4091169|NCT00996281|3915482|B1|Mild impairment: ≥60 and <90 ml/min/1.73 m^2||Estimated glomerular filtration rate||participants|Number|275|275.0||||||
4091170|NCT00996281|3915480|B3|Moderate impairment: ≥30 and <60 ml/min/1.73 m^2||Estimated glomerular filtration rate||participants|Number|97|97.0||||||
4091171|NCT00996281|3915481|B2|Moderate impairment: ≥30 and <60 ml/min/1.73 m^2||Estimated glomerular filtration rate||participants|Number|43|43.0||||||
4091172|NCT00996281|3915482|B1|Moderate impairment: ≥30 and <60 ml/min/1.73 m^2||Estimated glomerular filtration rate||participants|Number|54|54.0||||||
4091173|NCT00996281|3915480|B3|No||Diabetes Status||participants|Number|714|714.0||||||
4091174|NCT00996281|3915481|B2|No||Diabetes Status||participants|Number|360|360.0||||||
4091175|NCT00996281|3915482|B1|No||Diabetes Status||participants|Number|354|354.0||||||
4091176|NCT00996281|3915480|B3|Yes||Diabetes Status||participants|Number|123|123.0||||||
4091177|NCT00996281|3915481|B2|Yes||Diabetes Status||participants|Number|59|59.0||||||
4091178|NCT00996281|3915482|B1|Yes||Diabetes Status||participants|Number|64|64.0||||||
4091179|NCT00996281|3915480|B3|Ex-smoker||Smoking history||participants|Number|258|258.0||||||
4091180|NCT00996281|3915481|B2|Ex-smoker||Smoking history||participants|Number|136|136.0||||||
4091181|NCT00996281|3915482|B1|Ex-smoker||Smoking history||participants|Number|122|122.0||||||
4091182|NCT00996281|3915480|B3|Current smoker||Smoking history||participants|Number|160|160.0||||||
4091183|NCT00996281|3915481|B2|Current smoker||Smoking history||participants|Number|78|78.0||||||
4091184|NCT00996281|3915482|B1|Current smoker||Smoking history||participants|Number|82|82.0||||||
4091185|NCT00996281|3915480|B3|Never smoked||Smoking history||participants|Number|419|419.0||||||
4091186|NCT00996281|3915481|B2|Never smoked||Smoking history||participants|Number|205|205.0||||||
4091187|NCT00996281|3915482|B1|Never smoked||Smoking history||participants|Number|214|214.0||||||
4091188|NCT00996281|3915480|B3|||Body Mass Index (BMI)||kg/m^2|Mean|31.7|31.7|Standard Deviation|6.42|6.42|||
4091189|NCT00996281|3915481|B2|||Body Mass Index (BMI)||kg/m^2|Mean|31.9|31.9|Standard Deviation|6.63|6.63|||
4091190|NCT00996281|3915482|B1|||Body Mass Index (BMI)||kg/m^2|Mean|31.4|31.4|Standard Deviation|6.21|6.21|||
4091191|NCT00996281|3915480|B3|||Weight||kg|Mean|91.50|91.5|Standard Deviation|21.373|21.373|||
4091192|NCT00996281|3915481|B2|||Weight||kg|Mean|92.00|92.0|Standard Deviation|21.727|21.727|||
4091193|NCT00996281|3915482|B1|||Weight||kg|Mean|91.00|91.0|Standard Deviation|21.025|21.025|||
4091194|NCT00996281|3915480|B3|||Height||cm|Mean|169.8|169.8|Standard Deviation|10.1|10.1|||
4091195|NCT00996281|3915481|B2|||Height||cm|Mean|169.6|169.6|Standard Deviation|10.1|10.1|||
4091196|NCT00996281|3915482|B1|||Height||cm|Mean|169.9|169.9|Standard Deviation|10.2|10.2|||
4091197|NCT00996281|3915480|B3|United Kingdom||Region of Enrollment||participants|Number|78|78.0||||||
4091198|NCT00996281|3915481|B2|United Kingdom||Region of Enrollment||participants|Number|39|39.0||||||
4091199|NCT00996281|3915482|B1|United Kingdom||Region of Enrollment||participants|Number|39|39.0||||||
4091200|NCT00996281|3915480|B3|Germany||Region of Enrollment||participants|Number|43|43.0||||||
4091201|NCT00996281|3915481|B2|Germany||Region of Enrollment||participants|Number|21|21.0||||||
4091202|NCT00996281|3915482|B1|Germany||Region of Enrollment||participants|Number|22|22.0||||||
4091203|NCT00996281|3915480|B3|Netherlands||Region of Enrollment||participants|Number|114|114.0||||||
4091204|NCT00996281|3915481|B2|Netherlands||Region of Enrollment||participants|Number|58|58.0||||||
4091205|NCT00996281|3915482|B1|Netherlands||Region of Enrollment||participants|Number|56|56.0||||||
4091206|NCT00996281|3915480|B3|United States||Region of Enrollment||participants|Number|496|496.0||||||
4091207|NCT00996281|3915481|B2|United States||Region of Enrollment||participants|Number|247|247.0||||||
4091208|NCT00996281|3915482|B1|United States||Region of Enrollment||participants|Number|249|249.0||||||
4091209|NCT00996281|3915480|B3|Poland||Region of Enrollment||participants|Number|106|106.0||||||
4091210|NCT00996281|3915481|B2|Poland||Region of Enrollment||participants|Number|54|54.0||||||
4091211|NCT00996281|3915482|B1|Poland||Region of Enrollment||participants|Number|52|52.0||||||
4091212|NCT00996281|3915480|B3|Multiracial||Race/Ethnicity, Customized|Participants could choose more than 1 category for race. Participants who choose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|6|6.0||||||
4091213|NCT00996281|3915481|B2|Multiracial||Race/Ethnicity, Customized|Participants could choose more than 1 category for race. Participants who choose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|3|3.0||||||
4091214|NCT00996281|3915482|B1|Multiracial||Race/Ethnicity, Customized|Participants could choose more than 1 category for race. Participants who choose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|3|3.0||||||
4091215|NCT00996281|3915480|B3|White||Race/Ethnicity, Customized|Participants could choose more than 1 category for race. Participants who choose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|677|677.0||||||
4091216|NCT00996281|3915481|B2|White||Race/Ethnicity, Customized|Participants could choose more than 1 category for race. Participants who choose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|336|336.0||||||
4091217|NCT00996281|3915482|B1|White||Race/Ethnicity, Customized|Participants could choose more than 1 category for race. Participants who choose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|341|341.0||||||
4091218|NCT00996281|3915480|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Participants could choose more than 1 category for race. Participants who choose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|0|0.0||||||
4091219|NCT00996281|3915481|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Participants could choose more than 1 category for race. Participants who choose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|0|0.0||||||
4091220|NCT00996281|3915482|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Participants could choose more than 1 category for race. Participants who choose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|0|0.0||||||
4091221|NCT00996281|3915480|B3|Black or African American||Race/Ethnicity, Customized|Participants could choose more than 1 category for race. Participants who choose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|146|146.0||||||
4091222|NCT00996281|3915481|B2|Black or African American||Race/Ethnicity, Customized|Participants could choose more than 1 category for race. Participants who choose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|74|74.0||||||
4091223|NCT00996281|3915482|B1|Black or African American||Race/Ethnicity, Customized|Participants could choose more than 1 category for race. Participants who choose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|72|72.0||||||
4091224|NCT00996281|3915480|B3|Asian||Race/Ethnicity, Customized|Participants could choose more than 1 category for race. Participants who choose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|11|11.0||||||
4091225|NCT00996281|3915481|B2|Asian||Race/Ethnicity, Customized|Participants could choose more than 1 category for race. Participants who choose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|7|7.0||||||
4091226|NCT00996281|3915482|B1|Asian||Race/Ethnicity, Customized|Participants could choose more than 1 category for race. Participants who choose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|4|4.0||||||
4091227|NCT00996281|3915480|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|Participants could choose more than 1 category for race. Participants who choose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|9|9.0||||||
4091228|NCT00996281|3915481|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|Participants could choose more than 1 category for race. Participants who choose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|5|5.0||||||
4091285|NCT00996164|3915528|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4091229|NCT00996281|3915482|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Participants could choose more than 1 category for race. Participants who choose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|4|4.0||||||
4091230|NCT00996281|3915480|B3|Missing||Race/Ethnicity, Customized|Ethnicity was only collected from U.S. sites.|participants|Number|1|1.0||||||
4091231|NCT00996281|3915481|B2|Missing||Race/Ethnicity, Customized|Ethnicity was only collected from U.S. sites.|participants|Number|1|1.0||||||
4091232|NCT00996281|3915482|B1|Missing||Race/Ethnicity, Customized|Ethnicity was only collected from U.S. sites.|participants|Number|0|0.0||||||
4091233|NCT00996281|3915480|B3|Not collected||Race/Ethnicity, Customized|Ethnicity was only collected from U.S. sites.|participants|Number|341|341.0||||||
4091234|NCT00996281|3915481|B2|Not collected||Race/Ethnicity, Customized|Ethnicity was only collected from U.S. sites.|participants|Number|172|172.0||||||
4091235|NCT00996281|3915482|B1|Not collected||Race/Ethnicity, Customized|Ethnicity was only collected from U.S. sites.|participants|Number|169|169.0||||||
4091236|NCT00996281|3915480|B3|Non-Hispanic or Latino||Race/Ethnicity, Customized|Ethnicity was only collected from U.S. sites.|participants|Number|414|414.0||||||
4091237|NCT00996281|3915481|B2|Non-Hispanic or Latino||Race/Ethnicity, Customized|Ethnicity was only collected from U.S. sites.|participants|Number|205|205.0||||||
4091238|NCT00996281|3915482|B1|Non-Hispanic or Latino||Race/Ethnicity, Customized|Ethnicity was only collected from U.S. sites.|participants|Number|209|209.0||||||
4091239|NCT00996281|3915480|B3|Hispanic or Latino||Race/Ethnicity, Customized|Ethnicity was only collected from U.S. sites.|participants|Number|81|81.0||||||
4091240|NCT00996281|3915481|B2|Hispanic or Latino||Race/Ethnicity, Customized|Ethnicity was only collected from U.S. sites.|participants|Number|41|41.0||||||
4091241|NCT00996281|3915482|B1|Hispanic or Latino||Race/Ethnicity, Customized|Ethnicity was only collected from U.S. sites.|participants|Number|40|40.0||||||
4091242|NCT00996281|3915480|B3||Male|Sex: Female, Male||Participants|Count of Participants|472|472.0||||||
4091243|NCT00996281|3915481|B2||Male|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
4091244|NCT00996281|3915482|B1||Male|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
4091245|NCT00996281|3915480|B3||Female|Sex: Female, Male||Participants|Count of Participants|365|365.0||||||
4091246|NCT00996281|3915481|B2||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4091247|NCT00996281|3915482|B1||Female|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4091248|NCT00996281|3915480|B3|≥75 years||Age, Customized||participants|Number|46|46.0||||||
4091249|NCT00996281|3915481|B2|≥75 years||Age, Customized||participants|Number|19|19.0||||||
4091250|NCT00996281|3915482|B1|≥75 years||Age, Customized||participants|Number|27|27.0||||||
4091251|NCT00996281|3915480|B3|65 to 74 years||Age, Customized||participants|Number|187|187.0||||||
4091252|NCT00996281|3915481|B2|65 to 74 years||Age, Customized||participants|Number|93|93.0||||||
4091253|NCT00996281|3915482|B1|65 to 74 years||Age, Customized||participants|Number|94|94.0||||||
4091254|NCT00996281|3915480|B3|45 to 64 years||Age, Customized||participants|Number|510|510.0||||||
4091255|NCT00996281|3915481|B2|45 to 64 years||Age, Customized||participants|Number|259|259.0||||||
4091256|NCT00996281|3915482|B1|45 to 64 years||Age, Customized||participants|Number|251|251.0||||||
4091257|NCT00996281|3915480|B3|<45 years||Age, Customized||participants|Number|94|94.0||||||
4091258|NCT00996281|3915481|B2|<45 years||Age, Customized||participants|Number|48|48.0||||||
4091259|NCT00996281|3915482|B1|<45 years||Age, Customized||participants|Number|46|46.0||||||
4091260|NCT00996281|3915480|B3|||Age||years|Mean|58.1|58.1|Standard Deviation|10.80|10.8|||
4091261|NCT00996281|3915481|B2|||Age||years|Mean|57.6|57.6|Standard Deviation|10.80|10.8|||
4091262|NCT00996281|3915482|B1|||Age||years|Mean|58.5|58.5|Standard Deviation|10.79|10.79|||
4091263|NCT00996216|3915491|B1|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4091264|NCT00996216|3915491|B1|Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4091265|NCT00996216|3915491|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4091266|NCT00996216|3915491|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4091267|NCT00996216|3915491|B1|||Age||Years|Mean|51.3|51.3|Standard Deviation|7.70|7.7|||
4091268|NCT00996203|3915507|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4091269|NCT00996203|3915507|B1||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4091270|NCT00996203|3915507|B1|||Age||years|Mean|49.0|49.0|Standard Deviation|12.0|12.0|||
4091271|NCT00996164|3915526|B3|United States||Region of Enrollment||participants|Number|1090|1090.0||||||
4091272|NCT00996164|3915527|B2|United States||Region of Enrollment||participants|Number|547|547.0||||||
4091273|NCT00996164|3915528|B1|United States||Region of Enrollment||participants|Number|543|543.0||||||
4091274|NCT00996164|3915526|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4091275|NCT00996164|3915527|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4091276|NCT00996164|3915528|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4091277|NCT00996164|3915526|B3||Female|Sex: Female, Male||Participants|Count of Participants|1090|1090.0||||||
4091278|NCT00996164|3915527|B2||Female|Sex: Female, Male||Participants|Count of Participants|547|547.0||||||
4091279|NCT00996164|3915528|B1||Female|Sex: Female, Male||Participants|Count of Participants|543|543.0||||||
4091280|NCT00996164|3915526|B3|||Age||years|Mean|36.5|36.5|Standard Deviation|7.3|7.3|||
4091281|NCT00996164|3915527|B2|||Age||years|Mean|36.6|36.6|Standard Deviation|8.0|8.0|||
4091282|NCT00996164|3915528|B1|||Age||years|Mean|36.5|36.5|Standard Deviation|7.8|7.8|||
4091283|NCT00996164|3915526|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4091284|NCT00996164|3915527|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4091286|NCT00996164|3915526|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1090|1090.0||||||
4091287|NCT00996164|3915527|B2||Between 18 and 65 years|Age||Participants|Count of Participants|547|547.0||||||
4091288|NCT00996164|3915528|B1||Between 18 and 65 years|Age||Participants|Count of Participants|543|543.0||||||
4091289|NCT00996164|3915526|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4091290|NCT00996164|3915527|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4091291|NCT00996164|3915528|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4091292|NCT00996125|3915537|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4091293|NCT00996125|3915538|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4091294|NCT00996125|3915539|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4091295|NCT00996125|3915537|B3||Female|Sex: Female, Male||Participants|Count of Participants|750|750.0||||||
4091296|NCT00996125|3915538|B2||Female|Sex: Female, Male||Participants|Count of Participants|376|376.0||||||
4091297|NCT00996125|3915539|B1||Female|Sex: Female, Male||Participants|Count of Participants|374|374.0||||||
4091298|NCT00996125|3915537|B3|||Age||Years|Mean|13.1|13.1|Standard Deviation|2.43|2.43|||
4091299|NCT00996125|3915538|B2|||Age||Years|Mean|13.1|13.1|Standard Deviation|2.42|2.42|||
4091300|NCT00996125|3915539|B1|||Age||Years|Mean|13.1|13.1|Standard Deviation|2.44|2.44|||
4091301|NCT00996034|3915560|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4091302|NCT00996034|3915560|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4091303|NCT00996034|3915560|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4091304|NCT00996034|3915560|B1|||Age||years|Mean|31.15|31.15|Standard Deviation|8.33|8.33|||
4091305|NCT00996034|3915560|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4091306|NCT00996034|3915560|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4091307|NCT00996034|3915560|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4091308|NCT00995930|3915564|B3||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4091309|NCT00995930|3915565|B2||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4091310|NCT00995930|3915566|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4091311|NCT00995930|3915564|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4091312|NCT00995930|3915565|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4091313|NCT00995930|3915566|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4091314|NCT00995930|3915564|B3|||Age||Years|Mean|61.8|61.8|Standard Deviation|7.38|7.38|||
4091315|NCT00995930|3915565|B2|||Age||Years|Mean|61.7|61.7|Standard Deviation|7.85|7.85|||
4091316|NCT00995930|3915566|B1|||Age||Years|Mean|61.9|61.9|Standard Deviation|6.92|6.92|||
4091317|NCT00995904|3915596|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4091318|NCT00995904|3915596|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4091319|NCT00995904|3915596|B1|||Age||years|Mean|8.3|8.3|Standard Deviation|1.88|1.88|||
4091320|NCT00995865|3915615|B4|United States||Region of Enrollment||participants|Number|57|57.0||||||
4091321|NCT00995865|3915616|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4091322|NCT00995865|3915617|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4091323|NCT00995865|3915618|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4091324|NCT00995865|3915615|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4091325|NCT00995865|3915616|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4091326|NCT00995865|3915617|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4091327|NCT00995865|3915618|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4091328|NCT00995865|3915615|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4091329|NCT00995865|3915616|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4091330|NCT00995865|3915617|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4091331|NCT00995865|3915618|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4091332|NCT00995865|3915615|B4|||Age||years|Mean|32|32.0|Standard Deviation|9.3|9.3|||
4091333|NCT00995865|3915616|B3|||Age||years|Mean|29|29.0|Standard Deviation|8.2|8.2|||
4091334|NCT00995865|3915617|B2|||Age||years|Mean|31|31.0|Standard Deviation|9.1|9.1|||
4091335|NCT00995865|3915618|B1|||Age||years|Mean|34|34.0|Standard Deviation|10.0|10.0|||
4091336|NCT00995865|3915615|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4091337|NCT00995865|3915616|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4091338|NCT00995865|3915617|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4091339|NCT00995865|3915618|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4091340|NCT00995865|3915615|B4||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4091341|NCT00995865|3915616|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4091342|NCT00995865|3915617|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4091343|NCT00995865|3915618|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4091344|NCT00995865|3915615|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4091345|NCT00995865|3915616|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4091346|NCT00995865|3915617|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4091347|NCT00995865|3915618|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4091348|NCT00995774|3915640|B3|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4091349|NCT00995774|3915641|B2|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4091350|NCT00995774|3915642|B1|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4091351|NCT00995774|3915640|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4091352|NCT00995774|3915641|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4091353|NCT00995774|3915642|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4091354|NCT00995774|3915640|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4091355|NCT00995774|3915641|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4091356|NCT00995774|3915642|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4091357|NCT00995774|3915640|B3|||Age||years|Mean|57.7|57.7|Standard Deviation|12.2|12.2|||
4091358|NCT00995774|3915641|B2|||Age||years|Mean|57.8|57.8|Standard Deviation|16.3|16.3|||
4091359|NCT00995774|3915642|B1|||Age||years|Mean|57.7|57.7|Standard Deviation|10.8|10.8|||
4091360|NCT00995774|3915640|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4091361|NCT00995774|3915641|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4091362|NCT00995774|3915642|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4091363|NCT00995774|3915640|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4091364|NCT00995774|3915641|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4091365|NCT00995774|3915642|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4091366|NCT00995774|3915640|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4091367|NCT00995774|3915641|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4091368|NCT00995774|3915642|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4091369|NCT00995761|3915653|B1|Korea, Republic of||Region of Enrollment||participants|Number|48|48.0||||||
4091370|NCT00995761|3915653|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4091371|NCT00995761|3915653|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4091372|NCT00995761|3915653|B1|||Age||years|Mean|66|66.0|Inter-Quartile Range|1.5|1.5|61.0|72.0|
4091373|NCT00995761|3915653|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4091374|NCT00995761|3915653|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4091375|NCT00995761|3915653|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4091376|NCT00995722|3915657|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091377|NCT00995722|3915658|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091378|NCT00995722|3915659|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091379|NCT00995722|3915657|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091380|NCT00995722|3915658|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091381|NCT00995722|3915659|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091382|NCT00995722|3915657|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4091383|NCT00995722|3915658|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4091384|NCT00995722|3915659|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4091385|NCT00995722|3915657|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4091386|NCT00995722|3915658|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4091387|NCT00995722|3915659|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4091388|NCT00995722|3915657|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091389|NCT00995722|3915658|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091390|NCT00995722|3915659|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091391|NCT00995722|3915657|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091392|NCT00995722|3915658|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091393|NCT00995722|3915659|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091394|NCT00995722|3915657|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091395|NCT00995722|3915658|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091396|NCT00995722|3915659|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091397|NCT00995722|3915657|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091398|NCT00995722|3915658|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091399|NCT00995722|3915659|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091400|NCT00995722|3915657|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4091401|NCT00995722|3915658|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4091402|NCT00995722|3915659|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4091403|NCT00995722|3915657|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091404|NCT00995722|3915658|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091405|NCT00995722|3915659|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091406|NCT00995722|3915657|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4091407|NCT00995722|3915658|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4091408|NCT00995722|3915659|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4091409|NCT00995722|3915657|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4091410|NCT00995722|3915658|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4091411|NCT00995722|3915659|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4091412|NCT00995722|3915657|B3|||Age||years|Mean|63|63.0|Standard Deviation|13.6|13.6|||
4091413|NCT00995722|3915658|B2|||Age||years|Mean|62|62.0|Standard Deviation|9|9.0|||
4091414|NCT00995722|3915659|B1|||Age||years|Mean|64|64.0|Standard Deviation|18|18.0|||
4091415|NCT00995722|3915657|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4091416|NCT00995722|3915658|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4091417|NCT00995722|3915659|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4091418|NCT00995722|3915657|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4091419|NCT00995722|3915658|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4091420|NCT00995722|3915659|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4091421|NCT00995722|3915657|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4091422|NCT00995722|3915658|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4091423|NCT00995722|3915659|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4091424|NCT00995709|3915674|B4|Taiwan, Province Of China||Region of Enrollment||Participants|Number|1|1.0||||||
4091425|NCT00995709|3915675|B3|Taiwan, Province Of China||Region of Enrollment||Participants|Number|0|0.0||||||
4091426|NCT00995709|3915676|B2|Taiwan, Province Of China||Region of Enrollment||Participants|Number|0|0.0||||||
4091427|NCT00995709|3915677|B1|Taiwan, Province Of China||Region of Enrollment||Participants|Number|1|1.0||||||
4091428|NCT00995709|3915674|B4|Singapore||Region of Enrollment||Participants|Number|2|2.0||||||
4091429|NCT00995709|3915675|B3|Singapore||Region of Enrollment||Participants|Number|1|1.0||||||
4091430|NCT00995709|3915676|B2|Singapore||Region of Enrollment||Participants|Number|0|0.0||||||
4091431|NCT00995709|3915677|B1|Singapore||Region of Enrollment||Participants|Number|1|1.0||||||
4091432|NCT00995709|3915674|B4|Korea, Republic Of||Region of Enrollment||Participants|Number|10|10.0||||||
4091433|NCT00995709|3915675|B3|Korea, Republic Of||Region of Enrollment||Participants|Number|4|4.0||||||
4091434|NCT00995709|3915676|B2|Korea, Republic Of||Region of Enrollment||Participants|Number|4|4.0||||||
4091435|NCT00995709|3915677|B1|Korea, Republic Of||Region of Enrollment||Participants|Number|2|2.0||||||
4091436|NCT00995709|3915674|B4|India||Region of Enrollment||Participants|Number|4|4.0||||||
4091437|NCT00995709|3915675|B3|India||Region of Enrollment||Participants|Number|1|1.0||||||
4091438|NCT00995709|3915676|B2|India||Region of Enrollment||Participants|Number|2|2.0||||||
4091439|NCT00995709|3915677|B1|India||Region of Enrollment||Participants|Number|1|1.0||||||
4091440|NCT00995709|3915674|B4|Hong Kong||Region of Enrollment||Participants|Number|3|3.0||||||
4091441|NCT00995709|3915675|B3|Hong Kong||Region of Enrollment||Participants|Number|1|1.0||||||
4091442|NCT00995709|3915676|B2|Hong Kong||Region of Enrollment||Participants|Number|1|1.0||||||
4091443|NCT00995709|3915677|B1|Hong Kong||Region of Enrollment||Participants|Number|1|1.0||||||
4091444|NCT00995709|3915674|B4|Tunisia||Region of Enrollment||Participants|Number|5|5.0||||||
4091445|NCT00995709|3915675|B3|Tunisia||Region of Enrollment||Participants|Number|2|2.0||||||
4091446|NCT00995709|3915676|B2|Tunisia||Region of Enrollment||Participants|Number|1|1.0||||||
4091447|NCT00995709|3915677|B1|Tunisia||Region of Enrollment||Participants|Number|2|2.0||||||
4091448|NCT00995709|3915674|B4|Jordan||Region of Enrollment||Participants|Number|3|3.0||||||
4091449|NCT00995709|3915675|B3|Jordan||Region of Enrollment||Participants|Number|1|1.0||||||
4091450|NCT00995709|3915676|B2|Jordan||Region of Enrollment||Participants|Number|2|2.0||||||
4091451|NCT00995709|3915677|B1|Jordan||Region of Enrollment||Participants|Number|0|0.0||||||
4091452|NCT00995709|3915674|B4|Israel||Region of Enrollment||Participants|Number|3|3.0||||||
4091453|NCT00995709|3915675|B3|Israel||Region of Enrollment||Participants|Number|1|1.0||||||
4091454|NCT00995709|3915676|B2|Israel||Region of Enrollment||Participants|Number|0|0.0||||||
4091455|NCT00995709|3915677|B1|Israel||Region of Enrollment||Participants|Number|2|2.0||||||
4091456|NCT00995709|3915674|B4|Egypt||Region of Enrollment||Participants|Number|5|5.0||||||
4091457|NCT00995709|3915675|B3|Egypt||Region of Enrollment||Participants|Number|2|2.0||||||
4091458|NCT00995709|3915676|B2|Egypt||Region of Enrollment||Participants|Number|2|2.0||||||
4091459|NCT00995709|3915677|B1|Egypt||Region of Enrollment||Participants|Number|1|1.0||||||
4091460|NCT00995709|3915674|B4|United States||Region of Enrollment||Participants|Number|2|2.0||||||
4091461|NCT00995709|3915675|B3|United States||Region of Enrollment||Participants|Number|0|0.0||||||
4091462|NCT00995709|3915676|B2|United States||Region of Enrollment||Participants|Number|2|2.0||||||
4091463|NCT00995709|3915677|B1|United States||Region of Enrollment||Participants|Number|0|0.0||||||
4091464|NCT00995709|3915674|B4|Spain||Region of Enrollment||Participants|Number|2|2.0||||||
4091465|NCT00995709|3915675|B3|Spain||Region of Enrollment||Participants|Number|1|1.0||||||
4091466|NCT00995709|3915676|B2|Spain||Region of Enrollment||Participants|Number|0|0.0||||||
4091467|NCT00995709|3915677|B1|Spain||Region of Enrollment||Participants|Number|1|1.0||||||
4091468|NCT00995709|3915674|B4|Italy||Region of Enrollment||Participants|Number|7|7.0||||||
4091469|NCT00995709|3915675|B3|Italy||Region of Enrollment||Participants|Number|2|2.0||||||
4091470|NCT00995709|3915676|B2|Italy||Region of Enrollment||Participants|Number|2|2.0||||||
4091471|NCT00995709|3915677|B1|Italy||Region of Enrollment||Participants|Number|3|3.0||||||
4091472|NCT00995709|3915674|B4|Greece||Region of Enrollment||Participants|Number|12|12.0||||||
4091473|NCT00995709|3915675|B3|Greece||Region of Enrollment||Participants|Number|4|4.0||||||
4091474|NCT00995709|3915676|B2|Greece||Region of Enrollment||Participants|Number|5|5.0||||||
4091475|NCT00995709|3915677|B1|Greece||Region of Enrollment||Participants|Number|3|3.0||||||
4091476|NCT00995709|3915674|B4|Germany||Region of Enrollment||Participants|Number|3|3.0||||||
4091477|NCT00995709|3915675|B3|Germany||Region of Enrollment||Participants|Number|1|1.0||||||
4091478|NCT00995709|3915676|B2|Germany||Region of Enrollment||Participants|Number|1|1.0||||||
4091479|NCT00995709|3915677|B1|Germany||Region of Enrollment||Participants|Number|1|1.0||||||
4091480|NCT00995709|3915674|B4|Turkey||Region of Enrollment||Participants|Number|55|55.0||||||
4091481|NCT00995709|3915675|B3|Turkey||Region of Enrollment||Participants|Number|18|18.0||||||
4091482|NCT00995709|3915676|B2|Turkey||Region of Enrollment||Participants|Number|18|18.0||||||
4091483|NCT00995709|3915677|B1|Turkey||Region of Enrollment||Participants|Number|19|19.0||||||
4091484|NCT00995709|3915674|B4|France||Region of Enrollment||Participants|Number|1|1.0||||||
4091485|NCT00995709|3915675|B3|France||Region of Enrollment||Participants|Number|0|0.0||||||
4091486|NCT00995709|3915676|B2|France||Region of Enrollment||Participants|Number|0|0.0||||||
4091487|NCT00995709|3915677|B1|France||Region of Enrollment||Participants|Number|1|1.0||||||
4091488|NCT00995709|3915674|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4091489|NCT00995709|3915675|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4091490|NCT00995709|3915676|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4091491|NCT00995709|3915677|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091492|NCT00995709|3915674|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
4091493|NCT00995709|3915675|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4091494|NCT00995709|3915676|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4091495|NCT00995709|3915677|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4091496|NCT00995709|3915674|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4091497|NCT00995709|3915675|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4091498|NCT00995709|3915676|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091499|NCT00995709|3915677|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091500|NCT00995709|3915674|B4||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4091501|NCT00995709|3915675|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4091502|NCT00995709|3915676|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4091503|NCT00995709|3915677|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4091504|NCT00995709|3915674|B4||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4091505|NCT00995709|3915675|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4091506|NCT00995709|3915676|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4091507|NCT00995709|3915677|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4091508|NCT00995709|3915674|B4|||Age||Years|Mean|34.2|34.2|Standard Deviation|11.09|11.09|||
4091509|NCT00995709|3915675|B3|||Age||Years|Mean|32.5|32.5|Standard Deviation|10.34|10.34|||
4091510|NCT00995709|3915676|B2|||Age||Years|Mean|34.0|34.0|Standard Deviation|11.86|11.86|||
4091511|NCT00995709|3915677|B1|||Age||Years|Mean|36.2|36.2|Standard Deviation|10.96|10.96|||
4091512|NCT00995670|3915702|B4|United States||Region of Enrollment||participants|Number|59|59.0||||||
4091513|NCT00995670|3915703|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4091514|NCT00995670|3915704|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4091515|NCT00995670|3915705|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4091516|NCT00995670|3915702|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4091517|NCT00995670|3915703|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4091518|NCT00995670|3915704|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4091519|NCT00995670|3915705|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4091520|NCT00995670|3915702|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4091521|NCT00995670|3915703|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4091522|NCT00995670|3915704|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4091523|NCT00995670|3915705|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4091524|NCT00995670|3915702|B4|18-35 years old||Age, Customized|Age range of participants was 18 to 35 years of age.|participants|Number|59|59.0||||||
4091525|NCT00995670|3915703|B3|18-35 years old||Age, Customized|Age range of participants was 18 to 35 years of age.|participants|Number|17|17.0||||||
4091526|NCT00995670|3915704|B2|18-35 years old||Age, Customized|Age range of participants was 18 to 35 years of age.|participants|Number|16|16.0||||||
4091527|NCT00995670|3915705|B1|18-35 years old||Age, Customized|Age range of participants was 18 to 35 years of age.|participants|Number|26|26.0||||||
4091528|NCT00995566|3915715|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4091529|NCT00995566|3915715|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4091530|NCT00995566|3915715|B1|||Age||years|Mean|60.5|60.5|Standard Deviation|18.1|18.1|||
4091531|NCT00995553|3915727|B3|United States||Region of Enrollment||participants|Number|81|81.0||||||
4091532|NCT00995553|3915728|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
4091533|NCT00995553|3915729|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4091534|NCT00995553|3915727|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4091535|NCT00995553|3915728|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4091536|NCT00995553|3915729|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4091537|NCT00995553|3915727|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4091538|NCT00995553|3915728|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4091539|NCT00995553|3915729|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4091540|NCT00995553|3915727|B3|||Age||years|Mean|46.28|46.28|Standard Deviation|9.63|9.63|||
4091541|NCT00995553|3915728|B2|||Age||years|Mean|46.73|46.73|Standard Deviation|10.24|10.24|||
4091542|NCT00995553|3915729|B1|||Age||years|Mean|45.83|45.83|Standard Deviation|9.08|9.08|||
4091543|NCT00995501|3915738|B9|||Body mass index||kg/m^2|Mean|28|28.0|Standard Deviation|6|6.0|||
4091544|NCT00995501|3915739|B8|||Body mass index||kg/m^2|Mean|29|29.0|Standard Deviation|6|6.0|||
4091545|NCT00995501|3915740|B7|||Body mass index||kg/m^2|Mean|27|27.0|Standard Deviation|6|6.0|||
4091546|NCT00995501|3915741|B6|||Body mass index||kg/m^2|Mean|27|27.0|Standard Deviation|5|5.0|||
4091547|NCT00995501|3915742|B5|||Body mass index||kg/m^2|Mean|28|28.0|Standard Deviation|6|6.0|||
4091548|NCT00995501|3915743|B4|||Body mass index||kg/m^2|Mean|28|28.0|Standard Deviation|8|8.0|||
4091549|NCT00995501|3915744|B3|||Body mass index||kg/m^2|Mean|28|28.0|Standard Deviation|6|6.0|||
4091550|NCT00995501|3915745|B2|||Body mass index||kg/m^2|Mean|30|30.0|Standard Deviation|6|6.0|||
4091551|NCT00995501|3915746|B1|||Body mass index||kg/m^2|Mean|28|28.0|Standard Deviation|4|4.0|||
4091552|NCT00995501|3915738|B9|African American||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
4091553|NCT00995501|3915739|B8|African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4091554|NCT00995501|3915740|B7|African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4091555|NCT00995501|3915741|B6|African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4091556|NCT00995501|3915742|B5|African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4091557|NCT00995501|3915743|B4|African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4091558|NCT00995501|3915744|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4091559|NCT00995501|3915745|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4091560|NCT00995501|3915746|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4091561|NCT00995501|3915738|B9|White||Race/Ethnicity, Customized||Participants|Count of Participants|362|362.0||||||
4091562|NCT00995501|3915739|B8|White||Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
4091563|NCT00995501|3915740|B7|White||Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
4091564|NCT00995501|3915741|B6|White||Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
4091565|NCT00995501|3915742|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
4091566|NCT00995501|3915743|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|45|45.0||||||
4091567|NCT00995501|3915744|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
4091568|NCT00995501|3915745|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|49|49.0||||||
4091569|NCT00995501|3915746|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|49|49.0||||||
4091570|NCT00995501|3915738|B9||Male|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
4091571|NCT00995501|3915739|B8||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4091572|NCT00995501|3915740|B7||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4091573|NCT00995501|3915741|B6||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4091574|NCT00995501|3915742|B5||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4091575|NCT00995501|3915743|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4091576|NCT00995501|3915744|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4091577|NCT00995501|3915745|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4091578|NCT00995501|3915746|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4091579|NCT00995501|3915738|B9||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4091580|NCT00995501|3915739|B8||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4091581|NCT00995501|3915740|B7||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4091582|NCT00995501|3915741|B6||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4091583|NCT00995501|3915742|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4091584|NCT00995501|3915743|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4091585|NCT00995501|3915744|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4091586|NCT00995501|3915745|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4091587|NCT00995501|3915746|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4091588|NCT00995501|3915738|B9|||Age||years|Mean|64|64.0|Standard Deviation|11|11.0|||
4091589|NCT00995501|3915739|B8|||Age||years|Mean|65|65.0|Standard Deviation|12|12.0|||
4091590|NCT00995501|3915740|B7|||Age||years|Mean|63|63.0|Standard Deviation|12|12.0|||
4091591|NCT00995501|3915741|B6|||Age||years|Mean|64|64.0|Standard Deviation|11|11.0|||
4091592|NCT00995501|3915742|B5|||Age||years|Mean|65|65.0|Standard Deviation|13|13.0|||
4091593|NCT00995501|3915743|B4|||Age||years|Mean|64|64.0|Standard Deviation|11|11.0|||
4091594|NCT00995501|3915744|B3|||Age||years|Mean|64|64.0|Standard Deviation|11|11.0|||
4091595|NCT00995501|3915745|B2|||Age||years|Mean|65|65.0|Standard Deviation|11|11.0|||
4091596|NCT00995501|3915746|B1|||Age||years|Mean|63|63.0|Standard Deviation|10|10.0|||
4091597|NCT00995488|3915779|B1|2||ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) performance status is the measure of a patients general well being and activities of daily life. The scoring system runs from 0 to 5 where 0 represents perfect health and 5 represents death.|participants|Number|1|1.0||||||
4091598|NCT00995488|3915779|B1|1||ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) performance status is the measure of a patients general well being and activities of daily life. The scoring system runs from 0 to 5 where 0 represents perfect health and 5 represents death.|participants|Number|11|11.0||||||
4091599|NCT00995488|3915779|B1|0||ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) performance status is the measure of a patients general well being and activities of daily life. The scoring system runs from 0 to 5 where 0 represents perfect health and 5 represents death.|participants|Number|4|4.0||||||
4091600|NCT00995488|3915779|B1|Less than 60 mL/min||GFR|GFR at baseline. Glomerular filtration rate (GFR) is a test used to check how well the kidneys are working.|participants|Number|7|7.0||||||
4091601|NCT00995488|3915779|B1|Greater than or Equal to 60 mL/min||GFR|GFR at baseline. Glomerular filtration rate (GFR) is a test used to check how well the kidneys are working.|participants|Number|9|9.0||||||
4091602|NCT00995488|3915779|B1|Locally Advanced or Recurrent Unresectable||Disease Status|The status of the disease at baseline (locally advanced or metastatic).|participants|Number|3|3.0||||||
4091603|NCT00995488|3915779|B1|Metastatic||Disease Status|The status of the disease at baseline (locally advanced or metastatic).|participants|Number|13|13.0||||||
4091604|NCT00995488|3915779|B1|Ureter/ Renal Pelvis||Primary Site|The site of cancer origin.|participants|Number|3|3.0||||||
4091605|NCT00995488|3915779|B1|Bladder||Primary Site|The site of cancer origin.|participants|Number|13|13.0||||||
4091606|NCT00995488|3915779|B1|Mixed Urothelial with Adenocarcinoma||Histology|Participant tumor histology at the start of the study.|participants|Number|1|1.0||||||
4091607|NCT00995488|3915779|B1|Mixed Urothelial with Squamous||Histology|Participant tumor histology at the start of the study.|participants|Number|2|2.0||||||
4091608|NCT00995488|3915779|B1|Pure Urothelial||Histology|Participant tumor histology at the start of the study.|participants|Number|13|13.0||||||
4091609|NCT00995488|3915779|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4091610|NCT00995488|3915779|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4091611|NCT00995488|3915779|B1|||Age||years|Median|73.9|73.9|Full Range|||51.3|83.0|
4091612|NCT00995449|3915784|B5|United States||Region of Enrollment||participants|Number|9|9.0||||||
4091613|NCT00995449|3915785|B4|United States||Region of Enrollment||participants|Number|2|2.0||||||
4091614|NCT00995449|3915786|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4091615|NCT00995449|3915784|B5|Male||Gender||participants|Number|4|4.0||||||
4091616|NCT00995449|3915785|B4|Male||Gender||participants|Number|1|1.0||||||
4091617|NCT00995449|3915786|B3|Male||Gender||participants|Number|3|3.0||||||
4091618|NCT00995449|3915784|B5|Female||Gender||participants|Number|5|5.0||||||
4091619|NCT00995449|3915785|B4|Female||Gender||participants|Number|1|1.0||||||
4091620|NCT00995449|3915786|B3|Female||Gender||participants|Number|4|4.0||||||
4091621|NCT00995449|3915784|B5|>=65 years||Age||participants|Number|2|2.0||||||
4091622|NCT00995449|3915785|B4|>=65 years||Age||participants|Number|0|0.0||||||
4091623|NCT00995449|3915786|B3|>=65 years||Age||participants|Number|2|2.0||||||
4091624|NCT00995449|3915784|B5|Between 18 and 65 years||Age||participants|Number|7|7.0||||||
4091625|NCT00995449|3915785|B4|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
4091626|NCT00995449|3915786|B3|Between 18 and 65 years||Age||participants|Number|5|5.0||||||
4091627|NCT00995449|3915784|B5|<=18 years||Age||participants|Number|0|0.0||||||
4091628|NCT00995449|3915785|B4|<=18 years||Age||participants|Number|0|0.0||||||
4091629|NCT00995449|3915786|B3|<=18 years||Age||participants|Number|0|0.0||||||
4091630|NCT00995436|3915799|B4|United Kingdom||Region of Enrollment||participants|Number|78|78.0||||||
4091631|NCT00995436|3915800|B3|United Kingdom||Region of Enrollment||participants|Number|26|26.0||||||
4091632|NCT00995436|3915801|B2|United Kingdom||Region of Enrollment||participants|Number|27|27.0||||||
4091633|NCT00995436|3915802|B1|United Kingdom||Region of Enrollment||participants|Number|25|25.0||||||
4091634|NCT00995436|3915799|B4||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4091635|NCT00995436|3915800|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4091636|NCT00995436|3915801|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4091637|NCT00995436|3915802|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4091638|NCT00995436|3915799|B4||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4091639|NCT00995436|3915800|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4091640|NCT00995436|3915801|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4091641|NCT00995436|3915802|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4091642|NCT00995436|3915799|B4|||Age||years|Mean|14.22|14.22|Standard Deviation|1.46|1.46|||
4091643|NCT00995436|3915800|B3|||Age||years|Mean|14.14|14.14|Standard Deviation|1.48|1.48|||
4091644|NCT00995436|3915801|B2|||Age||years|Mean|14.15|14.15|Standard Deviation|1.25|1.25|||
4091645|NCT00995436|3915802|B1|||Age||years|Mean|14.38|14.38|Standard Deviation|1.67|1.67|||
4091646|NCT00995410|3915812|B1||Male|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
4091647|NCT00995410|3915812|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4091648|NCT00995410|3915812|B1|||Age||years|Mean|67.3|67.3|Standard Deviation|7.8|7.8|||
4091649|NCT00995410|3915812|B1||>=65 years|Age||Participants|Count of Participants|249|249.0||||||
4091650|NCT00995410|3915812|B1||Between 18 and 65 years|Age||Participants|Count of Participants|130|130.0||||||
4091651|NCT00995410|3915812|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4091652|NCT00995371|3915817|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
4091653|NCT00995371|3915818|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4091654|NCT00995371|3915819|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4091655|NCT00995371|3915817|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4091656|NCT00995371|3915818|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4091657|NCT00995371|3915819|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4091658|NCT00995371|3915817|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4091659|NCT00995371|3915818|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4091660|NCT00995371|3915819|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4091661|NCT00995371|3915817|B3|||Age||years|Mean|76.26|76.26|Standard Deviation|9.18|9.18|||
4091662|NCT00995371|3915818|B2|||Age||years|Mean|78.71|78.71|Standard Deviation|7.11|7.11|||
4091663|NCT00995371|3915819|B1|||Age||years|Mean|74.24|74.24|Standard Deviation|10.12|10.12|||
4091664|NCT00995371|3915817|B3||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4091665|NCT00995371|3915818|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4091666|NCT00995371|3915819|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4091667|NCT00995371|3915817|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4091668|NCT00995371|3915818|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4091669|NCT00995371|3915819|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4091670|NCT00995371|3915817|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4091671|NCT00995371|3915818|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4091672|NCT00995371|3915819|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4091673|NCT00995345|3915833|B6|Russian Federation||Region of Enrollment||participants|Number|69|69.0||||||
4091674|NCT00995345|3915834|B5|Russian Federation||Region of Enrollment||participants|Number|14|14.0||||||
4091675|NCT00995345|3915835|B4|Russian Federation||Region of Enrollment||participants|Number|14|14.0||||||
4091676|NCT00995345|3915836|B3|Russian Federation||Region of Enrollment||participants|Number|14|14.0||||||
4091677|NCT00995345|3915837|B2|Russian Federation||Region of Enrollment||participants|Number|14|14.0||||||
4091678|NCT00995345|3915838|B1|Russian Federation||Region of Enrollment||participants|Number|13|13.0||||||
4091679|NCT00995345|3915833|B6|South Africa||Region of Enrollment||participants|Number|111|111.0||||||
4091680|NCT00995345|3915834|B5|South Africa||Region of Enrollment||participants|Number|22|22.0||||||
4091681|NCT00995345|3915835|B4|South Africa||Region of Enrollment||participants|Number|22|22.0||||||
4091682|NCT00995345|3915836|B3|South Africa||Region of Enrollment||participants|Number|23|23.0||||||
4091683|NCT00995345|3915837|B2|South Africa||Region of Enrollment||participants|Number|23|23.0||||||
4091684|NCT00995345|3915838|B1|South Africa||Region of Enrollment||participants|Number|21|21.0||||||
4091685|NCT00995345|3915833|B6|Guatemala||Region of Enrollment||participants|Number|76|76.0||||||
4091686|NCT00995345|3915834|B5|Guatemala||Region of Enrollment||participants|Number|16|16.0||||||
4091687|NCT00995345|3915835|B4|Guatemala||Region of Enrollment||participants|Number|14|14.0||||||
4091688|NCT00995345|3915836|B3|Guatemala||Region of Enrollment||participants|Number|15|15.0||||||
4091689|NCT00995345|3915837|B2|Guatemala||Region of Enrollment||participants|Number|15|15.0||||||
4091690|NCT00995345|3915838|B1|Guatemala||Region of Enrollment||participants|Number|16|16.0||||||
4091691|NCT00995345|3915833|B6|Poland||Region of Enrollment||participants|Number|16|16.0||||||
4091692|NCT00995345|3915834|B5|Poland||Region of Enrollment||participants|Number|3|3.0||||||
4091693|NCT00995345|3915835|B4|Poland||Region of Enrollment||participants|Number|4|4.0||||||
4091694|NCT00995345|3915836|B3|Poland||Region of Enrollment||participants|Number|2|2.0||||||
4091695|NCT00995345|3915837|B2|Poland||Region of Enrollment||participants|Number|3|3.0||||||
4091696|NCT00995345|3915838|B1|Poland||Region of Enrollment||participants|Number|4|4.0||||||
4091697|NCT00995345|3915833|B6|Czech Republic||Region of Enrollment||participants|Number|28|28.0||||||
4091698|NCT00995345|3915834|B5|Czech Republic||Region of Enrollment||participants|Number|5|5.0||||||
4091699|NCT00995345|3915835|B4|Czech Republic||Region of Enrollment||participants|Number|6|6.0||||||
4091700|NCT00995345|3915836|B3|Czech Republic||Region of Enrollment||participants|Number|5|5.0||||||
4091701|NCT00995345|3915837|B2|Czech Republic||Region of Enrollment||participants|Number|6|6.0||||||
4091702|NCT00995345|3915838|B1|Czech Republic||Region of Enrollment||participants|Number|6|6.0||||||
4091703|NCT00995345|3915833|B6|United States||Region of Enrollment||participants|Number|103|103.0||||||
4091704|NCT00995345|3915834|B5|United States||Region of Enrollment||participants|Number|20|20.0||||||
4091705|NCT00995345|3915835|B4|United States||Region of Enrollment||participants|Number|21|21.0||||||
4091706|NCT00995345|3915836|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4091707|NCT00995345|3915837|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4091708|NCT00995345|3915838|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4091709|NCT00995345|3915833|B6||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4091710|NCT00995345|3915834|B5||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4091711|NCT00995345|3915835|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4091712|NCT00995345|3915836|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4091713|NCT00995345|3915837|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4091714|NCT00995345|3915838|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4091715|NCT00995345|3915833|B6||Female|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
4091716|NCT00995345|3915834|B5||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4091717|NCT00995345|3915835|B4||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4091718|NCT00995345|3915836|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4091719|NCT00995345|3915837|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4091720|NCT00995345|3915838|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4091721|NCT00995345|3915833|B6|||Age||years|Mean|55.8|55.8|Standard Deviation|9.40|9.4|||
4091722|NCT00995345|3915834|B5|||Age||years|Mean|55.5|55.5|Standard Deviation|8.27|8.27|||
4091723|NCT00995345|3915835|B4|||Age||years|Mean|56.3|56.3|Standard Deviation|9.40|9.4|||
4091724|NCT00995345|3915836|B3|||Age||years|Mean|55.7|55.7|Standard Deviation|9.10|9.1|||
4091725|NCT00995345|3915837|B2|||Age||years|Mean|54.2|54.2|Standard Deviation|10.59|10.59|||
4091726|NCT00995345|3915838|B1|||Age||years|Mean|57.3|57.3|Standard Deviation|9.43|9.43|||
4091727|NCT00995345|3915833|B6||>=65 years|Age||Participants|Count of Participants|71|71.0||||||
4091728|NCT00995345|3915834|B5||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4091729|NCT00995345|3915835|B4||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4091730|NCT00995345|3915836|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4091731|NCT00995345|3915837|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4091732|NCT00995345|3915838|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4091733|NCT00995345|3915833|B6||Between 18 and 65 years|Age||Participants|Count of Participants|332|332.0||||||
4091734|NCT00995345|3915834|B5||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4091735|NCT00995345|3915835|B4||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4091736|NCT00995345|3915836|B3||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4091737|NCT00995345|3915837|B2||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
4091738|NCT00995345|3915838|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4091739|NCT00995345|3915833|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4091740|NCT00995345|3915834|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4091741|NCT00995345|3915835|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4091742|NCT00995345|3915836|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4091743|NCT00995345|3915837|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4091744|NCT00995345|3915838|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4091745|NCT00995085|3915869|B1|Israel||Region of Enrollment||participants|Number|43|43.0||||||
4091746|NCT00995085|3915869|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4091747|NCT00995085|3915869|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4091748|NCT00995085|3915869|B1|||Age||years|Mean|32.1|32.1|Standard Deviation|6.9|6.9|||
4091749|NCT00995020|3915873|B3|Ireland||Region of Enrollment||participants|Number|11|11.0||||||
4091750|NCT00995020|3915874|B2|Ireland||Region of Enrollment||participants|Number|6|6.0||||||
4091751|NCT00995020|3915875|B1|Ireland||Region of Enrollment||participants|Number|5|5.0||||||
4091752|NCT00995020|3915873|B3|Brazil||Region of Enrollment||participants|Number|92|92.0||||||
4091753|NCT00995020|3915874|B2|Brazil||Region of Enrollment||participants|Number|46|46.0||||||
4091754|NCT00995020|3915875|B1|Brazil||Region of Enrollment||participants|Number|46|46.0||||||
4091755|NCT00995020|3915873|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4091756|NCT00995020|3915874|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4091757|NCT00995020|3915875|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4091758|NCT00995020|3915873|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4091759|NCT00995020|3915874|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4091760|NCT00995020|3915875|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4091761|NCT00995020|3915873|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4091762|NCT00995020|3915874|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4091763|NCT00995020|3915875|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4091764|NCT00995020|3915873|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4091765|NCT00995020|3915874|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4091766|NCT00995020|3915875|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4091767|NCT00995020|3915873|B3|||Age||years|Mean|44.6|44.6|Standard Deviation|10.6|10.6|||
4091768|NCT00995020|3915874|B2|||Age||years|Mean|45.6|45.6|Standard Deviation|11.5|11.5|||
4091769|NCT00995020|3915875|B1|||Age||years|Mean|43.7|43.7|Standard Deviation|9.9|9.9|||
4091770|NCT00995007|3915884|B3|United States||Region of Enrollment||participants|Number|112|112.0||||||
4091771|NCT00995007|3915885|B2|United States||Region of Enrollment||participants|Number|56|56.0||||||
4091772|NCT00995007|3915886|B1|United States||Region of Enrollment||participants|Number|56|56.0||||||
4091773|NCT00995007|3915884|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4091774|NCT00995007|3915885|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091775|NCT00995007|3915886|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4091776|NCT00995007|3915884|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091777|NCT00995007|3915885|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091778|NCT00995007|3915886|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091779|NCT00995007|3915884|B3||White|Race (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
4091780|NCT00995007|3915885|B2||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4091781|NCT00995007|3915886|B1||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4091782|NCT00995007|3915884|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4091783|NCT00995007|3915885|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4091784|NCT00995007|3915886|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4091785|NCT00995007|3915884|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4091786|NCT00995007|3915885|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091787|NCT00995007|3915886|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4091788|NCT00995007|3915884|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4091789|NCT00995007|3915885|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4091790|NCT00995007|3915886|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091791|NCT00995007|3915884|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4091792|NCT00995007|3915885|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4091793|NCT00995007|3915886|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091794|NCT00995007|3915884|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4091795|NCT00995007|3915885|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091796|NCT00995007|3915886|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4091797|NCT00995007|3915884|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
4091798|NCT00995007|3915885|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4091799|NCT00995007|3915886|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4091800|NCT00995007|3915884|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091801|NCT00995007|3915885|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091802|NCT00995007|3915886|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091803|NCT00995007|3915884|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4091804|NCT00995007|3915885|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4091805|NCT00995007|3915886|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4091806|NCT00995007|3915884|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4091807|NCT00995007|3915885|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4091808|NCT00995007|3915886|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4091809|NCT00995007|3915884|B3|||Age||years|Mean|50.13|50.13|Standard Deviation|12.81|12.81|||
4091810|NCT00995007|3915885|B2|||Age||years|Mean|50.10|50.1|Standard Deviation|12.43|12.43|||
4091811|NCT00995007|3915886|B1|||Age||years|Mean|50.29|50.29|Standard Deviation|13.29|13.29|||
4091812|NCT00995007|3915884|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4091813|NCT00995007|3915885|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4091814|NCT00995007|3915886|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4091815|NCT00995007|3915884|B3||Between 18 and 65 years|Age||Participants|Count of Participants|105|105.0||||||
4091816|NCT00995007|3915885|B2||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4091817|NCT00995007|3915886|B1||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4091818|NCT00995007|3915884|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4091819|NCT00995007|3915885|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4091820|NCT00995007|3915886|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4091821|NCT00994929|3915903|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4091822|NCT00994929|3915903|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4091823|NCT00994929|3915903|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4091824|NCT00994929|3915903|B1|||Age||years|Median|26|26.0|Full Range|||22.0|51.0|
4091825|NCT00994929|3915903|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4091826|NCT00994929|3915903|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4091827|NCT00994929|3915903|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4091828|NCT00994760|3915909|B1|Previous BTP medic./Other reasons||Reason for the use of Instanyl|(multiple reasons possible)|participants|Number|7|7.0||||||
4091829|NCT00994760|3915909|B1|Previous BTP medic./Insufficient tolerability||Reason for the use of Instanyl|(multiple reasons possible)|participants|Number|6|6.0||||||
4091887|NCT00994682|3915949|B2|||Plasma AST||U/L|Mean|47|47.0|Standard Deviation|21|21.0|||
4091830|NCT00994760|3915909|B1|Previous BTP medic./Insufficient handling||Reason for the use of Instanyl|(multiple reasons possible)|participants|Number|12|12.0||||||
4091831|NCT00994760|3915909|B1|Previous BTP medic./Insufficient speed of action||Reason for the use of Instanyl|(multiple reasons possible)|participants|Number|32|32.0||||||
4091832|NCT00994760|3915909|B1|Previous BTP medic./Insufficient efficacy||Reason for the use of Instanyl|(multiple reasons possible)|participants|Number|32|32.0||||||
4091833|NCT00994760|3915909|B1|No previous BTP medication||Reason for the use of Instanyl|(multiple reasons possible)|participants|Number|86|86.0||||||
4091834|NCT00994760|3915909|B1|Missing||ECOG (Eastern Cooperative Oncology Group) performance status (0-4)|ECOG 0 (fully active) ECOG 1 (restricted in strenuous activity, ambulatory) ECOG 2 (ambulatory, up and about more than 50% of waking hours ECOG 3 (limited selfcare, confined to bed > 50% of waking hours ECOG 4 (completely disabled, no selfcare)|participants|Number|6|6.0||||||
4091835|NCT00994760|3915909|B1|ECOG 4||ECOG (Eastern Cooperative Oncology Group) performance status (0-4)|ECOG 0 (fully active) ECOG 1 (restricted in strenuous activity, ambulatory) ECOG 2 (ambulatory, up and about more than 50% of waking hours ECOG 3 (limited selfcare, confined to bed > 50% of waking hours ECOG 4 (completely disabled, no selfcare)|participants|Number|14|14.0||||||
4091836|NCT00994760|3915909|B1|ECOG 3||ECOG (Eastern Cooperative Oncology Group) performance status (0-4)|ECOG 0 (fully active) ECOG 1 (restricted in strenuous activity, ambulatory) ECOG 2 (ambulatory, up and about more than 50% of waking hours ECOG 3 (limited selfcare, confined to bed > 50% of waking hours ECOG 4 (completely disabled, no selfcare)|participants|Number|36|36.0||||||
4091837|NCT00994760|3915909|B1|ECOG 2||ECOG (Eastern Cooperative Oncology Group) performance status (0-4)|ECOG 0 (fully active) ECOG 1 (restricted in strenuous activity, ambulatory) ECOG 2 (ambulatory, up and about more than 50% of waking hours ECOG 3 (limited selfcare, confined to bed > 50% of waking hours ECOG 4 (completely disabled, no selfcare)|participants|Number|40|40.0||||||
4091838|NCT00994760|3915909|B1|ECOG 1||ECOG (Eastern Cooperative Oncology Group) performance status (0-4)|ECOG 0 (fully active) ECOG 1 (restricted in strenuous activity, ambulatory) ECOG 2 (ambulatory, up and about more than 50% of waking hours ECOG 3 (limited selfcare, confined to bed > 50% of waking hours ECOG 4 (completely disabled, no selfcare)|participants|Number|33|33.0||||||
4091839|NCT00994760|3915909|B1|ECOG 0||ECOG (Eastern Cooperative Oncology Group) performance status (0-4)|ECOG 0 (fully active) ECOG 1 (restricted in strenuous activity, ambulatory) ECOG 2 (ambulatory, up and about more than 50% of waking hours ECOG 3 (limited selfcare, confined to bed > 50% of waking hours ECOG 4 (completely disabled, no selfcare)|participants|Number|2|2.0||||||
4091840|NCT00994760|3915909|B1|Missing||American Society of Anesthesiologists (ASA)-physical state (2-5)|"ASA = physical status.~state 2: patient with slight generalized disease~state 3: patient with severe generalized disease~state 4: life threatening generalized disease~state 5: moribund patient, unlikly to survive without operation"|participants|Number|5|5.0||||||
4091841|NCT00994760|3915909|B1|ASA 5||American Society of Anesthesiologists (ASA)-physical state (2-5)|"ASA = physical status.~state 2: patient with slight generalized disease~state 3: patient with severe generalized disease~state 4: life threatening generalized disease~state 5: moribund patient, unlikly to survive without operation"|participants|Number|5|5.0||||||
4091842|NCT00994760|3915909|B1|ASA 4||American Society of Anesthesiologists (ASA)-physical state (2-5)|"ASA = physical status.~state 2: patient with slight generalized disease~state 3: patient with severe generalized disease~state 4: life threatening generalized disease~state 5: moribund patient, unlikly to survive without operation"|participants|Number|59|59.0||||||
4091843|NCT00994760|3915909|B1|ASA 3||American Society of Anesthesiologists (ASA)-physical state (2-5)|"ASA = physical status.~state 2: patient with slight generalized disease~state 3: patient with severe generalized disease~state 4: life threatening generalized disease~state 5: moribund patient, unlikly to survive without operation"|participants|Number|40|40.0||||||
4091844|NCT00994760|3915909|B1|ASA 2||American Society of Anesthesiologists (ASA)-physical state (2-5)|"ASA = physical status.~state 2: patient with slight generalized disease~state 3: patient with severe generalized disease~state 4: life threatening generalized disease~state 5: moribund patient, unlikly to survive without operation"|participants|Number|22|22.0||||||
4091845|NCT00994760|3915909|B1|||Karnofsky-index|"score 0= worst (death) , 100= best (no limitation in health)~Number of valid cases = 125. Number of valid cases = patients with data available."|scores|Mean|58.6|58.6|Standard Deviation|21.6|21.6|||
4091846|NCT00994760|3915909|B1|Missing||Tumor diagnosis (malignant neop-lasms ICD10)||percentage of participants|Number|3.8|3.8||||||
4091847|NCT00994760|3915909|B1|C81-C96 lymphoid, hematopoietic and related tissue||Tumor diagnosis (malignant neop-lasms ICD10)||percentage of participants|Number|0.8|0.8||||||
4091848|NCT00994760|3915909|B1|C76-C80 ill-defined, secondary + unspecified sites||Tumor diagnosis (malignant neop-lasms ICD10)||percentage of participants|Number|0.8|0.8||||||
4091849|NCT00994760|3915909|B1|C73-C75 thyroid and other endocrine glands||Tumor diagnosis (malignant neop-lasms ICD10)||percentage of participants|Number|0.8|0.8||||||
4091850|NCT00994760|3915909|B1|C64-C68 urinary tract||Tumor diagnosis (malignant neop-lasms ICD10)||percentage of participants|Number|5.3|5.3||||||
4091851|NCT00994760|3915909|B1|C60-C63 male genital organs||Tumor diagnosis (malignant neop-lasms ICD10)||percentage of participants|Number|13.0|13.0||||||
4091852|NCT00994760|3915909|B1|C51-C58 female genital organs||Tumor diagnosis (malignant neop-lasms ICD10)||percentage of participants|Number|3.1|3.1||||||
4091853|NCT00994760|3915909|B1|C50-C50 Mamma||Tumor diagnosis (malignant neop-lasms ICD10)||percentage of participants|Number|20.6|20.6||||||
4091854|NCT00994760|3915909|B1|C43-C44 Melanoma and other skin||Tumor diagnosis (malignant neop-lasms ICD10)||percentage of participants|Number|0.8|0.8||||||
4091855|NCT00994760|3915909|B1|C40-C41 bone and articular cartilage||Tumor diagnosis (malignant neop-lasms ICD10)||percentage of participants|Number|0.8|0.8||||||
4091856|NCT00994760|3915909|B1|C30-C39 respiratory and intrathoracic organs||Tumor diagnosis (malignant neop-lasms ICD10)||percentage of participants|Number|16.0|16.0||||||
4091857|NCT00994760|3915909|B1|C15-C26 digestive organs||Tumor diagnosis (malignant neop-lasms ICD10)||percentage of participants|Number|26.0|26.0||||||
4091858|NCT00994760|3915909|B1|C00-C14 lip, oral cavity and pharynx||Tumor diagnosis (malignant neop-lasms ICD10)||percentage of participants|Number|6.1|6.1||||||
4091888|NCT00994682|3915950|B1|||Plasma AST||U/L|Mean|43|43.0|Standard Deviation|22|22.0|||
4091859|NCT00994760|3915909|B1|Pain not caused by tumor||Tumor diagnosis (malignant neop-lasms ICD10)||percentage of participants|Number|2.3|2.3||||||
4091860|NCT00994760|3915909|B1|||Body Mass Index (BMI)|Number of valid cases = 126. Number of valid cases = patients with data available.|kgˆm2|Mean|23.2|23.2|Standard Deviation|4.4|4.4|||
4091861|NCT00994760|3915909|B1|Missing||Sex/Gender, Customized||participants|Number|4|4.0||||||
4091862|NCT00994760|3915909|B1|Male||Sex/Gender, Customized||participants|Number|67|67.0||||||
4091863|NCT00994760|3915909|B1|Female||Sex/Gender, Customized||participants|Number|60|60.0||||||
4091864|NCT00994760|3915909|B1|||Age|Number of valid cases = 130. Number of valid cases = patients with data available.|years|Mean|62.1|62.1|Standard Deviation|12.1|12.1|||
4091865|NCT00994682|3915948|B3|||Diagnosis of definite NASH||participants|Number|87|87.0||||||
4091866|NCT00994682|3915949|B2|||Diagnosis of definite NASH||participants|Number|42|42.0||||||
4091867|NCT00994682|3915950|B1|||Diagnosis of definite NASH||participants|Number|45|45.0||||||
4091868|NCT00994682|3915948|B3|||Fibrosis stage|"Fibrosis: 0 = No fibrosis in liver histology; 1 = Perisinusoidal or periportal, 1A = Mild, zone 3, perisinusoidal delicate fibrosis; 1B = Moderate, zone 3, perisinusoidal dense fibrosis; 1C = Portal/periportal; 2 = Perisinusoidal and portal/periportal; 3 = Bridging fibrosis, 4 = Cirrhosis, with higher scores indicating more severe disease."|units on a scale|Mean|1.0|1.0|Standard Deviation|1.0|1.0|||
4091869|NCT00994682|3915949|B2|||Fibrosis stage|"Fibrosis: 0 = No fibrosis in liver histology; 1 = Perisinusoidal or periportal, 1A = Mild, zone 3, perisinusoidal delicate fibrosis; 1B = Moderate, zone 3, perisinusoidal dense fibrosis; 1C = Portal/periportal; 2 = Perisinusoidal and portal/periportal; 3 = Bridging fibrosis, 4 = Cirrhosis, with higher scores indicating more severe disease."|units on a scale|Mean|1.1|1.1|Standard Deviation|1.1|1.1|||
4091870|NCT00994682|3915950|B1|||Fibrosis stage|"Fibrosis: 0 = No fibrosis in liver histology; 1 = Perisinusoidal or periportal, 1A = Mild, zone 3, perisinusoidal delicate fibrosis; 1B = Moderate, zone 3, perisinusoidal dense fibrosis; 1C = Portal/periportal; 2 = Perisinusoidal and portal/periportal; 3 = Bridging fibrosis, 4 = Cirrhosis, with higher scores indicating more severe disease."|units on a scale|Mean|0.9|0.9|Standard Deviation|0.9|0.9|||
4091871|NCT00994682|3915948|B3|||Ballooning grade|Hepatocyte Ballooning: 0 = No ballooning cells observed in liver histology; 1 = Few balloon cells; 2 = Many cells/prominent ballooning, with higher scores indicating more severe disease.|units on a scale|Mean|0.9|0.9|Standard Deviation|0.4|0.4|||
4091872|NCT00994682|3915949|B2|||Ballooning grade|Hepatocyte Ballooning: 0 = No ballooning cells observed in liver histology; 1 = Few balloon cells; 2 = Many cells/prominent ballooning, with higher scores indicating more severe disease.|units on a scale|Mean|0.8|0.8|Standard Deviation|0.4|0.4|||
4091873|NCT00994682|3915950|B1|||Ballooning grade|Hepatocyte Ballooning: 0 = No ballooning cells observed in liver histology; 1 = Few balloon cells; 2 = Many cells/prominent ballooning, with higher scores indicating more severe disease.|units on a scale|Mean|0.9|0.9|Standard Deviation|0.4|0.4|||
4091874|NCT00994682|3915948|B3|||Inflammation grade|Lobular Inflammation: grade 0 = No foci of inflammatory cells in the liver histology; grade 1 = <2 foci/200x; grade 2 = 2-4 foci/200x, grade 3 = >4 foci/200x, with higher scores indicating more severe disease.|units on a scale|Mean|1.7|1.7|Standard Deviation|0.5|0.5|||
4091875|NCT00994682|3915949|B2|||Inflammation grade|Lobular Inflammation: grade 0 = No foci of inflammatory cells in the liver histology; grade 1 = <2 foci/200x; grade 2 = 2-4 foci/200x, grade 3 = >4 foci/200x, with higher scores indicating more severe disease.|units on a scale|Mean|1.7|1.7|Standard Deviation|0.6|0.6|||
4091876|NCT00994682|3915950|B1|||Inflammation grade|Lobular Inflammation: grade 0 = No foci of inflammatory cells in the liver histology; grade 1 = <2 foci/200x; grade 2 = 2-4 foci/200x, grade 3 = >4 foci/200x, with higher scores indicating more severe disease.|units on a scale|Mean|1.7|1.7|Standard Deviation|0.5|0.5|||
4091877|NCT00994682|3915948|B3|||Steatosis grade|Steatosis: grade 0 = <5% of liver fat by histology; grade 1 = 5-33% liver fat; grade 2 = >33-66% liver fat; 3 = >66% liver fat, with higher scores indicating more severe disease.|units on a scale|Mean|2.0|2.0|Standard Deviation|0.8|0.8|||
4091878|NCT00994682|3915949|B2|||Steatosis grade|Steatosis: grade 0 = <5% of liver fat by histology; grade 1 = 5-33% liver fat; grade 2 = >33-66% liver fat; 3 = >66% liver fat, with higher scores indicating more severe disease.|units on a scale|Mean|2.0|2.0|Standard Deviation|0.8|0.8|||
4091879|NCT00994682|3915950|B1|||Steatosis grade|Steatosis: grade 0 = <5% of liver fat by histology; grade 1 = 5-33% liver fat; grade 2 = >33-66% liver fat; 3 = >66% liver fat, with higher scores indicating more severe disease.|units on a scale|Mean|1.9|1.9|Standard Deviation|0.8|0.8|||
4091880|NCT00994682|3915948|B3|||NAFLD activity score (NAS) Liver histology|"Steatosis: 0 = <5%; 1 = 5-33%; 2 = >33-66%; 3 = >66%. Lobular Inflammation: 0 = No foci 1 = <2 foci/200x; 2 = 2-4 foci/200x, 3 = >4 foci/200x.~Hepatocyte Ballooning: 0 = None; 1 = Few balloon cells; 2 = Many cells/prominent ballooning.~Total NAS score represents the sum of scores for steatosis, lobular inflammation, and ballooning. It is assessed on a scale of 0-8, with higher scores indicating more severe disease."|score on a scale|Mean|4.5|4.5|Standard Deviation|1.3|1.3|||
4091881|NCT00994682|3915949|B2|||NAFLD activity score (NAS) Liver histology|"Steatosis: 0 = <5%; 1 = 5-33%; 2 = >33-66%; 3 = >66%. Lobular Inflammation: 0 = No foci 1 = <2 foci/200x; 2 = 2-4 foci/200x, 3 = >4 foci/200x.~Hepatocyte Ballooning: 0 = None; 1 = Few balloon cells; 2 = Many cells/prominent ballooning.~Total NAS score represents the sum of scores for steatosis, lobular inflammation, and ballooning. It is assessed on a scale of 0-8, with higher scores indicating more severe disease."|score on a scale|Mean|4.5|4.5|Standard Deviation|1.5|1.5|||
4091882|NCT00994682|3915950|B1|||NAFLD activity score (NAS) Liver histology|"Steatosis: 0 = <5%; 1 = 5-33%; 2 = >33-66%; 3 = >66%. Lobular Inflammation: 0 = No foci 1 = <2 foci/200x; 2 = 2-4 foci/200x, 3 = >4 foci/200x.~Hepatocyte Ballooning: 0 = None; 1 = Few balloon cells; 2 = Many cells/prominent ballooning.~Total NAS score represents the sum of scores for steatosis, lobular inflammation, and ballooning. It is assessed on a scale of 0-8, with higher scores indicating more severe disease."|score on a scale|Mean|4.5|4.5|Standard Deviation|1.2|1.2|||
4091883|NCT00994682|3915948|B3|||Plasma ALT||U/L|Mean|60|60.0|Standard Deviation|33|33.0|||
4091884|NCT00994682|3915949|B2|||Plasma ALT||U/L|Mean|62|62.0|Standard Deviation|33|33.0|||
4091885|NCT00994682|3915950|B1|||Plasma ALT||U/L|Mean|57|57.0|Standard Deviation|33|33.0|||
4091886|NCT00994682|3915948|B3|||Plasma AST||U/L|Mean|45|45.0|Standard Deviation|22|22.0|||
4091889|NCT00994682|3915948|B3|||Plasma HDL-C||mg/dl|Mean|37|37.0|Standard Deviation|9|9.0|||
4091890|NCT00994682|3915949|B2|||Plasma HDL-C||mg/dl|Mean|36|36.0|Standard Deviation|9|9.0|||
4091891|NCT00994682|3915950|B1|||Plasma HDL-C||mg/dl|Mean|37|37.0|Standard Deviation|9|9.0|||
4091892|NCT00994682|3915948|B3|||Plasma LDL-C||mg/dl|Mean|109|109.0|Standard Deviation|38|38.0|||
4091893|NCT00994682|3915949|B2|||Plasma LDL-C||mg/dl|Mean|109|109.0|Standard Deviation|44|44.0|||
4091894|NCT00994682|3915950|B1|||Plasma LDL-C||mg/dl|Mean|109|109.0|Standard Deviation|33|33.0|||
4091895|NCT00994682|3915948|B3|||Plasma total cholesterol||mg/dl|Mean|185|185.0|Standard Deviation|44|44.0|||
4091896|NCT00994682|3915949|B2|||Plasma total cholesterol||mg/dl|Mean|187|187.0|Standard Deviation|46|46.0|||
4091897|NCT00994682|3915950|B1|||Plasma total cholesterol||mg/dl|Mean|182|182.0|Standard Deviation|42|42.0|||
4091898|NCT00994682|3915948|B3|||Plasma triglycerides||mg/dl|Mean|201|201.0|Standard Deviation|144|144.0|||
4091899|NCT00994682|3915949|B2|||Plasma triglycerides||mg/dl|Mean|224|224.0|Standard Deviation|171|171.0|||
4091900|NCT00994682|3915950|B1|||Plasma triglycerides||mg/dl|Mean|179|179.0|Standard Deviation|109|109.0|||
4091901|NCT00994682|3915948|B3|||Use of statins||participants|Number|38|38.0||||||
4091902|NCT00994682|3915949|B2|||Use of statins||participants|Number|19|19.0||||||
4091903|NCT00994682|3915950|B1|||Use of statins||participants|Number|19|19.0||||||
4091904|NCT00994682|3915948|B3|Insulin||Use of diabetes medications||participants|Number|11|11.0||||||
4091905|NCT00994682|3915949|B2|Insulin||Use of diabetes medications||participants|Number|5|5.0||||||
4091906|NCT00994682|3915950|B1|Insulin||Use of diabetes medications||participants|Number|6|6.0||||||
4091907|NCT00994682|3915948|B3|Sulfonylurea||Use of diabetes medications||participants|Number|28|28.0||||||
4091908|NCT00994682|3915949|B2|Sulfonylurea||Use of diabetes medications||participants|Number|12|12.0||||||
4091909|NCT00994682|3915950|B1|Sulfonylurea||Use of diabetes medications||participants|Number|16|16.0||||||
4091910|NCT00994682|3915948|B3|Metformin||Use of diabetes medications||participants|Number|36|36.0||||||
4091911|NCT00994682|3915949|B2|Metformin||Use of diabetes medications||participants|Number|19|19.0||||||
4091912|NCT00994682|3915950|B1|Metformin||Use of diabetes medications||participants|Number|17|17.0||||||
4091913|NCT00994682|3915948|B3|||Fasting free fatty acids||mmol/L|Mean|0.52|0.52|Standard Deviation|0.19|0.19|||
4091914|NCT00994682|3915949|B2|||Fasting free fatty acids||mmol/L|Mean|0.49|0.49|Standard Deviation|0.18|0.18|||
4091915|NCT00994682|3915950|B1|||Fasting free fatty acids||mmol/L|Mean|0.54|0.54|Standard Deviation|0.19|0.19|||
4091916|NCT00994682|3915948|B3|||Fasting plasma insulin||μU/mL|Mean|16|16.0|Standard Deviation|11|11.0|||
4091917|NCT00994682|3915949|B2|||Fasting plasma insulin||μU/mL|Mean|15|15.0|Standard Deviation|11|11.0|||
4091918|NCT00994682|3915950|B1|||Fasting plasma insulin||μU/mL|Mean|16|16.0|Standard Deviation|12|12.0|||
4091919|NCT00994682|3915948|B3|||Hemoglobin A1c||percentage|Mean|6.3|6.3|Standard Deviation|1.0|1.0|||
4091920|NCT00994682|3915949|B2|||Hemoglobin A1c||percentage|Mean|6.4|6.4|Standard Deviation|1.0|1.0|||
4091921|NCT00994682|3915950|B1|||Hemoglobin A1c||percentage|Mean|6.3|6.3|Standard Deviation|1.0|1.0|||
4091922|NCT00994682|3915948|B3|||2-hour plasma glucose||mg/dl|Mean|207|207.0|Standard Deviation|71|71.0|||
4091923|NCT00994682|3915949|B2|||2-hour plasma glucose||mg/dl|Mean|211|211.0|Standard Deviation|78|78.0|||
4091924|NCT00994682|3915950|B1|||2-hour plasma glucose||mg/dl|Mean|203|203.0|Standard Deviation|64|64.0|||
4091925|NCT00994682|3915948|B3|||Fasting plasma glucose||mg/dl|Mean|122|122.0|Standard Deviation|28|28.0|||
4091926|NCT00994682|3915949|B2|||Fasting plasma glucose||mg/dl|Mean|124|124.0|Standard Deviation|29|29.0|||
4091927|NCT00994682|3915950|B1|||Fasting plasma glucose||mg/dl|Mean|121|121.0|Standard Deviation|27|27.0|||
4091928|NCT00994682|3915948|B3|||Total body fat|Measured by DXA|percentage of fat mass|Mean|33|33.0|Standard Deviation|7|7.0|||
4091929|NCT00994682|3915949|B2|||Total body fat|Measured by DXA|percentage of fat mass|Mean|33|33.0|Standard Deviation|7|7.0|||
4091930|NCT00994682|3915950|B1|||Total body fat|Measured by DXA|percentage of fat mass|Mean|34|34.0|Standard Deviation|8|8.0|||
4091931|NCT00994682|3915948|B3|||Body mass index||kg/m^2|Mean|34.4|34.4|Standard Deviation|4.8|4.8|||
4091932|NCT00994682|3915949|B2|||Body mass index||kg/m^2|Mean|34.3|34.3|Standard Deviation|4.8|4.8|||
4091933|NCT00994682|3915950|B1|||Body mass index||kg/m^2|Mean|34.5|34.5|Standard Deviation|4.8|4.8|||
4091934|NCT00994682|3915948|B3|||Weight||kg|Mean|98.7|98.7|Standard Deviation|16.7|16.7|||
4091935|NCT00994682|3915949|B2|||Weight||kg|Mean|98.2|98.2|Standard Deviation|16.5|16.5|||
4091936|NCT00994682|3915950|B1|||Weight||kg|Mean|99.2|99.2|Standard Deviation|17.0|17.0|||
4091937|NCT00994682|3915948|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091938|NCT00994682|3915949|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091939|NCT00994682|3915950|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091940|NCT00994682|3915948|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4091941|NCT00994682|3915949|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4091942|NCT00994682|3915950|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4091943|NCT00994682|3915948|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4091944|NCT00994682|3915949|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4091945|NCT00994682|3915950|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4091946|NCT00994682|3915948|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4091947|NCT00994682|3915949|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4091948|NCT00994682|3915950|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4091949|NCT00994682|3915948|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4091950|NCT00994682|3915949|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4091951|NCT00994682|3915950|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4091952|NCT00994682|3915948|B3|||Age||years|Mean|50|50.0|Standard Deviation|11|11.0|||
4091953|NCT00994682|3915949|B2|||Age||years|Mean|52|52.0|Standard Deviation|10|10.0|||
4091954|NCT00994682|3915950|B1|||Age||years|Mean|49|49.0|Standard Deviation|11|11.0|||
4091955|NCT00994643|3915995|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4091956|NCT00994643|3915995|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091957|NCT00994643|3915995|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091958|NCT00994643|3915995|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4091959|NCT00994643|3915995|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091960|NCT00994643|3915995|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091961|NCT00994643|3915995|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091962|NCT00994643|3915995|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091963|NCT00994643|3915995|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4091964|NCT00994643|3915995|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4091965|NCT00994643|3915995|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4091966|NCT00994643|3915995|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4091967|NCT00994643|3915995|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4091968|NCT00994643|3915995|B1|||Age||years|Mean|59.3|59.3|Full Range|||27.0|75.0|
4091969|NCT00994643|3915995|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4091970|NCT00994643|3915995|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4091971|NCT00994643|3915995|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4091972|NCT00994604|3915999|B1||Male|Gender||Participants|Count of Participants|22|22.0||||||
4091973|NCT00994604|3915999|B1||Female|Gender||Participants|Count of Participants|29|29.0||||||
4091974|NCT00994604|3915999|B1|||Age||years|Mean|38|38.0|Standard Deviation|13|13.0|||
4091975|NCT00994461|3916006|B4|Negative||Helicobacter pylori (H. pylori) status||Participants|Number|108|108.0||||||
4091976|NCT00994461|3916007|B3|Negative||Helicobacter pylori (H. pylori) status||Participants|Number|21|21.0||||||
4091977|NCT00994461|3916008|B2|Negative||Helicobacter pylori (H. pylori) status||Participants|Number|43|43.0||||||
4091978|NCT00994461|3916009|B1|Negative||Helicobacter pylori (H. pylori) status||Participants|Number|44|44.0||||||
4091979|NCT00994461|3916006|B4|Positive||Helicobacter pylori (H. pylori) status||Participants|Number|81|81.0||||||
4091980|NCT00994461|3916007|B3|Positive||Helicobacter pylori (H. pylori) status||Participants|Number|16|16.0||||||
4091981|NCT00994461|3916008|B2|Positive||Helicobacter pylori (H. pylori) status||Participants|Number|33|33.0||||||
4091982|NCT00994461|3916009|B1|Positive||Helicobacter pylori (H. pylori) status||Participants|Number|32|32.0||||||
4091983|NCT00994461|3916006|B4||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4091984|NCT00994461|3916007|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4091985|NCT00994461|3916008|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4091986|NCT00994461|3916009|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4091987|NCT00994461|3916006|B4||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4091988|NCT00994461|3916007|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4091989|NCT00994461|3916008|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4091990|NCT00994461|3916009|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4091991|NCT00994461|3916006|B4|||Age||Years|Mean|57.5|57.5|Standard Deviation|9.45|9.45|||
4091992|NCT00994461|3916007|B3|||Age||Years|Mean|59.1|59.1|Standard Deviation|9.18|9.18|||
4091993|NCT00994461|3916008|B2|||Age||Years|Mean|57.8|57.8|Standard Deviation|9.38|9.38|||
4091994|NCT00994461|3916009|B1|||Age||Years|Mean|56.5|56.5|Standard Deviation|9.65|9.65|||
4091995|NCT00994448|3916037|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4091996|NCT00994448|3916038|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4091997|NCT00994448|3916039|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4091998|NCT00994448|3916037|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4091999|NCT00994448|3916038|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092000|NCT00994448|3916039|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092001|NCT00994448|3916037|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092002|NCT00994448|3916038|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092003|NCT00994448|3916039|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092004|NCT00994448|3916037|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4092005|NCT00994448|3916038|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4092006|NCT00994448|3916039|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4092007|NCT00994448|3916037|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092008|NCT00994448|3916038|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092009|NCT00994448|3916039|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092010|NCT00994448|3916037|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4092011|NCT00994448|3916038|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4092012|NCT00994448|3916039|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092013|NCT00994448|3916037|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092014|NCT00994448|3916038|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092015|NCT00994448|3916039|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092016|NCT00994448|3916037|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092017|NCT00994448|3916038|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092018|NCT00994448|3916039|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092019|NCT00994448|3916037|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092020|NCT00994448|3916038|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092021|NCT00994448|3916039|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092022|NCT00994448|3916037|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4092023|NCT00994448|3916038|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4092024|NCT00994448|3916039|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4092025|NCT00994448|3916037|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4092026|NCT00994448|3916038|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4092027|NCT00994448|3916039|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4092028|NCT00994448|3916037|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4092029|NCT00994448|3916038|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4092030|NCT00994448|3916039|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4092031|NCT00994448|3916037|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4092032|NCT00994448|3916038|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4092033|NCT00994448|3916039|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4092034|NCT00994448|3916037|B3|||Age||years|Mean|17.5|17.5|Standard Deviation|1.4|1.4|||
4092035|NCT00994448|3916038|B2|||Age||years|Mean|17.7|17.7|Standard Deviation|1.1|1.1|||
4092036|NCT00994448|3916039|B1|||Age||years|Mean|17.5|17.5|Standard Deviation|1.6|1.6|||
4092037|NCT00994448|3916037|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4092038|NCT00994448|3916038|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4092039|NCT00994448|3916039|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4092040|NCT00994448|3916037|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4092041|NCT00994448|3916038|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4092042|NCT00994448|3916039|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4092043|NCT00994448|3916037|B3||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4092044|NCT00994448|3916038|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4092045|NCT00994448|3916039|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4092046|NCT00994422|3916046|B3|United States||Region of Enrollment||Participants|Number|247|247.0||||||
4092047|NCT00994422|3916047|B2|United States||Region of Enrollment||Participants|Number|55|55.0||||||
4092048|NCT00994422|3916048|B1|United States||Region of Enrollment||Participants|Number|192|192.0||||||
4092049|NCT00994422|3916046|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4092050|NCT00994422|3916047|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4092051|NCT00994422|3916048|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4092052|NCT00994422|3916046|B3||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4092053|NCT00994422|3916047|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4092054|NCT00994422|3916048|B1||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4092055|NCT00994422|3916046|B3|||Age||Years|Mean|16.76|16.76|Standard Deviation|13.32|13.32|||
4092056|NCT00994422|3916047|B2|||Age||Years|Mean|19.6|19.6|Standard Deviation|14.4|14.4|||
4092057|NCT00994422|3916048|B1|||Age||Years|Mean|15.9|15.9|Standard Deviation|12.9|12.9|||
4092058|NCT00994422|3916046|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4092059|NCT00994422|3916047|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4092060|NCT00994422|3916048|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4092061|NCT00994422|3916046|B3||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4092062|NCT00994422|3916047|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4092063|NCT00994422|3916048|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4092064|NCT00994422|3916046|B3||<=18 years|Age||Participants|Count of Participants|182|182.0||||||
4092065|NCT00994422|3916047|B2||<=18 years|Age||Participants|Count of Participants|35|35.0||||||
4092066|NCT00994422|3916048|B1||<=18 years|Age||Participants|Count of Participants|147|147.0||||||
4092067|NCT00994318|3916059|B4|Spain||Region of Enrollment||participants|Number|18|18.0||||||
4092068|NCT00994318|3916060|B3|Spain||Region of Enrollment||participants|Number|10|10.0||||||
4092069|NCT00994318|3916061|B2|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4092070|NCT00994318|3916062|B1|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4092071|NCT00994318|3916059|B4|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
4092072|NCT00994318|3916060|B3|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
4092073|NCT00994318|3916061|B2|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
4092074|NCT00994318|3916062|B1|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
4092075|NCT00994318|3916059|B4|Norway||Region of Enrollment||participants|Number|5|5.0||||||
4092076|NCT00994318|3916060|B3|Norway||Region of Enrollment||participants|Number|4|4.0||||||
4092077|NCT00994318|3916061|B2|Norway||Region of Enrollment||participants|Number|1|1.0||||||
4092078|NCT00994318|3916062|B1|Norway||Region of Enrollment||participants|Number|0|0.0||||||
4092079|NCT00994318|3916059|B4|Netherlands||Region of Enrollment||participants|Number|16|16.0||||||
4092080|NCT00994318|3916060|B3|Netherlands||Region of Enrollment||participants|Number|8|8.0||||||
4092081|NCT00994318|3916061|B2|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
4092082|NCT00994318|3916062|B1|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
4092083|NCT00994318|3916059|B4|Germany||Region of Enrollment||participants|Number|100|100.0||||||
4092084|NCT00994318|3916060|B3|Germany||Region of Enrollment||participants|Number|49|49.0||||||
4092085|NCT00994318|3916061|B2|Germany||Region of Enrollment||participants|Number|25|25.0||||||
4092086|NCT00994318|3916062|B1|Germany||Region of Enrollment||participants|Number|26|26.0||||||
4092087|NCT00994318|3916059|B4|Denmark||Region of Enrollment||participants|Number|4|4.0||||||
4092088|NCT00994318|3916060|B3|Denmark||Region of Enrollment||participants|Number|2|2.0||||||
4092089|NCT00994318|3916061|B2|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
4092090|NCT00994318|3916062|B1|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
4092091|NCT00994318|3916059|B4|Australia||Region of Enrollment||participants|Number|62|62.0||||||
4092092|NCT00994318|3916060|B3|Australia||Region of Enrollment||participants|Number|31|31.0||||||
4092093|NCT00994318|3916061|B2|Australia||Region of Enrollment||participants|Number|16|16.0||||||
4092094|NCT00994318|3916062|B1|Australia||Region of Enrollment||participants|Number|15|15.0||||||
4092095|NCT00994318|3916059|B4|Romania||Region of Enrollment||participants|Number|8|8.0||||||
4092096|NCT00994318|3916060|B3|Romania||Region of Enrollment||participants|Number|4|4.0||||||
4092097|NCT00994318|3916061|B2|Romania||Region of Enrollment||participants|Number|2|2.0||||||
4092098|NCT00994318|3916062|B1|Romania||Region of Enrollment||participants|Number|2|2.0||||||
4092099|NCT00994318|3916059|B4|Poland||Region of Enrollment||participants|Number|42|42.0||||||
4092100|NCT00994318|3916060|B3|Poland||Region of Enrollment||participants|Number|20|20.0||||||
4092101|NCT00994318|3916061|B2|Poland||Region of Enrollment||participants|Number|11|11.0||||||
4092102|NCT00994318|3916062|B1|Poland||Region of Enrollment||participants|Number|11|11.0||||||
4092103|NCT00994318|3916059|B4|Belgium||Region of Enrollment||participants|Number|10|10.0||||||
4092104|NCT00994318|3916060|B3|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
4092105|NCT00994318|3916061|B2|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
4092106|NCT00994318|3916062|B1|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
4092107|NCT00994318|3916059|B4|Czech Republic||Region of Enrollment||participants|Number|62|62.0||||||
4092108|NCT00994318|3916060|B3|Czech Republic||Region of Enrollment||participants|Number|31|31.0||||||
4092109|NCT00994318|3916061|B2|Czech Republic||Region of Enrollment||participants|Number|15|15.0||||||
4092110|NCT00994318|3916062|B1|Czech Republic||Region of Enrollment||participants|Number|16|16.0||||||
4092111|NCT00994318|3916059|B4|France||Region of Enrollment||participants|Number|4|4.0||||||
4092112|NCT00994318|3916060|B3|France||Region of Enrollment||participants|Number|3|3.0||||||
4092113|NCT00994318|3916061|B2|France||Region of Enrollment||participants|Number|0|0.0||||||
4092114|NCT00994318|3916062|B1|France||Region of Enrollment||participants|Number|1|1.0||||||
4092115|NCT00994318|3916059|B4|Italy||Region of Enrollment||participants|Number|39|39.0||||||
4092116|NCT00994318|3916060|B3|Italy||Region of Enrollment||participants|Number|19|19.0||||||
4092117|NCT00994318|3916061|B2|Italy||Region of Enrollment||participants|Number|10|10.0||||||
4092118|NCT00994318|3916062|B1|Italy||Region of Enrollment||participants|Number|10|10.0||||||
4092119|NCT00994318|3916059|B4|United Kingdom||Region of Enrollment||participants|Number|71|71.0||||||
4092120|NCT00994318|3916060|B3|United Kingdom||Region of Enrollment||participants|Number|36|36.0||||||
4092121|NCT00994318|3916061|B2|United Kingdom||Region of Enrollment||participants|Number|18|18.0||||||
4092122|NCT00994318|3916062|B1|United Kingdom||Region of Enrollment||participants|Number|17|17.0||||||
4092123|NCT00994318|3916059|B4|Austria||Region of Enrollment||participants|Number|8|8.0||||||
4092124|NCT00994318|3916060|B3|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4092125|NCT00994318|3916061|B2|Austria||Region of Enrollment||participants|Number|2|2.0||||||
4092126|NCT00994318|3916062|B1|Austria||Region of Enrollment||participants|Number|2|2.0||||||
4092127|NCT00994318|3916059|B4|Turkey||Region of Enrollment||participants|Number|29|29.0||||||
4092128|NCT00994318|3916060|B3|Turkey||Region of Enrollment||participants|Number|15|15.0||||||
4092129|NCT00994318|3916061|B2|Turkey||Region of Enrollment||participants|Number|7|7.0||||||
4092130|NCT00994318|3916062|B1|Turkey||Region of Enrollment||participants|Number|7|7.0||||||
4092131|NCT00994318|3916059|B4|Greece||Region of Enrollment||participants|Number|111|111.0||||||
4092132|NCT00994318|3916060|B3|Greece||Region of Enrollment||participants|Number|55|55.0||||||
4092133|NCT00994318|3916061|B2|Greece||Region of Enrollment||participants|Number|28|28.0||||||
4092134|NCT00994318|3916062|B1|Greece||Region of Enrollment||participants|Number|28|28.0||||||
4092135|NCT00994318|3916059|B4|Portugal||Region of Enrollment||participants|Number|9|9.0||||||
4092136|NCT00994318|3916060|B3|Portugal||Region of Enrollment||participants|Number|5|5.0||||||
4092137|NCT00994318|3916061|B2|Portugal||Region of Enrollment||participants|Number|2|2.0||||||
4092138|NCT00994318|3916062|B1|Portugal||Region of Enrollment||participants|Number|2|2.0||||||
4092139|NCT00994318|3916059|B4|United States||Region of Enrollment||participants|Number|14|14.0||||||
4092140|NCT00994318|3916060|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4092141|NCT00994318|3916061|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4092142|NCT00994318|3916062|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4092143|NCT00994318|3916059|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092144|NCT00994318|3916060|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092145|NCT00994318|3916061|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092146|NCT00994318|3916062|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092147|NCT00994318|3916059|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092148|NCT00994318|3916060|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092149|NCT00994318|3916061|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092150|NCT00994318|3916062|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092151|NCT00994318|3916059|B4||White|Race (NIH/OMB)||Participants|Count of Participants|584|584.0||||||
4092152|NCT00994318|3916060|B3||White|Race (NIH/OMB)||Participants|Count of Participants|291|291.0||||||
4092153|NCT00994318|3916061|B2||White|Race (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
4092154|NCT00994318|3916062|B1||White|Race (NIH/OMB)||Participants|Count of Participants|149|149.0||||||
4092155|NCT00994318|3916059|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4092156|NCT00994318|3916060|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4092157|NCT00994318|3916061|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4092158|NCT00994318|3916062|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4092159|NCT00994318|3916059|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4092160|NCT00994318|3916060|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4092161|NCT00994318|3916061|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092162|NCT00994318|3916062|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092163|NCT00994318|3916059|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4092164|NCT00994318|3916060|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4092165|NCT00994318|3916061|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4092166|NCT00994318|3916062|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4092167|NCT00994318|3916059|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092168|NCT00994318|3916060|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092169|NCT00994318|3916061|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092170|NCT00994318|3916062|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092171|NCT00994318|3916059|B4||Male|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
4092172|NCT00994318|3916060|B3||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4092173|NCT00994318|3916061|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4092174|NCT00994318|3916062|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4092175|NCT00994318|3916059|B4||Female|Sex: Female, Male||Participants|Count of Participants|381|381.0||||||
4092176|NCT00994318|3916060|B3||Female|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4092177|NCT00994318|3916061|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4092178|NCT00994318|3916062|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4092179|NCT00994318|3916059|B4|||Age||years|Mean|69.07|69.07|Standard Deviation|13.172|13.172|||
4092180|NCT00994318|3916060|B3|||Age||years|Mean|69.31|69.31|Standard Deviation|13.404|13.404|||
4092181|NCT00994318|3916061|B2|||Age||years|Mean|68.19|68.19|Standard Deviation|13.264|13.264|||
4092182|NCT00994318|3916062|B1|||Age||years|Mean|69.46|69.46|Standard Deviation|12.643|12.643|||
4092183|NCT00994318|3916059|B4||>=65 years|Age||Participants|Count of Participants|431|431.0||||||
4092184|NCT00994318|3916060|B3||>=65 years|Age||Participants|Count of Participants|216|216.0||||||
4092185|NCT00994318|3916061|B2||>=65 years|Age||Participants|Count of Participants|103|103.0||||||
4092186|NCT00994318|3916062|B1||>=65 years|Age||Participants|Count of Participants|112|112.0||||||
4092187|NCT00994318|3916059|B4||Between 18 and 65 years|Age||Participants|Count of Participants|182|182.0||||||
4092188|NCT00994318|3916060|B3||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
4092189|NCT00994318|3916061|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4092190|NCT00994318|3916062|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4092191|NCT00994318|3916059|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4092192|NCT00994318|3916060|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4092193|NCT00994318|3916061|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4092194|NCT00994318|3916062|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4092195|NCT00994279|3916072|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4092196|NCT00994279|3916073|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4092197|NCT00994279|3916074|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4092198|NCT00994279|3916072|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092199|NCT00994279|3916073|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092200|NCT00994279|3916074|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092201|NCT00994279|3916072|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092202|NCT00994279|3916073|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092203|NCT00994279|3916074|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092204|NCT00994279|3916072|B3||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4092205|NCT00994279|3916073|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4092206|NCT00994279|3916074|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4092207|NCT00994279|3916072|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4092208|NCT00994279|3916073|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4092209|NCT00994279|3916074|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4092210|NCT00994279|3916072|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092211|NCT00994279|3916073|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092212|NCT00994279|3916074|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092213|NCT00994279|3916072|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092214|NCT00994279|3916073|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092215|NCT00994279|3916074|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092216|NCT00994279|3916072|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092217|NCT00994279|3916073|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092218|NCT00994279|3916074|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092219|NCT00994279|3916072|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092220|NCT00994279|3916073|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092221|NCT00994279|3916074|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092222|NCT00994279|3916072|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4092223|NCT00994279|3916073|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4092224|NCT00994279|3916074|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4092225|NCT00994279|3916072|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092226|NCT00994279|3916073|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092227|NCT00994279|3916074|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092228|NCT00994279|3916072|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4092229|NCT00994279|3916073|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4092230|NCT00994279|3916074|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4092231|NCT00994279|3916072|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4092232|NCT00994279|3916073|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4092233|NCT00994279|3916074|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4092234|NCT00994279|3916072|B3|||Age||years|Median|47|47.0|Full Range|||29.0|83.0|
4092235|NCT00994279|3916073|B2|||Age||years|Median|45|45.0|Full Range|||29.0|64.0|
4092236|NCT00994279|3916074|B1|||Age||years|Median|50|50.0|Full Range|||29.0|83.0|
4092237|NCT00994279|3916072|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4092238|NCT00994279|3916073|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4092239|NCT00994279|3916074|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4092240|NCT00994279|3916072|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4092241|NCT00994279|3916073|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4092242|NCT00994279|3916074|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4092243|NCT00994279|3916072|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4092244|NCT00994279|3916073|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4092245|NCT00994279|3916074|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4092246|NCT00994240|3916083|B3|United States||Region of Enrollment||participants|Number|85|85.0||||||
4092247|NCT00994240|3916084|B2|United States||Region of Enrollment||participants|Number|44|44.0||||||
4092248|NCT00994240|3916085|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4092249|NCT00994240|3916083|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4092250|NCT00994240|3916084|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4092251|NCT00994240|3916085|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4092252|NCT00994240|3916083|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4092253|NCT00994240|3916084|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4092254|NCT00994240|3916085|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4092255|NCT00994240|3916083|B3||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4092256|NCT00994240|3916084|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4092257|NCT00994240|3916085|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4092258|NCT00994240|3916083|B3||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4092259|NCT00994240|3916084|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4092260|NCT00994240|3916085|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4092261|NCT00994240|3916083|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4092262|NCT00994240|3916084|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4092263|NCT00994240|3916085|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4092264|NCT00994214|3916092|B5|||Ring Finger Circumference||mm|Mean|69.53|69.53|Standard Deviation|5.75|5.75|||
4092265|NCT00994214|3916093|B4|||Ring Finger Circumference||mm|Mean|68.4|68.4|Standard Deviation|6.3|6.3|||
4092266|NCT00994214|3916094|B3|||Ring Finger Circumference||mm|Mean|71.2|71.2|Standard Deviation|4.7|4.7|||
4092267|NCT00994214|3916095|B2|||Ring Finger Circumference||mm|Mean|68.5|68.5|Standard Deviation|6.2|6.2|||
4092268|NCT00994214|3916096|B1|||Ring Finger Circumference||mm|Mean|70.2|70.2|Standard Deviation|5.6|5.6|||
4092269|NCT00994214|3916092|B5|Post-menopausal female(n=A:6,B:9,C:2,D:6,&Totl:23)||Baseline Prolactin||μg/L|Mean|15.85|15.85|Standard Deviation|25.89|25.89|||
4092270|NCT00994214|3916093|B4|Post-menopausal female(n=A:6,B:9,C:2,D:6,&Totl:23)||Baseline Prolactin||μg/L|Mean|25.118|25.118|Standard Deviation|39.986|39.986|||
4092271|NCT00994214|3916094|B3|Post-menopausal female(n=A:6,B:9,C:2,D:6,&Totl:23)||Baseline Prolactin||μg/L|Mean|7.870|7.87|Standard Deviation|0.693|0.693|||
4092272|NCT00994214|3916095|B2|Post-menopausal female(n=A:6,B:9,C:2,D:6,&Totl:23)||Baseline Prolactin||μg/L|Mean|16.409|16.409|Standard Deviation|24.232|24.232|||
4092273|NCT00994214|3916096|B1|Post-menopausal female(n=A:6,B:9,C:2,D:6,&Totl:23)||Baseline Prolactin||μg/L|Mean|8.420|8.42|Standard Deviation|3.167|3.167|||
4092274|NCT00994214|3916092|B5|Pre-menopausal female(n=A:4,B:4,C:4,D:7,&Totl:19)||Baseline Prolactin||μg/L|Mean|25.88|25.88|Standard Deviation|21.94|21.94|||
4092275|NCT00994214|3916093|B4|Pre-menopausal female(n=A:4,B:4,C:4,D:7,&Totl:19)||Baseline Prolactin||μg/L|Mean|23.634|23.634|Standard Deviation|23.778|23.778|||
4092276|NCT00994214|3916094|B3|Pre-menopausal female(n=A:4,B:4,C:4,D:7,&Totl:19)||Baseline Prolactin||μg/L|Mean|35.608|35.608|Standard Deviation|25.536|25.536|||
4092277|NCT00994214|3916095|B2|Pre-menopausal female(n=A:4,B:4,C:4,D:7,&Totl:19)||Baseline Prolactin||μg/L|Mean|26.158|26.158|Standard Deviation|19.798|19.798|||
4092278|NCT00994214|3916096|B1|Pre-menopausal female(n=A:4,B:4,C:4,D:7,&Totl:19)||Baseline Prolactin||μg/L|Mean|19.838|19.838|Standard Deviation|15.247|15.247|||
4092279|NCT00994214|3916092|B5|Males (n=A:9,B:6,C:12, D:7, and Total:34)||Baseline Prolactin||μg/L|Mean|40.86|40.86|Standard Deviation|72.52|72.52|||
4092280|NCT00994214|3916093|B4|Males (n=A:9,B:6,C:12, D:7, and Total:34)||Baseline Prolactin||μg/L|Mean|83.036|83.036|Standard Deviation|131.024|131.024|||
4092281|NCT00994214|3916094|B3|Males (n=A:9,B:6,C:12, D:7, and Total:34)||Baseline Prolactin||μg/L|Mean|41.657|41.657|Standard Deviation|60.965|60.965|||
4092282|NCT00994214|3916095|B2|Males (n=A:9,B:6,C:12, D:7, and Total:34)||Baseline Prolactin||μg/L|Mean|34.113|34.113|Standard Deviation|49.588|49.588|||
4092283|NCT00994214|3916096|B1|Males (n=A:9,B:6,C:12, D:7, and Total:34)||Baseline Prolactin||μg/L|Mean|11.506|11.506|Standard Deviation|14.233|14.233|||
4092284|NCT00994214|3916092|B5|||Growth Hormone (GH)||ng/mL|Mean|23.21|23.21|Standard Deviation|55.54|55.54|||
4092285|NCT00994214|3916093|B4|||Growth Hormone (GH)||ng/mL|Mean|26.59|26.59|Standard Deviation|63.47|63.47|||
4092286|NCT00994214|3916094|B3|||Growth Hormone (GH)||ng/mL|Mean|28.60|28.6|Standard Deviation|64.83|64.83|||
4092287|NCT00994214|3916095|B2|||Growth Hormone (GH)||ng/mL|Mean|20.99|20.99|Standard Deviation|59.28|59.28|||
4092288|NCT00994214|3916096|B1|||Growth Hormone (GH)||ng/mL|Mean|16.79|16.79|Standard Deviation|24.56|24.56|||
4092289|NCT00994214|3916092|B5|||Insulin-like growth factor 1 (IGF-1)||Percentage of ULN(Upper limit of number)|Median|333|333.0|Full Range|||146.0|690.0|
4092290|NCT00994214|3916093|B4|||Insulin-like growth factor 1 (IGF-1)||Percentage of ULN(Upper limit of number)|Median|335|335.0|Full Range|||157.0|539.0|
4092291|NCT00994214|3916094|B3|||Insulin-like growth factor 1 (IGF-1)||Percentage of ULN(Upper limit of number)|Median|382|382.0|Full Range|||168.0|549.0|
4092292|NCT00994214|3916095|B2|||Insulin-like growth factor 1 (IGF-1)||Percentage of ULN(Upper limit of number)|Median|315|315.0|Full Range|||176.0|508.0|
4092293|NCT00994214|3916096|B1|||Insulin-like growth factor 1 (IGF-1)||Percentage of ULN(Upper limit of number)|Median|307|307.0|Full Range|||146.0|690.0|
4092294|NCT00994214|3916092|B5|Non-diabetic||Diabetic status at entry||Participants|Number|69|69.0||||||
4092295|NCT00994214|3916093|B4|Non-diabetic||Diabetic status at entry||Participants|Number|18|18.0||||||
4092296|NCT00994214|3916094|B3|Non-diabetic||Diabetic status at entry||Participants|Number|16|16.0||||||
4092297|NCT00994214|3916095|B2|Non-diabetic||Diabetic status at entry||Participants|Number|18|18.0||||||
4092298|NCT00994214|3916096|B1|Non-diabetic||Diabetic status at entry||Participants|Number|17|17.0||||||
4092299|NCT00994214|3916092|B5|Diabetic||Diabetic status at entry||Participants|Number|7|7.0||||||
4092300|NCT00994214|3916093|B4|Diabetic||Diabetic status at entry||Participants|Number|2|2.0||||||
4092301|NCT00994214|3916094|B3|Diabetic||Diabetic status at entry||Participants|Number|2|2.0||||||
4092302|NCT00994214|3916095|B2|Diabetic||Diabetic status at entry||Participants|Number|1|1.0||||||
4092303|NCT00994214|3916096|B1|Diabetic||Diabetic status at entry||Participants|Number|2|2.0||||||
4092304|NCT00994214|3916092|B5|||Height||cm|Mean|170.3|170.3|Standard Deviation|10.4|10.4|||
4092305|NCT00994214|3916093|B4|||Height||cm|Mean|166.4|166.4|Standard Deviation|8.6|8.6|||
4092306|NCT00994214|3916094|B3|||Height||cm|Mean|175.0|175.0|Standard Deviation|10.1|10.1|||
4092307|NCT00994214|3916095|B2|||Height||cm|Mean|170.3|170.3|Standard Deviation|13.2|13.2|||
4092308|NCT00994214|3916096|B1|||Height||cm|Mean|170.1|170.1|Standard Deviation|8.1|8.1|||
4092309|NCT00994214|3916092|B5|Sweden||Region of Enrollment|ITT population|Participants|Number|1|1.0||||||
4092310|NCT00994214|3916093|B4|Sweden||Region of Enrollment|ITT population|Participants|Number|0|0.0||||||
4092311|NCT00994214|3916094|B3|Sweden||Region of Enrollment|ITT population|Participants|Number|1|1.0||||||
4092312|NCT00994214|3916095|B2|Sweden||Region of Enrollment|ITT population|Participants|Number|0|0.0||||||
4092313|NCT00994214|3916096|B1|Sweden||Region of Enrollment|ITT population|Participants|Number|0|0.0||||||
4092314|NCT00994214|3916092|B5|Latvia||Region of Enrollment|ITT population|Participants|Number|1|1.0||||||
4092315|NCT00994214|3916093|B4|Latvia||Region of Enrollment|ITT population|Participants|Number|0|0.0||||||
4092316|NCT00994214|3916094|B3|Latvia||Region of Enrollment|ITT population|Participants|Number|1|1.0||||||
4092317|NCT00994214|3916095|B2|Latvia||Region of Enrollment|ITT population|Participants|Number|0|0.0||||||
4092318|NCT00994214|3916096|B1|Latvia||Region of Enrollment|ITT population|Participants|Number|0|0.0||||||
4092319|NCT00994214|3916092|B5|United States||Region of Enrollment|ITT population|Participants|Number|3|3.0||||||
4092320|NCT00994214|3916093|B4|United States||Region of Enrollment|ITT population|Participants|Number|0|0.0||||||
4092321|NCT00994214|3916094|B3|United States||Region of Enrollment|ITT population|Participants|Number|1|1.0||||||
4092322|NCT00994214|3916095|B2|United States||Region of Enrollment|ITT population|Participants|Number|2|2.0||||||
4092323|NCT00994214|3916096|B1|United States||Region of Enrollment|ITT population|Participants|Number|0|0.0||||||
4092324|NCT00994214|3916092|B5|France||Region of Enrollment|ITT population|Participants|Number|2|2.0||||||
4092325|NCT00994214|3916093|B4|France||Region of Enrollment|ITT population|Participants|Number|1|1.0||||||
4092326|NCT00994214|3916094|B3|France||Region of Enrollment|ITT population|Participants|Number|0|0.0||||||
4092327|NCT00994214|3916095|B2|France||Region of Enrollment|ITT population|Participants|Number|1|1.0||||||
4092328|NCT00994214|3916096|B1|France||Region of Enrollment|ITT population|Participants|Number|0|0.0||||||
4092329|NCT00994214|3916092|B5|Ukraine||Region of Enrollment|ITT population|Participants|Number|20|20.0||||||
4092330|NCT00994214|3916093|B4|Ukraine||Region of Enrollment|ITT population|Participants|Number|6|6.0||||||
4092331|NCT00994214|3916094|B3|Ukraine||Region of Enrollment|ITT population|Participants|Number|4|4.0||||||
4092332|NCT00994214|3916095|B2|Ukraine||Region of Enrollment|ITT population|Participants|Number|4|4.0||||||
4092333|NCT00994214|3916096|B1|Ukraine||Region of Enrollment|ITT population|Participants|Number|6|6.0||||||
4092334|NCT00994214|3916092|B5|Romania||Region of Enrollment|ITT population|Participants|Number|12|12.0||||||
4092335|NCT00994214|3916093|B4|Romania||Region of Enrollment|ITT population|Participants|Number|4|4.0||||||
4092336|NCT00994214|3916094|B3|Romania||Region of Enrollment|ITT population|Participants|Number|1|1.0||||||
4092337|NCT00994214|3916095|B2|Romania||Region of Enrollment|ITT population|Participants|Number|3|3.0||||||
4092338|NCT00994214|3916096|B1|Romania||Region of Enrollment|ITT population|Participants|Number|4|4.0||||||
4092339|NCT00994214|3916092|B5|Poland||Region of Enrollment|ITT population|Participants|Number|2|2.0||||||
4092340|NCT00994214|3916093|B4|Poland||Region of Enrollment|ITT population|Participants|Number|0|0.0||||||
4092341|NCT00994214|3916094|B3|Poland||Region of Enrollment|ITT population|Participants|Number|0|0.0||||||
4092342|NCT00994214|3916095|B2|Poland||Region of Enrollment|ITT population|Participants|Number|1|1.0||||||
4092343|NCT00994214|3916096|B1|Poland||Region of Enrollment|ITT population|Participants|Number|1|1.0||||||
4092344|NCT00994214|3916092|B5|Netherlands||Region of Enrollment|ITT population|Participants|Number|3|3.0||||||
4092345|NCT00994214|3916093|B4|Netherlands||Region of Enrollment|ITT population|Participants|Number|1|1.0||||||
4092346|NCT00994214|3916094|B3|Netherlands||Region of Enrollment|ITT population|Participants|Number|0|0.0||||||
4092347|NCT00994214|3916095|B2|Netherlands||Region of Enrollment|ITT population|Participants|Number|0|0.0||||||
4092348|NCT00994214|3916096|B1|Netherlands||Region of Enrollment|ITT population|Participants|Number|2|2.0||||||
4092349|NCT00994214|3916092|B5|Mexico||Region of Enrollment|ITT population|Participants|Number|11|11.0||||||
4092350|NCT00994214|3916093|B4|Mexico||Region of Enrollment|ITT population|Participants|Number|1|1.0||||||
4092351|NCT00994214|3916094|B3|Mexico||Region of Enrollment|ITT population|Participants|Number|4|4.0||||||
4092352|NCT00994214|3916095|B2|Mexico||Region of Enrollment|ITT population|Participants|Number|4|4.0||||||
4092353|NCT00994214|3916096|B1|Mexico||Region of Enrollment|ITT population|Participants|Number|2|2.0||||||
4092354|NCT00994214|3916092|B5|Lithuania||Region of Enrollment|ITT population|Participants|Number|6|6.0||||||
4092355|NCT00994214|3916093|B4|Lithuania||Region of Enrollment|ITT population|Participants|Number|1|1.0||||||
4092356|NCT00994214|3916094|B3|Lithuania||Region of Enrollment|ITT population|Participants|Number|3|3.0||||||
4092357|NCT00994214|3916095|B2|Lithuania||Region of Enrollment|ITT population|Participants|Number|1|1.0||||||
4092358|NCT00994214|3916096|B1|Lithuania||Region of Enrollment|ITT population|Participants|Number|1|1.0||||||
4092359|NCT00994214|3916092|B5|Czech Republic||Region of Enrollment|ITT population|Participants|Number|3|3.0||||||
4092360|NCT00994214|3916093|B4|Czech Republic||Region of Enrollment|ITT population|Participants|Number|1|1.0||||||
4092361|NCT00994214|3916094|B3|Czech Republic||Region of Enrollment|ITT population|Participants|Number|0|0.0||||||
4092362|NCT00994214|3916095|B2|Czech Republic||Region of Enrollment|ITT population|Participants|Number|1|1.0||||||
4092363|NCT00994214|3916096|B1|Czech Republic||Region of Enrollment|ITT population|Participants|Number|1|1.0||||||
4092364|NCT00994214|3916092|B5|Brazil||Region of Enrollment|ITT population|Participants|Number|10|10.0||||||
4092365|NCT00994214|3916093|B4|Brazil||Region of Enrollment|ITT population|Participants|Number|5|5.0||||||
4092366|NCT00994214|3916094|B3|Brazil||Region of Enrollment|ITT population|Participants|Number|3|3.0||||||
4092367|NCT00994214|3916095|B2|Brazil||Region of Enrollment|ITT population|Participants|Number|1|1.0||||||
4092368|NCT00994214|3916096|B1|Brazil||Region of Enrollment|ITT population|Participants|Number|1|1.0||||||
4092369|NCT00994214|3916092|B5|Belgium||Region of Enrollment|ITT population|Participants|Number|2|2.0||||||
4092370|NCT00994214|3916093|B4|Belgium||Region of Enrollment|ITT population|Participants|Number|0|0.0||||||
4092371|NCT00994214|3916094|B3|Belgium||Region of Enrollment|ITT population|Participants|Number|0|0.0||||||
4092372|NCT00994214|3916095|B2|Belgium||Region of Enrollment|ITT population|Participants|Number|1|1.0||||||
4092373|NCT00994214|3916096|B1|Belgium||Region of Enrollment|ITT population|Participants|Number|1|1.0||||||
4092374|NCT00994214|3916092|B5|Multiple race||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4092375|NCT00994214|3916093|B4|Multiple race||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4092376|NCT00994214|3916094|B3|Multiple race||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4092377|NCT00994214|3916095|B2|Multiple race||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4092378|NCT00994214|3916096|B1|Multiple race||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4092379|NCT00994214|3916092|B5|Caucasian/White||Race/Ethnicity, Customized||Participants|Number|62|62.0||||||
4092380|NCT00994214|3916093|B4|Caucasian/White||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4092381|NCT00994214|3916094|B3|Caucasian/White||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4092382|NCT00994214|3916095|B2|Caucasian/White||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4092383|NCT00994214|3916096|B1|Caucasian/White||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4092384|NCT00994214|3916092|B5||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4092385|NCT00994214|3916093|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4092386|NCT00994214|3916094|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4092387|NCT00994214|3916095|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4092388|NCT00994214|3916096|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4092389|NCT00994214|3916092|B5||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4092390|NCT00994214|3916093|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4092391|NCT00994214|3916094|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4092392|NCT00994214|3916095|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4092393|NCT00994214|3916096|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4092394|NCT00994214|3916092|B5|||Age||Years|Mean|43.8|43.8|Standard Deviation|11.9|11.9|||
4092395|NCT00994214|3916093|B4|||Age||Years|Mean|43.4|43.4|Standard Deviation|12.9|12.9|||
4092396|NCT00994214|3916094|B3|||Age||Years|Mean|40.3|40.3|Standard Deviation|11.3|11.3|||
4092397|NCT00994214|3916095|B2|||Age||Years|Mean|48.7|48.7|Standard Deviation|11.2|11.2|||
4092398|NCT00994214|3916096|B1|||Age||Years|Mean|42.8|42.8|Standard Deviation|11.3|11.3|||
4092399|NCT00994175|3916143|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092400|NCT00994175|3916143|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4092401|NCT00994175|3916143|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4092402|NCT00994175|3916143|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4092403|NCT00994175|3916143|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092404|NCT00994175|3916143|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4092405|NCT00994175|3916143|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092406|NCT00994175|3916143|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092407|NCT00994175|3916143|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4092408|NCT00994175|3916143|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4092409|NCT00994175|3916143|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4092410|NCT00994175|3916143|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4092411|NCT00994175|3916143|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4092412|NCT00994175|3916143|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4092413|NCT00994175|3916143|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4092414|NCT00994123|3916152|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092415|NCT00994123|3916153|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092416|NCT00994123|3916154|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092417|NCT00994123|3916155|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092418|NCT00994123|3916152|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092419|NCT00994123|3916153|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092420|NCT00994123|3916154|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092421|NCT00994123|3916155|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092422|NCT00994123|3916152|B4||White|Race (NIH/OMB)||Participants|Count of Participants|141|141.0||||||
4092423|NCT00994123|3916153|B3||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4092424|NCT00994123|3916154|B2||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4092425|NCT00994123|3916155|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4092426|NCT00994123|3916152|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4092427|NCT00994123|3916153|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4092428|NCT00994123|3916154|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4092429|NCT00994123|3916155|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4092430|NCT00994123|3916152|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092431|NCT00994123|3916153|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092432|NCT00994123|3916154|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092433|NCT00994123|3916155|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092434|NCT00994123|3916152|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4092435|NCT00994123|3916153|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4092436|NCT00994123|3916154|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4092437|NCT00994123|3916155|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092438|NCT00994123|3916152|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4092439|NCT00994123|3916153|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092440|NCT00994123|3916154|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4092441|NCT00994123|3916155|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092442|NCT00994123|3916152|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092443|NCT00994123|3916153|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092444|NCT00994123|3916154|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092445|NCT00994123|3916155|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092446|NCT00994123|3916152|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|156|156.0||||||
4092447|NCT00994123|3916153|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4092448|NCT00994123|3916154|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
4092449|NCT00994123|3916155|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4092450|NCT00994123|3916152|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4092451|NCT00994123|3916153|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4092452|NCT00994123|3916154|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4092453|NCT00994123|3916155|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4092454|NCT00994123|3916152|B4||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4092455|NCT00994123|3916153|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4092456|NCT00994123|3916154|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4092457|NCT00994123|3916155|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4092458|NCT00994123|3916152|B4||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4092459|NCT00994123|3916153|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4092460|NCT00994123|3916154|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4092461|NCT00994123|3916155|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4092462|NCT00994123|3916152|B4|||Age||years|Mean|63.2|63.2|Standard Deviation|10.53|10.53|||
4092463|NCT00994123|3916153|B3|||Age||years|Mean|63.9|63.9|Standard Deviation|10.16|10.16|||
4092464|NCT00994123|3916154|B2|||Age||years|Mean|62.9|62.9|Standard Deviation|10.74|10.74|||
4092465|NCT00994123|3916155|B1|||Age||years|Mean|63.5|63.5|Standard Deviation|10.12|10.12|||
4092466|NCT00994110|3916176|B3|United States||Region of Enrollment||participants|Number|439|439.0||||||
4092467|NCT00994110|3916177|B2|United States||Region of Enrollment||participants|Number|222|222.0||||||
4092468|NCT00994110|3916178|B1|United States||Region of Enrollment||participants|Number|217|217.0||||||
4092469|NCT00994110|3916176|B3||Male|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4092470|NCT00994110|3916177|B2||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4092471|NCT00994110|3916178|B1||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4092472|NCT00994110|3916176|B3||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4092473|NCT00994110|3916177|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4092474|NCT00994110|3916178|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4092475|NCT00994110|3916176|B3||>=65 years|Age||Participants|Count of Participants|228|228.0||||||
4092476|NCT00994110|3916177|B2||>=65 years|Age||Participants|Count of Participants|118|118.0||||||
4092477|NCT00994110|3916178|B1||>=65 years|Age||Participants|Count of Participants|110|110.0||||||
4092478|NCT00994110|3916176|B3||Between 18 and 65 years|Age||Participants|Count of Participants|211|211.0||||||
4092479|NCT00994110|3916177|B2||Between 18 and 65 years|Age||Participants|Count of Participants|104|104.0||||||
4092480|NCT00994110|3916178|B1||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
4092481|NCT00994110|3916176|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4092482|NCT00994110|3916177|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4092483|NCT00994110|3916178|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4092484|NCT00993967|3916185|B1|United Kingdom||Region of Enrollment||participants|Number|20|20.0||||||
4092485|NCT00993967|3916185|B1|Germany||Region of Enrollment||participants|Number|143|143.0||||||
4092486|NCT00993967|3916185|B1|France||Region of Enrollment||participants|Number|13|13.0||||||
4092487|NCT00993967|3916185|B1|Belgium||Region of Enrollment||participants|Number|10|10.0||||||
4092488|NCT00993967|3916185|B1|Austria||Region of Enrollment||participants|Number|6|6.0||||||
4092489|NCT00993967|3916185|B1|Netherlands||Region of Enrollment||participants|Number|8|8.0||||||
4092490|NCT00993967|3916185|B1||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4092491|NCT00993967|3916185|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4092492|NCT00993967|3916185|B1|||Age||years|Mean|32|32.0|Standard Deviation|13.68|13.68|||
4092493|NCT00993954|3916190|B3|||Number of patient with injury from other mechanisms||participants|Number|11|11.0||||||
4092494|NCT00993954|3916191|B2|||Number of patient with injury from other mechanisms||participants|Number|10|10.0||||||
4092495|NCT00993954|3916192|B1|||Number of patient with injury from other mechanisms||participants|Number|1|1.0||||||
4092496|NCT00993954|3916190|B3|||Number of patients with injury from fall mechanism||participants|Number|24|24.0||||||
4092497|NCT00993954|3916191|B2|||Number of patients with injury from fall mechanism||participants|Number|19|19.0||||||
4092498|NCT00993954|3916192|B1|||Number of patients with injury from fall mechanism||participants|Number|5|5.0||||||
4092499|NCT00993954|3916190|B3|||Number of patient with injury from pull mechanism||participants|Number|210|210.0||||||
4092500|NCT00993954|3916191|B2|||Number of patient with injury from pull mechanism||participants|Number|92|92.0||||||
4092501|NCT00993954|3916192|B1|||Number of patient with injury from pull mechanism||participants|Number|118|118.0||||||
4092502|NCT00993954|3916190|B3|||Time from injury||Minutes|Median|92|92.0|Inter-Quartile Range|||54.0|173.0|
4092503|NCT00993954|3916191|B2|||Time from injury||Minutes|Median|103|103.0|Inter-Quartile Range|||64.0|199.0|
4092504|NCT00993954|3916192|B1|||Time from injury||Minutes|Median|88|88.0|Inter-Quartile Range|||45.0|153.0|
4092505|NCT00993954|3916190|B3|Canada||Region of Enrollment||participants|Number|245|245.0||||||
4092506|NCT00993954|3916191|B2|Canada||Region of Enrollment||participants|Number|121|121.0||||||
4092507|NCT00993954|3916192|B1|Canada||Region of Enrollment||participants|Number|124|124.0||||||
4092508|NCT00993954|3916190|B3||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4092509|NCT00993954|3916191|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4092510|NCT00993954|3916192|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4092511|NCT00993954|3916190|B3||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4092512|NCT00993954|3916191|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4092513|NCT00993954|3916192|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4092514|NCT00993954|3916190|B3|||Age||Years|Mean|2.3|2.3|Standard Deviation|1.1|1.1|||
4092515|NCT00993954|3916191|B2|||Age||Years|Mean|2.2|2.2|Standard Deviation|1.1|1.1|||
4092516|NCT00993954|3916192|B1|||Age||Years|Mean|2.4|2.4|Standard Deviation|1.0|1.0|||
4092517|NCT00993928|3916204|B3|United States||Region of Enrollment||participants|Number|81|81.0||||||
4092518|NCT00993928|3916205|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
4092519|NCT00993928|3916206|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4092520|NCT00993928|3916204|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4092521|NCT00993928|3916205|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4092522|NCT00993928|3916206|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4092523|NCT00993928|3916204|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4092524|NCT00993928|3916205|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4092525|NCT00993928|3916206|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4092526|NCT00993928|3916204|B3|||Age||years|Median|57|57.0|Full Range|||31.0|78.0|
4092527|NCT00993928|3916205|B2|||Age||years|Median|59|59.0|Full Range|||31.0|77.0|
4092528|NCT00993928|3916206|B1|||Age||years|Median|55|55.0|Full Range|||36.0|78.0|
4092529|NCT00993915|3916221|B1|||Triglycerides|Number of participants with available data = 664|mg/dL|Mean|207.56|207.56|Standard Deviation|145.61|145.61|||
4092530|NCT00993915|3916221|B1|||High-density lipoprotein (HDL) cholesterol|Number of participants with available data = 633|mg/dL|Mean|48.37|48.37|Standard Deviation|20.14|20.14|||
4092531|NCT00993915|3916221|B1|||Low-density lipoprotein (LDL) cholesterol|Number of participants with available data = 661|mg/dL|Mean|179.09|179.09|Standard Deviation|54.19|54.19|||
4092532|NCT00993915|3916221|B1|||Total cholesterol|Number of participants with available data = 673|milligrams per deciliter (mg/dL)|Mean|271.69|271.69|Standard Deviation|61.99|61.99|||
4092533|NCT00993915|3916221|B1||Male|Sex: Female, Male||Participants|Count of Participants|404|404.0||||||
4092534|NCT00993915|3916221|B1||Female|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
4092535|NCT00993915|3916221|B1|Greater than or equal to (≥) 65 years||Age, Customized||participants|Number|159|159.0||||||
4092536|NCT00993915|3916221|B1|Between 45 and 64 years||Age, Customized||participants|Number|493|493.0||||||
4092537|NCT00993915|3916221|B1|Between 18 and 44 years||Age, Customized||participants|Number|35|35.0||||||
4092538|NCT00993824|3916230|B3|||Hypoglycemia percentage of time <70 mg/dL average by group|Hypoglycemia percentage of time <70 mg/dL average by group was assessed by the CGM. The baseline CGM period started 14 days before randomization (visit 1) and concluded at randomization (visit 2).|percentage of time <70 mg/dL|Mean|0.4|0.4|Standard Deviation|0.5|0.5|||
4092539|NCT00993824|3916231|B2|||Hypoglycemia percentage of time <70 mg/dL average by group|Hypoglycemia percentage of time <70 mg/dL average by group was assessed by the CGM. The baseline CGM period started 14 days before randomization (visit 1) and concluded at randomization (visit 2).|percentage of time <70 mg/dL|Mean|0.3|0.3|Standard Deviation|0.6|0.6|||
4092540|NCT00993824|3916232|B1|||Hypoglycemia percentage of time <70 mg/dL average by group|Hypoglycemia percentage of time <70 mg/dL average by group was assessed by the CGM. The baseline CGM period started 14 days before randomization (visit 1) and concluded at randomization (visit 2).|percentage of time <70 mg/dL|Mean|0.4|0.4|Standard Deviation|0.4|0.4|||
4092541|NCT00993824|3916230|B3|||Wake norm area under the curve average by group|Wake norm HbA1c AUC was assessed by the CGM. The baseline CGM period started 14 days before randomization (visit 1) and concluded at randomization (visit 2). The data was then normalized.|mg/(dL/hr) (normalized)|Mean|167.5|167.5|Standard Deviation|22.8|22.8|||
4092542|NCT00993824|3916231|B2|||Wake norm area under the curve average by group|Wake norm HbA1c AUC was assessed by the CGM. The baseline CGM period started 14 days before randomization (visit 1) and concluded at randomization (visit 2). The data was then normalized.|mg/(dL/hr) (normalized)|Mean|170.0|170.0|Standard Deviation|28.1|28.1|||
4092543|NCT00993824|3916232|B1|||Wake norm area under the curve average by group|Wake norm HbA1c AUC was assessed by the CGM. The baseline CGM period started 14 days before randomization (visit 1) and concluded at randomization (visit 2). The data was then normalized.|mg/(dL/hr) (normalized)|Mean|165.2|165.2|Standard Deviation|17.8|17.8|||
4092544|NCT00993824|3916230|B3|||Sleep norm Area under the curve average by group|Sleep norm HbA1c AUC was assessed by the CGM. The baseline CGM period started 14 days before randomization (visit 1) and concluded at randomization (visit 2). The data was then normalized.|mg/(dL/hr) (normalized)|Mean|159.1|159.1|Standard Deviation|18.8|18.8|||
4092545|NCT00993824|3916231|B2|||Sleep norm Area under the curve average by group|Sleep norm HbA1c AUC was assessed by the CGM. The baseline CGM period started 14 days before randomization (visit 1) and concluded at randomization (visit 2). The data was then normalized.|mg/(dL/hr) (normalized)|Mean|161.2|161.2|Standard Deviation|23.4|23.4|||
4092546|NCT00993824|3916232|B1|||Sleep norm Area under the curve average by group|Sleep norm HbA1c AUC was assessed by the CGM. The baseline CGM period started 14 days before randomization (visit 1) and concluded at randomization (visit 2). The data was then normalized.|mg/(dL/hr) (normalized)|Mean|157.1|157.1|Standard Deviation|14.3|14.3|||
4092547|NCT00993824|3916230|B3|||Total norm AUC average|Total norm HbA1c AUC was assessed by the CGM. The baseline CGM period started 14 days before randomization (visit 1) and concluded at randomization (visit 2). The data was then normalized.|mg/(dL/hr) (normalized)|Mean|164.8|164.8|Standard Deviation|20.9|20.9|||
4092548|NCT00993824|3916231|B2|||Total norm AUC average|Total norm HbA1c AUC was assessed by the CGM. The baseline CGM period started 14 days before randomization (visit 1) and concluded at randomization (visit 2). The data was then normalized.|mg/(dL/hr) (normalized)|Mean|167.7|167.7|Standard Deviation|25.9|25.9|||
4092549|NCT00993824|3916232|B1|||Total norm AUC average|Total norm HbA1c AUC was assessed by the CGM. The baseline CGM period started 14 days before randomization (visit 1) and concluded at randomization (visit 2). The data was then normalized.|mg/(dL/hr) (normalized)|Mean|162.2|162.2|Standard Deviation|16.0|16.0|||
4092550|NCT00993824|3916230|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4092551|NCT00993824|3916231|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4092552|NCT00993824|3916232|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4092553|NCT00993824|3916230|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4092554|NCT00993824|3916231|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4092555|NCT00993824|3916232|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4092556|NCT00993824|3916230|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4092557|NCT00993824|3916231|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4092558|NCT00993824|3916232|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4092559|NCT00993824|3916230|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|8.2|8.2|||
4092560|NCT00993824|3916231|B2|||Age||years|Mean|59.5|59.5|Standard Deviation|7.2|7.2|||
4092561|NCT00993824|3916232|B1|||Age||years|Mean|59.5|59.5|Standard Deviation|9.4|9.4|||
4092562|NCT00993824|3916230|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4092563|NCT00993824|3916231|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4092564|NCT00993824|3916232|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4092565|NCT00993824|3916230|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4092566|NCT00993824|3916231|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4092567|NCT00993824|3916232|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4092568|NCT00993824|3916230|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4092569|NCT00993824|3916231|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4092570|NCT00993824|3916232|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4092571|NCT00993668|3916245|B3|United States||Region of Enrollment||participants|Number|224|224.0||||||
4092572|NCT00993668|3916246|B2|United States||Region of Enrollment||participants|Number|110|110.0||||||
4092573|NCT00993668|3916247|B1|United States||Region of Enrollment||participants|Number|114|114.0||||||
4092574|NCT00993668|3916245|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4092575|NCT00993668|3916246|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4092576|NCT00993668|3916247|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4092577|NCT00993668|3916245|B3||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4092578|NCT00993668|3916246|B2||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4092579|NCT00993668|3916247|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4092580|NCT00993668|3916245|B3|||Age||years|Mean|52.85|52.85|Standard Deviation|11.42|11.42|||
4092581|NCT00993668|3916246|B2|||Age||years|Mean|53.05|53.05|Standard Deviation|11.78|11.78|||
4092582|NCT00993668|3916247|B1|||Age||years|Mean|52.65|52.65|Standard Deviation|11.12|11.12|||
4092583|NCT00993668|3916245|B3||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4092584|NCT00993668|3916246|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4092585|NCT00993668|3916247|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4092586|NCT00993668|3916245|B3||Between 18 and 65 years|Age||Participants|Count of Participants|196|196.0||||||
4092587|NCT00993668|3916246|B2||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
4092588|NCT00993668|3916247|B1||Between 18 and 65 years|Age||Participants|Count of Participants|102|102.0||||||
4092589|NCT00993668|3916245|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4092590|NCT00993668|3916246|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4092591|NCT00993668|3916247|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4092592|NCT00993655|3916273|B4|Spain||Region of Enrollment||participants|Number|18|18.0||||||
4092593|NCT00993655|3916274|B3|Spain||Region of Enrollment||participants|Number|6|6.0||||||
4092594|NCT00993655|3916275|B2|Spain||Region of Enrollment||participants|Number|6|6.0||||||
4092595|NCT00993655|3916276|B1|Spain||Region of Enrollment||participants|Number|6|6.0||||||
4092596|NCT00993655|3916273|B4|United Kingdom||Region of Enrollment||participants|Number|74|74.0||||||
4092597|NCT00993655|3916274|B3|United Kingdom||Region of Enrollment||participants|Number|27|27.0||||||
4092598|NCT00993655|3916275|B2|United Kingdom||Region of Enrollment||participants|Number|20|20.0||||||
4092599|NCT00993655|3916276|B1|United Kingdom||Region of Enrollment||participants|Number|27|27.0||||||
4092600|NCT00993655|3916273|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
4092601|NCT00993655|3916274|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4092602|NCT00993655|3916275|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4092603|NCT00993655|3916276|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4092604|NCT00993655|3916273|B4|Canada||Region of Enrollment||participants|Number|173|173.0||||||
4092605|NCT00993655|3916274|B3|Canada||Region of Enrollment||participants|Number|66|66.0||||||
4092606|NCT00993655|3916275|B2|Canada||Region of Enrollment||participants|Number|42|42.0||||||
4092607|NCT00993655|3916276|B1|Canada||Region of Enrollment||participants|Number|65|65.0||||||
4092608|NCT00993655|3916273|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4092609|NCT00993655|3916274|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4092610|NCT00993655|3916275|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4092611|NCT00993655|3916276|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4092612|NCT00993655|3916273|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092613|NCT00993655|3916274|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092614|NCT00993655|3916275|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092615|NCT00993655|3916276|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092616|NCT00993655|3916273|B4||White|Race (NIH/OMB)||Participants|Count of Participants|254|254.0||||||
4092617|NCT00993655|3916274|B3||White|Race (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
4092618|NCT00993655|3916275|B2||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4092619|NCT00993655|3916276|B1||White|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
4092620|NCT00993655|3916273|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4092621|NCT00993655|3916274|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4092622|NCT00993655|3916275|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4092623|NCT00993655|3916276|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4092624|NCT00993655|3916273|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4092625|NCT00993655|3916274|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4092626|NCT00993655|3916275|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4092627|NCT00993655|3916276|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092628|NCT00993655|3916273|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4092629|NCT00993655|3916274|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4092630|NCT00993655|3916275|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4092631|NCT00993655|3916276|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4092632|NCT00993655|3916273|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4092633|NCT00993655|3916274|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092634|NCT00993655|3916275|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092635|NCT00993655|3916276|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4092636|NCT00993655|3916273|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4092637|NCT00993655|3916274|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4092638|NCT00993655|3916275|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4092639|NCT00993655|3916276|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4092640|NCT00993655|3916273|B4||Female|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4092641|NCT00993655|3916274|B3||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4092642|NCT00993655|3916275|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4092643|NCT00993655|3916276|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4092644|NCT00993655|3916273|B4|||Age||years|Median|62|62.0|Full Range|||29.0|83.0|
4092645|NCT00993655|3916274|B3|||Age||years|Median|62|62.0|Full Range|||40.0|82.0|
4092646|NCT00993655|3916275|B2|||Age||years|Median|61|61.0|Full Range|||29.0|78.0|
4092647|NCT00993655|3916276|B1|||Age||years|Median|62|62.0|Full Range|||33.0|83.0|
4092648|NCT00993616|3916292|B1|Serous Adenocarcinoma||Cell Type||participants|Number|23|23.0||||||
4092649|NCT00993616|3916292|B1|Mixed Epithelial Carcinoma||Cell Type||participants|Number|1|1.0||||||
4092650|NCT00993616|3916292|B1|Clear Cell Carcinoma||Cell Type||participants|Number|2|2.0||||||
4092651|NCT00993616|3916292|B1|Adenocarcinoma, Unspecified||Cell Type||participants|Number|1|1.0||||||
4092652|NCT00993616|3916292|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4092653|NCT00993616|3916292|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4092654|NCT00993616|3916292|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4092655|NCT00993616|3916292|B1|70-79 years||Age, Customized||participants|Number|2|2.0||||||
4092656|NCT00993616|3916292|B1|60-69 years||Age, Customized||participants|Number|15|15.0||||||
4092657|NCT00993616|3916292|B1|50-59 years||Age, Customized||participants|Number|8|8.0||||||
4092658|NCT00993616|3916292|B1|40-49 years||Age, Customized||participants|Number|2|2.0||||||
4092659|NCT00993616|3916292|B1|||Age||years|Mean|61.2|61.2|Standard Deviation|6.8|6.8|||
4092660|NCT00993499|3916304|B7||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4092661|NCT00993499|3916305|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4092662|NCT00993499|3916306|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4092663|NCT00993499|3916307|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4092664|NCT00993499|3916308|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4092665|NCT00993499|3916309|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4092666|NCT00993499|3916310|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4092667|NCT00993499|3916304|B7||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4092668|NCT00993499|3916305|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4092669|NCT00993499|3916306|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4092670|NCT00993499|3916307|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4092671|NCT00993499|3916308|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4092672|NCT00993499|3916309|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4092673|NCT00993499|3916310|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4092674|NCT00993499|3916304|B7|||Age||Years|Mean|58.9|58.9|Standard Deviation|12.3|12.3|||
4092675|NCT00993499|3916305|B6|||Age||Years|Mean|56.5|56.5|Standard Deviation|17.2|17.2|||
4092676|NCT00993499|3916306|B5|||Age||Years|Mean|53.4|53.4|Standard Deviation|12.4|12.4|||
4092677|NCT00993499|3916307|B4|||Age||Years|Mean|50.8|50.8|Standard Deviation|7.5|7.5|||
4092678|NCT00993499|3916308|B3|||Age||Years|Mean|65.1|65.1|Standard Deviation|9.6|9.6|||
4092679|NCT00993499|3916309|B2|||Age||Years|Mean|56.5|56.5|Standard Deviation|12.5|12.5|||
4092680|NCT00993499|3916310|B1|||Age||Years|Mean|60.1|60.1|Standard Deviation|13.6|13.6|||
4092681|NCT00993473|3916395|B3|||Total daily dose of bolus insulin injection at baseline||International Units|Median|7.00|7.0|Full Range|||0.8|45.0|
4092682|NCT00993473|3916396|B2|||Total daily dose of bolus insulin injection at baseline||International Units|Median|7.00|7.0|Full Range|||0.8|45.0|
4092683|NCT00993473|3916397|B1|||Total daily dose of bolus insulin injection at baseline||International Units|Median|7.75|7.75|Full Range|||1.3|16.0|
4092684|NCT00993473|3916395|B3|||Total daily dose of bolus insulin injection at baseline||International Units|Mean|7.58|7.58|Standard Deviation|5.77|5.77|||
4092685|NCT00993473|3916396|B2|||Total daily dose of bolus insulin injection at baseline||International Units|Mean|7.98|7.98|Standard Deviation|7.20|7.2|||
4092686|NCT00993473|3916397|B1|||Total daily dose of bolus insulin injection at baseline||International Units|Mean|7.14|7.14|Standard Deviation|3.64|3.64|||
4092687|NCT00993473|3916395|B3|Not treated by bolus insulin or missing||Total daily dose of bolus insulin injection at baseline||participants|Number|16|16.0||||||
4092688|NCT00993473|3916396|B2|Not treated by bolus insulin or missing||Total daily dose of bolus insulin injection at baseline||participants|Number|7|7.0||||||
4092689|NCT00993473|3916397|B1|Not treated by bolus insulin or missing||Total daily dose of bolus insulin injection at baseline||participants|Number|9|9.0||||||
4092690|NCT00993473|3916395|B3|Analyzed||Total daily dose of bolus insulin injection at baseline||participants|Number|109|109.0||||||
4092691|NCT00993473|3916396|B2|Analyzed||Total daily dose of bolus insulin injection at baseline||participants|Number|57|57.0||||||
4092692|NCT00993473|3916397|B1|Analyzed||Total daily dose of bolus insulin injection at baseline||participants|Number|52|52.0||||||
4092693|NCT00993473|3916395|B3|||Total daily dose of basal insulin injection at baseline||International Units|Median|6.00|6.0|Full Range|||1.5|24.0|
4092694|NCT00993473|3916396|B2|||Total daily dose of basal insulin injection at baseline||International Units|Median|6.00|6.0|Full Range|||1.5|24.0|
4092695|NCT00993473|3916397|B1|||Total daily dose of basal insulin injection at baseline||International Units|Median|6.00|6.0|Full Range|||2.0|24.0|
4092696|NCT00993473|3916395|B3|||Total daily dose of basal insulin injection at baseline||International Units|Mean|7.45|7.45|Standard Deviation|4.43|4.43|||
4092697|NCT00993473|3916396|B2|||Total daily dose of basal insulin injection at baseline||International Units|Mean|7.61|7.61|Standard Deviation|4.77|4.77|||
4092698|NCT00993473|3916397|B1|||Total daily dose of basal insulin injection at baseline||International Units|Mean|7.29|7.29|Standard Deviation|4.11|4.11|||
4092699|NCT00993473|3916395|B3|Not treated by basal insulin or missing||Total daily dose of basal insulin injection at baseline||participants|Number|11|11.0||||||
4092700|NCT00993473|3916396|B2|Not treated by basal insulin or missing||Total daily dose of basal insulin injection at baseline||participants|Number|7|7.0||||||
4092701|NCT00993473|3916397|B1|Not treated by basal insulin or missing||Total daily dose of basal insulin injection at baseline||participants|Number|4|4.0||||||
4092702|NCT00993473|3916395|B3|Analyzed||Total daily dose of basal insulin injection at baseline||participants|Number|114|114.0||||||
4092703|NCT00993473|3916396|B2|Analyzed||Total daily dose of basal insulin injection at baseline||participants|Number|57|57.0||||||
4092704|NCT00993473|3916397|B1|Analyzed||Total daily dose of basal insulin injection at baseline||participants|Number|57|57.0||||||
4092705|NCT00993473|3916395|B3|Not treated with basal insulin at baseline||Number of daily basal insulin injections at baseline||participants|Number|10|10.0||||||
4092706|NCT00993473|3916396|B2|Not treated with basal insulin at baseline||Number of daily basal insulin injections at baseline||participants|Number|7|7.0||||||
4092707|NCT00993473|3916397|B1|Not treated with basal insulin at baseline||Number of daily basal insulin injections at baseline||participants|Number|3|3.0||||||
4092708|NCT00993473|3916395|B3|>=3||Number of daily basal insulin injections at baseline||participants|Number|6|6.0||||||
4092709|NCT00993473|3916396|B2|>=3||Number of daily basal insulin injections at baseline||participants|Number|1|1.0||||||
4092710|NCT00993473|3916397|B1|>=3||Number of daily basal insulin injections at baseline||participants|Number|5|5.0||||||
4092711|NCT00993473|3916395|B3|2||Number of daily basal insulin injections at baseline||participants|Number|36|36.0||||||
4092712|NCT00993473|3916396|B2|2||Number of daily basal insulin injections at baseline||participants|Number|15|15.0||||||
4092713|NCT00993473|3916397|B1|2||Number of daily basal insulin injections at baseline||participants|Number|21|21.0||||||
4092714|NCT00993473|3916395|B3|1||Number of daily basal insulin injections at baseline||participants|Number|73|73.0||||||
4092715|NCT00993473|3916396|B2|1||Number of daily basal insulin injections at baseline||participants|Number|41|41.0||||||
4092716|NCT00993473|3916397|B1|1||Number of daily basal insulin injections at baseline||participants|Number|32|32.0||||||
4092717|NCT00993473|3916395|B3|No||Treated by mixed (bolus & basal) insulin at baseline||participants|Number|112|112.0||||||
4092718|NCT00993473|3916396|B2|No||Treated by mixed (bolus & basal) insulin at baseline||participants|Number|56|56.0||||||
4092719|NCT00993473|3916397|B1|No||Treated by mixed (bolus & basal) insulin at baseline||participants|Number|56|56.0||||||
4092720|NCT00993473|3916395|B3|Yes||Treated by mixed (bolus & basal) insulin at baseline||participants|Number|13|13.0||||||
4092721|NCT00993473|3916396|B2|Yes||Treated by mixed (bolus & basal) insulin at baseline||participants|Number|8|8.0||||||
4092722|NCT00993473|3916397|B1|Yes||Treated by mixed (bolus & basal) insulin at baseline||participants|Number|5|5.0||||||
4092723|NCT00993473|3916395|B3|No||Treated by basal insulin at baseline||participants|Number|10|10.0||||||
4092724|NCT00993473|3916396|B2|No||Treated by basal insulin at baseline||participants|Number|7|7.0||||||
4092725|NCT00993473|3916397|B1|No||Treated by basal insulin at baseline||participants|Number|3|3.0||||||
4092726|NCT00993473|3916395|B3|Yes||Treated by basal insulin at baseline||participants|Number|115|115.0||||||
4092727|NCT00993473|3916396|B2|Yes||Treated by basal insulin at baseline||participants|Number|57|57.0||||||
4092728|NCT00993473|3916397|B1|Yes||Treated by basal insulin at baseline||participants|Number|58|58.0||||||
4092729|NCT00993473|3916395|B3|No||Treated by bolus insulin at baseline||participants|Number|13|13.0||||||
4092730|NCT00993473|3916396|B2|No||Treated by bolus insulin at baseline||participants|Number|6|6.0||||||
4092731|NCT00993473|3916397|B1|No||Treated by bolus insulin at baseline||participants|Number|7|7.0||||||
4092732|NCT00993473|3916395|B3|Yes||Treated by bolus insulin at baseline||participants|Number|112|112.0||||||
4092733|NCT00993473|3916396|B2|Yes||Treated by bolus insulin at baseline||participants|Number|58|58.0||||||
4092734|NCT00993473|3916397|B1|Yes||Treated by bolus insulin at baseline||participants|Number|54|54.0||||||
4092735|NCT00993473|3916395|B3|||Duration of diabetes||years|Median|1.81|1.81|Full Range|||1.0|5.3|
4092736|NCT00993473|3916396|B2|||Duration of diabetes||years|Median|2.05|2.05|Full Range|||1.0|4.9|
4092737|NCT00993473|3916397|B1|||Duration of diabetes||years|Median|1.63|1.63|Full Range|||1.0|5.3|
4092738|NCT00993473|3916395|B3|||Duration of diabetes||years|Mean|2.12|2.12|Standard Deviation|1.08|1.08|||
4092739|NCT00993473|3916396|B2|||Duration of diabetes||years|Mean|2.12|2.12|Standard Deviation|1.01|1.01|||
4092740|NCT00993473|3916397|B1|||Duration of diabetes||years|Mean|2.12|2.12|Standard Deviation|1.16|1.16|||
4092741|NCT00993473|3916395|B3|Non Hispanic||Race/Ethnicity, Customized||participants|Number|95|95.0||||||
4092742|NCT00993473|3916396|B2|Non Hispanic||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4092743|NCT00993473|3916397|B1|Non Hispanic||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4092744|NCT00993473|3916395|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4092745|NCT00993473|3916396|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4092746|NCT00993473|3916397|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4092747|NCT00993473|3916395|B3|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4092748|NCT00993473|3916396|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4092749|NCT00993473|3916397|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4092750|NCT00993473|3916395|B3|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4092751|NCT00993473|3916396|B2|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4092752|NCT00993473|3916397|B1|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4092753|NCT00993473|3916395|B3|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4092754|NCT00993473|3916396|B2|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4092755|NCT00993473|3916397|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4092756|NCT00993473|3916395|B3|Caucasian/White||Race/Ethnicity, Customized||participants|Number|101|101.0||||||
4092757|NCT00993473|3916396|B2|Caucasian/White||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
4092758|NCT00993473|3916397|B1|Caucasian/White||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
4092759|NCT00993473|3916395|B3|Female||Sex/Gender, Customized||participants|Number|63|63.0||||||
4092760|NCT00993473|3916396|B2|Female||Sex/Gender, Customized||participants|Number|34|34.0||||||
4092761|NCT00993473|3916397|B1|Female||Sex/Gender, Customized||participants|Number|29|29.0||||||
4092762|NCT00993473|3916395|B3|Male||Sex/Gender, Customized||participants|Number|62|62.0||||||
4092763|NCT00993473|3916396|B2|Male||Sex/Gender, Customized||participants|Number|30|30.0||||||
4092764|NCT00993473|3916397|B1|Male||Sex/Gender, Customized||participants|Number|32|32.0||||||
4092765|NCT00993473|3916395|B3|> 3 years||Age, Customized||participants|Number|98|98.0||||||
4092766|NCT00993473|3916396|B2|> 3 years||Age, Customized||participants|Number|47|47.0||||||
4092767|NCT00993473|3916397|B1|> 3 years||Age, Customized||participants|Number|51|51.0||||||
4092768|NCT00993473|3916395|B3|<= 3 years||Age, Customized||participants|Number|27|27.0||||||
4092769|NCT00993473|3916396|B2|<= 3 years||Age, Customized||participants|Number|17|17.0||||||
4092770|NCT00993473|3916397|B1|<= 3 years||Age, Customized||participants|Number|10|10.0||||||
4092771|NCT00993473|3916395|B3|||Age||years|Median|4.0|4.0|Full Range|||1.0|6.0|
4092772|NCT00993473|3916396|B2|||Age||years|Median|4.0|4.0|Full Range|||1.0|6.0|
4092773|NCT00993473|3916397|B1|||Age||years|Median|5.0|5.0|Full Range|||2.0|5.0|
4092774|NCT00993473|3916395|B3|||Age||years|Mean|4.2|4.2|Standard Deviation|1.0|1.0|||
4092775|NCT00993473|3916396|B2|||Age||years|Mean|4.1|4.1|Standard Deviation|1.0|1.0|||
4092776|NCT00993473|3916397|B1|||Age||years|Mean|4.3|4.3|Standard Deviation|0.9|0.9|||
4092777|NCT00993447|3916434|B3|Puerto Rico||Region of Enrollment||Participants|Number|106|106.0||||||
4092778|NCT00993447|3916435|B2|Puerto Rico||Region of Enrollment||Participants|Number|35|35.0||||||
4092779|NCT00993447|3916436|B1|Puerto Rico||Region of Enrollment||Participants|Number|71|71.0||||||
4092780|NCT00993447|3916434|B3|Mexico||Region of Enrollment||Participants|Number|177|177.0||||||
4092781|NCT00993447|3916435|B2|Mexico||Region of Enrollment||Participants|Number|58|58.0||||||
4092782|NCT00993447|3916436|B1|Mexico||Region of Enrollment||Participants|Number|119|119.0||||||
4092783|NCT00993447|3916434|B3|Honduras||Region of Enrollment||Participants|Number|158|158.0||||||
4092784|NCT00993447|3916435|B2|Honduras||Region of Enrollment||Participants|Number|52|52.0||||||
4092785|NCT00993447|3916436|B1|Honduras||Region of Enrollment||Participants|Number|106|106.0||||||
4092786|NCT00993447|3916434|B3|Colombia||Region of Enrollment||Participants|Number|159|159.0||||||
4092787|NCT00993447|3916435|B2|Colombia||Region of Enrollment||Participants|Number|54|54.0||||||
4092788|NCT00993447|3916436|B1|Colombia||Region of Enrollment||Participants|Number|105|105.0||||||
4092789|NCT00993447|3916434|B3||Male|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
4092790|NCT00993447|3916435|B2||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4092791|NCT00993447|3916436|B1||Male|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4092792|NCT00993447|3916434|B3||Female|Sex: Female, Male||Participants|Count of Participants|312|312.0||||||
4092793|NCT00993447|3916435|B2||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4092794|NCT00993447|3916436|B1||Female|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4092795|NCT00993447|3916434|B3|||Age||Years|Mean|12.55|12.55|Standard Deviation|2.1|2.1|||
4092796|NCT00993447|3916435|B2|||Age||Years|Mean|12.5|12.5|Standard Deviation|2.1|2.1|||
4092797|NCT00993447|3916436|B1|||Age||Years|Mean|12.6|12.6|Standard Deviation|2.1|2.1|||
4092798|NCT00993447|3916434|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4092799|NCT00993447|3916435|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4092800|NCT00993447|3916436|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4092801|NCT00993447|3916434|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4092802|NCT00993447|3916435|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4092803|NCT00993447|3916436|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4092804|NCT00993447|3916434|B3||<=18 years|Age||Participants|Count of Participants|600|600.0||||||
4092805|NCT00993447|3916435|B2||<=18 years|Age||Participants|Count of Participants|199|199.0||||||
4092806|NCT00993447|3916436|B1||<=18 years|Age||Participants|Count of Participants|401|401.0||||||
4092807|NCT00993421|3916467|B8|Hip Circumference||Waist and Hip Circumference||centimeters (cm)|Mean|118.70|118.7|Standard Deviation|11.83|11.83|||
4092808|NCT00993421|3916468|B7|Hip Circumference||Waist and Hip Circumference||centimeters (cm)|Mean|118.01|118.01|Standard Deviation|11.43|11.43|||
4092809|NCT00993421|3916469|B6|Hip Circumference||Waist and Hip Circumference||centimeters (cm)|Mean|119.43|119.43|Standard Deviation|11.45|11.45|||
4092810|NCT00993421|3916470|B5|Hip Circumference||Waist and Hip Circumference||centimeters (cm)|Mean|117.30|117.3|Standard Deviation|14.96|14.96|||
4092811|NCT00993421|3916471|B4|Hip Circumference||Waist and Hip Circumference||centimeters (cm)|Mean|117.65|117.65|Standard Deviation|11.13|11.13|||
4092812|NCT00993421|3916472|B3|Hip Circumference||Waist and Hip Circumference||centimeters (cm)|Mean|120.29|120.29|Standard Deviation|11.51|11.51|||
4092914|NCT00993421|3916470|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092813|NCT00993421|3916473|B2|Hip Circumference||Waist and Hip Circumference||centimeters (cm)|Mean|118.55|118.55|Standard Deviation|9.42|9.42|||
4092814|NCT00993421|3916474|B1|Hip Circumference||Waist and Hip Circumference||centimeters (cm)|Mean|119.76|119.76|Standard Deviation|12.36|12.36|||
4092815|NCT00993421|3916467|B8|Waist Circumference||Waist and Hip Circumference||centimeters (cm)|Mean|109.24|109.24|Standard Deviation|12.10|12.1|||
4092816|NCT00993421|3916468|B7|Waist Circumference||Waist and Hip Circumference||centimeters (cm)|Mean|109.15|109.15|Standard Deviation|12.95|12.95|||
4092817|NCT00993421|3916469|B6|Waist Circumference||Waist and Hip Circumference||centimeters (cm)|Mean|109.99|109.99|Standard Deviation|11.49|11.49|||
4092818|NCT00993421|3916470|B5|Waist Circumference||Waist and Hip Circumference||centimeters (cm)|Mean|110.18|110.18|Standard Deviation|10.80|10.8|||
4092819|NCT00993421|3916471|B4|Waist Circumference||Waist and Hip Circumference||centimeters (cm)|Mean|107.31|107.31|Standard Deviation|12.06|12.06|||
4092820|NCT00993421|3916472|B3|Waist Circumference||Waist and Hip Circumference||centimeters (cm)|Mean|111.47|111.47|Standard Deviation|12.58|12.58|||
4092821|NCT00993421|3916473|B2|Waist Circumference||Waist and Hip Circumference||centimeters (cm)|Mean|107.42|107.42|Standard Deviation|10.70|10.7|||
4092822|NCT00993421|3916474|B1|Waist Circumference||Waist and Hip Circumference||centimeters (cm)|Mean|109.13|109.13|Standard Deviation|14.10|14.1|||
4092823|NCT00993421|3916467|B8|Diastolic Blood Pressure (DBP)||Blood Pressure||mm Hg|Mean|76.44|76.44|Standard Deviation|6.97|6.97|||
4092824|NCT00993421|3916468|B7|Diastolic Blood Pressure (DBP)||Blood Pressure||mm Hg|Mean|78.38|78.38|Standard Deviation|6.23|6.23|||
4092825|NCT00993421|3916469|B6|Diastolic Blood Pressure (DBP)||Blood Pressure||mm Hg|Mean|77.87|77.87|Standard Deviation|6.82|6.82|||
4092826|NCT00993421|3916470|B5|Diastolic Blood Pressure (DBP)||Blood Pressure||mm Hg|Mean|76.94|76.94|Standard Deviation|6.31|6.31|||
4092827|NCT00993421|3916471|B4|Diastolic Blood Pressure (DBP)||Blood Pressure||mm Hg|Mean|76.61|76.61|Standard Deviation|7.07|7.07|||
4092828|NCT00993421|3916472|B3|Diastolic Blood Pressure (DBP)||Blood Pressure||mm Hg|Mean|75.83|75.83|Standard Deviation|6.76|6.76|||
4092829|NCT00993421|3916473|B2|Diastolic Blood Pressure (DBP)||Blood Pressure||mm Hg|Mean|74.40|74.4|Standard Deviation|7.70|7.7|||
4092830|NCT00993421|3916474|B1|Diastolic Blood Pressure (DBP)||Blood Pressure||mm Hg|Mean|75.12|75.12|Standard Deviation|7.31|7.31|||
4092831|NCT00993421|3916467|B8|Systolic Blood Pressure (SBP)||Blood Pressure||mm Hg|Mean|118.24|118.24|Standard Deviation|11.13|11.13|||
4092832|NCT00993421|3916468|B7|Systolic Blood Pressure (SBP)||Blood Pressure||mm Hg|Mean|120.72|120.72|Standard Deviation|11.36|11.36|||
4092833|NCT00993421|3916469|B6|Systolic Blood Pressure (SBP)||Blood Pressure||mm Hg|Mean|119.86|119.86|Standard Deviation|11.42|11.42|||
4092834|NCT00993421|3916470|B5|Systolic Blood Pressure (SBP)||Blood Pressure||mm Hg|Mean|118.34|118.34|Standard Deviation|11.37|11.37|||
4092835|NCT00993421|3916471|B4|Systolic Blood Pressure (SBP)||Blood Pressure||mm Hg|Mean|118.67|118.67|Standard Deviation|11.11|11.11|||
4092836|NCT00993421|3916472|B3|Systolic Blood Pressure (SBP)||Blood Pressure||mm Hg|Mean|117.35|117.35|Standard Deviation|10.13|10.13|||
4092837|NCT00993421|3916473|B2|Systolic Blood Pressure (SBP)||Blood Pressure||mm Hg|Mean|115.72|115.72|Standard Deviation|10.78|10.78|||
4092838|NCT00993421|3916474|B1|Systolic Blood Pressure (SBP)||Blood Pressure||mm Hg|Mean|117.11|117.11|Standard Deviation|11.53|11.53|||
4092839|NCT00993421|3916467|B8|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight (kilograms) divided by height (meters) squared.|kilograms/square meters (kg/m^2)|Mean|35.26|35.26|Standard Deviation|4.71|4.71|||
4092840|NCT00993421|3916468|B7|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight (kilograms) divided by height (meters) squared.|kilograms/square meters (kg/m^2)|Mean|35.22|35.22|Standard Deviation|4.87|4.87|||
4092841|NCT00993421|3916469|B6|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight (kilograms) divided by height (meters) squared.|kilograms/square meters (kg/m^2)|Mean|35.30|35.3|Standard Deviation|4.44|4.44|||
4092842|NCT00993421|3916470|B5|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight (kilograms) divided by height (meters) squared.|kilograms/square meters (kg/m^2)|Mean|34.86|34.86|Standard Deviation|4.39|4.39|||
4092843|NCT00993421|3916471|B4|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight (kilograms) divided by height (meters) squared.|kilograms/square meters (kg/m^2)|Mean|35.12|35.12|Standard Deviation|4.55|4.55|||
4092844|NCT00993421|3916472|B3|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight (kilograms) divided by height (meters) squared.|kilograms/square meters (kg/m^2)|Mean|36.34|36.34|Standard Deviation|5.36|5.36|||
4092845|NCT00993421|3916473|B2|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight (kilograms) divided by height (meters) squared.|kilograms/square meters (kg/m^2)|Mean|34.78|34.78|Standard Deviation|4.53|4.53|||
4092846|NCT00993421|3916474|B1|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight (kilograms) divided by height (meters) squared.|kilograms/square meters (kg/m^2)|Mean|35.22|35.22|Standard Deviation|4.96|4.96|||
4092847|NCT00993421|3916467|B8|||Weight||kilograms (kg)|Mean|99.10|99.1|Standard Deviation|17.46|17.46|||
4092848|NCT00993421|3916468|B7|||Weight||kilograms (kg)|Mean|100.09|100.09|Standard Deviation|17.11|17.11|||
4092849|NCT00993421|3916469|B6|||Weight||kilograms (kg)|Mean|100.96|100.96|Standard Deviation|17.20|17.2|||
4092850|NCT00993421|3916470|B5|||Weight||kilograms (kg)|Mean|99.09|99.09|Standard Deviation|17.73|17.73|||
4092851|NCT00993421|3916471|B4|||Weight||kilograms (kg)|Mean|96.36|96.36|Standard Deviation|18.08|18.08|||
4092852|NCT00993421|3916472|B3|||Weight||kilograms (kg)|Mean|102.25|102.25|Standard Deviation|17.80|17.8|||
4092853|NCT00993421|3916473|B2|||Weight||kilograms (kg)|Mean|97.15|97.15|Standard Deviation|15.67|15.67|||
4092854|NCT00993421|3916474|B1|||Weight||kilograms (kg)|Mean|97.92|97.92|Standard Deviation|18.73|18.73|||
4092855|NCT00993421|3916467|B8|||Height||centimeters (cm)|Mean|167.32|167.32|Standard Deviation|8.34|8.34|||
4092856|NCT00993421|3916468|B7|||Height||centimeters (cm)|Mean|168.38|168.38|Standard Deviation|7.50|7.5|||
4092857|NCT00993421|3916469|B6|||Height||centimeters (cm)|Mean|168.99|168.99|Standard Deviation|8.18|8.18|||
4092858|NCT00993421|3916470|B5|||Height||centimeters (cm)|Mean|168.13|168.13|Standard Deviation|7.88|7.88|||
4092859|NCT00993421|3916471|B4|||Height||centimeters (cm)|Mean|165.23|165.23|Standard Deviation|8.93|8.93|||
4092860|NCT00993421|3916472|B3|||Height||centimeters (cm)|Mean|167.51|167.51|Standard Deviation|9.22|9.22|||
4092861|NCT00993421|3916473|B2|||Height||centimeters (cm)|Mean|166.86|166.86|Standard Deviation|8.40|8.4|||
4092862|NCT00993421|3916474|B1|||Height||centimeters (cm)|Mean|166.10|166.1|Standard Deviation|8.02|8.02|||
4092863|NCT00993421|3916467|B8|United States||Region of Enrollment||participants|Number|343|343.0||||||
4092864|NCT00993421|3916468|B7|United States||Region of Enrollment||participants|Number|46|46.0||||||
4092865|NCT00993421|3916469|B6|United States||Region of Enrollment||participants|Number|50|50.0||||||
4092866|NCT00993421|3916470|B5|United States||Region of Enrollment||participants|Number|52|52.0||||||
4092867|NCT00993421|3916471|B4|United States||Region of Enrollment||participants|Number|49|49.0||||||
4092868|NCT00993421|3916472|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
4092869|NCT00993421|3916473|B2|United States||Region of Enrollment||participants|Number|49|49.0||||||
4092870|NCT00993421|3916474|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
4092871|NCT00993421|3916467|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092872|NCT00993421|3916468|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092873|NCT00993421|3916469|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092874|NCT00993421|3916470|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092875|NCT00993421|3916471|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092876|NCT00993421|3916472|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092877|NCT00993421|3916473|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092878|NCT00993421|3916474|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092879|NCT00993421|3916467|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4092880|NCT00993421|3916468|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4092881|NCT00993421|3916469|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4092882|NCT00993421|3916470|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4092883|NCT00993421|3916471|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4092884|NCT00993421|3916472|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4092885|NCT00993421|3916473|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4092886|NCT00993421|3916474|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4092887|NCT00993421|3916467|B8||White|Race (NIH/OMB)||Participants|Count of Participants|273|273.0||||||
4092888|NCT00993421|3916468|B7||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4092889|NCT00993421|3916469|B6||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4092890|NCT00993421|3916470|B5||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4092891|NCT00993421|3916471|B4||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4092892|NCT00993421|3916472|B3||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4092893|NCT00993421|3916473|B2||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4092894|NCT00993421|3916474|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4092895|NCT00993421|3916467|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4092896|NCT00993421|3916468|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4092897|NCT00993421|3916469|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4092898|NCT00993421|3916470|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4092899|NCT00993421|3916471|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4092900|NCT00993421|3916472|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4092901|NCT00993421|3916473|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4092902|NCT00993421|3916474|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4092903|NCT00993421|3916467|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4092904|NCT00993421|3916468|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4092905|NCT00993421|3916469|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092906|NCT00993421|3916470|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092907|NCT00993421|3916471|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4092908|NCT00993421|3916472|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092909|NCT00993421|3916473|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092910|NCT00993421|3916474|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092911|NCT00993421|3916467|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092912|NCT00993421|3916468|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092913|NCT00993421|3916469|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092915|NCT00993421|3916471|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092916|NCT00993421|3916472|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092917|NCT00993421|3916473|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092918|NCT00993421|3916474|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092919|NCT00993421|3916467|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4092920|NCT00993421|3916468|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092921|NCT00993421|3916469|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4092922|NCT00993421|3916470|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092923|NCT00993421|3916471|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4092924|NCT00993421|3916472|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092925|NCT00993421|3916473|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092926|NCT00993421|3916474|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4092927|NCT00993421|3916467|B8||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4092928|NCT00993421|3916468|B7||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4092929|NCT00993421|3916469|B6||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4092930|NCT00993421|3916470|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4092931|NCT00993421|3916471|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4092932|NCT00993421|3916472|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4092933|NCT00993421|3916473|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4092934|NCT00993421|3916474|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4092935|NCT00993421|3916467|B8||Female|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4092936|NCT00993421|3916468|B7||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4092937|NCT00993421|3916469|B6||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4092938|NCT00993421|3916470|B5||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4092939|NCT00993421|3916471|B4||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4092940|NCT00993421|3916472|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4092941|NCT00993421|3916473|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4092942|NCT00993421|3916474|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4092943|NCT00993421|3916467|B8|||Age||years|Mean|44.09|44.09|Standard Deviation|10.68|10.68|||
4092944|NCT00993421|3916468|B7|||Age||years|Mean|43.93|43.93|Standard Deviation|10.15|10.15|||
4092945|NCT00993421|3916469|B6|||Age||years|Mean|45.80|45.8|Standard Deviation|9.15|9.15|||
4092946|NCT00993421|3916470|B5|||Age||years|Mean|44.15|44.15|Standard Deviation|10.71|10.71|||
4092947|NCT00993421|3916471|B4|||Age||years|Mean|43.42|43.42|Standard Deviation|11.06|11.06|||
4092948|NCT00993421|3916472|B3|||Age||years|Mean|44.68|44.68|Standard Deviation|12.00|12.0|||
4092949|NCT00993421|3916473|B2|||Age||years|Mean|43.89|43.89|Standard Deviation|11.02|11.02|||
4092950|NCT00993421|3916474|B1|||Age||years|Mean|42.71|42.71|Standard Deviation|10.86|10.86|||
4092951|NCT00993317|3916629|B3|||Health Assessment Questionnaire Disability Index (HAQ-DI)|Total Scale Range: 0(Minimum)-3(Maximum) Lower values represent a better outcome.|scores on a scale|Mean|1.46|1.46|Standard Deviation|0.69|0.69|||
4092952|NCT00993317|3916630|B2|||Health Assessment Questionnaire Disability Index (HAQ-DI)|Total Scale Range: 0(Minimum)-3(Maximum) Lower values represent a better outcome.|scores on a scale|Mean|1.43|1.43|Standard Deviation|0.67|0.67|||
4092953|NCT00993317|3916631|B1|||Health Assessment Questionnaire Disability Index (HAQ-DI)|Total Scale Range: 0(Minimum)-3(Maximum) Lower values represent a better outcome.|scores on a scale|Mean|1.53|1.53|Standard Deviation|0.74|0.74|||
4092954|NCT00993317|3916629|B3|||Swollen Joint Count|Swollen joint count range from 0-66|Joints/participants|Mean|16.41|16.41|Standard Deviation|9.66|9.66|||
4092955|NCT00993317|3916630|B2|||Swollen Joint Count|Swollen joint count range from 0-66|Joints/participants|Mean|15.96|15.96|Standard Deviation|8.86|8.86|||
4092956|NCT00993317|3916631|B1|||Swollen Joint Count|Swollen joint count range from 0-66|Joints/participants|Mean|17.31|17.31|Standard Deviation|11.18|11.18|||
4092957|NCT00993317|3916629|B3|||Tender/Painful Joint Count|Tender/Painful joint count range from 0-68|Joints/participants|Mean|25.04|25.04|Standard Deviation|14.44|14.44|||
4092958|NCT00993317|3916630|B2|||Tender/Painful Joint Count|Tender/Painful joint count range from 0-68|Joints/participants|Mean|25.04|25.04|Standard Deviation|14.44|14.44|||
4092959|NCT00993317|3916631|B1|||Tender/Painful Joint Count|Tender/Painful joint count range from 0-68|Joints/participants|Mean|25.05|25.05|Standard Deviation|14.61|14.61|||
4092960|NCT00993317|3916629|B3|||Number of previous disease-modifying anti-rheumatoid drugs (DMARDs)||drugs/participants|Mean|3.3|3.3|Standard Deviation|1.4|1.4|||
4092961|NCT00993317|3916630|B2|||Number of previous disease-modifying anti-rheumatoid drugs (DMARDs)||drugs/participants|Mean|3.3|3.3|Standard Deviation|1.3|1.3|||
4092962|NCT00993317|3916631|B1|||Number of previous disease-modifying anti-rheumatoid drugs (DMARDs)||drugs/participants|Mean|3.2|3.2|Standard Deviation|1.5|1.5|||
4092963|NCT00993317|3916629|B3|||Concomitant MTX dose||mg/week|Mean|13.5|13.5|Standard Deviation|2.6|2.6|||
4092964|NCT00993317|3916630|B2|||Concomitant MTX dose||mg/week|Mean|13.4|13.4|Standard Deviation|2.5|2.5|||
4092965|NCT00993317|3916631|B1|||Concomitant MTX dose||mg/week|Mean|13.6|13.6|Standard Deviation|2.8|2.8|||
4092966|NCT00993317|3916629|B3|||Disease Duration||years|Mean|6.3|6.3|Standard Deviation|4.5|4.5|||
4092967|NCT00993317|3916630|B2|||Disease Duration||years|Mean|6.4|6.4|Standard Deviation|4.2|4.2|||
4092968|NCT00993317|3916631|B1|||Disease Duration||years|Mean|6.0|6.0|Standard Deviation|5.1|5.1|||
4092969|NCT00993317|3916629|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4092970|NCT00993317|3916630|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4092971|NCT00993317|3916631|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4092972|NCT00993317|3916629|B3||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4092973|NCT00993317|3916630|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4092974|NCT00993317|3916631|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4092975|NCT00993317|3916629|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4092976|NCT00993317|3916630|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4092977|NCT00993317|3916631|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4092978|NCT00993317|3916629|B3||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
4092979|NCT00993317|3916630|B2||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
4092980|NCT00993317|3916631|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4092981|NCT00993317|3916629|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4092982|NCT00993317|3916630|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4092983|NCT00993317|3916631|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4092984|NCT00993291|3916650|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4092985|NCT00993291|3916650|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4092986|NCT00993291|3916650|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4092987|NCT00993291|3916650|B1|||Age||years|Mean|62|62.0|Standard Deviation|5.54|5.54|||
4092988|NCT00993291|3916650|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4092989|NCT00993291|3916650|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4092990|NCT00993291|3916650|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4092991|NCT00993265|3916654|B3|||The Children's Depression Inventory (CDI)|The Children's Depression Inventory (CDI) assesses depressive symptoms in children. The assessment contains 27 items rated on a scale of 0-2, with scores ranging from 0-54. The higher the score, the more severe the depressive symptoms.|units on a scale|Mean|11.6|11.6|Standard Deviation|8.5|8.5|||
4092992|NCT00993265|3916655|B2|||The Children's Depression Inventory (CDI)|The Children's Depression Inventory (CDI) assesses depressive symptoms in children. The assessment contains 27 items rated on a scale of 0-2, with scores ranging from 0-54. The higher the score, the more severe the depressive symptoms.|units on a scale|Mean|10.8|10.8|Standard Deviation|8.5|8.5|||
4092993|NCT00993265|3916656|B1|||The Children's Depression Inventory (CDI)|The Children's Depression Inventory (CDI) assesses depressive symptoms in children. The assessment contains 27 items rated on a scale of 0-2, with scores ranging from 0-54. The higher the score, the more severe the depressive symptoms.|units on a scale|Mean|12.4|12.4|Standard Deviation|6.8|6.8|||
4092994|NCT00993265|3916654|B3|||Multidimensional Anxiety Scale for Children (MASC)|The Multidimensional Anxiety Scale for Children (MASC) assesses major dimensions of anxiety in children. The MASC contains 39 items rated on a scale of 0-3. Scores range from 0-117. The higher the score, the greater the anxiety.|units on a scale|Mean|50.8|50.8|Standard Deviation|19.0|19.0|||
4092995|NCT00993265|3916655|B2|||Multidimensional Anxiety Scale for Children (MASC)|The Multidimensional Anxiety Scale for Children (MASC) assesses major dimensions of anxiety in children. The MASC contains 39 items rated on a scale of 0-3. Scores range from 0-117. The higher the score, the greater the anxiety.|units on a scale|Mean|52.9|52.9|Standard Deviation|18.6|18.6|||
4092996|NCT00993265|3916656|B1|||Multidimensional Anxiety Scale for Children (MASC)|The Multidimensional Anxiety Scale for Children (MASC) assesses major dimensions of anxiety in children. The MASC contains 39 items rated on a scale of 0-3. Scores range from 0-117. The higher the score, the greater the anxiety.|units on a scale|Mean|48.7|48.7|Standard Deviation|19.0|19.0|||
4092997|NCT00993265|3916654|B3|Baseline MIST-C Automatic Pulling Subscale||The Milwaukee Inventory for Styles of Trichotillomania (MIST) - Child Version|"The Milwaukee Inventory for Styles of Trichotillomania (MIST) - Child Version assesses focused pulling, hair pulling that occurs intentionally to relieve tension or distress, and automatic pulling, hair pulling that occurs outside of the child's attention. This scale contains 25 questions, 21 questions in the focused pulling subscale and 4 questions in the automatic pulling subscale. The scores range from 0-36 on the automatic pulling subscale and 0-189 on the focused pulling subscale. Higher scores on the subscales indicate more of the hair pulling is of that style."|units on a scale|Mean|14.18|14.18|Standard Deviation|9.8|9.8|||
4092998|NCT00993265|3916655|B2|Baseline MIST-C Automatic Pulling Subscale||The Milwaukee Inventory for Styles of Trichotillomania (MIST) - Child Version|"The Milwaukee Inventory for Styles of Trichotillomania (MIST) - Child Version assesses focused pulling, hair pulling that occurs intentionally to relieve tension or distress, and automatic pulling, hair pulling that occurs outside of the child's attention. This scale contains 25 questions, 21 questions in the focused pulling subscale and 4 questions in the automatic pulling subscale. The scores range from 0-36 on the automatic pulling subscale and 0-189 on the focused pulling subscale. Higher scores on the subscales indicate more of the hair pulling is of that style."|units on a scale|Mean|16.26|16.26|Standard Deviation|9.8|9.8|||
4092999|NCT00993265|3916656|B1|Baseline MIST-C Automatic Pulling Subscale||The Milwaukee Inventory for Styles of Trichotillomania (MIST) - Child Version|"The Milwaukee Inventory for Styles of Trichotillomania (MIST) - Child Version assesses focused pulling, hair pulling that occurs intentionally to relieve tension or distress, and automatic pulling, hair pulling that occurs outside of the child's attention. This scale contains 25 questions, 21 questions in the focused pulling subscale and 4 questions in the automatic pulling subscale. The scores range from 0-36 on the automatic pulling subscale and 0-189 on the focused pulling subscale. Higher scores on the subscales indicate more of the hair pulling is of that style."|units on a scale|Mean|12.10|12.1|Standard Deviation|9.3|9.3|||
4093071|NCT00993148|3916709|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4093000|NCT00993265|3916654|B3|Baseline MIST-C Focused Pulling Subscale||The Milwaukee Inventory for Styles of Trichotillomania (MIST) - Child Version|"The Milwaukee Inventory for Styles of Trichotillomania (MIST) - Child Version assesses focused pulling, hair pulling that occurs intentionally to relieve tension or distress, and automatic pulling, hair pulling that occurs outside of the child's attention. This scale contains 25 questions, 21 questions in the focused pulling subscale and 4 questions in the automatic pulling subscale. The scores range from 0-36 on the automatic pulling subscale and 0-189 on the focused pulling subscale. Higher scores on the subscales indicate more of the hair pulling is of that style."|units on a scale|Mean|92.4|92.4|Standard Deviation|35.2|35.2|||
4093001|NCT00993265|3916655|B2|Baseline MIST-C Focused Pulling Subscale||The Milwaukee Inventory for Styles of Trichotillomania (MIST) - Child Version|"The Milwaukee Inventory for Styles of Trichotillomania (MIST) - Child Version assesses focused pulling, hair pulling that occurs intentionally to relieve tension or distress, and automatic pulling, hair pulling that occurs outside of the child's attention. This scale contains 25 questions, 21 questions in the focused pulling subscale and 4 questions in the automatic pulling subscale. The scores range from 0-36 on the automatic pulling subscale and 0-189 on the focused pulling subscale. Higher scores on the subscales indicate more of the hair pulling is of that style."|units on a scale|Mean|90.8|90.8|Standard Deviation|30.5|30.5|||
4093002|NCT00993265|3916656|B1|Baseline MIST-C Focused Pulling Subscale||The Milwaukee Inventory for Styles of Trichotillomania (MIST) - Child Version|"The Milwaukee Inventory for Styles of Trichotillomania (MIST) - Child Version assesses focused pulling, hair pulling that occurs intentionally to relieve tension or distress, and automatic pulling, hair pulling that occurs outside of the child's attention. This scale contains 25 questions, 21 questions in the focused pulling subscale and 4 questions in the automatic pulling subscale. The scores range from 0-36 on the automatic pulling subscale and 0-189 on the focused pulling subscale. Higher scores on the subscales indicate more of the hair pulling is of that style."|units on a scale|Mean|94|94.0|Standard Deviation|35.2|35.2|||
4093003|NCT00993265|3916654|B3|||The Trichotillomania Scale for Children (TSC)-Parent Report|The Trichotillomania Scale for Children (TSC) - Parent Version assesses hair pulling severity, distress, and impairment in children. The scale is split into two sections (severity and distress/impairment), with 12 questions (5 severity and 7 distress/impairment). The severity score is summed from questions 1-5 and divided by 5. The distress/impairment score is summed from questions 6-12 and divided by 7. The total score is calculated by summing the severity score and the distress/impairment score. Scores range from 0-4. Higher total scores indicate greater severity/distress/impairment.|units on a scale|Mean|2.26|2.26|Standard Deviation|0.71|0.71|||
4093004|NCT00993265|3916655|B2|||The Trichotillomania Scale for Children (TSC)-Parent Report|The Trichotillomania Scale for Children (TSC) - Parent Version assesses hair pulling severity, distress, and impairment in children. The scale is split into two sections (severity and distress/impairment), with 12 questions (5 severity and 7 distress/impairment). The severity score is summed from questions 1-5 and divided by 5. The distress/impairment score is summed from questions 6-12 and divided by 7. The total score is calculated by summing the severity score and the distress/impairment score. Scores range from 0-4. Higher total scores indicate greater severity/distress/impairment.|units on a scale|Mean|2.32|2.32|Standard Deviation|0.71|0.71|||
4093005|NCT00993265|3916656|B1|||The Trichotillomania Scale for Children (TSC)-Parent Report|The Trichotillomania Scale for Children (TSC) - Parent Version assesses hair pulling severity, distress, and impairment in children. The scale is split into two sections (severity and distress/impairment), with 12 questions (5 severity and 7 distress/impairment). The severity score is summed from questions 1-5 and divided by 5. The distress/impairment score is summed from questions 6-12 and divided by 7. The total score is calculated by summing the severity score and the distress/impairment score. Scores range from 0-4. Higher total scores indicate greater severity/distress/impairment.|units on a scale|Mean|2.20|2.2|Standard Deviation|0.71|0.71|||
4093006|NCT00993265|3916654|B3|||The Trichotillomania Scale for Children (TSC)-Child Report|The Trichotillomania Scale for Children (TSC) - Child Version assesses hair pulling severity, distress, and impairment in children. The scale is split into two sections (severity and distress/impairment), with 12 questions (5 severity and 7 distress/impairment). The severity score is summed from questions 1-5 and divided by 5. The distress/impairment score is summed from questions 6-12 and divided by 7. The total score is calculated by summing the severity score and the distress/impairment score. Scores range from 0-4. Higher total scores indicate greater severity/distress/impairment.|units on a scale|Mean|2.44|2.44|Standard Deviation|.85|0.85|||
4093007|NCT00993265|3916655|B2|||The Trichotillomania Scale for Children (TSC)-Child Report|The Trichotillomania Scale for Children (TSC) - Child Version assesses hair pulling severity, distress, and impairment in children. The scale is split into two sections (severity and distress/impairment), with 12 questions (5 severity and 7 distress/impairment). The severity score is summed from questions 1-5 and divided by 5. The distress/impairment score is summed from questions 6-12 and divided by 7. The total score is calculated by summing the severity score and the distress/impairment score. Scores range from 0-4. Higher total scores indicate greater severity/distress/impairment.|units on a scale|Mean|2.52|2.52|Standard Deviation|.85|0.85|||
4093008|NCT00993265|3916656|B1|||The Trichotillomania Scale for Children (TSC)-Child Report|The Trichotillomania Scale for Children (TSC) - Child Version assesses hair pulling severity, distress, and impairment in children. The scale is split into two sections (severity and distress/impairment), with 12 questions (5 severity and 7 distress/impairment). The severity score is summed from questions 1-5 and divided by 5. The distress/impairment score is summed from questions 6-12 and divided by 7. The total score is calculated by summing the severity score and the distress/impairment score. Scores range from 0-4. Higher total scores indicate greater severity/distress/impairment.|units on a scale|Mean|2.35|2.35|Standard Deviation|.74|0.74|||
4093009|NCT00993265|3916654|B3|||Massachusetts General Hospital - Hairpulling Scale (MGH-HPS)|The Massachusetts General Hospital - Hairpulling Scale (MGH-HPS) is a 7-question scale that measures the severity of hair pulling. The scale ranges from 0-28. The higher the score, the more severe the hairpulling.|units on a scale|Mean|14.9|14.9|Standard Deviation|5.3|5.3|||
4093010|NCT00993265|3916655|B2|||Massachusetts General Hospital - Hairpulling Scale (MGH-HPS)|The Massachusetts General Hospital - Hairpulling Scale (MGH-HPS) is a 7-question scale that measures the severity of hair pulling. The scale ranges from 0-28. The higher the score, the more severe the hairpulling.|units on a scale|Mean|16.6|16.6|Standard Deviation|4.8|4.8|||
4093189|NCT00992836|3916778|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4093011|NCT00993265|3916656|B1|||Massachusetts General Hospital - Hairpulling Scale (MGH-HPS)|The Massachusetts General Hospital - Hairpulling Scale (MGH-HPS) is a 7-question scale that measures the severity of hair pulling. The scale ranges from 0-28. The higher the score, the more severe the hairpulling.|units on a scale|Mean|13.2|13.2|Standard Deviation|5.3|5.3|||
4093012|NCT00993265|3916654|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
4093013|NCT00993265|3916655|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4093014|NCT00993265|3916656|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4093015|NCT00993265|3916654|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4093016|NCT00993265|3916655|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4093017|NCT00993265|3916656|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4093018|NCT00993265|3916654|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4093019|NCT00993265|3916655|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4093020|NCT00993265|3916656|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4093021|NCT00993265|3916654|B3|||Age||years|Mean|13.5|13.5|Standard Deviation|2.8|2.8|||
4093022|NCT00993265|3916655|B2|||Age||years|Mean|13.1|13.1|Standard Deviation|3.1|3.1|||
4093023|NCT00993265|3916656|B1|||Age||years|Mean|14|14.0|Standard Deviation|2.4|2.4|||
4093024|NCT00993265|3916654|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4093025|NCT00993265|3916655|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4093026|NCT00993265|3916656|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4093027|NCT00993265|3916654|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4093028|NCT00993265|3916655|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4093029|NCT00993265|3916656|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4093030|NCT00993265|3916654|B3||<=18 years|Age||Participants|Count of Participants|39|39.0||||||
4093031|NCT00993265|3916655|B2||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
4093032|NCT00993265|3916656|B1||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
4093033|NCT00993200|3916675|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4093034|NCT00993200|3916676|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4093035|NCT00993200|3916677|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4093036|NCT00993200|3916675|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4093037|NCT00993200|3916676|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4093038|NCT00993200|3916677|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4093039|NCT00993200|3916675|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4093040|NCT00993200|3916676|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4093041|NCT00993200|3916677|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4093042|NCT00993200|3916675|B3|||Age||years|Mean|52|52.0|Standard Deviation|10|10.0|||
4093043|NCT00993200|3916676|B2|||Age||years|Mean|59|59.0|Standard Deviation|10|10.0|||
4093044|NCT00993200|3916677|B1|||Age||years|Mean|45|45.0|Standard Deviation|10|10.0|||
4093045|NCT00993200|3916675|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4093046|NCT00993200|3916676|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4093047|NCT00993200|3916677|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4093048|NCT00993200|3916675|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4093049|NCT00993200|3916676|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4093050|NCT00993200|3916677|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4093051|NCT00993200|3916675|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093052|NCT00993200|3916676|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093053|NCT00993200|3916677|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093054|NCT00993187|3916688|B3||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4093055|NCT00993187|3916689|B2||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4093056|NCT00993187|3916690|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4093057|NCT00993187|3916688|B3||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4093058|NCT00993187|3916689|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4093059|NCT00993187|3916690|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4093060|NCT00993187|3916688|B3|||Age||Years|Mean|53.9|53.9|Standard Deviation|8.9|8.9|||
4093061|NCT00993187|3916689|B2|||Age||Years|Mean|53.1|53.1|Standard Deviation|9.2|9.2|||
4093062|NCT00993187|3916690|B1|||Age||Years|Mean|54.8|54.8|Standard Deviation|8.5|8.5|||
4093063|NCT00993148|3916709|B1|||Median HIV-1 RNA|Median HIV-1 RNA|log 10 copies|Median|4.62|4.62|Inter-Quartile Range|||4.18|4.8|
4093064|NCT00993148|3916709|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4093065|NCT00993148|3916709|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4093066|NCT00993148|3916709|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4093067|NCT00993148|3916709|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4093068|NCT00993148|3916709|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4093069|NCT00993148|3916709|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4093070|NCT00993148|3916709|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4093072|NCT00993148|3916709|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4093073|NCT00993148|3916709|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4093074|NCT00993148|3916709|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4093075|NCT00993148|3916709|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4093076|NCT00993148|3916709|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4093077|NCT00993148|3916709|B1|||Age||years|Median|38|38.0|Inter-Quartile Range|||31.0|43.0|
4093078|NCT00993044|3916721|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4093079|NCT00993044|3916721|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4093080|NCT00993044|3916721|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4093081|NCT00993044|3916721|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4093082|NCT00993044|3916721|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4093083|NCT00993044|3916721|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4093084|NCT00993044|3916721|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4093085|NCT00993044|3916721|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4093086|NCT00993044|3916721|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4093087|NCT00993044|3916721|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4093088|NCT00993044|3916721|B1|||Age||Years|Median|11|11.0|Full Range|||3.9|19.4|
4093089|NCT00993031|3916726|B3|4||WHO stage HIV disease|Stage 1=Asymptomatic; Stage 2= Moderate unexplained weight loss, Recurrent respiratory infections, Herpes zoster, Angular cheilitis, Recurrent oral ulceration, Papular pruritic eruptions, Seborrheic dermatitis, Fungal nail infections; Stage 3=Unexplained severe weight loss, Unexplained chronic diarrhea for >1 month, Unexplained persistent fever for >1 month, Persistent oral candidiasis, Oral hairy leukoplakia, Pulmonary tuberculosis, Severe presumed bacterial infections, Acute necrotizing ulcerative stomatitis, gingivitis, or periodontitis; Unexplained anemia; Stage 4 =HIV wasting syndrome,etc|participants|Number|0|0.0||||||
4093090|NCT00993031|3916727|B2|4||WHO stage HIV disease|Stage 1=Asymptomatic; Stage 2= Moderate unexplained weight loss, Recurrent respiratory infections, Herpes zoster, Angular cheilitis, Recurrent oral ulceration, Papular pruritic eruptions, Seborrheic dermatitis, Fungal nail infections; Stage 3=Unexplained severe weight loss, Unexplained chronic diarrhea for >1 month, Unexplained persistent fever for >1 month, Persistent oral candidiasis, Oral hairy leukoplakia, Pulmonary tuberculosis, Severe presumed bacterial infections, Acute necrotizing ulcerative stomatitis, gingivitis, or periodontitis; Unexplained anemia; Stage 4 =HIV wasting syndrome,etc|participants|Number|0|0.0||||||
4093091|NCT00993031|3916728|B1|4||WHO stage HIV disease|Stage 1=Asymptomatic; Stage 2= Moderate unexplained weight loss, Recurrent respiratory infections, Herpes zoster, Angular cheilitis, Recurrent oral ulceration, Papular pruritic eruptions, Seborrheic dermatitis, Fungal nail infections; Stage 3=Unexplained severe weight loss, Unexplained chronic diarrhea for >1 month, Unexplained persistent fever for >1 month, Persistent oral candidiasis, Oral hairy leukoplakia, Pulmonary tuberculosis, Severe presumed bacterial infections, Acute necrotizing ulcerative stomatitis, gingivitis, or periodontitis; Unexplained anemia; Stage 4 =HIV wasting syndrome,etc|participants|Number|0|0.0||||||
4093092|NCT00993031|3916726|B3|3||WHO stage HIV disease|Stage 1=Asymptomatic; Stage 2= Moderate unexplained weight loss, Recurrent respiratory infections, Herpes zoster, Angular cheilitis, Recurrent oral ulceration, Papular pruritic eruptions, Seborrheic dermatitis, Fungal nail infections; Stage 3=Unexplained severe weight loss, Unexplained chronic diarrhea for >1 month, Unexplained persistent fever for >1 month, Persistent oral candidiasis, Oral hairy leukoplakia, Pulmonary tuberculosis, Severe presumed bacterial infections, Acute necrotizing ulcerative stomatitis, gingivitis, or periodontitis; Unexplained anemia; Stage 4 =HIV wasting syndrome,etc|participants|Number|1|1.0||||||
4093093|NCT00993031|3916727|B2|3||WHO stage HIV disease|Stage 1=Asymptomatic; Stage 2= Moderate unexplained weight loss, Recurrent respiratory infections, Herpes zoster, Angular cheilitis, Recurrent oral ulceration, Papular pruritic eruptions, Seborrheic dermatitis, Fungal nail infections; Stage 3=Unexplained severe weight loss, Unexplained chronic diarrhea for >1 month, Unexplained persistent fever for >1 month, Persistent oral candidiasis, Oral hairy leukoplakia, Pulmonary tuberculosis, Severe presumed bacterial infections, Acute necrotizing ulcerative stomatitis, gingivitis, or periodontitis; Unexplained anemia; Stage 4 =HIV wasting syndrome,etc|participants|Number|0|0.0||||||
4093094|NCT00993031|3916728|B1|3||WHO stage HIV disease|Stage 1=Asymptomatic; Stage 2= Moderate unexplained weight loss, Recurrent respiratory infections, Herpes zoster, Angular cheilitis, Recurrent oral ulceration, Papular pruritic eruptions, Seborrheic dermatitis, Fungal nail infections; Stage 3=Unexplained severe weight loss, Unexplained chronic diarrhea for >1 month, Unexplained persistent fever for >1 month, Persistent oral candidiasis, Oral hairy leukoplakia, Pulmonary tuberculosis, Severe presumed bacterial infections, Acute necrotizing ulcerative stomatitis, gingivitis, or periodontitis; Unexplained anemia; Stage 4 =HIV wasting syndrome,etc|participants|Number|1|1.0||||||
4093095|NCT00993031|3916726|B3|2||WHO stage HIV disease|Stage 1=Asymptomatic; Stage 2= Moderate unexplained weight loss, Recurrent respiratory infections, Herpes zoster, Angular cheilitis, Recurrent oral ulceration, Papular pruritic eruptions, Seborrheic dermatitis, Fungal nail infections; Stage 3=Unexplained severe weight loss, Unexplained chronic diarrhea for >1 month, Unexplained persistent fever for >1 month, Persistent oral candidiasis, Oral hairy leukoplakia, Pulmonary tuberculosis, Severe presumed bacterial infections, Acute necrotizing ulcerative stomatitis, gingivitis, or periodontitis; Unexplained anemia; Stage 4 =HIV wasting syndrome,etc|participants|Number|18|18.0||||||
4093096|NCT00993031|3916727|B2|2||WHO stage HIV disease|Stage 1=Asymptomatic; Stage 2= Moderate unexplained weight loss, Recurrent respiratory infections, Herpes zoster, Angular cheilitis, Recurrent oral ulceration, Papular pruritic eruptions, Seborrheic dermatitis, Fungal nail infections; Stage 3=Unexplained severe weight loss, Unexplained chronic diarrhea for >1 month, Unexplained persistent fever for >1 month, Persistent oral candidiasis, Oral hairy leukoplakia, Pulmonary tuberculosis, Severe presumed bacterial infections, Acute necrotizing ulcerative stomatitis, gingivitis, or periodontitis; Unexplained anemia; Stage 4 =HIV wasting syndrome,etc|participants|Number|5|5.0||||||
4093097|NCT00993031|3916728|B1|2||WHO stage HIV disease|Stage 1=Asymptomatic; Stage 2= Moderate unexplained weight loss, Recurrent respiratory infections, Herpes zoster, Angular cheilitis, Recurrent oral ulceration, Papular pruritic eruptions, Seborrheic dermatitis, Fungal nail infections; Stage 3=Unexplained severe weight loss, Unexplained chronic diarrhea for >1 month, Unexplained persistent fever for >1 month, Persistent oral candidiasis, Oral hairy leukoplakia, Pulmonary tuberculosis, Severe presumed bacterial infections, Acute necrotizing ulcerative stomatitis, gingivitis, or periodontitis; Unexplained anemia; Stage 4 =HIV wasting syndrome,etc|participants|Number|13|13.0||||||
4093098|NCT00993031|3916726|B3|1||WHO stage HIV disease|Stage 1=Asymptomatic; Stage 2= Moderate unexplained weight loss, Recurrent respiratory infections, Herpes zoster, Angular cheilitis, Recurrent oral ulceration, Papular pruritic eruptions, Seborrheic dermatitis, Fungal nail infections; Stage 3=Unexplained severe weight loss, Unexplained chronic diarrhea for >1 month, Unexplained persistent fever for >1 month, Persistent oral candidiasis, Oral hairy leukoplakia, Pulmonary tuberculosis, Severe presumed bacterial infections, Acute necrotizing ulcerative stomatitis, gingivitis, or periodontitis; Unexplained anemia; Stage 4 =HIV wasting syndrome,etc|participants|Number|370|370.0||||||
4093099|NCT00993031|3916727|B2|1||WHO stage HIV disease|Stage 1=Asymptomatic; Stage 2= Moderate unexplained weight loss, Recurrent respiratory infections, Herpes zoster, Angular cheilitis, Recurrent oral ulceration, Papular pruritic eruptions, Seborrheic dermatitis, Fungal nail infections; Stage 3=Unexplained severe weight loss, Unexplained chronic diarrhea for >1 month, Unexplained persistent fever for >1 month, Persistent oral candidiasis, Oral hairy leukoplakia, Pulmonary tuberculosis, Severe presumed bacterial infections, Acute necrotizing ulcerative stomatitis, gingivitis, or periodontitis; Unexplained anemia; Stage 4 =HIV wasting syndrome,etc|participants|Number|189|189.0||||||
4093100|NCT00993031|3916728|B1|1||WHO stage HIV disease|Stage 1=Asymptomatic; Stage 2= Moderate unexplained weight loss, Recurrent respiratory infections, Herpes zoster, Angular cheilitis, Recurrent oral ulceration, Papular pruritic eruptions, Seborrheic dermatitis, Fungal nail infections; Stage 3=Unexplained severe weight loss, Unexplained chronic diarrhea for >1 month, Unexplained persistent fever for >1 month, Persistent oral candidiasis, Oral hairy leukoplakia, Pulmonary tuberculosis, Severe presumed bacterial infections, Acute necrotizing ulcerative stomatitis, gingivitis, or periodontitis; Unexplained anemia; Stage 4 =HIV wasting syndrome,etc|participants|Number|181|181.0||||||
4093101|NCT00993031|3916726|B3|||HIV RNA load||log10 copies/mL|Median|4.1|4.1|Inter-Quartile Range|||3.4|4.8|
4093102|NCT00993031|3916727|B2|||HIV RNA load||log10 copies/mL|Median|4.1|4.1|Inter-Quartile Range|||3.3|4.7|
4093103|NCT00993031|3916728|B1|||HIV RNA load||log10 copies/mL|Median|4.3|4.3|Inter-Quartile Range|||3.5|4.8|
4093104|NCT00993031|3916726|B3|||CD4+ T-cell count||cells/mm3|Median|370.5|370.5|Inter-Quartile Range|||274.0|494.0|
4093105|NCT00993031|3916727|B2|||CD4+ T-cell count||cells/mm3|Median|368|368.0|Inter-Quartile Range|||282.0|506.0|
4093106|NCT00993031|3916728|B1|||CD4+ T-cell count||cells/mm3|Median|374|374.0|Inter-Quartile Range|||270.0|485.0|
4093107|NCT00993031|3916726|B3|||Hemoglobin level, g/dL||g/dL|Mean|10.9|10.9|Standard Deviation|1.8|1.8|||
4093108|NCT00993031|3916727|B2|||Hemoglobin level, g/dL||g/dL|Mean|11.0|11.0|Standard Deviation|1.2|1.2|||
4093109|NCT00993031|3916728|B1|||Hemoglobin level, g/dL||g/dL|Mean|10.9|10.9|Standard Deviation|1.3|1.3|||
4093110|NCT00993031|3916726|B3|||Receiving TMP-SMX prophylaxis at enrollment|Trimethoprim/sulfamethoxazole (TMP-SMX) is an antibiotic used to treat a variety of bacterial infections. It consists of one part trimethoprim to five parts sulfamethoxazole.|participants|Number|249|249.0||||||
4093111|NCT00993031|3916727|B2|||Receiving TMP-SMX prophylaxis at enrollment|Trimethoprim/sulfamethoxazole (TMP-SMX) is an antibiotic used to treat a variety of bacterial infections. It consists of one part trimethoprim to five parts sulfamethoxazole.|participants|Number|124|124.0||||||
4093112|NCT00993031|3916728|B1|||Receiving TMP-SMX prophylaxis at enrollment|Trimethoprim/sulfamethoxazole (TMP-SMX) is an antibiotic used to treat a variety of bacterial infections. It consists of one part trimethoprim to five parts sulfamethoxazole.|participants|Number|125|125.0||||||
4093113|NCT00993031|3916726|B3|Unknown||Bed Net Ownership||participants|Number|1|1.0||||||
4093114|NCT00993031|3916727|B2|Unknown||Bed Net Ownership||participants|Number|1|1.0||||||
4093115|NCT00993031|3916728|B1|Unknown||Bed Net Ownership||participants|Number|0|0.0||||||
4093116|NCT00993031|3916726|B3|Yes; unknown treatment status||Bed Net Ownership||participants|Number|10|10.0||||||
4093117|NCT00993031|3916727|B2|Yes; unknown treatment status||Bed Net Ownership||participants|Number|5|5.0||||||
4093118|NCT00993031|3916728|B1|Yes; unknown treatment status||Bed Net Ownership||participants|Number|5|5.0||||||
4093119|NCT00993031|3916726|B3|ITN||Bed Net Ownership||participants|Number|147|147.0||||||
4093120|NCT00993031|3916727|B2|ITN||Bed Net Ownership||participants|Number|70|70.0||||||
4093121|NCT00993031|3916728|B1|ITN||Bed Net Ownership||participants|Number|77|77.0||||||
4093122|NCT00993031|3916726|B3|Untreated||Bed Net Ownership||participants|Number|61|61.0||||||
4093123|NCT00993031|3916727|B2|Untreated||Bed Net Ownership||participants|Number|33|33.0||||||
4093124|NCT00993031|3916728|B1|Untreated||Bed Net Ownership||participants|Number|28|28.0||||||
4093125|NCT00993031|3916726|B3|None||Bed Net Ownership||participants|Number|170|170.0||||||
4093126|NCT00993031|3916727|B2|None||Bed Net Ownership||participants|Number|85|85.0||||||
4093127|NCT00993031|3916728|B1|None||Bed Net Ownership||participants|Number|85|85.0||||||
4093128|NCT00993031|3916726|B3|≥2||Previous Preganancies||participants|Number|320|320.0||||||
4093129|NCT00993031|3916727|B2|≥2||Previous Preganancies||participants|Number|161|161.0||||||
4093130|NCT00993031|3916728|B1|≥2||Previous Preganancies||participants|Number|159|159.0||||||
4093131|NCT00993031|3916726|B3|1||Previous Preganancies||participants|Number|45|45.0||||||
4093132|NCT00993031|3916727|B2|1||Previous Preganancies||participants|Number|25|25.0||||||
4093133|NCT00993031|3916728|B1|1||Previous Preganancies||participants|Number|20|20.0||||||
4093134|NCT00993031|3916726|B3|0||Previous Preganancies||participants|Number|24|24.0||||||
4093135|NCT00993031|3916727|B2|0||Previous Preganancies||participants|Number|8|8.0||||||
4093136|NCT00993031|3916728|B1|0||Previous Preganancies||participants|Number|16|16.0||||||
4093137|NCT00993031|3916726|B3|||Gestational Age, wk||weeks|Mean|21.1|21.1|Standard Deviation|5.9|5.9|||
4093138|NCT00993031|3916727|B2|||Gestational Age, wk||weeks|Mean|21.2|21.2|Standard Deviation|4.3|4.3|||
4093139|NCT00993031|3916728|B1|||Gestational Age, wk||weeks|Mean|21.1|21.1|Standard Deviation|4.1|4.1|||
4093140|NCT00993031|3916726|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4093141|NCT00993031|3916727|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4093142|NCT00993031|3916728|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4093143|NCT00993031|3916726|B3||Female|Sex: Female, Male||Participants|Count of Participants|389|389.0||||||
4093144|NCT00993031|3916727|B2||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4093145|NCT00993031|3916728|B1||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4093146|NCT00993031|3916726|B3|||Age||years|Mean|29.3|29.3|Standard Deviation|7.6|7.6|||
4093147|NCT00993031|3916727|B2|||Age||years|Mean|29.0|29.0|Standard Deviation|5.4|5.4|||
4093148|NCT00993031|3916728|B1|||Age||years|Mean|29.5|29.5|Standard Deviation|5.4|5.4|||
4093149|NCT00992992|3916747|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4093150|NCT00992992|3916747|B1|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4093151|NCT00992992|3916747|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4093152|NCT00992992|3916747|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4093153|NCT00992992|3916747|B1|||Age||Years|Mean|64.4|64.4|Standard Deviation|9.6|9.6|||
4093154|NCT00992927|3916767|B3|||Range of Motion (ROM) of the Glenohumeral Joint|"before intervention for all participants~using a goniometer~patient sitting on a stool with the arm at anatomical position~worst: 0 degree~best: 360 degree"|degree|Mean|215.20|215.2|Standard Deviation|44.555|44.555|||
4093155|NCT00992927|3916768|B2|||Range of Motion (ROM) of the Glenohumeral Joint|"before intervention for all participants~using a goniometer~patient sitting on a stool with the arm at anatomical position~worst: 0 degree~best: 360 degree"|degree|Mean|203.05|203.05|Standard Deviation|46.163|46.163|||
4093156|NCT00992927|3916769|B1|||Range of Motion (ROM) of the Glenohumeral Joint|"before intervention for all participants~using a goniometer~patient sitting on a stool with the arm at anatomical position~worst: 0 degree~best: 360 degree"|degree|Mean|223.56|223.56|Standard Deviation|42.111|42.111|||
4093157|NCT00992927|3916767|B3|||Pain Measured by Visual Analogue Scale (VAS)|"before intervention for all participants~using 10cm horizontal visual analog scale~best: 0cm (no pain)~worst: 10cm (worst pain)"|cm|Mean|6.99|6.99|Standard Deviation|2.65|2.65|||
4093158|NCT00992927|3916768|B2|||Pain Measured by Visual Analogue Scale (VAS)|"before intervention for all participants~using 10cm horizontal visual analog scale~best: 0cm (no pain)~worst: 10cm (worst pain)"|cm|Mean|7.17|7.17|Standard Deviation|2.09|2.09|||
4093159|NCT00992927|3916769|B1|||Pain Measured by Visual Analogue Scale (VAS)|"before intervention for all participants~using 10cm horizontal visual analog scale~best: 0cm (no pain)~worst: 10cm (worst pain)"|cm|Mean|6.87|6.87|Standard Deviation|3.01|3.01|||
4093160|NCT00992927|3916767|B3|Korea, Republic of||Region of Enrollment||participants|Number|54|54.0||||||
4093161|NCT00992927|3916768|B2|Korea, Republic of||Region of Enrollment||participants|Number|22|22.0||||||
4093162|NCT00992927|3916769|B1|Korea, Republic of||Region of Enrollment||participants|Number|32|32.0||||||
4093163|NCT00992927|3916767|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4093164|NCT00992927|3916768|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4093165|NCT00992927|3916769|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4093166|NCT00992927|3916767|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4093167|NCT00992927|3916768|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4093168|NCT00992927|3916769|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4093169|NCT00992927|3916767|B3|||Age||years|Mean|59.24|59.24|Standard Deviation|10.343|10.343|||
4093170|NCT00992927|3916768|B2|||Age||years|Mean|56.55|56.55|Standard Deviation|9.521|9.521|||
4093171|NCT00992927|3916769|B1|||Age||years|Mean|61.09|61.09|Standard Deviation|10.621|10.621|||
4093172|NCT00992927|3916767|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4093173|NCT00992927|3916768|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4093174|NCT00992927|3916769|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4093175|NCT00992927|3916767|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4093176|NCT00992927|3916768|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4093177|NCT00992927|3916769|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4093178|NCT00992927|3916767|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093179|NCT00992927|3916768|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093180|NCT00992927|3916769|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093181|NCT00992836|3916778|B1|||Percentage of CD4 Cells|This measures the percentage of CD4 cells.|percentage|Mean|29|29.0|Standard Deviation|11|11.0|||
4093182|NCT00992836|3916778|B1|||CD4 Cells Count|This measures the number of CD4 cells.|cells / mm^3|Mean|568|568.0|Standard Deviation|242|242.0|||
4093183|NCT00992836|3916778|B1|>=18 to < 25 years old||Age Strata|Study participants were stratified by age into three groups.|Participants|Number|50|50.0||||||
4093184|NCT00992836|3916778|B1|>=9 to < 18 years old||Age Strata|Study participants were stratified by age into three groups.|Participants|Number|51|51.0||||||
4093185|NCT00992836|3916778|B1|>=4 to < 9 years old||Age Strata|Study participants were stratified by age into three groups.|Participants|Number|54|54.0||||||
4093186|NCT00992836|3916778|B1|Puerto Rico||Region of Enrollment||participants|Number|8|8.0||||||
4093187|NCT00992836|3916778|B1|United States||Region of Enrollment||participants|Number|147|147.0||||||
4093188|NCT00992836|3916778|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4093190|NCT00992836|3916778|B1|||Age||years|Mean|13|13.0|Standard Deviation|6|6.0|||
4093191|NCT00992784|3916790|B4||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4093192|NCT00992784|3916791|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4093193|NCT00992784|3916792|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4093194|NCT00992784|3916793|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4093195|NCT00992784|3916790|B4||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4093196|NCT00992784|3916791|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4093197|NCT00992784|3916792|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4093198|NCT00992784|3916793|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4093199|NCT00992784|3916790|B4|||Age||Years|Mean|64.2|64.2|Standard Deviation|19.70|19.7|||
4093200|NCT00992784|3916791|B3|||Age||Years|Mean|29.9|29.9|Standard Deviation|6.55|6.55|||
4093201|NCT00992784|3916792|B2|||Age||Years|Mean|74.8|74.8|Standard Deviation|5.26|5.26|||
4093202|NCT00992784|3916793|B1|||Age||Years|Mean|74.5|74.5|Standard Deviation|5.18|5.18|||
4093203|NCT00992719|3916863|B4|United States||Region of Enrollment||participants|Number|84|84.0||||||
4093204|NCT00992719|3916864|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
4093205|NCT00992719|3916865|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4093206|NCT00992719|3916866|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4093207|NCT00992719|3916863|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4093208|NCT00992719|3916864|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4093209|NCT00992719|3916865|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4093210|NCT00992719|3916866|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4093211|NCT00992719|3916863|B4||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4093212|NCT00992719|3916864|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4093213|NCT00992719|3916865|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4093214|NCT00992719|3916866|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4093215|NCT00992719|3916863|B4|||Age||years|Mean|29.9|29.9|Standard Deviation|5.5|5.5|||
4093216|NCT00992719|3916864|B3|||Age||years|Mean|30.8|30.8|Standard Deviation|5.6|5.6|||
4093217|NCT00992719|3916865|B2|||Age||years|Mean|28.8|28.8|Standard Deviation|4.9|4.9|||
4093218|NCT00992719|3916866|B1|||Age||years|Mean|30|30.0|Standard Deviation|6.0|6.0|||
4093219|NCT00992719|3916863|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4093220|NCT00992719|3916864|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4093221|NCT00992719|3916865|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4093222|NCT00992719|3916866|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4093223|NCT00992719|3916863|B4||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
4093224|NCT00992719|3916864|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4093225|NCT00992719|3916865|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4093226|NCT00992719|3916866|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4093227|NCT00992719|3916863|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093228|NCT00992719|3916864|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093229|NCT00992719|3916865|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093230|NCT00992719|3916866|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093231|NCT00992602|3916902|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4093232|NCT00992602|3916902|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4093233|NCT00992602|3916902|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4093234|NCT00992602|3916902|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4093235|NCT00992602|3916902|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4093236|NCT00992602|3916902|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4093237|NCT00992602|3916902|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4093238|NCT00992602|3916902|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4093239|NCT00992602|3916902|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4093240|NCT00992602|3916902|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4093241|NCT00992602|3916902|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4093242|NCT00992602|3916902|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4093243|NCT00992602|3916902|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4093244|NCT00992602|3916902|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4093245|NCT00992602|3916902|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4093246|NCT00992602|3916902|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093247|NCT00992589|3916907|B1|>= 8 to < 12 Months||AgeCategorical||participants|Number|45|45.0||||||
4093248|NCT00992589|3916907|B1|>= 4 to < 8 Months||AgeCategorical||participants|Number|124|124.0||||||
4093249|NCT00992589|3916907|B1|>= 1 to < 4 Months||AgeCategorical||participants|Number|175|175.0||||||
4093250|NCT00992589|3916907|B1|UNITED STATES||Region of Enrollment||participants|Number|133|133.0||||||
4093251|NCT00992589|3916907|B1|SOUTH AFRICA||Region of Enrollment||participants|Number|12|12.0||||||
4093252|NCT00992589|3916907|B1|POLAND||Region of Enrollment||participants|Number|56|56.0||||||
4093253|NCT00992589|3916907|B1|NETHERLANDS||Region of Enrollment||participants|Number|9|9.0||||||
4093254|NCT00992589|3916907|B1|ITALY||Region of Enrollment||participants|Number|5|5.0||||||
4093255|NCT00992589|3916907|B1|ISRAEL||Region of Enrollment||participants|Number|36|36.0||||||
4093256|NCT00992589|3916907|B1|HUNGARY||Region of Enrollment||participants|Number|51|51.0||||||
4093257|NCT00992589|3916907|B1|BULGARIA||Region of Enrollment||participants|Number|24|24.0||||||
4093258|NCT00992589|3916907|B1|BELGIUM||Region of Enrollment||participants|Number|11|11.0||||||
4093259|NCT00992589|3916907|B1|AUSTRALIA||Region of Enrollment||participants|Number|7|7.0||||||
4093260|NCT00992589|3916907|B1||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4093261|NCT00992589|3916907|B1||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4093262|NCT00992589|3916907|B1|||Age||months|Mean|4.6|4.6|Standard Deviation|2.55|2.55|||
4093263|NCT00992459|3916952|B3||Male|Gender||Participants|Count of Participants|14|14.0||||||
4093264|NCT00992459|3916953|B2||Male|Gender||Participants|Count of Participants|7|7.0||||||
4093265|NCT00992459|3916954|B1||Male|Gender||Participants|Count of Participants|7|7.0||||||
4093266|NCT00992459|3916952|B3||Female|Gender||Participants|Count of Participants|32|32.0||||||
4093267|NCT00992459|3916953|B2||Female|Gender||Participants|Count of Participants|17|17.0||||||
4093268|NCT00992459|3916954|B1||Female|Gender||Participants|Count of Participants|15|15.0||||||
4093269|NCT00992459|3916952|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4093270|NCT00992459|3916953|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4093271|NCT00992459|3916954|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4093272|NCT00992459|3916952|B3||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4093273|NCT00992459|3916953|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4093274|NCT00992459|3916954|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4093275|NCT00992459|3916952|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093276|NCT00992459|3916953|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093277|NCT00992459|3916954|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093278|NCT00992446|3916979|B1|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
4093279|NCT00992446|3916979|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4093280|NCT00992446|3916979|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4093281|NCT00992446|3916979|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4093282|NCT00992446|3916979|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4093283|NCT00992446|3916979|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4093284|NCT00992446|3916979|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4093285|NCT00992446|3916979|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4093286|NCT00992446|3916979|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4093287|NCT00992446|3916979|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4093288|NCT00992446|3916979|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4093289|NCT00992446|3916979|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4093290|NCT00992446|3916979|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4093291|NCT00992446|3916979|B1|||Age||years|Median|61|61.0|Full Range|||39.0|69.0|
4093292|NCT00992446|3916979|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4093293|NCT00992446|3916979|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4093294|NCT00992446|3916979|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093295|NCT00992433|3916984|B3|United States||Region of Enrollment||participants|Number|192|192.0||||||
4093296|NCT00992433|3916985|B2|United States||Region of Enrollment||participants|Number|97|97.0||||||
4093297|NCT00992433|3916986|B1|United States||Region of Enrollment||participants|Number|95|95.0||||||
4093298|NCT00992433|3916984|B3||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4093299|NCT00992433|3916985|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4093300|NCT00992433|3916986|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4093301|NCT00992433|3916984|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4093302|NCT00992433|3916985|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4093303|NCT00992433|3916986|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4093304|NCT00992433|3916984|B3|||Age||years|Mean|45.5|45.5|Standard Deviation|9.6|9.6|||
4093305|NCT00992433|3916985|B2|||Age||years|Mean|45.3|45.3|Standard Deviation|9.3|9.3|||
4093306|NCT00992433|3916986|B1|||Age||years|Mean|45.7|45.7|Standard Deviation|9.9|9.9|||
4093307|NCT00992433|3916984|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4093308|NCT00992433|3916985|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4093309|NCT00992433|3916986|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4093310|NCT00992433|3916984|B3||Between 18 and 65 years|Age||Participants|Count of Participants|192|192.0||||||
4093311|NCT00992433|3916985|B2||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
4093312|NCT00992433|3916986|B1||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
4093313|NCT00992433|3916984|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093314|NCT00992433|3916985|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093315|NCT00992433|3916986|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093316|NCT00992407|3917049|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4093317|NCT00992407|3917050|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4093318|NCT00992407|3917051|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4093319|NCT00992407|3917049|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4093320|NCT00992407|3917050|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4093321|NCT00992407|3917051|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4093322|NCT00992407|3917049|B3|||Age||years|Mean|34.5|34.5|Standard Deviation|10.0|10.0|||
4093323|NCT00992407|3917050|B2|||Age||years|Mean|32.8|32.8|Standard Deviation|9.4|9.4|||
4093324|NCT00992407|3917051|B1|||Age||years|Mean|36.9|36.9|Standard Deviation|10.5|10.5|||
4093325|NCT00992394|3917100|B3||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4093326|NCT00992394|3917101|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4093327|NCT00992394|3917102|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4093328|NCT00992394|3917100|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4093329|NCT00992394|3917101|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4093330|NCT00992394|3917102|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4093331|NCT00992394|3917100|B3|||Age||Years|Mean|49.08|49.08|Standard Deviation|13.96|13.96|||
4093332|NCT00992394|3917101|B2|||Age||Years|Mean|47.71|47.71|Standard Deviation|13.77|13.77|||
4093333|NCT00992394|3917102|B1|||Age||Years|Mean|50.39|50.39|Standard Deviation|14.10|14.1|||
4093334|NCT00992264|3917145|B17|United States||Region of Enrollment||participants|Number|1865|1865.0||||||
4093335|NCT00992264|3917146|B16|United States||Region of Enrollment||participants|Number|116|116.0||||||
4093336|NCT00992264|3917147|B15|United States||Region of Enrollment||participants|Number|117|117.0||||||
4093337|NCT00992264|3917148|B14|United States||Region of Enrollment||participants|Number|117|117.0||||||
4093338|NCT00992264|3917149|B13|United States||Region of Enrollment||participants|Number|116|116.0||||||
4093339|NCT00992264|3917150|B12|United States||Region of Enrollment||participants|Number|117|117.0||||||
4093340|NCT00992264|3917151|B11|United States||Region of Enrollment||participants|Number|117|117.0||||||
4093341|NCT00992264|3917152|B10|United States||Region of Enrollment||participants|Number|116|116.0||||||
4093342|NCT00992264|3917153|B9|United States||Region of Enrollment||participants|Number|116|116.0||||||
4093343|NCT00992264|3917154|B8|United States||Region of Enrollment||participants|Number|117|117.0||||||
4093344|NCT00992264|3917155|B7|United States||Region of Enrollment||participants|Number|116|116.0||||||
4093345|NCT00992264|3917156|B6|United States||Region of Enrollment||participants|Number|117|117.0||||||
4093346|NCT00992264|3917157|B5|United States||Region of Enrollment||participants|Number|117|117.0||||||
4093347|NCT00992264|3917158|B4|United States||Region of Enrollment||participants|Number|117|117.0||||||
4093348|NCT00992264|3917159|B3|United States||Region of Enrollment||participants|Number|117|117.0||||||
4093349|NCT00992264|3917160|B2|United States||Region of Enrollment||participants|Number|116|116.0||||||
4093350|NCT00992264|3917161|B1|United States||Region of Enrollment||participants|Number|116|116.0||||||
4093351|NCT00992264|3917145|B17||Male|Sex: Female, Male||Participants|Count of Participants|726|726.0||||||
4093352|NCT00992264|3917146|B16||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4093353|NCT00992264|3917147|B15||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4093354|NCT00992264|3917148|B14||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4093355|NCT00992264|3917149|B13||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4093356|NCT00992264|3917150|B12||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4093357|NCT00992264|3917151|B11||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4093358|NCT00992264|3917152|B10||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4093359|NCT00992264|3917153|B9||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4093360|NCT00992264|3917154|B8||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4093361|NCT00992264|3917155|B7||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4093362|NCT00992264|3917156|B6||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4093363|NCT00992264|3917157|B5||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4093364|NCT00992264|3917158|B4||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4093365|NCT00992264|3917159|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4093366|NCT00992264|3917160|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4093367|NCT00992264|3917161|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4093368|NCT00992264|3917145|B17||Female|Sex: Female, Male||Participants|Count of Participants|1139|1139.0||||||
4093369|NCT00992264|3917146|B16||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4093370|NCT00992264|3917147|B15||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4093371|NCT00992264|3917148|B14||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4093372|NCT00992264|3917149|B13||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4093373|NCT00992264|3917150|B12||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4093374|NCT00992264|3917151|B11||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4093375|NCT00992264|3917152|B10||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4093376|NCT00992264|3917153|B9||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4093377|NCT00992264|3917154|B8||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4093378|NCT00992264|3917155|B7||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4093379|NCT00992264|3917156|B6||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4093380|NCT00992264|3917157|B5||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4093381|NCT00992264|3917158|B4||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4093382|NCT00992264|3917159|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4093383|NCT00992264|3917160|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4093384|NCT00992264|3917161|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4093385|NCT00992264|3917145|B17|||Age||years|Mean|44.2|44.2|Standard Deviation|14.7|14.7|||
4093386|NCT00992264|3917146|B16|||Age||years|Mean|43.99|43.99|Standard Deviation|14.97|14.97|||
4093387|NCT00992264|3917147|B15|||Age||years|Mean|44.39|44.39|Standard Deviation|14.95|14.95|||
4093388|NCT00992264|3917148|B14|||Age||years|Mean|43.69|43.69|Standard Deviation|14.95|14.95|||
4093389|NCT00992264|3917149|B13|||Age||years|Mean|42.29|42.29|Standard Deviation|15.07|15.07|||
4093390|NCT00992264|3917150|B12|||Age||years|Mean|45.03|45.03|Standard Deviation|14.26|14.26|||
4093391|NCT00992264|3917151|B11|||Age||years|Mean|46.09|46.09|Standard Deviation|14.75|14.75|||
4093392|NCT00992264|3917152|B10|||Age||years|Mean|43.82|43.82|Standard Deviation|14.24|14.24|||
4093393|NCT00992264|3917153|B9|||Age||years|Mean|44.56|44.56|Standard Deviation|15.43|15.43|||
4093394|NCT00992264|3917154|B8|||Age||years|Mean|44.33|44.33|Standard Deviation|15.05|15.05|||
4093395|NCT00992264|3917155|B7|||Age||years|Mean|45.19|45.19|Standard Deviation|14.6|14.6|||
4093396|NCT00992264|3917156|B6|||Age||years|Mean|43.84|43.84|Standard Deviation|14.39|14.39|||
4093397|NCT00992264|3917157|B5|||Age||years|Mean|43.49|43.49|Standard Deviation|14.34|14.34|||
4093398|NCT00992264|3917158|B4|||Age||years|Mean|45.93|45.93|Standard Deviation|13.82|13.82|||
4093399|NCT00992264|3917159|B3|||Age||years|Mean|42.83|42.83|Standard Deviation|15.06|15.06|||
4093400|NCT00992264|3917160|B2|||Age||years|Mean|44.06|44.06|Standard Deviation|14.95|14.95|||
4093401|NCT00992264|3917161|B1|||Age||years|Mean|43.34|43.34|Standard Deviation|14.50|14.5|||
4093402|NCT00992264|3917145|B17||>=65 years|Age||Participants|Count of Participants|102|102.0||||||
4093403|NCT00992264|3917146|B16||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4093404|NCT00992264|3917147|B15||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4093405|NCT00992264|3917148|B14||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4093406|NCT00992264|3917149|B13||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4093407|NCT00992264|3917150|B12||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4093408|NCT00992264|3917151|B11||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4093409|NCT00992264|3917152|B10||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4093410|NCT00992264|3917153|B9||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4093411|NCT00992264|3917154|B8||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4093412|NCT00992264|3917155|B7||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4093413|NCT00992264|3917156|B6||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4093414|NCT00992264|3917157|B5||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4093415|NCT00992264|3917158|B4||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4093416|NCT00992264|3917159|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4093417|NCT00992264|3917160|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4093418|NCT00992264|3917161|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4093419|NCT00992264|3917145|B17||Between 18 and 65 years|Age||Participants|Count of Participants|1763|1763.0||||||
4093420|NCT00992264|3917146|B16||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
4093421|NCT00992264|3917147|B15||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
4093422|NCT00992264|3917148|B14||Between 18 and 65 years|Age||Participants|Count of Participants|113|113.0||||||
4093423|NCT00992264|3917149|B13||Between 18 and 65 years|Age||Participants|Count of Participants|114|114.0||||||
4093424|NCT00992264|3917150|B12||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
4093425|NCT00992264|3917151|B11||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
4093426|NCT00992264|3917152|B10||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
4093427|NCT00992264|3917153|B9||Between 18 and 65 years|Age||Participants|Count of Participants|108|108.0||||||
4093428|NCT00992264|3917154|B8||Between 18 and 65 years|Age||Participants|Count of Participants|108|108.0||||||
4093429|NCT00992264|3917155|B7||Between 18 and 65 years|Age||Participants|Count of Participants|108|108.0||||||
4093430|NCT00992264|3917156|B6||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
4093431|NCT00992264|3917157|B5||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
4093432|NCT00992264|3917158|B4||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
4093433|NCT00992264|3917159|B3||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
4093434|NCT00992264|3917160|B2||Between 18 and 65 years|Age||Participants|Count of Participants|108|108.0||||||
4093435|NCT00992264|3917161|B1||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
4093436|NCT00992264|3917145|B17||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093437|NCT00992264|3917146|B16||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093438|NCT00992264|3917147|B15||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093439|NCT00992264|3917148|B14||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093440|NCT00992264|3917149|B13||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093441|NCT00992264|3917150|B12||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093442|NCT00992264|3917151|B11||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093443|NCT00992264|3917152|B10||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093444|NCT00992264|3917153|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093445|NCT00992264|3917154|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093446|NCT00992264|3917155|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093447|NCT00992264|3917156|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093448|NCT00992264|3917157|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093449|NCT00992264|3917158|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093450|NCT00992264|3917159|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093451|NCT00992264|3917160|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093452|NCT00992264|3917161|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093453|NCT00992225|3917190|B1||1 - Ambulatory, restricted strenuous activity|Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|Participants|Count of Participants|23|23.0||||||
4093454|NCT00992225|3917190|B1||0 - Fully active|Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|Participants|Count of Participants|10|10.0||||||
4093455|NCT00992225|3917190|B1|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
4093456|NCT00992225|3917190|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
4093457|NCT00992225|3917190|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4093458|NCT00992225|3917190|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4093459|NCT00992225|3917190|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4093460|NCT00992225|3917190|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4093461|NCT00992225|3917190|B1|||Age||years|Mean|55.43|55.43|Standard Deviation|9.71|9.71|||
4093462|NCT00992186|3917200|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4093463|NCT00992186|3917200|B1|United Kingdom||Region of Enrollment||participants|Number|18|18.0||||||
4093464|NCT00992186|3917200|B1|Russian Federation||Region of Enrollment||participants|Number|10|10.0||||||
4093465|NCT00992186|3917200|B1|Belgium||Region of Enrollment||participants|Number|11|11.0||||||
4093466|NCT00992186|3917200|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4093467|NCT00992186|3917200|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4093468|NCT00992186|3917200|B1|||Age||Years|Mean|67.5|67.5|Standard Deviation|7.95|7.95|||
4093469|NCT00992108|3917217|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4093470|NCT00992108|3917218|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4093471|NCT00992108|3917219|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4093472|NCT00992108|3917217|B3||Male|Gender||Participants|Count of Participants|3|3.0||||||
4093473|NCT00992108|3917218|B2||Male|Gender||Participants|Count of Participants|2|2.0||||||
4093474|NCT00992108|3917219|B1||Male|Gender||Participants|Count of Participants|1|1.0||||||
4093475|NCT00992108|3917217|B3||Female|Gender||Participants|Count of Participants|14|14.0||||||
4093476|NCT00992108|3917218|B2||Female|Gender||Participants|Count of Participants|8|8.0||||||
4093477|NCT00992108|3917219|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
4093478|NCT00992108|3917217|B3|||Age||years|Mean|49.82|49.82|Full Range|||24.0|76.0|
4093479|NCT00992108|3917218|B2|||Age||years|Mean|44.7|44.7|Full Range|||24.0|65.0|
4093480|NCT00992108|3917219|B1|||Age||years|Mean|57.14|57.14|Full Range|||38.0|76.0|
4093481|NCT00992056|3917232|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4093482|NCT00992056|3917233|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4093483|NCT00992056|3917234|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4093484|NCT00992056|3917232|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4093485|NCT00992056|3917233|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4093486|NCT00992056|3917234|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4093487|NCT00992056|3917232|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4093488|NCT00992056|3917233|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4093489|NCT00992056|3917234|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4093490|NCT00992056|3917232|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4093491|NCT00992056|3917233|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4093492|NCT00992056|3917234|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4093493|NCT00992056|3917232|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4093494|NCT00992056|3917233|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4093495|NCT00992056|3917234|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4093496|NCT00992056|3917232|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4093497|NCT00992056|3917233|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4093498|NCT00992056|3917234|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4093499|NCT00992056|3917232|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4093500|NCT00992056|3917233|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4093501|NCT00992056|3917234|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4093502|NCT00992056|3917232|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4093503|NCT00992056|3917233|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4093504|NCT00992056|3917234|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4093505|NCT00992056|3917232|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093506|NCT00992056|3917233|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093507|NCT00992056|3917234|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093508|NCT00992017|3917241|B1|||Gestational Age|This shows the approximate gestational age at study entry.|Weeks|Mean|25|25.0|Standard Deviation|6|6.0|||
4093509|NCT00992017|3917241|B1|||Percentage of CD4 Cells|This measures the percentage of CD4 cells.|percentage of CD4 cells|Mean|30|30.0|Standard Deviation|11|11.0|||
4093510|NCT00992017|3917241|B1|||CD4 Cells Count|This measures the number of CD4 cells.|cells / mm^3|Mean|504|504.0|Standard Deviation|264|264.0|||
4093511|NCT00992017|3917241|B1|Puerto Rico||Region of Enrollment||participants|Number|16|16.0||||||
4093512|NCT00992017|3917241|B1|United States||Region of Enrollment||participants|Number|112|112.0||||||
4093513|NCT00992017|3917241|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4093514|NCT00992017|3917241|B1||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4093515|NCT00992017|3917241|B1|||Age||years|Mean|28|28.0|Standard Deviation|6|6.0|||
4093516|NCT00991952|3917254|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4093517|NCT00991952|3917255|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4093518|NCT00991952|3917256|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4093519|NCT00991952|3917254|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4093520|NCT00991952|3917255|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4093521|NCT00991952|3917256|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4093522|NCT00991952|3917254|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4093523|NCT00991952|3917255|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4093524|NCT00991952|3917256|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4093525|NCT00991952|3917254|B3|||Age||years|Mean|60|60.0|Standard Deviation|22.627417|22.627417|||
4093526|NCT00991952|3917255|B2|||Age||years|Mean|56|56.0|Standard Deviation|16.97056275|16.97056275|||
4093527|NCT00991952|3917256|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|19.0918830|19.091883|||
4093528|NCT00991952|3917254|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4093529|NCT00991952|3917255|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4093530|NCT00991952|3917256|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4093531|NCT00991952|3917254|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4093532|NCT00991952|3917255|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4093533|NCT00991952|3917256|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4093534|NCT00991952|3917254|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093535|NCT00991952|3917255|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093536|NCT00991952|3917256|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093537|NCT00991939|3917263|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4093538|NCT00991939|3917264|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4093539|NCT00991939|3917265|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4093540|NCT00991939|3917263|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4093541|NCT00991939|3917264|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4093542|NCT00991939|3917265|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4093543|NCT00991939|3917263|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4093544|NCT00991939|3917264|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4093545|NCT00991939|3917265|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4093546|NCT00991939|3917263|B3|||Age||years|Mean|46.7|46.7|Standard Deviation|26.0|26.0|||
4093547|NCT00991939|3917264|B2|||Age||years|Mean|62.5|62.5|Standard Deviation|35.8|35.8|||
4093548|NCT00991939|3917265|B1|||Age||years|Mean|37.2|37.2|Standard Deviation|15.6|15.6|||
4093549|NCT00991939|3917263|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4093550|NCT00991939|3917264|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4093551|NCT00991939|3917265|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4093552|NCT00991939|3917263|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4093553|NCT00991939|3917264|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4093554|NCT00991939|3917265|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4093555|NCT00991939|3917263|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093556|NCT00991939|3917264|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093557|NCT00991939|3917265|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093558|NCT00991887|3917298|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
4093559|NCT00991887|3917299|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4093560|NCT00991887|3917300|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4093561|NCT00991887|3917298|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4093562|NCT00991887|3917299|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4093563|NCT00991887|3917300|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4093564|NCT00991887|3917298|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4093565|NCT00991887|3917299|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4093566|NCT00991887|3917300|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4093567|NCT00991887|3917298|B3|||Age||years|Mean|45|45.0|Standard Deviation|17|17.0|||
4093568|NCT00991887|3917299|B2|||Age||years|Mean|44|44.0|Standard Deviation|17|17.0|||
4093569|NCT00991887|3917300|B1|||Age||years|Mean|45|45.0|Standard Deviation|15|15.0|||
4093570|NCT00991887|3917298|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4093571|NCT00991887|3917299|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4093572|NCT00991887|3917300|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4093573|NCT00991887|3917298|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4093574|NCT00991887|3917299|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4093575|NCT00991887|3917300|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4093576|NCT00991887|3917298|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093577|NCT00991887|3917299|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093578|NCT00991887|3917300|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093579|NCT00991809|3917307|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4093580|NCT00991809|3917308|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4093581|NCT00991809|3917309|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4093582|NCT00991809|3917307|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4093583|NCT00991809|3917308|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4093584|NCT00991809|3917309|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4093585|NCT00991809|3917307|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4093586|NCT00991809|3917308|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4093587|NCT00991809|3917309|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4093588|NCT00991809|3917307|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4093589|NCT00991809|3917308|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4093590|NCT00991809|3917309|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4093591|NCT00991809|3917307|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4093592|NCT00991809|3917308|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4093593|NCT00991809|3917309|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4093594|NCT00991809|3917307|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4093595|NCT00991809|3917308|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4093596|NCT00991809|3917309|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4093597|NCT00991809|3917307|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4093598|NCT00991809|3917308|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4093599|NCT00991809|3917309|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4093600|NCT00991809|3917307|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4093601|NCT00991809|3917308|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4093602|NCT00991809|3917309|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4093603|NCT00991809|3917307|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4093604|NCT00991809|3917308|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4093605|NCT00991809|3917309|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4093606|NCT00991809|3917307|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4093607|NCT00991809|3917308|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4093608|NCT00991809|3917309|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4093609|NCT00991809|3917307|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4093610|NCT00991809|3917308|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4093611|NCT00991809|3917309|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4093612|NCT00991809|3917307|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4093613|NCT00991809|3917308|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4093614|NCT00991809|3917309|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4093615|NCT00991809|3917307|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093616|NCT00991809|3917308|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093617|NCT00991809|3917309|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093618|NCT00991510|3917318|B3|||Body Mass Index||kg/m^2|Mean|26.09|26.09|Standard Deviation|3.557|3.557|||
4093619|NCT00991510|3917319|B2|||Body Mass Index||kg/m^2|Mean|25.93|25.93|Standard Deviation|3.422|3.422|||
4093620|NCT00991510|3917320|B1|||Body Mass Index||kg/m^2|Mean|26.24|26.24|Standard Deviation|3.756|3.756|||
4093621|NCT00991510|3917318|B3|||Weight||kilograms|Mean|77.21|77.21|Standard Deviation|15.072|15.072|||
4093622|NCT00991510|3917319|B2|||Weight||kilograms|Mean|77.23|77.23|Standard Deviation|15.661|15.661|||
4093623|NCT00991510|3917320|B1|||Weight||kilograms|Mean|77.19|77.19|Standard Deviation|14.856|14.856|||
4093624|NCT00991510|3917318|B3|||Height||meters|Mean|1.714|1.714|Standard Deviation|0.1012|0.1012|||
4093625|NCT00991510|3917319|B2|||Height||meters|Mean|1.718|1.718|Standard Deviation|0.0983|0.0983|||
4093626|NCT00991510|3917320|B1|||Height||meters|Mean|1.711|1.711|Standard Deviation|0.1061|0.1061|||
4093627|NCT00991510|3917318|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4093628|NCT00991510|3917319|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4093629|NCT00991510|3917320|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4093630|NCT00991510|3917318|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4093631|NCT00991510|3917319|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4093632|NCT00991510|3917320|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4093633|NCT00991510|3917318|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4093634|NCT00991510|3917319|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4093635|NCT00991510|3917320|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4093636|NCT00991510|3917318|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4093637|NCT00991510|3917319|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4093638|NCT00991510|3917320|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4093639|NCT00991510|3917318|B3|||Age||years|Mean|50.7|50.7|Standard Deviation|13.52|13.52|||
4093640|NCT00991510|3917319|B2|||Age||years|Mean|51.7|51.7|Standard Deviation|13.55|13.55|||
4093641|NCT00991510|3917320|B1|||Age||years|Mean|49.7|49.7|Standard Deviation|13.73|13.73|||
4093642|NCT00991458|3917343|B4||Male|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
4093643|NCT00991458|3917344|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4093644|NCT00991458|3917345|B2||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4093645|NCT00991458|3917346|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4093646|NCT00991458|3917343|B4||Female|Sex: Female, Male||Participants|Count of Participants|338|338.0||||||
4093647|NCT00991458|3917344|B3||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4093648|NCT00991458|3917345|B2||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4093649|NCT00991458|3917346|B1||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4093650|NCT00991458|3917343|B4|>40 years||Age, Customized||Participants|Number|108|108.0||||||
4093651|NCT00991458|3917344|B3|>40 years||Age, Customized||Participants|Number|36|36.0||||||
4093652|NCT00991458|3917345|B2|>40 years||Age, Customized||Participants|Number|43|43.0||||||
4093653|NCT00991458|3917346|B1|>40 years||Age, Customized||Participants|Number|29|29.0||||||
4093654|NCT00991458|3917343|B4|30 to 40 years||Age, Customized||Participants|Number|299|299.0||||||
4093655|NCT00991458|3917344|B3|30 to 40 years||Age, Customized||Participants|Number|92|92.0||||||
4093656|NCT00991458|3917345|B2|30 to 40 years||Age, Customized||Participants|Number|97|97.0||||||
4093657|NCT00991458|3917346|B1|30 to 40 years||Age, Customized||Participants|Number|110|110.0||||||
4093658|NCT00991458|3917343|B4|<30 years||Age, Customized||Participants|Number|214|214.0||||||
4093659|NCT00991458|3917344|B3|<30 years||Age, Customized||Participants|Number|77|77.0||||||
4093660|NCT00991458|3917345|B2|<30 years||Age, Customized||Participants|Number|69|69.0||||||
4093661|NCT00991458|3917346|B1|<30 years||Age, Customized||Participants|Number|68|68.0||||||
4093662|NCT00991341|3917365|B3|||Hemoglobin||g/L|Median|11.9|11.9|Inter-Quartile Range|||10.7|12.9|
4093663|NCT00991341|3917366|B2|||Hemoglobin||g/L|Median|12.0|12.0|Inter-Quartile Range|||10.8|13.0|
4093664|NCT00991341|3917367|B1|||Hemoglobin||g/L|Median|11.7|11.7|Inter-Quartile Range|||10.7|12.8|
4093665|NCT00991341|3917365|B3|AB||ABO Blood Group||participants|Number|46|46.0||||||
4093666|NCT00991341|3917366|B2|AB||ABO Blood Group||participants|Number|21|21.0||||||
4093667|NCT00991341|3917367|B1|AB||ABO Blood Group||participants|Number|25|25.0||||||
4093668|NCT00991341|3917365|B3|B||ABO Blood Group||participants|Number|127|127.0||||||
4093669|NCT00991341|3917366|B2|B||ABO Blood Group||participants|Number|63|63.0||||||
4093670|NCT00991341|3917367|B1|B||ABO Blood Group||participants|Number|64|64.0||||||
4093671|NCT00991341|3917365|B3|A||ABO Blood Group||participants|Number|481|481.0||||||
4093672|NCT00991341|3917366|B2|A||ABO Blood Group||participants|Number|241|241.0||||||
4093673|NCT00991341|3917367|B1|A||ABO Blood Group||participants|Number|240|240.0||||||
4093674|NCT00991341|3917365|B3|O||ABO Blood Group||participants|Number|444|444.0||||||
4093675|NCT00991341|3917366|B2|O||ABO Blood Group||participants|Number|235|235.0||||||
4093676|NCT00991341|3917367|B1|O||ABO Blood Group||participants|Number|209|209.0||||||
4093677|NCT00991341|3917365|B3|5||Baseline Multiple Organ Dysfunction Score|Per Marshall et al article in Critical Care Medicine (1995), increasing Multiple Organ Dysfunction Scores correlated with in-hospital mortality. No deaths occurred in patients with a MODS score of 0. The approximate in-hospital mortality rates were 6% for patients with MODS score of 1-4 points, 15% for patients with scores between 5-8, 50% for patients with scores between 8-12, 68% for patients with scores 13-16, 80% for patients with scores 17-20 and 100% for scores > 20.|participants|Number|2|2.0||||||
4093678|NCT00991341|3917366|B2|5||Baseline Multiple Organ Dysfunction Score|Per Marshall et al article in Critical Care Medicine (1995), increasing Multiple Organ Dysfunction Scores correlated with in-hospital mortality. No deaths occurred in patients with a MODS score of 0. The approximate in-hospital mortality rates were 6% for patients with MODS score of 1-4 points, 15% for patients with scores between 5-8, 50% for patients with scores between 8-12, 68% for patients with scores 13-16, 80% for patients with scores 17-20 and 100% for scores > 20.|participants|Number|1|1.0||||||
4093679|NCT00991341|3917367|B1|5||Baseline Multiple Organ Dysfunction Score|Per Marshall et al article in Critical Care Medicine (1995), increasing Multiple Organ Dysfunction Scores correlated with in-hospital mortality. No deaths occurred in patients with a MODS score of 0. The approximate in-hospital mortality rates were 6% for patients with MODS score of 1-4 points, 15% for patients with scores between 5-8, 50% for patients with scores between 8-12, 68% for patients with scores 13-16, 80% for patients with scores 17-20 and 100% for scores > 20.|participants|Number|1|1.0||||||
4093680|NCT00991341|3917365|B3|4||Baseline Multiple Organ Dysfunction Score|Per Marshall et al article in Critical Care Medicine (1995), increasing Multiple Organ Dysfunction Scores correlated with in-hospital mortality. No deaths occurred in patients with a MODS score of 0. The approximate in-hospital mortality rates were 6% for patients with MODS score of 1-4 points, 15% for patients with scores between 5-8, 50% for patients with scores between 8-12, 68% for patients with scores 13-16, 80% for patients with scores 17-20 and 100% for scores > 20.|participants|Number|8|8.0||||||
4093681|NCT00991341|3917366|B2|4||Baseline Multiple Organ Dysfunction Score|Per Marshall et al article in Critical Care Medicine (1995), increasing Multiple Organ Dysfunction Scores correlated with in-hospital mortality. No deaths occurred in patients with a MODS score of 0. The approximate in-hospital mortality rates were 6% for patients with MODS score of 1-4 points, 15% for patients with scores between 5-8, 50% for patients with scores between 8-12, 68% for patients with scores 13-16, 80% for patients with scores 17-20 and 100% for scores > 20.|participants|Number|4|4.0||||||
4093682|NCT00991341|3917367|B1|4||Baseline Multiple Organ Dysfunction Score|Per Marshall et al article in Critical Care Medicine (1995), increasing Multiple Organ Dysfunction Scores correlated with in-hospital mortality. No deaths occurred in patients with a MODS score of 0. The approximate in-hospital mortality rates were 6% for patients with MODS score of 1-4 points, 15% for patients with scores between 5-8, 50% for patients with scores between 8-12, 68% for patients with scores 13-16, 80% for patients with scores 17-20 and 100% for scores > 20.|participants|Number|4|4.0||||||
4093683|NCT00991341|3917365|B3|3||Baseline Multiple Organ Dysfunction Score|Per Marshall et al article in Critical Care Medicine (1995), increasing Multiple Organ Dysfunction Scores correlated with in-hospital mortality. No deaths occurred in patients with a MODS score of 0. The approximate in-hospital mortality rates were 6% for patients with MODS score of 1-4 points, 15% for patients with scores between 5-8, 50% for patients with scores between 8-12, 68% for patients with scores 13-16, 80% for patients with scores 17-20 and 100% for scores > 20.|participants|Number|21|21.0||||||
4093684|NCT00991341|3917366|B2|3||Baseline Multiple Organ Dysfunction Score|Per Marshall et al article in Critical Care Medicine (1995), increasing Multiple Organ Dysfunction Scores correlated with in-hospital mortality. No deaths occurred in patients with a MODS score of 0. The approximate in-hospital mortality rates were 6% for patients with MODS score of 1-4 points, 15% for patients with scores between 5-8, 50% for patients with scores between 8-12, 68% for patients with scores 13-16, 80% for patients with scores 17-20 and 100% for scores > 20.|participants|Number|11|11.0||||||
4093685|NCT00991341|3917367|B1|3||Baseline Multiple Organ Dysfunction Score|Per Marshall et al article in Critical Care Medicine (1995), increasing Multiple Organ Dysfunction Scores correlated with in-hospital mortality. No deaths occurred in patients with a MODS score of 0. The approximate in-hospital mortality rates were 6% for patients with MODS score of 1-4 points, 15% for patients with scores between 5-8, 50% for patients with scores between 8-12, 68% for patients with scores 13-16, 80% for patients with scores 17-20 and 100% for scores > 20.|participants|Number|10|10.0||||||
4093686|NCT00991341|3917365|B3|2||Baseline Multiple Organ Dysfunction Score|Per Marshall et al article in Critical Care Medicine (1995), increasing Multiple Organ Dysfunction Scores correlated with in-hospital mortality. No deaths occurred in patients with a MODS score of 0. The approximate in-hospital mortality rates were 6% for patients with MODS score of 1-4 points, 15% for patients with scores between 5-8, 50% for patients with scores between 8-12, 68% for patients with scores 13-16, 80% for patients with scores 17-20 and 100% for scores > 20.|participants|Number|105|105.0||||||
4093687|NCT00991341|3917366|B2|2||Baseline Multiple Organ Dysfunction Score|Per Marshall et al article in Critical Care Medicine (1995), increasing Multiple Organ Dysfunction Scores correlated with in-hospital mortality. No deaths occurred in patients with a MODS score of 0. The approximate in-hospital mortality rates were 6% for patients with MODS score of 1-4 points, 15% for patients with scores between 5-8, 50% for patients with scores between 8-12, 68% for patients with scores 13-16, 80% for patients with scores 17-20 and 100% for scores > 20.|participants|Number|57|57.0||||||
4093688|NCT00991341|3917367|B1|2||Baseline Multiple Organ Dysfunction Score|Per Marshall et al article in Critical Care Medicine (1995), increasing Multiple Organ Dysfunction Scores correlated with in-hospital mortality. No deaths occurred in patients with a MODS score of 0. The approximate in-hospital mortality rates were 6% for patients with MODS score of 1-4 points, 15% for patients with scores between 5-8, 50% for patients with scores between 8-12, 68% for patients with scores 13-16, 80% for patients with scores 17-20 and 100% for scores > 20.|participants|Number|48|48.0||||||
4093689|NCT00991341|3917365|B3|1||Baseline Multiple Organ Dysfunction Score|Per Marshall et al article in Critical Care Medicine (1995), increasing Multiple Organ Dysfunction Scores correlated with in-hospital mortality. No deaths occurred in patients with a MODS score of 0. The approximate in-hospital mortality rates were 6% for patients with MODS score of 1-4 points, 15% for patients with scores between 5-8, 50% for patients with scores between 8-12, 68% for patients with scores 13-16, 80% for patients with scores 17-20 and 100% for scores > 20.|participants|Number|417|417.0||||||
4093690|NCT00991341|3917366|B2|1||Baseline Multiple Organ Dysfunction Score|Per Marshall et al article in Critical Care Medicine (1995), increasing Multiple Organ Dysfunction Scores correlated with in-hospital mortality. No deaths occurred in patients with a MODS score of 0. The approximate in-hospital mortality rates were 6% for patients with MODS score of 1-4 points, 15% for patients with scores between 5-8, 50% for patients with scores between 8-12, 68% for patients with scores 13-16, 80% for patients with scores 17-20 and 100% for scores > 20.|participants|Number|194|194.0||||||
4093691|NCT00991341|3917367|B1|1||Baseline Multiple Organ Dysfunction Score|Per Marshall et al article in Critical Care Medicine (1995), increasing Multiple Organ Dysfunction Scores correlated with in-hospital mortality. No deaths occurred in patients with a MODS score of 0. The approximate in-hospital mortality rates were 6% for patients with MODS score of 1-4 points, 15% for patients with scores between 5-8, 50% for patients with scores between 8-12, 68% for patients with scores 13-16, 80% for patients with scores 17-20 and 100% for scores > 20.|participants|Number|223|223.0||||||
4093692|NCT00991341|3917365|B3|0||Baseline Multiple Organ Dysfunction Score|Per Marshall et al article in Critical Care Medicine (1995), increasing Multiple Organ Dysfunction Scores correlated with in-hospital mortality. No deaths occurred in patients with a MODS score of 0. The approximate in-hospital mortality rates were 6% for patients with MODS score of 1-4 points, 15% for patients with scores between 5-8, 50% for patients with scores between 8-12, 68% for patients with scores 13-16, 80% for patients with scores 17-20 and 100% for scores > 20.|participants|Number|545|545.0||||||
4093693|NCT00991341|3917366|B2|0||Baseline Multiple Organ Dysfunction Score|Per Marshall et al article in Critical Care Medicine (1995), increasing Multiple Organ Dysfunction Scores correlated with in-hospital mortality. No deaths occurred in patients with a MODS score of 0. The approximate in-hospital mortality rates were 6% for patients with MODS score of 1-4 points, 15% for patients with scores between 5-8, 50% for patients with scores between 8-12, 68% for patients with scores 13-16, 80% for patients with scores 17-20 and 100% for scores > 20.|participants|Number|293|293.0||||||
4093694|NCT00991341|3917367|B1|0||Baseline Multiple Organ Dysfunction Score|Per Marshall et al article in Critical Care Medicine (1995), increasing Multiple Organ Dysfunction Scores correlated with in-hospital mortality. No deaths occurred in patients with a MODS score of 0. The approximate in-hospital mortality rates were 6% for patients with MODS score of 1-4 points, 15% for patients with scores between 5-8, 50% for patients with scores between 8-12, 68% for patients with scores 13-16, 80% for patients with scores 17-20 and 100% for scores > 20.|participants|Number|252|252.0||||||
4093695|NCT00991341|3917365|B3|Not in ICU Before Surgery||ICU Status at Randomization||participants|Number|1031|1031.0||||||
4093696|NCT00991341|3917366|B2|Not in ICU Before Surgery||ICU Status at Randomization||participants|Number|527|527.0||||||
4093697|NCT00991341|3917367|B1|Not in ICU Before Surgery||ICU Status at Randomization||participants|Number|504|504.0||||||
4093698|NCT00991341|3917365|B3|In ICU Before Surgery||ICU Status at Randomization||participants|Number|67|67.0||||||
4093699|NCT00991341|3917366|B2|In ICU Before Surgery||ICU Status at Randomization||participants|Number|33|33.0||||||
4093700|NCT00991341|3917367|B1|In ICU Before Surgery||ICU Status at Randomization||participants|Number|34|34.0||||||
4093701|NCT00991341|3917365|B3|7||Minimum TRUST Score|Per Alghamdi et al article in Transfusion (2006), the Transfusion Risk Understanding Scoring Tool (TRUST) score is an additive algorithm that provides an overall score that ranges from 0 to 8. The interpretation of the total score as it relates to the probability of exposure to transfusion is as follows: 0=baseline risk; 1=low risk; 2=intermediate risk; 3=high risk; 4-8=very high risk.|participants|Number|5|5.0||||||
4093702|NCT00991341|3917366|B2|7||Minimum TRUST Score|Per Alghamdi et al article in Transfusion (2006), the Transfusion Risk Understanding Scoring Tool (TRUST) score is an additive algorithm that provides an overall score that ranges from 0 to 8. The interpretation of the total score as it relates to the probability of exposure to transfusion is as follows: 0=baseline risk; 1=low risk; 2=intermediate risk; 3=high risk; 4-8=very high risk.|participants|Number|2|2.0||||||
4093703|NCT00991341|3917367|B1|7||Minimum TRUST Score|Per Alghamdi et al article in Transfusion (2006), the Transfusion Risk Understanding Scoring Tool (TRUST) score is an additive algorithm that provides an overall score that ranges from 0 to 8. The interpretation of the total score as it relates to the probability of exposure to transfusion is as follows: 0=baseline risk; 1=low risk; 2=intermediate risk; 3=high risk; 4-8=very high risk.|participants|Number|3|3.0||||||
4093704|NCT00991341|3917365|B3|6||Minimum TRUST Score|Per Alghamdi et al article in Transfusion (2006), the Transfusion Risk Understanding Scoring Tool (TRUST) score is an additive algorithm that provides an overall score that ranges from 0 to 8. The interpretation of the total score as it relates to the probability of exposure to transfusion is as follows: 0=baseline risk; 1=low risk; 2=intermediate risk; 3=high risk; 4-8=very high risk.|participants|Number|53|53.0||||||
4093705|NCT00991341|3917366|B2|6||Minimum TRUST Score|Per Alghamdi et al article in Transfusion (2006), the Transfusion Risk Understanding Scoring Tool (TRUST) score is an additive algorithm that provides an overall score that ranges from 0 to 8. The interpretation of the total score as it relates to the probability of exposure to transfusion is as follows: 0=baseline risk; 1=low risk; 2=intermediate risk; 3=high risk; 4-8=very high risk.|participants|Number|27|27.0||||||
4093706|NCT00991341|3917367|B1|6||Minimum TRUST Score|Per Alghamdi et al article in Transfusion (2006), the Transfusion Risk Understanding Scoring Tool (TRUST) score is an additive algorithm that provides an overall score that ranges from 0 to 8. The interpretation of the total score as it relates to the probability of exposure to transfusion is as follows: 0=baseline risk; 1=low risk; 2=intermediate risk; 3=high risk; 4-8=very high risk.|participants|Number|26|26.0||||||
4093707|NCT00991341|3917365|B3|5||Minimum TRUST Score|Per Alghamdi et al article in Transfusion (2006), the Transfusion Risk Understanding Scoring Tool (TRUST) score is an additive algorithm that provides an overall score that ranges from 0 to 8. The interpretation of the total score as it relates to the probability of exposure to transfusion is as follows: 0=baseline risk; 1=low risk; 2=intermediate risk; 3=high risk; 4-8=very high risk.|participants|Number|245|245.0||||||
4093708|NCT00991341|3917366|B2|5||Minimum TRUST Score|Per Alghamdi et al article in Transfusion (2006), the Transfusion Risk Understanding Scoring Tool (TRUST) score is an additive algorithm that provides an overall score that ranges from 0 to 8. The interpretation of the total score as it relates to the probability of exposure to transfusion is as follows: 0=baseline risk; 1=low risk; 2=intermediate risk; 3=high risk; 4-8=very high risk.|participants|Number|113|113.0||||||
4093709|NCT00991341|3917367|B1|5||Minimum TRUST Score|Per Alghamdi et al article in Transfusion (2006), the Transfusion Risk Understanding Scoring Tool (TRUST) score is an additive algorithm that provides an overall score that ranges from 0 to 8. The interpretation of the total score as it relates to the probability of exposure to transfusion is as follows: 0=baseline risk; 1=low risk; 2=intermediate risk; 3=high risk; 4-8=very high risk.|participants|Number|132|132.0||||||
4093744|NCT00991341|3917366|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4093710|NCT00991341|3917365|B3|4||Minimum TRUST Score|Per Alghamdi et al article in Transfusion (2006), the Transfusion Risk Understanding Scoring Tool (TRUST) score is an additive algorithm that provides an overall score that ranges from 0 to 8. The interpretation of the total score as it relates to the probability of exposure to transfusion is as follows: 0=baseline risk; 1=low risk; 2=intermediate risk; 3=high risk; 4-8=very high risk.|participants|Number|406|406.0||||||
4093711|NCT00991341|3917366|B2|4||Minimum TRUST Score|Per Alghamdi et al article in Transfusion (2006), the Transfusion Risk Understanding Scoring Tool (TRUST) score is an additive algorithm that provides an overall score that ranges from 0 to 8. The interpretation of the total score as it relates to the probability of exposure to transfusion is as follows: 0=baseline risk; 1=low risk; 2=intermediate risk; 3=high risk; 4-8=very high risk.|participants|Number|196|196.0||||||
4093712|NCT00991341|3917367|B1|4||Minimum TRUST Score|Per Alghamdi et al article in Transfusion (2006), the Transfusion Risk Understanding Scoring Tool (TRUST) score is an additive algorithm that provides an overall score that ranges from 0 to 8. The interpretation of the total score as it relates to the probability of exposure to transfusion is as follows: 0=baseline risk; 1=low risk; 2=intermediate risk; 3=high risk; 4-8=very high risk.|participants|Number|210|210.0||||||
4093713|NCT00991341|3917365|B3|3||Minimum TRUST Score|Per Alghamdi et al article in Transfusion (2006), the Transfusion Risk Understanding Scoring Tool (TRUST) score is an additive algorithm that provides an overall score that ranges from 0 to 8. The interpretation of the total score as it relates to the probability of exposure to transfusion is as follows: 0=baseline risk; 1=low risk; 2=intermediate risk; 3=high risk; 4-8=very high risk.|participants|Number|388|388.0||||||
4093714|NCT00991341|3917366|B2|3||Minimum TRUST Score|Per Alghamdi et al article in Transfusion (2006), the Transfusion Risk Understanding Scoring Tool (TRUST) score is an additive algorithm that provides an overall score that ranges from 0 to 8. The interpretation of the total score as it relates to the probability of exposure to transfusion is as follows: 0=baseline risk; 1=low risk; 2=intermediate risk; 3=high risk; 4-8=very high risk.|participants|Number|222|222.0||||||
4093715|NCT00991341|3917367|B1|3||Minimum TRUST Score|Per Alghamdi et al article in Transfusion (2006), the Transfusion Risk Understanding Scoring Tool (TRUST) score is an additive algorithm that provides an overall score that ranges from 0 to 8. The interpretation of the total score as it relates to the probability of exposure to transfusion is as follows: 0=baseline risk; 1=low risk; 2=intermediate risk; 3=high risk; 4-8=very high risk.|participants|Number|166|166.0||||||
4093716|NCT00991341|3917365|B3|0||Minimum TRUST Score|Per Alghamdi et al article in Transfusion (2006), the Transfusion Risk Understanding Scoring Tool (TRUST) score is an additive algorithm that provides an overall score that ranges from 0 to 8. The interpretation of the total score as it relates to the probability of exposure to transfusion is as follows: 0=baseline risk; 1=low risk; 2=intermediate risk; 3=high risk; 4-8=very high risk.|participants|Number|1|1.0||||||
4093717|NCT00991341|3917366|B2|0||Minimum TRUST Score|Per Alghamdi et al article in Transfusion (2006), the Transfusion Risk Understanding Scoring Tool (TRUST) score is an additive algorithm that provides an overall score that ranges from 0 to 8. The interpretation of the total score as it relates to the probability of exposure to transfusion is as follows: 0=baseline risk; 1=low risk; 2=intermediate risk; 3=high risk; 4-8=very high risk.|participants|Number|0|0.0||||||
4093718|NCT00991341|3917367|B1|0||Minimum TRUST Score|Per Alghamdi et al article in Transfusion (2006), the Transfusion Risk Understanding Scoring Tool (TRUST) score is an additive algorithm that provides an overall score that ranges from 0 to 8. The interpretation of the total score as it relates to the probability of exposure to transfusion is as follows: 0=baseline risk; 1=low risk; 2=intermediate risk; 3=high risk; 4-8=very high risk.|participants|Number|1|1.0||||||
4093719|NCT00991341|3917365|B3|||Height||cm|Median|165|165.0|Inter-Quartile Range|||158.0|173.0|
4093720|NCT00991341|3917366|B2|||Height||cm|Median|165|165.0|Inter-Quartile Range|||160.0|175.0|
4093721|NCT00991341|3917367|B1|||Height||cm|Median|165|165.0|Inter-Quartile Range|||158.0|173.0|
4093722|NCT00991341|3917365|B3|||Weight||kg|Median|75|75.0|Inter-Quartile Range|||66.0|87.0|
4093723|NCT00991341|3917366|B2|||Weight||kg|Median|74|74.0|Inter-Quartile Range|||66.0|86.0|
4093724|NCT00991341|3917367|B1|||Weight||kg|Median|75|75.0|Inter-Quartile Range|||65.0|89.0|
4093725|NCT00991341|3917365|B3|United States||Region of Enrollment||participants|Number|1098|1098.0||||||
4093726|NCT00991341|3917366|B2|United States||Region of Enrollment||participants|Number|560|560.0||||||
4093727|NCT00991341|3917367|B1|United States||Region of Enrollment||participants|Number|538|538.0||||||
4093728|NCT00991341|3917365|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4093729|NCT00991341|3917366|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4093730|NCT00991341|3917367|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4093731|NCT00991341|3917365|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4093732|NCT00991341|3917366|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4093733|NCT00991341|3917367|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4093734|NCT00991341|3917365|B3||White|Race (NIH/OMB)||Participants|Count of Participants|978|978.0||||||
4093735|NCT00991341|3917366|B2||White|Race (NIH/OMB)||Participants|Count of Participants|493|493.0||||||
4093736|NCT00991341|3917367|B1||White|Race (NIH/OMB)||Participants|Count of Participants|485|485.0||||||
4093737|NCT00991341|3917365|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
4093738|NCT00991341|3917366|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4093739|NCT00991341|3917367|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4093740|NCT00991341|3917365|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4093741|NCT00991341|3917366|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4093742|NCT00991341|3917367|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4093743|NCT00991341|3917365|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4093745|NCT00991341|3917367|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4093746|NCT00991341|3917365|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4093747|NCT00991341|3917366|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4093748|NCT00991341|3917367|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4093749|NCT00991341|3917365|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4093750|NCT00991341|3917366|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4093751|NCT00991341|3917367|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4093752|NCT00991341|3917365|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1019|1019.0||||||
4093753|NCT00991341|3917366|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|513|513.0||||||
4093754|NCT00991341|3917367|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|506|506.0||||||
4093755|NCT00991341|3917365|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4093756|NCT00991341|3917366|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4093757|NCT00991341|3917367|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4093758|NCT00991341|3917365|B3||Male|Sex: Female, Male||Participants|Count of Participants|475|475.0||||||
4093759|NCT00991341|3917366|B2||Male|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
4093760|NCT00991341|3917367|B1||Male|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
4093761|NCT00991341|3917365|B3||Female|Sex: Female, Male||Participants|Count of Participants|623|623.0||||||
4093762|NCT00991341|3917366|B2||Female|Sex: Female, Male||Participants|Count of Participants|313|313.0||||||
4093763|NCT00991341|3917367|B1||Female|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
4093764|NCT00991341|3917365|B3|>= 18 years||Age, Customized||participants|Number|1094|1094.0||||||
4093765|NCT00991341|3917366|B2|>= 18 years||Age, Customized||participants|Number|558|558.0||||||
4093766|NCT00991341|3917367|B1|>= 18 years||Age, Customized||participants|Number|536|536.0||||||
4093767|NCT00991341|3917365|B3|<18 years||Age, Customized||participants|Number|4|4.0||||||
4093768|NCT00991341|3917366|B2|<18 years||Age, Customized||participants|Number|2|2.0||||||
4093769|NCT00991341|3917367|B1|<18 years||Age, Customized||participants|Number|2|2.0||||||
4093770|NCT00991341|3917365|B3|||Age||years|Median|72|72.0|Inter-Quartile Range|||66.0|79.0|
4093771|NCT00991341|3917366|B2|||Age||years|Median|72|72.0|Inter-Quartile Range|||65.0|79.0|
4093772|NCT00991341|3917367|B1|||Age||years|Median|73|73.0|Inter-Quartile Range|||66.0|80.0|
4093773|NCT00991302|3917404|B3|||CD4+ T-cell count||cells/mm^3|Mean|315|315.0|Standard Deviation|195|195.0|||
4093774|NCT00991302|3917405|B2|||CD4+ T-cell count||cells/mm^3|Mean|313|313.0|Standard Deviation|213|213.0|||
4093775|NCT00991302|3917406|B1|||CD4+ T-cell count||cells/mm^3|Mean|318|318.0|Standard Deviation|178|178.0|||
4093776|NCT00991302|3917404|B3|||HIV-1 RNA||log10 copies/mL|Mean|5.0|5.0|Standard Deviation|0.7|0.7|||
4093777|NCT00991302|3917405|B2|||HIV-1 RNA||log10 copies/mL|Mean|5.0|5.0|Standard Deviation|0.7|0.7|||
4093778|NCT00991302|3917406|B1|||HIV-1 RNA||log10 copies/mL|Mean|4.9|4.9|Standard Deviation|0.8|0.8|||
4093779|NCT00991302|3917404|B3|BID or TID||Regimen complexity||participants|Number|122|122.0||||||
4093780|NCT00991302|3917405|B2|BID or TID||Regimen complexity||participants|Number|61|61.0||||||
4093781|NCT00991302|3917406|B1|BID or TID||Regimen complexity||participants|Number|61|61.0||||||
4093782|NCT00991302|3917404|B3|QD||Regimen complexity||participants|Number|50|50.0||||||
4093783|NCT00991302|3917405|B2|QD||Regimen complexity||participants|Number|25|25.0||||||
4093784|NCT00991302|3917406|B1|QD||Regimen complexity||participants|Number|25|25.0||||||
4093785|NCT00991302|3917404|B3|Peru||Region of Enrollment||participants|Number|120|120.0||||||
4093786|NCT00991302|3917405|B2|Peru||Region of Enrollment||participants|Number|60|60.0||||||
4093787|NCT00991302|3917406|B1|Peru||Region of Enrollment||participants|Number|60|60.0||||||
4093788|NCT00991302|3917404|B3|United States||Region of Enrollment||participants|Number|52|52.0||||||
4093789|NCT00991302|3917405|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4093790|NCT00991302|3917406|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4093791|NCT00991302|3917404|B3|Missing||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4093792|NCT00991302|3917405|B2|Missing||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4093793|NCT00991302|3917406|B1|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4093794|NCT00991302|3917404|B3|More than Once Race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4093795|NCT00991302|3917405|B2|More than Once Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4093796|NCT00991302|3917406|B1|More than Once Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4093797|NCT00991302|3917404|B3|Asian, Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4093798|NCT00991302|3917405|B2|Asian, Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4093799|NCT00991302|3917406|B1|Asian, Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4093800|NCT00991302|3917404|B3|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||participants|Number|135|135.0||||||
4093801|NCT00991302|3917405|B2|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
4093802|NCT00991302|3917406|B1|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||participants|Number|73|73.0||||||
4093803|NCT00991302|3917404|B3|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4093804|NCT00991302|3917405|B2|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4093805|NCT00991302|3917406|B1|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4093806|NCT00991302|3917404|B3|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4093807|NCT00991302|3917405|B2|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4093808|NCT00991302|3917406|B1|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4093809|NCT00991302|3917404|B3||Male|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4093810|NCT00991302|3917405|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4093811|NCT00991302|3917406|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4093812|NCT00991302|3917404|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4093813|NCT00991302|3917405|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4093814|NCT00991302|3917406|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4093815|NCT00991302|3917404|B3|50+ years||Age, Customized||participants|Number|9|9.0||||||
4093816|NCT00991302|3917405|B2|50+ years||Age, Customized||participants|Number|6|6.0||||||
4093817|NCT00991302|3917406|B1|50+ years||Age, Customized||participants|Number|3|3.0||||||
4093818|NCT00991302|3917404|B3|40-49 years||Age, Customized||participants|Number|24|24.0||||||
4093819|NCT00991302|3917405|B2|40-49 years||Age, Customized||participants|Number|14|14.0||||||
4093820|NCT00991302|3917406|B1|40-49 years||Age, Customized||participants|Number|10|10.0||||||
4093821|NCT00991302|3917404|B3|30-39 years||Age, Customized||participants|Number|48|48.0||||||
4093822|NCT00991302|3917405|B2|30-39 years||Age, Customized||participants|Number|23|23.0||||||
4093823|NCT00991302|3917406|B1|30-39 years||Age, Customized||participants|Number|25|25.0||||||
4093824|NCT00991302|3917404|B3|18-29 years||Age, Customized||participants|Number|91|91.0||||||
4093825|NCT00991302|3917405|B2|18-29 years||Age, Customized||participants|Number|43|43.0||||||
4093826|NCT00991302|3917406|B1|18-29 years||Age, Customized||participants|Number|48|48.0||||||
4093827|NCT00991302|3917404|B3|||Age||years|Mean|31|31.0|Standard Deviation|9|9.0|||
4093828|NCT00991302|3917405|B2|||Age||years|Mean|32|32.0|Standard Deviation|10|10.0|||
4093829|NCT00991302|3917406|B1|||Age||years|Mean|31|31.0|Standard Deviation|8|8.0|||
4093830|NCT00991289|3917423|B1|Not on ART||HIV Antiretroviral therapy (ART) status||participant|Number|6|6.0||||||
4093831|NCT00991289|3917423|B1|On ART||HIV Antiretroviral therapy (ART) status||participant|Number|61|61.0||||||
4093832|NCT00991289|3917423|B1|Unknown||Number of participants with indicated HIV viral load|A blood sample was drawn to determine the HIV viral load by local laboratories. HIV viral load was categorized as <lower limit of quantification (undetectable) of the assay or >=lower limit of quantification of the assay (detectable). The assays used were bDNA assay (Versant HIV-1 RNA 3.0), Roche COBAS AmpliPrp/Taqman HIV-1 assay and Abbott RealTime HIV-1 assay.|participant|Number|2|2.0||||||
4093833|NCT00991289|3917423|B1|Detectable HIV viral load||Number of participants with indicated HIV viral load|A blood sample was drawn to determine the HIV viral load by local laboratories. HIV viral load was categorized as <lower limit of quantification (undetectable) of the assay or >=lower limit of quantification of the assay (detectable). The assays used were bDNA assay (Versant HIV-1 RNA 3.0), Roche COBAS AmpliPrp/Taqman HIV-1 assay and Abbott RealTime HIV-1 assay.|participant|Number|16|16.0||||||
4093834|NCT00991289|3917423|B1|Undetectable HIV viral load||Number of participants with indicated HIV viral load|A blood sample was drawn to determine the HIV viral load by local laboratories. HIV viral load was categorized as <lower limit of quantification (undetectable) of the assay or >=lower limit of quantification of the assay (detectable). The assays used were bDNA assay (Versant HIV-1 RNA 3.0), Roche COBAS AmpliPrp/Taqman HIV-1 assay and Abbott RealTime HIV-1 assay.|participant|Number|49|49.0||||||
4093835|NCT00991289|3917423|B1|||CD4+ T cell count||cells/mm3|Median|452|452.0|Inter-Quartile Range|||323.0|738.0|
4093836|NCT00991289|3917423|B1|||HCV viral load level|Hepatitis C virus (HCV) viral load testing was done using Cobas AmpliPrep/Taqman HCV Test with lower limit of quantitation of 43 IU/ml.|log10 IU/ml|Median|6.4|6.4|Inter-Quartile Range|||6.0|6.7|
4093837|NCT00991289|3917423|B1|United States||Region of Enrollment||participants|Number|67|67.0||||||
4093838|NCT00991289|3917423|B1|Other/Unknown||Race/Ethnicity, Customized|Race/ethnicity, self-reported (NIH categories)|Participants|Number|2|2.0||||||
4093839|NCT00991289|3917423|B1|Hispanic, Regardless of Race||Race/Ethnicity, Customized|Race/ethnicity, self-reported (NIH categories)|Participants|Number|12|12.0||||||
4093840|NCT00991289|3917423|B1|Black, Non-Hispanic||Race/Ethnicity, Customized|Race/ethnicity, self-reported (NIH categories)|Participants|Number|32|32.0||||||
4093841|NCT00991289|3917423|B1|White, Non-Hispanic||Race/Ethnicity, Customized|Race/ethnicity, self-reported (NIH categories)|Participants|Number|21|21.0||||||
4093842|NCT00991289|3917423|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4093843|NCT00991289|3917423|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4093844|NCT00991289|3917423|B1|>=60 years||Age, Customized||participants|Number|3|3.0||||||
4093845|NCT00991289|3917423|B1|55 to 60 years||Age, Customized||participants|Number|13|13.0||||||
4093846|NCT00991289|3917423|B1|50 to <55 years||Age, Customized||participants|Number|18|18.0||||||
4093847|NCT00991289|3917423|B1|45 to <50 years||Age, Customized||participants|Number|13|13.0||||||
4093848|NCT00991289|3917423|B1|40 to <45 years||Age, Customized||participants|Number|11|11.0||||||
4093849|NCT00991289|3917423|B1|35 to <40 years||Age, Customized||participants|Number|3|3.0||||||
4093850|NCT00991289|3917423|B1|30 to <35 years||Age, Customized||participants|Number|4|4.0||||||
4093851|NCT00991289|3917423|B1|25 to <30 years||Age, Customized||participants|Number|1|1.0||||||
4093852|NCT00991289|3917423|B1|<25 years||Age, Customized||participants|Number|1|1.0||||||
4093853|NCT00991289|3917423|B1|||Age||years|Mean|48.1|48.1|Standard Deviation|8.5|8.5|||
4093854|NCT00991276|3917437|B7||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4093855|NCT00991276|3917438|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4093856|NCT00991276|3917439|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4093857|NCT00991276|3917440|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4093858|NCT00991276|3917441|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4093859|NCT00991276|3917442|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4093860|NCT00991276|3917443|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4093861|NCT00991276|3917437|B7||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4093862|NCT00991276|3917438|B6||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4093863|NCT00991276|3917439|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4093864|NCT00991276|3917440|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4093865|NCT00991276|3917441|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4093866|NCT00991276|3917442|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4093867|NCT00991276|3917443|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4093868|NCT00991276|3917437|B7|Greater than or equal to 65 years||Age, Customized||participants|Number|15|15.0||||||
4093869|NCT00991276|3917438|B6|Greater than or equal to 65 years||Age, Customized||participants|Number|2|2.0||||||
4093870|NCT00991276|3917439|B5|Greater than or equal to 65 years||Age, Customized||participants|Number|2|2.0||||||
4093871|NCT00991276|3917440|B4|Greater than or equal to 65 years||Age, Customized||participants|Number|3|3.0||||||
4093872|NCT00991276|3917441|B3|Greater than or equal to 65 years||Age, Customized||participants|Number|2|2.0||||||
4093873|NCT00991276|3917442|B2|Greater than or equal to 65 years||Age, Customized||participants|Number|2|2.0||||||
4093874|NCT00991276|3917443|B1|Greater than or equal to 65 years||Age, Customized||participants|Number|4|4.0||||||
4093875|NCT00991276|3917437|B7|45 to 64 years||Age, Customized||participants|Number|52|52.0||||||
4093876|NCT00991276|3917438|B6|45 to 64 years||Age, Customized||participants|Number|8|8.0||||||
4093877|NCT00991276|3917439|B5|45 to 64 years||Age, Customized||participants|Number|8|8.0||||||
4093878|NCT00991276|3917440|B4|45 to 64 years||Age, Customized||participants|Number|10|10.0||||||
4093879|NCT00991276|3917441|B3|45 to 64 years||Age, Customized||participants|Number|11|11.0||||||
4093880|NCT00991276|3917442|B2|45 to 64 years||Age, Customized||participants|Number|7|7.0||||||
4093881|NCT00991276|3917443|B1|45 to 64 years||Age, Customized||participants|Number|8|8.0||||||
4093882|NCT00991276|3917437|B7|18 to 44 years||Age, Customized||participants|Number|18|18.0||||||
4093883|NCT00991276|3917438|B6|18 to 44 years||Age, Customized||participants|Number|3|3.0||||||
4093884|NCT00991276|3917439|B5|18 to 44 years||Age, Customized||participants|Number|5|5.0||||||
4093885|NCT00991276|3917440|B4|18 to 44 years||Age, Customized||participants|Number|2|2.0||||||
4093886|NCT00991276|3917441|B3|18 to 44 years||Age, Customized||participants|Number|1|1.0||||||
4093887|NCT00991276|3917442|B2|18 to 44 years||Age, Customized||participants|Number|4|4.0||||||
4093888|NCT00991276|3917443|B1|18 to 44 years||Age, Customized||participants|Number|3|3.0||||||
4093889|NCT00991276|3917437|B7|Less than 18 years||Age, Customized||participants|Number|0|0.0||||||
4093890|NCT00991276|3917438|B6|Less than 18 years||Age, Customized||participants|Number|0|0.0||||||
4093891|NCT00991276|3917439|B5|Less than 18 years||Age, Customized||participants|Number|0|0.0||||||
4093892|NCT00991276|3917440|B4|Less than 18 years||Age, Customized||participants|Number|0|0.0||||||
4093893|NCT00991276|3917441|B3|Less than 18 years||Age, Customized||participants|Number|0|0.0||||||
4093894|NCT00991276|3917442|B2|Less than 18 years||Age, Customized||participants|Number|0|0.0||||||
4093895|NCT00991276|3917443|B1|Less than 18 years||Age, Customized||participants|Number|0|0.0||||||
4093896|NCT00991185|3917546|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4093897|NCT00991185|3917546|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4093898|NCT00991185|3917546|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4093899|NCT00991185|3917546|B1|||Age||years|Median|4|4.0|Full Range|||0.2|17.0|
4093900|NCT00991081|3917550|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4093901|NCT00991081|3917551|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4093902|NCT00991081|3917552|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4093903|NCT00991081|3917550|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4093904|NCT00991081|3917551|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4093905|NCT00991081|3917552|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4093906|NCT00991081|3917550|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4093907|NCT00991081|3917551|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4093908|NCT00991081|3917552|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4093909|NCT00991081|3917550|B3|||Age||years|Mean|51.1|51.1|Standard Deviation|9.42|9.42|||
4093910|NCT00991081|3917551|B2|||Age||years|Mean|52.7|52.7|Standard Deviation|8.22|8.22|||
4093911|NCT00991081|3917552|B1|||Age||years|Mean|49.4|49.4|Standard Deviation|10.6|10.6|||
4093912|NCT00991081|3917550|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4093913|NCT00991081|3917551|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4093914|NCT00991081|3917552|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4093915|NCT00991081|3917550|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4093916|NCT00991081|3917551|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4093917|NCT00991081|3917552|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4093918|NCT00991081|3917550|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093919|NCT00991081|3917551|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093920|NCT00991081|3917552|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4093921|NCT00991029|3917586|B3|National Institutes of Health Stroke Scale||Qualifying Neurologic Score|"The ABCD2 score is a seven-point score for identifying patients who have suffered a transient ischemic attack (TIA) at the highest risk of stroke (scores ranges from 0 to 7, with higher scores indicating a greater risk of stroke).~The National Institutes of Health Stroke Scale (NIHSS) score is used quantify the impairment caused by a stroke (scores range from 0 to 42, with higher scores indicating greater stroke severity).~Patients were eligible if they had an acute ischemic stroke with a score of 3 or less on the NIHSS or had a TIA with a score of 4 or more on the ABCD2 scale."|units on a scale|Median|2.0|2.0|Inter-Quartile Range|||1.0|2.0|
4093922|NCT00991029|3917587|B2|National Institutes of Health Stroke Scale||Qualifying Neurologic Score|"The ABCD2 score is a seven-point score for identifying patients who have suffered a transient ischemic attack (TIA) at the highest risk of stroke (scores ranges from 0 to 7, with higher scores indicating a greater risk of stroke).~The National Institutes of Health Stroke Scale (NIHSS) score is used quantify the impairment caused by a stroke (scores range from 0 to 42, with higher scores indicating greater stroke severity).~Patients were eligible if they had an acute ischemic stroke with a score of 3 or less on the NIHSS or had a TIA with a score of 4 or more on the ABCD2 scale."|units on a scale|Median|2.0|2.0|Inter-Quartile Range|||1.0|2.0|
4093923|NCT00991029|3917588|B1|National Institutes of Health Stroke Scale||Qualifying Neurologic Score|"The ABCD2 score is a seven-point score for identifying patients who have suffered a transient ischemic attack (TIA) at the highest risk of stroke (scores ranges from 0 to 7, with higher scores indicating a greater risk of stroke).~The National Institutes of Health Stroke Scale (NIHSS) score is used quantify the impairment caused by a stroke (scores range from 0 to 42, with higher scores indicating greater stroke severity).~Patients were eligible if they had an acute ischemic stroke with a score of 3 or less on the NIHSS or had a TIA with a score of 4 or more on the ABCD2 scale."|units on a scale|Median|2.0|2.0|Inter-Quartile Range|||1.0|2.0|
4093924|NCT00991029|3917586|B3|ABCD2||Qualifying Neurologic Score|"The ABCD2 score is a seven-point score for identifying patients who have suffered a transient ischemic attack (TIA) at the highest risk of stroke (scores ranges from 0 to 7, with higher scores indicating a greater risk of stroke).~The National Institutes of Health Stroke Scale (NIHSS) score is used quantify the impairment caused by a stroke (scores range from 0 to 42, with higher scores indicating greater stroke severity).~Patients were eligible if they had an acute ischemic stroke with a score of 3 or less on the NIHSS or had a TIA with a score of 4 or more on the ABCD2 scale."|units on a scale|Median|5.0|5.0|Inter-Quartile Range|||4.0|6.0|
4093925|NCT00991029|3917587|B2|ABCD2||Qualifying Neurologic Score|"The ABCD2 score is a seven-point score for identifying patients who have suffered a transient ischemic attack (TIA) at the highest risk of stroke (scores ranges from 0 to 7, with higher scores indicating a greater risk of stroke).~The National Institutes of Health Stroke Scale (NIHSS) score is used quantify the impairment caused by a stroke (scores range from 0 to 42, with higher scores indicating greater stroke severity).~Patients were eligible if they had an acute ischemic stroke with a score of 3 or less on the NIHSS or had a TIA with a score of 4 or more on the ABCD2 scale."|units on a scale|Median|5.0|5.0|Inter-Quartile Range|||4.0|5.0|
4093926|NCT00991029|3917588|B1|ABCD2||Qualifying Neurologic Score|"The ABCD2 score is a seven-point score for identifying patients who have suffered a transient ischemic attack (TIA) at the highest risk of stroke (scores ranges from 0 to 7, with higher scores indicating a greater risk of stroke).~The National Institutes of Health Stroke Scale (NIHSS) score is used quantify the impairment caused by a stroke (scores range from 0 to 42, with higher scores indicating greater stroke severity).~Patients were eligible if they had an acute ischemic stroke with a score of 3 or less on the NIHSS or had a TIA with a score of 4 or more on the ABCD2 scale."|units on a scale|Median|5.0|5.0|Inter-Quartile Range|||4.0|6.0|
4093927|NCT00991029|3917586|B3||Ischemic Stroke|Qualifying Event|TIA or Ischemic Stroke|Participants|Count of Participants|2773|2773.0||||||
4093928|NCT00991029|3917587|B2||Ischemic Stroke|Qualifying Event|TIA or Ischemic Stroke|Participants|Count of Participants|1397|1397.0||||||
4093929|NCT00991029|3917588|B1||Ischemic Stroke|Qualifying Event|TIA or Ischemic Stroke|Participants|Count of Participants|1376|1376.0||||||
4093930|NCT00991029|3917586|B3||TIA|Qualifying Event|TIA or Ischemic Stroke|Participants|Count of Participants|2108|2108.0||||||
4093931|NCT00991029|3917587|B2||TIA|Qualifying Event|TIA or Ischemic Stroke|Participants|Count of Participants|1052|1052.0||||||
4093932|NCT00991029|3917588|B1||TIA|Qualifying Event|TIA or Ischemic Stroke|Participants|Count of Participants|1056|1056.0||||||
4093933|NCT00991029|3917586|B3|Spain||Region of Enrollment||Participants|Count of Participants|241|241.0||||||
4093934|NCT00991029|3917587|B2|Spain||Region of Enrollment||Participants|Count of Participants|122|122.0||||||
4093935|NCT00991029|3917588|B1|Spain||Region of Enrollment||Participants|Count of Participants|119|119.0||||||
4093936|NCT00991029|3917586|B3|Germany||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4093937|NCT00991029|3917587|B2|Germany||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4093938|NCT00991029|3917588|B1|Germany||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4093939|NCT00991029|3917586|B3|France||Region of Enrollment||Participants|Count of Participants|98|98.0||||||
4093940|NCT00991029|3917587|B2|France||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
4093941|NCT00991029|3917588|B1|France||Region of Enrollment||Participants|Count of Participants|51|51.0||||||
4093942|NCT00991029|3917586|B3|Australia||Region of Enrollment||Participants|Count of Participants|104|104.0||||||
4093943|NCT00991029|3917587|B2|Australia||Region of Enrollment||Participants|Count of Participants|51|51.0||||||
4093944|NCT00991029|3917588|B1|Australia||Region of Enrollment||Participants|Count of Participants|53|53.0||||||
4093945|NCT00991029|3917586|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|71|71.0||||||
4093946|NCT00991029|3917587|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
4093947|NCT00991029|3917588|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
4093948|NCT00991029|3917586|B3|Mexico||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4093949|NCT00991029|3917587|B2|Mexico||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4093950|NCT00991029|3917588|B1|Mexico||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4093951|NCT00991029|3917586|B3|Finland||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
4093952|NCT00991029|3917587|B2|Finland||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4093953|NCT00991029|3917588|B1|Finland||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4093954|NCT00991029|3917586|B3|United States||Region of Enrollment||Participants|Count of Participants|4043|4043.0||||||
4093955|NCT00991029|3917587|B2|United States||Region of Enrollment||Participants|Count of Participants|2029|2029.0||||||
4093956|NCT00991029|3917588|B1|United States||Region of Enrollment||Participants|Count of Participants|2014|2014.0||||||
4093957|NCT00991029|3917586|B3|Canada||Region of Enrollment||Participants|Count of Participants|240|240.0||||||
4093958|NCT00991029|3917587|B2|Canada||Region of Enrollment||Participants|Count of Participants|119|119.0||||||
4093959|NCT00991029|3917588|B1|Canada||Region of Enrollment||Participants|Count of Participants|121|121.0||||||
4093960|NCT00991029|3917586|B3|New Zealand||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4093961|NCT00991029|3917587|B2|New Zealand||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4093962|NCT00991029|3917588|B1|New Zealand||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4093963|NCT00991029|3917586|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|169|169.0||||||
4093964|NCT00991029|3917587|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
4093965|NCT00991029|3917588|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
4093966|NCT00991029|3917586|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4093967|NCT00991029|3917587|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4093968|NCT00991029|3917588|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4093969|NCT00991029|3917586|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3555|3555.0||||||
4093970|NCT00991029|3917587|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1781|1781.0||||||
4093971|NCT00991029|3917588|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1774|1774.0||||||
4093972|NCT00991029|3917586|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|966|966.0||||||
4093973|NCT00991029|3917587|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|493|493.0||||||
4093974|NCT00991029|3917588|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|473|473.0||||||
4093975|NCT00991029|3917586|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4093976|NCT00991029|3917587|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4093977|NCT00991029|3917588|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4093978|NCT00991029|3917586|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
4093979|NCT00991029|3917587|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4093980|NCT00991029|3917588|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
4093981|NCT00991029|3917586|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4093982|NCT00991029|3917587|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4093983|NCT00991029|3917588|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4093984|NCT00991029|3917586|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)|Race or ethnic group was determined by the investigator. Hispanic ethnic group was assessed only in patients in the United States.|Participants|Count of Participants|233|233.0||||||
4093985|NCT00991029|3917587|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)|Race or ethnic group was determined by the investigator. Hispanic ethnic group was assessed only in patients in the United States.|Participants|Count of Participants|121|121.0||||||
4093986|NCT00991029|3917588|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|Race or ethnic group was determined by the investigator. Hispanic ethnic group was assessed only in patients in the United States.|Participants|Count of Participants|112|112.0||||||
4093987|NCT00991029|3917586|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Race or ethnic group was determined by the investigator. Hispanic ethnic group was assessed only in patients in the United States.|Participants|Count of Participants|4358|4358.0||||||
4093988|NCT00991029|3917587|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Race or ethnic group was determined by the investigator. Hispanic ethnic group was assessed only in patients in the United States.|Participants|Count of Participants|2182|2182.0||||||
4093989|NCT00991029|3917588|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Race or ethnic group was determined by the investigator. Hispanic ethnic group was assessed only in patients in the United States.|Participants|Count of Participants|2176|2176.0||||||
4093990|NCT00991029|3917586|B3||Hispanic or Latino|Ethnicity (NIH/OMB)|Race or ethnic group was determined by the investigator. Hispanic ethnic group was assessed only in patients in the United States.|Participants|Count of Participants|290|290.0||||||
4093991|NCT00991029|3917587|B2||Hispanic or Latino|Ethnicity (NIH/OMB)|Race or ethnic group was determined by the investigator. Hispanic ethnic group was assessed only in patients in the United States.|Participants|Count of Participants|146|146.0||||||
4093992|NCT00991029|3917588|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|Race or ethnic group was determined by the investigator. Hispanic ethnic group was assessed only in patients in the United States.|Participants|Count of Participants|144|144.0||||||
4093993|NCT00991029|3917586|B3||Male|Sex: Female, Male||Participants|Count of Participants|2686|2686.0||||||
4093994|NCT00991029|3917587|B2||Male|Sex: Female, Male||Participants|Count of Participants|1351|1351.0||||||
4093995|NCT00991029|3917588|B1||Male|Sex: Female, Male||Participants|Count of Participants|1335|1335.0||||||
4093996|NCT00991029|3917586|B3||Female|Sex: Female, Male||Participants|Count of Participants|2195|2195.0||||||
4093997|NCT00991029|3917587|B2||Female|Sex: Female, Male||Participants|Count of Participants|1098|1098.0||||||
4093998|NCT00991029|3917588|B1||Female|Sex: Female, Male||Participants|Count of Participants|1097|1097.0||||||
4093999|NCT00991029|3917586|B3|||Age|Age at time of randomization|years|Median|65.0|65.0|Inter-Quartile Range|||55.0|74.0|
4094000|NCT00991029|3917587|B2|||Age|Age at time of randomization|years|Median|65.0|65.0|Inter-Quartile Range|||56.0|74.0|
4094001|NCT00991029|3917588|B1|||Age|Age at time of randomization|years|Median|65.0|65.0|Inter-Quartile Range|||55.0|74.0|
4094002|NCT00990964|3917619|B1|China||Region of Enrollment||participants|Number|46|46.0||||||
4094003|NCT00990964|3917619|B1|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4094004|NCT00990964|3917619|B1|Romania||Region of Enrollment||participants|Number|5|5.0||||||
4094005|NCT00990964|3917619|B1|Singapore||Region of Enrollment||participants|Number|3|3.0||||||
4094006|NCT00990964|3917619|B1|Poland||Region of Enrollment||participants|Number|22|22.0||||||
4094007|NCT00990964|3917619|B1|Malaysia||Region of Enrollment||participants|Number|12|12.0||||||
4094008|NCT00990964|3917619|B1|Puerto Rico||Region of Enrollment||participants|Number|35|35.0||||||
4094009|NCT00990964|3917619|B1|Canada||Region of Enrollment||participants|Number|15|15.0||||||
4094010|NCT00990964|3917619|B1|France||Region of Enrollment||participants|Number|83|83.0||||||
4094011|NCT00990964|3917619|B1|India||Region of Enrollment||participants|Number|79|79.0||||||
4094012|NCT00990964|3917619|B1|Malta||Region of Enrollment||participants|Number|8|8.0||||||
4094013|NCT00990964|3917619|B1|Thailand||Region of Enrollment||participants|Number|4|4.0||||||
4094014|NCT00990964|3917619|B1|Pakistan||Region of Enrollment||participants|Number|11|11.0||||||
4094015|NCT00990964|3917619|B1|Hong Kong||Region of Enrollment||participants|Number|7|7.0||||||
4094016|NCT00990964|3917619|B1|Taiwan||Region of Enrollment||participants|Number|30|30.0||||||
4094017|NCT00990964|3917619|B1|United States||Region of Enrollment||participants|Number|1648|1648.0||||||
4094018|NCT00990964|3917619|B1||Male|Sex: Female, Male||Participants|Count of Participants|1438|1438.0||||||
4094019|NCT00990964|3917619|B1||Female|Sex: Female, Male||Participants|Count of Participants|576|576.0||||||
4094020|NCT00990964|3917619|B1|||Age||years|Mean|69.1|69.1|Standard Deviation|12.0|12.0|||
4094021|NCT00990964|3917619|B1||>=65 years|Age||Participants|Count of Participants|1353|1353.0||||||
4094022|NCT00990964|3917619|B1||Between 18 and 65 years|Age||Participants|Count of Participants|661|661.0||||||
4094023|NCT00990964|3917619|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4094024|NCT00990821|3917624|B15||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4094025|NCT00990821|3917625|B14||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4094026|NCT00990821|3917626|B13||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4094027|NCT00990821|3917627|B12||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4094028|NCT00990821|3917628|B11||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4094029|NCT00990821|3917629|B10||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4094030|NCT00990821|3917630|B9||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4094031|NCT00990821|3917631|B8||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4094032|NCT00990821|3917632|B7||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4094033|NCT00990821|3917633|B6||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4094034|NCT00990821|3917634|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4094035|NCT00990821|3917635|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4094036|NCT00990821|3917636|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4094037|NCT00990821|3917637|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4094038|NCT00990821|3917638|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4094039|NCT00990821|3917624|B15||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4094040|NCT00990821|3917625|B14||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4094041|NCT00990821|3917626|B13||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4094042|NCT00990821|3917627|B12||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4094043|NCT00990821|3917628|B11||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4094044|NCT00990821|3917629|B10||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4094045|NCT00990821|3917630|B9||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4094046|NCT00990821|3917631|B8||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4094047|NCT00990821|3917632|B7||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4094048|NCT00990821|3917633|B6||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4094049|NCT00990821|3917634|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4094050|NCT00990821|3917635|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4094051|NCT00990821|3917636|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4094052|NCT00990821|3917637|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4094053|NCT00990821|3917638|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4094054|NCT00990821|3917624|B15|||Age||years|Mean|32.6|32.6|Full Range|||18.0|45.0|
4094055|NCT00990821|3917625|B14|||Age||years|Mean|36.5|36.5|Full Range|||20.0|43.0|
4094056|NCT00990821|3917626|B13|||Age||years|Mean|30.4|30.4|Full Range|||19.0|45.0|
4094057|NCT00990821|3917627|B12|||Age||years|Mean|29.1|29.1|Full Range|||19.0|41.0|
4094058|NCT00990821|3917628|B11|||Age||years|Mean|31.3|31.3|Full Range|||22.0|45.0|
4094059|NCT00990821|3917629|B10|||Age||years|Mean|33.5|33.5|Full Range|||22.0|44.0|
4094060|NCT00990821|3917630|B9|||Age||years|Mean|31.9|31.9|Full Range|||19.0|44.0|
4094061|NCT00990821|3917631|B8|||Age||years|Mean|29.4|29.4|Full Range|||18.0|45.0|
4094062|NCT00990821|3917632|B7|||Age||years|Mean|32.4|32.4|Full Range|||18.0|45.0|
4094063|NCT00990821|3917633|B6|||Age||years|Mean|33.2|33.2|Full Range|||19.0|43.0|
4094064|NCT00990821|3917634|B5|||Age||years|Mean|33.2|33.2|Full Range|||19.0|43.0|
4094065|NCT00990821|3917635|B4|||Age||years|Mean|36.9|36.9|Full Range|||25.0|45.0|
4094066|NCT00990821|3917636|B3|||Age||years|Mean|33.1|33.1|Full Range|||22.0|45.0|
4094067|NCT00990821|3917637|B2|||Age||years|Mean|35.2|35.2|Full Range|||23.0|44.0|
4094068|NCT00990821|3917638|B1|||Age||years|Mean|31.2|31.2|Full Range|||21.0|45.0|
4094069|NCT00990782|3917668|B1|United States||Region of Enrollment||Participants|Count of Participants|88|88.0||||||
4094070|NCT00990782|3917668|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4094071|NCT00990782|3917668|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4094072|NCT00990782|3917668|B1|||Age||Years|Mean|59.5|59.5|Standard Deviation|10.7|10.7|||
4094073|NCT00990769|3917673|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4094074|NCT00990769|3917674|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4094075|NCT00990769|3917675|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4094076|NCT00990769|3917673|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4094077|NCT00990769|3917674|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4094078|NCT00990769|3917675|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4094079|NCT00990769|3917673|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4094080|NCT00990769|3917674|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4094081|NCT00990769|3917675|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4094082|NCT00990769|3917673|B3|||Age||years|Mean|4.7|4.7|Standard Deviation|1.9|1.9|||
4094083|NCT00990769|3917674|B2|||Age||years|Mean|4.3|4.3|Standard Deviation|1.4|1.4|||
4094084|NCT00990769|3917675|B1|||Age||years|Mean|5.1|5.1|Standard Deviation|2.3|2.3|||
4094085|NCT00990769|3917673|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4094086|NCT00990769|3917674|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4094087|NCT00990769|3917675|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4094088|NCT00990769|3917673|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4094089|NCT00990769|3917674|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4094090|NCT00990769|3917675|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4094091|NCT00990769|3917673|B3||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
4094092|NCT00990769|3917674|B2||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
4094093|NCT00990769|3917675|B1||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
4094094|NCT00990704|3917686|B3|Japan||Region of Enrollment||participants|Number|47|47.0||||||
4094095|NCT00990704|3917687|B2|Japan||Region of Enrollment||participants|Number|33|33.0||||||
4094096|NCT00990704|3917688|B1|Japan||Region of Enrollment||participants|Number|14|14.0||||||
4094097|NCT00990704|3917686|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4094098|NCT00990704|3917687|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4094099|NCT00990704|3917688|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4094100|NCT00990704|3917686|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4094101|NCT00990704|3917687|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4094102|NCT00990704|3917688|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4094103|NCT00990704|3917686|B3|||Age||years|Mean|62.5|62.5|Standard Deviation|10.13|10.13|||
4094104|NCT00990704|3917687|B2|||Age||years|Mean|61.5|61.5|Standard Deviation|9.73|9.73|||
4094105|NCT00990704|3917688|B1|||Age||years|Mean|64.9|64.9|Standard Deviation|11.02|11.02|||
4094106|NCT00990704|3917686|B3||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4094107|NCT00990704|3917687|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4094108|NCT00990704|3917688|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4094109|NCT00990704|3917686|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4094110|NCT00990704|3917687|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4094111|NCT00990704|3917688|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4094112|NCT00990704|3917686|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4094113|NCT00990704|3917687|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4094114|NCT00990704|3917688|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4094115|NCT00990652|3917709|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4094116|NCT00990652|3917709|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4094117|NCT00990652|3917709|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4094118|NCT00990652|3917709|B1|81-90 years||Age, Customized||participants|Number|0|0.0||||||
4094119|NCT00990652|3917709|B1|71-80 years||Age, Customized||participants|Number|0|0.0||||||
4094120|NCT00990652|3917709|B1|61-70 years||Age, Customized||participants|Number|2|2.0||||||
4094121|NCT00990652|3917709|B1|51-60 years||Age, Customized||participants|Number|2|2.0||||||
4094122|NCT00990652|3917709|B1|41-50 years||Age, Customized||participants|Number|6|6.0||||||
4094123|NCT00990652|3917709|B1|31-40 years||Age, Customized||participants|Number|0|0.0||||||
4094124|NCT00990652|3917709|B1|21-30 years||Age, Customized||participants|Number|0|0.0||||||
4094125|NCT00990561|3917717|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4094126|NCT00990561|3917718|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4094127|NCT00990561|3917719|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4094128|NCT00990561|3917717|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4094129|NCT00990561|3917718|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4094130|NCT00990561|3917719|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4094131|NCT00990561|3917717|B3|||Age||Years|Mean|44.2|44.2|Full Range|||20.0|75.0|
4094132|NCT00990561|3917718|B2|||Age||Years|Mean|NA||Full Range|||0.0|0.0|Age was not analyzed by sub-group. Just overall.
4094133|NCT00990561|3917719|B1|||Age||Years|Mean|NA||Full Range|||0.0|0.0|Age was not analyzed by sub-group. Just overall.
4094134|NCT00990509|3917728|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4094135|NCT00990509|3917729|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4094136|NCT00990509|3917730|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4094137|NCT00990509|3917728|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094138|NCT00990509|3917729|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094139|NCT00990509|3917730|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094140|NCT00990509|3917728|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4094141|NCT00990509|3917729|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4094142|NCT00990509|3917730|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4094143|NCT00990509|3917728|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094144|NCT00990509|3917729|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094145|NCT00990509|3917730|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094146|NCT00990509|3917728|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094147|NCT00990509|3917729|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094148|NCT00990509|3917730|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094149|NCT00990509|3917728|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094150|NCT00990509|3917729|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094151|NCT00990509|3917730|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094152|NCT00990509|3917728|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4094153|NCT00990509|3917729|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4094154|NCT00990509|3917730|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4094155|NCT00990509|3917728|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4094156|NCT00990509|3917729|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4094157|NCT00990509|3917730|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4094158|NCT00990509|3917728|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094159|NCT00990509|3917729|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094160|NCT00990509|3917730|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094161|NCT00990509|3917728|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4094162|NCT00990509|3917729|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4094163|NCT00990509|3917730|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094164|NCT00990509|3917728|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094165|NCT00990509|3917729|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094166|NCT00990509|3917730|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094167|NCT00990509|3917728|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4094168|NCT00990509|3917729|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4094169|NCT00990509|3917730|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4094170|NCT00990509|3917728|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4094171|NCT00990509|3917729|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4094172|NCT00990509|3917730|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4094173|NCT00990509|3917728|B3|||Age||years|Mean|59.7|59.7|Full Range|||41.0|82.0|
4094174|NCT00990509|3917729|B2|||Age||years|Mean|58.1|58.1|Full Range|||41.0|76.0|
4094175|NCT00990509|3917730|B1|||Age||years|Mean|62.6|62.6|Full Range|||41.0|82.0|
4094176|NCT00990340|3917741|B3|United States||Region of Enrollment||participants|Number|52|52.0||||||
4094177|NCT00990340|3917742|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4094178|NCT00990340|3917743|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4094179|NCT00990340|3917741|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4094180|NCT00990340|3917742|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4094181|NCT00990340|3917743|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4094182|NCT00990340|3917741|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4094183|NCT00990340|3917742|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4094184|NCT00990340|3917743|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4094185|NCT00990340|3917741|B3|||Age||years|Mean|12.4|12.4|Standard Deviation|2.23|2.23|||
4094186|NCT00990340|3917742|B2|||Age||years|Mean|12.5|12.5|Standard Deviation|2.14|2.14|||
4094187|NCT00990340|3917743|B1|||Age||years|Mean|12.3|12.3|Standard Deviation|2.31|2.31|||
4094188|NCT00990340|3917741|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4094189|NCT00990340|3917742|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4094190|NCT00990340|3917743|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4094191|NCT00990340|3917741|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4094192|NCT00990340|3917742|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4094193|NCT00990340|3917743|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4094194|NCT00990340|3917741|B3||<=18 years|Age||Participants|Count of Participants|52|52.0||||||
4094195|NCT00990340|3917742|B2||<=18 years|Age||Participants|Count of Participants|25|25.0||||||
4094196|NCT00990340|3917743|B1||<=18 years|Age||Participants|Count of Participants|27|27.0||||||
4094197|NCT00990288|3917758|B3|United States||Region of Enrollment||participants|Number|196|196.0||||||
4094198|NCT00990288|3917759|B2|United States||Region of Enrollment||participants|Number|99|99.0||||||
4094199|NCT00990288|3917760|B1|United States||Region of Enrollment||participants|Number|97|97.0||||||
4094200|NCT00990288|3917758|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4094201|NCT00990288|3917759|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4094202|NCT00990288|3917760|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4094203|NCT00990288|3917758|B3||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4094204|NCT00990288|3917759|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4094205|NCT00990288|3917760|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4094206|NCT00990288|3917758|B3|||Age||years|Mean|71.58|71.58|Standard Deviation|9.77|9.77|||
4094207|NCT00990288|3917759|B2|||Age||years|Mean|70.40|70.4|Standard Deviation|10.47|10.47|||
4094208|NCT00990288|3917760|B1|||Age||years|Mean|72.78|72.78|Standard Deviation|8.90|8.9|||
4094209|NCT00990288|3917758|B3||>=65 years|Age||Participants|Count of Participants|103|103.0||||||
4094210|NCT00990288|3917759|B2||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4094211|NCT00990288|3917760|B1||>=65 years|Age||Participants|Count of Participants|77|77.0||||||
4094212|NCT00990288|3917758|B3||Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
4094213|NCT00990288|3917759|B2||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4094214|NCT00990288|3917760|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4094215|NCT00990288|3917758|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4094216|NCT00990288|3917759|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4094217|NCT00990288|3917760|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4094218|NCT00990249|3917791|B1|United States||Region of Enrollment||Participants|Count of Participants|120|120.0||||||
4094219|NCT00990249|3917791|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4094220|NCT00990249|3917791|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4094221|NCT00990249|3917791|B1||White|Race (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
4094222|NCT00990249|3917791|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4094223|NCT00990249|3917791|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094224|NCT00990249|3917791|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4094225|NCT00990249|3917791|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094226|NCT00990249|3917791|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4094227|NCT00990249|3917791|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4094228|NCT00990249|3917791|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4094229|NCT00990249|3917791|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4094230|NCT00990249|3917791|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4094231|NCT00990249|3917791|B1|||Age||years|Median|38|38.0|Full Range|||12.0|64.0|
4094232|NCT00990249|3917791|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4094233|NCT00990249|3917791|B1||Between 18 and 65 years|Age||Participants|Count of Participants|117|117.0||||||
4094234|NCT00990249|3917791|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4094235|NCT00990184|3917795|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4094236|NCT00990184|3917795|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4094237|NCT00990184|3917795|B1|||Age||years|Mean|60.7|60.7|Standard Deviation|8.7|8.7|||
4094238|NCT00990184|3917795|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4094239|NCT00990184|3917795|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4094240|NCT00990184|3917795|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4094241|NCT00990106|3917801|B3|United States||Region of Enrollment||participants|Number|67|67.0||||||
4094242|NCT00990106|3917802|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
4094243|NCT00990106|3917803|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4094244|NCT00990106|3917801|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4094245|NCT00990106|3917802|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4094246|NCT00990106|3917803|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4094247|NCT00990106|3917801|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4094248|NCT00990106|3917802|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4094249|NCT00990106|3917803|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4094250|NCT00990106|3917801|B3|||Age||years|Mean|30.4|30.4|Standard Deviation|6.5|6.5|||
4094251|NCT00990106|3917802|B2|||Age||years|Mean|30.8|30.8|Standard Deviation|6.5|6.5|||
4094252|NCT00990106|3917803|B1|||Age||years|Mean|30.0|30.0|Standard Deviation|6.6|6.6|||
4094253|NCT00990093|3917814|B1|France||Region of Enrollment||participants|Number|12|12.0||||||
4094254|NCT00990093|3917814|B1|Denmark||Region of Enrollment||participants|Number|24|24.0||||||
4094255|NCT00990093|3917814|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4094256|NCT00990093|3917814|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4094257|NCT00990093|3917814|B1|||Age||years|Median|43.2|43.2|Full Range|||20.0|69.9|
4094258|NCT00990093|3917814|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4094259|NCT00990093|3917814|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4094260|NCT00990093|3917814|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4094261|NCT00989989|3917821|B4||Male|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4094262|NCT00989989|3917822|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4094263|NCT00989989|3917823|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4094264|NCT00989989|3917824|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4094265|NCT00989989|3917821|B4||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4094266|NCT00989989|3917822|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4094267|NCT00989989|3917823|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4094268|NCT00989989|3917824|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4094269|NCT00989989|3917821|B4|||Age||years|Mean|61.1|61.1|Standard Deviation|9.85|9.85|||
4094270|NCT00989989|3917822|B3|||Age||years|Mean|61.5|61.5|Standard Deviation|9.68|9.68|||
4094271|NCT00989989|3917823|B2|||Age||years|Mean|60.7|60.7|Standard Deviation|9.37|9.37|||
4094272|NCT00989989|3917824|B1|||Age||years|Mean|61.2|61.2|Standard Deviation|10.52|10.52|||
4094273|NCT00989950|3917864|B5|||Sleep Quality|Sleep quality was documented by patient diary which included questions for the caregiver and patient to answer together regarding sleep patterns (time to sleep, duration of sleep, night awakenings, sleep quality). Assessed on a 5 point scale (0-lowest quality; 5-highest quality)|Score|Mean|3.9|3.9|Standard Deviation|.8|0.8|||
4094274|NCT00989950|3917865|B4|||Sleep Quality|Sleep quality was documented by patient diary which included questions for the caregiver and patient to answer together regarding sleep patterns (time to sleep, duration of sleep, night awakenings, sleep quality). Assessed on a 5 point scale (0-lowest quality; 5-highest quality)|Score|Mean|3.1|3.1|Standard Deviation|.7|0.7|||
4094275|NCT00989950|3917866|B3|||Sleep Quality|Sleep quality was documented by patient diary which included questions for the caregiver and patient to answer together regarding sleep patterns (time to sleep, duration of sleep, night awakenings, sleep quality). Assessed on a 5 point scale (0-lowest quality; 5-highest quality)|Score|Mean|4|4.0|Standard Deviation|.8|0.8|||
4094276|NCT00989950|3917867|B2|||Sleep Quality|Sleep quality was documented by patient diary which included questions for the caregiver and patient to answer together regarding sleep patterns (time to sleep, duration of sleep, night awakenings, sleep quality). Assessed on a 5 point scale (0-lowest quality; 5-highest quality)|Score|Mean|4|4.0|Standard Deviation|1|1.0|||
4094277|NCT00989950|3917868|B1|||Sleep Quality|Sleep quality was documented by patient diary which included questions for the caregiver and patient to answer together regarding sleep patterns (time to sleep, duration of sleep, night awakenings, sleep quality). Assessed on a 5 point scale (0-lowest quality; 5-highest quality)|Score|Mean|4.3|4.3|Standard Deviation|.8|0.8|||
4094278|NCT00989950|3917864|B5|||Total Sleep Time|Total sleep time was taken by patient diary which included questions for the caregiver and patient to answer together regarding sleep patterns (time to sleep, duration of sleep, night awakenings, sleep quality)|hours|Mean|9.9|9.9|Standard Deviation|1.8|1.8|||
4094279|NCT00989950|3917865|B4|||Total Sleep Time|Total sleep time was taken by patient diary which included questions for the caregiver and patient to answer together regarding sleep patterns (time to sleep, duration of sleep, night awakenings, sleep quality)|hours|Mean|9.6|9.6|Standard Deviation|1.8|1.8|||
4094280|NCT00989950|3917866|B3|||Total Sleep Time|Total sleep time was taken by patient diary which included questions for the caregiver and patient to answer together regarding sleep patterns (time to sleep, duration of sleep, night awakenings, sleep quality)|hours|Mean|10.6|10.6|Standard Deviation|1.2|1.2|||
4094281|NCT00989950|3917867|B2|||Total Sleep Time|Total sleep time was taken by patient diary which included questions for the caregiver and patient to answer together regarding sleep patterns (time to sleep, duration of sleep, night awakenings, sleep quality)|hours|Mean|9.5|9.5|Standard Deviation|.9|0.9|||
4094282|NCT00989950|3917868|B1|||Total Sleep Time|Total sleep time was taken by patient diary which included questions for the caregiver and patient to answer together regarding sleep patterns (time to sleep, duration of sleep, night awakenings, sleep quality)|hours|Mean|9.9|9.9|Standard Deviation|.9|0.9|||
4094283|NCT00989950|3917864|B5|||Sleep Latency|Sleep latency was taken by patient diary which included questions for the caregiver and patient to answer together regarding sleep patterns (time to sleep, duration of sleep, night awakenings, sleep quality)|minutes|Mean|37.8|37.8|Standard Deviation|27.9|27.9|||
4094345|NCT00989833|3917886|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4094284|NCT00989950|3917865|B4|||Sleep Latency|Sleep latency was taken by patient diary which included questions for the caregiver and patient to answer together regarding sleep patterns (time to sleep, duration of sleep, night awakenings, sleep quality)|minutes|Mean|50.7|50.7|Standard Deviation|12.4|12.4|||
4094285|NCT00989950|3917866|B3|||Sleep Latency|Sleep latency was taken by patient diary which included questions for the caregiver and patient to answer together regarding sleep patterns (time to sleep, duration of sleep, night awakenings, sleep quality)|minutes|Mean|54.5|54.5|Standard Deviation|64.8|64.8|||
4094286|NCT00989950|3917867|B2|||Sleep Latency|Sleep latency was taken by patient diary which included questions for the caregiver and patient to answer together regarding sleep patterns (time to sleep, duration of sleep, night awakenings, sleep quality)|minutes|Mean|23.3|23.3|Standard Deviation|21.8|21.8|||
4094287|NCT00989950|3917868|B1|||Sleep Latency|Sleep latency was taken by patient diary which included questions for the caregiver and patient to answer together regarding sleep patterns (time to sleep, duration of sleep, night awakenings, sleep quality)|minutes|Mean|22.5|22.5|Standard Deviation|12.6|12.6|||
4094288|NCT00989950|3917864|B5|||Attention Deficit Hyperactivity Disorder Rating Scale-IV Total Score|An 18-item scale corresponding to the 18 items in the DSM-IV-TR that is divided into two subsclaes: hyperactivity/impulsivity and inattentiveness. Items scored on a 4-point frequency scale ranging from 0=never/rarely to 3=very often; 54 points possible with higher score indicating more severe symptoms. Rating scale is filled out by the caregiver.|Score on scale|Mean|34.7|34.7|Standard Deviation|11|11.0|||
4094289|NCT00989950|3917865|B4|||Attention Deficit Hyperactivity Disorder Rating Scale-IV Total Score|An 18-item scale corresponding to the 18 items in the DSM-IV-TR that is divided into two subsclaes: hyperactivity/impulsivity and inattentiveness. Items scored on a 4-point frequency scale ranging from 0=never/rarely to 3=very often; 54 points possible with higher score indicating more severe symptoms. Rating scale is filled out by the caregiver.|Score on scale|Mean|33.7|33.7|Standard Deviation|10.6|10.6|||
4094290|NCT00989950|3917866|B3|||Attention Deficit Hyperactivity Disorder Rating Scale-IV Total Score|An 18-item scale corresponding to the 18 items in the DSM-IV-TR that is divided into two subsclaes: hyperactivity/impulsivity and inattentiveness. Items scored on a 4-point frequency scale ranging from 0=never/rarely to 3=very often; 54 points possible with higher score indicating more severe symptoms. Rating scale is filled out by the caregiver.|Score on scale|Mean|41|41.0|Standard Deviation|10.2|10.2|||
4094291|NCT00989950|3917867|B2|||Attention Deficit Hyperactivity Disorder Rating Scale-IV Total Score|An 18-item scale corresponding to the 18 items in the DSM-IV-TR that is divided into two subsclaes: hyperactivity/impulsivity and inattentiveness. Items scored on a 4-point frequency scale ranging from 0=never/rarely to 3=very often; 54 points possible with higher score indicating more severe symptoms. Rating scale is filled out by the caregiver.|Score on scale|Mean|37|37.0|Standard Deviation|9.2|9.2|||
4094292|NCT00989950|3917868|B1|||Attention Deficit Hyperactivity Disorder Rating Scale-IV Total Score|An 18-item scale corresponding to the 18 items in the DSM-IV-TR that is divided into two subsclaes: hyperactivity/impulsivity and inattentiveness. Items scored on a 4-point frequency scale ranging from 0=never/rarely to 3=very often; 54 points possible with higher score indicating more severe symptoms. Rating scale is filled out by the caregiver.|Score on scale|Mean|27|27.0|Standard Deviation|11|11.0|||
4094293|NCT00989950|3917864|B5|||Conner's Global Impression-Parent Scale|Rating scale filled out by the parents/caregivers. Scale consists of 28 questions divided into four subscales of oppositional problems, cognitive problems, hyperactivity and an ADHD index. Questions scored on a 4 point scale (0-3; 84 points possible), where a higher score indicates more severe symptom presentation.|scores on scale|Mean|19.78|19.78|Standard Deviation|6.8|6.8|||
4094294|NCT00989950|3917865|B4|||Conner's Global Impression-Parent Scale|Rating scale filled out by the parents/caregivers. Scale consists of 28 questions divided into four subscales of oppositional problems, cognitive problems, hyperactivity and an ADHD index. Questions scored on a 4 point scale (0-3; 84 points possible), where a higher score indicates more severe symptom presentation.|scores on scale|Mean|20.3|20.3|Standard Deviation|6.7|6.7|||
4094295|NCT00989950|3917866|B3|||Conner's Global Impression-Parent Scale|Rating scale filled out by the parents/caregivers. Scale consists of 28 questions divided into four subscales of oppositional problems, cognitive problems, hyperactivity and an ADHD index. Questions scored on a 4 point scale (0-3; 84 points possible), where a higher score indicates more severe symptom presentation.|scores on scale|Mean|25|25.0|Standard Deviation|2.3|2.3|||
4094296|NCT00989950|3917867|B2|||Conner's Global Impression-Parent Scale|Rating scale filled out by the parents/caregivers. Scale consists of 28 questions divided into four subscales of oppositional problems, cognitive problems, hyperactivity and an ADHD index. Questions scored on a 4 point scale (0-3; 84 points possible), where a higher score indicates more severe symptom presentation.|scores on scale|Mean|20.1|20.1|Standard Deviation|6.8|6.8|||
4094297|NCT00989950|3917868|B1|||Conner's Global Impression-Parent Scale|Rating scale filled out by the parents/caregivers. Scale consists of 28 questions divided into four subscales of oppositional problems, cognitive problems, hyperactivity and an ADHD index. Questions scored on a 4 point scale (0-3; 84 points possible), where a higher score indicates more severe symptom presentation.|scores on scale|Mean|13.7|13.7|Standard Deviation|7.6|7.6|||
4094298|NCT00989950|3917864|B5|Other Subtype||Attention Deficit Hyperactivity Disorder (ADHD) Subtype|"There are 3 subtypes of ADHD as defined by the DSM-IV-TR. Inattentive, Hyperactive/Impulsive and combined subtype (hyperactive/impulsive and inattentive). Other subtype refers to individuals who are not of the combined subtype but instead are either hyperactive/impulsive or inattentive type."|participants|Number|6|6.0||||||
4094299|NCT00989950|3917865|B4|Other Subtype||Attention Deficit Hyperactivity Disorder (ADHD) Subtype|"There are 3 subtypes of ADHD as defined by the DSM-IV-TR. Inattentive, Hyperactive/Impulsive and combined subtype (hyperactive/impulsive and inattentive). Other subtype refers to individuals who are not of the combined subtype but instead are either hyperactive/impulsive or inattentive type."|participants|Number|0|0.0||||||
4094300|NCT00989950|3917866|B3|Other Subtype||Attention Deficit Hyperactivity Disorder (ADHD) Subtype|"There are 3 subtypes of ADHD as defined by the DSM-IV-TR. Inattentive, Hyperactive/Impulsive and combined subtype (hyperactive/impulsive and inattentive). Other subtype refers to individuals who are not of the combined subtype but instead are either hyperactive/impulsive or inattentive type."|participants|Number|1|1.0||||||
4094346|NCT00989833|3917887|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4094301|NCT00989950|3917867|B2|Other Subtype||Attention Deficit Hyperactivity Disorder (ADHD) Subtype|"There are 3 subtypes of ADHD as defined by the DSM-IV-TR. Inattentive, Hyperactive/Impulsive and combined subtype (hyperactive/impulsive and inattentive). Other subtype refers to individuals who are not of the combined subtype but instead are either hyperactive/impulsive or inattentive type."|participants|Number|3|3.0||||||
4094302|NCT00989950|3917868|B1|Other Subtype||Attention Deficit Hyperactivity Disorder (ADHD) Subtype|"There are 3 subtypes of ADHD as defined by the DSM-IV-TR. Inattentive, Hyperactive/Impulsive and combined subtype (hyperactive/impulsive and inattentive). Other subtype refers to individuals who are not of the combined subtype but instead are either hyperactive/impulsive or inattentive type."|participants|Number|2|2.0||||||
4094303|NCT00989950|3917864|B5|Combined Subtype||Attention Deficit Hyperactivity Disorder (ADHD) Subtype|"There are 3 subtypes of ADHD as defined by the DSM-IV-TR. Inattentive, Hyperactive/Impulsive and combined subtype (hyperactive/impulsive and inattentive). Other subtype refers to individuals who are not of the combined subtype but instead are either hyperactive/impulsive or inattentive type."|participants|Number|20|20.0||||||
4094304|NCT00989950|3917865|B4|Combined Subtype||Attention Deficit Hyperactivity Disorder (ADHD) Subtype|"There are 3 subtypes of ADHD as defined by the DSM-IV-TR. Inattentive, Hyperactive/Impulsive and combined subtype (hyperactive/impulsive and inattentive). Other subtype refers to individuals who are not of the combined subtype but instead are either hyperactive/impulsive or inattentive type."|participants|Number|7|7.0||||||
4094305|NCT00989950|3917866|B3|Combined Subtype||Attention Deficit Hyperactivity Disorder (ADHD) Subtype|"There are 3 subtypes of ADHD as defined by the DSM-IV-TR. Inattentive, Hyperactive/Impulsive and combined subtype (hyperactive/impulsive and inattentive). Other subtype refers to individuals who are not of the combined subtype but instead are either hyperactive/impulsive or inattentive type."|participants|Number|3|3.0||||||
4094306|NCT00989950|3917867|B2|Combined Subtype||Attention Deficit Hyperactivity Disorder (ADHD) Subtype|"There are 3 subtypes of ADHD as defined by the DSM-IV-TR. Inattentive, Hyperactive/Impulsive and combined subtype (hyperactive/impulsive and inattentive). Other subtype refers to individuals who are not of the combined subtype but instead are either hyperactive/impulsive or inattentive type."|participants|Number|6|6.0||||||
4094307|NCT00989950|3917868|B1|Combined Subtype||Attention Deficit Hyperactivity Disorder (ADHD) Subtype|"There are 3 subtypes of ADHD as defined by the DSM-IV-TR. Inattentive, Hyperactive/Impulsive and combined subtype (hyperactive/impulsive and inattentive). Other subtype refers to individuals who are not of the combined subtype but instead are either hyperactive/impulsive or inattentive type."|participants|Number|4|4.0||||||
4094308|NCT00989950|3917864|B5||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4094309|NCT00989950|3917865|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4094310|NCT00989950|3917866|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4094311|NCT00989950|3917867|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4094312|NCT00989950|3917868|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4094313|NCT00989950|3917864|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4094314|NCT00989950|3917865|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4094315|NCT00989950|3917866|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4094316|NCT00989950|3917867|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4094317|NCT00989950|3917868|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4094318|NCT00989950|3917864|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4094319|NCT00989950|3917865|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4094320|NCT00989950|3917866|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4094321|NCT00989950|3917867|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4094322|NCT00989950|3917868|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4094323|NCT00989950|3917864|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4094324|NCT00989950|3917865|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4094325|NCT00989950|3917866|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4094326|NCT00989950|3917867|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4094327|NCT00989950|3917868|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4094328|NCT00989950|3917864|B5||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
4094329|NCT00989950|3917865|B4||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4094330|NCT00989950|3917866|B3||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4094331|NCT00989950|3917867|B2||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4094332|NCT00989950|3917868|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4094333|NCT00989911|3917881|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4094334|NCT00989911|3917881|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4094335|NCT00989911|3917881|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4094336|NCT00989911|3917881|B1|||Age||years|Mean|34|34.0|Standard Deviation|10.9|10.9|||
4094337|NCT00989911|3917881|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4094338|NCT00989911|3917881|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4094339|NCT00989911|3917881|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4094340|NCT00989833|3917885|B4||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4094341|NCT00989833|3917886|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4094342|NCT00989833|3917887|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4094343|NCT00989833|3917888|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4094344|NCT00989833|3917885|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4094347|NCT00989833|3917888|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4094348|NCT00989833|3917885|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4094349|NCT00989833|3917886|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4094350|NCT00989833|3917887|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4094351|NCT00989833|3917888|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4094352|NCT00989833|3917885|B4||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4094353|NCT00989833|3917886|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4094354|NCT00989833|3917887|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4094355|NCT00989833|3917888|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4094356|NCT00989833|3917885|B4||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4094357|NCT00989833|3917886|B3||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4094358|NCT00989833|3917887|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4094359|NCT00989833|3917888|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4094360|NCT00989781|3917919|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
4094361|NCT00989781|3917920|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4094362|NCT00989781|3917921|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4094363|NCT00989781|3917919|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4094364|NCT00989781|3917920|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4094365|NCT00989781|3917921|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4094366|NCT00989781|3917919|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4094367|NCT00989781|3917920|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4094368|NCT00989781|3917921|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4094369|NCT00989781|3917919|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4094370|NCT00989781|3917920|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4094371|NCT00989781|3917921|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4094372|NCT00989781|3917919|B3||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4094373|NCT00989781|3917920|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4094374|NCT00989781|3917921|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4094375|NCT00989781|3917919|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4094376|NCT00989781|3917920|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4094377|NCT00989781|3917921|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4094378|NCT00989768|3917941|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4094379|NCT00989768|3917941|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4094380|NCT00989768|3917941|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4094381|NCT00989768|3917941|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4094382|NCT00989768|3917941|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4094383|NCT00989664|3917952|B1|Black||Race/Ethnicity, Customized|Baseline characteristics are summarized for the ITT Exposed Population, comprised of all participants who were enrolled in the study and received at least one dose of study drug.|participants|Number|1|1.0||||||
4094384|NCT00989664|3917952|B1|Hispanic||Race/Ethnicity, Customized|Baseline characteristics are summarized for the ITT Exposed Population, comprised of all participants who were enrolled in the study and received at least one dose of study drug.|participants|Number|1|1.0||||||
4094385|NCT00989664|3917952|B1|White||Race/Ethnicity, Customized|Baseline characteristics are summarized for the ITT Exposed Population, comprised of all participants who were enrolled in the study and received at least one dose of study drug.|participants|Number|58|58.0||||||
4094386|NCT00989664|3917952|B1||Male|Gender|Baseline characteristics are summarized for the Intent-to-Treat (ITT) Exposed Population, comprised of all participants who were enrolled in the study and received at least one dose of study drug.|Participants|Count of Participants|38|38.0||||||
4094387|NCT00989664|3917952|B1||Female|Gender|Baseline characteristics are summarized for the Intent-to-Treat (ITT) Exposed Population, comprised of all participants who were enrolled in the study and received at least one dose of study drug.|Participants|Count of Participants|22|22.0||||||
4094388|NCT00989664|3917952|B1|||Age|Baseline characteristics are summarized for the Intent-to-Treat (ITT) Exposed Population, comprised of all participants who were enrolled in the study and received at least one dose of study drug.|Years|Mean|59.4|59.4|Standard Deviation|10.5|10.5|||
4094389|NCT00989586|3917980|B3|United States||Region of Enrollment||patients|Number|35|35.0||||||
4094390|NCT00989586|3917981|B2|United States||Region of Enrollment||patients|Number|17|17.0||||||
4094391|NCT00989586|3917982|B1|United States||Region of Enrollment||patients|Number|18|18.0||||||
4094392|NCT00989586|3917980|B3||Male|Gender||Participants|Count of Participants|23|23.0||||||
4094393|NCT00989586|3917981|B2||Male|Gender||Participants|Count of Participants|10|10.0||||||
4094394|NCT00989586|3917982|B1||Male|Gender||Participants|Count of Participants|13|13.0||||||
4094395|NCT00989586|3917980|B3||Female|Gender||Participants|Count of Participants|12|12.0||||||
4094396|NCT00989586|3917981|B2||Female|Gender||Participants|Count of Participants|7|7.0||||||
4094397|NCT00989586|3917982|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
4094398|NCT00989586|3917980|B3|||Age||years|Median|63|63.0|Full Range|||39.0|82.0|
4094399|NCT00989586|3917981|B2|||Age||years|Median|63|63.0|Full Range|||39.0|82.0|
4094400|NCT00989586|3917982|B1|||Age||years|Median|65|65.0|Full Range|||44.0|81.0|
4094401|NCT00989287|3917996|B3|Geographic ancestry|White-Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|130|130.0||||||
4094402|NCT00989287|3917997|B2|Geographic ancestry|White-Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|65|65.0||||||
4094403|NCT00989287|3917998|B1|Geographic ancestry|White-Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|65|65.0||||||
4094404|NCT00989287|3917996|B3|Geographic ancestry|Asian-East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4094405|NCT00989287|3917997|B2|Geographic ancestry|Asian-East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4094406|NCT00989287|3917998|B1|Geographic ancestry|Asian-East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4094407|NCT00989287|3917996|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4094408|NCT00989287|3917997|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4094409|NCT00989287|3917998|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4094410|NCT00989287|3917996|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4094411|NCT00989287|3917997|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4094412|NCT00989287|3917998|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4094413|NCT00989287|3917996|B3|||Age||Years|Mean|37.70|37.7|Standard Deviation|13.90|13.9|||
4094414|NCT00989287|3917997|B2|||Age||Years|Mean|38.4|38.4|Standard Deviation|13.61|13.61|||
4094415|NCT00989287|3917998|B1|||Age||Years|Mean|37.5|37.5|Standard Deviation|14.29|14.29|||
4094416|NCT00989235|3918099|B3|||Disease Activity Scores Using C-reactive Protein (DAS 28 [CRP])|"The DAS28 provides a score on a scale from 0 to 10 indicating the current activity of the rheumatoid arthritis (>5.1=high disease activity; <3.2=low disease activity; <2.6=remission).DAS 28 is a continuous variable which is a composite of 4 variables: the number of tender joints out of 28, the number of swollen joints out of 28 joints, C-reactive protein in mg/L (CRP) and subject assessment of disease activity measure on a visual analogue scale (VAS) of 100 mm based on the following formula:~DAS 28 = 0.56*sqrt(TJC28) + 0.28*sqrt(SJC28) + 0.36*ln(CRP+1) + 0.014*GH + 0.96."|units on a scale|Mean|2.1|2.1|Standard Deviation|0.6|0.6|||
4094417|NCT00989235|3918100|B2|||Disease Activity Scores Using C-reactive Protein (DAS 28 [CRP])|"The DAS28 provides a score on a scale from 0 to 10 indicating the current activity of the rheumatoid arthritis (>5.1=high disease activity; <3.2=low disease activity; <2.6=remission).DAS 28 is a continuous variable which is a composite of 4 variables: the number of tender joints out of 28, the number of swollen joints out of 28 joints, C-reactive protein in mg/L (CRP) and subject assessment of disease activity measure on a visual analogue scale (VAS) of 100 mm based on the following formula:~DAS 28 = 0.56*sqrt(TJC28) + 0.28*sqrt(SJC28) + 0.36*ln(CRP+1) + 0.014*GH + 0.96."|units on a scale|Mean|2.1|2.1|Standard Deviation|0.6|0.6|||
4094418|NCT00989235|3918101|B1|||Disease Activity Scores Using C-reactive Protein (DAS 28 [CRP])|"The DAS28 provides a score on a scale from 0 to 10 indicating the current activity of the rheumatoid arthritis (>5.1=high disease activity; <3.2=low disease activity; <2.6=remission).DAS 28 is a continuous variable which is a composite of 4 variables: the number of tender joints out of 28, the number of swollen joints out of 28 joints, C-reactive protein in mg/L (CRP) and subject assessment of disease activity measure on a visual analogue scale (VAS) of 100 mm based on the following formula:~DAS 28 = 0.56*sqrt(TJC28) + 0.28*sqrt(SJC28) + 0.36*ln(CRP+1) + 0.014*GH + 0.96."|units on a scale|Mean|2.1|2.1|Standard Deviation|0.6|0.6|||
4094419|NCT00989235|3918099|B3|||Weight|One participant in the 10 mg/kg group did not have weight reported.|kg|Mean|73.4|73.4|Standard Deviation|15.3|15.3|||
4094420|NCT00989235|3918100|B2|||Weight|One participant in the 10 mg/kg group did not have weight reported.|kg|Mean|73.8|73.8|Standard Deviation|16.0|16.0|||
4094421|NCT00989235|3918101|B1|||Weight|One participant in the 10 mg/kg group did not have weight reported.|kg|Mean|72.9|72.9|Standard Deviation|14.7|14.7|||
4094422|NCT00989235|3918099|B3|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4094423|NCT00989235|3918100|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4094424|NCT00989235|3918101|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4094425|NCT00989235|3918099|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4094426|NCT00989235|3918100|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4094427|NCT00989235|3918101|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4094428|NCT00989235|3918099|B3|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4094429|NCT00989235|3918100|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4094430|NCT00989235|3918101|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4094431|NCT00989235|3918099|B3|White||Race/Ethnicity, Customized||participants|Number|95|95.0||||||
4094432|NCT00989235|3918100|B2|White||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4094433|NCT00989235|3918101|B1|White||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4094434|NCT00989235|3918099|B3|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4094435|NCT00989235|3918100|B2|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4094436|NCT00989235|3918101|B1|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4094437|NCT00989235|3918099|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4094438|NCT00989235|3918100|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4094439|NCT00989235|3918101|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4094440|NCT00989235|3918099|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4094441|NCT00989235|3918100|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4094442|NCT00989235|3918101|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4094443|NCT00989235|3918099|B3|||Age||years|Mean|50.6|50.6|Standard Deviation|12.3|12.3|||
4094444|NCT00989235|3918100|B2|||Age||years|Mean|51.1|51.1|Standard Deviation|13.4|13.4|||
4094445|NCT00989235|3918101|B1|||Age||years|Mean|50.1|50.1|Standard Deviation|11.5|11.5|||
4094446|NCT00989196|3918147|B1|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4094447|NCT00989196|3918147|B1|Bulgaria||Region of Enrollment||participants|Number|6|6.0||||||
4094448|NCT00989196|3918147|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4094449|NCT00989196|3918147|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4094450|NCT00989196|3918147|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4094451|NCT00989196|3918147|B1|||Age||years|Mean|39.6|39.6|Standard Deviation|14.06|14.06|||
4094452|NCT00989196|3918147|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4094453|NCT00989196|3918147|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4094454|NCT00989196|3918147|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4094455|NCT00989157|3918167|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4094456|NCT00989157|3918168|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4094457|NCT00989157|3918169|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4094458|NCT00989157|3918167|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4094459|NCT00989157|3918168|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4094460|NCT00989157|3918169|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4094461|NCT00989157|3918167|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4094462|NCT00989157|3918168|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4094463|NCT00989157|3918169|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4094464|NCT00989157|3918167|B3|||Age||years|Mean|45|45.0|Standard Deviation|8.78|8.78|||
4094465|NCT00989157|3918168|B2|||Age||years|Mean|45.9|45.9|Standard Deviation|8.54|8.54|||
4094466|NCT00989157|3918169|B1|||Age||years|Mean|44.10|44.1|Standard Deviation|9.02|9.02|||
4094467|NCT00989092|3918184|B3|Other||Race/Ethnicity, Customized||Participant|Number|5|5.0||||||
4094468|NCT00989092|3918185|B2|Other||Race/Ethnicity, Customized||Participant|Number|0|0.0||||||
4094469|NCT00989092|3918186|B1|Other||Race/Ethnicity, Customized||Participant|Number|5|5.0||||||
4094470|NCT00989092|3918184|B3|Asian||Race/Ethnicity, Customized||Participant|Number|6|6.0||||||
4094471|NCT00989092|3918185|B2|Asian||Race/Ethnicity, Customized||Participant|Number|1|1.0||||||
4094472|NCT00989092|3918186|B1|Asian||Race/Ethnicity, Customized||Participant|Number|5|5.0||||||
4094473|NCT00989092|3918184|B3|Black||Race/Ethnicity, Customized||Participant|Number|40|40.0||||||
4094474|NCT00989092|3918185|B2|Black||Race/Ethnicity, Customized||Participant|Number|12|12.0||||||
4094475|NCT00989092|3918186|B1|Black||Race/Ethnicity, Customized||Participant|Number|28|28.0||||||
4094476|NCT00989092|3918184|B3|White||Race/Ethnicity, Customized||Participant|Number|234|234.0||||||
4094477|NCT00989092|3918185|B2|White||Race/Ethnicity, Customized||Participant|Number|46|46.0||||||
4094478|NCT00989092|3918186|B1|White||Race/Ethnicity, Customized||Participant|Number|188|188.0||||||
4094479|NCT00989092|3918184|B3||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4094480|NCT00989092|3918185|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4094481|NCT00989092|3918186|B1||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4094482|NCT00989092|3918184|B3||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4094483|NCT00989092|3918185|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4094484|NCT00989092|3918186|B1||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4094485|NCT00989092|3918184|B3|||Age|Demographic data are provided for the Efficacy Analysis Set (all patients who were randomized to the observation group or patients who were randomized to the treatment group and received at least 1 dose of investigational product).|Years|Mean|70.8|70.8|Standard Deviation|11|11.0|||
4094486|NCT00989092|3918185|B2|||Age|Demographic data are provided for the Efficacy Analysis Set (all patients who were randomized to the observation group or patients who were randomized to the treatment group and received at least 1 dose of investigational product).|Years|Mean|67.2|67.2|Standard Deviation|12.5|12.5|||
4094487|NCT00989092|3918186|B1|||Age|Demographic data are provided for the Efficacy Analysis Set (all patients who were randomized to the observation group or patients who were randomized to the treatment group and received at least 1 dose of investigational product).|Years|Mean|71.7|71.7|Standard Deviation|10.4|10.4|||
4094488|NCT00989014|3918220|B5|United States||Region of Enrollment||participants|Number|122|122.0||||||
4094489|NCT00989014|3918221|B4|United States||Region of Enrollment||participants|Number|32|32.0||||||
4094490|NCT00989014|3918222|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
4094491|NCT00989014|3918223|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
4094492|NCT00989014|3918224|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4094493|NCT00989014|3918220|B5||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4094494|NCT00989014|3918221|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4094495|NCT00989014|3918222|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4094496|NCT00989014|3918223|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4094497|NCT00989014|3918224|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4094498|NCT00989014|3918220|B5||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4094499|NCT00989014|3918221|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4094500|NCT00989014|3918222|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4094501|NCT00989014|3918223|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4094502|NCT00989014|3918224|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4094503|NCT00989014|3918220|B5|||Age||years|Mean|45.7|45.7|Standard Deviation|12.06|12.06|||
4094504|NCT00989014|3918221|B4|||Age||years|Mean|46.7|46.7|Standard Deviation|13.35|13.35|||
4094505|NCT00989014|3918222|B3|||Age||years|Mean|43.7|43.7|Standard Deviation|10.74|10.74|||
4094506|NCT00989014|3918223|B2|||Age||years|Mean|46.3|46.3|Standard Deviation|12.37|12.37|||
4094507|NCT00989014|3918224|B1|||Age||years|Mean|45.8|45.8|Standard Deviation|11.87|11.87|||
4094508|NCT00989014|3918220|B5||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4094509|NCT00989014|3918221|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4094510|NCT00989014|3918222|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4094511|NCT00989014|3918223|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4094512|NCT00989014|3918224|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4094513|NCT00989014|3918220|B5||Between 18 and 65 years|Age||Participants|Count of Participants|117|117.0||||||
4094514|NCT00989014|3918221|B4||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4094515|NCT00989014|3918222|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4094516|NCT00989014|3918223|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4094517|NCT00989014|3918224|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4094518|NCT00989014|3918220|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4094519|NCT00989014|3918221|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4094520|NCT00989014|3918222|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4094521|NCT00989014|3918223|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4094522|NCT00989014|3918224|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4094523|NCT00988884|3918237|B3||Male|Sex: Female, Male||Participants|Count of Participants|620|620.0||||||
4094524|NCT00988884|3918238|B2||Male|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
4094525|NCT00988884|3918239|B1||Male|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
4094526|NCT00988884|3918237|B3||Female|Sex: Female, Male||Participants|Count of Participants|621|621.0||||||
4094527|NCT00988884|3918238|B2||Female|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
4094528|NCT00988884|3918239|B1||Female|Sex: Female, Male||Participants|Count of Participants|311|311.0||||||
4094529|NCT00988884|3918237|B3|||Age||Years|Mean|12.2|12.2|Standard Deviation|1.4|1.4|||
4094530|NCT00988884|3918238|B2|||Age||Years|Mean|12.1|12.1|Standard Deviation|1.3|1.3|||
4094531|NCT00988884|3918239|B1|||Age||Years|Mean|12.2|12.2|Standard Deviation|1.4|1.4|||
4094532|NCT00988858|3918262|B1|Italy||Region of Enrollment||participants|Number|12|12.0||||||
4094533|NCT00988858|3918262|B1|Korea, Republic of||Region of Enrollment||participants|Number|14|14.0||||||
4094534|NCT00988858|3918262|B1|Taiwan||Region of Enrollment||participants|Number|5|5.0||||||
4094535|NCT00988858|3918262|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4094536|NCT00988858|3918262|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094537|NCT00988858|3918262|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094538|NCT00988858|3918262|B1||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4094539|NCT00988858|3918262|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4094540|NCT00988858|3918262|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094541|NCT00988858|3918262|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4094542|NCT00988858|3918262|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094543|NCT00988858|3918262|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094544|NCT00988858|3918262|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4094545|NCT00988858|3918262|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094546|NCT00988858|3918262|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4094547|NCT00988858|3918262|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4094548|NCT00988858|3918262|B1|||Age||years|Mean|61.2|61.2|Standard Deviation|8.6|8.6|||
4094549|NCT00988832|3918274|B1|Not Specified||Sex/Gender, Customized||participants|Number|1|1.0||||||
4094550|NCT00988832|3918274|B1|Male||Sex/Gender, Customized||participants|Number|171|171.0||||||
4094551|NCT00988832|3918274|B1|Female||Sex/Gender, Customized||participants|Number|208|208.0||||||
4094552|NCT00988832|3918274|B1|||Age|Age at first infusion of infliximab|years|Mean|37|37.0|Standard Deviation|13|13.0|||
4094553|NCT00988637|3918309|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4094554|NCT00988637|3918310|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4094555|NCT00988637|3918311|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4094556|NCT00988637|3918309|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4094557|NCT00988637|3918310|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4094558|NCT00988637|3918311|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4094559|NCT00988637|3918309|B3|||Age||years|Mean|45.4|45.4|Standard Deviation|14.21|14.21|||
4094560|NCT00988637|3918310|B2|||Age||years|Mean|44.5|44.5|Standard Deviation|14.43|14.43|||
4094561|NCT00988637|3918311|B1|||Age||years|Mean|46.4|46.4|Standard Deviation|14.03|14.03|||
4094562|NCT00988559|3918342|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094563|NCT00988559|3918343|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094564|NCT00988559|3918344|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094565|NCT00988559|3918345|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094566|NCT00988559|3918346|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094567|NCT00988559|3918342|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094568|NCT00988559|3918343|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094569|NCT00988559|3918344|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094570|NCT00988559|3918345|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094571|NCT00988559|3918346|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094572|NCT00988559|3918342|B5||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4094573|NCT00988559|3918343|B4||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4094574|NCT00988559|3918344|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4094575|NCT00988559|3918345|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4094576|NCT00988559|3918346|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4094577|NCT00988559|3918342|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4094578|NCT00988559|3918343|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4094579|NCT00988559|3918344|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4094580|NCT00988559|3918345|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4094581|NCT00988559|3918346|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094582|NCT00988559|3918342|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094583|NCT00988559|3918343|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094584|NCT00988559|3918344|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094585|NCT00988559|3918345|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094586|NCT00988559|3918346|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094587|NCT00988559|3918342|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4094588|NCT00988559|3918343|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094589|NCT00988559|3918344|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094590|NCT00988559|3918345|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4094591|NCT00988559|3918346|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4094592|NCT00988559|3918342|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094593|NCT00988559|3918343|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094594|NCT00988559|3918344|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094595|NCT00988559|3918345|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094596|NCT00988559|3918346|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094597|NCT00988559|3918342|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4094598|NCT00988559|3918343|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4094599|NCT00988559|3918344|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4094600|NCT00988559|3918345|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4094601|NCT00988559|3918346|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4094602|NCT00988559|3918342|B5||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4094603|NCT00988559|3918343|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4094604|NCT00988559|3918344|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4094605|NCT00988559|3918345|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4094606|NCT00988559|3918346|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4094607|NCT00988559|3918342|B5|||Age||years|Median|25.91|25.91|Full Range|||20.0|44.0|
4094608|NCT00988559|3918343|B4|||Age||years|Median|26.14|26.14|Full Range|||24.0|29.0|
4094609|NCT00988559|3918344|B3|||Age||years|Median|26|26.0|Full Range|||23.0|35.0|
4094610|NCT00988559|3918345|B2|||Age||years|Median|26|26.0|Full Range|||21.0|35.0|
4094611|NCT00988559|3918346|B1|||Age||years|Median|25.5|25.5|Full Range|||20.0|44.0|
4094612|NCT00988533|3918363|B1|United States||Region of Enrollment||Participants|Number|30|30.0||||||
4094613|NCT00988533|3918363|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4094614|NCT00988533|3918363|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4094615|NCT00988533|3918363|B1|||Age||Months|Mean|25.8|25.8|Standard Deviation|11.0|11.0|||
4094616|NCT00988533|3918363|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4094617|NCT00988533|3918363|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4094618|NCT00988533|3918363|B1||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4094619|NCT00988442|3918375|B3|||HIV-1 RNA||log10 copies/mL|Median|4.0|4.0|Inter-Quartile Range|||3.2|4.9|
4094620|NCT00988442|3918376|B2|||HIV-1 RNA||log10 copies/mL|Median|4.5|4.5|Inter-Quartile Range|||3.4|4.9|
4094621|NCT00988442|3918377|B1|||HIV-1 RNA||log10 copies/mL|Median|4.0|4.0|Inter-Quartile Range|||3.1|4.9|
4094622|NCT00988442|3918375|B3|||CD4+ Count||cells/mm^3|Median|180|180.0|Inter-Quartile Range|||57.0|333.0|
4094623|NCT00988442|3918376|B2|||CD4+ Count||cells/mm^3|Median|157|157.0|Inter-Quartile Range|||82.0|357.0|
4094624|NCT00988442|3918377|B1|||CD4+ Count||cells/mm^3|Median|180|180.0|Inter-Quartile Range|||48.0|314.0|
4094625|NCT00988442|3918375|B3|Previously||Intravenous (IV) Drug History||Participants|Count of Participants|8|8.0||||||
4094626|NCT00988442|3918376|B2|Previously||Intravenous (IV) Drug History||Participants|Count of Participants|4|4.0||||||
4094627|NCT00988442|3918377|B1|Previously||Intravenous (IV) Drug History||Participants|Count of Participants|4|4.0||||||
4094628|NCT00988442|3918375|B3|Never||Intravenous (IV) Drug History||Participants|Count of Participants|51|51.0||||||
4094629|NCT00988442|3918376|B2|Never||Intravenous (IV) Drug History||Participants|Count of Participants|25|25.0||||||
4094630|NCT00988442|3918377|B1|Never||Intravenous (IV) Drug History||Participants|Count of Participants|26|26.0||||||
4094631|NCT00988442|3918375|B3|United States||Region of Enrollment||Participants|Count of Participants|59|59.0||||||
4094632|NCT00988442|3918376|B2|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
4094633|NCT00988442|3918377|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4094634|NCT00988442|3918375|B3|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4094635|NCT00988442|3918376|B2|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4094636|NCT00988442|3918377|B1|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4094637|NCT00988442|3918375|B3|Black Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
4094638|NCT00988442|3918376|B2|Black Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
4094639|NCT00988442|3918377|B1|Black Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
4094640|NCT00988442|3918375|B3|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4094641|NCT00988442|3918376|B2|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4094642|NCT00988442|3918377|B1|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4094643|NCT00988442|3918375|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4094644|NCT00988442|3918376|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4094645|NCT00988442|3918377|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4094646|NCT00988442|3918375|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4094647|NCT00988442|3918376|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4094648|NCT00988442|3918377|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4094649|NCT00988442|3918375|B3|||Age||years|Mean|45.5|45.5|Standard Deviation|11.5|11.5|||
4094650|NCT00988442|3918376|B2|||Age||years|Mean|46.6|46.6|Standard Deviation|10.8|10.8|||
4094651|NCT00988442|3918377|B1|||Age||years|Mean|44.5|44.5|Standard Deviation|12.2|12.2|||
4094652|NCT00988429|3918438|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
4094653|NCT00988429|3918439|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4094654|NCT00988429|3918440|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4094655|NCT00988429|3918441|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4094656|NCT00988429|3918438|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094657|NCT00988429|3918439|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094658|NCT00988429|3918440|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094659|NCT00988429|3918441|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094660|NCT00988429|3918438|B4||White|Race (NIH/OMB)||Participants|Count of Participants|413|413.0||||||
4094661|NCT00988429|3918439|B3||White|Race (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
4094662|NCT00988429|3918440|B2||White|Race (NIH/OMB)||Participants|Count of Participants|137|137.0||||||
4094663|NCT00988429|3918441|B1||White|Race (NIH/OMB)||Participants|Count of Participants|142|142.0||||||
4094664|NCT00988429|3918438|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4094665|NCT00988429|3918439|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4094666|NCT00988429|3918440|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4094667|NCT00988429|3918441|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4094668|NCT00988429|3918438|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094669|NCT00988429|3918439|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094670|NCT00988429|3918440|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094671|NCT00988429|3918441|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094672|NCT00988429|3918438|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
4094673|NCT00988429|3918439|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4094674|NCT00988429|3918440|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4094675|NCT00988429|3918441|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4094676|NCT00988429|3918438|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094677|NCT00988429|3918439|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094678|NCT00988429|3918440|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094679|NCT00988429|3918441|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094680|NCT00988429|3918438|B4||Male|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
4094681|NCT00988429|3918439|B3||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4094682|NCT00988429|3918440|B2||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4094683|NCT00988429|3918441|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4094684|NCT00988429|3918438|B4||Female|Sex: Female, Male||Participants|Count of Participants|324|324.0||||||
4094685|NCT00988429|3918439|B3||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4094686|NCT00988429|3918440|B2||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4094687|NCT00988429|3918441|B1||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4094688|NCT00988429|3918438|B4||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4094689|NCT00988429|3918439|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4094690|NCT00988429|3918440|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4094691|NCT00988429|3918441|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4094692|NCT00988429|3918438|B4||Between 18 and 65 years|Age||Participants|Count of Participants|631|631.0||||||
4094693|NCT00988429|3918439|B3||Between 18 and 65 years|Age||Participants|Count of Participants|202|202.0||||||
4094694|NCT00988429|3918440|B2||Between 18 and 65 years|Age||Participants|Count of Participants|211|211.0||||||
4094695|NCT00988429|3918441|B1||Between 18 and 65 years|Age||Participants|Count of Participants|218|218.0||||||
4094696|NCT00988429|3918438|B4||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4094697|NCT00988429|3918439|B3||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4094698|NCT00988429|3918440|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4094699|NCT00988429|3918441|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4094700|NCT00988351|3918454|B3|||apnea+hypopnea index|AHI from Home sleep apnea test|number of apneas and hypopneas /hour|Mean|29.8|29.8|Standard Deviation|18.6|18.6|||
4094701|NCT00988351|3918455|B2|||apnea+hypopnea index|AHI from Home sleep apnea test|number of apneas and hypopneas /hour|Mean|28.6|28.6|Standard Deviation|18.2|18.2|||
4094702|NCT00988351|3918456|B1|||apnea+hypopnea index|AHI from Home sleep apnea test|number of apneas and hypopneas /hour|Mean|31.0|31.0|Standard Deviation|19.1|19.1|||
4094703|NCT00988351|3918454|B3|||Body mass index|measure weight and height compute as kg divided by height squared|kg/m^2|Mean|34.6|34.6|Standard Deviation|5.9|5.9|||
4094704|NCT00988351|3918455|B2|||Body mass index|measure weight and height compute as kg divided by height squared|kg/m^2|Mean|34.2|34.2|Standard Deviation|5.8|5.8|||
4094705|NCT00988351|3918456|B1|||Body mass index|measure weight and height compute as kg divided by height squared|kg/m^2|Mean|34.9|34.9|Standard Deviation|6.0|6.0|||
4094706|NCT00988351|3918454|B3|United States||Region of Enrollment||participants|Number|156|156.0||||||
4094707|NCT00988351|3918455|B2|United States||Region of Enrollment||participants|Number|78|78.0||||||
4094708|NCT00988351|3918456|B1|United States||Region of Enrollment||participants|Number|78|78.0||||||
4094709|NCT00988351|3918454|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094710|NCT00988351|3918455|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094711|NCT00988351|3918456|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094712|NCT00988351|3918454|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094713|NCT00988351|3918455|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094714|NCT00988351|3918456|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094715|NCT00988351|3918454|B3||White|Race (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
4094716|NCT00988351|3918455|B2||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4094717|NCT00988351|3918456|B1||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4094718|NCT00988351|3918454|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4094719|NCT00988351|3918455|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4094720|NCT00988351|3918456|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4094721|NCT00988351|3918454|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094722|NCT00988351|3918455|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094723|NCT00988351|3918456|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094724|NCT00988351|3918454|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094725|NCT00988351|3918455|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094726|NCT00988351|3918456|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094727|NCT00988351|3918454|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094728|NCT00988351|3918455|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094729|NCT00988351|3918456|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094730|NCT00988351|3918454|B3||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4094731|NCT00988351|3918455|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4094732|NCT00988351|3918456|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4094733|NCT00988351|3918454|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4094734|NCT00988351|3918455|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4094735|NCT00988351|3918456|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4094736|NCT00988351|3918454|B3|||Age||years|Mean|58.7|58.7|Standard Deviation|12.4|12.4|||
4094737|NCT00988351|3918455|B2|||Age||years|Mean|58.3|58.3|Standard Deviation|12.0|12.0|||
4094738|NCT00988351|3918456|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|11.9|11.9|||
4094739|NCT00988325|3918471|B4||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4094740|NCT00988325|3918472|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4094741|NCT00988325|3918473|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4094742|NCT00988325|3918474|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4094743|NCT00988325|3918471|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4094744|NCT00988325|3918472|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4094745|NCT00988325|3918473|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4094746|NCT00988325|3918474|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4094747|NCT00988325|3918471|B4|||Age||Days|Mean|156.8|156.8|Standard Deviation|105.62|105.62|||
4094748|NCT00988325|3918472|B3|||Age||Days|Mean|25.2|25.2|Standard Deviation|5.36|5.36|||
4094749|NCT00988325|3918473|B2|||Age||Days|Mean|57.0|57.0|Standard Deviation|17.24|17.24|||
4094750|NCT00988325|3918474|B1|||Age||Days|Mean|223.2|223.2|Standard Deviation|79.41|79.41|||
4094751|NCT00988247|3918532|B3|||Body mass index||kg/m^2|Mean|28.7|28.7|Standard Deviation|6.7|6.7|||
4094752|NCT00988247|3918533|B2|||Body mass index||kg/m^2|Mean|28.4|28.4|Standard Deviation|6.7|6.7|||
4094753|NCT00988247|3918534|B1|||Body mass index||kg/m^2|Mean|28.8|28.8|Standard Deviation|6.7|6.7|||
4094754|NCT00988247|3918532|B3|Unknown or Not Reported||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|1|1.0||||||
4094755|NCT00988247|3918533|B2|Unknown or Not Reported||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|0|0.0||||||
4094756|NCT00988247|3918534|B1|Unknown or Not Reported||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|1|1.0||||||
4094757|NCT00988247|3918532|B3|White||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|438|438.0||||||
4094758|NCT00988247|3918533|B2|White||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|97|97.0||||||
4094759|NCT00988247|3918534|B1|White||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|341|341.0||||||
4094760|NCT00988247|3918532|B3|Black or African American||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|77|77.0||||||
4094761|NCT00988247|3918533|B2|Black or African American||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|14|14.0||||||
4094762|NCT00988247|3918534|B1|Black or African American||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|63|63.0||||||
4094763|NCT00988247|3918532|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|3|3.0||||||
4094764|NCT00988247|3918533|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|0|0.0||||||
4094765|NCT00988247|3918534|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|3|3.0||||||
4094766|NCT00988247|3918532|B3|Asian||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|14|14.0||||||
4094767|NCT00988247|3918533|B2|Asian||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|1|1.0||||||
4094768|NCT00988247|3918534|B1|Asian||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|13|13.0||||||
4094769|NCT00988247|3918532|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|9|9.0||||||
4094770|NCT00988247|3918533|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|2|2.0||||||
4094771|NCT00988247|3918534|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|A participant may select more than one race type.|participants|Number|7|7.0||||||
4094772|NCT00988247|3918532|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094773|NCT00988247|3918533|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094774|NCT00988247|3918534|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094775|NCT00988247|3918532|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|467|467.0||||||
4094776|NCT00988247|3918533|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
4094777|NCT00988247|3918534|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|369|369.0||||||
4094778|NCT00988247|3918532|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4094779|NCT00988247|3918533|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4094780|NCT00988247|3918534|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4094781|NCT00988247|3918532|B3||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4094782|NCT00988247|3918533|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4094783|NCT00988247|3918534|B1||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4094784|NCT00988247|3918532|B3||Female|Sex: Female, Male||Participants|Count of Participants|352|352.0||||||
4094785|NCT00988247|3918533|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4094786|NCT00988247|3918534|B1||Female|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
4094787|NCT00988247|3918532|B3|||Age|Demographic data are provided for the Intent to Treat population.|years|Mean|37.1|37.1|Standard Deviation|13.4|13.4|||
4094788|NCT00988247|3918533|B2|||Age|Demographic data are provided for the Intent to Treat population.|years|Mean|35.7|35.7|Standard Deviation|12.9|12.9|||
4094789|NCT00988247|3918534|B1|||Age|Demographic data are provided for the Intent to Treat population.|years|Mean|37.4|37.4|Standard Deviation|13.6|13.6|||
4094790|NCT00988221|3918551|B4||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4094791|NCT00988221|3918552|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4094792|NCT00988221|3918553|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4094793|NCT00988221|3918554|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4094794|NCT00988221|3918551|B4||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4094795|NCT00988221|3918552|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4094796|NCT00988221|3918553|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4094797|NCT00988221|3918554|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4094798|NCT00988221|3918551|B4|||Age||years|Mean|11.0|11.0|Standard Deviation|4.01|4.01|||
4094799|NCT00988221|3918552|B3|||Age||years|Mean|13.1|13.1|Standard Deviation|2.78|2.78|||
4094800|NCT00988221|3918553|B2|||Age||years|Mean|7.6|7.6|Standard Deviation|2.71|2.71|||
4094801|NCT00988221|3918554|B1|||Age||years|Mean|6.9|6.9|Standard Deviation|3.02|3.02|||
4094802|NCT00988208|3918728|B3||None|Metastatic Sites of Disease Outside of Prostate|Specific sites of the body that have advanced spread of the prostate cancer.|Participants|Count of Participants|3|3.0||||||
4094803|NCT00988208|3918729|B2||None|Metastatic Sites of Disease Outside of Prostate|Specific sites of the body that have advanced spread of the prostate cancer.|Participants|Count of Participants|1|1.0||||||
4094804|NCT00988208|3918730|B1||None|Metastatic Sites of Disease Outside of Prostate|Specific sites of the body that have advanced spread of the prostate cancer.|Participants|Count of Participants|2|2.0||||||
4094805|NCT00988208|3918728|B3||Both bone and Soft tissues|Metastatic Sites of Disease Outside of Prostate|Specific sites of the body that have advanced spread of the prostate cancer.|Participants|Count of Participants|532|532.0||||||
4094806|NCT00988208|3918729|B2||Both bone and Soft tissues|Metastatic Sites of Disease Outside of Prostate|Specific sites of the body that have advanced spread of the prostate cancer.|Participants|Count of Participants|259|259.0||||||
4094807|NCT00988208|3918730|B1||Both bone and Soft tissues|Metastatic Sites of Disease Outside of Prostate|Specific sites of the body that have advanced spread of the prostate cancer.|Participants|Count of Participants|273|273.0||||||
4094808|NCT00988208|3918728|B3||Soft tissues only|Metastatic Sites of Disease Outside of Prostate|Specific sites of the body that have advanced spread of the prostate cancer.|Participants|Count of Participants|198|198.0||||||
4094809|NCT00988208|3918729|B2||Soft tissues only|Metastatic Sites of Disease Outside of Prostate|Specific sites of the body that have advanced spread of the prostate cancer.|Participants|Count of Participants|104|104.0||||||
4094810|NCT00988208|3918730|B1||Soft tissues only|Metastatic Sites of Disease Outside of Prostate|Specific sites of the body that have advanced spread of the prostate cancer.|Participants|Count of Participants|94|94.0||||||
4094811|NCT00988208|3918728|B3||Bone only|Metastatic Sites of Disease Outside of Prostate|Specific sites of the body that have advanced spread of the prostate cancer.|Participants|Count of Participants|326|326.0||||||
4094812|NCT00988208|3918729|B2||Bone only|Metastatic Sites of Disease Outside of Prostate|Specific sites of the body that have advanced spread of the prostate cancer.|Participants|Count of Participants|169|169.0||||||
4094813|NCT00988208|3918730|B1||Bone only|Metastatic Sites of Disease Outside of Prostate|Specific sites of the body that have advanced spread of the prostate cancer.|Participants|Count of Participants|157|157.0||||||
4094814|NCT00988208|3918728|B3|||Baseline PSA (Prostate Specific Antigen) Levels|Prostate-specific antigen (PSA) is a substance produced by the prostate gland. Elevated PSA levels may indicate prostate cancer or a noncancerous condition such as prostatitis or an enlarged prostate.|(ng/ml)|Mean|303.542|303.542|Standard Deviation|720.2895|720.2895|||
4094815|NCT00988208|3918729|B2|||Baseline PSA (Prostate Specific Antigen) Levels|Prostate-specific antigen (PSA) is a substance produced by the prostate gland. Elevated PSA levels may indicate prostate cancer or a noncancerous condition such as prostatitis or an enlarged prostate.|(ng/ml)|Mean|316.501|316.501|Standard Deviation|776.1133|776.1133|||
4094816|NCT00988208|3918730|B1|||Baseline PSA (Prostate Specific Antigen) Levels|Prostate-specific antigen (PSA) is a substance produced by the prostate gland. Elevated PSA levels may indicate prostate cancer or a noncancerous condition such as prostatitis or an enlarged prostate.|(ng/ml)|Mean|290.359|290.359|Standard Deviation|659.1583|659.1583|||
4094817|NCT00988208|3918728|B3||No|Other Prior Anti-Cancer Therapy|Participants who were treated with other types of anti-cancer therapies prior to participation in study|Participants|Count of Participants|909|909.0||||||
4094818|NCT00988208|3918729|B2||No|Other Prior Anti-Cancer Therapy|Participants who were treated with other types of anti-cancer therapies prior to participation in study|Participants|Count of Participants|462|462.0||||||
4094819|NCT00988208|3918730|B1||No|Other Prior Anti-Cancer Therapy|Participants who were treated with other types of anti-cancer therapies prior to participation in study|Participants|Count of Participants|447|447.0||||||
4094820|NCT00988208|3918728|B3||Yes|Other Prior Anti-Cancer Therapy|Participants who were treated with other types of anti-cancer therapies prior to participation in study|Participants|Count of Participants|150|150.0||||||
4094821|NCT00988208|3918729|B2||Yes|Other Prior Anti-Cancer Therapy|Participants who were treated with other types of anti-cancer therapies prior to participation in study|Participants|Count of Participants|71|71.0||||||
4094822|NCT00988208|3918730|B1||Yes|Other Prior Anti-Cancer Therapy|Participants who were treated with other types of anti-cancer therapies prior to participation in study|Participants|Count of Participants|79|79.0||||||
4094823|NCT00988208|3918728|B3||No|Prior Cancer Surgery|Participants who had undergone a surgical procedure associated with their prostate cancer diagnosis prior to study participation|Participants|Count of Participants|366|366.0||||||
4094824|NCT00988208|3918729|B2||No|Prior Cancer Surgery|Participants who had undergone a surgical procedure associated with their prostate cancer diagnosis prior to study participation|Participants|Count of Participants|175|175.0||||||
4094825|NCT00988208|3918730|B1||No|Prior Cancer Surgery|Participants who had undergone a surgical procedure associated with their prostate cancer diagnosis prior to study participation|Participants|Count of Participants|191|191.0||||||
4094826|NCT00988208|3918728|B3||Yes|Prior Cancer Surgery|Participants who had undergone a surgical procedure associated with their prostate cancer diagnosis prior to study participation|Participants|Count of Participants|693|693.0||||||
4094827|NCT00988208|3918729|B2||Yes|Prior Cancer Surgery|Participants who had undergone a surgical procedure associated with their prostate cancer diagnosis prior to study participation|Participants|Count of Participants|358|358.0||||||
4094828|NCT00988208|3918730|B1||Yes|Prior Cancer Surgery|Participants who had undergone a surgical procedure associated with their prostate cancer diagnosis prior to study participation|Participants|Count of Participants|335|335.0||||||
4094829|NCT00988208|3918728|B3||No|Prior Radiotherapy|Participants who had been treated with prior radiation therapy|Participants|Count of Participants|439|439.0||||||
4094830|NCT00988208|3918729|B2||No|Prior Radiotherapy|Participants who had been treated with prior radiation therapy|Participants|Count of Participants|221|221.0||||||
4094831|NCT00988208|3918730|B1||No|Prior Radiotherapy|Participants who had been treated with prior radiation therapy|Participants|Count of Participants|218|218.0||||||
4094832|NCT00988208|3918728|B3||Yes|Prior Radiotherapy|Participants who had been treated with prior radiation therapy|Participants|Count of Participants|620|620.0||||||
4094833|NCT00988208|3918729|B2||Yes|Prior Radiotherapy|Participants who had been treated with prior radiation therapy|Participants|Count of Participants|312|312.0||||||
4094834|NCT00988208|3918730|B1||Yes|Prior Radiotherapy|Participants who had been treated with prior radiation therapy|Participants|Count of Participants|308|308.0||||||
4094835|NCT00988208|3918728|B3||Radiographic progression|Type of Disease Progression|Categories of specific indicators of disease progression type|Participants|Count of Participants|754|754.0||||||
4094836|NCT00988208|3918729|B2||Radiographic progression|Type of Disease Progression|Categories of specific indicators of disease progression type|Participants|Count of Participants|374|374.0||||||
4094837|NCT00988208|3918730|B1||Radiographic progression|Type of Disease Progression|Categories of specific indicators of disease progression type|Participants|Count of Participants|380|380.0||||||
4094838|NCT00988208|3918728|B3||Rising PSA only|Type of Disease Progression|Categories of specific indicators of disease progression type|Participants|Count of Participants|305|305.0||||||
4094839|NCT00988208|3918729|B2||Rising PSA only|Type of Disease Progression|Categories of specific indicators of disease progression type|Participants|Count of Participants|159|159.0||||||
4094840|NCT00988208|3918730|B1||Rising PSA only|Type of Disease Progression|Categories of specific indicators of disease progression type|Participants|Count of Participants|146|146.0||||||
4094841|NCT00988208|3918728|B3||Not specified|ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis.|Participants|Count of Participants|1|1.0||||||
4094842|NCT00988208|3918729|B2||Not specified|ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis.|Participants|Count of Participants|1|1.0||||||
4094843|NCT00988208|3918730|B1||Not specified|ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis.|Participants|Count of Participants|0|0.0||||||
4094844|NCT00988208|3918728|B3||3 (Limited self-care)|ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis.|Participants|Count of Participants|1|1.0||||||
4094845|NCT00988208|3918729|B2||3 (Limited self-care)|ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis.|Participants|Count of Participants|0|0.0||||||
4094846|NCT00988208|3918730|B1||3 (Limited self-care)|ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis.|Participants|Count of Participants|1|1.0||||||
4094847|NCT00988208|3918728|B3||2 (Ambulatory but unable to work)|ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis.|Participants|Count of Participants|45|45.0||||||
4094848|NCT00988208|3918729|B2||2 (Ambulatory but unable to work)|ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis.|Participants|Count of Participants|24|24.0||||||
4094849|NCT00988208|3918730|B1||2 (Ambulatory but unable to work)|ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis.|Participants|Count of Participants|21|21.0||||||
4094850|NCT00988208|3918728|B3||1 (Restrictive but ambulatory)|ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis.|Participants|Count of Participants|503|503.0||||||
4094851|NCT00988208|3918729|B2||1 (Restrictive but ambulatory)|ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis.|Participants|Count of Participants|256|256.0||||||
4094852|NCT00988208|3918730|B1||1 (Restrictive but ambulatory)|ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis.|Participants|Count of Participants|247|247.0||||||
4094853|NCT00988208|3918728|B3||0 (Fully Active)|ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis.|Participants|Count of Participants|509|509.0||||||
4094854|NCT00988208|3918729|B2||0 (Fully Active)|ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis.|Participants|Count of Participants|252|252.0||||||
4094855|NCT00988208|3918730|B1||0 (Fully Active)|ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis.|Participants|Count of Participants|257|257.0||||||
4094856|NCT00988208|3918728|B3||>30 kg/m^2|Body Mass Index, Categorical||Participants|Count of Participants|323|323.0||||||
4094857|NCT00988208|3918729|B2||>30 kg/m^2|Body Mass Index, Categorical||Participants|Count of Participants|152|152.0||||||
4094858|NCT00988208|3918730|B1||>30 kg/m^2|Body Mass Index, Categorical||Participants|Count of Participants|171|171.0||||||
4094859|NCT00988208|3918728|B3||25-30 kg/m^2|Body Mass Index, Categorical||Participants|Count of Participants|464|464.0||||||
4094860|NCT00988208|3918729|B2||25-30 kg/m^2|Body Mass Index, Categorical||Participants|Count of Participants|243|243.0||||||
4094861|NCT00988208|3918730|B1||25-30 kg/m^2|Body Mass Index, Categorical||Participants|Count of Participants|221|221.0||||||
4094862|NCT00988208|3918728|B3||<25 kg/m^2|Body Mass Index, Categorical||Participants|Count of Participants|272|272.0||||||
4094863|NCT00988208|3918729|B2||<25 kg/m^2|Body Mass Index, Categorical||Participants|Count of Participants|138|138.0||||||
4094864|NCT00988208|3918730|B1||<25 kg/m^2|Body Mass Index, Categorical||Participants|Count of Participants|134|134.0||||||
4094865|NCT00988208|3918728|B3|||Body Mass Index|BMI or body mass index is a statistical benchmark that compares an individual’s height and weight.|kg/m^2|Mean|28.4|28.4|Standard Deviation|4.81|4.81|||
4094866|NCT00988208|3918729|B2|||Body Mass Index|BMI or body mass index is a statistical benchmark that compares an individual’s height and weight.|kg/m^2|Mean|28.3|28.3|Standard Deviation|4.60|4.6|||
4094867|NCT00988208|3918730|B1|||Body Mass Index|BMI or body mass index is a statistical benchmark that compares an individual’s height and weight.|kg/m^2|Mean|28.6|28.6|Standard Deviation|5.02|5.02|||
4094868|NCT00988208|3918728|B3|||Height||centimeters|Mean|174.2|174.2|Standard Deviation|7.60|7.6|||
4094869|NCT00988208|3918729|B2|||Height||centimeters|Mean|174.4|174.4|Standard Deviation|7.38|7.38|||
4094870|NCT00988208|3918730|B1|||Height||centimeters|Mean|174.0|174.0|Standard Deviation|7.81|7.81|||
4094871|NCT00988208|3918728|B3|||Weight||kilograms|Mean|86.2|86.2|Standard Deviation|15.93|15.93|||
4094872|NCT00988208|3918729|B2|||Weight||kilograms|Mean|86|86.0|Standard Deviation|15.70|15.7|||
4094873|NCT00988208|3918730|B1|||Weight||kilograms|Mean|86.4|86.4|Standard Deviation|16.18|16.18|||
4094874|NCT00988208|3918728|B3||American Indian or Alaska Native|Race, Customized||Participants|Count of Participants|8|8.0||||||
4094875|NCT00988208|3918729|B2||American Indian or Alaska Native|Race, Customized||Participants|Count of Participants|3|3.0||||||
4094876|NCT00988208|3918730|B1||American Indian or Alaska Native|Race, Customized||Participants|Count of Participants|5|5.0||||||
4094877|NCT00988208|3918728|B3||Asian|Race, Customized||Participants|Count of Participants|14|14.0||||||
4094878|NCT00988208|3918729|B2||Asian|Race, Customized||Participants|Count of Participants|6|6.0||||||
4094879|NCT00988208|3918730|B1||Asian|Race, Customized||Participants|Count of Participants|8|8.0||||||
4094880|NCT00988208|3918728|B3||Black or African American|Race, Customized||Participants|Count of Participants|46|46.0||||||
4094881|NCT00988208|3918729|B2||Black or African American|Race, Customized||Participants|Count of Participants|21|21.0||||||
4094882|NCT00988208|3918730|B1||Black or African American|Race, Customized||Participants|Count of Participants|25|25.0||||||
4094883|NCT00988208|3918728|B3||Other or no answer|Race, Customized||Participants|Count of Participants|122|122.0||||||
4094884|NCT00988208|3918729|B2||Other or no answer|Race, Customized||Participants|Count of Participants|67|67.0||||||
4094885|NCT00988208|3918730|B1||Other or no answer|Race, Customized||Participants|Count of Participants|55|55.0||||||
4094886|NCT00988208|3918728|B3||White|Race, Customized||Participants|Count of Participants|869|869.0||||||
4094887|NCT00988208|3918729|B2||White|Race, Customized||Participants|Count of Participants|436|436.0||||||
4094888|NCT00988208|3918730|B1||White|Race, Customized||Participants|Count of Participants|433|433.0||||||
4094889|NCT00988208|3918728|B3||Rest of World (Includes 4 additional countries)|Region of Enrollment|Rest of World includes Israel, Russia, Mexico and South Africa|Participants|Count of Participants|124|124.0||||||
4094890|NCT00988208|3918729|B2||Rest of World (Includes 4 additional countries)|Region of Enrollment|Rest of World includes Israel, Russia, Mexico and South Africa|Participants|Count of Participants|63|63.0||||||
4094891|NCT00988208|3918730|B1||Rest of World (Includes 4 additional countries)|Region of Enrollment|Rest of World includes Israel, Russia, Mexico and South Africa|Participants|Count of Participants|61|61.0||||||
4094892|NCT00988208|3918728|B3||EU or Australia|Region of Enrollment|Rest of World includes Israel, Russia, Mexico and South Africa|Participants|Count of Participants|659|659.0||||||
4094893|NCT00988208|3918729|B2||EU or Australia|Region of Enrollment|Rest of World includes Israel, Russia, Mexico and South Africa|Participants|Count of Participants|330|330.0||||||
4094894|NCT00988208|3918730|B1||EU or Australia|Region of Enrollment|Rest of World includes Israel, Russia, Mexico and South Africa|Participants|Count of Participants|329|329.0||||||
4094895|NCT00988208|3918728|B3||US or Canada|Region of Enrollment|Rest of World includes Israel, Russia, Mexico and South Africa|Participants|Count of Participants|276|276.0||||||
4094896|NCT00988208|3918729|B2||US or Canada|Region of Enrollment|Rest of World includes Israel, Russia, Mexico and South Africa|Participants|Count of Participants|140|140.0||||||
4094897|NCT00988208|3918730|B1||US or Canada|Region of Enrollment|Rest of World includes Israel, Russia, Mexico and South Africa|Participants|Count of Participants|136|136.0||||||
4094898|NCT00988208|3918728|B3|female||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4094899|NCT00988208|3918729|B2|female||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4094900|NCT00988208|3918730|B1|female||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4094901|NCT00988208|3918728|B3|male||Sex/Gender, Customized||Participants|Number|1059|1059.0||||||
4094902|NCT00988208|3918729|B2|male||Sex/Gender, Customized||Participants|Number|533|533.0||||||
4094903|NCT00988208|3918730|B1|male||Sex/Gender, Customized||Participants|Number|526|526.0||||||
4094904|NCT00988208|3918728|B3||>75 years|Age, Customized||Participants|Count of Participants|235|235.0||||||
4094905|NCT00988208|3918729|B2||>75 years|Age, Customized||Participants|Count of Participants|126|126.0||||||
4094906|NCT00988208|3918730|B1||>75 years|Age, Customized||Participants|Count of Participants|109|109.0||||||
4094907|NCT00988208|3918728|B3||> = to 65 years and < = 75years|Age, Customized||Participants|Count of Participants|490|490.0||||||
4094908|NCT00988208|3918729|B2||> = to 65 years and < = 75years|Age, Customized||Participants|Count of Participants|244|244.0||||||
4094909|NCT00988208|3918730|B1||> = to 65 years and < = 75years|Age, Customized||Participants|Count of Participants|246|246.0||||||
4094910|NCT00988208|3918728|B3||<65 years|Age, Customized||Participants|Count of Participants|334|334.0||||||
4094911|NCT00988208|3918729|B2||<65 years|Age, Customized||Participants|Count of Participants|163|163.0||||||
4094912|NCT00988208|3918730|B1||<65 years|Age, Customized||Participants|Count of Participants|171|171.0||||||
4094913|NCT00988208|3918728|B3|||Age||years|Mean|68.7|68.7|Standard Deviation|7.89|7.89|||
4094914|NCT00988208|3918729|B2|||Age||years|Mean|68.9|68.9|Standard Deviation|7.98|7.98|||
4094915|NCT00988208|3918730|B1|||Age||years|Mean|68.4|68.4|Standard Deviation|7.79|7.79|||
4094916|NCT00988169|3918749|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4094917|NCT00988169|3918749|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4094918|NCT00988169|3918749|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4094919|NCT00988169|3918749|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4094920|NCT00988169|3918749|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4094921|NCT00988156|3918753|B3||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4094922|NCT00988156|3918754|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4094923|NCT00988156|3918755|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4094924|NCT00988156|3918753|B3||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4094925|NCT00988156|3918754|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4094926|NCT00988156|3918755|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4094927|NCT00988156|3918753|B3|12-18 years||Age, Customized||participants|Number|97|97.0||||||
4094928|NCT00988156|3918754|B2|12-18 years||Age, Customized||participants|Number|52|52.0||||||
4094929|NCT00988156|3918755|B1|12-18 years||Age, Customized||participants|Number|45|45.0||||||
4094930|NCT00988156|3918753|B3|7-11 years||Age, Customized||participants|Number|104|104.0||||||
4094931|NCT00988156|3918754|B2|7-11 years||Age, Customized||participants|Number|51|51.0||||||
4094932|NCT00988156|3918755|B1|7-11 years||Age, Customized||participants|Number|53|53.0||||||
4094933|NCT00988156|3918753|B3|2-6 years||Age, Customized||participants|Number|62|62.0||||||
4094934|NCT00988156|3918754|B2|2-6 years||Age, Customized||participants|Number|31|31.0||||||
4094935|NCT00988156|3918755|B1|2-6 years||Age, Customized||participants|Number|31|31.0||||||
4094936|NCT00988143|3918764|B4|United States||Region of Enrollment||Participants|Number|600|600.0||||||
4094937|NCT00988143|3918765|B3|United States||Region of Enrollment||Participants|Number|190|190.0||||||
4094938|NCT00988143|3918766|B2|United States||Region of Enrollment||Participants|Number|190|190.0||||||
4094939|NCT00988143|3918767|B1|United States||Region of Enrollment||Participants|Number|220|220.0||||||
4094940|NCT00988143|3918764|B4||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4094941|NCT00988143|3918765|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4094942|NCT00988143|3918766|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4094943|NCT00988143|3918767|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4094944|NCT00988143|3918764|B4||Female|Sex: Female, Male||Participants|Count of Participants|398|398.0||||||
4094945|NCT00988143|3918765|B3||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4094946|NCT00988143|3918766|B2||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4094947|NCT00988143|3918767|B1||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4094948|NCT00988143|3918764|B4|||Age||Years|Mean|52.9|52.9|Standard Deviation|20.8|20.8|||
4094949|NCT00988143|3918765|B3|||Age||Years|Mean|56.7|56.7|Standard Deviation|17.2|17.2|||
4094950|NCT00988143|3918766|B2|||Age||Years|Mean|54.9|54.9|Standard Deviation|17.5|17.5|||
4094951|NCT00988143|3918767|B1|||Age||Years|Mean|47.8|47.8|Standard Deviation|24.9|24.9|||
4094952|NCT00988143|3918764|B4||>=65 years|Age||Participants|Count of Participants|185|185.0||||||
4094953|NCT00988143|3918765|B3||>=65 years|Age||Participants|Count of Participants|67|67.0||||||
4094954|NCT00988143|3918766|B2||>=65 years|Age||Participants|Count of Participants|55|55.0||||||
4094955|NCT00988143|3918767|B1||>=65 years|Age||Participants|Count of Participants|63|63.0||||||
4094956|NCT00988143|3918764|B4||Between 18 and 65 years|Age||Participants|Count of Participants|385|385.0||||||
4094957|NCT00988143|3918765|B3||Between 18 and 65 years|Age||Participants|Count of Participants|123|123.0||||||
4094958|NCT00988143|3918766|B2||Between 18 and 65 years|Age||Participants|Count of Participants|135|135.0||||||
4094959|NCT00988143|3918767|B1||Between 18 and 65 years|Age||Participants|Count of Participants|127|127.0||||||
4094960|NCT00988143|3918764|B4||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4094961|NCT00988143|3918765|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4094962|NCT00988143|3918766|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4094963|NCT00988143|3918767|B1||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4094964|NCT00988117|3918801|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4094965|NCT00988117|3918801|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4094966|NCT00988117|3918801|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4094967|NCT00988117|3918801|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4094968|NCT00988117|3918801|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4094969|NCT00988117|3918801|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4094970|NCT00988091|3918808|B3||Male|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4094971|NCT00988091|3918809|B2||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4094972|NCT00988091|3918810|B1||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4094973|NCT00988091|3918808|B3||Female|Sex: Female, Male||Participants|Count of Participants|361|361.0||||||
4094974|NCT00988091|3918809|B2||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4094975|NCT00988091|3918810|B1||Female|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4094976|NCT00988091|3918808|B3|||Age||years|Mean|60.50|60.5|Standard Deviation|10.708|10.708|||
4094977|NCT00988091|3918809|B2|||Age||years|Mean|60.70|60.7|Standard Deviation|10.228|10.228|||
4094978|NCT00988091|3918810|B1|||Age||years|Mean|60.30|60.3|Standard Deviation|11.180|11.18|||
4094979|NCT00988065|3918830|B4||Male|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4094980|NCT00988065|3918831|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4094981|NCT00988065|3918832|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4094982|NCT00988065|3918833|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4094983|NCT00988065|3918830|B4||Female|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4094984|NCT00988065|3918831|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4094985|NCT00988065|3918832|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4094986|NCT00988065|3918833|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4094987|NCT00988065|3918830|B4|||Age||years|Mean|33.8|33.8|Standard Deviation|10.5|10.5|||
4094988|NCT00988065|3918831|B3|||Age||years|Mean|33.8|33.8|Standard Deviation|10.8|10.8|||
4094989|NCT00988065|3918832|B2|||Age||years|Mean|33.2|33.2|Standard Deviation|10.2|10.2|||
4094990|NCT00988065|3918833|B1|||Age||years|Mean|34.4|34.4|Standard Deviation|10.6|10.6|||
4094991|NCT00987948|3918855|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4094992|NCT00987948|3918855|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094993|NCT00987948|3918855|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4094994|NCT00987948|3918855|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4094995|NCT00987948|3918855|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094996|NCT00987948|3918855|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4094997|NCT00987948|3918855|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4094998|NCT00987948|3918855|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4094999|NCT00987948|3918855|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4095000|NCT00987948|3918855|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4095001|NCT00987948|3918855|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4095002|NCT00987948|3918855|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4095003|NCT00987948|3918855|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4095004|NCT00987935|3918860|B10||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4095005|NCT00987935|3918861|B9||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4095006|NCT00987935|3918862|B8||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4095007|NCT00987935|3918863|B7||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4095008|NCT00987935|3918864|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4095009|NCT00987935|3918865|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4095010|NCT00987935|3918866|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4095011|NCT00987935|3918867|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4095012|NCT00987935|3918868|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4095013|NCT00987935|3918869|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4095014|NCT00987935|3918860|B10||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4095015|NCT00987935|3918861|B9||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4095016|NCT00987935|3918862|B8||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4095017|NCT00987935|3918863|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4095018|NCT00987935|3918864|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4095019|NCT00987935|3918865|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4095020|NCT00987935|3918866|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4095021|NCT00987935|3918867|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4095022|NCT00987935|3918868|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4095023|NCT00987935|3918869|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4095024|NCT00987935|3918860|B10|||Age||years|Mean|58.6|58.6|Standard Deviation|12.3|12.3|||
4095025|NCT00987935|3918861|B9|||Age||years|Mean|61.2|61.2|Standard Deviation|11.5|11.5|||
4095026|NCT00987935|3918862|B8|||Age||years|Mean|58.2|58.2|Standard Deviation|12.6|12.6|||
4095027|NCT00987935|3918863|B7|||Age||years|Mean|56.1|56.1|Standard Deviation|11.7|11.7|||
4095028|NCT00987935|3918864|B6|||Age||years|Mean|68.7|68.7|Standard Deviation|10.1|10.1|||
4095029|NCT00987935|3918865|B5|||Age||years|Mean|62.3|62.3|Standard Deviation|11.1|11.1|||
4095030|NCT00987935|3918866|B4|||Age||years|Mean|64.3|64.3|Standard Deviation|15.3|15.3|||
4095031|NCT00987935|3918867|B3|||Age||years|Mean|47.7|47.7|Standard Deviation|6.8|6.8|||
4095032|NCT00987935|3918868|B2|||Age||years|Mean|55.7|55.7|Standard Deviation|4.2|4.2|||
4095033|NCT00987935|3918869|B1|||Age||years|Mean|44.5|44.5|Standard Deviation|14.5|14.5|||
4095034|NCT00987831|3918930|B4|United States||Region of Enrollment||participants|Number|158|158.0||||||
4095035|NCT00987831|3918931|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
4095036|NCT00987831|3918932|B2|United States||Region of Enrollment||participants|Number|55|55.0||||||
4095037|NCT00987831|3918933|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4095038|NCT00987831|3918930|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4095039|NCT00987831|3918931|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4095040|NCT00987831|3918932|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4095041|NCT00987831|3918933|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4095042|NCT00987831|3918930|B4||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4095043|NCT00987831|3918931|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4095044|NCT00987831|3918932|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4095045|NCT00987831|3918933|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4095046|NCT00987831|3918930|B4|||Age||years|Mean|41.1|41.1|Standard Deviation|11.7|11.7|||
4095047|NCT00987831|3918931|B3|||Age||years|Mean|41.6|41.6|Standard Deviation|11.3|11.3|||
4095048|NCT00987831|3918932|B2|||Age||years|Mean|40.8|40.8|Standard Deviation|12.1|12.1|||
4095049|NCT00987831|3918933|B1|||Age||years|Mean|42.3|42.3|Standard Deviation|11.9|11.9|||
4095050|NCT00987831|3918930|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4095051|NCT00987831|3918931|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4095052|NCT00987831|3918932|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4095053|NCT00987831|3918933|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4095054|NCT00987831|3918930|B4||Between 18 and 65 years|Age||Participants|Count of Participants|157|157.0||||||
4095055|NCT00987831|3918931|B3||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4095056|NCT00987831|3918932|B2||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4095057|NCT00987831|3918933|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4095058|NCT00987831|3918930|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4095059|NCT00987831|3918931|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4095060|NCT00987831|3918932|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4095061|NCT00987831|3918933|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4095062|NCT00987727|3918944|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4095063|NCT00987727|3918945|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4095064|NCT00987727|3918946|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4095065|NCT00987727|3918944|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4095066|NCT00987727|3918945|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4095067|NCT00987727|3918946|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4095068|NCT00987727|3918944|B3|>=65 years||Age, Customized||participants|Number|31|31.0||||||
4095069|NCT00987727|3918945|B2|>=65 years||Age, Customized||participants|Number|12|12.0||||||
4095070|NCT00987727|3918946|B1|>=65 years||Age, Customized||participants|Number|19|19.0||||||
4095071|NCT00987727|3918944|B3|<65 years||Age, Customized||participants|Number|51|51.0||||||
4095072|NCT00987727|3918945|B2|<65 years||Age, Customized||participants|Number|29|29.0||||||
4095073|NCT00987727|3918946|B1|<65 years||Age, Customized||participants|Number|22|22.0||||||
4095074|NCT00987623|3918955|B3||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4095075|NCT00987623|3918956|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4095076|NCT00987623|3918957|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4095077|NCT00987623|3918955|B3||Female|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4095078|NCT00987623|3918956|B2||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4095079|NCT00987623|3918957|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4095080|NCT00987623|3918955|B3|||Age||years|Mean|26.5|26.5|Standard Deviation|10.12|10.12|||
4095081|NCT00987623|3918956|B2|||Age||years|Mean|26.5|26.5|Standard Deviation|10.5|10.5|||
4095082|NCT00987623|3918957|B1|||Age||years|Mean|26.5|26.5|Standard Deviation|9.8|9.8|||
4095083|NCT00987558|3918964|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4095084|NCT00987558|3918964|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4095085|NCT00987558|3918964|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4095086|NCT00987558|3918964|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4095087|NCT00987558|3918964|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4095088|NCT00987480|3918978|B1|United States||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
4095089|NCT00987480|3918978|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4095090|NCT00987480|3918978|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095091|NCT00987480|3918978|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4095092|NCT00987480|3918978|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4095093|NCT00987480|3918978|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095094|NCT00987480|3918978|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4095095|NCT00987480|3918978|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095096|NCT00987480|3918978|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4095097|NCT00987480|3918978|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095098|NCT00987480|3918978|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4095099|NCT00987480|3918978|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4095100|NCT00987480|3918978|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4095101|NCT00987480|3918978|B1|||Age||years|Median|8.2|8.2|Full Range|||4.3|44.0|
4095102|NCT00987467|3918987|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4095103|NCT00987467|3918987|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4095104|NCT00987467|3918987|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4095105|NCT00987467|3918987|B1|||Age||years|Mean|41|41.0|Standard Deviation|12.6|12.6|||
4095106|NCT00987467|3918987|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4095107|NCT00987467|3918987|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4095108|NCT00987467|3918987|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4095109|NCT00987415|3918992|B3|Canada||Region of Enrollment||participants|Number|69|69.0||||||
4095110|NCT00987415|3918993|B2|Canada||Region of Enrollment||participants|Number|33|33.0||||||
4095111|NCT00987415|3918994|B1|Canada||Region of Enrollment||participants|Number|36|36.0||||||
4095112|NCT00987415|3918992|B3|United States||Region of Enrollment||participants|Number|184|184.0||||||
4095113|NCT00987415|3918993|B2|United States||Region of Enrollment||participants|Number|92|92.0||||||
4095114|NCT00987415|3918994|B1|United States||Region of Enrollment||participants|Number|92|92.0||||||
4095115|NCT00987415|3918992|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095116|NCT00987415|3918993|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095117|NCT00987415|3918994|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095118|NCT00987415|3918992|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|250|250.0||||||
4095119|NCT00987415|3918993|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
4095120|NCT00987415|3918994|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
4095121|NCT00987415|3918992|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4095122|NCT00987415|3918993|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4095123|NCT00987415|3918994|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4095124|NCT00987415|3918992|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095125|NCT00987415|3918993|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095126|NCT00987415|3918994|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095127|NCT00987415|3918992|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4095128|NCT00987415|3918993|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4095129|NCT00987415|3918994|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4095130|NCT00987415|3918992|B3||White|Race (NIH/OMB)||Participants|Count of Participants|169|169.0||||||
4095131|NCT00987415|3918993|B2||White|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
4095132|NCT00987415|3918994|B1||White|Race (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
4095133|NCT00987415|3918992|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4095134|NCT00987415|3918993|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4095135|NCT00987415|3918994|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4095136|NCT00987415|3918992|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095137|NCT00987415|3918993|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095138|NCT00987415|3918994|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095139|NCT00987415|3918992|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4095140|NCT00987415|3918993|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4095141|NCT00987415|3918994|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4095142|NCT00987415|3918992|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4095143|NCT00987415|3918993|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4095144|NCT00987415|3918994|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4095145|NCT00987415|3918992|B3||Male|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4095146|NCT00987415|3918993|B2||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4095147|NCT00987415|3918994|B1||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4095148|NCT00987415|3918992|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4095149|NCT00987415|3918993|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4095150|NCT00987415|3918994|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4095151|NCT00987415|3918992|B3|||Age||years|Mean|61.9|61.9|Standard Deviation|13.6|13.6|||
4095152|NCT00987415|3918993|B2|||Age||years|Mean|61.8|61.8|Standard Deviation|13.1|13.1|||
4095153|NCT00987415|3918994|B1|||Age||years|Mean|62.1|62.1|Standard Deviation|14.2|14.2|||
4095154|NCT00987402|3919009|B3|Kenya||Region of Enrollment||participants|Number|3317|3317.0||||||
4095155|NCT00987402|3919010|B2|Kenya||Region of Enrollment||participants|Number|1635|1635.0||||||
4095156|NCT00987402|3919011|B1|Kenya||Region of Enrollment||participants|Number|1682|1682.0||||||
4095157|NCT00987402|3919009|B3||Male|Sex: Female, Male||Participants|Count of Participants|1445|1445.0||||||
4095158|NCT00987402|3919010|B2||Male|Sex: Female, Male||Participants|Count of Participants|727|727.0||||||
4095159|NCT00987402|3919011|B1||Male|Sex: Female, Male||Participants|Count of Participants|718|718.0||||||
4095160|NCT00987402|3919009|B3||Female|Sex: Female, Male||Participants|Count of Participants|1872|1872.0||||||
4095161|NCT00987402|3919010|B2||Female|Sex: Female, Male||Participants|Count of Participants|908|908.0||||||
4095162|NCT00987402|3919011|B1||Female|Sex: Female, Male||Participants|Count of Participants|964|964.0||||||
4095163|NCT00987402|3919009|B3|||Age||Participants|Mean|29|29.0|Standard Deviation|22|22.0|||
4095164|NCT00987402|3919010|B2|||Age||Participants|Mean|29|29.0|Standard Deviation|19|19.0|||
4095165|NCT00987402|3919011|B1|||Age||Participants|Mean|28|28.0|Standard Deviation|23|23.0|||
4095166|NCT00987337|3919018|B4||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4095167|NCT00987337|3919019|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4095168|NCT00987337|3919020|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4095169|NCT00987337|3919021|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4095170|NCT00987337|3919018|B4||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4095171|NCT00987337|3919019|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4095172|NCT00987337|3919020|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4095173|NCT00987337|3919021|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4095174|NCT00987337|3919018|B4|>=65 years||Age, Customized||participants|Number|11|11.0||||||
4095175|NCT00987337|3919019|B3|>=65 years||Age, Customized||participants|Number|4|4.0||||||
4095176|NCT00987337|3919020|B2|>=65 years||Age, Customized||participants|Number|3|3.0||||||
4095177|NCT00987337|3919021|B1|>=65 years||Age, Customized||participants|Number|4|4.0||||||
4095178|NCT00987337|3919018|B4|45 to 64 years||Age, Customized||participants|Number|185|185.0||||||
4095179|NCT00987337|3919019|B3|45 to 64 years||Age, Customized||participants|Number|61|61.0||||||
4095180|NCT00987337|3919020|B2|45 to 64 years||Age, Customized||participants|Number|68|68.0||||||
4095181|NCT00987337|3919021|B1|45 to 64 years||Age, Customized||participants|Number|56|56.0||||||
4095182|NCT00987337|3919018|B4|18 to 44 years||Age, Customized||participants|Number|92|92.0||||||
4095183|NCT00987337|3919019|B3|18 to 44 years||Age, Customized||participants|Number|31|31.0||||||
4095184|NCT00987337|3919020|B2|18 to 44 years||Age, Customized||participants|Number|25|25.0||||||
4095185|NCT00987337|3919021|B1|18 to 44 years||Age, Customized||participants|Number|36|36.0||||||
4095186|NCT00986999|3919067|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4095187|NCT00986999|3919067|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095188|NCT00986999|3919067|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095189|NCT00986999|3919067|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4095190|NCT00986999|3919067|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095191|NCT00986999|3919067|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4095192|NCT00986999|3919067|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4095193|NCT00986999|3919067|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095194|NCT00986999|3919067|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4095195|NCT00986999|3919067|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4095196|NCT00986999|3919067|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4095197|NCT00986999|3919067|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4095198|NCT00986999|3919067|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4095199|NCT00986986|3919076|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4095200|NCT00986986|3919077|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4095201|NCT00986986|3919078|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4095202|NCT00986986|3919076|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4095203|NCT00986986|3919077|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4095204|NCT00986986|3919078|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4095205|NCT00986986|3919076|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4095206|NCT00986986|3919077|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4095207|NCT00986986|3919078|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4095208|NCT00986986|3919076|B3|||Age||years|Mean|48.84|48.84|Standard Deviation|10.94|10.94|||
4095209|NCT00986986|3919077|B2|||Age||years|Mean|47.72|47.72|Standard Deviation|10.81|10.81|||
4095210|NCT00986986|3919078|B1|||Age||years|Mean|49.96|49.96|Standard Deviation|11.60|11.6|||
4095211|NCT00986986|3919076|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4095212|NCT00986986|3919077|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4095213|NCT00986986|3919078|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4095214|NCT00986986|3919076|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4095215|NCT00986986|3919077|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4095216|NCT00986986|3919078|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4095217|NCT00986986|3919076|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4095218|NCT00986986|3919077|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4095219|NCT00986986|3919078|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4095220|NCT00986973|3919089|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4095221|NCT00986973|3919089|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4095222|NCT00986973|3919089|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4095223|NCT00986973|3919089|B1|||Age||years|Mean|31|31.0|Standard Deviation|11.8|11.8|||
4095224|NCT00986973|3919089|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4095225|NCT00986973|3919089|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4095226|NCT00986973|3919089|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4095227|NCT00986947|3919108|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4095228|NCT00986947|3919108|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4095229|NCT00986947|3919108|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4095230|NCT00986947|3919108|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4095231|NCT00986947|3919108|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4095232|NCT00986947|3919108|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4095233|NCT00986921|3919113|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4095234|NCT00986921|3919114|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4095235|NCT00986921|3919115|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4095236|NCT00986921|3919113|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4095237|NCT00986921|3919114|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4095238|NCT00986921|3919115|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4095239|NCT00986921|3919113|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4095240|NCT00986921|3919114|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4095241|NCT00986921|3919115|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4095242|NCT00986921|3919113|B3|||Age||years|Mean|25|25.0|Standard Deviation|4|4.0|||
4095243|NCT00986921|3919114|B2|||Age||years|Mean|24|24.0|Standard Deviation|5|5.0|||
4095244|NCT00986921|3919115|B1|||Age||years|Mean|25|25.0|Standard Deviation|6|6.0|||
4095245|NCT00986921|3919113|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4095246|NCT00986921|3919114|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4095247|NCT00986921|3919115|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4095248|NCT00986921|3919113|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4095249|NCT00986921|3919114|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4095250|NCT00986921|3919115|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4095251|NCT00986921|3919113|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4095252|NCT00986921|3919114|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4095253|NCT00986921|3919115|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4095254|NCT00986856|3919126|B3|No S. aureus isolated||S.aureus susceptible to fusidic acid||S. aureus|Number|16|16.0||||||
4095255|NCT00986856|3919127|B2|No S. aureus isolated||S.aureus susceptible to fusidic acid||S. aureus|Number|4|4.0||||||
4095256|NCT00986856|3919128|B1|No S. aureus isolated||S.aureus susceptible to fusidic acid||S. aureus|Number|12|12.0||||||
4095257|NCT00986856|3919126|B3|S. aureus resistant to fusidic acid||S.aureus susceptible to fusidic acid||S. aureus|Number|26|26.0||||||
4095258|NCT00986856|3919127|B2|S. aureus resistant to fusidic acid||S.aureus susceptible to fusidic acid||S. aureus|Number|8|8.0||||||
4095259|NCT00986856|3919128|B1|S. aureus resistant to fusidic acid||S.aureus susceptible to fusidic acid||S. aureus|Number|18|18.0||||||
4095260|NCT00986856|3919126|B3|S. aureus susceptible to fusidic acid||S.aureus susceptible to fusidic acid||S. aureus|Number|16|16.0||||||
4095261|NCT00986856|3919127|B2|S. aureus susceptible to fusidic acid||S.aureus susceptible to fusidic acid||S. aureus|Number|4|4.0||||||
4095262|NCT00986856|3919128|B1|S. aureus susceptible to fusidic acid||S.aureus susceptible to fusidic acid||S. aureus|Number|12|12.0||||||
4095263|NCT00986856|3919126|B3|Norway||Region of Enrollment||participants|Number|11|11.0||||||
4095264|NCT00986856|3919127|B2|Norway||Region of Enrollment||participants|Number|1|1.0||||||
4095265|NCT00986856|3919128|B1|Norway||Region of Enrollment||participants|Number|10|10.0||||||
4095266|NCT00986856|3919126|B3|Sweden||Region of Enrollment||participants|Number|47|47.0||||||
4095267|NCT00986856|3919127|B2|Sweden||Region of Enrollment||participants|Number|15|15.0||||||
4095268|NCT00986856|3919128|B1|Sweden||Region of Enrollment||participants|Number|32|32.0||||||
4095269|NCT00986856|3919126|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4095270|NCT00986856|3919127|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4095271|NCT00986856|3919128|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4095272|NCT00986856|3919126|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4095273|NCT00986856|3919127|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4095274|NCT00986856|3919128|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4095275|NCT00986856|3919126|B3|||Age||years|Mean|5.2|5.2|Standard Deviation|2.8|2.8|||
4095276|NCT00986856|3919127|B2|||Age||years|Mean|6.3|6.3|Standard Deviation|2.9|2.9|||
4095277|NCT00986856|3919128|B1|||Age||years|Mean|4.8|4.8|Standard Deviation|2.7|2.7|||
4095278|NCT00986856|3919126|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4095279|NCT00986856|3919127|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4095280|NCT00986856|3919128|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4095281|NCT00986856|3919126|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4095282|NCT00986856|3919127|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4095283|NCT00986856|3919128|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4095284|NCT00986856|3919126|B3||<=18 years|Age||Participants|Count of Participants|58|58.0||||||
4095285|NCT00986856|3919127|B2||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4095286|NCT00986856|3919128|B1||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
4095287|NCT00986674|3919149|B4||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4095288|NCT00986674|3919150|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4095289|NCT00986674|3919151|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4095290|NCT00986674|3919152|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4095291|NCT00986674|3919149|B4||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4095292|NCT00986674|3919150|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4095293|NCT00986674|3919151|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4095294|NCT00986674|3919152|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4095295|NCT00986674|3919149|B4|||Age||years|Median|60|60.0|Full Range|||42.0|89.0|
4095296|NCT00986674|3919150|B3|||Age||years|Median|60|60.0|Full Range|||44.0|76.0|
4095297|NCT00986674|3919151|B2|||Age||years|Median|60|60.0|Full Range|||43.0|81.0|
4095298|NCT00986674|3919152|B1|||Age||years|Median|60|60.0|Full Range|||42.0|89.0|
4095299|NCT00986583|3919168|B3|United States||Region of Enrollment||participants|Number|70|70.0||||||
4095300|NCT00986583|3919169|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
4095301|NCT00986583|3919170|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4095302|NCT00986583|3919168|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4095303|NCT00986583|3919169|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4095304|NCT00986583|3919170|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4095305|NCT00986583|3919168|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4095306|NCT00986583|3919169|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4095307|NCT00986583|3919170|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4095308|NCT00986583|3919168|B3|||Age||years|Mean|59|59.0|Standard Deviation|10|10.0|||
4095309|NCT00986583|3919169|B2|||Age||years|Mean|57|57.0|Standard Deviation|10|10.0|||
4095310|NCT00986583|3919170|B1|||Age||years|Mean|61|61.0|Standard Deviation|9|9.0|||
4095311|NCT00986570|3919187|B1|Brazil||Region of Enrollment||participants|Number|121|121.0||||||
4095312|NCT00986570|3919187|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4095313|NCT00986570|3919187|B1||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4095314|NCT00986570|3919187|B1|||Age||years|Mean|42.52|42.52|Standard Deviation|0.42|0.42|||
4095315|NCT00986570|3919187|B1|Between 30 and 50 years||Age, Customized||participants|Number|121|121.0||||||
4095316|NCT00986544|3919191|B3|Italy||Region of Enrollment||participants|Number|106|106.0||||||
4095317|NCT00986544|3919192|B2|Italy||Region of Enrollment||participants|Number|53|53.0||||||
4095318|NCT00986544|3919193|B1|Italy||Region of Enrollment||participants|Number|53|53.0||||||
4095319|NCT00986544|3919191|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4095320|NCT00986544|3919192|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4095321|NCT00986544|3919193|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4095322|NCT00986544|3919191|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4095323|NCT00986544|3919192|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4095324|NCT00986544|3919193|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4095325|NCT00986544|3919191|B3|||Age||years|Mean|47.8|47.8|Standard Deviation|15.4|15.4|||
4095326|NCT00986544|3919192|B2|||Age||years|Mean|48.6|48.6|Standard Deviation|14.2|14.2|||
4095327|NCT00986544|3919193|B1|||Age||years|Mean|47.1|47.1|Standard Deviation|16.7|16.7|||
4095328|NCT00986544|3919191|B3||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
4095329|NCT00986544|3919192|B2||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4095330|NCT00986544|3919193|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4095331|NCT00986544|3919191|B3||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
4095332|NCT00986544|3919192|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4095333|NCT00986544|3919193|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4095334|NCT00986544|3919191|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4095335|NCT00986544|3919192|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4095336|NCT00986544|3919193|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4095337|NCT00986479|3919202|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4095338|NCT00986479|3919203|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4095339|NCT00986479|3919204|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4095340|NCT00986479|3919202|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4095341|NCT00986479|3919203|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4095342|NCT00986479|3919204|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4095343|NCT00986479|3919202|B3|||Age||years|Mean|51.5|51.5|Standard Deviation|10.1|10.1|||
4095344|NCT00986479|3919203|B2|||Age||years|Mean|52.4|52.4|Standard Deviation|10.5|10.5|||
4095345|NCT00986479|3919204|B1|||Age||years|Mean|50.7|50.7|Standard Deviation|10.9|10.9|||
4095346|NCT00986453|3919235|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4095347|NCT00986453|3919235|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4095348|NCT00986453|3919235|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4095349|NCT00986453|3919235|B1|||Age||years|Mean|41.12|41.12|Standard Deviation|14.20|14.2|||
4095350|NCT00986427|3919249|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4095351|NCT00986427|3919250|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4095352|NCT00986427|3919251|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4095353|NCT00986427|3919249|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4095354|NCT00986427|3919250|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4095355|NCT00986427|3919251|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4095356|NCT00986427|3919249|B3|||Age||years|Mean|59.7|59.7|Standard Deviation|13.28|13.28|||
4095357|NCT00986427|3919250|B2|||Age||years|Mean|59.6|59.6|Standard Deviation|12.69|12.69|||
4095358|NCT00986427|3919251|B1|||Age||years|Mean|59.8|59.8|Standard Deviation|49.40|49.4|||
4095359|NCT00986401|3919266|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4095360|NCT00986401|3919267|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4095361|NCT00986401|3919268|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4095362|NCT00986401|3919266|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4095363|NCT00986401|3919267|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4095364|NCT00986401|3919268|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4095365|NCT00986401|3919266|B3|||Age||years|Median|31.0|31.0|Full Range|||18.0|44.0|
4095366|NCT00986401|3919267|B2|||Age||years|Median|30.2|30.2|Full Range|||18.0|44.0|
4095367|NCT00986401|3919268|B1|||Age||years|Median|31.0|31.0|Full Range|||18.0|44.0|
4095368|NCT00986362|3919278|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4095369|NCT00986362|3919279|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4095370|NCT00986362|3919280|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4095371|NCT00986362|3919278|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4095372|NCT00986362|3919279|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4095373|NCT00986362|3919280|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4095374|NCT00986362|3919278|B3|||Age||years|Mean|6.8|6.8|Standard Deviation|6.39|6.39|||
4095375|NCT00986362|3919279|B2|||Age||years|Mean|8.0|8.0|Standard Deviation|6.61|6.61|||
4095376|NCT00986362|3919280|B1|||Age||years|Mean|6.1|6.1|Standard Deviation|6.40|6.4|||
4095377|NCT00986349|3919287|B1|Brazil||Region of Enrollment||participants|Number|20|20.0||||||
4095378|NCT00986349|3919287|B1||Male|Gender||Participants|Count of Participants|13|13.0||||||
4095379|NCT00986349|3919287|B1||Female|Gender||Participants|Count of Participants|7|7.0||||||
4095380|NCT00986349|3919287|B1|||Age||years|Mean|49.8|49.8|Standard Deviation|6.69|6.69|||
4095381|NCT00986258|3919300|B1|Switzerland||Region of Enrollment||participants|Number|5|5.0||||||
4095382|NCT00986258|3919300|B1|Germany||Region of Enrollment||participants|Number|34|34.0||||||
4095383|NCT00986258|3919300|B1|Netherlands||Region of Enrollment||participants|Number|14|14.0||||||
4095384|NCT00986258|3919300|B1|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4095385|NCT00986258|3919300|B1|Belgium||Region of Enrollment||participants|Number|17|17.0||||||
4095386|NCT00986258|3919300|B1|Poland||Region of Enrollment||participants|Number|9|9.0||||||
4095387|NCT00986258|3919300|B1|Spain||Region of Enrollment||participants|Number|21|21.0||||||
4095388|NCT00986258|3919300|B1|Czech Republic||Region of Enrollment||participants|Number|24|24.0||||||
4095389|NCT00986258|3919300|B1|France||Region of Enrollment||participants|Number|1|1.0||||||
4095390|NCT00986258|3919300|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4095391|NCT00986258|3919300|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4095392|NCT00986258|3919300|B1|||Age||years|Mean|57.1|57.1|Standard Deviation|12.00|12.0|||
4095393|NCT00986245|3919328|B1|Korea, Republic of||Region of Enrollment||participants|Number|82|82.0||||||
4095394|NCT00986245|3919328|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4095395|NCT00986245|3919328|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4095396|NCT00986245|3919328|B1|||Age||years|Mean|61.8|61.8|Standard Deviation|9.0|9.0|||
4095397|NCT00986245|3919328|B1||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4095398|NCT00986245|3919328|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4095399|NCT00986245|3919328|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4095400|NCT00986232|3919362|B5|Other||Race/Ethnicity, Customized||participants|Number|102|102.0||||||
4095401|NCT00986232|3919363|B4|Other||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4095402|NCT00986232|3919364|B3|Other||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4095403|NCT00986232|3919365|B2|Other||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4095404|NCT00986232|3919366|B1|Other||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4095405|NCT00986232|3919362|B5|Native American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4095406|NCT00986232|3919363|B4|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4095407|NCT00986232|3919364|B3|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4095408|NCT00986232|3919365|B2|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4095409|NCT00986232|3919366|B1|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4095410|NCT00986232|3919362|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|125|125.0||||||
4095411|NCT00986232|3919363|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4095412|NCT00986232|3919364|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4095413|NCT00986232|3919365|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4095414|NCT00986232|3919366|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4095415|NCT00986232|3919362|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|1021|1021.0||||||
4095416|NCT00986232|3919363|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|262|262.0||||||
4095417|NCT00986232|3919364|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|251|251.0||||||
4095418|NCT00986232|3919365|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|267|267.0||||||
4095419|NCT00986232|3919366|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|241|241.0||||||
4095420|NCT00986232|3919362|B5|Asian/Pacific||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
4095421|NCT00986232|3919363|B4|Asian/Pacific||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4095422|NCT00986232|3919364|B3|Asian/Pacific||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4095423|NCT00986232|3919365|B2|Asian/Pacific||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4095424|NCT00986232|3919366|B1|Asian/Pacific||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4095425|NCT00986232|3919362|B5|African American||Race/Ethnicity, Customized||participants|Number|238|238.0||||||
4095426|NCT00986232|3919363|B4|African American||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
4095427|NCT00986232|3919364|B3|African American||Race/Ethnicity, Customized||participants|Number|64|64.0||||||
4095428|NCT00986232|3919365|B2|African American||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
4095429|NCT00986232|3919366|B1|African American||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
4095430|NCT00986232|3919362|B5||Male|Sex: Female, Male||Participants|Count of Participants|831|831.0||||||
4095431|NCT00986232|3919363|B4||Male|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4095432|NCT00986232|3919364|B3||Male|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4095433|NCT00986232|3919365|B2||Male|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4095434|NCT00986232|3919366|B1||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4095435|NCT00986232|3919362|B5||Female|Sex: Female, Male||Participants|Count of Participants|720|720.0||||||
4095436|NCT00986232|3919363|B4||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4095437|NCT00986232|3919364|B3||Female|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4095438|NCT00986232|3919365|B2||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4095439|NCT00986232|3919366|B1||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4095440|NCT00986232|3919362|B5|||Age||Months|Mean|12.9|12.9|Standard Deviation|1.5|1.5|||
4095441|NCT00986232|3919363|B4|||Age||Months|Mean|13.0|13.0|Standard Deviation|1.7|1.7|||
4095442|NCT00986232|3919364|B3|||Age||Months|Mean|12.9|12.9|Standard Deviation|1.5|1.5|||
4095443|NCT00986232|3919365|B2|||Age||Months|Mean|12.9|12.9|Standard Deviation|1.5|1.5|||
4095444|NCT00986232|3919366|B1|||Age||Months|Mean|12.9|12.9|Standard Deviation|1.5|1.5|||
4095445|NCT00986180|3919441|B3|||Baseline BMI||kg/m^2|Mean|30.6|30.6|Standard Deviation|8.72|8.72|||
4095446|NCT00986180|3919442|B2|||Baseline BMI||kg/m^2|Mean|30.4|30.4|Standard Deviation|8.63|8.63|||
4095447|NCT00986180|3919443|B1|||Baseline BMI||kg/m^2|Mean|30.9|30.9|Standard Deviation|8.83|8.83|||
4095448|NCT00986180|3919441|B3|Not Reported||Ethnicity||participants|Number|2|2.0||||||
4095449|NCT00986180|3919442|B2|Not Reported||Ethnicity||participants|Number|2|2.0||||||
4095450|NCT00986180|3919443|B1|Not Reported||Ethnicity||participants|Number|0|0.0||||||
4095451|NCT00986180|3919441|B3|Not Hispanic or Latino||Ethnicity||participants|Number|561|561.0||||||
4095452|NCT00986180|3919442|B2|Not Hispanic or Latino||Ethnicity||participants|Number|283|283.0||||||
4095453|NCT00986180|3919443|B1|Not Hispanic or Latino||Ethnicity||participants|Number|278|278.0||||||
4095454|NCT00986180|3919441|B3|Hispanic or Latino||Ethnicity||participants|Number|82|82.0||||||
4095455|NCT00986180|3919442|B2|Hispanic or Latino||Ethnicity||participants|Number|39|39.0||||||
4095456|NCT00986180|3919443|B1|Hispanic or Latino||Ethnicity||participants|Number|43|43.0||||||
4095457|NCT00986180|3919441|B3|||Baseline Index Leg Pain Intensity|Pain intensity scale is: 0=no pain, 10=Pain as bad as you can imagine.|Units on a scale|Mean|6.2|6.2|Standard Deviation|2.15|2.15|||
4095458|NCT00986180|3919442|B2|||Baseline Index Leg Pain Intensity|Pain intensity scale is: 0=no pain, 10=Pain as bad as you can imagine.|Units on a scale|Mean|6.2|6.2|Standard Deviation|2.10|2.1|||
4095459|NCT00986180|3919443|B1|||Baseline Index Leg Pain Intensity|Pain intensity scale is: 0=no pain, 10=Pain as bad as you can imagine.|Units on a scale|Mean|6.2|6.2|Standard Deviation|2.21|2.21|||
4095460|NCT00986180|3919441|B3|||Baseline Low Back Pain Intensity|Pain intensity scale is: 0=no pain, 10=Pain as bad as you can imagine.|Units on a scale|Mean|7.2|7.2|Standard Deviation|1.60|1.6|||
4095461|NCT00986180|3919442|B2|||Baseline Low Back Pain Intensity|Pain intensity scale is: 0=no pain, 10=Pain as bad as you can imagine.|Units on a scale|Mean|7.2|7.2|Standard Deviation|1.54|1.54|||
4095462|NCT00986180|3919443|B1|||Baseline Low Back Pain Intensity|Pain intensity scale is: 0=no pain, 10=Pain as bad as you can imagine.|Units on a scale|Mean|7.2|7.2|Standard Deviation|1.66|1.66|||
4095463|NCT00986180|3919441|B3|UNITED STATES||Region of Enrollment||participants|Number|645|645.0||||||
4095464|NCT00986180|3919442|B2|UNITED STATES||Region of Enrollment||participants|Number|324|324.0||||||
4095465|NCT00986180|3919443|B1|UNITED STATES||Region of Enrollment||participants|Number|321|321.0||||||
4095466|NCT00986180|3919441|B3||Male|Sex: Female, Male||Participants|Count of Participants|324|324.0||||||
4095467|NCT00986180|3919442|B2||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4095468|NCT00986180|3919443|B1||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4095469|NCT00986180|3919441|B3||Female|Sex: Female, Male||Participants|Count of Participants|321|321.0||||||
4095470|NCT00986180|3919442|B2||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4095471|NCT00986180|3919443|B1||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4095472|NCT00986180|3919441|B3|||Age||years|Mean|45.4|45.4|Standard Deviation|14.26|14.26|||
4095473|NCT00986180|3919442|B2|||Age||years|Mean|45.1|45.1|Standard Deviation|14.36|14.36|||
4095474|NCT00986180|3919443|B1|||Age||years|Mean|45.7|45.7|Standard Deviation|14.18|14.18|||
4095475|NCT00986180|3919441|B3||>=65 years|Age||Participants|Count of Participants|65|65.0||||||
4095476|NCT00986180|3919442|B2||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4095477|NCT00986180|3919443|B1||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4095478|NCT00986180|3919441|B3||Between 18 and 65 years|Age||Participants|Count of Participants|579|579.0||||||
4095479|NCT00986180|3919442|B2||Between 18 and 65 years|Age||Participants|Count of Participants|297|297.0||||||
4095480|NCT00986180|3919443|B1||Between 18 and 65 years|Age||Participants|Count of Participants|282|282.0||||||
4095481|NCT00986180|3919441|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4095482|NCT00986180|3919442|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4095483|NCT00986180|3919443|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4095484|NCT00986154|3919520|B3|Sweden||Region of Enrollment||participants|Number|58|58.0||||||
4095485|NCT00986154|3919521|B2|Sweden||Region of Enrollment||participants|Number|22|22.0||||||
4095486|NCT00986154|3919522|B1|Sweden||Region of Enrollment||participants|Number|36|36.0||||||
4095487|NCT00986154|3919520|B3|New Zealand||Region of Enrollment||participants|Number|111|111.0||||||
4095488|NCT00986154|3919521|B2|New Zealand||Region of Enrollment||participants|Number|56|56.0||||||
4095489|NCT00986154|3919522|B1|New Zealand||Region of Enrollment||participants|Number|55|55.0||||||
4095490|NCT00986154|3919520|B3|Japan||Region of Enrollment||participants|Number|209|209.0||||||
4095491|NCT00986154|3919521|B2|Japan||Region of Enrollment||participants|Number|103|103.0||||||
4095492|NCT00986154|3919522|B1|Japan||Region of Enrollment||participants|Number|106|106.0||||||
4095493|NCT00986154|3919520|B3|Germany||Region of Enrollment||participants|Number|473|473.0||||||
4095494|NCT00986154|3919521|B2|Germany||Region of Enrollment||participants|Number|230|230.0||||||
4095495|NCT00986154|3919522|B1|Germany||Region of Enrollment||participants|Number|243|243.0||||||
4095496|NCT00986154|3919520|B3|Norway||Region of Enrollment||participants|Number|30|30.0||||||
4095497|NCT00986154|3919521|B2|Norway||Region of Enrollment||participants|Number|15|15.0||||||
4095498|NCT00986154|3919522|B1|Norway||Region of Enrollment||participants|Number|15|15.0||||||
4095499|NCT00986154|3919520|B3|Singapore||Region of Enrollment||participants|Number|11|11.0||||||
4095500|NCT00986154|3919521|B2|Singapore||Region of Enrollment||participants|Number|4|4.0||||||
4095501|NCT00986154|3919522|B1|Singapore||Region of Enrollment||participants|Number|7|7.0||||||
4095502|NCT00986154|3919520|B3|Belgium||Region of Enrollment||participants|Number|177|177.0||||||
4095503|NCT00986154|3919521|B2|Belgium||Region of Enrollment||participants|Number|79|79.0||||||
4095504|NCT00986154|3919522|B1|Belgium||Region of Enrollment||participants|Number|98|98.0||||||
4095505|NCT00986154|3919520|B3|Brazil||Region of Enrollment||participants|Number|90|90.0||||||
4095506|NCT00986154|3919521|B2|Brazil||Region of Enrollment||participants|Number|44|44.0||||||
4095507|NCT00986154|3919522|B1|Brazil||Region of Enrollment||participants|Number|46|46.0||||||
4095508|NCT00986154|3919520|B3|Poland||Region of Enrollment||participants|Number|43|43.0||||||
4095509|NCT00986154|3919521|B2|Poland||Region of Enrollment||participants|Number|21|21.0||||||
4095510|NCT00986154|3919522|B1|Poland||Region of Enrollment||participants|Number|22|22.0||||||
4095511|NCT00986154|3919520|B3|Argentina||Region of Enrollment||participants|Number|47|47.0||||||
4095512|NCT00986154|3919521|B2|Argentina||Region of Enrollment||participants|Number|21|21.0||||||
4095513|NCT00986154|3919522|B1|Argentina||Region of Enrollment||participants|Number|26|26.0||||||
4095514|NCT00986154|3919520|B3|Canada||Region of Enrollment||participants|Number|218|218.0||||||
4095515|NCT00986154|3919521|B2|Canada||Region of Enrollment||participants|Number|109|109.0||||||
4095516|NCT00986154|3919522|B1|Canada||Region of Enrollment||participants|Number|109|109.0||||||
4095517|NCT00986154|3919520|B3|Mexico||Region of Enrollment||participants|Number|126|126.0||||||
4095518|NCT00986154|3919521|B2|Mexico||Region of Enrollment||participants|Number|67|67.0||||||
4095519|NCT00986154|3919522|B1|Mexico||Region of Enrollment||participants|Number|59|59.0||||||
4095520|NCT00986154|3919520|B3|Hungary||Region of Enrollment||participants|Number|462|462.0||||||
4095521|NCT00986154|3919521|B2|Hungary||Region of Enrollment||participants|Number|232|232.0||||||
4095522|NCT00986154|3919522|B1|Hungary||Region of Enrollment||participants|Number|230|230.0||||||
4095523|NCT00986154|3919520|B3|Czech Republic||Region of Enrollment||participants|Number|427|427.0||||||
4095524|NCT00986154|3919521|B2|Czech Republic||Region of Enrollment||participants|Number|211|211.0||||||
4095525|NCT00986154|3919522|B1|Czech Republic||Region of Enrollment||participants|Number|216|216.0||||||
4095526|NCT00986154|3919520|B3|United Kingdom||Region of Enrollment||participants|Number|111|111.0||||||
4095527|NCT00986154|3919521|B2|United Kingdom||Region of Enrollment||participants|Number|67|67.0||||||
4095528|NCT00986154|3919522|B1|United Kingdom||Region of Enrollment||participants|Number|44|44.0||||||
4095529|NCT00986154|3919520|B3|Austria||Region of Enrollment||participants|Number|166|166.0||||||
4095530|NCT00986154|3919521|B2|Austria||Region of Enrollment||participants|Number|86|86.0||||||
4095531|NCT00986154|3919522|B1|Austria||Region of Enrollment||participants|Number|80|80.0||||||
4095532|NCT00986154|3919520|B3|Turkey||Region of Enrollment||participants|Number|51|51.0||||||
4095533|NCT00986154|3919521|B2|Turkey||Region of Enrollment||participants|Number|24|24.0||||||
4095534|NCT00986154|3919522|B1|Turkey||Region of Enrollment||participants|Number|27|27.0||||||
4095535|NCT00986154|3919520|B3|Korea, Republic of||Region of Enrollment||participants|Number|270|270.0||||||
4095536|NCT00986154|3919521|B2|Korea, Republic of||Region of Enrollment||participants|Number|130|130.0||||||
4095537|NCT00986154|3919522|B1|Korea, Republic of||Region of Enrollment||participants|Number|140|140.0||||||
4095538|NCT00986154|3919520|B3|China||Region of Enrollment||participants|Number|484|484.0||||||
4095539|NCT00986154|3919521|B2|China||Region of Enrollment||participants|Number|241|241.0||||||
4095540|NCT00986154|3919522|B1|China||Region of Enrollment||participants|Number|243|243.0||||||
4095541|NCT00986154|3919520|B3|Netherlands||Region of Enrollment||participants|Number|385|385.0||||||
4095542|NCT00986154|3919521|B2|Netherlands||Region of Enrollment||participants|Number|197|197.0||||||
4095543|NCT00986154|3919522|B1|Netherlands||Region of Enrollment||participants|Number|188|188.0||||||
4095544|NCT00986154|3919520|B3|South Africa||Region of Enrollment||participants|Number|365|365.0||||||
4095545|NCT00986154|3919521|B2|South Africa||Region of Enrollment||participants|Number|180|180.0||||||
4095546|NCT00986154|3919522|B1|South Africa||Region of Enrollment||participants|Number|185|185.0||||||
4095547|NCT00986154|3919520|B3|Australia||Region of Enrollment||participants|Number|179|179.0||||||
4095548|NCT00986154|3919521|B2|Australia||Region of Enrollment||participants|Number|89|89.0||||||
4095549|NCT00986154|3919522|B1|Australia||Region of Enrollment||participants|Number|90|90.0||||||
4095550|NCT00986154|3919520|B3|Denmark||Region of Enrollment||participants|Number|266|266.0||||||
4095551|NCT00986154|3919521|B2|Denmark||Region of Enrollment||participants|Number|143|143.0||||||
4095552|NCT00986154|3919522|B1|Denmark||Region of Enrollment||participants|Number|123|123.0||||||
4095553|NCT00986154|3919520|B3|France||Region of Enrollment||participants|Number|714|714.0||||||
4095554|NCT00986154|3919521|B2|France||Region of Enrollment||participants|Number|350|350.0||||||
4095555|NCT00986154|3919522|B1|France||Region of Enrollment||participants|Number|364|364.0||||||
4095556|NCT00986154|3919520|B3|India||Region of Enrollment||participants|Number|511|511.0||||||
4095557|NCT00986154|3919521|B2|India||Region of Enrollment||participants|Number|266|266.0||||||
4095558|NCT00986154|3919522|B1|India||Region of Enrollment||participants|Number|245|245.0||||||
4095559|NCT00986154|3919520|B3|Italy||Region of Enrollment||participants|Number|153|153.0||||||
4095560|NCT00986154|3919521|B2|Italy||Region of Enrollment||participants|Number|83|83.0||||||
4095561|NCT00986154|3919522|B1|Italy||Region of Enrollment||participants|Number|70|70.0||||||
4095562|NCT00986154|3919520|B3|Switzerland||Region of Enrollment||participants|Number|47|47.0||||||
4095563|NCT00986154|3919521|B2|Switzerland||Region of Enrollment||participants|Number|20|20.0||||||
4095564|NCT00986154|3919522|B1|Switzerland||Region of Enrollment||participants|Number|27|27.0||||||
4095565|NCT00986154|3919520|B3|Israel||Region of Enrollment||participants|Number|231|231.0||||||
4095566|NCT00986154|3919521|B2|Israel||Region of Enrollment||participants|Number|125|125.0||||||
4095567|NCT00986154|3919522|B1|Israel||Region of Enrollment||participants|Number|106|106.0||||||
4095568|NCT00986154|3919520|B3|Russian Federation||Region of Enrollment||participants|Number|517|517.0||||||
4095569|NCT00986154|3919521|B2|Russian Federation||Region of Enrollment||participants|Number|257|257.0||||||
4095570|NCT00986154|3919522|B1|Russian Federation||Region of Enrollment||participants|Number|260|260.0||||||
4095571|NCT00986154|3919520|B3|Ukraine||Region of Enrollment||participants|Number|291|291.0||||||
4095572|NCT00986154|3919521|B2|Ukraine||Region of Enrollment||participants|Number|148|148.0||||||
4095573|NCT00986154|3919522|B1|Ukraine||Region of Enrollment||participants|Number|143|143.0||||||
4095574|NCT00986154|3919520|B3|Spain||Region of Enrollment||participants|Number|27|27.0||||||
4095575|NCT00986154|3919521|B2|Spain||Region of Enrollment||participants|Number|8|8.0||||||
4095576|NCT00986154|3919522|B1|Spain||Region of Enrollment||participants|Number|19|19.0||||||
4095577|NCT00986154|3919520|B3|Thailand||Region of Enrollment||participants|Number|42|42.0||||||
4095578|NCT00986154|3919521|B2|Thailand||Region of Enrollment||participants|Number|24|24.0||||||
4095579|NCT00986154|3919522|B1|Thailand||Region of Enrollment||participants|Number|18|18.0||||||
4095580|NCT00986154|3919520|B3|Estonia||Region of Enrollment||participants|Number|76|76.0||||||
4095581|NCT00986154|3919521|B2|Estonia||Region of Enrollment||participants|Number|36|36.0||||||
4095582|NCT00986154|3919522|B1|Estonia||Region of Enrollment||participants|Number|40|40.0||||||
4095583|NCT00986154|3919520|B3|Taiwan||Region of Enrollment||participants|Number|138|138.0||||||
4095584|NCT00986154|3919521|B2|Taiwan||Region of Enrollment||participants|Number|64|64.0||||||
4095585|NCT00986154|3919522|B1|Taiwan||Region of Enrollment||participants|Number|74|74.0||||||
4095586|NCT00986154|3919520|B3|Philippines||Region of Enrollment||participants|Number|32|32.0||||||
4095587|NCT00986154|3919521|B2|Philippines||Region of Enrollment||participants|Number|15|15.0||||||
4095588|NCT00986154|3919522|B1|Philippines||Region of Enrollment||participants|Number|17|17.0||||||
4095589|NCT00986154|3919520|B3|United States||Region of Enrollment||participants|Number|618|618.0||||||
4095590|NCT00986154|3919521|B2|United States||Region of Enrollment||participants|Number|311|311.0||||||
4095591|NCT00986154|3919522|B1|United States||Region of Enrollment||participants|Number|307|307.0||||||
4095592|NCT00986154|3919520|B3|Belarus||Region of Enrollment||participants|Number|84|84.0||||||
4095593|NCT00986154|3919521|B2|Belarus||Region of Enrollment||participants|Number|44|44.0||||||
4095594|NCT00986154|3919522|B1|Belarus||Region of Enrollment||participants|Number|40|40.0||||||
4095595|NCT00986154|3919520|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|447|447.0||||||
4095596|NCT00986154|3919521|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|218|218.0||||||
4095597|NCT00986154|3919522|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|229|229.0||||||
4095598|NCT00986154|3919520|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095599|NCT00986154|3919521|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095600|NCT00986154|3919522|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095601|NCT00986154|3919520|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5762|5762.0||||||
4095602|NCT00986154|3919521|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2895|2895.0||||||
4095603|NCT00986154|3919522|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2867|2867.0||||||
4095604|NCT00986154|3919520|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|300|300.0||||||
4095605|NCT00986154|3919521|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
4095606|NCT00986154|3919522|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|156|156.0||||||
4095607|NCT00986154|3919520|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4095608|NCT00986154|3919521|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4095609|NCT00986154|3919522|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095610|NCT00986154|3919520|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1727|1727.0||||||
4095611|NCT00986154|3919521|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|861|861.0||||||
4095612|NCT00986154|3919522|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|866|866.0||||||
4095613|NCT00986154|3919520|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095614|NCT00986154|3919521|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095615|NCT00986154|3919522|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095616|NCT00986154|3919520|B3||Male|Sex: Female, Male||Participants|Count of Participants|4716|4716.0||||||
4095617|NCT00986154|3919521|B2||Male|Sex: Female, Male||Participants|Count of Participants|2356|2356.0||||||
4095618|NCT00986154|3919522|B1||Male|Sex: Female, Male||Participants|Count of Participants|2360|2360.0||||||
4095619|NCT00986154|3919520|B3||Female|Sex: Female, Male||Participants|Count of Participants|3524|3524.0||||||
4095620|NCT00986154|3919521|B2||Female|Sex: Female, Male||Participants|Count of Participants|1766|1766.0||||||
4095621|NCT00986154|3919522|B1||Female|Sex: Female, Male||Participants|Count of Participants|1758|1758.0||||||
4095622|NCT00986154|3919520|B3|||Age||years|Mean|55.8|55.8|Standard Deviation|16.2|16.2|||
4095623|NCT00986154|3919521|B2|||Age||years|Mean|55.9|55.9|Standard Deviation|16.2|16.2|||
4095624|NCT00986154|3919522|B1|||Age||years|Mean|55.7|55.7|Standard Deviation|16.3|16.3|||
4095625|NCT00986102|3919533|B5|Missing||Patient's location in the hospital upon enrollment||Participants|Number|2|2.0||||||
4095626|NCT00986102|3919534|B4|Missing||Patient's location in the hospital upon enrollment||Participants|Number|2|2.0||||||
4095627|NCT00986102|3919535|B3|Missing||Patient's location in the hospital upon enrollment||Participants|Number|0|0.0||||||
4095628|NCT00986102|3919536|B2|Missing||Patient's location in the hospital upon enrollment||Participants|Number|0|0.0||||||
4095629|NCT00986102|3919537|B1|Missing||Patient's location in the hospital upon enrollment||Participants|Number|0|0.0||||||
4095630|NCT00986102|3919533|B5|Non –ICU||Patient's location in the hospital upon enrollment||Participants|Number|77|77.0||||||
4095631|NCT00986102|3919534|B4|Non –ICU||Patient's location in the hospital upon enrollment||Participants|Number|36|36.0||||||
4095632|NCT00986102|3919535|B3|Non –ICU||Patient's location in the hospital upon enrollment||Participants|Number|10|10.0||||||
4095633|NCT00986102|3919536|B2|Non –ICU||Patient's location in the hospital upon enrollment||Participants|Number|8|8.0||||||
4095634|NCT00986102|3919537|B1|Non –ICU||Patient's location in the hospital upon enrollment||Participants|Number|23|23.0||||||
4095635|NCT00986102|3919533|B5|Intensive Care Unit (ICU)||Patient's location in the hospital upon enrollment||Participants|Number|137|137.0||||||
4095636|NCT00986102|3919534|B4|Intensive Care Unit (ICU)||Patient's location in the hospital upon enrollment||Participants|Number|29|29.0||||||
4095637|NCT00986102|3919535|B3|Intensive Care Unit (ICU)||Patient's location in the hospital upon enrollment||Participants|Number|9|9.0||||||
4095638|NCT00986102|3919536|B2|Intensive Care Unit (ICU)||Patient's location in the hospital upon enrollment||Participants|Number|69|69.0||||||
4095639|NCT00986102|3919537|B1|Intensive Care Unit (ICU)||Patient's location in the hospital upon enrollment||Participants|Number|30|30.0||||||
4095640|NCT00986102|3919533|B5|Others||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
4095641|NCT00986102|3919534|B4|Others||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4095642|NCT00986102|3919535|B3|Others||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4095643|NCT00986102|3919536|B2|Others||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4095644|NCT00986102|3919537|B1|Others||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4095645|NCT00986102|3919533|B5|White||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4095646|NCT00986102|3919534|B4|White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4095647|NCT00986102|3919535|B3|White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4095648|NCT00986102|3919536|B2|White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4095649|NCT00986102|3919537|B1|White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4095650|NCT00986102|3919533|B5|Aboriginal||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4095651|NCT00986102|3919534|B4|Aboriginal||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4095652|NCT00986102|3919535|B3|Aboriginal||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4095653|NCT00986102|3919536|B2|Aboriginal||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4095654|NCT00986102|3919537|B1|Aboriginal||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4095655|NCT00986102|3919533|B5|Indian||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4095656|NCT00986102|3919534|B4|Indian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4095657|NCT00986102|3919535|B3|Indian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4095658|NCT00986102|3919536|B2|Indian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4095659|NCT00986102|3919537|B1|Indian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4095660|NCT00986102|3919533|B5|Malay||Race/Ethnicity, Customized||Participants|Number|120|120.0||||||
4095661|NCT00986102|3919534|B4|Malay||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
4095662|NCT00986102|3919535|B3|Malay||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4095663|NCT00986102|3919536|B2|Malay||Race/Ethnicity, Customized||Participants|Number|44|44.0||||||
4095664|NCT00986102|3919537|B1|Malay||Race/Ethnicity, Customized||Participants|Number|33|33.0||||||
4095665|NCT00986102|3919533|B5|Chinese||Race/Ethnicity, Customized||Participants|Number|56|56.0||||||
4095666|NCT00986102|3919534|B4|Chinese||Race/Ethnicity, Customized||Participants|Number|28|28.0||||||
4095667|NCT00986102|3919535|B3|Chinese||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4095668|NCT00986102|3919536|B2|Chinese||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4095669|NCT00986102|3919537|B1|Chinese||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4095670|NCT00986102|3919533|B5||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4095671|NCT00986102|3919534|B4||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4095672|NCT00986102|3919535|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4095673|NCT00986102|3919536|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4095674|NCT00986102|3919537|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4095675|NCT00986102|3919533|B5||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4095676|NCT00986102|3919534|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4095677|NCT00986102|3919535|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4095678|NCT00986102|3919536|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4095679|NCT00986102|3919537|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4095680|NCT00986102|3919533|B5|||Age||years|Mean|49.5|49.5|Standard Deviation|17.88|17.88|||
4095681|NCT00986102|3919534|B4|||Age||years|Mean|49.2|49.2|Standard Deviation|16.13|16.13|||
4095682|NCT00986102|3919535|B3|||Age||years|Mean|58.2|58.2|Standard Deviation|13.23|13.23|||
4095683|NCT00986102|3919536|B2|||Age||years|Mean|44.4|44.4|Standard Deviation|19.17|19.17|||
4095684|NCT00986102|3919537|B1|||Age||years|Mean|54.1|54.1|Standard Deviation|17.52|17.52|||
4095685|NCT00985985|3919586|B5|||Body Weight|Baseline Parameters were evaluated for FAS population.|Kg|Mean|73.1|73.1|Standard Deviation|11.53|11.53|||
4095686|NCT00985985|3919587|B4|||Body Weight|Baseline Parameters were evaluated for FAS population.|Kg|Mean|74.3|74.3|Standard Deviation|12.15|12.15|||
4095687|NCT00985985|3919588|B3|||Body Weight|Baseline Parameters were evaluated for FAS population.|Kg|Mean|75.9|75.9|Standard Deviation|11.64|11.64|||
4095688|NCT00985985|3919589|B2|||Body Weight|Baseline Parameters were evaluated for FAS population.|Kg|Mean|72.3|72.3|Standard Deviation|11.42|11.42|||
4095689|NCT00985985|3919590|B1|||Body Weight|Baseline Parameters were evaluated for FAS population.|Kg|Mean|71.8|71.8|Standard Deviation|11.06|11.06|||
4095690|NCT00985985|3919586|B5||Male|Sex: Female, Male|Baseline parameter were evaluated for FAS population.|Participants|Count of Participants|699|699.0||||||
4095691|NCT00985985|3919587|B4||Male|Sex: Female, Male|Baseline parameter were evaluated for FAS population.|Participants|Count of Participants|116|116.0||||||
4095692|NCT00985985|3919588|B3||Male|Sex: Female, Male|Baseline parameter were evaluated for FAS population.|Participants|Count of Participants|118|118.0||||||
4095693|NCT00985985|3919589|B2||Male|Sex: Female, Male|Baseline parameter were evaluated for FAS population.|Participants|Count of Participants|235|235.0||||||
4095694|NCT00985985|3919590|B1||Male|Sex: Female, Male|Baseline parameter were evaluated for FAS population.|Participants|Count of Participants|230|230.0||||||
4095695|NCT00985985|3919586|B5||Female|Sex: Female, Male|Baseline parameter were evaluated for FAS population.|Participants|Count of Participants|23|23.0||||||
4095696|NCT00985985|3919587|B4||Female|Sex: Female, Male|Baseline parameter were evaluated for FAS population.|Participants|Count of Participants|3|3.0||||||
4095697|NCT00985985|3919588|B3||Female|Sex: Female, Male|Baseline parameter were evaluated for FAS population.|Participants|Count of Participants|2|2.0||||||
4095698|NCT00985985|3919589|B2||Female|Sex: Female, Male|Baseline parameter were evaluated for FAS population.|Participants|Count of Participants|7|7.0||||||
4095699|NCT00985985|3919590|B1||Female|Sex: Female, Male|Baseline parameter were evaluated for FAS population.|Participants|Count of Participants|11|11.0||||||
4095700|NCT00985985|3919586|B5|||Age|Baseline parameters were evaluated for FAS population.|Years|Mean|40.1|40.1|Standard Deviation|11.44|11.44|||
4095701|NCT00985985|3919587|B4|||Age|Baseline parameters were evaluated for FAS population.|Years|Mean|42.0|42.0|Standard Deviation|10.57|10.57|||
4095702|NCT00985985|3919588|B3|||Age|Baseline parameters were evaluated for FAS population.|Years|Mean|42.3|42.3|Standard Deviation|10.38|10.38|||
4095703|NCT00985985|3919589|B2|||Age|Baseline parameters were evaluated for FAS population.|Years|Mean|39.9|39.9|Standard Deviation|11.76|11.76|||
4095704|NCT00985985|3919590|B1|||Age|Baseline parameters were evaluated for FAS population.|Years|Mean|38.4|38.4|Standard Deviation|11.78|11.78|||
4095705|NCT00985959|3919631|B4||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4095706|NCT00985959|3919632|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4095707|NCT00985959|3919633|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4095708|NCT00985959|3919634|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4095709|NCT00985959|3919631|B4||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4095710|NCT00985959|3919632|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4095711|NCT00985959|3919633|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4095712|NCT00985959|3919634|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4095713|NCT00985959|3919631|B4|>=75 years||Age, Customized||Participants|Number|27|27.0||||||
4095714|NCT00985959|3919632|B3|>=75 years||Age, Customized||Participants|Number|24|24.0||||||
4095715|NCT00985959|3919633|B2|>=75 years||Age, Customized||Participants|Number|0|0.0||||||
4095716|NCT00985959|3919634|B1|>=75 years||Age, Customized||Participants|Number|3|3.0||||||
4095717|NCT00985959|3919631|B4|>= 65 and <= 74 years||Age, Customized||Participants|Number|67|67.0||||||
4095718|NCT00985959|3919632|B3|>= 65 and <= 74 years||Age, Customized||Participants|Number|60|60.0||||||
4095719|NCT00985959|3919633|B2|>= 65 and <= 74 years||Age, Customized||Participants|Number|5|5.0||||||
4095720|NCT00985959|3919634|B1|>= 65 and <= 74 years||Age, Customized||Participants|Number|2|2.0||||||
4095721|NCT00985959|3919631|B4|<65 years||Age, Customized||Participants|Number|5|5.0||||||
4095722|NCT00985959|3919632|B3|<65 years||Age, Customized||Participants|Number|3|3.0||||||
4095723|NCT00985959|3919633|B2|<65 years||Age, Customized||Participants|Number|1|1.0||||||
4095724|NCT00985959|3919634|B1|<65 years||Age, Customized||Participants|Number|1|1.0||||||
4095725|NCT00985959|3919631|B4|||Age||Years|Mean|70.9|70.9|Standard Deviation|5.94|5.94|||
4095726|NCT00985959|3919632|B3|||Age||Years|Mean|70.9|70.9|Standard Deviation|5.68|5.68|||
4095727|NCT00985959|3919633|B2|||Age||Years|Mean|68.5|68.5|Standard Deviation|6.47|6.47|||
4095728|NCT00985959|3919634|B1|||Age||Years|Mean|72.7|72.7|Standard Deviation|9.2|9.2|||
4095729|NCT00985946|3919659|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4095730|NCT00985946|3919659|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095731|NCT00985946|3919659|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095732|NCT00985946|3919659|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4095733|NCT00985946|3919659|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095734|NCT00985946|3919659|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095735|NCT00985946|3919659|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095736|NCT00985946|3919659|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095737|NCT00985946|3919659|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4095738|NCT00985946|3919659|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4095739|NCT00985946|3919659|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095740|NCT00985946|3919659|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4095741|NCT00985946|3919659|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4095742|NCT00985946|3919659|B1|>= 80 years of age||Age, Customized||participants|Number|1|1.0||||||
4095743|NCT00985946|3919659|B1|70-79 years of age||Age, Customized||participants|Number|2|2.0||||||
4095744|NCT00985946|3919659|B1|60-69 years of age||Age, Customized||participants|Number|4|4.0||||||
4095745|NCT00985946|3919659|B1|50-59 years of age||Age, Customized||participants|Number|5|5.0||||||
4095746|NCT00985946|3919659|B1|40-49 years of age||Age, Customized||participants|Number|3|3.0||||||
4095747|NCT00985829|3919667|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4095748|NCT00985829|3919667|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4095749|NCT00985829|3919667|B1|||Age||years|Mean|59.1|59.1|Standard Deviation|12.7|12.7|||
4095750|NCT00985790|3919676|B3||Male|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
4095751|NCT00985790|3919677|B2||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4095752|NCT00985790|3919678|B1||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4095753|NCT00985790|3919676|B3||Female|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
4095754|NCT00985790|3919677|B2||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4095755|NCT00985790|3919678|B1||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4095756|NCT00985790|3919676|B3|||Age||months|Mean|31.5|31.5|Standard Deviation|8.38|8.38|||
4095757|NCT00985790|3919677|B2|||Age||months|Mean|31.6|31.6|Standard Deviation|8.29|8.29|||
4095758|NCT00985790|3919678|B1|||Age||months|Mean|31.4|31.4|Standard Deviation|8.46|8.46|||
4095759|NCT00985751|3919715|B6|White-Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4095760|NCT00985751|3919716|B5|White-Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4095761|NCT00985751|3919717|B4|White-Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4095762|NCT00985751|3919718|B3|White-Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4095763|NCT00985751|3919719|B2|White-Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4095764|NCT00985751|3919720|B1|White-Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4095765|NCT00985751|3919715|B6|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|254|254.0||||||
4095766|NCT00985751|3919716|B5|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|49|49.0||||||
4095767|NCT00985751|3919717|B4|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
4095768|NCT00985751|3919718|B3|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
4095769|NCT00985751|3919719|B2|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|52|52.0||||||
4095770|NCT00985751|3919720|B1|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
4095771|NCT00985751|3919715|B6||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4095772|NCT00985751|3919716|B5||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4095773|NCT00985751|3919717|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4095774|NCT00985751|3919718|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4095775|NCT00985751|3919719|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4095776|NCT00985751|3919720|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4095777|NCT00985751|3919715|B6||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4095778|NCT00985751|3919716|B5||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4095779|NCT00985751|3919717|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4095780|NCT00985751|3919718|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4095781|NCT00985751|3919719|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4095782|NCT00985751|3919720|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4095783|NCT00985751|3919715|B6|||Age||Months|Mean|16.78|16.78|Standard Deviation|3.90|3.9|||
4095784|NCT00985751|3919716|B5|||Age||Months|Mean|16.3|16.3|Standard Deviation|4.18|4.18|||
4095785|NCT00985751|3919717|B4|||Age||Months|Mean|16.8|16.8|Standard Deviation|3.96|3.96|||
4095786|NCT00985751|3919718|B3|||Age||Months|Mean|17.1|17.1|Standard Deviation|4.03|4.03|||
4095787|NCT00985751|3919719|B2|||Age||Months|Mean|16.7|16.7|Standard Deviation|3.81|3.81|||
4095788|NCT00985751|3919720|B1|||Age||Months|Mean|17|17.0|Standard Deviation|3.6|3.6|||
4095789|NCT00985738|3919785|B3|United States||Region of Enrollment||Participants|Number|16|16.0||||||
4095790|NCT00985738|3919786|B2|United States||Region of Enrollment||Participants|Number|8|8.0||||||
4095791|NCT00985738|3919787|B1|United States||Region of Enrollment||Participants|Number|8|8.0||||||
4095792|NCT00985738|3919785|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095793|NCT00985738|3919786|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095794|NCT00985738|3919787|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095795|NCT00985738|3919785|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095796|NCT00985738|3919786|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095797|NCT00985738|3919787|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095798|NCT00985738|3919785|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4095799|NCT00985738|3919786|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4095800|NCT00985738|3919787|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4095801|NCT00985738|3919785|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4095802|NCT00985738|3919786|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4095803|NCT00985738|3919787|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4095804|NCT00985738|3919785|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095805|NCT00985738|3919786|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095806|NCT00985738|3919787|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095807|NCT00985738|3919785|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095808|NCT00985738|3919786|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095809|NCT00985738|3919787|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095810|NCT00985738|3919785|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095811|NCT00985738|3919786|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095812|NCT00985738|3919787|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095813|NCT00985738|3919785|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095814|NCT00985738|3919786|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095815|NCT00985738|3919787|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095816|NCT00985738|3919785|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4095817|NCT00985738|3919786|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4095818|NCT00985738|3919787|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4095819|NCT00985738|3919785|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095820|NCT00985738|3919786|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095821|NCT00985738|3919787|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4095822|NCT00985738|3919785|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4095823|NCT00985738|3919786|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4095824|NCT00985738|3919787|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4095825|NCT00985738|3919785|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4095826|NCT00985738|3919786|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4095827|NCT00985738|3919787|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4095828|NCT00985738|3919785|B3|||Age||Years|Mean|64.4|64.4|Standard Deviation|5.9|5.9|||
4095829|NCT00985738|3919786|B2|||Age||Years|Mean|65.8|65.8|Standard Deviation|6.3|6.3|||
4095830|NCT00985738|3919787|B1|||Age||Years|Mean|63.5|63.5|Standard Deviation|6.0|6.0|||
4095831|NCT00985738|3919785|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4095832|NCT00985738|3919786|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4095833|NCT00985738|3919787|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4095834|NCT00985738|3919785|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4095835|NCT00985738|3919786|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4095836|NCT00985738|3919787|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4095837|NCT00985738|3919785|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4095838|NCT00985738|3919786|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4095839|NCT00985738|3919787|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4095840|NCT00985725|3919794|B3|United States||Region of Enrollment||participants|Number|143|143.0||||||
4095841|NCT00985725|3919795|B2|United States||Region of Enrollment||participants|Number|72|72.0||||||
4095842|NCT00985725|3919796|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
4095843|NCT00985725|3919794|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4095844|NCT00985725|3919795|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4095845|NCT00985725|3919796|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4095846|NCT00985725|3919794|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4095847|NCT00985725|3919795|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4095848|NCT00985725|3919796|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4095849|NCT00985725|3919794|B3|40 to 55 years||Age, Customized||participants|Number|81|81.0||||||
4095850|NCT00985725|3919795|B2|40 to 55 years||Age, Customized||participants|Number|38|38.0||||||
4095851|NCT00985725|3919796|B1|40 to 55 years||Age, Customized||participants|Number|43|43.0||||||
4095852|NCT00985725|3919794|B3|18 to 39 years||Age, Customized||participants|Number|62|62.0||||||
4095853|NCT00985725|3919795|B2|18 to 39 years||Age, Customized||participants|Number|34|34.0||||||
4095854|NCT00985725|3919796|B1|18 to 39 years||Age, Customized||participants|Number|28|28.0||||||
4095855|NCT00985725|3919794|B3|||Age||years|Mean|40.7|40.7|Standard Deviation|10.23|10.23|||
4095856|NCT00985725|3919795|B2|||Age||years|Mean|39.5|39.5|Standard Deviation|10.59|10.59|||
4095857|NCT00985725|3919796|B1|||Age||years|Mean|41.9|41.9|Standard Deviation|9.79|9.79|||
4095919|NCT00985686|3919848|B5|No||Religions denomination indicated||participants|Number|32|32.0||||||
4095920|NCT00985686|3919849|B4|No||Religions denomination indicated||participants|Number|8|8.0||||||
4095858|NCT00985712|3919831|B3|||Hemoglobin A1c (HbA1c)|HbA1c is a form of hemoglobin which is measured primarily to identify the average plasma glucose concentration over prolonged periods of time.|percentage of glycosylated hemoglobin|Mean|9.09|9.09|Standard Deviation|0.99|0.99|||
4095859|NCT00985712|3919832|B2|||Hemoglobin A1c (HbA1c)|HbA1c is a form of hemoglobin which is measured primarily to identify the average plasma glucose concentration over prolonged periods of time.|percentage of glycosylated hemoglobin|Mean|9.12|9.12|Standard Deviation|1.04|1.04|||
4095860|NCT00985712|3919833|B1|||Hemoglobin A1c (HbA1c)|HbA1c is a form of hemoglobin which is measured primarily to identify the average plasma glucose concentration over prolonged periods of time.|percentage of glycosylated hemoglobin|Mean|9.06|9.06|Standard Deviation|0.93|0.93|||
4095861|NCT00985712|3919831|B3|Germany||Region of Enrollment||participants|Number|257|257.0||||||
4095862|NCT00985712|3919832|B2|Germany||Region of Enrollment||participants|Number|129|129.0||||||
4095863|NCT00985712|3919833|B1|Germany||Region of Enrollment||participants|Number|128|128.0||||||
4095864|NCT00985712|3919831|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4095865|NCT00985712|3919832|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4095866|NCT00985712|3919833|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4095867|NCT00985712|3919831|B3|White||Race/Ethnicity, Customized||participants|Number|255|255.0||||||
4095868|NCT00985712|3919832|B2|White||Race/Ethnicity, Customized||participants|Number|128|128.0||||||
4095869|NCT00985712|3919833|B1|White||Race/Ethnicity, Customized||participants|Number|127|127.0||||||
4095870|NCT00985712|3919831|B3||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4095871|NCT00985712|3919832|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4095872|NCT00985712|3919833|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4095873|NCT00985712|3919831|B3||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4095874|NCT00985712|3919832|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4095875|NCT00985712|3919833|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4095876|NCT00985712|3919831|B3|||Age||years|Mean|39.8|39.8|Standard Deviation|16.5|16.5|||
4095877|NCT00985712|3919832|B2|||Age||years|Mean|38.3|38.3|Standard Deviation|17.37|17.37|||
4095878|NCT00985712|3919833|B1|||Age||years|Mean|41.2|41.2|Standard Deviation|15.52|15.52|||
4095879|NCT00985686|3919848|B5|Other||Living situation||participants|Number|7|7.0||||||
4095880|NCT00985686|3919849|B4|Other||Living situation||participants|Number|2|2.0||||||
4095881|NCT00985686|3919850|B3|Other||Living situation||participants|Number|2|2.0||||||
4095882|NCT00985686|3919851|B2|Other||Living situation||participants|Number|0|0.0||||||
4095883|NCT00985686|3919852|B1|Other||Living situation||participants|Number|3|3.0||||||
4095884|NCT00985686|3919848|B5|Alone||Living situation||participants|Number|2|2.0||||||
4095885|NCT00985686|3919849|B4|Alone||Living situation||participants|Number|1|1.0||||||
4095886|NCT00985686|3919850|B3|Alone||Living situation||participants|Number|0|0.0||||||
4095887|NCT00985686|3919851|B2|Alone||Living situation||participants|Number|1|1.0||||||
4095888|NCT00985686|3919852|B1|Alone||Living situation||participants|Number|0|0.0||||||
4095889|NCT00985686|3919848|B5|Roommate||Living situation||participants|Number|2|2.0||||||
4095890|NCT00985686|3919849|B4|Roommate||Living situation||participants|Number|0|0.0||||||
4095891|NCT00985686|3919850|B3|Roommate||Living situation||participants|Number|0|0.0||||||
4095892|NCT00985686|3919851|B2|Roommate||Living situation||participants|Number|2|2.0||||||
4095893|NCT00985686|3919852|B1|Roommate||Living situation||participants|Number|0|0.0||||||
4095894|NCT00985686|3919848|B5|Partner||Living situation||participants|Number|1|1.0||||||
4095895|NCT00985686|3919849|B4|Partner||Living situation||participants|Number|0|0.0||||||
4095896|NCT00985686|3919850|B3|Partner||Living situation||participants|Number|0|0.0||||||
4095897|NCT00985686|3919851|B2|Partner||Living situation||participants|Number|1|1.0||||||
4095898|NCT00985686|3919852|B1|Partner||Living situation||participants|Number|0|0.0||||||
4095899|NCT00985686|3919848|B5|One parent||Living situation||participants|Number|17|17.0||||||
4095900|NCT00985686|3919849|B4|One parent||Living situation||participants|Number|3|3.0||||||
4095901|NCT00985686|3919850|B3|One parent||Living situation||participants|Number|3|3.0||||||
4095902|NCT00985686|3919851|B2|One parent||Living situation||participants|Number|3|3.0||||||
4095903|NCT00985686|3919852|B1|One parent||Living situation||participants|Number|8|8.0||||||
4095904|NCT00985686|3919848|B5|With both parents||Living situation||participants|Number|33|33.0||||||
4095905|NCT00985686|3919849|B4|With both parents||Living situation||participants|Number|10|10.0||||||
4095906|NCT00985686|3919850|B3|With both parents||Living situation||participants|Number|8|8.0||||||
4095907|NCT00985686|3919851|B2|With both parents||Living situation||participants|Number|8|8.0||||||
4095908|NCT00985686|3919852|B1|With both parents||Living situation||participants|Number|7|7.0||||||
4095909|NCT00985686|3919848|B5|Not Working||Work situation||participants|Number|36|36.0||||||
4095910|NCT00985686|3919849|B4|Not Working||Work situation||participants|Number|6|6.0||||||
4095911|NCT00985686|3919850|B3|Not Working||Work situation||participants|Number|10|10.0||||||
4095912|NCT00985686|3919851|B2|Not Working||Work situation||participants|Number|7|7.0||||||
4095913|NCT00985686|3919852|B1|Not Working||Work situation||participants|Number|13|13.0||||||
4095914|NCT00985686|3919848|B5|Working||Work situation||participants|Number|26|26.0||||||
4095915|NCT00985686|3919849|B4|Working||Work situation||participants|Number|10|10.0||||||
4095916|NCT00985686|3919850|B3|Working||Work situation||participants|Number|3|3.0||||||
4095917|NCT00985686|3919851|B2|Working||Work situation||participants|Number|8|8.0||||||
4095918|NCT00985686|3919852|B1|Working||Work situation||participants|Number|5|5.0||||||
4095921|NCT00985686|3919850|B3|No||Religions denomination indicated||participants|Number|8|8.0||||||
4095922|NCT00985686|3919851|B2|No||Religions denomination indicated||participants|Number|9|9.0||||||
4095923|NCT00985686|3919852|B1|No||Religions denomination indicated||participants|Number|7|7.0||||||
4095924|NCT00985686|3919848|B5|Yes||Religions denomination indicated||participants|Number|30|30.0||||||
4095925|NCT00985686|3919849|B4|Yes||Religions denomination indicated||participants|Number|8|8.0||||||
4095926|NCT00985686|3919850|B3|Yes||Religions denomination indicated||participants|Number|5|5.0||||||
4095927|NCT00985686|3919851|B2|Yes||Religions denomination indicated||participants|Number|6|6.0||||||
4095928|NCT00985686|3919852|B1|Yes||Religions denomination indicated||participants|Number|11|11.0||||||
4095929|NCT00985686|3919848|B5|Not in School||Education||participants|Number|9|9.0||||||
4095930|NCT00985686|3919849|B4|Not in School||Education||participants|Number|2|2.0||||||
4095931|NCT00985686|3919850|B3|Not in School||Education||participants|Number|0|0.0||||||
4095932|NCT00985686|3919851|B2|Not in School||Education||participants|Number|5|5.0||||||
4095933|NCT00985686|3919852|B1|Not in School||Education||participants|Number|2|2.0||||||
4095934|NCT00985686|3919848|B5|Post Secondary Institution||Education||participants|Number|25|25.0||||||
4095935|NCT00985686|3919849|B4|Post Secondary Institution||Education||participants|Number|14|14.0||||||
4095936|NCT00985686|3919850|B3|Post Secondary Institution||Education||participants|Number|0|0.0||||||
4095937|NCT00985686|3919851|B2|Post Secondary Institution||Education||participants|Number|10|10.0||||||
4095938|NCT00985686|3919852|B1|Post Secondary Institution||Education||participants|Number|1|1.0||||||
4095939|NCT00985686|3919848|B5|High School||Education||participants|Number|28|28.0||||||
4095940|NCT00985686|3919849|B4|High School||Education||participants|Number|0|0.0||||||
4095941|NCT00985686|3919850|B3|High School||Education||participants|Number|13|13.0||||||
4095942|NCT00985686|3919851|B2|High School||Education||participants|Number|0|0.0||||||
4095943|NCT00985686|3919852|B1|High School||Education||participants|Number|15|15.0||||||
4095944|NCT00985686|3919848|B5|None||Use of other treatments during intervention phase||participants|Number|34|34.0||||||
4095945|NCT00985686|3919849|B4|None||Use of other treatments during intervention phase||participants|Number|10|10.0||||||
4095946|NCT00985686|3919850|B3|None||Use of other treatments during intervention phase||participants|Number|7|7.0||||||
4095947|NCT00985686|3919851|B2|None||Use of other treatments during intervention phase||participants|Number|6|6.0||||||
4095948|NCT00985686|3919852|B1|None||Use of other treatments during intervention phase||participants|Number|11|11.0||||||
4095949|NCT00985686|3919848|B5|Anti-depressants and Counselling||Use of other treatments during intervention phase||participants|Number|2|2.0||||||
4095950|NCT00985686|3919849|B4|Anti-depressants and Counselling||Use of other treatments during intervention phase||participants|Number|1|1.0||||||
4095951|NCT00985686|3919850|B3|Anti-depressants and Counselling||Use of other treatments during intervention phase||participants|Number|1|1.0||||||
4095952|NCT00985686|3919851|B2|Anti-depressants and Counselling||Use of other treatments during intervention phase||participants|Number|0|0.0||||||
4095953|NCT00985686|3919852|B1|Anti-depressants and Counselling||Use of other treatments during intervention phase||participants|Number|0|0.0||||||
4095954|NCT00985686|3919848|B5|Counselling only||Use of other treatments during intervention phase||participants|Number|16|16.0||||||
4095955|NCT00985686|3919849|B4|Counselling only||Use of other treatments during intervention phase||participants|Number|4|4.0||||||
4095956|NCT00985686|3919850|B3|Counselling only||Use of other treatments during intervention phase||participants|Number|3|3.0||||||
4095957|NCT00985686|3919851|B2|Counselling only||Use of other treatments during intervention phase||participants|Number|5|5.0||||||
4095958|NCT00985686|3919852|B1|Counselling only||Use of other treatments during intervention phase||participants|Number|4|4.0||||||
4095959|NCT00985686|3919848|B5|Anti-depressants only||Use of other treatments during intervention phase||participants|Number|10|10.0||||||
4095960|NCT00985686|3919849|B4|Anti-depressants only||Use of other treatments during intervention phase||participants|Number|1|1.0||||||
4095961|NCT00985686|3919850|B3|Anti-depressants only||Use of other treatments during intervention phase||participants|Number|2|2.0||||||
4095962|NCT00985686|3919851|B2|Anti-depressants only||Use of other treatments during intervention phase||participants|Number|4|4.0||||||
4095963|NCT00985686|3919852|B1|Anti-depressants only||Use of other treatments during intervention phase||participants|Number|3|3.0||||||
4095964|NCT00985686|3919848|B5|Canada||Region of Enrollment||participants|Number|62|62.0||||||
4095965|NCT00985686|3919849|B4|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4095966|NCT00985686|3919850|B3|Canada||Region of Enrollment||participants|Number|13|13.0||||||
4095967|NCT00985686|3919851|B2|Canada||Region of Enrollment||participants|Number|15|15.0||||||
4095968|NCT00985686|3919852|B1|Canada||Region of Enrollment||participants|Number|18|18.0||||||
4095969|NCT00985686|3919848|B5||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4095970|NCT00985686|3919849|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4095971|NCT00985686|3919850|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4095972|NCT00985686|3919851|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4095973|NCT00985686|3919852|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4095974|NCT00985686|3919848|B5||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4095975|NCT00985686|3919849|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4095976|NCT00985686|3919850|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4095977|NCT00985686|3919851|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4095978|NCT00985686|3919852|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4095979|NCT00985686|3919848|B5|||Age||years|Mean|18.1|18.1|Full Range|||13.0|24.0|
4095980|NCT00985686|3919849|B4|||Age||years|Mean|20.9|20.9|Full Range|||19.0|24.0|
4095981|NCT00985686|3919850|B3|||Age||years|Mean|15.2|15.2|Full Range|||13.0|17.0|
4095982|NCT00985686|3919851|B2|||Age||years|Mean|21.0|21.0|Full Range|||19.0|24.0|
4095983|NCT00985686|3919852|B1|||Age||years|Mean|15.3|15.3|Full Range|||13.0|18.0|
4095984|NCT00985673|3919863|B7||Male|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
4095985|NCT00985673|3919864|B6||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4095986|NCT00985673|3919865|B5||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4095987|NCT00985673|3919866|B4||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4095988|NCT00985673|3919867|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4095989|NCT00985673|3919868|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4095990|NCT00985673|3919869|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4095991|NCT00985673|3919863|B7||Female|Sex: Female, Male||Participants|Count of Participants|335|335.0||||||
4095992|NCT00985673|3919864|B6||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4095993|NCT00985673|3919865|B5||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4095994|NCT00985673|3919866|B4||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4095995|NCT00985673|3919867|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4095996|NCT00985673|3919868|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4095997|NCT00985673|3919869|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4095998|NCT00985673|3919863|B7|||Age||Years|Mean|28.9|28.9|Standard Deviation|6.2|6.2|||
4095999|NCT00985673|3919864|B6|||Age||Years|Mean|28.1|28.1|Standard Deviation|6.08|6.08|||
4096000|NCT00985673|3919865|B5|||Age||Years|Mean|29.3|29.3|Standard Deviation|6.47|6.47|||
4096001|NCT00985673|3919866|B4|||Age||Years|Mean|29.2|29.2|Standard Deviation|6.12|6.12|||
4096002|NCT00985673|3919867|B3|||Age||Years|Mean|28.2|28.2|Standard Deviation|6.32|6.32|||
4096003|NCT00985673|3919868|B2|||Age||Years|Mean|28.6|28.6|Standard Deviation|6.24|6.24|||
4096004|NCT00985673|3919869|B1|||Age||Years|Mean|29.7|29.7|Standard Deviation|6.20|6.2|||
4096005|NCT00985543|3920125|B1|United Kingdom||Region of Enrollment||participants|Number|22|22.0||||||
4096006|NCT00985543|3920125|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4096007|NCT00985543|3920125|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4096008|NCT00985543|3920125|B1|||Age||years|Mean|36|36.0|Standard Deviation|9.49|9.49|||
4096009|NCT00985543|3920125|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4096010|NCT00985543|3920125|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4096011|NCT00985543|3920125|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4096012|NCT00985504|3920134|B3|||Sheehan Disability Scale - Total Score (SDS Total)|The SDS is completed by the participant and is used to assess the effect of the participant's symptoms on their work/social/family life. Total scores range from 0 to 30 with higher values indicating greater disruption in the participant's work/social/family life.|units on a scale|Mean|14.98|14.98|Standard Deviation|6.58|6.58|||
4096013|NCT00985504|3920135|B2|||Sheehan Disability Scale - Total Score (SDS Total)|The SDS is completed by the participant and is used to assess the effect of the participant's symptoms on their work/social/family life. Total scores range from 0 to 30 with higher values indicating greater disruption in the participant's work/social/family life.|units on a scale|Mean|14.62|14.62|Standard Deviation|6.39|6.39|||
4096014|NCT00985504|3920136|B1|||Sheehan Disability Scale - Total Score (SDS Total)|The SDS is completed by the participant and is used to assess the effect of the participant's symptoms on their work/social/family life. Total scores range from 0 to 30 with higher values indicating greater disruption in the participant's work/social/family life.|units on a scale|Mean|15.32|15.32|Standard Deviation|6.76|6.76|||
4096015|NCT00985504|3920134|B3|||The Massachusetts General Hospital Cognitive and Physical functioning Questionnaire (MGH-CPFQ) Total|"The MGH-CPFQ is a 7-item participant-rated questionnaire evaluating the participant's cognitive and physical well-being during the past month. It assesses motivation, wakefulness, energy, focus, recall, word-finding difficulty, and mental acuity. Each of the 7 items is scored on a 6-point scale ranging from greater than normal (score of 1) to normal (score of 2), to totally absent (score of 6). Total scores range from 7 to 42. Higher scores indicate greater disease severity."|units on a scale|Mean|24.73|24.73|Standard Deviation|5.78|5.78|||
4096016|NCT00985504|3920135|B2|||The Massachusetts General Hospital Cognitive and Physical functioning Questionnaire (MGH-CPFQ) Total|"The MGH-CPFQ is a 7-item participant-rated questionnaire evaluating the participant's cognitive and physical well-being during the past month. It assesses motivation, wakefulness, energy, focus, recall, word-finding difficulty, and mental acuity. Each of the 7 items is scored on a 6-point scale ranging from greater than normal (score of 1) to normal (score of 2), to totally absent (score of 6). Total scores range from 7 to 42. Higher scores indicate greater disease severity."|units on a scale|Mean|24.69|24.69|Standard Deviation|5.83|5.83|||
4096017|NCT00985504|3920136|B1|||The Massachusetts General Hospital Cognitive and Physical functioning Questionnaire (MGH-CPFQ) Total|"The MGH-CPFQ is a 7-item participant-rated questionnaire evaluating the participant's cognitive and physical well-being during the past month. It assesses motivation, wakefulness, energy, focus, recall, word-finding difficulty, and mental acuity. Each of the 7 items is scored on a 6-point scale ranging from greater than normal (score of 1) to normal (score of 2), to totally absent (score of 6). Total scores range from 7 to 42. Higher scores indicate greater disease severity."|units on a scale|Mean|24.78|24.78|Standard Deviation|5.73|5.73|||
4096072|NCT00985504|3920134|B3|Black or African American||Race (NIH/OMB)|One participant selected 2 races. Therefore, the total number of participants in the race category will be larger than the number of participants in the baseline table.|participants|Number|1|1.0||||||
4096018|NCT00985504|3920134|B3|||Rothschild Scale for Antidepressant Tachyphylaxis (RSAT) Total Score|RSAT assesses symptoms of apathy or decreased motivation among depressed participants who have achieved symptomatic remission with antidepressant treatment and consists of 6 self-report items assessing energy level, motivation and interest, cognitive functioning, weight gain, sleep and sexual functioning, as well as affect. Each item score ranges from 0 to 4 with total scores ranging from 0 to 28. Higher scores indicate greater disease severity.|units on a scale|Mean|10.62|10.62|Standard Deviation|4.93|4.93|||
4096019|NCT00985504|3920135|B2|||Rothschild Scale for Antidepressant Tachyphylaxis (RSAT) Total Score|RSAT assesses symptoms of apathy or decreased motivation among depressed participants who have achieved symptomatic remission with antidepressant treatment and consists of 6 self-report items assessing energy level, motivation and interest, cognitive functioning, weight gain, sleep and sexual functioning, as well as affect. Each item score ranges from 0 to 4 with total scores ranging from 0 to 28. Higher scores indicate greater disease severity.|units on a scale|Mean|10.51|10.51|Standard Deviation|4.95|4.95|||
4096020|NCT00985504|3920136|B1|||Rothschild Scale for Antidepressant Tachyphylaxis (RSAT) Total Score|RSAT assesses symptoms of apathy or decreased motivation among depressed participants who have achieved symptomatic remission with antidepressant treatment and consists of 6 self-report items assessing energy level, motivation and interest, cognitive functioning, weight gain, sleep and sexual functioning, as well as affect. Each item score ranges from 0 to 4 with total scores ranging from 0 to 28. Higher scores indicate greater disease severity.|units on a scale|Mean|10.72|10.72|Standard Deviation|4.92|4.92|||
4096021|NCT00985504|3920134|B3|||Clinical Global Impressions of Severity Scale (CGI-S)|The CGI-S measures severity of illness at the time of assessment compared with start of treatment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill participants).|units on a scale|Mean|3.05|3.05|Standard Deviation|0.91|0.91|||
4096022|NCT00985504|3920135|B2|||Clinical Global Impressions of Severity Scale (CGI-S)|The CGI-S measures severity of illness at the time of assessment compared with start of treatment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill participants).|units on a scale|Mean|3.04|3.04|Standard Deviation|0.91|0.91|||
4096023|NCT00985504|3920136|B1|||Clinical Global Impressions of Severity Scale (CGI-S)|The CGI-S measures severity of illness at the time of assessment compared with start of treatment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill participants).|units on a scale|Mean|3.05|3.05|Standard Deviation|0.91|0.91|||
4096024|NCT00985504|3920134|B3|||Montgomery-Asberg Depression Rating Scale (MADRS) Item 8 Score|The MADRS Item 8 assesses participants' inability to feel, through evaluation of their interest in their surroundings or activities that normally give pleasure, as well as their ability to react with adequate emotion to circumstances or people. The score ranges from 0 (normal interest in the surroundings and in other people) to 6 (the experience of being emotionally paralyzed, inability to feel anger, grief or pleasure and a complete or even painful failure to feel for close relatives and friends).|units on a scale|Mean|1.82|1.82|Standard Deviation|1.13|1.13|||
4096025|NCT00985504|3920135|B2|||Montgomery-Asberg Depression Rating Scale (MADRS) Item 8 Score|The MADRS Item 8 assesses participants' inability to feel, through evaluation of their interest in their surroundings or activities that normally give pleasure, as well as their ability to react with adequate emotion to circumstances or people. The score ranges from 0 (normal interest in the surroundings and in other people) to 6 (the experience of being emotionally paralyzed, inability to feel anger, grief or pleasure and a complete or even painful failure to feel for close relatives and friends).|units on a scale|Mean|1.82|1.82|Standard Deviation|1.15|1.15|||
4096026|NCT00985504|3920136|B1|||Montgomery-Asberg Depression Rating Scale (MADRS) Item 8 Score|The MADRS Item 8 assesses participants' inability to feel, through evaluation of their interest in their surroundings or activities that normally give pleasure, as well as their ability to react with adequate emotion to circumstances or people. The score ranges from 0 (normal interest in the surroundings and in other people) to 6 (the experience of being emotionally paralyzed, inability to feel anger, grief or pleasure and a complete or even painful failure to feel for close relatives and friends).|units on a scale|Mean|1.82|1.82|Standard Deviation|1.10|1.1|||
4096027|NCT00985504|3920134|B3|||Montgomery-Asberg Depression Rating Scale (MADRS) Total Score|The MADRS is a rating scale for severity of depressive mood symptoms. The MADRS has a 10-item checklist. Items are rated on a scale of 0-6, for a total score range of 0 (low severity of depressive symptoms) to 60 (high severity of depressive symptoms).|units on a scale|Mean|10.43|10.43|Standard Deviation|3.59|3.59|||
4096028|NCT00985504|3920135|B2|||Montgomery-Asberg Depression Rating Scale (MADRS) Total Score|The MADRS is a rating scale for severity of depressive mood symptoms. The MADRS has a 10-item checklist. Items are rated on a scale of 0-6, for a total score range of 0 (low severity of depressive symptoms) to 60 (high severity of depressive symptoms).|units on a scale|Mean|10.29|10.29|Standard Deviation|3.68|3.68|||
4096029|NCT00985504|3920136|B1|||Montgomery-Asberg Depression Rating Scale (MADRS) Total Score|The MADRS is a rating scale for severity of depressive mood symptoms. The MADRS has a 10-item checklist. Items are rated on a scale of 0-6, for a total score range of 0 (low severity of depressive symptoms) to 60 (high severity of depressive symptoms).|units on a scale|Mean|10.57|10.57|Standard Deviation|3.49|3.49|||
4096030|NCT00985504|3920134|B3|||Apathy Evaluation Scale - Clinician Rated Version (AES-C) Total Score|The AES-C is a validated 18-item instrument used to assess cognitive, behavioral, emotional and other symptoms of apathy. Clinicians rate each item based on verbal and nonverbal information provided by the participant. Item scores range from 1 (not at all characteristic) to 4 (a lot characteristic). Total scores range from 18 to 72 where higher derived scores indicate more severe apathy.|units on a scale|Mean|46.31|46.31|Standard Deviation|7.97|7.97|||
4096031|NCT00985504|3920135|B2|||Apathy Evaluation Scale - Clinician Rated Version (AES-C) Total Score|The AES-C is a validated 18-item instrument used to assess cognitive, behavioral, emotional and other symptoms of apathy. Clinicians rate each item based on verbal and nonverbal information provided by the participant. Item scores range from 1 (not at all characteristic) to 4 (a lot characteristic). Total scores range from 18 to 72 where higher derived scores indicate more severe apathy.|units on a scale|Mean|46.34|46.34|Standard Deviation|8.14|8.14|||
4096073|NCT00985504|3920135|B2|Black or African American||Race (NIH/OMB)|One participant selected 2 races. Therefore, the total number of participants in the race category will be larger than the number of participants in the baseline table.|participants|Number|1|1.0||||||
4096032|NCT00985504|3920136|B1|||Apathy Evaluation Scale - Clinician Rated Version (AES-C) Total Score|The AES-C is a validated 18-item instrument used to assess cognitive, behavioral, emotional and other symptoms of apathy. Clinicians rate each item based on verbal and nonverbal information provided by the participant. Item scores range from 1 (not at all characteristic) to 4 (a lot characteristic). Total scores range from 18 to 72 where higher derived scores indicate more severe apathy.|units on a scale|Mean|46.28|46.28|Standard Deviation|7.82|7.82|||
4096033|NCT00985504|3920134|B3|No||Taking Escitalopram 3 Months Prior to Study Entry|Previous therapy status is defined as the number of participants who had taken escitalopram 3 months prior to study entry.|participants|Number|357|357.0||||||
4096034|NCT00985504|3920135|B2|No||Taking Escitalopram 3 Months Prior to Study Entry|Previous therapy status is defined as the number of participants who had taken escitalopram 3 months prior to study entry.|participants|Number|180|180.0||||||
4096035|NCT00985504|3920136|B1|No||Taking Escitalopram 3 Months Prior to Study Entry|Previous therapy status is defined as the number of participants who had taken escitalopram 3 months prior to study entry.|participants|Number|177|177.0||||||
4096036|NCT00985504|3920134|B3|Yes||Taking Escitalopram 3 Months Prior to Study Entry|Previous therapy status is defined as the number of participants who had taken escitalopram 3 months prior to study entry.|participants|Number|126|126.0||||||
4096037|NCT00985504|3920135|B2|Yes||Taking Escitalopram 3 Months Prior to Study Entry|Previous therapy status is defined as the number of participants who had taken escitalopram 3 months prior to study entry.|participants|Number|59|59.0||||||
4096038|NCT00985504|3920136|B1|Yes||Taking Escitalopram 3 Months Prior to Study Entry|Previous therapy status is defined as the number of participants who had taken escitalopram 3 months prior to study entry.|participants|Number|67|67.0||||||
4096039|NCT00985504|3920134|B3|Taiwan||Region of Enrollment||participants|Number|48|48.0||||||
4096040|NCT00985504|3920135|B2|Taiwan||Region of Enrollment||participants|Number|25|25.0||||||
4096041|NCT00985504|3920136|B1|Taiwan||Region of Enrollment||participants|Number|23|23.0||||||
4096042|NCT00985504|3920134|B3|Russian Federation||Region of Enrollment||participants|Number|48|48.0||||||
4096043|NCT00985504|3920135|B2|Russian Federation||Region of Enrollment||participants|Number|25|25.0||||||
4096044|NCT00985504|3920136|B1|Russian Federation||Region of Enrollment||participants|Number|23|23.0||||||
4096045|NCT00985504|3920134|B3|Mexico||Region of Enrollment||participants|Number|85|85.0||||||
4096046|NCT00985504|3920135|B2|Mexico||Region of Enrollment||participants|Number|43|43.0||||||
4096047|NCT00985504|3920136|B1|Mexico||Region of Enrollment||participants|Number|42|42.0||||||
4096048|NCT00985504|3920134|B3|Korea, Republic of||Region of Enrollment||participants|Number|33|33.0||||||
4096049|NCT00985504|3920135|B2|Korea, Republic of||Region of Enrollment||participants|Number|15|15.0||||||
4096050|NCT00985504|3920136|B1|Korea, Republic of||Region of Enrollment||participants|Number|18|18.0||||||
4096051|NCT00985504|3920134|B3|Italy||Region of Enrollment||participants|Number|45|45.0||||||
4096052|NCT00985504|3920135|B2|Italy||Region of Enrollment||participants|Number|22|22.0||||||
4096053|NCT00985504|3920136|B1|Italy||Region of Enrollment||participants|Number|23|23.0||||||
4096054|NCT00985504|3920134|B3|China||Region of Enrollment||participants|Number|88|88.0||||||
4096055|NCT00985504|3920135|B2|China||Region of Enrollment||participants|Number|41|41.0||||||
4096056|NCT00985504|3920136|B1|China||Region of Enrollment||participants|Number|47|47.0||||||
4096057|NCT00985504|3920134|B3|Canada||Region of Enrollment||participants|Number|87|87.0||||||
4096058|NCT00985504|3920135|B2|Canada||Region of Enrollment||participants|Number|43|43.0||||||
4096059|NCT00985504|3920136|B1|Canada||Region of Enrollment||participants|Number|44|44.0||||||
4096060|NCT00985504|3920134|B3|Australia||Region of Enrollment||participants|Number|49|49.0||||||
4096061|NCT00985504|3920135|B2|Australia||Region of Enrollment||participants|Number|25|25.0||||||
4096062|NCT00985504|3920136|B1|Australia||Region of Enrollment||participants|Number|24|24.0||||||
4096063|NCT00985504|3920134|B3|Unknown or Not Reported||Race (NIH/OMB)|One participant selected 2 races. Therefore, the total number of participants in the race category will be larger than the number of participants in the baseline table.|participants|Number|0|0.0||||||
4096064|NCT00985504|3920135|B2|Unknown or Not Reported||Race (NIH/OMB)|One participant selected 2 races. Therefore, the total number of participants in the race category will be larger than the number of participants in the baseline table.|participants|Number|0|0.0||||||
4096065|NCT00985504|3920136|B1|Unknown or Not Reported||Race (NIH/OMB)|One participant selected 2 races. Therefore, the total number of participants in the race category will be larger than the number of participants in the baseline table.|participants|Number|0|0.0||||||
4096066|NCT00985504|3920134|B3|More than one race||Race (NIH/OMB)|One participant selected 2 races. Therefore, the total number of participants in the race category will be larger than the number of participants in the baseline table.|participants|Number|1|1.0||||||
4096067|NCT00985504|3920135|B2|More than one race||Race (NIH/OMB)|One participant selected 2 races. Therefore, the total number of participants in the race category will be larger than the number of participants in the baseline table.|participants|Number|0|0.0||||||
4096068|NCT00985504|3920136|B1|More than one race||Race (NIH/OMB)|One participant selected 2 races. Therefore, the total number of participants in the race category will be larger than the number of participants in the baseline table.|participants|Number|1|1.0||||||
4096069|NCT00985504|3920134|B3|White||Race (NIH/OMB)|One participant selected 2 races. Therefore, the total number of participants in the race category will be larger than the number of participants in the baseline table.|participants|Number|239|239.0||||||
4096070|NCT00985504|3920135|B2|White||Race (NIH/OMB)|One participant selected 2 races. Therefore, the total number of participants in the race category will be larger than the number of participants in the baseline table.|participants|Number|119|119.0||||||
4096071|NCT00985504|3920136|B1|White||Race (NIH/OMB)|One participant selected 2 races. Therefore, the total number of participants in the race category will be larger than the number of participants in the baseline table.|participants|Number|120|120.0||||||
4096121|NCT00985439|3920198|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
4096122|NCT00985439|3920194|B5||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4096074|NCT00985504|3920136|B1|Black or African American||Race (NIH/OMB)|One participant selected 2 races. Therefore, the total number of participants in the race category will be larger than the number of participants in the baseline table.|participants|Number|0|0.0||||||
4096075|NCT00985504|3920134|B3|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|One participant selected 2 races. Therefore, the total number of participants in the race category will be larger than the number of participants in the baseline table.|participants|Number|1|1.0||||||
4096076|NCT00985504|3920135|B2|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|One participant selected 2 races. Therefore, the total number of participants in the race category will be larger than the number of participants in the baseline table.|participants|Number|0|0.0||||||
4096077|NCT00985504|3920136|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|One participant selected 2 races. Therefore, the total number of participants in the race category will be larger than the number of participants in the baseline table.|participants|Number|1|1.0||||||
4096078|NCT00985504|3920134|B3|Asian||Race (NIH/OMB)|One participant selected 2 races. Therefore, the total number of participants in the race category will be larger than the number of participants in the baseline table.|participants|Number|172|172.0||||||
4096079|NCT00985504|3920135|B2|Asian||Race (NIH/OMB)|One participant selected 2 races. Therefore, the total number of participants in the race category will be larger than the number of participants in the baseline table.|participants|Number|82|82.0||||||
4096080|NCT00985504|3920136|B1|Asian||Race (NIH/OMB)|One participant selected 2 races. Therefore, the total number of participants in the race category will be larger than the number of participants in the baseline table.|participants|Number|90|90.0||||||
4096081|NCT00985504|3920134|B3|American Indian or Alaska Native||Race (NIH/OMB)|One participant selected 2 races. Therefore, the total number of participants in the race category will be larger than the number of participants in the baseline table.|participants|Number|71|71.0||||||
4096082|NCT00985504|3920135|B2|American Indian or Alaska Native||Race (NIH/OMB)|One participant selected 2 races. Therefore, the total number of participants in the race category will be larger than the number of participants in the baseline table.|participants|Number|37|37.0||||||
4096083|NCT00985504|3920136|B1|American Indian or Alaska Native||Race (NIH/OMB)|One participant selected 2 races. Therefore, the total number of participants in the race category will be larger than the number of participants in the baseline table.|participants|Number|34|34.0||||||
4096084|NCT00985504|3920134|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096085|NCT00985504|3920135|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096086|NCT00985504|3920136|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096087|NCT00985504|3920134|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|394|394.0||||||
4096088|NCT00985504|3920135|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|195|195.0||||||
4096089|NCT00985504|3920136|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|199|199.0||||||
4096090|NCT00985504|3920134|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
4096091|NCT00985504|3920135|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4096092|NCT00985504|3920136|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4096093|NCT00985504|3920134|B3||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4096094|NCT00985504|3920135|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4096095|NCT00985504|3920136|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4096096|NCT00985504|3920134|B3||Female|Sex: Female, Male||Participants|Count of Participants|366|366.0||||||
4096097|NCT00985504|3920135|B2||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4096098|NCT00985504|3920136|B1||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4096099|NCT00985504|3920134|B3|||Age||years|Mean|44.54|44.54|Standard Deviation|13.35|13.35|||
4096100|NCT00985504|3920135|B2|||Age||years|Mean|44.93|44.93|Standard Deviation|12.89|12.89|||
4096101|NCT00985504|3920136|B1|||Age||years|Mean|44.15|44.15|Standard Deviation|13.81|13.81|||
4096102|NCT00985491|3920163|B1|||Baseline Weight||kg|Mean|110.3|110.3|Standard Deviation|18.52|18.52|||
4096103|NCT00985491|3920163|B1|||HbA1c||%|Mean|7.7|7.7|Standard Deviation|2.03|2.03|||
4096104|NCT00985491|3920163|B1|Chile||Region of Enrollment||participants|Number|43|43.0||||||
4096105|NCT00985491|3920163|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4096106|NCT00985491|3920163|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4096107|NCT00985491|3920163|B1|||Age||years|Mean|35.8|35.8|Standard Deviation|10.3|10.3|||
4096108|NCT00985465|3920168|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4096109|NCT00985465|3920169|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4096110|NCT00985465|3920170|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4096111|NCT00985465|3920168|B3||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4096112|NCT00985465|3920169|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4096113|NCT00985465|3920170|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4096114|NCT00985465|3920168|B3|||Age||Months|Mean|16.97|16.97|Standard Deviation|1.12|1.12|||
4096115|NCT00985465|3920169|B2|||Age||Months|Mean|16.9|16.9|Standard Deviation|1.16|1.16|||
4096116|NCT00985465|3920170|B1|||Age||Months|Mean|17|17.0|Standard Deviation|1.11|1.11|||
4096117|NCT00985439|3920194|B5|United States||Region of Enrollment||participants|Number|202|202.0||||||
4096118|NCT00985439|3920195|B4|United States||Region of Enrollment||participants|Number|51|51.0||||||
4096119|NCT00985439|3920196|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
4096120|NCT00985439|3920197|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
4096123|NCT00985439|3920195|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4096124|NCT00985439|3920196|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4096125|NCT00985439|3920197|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4096126|NCT00985439|3920198|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4096127|NCT00985439|3920194|B5||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4096128|NCT00985439|3920195|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4096129|NCT00985439|3920196|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4096130|NCT00985439|3920197|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4096131|NCT00985439|3920198|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4096132|NCT00985439|3920194|B5|||Age||years|Mean|22.4|22.4|Standard Deviation|4.32|4.32|||
4096133|NCT00985439|3920195|B4|||Age||years|Mean|22.6|22.6|Standard Deviation|4.22|4.22|||
4096134|NCT00985439|3920196|B3|||Age||years|Mean|22.7|22.7|Standard Deviation|3.30|3.3|||
4096135|NCT00985439|3920197|B2|||Age||years|Mean|22.3|22.3|Standard Deviation|4.58|4.58|||
4096136|NCT00985439|3920198|B1|||Age||years|Mean|22.1|22.1|Standard Deviation|5.10|5.1|||
4096137|NCT00985439|3920194|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4096138|NCT00985439|3920195|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4096139|NCT00985439|3920196|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4096140|NCT00985439|3920197|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4096141|NCT00985439|3920198|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4096142|NCT00985439|3920194|B5||Between 18 and 65 years|Age||Participants|Count of Participants|202|202.0||||||
4096143|NCT00985439|3920195|B4||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4096144|NCT00985439|3920196|B3||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4096145|NCT00985439|3920197|B2||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4096146|NCT00985439|3920198|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4096147|NCT00985439|3920194|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4096148|NCT00985439|3920195|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4096149|NCT00985439|3920196|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4096150|NCT00985439|3920197|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4096151|NCT00985439|3920198|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4096152|NCT00985257|3920211|B1|United States||Region of Enrollment||participants|Number|123|123.0||||||
4096153|NCT00985257|3920211|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4096154|NCT00985257|3920211|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4096155|NCT00985257|3920211|B1|Age 18 to 24 years||Age, Customized||participants|Number|52|52.0||||||
4096156|NCT00985257|3920211|B1|Age 13 to 17 years||Age, Customized||participants|Number|30|30.0||||||
4096157|NCT00985257|3920211|B1|Age 4-12 years||Age, Customized||participants|Number|41|41.0||||||
4096158|NCT00985231|3920215|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4096159|NCT00985231|3920216|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4096160|NCT00985231|3920217|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096161|NCT00985231|3920215|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096162|NCT00985231|3920216|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096163|NCT00985231|3920217|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096164|NCT00985231|3920215|B3||White|Race (NIH/OMB)||Participants|Count of Participants|214|214.0||||||
4096165|NCT00985231|3920216|B2||White|Race (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
4096166|NCT00985231|3920217|B1||White|Race (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
4096167|NCT00985231|3920215|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4096168|NCT00985231|3920216|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4096169|NCT00985231|3920217|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4096170|NCT00985231|3920215|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096171|NCT00985231|3920216|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096172|NCT00985231|3920217|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096173|NCT00985231|3920215|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4096174|NCT00985231|3920216|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4096175|NCT00985231|3920217|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4096176|NCT00985231|3920215|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4096177|NCT00985231|3920216|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4096178|NCT00985231|3920217|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4096179|NCT00985231|3920215|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4096180|NCT00985231|3920216|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4096181|NCT00985231|3920217|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4096182|NCT00985231|3920215|B3||Female|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4096183|NCT00985231|3920216|B2||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4096184|NCT00985231|3920217|B1||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4096185|NCT00985231|3920215|B3|36 -40 years of age||Age, Customized||participants|Number|130|130.0||||||
4096186|NCT00985231|3920216|B2|36 -40 years of age||Age, Customized||participants|Number|65|65.0||||||
4096187|NCT00985231|3920217|B1|36 -40 years of age||Age, Customized||participants|Number|65|65.0||||||
4096188|NCT00985231|3920215|B3|30-35 years of age||Age, Customized||participants|Number|135|135.0||||||
4096189|NCT00985231|3920216|B2|30-35 years of age||Age, Customized||participants|Number|67|67.0||||||
4096190|NCT00985231|3920217|B1|30-35 years of age||Age, Customized||participants|Number|68|68.0||||||
4096191|NCT00985192|3920226|B1|1||Eastern Cooperative Oncology Group (ECOG) score|"The ECOG score runs from 0 to 5, with 0 denoting perfect health and 5 death. Evaluation is made during examination by a Physician.~0 – Asymptomatic 1 – Symptomatic but completely ambulatory 2 – Symptomatic, <50% in bed during the day 3 – Symptomatic, >50% in bed, but not bedbound (Capable of only limited self-care, confined to bed or chair 50% or more of waking hours) 4 – Bedbound (Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair) 5 – Death"|participants|Number|30|30.0||||||
4096192|NCT00985192|3920226|B1|0||Eastern Cooperative Oncology Group (ECOG) score|"The ECOG score runs from 0 to 5, with 0 denoting perfect health and 5 death. Evaluation is made during examination by a Physician.~0 – Asymptomatic 1 – Symptomatic but completely ambulatory 2 – Symptomatic, <50% in bed during the day 3 – Symptomatic, >50% in bed, but not bedbound (Capable of only limited self-care, confined to bed or chair 50% or more of waking hours) 4 – Bedbound (Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair) 5 – Death"|participants|Number|15|15.0||||||
4096193|NCT00985192|3920226|B1|Esophagus||Disease Site||participants|Number|11|11.0||||||
4096194|NCT00985192|3920226|B1|Gastroesophageal Junction||Disease Site||participants|Number|13|13.0||||||
4096195|NCT00985192|3920226|B1|Gastric||Disease Site||participants|Number|21|21.0||||||
4096196|NCT00985192|3920226|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4096197|NCT00985192|3920226|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4096198|NCT00985192|3920226|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4096199|NCT00985192|3920226|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4096200|NCT00985192|3920226|B1|White||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4096201|NCT00985192|3920226|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4096202|NCT00985192|3920226|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4096203|NCT00985192|3920226|B1|||Age||years|Median|64|64.0|Full Range|||38.0|82.0|
4096204|NCT00985166|3920235|B4|Other||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4096205|NCT00985166|3920236|B3|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4096206|NCT00985166|3920237|B2|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4096207|NCT00985166|3920238|B1|Other||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4096208|NCT00985166|3920235|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4096209|NCT00985166|3920236|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4096210|NCT00985166|3920237|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4096211|NCT00985166|3920238|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4096212|NCT00985166|3920235|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|628|628.0||||||
4096213|NCT00985166|3920236|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|153|153.0||||||
4096214|NCT00985166|3920237|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|162|162.0||||||
4096215|NCT00985166|3920238|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|313|313.0||||||
4096216|NCT00985166|3920235|B4|Asian/Pacific||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4096217|NCT00985166|3920236|B3|Asian/Pacific||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4096218|NCT00985166|3920237|B2|Asian/Pacific||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4096219|NCT00985166|3920238|B1|Asian/Pacific||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4096220|NCT00985166|3920235|B4|African American||Race/Ethnicity, Customized||participants|Number|93|93.0||||||
4096221|NCT00985166|3920236|B3|African American||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4096222|NCT00985166|3920237|B2|African American||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4096223|NCT00985166|3920238|B1|African American||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4096224|NCT00985166|3920235|B4||Male|Sex: Female, Male||Participants|Count of Participants|426|426.0||||||
4096225|NCT00985166|3920236|B3||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4096226|NCT00985166|3920237|B2||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4096227|NCT00985166|3920238|B1||Male|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4096228|NCT00985166|3920235|B4||Female|Sex: Female, Male||Participants|Count of Participants|373|373.0||||||
4096229|NCT00985166|3920236|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4096230|NCT00985166|3920237|B2||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4096231|NCT00985166|3920238|B1||Female|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4096232|NCT00985166|3920235|B4|||Age||years|Mean|4.3|4.3|Standard Deviation|0.5|0.5|||
4096233|NCT00985166|3920236|B3|||Age||years|Mean|4.3|4.3|Standard Deviation|0.5|0.5|||
4096234|NCT00985166|3920237|B2|||Age||years|Mean|4.3|4.3|Standard Deviation|0.5|0.5|||
4096235|NCT00985166|3920238|B1|||Age||years|Mean|4.3|4.3|Standard Deviation|0.5|0.5|||
4096236|NCT00985153|3920256|B5|Other||Race/Ethnicity, Customized||participants|Number|187|187.0||||||
4096237|NCT00985153|3920257|B4|Other||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4096238|NCT00985153|3920258|B3|Other||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4096239|NCT00985153|3920259|B2|Other||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4096240|NCT00985153|3920260|B1|Other||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4096241|NCT00985153|3920256|B5|Native American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4096242|NCT00985153|3920257|B4|Native American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4096243|NCT00985153|3920258|B3|Native American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4096244|NCT00985153|3920259|B2|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4096245|NCT00985153|3920260|B1|Native American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4096246|NCT00985153|3920256|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|498|498.0||||||
4096247|NCT00985153|3920257|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|119|119.0||||||
4096248|NCT00985153|3920258|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|116|116.0||||||
4096249|NCT00985153|3920259|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|113|113.0||||||
4096250|NCT00985153|3920260|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|150|150.0||||||
4096251|NCT00985153|3920256|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|2514|2514.0||||||
4096252|NCT00985153|3920257|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|647|647.0||||||
4096253|NCT00985153|3920258|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|622|622.0||||||
4096254|NCT00985153|3920259|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|630|630.0||||||
4096255|NCT00985153|3920260|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|615|615.0||||||
4096256|NCT00985153|3920256|B5|Asian/Pacific||Race/Ethnicity, Customized||participants|Number|191|191.0||||||
4096257|NCT00985153|3920257|B4|Asian/Pacific||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4096258|NCT00985153|3920258|B3|Asian/Pacific||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4096259|NCT00985153|3920259|B2|Asian/Pacific||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
4096260|NCT00985153|3920260|B1|Asian/Pacific||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4096261|NCT00985153|3920256|B5|African American||Race/Ethnicity, Customized||participants|Number|528|528.0||||||
4096262|NCT00985153|3920257|B4|African American||Race/Ethnicity, Customized||participants|Number|150|150.0||||||
4096263|NCT00985153|3920258|B3|African American||Race/Ethnicity, Customized||participants|Number|136|136.0||||||
4096264|NCT00985153|3920259|B2|African American||Race/Ethnicity, Customized||participants|Number|122|122.0||||||
4096265|NCT00985153|3920260|B1|African American||Race/Ethnicity, Customized||participants|Number|120|120.0||||||
4096266|NCT00985153|3920256|B5||Male|Sex: Female, Male||Participants|Count of Participants|2091|2091.0||||||
4096267|NCT00985153|3920257|B4||Male|Sex: Female, Male||Participants|Count of Participants|544|544.0||||||
4096268|NCT00985153|3920258|B3||Male|Sex: Female, Male||Participants|Count of Participants|520|520.0||||||
4096269|NCT00985153|3920259|B2||Male|Sex: Female, Male||Participants|Count of Participants|520|520.0||||||
4096270|NCT00985153|3920260|B1||Male|Sex: Female, Male||Participants|Count of Participants|507|507.0||||||
4096271|NCT00985153|3920256|B5||Female|Sex: Female, Male||Participants|Count of Participants|1836|1836.0||||||
4096272|NCT00985153|3920257|B4||Female|Sex: Female, Male||Participants|Count of Participants|468|468.0||||||
4096273|NCT00985153|3920258|B3||Female|Sex: Female, Male||Participants|Count of Participants|442|442.0||||||
4096274|NCT00985153|3920259|B2||Female|Sex: Female, Male||Participants|Count of Participants|448|448.0||||||
4096275|NCT00985153|3920260|B1||Female|Sex: Female, Male||Participants|Count of Participants|478|478.0||||||
4096276|NCT00985153|3920256|B5|||Age||Months|Mean|12.7|12.7|Standard Deviation|1.4|1.4|||
4096277|NCT00985153|3920257|B4|||Age||Months|Mean|12.8|12.8|Standard Deviation|1.4|1.4|||
4096278|NCT00985153|3920258|B3|||Age||Months|Mean|12.7|12.7|Standard Deviation|1.3|1.3|||
4096279|NCT00985153|3920259|B2|||Age||Months|Mean|12.8|12.8|Standard Deviation|1.4|1.4|||
4096280|NCT00985153|3920260|B1|||Age||Months|Mean|12.7|12.7|Standard Deviation|1.3|1.3|||
4096281|NCT00985140|3920305|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4096282|NCT00985140|3920305|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4096283|NCT00985140|3920305|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4096284|NCT00985140|3920305|B1|||Age||years|Mean|61.4|61.4|Standard Deviation|15.2|15.2|||
4096285|NCT00985140|3920305|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4096286|NCT00985140|3920305|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4096287|NCT00985140|3920305|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4096288|NCT00985114|3920309|B3|||Baseline weight||kg|Mean|111.9|111.9|Standard Deviation|19.3|19.3|||
4096289|NCT00985114|3920310|B2|||Baseline weight||kg|Mean|113.5|113.5|Standard Deviation|19.3|19.3|||
4096290|NCT00985114|3920311|B1|||Baseline weight||kg|Mean|110.1|110.1|Standard Deviation|19.5|19.5|||
4096291|NCT00985114|3920309|B3|Netherlands||Region of Enrollment||participants|Number|73|73.0||||||
4096292|NCT00985114|3920310|B2|Netherlands||Region of Enrollment||participants|Number|39|39.0||||||
4096293|NCT00985114|3920311|B1|Netherlands||Region of Enrollment||participants|Number|34|34.0||||||
4096294|NCT00985114|3920309|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4096295|NCT00985114|3920310|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4096296|NCT00985114|3920311|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4096297|NCT00985114|3920309|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4096298|NCT00985114|3920310|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4096299|NCT00985114|3920311|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4096300|NCT00985114|3920309|B3|||Age||years|Mean|49.3|49.3|Standard Deviation|8.3|8.3|||
4096301|NCT00985114|3920310|B2|||Age||years|Mean|49.3|49.3|Standard Deviation|7.8|7.8|||
4096302|NCT00985114|3920311|B1|||Age||years|Mean|49.8|49.8|Standard Deviation|9.1|9.1|||
4096303|NCT00985088|3920318|B9|Geographic ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
4096304|NCT00985088|3920319|B8|Geographic ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4096305|NCT00985088|3920320|B7|Geographic ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4096306|NCT00985088|3920321|B6|Geographic ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4096307|NCT00985088|3920322|B5|Geographic ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4096308|NCT00985088|3920323|B4|Geographic ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4096309|NCT00985088|3920324|B3|Geographic ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4096310|NCT00985088|3920325|B2|Geographic ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4096311|NCT00985088|3920326|B1|Geographic ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4096312|NCT00985088|3920318|B9|Geographic ancestry|White - Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1191|1191.0||||||
4096313|NCT00985088|3920319|B8|Geographic ancestry|White - Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|196|196.0||||||
4096314|NCT00985088|3920320|B7|Geographic ancestry|White - Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|102|102.0||||||
4096315|NCT00985088|3920321|B6|Geographic ancestry|White - Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|98|98.0||||||
4096316|NCT00985088|3920322|B5|Geographic ancestry|White - Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|199|199.0||||||
4096317|NCT00985088|3920323|B4|Geographic ancestry|White - Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|192|192.0||||||
4096318|NCT00985088|3920324|B3|Geographic ancestry|White - Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|101|101.0||||||
4096319|NCT00985088|3920325|B2|Geographic ancestry|White - Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|102|102.0||||||
4096320|NCT00985088|3920326|B1|Geographic ancestry|White - Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|201|201.0||||||
4096321|NCT00985088|3920318|B9|Geographic ancestry|White - Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4096322|NCT00985088|3920319|B8|Geographic ancestry|White - Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4096323|NCT00985088|3920320|B7|Geographic ancestry|White - Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4096324|NCT00985088|3920321|B6|Geographic ancestry|White - Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4096325|NCT00985088|3920322|B5|Geographic ancestry|White - Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4096326|NCT00985088|3920323|B4|Geographic ancestry|White - Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4096327|NCT00985088|3920324|B3|Geographic ancestry|White - Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4096328|NCT00985088|3920325|B2|Geographic ancestry|White - Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4096329|NCT00985088|3920326|B1|Geographic ancestry|White - Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4096330|NCT00985088|3920318|B9|Geographic ancestry|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4096331|NCT00985088|3920319|B8|Geographic ancestry|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4096332|NCT00985088|3920320|B7|Geographic ancestry|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4096333|NCT00985088|3920321|B6|Geographic ancestry|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4096334|NCT00985088|3920322|B5|Geographic ancestry|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4096335|NCT00985088|3920323|B4|Geographic ancestry|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4096336|NCT00985088|3920324|B3|Geographic ancestry|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4096337|NCT00985088|3920325|B2|Geographic ancestry|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4096338|NCT00985088|3920326|B1|Geographic ancestry|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4096339|NCT00985088|3920318|B9|Geographic ancestry|Asian - South East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4096340|NCT00985088|3920319|B8|Geographic ancestry|Asian - South East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4096341|NCT00985088|3920320|B7|Geographic ancestry|Asian - South East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4096342|NCT00985088|3920321|B6|Geographic ancestry|Asian - South East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4096343|NCT00985088|3920322|B5|Geographic ancestry|Asian - South East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4096344|NCT00985088|3920323|B4|Geographic ancestry|Asian - South East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4096345|NCT00985088|3920324|B3|Geographic ancestry|Asian - South East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4096346|NCT00985088|3920325|B2|Geographic ancestry|Asian - South East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4096347|NCT00985088|3920326|B1|Geographic ancestry|Asian - South East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4096348|NCT00985088|3920318|B9|Geographic ancestry|Asian - Japanese heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4096349|NCT00985088|3920319|B8|Geographic ancestry|Asian - Japanese heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4096350|NCT00985088|3920320|B7|Geographic ancestry|Asian - Japanese heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4096351|NCT00985088|3920321|B6|Geographic ancestry|Asian - Japanese heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4096352|NCT00985088|3920322|B5|Geographic ancestry|Asian - Japanese heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4096353|NCT00985088|3920323|B4|Geographic ancestry|Asian - Japanese heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4096354|NCT00985088|3920324|B3|Geographic ancestry|Asian - Japanese heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4096355|NCT00985088|3920325|B2|Geographic ancestry|Asian - Japanese heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4096356|NCT00985088|3920326|B1|Geographic ancestry|Asian - Japanese heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4096357|NCT00985088|3920318|B9|Geographic ancestry|Asian - East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4096358|NCT00985088|3920319|B8|Geographic ancestry|Asian - East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4096359|NCT00985088|3920320|B7|Geographic ancestry|Asian - East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4096360|NCT00985088|3920321|B6|Geographic ancestry|Asian - East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4096361|NCT00985088|3920322|B5|Geographic ancestry|Asian - East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4096362|NCT00985088|3920323|B4|Geographic ancestry|Asian - East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4096363|NCT00985088|3920324|B3|Geographic ancestry|Asian - East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4096364|NCT00985088|3920325|B2|Geographic ancestry|Asian - East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4096365|NCT00985088|3920326|B1|Geographic ancestry|Asian - East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4096366|NCT00985088|3920318|B9|Geographic ancestry|Asian - Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4096367|NCT00985088|3920319|B8|Geographic ancestry|Asian - Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4096368|NCT00985088|3920320|B7|Geographic ancestry|Asian - Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4096369|NCT00985088|3920321|B6|Geographic ancestry|Asian - Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4096370|NCT00985088|3920322|B5|Geographic ancestry|Asian - Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4096371|NCT00985088|3920323|B4|Geographic ancestry|Asian - Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4096372|NCT00985088|3920324|B3|Geographic ancestry|Asian - Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4096373|NCT00985088|3920325|B2|Geographic ancestry|Asian - Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4096374|NCT00985088|3920326|B1|Geographic ancestry|Asian - Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4096375|NCT00985088|3920318|B9|Geographic ancestry|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4096376|NCT00985088|3920319|B8|Geographic ancestry|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4096377|NCT00985088|3920320|B7|Geographic ancestry|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4096378|NCT00985088|3920321|B6|Geographic ancestry|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4096379|NCT00985088|3920322|B5|Geographic ancestry|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4096380|NCT00985088|3920323|B4|Geographic ancestry|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4096381|NCT00985088|3920324|B3|Geographic ancestry|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4096382|NCT00985088|3920325|B2|Geographic ancestry|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4096383|NCT00985088|3920326|B1|Geographic ancestry|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4096384|NCT00985088|3920318|B9|Geographic ancestry|African heritage/ African American|Race/Ethnicity, Customized||Participants|Count of Participants|75|75.0||||||
4096385|NCT00985088|3920319|B8|Geographic ancestry|African heritage/ African American|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4096386|NCT00985088|3920320|B7|Geographic ancestry|African heritage/ African American|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4096387|NCT00985088|3920321|B6|Geographic ancestry|African heritage/ African American|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4096388|NCT00985088|3920322|B5|Geographic ancestry|African heritage/ African American|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4096389|NCT00985088|3920323|B4|Geographic ancestry|African heritage/ African American|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4096390|NCT00985088|3920324|B3|Geographic ancestry|African heritage/ African American|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4096391|NCT00985088|3920325|B2|Geographic ancestry|African heritage/ African American|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4096392|NCT00985088|3920326|B1|Geographic ancestry|African heritage/ African American|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4096393|NCT00985088|3920318|B9||Male|Sex: Female, Male||Participants|Count of Participants|524|524.0||||||
4096394|NCT00985088|3920319|B8||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4096395|NCT00985088|3920320|B7||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4096396|NCT00985088|3920321|B6||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4096397|NCT00985088|3920322|B5||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4096398|NCT00985088|3920323|B4||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4096399|NCT00985088|3920324|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4096400|NCT00985088|3920325|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4096401|NCT00985088|3920326|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4096402|NCT00985088|3920318|B9||Female|Sex: Female, Male||Participants|Count of Participants|816|816.0||||||
4096403|NCT00985088|3920319|B8||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4096404|NCT00985088|3920320|B7||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4096405|NCT00985088|3920321|B6||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4096406|NCT00985088|3920322|B5||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4096407|NCT00985088|3920323|B4||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4096408|NCT00985088|3920324|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4096409|NCT00985088|3920325|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4096410|NCT00985088|3920326|B1||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4096411|NCT00985088|3920318|B9|||Age||Years|Mean|58.7|58.7|Standard Deviation|17.8|17.8|||
4096412|NCT00985088|3920319|B8|||Age||Years|Mean|58.7|58.7|Standard Deviation|18.16|18.16|||
4096413|NCT00985088|3920320|B7|||Age||Years|Mean|58.8|58.8|Standard Deviation|17.55|17.55|||
4096414|NCT00985088|3920321|B6|||Age||Years|Mean|58.4|58.4|Standard Deviation|17.96|17.96|||
4096415|NCT00985088|3920322|B5|||Age||Years|Mean|58.7|58.7|Standard Deviation|17.59|17.59|||
4096416|NCT00985088|3920323|B4|||Age||Years|Mean|58.6|58.6|Standard Deviation|17.91|17.91|||
4096417|NCT00985088|3920324|B3|||Age||Years|Mean|59.3|59.3|Standard Deviation|17.71|17.71|||
4096418|NCT00985088|3920325|B2|||Age||Years|Mean|58.8|58.8|Standard Deviation|18.69|18.69|||
4096419|NCT00985088|3920326|B1|||Age||Years|Mean|58.4|58.4|Standard Deviation|17.37|17.37|||
4096420|NCT00985010|3920589|B3|||Blood levels of manganese|Blood levels of manganese in patients with encephalopathy when arriving at the Emergency Room|µg/L|Mean|23.05|23.05|Standard Deviation|10.72|10.72|||
4096421|NCT00985010|3920590|B2|||Blood levels of manganese|Blood levels of manganese in patients with encephalopathy when arriving at the Emergency Room|µg/L|Mean|18.5|18.5|Standard Deviation|10.22|10.22|||
4096422|NCT00985010|3920591|B1|||Blood levels of manganese|Blood levels of manganese in patients with encephalopathy when arriving at the Emergency Room|µg/L|Mean|28.75|28.75|Standard Deviation|9.47|9.47|||
4096423|NCT00985010|3920589|B3|||Baseline blood hemoglobin|Blood samples when arriving at the Emergency Room were used to measure hemoglobin|mg/dL|Mean|11.86|11.86|Standard Deviation|1.61|1.61|||
4096424|NCT00985010|3920590|B2|||Baseline blood hemoglobin|Blood samples when arriving at the Emergency Room were used to measure hemoglobin|mg/dL|Mean|12.14|12.14|Standard Deviation|1.77|1.77|||
4096425|NCT00985010|3920591|B1|||Baseline blood hemoglobin|Blood samples when arriving at the Emergency Room were used to measure hemoglobin|mg/dL|Mean|11.52|11.52|Standard Deviation|1.57|1.57|||
4096426|NCT00985010|3920589|B3|Mexico||Region of Enrollment||participants|Number|9|9.0||||||
4096427|NCT00985010|3920590|B2|Mexico||Region of Enrollment||participants|Number|5|5.0||||||
4096428|NCT00985010|3920591|B1|Mexico||Region of Enrollment||participants|Number|4|4.0||||||
4096429|NCT00985010|3920589|B3|>= 65 years||Sex/Gender, Customized||participants|Number|3|3.0||||||
4096430|NCT00985010|3920590|B2|>= 65 years||Sex/Gender, Customized||participants|Number|2|2.0||||||
4096431|NCT00985010|3920591|B1|>= 65 years||Sex/Gender, Customized||participants|Number|1|1.0||||||
4096432|NCT00985010|3920589|B3|Between 18 and 65 years||Sex/Gender, Customized||participants|Number|6|6.0||||||
4096433|NCT00985010|3920590|B2|Between 18 and 65 years||Sex/Gender, Customized||participants|Number|3|3.0||||||
4096434|NCT00985010|3920591|B1|Between 18 and 65 years||Sex/Gender, Customized||participants|Number|3|3.0||||||
4096435|NCT00985010|3920589|B3|||Age||years|Mean|59.88|59.88|Standard Deviation|9.29|9.29|||
4096436|NCT00985010|3920590|B2|||Age||years|Mean|63|63.0|Standard Deviation|10.02|10.02|||
4096437|NCT00985010|3920591|B1|||Age||years|Mean|56|56.0|Standard Deviation|7.74|7.74|||
4096438|NCT00985010|3920589|B3|>=65 years||Age||years|Mean|70.66|70.66|Standard Deviation|4.04|4.04|||
4096439|NCT00985010|3920590|B2|>=65 years||Age||years|Mean|72.5|72.5|Standard Deviation|3.53|3.53|||
4096440|NCT00985010|3920591|B1|>=65 years||Age||years|Mean|67|67.0|Standard Deviation|0|0.0|||
4096441|NCT00985010|3920589|B3|Between 18 and 65 years||Age||years|Mean|54.5|54.5|Standard Deviation|5.2|5.2|||
4096442|NCT00985010|3920590|B2|Between 18 and 65 years||Age||years|Mean|56.66|56.66|Standard Deviation|6.65|6.65|||
4096443|NCT00985010|3920591|B1|Between 18 and 65 years||Age||years|Mean|52.33|52.33|Standard Deviation|3.05|3.05|||
4096444|NCT00984867|3920600|B3|||Seated SBP in subjects with baseline seated SBP ≥130 mmHg||mmHg|Mean|139.85|139.85|Standard Deviation|8.279|8.279|||
4096445|NCT00984867|3920601|B2|||Seated SBP in subjects with baseline seated SBP ≥130 mmHg||mmHg|Mean|140.46|140.46|Standard Deviation|8.018|8.018|||
4096446|NCT00984867|3920602|B1|||Seated SBP in subjects with baseline seated SBP ≥130 mmHg||mmHg|Mean|139.30|139.3|Standard Deviation|8.507|8.507|||
4096447|NCT00984867|3920600|B3|||FPG||mg/dL|Mean|162.58|162.58|Standard Deviation|35.618|35.618|||
4096448|NCT00984867|3920601|B2|||FPG||mg/dL|Mean|162.19|162.19|Standard Deviation|36.825|36.825|||
4096449|NCT00984867|3920602|B1|||FPG||mg/dL|Mean|162.97|162.97|Standard Deviation|34.452|34.452|||
4096450|NCT00984867|3920600|B3|||Body weight||kg|Mean|90.12|90.12|Standard Deviation|21.259|21.259|||
4096451|NCT00984867|3920601|B2|||Body weight||kg|Mean|91.02|91.02|Standard Deviation|21.637|21.637|||
4096452|NCT00984867|3920602|B1|||Body weight||kg|Mean|89.23|89.23|Standard Deviation|20.887|20.887|||
4096453|NCT00984867|3920600|B3|||HbA1c||HbA1c [%]|Mean|7.93|7.93|Standard Deviation|0.792|0.792|||
4096454|NCT00984867|3920601|B2|||HbA1c||HbA1c [%]|Mean|7.90|7.9|Standard Deviation|0.806|0.806|||
4096455|NCT00984867|3920602|B1|||HbA1c||HbA1c [%]|Mean|7.97|7.97|Standard Deviation|0.778|0.778|||
4096456|NCT00984867|3920600|B3||Male|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4096457|NCT00984867|3920601|B2||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4096458|NCT00984867|3920602|B1||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4096459|NCT00984867|3920600|B3||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4096460|NCT00984867|3920601|B2||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4096461|NCT00984867|3920602|B1||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4096462|NCT00984867|3920600|B3|||Age||Years|Mean|54.9|54.9|Standard Deviation|10.30|10.3|||
4096463|NCT00984867|3920601|B2|||Age||Years|Mean|54.8|54.8|Standard Deviation|10.42|10.42|||
4096464|NCT00984867|3920602|B1|||Age||Years|Mean|55.0|55.0|Standard Deviation|10.20|10.2|||
4096465|NCT00984815|3920621|B1|United States||Region of Enrollment||participants|Number|86|86.0||||||
4096466|NCT00984815|3920621|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4096467|NCT00984815|3920621|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4096468|NCT00984815|3920621|B1|||Age||years|Mean|56.3|56.3|Standard Deviation|9.39|9.39|||
4096469|NCT00984815|3920621|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4096470|NCT00984815|3920621|B1||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
4096471|NCT00984815|3920621|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4096472|NCT00984698|3920628|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4096473|NCT00984698|3920629|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4096474|NCT00984698|3920630|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096475|NCT00984698|3920628|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4096476|NCT00984698|3920629|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4096477|NCT00984698|3920630|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4096478|NCT00984698|3920628|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4096479|NCT00984698|3920629|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4096480|NCT00984698|3920630|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4096481|NCT00984698|3920628|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4096482|NCT00984698|3920629|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4096483|NCT00984698|3920630|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4096484|NCT00984698|3920628|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4096485|NCT00984698|3920629|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4096486|NCT00984698|3920630|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4096487|NCT00984698|3920628|B3|||Age||years|Mean|48.42|48.42|Standard Deviation|13.51|13.51|||
4096488|NCT00984698|3920629|B2|||Age||years|Mean|51.46|51.46|Standard Deviation|12.60|12.6|||
4096489|NCT00984698|3920630|B1|||Age||years|Mean|45.24|45.24|Standard Deviation|13.99|13.99|||
4096490|NCT00984698|3920628|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4096491|NCT00984698|3920629|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4096492|NCT00984698|3920630|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4096493|NCT00984698|3920628|B3||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4096494|NCT00984698|3920629|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4096495|NCT00984698|3920630|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4096496|NCT00984698|3920628|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4096497|NCT00984698|3920629|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4096498|NCT00984698|3920630|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4096499|NCT00984659|3920639|B5|White||Race/Ethnicity, Customized||participants|Number|376|376.0||||||
4096500|NCT00984659|3920640|B4|White||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4096501|NCT00984659|3920641|B3|White||Race/Ethnicity, Customized||participants|Number|127|127.0||||||
4096502|NCT00984659|3920642|B2|White||Race/Ethnicity, Customized||participants|Number|140|140.0||||||
4096503|NCT00984659|3920643|B1|White||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
4096504|NCT00984659|3920639|B5|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4096505|NCT00984659|3920640|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4096506|NCT00984659|3920641|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4096507|NCT00984659|3920642|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4096508|NCT00984659|3920643|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4096509|NCT00984659|3920639|B5|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4096510|NCT00984659|3920640|B4|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4096511|NCT00984659|3920641|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4096512|NCT00984659|3920642|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4096513|NCT00984659|3920643|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4096514|NCT00984659|3920639|B5||Male|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
4096515|NCT00984659|3920640|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4096516|NCT00984659|3920641|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4096517|NCT00984659|3920642|B2||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4096518|NCT00984659|3920643|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4096519|NCT00984659|3920639|B5||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4096520|NCT00984659|3920640|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4096521|NCT00984659|3920641|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4096522|NCT00984659|3920642|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4096523|NCT00984659|3920643|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4096524|NCT00984659|3920639|B5|||Age||Years|Mean|61.1|61.1|Standard Deviation|9.65|9.65|||
4096525|NCT00984659|3920640|B4|||Age||Years|Mean|63.8|63.8|Standard Deviation|9.61|9.61|||
4096526|NCT00984659|3920641|B3|||Age||Years|Mean|60.2|60.2|Standard Deviation|9.45|9.45|||
4096527|NCT00984659|3920642|B2|||Age||Years|Mean|60.1|60.1|Standard Deviation|9.58|9.58|||
4096528|NCT00984659|3920643|B1|||Age||Years|Mean|62.8|62.8|Standard Deviation|9.82|9.82|||
4096529|NCT00984620|3920671|B3||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4096530|NCT00984620|3920672|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4096531|NCT00984620|3920673|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4096532|NCT00984620|3920671|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4096533|NCT00984620|3920672|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4096534|NCT00984620|3920673|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4096535|NCT00984620|3920671|B3|||Age||years|Mean|46.5|46.5|Standard Deviation|10.8|10.8|||
4096536|NCT00984620|3920672|B2|||Age||years|Mean|44.9|44.9|Standard Deviation|11.9|11.9|||
4096537|NCT00984620|3920673|B1|||Age||years|Mean|48.1|48.1|Standard Deviation|9.4|9.4|||
4096538|NCT00984594|3920710|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4096539|NCT00984594|3920711|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4096540|NCT00984594|3920712|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4096541|NCT00984594|3920710|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4096542|NCT00984594|3920711|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4096543|NCT00984594|3920712|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4096544|NCT00984594|3920710|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4096545|NCT00984594|3920711|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4096546|NCT00984594|3920712|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4096547|NCT00984594|3920710|B3|||Age||years|Mean|24.7|24.7|Standard Deviation|10.8|10.8|||
4096548|NCT00984594|3920711|B2|||Age||years|Mean|17|17.0|Standard Deviation|0|0.0|||
4096549|NCT00984594|3920712|B1|||Age||years|Mean|28.5|28.5|Standard Deviation|12.02|12.02|||
4096550|NCT00984594|3920710|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4096551|NCT00984594|3920711|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4096552|NCT00984594|3920712|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4096553|NCT00984594|3920710|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4096554|NCT00984594|3920711|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4096555|NCT00984594|3920712|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4096556|NCT00984594|3920710|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4096557|NCT00984594|3920711|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4096558|NCT00984594|3920712|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4096559|NCT00984568|3920727|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4096560|NCT00984568|3920728|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4096561|NCT00984568|3920729|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4096562|NCT00984568|3920727|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4096563|NCT00984568|3920728|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4096564|NCT00984568|3920729|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4096565|NCT00984568|3920727|B3|||Age||years|Mean|40.7|40.7|Standard Deviation|15.0|15.0|||
4096566|NCT00984568|3920728|B2|||Age||years|Mean|41.6|41.6|Standard Deviation|15.3|15.3|||
4096567|NCT00984568|3920729|B1|||Age||years|Mean|39.9|39.9|Standard Deviation|15.2|15.2|||
4096568|NCT00984542|3920738|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4096569|NCT00984542|3920738|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4096570|NCT00984542|3920738|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4096571|NCT00984542|3920738|B1|||Age||years|Mean|62|62.0|Standard Deviation|8|8.0|||
4096572|NCT00984542|3920738|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4096573|NCT00984542|3920738|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4096574|NCT00984542|3920738|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4096575|NCT00984490|3920746|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4096576|NCT00984490|3920746|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4096577|NCT00984490|3920746|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4096578|NCT00984490|3920746|B1|||Age||years|Mean|45|45.0|Standard Deviation|1|1.0|||
4096579|NCT00984490|3920746|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4096580|NCT00984490|3920746|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4096581|NCT00984490|3920746|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4096582|NCT00984334|3920751|B6|United Kingdom||Region of Enrollment||participants|Number|14|14.0||||||
4096583|NCT00984334|3920752|B5|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4096584|NCT00984334|3920753|B4|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4096585|NCT00984334|3920754|B3|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4096586|NCT00984334|3920755|B2|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4096587|NCT00984334|3920756|B1|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4096588|NCT00984334|3920751|B6|Germany||Region of Enrollment||participants|Number|26|26.0||||||
4096589|NCT00984334|3920752|B5|Germany||Region of Enrollment||participants|Number|8|8.0||||||
4096590|NCT00984334|3920753|B4|Germany||Region of Enrollment||participants|Number|5|5.0||||||
4096591|NCT00984334|3920754|B3|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4096592|NCT00984334|3920755|B2|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4096593|NCT00984334|3920756|B1|Germany||Region of Enrollment||participants|Number|5|5.0||||||
4096594|NCT00984334|3920751|B6||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4096595|NCT00984334|3920752|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4096596|NCT00984334|3920753|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4096597|NCT00984334|3920754|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4096598|NCT00984334|3920755|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4096599|NCT00984334|3920756|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4096600|NCT00984334|3920751|B6||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4096601|NCT00984334|3920752|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4096602|NCT00984334|3920753|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4096603|NCT00984334|3920754|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4096604|NCT00984334|3920755|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4096605|NCT00984334|3920756|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4096606|NCT00984334|3920751|B6|||Age||years|Mean|53.3|53.3|Standard Deviation|11.6|11.6|||
4096607|NCT00984334|3920752|B5|||Age||years|Mean|60.5|60.5|Standard Deviation|8.8|8.8|||
4096608|NCT00984334|3920753|B4|||Age||years|Mean|48.6|48.6|Standard Deviation|8.6|8.6|||
4096609|NCT00984334|3920754|B3|||Age||years|Mean|50.6|50.6|Standard Deviation|12.7|12.7|||
4096610|NCT00984334|3920755|B2|||Age||years|Mean|53.4|53.4|Standard Deviation|15.7|15.7|||
4096611|NCT00984334|3920756|B1|||Age||years|Mean|53.3|53.3|Standard Deviation|10.2|10.2|||
4096612|NCT00984334|3920751|B6||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4096613|NCT00984334|3920752|B5||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4096614|NCT00984334|3920753|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4096615|NCT00984334|3920754|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4096616|NCT00984334|3920755|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4096617|NCT00984334|3920756|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4096618|NCT00984334|3920751|B6||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4096619|NCT00984334|3920752|B5||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4096620|NCT00984334|3920753|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4096621|NCT00984334|3920754|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4096622|NCT00984334|3920755|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4096623|NCT00984334|3920756|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4096624|NCT00984334|3920751|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4096625|NCT00984334|3920752|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4096626|NCT00984334|3920753|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4096627|NCT00984334|3920754|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4096628|NCT00984334|3920755|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4096629|NCT00984334|3920756|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4096630|NCT00984308|3920772|B3||Male|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
4096631|NCT00984308|3920773|B2||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4096632|NCT00984308|3920774|B1||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4096633|NCT00984308|3920772|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4096634|NCT00984308|3920773|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4096635|NCT00984308|3920774|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4096636|NCT00984308|3920772|B3|||Age||years|Mean|70|70.0|Standard Deviation|10|10.0|||
4096637|NCT00984308|3920773|B2|||Age||years|Mean|70.2|70.2|Standard Deviation|10.1|10.1|||
4096638|NCT00984308|3920774|B1|||Age||years|Mean|69.7|69.7|Standard Deviation|10.4|10.4|||
4096639|NCT00984295|3920785|B4|Other||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
4096640|NCT00984295|3920786|B3|Other||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4096641|NCT00984295|3920787|B2|Other||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4096642|NCT00984295|3920788|B1|Other||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4096643|NCT00984295|3920785|B4|Native American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4096644|NCT00984295|3920786|B3|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4096645|NCT00984295|3920787|B2|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4096646|NCT00984295|3920788|B1|Native American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4096647|NCT00984295|3920785|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|84|84.0||||||
4096648|NCT00984295|3920786|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4096649|NCT00984295|3920787|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4096650|NCT00984295|3920788|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4096651|NCT00984295|3920785|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|1356|1356.0||||||
4096652|NCT00984295|3920786|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|342|342.0||||||
4096653|NCT00984295|3920787|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|336|336.0||||||
4096654|NCT00984295|3920788|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|678|678.0||||||
4096655|NCT00984295|3920785|B4|Asian/Pacific||Race/Ethnicity, Customized||participants|Number|214|214.0||||||
4096656|NCT00984295|3920786|B3|Asian/Pacific||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
4096657|NCT00984295|3920787|B2|Asian/Pacific||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
4096658|NCT00984295|3920788|B1|Asian/Pacific||Race/Ethnicity, Customized||participants|Number|103|103.0||||||
4096659|NCT00984295|3920785|B4|African American||Race/Ethnicity, Customized||participants|Number|195|195.0||||||
4096660|NCT00984295|3920786|B3|African American||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4096661|NCT00984295|3920787|B2|African American||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
4096662|NCT00984295|3920788|B1|African American||Race/Ethnicity, Customized||participants|Number|101|101.0||||||
4096663|NCT00984295|3920785|B4||Male|Sex: Female, Male||Participants|Count of Participants|1002|1002.0||||||
4096664|NCT00984295|3920786|B3||Male|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
4096665|NCT00984295|3920787|B2||Male|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
4096666|NCT00984295|3920788|B1||Male|Sex: Female, Male||Participants|Count of Participants|507|507.0||||||
4096667|NCT00984295|3920785|B4||Female|Sex: Female, Male||Participants|Count of Participants|911|911.0||||||
4096668|NCT00984295|3920786|B3||Female|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
4096669|NCT00984295|3920787|B2||Female|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4096670|NCT00984295|3920788|B1||Female|Sex: Female, Male||Participants|Count of Participants|442|442.0||||||
4096671|NCT00984295|3920785|B4|||Age||years|Mean|12.4|12.4|Standard Deviation|0.7|0.7|||
4096672|NCT00984295|3920786|B3|||Age||years|Mean|12.4|12.4|Standard Deviation|0.7|0.7|||
4096673|NCT00984295|3920787|B2|||Age||years|Mean|12.3|12.3|Standard Deviation|0.7|0.7|||
4096674|NCT00984295|3920788|B1|||Age||years|Mean|12.4|12.4|Standard Deviation|0.7|0.7|||
4096675|NCT00984282|3920855|B3|Bone||Site of target/nontarget lesions at baseline - organ class|Participants could have had more than one site.|Participants|Number|113|113.0||||||
4096676|NCT00984282|3920856|B2|Bone||Site of target/nontarget lesions at baseline - organ class|Participants could have had more than one site.|Participants|Number|56|56.0||||||
4096677|NCT00984282|3920857|B1|Bone||Site of target/nontarget lesions at baseline - organ class|Participants could have had more than one site.|Participants|Number|57|57.0||||||
4096678|NCT00984282|3920855|B3|Lymph node||Site of target/nontarget lesions at baseline - organ class|Participants could have had more than one site.|Participants|Number|214|214.0||||||
4096679|NCT00984282|3920856|B2|Lymph node||Site of target/nontarget lesions at baseline - organ class|Participants could have had more than one site.|Participants|Number|101|101.0||||||
4096680|NCT00984282|3920857|B1|Lymph node||Site of target/nontarget lesions at baseline - organ class|Participants could have had more than one site.|Participants|Number|113|113.0||||||
4096681|NCT00984282|3920855|B3|Lung||Site of target/nontarget lesions at baseline - organ class|Participants could have had more than one site.|Participants|Number|359|359.0||||||
4096682|NCT00984282|3920856|B2|Lung||Site of target/nontarget lesions at baseline - organ class|Participants could have had more than one site.|Participants|Number|181|181.0||||||
4096683|NCT00984282|3920857|B1|Lung||Site of target/nontarget lesions at baseline - organ class|Participants could have had more than one site.|Participants|Number|178|178.0||||||
4096684|NCT00984282|3920855|B3||2|ECOG (Eastern Cooperative Oncology Group) performance status|The ECOG PS required for the study was 0 (fully active), 1 (restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature), or 2 (ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours)|Participants|Count of Participants|13|13.0||||||
4096685|NCT00984282|3920856|B2||2|ECOG (Eastern Cooperative Oncology Group) performance status|The ECOG PS required for the study was 0 (fully active), 1 (restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature), or 2 (ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours)|Participants|Count of Participants|6|6.0||||||
4096686|NCT00984282|3920857|B1||2|ECOG (Eastern Cooperative Oncology Group) performance status|The ECOG PS required for the study was 0 (fully active), 1 (restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature), or 2 (ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours)|Participants|Count of Participants|7|7.0||||||
4096687|NCT00984282|3920855|B3||1|ECOG (Eastern Cooperative Oncology Group) performance status|The ECOG PS required for the study was 0 (fully active), 1 (restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature), or 2 (ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours)|Participants|Count of Participants|143|143.0||||||
4096688|NCT00984282|3920856|B2||1|ECOG (Eastern Cooperative Oncology Group) performance status|The ECOG PS required for the study was 0 (fully active), 1 (restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature), or 2 (ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours)|Participants|Count of Participants|74|74.0||||||
4096689|NCT00984282|3920857|B1||1|ECOG (Eastern Cooperative Oncology Group) performance status|The ECOG PS required for the study was 0 (fully active), 1 (restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature), or 2 (ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours)|Participants|Count of Participants|69|69.0||||||
4096690|NCT00984282|3920855|B3||0|ECOG (Eastern Cooperative Oncology Group) performance status|The ECOG PS required for the study was 0 (fully active), 1 (restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature), or 2 (ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours)|Participants|Count of Participants|259|259.0||||||
4096691|NCT00984282|3920856|B2||0|ECOG (Eastern Cooperative Oncology Group) performance status|The ECOG PS required for the study was 0 (fully active), 1 (restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature), or 2 (ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours)|Participants|Count of Participants|129|129.0||||||
4096692|NCT00984282|3920857|B1||0|ECOG (Eastern Cooperative Oncology Group) performance status|The ECOG PS required for the study was 0 (fully active), 1 (restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature), or 2 (ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours)|Participants|Count of Participants|130|130.0||||||
4096693|NCT00984282|3920855|B3||Missing|ECOG (Eastern Cooperative Oncology Group) performance status|The ECOG PS required for the study was 0 (fully active), 1 (restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature), or 2 (ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours)|Participants|Count of Participants|2|2.0||||||
4096694|NCT00984282|3920856|B2||Missing|ECOG (Eastern Cooperative Oncology Group) performance status|The ECOG PS required for the study was 0 (fully active), 1 (restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature), or 2 (ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours)|Participants|Count of Participants|1|1.0||||||
4096695|NCT00984282|3920857|B1||Missing|ECOG (Eastern Cooperative Oncology Group) performance status|The ECOG PS required for the study was 0 (fully active), 1 (restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature), or 2 (ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours)|Participants|Count of Participants|1|1.0||||||
4096696|NCT00984282|3920855|B3||Asia|Geographic region||Participants|Count of Participants|96|96.0||||||
4096697|NCT00984282|3920856|B2||Asia|Geographic region||Participants|Count of Participants|49|49.0||||||
4096698|NCT00984282|3920857|B1||Asia|Geographic region||Participants|Count of Participants|47|47.0||||||
4096699|NCT00984282|3920855|B3||North America|Geographic region||Participants|Count of Participants|72|72.0||||||
4096700|NCT00984282|3920856|B2||North America|Geographic region||Participants|Count of Participants|36|36.0||||||
4096701|NCT00984282|3920857|B1||North America|Geographic region||Participants|Count of Participants|36|36.0||||||
4096702|NCT00984282|3920855|B3||Europe|Geographic region||Participants|Count of Participants|249|249.0||||||
4096703|NCT00984282|3920856|B2||Europe|Geographic region||Participants|Count of Participants|125|125.0||||||
4096704|NCT00984282|3920857|B1||Europe|Geographic region||Participants|Count of Participants|124|124.0||||||
4096705|NCT00984282|3920855|B3||Male|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4096706|NCT00984282|3920856|B2||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4096707|NCT00984282|3920857|B1||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4096708|NCT00984282|3920855|B3||Female|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4096709|NCT00984282|3920856|B2||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4096710|NCT00984282|3920857|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4096711|NCT00984282|3920855|B3||>= 60 years|Age, Customized||Participants|Count of Participants|256|256.0||||||
4096712|NCT00984282|3920856|B2||>= 60 years|Age, Customized||Participants|Count of Participants|129|129.0||||||
4096713|NCT00984282|3920857|B1||>= 60 years|Age, Customized||Participants|Count of Participants|127|127.0||||||
4096714|NCT00984282|3920855|B3||< 60 years|Age, Customized||Participants|Count of Participants|161|161.0||||||
4096715|NCT00984282|3920856|B2||< 60 years|Age, Customized||Participants|Count of Participants|81|81.0||||||
4096716|NCT00984282|3920857|B1||< 60 years|Age, Customized||Participants|Count of Participants|80|80.0||||||
4096717|NCT00984282|3920855|B3|||Age||Years|Mean|61.8|61.8|Standard Deviation|11.4|11.4|||
4096718|NCT00984282|3920856|B2|||Age||Years|Mean|62.0|62.0|Standard Deviation|11.7|11.7|||
4096719|NCT00984282|3920857|B1|||Age||Years|Mean|61.5|61.5|Standard Deviation|11.2|11.2|||
4096720|NCT00984256|3920879|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
4096721|NCT00984256|3920880|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4096722|NCT00984256|3920881|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4096723|NCT00984256|3920879|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4096724|NCT00984256|3920880|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4096725|NCT00984256|3920881|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4096726|NCT00984256|3920879|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4096727|NCT00984256|3920880|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4096728|NCT00984256|3920881|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4096729|NCT00984256|3920879|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4096730|NCT00984256|3920880|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4096731|NCT00984256|3920881|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4096732|NCT00984256|3920879|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4096733|NCT00984256|3920880|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4096734|NCT00984256|3920881|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4096735|NCT00984256|3920879|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4096736|NCT00984256|3920880|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4096737|NCT00984256|3920881|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4096738|NCT00984204|3920902|B1|Canada||Region of Enrollment||participants|Number|26|26.0||||||
4096739|NCT00984204|3920902|B1|United States||Region of Enrollment||participants|Number|162|162.0||||||
4096740|NCT00984204|3920902|B1||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4096741|NCT00984204|3920902|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4096742|NCT00984204|3920902|B1|||Age||years|Mean|66.47|66.47|Standard Deviation|11.16|11.16|||
4096743|NCT00984204|3920902|B1||>=65 years|Age||Participants|Count of Participants|111|111.0||||||
4096744|NCT00984204|3920902|B1||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
4096745|NCT00984204|3920902|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4096746|NCT00984165|3920908|B5|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4096747|NCT00984165|3920909|B4|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4096748|NCT00984165|3920910|B3|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4096749|NCT00984165|3920911|B2|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4096750|NCT00984165|3920912|B1|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4096751|NCT00984165|3920908|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096752|NCT00984165|3920909|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096753|NCT00984165|3920910|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096754|NCT00984165|3920911|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096755|NCT00984165|3920912|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096756|NCT00984165|3920908|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096757|NCT00984165|3920909|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096758|NCT00984165|3920910|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096759|NCT00984165|3920911|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096760|NCT00984165|3920912|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096761|NCT00984165|3920908|B5||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4096762|NCT00984165|3920909|B4||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4096763|NCT00984165|3920910|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4096764|NCT00984165|3920911|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4096765|NCT00984165|3920912|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4096766|NCT00984165|3920908|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096767|NCT00984165|3920909|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096768|NCT00984165|3920910|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096769|NCT00984165|3920911|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096770|NCT00984165|3920912|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096771|NCT00984165|3920908|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096772|NCT00984165|3920909|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096773|NCT00984165|3920910|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096774|NCT00984165|3920911|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096775|NCT00984165|3920912|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096776|NCT00984165|3920908|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096777|NCT00984165|3920909|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096778|NCT00984165|3920910|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096779|NCT00984165|3920911|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096780|NCT00984165|3920912|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096781|NCT00984165|3920908|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096782|NCT00984165|3920909|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096783|NCT00984165|3920910|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096784|NCT00984165|3920911|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096785|NCT00984165|3920912|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096786|NCT00984165|3920908|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096787|NCT00984165|3920909|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096788|NCT00984165|3920910|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096789|NCT00984165|3920911|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096790|NCT00984165|3920912|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096791|NCT00984165|3920908|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4096792|NCT00984165|3920909|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4096793|NCT00984165|3920910|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4096794|NCT00984165|3920911|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4096795|NCT00984165|3920912|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4096796|NCT00984165|3920908|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4096797|NCT00984165|3920909|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096798|NCT00984165|3920910|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096799|NCT00984165|3920911|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096800|NCT00984165|3920912|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4096801|NCT00984165|3920908|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4096802|NCT00984165|3920909|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4096803|NCT00984165|3920910|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4096804|NCT00984165|3920911|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4096805|NCT00984165|3920912|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4096806|NCT00984165|3920908|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4096807|NCT00984165|3920909|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4096808|NCT00984165|3920910|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4096809|NCT00984165|3920911|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4096810|NCT00984165|3920912|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4096811|NCT00984165|3920908|B5|||Age||years|Mean|36.15|36.15|Standard Deviation|0.01|0.01|||
4096812|NCT00984165|3920909|B4|||Age||years|Mean|34.83|34.83|Standard Deviation|3.97|3.97|||
4096813|NCT00984165|3920910|B3|||Age||years|Mean|29.5|29.5|Standard Deviation|3.41|3.41|||
4096814|NCT00984165|3920911|B2|||Age||years|Mean|33.5|33.5|Standard Deviation|0|0.0|||
4096815|NCT00984165|3920912|B1|||Age||years|Mean|46.78|46.78|Standard Deviation|14.84|14.84|||
4096816|NCT00984165|3920908|B5||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4096817|NCT00984165|3920909|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4096818|NCT00984165|3920910|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4096819|NCT00984165|3920911|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4096820|NCT00984165|3920912|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4096821|NCT00984165|3920908|B5||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4096822|NCT00984165|3920909|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4096823|NCT00984165|3920910|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4096824|NCT00984165|3920911|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4096825|NCT00984165|3920912|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4096826|NCT00984165|3920908|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4096827|NCT00984165|3920909|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4096828|NCT00984165|3920910|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4096829|NCT00984165|3920911|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4096830|NCT00984165|3920912|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4096831|NCT00984139|3920928|B1||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4096832|NCT00984139|3920928|B1||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4096833|NCT00984139|3920928|B1|||Age||Years|Mean|12.4|12.4|Standard Deviation|0.49|0.49|||
4096834|NCT00984126|3920940|B5||Male|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
4096835|NCT00984126|3920941|B4||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4096836|NCT00984126|3920942|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4096837|NCT00984126|3920943|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4096838|NCT00984126|3920944|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4096839|NCT00984126|3920940|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4096840|NCT00984126|3920941|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4096841|NCT00984126|3920942|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4096842|NCT00984126|3920943|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4096843|NCT00984126|3920944|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4096844|NCT00984126|3920940|B5|Adults (≥18 Years)||Age, Customized||participants|Number|135|135.0||||||
4096845|NCT00984126|3920941|B4|Adults (≥18 Years)||Age, Customized||participants|Number|135|135.0||||||
4096846|NCT00984126|3920942|B3|Adults (≥18 Years)||Age, Customized||participants|Number|0|0.0||||||
4096847|NCT00984126|3920943|B2|Adults (≥18 Years)||Age, Customized||participants|Number|0|0.0||||||
4096848|NCT00984126|3920944|B1|Adults (≥18 Years)||Age, Customized||participants|Number|0|0.0||||||
4096849|NCT00984126|3920940|B5|Adolescents (12 - <18 Years)||Age, Customized||participants|Number|23|23.0||||||
4096850|NCT00984126|3920941|B4|Adolescents (12 - <18 Years)||Age, Customized||participants|Number|0|0.0||||||
4096851|NCT00984126|3920942|B3|Adolescents (12 - <18 Years)||Age, Customized||participants|Number|23|23.0||||||
4096852|NCT00984126|3920943|B2|Adolescents (12 - <18 Years)||Age, Customized||participants|Number|0|0.0||||||
4096853|NCT00984126|3920944|B1|Adolescents (12 - <18 Years)||Age, Customized||participants|Number|0|0.0||||||
4096854|NCT00984126|3920940|B5|Older children (6 - <12 Years)||Age, Customized||participants|Number|28|28.0||||||
4096855|NCT00984126|3920941|B4|Older children (6 - <12 Years)||Age, Customized||participants|Number|0|0.0||||||
4096856|NCT00984126|3920942|B3|Older children (6 - <12 Years)||Age, Customized||participants|Number|0|0.0||||||
4096857|NCT00984126|3920943|B2|Older children (6 - <12 Years)||Age, Customized||participants|Number|28|28.0||||||
4096858|NCT00984126|3920944|B1|Older children (6 - <12 Years)||Age, Customized||participants|Number|0|0.0||||||
4096859|NCT00984126|3920940|B5|Small children (0 - <6 years)||Age, Customized||participants|Number|27|27.0||||||
4096860|NCT00984126|3920941|B4|Small children (0 - <6 years)||Age, Customized||participants|Number|0|0.0||||||
4096861|NCT00984126|3920942|B3|Small children (0 - <6 years)||Age, Customized||participants|Number|0|0.0||||||
4096862|NCT00984126|3920943|B2|Small children (0 - <6 years)||Age, Customized||participants|Number|0|0.0||||||
4096863|NCT00984126|3920944|B1|Small children (0 - <6 years)||Age, Customized||participants|Number|27|27.0||||||
4096864|NCT00984126|3920940|B5|||Age||years|Mean|23.6|23.6|Standard Deviation|14.6|14.6|||
4096865|NCT00984126|3920941|B4|||Age||years|Mean|32.0|32.0|Standard Deviation|11.5|11.5|||
4096866|NCT00984126|3920942|B3|||Age||years|Mean|14.9|14.9|Standard Deviation|1.7|1.7|||
4096867|NCT00984126|3920943|B2|||Age||years|Mean|9.0|9.0|Standard Deviation|1.8|1.8|||
4096868|NCT00984126|3920944|B1|||Age||years|Mean|4.6|4.6|Standard Deviation|1.4|1.4|||
4096869|NCT00984061|3920972|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4096870|NCT00984061|3920972|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4096871|NCT00984061|3920972|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4096872|NCT00984061|3920972|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4096873|NCT00984061|3920972|B1|||Age||years|Mean|22.3|22.3|Standard Deviation|4.1|4.1|||
4096874|NCT00984061|3920972|B1||>=65 years|Age|age range: >=18 and <=45 years old|Participants|Count of Participants|0|0.0||||||
4096875|NCT00984061|3920972|B1||Between 18 and 65 years|Age|age range: >=18 and <=45 years old|Participants|Count of Participants|24|24.0||||||
4096876|NCT00984061|3920972|B1||<=18 years|Age|age range: >=18 and <=45 years old|Participants|Count of Participants|0|0.0||||||
4096877|NCT00984022|3920983|B3|United States||Region of Enrollment||participants|Number|92|92.0||||||
4096878|NCT00984022|3920984|B2|United States||Region of Enrollment||participants|Number|49|49.0||||||
4096879|NCT00984022|3920985|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4096880|NCT00984022|3920983|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4096881|NCT00984022|3920984|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4096882|NCT00984022|3920985|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4096883|NCT00984022|3920983|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4096884|NCT00984022|3920984|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4096885|NCT00984022|3920985|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4096886|NCT00984022|3920983|B3|||Age||years|Mean|38.0|38.0|Standard Deviation|12.0|12.0|||
4096887|NCT00984022|3920984|B2|||Age||years|Mean|39.2|39.2|Standard Deviation|11.6|11.6|||
4096888|NCT00984022|3920985|B1|||Age||years|Mean|36.8|36.8|Standard Deviation|12.6|12.6|||
4096889|NCT00984022|3920983|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4096890|NCT00984022|3920984|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4096891|NCT00984022|3920985|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4096892|NCT00984022|3920983|B3||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
4096893|NCT00984022|3920984|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4096894|NCT00984022|3920985|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4096895|NCT00984022|3920983|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4096896|NCT00984022|3920984|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4096897|NCT00984022|3920985|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4096898|NCT00984009|3920996|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4096899|NCT00984009|3920996|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096900|NCT00984009|3920996|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096901|NCT00984009|3920996|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4096902|NCT00984009|3920996|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4096903|NCT00984009|3920996|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096904|NCT00984009|3920996|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096905|NCT00984009|3920996|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096906|NCT00984009|3920996|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096907|NCT00984009|3920996|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4096908|NCT00984009|3920996|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096909|NCT00984009|3920996|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4096910|NCT00984009|3920996|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4096911|NCT00984009|3920996|B1|||Age||years|Mean|26.9|26.9|Standard Deviation|6.9|6.9|||
4096912|NCT00984009|3920996|B1|>=65 years||Age, Customized|age range: ≥18 and ≤45|participants|Number|0|0.0||||||
4096913|NCT00984009|3920996|B1|Between 18 and 65 years||Age, Customized|age range: ≥18 and ≤45|participants|Number|22|22.0||||||
4096914|NCT00984009|3920996|B1|<=18 years||Age, Customized|age range: ≥18 and ≤45|participants|Number|0|0.0||||||
4096915|NCT00983983|3921007|B4|||Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R)|Total Score ranging from 0 (worst) to 48 (best)|units on a scale|Mean|26.3|26.3|Standard Deviation|7.6|7.6|||
4096916|NCT00983983|3921008|B3|||Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R)|Total Score ranging from 0 (worst) to 48 (best)|units on a scale|Mean|23.0|23.0|Standard Deviation|3.5|3.5|||
4096917|NCT00983983|3921009|B2|||Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R)|Total Score ranging from 0 (worst) to 48 (best)|units on a scale|Mean|25.5|25.5|Standard Deviation|9.4|9.4|||
4096918|NCT00983983|3921010|B1|||Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R)|Total Score ranging from 0 (worst) to 48 (best)|units on a scale|Mean|30.7|30.7|Standard Deviation|7.0|7.0|||
4096919|NCT00983983|3921007|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4096920|NCT00983983|3921008|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4096921|NCT00983983|3921009|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4096922|NCT00983983|3921010|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4096923|NCT00983983|3921007|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4096924|NCT00983983|3921008|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4096925|NCT00983983|3921009|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4096926|NCT00983983|3921010|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4096927|NCT00983983|3921007|B4|||Age||years|Mean|61.3|61.3|Standard Deviation|11.4|11.4|||
4096928|NCT00983983|3921008|B3|||Age||years|Mean|63.2|63.2|Standard Deviation|9.4|9.4|||
4096929|NCT00983983|3921009|B2|||Age||years|Mean|57.5|57.5|Standard Deviation|15.4|15.4|||
4096930|NCT00983983|3921010|B1|||Age||years|Mean|64.0|64.0|Standard Deviation|6.9|6.9|||
4096931|NCT00983957|3921029|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4096932|NCT00983957|3921029|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4096933|NCT00983957|3921029|B1|<= 45 years||Age, Customized||participants|Number|20|20.0||||||
4096934|NCT00983957|3921029|B1|||Age||years|Mean|29.8|29.8|Standard Deviation|7.36|7.36|||
4096935|NCT00983931|3921063|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4096936|NCT00983931|3921063|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096937|NCT00983931|3921063|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4096938|NCT00983931|3921063|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096939|NCT00983931|3921063|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096940|NCT00983931|3921063|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096941|NCT00983931|3921063|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4096942|NCT00983931|3921063|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096943|NCT00983931|3921063|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096944|NCT00983931|3921063|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096945|NCT00983931|3921063|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4096946|NCT00983931|3921063|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4096947|NCT00983931|3921063|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4096948|NCT00983931|3921063|B1|||Age|age range: >=18 and <=45 years old|years|Mean|29.0|29.0|Standard Deviation|6.9|6.9|||
4096949|NCT00983931|3921063|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4096950|NCT00983931|3921063|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4096951|NCT00983931|3921063|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4096952|NCT00983918|3921073|B5|United States||Region of Enrollment||participants|Number|80|80.0||||||
4096953|NCT00983918|3921074|B4|United States||Region of Enrollment||participants|Number|20|20.0||||||
4096954|NCT00983918|3921075|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4096955|NCT00983918|3921076|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4096956|NCT00983918|3921077|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4096957|NCT00983918|3921073|B5||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4096958|NCT00983918|3921074|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4096959|NCT00983918|3921075|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4096960|NCT00983918|3921076|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4096961|NCT00983918|3921077|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4096962|NCT00983918|3921073|B5||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4096963|NCT00983918|3921074|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4096964|NCT00983918|3921075|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4096965|NCT00983918|3921076|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4096966|NCT00983918|3921077|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4096967|NCT00983918|3921073|B5|||Age||years|Mean|33|33.0|Standard Deviation|11|11.0|||
4096968|NCT00983918|3921074|B4|||Age||years|Mean|29|29.0|Standard Deviation|7|7.0|||
4096969|NCT00983918|3921075|B3|||Age||years|Mean|34|34.0|Standard Deviation|12|12.0|||
4096970|NCT00983918|3921076|B2|||Age||years|Mean|34|34.0|Standard Deviation|14|14.0|||
4096971|NCT00983918|3921077|B1|||Age||years|Mean|33|33.0|Standard Deviation|12|12.0|||
4096972|NCT00983918|3921073|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4096973|NCT00983918|3921074|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4096974|NCT00983918|3921075|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4096975|NCT00983918|3921076|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4096976|NCT00983918|3921077|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4096977|NCT00983918|3921073|B5||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4096978|NCT00983918|3921074|B4||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4096979|NCT00983918|3921075|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4096980|NCT00983918|3921076|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4096981|NCT00983918|3921077|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4096982|NCT00983918|3921073|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4096983|NCT00983918|3921074|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4096984|NCT00983918|3921075|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4096985|NCT00983918|3921076|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4096986|NCT00983918|3921077|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4096987|NCT00983905|3921090|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4096988|NCT00983905|3921090|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096989|NCT00983905|3921090|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4096990|NCT00983905|3921090|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4096991|NCT00983905|3921090|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4096992|NCT00983905|3921090|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096993|NCT00983905|3921090|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096994|NCT00983905|3921090|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4096995|NCT00983905|3921090|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4096996|NCT00983905|3921090|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4096997|NCT00983905|3921090|B1|||Age||years|Mean|25.1|25.1|Standard Deviation|5.9|5.9|||
4096998|NCT00983905|3921090|B1||>=65 years|Age|age range: >=18 and <=45 years old|Participants|Count of Participants|0|0.0||||||
4096999|NCT00983905|3921090|B1||Between 18 and 65 years|Age|age range: >=18 and <=45 years old|Participants|Count of Participants|28|28.0||||||
4097000|NCT00983905|3921090|B1||<=18 years|Age|age range: >=18 and <=45 years old|Participants|Count of Participants|2|2.0||||||
4097001|NCT00983892|3921101|B3|||Summed symptom severity|symptom severity = the sum across 8 core symptoms rated by the patient on a scale of 0 to 10 (higher is worse).|units on a scale 0-80|Mean|28.0|28.0|Standard Deviation|15.2|15.2|||
4097002|NCT00983892|3921102|B2|||Summed symptom severity|symptom severity = the sum across 8 core symptoms rated by the patient on a scale of 0 to 10 (higher is worse).|units on a scale 0-80|Mean|28.1|28.1|Standard Deviation|16.6|16.6|||
4097003|NCT00983892|3921103|B1|||Summed symptom severity|symptom severity = the sum across 8 core symptoms rated by the patient on a scale of 0 to 10 (higher is worse).|units on a scale 0-80|Mean|27.8|27.8|Standard Deviation|13.7|13.7|||
4097004|NCT00983892|3921101|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4097005|NCT00983892|3921102|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4097006|NCT00983892|3921103|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4097007|NCT00983892|3921101|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097008|NCT00983892|3921102|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097009|NCT00983892|3921103|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097010|NCT00983892|3921101|B3||White|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4097011|NCT00983892|3921102|B2||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4097012|NCT00983892|3921103|B1||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4097013|NCT00983892|3921101|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4097014|NCT00983892|3921102|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4097015|NCT00983892|3921103|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4097016|NCT00983892|3921101|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097017|NCT00983892|3921102|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097018|NCT00983892|3921103|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097019|NCT00983892|3921101|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097020|NCT00983892|3921102|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097021|NCT00983892|3921103|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097022|NCT00983892|3921101|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4097023|NCT00983892|3921102|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4097024|NCT00983892|3921103|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4097025|NCT00983892|3921101|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4097026|NCT00983892|3921102|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4097027|NCT00983892|3921103|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4097028|NCT00983892|3921101|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
4097029|NCT00983892|3921102|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4097030|NCT00983892|3921103|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4097031|NCT00983892|3921101|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4097032|NCT00983892|3921102|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4097033|NCT00983892|3921103|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4097034|NCT00983892|3921101|B3||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4097035|NCT00983892|3921102|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4097036|NCT00983892|3921103|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4097037|NCT00983892|3921101|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4097038|NCT00983892|3921102|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4097039|NCT00983892|3921103|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4097040|NCT00983892|3921101|B3|||Age||years|Mean|63|63.0|Full Range|||29.0|87.0|
4097041|NCT00983892|3921102|B2|||Age||years|Mean|62|62.0|Full Range|||29.0|82.0|
4097042|NCT00983892|3921103|B1|||Age||years|Mean|64|64.0|Full Range|||46.0|87.0|
4097043|NCT00983853|3921110|B7|France||Region of Enrollment||participants|Number|2|2.0||||||
4097044|NCT00983853|3921111|B6|France||Region of Enrollment||participants|Number|0|0.0||||||
4097045|NCT00983853|3921112|B5|France||Region of Enrollment||participants|Number|2|2.0||||||
4097046|NCT00983853|3921113|B4|France||Region of Enrollment||participants|Number|0|0.0||||||
4097047|NCT00983853|3921114|B3|France||Region of Enrollment||participants|Number|0|0.0||||||
4097048|NCT00983853|3921115|B2|France||Region of Enrollment||participants|Number|0|0.0||||||
4097049|NCT00983853|3921116|B1|France||Region of Enrollment||participants|Number|0|0.0||||||
4097050|NCT00983853|3921110|B7|Spain||Region of Enrollment||participants|Number|9|9.0||||||
4097051|NCT00983853|3921111|B6|Spain||Region of Enrollment||participants|Number|3|3.0||||||
4097052|NCT00983853|3921112|B5|Spain||Region of Enrollment||participants|Number|3|3.0||||||
4097053|NCT00983853|3921113|B4|Spain||Region of Enrollment||participants|Number|0|0.0||||||
4097054|NCT00983853|3921114|B3|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4097055|NCT00983853|3921115|B2|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4097056|NCT00983853|3921116|B1|Spain||Region of Enrollment||participants|Number|0|0.0||||||
4097057|NCT00983853|3921110|B7|Germany||Region of Enrollment||participants|Number|3|3.0||||||
4097058|NCT00983853|3921111|B6|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4097059|NCT00983853|3921112|B5|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4097060|NCT00983853|3921113|B4|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4097061|NCT00983853|3921114|B3|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4097062|NCT00983853|3921115|B2|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4097063|NCT00983853|3921116|B1|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4097064|NCT00983853|3921110|B7|Europe||Region of Enrollment||participants|Number|14|14.0||||||
4097065|NCT00983853|3921111|B6|Europe||Region of Enrollment||participants|Number|4|4.0||||||
4097066|NCT00983853|3921112|B5|Europe||Region of Enrollment||participants|Number|6|6.0||||||
4097067|NCT00983853|3921113|B4|Europe||Region of Enrollment||participants|Number|0|0.0||||||
4097068|NCT00983853|3921114|B3|Europe||Region of Enrollment||participants|Number|3|3.0||||||
4097069|NCT00983853|3921115|B2|Europe||Region of Enrollment||participants|Number|1|1.0||||||
4097070|NCT00983853|3921116|B1|Europe||Region of Enrollment||participants|Number|0|0.0||||||
4097071|NCT00983853|3921110|B7|United States||Region of Enrollment||participants|Number|46|46.0||||||
4097072|NCT00983853|3921111|B6|United States||Region of Enrollment||participants|Number|4|4.0||||||
4097073|NCT00983853|3921112|B5|United States||Region of Enrollment||participants|Number|9|9.0||||||
4097074|NCT00983853|3921113|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
4097075|NCT00983853|3921114|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4097076|NCT00983853|3921115|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4097077|NCT00983853|3921116|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4097078|NCT00983853|3921110|B7|North America||Region of Enrollment||participants|Number|46|46.0||||||
4097079|NCT00983853|3921111|B6|North America||Region of Enrollment||participants|Number|4|4.0||||||
4097080|NCT00983853|3921112|B5|North America||Region of Enrollment||participants|Number|9|9.0||||||
4097081|NCT00983853|3921113|B4|North America||Region of Enrollment||participants|Number|8|8.0||||||
4097082|NCT00983853|3921114|B3|North America||Region of Enrollment||participants|Number|13|13.0||||||
4097083|NCT00983853|3921115|B2|North America||Region of Enrollment||participants|Number|5|5.0||||||
4097084|NCT00983853|3921116|B1|North America||Region of Enrollment||participants|Number|7|7.0||||||
4097085|NCT00983853|3921110|B7|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4097086|NCT00983853|3921111|B6|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4097087|NCT00983853|3921112|B5|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4097088|NCT00983853|3921113|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4097089|NCT00983853|3921114|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4097090|NCT00983853|3921115|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4097091|NCT00983853|3921116|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4097092|NCT00983853|3921110|B7|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4097093|NCT00983853|3921111|B6|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4097094|NCT00983853|3921112|B5|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4097095|NCT00983853|3921113|B4|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4097096|NCT00983853|3921114|B3|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4097097|NCT00983853|3921115|B2|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4097098|NCT00983853|3921116|B1|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4097099|NCT00983853|3921110|B7|Black/African American||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4097100|NCT00983853|3921111|B6|Black/African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4097101|NCT00983853|3921112|B5|Black/African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4097102|NCT00983853|3921113|B4|Black/African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4097103|NCT00983853|3921114|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4097104|NCT00983853|3921115|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4097105|NCT00983853|3921116|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4097106|NCT00983853|3921110|B7|White||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4097107|NCT00983853|3921111|B6|White||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4097108|NCT00983853|3921112|B5|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4097109|NCT00983853|3921113|B4|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4097110|NCT00983853|3921114|B3|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4097111|NCT00983853|3921115|B2|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4097112|NCT00983853|3921116|B1|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4097113|NCT00983853|3921110|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4097114|NCT00983853|3921111|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097115|NCT00983853|3921112|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097116|NCT00983853|3921113|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097117|NCT00983853|3921114|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4097118|NCT00983853|3921115|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097119|NCT00983853|3921116|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097120|NCT00983853|3921110|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4097121|NCT00983853|3921111|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4097122|NCT00983853|3921112|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4097123|NCT00983853|3921113|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4097124|NCT00983853|3921114|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4097125|NCT00983853|3921115|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4097126|NCT00983853|3921116|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4097127|NCT00983853|3921110|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4097128|NCT00983853|3921111|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4097129|NCT00983853|3921112|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4097130|NCT00983853|3921113|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4097131|NCT00983853|3921114|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4097132|NCT00983853|3921115|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4097133|NCT00983853|3921116|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4097134|NCT00983853|3921110|B7||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4097135|NCT00983853|3921111|B6||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4097136|NCT00983853|3921112|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4097137|NCT00983853|3921113|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4097138|NCT00983853|3921114|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4097139|NCT00983853|3921115|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4097140|NCT00983853|3921116|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4097141|NCT00983853|3921110|B7||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4097142|NCT00983853|3921111|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4097143|NCT00983853|3921112|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4097144|NCT00983853|3921113|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4097145|NCT00983853|3921114|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4097146|NCT00983853|3921115|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4097147|NCT00983853|3921116|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4097148|NCT00983853|3921110|B7|median (min, max)||Age||years|Median|44.5|44.5|Full Range|||26.0|65.0|
4097149|NCT00983853|3921111|B6|median (min, max)||Age||years|Median|39.0|39.0|Full Range|||26.0|53.0|
4097150|NCT00983853|3921112|B5|median (min, max)||Age||years|Median|52.0|52.0|Full Range|||36.0|59.0|
4097151|NCT00983853|3921113|B4|median (min, max)||Age||years|Median|47.0|47.0|Full Range|||31.0|53.0|
4097152|NCT00983853|3921114|B3|median (min, max)||Age||years|Median|47.5|47.5|Full Range|||31.0|57.0|
4097153|NCT00983853|3921115|B2|median (min, max)||Age||years|Median|47.5|47.5|Full Range|||42.0|65.0|
4097154|NCT00983853|3921116|B1|median (min, max)||Age||years|Median|39.4|39.4|Full Range|||34.0|50.0|
4097155|NCT00983827|3921149|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4097156|NCT00983827|3921149|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4097157|NCT00983827|3921149|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4097158|NCT00983827|3921149|B1|||Age||years|Mean|53.5|53.5|Standard Deviation|6.48|6.48|||
4097159|NCT00983827|3921149|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4097160|NCT00983827|3921149|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4097161|NCT00983827|3921149|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4097162|NCT00983801|3921153|B1|1 (symptoms, but fully ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is normal activity; 1=symptoms, but fully ambulatory; 2=symptomatic, but in bed <50% of the day; 3=needs to be in bed > 50% of the day, but not bedridden; 4=unable to get out of bed; 5=dead.|participants|Number|32|32.0||||||
4097163|NCT00983801|3921153|B1|0 (normal activity)||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is normal activity; 1=symptoms, but fully ambulatory; 2=symptomatic, but in bed <50% of the day; 3=needs to be in bed > 50% of the day, but not bedridden; 4=unable to get out of bed; 5=dead.|participants|Number|20|20.0||||||
4097164|NCT00983801|3921153|B1|Asian Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4097165|NCT00983801|3921153|B1|Korean||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4097166|NCT00983801|3921153|B1|Japanese||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4097167|NCT00983801|3921153|B1|Chinese||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4097168|NCT00983801|3921153|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4097169|NCT00983801|3921153|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4097170|NCT00983801|3921153|B1|||Age, Customized||years|Median|56.5|56.5|Full Range|||29.0|77.0|
4097171|NCT00983801|3921153|B1|>=50 years||Age, Customized||participants|Number|43|43.0||||||
4097172|NCT00983801|3921153|B1|< 50 years||Age, Customized||participants|Number|9|9.0||||||
4097173|NCT00983801|3921153|B1|>=65 years||Age, Customized||participants|Number|12|12.0||||||
4097174|NCT00983801|3921153|B1|< 65 years||Age, Customized||participants|Number|40|40.0||||||
4097175|NCT00983749|3921165|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4097176|NCT00983749|3921166|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4097177|NCT00983749|3921167|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4097178|NCT00983749|3921165|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4097179|NCT00983749|3921166|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4097180|NCT00983749|3921167|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4097181|NCT00983749|3921165|B3|||Age||years|Median|57|57.0|Inter-Quartile Range|||52.0|65.0|
4097182|NCT00983749|3921166|B2|||Age||years|Median|57|57.0|Inter-Quartile Range|||55.0|60.0|
4097183|NCT00983749|3921167|B1|||Age||years|Median|57|57.0|Inter-Quartile Range|||50.0|66.0|
4097184|NCT00983645|3921176|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4097185|NCT00983645|3921177|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4097186|NCT00983645|3921178|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4097187|NCT00983645|3921176|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4097188|NCT00983645|3921177|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4097189|NCT00983645|3921178|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4097190|NCT00983645|3921176|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4097191|NCT00983645|3921177|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4097192|NCT00983645|3921178|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4097193|NCT00983645|3921176|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4097194|NCT00983645|3921177|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4097195|NCT00983645|3921178|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4097196|NCT00983645|3921176|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4097197|NCT00983645|3921177|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4097198|NCT00983645|3921178|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4097199|NCT00983645|3921176|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4097200|NCT00983645|3921177|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4097201|NCT00983645|3921178|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4097202|NCT00983645|3921176|B3|||Age||years|Mean|35.6|35.6|Full Range|||18.0|56.0|
4097203|NCT00983645|3921177|B2|||Age||years|Mean|42.14|42.14|Full Range|||29.0|56.0|
4097204|NCT00983645|3921178|B1|||Age||years|Mean|29.875|29.875|Full Range|||18.0|53.0|
4097205|NCT00983580|3921191|B3|United States||Region of Enrollment||Participants|Count of Participants|98|98.0||||||
4097206|NCT00983580|3921192|B2|United States||Region of Enrollment||Participants|Count of Participants|49|49.0||||||
4097207|NCT00983580|3921193|B1|United States||Region of Enrollment||Participants|Count of Participants|49|49.0||||||
4097208|NCT00983580|3921191|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4097209|NCT00983580|3921192|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4097210|NCT00983580|3921193|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4097211|NCT00983580|3921191|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4097212|NCT00983580|3921192|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4097213|NCT00983580|3921193|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4097214|NCT00983580|3921191|B3|||Age||years|Median|62|62.0|Full Range|||46.0|83.0|
4097215|NCT00983580|3921192|B2|||Age||years|Median|62|62.0|Full Range|||50.0|79.0|
4097216|NCT00983580|3921193|B1|||Age||years|Median|62|62.0|Full Range|||46.0|83.0|
4097217|NCT00983541|3921210|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4097218|NCT00983541|3921210|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4097219|NCT00983541|3921210|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4097220|NCT00983541|3921210|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4097221|NCT00983541|3921210|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4097222|NCT00983541|3921210|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4097223|NCT00983515|3921220|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4097224|NCT00983515|3921220|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097225|NCT00983515|3921220|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4097226|NCT00983515|3921220|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097227|NCT00983515|3921220|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097228|NCT00983515|3921220|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097229|NCT00983515|3921220|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4097230|NCT00983515|3921220|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4097231|NCT00983515|3921220|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097232|NCT00983515|3921220|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097233|NCT00983515|3921220|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097234|NCT00983515|3921220|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4097235|NCT00983515|3921220|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4097236|NCT00983515|3921220|B1|||Age||years|Mean|23.0|23.0|Standard Deviation|4.7|4.7|||
4097237|NCT00983515|3921220|B1||>=65 years|Age|age range: >=18 and <=45 years old|Participants|Count of Participants|0|0.0||||||
4097238|NCT00983515|3921220|B1||Between 18 and 65 years|Age|age range: >=18 and <=45 years old|Participants|Count of Participants|19|19.0||||||
4097239|NCT00983515|3921220|B1||<=18 years|Age|age range: >=18 and <=45 years old|Participants|Count of Participants|5|5.0||||||
4097240|NCT00983489|3921231|B4|India||Region of Enrollment||participants|Number|1411|1411.0||||||
4097241|NCT00983489|3921232|B3|India||Region of Enrollment||participants|Number|447|447.0||||||
4097242|NCT00983489|3921233|B2|India||Region of Enrollment||participants|Number|453|453.0||||||
4097243|NCT00983489|3921234|B1|India||Region of Enrollment||participants|Number|511|511.0||||||
4097244|NCT00983489|3921231|B4||Male|Sex: Female, Male||Participants|Count of Participants|734|734.0||||||
4097245|NCT00983489|3921232|B3||Male|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
4097246|NCT00983489|3921233|B2||Male|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
4097247|NCT00983489|3921234|B1||Male|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
4097248|NCT00983489|3921231|B4||Female|Sex: Female, Male||Participants|Count of Participants|677|677.0||||||
4097249|NCT00983489|3921232|B3||Female|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
4097250|NCT00983489|3921233|B2||Female|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
4097251|NCT00983489|3921234|B1||Female|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
4097252|NCT00983489|3921231|B4|||Age||years|Mean|24.0|24.0|Standard Deviation|3.5|3.5|||
4097253|NCT00983489|3921232|B3|||Age||years|Mean|24.3|24.3|Standard Deviation|3.6|3.6|||
4097254|NCT00983489|3921233|B2|||Age||years|Mean|23.9|23.9|Standard Deviation|3.8|3.8|||
4097255|NCT00983489|3921234|B1|||Age||years|Mean|23.7|23.7|Standard Deviation|3.2|3.2|||
4097256|NCT00983476|3921244|B4|||Body Mass Index (BMI)|BMI = (weight in pounds * 703)/ height in inches²|kg/(meters squared)|Mean|34.5|34.5|Standard Deviation|5.3|5.3|||
4097257|NCT00983476|3921245|B3|||Body Mass Index (BMI)|BMI = (weight in pounds * 703)/ height in inches²|kg/(meters squared)|Mean|34.4|34.4|Standard Deviation|5.6|5.6|||
4097258|NCT00983476|3921246|B2|||Body Mass Index (BMI)|BMI = (weight in pounds * 703)/ height in inches²|kg/(meters squared)|Mean|34.2|34.2|Standard Deviation|5.3|5.3|||
4097259|NCT00983476|3921247|B1|||Body Mass Index (BMI)|BMI = (weight in pounds * 703)/ height in inches²|kg/(meters squared)|Mean|34.9|34.9|Standard Deviation|5.0|5.0|||
4097260|NCT00983476|3921244|B4|Graduate School (Degree or no degree)||Education|Patient reported educational level|participants|Number|10|10.0||||||
4097261|NCT00983476|3921245|B3|Graduate School (Degree or no degree)||Education|Patient reported educational level|participants|Number|4|4.0||||||
4097262|NCT00983476|3921246|B2|Graduate School (Degree or no degree)||Education|Patient reported educational level|participants|Number|3|3.0||||||
4097263|NCT00983476|3921247|B1|Graduate School (Degree or no degree)||Education|Patient reported educational level|participants|Number|3|3.0||||||
4097264|NCT00983476|3921244|B4|Degree (2 or 4 year)||Education|Patient reported educational level|participants|Number|73|73.0||||||
4097265|NCT00983476|3921245|B3|Degree (2 or 4 year)||Education|Patient reported educational level|participants|Number|22|22.0||||||
4097266|NCT00983476|3921246|B2|Degree (2 or 4 year)||Education|Patient reported educational level|participants|Number|24|24.0||||||
4097267|NCT00983476|3921247|B1|Degree (2 or 4 year)||Education|Patient reported educational level|participants|Number|27|27.0||||||
4097268|NCT00983476|3921244|B4|High School diploma or some college||Education|Patient reported educational level|participants|Number|180|180.0||||||
4097269|NCT00983476|3921245|B3|High School diploma or some college||Education|Patient reported educational level|participants|Number|56|56.0||||||
4097270|NCT00983476|3921246|B2|High School diploma or some college||Education|Patient reported educational level|participants|Number|64|64.0||||||
4097271|NCT00983476|3921247|B1|High School diploma or some college||Education|Patient reported educational level|participants|Number|60|60.0||||||
4097272|NCT00983476|3921244|B4|High School, no diploma||Education|Patient reported educational level|participants|Number|13|13.0||||||
4097273|NCT00983476|3921245|B3|High School, no diploma||Education|Patient reported educational level|participants|Number|6|6.0||||||
4097274|NCT00983476|3921246|B2|High School, no diploma||Education|Patient reported educational level|participants|Number|2|2.0||||||
4097275|NCT00983476|3921247|B1|High School, no diploma||Education|Patient reported educational level|participants|Number|5|5.0||||||
4097276|NCT00983476|3921244|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4097277|NCT00983476|3921245|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4097278|NCT00983476|3921246|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4097279|NCT00983476|3921247|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4097280|NCT00983476|3921244|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4097281|NCT00983476|3921245|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4097282|NCT00983476|3921246|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4097283|NCT00983476|3921247|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4097284|NCT00983476|3921244|B4||White|Race (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
4097285|NCT00983476|3921245|B3||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4097286|NCT00983476|3921246|B2||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4097287|NCT00983476|3921247|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4097288|NCT00983476|3921244|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
4097289|NCT00983476|3921245|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4097290|NCT00983476|3921246|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4097291|NCT00983476|3921247|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4097292|NCT00983476|3921244|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4097293|NCT00983476|3921245|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4097294|NCT00983476|3921246|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097295|NCT00983476|3921247|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097296|NCT00983476|3921244|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4097297|NCT00983476|3921245|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4097298|NCT00983476|3921246|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097299|NCT00983476|3921247|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4097300|NCT00983476|3921244|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4097301|NCT00983476|3921245|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4097302|NCT00983476|3921246|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4097303|NCT00983476|3921247|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4097304|NCT00983476|3921244|B4||Male|Sex: Female, Male|Observation of gender as male or female|Participants|Count of Participants|259|259.0||||||
4097305|NCT00983476|3921245|B3||Male|Sex: Female, Male|Observation of gender as male or female|Participants|Count of Participants|86|86.0||||||
4097306|NCT00983476|3921246|B2||Male|Sex: Female, Male|Observation of gender as male or female|Participants|Count of Participants|85|85.0||||||
4097307|NCT00983476|3921247|B1||Male|Sex: Female, Male|Observation of gender as male or female|Participants|Count of Participants|88|88.0||||||
4097308|NCT00983476|3921244|B4||Female|Sex: Female, Male|Observation of gender as male or female|Participants|Count of Participants|17|17.0||||||
4097309|NCT00983476|3921245|B3||Female|Sex: Female, Male|Observation of gender as male or female|Participants|Count of Participants|2|2.0||||||
4097310|NCT00983476|3921246|B2||Female|Sex: Female, Male|Observation of gender as male or female|Participants|Count of Participants|8|8.0||||||
4097311|NCT00983476|3921247|B1||Female|Sex: Female, Male|Observation of gender as male or female|Participants|Count of Participants|7|7.0||||||
4097312|NCT00983476|3921244|B4|||Age||years|Mean|54.2|54.2|Standard Deviation|9.4|9.4|||
4097313|NCT00983476|3921245|B3|||Age||years|Mean|54.2|54.2|Standard Deviation|9.9|9.9|||
4097314|NCT00983476|3921246|B2|||Age||years|Mean|54.7|54.7|Standard Deviation|8.9|8.9|||
4097315|NCT00983476|3921247|B1|||Age||years|Mean|53.7|53.7|Standard Deviation|9.6|9.6|||
4097316|NCT00983437|3921281|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4097317|NCT00983437|3921281|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4097318|NCT00983437|3921281|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4097319|NCT00983437|3921281|B1|White||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4097320|NCT00983437|3921281|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4097321|NCT00983437|3921281|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4097322|NCT00983437|3921281|B1|||Age||years|Mean|31.1|31.1|Standard Deviation|10.15|10.15|||
4097323|NCT00983385|3921300|B1|Unknown||Prior analgesic medication||participants|Number|1|1.0||||||
4097324|NCT00983385|3921300|B1|Participants opioid naive (Step 1 analgesics)||Prior analgesic medication||participants|Number|87|87.0||||||
4097325|NCT00983385|3921300|B1|Participants pretreated with opioids||Prior analgesic medication||participants|Number|88|88.0||||||
4097326|NCT00983385|3921300|B1|Italy||Region of Enrollment||participants|Number|12|12.0||||||
4097327|NCT00983385|3921300|B1|Switzerland||Region of Enrollment||participants|Number|3|3.0||||||
4097328|NCT00983385|3921300|B1|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
4097329|NCT00983385|3921300|B1|Germany||Region of Enrollment||participants|Number|46|46.0||||||
4097330|NCT00983385|3921300|B1|Austria||Region of Enrollment||participants|Number|26|26.0||||||
4097331|NCT00983385|3921300|B1|Croatia||Region of Enrollment||participants|Number|0|0.0||||||
4097332|NCT00983385|3921300|B1|Poland||Region of Enrollment||participants|Number|11|11.0||||||
4097333|NCT00983385|3921300|B1|Spain||Region of Enrollment||participants|Number|52|52.0||||||
4097334|NCT00983385|3921300|B1|France||Region of Enrollment||participants|Number|14|14.0||||||
4097335|NCT00983385|3921300|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4097336|NCT00983385|3921300|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4097337|NCT00983385|3921300|B1|||Age||years|Mean|59.7|59.7|Standard Deviation|11.8|11.8|||
4097338|NCT00983372|3921345|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4097339|NCT00983372|3921345|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097340|NCT00983372|3921345|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4097341|NCT00983372|3921345|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4097342|NCT00983372|3921345|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097343|NCT00983372|3921345|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097344|NCT00983372|3921345|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4097345|NCT00983372|3921345|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4097346|NCT00983372|3921345|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4097347|NCT00983372|3921345|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097348|NCT00983372|3921345|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4097349|NCT00983372|3921345|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4097350|NCT00983372|3921345|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4097351|NCT00983372|3921345|B1|||Age||years|Mean|28.0|28.0|Standard Deviation|8.0|8.0|||
4097352|NCT00983372|3921345|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4097353|NCT00983372|3921345|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4097354|NCT00983372|3921345|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4097355|NCT00983359|3921356|B1|≥4||Number of brain metastases|Patients with ≥4 brain metastases were eligible for study if only 1 to 3 were symptomatic and all others asymptomatic.|patients with brain metastases|Number|2|2.0||||||
4097356|NCT00983359|3921356|B1|3||Number of brain metastases|Patients with ≥4 brain metastases were eligible for study if only 1 to 3 were symptomatic and all others asymptomatic.|patients with brain metastases|Number|8|8.0||||||
4097357|NCT00983359|3921356|B1|2||Number of brain metastases|Patients with ≥4 brain metastases were eligible for study if only 1 to 3 were symptomatic and all others asymptomatic.|patients with brain metastases|Number|4|4.0||||||
4097358|NCT00983359|3921356|B1|1||Number of brain metastases|Patients with ≥4 brain metastases were eligible for study if only 1 to 3 were symptomatic and all others asymptomatic.|patients with brain metastases|Number|25|25.0||||||
4097359|NCT00983359|3921356|B1|Present||Extracranial metastases||patients|Number|20|20.0||||||
4097360|NCT00983359|3921356|B1|Absent||Extracranial metastases||patients|Number|19|19.0||||||
4097361|NCT00983359|3921356|B1|United States||Region of Enrollment||patients|Number|39|39.0||||||
4097362|NCT00983359|3921356|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097363|NCT00983359|3921356|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4097364|NCT00983359|3921356|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097365|NCT00983359|3921356|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4097366|NCT00983359|3921356|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4097367|NCT00983359|3921356|B1|>60||Age, Customized||patients|Number|19|19.0||||||
4097368|NCT00983359|3921356|B1|≤60||Age, Customized||patients|Number|20|20.0||||||
4097369|NCT00983346|3921364|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4097370|NCT00983346|3921364|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4097371|NCT00983346|3921364|B1|||Age||years|Median|61|61.0|Full Range|||41.0|79.0|
4097372|NCT00983307|3921368|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4097373|NCT00983307|3921368|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097374|NCT00983307|3921368|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097375|NCT00983307|3921368|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4097376|NCT00983307|3921368|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4097377|NCT00983307|3921368|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097378|NCT00983307|3921368|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4097379|NCT00983307|3921368|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097380|NCT00983307|3921368|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4097381|NCT00983307|3921368|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4097382|NCT00983307|3921368|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097383|NCT00983307|3921368|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4097384|NCT00983307|3921368|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4097385|NCT00983307|3921368|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4097386|NCT00983307|3921368|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4097387|NCT00983307|3921368|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4097388|NCT00983294|3921372|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4097389|NCT00983294|3921372|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097390|NCT00983294|3921372|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4097391|NCT00983294|3921372|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097392|NCT00983294|3921372|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097393|NCT00983294|3921372|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097394|NCT00983294|3921372|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4097395|NCT00983294|3921372|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4097396|NCT00983294|3921372|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097397|NCT00983294|3921372|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4097398|NCT00983294|3921372|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4097399|NCT00983294|3921372|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4097400|NCT00983294|3921372|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4097401|NCT00983294|3921372|B1|||Age||years|Mean|27.7|27.7|Standard Deviation|8.1|8.1|||
4097402|NCT00983294|3921372|B1||>=65 years|Age|age range: >=18 and <=45|Participants|Count of Participants|0|0.0||||||
4097403|NCT00983294|3921372|B1||Between 18 and 65 years|Age|age range: >=18 and <=45|Participants|Count of Participants|24|24.0||||||
4097404|NCT00983294|3921372|B1||<=18 years|Age|age range: >=18 and <=45|Participants|Count of Participants|0|0.0||||||
4097405|NCT00983281|3921383|B3||Male|Sex: Female, Male||Participants|Count of Participants|1372|1372.0||||||
4097406|NCT00983281|3921384|B2||Male|Sex: Female, Male||Participants|Count of Participants|719|719.0||||||
4097407|NCT00983281|3921385|B1||Male|Sex: Female, Male||Participants|Count of Participants|653|653.0||||||
4097408|NCT00983281|3921383|B3||Female|Sex: Female, Male||Participants|Count of Participants|342|342.0||||||
4097409|NCT00983281|3921384|B2||Female|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4097410|NCT00983281|3921385|B1||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4097411|NCT00983281|3921383|B3|Mean Age||Age||years|Mean|40|40.0|Standard Deviation|18|18.0|||
4097412|NCT00983281|3921384|B2|Mean Age||Age||years|Mean|41|41.0|Standard Deviation|18|18.0|||
4097413|NCT00983281|3921385|B1|Mean Age||Age||years|Mean|39|39.0|Standard Deviation|17|17.0|||
4097414|NCT00983242|3921392|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4097415|NCT00983242|3921392|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097416|NCT00983242|3921392|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097417|NCT00983242|3921392|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4097418|NCT00983242|3921392|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097419|NCT00983242|3921392|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097420|NCT00983242|3921392|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4097421|NCT00983242|3921392|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097422|NCT00983242|3921392|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097423|NCT00983242|3921392|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4097424|NCT00983242|3921392|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4097425|NCT00983242|3921392|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4097426|NCT00983242|3921392|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4097427|NCT00983242|3921392|B1|||Age||years|Mean|27.75|27.75|Standard Deviation|9.15|9.15|||
4097428|NCT00983242|3921392|B1|>=65 years||Age, Customized|>=18 and <=45|participants|Number|0|0.0||||||
4097429|NCT00983242|3921392|B1|Between 18 and 65 years||Age, Customized|>=18 and <=45|participants|Number|22|22.0||||||
4097430|NCT00983242|3921392|B1|<=18 years||Age, Customized|>=18 and <=45|participants|Number|2|2.0||||||
4097431|NCT00983216|3921403|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4097432|NCT00983216|3921403|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097433|NCT00983216|3921403|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4097434|NCT00983216|3921403|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097435|NCT00983216|3921403|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097436|NCT00983216|3921403|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097437|NCT00983216|3921403|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4097438|NCT00983216|3921403|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4097439|NCT00983216|3921403|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097440|NCT00983216|3921403|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097441|NCT00983216|3921403|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4097442|NCT00983216|3921403|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4097443|NCT00983216|3921403|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4097444|NCT00983216|3921403|B1|||Age||years|Mean|24.4|24.4|Standard Deviation|5.7|5.7|||
4097445|NCT00983216|3921403|B1||>=65 years|Age|age range: ≥18 and ≤45 years|Participants|Count of Participants|0|0.0||||||
4097446|NCT00983216|3921403|B1||Between 18 and 65 years|Age|age range: ≥18 and ≤45 years|Participants|Count of Participants|22|22.0||||||
4097447|NCT00983216|3921403|B1||<=18 years|Age|age range: ≥18 and ≤45 years|Participants|Count of Participants|2|2.0||||||
4097448|NCT00983073|3921414|B1|||Baseline Average Pain Intensity|"For this pain assessment, the participant was to indicate the level of average pain experienced over the previous 3 days, prior to starting Tapentadol, on an 11-point Numerical Rating Scale(NRS) where a score of 0 indicated no pain and a score of 10 indicated pain as bad as you can imagine.~This value was obtained from 195 participants."|Units on a scale|Mean|7.5|7.5|Standard Deviation|1.08|1.08|||
4097449|NCT00983073|3921414|B1|United Kingdom||Region of Enrollment||participants|Number|22|22.0||||||
4097450|NCT00983073|3921414|B1|Germany||Region of Enrollment||participants|Number|91|91.0||||||
4097451|NCT00983073|3921414|B1|Spain||Region of Enrollment||participants|Number|57|57.0||||||
4097452|NCT00983073|3921414|B1|Poland||Region of Enrollment||participants|Number|6|6.0||||||
4097453|NCT00983073|3921414|B1|France||Region of Enrollment||participants|Number|24|24.0||||||
4097454|NCT00983073|3921414|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4097455|NCT00983073|3921414|B1||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4097456|NCT00983073|3921414|B1|40 years and older||Age, Customized|Age of all participants receiving at least one dose of study medication.|participants|Mean|67.4|67.4|Standard Deviation|10.8|10.8|||
4097457|NCT00982995|3921435|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4097458|NCT00982995|3921435|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4097459|NCT00982995|3921435|B1|||Age||years|Mean|65|65.0|Full Range|||55.0|84.0|
4097460|NCT00982865|3921440|B5||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4097461|NCT00982865|3921441|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4097462|NCT00982865|3921442|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4097463|NCT00982865|3921443|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4097464|NCT00982865|3921444|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4097465|NCT00982865|3921440|B5||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4097466|NCT00982865|3921441|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4097467|NCT00982865|3921442|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4097468|NCT00982865|3921443|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4097469|NCT00982865|3921444|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4097470|NCT00982865|3921440|B5|>=65 Years||Age, Customized||Participants|Number|54|54.0||||||
4097471|NCT00982865|3921441|B4|>=65 Years||Age, Customized||Participants|Number|14|14.0||||||
4097472|NCT00982865|3921442|B3|>=65 Years||Age, Customized||Participants|Number|2|2.0||||||
4097473|NCT00982865|3921443|B2|>=65 Years||Age, Customized||Participants|Number|23|23.0||||||
4097474|NCT00982865|3921444|B1|>=65 Years||Age, Customized||Participants|Number|15|15.0||||||
4097475|NCT00982865|3921440|B5|>=45 − <65 Years||Age, Customized||Participants|Number|101|101.0||||||
4097476|NCT00982865|3921441|B4|>=45 − <65 Years||Age, Customized||Participants|Number|13|13.0||||||
4097477|NCT00982865|3921442|B3|>=45 − <65 Years||Age, Customized||Participants|Number|9|9.0||||||
4097478|NCT00982865|3921443|B2|>=45 − <65 Years||Age, Customized||Participants|Number|49|49.0||||||
4097479|NCT00982865|3921444|B1|>=45 − <65 Years||Age, Customized||Participants|Number|30|30.0||||||
4097480|NCT00982865|3921440|B5|>= 18 − <45 Years||Age, Customized||Participants|Number|25|25.0||||||
4097481|NCT00982865|3921441|B4|>= 18 − <45 Years||Age, Customized||Participants|Number|7|7.0||||||
4097482|NCT00982865|3921442|B3|>= 18 − <45 Years||Age, Customized||Participants|Number|4|4.0||||||
4097483|NCT00982865|3921443|B2|>= 18 − <45 Years||Age, Customized||Participants|Number|10|10.0||||||
4097484|NCT00982865|3921444|B1|>= 18 − <45 Years||Age, Customized||Participants|Number|4|4.0||||||
4097485|NCT00982735|3921733|B1|Male||Gender|Data with regards to gender is not available for 27 out of the total number of 987 participants.|participants|Number|647|647.0||||||
4097486|NCT00982735|3921733|B1|Female||Gender|Data with regards to gender is not available for 27 out of the total number of 987 participants.|participants|Number|313|313.0||||||
4097487|NCT00982735|3921733|B1|||Age||years|Mean|50.12|50.12|Standard Deviation|8.54|8.54|||
4097488|NCT00982657|3921739|B5||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4097489|NCT00982657|3921740|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4097490|NCT00982657|3921741|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4097491|NCT00982657|3921742|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4097492|NCT00982657|3921743|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4097493|NCT00982657|3921739|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4097494|NCT00982657|3921740|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4097495|NCT00982657|3921741|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4097496|NCT00982657|3921742|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4097497|NCT00982657|3921743|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4097498|NCT00982657|3921739|B5|Greater than or equal to (>=) 65 years||Age, Customized||Participants|Number|12|12.0||||||
4097499|NCT00982657|3921740|B4|Greater than or equal to (>=) 65 years||Age, Customized||Participants|Number|5|5.0||||||
4097500|NCT00982657|3921741|B3|Greater than or equal to (>=) 65 years||Age, Customized||Participants|Number|0|0.0||||||
4097501|NCT00982657|3921742|B2|Greater than or equal to (>=) 65 years||Age, Customized||Participants|Number|1|1.0||||||
4097502|NCT00982657|3921743|B1|Greater than or equal to (>=) 65 years||Age, Customized||Participants|Number|6|6.0||||||
4097503|NCT00982657|3921739|B5|45 to 64 years||Age, Customized||Participants|Number|20|20.0||||||
4097504|NCT00982657|3921740|B4|45 to 64 years||Age, Customized||Participants|Number|9|9.0||||||
4097505|NCT00982657|3921741|B3|45 to 64 years||Age, Customized||Participants|Number|3|3.0||||||
4097506|NCT00982657|3921742|B2|45 to 64 years||Age, Customized||Participants|Number|2|2.0||||||
4097507|NCT00982657|3921743|B1|45 to 64 years||Age, Customized||Participants|Number|6|6.0||||||
4097508|NCT00982657|3921739|B5|18 to 44 years||Age, Customized||Participants|Number|2|2.0||||||
4097509|NCT00982657|3921740|B4|18 to 44 years||Age, Customized||Participants|Number|2|2.0||||||
4097510|NCT00982657|3921741|B3|18 to 44 years||Age, Customized||Participants|Number|0|0.0||||||
4097511|NCT00982657|3921742|B2|18 to 44 years||Age, Customized||Participants|Number|0|0.0||||||
4097512|NCT00982657|3921743|B1|18 to 44 years||Age, Customized||Participants|Number|0|0.0||||||
4097513|NCT00982657|3921739|B5|Less than (<) 18 years||Age, Customized||Participants|Number|0|0.0||||||
4097514|NCT00982657|3921740|B4|Less than (<) 18 years||Age, Customized||Participants|Number|0|0.0||13.7|13.7|||
4097515|NCT00982657|3921741|B3|Less than (<) 18 years||Age, Customized||Participants|Number|0|0.0||8.5|8.5|||
4097516|NCT00982657|3921742|B2|Less than (<) 18 years||Age, Customized||Participants|Number|0|0.0||8.5|8.5|||
4097517|NCT00982657|3921743|B1|Less than (<) 18 years||Age, Customized||Participants|Number|0|0.0||9.6|9.6|||
4097518|NCT00982644|3921785|B3|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.7|9.7|Standard Deviation|2.6|2.6|||
4097519|NCT00982644|3921786|B2|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.7|9.7|Standard Deviation|2.6|2.6|||
4097520|NCT00982644|3921787|B1|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.6|9.6|Standard Deviation|2.6|2.6|||
4097521|NCT00982644|3921785|B3|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.2|8.2|Standard Deviation|0.8|0.8|||
4097779|NCT00982397|3921901|B1|Czech Republic||Region of Enrollment||participants|Number|33|33.0||||||
4097522|NCT00982644|3921786|B2|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.2|8.2|Standard Deviation|0.8|0.8|||
4097523|NCT00982644|3921787|B1|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.2|8.2|Standard Deviation|0.8|0.8|||
4097524|NCT00982644|3921785|B3||Male|Gender||Participants|Count of Participants|638|638.0||||||
4097525|NCT00982644|3921786|B2||Male|Gender||Participants|Count of Participants|167|167.0||||||
4097526|NCT00982644|3921787|B1||Male|Gender||Participants|Count of Participants|471|471.0||||||
4097527|NCT00982644|3921785|B3||Female|Gender||Participants|Count of Participants|392|392.0||||||
4097528|NCT00982644|3921786|B2||Female|Gender||Participants|Count of Participants|90|90.0||||||
4097529|NCT00982644|3921787|B1||Female|Gender||Participants|Count of Participants|302|302.0||||||
4097530|NCT00982644|3921785|B3|||Age||years|Mean|59.1|59.1|Standard Deviation|9.8|9.8|||
4097531|NCT00982644|3921786|B2|||Age||years|Mean|58.7|58.7|Standard Deviation|9.9|9.9|||
4097532|NCT00982644|3921787|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|9.7|9.7|||
4097533|NCT00982592|3921810|B3|United States||Region of Enrollment||participants|Number|124|124.0||||||
4097534|NCT00982592|3921811|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
4097535|NCT00982592|3921812|B1|United States||Region of Enrollment||participants|Number|64|64.0||||||
4097536|NCT00982592|3921810|B3|Nor reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4097537|NCT00982592|3921811|B2|Nor reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4097538|NCT00982592|3921812|B1|Nor reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4097539|NCT00982592|3921810|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4097540|NCT00982592|3921811|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4097541|NCT00982592|3921812|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4097542|NCT00982592|3921810|B3|African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4097543|NCT00982592|3921811|B2|African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4097544|NCT00982592|3921812|B1|African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4097545|NCT00982592|3921810|B3|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4097546|NCT00982592|3921811|B2|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4097547|NCT00982592|3921812|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4097548|NCT00982592|3921810|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|92|92.0||||||
4097549|NCT00982592|3921811|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4097550|NCT00982592|3921812|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
4097551|NCT00982592|3921810|B3||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4097552|NCT00982592|3921811|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4097553|NCT00982592|3921812|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4097554|NCT00982592|3921810|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4097555|NCT00982592|3921811|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4097556|NCT00982592|3921812|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4097557|NCT00982592|3921810|B3|||Age||years|Median|60|60.0|Full Range|||25.0|77.0|
4097558|NCT00982592|3921811|B2|||Age||years|Median|57.5|57.5|Full Range|||29.0|74.0|
4097559|NCT00982592|3921812|B1|||Age||years|Median|61.5|61.5|Full Range|||25.0|77.0|
4097560|NCT00982553|3921827|B1|United Kingdom||Region of Enrollment||participants|Number|14|14.0||||||
4097561|NCT00982553|3921827|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4097562|NCT00982553|3921827|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4097563|NCT00982553|3921827|B1|||Age||years|Mean|35|35.0|Standard Deviation|10|10.0|||
4097564|NCT00982553|3921827|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4097565|NCT00982553|3921827|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4097566|NCT00982553|3921827|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4097567|NCT00982488|3921834|B6|Other||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4097568|NCT00982488|3921835|B5|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4097569|NCT00982488|3921836|B4|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4097570|NCT00982488|3921837|B3|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4097571|NCT00982488|3921838|B2|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4097572|NCT00982488|3921839|B1|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4097573|NCT00982488|3921834|B6|Asian||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4097574|NCT00982488|3921835|B5|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4097575|NCT00982488|3921836|B4|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4097576|NCT00982488|3921837|B3|Asian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4097577|NCT00982488|3921838|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4097578|NCT00982488|3921839|B1|Asian||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4097579|NCT00982488|3921834|B6|Black/African American||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4097580|NCT00982488|3921835|B5|Black/African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4097581|NCT00982488|3921836|B4|Black/African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4097582|NCT00982488|3921837|B3|Black/African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4097583|NCT00982488|3921838|B2|Black/African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4097584|NCT00982488|3921839|B1|Black/African American||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4097585|NCT00982488|3921834|B6|White||Race/Ethnicity, Customized||Participants|Number|206|206.0||||||
4097586|NCT00982488|3921835|B5|White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4097587|NCT00982488|3921836|B4|White||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4097588|NCT00982488|3921837|B3|White||Race/Ethnicity, Customized||Participants|Number|26|26.0||||||
4097589|NCT00982488|3921838|B2|White||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4097590|NCT00982488|3921839|B1|White||Race/Ethnicity, Customized||Participants|Number|167|167.0||||||
4097591|NCT00982488|3921834|B6||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4097592|NCT00982488|3921835|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4097593|NCT00982488|3921836|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4097594|NCT00982488|3921837|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4097595|NCT00982488|3921838|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4097596|NCT00982488|3921839|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4097597|NCT00982488|3921834|B6||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4097598|NCT00982488|3921835|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4097599|NCT00982488|3921836|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4097600|NCT00982488|3921837|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4097601|NCT00982488|3921838|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4097602|NCT00982488|3921839|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4097603|NCT00982488|3921834|B6|Older than 75 years||Age, Customized||Participants|Number|13|13.0||||||
4097604|NCT00982488|3921835|B5|Older than 75 years||Age, Customized||Participants|Number|0|0.0||||||
4097605|NCT00982488|3921836|B4|Older than 75 years||Age, Customized||Participants|Number|0|0.0||||||
4097606|NCT00982488|3921837|B3|Older than 75 years||Age, Customized||Participants|Number|1|1.0||||||
4097607|NCT00982488|3921838|B2|Older than 75 years||Age, Customized||Participants|Number|1|1.0||||||
4097608|NCT00982488|3921839|B1|Older than 75 years||Age, Customized||Participants|Number|11|11.0||||||
4097609|NCT00982488|3921834|B6|66-75 years||Age, Customized||Participants|Number|52|52.0||||||
4097610|NCT00982488|3921835|B5|66-75 years||Age, Customized||Participants|Number|0|0.0||||||
4097611|NCT00982488|3921836|B4|66-75 years||Age, Customized||Participants|Number|0|0.0||||||
4097612|NCT00982488|3921837|B3|66-75 years||Age, Customized||Participants|Number|9|9.0||||||
4097613|NCT00982488|3921838|B2|66-75 years||Age, Customized||Participants|Number|3|3.0||||||
4097614|NCT00982488|3921839|B1|66-75 years||Age, Customized||Participants|Number|40|40.0||||||
4097615|NCT00982488|3921834|B6|46-65 years||Age, Customized||Participants|Number|114|114.0||||||
4097616|NCT00982488|3921835|B5|46-65 years||Age, Customized||Participants|Number|1|1.0||||||
4097617|NCT00982488|3921836|B4|46-65 years||Age, Customized||Participants|Number|3|3.0||||||
4097618|NCT00982488|3921837|B3|46-65 years||Age, Customized||Participants|Number|17|17.0||||||
4097619|NCT00982488|3921838|B2|46-65 years||Age, Customized||Participants|Number|5|5.0||||||
4097620|NCT00982488|3921839|B1|46-65 years||Age, Customized||Participants|Number|88|88.0||||||
4097621|NCT00982488|3921834|B6|21-45 years||Age, Customized||Participants|Number|58|58.0||||||
4097622|NCT00982488|3921835|B5|21-45 years||Age, Customized||Participants|Number|0|0.0||||||
4097623|NCT00982488|3921836|B4|21-45 years||Age, Customized||Participants|Number|0|0.0||||||
4097624|NCT00982488|3921837|B3|21-45 years||Age, Customized||Participants|Number|7|7.0||||||
4097625|NCT00982488|3921838|B2|21-45 years||Age, Customized||Participants|Number|5|5.0||||||
4097626|NCT00982488|3921839|B1|21-45 years||Age, Customized||Participants|Number|46|46.0||||||
4097627|NCT00982488|3921834|B6|Younger than 21 years||Age, Customized||Participants|Number|0|0.0||||||
4097628|NCT00982488|3921835|B5|Younger than 21 years||Age, Customized||Participants|Number|0|0.0||||||
4097629|NCT00982488|3921836|B4|Younger than 21 years||Age, Customized||Participants|Number|0|0.0||||||
4097630|NCT00982488|3921837|B3|Younger than 21 years||Age, Customized||Participants|Number|0|0.0||||||
4097631|NCT00982488|3921838|B2|Younger than 21 years||Age, Customized||Participants|Number|0|0.0||||||
4097632|NCT00982488|3921839|B1|Younger than 21 years||Age, Customized||Participants|Number|0|0.0||||||
4097633|NCT00982423|3921855|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4097634|NCT00982423|3921856|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4097635|NCT00982423|3921857|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4097636|NCT00982423|3921855|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4097637|NCT00982423|3921856|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4097638|NCT00982423|3921857|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4097639|NCT00982423|3921855|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4097640|NCT00982423|3921856|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4097641|NCT00982423|3921857|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4097642|NCT00982423|3921855|B3|||Age||years|Mean|72.7|72.7|Standard Deviation|9.6|9.6|||
4097643|NCT00982423|3921856|B2|||Age||years|Mean|76|76.0|Standard Deviation|2|2.0|||
4097644|NCT00982423|3921857|B1|||Age||years|Mean|68|68.0|Standard Deviation|3|3.0|||
4097780|NCT00982397|3921899|B3|Colombia||Region of Enrollment||participants|Number|22|22.0||||||
4097781|NCT00982397|3921900|B2|Colombia||Region of Enrollment||participants|Number|4|4.0||||||
4097782|NCT00982397|3921901|B1|Colombia||Region of Enrollment||participants|Number|18|18.0||||||
4097645|NCT00982410|3921874|B3|Never misused Rx opioids||Prescription opioid misuse|"Binary variable; based on 4 COMM (17-item self-report measure of current aberrant drug-related behavior over the past 30 days and answer choices range from 0 (never) to 4 (often)), questions pertaining to a) taking more Rx opioids than prescribed, b) taking Rx opioids prescribed to someone else, c) borrowing Rx opioids from someone else, and d) using Rx opioids for non-pain symptoms. Persons reporting any history of doing any of these 4 things were classified into opioid misuse categories, and persons who answered never to all 4 questions were classified as not misusing opioids."|participants|Number|55|55.0||||||
4097646|NCT00982410|3921875|B2|Never misused Rx opioids||Prescription opioid misuse|"Binary variable; based on 4 COMM (17-item self-report measure of current aberrant drug-related behavior over the past 30 days and answer choices range from 0 (never) to 4 (often)), questions pertaining to a) taking more Rx opioids than prescribed, b) taking Rx opioids prescribed to someone else, c) borrowing Rx opioids from someone else, and d) using Rx opioids for non-pain symptoms. Persons reporting any history of doing any of these 4 things were classified into opioid misuse categories, and persons who answered never to all 4 questions were classified as not misusing opioids."|participants|Number|27|27.0||||||
4097647|NCT00982410|3921876|B1|Never misused Rx opioids||Prescription opioid misuse|"Binary variable; based on 4 COMM (17-item self-report measure of current aberrant drug-related behavior over the past 30 days and answer choices range from 0 (never) to 4 (often)), questions pertaining to a) taking more Rx opioids than prescribed, b) taking Rx opioids prescribed to someone else, c) borrowing Rx opioids from someone else, and d) using Rx opioids for non-pain symptoms. Persons reporting any history of doing any of these 4 things were classified into opioid misuse categories, and persons who answered never to all 4 questions were classified as not misusing opioids."|participants|Number|28|28.0||||||
4097648|NCT00982410|3921874|B3|Ever misused Rx opioids||Prescription opioid misuse|"Binary variable; based on 4 COMM (17-item self-report measure of current aberrant drug-related behavior over the past 30 days and answer choices range from 0 (never) to 4 (often)), questions pertaining to a) taking more Rx opioids than prescribed, b) taking Rx opioids prescribed to someone else, c) borrowing Rx opioids from someone else, and d) using Rx opioids for non-pain symptoms. Persons reporting any history of doing any of these 4 things were classified into opioid misuse categories, and persons who answered never to all 4 questions were classified as not misusing opioids."|participants|Number|76|76.0||||||
4097649|NCT00982410|3921875|B2|Ever misused Rx opioids||Prescription opioid misuse|"Binary variable; based on 4 COMM (17-item self-report measure of current aberrant drug-related behavior over the past 30 days and answer choices range from 0 (never) to 4 (often)), questions pertaining to a) taking more Rx opioids than prescribed, b) taking Rx opioids prescribed to someone else, c) borrowing Rx opioids from someone else, and d) using Rx opioids for non-pain symptoms. Persons reporting any history of doing any of these 4 things were classified into opioid misuse categories, and persons who answered never to all 4 questions were classified as not misusing opioids."|participants|Number|39|39.0||||||
4097650|NCT00982410|3921876|B1|Ever misused Rx opioids||Prescription opioid misuse|"Binary variable; based on 4 COMM (17-item self-report measure of current aberrant drug-related behavior over the past 30 days and answer choices range from 0 (never) to 4 (often)), questions pertaining to a) taking more Rx opioids than prescribed, b) taking Rx opioids prescribed to someone else, c) borrowing Rx opioids from someone else, and d) using Rx opioids for non-pain symptoms. Persons reporting any history of doing any of these 4 things were classified into opioid misuse categories, and persons who answered never to all 4 questions were classified as not misusing opioids."|participants|Number|37|37.0||||||
4097651|NCT00982410|3921874|B3|No Abuse; No dependence||Drug abuse or drug dependence|University of Arkansas Substance Abuse Outcomes Module (SAOM; Smith et al. 1996). 25-item self-report measure designed to assess the severity of alcohol and drug problems. Persons classified as drug abusers (a) had no dependence, but (b) did meet the criteria for abuse on one or more substance. If a person met criteria for abuse on one substance and dependence on another, they were classified as drug-dependent. Persons with no abuse and no dependence did not meet criteria for abuse or dependence. Based on use of cannabis, cocaine, opioids, or stimulants in past 4 weeks.|participants|Number|68|68.0||||||
4097652|NCT00982410|3921875|B2|No Abuse; No dependence||Drug abuse or drug dependence|University of Arkansas Substance Abuse Outcomes Module (SAOM; Smith et al. 1996). 25-item self-report measure designed to assess the severity of alcohol and drug problems. Persons classified as drug abusers (a) had no dependence, but (b) did meet the criteria for abuse on one or more substance. If a person met criteria for abuse on one substance and dependence on another, they were classified as drug-dependent. Persons with no abuse and no dependence did not meet criteria for abuse or dependence. Based on use of cannabis, cocaine, opioids, or stimulants in past 4 weeks.|participants|Number|33|33.0||||||
4097653|NCT00982410|3921876|B1|No Abuse; No dependence||Drug abuse or drug dependence|University of Arkansas Substance Abuse Outcomes Module (SAOM; Smith et al. 1996). 25-item self-report measure designed to assess the severity of alcohol and drug problems. Persons classified as drug abusers (a) had no dependence, but (b) did meet the criteria for abuse on one or more substance. If a person met criteria for abuse on one substance and dependence on another, they were classified as drug-dependent. Persons with no abuse and no dependence did not meet criteria for abuse or dependence. Based on use of cannabis, cocaine, opioids, or stimulants in past 4 weeks.|participants|Number|35|35.0||||||
4097654|NCT00982410|3921874|B3|Any drug abuse or dependence||Drug abuse or drug dependence|University of Arkansas Substance Abuse Outcomes Module (SAOM; Smith et al. 1996). 25-item self-report measure designed to assess the severity of alcohol and drug problems. Persons classified as drug abusers (a) had no dependence, but (b) did meet the criteria for abuse on one or more substance. If a person met criteria for abuse on one substance and dependence on another, they were classified as drug-dependent. Persons with no abuse and no dependence did not meet criteria for abuse or dependence. Based on use of cannabis, cocaine, opioids, or stimulants in past 4 weeks.|participants|Number|63|63.0||||||
4097655|NCT00982410|3921875|B2|Any drug abuse or dependence||Drug abuse or drug dependence|University of Arkansas Substance Abuse Outcomes Module (SAOM; Smith et al. 1996). 25-item self-report measure designed to assess the severity of alcohol and drug problems. Persons classified as drug abusers (a) had no dependence, but (b) did meet the criteria for abuse on one or more substance. If a person met criteria for abuse on one substance and dependence on another, they were classified as drug-dependent. Persons with no abuse and no dependence did not meet criteria for abuse or dependence. Based on use of cannabis, cocaine, opioids, or stimulants in past 4 weeks.|participants|Number|33|33.0||||||
4097656|NCT00982410|3921876|B1|Any drug abuse or dependence||Drug abuse or drug dependence|University of Arkansas Substance Abuse Outcomes Module (SAOM; Smith et al. 1996). 25-item self-report measure designed to assess the severity of alcohol and drug problems. Persons classified as drug abusers (a) had no dependence, but (b) did meet the criteria for abuse on one or more substance. If a person met criteria for abuse on one substance and dependence on another, they were classified as drug-dependent. Persons with no abuse and no dependence did not meet criteria for abuse or dependence. Based on use of cannabis, cocaine, opioids, or stimulants in past 4 weeks.|participants|Number|30|30.0||||||
4097657|NCT00982410|3921874|B3|No Abuse; No Dependence||Alcohol abuse or alcohol dependence|University of Arkansas Substance Abuse Outcomes Module (SAOM; Smith et al. 1996). 25-item self-report measure designed to assess the severity of alcohol and drug problems (coefficient alpha = .9). Persons classified as alcohol abusers (a) had no dependence, but (b) did meet the criteria for abuse. Alcohol use questions concern the number of days of alcohol use, the average consumption per drinking day, the maximum consumption, and the number of binge days (more than five drinks consumed). Standard drinks are explained prior to asking these questions.|participants|Number|58|58.0||||||
4097658|NCT00982410|3921875|B2|No Abuse; No Dependence||Alcohol abuse or alcohol dependence|University of Arkansas Substance Abuse Outcomes Module (SAOM; Smith et al. 1996). 25-item self-report measure designed to assess the severity of alcohol and drug problems (coefficient alpha = .9). Persons classified as alcohol abusers (a) had no dependence, but (b) did meet the criteria for abuse. Alcohol use questions concern the number of days of alcohol use, the average consumption per drinking day, the maximum consumption, and the number of binge days (more than five drinks consumed). Standard drinks are explained prior to asking these questions.|participants|Number|31|31.0||||||
4097659|NCT00982410|3921876|B1|No Abuse; No Dependence||Alcohol abuse or alcohol dependence|University of Arkansas Substance Abuse Outcomes Module (SAOM; Smith et al. 1996). 25-item self-report measure designed to assess the severity of alcohol and drug problems (coefficient alpha = .9). Persons classified as alcohol abusers (a) had no dependence, but (b) did meet the criteria for abuse. Alcohol use questions concern the number of days of alcohol use, the average consumption per drinking day, the maximum consumption, and the number of binge days (more than five drinks consumed). Standard drinks are explained prior to asking these questions.|participants|Number|27|27.0||||||
4097660|NCT00982410|3921874|B3|Abuse or Dependence||Alcohol abuse or alcohol dependence|University of Arkansas Substance Abuse Outcomes Module (SAOM; Smith et al. 1996). 25-item self-report measure designed to assess the severity of alcohol and drug problems (coefficient alpha = .9). Persons classified as alcohol abusers (a) had no dependence, but (b) did meet the criteria for abuse. Alcohol use questions concern the number of days of alcohol use, the average consumption per drinking day, the maximum consumption, and the number of binge days (more than five drinks consumed). Standard drinks are explained prior to asking these questions.|participants|Number|73|73.0||||||
4097661|NCT00982410|3921875|B2|Abuse or Dependence||Alcohol abuse or alcohol dependence|University of Arkansas Substance Abuse Outcomes Module (SAOM; Smith et al. 1996). 25-item self-report measure designed to assess the severity of alcohol and drug problems (coefficient alpha = .9). Persons classified as alcohol abusers (a) had no dependence, but (b) did meet the criteria for abuse. Alcohol use questions concern the number of days of alcohol use, the average consumption per drinking day, the maximum consumption, and the number of binge days (more than five drinks consumed). Standard drinks are explained prior to asking these questions.|participants|Number|35|35.0||||||
4097662|NCT00982410|3921876|B1|Abuse or Dependence||Alcohol abuse or alcohol dependence|University of Arkansas Substance Abuse Outcomes Module (SAOM; Smith et al. 1996). 25-item self-report measure designed to assess the severity of alcohol and drug problems (coefficient alpha = .9). Persons classified as alcohol abusers (a) had no dependence, but (b) did meet the criteria for abuse. Alcohol use questions concern the number of days of alcohol use, the average consumption per drinking day, the maximum consumption, and the number of binge days (more than five drinks consumed). Standard drinks are explained prior to asking these questions.|participants|Number|38|38.0||||||
4097663|NCT00982410|3921874|B3|||CPSS: self-efficacy for pain management (PSE score)|The CPSS is a 22-item questionnaire designed to measure chronic pain patients' perceived self-efficacy to cope with the consequences of chronic pain (Anderson et al. 1995). The CPSS has three primary subscales: self-efficacy for pain management (PSE), self-efficacy for physical function (FSE) and self-efficacy for coping with symptoms (CSE). These scales have high reliability. Scores range from 10-100, with higher scores representing a better outcome.|units on a scale|Mean|46.3|46.3|Standard Deviation|21.3|21.3|||
4097664|NCT00982410|3921875|B2|||CPSS: self-efficacy for pain management (PSE score)|The CPSS is a 22-item questionnaire designed to measure chronic pain patients' perceived self-efficacy to cope with the consequences of chronic pain (Anderson et al. 1995). The CPSS has three primary subscales: self-efficacy for pain management (PSE), self-efficacy for physical function (FSE) and self-efficacy for coping with symptoms (CSE). These scales have high reliability. Scores range from 10-100, with higher scores representing a better outcome.|units on a scale|Mean|42.1|42.1|Standard Deviation|19.8|19.8|||
4097665|NCT00982410|3921876|B1|||CPSS: self-efficacy for pain management (PSE score)|The CPSS is a 22-item questionnaire designed to measure chronic pain patients' perceived self-efficacy to cope with the consequences of chronic pain (Anderson et al. 1995). The CPSS has three primary subscales: self-efficacy for pain management (PSE), self-efficacy for physical function (FSE) and self-efficacy for coping with symptoms (CSE). These scales have high reliability. Scores range from 10-100, with higher scores representing a better outcome.|units on a scale|Mean|50.2|50.2|Standard Deviation|22.1|22.1|||
4097666|NCT00982410|3921874|B3|||CPSS: Self- efficacy for physical functioning (FSE score)|The CPSS is a 22-item questionnaire designed to measure chronic pain patients' perceived self-efficacy to cope with the consequences of chronic pain (Anderson et al. 1995). The CPSS has three primary subscales: self-efficacy for pain management (PSE), self-efficacy for physical function (FSE) and self-efficacy for coping with symptoms (CSE). These scales have high reliability. Scores range from 10-100, with higher scores representing a better outcome.|units on a scale|Mean|62.3|62.3|Standard Deviation|21.9|21.9|||
4097783|NCT00982397|3921899|B3|Canada||Region of Enrollment||participants|Number|264|264.0||||||
4097784|NCT00982397|3921900|B2|Canada||Region of Enrollment||participants|Number|145|145.0||||||
4097785|NCT00982397|3921901|B1|Canada||Region of Enrollment||participants|Number|119|119.0||||||
4097786|NCT00982397|3921899|B3|Austria||Region of Enrollment||participants|Number|58|58.0||||||
4097667|NCT00982410|3921875|B2|||CPSS: Self- efficacy for physical functioning (FSE score)|The CPSS is a 22-item questionnaire designed to measure chronic pain patients' perceived self-efficacy to cope with the consequences of chronic pain (Anderson et al. 1995). The CPSS has three primary subscales: self-efficacy for pain management (PSE), self-efficacy for physical function (FSE) and self-efficacy for coping with symptoms (CSE). These scales have high reliability. Scores range from 10-100, with higher scores representing a better outcome.|units on a scale|Mean|60.6|60.6|Standard Deviation|21.9|21.9|||
4097668|NCT00982410|3921876|B1|||CPSS: Self- efficacy for physical functioning (FSE score)|The CPSS is a 22-item questionnaire designed to measure chronic pain patients' perceived self-efficacy to cope with the consequences of chronic pain (Anderson et al. 1995). The CPSS has three primary subscales: self-efficacy for pain management (PSE), self-efficacy for physical function (FSE) and self-efficacy for coping with symptoms (CSE). These scales have high reliability. Scores range from 10-100, with higher scores representing a better outcome.|units on a scale|Mean|63.9|63.9|Standard Deviation|22.0|22.0|||
4097669|NCT00982410|3921874|B3|||WHY-MPI General Activity|West Haven-Yale M Pain Inventory: Score is a composite construct designed to assess the extent to which physical pain impacts daily living. Aspects include ability to perform chores inside home, activities away from home, and social functioning. WHY-MPI General Activity Score ranges from 0-6; high scores represent better outcomes.|units on a scale|Mean|2.14|2.14|Standard Deviation|0.86|0.86|||
4097670|NCT00982410|3921875|B2|||WHY-MPI General Activity|West Haven-Yale M Pain Inventory: Score is a composite construct designed to assess the extent to which physical pain impacts daily living. Aspects include ability to perform chores inside home, activities away from home, and social functioning. WHY-MPI General Activity Score ranges from 0-6; high scores represent better outcomes.|units on a scale|Mean|2.04|2.04|Standard Deviation|0.89|0.89|||
4097671|NCT00982410|3921876|B1|||WHY-MPI General Activity|West Haven-Yale M Pain Inventory: Score is a composite construct designed to assess the extent to which physical pain impacts daily living. Aspects include ability to perform chores inside home, activities away from home, and social functioning. WHY-MPI General Activity Score ranges from 0-6; high scores represent better outcomes.|units on a scale|Mean|2.24|2.24|Standard Deviation|0.82|0.82|||
4097672|NCT00982410|3921874|B3|||WHY-MPI: Pain Severity Score|To measure pain-severity, we will use the Interference subscale of the West Haven-Yale Multidimensional Pain Inventory (WHYMPI). The WHYMPI/MPI is designed to be a brief, psychometrically-valid, and comprehensive assessment of the chronic pain experience for an individual. The WHY-MPI scores range from 0 to 6 with lower scores representing a better outcome.|units on a scale|Mean|4.31|4.31|Standard Deviation|0.94|0.94|||
4097673|NCT00982410|3921875|B2|||WHY-MPI: Pain Severity Score|To measure pain-severity, we will use the Interference subscale of the West Haven-Yale Multidimensional Pain Inventory (WHYMPI). The WHYMPI/MPI is designed to be a brief, psychometrically-valid, and comprehensive assessment of the chronic pain experience for an individual. The WHY-MPI scores range from 0 to 6 with lower scores representing a better outcome.|units on a scale|Mean|4.31|4.31|Standard Deviation|0.89|0.89|||
4097674|NCT00982410|3921876|B1|||WHY-MPI: Pain Severity Score|To measure pain-severity, we will use the Interference subscale of the West Haven-Yale Multidimensional Pain Inventory (WHYMPI). The WHYMPI/MPI is designed to be a brief, psychometrically-valid, and comprehensive assessment of the chronic pain experience for an individual. The WHY-MPI scores range from 0 to 6 with lower scores representing a better outcome.|units on a scale|Mean|4.31|4.31|Standard Deviation|0.97|0.97|||
4097675|NCT00982410|3921874|B3|||Self-reported average pain level in the past week via NRS-1|Rate your pain, on average over the past week. Scale ranging from 0 (no pain) to 10 (worst possible pain). Average pain within last week.|units on a scale|Mean|7.14|7.14|Standard Deviation|1.62|1.62|||
4097676|NCT00982410|3921875|B2|||Self-reported average pain level in the past week via NRS-1|Rate your pain, on average over the past week. Scale ranging from 0 (no pain) to 10 (worst possible pain). Average pain within last week.|units on a scale|Mean|7.09|7.09|Standard Deviation|1.62|1.62|||
4097677|NCT00982410|3921876|B1|||Self-reported average pain level in the past week via NRS-1|Rate your pain, on average over the past week. Scale ranging from 0 (no pain) to 10 (worst possible pain). Average pain within last week.|units on a scale|Mean|7.15|7.15|Standard Deviation|1.61|1.61|||
4097678|NCT00982410|3921874|B3||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4097679|NCT00982410|3921875|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4097680|NCT00982410|3921876|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4097681|NCT00982410|3921874|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4097682|NCT00982410|3921875|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4097683|NCT00982410|3921876|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4097684|NCT00982410|3921874|B3|||Age||years|Mean|51.5|51.5|Standard Deviation|9.6|9.6|||
4097685|NCT00982410|3921875|B2|||Age||years|Mean|51.3|51.3|Standard Deviation|10.1|10.1|||
4097686|NCT00982410|3921876|B1|||Age||years|Mean|51.7|51.7|Standard Deviation|9.2|9.2|||
4097687|NCT00982410|3921874|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4097688|NCT00982410|3921875|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4097689|NCT00982410|3921876|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4097690|NCT00982410|3921874|B3||Between 18 and 65 years|Age||Participants|Count of Participants|128|128.0||||||
4097691|NCT00982410|3921875|B2||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4097692|NCT00982410|3921876|B1||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4097693|NCT00982410|3921874|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4097694|NCT00982410|3921875|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4097695|NCT00982410|3921876|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4097787|NCT00982397|3921900|B2|Austria||Region of Enrollment||participants|Number|14|14.0||||||
4097788|NCT00982397|3921901|B1|Austria||Region of Enrollment||participants|Number|44|44.0||||||
4097789|NCT00982397|3921899|B3||Male|Sex: Female, Male||Participants|Count of Participants|2200|2200.0||||||
4097696|NCT00982397|3921899|B3|Unknown||Heart Failure Status|"NYHA Class I-No limitation of physical activity. NYHA Class II-Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~NYHA Class III-Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~NYHA Class IV-Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases."|participants|Number|2|2.0||||||
4097697|NCT00982397|3921900|B2|Unknown||Heart Failure Status|"NYHA Class I-No limitation of physical activity. NYHA Class II-Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~NYHA Class III-Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~NYHA Class IV-Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases."|participants|Number|2|2.0||||||
4097698|NCT00982397|3921901|B1|Unknown||Heart Failure Status|"NYHA Class I-No limitation of physical activity. NYHA Class II-Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~NYHA Class III-Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~NYHA Class IV-Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases."|participants|Number|0|0.0||||||
4097699|NCT00982397|3921899|B3|No Heart Failure||Heart Failure Status|"NYHA Class I-No limitation of physical activity. NYHA Class II-Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~NYHA Class III-Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~NYHA Class IV-Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases."|participants|Number|354|354.0||||||
4097700|NCT00982397|3921900|B2|No Heart Failure||Heart Failure Status|"NYHA Class I-No limitation of physical activity. NYHA Class II-Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~NYHA Class III-Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~NYHA Class IV-Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases."|participants|Number|109|109.0||||||
4097701|NCT00982397|3921901|B1|No Heart Failure||Heart Failure Status|"NYHA Class I-No limitation of physical activity. NYHA Class II-Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~NYHA Class III-Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~NYHA Class IV-Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases."|participants|Number|245|245.0||||||
4097702|NCT00982397|3921899|B3|NYHA IV||Heart Failure Status|"NYHA Class I-No limitation of physical activity. NYHA Class II-Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~NYHA Class III-Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~NYHA Class IV-Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases."|participants|Number|38|38.0||||||
4097703|NCT00982397|3921900|B2|NYHA IV||Heart Failure Status|"NYHA Class I-No limitation of physical activity. NYHA Class II-Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~NYHA Class III-Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~NYHA Class IV-Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases."|participants|Number|8|8.0||||||
4097704|NCT00982397|3921901|B1|NYHA IV||Heart Failure Status|"NYHA Class I-No limitation of physical activity. NYHA Class II-Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~NYHA Class III-Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~NYHA Class IV-Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases."|participants|Number|30|30.0||||||
4097705|NCT00982397|3921899|B3|NYHA III||Heart Failure Status|"NYHA Class I-No limitation of physical activity. NYHA Class II-Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~NYHA Class III-Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~NYHA Class IV-Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases."|participants|Number|853|853.0||||||
4097706|NCT00982397|3921900|B2|NYHA III||Heart Failure Status|"NYHA Class I-No limitation of physical activity. NYHA Class II-Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~NYHA Class III-Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~NYHA Class IV-Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases."|participants|Number|99|99.0||||||
4097707|NCT00982397|3921901|B1|NYHA III||Heart Failure Status|"NYHA Class I-No limitation of physical activity. NYHA Class II-Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~NYHA Class III-Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~NYHA Class IV-Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases."|participants|Number|754|754.0||||||
4097790|NCT00982397|3921900|B2||Male|Sex: Female, Male||Participants|Count of Participants|611|611.0||||||
4097708|NCT00982397|3921899|B3|NYHA II||Heart Failure Status|"NYHA Class I-No limitation of physical activity. NYHA Class II-Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~NYHA Class III-Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~NYHA Class IV-Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases."|participants|Number|1104|1104.0||||||
4097709|NCT00982397|3921900|B2|NYHA II||Heart Failure Status|"NYHA Class I-No limitation of physical activity. NYHA Class II-Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~NYHA Class III-Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~NYHA Class IV-Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases."|participants|Number|346|346.0||||||
4097710|NCT00982397|3921901|B1|NYHA II||Heart Failure Status|"NYHA Class I-No limitation of physical activity. NYHA Class II-Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~NYHA Class III-Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~NYHA Class IV-Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases."|participants|Number|758|758.0||||||
4097711|NCT00982397|3921899|B3|NYHA I||Heart Failure Status|"NYHA Class I-No limitation of physical activity. NYHA Class II-Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~NYHA Class III-Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~NYHA Class IV-Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases."|participants|Number|419|419.0||||||
4097712|NCT00982397|3921900|B2|NYHA I||Heart Failure Status|"NYHA Class I-No limitation of physical activity. NYHA Class II-Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~NYHA Class III-Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~NYHA Class IV-Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases."|participants|Number|187|187.0||||||
4097713|NCT00982397|3921901|B1|NYHA I||Heart Failure Status|"NYHA Class I-No limitation of physical activity. NYHA Class II-Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~NYHA Class III-Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~NYHA Class IV-Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases."|participants|Number|232|232.0||||||
4097714|NCT00982397|3921899|B3|Primary Prevention||Indication|"Primary prevention is an ICD indication to prevent sudden cardiac death. It refers to use of ICDs in individuals who are at risk for, but have not yet had, an episode of sustained VT, VF, or cardiac arrest.~Secondary prevention refers to an ICD indication for patients who have survived 1 or more cardiac arrests or sustained ventricular tachycardia. Patients with cardiac conditions associated with a high risk of sudden death who have unexplained syncope that is likely to be due to self-terminating ventricular arrhythmias are also considered to have a secondary prevention indication."|participants|Number|1923|1923.0||||||
4097715|NCT00982397|3921900|B2|Primary Prevention||Indication|"Primary prevention is an ICD indication to prevent sudden cardiac death. It refers to use of ICDs in individuals who are at risk for, but have not yet had, an episode of sustained VT, VF, or cardiac arrest.~Secondary prevention refers to an ICD indication for patients who have survived 1 or more cardiac arrests or sustained ventricular tachycardia. Patients with cardiac conditions associated with a high risk of sudden death who have unexplained syncope that is likely to be due to self-terminating ventricular arrhythmias are also considered to have a secondary prevention indication."|participants|Number|497|497.0||||||
4097716|NCT00982397|3921901|B1|Primary Prevention||Indication|"Primary prevention is an ICD indication to prevent sudden cardiac death. It refers to use of ICDs in individuals who are at risk for, but have not yet had, an episode of sustained VT, VF, or cardiac arrest.~Secondary prevention refers to an ICD indication for patients who have survived 1 or more cardiac arrests or sustained ventricular tachycardia. Patients with cardiac conditions associated with a high risk of sudden death who have unexplained syncope that is likely to be due to self-terminating ventricular arrhythmias are also considered to have a secondary prevention indication."|participants|Number|1426|1426.0||||||
4097717|NCT00982397|3921899|B3|Secondary Prevention||Indication|"Primary prevention is an ICD indication to prevent sudden cardiac death. It refers to use of ICDs in individuals who are at risk for, but have not yet had, an episode of sustained VT, VF, or cardiac arrest.~Secondary prevention refers to an ICD indication for patients who have survived 1 or more cardiac arrests or sustained ventricular tachycardia. Patients with cardiac conditions associated with a high risk of sudden death who have unexplained syncope that is likely to be due to self-terminating ventricular arrhythmias are also considered to have a secondary prevention indication."|participants|Number|847|847.0||||||
4097718|NCT00982397|3921900|B2|Secondary Prevention||Indication|"Primary prevention is an ICD indication to prevent sudden cardiac death. It refers to use of ICDs in individuals who are at risk for, but have not yet had, an episode of sustained VT, VF, or cardiac arrest.~Secondary prevention refers to an ICD indication for patients who have survived 1 or more cardiac arrests or sustained ventricular tachycardia. Patients with cardiac conditions associated with a high risk of sudden death who have unexplained syncope that is likely to be due to self-terminating ventricular arrhythmias are also considered to have a secondary prevention indication."|participants|Number|254|254.0||||||
4097791|NCT00982397|3921901|B1||Male|Sex: Female, Male||Participants|Count of Participants|1589|1589.0||||||
4097792|NCT00982397|3921899|B3||Female|Sex: Female, Male||Participants|Count of Participants|570|570.0||||||
4097793|NCT00982397|3921900|B2||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4097794|NCT00982397|3921901|B1||Female|Sex: Female, Male||Participants|Count of Participants|430|430.0||||||
4097719|NCT00982397|3921901|B1|Secondary Prevention||Indication|"Primary prevention is an ICD indication to prevent sudden cardiac death. It refers to use of ICDs in individuals who are at risk for, but have not yet had, an episode of sustained VT, VF, or cardiac arrest.~Secondary prevention refers to an ICD indication for patients who have survived 1 or more cardiac arrests or sustained ventricular tachycardia. Patients with cardiac conditions associated with a high risk of sudden death who have unexplained syncope that is likely to be due to self-terminating ventricular arrhythmias are also considered to have a secondary prevention indication."|participants|Number|593|593.0||||||
4097720|NCT00982397|3921899|B3|||QRS||ms|Mean|125.9|125.9|Standard Deviation|33.0|33.0|||
4097721|NCT00982397|3921900|B2|||QRS||ms|Mean|107.1|107.1|Standard Deviation|21.9|21.9|||
4097722|NCT00982397|3921901|B1|||QRS||ms|Mean|133.7|133.7|Standard Deviation|33.7|33.7|||
4097723|NCT00982397|3921899|B3|||LVEF||%|Mean|32.2|32.2|Standard Deviation|13.2|13.2|||
4097724|NCT00982397|3921900|B2|||LVEF||%|Mean|33.3|33.3|Standard Deviation|13.5|13.5|||
4097725|NCT00982397|3921901|B1|||LVEF||%|Mean|31.8|31.8|Standard Deviation|13.0|13.0|||
4097726|NCT00982397|3921899|B3|United States||Region of Enrollment||participants|Number|865|865.0||||||
4097727|NCT00982397|3921900|B2|United States||Region of Enrollment||participants|Number|156|156.0||||||
4097728|NCT00982397|3921901|B1|United States||Region of Enrollment||participants|Number|709|709.0||||||
4097729|NCT00982397|3921899|B3|United Kingdom||Region of Enrollment||participants|Number|114|114.0||||||
4097730|NCT00982397|3921900|B2|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
4097731|NCT00982397|3921901|B1|United Kingdom||Region of Enrollment||participants|Number|103|103.0||||||
4097732|NCT00982397|3921899|B3|United Arab Emirates||Region of Enrollment||participants|Number|5|5.0||||||
4097733|NCT00982397|3921900|B2|United Arab Emirates||Region of Enrollment||participants|Number|4|4.0||||||
4097734|NCT00982397|3921901|B1|United Arab Emirates||Region of Enrollment||participants|Number|1|1.0||||||
4097735|NCT00982397|3921899|B3|Switzerland||Region of Enrollment||participants|Number|13|13.0||||||
4097736|NCT00982397|3921900|B2|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
4097737|NCT00982397|3921901|B1|Switzerland||Region of Enrollment||participants|Number|13|13.0||||||
4097738|NCT00982397|3921899|B3|Sweden||Region of Enrollment||participants|Number|20|20.0||||||
4097739|NCT00982397|3921900|B2|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
4097740|NCT00982397|3921901|B1|Sweden||Region of Enrollment||participants|Number|17|17.0||||||
4097741|NCT00982397|3921899|B3|Spain||Region of Enrollment||participants|Number|54|54.0||||||
4097742|NCT00982397|3921900|B2|Spain||Region of Enrollment||participants|Number|30|30.0||||||
4097743|NCT00982397|3921901|B1|Spain||Region of Enrollment||participants|Number|24|24.0||||||
4097744|NCT00982397|3921899|B3|South Africa||Region of Enrollment||participants|Number|7|7.0||||||
4097745|NCT00982397|3921900|B2|South Africa||Region of Enrollment||participants|Number|0|0.0||||||
4097746|NCT00982397|3921901|B1|South Africa||Region of Enrollment||participants|Number|7|7.0||||||
4097747|NCT00982397|3921899|B3|Slovenia||Region of Enrollment||participants|Number|15|15.0||||||
4097748|NCT00982397|3921900|B2|Slovenia||Region of Enrollment||participants|Number|0|0.0||||||
4097749|NCT00982397|3921901|B1|Slovenia||Region of Enrollment||participants|Number|15|15.0||||||
4097750|NCT00982397|3921899|B3|Saudi Arabia||Region of Enrollment||participants|Number|164|164.0||||||
4097751|NCT00982397|3921900|B2|Saudi Arabia||Region of Enrollment||participants|Number|43|43.0||||||
4097752|NCT00982397|3921901|B1|Saudi Arabia||Region of Enrollment||participants|Number|121|121.0||||||
4097753|NCT00982397|3921899|B3|Netherlands||Region of Enrollment||participants|Number|240|240.0||||||
4097754|NCT00982397|3921900|B2|Netherlands||Region of Enrollment||participants|Number|86|86.0||||||
4097755|NCT00982397|3921901|B1|Netherlands||Region of Enrollment||participants|Number|154|154.0||||||
4097756|NCT00982397|3921899|B3|Malaysia||Region of Enrollment||participants|Number|19|19.0||||||
4097757|NCT00982397|3921900|B2|Malaysia||Region of Enrollment||participants|Number|2|2.0||||||
4097758|NCT00982397|3921901|B1|Malaysia||Region of Enrollment||participants|Number|17|17.0||||||
4097759|NCT00982397|3921899|B3|Japan||Region of Enrollment||participants|Number|181|181.0||||||
4097760|NCT00982397|3921900|B2|Japan||Region of Enrollment||participants|Number|37|37.0||||||
4097761|NCT00982397|3921901|B1|Japan||Region of Enrollment||participants|Number|144|144.0||||||
4097762|NCT00982397|3921899|B3|Italy||Region of Enrollment||participants|Number|72|72.0||||||
4097763|NCT00982397|3921900|B2|Italy||Region of Enrollment||participants|Number|11|11.0||||||
4097764|NCT00982397|3921901|B1|Italy||Region of Enrollment||participants|Number|61|61.0||||||
4097765|NCT00982397|3921899|B3|Israel||Region of Enrollment||participants|Number|162|162.0||||||
4097766|NCT00982397|3921900|B2|Israel||Region of Enrollment||participants|Number|58|58.0||||||
4097767|NCT00982397|3921901|B1|Israel||Region of Enrollment||participants|Number|104|104.0||||||
4097768|NCT00982397|3921899|B3|India||Region of Enrollment||participants|Number|25|25.0||||||
4097769|NCT00982397|3921900|B2|India||Region of Enrollment||participants|Number|18|18.0||||||
4097770|NCT00982397|3921901|B1|India||Region of Enrollment||participants|Number|7|7.0||||||
4097771|NCT00982397|3921899|B3|Germany||Region of Enrollment||participants|Number|305|305.0||||||
4097772|NCT00982397|3921900|B2|Germany||Region of Enrollment||participants|Number|57|57.0||||||
4097773|NCT00982397|3921901|B1|Germany||Region of Enrollment||participants|Number|248|248.0||||||
4097774|NCT00982397|3921899|B3|Denmark||Region of Enrollment||participants|Number|102|102.0||||||
4097775|NCT00982397|3921900|B2|Denmark||Region of Enrollment||participants|Number|42|42.0||||||
4097776|NCT00982397|3921901|B1|Denmark||Region of Enrollment||participants|Number|60|60.0||||||
4097777|NCT00982397|3921899|B3|Czech Republic||Region of Enrollment||participants|Number|63|63.0||||||
4097778|NCT00982397|3921900|B2|Czech Republic||Region of Enrollment||participants|Number|30|30.0||||||
4097795|NCT00982397|3921899|B3|||Age||years|Mean|64.8|64.8|Standard Deviation|12.3|12.3|||
4097796|NCT00982397|3921900|B2|||Age||years|Mean|61.9|61.9|Standard Deviation|12.1|12.1|||
4097797|NCT00982397|3921901|B1|||Age||years|Mean|65.9|65.9|Standard Deviation|12.1|12.1|||
4097798|NCT00982345|3921912|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4097799|NCT00982345|3921912|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4097800|NCT00982345|3921912|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4097801|NCT00982345|3921912|B1|||Age||years|Mean|29|29.0|Standard Deviation|10|10.0|||
4097802|NCT00982345|3921912|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4097803|NCT00982345|3921912|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4097804|NCT00982345|3921912|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4097805|NCT00982319|3921916|B3|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4097806|NCT00982319|3921917|B2|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4097807|NCT00982319|3921918|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4097808|NCT00982319|3921916|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4097809|NCT00982319|3921917|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4097810|NCT00982319|3921918|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4097811|NCT00982319|3921916|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4097812|NCT00982319|3921917|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4097813|NCT00982319|3921918|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4097814|NCT00982319|3921916|B3|||Age||years|Median|53|53.0|Full Range|||35.0|72.0|
4097815|NCT00982319|3921917|B2|||Age||years|Median|54|54.0|Full Range|||40.0|72.0|
4097816|NCT00982319|3921918|B1|||Age||years|Median|52|52.0|Full Range|||35.0|71.0|
4097817|NCT00982319|3921916|B3||>=65 years|Age|Age collected on baseline survey. Participants had to be 18+ years old|Participants|Count of Participants|5|5.0||||||
4097818|NCT00982319|3921917|B2||>=65 years|Age|Age collected on baseline survey. Participants had to be 18+ years old|Participants|Count of Participants|3|3.0||||||
4097819|NCT00982319|3921918|B1||>=65 years|Age|Age collected on baseline survey. Participants had to be 18+ years old|Participants|Count of Participants|2|2.0||||||
4097820|NCT00982319|3921916|B3||Between 18 and 65 years|Age|Age collected on baseline survey. Participants had to be 18+ years old|Participants|Count of Participants|25|25.0||||||
4097821|NCT00982319|3921917|B2||Between 18 and 65 years|Age|Age collected on baseline survey. Participants had to be 18+ years old|Participants|Count of Participants|12|12.0||||||
4097822|NCT00982319|3921918|B1||Between 18 and 65 years|Age|Age collected on baseline survey. Participants had to be 18+ years old|Participants|Count of Participants|13|13.0||||||
4097823|NCT00982319|3921916|B3||<=18 years|Age|Age collected on baseline survey. Participants had to be 18+ years old|Participants|Count of Participants|0|0.0||||||
4097824|NCT00982319|3921917|B2||<=18 years|Age|Age collected on baseline survey. Participants had to be 18+ years old|Participants|Count of Participants|0|0.0||||||
4097825|NCT00982319|3921918|B1||<=18 years|Age|Age collected on baseline survey. Participants had to be 18+ years old|Participants|Count of Participants|0|0.0||||||
4097826|NCT00982280|3921927|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4097827|NCT00982280|3921927|B1|Germany||Region of Enrollment||participants|Number|34|34.0||||||
4097828|NCT00982280|3921927|B1|Australia||Region of Enrollment||participants|Number|2|2.0||||||
4097829|NCT00982280|3921927|B1|Denmark||Region of Enrollment||participants|Number|6|6.0||||||
4097830|NCT00982280|3921927|B1|Poland||Region of Enrollment||participants|Number|16|16.0||||||
4097831|NCT00982280|3921927|B1|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4097832|NCT00982280|3921927|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4097833|NCT00982280|3921927|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4097834|NCT00982280|3921927|B1|||Age||years|Mean|65.4|65.4|Standard Deviation|9.84|9.84|||
4097835|NCT00982228|3921950|B3|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.3|9.3|Standard Deviation|4.1|4.1|||
4097836|NCT00982228|3921951|B2|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.7|9.7|Standard Deviation|4.4|4.4|||
4097837|NCT00982228|3921952|B1|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.1|9.1|Standard Deviation|4.0|4.0|||
4097838|NCT00982228|3921950|B3|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|7.7|7.7|Standard Deviation|1.0|1.0|||
4097839|NCT00982228|3921951|B2|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|7.7|7.7|Standard Deviation|1.0|1.0|||
4097840|NCT00982228|3921952|B1|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|7.7|7.7|Standard Deviation|0.9|0.9|||
4097841|NCT00982228|3921950|B3||Male|Sex: Female, Male||Participants|Count of Participants|368|368.0||||||
4097842|NCT00982228|3921951|B2||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4097843|NCT00982228|3921952|B1||Male|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
4097844|NCT00982228|3921950|B3||Female|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
4097845|NCT00982228|3921951|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4097846|NCT00982228|3921952|B1||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4097847|NCT00982228|3921950|B3|||Age||years|Mean|43.0|43.0|Standard Deviation|13.6|13.6|||
4097848|NCT00982228|3921951|B2|||Age||years|Mean|43.7|43.7|Standard Deviation|13.3|13.3|||
4097849|NCT00982228|3921952|B1|||Age||years|Mean|42.8|42.8|Standard Deviation|13.7|13.7|||
4097850|NCT00982189|3921977|B5|United States||Region of Enrollment||participants|Number|37|37.0||||||
4097851|NCT00982189|3921978|B4|United States||Region of Enrollment||participants|Number|9|9.0||||||
4097852|NCT00982189|3921979|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4097853|NCT00982189|3921980|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4097854|NCT00982189|3921981|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4097855|NCT00982189|3921977|B5||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4097856|NCT00982189|3921978|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4097857|NCT00982189|3921979|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4097858|NCT00982189|3921980|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4097859|NCT00982189|3921981|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4097860|NCT00982189|3921977|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4097861|NCT00982189|3921978|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4097862|NCT00982189|3921979|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4097863|NCT00982189|3921980|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4097864|NCT00982189|3921981|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4097865|NCT00982189|3921977|B5|||Age||years|Mean|48|48.0|Standard Deviation|7|7.0|||
4097866|NCT00982189|3921978|B4|||Age||years|Mean|45|45.0|Standard Deviation|7|7.0|||
4097867|NCT00982189|3921979|B3|||Age||years|Mean|48|48.0|Standard Deviation|4|4.0|||
4097868|NCT00982189|3921980|B2|||Age||years|Mean|47|47.0|Standard Deviation|12|12.0|||
4097869|NCT00982189|3921981|B1|||Age||years|Mean|52|52.0|Standard Deviation|8|8.0|||
4097870|NCT00982189|3921977|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4097871|NCT00982189|3921978|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4097872|NCT00982189|3921979|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4097873|NCT00982189|3921980|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4097874|NCT00982189|3921981|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4097875|NCT00982189|3921977|B5||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4097876|NCT00982189|3921978|B4||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4097877|NCT00982189|3921979|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4097878|NCT00982189|3921980|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4097879|NCT00982189|3921981|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4097880|NCT00982189|3921977|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4097881|NCT00982189|3921978|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4097882|NCT00982189|3921979|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4097883|NCT00982189|3921980|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4097884|NCT00982189|3921981|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4097885|NCT00982137|3922008|B5|Australia||Region of Enrollment||Participants|Number|108|108.0||||||
4097886|NCT00982137|3922009|B4|Australia||Region of Enrollment||Participants|Number|18|18.0||||||
4097887|NCT00982137|3922010|B3|Australia||Region of Enrollment||Participants|Number|18|18.0||||||
4097888|NCT00982137|3922011|B2|Australia||Region of Enrollment||Participants|Number|36|36.0||||||
4097889|NCT00982137|3922012|B1|Australia||Region of Enrollment||Participants|Number|36|36.0||||||
4097890|NCT00982137|3922008|B5||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4097891|NCT00982137|3922009|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4097892|NCT00982137|3922010|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4097893|NCT00982137|3922011|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4097894|NCT00982137|3922012|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4097895|NCT00982137|3922008|B5||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4097896|NCT00982137|3922009|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4097897|NCT00982137|3922010|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4097898|NCT00982137|3922011|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4097899|NCT00982137|3922012|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4097900|NCT00982137|3922008|B5|||Age||Years|Mean|25.8|25.8|Standard Deviation|8.77|8.77|||
4097901|NCT00982137|3922009|B4|||Age||Years|Mean|25.8|25.8|Standard Deviation|8.26|8.26|||
4097902|NCT00982137|3922010|B3|||Age||Years|Mean|27.5|27.5|Standard Deviation|10.19|10.19|||
4097903|NCT00982137|3922011|B2|||Age||Years|Mean|23.4|23.4|Standard Deviation|6.95|6.95|||
4097904|NCT00982137|3922012|B1|||Age||Years|Mean|27.2|27.2|Standard Deviation|9.71|9.71|||
4097905|NCT00982137|3922008|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4097906|NCT00982137|3922009|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4097907|NCT00982137|3922010|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4097908|NCT00982137|3922011|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4097909|NCT00982137|3922012|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4097910|NCT00982137|3922008|B5||Between 18 and 65 years|Age||Participants|Count of Participants|108|108.0||||||
4097911|NCT00982137|3922009|B4||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4097912|NCT00982137|3922010|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4097913|NCT00982137|3922011|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4097914|NCT00982137|3922012|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4097915|NCT00982137|3922008|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4097916|NCT00982137|3922009|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4097917|NCT00982137|3922010|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4097918|NCT00982137|3922011|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4097919|NCT00982137|3922012|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4097920|NCT00982111|3922045|B3|Other||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|180|180.0||||||
4097921|NCT00982111|3922046|B2|Other||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|93|93.0||||||
4097922|NCT00982111|3922047|B1|Other||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|87|87.0||||||
4097923|NCT00982111|3922045|B3|Soft Tissue||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|40|40.0||||||
4097924|NCT00982111|3922046|B2|Soft Tissue||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|21|21.0||||||
4097925|NCT00982111|3922047|B1|Soft Tissue||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|19|19.0||||||
4097926|NCT00982111|3922045|B3|Skin||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|12|12.0||||||
4097927|NCT00982111|3922046|B2|Skin||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|5|5.0||||||
4097928|NCT00982111|3922047|B1|Skin||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|7|7.0||||||
4097929|NCT00982111|3922045|B3|Pleural||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|222|222.0||||||
4097930|NCT00982111|3922046|B2|Pleural||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|111|111.0||||||
4097931|NCT00982111|3922047|B1|Pleural||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|111|111.0||||||
4097932|NCT00982111|3922045|B3|Peritoneal||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|43|43.0||||||
4097933|NCT00982111|3922046|B2|Peritoneal||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|22|22.0||||||
4097934|NCT00982111|3922047|B1|Peritoneal||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|21|21.0||||||
4097935|NCT00982111|3922045|B3|Lymph Nodes||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|479|479.0||||||
4097936|NCT00982111|3922046|B2|Lymph Nodes||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|240|240.0||||||
4097937|NCT00982111|3922047|B1|Lymph Nodes||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|239|239.0||||||
4097938|NCT00982111|3922045|B3|Lung||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|527|527.0||||||
4097939|NCT00982111|3922046|B2|Lung||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|268|268.0||||||
4097940|NCT00982111|3922047|B1|Lung||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|259|259.0||||||
4097941|NCT00982111|3922045|B3|Liver||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|122|122.0||||||
4097942|NCT00982111|3922046|B2|Liver||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|64|64.0||||||
4097943|NCT00982111|3922047|B1|Liver||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|58|58.0||||||
4097944|NCT00982111|3922045|B3|Brain||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|52|52.0||||||
4097945|NCT00982111|3922046|B2|Brain||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|25|25.0||||||
4097946|NCT00982111|3922047|B1|Brain||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|27|27.0||||||
4097947|NCT00982111|3922045|B3|Bone||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|212|212.0||||||
4097948|NCT00982111|3922046|B2|Bone||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|109|109.0||||||
4097949|NCT00982111|3922047|B1|Bone||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|103|103.0||||||
4097950|NCT00982111|3922045|B3|Missing||Disease Histology||participants|Number|1|1.0||||||
4097951|NCT00982111|3922046|B2|Missing||Disease Histology||participants|Number|0|0.0||||||
4097952|NCT00982111|3922047|B1|Missing||Disease Histology||participants|Number|1|1.0||||||
4097953|NCT00982111|3922045|B3|Other||Disease Histology||participants|Number|14|14.0||||||
4097954|NCT00982111|3922046|B2|Other||Disease Histology||participants|Number|7|7.0||||||
4097955|NCT00982111|3922047|B1|Other||Disease Histology||participants|Number|7|7.0||||||
4097956|NCT00982111|3922045|B3|Adenocarcinoma/Large Cell Carcinoma||Disease Histology||participants|Number|618|618.0||||||
4097957|NCT00982111|3922046|B2|Adenocarcinoma/Large Cell Carcinoma||Disease Histology||participants|Number|311|311.0||||||
4097958|NCT00982111|3922047|B1|Adenocarcinoma/Large Cell Carcinoma||Disease Histology||participants|Number|307|307.0||||||
4097959|NCT00982111|3922045|B3|Missing||Disease Stage at Study Entry|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIB - the cancer has spread to nearby tissue or spread to far away lymph nodes. Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|participants|Number|1|1.0||||||
4097960|NCT00982111|3922046|B2|Missing||Disease Stage at Study Entry|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIB - the cancer has spread to nearby tissue or spread to far away lymph nodes. Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|participants|Number|0|0.0||||||
4097961|NCT00982111|3922047|B1|Missing||Disease Stage at Study Entry|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIB - the cancer has spread to nearby tissue or spread to far away lymph nodes. Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|participants|Number|1|1.0||||||
4097962|NCT00982111|3922045|B3|Stage IV||Disease Stage at Study Entry|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIB - the cancer has spread to nearby tissue or spread to far away lymph nodes. Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|participants|Number|612|612.0||||||
4097963|NCT00982111|3922046|B2|Stage IV||Disease Stage at Study Entry|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIB - the cancer has spread to nearby tissue or spread to far away lymph nodes. Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|participants|Number|307|307.0||||||
4097964|NCT00982111|3922047|B1|Stage IV||Disease Stage at Study Entry|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIB - the cancer has spread to nearby tissue or spread to far away lymph nodes. Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|participants|Number|305|305.0||||||
4097965|NCT00982111|3922045|B3|Stage IIIB||Disease Stage at Study Entry|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIB - the cancer has spread to nearby tissue or spread to far away lymph nodes. Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|participants|Number|20|20.0||||||
4097966|NCT00982111|3922046|B2|Stage IIIB||Disease Stage at Study Entry|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIB - the cancer has spread to nearby tissue or spread to far away lymph nodes. Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|participants|Number|11|11.0||||||
4097967|NCT00982111|3922047|B1|Stage IIIB||Disease Stage at Study Entry|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIB - the cancer has spread to nearby tissue or spread to far away lymph nodes. Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|participants|Number|9|9.0||||||
4097968|NCT00982111|3922045|B3|Smoker||Smoking||participants|Number|476|476.0||||||
4097969|NCT00982111|3922046|B2|Smoker||Smoking||participants|Number|238|238.0||||||
4097970|NCT00982111|3922047|B1|Smoker||Smoking||participants|Number|238|238.0||||||
4097971|NCT00982111|3922045|B3|Nonsmoker||Smoking||participants|Number|104|104.0||||||
4097972|NCT00982111|3922046|B2|Nonsmoker||Smoking||participants|Number|53|53.0||||||
4097973|NCT00982111|3922047|B1|Nonsmoker||Smoking||participants|Number|51|51.0||||||
4097974|NCT00982111|3922045|B3|Ex-Light Smoker||Smoking||participants|Number|53|53.0||||||
4097975|NCT00982111|3922046|B2|Ex-Light Smoker||Smoking||participants|Number|27|27.0||||||
4097976|NCT00982111|3922047|B1|Ex-Light Smoker||Smoking||participants|Number|26|26.0||||||
4097977|NCT00982111|3922045|B3|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) at Baseline|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 0 - Fully Active. 1 - Ambulatory, Restricted Strenuous Activity. 2 - Ambulatory, No Work Activities. 3 - Partially Confined to Bed, Limited Self Care. 4 - Completely Disabled. 5 - Death.|participants|Number|1|1.0||||||
4097978|NCT00982111|3922046|B2|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) at Baseline|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 0 - Fully Active. 1 - Ambulatory, Restricted Strenuous Activity. 2 - Ambulatory, No Work Activities. 3 - Partially Confined to Bed, Limited Self Care. 4 - Completely Disabled. 5 - Death.|participants|Number|0|0.0||||||
4097979|NCT00982111|3922047|B1|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) at Baseline|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 0 - Fully Active. 1 - Ambulatory, Restricted Strenuous Activity. 2 - Ambulatory, No Work Activities. 3 - Partially Confined to Bed, Limited Self Care. 4 - Completely Disabled. 5 - Death.|participants|Number|1|1.0||||||
4097980|NCT00982111|3922045|B3|2||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) at Baseline|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 0 - Fully Active. 1 - Ambulatory, Restricted Strenuous Activity. 2 - Ambulatory, No Work Activities. 3 - Partially Confined to Bed, Limited Self Care. 4 - Completely Disabled. 5 - Death.|participants|Number|36|36.0||||||
4097981|NCT00982111|3922046|B2|2||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) at Baseline|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 0 - Fully Active. 1 - Ambulatory, Restricted Strenuous Activity. 2 - Ambulatory, No Work Activities. 3 - Partially Confined to Bed, Limited Self Care. 4 - Completely Disabled. 5 - Death.|participants|Number|20|20.0||||||
4097982|NCT00982111|3922047|B1|2||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) at Baseline|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 0 - Fully Active. 1 - Ambulatory, Restricted Strenuous Activity. 2 - Ambulatory, No Work Activities. 3 - Partially Confined to Bed, Limited Self Care. 4 - Completely Disabled. 5 - Death.|participants|Number|16|16.0||||||
4097983|NCT00982111|3922045|B3|1||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) at Baseline|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 0 - Fully Active. 1 - Ambulatory, Restricted Strenuous Activity. 2 - Ambulatory, No Work Activities. 3 - Partially Confined to Bed, Limited Self Care. 4 - Completely Disabled. 5 - Death.|participants|Number|349|349.0||||||
4098035|NCT00982111|3922046|B2|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
4097984|NCT00982111|3922046|B2|1||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) at Baseline|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 0 - Fully Active. 1 - Ambulatory, Restricted Strenuous Activity. 2 - Ambulatory, No Work Activities. 3 - Partially Confined to Bed, Limited Self Care. 4 - Completely Disabled. 5 - Death.|participants|Number|166|166.0||||||
4097985|NCT00982111|3922047|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) at Baseline|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 0 - Fully Active. 1 - Ambulatory, Restricted Strenuous Activity. 2 - Ambulatory, No Work Activities. 3 - Partially Confined to Bed, Limited Self Care. 4 - Completely Disabled. 5 - Death.|participants|Number|183|183.0||||||
4097986|NCT00982111|3922045|B3|0||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) at Baseline|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 0 - Fully Active. 1 - Ambulatory, Restricted Strenuous Activity. 2 - Ambulatory, No Work Activities. 3 - Partially Confined to Bed, Limited Self Care. 4 - Completely Disabled. 5 - Death.|participants|Number|247|247.0||||||
4097987|NCT00982111|3922046|B2|0||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) at Baseline|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 0 - Fully Active. 1 - Ambulatory, Restricted Strenuous Activity. 2 - Ambulatory, No Work Activities. 3 - Partially Confined to Bed, Limited Self Care. 4 - Completely Disabled. 5 - Death.|participants|Number|132|132.0||||||
4097988|NCT00982111|3922047|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) at Baseline|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 0 - Fully Active. 1 - Ambulatory, Restricted Strenuous Activity. 2 - Ambulatory, No Work Activities. 3 - Partially Confined to Bed, Limited Self Care. 4 - Completely Disabled. 5 - Death.|participants|Number|115|115.0||||||
4097989|NCT00982111|3922045|B3|Croatia||Region of Enrollment||participants|Number|2|2.0||||||
4097990|NCT00982111|3922046|B2|Croatia||Region of Enrollment||participants|Number|2|2.0||||||
4097991|NCT00982111|3922047|B1|Croatia||Region of Enrollment||participants|Number|0|0.0||||||
4097992|NCT00982111|3922045|B3|Germany||Region of Enrollment||participants|Number|159|159.0||||||
4097993|NCT00982111|3922046|B2|Germany||Region of Enrollment||participants|Number|84|84.0||||||
4097994|NCT00982111|3922047|B1|Germany||Region of Enrollment||participants|Number|75|75.0||||||
4097995|NCT00982111|3922045|B3|France||Region of Enrollment||participants|Number|10|10.0||||||
4097996|NCT00982111|3922046|B2|France||Region of Enrollment||participants|Number|3|3.0||||||
4097997|NCT00982111|3922047|B1|France||Region of Enrollment||participants|Number|7|7.0||||||
4097998|NCT00982111|3922045|B3|Australia||Region of Enrollment||participants|Number|14|14.0||||||
4097999|NCT00982111|3922046|B2|Australia||Region of Enrollment||participants|Number|8|8.0||||||
4098000|NCT00982111|3922047|B1|Australia||Region of Enrollment||participants|Number|6|6.0||||||
4098001|NCT00982111|3922045|B3|Slovakia||Region of Enrollment||participants|Number|4|4.0||||||
4098002|NCT00982111|3922046|B2|Slovakia||Region of Enrollment||participants|Number|1|1.0||||||
4098003|NCT00982111|3922047|B1|Slovakia||Region of Enrollment||participants|Number|3|3.0||||||
4098004|NCT00982111|3922045|B3|South Africa||Region of Enrollment||participants|Number|7|7.0||||||
4098005|NCT00982111|3922046|B2|South Africa||Region of Enrollment||participants|Number|5|5.0||||||
4098006|NCT00982111|3922047|B1|South Africa||Region of Enrollment||participants|Number|2|2.0||||||
4098007|NCT00982111|3922045|B3|Italy||Region of Enrollment||participants|Number|36|36.0||||||
4098008|NCT00982111|3922046|B2|Italy||Region of Enrollment||participants|Number|19|19.0||||||
4098009|NCT00982111|3922047|B1|Italy||Region of Enrollment||participants|Number|17|17.0||||||
4098010|NCT00982111|3922045|B3|Poland||Region of Enrollment||participants|Number|52|52.0||||||
4098011|NCT00982111|3922046|B2|Poland||Region of Enrollment||participants|Number|24|24.0||||||
4098012|NCT00982111|3922047|B1|Poland||Region of Enrollment||participants|Number|28|28.0||||||
4098013|NCT00982111|3922045|B3|Brazil||Region of Enrollment||participants|Number|72|72.0||||||
4098014|NCT00982111|3922046|B2|Brazil||Region of Enrollment||participants|Number|35|35.0||||||
4098015|NCT00982111|3922047|B1|Brazil||Region of Enrollment||participants|Number|37|37.0||||||
4098016|NCT00982111|3922045|B3|Belgium||Region of Enrollment||participants|Number|17|17.0||||||
4098017|NCT00982111|3922046|B2|Belgium||Region of Enrollment||participants|Number|9|9.0||||||
4098018|NCT00982111|3922047|B1|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
4098019|NCT00982111|3922045|B3|Austria||Region of Enrollment||participants|Number|19|19.0||||||
4098020|NCT00982111|3922046|B2|Austria||Region of Enrollment||participants|Number|11|11.0||||||
4098021|NCT00982111|3922047|B1|Austria||Region of Enrollment||participants|Number|8|8.0||||||
4098022|NCT00982111|3922045|B3|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4098023|NCT00982111|3922046|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4098024|NCT00982111|3922047|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4098025|NCT00982111|3922045|B3|Greece||Region of Enrollment||participants|Number|15|15.0||||||
4098026|NCT00982111|3922046|B2|Greece||Region of Enrollment||participants|Number|10|10.0||||||
4098027|NCT00982111|3922047|B1|Greece||Region of Enrollment||participants|Number|5|5.0||||||
4098028|NCT00982111|3922045|B3|Spain||Region of Enrollment||participants|Number|67|67.0||||||
4098029|NCT00982111|3922046|B2|Spain||Region of Enrollment||participants|Number|27|27.0||||||
4098030|NCT00982111|3922047|B1|Spain||Region of Enrollment||participants|Number|40|40.0||||||
4098031|NCT00982111|3922045|B3|Portugal||Region of Enrollment||participants|Number|7|7.0||||||
4098032|NCT00982111|3922046|B2|Portugal||Region of Enrollment||participants|Number|1|1.0||||||
4098033|NCT00982111|3922047|B1|Portugal||Region of Enrollment||participants|Number|6|6.0||||||
4098034|NCT00982111|3922045|B3|United Kingdom||Region of Enrollment||participants|Number|22|22.0||||||
4098036|NCT00982111|3922047|B1|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
4098037|NCT00982111|3922045|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4098038|NCT00982111|3922046|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4098039|NCT00982111|3922047|B1|United States||Region of Enrollment||participants|Number|0|0.0||||||
4098040|NCT00982111|3922045|B3|Hungary||Region of Enrollment||participants|Number|45|45.0||||||
4098041|NCT00982111|3922046|B2|Hungary||Region of Enrollment||participants|Number|22|22.0||||||
4098042|NCT00982111|3922047|B1|Hungary||Region of Enrollment||participants|Number|23|23.0||||||
4098043|NCT00982111|3922045|B3|Romania||Region of Enrollment||participants|Number|52|52.0||||||
4098044|NCT00982111|3922046|B2|Romania||Region of Enrollment||participants|Number|31|31.0||||||
4098045|NCT00982111|3922047|B1|Romania||Region of Enrollment||participants|Number|21|21.0||||||
4098046|NCT00982111|3922045|B3|Russian Federation||Region of Enrollment||participants|Number|29|29.0||||||
4098047|NCT00982111|3922046|B2|Russian Federation||Region of Enrollment||participants|Number|13|13.0||||||
4098048|NCT00982111|3922047|B1|Russian Federation||Region of Enrollment||participants|Number|16|16.0||||||
4098049|NCT00982111|3922045|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098050|NCT00982111|3922046|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098051|NCT00982111|3922047|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098052|NCT00982111|3922045|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4098053|NCT00982111|3922046|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4098054|NCT00982111|3922047|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4098055|NCT00982111|3922045|B3||White|Race (NIH/OMB)||Participants|Count of Participants|590|590.0||||||
4098056|NCT00982111|3922046|B2||White|Race (NIH/OMB)||Participants|Count of Participants|298|298.0||||||
4098057|NCT00982111|3922047|B1||White|Race (NIH/OMB)||Participants|Count of Participants|292|292.0||||||
4098058|NCT00982111|3922045|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4098059|NCT00982111|3922046|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4098060|NCT00982111|3922047|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4098061|NCT00982111|3922045|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098062|NCT00982111|3922046|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098063|NCT00982111|3922047|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098064|NCT00982111|3922045|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4098065|NCT00982111|3922046|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098066|NCT00982111|3922047|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4098067|NCT00982111|3922045|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098068|NCT00982111|3922046|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098069|NCT00982111|3922047|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098070|NCT00982111|3922045|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098071|NCT00982111|3922046|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098072|NCT00982111|3922047|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098073|NCT00982111|3922045|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|540|540.0||||||
4098074|NCT00982111|3922046|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|272|272.0||||||
4098075|NCT00982111|3922047|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|268|268.0||||||
4098076|NCT00982111|3922045|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
4098077|NCT00982111|3922046|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4098078|NCT00982111|3922047|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4098079|NCT00982111|3922045|B3||Male|Sex: Female, Male||Participants|Count of Participants|424|424.0||||||
4098080|NCT00982111|3922046|B2||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4098081|NCT00982111|3922047|B1||Male|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4098082|NCT00982111|3922045|B3||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4098083|NCT00982111|3922046|B2||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4098084|NCT00982111|3922047|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4098085|NCT00982111|3922045|B3|||Age, Customized||years|Median|61.00|61.0|Full Range|||26.0|88.0|
4098086|NCT00982111|3922046|B2|||Age, Customized||years|Median|60.0|60.0|Full Range|||34.0|88.0|
4098087|NCT00982111|3922047|B1|||Age, Customized||years|Median|61.0|61.0|Full Range|||26.0|84.0|
4098088|NCT00982033|3922070|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4098089|NCT00982033|3922071|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4098090|NCT00982033|3922072|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4098091|NCT00982033|3922070|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4098092|NCT00982033|3922071|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4098093|NCT00982033|3922072|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4098094|NCT00982033|3922070|B3|||Age||years|Mean|69.9|69.9|Standard Deviation|7.04|7.04|||
4098095|NCT00982033|3922071|B2|||Age||years|Mean|70.6|70.6|Standard Deviation|7.7|7.7|||
4098096|NCT00982033|3922072|B1|||Age||years|Mean|69.3|69.3|Standard Deviation|6.3|6.3|||
4098097|NCT00982020|3922079|B3|Puerto Rico||Region of Enrollment||participants|Number|20|20.0||||||
4098098|NCT00982020|3922080|B2|Puerto Rico||Region of Enrollment||participants|Number|7|7.0||||||
4098099|NCT00982020|3922081|B1|Puerto Rico||Region of Enrollment||participants|Number|13|13.0||||||
4098100|NCT00982020|3922079|B3|United States||Region of Enrollment||participants|Number|107|107.0||||||
4098101|NCT00982020|3922080|B2|United States||Region of Enrollment||participants|Number|54|54.0||||||
4098102|NCT00982020|3922081|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
4098103|NCT00982020|3922079|B3|Russian Federation||Region of Enrollment||participants|Number|55|55.0||||||
4098104|NCT00982020|3922080|B2|Russian Federation||Region of Enrollment||participants|Number|27|27.0||||||
4098105|NCT00982020|3922081|B1|Russian Federation||Region of Enrollment||participants|Number|28|28.0||||||
4098106|NCT00982020|3922079|B3|Poland||Region of Enrollment||participants|Number|18|18.0||||||
4098107|NCT00982020|3922080|B2|Poland||Region of Enrollment||participants|Number|12|12.0||||||
4098108|NCT00982020|3922081|B1|Poland||Region of Enrollment||participants|Number|6|6.0||||||
4098109|NCT00982020|3922079|B3|Germany||Region of Enrollment||participants|Number|3|3.0||||||
4098110|NCT00982020|3922080|B2|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4098111|NCT00982020|3922081|B1|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4098112|NCT00982020|3922079|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098113|NCT00982020|3922080|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098114|NCT00982020|3922081|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098115|NCT00982020|3922079|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4098116|NCT00982020|3922080|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4098117|NCT00982020|3922081|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4098118|NCT00982020|3922079|B3||White|Race (NIH/OMB)||Participants|Count of Participants|164|164.0||||||
4098119|NCT00982020|3922080|B2||White|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
4098120|NCT00982020|3922081|B1||White|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
4098121|NCT00982020|3922079|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4098122|NCT00982020|3922080|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4098123|NCT00982020|3922081|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4098124|NCT00982020|3922079|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098125|NCT00982020|3922080|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098126|NCT00982020|3922081|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098127|NCT00982020|3922079|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4098128|NCT00982020|3922080|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4098129|NCT00982020|3922081|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4098130|NCT00982020|3922079|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4098131|NCT00982020|3922080|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4098132|NCT00982020|3922081|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098133|NCT00982020|3922079|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098134|NCT00982020|3922080|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098135|NCT00982020|3922081|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098136|NCT00982020|3922079|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|179|179.0||||||
4098137|NCT00982020|3922080|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
4098138|NCT00982020|3922081|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
4098139|NCT00982020|3922079|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4098140|NCT00982020|3922080|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4098141|NCT00982020|3922081|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4098142|NCT00982020|3922079|B3||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4098143|NCT00982020|3922080|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4098144|NCT00982020|3922081|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4098145|NCT00982020|3922079|B3||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4098146|NCT00982020|3922080|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4098147|NCT00982020|3922081|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4098148|NCT00982020|3922079|B3|||Age||years|Mean|15.76|15.76|Standard Deviation|1.51|1.51|||
4098149|NCT00982020|3922080|B2|||Age||years|Mean|15.66|15.66|Standard Deviation|1.52|1.52|||
4098150|NCT00982020|3922081|B1|||Age||years|Mean|15.86|15.86|Standard Deviation|1.49|1.49|||
4098151|NCT00982007|3922102|B5|United States||Region of Enrollment||participants|Number|997|997.0||||||
4098152|NCT00982007|3922103|B4|United States||Region of Enrollment||participants|Number|245|245.0||||||
4098153|NCT00982007|3922104|B3|United States||Region of Enrollment||participants|Number|253|253.0||||||
4098154|NCT00982007|3922105|B2|United States||Region of Enrollment||participants|Number|253|253.0||||||
4098155|NCT00982007|3922106|B1|United States||Region of Enrollment||participants|Number|246|246.0||||||
4098156|NCT00982007|3922102|B5||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4098157|NCT00982007|3922103|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4098158|NCT00982007|3922104|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4098159|NCT00982007|3922105|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4098160|NCT00982007|3922106|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4098161|NCT00982007|3922102|B5||Female|Sex: Female, Male||Participants|Count of Participants|941|941.0||||||
4098162|NCT00982007|3922103|B4||Female|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
4098163|NCT00982007|3922104|B3||Female|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
4098164|NCT00982007|3922105|B2||Female|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
4098165|NCT00982007|3922106|B1||Female|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
4098166|NCT00982007|3922102|B5|||Age||years|Mean|43.2|43.2|Standard Deviation|16.63|16.63|||
4098167|NCT00982007|3922103|B4|||Age||years|Mean|42.6|42.6|Standard Deviation|15.51|15.51|||
4098168|NCT00982007|3922104|B3|||Age||years|Mean|43.6|43.6|Standard Deviation|16.88|16.88|||
4098169|NCT00982007|3922105|B2|||Age||years|Mean|43.5|43.5|Standard Deviation|17.71|17.71|||
4098170|NCT00982007|3922106|B1|||Age||years|Mean|43.1|43.1|Standard Deviation|17.18|17.18|||
4098171|NCT00982007|3922102|B5||>=65 years|Age||Participants|Count of Participants|132|132.0||||||
4098172|NCT00982007|3922103|B4||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4098173|NCT00982007|3922104|B3||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
4098174|NCT00982007|3922105|B2||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4098175|NCT00982007|3922106|B1||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
4098176|NCT00982007|3922102|B5||Between 18 and 65 years|Age||Participants|Count of Participants|851|851.0||||||
4098177|NCT00982007|3922103|B4||Between 18 and 65 years|Age||Participants|Count of Participants|218|218.0||||||
4098178|NCT00982007|3922104|B3||Between 18 and 65 years|Age||Participants|Count of Participants|216|216.0||||||
4098179|NCT00982007|3922105|B2||Between 18 and 65 years|Age||Participants|Count of Participants|208|208.0||||||
4098180|NCT00982007|3922106|B1||Between 18 and 65 years|Age||Participants|Count of Participants|209|209.0||||||
4098181|NCT00982007|3922102|B5||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4098182|NCT00982007|3922103|B4||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4098183|NCT00982007|3922104|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4098184|NCT00982007|3922105|B2||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4098185|NCT00982007|3922106|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4098186|NCT00981825|3922119|B3|India||Region of Enrollment||participants|Number|22|22.0||||||
4098187|NCT00981825|3922120|B2|India||Region of Enrollment||participants|Number|11|11.0||||||
4098188|NCT00981825|3922121|B1|India||Region of Enrollment||participants|Number|11|11.0||||||
4098189|NCT00981825|3922119|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4098190|NCT00981825|3922120|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4098191|NCT00981825|3922121|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4098192|NCT00981825|3922119|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4098193|NCT00981825|3922120|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4098194|NCT00981825|3922121|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4098195|NCT00981825|3922119|B3|||Age||years|Mean|30.6|30.6|Standard Deviation|7.6|7.6|||
4098196|NCT00981825|3922120|B2|||Age||years|Mean|30.5|30.5|Standard Deviation|8.7|8.7|||
4098197|NCT00981825|3922121|B1|||Age||years|Mean|30.8|30.8|Standard Deviation|6.8|6.8|||
4098198|NCT00981825|3922119|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4098199|NCT00981825|3922120|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4098200|NCT00981825|3922121|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4098201|NCT00981825|3922119|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4098202|NCT00981825|3922120|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4098203|NCT00981825|3922121|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4098204|NCT00981825|3922119|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4098205|NCT00981825|3922120|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4098206|NCT00981825|3922121|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4098207|NCT00981812|3922128|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4098208|NCT00981812|3922128|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4098209|NCT00981812|3922128|B1||>=65 years|Age|Women 25 years of age or older with a highly suspicious breast mass recommended to biopsy.|Participants|Count of Participants|3|3.0||||||
4098210|NCT00981812|3922128|B1||Between 18 and 65 years|Age|Women 25 years of age or older with a highly suspicious breast mass recommended to biopsy.|Participants|Count of Participants|17|17.0||||||
4098211|NCT00981812|3922128|B1||<=18 years|Age|Women 25 years of age or older with a highly suspicious breast mass recommended to biopsy.|Participants|Count of Participants|0|0.0||||||
4098212|NCT00981747|3922132|B1|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4098213|NCT00981747|3922132|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098214|NCT00981747|3922132|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098215|NCT00981747|3922132|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4098216|NCT00981747|3922132|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098217|NCT00981747|3922132|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098218|NCT00981747|3922132|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098219|NCT00981747|3922132|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098220|NCT00981747|3922132|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4098221|NCT00981747|3922132|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4098222|NCT00981747|3922132|B1|||Age||years|Mean|63|63.0|Full Range|||45.0|76.0|
4098223|NCT00981669|3922150|B3|Brazil||Region of Enrollment||participants|Number|80|80.0||||||
4098224|NCT00981669|3922151|B2|Brazil||Region of Enrollment||participants|Number|40|40.0||||||
4098225|NCT00981669|3922152|B1|Brazil||Region of Enrollment||participants|Number|40|40.0||||||
4098226|NCT00981669|3922150|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4098227|NCT00981669|3922151|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4098228|NCT00981669|3922152|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4098229|NCT00981669|3922150|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4098230|NCT00981669|3922151|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4098231|NCT00981669|3922152|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4098232|NCT00981669|3922150|B3|||Age||years|Mean|28.7|28.7|Standard Deviation|6.2|6.2|||
4098233|NCT00981669|3922151|B2|||Age||years|Mean|28.2|28.2|Standard Deviation|6.2|6.2|||
4098234|NCT00981669|3922152|B1|||Age||years|Mean|29.2|29.2|Standard Deviation|6.6|6.6|||
4098235|NCT00981669|3922150|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4098236|NCT00981669|3922151|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4098237|NCT00981669|3922152|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4098238|NCT00981669|3922150|B3||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4098239|NCT00981669|3922151|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4098240|NCT00981669|3922152|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4098241|NCT00981669|3922150|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4098242|NCT00981669|3922151|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4098243|NCT00981669|3922152|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4098244|NCT00981630|3922161|B5|Australia||Region of Enrollment||Participants|Number|128|128.0||||||
4098245|NCT00981630|3922162|B4|Australia||Region of Enrollment||Participants|Number|32|32.0||||||
4098246|NCT00981630|3922163|B3|Australia||Region of Enrollment||Participants|Number|32|32.0||||||
4098247|NCT00981630|3922164|B2|Australia||Region of Enrollment||Participants|Number|32|32.0||||||
4098248|NCT00981630|3922165|B1|Australia||Region of Enrollment||Participants|Number|32|32.0||||||
4098249|NCT00981630|3922161|B5||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4098250|NCT00981630|3922162|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4098251|NCT00981630|3922163|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4098252|NCT00981630|3922164|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4098253|NCT00981630|3922165|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4098254|NCT00981630|3922161|B5||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4098255|NCT00981630|3922162|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4098256|NCT00981630|3922163|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4098257|NCT00981630|3922164|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4098258|NCT00981630|3922165|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4098259|NCT00981630|3922161|B5|||Age||Years|Mean|28.2|28.2|Standard Deviation|8.38|8.38|||
4098260|NCT00981630|3922162|B4|||Age||Years|Mean|29.4|29.4|Standard Deviation|8.43|8.43|||
4098261|NCT00981630|3922163|B3|||Age||Years|Mean|27.4|27.4|Standard Deviation|8.31|8.31|||
4098262|NCT00981630|3922164|B2|||Age||Years|Mean|26.7|26.7|Standard Deviation|9.17|9.17|||
4098263|NCT00981630|3922165|B1|||Age||Years|Mean|29.3|29.3|Standard Deviation|7.62|7.62|||
4098264|NCT00981630|3922161|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4098265|NCT00981630|3922162|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4098266|NCT00981630|3922163|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4098267|NCT00981630|3922164|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4098268|NCT00981630|3922165|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4098269|NCT00981630|3922161|B5||Between 18 and 65 years|Age||Participants|Count of Participants|128|128.0||||||
4098270|NCT00981630|3922162|B4||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4098271|NCT00981630|3922163|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4098272|NCT00981630|3922164|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4098273|NCT00981630|3922165|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4098274|NCT00981630|3922161|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4098275|NCT00981630|3922162|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4098276|NCT00981630|3922163|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4098277|NCT00981630|3922164|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4098278|NCT00981630|3922165|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4098279|NCT00981526|3922198|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4098280|NCT00981526|3922199|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4098281|NCT00981526|3922200|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4098282|NCT00981526|3922198|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4098283|NCT00981526|3922199|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4098284|NCT00981526|3922200|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4098285|NCT00981526|3922198|B3|||Age||years|Mean|43.22|43.22|Standard Deviation|11.56|11.56|||
4098286|NCT00981526|3922199|B2|||Age||years|Mean|44.68|44.68|Standard Deviation|11.02|11.02|||
4098287|NCT00981526|3922200|B1|||Age||years|Mean|41.65|41.65|Standard Deviation|12.14|12.14|||
4098288|NCT00981526|3922198|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4098289|NCT00981526|3922199|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4098290|NCT00981526|3922200|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4098291|NCT00981526|3922198|B3||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4098292|NCT00981526|3922199|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4098293|NCT00981526|3922200|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4098294|NCT00981526|3922198|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4098295|NCT00981526|3922199|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4098296|NCT00981526|3922200|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4098297|NCT00981461|3922217|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4098298|NCT00981461|3922218|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4098299|NCT00981461|3922219|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4098300|NCT00981461|3922217|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4098301|NCT00981461|3922218|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4098302|NCT00981461|3922219|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4098303|NCT00981461|3922217|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4098304|NCT00981461|3922218|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4098305|NCT00981461|3922219|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4098306|NCT00981461|3922217|B3||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4098307|NCT00981461|3922218|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4098308|NCT00981461|3922219|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4098309|NCT00981461|3922217|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4098310|NCT00981461|3922218|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4098311|NCT00981461|3922219|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4098312|NCT00981435|3922226|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4098313|NCT00981435|3922227|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098314|NCT00981435|3922228|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4098315|NCT00981435|3922229|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098316|NCT00981435|3922226|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098317|NCT00981435|3922227|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098318|NCT00981435|3922228|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098319|NCT00981435|3922229|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098320|NCT00981435|3922226|B4||White|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4098321|NCT00981435|3922227|B3||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4098322|NCT00981435|3922228|B2||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4098323|NCT00981435|3922229|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4098324|NCT00981435|3922226|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4098325|NCT00981435|3922227|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4098326|NCT00981435|3922228|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4098327|NCT00981435|3922229|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4098328|NCT00981435|3922226|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098329|NCT00981435|3922227|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098330|NCT00981435|3922228|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098331|NCT00981435|3922229|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098332|NCT00981435|3922226|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098333|NCT00981435|3922227|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098334|NCT00981435|3922228|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098335|NCT00981435|3922229|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098336|NCT00981435|3922226|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098337|NCT00981435|3922227|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098338|NCT00981435|3922228|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098339|NCT00981435|3922229|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098340|NCT00981435|3922226|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4098341|NCT00981435|3922227|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4098342|NCT00981435|3922228|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4098343|NCT00981435|3922229|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4098344|NCT00981435|3922226|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4098345|NCT00981435|3922227|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4098346|NCT00981435|3922228|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4098347|NCT00981435|3922229|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4098348|NCT00981435|3922226|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4098349|NCT00981435|3922227|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4098350|NCT00981435|3922228|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4098351|NCT00981435|3922229|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4098352|NCT00981435|3922226|B4||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4098353|NCT00981435|3922227|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4098354|NCT00981435|3922228|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4098355|NCT00981435|3922229|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4098356|NCT00981435|3922226|B4||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4098357|NCT00981435|3922227|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4098358|NCT00981435|3922228|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4098359|NCT00981435|3922229|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4098360|NCT00981435|3922226|B4|||Age||years|Mean|65|65.0|Standard Deviation|14|14.0|||
4098361|NCT00981435|3922227|B3|||Age||years|Mean|67|67.0|Standard Deviation|14|14.0|||
4098362|NCT00981435|3922228|B2|||Age||years|Mean|60|60.0|Standard Deviation|11|11.0|||
4098363|NCT00981435|3922229|B1|||Age||years|Mean|66|66.0|Standard Deviation|15|15.0|||
4098364|NCT00981409|3922242|B3|50-100 kg||Body weight|Participants were weighed at screening (within 10 days before randomisation). Analysis population was Full Analysis Set (FAS); all participants receiving at least one dose of medication (FPX or UFH) who had efficacy data and had a confirmed diagnosis of acute pulmonary thromboembolism (PE).|kilograms (kg)|Number|32|32.0||||||
4098365|NCT00981409|3922243|B2|50-100 kg||Body weight|Participants were weighed at screening (within 10 days before randomisation). Analysis population was Full Analysis Set (FAS); all participants receiving at least one dose of medication (FPX or UFH) who had efficacy data and had a confirmed diagnosis of acute pulmonary thromboembolism (PE).|kilograms (kg)|Number|9|9.0||||||
4098366|NCT00981409|3922244|B1|50-100 kg||Body weight|Participants were weighed at screening (within 10 days before randomisation). Analysis population was Full Analysis Set (FAS); all participants receiving at least one dose of medication (FPX or UFH) who had efficacy data and had a confirmed diagnosis of acute pulmonary thromboembolism (PE).|kilograms (kg)|Number|23|23.0||||||
4098367|NCT00981409|3922242|B3|<50 kg||Body weight|Participants were weighed at screening (within 10 days before randomisation). Analysis population was Full Analysis Set (FAS); all participants receiving at least one dose of medication (FPX or UFH) who had efficacy data and had a confirmed diagnosis of acute pulmonary thromboembolism (PE).|kilograms (kg)|Number|6|6.0||||||
4098368|NCT00981409|3922243|B2|<50 kg||Body weight|Participants were weighed at screening (within 10 days before randomisation). Analysis population was Full Analysis Set (FAS); all participants receiving at least one dose of medication (FPX or UFH) who had efficacy data and had a confirmed diagnosis of acute pulmonary thromboembolism (PE).|kilograms (kg)|Number|1|1.0||||||
4098369|NCT00981409|3922244|B1|<50 kg||Body weight|Participants were weighed at screening (within 10 days before randomisation). Analysis population was Full Analysis Set (FAS); all participants receiving at least one dose of medication (FPX or UFH) who had efficacy data and had a confirmed diagnosis of acute pulmonary thromboembolism (PE).|kilograms (kg)|Number|5|5.0||||||
4098370|NCT00981409|3922242|B3|Asian-Japanese||Race/Ethnicity, Customized|Analysis population was Full Analysis Set (FAS); all participants receiving at least one dose of medication (FPX or UFH) who had efficacy data and had a confirmed diagnosis of acute pulmonary thromboembolism (PE).|participants|Number|38|38.0||||||
4098371|NCT00981409|3922243|B2|Asian-Japanese||Race/Ethnicity, Customized|Analysis population was Full Analysis Set (FAS); all participants receiving at least one dose of medication (FPX or UFH) who had efficacy data and had a confirmed diagnosis of acute pulmonary thromboembolism (PE).|participants|Number|10|10.0||||||
4098372|NCT00981409|3922244|B1|Asian-Japanese||Race/Ethnicity, Customized|Analysis population was Full Analysis Set (FAS); all participants receiving at least one dose of medication (FPX or UFH) who had efficacy data and had a confirmed diagnosis of acute pulmonary thromboembolism (PE).|participants|Number|28|28.0||||||
4098373|NCT00981409|3922242|B3||Male|Gender|Analysis population was Full Analysis Set (FAS); all participants receiving at least one dose of medication (FPX or UFH) who had efficacy data and had a confirmed diagnosis of acute pulmonary thromboembolism (PE).|Participants|Count of Participants|18|18.0||||||
4098426|NCT00981292|3922284|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4098427|NCT00981292|3922278|B7||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4098374|NCT00981409|3922243|B2||Male|Gender|Analysis population was Full Analysis Set (FAS); all participants receiving at least one dose of medication (FPX or UFH) who had efficacy data and had a confirmed diagnosis of acute pulmonary thromboembolism (PE).|Participants|Count of Participants|3|3.0||||||
4098375|NCT00981409|3922244|B1||Male|Gender|Analysis population was Full Analysis Set (FAS); all participants receiving at least one dose of medication (FPX or UFH) who had efficacy data and had a confirmed diagnosis of acute pulmonary thromboembolism (PE).|Participants|Count of Participants|15|15.0||||||
4098376|NCT00981409|3922242|B3||Female|Gender|Analysis population was Full Analysis Set (FAS); all participants receiving at least one dose of medication (FPX or UFH) who had efficacy data and had a confirmed diagnosis of acute pulmonary thromboembolism (PE).|Participants|Count of Participants|20|20.0||||||
4098377|NCT00981409|3922243|B2||Female|Gender|Analysis population was Full Analysis Set (FAS); all participants receiving at least one dose of medication (FPX or UFH) who had efficacy data and had a confirmed diagnosis of acute pulmonary thromboembolism (PE).|Participants|Count of Participants|7|7.0||||||
4098378|NCT00981409|3922244|B1||Female|Gender|Analysis population was Full Analysis Set (FAS); all participants receiving at least one dose of medication (FPX or UFH) who had efficacy data and had a confirmed diagnosis of acute pulmonary thromboembolism (PE).|Participants|Count of Participants|13|13.0||||||
4098379|NCT00981409|3922242|B3|||Age|Analysis population was Full Analysis Set (FAS); all participants receiving at least one dose of medication (FPX or UFH) who had efficacy data and had a confirmed diagnosis of acute pulmonary thromboembolism (PE).|years|Mean|67.0|67.0|Standard Deviation|12.2|12.2|||
4098380|NCT00981409|3922243|B2|||Age|Analysis population was Full Analysis Set (FAS); all participants receiving at least one dose of medication (FPX or UFH) who had efficacy data and had a confirmed diagnosis of acute pulmonary thromboembolism (PE).|years|Mean|62.6|62.6|Standard Deviation|14.1|14.1|||
4098381|NCT00981409|3922244|B1|||Age|Analysis population was Full Analysis Set (FAS); all participants receiving at least one dose of medication (FPX or UFH) who had efficacy data and had a confirmed diagnosis of acute pulmonary thromboembolism (PE).|years|Mean|68.5|68.5|Standard Deviation|11.4|11.4|||
4098382|NCT00981370|3922259|B1|||Liver Iron Concentration > 8mg/g dry weight||||0|0.0||||||
4098383|NCT00981370|3922259|B1||Male|Gender||||0|0.0||||||
4098384|NCT00981370|3922259|B1||Female|Gender||||0|0.0||||||
4098385|NCT00981370|3922259|B1|||Age, Customized||||0|0.0||||||
4098386|NCT00981305|3922263|B3|No||Tamoxifen treatment||participants|Number|34|34.0||||||
4098387|NCT00981305|3922264|B2|No||Tamoxifen treatment||participants|Number|17|17.0||||||
4098388|NCT00981305|3922265|B1|No||Tamoxifen treatment||participants|Number|17|17.0||||||
4098389|NCT00981305|3922263|B3|Yes||Tamoxifen treatment||participants|Number|73|73.0||||||
4098390|NCT00981305|3922264|B2|Yes||Tamoxifen treatment||participants|Number|40|40.0||||||
4098391|NCT00981305|3922265|B1|Yes||Tamoxifen treatment||participants|Number|33|33.0||||||
4098392|NCT00981305|3922263|B3|No||Menopause||participants|Number|31|31.0||||||
4098393|NCT00981305|3922264|B2|No||Menopause||participants|Number|16|16.0||||||
4098394|NCT00981305|3922265|B1|No||Menopause||participants|Number|15|15.0||||||
4098395|NCT00981305|3922263|B3|Yes||Menopause||participants|Number|76|76.0||||||
4098396|NCT00981305|3922264|B2|Yes||Menopause||participants|Number|41|41.0||||||
4098397|NCT00981305|3922265|B1|Yes||Menopause||participants|Number|35|35.0||||||
4098398|NCT00981305|3922263|B3|||Body mass index||kg/m^2|Mean|23.2|23.2|Standard Deviation|2.9|2.9|||
4098399|NCT00981305|3922264|B2|||Body mass index||kg/m^2|Mean|23.3|23.3|Standard Deviation|3.3|3.3|||
4098400|NCT00981305|3922265|B1|||Body mass index||kg/m^2|Mean|23.1|23.1|Standard Deviation|2.4|2.4|||
4098401|NCT00981305|3922263|B3|||Parity||pregnancies|Median|2|2.0|Full Range|||0.0|5.0|
4098402|NCT00981305|3922264|B2|||Parity||pregnancies|Median|2|2.0|Full Range|||0.0|5.0|
4098403|NCT00981305|3922265|B1|||Parity||pregnancies|Median|2|2.0|Full Range|||0.0|3.0|
4098404|NCT00981305|3922263|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4098405|NCT00981305|3922264|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4098406|NCT00981305|3922265|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4098407|NCT00981305|3922263|B3||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4098408|NCT00981305|3922264|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4098409|NCT00981305|3922265|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4098410|NCT00981305|3922263|B3|||Age||years|Mean|48.8|48.8|Standard Deviation|5.6|5.6|||
4098411|NCT00981305|3922264|B2|||Age||years|Mean|49.0|49.0|Standard Deviation|5.2|5.2|||
4098412|NCT00981305|3922265|B1|||Age||years|Mean|48.6|48.6|Standard Deviation|6.0|6.0|||
4098413|NCT00981292|3922278|B7|United Kingdom||Region of Enrollment||participants|Number|32|32.0||||||
4098414|NCT00981292|3922279|B6|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
4098415|NCT00981292|3922280|B5|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4098416|NCT00981292|3922281|B4|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4098417|NCT00981292|3922282|B3|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4098418|NCT00981292|3922283|B2|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4098419|NCT00981292|3922284|B1|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
4098420|NCT00981292|3922278|B7||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4098421|NCT00981292|3922279|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4098422|NCT00981292|3922280|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4098423|NCT00981292|3922281|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4098424|NCT00981292|3922282|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4098425|NCT00981292|3922283|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4098428|NCT00981292|3922279|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4098429|NCT00981292|3922280|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4098430|NCT00981292|3922281|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4098431|NCT00981292|3922282|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4098432|NCT00981292|3922283|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4098433|NCT00981292|3922284|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4098434|NCT00981292|3922278|B7|||Age||years|Mean|22|22.0|Standard Deviation|4|4.0|||
4098435|NCT00981292|3922279|B6|||Age||years|Mean|22|22.0|Standard Deviation|4|4.0|||
4098436|NCT00981292|3922280|B5|||Age||years|Mean|22|22.0|Standard Deviation|4|4.0|||
4098437|NCT00981292|3922281|B4|||Age||years|Mean|22|22.0|Standard Deviation|4|4.0|||
4098438|NCT00981292|3922282|B3|||Age||years|Mean|22|22.0|Standard Deviation|4|4.0|||
4098439|NCT00981292|3922283|B2|||Age||years|Mean|22|22.0|Standard Deviation|4|4.0|||
4098440|NCT00981292|3922284|B1|||Age||years|Mean|22|22.0|Standard Deviation|4|4.0|||
4098441|NCT00981292|3922278|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4098442|NCT00981292|3922279|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4098443|NCT00981292|3922280|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4098444|NCT00981292|3922281|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4098445|NCT00981292|3922282|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4098446|NCT00981292|3922283|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4098447|NCT00981292|3922284|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4098448|NCT00981292|3922278|B7||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4098449|NCT00981292|3922279|B6||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4098450|NCT00981292|3922280|B5||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4098451|NCT00981292|3922281|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4098452|NCT00981292|3922282|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4098453|NCT00981292|3922283|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4098454|NCT00981292|3922284|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4098455|NCT00981292|3922278|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4098456|NCT00981292|3922279|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4098457|NCT00981292|3922280|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4098458|NCT00981292|3922281|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4098459|NCT00981292|3922282|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4098460|NCT00981292|3922283|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4098461|NCT00981292|3922284|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4098462|NCT00981253|3922306|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098463|NCT00981253|3922307|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098464|NCT00981253|3922308|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098465|NCT00981253|3922306|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098466|NCT00981253|3922307|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098467|NCT00981253|3922308|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098468|NCT00981253|3922306|B3||White|Race (NIH/OMB)||Participants|Count of Participants|109|109.0||||||
4098469|NCT00981253|3922307|B2||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4098470|NCT00981253|3922308|B1||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4098471|NCT00981253|3922306|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4098472|NCT00981253|3922307|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4098473|NCT00981253|3922308|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4098474|NCT00981253|3922306|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098475|NCT00981253|3922307|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098476|NCT00981253|3922308|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098477|NCT00981253|3922306|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4098478|NCT00981253|3922307|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4098479|NCT00981253|3922308|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4098480|NCT00981253|3922306|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098481|NCT00981253|3922307|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098482|NCT00981253|3922308|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4098483|NCT00981253|3922306|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4098484|NCT00981253|3922307|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4098485|NCT00981253|3922308|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4098486|NCT00981253|3922306|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4098487|NCT00981253|3922307|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4098488|NCT00981253|3922308|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4098489|NCT00981253|3922306|B3|||Age||years|Mean|61.0|61.0|Standard Deviation|10.6|10.6|||
4098490|NCT00981253|3922307|B2|||Age||years|Mean|60.4|60.4|Standard Deviation|10.6|10.6|||
4098491|NCT00981253|3922308|B1|||Age||years|Mean|61.8|61.8|Standard Deviation|10.8|10.8|||
4098492|NCT00981227|3922327|B7||Male|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
4098493|NCT00981227|3922328|B6||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4098494|NCT00981227|3922329|B5||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4098495|NCT00981227|3922330|B4||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4098496|NCT00981227|3922331|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4098497|NCT00981227|3922332|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4098498|NCT00981227|3922333|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4098499|NCT00981227|3922327|B7||Female|Sex: Female, Male||Participants|Count of Participants|341|341.0||||||
4098500|NCT00981227|3922328|B6||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4098501|NCT00981227|3922329|B5||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4098502|NCT00981227|3922330|B4||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4098503|NCT00981227|3922331|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4098504|NCT00981227|3922332|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4098505|NCT00981227|3922333|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4098506|NCT00981227|3922327|B7|>=65 years||Age, Customized||participants|Number|357|357.0||||||
4098507|NCT00981227|3922328|B6|>=65 years||Age, Customized||participants|Number|55|55.0||||||
4098508|NCT00981227|3922329|B5|>=65 years||Age, Customized||participants|Number|60|60.0||||||
4098509|NCT00981227|3922330|B4|>=65 years||Age, Customized||participants|Number|57|57.0||||||
4098510|NCT00981227|3922331|B3|>=65 years||Age, Customized||participants|Number|59|59.0||||||
4098511|NCT00981227|3922332|B2|>=65 years||Age, Customized||participants|Number|58|58.0||||||
4098512|NCT00981227|3922333|B1|>=65 years||Age, Customized||participants|Number|68|68.0||||||
4098513|NCT00981227|3922327|B7|Between 18 and 65 years||Age, Customized||participants|Number|210|210.0||||||
4098514|NCT00981227|3922328|B6|Between 18 and 65 years||Age, Customized||participants|Number|38|38.0||||||
4098515|NCT00981227|3922329|B5|Between 18 and 65 years||Age, Customized||participants|Number|30|30.0||||||
4098516|NCT00981227|3922330|B4|Between 18 and 65 years||Age, Customized||participants|Number|37|37.0||||||
4098517|NCT00981227|3922331|B3|Between 18 and 65 years||Age, Customized||participants|Number|35|35.0||||||
4098518|NCT00981227|3922332|B2|Between 18 and 65 years||Age, Customized||participants|Number|36|36.0||||||
4098519|NCT00981227|3922333|B1|Between 18 and 65 years||Age, Customized||participants|Number|34|34.0||||||
4098520|NCT00981227|3922327|B7|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4098521|NCT00981227|3922328|B6|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4098522|NCT00981227|3922329|B5|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4098523|NCT00981227|3922330|B4|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4098524|NCT00981227|3922331|B3|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4098525|NCT00981227|3922332|B2|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4098526|NCT00981227|3922333|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4098527|NCT00981214|3922356|B1|||Percentage of Participants Who Were Responders|Responders were defined as those participants without steatorrhea (defined as less than 30 percent (%) fecal fat content) and without signs and symptoms of malabsorption at baseline (under currently available pancreatic enzyme products taken during the screening period).|percentage of participants|Number|52.6|52.6||||||
4098528|NCT00981214|3922356|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4098529|NCT00981214|3922356|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4098530|NCT00981214|3922356|B1|||Age||years|Mean|3.9|3.9|Standard Deviation|1.58|1.58|||
4098531|NCT00981175|3922370|B4|Australia||Region of Enrollment||participants|Number|202|202.0||||||
4098532|NCT00981175|3922372|B2|Australia||Region of Enrollment||participants|Number|101|101.0||||||
4098533|NCT00981175|3922373|B1|Australia||Region of Enrollment||participants|Number|101|101.0||||||
4098534|NCT00981175|3922370|B4|Male||Gender||participants|Number|174|174.0||||||
4098535|NCT00981175|3922372|B2|Male||Gender||participants|Number|86|86.0||||||
4098536|NCT00981175|3922373|B1|Male||Gender||participants|Number|88|88.0||||||
4098537|NCT00981175|3922370|B4|Female||Gender||participants|Number|28|28.0||||||
4098538|NCT00981175|3922372|B2|Female||Gender||participants|Number|15|15.0||||||
4098539|NCT00981175|3922373|B1|Female||Gender||participants|Number|13|13.0||||||
4098540|NCT00981175|3922370|B4|||Age||Years|Mean|26.9|26.9|Standard Deviation|7.84|7.84|||
4098541|NCT00981175|3922372|B2|||Age||Years|Mean|27.7|27.7|Standard Deviation|8.25|8.25|||
4098542|NCT00981175|3922373|B1|||Age||Years|Mean|26.1|26.1|Standard Deviation|7.36|7.36|||
4098543|NCT00981175|3922370|B4|>=65 years||Age||participants|Number|0|0.0||||||
4098544|NCT00981175|3922372|B2|>=65 years||Age||participants|Number|0|0.0||||||
4098545|NCT00981175|3922373|B1|>=65 years||Age||participants|Number|0|0.0||||||
4098546|NCT00981175|3922370|B4|Between 18 and 65 years||Age||participants|Number|202|202.0||||||
4098547|NCT00981175|3922372|B2|Between 18 and 65 years||Age||participants|Number|101|101.0||||||
4098548|NCT00981175|3922373|B1|Between 18 and 65 years||Age||participants|Number|101|101.0||||||
4098549|NCT00981175|3922370|B4|<=18 years||Age||participants|Number|0|0.0||||||
4098550|NCT00981175|3922372|B2|<=18 years||Age||participants|Number|0|0.0||||||
4098551|NCT00981175|3922373|B1|<=18 years||Age||participants|Number|0|0.0||||||
4098552|NCT00981149|3922397|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4098553|NCT00981149|3922398|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4098554|NCT00981149|3922399|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4098555|NCT00981149|3922397|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4098556|NCT00981149|3922398|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4098557|NCT00981149|3922399|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4098558|NCT00981149|3922397|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4098559|NCT00981149|3922398|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4098560|NCT00981149|3922399|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4098561|NCT00981149|3922397|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4098562|NCT00981149|3922398|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4098563|NCT00981149|3922399|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4098564|NCT00981149|3922397|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4098565|NCT00981149|3922398|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4098566|NCT00981149|3922399|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4098567|NCT00981149|3922397|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4098568|NCT00981149|3922398|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4098569|NCT00981149|3922399|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4098570|NCT00981149|3922397|B3|18 to 65 years||Age, Customized||Participants|Count of Participants|24|24.0||||||
4098571|NCT00981149|3922398|B2|18 to 65 years||Age, Customized||Participants|Count of Participants|12|12.0||||||
4098572|NCT00981149|3922399|B1|18 to 65 years||Age, Customized||Participants|Count of Participants|12|12.0||||||
4098573|NCT00981084|3922408|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
4098574|NCT00981084|3922409|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4098575|NCT00981084|3922410|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4098576|NCT00981084|3922408|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4098577|NCT00981084|3922409|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4098578|NCT00981084|3922410|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4098579|NCT00981084|3922408|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4098580|NCT00981084|3922409|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4098581|NCT00981084|3922410|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4098582|NCT00981084|3922408|B3|||Age||years|Mean|49.15|49.15|Standard Deviation|6.54|6.54|||
4098583|NCT00981084|3922409|B2|||Age||years|Mean|49.94|49.94|Standard Deviation|7.22|7.22|||
4098584|NCT00981084|3922410|B1|||Age||years|Mean|47.71|47.71|Standard Deviation|5.89|5.89|||
4098585|NCT00981084|3922408|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4098586|NCT00981084|3922409|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4098587|NCT00981084|3922410|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4098588|NCT00981084|3922408|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4098589|NCT00981084|3922409|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4098590|NCT00981084|3922410|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4098591|NCT00981084|3922408|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4098592|NCT00981084|3922409|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4098593|NCT00981084|3922410|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4098594|NCT00981058|3922425|B3|Other||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|302|302.0||||||
4098595|NCT00981058|3922426|B2|Other||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|146|146.0||||||
4098596|NCT00981058|3922427|B1|Other||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|156|156.0||||||
4098597|NCT00981058|3922425|B3|Soft Tissue||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|44|44.0||||||
4098598|NCT00981058|3922426|B2|Soft Tissue||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|21|21.0||||||
4098599|NCT00981058|3922427|B1|Soft Tissue||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|23|23.0||||||
4098600|NCT00981058|3922425|B3|Skin||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|17|17.0||||||
4098601|NCT00981058|3922426|B2|Skin||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|8|8.0||||||
4098602|NCT00981058|3922427|B1|Skin||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|9|9.0||||||
4098603|NCT00981058|3922425|B3|Pleural||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|304|304.0||||||
4098604|NCT00981058|3922426|B2|Pleural||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|155|155.0||||||
4098605|NCT00981058|3922427|B1|Pleural||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|149|149.0||||||
4098606|NCT00981058|3922425|B3|Peritoneal||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|37|37.0||||||
4098607|NCT00981058|3922426|B2|Peritoneal||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|17|17.0||||||
4098608|NCT00981058|3922427|B1|Peritoneal||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|20|20.0||||||
4098609|NCT00981058|3922425|B3|Lymph Nodes||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|882|882.0||||||
4098610|NCT00981058|3922426|B2|Lymph Nodes||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|451|451.0||||||
4098611|NCT00981058|3922427|B1|Lymph Nodes||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|431|431.0||||||
4098612|NCT00981058|3922425|B3|Lung||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|906|906.0||||||
4098613|NCT00981058|3922426|B2|Lung||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|453|453.0||||||
4098614|NCT00981058|3922427|B1|Lung||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|453|453.0||||||
4098615|NCT00981058|3922425|B3|Liver||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|226|226.0||||||
4098616|NCT00981058|3922426|B2|Liver||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|117|117.0||||||
4098617|NCT00981058|3922427|B1|Liver||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|109|109.0||||||
4098618|NCT00981058|3922425|B3|Brain||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|58|58.0||||||
4098619|NCT00981058|3922426|B2|Brain||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|30|30.0||||||
4098620|NCT00981058|3922427|B1|Brain||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|28|28.0||||||
4098621|NCT00981058|3922425|B3|Bone||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|251|251.0||||||
4098622|NCT00981058|3922426|B2|Bone||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|131|131.0||||||
4098623|NCT00981058|3922427|B1|Bone||Sites of Metastatic Disease|Participants may record multiple sites of metastatic disease.|participants|Number|120|120.0||||||
4098624|NCT00981058|3922425|B3|Other Histology||Disease Histology||participants|Number|5|5.0||||||
4098625|NCT00981058|3922426|B2|Other Histology||Disease Histology||participants|Number|3|3.0||||||
4098626|NCT00981058|3922427|B1|Other Histology||Disease Histology||participants|Number|2|2.0||||||
4098627|NCT00981058|3922425|B3|Squamous||Disease Histology||participants|Number|1088|1088.0||||||
4098628|NCT00981058|3922426|B2|Squamous||Disease Histology||participants|Number|545|545.0||||||
4098629|NCT00981058|3922427|B1|Squamous||Disease Histology||participants|Number|543|543.0||||||
4098630|NCT00981058|3922425|B3|Missing||Disease Stage at Study Entry|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIB - the cancer has spread to nearby tissue or spread to far away lymph nodes. Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|participants|Number|2|2.0||||||
4098631|NCT00981058|3922426|B2|Missing||Disease Stage at Study Entry|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIB - the cancer has spread to nearby tissue or spread to far away lymph nodes. Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|participants|Number|1|1.0||||||
4098632|NCT00981058|3922427|B1|Missing||Disease Stage at Study Entry|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIB - the cancer has spread to nearby tissue or spread to far away lymph nodes. Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|participants|Number|1|1.0||||||
4098633|NCT00981058|3922425|B3|Stage IV||Disease Stage at Study Entry|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIB - the cancer has spread to nearby tissue or spread to far away lymph nodes. Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|participants|Number|1089|1089.0||||||
4098634|NCT00981058|3922426|B2|Stage IV||Disease Stage at Study Entry|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIB - the cancer has spread to nearby tissue or spread to far away lymph nodes. Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|participants|Number|546|546.0||||||
4098635|NCT00981058|3922427|B1|Stage IV||Disease Stage at Study Entry|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIB - the cancer has spread to nearby tissue or spread to far away lymph nodes. Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|participants|Number|543|543.0||||||
4098636|NCT00981058|3922425|B3|Stage IIIB||Disease Stage at Study Entry|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIB - the cancer has spread to nearby tissue or spread to far away lymph nodes. Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|participants|Number|2|2.0||||||
4098637|NCT00981058|3922426|B2|Stage IIIB||Disease Stage at Study Entry|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIB - the cancer has spread to nearby tissue or spread to far away lymph nodes. Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|participants|Number|1|1.0||||||
4098674|NCT00981058|3922427|B1|Italy||Region of Enrollment||participants|Number|13|13.0||||||
4098675|NCT00981058|3922425|B3|Taiwan||Region of Enrollment||participants|Number|5|5.0||||||
4098638|NCT00981058|3922427|B1|Stage IIIB||Disease Stage at Study Entry|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIB - the cancer has spread to nearby tissue or spread to far away lymph nodes. Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|participants|Number|1|1.0||||||
4098639|NCT00981058|3922425|B3|Missing||Smoking History||participants|Number|1|1.0||||||
4098640|NCT00981058|3922426|B2|Missing||Smoking History||participants|Number|0|0.0||||||
4098641|NCT00981058|3922427|B1|Missing||Smoking History||participants|Number|1|1.0||||||
4098642|NCT00981058|3922425|B3|Smoker||Smoking History||participants|Number|995|995.0||||||
4098643|NCT00981058|3922426|B2|Smoker||Smoking History||participants|Number|495|495.0||||||
4098644|NCT00981058|3922427|B1|Smoker||Smoking History||participants|Number|500|500.0||||||
4098645|NCT00981058|3922425|B3|Non-Smoker||Smoking History||participants|Number|53|53.0||||||
4098646|NCT00981058|3922426|B2|Non-Smoker||Smoking History||participants|Number|27|27.0||||||
4098647|NCT00981058|3922427|B1|Non-Smoker||Smoking History||participants|Number|26|26.0||||||
4098648|NCT00981058|3922425|B3|Ex-Light Smoker||Smoking History||participants|Number|44|44.0||||||
4098649|NCT00981058|3922426|B2|Ex-Light Smoker||Smoking History||participants|Number|26|26.0||||||
4098650|NCT00981058|3922427|B1|Ex-Light Smoker||Smoking History||participants|Number|18|18.0||||||
4098651|NCT00981058|3922425|B3|3||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) at Baseline|ECOG classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 1 participant with ECOG PS 3 was randomized to the Gemcitabine + Cisplatin arm but did not receive treatment.|participants|Number|1|1.0||||||
4098652|NCT00981058|3922426|B2|3||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) at Baseline|ECOG classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 1 participant with ECOG PS 3 was randomized to the Gemcitabine + Cisplatin arm but did not receive treatment.|participants|Number|1|1.0||||||
4098653|NCT00981058|3922427|B1|3||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) at Baseline|ECOG classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 1 participant with ECOG PS 3 was randomized to the Gemcitabine + Cisplatin arm but did not receive treatment.|participants|Number|0|0.0||||||
4098654|NCT00981058|3922425|B3|2||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) at Baseline|ECOG classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 1 participant with ECOG PS 3 was randomized to the Gemcitabine + Cisplatin arm but did not receive treatment.|participants|Number|96|96.0||||||
4098655|NCT00981058|3922426|B2|2||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) at Baseline|ECOG classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 1 participant with ECOG PS 3 was randomized to the Gemcitabine + Cisplatin arm but did not receive treatment.|participants|Number|47|47.0||||||
4098656|NCT00981058|3922427|B1|2||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) at Baseline|ECOG classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 1 participant with ECOG PS 3 was randomized to the Gemcitabine + Cisplatin arm but did not receive treatment.|participants|Number|49|49.0||||||
4098657|NCT00981058|3922425|B3|1||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) at Baseline|ECOG classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 1 participant with ECOG PS 3 was randomized to the Gemcitabine + Cisplatin arm but did not receive treatment.|participants|Number|652|652.0||||||
4098658|NCT00981058|3922426|B2|1||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) at Baseline|ECOG classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 1 participant with ECOG PS 3 was randomized to the Gemcitabine + Cisplatin arm but did not receive treatment.|participants|Number|320|320.0||||||
4098659|NCT00981058|3922427|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) at Baseline|ECOG classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 1 participant with ECOG PS 3 was randomized to the Gemcitabine + Cisplatin arm but did not receive treatment.|participants|Number|332|332.0||||||
4098660|NCT00981058|3922425|B3|0||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) at Baseline|ECOG classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 1 participant with ECOG PS 3 was randomized to the Gemcitabine + Cisplatin arm but did not receive treatment.|participants|Number|344|344.0||||||
4098661|NCT00981058|3922426|B2|0||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) at Baseline|ECOG classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 1 participant with ECOG PS 3 was randomized to the Gemcitabine + Cisplatin arm but did not receive treatment.|participants|Number|180|180.0||||||
4098662|NCT00981058|3922427|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) at Baseline|ECOG classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 1 participant with ECOG PS 3 was randomized to the Gemcitabine + Cisplatin arm but did not receive treatment.|participants|Number|164|164.0||||||
4098663|NCT00981058|3922425|B3|Germany||Region of Enrollment||participants|Number|108|108.0||||||
4098664|NCT00981058|3922426|B2|Germany||Region of Enrollment||participants|Number|59|59.0||||||
4098665|NCT00981058|3922427|B1|Germany||Region of Enrollment||participants|Number|49|49.0||||||
4098666|NCT00981058|3922425|B3|Australia||Region of Enrollment||participants|Number|10|10.0||||||
4098667|NCT00981058|3922426|B2|Australia||Region of Enrollment||participants|Number|6|6.0||||||
4098668|NCT00981058|3922427|B1|Australia||Region of Enrollment||participants|Number|4|4.0||||||
4098669|NCT00981058|3922425|B3|South Africa||Region of Enrollment||participants|Number|4|4.0||||||
4098670|NCT00981058|3922426|B2|South Africa||Region of Enrollment||participants|Number|2|2.0||||||
4098671|NCT00981058|3922427|B1|South Africa||Region of Enrollment||participants|Number|2|2.0||||||
4098672|NCT00981058|3922425|B3|Italy||Region of Enrollment||participants|Number|25|25.0||||||
4098673|NCT00981058|3922426|B2|Italy||Region of Enrollment||participants|Number|12|12.0||||||
4098676|NCT00981058|3922426|B2|Taiwan||Region of Enrollment||participants|Number|2|2.0||||||
4098677|NCT00981058|3922427|B1|Taiwan||Region of Enrollment||participants|Number|3|3.0||||||
4098678|NCT00981058|3922425|B3|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
4098679|NCT00981058|3922426|B2|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
4098680|NCT00981058|3922427|B1|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
4098681|NCT00981058|3922425|B3|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4098682|NCT00981058|3922426|B2|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4098683|NCT00981058|3922427|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4098684|NCT00981058|3922425|B3|Spain||Region of Enrollment||participants|Number|58|58.0||||||
4098685|NCT00981058|3922426|B2|Spain||Region of Enrollment||participants|Number|25|25.0||||||
4098686|NCT00981058|3922427|B1|Spain||Region of Enrollment||participants|Number|33|33.0||||||
4098687|NCT00981058|3922425|B3|United Kingdom||Region of Enrollment||participants|Number|19|19.0||||||
4098688|NCT00981058|3922426|B2|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
4098689|NCT00981058|3922427|B1|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
4098690|NCT00981058|3922425|B3|Philippines||Region of Enrollment||participants|Number|20|20.0||||||
4098691|NCT00981058|3922426|B2|Philippines||Region of Enrollment||participants|Number|8|8.0||||||
4098692|NCT00981058|3922427|B1|Philippines||Region of Enrollment||participants|Number|12|12.0||||||
4098693|NCT00981058|3922425|B3|Hungary||Region of Enrollment||participants|Number|84|84.0||||||
4098694|NCT00981058|3922426|B2|Hungary||Region of Enrollment||participants|Number|41|41.0||||||
4098695|NCT00981058|3922427|B1|Hungary||Region of Enrollment||participants|Number|43|43.0||||||
4098696|NCT00981058|3922425|B3|Romania||Region of Enrollment||participants|Number|91|91.0||||||
4098697|NCT00981058|3922426|B2|Romania||Region of Enrollment||participants|Number|45|45.0||||||
4098698|NCT00981058|3922427|B1|Romania||Region of Enrollment||participants|Number|46|46.0||||||
4098699|NCT00981058|3922425|B3|Croatia||Region of Enrollment||participants|Number|6|6.0||||||
4098700|NCT00981058|3922426|B2|Croatia||Region of Enrollment||participants|Number|4|4.0||||||
4098701|NCT00981058|3922427|B1|Croatia||Region of Enrollment||participants|Number|2|2.0||||||
4098702|NCT00981058|3922425|B3|Serbia||Region of Enrollment||participants|Number|24|24.0||||||
4098703|NCT00981058|3922426|B2|Serbia||Region of Enrollment||participants|Number|13|13.0||||||
4098704|NCT00981058|3922427|B1|Serbia||Region of Enrollment||participants|Number|11|11.0||||||
4098705|NCT00981058|3922425|B3|France||Region of Enrollment||participants|Number|73|73.0||||||
4098706|NCT00981058|3922426|B2|France||Region of Enrollment||participants|Number|39|39.0||||||
4098707|NCT00981058|3922427|B1|France||Region of Enrollment||participants|Number|34|34.0||||||
4098708|NCT00981058|3922425|B3|Slovakia||Region of Enrollment||participants|Number|19|19.0||||||
4098709|NCT00981058|3922426|B2|Slovakia||Region of Enrollment||participants|Number|10|10.0||||||
4098710|NCT00981058|3922427|B1|Slovakia||Region of Enrollment||participants|Number|9|9.0||||||
4098711|NCT00981058|3922425|B3|Poland||Region of Enrollment||participants|Number|128|128.0||||||
4098712|NCT00981058|3922426|B2|Poland||Region of Enrollment||participants|Number|59|59.0||||||
4098713|NCT00981058|3922427|B1|Poland||Region of Enrollment||participants|Number|69|69.0||||||
4098714|NCT00981058|3922425|B3|Korea, Republic of||Region of Enrollment||participants|Number|47|47.0||||||
4098715|NCT00981058|3922426|B2|Korea, Republic of||Region of Enrollment||participants|Number|23|23.0||||||
4098716|NCT00981058|3922427|B1|Korea, Republic of||Region of Enrollment||participants|Number|24|24.0||||||
4098717|NCT00981058|3922425|B3|Brazil||Region of Enrollment||participants|Number|58|58.0||||||
4098718|NCT00981058|3922426|B2|Brazil||Region of Enrollment||participants|Number|30|30.0||||||
4098719|NCT00981058|3922427|B1|Brazil||Region of Enrollment||participants|Number|28|28.0||||||
4098720|NCT00981058|3922425|B3|Austria||Region of Enrollment||participants|Number|8|8.0||||||
4098721|NCT00981058|3922426|B2|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4098722|NCT00981058|3922427|B1|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4098723|NCT00981058|3922425|B3|Greece||Region of Enrollment||participants|Number|32|32.0||||||
4098724|NCT00981058|3922426|B2|Greece||Region of Enrollment||participants|Number|14|14.0||||||
4098725|NCT00981058|3922427|B1|Greece||Region of Enrollment||participants|Number|18|18.0||||||
4098726|NCT00981058|3922425|B3|Portugal||Region of Enrollment||participants|Number|17|17.0||||||
4098727|NCT00981058|3922426|B2|Portugal||Region of Enrollment||participants|Number|9|9.0||||||
4098728|NCT00981058|3922427|B1|Portugal||Region of Enrollment||participants|Number|8|8.0||||||
4098729|NCT00981058|3922425|B3|Thailand||Region of Enrollment||participants|Number|9|9.0||||||
4098730|NCT00981058|3922426|B2|Thailand||Region of Enrollment||participants|Number|6|6.0||||||
4098731|NCT00981058|3922427|B1|Thailand||Region of Enrollment||participants|Number|3|3.0||||||
4098732|NCT00981058|3922425|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4098733|NCT00981058|3922426|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4098734|NCT00981058|3922427|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4098735|NCT00981058|3922425|B3|Singapore||Region of Enrollment||participants|Number|3|3.0||||||
4098736|NCT00981058|3922426|B2|Singapore||Region of Enrollment||participants|Number|2|2.0||||||
4098737|NCT00981058|3922427|B1|Singapore||Region of Enrollment||participants|Number|1|1.0||||||
4098738|NCT00981058|3922425|B3|Russian Federation||Region of Enrollment||participants|Number|195|195.0||||||
4098739|NCT00981058|3922426|B2|Russian Federation||Region of Enrollment||participants|Number|101|101.0||||||
4098740|NCT00981058|3922427|B1|Russian Federation||Region of Enrollment||participants|Number|94|94.0||||||
4098741|NCT00981058|3922425|B3|Other||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
4098742|NCT00981058|3922426|B2|Other||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4098743|NCT00981058|3922427|B1|Other||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4098744|NCT00981058|3922425|B3|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4098745|NCT00981058|3922426|B2|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4098746|NCT00981058|3922427|B1|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4098747|NCT00981058|3922425|B3|White||Race/Ethnicity, Customized||participants|Number|913|913.0||||||
4098748|NCT00981058|3922426|B2|White||Race/Ethnicity, Customized||participants|Number|456|456.0||||||
4098749|NCT00981058|3922427|B1|White||Race/Ethnicity, Customized||participants|Number|457|457.0||||||
4098750|NCT00981058|3922425|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4098751|NCT00981058|3922426|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4098752|NCT00981058|3922427|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4098753|NCT00981058|3922425|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4098754|NCT00981058|3922426|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4098755|NCT00981058|3922427|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4098756|NCT00981058|3922425|B3|Asian||Race/Ethnicity, Customized||participants|Number|85|85.0||||||
4098757|NCT00981058|3922426|B2|Asian||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4098758|NCT00981058|3922427|B1|Asian||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4098759|NCT00981058|3922425|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4098760|NCT00981058|3922426|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4098761|NCT00981058|3922427|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4098762|NCT00981058|3922425|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4098763|NCT00981058|3922426|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4098764|NCT00981058|3922427|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4098765|NCT00981058|3922425|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|979|979.0||||||
4098766|NCT00981058|3922426|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|490|490.0||||||
4098767|NCT00981058|3922427|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|489|489.0||||||
4098768|NCT00981058|3922425|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
4098769|NCT00981058|3922426|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4098770|NCT00981058|3922427|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4098771|NCT00981058|3922425|B3||Male|Sex: Female, Male||Participants|Count of Participants|908|908.0||||||
4098772|NCT00981058|3922426|B2||Male|Sex: Female, Male||Participants|Count of Participants|458|458.0||||||
4098773|NCT00981058|3922427|B1||Male|Sex: Female, Male||Participants|Count of Participants|450|450.0||||||
4098774|NCT00981058|3922425|B3||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4098775|NCT00981058|3922426|B2||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4098776|NCT00981058|3922427|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4098777|NCT00981058|3922425|B3|||Age||years|Median|62.0|62.0|Full Range|||32.0|86.0|
4098778|NCT00981058|3922426|B2|||Age||years|Median|62.0|62.0|Full Range|||32.0|86.0|
4098779|NCT00981058|3922427|B1|||Age||years|Median|62.0|62.0|Full Range|||32.0|84.0|
4098780|NCT00981045|3922448|B3|United States||Region of Enrollment||participants|Number|2561|2561.0||||||
4098781|NCT00981045|3922449|B2|United States||Region of Enrollment||participants|Number|1285|1285.0||||||
4098782|NCT00981045|3922450|B1|United States||Region of Enrollment||participants|Number|1276|1276.0||||||
4098783|NCT00981045|3922448|B3||Male|Sex: Female, Male||Participants|Count of Participants|933|933.0||||||
4098784|NCT00981045|3922449|B2||Male|Sex: Female, Male||Participants|Count of Participants|467|467.0||||||
4098785|NCT00981045|3922450|B1||Male|Sex: Female, Male||Participants|Count of Participants|466|466.0||||||
4098786|NCT00981045|3922448|B3||Female|Sex: Female, Male||Participants|Count of Participants|1628|1628.0||||||
4098787|NCT00981045|3922449|B2||Female|Sex: Female, Male||Participants|Count of Participants|818|818.0||||||
4098788|NCT00981045|3922450|B1||Female|Sex: Female, Male||Participants|Count of Participants|810|810.0||||||
4098789|NCT00981045|3922448|B3|||Age||years|Mean|67.3|67.3|Standard Deviation|12.99|12.99|||
4098790|NCT00981045|3922449|B2|||Age||years|Mean|67.2|67.2|Standard Deviation|13.00|13.0|||
4098791|NCT00981045|3922450|B1|||Age||years|Mean|67.5|67.5|Standard Deviation|13.00|13.0|||
4098792|NCT00981045|3922448|B3||>=65 years|Age||Participants|Count of Participants|1593|1593.0||||||
4098793|NCT00981045|3922449|B2||>=65 years|Age||Participants|Count of Participants|785|785.0||||||
4098794|NCT00981045|3922450|B1||>=65 years|Age||Participants|Count of Participants|808|808.0||||||
4098795|NCT00981045|3922448|B3||Between 18 and 65 years|Age||Participants|Count of Participants|968|968.0||||||
4098796|NCT00981045|3922449|B2||Between 18 and 65 years|Age||Participants|Count of Participants|500|500.0||||||
4098797|NCT00981045|3922450|B1||Between 18 and 65 years|Age||Participants|Count of Participants|468|468.0||||||
4098798|NCT00981045|3922448|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4098799|NCT00981045|3922449|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4098800|NCT00981045|3922450|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4098801|NCT00981019|3922459|B1|United States||Region of Enrollment||participants|Number|778|778.0||||||
4098802|NCT00981019|3922459|B1||Male|Sex: Female, Male||Participants|Count of Participants|620|620.0||||||
4098803|NCT00981019|3922459|B1||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4098804|NCT00981019|3922459|B1|||Age||years|Mean|49|49.0|Standard Deviation|11.6|11.6|||
4098805|NCT00981019|3922459|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4098806|NCT00981019|3922459|B1||Between 18 and 65 years|Age||Participants|Count of Participants|778|778.0||||||
4098807|NCT00981019|3922459|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4098808|NCT00980980|3922463|B4|Intervention Participants||Overall Number of Participants, by Phase|"This table reflects number of admissions with an ICU stay during the Baseline and Intervention periods, separately. Please note that the table above, Overall Number of Baseline Participants reflects the total number of participants for which baseline characteristics were measured, across Baseline and Intervention phases combined."|Admissions|Number|74256|74256.0||||||
4098809|NCT00980980|3922464|B3|Intervention Participants||Overall Number of Participants, by Phase|"This table reflects number of admissions with an ICU stay during the Baseline and Intervention periods, separately. Please note that the table above, Overall Number of Baseline Participants reflects the total number of participants for which baseline characteristics were measured, across Baseline and Intervention phases combined."|Admissions|Number|26024|26024.0||||||
4098810|NCT00980980|3922465|B2|Intervention Participants||Overall Number of Participants, by Phase|"This table reflects number of admissions with an ICU stay during the Baseline and Intervention periods, separately. Please note that the table above, Overall Number of Baseline Participants reflects the total number of participants for which baseline characteristics were measured, across Baseline and Intervention phases combined."|Admissions|Number|24752|24752.0||||||
4098811|NCT00980980|3922466|B1|Intervention Participants||Overall Number of Participants, by Phase|"This table reflects number of admissions with an ICU stay during the Baseline and Intervention periods, separately. Please note that the table above, Overall Number of Baseline Participants reflects the total number of participants for which baseline characteristics were measured, across Baseline and Intervention phases combined."|Admissions|Number|23480|23480.0||||||
4098812|NCT00980980|3922463|B4|Baseline Participants||Overall Number of Participants, by Phase|"This table reflects number of admissions with an ICU stay during the Baseline and Intervention periods, separately. Please note that the table above, Overall Number of Baseline Participants reflects the total number of participants for which baseline characteristics were measured, across Baseline and Intervention phases combined."|Admissions|Number|48390|48390.0||||||
4098813|NCT00980980|3922464|B3|Baseline Participants||Overall Number of Participants, by Phase|"This table reflects number of admissions with an ICU stay during the Baseline and Intervention periods, separately. Please note that the table above, Overall Number of Baseline Participants reflects the total number of participants for which baseline characteristics were measured, across Baseline and Intervention phases combined."|Admissions|Number|17356|17356.0||||||
4098814|NCT00980980|3922465|B2|Baseline Participants||Overall Number of Participants, by Phase|"This table reflects number of admissions with an ICU stay during the Baseline and Intervention periods, separately. Please note that the table above, Overall Number of Baseline Participants reflects the total number of participants for which baseline characteristics were measured, across Baseline and Intervention phases combined."|Admissions|Number|15218|15218.0||||||
4098815|NCT00980980|3922466|B1|Baseline Participants||Overall Number of Participants, by Phase|"This table reflects number of admissions with an ICU stay during the Baseline and Intervention periods, separately. Please note that the table above, Overall Number of Baseline Participants reflects the total number of participants for which baseline characteristics were measured, across Baseline and Intervention phases combined."|Admissions|Number|15816|15816.0||||||
4098816|NCT00980980|3922463|B4|Males - Intervention||Sex/Gender, Customized|Proportion of female study participants, during baseline and intervention study phases.|participants|Number|39036|39036.0||||||
4098817|NCT00980980|3922464|B3|Males - Intervention||Sex/Gender, Customized|Proportion of female study participants, during baseline and intervention study phases.|participants|Number|13663|13663.0||||||
4098818|NCT00980980|3922465|B2|Males - Intervention||Sex/Gender, Customized|Proportion of female study participants, during baseline and intervention study phases.|participants|Number|13069|13069.0||||||
4098819|NCT00980980|3922466|B1|Males - Intervention||Sex/Gender, Customized|Proportion of female study participants, during baseline and intervention study phases.|participants|Number|12304|12304.0||||||
4098820|NCT00980980|3922463|B4|Females - Intervention||Sex/Gender, Customized|Proportion of female study participants, during baseline and intervention study phases.|participants|Number|35220|35220.0||||||
4098821|NCT00980980|3922464|B3|Females - Intervention||Sex/Gender, Customized|Proportion of female study participants, during baseline and intervention study phases.|participants|Number|12361|12361.0||||||
4098822|NCT00980980|3922465|B2|Females - Intervention||Sex/Gender, Customized|Proportion of female study participants, during baseline and intervention study phases.|participants|Number|11683|11683.0||||||
4098823|NCT00980980|3922466|B1|Females - Intervention||Sex/Gender, Customized|Proportion of female study participants, during baseline and intervention study phases.|participants|Number|11176|11176.0||||||
4098824|NCT00980980|3922463|B4|Males - Baseline||Sex/Gender, Customized|Proportion of female study participants, during baseline and intervention study phases.|participants|Number|25428|25428.0||||||
4098825|NCT00980980|3922464|B3|Males - Baseline||Sex/Gender, Customized|Proportion of female study participants, during baseline and intervention study phases.|participants|Number|9042|9042.0||||||
4098826|NCT00980980|3922465|B2|Males - Baseline||Sex/Gender, Customized|Proportion of female study participants, during baseline and intervention study phases.|participants|Number|8035|8035.0||||||
4098827|NCT00980980|3922466|B1|Males - Baseline||Sex/Gender, Customized|Proportion of female study participants, during baseline and intervention study phases.|participants|Number|8351|8351.0||||||
4098828|NCT00980980|3922463|B4|Females - Baseline||Sex/Gender, Customized|Proportion of female study participants, during baseline and intervention study phases.|participants|Number|22962|22962.0||||||
4098890|NCT00980681|3922533|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4098829|NCT00980980|3922464|B3|Females - Baseline||Sex/Gender, Customized|Proportion of female study participants, during baseline and intervention study phases.|participants|Number|8314|8314.0||||||
4098830|NCT00980980|3922465|B2|Females - Baseline||Sex/Gender, Customized|Proportion of female study participants, during baseline and intervention study phases.|participants|Number|7183|7183.0||||||
4098831|NCT00980980|3922466|B1|Females - Baseline||Sex/Gender, Customized|Proportion of female study participants, during baseline and intervention study phases.|participants|Number|7465|7465.0||||||
4098832|NCT00980980|3922463|B4|Intervention Age||Age||Years|Median|65|65.0|Inter-Quartile Range|||52.0|77.0|
4098833|NCT00980980|3922464|B3|Intervention Age||Age||Years|Median|65|65.0|Inter-Quartile Range|||52.0|77.0|
4098834|NCT00980980|3922465|B2|Intervention Age||Age||Years|Median|66|66.0|Inter-Quartile Range|||53.0|77.0|
4098835|NCT00980980|3922466|B1|Intervention Age||Age||Years|Median|65|65.0|Inter-Quartile Range|||52.0|77.0|
4098836|NCT00980980|3922463|B4|Baseline Age||Age||Years|Median|65|65.0|Inter-Quartile Range|||52.0|77.0|
4098837|NCT00980980|3922464|B3|Baseline Age||Age||Years|Median|65|65.0|Inter-Quartile Range|||51.0|77.0|
4098838|NCT00980980|3922465|B2|Baseline Age||Age||Years|Median|66|66.0|Inter-Quartile Range|||53.0|77.0|
4098839|NCT00980980|3922466|B1|Baseline Age||Age||Years|Median|65|65.0|Inter-Quartile Range|||52.0|77.0|
4098840|NCT00980798|3922497|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4098841|NCT00980798|3922498|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4098842|NCT00980798|3922499|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4098843|NCT00980798|3922497|B3||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4098844|NCT00980798|3922498|B2||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4098845|NCT00980798|3922499|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4098846|NCT00980798|3922497|B3|||Age||years|Mean|65|65.0|Standard Deviation|10.16|10.16|||
4098847|NCT00980798|3922498|B2|||Age||years|Mean|65.1|65.1|Standard Deviation|9.96|9.96|||
4098848|NCT00980798|3922499|B1|||Age||years|Mean|64.9|64.9|Standard Deviation|10.37|10.37|||
4098849|NCT00980746|3922508|B7||Male|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
4098850|NCT00980746|3922509|B6||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4098851|NCT00980746|3922510|B5||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4098852|NCT00980746|3922511|B4||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4098853|NCT00980746|3922512|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4098854|NCT00980746|3922513|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4098855|NCT00980746|3922514|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4098856|NCT00980746|3922508|B7||Female|Sex: Female, Male||Participants|Count of Participants|309|309.0||||||
4098857|NCT00980746|3922509|B6||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4098858|NCT00980746|3922510|B5||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4098859|NCT00980746|3922511|B4||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4098860|NCT00980746|3922512|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4098861|NCT00980746|3922513|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4098862|NCT00980746|3922514|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4098863|NCT00980746|3922508|B7|>=65 years||Age, Customized||participants|Number|197|197.0||||||
4098864|NCT00980746|3922509|B6|>=65 years||Age, Customized||participants|Number|31|31.0||||||
4098865|NCT00980746|3922510|B5|>=65 years||Age, Customized||participants|Number|33|33.0||||||
4098866|NCT00980746|3922511|B4|>=65 years||Age, Customized||participants|Number|39|39.0||||||
4098867|NCT00980746|3922512|B3|>=65 years||Age, Customized||participants|Number|34|34.0||||||
4098868|NCT00980746|3922513|B2|>=65 years||Age, Customized||participants|Number|28|28.0||||||
4098869|NCT00980746|3922514|B1|>=65 years||Age, Customized||participants|Number|32|32.0||||||
4098870|NCT00980746|3922508|B7|Between 18 and 65 years||Age, Customized||participants|Number|360|360.0||||||
4098871|NCT00980746|3922509|B6|Between 18 and 65 years||Age, Customized||participants|Number|65|65.0||||||
4098872|NCT00980746|3922510|B5|Between 18 and 65 years||Age, Customized||participants|Number|59|59.0||||||
4098873|NCT00980746|3922511|B4|Between 18 and 65 years||Age, Customized||participants|Number|61|61.0||||||
4098874|NCT00980746|3922512|B3|Between 18 and 65 years||Age, Customized||participants|Number|61|61.0||||||
4098875|NCT00980746|3922513|B2|Between 18 and 65 years||Age, Customized||participants|Number|61|61.0||||||
4098876|NCT00980746|3922514|B1|Between 18 and 65 years||Age, Customized||participants|Number|53|53.0||||||
4098877|NCT00980746|3922508|B7|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4098878|NCT00980746|3922509|B6|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4098879|NCT00980746|3922510|B5|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4098880|NCT00980746|3922511|B4|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4098881|NCT00980746|3922512|B3|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4098882|NCT00980746|3922513|B2|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4098883|NCT00980746|3922514|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4098884|NCT00980681|3922533|B1|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4098885|NCT00980681|3922533|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4098886|NCT00980681|3922533|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4098887|NCT00980681|3922533|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4098888|NCT00980681|3922533|B1|||Age||years|Mean|59|59.0|Standard Deviation|16|16.0|||
4098889|NCT00980681|3922533|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4098891|NCT00980681|3922533|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4098892|NCT00980655|3922539|B3||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4098893|NCT00980655|3922540|B2||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4098894|NCT00980655|3922541|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4098895|NCT00980655|3922539|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4098896|NCT00980655|3922540|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4098897|NCT00980655|3922541|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4098898|NCT00980655|3922539|B3|||Age||years|Mean|38.4|38.4|Standard Deviation|19.26|19.26|||
4098899|NCT00980655|3922540|B2|||Age||years|Mean|47.3|47.3|Standard Deviation|12.39|12.39|||
4098900|NCT00980655|3922541|B1|||Age||years|Mean|10.3|10.3|Standard Deviation|4.41|4.41|||
4098901|NCT00980642|3922588|B3|||Duration of surgery||hours|Median|1.8|1.8|Inter-Quartile Range|||1.0|2.2|
4098902|NCT00980642|3922589|B2|||Duration of surgery||hours|Median|1.2|1.2|Inter-Quartile Range|||0.7|1.5|
4098903|NCT00980642|3922590|B1|||Duration of surgery||hours|Median|2.0|2.0|Inter-Quartile Range|||1.1|3.0|
4098904|NCT00980642|3922588|B3|||Ambient temperature||Celsius degree|Mean|19.4|19.4|Standard Deviation|1.1|1.1|||
4098905|NCT00980642|3922589|B2|||Ambient temperature||Celsius degree|Mean|19.5|19.5|Standard Deviation|1.0|1.0|||
4098906|NCT00980642|3922590|B1|||Ambient temperature||Celsius degree|Mean|19.2|19.2|Standard Deviation|1.2|1.2|||
4098907|NCT00980642|3922588|B3|Austria||Region of Enrollment||participants|Number|36|36.0||||||
4098908|NCT00980642|3922589|B2|Austria||Region of Enrollment||participants|Number|0|0.0||||||
4098909|NCT00980642|3922590|B1|Austria||Region of Enrollment||participants|Number|36|36.0||||||
4098910|NCT00980642|3922588|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4098911|NCT00980642|3922589|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4098912|NCT00980642|3922590|B1|United States||Region of Enrollment||participants|Number|0|0.0||||||
4098913|NCT00980642|3922588|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4098914|NCT00980642|3922589|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4098915|NCT00980642|3922590|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4098916|NCT00980642|3922588|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4098917|NCT00980642|3922589|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4098918|NCT00980642|3922590|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4098919|NCT00980642|3922588|B3|||Age||years|Median|64|64.0|Inter-Quartile Range|||30.0|80.0|
4098920|NCT00980642|3922589|B2|||Age||years|Median|65|65.0|Inter-Quartile Range|||47.0|79.0|
4098921|NCT00980642|3922590|B1|||Age||years|Median|64|64.0|Inter-Quartile Range|||19.0|80.0|
4098922|NCT00980590|3922601|B3|||Weight||kg|Mean|57|57.0|Standard Deviation|10|10.0|||
4098923|NCT00980590|3922602|B2|||Weight||kg|Mean|58|58.0|Standard Deviation|10|10.0|||
4098924|NCT00980590|3922603|B1|||Weight||kg|Mean|56|56.0|Standard Deviation|10|10.0|||
4098925|NCT00980590|3922601|B3|||Height||cm|Mean|160|160.0|Standard Deviation|10|10.0|||
4098926|NCT00980590|3922602|B2|||Height||cm|Mean|162|162.0|Standard Deviation|9|9.0|||
4098927|NCT00980590|3922603|B1|||Height||cm|Mean|158|158.0|Standard Deviation|9|9.0|||
4098928|NCT00980590|3922601|B3|||Mouth opening||cm|Mean|4.7|4.7|Standard Deviation|0.7|0.7|||
4098929|NCT00980590|3922602|B2|||Mouth opening||cm|Mean|4.7|4.7|Standard Deviation|0.7|0.7|||
4098930|NCT00980590|3922603|B1|||Mouth opening||cm|Mean|4.6|4.6|Standard Deviation|0.7|0.7|||
4098931|NCT00980590|3922601|B3||Male|Gender||Participants|Count of Participants|48|48.0||||||
4098932|NCT00980590|3922602|B2||Male|Gender||Participants|Count of Participants|28|28.0||||||
4098933|NCT00980590|3922603|B1||Male|Gender||Participants|Count of Participants|20|20.0||||||
4098934|NCT00980590|3922601|B3||Female|Gender||Participants|Count of Participants|52|52.0||||||
4098935|NCT00980590|3922602|B2||Female|Gender||Participants|Count of Participants|22|22.0||||||
4098936|NCT00980590|3922603|B1||Female|Gender||Participants|Count of Participants|30|30.0||||||
4098937|NCT00980590|3922601|B3|||Age||years|Mean|55|55.0|Standard Deviation|20|20.0|||
4098938|NCT00980590|3922602|B2|||Age||years|Mean|53|53.0|Standard Deviation|18|18.0|||
4098939|NCT00980590|3922603|B1|||Age||years|Mean|60|60.0|Standard Deviation|19|19.0|||
4098940|NCT00980343|3922616|B3|4 Prior Treatments||Number of Prior Treatments||participants|Number|2|2.0||||||
4098941|NCT00980343|3922617|B2|4 Prior Treatments||Number of Prior Treatments||participants|Number|0|0.0||||||
4098942|NCT00980343|3922618|B1|4 Prior Treatments||Number of Prior Treatments||participants|Number|2|2.0||||||
4098943|NCT00980343|3922616|B3|2 Prior Treatments||Number of Prior Treatments||participants|Number|11|11.0||||||
4098944|NCT00980343|3922617|B2|2 Prior Treatments||Number of Prior Treatments||participants|Number|5|5.0||||||
4098945|NCT00980343|3922618|B1|2 Prior Treatments||Number of Prior Treatments||participants|Number|6|6.0||||||
4098946|NCT00980343|3922616|B3|1 Prior Treatment||Number of Prior Treatments||participants|Number|27|27.0||||||
4098947|NCT00980343|3922617|B2|1 Prior Treatment||Number of Prior Treatments||participants|Number|15|15.0||||||
4098948|NCT00980343|3922618|B1|1 Prior Treatment||Number of Prior Treatments||participants|Number|12|12.0||||||
4098949|NCT00980343|3922616|B3|No||Measurable disease||participants|Number|4|4.0||||||
4098950|NCT00980343|3922617|B2|No||Measurable disease||participants|Number|2|2.0||||||
4098951|NCT00980343|3922618|B1|No||Measurable disease||participants|Number|2|2.0||||||
4098952|NCT00980343|3922616|B3|Yes||Measurable disease||participants|Number|36|36.0||||||
4098953|NCT00980343|3922617|B2|Yes||Measurable disease||participants|Number|18|18.0||||||
4098954|NCT00980343|3922618|B1|Yes||Measurable disease||participants|Number|18|18.0||||||
4098955|NCT00980343|3922616|B3|||Mini Mental State Exam (MMSE)|The higher the score the better Range 30 to 0|units on a scale|Median|28|28.0|Full Range|||16.0|30.0|
4098956|NCT00980343|3922617|B2|||Mini Mental State Exam (MMSE)|The higher the score the better Range 30 to 0|units on a scale|Median|29|29.0|Full Range|||16.0|30.0|
4098957|NCT00980343|3922618|B1|||Mini Mental State Exam (MMSE)|The higher the score the better Range 30 to 0|units on a scale|Median|28|28.0|Full Range|||16.0|30.0|
4098958|NCT00980343|3922616|B3|||Karnofsky Performance Status Scale|Higher score better 100 normal no complaints/disease 90 capable normal activity few symptoms/disease 80 normal activity, some difficulty some symptoms/signs 70 caring for self not capable normal activity/work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care/help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures/treatment 10 moribund rapidly progressive fatal disease processes 0 death|units on a scale|Median|80|80.0|Full Range|||60.0|100.0|
4098959|NCT00980343|3922617|B2|||Karnofsky Performance Status Scale|Higher score better 100 normal no complaints/disease 90 capable normal activity few symptoms/disease 80 normal activity, some difficulty some symptoms/signs 70 caring for self not capable normal activity/work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care/help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures/treatment 10 moribund rapidly progressive fatal disease processes 0 death|units on a scale|Median|90|90.0|Full Range|||60.0|100.0|
4098960|NCT00980343|3922618|B1|||Karnofsky Performance Status Scale|Higher score better 100 normal no complaints/disease 90 capable normal activity few symptoms/disease 80 normal activity, some difficulty some symptoms/signs 70 caring for self not capable normal activity/work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care/help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures/treatment 10 moribund rapidly progressive fatal disease processes 0 death|units on a scale|Median|80|80.0|Full Range|||60.0|100.0|
4098961|NCT00980343|3922616|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4098962|NCT00980343|3922617|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4098963|NCT00980343|3922618|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4098964|NCT00980343|3922616|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4098965|NCT00980343|3922617|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4098966|NCT00980343|3922618|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4098967|NCT00980343|3922616|B3|||Age||years|Median|59|59.0|Full Range|||37.0|79.0|
4098968|NCT00980343|3922617|B2|||Age||years|Median|60|60.0|Full Range|||37.0|74.0|
4098969|NCT00980343|3922618|B1|||Age||years|Median|57|57.0|Full Range|||42.0|79.0|
4098970|NCT00980330|3922636|B8|Score F4||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|83|83.0||||||
4098971|NCT00980330|3922637|B7|Score F4||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|10|10.0||||||
4098972|NCT00980330|3922638|B6|Score F4||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|13|13.0||||||
4098973|NCT00980330|3922639|B5|Score F4||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|13|13.0||||||
4098974|NCT00980330|3922640|B4|Score F4||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|13|13.0||||||
4098975|NCT00980330|3922641|B3|Score F4||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|14|14.0||||||
4098976|NCT00980330|3922642|B2|Score F4||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|13|13.0||||||
4098977|NCT00980330|3922643|B1|Score F4||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|7|7.0||||||
4098978|NCT00980330|3922636|B8|Score F3||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|86|86.0||||||
4098979|NCT00980330|3922637|B7|Score F3||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|13|13.0||||||
4098980|NCT00980330|3922638|B6|Score F3||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|7|7.0||||||
4098981|NCT00980330|3922639|B5|Score F3||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|11|11.0||||||
4098982|NCT00980330|3922640|B4|Score F3||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|11|11.0||||||
4098983|NCT00980330|3922641|B3|Score F3||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|14|14.0||||||
4098984|NCT00980330|3922642|B2|Score F3||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|16|16.0||||||
4098985|NCT00980330|3922643|B1|Score F3||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|14|14.0||||||
4098986|NCT00980330|3922636|B8|Score F2||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|118|118.0||||||
4098987|NCT00980330|3922637|B7|Score F2||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|16|16.0||||||
4098988|NCT00980330|3922638|B6|Score F2||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|16|16.0||||||
4098989|NCT00980330|3922639|B5|Score F2||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|21|21.0||||||
4098990|NCT00980330|3922640|B4|Score F2||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|18|18.0||||||
4098991|NCT00980330|3922641|B3|Score F2||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|9|9.0||||||
4098992|NCT00980330|3922642|B2|Score F2||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|17|17.0||||||
4098993|NCT00980330|3922643|B1|Score F2||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|21|21.0||||||
4098994|NCT00980330|3922636|B8|Score F1||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|129|129.0||||||
4098995|NCT00980330|3922637|B7|Score F1||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|18|18.0||||||
4098996|NCT00980330|3922638|B6|Score F1||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|27|27.0||||||
4098997|NCT00980330|3922639|B5|Score F1||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|11|11.0||||||
4098998|NCT00980330|3922640|B4|Score F1||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|19|19.0||||||
4098999|NCT00980330|3922641|B3|Score F1||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|23|23.0||||||
4099000|NCT00980330|3922642|B2|Score F1||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|14|14.0||||||
4099001|NCT00980330|3922643|B1|Score F1||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|17|17.0||||||
4099002|NCT00980330|3922636|B8|Score F0||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|39|39.0||||||
4099003|NCT00980330|3922637|B7|Score F0||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|7|7.0||||||
4099004|NCT00980330|3922638|B6|Score F0||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|1|1.0||||||
4099005|NCT00980330|3922639|B5|Score F0||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|11|11.0||||||
4099006|NCT00980330|3922640|B4|Score F0||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|5|5.0||||||
4099007|NCT00980330|3922641|B3|Score F0||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|6|6.0||||||
4099008|NCT00980330|3922642|B2|Score F0||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|3|3.0||||||
4099070|NCT00980330|3922640|B4||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4099009|NCT00980330|3922643|B1|Score F0||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|6|6.0||||||
4099010|NCT00980330|3922636|B8|Not reported||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|7|7.0||||||
4099011|NCT00980330|3922637|B7|Not reported||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|2|2.0||||||
4099012|NCT00980330|3922638|B6|Not reported||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|1|1.0||||||
4099013|NCT00980330|3922639|B5|Not reported||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|1|1.0||||||
4099014|NCT00980330|3922640|B4|Not reported||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|0|0.0||||||
4099015|NCT00980330|3922641|B3|Not reported||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|0|0.0||||||
4099016|NCT00980330|3922642|B2|Not reported||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|2|2.0||||||
4099017|NCT00980330|3922643|B1|Not reported||Metavir Score|A Metavir score is used to interpret the degree of inflammation and fibrosis in a liver biopsy. Below are fibrosis scores graded on a 5-point scale from F0 (no fibrosis) to F4 (cirrhosis).|participants|Number|1|1.0||||||
4099018|NCT00980330|3922636|B8|Relapser||Prior PR response|In the study, “Null Responders” were participants with less than 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12 of the previous PegIFNα-2a/b and RBV treatment; “Partial Responders” were participants with a greater than or equal to 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12, but not achieving an undetectable HCV RNA at the end of the previous PegIFNα-2a/b and RBV treatment; and “Relapsers” were participants with HCV RNA undetectable at end of the previous treatment with PegIFNα-2a/b and RBV, but detectable HCV RNA within 24 weeks of follow-up.|participants|Number|185|185.0||||||
4099019|NCT00980330|3922637|B7|Relapser||Prior PR response|In the study, “Null Responders” were participants with less than 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12 of the previous PegIFNα-2a/b and RBV treatment; “Partial Responders” were participants with a greater than or equal to 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12, but not achieving an undetectable HCV RNA at the end of the previous PegIFNα-2a/b and RBV treatment; and “Relapsers” were participants with HCV RNA undetectable at end of the previous treatment with PegIFNα-2a/b and RBV, but detectable HCV RNA within 24 weeks of follow-up.|participants|Number|27|27.0||||||
4099020|NCT00980330|3922638|B6|Relapser||Prior PR response|In the study, “Null Responders” were participants with less than 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12 of the previous PegIFNα-2a/b and RBV treatment; “Partial Responders” were participants with a greater than or equal to 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12, but not achieving an undetectable HCV RNA at the end of the previous PegIFNα-2a/b and RBV treatment; and “Relapsers” were participants with HCV RNA undetectable at end of the previous treatment with PegIFNα-2a/b and RBV, but detectable HCV RNA within 24 weeks of follow-up.|participants|Number|26|26.0||||||
4099021|NCT00980330|3922639|B5|Relapser||Prior PR response|In the study, “Null Responders” were participants with less than 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12 of the previous PegIFNα-2a/b and RBV treatment; “Partial Responders” were participants with a greater than or equal to 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12, but not achieving an undetectable HCV RNA at the end of the previous PegIFNα-2a/b and RBV treatment; and “Relapsers” were participants with HCV RNA undetectable at end of the previous treatment with PegIFNα-2a/b and RBV, but detectable HCV RNA within 24 weeks of follow-up.|participants|Number|27|27.0||||||
4099022|NCT00980330|3922640|B4|Relapser||Prior PR response|In the study, “Null Responders” were participants with less than 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12 of the previous PegIFNα-2a/b and RBV treatment; “Partial Responders” were participants with a greater than or equal to 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12, but not achieving an undetectable HCV RNA at the end of the previous PegIFNα-2a/b and RBV treatment; and “Relapsers” were participants with HCV RNA undetectable at end of the previous treatment with PegIFNα-2a/b and RBV, but detectable HCV RNA within 24 weeks of follow-up.|participants|Number|26|26.0||||||
4099023|NCT00980330|3922641|B3|Relapser||Prior PR response|In the study, “Null Responders” were participants with less than 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12 of the previous PegIFNα-2a/b and RBV treatment; “Partial Responders” were participants with a greater than or equal to 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12, but not achieving an undetectable HCV RNA at the end of the previous PegIFNα-2a/b and RBV treatment; and “Relapsers” were participants with HCV RNA undetectable at end of the previous treatment with PegIFNα-2a/b and RBV, but detectable HCV RNA within 24 weeks of follow-up.|participants|Number|26|26.0||||||
4099024|NCT00980330|3922642|B2|Relapser||Prior PR response|In the study, “Null Responders” were participants with less than 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12 of the previous PegIFNα-2a/b and RBV treatment; “Partial Responders” were participants with a greater than or equal to 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12, but not achieving an undetectable HCV RNA at the end of the previous PegIFNα-2a/b and RBV treatment; and “Relapsers” were participants with HCV RNA undetectable at end of the previous treatment with PegIFNα-2a/b and RBV, but detectable HCV RNA within 24 weeks of follow-up.|participants|Number|26|26.0||||||
4099071|NCT00980330|3922641|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4099025|NCT00980330|3922643|B1|Relapser||Prior PR response|In the study, “Null Responders” were participants with less than 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12 of the previous PegIFNα-2a/b and RBV treatment; “Partial Responders” were participants with a greater than or equal to 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12, but not achieving an undetectable HCV RNA at the end of the previous PegIFNα-2a/b and RBV treatment; and “Relapsers” were participants with HCV RNA undetectable at end of the previous treatment with PegIFNα-2a/b and RBV, but detectable HCV RNA within 24 weeks of follow-up.|participants|Number|27|27.0||||||
4099026|NCT00980330|3922636|B8|Partial responder||Prior PR response|In the study, “Null Responders” were participants with less than 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12 of the previous PegIFNα-2a/b and RBV treatment; “Partial Responders” were participants with a greater than or equal to 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12, but not achieving an undetectable HCV RNA at the end of the previous PegIFNα-2a/b and RBV treatment; and “Relapsers” were participants with HCV RNA undetectable at end of the previous treatment with PegIFNα-2a/b and RBV, but detectable HCV RNA within 24 weeks of follow-up.|participants|Number|160|160.0||||||
4099027|NCT00980330|3922637|B7|Partial responder||Prior PR response|In the study, “Null Responders” were participants with less than 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12 of the previous PegIFNα-2a/b and RBV treatment; “Partial Responders” were participants with a greater than or equal to 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12, but not achieving an undetectable HCV RNA at the end of the previous PegIFNα-2a/b and RBV treatment; and “Relapsers” were participants with HCV RNA undetectable at end of the previous treatment with PegIFNα-2a/b and RBV, but detectable HCV RNA within 24 weeks of follow-up.|participants|Number|23|23.0||||||
4099028|NCT00980330|3922638|B6|Partial responder||Prior PR response|In the study, “Null Responders” were participants with less than 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12 of the previous PegIFNα-2a/b and RBV treatment; “Partial Responders” were participants with a greater than or equal to 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12, but not achieving an undetectable HCV RNA at the end of the previous PegIFNα-2a/b and RBV treatment; and “Relapsers” were participants with HCV RNA undetectable at end of the previous treatment with PegIFNα-2a/b and RBV, but detectable HCV RNA within 24 weeks of follow-up.|participants|Number|22|22.0||||||
4099029|NCT00980330|3922639|B5|Partial responder||Prior PR response|In the study, “Null Responders” were participants with less than 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12 of the previous PegIFNα-2a/b and RBV treatment; “Partial Responders” were participants with a greater than or equal to 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12, but not achieving an undetectable HCV RNA at the end of the previous PegIFNα-2a/b and RBV treatment; and “Relapsers” were participants with HCV RNA undetectable at end of the previous treatment with PegIFNα-2a/b and RBV, but detectable HCV RNA within 24 weeks of follow-up.|participants|Number|24|24.0||||||
4099030|NCT00980330|3922640|B4|Partial responder||Prior PR response|In the study, “Null Responders” were participants with less than 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12 of the previous PegIFNα-2a/b and RBV treatment; “Partial Responders” were participants with a greater than or equal to 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12, but not achieving an undetectable HCV RNA at the end of the previous PegIFNα-2a/b and RBV treatment; and “Relapsers” were participants with HCV RNA undetectable at end of the previous treatment with PegIFNα-2a/b and RBV, but detectable HCV RNA within 24 weeks of follow-up.|participants|Number|23|23.0||||||
4099031|NCT00980330|3922641|B3|Partial responder||Prior PR response|In the study, “Null Responders” were participants with less than 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12 of the previous PegIFNα-2a/b and RBV treatment; “Partial Responders” were participants with a greater than or equal to 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12, but not achieving an undetectable HCV RNA at the end of the previous PegIFNα-2a/b and RBV treatment; and “Relapsers” were participants with HCV RNA undetectable at end of the previous treatment with PegIFNα-2a/b and RBV, but detectable HCV RNA within 24 weeks of follow-up.|participants|Number|22|22.0||||||
4099032|NCT00980330|3922642|B2|Partial responder||Prior PR response|In the study, “Null Responders” were participants with less than 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12 of the previous PegIFNα-2a/b and RBV treatment; “Partial Responders” were participants with a greater than or equal to 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12, but not achieving an undetectable HCV RNA at the end of the previous PegIFNα-2a/b and RBV treatment; and “Relapsers” were participants with HCV RNA undetectable at end of the previous treatment with PegIFNα-2a/b and RBV, but detectable HCV RNA within 24 weeks of follow-up.|participants|Number|23|23.0||||||
4099033|NCT00980330|3922643|B1|Partial responder||Prior PR response|In the study, “Null Responders” were participants with less than 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12 of the previous PegIFNα-2a/b and RBV treatment; “Partial Responders” were participants with a greater than or equal to 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12, but not achieving an undetectable HCV RNA at the end of the previous PegIFNα-2a/b and RBV treatment; and “Relapsers” were participants with HCV RNA undetectable at end of the previous treatment with PegIFNα-2a/b and RBV, but detectable HCV RNA within 24 weeks of follow-up.|participants|Number|23|23.0||||||
4099034|NCT00980330|3922636|B8|Null responder||Prior PR response|In the study, “Null Responders” were participants with less than 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12 of the previous PegIFNα-2a/b and RBV treatment; “Partial Responders” were participants with a greater than or equal to 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12, but not achieving an undetectable HCV RNA at the end of the previous PegIFNα-2a/b and RBV treatment; and “Relapsers” were participants with HCV RNA undetectable at end of the previous treatment with PegIFNα-2a/b and RBV, but detectable HCV RNA within 24 weeks of follow-up.|participants|Number|117|117.0||||||
4099035|NCT00980330|3922637|B7|Null responder||Prior PR response|In the study, “Null Responders” were participants with less than 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12 of the previous PegIFNα-2a/b and RBV treatment; “Partial Responders” were participants with a greater than or equal to 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12, but not achieving an undetectable HCV RNA at the end of the previous PegIFNα-2a/b and RBV treatment; and “Relapsers” were participants with HCV RNA undetectable at end of the previous treatment with PegIFNα-2a/b and RBV, but detectable HCV RNA within 24 weeks of follow-up.|participants|Number|16|16.0||||||
4099036|NCT00980330|3922638|B6|Null responder||Prior PR response|In the study, “Null Responders” were participants with less than 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12 of the previous PegIFNα-2a/b and RBV treatment; “Partial Responders” were participants with a greater than or equal to 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12, but not achieving an undetectable HCV RNA at the end of the previous PegIFNα-2a/b and RBV treatment; and “Relapsers” were participants with HCV RNA undetectable at end of the previous treatment with PegIFNα-2a/b and RBV, but detectable HCV RNA within 24 weeks of follow-up.|participants|Number|17|17.0||||||
4099037|NCT00980330|3922639|B5|Null responder||Prior PR response|In the study, “Null Responders” were participants with less than 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12 of the previous PegIFNα-2a/b and RBV treatment; “Partial Responders” were participants with a greater than or equal to 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12, but not achieving an undetectable HCV RNA at the end of the previous PegIFNα-2a/b and RBV treatment; and “Relapsers” were participants with HCV RNA undetectable at end of the previous treatment with PegIFNα-2a/b and RBV, but detectable HCV RNA within 24 weeks of follow-up.|participants|Number|17|17.0||||||
4099038|NCT00980330|3922640|B4|Null responder||Prior PR response|In the study, “Null Responders” were participants with less than 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12 of the previous PegIFNα-2a/b and RBV treatment; “Partial Responders” were participants with a greater than or equal to 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12, but not achieving an undetectable HCV RNA at the end of the previous PegIFNα-2a/b and RBV treatment; and “Relapsers” were participants with HCV RNA undetectable at end of the previous treatment with PegIFNα-2a/b and RBV, but detectable HCV RNA within 24 weeks of follow-up.|participants|Number|17|17.0||||||
4099039|NCT00980330|3922641|B3|Null responder||Prior PR response|In the study, “Null Responders” were participants with less than 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12 of the previous PegIFNα-2a/b and RBV treatment; “Partial Responders” were participants with a greater than or equal to 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12, but not achieving an undetectable HCV RNA at the end of the previous PegIFNα-2a/b and RBV treatment; and “Relapsers” were participants with HCV RNA undetectable at end of the previous treatment with PegIFNα-2a/b and RBV, but detectable HCV RNA within 24 weeks of follow-up.|participants|Number|18|18.0||||||
4099040|NCT00980330|3922642|B2|Null responder||Prior PR response|In the study, “Null Responders” were participants with less than 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12 of the previous PegIFNα-2a/b and RBV treatment; “Partial Responders” were participants with a greater than or equal to 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12, but not achieving an undetectable HCV RNA at the end of the previous PegIFNα-2a/b and RBV treatment; and “Relapsers” were participants with HCV RNA undetectable at end of the previous treatment with PegIFNα-2a/b and RBV, but detectable HCV RNA within 24 weeks of follow-up.|participants|Number|16|16.0||||||
4099041|NCT00980330|3922643|B1|Null responder||Prior PR response|In the study, “Null Responders” were participants with less than 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12 of the previous PegIFNα-2a/b and RBV treatment; “Partial Responders” were participants with a greater than or equal to 2 log10 IU/mL reduction in HCV RNA compared to baseline at Week 12, but not achieving an undetectable HCV RNA at the end of the previous PegIFNα-2a/b and RBV treatment; and “Relapsers” were participants with HCV RNA undetectable at end of the previous treatment with PegIFNα-2a/b and RBV, but detectable HCV RNA within 24 weeks of follow-up.|participants|Number|16|16.0||||||
4099042|NCT00980330|3922636|B8|North-America||Region of Enrollment||participants|Number|120|120.0||||||
4099043|NCT00980330|3922637|B7|North-America||Region of Enrollment||participants|Number|13|13.0||||||
4099044|NCT00980330|3922638|B6|North-America||Region of Enrollment||participants|Number|18|18.0||||||
4099045|NCT00980330|3922639|B5|North-America||Region of Enrollment||participants|Number|18|18.0||||||
4099046|NCT00980330|3922640|B4|North-America||Region of Enrollment||participants|Number|13|13.0||||||
4099047|NCT00980330|3922641|B3|North-America||Region of Enrollment||participants|Number|16|16.0||||||
4099048|NCT00980330|3922642|B2|North-America||Region of Enrollment||participants|Number|14|14.0||||||
4099049|NCT00980330|3922643|B1|North-America||Region of Enrollment||participants|Number|28|28.0||||||
4099050|NCT00980330|3922636|B8|Europe and Israel||Region of Enrollment||participants|Number|313|313.0||||||
4099051|NCT00980330|3922637|B7|Europe and Israel||Region of Enrollment||participants|Number|46|46.0||||||
4099052|NCT00980330|3922638|B6|Europe and Israel||Region of Enrollment||participants|Number|43|43.0||||||
4099053|NCT00980330|3922639|B5|Europe and Israel||Region of Enrollment||participants|Number|49|49.0||||||
4099054|NCT00980330|3922640|B4|Europe and Israel||Region of Enrollment||participants|Number|49|49.0||||||
4099055|NCT00980330|3922641|B3|Europe and Israel||Region of Enrollment||participants|Number|46|46.0||||||
4099056|NCT00980330|3922642|B2|Europe and Israel||Region of Enrollment||participants|Number|46|46.0||||||
4099057|NCT00980330|3922643|B1|Europe and Israel||Region of Enrollment||participants|Number|34|34.0||||||
4099058|NCT00980330|3922636|B8|Asia Pacific||Region of Enrollment||participants|Number|29|29.0||||||
4099059|NCT00980330|3922637|B7|Asia Pacific||Region of Enrollment||participants|Number|7|7.0||||||
4099060|NCT00980330|3922638|B6|Asia Pacific||Region of Enrollment||participants|Number|4|4.0||||||
4099061|NCT00980330|3922639|B5|Asia Pacific||Region of Enrollment||participants|Number|1|1.0||||||
4099062|NCT00980330|3922640|B4|Asia Pacific||Region of Enrollment||participants|Number|4|4.0||||||
4099063|NCT00980330|3922641|B3|Asia Pacific||Region of Enrollment||participants|Number|4|4.0||||||
4099064|NCT00980330|3922642|B2|Asia Pacific||Region of Enrollment||participants|Number|5|5.0||||||
4099065|NCT00980330|3922643|B1|Asia Pacific||Region of Enrollment||participants|Number|4|4.0||||||
4099066|NCT00980330|3922636|B8||Male|Sex: Female, Male||Participants|Count of Participants|311|311.0||||||
4099067|NCT00980330|3922637|B7||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4099068|NCT00980330|3922638|B6||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4099069|NCT00980330|3922639|B5||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4099072|NCT00980330|3922642|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4099073|NCT00980330|3922643|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4099074|NCT00980330|3922636|B8||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4099075|NCT00980330|3922637|B7||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4099076|NCT00980330|3922638|B6||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4099077|NCT00980330|3922639|B5||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4099078|NCT00980330|3922640|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4099079|NCT00980330|3922641|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4099080|NCT00980330|3922642|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4099081|NCT00980330|3922643|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4099082|NCT00980330|3922636|B8|||Age||years|Median|50|50.0|Full Range|||20.0|69.0|
4099083|NCT00980330|3922637|B7|||Age||years|Median|50.5|50.5|Full Range|||22.0|66.0|
4099084|NCT00980330|3922638|B6|||Age||years|Median|50|50.0|Full Range|||21.0|69.0|
4099085|NCT00980330|3922639|B5|||Age||years|Median|51.5|51.5|Full Range|||25.0|68.0|
4099086|NCT00980330|3922640|B4|||Age||years|Median|48|48.0|Full Range|||20.0|63.0|
4099087|NCT00980330|3922641|B3|||Age||years|Median|50|50.0|Full Range|||22.0|69.0|
4099088|NCT00980330|3922642|B2|||Age||years|Median|50|50.0|Full Range|||20.0|68.0|
4099089|NCT00980330|3922643|B1|||Age||years|Median|51.5|51.5|Full Range|||20.0|68.0|
4099090|NCT00980278|3922747|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4099091|NCT00980278|3922748|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4099092|NCT00980278|3922749|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4099093|NCT00980278|3922747|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4099094|NCT00980278|3922748|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4099095|NCT00980278|3922749|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4099096|NCT00980278|3922747|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4099097|NCT00980278|3922748|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4099098|NCT00980278|3922749|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4099099|NCT00980278|3922747|B3|>20 and <70||Age, Customized||participants|Number|26|26.0||||||
4099100|NCT00980278|3922748|B2|>20 and <70||Age, Customized||participants|Number|13|13.0||||||
4099101|NCT00980278|3922749|B1|>20 and <70||Age, Customized||participants|Number|13|13.0||||||
4099102|NCT00980200|3922764|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4099103|NCT00980200|3922764|B1|Asian-Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4099104|NCT00980200|3922764|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4099105|NCT00980200|3922764|B1||Male|Gender||Participants|Count of Participants|28|28.0||||||
4099106|NCT00980200|3922764|B1||Female|Gender||Participants|Count of Participants|47|47.0||||||
4099107|NCT00980200|3922764|B1|||Age||Years|Mean|38.9|38.9|Standard Deviation|14.37|14.37|||
4099108|NCT00980174|3922785|B3|North America||Region of Enrollment||Participants|Number|77|77.0||||||
4099109|NCT00980174|3922786|B2|North America||Region of Enrollment||Participants|Number|34|34.0||||||
4099110|NCT00980174|3922787|B1|North America||Region of Enrollment||Participants|Number|43|43.0||||||
4099111|NCT00980174|3922785|B3|Europe||Region of Enrollment||Participants|Number|165|165.0||||||
4099112|NCT00980174|3922786|B2|Europe||Region of Enrollment||Participants|Number|87|87.0||||||
4099113|NCT00980174|3922787|B1|Europe||Region of Enrollment||Participants|Number|78|78.0||||||
4099114|NCT00980174|3922785|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4099115|NCT00980174|3922786|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4099116|NCT00980174|3922787|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4099117|NCT00980174|3922785|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4099118|NCT00980174|3922786|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4099119|NCT00980174|3922787|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4099120|NCT00980174|3922785|B3|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4099121|NCT00980174|3922786|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4099122|NCT00980174|3922787|B1|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4099123|NCT00980174|3922785|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4099124|NCT00980174|3922786|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4099125|NCT00980174|3922787|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4099126|NCT00980174|3922785|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|228|228.0||||||
4099127|NCT00980174|3922786|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|121|121.0||||||
4099128|NCT00980174|3922787|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|107|107.0||||||
4099129|NCT00980174|3922785|B3||Male|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
4099130|NCT00980174|3922786|B2||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4099131|NCT00980174|3922787|B1||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4099132|NCT00980174|3922785|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4099133|NCT00980174|3922786|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4099134|NCT00980174|3922787|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4099135|NCT00980174|3922785|B3|||Age||years|Mean|65.0|65.0|Standard Deviation|9.8|9.8|||
4099136|NCT00980174|3922786|B2|||Age||years|Mean|64.9|64.9|Standard Deviation|10.5|10.5|||
4099137|NCT00980174|3922787|B1|||Age||years|Mean|65.0|65.0|Standard Deviation|9.1|9.1|||
4099138|NCT00980148|3922804|B3|United States||Region of Enrollment||participants|Number|310|310.0||||||
4099139|NCT00980148|3922805|B2|United States||Region of Enrollment||participants|Number|155|155.0||||||
4099140|NCT00980148|3922806|B1|United States||Region of Enrollment||participants|Number|155|155.0||||||
4099141|NCT00980148|3922804|B3||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4099142|NCT00980148|3922805|B2||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4099143|NCT00980148|3922806|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4099144|NCT00980148|3922804|B3||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4099145|NCT00980148|3922805|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4099146|NCT00980148|3922806|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4099147|NCT00980148|3922804|B3|||Age||years|Mean|16.9|16.9|Standard Deviation|1.0|1.0|||
4099148|NCT00980148|3922805|B2|||Age||years|Mean|16.8|16.8|Standard Deviation|1.1|1.1|||
4099149|NCT00980148|3922806|B1|||Age||years|Mean|17.0|17.0|Standard Deviation|0.9|0.9|||
4099150|NCT00980148|3922804|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4099151|NCT00980148|3922805|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4099152|NCT00980148|3922806|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4099153|NCT00980148|3922804|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4099154|NCT00980148|3922805|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4099155|NCT00980148|3922806|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4099156|NCT00980148|3922804|B3||<=18 years|Age||Participants|Count of Participants|309|309.0||||||
4099157|NCT00980148|3922805|B2||<=18 years|Age||Participants|Count of Participants|154|154.0||||||
4099158|NCT00980148|3922806|B1||<=18 years|Age||Participants|Count of Participants|155|155.0||||||
4099159|NCT00980057|3922813|B3|Germany||Region of Enrollment||participants|Number|45|45.0||||||
4099160|NCT00980057|3922814|B2|Germany||Region of Enrollment||participants|Number|14|14.0||||||
4099161|NCT00980057|3922815|B1|Germany||Region of Enrollment||participants|Number|31|31.0||||||
4099162|NCT00980057|3922813|B3|Serbia||Region of Enrollment||participants|Number|33|33.0||||||
4099163|NCT00980057|3922814|B2|Serbia||Region of Enrollment||participants|Number|10|10.0||||||
4099164|NCT00980057|3922815|B1|Serbia||Region of Enrollment||participants|Number|23|23.0||||||
4099165|NCT00980057|3922813|B3|Australia||Region of Enrollment||participants|Number|30|30.0||||||
4099166|NCT00980057|3922814|B2|Australia||Region of Enrollment||participants|Number|12|12.0||||||
4099167|NCT00980057|3922815|B1|Australia||Region of Enrollment||participants|Number|18|18.0||||||
4099168|NCT00980057|3922813|B3|Italy||Region of Enrollment||participants|Number|5|5.0||||||
4099169|NCT00980057|3922814|B2|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4099170|NCT00980057|3922815|B1|Italy||Region of Enrollment||participants|Number|3|3.0||||||
4099171|NCT00980057|3922813|B3|Denmark||Region of Enrollment||participants|Number|18|18.0||||||
4099172|NCT00980057|3922814|B2|Denmark||Region of Enrollment||participants|Number|7|7.0||||||
4099173|NCT00980057|3922815|B1|Denmark||Region of Enrollment||participants|Number|11|11.0||||||
4099174|NCT00980057|3922813|B3|Norway||Region of Enrollment||participants|Number|10|10.0||||||
4099175|NCT00980057|3922814|B2|Norway||Region of Enrollment||participants|Number|3|3.0||||||
4099176|NCT00980057|3922815|B1|Norway||Region of Enrollment||participants|Number|7|7.0||||||
4099177|NCT00980057|3922813|B3|Belgium||Region of Enrollment||participants|Number|9|9.0||||||
4099178|NCT00980057|3922814|B2|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
4099179|NCT00980057|3922815|B1|Belgium||Region of Enrollment||participants|Number|6|6.0||||||
4099180|NCT00980057|3922813|B3|Sweden||Region of Enrollment||participants|Number|4|4.0||||||
4099181|NCT00980057|3922814|B2|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
4099182|NCT00980057|3922815|B1|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
4099183|NCT00980057|3922813|B3|Netherlands||Region of Enrollment||participants|Number|16|16.0||||||
4099184|NCT00980057|3922814|B2|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
4099185|NCT00980057|3922815|B1|Netherlands||Region of Enrollment||participants|Number|11|11.0||||||
4099186|NCT00980057|3922813|B3|Austria||Region of Enrollment||participants|Number|7|7.0||||||
4099187|NCT00980057|3922814|B2|Austria||Region of Enrollment||participants|Number|2|2.0||||||
4099188|NCT00980057|3922815|B1|Austria||Region of Enrollment||participants|Number|5|5.0||||||
4099189|NCT00980057|3922813|B3|Canada||Region of Enrollment||participants|Number|25|25.0||||||
4099190|NCT00980057|3922814|B2|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4099191|NCT00980057|3922815|B1|Canada||Region of Enrollment||participants|Number|17|17.0||||||
4099192|NCT00980057|3922813|B3|Saudi Arabia||Region of Enrollment||participants|Number|2|2.0||||||
4099193|NCT00980057|3922814|B2|Saudi Arabia||Region of Enrollment||participants|Number|1|1.0||||||
4099194|NCT00980057|3922815|B1|Saudi Arabia||Region of Enrollment||participants|Number|1|1.0||||||
4099195|NCT00980057|3922813|B3|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4099196|NCT00980057|3922814|B2|Spain||Region of Enrollment||participants|Number|0|0.0||||||
4099197|NCT00980057|3922815|B1|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4099198|NCT00980057|3922813|B3|Japan||Region of Enrollment||participants|Number|6|6.0||||||
4099199|NCT00980057|3922814|B2|Japan||Region of Enrollment||participants|Number|2|2.0||||||
4099200|NCT00980057|3922815|B1|Japan||Region of Enrollment||participants|Number|4|4.0||||||
4099201|NCT00980057|3922813|B3|United States||Region of Enrollment||participants|Number|263|263.0||||||
4099202|NCT00980057|3922814|B2|United States||Region of Enrollment||participants|Number|87|87.0||||||
4099203|NCT00980057|3922815|B1|United States||Region of Enrollment||participants|Number|176|176.0||||||
4099204|NCT00980057|3922813|B3|Hong Kong||Region of Enrollment||participants|Number|3|3.0||||||
4099205|NCT00980057|3922814|B2|Hong Kong||Region of Enrollment||participants|Number|1|1.0||||||
4099206|NCT00980057|3922815|B1|Hong Kong||Region of Enrollment||participants|Number|2|2.0||||||
4099207|NCT00980057|3922813|B3|Russia||Region of Enrollment||participants|Number|1|1.0||||||
4099208|NCT00980057|3922814|B2|Russia||Region of Enrollment||participants|Number|0|0.0||||||
4099209|NCT00980057|3922815|B1|Russia||Region of Enrollment||participants|Number|1|1.0||||||
4099210|NCT00980057|3922813|B3|Not available||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4099211|NCT00980057|3922814|B2|Not available||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4099212|NCT00980057|3922815|B1|Not available||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4099213|NCT00980057|3922813|B3|Other race||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4099214|NCT00980057|3922814|B2|Other race||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4099215|NCT00980057|3922815|B1|Other race||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4099216|NCT00980057|3922813|B3|Two or more races||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4099217|NCT00980057|3922814|B2|Two or more races||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4099218|NCT00980057|3922815|B1|Two or more races||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4099219|NCT00980057|3922813|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|396|396.0||||||
4099220|NCT00980057|3922814|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|139|139.0||||||
4099221|NCT00980057|3922815|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|257|257.0||||||
4099222|NCT00980057|3922813|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4099223|NCT00980057|3922814|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4099224|NCT00980057|3922815|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4099225|NCT00980057|3922813|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
4099226|NCT00980057|3922814|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4099227|NCT00980057|3922815|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4099228|NCT00980057|3922813|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
4099229|NCT00980057|3922814|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4099230|NCT00980057|3922815|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
4099231|NCT00980057|3922813|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4099232|NCT00980057|3922814|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4099233|NCT00980057|3922815|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4099234|NCT00980057|3922813|B3||Male|Sex: Female, Male||Participants|Count of Participants|330|330.0||||||
4099235|NCT00980057|3922814|B2||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4099236|NCT00980057|3922815|B1||Male|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
4099237|NCT00980057|3922813|B3||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4099238|NCT00980057|3922814|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4099239|NCT00980057|3922815|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4099240|NCT00980057|3922813|B3|||Age||years|Mean|65.7|65.7|Standard Deviation|10.7|10.7|||
4099241|NCT00980057|3922814|B2|||Age||years|Mean|66.2|66.2|Standard Deviation|9.7|9.7|||
4099242|NCT00980057|3922815|B1|||Age||years|Mean|65.4|65.4|Standard Deviation|11.2|11.2|||
4099243|NCT00980044|3922836|B4|United States||Region of Enrollment||participants|Number|36|36.0||||||
4099244|NCT00980044|3922837|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4099245|NCT00980044|3922838|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4099246|NCT00980044|3922839|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4099247|NCT00980044|3922836|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4099248|NCT00980044|3922837|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4099249|NCT00980044|3922838|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4099250|NCT00980044|3922839|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4099251|NCT00980044|3922836|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4099252|NCT00980044|3922837|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4099253|NCT00980044|3922838|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4099254|NCT00980044|3922839|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4099255|NCT00980044|3922836|B4|||Age||years|Mean|30.1|30.1|Standard Deviation|1.5|1.5|||
4099256|NCT00980044|3922837|B3|||Age||years|Mean|31.6|31.6|Standard Deviation|1.5|1.5|||
4099257|NCT00980044|3922838|B2|||Age||years|Mean|32.2|32.2|Standard Deviation|2.2|2.2|||
4099258|NCT00980044|3922839|B1|||Age||years|Mean|26.8|26.8|Standard Deviation|0.9|0.9|||
4099259|NCT00980044|3922836|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4099260|NCT00980044|3922837|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4099261|NCT00980044|3922838|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4099262|NCT00980044|3922839|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4099263|NCT00980044|3922836|B4||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4099264|NCT00980044|3922837|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4099265|NCT00980044|3922838|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4099266|NCT00980044|3922839|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4099267|NCT00980044|3922836|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4099268|NCT00980044|3922837|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4099269|NCT00980044|3922838|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4099270|NCT00980044|3922839|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4099271|NCT00980005|3922858|B3||Male|Sex: Female, Male||Participants|Count of Participants|1120|1120.0||||||
4099272|NCT00980005|3922859|B2||Male|Sex: Female, Male||Participants|Count of Participants|565|565.0||||||
4099273|NCT00980005|3922860|B1||Male|Sex: Female, Male||Participants|Count of Participants|555|555.0||||||
4099274|NCT00980005|3922858|B3||Female|Sex: Female, Male||Participants|Count of Participants|996|996.0||||||
4099275|NCT00980005|3922859|B2||Female|Sex: Female, Male||Participants|Count of Participants|496|496.0||||||
4099276|NCT00980005|3922860|B1||Female|Sex: Female, Male||Participants|Count of Participants|500|500.0||||||
4099277|NCT00980005|3922858|B3|||Age||Years|Mean|7.8|7.8|Standard Deviation|4.14|4.14|||
4099278|NCT00980005|3922859|B2|||Age||Years|Mean|7.8|7.8|Standard Deviation|4.10|4.1|||
4099279|NCT00980005|3922860|B1|||Age||Years|Mean|7.8|7.8|Standard Deviation|4.18|4.18|||
4099280|NCT00979992|3922901|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4099281|NCT00979992|3922901|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4099282|NCT00979992|3922901|B1|70-79 years||Age, Customized||participants|Number|1|1.0||||||
4099283|NCT00979992|3922901|B1|60-69 years||Age, Customized||participants|Number|7|7.0||||||
4099284|NCT00979992|3922901|B1|50-59 years||Age, Customized||participants|Number|9|9.0||||||
4099285|NCT00979992|3922901|B1|40-49 years||Age, Customized||participants|Number|10|10.0||||||
4099286|NCT00979992|3922901|B1|30-39 years||Age, Customized||participants|Number|1|1.0||||||
4099287|NCT00979992|3922901|B1|20-29 years||Age, Customized||participants|Number|2|2.0||||||
4099288|NCT00979953|3922909|B5||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4099289|NCT00979953|3922910|B4||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4099290|NCT00979953|3922911|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4099291|NCT00979953|3922912|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4099292|NCT00979953|3922913|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4099293|NCT00979953|3922909|B5||Female|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
4099294|NCT00979953|3922910|B4||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4099295|NCT00979953|3922911|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4099296|NCT00979953|3922912|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4099297|NCT00979953|3922913|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4099298|NCT00979953|3922909|B5|||Age||years|Mean|57.0|57.0|Standard Deviation|8.34|8.34|||
4099299|NCT00979953|3922910|B4|||Age||years|Mean|56.5|56.5|Standard Deviation|8.11|8.11|||
4099300|NCT00979953|3922911|B3|||Age||years|Mean|57.8|57.8|Standard Deviation|8.39|8.39|||
4099301|NCT00979953|3922912|B2|||Age||years|Mean|57.3|57.3|Standard Deviation|8.74|8.74|||
4099302|NCT00979953|3922913|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|8.15|8.15|||
4099303|NCT00979940|3922926|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4099304|NCT00979940|3922927|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4099305|NCT00979940|3922928|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4099306|NCT00979940|3922926|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4099307|NCT00979940|3922927|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4099308|NCT00979940|3922928|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4099309|NCT00979940|3922926|B3|||Age||years|Mean|61.9|61.9|Standard Deviation|9|9.0|||
4099310|NCT00979940|3922927|B2|||Age||years|Mean|62.6|62.6|Standard Deviation|10|10.0|||
4099311|NCT00979940|3922928|B1|||Age||years|Mean|61.4|61.4|Standard Deviation|8|8.0|||
4099312|NCT00979901|3922935|B5|||Rhinoconjunctivitis quality-of-life questionnaire (RQLQ) overall score|Computed by averaging the scores of the 7 domains of activity, sleep, non-nose/eye symptoms, practical problems, nasal symptoms, eye symptoms, and emotions. Scores were measured as 0 (best) to 6 (worst). The 7 domains included 28 questions total. The average score was calculated for each domain, then the 7 domains were averaged to obtain the overall score. Baseline is the Visit 3 value.|Units on a Scale|Mean|3.13|3.13|Standard Deviation|1.01|1.01|||
4099387|NCT00979615|3923045|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4099388|NCT00979615|3923043|B3||Between 18 and 65 years|Age||Participants|Count of Participants|105|105.0||||||
4099313|NCT00979901|3922936|B4|||Rhinoconjunctivitis quality-of-life questionnaire (RQLQ) overall score|Computed by averaging the scores of the 7 domains of activity, sleep, non-nose/eye symptoms, practical problems, nasal symptoms, eye symptoms, and emotions. Scores were measured as 0 (best) to 6 (worst). The 7 domains included 28 questions total. The average score was calculated for each domain, then the 7 domains were averaged to obtain the overall score. Baseline is the Visit 3 value.|Units on a Scale|Mean|0|0.0|Standard Deviation|0|0.0|||
4099314|NCT00979901|3922937|B3|||Rhinoconjunctivitis quality-of-life questionnaire (RQLQ) overall score|Computed by averaging the scores of the 7 domains of activity, sleep, non-nose/eye symptoms, practical problems, nasal symptoms, eye symptoms, and emotions. Scores were measured as 0 (best) to 6 (worst). The 7 domains included 28 questions total. The average score was calculated for each domain, then the 7 domains were averaged to obtain the overall score. Baseline is the Visit 3 value.|Units on a Scale|Mean|3.09|3.09|Standard Deviation|1.03|1.03|||
4099315|NCT00979901|3922938|B2|||Rhinoconjunctivitis quality-of-life questionnaire (RQLQ) overall score|Computed by averaging the scores of the 7 domains of activity, sleep, non-nose/eye symptoms, practical problems, nasal symptoms, eye symptoms, and emotions. Scores were measured as 0 (best) to 6 (worst). The 7 domains included 28 questions total. The average score was calculated for each domain, then the 7 domains were averaged to obtain the overall score. Baseline is the Visit 3 value.|Units on a Scale|Mean|3.12|3.12|Standard Deviation|0.99|0.99|||
4099316|NCT00979901|3922939|B1|||Rhinoconjunctivitis quality-of-life questionnaire (RQLQ) overall score|Computed by averaging the scores of the 7 domains of activity, sleep, non-nose/eye symptoms, practical problems, nasal symptoms, eye symptoms, and emotions. Scores were measured as 0 (best) to 6 (worst). The 7 domains included 28 questions total. The average score was calculated for each domain, then the 7 domains were averaged to obtain the overall score. Baseline is the Visit 3 value.|Units on a Scale|Mean|3.22|3.22|Standard Deviation|0.99|0.99|||
4099317|NCT00979901|3922935|B5|||Nighttime symptoms score|Computed using the average values of the 3 individual nighttime symptoms scores of nasal congestion upon awakening, difficulty going to sleep, and nighttime awakenings. Scores were measured as 0 (best) to 3 (worst). Baseline is computed as the average daily value during the run-in period.|Units on a Scale|Mean|1.45|1.45|Standard Deviation|0.65|0.65|||
4099318|NCT00979901|3922936|B4|||Nighttime symptoms score|Computed using the average values of the 3 individual nighttime symptoms scores of nasal congestion upon awakening, difficulty going to sleep, and nighttime awakenings. Scores were measured as 0 (best) to 3 (worst). Baseline is computed as the average daily value during the run-in period.|Units on a Scale|Mean|0|0.0|Standard Deviation|0|0.0|||
4099319|NCT00979901|3922937|B3|||Nighttime symptoms score|Computed using the average values of the 3 individual nighttime symptoms scores of nasal congestion upon awakening, difficulty going to sleep, and nighttime awakenings. Scores were measured as 0 (best) to 3 (worst). Baseline is computed as the average daily value during the run-in period.|Units on a Scale|Mean|1.45|1.45|Standard Deviation|0.64|0.64|||
4099320|NCT00979901|3922938|B2|||Nighttime symptoms score|Computed using the average values of the 3 individual nighttime symptoms scores of nasal congestion upon awakening, difficulty going to sleep, and nighttime awakenings. Scores were measured as 0 (best) to 3 (worst). Baseline is computed as the average daily value during the run-in period.|Units on a Scale|Mean|1.43|1.43|Standard Deviation|0.64|0.64|||
4099321|NCT00979901|3922939|B1|||Nighttime symptoms score|Computed using the average values of the 3 individual nighttime symptoms scores of nasal congestion upon awakening, difficulty going to sleep, and nighttime awakenings. Scores were measured as 0 (best) to 3 (worst). Baseline is computed as the average daily value during the run-in period.|Units on a Scale|Mean|1.46|1.46|Standard Deviation|0.66|0.66|||
4099322|NCT00979901|3922935|B5|||Daytime nasal symptoms score|Computed using the average values of the 4 individual daytime nasal symptoms scores of congestion, rhinorrhea, itching, and sneezing. Scores were measured as 0 (best) to 3 (worst). Baseline is computed as the average daily value during the run-in period.|Units on a Scale|Mean|2.08|2.08|Standard Deviation|0.43|0.43|||
4099323|NCT00979901|3922936|B4|||Daytime nasal symptoms score|Computed using the average values of the 4 individual daytime nasal symptoms scores of congestion, rhinorrhea, itching, and sneezing. Scores were measured as 0 (best) to 3 (worst). Baseline is computed as the average daily value during the run-in period.|Units on a Scale|Mean|0|0.0|Standard Deviation|0|0.0|||
4099324|NCT00979901|3922937|B3|||Daytime nasal symptoms score|Computed using the average values of the 4 individual daytime nasal symptoms scores of congestion, rhinorrhea, itching, and sneezing. Scores were measured as 0 (best) to 3 (worst). Baseline is computed as the average daily value during the run-in period.|Units on a Scale|Mean|2.06|2.06|Standard Deviation|0.41|0.41|||
4099325|NCT00979901|3922938|B2|||Daytime nasal symptoms score|Computed using the average values of the 4 individual daytime nasal symptoms scores of congestion, rhinorrhea, itching, and sneezing. Scores were measured as 0 (best) to 3 (worst). Baseline is computed as the average daily value during the run-in period.|Units on a Scale|Mean|2.09|2.09|Standard Deviation|0.44|0.44|||
4099326|NCT00979901|3922939|B1|||Daytime nasal symptoms score|Computed using the average values of the 4 individual daytime nasal symptoms scores of congestion, rhinorrhea, itching, and sneezing. Scores were measured as 0 (best) to 3 (worst). Baseline is computed as the average daily value during the run-in period.|Units on a Scale|Mean|2.10|2.1|Standard Deviation|0.43|0.43|||
4099327|NCT00979901|3922935|B5|||Daytime eye symptoms score|Computed using the average values of the 4 individual daytime eye symptoms scores of tearing, itching, red, and puffy eyes. Scores were measured as 0 (best) to 3 (worst). Baseline is computed as the average daily value during the run-in period.|Units on a Scale|Mean|1.41|1.41|Standard Deviation|0.77|0.77|||
4099328|NCT00979901|3922936|B4|||Daytime eye symptoms score|Computed using the average values of the 4 individual daytime eye symptoms scores of tearing, itching, red, and puffy eyes. Scores were measured as 0 (best) to 3 (worst). Baseline is computed as the average daily value during the run-in period.|Units on a Scale|Mean|0|0.0|Standard Deviation|0|0.0|||
4099329|NCT00979901|3922937|B3|||Daytime eye symptoms score|Computed using the average values of the 4 individual daytime eye symptoms scores of tearing, itching, red, and puffy eyes. Scores were measured as 0 (best) to 3 (worst). Baseline is computed as the average daily value during the run-in period.|Units on a Scale|Mean|1.40|1.4|Standard Deviation|0.76|0.76|||
4099389|NCT00979615|3923044|B2||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4099439|NCT00979576|3923233|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4099330|NCT00979901|3922938|B2|||Daytime eye symptoms score|Computed using the average values of the 4 individual daytime eye symptoms scores of tearing, itching, red, and puffy eyes. Scores were measured as 0 (best) to 3 (worst). Baseline is computed as the average daily value during the run-in period.|Units on a Scale|Mean|1.39|1.39|Standard Deviation|0.77|0.77|||
4099331|NCT00979901|3922939|B1|||Daytime eye symptoms score|Computed using the average values of the 4 individual daytime eye symptoms scores of tearing, itching, red, and puffy eyes. Scores were measured as 0 (best) to 3 (worst). Baseline is computed as the average daily value during the run-in period.|Units on a Scale|Mean|1.44|1.44|Standard Deviation|0.78|0.78|||
4099332|NCT00979901|3922935|B5||Male|Sex: Female, Male||Participants|Count of Participants|541|541.0||||||
4099333|NCT00979901|3922936|B4||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4099334|NCT00979901|3922937|B3||Male|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4099335|NCT00979901|3922938|B2||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4099336|NCT00979901|3922939|B1||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4099337|NCT00979901|3922935|B5||Female|Sex: Female, Male||Participants|Count of Participants|1036|1036.0||||||
4099338|NCT00979901|3922936|B4||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4099339|NCT00979901|3922937|B3||Female|Sex: Female, Male||Participants|Count of Participants|390|390.0||||||
4099340|NCT00979901|3922938|B2||Female|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
4099341|NCT00979901|3922939|B1||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4099342|NCT00979901|3922935|B5|||Age||Years|Mean|36.39|36.39|Standard Deviation|12.61|12.61|||
4099343|NCT00979901|3922936|B4|||Age||Years|Mean|37.1|37.1|Standard Deviation|11.95|11.95|||
4099344|NCT00979901|3922937|B3|||Age||Years|Mean|36.3|36.3|Standard Deviation|13.0|13.0|||
4099345|NCT00979901|3922938|B2|||Age||Years|Mean|36.5|36.5|Standard Deviation|12.6|12.6|||
4099346|NCT00979901|3922939|B1|||Age||Years|Mean|35.9|35.9|Standard Deviation|12.4|12.4|||
4099347|NCT00979875|3922966|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4099348|NCT00979875|3922966|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099349|NCT00979875|3922966|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4099350|NCT00979875|3922966|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4099351|NCT00979875|3922966|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099352|NCT00979875|3922966|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099353|NCT00979875|3922966|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4099354|NCT00979875|3922966|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4099355|NCT00979875|3922966|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4099356|NCT00979875|3922966|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4099357|NCT00979875|3922966|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099358|NCT00979875|3922966|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4099359|NCT00979875|3922966|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4099360|NCT00979875|3922966|B1|||Age||years|Mean|33.7|33.7|Standard Deviation|8.96|8.96|||
4099361|NCT00979654|3923015|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4099362|NCT00979654|3923015|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4099363|NCT00979654|3923015|B1|>= 65||Age, Customized||Participants|Number|4|4.0||||||
4099364|NCT00979654|3923015|B1|40 - <65||Age, Customized||Participants|Number|78|78.0||||||
4099365|NCT00979654|3923015|B1|< 40||Age, Customized||Participants|Number|21|21.0||||||
4099366|NCT00979654|3923015|B1|||Age||Years|Mean|48.2|48.2|Standard Deviation|9.9|9.9|||
4099367|NCT00979628|3923027|B4||Male|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
4099368|NCT00979628|3923028|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4099369|NCT00979628|3923029|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4099370|NCT00979628|3923030|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4099371|NCT00979628|3923027|B4||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4099372|NCT00979628|3923028|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4099373|NCT00979628|3923029|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4099374|NCT00979628|3923030|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4099375|NCT00979628|3923027|B4|||Age||years|Mean|58.6|58.6|Standard Deviation|12|12.0|||
4099376|NCT00979628|3923028|B3|||Age||years|Mean|58.7|58.7|Standard Deviation|12|12.0|||
4099377|NCT00979628|3923029|B2|||Age||years|Mean|58.6|58.6|Standard Deviation|13|13.0|||
4099378|NCT00979628|3923030|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|11|11.0|||
4099379|NCT00979615|3923043|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4099380|NCT00979615|3923044|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4099381|NCT00979615|3923045|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4099382|NCT00979615|3923043|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4099383|NCT00979615|3923044|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4099384|NCT00979615|3923045|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4099385|NCT00979615|3923043|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4099386|NCT00979615|3923044|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4099390|NCT00979615|3923045|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4099391|NCT00979615|3923043|B3||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4099392|NCT00979615|3923044|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4099393|NCT00979615|3923045|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4099394|NCT00979602|3923060|B3|Geographic ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
4099395|NCT00979602|3923061|B2|Geographic ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
4099396|NCT00979602|3923062|B1|Geographic ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
4099397|NCT00979602|3923060|B3|Geographic ancestry|White - Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3577|3577.0||||||
4099398|NCT00979602|3923061|B2|Geographic ancestry|White - Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1790|1790.0||||||
4099399|NCT00979602|3923062|B1|Geographic ancestry|White - Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1787|1787.0||||||
4099400|NCT00979602|3923060|B3|Geographic ancestry|White - Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
4099401|NCT00979602|3923061|B2|Geographic ancestry|White - Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
4099402|NCT00979602|3923062|B1|Geographic ancestry|White - Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
4099403|NCT00979602|3923060|B3|Geographic ancestry|Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4099404|NCT00979602|3923061|B2|Geographic ancestry|Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4099405|NCT00979602|3923062|B1|Geographic ancestry|Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4099406|NCT00979602|3923060|B3|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
4099407|NCT00979602|3923061|B2|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4099408|NCT00979602|3923062|B1|Geographic ancestry|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4099409|NCT00979602|3923060|B3|Geographic ancestry|Asian - Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4099410|NCT00979602|3923061|B2|Geographic ancestry|Asian - Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4099411|NCT00979602|3923062|B1|Geographic ancestry|Asian - Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4099412|NCT00979602|3923060|B3|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
4099413|NCT00979602|3923061|B2|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4099414|NCT00979602|3923062|B1|Geographic ancestry|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4099415|NCT00979602|3923060|B3|Geographic ancestry|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|77|77.0||||||
4099416|NCT00979602|3923061|B2|Geographic ancestry|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
4099417|NCT00979602|3923062|B1|Geographic ancestry|Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
4099418|NCT00979602|3923060|B3|Geographic ancestry|American Indian or Alaskan native|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
4099419|NCT00979602|3923061|B2|Geographic ancestry|American Indian or Alaskan native|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4099420|NCT00979602|3923062|B1|Geographic ancestry|American Indian or Alaskan native|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4099421|NCT00979602|3923060|B3|Geographic ancestry|African Heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|231|231.0||||||
4099422|NCT00979602|3923061|B2|Geographic ancestry|African Heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|113|113.0||||||
4099423|NCT00979602|3923062|B1|Geographic ancestry|African Heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|118|118.0||||||
4099424|NCT00979602|3923060|B3||Male|Sex: Female, Male||Participants|Count of Participants|1678|1678.0||||||
4099425|NCT00979602|3923061|B2||Male|Sex: Female, Male||Participants|Count of Participants|838|838.0||||||
4099426|NCT00979602|3923062|B1||Male|Sex: Female, Male||Participants|Count of Participants|840|840.0||||||
4099427|NCT00979602|3923060|B3||Female|Sex: Female, Male||Participants|Count of Participants|2370|2370.0||||||
4099428|NCT00979602|3923061|B2||Female|Sex: Female, Male||Participants|Count of Participants|1185|1185.0||||||
4099429|NCT00979602|3923062|B1||Female|Sex: Female, Male||Participants|Count of Participants|1185|1185.0||||||
4099430|NCT00979602|3923060|B3|||Age||Years|Mean|45.5|45.5|Standard Deviation|18.4|18.4|||
4099431|NCT00979602|3923061|B2|||Age||Years|Mean|45.4|45.4|Standard Deviation|18.3|18.3|||
4099432|NCT00979602|3923062|B1|||Age||Years|Mean|45.5|45.5|Standard Deviation|18.6|18.6|||
4099433|NCT00979576|3923231|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4099434|NCT00979576|3923232|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4099435|NCT00979576|3923233|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4099436|NCT00979576|3923234|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4099437|NCT00979576|3923231|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4099438|NCT00979576|3923232|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4099440|NCT00979576|3923234|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4099441|NCT00979576|3923231|B4|||Age||years|Median|64.0|64.0|Full Range|||30.0|70.0|
4099442|NCT00979576|3923232|B3|||Age||years|Median|64.0|64.0|Full Range|||30.0|70.0|
4099443|NCT00979576|3923233|B2|||Age||years|Median|66.0|66.0|Full Range|||54.0|70.0|
4099444|NCT00979576|3923234|B1|||Age||years|Median|61.0|61.0|Full Range|||60.0|66.0|
4099445|NCT00979550|3923267|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4099446|NCT00979550|3923268|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4099447|NCT00979550|3923269|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4099448|NCT00979550|3923267|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4099449|NCT00979550|3923268|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4099450|NCT00979550|3923269|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4099451|NCT00979550|3923267|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4099452|NCT00979550|3923268|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4099453|NCT00979550|3923269|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4099454|NCT00979550|3923267|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4099455|NCT00979550|3923268|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4099456|NCT00979550|3923269|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4099457|NCT00979550|3923267|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4099458|NCT00979550|3923268|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4099459|NCT00979550|3923269|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4099460|NCT00979550|3923267|B3||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4099461|NCT00979550|3923268|B2||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4099462|NCT00979550|3923269|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4099463|NCT00979459|3923276|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4099464|NCT00979459|3923276|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4099465|NCT00979459|3923276|B1|>65 years||Age, Customized||participants|Number|0|0.0||||||
4099466|NCT00979459|3923276|B1|Between 35 and 65 years||Age, Customized||participants|Number|12|12.0||||||
4099467|NCT00979459|3923276|B1|<35 years||Age, Customized||participants|Number|0|0.0||||||
4099468|NCT00979420|3923289|B5|Missing||Sex/Gender, Customized||Participants|Number|1|1.0||||||
4099469|NCT00979420|3923290|B4|Missing||Sex/Gender, Customized||Participants|Number|1|1.0||||||
4099470|NCT00979420|3923291|B3|Missing||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4099471|NCT00979420|3923292|B2|Missing||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4099472|NCT00979420|3923293|B1|Missing||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4099473|NCT00979420|3923289|B5|Female||Sex/Gender, Customized||Participants|Number|77|77.0||||||
4099474|NCT00979420|3923290|B4|Female||Sex/Gender, Customized||Participants|Number|9|9.0||||||
4099475|NCT00979420|3923291|B3|Female||Sex/Gender, Customized||Participants|Number|19|19.0||||||
4099476|NCT00979420|3923292|B2|Female||Sex/Gender, Customized||Participants|Number|13|13.0||||||
4099477|NCT00979420|3923293|B1|Female||Sex/Gender, Customized||Participants|Number|36|36.0||||||
4099478|NCT00979420|3923289|B5|Male||Sex/Gender, Customized||Participants|Number|278|278.0||||||
4099479|NCT00979420|3923290|B4|Male||Sex/Gender, Customized||Participants|Number|51|51.0||||||
4099480|NCT00979420|3923291|B3|Male||Sex/Gender, Customized||Participants|Number|41|41.0||||||
4099481|NCT00979420|3923292|B2|Male||Sex/Gender, Customized||Participants|Number|44|44.0||||||
4099482|NCT00979420|3923293|B1|Male||Sex/Gender, Customized||Participants|Number|142|142.0||||||
4099483|NCT00979420|3923289|B5|||Age||Years|Mean|51.91|51.91|Standard Deviation|10.24|10.24|||
4099484|NCT00979420|3923290|B4|||Age||Years|Mean|53.69|53.69|Standard Deviation|11.05|11.05|||
4099485|NCT00979420|3923291|B3|||Age||Years|Mean|51.02|51.02|Standard Deviation|7.66|7.66|||
4099486|NCT00979420|3923292|B2|||Age||Years|Mean|54.21|54.21|Standard Deviation|10.42|10.42|||
4099487|NCT00979420|3923293|B1|||Age||Years|Mean|50.85|50.85|Standard Deviation|10.54|10.54|||
4099488|NCT00979407|3923364|B3|Geographic ancestry|White - caucasian / european heritage|Race/Ethnicity, Customized||Participants|Count of Participants|326|326.0||||||
4099489|NCT00979407|3923365|B2|Geographic ancestry|White - caucasian / european heritage|Race/Ethnicity, Customized||Participants|Count of Participants|161|161.0||||||
4099490|NCT00979407|3923366|B1|Geographic ancestry|White - caucasian / european heritage|Race/Ethnicity, Customized||Participants|Count of Participants|165|165.0||||||
4099491|NCT00979407|3923364|B3|Geographic ancestry|White - arabic / north african heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4099492|NCT00979407|3923365|B2|Geographic ancestry|White - arabic / north african heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4099493|NCT00979407|3923366|B1|Geographic ancestry|White - arabic / north african heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4099494|NCT00979407|3923364|B3|Geographic ancestry|African heritage / african american|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4099495|NCT00979407|3923365|B2|Geographic ancestry|African heritage / african american|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4099496|NCT00979407|3923366|B1|Geographic ancestry|African heritage / african american|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4099497|NCT00979407|3923364|B3||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4099498|NCT00979407|3923365|B2||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4099499|NCT00979407|3923366|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4099500|NCT00979407|3923364|B3||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4099501|NCT00979407|3923365|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4099502|NCT00979407|3923366|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4099503|NCT00979407|3923364|B3|||Age||Years|Mean|39.90|39.9|Standard Deviation|11.80|11.8|||
4099504|NCT00979407|3923365|B2|||Age||Years|Mean|39.7|39.7|Standard Deviation|11.98|11.98|||
4099505|NCT00979407|3923366|B1|||Age||Years|Mean|40.1|40.1|Standard Deviation|11.65|11.65|||
4099506|NCT00979303|3923407|B3|||BMI||kg/m^2|Mean|21.9|21.9|Full Range|||14.9|41.7|
4099507|NCT00979303|3923408|B2|||BMI||kg/m^2|Mean|22.3|22.3|Full Range|||14.9|41.7|
4099508|NCT00979303|3923409|B1|||BMI||kg/m^2|Mean|21.4|21.4|Full Range|||15.0|31.3|
4099509|NCT00979303|3923407|B3|||BSA||m^2|Mean|1.6|1.6|Full Range|||1.0|2.2|
4099510|NCT00979303|3923408|B2|||BSA||m^2|Mean|1.6|1.6|Full Range|||1.0|2.2|
4099511|NCT00979303|3923409|B1|||BSA||m^2|Mean|1.6|1.6|Full Range|||1.0|2.2|
4099512|NCT00979303|3923407|B3|||Chest circumference||cm|Mean|17.4|17.4|Full Range|||12.0|27.0|
4099513|NCT00979303|3923408|B2|||Chest circumference||cm|Mean|17.5|17.5|Full Range|||12.0|27.0|
4099514|NCT00979303|3923409|B1|||Chest circumference||cm|Mean|17.4|17.4|Full Range|||12.5|24.5|
4099515|NCT00979303|3923407|B3|||Height||cm|Mean|162.1|162.1|Full Range|||126.0|190.0|
4099516|NCT00979303|3923408|B2|||Height||cm|Mean|162.2|162.2|Full Range|||134.0|184.0|
4099517|NCT00979303|3923409|B1|||Height||cm|Mean|162|162.0|Full Range|||126.0|190.0|
4099518|NCT00979303|3923407|B3|||Weight||kg|Mean|58.5|58.5|Full Range|||26.8|104.0|
4099519|NCT00979303|3923408|B2|||Weight||kg|Mean|59.1|59.1|Full Range|||26.8|104.0|
4099520|NCT00979303|3923409|B1|||Weight||kg|Mean|57.9|57.9|Full Range|||27.4|92.2|
4099521|NCT00979303|3923407|B3|United States||Region of Enrollment||participants|Number|74|74.0||||||
4099522|NCT00979303|3923408|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4099523|NCT00979303|3923409|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4099524|NCT00979303|3923407|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4099525|NCT00979303|3923408|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4099526|NCT00979303|3923409|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4099527|NCT00979303|3923407|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4099528|NCT00979303|3923408|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4099529|NCT00979303|3923409|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4099530|NCT00979303|3923407|B3|||Age||years|Mean|14.5|14.5|Full Range|||8.0|22.3|
4099531|NCT00979303|3923408|B2|||Age||years|Mean|14.7|14.7|Full Range|||8.6|22.3|
4099532|NCT00979303|3923409|B1|||Age||years|Mean|14.2|14.2|Full Range|||8.0|20.5|
4099533|NCT00979303|3923407|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4099534|NCT00979303|3923408|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4099535|NCT00979303|3923409|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4099536|NCT00979303|3923407|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4099537|NCT00979303|3923408|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4099538|NCT00979303|3923409|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4099539|NCT00979303|3923407|B3||<=18 years|Age||Participants|Count of Participants|72|72.0||||||
4099540|NCT00979303|3923408|B2||<=18 years|Age||Participants|Count of Participants|35|35.0||||||
4099541|NCT00979303|3923409|B1||<=18 years|Age||Participants|Count of Participants|37|37.0||||||
4099542|NCT00979212|3923418|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4099543|NCT00979212|3923419|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4099544|NCT00979212|3923420|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4099545|NCT00979212|3923418|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4099546|NCT00979212|3923419|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4099547|NCT00979212|3923420|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4099548|NCT00979212|3923418|B3|||Age||years|Median|61|61.0|Full Range|||32.0|78.0|
4099549|NCT00979212|3923419|B2|||Age||years|Median|61|61.0|Full Range|||32.0|78.0|
4099550|NCT00979212|3923420|B1|||Age||years|Median|61|61.0|Full Range|||51.0|77.0|
4099551|NCT00979199|3923439|B1|Italy||Region of Enrollment||participants|Number|150|150.0||||||
4099552|NCT00979199|3923439|B1|Switzerland||Region of Enrollment||participants|Number|67|67.0||||||
4099553|NCT00979199|3923439|B1|United Kingdom||Region of Enrollment||participants|Number|27|27.0||||||
4099554|NCT00979199|3923439|B1|Germany||Region of Enrollment||participants|Number|35|35.0||||||
4099555|NCT00979199|3923439|B1|Spain||Region of Enrollment||participants|Number|61|61.0||||||
4099556|NCT00979199|3923439|B1|Poland||Region of Enrollment||participants|Number|36|36.0||||||
4099557|NCT00979199|3923439|B1|Finland||Region of Enrollment||participants|Number|71|71.0||||||
4099558|NCT00979199|3923439|B1|France||Region of Enrollment||participants|Number|28|28.0||||||
4099559|NCT00979199|3923439|B1|Female||Sex/Gender, Customized||participants|Number|184|184.0||||||
4099560|NCT00979199|3923439|B1|Male||Sex/Gender, Customized||participants|Number|291|291.0||||||
4099561|NCT00979199|3923439|B1|||Age||years|Mean|60|60.0|Standard Deviation|9|9.0|||
4099562|NCT00979121|3923443|B3|Unknown||Hours from intubation to randomization||participants|Number|1|1.0||||||
4099563|NCT00979121|3923444|B2|Unknown||Hours from intubation to randomization||participants|Number|1|1.0||||||
4099564|NCT00979121|3923445|B1|Unknown||Hours from intubation to randomization||participants|Number|0|0.0||||||
4099565|NCT00979121|3923443|B3|more than 72 hours||Hours from intubation to randomization||participants|Number|23|23.0||||||
4099566|NCT00979121|3923444|B2|more than 72 hours||Hours from intubation to randomization||participants|Number|13|13.0||||||
4099567|NCT00979121|3923445|B1|more than 72 hours||Hours from intubation to randomization||participants|Number|10|10.0||||||
4099568|NCT00979121|3923443|B3|between 48 and 72 hours||Hours from intubation to randomization||participants|Number|72|72.0||||||
4099569|NCT00979121|3923444|B2|between 48 and 72 hours||Hours from intubation to randomization||participants|Number|31|31.0||||||
4099570|NCT00979121|3923445|B1|between 48 and 72 hours||Hours from intubation to randomization||participants|Number|41|41.0||||||
4099571|NCT00979121|3923443|B3|between 24 and 48 hours||Hours from intubation to randomization||participants|Number|396|396.0||||||
4099572|NCT00979121|3923444|B2|between 24 and 48 hours||Hours from intubation to randomization||participants|Number|192|192.0||||||
4099573|NCT00979121|3923445|B1|between 24 and 48 hours||Hours from intubation to randomization||participants|Number|204|204.0||||||
4099574|NCT00979121|3923443|B3|24 hours or less||Hours from intubation to randomization||participants|Number|253|253.0||||||
4099575|NCT00979121|3923444|B2|24 hours or less||Hours from intubation to randomization||participants|Number|129|129.0||||||
4099576|NCT00979121|3923445|B1|24 hours or less||Hours from intubation to randomization||participants|Number|124|124.0||||||
4099577|NCT00979121|3923443|B3|||PaFiO2:FiO2 ratio less than or equal to 200 mm Hg|The number of participants with a P/F ratio of 200 mm Hg or less at baseline.|participants|Number|520|520.0||||||
4099578|NCT00979121|3923444|B2|||PaFiO2:FiO2 ratio less than or equal to 200 mm Hg|The number of participants with a P/F ratio of 200 mm Hg or less at baseline.|participants|Number|253|253.0||||||
4099579|NCT00979121|3923445|B1|||PaFiO2:FiO2 ratio less than or equal to 200 mm Hg|The number of participants with a P/F ratio of 200 mm Hg or less at baseline.|participants|Number|267|267.0||||||
4099580|NCT00979121|3923443|B3|||Baseline Shock|The number of participants who were in shock at the time of randomization. Baseline shock was defined as meeting one of the following conditions: a mean arterial pressure less than 60 mm Hg, receiving a vasopressor (norepinephrine, epinephrine, vasopressin or neosynephrine) at any dose, or receiving dopamine at a dose greater than or equal to 6 mcg/kg/min (or mcg/min) .|participants|Number|339|339.0||||||
4099581|NCT00979121|3923444|B2|||Baseline Shock|The number of participants who were in shock at the time of randomization. Baseline shock was defined as meeting one of the following conditions: a mean arterial pressure less than 60 mm Hg, receiving a vasopressor (norepinephrine, epinephrine, vasopressin or neosynephrine) at any dose, or receiving dopamine at a dose greater than or equal to 6 mcg/kg/min (or mcg/min) .|participants|Number|166|166.0||||||
4099582|NCT00979121|3923445|B1|||Baseline Shock|The number of participants who were in shock at the time of randomization. Baseline shock was defined as meeting one of the following conditions: a mean arterial pressure less than 60 mm Hg, receiving a vasopressor (norepinephrine, epinephrine, vasopressin or neosynephrine) at any dose, or receiving dopamine at a dose greater than or equal to 6 mcg/kg/min (or mcg/min) .|participants|Number|173|173.0||||||
4099583|NCT00979121|3923443|B3|Trauma||Primary cause of lung injury|Based on coding of primary vs. secondary by the site; data entry errors account for total count discrepancy.|participants|Number|6|6.0||||||
4099584|NCT00979121|3923444|B2|Trauma||Primary cause of lung injury|Based on coding of primary vs. secondary by the site; data entry errors account for total count discrepancy.|participants|Number|4|4.0||||||
4099585|NCT00979121|3923445|B1|Trauma||Primary cause of lung injury|Based on coding of primary vs. secondary by the site; data entry errors account for total count discrepancy.|participants|Number|2|2.0||||||
4099586|NCT00979121|3923443|B3|Sepsis||Primary cause of lung injury|Based on coding of primary vs. secondary by the site; data entry errors account for total count discrepancy.|participants|Number|145|145.0||||||
4099587|NCT00979121|3923444|B2|Sepsis||Primary cause of lung injury|Based on coding of primary vs. secondary by the site; data entry errors account for total count discrepancy.|participants|Number|73|73.0||||||
4099588|NCT00979121|3923445|B1|Sepsis||Primary cause of lung injury|Based on coding of primary vs. secondary by the site; data entry errors account for total count discrepancy.|participants|Number|72|72.0||||||
4099589|NCT00979121|3923443|B3|Pneumonia||Primary cause of lung injury|Based on coding of primary vs. secondary by the site; data entry errors account for total count discrepancy.|participants|Number|527|527.0||||||
4099590|NCT00979121|3923444|B2|Pneumonia||Primary cause of lung injury|Based on coding of primary vs. secondary by the site; data entry errors account for total count discrepancy.|participants|Number|260|260.0||||||
4099591|NCT00979121|3923445|B1|Pneumonia||Primary cause of lung injury|Based on coding of primary vs. secondary by the site; data entry errors account for total count discrepancy.|participants|Number|267|267.0||||||
4099592|NCT00979121|3923443|B3|Other||Primary cause of lung injury|Based on coding of primary vs. secondary by the site; data entry errors account for total count discrepancy.|participants|Number|11|11.0||||||
4099593|NCT00979121|3923444|B2|Other||Primary cause of lung injury|Based on coding of primary vs. secondary by the site; data entry errors account for total count discrepancy.|participants|Number|4|4.0||||||
4099594|NCT00979121|3923445|B1|Other||Primary cause of lung injury|Based on coding of primary vs. secondary by the site; data entry errors account for total count discrepancy.|participants|Number|7|7.0||||||
4099595|NCT00979121|3923443|B3|Multiple Transfusion||Primary cause of lung injury|Based on coding of primary vs. secondary by the site; data entry errors account for total count discrepancy.|participants|Number|4|4.0||||||
4099596|NCT00979121|3923444|B2|Multiple Transfusion||Primary cause of lung injury|Based on coding of primary vs. secondary by the site; data entry errors account for total count discrepancy.|participants|Number|1|1.0||||||
4099597|NCT00979121|3923445|B1|Multiple Transfusion||Primary cause of lung injury|Based on coding of primary vs. secondary by the site; data entry errors account for total count discrepancy.|participants|Number|3|3.0||||||
4099598|NCT00979121|3923443|B3|Aspiration||Primary cause of lung injury|Based on coding of primary vs. secondary by the site; data entry errors account for total count discrepancy.|participants|Number|49|49.0||||||
4099599|NCT00979121|3923444|B2|Aspiration||Primary cause of lung injury|Based on coding of primary vs. secondary by the site; data entry errors account for total count discrepancy.|participants|Number|23|23.0||||||
4099600|NCT00979121|3923445|B1|Aspiration||Primary cause of lung injury|Based on coding of primary vs. secondary by the site; data entry errors account for total count discrepancy.|participants|Number|26|26.0||||||
4099601|NCT00979121|3923443|B3|||APACHE III Score|APACHE III Score: Acute, Physiology, Age, Chronic Health Evaluation III Prognostic System is a measure of hospital mortality risk for critically ill adult patients. Our study used a refined version based on the study by Knause and colleagues (Chest, 1991; 100:1619-36). The score is based on results from addition of 3 groups of variables (physiology, range: 0-252; age: 0-23; and chronic health: 0-24). Overall score range: 0-299; higher number indicates higher risk.|units on a scale|Mean|93.4|93.4|Standard Deviation|28.2|28.2|||
4099602|NCT00979121|3923444|B2|||APACHE III Score|APACHE III Score: Acute, Physiology, Age, Chronic Health Evaluation III Prognostic System is a measure of hospital mortality risk for critically ill adult patients. Our study used a refined version based on the study by Knause and colleagues (Chest, 1991; 100:1619-36). The score is based on results from addition of 3 groups of variables (physiology, range: 0-252; age: 0-23; and chronic health: 0-24). Overall score range: 0-299; higher number indicates higher risk.|units on a scale|Mean|94.8|94.8|Standard Deviation|27.9|27.9|||
4099603|NCT00979121|3923445|B1|||APACHE III Score|APACHE III Score: Acute, Physiology, Age, Chronic Health Evaluation III Prognostic System is a measure of hospital mortality risk for critically ill adult patients. Our study used a refined version based on the study by Knause and colleagues (Chest, 1991; 100:1619-36). The score is based on results from addition of 3 groups of variables (physiology, range: 0-252; age: 0-23; and chronic health: 0-24). Overall score range: 0-299; higher number indicates higher risk.|units on a scale|Mean|92.1|92.1|Standard Deviation|28.4|28.4|||
4099604|NCT00979121|3923443|B3|United States||Region of Enrollment||participants|Number|745|745.0||||||
4099605|NCT00979121|3923444|B2|United States||Region of Enrollment||participants|Number|366|366.0||||||
4099606|NCT00979121|3923445|B1|United States||Region of Enrollment||participants|Number|379|379.0||||||
4099607|NCT00979121|3923443|B3|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|24|24.0||||||
4099608|NCT00979121|3923444|B2|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|10|10.0||||||
4099609|NCT00979121|3923445|B1|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|14|14.0||||||
4099610|NCT00979121|3923443|B3|More than one race||Race (NIH/OMB)||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4099611|NCT00979121|3923444|B2|More than one race||Race (NIH/OMB)||participants|Number|NA|||||||not captured
4099612|NCT00979121|3923445|B1|More than one race||Race (NIH/OMB)||participants|Number|NA|||||||not captured
4099613|NCT00979121|3923443|B3|White||Race (NIH/OMB)||participants|Number|590|590.0||||||
4099614|NCT00979121|3923444|B2|White||Race (NIH/OMB)||participants|Number|301|301.0||||||
4099615|NCT00979121|3923445|B1|White||Race (NIH/OMB)||participants|Number|289|289.0||||||
4099616|NCT00979121|3923443|B3|Black or African American||Race (NIH/OMB)||participants|Number|105|105.0||||||
4099617|NCT00979121|3923444|B2|Black or African American||Race (NIH/OMB)||participants|Number|53|53.0||||||
4099618|NCT00979121|3923445|B1|Black or African American||Race (NIH/OMB)||participants|Number|52|52.0||||||
4099619|NCT00979121|3923443|B3|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|5|5.0||||||
4099620|NCT00979121|3923444|B2|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|3|3.0||||||
4099621|NCT00979121|3923445|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|2|2.0||||||
4099622|NCT00979121|3923443|B3|Asian||Race (NIH/OMB)||participants|Number|16|16.0||||||
4099623|NCT00979121|3923444|B2|Asian||Race (NIH/OMB)||participants|Number|7|7.0||||||
4099624|NCT00979121|3923445|B1|Asian||Race (NIH/OMB)||participants|Number|9|9.0||||||
4099625|NCT00979121|3923443|B3|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|6|6.0||||||
4099626|NCT00979121|3923444|B2|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|5|5.0||||||
4099627|NCT00979121|3923445|B1|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|1|1.0||||||
4099628|NCT00979121|3923443|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099629|NCT00979121|3923444|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099630|NCT00979121|3923445|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099631|NCT00979121|3923443|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|659|659.0||||||
4099632|NCT00979121|3923444|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|326|326.0||||||
4099633|NCT00979121|3923445|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|333|333.0||||||
4099634|NCT00979121|3923443|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4099635|NCT00979121|3923444|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4099636|NCT00979121|3923445|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4099637|NCT00979121|3923443|B3||Male|Sex: Female, Male||Participants|Count of Participants|365|365.0||||||
4099638|NCT00979121|3923444|B2||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4099639|NCT00979121|3923445|B1||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4099640|NCT00979121|3923443|B3||Female|Sex: Female, Male||Participants|Count of Participants|380|380.0||||||
4099641|NCT00979121|3923444|B2||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4099642|NCT00979121|3923445|B1||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4099643|NCT00979121|3923443|B3|||Age||years|Mean|54.1|54.1|Standard Deviation|16.3|16.3|||
4099644|NCT00979121|3923444|B2|||Age||years|Mean|54.1|54.1|Standard Deviation|15.6|15.6|||
4099645|NCT00979121|3923445|B1|||Age||years|Mean|54.2|54.2|Standard Deviation|17.1|17.1|||
4099646|NCT00979121|3923443|B3||>=65 years|Age||Participants|Count of Participants|206|206.0||||||
4099647|NCT00979121|3923444|B2||>=65 years|Age||Participants|Count of Participants|92|92.0||||||
4099648|NCT00979121|3923445|B1||>=65 years|Age||Participants|Count of Participants|114|114.0||||||
4099649|NCT00979121|3923443|B3||Between 18 and 65 years|Age||Participants|Count of Participants|534|534.0||||||
4099650|NCT00979121|3923444|B2||Between 18 and 65 years|Age||Participants|Count of Participants|272|272.0||||||
4099651|NCT00979121|3923445|B1||Between 18 and 65 years|Age||Participants|Count of Participants|262|262.0||||||
4099652|NCT00979121|3923443|B3||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4099653|NCT00979121|3923444|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4099654|NCT00979121|3923445|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4099655|NCT00979069|3923462|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4099656|NCT00979069|3923463|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4099657|NCT00979069|3923464|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4099658|NCT00979069|3923462|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4099659|NCT00979069|3923463|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4099660|NCT00979069|3923464|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4099661|NCT00979069|3923462|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4099662|NCT00979069|3923463|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4099663|NCT00979069|3923464|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4099664|NCT00979069|3923462|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099665|NCT00979069|3923463|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099666|NCT00979069|3923464|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099667|NCT00979069|3923462|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4099668|NCT00979069|3923463|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4099669|NCT00979069|3923464|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4099670|NCT00979069|3923462|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4099671|NCT00979069|3923463|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4099672|NCT00979069|3923464|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099673|NCT00979069|3923462|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4099674|NCT00979069|3923463|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4099675|NCT00979069|3923464|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4099676|NCT00979069|3923462|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4099677|NCT00979069|3923463|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4099678|NCT00979069|3923464|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4099679|NCT00979069|3923462|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099680|NCT00979069|3923463|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099681|NCT00979069|3923464|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099682|NCT00979069|3923462|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099683|NCT00979069|3923463|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099684|NCT00979069|3923464|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099685|NCT00979069|3923462|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099686|NCT00979069|3923463|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099687|NCT00979069|3923464|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099688|NCT00979069|3923462|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4099689|NCT00979069|3923463|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4099690|NCT00979069|3923464|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4099691|NCT00979069|3923462|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4099692|NCT00979069|3923463|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4099693|NCT00979069|3923464|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4099694|NCT00979069|3923462|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4099695|NCT00979069|3923463|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4099696|NCT00979069|3923464|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4099697|NCT00979069|3923462|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4099698|NCT00979069|3923463|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4099699|NCT00979069|3923464|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4099700|NCT00979069|3923462|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4099701|NCT00979069|3923463|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4099702|NCT00979069|3923464|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4099703|NCT00979017|3923471|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4099704|NCT00979017|3923471|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4099705|NCT00979017|3923471|B1|||Age||years|Mean|58|58.0|Standard Deviation|10.2|10.2|||
4099706|NCT00978757|3923479|B3|Argentina||Region of Enrollment||participants|Number|42|42.0||||||
4099707|NCT00978757|3923480|B2|Argentina||Region of Enrollment||participants|Number|20|20.0||||||
4099708|NCT00978757|3923481|B1|Argentina||Region of Enrollment||participants|Number|22|22.0||||||
4099709|NCT00978757|3923479|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4099710|NCT00978757|3923480|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4099711|NCT00978757|3923481|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4099712|NCT00978757|3923479|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4099713|NCT00978757|3923480|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4099714|NCT00978757|3923481|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4099715|NCT00978757|3923479|B3|||Age||years|Mean|61.23|61.23|Standard Deviation|7.7|7.7|||
4099716|NCT00978757|3923480|B2|||Age||years|Mean|54.5|54.5|Standard Deviation|13.8|13.8|||
4099717|NCT00978757|3923481|B1|||Age||years|Mean|62|62.0|Standard Deviation|13.4|13.4|||
4099718|NCT00978731|3923488|B5|Not reported||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity, with 0 being the least severe score and 5 being the most severe score. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead.|participants|Number|1|1.0||||||
4099719|NCT00978731|3923489|B4|Not reported||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity, with 0 being the least severe score and 5 being the most severe score. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead.|participants|Number|0|0.0||||||
4099720|NCT00978731|3923490|B3|Not reported||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity, with 0 being the least severe score and 5 being the most severe score. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead.|participants|Number|0|0.0||||||
4099721|NCT00978731|3923491|B2|Not reported||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity, with 0 being the least severe score and 5 being the most severe score. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead.|participants|Number|1|1.0||||||
4099722|NCT00978731|3923492|B1|Not reported||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity, with 0 being the least severe score and 5 being the most severe score. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead.|participants|Number|0|0.0||||||
4099723|NCT00978731|3923488|B5|5 = dead||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity, with 0 being the least severe score and 5 being the most severe score. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead.|participants|Number|0|0.0||||||
4099724|NCT00978731|3923489|B4|5 = dead||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity, with 0 being the least severe score and 5 being the most severe score. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead.|participants|Number|0|0.0||||||
4099725|NCT00978731|3923490|B3|5 = dead||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity, with 0 being the least severe score and 5 being the most severe score. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead.|participants|Number|0|0.0||||||
4099726|NCT00978731|3923491|B2|5 = dead||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity, with 0 being the least severe score and 5 being the most severe score. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead.|participants|Number|0|0.0||||||
4099727|NCT00978731|3923492|B1|5 = dead||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity, with 0 being the least severe score and 5 being the most severe score. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead.|participants|Number|0|0.0||||||
4099728|NCT00978731|3923488|B5|4 = completely disabled||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity, with 0 being the least severe score and 5 being the most severe score. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead.|participants|Number|0|0.0||||||
4099729|NCT00978731|3923489|B4|4 = completely disabled||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity, with 0 being the least severe score and 5 being the most severe score. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead.|participants|Number|0|0.0||||||
4099730|NCT00978731|3923490|B3|4 = completely disabled||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity, with 0 being the least severe score and 5 being the most severe score. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead.|participants|Number|0|0.0||||||
4099793|NCT00978731|3923488|B5|||Age||years|Median|64|64.0|Full Range|||30.0|81.0|
4099794|NCT00978731|3923489|B4|||Age||years|Median|51|51.0|Full Range|||34.0|62.0|
4099795|NCT00978731|3923490|B3|||Age||years|Median|63|63.0|Full Range|||51.0|74.0|
4099796|NCT00978731|3923491|B2|||Age||years|Median|68|68.0|Full Range|||30.0|80.0|
4099731|NCT00978731|3923491|B2|4 = completely disabled||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity, with 0 being the least severe score and 5 being the most severe score. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead.|participants|Number|0|0.0||||||
4099732|NCT00978731|3923492|B1|4 = completely disabled||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity, with 0 being the least severe score and 5 being the most severe score. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead.|participants|Number|0|0.0||||||
4099733|NCT00978731|3923488|B5|3 = capable of only limited self care||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity, with 0 being the least severe score and 5 being the most severe score. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead.|participants|Number|0|0.0||||||
4099734|NCT00978731|3923489|B4|3 = capable of only limited self care||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity, with 0 being the least severe score and 5 being the most severe score. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead.|participants|Number|0|0.0||||||
4099735|NCT00978731|3923490|B3|3 = capable of only limited self care||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity, with 0 being the least severe score and 5 being the most severe score. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead.|participants|Number|0|0.0||||||
4099736|NCT00978731|3923491|B2|3 = capable of only limited self care||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity, with 0 being the least severe score and 5 being the most severe score. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead.|participants|Number|0|0.0||||||
4099737|NCT00978731|3923492|B1|3 = capable of only limited self care||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity, with 0 being the least severe score and 5 being the most severe score. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead.|participants|Number|0|0.0||||||
4099738|NCT00978731|3923488|B5|2 = ambulatory but unable to work||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity, with 0 being the least severe score and 5 being the most severe score. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead.|participants|Number|0|0.0||||||
4099739|NCT00978731|3923489|B4|2 = ambulatory but unable to work||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity, with 0 being the least severe score and 5 being the most severe score. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead.|participants|Number|0|0.0||||||
4099740|NCT00978731|3923490|B3|2 = ambulatory but unable to work||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity, with 0 being the least severe score and 5 being the most severe score. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead.|participants|Number|0|0.0||||||
4099741|NCT00978731|3923491|B2|2 = ambulatory but unable to work||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity, with 0 being the least severe score and 5 being the most severe score. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead.|participants|Number|0|0.0||||||
4099742|NCT00978731|3923492|B1|2 = ambulatory but unable to work||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity, with 0 being the least severe score and 5 being the most severe score. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead.|participants|Number|0|0.0||||||
4099743|NCT00978731|3923488|B5|1 = restricted physically strenuous activity||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity, with 0 being the least severe score and 5 being the most severe score. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead.|participants|Number|7|7.0||||||
4099744|NCT00978731|3923489|B4|1 = restricted physically strenuous activity||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity, with 0 being the least severe score and 5 being the most severe score. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead.|participants|Number|0|0.0||||||
4099745|NCT00978731|3923490|B3|1 = restricted physically strenuous activity||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity, with 0 being the least severe score and 5 being the most severe score. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead.|participants|Number|2|2.0||||||
4099746|NCT00978731|3923491|B2|1 = restricted physically strenuous activity||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity, with 0 being the least severe score and 5 being the most severe score. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead.|participants|Number|1|1.0||||||
4099747|NCT00978731|3923492|B1|1 = restricted physically strenuous activity||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity, with 0 being the least severe score and 5 being the most severe score. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead.|participants|Number|4|4.0||||||
4099748|NCT00978731|3923488|B5|0 = fully active||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity, with 0 being the least severe score and 5 being the most severe score. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead.|participants|Number|38|38.0||||||
4099749|NCT00978731|3923489|B4|0 = fully active||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity, with 0 being the least severe score and 5 being the most severe score. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead.|participants|Number|4|4.0||||||
4099750|NCT00978731|3923490|B3|0 = fully active||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity, with 0 being the least severe score and 5 being the most severe score. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead.|participants|Number|3|3.0||||||
4099751|NCT00978731|3923491|B2|0 = fully active||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity, with 0 being the least severe score and 5 being the most severe score. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead.|participants|Number|13|13.0||||||
4099752|NCT00978731|3923492|B1|0 = fully active||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity, with 0 being the least severe score and 5 being the most severe score. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead.|participants|Number|18|18.0||||||
4099753|NCT00978731|3923488|B5|Other races||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4099754|NCT00978731|3923489|B4|Other races||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4099755|NCT00978731|3923490|B3|Other races||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4099756|NCT00978731|3923491|B2|Other races||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4099757|NCT00978731|3923492|B1|Other races||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4099758|NCT00978731|3923488|B5|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4099759|NCT00978731|3923489|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4099760|NCT00978731|3923490|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4099761|NCT00978731|3923491|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4099762|NCT00978731|3923492|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4099763|NCT00978731|3923488|B5|Black/African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4099764|NCT00978731|3923489|B4|Black/African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4099765|NCT00978731|3923490|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4099766|NCT00978731|3923491|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4099767|NCT00978731|3923492|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4099768|NCT00978731|3923488|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4099769|NCT00978731|3923489|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4099770|NCT00978731|3923490|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4099771|NCT00978731|3923491|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4099772|NCT00978731|3923492|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4099773|NCT00978731|3923488|B5||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4099774|NCT00978731|3923489|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4099775|NCT00978731|3923490|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4099776|NCT00978731|3923491|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4099777|NCT00978731|3923492|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4099778|NCT00978731|3923488|B5||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4099779|NCT00978731|3923489|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4099780|NCT00978731|3923490|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4099781|NCT00978731|3923491|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4099782|NCT00978731|3923492|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4099783|NCT00978731|3923488|B5|>= 65 years||Age, Customized||participants|Number|22|22.0||||||
4099784|NCT00978731|3923489|B4|>= 65 years||Age, Customized||participants|Number|0|0.0||||||
4099785|NCT00978731|3923490|B3|>= 65 years||Age, Customized||participants|Number|2|2.0||||||
4099786|NCT00978731|3923491|B2|>= 65 years||Age, Customized||participants|Number|10|10.0||||||
4099787|NCT00978731|3923492|B1|>= 65 years||Age, Customized||participants|Number|10|10.0||||||
4099788|NCT00978731|3923488|B5|< 65 years||Age, Customized||participants|Number|24|24.0||||||
4099789|NCT00978731|3923489|B4|< 65 years||Age, Customized||participants|Number|4|4.0||||||
4099790|NCT00978731|3923490|B3|< 65 years||Age, Customized||participants|Number|3|3.0||||||
4099791|NCT00978731|3923491|B2|< 65 years||Age, Customized||participants|Number|5|5.0||||||
4099792|NCT00978731|3923492|B1|< 65 years||Age, Customized||participants|Number|12|12.0||||||
4099797|NCT00978731|3923492|B1|||Age||years|Median|58|58.0|Full Range|||41.0|81.0|
4099798|NCT00978627|3923533|B3|||Fasting plasma glucose (FPG)||mmol/L|Mean|10.5|10.5|Standard Deviation|4.8|4.8|||
4099799|NCT00978627|3923534|B2|||Fasting plasma glucose (FPG)||mmol/L|Mean|11.0|11.0|Standard Deviation|4.8|4.8|||
4099800|NCT00978627|3923535|B1|||Fasting plasma glucose (FPG)||mmol/L|Mean|10.3|10.3|Standard Deviation|4.7|4.7|||
4099801|NCT00978627|3923533|B3|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.3|8.3|Standard Deviation|0.8|0.8|||
4099802|NCT00978627|3923534|B2|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.3|8.3|Standard Deviation|0.7|0.7|||
4099803|NCT00978627|3923535|B1|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.3|8.3|Standard Deviation|0.8|0.8|||
4099804|NCT00978627|3923533|B3||Male|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
4099805|NCT00978627|3923534|B2||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4099806|NCT00978627|3923535|B1||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4099807|NCT00978627|3923533|B3||Female|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
4099808|NCT00978627|3923534|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4099809|NCT00978627|3923535|B1||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4099810|NCT00978627|3923533|B3|||Age||years|Mean|41.3|41.3|Standard Deviation|13.2|13.2|||
4099811|NCT00978627|3923534|B2|||Age||years|Mean|42.6|42.6|Standard Deviation|13.8|13.8|||
4099812|NCT00978627|3923535|B1|||Age||years|Mean|40.7|40.7|Standard Deviation|12.8|12.8|||
4099813|NCT00978562|3923558|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4099814|NCT00978562|3923558|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4099815|NCT00978562|3923558|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4099816|NCT00978562|3923558|B1|||Age||years|Mean|9.28|9.28|Standard Deviation|3.68|3.68|||
4099817|NCT00978445|3923563|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4099818|NCT00978445|3923563|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4099819|NCT00978445|3923563|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4099820|NCT00978445|3923563|B1|||Age||years|Mean|53.7|53.7|Standard Deviation|11.7|11.7|||
4099821|NCT00978445|3923563|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4099822|NCT00978445|3923563|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4099823|NCT00978445|3923563|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4099824|NCT00978432|3923571|B4|United States||Region of Enrollment||participants|Number|33|33.0||||||
4099825|NCT00978432|3923572|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4099826|NCT00978432|3923573|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4099827|NCT00978432|3923574|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4099828|NCT00978432|3923571|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099829|NCT00978432|3923572|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099830|NCT00978432|3923573|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099831|NCT00978432|3923574|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099832|NCT00978432|3923571|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099833|NCT00978432|3923572|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099834|NCT00978432|3923573|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099835|NCT00978432|3923574|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099836|NCT00978432|3923571|B4||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4099837|NCT00978432|3923572|B3||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4099838|NCT00978432|3923573|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4099839|NCT00978432|3923574|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4099840|NCT00978432|3923571|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4099841|NCT00978432|3923572|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4099842|NCT00978432|3923573|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099843|NCT00978432|3923574|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4099844|NCT00978432|3923571|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099845|NCT00978432|3923572|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099846|NCT00978432|3923573|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099847|NCT00978432|3923574|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099848|NCT00978432|3923571|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099849|NCT00978432|3923572|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099850|NCT00978432|3923573|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099851|NCT00978432|3923574|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099852|NCT00978432|3923571|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099853|NCT00978432|3923572|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099854|NCT00978432|3923573|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099855|NCT00978432|3923574|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099856|NCT00978432|3923571|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099857|NCT00978432|3923572|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099858|NCT00978432|3923573|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099859|NCT00978432|3923574|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099860|NCT00978432|3923571|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4099861|NCT00978432|3923572|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4099862|NCT00978432|3923573|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4099863|NCT00978432|3923574|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4099864|NCT00978432|3923571|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099865|NCT00978432|3923572|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099866|NCT00978432|3923573|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099867|NCT00978432|3923574|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4099868|NCT00978432|3923571|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4099869|NCT00978432|3923572|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4099870|NCT00978432|3923573|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4099871|NCT00978432|3923574|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4099872|NCT00978432|3923571|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4099873|NCT00978432|3923572|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4099874|NCT00978432|3923573|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4099875|NCT00978432|3923574|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4099876|NCT00978432|3923571|B4||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4099877|NCT00978432|3923572|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4099878|NCT00978432|3923573|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4099879|NCT00978432|3923574|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4099880|NCT00978432|3923571|B4||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4099881|NCT00978432|3923572|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4099882|NCT00978432|3923573|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4099883|NCT00978432|3923574|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4099884|NCT00978432|3923571|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4099885|NCT00978432|3923572|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4099886|NCT00978432|3923573|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4099887|NCT00978432|3923574|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4099888|NCT00978380|3923627|B1|Other||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4099889|NCT00978380|3923627|B1|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4099890|NCT00978380|3923627|B1|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4099891|NCT00978380|3923627|B1|White||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
4099892|NCT00978380|3923627|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4099893|NCT00978380|3923627|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4099894|NCT00978380|3923627|B1|Asian||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4099895|NCT00978380|3923627|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4099896|NCT00978380|3923627|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4099897|NCT00978380|3923627|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4099898|NCT00978380|3923627|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4099899|NCT00978380|3923627|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4099900|NCT00978380|3923627|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4099901|NCT00978380|3923627|B1|||Age||Years|Mean|31|31.0|Standard Deviation|16.8|16.8|||
4099902|NCT00978341|3923633|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4099903|NCT00978341|3923633|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4099904|NCT00978341|3923633|B1|>= 65 years||Age, Customized||participants|Number|3|3.0||||||
4099905|NCT00978341|3923633|B1|45-64 years||Age, Customized||participants|Number|7|7.0||||||
4099906|NCT00978341|3923633|B1|18-44 years||Age, Customized||participants|Number|5|5.0||||||
4099907|NCT00978120|3923652|B5|||FEV1/FVC Ratio|"The FEV1 (forced expiratory volume 1))/ FVC (forced vital capacity) ratio is used to evaluate airways obstructions since pure restrictive ventilatory defects cause an equal reduction in the FEV1 and the FVC. An FEV1/FVC ratio below 80% indicates airflow obstruction. Normal FEV1/FVC: 8 – 19 years of age=85%; 20-39 years of age=80%; 40- 59 years of age 75%; 60-80 years of age 70% [1]~[1]: National Asthma Education and Prevention Program Expert Panel Report 3, Guidelines for the Diagnosis and Management of Asthma. Oct. 2007. http://www.nhlbi.nih.gov/guidelines/asthma/asthsumm.pdf"|Ratio (x 100)|Mean|72.1|72.1|Standard Deviation|10.62|10.62|||
4099988|NCT00978068|3923710|B2|Previous ART||CD4 Percentage|The percentage represents the percentage of white cells that are CD4 cells.|% of white cells that are CD4 cells|Median|30|30.0|Full Range|||10.0|45.0|
4099908|NCT00978120|3923653|B4|||FEV1/FVC Ratio|"The FEV1 (forced expiratory volume 1))/ FVC (forced vital capacity) ratio is used to evaluate airways obstructions since pure restrictive ventilatory defects cause an equal reduction in the FEV1 and the FVC. An FEV1/FVC ratio below 80% indicates airflow obstruction. Normal FEV1/FVC: 8 – 19 years of age=85%; 20-39 years of age=80%; 40- 59 years of age 75%; 60-80 years of age 70% [1]~[1]: National Asthma Education and Prevention Program Expert Panel Report 3, Guidelines for the Diagnosis and Management of Asthma. Oct. 2007. http://www.nhlbi.nih.gov/guidelines/asthma/asthsumm.pdf"|Ratio (x 100)|Mean|68.4|68.4|Standard Deviation|11.76|11.76|||
4099909|NCT00978120|3923654|B3|||FEV1/FVC Ratio|"The FEV1 (forced expiratory volume 1))/ FVC (forced vital capacity) ratio is used to evaluate airways obstructions since pure restrictive ventilatory defects cause an equal reduction in the FEV1 and the FVC. An FEV1/FVC ratio below 80% indicates airflow obstruction. Normal FEV1/FVC: 8 – 19 years of age=85%; 20-39 years of age=80%; 40- 59 years of age 75%; 60-80 years of age 70% [1]~[1]: National Asthma Education and Prevention Program Expert Panel Report 3, Guidelines for the Diagnosis and Management of Asthma. Oct. 2007. http://www.nhlbi.nih.gov/guidelines/asthma/asthsumm.pdf"|Ratio (x 100)|Mean|68.4|68.4|Standard Deviation|10.91|10.91|||
4099910|NCT00978120|3923655|B2|||FEV1/FVC Ratio|"The FEV1 (forced expiratory volume 1))/ FVC (forced vital capacity) ratio is used to evaluate airways obstructions since pure restrictive ventilatory defects cause an equal reduction in the FEV1 and the FVC. An FEV1/FVC ratio below 80% indicates airflow obstruction. Normal FEV1/FVC: 8 – 19 years of age=85%; 20-39 years of age=80%; 40- 59 years of age 75%; 60-80 years of age 70% [1]~[1]: National Asthma Education and Prevention Program Expert Panel Report 3, Guidelines for the Diagnosis and Management of Asthma. Oct. 2007. http://www.nhlbi.nih.gov/guidelines/asthma/asthsumm.pdf"|Ratio (x 100)|Mean|75.7|75.7|Standard Deviation|8.99|8.99|||
4099911|NCT00978120|3923656|B1|||FEV1/FVC Ratio|"The FEV1 (forced expiratory volume 1))/ FVC (forced vital capacity) ratio is used to evaluate airways obstructions since pure restrictive ventilatory defects cause an equal reduction in the FEV1 and the FVC. An FEV1/FVC ratio below 80% indicates airflow obstruction. Normal FEV1/FVC: 8 – 19 years of age=85%; 20-39 years of age=80%; 40- 59 years of age 75%; 60-80 years of age 70% [1]~[1]: National Asthma Education and Prevention Program Expert Panel Report 3, Guidelines for the Diagnosis and Management of Asthma. Oct. 2007. http://www.nhlbi.nih.gov/guidelines/asthma/asthsumm.pdf"|Ratio (x 100)|Mean|74.5|74.5|Standard Deviation|9.07|9.07|||
4099912|NCT00978120|3923652|B5|||Forced Vital Capacity (FVC) % Predicted|FVC is a lung function test that measures the total amount of air exhaled. The percent of predicted value is FVC converted to a percentage of normal, based on height, weight, and race. Estimates of severity of abnormalities in flow volume measured by FVC: Mild-65-80% of predicted value; Moderate-50-65% of predicted value; Severe-<50% of predicted value.|percentage|Mean|88.8|88.8|Standard Deviation|17.3|17.3|||
4099913|NCT00978120|3923653|B4|||Forced Vital Capacity (FVC) % Predicted|FVC is a lung function test that measures the total amount of air exhaled. The percent of predicted value is FVC converted to a percentage of normal, based on height, weight, and race. Estimates of severity of abnormalities in flow volume measured by FVC: Mild-65-80% of predicted value; Moderate-50-65% of predicted value; Severe-<50% of predicted value.|percentage|Mean|80.9|80.9|Standard Deviation|18.7|18.7|||
4099914|NCT00978120|3923654|B3|||Forced Vital Capacity (FVC) % Predicted|FVC is a lung function test that measures the total amount of air exhaled. The percent of predicted value is FVC converted to a percentage of normal, based on height, weight, and race. Estimates of severity of abnormalities in flow volume measured by FVC: Mild-65-80% of predicted value; Moderate-50-65% of predicted value; Severe-<50% of predicted value.|percentage|Mean|85.0|85.0|Standard Deviation|17.1|17.1|||
4099915|NCT00978120|3923655|B2|||Forced Vital Capacity (FVC) % Predicted|FVC is a lung function test that measures the total amount of air exhaled. The percent of predicted value is FVC converted to a percentage of normal, based on height, weight, and race. Estimates of severity of abnormalities in flow volume measured by FVC: Mild-65-80% of predicted value; Moderate-50-65% of predicted value; Severe-<50% of predicted value.|percentage|Mean|94.3|94.3|Standard Deviation|16.1|16.1|||
4099916|NCT00978120|3923656|B1|||Forced Vital Capacity (FVC) % Predicted|FVC is a lung function test that measures the total amount of air exhaled. The percent of predicted value is FVC converted to a percentage of normal, based on height, weight, and race. Estimates of severity of abnormalities in flow volume measured by FVC: Mild-65-80% of predicted value; Moderate-50-65% of predicted value; Severe-<50% of predicted value.|percentage|Mean|92.6|92.6|Standard Deviation|14.3|14.3|||
4099917|NCT00978120|3923652|B5|||Forced Expiratory Volume in 1 second (FEV1) % Predicted|FEV1 is air volume exhaled in 1 second during spirometry. Asthma severity classification for trial: mild--pre-bronchodilator FEV1 ≥ 80% predicted requiring no/ low-moderate dose of inhaled glucocorticoids; moderate--pre-bronchodilator FEV1 <80% predicted requiring no/ low-moderate dose of inhaled glucocorticoids; severe--requiring high-dose inhaled glucocorticoids with/without continuous/near continuous oral glucocorticoids, or uncontrolled despite treatment. FEV1 percent of predicted value is FEV1 converted to a percentage of normal, based on height, weight, and race.|percentage|Mean|79.0|79.0|Standard Deviation|19.7|19.7|||
4099918|NCT00978120|3923653|B4|||Forced Expiratory Volume in 1 second (FEV1) % Predicted|FEV1 is air volume exhaled in 1 second during spirometry. Asthma severity classification for trial: mild--pre-bronchodilator FEV1 ≥ 80% predicted requiring no/ low-moderate dose of inhaled glucocorticoids; moderate--pre-bronchodilator FEV1 <80% predicted requiring no/ low-moderate dose of inhaled glucocorticoids; severe--requiring high-dose inhaled glucocorticoids with/without continuous/near continuous oral glucocorticoids, or uncontrolled despite treatment. FEV1 percent of predicted value is FEV1 converted to a percentage of normal, based on height, weight, and race.|percentage|Mean|69.8|69.8|Standard Deviation|20.8|20.8|||
4099919|NCT00978120|3923654|B3|||Forced Expiratory Volume in 1 second (FEV1) % Predicted|FEV1 is air volume exhaled in 1 second during spirometry. Asthma severity classification for trial: mild--pre-bronchodilator FEV1 ≥ 80% predicted requiring no/ low-moderate dose of inhaled glucocorticoids; moderate--pre-bronchodilator FEV1 <80% predicted requiring no/ low-moderate dose of inhaled glucocorticoids; severe--requiring high-dose inhaled glucocorticoids with/without continuous/near continuous oral glucocorticoids, or uncontrolled despite treatment. FEV1 percent of predicted value is FEV1 converted to a percentage of normal, based on height, weight, and race.|percentage|Mean|72.6|72.6|Standard Deviation|19.4|19.4|||
4099989|NCT00978068|3923711|B1|Previous ART||CD4 Percentage|The percentage represents the percentage of white cells that are CD4 cells.|% of white cells that are CD4 cells|Median|31|31.0|Full Range|||8.0|51.0|
4099920|NCT00978120|3923655|B2|||Forced Expiratory Volume in 1 second (FEV1) % Predicted|FEV1 is air volume exhaled in 1 second during spirometry. Asthma severity classification for trial: mild--pre-bronchodilator FEV1 ≥ 80% predicted requiring no/ low-moderate dose of inhaled glucocorticoids; moderate--pre-bronchodilator FEV1 <80% predicted requiring no/ low-moderate dose of inhaled glucocorticoids; severe--requiring high-dose inhaled glucocorticoids with/without continuous/near continuous oral glucocorticoids, or uncontrolled despite treatment. FEV1 percent of predicted value is FEV1 converted to a percentage of normal, based on height, weight, and race.|percentage|Mean|86.6|86.6|Standard Deviation|17.6|17.6|||
4099921|NCT00978120|3923656|B1|||Forced Expiratory Volume in 1 second (FEV1) % Predicted|FEV1 is air volume exhaled in 1 second during spirometry. Asthma severity classification for trial: mild--pre-bronchodilator FEV1 ≥ 80% predicted requiring no/ low-moderate dose of inhaled glucocorticoids; moderate--pre-bronchodilator FEV1 <80% predicted requiring no/ low-moderate dose of inhaled glucocorticoids; severe--requiring high-dose inhaled glucocorticoids with/without continuous/near continuous oral glucocorticoids, or uncontrolled despite treatment. FEV1 percent of predicted value is FEV1 converted to a percentage of normal, based on height, weight, and race.|percentage|Mean|83.8|83.8|Standard Deviation|16.3|16.3|||
4099922|NCT00978120|3923652|B5|||Body Mass Index (BMI)|"BMI is a number calculated from a person’s height and weight that provides a reliable indicator of body fatness for most people. Higher values reflect greater amount of body fat. [1] In adults, a BMI less than 18.5 is underweight; 18.5 to 24.9 is a normal or healthy weight; greater than or equal to 25.0 is overweight. The height and weight was collected at baseline only.~[1]: Healthy Weight , Assessing Your Weight , Body Mass Index http://www.cdc.gov/healthyweight/assessing/bmi/index.html"|kg/m^2|Mean|29.9|29.9|Standard Deviation|8.3|8.3|||
4099923|NCT00978120|3923653|B4|||Body Mass Index (BMI)|"BMI is a number calculated from a person’s height and weight that provides a reliable indicator of body fatness for most people. Higher values reflect greater amount of body fat. [1] In adults, a BMI less than 18.5 is underweight; 18.5 to 24.9 is a normal or healthy weight; greater than or equal to 25.0 is overweight. The height and weight was collected at baseline only.~[1]: Healthy Weight , Assessing Your Weight , Body Mass Index http://www.cdc.gov/healthyweight/assessing/bmi/index.html"|kg/m^2|Mean|30.1|30.1|Standard Deviation|8.0|8.0|||
4099924|NCT00978120|3923654|B3|||Body Mass Index (BMI)|"BMI is a number calculated from a person’s height and weight that provides a reliable indicator of body fatness for most people. Higher values reflect greater amount of body fat. [1] In adults, a BMI less than 18.5 is underweight; 18.5 to 24.9 is a normal or healthy weight; greater than or equal to 25.0 is overweight. The height and weight was collected at baseline only.~[1]: Healthy Weight , Assessing Your Weight , Body Mass Index http://www.cdc.gov/healthyweight/assessing/bmi/index.html"|kg/m^2|Mean|31.8|31.8|Standard Deviation|9.7|9.7|||
4099925|NCT00978120|3923655|B2|||Body Mass Index (BMI)|"BMI is a number calculated from a person’s height and weight that provides a reliable indicator of body fatness for most people. Higher values reflect greater amount of body fat. [1] In adults, a BMI less than 18.5 is underweight; 18.5 to 24.9 is a normal or healthy weight; greater than or equal to 25.0 is overweight. The height and weight was collected at baseline only.~[1]: Healthy Weight , Assessing Your Weight , Body Mass Index http://www.cdc.gov/healthyweight/assessing/bmi/index.html"|kg/m^2|Mean|28.5|28.5|Standard Deviation|6.8|6.8|||
4099926|NCT00978120|3923656|B1|||Body Mass Index (BMI)|"BMI is a number calculated from a person’s height and weight that provides a reliable indicator of body fatness for most people. Higher values reflect greater amount of body fat. [1] In adults, a BMI less than 18.5 is underweight; 18.5 to 24.9 is a normal or healthy weight; greater than or equal to 25.0 is overweight. The height and weight was collected at baseline only.~[1]: Healthy Weight , Assessing Your Weight , Body Mass Index http://www.cdc.gov/healthyweight/assessing/bmi/index.html"|kg/m^2|Mean|29.5|29.5|Standard Deviation|8.5|8.5|||
4099927|NCT00978120|3923652|B5|||Asthma Duration|Asthma duration is the number of years since the participant was told by a physician that he/she has asthma as reported at the baseline visit, visit 1.|years|Mean|22.3|22.3|Standard Deviation|15.3|15.3|||
4099928|NCT00978120|3923653|B4|||Asthma Duration|Asthma duration is the number of years since the participant was told by a physician that he/she has asthma as reported at the baseline visit, visit 1.|years|Mean|24.6|24.6|Standard Deviation|17.8|17.8|||
4099929|NCT00978120|3923654|B3|||Asthma Duration|Asthma duration is the number of years since the participant was told by a physician that he/she has asthma as reported at the baseline visit, visit 1.|years|Mean|23.3|23.3|Standard Deviation|16.5|16.5|||
4099930|NCT00978120|3923655|B2|||Asthma Duration|Asthma duration is the number of years since the participant was told by a physician that he/she has asthma as reported at the baseline visit, visit 1.|years|Mean|19.9|19.9|Standard Deviation|13.4|13.4|||
4099931|NCT00978120|3923656|B1|||Asthma Duration|Asthma duration is the number of years since the participant was told by a physician that he/she has asthma as reported at the baseline visit, visit 1.|years|Mean|21.9|21.9|Standard Deviation|13.9|13.9|||
4099932|NCT00978120|3923652|B5|||Age at Asthma Onset|The age at asthma onset is the age defined in years when the participant was told by a physician that he/she has asthma. This was calculated by subtracting the participant’s age at the baseline visit (visit 1) from the number of years the participant reported to have known having asthma.|years|Mean|19.0|19.0|Standard Deviation|17.9|17.9|||
4099933|NCT00978120|3923653|B4|||Age at Asthma Onset|The age at asthma onset is the age defined in years when the participant was told by a physician that he/she has asthma. This was calculated by subtracting the participant’s age at the baseline visit (visit 1) from the number of years the participant reported to have known having asthma.|years|Mean|21.9|21.9|Standard Deviation|20.1|20.1|||
4099934|NCT00978120|3923654|B3|||Age at Asthma Onset|The age at asthma onset is the age defined in years when the participant was told by a physician that he/she has asthma. This was calculated by subtracting the participant’s age at the baseline visit (visit 1) from the number of years the participant reported to have known having asthma.|years|Mean|21.9|21.9|Standard Deviation|19.7|19.7|||
4099935|NCT00978120|3923655|B2|||Age at Asthma Onset|The age at asthma onset is the age defined in years when the participant was told by a physician that he/she has asthma. This was calculated by subtracting the participant’s age at the baseline visit (visit 1) from the number of years the participant reported to have known having asthma.|years|Mean|16.4|16.4|Standard Deviation|14.9|14.9|||
4100035|NCT00978029|3923741|B4||Male|Gender||Participants|Count of Participants|75|75.0||||||
4099936|NCT00978120|3923656|B1|||Age at Asthma Onset|The age at asthma onset is the age defined in years when the participant was told by a physician that he/she has asthma. This was calculated by subtracting the participant’s age at the baseline visit (visit 1) from the number of years the participant reported to have known having asthma.|years|Mean|17.1|17.1|Standard Deviation|17.0|17.0|||
4099937|NCT00978120|3923652|B5|United States||Region of Enrollment||participants|Number|390|390.0||||||
4099938|NCT00978120|3923653|B4|United States||Region of Enrollment||participants|Number|86|86.0||||||
4099939|NCT00978120|3923654|B3|United States||Region of Enrollment||participants|Number|87|87.0||||||
4099940|NCT00978120|3923655|B2|United States||Region of Enrollment||participants|Number|107|107.0||||||
4099941|NCT00978120|3923656|B1|United States||Region of Enrollment||participants|Number|110|110.0||||||
4099942|NCT00978120|3923652|B5||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4099943|NCT00978120|3923653|B4||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4099944|NCT00978120|3923654|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4099945|NCT00978120|3923655|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4099946|NCT00978120|3923656|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4099947|NCT00978120|3923652|B5||Female|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
4099948|NCT00978120|3923653|B4||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4099949|NCT00978120|3923654|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4099950|NCT00978120|3923655|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4099951|NCT00978120|3923656|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4099952|NCT00978120|3923652|B5|||Age||years|Mean|41.3|41.3|Standard Deviation|17.8|17.8|||
4099953|NCT00978120|3923653|B4|||Age||years|Mean|46.5|46.5|Standard Deviation|17.3|17.3|||
4099954|NCT00978120|3923654|B3|||Age||years|Mean|45.2|45.2|Standard Deviation|17.0|17.0|||
4099955|NCT00978120|3923655|B2|||Age||years|Mean|36.3|36.3|Standard Deviation|17.0|17.0|||
4099956|NCT00978120|3923656|B1|||Age||years|Mean|39.1|39.1|Standard Deviation|18.1|18.1|||
4099957|NCT00978120|3923652|B5||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4099958|NCT00978120|3923653|B4||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4099959|NCT00978120|3923654|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4099960|NCT00978120|3923655|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4099961|NCT00978120|3923656|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4099962|NCT00978120|3923652|B5||Between 18 and 65 years|Age||Participants|Count of Participants|294|294.0||||||
4099963|NCT00978120|3923653|B4||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
4099964|NCT00978120|3923654|B3||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
4099965|NCT00978120|3923655|B2||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
4099966|NCT00978120|3923656|B1||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4099967|NCT00978120|3923652|B5||<=18 years|Age||Participants|Count of Participants|67|67.0||||||
4099968|NCT00978120|3923653|B4||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4099969|NCT00978120|3923654|B3||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4099970|NCT00978120|3923655|B2||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
4099971|NCT00978120|3923656|B1||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
4099972|NCT00978068|3923709|B3|Negative||Result of Baseline Blood Smear for Asexual Parasites||participants|Number|149|149.0||||||
4099973|NCT00978068|3923710|B2|Negative||Result of Baseline Blood Smear for Asexual Parasites||participants|Number|75|75.0||||||
4099974|NCT00978068|3923711|B1|Negative||Result of Baseline Blood Smear for Asexual Parasites||participants|Number|74|74.0||||||
4099975|NCT00978068|3923709|B3|Positive||Result of Baseline Blood Smear for Asexual Parasites||participants|Number|21|21.0||||||
4099976|NCT00978068|3923710|B2|Positive||Result of Baseline Blood Smear for Asexual Parasites||participants|Number|11|11.0||||||
4099977|NCT00978068|3923711|B1|Positive||Result of Baseline Blood Smear for Asexual Parasites||participants|Number|10|10.0||||||
4099978|NCT00978068|3923709|B3|||Hemoglobin||g/dL|Mean|10.5|10.5|Standard Deviation|1.4|1.4|||
4099979|NCT00978068|3923710|B2|||Hemoglobin||g/dL|Mean|10.6|10.6|Standard Deviation|1.5|1.5|||
4099980|NCT00978068|3923711|B1|||Hemoglobin||g/dL|Mean|10.4|10.4|Standard Deviation|1.3|1.3|||
4099981|NCT00978068|3923709|B3|Previous ART||Viral Load|0 = below the level of detection (<400 copies per microliter).|log10copies/mL|Median|NA||Full Range|||0.0|0.0|Below the level of detection (<400 copies per microliter)
4099982|NCT00978068|3923710|B2|Previous ART||Viral Load|0 = below the level of detection (<400 copies per microliter).|log10copies/mL|Median|NA||Full Range|||0.0|0.0|Below the level of detection (<400 copies per microliter)
4099983|NCT00978068|3923711|B1|Previous ART||Viral Load|0 = below the level of detection (<400 copies per microliter).|log10copies/mL|Median|NA||Full Range|||0.0|0.0|Below the level of detection (<400 copies per microliter)
4099984|NCT00978068|3923709|B3|No Previous ART||Viral Load|0 = below the level of detection (<400 copies per microliter).|log10copies/mL|Median|5.5|5.5|Full Range|||0.0|6.4|
4099985|NCT00978068|3923710|B2|No Previous ART||Viral Load|0 = below the level of detection (<400 copies per microliter).|log10copies/mL|Median|5.5|5.5|Full Range|||0.0|6.4|
4099986|NCT00978068|3923711|B1|No Previous ART||Viral Load|0 = below the level of detection (<400 copies per microliter).|log10copies/mL|Median|5.4|5.4|Full Range|||0.0|6.4|
4099987|NCT00978068|3923709|B3|Previous ART||CD4 Percentage|The percentage represents the percentage of white cells that are CD4 cells.|% of white cells that are CD4 cells|Median|30|30.0|Full Range|||8.0|51.0|
4100036|NCT00978029|3923742|B3||Male|Gender||Participants|Count of Participants|25|25.0||||||
4099990|NCT00978068|3923709|B3|No Previous ART||CD4 Percentage|The percentage represents the percentage of white cells that are CD4 cells.|% of white cells that are CD4 cells|Median|16|16.0|Full Range|||2.0|44.0|
4099991|NCT00978068|3923710|B2|No Previous ART||CD4 Percentage|The percentage represents the percentage of white cells that are CD4 cells.|% of white cells that are CD4 cells|Median|16|16.0|Full Range|||2.0|43.0|
4099992|NCT00978068|3923711|B1|No Previous ART||CD4 Percentage|The percentage represents the percentage of white cells that are CD4 cells.|% of white cells that are CD4 cells|Median|14|14.0|Full Range|||2.0|44.0|
4099993|NCT00978068|3923709|B3|Stage IV (HIV wasting syndrome)||WHO Clinical HIV stage|clinical staging is based on standard WHO grading scales found is the document: https://www.who.int/hiv/pub/guidelines/clinicalstaging.pdf|participants|Number|10|10.0||||||
4099994|NCT00978068|3923710|B2|Stage IV (HIV wasting syndrome)||WHO Clinical HIV stage|clinical staging is based on standard WHO grading scales found is the document: https://www.who.int/hiv/pub/guidelines/clinicalstaging.pdf|participants|Number|4|4.0||||||
4099995|NCT00978068|3923711|B1|Stage IV (HIV wasting syndrome)||WHO Clinical HIV stage|clinical staging is based on standard WHO grading scales found is the document: https://www.who.int/hiv/pub/guidelines/clinicalstaging.pdf|participants|Number|6|6.0||||||
4099996|NCT00978068|3923709|B3|Stage III (unexplained severe weight loss)||WHO Clinical HIV stage|clinical staging is based on standard WHO grading scales found is the document: https://www.who.int/hiv/pub/guidelines/clinicalstaging.pdf|participants|Number|3|3.0||||||
4099997|NCT00978068|3923710|B2|Stage III (unexplained severe weight loss)||WHO Clinical HIV stage|clinical staging is based on standard WHO grading scales found is the document: https://www.who.int/hiv/pub/guidelines/clinicalstaging.pdf|participants|Number|1|1.0||||||
4099998|NCT00978068|3923711|B1|Stage III (unexplained severe weight loss)||WHO Clinical HIV stage|clinical staging is based on standard WHO grading scales found is the document: https://www.who.int/hiv/pub/guidelines/clinicalstaging.pdf|participants|Number|2|2.0||||||
4099999|NCT00978068|3923709|B3|Stage II (mod. unexplained weight loss)||WHO Clinical HIV stage|clinical staging is based on standard WHO grading scales found is the document: https://www.who.int/hiv/pub/guidelines/clinicalstaging.pdf|participants|Number|31|31.0||||||
4100000|NCT00978068|3923710|B2|Stage II (mod. unexplained weight loss)||WHO Clinical HIV stage|clinical staging is based on standard WHO grading scales found is the document: https://www.who.int/hiv/pub/guidelines/clinicalstaging.pdf|participants|Number|15|15.0||||||
4100001|NCT00978068|3923711|B1|Stage II (mod. unexplained weight loss)||WHO Clinical HIV stage|clinical staging is based on standard WHO grading scales found is the document: https://www.who.int/hiv/pub/guidelines/clinicalstaging.pdf|participants|Number|16|16.0||||||
4100002|NCT00978068|3923709|B3|Stage I (Asymptomatic)||WHO Clinical HIV stage|clinical staging is based on standard WHO grading scales found is the document: https://www.who.int/hiv/pub/guidelines/clinicalstaging.pdf|participants|Number|126|126.0||||||
4100003|NCT00978068|3923710|B2|Stage I (Asymptomatic)||WHO Clinical HIV stage|clinical staging is based on standard WHO grading scales found is the document: https://www.who.int/hiv/pub/guidelines/clinicalstaging.pdf|participants|Number|66|66.0||||||
4100004|NCT00978068|3923711|B1|Stage I (Asymptomatic)||WHO Clinical HIV stage|clinical staging is based on standard WHO grading scales found is the document: https://www.who.int/hiv/pub/guidelines/clinicalstaging.pdf|participants|Number|60|60.0||||||
4100005|NCT00978068|3923709|B3|Previous ART||Previous ART to Enrollment||participants|Number|55|55.0||||||
4100006|NCT00978068|3923710|B2|Previous ART||Previous ART to Enrollment||participants|Number|28|28.0||||||
4100007|NCT00978068|3923711|B1|Previous ART||Previous ART to Enrollment||participants|Number|27|27.0||||||
4100008|NCT00978068|3923709|B3|No Previous ART||Previous ART to Enrollment||participants|Number|115|115.0||||||
4100009|NCT00978068|3923710|B2|No Previous ART||Previous ART to Enrollment||participants|Number|58|58.0||||||
4100010|NCT00978068|3923711|B1|No Previous ART||Previous ART to Enrollment||participants|Number|57|57.0||||||
4100011|NCT00978068|3923709|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4100012|NCT00978068|3923710|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4100013|NCT00978068|3923711|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4100014|NCT00978068|3923709|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4100015|NCT00978068|3923710|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4100016|NCT00978068|3923711|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4100017|NCT00978068|3923709|B3|||Age||years|Median|3.1|3.1|Full Range|||0.5|6.0|
4100018|NCT00978068|3923710|B2|||Age||years|Median|3.1|3.1|Full Range|||0.5|5.9|
4100019|NCT00978068|3923711|B1|||Age||years|Median|2.9|2.9|Full Range|||0.7|6.0|
4100020|NCT00978042|3923728|B3|Canada||Region of Enrollment||participants|Number|33|33.0||||||
4100021|NCT00978042|3923729|B2|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4100022|NCT00978042|3923730|B1|Canada||Region of Enrollment||participants|Number|27|27.0||||||
4100023|NCT00978042|3923728|B3|United States||Region of Enrollment||participants|Number|249|249.0||||||
4100024|NCT00978042|3923729|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
4100025|NCT00978042|3923730|B1|United States||Region of Enrollment||participants|Number|208|208.0||||||
4100026|NCT00978042|3923728|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4100027|NCT00978042|3923729|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4100028|NCT00978042|3923730|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4100029|NCT00978042|3923728|B3||Female|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
4100030|NCT00978042|3923729|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4100031|NCT00978042|3923730|B1||Female|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4100032|NCT00978042|3923728|B3|||Age||Years|Mean|54.4|54.4|Standard Deviation|6.98|6.98|||
4100033|NCT00978042|3923729|B2|||Age||Years|Mean|54.7|54.7|Standard Deviation|5.95|5.95|||
4100034|NCT00978042|3923730|B1|||Age||Years|Mean|54.4|54.4|Standard Deviation|7.18|7.18|||
4100037|NCT00978029|3923743|B2||Male|Gender||Participants|Count of Participants|23|23.0||||||
4100038|NCT00978029|3923744|B1||Male|Gender||Participants|Count of Participants|27|27.0||||||
4100039|NCT00978029|3923741|B4||Female|Gender||Participants|Count of Participants|121|121.0||||||
4100040|NCT00978029|3923742|B3||Female|Gender||Participants|Count of Participants|40|40.0||||||
4100041|NCT00978029|3923743|B2||Female|Gender||Participants|Count of Participants|43|43.0||||||
4100042|NCT00978029|3923744|B1||Female|Gender||Participants|Count of Participants|38|38.0||||||
4100043|NCT00978029|3923741|B4|||Age||Years|Mean|56.3|56.3|Standard Deviation|5.3|5.3|||
4100044|NCT00978029|3923742|B3|||Age||Years|Mean|56.2|56.2|Standard Deviation|5.7|5.7|||
4100045|NCT00978029|3923743|B2|||Age||Years|Mean|56.4|56.4|Standard Deviation|5.4|5.4|||
4100046|NCT00978029|3923744|B1|||Age||Years|Mean|56.4|56.4|Standard Deviation|4.7|4.7|||
4100047|NCT00977938|3923769|B5|||Modified ACC–AHA lesion class B2 or C|The 5,020 DES 30-month DAPT patients had a total of 6,594 lesions; The 4,941 DES 12-month DAPT patients had a total of 6,413 lesions; The 842 BMS 30-month DAPT patients had a total of 975 lesions; The 845 BMS 12-month DAPT patients had a total of 991 lesions; The definitions of class B2 and class C lesions according to the modified ACC/AHA criteria|lesions|Number|6287|6287.0||||||
4100048|NCT00977938|3923770|B4|||Modified ACC–AHA lesion class B2 or C|The 5,020 DES 30-month DAPT patients had a total of 6,594 lesions; The 4,941 DES 12-month DAPT patients had a total of 6,413 lesions; The 842 BMS 30-month DAPT patients had a total of 975 lesions; The 845 BMS 12-month DAPT patients had a total of 991 lesions; The definitions of class B2 and class C lesions according to the modified ACC/AHA criteria|lesions|Number|450|450.0||||||
4100049|NCT00977938|3923771|B3|||Modified ACC–AHA lesion class B2 or C|The 5,020 DES 30-month DAPT patients had a total of 6,594 lesions; The 4,941 DES 12-month DAPT patients had a total of 6,413 lesions; The 842 BMS 30-month DAPT patients had a total of 975 lesions; The 845 BMS 12-month DAPT patients had a total of 991 lesions; The definitions of class B2 and class C lesions according to the modified ACC/AHA criteria|lesions|Number|440|440.0||||||
4100050|NCT00977938|3923772|B2|||Modified ACC–AHA lesion class B2 or C|The 5,020 DES 30-month DAPT patients had a total of 6,594 lesions; The 4,941 DES 12-month DAPT patients had a total of 6,413 lesions; The 842 BMS 30-month DAPT patients had a total of 975 lesions; The 845 BMS 12-month DAPT patients had a total of 991 lesions; The definitions of class B2 and class C lesions according to the modified ACC/AHA criteria|lesions|Number|2643|2643.0||||||
4100051|NCT00977938|3923773|B1|||Modified ACC–AHA lesion class B2 or C|The 5,020 DES 30-month DAPT patients had a total of 6,594 lesions; The 4,941 DES 12-month DAPT patients had a total of 6,413 lesions; The 842 BMS 30-month DAPT patients had a total of 975 lesions; The 845 BMS 12-month DAPT patients had a total of 991 lesions; The definitions of class B2 and class C lesions according to the modified ACC/AHA criteria|lesions|Number|2754|2754.0||||||
4100052|NCT00977938|3923769|B5|Arterial graft||Treated Vessel|The 5,020 DES 30-month DAPT patients had a total of 6,594 lesions; The 4,941 DES 12-month DAPT patients had a total of 6,413 lesions; The 842 BMS 30-month DAPT patients had a total of 975 lesions; The 845 BMS 12-month DAPT patients had a total of 991 lesions|lesions|Number|66|66.0||||||
4100053|NCT00977938|3923770|B4|Arterial graft||Treated Vessel|The 5,020 DES 30-month DAPT patients had a total of 6,594 lesions; The 4,941 DES 12-month DAPT patients had a total of 6,413 lesions; The 842 BMS 30-month DAPT patients had a total of 975 lesions; The 845 BMS 12-month DAPT patients had a total of 991 lesions|lesions|Number|0|0.0||||||
4100054|NCT00977938|3923771|B3|Arterial graft||Treated Vessel|The 5,020 DES 30-month DAPT patients had a total of 6,594 lesions; The 4,941 DES 12-month DAPT patients had a total of 6,413 lesions; The 842 BMS 30-month DAPT patients had a total of 975 lesions; The 845 BMS 12-month DAPT patients had a total of 991 lesions|lesions|Number|0|0.0||||||
4100055|NCT00977938|3923772|B2|Arterial graft||Treated Vessel|The 5,020 DES 30-month DAPT patients had a total of 6,594 lesions; The 4,941 DES 12-month DAPT patients had a total of 6,413 lesions; The 842 BMS 30-month DAPT patients had a total of 975 lesions; The 845 BMS 12-month DAPT patients had a total of 991 lesions|lesions|Number|30|30.0||||||
4100056|NCT00977938|3923773|B1|Arterial graft||Treated Vessel|The 5,020 DES 30-month DAPT patients had a total of 6,594 lesions; The 4,941 DES 12-month DAPT patients had a total of 6,413 lesions; The 842 BMS 30-month DAPT patients had a total of 975 lesions; The 845 BMS 12-month DAPT patients had a total of 991 lesions|lesions|Number|36|36.0||||||
4100057|NCT00977938|3923769|B5|Venous graft||Treated Vessel|The 5,020 DES 30-month DAPT patients had a total of 6,594 lesions; The 4,941 DES 12-month DAPT patients had a total of 6,413 lesions; The 842 BMS 30-month DAPT patients had a total of 975 lesions; The 845 BMS 12-month DAPT patients had a total of 991 lesions|lesions|Number|376|376.0||||||
4100058|NCT00977938|3923770|B4|Venous graft||Treated Vessel|The 5,020 DES 30-month DAPT patients had a total of 6,594 lesions; The 4,941 DES 12-month DAPT patients had a total of 6,413 lesions; The 842 BMS 30-month DAPT patients had a total of 975 lesions; The 845 BMS 12-month DAPT patients had a total of 991 lesions|lesions|Number|25|25.0||||||
4100059|NCT00977938|3923771|B3|Venous graft||Treated Vessel|The 5,020 DES 30-month DAPT patients had a total of 6,594 lesions; The 4,941 DES 12-month DAPT patients had a total of 6,413 lesions; The 842 BMS 30-month DAPT patients had a total of 975 lesions; The 845 BMS 12-month DAPT patients had a total of 991 lesions|lesions|Number|24|24.0||||||
4100060|NCT00977938|3923772|B2|Venous graft||Treated Vessel|The 5,020 DES 30-month DAPT patients had a total of 6,594 lesions; The 4,941 DES 12-month DAPT patients had a total of 6,413 lesions; The 842 BMS 30-month DAPT patients had a total of 975 lesions; The 845 BMS 12-month DAPT patients had a total of 991 lesions|lesions|Number|173|173.0||||||
4100061|NCT00977938|3923773|B1|Venous graft||Treated Vessel|The 5,020 DES 30-month DAPT patients had a total of 6,594 lesions; The 4,941 DES 12-month DAPT patients had a total of 6,413 lesions; The 842 BMS 30-month DAPT patients had a total of 975 lesions; The 845 BMS 12-month DAPT patients had a total of 991 lesions|lesions|Number|154|154.0||||||
4100062|NCT00977938|3923769|B5|Circumflex||Treated Vessel|The 5,020 DES 30-month DAPT patients had a total of 6,594 lesions; The 4,941 DES 12-month DAPT patients had a total of 6,413 lesions; The 842 BMS 30-month DAPT patients had a total of 975 lesions; The 845 BMS 12-month DAPT patients had a total of 991 lesions|lesions|Number|3392|3392.0||||||
4100086|NCT00977938|3923773|B1|||Total stent length (per-patient)||mm|Mean|27.70|27.7|Standard Deviation|16.77|16.77|||
4100087|NCT00977938|3923769|B5|≥3 mm||Minimum stent diameter (per-patient)||participants|Number|6607|6607.0||||||
4100063|NCT00977938|3923770|B4|Circumflex||Treated Vessel|The 5,020 DES 30-month DAPT patients had a total of 6,594 lesions; The 4,941 DES 12-month DAPT patients had a total of 6,413 lesions; The 842 BMS 30-month DAPT patients had a total of 975 lesions; The 845 BMS 12-month DAPT patients had a total of 991 lesions|lesions|Number|207|207.0||||||
4100064|NCT00977938|3923771|B3|Circumflex||Treated Vessel|The 5,020 DES 30-month DAPT patients had a total of 6,594 lesions; The 4,941 DES 12-month DAPT patients had a total of 6,413 lesions; The 842 BMS 30-month DAPT patients had a total of 975 lesions; The 845 BMS 12-month DAPT patients had a total of 991 lesions|lesions|Number|206|206.0||||||
4100065|NCT00977938|3923772|B2|Circumflex||Treated Vessel|The 5,020 DES 30-month DAPT patients had a total of 6,594 lesions; The 4,941 DES 12-month DAPT patients had a total of 6,413 lesions; The 842 BMS 30-month DAPT patients had a total of 975 lesions; The 845 BMS 12-month DAPT patients had a total of 991 lesions|lesions|Number|1506|1506.0||||||
4100066|NCT00977938|3923773|B1|Circumflex||Treated Vessel|The 5,020 DES 30-month DAPT patients had a total of 6,594 lesions; The 4,941 DES 12-month DAPT patients had a total of 6,413 lesions; The 842 BMS 30-month DAPT patients had a total of 975 lesions; The 845 BMS 12-month DAPT patients had a total of 991 lesions|lesions|Number|1473|1473.0||||||
4100067|NCT00977938|3923769|B5|Right coronary artery (RCA)||Treated Vessel|The 5,020 DES 30-month DAPT patients had a total of 6,594 lesions; The 4,941 DES 12-month DAPT patients had a total of 6,413 lesions; The 842 BMS 30-month DAPT patients had a total of 975 lesions; The 845 BMS 12-month DAPT patients had a total of 991 lesions|lesions|Number|5099|5099.0||||||
4100068|NCT00977938|3923770|B4|Right coronary artery (RCA)||Treated Vessel|The 5,020 DES 30-month DAPT patients had a total of 6,594 lesions; The 4,941 DES 12-month DAPT patients had a total of 6,413 lesions; The 842 BMS 30-month DAPT patients had a total of 975 lesions; The 845 BMS 12-month DAPT patients had a total of 991 lesions|lesions|Number|452|452.0||||||
4100069|NCT00977938|3923771|B3|Right coronary artery (RCA)||Treated Vessel|The 5,020 DES 30-month DAPT patients had a total of 6,594 lesions; The 4,941 DES 12-month DAPT patients had a total of 6,413 lesions; The 842 BMS 30-month DAPT patients had a total of 975 lesions; The 845 BMS 12-month DAPT patients had a total of 991 lesions|lesions|Number|437|437.0||||||
4100070|NCT00977938|3923772|B2|Right coronary artery (RCA)||Treated Vessel|The 5,020 DES 30-month DAPT patients had a total of 6,594 lesions; The 4,941 DES 12-month DAPT patients had a total of 6,413 lesions; The 842 BMS 30-month DAPT patients had a total of 975 lesions; The 845 BMS 12-month DAPT patients had a total of 991 lesions|lesions|Number|2057|2057.0||||||
4100071|NCT00977938|3923773|B1|Right coronary artery (RCA)||Treated Vessel|The 5,020 DES 30-month DAPT patients had a total of 6,594 lesions; The 4,941 DES 12-month DAPT patients had a total of 6,413 lesions; The 842 BMS 30-month DAPT patients had a total of 975 lesions; The 845 BMS 12-month DAPT patients had a total of 991 lesions|lesions|Number|2153|2153.0||||||
4100072|NCT00977938|3923769|B5|Left anterior descending (LAD)||Treated Vessel|The 5,020 DES 30-month DAPT patients had a total of 6,594 lesions; The 4,941 DES 12-month DAPT patients had a total of 6,413 lesions; The 842 BMS 30-month DAPT patients had a total of 975 lesions; The 845 BMS 12-month DAPT patients had a total of 991 lesions|lesions|Number|5915|5915.0||||||
4100073|NCT00977938|3923770|B4|Left anterior descending (LAD)||Treated Vessel|The 5,020 DES 30-month DAPT patients had a total of 6,594 lesions; The 4,941 DES 12-month DAPT patients had a total of 6,413 lesions; The 842 BMS 30-month DAPT patients had a total of 975 lesions; The 845 BMS 12-month DAPT patients had a total of 991 lesions|lesions|Number|306|306.0||||||
4100074|NCT00977938|3923771|B3|Left anterior descending (LAD)||Treated Vessel|The 5,020 DES 30-month DAPT patients had a total of 6,594 lesions; The 4,941 DES 12-month DAPT patients had a total of 6,413 lesions; The 842 BMS 30-month DAPT patients had a total of 975 lesions; The 845 BMS 12-month DAPT patients had a total of 991 lesions|lesions|Number|308|308.0||||||
4100075|NCT00977938|3923772|B2|Left anterior descending (LAD)||Treated Vessel|The 5,020 DES 30-month DAPT patients had a total of 6,594 lesions; The 4,941 DES 12-month DAPT patients had a total of 6,413 lesions; The 842 BMS 30-month DAPT patients had a total of 975 lesions; The 845 BMS 12-month DAPT patients had a total of 991 lesions|lesions|Number|2586|2586.0||||||
4100076|NCT00977938|3923773|B1|Left anterior descending (LAD)||Treated Vessel|The 5,020 DES 30-month DAPT patients had a total of 6,594 lesions; The 4,941 DES 12-month DAPT patients had a total of 6,413 lesions; The 842 BMS 30-month DAPT patients had a total of 975 lesions; The 845 BMS 12-month DAPT patients had a total of 991 lesions|lesions|Number|2715|2715.0||||||
4100077|NCT00977938|3923769|B5|Left main||Treated Vessel|The 5,020 DES 30-month DAPT patients had a total of 6,594 lesions; The 4,941 DES 12-month DAPT patients had a total of 6,413 lesions; The 842 BMS 30-month DAPT patients had a total of 975 lesions; The 845 BMS 12-month DAPT patients had a total of 991 lesions|lesions|Number|111|111.0||||||
4100078|NCT00977938|3923770|B4|Left main||Treated Vessel|The 5,020 DES 30-month DAPT patients had a total of 6,594 lesions; The 4,941 DES 12-month DAPT patients had a total of 6,413 lesions; The 842 BMS 30-month DAPT patients had a total of 975 lesions; The 845 BMS 12-month DAPT patients had a total of 991 lesions|lesions|Number|1|1.0||||||
4100079|NCT00977938|3923771|B3|Left main||Treated Vessel|The 5,020 DES 30-month DAPT patients had a total of 6,594 lesions; The 4,941 DES 12-month DAPT patients had a total of 6,413 lesions; The 842 BMS 30-month DAPT patients had a total of 975 lesions; The 845 BMS 12-month DAPT patients had a total of 991 lesions|lesions|Number|0|0.0||||||
4100080|NCT00977938|3923772|B2|Left main||Treated Vessel|The 5,020 DES 30-month DAPT patients had a total of 6,594 lesions; The 4,941 DES 12-month DAPT patients had a total of 6,413 lesions; The 842 BMS 30-month DAPT patients had a total of 975 lesions; The 845 BMS 12-month DAPT patients had a total of 991 lesions|lesions|Number|55|55.0||||||
4100081|NCT00977938|3923773|B1|Left main||Treated Vessel|The 5,020 DES 30-month DAPT patients had a total of 6,594 lesions; The 4,941 DES 12-month DAPT patients had a total of 6,413 lesions; The 842 BMS 30-month DAPT patients had a total of 975 lesions; The 845 BMS 12-month DAPT patients had a total of 991 lesions|lesions|Number|55|55.0||||||
4100082|NCT00977938|3923769|B5|||Total stent length (per-patient)||mm|Mean|27.04|27.04|Standard Deviation|16.44|16.44|||
4100083|NCT00977938|3923770|B4|||Total stent length (per-patient)||mm|Mean|23.85|23.85|Standard Deviation|13.12|13.12|||
4100084|NCT00977938|3923771|B3|||Total stent length (per-patient)||mm|Mean|23.96|23.96|Standard Deviation|13.01|13.01|||
4100085|NCT00977938|3923772|B2|||Total stent length (per-patient)||mm|Mean|27.43|27.43|Standard Deviation|17.02|17.02|||
4100169|NCT00977938|3923771|B3|||Stroke/Transient Ischemic Attack (TIA)||participants|Number|43|43.0||||||
4100088|NCT00977938|3923770|B4|≥3 mm||Minimum stent diameter (per-patient)||participants|Number|639|639.0||||||
4100089|NCT00977938|3923771|B3|≥3 mm||Minimum stent diameter (per-patient)||participants|Number|641|641.0||||||
4100090|NCT00977938|3923772|B2|≥3 mm||Minimum stent diameter (per-patient)||participants|Number|2648|2648.0||||||
4100091|NCT00977938|3923773|B1|≥3 mm||Minimum stent diameter (per-patient)||participants|Number|2679|2679.0||||||
4100092|NCT00977938|3923769|B5|<3 mm||Minimum stent diameter (per-patient)||participants|Number|5041|5041.0||||||
4100093|NCT00977938|3923770|B4|<3 mm||Minimum stent diameter (per-patient)||participants|Number|206|206.0||||||
4100094|NCT00977938|3923771|B3|<3 mm||Minimum stent diameter (per-patient)||participants|Number|201|201.0||||||
4100095|NCT00977938|3923772|B2|<3 mm||Minimum stent diameter (per-patient)||participants|Number|2293|2293.0||||||
4100096|NCT00977938|3923773|B1|<3 mm||Minimum stent diameter (per-patient)||participants|Number|2341|2341.0||||||
4100097|NCT00977938|3923769|B5|||Number of stents (per-patient)||stents|Mean|1.44|1.44|Standard Deviation|0.73|0.73|||
4100098|NCT00977938|3923770|B4|||Number of stents (per-patient)||stents|Mean|1.32|1.32|Standard Deviation|0.60|0.6|||
4100099|NCT00977938|3923771|B3|||Number of stents (per-patient)||stents|Mean|1.32|1.32|Standard Deviation|0.60|0.6|||
4100100|NCT00977938|3923772|B2|||Number of stents (per-patient)||stents|Mean|1.45|1.45|Standard Deviation|0.75|0.75|||
4100101|NCT00977938|3923773|B1|||Number of stents (per-patient)||stents|Mean|1.47|1.47|Standard Deviation|0.75|0.75|||
4100102|NCT00977938|3923769|B5|||Number of treated vessels (per-patient)||vessels|Mean|1.11|1.11|Standard Deviation|0.32|0.32|||
4100103|NCT00977938|3923770|B4|||Number of treated vessels (per-patient)||vessels|Mean|1.05|1.05|Standard Deviation|0.23|0.23|||
4100104|NCT00977938|3923771|B3|||Number of treated vessels (per-patient)||vessels|Mean|1.03|1.03|Standard Deviation|0.18|0.18|||
4100105|NCT00977938|3923772|B2|||Number of treated vessels (per-patient)||vessels|Mean|1.12|1.12|Standard Deviation|0.34|0.34|||
4100106|NCT00977938|3923773|B1|||Number of treated vessels (per-patient)||vessels|Mean|1.11|1.11|Standard Deviation|0.33|0.33|||
4100107|NCT00977938|3923769|B5|||Number of treated lesions (per-patient)||lesions|Mean|1.28|1.28|Standard Deviation|0.53|0.53|||
4100108|NCT00977938|3923770|B4|||Number of treated lesions (per-patient)||lesions|Mean|1.17|1.17|Standard Deviation|0.42|0.42|||
4100109|NCT00977938|3923771|B3|||Number of treated lesions (per-patient)||lesions|Mean|1.16|1.16|Standard Deviation|0.40|0.4|||
4100110|NCT00977938|3923772|B2|||Number of treated lesions (per-patient)||lesions|Mean|1.29|1.29|Standard Deviation|0.54|0.54|||
4100111|NCT00977938|3923773|B1|||Number of treated lesions (per-patient)||lesions|Mean|1.30|1.3|Standard Deviation|0.55|0.55|||
4100112|NCT00977938|3923769|B5|||Any risk factor for stent thrombosis|"Any clinical or lesion-related risk factors for stent thrombosis.~Clinical risk factors for stent thrombosis included:~Acute coronary syndrome (ACS) at presentation~ST elevation MI (STEMI) at presentation~Renal insufficiency or failure~Ejection fraction <30%.~Lesion-related risk factors for stent thrombosis included:~More than two vessels stented~>2 lesions per vessel~Lesion length ≥30 mm~Bifurcation lesion with side branch ≥2.5 mm~In-stent restenosis of a DES~Vein bypass graft~Unprotected left main~Thrombus containing lesion~Prior brachytherapy"|participants|Number|5936|5936.0||||||
4100113|NCT00977938|3923770|B4|||Any risk factor for stent thrombosis|"Any clinical or lesion-related risk factors for stent thrombosis.~Clinical risk factors for stent thrombosis included:~Acute coronary syndrome (ACS) at presentation~ST elevation MI (STEMI) at presentation~Renal insufficiency or failure~Ejection fraction <30%.~Lesion-related risk factors for stent thrombosis included:~More than two vessels stented~>2 lesions per vessel~Lesion length ≥30 mm~Bifurcation lesion with side branch ≥2.5 mm~In-stent restenosis of a DES~Vein bypass graft~Unprotected left main~Thrombus containing lesion~Prior brachytherapy"|participants|Number|569|569.0||||||
4100114|NCT00977938|3923771|B3|||Any risk factor for stent thrombosis|"Any clinical or lesion-related risk factors for stent thrombosis.~Clinical risk factors for stent thrombosis included:~Acute coronary syndrome (ACS) at presentation~ST elevation MI (STEMI) at presentation~Renal insufficiency or failure~Ejection fraction <30%.~Lesion-related risk factors for stent thrombosis included:~More than two vessels stented~>2 lesions per vessel~Lesion length ≥30 mm~Bifurcation lesion with side branch ≥2.5 mm~In-stent restenosis of a DES~Vein bypass graft~Unprotected left main~Thrombus containing lesion~Prior brachytherapy"|participants|Number|568|568.0||||||
4100115|NCT00977938|3923772|B2|||Any risk factor for stent thrombosis|"Any clinical or lesion-related risk factors for stent thrombosis.~Clinical risk factors for stent thrombosis included:~Acute coronary syndrome (ACS) at presentation~ST elevation MI (STEMI) at presentation~Renal insufficiency or failure~Ejection fraction <30%.~Lesion-related risk factors for stent thrombosis included:~More than two vessels stented~>2 lesions per vessel~Lesion length ≥30 mm~Bifurcation lesion with side branch ≥2.5 mm~In-stent restenosis of a DES~Vein bypass graft~Unprotected left main~Thrombus containing lesion~Prior brachytherapy"|participants|Number|2389|2389.0||||||
4100116|NCT00977938|3923773|B1|||Any risk factor for stent thrombosis|"Any clinical or lesion-related risk factors for stent thrombosis.~Clinical risk factors for stent thrombosis included:~Acute coronary syndrome (ACS) at presentation~ST elevation MI (STEMI) at presentation~Renal insufficiency or failure~Ejection fraction <30%.~Lesion-related risk factors for stent thrombosis included:~More than two vessels stented~>2 lesions per vessel~Lesion length ≥30 mm~Bifurcation lesion with side branch ≥2.5 mm~In-stent restenosis of a DES~Vein bypass graft~Unprotected left main~Thrombus containing lesion~Prior brachytherapy"|participants|Number|2410|2410.0||||||
4100117|NCT00977938|3923769|B5|Other||Indication for PCI|"Unstable angina includes unstable angina without reported elevation of cardiac enzymes"|participants|Number|2102|2102.0||||||
4100118|NCT00977938|3923770|B4|Other||Indication for PCI|"Unstable angina includes unstable angina without reported elevation of cardiac enzymes"|participants|Number|73|73.0||||||
4100119|NCT00977938|3923771|B3|Other||Indication for PCI|"Unstable angina includes unstable angina without reported elevation of cardiac enzymes"|participants|Number|71|71.0||||||
4100120|NCT00977938|3923772|B2|Other||Indication for PCI|"Unstable angina includes unstable angina without reported elevation of cardiac enzymes"|participants|Number|968|968.0||||||
4100121|NCT00977938|3923773|B1|Other||Indication for PCI|"Unstable angina includes unstable angina without reported elevation of cardiac enzymes"|participants|Number|990|990.0||||||
4100122|NCT00977938|3923769|B5|Stable angina||Indication for PCI|"Unstable angina includes unstable angina without reported elevation of cardiac enzymes"|participants|Number|4149|4149.0||||||
4100123|NCT00977938|3923770|B4|Stable angina||Indication for PCI|"Unstable angina includes unstable angina without reported elevation of cardiac enzymes"|participants|Number|198|198.0||||||
4100124|NCT00977938|3923771|B3|Stable angina||Indication for PCI|"Unstable angina includes unstable angina without reported elevation of cardiac enzymes"|participants|Number|199|199.0||||||
4100125|NCT00977938|3923772|B2|Stable angina||Indication for PCI|"Unstable angina includes unstable angina without reported elevation of cardiac enzymes"|participants|Number|1870|1870.0||||||
4100126|NCT00977938|3923773|B1|Stable angina||Indication for PCI|"Unstable angina includes unstable angina without reported elevation of cardiac enzymes"|participants|Number|1882|1882.0||||||
4100127|NCT00977938|3923769|B5|Unstable angina||Indication for PCI|"Unstable angina includes unstable angina without reported elevation of cardiac enzymes"|participants|Number|1821|1821.0||||||
4100128|NCT00977938|3923770|B4|Unstable angina||Indication for PCI|"Unstable angina includes unstable angina without reported elevation of cardiac enzymes"|participants|Number|81|81.0||||||
4100129|NCT00977938|3923771|B3|Unstable angina||Indication for PCI|"Unstable angina includes unstable angina without reported elevation of cardiac enzymes"|participants|Number|77|77.0||||||
4100130|NCT00977938|3923772|B2|Unstable angina||Indication for PCI|"Unstable angina includes unstable angina without reported elevation of cardiac enzymes"|participants|Number|825|825.0||||||
4100131|NCT00977938|3923773|B1|Unstable angina||Indication for PCI|"Unstable angina includes unstable angina without reported elevation of cardiac enzymes"|participants|Number|838|838.0||||||
4100132|NCT00977938|3923769|B5|Non-ST elevation MI (NSTEMI)||Indication for PCI|"Unstable angina includes unstable angina without reported elevation of cardiac enzymes"|participants|Number|1896|1896.0||||||
4100133|NCT00977938|3923770|B4|Non-ST elevation MI (NSTEMI)||Indication for PCI|"Unstable angina includes unstable angina without reported elevation of cardiac enzymes"|participants|Number|169|169.0||||||
4100134|NCT00977938|3923771|B3|Non-ST elevation MI (NSTEMI)||Indication for PCI|"Unstable angina includes unstable angina without reported elevation of cardiac enzymes"|participants|Number|184|184.0||||||
4100135|NCT00977938|3923772|B2|Non-ST elevation MI (NSTEMI)||Indication for PCI|"Unstable angina includes unstable angina without reported elevation of cardiac enzymes"|participants|Number|767|767.0||||||
4100136|NCT00977938|3923773|B1|Non-ST elevation MI (NSTEMI)||Indication for PCI|"Unstable angina includes unstable angina without reported elevation of cardiac enzymes"|participants|Number|776|776.0||||||
4100137|NCT00977938|3923769|B5|ST elevation MI (STEMI)||Indication for PCI|"Unstable angina includes unstable angina without reported elevation of cardiac enzymes"|participants|Number|1680|1680.0||||||
4100138|NCT00977938|3923770|B4|ST elevation MI (STEMI)||Indication for PCI|"Unstable angina includes unstable angina without reported elevation of cardiac enzymes"|participants|Number|324|324.0||||||
4100139|NCT00977938|3923771|B3|ST elevation MI (STEMI)||Indication for PCI|"Unstable angina includes unstable angina without reported elevation of cardiac enzymes"|participants|Number|311|311.0||||||
4100140|NCT00977938|3923772|B2|ST elevation MI (STEMI)||Indication for PCI|"Unstable angina includes unstable angina without reported elevation of cardiac enzymes"|participants|Number|511|511.0||||||
4100141|NCT00977938|3923773|B1|ST elevation MI (STEMI)||Indication for PCI|"Unstable angina includes unstable angina without reported elevation of cardiac enzymes"|participants|Number|534|534.0||||||
4100142|NCT00977938|3923769|B5|||Prior myocardial infarction (MI)||participants|Number|2456|2456.0||||||
4100143|NCT00977938|3923770|B4|||Prior myocardial infarction (MI)||participants|Number|178|178.0||||||
4100144|NCT00977938|3923771|B3|||Prior myocardial infarction (MI)||participants|Number|160|160.0||||||
4100145|NCT00977938|3923772|B2|||Prior myocardial infarction (MI)||participants|Number|1026|1026.0||||||
4100146|NCT00977938|3923773|B1|||Prior myocardial infarction (MI)||participants|Number|1092|1092.0||||||
4100147|NCT00977938|3923769|B5|||Prior coronary artery bypass graf (CABG)||participants|Number|1249|1249.0||||||
4100148|NCT00977938|3923770|B4|||Prior coronary artery bypass graf (CABG)||participants|Number|50|50.0||||||
4100149|NCT00977938|3923771|B3|||Prior coronary artery bypass graf (CABG)||participants|Number|50|50.0||||||
4100150|NCT00977938|3923772|B2|||Prior coronary artery bypass graf (CABG)||participants|Number|581|581.0||||||
4100151|NCT00977938|3923773|B1|||Prior coronary artery bypass graf (CABG)||participants|Number|568|568.0||||||
4100152|NCT00977938|3923769|B5|||Prior percutaneous coronary intervention (PCI)||participants|Number|3368|3368.0||||||
4100153|NCT00977938|3923770|B4|||Prior percutaneous coronary intervention (PCI)||participants|Number|171|171.0||||||
4100154|NCT00977938|3923771|B3|||Prior percutaneous coronary intervention (PCI)||participants|Number|150|150.0||||||
4100155|NCT00977938|3923772|B2|||Prior percutaneous coronary intervention (PCI)||participants|Number|1529|1529.0||||||
4100156|NCT00977938|3923773|B1|||Prior percutaneous coronary intervention (PCI)||participants|Number|1518|1518.0||||||
4100157|NCT00977938|3923769|B5|||Peripheral arterial disease||participants|Number|649|649.0||||||
4100158|NCT00977938|3923770|B4|||Peripheral arterial disease||participants|Number|46|46.0||||||
4100159|NCT00977938|3923771|B3|||Peripheral arterial disease||participants|Number|35|35.0||||||
4100160|NCT00977938|3923772|B2|||Peripheral arterial disease||participants|Number|284|284.0||||||
4100161|NCT00977938|3923773|B1|||Peripheral arterial disease||participants|Number|284|284.0||||||
4100162|NCT00977938|3923769|B5|||Congestive heart failure||participants|Number|524|524.0||||||
4100163|NCT00977938|3923770|B4|||Congestive heart failure||participants|Number|28|28.0||||||
4100164|NCT00977938|3923771|B3|||Congestive heart failure||participants|Number|35|35.0||||||
4100165|NCT00977938|3923772|B2|||Congestive heart failure||participants|Number|223|223.0||||||
4100166|NCT00977938|3923773|B1|||Congestive heart failure||participants|Number|238|238.0||||||
4100167|NCT00977938|3923769|B5|||Stroke/Transient Ischemic Attack (TIA)||participants|Number|401|401.0||||||
4100168|NCT00977938|3923770|B4|||Stroke/Transient Ischemic Attack (TIA)||participants|Number|34|34.0||||||
4100170|NCT00977938|3923772|B2|||Stroke/Transient Ischemic Attack (TIA)||participants|Number|169|169.0||||||
4100171|NCT00977938|3923773|B1|||Stroke/Transient Ischemic Attack (TIA)||participants|Number|155|155.0||||||
4100172|NCT00977938|3923769|B5|||Current cigarette smoker or within past year|"“Current cigarette smoker or within past year” was defined as follows:~HCRI DAPT: current cigarette smoker or within past year~Abbott Xience V: current tobacco user or former tobacco user within the past month~Boston Scientific Liberte PAS: smoking status of “current” from medical history~Cordis CYPRESS: smoking within 30 days~Medtronic EDUCATE: smoking/tobacco usage = “current” or “within last year”"|participants|Number|3142|3142.0||||||
4100173|NCT00977938|3923770|B4|||Current cigarette smoker or within past year|"“Current cigarette smoker or within past year” was defined as follows:~HCRI DAPT: current cigarette smoker or within past year~Abbott Xience V: current tobacco user or former tobacco user within the past month~Boston Scientific Liberte PAS: smoking status of “current” from medical history~Cordis CYPRESS: smoking within 30 days~Medtronic EDUCATE: smoking/tobacco usage = “current” or “within last year”"|participants|Number|350|350.0||||||
4100174|NCT00977938|3923771|B3|||Current cigarette smoker or within past year|"“Current cigarette smoker or within past year” was defined as follows:~HCRI DAPT: current cigarette smoker or within past year~Abbott Xience V: current tobacco user or former tobacco user within the past month~Boston Scientific Liberte PAS: smoking status of “current” from medical history~Cordis CYPRESS: smoking within 30 days~Medtronic EDUCATE: smoking/tobacco usage = “current” or “within last year”"|participants|Number|360|360.0||||||
4100175|NCT00977938|3923772|B2|||Current cigarette smoker or within past year|"“Current cigarette smoker or within past year” was defined as follows:~HCRI DAPT: current cigarette smoker or within past year~Abbott Xience V: current tobacco user or former tobacco user within the past month~Boston Scientific Liberte PAS: smoking status of “current” from medical history~Cordis CYPRESS: smoking within 30 days~Medtronic EDUCATE: smoking/tobacco usage = “current” or “within last year”"|participants|Number|1210|1210.0||||||
4100176|NCT00977938|3923773|B1|||Current cigarette smoker or within past year|"“Current cigarette smoker or within past year” was defined as follows:~HCRI DAPT: current cigarette smoker or within past year~Abbott Xience V: current tobacco user or former tobacco user within the past month~Boston Scientific Liberte PAS: smoking status of “current” from medical history~Cordis CYPRESS: smoking within 30 days~Medtronic EDUCATE: smoking/tobacco usage = “current” or “within last year”"|participants|Number|1222|1222.0||||||
4100177|NCT00977938|3923769|B5|||Hypertension||participants|Number|8522|8522.0||||||
4100178|NCT00977938|3923770|B4|||Hypertension||participants|Number|543|543.0||||||
4100179|NCT00977938|3923771|B3|||Hypertension||participants|Number|534|534.0||||||
4100180|NCT00977938|3923772|B2|||Hypertension||participants|Number|3649|3649.0||||||
4100181|NCT00977938|3923773|B1|||Hypertension||participants|Number|3796|3796.0||||||
4100182|NCT00977938|3923769|B5|||Diabetes Mellitus||participants|Number|3391|3391.0||||||
4100183|NCT00977938|3923770|B4|||Diabetes Mellitus||participants|Number|173|173.0||||||
4100184|NCT00977938|3923771|B3|||Diabetes Mellitus||participants|Number|181|181.0||||||
4100185|NCT00977938|3923772|B2|||Diabetes Mellitus||participants|Number|1481|1481.0||||||
4100186|NCT00977938|3923773|B1|||Diabetes Mellitus||participants|Number|1556|1556.0||||||
4100187|NCT00977938|3923769|B5|||Body Mass Index (BMI)||kg/m2|Mean|30.40|30.4|Standard Deviation|5.73|5.73|||
4100188|NCT00977938|3923770|B4|||Body Mass Index (BMI)||kg/m2|Mean|29.61|29.61|Standard Deviation|5.55|5.55|||
4100189|NCT00977938|3923771|B3|||Body Mass Index (BMI)||kg/m2|Mean|29.49|29.49|Standard Deviation|5.18|5.18|||
4100190|NCT00977938|3923772|B2|||Body Mass Index (BMI)||kg/m2|Mean|30.55|30.55|Standard Deviation|5.77|5.77|||
4100191|NCT00977938|3923773|B1|||Body Mass Index (BMI)||kg/m2|Mean|30.54|30.54|Standard Deviation|5.79|5.79|||
4100192|NCT00977938|3923769|B5|||weight||kg|Mean|91.04|91.04|Standard Deviation|19.48|19.48|||
4100193|NCT00977938|3923770|B4|||weight||kg|Mean|88.54|88.54|Standard Deviation|18.77|18.77|||
4100194|NCT00977938|3923771|B3|||weight||kg|Mean|87.99|87.99|Standard Deviation|18.40|18.4|||
4100195|NCT00977938|3923772|B2|||weight||kg|Mean|91.52|91.52|Standard Deviation|19.43|19.43|||
4100196|NCT00977938|3923773|B1|||weight||kg|Mean|91.49|91.49|Standard Deviation|19.74|19.74|||
4100197|NCT00977938|3923769|B5|New Zealand||Region of Enrollment||participants|Number|163|163.0||||||
4100198|NCT00977938|3923770|B4|New Zealand||Region of Enrollment||participants|Number|14|14.0||||||
4100199|NCT00977938|3923771|B3|New Zealand||Region of Enrollment||participants|Number|15|15.0||||||
4100200|NCT00977938|3923772|B2|New Zealand||Region of Enrollment||participants|Number|65|65.0||||||
4100201|NCT00977938|3923773|B1|New Zealand||Region of Enrollment||participants|Number|69|69.0||||||
4100202|NCT00977938|3923769|B5|Australia||Region of Enrollment||participants|Number|128|128.0||||||
4100203|NCT00977938|3923770|B4|Australia||Region of Enrollment||participants|Number|12|12.0||||||
4100204|NCT00977938|3923771|B3|Australia||Region of Enrollment||participants|Number|14|14.0||||||
4100205|NCT00977938|3923772|B2|Australia||Region of Enrollment||participants|Number|55|55.0||||||
4100206|NCT00977938|3923773|B1|Australia||Region of Enrollment||participants|Number|47|47.0||||||
4100207|NCT00977938|3923769|B5|Europe||Region of Enrollment||participants|Number|1411|1411.0||||||
4100208|NCT00977938|3923770|B4|Europe||Region of Enrollment||participants|Number|300|300.0||||||
4100209|NCT00977938|3923771|B3|Europe||Region of Enrollment||participants|Number|304|304.0||||||
4100210|NCT00977938|3923772|B2|Europe||Region of Enrollment||participants|Number|405|405.0||||||
4100211|NCT00977938|3923773|B1|Europe||Region of Enrollment||participants|Number|402|402.0||||||
4100212|NCT00977938|3923769|B5|North America||Region of Enrollment||participants|Number|9946|9946.0||||||
4100213|NCT00977938|3923770|B4|North America||Region of Enrollment||participants|Number|519|519.0||||||
4100214|NCT00977938|3923771|B3|North America||Region of Enrollment||participants|Number|509|509.0||||||
4100215|NCT00977938|3923772|B2|North America||Region of Enrollment||participants|Number|4416|4416.0||||||
4100216|NCT00977938|3923773|B1|North America||Region of Enrollment||participants|Number|4502|4502.0||||||
4100217|NCT00977938|3923769|B5|Other||Race/Ethnicity, Customized|Race was self-reported|participants|Number|257|257.0||||||
4100218|NCT00977938|3923770|B4|Other||Race/Ethnicity, Customized|Race was self-reported|participants|Number|23|23.0||||||
4100219|NCT00977938|3923771|B3|Other||Race/Ethnicity, Customized|Race was self-reported|participants|Number|20|20.0||||||
4100220|NCT00977938|3923772|B2|Other||Race/Ethnicity, Customized|Race was self-reported|participants|Number|106|106.0||||||
4100221|NCT00977938|3923773|B1|Other||Race/Ethnicity, Customized|Race was self-reported|participants|Number|108|108.0||||||
4100222|NCT00977938|3923769|B5|White||Race/Ethnicity, Customized|Race was self-reported|participants|Number|10450|10450.0||||||
4100223|NCT00977938|3923770|B4|White||Race/Ethnicity, Customized|Race was self-reported|participants|Number|774|774.0||||||
4100224|NCT00977938|3923771|B3|White||Race/Ethnicity, Customized|Race was self-reported|participants|Number|768|768.0||||||
4100225|NCT00977938|3923772|B2|White||Race/Ethnicity, Customized|Race was self-reported|participants|Number|4428|4428.0||||||
4100226|NCT00977938|3923773|B1|White||Race/Ethnicity, Customized|Race was self-reported|participants|Number|4480|4480.0||||||
4100227|NCT00977938|3923769|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Race was self-reported|participants|Number|24|24.0||||||
4100228|NCT00977938|3923770|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Race was self-reported|participants|Number|1|1.0||||||
4100229|NCT00977938|3923771|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Race was self-reported|participants|Number|1|1.0||||||
4100230|NCT00977938|3923772|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Race was self-reported|participants|Number|9|9.0||||||
4100231|NCT00977938|3923773|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Race was self-reported|participants|Number|13|13.0||||||
4100232|NCT00977938|3923769|B5|Black or African American||Race/Ethnicity, Customized|Race was self-reported|participants|Number|576|576.0||||||
4100233|NCT00977938|3923770|B4|Black or African American||Race/Ethnicity, Customized|Race was self-reported|participants|Number|33|33.0||||||
4100234|NCT00977938|3923771|B3|Black or African American||Race/Ethnicity, Customized|Race was self-reported|participants|Number|38|38.0||||||
4100235|NCT00977938|3923772|B2|Black or African American||Race/Ethnicity, Customized|Race was self-reported|participants|Number|253|253.0||||||
4100236|NCT00977938|3923773|B1|Black or African American||Race/Ethnicity, Customized|Race was self-reported|participants|Number|252|252.0||||||
4100237|NCT00977938|3923769|B5|Asian||Race/Ethnicity, Customized|Race was self-reported|participants|Number|88|88.0||||||
4100238|NCT00977938|3923770|B4|Asian||Race/Ethnicity, Customized|Race was self-reported|participants|Number|2|2.0||||||
4100239|NCT00977938|3923771|B3|Asian||Race/Ethnicity, Customized|Race was self-reported|participants|Number|3|3.0||||||
4100240|NCT00977938|3923772|B2|Asian||Race/Ethnicity, Customized|Race was self-reported|participants|Number|35|35.0||||||
4100241|NCT00977938|3923773|B1|Asian||Race/Ethnicity, Customized|Race was self-reported|participants|Number|48|48.0||||||
4100242|NCT00977938|3923769|B5|American Indian or Alaska Native||Race/Ethnicity, Customized|Race was self-reported|participants|Number|60|60.0||||||
4100243|NCT00977938|3923770|B4|American Indian or Alaska Native||Race/Ethnicity, Customized|Race was self-reported|participants|Number|2|2.0||||||
4100244|NCT00977938|3923771|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|Race was self-reported|participants|Number|0|0.0||||||
4100245|NCT00977938|3923772|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|Race was self-reported|participants|Number|41|41.0||||||
4100246|NCT00977938|3923773|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Race was self-reported|participants|Number|17|17.0||||||
4100247|NCT00977938|3923769|B5||Male|Sex: Female, Male||Participants|Count of Participants|8723|8723.0||||||
4100248|NCT00977938|3923770|B4||Male|Sex: Female, Male||Participants|Count of Participants|661|661.0||||||
4100249|NCT00977938|3923771|B3||Male|Sex: Female, Male||Participants|Count of Participants|627|627.0||||||
4100250|NCT00977938|3923772|B2||Male|Sex: Female, Male||Participants|Count of Participants|3657|3657.0||||||
4100251|NCT00977938|3923773|B1||Male|Sex: Female, Male||Participants|Count of Participants|3778|3778.0||||||
4100252|NCT00977938|3923769|B5||Female|Sex: Female, Male||Participants|Count of Participants|2925|2925.0||||||
4100253|NCT00977938|3923770|B4||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4100254|NCT00977938|3923771|B3||Female|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
4100255|NCT00977938|3923772|B2||Female|Sex: Female, Male||Participants|Count of Participants|1284|1284.0||||||
4100256|NCT00977938|3923773|B1||Female|Sex: Female, Male||Participants|Count of Participants|1242|1242.0||||||
4100257|NCT00977938|3923769|B5|||Age||years|Mean|61.33|61.33|Standard Deviation|10.29|10.29|||
4100258|NCT00977938|3923770|B4|||Age||years|Mean|59.18|59.18|Standard Deviation|11.07|11.07|||
4100259|NCT00977938|3923771|B3|||Age||years|Mean|58.86|58.86|Standard Deviation|10.54|10.54|||
4100260|NCT00977938|3923772|B2|||Age||years|Mean|61.60|61.6|Standard Deviation|10.12|10.12|||
4100261|NCT00977938|3923773|B1|||Age||years|Mean|61.84|61.84|Standard Deviation|10.18|10.18|||
4100262|NCT00977808|3923810|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4100263|NCT00977808|3923810|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4100264|NCT00977808|3923810|B1|||Age||years|Mean|41.17|41.17|Standard Deviation|10.31|10.31|||
4100265|NCT00977808|3923810|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4100266|NCT00977808|3923810|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4100267|NCT00977808|3923810|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4100268|NCT00977769|3923815|B4|Norway||Region of Enrollment||participants|Number|76|76.0||||||
4100269|NCT00977769|3923816|B3|Norway||Region of Enrollment||participants|Number|25|25.0||||||
4100270|NCT00977769|3923817|B2|Norway||Region of Enrollment||participants|Number|26|26.0||||||
4100271|NCT00977769|3923818|B1|Norway||Region of Enrollment||participants|Number|25|25.0||||||
4100272|NCT00977769|3923815|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4100273|NCT00977769|3923816|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4100274|NCT00977769|3923817|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4100275|NCT00977769|3923818|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4100276|NCT00977769|3923815|B4||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4100277|NCT00977769|3923816|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4100278|NCT00977769|3923817|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4100279|NCT00977769|3923818|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4100280|NCT00977769|3923815|B4|||Age||years|Mean|34.5|34.5|Standard Deviation|4.6|4.6|||
4100281|NCT00977769|3923816|B3|||Age||years|Mean|34.8|34.8|Standard Deviation|4.0|4.0|||
4100282|NCT00977769|3923817|B2|||Age||years|Mean|35.0|35.0|Standard Deviation|5.0|5.0|||
4100283|NCT00977769|3923818|B1|||Age||years|Mean|34.2|34.2|Standard Deviation|3.8|3.8|||
4100284|NCT00977769|3923815|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4100285|NCT00977769|3923816|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4100286|NCT00977769|3923817|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4100287|NCT00977769|3923818|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4100288|NCT00977769|3923815|B4||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
4100289|NCT00977769|3923816|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4100290|NCT00977769|3923817|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4100291|NCT00977769|3923818|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4100292|NCT00977769|3923815|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4100293|NCT00977769|3923816|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4100294|NCT00977769|3923817|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4100295|NCT00977769|3923818|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4100296|NCT00977704|3923834|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4100297|NCT00977704|3923834|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4100298|NCT00977704|3923834|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4100299|NCT00977704|3923834|B1|||Age||years|Mean|59.6|59.6|Standard Deviation|4.04|4.04|||
4100300|NCT00977704|3923834|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4100301|NCT00977704|3923834|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4100302|NCT00977704|3923834|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4100303|NCT00977665|3923838|B3|Probable MSA-P||Multiple System Atrophy of the Parkinsonian Subtype (MSA-P)|"Possible or Probable MSA of the parkinsonian subtype (MSA-P) is according to The Gilman Criteria (2008).~Possible MSA requires a sporadic, progressive adult-onset disease including parkinsonism and at least one feature suggesting autonomic dysfunction plus one other feature that may be a clinical or a neuroimaging abnormality.~Probable MSA requires a sporadic, progressive adult-onset disorder including rigorously defined autonomic failure and poorly levodopa-responsive parkinsonism."|participants|Number|81|81.0||||||
4100304|NCT00977665|3923839|B2|Probable MSA-P||Multiple System Atrophy of the Parkinsonian Subtype (MSA-P)|"Possible or Probable MSA of the parkinsonian subtype (MSA-P) is according to The Gilman Criteria (2008).~Possible MSA requires a sporadic, progressive adult-onset disease including parkinsonism and at least one feature suggesting autonomic dysfunction plus one other feature that may be a clinical or a neuroimaging abnormality.~Probable MSA requires a sporadic, progressive adult-onset disorder including rigorously defined autonomic failure and poorly levodopa-responsive parkinsonism."|participants|Number|35|35.0||||||
4100305|NCT00977665|3923840|B1|Probable MSA-P||Multiple System Atrophy of the Parkinsonian Subtype (MSA-P)|"Possible or Probable MSA of the parkinsonian subtype (MSA-P) is according to The Gilman Criteria (2008).~Possible MSA requires a sporadic, progressive adult-onset disease including parkinsonism and at least one feature suggesting autonomic dysfunction plus one other feature that may be a clinical or a neuroimaging abnormality.~Probable MSA requires a sporadic, progressive adult-onset disorder including rigorously defined autonomic failure and poorly levodopa-responsive parkinsonism."|participants|Number|46|46.0||||||
4100306|NCT00977665|3923838|B3|Possible MSA-P||Multiple System Atrophy of the Parkinsonian Subtype (MSA-P)|"Possible or Probable MSA of the parkinsonian subtype (MSA-P) is according to The Gilman Criteria (2008).~Possible MSA requires a sporadic, progressive adult-onset disease including parkinsonism and at least one feature suggesting autonomic dysfunction plus one other feature that may be a clinical or a neuroimaging abnormality.~Probable MSA requires a sporadic, progressive adult-onset disorder including rigorously defined autonomic failure and poorly levodopa-responsive parkinsonism."|participants|Number|93|93.0||||||
4100307|NCT00977665|3923839|B2|Possible MSA-P||Multiple System Atrophy of the Parkinsonian Subtype (MSA-P)|"Possible or Probable MSA of the parkinsonian subtype (MSA-P) is according to The Gilman Criteria (2008).~Possible MSA requires a sporadic, progressive adult-onset disease including parkinsonism and at least one feature suggesting autonomic dysfunction plus one other feature that may be a clinical or a neuroimaging abnormality.~Probable MSA requires a sporadic, progressive adult-onset disorder including rigorously defined autonomic failure and poorly levodopa-responsive parkinsonism."|participants|Number|55|55.0||||||
4100308|NCT00977665|3923840|B1|Possible MSA-P||Multiple System Atrophy of the Parkinsonian Subtype (MSA-P)|"Possible or Probable MSA of the parkinsonian subtype (MSA-P) is according to The Gilman Criteria (2008).~Possible MSA requires a sporadic, progressive adult-onset disease including parkinsonism and at least one feature suggesting autonomic dysfunction plus one other feature that may be a clinical or a neuroimaging abnormality.~Probable MSA requires a sporadic, progressive adult-onset disorder including rigorously defined autonomic failure and poorly levodopa-responsive parkinsonism."|participants|Number|38|38.0||||||
4100309|NCT00977665|3923838|B3|||Body Mass Index||kg/m^2|Mean|27.0|27.0|Standard Deviation|4.4|4.4|||
4100310|NCT00977665|3923839|B2|||Body Mass Index||kg/m^2|Mean|26.8|26.8|Standard Deviation|4.4|4.4|||
4100311|NCT00977665|3923840|B1|||Body Mass Index||kg/m^2|Mean|27.2|27.2|Standard Deviation|4.4|4.4|||
4100312|NCT00977665|3923838|B3|||Height||cm|Mean|168.5|168.5|Standard Deviation|9.6|9.6|||
4100313|NCT00977665|3923839|B2|||Height||cm|Mean|169.0|169.0|Standard Deviation|8.9|8.9|||
4100314|NCT00977665|3923840|B1|||Height||cm|Mean|168.0|168.0|Standard Deviation|10.2|10.2|||
4100315|NCT00977665|3923838|B3|||Weight||kg|Mean|76.9|76.9|Standard Deviation|15.6|15.6|||
4100316|NCT00977665|3923839|B2|||Weight||kg|Mean|76.8|76.8|Standard Deviation|15.5|15.5|||
4100317|NCT00977665|3923840|B1|||Weight||kg|Mean|76.9|76.9|Standard Deviation|15.9|15.9|||
4100318|NCT00977665|3923838|B3|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4100319|NCT00977665|3923839|B2|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4100320|NCT00977665|3923840|B1|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4100321|NCT00977665|3923838|B3|Italy||Region of Enrollment||participants|Number|16|16.0||||||
4100322|NCT00977665|3923839|B2|Italy||Region of Enrollment||participants|Number|8|8.0||||||
4100323|NCT00977665|3923840|B1|Italy||Region of Enrollment||participants|Number|8|8.0||||||
4100324|NCT00977665|3923838|B3|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
4100325|NCT00977665|3923839|B2|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
4100326|NCT00977665|3923840|B1|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
4100327|NCT00977665|3923838|B3|Germany||Region of Enrollment||participants|Number|19|19.0||||||
4100328|NCT00977665|3923839|B2|Germany||Region of Enrollment||participants|Number|12|12.0||||||
4100329|NCT00977665|3923840|B1|Germany||Region of Enrollment||participants|Number|7|7.0||||||
4100330|NCT00977665|3923838|B3|Israel||Region of Enrollment||participants|Number|21|21.0||||||
4100331|NCT00977665|3923839|B2|Israel||Region of Enrollment||participants|Number|12|12.0||||||
4100332|NCT00977665|3923840|B1|Israel||Region of Enrollment||participants|Number|9|9.0||||||
4100333|NCT00977665|3923838|B3|Austria||Region of Enrollment||participants|Number|7|7.0||||||
4100334|NCT00977665|3923839|B2|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4100335|NCT00977665|3923840|B1|Austria||Region of Enrollment||participants|Number|3|3.0||||||
4100336|NCT00977665|3923838|B3|Spain||Region of Enrollment||participants|Number|7|7.0||||||
4100337|NCT00977665|3923839|B2|Spain||Region of Enrollment||participants|Number|3|3.0||||||
4100338|NCT00977665|3923840|B1|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4100339|NCT00977665|3923838|B3|Canada||Region of Enrollment||participants|Number|20|20.0||||||
4100340|NCT00977665|3923839|B2|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4100341|NCT00977665|3923840|B1|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4100342|NCT00977665|3923838|B3|Hungary||Region of Enrollment||participants|Number|21|21.0||||||
4100343|NCT00977665|3923839|B2|Hungary||Region of Enrollment||participants|Number|10|10.0||||||
4100344|NCT00977665|3923840|B1|Hungary||Region of Enrollment||participants|Number|11|11.0||||||
4100345|NCT00977665|3923838|B3|France||Region of Enrollment||participants|Number|17|17.0||||||
4100346|NCT00977665|3923839|B2|France||Region of Enrollment||participants|Number|8|8.0||||||
4100347|NCT00977665|3923840|B1|France||Region of Enrollment||participants|Number|9|9.0||||||
4100348|NCT00977665|3923838|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4100349|NCT00977665|3923839|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4100350|NCT00977665|3923840|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4100351|NCT00977665|3923838|B3|Portugal||Region of Enrollment||participants|Number|5|5.0||||||
4100352|NCT00977665|3923839|B2|Portugal||Region of Enrollment||participants|Number|3|3.0||||||
4100353|NCT00977665|3923840|B1|Portugal||Region of Enrollment||participants|Number|2|2.0||||||
4100354|NCT00977665|3923838|B3|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4100355|NCT00977665|3923839|B2|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4100356|NCT00977665|3923840|B1|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4100357|NCT00977665|3923838|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|166|166.0||||||
4100358|NCT00977665|3923839|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|85|85.0||||||
4100359|NCT00977665|3923840|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
4100360|NCT00977665|3923838|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4100361|NCT00977665|3923839|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4100362|NCT00977665|3923840|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4100363|NCT00977665|3923838|B3|Black of African Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4100364|NCT00977665|3923839|B2|Black of African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4100365|NCT00977665|3923840|B1|Black of African Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4100366|NCT00977665|3923838|B3|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4100367|NCT00977665|3923839|B2|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4100368|NCT00977665|3923840|B1|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4100369|NCT00977665|3923838|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4100370|NCT00977665|3923839|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4100371|NCT00977665|3923840|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4100372|NCT00977665|3923838|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4100373|NCT00977665|3923839|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4100374|NCT00977665|3923840|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4100375|NCT00977665|3923838|B3|||Age||years|Mean|65.0|65.0|Standard Deviation|8.5|8.5|||
4100376|NCT00977665|3923839|B2|||Age||years|Mean|65.1|65.1|Standard Deviation|8.6|8.6|||
4100377|NCT00977665|3923840|B1|||Age||years|Mean|64.9|64.9|Standard Deviation|8.5|8.5|||
4100378|NCT00977613|3923873|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4100379|NCT00977613|3923873|B1|Unknown||Sex/Gender, Customized||participants|Number|3|3.0||||||
4100380|NCT00977613|3923873|B1|Male||Sex/Gender, Customized||participants|Number|26|26.0||||||
4100381|NCT00977613|3923873|B1|Female||Sex/Gender, Customized||participants|Number|21|21.0||||||
4100382|NCT00977613|3923873|B1|Age greater than 18 years||Age, Customized||participants|Number|50|50.0||||||
4100383|NCT00977574|3923877|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4100384|NCT00977574|3923878|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4100385|NCT00977574|3923879|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4100386|NCT00977574|3923880|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4100387|NCT00977574|3923877|B4||Female|Sex: Female, Male||Participants|Count of Participants|349|349.0||||||
4100388|NCT00977574|3923878|B3||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4100389|NCT00977574|3923879|B2||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4100390|NCT00977574|3923880|B1||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4100391|NCT00977574|3923877|B4||>=80 years|Age, Customized||Participants|Count of Participants|6|6.0||||||
4100392|NCT00977574|3923878|B3||>=80 years|Age, Customized||Participants|Count of Participants|3|3.0||||||
4100393|NCT00977574|3923879|B2||>=80 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
4100394|NCT00977574|3923880|B1||>=80 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
4100395|NCT00977574|3923877|B4||70-79 years|Age, Customized||Participants|Count of Participants|72|72.0||||||
4100396|NCT00977574|3923878|B3||70-79 years|Age, Customized||Participants|Count of Participants|28|28.0||||||
4100397|NCT00977574|3923879|B2||70-79 years|Age, Customized||Participants|Count of Participants|22|22.0||||||
4100398|NCT00977574|3923880|B1||70-79 years|Age, Customized||Participants|Count of Participants|22|22.0||||||
4100399|NCT00977574|3923877|B4||60-69 years|Age, Customized||Participants|Count of Participants|155|155.0||||||
4100400|NCT00977574|3923878|B3||60-69 years|Age, Customized||Participants|Count of Participants|57|57.0||||||
4100401|NCT00977574|3923879|B2||60-69 years|Age, Customized||Participants|Count of Participants|50|50.0||||||
4100402|NCT00977574|3923880|B1||60-69 years|Age, Customized||Participants|Count of Participants|48|48.0||||||
4100403|NCT00977574|3923877|B4||50-59 years|Age, Customized||Participants|Count of Participants|90|90.0||||||
4100404|NCT00977574|3923878|B3||50-59 years|Age, Customized||Participants|Count of Participants|19|19.0||||||
4100405|NCT00977574|3923879|B2||50-59 years|Age, Customized||Participants|Count of Participants|35|35.0||||||
4100406|NCT00977574|3923880|B1||50-59 years|Age, Customized||Participants|Count of Participants|36|36.0||||||
4100407|NCT00977574|3923877|B4||40-49 years|Age, Customized||Participants|Count of Participants|19|19.0||||||
4100408|NCT00977574|3923878|B3||40-49 years|Age, Customized||Participants|Count of Participants|8|8.0||||||
4100409|NCT00977574|3923879|B2||40-49 years|Age, Customized||Participants|Count of Participants|5|5.0||||||
4100410|NCT00977574|3923880|B1||40-49 years|Age, Customized||Participants|Count of Participants|6|6.0||||||
4100411|NCT00977574|3923877|B4||30-39 years|Age, Customized||Participants|Count of Participants|7|7.0||||||
4100412|NCT00977574|3923878|B3||30-39 years|Age, Customized||Participants|Count of Participants|3|3.0||||||
4100413|NCT00977574|3923879|B2||30-39 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
4100414|NCT00977574|3923880|B1||30-39 years|Age, Customized||Participants|Count of Participants|2|2.0||||||
4100415|NCT00977561|3923899|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4100416|NCT00977561|3923900|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4100417|NCT00977561|3923901|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4100418|NCT00977561|3923899|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4100419|NCT00977561|3923900|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4100420|NCT00977561|3923901|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4100421|NCT00977561|3923899|B3|||Age||years|Mean|57.4|57.4|Standard Deviation|8.2|8.2|||
4100422|NCT00977561|3923900|B2|||Age||years|Mean|53.8|53.8|Standard Deviation|11.0|11.0|||
4100423|NCT00977561|3923901|B1|||Age||years|Mean|60.4|60.4|Standard Deviation|4.4|4.4|||
4100424|NCT00977548|3923929|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4100425|NCT00977548|3923929|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4100426|NCT00977548|3923929|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4100427|NCT00977548|3923929|B1|||Age||years|Mean|73|73.0|Full Range|||64.0|88.0|
4100428|NCT00977548|3923929|B1||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
4100429|NCT00977548|3923929|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4100430|NCT00977548|3923929|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4100431|NCT00977470|3923936|B3|||Prior chemotherapy||Participants|Count of Participants|22|22.0||||||
4100432|NCT00977470|3923937|B2|||Prior chemotherapy||Participants|Count of Participants|13|13.0||||||
4100433|NCT00977470|3923938|B1|||Prior chemotherapy||Participants|Count of Participants|9|9.0||||||
4100434|NCT00977470|3923936|B3|||Brain metastases||Participants|Count of Participants|27|27.0||||||
4100435|NCT00977470|3923937|B2|||Brain metastases||Participants|Count of Participants|16|16.0||||||
4100436|NCT00977470|3923938|B1|||Brain metastases||Participants|Count of Participants|11|11.0||||||
4100437|NCT00977470|3923936|B3||Non-small cell lung cancer, Not Otherwise Specifie|Histology||Participants|Count of Participants|12|12.0||||||
4100438|NCT00977470|3923937|B2||Non-small cell lung cancer, Not Otherwise Specifie|Histology||Participants|Count of Participants|7|7.0||||||
4100439|NCT00977470|3923938|B1||Non-small cell lung cancer, Not Otherwise Specifie|Histology||Participants|Count of Participants|5|5.0||||||
4100440|NCT00977470|3923936|B3||Adenocarcinoma|Histology||Participants|Count of Participants|64|64.0||||||
4100441|NCT00977470|3923937|B2||Adenocarcinoma|Histology||Participants|Count of Participants|31|31.0||||||
4100442|NCT00977470|3923938|B1||Adenocarcinoma|Histology||Participants|Count of Participants|33|33.0||||||
4100443|NCT00977470|3923936|B3||> 10 pack years/current|Smoking History||Participants|Count of Participants|16|16.0||||||
4100444|NCT00977470|3923937|B2||> 10 pack years/current|Smoking History||Participants|Count of Participants|10|10.0||||||
4100445|NCT00977470|3923938|B1||> 10 pack years/current|Smoking History||Participants|Count of Participants|6|6.0||||||
4100446|NCT00977470|3923936|B3||<= 10 pack years|Smoking History||Participants|Count of Participants|12|12.0||||||
4100447|NCT00977470|3923937|B2||<= 10 pack years|Smoking History||Participants|Count of Participants|8|8.0||||||
4100448|NCT00977470|3923938|B1||<= 10 pack years|Smoking History||Participants|Count of Participants|4|4.0||||||
4100449|NCT00977470|3923936|B3||Never smoked|Smoking History||Participants|Count of Participants|48|48.0||||||
4100450|NCT00977470|3923937|B2||Never smoked|Smoking History||Participants|Count of Participants|20|20.0||||||
4100451|NCT00977470|3923938|B1||Never smoked|Smoking History||Participants|Count of Participants|28|28.0||||||
4100452|NCT00977470|3923936|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4100453|NCT00977470|3923937|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4100454|NCT00977470|3923938|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4100455|NCT00977470|3923936|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4100456|NCT00977470|3923937|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4100457|NCT00977470|3923938|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4100458|NCT00977470|3923936|B3|||Age||years|Median|64|64.0|Full Range|||37.0|84.0|
4100459|NCT00977470|3923937|B2|||Age||years|Median|65|65.0|Full Range|||37.0|82.0|
4100460|NCT00977470|3923938|B1|||Age||years|Median|63|63.0|Full Range|||43.0|84.0|
4100461|NCT00977379|3923957|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4100462|NCT00977379|3923958|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4100463|NCT00977379|3923959|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4100464|NCT00977379|3923957|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4100465|NCT00977379|3923958|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4100466|NCT00977379|3923959|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4100467|NCT00977379|3923957|B3|||Age||years|Mean|56.2|56.2|Standard Deviation|14.2|14.2|||
4100468|NCT00977379|3923958|B2|||Age||years|Mean|57.8|57.8|Standard Deviation|13.1|13.1|||
4100469|NCT00977379|3923959|B1|||Age||years|Mean|54.8|54.8|Standard Deviation|15.6|15.6|||
4100470|NCT00977314|3923994|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
4100471|NCT00977314|3923995|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4100472|NCT00977314|3923996|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4100473|NCT00977314|3923994|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4100474|NCT00977314|3923995|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4100475|NCT00977314|3923996|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4100476|NCT00977314|3923994|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4100477|NCT00977314|3923995|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4100478|NCT00977314|3923996|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4100479|NCT00977314|3923994|B3|||Age||years|Mean|46.5|46.5|Standard Deviation|11.8|11.8|||
4100480|NCT00977314|3923995|B2|||Age||years|Mean|45.4|45.4|Standard Deviation|8.1|8.1|||
4100481|NCT00977314|3923996|B1|||Age||years|Mean|46.6|46.6|Standard Deviation|13|13.0|||
4100482|NCT00977314|3923994|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4100483|NCT00977314|3923995|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4100484|NCT00977314|3923996|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4100485|NCT00977314|3923994|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4100486|NCT00977314|3923995|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4100487|NCT00977314|3923996|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4100488|NCT00977314|3923994|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4100489|NCT00977314|3923995|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4100490|NCT00977314|3923996|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4100491|NCT00977197|3924003|B3|Fibromyalgia - Yes||Number of Subjects with Fibromyalgia at Baseline||participants|Number|17|17.0||||||
4100492|NCT00977197|3924004|B2|Fibromyalgia - Yes||Number of Subjects with Fibromyalgia at Baseline||participants|Number|7|7.0||||||
4100493|NCT00977197|3924005|B1|Fibromyalgia - Yes||Number of Subjects with Fibromyalgia at Baseline||participants|Number|10|10.0||||||
4100494|NCT00977197|3924003|B3|Fibromyalgia - No||Number of Subjects with Fibromyalgia at Baseline||participants|Number|68|68.0||||||
4100495|NCT00977197|3924004|B2|Fibromyalgia - No||Number of Subjects with Fibromyalgia at Baseline||participants|Number|37|37.0||||||
4100496|NCT00977197|3924005|B1|Fibromyalgia - No||Number of Subjects with Fibromyalgia at Baseline||participants|Number|31|31.0||||||
4100497|NCT00977197|3924003|B3|United States||Region of Enrollment||participants|Number|85|85.0||||||
4100498|NCT00977197|3924004|B2|United States||Region of Enrollment||participants|Number|44|44.0||||||
4100499|NCT00977197|3924005|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4100500|NCT00977197|3924003|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4100501|NCT00977197|3924004|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4100502|NCT00977197|3924005|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4100503|NCT00977197|3924003|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4100504|NCT00977197|3924004|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4100505|NCT00977197|3924005|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4100506|NCT00977197|3924003|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4100507|NCT00977197|3924004|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4100508|NCT00977197|3924005|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4100509|NCT00977197|3924003|B3||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
4100510|NCT00977197|3924004|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4100511|NCT00977197|3924005|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4100512|NCT00977197|3924003|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4100513|NCT00977197|3924004|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4100514|NCT00977197|3924005|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4100515|NCT00977184|3924034|B3|Absence of falls||Falls||participants|Number|25|25.0||||||
4100516|NCT00977184|3924035|B2|Absence of falls||Falls||participants|Number|13|13.0||||||
4100517|NCT00977184|3924036|B1|Absence of falls||Falls||participants|Number|12|12.0||||||
4100518|NCT00977184|3924034|B3|Presence of falls||Falls||participants|Number|1|1.0||||||
4100519|NCT00977184|3924035|B2|Presence of falls||Falls||participants|Number|0|0.0||||||
4100520|NCT00977184|3924036|B1|Presence of falls||Falls||participants|Number|1|1.0||||||
4100521|NCT00977184|3924034|B3|Absence of dyskinesias||Dyskinesias|Presence or absence of dyskinesias (diminished voluntary movements and the presence of involuntary movements).|participants|Number|17|17.0||||||
4100522|NCT00977184|3924035|B2|Absence of dyskinesias||Dyskinesias|Presence or absence of dyskinesias (diminished voluntary movements and the presence of involuntary movements).|participants|Number|8|8.0||||||
4100523|NCT00977184|3924036|B1|Absence of dyskinesias||Dyskinesias|Presence or absence of dyskinesias (diminished voluntary movements and the presence of involuntary movements).|participants|Number|9|9.0||||||
4100524|NCT00977184|3924034|B3|Presence of dyskinesias||Dyskinesias|Presence or absence of dyskinesias (diminished voluntary movements and the presence of involuntary movements).|participants|Number|9|9.0||||||
4100525|NCT00977184|3924035|B2|Presence of dyskinesias||Dyskinesias|Presence or absence of dyskinesias (diminished voluntary movements and the presence of involuntary movements).|participants|Number|5|5.0||||||
4100526|NCT00977184|3924036|B1|Presence of dyskinesias||Dyskinesias|Presence or absence of dyskinesias (diminished voluntary movements and the presence of involuntary movements).|participants|Number|4|4.0||||||
4100527|NCT00977184|3924034|B3|Absence of Fluctuations||Fluctuations||participants|Number|11|11.0||||||
4100528|NCT00977184|3924035|B2|Absence of Fluctuations||Fluctuations||participants|Number|5|5.0||||||
4100529|NCT00977184|3924036|B1|Absence of Fluctuations||Fluctuations||participants|Number|6|6.0||||||
4100530|NCT00977184|3924034|B3|Presence of Fluctuations||Fluctuations||participants|Number|15|15.0||||||
4100531|NCT00977184|3924035|B2|Presence of Fluctuations||Fluctuations||participants|Number|8|8.0||||||
4100532|NCT00977184|3924036|B1|Presence of Fluctuations||Fluctuations||participants|Number|7|7.0||||||
4100533|NCT00977184|3924034|B3|Absence of Gait Freezing||Gait freezing||participants|Number|10|10.0||||||
4100534|NCT00977184|3924035|B2|Absence of Gait Freezing||Gait freezing||participants|Number|4|4.0||||||
4100535|NCT00977184|3924036|B1|Absence of Gait Freezing||Gait freezing||participants|Number|6|6.0||||||
4100536|NCT00977184|3924034|B3|Presence of Gait Freezing||Gait freezing||participants|Number|16|16.0||||||
4100537|NCT00977184|3924035|B2|Presence of Gait Freezing||Gait freezing||participants|Number|9|9.0||||||
4100538|NCT00977184|3924036|B1|Presence of Gait Freezing||Gait freezing||participants|Number|7|7.0||||||
4100539|NCT00977184|3924034|B3|Absence of Tremor||Tremor||participants|Number|4|4.0||||||
4100540|NCT00977184|3924035|B2|Absence of Tremor||Tremor||participants|Number|1|1.0||||||
4100541|NCT00977184|3924036|B1|Absence of Tremor||Tremor||participants|Number|3|3.0||||||
4100542|NCT00977184|3924034|B3|Presence of Tremor||Tremor||participants|Number|22|22.0||||||
4100543|NCT00977184|3924035|B2|Presence of Tremor||Tremor||participants|Number|12|12.0||||||
4100544|NCT00977184|3924036|B1|Presence of Tremor||Tremor||participants|Number|10|10.0||||||
4100545|NCT00977184|3924034|B3|||Total LED|Total levodopa-equivalent dose (medication) that subject is currently on|milligrams|Mean|905|905.0|Standard Deviation|559.6|559.6|||
4100546|NCT00977184|3924035|B2|||Total LED|Total levodopa-equivalent dose (medication) that subject is currently on|milligrams|Mean|949|949.0|Standard Deviation|677|677.0|||
4100547|NCT00977184|3924036|B1|||Total LED|Total levodopa-equivalent dose (medication) that subject is currently on|milligrams|Mean|861|861.0|Standard Deviation|436|436.0|||
4100592|NCT00977080|3924159|B4|Yes||History of myocardial infarction||Participants|Number|8|8.0||||||
4100593|NCT00977080|3924160|B3|Yes||History of myocardial infarction||Participants|Number|10|10.0||||||
4100548|NCT00977184|3924034|B3|||"Hoehn-Yahr off"|The Hoehn and Yahr scale is a system used to describe how the symptoms of Parkinson's disease progress. The scale ranges from 1-5 with 1 representing unilateral involvement with minimal or no functional disability and 5 representing confinement to bed or wheelchair unless aided. The measurement on the Hoehn and Yahr was taken while the subject was off medication.|units on a scale|Mean|2.8|2.8|Standard Deviation|0.47|0.47|||
4100549|NCT00977184|3924035|B2|||"Hoehn-Yahr off"|The Hoehn and Yahr scale is a system used to describe how the symptoms of Parkinson's disease progress. The scale ranges from 1-5 with 1 representing unilateral involvement with minimal or no functional disability and 5 representing confinement to bed or wheelchair unless aided. The measurement on the Hoehn and Yahr was taken while the subject was off medication.|units on a scale|Mean|2.9|2.9|Standard Deviation|0.6|0.6|||
4100550|NCT00977184|3924036|B1|||"Hoehn-Yahr off"|The Hoehn and Yahr scale is a system used to describe how the symptoms of Parkinson's disease progress. The scale ranges from 1-5 with 1 representing unilateral involvement with minimal or no functional disability and 5 representing confinement to bed or wheelchair unless aided. The measurement on the Hoehn and Yahr was taken while the subject was off medication.|units on a scale|Mean|2.7|2.7|Standard Deviation|0.3|0.3|||
4100551|NCT00977184|3924034|B3|||"Hoehn-Yahr, on"|The Hoehn and Yahr scale is a system used to describe how the symptoms of Parkinson's disease progress. The scale ranges from 1-5 with 1 representing unilateral involvement with minimal or no functional disability and 5 representing confinement to bed or wheelchair unless aided. The measurement on the Hoehn and Yahr was taken while the subject was on medication.|units on a scale|Mean|2.42|2.42|Standard Deviation|.27|0.27|||
4100552|NCT00977184|3924035|B2|||"Hoehn-Yahr, on"|The Hoehn and Yahr scale is a system used to describe how the symptoms of Parkinson's disease progress. The scale ranges from 1-5 with 1 representing unilateral involvement with minimal or no functional disability and 5 representing confinement to bed or wheelchair unless aided. The measurement on the Hoehn and Yahr was taken while the subject was on medication.|units on a scale|Mean|2.5|2.5|Standard Deviation|0.3|0.3|||
4100553|NCT00977184|3924036|B1|||"Hoehn-Yahr, on"|The Hoehn and Yahr scale is a system used to describe how the symptoms of Parkinson's disease progress. The scale ranges from 1-5 with 1 representing unilateral involvement with minimal or no functional disability and 5 representing confinement to bed or wheelchair unless aided. The measurement on the Hoehn and Yahr was taken while the subject was on medication.|units on a scale|Mean|2.4|2.4|Standard Deviation|0.2|0.2|||
4100554|NCT00977184|3924034|B3|||Duration of Disease||years|Mean|8.96|8.96|Standard Deviation|5.5|5.5|||
4100555|NCT00977184|3924035|B2|||Duration of Disease||years|Mean|9.3|9.3|Standard Deviation|6.8|6.8|||
4100556|NCT00977184|3924036|B1|||Duration of Disease||years|Mean|8.6|8.6|Standard Deviation|4.1|4.1|||
4100557|NCT00977184|3924034|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4100558|NCT00977184|3924035|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4100559|NCT00977184|3924036|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4100560|NCT00977184|3924034|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4100561|NCT00977184|3924035|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4100562|NCT00977184|3924036|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4100563|NCT00977184|3924034|B3|||Age||years|Mean|64.1|64.1|Standard Deviation|8.6|8.6|||
4100564|NCT00977184|3924035|B2|||Age||years|Mean|63.7|63.7|Standard Deviation|8.3|8.3|||
4100565|NCT00977184|3924036|B1|||Age||years|Mean|64.5|64.5|Standard Deviation|9.1|9.1|||
4100566|NCT00977171|3924063|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4100567|NCT00977171|3924063|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4100568|NCT00977171|3924063|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4100569|NCT00977171|3924063|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4100570|NCT00977171|3924063|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4100571|NCT00977171|3924063|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4100572|NCT00977171|3924063|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4100573|NCT00977171|3924063|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4100574|NCT00977171|3924063|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4100575|NCT00977171|3924063|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4100576|NCT00977171|3924063|B1|||Age||years|Mean|51.8|51.8|Standard Deviation|11.0|11.0|||
4100577|NCT00977106|3924067|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4100578|NCT00977106|3924068|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4100579|NCT00977106|3924069|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4100580|NCT00977106|3924067|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4100581|NCT00977106|3924068|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4100582|NCT00977106|3924069|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4100583|NCT00977106|3924067|B3|||Age||years|Mean|52.0|52.0|Standard Deviation|11.6|11.6|||
4100584|NCT00977106|3924068|B2|||Age||years|Mean|52.8|52.8|Standard Deviation|11.6|11.6|||
4100585|NCT00977106|3924069|B1|||Age||years|Mean|51.3|51.3|Standard Deviation|11.8|11.8|||
4100586|NCT00977080|3924158|B5|No||History of myocardial infarction||Participants|Number|230|230.0||||||
4100587|NCT00977080|3924159|B4|No||History of myocardial infarction||Participants|Number|62|62.0||||||
4100588|NCT00977080|3924160|B3|No||History of myocardial infarction||Participants|Number|62|62.0||||||
4100589|NCT00977080|3924161|B2|No||History of myocardial infarction||Participants|Number|56|56.0||||||
4100590|NCT00977080|3924162|B1|No||History of myocardial infarction||Participants|Number|50|50.0||||||
4100591|NCT00977080|3924158|B5|Yes||History of myocardial infarction||Participants|Number|38|38.0||||||
4100594|NCT00977080|3924161|B2|Yes||History of myocardial infarction||Participants|Number|8|8.0||||||
4100595|NCT00977080|3924162|B1|Yes||History of myocardial infarction||Participants|Number|12|12.0||||||
4100596|NCT00977080|3924158|B5|No||History of left ventricular hypertrophy||Participants|Number|239|239.0||||||
4100597|NCT00977080|3924159|B4|No||History of left ventricular hypertrophy||Participants|Number|64|64.0||||||
4100598|NCT00977080|3924160|B3|No||History of left ventricular hypertrophy||Participants|Number|65|65.0||||||
4100599|NCT00977080|3924161|B2|No||History of left ventricular hypertrophy||Participants|Number|60|60.0||||||
4100600|NCT00977080|3924162|B1|No||History of left ventricular hypertrophy||Participants|Number|50|50.0||||||
4100601|NCT00977080|3924158|B5|Yes||History of left ventricular hypertrophy||Participants|Number|29|29.0||||||
4100602|NCT00977080|3924159|B4|Yes||History of left ventricular hypertrophy||Participants|Number|6|6.0||||||
4100603|NCT00977080|3924160|B3|Yes||History of left ventricular hypertrophy||Participants|Number|7|7.0||||||
4100604|NCT00977080|3924161|B2|Yes||History of left ventricular hypertrophy||Participants|Number|4|4.0||||||
4100605|NCT00977080|3924162|B1|Yes||History of left ventricular hypertrophy||Participants|Number|12|12.0||||||
4100606|NCT00977080|3924158|B5|No||History of coronary artery disease||Participants|Number|207|207.0||||||
4100607|NCT00977080|3924159|B4|No||History of coronary artery disease||Participants|Number|64|64.0||||||
4100608|NCT00977080|3924160|B3|No||History of coronary artery disease||Participants|Number|61|61.0||||||
4100609|NCT00977080|3924161|B2|No||History of coronary artery disease||Participants|Number|45|45.0||||||
4100610|NCT00977080|3924162|B1|No||History of coronary artery disease||Participants|Number|37|37.0||||||
4100611|NCT00977080|3924158|B5|Yes||History of coronary artery disease||Participants|Number|61|61.0||||||
4100612|NCT00977080|3924159|B4|Yes||History of coronary artery disease||Participants|Number|6|6.0||||||
4100613|NCT00977080|3924160|B3|Yes||History of coronary artery disease||Participants|Number|11|11.0||||||
4100614|NCT00977080|3924161|B2|Yes||History of coronary artery disease||Participants|Number|19|19.0||||||
4100615|NCT00977080|3924162|B1|Yes||History of coronary artery disease||Participants|Number|25|25.0||||||
4100616|NCT00977080|3924158|B5|No||History of angina||Participants|Number|240|240.0||||||
4100617|NCT00977080|3924159|B4|No||History of angina||Participants|Number|63|63.0||||||
4100618|NCT00977080|3924160|B3|No||History of angina||Participants|Number|61|61.0||||||
4100619|NCT00977080|3924161|B2|No||History of angina||Participants|Number|62|62.0||||||
4100620|NCT00977080|3924162|B1|No||History of angina||Participants|Number|54|54.0||||||
4100621|NCT00977080|3924158|B5|Yes||History of angina||Participants|Number|28|28.0||||||
4100622|NCT00977080|3924159|B4|Yes||History of angina||Participants|Number|7|7.0||||||
4100623|NCT00977080|3924160|B3|Yes||History of angina||Participants|Number|11|11.0||||||
4100624|NCT00977080|3924161|B2|Yes||History of angina||Participants|Number|2|2.0||||||
4100625|NCT00977080|3924162|B1|Yes||History of angina||Participants|Number|8|8.0||||||
4100626|NCT00977080|3924158|B5|No||History of type 2 diabetes mellitus||Participants|Number|160|160.0||||||
4100627|NCT00977080|3924159|B4|No||History of type 2 diabetes mellitus||Participants|Number|61|61.0||||||
4100628|NCT00977080|3924160|B3|No||History of type 2 diabetes mellitus||Participants|Number|44|44.0||||||
4100629|NCT00977080|3924161|B2|No||History of type 2 diabetes mellitus||Participants|Number|30|30.0||||||
4100630|NCT00977080|3924162|B1|No||History of type 2 diabetes mellitus||Participants|Number|25|25.0||||||
4100631|NCT00977080|3924158|B5|Yes||History of type 2 diabetes mellitus||Participants|Number|108|108.0||||||
4100632|NCT00977080|3924159|B4|Yes||History of type 2 diabetes mellitus||Participants|Number|9|9.0||||||
4100633|NCT00977080|3924160|B3|Yes||History of type 2 diabetes mellitus||Participants|Number|28|28.0||||||
4100634|NCT00977080|3924161|B2|Yes||History of type 2 diabetes mellitus||Participants|Number|34|34.0||||||
4100635|NCT00977080|3924162|B1|Yes||History of type 2 diabetes mellitus||Participants|Number|37|37.0||||||
4100636|NCT00977080|3924158|B5|No||History of type 1 diabetes mellitus||Participants|Number|258|258.0||||||
4100637|NCT00977080|3924159|B4|No||History of type 1 diabetes mellitus||Participants|Number|68|68.0||||||
4100638|NCT00977080|3924160|B3|No||History of type 1 diabetes mellitus||Participants|Number|71|71.0||||||
4100639|NCT00977080|3924161|B2|No||History of type 1 diabetes mellitus||Participants|Number|63|63.0||||||
4100640|NCT00977080|3924162|B1|No||History of type 1 diabetes mellitus||Participants|Number|56|56.0||||||
4100641|NCT00977080|3924158|B5|Yes||History of type 1 diabetes mellitus||Participants|Number|10|10.0||||||
4100642|NCT00977080|3924159|B4|Yes||History of type 1 diabetes mellitus||Participants|Number|2|2.0||||||
4100643|NCT00977080|3924160|B3|Yes||History of type 1 diabetes mellitus||Participants|Number|1|1.0||||||
4100644|NCT00977080|3924161|B2|Yes||History of type 1 diabetes mellitus||Participants|Number|1|1.0||||||
4100645|NCT00977080|3924162|B1|Yes||History of type 1 diabetes mellitus||Participants|Number|6|6.0||||||
4100646|NCT00977080|3924158|B5||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4100647|NCT00977080|3924159|B4||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4100648|NCT00977080|3924160|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4100649|NCT00977080|3924161|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4100650|NCT00977080|3924162|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4100651|NCT00977080|3924158|B5||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4100652|NCT00977080|3924159|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4100653|NCT00977080|3924160|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4100654|NCT00977080|3924161|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4100655|NCT00977080|3924162|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4100656|NCT00977080|3924158|B5|||Age||years|Mean|63.1|63.1|Standard Deviation|12.89|12.89|||
4100657|NCT00977080|3924159|B4|||Age||years|Mean|65.1|65.1|Standard Deviation|12.50|12.5|||
4100658|NCT00977080|3924160|B3|||Age||years|Mean|65.7|65.7|Standard Deviation|13.48|13.48|||
4100659|NCT00977080|3924161|B2|||Age||years|Mean|59.9|59.9|Standard Deviation|12.04|12.04|||
4100660|NCT00977080|3924162|B1|||Age||years|Mean|61.2|61.2|Standard Deviation|12.71|12.71|||
4100661|NCT00976989|3924195|B4||Male|Gender||Participants|Count of Participants|0|0.0||||||
4100662|NCT00976989|3924196|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
4100663|NCT00976989|3924197|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
4100664|NCT00976989|3924198|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4100665|NCT00976989|3924195|B4||Female|Gender||Participants|Count of Participants|225|225.0||||||
4100666|NCT00976989|3924196|B3||Female|Gender||Participants|Count of Participants|77|77.0||||||
4100667|NCT00976989|3924197|B2||Female|Gender||Participants|Count of Participants|75|75.0||||||
4100668|NCT00976989|3924198|B1||Female|Gender||Participants|Count of Participants|73|73.0||||||
4100669|NCT00976989|3924195|B4|||Age||years|Mean|50.6|50.6|Standard Deviation|10.86|10.86|||
4100670|NCT00976989|3924196|B3|||Age||years|Mean|50.6|50.6|Standard Deviation|10.58|10.58|||
4100671|NCT00976989|3924197|B2|||Age||years|Mean|50.5|50.5|Standard Deviation|10.70|10.7|||
4100672|NCT00976989|3924198|B1|||Age||years|Mean|49.6|49.6|Standard Deviation|11.41|11.41|||
4100673|NCT00976950|3924241|B1|>= 451 cells/mm^3||Baseline CD4+ count||Participants|Number|8|8.0||||||
4100674|NCT00976950|3924241|B1|251 - <451 cells/mm^3||Baseline CD4+ count||Participants|Number|13|13.0||||||
4100675|NCT00976950|3924241|B1|51 - <251 cells/mm^3||Baseline CD4+ count||Participants|Number|19|19.0||||||
4100676|NCT00976950|3924241|B1|<= 50 cells/mm^3||Baseline CD4+ count||Participants|Number|2|2.0||||||
4100677|NCT00976950|3924241|B1|Missing||Baseline HIV RNA values||Participants|Number|11|11.0||||||
4100678|NCT00976950|3924241|B1|>= 1,000,000 copies/ml||Baseline HIV RNA values||Participants|Number|0|0.0||||||
4100679|NCT00976950|3924241|B1|100,000 - <1,000,000 copies/ml||Baseline HIV RNA values||Participants|Number|12|12.0||||||
4100680|NCT00976950|3924241|B1|10,000 - <100,000 copies/ml||Baseline HIV RNA values||Participants|Number|13|13.0||||||
4100681|NCT00976950|3924241|B1|1,000 - <10,000 copies/ml||Baseline HIV RNA values||Participants|Number|5|5.0||||||
4100682|NCT00976950|3924241|B1|51 - <1,000 copies/ml||Baseline HIV RNA values||Participants|Number|1|1.0||||||
4100683|NCT00976950|3924241|B1|<= 50 copies/ml||Baseline HIV RNA values||Participants|Number|0|0.0||||||
4100684|NCT00976950|3924241|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4100685|NCT00976950|3924241|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4100686|NCT00976950|3924241|B1|||Age|Age is available for 41 patients.|years|Mean|25.5|25.5|Standard Deviation|10.4|10.4|||
4100687|NCT00976937|3924247|B3|||Homeostatic Model Assessment of Beta-cell Function (HOMA-beta)|HOMA-beta was derived from FPG and FPI as: (20 * FPI [micro units/milliliter]) divided by (FPG [mmol/L] minus 3.5). Here, number of patients analyzed = 148 and 154 for lixisenatide and sitagliptin treatment arm, respectively.|percentage of normal beta cells function|Mean|61.36|61.36|Standard Deviation|55.29|55.29|||
4100688|NCT00976937|3924248|B2|||Homeostatic Model Assessment of Beta-cell Function (HOMA-beta)|HOMA-beta was derived from FPG and FPI as: (20 * FPI [micro units/milliliter]) divided by (FPG [mmol/L] minus 3.5). Here, number of patients analyzed = 148 and 154 for lixisenatide and sitagliptin treatment arm, respectively.|percentage of normal beta cells function|Mean|60.74|60.74|Standard Deviation|50.80|50.8|||
4100689|NCT00976937|3924249|B1|||Homeostatic Model Assessment of Beta-cell Function (HOMA-beta)|HOMA-beta was derived from FPG and FPI as: (20 * FPI [micro units/milliliter]) divided by (FPG [mmol/L] minus 3.5). Here, number of patients analyzed = 148 and 154 for lixisenatide and sitagliptin treatment arm, respectively.|percentage of normal beta cells function|Mean|62.01|62.01|Standard Deviation|59.78|59.78|||
4100690|NCT00976937|3924247|B3|||Homeostatic Model Assessment of Insulin Resistance (HOMA-IR)|HOMA-IR was derived from FPG and FPI as: (FPI [micro units per milliliter] * FPG [mmol/L]) divided by 22.5. Here, number of patients analyzed = 148 and 154 for lixisenatide and sitagliptin treatment arm, respectively.|milliunit * mmol /liter^2(mU * mmol/L^2)|Mean|6.28|6.28|Standard Deviation|5.20|5.2|||
4100691|NCT00976937|3924248|B2|||Homeostatic Model Assessment of Insulin Resistance (HOMA-IR)|HOMA-IR was derived from FPG and FPI as: (FPI [micro units per milliliter] * FPG [mmol/L]) divided by 22.5. Here, number of patients analyzed = 148 and 154 for lixisenatide and sitagliptin treatment arm, respectively.|milliunit * mmol /liter^2(mU * mmol/L^2)|Mean|6.26|6.26|Standard Deviation|5.32|5.32|||
4100692|NCT00976937|3924249|B1|||Homeostatic Model Assessment of Insulin Resistance (HOMA-IR)|HOMA-IR was derived from FPG and FPI as: (FPI [micro units per milliliter] * FPG [mmol/L]) divided by 22.5. Here, number of patients analyzed = 148 and 154 for lixisenatide and sitagliptin treatment arm, respectively.|milliunit * mmol /liter^2(mU * mmol/L^2)|Mean|6.30|6.3|Standard Deviation|5.08|5.08|||
4100693|NCT00976937|3924247|B3|||2-hour Postprandial Proinsulin-to-Insulin Ratio|Here, number of patients analyzed = 152 and 151 for lixisenatide and sitagliptin treatment arm, respectively.|ratio|Mean|0.34|0.34|Standard Deviation|0.41|0.41|||
4100694|NCT00976937|3924248|B2|||2-hour Postprandial Proinsulin-to-Insulin Ratio|Here, number of patients analyzed = 152 and 151 for lixisenatide and sitagliptin treatment arm, respectively.|ratio|Mean|0.32|0.32|Standard Deviation|0.24|0.24|||
4100695|NCT00976937|3924249|B1|||2-hour Postprandial Proinsulin-to-Insulin Ratio|Here, number of patients analyzed = 152 and 151 for lixisenatide and sitagliptin treatment arm, respectively.|ratio|Mean|0.36|0.36|Standard Deviation|0.53|0.53|||
4100696|NCT00976937|3924247|B3|||Fasting Proinsulin-to-Insulin Ratio|Here, number of patients analyzed = 149 and 154 for lixisenatide and sitagliptin treatment arm, respectively.|ratio|Mean|0.56|0.56|Standard Deviation|0.71|0.71|||
4100697|NCT00976937|3924248|B2|||Fasting Proinsulin-to-Insulin Ratio|Here, number of patients analyzed = 149 and 154 for lixisenatide and sitagliptin treatment arm, respectively.|ratio|Mean|0.59|0.59|Standard Deviation|0.73|0.73|||
4100780|NCT00976898|3924311|B1|None||Previous Therapy||Participants|Count of Participants|45|45.0||||||
4100698|NCT00976937|3924249|B1|||Fasting Proinsulin-to-Insulin Ratio|Here, number of patients analyzed = 149 and 154 for lixisenatide and sitagliptin treatment arm, respectively.|ratio|Mean|0.53|0.53|Standard Deviation|0.70|0.7|||
4100699|NCT00976937|3924247|B3|||2-hour Postprandial Proinsulin|Here, number of patients analyzed = 154 and 156 for lixisenatide and sitagliptin treatment arm, respectively.|pmol/L|Mean|105.51|105.51|Standard Deviation|74.57|74.57|||
4100700|NCT00976937|3924248|B2|||2-hour Postprandial Proinsulin|Here, number of patients analyzed = 154 and 156 for lixisenatide and sitagliptin treatment arm, respectively.|pmol/L|Mean|105.51|105.51|Standard Deviation|74.00|74.0|||
4100701|NCT00976937|3924249|B1|||2-hour Postprandial Proinsulin|Here, number of patients analyzed = 154 and 156 for lixisenatide and sitagliptin treatment arm, respectively.|pmol/L|Mean|105.50|105.5|Standard Deviation|75.38|75.38|||
4100702|NCT00976937|3924247|B3|||Fasting Proinsulin|Here, number of patients analyzed = 154 and 157 for lixisenatide and sitagliptin treatment arm, respectively.|pmol/L|Mean|44.83|44.83|Standard Deviation|37.91|37.91|||
4100703|NCT00976937|3924248|B2|||Fasting Proinsulin|Here, number of patients analyzed = 154 and 157 for lixisenatide and sitagliptin treatment arm, respectively.|pmol/L|Mean|44.62|44.62|Standard Deviation|36.42|36.42|||
4100704|NCT00976937|3924249|B1|||Fasting Proinsulin|Here, number of patients analyzed = 154 and 157 for lixisenatide and sitagliptin treatment arm, respectively.|pmol/L|Mean|45.06|45.06|Standard Deviation|39.50|39.5|||
4100705|NCT00976937|3924247|B3|||2-hour Postprandial Glucagon|Here, number of patients analyzed = 154 and 155 for lixisenatide and sitagliptin treatment arm, respectively.|ng/L|Mean|67.04|67.04|Standard Deviation|22.05|22.05|||
4100706|NCT00976937|3924248|B2|||2-hour Postprandial Glucagon|Here, number of patients analyzed = 154 and 155 for lixisenatide and sitagliptin treatment arm, respectively.|ng/L|Mean|67.72|67.72|Standard Deviation|25.77|25.77|||
4100707|NCT00976937|3924249|B1|||2-hour Postprandial Glucagon|Here, number of patients analyzed = 154 and 155 for lixisenatide and sitagliptin treatment arm, respectively.|ng/L|Mean|66.36|66.36|Standard Deviation|17.58|17.58|||
4100708|NCT00976937|3924247|B3|||Fasting Glucagon|Here, number of patients analyzed = 154 and 157 for lixisenatide and sitagliptin treatment arm, respectively.|nanogram/liter (ng/L)|Mean|59.28|59.28|Standard Deviation|18.32|18.32|||
4100709|NCT00976937|3924248|B2|||Fasting Glucagon|Here, number of patients analyzed = 154 and 157 for lixisenatide and sitagliptin treatment arm, respectively.|nanogram/liter (ng/L)|Mean|59.43|59.43|Standard Deviation|20.53|20.53|||
4100710|NCT00976937|3924249|B1|||Fasting Glucagon|Here, number of patients analyzed = 154 and 157 for lixisenatide and sitagliptin treatment arm, respectively.|nanogram/liter (ng/L)|Mean|59.12|59.12|Standard Deviation|15.81|15.81|||
4100711|NCT00976937|3924247|B3|||2-hour Postprandial C-peptide|Here, number of patients analyzed = 154 and 156 for lixisenatide and sitagliptin treatment arm, respectively.|mmol/L|Mean|2.86|2.86|Standard Deviation|1.32|1.32|||
4100712|NCT00976937|3924248|B2|||2-hour Postprandial C-peptide|Here, number of patients analyzed = 154 and 156 for lixisenatide and sitagliptin treatment arm, respectively.|mmol/L|Mean|2.92|2.92|Standard Deviation|1.35|1.35|||
4100713|NCT00976937|3924249|B1|||2-hour Postprandial C-peptide|Here, number of patients analyzed = 154 and 156 for lixisenatide and sitagliptin treatment arm, respectively.|mmol/L|Mean|2.79|2.79|Standard Deviation|1.28|1.28|||
4100714|NCT00976937|3924247|B3|||Fasting C-Peptide|Here, number of patients analyzed = 154 and 156 for lixisenatide and sitagliptin treatment arm, respectively.|mmol/L|Mean|1.20|1.2|Standard Deviation|0.52|0.52|||
4100715|NCT00976937|3924248|B2|||Fasting C-Peptide|Here, number of patients analyzed = 154 and 156 for lixisenatide and sitagliptin treatment arm, respectively.|mmol/L|Mean|1.20|1.2|Standard Deviation|0.52|0.52|||
4100716|NCT00976937|3924249|B1|||Fasting C-Peptide|Here, number of patients analyzed = 154 and 156 for lixisenatide and sitagliptin treatment arm, respectively.|mmol/L|Mean|1.19|1.19|Standard Deviation|0.51|0.51|||
4100717|NCT00976937|3924247|B3|||2-hour Postprandial Plasma Insulin|Here, number of patients analyzed = 152 and 151 for lixisenatide and sitagliptin treatment arm, respectively.|pmol/L|Mean|422.56|422.56|Standard Deviation|327.02|327.02|||
4100718|NCT00976937|3924248|B2|||2-hour Postprandial Plasma Insulin|Here, number of patients analyzed = 152 and 151 for lixisenatide and sitagliptin treatment arm, respectively.|pmol/L|Mean|420.45|420.45|Standard Deviation|302.17|302.17|||
4100719|NCT00976937|3924249|B1|||2-hour Postprandial Plasma Insulin|Here, number of patients analyzed = 152 and 151 for lixisenatide and sitagliptin treatment arm, respectively.|pmol/L|Mean|424.67|424.67|Standard Deviation|350.96|350.96|||
4100720|NCT00976937|3924247|B3|||Fasting Plasma Insulin (FPI)|Here, number of patients analyzed = 149 and 154 for lixisenatide and sitagliptin treatment arm, respectively.|picomole/liter (pmol/L)|Mean|107.76|107.76|Standard Deviation|82.23|82.23|||
4100721|NCT00976937|3924248|B2|||Fasting Plasma Insulin (FPI)|Here, number of patients analyzed = 149 and 154 for lixisenatide and sitagliptin treatment arm, respectively.|picomole/liter (pmol/L)|Mean|106.99|106.99|Standard Deviation|82.69|82.69|||
4100722|NCT00976937|3924249|B1|||Fasting Plasma Insulin (FPI)|Here, number of patients analyzed = 149 and 154 for lixisenatide and sitagliptin treatment arm, respectively.|picomole/liter (pmol/L)|Mean|108.56|108.56|Standard Deviation|82.03|82.03|||
4100723|NCT00976937|3924247|B3|||Glucose Excursion|Glucose excursion = 2-hour PPG minus plasma glucose 30 minutes prior to the meal test, before study drug administration. Number of patients analyzed = 157 and 157 for lixisenatide and sitagliptin treatment arm, respectively.|mmol/L|Mean|4.42|4.42|Standard Deviation|2.61|2.61|||
4100724|NCT00976937|3924248|B2|||Glucose Excursion|Glucose excursion = 2-hour PPG minus plasma glucose 30 minutes prior to the meal test, before study drug administration. Number of patients analyzed = 157 and 157 for lixisenatide and sitagliptin treatment arm, respectively.|mmol/L|Mean|4.48|4.48|Standard Deviation|2.59|2.59|||
4100725|NCT00976937|3924249|B1|||Glucose Excursion|Glucose excursion = 2-hour PPG minus plasma glucose 30 minutes prior to the meal test, before study drug administration. Number of patients analyzed = 157 and 157 for lixisenatide and sitagliptin treatment arm, respectively.|mmol/L|Mean|4.37|4.37|Standard Deviation|2.64|2.64|||
4100726|NCT00976937|3924247|B3|||Fasting Plasma Glucose (FPG)||mmol/L|Mean|9.03|9.03|Standard Deviation|2.59|2.59|||
4100727|NCT00976937|3924248|B2|||Fasting Plasma Glucose (FPG)||mmol/L|Mean|8.96|8.96|Standard Deviation|2.59|2.59|||
4100728|NCT00976937|3924249|B1|||Fasting Plasma Glucose (FPG)||mmol/L|Mean|9.09|9.09|Standard Deviation|2.60|2.6|||
4100729|NCT00976937|3924247|B3|||2-hour Postprandial Plasma Glucose (PPG)|The 2-hour PPG test measured blood glucose 2 hours after eating a standardized meal. Number of patients analyzed = 158 and 157 for lixisenatide and sitagliptin treatment arm, respectively.|millimole per liter (mmol/L)|Mean|13.84|13.84|Standard Deviation|3.88|3.88|||
4100730|NCT00976937|3924248|B2|||2-hour Postprandial Plasma Glucose (PPG)|The 2-hour PPG test measured blood glucose 2 hours after eating a standardized meal. Number of patients analyzed = 158 and 157 for lixisenatide and sitagliptin treatment arm, respectively.|millimole per liter (mmol/L)|Mean|13.92|13.92|Standard Deviation|3.99|3.99|||
4100731|NCT00976937|3924249|B1|||2-hour Postprandial Plasma Glucose (PPG)|The 2-hour PPG test measured blood glucose 2 hours after eating a standardized meal. Number of patients analyzed = 158 and 157 for lixisenatide and sitagliptin treatment arm, respectively.|millimole per liter (mmol/L)|Mean|13.77|13.77|Standard Deviation|3.78|3.78|||
4100732|NCT00976937|3924247|B3|||Body Weight||kilogram|Mean|99.55|99.55|Standard Deviation|23.61|23.61|||
4100733|NCT00976937|3924248|B2|||Body Weight||kilogram|Mean|100.56|100.56|Standard Deviation|23.77|23.77|||
4100734|NCT00976937|3924249|B1|||Body Weight||kilogram|Mean|98.51|98.51|Standard Deviation|23.48|23.48|||
4100735|NCT00976937|3924247|B3|||Duration of Diabetes||years|Mean|4.42|4.42|Standard Deviation|3.70|3.7|||
4100736|NCT00976937|3924248|B2|||Duration of Diabetes||years|Mean|4.43|4.43|Standard Deviation|3.56|3.56|||
4100737|NCT00976937|3924249|B1|||Duration of Diabetes||years|Mean|4.40|4.4|Standard Deviation|3.86|3.86|||
4100738|NCT00976937|3924247|B3|||Body Mass Index (BMI)|BMI was calculated by dividing body weight by the height squared.|kilogram per square meter (kg/m^2)|Mean|36.76|36.76|Standard Deviation|6.80|6.8|||
4100739|NCT00976937|3924248|B2|||Body Mass Index (BMI)|BMI was calculated by dividing body weight by the height squared.|kilogram per square meter (kg/m^2)|Mean|36.76|36.76|Standard Deviation|6.34|6.34|||
4100740|NCT00976937|3924249|B1|||Body Mass Index (BMI)|BMI was calculated by dividing body weight by the height squared.|kilogram per square meter (kg/m^2)|Mean|36.76|36.76|Standard Deviation|7.25|7.25|||
4100741|NCT00976937|3924247|B3|||Glycosylated Hemoglobin (HbA1c)||percentage of hemoglobin|Mean|8.12|8.12|Standard Deviation|0.93|0.93|||
4100742|NCT00976937|3924248|B2|||Glycosylated Hemoglobin (HbA1c)||percentage of hemoglobin|Mean|8.09|8.09|Standard Deviation|0.96|0.96|||
4100743|NCT00976937|3924249|B1|||Glycosylated Hemoglobin (HbA1c)||percentage of hemoglobin|Mean|8.16|8.16|Standard Deviation|0.89|0.89|||
4100744|NCT00976937|3924247|B3|Ethnicity: Non Hispanic||Race/Ethnicity, Customized||participants|Number|174|174.0||||||
4100745|NCT00976937|3924248|B2|Ethnicity: Non Hispanic||Race/Ethnicity, Customized||participants|Number|89|89.0||||||
4100746|NCT00976937|3924249|B1|Ethnicity: Non Hispanic||Race/Ethnicity, Customized||participants|Number|85|85.0||||||
4100747|NCT00976937|3924247|B3|Ethnicity: Hispanic||Race/Ethnicity, Customized||participants|Number|145|145.0||||||
4100748|NCT00976937|3924248|B2|Ethnicity: Hispanic||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
4100749|NCT00976937|3924249|B1|Ethnicity: Hispanic||Race/Ethnicity, Customized||participants|Number|73|73.0||||||
4100750|NCT00976937|3924247|B3|Race: Other||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4100751|NCT00976937|3924248|B2|Race: Other||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4100752|NCT00976937|3924249|B1|Race: Other||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4100753|NCT00976937|3924247|B3|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4100754|NCT00976937|3924248|B2|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4100755|NCT00976937|3924249|B1|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4100756|NCT00976937|3924247|B3|Race: Black||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4100757|NCT00976937|3924248|B2|Race: Black||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4100758|NCT00976937|3924249|B1|Race: Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4100759|NCT00976937|3924247|B3|Race: Caucasian/White||Race/Ethnicity, Customized||participants|Number|259|259.0||||||
4100760|NCT00976937|3924248|B2|Race: Caucasian/White||Race/Ethnicity, Customized||participants|Number|127|127.0||||||
4100761|NCT00976937|3924249|B1|Race: Caucasian/White||Race/Ethnicity, Customized||participants|Number|132|132.0||||||
4100762|NCT00976937|3924247|B3||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4100763|NCT00976937|3924248|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4100764|NCT00976937|3924249|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4100765|NCT00976937|3924247|B3||Female|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4100766|NCT00976937|3924248|B2||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4100767|NCT00976937|3924249|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4100768|NCT00976937|3924247|B3|||Age||years|Mean|43.1|43.1|Standard Deviation|4.9|4.9|||
4100769|NCT00976937|3924248|B2|||Age||years|Mean|43.4|43.4|Standard Deviation|4.7|4.7|||
4100770|NCT00976937|3924249|B1|||Age||years|Mean|42.7|42.7|Standard Deviation|5.2|5.2|||
4100771|NCT00976911|3924290|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4100772|NCT00976911|3924291|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4100773|NCT00976911|3924292|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4100774|NCT00976911|3924290|B3||Female|Sex: Female, Male||Participants|Count of Participants|361|361.0||||||
4100775|NCT00976911|3924291|B2||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4100776|NCT00976911|3924292|B1||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4100777|NCT00976911|3924290|B3|||Age||years|Mean|60.3|60.3|Standard Deviation|10.4|10.4|||
4100778|NCT00976911|3924291|B2|||Age||years|Mean|60.0|60.0|Standard Deviation|11.1|11.1|||
4100779|NCT00976911|3924292|B1|||Age||years|Mean|60.7|60.7|Standard Deviation|9.8|9.8|||
4100781|NCT00976898|3924311|B1|Any other||Previous Therapy||Participants|Count of Participants|15|15.0||||||
4100782|NCT00976898|3924311|B1|Any chemotherapy||Previous Therapy||Participants|Count of Participants|27|27.0||||||
4100783|NCT00976898|3924311|B1|Any radiofrequency ablation||Previous Therapy||Participants|Count of Participants|2|2.0||||||
4100784|NCT00976898|3924311|B1|Any transarterial chemoembolization||Previous Therapy||Participants|Count of Participants|5|5.0||||||
4100785|NCT00976898|3924311|B1|Any surgical resection||Previous Therapy||Participants|Count of Participants|4|4.0||||||
4100786|NCT00976898|3924311|B1|3||Number of Nodular Tumors||Participants|Count of Participants|4|4.0||||||
4100787|NCT00976898|3924311|B1|2||Number of Nodular Tumors||Participants|Count of Participants|15|15.0||||||
4100788|NCT00976898|3924311|B1|1||Number of Nodular Tumors||Participants|Count of Participants|66|66.0||||||
4100789|NCT00976898|3924311|B1|Newly Diagnosed||Disease Status||Participants|Count of Participants|78|78.0||||||
4100790|NCT00976898|3924311|B1|Locally Recurrent||Disease Status||Participants|Count of Participants|5|5.0||||||
4100791|NCT00976898|3924311|B1|No Cirrhosis||Child-Turcotte-Pugh Class|Child-Turcotte-Pugh Class is used to evaluate the prognosis of chronic liver disease (primarily cirrhosis). Classes are determined using 5 clinical measures of liver disease with 1 to 3 points given for each measure, with more points given for less favorable clinical criteria. The 5 measures are total bilirubin, serum albumin, prothrombin time/international normalized ratio (INR), Ascites, and hepatic encephalopathy grade. The classes are A (5-6 points), B (7-9 points), and C (10-15 points) with 'A' having the best survival outcomes and C having the worst.|Participants|Count of Participants|4|4.0||||||
4100792|NCT00976898|3924311|B1|C||Child-Turcotte-Pugh Class|Child-Turcotte-Pugh Class is used to evaluate the prognosis of chronic liver disease (primarily cirrhosis). Classes are determined using 5 clinical measures of liver disease with 1 to 3 points given for each measure, with more points given for less favorable clinical criteria. The 5 measures are total bilirubin, serum albumin, prothrombin time/international normalized ratio (INR), Ascites, and hepatic encephalopathy grade. The classes are A (5-6 points), B (7-9 points), and C (10-15 points) with 'A' having the best survival outcomes and C having the worst.|Participants|Count of Participants|0|0.0||||||
4100793|NCT00976898|3924311|B1|B||Child-Turcotte-Pugh Class|Child-Turcotte-Pugh Class is used to evaluate the prognosis of chronic liver disease (primarily cirrhosis). Classes are determined using 5 clinical measures of liver disease with 1 to 3 points given for each measure, with more points given for less favorable clinical criteria. The 5 measures are total bilirubin, serum albumin, prothrombin time/international normalized ratio (INR), Ascites, and hepatic encephalopathy grade. The classes are A (5-6 points), B (7-9 points), and C (10-15 points) with 'A' having the best survival outcomes and C having the worst.|Participants|Count of Participants|15|15.0||||||
4100794|NCT00976898|3924311|B1|A||Child-Turcotte-Pugh Class|Child-Turcotte-Pugh Class is used to evaluate the prognosis of chronic liver disease (primarily cirrhosis). Classes are determined using 5 clinical measures of liver disease with 1 to 3 points given for each measure, with more points given for less favorable clinical criteria. The 5 measures are total bilirubin, serum albumin, prothrombin time/international normalized ratio (INR), Ascites, and hepatic encephalopathy grade. The classes are A (5-6 points), B (7-9 points), and C (10-15 points) with 'A' having the best survival outcomes and C having the worst.|Participants|Count of Participants|66|66.0||||||
4100795|NCT00976898|3924311|B1|2||ECOG Performance Status|"Eastern Cooperative Oncology Group (ECOG) score:~0 – Asymptomatic (Fully active, able to carry on all predisease activities without restriction)~1 – Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. For example, light housework, office work)~2 – Symptomatic, <50% in bed during the day (Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours)"|Participants|Count of Participants|3|3.0||||||
4100796|NCT00976898|3924311|B1|1||ECOG Performance Status|"Eastern Cooperative Oncology Group (ECOG) score:~0 – Asymptomatic (Fully active, able to carry on all predisease activities without restriction)~1 – Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. For example, light housework, office work)~2 – Symptomatic, <50% in bed during the day (Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours)"|Participants|Count of Participants|52|52.0||||||
4100797|NCT00976898|3924311|B1|0||ECOG Performance Status|"Eastern Cooperative Oncology Group (ECOG) score:~0 – Asymptomatic (Fully active, able to carry on all predisease activities without restriction)~1 – Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. For example, light housework, office work)~2 – Symptomatic, <50% in bed during the day (Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours)"|Participants|Count of Participants|28|28.0||||||
4100798|NCT00976898|3924311|B1|None||Underlying Liver Disease||Participants|Count of Participants|36|36.0||||||
4100799|NCT00976898|3924311|B1|Other||Underlying Liver Disease||Participants|Count of Participants|2|2.0||||||
4100800|NCT00976898|3924311|B1|No HCV/HBV/EtOH but nonalcoholic steatohepatitis||Underlying Liver Disease||Participants|Count of Participants|3|3.0||||||
4100801|NCT00976898|3924311|B1|No HCV/HBV but Ethyl Hepatocellularalcohol (EtOH)||Underlying Liver Disease||Participants|Count of Participants|8|8.0||||||
4100802|NCT00976898|3924311|B1|No HCV but Hepatitis B Virus (HBV) (± Others)||Underlying Liver Disease||Participants|Count of Participants|6|6.0||||||
4100803|NCT00976898|3924311|B1|Hepatitis C Virus (HCV) (± Others)||Underlying Liver Disease||Participants|Count of Participants|28|28.0||||||
4100804|NCT00976898|3924311|B1|United States||Region of Enrollment||participants|Number|83|83.0||||||
4100805|NCT00976898|3924311|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4100806|NCT00976898|3924311|B1|Hispanic (white or black)||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4100807|NCT00976898|3924311|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4100808|NCT00976898|3924311|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4100809|NCT00976898|3924311|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|76|76.0||||||
4100810|NCT00976898|3924311|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4100811|NCT00976898|3924311|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4100812|NCT00976898|3924311|B1|||Age||years|Median|67.6|67.6|Full Range|||29.9|89.7|
4100813|NCT00976820|3924318|B5|Not specified||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4100814|NCT00976820|3924319|B4|Not specified||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4100815|NCT00976820|3924320|B3|Not specified||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4100816|NCT00976820|3924321|B2|Not specified||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4100817|NCT00976820|3924322|B1|Not specified||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4100818|NCT00976820|3924318|B5|White - Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|214|214.0||||||
4100819|NCT00976820|3924319|B4|White - Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
4100820|NCT00976820|3924320|B3|White - Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
4100821|NCT00976820|3924321|B2|White - Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|86|86.0||||||
4100822|NCT00976820|3924322|B1|White - Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
4100823|NCT00976820|3924318|B5|White - Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4100824|NCT00976820|3924319|B4|White - Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4100825|NCT00976820|3924320|B3|White - Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4100826|NCT00976820|3924321|B2|White - Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4100827|NCT00976820|3924322|B1|White - Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4100828|NCT00976820|3924318|B5|Asian - South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4100829|NCT00976820|3924319|B4|Asian - South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4100830|NCT00976820|3924320|B3|Asian - South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4100831|NCT00976820|3924321|B2|Asian - South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4100832|NCT00976820|3924322|B1|Asian - South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4100833|NCT00976820|3924318|B5|Asian - East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4100834|NCT00976820|3924319|B4|Asian - East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4100835|NCT00976820|3924320|B3|Asian - East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4100836|NCT00976820|3924321|B2|Asian - East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4100837|NCT00976820|3924322|B1|Asian - East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4100838|NCT00976820|3924318|B5|Asian - Central/South Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|60|60.0||||||
4100839|NCT00976820|3924319|B4|Asian - Central/South Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4100840|NCT00976820|3924320|B3|Asian - Central/South Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
4100841|NCT00976820|3924321|B2|Asian - Central/South Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
4100842|NCT00976820|3924322|B1|Asian - Central/South Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4100843|NCT00976820|3924318|B5|American Indian or Alaskan native||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4100844|NCT00976820|3924319|B4|American Indian or Alaskan native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4100845|NCT00976820|3924320|B3|American Indian or Alaskan native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4100846|NCT00976820|3924321|B2|American Indian or Alaskan native||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4100847|NCT00976820|3924322|B1|American Indian or Alaskan native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4100848|NCT00976820|3924318|B5|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4100849|NCT00976820|3924319|B4|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4100850|NCT00976820|3924320|B3|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4100851|NCT00976820|3924321|B2|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4100852|NCT00976820|3924322|B1|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4100853|NCT00976820|3924318|B5||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4100854|NCT00976820|3924319|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4100855|NCT00976820|3924320|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4100856|NCT00976820|3924321|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4100857|NCT00976820|3924322|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4100858|NCT00976820|3924318|B5||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4100859|NCT00976820|3924319|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4100860|NCT00976820|3924320|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4100861|NCT00976820|3924321|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4100862|NCT00976820|3924322|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4100863|NCT00976820|3924318|B5|||Age||Months|Mean|50.6|50.6|Standard Deviation|29.7|29.7|||
4100864|NCT00976820|3924319|B4|||Age||Months|Mean|54.4|54.4|Standard Deviation|30.4|30.4|||
4100865|NCT00976820|3924320|B3|||Age||Months|Mean|50.3|50.3|Standard Deviation|29.0|29.0|||
4100866|NCT00976820|3924321|B2|||Age||Months|Mean|47.4|47.4|Standard Deviation|28.6|28.6|||
4100867|NCT00976820|3924322|B1|||Age||Months|Mean|53.6|53.6|Standard Deviation|31.6|31.6|||
4100868|NCT00976716|3924661|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4100869|NCT00976716|3924661|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4100870|NCT00976716|3924661|B1|||Age||Years|Mean|37.1|37.1|Standard Deviation|14.4|14.4|||
4100871|NCT00976703|3924677|B3|United States||Region of Enrollment||participants|Number|197|197.0||||||
4100872|NCT00976703|3924678|B2|United States||Region of Enrollment||participants|Number|98|98.0||||||
4100873|NCT00976703|3924679|B1|United States||Region of Enrollment||participants|Number|99|99.0||||||
4100874|NCT00976703|3924677|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4100875|NCT00976703|3924678|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4100876|NCT00976703|3924679|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4100877|NCT00976703|3924677|B3||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4100878|NCT00976703|3924678|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4100879|NCT00976703|3924679|B1||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4100880|NCT00976703|3924677|B3|||Age||years|Mean|25.6|25.6|Standard Deviation|6.4|6.4|||
4100881|NCT00976703|3924678|B2|||Age||years|Mean|25.5|25.5|Standard Deviation|5.9|5.9|||
4100882|NCT00976703|3924679|B1|||Age||years|Mean|25.7|25.7|Standard Deviation|6.9|6.9|||
4100883|NCT00976703|3924677|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4100884|NCT00976703|3924678|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4100885|NCT00976703|3924679|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4100886|NCT00976703|3924677|B3||Between 18 and 65 years|Age||Participants|Count of Participants|193|193.0||||||
4100887|NCT00976703|3924678|B2||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
4100888|NCT00976703|3924679|B1||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
4100889|NCT00976703|3924677|B3||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4100890|NCT00976703|3924678|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4100891|NCT00976703|3924679|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4100892|NCT00976677|3924692|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4100893|NCT00976677|3924693|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4100894|NCT00976677|3924694|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4100895|NCT00976677|3924692|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4100896|NCT00976677|3924693|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4100897|NCT00976677|3924694|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4100898|NCT00976677|3924692|B3|||Age||years|Median|62|62.0|Full Range|||38.0|76.0|
4100899|NCT00976677|3924693|B2|||Age||years|Median|63|63.0|Full Range|||60.0|75.0|
4100900|NCT00976677|3924694|B1|||Age||years|Median|53|53.0|Full Range|||38.0|76.0|
4100901|NCT00976664|3924701|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4100902|NCT00976664|3924702|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4100903|NCT00976664|3924703|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4100904|NCT00976664|3924701|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4100905|NCT00976664|3924702|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4100906|NCT00976664|3924703|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4100907|NCT00976664|3924701|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4100908|NCT00976664|3924702|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4100909|NCT00976664|3924703|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4100910|NCT00976664|3924701|B3|Age, Customized||Age, Customized||years|Mean|52|52.0|Standard Deviation|16|16.0|||
4100911|NCT00976664|3924702|B2|Age, Customized||Age, Customized||years|Mean|53|53.0|Standard Deviation|16|16.0|||
4100912|NCT00976664|3924703|B1|Age, Customized||Age, Customized||years|Mean|51|51.0|Standard Deviation|16|16.0|||
4100913|NCT00976599|3924712|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4100914|NCT00976599|3924713|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4100915|NCT00976599|3924714|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4100916|NCT00976599|3924712|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4100917|NCT00976599|3924713|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4100918|NCT00976599|3924714|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4100919|NCT00976599|3924712|B3|||Age||years|Mean|53.3|53.3|Standard Deviation|11.7|11.7|||
4100920|NCT00976599|3924713|B2|||Age||years|Mean|53.1|53.1|Standard Deviation|14.3|14.3|||
4100921|NCT00976599|3924714|B1|||Age||years|Mean|53.5|53.5|Standard Deviation|9.2|9.2|||
4100922|NCT00976573|3924901|B3|United States||Region of Enrollment||participants|Number|149|149.0||||||
4100923|NCT00976573|3924902|B2|United States||Region of Enrollment||participants|Number|74|74.0||||||
4100924|NCT00976573|3924903|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
4100925|NCT00976573|3924901|B3||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4100926|NCT00976573|3924902|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4100927|NCT00976573|3924903|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4100928|NCT00976573|3924901|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4100929|NCT00976573|3924902|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4100930|NCT00976573|3924903|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4100931|NCT00976573|3924901|B3|||Age||years|Median|59|59.0|Full Range|||26.0|85.0|
4100932|NCT00976573|3924902|B2|||Age||years|Median|58|58.0|Full Range|||29.0|81.0|
4100933|NCT00976573|3924903|B1|||Age||years|Median|59|59.0|Full Range|||26.0|85.0|
4100934|NCT00976560|3924916|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4100935|NCT00976560|3924917|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4100936|NCT00976560|3924918|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4100937|NCT00976560|3924916|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4100938|NCT00976560|3924917|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4100939|NCT00976560|3924918|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4100940|NCT00976560|3924916|B3||White|Race (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
4100941|NCT00976560|3924917|B2||White|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4100942|NCT00976560|3924918|B1||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4100943|NCT00976560|3924916|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4100944|NCT00976560|3924917|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4100945|NCT00976560|3924918|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4100946|NCT00976560|3924916|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4100947|NCT00976560|3924917|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4100948|NCT00976560|3924918|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4100949|NCT00976560|3924916|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4100950|NCT00976560|3924917|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4100951|NCT00976560|3924918|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4100952|NCT00976560|3924916|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4100953|NCT00976560|3924917|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4100954|NCT00976560|3924918|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4100955|NCT00976560|3924916|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4100956|NCT00976560|3924917|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4100957|NCT00976560|3924918|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4100958|NCT00976560|3924916|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4100959|NCT00976560|3924917|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4100960|NCT00976560|3924918|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4100961|NCT00976560|3924916|B3|18 to 60 years||Age, Customized||Participants|Count of Participants|128|128.0||||||
4100962|NCT00976560|3924917|B2|18 to 60 years||Age, Customized||Participants|Count of Participants|64|64.0||||||
4100963|NCT00976560|3924918|B1|18 to 60 years||Age, Customized||Participants|Count of Participants|64|64.0||||||
4100964|NCT00976521|3924967|B5|United Kingdom||Region of Enrollment||participants|Number|122|122.0||||||
4100965|NCT00976521|3924968|B4|United Kingdom||Region of Enrollment||participants|Number|34|34.0||||||
4100966|NCT00976521|3924969|B3|United Kingdom||Region of Enrollment||participants|Number|32|32.0||||||
4100967|NCT00976521|3924970|B2|United Kingdom||Region of Enrollment||participants|Number|26|26.0||||||
4100968|NCT00976521|3924971|B1|United Kingdom||Region of Enrollment||participants|Number|30|30.0||||||
4100969|NCT00976521|3924967|B5|Germany||Region of Enrollment||participants|Number|81|81.0||||||
4100970|NCT00976521|3924968|B4|Germany||Region of Enrollment||participants|Number|19|19.0||||||
4100971|NCT00976521|3924969|B3|Germany||Region of Enrollment||participants|Number|19|19.0||||||
4100972|NCT00976521|3924970|B2|Germany||Region of Enrollment||participants|Number|21|21.0||||||
4100973|NCT00976521|3924971|B1|Germany||Region of Enrollment||participants|Number|22|22.0||||||
4100974|NCT00976521|3924967|B5|Netherlands||Region of Enrollment||participants|Number|50|50.0||||||
4100975|NCT00976521|3924968|B4|Netherlands||Region of Enrollment||participants|Number|15|15.0||||||
4100976|NCT00976521|3924969|B3|Netherlands||Region of Enrollment||participants|Number|10|10.0||||||
4100977|NCT00976521|3924970|B2|Netherlands||Region of Enrollment||participants|Number|11|11.0||||||
4100978|NCT00976521|3924971|B1|Netherlands||Region of Enrollment||participants|Number|14|14.0||||||
4100979|NCT00976521|3924967|B5|Austria||Region of Enrollment||participants|Number|47|47.0||||||
4100980|NCT00976521|3924968|B4|Austria||Region of Enrollment||participants|Number|9|9.0||||||
4100981|NCT00976521|3924969|B3|Austria||Region of Enrollment||participants|Number|11|11.0||||||
4100982|NCT00976521|3924970|B2|Austria||Region of Enrollment||participants|Number|14|14.0||||||
4100983|NCT00976521|3924971|B1|Austria||Region of Enrollment||participants|Number|13|13.0||||||
4100984|NCT00976521|3924967|B5|Poland||Region of Enrollment||participants|Number|99|99.0||||||
4100985|NCT00976521|3924968|B4|Poland||Region of Enrollment||participants|Number|23|23.0||||||
4100986|NCT00976521|3924969|B3|Poland||Region of Enrollment||participants|Number|27|27.0||||||
4100987|NCT00976521|3924970|B2|Poland||Region of Enrollment||participants|Number|24|24.0||||||
4100988|NCT00976521|3924971|B1|Poland||Region of Enrollment||participants|Number|25|25.0||||||
4100989|NCT00976521|3924967|B5|United States||Region of Enrollment||participants|Number|53|53.0||||||
4100990|NCT00976521|3924968|B4|United States||Region of Enrollment||participants|Number|12|12.0||||||
4100991|NCT00976521|3924969|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4100992|NCT00976521|3924970|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4100993|NCT00976521|3924971|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4100994|NCT00976521|3924967|B5||Male|Sex: Female, Male||Participants|Count of Participants|334|334.0||||||
4100995|NCT00976521|3924968|B4||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4100996|NCT00976521|3924969|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4100997|NCT00976521|3924970|B2||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4100998|NCT00976521|3924971|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4100999|NCT00976521|3924967|B5||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4101000|NCT00976521|3924968|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4101001|NCT00976521|3924969|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4101002|NCT00976521|3924970|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4101003|NCT00976521|3924971|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4101004|NCT00976521|3924967|B5|||Age||years|Median|61.0|61.0|Inter-Quartile Range|||52.0|72.0|
4101005|NCT00976521|3924968|B4|||Age||years|Median|62.5|62.5|Inter-Quartile Range|||52.5|71.0|
4101006|NCT00976521|3924969|B3|||Age||years|Median|62.0|62.0|Inter-Quartile Range|||53.0|73.0|
4101007|NCT00976521|3924970|B2|||Age||years|Median|56.0|56.0|Inter-Quartile Range|||49.0|68.0|
4101008|NCT00976521|3924971|B1|||Age||years|Median|60.0|60.0|Inter-Quartile Range|||52.0|66.0|
4101009|NCT00976521|3924967|B5||>=65 years|Age||Participants|Count of Participants|165|165.0||||||
4101010|NCT00976521|3924968|B4||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
4101011|NCT00976521|3924969|B3||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
4101012|NCT00976521|3924970|B2||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4101013|NCT00976521|3924971|B1||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4101014|NCT00976521|3924967|B5||Between 18 and 65 years|Age||Participants|Count of Participants|287|287.0||||||
4101015|NCT00976521|3924968|B4||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
4101016|NCT00976521|3924969|B3||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4101017|NCT00976521|3924970|B2||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
4101018|NCT00976521|3924971|B1||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4101019|NCT00976521|3924967|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4101020|NCT00976521|3924968|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4101021|NCT00976521|3924969|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4101022|NCT00976521|3924970|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4101023|NCT00976521|3924971|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4101024|NCT00976508|3924986|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4101025|NCT00976508|3924987|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4101026|NCT00976508|3924988|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4101027|NCT00976508|3924986|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4101028|NCT00976508|3924987|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4101029|NCT00976508|3924988|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4101030|NCT00976508|3924986|B3|||Age||Years|Mean|45.0|45.0|Standard Deviation|17.4|17.4|||
4101031|NCT00976508|3924987|B2|||Age||Years|Mean|32.3|32.3|Standard Deviation|9.8|9.8|||
4101032|NCT00976508|3924988|B1|||Age||Years|Mean|49.5|49.5|Standard Deviation|17.4|17.4|||
4101033|NCT00976495|3925019|B4|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4101034|NCT00976495|3925020|B3|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4101035|NCT00976495|3925021|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4101036|NCT00976495|3925022|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4101037|NCT00976495|3925019|B4|Asian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4101038|NCT00976495|3925020|B3|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4101039|NCT00976495|3925021|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4101040|NCT00976495|3925022|B1|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4101041|NCT00976495|3925019|B4|Black/African American||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4101042|NCT00976495|3925020|B3|Black/African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4101043|NCT00976495|3925021|B2|Black/African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4101044|NCT00976495|3925022|B1|Black/African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4101045|NCT00976495|3925019|B4|White||Race/Ethnicity, Customized||Participants|Number|56|56.0||||||
4101046|NCT00976495|3925020|B3|White||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
4101047|NCT00976495|3925021|B2|White||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4101048|NCT00976495|3925022|B1|White||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4101049|NCT00976495|3925019|B4|Female||Sex/Gender, Customized||Participants|Number|26|26.0||||||
4101050|NCT00976495|3925020|B3|Female||Sex/Gender, Customized||Participants|Number|11|11.0||||||
4101051|NCT00976495|3925021|B2|Female||Sex/Gender, Customized||Participants|Number|8|8.0||||||
4101052|NCT00976495|3925022|B1|Female||Sex/Gender, Customized||Participants|Number|7|7.0||||||
4101053|NCT00976495|3925019|B4|Male||Sex/Gender, Customized||Participants|Number|49|49.0||||||
4101054|NCT00976495|3925020|B3|Male||Sex/Gender, Customized||Participants|Number|15|15.0||||||
4101055|NCT00976495|3925021|B2|Male||Sex/Gender, Customized||Participants|Number|16|16.0||||||
4101056|NCT00976495|3925022|B1|Male||Sex/Gender, Customized||Participants|Number|18|18.0||||||
4101057|NCT00976495|3925019|B4|65 - 75 years||Age, Customized||Participants|Number|13|13.0||||||
4101058|NCT00976495|3925020|B3|65 - 75 years||Age, Customized||Participants|Number|5|5.0||||||
4101059|NCT00976495|3925021|B2|65 - 75 years||Age, Customized||Participants|Number|2|2.0||||||
4101060|NCT00976495|3925022|B1|65 - 75 years||Age, Customized||Participants|Number|6|6.0||||||
4101061|NCT00976495|3925019|B4|Younger than 65 years||Age, Customized||Participants|Number|62|62.0||||||
4101062|NCT00976495|3925020|B3|Younger than 65 years||Age, Customized||Participants|Number|21|21.0||||||
4101063|NCT00976495|3925021|B2|Younger than 65 years||Age, Customized||Participants|Number|22|22.0||||||
4101064|NCT00976495|3925022|B1|Younger than 65 years||Age, Customized||Participants|Number|19|19.0||||||
4101065|NCT00976495|3925019|B4|||Age||Years|Mean|55.5|55.5|Standard Deviation|9.63|9.63|||
4101066|NCT00976495|3925020|B3|||Age||Years|Mean|54.8|54.8|Standard Deviation|9.87|9.87|||
4101067|NCT00976495|3925021|B2|||Age||Years|Mean|53.7|53.7|Standard Deviation|9.38|9.38|||
4101068|NCT00976495|3925022|B1|||Age||Years|Mean|58.0|58.0|Standard Deviation|9.50|9.5|||
4101069|NCT00976482|3925041|B1|Permanent AF with Slow Ventr. Response||Primary Indication for Permanent Pacing||participants|Number|274|274.0||||||
4101070|NCT00976482|3925041|B1|Neuro-mediated||Primary Indication for Permanent Pacing||participants|Number|61|61.0||||||
4101071|NCT00976482|3925041|B1|Atrioventricular Block||Primary Indication for Permanent Pacing||participants|Number|840|840.0||||||
4101072|NCT00976482|3925041|B1|sinus node dysfunction||Primary Indication for Permanent Pacing||participants|Number|565|565.0||||||
4101073|NCT00976482|3925041|B1||Male|Gender||Participants|Count of Participants|693|693.0||||||
4101074|NCT00976482|3925041|B1||Female|Gender||Participants|Count of Participants|1047|1047.0||||||
4101075|NCT00976482|3925041|B1|||Age||years|Mean|76|76.0|Standard Deviation|10|10.0|||
4101076|NCT00976456|3925045|B3||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4101077|NCT00976456|3925046|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4101078|NCT00976456|3925047|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4101079|NCT00976456|3925045|B3||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4101080|NCT00976456|3925046|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4101081|NCT00976456|3925047|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4101082|NCT00976456|3925045|B3|||Age||years|Median|71.5|71.5|Full Range|||65.0|86.0|
4101083|NCT00976456|3925046|B2|||Age||years|Median|72.0|72.0|Full Range|||65.0|86.0|
4101084|NCT00976456|3925047|B1|||Age||years|Median|71.0|71.0|Full Range|||65.0|86.0|
4101085|NCT00976404|3925056|B3|||HIV DNA||copies per 10^6 PBMC|Median|170|170.0|Inter-Quartile Range|||60.0|361.0|
4101086|NCT00976404|3925057|B2|||HIV DNA||copies per 10^6 PBMC|Median|228|228.0|Inter-Quartile Range|||98.0|383.0|
4101087|NCT00976404|3925058|B1|||HIV DNA||copies per 10^6 PBMC|Median|97|97.0|Inter-Quartile Range|||47.0|352.0|
4101088|NCT00976404|3925056|B3|||Adenovirus 5 antibody|Serum Ad5 90% neutralization antibody titer|titer|Median|12|12.0|Inter-Quartile Range|||12.0|41.0|
4101089|NCT00976404|3925057|B2|||Adenovirus 5 antibody|Serum Ad5 90% neutralization antibody titer|titer|Median|12|12.0|Inter-Quartile Range|||12.0|38.0|
4101090|NCT00976404|3925058|B1|||Adenovirus 5 antibody|Serum Ad5 90% neutralization antibody titer|titer|Median|18|18.0|Inter-Quartile Range|||12.0|68.0|
4101091|NCT00976404|3925056|B3|||Time on antiretroviral treatment (ART)||years|Median|13|13.0|Inter-Quartile Range|||8.0|19.0|
4101092|NCT00976404|3925057|B2|||Time on antiretroviral treatment (ART)||years|Median|13|13.0|Inter-Quartile Range|||6.0|19.0|
4101093|NCT00976404|3925058|B1|||Time on antiretroviral treatment (ART)||years|Median|13|13.0|Inter-Quartile Range|||8.0|19.0|
4101094|NCT00976404|3925056|B3|||CD4 cell count||cells per mm^3|Median|636|636.0|Inter-Quartile Range|||485.0|791.0|
4101095|NCT00976404|3925057|B2|||CD4 cell count||cells per mm^3|Median|563|563.0|Inter-Quartile Range|||468.0|718.0|
4101096|NCT00976404|3925058|B1|||CD4 cell count||cells per mm^3|Median|686|686.0|Inter-Quartile Range|||501.0|880.0|
4101097|NCT00976404|3925056|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4101098|NCT00976404|3925057|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4101099|NCT00976404|3925058|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4101100|NCT00976404|3925056|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4101101|NCT00976404|3925057|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4101102|NCT00976404|3925058|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4101103|NCT00976404|3925056|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4101104|NCT00976404|3925057|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4101105|NCT00976404|3925058|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4101106|NCT00976404|3925056|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4101107|NCT00976404|3925057|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4101108|NCT00976404|3925058|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4101109|NCT00976404|3925056|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4101110|NCT00976404|3925057|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4101111|NCT00976404|3925058|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4101112|NCT00976404|3925056|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4101113|NCT00976404|3925057|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4101114|NCT00976404|3925058|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4101115|NCT00976404|3925056|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4101116|NCT00976404|3925057|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4101117|NCT00976404|3925058|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4101118|NCT00976404|3925056|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4101119|NCT00976404|3925057|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4101120|NCT00976404|3925058|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4101121|NCT00976404|3925056|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4101122|NCT00976404|3925057|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4101123|NCT00976404|3925058|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4101124|NCT00976404|3925056|B3|||Age||years|Median|50|50.0|Inter-Quartile Range|||46.0|55.0|
4101125|NCT00976404|3925057|B2|||Age||years|Median|50|50.0|Inter-Quartile Range|||46.0|55.0|
4101126|NCT00976404|3925058|B1|||Age||years|Median|49|49.0|Inter-Quartile Range|||46.0|55.0|
4101127|NCT00976391|3925073|B3|Other-Native American||Race/Ethnicity, Customized|A participant may have been counted in more than 1 category.|Participants|Number|1|1.0||||||
4101128|NCT00976391|3925074|B2|Other-Native American||Race/Ethnicity, Customized|A participant may have been counted in more than 1 category.|Participants|Number|1|1.0||||||
4101129|NCT00976391|3925075|B1|Other-Native American||Race/Ethnicity, Customized|A participant may have been counted in more than 1 category.|Participants|Number|0|0.0||||||
4101130|NCT00976391|3925073|B3|Other-Black||Race/Ethnicity, Customized|A participant may have been counted in more than 1 category.|Participants|Number|1|1.0||||||
4101131|NCT00976391|3925074|B2|Other-Black||Race/Ethnicity, Customized|A participant may have been counted in more than 1 category.|Participants|Number|0|0.0||||||
4101132|NCT00976391|3925075|B1|Other-Black||Race/Ethnicity, Customized|A participant may have been counted in more than 1 category.|Participants|Number|1|1.0||||||
4101133|NCT00976391|3925073|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than 1 category.|Participants|Number|345|345.0||||||
4101134|NCT00976391|3925074|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than 1 category.|Participants|Number|171|171.0||||||
4101135|NCT00976391|3925075|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than 1 category.|Participants|Number|174|174.0||||||
4101136|NCT00976391|3925073|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than 1 category.|Participants|Number|5|5.0||||||
4101137|NCT00976391|3925074|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than 1 category.|Participants|Number|3|3.0||||||
4101138|NCT00976391|3925075|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than 1 category.|Participants|Number|2|2.0||||||
4101139|NCT00976391|3925073|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|A participant may have been counted in more than 1 category.|Participants|Number|4|4.0||||||
4101140|NCT00976391|3925074|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|A participant may have been counted in more than 1 category.|Participants|Number|3|3.0||||||
4101141|NCT00976391|3925075|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|A participant may have been counted in more than 1 category.|Participants|Number|1|1.0||||||
4101142|NCT00976391|3925073|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than 1 category.|Participants|Number|32|32.0||||||
4101143|NCT00976391|3925074|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than 1 category.|Participants|Number|16|16.0||||||
4101144|NCT00976391|3925075|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than 1 category.|Participants|Number|16|16.0||||||
4101145|NCT00976391|3925073|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than 1 category.|Participants|Number|32|32.0||||||
4101146|NCT00976391|3925074|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than 1 category.|Participants|Number|17|17.0||||||
4101147|NCT00976391|3925075|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than 1 category.|Participants|Number|15|15.0||||||
4101148|NCT00976391|3925073|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than 1 category.|Participants|Number|34|34.0||||||
4101149|NCT00976391|3925074|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than 1 category.|Participants|Number|17|17.0||||||
4101150|NCT00976391|3925075|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than 1 category.|Participants|Number|17|17.0||||||
4101151|NCT00976391|3925073|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized|A participant may have been counted in more than 1 category.|Participants|Number|49|49.0||||||
4101152|NCT00976391|3925074|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized|A participant may have been counted in more than 1 category.|Participants|Number|20|20.0||||||
4101153|NCT00976391|3925075|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized|A participant may have been counted in more than 1 category.|Participants|Number|29|29.0||||||
4101154|NCT00976391|3925073|B3|African American/African Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than 1 category.|Participants|Number|73|73.0||||||
4101155|NCT00976391|3925074|B2|African American/African Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than 1 category.|Participants|Number|34|34.0||||||
4101156|NCT00976391|3925075|B1|African American/African Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than 1 category.|Participants|Number|39|39.0||||||
4101157|NCT00976391|3925073|B3||Male|Gender||Participants|Count of Participants|268|268.0||||||
4101158|NCT00976391|3925074|B2||Male|Gender||Participants|Count of Participants|136|136.0||||||
4101159|NCT00976391|3925075|B1||Male|Gender||Participants|Count of Participants|132|132.0||||||
4101160|NCT00976391|3925073|B3||Female|Gender||Participants|Count of Participants|298|298.0||||||
4101161|NCT00976391|3925074|B2||Female|Gender||Participants|Count of Participants|145|145.0||||||
4101162|NCT00976391|3925075|B1||Female|Gender||Participants|Count of Participants|153|153.0||||||
4101163|NCT00976391|3925073|B3|||Age||Years|Mean|55.6|55.6|Standard Deviation|9.01|9.01|||
4101164|NCT00976391|3925074|B2|||Age||Years|Mean|56.3|56.3|Standard Deviation|8.87|8.87|||
4101165|NCT00976391|3925075|B1|||Age||Years|Mean|54.8|54.8|Standard Deviation|9.10|9.1|||
4101166|NCT00976352|3925096|B3|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4101167|NCT00976352|3925097|B2|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4101168|NCT00976352|3925098|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4101169|NCT00976352|3925096|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4101170|NCT00976352|3925097|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4101171|NCT00976352|3925098|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4101172|NCT00976352|3925096|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4101173|NCT00976352|3925097|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4101174|NCT00976352|3925098|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4101175|NCT00976352|3925096|B3|||Age||months|Mean|74.8|74.8|Full Range|||30.0|180.0|
4101176|NCT00976352|3925097|B2|||Age||months|Mean|67.3|67.3|Full Range|||30.0|180.0|
4101177|NCT00976352|3925098|B1|||Age||months|Mean|90|90.0|Full Range|||66.0|108.0|
4101178|NCT00976352|3925096|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4101179|NCT00976352|3925097|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4101180|NCT00976352|3925098|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4101181|NCT00976352|3925096|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4101182|NCT00976352|3925097|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4101183|NCT00976352|3925098|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4101184|NCT00976352|3925096|B3||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4101185|NCT00976352|3925097|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4101186|NCT00976352|3925098|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4101187|NCT00976339|3925111|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4101188|NCT00976339|3925112|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4101189|NCT00976339|3925113|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4101190|NCT00976339|3925111|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4101191|NCT00976339|3925112|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4101192|NCT00976339|3925113|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4101193|NCT00976339|3925111|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4101194|NCT00976339|3925112|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4101195|NCT00976339|3925113|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4101196|NCT00976339|3925111|B3|> 21 years||Age, Customized||Participants|Count of Participants|20|20.0||||||
4101197|NCT00976339|3925112|B2|> 21 years||Age, Customized||Participants|Count of Participants|10|10.0||||||
4101198|NCT00976339|3925113|B1|> 21 years||Age, Customized||Participants|Count of Participants|10|10.0||||||
4101199|NCT00976274|3925122|B3|Korea, Republic of||Region of Enrollment||participants|Number|60|60.0||||||
4101200|NCT00976274|3925123|B2|Korea, Republic of||Region of Enrollment||participants|Number|29|29.0||||||
4101201|NCT00976274|3925124|B1|Korea, Republic of||Region of Enrollment||participants|Number|31|31.0||||||
4101202|NCT00976274|3925122|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4101203|NCT00976274|3925123|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4101204|NCT00976274|3925124|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4101205|NCT00976274|3925122|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4101206|NCT00976274|3925123|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4101207|NCT00976274|3925124|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4101208|NCT00976274|3925122|B3|||Age||years|Mean|44.7|44.7|Standard Deviation|10.8|10.8|||
4101209|NCT00976274|3925123|B2|||Age||years|Mean|43.1|43.1|Standard Deviation|10.6|10.6|||
4101210|NCT00976274|3925124|B1|||Age||years|Mean|46.2|46.2|Standard Deviation|11.0|11.0|||
4101211|NCT00976274|3925122|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4101212|NCT00976274|3925123|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4101213|NCT00976274|3925124|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4101214|NCT00976274|3925122|B3||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4101215|NCT00976274|3925123|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4101216|NCT00976274|3925124|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4101217|NCT00976274|3925122|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4101218|NCT00976274|3925123|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4101219|NCT00976274|3925124|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4101220|NCT00976248|3925133|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4101221|NCT00976248|3925133|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4101222|NCT00976248|3925133|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4101223|NCT00976248|3925133|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4101224|NCT00976248|3925133|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4101225|NCT00976248|3925133|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4101226|NCT00976209|3925139|B3||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4101227|NCT00976209|3925140|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4101228|NCT00976209|3925141|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4101229|NCT00976209|3925139|B3||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4101230|NCT00976209|3925140|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4101231|NCT00976209|3925141|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4101232|NCT00976209|3925139|B3|||Age||years|Mean|39.5|39.5|Standard Deviation|11.31|11.31|||
4101233|NCT00976209|3925140|B2|||Age||years|Mean|38.3|38.3|Standard Deviation|11.45|11.45|||
4101234|NCT00976209|3925141|B1|||Age||years|Mean|40.7|40.7|Standard Deviation|11.07|11.07|||
4101235|NCT00976183|3925148|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4101236|NCT00976183|3925148|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4101237|NCT00976183|3925148|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4101238|NCT00976183|3925148|B1|||Age||years|Median|58|58.0|Full Range|||41.0|74.0|
4101239|NCT00976183|3925148|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4101240|NCT00976183|3925148|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4101241|NCT00976183|3925148|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4101242|NCT00976027|3925153|B3|United States||Region of Enrollment||Participants|Number|9158|9158.0||||||
4101243|NCT00976027|3925154|B2|United States||Region of Enrollment||Participants|Number|3050|3050.0||||||
4101244|NCT00976027|3925155|B1|United States||Region of Enrollment||Participants|Number|6108|6108.0||||||
4101245|NCT00976027|3925153|B3||Male|Sex: Female, Male||Participants|Count of Participants|4243|4243.0||||||
4101246|NCT00976027|3925154|B2||Male|Sex: Female, Male||Participants|Count of Participants|1403|1403.0||||||
4101247|NCT00976027|3925155|B1||Male|Sex: Female, Male||Participants|Count of Participants|2840|2840.0||||||
4101248|NCT00976027|3925153|B3||Female|Sex: Female, Male||Participants|Count of Participants|4915|4915.0||||||
4101249|NCT00976027|3925154|B2||Female|Sex: Female, Male||Participants|Count of Participants|1647|1647.0||||||
4101250|NCT00976027|3925155|B1||Female|Sex: Female, Male||Participants|Count of Participants|3268|3268.0||||||
4101251|NCT00976027|3925153|B3|||Age||Years|Mean|72.8|72.8|Standard Deviation|6.0|6.0|||
4101252|NCT00976027|3925154|B2|||Age||Years|Mean|72.8|72.8|Standard Deviation|5.9|5.9|||
4101253|NCT00976027|3925155|B1|||Age||Years|Mean|72.8|72.8|Standard Deviation|6.0|6.0|||
4101254|NCT00976027|3925153|B3||>=65 years|Age||Participants|Count of Participants|9158|9158.0||||||
4101255|NCT00976027|3925154|B2||>=65 years|Age||Participants|Count of Participants|3050|3050.0||||||
4101256|NCT00976027|3925155|B1||>=65 years|Age||Participants|Count of Participants|6108|6108.0||||||
4101257|NCT00976027|3925153|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4101258|NCT00976027|3925154|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4101259|NCT00976027|3925155|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4101260|NCT00976027|3925153|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4101261|NCT00976027|3925154|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4101262|NCT00976027|3925155|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4101263|NCT00975975|3925168|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4101264|NCT00975975|3925168|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4101265|NCT00975975|3925168|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4101266|NCT00975975|3925168|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4101267|NCT00975975|3925168|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4101268|NCT00975975|3925168|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4101269|NCT00975975|3925168|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4101270|NCT00975975|3925168|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4101271|NCT00975975|3925168|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4101272|NCT00975975|3925168|B1|||Age||years|Mean|59.1|59.1|Standard Deviation|7.05|7.05|||
4101273|NCT00975923|3925174|B3|||Medicare case-mix weight|Average Medicare Case-Mix Index for annual ICU patient volume collected by baseline survey of participating hospitals. Patients are assigned to Medicare Severity-Diagnosis Related Groups (MS-DRG) based on principal and secondary diagnoses, age, procedures performed, co-morbidity, complications, discharge status, and gender. Each MS-DRG has a numeric weight that indicates the amount of resources required to treat patients in the group. The index, the average of the MS-DRG weights, measures the relative cost needed to treat the case-mix of patients in a hospital during the calendar year.|Medicare Case-Mix Index/year|Mean|1250|1250.0|Standard Deviation|1000|1000.0|||
4101274|NCT00975923|3925175|B2|||Medicare case-mix weight|Average Medicare Case-Mix Index for annual ICU patient volume collected by baseline survey of participating hospitals. Patients are assigned to Medicare Severity-Diagnosis Related Groups (MS-DRG) based on principal and secondary diagnoses, age, procedures performed, co-morbidity, complications, discharge status, and gender. Each MS-DRG has a numeric weight that indicates the amount of resources required to treat patients in the group. The index, the average of the MS-DRG weights, measures the relative cost needed to treat the case-mix of patients in a hospital during the calendar year.|Medicare Case-Mix Index/year|Mean|1295|1295.0|Standard Deviation|1110|1110.0|||
4101275|NCT00975923|3925176|B1|||Medicare case-mix weight|Average Medicare Case-Mix Index for annual ICU patient volume collected by baseline survey of participating hospitals. Patients are assigned to Medicare Severity-Diagnosis Related Groups (MS-DRG) based on principal and secondary diagnoses, age, procedures performed, co-morbidity, complications, discharge status, and gender. Each MS-DRG has a numeric weight that indicates the amount of resources required to treat patients in the group. The index, the average of the MS-DRG weights, measures the relative cost needed to treat the case-mix of patients in a hospital during the calendar year.|Medicare Case-Mix Index/year|Mean|1221|1221.0|Standard Deviation|1007|1007.0|||
4101276|NCT00975923|3925174|B3|||ICU mortality rate|Annual ICU mortality rate provided by baseline survey among participating hospitals|ICU mortality rate/year|Mean|6|6.0|Standard Deviation|3.5|3.5|||
4101277|NCT00975923|3925175|B2|||ICU mortality rate|Annual ICU mortality rate provided by baseline survey among participating hospitals|ICU mortality rate/year|Mean|7.1|7.1|Standard Deviation|3.6|3.6|||
4101278|NCT00975923|3925176|B1|||ICU mortality rate|Annual ICU mortality rate provided by baseline survey among participating hospitals|ICU mortality rate/year|Mean|5.7|5.7|Standard Deviation|3.1|3.1|||
4101279|NCT00975923|3925174|B3|||ICU annual patient volume|Patient volume was collected by a baseline survey of each participating hospital|ICU patients/year|Median|570|570.0|Inter-Quartile Range|||250.0|950.0|
4101280|NCT00975923|3925175|B2|||ICU annual patient volume|Patient volume was collected by a baseline survey of each participating hospital|ICU patients/year|Median|578|578.0|Inter-Quartile Range|||244.0|1077.0|
4101281|NCT00975923|3925176|B1|||ICU annual patient volume|Patient volume was collected by a baseline survey of each participating hospital|ICU patients/year|Median|568|568.0|Inter-Quartile Range|||294.0|904.0|
4101282|NCT00975923|3925174|B3|Average % Female||Sex/Gender, Customized|baseline survey, percent of ICU patient volume that is female|Percentage of ICU female patient volume|Mean|50|50.0|Standard Deviation|6|6.0|||
4101283|NCT00975923|3925175|B2|Average % Female||Sex/Gender, Customized|baseline survey, percent of ICU patient volume that is female|Percentage of ICU female patient volume|Mean|50.3|50.3|Standard Deviation|7.7|7.7|||
4101284|NCT00975923|3925176|B1|Average % Female||Sex/Gender, Customized|baseline survey, percent of ICU patient volume that is female|Percentage of ICU female patient volume|Mean|49.7|49.7|Standard Deviation|5.7|5.7|||
4101285|NCT00975923|3925174|B3|Adult ICU (Age >= 18 years)||Age, Customized|Participants reporting whether ICU is pediatric (Age < 18 years) or adult (Age > 18 years) on baseline survey|Hospitals|Number|60|60.0||||||
4101286|NCT00975923|3925175|B2|Adult ICU (Age >= 18 years)||Age, Customized|Participants reporting whether ICU is pediatric (Age < 18 years) or adult (Age > 18 years) on baseline survey|Hospitals|Number|30|30.0||||||
4101287|NCT00975923|3925176|B1|Adult ICU (Age >= 18 years)||Age, Customized|Participants reporting whether ICU is pediatric (Age < 18 years) or adult (Age > 18 years) on baseline survey|Hospitals|Number|30|30.0||||||
4101288|NCT00975923|3925174|B3|Pediatric ICU (Age < 18 years)||Age, Customized|Participants reporting whether ICU is pediatric (Age < 18 years) or adult (Age > 18 years) on baseline survey|Hospitals|Number|0|0.0||||||
4101289|NCT00975923|3925175|B2|Pediatric ICU (Age < 18 years)||Age, Customized|Participants reporting whether ICU is pediatric (Age < 18 years) or adult (Age > 18 years) on baseline survey|Hospitals|Number|0|0.0||||||
4101290|NCT00975923|3925176|B1|Pediatric ICU (Age < 18 years)||Age, Customized|Participants reporting whether ICU is pediatric (Age < 18 years) or adult (Age > 18 years) on baseline survey|Hospitals|Number|0|0.0||||||
4101291|NCT00975806|3925185|B4|4 (Completely Disabled)||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity)~= Restricted activity but ambulatory~= Ambulatory but unable to carry out work activities~= Limited Self-Care~= Completely Disabled, No self-care (Least Favorable Activity)"|participants|Number|0|0.0||||||
4101292|NCT00975806|3925186|B3|4 (Completely Disabled)||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity)~= Restricted activity but ambulatory~= Ambulatory but unable to carry out work activities~= Limited Self-Care~= Completely Disabled, No self-care (Least Favorable Activity)"|participants|Number|0|0.0||||||
4101293|NCT00975806|3925187|B2|4 (Completely Disabled)||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity)~= Restricted activity but ambulatory~= Ambulatory but unable to carry out work activities~= Limited Self-Care~= Completely Disabled, No self-care (Least Favorable Activity)"|participants|Number|0|0.0||||||
4101364|NCT00975689|3925241|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4101294|NCT00975806|3925188|B1|4 (Completely Disabled)||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity)~= Restricted activity but ambulatory~= Ambulatory but unable to carry out work activities~= Limited Self-Care~= Completely Disabled, No self-care (Least Favorable Activity)"|participants|Number|0|0.0||||||
4101295|NCT00975806|3925185|B4|3 (Limited Self-Care)||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity)~= Restricted activity but ambulatory~= Ambulatory but unable to carry out work activities~= Limited Self-Care~= Completely Disabled, No self-care (Least Favorable Activity)"|participants|Number|0|0.0||||||
4101296|NCT00975806|3925186|B3|3 (Limited Self-Care)||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity)~= Restricted activity but ambulatory~= Ambulatory but unable to carry out work activities~= Limited Self-Care~= Completely Disabled, No self-care (Least Favorable Activity)"|participants|Number|0|0.0||||||
4101297|NCT00975806|3925187|B2|3 (Limited Self-Care)||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity)~= Restricted activity but ambulatory~= Ambulatory but unable to carry out work activities~= Limited Self-Care~= Completely Disabled, No self-care (Least Favorable Activity)"|participants|Number|0|0.0||||||
4101298|NCT00975806|3925188|B1|3 (Limited Self-Care)||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity)~= Restricted activity but ambulatory~= Ambulatory but unable to carry out work activities~= Limited Self-Care~= Completely Disabled, No self-care (Least Favorable Activity)"|participants|Number|0|0.0||||||
4101299|NCT00975806|3925185|B4|1 = restricted activity but ambulatory||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity)~= Restricted activity but ambulatory~= Ambulatory but unable to carry out work activities~= Limited Self-Care~= Completely Disabled, No self-care (Least Favorable Activity)"|participants|Number|4|4.0||||||
4101300|NCT00975806|3925186|B3|1 = restricted activity but ambulatory||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity)~= Restricted activity but ambulatory~= Ambulatory but unable to carry out work activities~= Limited Self-Care~= Completely Disabled, No self-care (Least Favorable Activity)"|participants|Number|0|0.0||||||
4101301|NCT00975806|3925187|B2|1 = restricted activity but ambulatory||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity)~= Restricted activity but ambulatory~= Ambulatory but unable to carry out work activities~= Limited Self-Care~= Completely Disabled, No self-care (Least Favorable Activity)"|participants|Number|3|3.0||||||
4101302|NCT00975806|3925188|B1|1 = restricted activity but ambulatory||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity)~= Restricted activity but ambulatory~= Ambulatory but unable to carry out work activities~= Limited Self-Care~= Completely Disabled, No self-care (Least Favorable Activity)"|participants|Number|1|1.0||||||
4101303|NCT00975806|3925185|B4|0 = fully active||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity)~= Restricted activity but ambulatory~= Ambulatory but unable to carry out work activities~= Limited Self-Care~= Completely Disabled, No self-care (Least Favorable Activity)"|participants|Number|12|12.0||||||
4101304|NCT00975806|3925186|B3|0 = fully active||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity)~= Restricted activity but ambulatory~= Ambulatory but unable to carry out work activities~= Limited Self-Care~= Completely Disabled, No self-care (Least Favorable Activity)"|participants|Number|4|4.0||||||
4101305|NCT00975806|3925187|B2|0 = fully active||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity)~= Restricted activity but ambulatory~= Ambulatory but unable to carry out work activities~= Limited Self-Care~= Completely Disabled, No self-care (Least Favorable Activity)"|participants|Number|4|4.0||||||
4101365|NCT00975689|3925242|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4101366|NCT00975689|3925240|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4101367|NCT00975689|3925241|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4101306|NCT00975806|3925188|B1|0 = fully active||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity)~= Restricted activity but ambulatory~= Ambulatory but unable to carry out work activities~= Limited Self-Care~= Completely Disabled, No self-care (Least Favorable Activity)"|participants|Number|4|4.0||||||
4101307|NCT00975806|3925185|B4|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4101308|NCT00975806|3925186|B3|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4101309|NCT00975806|3925187|B2|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4101310|NCT00975806|3925188|B1|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4101311|NCT00975806|3925185|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4101312|NCT00975806|3925186|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4101313|NCT00975806|3925187|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4101314|NCT00975806|3925188|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4101315|NCT00975806|3925185|B4|Caucasian (White)||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4101316|NCT00975806|3925186|B3|Caucasian (White)||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4101317|NCT00975806|3925187|B2|Caucasian (White)||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4101318|NCT00975806|3925188|B1|Caucasian (White)||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4101319|NCT00975806|3925185|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4101320|NCT00975806|3925186|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4101321|NCT00975806|3925187|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4101322|NCT00975806|3925188|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4101323|NCT00975806|3925185|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4101324|NCT00975806|3925186|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4101325|NCT00975806|3925187|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4101326|NCT00975806|3925188|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4101327|NCT00975806|3925185|B4|>65 years||Age, Customized||participants|Number|1|1.0||||||
4101328|NCT00975806|3925186|B3|>65 years||Age, Customized||participants|Number|0|0.0||||||
4101329|NCT00975806|3925187|B2|>65 years||Age, Customized||participants|Number|0|0.0||||||
4101330|NCT00975806|3925188|B1|>65 years||Age, Customized||participants|Number|1|1.0||||||
4101331|NCT00975806|3925185|B4|≤65 years||Age, Customized||participants|Number|15|15.0||||||
4101332|NCT00975806|3925186|B3|≤65 years||Age, Customized||participants|Number|4|4.0||||||
4101333|NCT00975806|3925187|B2|≤65 years||Age, Customized||participants|Number|7|7.0||||||
4101334|NCT00975806|3925188|B1|≤65 years||Age, Customized||participants|Number|4|4.0||||||
4101335|NCT00975806|3925185|B4|||Age||years|Mean|56.5|56.5|Standard Deviation|10.56|10.56|||
4101336|NCT00975806|3925186|B3|||Age||years|Mean|57.3|57.3|Standard Deviation|5.62|5.62|||
4101337|NCT00975806|3925187|B2|||Age||years|Mean|57.1|57.1|Standard Deviation|4.88|4.88|||
4101338|NCT00975806|3925188|B1|||Age||years|Mean|55.0|55.0|Standard Deviation|18.84|18.84|||
4101339|NCT00975780|3925212|B3||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4101340|NCT00975780|3925213|B2||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4101341|NCT00975780|3925214|B1||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4101342|NCT00975780|3925212|B3||Female|Sex: Female, Male||Participants|Count of Participants|636|636.0||||||
4101343|NCT00975780|3925213|B2||Female|Sex: Female, Male||Participants|Count of Participants|307|307.0||||||
4101344|NCT00975780|3925214|B1||Female|Sex: Female, Male||Participants|Count of Participants|329|329.0||||||
4101345|NCT00975780|3925212|B3|||Age||years|Mean|86.3|86.3|Standard Deviation|8.1|8.1|||
4101346|NCT00975780|3925213|B2|||Age||years|Mean|86.1|86.1|Standard Deviation|8.3|8.3|||
4101347|NCT00975780|3925214|B1|||Age||years|Mean|86.5|86.5|Standard Deviation|8.0|8.0|||
4101348|NCT00975715|3925223|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4101349|NCT00975715|3925224|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4101350|NCT00975715|3925225|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4101351|NCT00975715|3925223|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4101352|NCT00975715|3925224|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4101353|NCT00975715|3925225|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4101354|NCT00975715|3925223|B3|||Age||years|Mean|9.5|9.5|Standard Deviation|2.87|2.87|||
4101355|NCT00975715|3925224|B2|||Age||years|Mean|9.2|9.2|Standard Deviation|2.83|2.83|||
4101356|NCT00975715|3925225|B1|||Age||years|Mean|9.8|9.8|Standard Deviation|2.91|2.91|||
4101357|NCT00975689|3925240|B3|Costa Rica||Region of Enrollment||participants|Number|1|1.0||||||
4101358|NCT00975689|3925241|B2|Costa Rica||Region of Enrollment||participants|Number|0|0.0||||||
4101359|NCT00975689|3925242|B1|Costa Rica||Region of Enrollment||participants|Number|1|1.0||||||
4101360|NCT00975689|3925240|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
4101361|NCT00975689|3925241|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4101362|NCT00975689|3925242|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4101363|NCT00975689|3925240|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4101368|NCT00975689|3925242|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4101369|NCT00975689|3925240|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4101370|NCT00975689|3925241|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4101371|NCT00975689|3925242|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4101372|NCT00975689|3925240|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4101373|NCT00975689|3925241|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4101374|NCT00975689|3925242|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4101375|NCT00975689|3925240|B3||<=18 years|Age||Participants|Count of Participants|25|25.0||||||
4101376|NCT00975689|3925241|B2||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4101377|NCT00975689|3925242|B1||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4101378|NCT00975650|3925249|B1|United States||Region of Enrollment||Participants|Count of Participants|57|57.0||||||
4101379|NCT00975650|3925249|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4101380|NCT00975650|3925249|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4101381|NCT00975650|3925249|B1||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4101382|NCT00975650|3925249|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4101383|NCT00975650|3925249|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4101384|NCT00975650|3925249|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4101385|NCT00975650|3925249|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4101386|NCT00975650|3925249|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4101387|NCT00975650|3925249|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4101388|NCT00975650|3925249|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4101389|NCT00975650|3925249|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4101390|NCT00975650|3925249|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4101391|NCT00975650|3925249|B1|||Age||years|Mean|52.0|52.0|Standard Deviation|12.0|12.0|||
4101392|NCT00975637|3925286|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4101393|NCT00975637|3925287|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4101394|NCT00975637|3925288|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4101395|NCT00975637|3925289|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4101396|NCT00975637|3925290|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4101397|NCT00975637|3925291|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4101398|NCT00975637|3925286|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|191|191.0||||||
4101399|NCT00975637|3925287|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4101400|NCT00975637|3925288|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4101401|NCT00975637|3925289|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4101402|NCT00975637|3925290|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4101403|NCT00975637|3925291|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4101404|NCT00975637|3925286|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4101405|NCT00975637|3925287|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4101406|NCT00975637|3925288|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4101407|NCT00975637|3925289|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4101408|NCT00975637|3925290|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4101409|NCT00975637|3925291|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4101410|NCT00975637|3925286|B6||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4101411|NCT00975637|3925287|B5||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4101412|NCT00975637|3925288|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4101413|NCT00975637|3925289|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4101414|NCT00975637|3925290|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4101415|NCT00975637|3925291|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4101416|NCT00975637|3925286|B6||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4101417|NCT00975637|3925287|B5||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4101418|NCT00975637|3925288|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4101419|NCT00975637|3925289|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4101420|NCT00975637|3925290|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4101421|NCT00975637|3925291|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4101422|NCT00975637|3925286|B6|||Age||years|Mean|42.6|42.6|Standard Deviation|11.7|11.7|||
4101423|NCT00975637|3925287|B5|||Age||years|Mean|42.1|42.1|Standard Deviation|11.1|11.1|||
4101424|NCT00975637|3925288|B4|||Age||years|Mean|41.8|41.8|Standard Deviation|14.4|14.4|||
4101425|NCT00975637|3925289|B3|||Age||years|Mean|42.3|42.3|Standard Deviation|12.2|12.2|||
4101426|NCT00975637|3925290|B2|||Age||years|Mean|44.0|44.0|Standard Deviation|11.7|11.7|||
4101427|NCT00975637|3925291|B1|||Age||years|Mean|42.1|42.1|Standard Deviation|12.2|12.2|||
4101428|NCT00975637|3925286|B6||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4101429|NCT00975637|3925287|B5||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4101430|NCT00975637|3925288|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4101431|NCT00975637|3925289|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4101432|NCT00975637|3925290|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4101433|NCT00975637|3925291|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4101434|NCT00975637|3925286|B6||Between 18 and 65 years|Age||Participants|Count of Participants|190|190.0||||||
4101435|NCT00975637|3925287|B5||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4101436|NCT00975637|3925288|B4||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4101437|NCT00975637|3925289|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4101438|NCT00975637|3925290|B2||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4101439|NCT00975637|3925291|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4101440|NCT00975637|3925286|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4101441|NCT00975637|3925287|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4101442|NCT00975637|3925288|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4101443|NCT00975637|3925289|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4101444|NCT00975637|3925290|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4101445|NCT00975637|3925291|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4101446|NCT00975611|3925312|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4101447|NCT00975611|3925312|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4101448|NCT00975611|3925312|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4101449|NCT00975611|3925312|B1|||Age||years|Mean|43.14|43.14|Standard Deviation|10.95|10.95|||
4101450|NCT00975611|3925312|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4101451|NCT00975611|3925312|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4101452|NCT00975611|3925312|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4101453|NCT00975585|3925316|B3|United States||Region of Enrollment||participants|Number|379|379.0||||||
4101454|NCT00975585|3925317|B2|United States||Region of Enrollment||participants|Number|195|195.0||||||
4101455|NCT00975585|3925318|B1|United States||Region of Enrollment||participants|Number|184|184.0||||||
4101456|NCT00975585|3925316|B3||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4101457|NCT00975585|3925317|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4101458|NCT00975585|3925318|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4101459|NCT00975585|3925316|B3||Female|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
4101460|NCT00975585|3925317|B2||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4101461|NCT00975585|3925318|B1||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4101462|NCT00975585|3925316|B3|||Age||years|Mean|29.5|29.5|Standard Deviation|6.9|6.9|||
4101463|NCT00975585|3925317|B2|||Age||years|Mean|29.3|29.3|Standard Deviation|6.9|6.9|||
4101464|NCT00975585|3925318|B1|||Age||years|Mean|29.7|29.7|Standard Deviation|7.0|7.0|||
4101465|NCT00975507|3925337|B3|Other||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4101466|NCT00975507|3925338|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4101467|NCT00975507|3925339|B1|Other||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4101468|NCT00975507|3925337|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4101469|NCT00975507|3925338|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4101470|NCT00975507|3925339|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4101471|NCT00975507|3925337|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|318|318.0||||||
4101472|NCT00975507|3925338|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|107|107.0||||||
4101473|NCT00975507|3925339|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|211|211.0||||||
4101474|NCT00975507|3925337|B3|Asian/Pacific||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4101475|NCT00975507|3925338|B2|Asian/Pacific||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4101476|NCT00975507|3925339|B1|Asian/Pacific||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4101477|NCT00975507|3925337|B3|African American||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
4101478|NCT00975507|3925338|B2|African American||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4101479|NCT00975507|3925339|B1|African American||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4101480|NCT00975507|3925337|B3||Male|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
4101481|NCT00975507|3925338|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4101482|NCT00975507|3925339|B1||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4101483|NCT00975507|3925337|B3||Female|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
4101484|NCT00975507|3925338|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4101485|NCT00975507|3925339|B1||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4101486|NCT00975507|3925337|B3|||Age||Months|Mean|14.1|14.1|Standard Deviation|1.8|1.8|||
4101487|NCT00975507|3925338|B2|||Age||Months|Mean|14.0|14.0|Standard Deviation|1.7|1.7|||
4101488|NCT00975507|3925339|B1|||Age||Months|Mean|14.1|14.1|Standard Deviation|1.9|1.9|||
4101489|NCT00975481|3925360|B1|||Body Mass Index||kilogram/square meter (kg/m^2)|Mean|24.6|24.6|Standard Deviation|3.4|3.4|||
4101490|NCT00975481|3925360|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4101491|NCT00975481|3925360|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4101492|NCT00975481|3925360|B1|||Age||Years|Mean|35.4|35.4|Standard Deviation|9.7|9.7|||
4101493|NCT00975416|3925463|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4101494|NCT00975416|3925464|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4101495|NCT00975416|3925465|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4101496|NCT00975416|3925463|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4101497|NCT00975416|3925464|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4101498|NCT00975416|3925465|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4101499|NCT00975416|3925463|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4101500|NCT00975416|3925464|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4101501|NCT00975416|3925465|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4101502|NCT00975416|3925463|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4101503|NCT00975416|3925464|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4101504|NCT00975416|3925465|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4101505|NCT00975416|3925463|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4101506|NCT00975416|3925464|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4101507|NCT00975416|3925465|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4101508|NCT00975416|3925463|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4101509|NCT00975416|3925464|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4101510|NCT00975416|3925465|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4101511|NCT00975416|3925463|B3|||Age||years|Mean|40.9|40.9|Standard Deviation|9.9|9.9|||
4101512|NCT00975416|3925464|B2|||Age||years|Mean|40.8|40.8|Standard Deviation|10.0|10.0|||
4101513|NCT00975416|3925465|B1|||Age||years|Mean|41.1|41.1|Standard Deviation|10.2|10.2|||
4101514|NCT00975286|3925473|B3|Greater than or equal to 30||Number of Patients With Categorical BMI||participants|Number|240|240.0||||||
4101515|NCT00975286|3925474|B2|Greater than or equal to 30||Number of Patients With Categorical BMI||participants|Number|120|120.0||||||
4101516|NCT00975286|3925475|B1|Greater than or equal to 30||Number of Patients With Categorical BMI||participants|Number|120|120.0||||||
4101517|NCT00975286|3925473|B3|Less than 30||Number of Patients With Categorical BMI||participants|Number|206|206.0||||||
4101518|NCT00975286|3925474|B2|Less than 30||Number of Patients With Categorical BMI||participants|Number|103|103.0||||||
4101519|NCT00975286|3925475|B1|Less than 30||Number of Patients With Categorical BMI||participants|Number|103|103.0||||||
4101520|NCT00975286|3925473|B3|||Body Mass Index (BMI)|BMI was calculated by dividing body weight by the height squared.|kilogram per square meter (kg/m^2)|Mean|31.82|31.82|Standard Deviation|6.32|6.32|||
4101521|NCT00975286|3925474|B2|||Body Mass Index (BMI)|BMI was calculated by dividing body weight by the height squared.|kilogram per square meter (kg/m^2)|Mean|31.99|31.99|Standard Deviation|6.63|6.63|||
4101522|NCT00975286|3925475|B1|||Body Mass Index (BMI)|BMI was calculated by dividing body weight by the height squared.|kilogram per square meter (kg/m^2)|Mean|31.65|31.65|Standard Deviation|6.01|6.01|||
4101523|NCT00975286|3925473|B3|No||Number of Patients With Thiazolidinedione (TZD) use at Baseline||participants|Number|392|392.0||||||
4101524|NCT00975286|3925474|B2|No||Number of Patients With Thiazolidinedione (TZD) use at Baseline||participants|Number|196|196.0||||||
4101525|NCT00975286|3925475|B1|No||Number of Patients With Thiazolidinedione (TZD) use at Baseline||participants|Number|196|196.0||||||
4101526|NCT00975286|3925473|B3|Yes||Number of Patients With Thiazolidinedione (TZD) use at Baseline||participants|Number|54|54.0||||||
4101527|NCT00975286|3925474|B2|Yes||Number of Patients With Thiazolidinedione (TZD) use at Baseline||participants|Number|27|27.0||||||
4101528|NCT00975286|3925475|B1|Yes||Number of Patients With Thiazolidinedione (TZD) use at Baseline||participants|Number|27|27.0||||||
4101529|NCT00975286|3925473|B3|||Metformin Daily Dose||milligram (mg) per day|Mean|2048.7|2048.7|Standard Deviation|417.8|417.8|||
4101530|NCT00975286|3925474|B2|||Metformin Daily Dose||milligram (mg) per day|Mean|2039.2|2039.2|Standard Deviation|405.3|405.3|||
4101531|NCT00975286|3925475|B1|||Metformin Daily Dose||milligram (mg) per day|Mean|2058.1|2058.1|Standard Deviation|430.6|430.6|||
4101532|NCT00975286|3925473|B3|||Duration of Diabetes|Duration of diabetes at screening is reported.|years|Mean|9.17|9.17|Standard Deviation|5.94|5.94|||
4101533|NCT00975286|3925474|B2|||Duration of Diabetes|Duration of diabetes at screening is reported.|years|Mean|9.62|9.62|Standard Deviation|6.03|6.03|||
4101534|NCT00975286|3925475|B1|||Duration of Diabetes|Duration of diabetes at screening is reported.|years|Mean|8.72|8.72|Standard Deviation|5.82|5.82|||
4101535|NCT00975286|3925473|B3|||Treatment Satisfaction Score (Diabetes Treatment Satisfaction Questionnaire [DTSQ])|DTSQ: 8-item questionnaire to assess treatment satisfaction and patient perception of hyper and hypoglycemia. Each question (Q) scored on a Likert scale from 0 (worst case) to 6 (best case) except Q2 and 3 where 0 (best case) to 6 (worst case). Six items (Q1 and 4-8) measured treatment satisfaction and were summed to calculate treatment satisfaction score which ranged from 0 (very dissatisfied) to 36 (very satisfied). Two items (Q2 and 3), which were not included, measured perceived hyperglycemia and hypoglycemia, respectively and lower score represented good perceived blood glucose control.|units on a scale|Mean|31.6|31.6|Standard Deviation|4.8|4.8|||
4101562|NCT00975286|3925473|B3|Ethnicity: Hispanic||Race/Ethnicity, Customized||participants|Number|101|101.0||||||
4101536|NCT00975286|3925474|B2|||Treatment Satisfaction Score (Diabetes Treatment Satisfaction Questionnaire [DTSQ])|DTSQ: 8-item questionnaire to assess treatment satisfaction and patient perception of hyper and hypoglycemia. Each question (Q) scored on a Likert scale from 0 (worst case) to 6 (best case) except Q2 and 3 where 0 (best case) to 6 (worst case). Six items (Q1 and 4-8) measured treatment satisfaction and were summed to calculate treatment satisfaction score which ranged from 0 (very dissatisfied) to 36 (very satisfied). Two items (Q2 and 3), which were not included, measured perceived hyperglycemia and hypoglycemia, respectively and lower score represented good perceived blood glucose control.|units on a scale|Mean|31.7|31.7|Standard Deviation|4.5|4.5|||
4101537|NCT00975286|3925475|B1|||Treatment Satisfaction Score (Diabetes Treatment Satisfaction Questionnaire [DTSQ])|DTSQ: 8-item questionnaire to assess treatment satisfaction and patient perception of hyper and hypoglycemia. Each question (Q) scored on a Likert scale from 0 (worst case) to 6 (best case) except Q2 and 3 where 0 (best case) to 6 (worst case). Six items (Q1 and 4-8) measured treatment satisfaction and were summed to calculate treatment satisfaction score which ranged from 0 (very dissatisfied) to 36 (very satisfied). Two items (Q2 and 3), which were not included, measured perceived hyperglycemia and hypoglycemia, respectively and lower score represented good perceived blood glucose control.|units on a scale|Mean|31.5|31.5|Standard Deviation|5.1|5.1|||
4101538|NCT00975286|3925473|B3|||Average Insulin Glargine Daily Dose|Insulin glargine average daily dose at Baseline is the average daily dose for the week prior to Visit 12 (Week -1).|units per day|Mean|43.84|43.84|Standard Deviation|19.34|19.34|||
4101539|NCT00975286|3925474|B2|||Average Insulin Glargine Daily Dose|Insulin glargine average daily dose at Baseline is the average daily dose for the week prior to Visit 12 (Week -1).|units per day|Mean|43.44|43.44|Standard Deviation|18.84|18.84|||
4101540|NCT00975286|3925475|B1|||Average Insulin Glargine Daily Dose|Insulin glargine average daily dose at Baseline is the average daily dose for the week prior to Visit 12 (Week -1).|units per day|Mean|44.24|44.24|Standard Deviation|19.86|19.86|||
4101541|NCT00975286|3925473|B3|||Body Weight||kilogram (kg)|Mean|87.03|87.03|Standard Deviation|21.07|21.07|||
4101542|NCT00975286|3925474|B2|||Body Weight||kilogram (kg)|Mean|87.31|87.31|Standard Deviation|21.76|21.76|||
4101543|NCT00975286|3925475|B1|||Body Weight||kilogram (kg)|Mean|86.75|86.75|Standard Deviation|20.41|20.41|||
4101544|NCT00975286|3925473|B3|||Average 7-Point Self Monitored Plasma Glucose (SMPG)|Patients recorded a 7-point plasma glucose profile before and 2 hours after each meal and at bedtime once in a week and the average value for the 7-time points was calculated. Number of patients evaluable for this Baseline characteristic were 221 and 221 for Placebo and Lixisenatide arm, respectively.|mmol/L|Mean|8.23|8.23|Standard Deviation|1.49|1.49|||
4101545|NCT00975286|3925474|B2|||Average 7-Point Self Monitored Plasma Glucose (SMPG)|Patients recorded a 7-point plasma glucose profile before and 2 hours after each meal and at bedtime once in a week and the average value for the 7-time points was calculated. Number of patients evaluable for this Baseline characteristic were 221 and 221 for Placebo and Lixisenatide arm, respectively.|mmol/L|Mean|8.20|8.2|Standard Deviation|1.47|1.47|||
4101546|NCT00975286|3925475|B1|||Average 7-Point Self Monitored Plasma Glucose (SMPG)|Patients recorded a 7-point plasma glucose profile before and 2 hours after each meal and at bedtime once in a week and the average value for the 7-time points was calculated. Number of patients evaluable for this Baseline characteristic were 221 and 221 for Placebo and Lixisenatide arm, respectively.|mmol/L|Mean|8.26|8.26|Standard Deviation|1.52|1.52|||
4101547|NCT00975286|3925473|B3|||Glucose Excursion|Glucose excursion = 2-hour PPG minus plasma glucose 30 minutes prior to the meal test, before study drug administration. Number of patients evaluable for this Baseline characteristic were 221 and 219 for Placebo and Lixisenatide arm, respectively.|mmol/L|Mean|6.29|6.29|Standard Deviation|3.96|3.96|||
4101548|NCT00975286|3925474|B2|||Glucose Excursion|Glucose excursion = 2-hour PPG minus plasma glucose 30 minutes prior to the meal test, before study drug administration. Number of patients evaluable for this Baseline characteristic were 221 and 219 for Placebo and Lixisenatide arm, respectively.|mmol/L|Mean|6.24|6.24|Standard Deviation|4.35|4.35|||
4101549|NCT00975286|3925475|B1|||Glucose Excursion|Glucose excursion = 2-hour PPG minus plasma glucose 30 minutes prior to the meal test, before study drug administration. Number of patients evaluable for this Baseline characteristic were 221 and 219 for Placebo and Lixisenatide arm, respectively.|mmol/L|Mean|6.33|6.33|Standard Deviation|3.54|3.54|||
4101550|NCT00975286|3925473|B3|||2-Hour Postprandial Plasma Glucose (PPG)|The 2-hour PPG test measured blood glucose 2 hours after eating a standardized meal. Number of patients evaluable for this Baseline characteristic were 221 and 219 for Placebo and Lixisenatide arm, respectively.|mmol/L|Mean|12.85|12.85|Standard Deviation|3.81|3.81|||
4101551|NCT00975286|3925474|B2|||2-Hour Postprandial Plasma Glucose (PPG)|The 2-hour PPG test measured blood glucose 2 hours after eating a standardized meal. Number of patients evaluable for this Baseline characteristic were 221 and 219 for Placebo and Lixisenatide arm, respectively.|mmol/L|Mean|12.90|12.9|Standard Deviation|3.94|3.94|||
4101552|NCT00975286|3925475|B1|||2-Hour Postprandial Plasma Glucose (PPG)|The 2-hour PPG test measured blood glucose 2 hours after eating a standardized meal. Number of patients evaluable for this Baseline characteristic were 221 and 219 for Placebo and Lixisenatide arm, respectively.|mmol/L|Mean|12.79|12.79|Standard Deviation|3.69|3.69|||
4101553|NCT00975286|3925473|B3|||Fasting Plasma Glucose (FPG)||millimole per liter (mmol/L)|Mean|6.62|6.62|Standard Deviation|1.85|1.85|||
4101554|NCT00975286|3925474|B2|||Fasting Plasma Glucose (FPG)||millimole per liter (mmol/L)|Mean|6.55|6.55|Standard Deviation|1.72|1.72|||
4101555|NCT00975286|3925475|B1|||Fasting Plasma Glucose (FPG)||millimole per liter (mmol/L)|Mean|6.70|6.7|Standard Deviation|1.97|1.97|||
4101556|NCT00975286|3925473|B3|||Glycosylated Hemoglobin (HbA1c)||percentage of hemoglobin|Mean|7.58|7.58|Standard Deviation|0.54|0.54|||
4101557|NCT00975286|3925474|B2|||Glycosylated Hemoglobin (HbA1c)||percentage of hemoglobin|Mean|7.56|7.56|Standard Deviation|0.55|0.55|||
4101558|NCT00975286|3925475|B1|||Glycosylated Hemoglobin (HbA1c)||percentage of hemoglobin|Mean|7.60|7.6|Standard Deviation|0.54|0.54|||
4101559|NCT00975286|3925473|B3|Ethnicity: Non Hispanic||Race/Ethnicity, Customized||participants|Number|345|345.0||||||
4101560|NCT00975286|3925474|B2|Ethnicity: Non Hispanic||Race/Ethnicity, Customized||participants|Number|171|171.0||||||
4101561|NCT00975286|3925475|B1|Ethnicity: Non Hispanic||Race/Ethnicity, Customized||participants|Number|174|174.0||||||
4101563|NCT00975286|3925474|B2|Ethnicity: Hispanic||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
4101564|NCT00975286|3925475|B1|Ethnicity: Hispanic||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4101565|NCT00975286|3925473|B3|Race: Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4101566|NCT00975286|3925474|B2|Race: Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4101567|NCT00975286|3925475|B1|Race: Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4101568|NCT00975286|3925473|B3|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|87|87.0||||||
4101569|NCT00975286|3925474|B2|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4101570|NCT00975286|3925475|B1|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4101571|NCT00975286|3925473|B3|Race: Black||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4101572|NCT00975286|3925474|B2|Race: Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4101573|NCT00975286|3925475|B1|Race: Black||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4101574|NCT00975286|3925473|B3|Race: Caucasian/White||Race/Ethnicity, Customized||participants|Number|332|332.0||||||
4101575|NCT00975286|3925474|B2|Race: Caucasian/White||Race/Ethnicity, Customized||participants|Number|165|165.0||||||
4101576|NCT00975286|3925475|B1|Race: Caucasian/White||Race/Ethnicity, Customized||participants|Number|167|167.0||||||
4101577|NCT00975286|3925473|B3||Male|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4101578|NCT00975286|3925474|B2||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4101579|NCT00975286|3925475|B1||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4101580|NCT00975286|3925473|B3||Female|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
4101581|NCT00975286|3925474|B2||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4101582|NCT00975286|3925475|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4101583|NCT00975286|3925473|B3|||Age|Age at screening is reported.|years|Mean|56.2|56.2|Standard Deviation|9.9|9.9|||
4101584|NCT00975286|3925474|B2|||Age|Age at screening is reported.|years|Mean|56.4|56.4|Standard Deviation|9.7|9.7|||
4101585|NCT00975286|3925475|B1|||Age|Age at screening is reported.|years|Mean|56.1|56.1|Standard Deviation|10.2|10.2|||
4101586|NCT00975221|3925506|B3|No||Bisphosphonate Use||participants|Number|48|48.0||||||
4101587|NCT00975221|3925507|B2|No||Bisphosphonate Use||participants|Number|24|24.0||||||
4101588|NCT00975221|3925508|B1|No||Bisphosphonate Use||participants|Number|24|24.0||||||
4101589|NCT00975221|3925506|B3|Yes||Bisphosphonate Use||participants|Number|19|19.0||||||
4101590|NCT00975221|3925507|B2|Yes||Bisphosphonate Use||participants|Number|9|9.0||||||
4101591|NCT00975221|3925508|B1|Yes||Bisphosphonate Use||participants|Number|10|10.0||||||
4101592|NCT00975221|3925506|B3|||Intact Parathyroid Hormone (iPTH)||pg/mL|Mean|209.7|209.7|Standard Deviation|168.4|168.4|||
4101593|NCT00975221|3925507|B2|||Intact Parathyroid Hormone (iPTH)||pg/mL|Mean|179.0|179.0|Standard Deviation|98.0|98.0|||
4101594|NCT00975221|3925508|B1|||Intact Parathyroid Hormone (iPTH)||pg/mL|Mean|238.6|238.6|Standard Deviation|212.2|212.2|||
4101595|NCT00975221|3925506|B3|||Albumin-corrected Calcium||mg/dL|Mean|11.77|11.77|Standard Deviation|0.46|0.46|||
4101596|NCT00975221|3925507|B2|||Albumin-corrected Calcium||mg/dL|Mean|11.73|11.73|Standard Deviation|0.45|0.45|||
4101597|NCT00975221|3925508|B1|||Albumin-corrected Calcium||mg/dL|Mean|11.80|11.8|Standard Deviation|0.48|0.48|||
4101598|NCT00975221|3925506|B3|White or Caucasian||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
4101599|NCT00975221|3925507|B2|White or Caucasian||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4101600|NCT00975221|3925508|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4101601|NCT00975221|3925506|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4101602|NCT00975221|3925507|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4101603|NCT00975221|3925508|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4101604|NCT00975221|3925506|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4101605|NCT00975221|3925507|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4101606|NCT00975221|3925508|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4101607|NCT00975221|3925506|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4101608|NCT00975221|3925507|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4101609|NCT00975221|3925508|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4101610|NCT00975221|3925506|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4101611|NCT00975221|3925507|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4101612|NCT00975221|3925508|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4101613|NCT00975221|3925506|B3|||Age||years|Mean|72.3|72.3|Standard Deviation|11.4|11.4|||
4101614|NCT00975221|3925507|B2|||Age||years|Mean|69.5|69.5|Standard Deviation|13.0|13.0|||
4101615|NCT00975221|3925508|B1|||Age||years|Mean|75.0|75.0|Standard Deviation|8.9|8.9|||
4101616|NCT00975195|3925523|B3||Male|Sex: Female, Male||Participants|Count of Participants|2049|2049.0||||||
4101617|NCT00975195|3925524|B2||Male|Sex: Female, Male||Participants|Count of Participants|1036|1036.0||||||
4101618|NCT00975195|3925525|B1||Male|Sex: Female, Male||Participants|Count of Participants|1013|1013.0||||||
4101619|NCT00975195|3925523|B3||Female|Sex: Female, Male||Participants|Count of Participants|436|436.0||||||
4101620|NCT00975195|3925524|B2||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
4101621|NCT00975195|3925525|B1||Female|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4101622|NCT00975195|3925523|B3|||Age||years|Mean|63.8|63.8|Standard Deviation|8.5|8.5|||
4101623|NCT00975195|3925524|B2|||Age||years|Mean|64.0|64.0|Standard Deviation|8.4|8.4|||
4101624|NCT00975195|3925525|B1|||Age||years|Mean|63.6|63.6|Standard Deviation|8.6|8.6|||
4101625|NCT00975156|3925584|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4101626|NCT00975156|3925585|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4101627|NCT00975156|3925586|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4101628|NCT00975156|3925584|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4101629|NCT00975156|3925585|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4101630|NCT00975156|3925586|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4101631|NCT00975156|3925584|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4101632|NCT00975156|3925585|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4101633|NCT00975156|3925586|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4101634|NCT00975156|3925584|B3|||Age||years|Mean|65.75|65.75|Standard Deviation|9.48|9.48|||
4101635|NCT00975156|3925585|B2|||Age||years|Mean|64.33|64.33|Standard Deviation|10.91|10.91|||
4101636|NCT00975156|3925586|B1|||Age||years|Mean|66.91|66.91|Standard Deviation|8.50|8.5|||
4101637|NCT00975156|3925584|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4101638|NCT00975156|3925585|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4101639|NCT00975156|3925586|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4101640|NCT00975156|3925584|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4101641|NCT00975156|3925585|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4101642|NCT00975156|3925586|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4101643|NCT00975156|3925584|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4101644|NCT00975156|3925585|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4101645|NCT00975156|3925586|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4101646|NCT00975143|3925597|B3|Not assessed||Physician's Global Severity Assessment (PGSA)|Acne severity status was graded by the investigator on a 6-point scale, from 0 = Clear (No nodules, pustules or papules visible) to 5 = Very Severe (Highly inflammatory acne covering the affected area, with many nodules and cysts present ). The PGSA was applied to facial lesions only (ie, not conducted on patients with only truncal lesions).|participants|Number|12|12.0||||||
4101647|NCT00975143|3925598|B2|Not assessed||Physician's Global Severity Assessment (PGSA)|Acne severity status was graded by the investigator on a 6-point scale, from 0 = Clear (No nodules, pustules or papules visible) to 5 = Very Severe (Highly inflammatory acne covering the affected area, with many nodules and cysts present ). The PGSA was applied to facial lesions only (ie, not conducted on patients with only truncal lesions).|participants|Number|4|4.0||||||
4101648|NCT00975143|3925599|B1|Not assessed||Physician's Global Severity Assessment (PGSA)|Acne severity status was graded by the investigator on a 6-point scale, from 0 = Clear (No nodules, pustules or papules visible) to 5 = Very Severe (Highly inflammatory acne covering the affected area, with many nodules and cysts present ). The PGSA was applied to facial lesions only (ie, not conducted on patients with only truncal lesions).|participants|Number|8|8.0||||||
4101649|NCT00975143|3925597|B3|5 (Very Severe)||Physician's Global Severity Assessment (PGSA)|Acne severity status was graded by the investigator on a 6-point scale, from 0 = Clear (No nodules, pustules or papules visible) to 5 = Very Severe (Highly inflammatory acne covering the affected area, with many nodules and cysts present ). The PGSA was applied to facial lesions only (ie, not conducted on patients with only truncal lesions).|participants|Number|127|127.0||||||
4101650|NCT00975143|3925598|B2|5 (Very Severe)||Physician's Global Severity Assessment (PGSA)|Acne severity status was graded by the investigator on a 6-point scale, from 0 = Clear (No nodules, pustules or papules visible) to 5 = Very Severe (Highly inflammatory acne covering the affected area, with many nodules and cysts present ). The PGSA was applied to facial lesions only (ie, not conducted on patients with only truncal lesions).|participants|Number|63|63.0||||||
4101651|NCT00975143|3925599|B1|5 (Very Severe)||Physician's Global Severity Assessment (PGSA)|Acne severity status was graded by the investigator on a 6-point scale, from 0 = Clear (No nodules, pustules or papules visible) to 5 = Very Severe (Highly inflammatory acne covering the affected area, with many nodules and cysts present ). The PGSA was applied to facial lesions only (ie, not conducted on patients with only truncal lesions).|participants|Number|64|64.0||||||
4101652|NCT00975143|3925597|B3|4 (Severe)||Physician's Global Severity Assessment (PGSA)|Acne severity status was graded by the investigator on a 6-point scale, from 0 = Clear (No nodules, pustules or papules visible) to 5 = Very Severe (Highly inflammatory acne covering the affected area, with many nodules and cysts present ). The PGSA was applied to facial lesions only (ie, not conducted on patients with only truncal lesions).|participants|Number|651|651.0||||||
4101653|NCT00975143|3925598|B2|4 (Severe)||Physician's Global Severity Assessment (PGSA)|Acne severity status was graded by the investigator on a 6-point scale, from 0 = Clear (No nodules, pustules or papules visible) to 5 = Very Severe (Highly inflammatory acne covering the affected area, with many nodules and cysts present ). The PGSA was applied to facial lesions only (ie, not conducted on patients with only truncal lesions).|participants|Number|322|322.0||||||
4101654|NCT00975143|3925599|B1|4 (Severe)||Physician's Global Severity Assessment (PGSA)|Acne severity status was graded by the investigator on a 6-point scale, from 0 = Clear (No nodules, pustules or papules visible) to 5 = Very Severe (Highly inflammatory acne covering the affected area, with many nodules and cysts present ). The PGSA was applied to facial lesions only (ie, not conducted on patients with only truncal lesions).|participants|Number|329|329.0||||||
4101655|NCT00975143|3925597|B3|3 (Moderate)||Physician's Global Severity Assessment (PGSA)|Acne severity status was graded by the investigator on a 6-point scale, from 0 = Clear (No nodules, pustules or papules visible) to 5 = Very Severe (Highly inflammatory acne covering the affected area, with many nodules and cysts present ). The PGSA was applied to facial lesions only (ie, not conducted on patients with only truncal lesions).|participants|Number|109|109.0||||||
4101733|NCT00975000|3925794|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4101656|NCT00975143|3925598|B2|3 (Moderate)||Physician's Global Severity Assessment (PGSA)|Acne severity status was graded by the investigator on a 6-point scale, from 0 = Clear (No nodules, pustules or papules visible) to 5 = Very Severe (Highly inflammatory acne covering the affected area, with many nodules and cysts present ). The PGSA was applied to facial lesions only (ie, not conducted on patients with only truncal lesions).|participants|Number|60|60.0||||||
4101657|NCT00975143|3925599|B1|3 (Moderate)||Physician's Global Severity Assessment (PGSA)|Acne severity status was graded by the investigator on a 6-point scale, from 0 = Clear (No nodules, pustules or papules visible) to 5 = Very Severe (Highly inflammatory acne covering the affected area, with many nodules and cysts present ). The PGSA was applied to facial lesions only (ie, not conducted on patients with only truncal lesions).|participants|Number|49|49.0||||||
4101658|NCT00975143|3925597|B3|2 (Mild)||Physician's Global Severity Assessment (PGSA)|Acne severity status was graded by the investigator on a 6-point scale, from 0 = Clear (No nodules, pustules or papules visible) to 5 = Very Severe (Highly inflammatory acne covering the affected area, with many nodules and cysts present ). The PGSA was applied to facial lesions only (ie, not conducted on patients with only truncal lesions).|participants|Number|21|21.0||||||
4101659|NCT00975143|3925598|B2|2 (Mild)||Physician's Global Severity Assessment (PGSA)|Acne severity status was graded by the investigator on a 6-point scale, from 0 = Clear (No nodules, pustules or papules visible) to 5 = Very Severe (Highly inflammatory acne covering the affected area, with many nodules and cysts present ). The PGSA was applied to facial lesions only (ie, not conducted on patients with only truncal lesions).|participants|Number|10|10.0||||||
4101660|NCT00975143|3925599|B1|2 (Mild)||Physician's Global Severity Assessment (PGSA)|Acne severity status was graded by the investigator on a 6-point scale, from 0 = Clear (No nodules, pustules or papules visible) to 5 = Very Severe (Highly inflammatory acne covering the affected area, with many nodules and cysts present ). The PGSA was applied to facial lesions only (ie, not conducted on patients with only truncal lesions).|participants|Number|11|11.0||||||
4101661|NCT00975143|3925597|B3|1 (Almost clear)||Physician's Global Severity Assessment (PGSA)|Acne severity status was graded by the investigator on a 6-point scale, from 0 = Clear (No nodules, pustules or papules visible) to 5 = Very Severe (Highly inflammatory acne covering the affected area, with many nodules and cysts present ). The PGSA was applied to facial lesions only (ie, not conducted on patients with only truncal lesions).|participants|Number|5|5.0||||||
4101662|NCT00975143|3925598|B2|1 (Almost clear)||Physician's Global Severity Assessment (PGSA)|Acne severity status was graded by the investigator on a 6-point scale, from 0 = Clear (No nodules, pustules or papules visible) to 5 = Very Severe (Highly inflammatory acne covering the affected area, with many nodules and cysts present ). The PGSA was applied to facial lesions only (ie, not conducted on patients with only truncal lesions).|participants|Number|2|2.0||||||
4101663|NCT00975143|3925599|B1|1 (Almost clear)||Physician's Global Severity Assessment (PGSA)|Acne severity status was graded by the investigator on a 6-point scale, from 0 = Clear (No nodules, pustules or papules visible) to 5 = Very Severe (Highly inflammatory acne covering the affected area, with many nodules and cysts present ). The PGSA was applied to facial lesions only (ie, not conducted on patients with only truncal lesions).|participants|Number|3|3.0||||||
4101664|NCT00975143|3925597|B3|||Inflammatory Lesion Count|Qualified medical practitioners, blinded to treatment group assignment made counts of inflammatory lesions (papules and pustules) in the facial and truncal area. Where possible, the same individual performed all evaluations for a patient.|Lesions|Mean|38.1|38.1|Standard Deviation|33.0|33.0|||
4101665|NCT00975143|3925598|B2|||Inflammatory Lesion Count|Qualified medical practitioners, blinded to treatment group assignment made counts of inflammatory lesions (papules and pustules) in the facial and truncal area. Where possible, the same individual performed all evaluations for a patient.|Lesions|Mean|38.4|38.4|Standard Deviation|34.5|34.5|||
4101666|NCT00975143|3925599|B1|||Inflammatory Lesion Count|Qualified medical practitioners, blinded to treatment group assignment made counts of inflammatory lesions (papules and pustules) in the facial and truncal area. Where possible, the same individual performed all evaluations for a patient.|Lesions|Mean|37.8|37.8|Standard Deviation|31.3|31.3|||
4101667|NCT00975143|3925597|B3|||Nodular Lesion Count|Qualified medical practitioners, blinded to treatment group assignment made counts of nodules in the facial and truncal area. Where possible, the same individual performed all evaluations for a patient.|Lesions|Mean|18.0|18.0|Standard Deviation|12.9|12.9|||
4101668|NCT00975143|3925598|B2|||Nodular Lesion Count|Qualified medical practitioners, blinded to treatment group assignment made counts of nodules in the facial and truncal area. Where possible, the same individual performed all evaluations for a patient.|Lesions|Mean|17.7|17.7|Standard Deviation|10.8|10.8|||
4101669|NCT00975143|3925599|B1|||Nodular Lesion Count|Qualified medical practitioners, blinded to treatment group assignment made counts of nodules in the facial and truncal area. Where possible, the same individual performed all evaluations for a patient.|Lesions|Mean|18.4|18.4|Standard Deviation|14.7|14.7|||
4101670|NCT00975143|3925597|B3|Canada||Region of Enrollment||participants|Number|172|172.0||||||
4101671|NCT00975143|3925598|B2|Canada||Region of Enrollment||participants|Number|88|88.0||||||
4101672|NCT00975143|3925599|B1|Canada||Region of Enrollment||participants|Number|84|84.0||||||
4101673|NCT00975143|3925597|B3|United States||Region of Enrollment||participants|Number|753|753.0||||||
4101674|NCT00975143|3925598|B2|United States||Region of Enrollment||participants|Number|373|373.0||||||
4101675|NCT00975143|3925599|B1|United States||Region of Enrollment||participants|Number|380|380.0||||||
4101676|NCT00975143|3925597|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)|Ethnicity was designated as Hispanic or Non-Hispanic.|Participants|Count of Participants|0|0.0||||||
4101677|NCT00975143|3925598|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)|Ethnicity was designated as Hispanic or Non-Hispanic.|Participants|Count of Participants|0|0.0||||||
4101678|NCT00975143|3925599|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|Ethnicity was designated as Hispanic or Non-Hispanic.|Participants|Count of Participants|0|0.0||||||
4101679|NCT00975143|3925597|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity was designated as Hispanic or Non-Hispanic.|Participants|Count of Participants|803|803.0||||||
4101680|NCT00975143|3925598|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity was designated as Hispanic or Non-Hispanic.|Participants|Count of Participants|398|398.0||||||
4101734|NCT00975000|3925795|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4101681|NCT00975143|3925599|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity was designated as Hispanic or Non-Hispanic.|Participants|Count of Participants|405|405.0||||||
4101682|NCT00975143|3925597|B3||Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity was designated as Hispanic or Non-Hispanic.|Participants|Count of Participants|122|122.0||||||
4101683|NCT00975143|3925598|B2||Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity was designated as Hispanic or Non-Hispanic.|Participants|Count of Participants|63|63.0||||||
4101684|NCT00975143|3925599|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity was designated as Hispanic or Non-Hispanic.|Participants|Count of Participants|59|59.0||||||
4101685|NCT00975143|3925597|B3||Male|Sex: Female, Male||Participants|Count of Participants|560|560.0||||||
4101686|NCT00975143|3925598|B2||Male|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
4101687|NCT00975143|3925599|B1||Male|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
4101688|NCT00975143|3925597|B3||Female|Sex: Female, Male||Participants|Count of Participants|365|365.0||||||
4101689|NCT00975143|3925598|B2||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4101690|NCT00975143|3925599|B1||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4101691|NCT00975143|3925597|B3|||Age||years|Mean|20.8|20.8|Standard Deviation|7.2|7.2|||
4101692|NCT00975143|3925598|B2|||Age||years|Mean|20.7|20.7|Standard Deviation|6.8|6.8|||
4101693|NCT00975143|3925599|B1|||Age||years|Mean|20.8|20.8|Standard Deviation|7.5|7.5|||
4101694|NCT00975143|3925597|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4101695|NCT00975143|3925598|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4101696|NCT00975143|3925599|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4101697|NCT00975143|3925597|B3||Between 18 and 65 years|Age||Participants|Count of Participants|528|528.0||||||
4101698|NCT00975143|3925598|B2||Between 18 and 65 years|Age||Participants|Count of Participants|269|269.0||||||
4101699|NCT00975143|3925599|B1||Between 18 and 65 years|Age||Participants|Count of Participants|259|259.0||||||
4101700|NCT00975143|3925597|B3||<=18 years|Age||Participants|Count of Participants|397|397.0||||||
4101701|NCT00975143|3925598|B2||<=18 years|Age||Participants|Count of Participants|192|192.0||||||
4101702|NCT00975143|3925599|B1||<=18 years|Age||Participants|Count of Participants|205|205.0||||||
4101703|NCT00975130|3925610|B1||Male|Sex: Female, Male||Participants|Count of Participants|564|564.0||||||
4101704|NCT00975130|3925610|B1||Female|Sex: Female, Male||Participants|Count of Participants|2716|2716.0||||||
4101705|NCT00975130|3925610|B1|||Age||Years|Median|53|53.0|Full Range|||18.0|88.0|
4101706|NCT00975000|3925794|B3|||Estimated Glomerular Filtration Rate (eGFR)|eGFR was calculated using the Modification of Diet in Renal Disease (MDRD) formula.|mL/min/1.73 m²|Mean|55.84|55.84|Standard Deviation|16.07|16.07|||
4101707|NCT00975000|3925795|B2|||Estimated Glomerular Filtration Rate (eGFR)|eGFR was calculated using the Modification of Diet in Renal Disease (MDRD) formula.|mL/min/1.73 m²|Mean|57.00|57.0|Standard Deviation|17.31|17.31|||
4101708|NCT00975000|3925796|B1|||Estimated Glomerular Filtration Rate (eGFR)|eGFR was calculated using the Modification of Diet in Renal Disease (MDRD) formula.|mL/min/1.73 m²|Mean|54.68|54.68|Standard Deviation|14.79|14.79|||
4101709|NCT00975000|3925794|B3|||Serum Phosphorus|Data available for 56 participants in each treatment group.|mg/dL|Mean|2.57|2.57|Standard Deviation|0.54|0.54|||
4101710|NCT00975000|3925795|B2|||Serum Phosphorus|Data available for 56 participants in each treatment group.|mg/dL|Mean|2.66|2.66|Standard Deviation|0.54|0.54|||
4101711|NCT00975000|3925796|B1|||Serum Phosphorus|Data available for 56 participants in each treatment group.|mg/dL|Mean|2.48|2.48|Standard Deviation|0.52|0.52|||
4101712|NCT00975000|3925794|B3|||Intact Parathyroid Hormone||pg/mL|Mean|317.6|317.6|Standard Deviation|224.5|224.5|||
4101713|NCT00975000|3925795|B2|||Intact Parathyroid Hormone||pg/mL|Mean|327.7|327.7|Standard Deviation|262.6|262.6|||
4101714|NCT00975000|3925796|B1|||Intact Parathyroid Hormone||pg/mL|Mean|307.5|307.5|Standard Deviation|180.5|180.5|||
4101715|NCT00975000|3925794|B3|||Corrected Total Serum Calcium||mg/dL|Mean|11.29|11.29|Standard Deviation|0.45|0.45|||
4101716|NCT00975000|3925795|B2|||Corrected Total Serum Calcium||mg/dL|Mean|11.28|11.28|Standard Deviation|0.41|0.41|||
4101717|NCT00975000|3925796|B1|||Corrected Total Serum Calcium||mg/dL|Mean|11.31|11.31|Standard Deviation|0.50|0.5|||
4101718|NCT00975000|3925794|B3|Corrected calcium > 11.2 mg/dL||Stratification Factor: Albumin-corrected Calcium Level||participants|Number|69|69.0||||||
4101719|NCT00975000|3925795|B2|Corrected calcium > 11.2 mg/dL||Stratification Factor: Albumin-corrected Calcium Level||participants|Number|34|34.0||||||
4101720|NCT00975000|3925796|B1|Corrected calcium > 11.2 mg/dL||Stratification Factor: Albumin-corrected Calcium Level||participants|Number|35|35.0||||||
4101721|NCT00975000|3925794|B3|Corrected calcium ≤ 11.2 mg/dL||Stratification Factor: Albumin-corrected Calcium Level||participants|Number|45|45.0||||||
4101722|NCT00975000|3925795|B2|Corrected calcium ≤ 11.2 mg/dL||Stratification Factor: Albumin-corrected Calcium Level||participants|Number|23|23.0||||||
4101723|NCT00975000|3925796|B1|Corrected calcium ≤ 11.2 mg/dL||Stratification Factor: Albumin-corrected Calcium Level||participants|Number|22|22.0||||||
4101724|NCT00975000|3925794|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4101725|NCT00975000|3925795|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4101726|NCT00975000|3925796|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4101727|NCT00975000|3925794|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4101728|NCT00975000|3925795|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4101729|NCT00975000|3925796|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4101730|NCT00975000|3925794|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4101731|NCT00975000|3925795|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4101732|NCT00975000|3925796|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4101735|NCT00975000|3925796|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4101736|NCT00975000|3925794|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4101737|NCT00975000|3925795|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4101738|NCT00975000|3925796|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4101739|NCT00975000|3925794|B3|White or Caucasian||Race/Ethnicity, Customized||participants|Number|93|93.0||||||
4101740|NCT00975000|3925795|B2|White or Caucasian||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4101741|NCT00975000|3925796|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4101742|NCT00975000|3925794|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4101743|NCT00975000|3925795|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4101744|NCT00975000|3925796|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4101745|NCT00975000|3925794|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4101746|NCT00975000|3925795|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4101747|NCT00975000|3925796|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4101748|NCT00975000|3925794|B3|||Age||years|Mean|52.3|52.3|Standard Deviation|10.3|10.3|||
4101749|NCT00975000|3925795|B2|||Age||years|Mean|53.0|53.0|Standard Deviation|10.7|10.7|||
4101750|NCT00975000|3925796|B1|||Age||years|Mean|51.7|51.7|Standard Deviation|9.9|9.9|||
4101751|NCT00974974|3925819|B3|Spain||Region of Enrollment||participants|Number|9|9.0||||||
4101752|NCT00974974|3925820|B2|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4101753|NCT00974974|3925821|B1|Spain||Region of Enrollment||participants|Number|5|5.0||||||
4101754|NCT00974974|3925819|B3|Germany||Region of Enrollment||participants|Number|23|23.0||||||
4101755|NCT00974974|3925820|B2|Germany||Region of Enrollment||participants|Number|11|11.0||||||
4101756|NCT00974974|3925821|B1|Germany||Region of Enrollment||participants|Number|12|12.0||||||
4101757|NCT00974974|3925819|B3|France||Region of Enrollment||participants|Number|3|3.0||||||
4101758|NCT00974974|3925820|B2|France||Region of Enrollment||participants|Number|1|1.0||||||
4101759|NCT00974974|3925821|B1|France||Region of Enrollment||participants|Number|2|2.0||||||
4101760|NCT00974974|3925819|B3|Poland||Region of Enrollment||participants|Number|67|67.0||||||
4101761|NCT00974974|3925820|B2|Poland||Region of Enrollment||participants|Number|33|33.0||||||
4101762|NCT00974974|3925821|B1|Poland||Region of Enrollment||participants|Number|34|34.0||||||
4101763|NCT00974974|3925819|B3|Ukraine||Region of Enrollment||participants|Number|75|75.0||||||
4101764|NCT00974974|3925820|B2|Ukraine||Region of Enrollment||participants|Number|38|38.0||||||
4101765|NCT00974974|3925821|B1|Ukraine||Region of Enrollment||participants|Number|37|37.0||||||
4101766|NCT00974974|3925819|B3|United States||Region of Enrollment||participants|Number|191|191.0||||||
4101767|NCT00974974|3925820|B2|United States||Region of Enrollment||participants|Number|93|93.0||||||
4101768|NCT00974974|3925821|B1|United States||Region of Enrollment||participants|Number|98|98.0||||||
4101769|NCT00974974|3925819|B3|Romania||Region of Enrollment||participants|Number|7|7.0||||||
4101770|NCT00974974|3925820|B2|Romania||Region of Enrollment||participants|Number|4|4.0||||||
4101771|NCT00974974|3925821|B1|Romania||Region of Enrollment||participants|Number|3|3.0||||||
4101772|NCT00974974|3925819|B3|Canada||Region of Enrollment||participants|Number|18|18.0||||||
4101773|NCT00974974|3925820|B2|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4101774|NCT00974974|3925821|B1|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4101775|NCT00974974|3925819|B3|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4101776|NCT00974974|3925820|B2|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4101777|NCT00974974|3925821|B1|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4101778|NCT00974974|3925819|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4101779|NCT00974974|3925820|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4101780|NCT00974974|3925821|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4101781|NCT00974974|3925819|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4101782|NCT00974974|3925820|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4101783|NCT00974974|3925821|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4101784|NCT00974974|3925819|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4101785|NCT00974974|3925820|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4101786|NCT00974974|3925821|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4101787|NCT00974974|3925819|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4101788|NCT00974974|3925820|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4101789|NCT00974974|3925821|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4101790|NCT00974974|3925819|B3|White||Race/Ethnicity, Customized||participants|Number|382|382.0||||||
4101791|NCT00974974|3925820|B2|White||Race/Ethnicity, Customized||participants|Number|186|186.0||||||
4101792|NCT00974974|3925821|B1|White||Race/Ethnicity, Customized||participants|Number|196|196.0||||||
4101793|NCT00974974|3925819|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4101794|NCT00974974|3925820|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4101795|NCT00974974|3925821|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4101796|NCT00974974|3925819|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|374|374.0||||||
4101797|NCT00974974|3925820|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|182|182.0||||||
4101798|NCT00974974|3925821|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|192|192.0||||||
4101799|NCT00974974|3925819|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4101800|NCT00974974|3925820|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4101801|NCT00974974|3925821|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4101802|NCT00974974|3925819|B3||Male|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
4101803|NCT00974974|3925820|B2||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4101804|NCT00974974|3925821|B1||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4101805|NCT00974974|3925819|B3||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4101806|NCT00974974|3925820|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4101807|NCT00974974|3925821|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4101808|NCT00974974|3925819|B3|||Age||years|Mean|63.2|63.2|Standard Deviation|9.4|9.4|||
4101809|NCT00974974|3925820|B2|||Age||years|Mean|63.4|63.4|Standard Deviation|8.8|8.8|||
4101810|NCT00974974|3925821|B1|||Age||years|Mean|63.1|63.1|Standard Deviation|10.0|10.0|||
4101811|NCT00974922|3925832|B1||Male|Sex: Female, Male|Data not analyzed by groups as group assignment was blinded (and never un-blinded due to discontinuation by the sponsor). There were 25 females and 15 males in total randomized to the study.|Participants|Count of Participants|15|15.0||||||
4101812|NCT00974922|3925832|B1||Female|Sex: Female, Male|Data not analyzed by groups as group assignment was blinded (and never un-blinded due to discontinuation by the sponsor). There were 25 females and 15 males in total randomized to the study.|Participants|Count of Participants|25|25.0||||||
4101813|NCT00974922|3925832|B1|||Age||years|Mean|54.85|54.85|Standard Deviation|11.3|11.3|||
4101814|NCT00974922|3925832|B1||>=65 years|Age|Data not analyzed by groups as group assignment was blinded (and never un-blinded due to discontinuation by the sponsor). There were 30 participants between 18 and 65 years, and 10 participants over 65 years.|Participants|Count of Participants|4|4.0||||||
4101815|NCT00974922|3925832|B1||Between 18 and 65 years|Age|Data not analyzed by groups as group assignment was blinded (and never un-blinded due to discontinuation by the sponsor). There were 30 participants between 18 and 65 years, and 10 participants over 65 years.|Participants|Count of Participants|36|36.0||||||
4101816|NCT00974922|3925832|B1||<=18 years|Age|Data not analyzed by groups as group assignment was blinded (and never un-blinded due to discontinuation by the sponsor). There were 30 participants between 18 and 65 years, and 10 participants over 65 years.|Participants|Count of Participants|0|0.0||||||
4101817|NCT00974818|3925837|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4101818|NCT00974818|3925838|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4101819|NCT00974818|3925839|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4101820|NCT00974818|3925837|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4101821|NCT00974818|3925838|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4101822|NCT00974818|3925839|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4101823|NCT00974818|3925837|B3||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4101824|NCT00974818|3925838|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4101825|NCT00974818|3925839|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4101826|NCT00974818|3925837|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4101827|NCT00974818|3925838|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4101828|NCT00974818|3925839|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4101829|NCT00974818|3925837|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4101830|NCT00974818|3925838|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4101831|NCT00974818|3925839|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4101832|NCT00974675|3925846|B5||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4101833|NCT00974675|3925847|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4101834|NCT00974675|3925848|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4101835|NCT00974675|3925849|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4101836|NCT00974675|3925850|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4101837|NCT00974675|3925846|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4101838|NCT00974675|3925847|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4101839|NCT00974675|3925848|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4101840|NCT00974675|3925849|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4101841|NCT00974675|3925850|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4101842|NCT00974675|3925846|B5|||Age||years|Mean|38.3|38.3|Standard Deviation|9.80|9.8|||
4101843|NCT00974675|3925847|B4|||Age||years|Mean|40.0|40.0|Standard Deviation|13.04|13.04|||
4101844|NCT00974675|3925848|B3|||Age||years|Mean|43.3|43.3|Standard Deviation|14.47|14.47|||
4101845|NCT00974675|3925849|B2|||Age||years|Mean|34.6|34.6|Standard Deviation|7.58|7.58|||
4101846|NCT00974675|3925850|B1|||Age||years|Mean|39.4|39.4|Standard Deviation|9.07|9.07|||
4101905|NCT00974480|3925926|B2|Spots||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|3.97|3.97|Standard Deviation|2.60|2.6|||
4101847|NCT00974571|3925899|B4|||Nighttime Symptoms score|Patients were asked to rate each of 3 symptoms of Nasal Congestion Upon Awakening, Difficulty Going to Sleep, and Nighttime Awakenings daily on a 4-point scale [Score 0 (best) to 3 (worst)], and the average score of the 3 symptoms was reported as the Nighttime Symptoms Score.|Scores on a scale|Mean|1.61|1.61|Standard Deviation|0.62|0.62|||
4101848|NCT00974571|3925900|B3|||Nighttime Symptoms score|Patients were asked to rate each of 3 symptoms of Nasal Congestion Upon Awakening, Difficulty Going to Sleep, and Nighttime Awakenings daily on a 4-point scale [Score 0 (best) to 3 (worst)], and the average score of the 3 symptoms was reported as the Nighttime Symptoms Score.|Scores on a scale|Mean|1.58|1.58|Standard Deviation|0.62|0.62|||
4101849|NCT00974571|3925901|B2|||Nighttime Symptoms score|Patients were asked to rate each of 3 symptoms of Nasal Congestion Upon Awakening, Difficulty Going to Sleep, and Nighttime Awakenings daily on a 4-point scale [Score 0 (best) to 3 (worst)], and the average score of the 3 symptoms was reported as the Nighttime Symptoms Score.|Scores on a scale|Mean|1.65|1.65|Standard Deviation|0.61|0.61|||
4101850|NCT00974571|3925902|B1|||Nighttime Symptoms score|Patients were asked to rate each of 3 symptoms of Nasal Congestion Upon Awakening, Difficulty Going to Sleep, and Nighttime Awakenings daily on a 4-point scale [Score 0 (best) to 3 (worst)], and the average score of the 3 symptoms was reported as the Nighttime Symptoms Score.|Scores on a scale|Mean|1.63|1.63|Standard Deviation|0.62|0.62|||
4101851|NCT00974571|3925899|B4|||Daytime Nasal Symptoms score|Patients were asked to rate each of 4 nasal symptoms of Congestion, Rhinorrhea, Itching, and Sneezing daily on a 4-point scale [Score 0 (best) to 3 (worst)]. The average of the 4 individual nasal symptom scores was reported as the Daytime Nasal Symptoms Score.|Scores on a scale|Mean|2.08|2.08|Standard Deviation|0.40|0.4|||
4101852|NCT00974571|3925900|B3|||Daytime Nasal Symptoms score|Patients were asked to rate each of 4 nasal symptoms of Congestion, Rhinorrhea, Itching, and Sneezing daily on a 4-point scale [Score 0 (best) to 3 (worst)]. The average of the 4 individual nasal symptom scores was reported as the Daytime Nasal Symptoms Score.|Scores on a scale|Mean|2.07|2.07|Standard Deviation|0.40|0.4|||
4101853|NCT00974571|3925901|B2|||Daytime Nasal Symptoms score|Patients were asked to rate each of 4 nasal symptoms of Congestion, Rhinorrhea, Itching, and Sneezing daily on a 4-point scale [Score 0 (best) to 3 (worst)]. The average of the 4 individual nasal symptom scores was reported as the Daytime Nasal Symptoms Score.|Scores on a scale|Mean|2.13|2.13|Standard Deviation|0.37|0.37|||
4101854|NCT00974571|3925902|B1|||Daytime Nasal Symptoms score|Patients were asked to rate each of 4 nasal symptoms of Congestion, Rhinorrhea, Itching, and Sneezing daily on a 4-point scale [Score 0 (best) to 3 (worst)]. The average of the 4 individual nasal symptom scores was reported as the Daytime Nasal Symptoms Score.|Scores on a scale|Mean|2.08|2.08|Standard Deviation|0.40|0.4|||
4101855|NCT00974571|3925899|B4|||Composite Symptoms score|Composite Symptoms Scores were computed as the average of the Daytime Nasal Symptoms Scores [Score 0 (best) to 3 (worst)] and Nighttime Symptoms Scores [Score 0 (best) to 3 (worst)].|Scores on a scale|Mean|1.85|1.85|Standard Deviation|0.44|0.44|||
4101856|NCT00974571|3925900|B3|||Composite Symptoms score|Composite Symptoms Scores were computed as the average of the Daytime Nasal Symptoms Scores [Score 0 (best) to 3 (worst)] and Nighttime Symptoms Scores [Score 0 (best) to 3 (worst)].|Scores on a scale|Mean|1.82|1.82|Standard Deviation|0.45|0.45|||
4101857|NCT00974571|3925901|B2|||Composite Symptoms score|Composite Symptoms Scores were computed as the average of the Daytime Nasal Symptoms Scores [Score 0 (best) to 3 (worst)] and Nighttime Symptoms Scores [Score 0 (best) to 3 (worst)].|Scores on a scale|Mean|1.89|1.89|Standard Deviation|0.43|0.43|||
4101858|NCT00974571|3925902|B1|||Composite Symptoms score|Composite Symptoms Scores were computed as the average of the Daytime Nasal Symptoms Scores [Score 0 (best) to 3 (worst)] and Nighttime Symptoms Scores [Score 0 (best) to 3 (worst)].|Scores on a scale|Mean|1.86|1.86|Standard Deviation|0.44|0.44|||
4101859|NCT00974571|3925899|B4||Male|Sex: Female, Male||Participants|Count of Participants|443|443.0||||||
4101860|NCT00974571|3925900|B3||Male|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4101861|NCT00974571|3925901|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4101862|NCT00974571|3925902|B1||Male|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4101863|NCT00974571|3925899|B4||Female|Sex: Female, Male||Participants|Count of Participants|922|922.0||||||
4101864|NCT00974571|3925900|B3||Female|Sex: Female, Male||Participants|Count of Participants|418|418.0||||||
4101865|NCT00974571|3925901|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4101866|NCT00974571|3925902|B1||Female|Sex: Female, Male||Participants|Count of Participants|419|419.0||||||
4101867|NCT00974571|3925899|B4|||Age||years|Mean|35.4|35.4|Standard Deviation|13.07|13.07|||
4101868|NCT00974571|3925900|B3|||Age||years|Mean|35.3|35.3|Standard Deviation|13.17|13.17|||
4101869|NCT00974571|3925901|B2|||Age||years|Mean|36.3|36.3|Standard Deviation|13.67|13.67|||
4101870|NCT00974571|3925902|B1|||Age||years|Mean|35.3|35.3|Standard Deviation|12.87|12.87|||
4101871|NCT00974480|3925924|B4|Burning and itching||Tolerance evaluated by investigator|"Tolerance was studied by evaluating scaling, dryness, erythema and burning/itching sensation on a 5-point scale.~Scaling, Dryness and Erythema Evaluations~- None (0) - Very Severe = (4)~Burning and Itching Evaluation Scale~None (0) = Normal, no discomfort~Mild (1) = Slight discomfort that is not bothersome~Moderate (2) = Discomfort that is somewhat bothersome~Marked (3) = Discomfort that is bothersome and that occasionally interferes with normal daily activities~Severe (4) = Continuous discomfort that interferes with normal daily activities"|Units on a scale|Mean|0.13|0.13|Standard Deviation|0.42|0.42|||
4101872|NCT00974480|3925925|B3|Burning and itching||Tolerance evaluated by investigator|"Tolerance was studied by evaluating scaling, dryness, erythema and burning/itching sensation on a 5-point scale.~Scaling, Dryness and Erythema Evaluations~- None (0) - Very Severe = (4)~Burning and Itching Evaluation Scale~None (0) = Normal, no discomfort~Mild (1) = Slight discomfort that is not bothersome~Moderate (2) = Discomfort that is somewhat bothersome~Marked (3) = Discomfort that is bothersome and that occasionally interferes with normal daily activities~Severe (4) = Continuous discomfort that interferes with normal daily activities"|Units on a scale|Mean|0.08|0.08|Standard Deviation|0.27|0.27|||
4102037|NCT00974311|3925999|B3|Poland||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4102038|NCT00974311|3926000|B2|Poland||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4101873|NCT00974480|3925926|B2|Burning and itching||Tolerance evaluated by investigator|"Tolerance was studied by evaluating scaling, dryness, erythema and burning/itching sensation on a 5-point scale.~Scaling, Dryness and Erythema Evaluations~- None (0) - Very Severe = (4)~Burning and Itching Evaluation Scale~None (0) = Normal, no discomfort~Mild (1) = Slight discomfort that is not bothersome~Moderate (2) = Discomfort that is somewhat bothersome~Marked (3) = Discomfort that is bothersome and that occasionally interferes with normal daily activities~Severe (4) = Continuous discomfort that interferes with normal daily activities"|Units on a scale|Mean|0.18|0.18|Standard Deviation|0.59|0.59|||
4101874|NCT00974480|3925927|B1|Burning and itching||Tolerance evaluated by investigator|"Tolerance was studied by evaluating scaling, dryness, erythema and burning/itching sensation on a 5-point scale.~Scaling, Dryness and Erythema Evaluations~- None (0) - Very Severe = (4)~Burning and Itching Evaluation Scale~None (0) = Normal, no discomfort~Mild (1) = Slight discomfort that is not bothersome~Moderate (2) = Discomfort that is somewhat bothersome~Marked (3) = Discomfort that is bothersome and that occasionally interferes with normal daily activities~Severe (4) = Continuous discomfort that interferes with normal daily activities"|Units on a scale|Mean|0.13|0.13|Standard Deviation|0.33|0.33|||
4101875|NCT00974480|3925924|B4|Erythema||Tolerance evaluated by investigator|"Tolerance was studied by evaluating scaling, dryness, erythema and burning/itching sensation on a 5-point scale.~Scaling, Dryness and Erythema Evaluations~- None (0) - Very Severe = (4)~Burning and Itching Evaluation Scale~None (0) = Normal, no discomfort~Mild (1) = Slight discomfort that is not bothersome~Moderate (2) = Discomfort that is somewhat bothersome~Marked (3) = Discomfort that is bothersome and that occasionally interferes with normal daily activities~Severe (4) = Continuous discomfort that interferes with normal daily activities"|Units on a scale|Mean|0.04|0.04|Standard Deviation|0.24|0.24|||
4101876|NCT00974480|3925925|B3|Erythema||Tolerance evaluated by investigator|"Tolerance was studied by evaluating scaling, dryness, erythema and burning/itching sensation on a 5-point scale.~Scaling, Dryness and Erythema Evaluations~- None (0) - Very Severe = (4)~Burning and Itching Evaluation Scale~None (0) = Normal, no discomfort~Mild (1) = Slight discomfort that is not bothersome~Moderate (2) = Discomfort that is somewhat bothersome~Marked (3) = Discomfort that is bothersome and that occasionally interferes with normal daily activities~Severe (4) = Continuous discomfort that interferes with normal daily activities"|Units on a scale|Mean|0.08|0.08|Standard Deviation|0.27|0.27|||
4101877|NCT00974480|3925926|B2|Erythema||Tolerance evaluated by investigator|"Tolerance was studied by evaluating scaling, dryness, erythema and burning/itching sensation on a 5-point scale.~Scaling, Dryness and Erythema Evaluations~- None (0) - Very Severe = (4)~Burning and Itching Evaluation Scale~None (0) = Normal, no discomfort~Mild (1) = Slight discomfort that is not bothersome~Moderate (2) = Discomfort that is somewhat bothersome~Marked (3) = Discomfort that is bothersome and that occasionally interferes with normal daily activities~Severe (4) = Continuous discomfort that interferes with normal daily activities"|Units on a scale|Mean|0.0|0.0|Standard Deviation|0.0|0.0|||
4101878|NCT00974480|3925927|B1|Erythema||Tolerance evaluated by investigator|"Tolerance was studied by evaluating scaling, dryness, erythema and burning/itching sensation on a 5-point scale.~Scaling, Dryness and Erythema Evaluations~- None (0) - Very Severe = (4)~Burning and Itching Evaluation Scale~None (0) = Normal, no discomfort~Mild (1) = Slight discomfort that is not bothersome~Moderate (2) = Discomfort that is somewhat bothersome~Marked (3) = Discomfort that is bothersome and that occasionally interferes with normal daily activities~Severe (4) = Continuous discomfort that interferes with normal daily activities"|Units on a scale|Mean|0.05|0.05|Standard Deviation|0.32|0.32|||
4101879|NCT00974480|3925924|B4|Dryness||Tolerance evaluated by investigator|"Tolerance was studied by evaluating scaling, dryness, erythema and burning/itching sensation on a 5-point scale.~Scaling, Dryness and Erythema Evaluations~- None (0) - Very Severe = (4)~Burning and Itching Evaluation Scale~None (0) = Normal, no discomfort~Mild (1) = Slight discomfort that is not bothersome~Moderate (2) = Discomfort that is somewhat bothersome~Marked (3) = Discomfort that is bothersome and that occasionally interferes with normal daily activities~Severe (4) = Continuous discomfort that interferes with normal daily activities"|Units on a scale|Mean|0.13|0.13|Standard Deviation|0.33|0.33|||
4101880|NCT00974480|3925925|B3|Dryness||Tolerance evaluated by investigator|"Tolerance was studied by evaluating scaling, dryness, erythema and burning/itching sensation on a 5-point scale.~Scaling, Dryness and Erythema Evaluations~- None (0) - Very Severe = (4)~Burning and Itching Evaluation Scale~None (0) = Normal, no discomfort~Mild (1) = Slight discomfort that is not bothersome~Moderate (2) = Discomfort that is somewhat bothersome~Marked (3) = Discomfort that is bothersome and that occasionally interferes with normal daily activities~Severe (4) = Continuous discomfort that interferes with normal daily activities"|Units on a scale|Mean|0.15|0.15|Standard Deviation|0.36|0.36|||
4101881|NCT00974480|3925926|B2|Dryness||Tolerance evaluated by investigator|"Tolerance was studied by evaluating scaling, dryness, erythema and burning/itching sensation on a 5-point scale.~Scaling, Dryness and Erythema Evaluations~- None (0) - Very Severe = (4)~Burning and Itching Evaluation Scale~None (0) = Normal, no discomfort~Mild (1) = Slight discomfort that is not bothersome~Moderate (2) = Discomfort that is somewhat bothersome~Marked (3) = Discomfort that is bothersome and that occasionally interferes with normal daily activities~Severe (4) = Continuous discomfort that interferes with normal daily activities"|Units on a scale|Mean|0.10|0.1|Standard Deviation|0.30|0.3|||
4101882|NCT00974480|3925927|B1|Dryness||Tolerance evaluated by investigator|"Tolerance was studied by evaluating scaling, dryness, erythema and burning/itching sensation on a 5-point scale.~Scaling, Dryness and Erythema Evaluations~- None (0) - Very Severe = (4)~Burning and Itching Evaluation Scale~None (0) = Normal, no discomfort~Mild (1) = Slight discomfort that is not bothersome~Moderate (2) = Discomfort that is somewhat bothersome~Marked (3) = Discomfort that is bothersome and that occasionally interferes with normal daily activities~Severe (4) = Continuous discomfort that interferes with normal daily activities"|Units on a scale|Mean|0.13|0.13|Standard Deviation|0.33|0.33|||
4101883|NCT00974480|3925924|B4|Scaling||Tolerance evaluated by investigator|"Tolerance was studied by evaluating scaling, dryness, erythema and burning/itching sensation on a 5-point scale.~Scaling, Dryness and Erythema Evaluations~- None (0) - Very Severe = (4)~Burning and Itching Evaluation Scale~None (0) = Normal, no discomfort~Mild (1) = Slight discomfort that is not bothersome~Moderate (2) = Discomfort that is somewhat bothersome~Marked (3) = Discomfort that is bothersome and that occasionally interferes with normal daily activities~Severe (4) = Continuous discomfort that interferes with normal daily activities"|Units on a scale|Mean|0.05|0.05|Standard Deviation|0.22|0.22|||
4102039|NCT00974311|3926001|B1|Poland||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4101884|NCT00974480|3925925|B3|Scaling||Tolerance evaluated by investigator|"Tolerance was studied by evaluating scaling, dryness, erythema and burning/itching sensation on a 5-point scale.~Scaling, Dryness and Erythema Evaluations~- None (0) - Very Severe = (4)~Burning and Itching Evaluation Scale~None (0) = Normal, no discomfort~Mild (1) = Slight discomfort that is not bothersome~Moderate (2) = Discomfort that is somewhat bothersome~Marked (3) = Discomfort that is bothersome and that occasionally interferes with normal daily activities~Severe (4) = Continuous discomfort that interferes with normal daily activities"|Units on a scale|Mean|0.03|0.03|Standard Deviation|0.16|0.16|||
4101885|NCT00974480|3925926|B2|Scaling||Tolerance evaluated by investigator|"Tolerance was studied by evaluating scaling, dryness, erythema and burning/itching sensation on a 5-point scale.~Scaling, Dryness and Erythema Evaluations~- None (0) - Very Severe = (4)~Burning and Itching Evaluation Scale~None (0) = Normal, no discomfort~Mild (1) = Slight discomfort that is not bothersome~Moderate (2) = Discomfort that is somewhat bothersome~Marked (3) = Discomfort that is bothersome and that occasionally interferes with normal daily activities~Severe (4) = Continuous discomfort that interferes with normal daily activities"|Units on a scale|Mean|0.05|0.05|Standard Deviation|0.22|0.22|||
4101886|NCT00974480|3925927|B1|Scaling||Tolerance evaluated by investigator|"Tolerance was studied by evaluating scaling, dryness, erythema and burning/itching sensation on a 5-point scale.~Scaling, Dryness and Erythema Evaluations~- None (0) - Very Severe = (4)~Burning and Itching Evaluation Scale~None (0) = Normal, no discomfort~Mild (1) = Slight discomfort that is not bothersome~Moderate (2) = Discomfort that is somewhat bothersome~Marked (3) = Discomfort that is bothersome and that occasionally interferes with normal daily activities~Severe (4) = Continuous discomfort that interferes with normal daily activities"|Units on a scale|Mean|0.08|0.08|Standard Deviation|0.27|0.27|||
4101887|NCT00974480|3925924|B4|Redness||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|2.99|2.99|Standard Deviation|2.89|2.89|||
4101888|NCT00974480|3925925|B3|Redness||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|2.92|2.92|Standard Deviation|3.00|3.0|||
4101889|NCT00974480|3925926|B2|Redness||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|3.00|3.0|Standard Deviation|3.09|3.09|||
4101890|NCT00974480|3925927|B1|Redness||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|3.04|3.04|Standard Deviation|2.65|2.65|||
4101891|NCT00974480|3925924|B4|Dryness||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|4.83|4.83|Standard Deviation|2.45|2.45|||
4101892|NCT00974480|3925925|B3|Dryness||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|4.35|4.35|Standard Deviation|2.65|2.65|||
4101893|NCT00974480|3925926|B2|Dryness||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|5.15|5.15|Standard Deviation|2.34|2.34|||
4101894|NCT00974480|3925927|B1|Dryness||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|5.01|5.01|Standard Deviation|2.32|2.32|||
4101895|NCT00974480|3925924|B4|Imperfections||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|5.01|5.01|Standard Deviation|2.38|2.38|||
4101896|NCT00974480|3925925|B3|Imperfections||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|5.24|5.24|Standard Deviation|2.57|2.57|||
4101897|NCT00974480|3925926|B2|Imperfections||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|5.08|5.08|Standard Deviation|2.18|2.18|||
4101898|NCT00974480|3925927|B1|Imperfections||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|4.73|4.73|Standard Deviation|2.41|2.41|||
4101899|NCT00974480|3925924|B4|Roughness||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|2.72|2.72|Standard Deviation|2.31|2.31|||
4101900|NCT00974480|3925925|B3|Roughness||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|2.50|2.5|Standard Deviation|2.14|2.14|||
4101901|NCT00974480|3925926|B2|Roughness||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|3.02|3.02|Standard Deviation|2.62|2.62|||
4101902|NCT00974480|3925927|B1|Roughness||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|2.65|2.65|Standard Deviation|2.14|2.14|||
4101903|NCT00974480|3925924|B4|Spots||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|3.68|3.68|Standard Deviation|2.62|2.62|||
4101904|NCT00974480|3925925|B3|Spots||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|4.17|4.17|Standard Deviation|2.81|2.81|||
4101906|NCT00974480|3925927|B1|Spots||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|2.92|2.92|Standard Deviation|2.31|2.31|||
4101907|NCT00974480|3925924|B4|Wrinkles||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|5.29|5.29|Standard Deviation|2.15|2.15|||
4101908|NCT00974480|3925925|B3|Wrinkles||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|5.06|5.06|Standard Deviation|2.17|2.17|||
4101909|NCT00974480|3925926|B2|Wrinkles||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|5.67|5.67|Standard Deviation|2.15|2.15|||
4101910|NCT00974480|3925927|B1|Wrinkles||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|5.14|5.14|Standard Deviation|2.14|2.14|||
4101911|NCT00974480|3925924|B4|Fine Lines||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|5.23|5.23|Standard Deviation|2.03|2.03|||
4101912|NCT00974480|3925925|B3|Fine Lines||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|5.11|5.11|Standard Deviation|2.12|2.12|||
4101913|NCT00974480|3925926|B2|Fine Lines||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|5.52|5.52|Standard Deviation|2.12|2.12|||
4101914|NCT00974480|3925927|B1|Fine Lines||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|5.06|5.06|Standard Deviation|1.85|1.85|||
4101915|NCT00974480|3925924|B4|Smoothness||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|6.41|6.41|Standard Deviation|2.07|2.07|||
4101916|NCT00974480|3925925|B3|Smoothness||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|6.51|6.51|Standard Deviation|1.95|1.95|||
4101917|NCT00974480|3925926|B2|Smoothness||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|6.53|6.53|Standard Deviation|2.25|2.25|||
4101918|NCT00974480|3925927|B1|Smoothness||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|6.20|6.2|Standard Deviation|2.02|2.02|||
4101919|NCT00974480|3925924|B4|Comfort||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|5.82|5.82|Standard Deviation|2.16|2.16|||
4101920|NCT00974480|3925925|B3|Comfort||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|6.31|6.31|Standard Deviation|2.48|2.48|||
4101921|NCT00974480|3925926|B2|Comfort||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|5.75|5.75|Standard Deviation|1.93|1.93|||
4101922|NCT00974480|3925927|B1|Comfort||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|5.39|5.39|Standard Deviation|1.97|1.97|||
4101923|NCT00974480|3925924|B4|Softness||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|5.29|5.29|Standard Deviation|1.90|1.9|||
4101924|NCT00974480|3925925|B3|Softness||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|5.24|5.24|Standard Deviation|1.93|1.93|||
4101925|NCT00974480|3925926|B2|Softness||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|5.10|5.1|Standard Deviation|2.19|2.19|||
4101926|NCT00974480|3925927|B1|Softness||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|5.54|5.54|Standard Deviation|1.54|1.54|||
4101927|NCT00974480|3925924|B4|Radiance||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|5.00|5.0|Standard Deviation|1.83|1.83|||
4101928|NCT00974480|3925925|B3|Radiance||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|5.01|5.01|Standard Deviation|2.10|2.1|||
4101929|NCT00974480|3925926|B2|Radiance||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|4.86|4.86|Standard Deviation|1.69|1.69|||
4102040|NCT00974311|3925999|B3|Belgium||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
4101930|NCT00974480|3925927|B1|Radiance||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|5.14|5.14|Standard Deviation|1.72|1.72|||
4101931|NCT00974480|3925924|B4|Firmness||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|4.88|4.88|Standard Deviation|1.99|1.99|||
4101932|NCT00974480|3925925|B3|Firmness||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|4.62|4.62|Standard Deviation|1.60|1.6|||
4101933|NCT00974480|3925926|B2|Firmness||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|5.34|5.34|Standard Deviation|2.27|2.27|||
4101934|NCT00974480|3925927|B1|Firmness||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|4.67|4.67|Standard Deviation|2.00|2.0|||
4101935|NCT00974480|3925924|B4|Hydration||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|4.75|4.75|Standard Deviation|1.79|1.79|||
4101936|NCT00974480|3925925|B3|Hydration||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|4.98|4.98|Standard Deviation|1.55|1.55|||
4101937|NCT00974480|3925926|B2|Hydration||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|4.61|4.61|Standard Deviation|1.81|1.81|||
4101938|NCT00974480|3925927|B1|Hydration||Facial skin self-evaluation|A visual analog scale of 13 evaluations were performed by the subject. Scale is from 1 - 10 for each evaluation individually evaluated. 0 = absent, 10 = important|Units on a scale|Mean|4.65|4.65|Standard Deviation|2.01|2.01|||
4101939|NCT00974480|3925924|B4|Tightness||Sensitivity of the face evaluated by subject|"Sensitivity of the entire face evaluated by the subject was performed using 4 different 10 cm visual analog scales (pruritus, tingling, burning, tightness). Each score was analysed separately.~Each score is from 0 = absent to 10 important."|Units on a scale|Mean|1.49|1.49|Standard Deviation|2.23|2.23|||
4101940|NCT00974480|3925925|B3|Tightness||Sensitivity of the face evaluated by subject|"Sensitivity of the entire face evaluated by the subject was performed using 4 different 10 cm visual analog scales (pruritus, tingling, burning, tightness). Each score was analysed separately.~Each score is from 0 = absent to 10 important."|Units on a scale|Mean|1.30|1.3|Standard Deviation|2.47|2.47|||
4101941|NCT00974480|3925926|B2|Tightness||Sensitivity of the face evaluated by subject|"Sensitivity of the entire face evaluated by the subject was performed using 4 different 10 cm visual analog scales (pruritus, tingling, burning, tightness). Each score was analysed separately.~Each score is from 0 = absent to 10 important."|Units on a scale|Mean|1.62|1.62|Standard Deviation|2.21|2.21|||
4101942|NCT00974480|3925927|B1|Tightness||Sensitivity of the face evaluated by subject|"Sensitivity of the entire face evaluated by the subject was performed using 4 different 10 cm visual analog scales (pruritus, tingling, burning, tightness). Each score was analysed separately.~Each score is from 0 = absent to 10 important."|Units on a scale|Mean|1.56|1.56|Standard Deviation|2.02|2.02|||
4101943|NCT00974480|3925924|B4|Burning||Sensitivity of the face evaluated by subject|"Sensitivity of the entire face evaluated by the subject was performed using 4 different 10 cm visual analog scales (pruritus, tingling, burning, tightness). Each score was analysed separately.~Each score is from 0 = absent to 10 important."|Units on a scale|Mean|0.61|0.61|Standard Deviation|1.39|1.39|||
4101944|NCT00974480|3925925|B3|Burning||Sensitivity of the face evaluated by subject|"Sensitivity of the entire face evaluated by the subject was performed using 4 different 10 cm visual analog scales (pruritus, tingling, burning, tightness). Each score was analysed separately.~Each score is from 0 = absent to 10 important."|Units on a scale|Mean|0.45|0.45|Standard Deviation|1.19|1.19|||
4101945|NCT00974480|3925926|B2|Burning||Sensitivity of the face evaluated by subject|"Sensitivity of the entire face evaluated by the subject was performed using 4 different 10 cm visual analog scales (pruritus, tingling, burning, tightness). Each score was analysed separately.~Each score is from 0 = absent to 10 important."|Units on a scale|Mean|0.55|0.55|Standard Deviation|1.27|1.27|||
4101946|NCT00974480|3925927|B1|Burning||Sensitivity of the face evaluated by subject|"Sensitivity of the entire face evaluated by the subject was performed using 4 different 10 cm visual analog scales (pruritus, tingling, burning, tightness). Each score was analysed separately.~Each score is from 0 = absent to 10 important."|Units on a scale|Mean|0.83|0.83|Standard Deviation|1.67|1.67|||
4101947|NCT00974480|3925924|B4|Tingling||Sensitivity of the face evaluated by subject|"Sensitivity of the entire face evaluated by the subject was performed using 4 different 10 cm visual analog scales (pruritus, tingling, burning, tightness). Each score was analysed separately.~Each score is from 0 = absent to 10 important."|Units on a scale|Mean|0.91|0.91|Standard Deviation|1.53|1.53|||
4101948|NCT00974480|3925925|B3|Tingling||Sensitivity of the face evaluated by subject|"Sensitivity of the entire face evaluated by the subject was performed using 4 different 10 cm visual analog scales (pruritus, tingling, burning, tightness). Each score was analysed separately.~Each score is from 0 = absent to 10 important."|Units on a scale|Mean|1.04|1.04|Standard Deviation|1.77|1.77|||
4101949|NCT00974480|3925926|B2|Tingling||Sensitivity of the face evaluated by subject|"Sensitivity of the entire face evaluated by the subject was performed using 4 different 10 cm visual analog scales (pruritus, tingling, burning, tightness). Each score was analysed separately.~Each score is from 0 = absent to 10 important."|Units on a scale|Mean|0.69|0.69|Standard Deviation|1.28|1.28|||
4101950|NCT00974480|3925927|B1|Tingling||Sensitivity of the face evaluated by subject|"Sensitivity of the entire face evaluated by the subject was performed using 4 different 10 cm visual analog scales (pruritus, tingling, burning, tightness). Each score was analysed separately.~Each score is from 0 = absent to 10 important."|Units on a scale|Mean|0.99|0.99|Standard Deviation|1.51|1.51|||
4101951|NCT00974480|3925924|B4|Pruritus||Sensitivity of the face evaluated by subject|"Sensitivity of the entire face evaluated by the subject was performed using 4 different 10 cm visual analog scales (pruritus, tingling, burning, tightness). Each score was analysed separately.~Each score is from 0 = absent to 10 important."|Units on a scale|Mean|0.87|0.87|Standard Deviation|1.71|1.71|||
4101952|NCT00974480|3925925|B3|Pruritus||Sensitivity of the face evaluated by subject|"Sensitivity of the entire face evaluated by the subject was performed using 4 different 10 cm visual analog scales (pruritus, tingling, burning, tightness). Each score was analysed separately.~Each score is from 0 = absent to 10 important."|Units on a scale|Mean|0.65|0.65|Standard Deviation|1.73|1.73|||
4101953|NCT00974480|3925926|B2|Pruritus||Sensitivity of the face evaluated by subject|"Sensitivity of the entire face evaluated by the subject was performed using 4 different 10 cm visual analog scales (pruritus, tingling, burning, tightness). Each score was analysed separately.~Each score is from 0 = absent to 10 important."|Units on a scale|Mean|1.01|1.01|Standard Deviation|1.88|1.88|||
4101954|NCT00974480|3925927|B1|Pruritus||Sensitivity of the face evaluated by subject|"Sensitivity of the entire face evaluated by the subject was performed using 4 different 10 cm visual analog scales (pruritus, tingling, burning, tightness). Each score was analysed separately.~Each score is from 0 = absent to 10 important."|Units on a scale|Mean|0.94|0.94|Standard Deviation|1.51|1.51|||
4101955|NCT00974480|3925924|B4|||Clinical skin evaluation|A clinical skin evaluation of the face was performed by a dermatologist using 8 scales (skin hydration, radiance, roughness, spots, laxity, skin tone homogeneity, softness, relief (variations in depth)). The individual scores were totalled (worst = 0, best = 47) and the total score was used for analyses.|Units on a scale|Mean|28.97|28.97|Standard Deviation|5.81|5.81|||
4101956|NCT00974480|3925925|B3|||Clinical skin evaluation|A clinical skin evaluation of the face was performed by a dermatologist using 8 scales (skin hydration, radiance, roughness, spots, laxity, skin tone homogeneity, softness, relief (variations in depth)). The individual scores were totalled (worst = 0, best = 47) and the total score was used for analyses.|Units on a scale|Mean|28.65|28.65|Standard Deviation|6.06|6.06|||
4101957|NCT00974480|3925926|B2|||Clinical skin evaluation|A clinical skin evaluation of the face was performed by a dermatologist using 8 scales (skin hydration, radiance, roughness, spots, laxity, skin tone homogeneity, softness, relief (variations in depth)). The individual scores were totalled (worst = 0, best = 47) and the total score was used for analyses.|Units on a scale|Mean|29.20|29.2|Standard Deviation|5.96|5.96|||
4101958|NCT00974480|3925927|B1|||Clinical skin evaluation|A clinical skin evaluation of the face was performed by a dermatologist using 8 scales (skin hydration, radiance, roughness, spots, laxity, skin tone homogeneity, softness, relief (variations in depth)). The individual scores were totalled (worst = 0, best = 47) and the total score was used for analyses.|Units on a scale|Mean|29.05|29.05|Standard Deviation|5.52|5.52|||
4101959|NCT00974480|3925924|B4|||Crow's feet replicas - area ratio|An illuminator is used to cross illuminate the specimen (silicone mold replicas) perpendicular to the major lines which accentuate the surface details. The resulting image which consists of a series of shadows that directly correspond to the pattern of wrinkles is digitized for analysis. One can measure changes in skin surface topography by selecting an area range (shadow size) that allows one to directly determine the projected area of the shadowed region associated with the wrinkles and major lines. The Area Ratio is the area of the shadows. The higher the ratio, the greater the wrinkling.|mm²|Mean|7.53|7.53|Standard Deviation|5.52|5.52|||
4101960|NCT00974480|3925925|B3|||Crow's feet replicas - area ratio|An illuminator is used to cross illuminate the specimen (silicone mold replicas) perpendicular to the major lines which accentuate the surface details. The resulting image which consists of a series of shadows that directly correspond to the pattern of wrinkles is digitized for analysis. One can measure changes in skin surface topography by selecting an area range (shadow size) that allows one to directly determine the projected area of the shadowed region associated with the wrinkles and major lines. The Area Ratio is the area of the shadows. The higher the ratio, the greater the wrinkling.|mm²|Mean|9.28|9.28|Standard Deviation|7.71|7.71|||
4101961|NCT00974480|3925926|B2|||Crow's feet replicas - area ratio|An illuminator is used to cross illuminate the specimen (silicone mold replicas) perpendicular to the major lines which accentuate the surface details. The resulting image which consists of a series of shadows that directly correspond to the pattern of wrinkles is digitized for analysis. One can measure changes in skin surface topography by selecting an area range (shadow size) that allows one to directly determine the projected area of the shadowed region associated with the wrinkles and major lines. The Area Ratio is the area of the shadows. The higher the ratio, the greater the wrinkling.|mm²|Mean|5.87|5.87|Standard Deviation|4.78|4.78|||
4101962|NCT00974480|3925927|B1|||Crow's feet replicas - area ratio|An illuminator is used to cross illuminate the specimen (silicone mold replicas) perpendicular to the major lines which accentuate the surface details. The resulting image which consists of a series of shadows that directly correspond to the pattern of wrinkles is digitized for analysis. One can measure changes in skin surface topography by selecting an area range (shadow size) that allows one to directly determine the projected area of the shadowed region associated with the wrinkles and major lines. The Area Ratio is the area of the shadows. The higher the ratio, the greater the wrinkling.|mm²|Mean|7.98|7.98|Standard Deviation|6.31|6.31|||
4101963|NCT00974480|3925924|B4|||Skin elasticity|Skin elasticity was measured with a DermaLab device (Cortex Technology, Denmark) equipped with a skin elasticity probe. Pressure required to raise the skin 1mm was recorded. Measurements were performed on the upper cheeks and care was taken to use the same location for all measurements. Final measurements were the average of left and right cheeks. When the product is a moisturizer, lower pressures are indicative of efficacy.|kilo Pascals|Mean|20.16|20.16|Standard Deviation|9.68|9.68|||
4101964|NCT00974480|3925925|B3|||Skin elasticity|Skin elasticity was measured with a DermaLab device (Cortex Technology, Denmark) equipped with a skin elasticity probe. Pressure required to raise the skin 1mm was recorded. Measurements were performed on the upper cheeks and care was taken to use the same location for all measurements. Final measurements were the average of left and right cheeks. When the product is a moisturizer, lower pressures are indicative of efficacy.|kilo Pascals|Mean|20.61|20.61|Standard Deviation|9.75|9.75|||
4102041|NCT00974311|3926000|B2|Belgium||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4102042|NCT00974311|3926001|B1|Belgium||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
4101965|NCT00974480|3925926|B2|||Skin elasticity|Skin elasticity was measured with a DermaLab device (Cortex Technology, Denmark) equipped with a skin elasticity probe. Pressure required to raise the skin 1mm was recorded. Measurements were performed on the upper cheeks and care was taken to use the same location for all measurements. Final measurements were the average of left and right cheeks. When the product is a moisturizer, lower pressures are indicative of efficacy.|kilo Pascals|Mean|19.27|19.27|Standard Deviation|8.51|8.51|||
4101966|NCT00974480|3925927|B1|||Skin elasticity|Skin elasticity was measured with a DermaLab device (Cortex Technology, Denmark) equipped with a skin elasticity probe. Pressure required to raise the skin 1mm was recorded. Measurements were performed on the upper cheeks and care was taken to use the same location for all measurements. Final measurements were the average of left and right cheeks. When the product is a moisturizer, lower pressures are indicative of efficacy.|kilo Pascals|Mean|20.61|20.61|Standard Deviation|10.83|10.83|||
4101967|NCT00974480|3925924|B4|||Skin hydration (conductance)|"Skin hydration was measured with a DermaLab device (Cortex Technology, Denmark) equipped with a skin hydration probe.~Measurements were performed in a room with controlled temperature (20°C +/-2) and humidity (45% +/- 15%). All measurements were performed at least 30 minutes after the subject had been transferred into this room. Care was taken to use the same cheek for each subject throughout the study. Higher values indicate greater hydration."|µsiemens (µmho)|Mean|57.53|57.53|Standard Deviation|32.64|32.64|||
4101968|NCT00974480|3925925|B3|||Skin hydration (conductance)|"Skin hydration was measured with a DermaLab device (Cortex Technology, Denmark) equipped with a skin hydration probe.~Measurements were performed in a room with controlled temperature (20°C +/-2) and humidity (45% +/- 15%). All measurements were performed at least 30 minutes after the subject had been transferred into this room. Care was taken to use the same cheek for each subject throughout the study. Higher values indicate greater hydration."|µsiemens (µmho)|Mean|57.25|57.25|Standard Deviation|26.54|26.54|||
4101969|NCT00974480|3925926|B2|||Skin hydration (conductance)|"Skin hydration was measured with a DermaLab device (Cortex Technology, Denmark) equipped with a skin hydration probe.~Measurements were performed in a room with controlled temperature (20°C +/-2) and humidity (45% +/- 15%). All measurements were performed at least 30 minutes after the subject had been transferred into this room. Care was taken to use the same cheek for each subject throughout the study. Higher values indicate greater hydration."|µsiemens (µmho)|Mean|64.35|64.35|Standard Deviation|42.44|42.44|||
4101970|NCT00974480|3925927|B1|||Skin hydration (conductance)|"Skin hydration was measured with a DermaLab device (Cortex Technology, Denmark) equipped with a skin hydration probe.~Measurements were performed in a room with controlled temperature (20°C +/-2) and humidity (45% +/- 15%). All measurements were performed at least 30 minutes after the subject had been transferred into this room. Care was taken to use the same cheek for each subject throughout the study. Higher values indicate greater hydration."|µsiemens (µmho)|Mean|51.00|51.0|Standard Deviation|25.58|25.58|||
4101971|NCT00974480|3925924|B4|||Transepidermal water loss (TEWL)|Trans Epidermal Water Loss (TEWL) was measured with a DermaLab device (Cortex Technology, Denmark) equipped with a TEWL probe. Measurements were performed with the subject lying down on the back in a room with controlled temperature (20°C +/-2) and relative humidity (45% +/- 15%). All measurements were performed at least 30 minutes after the subject was transferred into this room. The measurements were performed on the cheek. Care was taken to use the same cheek for each subject throughout the study.|g / m² / h|Mean|9.74|9.74|Standard Deviation|2.91|2.91|||
4101972|NCT00974480|3925925|B3|||Transepidermal water loss (TEWL)|Trans Epidermal Water Loss (TEWL) was measured with a DermaLab device (Cortex Technology, Denmark) equipped with a TEWL probe. Measurements were performed with the subject lying down on the back in a room with controlled temperature (20°C +/-2) and relative humidity (45% +/- 15%). All measurements were performed at least 30 minutes after the subject was transferred into this room. The measurements were performed on the cheek. Care was taken to use the same cheek for each subject throughout the study.|g / m² / h|Mean|9.71|9.71|Standard Deviation|2.47|2.47|||
4101973|NCT00974480|3925926|B2|||Transepidermal water loss (TEWL)|Trans Epidermal Water Loss (TEWL) was measured with a DermaLab device (Cortex Technology, Denmark) equipped with a TEWL probe. Measurements were performed with the subject lying down on the back in a room with controlled temperature (20°C +/-2) and relative humidity (45% +/- 15%). All measurements were performed at least 30 minutes after the subject was transferred into this room. The measurements were performed on the cheek. Care was taken to use the same cheek for each subject throughout the study.|g / m² / h|Mean|9.61|9.61|Standard Deviation|2.95|2.95|||
4101974|NCT00974480|3925927|B1|||Transepidermal water loss (TEWL)|Trans Epidermal Water Loss (TEWL) was measured with a DermaLab device (Cortex Technology, Denmark) equipped with a TEWL probe. Measurements were performed with the subject lying down on the back in a room with controlled temperature (20°C +/-2) and relative humidity (45% +/- 15%). All measurements were performed at least 30 minutes after the subject was transferred into this room. The measurements were performed on the cheek. Care was taken to use the same cheek for each subject throughout the study.|g / m² / h|Mean|9.90|9.9|Standard Deviation|3.32|3.32|||
4101975|NCT00974480|3925924|B4|||Skin aging measured with photonumeric scale|Scoring was accomplished by matching each part of the face (forehead, glabella, corners of the mouth, nasal labial fold, crow's feet, below eyes and upper lip) to photographs in the scales and reporting the appropriate number in the tables. All individual scores were added to obtain the total score (Less signs of skin aging = 0, more signs of skin aging = 41.6).|Units on a Scale|Mean|22.08|22.08|Standard Deviation|6.06|6.06|||
4101976|NCT00974480|3925925|B3|||Skin aging measured with photonumeric scale|Scoring was accomplished by matching each part of the face (forehead, glabella, corners of the mouth, nasal labial fold, crow's feet, below eyes and upper lip) to photographs in the scales and reporting the appropriate number in the tables. All individual scores were added to obtain the total score (Less signs of skin aging = 0, more signs of skin aging = 41.6).|Units on a Scale|Mean|22.14|22.14|Standard Deviation|5.13|5.13|||
4101977|NCT00974480|3925926|B2|||Skin aging measured with photonumeric scale|Scoring was accomplished by matching each part of the face (forehead, glabella, corners of the mouth, nasal labial fold, crow's feet, below eyes and upper lip) to photographs in the scales and reporting the appropriate number in the tables. All individual scores were added to obtain the total score (Less signs of skin aging = 0, more signs of skin aging = 41.6).|Units on a Scale|Mean|21.88|21.88|Standard Deviation|5.83|5.83|||
4102043|NCT00974311|3925999|B3|Argentina||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4101978|NCT00974480|3925927|B1|||Skin aging measured with photonumeric scale|Scoring was accomplished by matching each part of the face (forehead, glabella, corners of the mouth, nasal labial fold, crow's feet, below eyes and upper lip) to photographs in the scales and reporting the appropriate number in the tables. All individual scores were added to obtain the total score (Less signs of skin aging = 0, more signs of skin aging = 41.6).|Units on a Scale|Mean|22.23|22.23|Standard Deviation|7.10|7.1|||
4101979|NCT00974480|3925924|B4|Canada||Region of Enrollment||participants|Number|120|120.0||||||
4101980|NCT00974480|3925925|B3|Canada||Region of Enrollment||participants|Number|40|40.0||||||
4101981|NCT00974480|3925926|B2|Canada||Region of Enrollment||participants|Number|40|40.0||||||
4101982|NCT00974480|3925927|B1|Canada||Region of Enrollment||participants|Number|40|40.0||||||
4101983|NCT00974480|3925924|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4101984|NCT00974480|3925925|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4101985|NCT00974480|3925926|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4101986|NCT00974480|3925927|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4101987|NCT00974480|3925924|B4||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4101988|NCT00974480|3925925|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4101989|NCT00974480|3925926|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4101990|NCT00974480|3925927|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4101991|NCT00974480|3925924|B4|||Age||years|Mean|50.51|50.51|Standard Deviation|3.10|3.1|||
4101992|NCT00974480|3925925|B3|||Age||years|Mean|50.53|50.53|Standard Deviation|2.84|2.84|||
4101993|NCT00974480|3925926|B2|||Age||years|Mean|51.15|51.15|Standard Deviation|3.20|3.2|||
4101994|NCT00974480|3925927|B1|||Age||years|Mean|49.85|49.85|Standard Deviation|3.18|3.18|||
4101995|NCT00974480|3925924|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4101996|NCT00974480|3925925|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4101997|NCT00974480|3925926|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4101998|NCT00974480|3925927|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4101999|NCT00974480|3925924|B4||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
4102000|NCT00974480|3925925|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4102001|NCT00974480|3925926|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4102002|NCT00974480|3925927|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4102003|NCT00974480|3925924|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4102004|NCT00974480|3925925|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4102005|NCT00974480|3925926|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4102006|NCT00974480|3925927|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4102007|NCT00974376|3925967|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4102008|NCT00974376|3925968|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4102009|NCT00974376|3925969|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4102010|NCT00974376|3925967|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4102011|NCT00974376|3925968|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4102012|NCT00974376|3925969|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4102013|NCT00974376|3925967|B3|||Age||years|Mean|34.76|34.76|Standard Deviation|11.32|11.32|||
4102014|NCT00974376|3925968|B2|||Age||years|Mean|34.53|34.53|Standard Deviation|11.99|11.99|||
4102015|NCT00974376|3925969|B1|||Age||years|Mean|34.99|34.99|Standard Deviation|10.68|10.68|||
4102016|NCT00974363|3925976|B3||Male|Sex: Female, Male||Participants|Count of Participants|330|330.0||||||
4102017|NCT00974363|3925977|B2||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4102018|NCT00974363|3925978|B1||Male|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
4102019|NCT00974363|3925976|B3||Female|Sex: Female, Male||Participants|Count of Participants|359|359.0||||||
4102020|NCT00974363|3925977|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4102021|NCT00974363|3925978|B1||Female|Sex: Female, Male||Participants|Count of Participants|273|273.0||||||
4102022|NCT00974363|3925976|B3|||Age||Years|Mean|16.4|16.4|Standard Deviation|1.95|1.95|||
4102023|NCT00974363|3925977|B2|||Age||Years|Mean|16.4|16.4|Standard Deviation|2|2.0|||
4102024|NCT00974363|3925978|B1|||Age||Years|Mean|16.4|16.4|Standard Deviation|1.94|1.94|||
4102025|NCT00974311|3925999|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
4102026|NCT00974311|3926000|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4102027|NCT00974311|3926001|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
4102028|NCT00974311|3925999|B3|Germany||Region of Enrollment||Participants|Count of Participants|86|86.0||||||
4102029|NCT00974311|3926000|B2|Germany||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
4102030|NCT00974311|3926001|B1|Germany||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
4102031|NCT00974311|3925999|B3|South Africa||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4102032|NCT00974311|3926000|B2|South Africa||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4102033|NCT00974311|3926001|B1|South Africa||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4102034|NCT00974311|3925999|B3|Australia||Region of Enrollment||Participants|Count of Participants|93|93.0||||||
4102035|NCT00974311|3926000|B2|Australia||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
4102036|NCT00974311|3926001|B1|Australia||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
4102044|NCT00974311|3926000|B2|Argentina||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4102045|NCT00974311|3926001|B1|Argentina||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4102046|NCT00974311|3925999|B3|Canada||Region of Enrollment||Participants|Count of Participants|107|107.0||||||
4102047|NCT00974311|3926000|B2|Canada||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4102048|NCT00974311|3926001|B1|Canada||Region of Enrollment||Participants|Count of Participants|82|82.0||||||
4102049|NCT00974311|3925999|B3|France||Region of Enrollment||Participants|Count of Participants|273|273.0||||||
4102050|NCT00974311|3926000|B2|France||Region of Enrollment||Participants|Count of Participants|80|80.0||||||
4102051|NCT00974311|3926001|B1|France||Region of Enrollment||Participants|Count of Participants|193|193.0||||||
4102052|NCT00974311|3925999|B3|Italy||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4102053|NCT00974311|3926000|B2|Italy||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4102054|NCT00974311|3926001|B1|Italy||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4102055|NCT00974311|3925999|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|132|132.0||||||
4102056|NCT00974311|3926000|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
4102057|NCT00974311|3926001|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|82|82.0||||||
4102058|NCT00974311|3925999|B3|Chile||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4102059|NCT00974311|3926000|B2|Chile||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4102060|NCT00974311|3926001|B1|Chile||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4102061|NCT00974311|3925999|B3|Austria||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4102062|NCT00974311|3926000|B2|Austria||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4102063|NCT00974311|3926001|B1|Austria||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4102064|NCT00974311|3925999|B3|Spain||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
4102065|NCT00974311|3926000|B2|Spain||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4102066|NCT00974311|3926001|B1|Spain||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4102067|NCT00974311|3925999|B3|United States||Region of Enrollment||Participants|Count of Participants|288|288.0||||||
4102068|NCT00974311|3926000|B2|United States||Region of Enrollment||Participants|Count of Participants|107|107.0||||||
4102069|NCT00974311|3926001|B1|United States||Region of Enrollment||Participants|Count of Participants|181|181.0||||||
4102070|NCT00974311|3925999|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4102071|NCT00974311|3926000|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4102072|NCT00974311|3926001|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4102073|NCT00974311|3925999|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4102074|NCT00974311|3926000|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4102075|NCT00974311|3926001|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4102076|NCT00974311|3925999|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1111|1111.0||||||
4102077|NCT00974311|3926000|B2||White|Race (NIH/OMB)||Participants|Count of Participants|366|366.0||||||
4102078|NCT00974311|3926001|B1||White|Race (NIH/OMB)||Participants|Count of Participants|745|745.0||||||
4102079|NCT00974311|3925999|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4102080|NCT00974311|3926000|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4102081|NCT00974311|3926001|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4102082|NCT00974311|3925999|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4102083|NCT00974311|3926000|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4102084|NCT00974311|3926001|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4102085|NCT00974311|3925999|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4102086|NCT00974311|3926000|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4102087|NCT00974311|3926001|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4102088|NCT00974311|3925999|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4102089|NCT00974311|3926000|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4102090|NCT00974311|3926001|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4102091|NCT00974311|3925999|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4102092|NCT00974311|3926000|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4102093|NCT00974311|3926001|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4102094|NCT00974311|3925999|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1144|1144.0||||||
4102095|NCT00974311|3926000|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|376|376.0||||||
4102096|NCT00974311|3926001|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|768|768.0||||||
4102097|NCT00974311|3925999|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4102098|NCT00974311|3926000|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4102099|NCT00974311|3926001|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4102100|NCT00974311|3925999|B3||Male|Sex: Female, Male||Participants|Count of Participants|1199|1199.0||||||
4102101|NCT00974311|3926000|B2||Male|Sex: Female, Male||Participants|Count of Participants|399|399.0||||||
4102102|NCT00974311|3926001|B1||Male|Sex: Female, Male||Participants|Count of Participants|800|800.0||||||
4102103|NCT00974311|3925999|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4102104|NCT00974311|3926000|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4102105|NCT00974311|3926001|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4102106|NCT00974311|3925999|B3|||Age||years|Mean|68.7|68.7|Standard Deviation|8.11|8.11|||
4102107|NCT00974311|3926000|B2|||Age||years|Mean|68.6|68.6|Standard Deviation|8.39|8.39|||
4102108|NCT00974311|3926001|B1|||Age||years|Mean|68.8|68.8|Standard Deviation|7.96|7.96|||
4102109|NCT00974311|3925999|B3||>=65 years|Age||Participants|Count of Participants|837|837.0||||||
4102110|NCT00974311|3926000|B2||>=65 years|Age||Participants|Count of Participants|269|269.0||||||
4102111|NCT00974311|3926001|B1||>=65 years|Age||Participants|Count of Participants|568|568.0||||||
4102112|NCT00974311|3925999|B3||Between 18 and 65 years|Age||Participants|Count of Participants|362|362.0||||||
4102113|NCT00974311|3926000|B2||Between 18 and 65 years|Age||Participants|Count of Participants|130|130.0||||||
4102114|NCT00974311|3926001|B1||Between 18 and 65 years|Age||Participants|Count of Participants|232|232.0||||||
4102115|NCT00974311|3925999|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4102116|NCT00974311|3926000|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4102117|NCT00974311|3926001|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4102118|NCT00974246|3926038|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4102119|NCT00974246|3926038|B1||Male|Gender||Participants|Count of Participants|7|7.0||||||
4102120|NCT00974246|3926038|B1||Female|Gender||Participants|Count of Participants|20|20.0||||||
4102121|NCT00974246|3926038|B1|||Age||years|Mean|79.7|79.7|Standard Deviation|12.4|12.4|||
4102122|NCT00974233|3926044|B1|No prior therapy with rituximab||Prior therapy with rituximab||participants|Number|7|7.0||||||
4102123|NCT00974233|3926044|B1|Prior therapy with rituximab||Prior therapy with rituximab||participants|Number|27|27.0||||||
4102124|NCT00974233|3926044|B1|Unknown||Baseline cytogenetics||participants|Number|10|10.0||||||
4102125|NCT00974233|3926044|B1|Normal||Baseline cytogenetics||participants|Number|3|3.0||||||
4102126|NCT00974233|3926044|B1|Trisomy 12||Baseline cytogenetics||participants|Number|8|8.0||||||
4102127|NCT00974233|3926044|B1|13q deletion||Baseline cytogenetics||participants|Number|2|2.0||||||
4102128|NCT00974233|3926044|B1|17p or 11q deletions||Baseline cytogenetics||participants|Number|11|11.0||||||
4102129|NCT00974233|3926044|B1|Enrollment LDH not elevated||Elevated serum lactate dehydrogenase (LDH) level|Lactate dehydrogenase (LDH) is associated with cell growth and turnover in the body. Higher levels of LDH tend to be associated with more rapid tumor growth and is a marker of higher risk lymphoma/leukemia.|participants|Number|14|14.0||||||
4102130|NCT00974233|3926044|B1|Enrollment LDH elevated||Elevated serum lactate dehydrogenase (LDH) level|Lactate dehydrogenase (LDH) is associated with cell growth and turnover in the body. Higher levels of LDH tend to be associated with more rapid tumor growth and is a marker of higher risk lymphoma/leukemia.|participants|Number|20|20.0||||||
4102131|NCT00974233|3926044|B1|Not refractory to most recent therapy||Refractory to most recent therapy||participants|Number|30|30.0||||||
4102132|NCT00974233|3926044|B1|Refractory to most recent therapy||Refractory to most recent therapy||participants|Number|4|4.0||||||
4102133|NCT00974233|3926044|B1|No previous fludrarabine exposure||Prior therapy with fludarabine||participants|Number|11|11.0||||||
4102134|NCT00974233|3926044|B1|Prior fludarabine-based therapy||Prior therapy with fludarabine||participants|Number|23|23.0||||||
4102135|NCT00974233|3926044|B1|||Median prior therapies|Describes number of unique prior therapies received by subjects, including monoclonal antibody therapy (i.e., single-agent rituximab) or cytotoxic chemotherapy-based therapies. Retreatment with an identical regimen was not counted as a unique therapy. Subjects required at least one cytotoxic chemotherapy-based therapy for eligibility.|prior therapies|Median|2|2.0|Full Range|||1.0|4.0|
4102136|NCT00974233|3926044|B1|Ann Arbor 3/4 (SLL)||Disease staging|"Rai staging is a clinical evaluation taking into account blood counts and physical exam findings, with staging ranging from 0-4 (more advanced staging corresponding with higher numbers).~Ann Arbor staging is an evaluation of physical exam finding combined with imaging evaluation (usually CT imaging) to determine extent of lymph node enlargement, with staging ranging from 1-4 (more advanced staging corresponding with higher numbers)."|participants|Number|7|7.0||||||
4102137|NCT00974233|3926044|B1|Ann Arbor stage 1/2 (SLL)||Disease staging|"Rai staging is a clinical evaluation taking into account blood counts and physical exam findings, with staging ranging from 0-4 (more advanced staging corresponding with higher numbers).~Ann Arbor staging is an evaluation of physical exam finding combined with imaging evaluation (usually CT imaging) to determine extent of lymph node enlargement, with staging ranging from 1-4 (more advanced staging corresponding with higher numbers)."|participants|Number|1|1.0||||||
4102138|NCT00974233|3926044|B1|Rai stage 3/4 (CLL)||Disease staging|"Rai staging is a clinical evaluation taking into account blood counts and physical exam findings, with staging ranging from 0-4 (more advanced staging corresponding with higher numbers).~Ann Arbor staging is an evaluation of physical exam finding combined with imaging evaluation (usually CT imaging) to determine extent of lymph node enlargement, with staging ranging from 1-4 (more advanced staging corresponding with higher numbers)."|participants|Number|14|14.0||||||
4102139|NCT00974233|3926044|B1|Rai stage 1/2 (CLL)||Disease staging|"Rai staging is a clinical evaluation taking into account blood counts and physical exam findings, with staging ranging from 0-4 (more advanced staging corresponding with higher numbers).~Ann Arbor staging is an evaluation of physical exam finding combined with imaging evaluation (usually CT imaging) to determine extent of lymph node enlargement, with staging ranging from 1-4 (more advanced staging corresponding with higher numbers)."|participants|Number|12|12.0||||||
4102196|NCT00974142|3926068|B3|||Forced Expiratory Volume 1 second (%)||% predicted|Median|39|39.0|Full Range|||27.0|58.0|
4102140|NCT00974233|3926044|B1|ECOG performance status 2||ECOG performance status|ECOG performance status (PS) evaluated clinically in all patients on a scale from 0-5, with higher ECOG PS indicating worse functional impairment (i.e., ECOG PS of zero = asymptomatic, fully functional patient; ECOG PS of 5 = death).|participants|Number|2|2.0||||||
4102141|NCT00974233|3926044|B1|ECOG performance status 0-1||ECOG performance status|ECOG performance status (PS) evaluated clinically in all patients on a scale from 0-5, with higher ECOG PS indicating worse functional impairment (i.e., ECOG PS of zero = asymptomatic, fully functional patient; ECOG PS of 5 = death).|participants|Number|32|32.0||||||
4102142|NCT00974233|3926044|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4102143|NCT00974233|3926044|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4102144|NCT00974233|3926044|B1|||Age||years|Median|67|67.0|Full Range|||48.0|86.0|
4102145|NCT00974220|3926057|B3|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4102146|NCT00974220|3926058|B2|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4102147|NCT00974220|3926059|B1|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4102148|NCT00974220|3926057|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4102149|NCT00974220|3926058|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4102150|NCT00974220|3926059|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4102151|NCT00974220|3926057|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4102152|NCT00974220|3926058|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4102153|NCT00974220|3926059|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4102154|NCT00974220|3926057|B3|||Age||years|Mean|68|68.0|Standard Deviation|9|9.0|||
4102155|NCT00974220|3926058|B2|||Age||years|Mean|66|66.0|Standard Deviation|10|10.0|||
4102156|NCT00974220|3926059|B1|||Age||years|Mean|69|69.0|Standard Deviation|8|8.0|||
4102157|NCT00974142|3926068|B3|||Cholesterol||mg / dL|Mean|183|183.0|Standard Deviation|20|20.0|||
4102158|NCT00974142|3926069|B2|||Cholesterol||mg / dL|Mean|193|193.0|Standard Deviation|20|20.0|||
4102159|NCT00974142|3926070|B1|||Cholesterol||mg / dL|Mean|183|183.0|Standard Deviation|30|30.0|||
4102160|NCT00974142|3926068|B3|||Glucose||mg / dL|Mean|111|111.0|Standard Deviation|29|29.0|||
4102161|NCT00974142|3926069|B2|||Glucose||mg / dL|Mean|113|113.0|Standard Deviation|29|29.0|||
4102162|NCT00974142|3926070|B1|||Glucose||mg / dL|Mean|102|102.0|Standard Deviation|13|13.0|||
4102163|NCT00974142|3926068|B3|||Creatinine||mg / dL|Mean|0.9|0.9|Standard Deviation|0.2|0.2|||
4102164|NCT00974142|3926069|B2|||Creatinine||mg / dL|Mean|0.9|0.9|Standard Deviation|0.2|0.2|||
4102165|NCT00974142|3926070|B1|||Creatinine||mg / dL|Mean|0.9|0.9|Standard Deviation|0.2|0.2|||
4102166|NCT00974142|3926068|B3|||Blood Urea Nitrogen||mg / dL|Mean|13.4|13.4|Standard Deviation|3.9|3.9|||
4102167|NCT00974142|3926069|B2|||Blood Urea Nitrogen||mg / dL|Mean|13|13.0|Standard Deviation|3.2|3.2|||
4102168|NCT00974142|3926070|B1|||Blood Urea Nitrogen||mg / dL|Mean|16|16.0|Standard Deviation|5.4|5.4|||
4102169|NCT00974142|3926068|B3|||Hemoglobin||grams / dL|Mean|13.7|13.7|Standard Deviation|1.03|1.03|||
4102170|NCT00974142|3926069|B2|||Hemoglobin||grams / dL|Mean|13.6|13.6|Standard Deviation|0.9|0.9|||
4102171|NCT00974142|3926070|B1|||Hemoglobin||grams / dL|Mean|13.7|13.7|Standard Deviation|1.0|1.0|||
4102172|NCT00974142|3926068|B3|||White blood cell count||x10E ^09/L|Mean|7.1|7.1|Standard Deviation|2.2|2.2|||
4102173|NCT00974142|3926069|B2|||White blood cell count||x10E ^09/L|Mean|6.6|6.6|Standard Deviation|2.0|2.0|||
4102174|NCT00974142|3926070|B1|||White blood cell count||x10E ^09/L|Mean|7.3|7.3|Standard Deviation|1.3|1.3|||
4102175|NCT00974142|3926068|B3|||Diastolic blood pressure (mm Hg)||mm Hg|Median|79|79.0|Full Range|||70.0|95.0|
4102176|NCT00974142|3926069|B2|||Diastolic blood pressure (mm Hg)||mm Hg|Median|78|78.0|Full Range|||70.0|91.0|
4102177|NCT00974142|3926070|B1|||Diastolic blood pressure (mm Hg)||mm Hg|Median|82|82.0|Full Range|||71.0|95.0|
4102178|NCT00974142|3926068|B3|||Systolic blood pressure (mm Hg)||mm Hg|Median|138|138.0|Full Range|||104.0|152.0|
4102179|NCT00974142|3926069|B2|||Systolic blood pressure (mm Hg)||mm Hg|Median|133|133.0|Full Range|||104.0|150.0|
4102180|NCT00974142|3926070|B1|||Systolic blood pressure (mm Hg)||mm Hg|Median|141|141.0|Full Range|||125.0|152.0|
4102181|NCT00974142|3926068|B3|||Weight||kilograms|Median|84|84.0|Full Range|||55.0|119.0|
4102182|NCT00974142|3926069|B2|||Weight||kilograms|Median|93|93.0|Full Range|||55.0|119.0|
4102183|NCT00974142|3926070|B1|||Weight||kilograms|Median|83|83.0|Full Range|||60.0|105.0|
4102184|NCT00974142|3926068|B3|||Partial pressure of oxygen (pO2)||mm Hg|Mean|74|74.0|Standard Deviation|15|15.0|||
4102185|NCT00974142|3926069|B2|||Partial pressure of oxygen (pO2)||mm Hg|Mean|76|76.0|Standard Deviation|20|20.0|||
4102186|NCT00974142|3926070|B1|||Partial pressure of oxygen (pO2)||mm Hg|Mean|71|71.0|Standard Deviation|11|11.0|||
4102187|NCT00974142|3926068|B3|||Partial pressure of carbon dioxide (pCO2)||mm Hg|Mean|41.2|41.2|Standard Deviation|3.7|3.7|||
4102188|NCT00974142|3926069|B2|||Partial pressure of carbon dioxide (pCO2)||mm Hg|Mean|42.6|42.6|Standard Deviation|3.9|3.9|||
4102189|NCT00974142|3926070|B1|||Partial pressure of carbon dioxide (pCO2)||mm Hg|Mean|40|40.0|Standard Deviation|3.6|3.6|||
4102190|NCT00974142|3926068|B3|||Total Lung Capacity (%)||% predicted|Median|119|119.0|Full Range|||84.0|145.0|
4102191|NCT00974142|3926069|B2|||Total Lung Capacity (%)||% predicted|Median|119|119.0|Full Range|||84.0|138.0|
4102192|NCT00974142|3926070|B1|||Total Lung Capacity (%)||% predicted|Median|123|123.0|Full Range|||100.0|145.0|
4102193|NCT00974142|3926068|B3|||Functional Residual Capacity (%)||% predicted|Median|149|149.0|Full Range|||81.0|180.0|
4102194|NCT00974142|3926069|B2|||Functional Residual Capacity (%)||% predicted|Median|149|149.0|Full Range|||81.0|170.0|
4102195|NCT00974142|3926070|B1|||Functional Residual Capacity (%)||% predicted|Median|146|146.0|Full Range|||108.0|180.0|
4102256|NCT00973921|3926203|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4102197|NCT00974142|3926069|B2|||Forced Expiratory Volume 1 second (%)||% predicted|Median|43|43.0|Full Range|||27.0|58.0|
4102198|NCT00974142|3926070|B1|||Forced Expiratory Volume 1 second (%)||% predicted|Median|38|38.0|Full Range|||31.0|54.0|
4102199|NCT00974142|3926068|B3|||Forced Vital Capacity (%)||% predicted|Median|79|79.0|Inter-Quartile Range|||60.0|105.0|
4102200|NCT00974142|3926069|B2|||Forced Vital Capacity (%)||% predicted|Median|77|77.0|Inter-Quartile Range|||60.0|94.0|
4102201|NCT00974142|3926070|B1|||Forced Vital Capacity (%)||% predicted|Median|88|88.0|Inter-Quartile Range|||71.0|105.0|
4102202|NCT00974142|3926068|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4102203|NCT00974142|3926069|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4102204|NCT00974142|3926070|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4102205|NCT00974142|3926068|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4102206|NCT00974142|3926069|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4102207|NCT00974142|3926070|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4102208|NCT00974142|3926068|B3|||Age||years|Median|67|67.0|Full Range|||48.0|79.0|
4102209|NCT00974142|3926069|B2|||Age||years|Median|63|63.0|Full Range|||48.0|77.0|
4102210|NCT00974142|3926070|B1|||Age||years|Median|68|68.0|Full Range|||55.0|79.0|
4102211|NCT00974090|3926103|B3||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4102212|NCT00974090|3926104|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4102213|NCT00974090|3926105|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4102214|NCT00974090|3926103|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4102215|NCT00974090|3926104|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4102216|NCT00974090|3926105|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4102217|NCT00974090|3926103|B3|||Age||years|Mean|59.4|59.4|Standard Deviation|8.2|8.2|||
4102218|NCT00974090|3926104|B2|||Age||years|Mean|58.4|58.4|Standard Deviation|8.6|8.6|||
4102219|NCT00974090|3926105|B1|||Age||years|Mean|60.3|60.3|Standard Deviation|7.8|7.8|||
4102220|NCT00974051|3926120|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4102221|NCT00974051|3926120|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4102222|NCT00974051|3926120|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4102223|NCT00974051|3926120|B1|||Age||years|Mean|13.3|13.3|Standard Deviation|1.8|1.8|||
4102224|NCT00974051|3926120|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4102225|NCT00974051|3926120|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4102226|NCT00974051|3926120|B1||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4102227|NCT00973973|3926140|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4102228|NCT00973973|3926141|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4102229|NCT00973973|3926142|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4102230|NCT00973973|3926140|B3||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4102231|NCT00973973|3926141|B2||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4102232|NCT00973973|3926142|B1||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4102233|NCT00973973|3926140|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|112|112.0||||||
4102234|NCT00973973|3926141|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|55|55.0||||||
4102235|NCT00973973|3926142|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|57|57.0||||||
4102236|NCT00973973|3926140|B3||Black|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4102237|NCT00973973|3926141|B2||Black|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4102238|NCT00973973|3926142|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4102239|NCT00973973|3926140|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4102240|NCT00973973|3926141|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4102241|NCT00973973|3926142|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4102242|NCT00973973|3926140|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4102243|NCT00973973|3926141|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4102244|NCT00973973|3926142|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4102245|NCT00973973|3926140|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4102246|NCT00973973|3926141|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4102247|NCT00973973|3926142|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4102248|NCT00973973|3926140|B3||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4102249|NCT00973973|3926141|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4102250|NCT00973973|3926142|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4102251|NCT00973973|3926140|B3|||Age||years|Mean|32.9|32.9|Standard Deviation|0.6|0.6|||
4102252|NCT00973973|3926141|B2|||Age||years|Mean|32.8|32.8|Standard Deviation|0.7|0.7|||
4102253|NCT00973973|3926142|B1|||Age||years|Mean|33.0|33.0|Standard Deviation|0.9|0.9|||
4102254|NCT00973921|3926203|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4102255|NCT00973921|3926203|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4102257|NCT00973921|3926203|B1|||Age||years|Mean|62.2|62.2|Standard Deviation|9.2|9.2|||
4102258|NCT00973921|3926203|B1||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4102259|NCT00973921|3926203|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4102260|NCT00973921|3926203|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4102261|NCT00973765|3926210|B3|United States||Region of Enrollment||participants|Number|212|212.0||||||
4102262|NCT00973765|3926211|B2|United States||Region of Enrollment||participants|Number|116|116.0||||||
4102263|NCT00973765|3926212|B1|United States||Region of Enrollment||participants|Number|96|96.0||||||
4102264|NCT00973765|3926210|B3||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4102265|NCT00973765|3926211|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4102266|NCT00973765|3926212|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4102267|NCT00973765|3926210|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4102268|NCT00973765|3926211|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4102269|NCT00973765|3926212|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4102270|NCT00973765|3926210|B3|||Age||years|Mean|31.3|31.3|Standard Deviation|12.8|12.8|||
4102271|NCT00973765|3926211|B2|||Age||years|Mean|31.1|31.1|Standard Deviation|12.5|12.5|||
4102272|NCT00973765|3926212|B1|||Age||years|Mean|31.5|31.5|Standard Deviation|13.3|13.3|||
4102273|NCT00973765|3926210|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4102274|NCT00973765|3926211|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4102275|NCT00973765|3926212|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4102276|NCT00973765|3926210|B3||Between 18 and 65 years|Age||Participants|Count of Participants|210|210.0||||||
4102277|NCT00973765|3926211|B2||Between 18 and 65 years|Age||Participants|Count of Participants|116|116.0||||||
4102278|NCT00973765|3926212|B1||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
4102279|NCT00973765|3926210|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4102280|NCT00973765|3926211|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4102281|NCT00973765|3926212|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4102282|NCT00973752|3926219|B1|T-cell ALL||Immunophenotype|acute lymphoblastic leukemia (ALL) immunophenotype|Participants|Count of Participants|1|1.0||||||
4102283|NCT00973752|3926219|B1|B-cell ALL||Immunophenotype|acute lymphoblastic leukemia (ALL) immunophenotype|Participants|Count of Participants|29|29.0||||||
4102284|NCT00973752|3926219|B1|Mixed lineage leukemia rearrangement||Chromosomal alterations||Participants|Count of Participants|2|2.0||||||
4102285|NCT00973752|3926219|B1|Philadelphia chromosome positive||Chromosomal alterations||Participants|Count of Participants|12|12.0||||||
4102286|NCT00973752|3926219|B1|ECOG 2||Performance status|"Eastern Cooperative Oncology Group Performance Status 0 Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any self-care totally confined to bed or chair~Dead"|Participants|Count of Participants|5|5.0||||||
4102287|NCT00973752|3926219|B1|ECOG 1||Performance status|"Eastern Cooperative Oncology Group Performance Status 0 Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any self-care totally confined to bed or chair~Dead"|Participants|Count of Participants|11|11.0||||||
4102288|NCT00973752|3926219|B1|ECOG 0||Performance status|"Eastern Cooperative Oncology Group Performance Status 0 Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any self-care totally confined to bed or chair~Dead"|Participants|Count of Participants|14|14.0||||||
4102289|NCT00973752|3926219|B1|||White blood cell count||10^3 cell per μL|Median|10.4|10.4|Full Range|||0.7|570.0|
4102290|NCT00973752|3926219|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4102291|NCT00973752|3926219|B1|Not Available||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4102292|NCT00973752|3926219|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
4102293|NCT00973752|3926219|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4102294|NCT00973752|3926219|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4102295|NCT00973752|3926219|B1|||Age||years|Median|58|58.0|Full Range|||51.0|72.0|
4102296|NCT00973739|3926223|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4102297|NCT00973739|3926223|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4102298|NCT00973739|3926223|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4102299|NCT00973739|3926223|B1|||Age||years|Mean|28|28.0|Standard Deviation|5|5.0|||
4102300|NCT00973739|3926223|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4102301|NCT00973739|3926223|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4102302|NCT00973739|3926223|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4102303|NCT00973700|3926230|B6|Male (18 to 64 years)||Sex/Gender, Customized||Subjects|Number|165|165.0||||||
4102304|NCT00973700|3926231|B5|Male (18 to 64 years)||Sex/Gender, Customized||Subjects|Number|27|27.0||||||
4102305|NCT00973700|3926232|B4|Male (18 to 64 years)||Sex/Gender, Customized||Subjects|Number|72|72.0||||||
4102306|NCT00973700|3926233|B3|Male (18 to 64 years)||Sex/Gender, Customized||Subjects|Number|27|27.0||||||
4102307|NCT00973700|3926234|B2|Male (18 to 64 years)||Sex/Gender, Customized||Subjects|Number|16|16.0||||||
4102308|NCT00973700|3926235|B1|Male (18 to 64 years)||Sex/Gender, Customized||Subjects|Number|23|23.0||||||
4102309|NCT00973700|3926230|B6|Female (18 to 64 years)||Sex/Gender, Customized||Subjects|Number|227|227.0||||||
4102310|NCT00973700|3926231|B5|Female (18 to 64 years)||Sex/Gender, Customized||Subjects|Number|29|29.0||||||
4102311|NCT00973700|3926232|B4|Female (18 to 64 years)||Sex/Gender, Customized||Subjects|Number|96|96.0||||||
4102312|NCT00973700|3926233|B3|Female (18 to 64 years)||Sex/Gender, Customized||Subjects|Number|29|29.0||||||
4102313|NCT00973700|3926234|B2|Female (18 to 64 years)||Sex/Gender, Customized||Subjects|Number|40|40.0||||||
4102314|NCT00973700|3926235|B1|Female (18 to 64 years)||Sex/Gender, Customized||Subjects|Number|33|33.0||||||
4102315|NCT00973700|3926230|B6|Male (9 to 17 years)||Sex/Gender, Customized||Subjects|Number|86|86.0||||||
4102316|NCT00973700|3926231|B5|Male (9 to 17 years)||Sex/Gender, Customized||Subjects|Number|26|26.0||||||
4102317|NCT00973700|3926232|B4|Male (9 to 17 years)||Sex/Gender, Customized||Subjects|Number|44|44.0||||||
4102318|NCT00973700|3926233|B3|Male (9 to 17 years)||Sex/Gender, Customized||Subjects|Number|16|16.0||||||
4102319|NCT00973700|3926234|B2|Male (9 to 17 years)||Sex/Gender, Customized||Subjects|Number|0|0.0||||||
4102320|NCT00973700|3926235|B1|Male (9 to 17 years)||Sex/Gender, Customized||Subjects|Number|0|0.0||||||
4102321|NCT00973700|3926230|B6|Female (9 to 17 years)||Sex/Gender, Customized||Subjects|Number|110|110.0||||||
4102322|NCT00973700|3926231|B5|Female (9 to 17 years)||Sex/Gender, Customized||Subjects|Number|30|30.0||||||
4102323|NCT00973700|3926232|B4|Female (9 to 17 years)||Sex/Gender, Customized||Subjects|Number|40|40.0||||||
4102324|NCT00973700|3926233|B3|Female (9 to 17 years)||Sex/Gender, Customized||Subjects|Number|40|40.0||||||
4102325|NCT00973700|3926234|B2|Female (9 to 17 years)||Sex/Gender, Customized||Subjects|Number|0|0.0||||||
4102326|NCT00973700|3926235|B1|Female (9 to 17 years)||Sex/Gender, Customized||Subjects|Number|0|0.0||||||
4102327|NCT00973700|3926230|B6|Male (3 to < 9 years)||Sex/Gender, Customized||Subjects|Number|98|98.0||||||
4102328|NCT00973700|3926231|B5|Male (3 to < 9 years)||Sex/Gender, Customized||Subjects|Number|33|33.0||||||
4102329|NCT00973700|3926232|B4|Male (3 to < 9 years)||Sex/Gender, Customized||Subjects|Number|38|38.0||||||
4102330|NCT00973700|3926233|B3|Male (3 to < 9 years)||Sex/Gender, Customized||Subjects|Number|27|27.0||||||
4102331|NCT00973700|3926234|B2|Male (3 to < 9 years)||Sex/Gender, Customized||Subjects|Number|0|0.0||||||
4102332|NCT00973700|3926235|B1|Male (3 to < 9 years)||Sex/Gender, Customized||Subjects|Number|0|0.0||||||
4102333|NCT00973700|3926230|B6|Female (3 to <9 years)||Sex/Gender, Customized||Subjects|Number|98|98.0||||||
4102334|NCT00973700|3926231|B5|Female (3 to <9 years)||Sex/Gender, Customized||Subjects|Number|23|23.0||||||
4102335|NCT00973700|3926232|B4|Female (3 to <9 years)||Sex/Gender, Customized||Subjects|Number|46|46.0||||||
4102336|NCT00973700|3926233|B3|Female (3 to <9 years)||Sex/Gender, Customized||Subjects|Number|29|29.0||||||
4102337|NCT00973700|3926234|B2|Female (3 to <9 years)||Sex/Gender, Customized||Subjects|Number|0|0.0||||||
4102338|NCT00973700|3926235|B1|Female (3 to <9 years)||Sex/Gender, Customized||Subjects|Number|0|0.0||||||
4102339|NCT00973700|3926230|B6|18 to 64 years||Age, Customized|The number of participants analyzed for each outcome measure below is not the same with the numbers provided in the participant flow module as this number is based on the age and/or the group analyses.|subjects|Number|392|392.0||||||
4102340|NCT00973700|3926231|B5|18 to 64 years||Age, Customized|The number of participants analyzed for each outcome measure below is not the same with the numbers provided in the participant flow module as this number is based on the age and/or the group analyses.|subjects|Number|56|56.0||11.0|11.0|||
4102341|NCT00973700|3926232|B4|18 to 64 years||Age, Customized|The number of participants analyzed for each outcome measure below is not the same with the numbers provided in the participant flow module as this number is based on the age and/or the group analyses.|subjects|Number|168|168.0||11.7|11.7|||
4102342|NCT00973700|3926233|B3|18 to 64 years||Age, Customized|The number of participants analyzed for each outcome measure below is not the same with the numbers provided in the participant flow module as this number is based on the age and/or the group analyses.|subjects|Number|56|56.0||11.2|11.2|||
4102343|NCT00973700|3926234|B2|18 to 64 years||Age, Customized|The number of participants analyzed for each outcome measure below is not the same with the numbers provided in the participant flow module as this number is based on the age and/or the group analyses.|subjects|Number|56|56.0||11.1|11.1|||
4102344|NCT00973700|3926235|B1|18 to 64 years||Age, Customized|The number of participants analyzed for each outcome measure below is not the same with the numbers provided in the participant flow module as this number is based on the age and/or the group analyses.|subjects|Number|56|56.0||10.8|10.8|||
4102345|NCT00973700|3926230|B6|9 to 17 years||Age, Customized|The number of participants analyzed for each outcome measure below is not the same with the numbers provided in the participant flow module as this number is based on the age and/or the group analyses.|subjects|Number|196|196.0||||||
4102346|NCT00973700|3926231|B5|9 to 17 years||Age, Customized|The number of participants analyzed for each outcome measure below is not the same with the numbers provided in the participant flow module as this number is based on the age and/or the group analyses.|subjects|Number|56|56.0||2.5|2.5|||
4102347|NCT00973700|3926232|B4|9 to 17 years||Age, Customized|The number of participants analyzed for each outcome measure below is not the same with the numbers provided in the participant flow module as this number is based on the age and/or the group analyses.|subjects|Number|84|84.0||2.3|2.3|||
4102348|NCT00973700|3926233|B3|9 to 17 years||Age, Customized|The number of participants analyzed for each outcome measure below is not the same with the numbers provided in the participant flow module as this number is based on the age and/or the group analyses.|subjects|Number|56|56.0||2.5|2.5|||
4102349|NCT00973700|3926234|B2|9 to 17 years||Age, Customized|The number of participants analyzed for each outcome measure below is not the same with the numbers provided in the participant flow module as this number is based on the age and/or the group analyses.|subjects|Number|0|0.0||0|0.0|||
4102350|NCT00973700|3926235|B1|9 to 17 years||Age, Customized|The number of participants analyzed for each outcome measure below is not the same with the numbers provided in the participant flow module as this number is based on the age and/or the group analyses.|subjects|Number|0|0.0||0|0.0|||
4102351|NCT00973700|3926230|B6|3 to < 9 years||Age, Customized|The number of participants analyzed for each outcome measure below is not the same with the numbers provided in the participant flow module as this number is based on the age and/or the group analyses.|subjects|Number|196|196.0||||||
4102352|NCT00973700|3926231|B5|3 to < 9 years||Age, Customized|The number of participants analyzed for each outcome measure below is not the same with the numbers provided in the participant flow module as this number is based on the age and/or the group analyses.|subjects|Number|56|56.0||1.9|1.9|||
4102353|NCT00973700|3926232|B4|3 to < 9 years||Age, Customized|The number of participants analyzed for each outcome measure below is not the same with the numbers provided in the participant flow module as this number is based on the age and/or the group analyses.|subjects|Number|84|84.0||1.7|1.7|||
4102354|NCT00973700|3926233|B3|3 to < 9 years||Age, Customized|The number of participants analyzed for each outcome measure below is not the same with the numbers provided in the participant flow module as this number is based on the age and/or the group analyses.|subjects|Number|56|56.0||1.7|1.7|||
4102355|NCT00973700|3926234|B2|3 to < 9 years||Age, Customized|The number of participants analyzed for each outcome measure below is not the same with the numbers provided in the participant flow module as this number is based on the age and/or the group analyses.|subjects|Number|0|0.0||0|0.0|||
4102356|NCT00973700|3926235|B1|3 to < 9 years||Age, Customized|The number of participants analyzed for each outcome measure below is not the same with the numbers provided in the participant flow module as this number is based on the age and/or the group analyses.|subjects|Number|0|0.0||0|0.0|||
4102357|NCT00973622|3926286|B3|United States||Region of Enrollment||participants|Number|66|66.0||||||
4102358|NCT00973622|3926287|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4102359|NCT00973622|3926288|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
4102360|NCT00973622|3926286|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4102361|NCT00973622|3926287|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4102362|NCT00973622|3926288|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4102363|NCT00973622|3926286|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4102364|NCT00973622|3926287|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4102365|NCT00973622|3926288|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4102366|NCT00973622|3926286|B3|||Age||years|Mean|41.45|41.45|Standard Deviation|10.39|10.39|||
4102367|NCT00973622|3926287|B2|||Age||years|Mean|39.16|39.16|Standard Deviation|11.21|11.21|||
4102368|NCT00973622|3926288|B1|||Age||years|Mean|42.38|42.38|Standard Deviation|10.01|10.01|||
4102369|NCT00973622|3926286|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4102370|NCT00973622|3926287|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4102371|NCT00973622|3926288|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4102372|NCT00973622|3926286|B3||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4102373|NCT00973622|3926287|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4102374|NCT00973622|3926288|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4102375|NCT00973622|3926286|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4102376|NCT00973622|3926287|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4102377|NCT00973622|3926288|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4102378|NCT00973479|3926295|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4102379|NCT00973479|3926296|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4102380|NCT00973479|3926297|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4102381|NCT00973479|3926295|B3|Ukraine||Region of Enrollment||participants|Number|90|90.0||||||
4102382|NCT00973479|3926296|B2|Ukraine||Region of Enrollment||participants|Number|58|58.0||||||
4102383|NCT00973479|3926297|B1|Ukraine||Region of Enrollment||participants|Number|32|32.0||||||
4102384|NCT00973479|3926295|B3|Russian Federation||Region of Enrollment||participants|Number|69|69.0||||||
4102385|NCT00973479|3926296|B2|Russian Federation||Region of Enrollment||participants|Number|46|46.0||||||
4102386|NCT00973479|3926297|B1|Russian Federation||Region of Enrollment||participants|Number|23|23.0||||||
4102387|NCT00973479|3926295|B3|Poland||Region of Enrollment||participants|Number|101|101.0||||||
4102388|NCT00973479|3926296|B2|Poland||Region of Enrollment||participants|Number|65|65.0||||||
4102389|NCT00973479|3926297|B1|Poland||Region of Enrollment||participants|Number|36|36.0||||||
4102390|NCT00973479|3926295|B3|New Zealand||Region of Enrollment||participants|Number|6|6.0||||||
4102391|NCT00973479|3926296|B2|New Zealand||Region of Enrollment||participants|Number|4|4.0||||||
4102392|NCT00973479|3926297|B1|New Zealand||Region of Enrollment||participants|Number|2|2.0||||||
4102393|NCT00973479|3926295|B3|Mexico||Region of Enrollment||participants|Number|38|38.0||||||
4102394|NCT00973479|3926296|B2|Mexico||Region of Enrollment||participants|Number|25|25.0||||||
4102395|NCT00973479|3926297|B1|Mexico||Region of Enrollment||participants|Number|13|13.0||||||
4102396|NCT00973479|3926295|B3|Malaysia||Region of Enrollment||participants|Number|26|26.0||||||
4102397|NCT00973479|3926296|B2|Malaysia||Region of Enrollment||participants|Number|18|18.0||||||
4102398|NCT00973479|3926297|B1|Malaysia||Region of Enrollment||participants|Number|8|8.0||||||
4102399|NCT00973479|3926295|B3|Lithuania||Region of Enrollment||participants|Number|64|64.0||||||
4102400|NCT00973479|3926296|B2|Lithuania||Region of Enrollment||participants|Number|44|44.0||||||
4102401|NCT00973479|3926297|B1|Lithuania||Region of Enrollment||participants|Number|20|20.0||||||
4102402|NCT00973479|3926295|B3|Korea, Republic of||Region of Enrollment||participants|Number|16|16.0||||||
4102403|NCT00973479|3926296|B2|Korea, Republic of||Region of Enrollment||participants|Number|12|12.0||||||
4102404|NCT00973479|3926297|B1|Korea, Republic of||Region of Enrollment||participants|Number|4|4.0||||||
4102405|NCT00973479|3926295|B3|Hungary||Region of Enrollment||participants|Number|31|31.0||||||
4102406|NCT00973479|3926296|B2|Hungary||Region of Enrollment||participants|Number|21|21.0||||||
4102407|NCT00973479|3926297|B1|Hungary||Region of Enrollment||participants|Number|10|10.0||||||
4102408|NCT00973479|3926295|B3|Columbia||Region of Enrollment||participants|Number|37|37.0||||||
4102409|NCT00973479|3926296|B2|Columbia||Region of Enrollment||participants|Number|25|25.0||||||
4102410|NCT00973479|3926297|B1|Columbia||Region of Enrollment||participants|Number|12|12.0||||||
4102411|NCT00973479|3926295|B3|Australia||Region of Enrollment||participants|Number|9|9.0||||||
4102412|NCT00973479|3926296|B2|Australia||Region of Enrollment||participants|Number|6|6.0||||||
4102413|NCT00973479|3926297|B1|Australia||Region of Enrollment||participants|Number|3|3.0||||||
4102414|NCT00973479|3926295|B3|Argentina||Region of Enrollment||participants|Number|82|82.0||||||
4102415|NCT00973479|3926296|B2|Argentina||Region of Enrollment||participants|Number|54|54.0||||||
4102416|NCT00973479|3926297|B1|Argentina||Region of Enrollment||participants|Number|28|28.0||||||
4102417|NCT00973479|3926295|B3||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4102418|NCT00973479|3926296|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4102419|NCT00973479|3926297|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4102420|NCT00973479|3926295|B3||Female|Sex: Female, Male||Participants|Count of Participants|483|483.0||||||
4102421|NCT00973479|3926296|B2||Female|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
4102422|NCT00973479|3926297|B1||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4102423|NCT00973479|3926295|B3|||Age||years|Mean|51.8|51.8|Standard Deviation|12.13|12.13|||
4102424|NCT00973479|3926296|B2|||Age||years|Mean|51.9|51.9|Standard Deviation|12.55|12.55|||
4102425|NCT00973479|3926297|B1|||Age||years|Mean|51.4|51.4|Standard Deviation|11.26|11.26|||
4102426|NCT00973362|3926314|B3|United States||Region of Enrollment||participants|Number|11829|11829.0||||||
4102427|NCT00973362|3926315|B2|United States||Region of Enrollment||participants|Number|958|958.0||||||
4102428|NCT00973362|3926316|B1|United States||Region of Enrollment||participants|Number|10871|10871.0||||||
4102429|NCT00973362|3926314|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1914|1914.0||||||
4102430|NCT00973362|3926315|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
4102431|NCT00973362|3926316|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1808|1808.0||||||
4102432|NCT00973362|3926314|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|156|156.0||||||
4102433|NCT00973362|3926315|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4102434|NCT00973362|3926316|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
4102435|NCT00973362|3926314|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7397|7397.0||||||
4102436|NCT00973362|3926315|B2||White|Race (NIH/OMB)||Participants|Count of Participants|566|566.0||||||
4102437|NCT00973362|3926316|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6831|6831.0||||||
4102438|NCT00973362|3926314|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1576|1576.0||||||
4102439|NCT00973362|3926315|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|218|218.0||||||
4102440|NCT00973362|3926316|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1358|1358.0||||||
4102441|NCT00973362|3926314|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4102442|NCT00973362|3926315|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4102443|NCT00973362|3926316|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4102444|NCT00973362|3926314|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|649|649.0||||||
4102445|NCT00973362|3926315|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4102446|NCT00973362|3926316|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|622|622.0||||||
4102447|NCT00973362|3926314|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
4102448|NCT00973362|3926315|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4102449|NCT00973362|3926316|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
4102450|NCT00973362|3926314|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|620|620.0||||||
4102451|NCT00973362|3926315|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4102452|NCT00973362|3926316|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|569|569.0||||||
4102453|NCT00973362|3926314|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7593|7593.0||||||
4102454|NCT00973362|3926315|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|712|712.0||||||
4102455|NCT00973362|3926316|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6881|6881.0||||||
4102456|NCT00973362|3926314|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3616|3616.0||||||
4102457|NCT00973362|3926315|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|195|195.0||||||
4102458|NCT00973362|3926316|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3421|3421.0||||||
4102459|NCT00973362|3926314|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
4102460|NCT00973362|3926315|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
4102461|NCT00973362|3926316|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4102462|NCT00973362|3926314|B3||Female|Gender||Participants|Count of Participants|11829|11829.0||||||
4102463|NCT00973362|3926315|B2||Female|Gender||Participants|Count of Participants|958|958.0||||||
4102464|NCT00973362|3926316|B1||Female|Gender||Participants|Count of Participants|10871|10871.0||||||
4102465|NCT00973362|3926314|B3|40+ years||Age, Customized||participants|Number|6946|6946.0||||||
4102466|NCT00973362|3926315|B2|40+ years||Age, Customized||participants|Number|274|274.0||||||
4102467|NCT00973362|3926316|B1|40+ years||Age, Customized||participants|Number|6672|6672.0||||||
4102468|NCT00973362|3926314|B3|30 - <40 years||Age, Customized||participants|Number|4465|4465.0||||||
4102469|NCT00973362|3926315|B2|30 - <40 years||Age, Customized||participants|Number|266|266.0||||||
4102470|NCT00973362|3926316|B1|30 - <40 years||Age, Customized||participants|Number|4199|4199.0||||||
4102471|NCT00973362|3926314|B3|21 - <30 years||Age, Customized||participants|Number|418|418.0||||||
4102472|NCT00973362|3926315|B2|21 - <30 years||Age, Customized||participants|Number|418|418.0||||||
4102473|NCT00973362|3926316|B1|21 - <30 years||Age, Customized||participants|Number|0|0.0||||||
4102474|NCT00973362|3926314|B3|||Age||Years|Mean|43.3|43.3|Standard Deviation|10.5|10.5|||
4102475|NCT00973362|3926315|B2|||Age||Years|Mean|33.8|33.8|Standard Deviation|10.3|10.3|||
4102476|NCT00973362|3926316|B1|||Age||Years|Mean|44.1|44.1|Standard Deviation|10.1|10.1|||
4102477|NCT00973349|3926326|B17|Female(18 to 64 or ≥65 yrs)||Sex/Gender, Customized||participants|Number|1513|1513.0||||||
4102478|NCT00973349|3926327|B16|Female(18 to 64 or ≥65 yrs)||Sex/Gender, Customized||participants|Number|90|90.0||||||
4102479|NCT00973349|3926328|B15|Female(18 to 64 or ≥65 yrs)||Sex/Gender, Customized||participants|Number|90|90.0||||||
4102480|NCT00973349|3926329|B14|Female(18 to 64 or ≥65 yrs)||Sex/Gender, Customized||participants|Number|97|97.0||||||
4102481|NCT00973349|3926330|B13|Female(18 to 64 or ≥65 yrs)||Sex/Gender, Customized||participants|Number|100|100.0||||||
4102482|NCT00973349|3926331|B12|Female(18 to 64 or ≥65 yrs)||Sex/Gender, Customized||participants|Number|98|98.0||||||
4102483|NCT00973349|3926332|B11|Female(18 to 64 or ≥65 yrs)||Sex/Gender, Customized||participants|Number|101|101.0||||||
4102484|NCT00973349|3926333|B10|Female(18 to 64 or ≥65 yrs)||Sex/Gender, Customized||participants|Number|80|80.0||||||
4102485|NCT00973349|3926334|B9|Female(18 to 64 or ≥65 yrs)||Sex/Gender, Customized||participants|Number|116|116.0||||||
4102486|NCT00973349|3926335|B8|Female(18 to 64 or ≥65 yrs)||Sex/Gender, Customized||participants|Number|91|91.0||||||
4102487|NCT00973349|3926336|B7|Female(18 to 64 or ≥65 yrs)||Sex/Gender, Customized||participants|Number|88|88.0||||||
4102488|NCT00973349|3926337|B6|Female(18 to 64 or ≥65 yrs)||Sex/Gender, Customized||participants|Number|85|85.0||||||
4102489|NCT00973349|3926338|B5|Female(18 to 64 or ≥65 yrs)||Sex/Gender, Customized||participants|Number|98|98.0||||||
4102490|NCT00973349|3926339|B4|Female(18 to 64 or ≥65 yrs)||Sex/Gender, Customized||participants|Number|94|94.0||||||
4102491|NCT00973349|3926340|B3|Female(18 to 64 or ≥65 yrs)||Sex/Gender, Customized||participants|Number|100|100.0||||||
4102492|NCT00973349|3926341|B2|Female(18 to 64 or ≥65 yrs)||Sex/Gender, Customized||participants|Number|91|91.0||||||
4102493|NCT00973349|3926342|B1|Female(18 to 64 or ≥65 yrs)||Sex/Gender, Customized||participants|Number|94|94.0||||||
4102494|NCT00973349|3926326|B17|Male(18 to 64 or ≥65 years)||Sex/Gender, Customized||participants|Number|1079|1079.0||||||
4102495|NCT00973349|3926327|B16|Male(18 to 64 or ≥65 years)||Sex/Gender, Customized||participants|Number|76|76.0||||||
4102496|NCT00973349|3926328|B15|Male(18 to 64 or ≥65 years)||Sex/Gender, Customized||participants|Number|79|79.0||||||
4102497|NCT00973349|3926329|B14|Male(18 to 64 or ≥65 years)||Sex/Gender, Customized||participants|Number|74|74.0||||||
4102498|NCT00973349|3926330|B13|Male(18 to 64 or ≥65 years)||Sex/Gender, Customized||participants|Number|68|68.0||||||
4102499|NCT00973349|3926331|B12|Male(18 to 64 or ≥65 years)||Sex/Gender, Customized||participants|Number|70|70.0||||||
4102500|NCT00973349|3926332|B11|Male(18 to 64 or ≥65 years)||Sex/Gender, Customized||participants|Number|71|71.0||||||
4102501|NCT00973349|3926333|B10|Male(18 to 64 or ≥65 years)||Sex/Gender, Customized||participants|Number|88|88.0||||||
4102502|NCT00973349|3926334|B9|Male(18 to 64 or ≥65 years)||Sex/Gender, Customized||participants|Number|54|54.0||||||
4102503|NCT00973349|3926335|B8|Male(18 to 64 or ≥65 years)||Sex/Gender, Customized||participants|Number|63|63.0||||||
4102504|NCT00973349|3926336|B7|Male(18 to 64 or ≥65 years)||Sex/Gender, Customized||participants|Number|71|71.0||||||
4102505|NCT00973349|3926337|B6|Male(18 to 64 or ≥65 years)||Sex/Gender, Customized||participants|Number|69|69.0||||||
4102506|NCT00973349|3926338|B5|Male(18 to 64 or ≥65 years)||Sex/Gender, Customized||participants|Number|57|57.0||||||
4102507|NCT00973349|3926339|B4|Male(18 to 64 or ≥65 years)||Sex/Gender, Customized||participants|Number|59|59.0||||||
4102508|NCT00973349|3926340|B3|Male(18 to 64 or ≥65 years)||Sex/Gender, Customized||participants|Number|57|57.0||||||
4102509|NCT00973349|3926341|B2|Male(18 to 64 or ≥65 years)||Sex/Gender, Customized||participants|Number|62|62.0||||||
4102510|NCT00973349|3926342|B1|Male(18 to 64 or ≥65 years)||Sex/Gender, Customized||participants|Number|61|61.0||||||
4102511|NCT00973349|3926326|B17|||Age||years|Mean|39.6|39.6|Standard Deviation|12.8|12.8|||
4102512|NCT00973349|3926327|B16|||Age||years|Mean|70.8|70.8|Standard Deviation|5.3|5.3|||
4102513|NCT00973349|3926328|B15|||Age||years|Mean|71.3|71.3|Standard Deviation|5.2|5.2|||
4102514|NCT00973349|3926329|B14|||Age||years|Mean|70.4|70.4|Standard Deviation|4.9|4.9|||
4102515|NCT00973349|3926330|B13|||Age||years|Mean|71.0|71.0|Standard Deviation|5.0|5.0|||
4102516|NCT00973349|3926331|B12|||Age||years|Mean|70.7|70.7|Standard Deviation|5.1|5.1|||
4102517|NCT00973349|3926332|B11|||Age||years|Mean|71.4|71.4|Standard Deviation|5.6|5.6|||
4102518|NCT00973349|3926333|B10|||Age||years|Mean|71.8|71.8|Standard Deviation|5.6|5.6|||
4102519|NCT00973349|3926334|B9|||Age||years|Mean|70.8|70.8|Standard Deviation|5.1|5.1|||
4102520|NCT00973349|3926335|B8|||Age||years|Mean|40.8|40.8|Standard Deviation|13.0|13.0|||
4102521|NCT00973349|3926336|B7|||Age||years|Mean|38.8|38.8|Standard Deviation|11.9|11.9|||
4102522|NCT00973349|3926337|B6|||Age||years|Mean|39.7|39.7|Standard Deviation|13.1|13.1|||
4102523|NCT00973349|3926338|B5|||Age||years|Mean|41.8|41.8|Standard Deviation|12.9|12.9|||
4102524|NCT00973349|3926339|B4|||Age||years|Mean|40.6|40.6|Standard Deviation|12.2|12.2|||
4102525|NCT00973349|3926340|B3|||Age||years|Mean|39.1|39.1|Standard Deviation|13.5|13.5|||
4102526|NCT00973349|3926341|B2|||Age||years|Mean|39.8|39.8|Standard Deviation|12.9|12.9|||
4102527|NCT00973349|3926342|B1|||Age||years|Mean|40.3|40.3|Standard Deviation|12.8|12.8|||
4102528|NCT00972959|3926455|B1|||Bone remodelling|Bone remodelling was studied by the measurement of the following serum bone metabolism parameters indices using an enzyme-linked immunosorbent assay (ELISA) bone formation marker [bone-specific alkaline phosphatase (bALP)].|U/L|Median|15.8|15.8|Full Range|||4.5|34.0|
4102529|NCT00972959|3926455|B1|||Bone pain|"Bone pain was measured with the use of the Visual Analogue Scale. The visual analogue scale or visual analog scale (VAS) is a psychometric response scale which can be used in questionnaires. It is a measurement instrument for subjective characteristics or attitudes that cannot be directly measured.~The VAS for Bone Pain was constructed as follows:~None Mild Moderate Severe Worst possible 1,2 3,4 5,6 7,8 9,10 Lower values are considered to be of a better outcome, higher values are considered to be of a worst outcome."|units on a scale|Median|5|5.0|Full Range|||3.0|10.0|
4102530|NCT00972959|3926455|B1|||Skeletal survey for osteolytic lesions/fractures|Skeletal survey was measured using conventional radiography [imaging of the whole skeleton (skull, cervical spine, thoracic spine, lumbar spine, pelvis, humeri, femoral bones)].|participants|Number|17|17.0||||||
4102531|NCT00972959|3926455|B1|OC||Bone remodelling|Bone remodelling was studied by the measurement of the following serum bone metabolism parameters indices using an enzyme-linked immunosorbent assay (ELISA): i) bone resorption marker C-terminal cross-linking telopeptide of collagen type I (CTX) and ii) bone formation marker [osteocalcin (OC)].|ng/ml|Median|5.1|5.1|Full Range|||0.1|14.0|
4102532|NCT00972959|3926455|B1|CTX||Bone remodelling|Bone remodelling was studied by the measurement of the following serum bone metabolism parameters indices using an enzyme-linked immunosorbent assay (ELISA): i) bone resorption marker C-terminal cross-linking telopeptide of collagen type I (CTX) and ii) bone formation marker [osteocalcin (OC)].|ng/ml|Median|0.6|0.6|Full Range|||0.3|2.1|
4102533|NCT00972959|3926455|B1|Femoral neck (FN)||BMD|Bone Mineral Density of the lumbar spine (L1–L4, anteroposterior view) and femoral neck (FN) was measured by Dual Energy X-Absorptiometry scan (DEXA-scan) using a Hologic QDR-1000 scanner|T-score|Median|-2.83|-2.83|Full Range|||-3.91|0.55|
4102534|NCT00972959|3926455|B1|Lumbar spine (L1-L4)||BMD|Bone Mineral Density of the lumbar spine (L1–L4, anteroposterior view) and femoral neck (FN) was measured by Dual Energy X-Absorptiometry scan (DEXA-scan) using a Hologic QDR-1000 scanner|T-score|Median|-0.29|-0.29|Full Range|||-3.8|2.88|
4102535|NCT00972959|3926455|B1|Greece||Region of Enrollment||participants|Number|17|17.0||||||
4102536|NCT00972959|3926455|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4102537|NCT00972959|3926455|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4102538|NCT00972959|3926455|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4102539|NCT00972959|3926455|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4102540|NCT00972959|3926455|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4102541|NCT00972816|3926470|B9||Male|Sex: Female, Male||Participants|Count of Participants|705|705.0||||||
4102542|NCT00972816|3926471|B8||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4102543|NCT00972816|3926472|B7||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4102544|NCT00972816|3926473|B6||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4102545|NCT00972816|3926474|B5||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4102546|NCT00972816|3926475|B4||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4102547|NCT00972816|3926476|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4102548|NCT00972816|3926477|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4102549|NCT00972816|3926478|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4102550|NCT00972816|3926470|B9||Female|Sex: Female, Male||Participants|Count of Participants|652|652.0||||||
4102551|NCT00972816|3926471|B8||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4102552|NCT00972816|3926472|B7||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4102553|NCT00972816|3926473|B6||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4102554|NCT00972816|3926474|B5||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4102555|NCT00972816|3926475|B4||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4102556|NCT00972816|3926476|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4102557|NCT00972816|3926477|B2||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4102558|NCT00972816|3926478|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4102559|NCT00972816|3926470|B9|||Age||years|Mean|5.5|5.5|Standard Deviation|1.7|1.7|||
4102560|NCT00972816|3926471|B8|||Age||years|Mean|5.5|5.5|Standard Deviation|1.7|1.7|||
4102561|NCT00972816|3926472|B7|||Age||years|Mean|5.5|5.5|Standard Deviation|1.7|1.7|||
4102562|NCT00972816|3926473|B6|||Age||years|Mean|5.5|5.5|Standard Deviation|1.7|1.7|||
4102563|NCT00972816|3926474|B5|||Age||years|Mean|5.6|5.6|Standard Deviation|1.7|1.7|||
4102564|NCT00972816|3926475|B4|||Age||years|Mean|5.9|5.9|Standard Deviation|1.7|1.7|||
4102565|NCT00972816|3926476|B3|||Age||years|Mean|5.5|5.5|Standard Deviation|1.8|1.8|||
4102566|NCT00972816|3926477|B2|||Age||years|Mean|5.2|5.2|Standard Deviation|1.7|1.7|||
4102567|NCT00972816|3926478|B1|||Age||years|Mean|5.6|5.6|Standard Deviation|1.7|1.7|||
4102568|NCT00972777|3926567|B3|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4102569|NCT00972777|3926568|B2|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4102570|NCT00972777|3926569|B1|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4102571|NCT00972777|3926567|B3|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4102572|NCT00972777|3926568|B2|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4102573|NCT00972777|3926569|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4102574|NCT00972777|3926567|B3|White||Race/Ethnicity, Customized||participants|Number|333|333.0||||||
4102575|NCT00972777|3926568|B2|White||Race/Ethnicity, Customized||participants|Number|166|166.0||||||
4102576|NCT00972777|3926569|B1|White||Race/Ethnicity, Customized||participants|Number|167|167.0||||||
4102577|NCT00972777|3926567|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|103|103.0||||||
4102578|NCT00972777|3926568|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
4102579|NCT00972777|3926569|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4102580|NCT00972777|3926567|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4102581|NCT00972777|3926568|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4102582|NCT00972777|3926569|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4102583|NCT00972777|3926567|B3|Asian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4102584|NCT00972777|3926568|B2|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4102585|NCT00972777|3926569|B1|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4102586|NCT00972777|3926567|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4102587|NCT00972777|3926568|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4102588|NCT00972777|3926569|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4102589|NCT00972777|3926567|B3||Male|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4102590|NCT00972777|3926568|B2||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4102591|NCT00972777|3926569|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4102592|NCT00972777|3926567|B3||Female|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4102593|NCT00972777|3926568|B2||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4102594|NCT00972777|3926569|B1||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4102595|NCT00972777|3926567|B3|Missing||Age, Customized||participants|Number|1|1.0||||||
4102596|NCT00972777|3926568|B2|Missing||Age, Customized||participants|Number|0|0.0||||||
4102597|NCT00972777|3926569|B1|Missing||Age, Customized||participants|Number|1|1.0||||||
4102598|NCT00972777|3926567|B3|>=60 years||Age, Customized||participants|Number|66|66.0||||||
4102599|NCT00972777|3926568|B2|>=60 years||Age, Customized||participants|Number|31|31.0||||||
4102600|NCT00972777|3926569|B1|>=60 years||Age, Customized||participants|Number|35|35.0||||||
4102601|NCT00972777|3926567|B3|50 - 59 years||Age, Customized||participants|Number|39|39.0||||||
4102602|NCT00972777|3926568|B2|50 - 59 years||Age, Customized||participants|Number|19|19.0||||||
4102603|NCT00972777|3926569|B1|50 - 59 years||Age, Customized||participants|Number|20|20.0||||||
4102604|NCT00972777|3926567|B3|40 - 49 years||Age, Customized||participants|Number|37|37.0||||||
4102605|NCT00972777|3926568|B2|40 - 49 years||Age, Customized||participants|Number|14|14.0||||||
4102606|NCT00972777|3926569|B1|40 - 49 years||Age, Customized||participants|Number|23|23.0||||||
4102607|NCT00972777|3926567|B3|30 - 39 years||Age, Customized||participants|Number|50|50.0||||||
4102608|NCT00972777|3926568|B2|30 - 39 years||Age, Customized||participants|Number|29|29.0||||||
4102609|NCT00972777|3926569|B1|30 - 39 years||Age, Customized||participants|Number|21|21.0||||||
4102610|NCT00972777|3926567|B3|18 - 29 years||Age, Customized||participants|Number|72|72.0||||||
4102611|NCT00972777|3926568|B2|18 - 29 years||Age, Customized||participants|Number|40|40.0||||||
4102612|NCT00972777|3926569|B1|18 - 29 years||Age, Customized||participants|Number|32|32.0||||||
4102613|NCT00972777|3926567|B3|12 - 17 years||Age, Customized||participants|Number|39|39.0||||||
4102614|NCT00972777|3926568|B2|12 - 17 years||Age, Customized||participants|Number|20|20.0||||||
4102615|NCT00972777|3926569|B1|12 - 17 years||Age, Customized||participants|Number|19|19.0||||||
4102616|NCT00972777|3926567|B3|2 - 11 years||Age, Customized||participants|Number|143|143.0||||||
4102617|NCT00972777|3926568|B2|2 - 11 years||Age, Customized||participants|Number|77|77.0||||||
4102618|NCT00972777|3926569|B1|2 - 11 years||Age, Customized||participants|Number|66|66.0||||||
4102619|NCT00972777|3926567|B3|<2 years||Age, Customized||participants|Number|27|27.0||||||
4102620|NCT00972777|3926568|B2|<2 years||Age, Customized||participants|Number|13|13.0||||||
4102621|NCT00972777|3926569|B1|<2 years||Age, Customized||participants|Number|14|14.0||||||
4102622|NCT00972738|3926582|B4|||Rhinoconjunctivitis Quality-of-Life score|Rhinoconjunctivitis Quality-of-Life score Description (see instructions; limit 350 characters) Self-administered questionnaire which included 28 questions on a 7-point scale [0(best) to 6(worst)] across 7 domains : activity, sleep, non-nose/eye symptoms, practical problems, nasal symptoms, eye symptoms, and emotions. Scores for each domain were average, then scores for the 7 domains were averaged for overall score.|Scores on a scale|Mean|3.25|3.25|Standard Deviation|1.03|1.03|||
4102648|NCT00972738|3926584|B2|||Age||years|Mean|34.7|34.7|Standard Deviation|12.73|12.73|||
4102623|NCT00972738|3926583|B3|||Rhinoconjunctivitis Quality-of-Life score|Rhinoconjunctivitis Quality-of-Life score Description (see instructions; limit 350 characters) Self-administered questionnaire which included 28 questions on a 7-point scale [0(best) to 6(worst)] across 7 domains : activity, sleep, non-nose/eye symptoms, practical problems, nasal symptoms, eye symptoms, and emotions. Scores for each domain were average, then scores for the 7 domains were averaged for overall score.|Scores on a scale|Mean|3.29|3.29|Standard Deviation|1.01|1.01|||
4102624|NCT00972738|3926584|B2|||Rhinoconjunctivitis Quality-of-Life score|Rhinoconjunctivitis Quality-of-Life score Description (see instructions; limit 350 characters) Self-administered questionnaire which included 28 questions on a 7-point scale [0(best) to 6(worst)] across 7 domains : activity, sleep, non-nose/eye symptoms, practical problems, nasal symptoms, eye symptoms, and emotions. Scores for each domain were average, then scores for the 7 domains were averaged for overall score.|Scores on a scale|Mean|3.24|3.24|Standard Deviation|0.97|0.97|||
4102625|NCT00972738|3926585|B1|||Rhinoconjunctivitis Quality-of-Life score|Rhinoconjunctivitis Quality-of-Life score Description (see instructions; limit 350 characters) Self-administered questionnaire which included 28 questions on a 7-point scale [0(best) to 6(worst)] across 7 domains : activity, sleep, non-nose/eye symptoms, practical problems, nasal symptoms, eye symptoms, and emotions. Scores for each domain were average, then scores for the 7 domains were averaged for overall score.|Scores on a scale|Mean|3.22|3.22|Standard Deviation|1.06|1.06|||
4102626|NCT00972738|3926582|B4|||Nighttime Symptoms score|Patients were asked to rate each symptoms of Nasal Congestion Upon Awakening, Difficulty Going to Sleep, and Nighttime Awakenings daily on a 4-point [Scale 0 (best) to 3 (worst)]. The average of the individual symptoms scores was reported as the Nighttime Symptoms Score.|Scores on a scale|Mean|1.49|1.49|Standard Deviation|0.65|0.65|||
4102627|NCT00972738|3926583|B3|||Nighttime Symptoms score|Patients were asked to rate each symptoms of Nasal Congestion Upon Awakening, Difficulty Going to Sleep, and Nighttime Awakenings daily on a 4-point [Scale 0 (best) to 3 (worst)]. The average of the individual symptoms scores was reported as the Nighttime Symptoms Score.|Scores on a scale|Mean|1.47|1.47|Standard Deviation|0.65|0.65|||
4102628|NCT00972738|3926584|B2|||Nighttime Symptoms score|Patients were asked to rate each symptoms of Nasal Congestion Upon Awakening, Difficulty Going to Sleep, and Nighttime Awakenings daily on a 4-point [Scale 0 (best) to 3 (worst)]. The average of the individual symptoms scores was reported as the Nighttime Symptoms Score.|Scores on a scale|Mean|1.49|1.49|Standard Deviation|0.64|0.64|||
4102629|NCT00972738|3926585|B1|||Nighttime Symptoms score|Patients were asked to rate each symptoms of Nasal Congestion Upon Awakening, Difficulty Going to Sleep, and Nighttime Awakenings daily on a 4-point [Scale 0 (best) to 3 (worst)]. The average of the individual symptoms scores was reported as the Nighttime Symptoms Score.|Scores on a scale|Mean|1.51|1.51|Standard Deviation|0.65|0.65|||
4102630|NCT00972738|3926582|B4|||Daytime Nasal Symptoms score|Patients were asked to rate each of the 4 nasal symptoms of Congestion, Rhinorrhea, Itching, and Sneezing daily on a 4-point scale [Score 0 (best) to 3 (worst)]. The average of the 4 individual nasal symptoms scores was reported as the Daytime Nasal Symptoms Score.|Scores on a scale|Mean|2.12|2.12|Standard Deviation|0.43|0.43|||
4102631|NCT00972738|3926583|B3|||Daytime Nasal Symptoms score|Patients were asked to rate each of the 4 nasal symptoms of Congestion, Rhinorrhea, Itching, and Sneezing daily on a 4-point scale [Score 0 (best) to 3 (worst)]. The average of the 4 individual nasal symptoms scores was reported as the Daytime Nasal Symptoms Score.|Scores on a scale|Mean|2.14|2.14|Standard Deviation|0.43|0.43|||
4102632|NCT00972738|3926584|B2|||Daytime Nasal Symptoms score|Patients were asked to rate each of the 4 nasal symptoms of Congestion, Rhinorrhea, Itching, and Sneezing daily on a 4-point scale [Score 0 (best) to 3 (worst)]. The average of the 4 individual nasal symptoms scores was reported as the Daytime Nasal Symptoms Score.|Scores on a scale|Mean|2.15|2.15|Standard Deviation|0.45|0.45|||
4102633|NCT00972738|3926585|B1|||Daytime Nasal Symptoms score|Patients were asked to rate each of the 4 nasal symptoms of Congestion, Rhinorrhea, Itching, and Sneezing daily on a 4-point scale [Score 0 (best) to 3 (worst)]. The average of the 4 individual nasal symptoms scores was reported as the Daytime Nasal Symptoms Score.|Scores on a scale|Mean|2.10|2.1|Standard Deviation|0.43|0.43|||
4102634|NCT00972738|3926582|B4|||Daytime Eye Symptoms score|Patients were asked to rate each of the 4 eye symptoms of tearing, itchy, red, and puffy eyes daily on a 4-point scale [0 (best) to 3 (worst)]. The average of the 4 individual eye symptoms scores was reported as the Daytime Eye Symptoms Score.|Scores on a scale|Mean|1.51|1.51|Standard Deviation|0.79|0.79|||
4102635|NCT00972738|3926583|B3|||Daytime Eye Symptoms score|Patients were asked to rate each of the 4 eye symptoms of tearing, itchy, red, and puffy eyes daily on a 4-point scale [0 (best) to 3 (worst)]. The average of the 4 individual eye symptoms scores was reported as the Daytime Eye Symptoms Score.|Scores on a scale|Mean|1.53|1.53|Standard Deviation|0.81|0.81|||
4102636|NCT00972738|3926584|B2|||Daytime Eye Symptoms score|Patients were asked to rate each of the 4 eye symptoms of tearing, itchy, red, and puffy eyes daily on a 4-point scale [0 (best) to 3 (worst)]. The average of the 4 individual eye symptoms scores was reported as the Daytime Eye Symptoms Score.|Scores on a scale|Mean|1.48|1.48|Standard Deviation|0.79|0.79|||
4102637|NCT00972738|3926585|B1|||Daytime Eye Symptoms score|Patients were asked to rate each of the 4 eye symptoms of tearing, itchy, red, and puffy eyes daily on a 4-point scale [0 (best) to 3 (worst)]. The average of the 4 individual eye symptoms scores was reported as the Daytime Eye Symptoms Score.|Scores on a scale|Mean|1.49|1.49|Standard Deviation|0.77|0.77|||
4102638|NCT00972738|3926582|B4||Male|Sex: Female, Male||Participants|Count of Participants|450|450.0||||||
4102639|NCT00972738|3926583|B3||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4102640|NCT00972738|3926584|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4102641|NCT00972738|3926585|B1||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4102642|NCT00972738|3926582|B4||Female|Sex: Female, Male||Participants|Count of Participants|764|764.0||||||
4102643|NCT00972738|3926583|B3||Female|Sex: Female, Male||Participants|Count of Participants|338|338.0||||||
4102644|NCT00972738|3926584|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4102645|NCT00972738|3926585|B1||Female|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
4102646|NCT00972738|3926582|B4|||Age||years|Mean|35.5|35.5|Standard Deviation|13.20|13.2|||
4102647|NCT00972738|3926583|B3|||Age||years|Mean|35.8|35.8|Standard Deviation|12.61|12.61|||
4102649|NCT00972738|3926585|B1|||Age||years|Mean|35.5|35.5|Standard Deviation|13.93|13.93|||
4102650|NCT00972725|3926610|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4102651|NCT00972725|3926611|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4102652|NCT00972725|3926612|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4102653|NCT00972725|3926610|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4102654|NCT00972725|3926611|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4102655|NCT00972725|3926612|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4102656|NCT00972725|3926610|B3|||Age||Years|Mean|24.67|24.67|Standard Deviation|4.47|4.47|||
4102657|NCT00972725|3926611|B2|||Age||Years|Mean|24.3|24.3|Standard Deviation|3.73|3.73|||
4102658|NCT00972725|3926612|B1|||Age||Years|Mean|25.1|25.1|Standard Deviation|5.33|5.33|||
4102659|NCT00972621|3926693|B3|United States||Region of Enrollment||participants|Number|400|400.0||||||
4102660|NCT00972621|3926694|B2|United States||Region of Enrollment||participants|Number|200|200.0||||||
4102661|NCT00972621|3926695|B1|United States||Region of Enrollment||participants|Number|200|200.0||||||
4102662|NCT00972621|3926693|B3||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4102663|NCT00972621|3926694|B2||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4102664|NCT00972621|3926695|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4102665|NCT00972621|3926693|B3||Female|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
4102666|NCT00972621|3926694|B2||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4102667|NCT00972621|3926695|B1||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4102668|NCT00972621|3926693|B3|||Age||years|Mean|69.03|69.03|Standard Deviation|8.92|8.92|||
4102669|NCT00972621|3926694|B2|||Age||years|Mean|70.1|70.1|Standard Deviation|8.86|8.86|||
4102670|NCT00972621|3926695|B1|||Age||years|Mean|68.0|68.0|Standard Deviation|8.88|8.88|||
4102671|NCT00972621|3926693|B3||>=65 years|Age||Participants|Count of Participants|279|279.0||||||
4102672|NCT00972621|3926694|B2||>=65 years|Age||Participants|Count of Participants|146|146.0||||||
4102673|NCT00972621|3926695|B1||>=65 years|Age||Participants|Count of Participants|133|133.0||||||
4102674|NCT00972621|3926693|B3||Between 18 and 65 years|Age||Participants|Count of Participants|121|121.0||||||
4102675|NCT00972621|3926694|B2||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4102676|NCT00972621|3926695|B1||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
4102677|NCT00972621|3926693|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4102678|NCT00972621|3926694|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4102679|NCT00972621|3926695|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4102680|NCT00972595|3926704|B1|||Weight||Killograms|Mean|72.0|72.0|Full Range|||45.5|102.7|
4102681|NCT00972595|3926704|B1|||Height||Centimeters|Mean|170.8|170.8|Full Range|||154.9|188.0|
4102682|NCT00972595|3926704|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4102683|NCT00972595|3926704|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4102684|NCT00972595|3926704|B1|||Age||Years|Mean|34|34.0|Full Range|||18.0|54.0|
4102685|NCT00972543|3926713|B3|Not tested (Male or surgically sterile female)||Negative Urinary Pregnancy Test|Participants with negative urinary human chorionic gonadotrophin pregnancy test|participants|Number|5|5.0||||||
4102686|NCT00972543|3926714|B2|Not tested (Male or surgically sterile female)||Negative Urinary Pregnancy Test|Participants with negative urinary human chorionic gonadotrophin pregnancy test|participants|Number|1|1.0||||||
4102687|NCT00972543|3926715|B1|Not tested (Male or surgically sterile female)||Negative Urinary Pregnancy Test|Participants with negative urinary human chorionic gonadotrophin pregnancy test|participants|Number|4|4.0||||||
4102688|NCT00972543|3926713|B3|Negative test||Negative Urinary Pregnancy Test|Participants with negative urinary human chorionic gonadotrophin pregnancy test|participants|Number|1|1.0||||||
4102689|NCT00972543|3926714|B2|Negative test||Negative Urinary Pregnancy Test|Participants with negative urinary human chorionic gonadotrophin pregnancy test|participants|Number|0|0.0||||||
4102690|NCT00972543|3926715|B1|Negative test||Negative Urinary Pregnancy Test|Participants with negative urinary human chorionic gonadotrophin pregnancy test|participants|Number|1|1.0||||||
4102691|NCT00972543|3926713|B3|Not tested (Male or surgically sterile female)||Negative Serum Pregnancy Test|Participants with negative serum human chorionic gonadotrophin pregnancy test|participants|Number|5|5.0||||||
4102692|NCT00972543|3926714|B2|Not tested (Male or surgically sterile female)||Negative Serum Pregnancy Test|Participants with negative serum human chorionic gonadotrophin pregnancy test|participants|Number|1|1.0||||||
4102693|NCT00972543|3926715|B1|Not tested (Male or surgically sterile female)||Negative Serum Pregnancy Test|Participants with negative serum human chorionic gonadotrophin pregnancy test|participants|Number|4|4.0||||||
4102694|NCT00972543|3926713|B3|Negative test||Negative Serum Pregnancy Test|Participants with negative serum human chorionic gonadotrophin pregnancy test|participants|Number|1|1.0||||||
4102695|NCT00972543|3926714|B2|Negative test||Negative Serum Pregnancy Test|Participants with negative serum human chorionic gonadotrophin pregnancy test|participants|Number|0|0.0||||||
4102696|NCT00972543|3926715|B1|Negative test||Negative Serum Pregnancy Test|Participants with negative serum human chorionic gonadotrophin pregnancy test|participants|Number|1|1.0||||||
4102697|NCT00972543|3926713|B3|Australia||Region of Enrollment||participants|Number|6|6.0||||||
4102698|NCT00972543|3926714|B2|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4102699|NCT00972543|3926715|B1|Australia||Region of Enrollment||participants|Number|5|5.0||||||
4102700|NCT00972543|3926713|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4102701|NCT00972543|3926714|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4102702|NCT00972543|3926715|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4102703|NCT00972543|3926713|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4102704|NCT00972543|3926714|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4102705|NCT00972543|3926715|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4102706|NCT00972543|3926713|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4102707|NCT00972543|3926714|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4102708|NCT00972543|3926715|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4102709|NCT00972543|3926713|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4102710|NCT00972543|3926714|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4102711|NCT00972543|3926715|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4102712|NCT00972543|3926713|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4102713|NCT00972543|3926714|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4102714|NCT00972543|3926715|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4102715|NCT00972530|3926790|B3|Sweden||Region of Enrollment||participants|Number|90|90.0||||||
4102716|NCT00972530|3926791|B2|Sweden||Region of Enrollment||participants|Number|46|46.0||||||
4102717|NCT00972530|3926792|B1|Sweden||Region of Enrollment||participants|Number|44|44.0||||||
4102718|NCT00972530|3926790|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4102719|NCT00972530|3926791|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4102720|NCT00972530|3926792|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4102721|NCT00972530|3926790|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4102722|NCT00972530|3926791|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4102723|NCT00972530|3926792|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4102724|NCT00972530|3926790|B3|||Age||years|Mean|59.3|59.3|Standard Deviation|14.8|14.8|||
4102725|NCT00972530|3926791|B2|||Age||years|Mean|59.0|59.0|Standard Deviation|14.6|14.6|||
4102726|NCT00972530|3926792|B1|||Age||years|Mean|59.7|59.7|Standard Deviation|15.2|15.2|||
4102727|NCT00972530|3926790|B3||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4102728|NCT00972530|3926791|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4102729|NCT00972530|3926792|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4102730|NCT00972530|3926790|B3||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4102731|NCT00972530|3926791|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4102732|NCT00972530|3926792|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4102733|NCT00972530|3926790|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4102734|NCT00972530|3926791|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4102735|NCT00972530|3926792|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4102736|NCT00972517|3926799|B1||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4102737|NCT00972517|3926799|B1||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4102738|NCT00972517|3926799|B1|||Age||Years|Geometric Mean|9.2|9.2|Standard Deviation|4.15|4.15|||
4102739|NCT00972504|3926899|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|54|54.0||||||
4102740|NCT00972504|3926899|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4102741|NCT00972504|3926899|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4102742|NCT00972504|3926899|B1|||Age||Years|Mean|37.9|37.9|Standard Deviation|10.92|10.92|||
4102743|NCT00972478|3926929|B3|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
4102744|NCT00972478|3926930|B2|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
4102745|NCT00972478|3926931|B1|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4102746|NCT00972478|3926929|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4102747|NCT00972478|3926930|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4102748|NCT00972478|3926931|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4102749|NCT00972478|3926929|B3|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4102750|NCT00972478|3926930|B2|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4102751|NCT00972478|3926931|B1|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4102752|NCT00972478|3926929|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4102753|NCT00972478|3926930|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4102754|NCT00972478|3926931|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4102755|NCT00972478|3926929|B3|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4102756|NCT00972478|3926930|B2|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4102757|NCT00972478|3926931|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4102758|NCT00972478|3926929|B3|White||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
4102759|NCT00972478|3926930|B2|White||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
4102760|NCT00972478|3926931|B1|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4102761|NCT00972478|3926929|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4102762|NCT00972478|3926930|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4102763|NCT00972478|3926931|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4102764|NCT00972478|3926929|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4102765|NCT00972478|3926930|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4102766|NCT00972478|3926931|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4102767|NCT00972478|3926929|B3|||Age||years|Median|64.2|64.2|Full Range|||19.6|83.8|
4102768|NCT00972478|3926930|B2|||Age||years|Median|64.1|64.1|Full Range|||19.6|80.8|
4102769|NCT00972478|3926931|B1|||Age||years|Median|66.9|66.9|Full Range|||46.4|83.8|
4102770|NCT00972439|3926942|B3|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
4102771|NCT00972439|3926943|B2|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4102772|NCT00972439|3926944|B1|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
4102773|NCT00972439|3926942|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4102774|NCT00972439|3926943|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4102775|NCT00972439|3926944|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4102776|NCT00972439|3926942|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4102777|NCT00972439|3926943|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4102778|NCT00972439|3926944|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4102779|NCT00972439|3926942|B3|||Age||years|Mean|26.8|26.8|Standard Deviation|4.8|4.8|||
4102780|NCT00972439|3926943|B2|||Age||years|Mean|28.1|28.1|Standard Deviation|4.8|4.8|||
4102781|NCT00972439|3926944|B1|||Age||years|Mean|25.3|25.3|Standard Deviation|4.4|4.4|||
4102782|NCT00972439|3926942|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4102783|NCT00972439|3926943|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4102784|NCT00972439|3926944|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4102785|NCT00972439|3926942|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4102786|NCT00972439|3926943|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4102787|NCT00972439|3926944|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4102788|NCT00972439|3926942|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4102789|NCT00972439|3926943|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4102790|NCT00972439|3926944|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4102791|NCT00972374|3926951|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4102792|NCT00972374|3926952|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4102793|NCT00972374|3926953|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4102794|NCT00972374|3926954|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4102795|NCT00972374|3926951|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4102796|NCT00972374|3926952|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4102797|NCT00972374|3926953|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4102798|NCT00972374|3926954|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4102799|NCT00972374|3926951|B4|||Age||Years|Mean|54.9|54.9|Standard Deviation|17.35|17.35|||
4102800|NCT00972374|3926952|B3|||Age||Years|Mean|56.1|56.1|Standard Deviation|15.19|15.19|||
4102801|NCT00972374|3926953|B2|||Age||Years|Mean|54.3|54.3|Standard Deviation|20.36|20.36|||
4102802|NCT00972374|3926954|B1|||Age||Years|Mean|54.2|54.2|Standard Deviation|17.12|17.12|||
4102803|NCT00972335|3926970|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4102804|NCT00972335|3926970|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4102805|NCT00972335|3926970|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4102806|NCT00972335|3926970|B1|||Age||years|Median|59|59.0|Full Range|||29.0|84.0|
4102807|NCT00972322|3926975|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4102808|NCT00972322|3926976|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4102809|NCT00972322|3926977|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4102810|NCT00972322|3926975|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4102811|NCT00972322|3926976|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4102812|NCT00972322|3926977|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4102813|NCT00972322|3926975|B3|||Age||Years|Mean|53.7|53.7|Standard Deviation|7.93|7.93|||
4102814|NCT00972322|3926976|B2|||Age||Years|Mean|52.7|52.7|Standard Deviation|7.30|7.3|||
4102815|NCT00972322|3926977|B1|||Age||Years|Mean|54.7|54.7|Standard Deviation|8.53|8.53|||
4102816|NCT00972283|3926988|B3|||Glycosylated Haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.3|8.3|Standard Deviation|0.8|0.8|||
4102817|NCT00972283|3926989|B2|||Glycosylated Haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.4|8.4|Standard Deviation|0.9|0.9|||
4102818|NCT00972283|3926990|B1|||Glycosylated Haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.3|8.3|Standard Deviation|0.8|0.8|||
4102819|NCT00972283|3926988|B3||Male|Sex: Female, Male||Participants|Count of Participants|538|538.0||||||
4102820|NCT00972283|3926989|B2||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4102821|NCT00972283|3926990|B1||Male|Sex: Female, Male||Participants|Count of Participants|405|405.0||||||
4102822|NCT00972283|3926988|B3||Female|Sex: Female, Male||Participants|Count of Participants|454|454.0||||||
4102823|NCT00972283|3926989|B2||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4102824|NCT00972283|3926990|B1||Female|Sex: Female, Male||Participants|Count of Participants|339|339.0||||||
4102825|NCT00972283|3926988|B3|||Age||years|Mean|58.9|58.9|Standard Deviation|9.3|9.3|||
4102826|NCT00972283|3926989|B2|||Age||years|Mean|58.1|58.1|Standard Deviation|10.0|10.0|||
4102827|NCT00972283|3926990|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|9.1|9.1|||
4102828|NCT00972244|3927013|B6|||HBA1C||percent|Mean|8.07|8.07|Standard Deviation|0.720|0.72|||
4102829|NCT00972244|3927014|B5|||HBA1C||percent|Mean|8.12|8.12|Standard Deviation|0.714|0.714|||
4102830|NCT00972244|3927015|B4|||HBA1C||percent|Mean|8.18|8.18|Standard Deviation|0.690|0.69|||
4102831|NCT00972244|3927016|B3|||HBA1C||percent|Mean|8.05|8.05|Standard Deviation|0.660|0.66|||
4102832|NCT00972244|3927017|B2|||HBA1C||percent|Mean|7.92|7.92|Standard Deviation|0.740|0.74|||
4102833|NCT00972244|3927018|B1|||HBA1C||percent|Mean|8.10|8.1|Standard Deviation|0.785|0.785|||
4102834|NCT00972244|3927013|B6|Japanese||Race/Ethnicity, Customized||Participants|Number|279|279.0||||||
4102835|NCT00972244|3927014|B5|Japanese||Race/Ethnicity, Customized||Participants|Number|54|54.0||||||
4102836|NCT00972244|3927015|B4|Japanese||Race/Ethnicity, Customized||Participants|Number|52|52.0||||||
4102837|NCT00972244|3927016|B3|Japanese||Race/Ethnicity, Customized||Participants|Number|58|58.0||||||
4102838|NCT00972244|3927017|B2|Japanese||Race/Ethnicity, Customized||Participants|Number|56|56.0||||||
4102839|NCT00972244|3927018|B1|Japanese||Race/Ethnicity, Customized||Participants|Number|59|59.0||||||
4102840|NCT00972244|3927013|B6||Male|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
4102841|NCT00972244|3927014|B5||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4102842|NCT00972244|3927015|B4||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4102843|NCT00972244|3927016|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4102844|NCT00972244|3927017|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4102845|NCT00972244|3927018|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4102846|NCT00972244|3927013|B6||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4102847|NCT00972244|3927014|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4102848|NCT00972244|3927015|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4102849|NCT00972244|3927016|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4102850|NCT00972244|3927017|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4102851|NCT00972244|3927018|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4102852|NCT00972244|3927013|B6|||Age||years|Mean|57.3|57.3|Standard Deviation|9.98|9.98|||
4102853|NCT00972244|3927014|B5|||Age||years|Mean|58.4|58.4|Standard Deviation|9.97|9.97|||
4102854|NCT00972244|3927015|B4|||Age||years|Mean|56.5|56.5|Standard Deviation|11.47|11.47|||
4102855|NCT00972244|3927016|B3|||Age||years|Mean|58.0|58.0|Standard Deviation|9.50|9.5|||
4102856|NCT00972244|3927017|B2|||Age||years|Mean|57.7|57.7|Standard Deviation|9.33|9.33|||
4102857|NCT00972244|3927018|B1|||Age||years|Mean|55.9|55.9|Standard Deviation|9.73|9.73|||
4102858|NCT00972205|3927044|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4102859|NCT00972205|3927044|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4102860|NCT00972205|3927044|B1|White||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4102861|NCT00972205|3927044|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4102862|NCT00972205|3927044|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4102863|NCT00972205|3927044|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4102864|NCT00972205|3927044|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4102865|NCT00972205|3927044|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4102866|NCT00972205|3927044|B1|||Age||years|Mean|60.79|60.79|Standard Deviation|9.50|9.5|||
4102867|NCT00972205|3927044|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4102868|NCT00972205|3927044|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4102869|NCT00972205|3927044|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4102870|NCT00972153|3927051|B4|United States||Region of Enrollment||participants|Number|36|36.0||||||
4102871|NCT00972153|3927052|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4102872|NCT00972153|3927053|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4102873|NCT00972153|3927054|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4102874|NCT00972153|3927051|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4102875|NCT00972153|3927052|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4102876|NCT00972153|3927053|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4102877|NCT00972153|3927054|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4102878|NCT00972153|3927051|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4102879|NCT00972153|3927052|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4102880|NCT00972153|3927053|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4102881|NCT00972153|3927054|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4102882|NCT00972153|3927051|B4||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4102883|NCT00972153|3927052|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4102884|NCT00972153|3927053|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4102885|NCT00972153|3927054|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4102886|NCT00972153|3927051|B4||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4102887|NCT00972153|3927052|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4102888|NCT00972153|3927053|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4102889|NCT00972153|3927054|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4102890|NCT00972153|3927051|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4102891|NCT00972153|3927052|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4102892|NCT00972153|3927053|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4102893|NCT00972153|3927054|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4102894|NCT00972088|3927067|B1|Israel||Region of Enrollment||participants|Number|26|26.0||||||
4102895|NCT00972088|3927067|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4102896|NCT00972088|3927067|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4102897|NCT00972088|3927067|B1|||Age||years|Mean|34.3|34.3|Standard Deviation|12.6|12.6|||
4102898|NCT00972088|3927067|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4102899|NCT00972088|3927067|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4102900|NCT00972088|3927067|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4102901|NCT00972023|3927071|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4102902|NCT00972023|3927071|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4102903|NCT00972023|3927071|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4102904|NCT00972023|3927071|B1|||Age||years|Mean|52|52.0|Standard Deviation|0|0.0|||
4102905|NCT00971997|3927078|B1|Japan||Region of Enrollment||participants|Number|135|135.0||||||
4102906|NCT00971997|3927078|B1|Japanese||Race/Ethnicity, Customized||participants|Number|135|135.0||||||
4102907|NCT00971997|3927078|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4102908|NCT00971997|3927078|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4102909|NCT00971997|3927078|B1|||Age||years|Mean|60.3|60.3|Standard Deviation|10.2|10.2|||
4102910|NCT00971932|3927096|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4102911|NCT00971932|3927096|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4102912|NCT00971932|3927096|B1|||Age||years|Mean|57.20|57.2|Standard Deviation|11.42|11.42|||
4102913|NCT00971841|3927106|B1|Japan||Region of Enrollment||participants|Number|1|1.0||||||
4102914|NCT00971841|3927106|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4102915|NCT00971841|3927106|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4102916|NCT00971841|3927106|B1|||Age||years|Mean|47|47.0|Standard Deviation|NA||||Only one participant, therefore no standard deviation available.
4102917|NCT00971841|3927106|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4102918|NCT00971841|3927106|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4102919|NCT00971841|3927106|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4102920|NCT00971789|3927111|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4102921|NCT00971789|3927111|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4102922|NCT00971789|3927111|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4102923|NCT00971789|3927111|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4102924|NCT00971789|3927111|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4102925|NCT00971789|3927111|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4102926|NCT00971789|3927111|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4102927|NCT00971789|3927111|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4102928|NCT00971789|3927111|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4102929|NCT00971789|3927111|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4102930|NCT00971789|3927111|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4102931|NCT00971789|3927111|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4102932|NCT00971789|3927111|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4102933|NCT00971789|3927111|B1|||Age||years|Mean|43.54|43.54|Standard Deviation|15.54|15.54|||
4102934|NCT00971789|3927111|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4102935|NCT00971789|3927111|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4102936|NCT00971789|3927111|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4102937|NCT00971750|3927116|B1|United States||Region of Enrollment||participants|Number|253|253.0||||||
4102938|NCT00971750|3927116|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4102939|NCT00971750|3927116|B1||Female|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4102940|NCT00971750|3927116|B1|||Age||years|Mean|43.5|43.5|Standard Deviation|9.2|9.2|||
4102941|NCT00971750|3927116|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4102942|NCT00971750|3927116|B1||Between 18 and 65 years|Age||Participants|Count of Participants|251|251.0||||||
4102943|NCT00971750|3927116|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4102944|NCT00971633|3927125|B1|||Height||centimeters|Mean|171.1|171.1|Full Range|||155.0|183.0|
4102945|NCT00971633|3927125|B1|||Weight||kilograms|Mean|78.5|78.5|Full Range|||61.1|101.0|
4102946|NCT00971633|3927125|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4102947|NCT00971633|3927125|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4102948|NCT00971633|3927125|B1|||Age||years|Mean|31.7|31.7|Full Range|||25.0|41.0|
4102949|NCT00971620|3927141|B3|||Volume of Drug Administered||mL|Mean|1.76|1.76|Standard Deviation|.54|0.54|||
4102950|NCT00971620|3927142|B2|||Volume of Drug Administered||mL|Mean|1.12|1.12|Standard Deviation|0.38|0.38|||
4102951|NCT00971620|3927143|B1|||Volume of Drug Administered||mL|Mean|2.41|2.41|Standard Deviation|0.70|0.7|||
4102952|NCT00971620|3927141|B3|Extremity||Location of Lesions||Participants|Count of Participants|7|7.0||||||
4102953|NCT00971620|3927142|B2|Extremity||Location of Lesions||Participants|Count of Participants|5|5.0||||||
4102954|NCT00971620|3927143|B1|Extremity||Location of Lesions||Participants|Count of Participants|2|2.0||||||
4102955|NCT00971620|3927141|B3|Torso||Location of Lesions||Participants|Count of Participants|10|10.0||||||
4102956|NCT00971620|3927142|B2|Torso||Location of Lesions||Participants|Count of Participants|4|4.0||||||
4102957|NCT00971620|3927143|B1|Torso||Location of Lesions||Participants|Count of Participants|6|6.0||||||
4102958|NCT00971620|3927141|B3|Neck||Location of Lesions||Participants|Count of Participants|1|1.0||||||
4102959|NCT00971620|3927142|B2|Neck||Location of Lesions||Participants|Count of Participants|0|0.0||||||
4102960|NCT00971620|3927143|B1|Neck||Location of Lesions||Participants|Count of Participants|1|1.0||||||
4102961|NCT00971620|3927141|B3|Disseminated||Leiomyoma Distribution||Participants|Count of Participants|1|1.0||||||
4102962|NCT00971620|3927142|B2|Disseminated||Leiomyoma Distribution||Participants|Count of Participants|0|0.0||||||
4102963|NCT00971620|3927143|B1|Disseminated||Leiomyoma Distribution||Participants|Count of Participants|1|1.0||||||
4102964|NCT00971620|3927141|B3|Segmental||Leiomyoma Distribution||Participants|Count of Participants|13|13.0||||||
4102965|NCT00971620|3927142|B2|Segmental||Leiomyoma Distribution||Participants|Count of Participants|6|6.0||||||
4102966|NCT00971620|3927143|B1|Segmental||Leiomyoma Distribution||Participants|Count of Participants|7|7.0||||||
4102967|NCT00971620|3927141|B3|Single||Leiomyoma Distribution||Participants|Count of Participants|4|4.0||||||
4102968|NCT00971620|3927142|B2|Single||Leiomyoma Distribution||Participants|Count of Participants|3|3.0||||||
4102969|NCT00971620|3927143|B1|Single||Leiomyoma Distribution||Participants|Count of Participants|1|1.0||||||
4102970|NCT00971620|3927141|B3|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4102971|NCT00971620|3927142|B2|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4102972|NCT00971620|3927143|B1|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4102973|NCT00971620|3927141|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4102974|NCT00971620|3927142|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4102975|NCT00971620|3927143|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4102976|NCT00971620|3927141|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4102977|NCT00971620|3927142|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4102978|NCT00971620|3927143|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4102979|NCT00971620|3927141|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4102980|NCT00971620|3927142|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4102981|NCT00971620|3927143|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4102982|NCT00971620|3927141|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4102983|NCT00971620|3927142|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4102984|NCT00971620|3927143|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4102985|NCT00971620|3927141|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4102986|NCT00971620|3927142|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4102987|NCT00971620|3927143|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4102988|NCT00971620|3927141|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4102989|NCT00971620|3927142|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4102990|NCT00971620|3927143|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4102991|NCT00971620|3927141|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4102992|NCT00971620|3927142|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4102993|NCT00971620|3927143|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4102994|NCT00971620|3927141|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4102995|NCT00971620|3927142|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4102996|NCT00971620|3927143|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4102997|NCT00971620|3927141|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4102998|NCT00971620|3927142|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4102999|NCT00971620|3927143|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4103000|NCT00971620|3927141|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4103001|NCT00971620|3927142|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4103002|NCT00971620|3927143|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4103003|NCT00971620|3927141|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4103004|NCT00971620|3927142|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4103005|NCT00971620|3927143|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4103006|NCT00971620|3927141|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4103007|NCT00971620|3927142|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4103008|NCT00971620|3927143|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4103009|NCT00971620|3927141|B3|||Age||years|Mean|47.0|47.0|Standard Deviation|13.8|13.8|||
4103010|NCT00971620|3927142|B2|||Age||years|Mean|45.5|45.5|Standard Deviation|11.4|11.4|||
4103011|NCT00971620|3927143|B1|||Age||years|Mean|48.4|48.4|Standard Deviation|15.6|15.6|||
4103012|NCT00971620|3927141|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4103013|NCT00971620|3927142|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4103014|NCT00971620|3927143|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4103015|NCT00971620|3927141|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4103016|NCT00971620|3927142|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4103017|NCT00971620|3927143|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4103018|NCT00971620|3927141|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4103019|NCT00971620|3927142|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4103020|NCT00971620|3927143|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4103021|NCT00971425|3927174|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4103022|NCT00971425|3927175|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4103023|NCT00971425|3927176|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4103024|NCT00971425|3927174|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4103025|NCT00971425|3927175|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4103026|NCT00971425|3927176|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4103027|NCT00971425|3927174|B3|||Age||Years|Mean|69.4|69.4|Standard Deviation|5.37|5.37|||
4103028|NCT00971425|3927175|B2|||Age||Years|Mean|69.7|69.7|Standard Deviation|5.59|5.59|||
4103029|NCT00971425|3927176|B1|||Age||Years|Mean|69.1|69.1|Standard Deviation|5.16|5.16|||
4103030|NCT00971295|3927211|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4103031|NCT00971295|3927211|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4103032|NCT00971295|3927211|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4103033|NCT00971295|3927211|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4103034|NCT00971295|3927211|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4103035|NCT00971282|3927222|B1|Singapore||Region of Enrollment||participants|Number|30|30.0||||||
4103036|NCT00971282|3927222|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4103037|NCT00971282|3927222|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4103038|NCT00971282|3927222|B1|||Age||years|Mean|39.9|39.9|Standard Deviation|11.8|11.8|||
4103039|NCT00971282|3927222|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4103040|NCT00971282|3927222|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4103041|NCT00971282|3927222|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4103042|NCT00971243|3927236|B6||Male|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
4103043|NCT00971243|3927237|B5||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4103044|NCT00971243|3927238|B4||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4103045|NCT00971243|3927239|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4103046|NCT00971243|3927240|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4103047|NCT00971243|3927241|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4103048|NCT00971243|3927236|B6||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4103049|NCT00971243|3927237|B5||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4103050|NCT00971243|3927238|B4||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4103051|NCT00971243|3927239|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4103052|NCT00971243|3927240|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4103053|NCT00971243|3927241|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4103054|NCT00971243|3927236|B6|||Age||years|Mean|58.5|58.5|Standard Deviation|8.5|8.5|||
4103055|NCT00971243|3927237|B5|||Age||years|Mean|58.9|58.9|Standard Deviation|8.2|8.2|||
4103056|NCT00971243|3927238|B4|||Age||years|Mean|58.2|58.2|Standard Deviation|8.6|8.6|||
4103057|NCT00971243|3927239|B3|||Age||years|Mean|58.3|58.3|Standard Deviation|9.5|9.5|||
4103058|NCT00971243|3927240|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|8.4|8.4|||
4103059|NCT00971243|3927241|B1|||Age||years|Mean|58.8|58.8|Standard Deviation|7.7|7.7|||
4103060|NCT00971204|3927262|B1|United States||Region of Enrollment||participants|Number|86|86.0||||||
4103061|NCT00971204|3927262|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4103062|NCT00971204|3927262|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4103063|NCT00971204|3927262|B1||White|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
4103064|NCT00971204|3927262|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4103065|NCT00971204|3927262|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4103066|NCT00971204|3927262|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4103067|NCT00971204|3927262|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4103068|NCT00971204|3927262|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4103069|NCT00971204|3927262|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4103070|NCT00971204|3927262|B1|||Age||years|Mean|56.7|56.7|Standard Deviation|10.2|10.2|||
4103071|NCT00971048|3927266|B5|United States||Region of Enrollment||participants|Number|88|88.0||||||
4103072|NCT00971048|3927267|B4|United States||Region of Enrollment||participants|Number|13|13.0||||||
4103073|NCT00971048|3927268|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4103074|NCT00971048|3927269|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4103075|NCT00971048|3927270|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4103076|NCT00971048|3927266|B5||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4103077|NCT00971048|3927267|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4103078|NCT00971048|3927268|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4103079|NCT00971048|3927269|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4103080|NCT00971048|3927270|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4103081|NCT00971048|3927266|B5||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4103082|NCT00971048|3927267|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4103083|NCT00971048|3927268|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4103084|NCT00971048|3927269|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4103085|NCT00971048|3927270|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4103086|NCT00971048|3927266|B5|||Age||years|Mean|62.6|62.6|Standard Deviation|12.7|12.7|||
4103087|NCT00971048|3927267|B4|||Age||years|Mean|64.1|64.1|Standard Deviation|17.0|17.0|||
4103088|NCT00971048|3927268|B3|||Age||years|Mean|61.3|61.3|Standard Deviation|12.6|12.6|||
4103089|NCT00971048|3927269|B2|||Age||years|Mean|63.5|63.5|Standard Deviation|10.4|10.4|||
4103090|NCT00971048|3927270|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|13.5|13.5|||
4103091|NCT00971048|3927266|B5||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4103092|NCT00971048|3927267|B4||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4103093|NCT00971048|3927268|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4103094|NCT00971048|3927269|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4103095|NCT00971048|3927270|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4103096|NCT00971048|3927266|B5||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4103097|NCT00971048|3927267|B4||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4103098|NCT00971048|3927268|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4103099|NCT00971048|3927269|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4103100|NCT00971048|3927270|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4103101|NCT00971048|3927266|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4103102|NCT00971048|3927267|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4103103|NCT00971048|3927268|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4103104|NCT00971048|3927269|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4103105|NCT00971048|3927270|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4103106|NCT00970944|3927295|B3|Germany||Region of Enrollment||participants|Number|45|45.0||||||
4103107|NCT00970944|3927296|B2|Germany||Region of Enrollment||participants|Number|22|22.0||||||
4103108|NCT00970944|3927297|B1|Germany||Region of Enrollment||participants|Number|23|23.0||||||
4103109|NCT00970944|3927295|B3|Denmark||Region of Enrollment||participants|Number|5|5.0||||||
4103110|NCT00970944|3927296|B2|Denmark||Region of Enrollment||participants|Number|2|2.0||||||
4103111|NCT00970944|3927297|B1|Denmark||Region of Enrollment||participants|Number|3|3.0||||||
4103112|NCT00970944|3927295|B3|United States||Region of Enrollment||participants|Number|134|134.0||||||
4103113|NCT00970944|3927296|B2|United States||Region of Enrollment||participants|Number|73|73.0||||||
4103114|NCT00970944|3927297|B1|United States||Region of Enrollment||participants|Number|61|61.0||||||
4103115|NCT00970944|3927295|B3||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4103116|NCT00970944|3927296|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4103117|NCT00970944|3927297|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4103118|NCT00970944|3927295|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4103119|NCT00970944|3927296|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4103120|NCT00970944|3927297|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4103121|NCT00970944|3927295|B3|||Age||years|Mean|36.4|36.4|Standard Deviation|15.4|15.4|||
4103122|NCT00970944|3927296|B2|||Age||years|Mean|37.2|37.2|Standard Deviation|15.4|15.4|||
4103123|NCT00970944|3927297|B1|||Age||years|Mean|35.5|35.5|Standard Deviation|15.3|15.3|||
4103124|NCT00970944|3927295|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4103125|NCT00970944|3927296|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4103126|NCT00970944|3927297|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4103127|NCT00970944|3927295|B3||Between 18 and 65 years|Age||Participants|Count of Participants|178|178.0||||||
4103128|NCT00970944|3927296|B2||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
4103129|NCT00970944|3927297|B1||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
4103130|NCT00970944|3927295|B3||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4103131|NCT00970944|3927296|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4103132|NCT00970944|3927297|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4103133|NCT00970853|3927306|B3|United States||Region of Enrollment||participants|Number|187|187.0||||||
4103134|NCT00970853|3927307|B2|United States||Region of Enrollment||participants|Number|98|98.0||||||
4103135|NCT00970853|3927308|B1|United States||Region of Enrollment||participants|Number|89|89.0||||||
4103136|NCT00970853|3927306|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4103137|NCT00970853|3927307|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4103138|NCT00970853|3927308|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4103139|NCT00970853|3927306|B3||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4103140|NCT00970853|3927307|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4103141|NCT00970853|3927308|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4103142|NCT00970853|3927306|B3|||Age||years|Mean|7.95|7.95|Standard Deviation|.12|0.12|||
4103143|NCT00970853|3927307|B2|||Age||years|Mean|7.95|7.95|Standard Deviation|.13|0.13|||
4103144|NCT00970853|3927308|B1|||Age||years|Mean|7.96|7.96|Standard Deviation|.12|0.12|||
4103145|NCT00970853|3927306|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4103146|NCT00970853|3927307|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4103147|NCT00970853|3927308|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4103148|NCT00970853|3927306|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4103149|NCT00970853|3927307|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4103150|NCT00970853|3927308|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4103151|NCT00970853|3927306|B3||<=18 years|Age||Participants|Count of Participants|187|187.0||||||
4103152|NCT00970853|3927307|B2||<=18 years|Age||Participants|Count of Participants|98|98.0||||||
4103153|NCT00970853|3927308|B1||<=18 years|Age||Participants|Count of Participants|89|89.0||||||
4103154|NCT00970814|3927331|B3|United States||Region of Enrollment||participants|Number|130|130.0||||||
4103155|NCT00970814|3927332|B2|United States||Region of Enrollment||participants|Number|64|64.0||||||
4103156|NCT00970814|3927333|B1|United States||Region of Enrollment||participants|Number|66|66.0||||||
4103157|NCT00970814|3927331|B3||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4103158|NCT00970814|3927332|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4103159|NCT00970814|3927333|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4103160|NCT00970814|3927331|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4103161|NCT00970814|3927332|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4103162|NCT00970814|3927333|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4103163|NCT00970814|3927331|B3|||Age||years|Mean|44|44.0|Standard Deviation|11.9|11.9|||
4103164|NCT00970814|3927332|B2|||Age||years|Mean|41.7|41.7|Standard Deviation|11.7|11.7|||
4103165|NCT00970814|3927333|B1|||Age||years|Mean|47|47.0|Standard Deviation|11.5|11.5|||
4103166|NCT00970814|3927331|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4103167|NCT00970814|3927332|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4103168|NCT00970814|3927333|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4103169|NCT00970814|3927331|B3||Between 18 and 65 years|Age||Participants|Count of Participants|130|130.0||||||
4103170|NCT00970814|3927332|B2||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4103171|NCT00970814|3927333|B1||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4103172|NCT00970814|3927331|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4103173|NCT00970814|3927332|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4103174|NCT00970814|3927333|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4103175|NCT00970736|3927344|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4103176|NCT00970736|3927344|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4103177|NCT00970736|3927344|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4103178|NCT00970736|3927344|B1|||Age||years|Mean|68|68.0|Standard Deviation|6|6.0|||
4103179|NCT00970736|3927344|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4103180|NCT00970736|3927344|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4103181|NCT00970736|3927344|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4103182|NCT00970684|3927350|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4103183|NCT00970684|3927350|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4103184|NCT00970684|3927350|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4103185|NCT00970684|3927350|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4103186|NCT00970684|3927350|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4103187|NCT00970684|3927350|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4103188|NCT00970684|3927350|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4103189|NCT00970684|3927350|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4103190|NCT00970684|3927350|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4103191|NCT00970684|3927350|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4103192|NCT00970684|3927350|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4103193|NCT00970684|3927350|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4103194|NCT00970684|3927350|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4103195|NCT00970684|3927350|B1|||Age||years|Median|63|63.0|Full Range|||35.0|69.0|
4103196|NCT00970632|3927356|B4|No||Expect to Remain Sexually Active|The participant population was based on 427 randomized subjects who reported being sexually active with a female partner.|participants|Number|1|1.0||||||
4103197|NCT00970632|3927357|B3|No||Expect to Remain Sexually Active|The participant population was based on 427 randomized subjects who reported being sexually active with a female partner.|participants|Number|0|0.0||||||
4103198|NCT00970632|3927358|B2|No||Expect to Remain Sexually Active|The participant population was based on 427 randomized subjects who reported being sexually active with a female partner.|participants|Number|1|1.0||||||
4103199|NCT00970632|3927359|B1|No||Expect to Remain Sexually Active|The participant population was based on 427 randomized subjects who reported being sexually active with a female partner.|participants|Number|0|0.0||||||
4103200|NCT00970632|3927356|B4|Yes||Expect to Remain Sexually Active|The participant population was based on 427 randomized subjects who reported being sexually active with a female partner.|participants|Number|426|426.0||||||
4103201|NCT00970632|3927357|B3|Yes||Expect to Remain Sexually Active|The participant population was based on 427 randomized subjects who reported being sexually active with a female partner.|participants|Number|139|139.0||||||
4103202|NCT00970632|3927358|B2|Yes||Expect to Remain Sexually Active|The participant population was based on 427 randomized subjects who reported being sexually active with a female partner.|participants|Number|142|142.0||||||
4103203|NCT00970632|3927359|B1|Yes||Expect to Remain Sexually Active|The participant population was based on 427 randomized subjects who reported being sexually active with a female partner.|participants|Number|145|145.0||||||
4103204|NCT00970632|3927356|B4|No||Sexually Active with a Female Partner||participants|Number|84|84.0||||||
4103205|NCT00970632|3927357|B3|No||Sexually Active with a Female Partner||participants|Number|29|29.0||||||
4103206|NCT00970632|3927358|B2|No||Sexually Active with a Female Partner||participants|Number|28|28.0||||||
4103207|NCT00970632|3927359|B1|No||Sexually Active with a Female Partner||participants|Number|27|27.0||||||
4103208|NCT00970632|3927356|B4|Yes||Sexually Active with a Female Partner||participants|Number|427|427.0||||||
4103209|NCT00970632|3927357|B3|Yes||Sexually Active with a Female Partner||participants|Number|139|139.0||||||
4103210|NCT00970632|3927358|B2|Yes||Sexually Active with a Female Partner||participants|Number|143|143.0||||||
4103211|NCT00970632|3927359|B1|Yes||Sexually Active with a Female Partner||participants|Number|145|145.0||||||
4103212|NCT00970632|3927356|B4|≥1 year||Erectile Dysfunction (ED) Duration|ED was defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse. The participant population included 357 randomized subjects with ED.|participants|Number|285|285.0||||||
4103213|NCT00970632|3927357|B3|≥1 year||Erectile Dysfunction (ED) Duration|ED was defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse. The participant population included 357 randomized subjects with ED.|participants|Number|87|87.0||||||
4103214|NCT00970632|3927358|B2|≥1 year||Erectile Dysfunction (ED) Duration|ED was defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse. The participant population included 357 randomized subjects with ED.|participants|Number|93|93.0||||||
4103215|NCT00970632|3927359|B1|≥1 year||Erectile Dysfunction (ED) Duration|ED was defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse. The participant population included 357 randomized subjects with ED.|participants|Number|105|105.0||||||
4103216|NCT00970632|3927356|B4|<1 year||Erectile Dysfunction (ED) Duration|ED was defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse. The participant population included 357 randomized subjects with ED.|participants|Number|72|72.0||||||
4103217|NCT00970632|3927357|B3|<1 year||Erectile Dysfunction (ED) Duration|ED was defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse. The participant population included 357 randomized subjects with ED.|participants|Number|29|29.0||||||
4103218|NCT00970632|3927358|B2|<1 year||Erectile Dysfunction (ED) Duration|ED was defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse. The participant population included 357 randomized subjects with ED.|participants|Number|28|28.0||||||
4103219|NCT00970632|3927359|B1|<1 year||Erectile Dysfunction (ED) Duration|ED was defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse. The participant population included 357 randomized subjects with ED.|participants|Number|15|15.0||||||
4103220|NCT00970632|3927356|B4|Severe||Erectile Dysfunction (ED) Severity|ED was defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse. Severity was based on investigator opinion. The participant population included 357 randomized subjects with ED.|participants|Number|61|61.0||||||
4103221|NCT00970632|3927357|B3|Severe||Erectile Dysfunction (ED) Severity|ED was defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse. Severity was based on investigator opinion. The participant population included 357 randomized subjects with ED.|participants|Number|23|23.0||||||
4103222|NCT00970632|3927358|B2|Severe||Erectile Dysfunction (ED) Severity|ED was defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse. Severity was based on investigator opinion. The participant population included 357 randomized subjects with ED.|participants|Number|18|18.0||||||
4103223|NCT00970632|3927359|B1|Severe||Erectile Dysfunction (ED) Severity|ED was defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse. Severity was based on investigator opinion. The participant population included 357 randomized subjects with ED.|participants|Number|20|20.0||||||
4103303|NCT00970632|3927359|B1|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
4103304|NCT00970632|3927356|B4|Austria||Region of Enrollment||participants|Number|30|30.0||||||
4103305|NCT00970632|3927357|B3|Austria||Region of Enrollment||participants|Number|7|7.0||||||
4103224|NCT00970632|3927356|B4|Moderate||Erectile Dysfunction (ED) Severity|ED was defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse. Severity was based on investigator opinion. The participant population included 357 randomized subjects with ED.|participants|Number|189|189.0||||||
4103225|NCT00970632|3927357|B3|Moderate||Erectile Dysfunction (ED) Severity|ED was defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse. Severity was based on investigator opinion. The participant population included 357 randomized subjects with ED.|participants|Number|60|60.0||||||
4103226|NCT00970632|3927358|B2|Moderate||Erectile Dysfunction (ED) Severity|ED was defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse. Severity was based on investigator opinion. The participant population included 357 randomized subjects with ED.|participants|Number|65|65.0||||||
4103227|NCT00970632|3927359|B1|Moderate||Erectile Dysfunction (ED) Severity|ED was defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse. Severity was based on investigator opinion. The participant population included 357 randomized subjects with ED.|participants|Number|64|64.0||||||
4103228|NCT00970632|3927356|B4|Mild||Erectile Dysfunction (ED) Severity|ED was defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse. Severity was based on investigator opinion. The participant population included 357 randomized subjects with ED.|participants|Number|107|107.0||||||
4103229|NCT00970632|3927357|B3|Mild||Erectile Dysfunction (ED) Severity|ED was defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse. Severity was based on investigator opinion. The participant population included 357 randomized subjects with ED.|participants|Number|33|33.0||||||
4103230|NCT00970632|3927358|B2|Mild||Erectile Dysfunction (ED) Severity|ED was defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse. Severity was based on investigator opinion. The participant population included 357 randomized subjects with ED.|participants|Number|38|38.0||||||
4103231|NCT00970632|3927359|B1|Mild||Erectile Dysfunction (ED) Severity|ED was defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse. Severity was based on investigator opinion. The participant population included 357 randomized subjects with ED.|participants|Number|36|36.0||||||
4103232|NCT00970632|3927356|B4|No||Erectile Dysfunction (ED)|ED was defined as a consistent change in the quality of erection adversely affecting participant satisfaction with sexual intercourse.|participants|Number|154|154.0||||||
4103233|NCT00970632|3927357|B3|No||Erectile Dysfunction (ED)|ED was defined as a consistent change in the quality of erection adversely affecting participant satisfaction with sexual intercourse.|participants|Number|52|52.0||||||
4103234|NCT00970632|3927358|B2|No||Erectile Dysfunction (ED)|ED was defined as a consistent change in the quality of erection adversely affecting participant satisfaction with sexual intercourse.|participants|Number|50|50.0||||||
4103235|NCT00970632|3927359|B1|No||Erectile Dysfunction (ED)|ED was defined as a consistent change in the quality of erection adversely affecting participant satisfaction with sexual intercourse.|participants|Number|52|52.0||||||
4103236|NCT00970632|3927356|B4|Yes||Erectile Dysfunction (ED)|ED was defined as a consistent change in the quality of erection adversely affecting participant satisfaction with sexual intercourse.|participants|Number|357|357.0||||||
4103237|NCT00970632|3927357|B3|Yes||Erectile Dysfunction (ED)|ED was defined as a consistent change in the quality of erection adversely affecting participant satisfaction with sexual intercourse.|participants|Number|116|116.0||||||
4103238|NCT00970632|3927358|B2|Yes||Erectile Dysfunction (ED)|ED was defined as a consistent change in the quality of erection adversely affecting participant satisfaction with sexual intercourse.|participants|Number|121|121.0||||||
4103239|NCT00970632|3927359|B1|Yes||Erectile Dysfunction (ED)|ED was defined as a consistent change in the quality of erection adversely affecting participant satisfaction with sexual intercourse.|participants|Number|120|120.0||||||
4103240|NCT00970632|3927356|B4|||Prostate Specific Antigen (PSA)|PSA is a protein produced by the cells of the prostate gland. PSA is present in small quantities in the serum of men with healthy prostates, but is often elevated in the presence of prostate disorders, such as prostate cancer.|nanograms per milliliter (ng/mL)|Mean|2.0|2.0|Standard Deviation|1.70|1.7|||
4103241|NCT00970632|3927357|B3|||Prostate Specific Antigen (PSA)|PSA is a protein produced by the cells of the prostate gland. PSA is present in small quantities in the serum of men with healthy prostates, but is often elevated in the presence of prostate disorders, such as prostate cancer.|nanograms per milliliter (ng/mL)|Mean|1.9|1.9|Standard Deviation|1.57|1.57|||
4103242|NCT00970632|3927358|B2|||Prostate Specific Antigen (PSA)|PSA is a protein produced by the cells of the prostate gland. PSA is present in small quantities in the serum of men with healthy prostates, but is often elevated in the presence of prostate disorders, such as prostate cancer.|nanograms per milliliter (ng/mL)|Mean|2.1|2.1|Standard Deviation|1.83|1.83|||
4103243|NCT00970632|3927359|B1|||Prostate Specific Antigen (PSA)|PSA is a protein produced by the cells of the prostate gland. PSA is present in small quantities in the serum of men with healthy prostates, but is often elevated in the presence of prostate disorders, such as prostate cancer.|nanograms per milliliter (ng/mL)|Mean|2.0|2.0|Standard Deviation|1.69|1.69|||
4103244|NCT00970632|3927356|B4|||Postvoid Residual Volume (PVR)|PVR was determined by ultrasound at baseline. Urine volume was measured after complete emptying of the participant's bladder.|milliliter (mL)|Mean|55.1|55.1|Standard Deviation|53.88|53.88|||
4103245|NCT00970632|3927357|B3|||Postvoid Residual Volume (PVR)|PVR was determined by ultrasound at baseline. Urine volume was measured after complete emptying of the participant's bladder.|milliliter (mL)|Mean|59.8|59.8|Standard Deviation|57.99|57.99|||
4103246|NCT00970632|3927358|B2|||Postvoid Residual Volume (PVR)|PVR was determined by ultrasound at baseline. Urine volume was measured after complete emptying of the participant's bladder.|milliliter (mL)|Mean|54.6|54.6|Standard Deviation|52.29|52.29|||
4103247|NCT00970632|3927359|B1|||Postvoid Residual Volume (PVR)|PVR was determined by ultrasound at baseline. Urine volume was measured after complete emptying of the participant's bladder.|milliliter (mL)|Mean|50.9|50.9|Standard Deviation|51.14|51.14|||
4103306|NCT00970632|3927358|B2|Austria||Region of Enrollment||participants|Number|10|10.0||||||
4103248|NCT00970632|3927356|B4|>15 mL/sec||Peak Urine Flow Rate (Qmax) Category|Qmax is a uroflowmetry parameter used to measure peak urine flow rate with a standard calibrated flowmeter in milliliters per second (mL/sec) at Visit 3 (Week 0). Percentages were based on the prevoid number of randomized participants with valid uroflowmetry data (N=498 participants). The uroflowmetry assessment was considered valid and data were included in this summary only if total bladder volume (assessed by ultrasound) was ≥150 to ≤550 mL and voided volume (V-Comp) was ≥125 mL.|participants|Number|37|37.0||||||
4103249|NCT00970632|3927357|B3|>15 mL/sec||Peak Urine Flow Rate (Qmax) Category|Qmax is a uroflowmetry parameter used to measure peak urine flow rate with a standard calibrated flowmeter in milliliters per second (mL/sec) at Visit 3 (Week 0). Percentages were based on the prevoid number of randomized participants with valid uroflowmetry data (N=498 participants). The uroflowmetry assessment was considered valid and data were included in this summary only if total bladder volume (assessed by ultrasound) was ≥150 to ≤550 mL and voided volume (V-Comp) was ≥125 mL.|participants|Number|7|7.0||||||
4103250|NCT00970632|3927358|B2|>15 mL/sec||Peak Urine Flow Rate (Qmax) Category|Qmax is a uroflowmetry parameter used to measure peak urine flow rate with a standard calibrated flowmeter in milliliters per second (mL/sec) at Visit 3 (Week 0). Percentages were based on the prevoid number of randomized participants with valid uroflowmetry data (N=498 participants). The uroflowmetry assessment was considered valid and data were included in this summary only if total bladder volume (assessed by ultrasound) was ≥150 to ≤550 mL and voided volume (V-Comp) was ≥125 mL.|participants|Number|12|12.0||||||
4103251|NCT00970632|3927359|B1|>15 mL/sec||Peak Urine Flow Rate (Qmax) Category|Qmax is a uroflowmetry parameter used to measure peak urine flow rate with a standard calibrated flowmeter in milliliters per second (mL/sec) at Visit 3 (Week 0). Percentages were based on the prevoid number of randomized participants with valid uroflowmetry data (N=498 participants). The uroflowmetry assessment was considered valid and data were included in this summary only if total bladder volume (assessed by ultrasound) was ≥150 to ≤550 mL and voided volume (V-Comp) was ≥125 mL.|participants|Number|18|18.0||||||
4103252|NCT00970632|3927356|B4|10-15 mL/sec||Peak Urine Flow Rate (Qmax) Category|Qmax is a uroflowmetry parameter used to measure peak urine flow rate with a standard calibrated flowmeter in milliliters per second (mL/sec) at Visit 3 (Week 0). Percentages were based on the prevoid number of randomized participants with valid uroflowmetry data (N=498 participants). The uroflowmetry assessment was considered valid and data were included in this summary only if total bladder volume (assessed by ultrasound) was ≥150 to ≤550 mL and voided volume (V-Comp) was ≥125 mL.|participants|Number|185|185.0||||||
4103253|NCT00970632|3927357|B3|10-15 mL/sec||Peak Urine Flow Rate (Qmax) Category|Qmax is a uroflowmetry parameter used to measure peak urine flow rate with a standard calibrated flowmeter in milliliters per second (mL/sec) at Visit 3 (Week 0). Percentages were based on the prevoid number of randomized participants with valid uroflowmetry data (N=498 participants). The uroflowmetry assessment was considered valid and data were included in this summary only if total bladder volume (assessed by ultrasound) was ≥150 to ≤550 mL and voided volume (V-Comp) was ≥125 mL.|participants|Number|53|53.0||||||
4103254|NCT00970632|3927358|B2|10-15 mL/sec||Peak Urine Flow Rate (Qmax) Category|Qmax is a uroflowmetry parameter used to measure peak urine flow rate with a standard calibrated flowmeter in milliliters per second (mL/sec) at Visit 3 (Week 0). Percentages were based on the prevoid number of randomized participants with valid uroflowmetry data (N=498 participants). The uroflowmetry assessment was considered valid and data were included in this summary only if total bladder volume (assessed by ultrasound) was ≥150 to ≤550 mL and voided volume (V-Comp) was ≥125 mL.|participants|Number|63|63.0||||||
4103255|NCT00970632|3927359|B1|10-15 mL/sec||Peak Urine Flow Rate (Qmax) Category|Qmax is a uroflowmetry parameter used to measure peak urine flow rate with a standard calibrated flowmeter in milliliters per second (mL/sec) at Visit 3 (Week 0). Percentages were based on the prevoid number of randomized participants with valid uroflowmetry data (N=498 participants). The uroflowmetry assessment was considered valid and data were included in this summary only if total bladder volume (assessed by ultrasound) was ≥150 to ≤550 mL and voided volume (V-Comp) was ≥125 mL.|participants|Number|69|69.0||||||
4103256|NCT00970632|3927356|B4|<10 mL/sec||Peak Urine Flow Rate (Qmax) Category|Qmax is a uroflowmetry parameter used to measure peak urine flow rate with a standard calibrated flowmeter in milliliters per second (mL/sec) at Visit 3 (Week 0). Percentages were based on the prevoid number of randomized participants with valid uroflowmetry data (N=498 participants). The uroflowmetry assessment was considered valid and data were included in this summary only if total bladder volume (assessed by ultrasound) was ≥150 to ≤550 mL and voided volume (V-Comp) was ≥125 mL.|participants|Number|276|276.0||||||
4103257|NCT00970632|3927357|B3|<10 mL/sec||Peak Urine Flow Rate (Qmax) Category|Qmax is a uroflowmetry parameter used to measure peak urine flow rate with a standard calibrated flowmeter in milliliters per second (mL/sec) at Visit 3 (Week 0). Percentages were based on the prevoid number of randomized participants with valid uroflowmetry data (N=498 participants). The uroflowmetry assessment was considered valid and data were included in this summary only if total bladder volume (assessed by ultrasound) was ≥150 to ≤550 mL and voided volume (V-Comp) was ≥125 mL.|participants|Number|105|105.0||||||
4103258|NCT00970632|3927358|B2|<10 mL/sec||Peak Urine Flow Rate (Qmax) Category|Qmax is a uroflowmetry parameter used to measure peak urine flow rate with a standard calibrated flowmeter in milliliters per second (mL/sec) at Visit 3 (Week 0). Percentages were based on the prevoid number of randomized participants with valid uroflowmetry data (N=498 participants). The uroflowmetry assessment was considered valid and data were included in this summary only if total bladder volume (assessed by ultrasound) was ≥150 to ≤550 mL and voided volume (V-Comp) was ≥125 mL.|participants|Number|92|92.0||||||
4103259|NCT00970632|3927359|B1|<10 mL/sec||Peak Urine Flow Rate (Qmax) Category|Qmax is a uroflowmetry parameter used to measure peak urine flow rate with a standard calibrated flowmeter in milliliters per second (mL/sec) at Visit 3 (Week 0). Percentages were based on the prevoid number of randomized participants with valid uroflowmetry data (N=498 participants). The uroflowmetry assessment was considered valid and data were included in this summary only if total bladder volume (assessed by ultrasound) was ≥150 to ≤550 mL and voided volume (V-Comp) was ≥125 mL.|participants|Number|79|79.0||||||
4103260|NCT00970632|3927356|B4|Severe (IPSS ≥20)||Lower Urinary Tract Symptom (LUTS) Severity|The total International Prostate Symptom Score (IPSS) was obtained by combining the scores of the responses to Component Questions 1-7. Each question was scored from 0-5 for a total IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represented greater severity of symptoms.|participants|Number|151|151.0||||||
4103261|NCT00970632|3927357|B3|Severe (IPSS ≥20)||Lower Urinary Tract Symptom (LUTS) Severity|The total International Prostate Symptom Score (IPSS) was obtained by combining the scores of the responses to Component Questions 1-7. Each question was scored from 0-5 for a total IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represented greater severity of symptoms.|participants|Number|49|49.0||||||
4103262|NCT00970632|3927358|B2|Severe (IPSS ≥20)||Lower Urinary Tract Symptom (LUTS) Severity|The total International Prostate Symptom Score (IPSS) was obtained by combining the scores of the responses to Component Questions 1-7. Each question was scored from 0-5 for a total IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represented greater severity of symptoms.|participants|Number|48|48.0||||||
4103263|NCT00970632|3927359|B1|Severe (IPSS ≥20)||Lower Urinary Tract Symptom (LUTS) Severity|The total International Prostate Symptom Score (IPSS) was obtained by combining the scores of the responses to Component Questions 1-7. Each question was scored from 0-5 for a total IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represented greater severity of symptoms.|participants|Number|54|54.0||||||
4103264|NCT00970632|3927356|B4|Moderate (IPSS <20)||Lower Urinary Tract Symptom (LUTS) Severity|The total International Prostate Symptom Score (IPSS) was obtained by combining the scores of the responses to Component Questions 1-7. Each question was scored from 0-5 for a total IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represented greater severity of symptoms.|participants|Number|360|360.0||||||
4103265|NCT00970632|3927357|B3|Moderate (IPSS <20)||Lower Urinary Tract Symptom (LUTS) Severity|The total International Prostate Symptom Score (IPSS) was obtained by combining the scores of the responses to Component Questions 1-7. Each question was scored from 0-5 for a total IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represented greater severity of symptoms.|participants|Number|119|119.0||||||
4103266|NCT00970632|3927358|B2|Moderate (IPSS <20)||Lower Urinary Tract Symptom (LUTS) Severity|The total International Prostate Symptom Score (IPSS) was obtained by combining the scores of the responses to Component Questions 1-7. Each question was scored from 0-5 for a total IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represented greater severity of symptoms.|participants|Number|123|123.0||||||
4103267|NCT00970632|3927359|B1|Moderate (IPSS <20)||Lower Urinary Tract Symptom (LUTS) Severity|The total International Prostate Symptom Score (IPSS) was obtained by combining the scores of the responses to Component Questions 1-7. Each question was scored from 0-5 for a total IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represented greater severity of symptoms.|participants|Number|118|118.0||||||
4103268|NCT00970632|3927356|B4|||Body Mass Index (BMI)|BMI measured the participant's body weight divided by the square of his or her height.|kilogram per square meter (kg/m^2)|Mean|27.7|27.7|Standard Deviation|3.96|3.96|||
4103269|NCT00970632|3927357|B3|||Body Mass Index (BMI)|BMI measured the participant's body weight divided by the square of his or her height.|kilogram per square meter (kg/m^2)|Mean|27.9|27.9|Standard Deviation|3.73|3.73|||
4103270|NCT00970632|3927358|B2|||Body Mass Index (BMI)|BMI measured the participant's body weight divided by the square of his or her height.|kilogram per square meter (kg/m^2)|Mean|27.1|27.1|Standard Deviation|4.03|4.03|||
4103271|NCT00970632|3927359|B1|||Body Mass Index (BMI)|BMI measured the participant's body weight divided by the square of his or her height.|kilogram per square meter (kg/m^2)|Mean|28.1|28.1|Standard Deviation|4.09|4.09|||
4103272|NCT00970632|3927356|B4|Poland||Region of Enrollment||participants|Number|35|35.0||||||
4103273|NCT00970632|3927357|B3|Poland||Region of Enrollment||participants|Number|10|10.0||||||
4103274|NCT00970632|3927358|B2|Poland||Region of Enrollment||participants|Number|13|13.0||||||
4103275|NCT00970632|3927359|B1|Poland||Region of Enrollment||participants|Number|12|12.0||||||
4103276|NCT00970632|3927356|B4|Netherlands||Region of Enrollment||participants|Number|11|11.0||||||
4103277|NCT00970632|3927357|B3|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
4103278|NCT00970632|3927358|B2|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
4103279|NCT00970632|3927359|B1|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
4103280|NCT00970632|3927356|B4|Mexico||Region of Enrollment||participants|Number|122|122.0||||||
4103281|NCT00970632|3927357|B3|Mexico||Region of Enrollment||participants|Number|38|38.0||||||
4103282|NCT00970632|3927358|B2|Mexico||Region of Enrollment||participants|Number|41|41.0||||||
4103283|NCT00970632|3927359|B1|Mexico||Region of Enrollment||participants|Number|43|43.0||||||
4103284|NCT00970632|3927356|B4|Italy||Region of Enrollment||participants|Number|59|59.0||||||
4103285|NCT00970632|3927357|B3|Italy||Region of Enrollment||participants|Number|15|15.0||||||
4103286|NCT00970632|3927358|B2|Italy||Region of Enrollment||participants|Number|26|26.0||||||
4103287|NCT00970632|3927359|B1|Italy||Region of Enrollment||participants|Number|18|18.0||||||
4103288|NCT00970632|3927356|B4|Greece||Region of Enrollment||participants|Number|19|19.0||||||
4103289|NCT00970632|3927357|B3|Greece||Region of Enrollment||participants|Number|7|7.0||||||
4103290|NCT00970632|3927358|B2|Greece||Region of Enrollment||participants|Number|4|4.0||||||
4103291|NCT00970632|3927359|B1|Greece||Region of Enrollment||participants|Number|8|8.0||||||
4103292|NCT00970632|3927356|B4|Germany||Region of Enrollment||participants|Number|162|162.0||||||
4103293|NCT00970632|3927357|B3|Germany||Region of Enrollment||participants|Number|56|56.0||||||
4103294|NCT00970632|3927358|B2|Germany||Region of Enrollment||participants|Number|50|50.0||||||
4103295|NCT00970632|3927359|B1|Germany||Region of Enrollment||participants|Number|56|56.0||||||
4103296|NCT00970632|3927356|B4|France||Region of Enrollment||participants|Number|30|30.0||||||
4103297|NCT00970632|3927357|B3|France||Region of Enrollment||participants|Number|12|12.0||||||
4103298|NCT00970632|3927358|B2|France||Region of Enrollment||participants|Number|9|9.0||||||
4103299|NCT00970632|3927359|B1|France||Region of Enrollment||participants|Number|9|9.0||||||
4103300|NCT00970632|3927356|B4|Belgium||Region of Enrollment||participants|Number|18|18.0||||||
4103301|NCT00970632|3927357|B3|Belgium||Region of Enrollment||participants|Number|7|7.0||||||
4103302|NCT00970632|3927358|B2|Belgium||Region of Enrollment||participants|Number|6|6.0||||||
4103307|NCT00970632|3927359|B1|Austria||Region of Enrollment||participants|Number|13|13.0||||||
4103308|NCT00970632|3927356|B4|Australia||Region of Enrollment||participants|Number|25|25.0||||||
4103309|NCT00970632|3927357|B3|Australia||Region of Enrollment||participants|Number|10|10.0||||||
4103310|NCT00970632|3927358|B2|Australia||Region of Enrollment||participants|Number|9|9.0||||||
4103311|NCT00970632|3927359|B1|Australia||Region of Enrollment||participants|Number|6|6.0||||||
4103312|NCT00970632|3927356|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4103313|NCT00970632|3927357|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4103314|NCT00970632|3927358|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4103315|NCT00970632|3927359|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4103316|NCT00970632|3927356|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4103317|NCT00970632|3927357|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4103318|NCT00970632|3927358|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4103319|NCT00970632|3927359|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4103320|NCT00970632|3927356|B4||White|Race (NIH/OMB)||Participants|Count of Participants|392|392.0||||||
4103321|NCT00970632|3927357|B3||White|Race (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
4103322|NCT00970632|3927358|B2||White|Race (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
4103323|NCT00970632|3927359|B1||White|Race (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
4103324|NCT00970632|3927356|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4103325|NCT00970632|3927357|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4103326|NCT00970632|3927358|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4103327|NCT00970632|3927359|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4103328|NCT00970632|3927356|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4103329|NCT00970632|3927357|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4103330|NCT00970632|3927358|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4103331|NCT00970632|3927359|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4103332|NCT00970632|3927356|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4103333|NCT00970632|3927357|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4103334|NCT00970632|3927358|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4103335|NCT00970632|3927359|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4103336|NCT00970632|3927356|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|118|118.0||||||
4103337|NCT00970632|3927357|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4103338|NCT00970632|3927358|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4103339|NCT00970632|3927359|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4103340|NCT00970632|3927356|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4103341|NCT00970632|3927357|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4103342|NCT00970632|3927358|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4103343|NCT00970632|3927359|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4103344|NCT00970632|3927356|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|372|372.0||||||
4103345|NCT00970632|3927357|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
4103346|NCT00970632|3927358|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
4103347|NCT00970632|3927359|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
4103348|NCT00970632|3927356|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|139|139.0||||||
4103349|NCT00970632|3927357|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4103350|NCT00970632|3927358|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4103351|NCT00970632|3927359|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4103352|NCT00970632|3927356|B4||Male|Sex: Female, Male||Participants|Count of Participants|511|511.0||||||
4103353|NCT00970632|3927357|B3||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4103354|NCT00970632|3927358|B2||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4103355|NCT00970632|3927359|B1||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4103356|NCT00970632|3927356|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4103357|NCT00970632|3927357|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4103358|NCT00970632|3927358|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4103359|NCT00970632|3927359|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4103360|NCT00970632|3927356|B4|||Age||years|Mean|63.6|63.6|Standard Deviation|8.16|8.16|||
4103361|NCT00970632|3927357|B3|||Age||years|Mean|63.5|63.5|Standard Deviation|7.76|7.76|||
4103362|NCT00970632|3927358|B2|||Age||years|Mean|63.5|63.5|Standard Deviation|8.08|8.08|||
4103363|NCT00970632|3927359|B1|||Age||years|Mean|63.7|63.7|Standard Deviation|8.65|8.65|||
4103364|NCT00970606|3927417|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4103365|NCT00970606|3927418|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4103366|NCT00970606|3927419|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4103367|NCT00970606|3927417|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4103368|NCT00970606|3927418|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4103369|NCT00970606|3927419|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4103370|NCT00970606|3927417|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4103371|NCT00970606|3927418|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4103372|NCT00970606|3927419|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4103373|NCT00970606|3927417|B3|||Age||years|Mean|41.68|41.68|Standard Deviation|9.76|9.76|||
4103374|NCT00970606|3927418|B2|||Age||years|Mean|39.88|39.88|Standard Deviation|5.32|5.32|||
4103375|NCT00970606|3927419|B1|||Age||years|Mean|43.03|43.03|Standard Deviation|12.89|12.89|||
4103376|NCT00970606|3927417|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4103377|NCT00970606|3927418|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4103378|NCT00970606|3927419|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4103379|NCT00970606|3927417|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4103380|NCT00970606|3927418|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4103381|NCT00970606|3927419|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4103382|NCT00970606|3927417|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4103383|NCT00970606|3927418|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4103384|NCT00970606|3927419|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4103385|NCT00970502|3927426|B1|N1||Lymph node status|N0 - tumor cells absent from regional lymph nodes N1 - regional lymph node metastasis present; (at some sites; tumor spread to closest or small number of regional lymph nodes)|participants|Number|11|11.0||||||
4103386|NCT00970502|3927426|B1|N0||Lymph node status|N0 - tumor cells absent from regional lymph nodes N1 - regional lymph node metastasis present; (at some sites; tumor spread to closest or small number of regional lymph nodes)|participants|Number|3|3.0||||||
4103387|NCT00970502|3927426|B1|T4||Primary tumor classification|T4 --> Tumor of any size with direct extension to chest wall or skin Tx - T3 --> any tumor not classified as T4|participants|Number|10|10.0||||||
4103388|NCT00970502|3927426|B1|Tx-T3||Primary tumor classification|T4 --> Tumor of any size with direct extension to chest wall or skin Tx - T3 --> any tumor not classified as T4|participants|Number|4|4.0||||||
4103389|NCT00970502|3927426|B1|Larynx||Primary Site||participants|Number|1|1.0||||||
4103390|NCT00970502|3927426|B1|Hypopharynx||Primary Site||participants|Number|4|4.0||||||
4103391|NCT00970502|3927426|B1|Oral cavity||Primary Site||participants|Number|1|1.0||||||
4103392|NCT00970502|3927426|B1|Oropharynx||Primary Site||participants|Number|3|3.0||||||
4103393|NCT00970502|3927426|B1|Ear/facial skin||Primary Site||participants|Number|2|2.0||||||
4103394|NCT00970502|3927426|B1|Sinonasal||Primary Site||participants|Number|3|3.0||||||
4103395|NCT00970502|3927426|B1|Adenoid cystic||Histology||participants|Number|1|1.0||||||
4103396|NCT00970502|3927426|B1|Squamous cell carcinoma||Histology||participants|Number|13|13.0||||||
4103397|NCT00970502|3927426|B1|Second primary cancer||Recurrent vs secondary primary||participants|Number|3|3.0||||||
4103398|NCT00970502|3927426|B1|Second or later recurrence||Recurrent vs secondary primary||participants|Number|4|4.0||||||
4103399|NCT00970502|3927426|B1|Primary recurrence||Recurrent vs secondary primary||participants|Number|7|7.0||||||
4103400|NCT00970502|3927426|B1|Unknown||Tobacco use, pack-years||participants|Number|1|1.0||||||
4103401|NCT00970502|3927426|B1|>40||Tobacco use, pack-years||participants|Number|2|2.0||||||
4103402|NCT00970502|3927426|B1|20-40||Tobacco use, pack-years||participants|Number|3|3.0||||||
4103403|NCT00970502|3927426|B1|<20||Tobacco use, pack-years||participants|Number|6|6.0||||||
4103404|NCT00970502|3927426|B1|None to minimal||Tobacco use, pack-years||participants|Number|2|2.0||||||
4103405|NCT00970502|3927426|B1|2||ECOG Performance Status|"The Eastern Cooperative Oncology Group (ECOG) 0 - Fully active, able to carry on all pre-disease performance without restriction~1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature 2- Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|participants|Number|9|9.0||||||
4103406|NCT00970502|3927426|B1|1||ECOG Performance Status|"The Eastern Cooperative Oncology Group (ECOG) 0 - Fully active, able to carry on all pre-disease performance without restriction~1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature 2- Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|participants|Number|5|5.0||||||
4103407|NCT00970502|3927426|B1|0||ECOG Performance Status|"The Eastern Cooperative Oncology Group (ECOG) 0 - Fully active, able to carry on all pre-disease performance without restriction~1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature 2- Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|participants|Number|0|0.0||||||
4103408|NCT00970502|3927426|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4103409|NCT00970502|3927426|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4103410|NCT00970502|3927426|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4103411|NCT00970502|3927426|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4103412|NCT00970502|3927426|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4103413|NCT00970502|3927426|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4103462|NCT00970320|3927461|B1|||Age||years|Mean|29.1|29.1|Standard Deviation|3.9|3.9|||
4103414|NCT00970502|3927426|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4103415|NCT00970502|3927426|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4103416|NCT00970502|3927426|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4103417|NCT00970502|3927426|B1|||Age||years|Median|64|64.0|Full Range|||43.0|93.0|
4103418|NCT00970489|3927435|B3||Male|Sex: Female, Male||Participants|Count of Participants|1094|1094.0||||||
4103419|NCT00970489|3927436|B2||Male|Sex: Female, Male||Participants|Count of Participants|551|551.0||||||
4103420|NCT00970489|3927437|B1||Male|Sex: Female, Male||Participants|Count of Participants|543|543.0||||||
4103421|NCT00970489|3927435|B3||Female|Sex: Female, Male||Participants|Count of Participants|422|422.0||||||
4103422|NCT00970489|3927436|B2||Female|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4103423|NCT00970489|3927437|B1||Female|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
4103424|NCT00970489|3927435|B3|||Age||years|Mean|63.7|63.7|Standard Deviation|12.5|12.5|||
4103425|NCT00970489|3927436|B2|||Age||years|Mean|63.8|63.8|Standard Deviation|12.6|12.6|||
4103426|NCT00970489|3927437|B1|||Age||years|Mean|63.6|63.6|Standard Deviation|12.4|12.4|||
4103427|NCT00970359|3927450|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4103428|NCT00970359|3927450|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4103429|NCT00970359|3927450|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4103430|NCT00970359|3927450|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4103431|NCT00970359|3927450|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4103432|NCT00970359|3927450|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4103433|NCT00970320|3927456|B6|||Anal incontinence (AI)|The St Mark's score ranges from 0-24 points and measures the frequency of AI complaints. There is no standard grading of the scale. A change of +/- 5 points has been suggested as a minimal clinical important difference in severe AI patients, and +/- 2-3 points in less severely affected populations.|units on a scale|Mean|4.5|4.5|Standard Deviation|3.9|3.9|||
4103434|NCT00970320|3927457|B5|||Anal incontinence (AI)|The St Mark's score ranges from 0-24 points and measures the frequency of AI complaints. There is no standard grading of the scale. A change of +/- 5 points has been suggested as a minimal clinical important difference in severe AI patients, and +/- 2-3 points in less severely affected populations.|units on a scale|Mean|6.0|6.0|Standard Deviation|5.0|5.0|||
4103435|NCT00970320|3927458|B4|||Anal incontinence (AI)|The St Mark's score ranges from 0-24 points and measures the frequency of AI complaints. There is no standard grading of the scale. A change of +/- 5 points has been suggested as a minimal clinical important difference in severe AI patients, and +/- 2-3 points in less severely affected populations.|units on a scale|Mean|4.1|4.1|Standard Deviation|4.1|4.1|||
4103436|NCT00970320|3927459|B3|||Anal incontinence (AI)|The St Mark's score ranges from 0-24 points and measures the frequency of AI complaints. There is no standard grading of the scale. A change of +/- 5 points has been suggested as a minimal clinical important difference in severe AI patients, and +/- 2-3 points in less severely affected populations.|units on a scale|Mean|3.6|3.6|Standard Deviation|3.3|3.3|||
4103437|NCT00970320|3927460|B2|||Anal incontinence (AI)|The St Mark's score ranges from 0-24 points and measures the frequency of AI complaints. There is no standard grading of the scale. A change of +/- 5 points has been suggested as a minimal clinical important difference in severe AI patients, and +/- 2-3 points in less severely affected populations.|units on a scale|Mean|4.5|4.5|Standard Deviation|3.2|3.2|||
4103438|NCT00970320|3927461|B1|||Anal incontinence (AI)|The St Mark's score ranges from 0-24 points and measures the frequency of AI complaints. There is no standard grading of the scale. A change of +/- 5 points has been suggested as a minimal clinical important difference in severe AI patients, and +/- 2-3 points in less severely affected populations.|units on a scale|Mean|4.3|4.3|Standard Deviation|4.0|4.0|||
4103439|NCT00970320|3927456|B6|Norway||Region of Enrollment||participants|Number|1718|1718.0||||||
4103440|NCT00970320|3927457|B5|Norway||Region of Enrollment||participants|Number|1571|1571.0||||||
4103441|NCT00970320|3927458|B4|Norway||Region of Enrollment||participants|Number|50|50.0||||||
4103442|NCT00970320|3927459|B3|Norway||Region of Enrollment||participants|Number|48|48.0||||||
4103443|NCT00970320|3927460|B2|Norway||Region of Enrollment||participants|Number|24|24.0||||||
4103444|NCT00970320|3927461|B1|Norway||Region of Enrollment||participants|Number|25|25.0||||||
4103445|NCT00970320|3927456|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4103446|NCT00970320|3927457|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4103447|NCT00970320|3927458|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4103448|NCT00970320|3927459|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4103449|NCT00970320|3927460|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4103450|NCT00970320|3927461|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4103451|NCT00970320|3927456|B6||Female|Sex: Female, Male||Participants|Count of Participants|1718|1718.0||||||
4103452|NCT00970320|3927457|B5||Female|Sex: Female, Male||Participants|Count of Participants|1571|1571.0||||||
4103453|NCT00970320|3927458|B4||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4103454|NCT00970320|3927459|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4103455|NCT00970320|3927460|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4103456|NCT00970320|3927461|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4103457|NCT00970320|3927456|B6|||Age||years|Mean|29.3|29.3|Standard Deviation|4.1|4.1|||
4103458|NCT00970320|3927457|B5|||Age||years|Mean|28.2|28.2|Standard Deviation|4.7|4.7|||
4103459|NCT00970320|3927458|B4|||Age||years|Mean|30.5|30.5|Standard Deviation|3.7|3.7|||
4103460|NCT00970320|3927459|B3|||Age||years|Mean|30.8|30.8|Standard Deviation|4|4.0|||
4103461|NCT00970320|3927460|B2|||Age||years|Mean|27.8|27.8|Standard Deviation|4.1|4.1|||
4103463|NCT00970320|3927456|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4103464|NCT00970320|3927457|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4103465|NCT00970320|3927458|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4103466|NCT00970320|3927459|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4103467|NCT00970320|3927460|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4103468|NCT00970320|3927461|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4103469|NCT00970320|3927456|B6||Between 18 and 65 years|Age||Participants|Count of Participants|1718|1718.0||||||
4103470|NCT00970320|3927457|B5||Between 18 and 65 years|Age||Participants|Count of Participants|1571|1571.0||||||
4103471|NCT00970320|3927458|B4||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4103472|NCT00970320|3927459|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4103473|NCT00970320|3927460|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4103474|NCT00970320|3927461|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4103475|NCT00970320|3927456|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4103476|NCT00970320|3927457|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4103477|NCT00970320|3927458|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4103478|NCT00970320|3927459|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4103479|NCT00970320|3927460|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4103480|NCT00970320|3927461|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4103481|NCT00970307|3927477|B4|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|421|421.0||||||
4103482|NCT00970307|3927478|B3|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|141|141.0||||||
4103483|NCT00970307|3927479|B2|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|139|139.0||||||
4103484|NCT00970307|3927480|B1|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|141|141.0||||||
4103485|NCT00970307|3927477|B4||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4103486|NCT00970307|3927478|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4103487|NCT00970307|3927479|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4103488|NCT00970307|3927480|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4103489|NCT00970307|3927477|B4||Female|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
4103490|NCT00970307|3927478|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4103491|NCT00970307|3927479|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4103492|NCT00970307|3927480|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4103493|NCT00970307|3927477|B4|||Age||Weeks|Mean|8.63|8.63|Standard Deviation|1.05|1.05|||
4103494|NCT00970307|3927478|B3|||Age||Weeks|Mean|8.7|8.7|Standard Deviation|1.13|1.13|||
4103495|NCT00970307|3927479|B2|||Age||Weeks|Mean|8.7|8.7|Standard Deviation|1.02|1.02|||
4103496|NCT00970307|3927480|B1|||Age||Weeks|Mean|8.5|8.5|Standard Deviation|0.98|0.98|||
4103497|NCT00970294|3927556|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4103498|NCT00970294|3927556|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4103499|NCT00970294|3927556|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4103500|NCT00970294|3927556|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|8.8|8.8|||
4103501|NCT00970294|3927556|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4103502|NCT00970294|3927556|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4103503|NCT00970294|3927556|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4103504|NCT00970281|3927562|B3|||Positive and Negative Syndrome Scale-Excited Component (PANSS-EC) Total Score|Measures excitability and consists of the following 5 items from the PANSS: Excitement, Hostility, Tension, Uncooperativeness, and Poor Impulse Control. Each item is rated on a scale from 1 (absent) to 7 (extreme). The sum of the 5 items is defined as the PANSS-EC total score which ranges from 5 to 35.|units on a scale|Mean|23.4|23.4|Standard Deviation|5.5|5.5|||
4103505|NCT00970281|3927563|B2|||Positive and Negative Syndrome Scale-Excited Component (PANSS-EC) Total Score|Measures excitability and consists of the following 5 items from the PANSS: Excitement, Hostility, Tension, Uncooperativeness, and Poor Impulse Control. Each item is rated on a scale from 1 (absent) to 7 (extreme). The sum of the 5 items is defined as the PANSS-EC total score which ranges from 5 to 35.|units on a scale|Mean|23.2|23.2|Standard Deviation|4.9|4.9|||
4103506|NCT00970281|3927564|B1|||Positive and Negative Syndrome Scale-Excited Component (PANSS-EC) Total Score|Measures excitability and consists of the following 5 items from the PANSS: Excitement, Hostility, Tension, Uncooperativeness, and Poor Impulse Control. Each item is rated on a scale from 1 (absent) to 7 (extreme). The sum of the 5 items is defined as the PANSS-EC total score which ranges from 5 to 35.|units on a scale|Mean|23.5|23.5|Standard Deviation|6.1|6.1|||
4103507|NCT00970281|3927562|B3|||Agitation-Calmness Evaluation Scale (ACES) Score|The ACES differentiates agitation, calmness, and sleep-state, using a 9-point scale: 1 (Marked Agitation) to 9 (Unarousable).|units on a scale|Mean|1.6|1.6|Standard Deviation|0.5|0.5|||
4103508|NCT00970281|3927563|B2|||Agitation-Calmness Evaluation Scale (ACES) Score|The ACES differentiates agitation, calmness, and sleep-state, using a 9-point scale: 1 (Marked Agitation) to 9 (Unarousable).|units on a scale|Mean|1.6|1.6|Standard Deviation|0.5|0.5|||
4103509|NCT00970281|3927564|B1|||Agitation-Calmness Evaluation Scale (ACES) Score|The ACES differentiates agitation, calmness, and sleep-state, using a 9-point scale: 1 (Marked Agitation) to 9 (Unarousable).|units on a scale|Mean|1.6|1.6|Standard Deviation|0.5|0.5|||
4103510|NCT00970281|3927562|B3|||Age at Onset||years|Mean|25.9|25.9|Standard Deviation|9.4|9.4|||
4103511|NCT00970281|3927563|B2|||Age at Onset||years|Mean|27.2|27.2|Standard Deviation|9.3|9.3|||
4103512|NCT00970281|3927564|B1|||Age at Onset||years|Mean|24.7|24.7|Standard Deviation|9.4|9.4|||
4103513|NCT00970281|3927562|B3|No||Pre-therapy Antipsychotic Usage||participants|Number|10|10.0||||||
4103514|NCT00970281|3927563|B2|No||Pre-therapy Antipsychotic Usage||participants|Number|4|4.0||||||
4103515|NCT00970281|3927564|B1|No||Pre-therapy Antipsychotic Usage||participants|Number|6|6.0||||||
4103516|NCT00970281|3927562|B3|Yes (<1000 mg)||Pre-therapy Antipsychotic Usage||participants|Number|57|57.0||||||
4103517|NCT00970281|3927563|B2|Yes (<1000 mg)||Pre-therapy Antipsychotic Usage||participants|Number|30|30.0||||||
4103518|NCT00970281|3927564|B1|Yes (<1000 mg)||Pre-therapy Antipsychotic Usage||participants|Number|27|27.0||||||
4103519|NCT00970281|3927562|B3|Yes (>=1000 milligrams [mg])||Pre-therapy Antipsychotic Usage||participants|Number|23|23.0||||||
4103520|NCT00970281|3927563|B2|Yes (>=1000 milligrams [mg])||Pre-therapy Antipsychotic Usage||participants|Number|11|11.0||||||
4103521|NCT00970281|3927564|B1|Yes (>=1000 milligrams [mg])||Pre-therapy Antipsychotic Usage||participants|Number|12|12.0||||||
4103522|NCT00970281|3927562|B3|Residual||Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Text Revision Diagnosis Status|Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Text Revision (DSM-IV-TR) diagnosis status.|participants|Number|0|0.0||||||
4103523|NCT00970281|3927563|B2|Residual||Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Text Revision Diagnosis Status|Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Text Revision (DSM-IV-TR) diagnosis status.|participants|Number|0|0.0||||||
4103524|NCT00970281|3927564|B1|Residual||Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Text Revision Diagnosis Status|Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Text Revision (DSM-IV-TR) diagnosis status.|participants|Number|0|0.0||||||
4103525|NCT00970281|3927562|B3|Undifferentiated||Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Text Revision Diagnosis Status|Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Text Revision (DSM-IV-TR) diagnosis status.|participants|Number|1|1.0||||||
4103526|NCT00970281|3927563|B2|Undifferentiated||Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Text Revision Diagnosis Status|Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Text Revision (DSM-IV-TR) diagnosis status.|participants|Number|0|0.0||||||
4103527|NCT00970281|3927564|B1|Undifferentiated||Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Text Revision Diagnosis Status|Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Text Revision (DSM-IV-TR) diagnosis status.|participants|Number|1|1.0||||||
4103528|NCT00970281|3927562|B3|Paranoid||Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Text Revision Diagnosis Status|Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Text Revision (DSM-IV-TR) diagnosis status.|participants|Number|80|80.0||||||
4103529|NCT00970281|3927563|B2|Paranoid||Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Text Revision Diagnosis Status|Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Text Revision (DSM-IV-TR) diagnosis status.|participants|Number|40|40.0||||||
4103530|NCT00970281|3927564|B1|Paranoid||Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Text Revision Diagnosis Status|Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Text Revision (DSM-IV-TR) diagnosis status.|participants|Number|40|40.0||||||
4103531|NCT00970281|3927562|B3|Disorganized||Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Text Revision Diagnosis Status|Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Text Revision (DSM-IV-TR) diagnosis status.|participants|Number|7|7.0||||||
4103532|NCT00970281|3927563|B2|Disorganized||Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Text Revision Diagnosis Status|Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Text Revision (DSM-IV-TR) diagnosis status.|participants|Number|3|3.0||||||
4103533|NCT00970281|3927564|B1|Disorganized||Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Text Revision Diagnosis Status|Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Text Revision (DSM-IV-TR) diagnosis status.|participants|Number|4|4.0||||||
4103534|NCT00970281|3927562|B3|Catatonic||Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Text Revision Diagnosis Status|Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Text Revision (DSM-IV-TR) diagnosis status.|participants|Number|2|2.0||||||
4103535|NCT00970281|3927563|B2|Catatonic||Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Text Revision Diagnosis Status|Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Text Revision (DSM-IV-TR) diagnosis status.|participants|Number|2|2.0||||||
4103536|NCT00970281|3927564|B1|Catatonic||Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Text Revision Diagnosis Status|Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Text Revision (DSM-IV-TR) diagnosis status.|participants|Number|0|0.0||||||
4103537|NCT00970281|3927562|B3|Diabetes Mellitus - No||Diabetes Mellitus Status||participants|Number|84|84.0||||||
4103538|NCT00970281|3927563|B2|Diabetes Mellitus - No||Diabetes Mellitus Status||participants|Number|42|42.0||||||
4103539|NCT00970281|3927564|B1|Diabetes Mellitus - No||Diabetes Mellitus Status||participants|Number|42|42.0||||||
4103540|NCT00970281|3927562|B3|Diabetes Mellitus - Yes||Diabetes Mellitus Status||participants|Number|6|6.0||||||
4103541|NCT00970281|3927563|B2|Diabetes Mellitus - Yes||Diabetes Mellitus Status||participants|Number|3|3.0||||||
4103542|NCT00970281|3927564|B1|Diabetes Mellitus - Yes||Diabetes Mellitus Status||participants|Number|3|3.0||||||
4103543|NCT00970281|3927562|B3|Japan||Region of Enrollment||participants|Number|90|90.0||||||
4103544|NCT00970281|3927563|B2|Japan||Region of Enrollment||participants|Number|45|45.0||||||
4103545|NCT00970281|3927564|B1|Japan||Region of Enrollment||participants|Number|45|45.0||||||
4103546|NCT00970281|3927562|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4103547|NCT00970281|3927563|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4103548|NCT00970281|3927564|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4103549|NCT00970281|3927562|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4103550|NCT00970281|3927563|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4103551|NCT00970281|3927564|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4103552|NCT00970281|3927562|B3|||Age||years|Mean|46.7|46.7|Standard Deviation|11.9|11.9|||
4103553|NCT00970281|3927563|B2|||Age||years|Mean|47.0|47.0|Standard Deviation|12.1|12.1|||
4103554|NCT00970281|3927564|B1|||Age||years|Mean|46.4|46.4|Standard Deviation|11.7|11.7|||
4103555|NCT00970268|3927581|B3|Canada||Region of Enrollment||participants|Number|23|23.0||||||
4103556|NCT00970268|3927582|B2|Canada||Region of Enrollment||participants|Number|14|14.0||||||
4103557|NCT00970268|3927583|B1|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4103558|NCT00970268|3927581|B3|United States||Region of Enrollment||participants|Number|266|266.0||||||
4103559|NCT00970268|3927582|B2|United States||Region of Enrollment||participants|Number|138|138.0||||||
4103560|NCT00970268|3927583|B1|United States||Region of Enrollment||participants|Number|128|128.0||||||
4103561|NCT00970268|3927581|B3||Male|Gender||Participants|Count of Participants|150|150.0||||||
4103562|NCT00970268|3927582|B2||Male|Gender||Participants|Count of Participants|76|76.0||||||
4103563|NCT00970268|3927583|B1||Male|Gender||Participants|Count of Participants|74|74.0||||||
4103564|NCT00970268|3927581|B3||Female|Gender||Participants|Count of Participants|139|139.0||||||
4103565|NCT00970268|3927582|B2||Female|Gender||Participants|Count of Participants|76|76.0||||||
4103566|NCT00970268|3927583|B1||Female|Gender||Participants|Count of Participants|63|63.0||||||
4103567|NCT00970268|3927581|B3|≥ 70 years||Age, Customized||participants|Number|82|82.0||||||
4103568|NCT00970268|3927582|B2|≥ 70 years||Age, Customized||participants|Number|45|45.0||||||
4103569|NCT00970268|3927583|B1|≥ 70 years||Age, Customized||participants|Number|37|37.0||||||
4103570|NCT00970268|3927581|B3|≥ 60 to < 70 years||Age, Customized||participants|Number|118|118.0||||||
4103571|NCT00970268|3927582|B2|≥ 60 to < 70 years||Age, Customized||participants|Number|67|67.0||||||
4103572|NCT00970268|3927583|B1|≥ 60 to < 70 years||Age, Customized||participants|Number|51|51.0||||||
4103573|NCT00970268|3927581|B3|≥ 40 to < 60 years||Age, Customized||participants|Number|89|89.0||||||
4103574|NCT00970268|3927582|B2|≥ 40 to < 60 years||Age, Customized||participants|Number|40|40.0||||||
4103575|NCT00970268|3927583|B1|≥ 40 to < 60 years||Age, Customized||participants|Number|49|49.0||||||
4103576|NCT00970268|3927581|B3|||Age||years|Mean|63.9|63.9|Standard Deviation|9.9|9.9|||
4103577|NCT00970268|3927582|B2|||Age||years|Mean|64.4|64.4|Standard Deviation|10.0|10.0|||
4103578|NCT00970268|3927583|B1|||Age||years|Mean|63.3|63.3|Standard Deviation|10.1|10.1|||
4103579|NCT00970216|3927598|B1|Taiwan||Region of Enrollment||participants|Number|160|160.0||||||
4103580|NCT00970216|3927598|B1||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4103581|NCT00970216|3927598|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4103582|NCT00970216|3927598|B1|||Age||years|Mean|52.9|52.9|Standard Deviation|10.1|10.1|||
4103583|NCT00970216|3927598|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4103584|NCT00970216|3927598|B1||Between 18 and 65 years|Age||Participants|Count of Participants|150|150.0||||||
4103585|NCT00970216|3927598|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4103586|NCT00970073|3927602|B4|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4103587|NCT00970073|3927603|B3|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4103588|NCT00970073|3927604|B2|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4103589|NCT00970073|3927605|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4103590|NCT00970073|3927602|B4|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4103591|NCT00970073|3927602|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4103592|NCT00970073|3927603|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4103593|NCT00970073|3927604|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4103594|NCT00970073|3927605|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4103595|NCT00970073|3927602|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4103596|NCT00970073|3927603|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4103597|NCT00970073|3927604|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4103598|NCT00970073|3927605|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4103599|NCT00970073|3927602|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4103600|NCT00970073|3927603|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4103601|NCT00970073|3927604|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4103602|NCT00970073|3927605|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4103603|NCT00970073|3927602|B4||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4103604|NCT00970073|3927603|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4103605|NCT00970073|3927604|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4103606|NCT00970073|3927605|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4103607|NCT00970073|3927602|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4103608|NCT00970073|3927603|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4103609|NCT00970073|3927604|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4103610|NCT00970073|3927605|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4103611|NCT00969878|3927624|B3|United States||Region of Enrollment||participants|Number|300|300.0||||||
4103612|NCT00969878|3927625|B2|United States||Region of Enrollment||participants|Number|152|152.0||||||
4103613|NCT00969878|3927626|B1|United States||Region of Enrollment||participants|Number|148|148.0||||||
4103614|NCT00969878|3927624|B3||Male|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
4103615|NCT00969878|3927625|B2||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4103616|NCT00969878|3927626|B1||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4103617|NCT00969878|3927624|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4103618|NCT00969878|3927625|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4103619|NCT00969878|3927626|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4103620|NCT00969878|3927624|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4103621|NCT00969878|3927625|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4103622|NCT00969878|3927626|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4103623|NCT00969878|3927624|B3||Between 18 and 65 years|Age||Participants|Count of Participants|300|300.0||||||
4103624|NCT00969878|3927625|B2||Between 18 and 65 years|Age||Participants|Count of Participants|152|152.0||||||
4103625|NCT00969878|3927626|B1||Between 18 and 65 years|Age||Participants|Count of Participants|148|148.0||||||
4103626|NCT00969878|3927624|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4103627|NCT00969878|3927625|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4103628|NCT00969878|3927626|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4103629|NCT00969709|3927635|B5|||Body Mass Index (BMI)||Kilograms Per Meter Squared|Mean|28.8|28.8|Standard Deviation|5.5|5.5|||
4103630|NCT00969709|3927636|B4|||Body Mass Index (BMI)||Kilograms Per Meter Squared|Mean|29.2|29.2|Standard Deviation|5.4|5.4|||
4103631|NCT00969709|3927637|B3|||Body Mass Index (BMI)||Kilograms Per Meter Squared|Mean|28.9|28.9|Standard Deviation|5.4|5.4|||
4103632|NCT00969709|3927638|B2|||Body Mass Index (BMI)||Kilograms Per Meter Squared|Mean|28.0|28.0|Standard Deviation|5.3|5.3|||
4103633|NCT00969709|3927639|B1|||Body Mass Index (BMI)||Kilograms Per Meter Squared|Mean|29.0|29.0|Standard Deviation|5.8|5.8|||
4103634|NCT00969709|3927635|B5|||Weight||kg|Mean|82.6|82.6|Standard Deviation|18.1|18.1|||
4103635|NCT00969709|3927636|B4|||Weight||kg|Mean|84.2|84.2|Standard Deviation|18.6|18.6|||
4103636|NCT00969709|3927637|B3|||Weight||kg|Mean|83.0|83.0|Standard Deviation|17.3|17.3|||
4103637|NCT00969709|3927638|B2|||Weight||kg|Mean|79.5|79.5|Standard Deviation|17.1|17.1|||
4103638|NCT00969709|3927639|B1|||Weight||kg|Mean|83.8|83.8|Standard Deviation|19.3|19.3|||
4103639|NCT00969709|3927635|B5|United States||Region of Enrollment||participants|Number|713|713.0||||||
4103640|NCT00969709|3927636|B4|United States||Region of Enrollment||participants|Number|180|180.0||||||
4103641|NCT00969709|3927637|B3|United States||Region of Enrollment||participants|Number|179|179.0||||||
4103642|NCT00969709|3927638|B2|United States||Region of Enrollment||participants|Number|178|178.0||||||
4103643|NCT00969709|3927639|B1|United States||Region of Enrollment||participants|Number|176|176.0||||||
4103644|NCT00969709|3927635|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|620|620.0||||||
4103645|NCT00969709|3927636|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|158|158.0||||||
4103646|NCT00969709|3927637|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|151|151.0||||||
4103647|NCT00969709|3927638|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|155|155.0||||||
4103648|NCT00969709|3927639|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|156|156.0||||||
4103649|NCT00969709|3927635|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|92|92.0||||||
4103650|NCT00969709|3927636|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4103651|NCT00969709|3927637|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4103652|NCT00969709|3927638|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4103653|NCT00969709|3927639|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4103654|NCT00969709|3927635|B5|Other||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4103655|NCT00969709|3927636|B4|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4103656|NCT00969709|3927637|B3|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4103657|NCT00969709|3927638|B2|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4103658|NCT00969709|3927639|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4103659|NCT00969709|3927635|B5|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4103660|NCT00969709|3927636|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4103661|NCT00969709|3927637|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4103662|NCT00969709|3927638|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4103663|NCT00969709|3927639|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4103664|NCT00969709|3927635|B5|American Indian or Alaska native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4103665|NCT00969709|3927636|B4|American Indian or Alaska native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4103666|NCT00969709|3927637|B3|American Indian or Alaska native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4103667|NCT00969709|3927638|B2|American Indian or Alaska native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4103668|NCT00969709|3927639|B1|American Indian or Alaska native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4103669|NCT00969709|3927635|B5|Asian||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4103670|NCT00969709|3927636|B4|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4103671|NCT00969709|3927637|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4103672|NCT00969709|3927638|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4103673|NCT00969709|3927639|B1|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4103674|NCT00969709|3927635|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|145|145.0||||||
4103675|NCT00969709|3927636|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4103676|NCT00969709|3927637|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4103677|NCT00969709|3927638|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4103678|NCT00969709|3927639|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4103679|NCT00969709|3927635|B5|White||Race/Ethnicity, Customized||participants|Number|526|526.0||||||
4103680|NCT00969709|3927636|B4|White||Race/Ethnicity, Customized||participants|Number|130|130.0||||||
4103681|NCT00969709|3927637|B3|White||Race/Ethnicity, Customized||participants|Number|129|129.0||||||
4103682|NCT00969709|3927638|B2|White||Race/Ethnicity, Customized||participants|Number|133|133.0||||||
4103683|NCT00969709|3927639|B1|White||Race/Ethnicity, Customized||participants|Number|134|134.0||||||
4103684|NCT00969709|3927635|B5||Male|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
4103685|NCT00969709|3927636|B4||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4103686|NCT00969709|3927637|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4103687|NCT00969709|3927638|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4103688|NCT00969709|3927639|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4103689|NCT00969709|3927635|B5||Female|Sex: Female, Male||Participants|Count of Participants|447|447.0||||||
4103690|NCT00969709|3927636|B4||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4103691|NCT00969709|3927637|B3||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4103692|NCT00969709|3927638|B2||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4103693|NCT00969709|3927639|B1||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4103694|NCT00969709|3927635|B5|60 years to 65 years||Age, Customized||participants|Number|47|47.0||||||
4103695|NCT00969709|3927636|B4|60 years to 65 years||Age, Customized||participants|Number|11|11.0||||||
4103696|NCT00969709|3927637|B3|60 years to 65 years||Age, Customized||participants|Number|14|14.0||||||
4103697|NCT00969709|3927638|B2|60 years to 65 years||Age, Customized||participants|Number|15|15.0||||||
4103698|NCT00969709|3927639|B1|60 years to 65 years||Age, Customized||participants|Number|7|7.0||||||
4103699|NCT00969709|3927635|B5|50 years to 59 years||Age, Customized||participants|Number|171|171.0||||||
4103700|NCT00969709|3927636|B4|50 years to 59 years||Age, Customized||participants|Number|41|41.0||||||
4103701|NCT00969709|3927637|B3|50 years to 59 years||Age, Customized||participants|Number|36|36.0||||||
4103702|NCT00969709|3927638|B2|50 years to 59 years||Age, Customized||participants|Number|48|48.0||||||
4103703|NCT00969709|3927639|B1|50 years to 59 years||Age, Customized||participants|Number|46|46.0||||||
4103704|NCT00969709|3927635|B5|40 years to 49 years||Age, Customized||participants|Number|174|174.0||||||
4103705|NCT00969709|3927636|B4|40 years to 49 years||Age, Customized||participants|Number|46|46.0||||||
4103706|NCT00969709|3927637|B3|40 years to 49 years||Age, Customized||participants|Number|48|48.0||||||
4103707|NCT00969709|3927638|B2|40 years to 49 years||Age, Customized||participants|Number|36|36.0||||||
4103708|NCT00969709|3927639|B1|40 years to 49 years||Age, Customized||participants|Number|44|44.0||||||
4103709|NCT00969709|3927635|B5|30 years to 39 years||Age, Customized||participants|Number|152|152.0||||||
4103710|NCT00969709|3927636|B4|30 years to 39 years||Age, Customized||participants|Number|38|38.0||||||
4103711|NCT00969709|3927637|B3|30 years to 39 years||Age, Customized||participants|Number|33|33.0||||||
4103712|NCT00969709|3927638|B2|30 years to 39 years||Age, Customized||participants|Number|34|34.0||||||
4103713|NCT00969709|3927639|B1|30 years to 39 years||Age, Customized||participants|Number|47|47.0||||||
4103714|NCT00969709|3927635|B5|20 years to 29 years||Age, Customized||participants|Number|160|160.0||||||
4103715|NCT00969709|3927636|B4|20 years to 29 years||Age, Customized||participants|Number|42|42.0||||||
4103716|NCT00969709|3927637|B3|20 years to 29 years||Age, Customized||participants|Number|44|44.0||||||
4103717|NCT00969709|3927638|B2|20 years to 29 years||Age, Customized||participants|Number|43|43.0||||||
4103718|NCT00969709|3927639|B1|20 years to 29 years||Age, Customized||participants|Number|31|31.0||||||
4103719|NCT00969709|3927635|B5|18 years to 19 years||Age, Customized||participants|Number|9|9.0||||||
4103720|NCT00969709|3927636|B4|18 years to 19 years||Age, Customized||participants|Number|2|2.0||||||
4103721|NCT00969709|3927637|B3|18 years to 19 years||Age, Customized||participants|Number|4|4.0||||||
4103722|NCT00969709|3927638|B2|18 years to 19 years||Age, Customized||participants|Number|2|2.0||||||
4103723|NCT00969709|3927639|B1|18 years to 19 years||Age, Customized||participants|Number|1|1.0||||||
4103724|NCT00969709|3927635|B5|||Age||years|Mean|41.1|41.1|Standard Deviation|12.3|12.3|||
4103725|NCT00969709|3927636|B4|||Age||years|Mean|40.3|40.3|Standard Deviation|11.9|11.9|||
4103726|NCT00969709|3927637|B3|||Age||years|Mean|41.0|41.0|Standard Deviation|12.8|12.8|||
4103727|NCT00969709|3927638|B2|||Age||years|Mean|41.6|41.6|Standard Deviation|13.1|13.1|||
4103728|NCT00969709|3927639|B1|||Age||years|Mean|43.1|43.1|Standard Deviation|11.3|11.3|||
4103729|NCT00969618|3927656|B1|Japan||Region of Enrollment||participants|Number|211|211.0||||||
4103730|NCT00969618|3927656|B1|Asian||Race/Ethnicity, Customized||participants|Number|211|211.0||||||
4103731|NCT00969618|3927656|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4103732|NCT00969618|3927656|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4103733|NCT00969618|3927656|B1|||Age||years|Mean|32.6|32.6|Standard Deviation|7.5|7.5|||
4103734|NCT00969540|3927667|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4103735|NCT00969540|3927668|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4103736|NCT00969540|3927669|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4103737|NCT00969540|3927667|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4103738|NCT00969540|3927668|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4103739|NCT00969540|3927669|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4103740|NCT00969540|3927667|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4103741|NCT00969540|3927668|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4103742|NCT00969540|3927669|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4103743|NCT00969540|3927667|B3|||Age||years|Mean|47|47.0|Standard Deviation|9.6|9.6|||
4103744|NCT00969540|3927668|B2|||Age||years|Mean|48|48.0|Standard Deviation|7|7.0|||
4103745|NCT00969540|3927669|B1|||Age||years|Mean|46|46.0|Standard Deviation|13|13.0|||
4103746|NCT00969540|3927667|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4103747|NCT00969540|3927668|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4103748|NCT00969540|3927669|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4103749|NCT00969540|3927667|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4103750|NCT00969540|3927668|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4103751|NCT00969540|3927669|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4103752|NCT00969540|3927667|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4103753|NCT00969540|3927668|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4103754|NCT00969540|3927669|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4103755|NCT00969501|3927688|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4103756|NCT00969501|3927688|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4103757|NCT00969501|3927688|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4103758|NCT00969501|3927688|B1|||Age||years|Mean|59.1|59.1|Standard Deviation|1|1.0|||
4103759|NCT00969501|3927688|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4103760|NCT00969501|3927688|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4103761|NCT00969501|3927688|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4103762|NCT00969436|3927692|B4|American Indian or Alaskan native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4103763|NCT00969436|3927693|B3|American Indian or Alaskan native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4103764|NCT00969436|3927694|B2|American Indian or Alaskan native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4103765|NCT00969436|3927695|B1|American Indian or Alaskan native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4103766|NCT00969436|3927692|B4|Asian - south east Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4103767|NCT00969436|3927693|B3|Asian - south east Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4103768|NCT00969436|3927694|B2|Asian - south east Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4103769|NCT00969436|3927695|B1|Asian - south east Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4103770|NCT00969436|3927692|B4|Asian - central/ south Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|440|440.0||||||
4103771|NCT00969436|3927693|B3|Asian - central/ south Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|88|88.0||||||
4103772|NCT00969436|3927694|B2|Asian - central/ south Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|175|175.0||||||
4103773|NCT00969436|3927695|B1|Asian - central/ south Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|177|177.0||||||
4103774|NCT00969436|3927692|B4||Male|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
4103775|NCT00969436|3927693|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4103776|NCT00969436|3927694|B2||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4103777|NCT00969436|3927695|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4103778|NCT00969436|3927692|B4||Female|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
4103779|NCT00969436|3927693|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4103780|NCT00969436|3927694|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4103781|NCT00969436|3927695|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4103782|NCT00969436|3927692|B4|||Age||Months|Mean|9|9.0|Standard Deviation|0.07|0.07|||
4103783|NCT00969436|3927693|B3|||Age||Months|Mean|9|9.0|Standard Deviation|0|0.0|||
4103784|NCT00969436|3927694|B2|||Age||Months|Mean|9|9.0|Standard Deviation|0.11|0.11|||
4103785|NCT00969436|3927695|B1|||Age||Months|Mean|9|9.0|Standard Deviation|0|0.0|||
4103786|NCT00969280|3927729|B3|Korea, Republic of||Region of Enrollment||participants|Number|42|42.0||||||
4103787|NCT00969280|3927730|B2|Korea, Republic of||Region of Enrollment||participants|Number|21|21.0||||||
4103788|NCT00969280|3927731|B1|Korea, Republic of||Region of Enrollment||participants|Number|21|21.0||||||
4103789|NCT00969280|3927729|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4103790|NCT00969280|3927730|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4103791|NCT00969280|3927731|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4103792|NCT00969280|3927729|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4103793|NCT00969280|3927730|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4103794|NCT00969280|3927731|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4103795|NCT00969280|3927729|B3|||Age||years|Mean|41.64|41.64|Standard Deviation|10.68|10.68|||
4103796|NCT00969280|3927730|B2|||Age||years|Mean|42.76|42.76|Standard Deviation|9.59|9.59|||
4103797|NCT00969280|3927731|B1|||Age||years|Mean|40.52|40.52|Standard Deviation|11.8|11.8|||
4103798|NCT00969280|3927729|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4103799|NCT00969280|3927730|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4103800|NCT00969280|3927731|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4103801|NCT00969280|3927729|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4103802|NCT00969280|3927730|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4103803|NCT00969280|3927731|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4103804|NCT00969280|3927729|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4103805|NCT00969280|3927730|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4103806|NCT00969280|3927731|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4103807|NCT00969228|3927738|B3||Male|Sex: Female, Male||Participants|Count of Participants|374|374.0||||||
4103808|NCT00969228|3927739|B2||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4103809|NCT00969228|3927740|B1||Male|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
4103810|NCT00969228|3927738|B3||Female|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
4103811|NCT00969228|3927739|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4103812|NCT00969228|3927740|B1||Female|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
4103813|NCT00969228|3927738|B3|||Age||Weeks|Mean|8.8|8.8|Standard Deviation|1.25|1.25|||
4103814|NCT00969228|3927739|B2|||Age||Weeks|Mean|8.9|8.9|Standard Deviation|1.26|1.26|||
4103815|NCT00969228|3927740|B1|||Age||Weeks|Mean|8.8|8.8|Standard Deviation|1.25|1.25|||
4103816|NCT00969150|3927757|B3|||Body Mass Index (BMI)||Kilograms Per Meter Squared|Mean|28.8|28.8|Standard Deviation|5.5|5.5|||
4103817|NCT00969150|3927758|B2|||Body Mass Index (BMI)||Kilograms Per Meter Squared|Mean|28.7|28.7|Standard Deviation|5.4|5.4|||
4103818|NCT00969150|3927759|B1|||Body Mass Index (BMI)||Kilograms Per Meter Squared|Mean|28.9|28.9|Standard Deviation|5.7|5.7|||
4103819|NCT00969150|3927757|B3|||Weight||kg|Mean|82.7|82.7|Standard Deviation|18.0|18.0|||
4103820|NCT00969150|3927758|B2|||Weight||kg|Mean|82.4|82.4|Standard Deviation|18.1|18.1|||
4103821|NCT00969150|3927759|B1|||Weight||kg|Mean|82.9|82.9|Standard Deviation|18.0|18.0|||
4103822|NCT00969150|3927757|B3|United States||Region of Enrollment||participants|Number|357|357.0||||||
4103823|NCT00969150|3927758|B2|United States||Region of Enrollment||participants|Number|175|175.0||||||
4103824|NCT00969150|3927759|B1|United States||Region of Enrollment||participants|Number|182|182.0||||||
4103825|NCT00969150|3927757|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|323|323.0||||||
4103826|NCT00969150|3927758|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|159|159.0||||||
4103827|NCT00969150|3927759|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|164|164.0||||||
4103828|NCT00969150|3927757|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4103829|NCT00969150|3927758|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4103830|NCT00969150|3927759|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4103831|NCT00969150|3927757|B3|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4103832|NCT00969150|3927758|B2|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4103833|NCT00969150|3927759|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4103834|NCT00969150|3927757|B3|American Indian or Alaska native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4103835|NCT00969150|3927758|B2|American Indian or Alaska native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4103836|NCT00969150|3927759|B1|American Indian or Alaska native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4103837|NCT00969150|3927757|B3|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4103838|NCT00969150|3927758|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4103839|NCT00969150|3927759|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4103840|NCT00969150|3927757|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
4103841|NCT00969150|3927758|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4103842|NCT00969150|3927759|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4103843|NCT00969150|3927757|B3|White||Race/Ethnicity, Customized||participants|Number|282|282.0||||||
4103844|NCT00969150|3927758|B2|White||Race/Ethnicity, Customized||participants|Number|133|133.0||||||
4103845|NCT00969150|3927759|B1|White||Race/Ethnicity, Customized||participants|Number|149|149.0||||||
4103846|NCT00969150|3927757|B3||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4103847|NCT00969150|3927758|B2||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4103848|NCT00969150|3927759|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4103849|NCT00969150|3927757|B3||Female|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
4103850|NCT00969150|3927758|B2||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4103851|NCT00969150|3927759|B1||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4103852|NCT00969150|3927757|B3|60 years to 80 years||Age, Customized||participants|Number|43|43.0||||||
4103853|NCT00969150|3927758|B2|60 years to 80 years||Age, Customized||participants|Number|18|18.0||||||
4103854|NCT00969150|3927759|B1|60 years to 80 years||Age, Customized||participants|Number|25|25.0||||||
4103855|NCT00969150|3927757|B3|50 years to 59 years||Age, Customized||participants|Number|77|77.0||||||
4103856|NCT00969150|3927758|B2|50 years to 59 years||Age, Customized||participants|Number|37|37.0||||||
4103857|NCT00969150|3927759|B1|50 years to 59 years||Age, Customized||participants|Number|40|40.0||||||
4103858|NCT00969150|3927757|B3|40 years to 49 years||Age, Customized||participants|Number|100|100.0||||||
4103859|NCT00969150|3927758|B2|40 years to 49 years||Age, Customized||participants|Number|53|53.0||||||
4103860|NCT00969150|3927759|B1|40 years to 49 years||Age, Customized||participants|Number|47|47.0||||||
4103861|NCT00969150|3927757|B3|30 years to 39 years||Age, Customized||participants|Number|67|67.0||||||
4103862|NCT00969150|3927758|B2|30 years to 39 years||Age, Customized||participants|Number|32|32.0||||||
4103863|NCT00969150|3927759|B1|30 years to 39 years||Age, Customized||participants|Number|35|35.0||||||
4103864|NCT00969150|3927757|B3|20 years to 29 years||Age, Customized||participants|Number|67|67.0||||||
4103865|NCT00969150|3927758|B2|20 years to 29 years||Age, Customized||participants|Number|34|34.0||||||
4103866|NCT00969150|3927759|B1|20 years to 29 years||Age, Customized||participants|Number|33|33.0||||||
4103867|NCT00969150|3927757|B3|18 years to 19 years||Age, Customized||participants|Number|3|3.0||||||
4103868|NCT00969150|3927758|B2|18 years to 19 years||Age, Customized||participants|Number|1|1.0||||||
4103869|NCT00969150|3927759|B1|18 years to 19 years||Age, Customized||participants|Number|2|2.0||||||
4103870|NCT00969150|3927757|B3|||Age||years|Mean|43.3|43.3|Standard Deviation|13.1|13.1|||
4103871|NCT00969150|3927758|B2|||Age||years|Mean|42.8|42.8|Standard Deviation|12.9|12.9|||
4103872|NCT00969150|3927759|B1|||Age||years|Mean|43.7|43.7|Standard Deviation|13.3|13.3|||
4103873|NCT00969124|3927768|B1|Diagnostic||Indication for colonoscopy procedure (screening, surveillance or diagnostic)||participants|Number|72|72.0||||||
4103874|NCT00969124|3927768|B1|Surveillance||Indication for colonoscopy procedure (screening, surveillance or diagnostic)||participants|Number|62|62.0||||||
4103875|NCT00969124|3927768|B1|Screening||Indication for colonoscopy procedure (screening, surveillance or diagnostic)||participants|Number|164|164.0||||||
4103876|NCT00969124|3927768|B1|United States||Region of Enrollment||participants|Number|298|298.0||||||
4103877|NCT00969124|3927768|B1||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4103878|NCT00969124|3927768|B1||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4103879|NCT00969124|3927768|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|11.3|11.3|||
4103880|NCT00968981|3927774|B4||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4103881|NCT00968981|3927775|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4103882|NCT00968981|3927776|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4103883|NCT00968981|3927777|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4103884|NCT00968981|3927774|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4103885|NCT00968981|3927775|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4103886|NCT00968981|3927776|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4103887|NCT00968981|3927777|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4103888|NCT00968981|3927774|B4|||Age||years|Mean|63.0|63.0|Standard Deviation|10.9|10.9|||
4103889|NCT00968981|3927775|B3|||Age||years|Mean|62.9|62.9|Standard Deviation|10.3|10.3|||
4103890|NCT00968981|3927776|B2|||Age||years|Mean|64.0|64.0|Standard Deviation|12.3|12.3|||
4103891|NCT00968981|3927777|B1|||Age||years|Mean|62.1|62.1|Standard Deviation|10.4|10.4|||
4103892|NCT00968890|3927815|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4103893|NCT00968890|3927816|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4103894|NCT00968890|3927817|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4103895|NCT00968890|3927815|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4103896|NCT00968890|3927816|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4103897|NCT00968890|3927817|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4103898|NCT00968890|3927815|B3|||Age||Years|Mean|69.0|69.0|Standard Deviation|4.65|4.65|||
4103899|NCT00968890|3927816|B2|||Age||Years|Mean|69.1|69.1|Standard Deviation|4.70|4.7|||
4103900|NCT00968890|3927817|B1|||Age||Years|Mean|68.9|68.9|Standard Deviation|4.63|4.63|||
4103901|NCT00968864|3927846|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4103902|NCT00968864|3927846|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4103903|NCT00968864|3927846|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
4103904|NCT00968864|3927846|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4103905|NCT00968864|3927846|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4103906|NCT00968864|3927846|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4103907|NCT00968864|3927846|B1|Greater than 18 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
4103908|NCT00968864|3927846|B1|16-18 years||Age, Customized||Participants|Count of Participants|8|8.0||||||
4103909|NCT00968864|3927846|B1|14-16 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
4103910|NCT00968864|3927846|B1|12-14 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
4103911|NCT00968864|3927846|B1|10-12 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
4103912|NCT00968864|3927846|B1|8-10 years||Age, Customized||Participants|Count of Participants|4|4.0||||||
4103913|NCT00968864|3927846|B1|6-8 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
4103914|NCT00968864|3927846|B1|4-6 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
4103915|NCT00968864|3927846|B1|2-4 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
4103916|NCT00968864|3927846|B1|1-2 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
4103917|NCT00968864|3927846|B1|Less than 1 year||Age, Customized||Participants|Count of Participants|4|4.0||||||
4103918|NCT00968838|3927862|B3|United States||Region of Enrollment||participants|Number|108|108.0||||||
4103919|NCT00968838|3927863|B2|United States||Region of Enrollment||participants|Number|58|58.0||||||
4103920|NCT00968838|3927864|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4103921|NCT00968838|3927862|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4103922|NCT00968838|3927863|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4103923|NCT00968838|3927864|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4103924|NCT00968838|3927862|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4103925|NCT00968838|3927863|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4103926|NCT00968838|3927864|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4103927|NCT00968838|3927862|B3|||Age||Years|Median|59|59.0|Full Range|||19.0|84.0|
4103928|NCT00968838|3927863|B2|||Age||Years|Median|60|60.0|Full Range|||19.0|79.0|
4103929|NCT00968838|3927864|B1|||Age||Years|Median|57.5|57.5|Full Range|||20.0|84.0|
4103930|NCT00968812|3927871|B4|UNITED STATES||Region Enroll||participants|Number|350|350.0||||||
4103931|NCT00968812|3927872|B3|UNITED STATES||Region Enroll||participants|Number|116|116.0||||||
4103932|NCT00968812|3927873|B2|UNITED STATES||Region Enroll||participants|Number|117|117.0||||||
4103933|NCT00968812|3927874|B1|UNITED STATES||Region Enroll||participants|Number|117|117.0||||||
4103934|NCT00968812|3927871|B4|UKRAINE||Region Enroll||participants|Number|66|66.0||||||
4103935|NCT00968812|3927872|B3|UKRAINE||Region Enroll||participants|Number|22|22.0||||||
4103936|NCT00968812|3927873|B2|UKRAINE||Region Enroll||participants|Number|22|22.0||||||
4103937|NCT00968812|3927874|B1|UKRAINE||Region Enroll||participants|Number|22|22.0||||||
4103938|NCT00968812|3927871|B4|SOUTH KOREA||Region Enroll||participants|Number|94|94.0||||||
4103939|NCT00968812|3927872|B3|SOUTH KOREA||Region Enroll||participants|Number|31|31.0||||||
4103940|NCT00968812|3927873|B2|SOUTH KOREA||Region Enroll||participants|Number|32|32.0||||||
4103941|NCT00968812|3927874|B1|SOUTH KOREA||Region Enroll||participants|Number|31|31.0||||||
4103942|NCT00968812|3927871|B4|SLOVAKIA||Region Enroll||participants|Number|42|42.0||||||
4103943|NCT00968812|3927872|B3|SLOVAKIA||Region Enroll||participants|Number|13|13.0||||||
4103944|NCT00968812|3927873|B2|SLOVAKIA||Region Enroll||participants|Number|14|14.0||||||
4103945|NCT00968812|3927874|B1|SLOVAKIA||Region Enroll||participants|Number|15|15.0||||||
4103946|NCT00968812|3927871|B4|RUSSIAN FEDERATION||Region Enroll||participants|Number|67|67.0||||||
4103947|NCT00968812|3927872|B3|RUSSIAN FEDERATION||Region Enroll||participants|Number|22|22.0||||||
4103948|NCT00968812|3927873|B2|RUSSIAN FEDERATION||Region Enroll||participants|Number|22|22.0||||||
4103949|NCT00968812|3927874|B1|RUSSIAN FEDERATION||Region Enroll||participants|Number|23|23.0||||||
4103950|NCT00968812|3927871|B4|ROMANIA||Region Enroll||participants|Number|130|130.0||||||
4103951|NCT00968812|3927872|B3|ROMANIA||Region Enroll||participants|Number|44|44.0||||||
4103952|NCT00968812|3927873|B2|ROMANIA||Region Enroll||participants|Number|43|43.0||||||
4103953|NCT00968812|3927874|B1|ROMANIA||Region Enroll||participants|Number|43|43.0||||||
4103954|NCT00968812|3927871|B4|POLAND||Region Enroll||participants|Number|44|44.0||||||
4103955|NCT00968812|3927872|B3|POLAND||Region Enroll||participants|Number|15|15.0||||||
4103956|NCT00968812|3927873|B2|POLAND||Region Enroll||participants|Number|15|15.0||||||
4103957|NCT00968812|3927874|B1|POLAND||Region Enroll||participants|Number|14|14.0||||||
4103958|NCT00968812|3927871|B4|PHILIPPINES||Region Enroll||participants|Number|40|40.0||||||
4103959|NCT00968812|3927872|B3|PHILIPPINES||Region Enroll||participants|Number|13|13.0||||||
4103960|NCT00968812|3927873|B2|PHILIPPINES||Region Enroll||participants|Number|13|13.0||||||
4103961|NCT00968812|3927874|B1|PHILIPPINES||Region Enroll||participants|Number|14|14.0||||||
4103962|NCT00968812|3927871|B4|NORWAY||Region Enroll||participants|Number|27|27.0||||||
4103963|NCT00968812|3927872|B3|NORWAY||Region Enroll||participants|Number|9|9.0||||||
4103964|NCT00968812|3927873|B2|NORWAY||Region Enroll||participants|Number|9|9.0||||||
4103965|NCT00968812|3927874|B1|NORWAY||Region Enroll||participants|Number|9|9.0||||||
4103966|NCT00968812|3927871|B4|MEXICO||Region Enroll||participants|Number|73|73.0||||||
4103967|NCT00968812|3927872|B3|MEXICO||Region Enroll||participants|Number|24|24.0||||||
4103968|NCT00968812|3927873|B2|MEXICO||Region Enroll||participants|Number|25|25.0||||||
4103969|NCT00968812|3927874|B1|MEXICO||Region Enroll||participants|Number|24|24.0||||||
4103970|NCT00968812|3927871|B4|ISRAEL||Region Enroll||participants|Number|43|43.0||||||
4103971|NCT00968812|3927872|B3|ISRAEL||Region Enroll||participants|Number|14|14.0||||||
4103972|NCT00968812|3927873|B2|ISRAEL||Region Enroll||participants|Number|15|15.0||||||
4103973|NCT00968812|3927874|B1|ISRAEL||Region Enroll||participants|Number|14|14.0||||||
4103974|NCT00968812|3927871|B4|INDIA||Region Enroll||participants|Number|166|166.0||||||
4103975|NCT00968812|3927872|B3|INDIA||Region Enroll||participants|Number|56|56.0||||||
4103976|NCT00968812|3927873|B2|INDIA||Region Enroll||participants|Number|55|55.0||||||
4103977|NCT00968812|3927874|B1|INDIA||Region Enroll||participants|Number|55|55.0||||||
4103978|NCT00968812|3927871|B4|GERMANY||Region Enroll||participants|Number|19|19.0||||||
4103979|NCT00968812|3927872|B3|GERMANY||Region Enroll||participants|Number|6|6.0||||||
4103980|NCT00968812|3927873|B2|GERMANY||Region Enroll||participants|Number|7|7.0||||||
4103981|NCT00968812|3927874|B1|GERMANY||Region Enroll||participants|Number|6|6.0||||||
4103982|NCT00968812|3927871|B4|FINLAND||Region Enroll||participants|Number|54|54.0||||||
4103983|NCT00968812|3927872|B3|FINLAND||Region Enroll||participants|Number|19|19.0||||||
4103984|NCT00968812|3927873|B2|FINLAND||Region Enroll||participants|Number|17|17.0||||||
4103985|NCT00968812|3927874|B1|FINLAND||Region Enroll||participants|Number|18|18.0||||||
4103986|NCT00968812|3927871|B4|DENMARK||Region Enroll||participants|Number|74|74.0||||||
4103987|NCT00968812|3927872|B3|DENMARK||Region Enroll||participants|Number|25|25.0||||||
4103988|NCT00968812|3927873|B2|DENMARK||Region Enroll||participants|Number|25|25.0||||||
4103989|NCT00968812|3927874|B1|DENMARK||Region Enroll||participants|Number|24|24.0||||||
4103990|NCT00968812|3927871|B4|COSTA RICA||Region Enroll||participants|Number|28|28.0||||||
4103991|NCT00968812|3927872|B3|COSTA RICA||Region Enroll||participants|Number|9|9.0||||||
4103992|NCT00968812|3927873|B2|COSTA RICA||Region Enroll||participants|Number|9|9.0||||||
4103993|NCT00968812|3927874|B1|COSTA RICA||Region Enroll||participants|Number|10|10.0||||||
4103994|NCT00968812|3927871|B4|CANADA||Region Enroll||participants|Number|58|58.0||||||
4103995|NCT00968812|3927872|B3|CANADA||Region Enroll||participants|Number|19|19.0||||||
4103996|NCT00968812|3927873|B2|CANADA||Region Enroll||participants|Number|20|20.0||||||
4103997|NCT00968812|3927874|B1|CANADA||Region Enroll||participants|Number|19|19.0||||||
4103998|NCT00968812|3927871|B4|BULGARIA||Region Enroll||participants|Number|21|21.0||||||
4103999|NCT00968812|3927872|B3|BULGARIA||Region Enroll||participants|Number|7|7.0||||||
4104000|NCT00968812|3927873|B2|BULGARIA||Region Enroll||participants|Number|7|7.0||||||
4104001|NCT00968812|3927874|B1|BULGARIA||Region Enroll||participants|Number|7|7.0||||||
4104002|NCT00968812|3927871|B4|ARGENTINA||Region Enroll||participants|Number|54|54.0||||||
4104003|NCT00968812|3927872|B3|ARGENTINA||Region Enroll||participants|Number|18|18.0||||||
4104004|NCT00968812|3927873|B2|ARGENTINA||Region Enroll||participants|Number|18|18.0||||||
4104005|NCT00968812|3927874|B1|ARGENTINA||Region Enroll||participants|Number|18|18.0||||||
4104006|NCT00968812|3927871|B4||Male|Gender||Participants|Count of Participants|756|756.0||||||
4104007|NCT00968812|3927872|B3||Male|Gender||Participants|Count of Participants|263|263.0||||||
4104008|NCT00968812|3927873|B2||Male|Gender||Participants|Count of Participants|241|241.0||||||
4104009|NCT00968812|3927874|B1||Male|Gender||Participants|Count of Participants|252|252.0||||||
4104010|NCT00968812|3927871|B4||Female|Gender||Participants|Count of Participants|694|694.0||||||
4104011|NCT00968812|3927872|B3||Female|Gender||Participants|Count of Participants|219|219.0||||||
4104012|NCT00968812|3927873|B2||Female|Gender||Participants|Count of Participants|244|244.0||||||
4104013|NCT00968812|3927874|B1||Female|Gender||Participants|Count of Participants|231|231.0||||||
4104014|NCT00968812|3927871|B4|||Age||years|Mean|56.2|56.2|Standard Deviation|9.22|9.22|||
4104015|NCT00968812|3927872|B3|||Age||years|Mean|56.3|56.3|Standard Deviation|9.01|9.01|||
4104016|NCT00968812|3927873|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|9.17|9.17|||
4104017|NCT00968812|3927874|B1|||Age||years|Mean|56.4|56.4|Standard Deviation|9.49|9.49|||
4104018|NCT00968812|3927871|B4||>=65 years|Age||Participants|Count of Participants|243|243.0||||||
4104019|NCT00968812|3927872|B3||>=65 years|Age||Participants|Count of Participants|83|83.0||||||
4104020|NCT00968812|3927873|B2||>=65 years|Age||Participants|Count of Participants|74|74.0||||||
4104021|NCT00968812|3927874|B1||>=65 years|Age||Participants|Count of Participants|86|86.0||||||
4104022|NCT00968812|3927871|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1207|1207.0||||||
4104023|NCT00968812|3927872|B3||Between 18 and 65 years|Age||Participants|Count of Participants|399|399.0||||||
4104024|NCT00968812|3927873|B2||Between 18 and 65 years|Age||Participants|Count of Participants|411|411.0||||||
4104025|NCT00968812|3927874|B1||Between 18 and 65 years|Age||Participants|Count of Participants|397|397.0||||||
4104026|NCT00968812|3927871|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4104027|NCT00968812|3927872|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4104028|NCT00968812|3927873|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4104029|NCT00968812|3927874|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4104030|NCT00968799|3927896|B1|Switzerland||Region of Enrollment||participants|Number|6|6.0||||||
4104031|NCT00968799|3927896|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4104032|NCT00968799|3927896|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4104033|NCT00968799|3927896|B1|||Age||years|Mean|55|55.0|Standard Deviation|6.6|6.6|||
4104034|NCT00968799|3927896|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4104035|NCT00968799|3927896|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4104036|NCT00968799|3927896|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4104037|NCT00968708|3927904|B3|||Time From Index ACS Event to Randomization|Six participants in the placebo arm and 7 participants in the alogliptin arm are not included because they did not meet the ACS requirements for study inclusion.|days|Mean|47.8|47.8|Standard Deviation|22.00|22.0|||
4104038|NCT00968708|3927905|B2|||Time From Index ACS Event to Randomization|Six participants in the placebo arm and 7 participants in the alogliptin arm are not included because they did not meet the ACS requirements for study inclusion.|days|Mean|47.6|47.6|Standard Deviation|22.04|22.04|||
4104039|NCT00968708|3927906|B1|||Time From Index ACS Event to Randomization|Six participants in the placebo arm and 7 participants in the alogliptin arm are not included because they did not meet the ACS requirements for study inclusion.|days|Mean|48.0|48.0|Standard Deviation|21.95|21.95|||
4104040|NCT00968708|3927904|B3|Unstable Angina||Index Acute Coronary Syndrome (ACS) Event Type|Six participants in the placebo arm and 7 participants in the alogliptin arm are not included because they did not meet the ACS requirements for study inclusion.|participants|Number|1214|1214.0||||||
4104041|NCT00968708|3927905|B2|Unstable Angina||Index Acute Coronary Syndrome (ACS) Event Type|Six participants in the placebo arm and 7 participants in the alogliptin arm are not included because they did not meet the ACS requirements for study inclusion.|participants|Number|609|609.0||||||
4104042|NCT00968708|3927906|B1|Unstable Angina||Index Acute Coronary Syndrome (ACS) Event Type|Six participants in the placebo arm and 7 participants in the alogliptin arm are not included because they did not meet the ACS requirements for study inclusion.|participants|Number|605|605.0||||||
4104043|NCT00968708|3927904|B3|Myocardial Infarction||Index Acute Coronary Syndrome (ACS) Event Type|Six participants in the placebo arm and 7 participants in the alogliptin arm are not included because they did not meet the ACS requirements for study inclusion.|participants|Number|4152|4152.0||||||
4104044|NCT00968708|3927905|B2|Myocardial Infarction||Index Acute Coronary Syndrome (ACS) Event Type|Six participants in the placebo arm and 7 participants in the alogliptin arm are not included because they did not meet the ACS requirements for study inclusion.|participants|Number|2084|2084.0||||||
4104045|NCT00968708|3927906|B1|Myocardial Infarction||Index Acute Coronary Syndrome (ACS) Event Type|Six participants in the placebo arm and 7 participants in the alogliptin arm are not included because they did not meet the ACS requirements for study inclusion.|participants|Number|2068|2068.0||||||
4104046|NCT00968708|3927904|B3|Severe Renal Impairment/End-Stage Renal Disease||Renal Impairment Category|Normal renal function: eGFR ≥90 mL/min/1.73 m^2; Mild renal impairment: eGFR ≥60 and <90 mL/min/1.73 m^2; Moderate renal impairment: eGFR ≥30 and <60 mL/min/1.73 m^2; Severe renal impairment: eGFR <30 mL/min/1.73 m^2; End-stage renal disease (ESRD): eGFR <15 mL/min/1.73 m^2|participants|Number|157|157.0||||||
4104047|NCT00968708|3927905|B2|Severe Renal Impairment/End-Stage Renal Disease||Renal Impairment Category|Normal renal function: eGFR ≥90 mL/min/1.73 m^2; Mild renal impairment: eGFR ≥60 and <90 mL/min/1.73 m^2; Moderate renal impairment: eGFR ≥30 and <60 mL/min/1.73 m^2; Severe renal impairment: eGFR <30 mL/min/1.73 m^2; End-stage renal disease (ESRD): eGFR <15 mL/min/1.73 m^2|participants|Number|78|78.0||||||
4104048|NCT00968708|3927906|B1|Severe Renal Impairment/End-Stage Renal Disease||Renal Impairment Category|Normal renal function: eGFR ≥90 mL/min/1.73 m^2; Mild renal impairment: eGFR ≥60 and <90 mL/min/1.73 m^2; Moderate renal impairment: eGFR ≥30 and <60 mL/min/1.73 m^2; Severe renal impairment: eGFR <30 mL/min/1.73 m^2; End-stage renal disease (ESRD): eGFR <15 mL/min/1.73 m^2|participants|Number|79|79.0||||||
4104049|NCT00968708|3927904|B3|Moderate Renal Impairment||Renal Impairment Category|Normal renal function: eGFR ≥90 mL/min/1.73 m^2; Mild renal impairment: eGFR ≥60 and <90 mL/min/1.73 m^2; Moderate renal impairment: eGFR ≥30 and <60 mL/min/1.73 m^2; Severe renal impairment: eGFR <30 mL/min/1.73 m^2; End-stage renal disease (ESRD): eGFR <15 mL/min/1.73 m^2|participants|Number|1408|1408.0||||||
4104050|NCT00968708|3927905|B2|Moderate Renal Impairment||Renal Impairment Category|Normal renal function: eGFR ≥90 mL/min/1.73 m^2; Mild renal impairment: eGFR ≥60 and <90 mL/min/1.73 m^2; Moderate renal impairment: eGFR ≥30 and <60 mL/min/1.73 m^2; Severe renal impairment: eGFR <30 mL/min/1.73 m^2; End-stage renal disease (ESRD): eGFR <15 mL/min/1.73 m^2|participants|Number|694|694.0||||||
4104051|NCT00968708|3927906|B1|Moderate Renal Impairment||Renal Impairment Category|Normal renal function: eGFR ≥90 mL/min/1.73 m^2; Mild renal impairment: eGFR ≥60 and <90 mL/min/1.73 m^2; Moderate renal impairment: eGFR ≥30 and <60 mL/min/1.73 m^2; Severe renal impairment: eGFR <30 mL/min/1.73 m^2; End-stage renal disease (ESRD): eGFR <15 mL/min/1.73 m^2|participants|Number|714|714.0||||||
4104052|NCT00968708|3927904|B3|Mild Renal Impairment||Renal Impairment Category|Normal renal function: eGFR ≥90 mL/min/1.73 m^2; Mild renal impairment: eGFR ≥60 and <90 mL/min/1.73 m^2; Moderate renal impairment: eGFR ≥30 and <60 mL/min/1.73 m^2; Severe renal impairment: eGFR <30 mL/min/1.73 m^2; End-stage renal disease (ESRD): eGFR <15 mL/min/1.73 m^2|participants|Number|2976|2976.0||||||
4104053|NCT00968708|3927905|B2|Mild Renal Impairment||Renal Impairment Category|Normal renal function: eGFR ≥90 mL/min/1.73 m^2; Mild renal impairment: eGFR ≥60 and <90 mL/min/1.73 m^2; Moderate renal impairment: eGFR ≥30 and <60 mL/min/1.73 m^2; Severe renal impairment: eGFR <30 mL/min/1.73 m^2; End-stage renal disease (ESRD): eGFR <15 mL/min/1.73 m^2|participants|Number|1530|1530.0||||||
4104054|NCT00968708|3927906|B1|Mild Renal Impairment||Renal Impairment Category|Normal renal function: eGFR ≥90 mL/min/1.73 m^2; Mild renal impairment: eGFR ≥60 and <90 mL/min/1.73 m^2; Moderate renal impairment: eGFR ≥30 and <60 mL/min/1.73 m^2; Severe renal impairment: eGFR <30 mL/min/1.73 m^2; End-stage renal disease (ESRD): eGFR <15 mL/min/1.73 m^2|participants|Number|1446|1446.0||||||
4104055|NCT00968708|3927904|B3|Normal Renal Function||Renal Impairment Category|Normal renal function: eGFR ≥90 mL/min/1.73 m^2; Mild renal impairment: eGFR ≥60 and <90 mL/min/1.73 m^2; Moderate renal impairment: eGFR ≥30 and <60 mL/min/1.73 m^2; Severe renal impairment: eGFR <30 mL/min/1.73 m^2; End-stage renal disease (ESRD): eGFR <15 mL/min/1.73 m^2|participants|Number|839|839.0||||||
4104056|NCT00968708|3927905|B2|Normal Renal Function||Renal Impairment Category|Normal renal function: eGFR ≥90 mL/min/1.73 m^2; Mild renal impairment: eGFR ≥60 and <90 mL/min/1.73 m^2; Moderate renal impairment: eGFR ≥30 and <60 mL/min/1.73 m^2; Severe renal impairment: eGFR <30 mL/min/1.73 m^2; End-stage renal disease (ESRD): eGFR <15 mL/min/1.73 m^2|participants|Number|399|399.0||||||
4104057|NCT00968708|3927906|B1|Normal Renal Function||Renal Impairment Category|Normal renal function: eGFR ≥90 mL/min/1.73 m^2; Mild renal impairment: eGFR ≥60 and <90 mL/min/1.73 m^2; Moderate renal impairment: eGFR ≥30 and <60 mL/min/1.73 m^2; Severe renal impairment: eGFR <30 mL/min/1.73 m^2; End-stage renal disease (ESRD): eGFR <15 mL/min/1.73 m^2|participants|Number|440|440.0||||||
4104058|NCT00968708|3927904|B3|||Estimated Glomerular Filtration Rate (eGFR)|Calculated using the Modification of Diet in Renal Disease (MDRD) formula|mL/min/1.73 m^2|Mean|70.93|70.93|Standard Deviation|21.417|21.417|||
4104059|NCT00968708|3927905|B2|||Estimated Glomerular Filtration Rate (eGFR)|Calculated using the Modification of Diet in Renal Disease (MDRD) formula|mL/min/1.73 m^2|Mean|70.86|70.86|Standard Deviation|21.297|21.297|||
4104122|NCT00968708|3927905|B2|Portugal||Region of Enrollment||participants|Number|16|16.0||||||
4104060|NCT00968708|3927906|B1|||Estimated Glomerular Filtration Rate (eGFR)|Calculated using the Modification of Diet in Renal Disease (MDRD) formula|mL/min/1.73 m^2|Mean|71.01|71.01|Standard Deviation|21.541|21.541|||
4104061|NCT00968708|3927904|B3|Ex-smoker||Smoking History||participants|Number|2344|2344.0||||||
4104062|NCT00968708|3927905|B2|Ex-smoker||Smoking History||participants|Number|1192|1192.0||||||
4104063|NCT00968708|3927906|B1|Ex-smoker||Smoking History||participants|Number|1152|1152.0||||||
4104064|NCT00968708|3927904|B3|Current smoker||Smoking History||participants|Number|734|734.0||||||
4104065|NCT00968708|3927905|B2|Current smoker||Smoking History||participants|Number|351|351.0||||||
4104066|NCT00968708|3927906|B1|Current smoker||Smoking History||participants|Number|383|383.0||||||
4104067|NCT00968708|3927904|B3|Never smoked||Smoking History||participants|Number|2302|2302.0||||||
4104068|NCT00968708|3927905|B2|Never smoked||Smoking History||participants|Number|1158|1158.0||||||
4104069|NCT00968708|3927906|B1|Never smoked||Smoking History||participants|Number|1144|1144.0||||||
4104070|NCT00968708|3927904|B3|||Duration of Type 2 Diabetes Mellitus||years|Mean|9.16|9.16|Standard Deviation|8.159|8.159|||
4104071|NCT00968708|3927905|B2|||Duration of Type 2 Diabetes Mellitus||years|Mean|9.13|9.13|Standard Deviation|8.198|8.198|||
4104072|NCT00968708|3927906|B1|||Duration of Type 2 Diabetes Mellitus||years|Mean|9.18|9.18|Standard Deviation|8.121|8.121|||
4104073|NCT00968708|3927904|B3|||Body Mass Index||kg/m^2|Mean|29.48|29.48|Standard Deviation|5.591|5.591|||
4104074|NCT00968708|3927905|B2|||Body Mass Index||kg/m^2|Mean|29.42|29.42|Standard Deviation|5.422|5.422|||
4104075|NCT00968708|3927906|B1|||Body Mass Index||kg/m^2|Mean|29.53|29.53|Standard Deviation|5.758|5.758|||
4104076|NCT00968708|3927904|B3|United States||Region of Enrollment||participants|Number|744|744.0||||||
4104077|NCT00968708|3927905|B2|United States||Region of Enrollment||participants|Number|372|372.0||||||
4104078|NCT00968708|3927906|B1|United States||Region of Enrollment||participants|Number|372|372.0||||||
4104079|NCT00968708|3927904|B3|United Kingdom||Region of Enrollment||participants|Number|66|66.0||||||
4104080|NCT00968708|3927905|B2|United Kingdom||Region of Enrollment||participants|Number|34|34.0||||||
4104081|NCT00968708|3927906|B1|United Kingdom||Region of Enrollment||participants|Number|32|32.0||||||
4104082|NCT00968708|3927904|B3|United Arab Emirates||Region of Enrollment||participants|Number|6|6.0||||||
4104083|NCT00968708|3927905|B2|United Arab Emirates||Region of Enrollment||participants|Number|3|3.0||||||
4104084|NCT00968708|3927906|B1|United Arab Emirates||Region of Enrollment||participants|Number|3|3.0||||||
4104085|NCT00968708|3927904|B3|Ukraine||Region of Enrollment||participants|Number|276|276.0||||||
4104086|NCT00968708|3927905|B2|Ukraine||Region of Enrollment||participants|Number|138|138.0||||||
4104087|NCT00968708|3927906|B1|Ukraine||Region of Enrollment||participants|Number|138|138.0||||||
4104088|NCT00968708|3927904|B3|Thailand||Region of Enrollment||participants|Number|115|115.0||||||
4104089|NCT00968708|3927905|B2|Thailand||Region of Enrollment||participants|Number|58|58.0||||||
4104090|NCT00968708|3927906|B1|Thailand||Region of Enrollment||participants|Number|57|57.0||||||
4104091|NCT00968708|3927904|B3|Taiwan, Province Of China||Region of Enrollment||participants|Number|27|27.0||||||
4104092|NCT00968708|3927905|B2|Taiwan, Province Of China||Region of Enrollment||participants|Number|13|13.0||||||
4104093|NCT00968708|3927906|B1|Taiwan, Province Of China||Region of Enrollment||participants|Number|14|14.0||||||
4104094|NCT00968708|3927904|B3|Sweden||Region of Enrollment||participants|Number|32|32.0||||||
4104095|NCT00968708|3927905|B2|Sweden||Region of Enrollment||participants|Number|16|16.0||||||
4104096|NCT00968708|3927906|B1|Sweden||Region of Enrollment||participants|Number|16|16.0||||||
4104097|NCT00968708|3927904|B3|Spain||Region of Enrollment||participants|Number|43|43.0||||||
4104098|NCT00968708|3927905|B2|Spain||Region of Enrollment||participants|Number|22|22.0||||||
4104099|NCT00968708|3927906|B1|Spain||Region of Enrollment||participants|Number|21|21.0||||||
4104100|NCT00968708|3927904|B3|South Africa||Region of Enrollment||participants|Number|80|80.0||||||
4104101|NCT00968708|3927905|B2|South Africa||Region of Enrollment||participants|Number|41|41.0||||||
4104102|NCT00968708|3927906|B1|South Africa||Region of Enrollment||participants|Number|39|39.0||||||
4104103|NCT00968708|3927904|B3|Slovakia||Region of Enrollment||participants|Number|95|95.0||||||
4104104|NCT00968708|3927905|B2|Slovakia||Region of Enrollment||participants|Number|49|49.0||||||
4104105|NCT00968708|3927906|B1|Slovakia||Region of Enrollment||participants|Number|46|46.0||||||
4104106|NCT00968708|3927904|B3|Serbia||Region of Enrollment||participants|Number|70|70.0||||||
4104107|NCT00968708|3927905|B2|Serbia||Region of Enrollment||participants|Number|35|35.0||||||
4104108|NCT00968708|3927906|B1|Serbia||Region of Enrollment||participants|Number|35|35.0||||||
4104109|NCT00968708|3927904|B3|Russian Federation||Region of Enrollment||participants|Number|304|304.0||||||
4104110|NCT00968708|3927905|B2|Russian Federation||Region of Enrollment||participants|Number|151|151.0||||||
4104111|NCT00968708|3927906|B1|Russian Federation||Region of Enrollment||participants|Number|153|153.0||||||
4104112|NCT00968708|3927904|B3|Romania||Region of Enrollment||participants|Number|78|78.0||||||
4104113|NCT00968708|3927905|B2|Romania||Region of Enrollment||participants|Number|38|38.0||||||
4104114|NCT00968708|3927906|B1|Romania||Region of Enrollment||participants|Number|40|40.0||||||
4104115|NCT00968708|3927904|B3|Korea, Republic Of||Region of Enrollment||participants|Number|123|123.0||||||
4104116|NCT00968708|3927905|B2|Korea, Republic Of||Region of Enrollment||participants|Number|62|62.0||||||
4104117|NCT00968708|3927906|B1|Korea, Republic Of||Region of Enrollment||participants|Number|61|61.0||||||
4104118|NCT00968708|3927904|B3|Puerto Rico||Region of Enrollment||participants|Number|35|35.0||||||
4104119|NCT00968708|3927905|B2|Puerto Rico||Region of Enrollment||participants|Number|19|19.0||||||
4104120|NCT00968708|3927906|B1|Puerto Rico||Region of Enrollment||participants|Number|16|16.0||||||
4104121|NCT00968708|3927904|B3|Portugal||Region of Enrollment||participants|Number|29|29.0||||||
4104123|NCT00968708|3927906|B1|Portugal||Region of Enrollment||participants|Number|13|13.0||||||
4104124|NCT00968708|3927904|B3|Poland||Region of Enrollment||participants|Number|239|239.0||||||
4104125|NCT00968708|3927905|B2|Poland||Region of Enrollment||participants|Number|118|118.0||||||
4104126|NCT00968708|3927906|B1|Poland||Region of Enrollment||participants|Number|121|121.0||||||
4104127|NCT00968708|3927904|B3|Philippines||Region of Enrollment||participants|Number|102|102.0||||||
4104128|NCT00968708|3927905|B2|Philippines||Region of Enrollment||participants|Number|50|50.0||||||
4104129|NCT00968708|3927906|B1|Philippines||Region of Enrollment||participants|Number|52|52.0||||||
4104130|NCT00968708|3927904|B3|Peru||Region of Enrollment||participants|Number|160|160.0||||||
4104131|NCT00968708|3927905|B2|Peru||Region of Enrollment||participants|Number|81|81.0||||||
4104132|NCT00968708|3927906|B1|Peru||Region of Enrollment||participants|Number|79|79.0||||||
4104133|NCT00968708|3927904|B3|New Zealand||Region of Enrollment||participants|Number|26|26.0||||||
4104134|NCT00968708|3927905|B2|New Zealand||Region of Enrollment||participants|Number|13|13.0||||||
4104135|NCT00968708|3927906|B1|New Zealand||Region of Enrollment||participants|Number|13|13.0||||||
4104136|NCT00968708|3927904|B3|Mexico||Region of Enrollment||participants|Number|383|383.0||||||
4104137|NCT00968708|3927905|B2|Mexico||Region of Enrollment||participants|Number|191|191.0||||||
4104138|NCT00968708|3927906|B1|Mexico||Region of Enrollment||participants|Number|192|192.0||||||
4104139|NCT00968708|3927904|B3|Malaysia||Region of Enrollment||participants|Number|81|81.0||||||
4104140|NCT00968708|3927905|B2|Malaysia||Region of Enrollment||participants|Number|42|42.0||||||
4104141|NCT00968708|3927906|B1|Malaysia||Region of Enrollment||participants|Number|39|39.0||||||
4104142|NCT00968708|3927904|B3|Lithuania||Region of Enrollment||participants|Number|36|36.0||||||
4104143|NCT00968708|3927905|B2|Lithuania||Region of Enrollment||participants|Number|20|20.0||||||
4104144|NCT00968708|3927906|B1|Lithuania||Region of Enrollment||participants|Number|16|16.0||||||
4104145|NCT00968708|3927904|B3|Latvia||Region of Enrollment||participants|Number|12|12.0||||||
4104146|NCT00968708|3927905|B2|Latvia||Region of Enrollment||participants|Number|6|6.0||||||
4104147|NCT00968708|3927906|B1|Latvia||Region of Enrollment||participants|Number|6|6.0||||||
4104148|NCT00968708|3927904|B3|Kuwait||Region of Enrollment||participants|Number|5|5.0||||||
4104149|NCT00968708|3927905|B2|Kuwait||Region of Enrollment||participants|Number|3|3.0||||||
4104150|NCT00968708|3927906|B1|Kuwait||Region of Enrollment||participants|Number|2|2.0||||||
4104151|NCT00968708|3927904|B3|Japan||Region of Enrollment||participants|Number|209|209.0||||||
4104152|NCT00968708|3927905|B2|Japan||Region of Enrollment||participants|Number|104|104.0||||||
4104153|NCT00968708|3927906|B1|Japan||Region of Enrollment||participants|Number|105|105.0||||||
4104154|NCT00968708|3927904|B3|Italy||Region of Enrollment||participants|Number|50|50.0||||||
4104155|NCT00968708|3927905|B2|Italy||Region of Enrollment||participants|Number|25|25.0||||||
4104156|NCT00968708|3927906|B1|Italy||Region of Enrollment||participants|Number|25|25.0||||||
4104157|NCT00968708|3927904|B3|Israel||Region of Enrollment||participants|Number|201|201.0||||||
4104158|NCT00968708|3927905|B2|Israel||Region of Enrollment||participants|Number|101|101.0||||||
4104159|NCT00968708|3927906|B1|Israel||Region of Enrollment||participants|Number|100|100.0||||||
4104160|NCT00968708|3927904|B3|India||Region of Enrollment||participants|Number|330|330.0||||||
4104161|NCT00968708|3927905|B2|India||Region of Enrollment||participants|Number|165|165.0||||||
4104162|NCT00968708|3927906|B1|India||Region of Enrollment||participants|Number|165|165.0||||||
4104163|NCT00968708|3927904|B3|Hungary||Region of Enrollment||participants|Number|119|119.0||||||
4104164|NCT00968708|3927905|B2|Hungary||Region of Enrollment||participants|Number|59|59.0||||||
4104165|NCT00968708|3927906|B1|Hungary||Region of Enrollment||participants|Number|60|60.0||||||
4104166|NCT00968708|3927904|B3|Hong Kong||Region of Enrollment||participants|Number|23|23.0||||||
4104167|NCT00968708|3927905|B2|Hong Kong||Region of Enrollment||participants|Number|12|12.0||||||
4104168|NCT00968708|3927906|B1|Hong Kong||Region of Enrollment||participants|Number|11|11.0||||||
4104169|NCT00968708|3927904|B3|Guatemala||Region of Enrollment||participants|Number|49|49.0||||||
4104170|NCT00968708|3927905|B2|Guatemala||Region of Enrollment||participants|Number|24|24.0||||||
4104171|NCT00968708|3927906|B1|Guatemala||Region of Enrollment||participants|Number|25|25.0||||||
4104172|NCT00968708|3927904|B3|Greece||Region of Enrollment||participants|Number|1|1.0||||||
4104173|NCT00968708|3927905|B2|Greece||Region of Enrollment||participants|Number|1|1.0||||||
4104174|NCT00968708|3927906|B1|Greece||Region of Enrollment||participants|Number|0|0.0||||||
4104175|NCT00968708|3927904|B3|Germany||Region of Enrollment||participants|Number|53|53.0||||||
4104176|NCT00968708|3927905|B2|Germany||Region of Enrollment||participants|Number|27|27.0||||||
4104177|NCT00968708|3927906|B1|Germany||Region of Enrollment||participants|Number|26|26.0||||||
4104178|NCT00968708|3927904|B3|France||Region of Enrollment||participants|Number|22|22.0||||||
4104179|NCT00968708|3927905|B2|France||Region of Enrollment||participants|Number|11|11.0||||||
4104180|NCT00968708|3927906|B1|France||Region of Enrollment||participants|Number|11|11.0||||||
4104181|NCT00968708|3927904|B3|Finland||Region of Enrollment||participants|Number|22|22.0||||||
4104182|NCT00968708|3927905|B2|Finland||Region of Enrollment||participants|Number|10|10.0||||||
4104183|NCT00968708|3927906|B1|Finland||Region of Enrollment||participants|Number|12|12.0||||||
4104184|NCT00968708|3927904|B3|Egypt||Region of Enrollment||participants|Number|14|14.0||||||
4104185|NCT00968708|3927905|B2|Egypt||Region of Enrollment||participants|Number|7|7.0||||||
4104186|NCT00968708|3927906|B1|Egypt||Region of Enrollment||participants|Number|7|7.0||||||
4104187|NCT00968708|3927904|B3|Denmark||Region of Enrollment||participants|Number|6|6.0||||||
4104188|NCT00968708|3927905|B2|Denmark||Region of Enrollment||participants|Number|3|3.0||||||
4104189|NCT00968708|3927906|B1|Denmark||Region of Enrollment||participants|Number|3|3.0||||||
4104190|NCT00968708|3927904|B3|Czech Republic||Region of Enrollment||participants|Number|26|26.0||||||
4104191|NCT00968708|3927905|B2|Czech Republic||Region of Enrollment||participants|Number|13|13.0||||||
4104192|NCT00968708|3927906|B1|Czech Republic||Region of Enrollment||participants|Number|13|13.0||||||
4104193|NCT00968708|3927904|B3|Croatia||Region of Enrollment||participants|Number|77|77.0||||||
4104194|NCT00968708|3927905|B2|Croatia||Region of Enrollment||participants|Number|39|39.0||||||
4104195|NCT00968708|3927906|B1|Croatia||Region of Enrollment||participants|Number|38|38.0||||||
4104196|NCT00968708|3927904|B3|Colombia||Region of Enrollment||participants|Number|28|28.0||||||
4104197|NCT00968708|3927905|B2|Colombia||Region of Enrollment||participants|Number|13|13.0||||||
4104198|NCT00968708|3927906|B1|Colombia||Region of Enrollment||participants|Number|15|15.0||||||
4104199|NCT00968708|3927904|B3|Chile||Region of Enrollment||participants|Number|106|106.0||||||
4104200|NCT00968708|3927905|B2|Chile||Region of Enrollment||participants|Number|55|55.0||||||
4104201|NCT00968708|3927906|B1|Chile||Region of Enrollment||participants|Number|51|51.0||||||
4104202|NCT00968708|3927904|B3|Canada||Region of Enrollment||participants|Number|109|109.0||||||
4104203|NCT00968708|3927905|B2|Canada||Region of Enrollment||participants|Number|55|55.0||||||
4104204|NCT00968708|3927906|B1|Canada||Region of Enrollment||participants|Number|54|54.0||||||
4104205|NCT00968708|3927904|B3|Bulgaria||Region of Enrollment||participants|Number|82|82.0||||||
4104206|NCT00968708|3927905|B2|Bulgaria||Region of Enrollment||participants|Number|41|41.0||||||
4104207|NCT00968708|3927906|B1|Bulgaria||Region of Enrollment||participants|Number|41|41.0||||||
4104208|NCT00968708|3927904|B3|Brazil||Region of Enrollment||participants|Number|360|360.0||||||
4104209|NCT00968708|3927905|B2|Brazil||Region of Enrollment||participants|Number|181|181.0||||||
4104210|NCT00968708|3927906|B1|Brazil||Region of Enrollment||participants|Number|179|179.0||||||
4104211|NCT00968708|3927904|B3|Belgium||Region of Enrollment||participants|Number|23|23.0||||||
4104212|NCT00968708|3927905|B2|Belgium||Region of Enrollment||participants|Number|12|12.0||||||
4104213|NCT00968708|3927906|B1|Belgium||Region of Enrollment||participants|Number|11|11.0||||||
4104214|NCT00968708|3927904|B3|Austria||Region of Enrollment||participants|Number|16|16.0||||||
4104215|NCT00968708|3927905|B2|Austria||Region of Enrollment||participants|Number|8|8.0||||||
4104216|NCT00968708|3927906|B1|Austria||Region of Enrollment||participants|Number|8|8.0||||||
4104217|NCT00968708|3927904|B3|Australia||Region of Enrollment||participants|Number|15|15.0||||||
4104218|NCT00968708|3927905|B2|Australia||Region of Enrollment||participants|Number|8|8.0||||||
4104219|NCT00968708|3927906|B1|Australia||Region of Enrollment||participants|Number|7|7.0||||||
4104220|NCT00968708|3927904|B3|Argentina||Region of Enrollment||participants|Number|272|272.0||||||
4104221|NCT00968708|3927905|B2|Argentina||Region of Enrollment||participants|Number|136|136.0||||||
4104222|NCT00968708|3927906|B1|Argentina||Region of Enrollment||participants|Number|136|136.0||||||
4104223|NCT00968708|3927904|B3|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3843|3843.0||||||
4104224|NCT00968708|3927905|B2|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1928|1928.0||||||
4104225|NCT00968708|3927906|B1|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1915|1915.0||||||
4104226|NCT00968708|3927904|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1537|1537.0||||||
4104227|NCT00968708|3927905|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|773|773.0||||||
4104228|NCT00968708|3927906|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|764|764.0||||||
4104229|NCT00968708|3927904|B3|More than one race||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4104230|NCT00968708|3927905|B2|More than one race||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4104231|NCT00968708|3927906|B1|More than one race||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4104232|NCT00968708|3927904|B3|White||Race/Ethnicity, Customized||participants|Number|3909|3909.0||||||
4104233|NCT00968708|3927905|B2|White||Race/Ethnicity, Customized||participants|Number|1966|1966.0||||||
4104234|NCT00968708|3927906|B1|White||Race/Ethnicity, Customized||participants|Number|1943|1943.0||||||
4104235|NCT00968708|3927904|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4104236|NCT00968708|3927905|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4104237|NCT00968708|3927906|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4104238|NCT00968708|3927904|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|216|216.0||||||
4104239|NCT00968708|3927905|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|101|101.0||||||
4104240|NCT00968708|3927906|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|115|115.0||||||
4104241|NCT00968708|3927904|B3|Asian||Race/Ethnicity, Customized||participants|Number|1089|1089.0||||||
4104242|NCT00968708|3927905|B2|Asian||Race/Ethnicity, Customized||participants|Number|547|547.0||||||
4104243|NCT00968708|3927906|B1|Asian||Race/Ethnicity, Customized||participants|Number|542|542.0||||||
4104244|NCT00968708|3927904|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|110|110.0||||||
4104245|NCT00968708|3927905|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
4104246|NCT00968708|3927906|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
4104247|NCT00968708|3927904|B3||Male|Sex: Female, Male||Participants|Count of Participants|3651|3651.0||||||
4104248|NCT00968708|3927905|B2||Male|Sex: Female, Male||Participants|Count of Participants|1828|1828.0||||||
4104249|NCT00968708|3927906|B1||Male|Sex: Female, Male||Participants|Count of Participants|1823|1823.0||||||
4104250|NCT00968708|3927904|B3||Female|Sex: Female, Male||Participants|Count of Participants|1729|1729.0||||||
4104251|NCT00968708|3927905|B2||Female|Sex: Female, Male||Participants|Count of Participants|873|873.0||||||
4104252|NCT00968708|3927906|B1||Female|Sex: Female, Male||Participants|Count of Participants|856|856.0||||||
4104253|NCT00968708|3927904|B3|||Age||years|Mean|60.9|60.9|Standard Deviation|9.92|9.92|||
4104254|NCT00968708|3927905|B2|||Age||years|Mean|61.0|61.0|Standard Deviation|9.96|9.96|||
4104255|NCT00968708|3927906|B1|||Age||years|Mean|60.7|60.7|Standard Deviation|9.88|9.88|||
4104256|NCT00968669|3927915|B5||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4104257|NCT00968669|3927916|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4104258|NCT00968669|3927917|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4104259|NCT00968669|3927918|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4104260|NCT00968669|3927919|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4104261|NCT00968669|3927915|B5||Female|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
4104262|NCT00968669|3927916|B4||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4104263|NCT00968669|3927917|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4104264|NCT00968669|3927918|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4104265|NCT00968669|3927919|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4104266|NCT00968669|3927915|B5|||Age||Years|Mean|43.0|43.0|Standard Deviation|11.7|11.7|||
4104267|NCT00968669|3927916|B4|||Age||Years|Mean|41.5|41.5|Standard Deviation|12.3|12.3|||
4104268|NCT00968669|3927917|B3|||Age||Years|Mean|45.1|45.1|Standard Deviation|11.6|11.6|||
4104269|NCT00968669|3927918|B2|||Age||Years|Mean|41.8|41.8|Standard Deviation|11.1|11.1|||
4104270|NCT00968669|3927919|B1|||Age||Years|Mean|43.6|43.6|Standard Deviation|11.6|11.6|||
4104271|NCT00968617|3928012|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4104272|NCT00968617|3928012|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4104273|NCT00968617|3928012|B1|||Age||years|Mean|60.9|60.9|Standard Deviation|5.01|5.01|||
4104274|NCT00968539|3928024|B3|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|129|129.0||||||
4104275|NCT00968539|3928025|B2|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|65|65.0||||||
4104276|NCT00968539|3928026|B1|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|64|64.0||||||
4104277|NCT00968539|3928024|B3|Asian-East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4104278|NCT00968539|3928025|B2|Asian-East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4104279|NCT00968539|3928026|B1|Asian-East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4104280|NCT00968539|3928024|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4104281|NCT00968539|3928025|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4104282|NCT00968539|3928026|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4104283|NCT00968539|3928024|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4104284|NCT00968539|3928025|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4104285|NCT00968539|3928026|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4104286|NCT00968539|3928024|B3|||Age||Years|Mean|38.64|38.64|Standard Deviation|13.78|13.78|||
4104287|NCT00968539|3928025|B2|||Age||Years|Mean|38.2|38.2|Standard Deviation|14.10|14.1|||
4104288|NCT00968539|3928026|B1|||Age||Years|Mean|39.1|39.1|Standard Deviation|13.53|13.53|||
4104289|NCT00968526|3928085|B3|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|240|240.0||||||
4104290|NCT00968526|3928086|B2|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|102|102.0||||||
4104291|NCT00968526|3928087|B1|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|138|138.0||||||
4104292|NCT00968526|3928085|B3||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4104293|NCT00968526|3928086|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4104294|NCT00968526|3928087|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4104295|NCT00968526|3928085|B3||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4104296|NCT00968526|3928086|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4104297|NCT00968526|3928087|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4104298|NCT00968526|3928085|B3|||Age||Years|Mean|54.4|54.4|Standard Deviation|18.2|18.2|||
4104299|NCT00968526|3928086|B2|||Age||Years|Mean|53.6|53.6|Standard Deviation|18.3|18.3|||
4104300|NCT00968526|3928087|B1|||Age||Years|Mean|55.0|55.0|Standard Deviation|18.2|18.2|||
4104301|NCT00968253|3928178|B4|United States||Region of Enrollment||participants|Number|24|24.0||||||
4104302|NCT00968253|3928179|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4104303|NCT00968253|3928180|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4104304|NCT00968253|3928181|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4104305|NCT00968253|3928178|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4104306|NCT00968253|3928179|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4104307|NCT00968253|3928180|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4104308|NCT00968253|3928181|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4104309|NCT00968253|3928178|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4104310|NCT00968253|3928179|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4104311|NCT00968253|3928180|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4104312|NCT00968253|3928181|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4104313|NCT00968253|3928178|B4|||Age||years|Median|25|25.0|Full Range|||11.0|64.0|
4104314|NCT00968253|3928179|B3|||Age||years|Median|30|30.0|Full Range|||14.0|64.0|
4104315|NCT00968253|3928180|B2|||Age||years|Median|24|24.0|Full Range|||11.0|59.0|
4104316|NCT00968253|3928181|B1|||Age||years|Median|29|29.0|Full Range|||24.0|52.0|
4104317|NCT00968227|3928197|B1|United States||Region of Enrollment||participants|Number|56|56.0||||||
4104318|NCT00968227|3928197|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104319|NCT00968227|3928197|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104320|NCT00968227|3928197|B1||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4104321|NCT00968227|3928197|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4104322|NCT00968227|3928197|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104323|NCT00968227|3928197|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104324|NCT00968227|3928197|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104325|NCT00968227|3928197|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4104326|NCT00968227|3928197|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4104327|NCT00968227|3928197|B1|||Age||years|Mean|54|54.0|Full Range|||48.0|70.0|
4104328|NCT00968201|3928202|B3||Male|Sex: Female, Male||Participants|Count of Participants|403|403.0||||||
4104329|NCT00968201|3928203|B2||Male|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
4104330|NCT00968201|3928204|B1||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4104331|NCT00968201|3928202|B3||Female|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
4104332|NCT00968201|3928203|B2||Female|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4104333|NCT00968201|3928204|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4104334|NCT00968201|3928202|B3|||Age||years|Mean|3.59|3.59|Standard Deviation|1.10|1.1|||
4104335|NCT00968201|3928203|B2|||Age||years|Mean|3.58|3.58|Standard Deviation|1.11|1.11|||
4104336|NCT00968201|3928204|B1|||Age||years|Mean|3.62|3.62|Standard Deviation|1.10|1.1|||
4104337|NCT00968149|3928265|B3|Girls||Sex/Gender, Customized||participants|Number|179|179.0||||||
4104338|NCT00968149|3928266|B2|Girls||Sex/Gender, Customized||participants|Number|56|56.0||||||
4104339|NCT00968149|3928267|B1|Girls||Sex/Gender, Customized||participants|Number|123|123.0||||||
4104340|NCT00968149|3928265|B3|Boys||Sex/Gender, Customized||participants|Number|234|234.0||||||
4104341|NCT00968149|3928266|B2|Boys||Sex/Gender, Customized||participants|Number|77|77.0||||||
4104342|NCT00968149|3928267|B1|Boys||Sex/Gender, Customized||participants|Number|157|157.0||||||
4104343|NCT00968149|3928265|B3|||Age||years|Mean|8.0|8.0|Standard Deviation|3.7|3.7|||
4104344|NCT00968149|3928266|B2|||Age||years|Mean|8.4|8.4|Standard Deviation|3.8|3.8|||
4104345|NCT00968149|3928267|B1|||Age||years|Mean|7.9|7.9|Standard Deviation|3.7|3.7|||
4104346|NCT00968071|3928288|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
4104347|NCT00968071|3928288|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4104348|NCT00968071|3928288|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4104349|NCT00968071|3928288|B1|||Age||years|Median|65|65.0|Full Range|||26.0|65.0|
4104350|NCT00968032|3928292|B1|Germany||Region of Enrollment||participants|Number|63|63.0||||||
4104351|NCT00968032|3928292|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4104352|NCT00968032|3928292|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4104353|NCT00968032|3928292|B1|||Age||years|Mean|45.7|45.7|Standard Deviation|11.2|11.2|||
4104354|NCT00968032|3928292|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4104355|NCT00968032|3928292|B1||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4104356|NCT00968032|3928292|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4104357|NCT00968019|3928296|B1|Spain||Region of Enrollment||participants|Number|262|262.0||||||
4104358|NCT00968019|3928296|B1|Portugal||Region of Enrollment||participants|Number|56|56.0||||||
4104359|NCT00968019|3928296|B1||Male|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
4104360|NCT00968019|3928296|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4104361|NCT00968019|3928296|B1|||Age||years|Mean|65.5|65.5|Standard Deviation|12.4|12.4|||
4104362|NCT00967993|3928317|B1|Israel||Region of Enrollment||participants|Number|22|22.0||||||
4104363|NCT00967993|3928317|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4104364|NCT00967993|3928317|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4104365|NCT00967993|3928317|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4104366|NCT00967993|3928317|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4104367|NCT00967993|3928317|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4104368|NCT00967993|3928317|B1|||Age||years|Mean|55|55.0|Standard Deviation|0.8|0.8|||
4104369|NCT00967798|3928321|B3|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
4104370|NCT00967798|3928322|B2|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4104425|NCT00967668|3928343|B3|No||Diabetes||participants|Number|99|99.0||||||
4104371|NCT00967798|3928323|B1|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
4104372|NCT00967798|3928321|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4104373|NCT00967798|3928322|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4104374|NCT00967798|3928323|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104375|NCT00967798|3928321|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104376|NCT00967798|3928322|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104377|NCT00967798|3928323|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104378|NCT00967798|3928321|B3||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4104379|NCT00967798|3928322|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4104380|NCT00967798|3928323|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4104381|NCT00967798|3928321|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4104382|NCT00967798|3928322|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104383|NCT00967798|3928323|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4104384|NCT00967798|3928321|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104385|NCT00967798|3928322|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104386|NCT00967798|3928323|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104387|NCT00967798|3928321|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104388|NCT00967798|3928322|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104389|NCT00967798|3928323|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104390|NCT00967798|3928321|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104391|NCT00967798|3928322|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104392|NCT00967798|3928323|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104393|NCT00967798|3928321|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104394|NCT00967798|3928322|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104395|NCT00967798|3928323|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104396|NCT00967798|3928321|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4104397|NCT00967798|3928322|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4104398|NCT00967798|3928323|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4104399|NCT00967798|3928321|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4104400|NCT00967798|3928322|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4104401|NCT00967798|3928323|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104402|NCT00967798|3928321|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4104403|NCT00967798|3928322|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4104404|NCT00967798|3928323|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4104405|NCT00967798|3928321|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4104406|NCT00967798|3928322|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4104407|NCT00967798|3928323|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4104408|NCT00967798|3928321|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4104409|NCT00967798|3928322|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4104410|NCT00967798|3928323|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4104411|NCT00967798|3928321|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4104412|NCT00967798|3928322|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4104413|NCT00967798|3928323|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4104414|NCT00967798|3928321|B3||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4104415|NCT00967798|3928322|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4104416|NCT00967798|3928323|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4104417|NCT00967694|3928338|B1|||Baseline Mean Arterial Pressure||mmHg|Mean|86.4|86.4|Standard Deviation|6.8|6.8|||
4104418|NCT00967694|3928338|B1|||Baseline Mean Intraocular Pressure (IOP)||mmHg|Mean|11.0|11.0|Standard Deviation|2.4|2.4|||
4104419|NCT00967694|3928338|B1|||American Society of Anesthesiologists Physical Classification System (ASA) class|"Scale Range 1 to 6 with one being better, 6 being worst.~ASA Physical Status 1 - A normal healthy patient ASA Physical Status 2 - A patient with mild systemic disease ASA Physical Status 3 - A patient with severe systemic disease ASA Physical Status 4 - A patient with severe systemic disease that is a constant threat to life ASA Physical Status 5 - A moribund patient who is not expected to survive without the operation ASA Physical Status 6 - A declared brain-dead patient whose organs are being removed for donor purposes"|units on a scale|Mean|1.1|1.1|Standard Deviation|0.307|0.307|||
4104420|NCT00967694|3928338|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4104421|NCT00967694|3928338|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4104422|NCT00967694|3928338|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4104423|NCT00967694|3928338|B1|||Age||years|Mean|29.6|29.6|Standard Deviation|6.7|6.7|||
4104424|NCT00967668|3928342|B4|No||Diabetes||participants|Number|304|304.0||||||
4104426|NCT00967668|3928344|B2|No||Diabetes||participants|Number|96|96.0||||||
4104427|NCT00967668|3928345|B1|No||Diabetes||participants|Number|109|109.0||||||
4104428|NCT00967668|3928342|B4|Yes||Diabetes||participants|Number|177|177.0||||||
4104429|NCT00967668|3928343|B3|Yes||Diabetes||participants|Number|60|60.0||||||
4104430|NCT00967668|3928344|B2|Yes||Diabetes||participants|Number|64|64.0||||||
4104431|NCT00967668|3928345|B1|Yes||Diabetes||participants|Number|53|53.0||||||
4104432|NCT00967668|3928342|B4|No||Depression||participants|Number|325|325.0||||||
4104433|NCT00967668|3928343|B3|No||Depression||participants|Number|100|100.0||||||
4104434|NCT00967668|3928344|B2|No||Depression||participants|Number|98|98.0||||||
4104435|NCT00967668|3928345|B1|No||Depression||participants|Number|127|127.0||||||
4104436|NCT00967668|3928342|B4|Yes||Depression||participants|Number|156|156.0||||||
4104437|NCT00967668|3928343|B3|Yes||Depression||participants|Number|59|59.0||||||
4104438|NCT00967668|3928344|B2|Yes||Depression||participants|Number|62|62.0||||||
4104439|NCT00967668|3928345|B1|Yes||Depression||participants|Number|35|35.0||||||
4104440|NCT00967668|3928342|B4|||Charlson Index|"Indicates burden of disease (Ref #1 below).~Total score reported. Published score range 0-8 (see Ref #2 below).~Lower score indicates lower burden of disease; 1-point increase in score value is approximately 1.45 increase in relative risk of death.~Scores computed by assigning points based on disease and age (See Ref #2)~Refs: Quan H, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43(11):1130–9.~Charlson M, et al. Validation of a combined comorbidity index. J. Clin. Epidemiol. Nov 1994;47(11):1245-1251."|units on a scale|Mean|1.1|1.1|Standard Deviation|1.5|1.5|||
4104441|NCT00967668|3928343|B3|||Charlson Index|"Indicates burden of disease (Ref #1 below).~Total score reported. Published score range 0-8 (see Ref #2 below).~Lower score indicates lower burden of disease; 1-point increase in score value is approximately 1.45 increase in relative risk of death.~Scores computed by assigning points based on disease and age (See Ref #2)~Refs: Quan H, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43(11):1130–9.~Charlson M, et al. Validation of a combined comorbidity index. J. Clin. Epidemiol. Nov 1994;47(11):1245-1251."|units on a scale|Mean|1.2|1.2|Standard Deviation|1.6|1.6|||
4104442|NCT00967668|3928344|B2|||Charlson Index|"Indicates burden of disease (Ref #1 below).~Total score reported. Published score range 0-8 (see Ref #2 below).~Lower score indicates lower burden of disease; 1-point increase in score value is approximately 1.45 increase in relative risk of death.~Scores computed by assigning points based on disease and age (See Ref #2)~Refs: Quan H, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43(11):1130–9.~Charlson M, et al. Validation of a combined comorbidity index. J. Clin. Epidemiol. Nov 1994;47(11):1245-1251."|units on a scale|Mean|1.2|1.2|Standard Deviation|1.4|1.4|||
4104443|NCT00967668|3928345|B1|||Charlson Index|"Indicates burden of disease (Ref #1 below).~Total score reported. Published score range 0-8 (see Ref #2 below).~Lower score indicates lower burden of disease; 1-point increase in score value is approximately 1.45 increase in relative risk of death.~Scores computed by assigning points based on disease and age (See Ref #2)~Refs: Quan H, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43(11):1130–9.~Charlson M, et al. Validation of a combined comorbidity index. J. Clin. Epidemiol. Nov 1994;47(11):1245-1251."|units on a scale|Mean|1.0|1.0|Standard Deviation|1.3|1.3|||
4104444|NCT00967668|3928342|B4|No||Health-related disability||participants|Number|232|232.0||||||
4104445|NCT00967668|3928343|B3|No||Health-related disability||participants|Number|71|71.0||||||
4104446|NCT00967668|3928344|B2|No||Health-related disability||participants|Number|73|73.0||||||
4104447|NCT00967668|3928345|B1|No||Health-related disability||participants|Number|88|88.0||||||
4104448|NCT00967668|3928342|B4|Yes||Health-related disability||participants|Number|249|249.0||||||
4104449|NCT00967668|3928343|B3|Yes||Health-related disability||participants|Number|88|88.0||||||
4104450|NCT00967668|3928344|B2|Yes||Health-related disability||participants|Number|87|87.0||||||
4104451|NCT00967668|3928345|B1|Yes||Health-related disability||participants|Number|74|74.0||||||
4104452|NCT00967668|3928342|B4|Income $20k or more||Income less than $20k||participants|Number|285|285.0||||||
4104453|NCT00967668|3928343|B3|Income $20k or more||Income less than $20k||participants|Number|88|88.0||||||
4104454|NCT00967668|3928344|B2|Income $20k or more||Income less than $20k||participants|Number|90|90.0||||||
4104455|NCT00967668|3928345|B1|Income $20k or more||Income less than $20k||participants|Number|107|107.0||||||
4104456|NCT00967668|3928342|B4|Income less than $20k||Income less than $20k||participants|Number|196|196.0||||||
4104457|NCT00967668|3928343|B3|Income less than $20k||Income less than $20k||participants|Number|71|71.0||||||
4104458|NCT00967668|3928344|B2|Income less than $20k||Income less than $20k||participants|Number|70|70.0||||||
4104459|NCT00967668|3928345|B1|Income less than $20k||Income less than $20k||participants|Number|55|55.0||||||
4104460|NCT00967668|3928342|B4|Missing||Education, years||participants|Number|11|11.0||||||
4104461|NCT00967668|3928343|B3|Missing||Education, years||participants|Number|5|5.0||||||
4104462|NCT00967668|3928344|B2|Missing||Education, years||participants|Number|3|3.0||||||
4104463|NCT00967668|3928345|B1|Missing||Education, years||participants|Number|3|3.0||||||
4104464|NCT00967668|3928342|B4|16 or more||Education, years||participants|Number|108|108.0||||||
4104465|NCT00967668|3928343|B3|16 or more||Education, years||participants|Number|26|26.0||||||
4104466|NCT00967668|3928344|B2|16 or more||Education, years||participants|Number|42|42.0||||||
4104467|NCT00967668|3928345|B1|16 or more||Education, years||participants|Number|40|40.0||||||
4104468|NCT00967668|3928342|B4|13-15||Education, years||participants|Number|254|254.0||||||
4104469|NCT00967668|3928343|B3|13-15||Education, years||participants|Number|92|92.0||||||
4104470|NCT00967668|3928344|B2|13-15||Education, years||participants|Number|81|81.0||||||
4104471|NCT00967668|3928345|B1|13-15||Education, years||participants|Number|81|81.0||||||
4104472|NCT00967668|3928342|B4|Less than 13||Education, years||participants|Number|108|108.0||||||
4104473|NCT00967668|3928343|B3|Less than 13||Education, years||participants|Number|36|36.0||||||
4104474|NCT00967668|3928344|B2|Less than 13||Education, years||participants|Number|34|34.0||||||
4104475|NCT00967668|3928345|B1|Less than 13||Education, years||participants|Number|38|38.0||||||
4104476|NCT00967668|3928342|B4|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4104477|NCT00967668|3928343|B3|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4104478|NCT00967668|3928344|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4104479|NCT00967668|3928345|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4104480|NCT00967668|3928342|B4|White||Race/Ethnicity, Customized||participants|Number|276|276.0||||||
4104481|NCT00967668|3928343|B3|White||Race/Ethnicity, Customized||participants|Number|91|91.0||||||
4104482|NCT00967668|3928344|B2|White||Race/Ethnicity, Customized||participants|Number|94|94.0||||||
4104483|NCT00967668|3928345|B1|White||Race/Ethnicity, Customized||participants|Number|91|91.0||||||
4104484|NCT00967668|3928342|B4|Black||Race/Ethnicity, Customized||participants|Number|196|196.0||||||
4104485|NCT00967668|3928343|B3|Black||Race/Ethnicity, Customized||participants|Number|64|64.0||||||
4104486|NCT00967668|3928344|B2|Black||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
4104487|NCT00967668|3928345|B1|Black||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
4104488|NCT00967668|3928342|B4||Male|Sex: Female, Male||Participants|Count of Participants|409|409.0||||||
4104489|NCT00967668|3928343|B3||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4104490|NCT00967668|3928344|B2||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4104491|NCT00967668|3928345|B1||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4104492|NCT00967668|3928342|B4||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4104493|NCT00967668|3928343|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4104494|NCT00967668|3928344|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4104495|NCT00967668|3928345|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4104496|NCT00967668|3928342|B4|||Age||years|Mean|55.0|55.0|Standard Deviation|10.0|10.0|||
4104497|NCT00967668|3928343|B3|||Age||years|Mean|54.6|54.6|Standard Deviation|10.5|10.5|||
4104498|NCT00967668|3928344|B2|||Age||years|Mean|54.9|54.9|Standard Deviation|9.5|9.5|||
4104499|NCT00967668|3928345|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|10.0|10.0|||
4104500|NCT00967551|3928358|B3|Brazil||Region of Enrollment||participants|Number|143|143.0||||||
4104501|NCT00967551|3928359|B2|Brazil||Region of Enrollment||participants|Number|75|75.0||||||
4104502|NCT00967551|3928360|B1|Brazil||Region of Enrollment||participants|Number|68|68.0||||||
4104503|NCT00967551|3928358|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4104504|NCT00967551|3928359|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4104505|NCT00967551|3928360|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4104506|NCT00967551|3928358|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4104507|NCT00967551|3928359|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4104508|NCT00967551|3928360|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4104509|NCT00967551|3928358|B3|||Age||years|Mean|2.1|2.1|Standard Deviation|2|2.0|||
4104510|NCT00967551|3928359|B2|||Age||years|Mean|2.2|2.2|Standard Deviation|2|2.0|||
4104511|NCT00967551|3928360|B1|||Age||years|Mean|2.1|2.1|Standard Deviation|2|2.0|||
4104512|NCT00967551|3928358|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4104513|NCT00967551|3928359|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4104514|NCT00967551|3928360|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4104515|NCT00967551|3928358|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4104516|NCT00967551|3928359|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4104517|NCT00967551|3928360|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4104518|NCT00967551|3928358|B3||<=18 years|Age||Participants|Count of Participants|143|143.0||||||
4104519|NCT00967551|3928359|B2||<=18 years|Age||Participants|Count of Participants|75|75.0||||||
4104520|NCT00967551|3928360|B1||<=18 years|Age||Participants|Count of Participants|68|68.0||||||
4104521|NCT00967486|3928369|B3|United States||Region of Enrollment||participants|Number|200|200.0||||||
4104522|NCT00967486|3928370|B2|United States||Region of Enrollment||participants|Number|102|102.0||||||
4104523|NCT00967486|3928371|B1|United States||Region of Enrollment||participants|Number|98|98.0||||||
4104524|NCT00967486|3928369|B3||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4104525|NCT00967486|3928370|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4104526|NCT00967486|3928371|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4104527|NCT00967486|3928369|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4104528|NCT00967486|3928370|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4104529|NCT00967486|3928371|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4104530|NCT00967486|3928369|B3|||Age||years|Mean|68.02|68.02|Standard Deviation|9.46|9.46|||
4104531|NCT00967486|3928370|B2|||Age||years|Mean|67.29|67.29|Standard Deviation|9.81|9.81|||
4104532|NCT00967486|3928371|B1|||Age||years|Mean|68.78|68.78|Standard Deviation|9.08|9.08|||
4104533|NCT00967486|3928369|B3||>=65 years|Age||Participants|Count of Participants|118|118.0||||||
4104534|NCT00967486|3928370|B2||>=65 years|Age||Participants|Count of Participants|58|58.0||||||
4104535|NCT00967486|3928371|B1||>=65 years|Age||Participants|Count of Participants|60|60.0||||||
4104536|NCT00967486|3928369|B3||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
4104537|NCT00967486|3928370|B2||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4104538|NCT00967486|3928371|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4104539|NCT00967473|3928378|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
4104540|NCT00967473|3928378|B1||Female|Gender||Participants|Count of Participants|12|12.0||||||
4104541|NCT00967473|3928378|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4104542|NCT00967473|3928378|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4104543|NCT00967473|3928378|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4104544|NCT00967330|3928391|B3||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4104545|NCT00967330|3928392|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4104546|NCT00967330|3928393|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4104547|NCT00967330|3928391|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4104548|NCT00967330|3928392|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4104549|NCT00967330|3928393|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4104550|NCT00967330|3928391|B3|||Age||years|Mean|55.7|55.7|Standard Deviation|10.37|10.37|||
4104551|NCT00967330|3928392|B2|||Age||years|Mean|56.4|56.4|Standard Deviation|10.84|10.84|||
4104552|NCT00967330|3928393|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|10.17|10.17|||
4104553|NCT00967226|3928422|B3|mixed||Depth||participants|Number|10|10.0||||||
4104554|NCT00967226|3928423|B2|mixed||Depth||participants|Number|4|4.0||||||
4104555|NCT00967226|3928424|B1|mixed||Depth||participants|Number|6|6.0||||||
4104556|NCT00967226|3928422|B3|deep||Depth||participants|Number|4|4.0||||||
4104557|NCT00967226|3928423|B2|deep||Depth||participants|Number|2|2.0||||||
4104558|NCT00967226|3928424|B1|deep||Depth||participants|Number|2|2.0||||||
4104559|NCT00967226|3928422|B3|superficial||Depth||participants|Number|5|5.0||||||
4104560|NCT00967226|3928423|B2|superficial||Depth||participants|Number|2|2.0||||||
4104561|NCT00967226|3928424|B1|superficial||Depth||participants|Number|3|3.0||||||
4104562|NCT00967226|3928422|B3|Intermediate||Morphology|Local, Segmental, Intermediate|participants|Number|2|2.0||||||
4104563|NCT00967226|3928423|B2|Intermediate||Morphology|Local, Segmental, Intermediate|participants|Number|0|0.0||||||
4104564|NCT00967226|3928424|B1|Intermediate||Morphology|Local, Segmental, Intermediate|participants|Number|2|2.0||||||
4104565|NCT00967226|3928422|B3|Segmental||Morphology|Local, Segmental, Intermediate|participants|Number|3|3.0||||||
4104566|NCT00967226|3928423|B2|Segmental||Morphology|Local, Segmental, Intermediate|participants|Number|0|0.0||||||
4104567|NCT00967226|3928424|B1|Segmental||Morphology|Local, Segmental, Intermediate|participants|Number|3|3.0||||||
4104568|NCT00967226|3928422|B3|Local||Morphology|Local, Segmental, Intermediate|participants|Number|14|14.0||||||
4104569|NCT00967226|3928423|B2|Local||Morphology|Local, Segmental, Intermediate|participants|Number|8|8.0||||||
4104570|NCT00967226|3928424|B1|Local||Morphology|Local, Segmental, Intermediate|participants|Number|6|6.0||||||
4104571|NCT00967226|3928422|B3|||Ulceration|(not present in all participants)|participants|Number|3|3.0||||||
4104572|NCT00967226|3928423|B2|||Ulceration|(not present in all participants)|participants|Number|1|1.0||||||
4104573|NCT00967226|3928424|B1|||Ulceration|(not present in all participants)|participants|Number|2|2.0||||||
4104574|NCT00967226|3928422|B3|||Adjusted total surface area (length x width x proportion of skin involved||mm squared|Mean|4.0|4.0|Full Range|||0.2|24.3|
4104575|NCT00967226|3928423|B2|||Adjusted total surface area (length x width x proportion of skin involved||mm squared|Mean|2.5|2.5|Full Range|||0.2|9.4|
4104576|NCT00967226|3928424|B1|||Adjusted total surface area (length x width x proportion of skin involved||mm squared|Mean|5.0|5.0|Full Range|||1.5|24.3|
4104577|NCT00967226|3928422|B3|||Total surface area (length x width)||mm squared|Mean|4.2|4.2|Full Range|||0.8|25.6|
4104578|NCT00967226|3928423|B2|||Total surface area (length x width)||mm squared|Mean|3.1|3.1|Full Range|||0.8|10.5|
4104579|NCT00967226|3928424|B1|||Total surface area (length x width)||mm squared|Mean|5.0|5.0|Full Range|||1.9|25.6|
4104580|NCT00967226|3928422|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4104581|NCT00967226|3928423|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4104582|NCT00967226|3928424|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4104583|NCT00967226|3928422|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104584|NCT00967226|3928423|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104585|NCT00967226|3928424|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104586|NCT00967226|3928422|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4104587|NCT00967226|3928423|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4104588|NCT00967226|3928424|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4104589|NCT00967226|3928422|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4104590|NCT00967226|3928423|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4104591|NCT00967226|3928424|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4104592|NCT00967226|3928422|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104593|NCT00967226|3928423|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104594|NCT00967226|3928424|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104595|NCT00967226|3928422|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104596|NCT00967226|3928423|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104597|NCT00967226|3928424|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104598|NCT00967226|3928422|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4104599|NCT00967226|3928423|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4104600|NCT00967226|3928424|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4104601|NCT00967226|3928422|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4104602|NCT00967226|3928423|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4104603|NCT00967226|3928424|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4104604|NCT00967226|3928422|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104605|NCT00967226|3928423|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104606|NCT00967226|3928424|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104607|NCT00967226|3928422|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4104608|NCT00967226|3928423|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104609|NCT00967226|3928424|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4104610|NCT00967226|3928422|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104611|NCT00967226|3928423|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104612|NCT00967226|3928424|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104613|NCT00967226|3928422|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4104614|NCT00967226|3928423|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4104615|NCT00967226|3928424|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4104616|NCT00967226|3928422|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4104617|NCT00967226|3928423|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4104618|NCT00967226|3928424|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4104619|NCT00967226|3928422|B3|||Age||months|Mean|3.4|3.4|Full Range|||1.7|5.2|
4104620|NCT00967226|3928423|B2|||Age||months|Mean|2.5|2.5|Full Range|||1.7|3.4|
4104621|NCT00967226|3928424|B1|||Age||months|Mean|4.0|4.0|Full Range|||2.8|5.2|
4104622|NCT00967044|3928455|B1|Panobinostat 30 mg/Everolimus 10 mg||Participation by Cohort|Participant by Cohort (1 to 4) according to Panobinostat dose (mg/orally taken three times weekly) and Everolimus dose (mg/orally taken daily).|participants|Number|2|2.0||||||
4104623|NCT00967044|3928455|B1|Panobinostat 20 mg/Everolimus 10 mg||Participation by Cohort|Participant by Cohort (1 to 4) according to Panobinostat dose (mg/orally taken three times weekly) and Everolimus dose (mg/orally taken daily).|participants|Number|22|22.0||||||
4104624|NCT00967044|3928455|B1|Panobinostat 20 mg/Everolimus 5 mg||Participation by Cohort|Participant by Cohort (1 to 4) according to Panobinostat dose (mg/orally taken three times weekly) and Everolimus dose (mg/orally taken daily).|participants|Number|3|3.0||||||
4104625|NCT00967044|3928455|B1|Panobinostat 10 mg/Everolimus 5 mg||Participation by Cohort|Participant by Cohort (1 to 4) according to Panobinostat dose (mg/orally taken three times weekly) and Everolimus dose (mg/orally taken daily).|participants|Number|3|3.0||||||
4104626|NCT00967044|3928455|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4104627|NCT00967044|3928455|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4104628|NCT00967044|3928455|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4104629|NCT00967044|3928455|B1|||Age||years|Median|52|52.0|Full Range|||20.0|74.0|
4104630|NCT00967018|3928459|B1|Not Classifiable||Stage of Prostate Cancer|Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. Some participants did not have their prostate cancer classified for the complete TNM scale (7 participants).|Participants|Number|7|7.0||||||
4104631|NCT00967018|3928459|B1|Metastatic||Stage of Prostate Cancer|Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. Some participants did not have their prostate cancer classified for the complete TNM scale (7 participants).|Participants|Number|15|15.0||||||
4104632|NCT00967018|3928459|B1|Locally Advanced||Stage of Prostate Cancer|Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. Some participants did not have their prostate cancer classified for the complete TNM scale (7 participants).|Participants|Number|19|19.0||||||
4104633|NCT00967018|3928459|B1|Localized||Stage of Prostate Cancer|Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. Some participants did not have their prostate cancer classified for the complete TNM scale (7 participants).|Participants|Number|36|36.0||||||
4104693|NCT00966953|3928543|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4104694|NCT00966953|3928544|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4104634|NCT00967018|3928459|B1|Gleason Score 7-10||Gleason Score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|Participants|Number|58|58.0||||||
4104635|NCT00967018|3928459|B1|Gleason Score 5-6||Gleason Score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|Participants|Number|18|18.0||||||
4104636|NCT00967018|3928459|B1|Gleason Score 2-4||Gleason Score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|Participants|Number|1|1.0||||||
4104637|NCT00967018|3928459|B1|||Body Mass Index (BMI)||kilogram per square meter|Mean|27.2|27.2|Standard Deviation|4.2|4.2|||
4104638|NCT00967018|3928459|B1|Sweden||Region of Enrollment||participants|Number|13|13.0||||||
4104639|NCT00967018|3928459|B1|Italy||Region of Enrollment||participants|Number|35|35.0||||||
4104640|NCT00967018|3928459|B1|Turkey||Region of Enrollment||participants|Number|14|14.0||||||
4104641|NCT00967018|3928459|B1|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
4104642|NCT00967018|3928459|B1|Spain||Region of Enrollment||participants|Number|11|11.0||||||
4104643|NCT00967018|3928459|B1|France||Region of Enrollment||participants|Number|2|2.0||||||
4104644|NCT00967018|3928459|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4104645|NCT00967018|3928459|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4104646|NCT00967018|3928459|B1|||Age||years|Mean|71.9|71.9|Standard Deviation|7.59|7.59|||
4104647|NCT00967005|3928466|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
4104648|NCT00967005|3928467|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4104649|NCT00967005|3928468|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4104650|NCT00967005|3928466|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4104651|NCT00967005|3928467|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4104652|NCT00967005|3928468|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4104653|NCT00967005|3928466|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4104654|NCT00967005|3928467|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4104655|NCT00967005|3928468|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4104656|NCT00967005|3928466|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4104657|NCT00967005|3928467|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4104658|NCT00967005|3928468|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4104659|NCT00967005|3928466|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4104660|NCT00967005|3928467|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4104661|NCT00967005|3928468|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4104662|NCT00967005|3928466|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4104663|NCT00967005|3928467|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4104664|NCT00967005|3928468|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4104665|NCT00967005|3928466|B3|||Age||years|Mean|47.6|47.6|Standard Deviation|10.9|10.9|||
4104666|NCT00967005|3928467|B2|||Age||years|Mean|47.7|47.7|Standard Deviation|10.6|10.6|||
4104667|NCT00967005|3928468|B1|||Age||years|Mean|47.5|47.5|Standard Deviation|10.1|10.1|||
4104668|NCT00966992|3928521|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4104669|NCT00966992|3928523|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4104670|NCT00966992|3928521|B3|Male||Gender||participants|Number|0|0.0||||||
4104671|NCT00966992|3928523|B1|Male||Gender||participants|Number|0|0.0||||||
4104672|NCT00966992|3928521|B3|Female||Gender||participants|Number|3|3.0||||||
4104673|NCT00966992|3928523|B1|Female||Gender||participants|Number|3|3.0||||||
4104674|NCT00966992|3928521|B3|>=65 years||Age||participants|Number|1|1.0||||||
4104675|NCT00966992|3928523|B1|>=65 years||Age||participants|Number|1|1.0||||||
4104676|NCT00966992|3928521|B3|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
4104677|NCT00966992|3928523|B1|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
4104678|NCT00966992|3928521|B3|<=18 years||Age||participants|Number|0|0.0||||||
4104679|NCT00966992|3928523|B1|<=18 years||Age||participants|Number|0|0.0||||||
4104680|NCT00966953|3928540|B5|United States||Region of Enrollment||participants|Number|25|25.0||||||
4104681|NCT00966953|3928541|B4|United States||Region of Enrollment||participants|Number|7|7.0||||||
4104682|NCT00966953|3928542|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4104683|NCT00966953|3928543|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4104684|NCT00966953|3928544|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4104685|NCT00966953|3928540|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4104686|NCT00966953|3928541|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4104687|NCT00966953|3928542|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4104688|NCT00966953|3928543|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4104689|NCT00966953|3928544|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4104690|NCT00966953|3928540|B5||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4104691|NCT00966953|3928541|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4104692|NCT00966953|3928542|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4104695|NCT00966953|3928540|B5|||Age||years|Mean|42.1|42.1|Standard Deviation|10.5|10.5|||
4104696|NCT00966953|3928541|B4|||Age||years|Mean|44.3|44.3|Standard Deviation|7|7.0|||
4104697|NCT00966953|3928542|B3|||Age||years|Mean|46.4|46.4|Standard Deviation|10.9|10.9|||
4104698|NCT00966953|3928543|B2|||Age||years|Mean|37.8|37.8|Standard Deviation|11.6|11.6|||
4104699|NCT00966953|3928544|B1|||Age||years|Mean|42|42.0|Standard Deviation|11.8|11.8|||
4104700|NCT00966953|3928540|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4104701|NCT00966953|3928541|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4104702|NCT00966953|3928542|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4104703|NCT00966953|3928543|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4104704|NCT00966953|3928544|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4104705|NCT00966953|3928540|B5||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4104706|NCT00966953|3928541|B4||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4104707|NCT00966953|3928542|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4104708|NCT00966953|3928543|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4104709|NCT00966953|3928544|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4104710|NCT00966953|3928540|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4104711|NCT00966953|3928541|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4104712|NCT00966953|3928542|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4104713|NCT00966953|3928543|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4104714|NCT00966953|3928544|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4104715|NCT00966940|3928553|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4104716|NCT00966940|3928554|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4104717|NCT00966940|3928555|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4104718|NCT00966940|3928553|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4104719|NCT00966940|3928554|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4104720|NCT00966940|3928555|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4104721|NCT00966940|3928553|B3|||Age||years|Mean|68.8|68.8|Standard Deviation|9.0|9.0|||
4104722|NCT00966940|3928554|B2|||Age||years|Mean|68.5|68.5|Standard Deviation|10.5|10.5|||
4104723|NCT00966940|3928555|B1|||Age||years|Mean|69.1|69.1|Standard Deviation|7.8|7.8|||
4104724|NCT00966875|3928574|B10|India||Region of Enrollment||participants|Number|46|46.0||||||
4104725|NCT00966875|3928575|B9|India||Region of Enrollment||participants|Number|0|0.0||||||
4104726|NCT00966875|3928576|B8|India||Region of Enrollment||participants|Number|0|0.0||||||
4104727|NCT00966875|3928577|B7|India||Region of Enrollment||participants|Number|0|0.0||||||
4104728|NCT00966875|3928578|B6|India||Region of Enrollment||participants|Number|6|6.0||||||
4104729|NCT00966875|3928579|B5|India||Region of Enrollment||participants|Number|11|11.0||||||
4104730|NCT00966875|3928580|B4|India||Region of Enrollment||participants|Number|7|7.0||||||
4104731|NCT00966875|3928581|B3|India||Region of Enrollment||participants|Number|6|6.0||||||
4104732|NCT00966875|3928582|B2|India||Region of Enrollment||participants|Number|7|7.0||||||
4104733|NCT00966875|3928583|B1|India||Region of Enrollment||participants|Number|9|9.0||||||
4104734|NCT00966875|3928574|B10|Korea, Republic of||Region of Enrollment||participants|Number|16|16.0||||||
4104735|NCT00966875|3928575|B9|Korea, Republic of||Region of Enrollment||participants|Number|2|2.0||||||
4104736|NCT00966875|3928576|B8|Korea, Republic of||Region of Enrollment||participants|Number|3|3.0||||||
4104737|NCT00966875|3928577|B7|Korea, Republic of||Region of Enrollment||participants|Number|2|2.0||||||
4104738|NCT00966875|3928578|B6|Korea, Republic of||Region of Enrollment||participants|Number|1|1.0||||||
4104739|NCT00966875|3928579|B5|Korea, Republic of||Region of Enrollment||participants|Number|2|2.0||||||
4104740|NCT00966875|3928580|B4|Korea, Republic of||Region of Enrollment||participants|Number|1|1.0||||||
4104741|NCT00966875|3928581|B3|Korea, Republic of||Region of Enrollment||participants|Number|1|1.0||||||
4104742|NCT00966875|3928582|B2|Korea, Republic of||Region of Enrollment||participants|Number|2|2.0||||||
4104743|NCT00966875|3928583|B1|Korea, Republic of||Region of Enrollment||participants|Number|2|2.0||||||
4104744|NCT00966875|3928574|B10|Germany||Region of Enrollment||participants|Number|8|8.0||||||
4104745|NCT00966875|3928575|B9|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4104746|NCT00966875|3928576|B8|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4104747|NCT00966875|3928577|B7|Germany||Region of Enrollment||participants|Number|3|3.0||||||
4104748|NCT00966875|3928578|B6|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4104749|NCT00966875|3928579|B5|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4104750|NCT00966875|3928580|B4|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4104751|NCT00966875|3928581|B3|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4104752|NCT00966875|3928582|B2|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4104753|NCT00966875|3928583|B1|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4104754|NCT00966875|3928574|B10|Russian Federation||Region of Enrollment||participants|Number|13|13.0||||||
4104755|NCT00966875|3928575|B9|Russian Federation||Region of Enrollment||participants|Number|1|1.0||||||
4104756|NCT00966875|3928576|B8|Russian Federation||Region of Enrollment||participants|Number|1|1.0||||||
4104757|NCT00966875|3928577|B7|Russian Federation||Region of Enrollment||participants|Number|1|1.0||||||
4104758|NCT00966875|3928578|B6|Russian Federation||Region of Enrollment||participants|Number|2|2.0||||||
4104759|NCT00966875|3928579|B5|Russian Federation||Region of Enrollment||participants|Number|3|3.0||||||
4104760|NCT00966875|3928580|B4|Russian Federation||Region of Enrollment||participants|Number|1|1.0||||||
4104761|NCT00966875|3928581|B3|Russian Federation||Region of Enrollment||participants|Number|0|0.0||||||
4104762|NCT00966875|3928582|B2|Russian Federation||Region of Enrollment||participants|Number|1|1.0||||||
4104763|NCT00966875|3928583|B1|Russian Federation||Region of Enrollment||participants|Number|3|3.0||||||
4104764|NCT00966875|3928574|B10|Chile||Region of Enrollment||participants|Number|11|11.0||||||
4104765|NCT00966875|3928575|B9|Chile||Region of Enrollment||participants|Number|1|1.0||||||
4104766|NCT00966875|3928576|B8|Chile||Region of Enrollment||participants|Number|2|2.0||||||
4104767|NCT00966875|3928577|B7|Chile||Region of Enrollment||participants|Number|1|1.0||||||
4104768|NCT00966875|3928578|B6|Chile||Region of Enrollment||participants|Number|2|2.0||||||
4104769|NCT00966875|3928579|B5|Chile||Region of Enrollment||participants|Number|2|2.0||||||
4104770|NCT00966875|3928580|B4|Chile||Region of Enrollment||participants|Number|0|0.0||||||
4104771|NCT00966875|3928581|B3|Chile||Region of Enrollment||participants|Number|2|2.0||||||
4104772|NCT00966875|3928582|B2|Chile||Region of Enrollment||participants|Number|1|1.0||||||
4104773|NCT00966875|3928583|B1|Chile||Region of Enrollment||participants|Number|0|0.0||||||
4104774|NCT00966875|3928574|B10|Peru||Region of Enrollment||participants|Number|31|31.0||||||
4104775|NCT00966875|3928575|B9|Peru||Region of Enrollment||participants|Number|1|1.0||||||
4104776|NCT00966875|3928576|B8|Peru||Region of Enrollment||participants|Number|1|1.0||||||
4104777|NCT00966875|3928577|B7|Peru||Region of Enrollment||participants|Number|1|1.0||||||
4104778|NCT00966875|3928578|B6|Peru||Region of Enrollment||participants|Number|4|4.0||||||
4104779|NCT00966875|3928579|B5|Peru||Region of Enrollment||participants|Number|6|6.0||||||
4104780|NCT00966875|3928580|B4|Peru||Region of Enrollment||participants|Number|4|4.0||||||
4104781|NCT00966875|3928581|B3|Peru||Region of Enrollment||participants|Number|4|4.0||||||
4104782|NCT00966875|3928582|B2|Peru||Region of Enrollment||participants|Number|4|4.0||||||
4104783|NCT00966875|3928583|B1|Peru||Region of Enrollment||participants|Number|6|6.0||||||
4104784|NCT00966875|3928574|B10|Romania||Region of Enrollment||participants|Number|27|27.0||||||
4104785|NCT00966875|3928575|B9|Romania||Region of Enrollment||participants|Number|0|0.0||||||
4104786|NCT00966875|3928576|B8|Romania||Region of Enrollment||participants|Number|1|1.0||||||
4104787|NCT00966875|3928577|B7|Romania||Region of Enrollment||participants|Number|1|1.0||||||
4104788|NCT00966875|3928578|B6|Romania||Region of Enrollment||participants|Number|3|3.0||||||
4104789|NCT00966875|3928579|B5|Romania||Region of Enrollment||participants|Number|6|6.0||||||
4104790|NCT00966875|3928580|B4|Romania||Region of Enrollment||participants|Number|4|4.0||||||
4104791|NCT00966875|3928581|B3|Romania||Region of Enrollment||participants|Number|3|3.0||||||
4104792|NCT00966875|3928582|B2|Romania||Region of Enrollment||participants|Number|4|4.0||||||
4104793|NCT00966875|3928583|B1|Romania||Region of Enrollment||participants|Number|5|5.0||||||
4104794|NCT00966875|3928574|B10|Poland||Region of Enrollment||participants|Number|82|82.0||||||
4104795|NCT00966875|3928575|B9|Poland||Region of Enrollment||participants|Number|10|10.0||||||
4104796|NCT00966875|3928576|B8|Poland||Region of Enrollment||participants|Number|11|11.0||||||
4104797|NCT00966875|3928577|B7|Poland||Region of Enrollment||participants|Number|11|11.0||||||
4104798|NCT00966875|3928578|B6|Poland||Region of Enrollment||participants|Number|7|7.0||||||
4104799|NCT00966875|3928579|B5|Poland||Region of Enrollment||participants|Number|9|9.0||||||
4104800|NCT00966875|3928580|B4|Poland||Region of Enrollment||participants|Number|7|7.0||||||
4104801|NCT00966875|3928581|B3|Poland||Region of Enrollment||participants|Number|8|8.0||||||
4104802|NCT00966875|3928582|B2|Poland||Region of Enrollment||participants|Number|8|8.0||||||
4104803|NCT00966875|3928583|B1|Poland||Region of Enrollment||participants|Number|11|11.0||||||
4104804|NCT00966875|3928574|B10|Argentina||Region of Enrollment||participants|Number|34|34.0||||||
4104805|NCT00966875|3928575|B9|Argentina||Region of Enrollment||participants|Number|10|10.0||||||
4104806|NCT00966875|3928576|B8|Argentina||Region of Enrollment||participants|Number|11|11.0||||||
4104807|NCT00966875|3928577|B7|Argentina||Region of Enrollment||participants|Number|10|10.0||||||
4104808|NCT00966875|3928578|B6|Argentina||Region of Enrollment||participants|Number|0|0.0||||||
4104809|NCT00966875|3928579|B5|Argentina||Region of Enrollment||participants|Number|1|1.0||||||
4104810|NCT00966875|3928580|B4|Argentina||Region of Enrollment||participants|Number|1|1.0||||||
4104811|NCT00966875|3928581|B3|Argentina||Region of Enrollment||participants|Number|0|0.0||||||
4104812|NCT00966875|3928582|B2|Argentina||Region of Enrollment||participants|Number|0|0.0||||||
4104813|NCT00966875|3928583|B1|Argentina||Region of Enrollment||participants|Number|1|1.0||||||
4104814|NCT00966875|3928574|B10|Taiwan||Region of Enrollment||participants|Number|26|26.0||||||
4104815|NCT00966875|3928575|B9|Taiwan||Region of Enrollment||participants|Number|1|1.0||||||
4104816|NCT00966875|3928576|B8|Taiwan||Region of Enrollment||participants|Number|1|1.0||||||
4104817|NCT00966875|3928577|B7|Taiwan||Region of Enrollment||participants|Number|1|1.0||||||
4104818|NCT00966875|3928578|B6|Taiwan||Region of Enrollment||participants|Number|3|3.0||||||
4104819|NCT00966875|3928579|B5|Taiwan||Region of Enrollment||participants|Number|4|4.0||||||
4104820|NCT00966875|3928580|B4|Taiwan||Region of Enrollment||participants|Number|4|4.0||||||
4104821|NCT00966875|3928581|B3|Taiwan||Region of Enrollment||participants|Number|3|3.0||||||
4104822|NCT00966875|3928582|B2|Taiwan||Region of Enrollment||participants|Number|4|4.0||||||
4104823|NCT00966875|3928583|B1|Taiwan||Region of Enrollment||participants|Number|5|5.0||||||
4104824|NCT00966875|3928574|B10|United States||Region of Enrollment||participants|Number|154|154.0||||||
4104825|NCT00966875|3928575|B9|United States||Region of Enrollment||participants|Number|31|31.0||||||
4104826|NCT00966875|3928576|B8|United States||Region of Enrollment||participants|Number|32|32.0||||||
4104827|NCT00966875|3928577|B7|United States||Region of Enrollment||participants|Number|33|33.0||||||
4104828|NCT00966875|3928578|B6|United States||Region of Enrollment||participants|Number|9|9.0||||||
4104829|NCT00966875|3928579|B5|United States||Region of Enrollment||participants|Number|12|12.0||||||
4104830|NCT00966875|3928580|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
4104831|NCT00966875|3928581|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4104832|NCT00966875|3928582|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4104833|NCT00966875|3928583|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4104834|NCT00966875|3928574|B10||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104835|NCT00966875|3928575|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104836|NCT00966875|3928576|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104837|NCT00966875|3928577|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104838|NCT00966875|3928578|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104839|NCT00966875|3928579|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104840|NCT00966875|3928580|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104841|NCT00966875|3928581|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104842|NCT00966875|3928582|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104843|NCT00966875|3928583|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104844|NCT00966875|3928574|B10||More than one race|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4104845|NCT00966875|3928575|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104846|NCT00966875|3928576|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4104847|NCT00966875|3928577|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4104848|NCT00966875|3928578|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104849|NCT00966875|3928579|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4104850|NCT00966875|3928580|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4104851|NCT00966875|3928581|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4104852|NCT00966875|3928582|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4104853|NCT00966875|3928583|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4104854|NCT00966875|3928574|B10||White|Race (NIH/OMB)||Participants|Count of Participants|305|305.0||||||
4104855|NCT00966875|3928575|B9||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4104856|NCT00966875|3928576|B8||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4104857|NCT00966875|3928577|B7||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4104858|NCT00966875|3928578|B6||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4104859|NCT00966875|3928579|B5||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4104860|NCT00966875|3928580|B4||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4104861|NCT00966875|3928581|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4104862|NCT00966875|3928582|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4104863|NCT00966875|3928583|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4104864|NCT00966875|3928574|B10||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4104865|NCT00966875|3928575|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4104866|NCT00966875|3928576|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4104867|NCT00966875|3928577|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4104868|NCT00966875|3928578|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4104869|NCT00966875|3928579|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4104870|NCT00966875|3928580|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4104871|NCT00966875|3928581|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104872|NCT00966875|3928582|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4104873|NCT00966875|3928583|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4104874|NCT00966875|3928574|B10||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104875|NCT00966875|3928575|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104876|NCT00966875|3928576|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104877|NCT00966875|3928577|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104878|NCT00966875|3928578|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104879|NCT00966875|3928579|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104880|NCT00966875|3928580|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104935|NCT00966875|3928575|B9||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4104881|NCT00966875|3928581|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104882|NCT00966875|3928582|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104883|NCT00966875|3928583|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104884|NCT00966875|3928574|B10||Asian|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
4104885|NCT00966875|3928575|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4104886|NCT00966875|3928576|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4104887|NCT00966875|3928577|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4104888|NCT00966875|3928578|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4104889|NCT00966875|3928579|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4104890|NCT00966875|3928580|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4104891|NCT00966875|3928581|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4104892|NCT00966875|3928582|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4104893|NCT00966875|3928583|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4104894|NCT00966875|3928574|B10||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4104895|NCT00966875|3928575|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4104896|NCT00966875|3928576|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104897|NCT00966875|3928577|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104898|NCT00966875|3928578|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4104899|NCT00966875|3928579|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4104900|NCT00966875|3928580|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4104901|NCT00966875|3928581|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4104902|NCT00966875|3928582|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4104903|NCT00966875|3928583|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4104904|NCT00966875|3928574|B10||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4104905|NCT00966875|3928575|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4104906|NCT00966875|3928576|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4104907|NCT00966875|3928577|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4104908|NCT00966875|3928578|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4104909|NCT00966875|3928579|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4104910|NCT00966875|3928580|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4104911|NCT00966875|3928581|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4104912|NCT00966875|3928582|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4104913|NCT00966875|3928583|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4104914|NCT00966875|3928574|B10||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|338|338.0||||||
4104915|NCT00966875|3928575|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4104916|NCT00966875|3928576|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4104917|NCT00966875|3928577|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4104918|NCT00966875|3928578|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4104919|NCT00966875|3928579|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4104920|NCT00966875|3928580|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4104921|NCT00966875|3928581|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4104922|NCT00966875|3928582|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4104923|NCT00966875|3928583|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4104924|NCT00966875|3928574|B10||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
4104925|NCT00966875|3928575|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4104926|NCT00966875|3928576|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4104927|NCT00966875|3928577|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4104928|NCT00966875|3928578|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4104929|NCT00966875|3928579|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4104930|NCT00966875|3928580|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4104931|NCT00966875|3928581|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4104932|NCT00966875|3928582|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4104933|NCT00966875|3928583|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4104934|NCT00966875|3928574|B10||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4104936|NCT00966875|3928576|B8||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4104937|NCT00966875|3928577|B7||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4104938|NCT00966875|3928578|B6||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4104939|NCT00966875|3928579|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4104940|NCT00966875|3928580|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4104941|NCT00966875|3928581|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4104942|NCT00966875|3928582|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4104943|NCT00966875|3928583|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4104944|NCT00966875|3928574|B10||Female|Sex: Female, Male||Participants|Count of Participants|383|383.0||||||
4104945|NCT00966875|3928575|B9||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4104946|NCT00966875|3928576|B8||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4104947|NCT00966875|3928577|B7||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4104948|NCT00966875|3928578|B6||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4104949|NCT00966875|3928579|B5||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4104950|NCT00966875|3928580|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4104951|NCT00966875|3928581|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4104952|NCT00966875|3928582|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4104953|NCT00966875|3928583|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4104954|NCT00966875|3928574|B10|||Age||years|Mean|53.08|53.08|Standard Deviation|10.61|10.61|||
4104955|NCT00966875|3928575|B9|||Age||years|Mean|52.43|52.43|Standard Deviation|9.90|9.9|||
4104956|NCT00966875|3928576|B8|||Age||years|Mean|54.74|54.74|Standard Deviation|11.12|11.12|||
4104957|NCT00966875|3928577|B7|||Age||years|Mean|53.19|53.19|Standard Deviation|10.44|10.44|||
4104958|NCT00966875|3928578|B6|||Age||years|Mean|52.21|52.21|Standard Deviation|11.33|11.33|||
4104959|NCT00966875|3928579|B5|||Age||years|Mean|52.60|52.6|Standard Deviation|10.91|10.91|||
4104960|NCT00966875|3928580|B4|||Age||years|Mean|53.03|53.03|Standard Deviation|12.16|12.16|||
4104961|NCT00966875|3928581|B3|||Age||years|Mean|53.86|53.86|Standard Deviation|10.62|10.62|||
4104962|NCT00966875|3928582|B2|||Age||years|Mean|52.19|52.19|Standard Deviation|9.67|9.67|||
4104963|NCT00966875|3928583|B1|||Age||years|Mean|52.99|52.99|Standard Deviation|10.18|10.18|||
4104964|NCT00966875|3928574|B10||>=65 years|Age||Participants|Count of Participants|61|61.0||||||
4104965|NCT00966875|3928575|B9||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4104966|NCT00966875|3928576|B8||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4104967|NCT00966875|3928577|B7||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4104968|NCT00966875|3928578|B6||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4104969|NCT00966875|3928579|B5||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4104970|NCT00966875|3928580|B4||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4104971|NCT00966875|3928581|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4104972|NCT00966875|3928582|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4104973|NCT00966875|3928583|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4104974|NCT00966875|3928574|B10||Between 18 and 65 years|Age||Participants|Count of Participants|387|387.0||||||
4104975|NCT00966875|3928575|B9||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4104976|NCT00966875|3928576|B8||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4104977|NCT00966875|3928577|B7||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4104978|NCT00966875|3928578|B6||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4104979|NCT00966875|3928579|B5||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4104980|NCT00966875|3928580|B4||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4104981|NCT00966875|3928581|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4104982|NCT00966875|3928582|B2||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4104983|NCT00966875|3928583|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4104984|NCT00966875|3928574|B10||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4104985|NCT00966875|3928575|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4104986|NCT00966875|3928576|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4104987|NCT00966875|3928577|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4104988|NCT00966875|3928578|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4104989|NCT00966875|3928579|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4104990|NCT00966875|3928580|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4104991|NCT00966875|3928581|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4104992|NCT00966875|3928582|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4104993|NCT00966875|3928583|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4104994|NCT00966823|3928910|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4104995|NCT00966823|3928910|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4104996|NCT00966823|3928910|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4104997|NCT00966823|3928910|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4104998|NCT00966823|3928910|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4104999|NCT00966823|3928910|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105000|NCT00966654|3928918|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4105001|NCT00966654|3928918|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4105002|NCT00966654|3928918|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4105003|NCT00966654|3928918|B1|Age, years (18-75)||Age, Customized||participants|Number|12|12.0||||||
4105004|NCT00966641|3928926|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4105005|NCT00966641|3928926|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4105006|NCT00966641|3928926|B1|||Age||years|Mean|38.2|38.2|Standard Deviation|12.43|12.43|||
4105007|NCT00966550|3928933|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4105008|NCT00966550|3928934|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4105009|NCT00966550|3928935|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4105010|NCT00966550|3928933|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4105011|NCT00966550|3928934|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4105012|NCT00966550|3928935|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4105013|NCT00966550|3928933|B3|||Age||years|Mean|27|27.0|Standard Deviation|8|8.0|||
4105014|NCT00966550|3928934|B2|||Age||years|Mean|28.7|28.7|Standard Deviation|10.7|10.7|||
4105015|NCT00966550|3928935|B1|||Age||years|Mean|24.9|24.9|Standard Deviation|5|5.0|||
4105016|NCT00966446|3928942|B4|United States||Region of Enrollment||participants|Number|223|223.0||||||
4105017|NCT00966446|3928943|B3|United States||Region of Enrollment||participants|Number|73|73.0||||||
4105018|NCT00966446|3928944|B2|United States||Region of Enrollment||participants|Number|74|74.0||||||
4105019|NCT00966446|3928945|B1|United States||Region of Enrollment||participants|Number|76|76.0||||||
4105020|NCT00966446|3928942|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4105021|NCT00966446|3928943|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4105022|NCT00966446|3928944|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4105023|NCT00966446|3928945|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4105024|NCT00966446|3928942|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4105025|NCT00966446|3928943|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4105026|NCT00966446|3928944|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4105027|NCT00966446|3928945|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4105028|NCT00966446|3928942|B4||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4105029|NCT00966446|3928943|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4105030|NCT00966446|3928944|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4105031|NCT00966446|3928945|B1||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4105032|NCT00966446|3928942|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|135|135.0||||||
4105033|NCT00966446|3928943|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4105034|NCT00966446|3928944|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4105035|NCT00966446|3928945|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4105036|NCT00966446|3928942|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4105037|NCT00966446|3928943|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4105038|NCT00966446|3928944|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4105039|NCT00966446|3928945|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4105040|NCT00966446|3928942|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4105041|NCT00966446|3928943|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4105042|NCT00966446|3928944|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4105043|NCT00966446|3928945|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4105044|NCT00966446|3928942|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4105045|NCT00966446|3928943|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4105046|NCT00966446|3928944|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4105047|NCT00966446|3928945|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4105048|NCT00966446|3928942|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4105049|NCT00966446|3928943|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4105050|NCT00966446|3928944|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4105051|NCT00966446|3928945|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4105052|NCT00966446|3928942|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|203|203.0||||||
4105053|NCT00966446|3928943|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4105054|NCT00966446|3928944|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4105055|NCT00966446|3928945|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4105112|NCT00966355|3928989|B4|||Age||years|Mean|53.3|53.3|Standard Deviation|9.6|9.6|||
4105056|NCT00966446|3928942|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4105057|NCT00966446|3928943|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4105058|NCT00966446|3928944|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4105059|NCT00966446|3928945|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4105060|NCT00966446|3928942|B4||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4105061|NCT00966446|3928943|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4105062|NCT00966446|3928944|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4105063|NCT00966446|3928945|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4105064|NCT00966446|3928942|B4||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4105065|NCT00966446|3928943|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4105066|NCT00966446|3928944|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4105067|NCT00966446|3928945|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4105068|NCT00966446|3928942|B4||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4105069|NCT00966446|3928943|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4105070|NCT00966446|3928944|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4105071|NCT00966446|3928945|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4105072|NCT00966446|3928942|B4||Between 18 and 65 years|Age||Participants|Count of Participants|106|106.0||||||
4105073|NCT00966446|3928943|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4105074|NCT00966446|3928944|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4105075|NCT00966446|3928945|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4105076|NCT00966446|3928942|B4||<=18 years|Age||Participants|Count of Participants|110|110.0||||||
4105077|NCT00966446|3928943|B3||<=18 years|Age||Participants|Count of Participants|38|38.0||||||
4105078|NCT00966446|3928944|B2||<=18 years|Age||Participants|Count of Participants|37|37.0||||||
4105079|NCT00966446|3928945|B1||<=18 years|Age||Participants|Count of Participants|35|35.0||||||
4105080|NCT00966433|3928961|B4||II|ASA Status|A grade I is a normal healthy patient and a grade II is a patient with severe systemic disease|Participants|Count of Participants|5|5.0||||||
4105081|NCT00966433|3928962|B3||II|ASA Status|A grade I is a normal healthy patient and a grade II is a patient with severe systemic disease|Participants|Count of Participants|2|2.0||||||
4105082|NCT00966433|3928963|B2||II|ASA Status|A grade I is a normal healthy patient and a grade II is a patient with severe systemic disease|Participants|Count of Participants|2|2.0||||||
4105083|NCT00966433|3928964|B1||II|ASA Status|A grade I is a normal healthy patient and a grade II is a patient with severe systemic disease|Participants|Count of Participants|1|1.0||||||
4105084|NCT00966433|3928961|B4||I|ASA Status|A grade I is a normal healthy patient and a grade II is a patient with severe systemic disease|Participants|Count of Participants|26|26.0||||||
4105085|NCT00966433|3928962|B3||I|ASA Status|A grade I is a normal healthy patient and a grade II is a patient with severe systemic disease|Participants|Count of Participants|9|9.0||||||
4105086|NCT00966433|3928963|B2||I|ASA Status|A grade I is a normal healthy patient and a grade II is a patient with severe systemic disease|Participants|Count of Participants|8|8.0||||||
4105087|NCT00966433|3928964|B1||I|ASA Status|A grade I is a normal healthy patient and a grade II is a patient with severe systemic disease|Participants|Count of Participants|9|9.0||||||
4105088|NCT00966433|3928961|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4105089|NCT00966433|3928962|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4105090|NCT00966433|3928963|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4105091|NCT00966433|3928964|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4105092|NCT00966433|3928961|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4105093|NCT00966433|3928962|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4105094|NCT00966433|3928963|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4105095|NCT00966433|3928964|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4105096|NCT00966433|3928961|B4|||Age||Months|Mean|28.9|28.9|Standard Deviation|17.01|17.01|||
4105097|NCT00966433|3928962|B3|||Age||Months|Mean|27|27.0|Standard Deviation|16|16.0|||
4105098|NCT00966433|3928963|B2|||Age||Months|Mean|32|32.0|Standard Deviation|17|17.0|||
4105099|NCT00966433|3928964|B1|||Age||Months|Mean|28|28.0|Standard Deviation|18|18.0|||
4105100|NCT00966355|3928989|B4|Korea, Republic of||Region of Enrollment||participants|Number|780|780.0||||||
4105101|NCT00966355|3928990|B3|Korea, Republic of||Region of Enrollment||participants|Number|261|261.0||||||
4105102|NCT00966355|3928991|B2|Korea, Republic of||Region of Enrollment||participants|Number|259|259.0||||||
4105103|NCT00966355|3928992|B1|Korea, Republic of||Region of Enrollment||participants|Number|260|260.0||||||
4105104|NCT00966355|3928989|B4||Male|Sex: Female, Male||Participants|Count of Participants|666|666.0||||||
4105105|NCT00966355|3928990|B3||Male|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4105106|NCT00966355|3928991|B2||Male|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4105107|NCT00966355|3928992|B1||Male|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
4105108|NCT00966355|3928989|B4||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4105109|NCT00966355|3928990|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4105110|NCT00966355|3928991|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4105111|NCT00966355|3928992|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4105113|NCT00966355|3928990|B3|||Age||years|Mean|52.9|52.9|Standard Deviation|9.2|9.2|||
4105114|NCT00966355|3928991|B2|||Age||years|Mean|53.1|53.1|Standard Deviation|9.7|9.7|||
4105115|NCT00966355|3928992|B1|||Age||years|Mean|53.8|53.8|Standard Deviation|10.0|10.0|||
4105116|NCT00966355|3928989|B4||>=65 years|Age||Participants|Count of Participants|119|119.0||||||
4105117|NCT00966355|3928990|B3||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4105118|NCT00966355|3928991|B2||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
4105119|NCT00966355|3928992|B1||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
4105120|NCT00966355|3928989|B4||Between 18 and 65 years|Age||Participants|Count of Participants|661|661.0||||||
4105121|NCT00966355|3928990|B3||Between 18 and 65 years|Age||Participants|Count of Participants|223|223.0||||||
4105122|NCT00966355|3928991|B2||Between 18 and 65 years|Age||Participants|Count of Participants|218|218.0||||||
4105123|NCT00966355|3928992|B1||Between 18 and 65 years|Age||Participants|Count of Participants|220|220.0||||||
4105124|NCT00966355|3928989|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105125|NCT00966355|3928990|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105126|NCT00966355|3928991|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105127|NCT00966355|3928992|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105128|NCT00966277|3929005|B3|United States||Region of Enrollment||participants|Number|75|75.0||||||
4105129|NCT00966277|3929006|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4105130|NCT00966277|3929007|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4105131|NCT00966277|3929005|B3|Unknown or Unreported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4105132|NCT00966277|3929006|B2|Unknown or Unreported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4105133|NCT00966277|3929007|B1|Unknown or Unreported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4105134|NCT00966277|3929005|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4105135|NCT00966277|3929006|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4105136|NCT00966277|3929007|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4105137|NCT00966277|3929005|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4105138|NCT00966277|3929006|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4105139|NCT00966277|3929007|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4105140|NCT00966277|3929005|B3|Causacian||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
4105141|NCT00966277|3929006|B2|Causacian||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4105142|NCT00966277|3929007|B1|Causacian||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4105143|NCT00966277|3929005|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4105144|NCT00966277|3929006|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4105145|NCT00966277|3929007|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4105146|NCT00966277|3929005|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4105147|NCT00966277|3929006|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4105148|NCT00966277|3929007|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4105149|NCT00966277|3929005|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4105150|NCT00966277|3929006|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4105151|NCT00966277|3929007|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4105152|NCT00966277|3929005|B3|>=60||Age, Customized||years|Number|44|44.0||||||
4105153|NCT00966277|3929006|B2|>=60||Age, Customized||years|Number|27|27.0||||||
4105154|NCT00966277|3929007|B1|>=60||Age, Customized||years|Number|17|17.0||||||
4105155|NCT00966277|3929005|B3|<60||Age, Customized||years|Number|31|31.0||||||
4105156|NCT00966277|3929006|B2|<60||Age, Customized||years|Number|10|10.0||||||
4105157|NCT00966277|3929007|B1|<60||Age, Customized||years|Number|21|21.0||||||
4105158|NCT00966277|3929005|B3|||Age||years|Mean|61.5|61.5|Full Range|||36.0|77.0|
4105159|NCT00966277|3929006|B2|||Age||years|Mean|64|64.0|Full Range|||38.0|77.0|
4105160|NCT00966277|3929007|B1|||Age||years|Mean|59|59.0|Full Range|||36.0|75.0|
4105161|NCT00966264|3929014|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4105162|NCT00966264|3929015|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4105163|NCT00966264|3929016|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4105164|NCT00966264|3929014|B3||Female|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
4105165|NCT00966264|3929015|B2||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4105166|NCT00966264|3929016|B1||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4105167|NCT00966264|3929014|B3|||Age||years|Mean|43|43.0|Standard Deviation|3.3|3.3|||
4105168|NCT00966264|3929015|B2|||Age||years|Mean|43.0|43.0|Standard Deviation|3.2|3.2|||
4105169|NCT00966264|3929016|B1|||Age||years|Mean|43.1|43.1|Standard Deviation|3.5|3.5|||
4105170|NCT00966264|3929014|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4105171|NCT00966264|3929015|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4105172|NCT00966264|3929016|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4105173|NCT00966264|3929014|B3||Between 18 and 65 years|Age||Participants|Count of Participants|236|236.0||||||
4105174|NCT00966264|3929015|B2||Between 18 and 65 years|Age||Participants|Count of Participants|117|117.0||||||
4105175|NCT00966264|3929016|B1||Between 18 and 65 years|Age||Participants|Count of Participants|119|119.0||||||
4105176|NCT00966264|3929014|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105177|NCT00966264|3929015|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105178|NCT00966264|3929016|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105179|NCT00966238|3929023|B7||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4105180|NCT00966238|3929024|B6||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4105181|NCT00966238|3929025|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4105182|NCT00966238|3929026|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4105183|NCT00966238|3929027|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4105184|NCT00966238|3929028|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4105185|NCT00966238|3929029|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4105186|NCT00966238|3929023|B7||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4105187|NCT00966238|3929024|B6||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4105188|NCT00966238|3929025|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4105189|NCT00966238|3929026|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4105190|NCT00966238|3929027|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4105191|NCT00966238|3929028|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4105192|NCT00966238|3929029|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4105193|NCT00966238|3929023|B7|||Age||years|Mean|71.5|71.5|Standard Deviation|4.71|4.71|||
4105194|NCT00966238|3929024|B6|||Age||years|Mean|70.6|70.6|Standard Deviation|4.91|4.91|||
4105195|NCT00966238|3929025|B5|||Age||years|Mean|70.7|70.7|Standard Deviation|4.07|4.07|||
4105196|NCT00966238|3929026|B4|||Age||years|Mean|71.9|71.9|Standard Deviation|4.28|4.28|||
4105197|NCT00966238|3929027|B3|||Age||years|Mean|71.7|71.7|Standard Deviation|4.16|4.16|||
4105198|NCT00966238|3929028|B2|||Age||years|Mean|71.2|71.2|Standard Deviation|4.65|4.65|||
4105199|NCT00966238|3929029|B1|||Age||years|Mean|72.8|72.8|Standard Deviation|6.12|6.12|||
4105200|NCT00966238|3929023|B7||>=65 years|Age||Participants|Count of Participants|120|120.0||||||
4105201|NCT00966238|3929024|B6||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4105202|NCT00966238|3929025|B5||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4105203|NCT00966238|3929026|B4||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4105204|NCT00966238|3929027|B3||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4105205|NCT00966238|3929028|B2||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4105206|NCT00966238|3929029|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4105207|NCT00966238|3929023|B7||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4105208|NCT00966238|3929024|B6||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4105209|NCT00966238|3929025|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4105210|NCT00966238|3929026|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4105211|NCT00966238|3929027|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4105212|NCT00966238|3929028|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4105213|NCT00966238|3929029|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4105214|NCT00966238|3929023|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105215|NCT00966238|3929024|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105216|NCT00966238|3929025|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105217|NCT00966238|3929026|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105218|NCT00966238|3929027|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105219|NCT00966238|3929028|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105220|NCT00966238|3929029|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105221|NCT00966186|3929054|B3|Korea, Republic of||Region of Enrollment||participants|Number|120|120.0||||||
4105222|NCT00966186|3929055|B2|Korea, Republic of||Region of Enrollment||participants|Number|60|60.0||||||
4105223|NCT00966186|3929056|B1|Korea, Republic of||Region of Enrollment||participants|Number|60|60.0||||||
4105224|NCT00966186|3929054|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4105225|NCT00966186|3929055|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4105226|NCT00966186|3929056|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4105227|NCT00966186|3929054|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4105228|NCT00966186|3929055|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4105229|NCT00966186|3929056|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4105230|NCT00966186|3929054|B3|||Age||years|Mean|48.5|48.5|Standard Deviation|11.8|11.8|||
4105231|NCT00966186|3929055|B2|||Age||years|Mean|47.4|47.4|Standard Deviation|10.7|10.7|||
4105232|NCT00966186|3929056|B1|||Age||years|Mean|49.6|49.6|Standard Deviation|12.9|12.9|||
4105233|NCT00966186|3929054|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4105234|NCT00966186|3929055|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4105235|NCT00966186|3929056|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4105236|NCT00966186|3929054|B3||Between 18 and 65 years|Age||Participants|Count of Participants|108|108.0||||||
4105237|NCT00966186|3929055|B2||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4105238|NCT00966186|3929056|B1||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4105239|NCT00966186|3929054|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105240|NCT00966186|3929055|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105241|NCT00966186|3929056|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105242|NCT00965848|3929063|B1||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4105243|NCT00965848|3929063|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4105244|NCT00965848|3929063|B1|||Age||Years|Mean|64.6|64.6|Standard Deviation|16.5|16.5|||
4105245|NCT00965757|3929082|B3|||Duration of Rheumatoid Arthritis||Months|Mean|52.6|52.6|Standard Deviation|34.6|34.6|||
4105246|NCT00965757|3929083|B2|||Duration of Rheumatoid Arthritis||Months|Mean|50.3|50.3|Standard Deviation|34|34.0|||
4105247|NCT00965757|3929084|B1|||Duration of Rheumatoid Arthritis||Months|Mean|53.8|53.8|Standard Deviation|35|35.0|||
4105248|NCT00965757|3929082|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4105249|NCT00965757|3929083|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4105250|NCT00965757|3929084|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4105251|NCT00965757|3929082|B3||Female|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4105252|NCT00965757|3929083|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4105253|NCT00965757|3929084|B1||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4105254|NCT00965757|3929082|B3|||Age||Years|Mean|54.3|54.3|Standard Deviation|10|10.0|||
4105255|NCT00965757|3929083|B2|||Age||Years|Mean|53.5|53.5|Standard Deviation|10|10.0|||
4105256|NCT00965757|3929084|B1|||Age||Years|Mean|54.8|54.8|Standard Deviation|9.9|9.9|||
4105257|NCT00965731|3929119|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4105258|NCT00965731|3929120|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4105259|NCT00965731|3929121|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4105260|NCT00965731|3929119|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4105261|NCT00965731|3929120|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4105262|NCT00965731|3929121|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4105263|NCT00965731|3929119|B3|greater than or equal to (≥) 65||Age, Customized||participants|Number|10|10.0||||||
4105264|NCT00965731|3929120|B2|greater than or equal to (≥) 65||Age, Customized||participants|Number|9|9.0||||||
4105265|NCT00965731|3929121|B1|greater than or equal to (≥) 65||Age, Customized||participants|Number|1|1.0||||||
4105266|NCT00965731|3929119|B3|45 to 64 years||Age, Customized||participants|Number|16|16.0||||||
4105267|NCT00965731|3929120|B2|45 to 64 years||Age, Customized||participants|Number|11|11.0||||||
4105268|NCT00965731|3929121|B1|45 to 64 years||Age, Customized||participants|Number|5|5.0||||||
4105269|NCT00965731|3929119|B3|18 to 44 years||Age, Customized||participants|Number|1|1.0||||||
4105270|NCT00965731|3929120|B2|18 to 44 years||Age, Customized||participants|Number|0|0.0||||||
4105271|NCT00965731|3929121|B1|18 to 44 years||Age, Customized||participants|Number|1|1.0||||||
4105272|NCT00965718|3929186|B1|Lymph node||Site of metastasis||participants|Number|5|5.0||||||
4105273|NCT00965718|3929186|B1|Lung||Site of metastasis||participants|Number|6|6.0||||||
4105274|NCT00965718|3929186|B1|Liver||Site of metastasis||participants|Number|9|9.0||||||
4105275|NCT00965718|3929186|B1|||Period of prior chemotherapy||months|Median|5.2|5.2|Full Range|||2.0|13.9|
4105276|NCT00965718|3929186|B1|||Duration since diagnosis||months|Median|9.2|9.2|Full Range|||3.8|94.6|
4105277|NCT00965718|3929186|B1|2||ECOG-PS|"Eastern Cooperative Oncology Group performance status (ECOG-PS) is used by researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.~0-Fully active, able to carry on all pre-disease performance without restriction 1-Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature 2-Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours"|participants|Number|1|1.0||||||
4105278|NCT00965718|3929186|B1|1||ECOG-PS|"Eastern Cooperative Oncology Group performance status (ECOG-PS) is used by researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.~0-Fully active, able to carry on all pre-disease performance without restriction 1-Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature 2-Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours"|participants|Number|7|7.0||||||
4105279|NCT00965718|3929186|B1|0||ECOG-PS|"Eastern Cooperative Oncology Group performance status (ECOG-PS) is used by researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.~0-Fully active, able to carry on all pre-disease performance without restriction 1-Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature 2-Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours"|participants|Number|12|12.0||||||
4105280|NCT00965718|3929186|B1|Korea, Republic of||Region of Enrollment||participants|Number|20|20.0||||||
4105281|NCT00965718|3929186|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4105282|NCT00965718|3929186|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4105283|NCT00965718|3929186|B1|||Age||years|Median|59.2|59.2|Full Range|||41.0|69.0|
4105312|NCT00965562|3929196|B4|||Ever spoken to a doctor about PMS|PMS= premenstrual syndrome. Only participants who indicated that they had spoken to a doctor about their PMS were included in this affirmative measure.|participants|Number|15|15.0||||||
4105370|NCT00965562|3929198|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4105371|NCT00965562|3929199|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4105284|NCT00965562|3929196|B4|Clinical Global Impression - Severity (CGI-S)||Baseline Symptom Scores|IDS= sum of responses to 28 of 30 possible items each scored 0 to 3 points (0=least severe 84= most severe); PMTS= total score 10 items, each with 4 points (0 is no symptom and 40 total = most severe); CGI-S= illness severity (1=normal 7=among most critically ill) . The IDS, PMTS, and CGI-S were scored on the basis of severity during the prior premenstrual phase. DRSP= 21 items each with scale (1=no symptom 6=extreme); The DRSP score was generated by subtracting average follicular phase severity from average luteal phase severity, and averaging these phase change means across symptoms.|units on a scale|Mean|4.51|4.51|Standard Deviation|0.68|0.68|||
4105285|NCT00965562|3929197|B3|Clinical Global Impression - Severity (CGI-S)||Baseline Symptom Scores|IDS= sum of responses to 28 of 30 possible items each scored 0 to 3 points (0=least severe 84= most severe); PMTS= total score 10 items, each with 4 points (0 is no symptom and 40 total = most severe); CGI-S= illness severity (1=normal 7=among most critically ill) . The IDS, PMTS, and CGI-S were scored on the basis of severity during the prior premenstrual phase. DRSP= 21 items each with scale (1=no symptom 6=extreme); The DRSP score was generated by subtracting average follicular phase severity from average luteal phase severity, and averaging these phase change means across symptoms.|units on a scale|Mean|4.15|4.15|Standard Deviation|1.28|1.28|||
4105286|NCT00965562|3929198|B2|Clinical Global Impression - Severity (CGI-S)||Baseline Symptom Scores|IDS= sum of responses to 28 of 30 possible items each scored 0 to 3 points (0=least severe 84= most severe); PMTS= total score 10 items, each with 4 points (0 is no symptom and 40 total = most severe); CGI-S= illness severity (1=normal 7=among most critically ill) . The IDS, PMTS, and CGI-S were scored on the basis of severity during the prior premenstrual phase. DRSP= 21 items each with scale (1=no symptom 6=extreme); The DRSP score was generated by subtracting average follicular phase severity from average luteal phase severity, and averaging these phase change means across symptoms.|units on a scale|Mean|4.46|4.46|Standard Deviation|1.27|1.27|||
4105287|NCT00965562|3929199|B1|Clinical Global Impression - Severity (CGI-S)||Baseline Symptom Scores|IDS= sum of responses to 28 of 30 possible items each scored 0 to 3 points (0=least severe 84= most severe); PMTS= total score 10 items, each with 4 points (0 is no symptom and 40 total = most severe); CGI-S= illness severity (1=normal 7=among most critically ill) . The IDS, PMTS, and CGI-S were scored on the basis of severity during the prior premenstrual phase. DRSP= 21 items each with scale (1=no symptom 6=extreme); The DRSP score was generated by subtracting average follicular phase severity from average luteal phase severity, and averaging these phase change means across symptoms.|units on a scale|Mean|4.92|4.92|Standard Deviation|0.95|0.95|||
4105288|NCT00965562|3929196|B4|Daily Record of Severity of Problems (DRSP)||Baseline Symptom Scores|IDS= sum of responses to 28 of 30 possible items each scored 0 to 3 points (0=least severe 84= most severe); PMTS= total score 10 items, each with 4 points (0 is no symptom and 40 total = most severe); CGI-S= illness severity (1=normal 7=among most critically ill) . The IDS, PMTS, and CGI-S were scored on the basis of severity during the prior premenstrual phase. DRSP= 21 items each with scale (1=no symptom 6=extreme); The DRSP score was generated by subtracting average follicular phase severity from average luteal phase severity, and averaging these phase change means across symptoms.|units on a scale|Mean|1.52|1.52|Standard Deviation|0.37|0.37|||
4105289|NCT00965562|3929197|B3|Daily Record of Severity of Problems (DRSP)||Baseline Symptom Scores|IDS= sum of responses to 28 of 30 possible items each scored 0 to 3 points (0=least severe 84= most severe); PMTS= total score 10 items, each with 4 points (0 is no symptom and 40 total = most severe); CGI-S= illness severity (1=normal 7=among most critically ill) . The IDS, PMTS, and CGI-S were scored on the basis of severity during the prior premenstrual phase. DRSP= 21 items each with scale (1=no symptom 6=extreme); The DRSP score was generated by subtracting average follicular phase severity from average luteal phase severity, and averaging these phase change means across symptoms.|units on a scale|Mean|1.29|1.29|Standard Deviation|0.60|0.6|||
4105290|NCT00965562|3929198|B2|Daily Record of Severity of Problems (DRSP)||Baseline Symptom Scores|IDS= sum of responses to 28 of 30 possible items each scored 0 to 3 points (0=least severe 84= most severe); PMTS= total score 10 items, each with 4 points (0 is no symptom and 40 total = most severe); CGI-S= illness severity (1=normal 7=among most critically ill) . The IDS, PMTS, and CGI-S were scored on the basis of severity during the prior premenstrual phase. DRSP= 21 items each with scale (1=no symptom 6=extreme); The DRSP score was generated by subtracting average follicular phase severity from average luteal phase severity, and averaging these phase change means across symptoms.|units on a scale|Mean|1.12|1.12|Standard Deviation|0.38|0.38|||
4105291|NCT00965562|3929199|B1|Daily Record of Severity of Problems (DRSP)||Baseline Symptom Scores|IDS= sum of responses to 28 of 30 possible items each scored 0 to 3 points (0=least severe 84= most severe); PMTS= total score 10 items, each with 4 points (0 is no symptom and 40 total = most severe); CGI-S= illness severity (1=normal 7=among most critically ill) . The IDS, PMTS, and CGI-S were scored on the basis of severity during the prior premenstrual phase. DRSP= 21 items each with scale (1=no symptom 6=extreme); The DRSP score was generated by subtracting average follicular phase severity from average luteal phase severity, and averaging these phase change means across symptoms.|units on a scale|Mean|2.16|2.16|Standard Deviation|0.86|0.86|||
4105292|NCT00965562|3929196|B4|Premenstrual Tension Syndrome-Observer (PMTS-O)||Baseline Symptom Scores|IDS= sum of responses to 28 of 30 possible items each scored 0 to 3 points (0=least severe 84= most severe); PMTS= total score 10 items, each with 4 points (0 is no symptom and 40 total = most severe); CGI-S= illness severity (1=normal 7=among most critically ill) . The IDS, PMTS, and CGI-S were scored on the basis of severity during the prior premenstrual phase. DRSP= 21 items each with scale (1=no symptom 6=extreme); The DRSP score was generated by subtracting average follicular phase severity from average luteal phase severity, and averaging these phase change means across symptoms.|units on a scale|Mean|22.19|22.19|Standard Deviation|3.11|3.11|||
4105293|NCT00965562|3929197|B3|Premenstrual Tension Syndrome-Observer (PMTS-O)||Baseline Symptom Scores|IDS= sum of responses to 28 of 30 possible items each scored 0 to 3 points (0=least severe 84= most severe); PMTS= total score 10 items, each with 4 points (0 is no symptom and 40 total = most severe); CGI-S= illness severity (1=normal 7=among most critically ill) . The IDS, PMTS, and CGI-S were scored on the basis of severity during the prior premenstrual phase. DRSP= 21 items each with scale (1=no symptom 6=extreme); The DRSP score was generated by subtracting average follicular phase severity from average luteal phase severity, and averaging these phase change means across symptoms.|units on a scale|Mean|20.85|20.85|Standard Deviation|6.62|6.62|||
4105369|NCT00965562|3929197|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4105294|NCT00965562|3929198|B2|Premenstrual Tension Syndrome-Observer (PMTS-O)||Baseline Symptom Scores|IDS= sum of responses to 28 of 30 possible items each scored 0 to 3 points (0=least severe 84= most severe); PMTS= total score 10 items, each with 4 points (0 is no symptom and 40 total = most severe); CGI-S= illness severity (1=normal 7=among most critically ill) . The IDS, PMTS, and CGI-S were scored on the basis of severity during the prior premenstrual phase. DRSP= 21 items each with scale (1=no symptom 6=extreme); The DRSP score was generated by subtracting average follicular phase severity from average luteal phase severity, and averaging these phase change means across symptoms.|units on a scale|Mean|21.58|21.58|Standard Deviation|3.73|3.73|||
4105295|NCT00965562|3929199|B1|Premenstrual Tension Syndrome-Observer (PMTS-O)||Baseline Symptom Scores|IDS= sum of responses to 28 of 30 possible items each scored 0 to 3 points (0=least severe 84= most severe); PMTS= total score 10 items, each with 4 points (0 is no symptom and 40 total = most severe); CGI-S= illness severity (1=normal 7=among most critically ill) . The IDS, PMTS, and CGI-S were scored on the basis of severity during the prior premenstrual phase. DRSP= 21 items each with scale (1=no symptom 6=extreme); The DRSP score was generated by subtracting average follicular phase severity from average luteal phase severity, and averaging these phase change means across symptoms.|units on a scale|Mean|24.15|24.15|Standard Deviation|5.40|5.4|||
4105296|NCT00965562|3929196|B4|Inventory of Depressive Symptomatology (IDS-C30)||Baseline Symptom Scores|IDS= sum of responses to 28 of 30 possible items each scored 0 to 3 points (0=least severe 84= most severe); PMTS= total score 10 items, each with 4 points (0 is no symptom and 40 total = most severe); CGI-S= illness severity (1=normal 7=among most critically ill) . The IDS, PMTS, and CGI-S were scored on the basis of severity during the prior premenstrual phase. DRSP= 21 items each with scale (1=no symptom 6=extreme); The DRSP score was generated by subtracting average follicular phase severity from average luteal phase severity, and averaging these phase change means across symptoms.|units on a scale|Mean|30.54|30.54|Standard Deviation|5.17|5.17|||
4105297|NCT00965562|3929197|B3|Inventory of Depressive Symptomatology (IDS-C30)||Baseline Symptom Scores|IDS= sum of responses to 28 of 30 possible items each scored 0 to 3 points (0=least severe 84= most severe); PMTS= total score 10 items, each with 4 points (0 is no symptom and 40 total = most severe); CGI-S= illness severity (1=normal 7=among most critically ill) . The IDS, PMTS, and CGI-S were scored on the basis of severity during the prior premenstrual phase. DRSP= 21 items each with scale (1=no symptom 6=extreme); The DRSP score was generated by subtracting average follicular phase severity from average luteal phase severity, and averaging these phase change means across symptoms.|units on a scale|Mean|28.85|28.85|Standard Deviation|9.97|9.97|||
4105298|NCT00965562|3929198|B2|Inventory of Depressive Symptomatology (IDS-C30)||Baseline Symptom Scores|IDS= sum of responses to 28 of 30 possible items each scored 0 to 3 points (0=least severe 84= most severe); PMTS= total score 10 items, each with 4 points (0 is no symptom and 40 total = most severe); CGI-S= illness severity (1=normal 7=among most critically ill) . The IDS, PMTS, and CGI-S were scored on the basis of severity during the prior premenstrual phase. DRSP= 21 items each with scale (1=no symptom 6=extreme); The DRSP score was generated by subtracting average follicular phase severity from average luteal phase severity, and averaging these phase change means across symptoms.|units on a scale|Mean|30.92|30.92|Standard Deviation|7.62|7.62|||
4105299|NCT00965562|3929199|B1|Inventory of Depressive Symptomatology (IDS-C30)||Baseline Symptom Scores|IDS= sum of responses to 28 of 30 possible items each scored 0 to 3 points (0=least severe 84= most severe); PMTS= total score 10 items, each with 4 points (0 is no symptom and 40 total = most severe); CGI-S= illness severity (1=normal 7=among most critically ill) . The IDS, PMTS, and CGI-S were scored on the basis of severity during the prior premenstrual phase. DRSP= 21 items each with scale (1=no symptom 6=extreme); The DRSP score was generated by subtracting average follicular phase severity from average luteal phase severity, and averaging these phase change means across symptoms.|units on a scale|Mean|31.85|31.85|Standard Deviation|9.14|9.14|||
4105300|NCT00965562|3929196|B4|||Concurrent oral contraceptive use|Only participants who indicated that they were concurrently taking contraceptives were included in this affirmative measure.|participants|Number|10|10.0||||||
4105301|NCT00965562|3929197|B3|||Concurrent oral contraceptive use|Only participants who indicated that they were concurrently taking contraceptives were included in this affirmative measure.|participants|Number|3|3.0||||||
4105302|NCT00965562|3929198|B2|||Concurrent oral contraceptive use|Only participants who indicated that they were concurrently taking contraceptives were included in this affirmative measure.|participants|Number|3|3.0||||||
4105303|NCT00965562|3929199|B1|||Concurrent oral contraceptive use|Only participants who indicated that they were concurrently taking contraceptives were included in this affirmative measure.|participants|Number|4|4.0||||||
4105304|NCT00965562|3929196|B4|||Thought about getting help for PMS|PMS= premenstrual syndrome. Only participants who indicated that they had thought about getting help for their PMS symptoms were included in this affirmative measure.|participants|Number|20|20.0||||||
4105305|NCT00965562|3929197|B3|||Thought about getting help for PMS|PMS= premenstrual syndrome. Only participants who indicated that they had thought about getting help for their PMS symptoms were included in this affirmative measure.|participants|Number|6|6.0||||||
4105306|NCT00965562|3929198|B2|||Thought about getting help for PMS|PMS= premenstrual syndrome. Only participants who indicated that they had thought about getting help for their PMS symptoms were included in this affirmative measure.|participants|Number|7|7.0||||||
4105307|NCT00965562|3929199|B1|||Thought about getting help for PMS|PMS= premenstrual syndrome. Only participants who indicated that they had thought about getting help for their PMS symptoms were included in this affirmative measure.|participants|Number|7|7.0||||||
4105308|NCT00965562|3929196|B4|||OB-GYN asked about PMS|PMS= premenstrual syndrome. Only participants who indicated that their OB-GYN had asked about PMS were included in this affirmative measure.|participants|Number|9|9.0||||||
4105309|NCT00965562|3929197|B3|||OB-GYN asked about PMS|PMS= premenstrual syndrome. Only participants who indicated that their OB-GYN had asked about PMS were included in this affirmative measure.|participants|Number|2|2.0||||||
4105310|NCT00965562|3929198|B2|||OB-GYN asked about PMS|PMS= premenstrual syndrome. Only participants who indicated that their OB-GYN had asked about PMS were included in this affirmative measure.|participants|Number|5|5.0||||||
4105311|NCT00965562|3929199|B1|||OB-GYN asked about PMS|PMS= premenstrual syndrome. Only participants who indicated that their OB-GYN had asked about PMS were included in this affirmative measure.|participants|Number|2|2.0||||||
4105313|NCT00965562|3929197|B3|||Ever spoken to a doctor about PMS|PMS= premenstrual syndrome. Only participants who indicated that they had spoken to a doctor about their PMS were included in this affirmative measure.|participants|Number|6|6.0||||||
4105314|NCT00965562|3929198|B2|||Ever spoken to a doctor about PMS|PMS= premenstrual syndrome. Only participants who indicated that they had spoken to a doctor about their PMS were included in this affirmative measure.|participants|Number|5|5.0||||||
4105315|NCT00965562|3929199|B1|||Ever spoken to a doctor about PMS|PMS= premenstrual syndrome. Only participants who indicated that they had spoken to a doctor about their PMS were included in this affirmative measure.|participants|Number|4|4.0||||||
4105316|NCT00965562|3929196|B4|Number of years not collected||Years with PMS|PMS= premenstrual syndrome.|participants|Number|1|1.0||||||
4105317|NCT00965562|3929197|B3|Number of years not collected||Years with PMS|PMS= premenstrual syndrome.|participants|Number|0|0.0||||||
4105318|NCT00965562|3929198|B2|Number of years not collected||Years with PMS|PMS= premenstrual syndrome.|participants|Number|0|0.0||||||
4105319|NCT00965562|3929199|B1|Number of years not collected||Years with PMS|PMS= premenstrual syndrome.|participants|Number|1|1.0||||||
4105320|NCT00965562|3929196|B4|>10 years||Years with PMS|PMS= premenstrual syndrome.|participants|Number|14|14.0||||||
4105321|NCT00965562|3929197|B3|>10 years||Years with PMS|PMS= premenstrual syndrome.|participants|Number|6|6.0||||||
4105322|NCT00965562|3929198|B2|>10 years||Years with PMS|PMS= premenstrual syndrome.|participants|Number|5|5.0||||||
4105323|NCT00965562|3929199|B1|>10 years||Years with PMS|PMS= premenstrual syndrome.|participants|Number|3|3.0||||||
4105324|NCT00965562|3929196|B4|5-10 years||Years with PMS|PMS= premenstrual syndrome.|participants|Number|10|10.0||||||
4105325|NCT00965562|3929197|B3|5-10 years||Years with PMS|PMS= premenstrual syndrome.|participants|Number|1|1.0||||||
4105326|NCT00965562|3929198|B2|5-10 years||Years with PMS|PMS= premenstrual syndrome.|participants|Number|6|6.0||||||
4105327|NCT00965562|3929199|B1|5-10 years||Years with PMS|PMS= premenstrual syndrome.|participants|Number|3|3.0||||||
4105328|NCT00965562|3929196|B4|<4 years||Years with PMS|PMS= premenstrual syndrome.|participants|Number|14|14.0||||||
4105329|NCT00965562|3929197|B3|<4 years||Years with PMS|PMS= premenstrual syndrome.|participants|Number|6|6.0||||||
4105330|NCT00965562|3929198|B2|<4 years||Years with PMS|PMS= premenstrual syndrome.|participants|Number|2|2.0||||||
4105331|NCT00965562|3929199|B1|<4 years||Years with PMS|PMS= premenstrual syndrome.|participants|Number|6|6.0||||||
4105332|NCT00965562|3929196|B4|2+ pregnancies||Number of pregnancies||participants|Number|21|21.0||||||
4105333|NCT00965562|3929197|B3|2+ pregnancies||Number of pregnancies||participants|Number|8|8.0||||||
4105334|NCT00965562|3929198|B2|2+ pregnancies||Number of pregnancies||participants|Number|9|9.0||||||
4105335|NCT00965562|3929199|B1|2+ pregnancies||Number of pregnancies||participants|Number|4|4.0||||||
4105336|NCT00965562|3929196|B4|1 pregnancy||Number of pregnancies||participants|Number|4|4.0||||||
4105337|NCT00965562|3929197|B3|1 pregnancy||Number of pregnancies||participants|Number|0|0.0||||||
4105338|NCT00965562|3929198|B2|1 pregnancy||Number of pregnancies||participants|Number|1|1.0||||||
4105339|NCT00965562|3929199|B1|1 pregnancy||Number of pregnancies||participants|Number|3|3.0||||||
4105340|NCT00965562|3929196|B4|0 pregnancies||Number of pregnancies||participants|Number|14|14.0||||||
4105341|NCT00965562|3929197|B3|0 pregnancies||Number of pregnancies||participants|Number|5|5.0||||||
4105342|NCT00965562|3929198|B2|0 pregnancies||Number of pregnancies||participants|Number|3|3.0||||||
4105343|NCT00965562|3929199|B1|0 pregnancies||Number of pregnancies||participants|Number|6|6.0||||||
4105344|NCT00965562|3929196|B4|Not collected||Marital Status||participants|Number|1|1.0||||||
4105345|NCT00965562|3929197|B3|Not collected||Marital Status||participants|Number|0|0.0||||||
4105346|NCT00965562|3929198|B2|Not collected||Marital Status||participants|Number|0|0.0||||||
4105347|NCT00965562|3929199|B1|Not collected||Marital Status||participants|Number|1|1.0||||||
4105348|NCT00965562|3929196|B4|Single/Divorced/Widowed||Marital Status||participants|Number|14|14.0||||||
4105349|NCT00965562|3929197|B3|Single/Divorced/Widowed||Marital Status||participants|Number|4|4.0||||||
4105350|NCT00965562|3929198|B2|Single/Divorced/Widowed||Marital Status||participants|Number|5|5.0||||||
4105351|NCT00965562|3929199|B1|Single/Divorced/Widowed||Marital Status||participants|Number|5|5.0||||||
4105352|NCT00965562|3929196|B4|Married||Marital Status||participants|Number|24|24.0||||||
4105353|NCT00965562|3929197|B3|Married||Marital Status||participants|Number|9|9.0||||||
4105354|NCT00965562|3929198|B2|Married||Marital Status||participants|Number|8|8.0||||||
4105355|NCT00965562|3929199|B1|Married||Marital Status||participants|Number|7|7.0||||||
4105356|NCT00965562|3929196|B4|United States||Region of Enrollment||participants|Number|39|39.0||||||
4105357|NCT00965562|3929197|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4105358|NCT00965562|3929198|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4105359|NCT00965562|3929199|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4105360|NCT00965562|3929196|B4|Not collected||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4105361|NCT00965562|3929197|B3|Not collected||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4105362|NCT00965562|3929198|B2|Not collected||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4105363|NCT00965562|3929199|B1|Not collected||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4105364|NCT00965562|3929196|B4|Other/Mixed||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4105365|NCT00965562|3929197|B3|Other/Mixed||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4105366|NCT00965562|3929198|B2|Other/Mixed||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4105367|NCT00965562|3929199|B1|Other/Mixed||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4105368|NCT00965562|3929196|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4105372|NCT00965562|3929196|B4|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4105373|NCT00965562|3929197|B3|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4105374|NCT00965562|3929198|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4105375|NCT00965562|3929199|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4105376|NCT00965562|3929196|B4|White||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4105377|NCT00965562|3929197|B3|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4105378|NCT00965562|3929198|B2|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4105379|NCT00965562|3929199|B1|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4105380|NCT00965562|3929196|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4105381|NCT00965562|3929197|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4105382|NCT00965562|3929198|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4105383|NCT00965562|3929199|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4105384|NCT00965562|3929196|B4||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4105385|NCT00965562|3929197|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4105386|NCT00965562|3929198|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4105387|NCT00965562|3929199|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4105388|NCT00965562|3929196|B4|40-45 years old||Age, Customized||participants|Number|11|11.0||||||
4105389|NCT00965562|3929197|B3|40-45 years old||Age, Customized||participants|Number|4|4.0||||||
4105390|NCT00965562|3929198|B2|40-45 years old||Age, Customized||participants|Number|6|6.0||||||
4105391|NCT00965562|3929199|B1|40-45 years old||Age, Customized||participants|Number|1|1.0||||||
4105392|NCT00965562|3929196|B4|30-39 years old||Age, Customized||participants|Number|24|24.0||||||
4105393|NCT00965562|3929197|B3|30-39 years old||Age, Customized||participants|Number|7|7.0||||||
4105394|NCT00965562|3929198|B2|30-39 years old||Age, Customized||participants|Number|6|6.0||||||
4105395|NCT00965562|3929199|B1|30-39 years old||Age, Customized||participants|Number|11|11.0||||||
4105396|NCT00965562|3929196|B4|25-29 years old||Age, Customized||participants|Number|4|4.0||||||
4105397|NCT00965562|3929197|B3|25-29 years old||Age, Customized||participants|Number|2|2.0||||||
4105398|NCT00965562|3929198|B2|25-29 years old||Age, Customized||participants|Number|1|1.0||||||
4105399|NCT00965562|3929199|B1|25-29 years old||Age, Customized||participants|Number|1|1.0||||||
4105400|NCT00965523|3929239|B1|Japan||Region of Enrollment|Full Analysis Set|participants|Number|80|80.0||||||
4105401|NCT00965523|3929239|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4105402|NCT00965523|3929239|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4105403|NCT00965523|3929239|B1|||Age||years|Mean|53.6|53.6|Standard Deviation|9.7|9.7|||
4105404|NCT00965497|3929244|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4105405|NCT00965497|3929244|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4105406|NCT00965497|3929244|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4105407|NCT00965497|3929244|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4105408|NCT00965497|3929244|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4105409|NCT00965497|3929244|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105410|NCT00965484|3929249|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4105411|NCT00965484|3929249|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4105412|NCT00965484|3929249|B1|≥15 years of age||Age, Customized||participants|Number|29|29.0||||||
4105413|NCT00965484|3929249|B1|Between 13 and 14 years of age||Age, Customized||participants|Number|40|40.0||||||
4105414|NCT00965484|3929249|B1|Between 11 and 12 years of age||Age, Customized||participants|Number|30|30.0||||||
4105415|NCT00965484|3929249|B1|≤10 years of age||Age, Customized||participants|Number|37|37.0||||||
4105416|NCT00965458|3929256|B3|||2-Hour C-peptide Area Under the Curve Result in Response to Standardized Mixed Meal Tolerance Test|C-peptide is a substance released by the pancreas into the bloodstream in equal amounts to insulin and reflects how much insulin pancreatic beta cells are making. The MMTT evaluates whether beta cells are producing endogenous insulin. The MMTT was performed in the morning and blood samples for C-peptide collected at baseline (pre-meal) and 15, 30, 60, 90, 120, 150, 180, 210,and 240 minutes post-meal. Results of the stimulated 2-hour post-meal C-peptide AUC are provided. Larger numbers are preferable (better) in these AUC results: more insulin being produced reflects less severe disease.|pmol/mL|Mean|0.78|0.78|Standard Deviation|0.38|0.38|||
4105417|NCT00965458|3929257|B2|||2-Hour C-peptide Area Under the Curve Result in Response to Standardized Mixed Meal Tolerance Test|C-peptide is a substance released by the pancreas into the bloodstream in equal amounts to insulin and reflects how much insulin pancreatic beta cells are making. The MMTT evaluates whether beta cells are producing endogenous insulin. The MMTT was performed in the morning and blood samples for C-peptide collected at baseline (pre-meal) and 15, 30, 60, 90, 120, 150, 180, 210,and 240 minutes post-meal. Results of the stimulated 2-hour post-meal C-peptide AUC are provided. Larger numbers are preferable (better) in these AUC results: more insulin being produced reflects less severe disease.|pmol/mL|Mean|0.64|0.64|Standard Deviation|0.22|0.22|||
4105418|NCT00965458|3929258|B1|||2-Hour C-peptide Area Under the Curve Result in Response to Standardized Mixed Meal Tolerance Test|C-peptide is a substance released by the pancreas into the bloodstream in equal amounts to insulin and reflects how much insulin pancreatic beta cells are making. The MMTT evaluates whether beta cells are producing endogenous insulin. The MMTT was performed in the morning and blood samples for C-peptide collected at baseline (pre-meal) and 15, 30, 60, 90, 120, 150, 180, 210,and 240 minutes post-meal. Results of the stimulated 2-hour post-meal C-peptide AUC are provided. Larger numbers are preferable (better) in these AUC results: more insulin being produced reflects less severe disease.|pmol/mL|Mean|0.85|0.85|Standard Deviation|0.42|0.42|||
4105419|NCT00965458|3929256|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
4105420|NCT00965458|3929257|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4105421|NCT00965458|3929258|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4105422|NCT00965458|3929256|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4105423|NCT00965458|3929257|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4105424|NCT00965458|3929258|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4105425|NCT00965458|3929256|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4105426|NCT00965458|3929257|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4105427|NCT00965458|3929258|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4105428|NCT00965458|3929256|B3|||Age||years|Mean|20.0|20.0|Standard Deviation|6.3|6.3|||
4105429|NCT00965458|3929257|B2|||Age||years|Mean|19.5|19.5|Standard Deviation|6.2|6.2|||
4105430|NCT00965458|3929258|B1|||Age||years|Mean|20.3|20.3|Standard Deviation|6.4|6.4|||
4105431|NCT00965458|3929256|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4105432|NCT00965458|3929257|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4105433|NCT00965458|3929258|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4105434|NCT00965458|3929256|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4105435|NCT00965458|3929257|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4105436|NCT00965458|3929258|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4105437|NCT00965458|3929256|B3||<=18 years|Age||Participants|Count of Participants|25|25.0||||||
4105438|NCT00965458|3929257|B2||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4105439|NCT00965458|3929258|B1||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
4105440|NCT00965419|3929275|B1|Mexico||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4105441|NCT00965419|3929275|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4105442|NCT00965419|3929275|B1|United States||Region of Enrollment||Participants|Count of Participants|235|235.0||||||
4105443|NCT00965419|3929275|B1|Puerto Rico||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4105444|NCT00965419|3929275|B1|Canada||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4105445|NCT00965419|3929275|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4105446|NCT00965419|3929275|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4105447|NCT00965419|3929275|B1||White|Race (NIH/OMB)||Participants|Count of Participants|180|180.0||||||
4105448|NCT00965419|3929275|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4105449|NCT00965419|3929275|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4105450|NCT00965419|3929275|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4105451|NCT00965419|3929275|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4105452|NCT00965419|3929275|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4105453|NCT00965419|3929275|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|202|202.0||||||
4105454|NCT00965419|3929275|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4105455|NCT00965419|3929275|B1||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4105456|NCT00965419|3929275|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4105457|NCT00965419|3929275|B1|||Age||years|Mean|11.64|11.64|Standard Deviation|2.99|2.99|||
4105458|NCT00965341|3929319|B3|United States||Region of Enrollment||participants|Number|43|43.0||||||
4105459|NCT00965341|3929320|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4105460|NCT00965341|3929321|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4105461|NCT00965341|3929319|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4105462|NCT00965341|3929320|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4105463|NCT00965341|3929321|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4105464|NCT00965341|3929319|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4105465|NCT00965341|3929320|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4105466|NCT00965341|3929321|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4105467|NCT00965341|3929319|B3||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4105468|NCT00965341|3929320|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4105469|NCT00965341|3929321|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4105470|NCT00965341|3929319|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4105471|NCT00965341|3929320|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4105472|NCT00965341|3929321|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4105473|NCT00965341|3929319|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105474|NCT00965341|3929320|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105475|NCT00965341|3929321|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105476|NCT00965263|3929330|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4105477|NCT00965263|3929331|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4105478|NCT00965263|3929332|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4105479|NCT00965263|3929330|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4105480|NCT00965263|3929331|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4105481|NCT00965263|3929332|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4105482|NCT00965263|3929330|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4105483|NCT00965263|3929331|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4105484|NCT00965263|3929332|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4105485|NCT00965263|3929330|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4105486|NCT00965263|3929331|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4105487|NCT00965263|3929332|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4105488|NCT00965263|3929330|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4105489|NCT00965263|3929331|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4105490|NCT00965263|3929332|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4105491|NCT00965263|3929330|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4105492|NCT00965263|3929331|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4105493|NCT00965263|3929332|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4105494|NCT00965263|3929330|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4105495|NCT00965263|3929331|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4105496|NCT00965263|3929332|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4105497|NCT00965263|3929330|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4105498|NCT00965263|3929331|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4105499|NCT00965263|3929332|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4105500|NCT00965263|3929330|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4105501|NCT00965263|3929331|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4105502|NCT00965263|3929332|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4105503|NCT00965263|3929330|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4105504|NCT00965263|3929331|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4105505|NCT00965263|3929332|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4105506|NCT00965263|3929330|B3|||Age||years|Mean|39|39.0|Standard Deviation|1.9|1.9|||
4105507|NCT00965263|3929331|B2|||Age||years|Mean|39|39.0|Standard Deviation|1.9|1.9|||
4105508|NCT00965263|3929332|B1|||Age||years|Mean|38|38.0|Standard Deviation|1.8|1.8|||
4105509|NCT00965263|3929330|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4105510|NCT00965263|3929331|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4105511|NCT00965263|3929332|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4105512|NCT00965263|3929330|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4105513|NCT00965263|3929331|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4105514|NCT00965263|3929332|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4105515|NCT00965263|3929330|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105516|NCT00965263|3929331|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105517|NCT00965263|3929332|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105518|NCT00965250|3929363|B3|2 - In bed <50% of the time||Eastern Cooperative Oncology Group (ECOG) Performance Status||participants|Number|8|8.0||||||
4105519|NCT00965250|3929364|B2|2 - In bed <50% of the time||Eastern Cooperative Oncology Group (ECOG) Performance Status||participants|Number|3|3.0||||||
4105520|NCT00965250|3929365|B1|2 - In bed <50% of the time||Eastern Cooperative Oncology Group (ECOG) Performance Status||participants|Number|5|5.0||||||
4105521|NCT00965250|3929363|B3|1 - Symptoms, but ambulatory||Eastern Cooperative Oncology Group (ECOG) Performance Status||participants|Number|37|37.0||||||
4105522|NCT00965250|3929364|B2|1 - Symptoms, but ambulatory||Eastern Cooperative Oncology Group (ECOG) Performance Status||participants|Number|8|8.0||||||
4105523|NCT00965250|3929365|B1|1 - Symptoms, but ambulatory||Eastern Cooperative Oncology Group (ECOG) Performance Status||participants|Number|29|29.0||||||
4105524|NCT00965250|3929363|B3|0 - Normal Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status||participants|Number|4|4.0||||||
4105525|NCT00965250|3929364|B2|0 - Normal Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status||participants|Number|1|1.0||||||
4105526|NCT00965250|3929365|B1|0 - Normal Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status||participants|Number|3|3.0||||||
4105527|NCT00965250|3929363|B3|Biopsy||Previous surgery||participants|Number|17|17.0||||||
4105528|NCT00965250|3929364|B2|Biopsy||Previous surgery||participants|Number|9|9.0||||||
4105529|NCT00965250|3929365|B1|Biopsy||Previous surgery||participants|Number|8|8.0||||||
4105530|NCT00965250|3929363|B3|Debulking||Previous surgery||participants|Number|2|2.0||||||
4105531|NCT00965250|3929364|B2|Debulking||Previous surgery||participants|Number|1|1.0||||||
4105532|NCT00965250|3929365|B1|Debulking||Previous surgery||participants|Number|1|1.0||||||
4105533|NCT00965250|3929363|B3|Radical||Previous surgery||participants|Number|30|30.0||||||
4105534|NCT00965250|3929364|B2|Radical||Previous surgery||participants|Number|2|2.0||||||
4105535|NCT00965250|3929365|B1|Radical||Previous surgery||participants|Number|28|28.0||||||
4105536|NCT00965250|3929363|B3|||Previous radiotherapy||participants|Number|27|27.0||||||
4105537|NCT00965250|3929364|B2|||Previous radiotherapy||participants|Number|4|4.0||||||
4105538|NCT00965250|3929365|B1|||Previous radiotherapy||participants|Number|23|23.0||||||
4105539|NCT00965250|3929363|B3|||Investigational drugs|Counted as previous lines of systemic treatment, but not as previous lines of chemotherapy.|participants|Number|21|21.0||||||
4105540|NCT00965250|3929364|B2|||Investigational drugs|Counted as previous lines of systemic treatment, but not as previous lines of chemotherapy.|participants|Number|4|4.0||||||
4105541|NCT00965250|3929365|B1|||Investigational drugs|Counted as previous lines of systemic treatment, but not as previous lines of chemotherapy.|participants|Number|17|17.0||||||
4105542|NCT00965250|3929363|B3|||Previous anthracycline||participants|Number|32|32.0||||||
4105543|NCT00965250|3929364|B2|||Previous anthracycline||participants|Number|5|5.0||||||
4105544|NCT00965250|3929365|B1|||Previous anthracycline||participants|Number|27|27.0||||||
4105545|NCT00965250|3929363|B3|||Previous platinum treatment||participants|Number|49|49.0||||||
4105546|NCT00965250|3929364|B2|||Previous platinum treatment||participants|Number|12|12.0||||||
4105547|NCT00965250|3929365|B1|||Previous platinum treatment||participants|Number|37|37.0||||||
4105548|NCT00965250|3929363|B3|Three or more lines||Previous chemotherapy||participants|Number|20|20.0||||||
4105549|NCT00965250|3929364|B2|Three or more lines||Previous chemotherapy||participants|Number|3|3.0||||||
4105550|NCT00965250|3929365|B1|Three or more lines||Previous chemotherapy||participants|Number|17|17.0||||||
4105551|NCT00965250|3929363|B3|Two lines||Previous chemotherapy||participants|Number|10|10.0||||||
4105552|NCT00965250|3929364|B2|Two lines||Previous chemotherapy||participants|Number|2|2.0||||||
4105553|NCT00965250|3929365|B1|Two lines||Previous chemotherapy||participants|Number|8|8.0||||||
4105554|NCT00965250|3929363|B3|One line||Previous chemotherapy||participants|Number|19|19.0||||||
4105555|NCT00965250|3929364|B2|One line||Previous chemotherapy||participants|Number|7|7.0||||||
4105556|NCT00965250|3929365|B1|One line||Previous chemotherapy||participants|Number|12|12.0||||||
4105557|NCT00965250|3929363|B3|||Previous systemic treatment (six or more regimens)||participants|Number|12|12.0||||||
4105558|NCT00965250|3929364|B2|||Previous systemic treatment (six or more regimens)||participants|Number|2|2.0||||||
4105559|NCT00965250|3929365|B1|||Previous systemic treatment (six or more regimens)||participants|Number|10|10.0||||||
4105560|NCT00965250|3929363|B3|||Previous systemic treatment (number of regimens)||regimens|Median|2|2.0|Full Range|||1.0|11.0|
4105561|NCT00965250|3929364|B2|||Previous systemic treatment (number of regimens)||regimens|Median|2|2.0|Full Range|||1.0|11.0|
4105562|NCT00965250|3929365|B1|||Previous systemic treatment (number of regimens)||regimens|Median|3|3.0|Full Range|||1.0|11.0|
4105563|NCT00965250|3929363|B3|Mucocutaneous candidiasis||Paraneoplastic Syndromes||participants|Number|1|1.0||||||
4105564|NCT00965250|3929364|B2|Mucocutaneous candidiasis||Paraneoplastic Syndromes||participants|Number|0|0.0||||||
4105565|NCT00965250|3929365|B1|Mucocutaneous candidiasis||Paraneoplastic Syndromes||participants|Number|1|1.0||||||
4105566|NCT00965250|3929363|B3|Ulcerative colitis||Paraneoplastic Syndromes||participants|Number|1|1.0||||||
4105567|NCT00965250|3929364|B2|Ulcerative colitis||Paraneoplastic Syndromes||participants|Number|0|0.0||||||
4105568|NCT00965250|3929365|B1|Ulcerative colitis||Paraneoplastic Syndromes||participants|Number|1|1.0||||||
4105569|NCT00965250|3929363|B3|Crohn's disease||Paraneoplastic Syndromes||participants|Number|1|1.0||||||
4105570|NCT00965250|3929364|B2|Crohn's disease||Paraneoplastic Syndromes||participants|Number|0|0.0||||||
4105571|NCT00965250|3929365|B1|Crohn's disease||Paraneoplastic Syndromes||participants|Number|1|1.0||||||
4105572|NCT00965250|3929363|B3|Pure red-cell aplasia||Paraneoplastic Syndromes||participants|Number|3|3.0||||||
4105573|NCT00965250|3929364|B2|Pure red-cell aplasia||Paraneoplastic Syndromes||participants|Number|0|0.0||||||
4105574|NCT00965250|3929365|B1|Pure red-cell aplasia||Paraneoplastic Syndromes||participants|Number|3|3.0||||||
4105575|NCT00965250|3929363|B3|Shulman's syndrome||Paraneoplastic Syndromes||participants|Number|1|1.0||||||
4105576|NCT00965250|3929364|B2|Shulman's syndrome||Paraneoplastic Syndromes||participants|Number|0|0.0||||||
4105577|NCT00965250|3929365|B1|Shulman's syndrome||Paraneoplastic Syndromes||participants|Number|1|1.0||||||
4105578|NCT00965250|3929363|B3|Myastenia gravis||Paraneoplastic Syndromes||participants|Number|9|9.0||||||
4105579|NCT00965250|3929364|B2|Myastenia gravis||Paraneoplastic Syndromes||participants|Number|0|0.0||||||
4105580|NCT00965250|3929365|B1|Myastenia gravis||Paraneoplastic Syndromes||participants|Number|9|9.0||||||
4105581|NCT00965250|3929363|B3|Not otherwise specified||Histological Analysis (WHO classification)|WHO (World Health Organization) classification of epithelial thymic malignancies: AB - Mixed, B1 - Predominantly cortical thymoma, B2 - Cortical thymoma, B2/B3 - Cortical thymoma/Well differentiated thymoma, B3 - Well differentiated thymoma, and C - Thymic carcinoma.|participants|Number|4|4.0||||||
4105582|NCT00965250|3929364|B2|Not otherwise specified||Histological Analysis (WHO classification)|WHO (World Health Organization) classification of epithelial thymic malignancies: AB - Mixed, B1 - Predominantly cortical thymoma, B2 - Cortical thymoma, B2/B3 - Cortical thymoma/Well differentiated thymoma, B3 - Well differentiated thymoma, and C - Thymic carcinoma.|participants|Number|0|0.0||||||
4105583|NCT00965250|3929365|B1|Not otherwise specified||Histological Analysis (WHO classification)|WHO (World Health Organization) classification of epithelial thymic malignancies: AB - Mixed, B1 - Predominantly cortical thymoma, B2 - Cortical thymoma, B2/B3 - Cortical thymoma/Well differentiated thymoma, B3 - Well differentiated thymoma, and C - Thymic carcinoma.|participants|Number|4|4.0||||||
4105584|NCT00965250|3929363|B3|C||Histological Analysis (WHO classification)|WHO (World Health Organization) classification of epithelial thymic malignancies: AB - Mixed, B1 - Predominantly cortical thymoma, B2 - Cortical thymoma, B2/B3 - Cortical thymoma/Well differentiated thymoma, B3 - Well differentiated thymoma, and C - Thymic carcinoma.|participants|Number|12|12.0||||||
4105663|NCT00965185|3929392|B2|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4105664|NCT00965185|3929393|B1|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4105585|NCT00965250|3929364|B2|C||Histological Analysis (WHO classification)|WHO (World Health Organization) classification of epithelial thymic malignancies: AB - Mixed, B1 - Predominantly cortical thymoma, B2 - Cortical thymoma, B2/B3 - Cortical thymoma/Well differentiated thymoma, B3 - Well differentiated thymoma, and C - Thymic carcinoma.|participants|Number|12|12.0||||||
4105586|NCT00965250|3929365|B1|C||Histological Analysis (WHO classification)|WHO (World Health Organization) classification of epithelial thymic malignancies: AB - Mixed, B1 - Predominantly cortical thymoma, B2 - Cortical thymoma, B2/B3 - Cortical thymoma/Well differentiated thymoma, B3 - Well differentiated thymoma, and C - Thymic carcinoma.|participants|Number|0|0.0||||||
4105587|NCT00965250|3929363|B3|B3||Histological Analysis (WHO classification)|WHO (World Health Organization) classification of epithelial thymic malignancies: AB - Mixed, B1 - Predominantly cortical thymoma, B2 - Cortical thymoma, B2/B3 - Cortical thymoma/Well differentiated thymoma, B3 - Well differentiated thymoma, and C - Thymic carcinoma.|participants|Number|9|9.0||||||
4105588|NCT00965250|3929364|B2|B3||Histological Analysis (WHO classification)|WHO (World Health Organization) classification of epithelial thymic malignancies: AB - Mixed, B1 - Predominantly cortical thymoma, B2 - Cortical thymoma, B2/B3 - Cortical thymoma/Well differentiated thymoma, B3 - Well differentiated thymoma, and C - Thymic carcinoma.|participants|Number|0|0.0||||||
4105589|NCT00965250|3929365|B1|B3||Histological Analysis (WHO classification)|WHO (World Health Organization) classification of epithelial thymic malignancies: AB - Mixed, B1 - Predominantly cortical thymoma, B2 - Cortical thymoma, B2/B3 - Cortical thymoma/Well differentiated thymoma, B3 - Well differentiated thymoma, and C - Thymic carcinoma.|participants|Number|9|9.0||||||
4105590|NCT00965250|3929363|B3|B2/B3||Histological Analysis (WHO classification)|WHO (World Health Organization) classification of epithelial thymic malignancies: AB - Mixed, B1 - Predominantly cortical thymoma, B2 - Cortical thymoma, B2/B3 - Cortical thymoma/Well differentiated thymoma, B3 - Well differentiated thymoma, and C - Thymic carcinoma.|participants|Number|3|3.0||||||
4105591|NCT00965250|3929364|B2|B2/B3||Histological Analysis (WHO classification)|WHO (World Health Organization) classification of epithelial thymic malignancies: AB - Mixed, B1 - Predominantly cortical thymoma, B2 - Cortical thymoma, B2/B3 - Cortical thymoma/Well differentiated thymoma, B3 - Well differentiated thymoma, and C - Thymic carcinoma.|participants|Number|0|0.0||||||
4105592|NCT00965250|3929365|B1|B2/B3||Histological Analysis (WHO classification)|WHO (World Health Organization) classification of epithelial thymic malignancies: AB - Mixed, B1 - Predominantly cortical thymoma, B2 - Cortical thymoma, B2/B3 - Cortical thymoma/Well differentiated thymoma, B3 - Well differentiated thymoma, and C - Thymic carcinoma.|participants|Number|3|3.0||||||
4105593|NCT00965250|3929363|B3|B2||Histological Analysis (WHO classification)|WHO (World Health Organization) classification of epithelial thymic malignancies: AB - Mixed, B1 - Predominantly cortical thymoma, B2 - Cortical thymoma, B2/B3 - Cortical thymoma/Well differentiated thymoma, B3 - Well differentiated thymoma, and C - Thymic carcinoma.|participants|Number|15|15.0||||||
4105594|NCT00965250|3929364|B2|B2||Histological Analysis (WHO classification)|WHO (World Health Organization) classification of epithelial thymic malignancies: AB - Mixed, B1 - Predominantly cortical thymoma, B2 - Cortical thymoma, B2/B3 - Cortical thymoma/Well differentiated thymoma, B3 - Well differentiated thymoma, and C - Thymic carcinoma.|participants|Number|0|0.0||||||
4105595|NCT00965250|3929365|B1|B2||Histological Analysis (WHO classification)|WHO (World Health Organization) classification of epithelial thymic malignancies: AB - Mixed, B1 - Predominantly cortical thymoma, B2 - Cortical thymoma, B2/B3 - Cortical thymoma/Well differentiated thymoma, B3 - Well differentiated thymoma, and C - Thymic carcinoma.|participants|Number|15|15.0||||||
4105596|NCT00965250|3929363|B3|B1||Histological Analysis (WHO classification)|WHO (World Health Organization) classification of epithelial thymic malignancies: AB - Mixed, B1 - Predominantly cortical thymoma, B2 - Cortical thymoma, B2/B3 - Cortical thymoma/Well differentiated thymoma, B3 - Well differentiated thymoma, and C - Thymic carcinoma.|participants|Number|4|4.0||||||
4105597|NCT00965250|3929364|B2|B1||Histological Analysis (WHO classification)|WHO (World Health Organization) classification of epithelial thymic malignancies: AB - Mixed, B1 - Predominantly cortical thymoma, B2 - Cortical thymoma, B2/B3 - Cortical thymoma/Well differentiated thymoma, B3 - Well differentiated thymoma, and C - Thymic carcinoma.|participants|Number|0|0.0||||||
4105598|NCT00965250|3929365|B1|B1||Histological Analysis (WHO classification)|WHO (World Health Organization) classification of epithelial thymic malignancies: AB - Mixed, B1 - Predominantly cortical thymoma, B2 - Cortical thymoma, B2/B3 - Cortical thymoma/Well differentiated thymoma, B3 - Well differentiated thymoma, and C - Thymic carcinoma.|participants|Number|4|4.0||||||
4105599|NCT00965250|3929363|B3|AB||Histological Analysis (WHO classification)|WHO (World Health Organization) classification of epithelial thymic malignancies: AB - Mixed, B1 - Predominantly cortical thymoma, B2 - Cortical thymoma, B2/B3 - Cortical thymoma/Well differentiated thymoma, B3 - Well differentiated thymoma, and C - Thymic carcinoma.|participants|Number|2|2.0||||||
4105600|NCT00965250|3929364|B2|AB||Histological Analysis (WHO classification)|WHO (World Health Organization) classification of epithelial thymic malignancies: AB - Mixed, B1 - Predominantly cortical thymoma, B2 - Cortical thymoma, B2/B3 - Cortical thymoma/Well differentiated thymoma, B3 - Well differentiated thymoma, and C - Thymic carcinoma.|participants|Number|0|0.0||||||
4105601|NCT00965250|3929365|B1|AB||Histological Analysis (WHO classification)|WHO (World Health Organization) classification of epithelial thymic malignancies: AB - Mixed, B1 - Predominantly cortical thymoma, B2 - Cortical thymoma, B2/B3 - Cortical thymoma/Well differentiated thymoma, B3 - Well differentiated thymoma, and C - Thymic carcinoma.|participants|Number|2|2.0||||||
4105602|NCT00965250|3929363|B3|Extrathoracic sites(w/without intrathoracic sites||Metastatic Sites|Data on metastatic sites is provided for 41 patients (29 thymoma, 12 thymic carcinoma) enrolled at the NCI. Eight thymoma patients were enrolled at Memorial Sloan Kettering Cancer Center, New York.|participants|Number|23|23.0||||||
4105603|NCT00965250|3929364|B2|Extrathoracic sites(w/without intrathoracic sites||Metastatic Sites|Data on metastatic sites is provided for 41 patients (29 thymoma, 12 thymic carcinoma) enrolled at the NCI. Eight thymoma patients were enrolled at Memorial Sloan Kettering Cancer Center, New York.|participants|Number|12|12.0||||||
4105604|NCT00965250|3929365|B1|Extrathoracic sites(w/without intrathoracic sites||Metastatic Sites|Data on metastatic sites is provided for 41 patients (29 thymoma, 12 thymic carcinoma) enrolled at the NCI. Eight thymoma patients were enrolled at Memorial Sloan Kettering Cancer Center, New York.|participants|Number|11|11.0||||||
4105605|NCT00965250|3929363|B3|Intrathoracic sites only||Metastatic Sites|Data on metastatic sites is provided for 41 patients (29 thymoma, 12 thymic carcinoma) enrolled at the NCI. Eight thymoma patients were enrolled at Memorial Sloan Kettering Cancer Center, New York.|participants|Number|18|18.0||||||
4105606|NCT00965250|3929364|B2|Intrathoracic sites only||Metastatic Sites|Data on metastatic sites is provided for 41 patients (29 thymoma, 12 thymic carcinoma) enrolled at the NCI. Eight thymoma patients were enrolled at Memorial Sloan Kettering Cancer Center, New York.|participants|Number|0|0.0||||||
4105607|NCT00965250|3929365|B1|Intrathoracic sites only||Metastatic Sites|Data on metastatic sites is provided for 41 patients (29 thymoma, 12 thymic carcinoma) enrolled at the NCI. Eight thymoma patients were enrolled at Memorial Sloan Kettering Cancer Center, New York.|participants|Number|18|18.0||||||
4105608|NCT00965250|3929363|B3|||Median age||years|Median|52|52.0|Full Range|||26.0|86.0|
4105609|NCT00965250|3929364|B2|||Median age||years|Median|55|55.0|Full Range|||26.0|71.0|
4105610|NCT00965250|3929365|B1|||Median age||years|Median|52|52.0|Full Range|||31.0|86.0|
4105611|NCT00965250|3929363|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
4105612|NCT00965250|3929364|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4105613|NCT00965250|3929365|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4105614|NCT00965250|3929363|B3|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4105615|NCT00965250|3929364|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4105616|NCT00965250|3929365|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4105617|NCT00965250|3929363|B3|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4105618|NCT00965250|3929364|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4105619|NCT00965250|3929365|B1|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4105620|NCT00965250|3929363|B3|White, Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4105621|NCT00965250|3929364|B2|White, Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4105622|NCT00965250|3929365|B1|White, Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4105623|NCT00965250|3929363|B3|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4105624|NCT00965250|3929364|B2|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4105625|NCT00965250|3929365|B1|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4105626|NCT00965250|3929363|B3||Male|Gender||Participants|Count of Participants|26|26.0||||||
4105627|NCT00965250|3929364|B2||Male|Gender||Participants|Count of Participants|7|7.0||||||
4105628|NCT00965250|3929365|B1||Male|Gender||Participants|Count of Participants|19|19.0||||||
4105629|NCT00965250|3929363|B3||Female|Gender||Participants|Count of Participants|23|23.0||||||
4105630|NCT00965250|3929364|B2||Female|Gender||Participants|Count of Participants|5|5.0||||||
4105631|NCT00965250|3929365|B1||Female|Gender||Participants|Count of Participants|18|18.0||||||
4105632|NCT00965250|3929363|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4105633|NCT00965250|3929364|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4105634|NCT00965250|3929365|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4105635|NCT00965250|3929363|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4105636|NCT00965250|3929364|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4105637|NCT00965250|3929365|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4105638|NCT00965250|3929363|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105639|NCT00965250|3929364|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105640|NCT00965250|3929365|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105641|NCT00965237|3929384|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4105642|NCT00965237|3929384|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4105643|NCT00965237|3929384|B1|||Age||years|Mean|48.3|48.3|Standard Deviation|4.5|4.5|||
4105644|NCT00965185|3929391|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4105645|NCT00965185|3929392|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4105646|NCT00965185|3929393|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4105647|NCT00965185|3929391|B3|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4105648|NCT00965185|3929392|B2|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4105649|NCT00965185|3929393|B1|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4105650|NCT00965185|3929391|B3|More than one race||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4105651|NCT00965185|3929392|B2|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4105652|NCT00965185|3929393|B1|More than one race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4105653|NCT00965185|3929391|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4105654|NCT00965185|3929392|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4105655|NCT00965185|3929393|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4105656|NCT00965185|3929391|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4105657|NCT00965185|3929392|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4105658|NCT00965185|3929393|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4105659|NCT00965185|3929391|B3|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4105660|NCT00965185|3929392|B2|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4105661|NCT00965185|3929393|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4105662|NCT00965185|3929391|B3|White||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4105665|NCT00965185|3929391|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4105666|NCT00965185|3929392|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4105667|NCT00965185|3929393|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4105668|NCT00965185|3929391|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4105669|NCT00965185|3929392|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4105670|NCT00965185|3929393|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4105671|NCT00965185|3929391|B3|||Age||years|Mean|51.1|51.1|Standard Deviation|4.9|4.9|||
4105672|NCT00965185|3929392|B2|||Age||years|Mean|50.0|50.0|Standard Deviation|5.6|5.6|||
4105673|NCT00965185|3929393|B1|||Age||years|Mean|52.2|52.2|Standard Deviation|3.8|3.8|||
4105674|NCT00965185|3929391|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4105675|NCT00965185|3929392|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4105676|NCT00965185|3929393|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4105677|NCT00965185|3929391|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4105678|NCT00965185|3929392|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4105679|NCT00965185|3929393|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4105680|NCT00965185|3929391|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105681|NCT00965185|3929392|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105682|NCT00965185|3929393|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105683|NCT00965146|3929414|B1|United States||Region of Enrollment||participants|Number|210|210.0||||||
4105684|NCT00965146|3929414|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4105685|NCT00965146|3929414|B1||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4105686|NCT00965146|3929414|B1|||Age|"For participants who had both knees replaced and enrolled in the study, the age at the time of the first surgery was used.~One 81 year old participant was enrolled in error and was considered a protocol deviation case, but remained in the study."|years|Mean|64.46|64.46|Full Range|8.98|8.98|38.0|81.0|
4105687|NCT00965094|3929419|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4105688|NCT00965094|3929420|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4105689|NCT00965094|3929421|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4105690|NCT00965094|3929419|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4105691|NCT00965094|3929420|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4105692|NCT00965094|3929421|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4105693|NCT00965094|3929419|B3|||Age||Years|Mean|51.4|51.4|Standard Deviation|12.7|12.7|||
4105694|NCT00965094|3929420|B2|||Age||Years|Mean|49.6|49.6|Standard Deviation|12.1|12.1|||
4105695|NCT00965094|3929421|B1|||Age||Years|Mean|53.1|53.1|Standard Deviation|13.4|13.4|||
4105696|NCT00965081|3929436|B3|No diagnosis of GAD||Diagnosis of Generalized Anxiety Disorder (GAD)|The MINI was administered to establish if the participant had GAD.|Participants|Number|289|289.0||||||
4105697|NCT00965081|3929437|B2|No diagnosis of GAD||Diagnosis of Generalized Anxiety Disorder (GAD)|The MINI was administered to establish if the participant had GAD.|Participants|Number|145|145.0||||||
4105698|NCT00965081|3929438|B1|No diagnosis of GAD||Diagnosis of Generalized Anxiety Disorder (GAD)|The MINI was administered to establish if the participant had GAD.|Participants|Number|144|144.0||||||
4105699|NCT00965081|3929436|B3|Diagnosis of GAD||Diagnosis of Generalized Anxiety Disorder (GAD)|The MINI was administered to establish if the participant had GAD.|Participants|Number|19|19.0||||||
4105700|NCT00965081|3929437|B2|Diagnosis of GAD||Diagnosis of Generalized Anxiety Disorder (GAD)|The MINI was administered to establish if the participant had GAD.|Participants|Number|8|8.0||||||
4105701|NCT00965081|3929438|B1|Diagnosis of GAD||Diagnosis of Generalized Anxiety Disorder (GAD)|The MINI was administered to establish if the participant had GAD.|Participants|Number|11|11.0||||||
4105702|NCT00965081|3929436|B3|No diagnosis of MDD||Diagnosis of Major Depressive Disorder (MDD)|The Mini International Neuropsychiatric Interview (MINI)was administered to establish if the participant had MDD.|Participants|Number|239|239.0||||||
4105703|NCT00965081|3929437|B2|No diagnosis of MDD||Diagnosis of Major Depressive Disorder (MDD)|The Mini International Neuropsychiatric Interview (MINI)was administered to establish if the participant had MDD.|Participants|Number|116|116.0||||||
4105704|NCT00965081|3929438|B1|No diagnosis of MDD||Diagnosis of Major Depressive Disorder (MDD)|The Mini International Neuropsychiatric Interview (MINI)was administered to establish if the participant had MDD.|Participants|Number|123|123.0||||||
4105705|NCT00965081|3929436|B3|Diagnosis of MDD||Diagnosis of Major Depressive Disorder (MDD)|The Mini International Neuropsychiatric Interview (MINI)was administered to establish if the participant had MDD.|Participants|Number|69|69.0||||||
4105706|NCT00965081|3929437|B2|Diagnosis of MDD||Diagnosis of Major Depressive Disorder (MDD)|The Mini International Neuropsychiatric Interview (MINI)was administered to establish if the participant had MDD.|Participants|Number|37|37.0||||||
4105707|NCT00965081|3929438|B1|Diagnosis of MDD||Diagnosis of Major Depressive Disorder (MDD)|The Mini International Neuropsychiatric Interview (MINI)was administered to establish if the participant had MDD.|Participants|Number|32|32.0||||||
4105708|NCT00965081|3929436|B3|||Beck Anxiety Inventory (BAI) Total Score|The BAI is a 21-item patient-completed questionnaire designed to assess characteristics of anxiety. Each item is rated on a 4-point scale (0 = not present; 3 = present in the extreme). This questionnaire was used to rate the severity of anxiety symptoms and any improvement during the course of the trial. The total score ranges from 0 to 63; the higher the score, the more severe the anxiety symptoms. Number of Participants: Duloxetine = 152, Placebo = 153; scales incorrectly administered were omitted from summary.|Units on a scale|Mean|14.65|14.65|Standard Deviation|10.04|10.04|||
4105755|NCT00965081|3929438|B1|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4105709|NCT00965081|3929437|B2|||Beck Anxiety Inventory (BAI) Total Score|The BAI is a 21-item patient-completed questionnaire designed to assess characteristics of anxiety. Each item is rated on a 4-point scale (0 = not present; 3 = present in the extreme). This questionnaire was used to rate the severity of anxiety symptoms and any improvement during the course of the trial. The total score ranges from 0 to 63; the higher the score, the more severe the anxiety symptoms. Number of Participants: Duloxetine = 152, Placebo = 153; scales incorrectly administered were omitted from summary.|Units on a scale|Mean|15.04|15.04|Standard Deviation|10.69|10.69|||
4105710|NCT00965081|3929438|B1|||Beck Anxiety Inventory (BAI) Total Score|The BAI is a 21-item patient-completed questionnaire designed to assess characteristics of anxiety. Each item is rated on a 4-point scale (0 = not present; 3 = present in the extreme). This questionnaire was used to rate the severity of anxiety symptoms and any improvement during the course of the trial. The total score ranges from 0 to 63; the higher the score, the more severe the anxiety symptoms. Number of Participants: Duloxetine = 152, Placebo = 153; scales incorrectly administered were omitted from summary.|Units on a scale|Mean|14.26|14.26|Standard Deviation|9.35|9.35|||
4105711|NCT00965081|3929436|B3|||Patient's Global Impressions of Severity (PGI-S) Score|The PGI-S scale is a participant-rated instrument that measures perceived severity of symptoms. It is a 7-point scale where a score of 1 indicates that the patient is “normal, not at all ill,” a score of 4 indicates that the patient is “moderately ill,” and a score of 7 indicates that the patient is “extremely ill.”|Units on a scale|Mean|3.74|3.74|Standard Deviation|1.40|1.4|||
4105712|NCT00965081|3929437|B2|||Patient's Global Impressions of Severity (PGI-S) Score|The PGI-S scale is a participant-rated instrument that measures perceived severity of symptoms. It is a 7-point scale where a score of 1 indicates that the patient is “normal, not at all ill,” a score of 4 indicates that the patient is “moderately ill,” and a score of 7 indicates that the patient is “extremely ill.”|Units on a scale|Mean|3.74|3.74|Standard Deviation|1.47|1.47|||
4105713|NCT00965081|3929438|B1|||Patient's Global Impressions of Severity (PGI-S) Score|The PGI-S scale is a participant-rated instrument that measures perceived severity of symptoms. It is a 7-point scale where a score of 1 indicates that the patient is “normal, not at all ill,” a score of 4 indicates that the patient is “moderately ill,” and a score of 7 indicates that the patient is “extremely ill.”|Units on a scale|Mean|3.74|3.74|Standard Deviation|1.33|1.33|||
4105714|NCT00965081|3929436|B3|||Clinical Global Impression of Severity (CGI-S) for Depression Score|The CGI-S for depression scale evaluates the severity of depression at the time of assessment. The score ranges from 1 (normal, not at all ill) to 7 (among the most extremely ill participants). The CGI-S for depression scale was administered by a study physician in the presence of the participant or after having been in the presence of the participant. Number of Participants: Duloxetine = 153, Placebo = 151; scales incorrectly administered were omitted from summary.|Units on a scale|Mean|2.38|2.38|Standard Deviation|1.42|1.42|||
4105715|NCT00965081|3929437|B2|||Clinical Global Impression of Severity (CGI-S) for Depression Score|The CGI-S for depression scale evaluates the severity of depression at the time of assessment. The score ranges from 1 (normal, not at all ill) to 7 (among the most extremely ill participants). The CGI-S for depression scale was administered by a study physician in the presence of the participant or after having been in the presence of the participant. Number of Participants: Duloxetine = 153, Placebo = 151; scales incorrectly administered were omitted from summary.|Units on a scale|Mean|2.45|2.45|Standard Deviation|1.45|1.45|||
4105716|NCT00965081|3929438|B1|||Clinical Global Impression of Severity (CGI-S) for Depression Score|The CGI-S for depression scale evaluates the severity of depression at the time of assessment. The score ranges from 1 (normal, not at all ill) to 7 (among the most extremely ill participants). The CGI-S for depression scale was administered by a study physician in the presence of the participant or after having been in the presence of the participant. Number of Participants: Duloxetine = 153, Placebo = 151; scales incorrectly administered were omitted from summary.|Units on a scale|Mean|2.30|2.3|Standard Deviation|1.38|1.38|||
4105717|NCT00965081|3929436|B3|||Beck Depression Inventory (BDI) Total Score|The BDI-II is a 21-item patient-completed questionnaire designed to assess characteristics of depression. Each item is rated on a 4-point scale (0 = not present; 3 = present in the extreme). This questionnaire was used to rate the severity of depressive symptoms and any improvement during the course of the trial. The total score ranges from 0 to 63; the higher the score, the more severe the depressive symptoms.|Units on a scale|Mean|15.92|15.92|Standard Deviation|10.61|10.61|||
4105718|NCT00965081|3929437|B2|||Beck Depression Inventory (BDI) Total Score|The BDI-II is a 21-item patient-completed questionnaire designed to assess characteristics of depression. Each item is rated on a 4-point scale (0 = not present; 3 = present in the extreme). This questionnaire was used to rate the severity of depressive symptoms and any improvement during the course of the trial. The total score ranges from 0 to 63; the higher the score, the more severe the depressive symptoms.|Units on a scale|Mean|16.84|16.84|Standard Deviation|11.47|11.47|||
4105719|NCT00965081|3929438|B1|||Beck Depression Inventory (BDI) Total Score|The BDI-II is a 21-item patient-completed questionnaire designed to assess characteristics of depression. Each item is rated on a 4-point scale (0 = not present; 3 = present in the extreme). This questionnaire was used to rate the severity of depressive symptoms and any improvement during the course of the trial. The total score ranges from 0 to 63; the higher the score, the more severe the depressive symptoms.|Units on a scale|Mean|15.00|15.0|Standard Deviation|9.64|9.64|||
4105720|NCT00965081|3929436|B3|||Fibromyalgia Impact Questionnaire (FIQ) Total Score|The FIQ measures participant status, progress, and outcomes over the past week. It consists of 20 items; the first 11 items measure physical functioning. Each item is rated on a 4-point scale. Items 12 and 13 measure number of days participant felt well and number of days participant felt unable to work due to fibromyalgia symptoms. Items 14-20 are numerical, 11-point scales rating work difficulty, pain, fatigue, morning tiredness, stiffness, anxiety, and depression. The total score ranges from 0 to 80. A higher score indicates a more negative impact.|Units on a scale|Mean|50.78|50.78|Standard Deviation|12.94|12.94|||
4105756|NCT00965081|3929436|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
4105757|NCT00965081|3929437|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4105758|NCT00965081|3929438|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4105759|NCT00965081|3929436|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4105721|NCT00965081|3929437|B2|||Fibromyalgia Impact Questionnaire (FIQ) Total Score|The FIQ measures participant status, progress, and outcomes over the past week. It consists of 20 items; the first 11 items measure physical functioning. Each item is rated on a 4-point scale. Items 12 and 13 measure number of days participant felt well and number of days participant felt unable to work due to fibromyalgia symptoms. Items 14-20 are numerical, 11-point scales rating work difficulty, pain, fatigue, morning tiredness, stiffness, anxiety, and depression. The total score ranges from 0 to 80. A higher score indicates a more negative impact.|Units on a scale|Mean|50.44|50.44|Standard Deviation|13.71|13.71|||
4105722|NCT00965081|3929438|B1|||Fibromyalgia Impact Questionnaire (FIQ) Total Score|The FIQ measures participant status, progress, and outcomes over the past week. It consists of 20 items; the first 11 items measure physical functioning. Each item is rated on a 4-point scale. Items 12 and 13 measure number of days participant felt well and number of days participant felt unable to work due to fibromyalgia symptoms. Items 14-20 are numerical, 11-point scales rating work difficulty, pain, fatigue, morning tiredness, stiffness, anxiety, and depression. The total score ranges from 0 to 80. A higher score indicates a more negative impact.|Units on a scale|Mean|51.11|51.11|Standard Deviation|12.17|12.17|||
4105723|NCT00965081|3929436|B3|||Brief Pain Inventory (BPI) Mean Interference Score|The BPI Mean Interference Score measures mean interference of pain on function in the past 24 hours on 7 items including general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Scores range from 0 (does not interfere) to 10 (completely interferes).|Units on a scale|Mean|5.88|5.88|Standard Deviation|2.23|2.23|||
4105724|NCT00965081|3929437|B2|||Brief Pain Inventory (BPI) Mean Interference Score|The BPI Mean Interference Score measures mean interference of pain on function in the past 24 hours on 7 items including general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Scores range from 0 (does not interfere) to 10 (completely interferes).|Units on a scale|Mean|5.78|5.78|Standard Deviation|2.28|2.28|||
4105725|NCT00965081|3929438|B1|||Brief Pain Inventory (BPI) Mean Interference Score|The BPI Mean Interference Score measures mean interference of pain on function in the past 24 hours on 7 items including general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Scores range from 0 (does not interfere) to 10 (completely interferes).|Units on a scale|Mean|5.97|5.97|Standard Deviation|2.17|2.17|||
4105726|NCT00965081|3929436|B3|||Brief Pain Inventory (BPI) Average Pain Score|The BPI-Modified Short Form is a self-reported scale that measures the severity of pain and the interference of pain on function. Severity scores range from 0 (no pain) to 10 (pain as bad as you can imagine). The BPI Average Pain score assesses severity of average pain in the past 24 hours.|Units on a scale|Mean|6.44|6.44|Standard Deviation|1.57|1.57|||
4105727|NCT00965081|3929437|B2|||Brief Pain Inventory (BPI) Average Pain Score|The BPI-Modified Short Form is a self-reported scale that measures the severity of pain and the interference of pain on function. Severity scores range from 0 (no pain) to 10 (pain as bad as you can imagine). The BPI Average Pain score assesses severity of average pain in the past 24 hours.|Units on a scale|Mean|6.37|6.37|Standard Deviation|1.67|1.67|||
4105728|NCT00965081|3929438|B1|||Brief Pain Inventory (BPI) Average Pain Score|The BPI-Modified Short Form is a self-reported scale that measures the severity of pain and the interference of pain on function. Severity scores range from 0 (no pain) to 10 (pain as bad as you can imagine). The BPI Average Pain score assesses severity of average pain in the past 24 hours.|Units on a scale|Mean|6.50|6.5|Standard Deviation|1.47|1.47|||
4105729|NCT00965081|3929436|B3|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared (kg/m^2).|kilograms/meters squared (kg/m2)|Mean|29.20|29.2|Standard Deviation|6.46|6.46|||
4105730|NCT00965081|3929437|B2|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared (kg/m^2).|kilograms/meters squared (kg/m2)|Mean|29.49|29.49|Standard Deviation|6.90|6.9|||
4105731|NCT00965081|3929438|B1|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared (kg/m^2).|kilograms/meters squared (kg/m2)|Mean|28.91|28.91|Standard Deviation|6.00|6.0|||
4105732|NCT00965081|3929436|B3|United States||Region of Enrollment||Participants|Number|112|112.0||||||
4105733|NCT00965081|3929437|B2|United States||Region of Enrollment||Participants|Number|56|56.0||||||
4105734|NCT00965081|3929438|B1|United States||Region of Enrollment||Participants|Number|56|56.0||||||
4105735|NCT00965081|3929436|B3|Puerto Rico||Region of Enrollment||Participants|Number|6|6.0||||||
4105736|NCT00965081|3929437|B2|Puerto Rico||Region of Enrollment||Participants|Number|3|3.0||||||
4105737|NCT00965081|3929438|B1|Puerto Rico||Region of Enrollment||Participants|Number|3|3.0||||||
4105738|NCT00965081|3929436|B3|Mexico||Region of Enrollment||Participants|Number|84|84.0||||||
4105739|NCT00965081|3929437|B2|Mexico||Region of Enrollment||Participants|Number|42|42.0||||||
4105740|NCT00965081|3929438|B1|Mexico||Region of Enrollment||Participants|Number|42|42.0||||||
4105741|NCT00965081|3929436|B3|Israel||Region of Enrollment||Participants|Number|28|28.0||||||
4105742|NCT00965081|3929437|B2|Israel||Region of Enrollment||Participants|Number|14|14.0||||||
4105743|NCT00965081|3929438|B1|Israel||Region of Enrollment||Participants|Number|14|14.0||||||
4105744|NCT00965081|3929436|B3|Argentina||Region of Enrollment||Participants|Number|78|78.0||||||
4105745|NCT00965081|3929437|B2|Argentina||Region of Enrollment||Participants|Number|38|38.0||||||
4105746|NCT00965081|3929438|B1|Argentina||Region of Enrollment||Participants|Number|40|40.0||||||
4105747|NCT00965081|3929436|B3|White||Race/Ethnicity, Customized||Participants|Number|269|269.0||||||
4105748|NCT00965081|3929437|B2|White||Race/Ethnicity, Customized||Participants|Number|136|136.0||||||
4105749|NCT00965081|3929438|B1|White||Race/Ethnicity, Customized||Participants|Number|133|133.0||||||
4105750|NCT00965081|3929436|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4105751|NCT00965081|3929437|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4105752|NCT00965081|3929438|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4105753|NCT00965081|3929436|B3|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4105754|NCT00965081|3929437|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4105760|NCT00965081|3929437|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4105761|NCT00965081|3929438|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4105762|NCT00965081|3929436|B3||Female|Sex: Female, Male||Participants|Count of Participants|293|293.0||||||
4105763|NCT00965081|3929437|B2||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4105764|NCT00965081|3929438|B1||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4105765|NCT00965081|3929436|B3|||Age||Years|Mean|50.80|50.8|Standard Deviation|12.16|12.16|||
4105766|NCT00965081|3929437|B2|||Age||Years|Mean|50.72|50.72|Standard Deviation|12.45|12.45|||
4105767|NCT00965081|3929438|B1|||Age||Years|Mean|50.89|50.89|Standard Deviation|11.90|11.9|||
4105768|NCT00964886|3929462|B5|Back Pain Disability (Roland and Morris)||Pain Intensity and Back Pain Disability|"The DDS is self-report measure of current pain intensity on a 20 point scale relative to 12 adjectival descriptor words which serve as anchors (eg, greater or less than faint, moderate, strong). Scores range from 0 to 20 with higher scores indicating higher pain intensity.~The Roland and Morris questionnaire is a 24-item checklist asking patients whether or not back pain limits activities they normally do (eg, I stay at home most of the time because of my back). Scores range from 0 to 24, with higher scores indicating greater disability in everyday function due to back pain"|units on a scale|Mean|11.8|11.8|Standard Deviation|4.9|4.9|||
4105769|NCT00964886|3929463|B4|Back Pain Disability (Roland and Morris)||Pain Intensity and Back Pain Disability|"The DDS is self-report measure of current pain intensity on a 20 point scale relative to 12 adjectival descriptor words which serve as anchors (eg, greater or less than faint, moderate, strong). Scores range from 0 to 20 with higher scores indicating higher pain intensity.~The Roland and Morris questionnaire is a 24-item checklist asking patients whether or not back pain limits activities they normally do (eg, I stay at home most of the time because of my back). Scores range from 0 to 24, with higher scores indicating greater disability in everyday function due to back pain"|units on a scale|Mean|12.6|12.6|Standard Deviation|3.8|3.8|||
4105770|NCT00964886|3929464|B3|Back Pain Disability (Roland and Morris)||Pain Intensity and Back Pain Disability|"The DDS is self-report measure of current pain intensity on a 20 point scale relative to 12 adjectival descriptor words which serve as anchors (eg, greater or less than faint, moderate, strong). Scores range from 0 to 20 with higher scores indicating higher pain intensity.~The Roland and Morris questionnaire is a 24-item checklist asking patients whether or not back pain limits activities they normally do (eg, I stay at home most of the time because of my back). Scores range from 0 to 24, with higher scores indicating greater disability in everyday function due to back pain"|units on a scale|Mean|11.7|11.7|Standard Deviation|5.4|5.4|||
4105771|NCT00964886|3929465|B2|Back Pain Disability (Roland and Morris)||Pain Intensity and Back Pain Disability|"The DDS is self-report measure of current pain intensity on a 20 point scale relative to 12 adjectival descriptor words which serve as anchors (eg, greater or less than faint, moderate, strong). Scores range from 0 to 20 with higher scores indicating higher pain intensity.~The Roland and Morris questionnaire is a 24-item checklist asking patients whether or not back pain limits activities they normally do (eg, I stay at home most of the time because of my back). Scores range from 0 to 24, with higher scores indicating greater disability in everyday function due to back pain"|units on a scale|Mean|13.0|13.0|Standard Deviation|4.3|4.3|||
4105772|NCT00964886|3929466|B1|Back Pain Disability (Roland and Morris)||Pain Intensity and Back Pain Disability|"The DDS is self-report measure of current pain intensity on a 20 point scale relative to 12 adjectival descriptor words which serve as anchors (eg, greater or less than faint, moderate, strong). Scores range from 0 to 20 with higher scores indicating higher pain intensity.~The Roland and Morris questionnaire is a 24-item checklist asking patients whether or not back pain limits activities they normally do (eg, I stay at home most of the time because of my back). Scores range from 0 to 24, with higher scores indicating greater disability in everyday function due to back pain"|units on a scale|Mean|8.7|8.7|Standard Deviation|5.4|5.4|||
4105773|NCT00964886|3929462|B5|Pain Intensity (Descriptor Differential Scale)||Pain Intensity and Back Pain Disability|"The DDS is self-report measure of current pain intensity on a 20 point scale relative to 12 adjectival descriptor words which serve as anchors (eg, greater or less than faint, moderate, strong). Scores range from 0 to 20 with higher scores indicating higher pain intensity.~The Roland and Morris questionnaire is a 24-item checklist asking patients whether or not back pain limits activities they normally do (eg, I stay at home most of the time because of my back). Scores range from 0 to 24, with higher scores indicating greater disability in everyday function due to back pain"|units on a scale|Mean|11.4|11.4|Standard Deviation|4.0|4.0|||
4105774|NCT00964886|3929463|B4|Pain Intensity (Descriptor Differential Scale)||Pain Intensity and Back Pain Disability|"The DDS is self-report measure of current pain intensity on a 20 point scale relative to 12 adjectival descriptor words which serve as anchors (eg, greater or less than faint, moderate, strong). Scores range from 0 to 20 with higher scores indicating higher pain intensity.~The Roland and Morris questionnaire is a 24-item checklist asking patients whether or not back pain limits activities they normally do (eg, I stay at home most of the time because of my back). Scores range from 0 to 24, with higher scores indicating greater disability in everyday function due to back pain"|units on a scale|Mean|12.1|12.1|Standard Deviation|4.6|4.6|||
4105775|NCT00964886|3929464|B3|Pain Intensity (Descriptor Differential Scale)||Pain Intensity and Back Pain Disability|"The DDS is self-report measure of current pain intensity on a 20 point scale relative to 12 adjectival descriptor words which serve as anchors (eg, greater or less than faint, moderate, strong). Scores range from 0 to 20 with higher scores indicating higher pain intensity.~The Roland and Morris questionnaire is a 24-item checklist asking patients whether or not back pain limits activities they normally do (eg, I stay at home most of the time because of my back). Scores range from 0 to 24, with higher scores indicating greater disability in everyday function due to back pain"|units on a scale|Mean|11.9|11.9|Standard Deviation|5.1|5.1|||
4105823|NCT00964886|3929462|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
4105824|NCT00964886|3929463|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4105825|NCT00964886|3929464|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4105826|NCT00964886|3929465|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4105776|NCT00964886|3929465|B2|Pain Intensity (Descriptor Differential Scale)||Pain Intensity and Back Pain Disability|"The DDS is self-report measure of current pain intensity on a 20 point scale relative to 12 adjectival descriptor words which serve as anchors (eg, greater or less than faint, moderate, strong). Scores range from 0 to 20 with higher scores indicating higher pain intensity.~The Roland and Morris questionnaire is a 24-item checklist asking patients whether or not back pain limits activities they normally do (eg, I stay at home most of the time because of my back). Scores range from 0 to 24, with higher scores indicating greater disability in everyday function due to back pain"|units on a scale|Mean|11.9|11.9|Standard Deviation|4.3|4.3|||
4105777|NCT00964886|3929466|B1|Pain Intensity (Descriptor Differential Scale)||Pain Intensity and Back Pain Disability|"The DDS is self-report measure of current pain intensity on a 20 point scale relative to 12 adjectival descriptor words which serve as anchors (eg, greater or less than faint, moderate, strong). Scores range from 0 to 20 with higher scores indicating higher pain intensity.~The Roland and Morris questionnaire is a 24-item checklist asking patients whether or not back pain limits activities they normally do (eg, I stay at home most of the time because of my back). Scores range from 0 to 24, with higher scores indicating greater disability in everyday function due to back pain"|units on a scale|Mean|9.9|9.9|Standard Deviation|4.9|4.9|||
4105778|NCT00964886|3929462|B5|United States||Region of Enrollment||participants|Number|139|139.0||||||
4105779|NCT00964886|3929463|B4|United States||Region of Enrollment||participants|Number|32|32.0||||||
4105780|NCT00964886|3929464|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
4105781|NCT00964886|3929465|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4105782|NCT00964886|3929466|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4105783|NCT00964886|3929462|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4105784|NCT00964886|3929463|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4105785|NCT00964886|3929464|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4105786|NCT00964886|3929465|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4105787|NCT00964886|3929466|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4105788|NCT00964886|3929462|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4105789|NCT00964886|3929463|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4105790|NCT00964886|3929464|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4105791|NCT00964886|3929465|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4105792|NCT00964886|3929466|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4105793|NCT00964886|3929462|B5||White|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
4105794|NCT00964886|3929463|B4||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4105795|NCT00964886|3929464|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4105796|NCT00964886|3929465|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4105797|NCT00964886|3929466|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4105798|NCT00964886|3929462|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4105799|NCT00964886|3929463|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4105800|NCT00964886|3929464|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4105801|NCT00964886|3929465|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4105802|NCT00964886|3929466|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4105803|NCT00964886|3929462|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4105804|NCT00964886|3929463|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4105805|NCT00964886|3929464|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4105806|NCT00964886|3929465|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4105807|NCT00964886|3929466|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4105808|NCT00964886|3929462|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4105809|NCT00964886|3929463|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4105810|NCT00964886|3929464|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4105811|NCT00964886|3929465|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4105812|NCT00964886|3929466|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4105813|NCT00964886|3929462|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4105814|NCT00964886|3929463|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4105815|NCT00964886|3929464|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4105816|NCT00964886|3929465|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4105817|NCT00964886|3929466|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4105818|NCT00964886|3929462|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4105819|NCT00964886|3929463|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4105820|NCT00964886|3929464|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4105821|NCT00964886|3929465|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4105822|NCT00964886|3929466|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4105827|NCT00964886|3929466|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4105828|NCT00964886|3929462|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4105829|NCT00964886|3929463|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4105830|NCT00964886|3929464|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4105831|NCT00964886|3929465|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4105832|NCT00964886|3929466|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4105833|NCT00964886|3929462|B5||Male|Gender||Participants|Count of Participants|123|123.0||||||
4105834|NCT00964886|3929463|B4||Male|Gender||Participants|Count of Participants|28|28.0||||||
4105835|NCT00964886|3929464|B3||Male|Gender||Participants|Count of Participants|34|34.0||||||
4105836|NCT00964886|3929465|B2||Male|Gender||Participants|Count of Participants|29|29.0||||||
4105837|NCT00964886|3929466|B1||Male|Gender||Participants|Count of Participants|32|32.0||||||
4105838|NCT00964886|3929462|B5||Female|Gender||Participants|Count of Participants|15|15.0||||||
4105839|NCT00964886|3929463|B4||Female|Gender||Participants|Count of Participants|3|3.0||||||
4105840|NCT00964886|3929464|B3||Female|Gender||Participants|Count of Participants|3|3.0||||||
4105841|NCT00964886|3929465|B2||Female|Gender||Participants|Count of Participants|4|4.0||||||
4105842|NCT00964886|3929466|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
4105843|NCT00964886|3929462|B5|||Age||years|Mean|55.8|55.8|Standard Deviation|11.7|11.7|||
4105844|NCT00964886|3929463|B4|||Age||years|Mean|57.9|57.9|Standard Deviation|10.9|10.9|||
4105845|NCT00964886|3929464|B3|||Age||years|Mean|51.5|51.5|Standard Deviation|13.7|13.7|||
4105846|NCT00964886|3929465|B2|||Age||years|Mean|57.8|57.8|Standard Deviation|9.2|9.2|||
4105847|NCT00964886|3929466|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|11.7|11.7|||
4105848|NCT00964860|3929483|B3|Guatemala||Region of Enrollment||participants|Number|60|60.0||||||
4105849|NCT00964860|3929484|B2|Guatemala||Region of Enrollment||participants|Number|30|30.0||||||
4105850|NCT00964860|3929485|B1|Guatemala||Region of Enrollment||participants|Number|30|30.0||||||
4105851|NCT00964860|3929483|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4105852|NCT00964860|3929484|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4105853|NCT00964860|3929485|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4105854|NCT00964860|3929483|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4105855|NCT00964860|3929484|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4105856|NCT00964860|3929485|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4105857|NCT00964860|3929483|B3|||Age||years|Mean|28.6|28.6|Standard Deviation|8.1|8.1|||
4105858|NCT00964860|3929484|B2|||Age||years|Mean|28.2|28.2|Standard Deviation|8.5|8.5|||
4105859|NCT00964860|3929485|B1|||Age||years|Mean|29.0|29.0|Standard Deviation|7.8|7.8|||
4105860|NCT00964860|3929483|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4105861|NCT00964860|3929484|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4105862|NCT00964860|3929485|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4105863|NCT00964860|3929483|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4105864|NCT00964860|3929484|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4105865|NCT00964860|3929485|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4105866|NCT00964860|3929483|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105867|NCT00964860|3929484|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105868|NCT00964860|3929485|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105869|NCT00964795|3929494|B1||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4105870|NCT00964795|3929494|B1||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4105871|NCT00964795|3929494|B1|||Age||years|Mean|79|79.0|Standard Deviation|7.83|7.83|||
4105872|NCT00964743|3929501|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4105873|NCT00964743|3929501|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4105874|NCT00964743|3929501|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4105875|NCT00964743|3929501|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4105876|NCT00964743|3929501|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4105877|NCT00964743|3929501|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105878|NCT00964678|3929509|B1|||Six minute walk distance||meters|Mean|321|321.0|Full Range|||292.0|559.0|
4105879|NCT00964678|3929509|B1|||Right ventricular ejection fraction of blood||% of ejected ventricular vol of blood|Mean|38|38.0|Full Range|||19.0|56.0|
4105880|NCT00964678|3929509|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4105881|NCT00964678|3929509|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4105882|NCT00964678|3929509|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4105883|NCT00964678|3929509|B1|||Age||years|Mean|60.6|60.6|Full Range|||49.0|73.0|
4105884|NCT00964678|3929509|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4105885|NCT00964678|3929509|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4105886|NCT00964678|3929509|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105887|NCT00964548|3929516|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4105888|NCT00964548|3929517|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4105889|NCT00964548|3929518|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4105890|NCT00964548|3929516|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4105891|NCT00964548|3929517|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4105892|NCT00964548|3929518|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4105893|NCT00964548|3929516|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4105894|NCT00964548|3929517|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4105895|NCT00964548|3929518|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4105896|NCT00964548|3929516|B3|||Age||years|Mean|43|43.0|Standard Deviation|9.5|9.5|||
4105897|NCT00964548|3929517|B2|||Age||years|Mean|44|44.0|Standard Deviation|10|10.0|||
4105898|NCT00964548|3929518|B1|||Age||years|Mean|42|42.0|Standard Deviation|9|9.0|||
4105899|NCT00964548|3929516|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4105900|NCT00964548|3929517|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4105901|NCT00964548|3929518|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4105902|NCT00964548|3929516|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4105903|NCT00964548|3929517|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4105904|NCT00964548|3929518|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4105905|NCT00964548|3929516|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105906|NCT00964548|3929517|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105907|NCT00964548|3929518|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105908|NCT00964496|3929529|B3|||pre-bleeding episodes per year||bleeding episodes|Mean|13.96|13.96|Standard Deviation|3.394|3.394|7.0|21.0|
4105909|NCT00964496|3929530|B2|||pre-bleeding episodes per year||bleeding episodes|Mean|13.96|13.96|Standard Deviation|3.469|3.469|7.0|21.0|
4105910|NCT00964496|3929531|B1|||pre-bleeding episodes per year||bleeding episodes|Mean|13.96|13.96|Standard Deviation|3.383|3.383|7.0|19.0|
4105911|NCT00964496|3929529|B3|||White blood cell (WBC)||10^9/L|Mean|6.5164|6.5164|Standard Deviation|1.6416|1.6416|||
4105912|NCT00964496|3929530|B2|||White blood cell (WBC)||10^9/L|Mean|6.5926|6.5926|Standard Deviation|1.7389|1.7389|||
4105913|NCT00964496|3929531|B1|||White blood cell (WBC)||10^9/L|Mean|6.4429|6.4429|Standard Deviation|1.5704|1.5704|||
4105914|NCT00964496|3929529|B3|||Total bilirubin||μmol/L|Mean|9.1509|9.1509|Standard Deviation|4.2361|4.2361|||
4105915|NCT00964496|3929530|B2|||Total bilirubin||μmol/L|Mean|9.1407|9.1407|Standard Deviation|4.1196|4.1196|||
4105916|NCT00964496|3929531|B1|||Total bilirubin||μmol/L|Mean|9.1607|9.1607|Standard Deviation|4.4212|4.4212|||
4105917|NCT00964496|3929529|B3|||Serum creatinine||mg/dl|Mean|83.1382|83.1382|Standard Deviation|23.1514|23.1514|||
4105918|NCT00964496|3929530|B2|||Serum creatinine||mg/dl|Mean|88.9296|88.9296|Standard Deviation|24.2665|24.2665|||
4105919|NCT00964496|3929531|B1|||Serum creatinine||mg/dl|Mean|77.5536|77.5536|Standard Deviation|20.9532|20.9532|||
4105920|NCT00964496|3929529|B3|||Prothrombin time-international normalized ratio (PT-INR)||seconds|Mean|1.0765|1.0765|Standard Deviation|0.1534|0.1534|||
4105921|NCT00964496|3929530|B2|||Prothrombin time-international normalized ratio (PT-INR)||seconds|Mean|1.0989|1.0989|Standard Deviation|0.1533|0.1533|||
4105922|NCT00964496|3929531|B1|||Prothrombin time-international normalized ratio (PT-INR)||seconds|Mean|1.0550|1.055|Standard Deviation|0.1530|0.153|||
4105923|NCT00964496|3929529|B3|||Pre-treatment hemoglobin level||g/dl|Mean|6.1996|6.1996|Standard Deviation|1.6652|1.6652|||
4105924|NCT00964496|3929530|B2|||Pre-treatment hemoglobin level||g/dl|Mean|5.9919|5.9919|Standard Deviation|1.5304|1.5304|||
4105925|NCT00964496|3929531|B1|||Pre-treatment hemoglobin level||g/dl|Mean|6.4000|6.4|Standard Deviation|1.7904|1.7904|||
4105926|NCT00964496|3929529|B3|||Pre-bleeding duration||days|Mean|8.7818|8.7818|Standard Deviation|3.8088|3.8088|3.0|21.0|
4105927|NCT00964496|3929530|B2|||Pre-bleeding duration||days|Mean|8.7407|8.7407|Standard Deviation|4.5029|4.5029|3.0|21.0|
4105928|NCT00964496|3929531|B1|||Pre-bleeding duration||days|Mean|8.8214|8.8214|Standard Deviation|3.0799|3.0799|5.0|20.0|
4105929|NCT00964496|3929529|B3|||Pre- packed red cell units transfused per year|Total packed red cell units transfused per year(milliliter) before randomization in transfusion dependent subjects.|milliliter|Mean|1957.14|1957.14|Standard Deviation|751.01|751.01|||
4105930|NCT00964496|3929530|B2|||Pre- packed red cell units transfused per year|Total packed red cell units transfused per year(milliliter) before randomization in transfusion dependent subjects.|milliliter|Mean|1985.71|1985.71|Standard Deviation|766.47|766.47|||
4105931|NCT00964496|3929531|B1|||Pre- packed red cell units transfused per year|Total packed red cell units transfused per year(milliliter) before randomization in transfusion dependent subjects.|milliliter|Mean|1928.57|1928.57|Standard Deviation|763.02|763.02|||
4105932|NCT00964496|3929529|B3|||Platelet count (PLT)||10^9/L|Mean|202.1618|202.1618|Standard Deviation|56.3131|56.3131|||
4105933|NCT00964496|3929530|B2|||Platelet count (PLT)||10^9/L|Mean|197.7111|197.7111|Standard Deviation|60.0851|60.0851|||
4105934|NCT00964496|3929531|B1|||Platelet count (PLT)||10^9/L|Mean|206.4536|206.4536|Standard Deviation|53.1686|53.1686|||
4105935|NCT00964496|3929529|B3|||Mean Corpuscular Hemoglobin Concentration||g/L|Mean|297.4000|297.4|Standard Deviation|14.2888|14.2888|||
4105936|NCT00964496|3929530|B2|||Mean Corpuscular Hemoglobin Concentration||g/L|Mean|299.0000|299.0|Standard Deviation|13.3012|13.3012|||
4105937|NCT00964496|3929531|B1|||Mean Corpuscular Hemoglobin Concentration||g/L|Mean|295.8571|295.8571|Standard Deviation|15.2624|15.2624|||
4105938|NCT00964496|3929529|B3|||Mean corpuscular volume (MCV)||femtoliter|Mean|76.0364|76.0364|Standard Deviation|4.2282|4.2282|||
4105939|NCT00964496|3929530|B2|||Mean corpuscular volume (MCV)||femtoliter|Mean|75.2444|75.2444|Standard Deviation|4.4130|4.413|||
4105940|NCT00964496|3929531|B1|||Mean corpuscular volume (MCV)||femtoliter|Mean|76.8000|76.8|Standard Deviation|3.9711|3.9711|||
4105941|NCT00964496|3929529|B3|||History of bleeding time||years|Median|5|5.0|Full Range|4.2552|4.2552|1.0|21.0|
4105942|NCT00964496|3929530|B2|||History of bleeding time||years|Median|3|3.0|Full Range|4.4331|4.4331|1.0|20.0|
4105943|NCT00964496|3929531|B1|||History of bleeding time||years|Median|5|5.0|Full Range|4.1404|4.1404|1.0|21.0|
4105944|NCT00964496|3929529|B3|||Glutamic-pyruvic transaminase (GPT)||IU/L|Mean|25.0045|25.0045|Standard Deviation|12.4753|12.4753|||
4105945|NCT00964496|3929530|B2|||Glutamic-pyruvic transaminase (GPT)||IU/L|Mean|25.2019|25.2019|Standard Deviation|14.1123|14.1123|||
4105946|NCT00964496|3929531|B1|||Glutamic-pyruvic transaminase (GPT)||IU/L|Mean|24.8143|24.8143|Standard Deviation|13.4963|13.4963|||
4105947|NCT00964496|3929529|B3|||Follow-up time||months|Mean|35.5273|35.5273|Standard Deviation|13.50563|13.50563|||
4105948|NCT00964496|3929530|B2|||Follow-up time||months|Mean|36.1481|36.1481|Standard Deviation|13.49274|13.49274|||
4105949|NCT00964496|3929531|B1|||Follow-up time||months|Mean|34.9286|34.9286|Standard Deviation|13.73810|13.7381|||
4105950|NCT00964496|3929529|B3|||Activated partial thromboplastin time (APTT)||seconds|Mean|27.7745|27.7745|Standard Deviation|6.1760|6.176|||
4105951|NCT00964496|3929530|B2|||Activated partial thromboplastin time (APTT)||seconds|Mean|28.0667|28.0667|Standard Deviation|5.9947|5.9947|||
4105952|NCT00964496|3929531|B1|||Activated partial thromboplastin time (APTT)||seconds|Mean|27.4929|27.4929|Standard Deviation|6.4430|6.443|||
4105953|NCT00964496|3929529|B3|Gastroscopy||Ways of diagnose||participants|Number|3|3.0||||||
4105954|NCT00964496|3929530|B2|Gastroscopy||Ways of diagnose||participants|Number|1|1.0||||||
4105955|NCT00964496|3929531|B1|Gastroscopy||Ways of diagnose||participants|Number|2|2.0||||||
4105956|NCT00964496|3929529|B3|Enteroscopies||Ways of diagnose||participants|Number|4|4.0||||||
4105957|NCT00964496|3929530|B2|Enteroscopies||Ways of diagnose||participants|Number|2|2.0||||||
4105958|NCT00964496|3929531|B1|Enteroscopies||Ways of diagnose||participants|Number|2|2.0||||||
4105959|NCT00964496|3929529|B3|Capsule endoscopy||Ways of diagnose||participants|Number|48|48.0||||||
4105960|NCT00964496|3929530|B2|Capsule endoscopy||Ways of diagnose||participants|Number|24|24.0||||||
4105961|NCT00964496|3929531|B1|Capsule endoscopy||Ways of diagnose||participants|Number|24|24.0||||||
4105962|NCT00964496|3929529|B3|independent||Transfusion dependence||participants|Number|27|27.0||||||
4105963|NCT00964496|3929530|B2|independent||Transfusion dependence||participants|Number|13|13.0||||||
4105964|NCT00964496|3929531|B1|independent||Transfusion dependence||participants|Number|14|14.0||||||
4105965|NCT00964496|3929529|B3|dependent||Transfusion dependence||participants|Number|28|28.0||||||
4105966|NCT00964496|3929530|B2|dependent||Transfusion dependence||participants|Number|14|14.0||||||
4105967|NCT00964496|3929531|B1|dependent||Transfusion dependence||participants|Number|14|14.0||||||
4105968|NCT00964496|3929529|B3|Incomplete study||Outcome||participants|Number|3|3.0||||||
4105969|NCT00964496|3929530|B2|Incomplete study||Outcome||participants|Number|1|1.0||||||
4105970|NCT00964496|3929531|B1|Incomplete study||Outcome||participants|Number|2|2.0||||||
4105971|NCT00964496|3929529|B3|Completion of study||Outcome||participants|Number|52|52.0||||||
4105972|NCT00964496|3929530|B2|Completion of study||Outcome||participants|Number|26|26.0||||||
4105973|NCT00964496|3929531|B1|Completion of study||Outcome||participants|Number|26|26.0||||||
4105974|NCT00964496|3929529|B3|Single||Location||participants|Number|28|28.0||||||
4105975|NCT00964496|3929530|B2|Single||Location||participants|Number|13|13.0||||||
4105976|NCT00964496|3929531|B1|Single||Location||participants|Number|15|15.0||||||
4105977|NCT00964496|3929529|B3|Multiple||Location||participants|Number|27|27.0||||||
4105978|NCT00964496|3929530|B2|Multiple||Location||participants|Number|14|14.0||||||
4105979|NCT00964496|3929531|B1|Multiple||Location||participants|Number|13|13.0||||||
4105980|NCT00964496|3929529|B3|China||Region of Enrollment||participants|Number|55|55.0||||||
4105981|NCT00964496|3929530|B2|China||Region of Enrollment||participants|Number|27|27.0||||||
4105982|NCT00964496|3929531|B1|China||Region of Enrollment||participants|Number|28|28.0||||||
4105983|NCT00964496|3929529|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4105984|NCT00964496|3929530|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4105985|NCT00964496|3929531|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4105986|NCT00964496|3929529|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4105987|NCT00964496|3929530|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4105988|NCT00964496|3929531|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4105989|NCT00964496|3929529|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4105990|NCT00964496|3929530|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4105991|NCT00964496|3929531|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4105992|NCT00964496|3929529|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4105993|NCT00964496|3929530|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4105994|NCT00964496|3929531|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4105995|NCT00964496|3929529|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105996|NCT00964496|3929530|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105997|NCT00964496|3929531|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4105998|NCT00964444|3929550|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4105999|NCT00964444|3929550|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4106000|NCT00964444|3929550|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4106001|NCT00964444|3929550|B1|||Age||years|Mean|25.6|25.6|Standard Deviation|4.4|4.4|||
4106002|NCT00964444|3929550|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4106003|NCT00964444|3929550|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4106004|NCT00964444|3929550|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4106005|NCT00964431|3929554|B5|United States||Region of Enrollment||participants|Number|203|203.0||||||
4106006|NCT00964431|3929555|B4|United States||Region of Enrollment||participants|Number|51|51.0||||||
4106007|NCT00964431|3929556|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
4106008|NCT00964431|3929557|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
4106009|NCT00964431|3929558|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4106010|NCT00964431|3929554|B5||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4106011|NCT00964431|3929555|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4106012|NCT00964431|3929556|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4106013|NCT00964431|3929557|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4106014|NCT00964431|3929558|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4106015|NCT00964431|3929554|B5||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4106016|NCT00964431|3929555|B4||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4106017|NCT00964431|3929556|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4106018|NCT00964431|3929557|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4106019|NCT00964431|3929558|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4106020|NCT00964431|3929554|B5|||Age||years|Mean|22.1|22.1|Standard Deviation|3.38|3.38|||
4106021|NCT00964431|3929555|B4|||Age||years|Mean|22.1|22.1|Standard Deviation|2.97|2.97|||
4106022|NCT00964431|3929556|B3|||Age||years|Mean|22.1|22.1|Standard Deviation|3.46|3.46|||
4106023|NCT00964431|3929557|B2|||Age||years|Mean|22.2|22.2|Standard Deviation|3.81|3.81|||
4106024|NCT00964431|3929558|B1|||Age||years|Mean|22.0|22.0|Standard Deviation|3.32|3.32|||
4106025|NCT00964431|3929554|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4106026|NCT00964431|3929555|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4106027|NCT00964431|3929556|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4106028|NCT00964431|3929557|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4106029|NCT00964431|3929558|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4106030|NCT00964431|3929554|B5||Between 18 and 65 years|Age||Participants|Count of Participants|203|203.0||||||
4106031|NCT00964431|3929555|B4||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4106032|NCT00964431|3929556|B3||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4106033|NCT00964431|3929557|B2||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4106034|NCT00964431|3929558|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4106035|NCT00964431|3929554|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4106036|NCT00964431|3929555|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4106037|NCT00964431|3929556|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4106038|NCT00964431|3929557|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4106039|NCT00964431|3929558|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4106040|NCT00964392|3929571|B3|United States||Region of Enrollment||participants|Number|420|420.0||||||
4106041|NCT00964392|3929572|B2|United States||Region of Enrollment||participants|Number|292|292.0||||||
4106042|NCT00964392|3929573|B1|United States||Region of Enrollment||participants|Number|128|128.0||||||
4106043|NCT00964392|3929571|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4106044|NCT00964392|3929572|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4106045|NCT00964392|3929573|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4106046|NCT00964392|3929571|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106047|NCT00964392|3929572|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106048|NCT00964392|3929573|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106049|NCT00964392|3929571|B3||White|Race (NIH/OMB)||Participants|Count of Participants|387|387.0||||||
4106050|NCT00964392|3929572|B2||White|Race (NIH/OMB)||Participants|Count of Participants|262|262.0||||||
4106051|NCT00964392|3929573|B1||White|Race (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
4106052|NCT00964392|3929571|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4106053|NCT00964392|3929572|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4106054|NCT00964392|3929573|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4106055|NCT00964392|3929571|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106056|NCT00964392|3929572|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106057|NCT00964392|3929573|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106058|NCT00964392|3929571|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4106059|NCT00964392|3929572|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4106060|NCT00964392|3929573|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4106061|NCT00964392|3929571|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106062|NCT00964392|3929572|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106063|NCT00964392|3929573|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106064|NCT00964392|3929571|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4106065|NCT00964392|3929572|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4106066|NCT00964392|3929573|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106067|NCT00964392|3929571|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|410|410.0||||||
4106068|NCT00964392|3929572|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|284|284.0||||||
4106069|NCT00964392|3929573|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
4106070|NCT00964392|3929571|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4106071|NCT00964392|3929572|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4106072|NCT00964392|3929573|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4106073|NCT00964392|3929571|B3||Male|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
4106074|NCT00964392|3929572|B2||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4106075|NCT00964392|3929573|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4106076|NCT00964392|3929571|B3||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4106077|NCT00964392|3929572|B2||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4106078|NCT00964392|3929573|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4106079|NCT00964392|3929571|B3|||Age||years|Mean|60.5|60.5|Standard Deviation|9.5|9.5|||
4106080|NCT00964392|3929572|B2|||Age||years|Mean|60.3|60.3|Standard Deviation|9.5|9.5|||
4106081|NCT00964392|3929573|B1|||Age||years|Mean|61.0|61.0|Standard Deviation|9.6|9.6|||
4106082|NCT00964366|3929582|B3|United States||Region of Enrollment||participants|Number|53|53.0||||||
4106083|NCT00964366|3929583|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4106084|NCT00964366|3929584|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4106085|NCT00964366|3929582|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4106086|NCT00964366|3929583|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4106087|NCT00964366|3929584|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4106088|NCT00964366|3929582|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4106089|NCT00964366|3929583|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4106090|NCT00964366|3929584|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4106091|NCT00964366|3929582|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4106092|NCT00964366|3929583|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4106093|NCT00964366|3929584|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4106094|NCT00964366|3929582|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4106095|NCT00964366|3929583|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4106096|NCT00964366|3929584|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4106097|NCT00964366|3929582|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4106098|NCT00964366|3929583|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4106099|NCT00964366|3929584|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4106100|NCT00964223|3929599|B1|||Total Acne Lesion Count|Total acne lesion count (includes inflammatory and non-inflammatory lesions)|Acne lesions|Mean|54.5|54.5|Standard Deviation|27.1|27.1|||
4106101|NCT00964223|3929599|B1|||Non-Inflammatory Acne Lesion Count|Non-Inflammatory acne lesion count at baseline (number of whiteheads and blackheads)|Non-Inflammatory lesion|Mean|33.0|33.0|Standard Deviation|24.7|24.7|||
4106102|NCT00964223|3929599|B1|||Inflammatory Acne Lesion Count|Inflammatory acne lesion count at baseline (number of pustules and papules).|Inflammatory Lesion|Mean|21.5|21.5|Standard Deviation|9.3|9.3|||
4106103|NCT00964223|3929599|B1|Severe||Investigators Static Global Assessment (ISGA)|Patients with the following ISGA grades were eligible for enrollment on this study: 0, Clear: clear skin with no inflammatory lesions (IL) or non-inflammatory lesions (NIL); 1, Almost clear: rare NIL with no more than one small IL; 2, Mild: some NIL with no more than a few IL (papules/pustules only, no nodular lesions); 3, Moderate: up to many NIL and may have some IL, but no more than one small nodular lesion; 4, Severe: up to many NIL and IL, but no more than a few small nodular lesions; 5, Very severe: many NIL and IL and more than a few nodular lesions. May have cystic lesions.|Participants|Number|6|6.0||||||
4106104|NCT00964223|3929599|B1|Moderate||Investigators Static Global Assessment (ISGA)|Patients with the following ISGA grades were eligible for enrollment on this study: 0, Clear: clear skin with no inflammatory lesions (IL) or non-inflammatory lesions (NIL); 1, Almost clear: rare NIL with no more than one small IL; 2, Mild: some NIL with no more than a few IL (papules/pustules only, no nodular lesions); 3, Moderate: up to many NIL and may have some IL, but no more than one small nodular lesion; 4, Severe: up to many NIL and IL, but no more than a few small nodular lesions; 5, Very severe: many NIL and IL and more than a few nodular lesions. May have cystic lesions.|Participants|Number|20|20.0||||||
4106105|NCT00964223|3929599|B1|Mild||Investigators Static Global Assessment (ISGA)|Patients with the following ISGA grades were eligible for enrollment on this study: 0, Clear: clear skin with no inflammatory lesions (IL) or non-inflammatory lesions (NIL); 1, Almost clear: rare NIL with no more than one small IL; 2, Mild: some NIL with no more than a few IL (papules/pustules only, no nodular lesions); 3, Moderate: up to many NIL and may have some IL, but no more than one small nodular lesion; 4, Severe: up to many NIL and IL, but no more than a few small nodular lesions; 5, Very severe: many NIL and IL and more than a few nodular lesions. May have cystic lesions.|Participants|Number|2|2.0||||||
4106106|NCT00964223|3929599|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4106107|NCT00964223|3929599|B1|White||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4106108|NCT00964223|3929599|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4106109|NCT00964223|3929599|B1|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4106110|NCT00964223|3929599|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4106111|NCT00964223|3929599|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4106112|NCT00964223|3929599|B1|||Age||years|Mean|29.6|29.6|Standard Deviation|9.5|9.5|||
4106113|NCT00964158|3929664|B4|Geographic ancestry|Unspecified|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4106114|NCT00964158|3929665|B3|Geographic ancestry|Unspecified|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4106115|NCT00964158|3929666|B2|Geographic ancestry|Unspecified|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4106116|NCT00964158|3929667|B1|Geographic ancestry|Unspecified|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4106117|NCT00964158|3929664|B4|Geographic ancestry|White - Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|208|208.0||||||
4106118|NCT00964158|3929665|B3|Geographic ancestry|White - Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|99|99.0||||||
4106119|NCT00964158|3929666|B2|Geographic ancestry|White - Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|56|56.0||||||
4106120|NCT00964158|3929667|B1|Geographic ancestry|White - Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|53|53.0||||||
4106121|NCT00964158|3929664|B4|Geographic ancestry|Asian - East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4106122|NCT00964158|3929665|B3|Geographic ancestry|Asian - East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4106123|NCT00964158|3929666|B2|Geographic ancestry|Asian - East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4106124|NCT00964158|3929667|B1|Geographic ancestry|Asian - East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4106125|NCT00964158|3929664|B4||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4106126|NCT00964158|3929665|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4106127|NCT00964158|3929666|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4106128|NCT00964158|3929667|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4106129|NCT00964158|3929664|B4||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4106130|NCT00964158|3929665|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4106131|NCT00964158|3929666|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4106132|NCT00964158|3929667|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4106133|NCT00964158|3929664|B4|||Age||Years|Mean|9.25|9.25|Standard Deviation|4.46|4.46|||
4106134|NCT00964158|3929665|B3|||Age||Years|Mean|13.3|13.3|Standard Deviation|2.23|2.23|||
4106135|NCT00964158|3929666|B2|||Age||Years|Mean|7.5|7.5|Standard Deviation|1.18|1.18|||
4106136|NCT00964158|3929667|B1|||Age||Years|Mean|3.5|3.5|Standard Deviation|0.7|0.7|||
4106137|NCT00964119|3929738|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4106138|NCT00964119|3929738|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4106139|NCT00964119|3929738|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4106140|NCT00964119|3929738|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4106141|NCT00964119|3929738|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4106142|NCT00964119|3929738|B1||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4106143|NCT00964028|3929742|B3|Asian-Japanese heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4106144|NCT00964028|3929743|B2|Asian-Japanese heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4106145|NCT00964028|3929744|B1|Asian-Japanese heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4106146|NCT00964028|3929742|B3|Asian-East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|49|49.0||||||
4106147|NCT00964028|3929743|B2|Asian-East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
4106148|NCT00964028|3929744|B1|Asian-East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
4106149|NCT00964028|3929742|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4106150|NCT00964028|3929743|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4106151|NCT00964028|3929744|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4106152|NCT00964028|3929742|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4106153|NCT00964028|3929743|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4106154|NCT00964028|3929744|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4106155|NCT00964028|3929742|B3|||Age||Weeks|Mean|12.15|12.15|Standard Deviation|2.42|2.42|||
4106156|NCT00964028|3929743|B2|||Age||Weeks|Mean|14.2|14.2|Standard Deviation|1.18|1.18|||
4106157|NCT00964028|3929744|B1|||Age||Weeks|Mean|10.1|10.1|Standard Deviation|1.36|1.36|||
4106158|NCT00963937|3929757|B4|||Race/Ethnicity, Customized|Baseline characteristics were collected in the Full Analysis Set (FAS), comprised of all participants who took at least one dose of investigational product (IP) and provided any post-treatment efficacy assessment. Participants who withdrew from the study before completion did not receive IP and thus contributed no baseline data.|participants|Number|144|144.0||||||
4106159|NCT00963937|3929758|B3|||Race/Ethnicity, Customized|Baseline characteristics were collected in the Full Analysis Set (FAS), comprised of all participants who took at least one dose of investigational product (IP) and provided any post-treatment efficacy assessment. Participants who withdrew from the study before completion did not receive IP and thus contributed no baseline data.|participants|Number|41|41.0||||||
4106160|NCT00963937|3929759|B2|||Race/Ethnicity, Customized|Baseline characteristics were collected in the Full Analysis Set (FAS), comprised of all participants who took at least one dose of investigational product (IP) and provided any post-treatment efficacy assessment. Participants who withdrew from the study before completion did not receive IP and thus contributed no baseline data.|participants|Number|33|33.0||||||
4106161|NCT00963937|3929760|B1|||Race/Ethnicity, Customized|Baseline characteristics were collected in the Full Analysis Set (FAS), comprised of all participants who took at least one dose of investigational product (IP) and provided any post-treatment efficacy assessment. Participants who withdrew from the study before completion did not receive IP and thus contributed no baseline data.|participants|Number|70|70.0||||||
4106162|NCT00963937|3929757|B4||Male|Sex: Female, Male|Baseline characteristics were collected in the Full Analysis Set (FAS), comprised of all participants who took at least one dose of investigational product (IP) and provided any post-treatment efficacy assessment. Participants who withdrew from the study before completion did not receive IP and thus contributed no baseline data.|Participants|Count of Participants|60|60.0||||||
4106163|NCT00963937|3929758|B3||Male|Sex: Female, Male|Baseline characteristics were collected in the Full Analysis Set (FAS), comprised of all participants who took at least one dose of investigational product (IP) and provided any post-treatment efficacy assessment. Participants who withdrew from the study before completion did not receive IP and thus contributed no baseline data.|Participants|Count of Participants|13|13.0||||||
4106164|NCT00963937|3929759|B2||Male|Sex: Female, Male|Baseline characteristics were collected in the Full Analysis Set (FAS), comprised of all participants who took at least one dose of investigational product (IP) and provided any post-treatment efficacy assessment. Participants who withdrew from the study before completion did not receive IP and thus contributed no baseline data.|Participants|Count of Participants|16|16.0||||||
4106165|NCT00963937|3929760|B1||Male|Sex: Female, Male|Baseline characteristics were collected in the Full Analysis Set (FAS), comprised of all participants who took at least one dose of investigational product (IP) and provided any post-treatment efficacy assessment. Participants who withdrew from the study before completion did not receive IP and thus contributed no baseline data.|Participants|Count of Participants|31|31.0||||||
4106166|NCT00963937|3929757|B4||Female|Sex: Female, Male|Baseline characteristics were collected in the Full Analysis Set (FAS), comprised of all participants who took at least one dose of investigational product (IP) and provided any post-treatment efficacy assessment. Participants who withdrew from the study before completion did not receive IP and thus contributed no baseline data.|Participants|Count of Participants|84|84.0||||||
4106167|NCT00963937|3929758|B3||Female|Sex: Female, Male|Baseline characteristics were collected in the Full Analysis Set (FAS), comprised of all participants who took at least one dose of investigational product (IP) and provided any post-treatment efficacy assessment. Participants who withdrew from the study before completion did not receive IP and thus contributed no baseline data.|Participants|Count of Participants|28|28.0||||||
4106168|NCT00963937|3929759|B2||Female|Sex: Female, Male|Baseline characteristics were collected in the Full Analysis Set (FAS), comprised of all participants who took at least one dose of investigational product (IP) and provided any post-treatment efficacy assessment. Participants who withdrew from the study before completion did not receive IP and thus contributed no baseline data.|Participants|Count of Participants|17|17.0||||||
4106169|NCT00963937|3929760|B1||Female|Sex: Female, Male|Baseline characteristics were collected in the Full Analysis Set (FAS), comprised of all participants who took at least one dose of investigational product (IP) and provided any post-treatment efficacy assessment. Participants who withdrew from the study before completion did not receive IP and thus contributed no baseline data.|Participants|Count of Participants|39|39.0||||||
4106170|NCT00963937|3929757|B4|||Age|Baseline characteristics were collected in the Full Analysis Set (FAS), comprised of all participants who took at least one dose of investigational product (IP) and provided any post-treatment efficacy assessment. Participants who withdrew from the study before completion did not receive IP and thus contributed no baseline data.|Years|Mean|14.1|14.1|Standard Deviation|2.05|2.05|||
4106171|NCT00963937|3929758|B3|||Age|Baseline characteristics were collected in the Full Analysis Set (FAS), comprised of all participants who took at least one dose of investigational product (IP) and provided any post-treatment efficacy assessment. Participants who withdrew from the study before completion did not receive IP and thus contributed no baseline data.|Years|Mean|14.1|14.1|Standard Deviation|1.96|1.96|||
4106172|NCT00963937|3929759|B2|||Age|Baseline characteristics were collected in the Full Analysis Set (FAS), comprised of all participants who took at least one dose of investigational product (IP) and provided any post-treatment efficacy assessment. Participants who withdrew from the study before completion did not receive IP and thus contributed no baseline data.|Years|Mean|14.5|14.5|Standard Deviation|2.18|2.18|||
4106173|NCT00963937|3929760|B1|||Age|Baseline characteristics were collected in the Full Analysis Set (FAS), comprised of all participants who took at least one dose of investigational product (IP) and provided any post-treatment efficacy assessment. Participants who withdrew from the study before completion did not receive IP and thus contributed no baseline data.|Years|Mean|13.9|13.9|Standard Deviation|2.04|2.04|||
4106174|NCT00963924|3929798|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4106175|NCT00963924|3929799|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4106176|NCT00963924|3929800|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4106177|NCT00963924|3929798|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4106178|NCT00963924|3929799|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4106179|NCT00963924|3929800|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4106180|NCT00963924|3929798|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4106181|NCT00963924|3929799|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4106182|NCT00963924|3929800|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4106183|NCT00963924|3929798|B3|||Age||years|Mean|47.5|47.5|Standard Deviation|12.4|12.4|||
4106184|NCT00963924|3929799|B2|||Age||years|Mean|46.2|46.2|Standard Deviation|13.3|13.3|||
4106185|NCT00963924|3929800|B1|||Age||years|Mean|48.8|48.8|Standard Deviation|11.5|11.5|||
4106186|NCT00963924|3929798|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4106187|NCT00963924|3929799|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4106188|NCT00963924|3929800|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4106189|NCT00963924|3929798|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4106190|NCT00963924|3929799|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4106191|NCT00963924|3929800|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4106192|NCT00963924|3929798|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4106193|NCT00963924|3929799|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4106194|NCT00963924|3929800|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4106195|NCT00963872|3929823|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4106196|NCT00963872|3929824|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4106197|NCT00963872|3929825|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4106198|NCT00963872|3929823|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4106199|NCT00963872|3929824|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4106200|NCT00963872|3929825|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4106201|NCT00963872|3929823|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4106202|NCT00963872|3929824|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4106203|NCT00963872|3929825|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4106204|NCT00963872|3929823|B3|||Age||years|Mean|54|54.0|Standard Deviation|13.4|13.4|||
4106205|NCT00963872|3929824|B2|||Age||years|Mean|50|50.0|Standard Deviation|15.7|15.7|||
4106206|NCT00963872|3929825|B1|||Age||years|Mean|55|55.0|Standard Deviation|13.0|13.0|||
4106207|NCT00963872|3929823|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4106208|NCT00963872|3929824|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4106209|NCT00963872|3929825|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4106210|NCT00963872|3929823|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4106211|NCT00963872|3929824|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4106212|NCT00963872|3929825|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4106213|NCT00963872|3929823|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4106214|NCT00963872|3929824|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4106215|NCT00963872|3929825|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4106216|NCT00963859|3929870|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4106217|NCT00963859|3929870|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4106218|NCT00963859|3929870|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4106219|NCT00963859|3929870|B1|||Age||years|Median|73|73.0|Full Range|||40.0|82.0|
4106220|NCT00963820|3929875|B1|||Body Surface Area at Baseline|Body Surface Area (BSA) was missing for 1 participant. Mean and standard deviation are based on 59 participants.|m^2|Mean|1.96|1.96|Standard Deviation|0.247|0.247|||
4106221|NCT00963820|3929875|B1|||Weight||kg|Mean|83.26|83.26|Standard Deviation|18.106|18.106|||
4106222|NCT00963820|3929875|B1|||Height|Height data was missing for 1 participant. Mean and standard deviation calculation is based on 59 participants.|cm|Mean|168.4|168.4|Standard Deviation|9.34|9.34|||
4106223|NCT00963820|3929875|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4106224|NCT00963820|3929875|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4106225|NCT00963820|3929875|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4106226|NCT00963820|3929875|B1|White||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4106227|NCT00963820|3929875|B1|Missing||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4106228|NCT00963820|3929875|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
4106229|NCT00963820|3929875|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4106230|NCT00963820|3929875|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4106231|NCT00963820|3929875|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4106232|NCT00963820|3929875|B1|||Age||years|Mean|63.0|63.0|Standard Deviation|9.10|9.1|||
4106233|NCT00963807|3930022|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4106234|NCT00963807|3930022|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4106235|NCT00963807|3930022|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4106236|NCT00963807|3930022|B1|||Age||years|Mean|56.4|56.4|Full Range|||33.0|77.0|
4106237|NCT00963677|3930031|B3|China||Region of Enrollment||participants|Number|55|55.0||||||
4106238|NCT00963677|3930032|B2|China||Region of Enrollment||participants|Number|20|20.0||||||
4106239|NCT00963677|3930033|B1|China||Region of Enrollment||participants|Number|35|35.0||||||
4106240|NCT00963677|3930031|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4106241|NCT00963677|3930032|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4106242|NCT00963677|3930033|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4106243|NCT00963677|3930031|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4106244|NCT00963677|3930032|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4106245|NCT00963677|3930033|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4106246|NCT00963677|3930031|B3|||Age||years|Mean|33.4|33.4|Standard Deviation|7.1|7.1|||
4106247|NCT00963677|3930032|B2|||Age||years|Mean|32.7|32.7|Standard Deviation|6.3|6.3|||
4106248|NCT00963677|3930033|B1|||Age||years|Mean|34.2|34.2|Standard Deviation|6.7|6.7|||
4106249|NCT00963677|3930031|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4106250|NCT00963677|3930032|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4106251|NCT00963677|3930033|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4106252|NCT00963677|3930031|B3||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4106253|NCT00963677|3930032|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4106254|NCT00963677|3930033|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4106255|NCT00963677|3930031|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4106256|NCT00963677|3930032|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4106257|NCT00963677|3930033|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4106258|NCT00963638|3930042|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4106259|NCT00963638|3930043|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4106260|NCT00963638|3930044|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4106261|NCT00963638|3930042|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4106262|NCT00963638|3930043|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4106263|NCT00963638|3930044|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4106264|NCT00963638|3930042|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4106265|NCT00963638|3930043|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4106266|NCT00963638|3930044|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4106267|NCT00963638|3930042|B3|||Age||years|Mean|66.62|66.62|Standard Deviation|9.5|9.5|||
4106268|NCT00963638|3930043|B2|||Age||years|Mean|66.00|66.0|Standard Deviation|9.3|9.3|||
4106269|NCT00963638|3930044|B1|||Age||years|Mean|67.25|67.25|Standard Deviation|9.9|9.9|||
4106270|NCT00963638|3930042|B3||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4106271|NCT00963638|3930043|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4106272|NCT00963638|3930044|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4106273|NCT00963638|3930042|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4106274|NCT00963638|3930043|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4106275|NCT00963638|3930044|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4106276|NCT00963638|3930042|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4106277|NCT00963638|3930043|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4106278|NCT00963638|3930044|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4106279|NCT00963599|3930051|B5|||Rhinoconjunctivitis Quality-of-Life Score|0 (best) to 6 (worst) point scale|Units on a Scale|Mean|3.15|3.15|Standard Deviation|1.05|1.05|||
4106280|NCT00963599|3930052|B4|||Rhinoconjunctivitis Quality-of-Life Score|0 (best) to 6 (worst) point scale|Units on a Scale|Mean|3.25|3.25|Standard Deviation|1.08|1.08|||
4106281|NCT00963599|3930053|B3|||Rhinoconjunctivitis Quality-of-Life Score|0 (best) to 6 (worst) point scale|Units on a Scale|Mean|3.10|3.1|Standard Deviation|1.02|1.02|||
4106282|NCT00963599|3930054|B2|||Rhinoconjunctivitis Quality-of-Life Score|0 (best) to 6 (worst) point scale|Units on a Scale|Mean|3.14|3.14|Standard Deviation|0.98|0.98|||
4106283|NCT00963599|3930055|B1|||Rhinoconjunctivitis Quality-of-Life Score|0 (best) to 6 (worst) point scale|Units on a Scale|Mean|3.06|3.06|Standard Deviation|1.09|1.09|||
4106284|NCT00963599|3930051|B5|||Nighttime Symptoms Score|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|1.45|1.45|Standard Deviation|0.65|0.65|||
4106285|NCT00963599|3930052|B4|||Nighttime Symptoms Score|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|1.46|1.46|Standard Deviation|0.66|0.66|||
4106286|NCT00963599|3930053|B3|||Nighttime Symptoms Score|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|1.47|1.47|Standard Deviation|0.63|0.63|||
4106287|NCT00963599|3930054|B2|||Nighttime Symptoms Score|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|1.50|1.5|Standard Deviation|0.64|0.64|||
4106288|NCT00963599|3930055|B1|||Nighttime Symptoms Score|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|1.32|1.32|Standard Deviation|0.65|0.65|||
4106289|NCT00963599|3930051|B5|||Nasal Congestion Upon Awakening|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|2.23|2.23|Standard Deviation|0.62|0.62|||
4106290|NCT00963599|3930052|B4|||Nasal Congestion Upon Awakening|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|2.20|2.2|Standard Deviation|0.63|0.63|||
4106291|NCT00963599|3930053|B3|||Nasal Congestion Upon Awakening|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|2.26|2.26|Standard Deviation|0.61|0.61|||
4106292|NCT00963599|3930054|B2|||Nasal Congestion Upon Awakening|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|2.25|2.25|Standard Deviation|0.56|0.56|||
4106293|NCT00963599|3930055|B1|||Nasal Congestion Upon Awakening|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|2.17|2.17|Standard Deviation|0.65|0.65|||
4106294|NCT00963599|3930051|B5|||Daytime Sneezing score|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|1.87|1.87|Standard Deviation|0.71|0.71|||
4106295|NCT00963599|3930052|B4|||Daytime Sneezing score|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|1.87|1.87|Standard Deviation|0.68|0.68|||
4106296|NCT00963599|3930053|B3|||Daytime Sneezing score|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|1.89|1.89|Standard Deviation|0.74|0.74|||
4106297|NCT00963599|3930054|B2|||Daytime Sneezing score|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|1.93|1.93|Standard Deviation|0.65|0.65|||
4106298|NCT00963599|3930055|B1|||Daytime Sneezing score|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|1.81|1.81|Standard Deviation|0.74|0.74|||
4106347|NCT00963560|3930115|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4106299|NCT00963599|3930051|B5|||Daytime Rhinorrhea score|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|2.06|2.06|Standard Deviation|0.64|0.64|||
4106300|NCT00963599|3930052|B4|||Daytime Rhinorrhea score|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|1.98|1.98|Standard Deviation|0.66|0.66|||
4106301|NCT00963599|3930053|B3|||Daytime Rhinorrhea score|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|2.16|2.16|Standard Deviation|0.58|0.58|||
4106302|NCT00963599|3930054|B2|||Daytime Rhinorrhea score|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|2.05|2.05|Standard Deviation|0.61|0.61|||
4106303|NCT00963599|3930055|B1|||Daytime Rhinorrhea score|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|2.02|2.02|Standard Deviation|0.70|0.7|||
4106304|NCT00963599|3930051|B5|||Daytime Nasal Symptoms Score|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|2.04|2.04|Standard Deviation|0.43|0.43|||
4106305|NCT00963599|3930052|B4|||Daytime Nasal Symptoms Score|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|2.01|2.01|Standard Deviation|0.43|0.43|||
4106306|NCT00963599|3930053|B3|||Daytime Nasal Symptoms Score|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|2.09|2.09|Standard Deviation|0.44|0.44|||
4106307|NCT00963599|3930054|B2|||Daytime Nasal Symptoms Score|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|2.06|2.06|Standard Deviation|0.39|0.39|||
4106308|NCT00963599|3930055|B1|||Daytime Nasal Symptoms Score|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|2.01|2.01|Standard Deviation|0.44|0.44|||
4106309|NCT00963599|3930051|B5|||Daytime Nasal Itching score|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|1.92|1.92|Standard Deviation|0.74|0.74|||
4106310|NCT00963599|3930052|B4|||Daytime Nasal Itching score|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|1.89|1.89|Standard Deviation|0.73|0.73|||
4106311|NCT00963599|3930053|B3|||Daytime Nasal Itching score|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|1.93|1.93|Standard Deviation|0.79|0.79|||
4106312|NCT00963599|3930054|B2|||Daytime Nasal Itching score|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|1.94|1.94|Standard Deviation|0.70|0.7|||
4106313|NCT00963599|3930055|B1|||Daytime Nasal Itching score|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|1.94|1.94|Standard Deviation|0.67|0.67|||
4106314|NCT00963599|3930051|B5|||Daytime Eye Symptoms Score|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|1.37|1.37|Standard Deviation|0.76|0.76|||
4106315|NCT00963599|3930052|B4|||Daytime Eye Symptoms Score|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|1.38|1.38|Standard Deviation|0.77|0.77|||
4106316|NCT00963599|3930053|B3|||Daytime Eye Symptoms Score|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|1.38|1.38|Standard Deviation|0.78|0.78|||
4106317|NCT00963599|3930054|B2|||Daytime Eye Symptoms Score|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|1.38|1.38|Standard Deviation|0.73|0.73|||
4106318|NCT00963599|3930055|B1|||Daytime Eye Symptoms Score|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|1.31|1.31|Standard Deviation|0.73|0.73|||
4106319|NCT00963599|3930051|B5|||Daytime Congestion score|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|2.32|2.32|Standard Deviation|0.54|0.54|||
4106320|NCT00963599|3930052|B4|||Daytime Congestion score|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|2.31|2.31|Standard Deviation|0.58|0.58|||
4106321|NCT00963599|3930053|B3|||Daytime Congestion score|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|2.37|2.37|Standard Deviation|0.52|0.52|||
4106322|NCT00963599|3930054|B2|||Daytime Congestion score|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|2.31|2.31|Standard Deviation|0.50|0.5|||
4106323|NCT00963599|3930055|B1|||Daytime Congestion score|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|2.26|2.26|Standard Deviation|0.56|0.56|||
4106324|NCT00963599|3930051|B5|||Composite Symptoms Score (Daytime Nasal and Nighttime Symptoms)|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|1.79|1.79|Standard Deviation|0.45|0.45|||
4106325|NCT00963599|3930052|B4|||Composite Symptoms Score (Daytime Nasal and Nighttime Symptoms)|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|1.78|1.78|Standard Deviation|0.46|0.46|||
4106326|NCT00963599|3930053|B3|||Composite Symptoms Score (Daytime Nasal and Nighttime Symptoms)|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|1.82|1.82|Standard Deviation|0.45|0.45|||
4106327|NCT00963599|3930054|B2|||Composite Symptoms Score (Daytime Nasal and Nighttime Symptoms)|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|1.82|1.82|Standard Deviation|0.43|0.43|||
4106328|NCT00963599|3930055|B1|||Composite Symptoms Score (Daytime Nasal and Nighttime Symptoms)|0 (best) to 3 (worst) point scale|Units on a Scale|Mean|1.71|1.71|Standard Deviation|0.45|0.45|||
4106329|NCT00963599|3930051|B5||Male|Sex: Female, Male||Participants|Count of Participants|320|320.0||||||
4106330|NCT00963599|3930052|B4||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4106331|NCT00963599|3930053|B3||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4106332|NCT00963599|3930054|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4106333|NCT00963599|3930055|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4106334|NCT00963599|3930051|B5||Female|Sex: Female, Male||Participants|Count of Participants|587|587.0||||||
4106335|NCT00963599|3930052|B4||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4106336|NCT00963599|3930053|B3||Female|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4106337|NCT00963599|3930054|B2||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4106338|NCT00963599|3930055|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4106339|NCT00963599|3930051|B5|||Age||Years|Mean|36.9|36.9|Full Range|||15.0|82.0|
4106340|NCT00963599|3930052|B4|||Age||Years|Mean|37.6|37.6|Full Range|||15.0|78.0|
4106341|NCT00963599|3930053|B3|||Age||Years|Mean|37.1|37.1|Full Range|||15.0|82.0|
4106342|NCT00963599|3930054|B2|||Age||Years|Mean|35.2|35.2|Full Range|||15.0|65.0|
4106343|NCT00963599|3930055|B1|||Age||Years|Mean|36.9|36.9|Full Range|||15.0|81.0|
4106344|NCT00963560|3930112|B4||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4106345|NCT00963560|3930113|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4106346|NCT00963560|3930114|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4106348|NCT00963560|3930112|B4||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4106349|NCT00963560|3930113|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4106350|NCT00963560|3930114|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4106351|NCT00963560|3930115|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4106352|NCT00963560|3930112|B4|||Age||years|Mean|64.23|64.23|Standard Deviation|8.23|8.23|||
4106353|NCT00963560|3930113|B3|||Age||years|Mean|65.3|65.3|Standard Deviation|7.5|7.5|50.0|81.0|
4106354|NCT00963560|3930114|B2|||Age||years|Mean|64|64.0|Standard Deviation|7.8|7.8|50.0|79.0|
4106355|NCT00963560|3930115|B1|||Age||years|Mean|63.4|63.4|Standard Deviation|9.4|9.4|41.0|81.0|
4106356|NCT00963547|3930125|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4106357|NCT00963547|3930126|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4106358|NCT00963547|3930127|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4106359|NCT00963547|3930128|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4106360|NCT00963547|3930129|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4106361|NCT00963547|3930125|B5||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4106362|NCT00963547|3930126|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4106363|NCT00963547|3930127|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4106364|NCT00963547|3930128|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4106365|NCT00963547|3930129|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4106366|NCT00963547|3930125|B5|||Age||Years|Mean|51.2|51.2|Standard Deviation|7.7|7.7|||
4106367|NCT00963547|3930126|B4|||Age||Years|Mean|49.7|49.7|Standard Deviation|7.4|7.4|||
4106368|NCT00963547|3930127|B3|||Age||Years|Mean|49.6|49.6|Standard Deviation|7.4|7.4|||
4106369|NCT00963547|3930128|B2|||Age||Years|Mean|55.2|55.2|Standard Deviation|6.9|6.9|||
4106370|NCT00963547|3930129|B1|||Age||Years|Mean|45.0|45.0|Standard Deviation|8.2|8.2|||
4106371|NCT00963508|3930159|B3|United States||Region of Enrollment||participants|Number|403|403.0||||||
4106372|NCT00963508|3930160|B2|United States||Region of Enrollment||participants|Number|197|197.0||||||
4106373|NCT00963508|3930161|B1|United States||Region of Enrollment||participants|Number|206|206.0||||||
4106374|NCT00963508|3930159|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4106375|NCT00963508|3930160|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4106376|NCT00963508|3930161|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4106377|NCT00963508|3930159|B3||Female|Sex: Female, Male||Participants|Count of Participants|349|349.0||||||
4106378|NCT00963508|3930160|B2||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4106379|NCT00963508|3930161|B1||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4106380|NCT00963508|3930159|B3|||Age||years|Mean|13.66|13.66|Standard Deviation|12.30|12.3|2.0|44.0|
4106381|NCT00963508|3930160|B2|||Age||years|Mean|13.85|13.85|Standard Deviation|12.80|12.8|2.0|44.0|
4106382|NCT00963508|3930161|B1|||Age||years|Mean|13.45|13.45|Standard Deviation|11.81|11.81|2.0|44.0|
4106383|NCT00963508|3930159|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4106384|NCT00963508|3930160|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4106385|NCT00963508|3930161|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4106386|NCT00963508|3930159|B3||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
4106387|NCT00963508|3930160|B2||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4106388|NCT00963508|3930161|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4106389|NCT00963508|3930159|B3||<=18 years|Age||Participants|Count of Participants|315|315.0||||||
4106390|NCT00963508|3930160|B2||<=18 years|Age||Participants|Count of Participants|154|154.0||||||
4106391|NCT00963508|3930161|B1||<=18 years|Age||Participants|Count of Participants|161|161.0||||||
4106392|NCT00963482|3930170|B3|Switzerland||Region of Enrollment||participants|Number|103|103.0||||||
4106393|NCT00963482|3930171|B2|Switzerland||Region of Enrollment||participants|Number|50|50.0||||||
4106394|NCT00963482|3930172|B1|Switzerland||Region of Enrollment||participants|Number|53|53.0||||||
4106395|NCT00963482|3930170|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4106396|NCT00963482|3930171|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4106397|NCT00963482|3930172|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4106398|NCT00963482|3930170|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4106399|NCT00963482|3930171|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4106400|NCT00963482|3930172|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4106401|NCT00963482|3930170|B3|||Age||years|Mean|44|44.0|Standard Deviation|10|10.0|||
4106402|NCT00963482|3930171|B2|||Age||years|Mean|44|44.0|Standard Deviation|9|9.0|||
4106403|NCT00963482|3930172|B1|||Age||years|Mean|44|44.0|Standard Deviation|11|11.0|||
4106404|NCT00963482|3930170|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4106405|NCT00963482|3930171|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4106406|NCT00963482|3930172|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4106407|NCT00963482|3930170|B3||Between 18 and 65 years|Age||Participants|Count of Participants|103|103.0||||||
4106408|NCT00963482|3930171|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4106409|NCT00963482|3930172|B1||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4106410|NCT00963482|3930170|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4106411|NCT00963482|3930171|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4106412|NCT00963482|3930172|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4106413|NCT00963469|3930179|B4|||Rhinoconjunctivitis Quality of Life Score|Patients completed a Rhinoconjunctivitis Quality-of-Life Questionnaire-28 questions on a 7-point scale [0(best) to 6(worst)] across 7 domains: activity,sleep,non-nose/eye symptoms,practical problems,nasal symptoms, eye symptoms, and emotions. The scores for each domain were averaged, then scores for the 7 domains were averaged for an overall score.|Scores on a scale|Mean|3.40|3.4|Standard Deviation|1.02|1.02|||
4106414|NCT00963469|3930180|B3|||Rhinoconjunctivitis Quality of Life Score|Patients completed a Rhinoconjunctivitis Quality-of-Life Questionnaire-28 questions on a 7-point scale [0(best) to 6(worst)] across 7 domains: activity,sleep,non-nose/eye symptoms,practical problems,nasal symptoms, eye symptoms, and emotions. The scores for each domain were averaged, then scores for the 7 domains were averaged for an overall score.|Scores on a scale|Mean|3.46|3.46|Standard Deviation|1.08|1.08|||
4106415|NCT00963469|3930181|B2|||Rhinoconjunctivitis Quality of Life Score|Patients completed a Rhinoconjunctivitis Quality-of-Life Questionnaire-28 questions on a 7-point scale [0(best) to 6(worst)] across 7 domains: activity,sleep,non-nose/eye symptoms,practical problems,nasal symptoms, eye symptoms, and emotions. The scores for each domain were averaged, then scores for the 7 domains were averaged for an overall score.|Scores on a scale|Mean|3.41|3.41|Standard Deviation|1.00|1.0|||
4106416|NCT00963469|3930182|B1|||Rhinoconjunctivitis Quality of Life Score|Patients completed a Rhinoconjunctivitis Quality-of-Life Questionnaire-28 questions on a 7-point scale [0(best) to 6(worst)] across 7 domains: activity,sleep,non-nose/eye symptoms,practical problems,nasal symptoms, eye symptoms, and emotions. The scores for each domain were averaged, then scores for the 7 domains were averaged for an overall score.|Scores on a scale|Mean|3.37|3.37|Standard Deviation|1.02|1.02|||
4106417|NCT00963469|3930179|B4|||Nighttime Symptoms Score|Nighttime Symptoms Score. Patients were asked to rate each symptom of Nasal Congestion Upon Awakening, Difficulty Going to Sleep, and Nighttime Awakenings daily on a 4-point scale [Score 0 (best) to 3 (worse)], and the average score of the 3 symptoms was reported as the Nighttime Symptoms Score.|Scores on a scale|Mean|1.69|1.69|Standard Deviation|0.64|0.64|||
4106418|NCT00963469|3930180|B3|||Nighttime Symptoms Score|Nighttime Symptoms Score. Patients were asked to rate each symptom of Nasal Congestion Upon Awakening, Difficulty Going to Sleep, and Nighttime Awakenings daily on a 4-point scale [Score 0 (best) to 3 (worse)], and the average score of the 3 symptoms was reported as the Nighttime Symptoms Score.|Scores on a scale|Mean|1.77|1.77|Standard Deviation|0.63|0.63|||
4106419|NCT00963469|3930181|B2|||Nighttime Symptoms Score|Nighttime Symptoms Score. Patients were asked to rate each symptom of Nasal Congestion Upon Awakening, Difficulty Going to Sleep, and Nighttime Awakenings daily on a 4-point scale [Score 0 (best) to 3 (worse)], and the average score of the 3 symptoms was reported as the Nighttime Symptoms Score.|Scores on a scale|Mean|1.69|1.69|Standard Deviation|0.64|0.64|||
4106420|NCT00963469|3930182|B1|||Nighttime Symptoms Score|Nighttime Symptoms Score. Patients were asked to rate each symptom of Nasal Congestion Upon Awakening, Difficulty Going to Sleep, and Nighttime Awakenings daily on a 4-point scale [Score 0 (best) to 3 (worse)], and the average score of the 3 symptoms was reported as the Nighttime Symptoms Score.|Scores on a scale|Mean|1.65|1.65|Standard Deviation|0.64|0.64|||
4106421|NCT00963469|3930179|B4|||Daytime Nasal Symptoms Score|Daytime Nasal Symptoms Score. Patients were asked to rate each nasal symptom of Congestion, Rhinorrhea, Itching, and Sneezing daily on a 4-point scale [Score 0 (best) to 3 (worse)]. The average of the 4 individual nasal symptoms scores was reported as the Daytime Nasal Symptoms Score.|Scores on a scale|Mean|2.19|2.19|Standard Deviation|0.45|0.45|||
4106422|NCT00963469|3930180|B3|||Daytime Nasal Symptoms Score|Daytime Nasal Symptoms Score. Patients were asked to rate each nasal symptom of Congestion, Rhinorrhea, Itching, and Sneezing daily on a 4-point scale [Score 0 (best) to 3 (worse)]. The average of the 4 individual nasal symptoms scores was reported as the Daytime Nasal Symptoms Score.|Scores on a scale|Mean|2.23|2.23|Standard Deviation|0.44|0.44|||
4106423|NCT00963469|3930181|B2|||Daytime Nasal Symptoms Score|Daytime Nasal Symptoms Score. Patients were asked to rate each nasal symptom of Congestion, Rhinorrhea, Itching, and Sneezing daily on a 4-point scale [Score 0 (best) to 3 (worse)]. The average of the 4 individual nasal symptoms scores was reported as the Daytime Nasal Symptoms Score.|Scores on a scale|Mean|2.20|2.2|Standard Deviation|0.46|0.46|||
4106424|NCT00963469|3930182|B1|||Daytime Nasal Symptoms Score|Daytime Nasal Symptoms Score. Patients were asked to rate each nasal symptom of Congestion, Rhinorrhea, Itching, and Sneezing daily on a 4-point scale [Score 0 (best) to 3 (worse)]. The average of the 4 individual nasal symptoms scores was reported as the Daytime Nasal Symptoms Score.|Scores on a scale|Mean|2.16|2.16|Standard Deviation|0.44|0.44|||
4106425|NCT00963469|3930179|B4|||Daytime Eye Symptoms score|Daytime Eye Symptoms scores. Patients were asked to rate each of the 4 eye symptoms of tearing, itchy, red, and puffy eyes daily on a 4-point scale [Score 0 (best) to 3 (worst)]. The average of the 4 individual eye symptoms scores was reported as the Daytime Eye Symptoms Score.|Scores on a scale|Mean|1.63|1.63|Standard Deviation|0.77|0.77|||
4106426|NCT00963469|3930180|B3|||Daytime Eye Symptoms score|Daytime Eye Symptoms scores. Patients were asked to rate each of the 4 eye symptoms of tearing, itchy, red, and puffy eyes daily on a 4-point scale [Score 0 (best) to 3 (worst)]. The average of the 4 individual eye symptoms scores was reported as the Daytime Eye Symptoms Score.|Scores on a scale|Mean|1.64|1.64|Standard Deviation|0.78|0.78|||
4106427|NCT00963469|3930181|B2|||Daytime Eye Symptoms score|Daytime Eye Symptoms scores. Patients were asked to rate each of the 4 eye symptoms of tearing, itchy, red, and puffy eyes daily on a 4-point scale [Score 0 (best) to 3 (worst)]. The average of the 4 individual eye symptoms scores was reported as the Daytime Eye Symptoms Score.|Scores on a scale|Mean|1.64|1.64|Standard Deviation|0.73|0.73|||
4106428|NCT00963469|3930182|B1|||Daytime Eye Symptoms score|Daytime Eye Symptoms scores. Patients were asked to rate each of the 4 eye symptoms of tearing, itchy, red, and puffy eyes daily on a 4-point scale [Score 0 (best) to 3 (worst)]. The average of the 4 individual eye symptoms scores was reported as the Daytime Eye Symptoms Score.|Scores on a scale|Mean|1.61|1.61|Standard Deviation|0.81|0.81|||
4106429|NCT00963469|3930179|B4|||Composite Symptoms Score|Composite Symptoms Scores were computed as the average of Daytime Nasal Scores (Score 0 (best) to 3 (worst)) and Nighttime Symptoms Scores [Score 0 (best) to 3 (worst)].|Scores on a scale|Mean|1.97|1.97|Standard Deviation|0.46|0.46|||
4106430|NCT00963469|3930180|B3|||Composite Symptoms Score|Composite Symptoms Scores were computed as the average of Daytime Nasal Scores (Score 0 (best) to 3 (worst)) and Nighttime Symptoms Scores [Score 0 (best) to 3 (worst)].|Scores on a scale|Mean|2.03|2.03|Standard Deviation|0.46|0.46|||
4106431|NCT00963469|3930181|B2|||Composite Symptoms Score|Composite Symptoms Scores were computed as the average of Daytime Nasal Scores (Score 0 (best) to 3 (worst)) and Nighttime Symptoms Scores [Score 0 (best) to 3 (worst)].|Scores on a scale|Mean|1.98|1.98|Standard Deviation|0.47|0.47|||
4106432|NCT00963469|3930182|B1|||Composite Symptoms Score|Composite Symptoms Scores were computed as the average of Daytime Nasal Scores (Score 0 (best) to 3 (worst)) and Nighttime Symptoms Scores [Score 0 (best) to 3 (worst)].|Scores on a scale|Mean|1.94|1.94|Standard Deviation|0.46|0.46|||
4106433|NCT00963469|3930179|B4||Male|Sex: Female, Male||Participants|Count of Participants|358|358.0||||||
4106434|NCT00963469|3930180|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4106435|NCT00963469|3930181|B2||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4106436|NCT00963469|3930182|B1||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4106437|NCT00963469|3930179|B4||Female|Sex: Female, Male||Participants|Count of Participants|721|721.0||||||
4106438|NCT00963469|3930180|B3||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4106439|NCT00963469|3930181|B2||Female|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
4106440|NCT00963469|3930182|B1||Female|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
4106441|NCT00963469|3930179|B4|||Age||years|Mean|36.2|36.2|Full Range|||15.0|82.0|
4106442|NCT00963469|3930180|B3|||Age||years|Mean|38.7|38.7|Full Range|||15.0|79.0|
4106443|NCT00963469|3930181|B2|||Age||years|Mean|35.5|35.5|Full Range|||15.0|82.0|
4106444|NCT00963469|3930182|B1|||Age||years|Mean|35.9|35.9|Full Range|||15.0|82.0|
4106445|NCT00963430|3930210|B3|United States||Region of Enrollment||participants|Number|120|120.0||||||
4106446|NCT00963430|3930211|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
4106447|NCT00963430|3930212|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4106448|NCT00963430|3930210|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4106449|NCT00963430|3930211|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4106450|NCT00963430|3930212|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4106451|NCT00963430|3930210|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4106452|NCT00963430|3930211|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4106453|NCT00963430|3930212|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4106454|NCT00963430|3930210|B3|||Age||years|Mean|31.4|31.4|Standard Deviation|4.3|4.3|||
4106455|NCT00963430|3930211|B2|||Age||years|Mean|31.2|31.2|Standard Deviation|4.3|4.3|||
4106456|NCT00963430|3930212|B1|||Age||years|Mean|31.7|31.7|Standard Deviation|4.3|4.3|||
4106457|NCT00963430|3930210|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4106458|NCT00963430|3930211|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4106459|NCT00963430|3930212|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4106460|NCT00963430|3930210|B3||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
4106461|NCT00963430|3930211|B2||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4106462|NCT00963430|3930212|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4106463|NCT00963430|3930210|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4106464|NCT00963430|3930211|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4106465|NCT00963430|3930212|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4106466|NCT00963235|3930251|B1||Male|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
4106467|NCT00963235|3930251|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4106468|NCT00963235|3930251|B1|||Age||years|Mean|47.3|47.3|Standard Deviation|9.10|9.1|||
4106469|NCT00963157|3930270|B6|United States||Region of Enrollment||participants|Number|789|789.0||||||
4106470|NCT00963157|3930271|B5|United States||Region of Enrollment||participants|Number|153|153.0||||||
4106471|NCT00963157|3930272|B4|United States||Region of Enrollment||participants|Number|157|157.0||||||
4106472|NCT00963157|3930273|B3|United States||Region of Enrollment||participants|Number|160|160.0||||||
4106473|NCT00963157|3930274|B2|United States||Region of Enrollment||participants|Number|163|163.0||||||
4106474|NCT00963157|3930275|B1|United States||Region of Enrollment||participants|Number|156|156.0||||||
4106475|NCT00963157|3930270|B6||Male|Sex: Female, Male||Participants|Count of Participants|366|366.0||||||
4106476|NCT00963157|3930271|B5||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4106477|NCT00963157|3930272|B4||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4106478|NCT00963157|3930273|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4106479|NCT00963157|3930274|B2||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4106480|NCT00963157|3930275|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4106481|NCT00963157|3930270|B6||Female|Sex: Female, Male||Participants|Count of Participants|423|423.0||||||
4106482|NCT00963157|3930271|B5||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4106483|NCT00963157|3930272|B4||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4106484|NCT00963157|3930273|B3||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4106485|NCT00963157|3930274|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4106486|NCT00963157|3930275|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4106487|NCT00963157|3930270|B6|||Age||years|Mean|51.4|51.4|Standard Deviation|18.0|18.0|||
4106488|NCT00963157|3930271|B5|||Age||years|Mean|52.1|52.1|Standard Deviation|18.6|18.6|||
4106489|NCT00963157|3930272|B4|||Age||years|Mean|50.1|50.1|Standard Deviation|18.3|18.3|||
4106490|NCT00963157|3930273|B3|||Age||years|Mean|51.6|51.6|Standard Deviation|17.8|17.8|||
4106491|NCT00963157|3930274|B2|||Age||years|Mean|51.7|51.7|Standard Deviation|18.0|18.0|||
4106492|NCT00963157|3930275|B1|||Age||years|Mean|51.3|51.3|Standard Deviation|17.6|17.6|||
4106493|NCT00963157|3930270|B6||>=65 years|Age||Participants|Count of Participants|245|245.0||||||
4106494|NCT00963157|3930271|B5||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
4106495|NCT00963157|3930272|B4||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4106496|NCT00963157|3930273|B3||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
4106497|NCT00963157|3930274|B2||>=65 years|Age||Participants|Count of Participants|52|52.0||||||
4106498|NCT00963157|3930275|B1||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
4106499|NCT00963157|3930270|B6||Between 18 and 65 years|Age||Participants|Count of Participants|544|544.0||||||
4106500|NCT00963157|3930271|B5||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
4106501|NCT00963157|3930272|B4||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
4106502|NCT00963157|3930273|B3||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
4106503|NCT00963157|3930274|B2||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
4106504|NCT00963157|3930275|B1||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
4106505|NCT00963157|3930270|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4106506|NCT00963157|3930271|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4106507|NCT00963157|3930272|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4106508|NCT00963157|3930273|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4106509|NCT00963157|3930274|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4106510|NCT00963157|3930275|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4106511|NCT00963105|3930471|B4||Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4106512|NCT00963105|3930472|B3||Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4106513|NCT00963105|3930473|B2||Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4106514|NCT00963105|3930474|B1||Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4106515|NCT00963105|3930471|B4||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4106516|NCT00963105|3930472|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4106517|NCT00963105|3930473|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4106518|NCT00963105|3930474|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4106519|NCT00963105|3930471|B4||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4106520|NCT00963105|3930472|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4106521|NCT00963105|3930473|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4106522|NCT00963105|3930474|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4106523|NCT00963105|3930471|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|94|94.0||||||
4106524|NCT00963105|3930472|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
4106525|NCT00963105|3930473|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
4106526|NCT00963105|3930474|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
4106527|NCT00963105|3930471|B4||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4106528|NCT00963105|3930472|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4106529|NCT00963105|3930473|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4106530|NCT00963105|3930474|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4106531|NCT00963105|3930471|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4106532|NCT00963105|3930472|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4106533|NCT00963105|3930473|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4106534|NCT00963105|3930474|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4106535|NCT00963105|3930471|B4||≥ 65 years|Age, Customized||Participants|Count of Participants|52|52.0||||||
4106536|NCT00963105|3930472|B3||≥ 65 years|Age, Customized||Participants|Count of Participants|18|18.0||||||
4106537|NCT00963105|3930473|B2||≥ 65 years|Age, Customized||Participants|Count of Participants|16|16.0||||||
4106538|NCT00963105|3930474|B1||≥ 65 years|Age, Customized||Participants|Count of Participants|18|18.0||||||
4106539|NCT00963105|3930471|B4||< 65 years|Age, Customized||Participants|Count of Participants|52|52.0||||||
4106540|NCT00963105|3930472|B3||< 65 years|Age, Customized||Participants|Count of Participants|17|17.0||||||
4106541|NCT00963105|3930473|B2||< 65 years|Age, Customized||Participants|Count of Participants|19|19.0||||||
4106542|NCT00963105|3930474|B1||< 65 years|Age, Customized||Participants|Count of Participants|16|16.0||||||
4106543|NCT00963105|3930471|B4|||Age||years|Mean|63.6|63.6|Standard Deviation|8.39|8.39|||
4106544|NCT00963105|3930472|B3|||Age||years|Mean|63.7|63.7|Standard Deviation|7.56|7.56|||
4106545|NCT00963105|3930473|B2|||Age||years|Mean|63.3|63.3|Standard Deviation|8.31|8.31|||
4106546|NCT00963105|3930474|B1|||Age||years|Mean|64.0|64.0|Standard Deviation|9.46|9.46|||
4106547|NCT00962949|3930505|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
4106548|NCT00962949|3930506|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4106549|NCT00962949|3930507|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4106550|NCT00962949|3930505|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4106551|NCT00962949|3930506|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4106552|NCT00962949|3930507|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4106553|NCT00962949|3930505|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4106554|NCT00962949|3930506|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4106555|NCT00962949|3930507|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4106556|NCT00962949|3930505|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4106557|NCT00962949|3930506|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4106558|NCT00962949|3930507|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4106559|NCT00962949|3930505|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4106560|NCT00962949|3930506|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4106561|NCT00962949|3930507|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4106562|NCT00962949|3930505|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4106563|NCT00962949|3930506|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4106564|NCT00962949|3930507|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4106565|NCT00962871|3930520|B5||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4106566|NCT00962871|3930521|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4106567|NCT00962871|3930522|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4106568|NCT00962871|3930523|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4106569|NCT00962871|3930524|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4106570|NCT00962871|3930520|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4106571|NCT00962871|3930521|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4106572|NCT00962871|3930522|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4106573|NCT00962871|3930523|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4106574|NCT00962871|3930524|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4106575|NCT00962871|3930520|B5|||Age||years|Mean|30|30.0|Standard Deviation|7.26|7.26|||
4106576|NCT00962871|3930521|B4|||Age||years|Mean|27.2|27.2|Standard Deviation|3.87|3.87|||
4106577|NCT00962871|3930522|B3|||Age||years|Mean|28.5|28.5|Standard Deviation|5.40|5.4|||
4106578|NCT00962871|3930523|B2|||Age||years|Mean|28|28.0|Standard Deviation|3.16|3.16|||
4106579|NCT00962871|3930524|B1|||Age||years|Mean|37.8|37.8|Standard Deviation|11.09|11.09|||
4106580|NCT00962871|3930520|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4106581|NCT00962871|3930521|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4106582|NCT00962871|3930522|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4106583|NCT00962871|3930523|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4106584|NCT00962871|3930524|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4106585|NCT00962871|3930520|B5||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4106586|NCT00962871|3930521|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4106587|NCT00962871|3930522|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4106588|NCT00962871|3930523|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4106589|NCT00962871|3930524|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4106590|NCT00962871|3930520|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4106591|NCT00962871|3930521|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4106592|NCT00962871|3930522|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4106593|NCT00962871|3930523|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4106594|NCT00962871|3930524|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4106595|NCT00962780|3930541|B3||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4106596|NCT00962780|3930542|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4106597|NCT00962780|3930543|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4106598|NCT00962780|3930541|B3||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4106599|NCT00962780|3930542|B2||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4106600|NCT00962780|3930543|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4106601|NCT00962780|3930541|B3|||Age||years|Mean|25.8|25.8|Standard Deviation|16.72|16.72|||
4106602|NCT00962780|3930542|B2|||Age||years|Mean|41.2|41.2|Standard Deviation|8.45|8.45|||
4106603|NCT00962780|3930543|B1|||Age||years|Mean|10.3|10.3|Standard Deviation|3.04|3.04|||
4106604|NCT00962754|3930606|B3|Netherlands||Region of Enrollment||participants|Number|170|170.0||||||
4106605|NCT00962754|3930607|B2|Netherlands||Region of Enrollment||participants|Number|84|84.0||||||
4106606|NCT00962754|3930608|B1|Netherlands||Region of Enrollment||participants|Number|86|86.0||||||
4106607|NCT00962754|3930606|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4106608|NCT00962754|3930607|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4106609|NCT00962754|3930608|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4106610|NCT00962754|3930606|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4106611|NCT00962754|3930607|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4106612|NCT00962754|3930608|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4106613|NCT00962754|3930606|B3|||Age||years|Mean|0.01|0.01|Standard Deviation|0|0.0|||
4106614|NCT00962754|3930607|B2|||Age||years|Mean|0.01|0.01|Standard Deviation|0|0.0|||
4106615|NCT00962754|3930608|B1|||Age||years|Mean|0.01|0.01|Standard Deviation|0|0.0|||
4106616|NCT00962754|3930606|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4106617|NCT00962754|3930607|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4106618|NCT00962754|3930608|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4106619|NCT00962754|3930606|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4106620|NCT00962754|3930607|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4106621|NCT00962754|3930608|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4106622|NCT00962754|3930606|B3||<=18 years|Age||Participants|Count of Participants|170|170.0||||||
4106623|NCT00962754|3930607|B2||<=18 years|Age||Participants|Count of Participants|84|84.0||||||
4106624|NCT00962754|3930608|B1||<=18 years|Age||Participants|Count of Participants|86|86.0||||||
4106625|NCT00962741|3930619|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4106626|NCT00962741|3930619|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4106627|NCT00962741|3930619|B1|||Age||Years|Mean|11.70|11.7|Standard Deviation|4.51|4.51|||
4106628|NCT00962650|3930710|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4106629|NCT00962650|3930710|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4106630|NCT00962650|3930710|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4106631|NCT00962650|3930710|B1|||Age||years|Mean|54.2|54.2|Standard Deviation|9.76|9.76|||
4106632|NCT00962650|3930710|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4106633|NCT00962650|3930710|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4106634|NCT00962650|3930710|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4106635|NCT00962598|3930714|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4106636|NCT00962598|3930715|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4106637|NCT00962598|3930716|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4106638|NCT00962598|3930714|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4106639|NCT00962598|3930715|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4106640|NCT00962598|3930716|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4106641|NCT00962598|3930714|B3|||Age||years|Mean|16.56|16.56|Standard Deviation|2.805|2.805|||
4106642|NCT00962598|3930715|B2|||Age||years|Mean|16.51|16.51|Standard Deviation|2.756|2.756|||
4106643|NCT00962598|3930716|B1|||Age||years|Mean|16.62|16.62|Standard Deviation|3.087|3.087|||
4106644|NCT00962585|3930725|B5|||Body Mass Index||kilogram/meter^2|Mean|27.2|27.2|Standard Deviation|3.9|3.9|||
4106645|NCT00962585|3930726|B4|||Body Mass Index||kilogram/meter^2|Mean|27.4|27.4|Standard Deviation|4.1|4.1|||
4106646|NCT00962585|3930727|B3|||Body Mass Index||kilogram/meter^2|Mean|27.2|27.2|Standard Deviation|3.5|3.5|||
4106647|NCT00962585|3930728|B2|||Body Mass Index||kilogram/meter^2|Mean|27.1|27.1|Standard Deviation|4.1|4.1|||
4106648|NCT00962585|3930729|B1|||Body Mass Index||kilogram/meter^2|Mean|27.1|27.1|Standard Deviation|3.9|3.9|||
4106649|NCT00962585|3930725|B5|||Weight||kilograms|Mean|73.7|73.7|Standard Deviation|11.3|11.3|||
4106650|NCT00962585|3930726|B4|||Weight||kilograms|Mean|73.2|73.2|Standard Deviation|12.8|12.8|||
4106651|NCT00962585|3930727|B3|||Weight||kilograms|Mean|74.4|74.4|Standard Deviation|10.1|10.1|||
4106652|NCT00962585|3930728|B2|||Weight||kilograms|Mean|73.0|73.0|Standard Deviation|10.7|10.7|||
4106653|NCT00962585|3930729|B1|||Weight||kilograms|Mean|74.1|74.1|Standard Deviation|11.6|11.6|||
4106654|NCT00962585|3930725|B5|||Height||centimeters|Mean|164.5|164.5|Standard Deviation|5.6|5.6|||
4106655|NCT00962585|3930726|B4|||Height||centimeters|Mean|163.3|163.3|Standard Deviation|5.9|5.9|||
4106656|NCT00962585|3930727|B3|||Height||centimeters|Mean|165.4|165.4|Standard Deviation|6.7|6.7|||
4106657|NCT00962585|3930728|B2|||Height||centimeters|Mean|164.1|164.1|Standard Deviation|4.6|4.6|||
4106658|NCT00962585|3930729|B1|||Height||centimeters|Mean|165.3|165.3|Standard Deviation|5.1|5.1|||
4106659|NCT00962585|3930725|B5|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4106660|NCT00962585|3930726|B4|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4106661|NCT00962585|3930727|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4106662|NCT00962585|3930728|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4106663|NCT00962585|3930729|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4106664|NCT00962585|3930725|B5|White||Race/Ethnicity, Customized||participants|Number|140|140.0||||||
4106665|NCT00962585|3930726|B4|White||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4106666|NCT00962585|3930727|B3|White||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4106667|NCT00962585|3930728|B2|White||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4106668|NCT00962585|3930729|B1|White||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4106669|NCT00962585|3930725|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4106670|NCT00962585|3930726|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4106671|NCT00962585|3930727|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4106672|NCT00962585|3930728|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4106673|NCT00962585|3930729|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4106674|NCT00962585|3930725|B5|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4106675|NCT00962585|3930726|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4106676|NCT00962585|3930727|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4106677|NCT00962585|3930728|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4106678|NCT00962585|3930729|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4106679|NCT00962585|3930725|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4106680|NCT00962585|3930726|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4106681|NCT00962585|3930727|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4106682|NCT00962585|3930728|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4106683|NCT00962585|3930729|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4106684|NCT00962585|3930725|B5||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4106685|NCT00962585|3930726|B4||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4106686|NCT00962585|3930727|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4106687|NCT00962585|3930728|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4106688|NCT00962585|3930729|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4106689|NCT00962585|3930725|B5|||Age, Customized||years|Mean|54.5|54.5|Standard Deviation|6.9|6.9|||
4106690|NCT00962585|3930726|B4|||Age, Customized||years|Mean|56.2|56.2|Standard Deviation|6.7|6.7|||
4106691|NCT00962585|3930727|B3|||Age, Customized||years|Mean|54.9|54.9|Standard Deviation|5.8|5.8|||
4106692|NCT00962585|3930728|B2|||Age, Customized||years|Mean|53.1|53.1|Standard Deviation|6.9|6.9|||
4106693|NCT00962585|3930729|B1|||Age, Customized||years|Mean|53.8|53.8|Standard Deviation|7.9|7.9|||
4106694|NCT00962390|3930790|B5|||Total Danish Prostatic Symptom Score (DAN-PSS-1)|The DAN-PSS-1 is a self-administered quality-of-life questionnaire comprising 12 questions related to lower urinary tract symptoms (bladder storage and voiding function), and 3 questions related to sexual function (symptom score). All answers for symptom and bothersomeness were classified in a 4-ranked scale from 0 (absence of symptoms or no impact on daily life) to 3 (the maximum severity of symptoms or impact on daily life). A weighted score was then calculated to give a total score that ranged from 0 to 108, where higher scores represented worsening symptoms and bothersomeness.|units on a scale|Mean|29.5|29.5|Standard Deviation|15.6|15.6|||
4106695|NCT00962390|3930791|B4|||Total Danish Prostatic Symptom Score (DAN-PSS-1)|The DAN-PSS-1 is a self-administered quality-of-life questionnaire comprising 12 questions related to lower urinary tract symptoms (bladder storage and voiding function), and 3 questions related to sexual function (symptom score). All answers for symptom and bothersomeness were classified in a 4-ranked scale from 0 (absence of symptoms or no impact on daily life) to 3 (the maximum severity of symptoms or impact on daily life). A weighted score was then calculated to give a total score that ranged from 0 to 108, where higher scores represented worsening symptoms and bothersomeness.|units on a scale|Mean|31.1|31.1|Standard Deviation|19.1|19.1|||
4106696|NCT00962390|3930792|B3|||Total Danish Prostatic Symptom Score (DAN-PSS-1)|The DAN-PSS-1 is a self-administered quality-of-life questionnaire comprising 12 questions related to lower urinary tract symptoms (bladder storage and voiding function), and 3 questions related to sexual function (symptom score). All answers for symptom and bothersomeness were classified in a 4-ranked scale from 0 (absence of symptoms or no impact on daily life) to 3 (the maximum severity of symptoms or impact on daily life). A weighted score was then calculated to give a total score that ranged from 0 to 108, where higher scores represented worsening symptoms and bothersomeness.|units on a scale|Mean|27.2|27.2|Standard Deviation|15.5|15.5|||
4106697|NCT00962390|3930793|B2|||Total Danish Prostatic Symptom Score (DAN-PSS-1)|The DAN-PSS-1 is a self-administered quality-of-life questionnaire comprising 12 questions related to lower urinary tract symptoms (bladder storage and voiding function), and 3 questions related to sexual function (symptom score). All answers for symptom and bothersomeness were classified in a 4-ranked scale from 0 (absence of symptoms or no impact on daily life) to 3 (the maximum severity of symptoms or impact on daily life). A weighted score was then calculated to give a total score that ranged from 0 to 108, where higher scores represented worsening symptoms and bothersomeness.|units on a scale|Mean|33.5|33.5|Standard Deviation|15.3|15.3|||
4106698|NCT00962390|3930794|B1|||Total Danish Prostatic Symptom Score (DAN-PSS-1)|The DAN-PSS-1 is a self-administered quality-of-life questionnaire comprising 12 questions related to lower urinary tract symptoms (bladder storage and voiding function), and 3 questions related to sexual function (symptom score). All answers for symptom and bothersomeness were classified in a 4-ranked scale from 0 (absence of symptoms or no impact on daily life) to 3 (the maximum severity of symptoms or impact on daily life). A weighted score was then calculated to give a total score that ranged from 0 to 108, where higher scores represented worsening symptoms and bothersomeness.|units on a scale|Mean|26.1|26.1|Standard Deviation|10.9|10.9|||
4106699|NCT00962390|3930790|B5|||Total International Prostate Symptom Score (I-PSS)|The I-PSS is based on the answers to 7 questions concerning urinary symptoms and one question concerning the quality of life. Each question concerning urinary symptoms allows the subject to choose 1 out of 6 answers indicating increasing severity of the particular symptom. The answers are assigned points from 0 to 5. The total score can, therefore, range from 0 (asymptomatic) to 35 (very symptomatic).|units on a scale|Mean|21.89|21.89|Standard Deviation|4.96|4.96|||
4106700|NCT00962390|3930791|B4|||Total International Prostate Symptom Score (I-PSS)|The I-PSS is based on the answers to 7 questions concerning urinary symptoms and one question concerning the quality of life. Each question concerning urinary symptoms allows the subject to choose 1 out of 6 answers indicating increasing severity of the particular symptom. The answers are assigned points from 0 to 5. The total score can, therefore, range from 0 (asymptomatic) to 35 (very symptomatic).|units on a scale|Mean|21.32|21.32|Standard Deviation|5.21|5.21|||
4106701|NCT00962390|3930792|B3|||Total International Prostate Symptom Score (I-PSS)|The I-PSS is based on the answers to 7 questions concerning urinary symptoms and one question concerning the quality of life. Each question concerning urinary symptoms allows the subject to choose 1 out of 6 answers indicating increasing severity of the particular symptom. The answers are assigned points from 0 to 5. The total score can, therefore, range from 0 (asymptomatic) to 35 (very symptomatic).|units on a scale|Mean|21.50|21.5|Standard Deviation|4.59|4.59|||
4106702|NCT00962390|3930793|B2|||Total International Prostate Symptom Score (I-PSS)|The I-PSS is based on the answers to 7 questions concerning urinary symptoms and one question concerning the quality of life. Each question concerning urinary symptoms allows the subject to choose 1 out of 6 answers indicating increasing severity of the particular symptom. The answers are assigned points from 0 to 5. The total score can, therefore, range from 0 (asymptomatic) to 35 (very symptomatic).|units on a scale|Mean|23.64|23.64|Standard Deviation|4.57|4.57|||
4106703|NCT00962390|3930794|B1|||Total International Prostate Symptom Score (I-PSS)|The I-PSS is based on the answers to 7 questions concerning urinary symptoms and one question concerning the quality of life. Each question concerning urinary symptoms allows the subject to choose 1 out of 6 answers indicating increasing severity of the particular symptom. The answers are assigned points from 0 to 5. The total score can, therefore, range from 0 (asymptomatic) to 35 (very symptomatic).|units on a scale|Mean|21.11|21.11|Standard Deviation|5.24|5.24|||
4106704|NCT00962390|3930790|B5|||Testosterone, Total||nmol/L|Mean|369.5|369.5|Standard Deviation|243.2|243.2|||
4106705|NCT00962390|3930791|B4|||Testosterone, Total||nmol/L|Mean|372.7|372.7|Standard Deviation|202.0|202.0|||
4106706|NCT00962390|3930792|B3|||Testosterone, Total||nmol/L|Mean|340.6|340.6|Standard Deviation|180.9|180.9|||
4106707|NCT00962390|3930793|B2|||Testosterone, Total||nmol/L|Mean|319.9|319.9|Standard Deviation|248.0|248.0|||
4106708|NCT00962390|3930794|B1|||Testosterone, Total||nmol/L|Mean|442.6|442.6|Standard Deviation|311.7|311.7|||
4106709|NCT00962390|3930790|B5|||Luteinizing Hormone||IU/L|Mean|5.7|5.7|Standard Deviation|3.5|3.5|||
4106710|NCT00962390|3930791|B4|||Luteinizing Hormone||IU/L|Mean|5.9|5.9|Standard Deviation|2.8|2.8|||
4106711|NCT00962390|3930792|B3|||Luteinizing Hormone||IU/L|Mean|6.5|6.5|Standard Deviation|4.1|4.1|||
4106712|NCT00962390|3930793|B2|||Luteinizing Hormone||IU/L|Mean|5.1|5.1|Standard Deviation|2.5|2.5|||
4106713|NCT00962390|3930794|B1|||Luteinizing Hormone||IU/L|Mean|5.4|5.4|Standard Deviation|4.2|4.2|||
4106714|NCT00962390|3930790|B5|||Dihydrotestosterone||pg/mL|Mean|502.6|502.6|Standard Deviation|378.3|378.3|||
4106715|NCT00962390|3930791|B4|||Dihydrotestosterone||pg/mL|Mean|446.1|446.1|Standard Deviation|185.5|185.5|||
4106716|NCT00962390|3930792|B3|||Dihydrotestosterone||pg/mL|Mean|534.7|534.7|Standard Deviation|467.4|467.4|||
4106717|NCT00962390|3930793|B2|||Dihydrotestosterone||pg/mL|Mean|533.6|533.6|Standard Deviation|388.5|388.5|||
4106718|NCT00962390|3930794|B1|||Dihydrotestosterone||pg/mL|Mean|496.2|496.2|Standard Deviation|425.2|425.2|||
4106719|NCT00962390|3930790|B5|||Void Volume||mL|Mean|245.14|245.14|Standard Deviation|110.39|110.39|||
4106720|NCT00962390|3930791|B4|||Void Volume||mL|Mean|261.48|261.48|Standard Deviation|86.07|86.07|||
4106721|NCT00962390|3930792|B3|||Void Volume||mL|Mean|243.54|243.54|Standard Deviation|115.54|115.54|||
4106722|NCT00962390|3930793|B2|||Void Volume||mL|Mean|245.75|245.75|Standard Deviation|111.49|111.49|||
4106723|NCT00962390|3930794|B1|||Void Volume||mL|Mean|229.21|229.21|Standard Deviation|128.59|128.59|||
4106724|NCT00962390|3930790|B5|||Qmax Result||mL/second|Mean|10.66|10.66|Standard Deviation|3.32|3.32|||
4106725|NCT00962390|3930791|B4|||Qmax Result||mL/second|Mean|10.98|10.98|Standard Deviation|3.59|3.59|||
4106726|NCT00962390|3930792|B3|||Qmax Result||mL/second|Mean|11.17|11.17|Standard Deviation|3.30|3.3|||
4106727|NCT00962390|3930793|B2|||Qmax Result||mL/second|Mean|10.27|10.27|Standard Deviation|3.29|3.29|||
4106728|NCT00962390|3930794|B1|||Qmax Result||mL/second|Mean|10.22|10.22|Standard Deviation|3.13|3.13|||
4106729|NCT00962390|3930790|B5|||Post Void Residual Urine Volume||mL|Mean|71.91|71.91|Standard Deviation|58.55|58.55|||
4106730|NCT00962390|3930791|B4|||Post Void Residual Urine Volume||mL|Mean|89.07|89.07|Standard Deviation|56.01|56.01|||
4106731|NCT00962390|3930792|B3|||Post Void Residual Urine Volume||mL|Mean|61.38|61.38|Standard Deviation|60.37|60.37|||
4106732|NCT00962390|3930793|B2|||Post Void Residual Urine Volume||mL|Mean|62.00|62.0|Standard Deviation|55.93|55.93|||
4106733|NCT00962390|3930794|B1|||Post Void Residual Urine Volume||mL|Mean|74.59|74.59|Standard Deviation|60.45|60.45|||
4106734|NCT00962390|3930790|B5|||Prostate Volume||mL|Mean|42.61|42.61|Standard Deviation|12.62|12.62|||
4106735|NCT00962390|3930791|B4|||Prostate Volume||mL|Mean|41.41|41.41|Standard Deviation|11.39|11.39|||
4106736|NCT00962390|3930792|B3|||Prostate Volume||mL|Mean|40.83|40.83|Standard Deviation|11.40|11.4|||
4106737|NCT00962390|3930793|B2|||Prostate Volume||mL|Mean|44.79|44.79|Standard Deviation|14.27|14.27|||
4106738|NCT00962390|3930794|B1|||Prostate Volume||mL|Mean|43.46|43.46|Standard Deviation|13.47|13.47|||
4106739|NCT00962390|3930790|B5|||Prostate specific antigen (PSA) concentration||ng/mL|Mean|3.386|3.386|Standard Deviation|1.775|1.775|||
4106740|NCT00962390|3930791|B4|||Prostate specific antigen (PSA) concentration||ng/mL|Mean|3.514|3.514|Standard Deviation|1.860|1.86|||
4106741|NCT00962390|3930792|B3|||Prostate specific antigen (PSA) concentration||ng/mL|Mean|3.210|3.21|Standard Deviation|1.075|1.075|||
4106742|NCT00962390|3930793|B2|||Prostate specific antigen (PSA) concentration||ng/mL|Mean|3.308|3.308|Standard Deviation|1.796|1.796|||
4106743|NCT00962390|3930794|B1|||Prostate specific antigen (PSA) concentration||ng/mL|Mean|3.509|3.509|Standard Deviation|2.241|2.241|||
4106744|NCT00962390|3930790|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4106745|NCT00962390|3930791|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106746|NCT00962390|3930792|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106747|NCT00962390|3930793|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106748|NCT00962390|3930794|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4106749|NCT00962390|3930790|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106750|NCT00962390|3930791|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106751|NCT00962390|3930792|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106752|NCT00962390|3930793|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106753|NCT00962390|3930794|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106754|NCT00962390|3930790|B5||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4106755|NCT00962390|3930791|B4||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4106756|NCT00962390|3930792|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4106757|NCT00962390|3930793|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4106758|NCT00962390|3930794|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4106759|NCT00962390|3930790|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4106760|NCT00962390|3930791|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106761|NCT00962390|3930792|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4106762|NCT00962390|3930793|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4106763|NCT00962390|3930794|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4106764|NCT00962390|3930790|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106765|NCT00962390|3930791|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106766|NCT00962390|3930792|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106767|NCT00962390|3930793|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106768|NCT00962390|3930794|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106769|NCT00962390|3930790|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4106770|NCT00962390|3930791|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4106771|NCT00962390|3930792|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4106772|NCT00962390|3930793|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4106773|NCT00962390|3930794|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4106774|NCT00962390|3930790|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106775|NCT00962390|3930791|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106776|NCT00962390|3930792|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106777|NCT00962390|3930793|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106778|NCT00962390|3930794|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106779|NCT00962390|3930790|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106780|NCT00962390|3930791|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106781|NCT00962390|3930792|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106782|NCT00962390|3930793|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106783|NCT00962390|3930794|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106784|NCT00962390|3930790|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
4106785|NCT00962390|3930791|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4106786|NCT00962390|3930792|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4106787|NCT00962390|3930793|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4106788|NCT00962390|3930794|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4106789|NCT00962390|3930790|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4106790|NCT00962390|3930791|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4106791|NCT00962390|3930792|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4106792|NCT00962390|3930793|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4106793|NCT00962390|3930794|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4106794|NCT00962390|3930790|B5||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4106795|NCT00962390|3930791|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4106796|NCT00962390|3930792|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4106797|NCT00962390|3930793|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4106798|NCT00962390|3930794|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4106799|NCT00962390|3930790|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4106800|NCT00962390|3930791|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4106801|NCT00962390|3930792|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4106802|NCT00962390|3930793|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4106803|NCT00962390|3930794|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4106804|NCT00962390|3930790|B5|||Age||years|Mean|63.4|63.4|Standard Deviation|8.0|8.0|||
4106805|NCT00962390|3930791|B4|||Age||years|Mean|62.7|62.7|Standard Deviation|7.7|7.7|||
4106806|NCT00962390|3930792|B3|||Age||years|Mean|63.1|63.1|Standard Deviation|8.8|8.8|||
4106807|NCT00962390|3930793|B2|||Age||years|Mean|64.6|64.6|Standard Deviation|6.5|6.5|||
4106808|NCT00962390|3930794|B1|||Age||years|Mean|63.1|63.1|Standard Deviation|9.1|9.1|||
4106809|NCT00962247|3930859|B1|||zBMI||z-score|Mean|1.8|1.8|Standard Deviation|0.4|0.4|||
4106810|NCT00962247|3930859|B1|||Body Mass Index||kg/m^2|Mean|25.0|25.0|Standard Deviation|4.2|4.2|||
4106811|NCT00962247|3930859|B1|||Weight||lbs|Mean|118.8|118.8|Standard Deviation|30.5|30.5|||
4106812|NCT00962247|3930859|B1|||Height||Inches|Mean|57.4|57.4|Standard Deviation|3.7|3.7|||
4106813|NCT00962247|3930859|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106814|NCT00962247|3930859|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4106815|NCT00962247|3930859|B1||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4106816|NCT00962247|3930859|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4106817|NCT00962247|3930859|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106818|NCT00962247|3930859|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106819|NCT00962247|3930859|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106820|NCT00962247|3930859|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4106821|NCT00962247|3930859|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4106822|NCT00962247|3930859|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4106823|NCT00962247|3930859|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4106824|NCT00962247|3930859|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4106825|NCT00962247|3930859|B1|||Age||Years|Mean|10.7|10.7|Standard Deviation|1.2|1.2|||
4106826|NCT00962208|3930868|B3|China||Region of Enrollment||participants|Number|102|102.0||||||
4106827|NCT00962208|3930869|B2|China||Region of Enrollment||participants|Number|51|51.0||||||
4106828|NCT00962208|3930870|B1|China||Region of Enrollment||participants|Number|51|51.0||||||
4106829|NCT00962208|3930868|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4106830|NCT00962208|3930869|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4106831|NCT00962208|3930870|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4106832|NCT00962208|3930868|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4106833|NCT00962208|3930869|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4106834|NCT00962208|3930870|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4106835|NCT00962208|3930868|B3|||Age||years|Mean|9.28|9.28|Standard Deviation|1.09|1.09|||
4106836|NCT00962208|3930869|B2|||Age||years|Mean|9.27|9.27|Standard Deviation|1.09|1.09|||
4106837|NCT00962208|3930870|B1|||Age||years|Mean|9.28|9.28|Standard Deviation|1.10|1.1|||
4106838|NCT00962208|3930868|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4106839|NCT00962208|3930869|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4106840|NCT00962208|3930870|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4106841|NCT00962208|3930868|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4106842|NCT00962208|3930869|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4106843|NCT00962208|3930870|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4106844|NCT00962208|3930868|B3||<=18 years|Age||Participants|Count of Participants|102|102.0||||||
4106845|NCT00962208|3930869|B2||<=18 years|Age||Participants|Count of Participants|51|51.0||||||
4106846|NCT00962208|3930870|B1||<=18 years|Age||Participants|Count of Participants|51|51.0||||||
4106847|NCT00962104|3930877|B3|||Conners' Adult Attention-Deficit Hyperactivity/Disorder Rating Scale-Investigator Rated: Screening V|Conners' Adult Attention-Deficit/Hyperactivity Disorder Rating Scale-Investigator Rated: Screening Version (CAARS-Inv:SV) is a scale that assesses symptom severity over past week. Total ADHD symptom score consisted of 18 items (sum of inattention [9 items, range: 0-27] and hyperactivity-impulsivity [9 items, range: 0-27] subscales) using a 4-point scale (0=not at all/never to 3=very much/very frequently) for total score range of 0 to 54. Higher scores indicate greater impairment.|units on a scale|Mean|33.6|33.6|Standard Deviation|7.6|7.6|||
4106848|NCT00962104|3930878|B2|||Conners' Adult Attention-Deficit Hyperactivity/Disorder Rating Scale-Investigator Rated: Screening V|Conners' Adult Attention-Deficit/Hyperactivity Disorder Rating Scale-Investigator Rated: Screening Version (CAARS-Inv:SV) is a scale that assesses symptom severity over past week. Total ADHD symptom score consisted of 18 items (sum of inattention [9 items, range: 0-27] and hyperactivity-impulsivity [9 items, range: 0-27] subscales) using a 4-point scale (0=not at all/never to 3=very much/very frequently) for total score range of 0 to 54. Higher scores indicate greater impairment.|units on a scale|Mean|33.9|33.9|Standard Deviation|7.5|7.5|||
4106849|NCT00962104|3930879|B1|||Conners' Adult Attention-Deficit Hyperactivity/Disorder Rating Scale-Investigator Rated: Screening V|Conners' Adult Attention-Deficit/Hyperactivity Disorder Rating Scale-Investigator Rated: Screening Version (CAARS-Inv:SV) is a scale that assesses symptom severity over past week. Total ADHD symptom score consisted of 18 items (sum of inattention [9 items, range: 0-27] and hyperactivity-impulsivity [9 items, range: 0-27] subscales) using a 4-point scale (0=not at all/never to 3=very much/very frequently) for total score range of 0 to 54. Higher scores indicate greater impairment.|units on a scale|Mean|33.2|33.2|Standard Deviation|7.7|7.7|||
4106934|NCT00962065|3930908|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4106935|NCT00962065|3930909|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4106850|NCT00962104|3930877|B3|Current OCD - No||Obsessive-Compulsive Disorder (OCD) Status|Current (past month) OCD status was assessed using the Mini International Neuropsychiatric Interview (MINI), a structured diagnostic interview that assesses psychiatric disorders.|participants|Number|385|385.0||||||
4106851|NCT00962104|3930878|B2|Current OCD - No||Obsessive-Compulsive Disorder (OCD) Status|Current (past month) OCD status was assessed using the Mini International Neuropsychiatric Interview (MINI), a structured diagnostic interview that assesses psychiatric disorders.|participants|Number|193|193.0||||||
4106852|NCT00962104|3930879|B1|Current OCD - No||Obsessive-Compulsive Disorder (OCD) Status|Current (past month) OCD status was assessed using the Mini International Neuropsychiatric Interview (MINI), a structured diagnostic interview that assesses psychiatric disorders.|participants|Number|192|192.0||||||
4106853|NCT00962104|3930877|B3|Current OCD - Yes||Obsessive-Compulsive Disorder (OCD) Status|Current (past month) OCD status was assessed using the Mini International Neuropsychiatric Interview (MINI), a structured diagnostic interview that assesses psychiatric disorders.|participants|Number|3|3.0||||||
4106854|NCT00962104|3930878|B2|Current OCD - Yes||Obsessive-Compulsive Disorder (OCD) Status|Current (past month) OCD status was assessed using the Mini International Neuropsychiatric Interview (MINI), a structured diagnostic interview that assesses psychiatric disorders.|participants|Number|2|2.0||||||
4106855|NCT00962104|3930879|B1|Current OCD - Yes||Obsessive-Compulsive Disorder (OCD) Status|Current (past month) OCD status was assessed using the Mini International Neuropsychiatric Interview (MINI), a structured diagnostic interview that assesses psychiatric disorders.|participants|Number|1|1.0||||||
4106856|NCT00962104|3930877|B3|Current Social Phobia (SAD) - No||Current Social Phobia (Social Anxiety Disorder [SAD]) Status|Current (past month) social phobia (SAD) status was assessed using the Mini International Neuropsychiatric Interview (MINI), a structured diagnostic interview that assesses psychiatric disorders.|participants|Number|381|381.0||||||
4106857|NCT00962104|3930878|B2|Current Social Phobia (SAD) - No||Current Social Phobia (Social Anxiety Disorder [SAD]) Status|Current (past month) social phobia (SAD) status was assessed using the Mini International Neuropsychiatric Interview (MINI), a structured diagnostic interview that assesses psychiatric disorders.|participants|Number|191|191.0||||||
4106858|NCT00962104|3930879|B1|Current Social Phobia (SAD) - No||Current Social Phobia (Social Anxiety Disorder [SAD]) Status|Current (past month) social phobia (SAD) status was assessed using the Mini International Neuropsychiatric Interview (MINI), a structured diagnostic interview that assesses psychiatric disorders.|participants|Number|190|190.0||||||
4106859|NCT00962104|3930877|B3|Current Social Phobia (SAD) - Yes||Current Social Phobia (Social Anxiety Disorder [SAD]) Status|Current (past month) social phobia (SAD) status was assessed using the Mini International Neuropsychiatric Interview (MINI), a structured diagnostic interview that assesses psychiatric disorders.|participants|Number|7|7.0||||||
4106860|NCT00962104|3930878|B2|Current Social Phobia (SAD) - Yes||Current Social Phobia (Social Anxiety Disorder [SAD]) Status|Current (past month) social phobia (SAD) status was assessed using the Mini International Neuropsychiatric Interview (MINI), a structured diagnostic interview that assesses psychiatric disorders.|participants|Number|4|4.0||||||
4106861|NCT00962104|3930879|B1|Current Social Phobia (SAD) - Yes||Current Social Phobia (Social Anxiety Disorder [SAD]) Status|Current (past month) social phobia (SAD) status was assessed using the Mini International Neuropsychiatric Interview (MINI), a structured diagnostic interview that assesses psychiatric disorders.|participants|Number|3|3.0||||||
4106862|NCT00962104|3930877|B3|Current Major Depressive Episode with - No||Current Major Depressive Episode with Melancholic Features Status|Current (past 2 weeks) major depressive episode with melancholic features status was assessed using the Mini International Neuropsychiatric Interview (MINI), a structured diagnostic interview that assesses psychiatric disorders.|participants|Number|386|386.0||||||
4106863|NCT00962104|3930878|B2|Current Major Depressive Episode with - No||Current Major Depressive Episode with Melancholic Features Status|Current (past 2 weeks) major depressive episode with melancholic features status was assessed using the Mini International Neuropsychiatric Interview (MINI), a structured diagnostic interview that assesses psychiatric disorders.|participants|Number|195|195.0||||||
4106864|NCT00962104|3930879|B1|Current Major Depressive Episode with - No||Current Major Depressive Episode with Melancholic Features Status|Current (past 2 weeks) major depressive episode with melancholic features status was assessed using the Mini International Neuropsychiatric Interview (MINI), a structured diagnostic interview that assesses psychiatric disorders.|participants|Number|191|191.0||||||
4106865|NCT00962104|3930877|B3|Current Major Depressive Episode with - Yes||Current Major Depressive Episode with Melancholic Features Status|Current (past 2 weeks) major depressive episode with melancholic features status was assessed using the Mini International Neuropsychiatric Interview (MINI), a structured diagnostic interview that assesses psychiatric disorders.|participants|Number|2|2.0||||||
4106866|NCT00962104|3930878|B2|Current Major Depressive Episode with - Yes||Current Major Depressive Episode with Melancholic Features Status|Current (past 2 weeks) major depressive episode with melancholic features status was assessed using the Mini International Neuropsychiatric Interview (MINI), a structured diagnostic interview that assesses psychiatric disorders.|participants|Number|0|0.0||||||
4106867|NCT00962104|3930879|B1|Current Major Depressive Episode with - Yes||Current Major Depressive Episode with Melancholic Features Status|Current (past 2 weeks) major depressive episode with melancholic features status was assessed using the Mini International Neuropsychiatric Interview (MINI), a structured diagnostic interview that assesses psychiatric disorders.|participants|Number|2|2.0||||||
4106868|NCT00962104|3930877|B3|Recurrent Major Depressive Episode - No||Recurrent Major Depressive Episode Status|Recurrent major depressive episode status was assessed using the Mini International Neuropsychiatric Interview (MINI), a structured diagnostic interview that assesses psychiatric disorders.|participants|Number|387|387.0||||||
4106869|NCT00962104|3930878|B2|Recurrent Major Depressive Episode - No||Recurrent Major Depressive Episode Status|Recurrent major depressive episode status was assessed using the Mini International Neuropsychiatric Interview (MINI), a structured diagnostic interview that assesses psychiatric disorders.|participants|Number|195|195.0||||||
4106870|NCT00962104|3930879|B1|Recurrent Major Depressive Episode - No||Recurrent Major Depressive Episode Status|Recurrent major depressive episode status was assessed using the Mini International Neuropsychiatric Interview (MINI), a structured diagnostic interview that assesses psychiatric disorders.|participants|Number|192|192.0||||||
4106871|NCT00962104|3930877|B3|Recurrent Major Depressive Episode - Yes||Recurrent Major Depressive Episode Status|Recurrent major depressive episode status was assessed using the Mini International Neuropsychiatric Interview (MINI), a structured diagnostic interview that assesses psychiatric disorders.|participants|Number|1|1.0||||||
4106872|NCT00962104|3930878|B2|Recurrent Major Depressive Episode - Yes||Recurrent Major Depressive Episode Status|Recurrent major depressive episode status was assessed using the Mini International Neuropsychiatric Interview (MINI), a structured diagnostic interview that assesses psychiatric disorders.|participants|Number|0|0.0||||||
4106873|NCT00962104|3930879|B1|Recurrent Major Depressive Episode - Yes||Recurrent Major Depressive Episode Status|Recurrent major depressive episode status was assessed using the Mini International Neuropsychiatric Interview (MINI), a structured diagnostic interview that assesses psychiatric disorders.|participants|Number|1|1.0||||||
4106874|NCT00962104|3930877|B3|Major Depressive Episode - No||Current Major Depressive Episode Status|Current (past 2 weeks) major depressive episode status was assessed using the Mini International Neuropsychiatric Interview (MINI), a structured diagnostic interview that assesses psychiatric disorders.|participants|Number|384|384.0||||||
4106875|NCT00962104|3930878|B2|Major Depressive Episode - No||Current Major Depressive Episode Status|Current (past 2 weeks) major depressive episode status was assessed using the Mini International Neuropsychiatric Interview (MINI), a structured diagnostic interview that assesses psychiatric disorders.|participants|Number|195|195.0||||||
4106876|NCT00962104|3930879|B1|Major Depressive Episode - No||Current Major Depressive Episode Status|Current (past 2 weeks) major depressive episode status was assessed using the Mini International Neuropsychiatric Interview (MINI), a structured diagnostic interview that assesses psychiatric disorders.|participants|Number|189|189.0||||||
4106877|NCT00962104|3930877|B3|Major Depressive Episode - Yes||Current Major Depressive Episode Status|Current (past 2 weeks) major depressive episode status was assessed using the Mini International Neuropsychiatric Interview (MINI), a structured diagnostic interview that assesses psychiatric disorders.|participants|Number|4|4.0||||||
4106878|NCT00962104|3930878|B2|Major Depressive Episode - Yes||Current Major Depressive Episode Status|Current (past 2 weeks) major depressive episode status was assessed using the Mini International Neuropsychiatric Interview (MINI), a structured diagnostic interview that assesses psychiatric disorders.|participants|Number|0|0.0||||||
4106879|NCT00962104|3930879|B1|Major Depressive Episode - Yes||Current Major Depressive Episode Status|Current (past 2 weeks) major depressive episode status was assessed using the Mini International Neuropsychiatric Interview (MINI), a structured diagnostic interview that assesses psychiatric disorders.|participants|Number|4|4.0||||||
4106880|NCT00962104|3930877|B3|Prior Stimulant Exposure - No||Prior Stimulant Exposure Status||participants|Number|303|303.0||||||
4106881|NCT00962104|3930878|B2|Prior Stimulant Exposure - No||Prior Stimulant Exposure Status||participants|Number|153|153.0||||||
4106882|NCT00962104|3930879|B1|Prior Stimulant Exposure - No||Prior Stimulant Exposure Status||participants|Number|150|150.0||||||
4106883|NCT00962104|3930877|B3|Prior Stimulant Exposure - Yes||Prior Stimulant Exposure Status||participants|Number|85|85.0||||||
4106884|NCT00962104|3930878|B2|Prior Stimulant Exposure - Yes||Prior Stimulant Exposure Status||participants|Number|42|42.0||||||
4106885|NCT00962104|3930879|B1|Prior Stimulant Exposure - Yes||Prior Stimulant Exposure Status||participants|Number|43|43.0||||||
4106886|NCT00962104|3930877|B3|Combined||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype Current|ADHD subtype was classified by Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) criteria.|participants|Number|189|189.0||||||
4106887|NCT00962104|3930878|B2|Combined||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype Current|ADHD subtype was classified by Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) criteria.|participants|Number|96|96.0||||||
4106888|NCT00962104|3930879|B1|Combined||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype Current|ADHD subtype was classified by Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) criteria.|participants|Number|93|93.0||||||
4106889|NCT00962104|3930877|B3|Hyperactive/Impulsive||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype Current|ADHD subtype was classified by Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) criteria.|participants|Number|8|8.0||||||
4106890|NCT00962104|3930878|B2|Hyperactive/Impulsive||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype Current|ADHD subtype was classified by Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) criteria.|participants|Number|4|4.0||||||
4106891|NCT00962104|3930879|B1|Hyperactive/Impulsive||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype Current|ADHD subtype was classified by Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) criteria.|participants|Number|4|4.0||||||
4106892|NCT00962104|3930877|B3|Inattentive||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype Current|ADHD subtype was classified by Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) criteria.|participants|Number|191|191.0||||||
4106893|NCT00962104|3930878|B2|Inattentive||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype Current|ADHD subtype was classified by Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) criteria.|participants|Number|95|95.0||||||
4106894|NCT00962104|3930879|B1|Inattentive||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype Current|ADHD subtype was classified by Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) criteria.|participants|Number|96|96.0||||||
4106895|NCT00962104|3930877|B3|Ultra-rapid metabolizer (UM)||Number of Participants with the Cytochrome P450 2D6 (CYP2D6) Genotype|Genotype characterization was used to determine participants' metabolic status. The number of participants differs from the overall number of baseline participants because either cytochrome P450 2D6 (CYP2D6) was not collected or was not evaluated due to an error.|participants|Number|6|6.0||||||
4106896|NCT00962104|3930878|B2|Ultra-rapid metabolizer (UM)||Number of Participants with the Cytochrome P450 2D6 (CYP2D6) Genotype|Genotype characterization was used to determine participants' metabolic status. The number of participants differs from the overall number of baseline participants because either cytochrome P450 2D6 (CYP2D6) was not collected or was not evaluated due to an error.|participants|Number|2|2.0||||||
4106936|NCT00962065|3930906|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4106937|NCT00962065|3930907|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4106897|NCT00962104|3930879|B1|Ultra-rapid metabolizer (UM)||Number of Participants with the Cytochrome P450 2D6 (CYP2D6) Genotype|Genotype characterization was used to determine participants' metabolic status. The number of participants differs from the overall number of baseline participants because either cytochrome P450 2D6 (CYP2D6) was not collected or was not evaluated due to an error.|participants|Number|4|4.0||||||
4106898|NCT00962104|3930877|B3|Poor metabolizer (PM)||Number of Participants with the Cytochrome P450 2D6 (CYP2D6) Genotype|Genotype characterization was used to determine participants' metabolic status. The number of participants differs from the overall number of baseline participants because either cytochrome P450 2D6 (CYP2D6) was not collected or was not evaluated due to an error.|participants|Number|0|0.0||||||
4106899|NCT00962104|3930878|B2|Poor metabolizer (PM)||Number of Participants with the Cytochrome P450 2D6 (CYP2D6) Genotype|Genotype characterization was used to determine participants' metabolic status. The number of participants differs from the overall number of baseline participants because either cytochrome P450 2D6 (CYP2D6) was not collected or was not evaluated due to an error.|participants|Number|0|0.0||||||
4106900|NCT00962104|3930879|B1|Poor metabolizer (PM)||Number of Participants with the Cytochrome P450 2D6 (CYP2D6) Genotype|Genotype characterization was used to determine participants' metabolic status. The number of participants differs from the overall number of baseline participants because either cytochrome P450 2D6 (CYP2D6) was not collected or was not evaluated due to an error.|participants|Number|0|0.0||||||
4106901|NCT00962104|3930877|B3|Intermediate metabolizer (IM)||Number of Participants with the Cytochrome P450 2D6 (CYP2D6) Genotype|Genotype characterization was used to determine participants' metabolic status. The number of participants differs from the overall number of baseline participants because either cytochrome P450 2D6 (CYP2D6) was not collected or was not evaluated due to an error.|participants|Number|274|274.0||||||
4106902|NCT00962104|3930878|B2|Intermediate metabolizer (IM)||Number of Participants with the Cytochrome P450 2D6 (CYP2D6) Genotype|Genotype characterization was used to determine participants' metabolic status. The number of participants differs from the overall number of baseline participants because either cytochrome P450 2D6 (CYP2D6) was not collected or was not evaluated due to an error.|participants|Number|137|137.0||||||
4106903|NCT00962104|3930879|B1|Intermediate metabolizer (IM)||Number of Participants with the Cytochrome P450 2D6 (CYP2D6) Genotype|Genotype characterization was used to determine participants' metabolic status. The number of participants differs from the overall number of baseline participants because either cytochrome P450 2D6 (CYP2D6) was not collected or was not evaluated due to an error.|participants|Number|137|137.0||||||
4106904|NCT00962104|3930877|B3|Extensive metabolizer (EM)||Number of Participants with the Cytochrome P450 2D6 (CYP2D6) Genotype|Genotype characterization was used to determine participants' metabolic status. The number of participants differs from the overall number of baseline participants because either cytochrome P450 2D6 (CYP2D6) was not collected or was not evaluated due to an error.|participants|Number|85|85.0||||||
4106905|NCT00962104|3930878|B2|Extensive metabolizer (EM)||Number of Participants with the Cytochrome P450 2D6 (CYP2D6) Genotype|Genotype characterization was used to determine participants' metabolic status. The number of participants differs from the overall number of baseline participants because either cytochrome P450 2D6 (CYP2D6) was not collected or was not evaluated due to an error.|participants|Number|45|45.0||||||
4106906|NCT00962104|3930879|B1|Extensive metabolizer (EM)||Number of Participants with the Cytochrome P450 2D6 (CYP2D6) Genotype|Genotype characterization was used to determine participants' metabolic status. The number of participants differs from the overall number of baseline participants because either cytochrome P450 2D6 (CYP2D6) was not collected or was not evaluated due to an error.|participants|Number|40|40.0||||||
4106907|NCT00962104|3930877|B3|Korea, Republic of||Region of Enrollment||participants|Number|73|73.0||||||
4106908|NCT00962104|3930878|B2|Korea, Republic of||Region of Enrollment||participants|Number|37|37.0||||||
4106909|NCT00962104|3930879|B1|Korea, Republic of||Region of Enrollment||participants|Number|36|36.0||||||
4106910|NCT00962104|3930877|B3|Japan||Region of Enrollment||participants|Number|247|247.0||||||
4106911|NCT00962104|3930878|B2|Japan||Region of Enrollment||participants|Number|124|124.0||||||
4106912|NCT00962104|3930879|B1|Japan||Region of Enrollment||participants|Number|123|123.0||||||
4106913|NCT00962104|3930877|B3|Taiwan||Region of Enrollment||participants|Number|68|68.0||||||
4106914|NCT00962104|3930878|B2|Taiwan||Region of Enrollment||participants|Number|34|34.0||||||
4106915|NCT00962104|3930879|B1|Taiwan||Region of Enrollment||participants|Number|34|34.0||||||
4106916|NCT00962104|3930877|B3|Asian||Race/Ethnicity, Customized||participants|Number|388|388.0||||||
4106917|NCT00962104|3930878|B2|Asian||Race/Ethnicity, Customized||participants|Number|195|195.0||||||
4106918|NCT00962104|3930879|B1|Asian||Race/Ethnicity, Customized||participants|Number|193|193.0||||||
4106919|NCT00962104|3930877|B3||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4106920|NCT00962104|3930878|B2||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4106921|NCT00962104|3930879|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4106922|NCT00962104|3930877|B3||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4106923|NCT00962104|3930878|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4106924|NCT00962104|3930879|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4106925|NCT00962104|3930877|B3|||Age||years|Mean|32.3|32.3|Standard Deviation|8.0|8.0|||
4106926|NCT00962104|3930878|B2|||Age||years|Mean|31.7|31.7|Standard Deviation|7.8|7.8|||
4106927|NCT00962104|3930879|B1|||Age||years|Mean|32.8|32.8|Standard Deviation|8.1|8.1|||
4106928|NCT00962065|3930906|B4|United States||Region of Enrollment||participants|Number|36|36.0||||||
4106929|NCT00962065|3930907|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4106930|NCT00962065|3930908|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4106931|NCT00962065|3930909|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4106932|NCT00962065|3930906|B4|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
4106933|NCT00962065|3930907|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4106938|NCT00962065|3930908|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4106939|NCT00962065|3930909|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4106940|NCT00962065|3930906|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4106941|NCT00962065|3930907|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4106942|NCT00962065|3930908|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4106943|NCT00962065|3930909|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4106944|NCT00962065|3930906|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106945|NCT00962065|3930907|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106946|NCT00962065|3930908|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106947|NCT00962065|3930909|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4106948|NCT00962065|3930906|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4106949|NCT00962065|3930907|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4106950|NCT00962065|3930908|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4106951|NCT00962065|3930909|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4106952|NCT00962065|3930906|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4106953|NCT00962065|3930907|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4106954|NCT00962065|3930908|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4106955|NCT00962065|3930909|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4106956|NCT00962065|3930906|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4106957|NCT00962065|3930907|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4106958|NCT00962065|3930908|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4106959|NCT00962065|3930909|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4106960|NCT00962065|3930906|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4106961|NCT00962065|3930907|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4106962|NCT00962065|3930908|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4106963|NCT00962065|3930909|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4106964|NCT00962065|3930906|B4|||Age||years|Mean|53.2|53.2|Standard Deviation|7.15|7.15|||
4106965|NCT00962065|3930907|B3|||Age||years|Mean|54.5|54.5|Standard Deviation|7.23|7.23|||
4106966|NCT00962065|3930908|B2|||Age||years|Mean|52.3|52.3|Standard Deviation|8.40|8.4|||
4106967|NCT00962065|3930909|B1|||Age||years|Mean|52.7|52.7|Standard Deviation|6.07|6.07|||
4106968|NCT00962013|3930934|B1|United States||Region of Enrollment||participants|Number|120|120.0||||||
4106969|NCT00962013|3930934|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4106970|NCT00962013|3930934|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4106971|NCT00962013|3930934|B1|||Age|Age results are based on 118 participants as there were 2 participants missing age data. For bilateral participants, age at the time surgery for the first hip enrolled is used for the baseline measurement.|years|Mean|67.72|67.72|Standard Deviation|12.05|12.05|||
4106972|NCT00962000|3930943|B1|||Pre-dialysis Weight||kg|Mean|84|84.0|Full Range|||48.0|147.0|
4106973|NCT00962000|3930943|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4106974|NCT00962000|3930943|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4106975|NCT00962000|3930943|B1|>=18 years||Age||years|Mean|50|50.0|Full Range|||19.0|85.0|
4106976|NCT00961896|3930954|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4106977|NCT00961896|3930955|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4106978|NCT00961896|3930956|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4106979|NCT00961896|3930957|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4106980|NCT00961896|3930954|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4106981|NCT00961896|3930955|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4106982|NCT00961896|3930956|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4106983|NCT00961896|3930957|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4106984|NCT00961896|3930954|B4|||Age||Years|Mean|50|50.0|Standard Deviation|12.9|12.9|||
4106985|NCT00961896|3930955|B3|||Age||Years|Mean|48|48.0|Standard Deviation|13.4|13.4|||
4106986|NCT00961896|3930956|B2|||Age||Years|Mean|52|52.0|Standard Deviation|11.7|11.7|||
4106987|NCT00961896|3930957|B1|||Age||Years|Mean|50|50.0|Standard Deviation|13.5|13.5|||
4106988|NCT00961805|3930978|B3|Brazil||Region of Enrollment||participants|Number|80|80.0||||||
4106989|NCT00961805|3930979|B2|Brazil||Region of Enrollment||participants|Number|40|40.0||||||
4106990|NCT00961805|3930980|B1|Brazil||Region of Enrollment||participants|Number|40|40.0||||||
4106991|NCT00961805|3930978|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4106992|NCT00961805|3930979|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4106993|NCT00961805|3930980|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4106994|NCT00961805|3930978|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4106995|NCT00961805|3930979|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4106996|NCT00961805|3930980|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4106997|NCT00961805|3930978|B3|||Age||years|Mean|49.3|49.3|Standard Deviation|11.2|11.2|||
4106998|NCT00961805|3930979|B2|||Age||years|Mean|49.5|49.5|Standard Deviation|10.9|10.9|||
4106999|NCT00961805|3930980|B1|||Age||years|Mean|49.1|49.1|Standard Deviation|11.5|11.5|||
4107000|NCT00961805|3930978|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4107001|NCT00961805|3930979|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4107002|NCT00961805|3930980|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4107003|NCT00961805|3930978|B3||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4107004|NCT00961805|3930979|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4107005|NCT00961805|3930980|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4107006|NCT00961805|3930978|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107007|NCT00961805|3930979|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107008|NCT00961805|3930980|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107009|NCT00961662|3931009|B4||Male|Sex: Female, Male|Baseline participants are from the safety population|Participants|Count of Participants|90|90.0||||||
4107010|NCT00961662|3931010|B3||Male|Sex: Female, Male|Baseline participants are from the safety population|Participants|Count of Participants|28|28.0||||||
4107011|NCT00961662|3931011|B2||Male|Sex: Female, Male|Baseline participants are from the safety population|Participants|Count of Participants|32|32.0||||||
4107012|NCT00961662|3931012|B1||Male|Sex: Female, Male|Baseline participants are from the safety population|Participants|Count of Participants|30|30.0||||||
4107013|NCT00961662|3931009|B4||Female|Sex: Female, Male|Baseline participants are from the safety population|Participants|Count of Participants|55|55.0||||||
4107014|NCT00961662|3931010|B3||Female|Sex: Female, Male|Baseline participants are from the safety population|Participants|Count of Participants|19|19.0||||||
4107015|NCT00961662|3931011|B2||Female|Sex: Female, Male|Baseline participants are from the safety population|Participants|Count of Participants|14|14.0||||||
4107016|NCT00961662|3931012|B1||Female|Sex: Female, Male|Baseline participants are from the safety population|Participants|Count of Participants|22|22.0||||||
4107017|NCT00961662|3931009|B4|Age, Continuous||Age, Customized|Baseline participants are those from the safety population.|years|Mean|52.1|52.1|Standard Deviation|11.1|11.1|||
4107018|NCT00961662|3931010|B3|Age, Continuous||Age, Customized|Baseline participants are those from the safety population.|years|Mean|51.8|51.8|Standard Deviation|12.3|12.3|||
4107019|NCT00961662|3931011|B2|Age, Continuous||Age, Customized|Baseline participants are those from the safety population.|years|Mean|51.1|51.1|Standard Deviation|11.1|11.1|||
4107020|NCT00961662|3931012|B1|Age, Continuous||Age, Customized|Baseline participants are those from the safety population.|years|Mean|53.1|53.1|Standard Deviation|10.2|10.2|||
4107021|NCT00961649|3931022|B5|United States||Region of Enrollment||participants|Number|170|170.0||||||
4107022|NCT00961649|3931023|B4|United States||Region of Enrollment||participants|Number|41|41.0||||||
4107023|NCT00961649|3931024|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
4107024|NCT00961649|3931025|B2|United States||Region of Enrollment||participants|Number|44|44.0||||||
4107025|NCT00961649|3931026|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4107026|NCT00961649|3931022|B5||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4107027|NCT00961649|3931023|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4107028|NCT00961649|3931024|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4107029|NCT00961649|3931025|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4107030|NCT00961649|3931026|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4107031|NCT00961649|3931022|B5||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4107032|NCT00961649|3931023|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4107033|NCT00961649|3931024|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4107034|NCT00961649|3931025|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4107035|NCT00961649|3931026|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4107036|NCT00961649|3931022|B5|≥65 years||Age, Customized||participants|Number|94|94.0||||||
4107037|NCT00961649|3931023|B4|≥65 years||Age, Customized||participants|Number|20|20.0||||||
4107038|NCT00961649|3931024|B3|≥65 years||Age, Customized||participants|Number|24|24.0||||||
4107039|NCT00961649|3931025|B2|≥65 years||Age, Customized||participants|Number|24|24.0||||||
4107040|NCT00961649|3931026|B1|≥65 years||Age, Customized||participants|Number|26|26.0||||||
4107041|NCT00961649|3931022|B5|18 to 64 years||Age, Customized||participants|Number|76|76.0||||||
4107042|NCT00961649|3931023|B4|18 to 64 years||Age, Customized||participants|Number|21|21.0||||||
4107043|NCT00961649|3931024|B3|18 to 64 years||Age, Customized||participants|Number|20|20.0||||||
4107044|NCT00961649|3931025|B2|18 to 64 years||Age, Customized||participants|Number|20|20.0||||||
4107045|NCT00961649|3931026|B1|18 to 64 years||Age, Customized||participants|Number|15|15.0||||||
4107046|NCT00961636|3931040|B4||Male|Sex: Female, Male||Participants|Count of Participants|737|737.0||||||
4107047|NCT00961636|3931041|B3||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4107048|NCT00961636|3931042|B2||Male|Sex: Female, Male||Participants|Count of Participants|312|312.0||||||
4107049|NCT00961636|3931043|B1||Male|Sex: Female, Male||Participants|Count of Participants|279|279.0||||||
4107050|NCT00961636|3931040|B4||Female|Sex: Female, Male||Participants|Count of Participants|415|415.0||||||
4107051|NCT00961636|3931041|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4107052|NCT00961636|3931042|B2||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4107053|NCT00961636|3931043|B1||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4107054|NCT00961636|3931040|B4|>=65 years||Age, Customized||Participants|Number|324|324.0||||||
4107055|NCT00961636|3931041|B3|>=65 years||Age, Customized||Participants|Number|67|67.0||||||
4107056|NCT00961636|3931042|B2|>=65 years||Age, Customized||Participants|Number|128|128.0||||||
4107057|NCT00961636|3931043|B1|>=65 years||Age, Customized||Participants|Number|129|129.0||||||
4107058|NCT00961636|3931040|B4|< 65 years||Age, Customized||Participants|Number|828|828.0||||||
4107059|NCT00961636|3931041|B3|< 65 years||Age, Customized||Participants|Number|166|166.0||||||
4107060|NCT00961636|3931042|B2|< 65 years||Age, Customized||Participants|Number|328|328.0||||||
4107061|NCT00961636|3931043|B1|< 65 years||Age, Customized||Participants|Number|334|334.0||||||
4107062|NCT00961571|3931056|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4107063|NCT00961571|3931056|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4107064|NCT00961571|3931056|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4107065|NCT00961571|3931056|B1|||Age||years|Median|67|67.0|Full Range|||23.0|88.0|
4107066|NCT00961571|3931056|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4107067|NCT00961571|3931056|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4107068|NCT00961571|3931056|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107069|NCT00961532|3931060|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4107070|NCT00961532|3931060|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4107071|NCT00961532|3931060|B1|||Age||years|Mean|66.8|66.8|Standard Deviation|14.6|14.6|||
4107072|NCT00961441|3931065|B3|Other / mixed||Race||Participants|Number|1|1.0||||||
4107073|NCT00961441|3931066|B2|Other / mixed||Race||Participants|Number|1|1.0||||||
4107074|NCT00961441|3931067|B1|Other / mixed||Race||Participants|Number|0|0.0||||||
4107075|NCT00961441|3931065|B3|Caucasian||Race||Participants|Number|17|17.0||||||
4107076|NCT00961441|3931066|B2|Caucasian||Race||Participants|Number|9|9.0||||||
4107077|NCT00961441|3931067|B1|Caucasian||Race||Participants|Number|8|8.0||||||
4107078|NCT00961441|3931065|B3|Black||Race||Participants|Number|7|7.0||||||
4107079|NCT00961441|3931066|B2|Black||Race||Participants|Number|3|3.0||||||
4107080|NCT00961441|3931067|B1|Black||Race||Participants|Number|4|4.0||||||
4107081|NCT00961441|3931065|B3|||Body Surface Area (BSA)||m^2|Mean|1.91|1.91|Standard Deviation|0.32|0.32|||
4107082|NCT00961441|3931066|B2|||Body Surface Area (BSA)||m^2|Mean|1.95|1.95|Standard Deviation|0.32|0.32|||
4107083|NCT00961441|3931067|B1|||Body Surface Area (BSA)||m^2|Mean|1.87|1.87|Standard Deviation|0.34|0.34|||
4107084|NCT00961441|3931065|B3|||Body Mass Index (BMI)||kg/m^2|Mean|28.14|28.14|Standard Deviation|6.95|6.95|||
4107085|NCT00961441|3931066|B2|||Body Mass Index (BMI)||kg/m^2|Mean|28.63|28.63|Standard Deviation|7.14|7.14|||
4107086|NCT00961441|3931067|B1|||Body Mass Index (BMI)||kg/m^2|Mean|27.62|27.62|Standard Deviation|7.01|7.01|||
4107087|NCT00961441|3931065|B3|||Height||centimeter (cm)|Mean|167.7|167.7|Standard Deviation|9.6|9.6|||
4107088|NCT00961441|3931066|B2|||Height||centimeter (cm)|Mean|169.3|169.3|Standard Deviation|10.3|10.3|||
4107089|NCT00961441|3931067|B1|||Height||centimeter (cm)|Mean|165.9|165.9|Standard Deviation|8.8|8.8|||
4107090|NCT00961441|3931065|B3|||Weight||kilogram (kg)|Mean|80.0|80.0|Standard Deviation|23.2|23.2|||
4107091|NCT00961441|3931066|B2|||Weight||kilogram (kg)|Mean|82.5|82.5|Standard Deviation|23.0|23.0|||
4107092|NCT00961441|3931067|B1|||Weight||kilogram (kg)|Mean|77.2|77.2|Standard Deviation|24.1|24.1|||
4107093|NCT00961441|3931065|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4107094|NCT00961441|3931066|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4107095|NCT00961441|3931067|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4107096|NCT00961441|3931065|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4107097|NCT00961441|3931066|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4107098|NCT00961441|3931067|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4107099|NCT00961441|3931065|B3|||Age||years|Mean|28.87|28.87|Standard Deviation|15.21|15.21|||
4107100|NCT00961441|3931066|B2|||Age||years|Mean|41.78|41.78|Standard Deviation|9.21|9.21|||
4107101|NCT00961441|3931067|B1|||Age||years|Mean|14.88|14.88|Standard Deviation|1.37|1.37|||
4107102|NCT00961415|3931082|B3||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4107103|NCT00961415|3931083|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4107104|NCT00961415|3931084|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4107105|NCT00961415|3931082|B3||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4107106|NCT00961415|3931083|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4107107|NCT00961415|3931084|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4107108|NCT00961415|3931082|B3|||Age||years|Mean|59.4|59.4|Standard Deviation|8.55|8.55|||
4107109|NCT00961415|3931083|B2|||Age||years|Mean|59.3|59.3|Standard Deviation|8.86|8.86|||
4107110|NCT00961415|3931084|B1|||Age||years|Mean|59.5|59.5|Standard Deviation|8.25|8.25|||
4107111|NCT00961402|3931109|B3|||Pittsburgh Sleep Quality Index|This measure assesses sleep problems. This 9-item measure ranges from 0-21 with higher scores indicating more sleep problems.|units on a scale|Mean|7.11|7.11|Standard Deviation|2.84|2.84|||
4107112|NCT00961402|3931110|B2|||Pittsburgh Sleep Quality Index|This measure assesses sleep problems. This 9-item measure ranges from 0-21 with higher scores indicating more sleep problems.|units on a scale|Mean|7.11|7.11|Standard Deviation|2.61|2.61|||
4107162|NCT00961350|3931124|B3||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4107113|NCT00961402|3931111|B1|||Pittsburgh Sleep Quality Index|This measure assesses sleep problems. This 9-item measure ranges from 0-21 with higher scores indicating more sleep problems.|units on a scale|Mean|7.11|7.11|Standard Deviation|3.08|3.08|||
4107114|NCT00961402|3931109|B3|||Patient Health Questionnaire (PHQ-9)|This measure assess depressive symptoms. There are 9 items and scores range from 0-27 with higher scores indicating higher levels of depression.|units on a scale|Mean|5.99|5.99|Standard Deviation|3.83|3.83|||
4107115|NCT00961402|3931110|B2|||Patient Health Questionnaire (PHQ-9)|This measure assess depressive symptoms. There are 9 items and scores range from 0-27 with higher scores indicating higher levels of depression.|units on a scale|Mean|5.42|5.42|Standard Deviation|3.28|3.28|||
4107116|NCT00961402|3931111|B1|||Patient Health Questionnaire (PHQ-9)|This measure assess depressive symptoms. There are 9 items and scores range from 0-27 with higher scores indicating higher levels of depression.|units on a scale|Mean|6.56|6.56|Standard Deviation|4.27|4.27|||
4107117|NCT00961402|3931109|B3|||Perceived Stress Scale|This scale measures the participant's perception of stress. This is a 14 item scale ranging from 0-56, with higher scores indicating higher stress.|units on a scale|Mean|23.96|23.96|Standard Deviation|7.50|7.5|||
4107118|NCT00961402|3931110|B2|||Perceived Stress Scale|This scale measures the participant's perception of stress. This is a 14 item scale ranging from 0-56, with higher scores indicating higher stress.|units on a scale|Mean|23.21|23.21|Standard Deviation|7.94|7.94|||
4107119|NCT00961402|3931111|B1|||Perceived Stress Scale|This scale measures the participant's perception of stress. This is a 14 item scale ranging from 0-56, with higher scores indicating higher stress.|units on a scale|Mean|24.73|24.73|Standard Deviation|6.98|6.98|||
4107120|NCT00961402|3931109|B3|United States||Region of Enrollment||participants|Number|130|130.0||||||
4107121|NCT00961402|3931110|B2|United States||Region of Enrollment||participants|Number|66|66.0||||||
4107122|NCT00961402|3931111|B1|United States||Region of Enrollment||participants|Number|64|64.0||||||
4107123|NCT00961402|3931109|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107124|NCT00961402|3931110|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107125|NCT00961402|3931111|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107126|NCT00961402|3931109|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4107127|NCT00961402|3931110|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4107128|NCT00961402|3931111|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4107129|NCT00961402|3931109|B3||White|Race (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
4107130|NCT00961402|3931110|B2||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4107131|NCT00961402|3931111|B1||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4107132|NCT00961402|3931109|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4107133|NCT00961402|3931110|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4107134|NCT00961402|3931111|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4107135|NCT00961402|3931109|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107136|NCT00961402|3931110|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107137|NCT00961402|3931111|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107138|NCT00961402|3931109|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4107139|NCT00961402|3931110|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4107140|NCT00961402|3931111|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4107141|NCT00961402|3931109|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4107142|NCT00961402|3931110|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4107143|NCT00961402|3931111|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107144|NCT00961402|3931109|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107145|NCT00961402|3931110|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107146|NCT00961402|3931111|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107147|NCT00961402|3931109|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
4107148|NCT00961402|3931110|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4107149|NCT00961402|3931111|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4107150|NCT00961402|3931109|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4107151|NCT00961402|3931110|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4107152|NCT00961402|3931111|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4107153|NCT00961402|3931109|B3|Females||Sex/Gender, Customized||participants|Number|130|130.0||||||
4107154|NCT00961402|3931110|B2|Females||Sex/Gender, Customized||participants|Number|66|66.0||||||
4107155|NCT00961402|3931111|B1|Females||Sex/Gender, Customized||participants|Number|64|64.0||||||
4107156|NCT00961402|3931109|B3|||Age||years|Mean|31.54|31.54|Standard Deviation|4.95|4.95|||
4107157|NCT00961402|3931110|B2|||Age||years|Mean|31.69|31.69|Standard Deviation|5.27|5.27|||
4107158|NCT00961402|3931111|B1|||Age||years|Mean|31.39|31.39|Standard Deviation|4.63|4.63|||
4107159|NCT00961350|3931124|B3||Male|Sex: Female, Male||Participants|Count of Participants|378|378.0||||||
4107160|NCT00961350|3931125|B2||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4107161|NCT00961350|3931126|B1||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4107163|NCT00961350|3931125|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4107164|NCT00961350|3931126|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4107165|NCT00961350|3931124|B3|||Age||years|Mean|66.1|66.1|Standard Deviation|6.96|6.96|||
4107166|NCT00961350|3931125|B2|||Age||years|Mean|65.8|65.8|Standard Deviation|6.7|6.7|||
4107167|NCT00961350|3931126|B1|||Age||years|Mean|66.3|66.3|Standard Deviation|7.2|7.2|||
4107168|NCT00961311|3931141|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4107169|NCT00961311|3931141|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4107170|NCT00961311|3931141|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4107171|NCT00961311|3931141|B1|||Age||years|Mean|67|67.0|Standard Deviation|10|10.0|||
4107172|NCT00961298|3931148|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107173|NCT00961298|3931148|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107174|NCT00961298|3931148|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4107175|NCT00961298|3931148|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107176|NCT00961298|3931148|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107177|NCT00961298|3931148|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107178|NCT00961298|3931148|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107179|NCT00961298|3931148|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4107180|NCT00961298|3931148|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4107181|NCT00961298|3931148|B1|||Age||years|Mean|42.54|42.54|Standard Deviation|12.70|12.7|||
4107182|NCT00961259|3931155|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107183|NCT00961259|3931155|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107184|NCT00961259|3931155|B1||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4107185|NCT00961259|3931155|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4107186|NCT00961259|3931155|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107187|NCT00961259|3931155|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4107188|NCT00961259|3931155|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4107189|NCT00961259|3931155|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107190|NCT00961259|3931155|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4107191|NCT00961259|3931155|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4107192|NCT00961259|3931155|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4107193|NCT00961259|3931155|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4107194|NCT00961259|3931155|B1|||Age||years|Mean|24.46|24.46|Standard Deviation|7.10|7.1|||
4107195|NCT00961259|3931155|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4107196|NCT00961259|3931155|B1||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4107197|NCT00961259|3931155|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107198|NCT00961233|3931174|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4107199|NCT00961233|3931175|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4107200|NCT00961233|3931176|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4107201|NCT00961233|3931174|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4107202|NCT00961233|3931175|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4107203|NCT00961233|3931176|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4107204|NCT00961233|3931174|B3|||Age||years|Mean|34.7|34.7|Standard Deviation|7.4|7.4|||
4107205|NCT00961233|3931175|B2|||Age||years|Mean|34.4|34.4|Standard Deviation|7.5|7.5|||
4107206|NCT00961233|3931176|B1|||Age||years|Mean|34.9|34.9|Standard Deviation|7.3|7.3|||
4107207|NCT00961220|3931185|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4107208|NCT00961220|3931185|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107209|NCT00961220|3931185|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107210|NCT00961220|3931185|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4107211|NCT00961220|3931185|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4107212|NCT00961220|3931185|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107213|NCT00961220|3931185|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107214|NCT00961220|3931185|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107215|NCT00961220|3931185|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107216|NCT00961220|3931185|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4107217|NCT00961220|3931185|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107218|NCT00961220|3931185|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4107219|NCT00961220|3931185|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4107220|NCT00961220|3931185|B1|70-79 years||Age, Customized||participants|Number|1|1.0||||||
4107221|NCT00961220|3931185|B1|60-69 years||Age, Customized||participants|Number|3|3.0||||||
4107222|NCT00961220|3931185|B1|50-59 years||Age, Customized||participants|Number|2|2.0||||||
4107223|NCT00961220|3931185|B1|40-49 years||Age, Customized||participants|Number|4|4.0||||||
4107224|NCT00961220|3931185|B1|30-39 years||Age, Customized||participants|Number|5|5.0||||||
4107225|NCT00961220|3931185|B1|20-29 years||Age, Customized||participants|Number|2|2.0||||||
4107226|NCT00961181|3931201|B1|Denmark||Region of Enrollment||participants|Number|5|5.0||||||
4107227|NCT00961181|3931201|B1|Poland||Region of Enrollment||participants|Number|9|9.0||||||
4107228|NCT00961181|3931201|B1|Germany||Region of Enrollment||participants|Number|67|67.0||||||
4107229|NCT00961181|3931201|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4107230|NCT00961181|3931201|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4107231|NCT00961181|3931201|B1|||Age||years|Mean|66|66.0|Standard Deviation|9.4|9.4|||
4107232|NCT00961181|3931201|B1||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
4107233|NCT00961181|3931201|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4107234|NCT00961181|3931201|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107235|NCT00961116|3931214|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107236|NCT00961116|3931214|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4107237|NCT00961116|3931214|B1||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4107238|NCT00961116|3931214|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4107239|NCT00961116|3931214|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107240|NCT00961116|3931214|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4107241|NCT00961116|3931214|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4107242|NCT00961116|3931214|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107243|NCT00961116|3931214|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4107244|NCT00961116|3931214|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107245|NCT00961116|3931214|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4107246|NCT00961116|3931214|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4107247|NCT00961116|3931214|B1|||Age||years|Mean|23.7|23.7|Standard Deviation|5.5|5.5|||
4107248|NCT00961116|3931214|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4107249|NCT00961116|3931214|B1||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4107250|NCT00961116|3931214|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107251|NCT00961051|3931225|B3|United States||Region of Enrollment||participants|Number|270|270.0||||||
4107252|NCT00961051|3931226|B2|United States||Region of Enrollment||participants|Number|93|93.0||||||
4107253|NCT00961051|3931227|B1|United States||Region of Enrollment||participants|Number|177|177.0||||||
4107254|NCT00961051|3931225|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4107255|NCT00961051|3931226|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4107256|NCT00961051|3931227|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4107257|NCT00961051|3931225|B3||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4107258|NCT00961051|3931226|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4107259|NCT00961051|3931227|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4107260|NCT00961051|3931225|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4107261|NCT00961051|3931226|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4107262|NCT00961051|3931227|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4107263|NCT00961051|3931225|B3||Between 18 and 65 years|Age||Participants|Count of Participants|270|270.0||||||
4107264|NCT00961051|3931226|B2||Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
4107265|NCT00961051|3931227|B1||Between 18 and 65 years|Age||Participants|Count of Participants|177|177.0||||||
4107266|NCT00961051|3931225|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107267|NCT00961051|3931226|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107268|NCT00961051|3931227|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107269|NCT00960999|3931236|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4107270|NCT00960999|3931237|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4107271|NCT00960999|3931238|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4107272|NCT00960999|3931236|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4107273|NCT00960999|3931237|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4107274|NCT00960999|3931238|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4107275|NCT00960999|3931236|B3|||Age||years|Median|75|75.0|Full Range|||52.0|89.0|
4107276|NCT00960999|3931237|B2|||Age||years|Median|75|75.0|Full Range|||52.0|87.0|
4107277|NCT00960999|3931238|B1|||Age||years|Median|75|75.0|Full Range|||57.0|89.0|
4107278|NCT00960986|3931245|B5|||Association for Methodology and Documentation in Psychiatry (AMDP-5) Item 112 (Nausea) Score|AMDP-5 Item 112 (nausea) measured nausea severity. The scores ranged from 0-3: 0=Not present; 1=Mild; 2=Moderate; 3=Severe.|units on a scale|Mean|0.2|0.2|Standard Deviation|0.58|0.58|0.0|0.0|
4107279|NCT00960986|3931246|B4|||Association for Methodology and Documentation in Psychiatry (AMDP-5) Item 112 (Nausea) Score|AMDP-5 Item 112 (nausea) measured nausea severity. The scores ranged from 0-3: 0=Not present; 1=Mild; 2=Moderate; 3=Severe.|units on a scale|Mean|0.1|0.1|Standard Deviation|0.38|0.38|0.0|0.0|
4107280|NCT00960986|3931247|B3|||Association for Methodology and Documentation in Psychiatry (AMDP-5) Item 112 (Nausea) Score|AMDP-5 Item 112 (nausea) measured nausea severity. The scores ranged from 0-3: 0=Not present; 1=Mild; 2=Moderate; 3=Severe.|units on a scale|Mean|0.2|0.2|Standard Deviation|0.61|0.61|0.0|0.0|
4107281|NCT00960986|3931248|B2|||Association for Methodology and Documentation in Psychiatry (AMDP-5) Item 112 (Nausea) Score|AMDP-5 Item 112 (nausea) measured nausea severity. The scores ranged from 0-3: 0=Not present; 1=Mild; 2=Moderate; 3=Severe.|units on a scale|Mean|0.2|0.2|Standard Deviation|0.59|0.59|0.0|0.0|
4107282|NCT00960986|3931249|B1|||Association for Methodology and Documentation in Psychiatry (AMDP-5) Item 112 (Nausea) Score|AMDP-5 Item 112 (nausea) measured nausea severity. The scores ranged from 0-3: 0=Not present; 1=Mild; 2=Moderate; 3=Severe.|units on a scale|Mean|0.3|0.3|Standard Deviation|0.72|0.72|0.0|0.0|
4107283|NCT00960986|3931245|B5|||Clinical Global Impression of Severity (CGI-S) Score|The CGI-S Rating Scale was a 7-point scale: 1=normal, not at all ill; 2=borderline mentally ill; 3=mildly ill; 4=moderately ill; 5=markedly ill; 6=severely ill; or 7=extremely ill.|units on a scale|Mean|4.4|4.4|Inter-Quartile Range|||4.0|5.0|
4107284|NCT00960986|3931246|B4|||Clinical Global Impression of Severity (CGI-S) Score|The CGI-S Rating Scale was a 7-point scale: 1=normal, not at all ill; 2=borderline mentally ill; 3=mildly ill; 4=moderately ill; 5=markedly ill; 6=severely ill; or 7=extremely ill.|units on a scale|Mean|4.2|4.2|Inter-Quartile Range|||4.0|5.0|
4107285|NCT00960986|3931247|B3|||Clinical Global Impression of Severity (CGI-S) Score|The CGI-S Rating Scale was a 7-point scale: 1=normal, not at all ill; 2=borderline mentally ill; 3=mildly ill; 4=moderately ill; 5=markedly ill; 6=severely ill; or 7=extremely ill.|units on a scale|Mean|4.7|4.7|Inter-Quartile Range|||4.0|5.0|
4107286|NCT00960986|3931248|B2|||Clinical Global Impression of Severity (CGI-S) Score|The CGI-S Rating Scale was a 7-point scale: 1=normal, not at all ill; 2=borderline mentally ill; 3=mildly ill; 4=moderately ill; 5=markedly ill; 6=severely ill; or 7=extremely ill.|units on a scale|Mean|4.5|4.5|Inter-Quartile Range|||4.0|5.0|
4107287|NCT00960986|3931249|B1|||Clinical Global Impression of Severity (CGI-S) Score|The CGI-S Rating Scale was a 7-point scale: 1=normal, not at all ill; 2=borderline mentally ill; 3=mildly ill; 4=moderately ill; 5=markedly ill; 6=severely ill; or 7=extremely ill.|units on a scale|Mean|4.4|4.4|Inter-Quartile Range|||4.0|5.0|
4107288|NCT00960986|3931245|B5|||17-item Hamilton Depression Rating Scale (HAMD-17) Total Score|The HAMD-17 measured depression severity. Each item was evaluated and scored using either a 5-point scale (for example, absent; mild; moderate; severe; very severe) or a 3-point scale (for example, absent; mild; marked). The total score ranged from 0 (not at all depressed)-52 (severely depressed).|units on a scale|Mean|21.6|21.6|Standard Deviation|5.46|5.46|||
4107289|NCT00960986|3931246|B4|||17-item Hamilton Depression Rating Scale (HAMD-17) Total Score|The HAMD-17 measured depression severity. Each item was evaluated and scored using either a 5-point scale (for example, absent; mild; moderate; severe; very severe) or a 3-point scale (for example, absent; mild; marked). The total score ranged from 0 (not at all depressed)-52 (severely depressed).|units on a scale|Mean|20.3|20.3|Standard Deviation|5.23|5.23|||
4107290|NCT00960986|3931247|B3|||17-item Hamilton Depression Rating Scale (HAMD-17) Total Score|The HAMD-17 measured depression severity. Each item was evaluated and scored using either a 5-point scale (for example, absent; mild; moderate; severe; very severe) or a 3-point scale (for example, absent; mild; marked). The total score ranged from 0 (not at all depressed)-52 (severely depressed).|units on a scale|Mean|22.9|22.9|Standard Deviation|5.45|5.45|||
4107291|NCT00960986|3931248|B2|||17-item Hamilton Depression Rating Scale (HAMD-17) Total Score|The HAMD-17 measured depression severity. Each item was evaluated and scored using either a 5-point scale (for example, absent; mild; moderate; severe; very severe) or a 3-point scale (for example, absent; mild; marked). The total score ranged from 0 (not at all depressed)-52 (severely depressed).|units on a scale|Mean|22.3|22.3|Standard Deviation|5.69|5.69|||
4107292|NCT00960986|3931249|B1|||17-item Hamilton Depression Rating Scale (HAMD-17) Total Score|The HAMD-17 measured depression severity. Each item was evaluated and scored using either a 5-point scale (for example, absent; mild; moderate; severe; very severe) or a 3-point scale (for example, absent; mild; marked). The total score ranged from 0 (not at all depressed)-52 (severely depressed).|units on a scale|Mean|21.0|21.0|Standard Deviation|5.18|5.18|||
4107293|NCT00960986|3931245|B5|no||Received previous therapy for current episode||participants|Number|162|162.0||||||
4107294|NCT00960986|3931246|B4|no||Received previous therapy for current episode||participants|Number|38|38.0||||||
4107295|NCT00960986|3931247|B3|no||Received previous therapy for current episode||participants|Number|45|45.0||||||
4107296|NCT00960986|3931248|B2|no||Received previous therapy for current episode||participants|Number|38|38.0||||||
4107297|NCT00960986|3931249|B1|no||Received previous therapy for current episode||participants|Number|41|41.0||||||
4107298|NCT00960986|3931245|B5|yes||Received previous therapy for current episode||participants|Number|87|87.0||||||
4107299|NCT00960986|3931246|B4|yes||Received previous therapy for current episode||participants|Number|26|26.0||||||
4107300|NCT00960986|3931247|B3|yes||Received previous therapy for current episode||participants|Number|18|18.0||||||
4107301|NCT00960986|3931248|B2|yes||Received previous therapy for current episode||participants|Number|25|25.0||||||
4107302|NCT00960986|3931249|B1|yes||Received previous therapy for current episode||participants|Number|18|18.0||||||
4107303|NCT00960986|3931245|B5|||Number of previous MDD episodes/exacerbations in the last 24 months||number of episodes in last 24 months|Median|1.0|1.0|Inter-Quartile Range|||0.0|1.0|
4107304|NCT00960986|3931246|B4|||Number of previous MDD episodes/exacerbations in the last 24 months||number of episodes in last 24 months|Median|1.0|1.0|Inter-Quartile Range|||0.0|1.0|
4107305|NCT00960986|3931247|B3|||Number of previous MDD episodes/exacerbations in the last 24 months||number of episodes in last 24 months|Median|1.0|1.0|Inter-Quartile Range|||0.0|1.0|
4107306|NCT00960986|3931248|B2|||Number of previous MDD episodes/exacerbations in the last 24 months||number of episodes in last 24 months|Median|1.0|1.0|Inter-Quartile Range|||0.0|1.0|
4107307|NCT00960986|3931249|B1|||Number of previous MDD episodes/exacerbations in the last 24 months||number of episodes in last 24 months|Median|1.0|1.0|Inter-Quartile Range|||0.0|1.0|
4107308|NCT00960986|3931245|B5|||Age at first major depressive disorder (MDD) episode||years|Mean|42.52|42.52|Inter-Quartile Range|||30.0|54.0|
4107309|NCT00960986|3931246|B4|||Age at first major depressive disorder (MDD) episode||years|Mean|41.58|41.58|Inter-Quartile Range|||29.0|54.0|
4107310|NCT00960986|3931247|B3|||Age at first major depressive disorder (MDD) episode||years|Mean|43.86|43.86|Inter-Quartile Range|||27.0|59.6|
4107311|NCT00960986|3931248|B2|||Age at first major depressive disorder (MDD) episode||years|Mean|43.33|43.33|Inter-Quartile Range|||34.67|53.0|
4107312|NCT00960986|3931249|B1|||Age at first major depressive disorder (MDD) episode||years|Mean|41.21|41.21|Inter-Quartile Range|||29.0|51.0|
4107313|NCT00960986|3931245|B5|||Duration since first major depressive disorder (MDD) episode||years|Median|1.92|1.92|Inter-Quartile Range|||0.54|5.55|
4107314|NCT00960986|3931246|B4|||Duration since first major depressive disorder (MDD) episode||years|Median|1.29|1.29|Inter-Quartile Range|||0.52|4.4|
4107315|NCT00960986|3931247|B3|||Duration since first major depressive disorder (MDD) episode||years|Median|2.52|2.52|Inter-Quartile Range|||0.48|9.12|
4107316|NCT00960986|3931248|B2|||Duration since first major depressive disorder (MDD) episode||years|Median|2.65|2.65|Inter-Quartile Range|||0.77|5.32|
4107317|NCT00960986|3931249|B1|||Duration since first major depressive disorder (MDD) episode||years|Median|1.47|1.47|Inter-Quartile Range|||0.52|4.29|
4107318|NCT00960986|3931245|B5|||Previously diagnosed with major depressive disorder (MDD)||participants|Number|249|249.0||||||
4107319|NCT00960986|3931246|B4|||Previously diagnosed with major depressive disorder (MDD)||participants|Number|64|64.0||||||
4107320|NCT00960986|3931247|B3|||Previously diagnosed with major depressive disorder (MDD)||participants|Number|63|63.0||||||
4107321|NCT00960986|3931248|B2|||Previously diagnosed with major depressive disorder (MDD)||participants|Number|63|63.0||||||
4107322|NCT00960986|3931249|B1|||Previously diagnosed with major depressive disorder (MDD)||participants|Number|59|59.0||||||
4107323|NCT00960986|3931245|B5|||Body Mass Index (BMI)|BMI measures the participant's body weight divided by the square of his or her height.|kilogram per square meter (kg/m^2)|Mean|23.67|23.67|Standard Deviation|3.584|3.584|||
4107324|NCT00960986|3931246|B4|||Body Mass Index (BMI)|BMI measures the participant's body weight divided by the square of his or her height.|kilogram per square meter (kg/m^2)|Mean|23.84|23.84|Standard Deviation|3.612|3.612|||
4107325|NCT00960986|3931247|B3|||Body Mass Index (BMI)|BMI measures the participant's body weight divided by the square of his or her height.|kilogram per square meter (kg/m^2)|Mean|23.06|23.06|Standard Deviation|3.430|3.43|||
4107326|NCT00960986|3931248|B2|||Body Mass Index (BMI)|BMI measures the participant's body weight divided by the square of his or her height.|kilogram per square meter (kg/m^2)|Mean|23.28|23.28|Standard Deviation|3.133|3.133|||
4107327|NCT00960986|3931249|B1|||Body Mass Index (BMI)|BMI measures the participant's body weight divided by the square of his or her height.|kilogram per square meter (kg/m^2)|Mean|24.56|24.56|Standard Deviation|4.034|4.034|||
4107328|NCT00960986|3931245|B5|Korea, Republic of||Region of Enrollment||participants|Number|249|249.0||||||
4107329|NCT00960986|3931246|B4|Korea, Republic of||Region of Enrollment||participants|Number|64|64.0||||||
4107330|NCT00960986|3931247|B3|Korea, Republic of||Region of Enrollment||participants|Number|63|63.0||||||
4107331|NCT00960986|3931248|B2|Korea, Republic of||Region of Enrollment||participants|Number|63|63.0||||||
4107332|NCT00960986|3931249|B1|Korea, Republic of||Region of Enrollment||participants|Number|59|59.0||||||
4107333|NCT00960986|3931245|B5|Korean||Race/Ethnicity, Customized||participants|Number|249|249.0||||||
4107334|NCT00960986|3931246|B4|Korean||Race/Ethnicity, Customized||participants|Number|64|64.0||||||
4107335|NCT00960986|3931247|B3|Korean||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
4107336|NCT00960986|3931248|B2|Korean||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
4107337|NCT00960986|3931249|B1|Korean||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
4107338|NCT00960986|3931245|B5||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4107339|NCT00960986|3931246|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4107340|NCT00960986|3931247|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4107341|NCT00960986|3931248|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4107342|NCT00960986|3931249|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4107343|NCT00960986|3931245|B5||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4107344|NCT00960986|3931246|B4||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4107345|NCT00960986|3931247|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4107346|NCT00960986|3931248|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4107347|NCT00960986|3931249|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4107348|NCT00960986|3931245|B5|||Age||years|Mean|46.81|46.81|Inter-Quartile Range|||34.78|59.25|
4107349|NCT00960986|3931246|B4|||Age||years|Mean|44.65|44.65|Inter-Quartile Range|||32.84|56.92|
4107350|NCT00960986|3931247|B3|||Age||years|Mean|49.94|49.94|Inter-Quartile Range|||40.04|62.24|
4107351|NCT00960986|3931248|B2|||Age||years|Mean|47.90|47.9|Inter-Quartile Range|||38.65|58.9|
4107352|NCT00960986|3931249|B1|||Age||years|Mean|44.65|44.65|Inter-Quartile Range|||31.58|53.73|
4107353|NCT00960934|3931322|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4107354|NCT00960934|3931323|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4107355|NCT00960934|3931324|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4107356|NCT00960934|3931325|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4107357|NCT00960934|3931326|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4107358|NCT00960934|3931327|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4107359|NCT00960934|3931328|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4107360|NCT00960934|3931322|B7||Female|Sex: Female, Male||Participants|Count of Participants|383|383.0||||||
4107361|NCT00960934|3931323|B6||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4107362|NCT00960934|3931324|B5||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4107363|NCT00960934|3931325|B4||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4107364|NCT00960934|3931326|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4107365|NCT00960934|3931327|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4107366|NCT00960934|3931328|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4107367|NCT00960934|3931322|B7|||Age||years|Mean|67.2|67.2|Standard Deviation|6.2|6.2|||
4107368|NCT00960934|3931323|B6|||Age||years|Mean|67.6|67.6|Standard Deviation|6.7|6.7|||
4107369|NCT00960934|3931324|B5|||Age||years|Mean|66.5|66.5|Standard Deviation|5.4|5.4|||
4107370|NCT00960934|3931325|B4|||Age||years|Mean|67.8|67.8|Standard Deviation|6.4|6.4|||
4107371|NCT00960934|3931326|B3|||Age||years|Mean|67.4|67.4|Standard Deviation|6.0|6.0|||
4107372|NCT00960934|3931327|B2|||Age||years|Mean|67.3|67.3|Standard Deviation|6.5|6.5|||
4107373|NCT00960934|3931328|B1|||Age||years|Mean|66.7|66.7|Standard Deviation|6.3|6.3|||
4107374|NCT00960869|3931443|B3||Male|Sex: Female, Male||Participants|Count of Participants|371|371.0||||||
4107375|NCT00960869|3931444|B2||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4107376|NCT00960869|3931445|B1||Male|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4107377|NCT00960869|3931443|B3||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4107378|NCT00960869|3931444|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4107379|NCT00960869|3931445|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4107380|NCT00960869|3931443|B3|||Age||years|Mean|65.9|65.9|Standard Deviation|7.7|7.7|||
4107381|NCT00960869|3931444|B2|||Age||years|Mean|65.6|65.6|Standard Deviation|7.2|7.2|||
4107382|NCT00960869|3931445|B1|||Age||years|Mean|66.2|66.2|Standard Deviation|7.8|7.8|||
4107383|NCT00960856|3931460|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107384|NCT00960856|3931460|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107385|NCT00960856|3931460|B1||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4107386|NCT00960856|3931460|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4107387|NCT00960856|3931460|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107388|NCT00960856|3931460|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4107389|NCT00960856|3931460|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4107390|NCT00960856|3931460|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107391|NCT00960856|3931460|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4107392|NCT00960856|3931460|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4107393|NCT00960856|3931460|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4107394|NCT00960856|3931460|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4107395|NCT00960856|3931460|B1|||Age||years|Mean|23.89|23.89|Standard Deviation|6.27|6.27|||
4107396|NCT00960856|3931460|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4107397|NCT00960856|3931460|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4107398|NCT00960856|3931460|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107399|NCT00960843|3931481|B3|Australia||Region of Enrollment||participants|Number|27|27.0||||||
4107400|NCT00960843|3931482|B2|Australia||Region of Enrollment||participants|Number|14|14.0||||||
4107401|NCT00960843|3931483|B1|Australia||Region of Enrollment||participants|Number|13|13.0||||||
4107402|NCT00960843|3931481|B3|Czech Republic||Region of Enrollment||participants|Number|24|24.0||||||
4107403|NCT00960843|3931482|B2|Czech Republic||Region of Enrollment||participants|Number|12|12.0||||||
4107404|NCT00960843|3931483|B1|Czech Republic||Region of Enrollment||participants|Number|12|12.0||||||
4107405|NCT00960843|3931481|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4107406|NCT00960843|3931482|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4107407|NCT00960843|3931483|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4107408|NCT00960843|3931481|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4107409|NCT00960843|3931482|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4107410|NCT00960843|3931483|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4107411|NCT00960843|3931481|B3|||Age||years|Mean|46.1|46.1|Standard Deviation|12.25|12.25|||
4107412|NCT00960843|3931482|B2|||Age||years|Mean|45.1|45.1|Standard Deviation|12.69|12.69|||
4107413|NCT00960843|3931483|B1|||Age||years|Mean|47.2|47.2|Standard Deviation|11.93|11.93|||
4107414|NCT00960843|3931481|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4107415|NCT00960843|3931482|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4107416|NCT00960843|3931483|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4107417|NCT00960843|3931481|B3||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4107418|NCT00960843|3931482|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4107419|NCT00960843|3931483|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4107420|NCT00960843|3931481|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107421|NCT00960843|3931482|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107422|NCT00960843|3931483|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107423|NCT00960778|3931494|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
4107424|NCT00960778|3931495|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4107425|NCT00960778|3931496|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4107426|NCT00960778|3931494|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107427|NCT00960778|3931495|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107428|NCT00960778|3931496|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107429|NCT00960778|3931494|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4107430|NCT00960778|3931495|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107431|NCT00960778|3931496|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4107432|NCT00960778|3931494|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4107433|NCT00960778|3931495|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4107434|NCT00960778|3931496|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4107435|NCT00960778|3931494|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4107436|NCT00960778|3931495|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4107437|NCT00960778|3931496|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4107438|NCT00960778|3931494|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4107439|NCT00960778|3931495|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4107440|NCT00960778|3931496|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107441|NCT00960778|3931494|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107442|NCT00960778|3931495|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107443|NCT00960778|3931496|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107444|NCT00960778|3931494|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4107445|NCT00960778|3931495|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107446|NCT00960778|3931496|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4107447|NCT00960778|3931494|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4107448|NCT00960778|3931495|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4107449|NCT00960778|3931496|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4107450|NCT00960778|3931494|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4107451|NCT00960778|3931495|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4107452|NCT00960778|3931496|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4107453|NCT00960778|3931494|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4107454|NCT00960778|3931495|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4107455|NCT00960778|3931496|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4107456|NCT00960778|3931494|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4107457|NCT00960778|3931495|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4107458|NCT00960778|3931496|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4107459|NCT00960778|3931494|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107460|NCT00960778|3931495|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107461|NCT00960778|3931496|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107462|NCT00960687|3931505|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107463|NCT00960687|3931505|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107464|NCT00960687|3931505|B1||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4107465|NCT00960687|3931505|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4107466|NCT00960687|3931505|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107467|NCT00960687|3931505|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107468|NCT00960687|3931505|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107469|NCT00960687|3931505|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107470|NCT00960687|3931505|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4107471|NCT00960687|3931505|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4107472|NCT00960687|3931505|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4107473|NCT00960687|3931505|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4107474|NCT00960687|3931505|B1|||Age||years|Mean|24.4|24.4|Standard Deviation|6.4|6.4|||
4107475|NCT00960687|3931505|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4107476|NCT00960687|3931505|B1||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4107477|NCT00960687|3931505|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107478|NCT00960661|3931516|B3|||Glycosylated hemoglobin (HbA1c)||Percent|Mean|8.24|8.24|Standard Deviation|0.927|0.927|||
4107479|NCT00960661|3931517|B2|||Glycosylated hemoglobin (HbA1c)||Percent|Mean|8.21|8.21|Standard Deviation|0.871|0.871|||
4107480|NCT00960661|3931518|B1|||Glycosylated hemoglobin (HbA1c)||Percent|Mean|8.27|8.27|Standard Deviation|0.983|0.983|||
4107481|NCT00960661|3931516|B3|NO||prior use of Sulfonylurea (SU)||participants|Number|326|326.0||||||
4107482|NCT00960661|3931517|B2|NO||prior use of Sulfonylurea (SU)||participants|Number|164|164.0||||||
4107483|NCT00960661|3931518|B1|NO||prior use of Sulfonylurea (SU)||participants|Number|162|162.0||||||
4107484|NCT00960661|3931516|B3|YES||prior use of Sulfonylurea (SU)||participants|Number|184|184.0||||||
4107485|NCT00960661|3931517|B2|YES||prior use of Sulfonylurea (SU)||participants|Number|99|99.0||||||
4107486|NCT00960661|3931518|B1|YES||prior use of Sulfonylurea (SU)||participants|Number|85|85.0||||||
4107487|NCT00960661|3931516|B3||Male|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
4107488|NCT00960661|3931517|B2||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4107489|NCT00960661|3931518|B1||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4107490|NCT00960661|3931516|B3||Female|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
4107491|NCT00960661|3931517|B2||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4107492|NCT00960661|3931518|B1||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4107493|NCT00960661|3931516|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|9.43|9.43|||
4107494|NCT00960661|3931517|B2|||Age||years|Mean|59.4|59.4|Standard Deviation|9.27|9.27|||
4107495|NCT00960661|3931518|B1|||Age||years|Mean|59.5|59.5|Standard Deviation|9.6|9.6|||
4107496|NCT00960661|3931516|B3||>=65 years|Age||Participants|Count of Participants|148|148.0||||||
4107497|NCT00960661|3931517|B2||>=65 years|Age||Participants|Count of Participants|81|81.0||||||
4107498|NCT00960661|3931518|B1||>=65 years|Age||Participants|Count of Participants|67|67.0||||||
4107499|NCT00960661|3931516|B3||Between 18 and 65 years|Age||Participants|Count of Participants|362|362.0||||||
4107500|NCT00960661|3931517|B2||Between 18 and 65 years|Age||Participants|Count of Participants|182|182.0||||||
4107501|NCT00960661|3931518|B1||Between 18 and 65 years|Age||Participants|Count of Participants|180|180.0||||||
4107502|NCT00960661|3931516|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107503|NCT00960661|3931517|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107504|NCT00960661|3931518|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107505|NCT00960622|3931550|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4107506|NCT00960622|3931551|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4107507|NCT00960622|3931552|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4107508|NCT00960622|3931550|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4107509|NCT00960622|3931551|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4107510|NCT00960622|3931552|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4107511|NCT00960622|3931550|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4107512|NCT00960622|3931551|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4107513|NCT00960622|3931552|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4107514|NCT00960622|3931550|B3|||Age||years|Mean|53|53.0|Standard Deviation|7|7.0|||
4107515|NCT00960622|3931551|B2|||Age||years|Mean|53|53.0|Standard Deviation|4|4.0|||
4107516|NCT00960622|3931552|B1|||Age||years|Mean|52|52.0|Standard Deviation|6|6.0|||
4107517|NCT00960622|3931550|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4107518|NCT00960622|3931551|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4107519|NCT00960622|3931552|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4107520|NCT00960622|3931550|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4107521|NCT00960622|3931551|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4107522|NCT00960622|3931552|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4107523|NCT00960622|3931550|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107524|NCT00960622|3931551|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107525|NCT00960622|3931552|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107526|NCT00960570|3931559|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107527|NCT00960570|3931559|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107528|NCT00960570|3931559|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4107529|NCT00960570|3931559|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4107530|NCT00960570|3931559|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107531|NCT00960570|3931559|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107532|NCT00960570|3931559|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107533|NCT00960570|3931559|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4107534|NCT00960570|3931559|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4107535|NCT00960570|3931559|B1|||Age||years|Mean|26.8|26.8|Standard Deviation|6.4|6.4|||
4107536|NCT00960570|3931559|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4107537|NCT00960570|3931559|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4107538|NCT00960570|3931559|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107539|NCT00960531|3931570|B11|MMSE score <10||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|1|1.0||||||
4107540|NCT00960531|3931571|B10|MMSE score <10||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|0|0.0||||||
4107541|NCT00960531|3931572|B9|MMSE score <10||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|0|0.0||||||
4107542|NCT00960531|3931573|B8|MMSE score <10||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|0|0.0||||||
4107543|NCT00960531|3931574|B7|MMSE score <10||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|0|0.0||||||
4107544|NCT00960531|3931575|B6|MMSE score <10||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|0|0.0||||||
4107545|NCT00960531|3931576|B5|MMSE score <10||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|0|0.0||||||
4107546|NCT00960531|3931577|B4|MMSE score <10||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|0|0.0||||||
4107547|NCT00960531|3931578|B3|MMSE score <10||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|0|0.0||||||
4107548|NCT00960531|3931579|B2|MMSE score <10||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|0|0.0||||||
4107549|NCT00960531|3931580|B1|MMSE score <10||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|1|1.0||||||
4107550|NCT00960531|3931570|B11|MMSE score 10-15||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|46|46.0||||||
4107551|NCT00960531|3931571|B10|MMSE score 10-15||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|1|1.0||||||
4107552|NCT00960531|3931572|B9|MMSE score 10-15||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|3|3.0||||||
4107553|NCT00960531|3931573|B8|MMSE score 10-15||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|1|1.0||||||
4107554|NCT00960531|3931574|B7|MMSE score 10-15||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|7|7.0||||||
4107555|NCT00960531|3931575|B6|MMSE score 10-15||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|2|2.0||||||
4107556|NCT00960531|3931576|B5|MMSE score 10-15||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|0|0.0||||||
4107616|NCT00960531|3931570|B11|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4107617|NCT00960531|3931571|B10|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4107557|NCT00960531|3931577|B4|MMSE score 10-15||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|5|5.0||||||
4107558|NCT00960531|3931578|B3|MMSE score 10-15||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|15|15.0||||||
4107559|NCT00960531|3931579|B2|MMSE score 10-15||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|2|2.0||||||
4107560|NCT00960531|3931580|B1|MMSE score 10-15||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|10|10.0||||||
4107561|NCT00960531|3931570|B11|MMSE score 16-20||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|53|53.0||||||
4107562|NCT00960531|3931571|B10|MMSE score 16-20||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|0|0.0||||||
4107563|NCT00960531|3931572|B9|MMSE score 16-20||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|6|6.0||||||
4107564|NCT00960531|3931573|B8|MMSE score 16-20||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|2|2.0||||||
4107565|NCT00960531|3931574|B7|MMSE score 16-20||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|11|11.0||||||
4107566|NCT00960531|3931575|B6|MMSE score 16-20||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|3|3.0||||||
4107567|NCT00960531|3931576|B5|MMSE score 16-20||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|2|2.0||||||
4107568|NCT00960531|3931577|B4|MMSE score 16-20||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|10|10.0||||||
4107569|NCT00960531|3931578|B3|MMSE score 16-20||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|12|12.0||||||
4107570|NCT00960531|3931579|B2|MMSE score 16-20||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|2|2.0||||||
4107571|NCT00960531|3931580|B1|MMSE score 16-20||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|5|5.0||||||
4107572|NCT00960531|3931570|B11|MMSE score 21-26||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|48|48.0||||||
4107573|NCT00960531|3931571|B10|MMSE score 21-26||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|3|3.0||||||
4107618|NCT00960531|3931572|B9|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4107574|NCT00960531|3931572|B9|MMSE score 21-26||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|6|6.0||||||
4107575|NCT00960531|3931573|B8|MMSE score 21-26||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|3|3.0||||||
4107576|NCT00960531|3931574|B7|MMSE score 21-26||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|8|8.0||||||
4107577|NCT00960531|3931575|B6|MMSE score 21-26||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|3|3.0||||||
4107578|NCT00960531|3931576|B5|MMSE score 21-26||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|2|2.0||||||
4107579|NCT00960531|3931577|B4|MMSE score 21-26||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|7|7.0||||||
4107580|NCT00960531|3931578|B3|MMSE score 21-26||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|9|9.0||||||
4107581|NCT00960531|3931579|B2|MMSE score 21-26||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|2|2.0||||||
4107582|NCT00960531|3931580|B1|MMSE score 21-26||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|5|5.0||||||
4107583|NCT00960531|3931570|B11|MMSE score >26||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|12|12.0||||||
4107584|NCT00960531|3931571|B10|MMSE score >26||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|0|0.0||||||
4107585|NCT00960531|3931572|B9|MMSE score >26||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|1|1.0||||||
4107586|NCT00960531|3931573|B8|MMSE score >26||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|0|0.0||||||
4107587|NCT00960531|3931574|B7|MMSE score >26||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|1|1.0||||||
4107588|NCT00960531|3931575|B6|MMSE score >26||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|1|1.0||||||
4107589|NCT00960531|3931576|B5|MMSE score >26||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|1|1.0||||||
4107590|NCT00960531|3931577|B4|MMSE score >26||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|3|3.0||||||
4107619|NCT00960531|3931573|B8|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4107620|NCT00960531|3931574|B7|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4107591|NCT00960531|3931578|B3|MMSE score >26||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|5|5.0||||||
4107592|NCT00960531|3931579|B2|MMSE score >26||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|0|0.0||||||
4107593|NCT00960531|3931580|B1|MMSE score >26||MMSE Ranges|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|participants|Number|0|0.0||||||
4107594|NCT00960531|3931570|B11|||MMSE Score|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|Units on a scale|Mean|18.8|18.8|Standard Deviation|5.29|5.29|||
4107595|NCT00960531|3931571|B10|||MMSE Score|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|Units on a scale|Mean|20.0|20.0|Standard Deviation|4.69|4.69|||
4107596|NCT00960531|3931572|B9|||MMSE Score|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|Units on a scale|Mean|19.1|19.1|Standard Deviation|4.84|4.84|||
4107597|NCT00960531|3931573|B8|||MMSE Score|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|Units on a scale|Mean|20.5|20.5|Standard Deviation|4.76|4.76|||
4107598|NCT00960531|3931574|B7|||MMSE Score|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|Units on a scale|Mean|18.7|18.7|Standard Deviation|4.98|4.98|||
4107599|NCT00960531|3931575|B6|||MMSE Score|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|Units on a scale|Mean|20.0|20.0|Standard Deviation|6.14|6.14|||
4107600|NCT00960531|3931576|B5|||MMSE Score|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|Units on a scale|Mean|21.8|21.8|Standard Deviation|4.21|4.21|||
4107601|NCT00960531|3931577|B4|||MMSE Score|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|Units on a scale|Mean|19.6|19.6|Standard Deviation|5.45|5.45|||
4107602|NCT00960531|3931578|B3|||MMSE Score|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|Units on a scale|Mean|18.4|18.4|Standard Deviation|5.92|5.92|||
4107603|NCT00960531|3931579|B2|||MMSE Score|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|Units on a scale|Mean|18.3|18.3|Standard Deviation|5.61|5.61|||
4107604|NCT00960531|3931580|B1|||MMSE Score|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|Units on a scale|Mean|16.7|16.7|Standard Deviation|4.64|4.64|||
4107605|NCT00960531|3931570|B11|White||Race/Ethnicity, Customized||participants|Number|156|156.0||||||
4107606|NCT00960531|3931571|B10|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4107607|NCT00960531|3931572|B9|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4107608|NCT00960531|3931573|B8|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4107609|NCT00960531|3931574|B7|White||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4107610|NCT00960531|3931575|B6|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4107611|NCT00960531|3931576|B5|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4107612|NCT00960531|3931577|B4|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4107613|NCT00960531|3931578|B3|White||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4107614|NCT00960531|3931579|B2|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4107615|NCT00960531|3931580|B1|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4107621|NCT00960531|3931575|B6|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4107622|NCT00960531|3931576|B5|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4107623|NCT00960531|3931577|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4107624|NCT00960531|3931578|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4107625|NCT00960531|3931579|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4107626|NCT00960531|3931580|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4107627|NCT00960531|3931570|B11|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4107628|NCT00960531|3931571|B10|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4107629|NCT00960531|3931572|B9|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4107630|NCT00960531|3931573|B8|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4107631|NCT00960531|3931574|B7|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4107632|NCT00960531|3931575|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4107633|NCT00960531|3931576|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4107634|NCT00960531|3931577|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4107635|NCT00960531|3931578|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4107636|NCT00960531|3931579|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4107637|NCT00960531|3931580|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4107638|NCT00960531|3931570|B11|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4107639|NCT00960531|3931571|B10|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4107640|NCT00960531|3931572|B9|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4107641|NCT00960531|3931573|B8|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4107642|NCT00960531|3931574|B7|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4107643|NCT00960531|3931575|B6|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4107644|NCT00960531|3931576|B5|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4107645|NCT00960531|3931577|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4107646|NCT00960531|3931578|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4107647|NCT00960531|3931579|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4107648|NCT00960531|3931580|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4107649|NCT00960531|3931570|B11||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4107650|NCT00960531|3931571|B10||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4107651|NCT00960531|3931572|B9||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4107652|NCT00960531|3931573|B8||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4107653|NCT00960531|3931574|B7||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4107654|NCT00960531|3931575|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4107655|NCT00960531|3931576|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4107656|NCT00960531|3931577|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4107657|NCT00960531|3931578|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4107658|NCT00960531|3931579|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4107659|NCT00960531|3931580|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4107660|NCT00960531|3931570|B11||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4107661|NCT00960531|3931571|B10||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4107662|NCT00960531|3931572|B9||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4107663|NCT00960531|3931573|B8||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4107664|NCT00960531|3931574|B7||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4107665|NCT00960531|3931575|B6||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4107666|NCT00960531|3931576|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4107667|NCT00960531|3931577|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4107668|NCT00960531|3931578|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4107669|NCT00960531|3931579|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4107670|NCT00960531|3931580|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4107671|NCT00960531|3931570|B11|||Age||years|Mean|70.4|70.4|Standard Deviation|8.61|8.61|||
4107672|NCT00960531|3931571|B10|||Age||years|Mean|75.8|75.8|Standard Deviation|7.89|7.89|||
4107673|NCT00960531|3931572|B9|||Age||years|Mean|69.5|69.5|Standard Deviation|6.95|6.95|||
4107674|NCT00960531|3931573|B8|||Age||years|Mean|66.3|66.3|Standard Deviation|9.42|9.42|||
4107675|NCT00960531|3931574|B7|||Age||years|Mean|71.3|71.3|Standard Deviation|9.20|9.2|||
4107676|NCT00960531|3931575|B6|||Age||years|Mean|69.6|69.6|Standard Deviation|7.94|7.94|||
4107677|NCT00960531|3931576|B5|||Age||years|Mean|75.2|75.2|Standard Deviation|8.23|8.23|||
4107678|NCT00960531|3931577|B4|||Age||years|Mean|72.4|72.4|Standard Deviation|9.12|9.12|||
4107679|NCT00960531|3931578|B3|||Age||years|Mean|69.7|69.7|Standard Deviation|9.29|9.29|||
4107680|NCT00960531|3931579|B2|||Age||years|Mean|67.7|67.7|Standard Deviation|9.52|9.52|||
4107681|NCT00960531|3931580|B1|||Age||years|Mean|68.7|68.7|Standard Deviation|6.94|6.94|||
4107682|NCT00960440|3931633|B5||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4107683|NCT00960440|3931634|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4107684|NCT00960440|3931635|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4107685|NCT00960440|3931636|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4107686|NCT00960440|3931637|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4107687|NCT00960440|3931633|B5||Female|Sex: Female, Male||Participants|Count of Participants|335|335.0||||||
4107688|NCT00960440|3931634|B4||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4107689|NCT00960440|3931635|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4107690|NCT00960440|3931636|B2||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4107691|NCT00960440|3931637|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4107692|NCT00960440|3931633|B5|||Age||years|Mean|55.0|55.0|Standard Deviation|11.3|11.3|||
4107693|NCT00960440|3931634|B4|||Age||years|Mean|54.5|54.5|Standard Deviation|11.0|11.0|||
4107694|NCT00960440|3931635|B3|||Age||years|Mean|54.3|54.3|Standard Deviation|11.7|11.7|||
4107695|NCT00960440|3931636|B2|||Age||years|Mean|55.1|55.1|Standard Deviation|11.3|11.3|||
4107696|NCT00960440|3931637|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|11.5|11.5|||
4107697|NCT00960375|3931810|B3|United States||Region of Enrollment||participants|Number|179|179.0||||||
4107698|NCT00960375|3931811|B2|United States||Region of Enrollment||participants|Number|87|87.0||||||
4107699|NCT00960375|3931812|B1|United States||Region of Enrollment||participants|Number|92|92.0||||||
4107700|NCT00960375|3931810|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4107701|NCT00960375|3931811|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4107702|NCT00960375|3931812|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4107703|NCT00960375|3931810|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107704|NCT00960375|3931811|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107705|NCT00960375|3931812|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107706|NCT00960375|3931810|B3||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4107707|NCT00960375|3931811|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4107708|NCT00960375|3931812|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4107709|NCT00960375|3931810|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|127|127.0||||||
4107710|NCT00960375|3931811|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4107711|NCT00960375|3931812|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4107712|NCT00960375|3931810|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107713|NCT00960375|3931811|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107714|NCT00960375|3931812|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107715|NCT00960375|3931810|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107716|NCT00960375|3931811|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107717|NCT00960375|3931812|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107718|NCT00960375|3931810|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107719|NCT00960375|3931811|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107720|NCT00960375|3931812|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107721|NCT00960375|3931810|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107722|NCT00960375|3931811|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107723|NCT00960375|3931812|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107724|NCT00960375|3931810|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|177|177.0||||||
4107725|NCT00960375|3931811|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
4107726|NCT00960375|3931812|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4107727|NCT00960375|3931810|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4107728|NCT00960375|3931811|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107729|NCT00960375|3931812|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4107730|NCT00960375|3931810|B3||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4107731|NCT00960375|3931811|B2||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4107732|NCT00960375|3931812|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4107733|NCT00960375|3931810|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4107734|NCT00960375|3931811|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4107735|NCT00960375|3931812|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4107736|NCT00960375|3931810|B3|||Age||years|Mean|54.8|54.8|Standard Deviation|7.2|7.2|||
4107737|NCT00960375|3931811|B2|||Age||years|Mean|54.1|54.1|Standard Deviation|7.0|7.0|||
4107738|NCT00960375|3931812|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|13.0|13.0|||
4107739|NCT00960323|3931821|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4107740|NCT00960323|3931821|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107741|NCT00960323|3931821|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107742|NCT00960323|3931821|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4107743|NCT00960323|3931821|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4107744|NCT00960323|3931821|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107745|NCT00960323|3931821|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4107746|NCT00960323|3931821|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107747|NCT00960323|3931821|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107748|NCT00960323|3931821|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4107749|NCT00960323|3931821|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107750|NCT00960323|3931821|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4107751|NCT00960323|3931821|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4107752|NCT00960323|3931821|B1|||Age||years|Mean|26.29|26.29|Standard Deviation|6.46|6.46|||
4107753|NCT00960323|3931821|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4107754|NCT00960323|3931821|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4107755|NCT00960323|3931821|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107756|NCT00960297|3931832|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4107757|NCT00960297|3931832|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4107758|NCT00960297|3931832|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4107759|NCT00960297|3931832|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4107760|NCT00960297|3931832|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4107761|NCT00960297|3931832|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107762|NCT00960206|3931836|B4|United States||Region of Enrollment||hips|Number|464|464.0||||||
4107763|NCT00960206|3931837|B3|United States||Region of Enrollment||hips|Number|89|89.0||||||
4107764|NCT00960206|3931838|B2|United States||Region of Enrollment||hips|Number|185|185.0||||||
4107765|NCT00960206|3931839|B1|United States||Region of Enrollment||hips|Number|190|190.0||||||
4107766|NCT00960206|3931836|B4|Male||Sex/Gender, Customized||hips|Number|298|298.0||||||
4107767|NCT00960206|3931837|B3|Male||Sex/Gender, Customized||hips|Number|54|54.0||||||
4107768|NCT00960206|3931838|B2|Male||Sex/Gender, Customized||hips|Number|121|121.0||||||
4107769|NCT00960206|3931839|B1|Male||Sex/Gender, Customized||hips|Number|123|123.0||||||
4107770|NCT00960206|3931836|B4|Female||Sex/Gender, Customized||hips|Number|166|166.0||||||
4107771|NCT00960206|3931837|B3|Female||Sex/Gender, Customized||hips|Number|35|35.0||||||
4107772|NCT00960206|3931838|B2|Female||Sex/Gender, Customized||hips|Number|64|64.0||||||
4107773|NCT00960206|3931839|B1|Female||Sex/Gender, Customized||hips|Number|67|67.0||||||
4107774|NCT00960206|3931836|B4|||Age|An approved protocol deviation allowed enrollment of a 12 y.o. female with juvenile RA.|years|Mean|53.08|53.08|Full Range|||12.0|75.0|
4107775|NCT00960206|3931837|B3|||Age|An approved protocol deviation allowed enrollment of a 12 y.o. female with juvenile RA.|years|Mean|54.7|54.7|Full Range|||26.0|75.0|
4107776|NCT00960206|3931838|B2|||Age|An approved protocol deviation allowed enrollment of a 12 y.o. female with juvenile RA.|years|Mean|53.9|53.9|Full Range|||26.0|75.0|
4107777|NCT00960206|3931839|B1|||Age|An approved protocol deviation allowed enrollment of a 12 y.o. female with juvenile RA.|years|Mean|51.5|51.5|Full Range|||12.0|74.0|
4107778|NCT00960193|3931859|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4107779|NCT00960193|3931859|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107780|NCT00960193|3931859|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107781|NCT00960193|3931859|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4107782|NCT00960193|3931859|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107783|NCT00960193|3931859|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107784|NCT00960193|3931859|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107785|NCT00960193|3931859|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107786|NCT00960193|3931859|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107787|NCT00960193|3931859|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4107788|NCT00960193|3931859|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4107789|NCT00960193|3931859|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4107790|NCT00960193|3931859|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4107791|NCT00960193|3931859|B1|||Age||years|Mean|25.83|25.83|Standard Deviation|7.73|7.73|||
4107792|NCT00960193|3931859|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4107793|NCT00960193|3931859|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4107794|NCT00960193|3931859|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107795|NCT00960154|3931870|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4107796|NCT00960154|3931871|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4107797|NCT00960154|3931872|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4107798|NCT00960154|3931870|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4107799|NCT00960154|3931871|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4107800|NCT00960154|3931872|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4107801|NCT00960154|3931870|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4107802|NCT00960154|3931871|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4107803|NCT00960154|3931872|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4107804|NCT00960154|3931870|B3|18 to 90 years||Age, Customized|An integrity audit found that the data for this study could not be analyzed owing to unverifiable source documentation. The protocol-specified age range is used for this baseline measure.|participants|Number|50|50.0||||||
4107805|NCT00960154|3931871|B2|18 to 90 years||Age, Customized|An integrity audit found that the data for this study could not be analyzed owing to unverifiable source documentation. The protocol-specified age range is used for this baseline measure.|participants|Number|25|25.0||||||
4107806|NCT00960154|3931872|B1|18 to 90 years||Age, Customized|An integrity audit found that the data for this study could not be analyzed owing to unverifiable source documentation. The protocol-specified age range is used for this baseline measure.|participants|Number|25|25.0||||||
4107807|NCT00960141|3931881|B4|||Rhinoconjunctivitis Quality-of-Life score|Patients completed a validated, self-administered Rhinoconjunctivitis Quality-of-Life Questionnaire Scored [0(best) to 3(worst)].|Units on a Scale|Mean|3.20|3.2|Standard Deviation|1.02|1.02|||
4107808|NCT00960141|3931882|B3|||Rhinoconjunctivitis Quality-of-Life score|Patients completed a validated, self-administered Rhinoconjunctivitis Quality-of-Life Questionnaire Scored [0(best) to 3(worst)].|Units on a Scale|Mean|3.26|3.26|Standard Deviation|1.08|1.08|||
4107809|NCT00960141|3931883|B2|||Rhinoconjunctivitis Quality-of-Life score|Patients completed a validated, self-administered Rhinoconjunctivitis Quality-of-Life Questionnaire Scored [0(best) to 3(worst)].|Units on a Scale|Mean|3.20|3.2|Standard Deviation|1.00|1.0|||
4107810|NCT00960141|3931884|B1|||Rhinoconjunctivitis Quality-of-Life score|Patients completed a validated, self-administered Rhinoconjunctivitis Quality-of-Life Questionnaire Scored [0(best) to 3(worst)].|Units on a Scale|Mean|3.18|3.18|Standard Deviation|1.00|1.0|||
4107811|NCT00960141|3931881|B4|||Nighttime Symptoms Score|Patients were asked to rate each symptom (Nasal Congestion Upon Awakening, Difficulty Going to Sleep, and Nighttime Awakenings) daily in the morning on a 4-point scale [0(best) to 3(worst)]. The Nighttime Symptoms Score is the average of these 3 symptoms. Baseline is computed as average of daily values during the prerandomization run-in period.|Units on a Scale|Mean|1.52|1.52|Standard Deviation|0.62|0.62|||
4107812|NCT00960141|3931882|B3|||Nighttime Symptoms Score|Patients were asked to rate each symptom (Nasal Congestion Upon Awakening, Difficulty Going to Sleep, and Nighttime Awakenings) daily in the morning on a 4-point scale [0(best) to 3(worst)]. The Nighttime Symptoms Score is the average of these 3 symptoms. Baseline is computed as average of daily values during the prerandomization run-in period.|Units on a Scale|Mean|1.54|1.54|Standard Deviation|0.68|0.68|||
4107813|NCT00960141|3931883|B2|||Nighttime Symptoms Score|Patients were asked to rate each symptom (Nasal Congestion Upon Awakening, Difficulty Going to Sleep, and Nighttime Awakenings) daily in the morning on a 4-point scale [0(best) to 3(worst)]. The Nighttime Symptoms Score is the average of these 3 symptoms. Baseline is computed as average of daily values during the prerandomization run-in period.|Units on a Scale|Mean|1.49|1.49|Standard Deviation|0.60|0.6|||
4107814|NCT00960141|3931884|B1|||Nighttime Symptoms Score|Patients were asked to rate each symptom (Nasal Congestion Upon Awakening, Difficulty Going to Sleep, and Nighttime Awakenings) daily in the morning on a 4-point scale [0(best) to 3(worst)]. The Nighttime Symptoms Score is the average of these 3 symptoms. Baseline is computed as average of daily values during the prerandomization run-in period.|Units on a Scale|Mean|1.53|1.53|Standard Deviation|0.62|0.62|||
4107815|NCT00960141|3931881|B4|||Daytime Nasal Symptoms Score|Patients were asked to rate each of 4 nasal symptoms (Congestion, Rhinorrhea, Itching, and Sneezing) daily in the evening on a 4-point scale [0(best) to 3(worst)]. The Daytime Nasal Symptoms Score is the average of these 4 symptoms . Baseline is computed as average of daily values during the prerandomization run-in period (includes the 3 to 5 days prior to Visit 3).|Units on a Scale|Mean|2.11|2.11|Standard Deviation|0.43|0.43|||
4107816|NCT00960141|3931882|B3|||Daytime Nasal Symptoms Score|Patients were asked to rate each of 4 nasal symptoms (Congestion, Rhinorrhea, Itching, and Sneezing) daily in the evening on a 4-point scale [0(best) to 3(worst)]. The Daytime Nasal Symptoms Score is the average of these 4 symptoms . Baseline is computed as average of daily values during the prerandomization run-in period (includes the 3 to 5 days prior to Visit 3).|Units on a Scale|Mean|2.08|2.08|Standard Deviation|0.40|0.4|||
4107817|NCT00960141|3931883|B2|||Daytime Nasal Symptoms Score|Patients were asked to rate each of 4 nasal symptoms (Congestion, Rhinorrhea, Itching, and Sneezing) daily in the evening on a 4-point scale [0(best) to 3(worst)]. The Daytime Nasal Symptoms Score is the average of these 4 symptoms . Baseline is computed as average of daily values during the prerandomization run-in period (includes the 3 to 5 days prior to Visit 3).|Units on a Scale|Mean|2.14|2.14|Standard Deviation|0.43|0.43|||
4107818|NCT00960141|3931884|B1|||Daytime Nasal Symptoms Score|Patients were asked to rate each of 4 nasal symptoms (Congestion, Rhinorrhea, Itching, and Sneezing) daily in the evening on a 4-point scale [0(best) to 3(worst)]. The Daytime Nasal Symptoms Score is the average of these 4 symptoms . Baseline is computed as average of daily values during the prerandomization run-in period (includes the 3 to 5 days prior to Visit 3).|Units on a Scale|Mean|2.09|2.09|Standard Deviation|0.44|0.44|||
4107819|NCT00960141|3931881|B4|||Daytime Eye Symptoms score|Patients were asked to rate each eye symptom (tearing, itchy, red, and puffy eyes) daily in the evening on a 4-point scale [0(best) to 3(worst)]. The Daytime Eye Symptoms score is the average of these 4 symptoms. Baseline is computed as average of daily values during the prerandomization run-in period.|Units on a Scale|Mean|1.46|1.46|Standard Deviation|0.77|0.77|||
4107820|NCT00960141|3931882|B3|||Daytime Eye Symptoms score|Patients were asked to rate each eye symptom (tearing, itchy, red, and puffy eyes) daily in the evening on a 4-point scale [0(best) to 3(worst)]. The Daytime Eye Symptoms score is the average of these 4 symptoms. Baseline is computed as average of daily values during the prerandomization run-in period.|Units on a Scale|Mean|1.44|1.44|Standard Deviation|0.80|0.8|||
4107879|NCT00959985|3931984|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4107880|NCT00959985|3931985|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4107821|NCT00960141|3931883|B2|||Daytime Eye Symptoms score|Patients were asked to rate each eye symptom (tearing, itchy, red, and puffy eyes) daily in the evening on a 4-point scale [0(best) to 3(worst)]. The Daytime Eye Symptoms score is the average of these 4 symptoms. Baseline is computed as average of daily values during the prerandomization run-in period.|Units on a Scale|Mean|1.46|1.46|Standard Deviation|0.76|0.76|||
4107822|NCT00960141|3931884|B1|||Daytime Eye Symptoms score|Patients were asked to rate each eye symptom (tearing, itchy, red, and puffy eyes) daily in the evening on a 4-point scale [0(best) to 3(worst)]. The Daytime Eye Symptoms score is the average of these 4 symptoms. Baseline is computed as average of daily values during the prerandomization run-in period.|Units on a Scale|Mean|1.46|1.46|Standard Deviation|0.78|0.78|||
4107823|NCT00960141|3931881|B4||Male|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
4107824|NCT00960141|3931882|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4107825|NCT00960141|3931883|B2||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4107826|NCT00960141|3931884|B1||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4107827|NCT00960141|3931881|B4||Female|Sex: Female, Male||Participants|Count of Participants|568|568.0||||||
4107828|NCT00960141|3931882|B3||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4107829|NCT00960141|3931883|B2||Female|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
4107830|NCT00960141|3931884|B1||Female|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4107831|NCT00960141|3931881|B4|||Age||years|Mean|36.6|36.6|Full Range|||15.0|82.0|
4107832|NCT00960141|3931882|B3|||Age||years|Mean|37.5|37.5|Full Range|||15.0|66.0|
4107833|NCT00960141|3931883|B2|||Age||years|Mean|36.3|36.3|Full Range|||15.0|75.0|
4107834|NCT00960141|3931884|B1|||Age||years|Mean|36.4|36.4|Full Range|||15.0|82.0|
4107835|NCT00960115|3931909|B3||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4107836|NCT00960115|3931910|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4107837|NCT00960115|3931911|B1||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4107838|NCT00960115|3931909|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4107839|NCT00960115|3931910|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4107840|NCT00960115|3931911|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4107841|NCT00960115|3931909|B3|||Age||Years|Mean|62.0|62.0|Standard Deviation|9.55|9.55|||
4107842|NCT00960115|3931910|B2|||Age||Years|Mean|60.1|60.1|Standard Deviation|9.81|9.81|||
4107843|NCT00960115|3931911|B1|||Age||Years|Mean|63.0|63.0|Standard Deviation|9.31|9.31|||
4107844|NCT00960076|3931924|B3||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4107845|NCT00960076|3931925|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4107846|NCT00960076|3931926|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4107847|NCT00960076|3931924|B3||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4107848|NCT00960076|3931925|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4107849|NCT00960076|3931926|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4107850|NCT00960076|3931924|B3|||Age||years|Mean|55.34|55.34|Standard Deviation|9.64|9.64|||
4107851|NCT00960076|3931925|B2|||Age||years|Mean|55.46|55.46|Standard Deviation|9.86|9.86|||
4107852|NCT00960076|3931926|B1|||Age||years|Mean|55.22|55.22|Standard Deviation|9.41|9.41|||
4107853|NCT00960063|3931939|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4107854|NCT00960063|3931940|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4107855|NCT00960063|3931942|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4107856|NCT00960063|3931939|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4107857|NCT00960063|3931940|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4107858|NCT00960063|3931942|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4107859|NCT00960063|3931939|B4|||Age||Years|Mean|12.0|12.0|Standard Deviation|8.2|8.2|||
4107860|NCT00960063|3931940|B3|||Age||Years|Mean|8.3|8.3|Standard Deviation|4.5|4.5|||
4107861|NCT00960063|3931942|B1|||Age||Years|Mean|23.0|23.0|Standard Deviation|0.0|0.0|||
4107862|NCT00959985|3931982|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4107863|NCT00959985|3931983|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4107864|NCT00959985|3931984|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4107865|NCT00959985|3931985|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4107866|NCT00959985|3931986|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4107867|NCT00959985|3931982|B5||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4107868|NCT00959985|3931983|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4107869|NCT00959985|3931984|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4107870|NCT00959985|3931985|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4107871|NCT00959985|3931986|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4107872|NCT00959985|3931982|B5||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4107873|NCT00959985|3931983|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4107874|NCT00959985|3931984|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4107875|NCT00959985|3931985|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4107876|NCT00959985|3931986|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4107877|NCT00959985|3931982|B5||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4107878|NCT00959985|3931983|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4107881|NCT00959985|3931986|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4107882|NCT00959985|3931982|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107883|NCT00959985|3931983|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107884|NCT00959985|3931984|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107885|NCT00959985|3931985|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107886|NCT00959985|3931986|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107887|NCT00959946|3932027|B9||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4107888|NCT00959946|3932028|B8||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4107889|NCT00959946|3932029|B7||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4107890|NCT00959946|3932030|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4107891|NCT00959946|3932031|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4107892|NCT00959946|3932032|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4107893|NCT00959946|3932033|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4107894|NCT00959946|3932034|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4107895|NCT00959946|3932035|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4107896|NCT00959946|3932027|B9||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4107897|NCT00959946|3932028|B8||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4107898|NCT00959946|3932029|B7||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4107899|NCT00959946|3932030|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4107900|NCT00959946|3932031|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4107901|NCT00959946|3932032|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4107902|NCT00959946|3932033|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4107903|NCT00959946|3932034|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4107904|NCT00959946|3932035|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4107905|NCT00959946|3932027|B9|||Age||Years|Mean|60.7|60.7|Standard Deviation|9.24|9.24|||
4107906|NCT00959946|3932028|B8|||Age||Years|Mean|61.5|61.5|Standard Deviation|4.95|4.95|||
4107907|NCT00959946|3932029|B7|||Age||Years|Mean|51.5|51.5|Standard Deviation|6.36|6.36|||
4107908|NCT00959946|3932030|B6|||Age||Years|Mean|63.8|63.8|Standard Deviation|5.49|5.49|||
4107909|NCT00959946|3932031|B5|||Age||Years|Mean|56.0|56.0|Standard Deviation|8.45|8.45|||
4107910|NCT00959946|3932032|B4|||Age||Years|Mean|63.0|63.0|Standard Deviation|8.43|8.43|||
4107911|NCT00959946|3932033|B3|||Age||Years|Mean|67.3|67.3|Standard Deviation|10.05|10.05|||
4107912|NCT00959946|3932034|B2|||Age||Years|Mean|56.8|56.8|Standard Deviation|16.32|16.32|||
4107913|NCT00959946|3932035|B1|||Age||Years|Mean|53.0|53.0|Standard Deviation|4.24|4.24|||
4107914|NCT00959920|3932093|B3|United States||Region of Enrollment||participants|Number|139|139.0||||||
4107915|NCT00959920|3932094|B2|United States||Region of Enrollment||participants|Number|67|67.0||||||
4107916|NCT00959920|3932095|B1|United States||Region of Enrollment||participants|Number|72|72.0||||||
4107917|NCT00959920|3932093|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4107918|NCT00959920|3932094|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4107919|NCT00959920|3932095|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4107920|NCT00959920|3932093|B3||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4107921|NCT00959920|3932094|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4107922|NCT00959920|3932095|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4107923|NCT00959920|3932093|B3|||Age||years|Mean|28.14|28.14|Standard Deviation|6.13|6.13|||
4107924|NCT00959920|3932094|B2|||Age||years|Mean|28.7|28.7|Standard Deviation|6|6.0|||
4107925|NCT00959920|3932095|B1|||Age||years|Mean|27.6|27.6|Standard Deviation|6|6.0|||
4107926|NCT00959920|3932093|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4107927|NCT00959920|3932094|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4107928|NCT00959920|3932095|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4107929|NCT00959920|3932093|B3||Between 18 and 65 years|Age||Participants|Count of Participants|139|139.0||||||
4107930|NCT00959920|3932094|B2||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
4107931|NCT00959920|3932095|B1||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
4107932|NCT00959920|3932093|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107933|NCT00959920|3932094|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107934|NCT00959920|3932095|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107935|NCT00959907|3932104|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4107936|NCT00959907|3932105|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4107937|NCT00959907|3932106|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4107938|NCT00959907|3932104|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4107939|NCT00959907|3932105|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4107940|NCT00959907|3932106|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4107941|NCT00959907|3932104|B3|||Age||years|Mean|42.88|42.88|Standard Deviation|10.54|10.54|||
4107942|NCT00959907|3932105|B2|||Age||years|Mean|41.86|41.86|Standard Deviation|11.98|11.98|||
4107943|NCT00959907|3932106|B1|||Age||years|Mean|44.77|44.77|Standard Deviation|8.67|8.67|||
4107944|NCT00959894|3932117|B1|United States||Region of Enrollment||participants|Number|79|79.0||||||
4107945|NCT00959894|3932117|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4107946|NCT00959894|3932117|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4107947|NCT00959894|3932117|B1|||Age||years|Median|29|29.0|Inter-Quartile Range|||23.0|44.0|
4107948|NCT00959894|3932117|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4107949|NCT00959894|3932117|B1||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
4107950|NCT00959894|3932117|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107951|NCT00959764|3932145|B4|United Kingdom||Region of Enrollment||participants|Number|159|159.0||||||
4107952|NCT00959764|3932146|B3|United Kingdom||Region of Enrollment||participants|Number|32|32.0||||||
4107953|NCT00959764|3932147|B2|United Kingdom||Region of Enrollment||participants|Number|52|52.0||||||
4107954|NCT00959764|3932148|B1|United Kingdom||Region of Enrollment||participants|Number|75|75.0||||||
4107955|NCT00959764|3932145|B4|Bulgaria||Region of Enrollment||participants|Number|45|45.0||||||
4107956|NCT00959764|3932146|B3|Bulgaria||Region of Enrollment||participants|Number|9|9.0||||||
4107957|NCT00959764|3932147|B2|Bulgaria||Region of Enrollment||participants|Number|15|15.0||||||
4107958|NCT00959764|3932148|B1|Bulgaria||Region of Enrollment||participants|Number|21|21.0||||||
4107959|NCT00959764|3932145|B4|South Africa||Region of Enrollment||participants|Number|99|99.0||||||
4107960|NCT00959764|3932146|B3|South Africa||Region of Enrollment||participants|Number|14|14.0||||||
4107961|NCT00959764|3932147|B2|South Africa||Region of Enrollment||participants|Number|33|33.0||||||
4107962|NCT00959764|3932148|B1|South Africa||Region of Enrollment||participants|Number|52|52.0||||||
4107963|NCT00959764|3932145|B4|Poland||Region of Enrollment||participants|Number|137|137.0||||||
4107964|NCT00959764|3932146|B3|Poland||Region of Enrollment||participants|Number|33|33.0||||||
4107965|NCT00959764|3932147|B2|Poland||Region of Enrollment||participants|Number|45|45.0||||||
4107966|NCT00959764|3932148|B1|Poland||Region of Enrollment||participants|Number|59|59.0||||||
4107967|NCT00959764|3932145|B4|Hungary||Region of Enrollment||participants|Number|54|54.0||||||
4107968|NCT00959764|3932146|B3|Hungary||Region of Enrollment||participants|Number|9|9.0||||||
4107969|NCT00959764|3932147|B2|Hungary||Region of Enrollment||participants|Number|16|16.0||||||
4107970|NCT00959764|3932148|B1|Hungary||Region of Enrollment||participants|Number|29|29.0||||||
4107971|NCT00959764|3932145|B4|United States||Region of Enrollment||participants|Number|71|71.0||||||
4107972|NCT00959764|3932146|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4107973|NCT00959764|3932147|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4107974|NCT00959764|3932148|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4107975|NCT00959764|3932145|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4107976|NCT00959764|3932146|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4107977|NCT00959764|3932147|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4107978|NCT00959764|3932148|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4107979|NCT00959764|3932145|B4||Female|Sex: Female, Male||Participants|Count of Participants|565|565.0||||||
4107980|NCT00959764|3932146|B3||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4107981|NCT00959764|3932147|B2||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4107982|NCT00959764|3932148|B1||Female|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
4107983|NCT00959764|3932145|B4|||Age||years|Mean|66.5|66.5|Standard Deviation|7.5|7.5|||
4107984|NCT00959764|3932146|B3|||Age||years|Mean|66.5|66.5|Standard Deviation|8.0|8.0|||
4107985|NCT00959764|3932147|B2|||Age||years|Mean|66.4|66.4|Standard Deviation|7.0|7.0|||
4107986|NCT00959764|3932148|B1|||Age||years|Mean|66.5|66.5|Standard Deviation|7.6|7.6|||
4107987|NCT00959764|3932145|B4||>=65 years|Age||Participants|Count of Participants|334|334.0||||||
4107988|NCT00959764|3932146|B3||>=65 years|Age||Participants|Count of Participants|70|70.0||||||
4107989|NCT00959764|3932147|B2||>=65 years|Age||Participants|Count of Participants|108|108.0||||||
4107990|NCT00959764|3932148|B1||>=65 years|Age||Participants|Count of Participants|156|156.0||||||
4107991|NCT00959764|3932145|B4||Between 18 and 65 years|Age||Participants|Count of Participants|231|231.0||||||
4107992|NCT00959764|3932146|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4107993|NCT00959764|3932147|B2||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
4107994|NCT00959764|3932148|B1||Between 18 and 65 years|Age||Participants|Count of Participants|115|115.0||||||
4107995|NCT00959764|3932145|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107996|NCT00959764|3932146|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107997|NCT00959764|3932147|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107998|NCT00959764|3932148|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4107999|NCT00959751|3932164|B3|||Number of Previous Migraines|Previous Migraines for each subject was based on the total number of migraine entries reported on the Migraine History CRF|migraine episodes|Mean|1.1|1.1|Standard Deviation|0.27|0.27|||
4108000|NCT00959751|3932165|B2|||Number of Previous Migraines|Previous Migraines for each subject was based on the total number of migraine entries reported on the Migraine History CRF|migraine episodes|Mean|1.1|1.1|Standard Deviation|0.23|0.23|||
4108001|NCT00959751|3932166|B1|||Number of Previous Migraines|Previous Migraines for each subject was based on the total number of migraine entries reported on the Migraine History CRF|migraine episodes|Mean|1.1|1.1|Standard Deviation|0.30|0.3|||
4108002|NCT00959751|3932164|B3|With Aura||Type of Migraine|Subjects are counted once within each type where at least one migraine is recorded.|Participants|Number|0|0.0||||||
4108003|NCT00959751|3932165|B2|With Aura||Type of Migraine|Subjects are counted once within each type where at least one migraine is recorded.|Participants|Number|0|0.0||||||
4108004|NCT00959751|3932166|B1|With Aura||Type of Migraine|Subjects are counted once within each type where at least one migraine is recorded.|Participants|Number|0|0.0||||||
4108005|NCT00959751|3932164|B3|Without Aura||Type of Migraine|Subjects are counted once within each type where at least one migraine is recorded.|Participants|Number|174|174.0||||||
4108006|NCT00959751|3932165|B2|Without Aura||Type of Migraine|Subjects are counted once within each type where at least one migraine is recorded.|Participants|Number|88|88.0||||||
4108007|NCT00959751|3932166|B1|Without Aura||Type of Migraine|Subjects are counted once within each type where at least one migraine is recorded.|Participants|Number|86|86.0||||||
4108008|NCT00959751|3932164|B3|||Body Mass Index (BMI)||kg/m^2|Mean|26.7|26.7|Standard Deviation|4.74|4.74|||
4108009|NCT00959751|3932165|B2|||Body Mass Index (BMI)||kg/m^2|Mean|27.2|27.2|Standard Deviation|5.28|5.28|||
4108010|NCT00959751|3932166|B1|||Body Mass Index (BMI)||kg/m^2|Mean|26.2|26.2|Standard Deviation|4.09|4.09|||
4108011|NCT00959751|3932164|B3|||Height||cm|Mean|167.10|167.1|Standard Deviation|9.321|9.321|||
4108012|NCT00959751|3932165|B2|||Height||cm|Mean|165.91|165.91|Standard Deviation|9.960|9.96|||
4108013|NCT00959751|3932166|B1|||Height||cm|Mean|168.33|168.33|Standard Deviation|8.502|8.502|||
4108014|NCT00959751|3932164|B3|||Weight||kg|Mean|74.84|74.84|Standard Deviation|15.893|15.893|||
4108015|NCT00959751|3932165|B2|||Weight||kg|Mean|74.74|74.74|Standard Deviation|17.066|17.066|||
4108016|NCT00959751|3932166|B1|||Weight||kg|Mean|74.94|74.94|Standard Deviation|14.695|14.695|||
4108017|NCT00959751|3932164|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108018|NCT00959751|3932165|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108019|NCT00959751|3932166|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108020|NCT00959751|3932164|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4108021|NCT00959751|3932165|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4108022|NCT00959751|3932166|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4108023|NCT00959751|3932164|B3||White|Race (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
4108024|NCT00959751|3932165|B2||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4108025|NCT00959751|3932166|B1||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4108026|NCT00959751|3932164|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4108027|NCT00959751|3932165|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4108028|NCT00959751|3932166|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4108029|NCT00959751|3932164|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108030|NCT00959751|3932165|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108031|NCT00959751|3932166|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108032|NCT00959751|3932164|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4108033|NCT00959751|3932165|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4108034|NCT00959751|3932166|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108035|NCT00959751|3932164|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108036|NCT00959751|3932165|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108037|NCT00959751|3932166|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108038|NCT00959751|3932164|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108039|NCT00959751|3932165|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108040|NCT00959751|3932166|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108041|NCT00959751|3932164|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
4108042|NCT00959751|3932165|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4108043|NCT00959751|3932166|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4108044|NCT00959751|3932164|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4108045|NCT00959751|3932165|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4108046|NCT00959751|3932166|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4108047|NCT00959751|3932164|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4108048|NCT00959751|3932165|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4108049|NCT00959751|3932166|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4108050|NCT00959751|3932164|B3||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4108051|NCT00959751|3932165|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4108052|NCT00959751|3932166|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4108053|NCT00959751|3932164|B3|||Age||years|Mean|39.3|39.3|Standard Deviation|12.49|12.49|||
4108054|NCT00959751|3932165|B2|||Age||years|Mean|38.4|38.4|Standard Deviation|12.63|12.63|||
4108055|NCT00959751|3932166|B1|||Age||years|Mean|40.2|40.2|Standard Deviation|12.34|12.34|||
4108056|NCT00959699|3932187|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4108057|NCT00959699|3932188|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4108058|NCT00959699|3932189|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4108059|NCT00959699|3932187|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4108060|NCT00959699|3932188|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4108061|NCT00959699|3932189|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4108062|NCT00959699|3932187|B3|||Age||years|Mean|43.6|43.6|Standard Deviation|8.8|8.8|||
4108063|NCT00959699|3932188|B2|||Age||years|Mean|42.9|42.9|Standard Deviation|8.3|8.3|||
4108064|NCT00959699|3932189|B1|||Age||years|Mean|45.1|45.1|Standard Deviation|9.8|9.8|||
4108065|NCT00959660|3932207|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108066|NCT00959660|3932208|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108067|NCT00959660|3932209|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108068|NCT00959660|3932210|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108069|NCT00959660|3932211|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108070|NCT00959660|3932207|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108071|NCT00959660|3932208|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108072|NCT00959660|3932209|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108073|NCT00959660|3932210|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108074|NCT00959660|3932211|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108075|NCT00959660|3932207|B5||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4108076|NCT00959660|3932208|B4||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4108077|NCT00959660|3932209|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4108078|NCT00959660|3932210|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4108079|NCT00959660|3932211|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4108080|NCT00959660|3932207|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4108081|NCT00959660|3932208|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4108082|NCT00959660|3932209|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4108083|NCT00959660|3932210|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4108084|NCT00959660|3932211|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4108085|NCT00959660|3932207|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108086|NCT00959660|3932208|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108087|NCT00959660|3932209|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108088|NCT00959660|3932210|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108089|NCT00959660|3932211|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108090|NCT00959660|3932207|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108091|NCT00959660|3932208|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108092|NCT00959660|3932209|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108093|NCT00959660|3932210|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108094|NCT00959660|3932211|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108095|NCT00959660|3932207|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108096|NCT00959660|3932208|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108097|NCT00959660|3932209|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108098|NCT00959660|3932210|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108099|NCT00959660|3932211|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108100|NCT00959660|3932207|B5||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4108101|NCT00959660|3932208|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4108102|NCT00959660|3932209|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4108103|NCT00959660|3932210|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4108104|NCT00959660|3932211|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4108105|NCT00959660|3932207|B5||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4108106|NCT00959660|3932208|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4108107|NCT00959660|3932209|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4108108|NCT00959660|3932210|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4108109|NCT00959660|3932211|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4108110|NCT00959660|3932207|B5|||Age||years|Mean|66.5|66.5|Standard Deviation|5.2|5.2|||
4108111|NCT00959660|3932208|B4|||Age||years|Mean|66.3|66.3|Standard Deviation|5.2|5.2|||
4108112|NCT00959660|3932209|B3|||Age||years|Mean|65.6|65.6|Standard Deviation|4.8|4.8|||
4108113|NCT00959660|3932210|B2|||Age||years|Mean|66.5|66.5|Standard Deviation|4.9|4.9|||
4108114|NCT00959660|3932211|B1|||Age||years|Mean|67.5|67.5|Standard Deviation|5.9|5.9|||
4108115|NCT00959647|3932236|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4108116|NCT00959647|3932236|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4108117|NCT00959647|3932236|B1|||Age||years|Mean|57.4|57.4|Standard Deviation|15.4|15.4|||
4108118|NCT00959374|3932241|B1|||Surgical Procedure|Must be scheduled for individual or combined abdominoplasty, mastopexy or reduction mammaplasty|Participants|Number|229|229.0||||||
4108119|NCT00959374|3932241|B1|United States||Region of Enrollment||participants|Number|143|143.0||||||
4108120|NCT00959374|3932241|B1|Europe||Region of Enrollment||participants|Number|86|86.0||||||
4108121|NCT00959374|3932241|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4108122|NCT00959374|3932241|B1||Female|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
4108123|NCT00959374|3932241|B1|||Age||years|Mean|42.6|42.6|Standard Deviation|12.1|12.1|||
4108124|NCT00959374|3932241|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4108125|NCT00959374|3932241|B1||Between 18 and 65 years|Age||Participants|Count of Participants|229|229.0||||||
4108126|NCT00959374|3932241|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4108127|NCT00959192|3932251|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4108128|NCT00959192|3932252|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4108129|NCT00959192|3932253|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4108130|NCT00959192|3932254|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4108131|NCT00959192|3932255|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4108132|NCT00959192|3932251|B5||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4108133|NCT00959192|3932252|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4108134|NCT00959192|3932253|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4108135|NCT00959192|3932254|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4108136|NCT00959192|3932255|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4108137|NCT00959192|3932251|B5|||Age||years|Mean|69.81|69.81|Standard Deviation|8.83|8.83|||
4108138|NCT00959192|3932252|B4|||Age||years|Mean|64.75|64.75|Standard Deviation|7.15|7.15|||
4108139|NCT00959192|3932253|B3|||Age||years|Mean|74.33|74.33|Standard Deviation|6.69|6.69|||
4108140|NCT00959192|3932254|B2|||Age||years|Mean|68.00|68.0|Standard Deviation|10.34|10.34|||
4108141|NCT00959192|3932255|B1|||Age||years|Mean|72.50|72.5|Standard Deviation|8.73|8.73|||
4108142|NCT00959049|3932300|B7|United States||Region of Enrollment||participants|Number|1474|1474.0||||||
4108143|NCT00959049|3932301|B6|United States||Region of Enrollment||participants|Number|250|250.0||||||
4108144|NCT00959049|3932302|B5|United States||Region of Enrollment||participants|Number|257|257.0||||||
4108145|NCT00959049|3932303|B4|United States||Region of Enrollment||participants|Number|228|228.0||||||
4108146|NCT00959049|3932304|B3|United States||Region of Enrollment||participants|Number|254|254.0||||||
4108147|NCT00959049|3932305|B2|United States||Region of Enrollment||participants|Number|254|254.0||||||
4108148|NCT00959049|3932306|B1|United States||Region of Enrollment||participants|Number|231|231.0||||||
4108149|NCT00959049|3932300|B7||Male|Sex: Female, Male||Participants|Count of Participants|746|746.0||||||
4108150|NCT00959049|3932301|B6||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4108151|NCT00959049|3932302|B5||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4108152|NCT00959049|3932303|B4||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4108153|NCT00959049|3932304|B3||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4108154|NCT00959049|3932305|B2||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4108155|NCT00959049|3932306|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4108156|NCT00959049|3932300|B7||Female|Sex: Female, Male||Participants|Count of Participants|728|728.0||||||
4108157|NCT00959049|3932301|B6||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4108158|NCT00959049|3932302|B5||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4108159|NCT00959049|3932303|B4||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4108160|NCT00959049|3932304|B3||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4108161|NCT00959049|3932305|B2||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4108162|NCT00959049|3932306|B1||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4108163|NCT00959049|3932300|B7|||Age||years|Mean|7.06|7.06|Standard Deviation|4.855|4.855|||
4108164|NCT00959049|3932301|B6|||Age||years|Mean|12.86|12.86|Standard Deviation|2.474|2.474|||
4108165|NCT00959049|3932302|B5|||Age||years|Mean|5.82|5.82|Standard Deviation|1.748|1.748|||
4108166|NCT00959049|3932303|B4|||Age||years|Mean|1.96|1.96|Standard Deviation|0.673|0.673|||
4108167|NCT00959049|3932304|B3|||Age||years|Mean|12.98|12.98|Standard Deviation|2.388|2.388|||
4108168|NCT00959049|3932305|B2|||Age||years|Mean|5.93|5.93|Standard Deviation|1.725|1.725|||
4108169|NCT00959049|3932306|B1|||Age||years|Mean|1.94|1.94|Standard Deviation|0.667|0.667|||
4108170|NCT00959049|3932300|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4108171|NCT00959049|3932301|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4108172|NCT00959049|3932302|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4108173|NCT00959049|3932303|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4108174|NCT00959049|3932304|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4108175|NCT00959049|3932305|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4108176|NCT00959049|3932306|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4108177|NCT00959049|3932300|B7||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4108178|NCT00959049|3932301|B6||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4108179|NCT00959049|3932302|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4108180|NCT00959049|3932303|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4108181|NCT00959049|3932304|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4108182|NCT00959049|3932305|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4108183|NCT00959049|3932306|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4108184|NCT00959049|3932300|B7||<=18 years|Age||Participants|Count of Participants|1474|1474.0||||||
4108185|NCT00959049|3932301|B6||<=18 years|Age||Participants|Count of Participants|250|250.0||||||
4108186|NCT00959049|3932302|B5||<=18 years|Age||Participants|Count of Participants|257|257.0||||||
4108187|NCT00959049|3932303|B4||<=18 years|Age||Participants|Count of Participants|228|228.0||||||
4108188|NCT00959049|3932304|B3||<=18 years|Age||Participants|Count of Participants|254|254.0||||||
4108189|NCT00959049|3932305|B2||<=18 years|Age||Participants|Count of Participants|254|254.0||||||
4108190|NCT00959049|3932306|B1||<=18 years|Age||Participants|Count of Participants|231|231.0||||||
4108191|NCT00958919|3932361|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4108192|NCT00958919|3932361|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4108193|NCT00958919|3932361|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4108194|NCT00958919|3932361|B1|||Age||years|Mean|64|64.0|Standard Deviation|9|9.0|||
4108195|NCT00958880|3932380|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4108196|NCT00958880|3932381|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4108197|NCT00958880|3932382|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4108198|NCT00958880|3932380|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4108199|NCT00958880|3932381|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4108200|NCT00958880|3932382|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4108201|NCT00958880|3932380|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4108202|NCT00958880|3932381|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4108203|NCT00958880|3932382|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4108204|NCT00958880|3932380|B3|||Age||years|Mean|36.13|36.13|Standard Deviation|12.83|12.83|||
4108205|NCT00958880|3932381|B2|||Age||years|Mean|35.50|35.5|Standard Deviation|14.02|14.02|||
4108206|NCT00958880|3932382|B1|||Age||years|Mean|38.70|38.7|Standard Deviation|12.08|12.08|||
4108207|NCT00958880|3932380|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4108208|NCT00958880|3932381|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4108209|NCT00958880|3932382|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4108210|NCT00958880|3932380|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4108211|NCT00958880|3932381|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4108212|NCT00958880|3932382|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4108213|NCT00958880|3932380|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4108214|NCT00958880|3932381|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4108215|NCT00958880|3932382|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4108216|NCT00958841|3932391|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4108217|NCT00958841|3932391|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4108218|NCT00958841|3932391|B1|||Age||Years|Mean|45.9|45.9|Standard Deviation|14.56|14.56|||
4108219|NCT00958828|3932409|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4108220|NCT00958828|3932409|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4108221|NCT00958828|3932409|B1|||Age||years|Mean|30.0|30.0|Standard Deviation|12.1|12.1|||
4108222|NCT00958789|3932416|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4108223|NCT00958789|3932416|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4108224|NCT00958789|3932416|B1|||Age||years|Mean|67.24|67.24|Standard Deviation|9.56|9.56|||
4108225|NCT00958776|3932421|B3|Abnormal||Chest X-ray at Screening||participants|Number|169|169.0||||||
4108226|NCT00958776|3932422|B2|Abnormal||Chest X-ray at Screening||participants|Number|120|120.0||||||
4108227|NCT00958776|3932423|B1|Abnormal||Chest X-ray at Screening||participants|Number|49|49.0||||||
4108228|NCT00958776|3932421|B3|Normal||Chest X-ray at Screening||participants|Number|236|236.0||||||
4108229|NCT00958776|3932422|B2|Normal||Chest X-ray at Screening||participants|Number|148|148.0||||||
4108230|NCT00958776|3932423|B1|Normal||Chest X-ray at Screening||participants|Number|88|88.0||||||
4108231|NCT00958776|3932421|B3|||Absolute Lymphocyte Count at Baseline||cell count|Mean|1.3|1.3|Standard Deviation|1.44|1.44|||
4108232|NCT00958776|3932422|B2|||Absolute Lymphocyte Count at Baseline||cell count|Mean|1.3|1.3|Standard Deviation|1.52|1.52|||
4108233|NCT00958776|3932423|B1|||Absolute Lymphocyte Count at Baseline||cell count|Mean|1.3|1.3|Standard Deviation|1.25|1.25|||
4108234|NCT00958776|3932421|B3|Supportive Care/No Antiviral Therapy||Standard of Care Received (CRF)||participants|Number|121|121.0||||||
4108235|NCT00958776|3932422|B2|Supportive Care/No Antiviral Therapy||Standard of Care Received (CRF)||participants|Number|82|82.0||||||
4108236|NCT00958776|3932423|B1|Supportive Care/No Antiviral Therapy||Standard of Care Received (CRF)||participants|Number|39|39.0||||||
4108237|NCT00958776|3932421|B3|Non-NAI-Containing Antiviral Therapy||Standard of Care Received (CRF)||participants|Number|16|16.0||||||
4108238|NCT00958776|3932422|B2|Non-NAI-Containing Antiviral Therapy||Standard of Care Received (CRF)||participants|Number|7|7.0||||||
4108239|NCT00958776|3932423|B1|Non-NAI-Containing Antiviral Therapy||Standard of Care Received (CRF)||participants|Number|9|9.0||||||
4108240|NCT00958776|3932421|B3|NAI-Containing Antiviral Therapy||Standard of Care Received (CRF)||participants|Number|268|268.0||||||
4108241|NCT00958776|3932422|B2|NAI-Containing Antiviral Therapy||Standard of Care Received (CRF)||participants|Number|179|179.0||||||
4108242|NCT00958776|3932423|B1|NAI-Containing Antiviral Therapy||Standard of Care Received (CRF)||participants|Number|89|89.0||||||
4108243|NCT00958776|3932421|B3|> 48 hours||Duration of Illness||participants|Number|180|180.0||||||
4108244|NCT00958776|3932422|B2|> 48 hours||Duration of Illness||participants|Number|118|118.0||||||
4108245|NCT00958776|3932423|B1|> 48 hours||Duration of Illness||participants|Number|62|62.0||||||
4108246|NCT00958776|3932421|B3|≤ 48 hours||Duration of Illness||participants|Number|225|225.0||||||
4108247|NCT00958776|3932422|B2|≤ 48 hours||Duration of Illness||participants|Number|150|150.0||||||
4108248|NCT00958776|3932423|B1|≤ 48 hours||Duration of Illness||participants|Number|75|75.0||||||
4108249|NCT00958776|3932421|B3|Missing||Influenza Vaccination Status||participants|Number|1|1.0||||||
4108250|NCT00958776|3932422|B2|Missing||Influenza Vaccination Status||participants|Number|1|1.0||||||
4108251|NCT00958776|3932423|B1|Missing||Influenza Vaccination Status||participants|Number|0|0.0||||||
4108252|NCT00958776|3932421|B3|Vaccinated this year||Influenza Vaccination Status||participants|Number|67|67.0||||||
4108253|NCT00958776|3932422|B2|Vaccinated this year||Influenza Vaccination Status||participants|Number|41|41.0||||||
4108254|NCT00958776|3932423|B1|Vaccinated this year||Influenza Vaccination Status||participants|Number|26|26.0||||||
4108255|NCT00958776|3932421|B3|Not vaccinated this year||Influenza Vaccination Status||participants|Number|337|337.0||||||
4108256|NCT00958776|3932422|B2|Not vaccinated this year||Influenza Vaccination Status||participants|Number|226|226.0||||||
4108257|NCT00958776|3932423|B1|Not vaccinated this year||Influenza Vaccination Status||participants|Number|111|111.0||||||
4108258|NCT00958776|3932421|B3|Missing||ICU admission at Baseline||participants|Number|7|7.0||||||
4108259|NCT00958776|3932422|B2|Missing||ICU admission at Baseline||participants|Number|4|4.0||||||
4108260|NCT00958776|3932423|B1|Missing||ICU admission at Baseline||participants|Number|3|3.0||||||
4108261|NCT00958776|3932421|B3|Not admitted||ICU admission at Baseline||participants|Number|348|348.0||||||
4108262|NCT00958776|3932422|B2|Not admitted||ICU admission at Baseline||participants|Number|231|231.0||||||
4108263|NCT00958776|3932423|B1|Not admitted||ICU admission at Baseline||participants|Number|117|117.0||||||
4108264|NCT00958776|3932421|B3|Admitted||ICU admission at Baseline||participants|Number|50|50.0||||||
4108265|NCT00958776|3932422|B2|Admitted||ICU admission at Baseline||participants|Number|33|33.0||||||
4108266|NCT00958776|3932423|B1|Admitted||ICU admission at Baseline||participants|Number|17|17.0||||||
4108267|NCT00958776|3932421|B3|Missing||Supplemental oxygen required at Screening||participants|Number|7|7.0||||||
4108268|NCT00958776|3932422|B2|Missing||Supplemental oxygen required at Screening||participants|Number|4|4.0||||||
4108269|NCT00958776|3932423|B1|Missing||Supplemental oxygen required at Screening||participants|Number|3|3.0||||||
4108270|NCT00958776|3932421|B3|Not needed||Supplemental oxygen required at Screening||participants|Number|266|266.0||||||
4108271|NCT00958776|3932422|B2|Not needed||Supplemental oxygen required at Screening||participants|Number|177|177.0||||||
4108272|NCT00958776|3932423|B1|Not needed||Supplemental oxygen required at Screening||participants|Number|89|89.0||||||
4108273|NCT00958776|3932421|B3|Needed||Supplemental oxygen required at Screening||participants|Number|132|132.0||||||
4108274|NCT00958776|3932422|B2|Needed||Supplemental oxygen required at Screening||participants|Number|87|87.0||||||
4108275|NCT00958776|3932423|B1|Needed||Supplemental oxygen required at Screening||participants|Number|45|45.0||||||
4108276|NCT00958776|3932421|B3|||Body mass index (BMI)||kg/m^2|Mean|27.6|27.6|Full Range|||12.3|66.0|
4108277|NCT00958776|3932422|B2|||Body mass index (BMI)||kg/m^2|Mean|27.5|27.5|Full Range|||12.3|66.0|
4108278|NCT00958776|3932423|B1|||Body mass index (BMI)||kg/m^2|Mean|27.7|27.7|Full Range|||15.2|59.9|
4108279|NCT00958776|3932421|B3|Other||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4108280|NCT00958776|3932422|B2|Other||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4108281|NCT00958776|3932423|B1|Other||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4108282|NCT00958776|3932421|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4108283|NCT00958776|3932422|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4108284|NCT00958776|3932423|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4108285|NCT00958776|3932421|B3|Black, of African Heritage or African American||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4108286|NCT00958776|3932422|B2|Black, of African Heritage or African American||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4108287|NCT00958776|3932423|B1|Black, of African Heritage or African American||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4108288|NCT00958776|3932421|B3|White||Race/Ethnicity, Customized||participants|Number|240|240.0||||||
4108289|NCT00958776|3932422|B2|White||Race/Ethnicity, Customized||participants|Number|169|169.0||||||
4108290|NCT00958776|3932423|B1|White||Race/Ethnicity, Customized||participants|Number|71|71.0||||||
4108291|NCT00958776|3932421|B3|Asian||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
4108292|NCT00958776|3932422|B2|Asian||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
4108293|NCT00958776|3932423|B1|Asian||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4108294|NCT00958776|3932421|B3||Male|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
4108295|NCT00958776|3932422|B2||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4108296|NCT00958776|3932423|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4108297|NCT00958776|3932421|B3||Female|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4108298|NCT00958776|3932422|B2||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4108299|NCT00958776|3932423|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4108300|NCT00958776|3932421|B3|Adults ≥ 75 Years||Age, Customized|There were no subjects 6-11 years of age in the ITTI population.|participants|Number|37|37.0||||||
4108301|NCT00958776|3932422|B2|Adults ≥ 75 Years||Age, Customized|There were no subjects 6-11 years of age in the ITTI population.|participants|Number|28|28.0||||||
4108302|NCT00958776|3932423|B1|Adults ≥ 75 Years||Age, Customized|There were no subjects 6-11 years of age in the ITTI population.|participants|Number|9|9.0||||||
4108303|NCT00958776|3932421|B3|Adults 65-74 Years||Age, Customized|There were no subjects 6-11 years of age in the ITTI population.|participants|Number|36|36.0||||||
4108304|NCT00958776|3932422|B2|Adults 65-74 Years||Age, Customized|There were no subjects 6-11 years of age in the ITTI population.|participants|Number|25|25.0||||||
4108305|NCT00958776|3932423|B1|Adults 65-74 Years||Age, Customized|There were no subjects 6-11 years of age in the ITTI population.|participants|Number|11|11.0||||||
4108306|NCT00958776|3932421|B3|Adults 55-64 Years||Age, Customized|There were no subjects 6-11 years of age in the ITTI population.|participants|Number|62|62.0||||||
4108307|NCT00958776|3932422|B2|Adults 55-64 Years||Age, Customized|There were no subjects 6-11 years of age in the ITTI population.|participants|Number|45|45.0||||||
4108308|NCT00958776|3932423|B1|Adults 55-64 Years||Age, Customized|There were no subjects 6-11 years of age in the ITTI population.|participants|Number|17|17.0||||||
4108309|NCT00958776|3932421|B3|Adults 45-54 Years||Age, Customized|There were no subjects 6-11 years of age in the ITTI population.|participants|Number|71|71.0||||||
4108310|NCT00958776|3932422|B2|Adults 45-54 Years||Age, Customized|There were no subjects 6-11 years of age in the ITTI population.|participants|Number|44|44.0||||||
4108311|NCT00958776|3932423|B1|Adults 45-54 Years||Age, Customized|There were no subjects 6-11 years of age in the ITTI population.|participants|Number|27|27.0||||||
4108312|NCT00958776|3932421|B3|Adults 35-44 Years||Age, Customized|There were no subjects 6-11 years of age in the ITTI population.|participants|Number|65|65.0||||||
4108313|NCT00958776|3932422|B2|Adults 35-44 Years||Age, Customized|There were no subjects 6-11 years of age in the ITTI population.|participants|Number|44|44.0||||||
4108314|NCT00958776|3932423|B1|Adults 35-44 Years||Age, Customized|There were no subjects 6-11 years of age in the ITTI population.|participants|Number|21|21.0||||||
4108315|NCT00958776|3932421|B3|Adults 25-34 Years||Age, Customized|There were no subjects 6-11 years of age in the ITTI population.|participants|Number|63|63.0||||||
4108316|NCT00958776|3932422|B2|Adults 25-34 Years||Age, Customized|There were no subjects 6-11 years of age in the ITTI population.|participants|Number|40|40.0||||||
4108317|NCT00958776|3932423|B1|Adults 25-34 Years||Age, Customized|There were no subjects 6-11 years of age in the ITTI population.|participants|Number|23|23.0||||||
4108318|NCT00958776|3932421|B3|Adults 18-24 Years||Age, Customized|There were no subjects 6-11 years of age in the ITTI population.|participants|Number|56|56.0||||||
4108319|NCT00958776|3932422|B2|Adults 18-24 Years||Age, Customized|There were no subjects 6-11 years of age in the ITTI population.|participants|Number|33|33.0||||||
4108320|NCT00958776|3932423|B1|Adults 18-24 Years||Age, Customized|There were no subjects 6-11 years of age in the ITTI population.|participants|Number|23|23.0||||||
4108321|NCT00958776|3932421|B3|Adolescents 12-17 Years||Age, Customized|There were no subjects 6-11 years of age in the ITTI population.|participants|Number|11|11.0||||||
4108322|NCT00958776|3932422|B2|Adolescents 12-17 Years||Age, Customized|There were no subjects 6-11 years of age in the ITTI population.|participants|Number|7|7.0||||||
4108323|NCT00958776|3932423|B1|Adolescents 12-17 Years||Age, Customized|There were no subjects 6-11 years of age in the ITTI population.|participants|Number|4|4.0||||||
4108324|NCT00958776|3932421|B3|Children 6-11 Years||Age, Customized|There were no subjects 6-11 years of age in the ITTI population.|participants|Number|4|4.0||||||
4108325|NCT00958776|3932422|B2|Children 6-11 Years||Age, Customized|There were no subjects 6-11 years of age in the ITTI population.|participants|Number|2|2.0||||||
4108326|NCT00958776|3932423|B1|Children 6-11 Years||Age, Customized|There were no subjects 6-11 years of age in the ITTI population.|participants|Number|2|2.0||||||
4108327|NCT00958776|3932421|B3|||Age||years|Mean|46|46.0|Full Range|||6.0|92.0|
4108328|NCT00958776|3932422|B2|||Age||years|Mean|47|47.0|Full Range|||6.0|92.0|
4108329|NCT00958776|3932423|B1|||Age||years|Mean|43|43.0|Full Range|||7.0|92.0|
4108330|NCT00958724|3932454|B1|Japanese||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4108331|NCT00958724|3932454|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4108332|NCT00958724|3932454|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4108333|NCT00958724|3932454|B1|||Age||years|Mean|54|54.0|Standard Deviation|13.37|13.37|||
4108334|NCT00958724|3932454|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4108335|NCT00958724|3932454|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4108336|NCT00958724|3932454|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4108337|NCT00958581|3932464|B4|United States||Region of Enrollment||Participants|Count of Participants|177|177.0||||||
4108338|NCT00958581|3932465|B3|United States||Region of Enrollment||Participants|Count of Participants|55|55.0||||||
4108339|NCT00958581|3932466|B2|United States||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
4108340|NCT00958581|3932467|B1|United States||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
4108341|NCT00958581|3932464|B4||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4108342|NCT00958581|3932465|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4108343|NCT00958581|3932466|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4108344|NCT00958581|3932467|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4108345|NCT00958581|3932464|B4||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4108346|NCT00958581|3932465|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4108347|NCT00958581|3932466|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4108348|NCT00958581|3932467|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4108349|NCT00958581|3932464|B4||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4108350|NCT00958581|3932465|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4108351|NCT00958581|3932466|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4108352|NCT00958581|3932467|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4108353|NCT00958581|3932464|B4||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4108354|NCT00958581|3932465|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4108355|NCT00958581|3932466|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4108356|NCT00958581|3932467|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4108357|NCT00958581|3932464|B4||<=18 years|Age||Participants|Count of Participants|125|125.0||||||
4108358|NCT00958581|3932465|B3||<=18 years|Age||Participants|Count of Participants|36|36.0||||||
4108359|NCT00958581|3932466|B2||<=18 years|Age||Participants|Count of Participants|47|47.0||||||
4108360|NCT00958581|3932467|B1||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
4108361|NCT00958568|3932483|B1|||Body Mass Index (BMI)|N=892, data was not reported for 1 participant|kilograms/square meter (kg/m²)|Mean|29.12|29.12|Standard Deviation|7.36|7.36|||
4108362|NCT00958568|3932483|B1|India||Region of Enrollment||participants|Number|108|108.0||||||
4108363|NCT00958568|3932483|B1|South Africa||Region of Enrollment||participants|Number|40|40.0||||||
4108364|NCT00958568|3932483|B1|Russian Federation||Region of Enrollment||participants|Number|66|66.0||||||
4108365|NCT00958568|3932483|B1|Turkey||Region of Enrollment||participants|Number|28|28.0||||||
4108366|NCT00958568|3932483|B1|Argentina||Region of Enrollment||participants|Number|53|53.0||||||
4108367|NCT00958568|3932483|B1|Puerto Rico||Region of Enrollment||participants|Number|20|20.0||||||
4108368|NCT00958568|3932483|B1|Mexico||Region of Enrollment||participants|Number|44|44.0||||||
4108369|NCT00958568|3932483|B1|United States||Region of Enrollment||participants|Number|533|533.0||||||
4108370|NCT00958568|3932483|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4108371|NCT00958568|3932483|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4108372|NCT00958568|3932483|B1||White|Race (NIH/OMB)||Participants|Count of Participants|634|634.0||||||
4108373|NCT00958568|3932483|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
4108374|NCT00958568|3932483|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4108375|NCT00958568|3932483|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
4108376|NCT00958568|3932483|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4108377|NCT00958568|3932483|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108378|NCT00958568|3932483|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|725|725.0||||||
4108379|NCT00958568|3932483|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
4108380|NCT00958568|3932483|B1||Male|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
4108381|NCT00958568|3932483|B1||Female|Sex: Female, Male||Participants|Count of Participants|591|591.0||||||
4108382|NCT00958568|3932483|B1|||Age||years|Mean|44.38|44.38|Standard Deviation|11.98|11.98|||
4108383|NCT00958477|3932567|B5||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4108384|NCT00958477|3932568|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4108385|NCT00958477|3932569|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4108386|NCT00958477|3932570|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4108387|NCT00958477|3932571|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4108388|NCT00958477|3932567|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4108389|NCT00958477|3932568|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4108390|NCT00958477|3932569|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4108391|NCT00958477|3932570|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4108392|NCT00958477|3932571|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4108393|NCT00958477|3932567|B5|||Age||years|Mean|65.0|65.0|Standard Deviation|9.0|9.0|||
4108394|NCT00958477|3932568|B4|||Age||years|Mean|66.0|66.0|Standard Deviation|9.0|9.0|||
4108395|NCT00958477|3932569|B3|||Age||years|Mean|62.0|62.0|Standard Deviation|12.0|12.0|||
4108396|NCT00958477|3932570|B2|||Age||years|Mean|63.0|63.0|Standard Deviation|12.0|12.0|||
4108397|NCT00958477|3932571|B1|||Age||years|Mean|67.0|67.0|Standard Deviation|6.0|6.0|||
4108398|NCT00958438|3932720|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108399|NCT00958438|3932721|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108400|NCT00958438|3932722|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108401|NCT00958438|3932723|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108402|NCT00958438|3932720|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108403|NCT00958438|3932721|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108404|NCT00958438|3932722|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108405|NCT00958438|3932723|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108406|NCT00958438|3932720|B4||White|Race (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
4108407|NCT00958438|3932721|B3||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4108408|NCT00958438|3932722|B2||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4108409|NCT00958438|3932723|B1||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4108410|NCT00958438|3932720|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4108411|NCT00958438|3932721|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4108412|NCT00958438|3932722|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4108413|NCT00958438|3932723|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4108414|NCT00958438|3932720|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108415|NCT00958438|3932721|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108416|NCT00958438|3932722|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108417|NCT00958438|3932723|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108418|NCT00958438|3932720|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
4108419|NCT00958438|3932721|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4108420|NCT00958438|3932722|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4108421|NCT00958438|3932723|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4108422|NCT00958438|3932720|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108423|NCT00958438|3932721|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108424|NCT00958438|3932722|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108425|NCT00958438|3932723|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108426|NCT00958438|3932720|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108427|NCT00958438|3932721|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108428|NCT00958438|3932722|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108429|NCT00958438|3932723|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108430|NCT00958438|3932720|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|248|248.0||||||
4108431|NCT00958438|3932721|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
4108432|NCT00958438|3932722|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
4108433|NCT00958438|3932723|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
4108434|NCT00958438|3932720|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108435|NCT00958438|3932721|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108436|NCT00958438|3932722|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108437|NCT00958438|3932723|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108438|NCT00958438|3932720|B4||Male|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
4108439|NCT00958438|3932721|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4108440|NCT00958438|3932722|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4108441|NCT00958438|3932723|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4108442|NCT00958438|3932720|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4108443|NCT00958438|3932721|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4108444|NCT00958438|3932722|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4108445|NCT00958438|3932723|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4108446|NCT00958438|3932720|B4|||Age||years|Mean|51.1|51.1|Standard Deviation|12.10|12.1|||
4108447|NCT00958438|3932721|B3|||Age||years|Mean|49|49.0|Standard Deviation|11.77|11.77|||
4108448|NCT00958438|3932722|B2|||Age||years|Mean|52.6|52.6|Standard Deviation|11.47|11.47|||
4108449|NCT00958438|3932723|B1|||Age||years|Mean|51.7|51.7|Standard Deviation|12.87|12.87|||
4108450|NCT00958360|3932748|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108451|NCT00958360|3932749|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108452|NCT00958360|3932750|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108453|NCT00958360|3932748|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108454|NCT00958360|3932749|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108455|NCT00958360|3932750|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108456|NCT00958360|3932748|B3||White|Race (NIH/OMB)||Participants|Count of Participants|292|292.0||||||
4108457|NCT00958360|3932749|B2||White|Race (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
4108458|NCT00958360|3932750|B1||White|Race (NIH/OMB)||Participants|Count of Participants|148|148.0||||||
4108459|NCT00958360|3932748|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4108460|NCT00958360|3932749|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4108461|NCT00958360|3932750|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4108462|NCT00958360|3932748|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4108463|NCT00958360|3932749|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4108464|NCT00958360|3932750|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108465|NCT00958360|3932748|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108466|NCT00958360|3932749|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108467|NCT00958360|3932750|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108468|NCT00958360|3932748|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108469|NCT00958360|3932749|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108470|NCT00958360|3932750|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108471|NCT00958360|3932748|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108472|NCT00958360|3932749|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108473|NCT00958360|3932750|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108474|NCT00958360|3932748|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|309|309.0||||||
4108475|NCT00958360|3932749|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|152|152.0||||||
4108476|NCT00958360|3932750|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|157|157.0||||||
4108477|NCT00958360|3932748|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4108478|NCT00958360|3932749|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4108479|NCT00958360|3932750|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4108480|NCT00958360|3932748|B3||Male|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
4108481|NCT00958360|3932749|B2||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4108482|NCT00958360|3932750|B1||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4108483|NCT00958360|3932748|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4108484|NCT00958360|3932749|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4108485|NCT00958360|3932750|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4108486|NCT00958360|3932748|B3|||Age||years|Mean|79.7|79.7|Standard Deviation|10.5|10.5|||
4108487|NCT00958360|3932749|B2|||Age||years|Mean|79.2|79.2|Standard Deviation|10.1|10.1|||
4108488|NCT00958360|3932750|B1|||Age||years|Mean|80.1|80.1|Standard Deviation|10.8|10.8|||
4108489|NCT00958347|3932765|B1||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4108490|NCT00958347|3932765|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4108491|NCT00958347|3932765|B1|||Age|For bilateral total hip replacement participants, the age at the time of the initial hip replacement surgery is used.|years|Mean|51.55|51.55|Standard Deviation|10.83|10.83|||
4108492|NCT00958334|3932769|B4|United States||Region of Enrollment||participants|Number|65|65.0||||||
4108493|NCT00958334|3932770|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4108494|NCT00958334|3932771|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4108495|NCT00958334|3932772|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4108496|NCT00958334|3932769|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4108497|NCT00958334|3932770|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4108498|NCT00958334|3932771|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4108499|NCT00958334|3932772|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4108500|NCT00958334|3932769|B4||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4108501|NCT00958334|3932770|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4108502|NCT00958334|3932771|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4108503|NCT00958334|3932772|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4108504|NCT00958334|3932769|B4|||Age||years|Mean|41.6|41.6|Standard Deviation|5.78|5.78|||
4108505|NCT00958334|3932770|B3|||Age||years|Mean|40.6|40.6|Standard Deviation|6.48|6.48|||
4108506|NCT00958334|3932771|B2|||Age||years|Mean|42.6|42.6|Standard Deviation|5.38|5.38|||
4108507|NCT00958334|3932772|B1|||Age||years|Mean|41.5|41.5|Standard Deviation|5.55|5.55|||
4108508|NCT00958334|3932769|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4108509|NCT00958334|3932770|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4108510|NCT00958334|3932771|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4108511|NCT00958334|3932772|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4108512|NCT00958334|3932769|B4||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4108513|NCT00958334|3932770|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4108514|NCT00958334|3932771|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4108515|NCT00958334|3932772|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4108516|NCT00958334|3932769|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4108517|NCT00958334|3932770|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4108518|NCT00958334|3932771|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4108519|NCT00958334|3932772|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4108520|NCT00958308|3932782|B4|China||Region of Enrollment||participants|Number|255|255.0||||||
4108521|NCT00958308|3932783|B3|China||Region of Enrollment||participants|Number|86|86.0||||||
4108522|NCT00958308|3932784|B2|China||Region of Enrollment||participants|Number|85|85.0||||||
4108523|NCT00958308|3932785|B1|China||Region of Enrollment||participants|Number|84|84.0||||||
4108524|NCT00958308|3932782|B4||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4108525|NCT00958308|3932783|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4108526|NCT00958308|3932784|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4108527|NCT00958308|3932785|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4108528|NCT00958308|3932782|B4||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4108529|NCT00958308|3932783|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4108530|NCT00958308|3932784|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4108531|NCT00958308|3932785|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4108532|NCT00958308|3932782|B4|||Age||years|Mean|60|60.0|Standard Deviation|6|6.0|||
4108533|NCT00958308|3932783|B3|||Age||years|Mean|60.0|60.0|Standard Deviation|6.32|6.32|||
4108534|NCT00958308|3932784|B2|||Age||years|Mean|60.2|60.2|Standard Deviation|6.03|6.03|||
4108535|NCT00958308|3932785|B1|||Age||years|Mean|60.4|60.4|Standard Deviation|5.88|5.88|||
4108536|NCT00958282|3932795|B3|United States||Region of Enrollment||participants|Number|43|43.0||||||
4108537|NCT00958282|3932796|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4108538|NCT00958282|3932797|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4108539|NCT00958282|3932795|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108540|NCT00958282|3932796|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108541|NCT00958282|3932797|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108542|NCT00958282|3932795|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4108543|NCT00958282|3932796|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4108544|NCT00958282|3932797|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108545|NCT00958282|3932795|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4108546|NCT00958282|3932796|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4108547|NCT00958282|3932797|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4108548|NCT00958282|3932795|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4108549|NCT00958282|3932796|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4108550|NCT00958282|3932797|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4108551|NCT00958282|3932795|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4108552|NCT00958282|3932796|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4108553|NCT00958282|3932797|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108554|NCT00958282|3932795|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108555|NCT00958282|3932796|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108556|NCT00958282|3932797|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108557|NCT00958282|3932795|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108558|NCT00958282|3932796|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108559|NCT00958282|3932797|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108560|NCT00958282|3932795|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4108561|NCT00958282|3932796|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4108562|NCT00958282|3932797|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4108563|NCT00958282|3932795|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4108564|NCT00958282|3932796|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4108565|NCT00958282|3932797|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4108566|NCT00958282|3932795|B3|||Age||years|Mean|46.1|46.1|Standard Deviation|7.9|7.9|||
4108567|NCT00958282|3932796|B2|||Age||years|Mean|46.4|46.4|Standard Deviation|10|10.0|||
4108568|NCT00958282|3932797|B1|||Age||years|Mean|45.1|45.1|Standard Deviation|5.9|5.9|||
4108569|NCT00958256|3932806|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4108570|NCT00958256|3932806|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4108571|NCT00958256|3932806|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4108572|NCT00958256|3932806|B1|||Age||years|Median|66|66.0|Full Range|||48.0|85.0|
4108573|NCT00958243|3932810|B7|United States||Region of Enrollment||participants|Number|473|473.0||||||
4108574|NCT00958243|3932811|B6|United States||Region of Enrollment||participants|Number|109|109.0||||||
4108575|NCT00958243|3932812|B5|United States||Region of Enrollment||participants|Number|109|109.0||||||
4108576|NCT00958243|3932813|B4|United States||Region of Enrollment||participants|Number|28|28.0||||||
4108577|NCT00958243|3932814|B3|United States||Region of Enrollment||participants|Number|96|96.0||||||
4108578|NCT00958243|3932815|B2|United States||Region of Enrollment||participants|Number|105|105.0||||||
4108579|NCT00958243|3932816|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4108580|NCT00958243|3932810|B7||Male|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4108581|NCT00958243|3932811|B6||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4108582|NCT00958243|3932812|B5||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4108583|NCT00958243|3932813|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4108584|NCT00958243|3932814|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4108585|NCT00958243|3932815|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4108586|NCT00958243|3932816|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4108587|NCT00958243|3932810|B7||Female|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
4108588|NCT00958243|3932811|B6||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4108589|NCT00958243|3932812|B5||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4108590|NCT00958243|3932813|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4108591|NCT00958243|3932814|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4108592|NCT00958243|3932815|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4108593|NCT00958243|3932816|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4108594|NCT00958243|3932810|B7|||Age||years|Mean|3.93|3.93|Standard Deviation|2.45|2.45|||
4108595|NCT00958243|3932811|B6|||Age||years|Mean|5.91|5.91|Standard Deviation|1.70|1.7|||
4108596|NCT00958243|3932812|B5|||Age||years|Mean|5.94|5.94|Standard Deviation|1.71|1.71|||
4108597|NCT00958243|3932813|B4|||Age||years|Mean|5.90|5.9|Standard Deviation|1.71|1.71|||
4108598|NCT00958243|3932814|B3|||Age||years|Mean|1.85|1.85|Standard Deviation|0.66|0.66|||
4108599|NCT00958243|3932815|B2|||Age||years|Mean|1.73|1.73|Standard Deviation|0.72|0.72|||
4108600|NCT00958243|3932816|B1|||Age||years|Mean|1.87|1.87|Standard Deviation|0.77|0.77|||
4108601|NCT00958243|3932810|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4108602|NCT00958243|3932811|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4108603|NCT00958243|3932812|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4108604|NCT00958243|3932813|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4108605|NCT00958243|3932814|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4108606|NCT00958243|3932815|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4108607|NCT00958243|3932816|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4108608|NCT00958243|3932810|B7||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4108609|NCT00958243|3932811|B6||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4108610|NCT00958243|3932812|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4108611|NCT00958243|3932813|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4108612|NCT00958243|3932814|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4108613|NCT00958243|3932815|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4108614|NCT00958243|3932816|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4108615|NCT00958243|3932810|B7||<=18 years|Age||Participants|Count of Participants|473|473.0||||||
4108616|NCT00958243|3932811|B6||<=18 years|Age||Participants|Count of Participants|109|109.0||||||
4108617|NCT00958243|3932812|B5||<=18 years|Age||Participants|Count of Participants|109|109.0||||||
4108618|NCT00958243|3932813|B4||<=18 years|Age||Participants|Count of Participants|28|28.0||||||
4108619|NCT00958243|3932814|B3||<=18 years|Age||Participants|Count of Participants|96|96.0||||||
4108620|NCT00958243|3932815|B2||<=18 years|Age||Participants|Count of Participants|105|105.0||||||
4108621|NCT00958243|3932816|B1||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
4108622|NCT00958217|3932877|B3|without PTSD diagnosis||PTSD Current diagnosis||participants|Number|22|22.0||||||
4108623|NCT00958217|3932878|B2|without PTSD diagnosis||PTSD Current diagnosis||participants|Number|12|12.0||||||
4108624|NCT00958217|3932879|B1|without PTSD diagnosis||PTSD Current diagnosis||participants|Number|10|10.0||||||
4108625|NCT00958217|3932877|B3|with PTSD diagnosis||PTSD Current diagnosis||participants|Number|101|101.0||||||
4108626|NCT00958217|3932878|B2|with PTSD diagnosis||PTSD Current diagnosis||participants|Number|50|50.0||||||
4108627|NCT00958217|3932879|B1|with PTSD diagnosis||PTSD Current diagnosis||participants|Number|51|51.0||||||
4108628|NCT00958217|3932877|B3||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4108629|NCT00958217|3932878|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4108630|NCT00958217|3932879|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4108631|NCT00958217|3932877|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4108632|NCT00958217|3932878|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4108633|NCT00958217|3932879|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4108634|NCT00958217|3932877|B3|||Age||years|Mean|47.3|47.3|Standard Deviation|12.0|12.0|||
4108635|NCT00958217|3932878|B2|||Age||years|Mean|47.3|47.3|Standard Deviation|11.9|11.9|||
4108636|NCT00958217|3932879|B1|||Age||years|Mean|47.2|47.2|Standard Deviation|12.1|12.1|||
4108637|NCT00958191|3932891|B1|United States||Region of Enrollment||Participants|Count of Participants|221|221.0||||||
4108638|NCT00958191|3932891|B1||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4108639|NCT00958191|3932891|B1||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4108640|NCT00958191|3932891|B1|||Age|For bilateral participants, age at the time of surgery for the first hip enrolled is used for the baseline measurement.|years|Mean|62.04|62.04|Standard Deviation|8.74|8.74|||
4108641|NCT00958165|3932906|B1|Germany||Region of Enrollment||participants|Number|72|72.0||||||
4108642|NCT00958165|3932906|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4108643|NCT00958165|3932906|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4108644|NCT00958165|3932906|B1|||Age||years|Mean|58|58.0|Standard Deviation|10|10.0|||
4108645|NCT00958126|3932910|B9||Male|Sex: Female, Male||Participants|Count of Participants|564|564.0||||||
4108646|NCT00958126|3932911|B8||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4108647|NCT00958126|3932912|B7||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4108648|NCT00958126|3932913|B6||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4108649|NCT00958126|3932914|B5||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4108650|NCT00958126|3932915|B4||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4108651|NCT00958126|3932916|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4108652|NCT00958126|3932917|B2||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4108653|NCT00958126|3932918|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4108654|NCT00958126|3932910|B9||Female|Sex: Female, Male||Participants|Count of Participants|749|749.0||||||
4108655|NCT00958126|3932911|B8||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4108656|NCT00958126|3932912|B7||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4108657|NCT00958126|3932913|B6||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4108658|NCT00958126|3932914|B5||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4108659|NCT00958126|3932915|B4||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4108660|NCT00958126|3932916|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4108661|NCT00958126|3932917|B2||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4108662|NCT00958126|3932918|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4108663|NCT00958126|3932910|B9|>=65 years||Age, Customized||participants|Number|655|655.0||||||
4108664|NCT00958126|3932911|B8|>=65 years||Age, Customized||participants|Number|202|202.0||||||
4108665|NCT00958126|3932912|B7|>=65 years||Age, Customized||participants|Number|200|200.0||||||
4108666|NCT00958126|3932913|B6|>=65 years||Age, Customized||participants|Number|203|203.0||||||
4108667|NCT00958126|3932914|B5|>=65 years||Age, Customized||participants|Number|50|50.0||||||
4108668|NCT00958126|3932915|B4|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4108669|NCT00958126|3932916|B3|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4108670|NCT00958126|3932917|B2|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4108671|NCT00958126|3932918|B1|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4108672|NCT00958126|3932910|B9|>= 18 years to 64 years||Age, Customized||participants|Number|658|658.0||||||
4108673|NCT00958126|3932911|B8|>= 18 years to 64 years||Age, Customized||participants|Number|0|0.0||||||
4108674|NCT00958126|3932912|B7|>= 18 years to 64 years||Age, Customized||participants|Number|0|0.0||||||
4108675|NCT00958126|3932913|B6|>= 18 years to 64 years||Age, Customized||participants|Number|0|0.0||||||
4108676|NCT00958126|3932914|B5|>= 18 years to 64 years||Age, Customized||participants|Number|0|0.0||||||
4108677|NCT00958126|3932915|B4|>= 18 years to 64 years||Age, Customized||participants|Number|203|203.0||||||
4108678|NCT00958126|3932916|B3|>= 18 years to 64 years||Age, Customized||participants|Number|201|201.0||||||
4108679|NCT00958126|3932917|B2|>= 18 years to 64 years||Age, Customized||participants|Number|205|205.0||||||
4108680|NCT00958126|3932918|B1|>= 18 years to 64 years||Age, Customized||participants|Number|49|49.0||||||
4108681|NCT00958074|3932995|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4108682|NCT00958074|3932996|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4108683|NCT00958074|3932997|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4108684|NCT00958074|3932995|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4108685|NCT00958074|3932996|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4108686|NCT00958074|3932997|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4108687|NCT00958074|3932995|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4108688|NCT00958074|3932996|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4108689|NCT00958074|3932997|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4108690|NCT00958074|3932995|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4108691|NCT00958074|3932996|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4108692|NCT00958074|3932997|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4108693|NCT00958074|3932995|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4108694|NCT00958074|3932996|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4108695|NCT00958074|3932997|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4108696|NCT00958035|3933012|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4108697|NCT00958035|3933013|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4108698|NCT00958035|3933014|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4108699|NCT00958035|3933012|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4108700|NCT00958035|3933013|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4108701|NCT00958035|3933014|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4108702|NCT00958035|3933012|B3|> 65 years||Age, Customized||participants|Number|4|4.0||||||
4108703|NCT00958035|3933013|B2|> 65 years||Age, Customized||participants|Number|2|2.0||||||
4108704|NCT00958035|3933014|B1|> 65 years||Age, Customized||participants|Number|2|2.0||||||
4108705|NCT00958035|3933012|B3|45 - 65 years||Age, Customized||participants|Number|50|50.0||||||
4108706|NCT00958035|3933013|B2|45 - 65 years||Age, Customized||participants|Number|25|25.0||||||
4108707|NCT00958035|3933014|B1|45 - 65 years||Age, Customized||participants|Number|25|25.0||||||
4108708|NCT00958035|3933012|B3|< 45 years||Age, Customized||participants|Number|35|35.0||||||
4108709|NCT00958035|3933013|B2|< 45 years||Age, Customized||participants|Number|16|16.0||||||
4108710|NCT00958035|3933014|B1|< 45 years||Age, Customized||participants|Number|19|19.0||||||
4108711|NCT00958009|3933021|B1|United States||Region of Enrollment||participants|Number|109|109.0||||||
4108712|NCT00958009|3933021|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4108713|NCT00958009|3933021|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4108714|NCT00958009|3933021|B1|||Age||years|Mean|46.0|46.0|Standard Deviation|9.32|9.32|||
4108715|NCT00958009|3933021|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4108716|NCT00958009|3933021|B1||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
4108717|NCT00958009|3933021|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4108718|NCT00957996|3933026|B3|No||Corticosteroid at enrollment||participants|Number|114|114.0||||||
4108719|NCT00957996|3933027|B2|No||Corticosteroid at enrollment||participants|Number|49|49.0||||||
4108720|NCT00957996|3933028|B1|No||Corticosteroid at enrollment||participants|Number|65|65.0||||||
4108721|NCT00957996|3933026|B3|Yes||Corticosteroid at enrollment||participants|Number|120|120.0||||||
4108722|NCT00957996|3933027|B2|Yes||Corticosteroid at enrollment||participants|Number|68|68.0||||||
4108723|NCT00957996|3933028|B1|Yes||Corticosteroid at enrollment||participants|Number|52|52.0||||||
4108724|NCT00957996|3933026|B3|||Duration of hospital admission prior to first dose||days|Mean|1.2|1.2|Standard Deviation|2.13|2.13|||
4108725|NCT00957996|3933027|B2|||Duration of hospital admission prior to first dose||days|Mean|1.3|1.3|Standard Deviation|2.86|2.86|||
4108726|NCT00957996|3933028|B1|||Duration of hospital admission prior to first dose||days|Mean|1.1|1.1|Standard Deviation|0.98|0.98|||
4108727|NCT00957996|3933026|B3|||Subjects who received antivirals prior to treatment||participants|Number|170|170.0||||||
4108728|NCT00957996|3933027|B2|||Subjects who received antivirals prior to treatment||participants|Number|82|82.0||||||
4108729|NCT00957996|3933028|B1|||Subjects who received antivirals prior to treatment||participants|Number|88|88.0||||||
4108730|NCT00957996|3933026|B3|Missing||Supplemental oxygen required at Screening||participants|Number|3|3.0||||||
4108731|NCT00957996|3933027|B2|Missing||Supplemental oxygen required at Screening||participants|Number|2|2.0||||||
4108732|NCT00957996|3933028|B1|Missing||Supplemental oxygen required at Screening||participants|Number|1|1.0||||||
4108733|NCT00957996|3933026|B3|No||Supplemental oxygen required at Screening||participants|Number|73|73.0||||||
4108734|NCT00957996|3933027|B2|No||Supplemental oxygen required at Screening||participants|Number|32|32.0||||||
4108735|NCT00957996|3933028|B1|No||Supplemental oxygen required at Screening||participants|Number|41|41.0||||||
4108736|NCT00957996|3933026|B3|Yes||Supplemental oxygen required at Screening||participants|Number|158|158.0||||||
4108737|NCT00957996|3933027|B2|Yes||Supplemental oxygen required at Screening||participants|Number|83|83.0||||||
4108738|NCT00957996|3933028|B1|Yes||Supplemental oxygen required at Screening||participants|Number|75|75.0||||||
4108739|NCT00957996|3933026|B3|Missing||Screening neutrophils|"Grade 3 = 500 – 749/mm^3 (severe)~Grade 4 = < 500/mm^3 (potentially life-threatening)~Other Grade = Grade 1 (mild; 1,000 – 1,300/mm^3) or Grade 2 (moderate; 750 – 999/mm^3)"|participants|Number|19|19.0||||||
4108740|NCT00957996|3933027|B2|Missing||Screening neutrophils|"Grade 3 = 500 – 749/mm^3 (severe)~Grade 4 = < 500/mm^3 (potentially life-threatening)~Other Grade = Grade 1 (mild; 1,000 – 1,300/mm^3) or Grade 2 (moderate; 750 – 999/mm^3)"|participants|Number|6|6.0||||||
4108741|NCT00957996|3933028|B1|Missing||Screening neutrophils|"Grade 3 = 500 – 749/mm^3 (severe)~Grade 4 = < 500/mm^3 (potentially life-threatening)~Other Grade = Grade 1 (mild; 1,000 – 1,300/mm^3) or Grade 2 (moderate; 750 – 999/mm^3)"|participants|Number|13|13.0||||||
4108742|NCT00957996|3933026|B3|Other Grade||Screening neutrophils|"Grade 3 = 500 – 749/mm^3 (severe)~Grade 4 = < 500/mm^3 (potentially life-threatening)~Other Grade = Grade 1 (mild; 1,000 – 1,300/mm^3) or Grade 2 (moderate; 750 – 999/mm^3)"|participants|Number|212|212.0||||||
4108743|NCT00957996|3933027|B2|Other Grade||Screening neutrophils|"Grade 3 = 500 – 749/mm^3 (severe)~Grade 4 = < 500/mm^3 (potentially life-threatening)~Other Grade = Grade 1 (mild; 1,000 – 1,300/mm^3) or Grade 2 (moderate; 750 – 999/mm^3)"|participants|Number|108|108.0||||||
4108744|NCT00957996|3933028|B1|Other Grade||Screening neutrophils|"Grade 3 = 500 – 749/mm^3 (severe)~Grade 4 = < 500/mm^3 (potentially life-threatening)~Other Grade = Grade 1 (mild; 1,000 – 1,300/mm^3) or Grade 2 (moderate; 750 – 999/mm^3)"|participants|Number|104|104.0||||||
4108745|NCT00957996|3933026|B3|Grade 3/4||Screening neutrophils|"Grade 3 = 500 – 749/mm^3 (severe)~Grade 4 = < 500/mm^3 (potentially life-threatening)~Other Grade = Grade 1 (mild; 1,000 – 1,300/mm^3) or Grade 2 (moderate; 750 – 999/mm^3)"|participants|Number|3|3.0||||||
4108746|NCT00957996|3933027|B2|Grade 3/4||Screening neutrophils|"Grade 3 = 500 – 749/mm^3 (severe)~Grade 4 = < 500/mm^3 (potentially life-threatening)~Other Grade = Grade 1 (mild; 1,000 – 1,300/mm^3) or Grade 2 (moderate; 750 – 999/mm^3)"|participants|Number|3|3.0||||||
4108747|NCT00957996|3933028|B1|Grade 3/4||Screening neutrophils|"Grade 3 = 500 – 749/mm^3 (severe)~Grade 4 = < 500/mm^3 (potentially life-threatening)~Other Grade = Grade 1 (mild; 1,000 – 1,300/mm^3) or Grade 2 (moderate; 750 – 999/mm^3)"|participants|Number|0|0.0||||||
4108748|NCT00957996|3933026|B3|Missing||Screening lymphocytes|"Grade 3 = 350 - 499/mm^3 (severe)~Grade 4 = < 350/mm^3 (potentially life-threatening)~Other Grade = Grade 1 (mild; 600 – 650/mm^3) or Grade 2 (moderate; 500 – 599/mm^3)"|participants|Number|19|19.0||||||
4108749|NCT00957996|3933027|B2|Missing||Screening lymphocytes|"Grade 3 = 350 - 499/mm^3 (severe)~Grade 4 = < 350/mm^3 (potentially life-threatening)~Other Grade = Grade 1 (mild; 600 – 650/mm^3) or Grade 2 (moderate; 500 – 599/mm^3)"|participants|Number|6|6.0||||||
4108750|NCT00957996|3933028|B1|Missing||Screening lymphocytes|"Grade 3 = 350 - 499/mm^3 (severe)~Grade 4 = < 350/mm^3 (potentially life-threatening)~Other Grade = Grade 1 (mild; 600 – 650/mm^3) or Grade 2 (moderate; 500 – 599/mm^3)"|participants|Number|13|13.0||||||
4108751|NCT00957996|3933026|B3|Other Grade||Screening lymphocytes|"Grade 3 = 350 - 499/mm^3 (severe)~Grade 4 = < 350/mm^3 (potentially life-threatening)~Other Grade = Grade 1 (mild; 600 – 650/mm^3) or Grade 2 (moderate; 500 – 599/mm^3)"|participants|Number|178|178.0||||||
4108752|NCT00957996|3933027|B2|Other Grade||Screening lymphocytes|"Grade 3 = 350 - 499/mm^3 (severe)~Grade 4 = < 350/mm^3 (potentially life-threatening)~Other Grade = Grade 1 (mild; 600 – 650/mm^3) or Grade 2 (moderate; 500 – 599/mm^3)"|participants|Number|89|89.0||||||
4108753|NCT00957996|3933028|B1|Other Grade||Screening lymphocytes|"Grade 3 = 350 - 499/mm^3 (severe)~Grade 4 = < 350/mm^3 (potentially life-threatening)~Other Grade = Grade 1 (mild; 600 – 650/mm^3) or Grade 2 (moderate; 500 – 599/mm^3)"|participants|Number|89|89.0||||||
4108754|NCT00957996|3933026|B3|Grade 3/4||Screening lymphocytes|"Grade 3 = 350 - 499/mm^3 (severe)~Grade 4 = < 350/mm^3 (potentially life-threatening)~Other Grade = Grade 1 (mild; 600 – 650/mm^3) or Grade 2 (moderate; 500 – 599/mm^3)"|participants|Number|37|37.0||||||
4108755|NCT00957996|3933027|B2|Grade 3/4||Screening lymphocytes|"Grade 3 = 350 - 499/mm^3 (severe)~Grade 4 = < 350/mm^3 (potentially life-threatening)~Other Grade = Grade 1 (mild; 600 – 650/mm^3) or Grade 2 (moderate; 500 – 599/mm^3)"|participants|Number|22|22.0||||||
4108756|NCT00957996|3933028|B1|Grade 3/4||Screening lymphocytes|"Grade 3 = 350 - 499/mm^3 (severe)~Grade 4 = < 350/mm^3 (potentially life-threatening)~Other Grade = Grade 1 (mild; 600 – 650/mm^3) or Grade 2 (moderate; 500 – 599/mm^3)"|participants|Number|15|15.0||||||
4108757|NCT00957996|3933026|B3|Missing||Screening serum albumin|"Grade 3 (severe) = albumin < 2.0 g/dL~Other Grade = Grades 1 (mild; 3.0 g/dL) or 2 (moderate; 2.0 – 2.9 g/dL)~DAIDS = Division of AIDS"|participants|Number|12|12.0||||||
4108758|NCT00957996|3933027|B2|Missing||Screening serum albumin|"Grade 3 (severe) = albumin < 2.0 g/dL~Other Grade = Grades 1 (mild; 3.0 g/dL) or 2 (moderate; 2.0 – 2.9 g/dL)~DAIDS = Division of AIDS"|participants|Number|6|6.0||||||
4108759|NCT00957996|3933028|B1|Missing||Screening serum albumin|"Grade 3 (severe) = albumin < 2.0 g/dL~Other Grade = Grades 1 (mild; 3.0 g/dL) or 2 (moderate; 2.0 – 2.9 g/dL)~DAIDS = Division of AIDS"|participants|Number|6|6.0||||||
4108760|NCT00957996|3933026|B3|Other Grade||Screening serum albumin|"Grade 3 (severe) = albumin < 2.0 g/dL~Other Grade = Grades 1 (mild; 3.0 g/dL) or 2 (moderate; 2.0 – 2.9 g/dL)~DAIDS = Division of AIDS"|participants|Number|208|208.0||||||
4108761|NCT00957996|3933027|B2|Other Grade||Screening serum albumin|"Grade 3 (severe) = albumin < 2.0 g/dL~Other Grade = Grades 1 (mild; 3.0 g/dL) or 2 (moderate; 2.0 – 2.9 g/dL)~DAIDS = Division of AIDS"|participants|Number|103|103.0||||||
4108762|NCT00957996|3933028|B1|Other Grade||Screening serum albumin|"Grade 3 (severe) = albumin < 2.0 g/dL~Other Grade = Grades 1 (mild; 3.0 g/dL) or 2 (moderate; 2.0 – 2.9 g/dL)~DAIDS = Division of AIDS"|participants|Number|105|105.0||||||
4108763|NCT00957996|3933026|B3|Grade 3||Screening serum albumin|"Grade 3 (severe) = albumin < 2.0 g/dL~Other Grade = Grades 1 (mild; 3.0 g/dL) or 2 (moderate; 2.0 – 2.9 g/dL)~DAIDS = Division of AIDS"|participants|Number|14|14.0||||||
4108764|NCT00957996|3933027|B2|Grade 3||Screening serum albumin|"Grade 3 (severe) = albumin < 2.0 g/dL~Other Grade = Grades 1 (mild; 3.0 g/dL) or 2 (moderate; 2.0 – 2.9 g/dL)~DAIDS = Division of AIDS"|participants|Number|8|8.0||||||
4108765|NCT00957996|3933028|B1|Grade 3||Screening serum albumin|"Grade 3 (severe) = albumin < 2.0 g/dL~Other Grade = Grades 1 (mild; 3.0 g/dL) or 2 (moderate; 2.0 – 2.9 g/dL)~DAIDS = Division of AIDS"|participants|Number|6|6.0||||||
4108766|NCT00957996|3933026|B3|Missing||Moderate renal impairment||participants|Number|5|5.0||||||
4108767|NCT00957996|3933027|B2|Missing||Moderate renal impairment||participants|Number|1|1.0||||||
4108768|NCT00957996|3933028|B1|Missing||Moderate renal impairment||participants|Number|4|4.0||||||
4108769|NCT00957996|3933026|B3|Not impaired||Moderate renal impairment||participants|Number|208|208.0||||||
4108770|NCT00957996|3933027|B2|Not impaired||Moderate renal impairment||participants|Number|105|105.0||||||
4108771|NCT00957996|3933028|B1|Not impaired||Moderate renal impairment||participants|Number|103|103.0||||||
4108772|NCT00957996|3933026|B3|Impaired||Moderate renal impairment||participants|Number|21|21.0||||||
4108773|NCT00957996|3933027|B2|Impaired||Moderate renal impairment||participants|Number|11|11.0||||||
4108774|NCT00957996|3933028|B1|Impaired||Moderate renal impairment||participants|Number|10|10.0||||||
4108775|NCT00957996|3933026|B3|Southern Hemisphere 10||Hemisphere of enrollment||participants|Number|19|19.0||||||
4108776|NCT00957996|3933027|B2|Southern Hemisphere 10||Hemisphere of enrollment||participants|Number|9|9.0||||||
4108777|NCT00957996|3933028|B1|Southern Hemisphere 10||Hemisphere of enrollment||participants|Number|10|10.0||||||
4108778|NCT00957996|3933026|B3|Northern Hemisphere 09-10||Hemisphere of enrollment||participants|Number|215|215.0||||||
4108779|NCT00957996|3933027|B2|Northern Hemisphere 09-10||Hemisphere of enrollment||participants|Number|108|108.0||||||
4108780|NCT00957996|3933028|B1|Northern Hemisphere 09-10||Hemisphere of enrollment||participants|Number|107|107.0||||||
4108781|NCT00957996|3933026|B3|>48 hours||Duration of illness||participants|Number|200|200.0||||||
4108782|NCT00957996|3933027|B2|>48 hours||Duration of illness||participants|Number|101|101.0||||||
4108783|NCT00957996|3933028|B1|>48 hours||Duration of illness||participants|Number|99|99.0||||||
4108784|NCT00957996|3933026|B3|≤48 hours||Duration of illness||participants|Number|34|34.0||||||
4108785|NCT00957996|3933027|B2|≤48 hours||Duration of illness||participants|Number|16|16.0||||||
4108786|NCT00957996|3933028|B1|≤48 hours||Duration of illness||participants|Number|18|18.0||||||
4108787|NCT00957996|3933026|B3|Missing||Chest X-ray at Screening||participants|Number|7|7.0||||||
4108788|NCT00957996|3933027|B2|Missing||Chest X-ray at Screening||participants|Number|3|3.0||||||
4108789|NCT00957996|3933028|B1|Missing||Chest X-ray at Screening||participants|Number|4|4.0||||||
4108790|NCT00957996|3933026|B3|Abnormal||Chest X-ray at Screening||participants|Number|59|59.0||||||
4108791|NCT00957996|3933027|B2|Abnormal||Chest X-ray at Screening||participants|Number|28|28.0||||||
4108792|NCT00957996|3933028|B1|Abnormal||Chest X-ray at Screening||participants|Number|31|31.0||||||
4108793|NCT00957996|3933026|B3|Normal||Chest X-ray at Screening||participants|Number|168|168.0||||||
4108794|NCT00957996|3933027|B2|Normal||Chest X-ray at Screening||participants|Number|86|86.0||||||
4108795|NCT00957996|3933028|B1|Normal||Chest X-ray at Screening||participants|Number|82|82.0||||||
4108796|NCT00957996|3933026|B3|||APACHE II Score|Acute physiology and chronic health evaluation (APACHE) Score was captured only for the first ICU admission. The APACHE II Score ranges from 0 to 71 with higher scores indicating greater disease severity and a higher risk of death.|units on a scale|Mean|15|15.0|Standard Deviation|6.6|6.6|||
4108797|NCT00957996|3933027|B2|||APACHE II Score|Acute physiology and chronic health evaluation (APACHE) Score was captured only for the first ICU admission. The APACHE II Score ranges from 0 to 71 with higher scores indicating greater disease severity and a higher risk of death.|units on a scale|Mean|17|17.0|Standard Deviation|5.4|5.4|||
4108798|NCT00957996|3933028|B1|||APACHE II Score|Acute physiology and chronic health evaluation (APACHE) Score was captured only for the first ICU admission. The APACHE II Score ranges from 0 to 71 with higher scores indicating greater disease severity and a higher risk of death.|units on a scale|Mean|14|14.0|Standard Deviation|7.5|7.5|||
4108799|NCT00957996|3933026|B3|||Number of subjects with ICU admission at Baseline||participants|Number|39|39.0||||||
4108800|NCT00957996|3933027|B2|||Number of subjects with ICU admission at Baseline||participants|Number|21|21.0||||||
4108801|NCT00957996|3933028|B1|||Number of subjects with ICU admission at Baseline||participants|Number|18|18.0||||||
4108802|NCT00957996|3933026|B3|Missing||Influenza vaccination status|Subjects may have had more than one vaccination.|participants|Number|2|2.0||||||
4108803|NCT00957996|3933027|B2|Missing||Influenza vaccination status|Subjects may have had more than one vaccination.|participants|Number|0|0.0||||||
4108804|NCT00957996|3933028|B1|Missing||Influenza vaccination status|Subjects may have had more than one vaccination.|participants|Number|2|2.0||||||
4108805|NCT00957996|3933026|B3|Vaccinated this year||Influenza vaccination status|Subjects may have had more than one vaccination.|participants|Number|77|77.0||||||
4108806|NCT00957996|3933027|B2|Vaccinated this year||Influenza vaccination status|Subjects may have had more than one vaccination.|participants|Number|36|36.0||||||
4108807|NCT00957996|3933028|B1|Vaccinated this year||Influenza vaccination status|Subjects may have had more than one vaccination.|participants|Number|41|41.0||||||
4108808|NCT00957996|3933026|B3|Not vaccinated this year||Influenza vaccination status|Subjects may have had more than one vaccination.|participants|Number|155|155.0||||||
4108809|NCT00957996|3933027|B2|Not vaccinated this year||Influenza vaccination status|Subjects may have had more than one vaccination.|participants|Number|81|81.0||||||
4108810|NCT00957996|3933028|B1|Not vaccinated this year||Influenza vaccination status|Subjects may have had more than one vaccination.|participants|Number|74|74.0||||||
4108811|NCT00957996|3933026|B3|Missing||Smoking status||participants|Number|1|1.0||||||
4108812|NCT00957996|3933027|B2|Missing||Smoking status||participants|Number|0|0.0||||||
4108813|NCT00957996|3933028|B1|Missing||Smoking status||participants|Number|1|1.0||||||
4108814|NCT00957996|3933026|B3|Not current smoker||Smoking status||participants|Number|145|145.0||||||
4108815|NCT00957996|3933027|B2|Not current smoker||Smoking status||participants|Number|72|72.0||||||
4108816|NCT00957996|3933028|B1|Not current smoker||Smoking status||participants|Number|73|73.0||||||
4108817|NCT00957996|3933026|B3|Current smoker||Smoking status||participants|Number|88|88.0||||||
4108818|NCT00957996|3933027|B2|Current smoker||Smoking status||participants|Number|45|45.0||||||
4108819|NCT00957996|3933028|B1|Current smoker||Smoking status||participants|Number|43|43.0||||||
4108820|NCT00957996|3933026|B3|||Body mass index (BMI)||kg/m^2|Mean|31|31.0|Full Range|||17.0|70.0|
4108821|NCT00957996|3933027|B2|||Body mass index (BMI)||kg/m^2|Mean|31|31.0|Full Range|||18.0|59.0|
4108822|NCT00957996|3933028|B1|||Body mass index (BMI)||kg/m^2|Mean|32|32.0|Full Range|||17.0|70.0|
4108823|NCT00957996|3933026|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4108824|NCT00957996|3933027|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4108825|NCT00957996|3933028|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4108826|NCT00957996|3933026|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4108827|NCT00957996|3933027|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4108828|NCT00957996|3933028|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4108829|NCT00957996|3933026|B3|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4108830|NCT00957996|3933027|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4108831|NCT00957996|3933028|B1|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4108832|NCT00957996|3933026|B3|Other||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4108833|NCT00957996|3933027|B2|Other||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4108834|NCT00957996|3933028|B1|Other||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4108835|NCT00957996|3933026|B3|Black, of African Heritage or African American||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4108836|NCT00957996|3933027|B2|Black, of African Heritage or African American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4108837|NCT00957996|3933028|B1|Black, of African Heritage or African American||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4108838|NCT00957996|3933026|B3|White||Race/Ethnicity, Customized||participants|Number|162|162.0||||||
4108839|NCT00957996|3933027|B2|White||Race/Ethnicity, Customized||participants|Number|84|84.0||||||
4108840|NCT00957996|3933028|B1|White||Race/Ethnicity, Customized||participants|Number|78|78.0||||||
4108841|NCT00957996|3933026|B3||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4108842|NCT00957996|3933027|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4108843|NCT00957996|3933028|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4108844|NCT00957996|3933026|B3||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4108845|NCT00957996|3933027|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4108846|NCT00957996|3933028|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4108847|NCT00957996|3933026|B3|Adults ≥75 years||Age, Customized||participants|Number|14|14.0||||||
4108848|NCT00957996|3933027|B2|Adults ≥75 years||Age, Customized||participants|Number|5|5.0||||||
4108849|NCT00957996|3933028|B1|Adults ≥75 years||Age, Customized||participants|Number|9|9.0||||||
4108850|NCT00957996|3933026|B3|Adults 65-74 years||Age, Customized||participants|Number|21|21.0||||||
4108851|NCT00957996|3933027|B2|Adults 65-74 years||Age, Customized||participants|Number|10|10.0||||||
4108852|NCT00957996|3933028|B1|Adults 65-74 years||Age, Customized||participants|Number|11|11.0||||||
4108853|NCT00957996|3933026|B3|Adults 55-64 years||Age, Customized||participants|Number|45|45.0||||||
4108854|NCT00957996|3933027|B2|Adults 55-64 years||Age, Customized||participants|Number|27|27.0||||||
4108855|NCT00957996|3933028|B1|Adults 55-64 years||Age, Customized||participants|Number|18|18.0||||||
4108856|NCT00957996|3933026|B3|Adults 45-54 years||Age, Customized||participants|Number|55|55.0||||||
4108857|NCT00957996|3933027|B2|Adults 45-54 years||Age, Customized||participants|Number|29|29.0||||||
4108858|NCT00957996|3933028|B1|Adults 45-54 years||Age, Customized||participants|Number|26|26.0||||||
4108859|NCT00957996|3933026|B3|Adults 35-44 years||Age, Customized||participants|Number|47|47.0||||||
4108860|NCT00957996|3933027|B2|Adults 35-44 years||Age, Customized||participants|Number|18|18.0||||||
4108861|NCT00957996|3933028|B1|Adults 35-44 years||Age, Customized||participants|Number|29|29.0||||||
4108862|NCT00957996|3933026|B3|Adults 25-34 years||Age, Customized||participants|Number|36|36.0||||||
4108863|NCT00957996|3933027|B2|Adults 25-34 years||Age, Customized||participants|Number|19|19.0||||||
4108864|NCT00957996|3933028|B1|Adults 25-34 years||Age, Customized||participants|Number|17|17.0||||||
4108865|NCT00957996|3933026|B3|Adults 18-24 years||Age, Customized||participants|Number|12|12.0||||||
4108866|NCT00957996|3933027|B2|Adults 18-24 years||Age, Customized||participants|Number|8|8.0||||||
4108867|NCT00957996|3933028|B1|Adults 18-24 years||Age, Customized||participants|Number|4|4.0||||||
4108868|NCT00957996|3933026|B3|Adolescents 12-17 years||Age, Customized||participants|Number|4|4.0||||||
4108869|NCT00957996|3933027|B2|Adolescents 12-17 years||Age, Customized||participants|Number|1|1.0||||||
4108870|NCT00957996|3933028|B1|Adolescents 12-17 years||Age, Customized||participants|Number|3|3.0||||||
4108871|NCT00957996|3933026|B3|Children 6-11 years||Age, Customized||participants|Number|0|0.0||||||
4108872|NCT00957996|3933027|B2|Children 6-11 years||Age, Customized||participants|Number|0|0.0||||||
4108873|NCT00957996|3933028|B1|Children 6-11 years||Age, Customized||participants|Number|0|0.0||||||
4108874|NCT00957996|3933026|B3|||Age||years|Mean|48.3|48.3|Full Range|||14.0|93.0|
4108875|NCT00957996|3933027|B2|||Age||years|Mean|48.4|48.4|Full Range|||15.0|92.0|
4108876|NCT00957996|3933028|B1|||Age||years|Mean|48.3|48.3|Full Range|||14.0|93.0|
4108877|NCT00957944|3933059|B3|||Weight||kilogram (kg)|Mean|84.20|84.2|Standard Deviation|9.16|9.16|||
4108878|NCT00957944|3933060|B2|||Weight||kilogram (kg)|Mean|85.33|85.33|Standard Deviation|8.75|8.75|||
4108879|NCT00957944|3933061|B1|||Weight||kilogram (kg)|Mean|83.18|83.18|Standard Deviation|9.62|9.62|||
4108880|NCT00957944|3933059|B3|||Height||meter (m)|Mean|1.82|1.82|Standard Deviation|0.08|0.08|||
4108881|NCT00957944|3933060|B2|||Height||meter (m)|Mean|1.82|1.82|Standard Deviation|0.08|0.08|||
4108882|NCT00957944|3933061|B1|||Height||meter (m)|Mean|1.82|1.82|Standard Deviation|0.07|0.07|||
4108883|NCT00957944|3933059|B3|||Body Mass Index (BMI)|BMI= Weight/(Height)^2|kilogram per square meter (kg/m^2)|Mean|25.43|25.43|Standard Deviation|2.00|2.0|||
4108884|NCT00957944|3933060|B2|||Body Mass Index (BMI)|BMI= Weight/(Height)^2|kilogram per square meter (kg/m^2)|Mean|25.87|25.87|Standard Deviation|1.77|1.77|||
4108885|NCT00957944|3933061|B1|||Body Mass Index (BMI)|BMI= Weight/(Height)^2|kilogram per square meter (kg/m^2)|Mean|25.03|25.03|Standard Deviation|2.16|2.16|||
4108886|NCT00957944|3933059|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108887|NCT00957944|3933060|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108888|NCT00957944|3933061|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108889|NCT00957944|3933059|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108890|NCT00957944|3933060|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108891|NCT00957944|3933061|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108892|NCT00957944|3933059|B3||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4108893|NCT00957944|3933060|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4108894|NCT00957944|3933061|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4108895|NCT00957944|3933059|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108896|NCT00957944|3933060|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108897|NCT00957944|3933061|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108898|NCT00957944|3933059|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108899|NCT00957944|3933060|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108900|NCT00957944|3933061|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108901|NCT00957944|3933059|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108902|NCT00957944|3933060|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108903|NCT00957944|3933061|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108904|NCT00957944|3933059|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108905|NCT00957944|3933060|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108906|NCT00957944|3933061|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108907|NCT00957944|3933059|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108908|NCT00957944|3933060|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108909|NCT00957944|3933061|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108910|NCT00957944|3933059|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4108911|NCT00957944|3933060|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4108912|NCT00957944|3933061|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4108913|NCT00957944|3933059|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108914|NCT00957944|3933060|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108915|NCT00957944|3933061|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108916|NCT00957944|3933059|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4108917|NCT00957944|3933060|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4108918|NCT00957944|3933061|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4108919|NCT00957944|3933059|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4108920|NCT00957944|3933060|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4108921|NCT00957944|3933061|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4108922|NCT00957944|3933059|B3|||Age||years|Mean|35.0|35.0|Standard Deviation|9.9|9.9|||
4108923|NCT00957944|3933060|B2|||Age||years|Mean|32.8|32.8|Standard Deviation|7.2|7.2|||
4108924|NCT00957944|3933061|B1|||Age||years|Mean|37.0|37.0|Standard Deviation|11.7|11.7|||
4108925|NCT00957931|3933096|B1||Thalassemia major|Diagnosis||Participants|Count of Participants|2|2.0||||||
4108926|NCT00957931|3933096|B1||Sickle cell disease|Diagnosis||Participants|Count of Participants|4|4.0||||||
4108927|NCT00957931|3933096|B1|||Number of known transfusions prior to HSCT|HSCT = hematopoietic stem cell transplantation|transfusions|Median|47.5|47.5|Full Range|||4.0|220.0|
4108928|NCT00957931|3933096|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4108929|NCT00957931|3933096|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4108930|NCT00957931|3933096|B1|||Age||years|Median|10|10.0|Full Range|||8.0|18.0|
4108931|NCT00957905|3933104|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4108932|NCT00957905|3933105|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4108933|NCT00957905|3933106|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4108934|NCT00957905|3933104|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4108935|NCT00957905|3933105|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4108936|NCT00957905|3933106|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4108937|NCT00957905|3933104|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4108938|NCT00957905|3933105|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4108939|NCT00957905|3933106|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4108940|NCT00957905|3933104|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4108941|NCT00957905|3933105|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4108942|NCT00957905|3933106|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4108943|NCT00957905|3933104|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4108944|NCT00957905|3933105|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4108945|NCT00957905|3933106|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4108946|NCT00957905|3933104|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4108947|NCT00957905|3933105|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4108948|NCT00957905|3933106|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4108949|NCT00957801|3933113|B5|||Fat Mass as measured by DEXA||kilograms|Mean|28.59|28.59|Standard Deviation|9.99|9.99|||
4108950|NCT00957801|3933114|B4|||Fat Mass as measured by DEXA||kilograms|Mean|28.40|28.4|Standard Deviation|28.01|28.01|||
4108951|NCT00957801|3933115|B3|||Fat Mass as measured by DEXA||kilograms|Mean|25.33|25.33|Standard Deviation|26.12|26.12|||
4108952|NCT00957801|3933116|B2|||Fat Mass as measured by DEXA||kilograms|Mean|33.32|33.32|Standard Deviation|33.82|33.82|||
4108953|NCT00957801|3933117|B1|||Fat Mass as measured by DEXA||kilograms|Mean|28.74|28.74|Standard Deviation|28.64|28.64|||
4108954|NCT00957801|3933113|B5|||Lean Body Mass as measured by DEXA||kilograms|Mean|52.77|52.77|Standard Deviation|7.73|7.73|||
4108955|NCT00957801|3933114|B4|||Lean Body Mass as measured by DEXA||kilograms|Mean|57.34|57.34|Standard Deviation|57.84|57.84|||
4108956|NCT00957801|3933115|B3|||Lean Body Mass as measured by DEXA||kilograms|Mean|49.22|49.22|Standard Deviation|47.85|47.85|||
4108957|NCT00957801|3933116|B2|||Lean Body Mass as measured by DEXA||kilograms|Mean|53.06|53.06|Standard Deviation|52.66|52.66|||
4108958|NCT00957801|3933117|B1|||Lean Body Mass as measured by DEXA||kilograms|Mean|52.60|52.6|Standard Deviation|51.42|51.42|||
4108959|NCT00957801|3933113|B5|||Total Mass as Measured by DEXA||kilograms|Mean|84.42|84.42|Standard Deviation|15.8|15.8|||
4108960|NCT00957801|3933114|B4|||Total Mass as Measured by DEXA||kilograms|Mean|89.04|89.04|Standard Deviation|89.15|89.15|||
4108961|NCT00957801|3933115|B3|||Total Mass as Measured by DEXA||kilograms|Mean|77.51|77.51|Standard Deviation|76.93|76.93|||
4108962|NCT00957801|3933116|B2|||Total Mass as Measured by DEXA||kilograms|Mean|89.6|89.6|Standard Deviation|89.7|89.7|||
4108963|NCT00957801|3933117|B1|||Total Mass as Measured by DEXA||kilograms|Mean|84.2|84.2|Standard Deviation|82.83|82.83|||
4108964|NCT00957801|3933113|B5|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
4108965|NCT00957801|3933114|B4|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4108966|NCT00957801|3933115|B3|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4108967|NCT00957801|3933116|B2|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4108968|NCT00957801|3933117|B1|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4108969|NCT00957801|3933113|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108970|NCT00957801|3933114|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108971|NCT00957801|3933115|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108972|NCT00957801|3933116|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108973|NCT00957801|3933117|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108974|NCT00957801|3933113|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108975|NCT00957801|3933114|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108976|NCT00957801|3933115|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108977|NCT00957801|3933116|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108978|NCT00957801|3933117|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108979|NCT00957801|3933113|B5||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4108980|NCT00957801|3933114|B4||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4108981|NCT00957801|3933115|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4108982|NCT00957801|3933116|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4108983|NCT00957801|3933117|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4108984|NCT00957801|3933113|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4108985|NCT00957801|3933114|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4108986|NCT00957801|3933115|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4108987|NCT00957801|3933116|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108988|NCT00957801|3933117|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108989|NCT00957801|3933113|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108990|NCT00957801|3933114|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108991|NCT00957801|3933115|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108992|NCT00957801|3933116|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108993|NCT00957801|3933117|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108994|NCT00957801|3933113|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108995|NCT00957801|3933114|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108996|NCT00957801|3933115|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108997|NCT00957801|3933116|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108998|NCT00957801|3933117|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4108999|NCT00957801|3933113|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109000|NCT00957801|3933114|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109001|NCT00957801|3933115|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109002|NCT00957801|3933116|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109003|NCT00957801|3933117|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109004|NCT00957801|3933113|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109005|NCT00957801|3933114|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109006|NCT00957801|3933115|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109007|NCT00957801|3933116|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109008|NCT00957801|3933117|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109009|NCT00957801|3933113|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4109010|NCT00957801|3933114|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4109011|NCT00957801|3933115|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4109012|NCT00957801|3933116|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4109013|NCT00957801|3933117|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4109014|NCT00957801|3933113|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4109015|NCT00957801|3933114|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109016|NCT00957801|3933115|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109017|NCT00957801|3933116|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4109018|NCT00957801|3933117|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109019|NCT00957801|3933113|B5||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4109020|NCT00957801|3933114|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4109021|NCT00957801|3933115|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4109022|NCT00957801|3933116|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4109023|NCT00957801|3933117|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4109024|NCT00957801|3933113|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4109025|NCT00957801|3933114|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4109026|NCT00957801|3933115|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4109027|NCT00957801|3933116|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4109028|NCT00957801|3933117|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4109029|NCT00957801|3933113|B5|||Age||years|Mean|72|72.0|Standard Deviation|6|6.0|||
4109030|NCT00957801|3933114|B4|||Age||years|Mean|71|71.0|Standard Deviation|7|7.0|||
4109031|NCT00957801|3933115|B3|||Age||years|Mean|73|73.0|Standard Deviation|7.5|7.5|||
4109032|NCT00957801|3933116|B2|||Age||years|Mean|73|73.0|Standard Deviation|5|5.0|||
4109033|NCT00957801|3933117|B1|||Age||years|Mean|72|72.0|Standard Deviation|4|4.0|||
4109034|NCT00957723|3933286|B1|United States||Region of Enrollment||participants|Number|411|411.0||||||
4109035|NCT00957723|3933286|B1||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4109036|NCT00957723|3933286|B1||Female|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
4109037|NCT00957723|3933286|B1|||Age||years|Mean|65.5|65.5|Standard Deviation|8.63|8.63|||
4109038|NCT00957684|3933300|B5||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4109039|NCT00957684|3933301|B4||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4109040|NCT00957684|3933302|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4109041|NCT00957684|3933303|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4109042|NCT00957684|3933304|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4109043|NCT00957684|3933300|B5||Female|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4109044|NCT00957684|3933301|B4||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4109045|NCT00957684|3933302|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4109046|NCT00957684|3933303|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4109047|NCT00957684|3933304|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4109048|NCT00957684|3933300|B5|>70 years||Age, Customized||participants|Number|3|3.0||||||
4109049|NCT00957684|3933301|B4|>70 years||Age, Customized||participants|Number|0|0.0||||||
4109050|NCT00957684|3933302|B3|>70 years||Age, Customized||participants|Number|1|1.0||||||
4109051|NCT00957684|3933303|B2|>70 years||Age, Customized||participants|Number|2|2.0||||||
4109052|NCT00957684|3933304|B1|>70 years||Age, Customized||participants|Number|0|0.0||||||
4109053|NCT00957684|3933300|B5|Between 18 and 70 years||Age, Customized||participants|Number|399|399.0||||||
4109054|NCT00957684|3933301|B4|Between 18 and 70 years||Age, Customized||participants|Number|102|102.0||||||
4109055|NCT00957684|3933302|B3|Between 18 and 70 years||Age, Customized||participants|Number|99|99.0||||||
4109056|NCT00957684|3933303|B2|Between 18 and 70 years||Age, Customized||participants|Number|96|96.0||||||
4109057|NCT00957684|3933304|B1|Between 18 and 70 years||Age, Customized||participants|Number|102|102.0||||||
4109058|NCT00957684|3933300|B5|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4109059|NCT00957684|3933301|B4|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4109060|NCT00957684|3933302|B3|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4109061|NCT00957684|3933303|B2|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4109062|NCT00957684|3933304|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4109063|NCT00957671|3933318|B1|||Age at time of injury||years|Mean|34.3|34.3|Standard Deviation|15.7|15.7|||
4109064|NCT00957671|3933318|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4109065|NCT00957671|3933318|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4109066|NCT00957671|3933318|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4109067|NCT00957671|3933318|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|11.2|11.2|||
4109068|NCT00957671|3933318|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4109069|NCT00957671|3933318|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4109070|NCT00957671|3933318|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109071|NCT00957658|3933375|B1|United States||Region of Enrollment||participants|Number|234|234.0||||||
4109072|NCT00957658|3933375|B1|Male||Sex/Gender, Customized|Gender is based on 229 participants as there were 5 participants missing gender data.|participants|Number|80|80.0||||||
4109073|NCT00957658|3933375|B1|Female||Sex/Gender, Customized|Gender is based on 229 participants as there were 5 participants missing gender data.|participants|Number|149|149.0||||||
4109074|NCT00957658|3933375|B1|||Age|"Age results are based on 226 participants as there were 8 participants missing age data.~For bilateral total hip replacement participants, the age at the time of the initial hip surgery is used."|years|Mean|68.94|68.94|Standard Deviation|9.77|9.77|||
4109075|NCT00957593|3933388|B3|United States||Region of Enrollment||participants|Number|252|252.0||||||
4109076|NCT00957593|3933389|B2|United States||Region of Enrollment||participants|Number|125|125.0||||||
4109077|NCT00957593|3933390|B1|United States||Region of Enrollment||participants|Number|127|127.0||||||
4109078|NCT00957593|3933388|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4109079|NCT00957593|3933389|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4109080|NCT00957593|3933390|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4109081|NCT00957593|3933388|B3||Female|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
4109082|NCT00957593|3933389|B2||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4109083|NCT00957593|3933390|B1||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4109084|NCT00957593|3933388|B3|||Age||years|Mean|27.4|27.4|Standard Deviation|0.4|0.4|||
4109085|NCT00957593|3933389|B2|||Age||years|Mean|27.7|27.7|Standard Deviation|5.7|5.7|||
4109086|NCT00957593|3933390|B1|||Age||years|Mean|27.1|27.1|Standard Deviation|5.6|5.6|||
4109087|NCT00957593|3933388|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4109088|NCT00957593|3933389|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4109089|NCT00957593|3933390|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4109090|NCT00957593|3933388|B3||Between 18 and 65 years|Age||Participants|Count of Participants|252|252.0||||||
4109091|NCT00957593|3933389|B2||Between 18 and 65 years|Age||Participants|Count of Participants|125|125.0||||||
4109092|NCT00957593|3933390|B1||Between 18 and 65 years|Age||Participants|Count of Participants|127|127.0||||||
4109093|NCT00957593|3933388|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109094|NCT00957593|3933389|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109095|NCT00957593|3933390|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109096|NCT00957580|3933397|B4||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4109097|NCT00957580|3933398|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4109098|NCT00957580|3933399|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4109099|NCT00957580|3933400|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4109100|NCT00957580|3933397|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4109101|NCT00957580|3933398|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4109102|NCT00957580|3933399|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4109103|NCT00957580|3933400|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4109104|NCT00957580|3933397|B4|Greater than or equal to (>=) 75||Age, Customized||Subjects|Number|13|13.0||||||
4109105|NCT00957580|3933398|B3|Greater than or equal to (>=) 75||Age, Customized||Subjects|Number|3|3.0||||||
4109106|NCT00957580|3933399|B2|Greater than or equal to (>=) 75||Age, Customized||Subjects|Number|4|4.0||||||
4109107|NCT00957580|3933400|B1|Greater than or equal to (>=) 75||Age, Customized||Subjects|Number|6|6.0||||||
4109108|NCT00957580|3933397|B4|60 to <75||Age, Customized||Subjects|Number|35|35.0||||||
4109109|NCT00957580|3933398|B3|60 to <75||Age, Customized||Subjects|Number|6|6.0||||||
4109110|NCT00957580|3933399|B2|60 to <75||Age, Customized||Subjects|Number|16|16.0||||||
4109111|NCT00957580|3933400|B1|60 to <75||Age, Customized||Subjects|Number|13|13.0||||||
4109112|NCT00957580|3933397|B4|18 to less than (<) 60||Age, Customized||Subjects|Number|32|32.0||||||
4109113|NCT00957580|3933398|B3|18 to less than (<) 60||Age, Customized||Subjects|Number|6|6.0||||||
4109114|NCT00957580|3933399|B2|18 to less than (<) 60||Age, Customized||Subjects|Number|12|12.0||||||
4109115|NCT00957580|3933400|B1|18 to less than (<) 60||Age, Customized||Subjects|Number|14|14.0||||||
4109116|NCT00957528|3933546|B4|United States||Region of Enrollment||participants|Number|26|26.0||||||
4109117|NCT00957528|3933547|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4109118|NCT00957528|3933548|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4109119|NCT00957528|3933549|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4109120|NCT00957528|3933546|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4109121|NCT00957528|3933547|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4109122|NCT00957528|3933548|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4109123|NCT00957528|3933549|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4109124|NCT00957528|3933546|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4109125|NCT00957528|3933547|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4109126|NCT00957528|3933548|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4109127|NCT00957528|3933549|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4109128|NCT00957528|3933546|B4|||Age||years|Mean|70.1|70.1|Standard Deviation|6.18|6.18|||
4109129|NCT00957528|3933547|B3|||Age||years|Mean|73.3|73.3|Standard Deviation|7.54|7.54|||
4109130|NCT00957528|3933548|B2|||Age||years|Mean|71.6|71.6|Standard Deviation|7.78|7.78|||
4109131|NCT00957528|3933549|B1|||Age||years|Mean|65.4|65.4|Standard Deviation|3.22|3.22|||
4109132|NCT00957528|3933546|B4||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4109133|NCT00957528|3933547|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4109134|NCT00957528|3933548|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4109135|NCT00957528|3933549|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4109136|NCT00957528|3933546|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4109137|NCT00957528|3933547|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4109138|NCT00957528|3933548|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4109139|NCT00957528|3933549|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4109140|NCT00957528|3933546|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109141|NCT00957528|3933547|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109142|NCT00957528|3933548|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109143|NCT00957528|3933549|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109144|NCT00957424|3933574|B1|United States||Region of Enrollment||participants|Number|67|67.0||||||
4109145|NCT00957424|3933574|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4109146|NCT00957424|3933574|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4109147|NCT00957424|3933574|B1||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4109148|NCT00957424|3933574|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4109149|NCT00957424|3933574|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109150|NCT00957424|3933574|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109151|NCT00957424|3933574|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109152|NCT00957424|3933574|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4109153|NCT00957424|3933574|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4109154|NCT00957424|3933574|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4109155|NCT00957424|3933574|B1||Male|Gender||Participants|Count of Participants|32|32.0||||||
4109156|NCT00957424|3933574|B1||Female|Gender||Participants|Count of Participants|35|35.0||||||
4109157|NCT00957424|3933574|B1|||Age||years|Mean|46.7|46.7|Standard Deviation|9.59|9.59|||
4109158|NCT00957372|3933581|B4||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4109159|NCT00957372|3933582|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4109160|NCT00957372|3933583|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4109161|NCT00957372|3933584|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4109162|NCT00957372|3933581|B4||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4109163|NCT00957372|3933582|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4109164|NCT00957372|3933583|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4109165|NCT00957372|3933584|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4109166|NCT00957372|3933581|B4|>=65 years||Age, Customized||participants|Number|6|6.0||||||
4109167|NCT00957372|3933582|B3|>=65 years||Age, Customized||participants|Number|3|3.0||||||
4109168|NCT00957372|3933583|B2|>=65 years||Age, Customized||participants|Number|1|1.0||||||
4109169|NCT00957372|3933584|B1|>=65 years||Age, Customized||participants|Number|2|2.0||||||
4109170|NCT00957372|3933581|B4|Between 18 and 65 years||Age, Customized||participants|Number|241|241.0||||||
4109171|NCT00957372|3933582|B3|Between 18 and 65 years||Age, Customized||participants|Number|83|83.0||||||
4109172|NCT00957372|3933583|B2|Between 18 and 65 years||Age, Customized||participants|Number|82|82.0||||||
4109173|NCT00957372|3933584|B1|Between 18 and 65 years||Age, Customized||participants|Number|76|76.0||||||
4109174|NCT00957372|3933581|B4|<=18 years||Age, Customized||participants|Number|6|6.0||||||
4109175|NCT00957372|3933582|B3|<=18 years||Age, Customized||participants|Number|2|2.0||||||
4109176|NCT00957372|3933583|B2|<=18 years||Age, Customized||participants|Number|2|2.0||||||
4109177|NCT00957372|3933584|B1|<=18 years||Age, Customized||participants|Number|2|2.0||||||
4109178|NCT00957333|3933603|B1|Taiwan||Region of Enrollment||participants|Number|44|44.0||||||
4109179|NCT00957333|3933603|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4109180|NCT00957333|3933603|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4109181|NCT00957333|3933603|B1|||Age||years|Mean|28|28.0|Standard Deviation|6|6.0|||
4109182|NCT00957333|3933603|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4109183|NCT00957333|3933603|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4109184|NCT00957333|3933603|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109185|NCT00957268|3933607|B6|Ex-smoker||Smoking Status||participants|Number|8|8.0||||||
4109186|NCT00957268|3933608|B5|Ex-smoker||Smoking Status||participants|Number|8|8.0||||||
4109187|NCT00957268|3933609|B4|Ex-smoker||Smoking Status||participants|Number|0|0.0||||||
4109188|NCT00957268|3933610|B3|Ex-smoker||Smoking Status||participants|Number|0|0.0||||||
4109189|NCT00957268|3933611|B2|Ex-smoker||Smoking Status||participants|Number|0|0.0||||||
4109190|NCT00957268|3933612|B1|Ex-smoker||Smoking Status||participants|Number|0|0.0||||||
4109191|NCT00957268|3933607|B6|Current Smoker||Smoking Status||participants|Number|0|0.0||||||
4109192|NCT00957268|3933608|B5|Current Smoker||Smoking Status||participants|Number|0|0.0||||||
4109193|NCT00957268|3933609|B4|Current Smoker||Smoking Status||participants|Number|0|0.0||||||
4109194|NCT00957268|3933610|B3|Current Smoker||Smoking Status||participants|Number|0|0.0||||||
4109195|NCT00957268|3933611|B2|Current Smoker||Smoking Status||participants|Number|0|0.0||||||
4109196|NCT00957268|3933612|B1|Current Smoker||Smoking Status||participants|Number|0|0.0||||||
4109197|NCT00957268|3933607|B6|Never Smoked||Smoking Status||participants|Number|38|38.0||||||
4109198|NCT00957268|3933608|B5|Never Smoked||Smoking Status||participants|Number|14|14.0||||||
4109199|NCT00957268|3933609|B4|Never Smoked||Smoking Status||participants|Number|7|7.0||||||
4109200|NCT00957268|3933610|B3|Never Smoked||Smoking Status||participants|Number|8|8.0||||||
4109201|NCT00957268|3933611|B2|Never Smoked||Smoking Status||participants|Number|4|4.0||||||
4109202|NCT00957268|3933612|B1|Never Smoked||Smoking Status||participants|Number|5|5.0||||||
4109203|NCT00957268|3933607|B6|||Body Mass Index (BMI)||kg/m^2|Mean|35.01|35.01|Standard Deviation|6.439|6.439|||
4109204|NCT00957268|3933608|B5|||Body Mass Index (BMI)||kg/m^2|Mean|32.84|32.84|Standard Deviation|4.490|4.49|||
4109205|NCT00957268|3933609|B4|||Body Mass Index (BMI)||kg/m^2|Mean|36.46|36.46|Standard Deviation|6.764|6.764|||
4109206|NCT00957268|3933610|B3|||Body Mass Index (BMI)||kg/m^2|Mean|40.92|40.92|Standard Deviation|9.190|9.19|||
4109207|NCT00957268|3933611|B2|||Body Mass Index (BMI)||kg/m^2|Mean|36.16|36.16|Standard Deviation|3.422|3.422|||
4109208|NCT00957268|3933612|B1|||Body Mass Index (BMI)||kg/m^2|Mean|33.22|33.22|Standard Deviation|4.621|4.621|||
4109209|NCT00957268|3933607|B6|||Weight||kg|Mean|97.14|97.14|Standard Deviation|21.409|21.409|||
4109210|NCT00957268|3933608|B5|||Weight||kg|Mean|92.25|92.25|Standard Deviation|16.454|16.454|||
4109211|NCT00957268|3933609|B4|||Weight||kg|Mean|103.71|103.71|Standard Deviation|17.103|17.103|||
4109212|NCT00957268|3933610|B3|||Weight||kg|Mean|116.28|116.28|Standard Deviation|33.163|33.163|||
4109213|NCT00957268|3933611|B2|||Weight||kg|Mean|98.90|98.9|Standard Deviation|11.957|11.957|||
4109214|NCT00957268|3933612|B1|||Weight||kg|Mean|86.62|86.62|Standard Deviation|13.979|13.979|||
4109215|NCT00957268|3933607|B6|||Height||cm|Mean|167.2|167.2|Standard Deviation|8.73|8.73|||
4109216|NCT00957268|3933608|B5|||Height||cm|Mean|167.5|167.5|Standard Deviation|9.81|9.81|||
4109217|NCT00957268|3933609|B4|||Height||cm|Mean|168.9|168.9|Standard Deviation|9.03|9.03|||
4109218|NCT00957268|3933610|B3|||Height||cm|Mean|168.6|168.6|Standard Deviation|5.71|5.71|||
4109219|NCT00957268|3933611|B2|||Height||cm|Mean|165.8|165.8|Standard Deviation|8.88|8.88|||
4109220|NCT00957268|3933612|B1|||Height||cm|Mean|162.4|162.4|Standard Deviation|8.56|8.56|||
4109221|NCT00957268|3933607|B6|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4109222|NCT00957268|3933608|B5|White||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4109223|NCT00957268|3933609|B4|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4109224|NCT00957268|3933610|B3|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4109225|NCT00957268|3933611|B2|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4109226|NCT00957268|3933612|B1|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4109227|NCT00957268|3933607|B6|Asian Black or African American||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4109228|NCT00957268|3933608|B5|Asian Black or African American||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4109229|NCT00957268|3933609|B4|Asian Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4109230|NCT00957268|3933610|B3|Asian Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4109231|NCT00957268|3933611|B2|Asian Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4109232|NCT00957268|3933612|B1|Asian Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4109233|NCT00957268|3933607|B6|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4109234|NCT00957268|3933608|B5|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4109235|NCT00957268|3933609|B4|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4109236|NCT00957268|3933610|B3|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4109237|NCT00957268|3933611|B2|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4109238|NCT00957268|3933612|B1|Non-Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4109239|NCT00957268|3933607|B6|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4109240|NCT00957268|3933608|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4109241|NCT00957268|3933609|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4109242|NCT00957268|3933610|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4109243|NCT00957268|3933611|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4109244|NCT00957268|3933612|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4109245|NCT00957268|3933607|B6||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4109246|NCT00957268|3933608|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4109247|NCT00957268|3933609|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4109248|NCT00957268|3933610|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4109249|NCT00957268|3933611|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4109250|NCT00957268|3933612|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4109251|NCT00957268|3933607|B6||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4109252|NCT00957268|3933608|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4109253|NCT00957268|3933609|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4109254|NCT00957268|3933610|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4109255|NCT00957268|3933611|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4109256|NCT00957268|3933612|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4109257|NCT00957268|3933607|B6|||Age||years|Mean|31.96|31.96|Standard Deviation|19.67|19.67|||
4109258|NCT00957268|3933608|B5|||Age||years|Mean|51.3|51.3|Standard Deviation|8.24|8.24|||
4109259|NCT00957268|3933609|B4|||Age||years|Mean|15.1|15.1|Standard Deviation|0.69|0.69|||
4109260|NCT00957268|3933610|B3|||Age||years|Mean|15.4|15.4|Standard Deviation|0.92|0.92|||
4109261|NCT00957268|3933611|B2|||Age||years|Mean|12.0|12.0|Standard Deviation|0.82|0.82|||
4109262|NCT00957268|3933612|B1|||Age||years|Mean|12.4|12.4|Standard Deviation|0.89|0.89|||
4109263|NCT00957242|3933678|B3|United States||Region of Enrollment||participants|Number|145|145.0||||||
4109264|NCT00957242|3933679|B2|United States||Region of Enrollment||participants|Number|72|72.0||||||
4109265|NCT00957242|3933680|B1|United States||Region of Enrollment||participants|Number|73|73.0||||||
4109266|NCT00957242|3933678|B3||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4109267|NCT00957242|3933679|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4109268|NCT00957242|3933680|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4109269|NCT00957242|3933678|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4109270|NCT00957242|3933679|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4109271|NCT00957242|3933680|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4109272|NCT00957242|3933678|B3|||Age||years|Mean|67|67.0|Standard Deviation|7.3|7.3|||
4109273|NCT00957242|3933679|B2|||Age||years|Mean|67.3|67.3|Standard Deviation|7.1|7.1|||
4109274|NCT00957242|3933680|B1|||Age||years|Mean|66.7|66.7|Standard Deviation|7.4|7.4|||
4109275|NCT00957242|3933678|B3||>=65 years|Age||Participants|Count of Participants|92|92.0||||||
4109276|NCT00957242|3933679|B2||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
4109277|NCT00957242|3933680|B1||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
4109278|NCT00957242|3933678|B3||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4109279|NCT00957242|3933679|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4109280|NCT00957242|3933680|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4109281|NCT00957242|3933678|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109282|NCT00957242|3933679|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109283|NCT00957242|3933680|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109284|NCT00957047|3933709|B5||Male|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4109285|NCT00957047|3933710|B4||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4109286|NCT00957047|3933711|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4109287|NCT00957047|3933712|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4109288|NCT00957047|3933713|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4109289|NCT00957047|3933709|B5||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4109290|NCT00957047|3933710|B4||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4109291|NCT00957047|3933711|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4109292|NCT00957047|3933712|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4109293|NCT00957047|3933713|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4109294|NCT00957047|3933709|B5||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4109295|NCT00957047|3933710|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4109296|NCT00957047|3933711|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4109297|NCT00957047|3933712|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4109298|NCT00957047|3933713|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4109299|NCT00957047|3933709|B5||Between 18 and 65 years|Age||Participants|Count of Participants|393|393.0||||||
4109300|NCT00957047|3933710|B4||Between 18 and 65 years|Age||Participants|Count of Participants|98|98.0||||||
4109301|NCT00957047|3933711|B3||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
4109302|NCT00957047|3933712|B2||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
4109303|NCT00957047|3933713|B1||Between 18 and 65 years|Age||Participants|Count of Participants|98|98.0||||||
4109304|NCT00957047|3933709|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109305|NCT00957047|3933710|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109306|NCT00957047|3933711|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109307|NCT00957047|3933712|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109308|NCT00957047|3933713|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109309|NCT00957034|3933735|B4|United States||Region of Enrollment||participants|Number|17|17.0||||||
4109310|NCT00957034|3933736|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4109311|NCT00957034|3933737|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4109312|NCT00957034|3933738|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4109313|NCT00957034|3933735|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4109314|NCT00957034|3933736|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4109315|NCT00957034|3933737|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4109316|NCT00957034|3933738|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4109317|NCT00957034|3933735|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4109318|NCT00957034|3933736|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4109319|NCT00957034|3933737|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4109320|NCT00957034|3933738|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4109321|NCT00957034|3933735|B4|||Age||years|Mean|71.8|71.8|Standard Deviation|7.2|7.2|||
4109322|NCT00957034|3933736|B3|||Age||years|Mean|74.3|74.3|Standard Deviation|9.0|9.0|||
4109323|NCT00957034|3933737|B2|||Age||years|Mean|69.8|69.8|Standard Deviation|5.0|5.0|||
4109324|NCT00957034|3933738|B1|||Age||years|Mean|70.3|70.3|Standard Deviation|6.2|6.2|||
4109325|NCT00957021|3933763|B1|United States||Region of Enrollment||participants|Number|351|351.0||||||
4109326|NCT00957021|3933763|B1||Male|Gender||Participants|Count of Participants|151|151.0||||||
4109327|NCT00957021|3933763|B1||Female|Gender||Participants|Count of Participants|200|200.0||||||
4109328|NCT00957021|3933763|B1|||Age|"For bilateral total knee replacement participants, the age at the time of the initial knee replacement surgery is used.~3 participants did not have demographic data which would allow calculation of age; these participants did not receive the Triathlon® PS Total Knee System and are part of the surgery cancelled participant flow category."|years|Mean|65.12|65.12|Standard Deviation|8.59|8.59|||
4109329|NCT00957008|3933772|B5|United States||Region of Enrollment||participants|Number|197|197.0||||||
4109330|NCT00957008|3933773|B4|United States||Region of Enrollment||participants|Number|50|50.0||||||
4109331|NCT00957008|3933774|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
4109332|NCT00957008|3933775|B2|United States||Region of Enrollment||participants|Number|49|49.0||||||
4109333|NCT00957008|3933776|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
4109334|NCT00957008|3933772|B5||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4109335|NCT00957008|3933773|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4109336|NCT00957008|3933774|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4109337|NCT00957008|3933775|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4109338|NCT00957008|3933776|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4109339|NCT00957008|3933772|B5||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4109340|NCT00957008|3933773|B4||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4109341|NCT00957008|3933774|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4109342|NCT00957008|3933775|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4109343|NCT00957008|3933776|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4109344|NCT00957008|3933772|B5|||Age||years|Mean|46.9|46.9|Standard Deviation|10.8|10.8|||
4109345|NCT00957008|3933773|B4|||Age||years|Mean|47.2|47.2|Standard Deviation|8.9|8.9|||
4109346|NCT00957008|3933774|B3|||Age||years|Mean|47.7|47.7|Standard Deviation|11.6|11.6|||
4109347|NCT00957008|3933775|B2|||Age||years|Mean|45.7|45.7|Standard Deviation|10.4|10.4|||
4109348|NCT00957008|3933776|B1|||Age||years|Mean|46.8|46.8|Standard Deviation|12.4|12.4|||
4109349|NCT00957008|3933772|B5||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4109350|NCT00957008|3933773|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4109351|NCT00957008|3933774|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4109352|NCT00957008|3933775|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4109353|NCT00957008|3933776|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4109354|NCT00957008|3933772|B5||Between 18 and 65 years|Age||Participants|Count of Participants|194|194.0||||||
4109355|NCT00957008|3933773|B4||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4109356|NCT00957008|3933774|B3||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4109357|NCT00957008|3933775|B2||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4109358|NCT00957008|3933776|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4109359|NCT00957008|3933772|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109360|NCT00957008|3933773|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109361|NCT00957008|3933774|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109362|NCT00957008|3933775|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109363|NCT00957008|3933776|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109364|NCT00956943|3933805|B3|United States||Region of Enrollment||participants|Number|87|87.0||||||
4109365|NCT00956943|3933806|B2|United States||Region of Enrollment||participants|Number|44|44.0||||||
4109366|NCT00956943|3933807|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4109367|NCT00956943|3933805|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4109368|NCT00956943|3933806|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4109369|NCT00956943|3933807|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4109370|NCT00956943|3933805|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4109371|NCT00956943|3933806|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4109372|NCT00956943|3933807|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4109373|NCT00956943|3933805|B3|||Age||years|Mean|38|38.0|Standard Deviation|9|9.0|||
4109374|NCT00956943|3933806|B2|||Age||years|Mean|38.8|38.8|Standard Deviation|9.0|9.0|||
4109375|NCT00956943|3933807|B1|||Age||years|Mean|37.1|37.1|Standard Deviation|9.0|9.0|||
4109376|NCT00956943|3933805|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4109377|NCT00956943|3933806|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4109378|NCT00956943|3933807|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4109379|NCT00956943|3933805|B3||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
4109380|NCT00956943|3933806|B2||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4109381|NCT00956943|3933807|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4109382|NCT00956943|3933805|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109383|NCT00956943|3933806|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109384|NCT00956943|3933807|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109385|NCT00956839|3933816|B4|India||Region of Enrollment||participants|Number|40|40.0||||||
4109386|NCT00956839|3933817|B3|India||Region of Enrollment||participants|Number|13|13.0||||||
4109387|NCT00956839|3933818|B2|India||Region of Enrollment||participants|Number|13|13.0||||||
4109388|NCT00956839|3933819|B1|India||Region of Enrollment||participants|Number|14|14.0||||||
4109389|NCT00956839|3933816|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4109390|NCT00956839|3933817|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4109391|NCT00956839|3933818|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4109392|NCT00956839|3933819|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4109393|NCT00956839|3933816|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4109394|NCT00956839|3933817|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4109395|NCT00956839|3933818|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4109396|NCT00956839|3933819|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4109397|NCT00956839|3933816|B4|||Age||years|Mean|33|33.0|Standard Deviation|9|9.0|||
4109398|NCT00956839|3933817|B3|||Age||years|Mean|34.3|34.3|Standard Deviation|9.2|9.2|||
4109399|NCT00956839|3933818|B2|||Age||years|Mean|33.9|33.9|Standard Deviation|10.6|10.6|||
4109400|NCT00956839|3933819|B1|||Age||years|Mean|30.3|30.3|Standard Deviation|8.9|8.9|||
4109401|NCT00956839|3933816|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4109402|NCT00956839|3933817|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4109403|NCT00956839|3933818|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4109404|NCT00956839|3933819|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4109405|NCT00956839|3933816|B4||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4109406|NCT00956839|3933817|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4109407|NCT00956839|3933818|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4109408|NCT00956839|3933819|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4109409|NCT00956839|3933816|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109410|NCT00956839|3933817|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109411|NCT00956839|3933818|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109412|NCT00956839|3933819|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109413|NCT00956813|3933832|B3|United States||Region of Enrollment||participants|Number|210|210.0||||||
4109414|NCT00956813|3933833|B2|United States||Region of Enrollment||participants|Number|105|105.0||||||
4109415|NCT00956813|3933834|B1|United States||Region of Enrollment||participants|Number|105|105.0||||||
4109416|NCT00956813|3933832|B3|Optional Flaxseed Continuation|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4109417|NCT00956813|3933833|B2|Optional Flaxseed Continuation|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4109418|NCT00956813|3933834|B1|Optional Flaxseed Continuation|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4109419|NCT00956813|3933832|B3|Optional Flaxseed Continuation|Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4109420|NCT00956813|3933833|B2|Optional Flaxseed Continuation|Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4109421|NCT00956813|3933834|B1|Optional Flaxseed Continuation|Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4109422|NCT00956813|3933832|B3|Flaxseed and Placebo Period|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4109423|NCT00956813|3933833|B2|Flaxseed and Placebo Period|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4109424|NCT00956813|3933834|B1|Flaxseed and Placebo Period|Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4109425|NCT00956813|3933832|B3|Flaxseed and Placebo Period|Female|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4109426|NCT00956813|3933833|B2|Flaxseed and Placebo Period|Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4109427|NCT00956813|3933834|B1|Flaxseed and Placebo Period|Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4109428|NCT00956813|3933832|B3|Optional Flaxseed Continuation|>=50|Age, Customized||Participants|Count of Participants|55|55.0||||||
4109429|NCT00956813|3933834|B1|Optional Flaxseed Continuation|>=50|Age, Customized||Participants|Count of Participants|55|55.0||||||
4109430|NCT00956813|3933832|B3|Optional Flaxseed Continuation|<50|Age, Customized||Participants|Count of Participants|25|25.0||||||
4109431|NCT00956813|3933834|B1|Optional Flaxseed Continuation|<50|Age, Customized||Participants|Count of Participants|25|25.0||||||
4109432|NCT00956813|3933832|B3|Flaxseed and Placebo Period|>=50|Age, Customized||Participants|Count of Participants|161|161.0||||||
4109433|NCT00956813|3933833|B2|Flaxseed and Placebo Period|>=50|Age, Customized||Participants|Count of Participants|81|81.0||||||
4109434|NCT00956813|3933834|B1|Flaxseed and Placebo Period|>=50|Age, Customized||Participants|Count of Participants|80|80.0||||||
4109435|NCT00956813|3933832|B3|Flaxseed and Placebo Period|<50|Age, Customized||Participants|Count of Participants|49|49.0||||||
4109436|NCT00956813|3933833|B2|Flaxseed and Placebo Period|<50|Age, Customized||Participants|Count of Participants|24|24.0||||||
4109437|NCT00956813|3933834|B1|Flaxseed and Placebo Period|<50|Age, Customized||Participants|Count of Participants|25|25.0||||||
4109438|NCT00956761|3933850|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4109439|NCT00956761|3933850|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4109440|NCT00956761|3933850|B1|||Age||Years|Mean|72.9|72.9|Standard Deviation|6.0|6.0|||
4109441|NCT00956709|3933857|B3|France||Region of Enrollment||participants|Number|35|35.0||||||
4109442|NCT00956709|3933858|B2|France||Region of Enrollment||participants|Number|19|19.0||||||
4109443|NCT00956709|3933859|B1|France||Region of Enrollment||participants|Number|16|16.0||||||
4109444|NCT00956709|3933857|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4109445|NCT00956709|3933858|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4109446|NCT00956709|3933859|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4109447|NCT00956709|3933857|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4109448|NCT00956709|3933858|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4109449|NCT00956709|3933859|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4109450|NCT00956709|3933857|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4109451|NCT00956709|3933858|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4109452|NCT00956709|3933859|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4109453|NCT00956709|3933857|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4109454|NCT00956709|3933858|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4109455|NCT00956709|3933859|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4109456|NCT00956709|3933857|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109457|NCT00956709|3933858|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109458|NCT00956709|3933859|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109459|NCT00956709|3933857|B3|||Age||years|Median|62|62.0|Full Range|||35.0|83.0|
4109460|NCT00956709|3933858|B2|||Age||years|Median|62|62.0|Full Range|||35.0|75.0|
4109461|NCT00956709|3933859|B1|||Age||years|Median|62|62.0|Full Range|||36.0|83.0|
4109462|NCT00956657|3933870|B3|United Kingdom||Region of Enrollment||participants|Number|31|31.0||||||
4109463|NCT00956657|3933871|B2|United Kingdom||Region of Enrollment||participants|Number|13|13.0||||||
4109464|NCT00956657|3933872|B1|United Kingdom||Region of Enrollment||participants|Number|18|18.0||||||
4109465|NCT00956657|3933870|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4109466|NCT00956657|3933871|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4109467|NCT00956657|3933872|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4109468|NCT00956657|3933870|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4109469|NCT00956657|3933871|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4109470|NCT00956657|3933872|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4109471|NCT00956657|3933870|B3|||Age||years|Mean|62|62.0|Standard Deviation|9.9|9.9|||
4109472|NCT00956657|3933871|B2|||Age||years|Mean|61|61.0|Standard Deviation|10.6|10.6|||
4109473|NCT00956657|3933872|B1|||Age||years|Mean|63|63.0|Standard Deviation|9.6|9.6|||
4109474|NCT00956657|3933870|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4109475|NCT00956657|3933871|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4109476|NCT00956657|3933872|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4109477|NCT00956657|3933870|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4109478|NCT00956657|3933871|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4109479|NCT00956657|3933872|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4109480|NCT00956657|3933870|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109481|NCT00956657|3933871|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109482|NCT00956657|3933872|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109483|NCT00956631|3933879|B1|United States||Region of Enrollment||participants|Number|78|78.0||||||
4109484|NCT00956631|3933879|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4109485|NCT00956631|3933879|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4109486|NCT00956631|3933879|B1|||Age||years|Mean|70|70.0|Standard Deviation|11|11.0|||
4109487|NCT00956631|3933879|B1||>=65 years|Age||Participants|Count of Participants|55|55.0||||||
4109488|NCT00956631|3933879|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4109489|NCT00956631|3933879|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109490|NCT00956592|3933885|B3|United States||Region of Enrollment||participants|Number|300|300.0||||||
4109491|NCT00956592|3933886|B2|United States||Region of Enrollment||participants|Number|150|150.0||||||
4109492|NCT00956592|3933887|B1|United States||Region of Enrollment||participants|Number|150|150.0||||||
4109493|NCT00956592|3933885|B3||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4109494|NCT00956592|3933886|B2||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4109495|NCT00956592|3933887|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4109496|NCT00956592|3933885|B3||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4109497|NCT00956592|3933886|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4109498|NCT00956592|3933887|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4109499|NCT00956592|3933885|B3|||Age||years|Mean|54.6|54.6|Standard Deviation|14.5|14.5|||
4109500|NCT00956592|3933886|B2|||Age||years|Mean|55.4|55.4|Standard Deviation|14.5|14.5|||
4109501|NCT00956592|3933887|B1|||Age||years|Mean|53.8|53.8|Standard Deviation|14.2|14.2|||
4109502|NCT00956592|3933885|B3||>=65 years|Age||Participants|Count of Participants|64|64.0||||||
4109503|NCT00956592|3933886|B2||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4109504|NCT00956592|3933887|B1||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4109505|NCT00956592|3933885|B3||Between 18 and 65 years|Age||Participants|Count of Participants|236|236.0||||||
4109506|NCT00956592|3933886|B2||Between 18 and 65 years|Age||Participants|Count of Participants|114|114.0||||||
4109507|NCT00956592|3933887|B1||Between 18 and 65 years|Age||Participants|Count of Participants|122|122.0||||||
4109508|NCT00956592|3933885|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109509|NCT00956592|3933886|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109510|NCT00956592|3933887|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109511|NCT00956540|3933904|B5|Spain||Region of Enrollment||participants|Number|195|195.0||||||
4109512|NCT00956540|3933905|B4|Spain||Region of Enrollment||participants|Number|45|45.0||||||
4109513|NCT00956540|3933906|B3|Spain||Region of Enrollment||participants|Number|46|46.0||||||
4109514|NCT00956540|3933907|B2|Spain||Region of Enrollment||participants|Number|50|50.0||||||
4109515|NCT00956540|3933908|B1|Spain||Region of Enrollment||participants|Number|54|54.0||||||
4109516|NCT00956540|3933904|B5||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4109517|NCT00956540|3933905|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4109518|NCT00956540|3933906|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4109519|NCT00956540|3933907|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4109520|NCT00956540|3933908|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4109521|NCT00956540|3933904|B5||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4109522|NCT00956540|3933905|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4109523|NCT00956540|3933906|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4109524|NCT00956540|3933907|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4109525|NCT00956540|3933908|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4109526|NCT00956540|3933904|B5|||Age||years|Mean|57|57.0|Standard Deviation|17|17.0|||
4109527|NCT00956540|3933905|B4|||Age||years|Mean|58|58.0|Standard Deviation|19|19.0|||
4109528|NCT00956540|3933906|B3|||Age||years|Mean|56|56.0|Standard Deviation|16|16.0|||
4109529|NCT00956540|3933907|B2|||Age||years|Mean|58|58.0|Standard Deviation|19|19.0|||
4109530|NCT00956540|3933908|B1|||Age||years|Mean|56|56.0|Standard Deviation|16|16.0|||
4109531|NCT00956540|3933904|B5||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4109532|NCT00956540|3933905|B4||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4109533|NCT00956540|3933906|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4109534|NCT00956540|3933907|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4109535|NCT00956540|3933908|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4109536|NCT00956540|3933904|B5||Between 18 and 65 years|Age||Participants|Count of Participants|159|159.0||||||
4109537|NCT00956540|3933905|B4||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4109538|NCT00956540|3933906|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4109539|NCT00956540|3933907|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4109540|NCT00956540|3933908|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4109541|NCT00956540|3933904|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109542|NCT00956540|3933905|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109543|NCT00956540|3933906|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109544|NCT00956540|3933907|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109545|NCT00956540|3933908|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109546|NCT00956293|3933921|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4109547|NCT00956293|3933922|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4109548|NCT00956293|3933923|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4109549|NCT00956293|3933921|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4109550|NCT00956293|3933922|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4109551|NCT00956293|3933923|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4109552|NCT00956293|3933921|B3|||Age||Years|Mean|68.7|68.7|Standard Deviation|3.3|3.3|||
4109553|NCT00956293|3933922|B2|||Age||Years|Mean|68.4|68.4|Standard Deviation|3.3|3.3|||
4109554|NCT00956293|3933923|B1|||Age||Years|Mean|69.3|69.3|Standard Deviation|3.1|3.1|||
4109555|NCT00956254|3933949|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4109556|NCT00956254|3933949|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4109557|NCT00956254|3933949|B1|||Age||years|Mean|46.6|46.6|Standard Deviation|12.1|12.1|||
4109558|NCT00956085|3933959|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109559|NCT00956085|3933959|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109560|NCT00956085|3933959|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4109561|NCT00956085|3933959|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4109562|NCT00956085|3933959|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109563|NCT00956085|3933959|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4109564|NCT00956085|3933959|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109565|NCT00956085|3933959|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109566|NCT00956085|3933959|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4109567|NCT00956085|3933959|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4109568|NCT00956085|3933959|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4109569|NCT00956085|3933959|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4109570|NCT00956085|3933959|B1|||Age||years|Mean|34|34.0|Standard Deviation|9|9.0|||
4109571|NCT00956020|3933963|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4109572|NCT00956020|3933963|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4109573|NCT00956020|3933963|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4109574|NCT00956020|3933963|B1|||Age||years|Mean|44|44.0|Standard Deviation|8|8.0|||
4109575|NCT00956020|3933963|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4109576|NCT00956020|3933963|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4109577|NCT00956020|3933963|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109578|NCT00955968|3933978|B3|>=100000 copies/ml||Plasma HIV Viral Load||Participants|Count of Participants|1|1.0||||||
4109579|NCT00955968|3933979|B2|>=100000 copies/ml||Plasma HIV Viral Load||Participants|Count of Participants|0|0.0||||||
4109580|NCT00955968|3933980|B1|>=100000 copies/ml||Plasma HIV Viral Load||Participants|Count of Participants|1|1.0||||||
4109581|NCT00955968|3933978|B3|10000-<100000 copies/ml||Plasma HIV Viral Load||Participants|Count of Participants|39|39.0||||||
4109582|NCT00955968|3933979|B2|10000-<100000 copies/ml||Plasma HIV Viral Load||Participants|Count of Participants|24|24.0||||||
4109583|NCT00955968|3933980|B1|10000-<100000 copies/ml||Plasma HIV Viral Load||Participants|Count of Participants|15|15.0||||||
4109584|NCT00955968|3933978|B3|1000- <10000 copies/ml||Plasma HIV Viral Load||Participants|Count of Participants|61|61.0||||||
4109585|NCT00955968|3933979|B2|1000- <10000 copies/ml||Plasma HIV Viral Load||Participants|Count of Participants|29|29.0||||||
4109586|NCT00955968|3933980|B1|1000- <10000 copies/ml||Plasma HIV Viral Load||Participants|Count of Participants|32|32.0||||||
4109587|NCT00955968|3933978|B3|400 - <1000 copies/ml||Plasma HIV Viral Load||Participants|Count of Participants|54|54.0||||||
4109588|NCT00955968|3933979|B2|400 - <1000 copies/ml||Plasma HIV Viral Load||Participants|Count of Participants|24|24.0||||||
4109589|NCT00955968|3933980|B1|400 - <1000 copies/ml||Plasma HIV Viral Load||Participants|Count of Participants|30|30.0||||||
4109590|NCT00955968|3933978|B3|< 400 copies/ml||Plasma HIV Viral Load||Participants|Count of Participants|1486|1486.0||||||
4109591|NCT00955968|3933979|B2|< 400 copies/ml||Plasma HIV Viral Load||Participants|Count of Participants|742|742.0||||||
4109592|NCT00955968|3933980|B1|< 400 copies/ml||Plasma HIV Viral Load||Participants|Count of Participants|744|744.0||||||
4109593|NCT00955968|3933978|B3|||Pre-ART CD4+ cell count||cells/mm^3|Median|549|549.0|Inter-Quartile Range|||462.0|680.0|
4109594|NCT00955968|3933979|B2|||Pre-ART CD4+ cell count||cells/mm^3|Median|548|548.0|Inter-Quartile Range|||463.0|677.0|
4109595|NCT00955968|3933980|B1|||Pre-ART CD4+ cell count||cells/mm^3|Median|550|550.0|Inter-Quartile Range|||461.0|682.0|
4109596|NCT00955968|3933978|B3|||CD4+ cell count on ART|CD4+ cell count was evaluated at screening|cells/mm^3|Median|696|696.0|Inter-Quartile Range|||575.0|869.0|
4109597|NCT00955968|3933979|B2|||CD4+ cell count on ART|CD4+ cell count was evaluated at screening|cells/mm^3|Median|695|695.0|Inter-Quartile Range|||575.0|868.0|
4109598|NCT00955968|3933980|B1|||CD4+ cell count on ART|CD4+ cell count was evaluated at screening|cells/mm^3|Median|696|696.0|Inter-Quartile Range|||575.0|870.0|
4109599|NCT00955968|3933978|B3|Not obtained, Hep B antibody +ve||Hepatitis B surface antibody||Participants|Count of Participants|286|286.0||||||
4109600|NCT00955968|3933979|B2|Not obtained, Hep B antibody +ve||Hepatitis B surface antibody||Participants|Count of Participants|148|148.0||||||
4109601|NCT00955968|3933980|B1|Not obtained, Hep B antibody +ve||Hepatitis B surface antibody||Participants|Count of Participants|138|138.0||||||
4109602|NCT00955968|3933978|B3|Indeterminate||Hepatitis B surface antibody||Participants|Count of Participants|3|3.0||||||
4109603|NCT00955968|3933979|B2|Indeterminate||Hepatitis B surface antibody||Participants|Count of Participants|2|2.0||||||
4109604|NCT00955968|3933980|B1|Indeterminate||Hepatitis B surface antibody||Participants|Count of Participants|1|1.0||||||
4109605|NCT00955968|3933978|B3|Negative||Hepatitis B surface antibody||Participants|Count of Participants|849|849.0||||||
4109606|NCT00955968|3933979|B2|Negative||Hepatitis B surface antibody||Participants|Count of Participants|425|425.0||||||
4109607|NCT00955968|3933980|B1|Negative||Hepatitis B surface antibody||Participants|Count of Participants|424|424.0||||||
4109608|NCT00955968|3933978|B3|Positive||Hepatitis B surface antibody||Participants|Count of Participants|511|511.0||||||
4109609|NCT00955968|3933979|B2|Positive||Hepatitis B surface antibody||Participants|Count of Participants|248|248.0||||||
4109610|NCT00955968|3933980|B1|Positive||Hepatitis B surface antibody||Participants|Count of Participants|263|263.0||||||
4109611|NCT00955968|3933978|B3|Not obtained, Hep B antibody +ve||Hepatitis B surface antigen||Participants|Count of Participants|43|43.0||||||
4109612|NCT00955968|3933979|B2|Not obtained, Hep B antibody +ve||Hepatitis B surface antigen||Participants|Count of Participants|23|23.0||||||
4109613|NCT00955968|3933980|B1|Not obtained, Hep B antibody +ve||Hepatitis B surface antigen||Participants|Count of Participants|20|20.0||||||
4109614|NCT00955968|3933978|B3|Indeterminate||Hepatitis B surface antigen||Participants|Count of Participants|1|1.0||||||
4109615|NCT00955968|3933979|B2|Indeterminate||Hepatitis B surface antigen||Participants|Count of Participants|0|0.0||||||
4109616|NCT00955968|3933980|B1|Indeterminate||Hepatitis B surface antigen||Participants|Count of Participants|1|1.0||||||
4109617|NCT00955968|3933978|B3|Negative||Hepatitis B surface antigen||Participants|Count of Participants|1539|1539.0||||||
4109618|NCT00955968|3933979|B2|Negative||Hepatitis B surface antigen||Participants|Count of Participants|768|768.0||||||
4109619|NCT00955968|3933980|B1|Negative||Hepatitis B surface antigen||Participants|Count of Participants|771|771.0||||||
4109620|NCT00955968|3933978|B3|Positive||Hepatitis B surface antigen||Participants|Count of Participants|57|57.0||||||
4109621|NCT00955968|3933979|B2|Positive||Hepatitis B surface antigen||Participants|Count of Participants|28|28.0||||||
4109622|NCT00955968|3933980|B1|Positive||Hepatitis B surface antigen||Participants|Count of Participants|29|29.0||||||
4109623|NCT00955968|3933978|B3|HAART including PI and II||ART regimen prior to entry|PI - Protease Inhibitor, NNRTI - Non Nucleoside Reverse Transcriptase Inhibitor, EFV - Efavirenz, NVP - Nevirapine, RPV - Rilpivirine, NRTI - Nucleoside Reverse Transcriptase Inhibitor, II - Integrase Inhibitor|Participants|Count of Participants|2|2.0||||||
4109624|NCT00955968|3933979|B2|HAART including PI and II||ART regimen prior to entry|PI - Protease Inhibitor, NNRTI - Non Nucleoside Reverse Transcriptase Inhibitor, EFV - Efavirenz, NVP - Nevirapine, RPV - Rilpivirine, NRTI - Nucleoside Reverse Transcriptase Inhibitor, II - Integrase Inhibitor|Participants|Count of Participants|0|0.0||||||
4109625|NCT00955968|3933980|B1|HAART including PI and II||ART regimen prior to entry|PI - Protease Inhibitor, NNRTI - Non Nucleoside Reverse Transcriptase Inhibitor, EFV - Efavirenz, NVP - Nevirapine, RPV - Rilpivirine, NRTI - Nucleoside Reverse Transcriptase Inhibitor, II - Integrase Inhibitor|Participants|Count of Participants|2|2.0||||||
4109626|NCT00955968|3933978|B3|HAART including II||ART regimen prior to entry|PI - Protease Inhibitor, NNRTI - Non Nucleoside Reverse Transcriptase Inhibitor, EFV - Efavirenz, NVP - Nevirapine, RPV - Rilpivirine, NRTI - Nucleoside Reverse Transcriptase Inhibitor, II - Integrase Inhibitor|Participants|Count of Participants|8|8.0||||||
4109627|NCT00955968|3933979|B2|HAART including II||ART regimen prior to entry|PI - Protease Inhibitor, NNRTI - Non Nucleoside Reverse Transcriptase Inhibitor, EFV - Efavirenz, NVP - Nevirapine, RPV - Rilpivirine, NRTI - Nucleoside Reverse Transcriptase Inhibitor, II - Integrase Inhibitor|Participants|Count of Participants|4|4.0||||||
4109628|NCT00955968|3933980|B1|HAART including II||ART regimen prior to entry|PI - Protease Inhibitor, NNRTI - Non Nucleoside Reverse Transcriptase Inhibitor, EFV - Efavirenz, NVP - Nevirapine, RPV - Rilpivirine, NRTI - Nucleoside Reverse Transcriptase Inhibitor, II - Integrase Inhibitor|Participants|Count of Participants|4|4.0||||||
4109629|NCT00955968|3933978|B3|Zero NRTIs||ART regimen prior to entry|PI - Protease Inhibitor, NNRTI - Non Nucleoside Reverse Transcriptase Inhibitor, EFV - Efavirenz, NVP - Nevirapine, RPV - Rilpivirine, NRTI - Nucleoside Reverse Transcriptase Inhibitor, II - Integrase Inhibitor|Participants|Count of Participants|1|1.0||||||
4109630|NCT00955968|3933979|B2|Zero NRTIs||ART regimen prior to entry|PI - Protease Inhibitor, NNRTI - Non Nucleoside Reverse Transcriptase Inhibitor, EFV - Efavirenz, NVP - Nevirapine, RPV - Rilpivirine, NRTI - Nucleoside Reverse Transcriptase Inhibitor, II - Integrase Inhibitor|Participants|Count of Participants|1|1.0||||||
4109631|NCT00955968|3933980|B1|Zero NRTIs||ART regimen prior to entry|PI - Protease Inhibitor, NNRTI - Non Nucleoside Reverse Transcriptase Inhibitor, EFV - Efavirenz, NVP - Nevirapine, RPV - Rilpivirine, NRTI - Nucleoside Reverse Transcriptase Inhibitor, II - Integrase Inhibitor|Participants|Count of Participants|0|0.0||||||
4109632|NCT00955968|3933978|B3|Three or more NRTIs||ART regimen prior to entry|PI - Protease Inhibitor, NNRTI - Non Nucleoside Reverse Transcriptase Inhibitor, EFV - Efavirenz, NVP - Nevirapine, RPV - Rilpivirine, NRTI - Nucleoside Reverse Transcriptase Inhibitor, II - Integrase Inhibitor|Participants|Count of Participants|14|14.0||||||
4109633|NCT00955968|3933979|B2|Three or more NRTIs||ART regimen prior to entry|PI - Protease Inhibitor, NNRTI - Non Nucleoside Reverse Transcriptase Inhibitor, EFV - Efavirenz, NVP - Nevirapine, RPV - Rilpivirine, NRTI - Nucleoside Reverse Transcriptase Inhibitor, II - Integrase Inhibitor|Participants|Count of Participants|11|11.0||||||
4109634|NCT00955968|3933980|B1|Three or more NRTIs||ART regimen prior to entry|PI - Protease Inhibitor, NNRTI - Non Nucleoside Reverse Transcriptase Inhibitor, EFV - Efavirenz, NVP - Nevirapine, RPV - Rilpivirine, NRTI - Nucleoside Reverse Transcriptase Inhibitor, II - Integrase Inhibitor|Participants|Count of Participants|3|3.0||||||
4109635|NCT00955968|3933978|B3|HAART including NNRTI and PI||ART regimen prior to entry|PI - Protease Inhibitor, NNRTI - Non Nucleoside Reverse Transcriptase Inhibitor, EFV - Efavirenz, NVP - Nevirapine, RPV - Rilpivirine, NRTI - Nucleoside Reverse Transcriptase Inhibitor, II - Integrase Inhibitor|Participants|Count of Participants|1|1.0||||||
4109636|NCT00955968|3933979|B2|HAART including NNRTI and PI||ART regimen prior to entry|PI - Protease Inhibitor, NNRTI - Non Nucleoside Reverse Transcriptase Inhibitor, EFV - Efavirenz, NVP - Nevirapine, RPV - Rilpivirine, NRTI - Nucleoside Reverse Transcriptase Inhibitor, II - Integrase Inhibitor|Participants|Count of Participants|0|0.0||||||
4109637|NCT00955968|3933980|B1|HAART including NNRTI and PI||ART regimen prior to entry|PI - Protease Inhibitor, NNRTI - Non Nucleoside Reverse Transcriptase Inhibitor, EFV - Efavirenz, NVP - Nevirapine, RPV - Rilpivirine, NRTI - Nucleoside Reverse Transcriptase Inhibitor, II - Integrase Inhibitor|Participants|Count of Participants|1|1.0||||||
4109638|NCT00955968|3933978|B3|HAART including NNRTI [RPV]||ART regimen prior to entry|PI - Protease Inhibitor, NNRTI - Non Nucleoside Reverse Transcriptase Inhibitor, EFV - Efavirenz, NVP - Nevirapine, RPV - Rilpivirine, NRTI - Nucleoside Reverse Transcriptase Inhibitor, II - Integrase Inhibitor|Participants|Count of Participants|2|2.0||||||
4109639|NCT00955968|3933979|B2|HAART including NNRTI [RPV]||ART regimen prior to entry|PI - Protease Inhibitor, NNRTI - Non Nucleoside Reverse Transcriptase Inhibitor, EFV - Efavirenz, NVP - Nevirapine, RPV - Rilpivirine, NRTI - Nucleoside Reverse Transcriptase Inhibitor, II - Integrase Inhibitor|Participants|Count of Participants|1|1.0||||||
4109640|NCT00955968|3933980|B1|HAART including NNRTI [RPV]||ART regimen prior to entry|PI - Protease Inhibitor, NNRTI - Non Nucleoside Reverse Transcriptase Inhibitor, EFV - Efavirenz, NVP - Nevirapine, RPV - Rilpivirine, NRTI - Nucleoside Reverse Transcriptase Inhibitor, II - Integrase Inhibitor|Participants|Count of Participants|1|1.0||||||
4109641|NCT00955968|3933978|B3|HAART including NNRTI [NVP]||ART regimen prior to entry|PI - Protease Inhibitor, NNRTI - Non Nucleoside Reverse Transcriptase Inhibitor, EFV - Efavirenz, NVP - Nevirapine, RPV - Rilpivirine, NRTI - Nucleoside Reverse Transcriptase Inhibitor, II - Integrase Inhibitor|Participants|Count of Participants|12|12.0||||||
4109642|NCT00955968|3933979|B2|HAART including NNRTI [NVP]||ART regimen prior to entry|PI - Protease Inhibitor, NNRTI - Non Nucleoside Reverse Transcriptase Inhibitor, EFV - Efavirenz, NVP - Nevirapine, RPV - Rilpivirine, NRTI - Nucleoside Reverse Transcriptase Inhibitor, II - Integrase Inhibitor|Participants|Count of Participants|8|8.0||||||
4109643|NCT00955968|3933980|B1|HAART including NNRTI [NVP]||ART regimen prior to entry|PI - Protease Inhibitor, NNRTI - Non Nucleoside Reverse Transcriptase Inhibitor, EFV - Efavirenz, NVP - Nevirapine, RPV - Rilpivirine, NRTI - Nucleoside Reverse Transcriptase Inhibitor, II - Integrase Inhibitor|Participants|Count of Participants|4|4.0||||||
4109776|NCT00955955|3934016|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109644|NCT00955968|3933978|B3|HAART including NNRTI [EFV]||ART regimen prior to entry|PI - Protease Inhibitor, NNRTI - Non Nucleoside Reverse Transcriptase Inhibitor, EFV - Efavirenz, NVP - Nevirapine, RPV - Rilpivirine, NRTI - Nucleoside Reverse Transcriptase Inhibitor, II - Integrase Inhibitor|Participants|Count of Participants|352|352.0||||||
4109645|NCT00955968|3933979|B2|HAART including NNRTI [EFV]||ART regimen prior to entry|PI - Protease Inhibitor, NNRTI - Non Nucleoside Reverse Transcriptase Inhibitor, EFV - Efavirenz, NVP - Nevirapine, RPV - Rilpivirine, NRTI - Nucleoside Reverse Transcriptase Inhibitor, II - Integrase Inhibitor|Participants|Count of Participants|172|172.0||||||
4109646|NCT00955968|3933980|B1|HAART including NNRTI [EFV]||ART regimen prior to entry|PI - Protease Inhibitor, NNRTI - Non Nucleoside Reverse Transcriptase Inhibitor, EFV - Efavirenz, NVP - Nevirapine, RPV - Rilpivirine, NRTI - Nucleoside Reverse Transcriptase Inhibitor, II - Integrase Inhibitor|Participants|Count of Participants|180|180.0||||||
4109647|NCT00955968|3933978|B3|HAART including non-boosted PI||ART regimen prior to entry|PI - Protease Inhibitor, NNRTI - Non Nucleoside Reverse Transcriptase Inhibitor, EFV - Efavirenz, NVP - Nevirapine, RPV - Rilpivirine, NRTI - Nucleoside Reverse Transcriptase Inhibitor, II - Integrase Inhibitor|Participants|Count of Participants|28|28.0||||||
4109648|NCT00955968|3933979|B2|HAART including non-boosted PI||ART regimen prior to entry|PI - Protease Inhibitor, NNRTI - Non Nucleoside Reverse Transcriptase Inhibitor, EFV - Efavirenz, NVP - Nevirapine, RPV - Rilpivirine, NRTI - Nucleoside Reverse Transcriptase Inhibitor, II - Integrase Inhibitor|Participants|Count of Participants|16|16.0||||||
4109649|NCT00955968|3933980|B1|HAART including non-boosted PI||ART regimen prior to entry|PI - Protease Inhibitor, NNRTI - Non Nucleoside Reverse Transcriptase Inhibitor, EFV - Efavirenz, NVP - Nevirapine, RPV - Rilpivirine, NRTI - Nucleoside Reverse Transcriptase Inhibitor, II - Integrase Inhibitor|Participants|Count of Participants|12|12.0||||||
4109650|NCT00955968|3933978|B3|HAART including boosted PI||ART regimen prior to entry|PI - Protease Inhibitor, NNRTI - Non Nucleoside Reverse Transcriptase Inhibitor, EFV - Efavirenz, NVP - Nevirapine, RPV - Rilpivirine, NRTI - Nucleoside Reverse Transcriptase Inhibitor, II - Integrase Inhibitor|Participants|Count of Participants|1241|1241.0||||||
4109651|NCT00955968|3933979|B2|HAART including boosted PI||ART regimen prior to entry|PI - Protease Inhibitor, NNRTI - Non Nucleoside Reverse Transcriptase Inhibitor, EFV - Efavirenz, NVP - Nevirapine, RPV - Rilpivirine, NRTI - Nucleoside Reverse Transcriptase Inhibitor, II - Integrase Inhibitor|Participants|Count of Participants|612|612.0||||||
4109652|NCT00955968|3933980|B1|HAART including boosted PI||ART regimen prior to entry|PI - Protease Inhibitor, NNRTI - Non Nucleoside Reverse Transcriptase Inhibitor, EFV - Efavirenz, NVP - Nevirapine, RPV - Rilpivirine, NRTI - Nucleoside Reverse Transcriptase Inhibitor, II - Integrase Inhibitor|Participants|Count of Participants|629|629.0||||||
4109653|NCT00955968|3933978|B3|||Duration of Antiretroviral therapy (ART) prior to study entry||weeks|Median|17|17.0|Inter-Quartile Range|||11.0|23.0|
4109654|NCT00955968|3933979|B2|||Duration of Antiretroviral therapy (ART) prior to study entry||weeks|Median|17|17.0|Inter-Quartile Range|||11.0|23.0|
4109655|NCT00955968|3933980|B1|||Duration of Antiretroviral therapy (ART) prior to study entry||weeks|Median|17|17.0|Inter-Quartile Range|||11.0|23.0|
4109656|NCT00955968|3933978|B3||Clinical Stage III|WHO stage at entry|Clinical staging of HIV/AIDS by WHO definitions (WHO, 2007). Staging is based on clinical findings that guide the diagnosis, evaluation, and management of HIV/AIDS. Clinical stages are categorized as 1 through 4, progressing from primary HIV infection to advanced HIV/AIDS. These stages are defined by specific clinical conditions or symptoms as described in the reference (see the References in the Protocol Section).|Participants|Count of Participants|2|2.0||||||
4109657|NCT00955968|3933979|B2||Clinical Stage III|WHO stage at entry|Clinical staging of HIV/AIDS by WHO definitions (WHO, 2007). Staging is based on clinical findings that guide the diagnosis, evaluation, and management of HIV/AIDS. Clinical stages are categorized as 1 through 4, progressing from primary HIV infection to advanced HIV/AIDS. These stages are defined by specific clinical conditions or symptoms as described in the reference (see the References in the Protocol Section).|Participants|Count of Participants|1|1.0||||||
4109658|NCT00955968|3933980|B1||Clinical Stage III|WHO stage at entry|Clinical staging of HIV/AIDS by WHO definitions (WHO, 2007). Staging is based on clinical findings that guide the diagnosis, evaluation, and management of HIV/AIDS. Clinical stages are categorized as 1 through 4, progressing from primary HIV infection to advanced HIV/AIDS. These stages are defined by specific clinical conditions or symptoms as described in the reference (see the References in the Protocol Section).|Participants|Count of Participants|1|1.0||||||
4109659|NCT00955968|3933978|B3||Clinical Stage II|WHO stage at entry|Clinical staging of HIV/AIDS by WHO definitions (WHO, 2007). Staging is based on clinical findings that guide the diagnosis, evaluation, and management of HIV/AIDS. Clinical stages are categorized as 1 through 4, progressing from primary HIV infection to advanced HIV/AIDS. These stages are defined by specific clinical conditions or symptoms as described in the reference (see the References in the Protocol Section).|Participants|Count of Participants|27|27.0||||||
4109660|NCT00955968|3933979|B2||Clinical Stage II|WHO stage at entry|Clinical staging of HIV/AIDS by WHO definitions (WHO, 2007). Staging is based on clinical findings that guide the diagnosis, evaluation, and management of HIV/AIDS. Clinical stages are categorized as 1 through 4, progressing from primary HIV infection to advanced HIV/AIDS. These stages are defined by specific clinical conditions or symptoms as described in the reference (see the References in the Protocol Section).|Participants|Count of Participants|11|11.0||||||
4109661|NCT00955968|3933980|B1||Clinical Stage II|WHO stage at entry|Clinical staging of HIV/AIDS by WHO definitions (WHO, 2007). Staging is based on clinical findings that guide the diagnosis, evaluation, and management of HIV/AIDS. Clinical stages are categorized as 1 through 4, progressing from primary HIV infection to advanced HIV/AIDS. These stages are defined by specific clinical conditions or symptoms as described in the reference (see the References in the Protocol Section).|Participants|Count of Participants|16|16.0||||||
4109662|NCT00955968|3933978|B3||Clinical Stage I|WHO stage at entry|Clinical staging of HIV/AIDS by WHO definitions (WHO, 2007). Staging is based on clinical findings that guide the diagnosis, evaluation, and management of HIV/AIDS. Clinical stages are categorized as 1 through 4, progressing from primary HIV infection to advanced HIV/AIDS. These stages are defined by specific clinical conditions or symptoms as described in the reference (see the References in the Protocol Section).|Participants|Count of Participants|1621|1621.0||||||
4109714|NCT00955968|3933979|B2|Thailand||Region of Enrollment||Participants|Count of Participants|151|151.0||||||
4109663|NCT00955968|3933979|B2||Clinical Stage I|WHO stage at entry|Clinical staging of HIV/AIDS by WHO definitions (WHO, 2007). Staging is based on clinical findings that guide the diagnosis, evaluation, and management of HIV/AIDS. Clinical stages are categorized as 1 through 4, progressing from primary HIV infection to advanced HIV/AIDS. These stages are defined by specific clinical conditions or symptoms as described in the reference (see the References in the Protocol Section).|Participants|Count of Participants|811|811.0||||||
4109664|NCT00955968|3933980|B1||Clinical Stage I|WHO stage at entry|Clinical staging of HIV/AIDS by WHO definitions (WHO, 2007). Staging is based on clinical findings that guide the diagnosis, evaluation, and management of HIV/AIDS. Clinical stages are categorized as 1 through 4, progressing from primary HIV infection to advanced HIV/AIDS. These stages are defined by specific clinical conditions or symptoms as described in the reference (see the References in the Protocol Section).|Participants|Count of Participants|810|810.0||||||
4109665|NCT00955968|3933978|B3|||Body Mass Index (BMI)||kg/m^2|Median|24.5|24.5|Inter-Quartile Range|||21.8|28.1|
4109666|NCT00955968|3933979|B2|||Body Mass Index (BMI)||kg/m^2|Median|24.6|24.6|Inter-Quartile Range|||21.8|28.3|
4109667|NCT00955968|3933980|B1|||Body Mass Index (BMI)||kg/m^2|Median|24.4|24.4|Inter-Quartile Range|||21.7|28.0|
4109668|NCT00955968|3933978|B3||Race not available to clinic|Race/Ethnicity||Participants|Count of Participants|30|30.0||||||
4109669|NCT00955968|3933979|B2||Race not available to clinic|Race/Ethnicity||Participants|Count of Participants|16|16.0||||||
4109670|NCT00955968|3933980|B1||Race not available to clinic|Race/Ethnicity||Participants|Count of Participants|14|14.0||||||
4109671|NCT00955968|3933978|B3||Subject does not know|Race/Ethnicity||Participants|Count of Participants|6|6.0||||||
4109672|NCT00955968|3933979|B2||Subject does not know|Race/Ethnicity||Participants|Count of Participants|2|2.0||||||
4109673|NCT00955968|3933980|B1||Subject does not know|Race/Ethnicity||Participants|Count of Participants|4|4.0||||||
4109674|NCT00955968|3933978|B3||Other|Race/Ethnicity||Participants|Count of Participants|62|62.0||||||
4109675|NCT00955968|3933979|B2||Other|Race/Ethnicity||Participants|Count of Participants|31|31.0||||||
4109676|NCT00955968|3933980|B1||Other|Race/Ethnicity||Participants|Count of Participants|31|31.0||||||
4109677|NCT00955968|3933978|B3||Native (native Brazilian-Xavante/Kaigang/Guarani)|Race/Ethnicity||Participants|Count of Participants|2|2.0||||||
4109678|NCT00955968|3933979|B2||Native (native Brazilian-Xavante/Kaigang/Guarani)|Race/Ethnicity||Participants|Count of Participants|1|1.0||||||
4109679|NCT00955968|3933980|B1||Native (native Brazilian-Xavante/Kaigang/Guarani)|Race/Ethnicity||Participants|Count of Participants|1|1.0||||||
4109680|NCT00955968|3933978|B3||Mixed native|Race/Ethnicity||Participants|Count of Participants|4|4.0||||||
4109681|NCT00955968|3933979|B2||Mixed native|Race/Ethnicity||Participants|Count of Participants|4|4.0||||||
4109682|NCT00955968|3933980|B1||Mixed native|Race/Ethnicity||Participants|Count of Participants|0|0.0||||||
4109683|NCT00955968|3933978|B3||Mixed Black|Race/Ethnicity||Participants|Count of Participants|149|149.0||||||
4109684|NCT00955968|3933979|B2||Mixed Black|Race/Ethnicity||Participants|Count of Participants|76|76.0||||||
4109685|NCT00955968|3933980|B1||Mixed Black|Race/Ethnicity||Participants|Count of Participants|73|73.0||||||
4109686|NCT00955968|3933978|B3||Mestizo|Race/Ethnicity||Participants|Count of Participants|14|14.0||||||
4109687|NCT00955968|3933979|B2||Mestizo|Race/Ethnicity||Participants|Count of Participants|8|8.0||||||
4109688|NCT00955968|3933980|B1||Mestizo|Race/Ethnicity||Participants|Count of Participants|6|6.0||||||
4109689|NCT00955968|3933978|B3||Black of African origin|Race/Ethnicity||Participants|Count of Participants|147|147.0||||||
4109690|NCT00955968|3933979|B2||Black of African origin|Race/Ethnicity||Participants|Count of Participants|70|70.0||||||
4109691|NCT00955968|3933980|B1||Black of African origin|Race/Ethnicity||Participants|Count of Participants|77|77.0||||||
4109692|NCT00955968|3933978|B3||Black African|Race/Ethnicity||Participants|Count of Participants|457|457.0||||||
4109693|NCT00955968|3933979|B2||Black African|Race/Ethnicity||Participants|Count of Participants|227|227.0||||||
4109694|NCT00955968|3933980|B1||Black African|Race/Ethnicity||Participants|Count of Participants|230|230.0||||||
4109695|NCT00955968|3933978|B3||Alaskan Native|Race/Ethnicity||Participants|Count of Participants|1|1.0||||||
4109696|NCT00955968|3933979|B2||Alaskan Native|Race/Ethnicity||Participants|Count of Participants|1|1.0||||||
4109697|NCT00955968|3933980|B1||Alaskan Native|Race/Ethnicity||Participants|Count of Participants|0|0.0||||||
4109698|NCT00955968|3933978|B3||American Indian|Race/Ethnicity||Participants|Count of Participants|2|2.0||||||
4109699|NCT00955968|3933979|B2||American Indian|Race/Ethnicity||Participants|Count of Participants|1|1.0||||||
4109700|NCT00955968|3933980|B1||American Indian|Race/Ethnicity||Participants|Count of Participants|1|1.0||||||
4109701|NCT00955968|3933978|B3||White|Race/Ethnicity||Participants|Count of Participants|250|250.0||||||
4109702|NCT00955968|3933979|B2||White|Race/Ethnicity||Participants|Count of Participants|127|127.0||||||
4109703|NCT00955968|3933980|B1||White|Race/Ethnicity||Participants|Count of Participants|123|123.0||||||
4109704|NCT00955968|3933978|B3||Black or African American|Race/Ethnicity||Participants|Count of Participants|116|116.0||||||
4109705|NCT00955968|3933979|B2||Black or African American|Race/Ethnicity||Participants|Count of Participants|58|58.0||||||
4109706|NCT00955968|3933980|B1||Black or African American|Race/Ethnicity||Participants|Count of Participants|58|58.0||||||
4109707|NCT00955968|3933978|B3||Asian|Race/Ethnicity||Participants|Count of Participants|412|412.0||||||
4109708|NCT00955968|3933979|B2||Asian|Race/Ethnicity||Participants|Count of Participants|203|203.0||||||
4109709|NCT00955968|3933980|B1||Asian|Race/Ethnicity||Participants|Count of Participants|209|209.0||||||
4109710|NCT00955968|3933978|B3|Peru||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4109711|NCT00955968|3933979|B2|Peru||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4109712|NCT00955968|3933980|B1|Peru||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4109713|NCT00955968|3933978|B3|Thailand||Region of Enrollment||Participants|Count of Participants|307|307.0||||||
4109715|NCT00955968|3933980|B1|Thailand||Region of Enrollment||Participants|Count of Participants|156|156.0||||||
4109716|NCT00955968|3933978|B3|Brazil||Region of Enrollment||Participants|Count of Participants|514|514.0||||||
4109717|NCT00955968|3933979|B2|Brazil||Region of Enrollment||Participants|Count of Participants|255|255.0||||||
4109718|NCT00955968|3933980|B1|Brazil||Region of Enrollment||Participants|Count of Participants|259|259.0||||||
4109719|NCT00955968|3933978|B3|China||Region of Enrollment||Participants|Count of Participants|104|104.0||||||
4109720|NCT00955968|3933979|B2|China||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
4109721|NCT00955968|3933980|B1|China||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
4109722|NCT00955968|3933978|B3|Botswana||Region of Enrollment||Participants|Count of Participants|457|457.0||||||
4109723|NCT00955968|3933979|B2|Botswana||Region of Enrollment||Participants|Count of Participants|227|227.0||||||
4109724|NCT00955968|3933980|B1|Botswana||Region of Enrollment||Participants|Count of Participants|230|230.0||||||
4109725|NCT00955968|3933978|B3|United States||Region of Enrollment||Participants|Count of Participants|149|149.0||||||
4109726|NCT00955968|3933979|B2|United States||Region of Enrollment||Participants|Count of Participants|77|77.0||||||
4109727|NCT00955968|3933980|B1|United States||Region of Enrollment||Participants|Count of Participants|72|72.0||||||
4109728|NCT00955968|3933978|B3|Argentina||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
4109729|NCT00955968|3933979|B2|Argentina||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4109730|NCT00955968|3933980|B1|Argentina||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4109731|NCT00955968|3933978|B3|Haiti||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
4109732|NCT00955968|3933979|B2|Haiti||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
4109733|NCT00955968|3933980|B1|Haiti||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
4109734|NCT00955968|3933978|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4109735|NCT00955968|3933979|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4109736|NCT00955968|3933980|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4109737|NCT00955968|3933978|B3||Female|Sex: Female, Male||Participants|Count of Participants|1652|1652.0||||||
4109738|NCT00955968|3933979|B2||Female|Sex: Female, Male||Participants|Count of Participants|825|825.0||||||
4109739|NCT00955968|3933980|B1||Female|Sex: Female, Male||Participants|Count of Participants|827|827.0||||||
4109740|NCT00955968|3933978|B3|||Age||years|Median|28|28.0|Inter-Quartile Range|||23.0|32.0|
4109741|NCT00955968|3933979|B2|||Age||years|Median|28|28.0|Inter-Quartile Range|||24.0|32.0|
4109742|NCT00955968|3933980|B1|||Age||years|Median|27|27.0|Inter-Quartile Range|||23.0|32.0|
4109743|NCT00955968|3933978|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4109744|NCT00955968|3933979|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4109745|NCT00955968|3933980|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4109746|NCT00955968|3933978|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1616|1616.0||||||
4109747|NCT00955968|3933979|B2||Between 18 and 65 years|Age||Participants|Count of Participants|807|807.0||||||
4109748|NCT00955968|3933980|B1||Between 18 and 65 years|Age||Participants|Count of Participants|809|809.0||||||
4109749|NCT00955968|3933978|B3||<=18 years|Age||Participants|Count of Participants|36|36.0||||||
4109750|NCT00955968|3933979|B2||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
4109751|NCT00955968|3933980|B1||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
4109752|NCT00955955|3934016|B4|United States||Region of Enrollment||participants|Number|75|75.0||||||
4109753|NCT00955955|3934017|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
4109754|NCT00955955|3934018|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4109755|NCT00955955|3934019|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4109756|NCT00955955|3934016|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4109757|NCT00955955|3934017|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4109758|NCT00955955|3934018|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4109759|NCT00955955|3934019|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4109760|NCT00955955|3934016|B4||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4109761|NCT00955955|3934017|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4109762|NCT00955955|3934018|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4109763|NCT00955955|3934019|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4109764|NCT00955955|3934016|B4|||Age||years|Mean|48.49|48.49|Standard Deviation|12.17|12.17|||
4109765|NCT00955955|3934017|B3|||Age||years|Mean|45.39|45.39|Standard Deviation|11.60|11.6|||
4109766|NCT00955955|3934018|B2|||Age||years|Mean|50.86|50.86|Standard Deviation|10.58|10.58|||
4109767|NCT00955955|3934019|B1|||Age||years|Mean|49.58|49.58|Standard Deviation|14.64|14.64|||
4109768|NCT00955955|3934016|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4109769|NCT00955955|3934017|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4109770|NCT00955955|3934018|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4109771|NCT00955955|3934019|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4109772|NCT00955955|3934016|B4||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
4109773|NCT00955955|3934017|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4109774|NCT00955955|3934018|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4109775|NCT00955955|3934019|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4109777|NCT00955955|3934017|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109778|NCT00955955|3934018|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109779|NCT00955955|3934019|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109780|NCT00955916|3934035|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4109781|NCT00955916|3934035|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4109782|NCT00955916|3934035|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4109783|NCT00955916|3934035|B1|||Age||years|Median|62|62.0|Full Range|||26.0|79.0|
4109784|NCT00955916|3934035|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4109785|NCT00955916|3934035|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4109786|NCT00955916|3934035|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109787|NCT00955903|3934041|B4|United States||Region of Enrollment||participants|Number|164|164.0||||||
4109788|NCT00955903|3934042|B3|United States||Region of Enrollment||participants|Number|55|55.0||||||
4109789|NCT00955903|3934043|B2|United States||Region of Enrollment||participants|Number|54|54.0||||||
4109790|NCT00955903|3934044|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4109791|NCT00955903|3934041|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109792|NCT00955903|3934042|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109793|NCT00955903|3934043|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109794|NCT00955903|3934044|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109795|NCT00955903|3934041|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109796|NCT00955903|3934042|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109797|NCT00955903|3934043|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109798|NCT00955903|3934044|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109799|NCT00955903|3934041|B4||White|Race (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
4109800|NCT00955903|3934042|B3||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4109801|NCT00955903|3934043|B2||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4109802|NCT00955903|3934044|B1||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4109803|NCT00955903|3934041|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4109804|NCT00955903|3934042|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4109805|NCT00955903|3934043|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4109806|NCT00955903|3934044|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4109807|NCT00955903|3934041|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109808|NCT00955903|3934042|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109809|NCT00955903|3934043|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109810|NCT00955903|3934044|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109811|NCT00955903|3934041|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4109812|NCT00955903|3934042|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109813|NCT00955903|3934043|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109814|NCT00955903|3934044|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4109815|NCT00955903|3934041|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109816|NCT00955903|3934042|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109817|NCT00955903|3934043|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109818|NCT00955903|3934044|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109819|NCT00955903|3934041|B4||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4109820|NCT00955903|3934042|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4109821|NCT00955903|3934043|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4109822|NCT00955903|3934044|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4109823|NCT00955903|3934041|B4||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4109824|NCT00955903|3934042|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4109825|NCT00955903|3934043|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4109826|NCT00955903|3934044|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4109827|NCT00955903|3934041|B4|||Age||years|Mean|70.3|70.3|Standard Deviation|4.7|4.7|||
4109828|NCT00955903|3934042|B3|||Age||years|Mean|70.5|70.5|Standard Deviation|4.8|4.8|||
4109829|NCT00955903|3934043|B2|||Age||years|Mean|69.9|69.9|Standard Deviation|4.5|4.5|||
4109830|NCT00955903|3934044|B1|||Age||years|Mean|70.3|70.3|Standard Deviation|4.8|4.8|||
4109831|NCT00955877|3934060|B4|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4109832|NCT00955877|3934061|B3|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4109833|NCT00955877|3934063|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4109834|NCT00955877|3934060|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4109835|NCT00955877|3934061|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4109836|NCT00955877|3934062|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4109837|NCT00955877|3934063|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4109838|NCT00955877|3934060|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4109839|NCT00955877|3934061|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4109840|NCT00955877|3934062|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4109841|NCT00955877|3934063|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4109842|NCT00955877|3934060|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4109843|NCT00955877|3934061|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4109844|NCT00955877|3934062|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4109845|NCT00955877|3934063|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4109846|NCT00955877|3934060|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4109847|NCT00955877|3934061|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4109848|NCT00955877|3934062|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4109849|NCT00955877|3934063|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4109850|NCT00955877|3934060|B4||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4109851|NCT00955877|3934061|B3||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4109852|NCT00955877|3934062|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109853|NCT00955877|3934063|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4109854|NCT00955825|3934103|B3||Male|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4109855|NCT00955825|3934104|B2||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4109856|NCT00955825|3934105|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4109857|NCT00955825|3934103|B3||Female|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
4109858|NCT00955825|3934104|B2||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4109859|NCT00955825|3934105|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4109860|NCT00955825|3934103|B3|||Age||years|Mean|37.2|37.2|Standard Deviation|11.46|11.46|||
4109861|NCT00955825|3934104|B2|||Age||years|Mean|37.6|37.6|Standard Deviation|11.64|11.64|||
4109862|NCT00955825|3934105|B1|||Age||years|Mean|36.8|36.8|Standard Deviation|11.27|11.27|||
4109863|NCT00955747|3934112|B3|India||Region of Enrollment||participants|Number|256|256.0||||||
4109864|NCT00955747|3934113|B2|India||Region of Enrollment||participants|Number|120|120.0||||||
4109865|NCT00955747|3934114|B1|India||Region of Enrollment||participants|Number|136|136.0||||||
4109866|NCT00955747|3934112|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
4109867|NCT00955747|3934113|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
4109868|NCT00955747|3934114|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4109869|NCT00955747|3934112|B3||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4109870|NCT00955747|3934113|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4109871|NCT00955747|3934114|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4109872|NCT00955747|3934112|B3||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4109873|NCT00955747|3934113|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4109874|NCT00955747|3934114|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4109875|NCT00955747|3934112|B3|||Age||years|Mean|51.7|51.7|Standard Deviation|10.4|10.4|||
4109876|NCT00955747|3934113|B2|||Age||years|Mean|51.7|51.7|Standard Deviation|9.7|9.7|||
4109877|NCT00955747|3934114|B1|||Age||years|Mean|51.6|51.6|Standard Deviation|11.0|11.0|||
4109878|NCT00955747|3934112|B3||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
4109879|NCT00955747|3934113|B2||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4109880|NCT00955747|3934114|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4109881|NCT00955747|3934112|B3||Between 18 and 65 years|Age||Participants|Count of Participants|312|312.0||||||
4109882|NCT00955747|3934113|B2||Between 18 and 65 years|Age||Participants|Count of Participants|152|152.0||||||
4109883|NCT00955747|3934114|B1||Between 18 and 65 years|Age||Participants|Count of Participants|160|160.0||||||
4109884|NCT00955747|3934112|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109885|NCT00955747|3934113|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109886|NCT00955747|3934114|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109887|NCT00955721|3934121|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4109888|NCT00955721|3934123|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4109889|NCT00955721|3934121|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4109890|NCT00955721|3934123|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4109891|NCT00955721|3934121|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4109892|NCT00955721|3934123|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4109893|NCT00955721|3934121|B3|||Age||years|Mean|67.4|67.4|Full Range|||59.0|74.0|
4109894|NCT00955721|3934123|B1|||Age||years|Mean|67.4|67.4|Full Range|||59.0|74.0|
4109895|NCT00955721|3934121|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4109896|NCT00955721|3934123|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4109897|NCT00955721|3934121|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4109898|NCT00955721|3934123|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4109899|NCT00955721|3934121|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109900|NCT00955721|3934123|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109901|NCT00955617|3934134|B1|Germany||Region of Enrollment||participants|Number|20|20.0||||||
4109902|NCT00955617|3934134|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4109903|NCT00955617|3934134|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4109904|NCT00955617|3934134|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|8.1|8.1|||
4109905|NCT00955617|3934134|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4109906|NCT00955617|3934134|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4109907|NCT00955617|3934134|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109908|NCT00955513|3934145|B4|Germany||Region of Enrollment||participants|Number|242|242.0||||||
4109909|NCT00955513|3934146|B3|Germany||Region of Enrollment||participants|Number|82|82.0||||||
4109910|NCT00955513|3934147|B2|Germany||Region of Enrollment||participants|Number|80|80.0||||||
4109911|NCT00955513|3934148|B1|Germany||Region of Enrollment||participants|Number|80|80.0||||||
4109912|NCT00955513|3934145|B4||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4109913|NCT00955513|3934146|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4109914|NCT00955513|3934147|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4109915|NCT00955513|3934148|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4109916|NCT00955513|3934145|B4||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4109917|NCT00955513|3934146|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4109918|NCT00955513|3934147|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4109919|NCT00955513|3934148|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4109920|NCT00955513|3934145|B4|||Age||years|Mean|32.4|32.4|Standard Deviation|12.7|12.7|||
4109921|NCT00955513|3934146|B3|||Age||years|Mean|34.0|34.0|Standard Deviation|12.9|12.9|||
4109922|NCT00955513|3934147|B2|||Age||years|Mean|32.2|32.2|Standard Deviation|13.7|13.7|||
4109923|NCT00955513|3934148|B1|||Age||years|Mean|30.9|30.9|Standard Deviation|11.4|11.4|||
4109924|NCT00955513|3934145|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4109925|NCT00955513|3934146|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4109926|NCT00955513|3934147|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4109927|NCT00955513|3934148|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4109928|NCT00955513|3934145|B4||Between 18 and 65 years|Age||Participants|Count of Participants|238|238.0||||||
4109929|NCT00955513|3934146|B3||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
4109930|NCT00955513|3934147|B2||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
4109931|NCT00955513|3934148|B1||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4109932|NCT00955513|3934145|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109933|NCT00955513|3934146|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109934|NCT00955513|3934147|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109935|NCT00955513|3934148|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4109936|NCT00955487|3934158|B3|United States||Region of Enrollment||Participants|Count of Participants|124|124.0||||||
4109937|NCT00955487|3934159|B2|United States||Region of Enrollment||Participants|Count of Participants|65|65.0||||||
4109938|NCT00955487|3934160|B1|United States||Region of Enrollment||Participants|Count of Participants|59|59.0||||||
4109939|NCT00955487|3934158|B3|Other||Race/Ethnicity, Customized|Mother's race/ethnic group|Participants|Count of Participants|9|9.0||||||
4109940|NCT00955487|3934159|B2|Other||Race/Ethnicity, Customized|Mother's race/ethnic group|Participants|Count of Participants|6|6.0||||||
4109941|NCT00955487|3934160|B1|Other||Race/Ethnicity, Customized|Mother's race/ethnic group|Participants|Count of Participants|3|3.0||||||
4109942|NCT00955487|3934158|B3|Black||Race/Ethnicity, Customized|Mother's race/ethnic group|Participants|Count of Participants|19|19.0||||||
4109943|NCT00955487|3934159|B2|Black||Race/Ethnicity, Customized|Mother's race/ethnic group|Participants|Count of Participants|11|11.0||||||
4109944|NCT00955487|3934160|B1|Black||Race/Ethnicity, Customized|Mother's race/ethnic group|Participants|Count of Participants|8|8.0||||||
4109945|NCT00955487|3934158|B3|White||Race/Ethnicity, Customized|Mother's race/ethnic group|Participants|Count of Participants|96|96.0||||||
4109946|NCT00955487|3934159|B2|White||Race/Ethnicity, Customized|Mother's race/ethnic group|Participants|Count of Participants|48|48.0||||||
4109947|NCT00955487|3934160|B1|White||Race/Ethnicity, Customized|Mother's race/ethnic group|Participants|Count of Participants|48|48.0||||||
4109948|NCT00955487|3934158|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4109949|NCT00955487|3934159|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4109950|NCT00955487|3934160|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4109951|NCT00955487|3934158|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4109952|NCT00955487|3934159|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4109953|NCT00955487|3934160|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4109954|NCT00955487|3934158|B3|Gestational Age at Baseline||Age, Customized||Weeks|Mean|27.4|27.4|Standard Deviation|1.7|1.7|||
4109955|NCT00955487|3934159|B2|Gestational Age at Baseline||Age, Customized||Weeks|Mean|27.3|27.3|Standard Deviation|1.8|1.8|||
4109956|NCT00955487|3934160|B1|Gestational Age at Baseline||Age, Customized||Weeks|Mean|27.5|27.5|Standard Deviation|1.6|1.6|||
4109957|NCT00955474|3934197|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4109958|NCT00955474|3934198|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4109959|NCT00955474|3934199|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4109960|NCT00955474|3934197|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4109961|NCT00955474|3934198|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109962|NCT00955474|3934199|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4109963|NCT00955474|3934197|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109964|NCT00955474|3934198|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109965|NCT00955474|3934199|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109966|NCT00955474|3934197|B3||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4109967|NCT00955474|3934198|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4109968|NCT00955474|3934199|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4109969|NCT00955474|3934197|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4109970|NCT00955474|3934198|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4109971|NCT00955474|3934199|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109972|NCT00955474|3934197|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109973|NCT00955474|3934198|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109974|NCT00955474|3934199|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109975|NCT00955474|3934197|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4109976|NCT00955474|3934198|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4109977|NCT00955474|3934199|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109978|NCT00955474|3934197|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109979|NCT00955474|3934198|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109980|NCT00955474|3934199|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109981|NCT00955474|3934197|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4109982|NCT00955474|3934198|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4109983|NCT00955474|3934199|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4109984|NCT00955474|3934197|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4109985|NCT00955474|3934198|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4109986|NCT00955474|3934199|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4109987|NCT00955474|3934197|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4109988|NCT00955474|3934198|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4109989|NCT00955474|3934199|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4109990|NCT00955474|3934197|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4109991|NCT00955474|3934198|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4109992|NCT00955474|3934199|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4109993|NCT00955474|3934197|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4109994|NCT00955474|3934198|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4109995|NCT00955474|3934199|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4109996|NCT00955474|3934197|B3|||Age||years|Mean|40.32|40.32|Full Range|||21.0|62.0|
4109997|NCT00955474|3934198|B2|||Age||years|Mean|42.85|42.85|Full Range|||21.0|62.0|
4109998|NCT00955474|3934199|B1|||Age||years|Mean|39.25|39.25|Full Range|||25.0|58.0|
4109999|NCT00955474|3934197|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4110000|NCT00955474|3934198|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4110001|NCT00955474|3934199|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4110002|NCT00955474|3934197|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4110003|NCT00955474|3934198|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4110004|NCT00955474|3934199|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4110005|NCT00955474|3934197|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4110006|NCT00955474|3934198|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4110007|NCT00955474|3934199|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4110008|NCT00955357|3934234|B3|||BMI||kilogram per m^2|Median|25.4|25.4|Full Range|||14.5|53.9|
4110009|NCT00955357|3934235|B2|||BMI||kilogram per m^2|Median|25.5|25.5|Full Range|||17.3|53.9|
4110010|NCT00955357|3934236|B1|||BMI||kilogram per m^2|Median|25.3|25.3|Full Range|||14.5|42.5|
4110011|NCT00955357|3934234|B3|||Height||centimeter|Median|167.6|167.6|Full Range|||140.0|197.0|
4110012|NCT00955357|3934235|B2|||Height||centimeter|Median|167.6|167.6|Full Range|||140.0|197.0|
4110013|NCT00955357|3934236|B1|||Height||centimeter|Median|166.5|166.5|Full Range|||149.0|186.0|
4110014|NCT00955357|3934234|B3|||Weight||kilogram|Median|73.0|73.0|Full Range|||41.9|147.4|
4110015|NCT00955357|3934235|B2|||Weight||kilogram|Median|73.0|73.0|Full Range|||41.9|147.4|
4110016|NCT00955357|3934236|B1|||Weight||kilogram|Median|71.8|71.8|Full Range|||42.0|132.9|
4110017|NCT00955357|3934234|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110018|NCT00955357|3934235|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110019|NCT00955357|3934236|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110020|NCT00955357|3934234|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|333|333.0||||||
4110021|NCT00955357|3934235|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|261|261.0||||||
4110022|NCT00955357|3934236|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4110023|NCT00955357|3934234|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
4110024|NCT00955357|3934235|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
4110025|NCT00955357|3934236|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4110026|NCT00955357|3934234|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110027|NCT00955357|3934235|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110028|NCT00955357|3934236|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110029|NCT00955357|3934234|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4110030|NCT00955357|3934235|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4110031|NCT00955357|3934236|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4110032|NCT00955357|3934234|B3||White|Race (NIH/OMB)||Participants|Count of Participants|357|357.0||||||
4110033|NCT00955357|3934235|B2||White|Race (NIH/OMB)||Participants|Count of Participants|278|278.0||||||
4110034|NCT00955357|3934236|B1||White|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
4110035|NCT00955357|3934234|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4110036|NCT00955357|3934235|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4110037|NCT00955357|3934236|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4110038|NCT00955357|3934234|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110039|NCT00955357|3934235|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110040|NCT00955357|3934236|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110041|NCT00955357|3934234|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4110042|NCT00955357|3934235|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4110043|NCT00955357|3934236|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110044|NCT00955357|3934234|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4110045|NCT00955357|3934235|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4110046|NCT00955357|3934236|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4110047|NCT00955357|3934234|B3||Male|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4110048|NCT00955357|3934235|B2||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4110049|NCT00955357|3934236|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4110050|NCT00955357|3934234|B3||Female|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
4110051|NCT00955357|3934235|B2||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4110052|NCT00955357|3934236|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4110053|NCT00955357|3934234|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4110054|NCT00955357|3934235|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4110055|NCT00955357|3934236|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4110056|NCT00955357|3934234|B3||Between 18 and 65 years|Age||Participants|Count of Participants|431|431.0||||||
4110057|NCT00955357|3934235|B2||Between 18 and 65 years|Age||Participants|Count of Participants|349|349.0||||||
4110058|NCT00955357|3934236|B1||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
4110059|NCT00955357|3934234|B3||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4110060|NCT00955357|3934235|B2||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4110061|NCT00955357|3934236|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4110062|NCT00955357|3934234|B3|||Age||years|Median|38.0|38.0|Full Range|||16.0|82.0|
4110063|NCT00955357|3934235|B2|||Age||years|Median|38.0|38.0|Full Range|||16.0|74.0|
4110064|NCT00955357|3934236|B1|||Age||years|Median|37.5|37.5|Full Range|||18.0|82.0|
4110065|NCT00955305|3934243|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4110066|NCT00955305|3934244|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4110067|NCT00955305|3934245|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4110068|NCT00955305|3934243|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4110069|NCT00955305|3934244|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4110070|NCT00955305|3934245|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4110071|NCT00955305|3934243|B3|||Age||years|Median|63|63.0|Full Range|||28.0|82.0|
4110072|NCT00955305|3934244|B2|||Age||years|Median|61|61.0|Full Range|||28.0|82.0|
4110073|NCT00955305|3934245|B1|||Age||years|Median|64|64.0|Full Range|||38.0|82.0|
4110095|NCT00955279|3934257|B3|||Age||Years|Mean|49.8|49.8|Standard Deviation|10.17|10.17|||
4110096|NCT00955279|3934258|B2|||Age||Years|Mean|50.0|50.0|Standard Deviation|9.44|9.44|||
4110074|NCT00955279|3934256|B4|Skin Only||Number of Participants by stratification factors|Participant allocation to treatment group was performed by interactive voice response system (IVRS) using a permuted block randomization stratified by baseline disease organ involvement (participants with pulmonary involvement only, participants with skin involvement only, and participants with both pulmonary and skin involvement) and prior use of anti-Tumor necrosis factor (TNF) biological therapy (yes or no).|participants|Number|41|41.0||||||
4110075|NCT00955279|3934257|B3|Skin Only||Number of Participants by stratification factors|Participant allocation to treatment group was performed by interactive voice response system (IVRS) using a permuted block randomization stratified by baseline disease organ involvement (participants with pulmonary involvement only, participants with skin involvement only, and participants with both pulmonary and skin involvement) and prior use of anti-Tumor necrosis factor (TNF) biological therapy (yes or no).|participants|Number|14|14.0||||||
4110076|NCT00955279|3934258|B2|Skin Only||Number of Participants by stratification factors|Participant allocation to treatment group was performed by interactive voice response system (IVRS) using a permuted block randomization stratified by baseline disease organ involvement (participants with pulmonary involvement only, participants with skin involvement only, and participants with both pulmonary and skin involvement) and prior use of anti-Tumor necrosis factor (TNF) biological therapy (yes or no).|participants|Number|13|13.0||||||
4110077|NCT00955279|3934259|B1|Skin Only||Number of Participants by stratification factors|Participant allocation to treatment group was performed by interactive voice response system (IVRS) using a permuted block randomization stratified by baseline disease organ involvement (participants with pulmonary involvement only, participants with skin involvement only, and participants with both pulmonary and skin involvement) and prior use of anti-Tumor necrosis factor (TNF) biological therapy (yes or no).|participants|Number|14|14.0||||||
4110078|NCT00955279|3934256|B4|Pulmonary Only||Number of Participants by stratification factors|Participant allocation to treatment group was performed by interactive voice response system (IVRS) using a permuted block randomization stratified by baseline disease organ involvement (participants with pulmonary involvement only, participants with skin involvement only, and participants with both pulmonary and skin involvement) and prior use of anti-Tumor necrosis factor (TNF) biological therapy (yes or no).|participants|Number|115|115.0||||||
4110079|NCT00955279|3934257|B3|Pulmonary Only||Number of Participants by stratification factors|Participant allocation to treatment group was performed by interactive voice response system (IVRS) using a permuted block randomization stratified by baseline disease organ involvement (participants with pulmonary involvement only, participants with skin involvement only, and participants with both pulmonary and skin involvement) and prior use of anti-Tumor necrosis factor (TNF) biological therapy (yes or no).|participants|Number|39|39.0||||||
4110080|NCT00955279|3934258|B2|Pulmonary Only||Number of Participants by stratification factors|Participant allocation to treatment group was performed by interactive voice response system (IVRS) using a permuted block randomization stratified by baseline disease organ involvement (participants with pulmonary involvement only, participants with skin involvement only, and participants with both pulmonary and skin involvement) and prior use of anti-Tumor necrosis factor (TNF) biological therapy (yes or no).|participants|Number|38|38.0||||||
4110081|NCT00955279|3934259|B1|Pulmonary Only||Number of Participants by stratification factors|Participant allocation to treatment group was performed by interactive voice response system (IVRS) using a permuted block randomization stratified by baseline disease organ involvement (participants with pulmonary involvement only, participants with skin involvement only, and participants with both pulmonary and skin involvement) and prior use of anti-Tumor necrosis factor (TNF) biological therapy (yes or no).|participants|Number|38|38.0||||||
4110082|NCT00955279|3934256|B4|Both Pulmonary and Skin||Number of Participants by stratification factors|Participant allocation to treatment group was performed by interactive voice response system (IVRS) using a permuted block randomization stratified by baseline disease organ involvement (participants with pulmonary involvement only, participants with skin involvement only, and participants with both pulmonary and skin involvement) and prior use of anti-Tumor necrosis factor (TNF) biological therapy (yes or no).|participants|Number|17|17.0||||||
4110083|NCT00955279|3934257|B3|Both Pulmonary and Skin||Number of Participants by stratification factors|Participant allocation to treatment group was performed by interactive voice response system (IVRS) using a permuted block randomization stratified by baseline disease organ involvement (participants with pulmonary involvement only, participants with skin involvement only, and participants with both pulmonary and skin involvement) and prior use of anti-Tumor necrosis factor (TNF) biological therapy (yes or no).|participants|Number|7|7.0||||||
4110084|NCT00955279|3934258|B2|Both Pulmonary and Skin||Number of Participants by stratification factors|Participant allocation to treatment group was performed by interactive voice response system (IVRS) using a permuted block randomization stratified by baseline disease organ involvement (participants with pulmonary involvement only, participants with skin involvement only, and participants with both pulmonary and skin involvement) and prior use of anti-Tumor necrosis factor (TNF) biological therapy (yes or no).|participants|Number|4|4.0||||||
4110085|NCT00955279|3934259|B1|Both Pulmonary and Skin||Number of Participants by stratification factors|Participant allocation to treatment group was performed by interactive voice response system (IVRS) using a permuted block randomization stratified by baseline disease organ involvement (participants with pulmonary involvement only, participants with skin involvement only, and participants with both pulmonary and skin involvement) and prior use of anti-Tumor necrosis factor (TNF) biological therapy (yes or no).|participants|Number|6|6.0||||||
4110086|NCT00955279|3934256|B4||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4110087|NCT00955279|3934257|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4110088|NCT00955279|3934258|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4110089|NCT00955279|3934259|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4110090|NCT00955279|3934256|B4||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4110091|NCT00955279|3934257|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4110092|NCT00955279|3934258|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4110093|NCT00955279|3934259|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4110094|NCT00955279|3934256|B4|||Age||Years|Mean|49.8|49.8|Standard Deviation|9.67|9.67|||
4110097|NCT00955279|3934259|B1|||Age||Years|Mean|49.5|49.5|Standard Deviation|9.51|9.51|||
4110098|NCT00955266|3934281|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4110099|NCT00955266|3934282|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4110100|NCT00955266|3934283|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4110101|NCT00955266|3934281|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4110102|NCT00955266|3934282|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4110103|NCT00955266|3934283|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4110104|NCT00955266|3934281|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4110105|NCT00955266|3934282|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4110106|NCT00955266|3934283|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4110107|NCT00955266|3934281|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4110108|NCT00955266|3934282|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4110109|NCT00955266|3934283|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4110110|NCT00955266|3934281|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4110111|NCT00955266|3934282|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4110112|NCT00955266|3934283|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4110113|NCT00955110|3934298|B1|Canada||Region of Enrollment||participants|Number|41|41.0||||||
4110114|NCT00955110|3934298|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4110115|NCT00955110|3934298|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4110116|NCT00955110|3934298|B1|||Age||years|Mean|32.4|32.4|Standard Deviation|9.04|9.04|||
4110117|NCT00955110|3934298|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4110118|NCT00955110|3934298|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4110119|NCT00955110|3934298|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4110120|NCT00955032|3934310|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4110121|NCT00955032|3934311|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4110122|NCT00955032|3934312|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4110123|NCT00955032|3934310|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4110124|NCT00955032|3934311|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4110125|NCT00955032|3934312|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4110126|NCT00955032|3934310|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4110127|NCT00955032|3934311|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4110128|NCT00955032|3934312|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4110129|NCT00955032|3934310|B3|||Age||years|Mean|66.8|66.8|Standard Deviation|7.9|7.9|||
4110130|NCT00955032|3934311|B2|||Age||years|Mean|72.8|72.8|Standard Deviation|5.7|5.7|||
4110131|NCT00955032|3934312|B1|||Age||years|Mean|63.8|63.8|Standard Deviation|7.2|7.2|||
4110132|NCT00955032|3934310|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4110133|NCT00955032|3934311|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4110134|NCT00955032|3934312|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4110135|NCT00955032|3934310|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4110136|NCT00955032|3934311|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4110137|NCT00955032|3934312|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4110138|NCT00955032|3934310|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4110139|NCT00955032|3934311|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4110140|NCT00955032|3934312|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4110141|NCT00954993|3934333|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4110142|NCT00954993|3934333|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4110143|NCT00954993|3934333|B1|||Age||Years|Mean|53|53.0|Standard Deviation|8.89|8.89|||
4110144|NCT00954941|3934343|B3|United States||Region of Enrollment||participants|Number|98|98.0||||||
4110145|NCT00954941|3934344|B2|United States||Region of Enrollment||participants|Number|48|48.0||||||
4110146|NCT00954941|3934345|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4110147|NCT00954941|3934343|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4110148|NCT00954941|3934344|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4110149|NCT00954941|3934345|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4110150|NCT00954941|3934343|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4110151|NCT00954941|3934344|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4110152|NCT00954941|3934345|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4110153|NCT00954941|3934343|B3|||Age||years|Median|55|55.0|Full Range|||21.0|70.0|
4110154|NCT00954941|3934344|B2|||Age||years|Median|53|53.0|Full Range|||21.0|70.0|
4110155|NCT00954941|3934345|B1|||Age||years|Median|56|56.0|Full Range|||30.0|68.0|
4110156|NCT00954915|3934354|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4110157|NCT00954915|3934354|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4110158|NCT00954915|3934354|B1|||Age||years|Mean|43|43.0|Standard Deviation|0|0.0|||
4110159|NCT00954915|3934354|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4110160|NCT00954915|3934354|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4110161|NCT00954915|3934354|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4110162|NCT00954824|3934358|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4110163|NCT00954824|3934358|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4110164|NCT00954824|3934358|B1|||Age||years|Mean|25.6|25.6|Full Range|||19.0|40.0|
4110165|NCT00954733|3934362|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4110166|NCT00954733|3934362|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4110167|NCT00954733|3934362|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4110168|NCT00954733|3934362|B1|||Age||years|Mean|42|42.0|Full Range|||27.0|65.0|
4110169|NCT00954733|3934362|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4110170|NCT00954733|3934362|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4110171|NCT00954733|3934362|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4110172|NCT00954707|3934366|B1|United States||Region of Enrollment||participants|Number|2509|2509.0||||||
4110173|NCT00954707|3934366|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4110174|NCT00954707|3934366|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110175|NCT00954707|3934366|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2225|2225.0||||||
4110176|NCT00954707|3934366|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|185|185.0||||||
4110177|NCT00954707|3934366|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4110178|NCT00954707|3934366|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4110179|NCT00954707|3934366|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4110180|NCT00954707|3934366|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
4110181|NCT00954707|3934366|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2293|2293.0||||||
4110182|NCT00954707|3934366|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
4110183|NCT00954707|3934366|B1||Male|Sex: Female, Male||Participants|Count of Participants|1724|1724.0||||||
4110184|NCT00954707|3934366|B1||Female|Sex: Female, Male||Participants|Count of Participants|785|785.0||||||
4110185|NCT00954707|3934366|B1|||Age||years|Mean|63.26|63.26|Standard Deviation|10.64|10.64|||
4110186|NCT00954707|3934366|B1||>=65 years|Age||Participants|Count of Participants|1141|1141.0||||||
4110187|NCT00954707|3934366|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1368|1368.0||||||
4110188|NCT00954707|3934366|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4110189|NCT00954681|3934382|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4110190|NCT00954681|3934382|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110191|NCT00954681|3934382|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4110192|NCT00954681|3934382|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4110193|NCT00954681|3934382|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110194|NCT00954681|3934382|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110195|NCT00954681|3934382|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110196|NCT00954681|3934382|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110197|NCT00954681|3934382|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4110198|NCT00954681|3934382|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4110199|NCT00954681|3934382|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4110200|NCT00954681|3934382|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4110201|NCT00954681|3934382|B1|||Age||years|Mean|28.2|28.2|Full Range|||18.0|65.0|
4110202|NCT00954538|3934386|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4110203|NCT00954538|3934387|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4110204|NCT00954538|3934388|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4110205|NCT00954538|3934386|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4110206|NCT00954538|3934387|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4110207|NCT00954538|3934388|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4110208|NCT00954538|3934386|B3|||Age||Years|Mean|65.8|65.8|Standard Deviation|7.4|7.4|||
4110209|NCT00954538|3934387|B2|||Age||Years|Mean|70.7|70.7|Standard Deviation|5.5|5.5|||
4110210|NCT00954538|3934388|B1|||Age||Years|Mean|61.5|61.5|Standard Deviation|6.3|6.3|||
4110211|NCT00954512|3934404|B7||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4110212|NCT00954512|3934405|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4110213|NCT00954512|3934406|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4110214|NCT00954512|3934407|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4110215|NCT00954512|3934409|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4110216|NCT00954512|3934410|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4110217|NCT00954512|3934404|B7||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4110218|NCT00954512|3934405|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4110219|NCT00954512|3934406|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4110220|NCT00954512|3934407|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4110221|NCT00954512|3934409|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4110222|NCT00954512|3934410|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4110223|NCT00954512|3934404|B7|||Age||Years|Mean|56.5|56.5|Standard Deviation|11.4|11.4|||
4110224|NCT00954512|3934405|B6|||Age||Years|Mean|70.8|70.8|Standard Deviation|3.0|3.0|||
4110225|NCT00954512|3934406|B5|||Age||Years|Mean|53.3|53.3|Standard Deviation|13.5|13.5|||
4110226|NCT00954512|3934407|B4|||Age||Years|Mean|48.0|48.0|Standard Deviation|2.8|2.8|||
4110227|NCT00954512|3934409|B2|||Age||Years|Mean|54.0|54.0|Standard Deviation|4.4|4.4|||
4110228|NCT00954512|3934410|B1|||Age||Years|Mean|47.0|47.0|Standard Deviation|2.8|2.8|||
4110229|NCT00954447|3934434|B3|||Baseline HbA1c|Baseline HbA1c was defined as the last available HbA1c measurement prior to the start of randomised study treatment.There were 617 patients with non-missing baseline HbA1c in Placebo group and 618 patients with non-missing values in Linagliptin 5 mg.|Percentage|Mean|8.30|8.3|Standard Deviation|0.85|0.85|||
4110230|NCT00954447|3934435|B2|||Baseline HbA1c|Baseline HbA1c was defined as the last available HbA1c measurement prior to the start of randomised study treatment.There were 617 patients with non-missing baseline HbA1c in Placebo group and 618 patients with non-missing values in Linagliptin 5 mg.|Percentage|Mean|8.31|8.31|Standard Deviation|0.85|0.85|||
4110231|NCT00954447|3934436|B1|||Baseline HbA1c|Baseline HbA1c was defined as the last available HbA1c measurement prior to the start of randomised study treatment.There were 617 patients with non-missing baseline HbA1c in Placebo group and 618 patients with non-missing values in Linagliptin 5 mg.|Percentage|Mean|8.29|8.29|Standard Deviation|0.85|0.85|||
4110232|NCT00954447|3934434|B3||Male|Sex: Female, Male||Participants|Count of Participants|658|658.0||||||
4110233|NCT00954447|3934435|B2||Male|Sex: Female, Male||Participants|Count of Participants|329|329.0||||||
4110234|NCT00954447|3934436|B1||Male|Sex: Female, Male||Participants|Count of Participants|329|329.0||||||
4110235|NCT00954447|3934434|B3||Female|Sex: Female, Male||Participants|Count of Participants|603|603.0||||||
4110236|NCT00954447|3934435|B2||Female|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
4110237|NCT00954447|3934436|B1||Female|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
4110238|NCT00954447|3934434|B3|||Age||Years|Mean|60.0|60.0|Standard Deviation|10.0|10.0|||
4110239|NCT00954447|3934435|B2|||Age||Years|Mean|59.7|59.7|Standard Deviation|9.9|9.9|||
4110240|NCT00954447|3934436|B1|||Age||Years|Mean|60.4|60.4|Standard Deviation|10.0|10.0|||
4110241|NCT00954421|3934473|B1|||Baseline Total Fain-Tolosa-Marin Tremor Rating Scale (TRS)|Tremor was evaluated using the Fain-Tolosa-Marin Tremor Rating Scale (TRS). Score was obtained by summing all 21 items, each of which assessed tremor on a scale of 0-4. Because some of the 21 items contained more than one subsection, total maximum score was 144, and minimum score was 0. Higher scores represent worse tremor.|units on a scale|Mean|56.2|56.2|Standard Deviation|9.4|9.4|||
4110242|NCT00954421|3934473|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4110243|NCT00954421|3934473|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4110244|NCT00954421|3934473|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4110245|NCT00954421|3934473|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4110246|NCT00954421|3934473|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4110247|NCT00954421|3934473|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4110248|NCT00954421|3934473|B1|||Age||years|Mean|41.54|41.54|Standard Deviation|15.03|15.03|||
4110249|NCT00954356|3934479|B3|United States||Region of Enrollment||participants|Number|61|61.0||||||
4110250|NCT00954356|3934480|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4110251|NCT00954356|3934481|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4110252|NCT00954356|3934479|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4110253|NCT00954356|3934480|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4110254|NCT00954356|3934481|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4110255|NCT00954356|3934479|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4110256|NCT00954356|3934480|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4110257|NCT00954356|3934481|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4110258|NCT00954356|3934479|B3|||Age||years|Mean|20.4|20.4|Standard Deviation|2.96|2.96|||
4110259|NCT00954356|3934480|B2|||Age||years|Mean|20.9|20.9|Standard Deviation|3.01|3.01|||
4110260|NCT00954356|3934481|B1|||Age||years|Mean|20.2|20.2|Standard Deviation|2.94|2.94|||
4110261|NCT00954356|3934479|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4110262|NCT00954356|3934480|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4110263|NCT00954356|3934481|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4110264|NCT00954356|3934479|B3||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4110265|NCT00954356|3934480|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4110266|NCT00954356|3934481|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4110267|NCT00954356|3934479|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4110268|NCT00954356|3934480|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4110269|NCT00954356|3934481|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4110270|NCT00954187|3934510|B3||Male|Gender||||0|0.0||||||
4110271|NCT00954187|3934510|B3||Female|Gender||||0|0.0||||||
4110272|NCT00954122|3934519|B1|Malaysia||Region of Enrollment||participants|Number|35|35.0||||||
4110273|NCT00954122|3934519|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4110274|NCT00954122|3934519|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4110275|NCT00954122|3934519|B1|||Age||years|Mean|38.3|38.3|Standard Deviation|11|11.0|||
4110276|NCT00954122|3934519|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4110277|NCT00954122|3934519|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4110278|NCT00954122|3934519|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4110279|NCT00954109|3934529|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4110280|NCT00954109|3934529|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110281|NCT00954109|3934529|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110282|NCT00954109|3934529|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4110283|NCT00954109|3934529|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4110284|NCT00954109|3934529|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110285|NCT00954109|3934529|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110286|NCT00954109|3934529|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110287|NCT00954109|3934529|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4110288|NCT00954109|3934529|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4110289|NCT00954109|3934529|B1|||Age||years|Mean|53|53.0|Standard Deviation|2|2.0|||
4110290|NCT00954109|3934529|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4110291|NCT00954109|3934529|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4110292|NCT00954109|3934529|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4110293|NCT00953927|3934534|B3|South Africa||Region of Enrollment||participants|Number|2797|2797.0||||||
4110294|NCT00953927|3934535|B2|South Africa||Region of Enrollment||participants|Number|1398|1398.0||||||
4110295|NCT00953927|3934536|B1|South Africa||Region of Enrollment||participants|Number|1399|1399.0||||||
4110296|NCT00953927|3934534|B3||Male|Sex: Female, Male||Participants|Count of Participants|1424|1424.0||||||
4110297|NCT00953927|3934535|B2||Male|Sex: Female, Male||Participants|Count of Participants|716|716.0||||||
4110298|NCT00953927|3934536|B1||Male|Sex: Female, Male||Participants|Count of Participants|708|708.0||||||
4110299|NCT00953927|3934534|B3||Female|Sex: Female, Male||Participants|Count of Participants|1373|1373.0||||||
4110300|NCT00953927|3934535|B2||Female|Sex: Female, Male||Participants|Count of Participants|682|682.0||||||
4110301|NCT00953927|3934536|B1||Female|Sex: Female, Male||Participants|Count of Participants|691|691.0||||||
4110302|NCT00953927|3934534|B3|||Age||years|Mean|.400|0.4|Standard Deviation|.038|0.038|||
4110303|NCT00953927|3934535|B2|||Age||years|Mean|.399|0.399|Standard Deviation|.037|0.037|||
4110304|NCT00953927|3934536|B1|||Age||years|Mean|.401|0.401|Standard Deviation|.039|0.039|||
4110305|NCT00953927|3934534|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4110306|NCT00953927|3934535|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4110307|NCT00953927|3934536|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4110308|NCT00953927|3934534|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4110309|NCT00953927|3934535|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4110310|NCT00953927|3934536|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4110311|NCT00953927|3934534|B3||<=18 years|Age||Participants|Count of Participants|2797|2797.0||||||
4110312|NCT00953927|3934535|B2||<=18 years|Age||Participants|Count of Participants|1398|1398.0||||||
4110313|NCT00953927|3934536|B1||<=18 years|Age||Participants|Count of Participants|1399|1399.0||||||
4110314|NCT00953862|3934555|B1|||Length of Abstinence from all Substances||Weeks|Mean|14.1|14.1|Standard Deviation|18.5|18.5|||
4110315|NCT00953862|3934555|B1|Other/Unable to report||Substance Used||Participants|Number|1|1.0||||||
4110316|NCT00953862|3934555|B1|Opioid||Substance Used||Participants|Number|3|3.0||||||
4110317|NCT00953862|3934555|B1|Alcohol||Substance Used||Participants|Number|3|3.0||||||
4110318|NCT00953862|3934555|B1|Cannabis||Substance Used||Participants|Number|5|5.0||||||
4110319|NCT00953862|3934555|B1|Cocaine||Substance Used||Participants|Number|6|6.0||||||
4110320|NCT00953862|3934555|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4110321|NCT00953862|3934555|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4110322|NCT00953862|3934555|B1|African-American||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4110323|NCT00953862|3934555|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4110324|NCT00953862|3934555|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4110325|NCT00953862|3934555|B1|||Age||years|Mean|36.8|36.8|Standard Deviation|10|10.0|||
4110326|NCT00953849|3934561|B5||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4110327|NCT00953849|3934562|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4110328|NCT00953849|3934563|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4110329|NCT00953849|3934564|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4110330|NCT00953849|3934565|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4110331|NCT00953849|3934561|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4110332|NCT00953849|3934562|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4110333|NCT00953849|3934563|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4110334|NCT00953849|3934564|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4110335|NCT00953849|3934565|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4110336|NCT00953849|3934561|B5||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4110337|NCT00953849|3934562|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4110338|NCT00953849|3934563|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4110339|NCT00953849|3934564|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4110340|NCT00953849|3934565|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4110341|NCT00953849|3934561|B5||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4110342|NCT00953849|3934562|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4110343|NCT00953849|3934563|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4110344|NCT00953849|3934564|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4110345|NCT00953849|3934565|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4110346|NCT00953849|3934561|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4110347|NCT00953849|3934562|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4110348|NCT00953849|3934563|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4110349|NCT00953849|3934564|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4110350|NCT00953849|3934565|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4110351|NCT00953745|3934590|B3|United States||Region of Enrollment||participants|Number|43|43.0||||||
4110352|NCT00953745|3934591|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4110353|NCT00953745|3934592|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4110354|NCT00953745|3934590|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4110355|NCT00953745|3934591|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4110356|NCT00953745|3934592|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4110357|NCT00953745|3934590|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4110358|NCT00953745|3934591|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4110359|NCT00953745|3934592|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4110360|NCT00953745|3934590|B3|||Age||years|Mean|42.27|42.27|Full Range|||19.0|54.0|
4110361|NCT00953745|3934591|B2|||Age||years|Mean|45.67|45.67|Full Range|||31.0|54.0|
4110362|NCT00953745|3934592|B1|||Age||years|Mean|41.69|41.69|Full Range|||19.0|54.0|
4110363|NCT00953719|3934601|B3|United States||Region of Enrollment||participants|Number|242|242.0||||||
4110364|NCT00953719|3934602|B2|United States||Region of Enrollment||participants|Number|74|74.0||||||
4110365|NCT00953719|3934603|B1|United States||Region of Enrollment||participants|Number|168|168.0||||||
4110366|NCT00953719|3934601|B3||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4110367|NCT00953719|3934602|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4110368|NCT00953719|3934603|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4110369|NCT00953719|3934601|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4110370|NCT00953719|3934602|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4110371|NCT00953719|3934603|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4110372|NCT00953719|3934601|B3|||Age||years|Mean|57.2|57.2|Standard Deviation|10.6|10.6|||
4110373|NCT00953719|3934602|B2|||Age||years|Mean|56.9|56.9|Standard Deviation|9.7|9.7|||
4110374|NCT00953719|3934603|B1|||Age||years|Mean|57.3|57.3|Standard Deviation|11.0|11.0|||
4110375|NCT00953706|3934624|B3|||Sweat Chloride||millimoles per liter|Mean|101.6|101.6|Standard Deviation|9.83|9.83|||
4110376|NCT00953706|3934625|B2|||Sweat Chloride||millimoles per liter|Mean|101.4|101.4|Standard Deviation|10.28|10.28|||
4110377|NCT00953706|3934626|B1|||Sweat Chloride||millimoles per liter|Mean|102.4|102.4|Standard Deviation|7.91|7.91|||
4110378|NCT00953706|3934624|B3|||Body Mass Index||kilogram per square meter|Mean|21.4|21.4|Standard Deviation|3.54|3.54|||
4110379|NCT00953706|3934625|B2|||Body Mass Index||kilogram per square meter|Mean|21.2|21.2|Standard Deviation|3.25|3.25|||
4110380|NCT00953706|3934626|B1|||Body Mass Index||kilogram per square meter|Mean|22.2|22.2|Standard Deviation|4.48|4.48|||
4110381|NCT00953706|3934624|B3|||Weight||kilograms|Mean|59.2|59.2|Standard Deviation|13.89|13.89|||
4110382|NCT00953706|3934625|B2|||Weight||kilograms|Mean|58.2|58.2|Standard Deviation|13.49|13.49|||
4110383|NCT00953706|3934626|B1|||Weight||kilograms|Mean|63.2|63.2|Standard Deviation|14.96|14.96|||
4110384|NCT00953706|3934624|B3|> 90%||ppFEV1, Categorical|Percent predicted for age, gender, and height.|participants|Number|47|47.0||||||
4110385|NCT00953706|3934625|B2|> 90%||ppFEV1, Categorical|Percent predicted for age, gender, and height.|participants|Number|39|39.0||||||
4110386|NCT00953706|3934626|B1|> 90%||ppFEV1, Categorical|Percent predicted for age, gender, and height.|participants|Number|8|8.0||||||
4110387|NCT00953706|3934624|B3|≥ 70% to ≤ 90%||ppFEV1, Categorical|Percent predicted for age, gender, and height.|participants|Number|40|40.0||||||
4110388|NCT00953706|3934625|B2|≥ 70% to ≤ 90%||ppFEV1, Categorical|Percent predicted for age, gender, and height.|participants|Number|35|35.0||||||
4110389|NCT00953706|3934626|B1|≥ 70% to ≤ 90%||ppFEV1, Categorical|Percent predicted for age, gender, and height.|participants|Number|5|5.0||||||
4110390|NCT00953706|3934624|B3|< 70%||ppFEV1, Categorical|Percent predicted for age, gender, and height.|participants|Number|53|53.0||||||
4110391|NCT00953706|3934625|B2|< 70%||ppFEV1, Categorical|Percent predicted for age, gender, and height.|participants|Number|38|38.0||||||
4110392|NCT00953706|3934626|B1|< 70%||ppFEV1, Categorical|Percent predicted for age, gender, and height.|participants|Number|15|15.0||||||
4110393|NCT00953706|3934624|B3|||Percent Predicted Forced Expiratory Volume in 1 Second (ppFEV1), Continuous|Percent predicted for age, gender, and height.|percent predicted of FEV1|Mean|78.7|78.7|Standard Deviation|22.95|22.95|||
4110394|NCT00953706|3934625|B2|||Percent Predicted Forced Expiratory Volume in 1 Second (ppFEV1), Continuous|Percent predicted for age, gender, and height.|percent predicted of FEV1|Mean|79.7|79.7|Standard Deviation|22.67|22.67|||
4110395|NCT00953706|3934626|B1|||Percent Predicted Forced Expiratory Volume in 1 Second (ppFEV1), Continuous|Percent predicted for age, gender, and height.|percent predicted of FEV1|Mean|74.8|74.8|Standard Deviation|24.06|24.06|||
4110396|NCT00953706|3934624|B3|White||Race/Ethnicity, Customized||participants|Number|139|139.0||||||
4110397|NCT00953706|3934625|B2|White||Race/Ethnicity, Customized||participants|Number|111|111.0||||||
4110398|NCT00953706|3934626|B1|White||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4110399|NCT00953706|3934624|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4110400|NCT00953706|3934625|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4110401|NCT00953706|3934626|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4110402|NCT00953706|3934624|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|137|137.0||||||
4110403|NCT00953706|3934625|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|110|110.0||||||
4110404|NCT00953706|3934626|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4110405|NCT00953706|3934624|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4110406|NCT00953706|3934625|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4110407|NCT00953706|3934626|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4110408|NCT00953706|3934624|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4110409|NCT00953706|3934625|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4110410|NCT00953706|3934626|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4110411|NCT00953706|3934624|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4110412|NCT00953706|3934625|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4110413|NCT00953706|3934626|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4110414|NCT00953706|3934624|B3|> 45 Years||Age, Customized||participants|Number|5|5.0||||||
4110415|NCT00953706|3934625|B2|> 45 Years||Age, Customized||participants|Number|5|5.0||||||
4110416|NCT00953706|3934626|B1|> 45 Years||Age, Customized||participants|Number|0|0.0||||||
4110417|NCT00953706|3934624|B3|40 to 45 Years||Age, Customized||participants|Number|5|5.0||||||
4110418|NCT00953706|3934625|B2|40 to 45 Years||Age, Customized||participants|Number|5|5.0||||||
4110419|NCT00953706|3934626|B1|40 to 45 Years||Age, Customized||participants|Number|0|0.0||||||
4110420|NCT00953706|3934624|B3|25 to 39 Years||Age, Customized||participants|Number|38|38.0||||||
4110421|NCT00953706|3934625|B2|25 to 39 Years||Age, Customized||participants|Number|26|26.0||||||
4110422|NCT00953706|3934626|B1|25 to 39 Years||Age, Customized||participants|Number|12|12.0||||||
4110423|NCT00953706|3934624|B3|18 to 24 Years||Age, Customized||participants|Number|42|42.0||||||
4110424|NCT00953706|3934625|B2|18 to 24 Years||Age, Customized||participants|Number|32|32.0||||||
4110425|NCT00953706|3934626|B1|18 to 24 Years||Age, Customized||participants|Number|10|10.0||||||
4110426|NCT00953706|3934624|B3|12 to 17 Years||Age, Customized||participants|Number|50|50.0||||||
4110427|NCT00953706|3934625|B2|12 to 17 Years||Age, Customized||participants|Number|44|44.0||||||
4110428|NCT00953706|3934626|B1|12 to 17 Years||Age, Customized||participants|Number|6|6.0||||||
4110429|NCT00953706|3934624|B3|||Age||years|Mean|23.2|23.2|Standard Deviation|9.91|9.91|||
4110430|NCT00953706|3934625|B2|||Age||years|Mean|22.8|22.8|Standard Deviation|10.26|10.26|||
4110431|NCT00953706|3934626|B1|||Age||years|Mean|25.0|25.0|Standard Deviation|8.35|8.35|||
4110432|NCT00953680|3934661|B1|||Weight||kilograms|Mean|73.01|73.01|Full Range|||50.0|99.1|
4110433|NCT00953680|3934661|B1|||Height||Centimeters|Mean|166.81|166.81|Full Range|||152.0|191.0|
4110434|NCT00953680|3934661|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4110435|NCT00953680|3934661|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4110436|NCT00953680|3934661|B1|||Age||years|Mean|33.87|33.87|Full Range|||18.0|45.0|
4110437|NCT00953667|3934674|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110438|NCT00953667|3934674|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4110439|NCT00953667|3934674|B1||White|Race (NIH/OMB)||Participants|Count of Participants|255|255.0||||||
4110440|NCT00953667|3934674|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|143|143.0||||||
4110441|NCT00953667|3934674|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110442|NCT00953667|3934674|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110443|NCT00953667|3934674|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110444|NCT00953667|3934674|B1||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4110445|NCT00953667|3934674|B1||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4110446|NCT00953667|3934674|B1|||Age||years|Mean|25.42|25.42|Full Range|||18.0|45.0|
4110447|NCT00953654|3934679|B4|||Height||centimeters|Mean|164.7|164.7|Standard Deviation|6.6|6.6|||
4110448|NCT00953654|3934680|B3|||Height||centimeters|Mean|166.5|166.5|Standard Deviation|4.6|4.6|||
4110449|NCT00953654|3934681|B2|||Height||centimeters|Mean|165.0|165.0|Standard Deviation|7.6|7.6|||
4110450|NCT00953654|3934682|B1|||Height||centimeters|Mean|162.6|162.6|Standard Deviation|6.2|6.2|||
4110451|NCT00953654|3934679|B4|||Weight||Kilograms|Mean|65.7|65.7|Standard Deviation|12.2|12.2|||
4110452|NCT00953654|3934680|B3|||Weight||Kilograms|Mean|66.4|66.4|Standard Deviation|8.1|8.1|||
4110453|NCT00953654|3934681|B2|||Weight||Kilograms|Mean|70.0|70.0|Standard Deviation|15.5|15.5|||
4110454|NCT00953654|3934682|B1|||Weight||Kilograms|Mean|60.6|60.6|Standard Deviation|9.1|9.1|||
4110455|NCT00953654|3934679|B4|Antihistamine||Medication|Non-psychoactive and psychoactive medication use was assessed by self-report using a medication use recall questionnaire.|Participants|Number|1|1.0||||||
4110456|NCT00953654|3934680|B3|Antihistamine||Medication|Non-psychoactive and psychoactive medication use was assessed by self-report using a medication use recall questionnaire.|Participants|Number|0|0.0||||||
4110457|NCT00953654|3934681|B2|Antihistamine||Medication|Non-psychoactive and psychoactive medication use was assessed by self-report using a medication use recall questionnaire.|Participants|Number|0|0.0||||||
4110458|NCT00953654|3934682|B1|Antihistamine||Medication|Non-psychoactive and psychoactive medication use was assessed by self-report using a medication use recall questionnaire.|Participants|Number|1|1.0||||||
4110459|NCT00953654|3934679|B4|Antibiotic||Medication|Non-psychoactive and psychoactive medication use was assessed by self-report using a medication use recall questionnaire.|Participants|Number|1|1.0||||||
4110460|NCT00953654|3934680|B3|Antibiotic||Medication|Non-psychoactive and psychoactive medication use was assessed by self-report using a medication use recall questionnaire.|Participants|Number|0|0.0||||||
4110461|NCT00953654|3934681|B2|Antibiotic||Medication|Non-psychoactive and psychoactive medication use was assessed by self-report using a medication use recall questionnaire.|Participants|Number|1|1.0||||||
4110462|NCT00953654|3934682|B1|Antibiotic||Medication|Non-psychoactive and psychoactive medication use was assessed by self-report using a medication use recall questionnaire.|Participants|Number|0|0.0||||||
4110463|NCT00953654|3934679|B4|Psychostimulant||Medication|Non-psychoactive and psychoactive medication use was assessed by self-report using a medication use recall questionnaire.|Participants|Number|1|1.0||||||
4110464|NCT00953654|3934680|B3|Psychostimulant||Medication|Non-psychoactive and psychoactive medication use was assessed by self-report using a medication use recall questionnaire.|Participants|Number|1|1.0||||||
4110465|NCT00953654|3934681|B2|Psychostimulant||Medication|Non-psychoactive and psychoactive medication use was assessed by self-report using a medication use recall questionnaire.|Participants|Number|0|0.0||||||
4110466|NCT00953654|3934682|B1|Psychostimulant||Medication|Non-psychoactive and psychoactive medication use was assessed by self-report using a medication use recall questionnaire.|Participants|Number|0|0.0||||||
4110467|NCT00953654|3934679|B4|Muscle Relaxant||Medication|Non-psychoactive and psychoactive medication use was assessed by self-report using a medication use recall questionnaire.|Participants|Number|2|2.0||||||
4110468|NCT00953654|3934680|B3|Muscle Relaxant||Medication|Non-psychoactive and psychoactive medication use was assessed by self-report using a medication use recall questionnaire.|Participants|Number|0|0.0||||||
4110469|NCT00953654|3934681|B2|Muscle Relaxant||Medication|Non-psychoactive and psychoactive medication use was assessed by self-report using a medication use recall questionnaire.|Participants|Number|1|1.0||||||
4110470|NCT00953654|3934682|B1|Muscle Relaxant||Medication|Non-psychoactive and psychoactive medication use was assessed by self-report using a medication use recall questionnaire.|Participants|Number|1|1.0||||||
4110471|NCT00953654|3934679|B4|Norepinephrine-Dopamine Reuptake Inhibitor (NDRI)||Medication|Non-psychoactive and psychoactive medication use was assessed by self-report using a medication use recall questionnaire.|Participants|Number|2|2.0||||||
4110472|NCT00953654|3934680|B3|Norepinephrine-Dopamine Reuptake Inhibitor (NDRI)||Medication|Non-psychoactive and psychoactive medication use was assessed by self-report using a medication use recall questionnaire.|Participants|Number|1|1.0||||||
4110473|NCT00953654|3934681|B2|Norepinephrine-Dopamine Reuptake Inhibitor (NDRI)||Medication|Non-psychoactive and psychoactive medication use was assessed by self-report using a medication use recall questionnaire.|Participants|Number|1|1.0||||||
4110474|NCT00953654|3934682|B1|Norepinephrine-Dopamine Reuptake Inhibitor (NDRI)||Medication|Non-psychoactive and psychoactive medication use was assessed by self-report using a medication use recall questionnaire.|Participants|Number|0|0.0||||||
4110475|NCT00953654|3934679|B4|Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)||Medication|Non-psychoactive and psychoactive medication use was assessed by self-report using a medication use recall questionnaire.|Participants|Number|2|2.0||||||
4110476|NCT00953654|3934680|B3|Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)||Medication|Non-psychoactive and psychoactive medication use was assessed by self-report using a medication use recall questionnaire.|Participants|Number|0|0.0||||||
4110477|NCT00953654|3934681|B2|Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)||Medication|Non-psychoactive and psychoactive medication use was assessed by self-report using a medication use recall questionnaire.|Participants|Number|1|1.0||||||
4110478|NCT00953654|3934682|B1|Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)||Medication|Non-psychoactive and psychoactive medication use was assessed by self-report using a medication use recall questionnaire.|Participants|Number|1|1.0||||||
4110479|NCT00953654|3934679|B4|Selective Serotonin Reuptake Inhibitor (SSRI)||Medication|Non-psychoactive and psychoactive medication use was assessed by self-report using a medication use recall questionnaire.|Participants|Number|7|7.0||||||
4110480|NCT00953654|3934680|B3|Selective Serotonin Reuptake Inhibitor (SSRI)||Medication|Non-psychoactive and psychoactive medication use was assessed by self-report using a medication use recall questionnaire.|Participants|Number|3|3.0||||||
4110481|NCT00953654|3934681|B2|Selective Serotonin Reuptake Inhibitor (SSRI)||Medication|Non-psychoactive and psychoactive medication use was assessed by self-report using a medication use recall questionnaire.|Participants|Number|2|2.0||||||
4110482|NCT00953654|3934682|B1|Selective Serotonin Reuptake Inhibitor (SSRI)||Medication|Non-psychoactive and psychoactive medication use was assessed by self-report using a medication use recall questionnaire.|Participants|Number|2|2.0||||||
4110483|NCT00953654|3934679|B4|Contraceptive||Medication|Non-psychoactive and psychoactive medication use was assessed by self-report using a medication use recall questionnaire.|Participants|Number|15|15.0||||||
4110484|NCT00953654|3934680|B3|Contraceptive||Medication|Non-psychoactive and psychoactive medication use was assessed by self-report using a medication use recall questionnaire.|Participants|Number|5|5.0||||||
4110485|NCT00953654|3934681|B2|Contraceptive||Medication|Non-psychoactive and psychoactive medication use was assessed by self-report using a medication use recall questionnaire.|Participants|Number|5|5.0||||||
4110486|NCT00953654|3934682|B1|Contraceptive||Medication|Non-psychoactive and psychoactive medication use was assessed by self-report using a medication use recall questionnaire.|Participants|Number|5|5.0||||||
4110487|NCT00953654|3934679|B4|Substance Abuse||Psychiatric Comorbidity|Number of comorbid psychiatric diagnoses was assessed using the Adult Version of the Anxiety Disorders Interview Schedule for the DSM-IV (ADIS-IV).|cases|Number|1|1.0||||||
4110488|NCT00953654|3934680|B3|Substance Abuse||Psychiatric Comorbidity|Number of comorbid psychiatric diagnoses was assessed using the Adult Version of the Anxiety Disorders Interview Schedule for the DSM-IV (ADIS-IV).|cases|Number|0|0.0||||||
4110489|NCT00953654|3934681|B2|Substance Abuse||Psychiatric Comorbidity|Number of comorbid psychiatric diagnoses was assessed using the Adult Version of the Anxiety Disorders Interview Schedule for the DSM-IV (ADIS-IV).|cases|Number|0|0.0||||||
4110490|NCT00953654|3934682|B1|Substance Abuse||Psychiatric Comorbidity|Number of comorbid psychiatric diagnoses was assessed using the Adult Version of the Anxiety Disorders Interview Schedule for the DSM-IV (ADIS-IV).|cases|Number|1|1.0||||||
4110491|NCT00953654|3934679|B4|Dysthymia||Psychiatric Comorbidity|Number of comorbid psychiatric diagnoses was assessed using the Adult Version of the Anxiety Disorders Interview Schedule for the DSM-IV (ADIS-IV).|cases|Number|4|4.0||||||
4110492|NCT00953654|3934680|B3|Dysthymia||Psychiatric Comorbidity|Number of comorbid psychiatric diagnoses was assessed using the Adult Version of the Anxiety Disorders Interview Schedule for the DSM-IV (ADIS-IV).|cases|Number|2|2.0||||||
4110493|NCT00953654|3934681|B2|Dysthymia||Psychiatric Comorbidity|Number of comorbid psychiatric diagnoses was assessed using the Adult Version of the Anxiety Disorders Interview Schedule for the DSM-IV (ADIS-IV).|cases|Number|0|0.0||||||
4110494|NCT00953654|3934682|B1|Dysthymia||Psychiatric Comorbidity|Number of comorbid psychiatric diagnoses was assessed using the Adult Version of the Anxiety Disorders Interview Schedule for the DSM-IV (ADIS-IV).|cases|Number|2|2.0||||||
4110495|NCT00953654|3934679|B4|Major Depressive Disorder (MDD)||Psychiatric Comorbidity|Number of comorbid psychiatric diagnoses was assessed using the Adult Version of the Anxiety Disorders Interview Schedule for the DSM-IV (ADIS-IV).|cases|Number|7|7.0||||||
4110496|NCT00953654|3934680|B3|Major Depressive Disorder (MDD)||Psychiatric Comorbidity|Number of comorbid psychiatric diagnoses was assessed using the Adult Version of the Anxiety Disorders Interview Schedule for the DSM-IV (ADIS-IV).|cases|Number|3|3.0||||||
4110497|NCT00953654|3934681|B2|Major Depressive Disorder (MDD)||Psychiatric Comorbidity|Number of comorbid psychiatric diagnoses was assessed using the Adult Version of the Anxiety Disorders Interview Schedule for the DSM-IV (ADIS-IV).|cases|Number|3|3.0||||||
4110498|NCT00953654|3934682|B1|Major Depressive Disorder (MDD)||Psychiatric Comorbidity|Number of comorbid psychiatric diagnoses was assessed using the Adult Version of the Anxiety Disorders Interview Schedule for the DSM-IV (ADIS-IV).|cases|Number|1|1.0||||||
4110499|NCT00953654|3934679|B4|Post-Traumatic Stress Disorder (PTSD)||Psychiatric Comorbidity|Number of comorbid psychiatric diagnoses was assessed using the Adult Version of the Anxiety Disorders Interview Schedule for the DSM-IV (ADIS-IV).|cases|Number|2|2.0||||||
4110500|NCT00953654|3934680|B3|Post-Traumatic Stress Disorder (PTSD)||Psychiatric Comorbidity|Number of comorbid psychiatric diagnoses was assessed using the Adult Version of the Anxiety Disorders Interview Schedule for the DSM-IV (ADIS-IV).|cases|Number|2|2.0||||||
4110501|NCT00953654|3934681|B2|Post-Traumatic Stress Disorder (PTSD)||Psychiatric Comorbidity|Number of comorbid psychiatric diagnoses was assessed using the Adult Version of the Anxiety Disorders Interview Schedule for the DSM-IV (ADIS-IV).|cases|Number|0|0.0||||||
4110502|NCT00953654|3934682|B1|Post-Traumatic Stress Disorder (PTSD)||Psychiatric Comorbidity|Number of comorbid psychiatric diagnoses was assessed using the Adult Version of the Anxiety Disorders Interview Schedule for the DSM-IV (ADIS-IV).|cases|Number|0|0.0||||||
4110503|NCT00953654|3934679|B4|Obsessive Compulsive Disorder (OCD)||Psychiatric Comorbidity|Number of comorbid psychiatric diagnoses was assessed using the Adult Version of the Anxiety Disorders Interview Schedule for the DSM-IV (ADIS-IV).|cases|Number|5|5.0||||||
4110504|NCT00953654|3934680|B3|Obsessive Compulsive Disorder (OCD)||Psychiatric Comorbidity|Number of comorbid psychiatric diagnoses was assessed using the Adult Version of the Anxiety Disorders Interview Schedule for the DSM-IV (ADIS-IV).|cases|Number|3|3.0||||||
4110505|NCT00953654|3934681|B2|Obsessive Compulsive Disorder (OCD)||Psychiatric Comorbidity|Number of comorbid psychiatric diagnoses was assessed using the Adult Version of the Anxiety Disorders Interview Schedule for the DSM-IV (ADIS-IV).|cases|Number|1|1.0||||||
4110506|NCT00953654|3934682|B1|Obsessive Compulsive Disorder (OCD)||Psychiatric Comorbidity|Number of comorbid psychiatric diagnoses was assessed using the Adult Version of the Anxiety Disorders Interview Schedule for the DSM-IV (ADIS-IV).|cases|Number|1|1.0||||||
4110507|NCT00953654|3934679|B4|Social Phobia||Psychiatric Comorbidity|Number of comorbid psychiatric diagnoses was assessed using the Adult Version of the Anxiety Disorders Interview Schedule for the DSM-IV (ADIS-IV).|cases|Number|12|12.0||||||
4110508|NCT00953654|3934680|B3|Social Phobia||Psychiatric Comorbidity|Number of comorbid psychiatric diagnoses was assessed using the Adult Version of the Anxiety Disorders Interview Schedule for the DSM-IV (ADIS-IV).|cases|Number|5|5.0||||||
4110509|NCT00953654|3934681|B2|Social Phobia||Psychiatric Comorbidity|Number of comorbid psychiatric diagnoses was assessed using the Adult Version of the Anxiety Disorders Interview Schedule for the DSM-IV (ADIS-IV).|cases|Number|5|5.0||||||
4110510|NCT00953654|3934682|B1|Social Phobia||Psychiatric Comorbidity|Number of comorbid psychiatric diagnoses was assessed using the Adult Version of the Anxiety Disorders Interview Schedule for the DSM-IV (ADIS-IV).|cases|Number|2|2.0||||||
4110511|NCT00953654|3934679|B4|Specific Phobia||Psychiatric Comorbidity|Number of comorbid psychiatric diagnoses was assessed using the Adult Version of the Anxiety Disorders Interview Schedule for the DSM-IV (ADIS-IV).|cases|Number|17|17.0||||||
4110512|NCT00953654|3934680|B3|Specific Phobia||Psychiatric Comorbidity|Number of comorbid psychiatric diagnoses was assessed using the Adult Version of the Anxiety Disorders Interview Schedule for the DSM-IV (ADIS-IV).|cases|Number|10|10.0||||||
4110513|NCT00953654|3934681|B2|Specific Phobia||Psychiatric Comorbidity|Number of comorbid psychiatric diagnoses was assessed using the Adult Version of the Anxiety Disorders Interview Schedule for the DSM-IV (ADIS-IV).|cases|Number|5|5.0||||||
4110575|NCT00953524|3934719|B2|||Age||Years|Mean|53.4|53.4|Standard Deviation|18.9|18.9|||
4110514|NCT00953654|3934682|B1|Specific Phobia||Psychiatric Comorbidity|Number of comorbid psychiatric diagnoses was assessed using the Adult Version of the Anxiety Disorders Interview Schedule for the DSM-IV (ADIS-IV).|cases|Number|2|2.0||||||
4110515|NCT00953654|3934679|B4|United States||Region of Enrollment||participants|Number|30|30.0||||||
4110516|NCT00953654|3934680|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4110517|NCT00953654|3934681|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4110518|NCT00953654|3934682|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4110519|NCT00953654|3934679|B4|Female||Sex/Gender, Customized||participants|Number|30|30.0||||||
4110520|NCT00953654|3934680|B3|Female||Sex/Gender, Customized||participants|Number|10|10.0||||||
4110521|NCT00953654|3934681|B2|Female||Sex/Gender, Customized||participants|Number|10|10.0||||||
4110522|NCT00953654|3934682|B1|Female||Sex/Gender, Customized||participants|Number|10|10.0||||||
4110523|NCT00953654|3934679|B4|||Age||years|Mean|23.5|23.5|Standard Deviation|5.9|5.9|||
4110524|NCT00953654|3934680|B3|||Age||years|Mean|24.2|24.2|Standard Deviation|6.3|6.3|||
4110525|NCT00953654|3934681|B2|||Age||years|Mean|20.7|20.7|Standard Deviation|3.0|3.0|||
4110526|NCT00953654|3934682|B1|||Age||years|Mean|25.6|25.6|Standard Deviation|7.1|7.1|||
4110527|NCT00953654|3934679|B4|>29 and ≤37 years||Age, Customized||participants|Number|6|6.0||||||
4110528|NCT00953654|3934680|B3|>29 and ≤37 years||Age, Customized||participants|Number|3|3.0||||||
4110529|NCT00953654|3934681|B2|>29 and ≤37 years||Age, Customized||participants|Number|0|0.0||||||
4110530|NCT00953654|3934682|B1|>29 and ≤37 years||Age, Customized||participants|Number|3|3.0||||||
4110531|NCT00953654|3934679|B4|>23 and ≤29 years||Age, Customized||participants|Number|4|4.0||||||
4110532|NCT00953654|3934680|B3|>23 and ≤29 years||Age, Customized||participants|Number|1|1.0||||||
4110533|NCT00953654|3934681|B2|>23 and ≤29 years||Age, Customized||participants|Number|2|2.0||||||
4110534|NCT00953654|3934682|B1|>23 and ≤29 years||Age, Customized||participants|Number|1|1.0||||||
4110535|NCT00953654|3934679|B4|≥18 and ≤23 years||Age, Customized||participants|Number|20|20.0||||||
4110536|NCT00953654|3934680|B3|≥18 and ≤23 years||Age, Customized||participants|Number|6|6.0||||||
4110537|NCT00953654|3934681|B2|≥18 and ≤23 years||Age, Customized||participants|Number|8|8.0||||||
4110538|NCT00953654|3934682|B1|≥18 and ≤23 years||Age, Customized||participants|Number|6|6.0||||||
4110539|NCT00953615|3934695|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4110540|NCT00953615|3934695|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4110541|NCT00953615|3934695|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4110542|NCT00953615|3934695|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4110543|NCT00953615|3934695|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4110544|NCT00953615|3934695|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4110545|NCT00953576|3934702|B3|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4110546|NCT00953576|3934703|B2|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4110547|NCT00953576|3934704|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4110548|NCT00953576|3934702|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4110549|NCT00953576|3934703|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4110550|NCT00953576|3934704|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4110551|NCT00953576|3934702|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4110552|NCT00953576|3934703|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4110553|NCT00953576|3934704|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4110554|NCT00953576|3934702|B3|||Age||years|Mean|67|67.0|Full Range|||51.0|87.0|
4110555|NCT00953576|3934703|B2|||Age||years|Mean|67|67.0|Full Range|||65.0|69.0|
4110556|NCT00953576|3934704|B1|||Age||years|Mean|66|66.0|Full Range|||51.0|87.0|
4110557|NCT00953524|3934716|B5|United States||Region of Enrollment||participants|Number|849|849.0||||||
4110558|NCT00953524|3934717|B4|United States||Region of Enrollment||participants|Number|99|99.0||||||
4110559|NCT00953524|3934718|B3|United States||Region of Enrollment||participants|Number|247|247.0||||||
4110560|NCT00953524|3934719|B2|United States||Region of Enrollment||participants|Number|254|254.0||||||
4110561|NCT00953524|3934720|B1|United States||Region of Enrollment||participants|Number|249|249.0||||||
4110562|NCT00953524|3934716|B5||Male|Sex: Female, Male||Participants|Count of Participants|364|364.0||||||
4110563|NCT00953524|3934717|B4||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4110564|NCT00953524|3934718|B3||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4110565|NCT00953524|3934719|B2||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4110566|NCT00953524|3934720|B1||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4110567|NCT00953524|3934716|B5||Female|Sex: Female, Male||Participants|Count of Participants|485|485.0||||||
4110568|NCT00953524|3934717|B4||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4110569|NCT00953524|3934718|B3||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4110570|NCT00953524|3934719|B2||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4110571|NCT00953524|3934720|B1||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4110572|NCT00953524|3934716|B5|||Age||Years|Mean|53.4|53.4|Standard Deviation|18.9|18.9|||
4110573|NCT00953524|3934717|B4|||Age||Years|Mean|56.4|56.4|Standard Deviation|18.1|18.1|||
4110574|NCT00953524|3934718|B3|||Age||Years|Mean|54.4|54.4|Standard Deviation|18.4|18.4|||
4110576|NCT00953524|3934720|B1|||Age||Years|Mean|52.8|52.8|Standard Deviation|19.2|19.2|||
4110577|NCT00953524|3934716|B5||>=65 years|Age||Participants|Count of Participants|350|350.0||||||
4110578|NCT00953524|3934717|B4||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
4110579|NCT00953524|3934718|B3||>=65 years|Age||Participants|Count of Participants|99|99.0||||||
4110580|NCT00953524|3934719|B2||>=65 years|Age||Participants|Count of Participants|102|102.0||||||
4110581|NCT00953524|3934720|B1||>=65 years|Age||Participants|Count of Participants|99|99.0||||||
4110582|NCT00953524|3934716|B5||Between 18 and 65 years|Age||Participants|Count of Participants|499|499.0||||||
4110583|NCT00953524|3934717|B4||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4110584|NCT00953524|3934718|B3||Between 18 and 65 years|Age||Participants|Count of Participants|148|148.0||||||
4110585|NCT00953524|3934719|B2||Between 18 and 65 years|Age||Participants|Count of Participants|152|152.0||||||
4110586|NCT00953524|3934720|B1||Between 18 and 65 years|Age||Participants|Count of Participants|150|150.0||||||
4110587|NCT00953524|3934716|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4110588|NCT00953524|3934717|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4110589|NCT00953524|3934718|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4110590|NCT00953524|3934719|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4110591|NCT00953524|3934720|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4110592|NCT00953407|3934761|B6||Male|Sex: Female, Male|This reporting group includes all enrolled and dispensed subjects.|Participants|Count of Participants|37|37.0||||||
4110593|NCT00953407|3934762|B5||Male|Sex: Female, Male|This reporting group includes all enrolled and dispensed subjects.|Participants|Count of Participants|7|7.0||||||
4110594|NCT00953407|3934763|B4||Male|Sex: Female, Male|This reporting group includes all enrolled and dispensed subjects.|Participants|Count of Participants|6|6.0||||||
4110595|NCT00953407|3934764|B3||Male|Sex: Female, Male|This reporting group includes all enrolled and dispensed subjects.|Participants|Count of Participants|6|6.0||||||
4110596|NCT00953407|3934765|B2||Male|Sex: Female, Male|This reporting group includes all enrolled and dispensed subjects.|Participants|Count of Participants|10|10.0||||||
4110597|NCT00953407|3934766|B1||Male|Sex: Female, Male|This reporting group includes all enrolled and dispensed subjects.|Participants|Count of Participants|8|8.0||||||
4110598|NCT00953407|3934761|B6||Female|Sex: Female, Male|This reporting group includes all enrolled and dispensed subjects.|Participants|Count of Participants|89|89.0||||||
4110599|NCT00953407|3934762|B5||Female|Sex: Female, Male|This reporting group includes all enrolled and dispensed subjects.|Participants|Count of Participants|17|17.0||||||
4110600|NCT00953407|3934763|B4||Female|Sex: Female, Male|This reporting group includes all enrolled and dispensed subjects.|Participants|Count of Participants|19|19.0||||||
4110601|NCT00953407|3934764|B3||Female|Sex: Female, Male|This reporting group includes all enrolled and dispensed subjects.|Participants|Count of Participants|20|20.0||||||
4110602|NCT00953407|3934765|B2||Female|Sex: Female, Male|This reporting group includes all enrolled and dispensed subjects.|Participants|Count of Participants|15|15.0||||||
4110603|NCT00953407|3934766|B1||Female|Sex: Female, Male|This reporting group includes all enrolled and dispensed subjects.|Participants|Count of Participants|18|18.0||||||
4110604|NCT00953407|3934761|B6|||Age|This reporting group includes all enrolled and dispensed subjects.|years|Mean|29.9|29.9|Standard Deviation|9.3|9.3|||
4110605|NCT00953407|3934762|B5|||Age|This reporting group includes all enrolled and dispensed subjects.|years|Mean|30.5|30.5|Standard Deviation|9.6|9.6|||
4110606|NCT00953407|3934763|B4|||Age|This reporting group includes all enrolled and dispensed subjects.|years|Mean|28.3|28.3|Standard Deviation|7.7|7.7|||
4110607|NCT00953407|3934764|B3|||Age|This reporting group includes all enrolled and dispensed subjects.|years|Mean|29.9|29.9|Standard Deviation|10.1|10.1|||
4110608|NCT00953407|3934765|B2|||Age|This reporting group includes all enrolled and dispensed subjects.|years|Mean|31.5|31.5|Standard Deviation|11.9|11.9|||
4110609|NCT00953407|3934766|B1|||Age|This reporting group includes all enrolled and dispensed subjects.|years|Mean|29.5|29.5|Standard Deviation|7.0|7.0|||
4110610|NCT00953329|3934782|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4110611|NCT00953329|3934782|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4110612|NCT00953329|3934782|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4110613|NCT00953329|3934782|B1|||Age||years|Mean|35|35.0|Standard Deviation|||||
4110614|NCT00953329|3934782|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4110615|NCT00953329|3934782|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4110616|NCT00953329|3934782|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4110617|NCT00953290|3934786|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4110618|NCT00953290|3934786|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4110619|NCT00953290|3934786|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4110620|NCT00953290|3934786|B1|||Age||years|Mean|43|43.0|Standard Deviation|10.98|10.98|||
4110621|NCT00953290|3934786|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4110622|NCT00953290|3934786|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4110623|NCT00953290|3934786|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4110624|NCT00953225|3934793|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110625|NCT00953225|3934794|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110626|NCT00953225|3934795|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110627|NCT00953225|3934793|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4110628|NCT00953225|3934794|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110629|NCT00953225|3934795|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4110630|NCT00953225|3934793|B3||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4110631|NCT00953225|3934794|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4110632|NCT00953225|3934795|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4110633|NCT00953225|3934793|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4110634|NCT00953225|3934794|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4110635|NCT00953225|3934795|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4110636|NCT00953225|3934793|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110637|NCT00953225|3934794|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110638|NCT00953225|3934795|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110639|NCT00953225|3934793|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110640|NCT00953225|3934794|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110641|NCT00953225|3934795|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110642|NCT00953225|3934793|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110643|NCT00953225|3934794|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110644|NCT00953225|3934795|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110645|NCT00953225|3934793|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110646|NCT00953225|3934794|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110647|NCT00953225|3934795|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110648|NCT00953225|3934793|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
4110649|NCT00953225|3934794|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4110650|NCT00953225|3934795|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4110651|NCT00953225|3934793|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110652|NCT00953225|3934794|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110653|NCT00953225|3934795|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110654|NCT00953225|3934793|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4110655|NCT00953225|3934794|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4110656|NCT00953225|3934795|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4110657|NCT00953225|3934793|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4110658|NCT00953225|3934794|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4110659|NCT00953225|3934795|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4110660|NCT00953225|3934793|B3||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4110661|NCT00953225|3934794|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4110662|NCT00953225|3934795|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4110663|NCT00953225|3934793|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4110664|NCT00953225|3934794|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4110665|NCT00953225|3934795|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4110666|NCT00953225|3934793|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4110667|NCT00953225|3934794|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4110668|NCT00953225|3934795|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4110669|NCT00953212|3934804|B5|||Urgent Surgery||Participants|Count of Participants|284|284.0||||||
4110670|NCT00953212|3934805|B4|||Urgent Surgery||Participants|Count of Participants|73|73.0||||||
4110671|NCT00953212|3934806|B3|||Urgent Surgery||Participants|Count of Participants|71|71.0||||||
4110672|NCT00953212|3934807|B2|||Urgent Surgery||Participants|Count of Participants|72|72.0||||||
4110673|NCT00953212|3934808|B1|||Urgent Surgery||Participants|Count of Participants|68|68.0||||||
4110674|NCT00953212|3934804|B5|||Surgery Type - Other|Other surgeries include ascending aortic repair, myxoma excision, patent ductus foramen ovale closure, or endarterectomy|Participants|Count of Participants|8|8.0||||||
4110675|NCT00953212|3934805|B4|||Surgery Type - Other|Other surgeries include ascending aortic repair, myxoma excision, patent ductus foramen ovale closure, or endarterectomy|Participants|Count of Participants|3|3.0||||||
4110676|NCT00953212|3934806|B3|||Surgery Type - Other|Other surgeries include ascending aortic repair, myxoma excision, patent ductus foramen ovale closure, or endarterectomy|Participants|Count of Participants|1|1.0||||||
4110677|NCT00953212|3934807|B2|||Surgery Type - Other|Other surgeries include ascending aortic repair, myxoma excision, patent ductus foramen ovale closure, or endarterectomy|Participants|Count of Participants|2|2.0||||||
4110678|NCT00953212|3934808|B1|||Surgery Type - Other|Other surgeries include ascending aortic repair, myxoma excision, patent ductus foramen ovale closure, or endarterectomy|Participants|Count of Participants|2|2.0||||||
4110679|NCT00953212|3934804|B5|||Surgery Type - CABG/Valve||Participants|Count of Participants|36|36.0||||||
4110680|NCT00953212|3934805|B4|||Surgery Type - CABG/Valve||Participants|Count of Participants|12|12.0||||||
4110681|NCT00953212|3934806|B3|||Surgery Type - CABG/Valve||Participants|Count of Participants|9|9.0||||||
4110682|NCT00953212|3934807|B2|||Surgery Type - CABG/Valve||Participants|Count of Participants|9|9.0||||||
4110683|NCT00953212|3934808|B1|||Surgery Type - CABG/Valve||Participants|Count of Participants|6|6.0||||||
4110684|NCT00953212|3934804|B5|||Surgery Type - Valve||Participants|Count of Participants|28|28.0||||||
4110685|NCT00953212|3934805|B4|||Surgery Type - Valve||Participants|Count of Participants|3|3.0||||||
4110686|NCT00953212|3934806|B3|||Surgery Type - Valve||Participants|Count of Participants|13|13.0||||||
4110687|NCT00953212|3934807|B2|||Surgery Type - Valve||Participants|Count of Participants|6|6.0||||||
4110688|NCT00953212|3934808|B1|||Surgery Type - Valve||Participants|Count of Participants|6|6.0||||||
4110689|NCT00953212|3934804|B5|||Surgery Type - CABG||Participants|Count of Participants|232|232.0||||||
4110690|NCT00953212|3934805|B4|||Surgery Type - CABG||Participants|Count of Participants|58|58.0||||||
4110691|NCT00953212|3934806|B3|||Surgery Type - CABG||Participants|Count of Participants|55|55.0||||||
4110692|NCT00953212|3934807|B2|||Surgery Type - CABG||Participants|Count of Participants|57|57.0||||||
4110693|NCT00953212|3934808|B1|||Surgery Type - CABG||Participants|Count of Participants|62|62.0||||||
4110694|NCT00953212|3934804|B5|||Congestive Heart Failure||Participants|Count of Participants|26|26.0||||||
4110695|NCT00953212|3934805|B4|||Congestive Heart Failure||Participants|Count of Participants|8|8.0||||||
4110696|NCT00953212|3934806|B3|||Congestive Heart Failure||Participants|Count of Participants|4|4.0||||||
4110697|NCT00953212|3934807|B2|||Congestive Heart Failure||Participants|Count of Participants|8|8.0||||||
4110698|NCT00953212|3934808|B1|||Congestive Heart Failure||Participants|Count of Participants|6|6.0||||||
4110699|NCT00953212|3934804|B5|||Statin||Participants|Count of Participants|203|203.0||||||
4110700|NCT00953212|3934805|B4|||Statin||Participants|Count of Participants|47|47.0||||||
4110701|NCT00953212|3934806|B3|||Statin||Participants|Count of Participants|52|52.0||||||
4110702|NCT00953212|3934807|B2|||Statin||Participants|Count of Participants|50|50.0||||||
4110703|NCT00953212|3934808|B1|||Statin||Participants|Count of Participants|54|54.0||||||
4110704|NCT00953212|3934804|B5|||Chronic Obstructive Pulmonary Disease||Participants|Count of Participants|31|31.0||||||
4110705|NCT00953212|3934805|B4|||Chronic Obstructive Pulmonary Disease||Participants|Count of Participants|11|11.0||||||
4110706|NCT00953212|3934806|B3|||Chronic Obstructive Pulmonary Disease||Participants|Count of Participants|3|3.0||||||
4110707|NCT00953212|3934807|B2|||Chronic Obstructive Pulmonary Disease||Participants|Count of Participants|7|7.0||||||
4110708|NCT00953212|3934808|B1|||Chronic Obstructive Pulmonary Disease||Participants|Count of Participants|10|10.0||||||
4110709|NCT00953212|3934804|B5|||Peripheral Vascular Disease||Participants|Count of Participants|37|37.0||||||
4110710|NCT00953212|3934805|B4|||Peripheral Vascular Disease||Participants|Count of Participants|10|10.0||||||
4110711|NCT00953212|3934806|B3|||Peripheral Vascular Disease||Participants|Count of Participants|9|9.0||||||
4110712|NCT00953212|3934807|B2|||Peripheral Vascular Disease||Participants|Count of Participants|8|8.0||||||
4110713|NCT00953212|3934808|B1|||Peripheral Vascular Disease||Participants|Count of Participants|10|10.0||||||
4110714|NCT00953212|3934804|B5|||Diabetes||Participants|Count of Participants|106|106.0||||||
4110715|NCT00953212|3934805|B4|||Diabetes||Participants|Count of Participants|27|27.0||||||
4110716|NCT00953212|3934806|B3|||Diabetes||Participants|Count of Participants|23|23.0||||||
4110717|NCT00953212|3934807|B2|||Diabetes||Participants|Count of Participants|28|28.0||||||
4110718|NCT00953212|3934808|B1|||Diabetes||Participants|Count of Participants|28|28.0||||||
4110719|NCT00953212|3934804|B5|||Pre-op Myocardial Infarction||Participants|Count of Participants|118|118.0||||||
4110720|NCT00953212|3934805|B4|||Pre-op Myocardial Infarction||Participants|Count of Participants|35|35.0||||||
4110721|NCT00953212|3934806|B3|||Pre-op Myocardial Infarction||Participants|Count of Participants|29|29.0||||||
4110722|NCT00953212|3934807|B2|||Pre-op Myocardial Infarction||Participants|Count of Participants|30|30.0||||||
4110723|NCT00953212|3934808|B1|||Pre-op Myocardial Infarction||Participants|Count of Participants|24|24.0||||||
4110724|NCT00953212|3934804|B5|||Hypertension||Participants|Count of Participants|259|259.0||||||
4110725|NCT00953212|3934805|B4|||Hypertension||Participants|Count of Participants|65|65.0||||||
4110726|NCT00953212|3934806|B3|||Hypertension||Participants|Count of Participants|62|62.0||||||
4110727|NCT00953212|3934807|B2|||Hypertension||Participants|Count of Participants|63|63.0||||||
4110728|NCT00953212|3934808|B1|||Hypertension||Participants|Count of Participants|69|69.0||||||
4110729|NCT00953212|3934804|B5|||Cardiovascular Disease||Participants|Count of Participants|51|51.0||||||
4110730|NCT00953212|3934805|B4|||Cardiovascular Disease||Participants|Count of Participants|13|13.0||||||
4110731|NCT00953212|3934806|B3|||Cardiovascular Disease||Participants|Count of Participants|14|14.0||||||
4110732|NCT00953212|3934807|B2|||Cardiovascular Disease||Participants|Count of Participants|13|13.0||||||
4110733|NCT00953212|3934808|B1|||Cardiovascular Disease||Participants|Count of Participants|11|11.0||||||
4110734|NCT00953212|3934804|B5|||BMI (mean, SD)||kg/m^2|Mean|29.7|29.7|Standard Deviation|5.8|5.8|||
4110735|NCT00953212|3934805|B4|||BMI (mean, SD)||kg/m^2|Mean|29.5|29.5|Standard Deviation|6.2|6.2|||
4110736|NCT00953212|3934806|B3|||BMI (mean, SD)||kg/m^2|Mean|27.9|27.9|Standard Deviation|4.7|4.7|||
4110737|NCT00953212|3934807|B2|||BMI (mean, SD)||kg/m^2|Mean|31.1|31.1|Standard Deviation|5.7|5.7|||
4110738|NCT00953212|3934808|B1|||BMI (mean, SD)||kg/m^2|Mean|30.6|30.6|Standard Deviation|6.1|6.1|||
4110739|NCT00953212|3934804|B5|||Smoker||Participants|Count of Participants|75|75.0||||||
4110740|NCT00953212|3934805|B4|||Smoker||Participants|Count of Participants|19|19.0||||||
4110741|NCT00953212|3934806|B3|||Smoker||Participants|Count of Participants|21|21.0||||||
4110742|NCT00953212|3934807|B2|||Smoker||Participants|Count of Participants|19|19.0||||||
4110743|NCT00953212|3934808|B1|||Smoker||Participants|Count of Participants|16|16.0||||||
4110744|NCT00953212|3934804|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4110745|NCT00953212|3934805|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110746|NCT00953212|3934806|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4110747|NCT00953212|3934807|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110748|NCT00953212|3934808|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110749|NCT00953212|3934804|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110750|NCT00953212|3934805|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110751|NCT00953212|3934806|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110752|NCT00953212|3934807|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110753|NCT00953212|3934808|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110754|NCT00953212|3934804|B5||White|Race (NIH/OMB)||Participants|Count of Participants|302|302.0||||||
4110755|NCT00953212|3934805|B4||White|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4110756|NCT00953212|3934806|B3||White|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
4110757|NCT00953212|3934807|B2||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4110758|NCT00953212|3934808|B1||White|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
4110759|NCT00953212|3934804|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4110760|NCT00953212|3934805|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4110761|NCT00953212|3934806|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110762|NCT00953212|3934807|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110763|NCT00953212|3934808|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110764|NCT00953212|3934804|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110765|NCT00953212|3934805|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110766|NCT00953212|3934806|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110767|NCT00953212|3934807|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110768|NCT00953212|3934808|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110769|NCT00953212|3934804|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110770|NCT00953212|3934805|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110771|NCT00953212|3934806|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110772|NCT00953212|3934807|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110773|NCT00953212|3934808|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110774|NCT00953212|3934804|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110775|NCT00953212|3934805|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110776|NCT00953212|3934806|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110777|NCT00953212|3934807|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110778|NCT00953212|3934808|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110779|NCT00953212|3934804|B5||Male|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4110780|NCT00953212|3934805|B4||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4110781|NCT00953212|3934806|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4110782|NCT00953212|3934807|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4110783|NCT00953212|3934808|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4110784|NCT00953212|3934804|B5||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4110785|NCT00953212|3934805|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4110786|NCT00953212|3934806|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4110787|NCT00953212|3934807|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4110788|NCT00953212|3934808|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4110789|NCT00953212|3934804|B5|||Age||years|Mean|61|61.0|Standard Deviation|15|15.0|||
4110790|NCT00953212|3934805|B4|||Age||years|Mean|33.4|33.4|Standard Deviation|931|931.0|||
4110791|NCT00953212|3934806|B3|||Age||years|Mean|63.9|63.9|Standard Deviation|10.7|10.7|||
4110792|NCT00953212|3934807|B2|||Age||years|Mean|65.9|65.9|Standard Deviation|9.4|9.4|||
4110793|NCT00953212|3934808|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|9.6|9.6|||
4110794|NCT00953199|3934865|B3||Male|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
4110795|NCT00953199|3934866|B2||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4110796|NCT00953199|3934867|B1||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4110797|NCT00953199|3934865|B3||Female|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
4110798|NCT00953199|3934866|B2||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4110799|NCT00953199|3934867|B1||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4110800|NCT00953199|3934865|B3|||Age||years|Mean|55.8|55.8|Full Range|||18.0|99.0|
4110801|NCT00953199|3934866|B2|||Age||years|Mean|55.6|55.6|Full Range|||19.0|92.0|
4110802|NCT00953199|3934867|B1|||Age||years|Mean|56|56.0|Full Range|||18.0|99.0|
4110803|NCT00953173|3934876|B1||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4110804|NCT00953173|3934876|B1||Female|Sex: Female, Male||Participants|Count of Participants|517|517.0||||||
4110805|NCT00953173|3934876|B1|60+ years||Age, Customized||Participants|Count of Participants|51|51.0||||||
4110806|NCT00953173|3934876|B1|50-59 years||Age, Customized||Participants|Count of Participants|166|166.0||||||
4110807|NCT00953173|3934876|B1|40-49 years||Age, Customized||Participants|Count of Participants|199|199.0||||||
4110808|NCT00953173|3934876|B1|30-39 years||Age, Customized||Participants|Count of Participants|164|164.0||||||
4110809|NCT00953173|3934876|B1|21-29 years||Age, Customized||Participants|Count of Participants|63|63.0||||||
4110810|NCT00953173|3934876|B1|18-20 years||Age, Customized||Participants|Count of Participants|9|9.0||||||
4110811|NCT00953160|3934880|B1|United States||Region of Enrollment||participants|Number|76|76.0||||||
4110812|NCT00953160|3934880|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4110813|NCT00953160|3934880|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4110814|NCT00953160|3934880|B1|||Age||years|Mean|43|43.0|Standard Deviation|8.5|8.5|||
4110815|NCT00953160|3934880|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4110816|NCT00953160|3934880|B1||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
4110817|NCT00953160|3934880|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4110818|NCT00953147|3934886|B4|||Baseline Rhinoconjunctivitis Quality of Life Questionnaire score [RQLQ (S)] )≥3.0|Baseline Rhinoconjunctivitis Quality of Life Questionnaire [RQLQ(S)] Score in Subjects with baseline RQLQ(S) ≥3.0. RQLQ(s)consists of 28 questions, each question measured on a scale of 0-6 where a higher score indicates poor quality of life. Domains: Activities (questions 1-3), Sleep (questions 4-6), Non-Nose/Eye Symptoms (questions 7-13), Practical Problems (questions 14-16), Nasal Symptoms (questions 17-20), Eye Symptoms (questions 21-24), and Emotional (questions 25-28). The overall RQLQ(S) score was calculated as the average of the mean domain scores.|units on a scale|Mean|4.10|4.1|Standard Deviation|0.77|0.77|||
4110819|NCT00953147|3934887|B3|||Baseline Rhinoconjunctivitis Quality of Life Questionnaire score [RQLQ (S)] )≥3.0|Baseline Rhinoconjunctivitis Quality of Life Questionnaire [RQLQ(S)] Score in Subjects with baseline RQLQ(S) ≥3.0. RQLQ(s)consists of 28 questions, each question measured on a scale of 0-6 where a higher score indicates poor quality of life. Domains: Activities (questions 1-3), Sleep (questions 4-6), Non-Nose/Eye Symptoms (questions 7-13), Practical Problems (questions 14-16), Nasal Symptoms (questions 17-20), Eye Symptoms (questions 21-24), and Emotional (questions 25-28). The overall RQLQ(S) score was calculated as the average of the mean domain scores.|units on a scale|Mean|4.12|4.12|Standard Deviation|0.78|0.78|||
4110820|NCT00953147|3934888|B2|||Baseline Rhinoconjunctivitis Quality of Life Questionnaire score [RQLQ (S)] )≥3.0|Baseline Rhinoconjunctivitis Quality of Life Questionnaire [RQLQ(S)] Score in Subjects with baseline RQLQ(S) ≥3.0. RQLQ(s)consists of 28 questions, each question measured on a scale of 0-6 where a higher score indicates poor quality of life. Domains: Activities (questions 1-3), Sleep (questions 4-6), Non-Nose/Eye Symptoms (questions 7-13), Practical Problems (questions 14-16), Nasal Symptoms (questions 17-20), Eye Symptoms (questions 21-24), and Emotional (questions 25-28). The overall RQLQ(S) score was calculated as the average of the mean domain scores.|units on a scale|Mean|4.05|4.05|Standard Deviation|0.76|0.76|||
4110821|NCT00953147|3934889|B1|||Baseline Rhinoconjunctivitis Quality of Life Questionnaire score [RQLQ (S)] )≥3.0|Baseline Rhinoconjunctivitis Quality of Life Questionnaire [RQLQ(S)] Score in Subjects with baseline RQLQ(S) ≥3.0. RQLQ(s)consists of 28 questions, each question measured on a scale of 0-6 where a higher score indicates poor quality of life. Domains: Activities (questions 1-3), Sleep (questions 4-6), Non-Nose/Eye Symptoms (questions 7-13), Practical Problems (questions 14-16), Nasal Symptoms (questions 17-20), Eye Symptoms (questions 21-24), and Emotional (questions 25-28). The overall RQLQ(S) score was calculated as the average of the mean domain scores.|units on a scale|Mean|4.16|4.16|Standard Deviation|0.77|0.77|||
4110822|NCT00953147|3934886|B4|AM and PM Nasal Congestion||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.29|2.29|Standard Deviation|0.57|0.57|||
4110823|NCT00953147|3934887|B3|AM and PM Nasal Congestion||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.28|2.28|Standard Deviation|0.60|0.6|||
4110824|NCT00953147|3934888|B2|AM and PM Nasal Congestion||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.28|2.28|Standard Deviation|0.57|0.57|||
4110825|NCT00953147|3934889|B1|AM and PM Nasal Congestion||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.32|2.32|Standard Deviation|0.54|0.54|||
4110965|NCT00953147|3934889|B1|Black or African American||Race/Ethnicity||participants|Number|40|40.0||||||
4110966|NCT00953147|3934886|B4|White/Caucasian||Race/Ethnicity||participants|Number|922|922.0||||||
4110967|NCT00953147|3934887|B3|White/Caucasian||Race/Ethnicity||participants|Number|253|253.0||||||
4110968|NCT00953147|3934888|B2|White/Caucasian||Race/Ethnicity||participants|Number|420|420.0||||||
4110826|NCT00953147|3934886|B4|AM and PM Nasal Itching||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|1.93|1.93|Standard Deviation|0.70|0.7|||
4110827|NCT00953147|3934887|B3|AM and PM Nasal Itching||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|1.91|1.91|Standard Deviation|0.75|0.75|||
4110828|NCT00953147|3934888|B2|AM and PM Nasal Itching||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|1.95|1.95|Standard Deviation|0.68|0.68|||
4110829|NCT00953147|3934889|B1|AM and PM Nasal Itching||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|1.94|1.94|Standard Deviation|0.70|0.7|||
4110830|NCT00953147|3934886|B4|AM and PM Runny Nose||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.07|2.07|Standard Deviation|0.67|0.67|||
4110831|NCT00953147|3934887|B3|AM and PM Runny Nose||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.11|2.11|Standard Deviation|0.65|0.65|||
4110832|NCT00953147|3934888|B2|AM and PM Runny Nose||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.05|2.05|Standard Deviation|0.68|0.68|||
4110833|NCT00953147|3934889|B1|AM and PM Runny Nose||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.06|2.06|Standard Deviation|0.67|0.67|||
4110834|NCT00953147|3934886|B4|AM and PM Sneezing||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|1.36|1.36|Standard Deviation|0.88|0.88|||
4110835|NCT00953147|3934887|B3|AM and PM Sneezing||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|1.39|1.39|Standard Deviation|0.89|0.89|||
4110836|NCT00953147|3934888|B2|AM and PM Sneezing||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|1.36|1.36|Standard Deviation|0.86|0.86|||
4110837|NCT00953147|3934889|B1|AM and PM Sneezing||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|1.35|1.35|Standard Deviation|0.89|0.89|||
4110969|NCT00953147|3934889|B1|White/Caucasian||Race/Ethnicity||participants|Number|249|249.0||||||
4110970|NCT00953147|3934886|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110838|NCT00953147|3934886|B4|PM Nasal Congestion||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.19|2.19|Standard Deviation|0.63|0.63|||
4110839|NCT00953147|3934887|B3|PM Nasal Congestion||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.17|2.17|Standard Deviation|0.66|0.66|||
4110840|NCT00953147|3934888|B2|PM Nasal Congestion||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.19|2.19|Standard Deviation|0.63|0.63|||
4110841|NCT00953147|3934889|B1|PM Nasal Congestion||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.22|2.22|Standard Deviation|0.61|0.61|||
4110842|NCT00953147|3934886|B4|PM Nasal Itching||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|1.87|1.87|Standard Deviation|0.74|0.74|||
4110843|NCT00953147|3934887|B3|PM Nasal Itching||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|1.83|1.83|Standard Deviation|0.80|0.8|||
4110844|NCT00953147|3934888|B2|PM Nasal Itching||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|1.90|1.9|Standard Deviation|0.71|0.71|||
4110845|NCT00953147|3934889|B1|PM Nasal Itching||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|1.87|1.87|Standard Deviation|0.73|0.73|||
4110846|NCT00953147|3934886|B4|PM Runny Nose||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|1.99|1.99|Standard Deviation|0.73|0.73|||
4110847|NCT00953147|3934887|B3|PM Runny Nose||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.02|2.02|Standard Deviation|0.72|0.72|||
4110848|NCT00953147|3934888|B2|PM Runny Nose||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|1.98|1.98|Standard Deviation|0.74|0.74|||
4110849|NCT00953147|3934889|B1|PM Runny Nose||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|1.98|1.98|Standard Deviation|0.73|0.73|||
4110971|NCT00953147|3934887|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110972|NCT00953147|3934888|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110850|NCT00953147|3934886|B4|PM Sneezing||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|1.32|1.32|Standard Deviation|0.90|0.9|||
4110851|NCT00953147|3934887|B3|PM Sneezing||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|1.36|1.36|Standard Deviation|0.90|0.9|||
4110852|NCT00953147|3934888|B2|PM Sneezing||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|1.32|1.32|Standard Deviation|0.89|0.89|||
4110853|NCT00953147|3934889|B1|PM Sneezing||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|1.30|1.3|Standard Deviation|0.90|0.9|||
4110854|NCT00953147|3934886|B4|AM Nasal Congestion||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.39|2.39|Standard Deviation|0.57|0.57|||
4110855|NCT00953147|3934887|B3|AM Nasal Congestion||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.38|2.38|Standard Deviation|0.60|0.6|||
4110856|NCT00953147|3934888|B2|AM Nasal Congestion||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.38|2.38|Standard Deviation|0.56|0.56|||
4110857|NCT00953147|3934889|B1|AM Nasal Congestion||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.41|2.41|Standard Deviation|0.53|0.53|||
4110858|NCT00953147|3934886|B4|AM Nasal Itching||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.00|2.0|Standard Deviation|0.72|0.72|||
4110859|NCT00953147|3934887|B3|AM Nasal Itching||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.00|2.0|Standard Deviation|0.76|0.76|||
4110860|NCT00953147|3934888|B2|AM Nasal Itching||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|1.99|1.99|Standard Deviation|0.69|0.69|||
4110861|NCT00953147|3934889|B1|AM Nasal Itching||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.00|2.0|Standard Deviation|0.72|0.72|||
4110973|NCT00953147|3934889|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4110974|NCT00953147|3934886|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|894|894.0||||||
4110862|NCT00953147|3934886|B4|AM Runny Nose||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.15|2.15|Standard Deviation|0.68|0.68|||
4110863|NCT00953147|3934887|B3|AM Runny Nose||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.20|2.2|Standard Deviation|0.67|0.67|||
4110864|NCT00953147|3934888|B2|AM Runny Nose||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.13|2.13|Standard Deviation|0.68|0.68|||
4110865|NCT00953147|3934889|B1|AM Runny Nose||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.14|2.14|Standard Deviation|0.68|0.68|||
4110866|NCT00953147|3934886|B4|AM Sneezing||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|1.40|1.4|Standard Deviation|0.91|0.91|||
4110867|NCT00953147|3934887|B3|AM Sneezing||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|1.43|1.43|Standard Deviation|0.93|0.93|||
4110868|NCT00953147|3934888|B2|AM Sneezing||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|1.40|1.4|Standard Deviation|0.88|0.88|||
4110869|NCT00953147|3934889|B1|AM Sneezing||Baseline Instantaneous Nasal Symptom Score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|1.38|1.38|Standard Deviation|0.91|0.91|||
4110870|NCT00953147|3934886|B4|AM and PM Nasal Congestion||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.43|2.43|Standard Deviation|0.49|0.49|||
4110871|NCT00953147|3934887|B3|AM and PM Nasal Congestion||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.42|2.42|Standard Deviation|0.51|0.51|||
4110872|NCT00953147|3934888|B2|AM and PM Nasal Congestion||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.42|2.42|Standard Deviation|0.48|0.48|||
4110873|NCT00953147|3934889|B1|AM and PM Nasal Congestion||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.45|2.45|Standard Deviation|0.48|0.48|||
4110975|NCT00953147|3934887|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|247|247.0||||||
4110976|NCT00953147|3934888|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|411|411.0||||||
4110977|NCT00953147|3934889|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|236|236.0||||||
4110874|NCT00953147|3934886|B4|AM and PM Nasal Itching||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.09|2.09|Standard Deviation|0.62|0.62|||
4110875|NCT00953147|3934887|B3|AM and PM Nasal Itching||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.11|2.11|Standard Deviation|0.67|0.67|||
4110876|NCT00953147|3934888|B2|AM and PM Nasal Itching||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.10|2.1|Standard Deviation|0.60|0.6|||
4110877|NCT00953147|3934889|B1|AM and PM Nasal Itching||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.07|2.07|Standard Deviation|0.62|0.62|||
4110878|NCT00953147|3934886|B4|AM and PM Runny Nose||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.24|2.24|Standard Deviation|0.57|0.57|||
4110879|NCT00953147|3934887|B3|AM and PM Runny Nose||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.27|2.27|Standard Deviation|0.58|0.58|||
4110880|NCT00953147|3934888|B2|AM and PM Runny Nose||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.22|2.22|Standard Deviation|0.58|0.58|||
4110881|NCT00953147|3934889|B1|AM and PM Runny Nose||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.24|2.24|Standard Deviation|0.56|0.56|||
4110882|NCT00953147|3934886|B4|AM and PM Sneezing||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|1.78|1.78|Standard Deviation|0.69|0.69|||
4110883|NCT00953147|3934887|B3|AM and PM Sneezing||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|1.81|1.81|Standard Deviation|0.69|0.69|||
4110884|NCT00953147|3934888|B2|AM and PM Sneezing||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|1.76|1.76|Standard Deviation|0.69|0.69|||
4110885|NCT00953147|3934889|B1|AM and PM Sneezing||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|1.77|1.77|Standard Deviation|0.68|0.68|||
4110886|NCT00953147|3934886|B4|PM Nasal Congestion||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.39|2.39|Standard Deviation|0.53|0.53|||
4110978|NCT00953147|3934886|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|216|216.0||||||
4110887|NCT00953147|3934887|B3|PM Nasal Congestion||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.38|2.38|Standard Deviation|0.54|0.54|||
4110888|NCT00953147|3934888|B2|PM Nasal Congestion||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.38|2.38|Standard Deviation|0.52|0.52|||
4110889|NCT00953147|3934889|B1|PM Nasal Congestion||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.42|2.42|Standard Deviation|0.53|0.53|||
4110890|NCT00953147|3934886|B4|PM Nasal Itching||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.11|2.11|Standard Deviation|0.64|0.64|||
4110891|NCT00953147|3934887|B3|PM Nasal Itching||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.12|2.12|Standard Deviation|0.69|0.69|||
4110892|NCT00953147|3934888|B2|PM Nasal Itching||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.12|2.12|Standard Deviation|0.60|0.6|||
4110893|NCT00953147|3934889|B1|PM Nasal Itching||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.08|2.08|Standard Deviation|0.64|0.64|||
4110894|NCT00953147|3934886|B4|PM Runny Nose||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.24|2.24|Standard Deviation|0.60|0.6|||
4110895|NCT00953147|3934887|B3|PM Runny Nose||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.27|2.27|Standard Deviation|0.60|0.6|||
4110896|NCT00953147|3934888|B2|PM Runny Nose||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.23|2.23|Standard Deviation|0.60|0.6|||
4110897|NCT00953147|3934889|B1|PM Runny Nose||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.23|2.23|Standard Deviation|0.59|0.59|||
4110898|NCT00953147|3934886|B4|PM Sneezing||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|1.83|1.83|Standard Deviation|0.69|0.69|||
4110899|NCT00953147|3934887|B3|PM Sneezing||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|1.88|1.88|Standard Deviation|0.69|0.69|||
4110979|NCT00953147|3934887|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4110900|NCT00953147|3934888|B2|PM Sneezing||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|1.81|1.81|Standard Deviation|0.70|0.7|||
4110901|NCT00953147|3934889|B1|PM Sneezing||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|1.81|1.81|Standard Deviation|0.68|0.68|||
4110902|NCT00953147|3934886|B4|AM Nasal Congestion||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.47|2.47|Standard Deviation|0.50|0.5|||
4110903|NCT00953147|3934887|B3|AM Nasal Congestion||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.47|2.47|Standard Deviation|0.53|0.53|||
4110904|NCT00953147|3934888|B2|AM Nasal Congestion||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.46|2.46|Standard Deviation|0.49|0.49|||
4110905|NCT00953147|3934889|B1|AM Nasal Congestion||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.48|2.48|Standard Deviation|0.49|0.49|||
4110906|NCT00953147|3934886|B4|AM Nasal Itching||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.08|2.08|Standard Deviation|0.64|0.64|||
4110907|NCT00953147|3934887|B3|AM Nasal Itching||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.09|2.09|Standard Deviation|0.69|0.69|||
4110908|NCT00953147|3934888|B2|AM Nasal Itching||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.08|2.08|Standard Deviation|0.62|0.62|||
4110909|NCT00953147|3934889|B1|AM Nasal Itching||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.06|2.06|Standard Deviation|0.64|0.64|||
4110910|NCT00953147|3934886|B4|AM Runny Nose||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.24|2.24|Standard Deviation|0.59|0.59|||
4110911|NCT00953147|3934887|B3|AM Runny Nose||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.28|2.28|Standard Deviation|0.60|0.6|||
4110912|NCT00953147|3934888|B2|AM Runny Nose||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.22|2.22|Standard Deviation|0.59|0.59|||
4110980|NCT00953147|3934888|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
4110913|NCT00953147|3934889|B1|AM Runny Nose||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|2.24|2.24|Standard Deviation|0.59|0.59|||
4110914|NCT00953147|3934886|B4|AM Sneezing||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|1.73|1.73|Standard Deviation|0.73|0.73|||
4110915|NCT00953147|3934887|B3|AM Sneezing||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|1.75|1.75|Standard Deviation|0.74|0.74|||
4110916|NCT00953147|3934888|B2|AM Sneezing||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|1.71|1.71|Standard Deviation|0.72|0.72|||
4110917|NCT00953147|3934889|B1|AM Sneezing||Baseline Reflective Nasal Symptom Score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|1.73|1.73|Standard Deviation|0.73|0.73|||
4110918|NCT00953147|3934886|B4|AM and PM||Baseline Instanteous Total Nasal Symptom Score (iTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, iTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TNSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|7.66|7.66|Standard Deviation|2.30|2.3|||
4110919|NCT00953147|3934887|B3|AM and PM||Baseline Instanteous Total Nasal Symptom Score (iTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, iTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TNSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|7.70|7.7|Standard Deviation|2.38|2.38|||
4110920|NCT00953147|3934888|B2|AM and PM||Baseline Instanteous Total Nasal Symptom Score (iTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, iTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TNSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|7.64|7.64|Standard Deviation|2.27|2.27|||
4110921|NCT00953147|3934889|B1|AM and PM||Baseline Instanteous Total Nasal Symptom Score (iTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, iTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TNSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|7.66|7.66|Standard Deviation|2.28|2.28|||
4110922|NCT00953147|3934886|B4|PM||Baseline Instanteous Total Nasal Symptom Score (iTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, iTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TNSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|7.38|7.38|Standard Deviation|2.46|2.46|||
4110923|NCT00953147|3934887|B3|PM||Baseline Instanteous Total Nasal Symptom Score (iTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, iTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TNSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|7.39|7.39|Standard Deviation|2.55|2.55|||
4110981|NCT00953147|3934889|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4110982|NCT00953147|3934886|B4||Male|Sex: Female, Male||Participants|Count of Participants|394|394.0||||||
4110983|NCT00953147|3934887|B3||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4110984|NCT00953147|3934888|B2||Male|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4110924|NCT00953147|3934888|B2|PM||Baseline Instanteous Total Nasal Symptom Score (iTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, iTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TNSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|7.38|7.38|Standard Deviation|2.41|2.41|||
4110925|NCT00953147|3934889|B1|PM||Baseline Instanteous Total Nasal Symptom Score (iTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, iTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TNSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|7.38|7.38|Standard Deviation|2.43|2.43|||
4110926|NCT00953147|3934886|B4|AM||Baseline Instanteous Total Nasal Symptom Score (iTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, iTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TNSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|7.93|7.93|Standard Deviation|2.29|2.29|||
4110927|NCT00953147|3934887|B3|AM||Baseline Instanteous Total Nasal Symptom Score (iTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, iTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TNSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|8.01|8.01|Standard Deviation|2.37|2.37|||
4110928|NCT00953147|3934888|B2|AM||Baseline Instanteous Total Nasal Symptom Score (iTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, iTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TNSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|7.89|7.89|Standard Deviation|2.24|2.24|||
4110929|NCT00953147|3934889|B1|AM||Baseline Instanteous Total Nasal Symptom Score (iTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, iTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TNSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|7.93|7.93|Standard Deviation|2.27|2.27|||
4110930|NCT00953147|3934886|B4|AM and PM||Baseline Reflective Total Nasal Symptom Score (rTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|8.54|8.54|Standard Deviation|1.83|1.83|||
4110931|NCT00953147|3934887|B3|AM and PM||Baseline Reflective Total Nasal Symptom Score (rTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|8.62|8.62|Standard Deviation|1.88|1.88|||
4110932|NCT00953147|3934888|B2|AM and PM||Baseline Reflective Total Nasal Symptom Score (rTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|8.50|8.5|Standard Deviation|1.81|1.81|||
4110933|NCT00953147|3934889|B1|AM and PM||Baseline Reflective Total Nasal Symptom Score (rTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|8.53|8.53|Standard Deviation|1.82|1.82|||
4110934|NCT00953147|3934886|B4|PM||Baseline Reflective Total Nasal Symptom Score (rTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|8.57|8.57|Standard Deviation|1.88|1.88|||
4110935|NCT00953147|3934887|B3|PM||Baseline Reflective Total Nasal Symptom Score (rTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|8.64|8.64|Standard Deviation|1.92|1.92|||
4110936|NCT00953147|3934888|B2|PM||Baseline Reflective Total Nasal Symptom Score (rTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|8.54|8.54|Standard Deviation|1.84|1.84|||
4110937|NCT00953147|3934889|B1|PM||Baseline Reflective Total Nasal Symptom Score (rTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|8.53|8.53|Standard Deviation|1.91|1.91|||
4110938|NCT00953147|3934886|B4|AM||Baseline Reflective Total Nasal Symptom Score (rTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|8.52|8.52|Standard Deviation|1.90|1.9|||
4110939|NCT00953147|3934887|B3|AM||Baseline Reflective Total Nasal Symptom Score (rTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|8.60|8.6|Standard Deviation|1.96|1.96|||
4110940|NCT00953147|3934888|B2|AM||Baseline Reflective Total Nasal Symptom Score (rTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|8.48|8.48|Standard Deviation|1.88|1.88|||
4110941|NCT00953147|3934889|B1|AM||Baseline Reflective Total Nasal Symptom Score (rTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|units on a scale|Mean|8.51|8.51|Standard Deviation|1.89|1.89|||
4110942|NCT00953147|3934886|B4|Multiple||Race/Ethnicity||participants|Number|6|6.0||||||
4110943|NCT00953147|3934887|B3|Multiple||Race/Ethnicity||participants|Number|0|0.0||||||
4110944|NCT00953147|3934888|B2|Multiple||Race/Ethnicity||participants|Number|5|5.0||||||
4110945|NCT00953147|3934889|B1|Multiple||Race/Ethnicity||participants|Number|1|1.0||||||
4110946|NCT00953147|3934886|B4|Other||Race/Ethnicity||participants|Number|12|12.0||||||
4110947|NCT00953147|3934887|B3|Other||Race/Ethnicity||participants|Number|3|3.0||||||
4110948|NCT00953147|3934888|B2|Other||Race/Ethnicity||participants|Number|6|6.0||||||
4110949|NCT00953147|3934889|B1|Other||Race/Ethnicity||participants|Number|3|3.0||||||
4110950|NCT00953147|3934886|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity||participants|Number|4|4.0||||||
4110951|NCT00953147|3934887|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity||participants|Number|0|0.0||||||
4110952|NCT00953147|3934888|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity||participants|Number|4|4.0||||||
4110953|NCT00953147|3934889|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity||participants|Number|0|0.0||||||
4110954|NCT00953147|3934886|B4|American Indian or Alaska Native||Race/Ethnicity||participants|Number|2|2.0||||||
4110955|NCT00953147|3934887|B3|American Indian or Alaska Native||Race/Ethnicity||participants|Number|0|0.0||||||
4110956|NCT00953147|3934888|B2|American Indian or Alaska Native||Race/Ethnicity||participants|Number|0|0.0||||||
4110957|NCT00953147|3934889|B1|American Indian or Alaska Native||Race/Ethnicity||participants|Number|2|2.0||||||
4110958|NCT00953147|3934886|B4|Asian||Race/Ethnicity||participants|Number|18|18.0||||||
4110959|NCT00953147|3934887|B3|Asian||Race/Ethnicity||participants|Number|10|10.0||||||
4110960|NCT00953147|3934888|B2|Asian||Race/Ethnicity||participants|Number|5|5.0||||||
4110961|NCT00953147|3934889|B1|Asian||Race/Ethnicity||participants|Number|3|3.0||||||
4110962|NCT00953147|3934886|B4|Black or African American||Race/Ethnicity||participants|Number|146|146.0||||||
4110963|NCT00953147|3934887|B3|Black or African American||Race/Ethnicity||participants|Number|41|41.0||||||
4110964|NCT00953147|3934888|B2|Black or African American||Race/Ethnicity||participants|Number|65|65.0||||||
4110985|NCT00953147|3934889|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4110986|NCT00953147|3934886|B4||Female|Sex: Female, Male||Participants|Count of Participants|716|716.0||||||
4110987|NCT00953147|3934887|B3||Female|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4110988|NCT00953147|3934888|B2||Female|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
4110989|NCT00953147|3934889|B1||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4110990|NCT00953147|3934886|B4|||Age||years|Mean|37.2|37.2|Standard Deviation|13.5|13.5|||
4110991|NCT00953147|3934887|B3|||Age||years|Mean|38.0|38.0|Standard Deviation|13.1|13.1|||
4110992|NCT00953147|3934888|B2|||Age||years|Mean|36.5|36.5|Standard Deviation|13.2|13.2|||
4110993|NCT00953147|3934889|B1|||Age||years|Mean|37.5|37.5|Standard Deviation|14.3|14.3|||
4110994|NCT00953147|3934886|B4||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4110995|NCT00953147|3934887|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4110996|NCT00953147|3934888|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4110997|NCT00953147|3934889|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4110998|NCT00953147|3934886|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1001|1001.0||||||
4110999|NCT00953147|3934887|B3||Between 18 and 65 years|Age||Participants|Count of Participants|282|282.0||||||
4111000|NCT00953147|3934888|B2||Between 18 and 65 years|Age||Participants|Count of Participants|455|455.0||||||
4111001|NCT00953147|3934889|B1||Between 18 and 65 years|Age||Participants|Count of Participants|264|264.0||||||
4111002|NCT00953147|3934886|B4||<=18 years|Age||Participants|Count of Participants|88|88.0||||||
4111003|NCT00953147|3934887|B3||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
4111004|NCT00953147|3934888|B2||<=18 years|Age||Participants|Count of Participants|44|44.0||||||
4111005|NCT00953147|3934889|B1||<=18 years|Age||Participants|Count of Participants|27|27.0||||||
4111006|NCT00953121|3934938|B4||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4111007|NCT00953121|3934939|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4111008|NCT00953121|3934940|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4111009|NCT00953121|3934941|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4111010|NCT00953121|3934938|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4111011|NCT00953121|3934939|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4111012|NCT00953121|3934940|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4111013|NCT00953121|3934941|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4111014|NCT00953121|3934938|B4|||Age||years|Median|50|50.0|Full Range|||19.0|76.0|
4111015|NCT00953121|3934939|B3|||Age||years|Median|52|52.0|Full Range|||19.0|76.0|
4111016|NCT00953121|3934940|B2|||Age||years|Median|47|47.0|Full Range|||26.0|71.0|
4111017|NCT00953121|3934941|B1|||Age||years|Median|51|51.0|Full Range|||25.0|72.0|
4111018|NCT00953056|3934963|B7|China||Region of Enrollment||participants|Number|144|144.0||||||
4111019|NCT00953056|3934964|B6|China||Region of Enrollment||participants|Number|24|24.0||||||
4111020|NCT00953056|3934965|B5|China||Region of Enrollment||participants|Number|24|24.0||||||
4111021|NCT00953056|3934966|B4|China||Region of Enrollment||participants|Number|24|24.0||||||
4111022|NCT00953056|3934967|B3|China||Region of Enrollment||participants|Number|24|24.0||||||
4111023|NCT00953056|3934968|B2|China||Region of Enrollment||participants|Number|24|24.0||||||
4111024|NCT00953056|3934969|B1|China||Region of Enrollment||participants|Number|24|24.0||||||
4111025|NCT00953056|3934963|B7||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4111026|NCT00953056|3934964|B6||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4111027|NCT00953056|3934965|B5||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4111028|NCT00953056|3934966|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4111029|NCT00953056|3934967|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4111030|NCT00953056|3934968|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4111031|NCT00953056|3934969|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4111032|NCT00953056|3934963|B7||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4111033|NCT00953056|3934964|B6||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4111034|NCT00953056|3934965|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4111035|NCT00953056|3934966|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4111036|NCT00953056|3934967|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4111037|NCT00953056|3934968|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4111038|NCT00953056|3934969|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4111039|NCT00953056|3934963|B7|19 years to 49 years (adults)||Age, Customized|The inclusion criterion for Cohort I (adults) in this study was 19-47 years. However, one participant who was 49 years at study entry was randomized.|participants|Number|48|48.0||||||
4111040|NCT00953056|3934964|B6|19 years to 49 years (adults)||Age, Customized|The inclusion criterion for Cohort I (adults) in this study was 19-47 years. However, one participant who was 49 years at study entry was randomized.|participants|Number|0|0.0||||||
4111041|NCT00953056|3934965|B5|19 years to 49 years (adults)||Age, Customized|The inclusion criterion for Cohort I (adults) in this study was 19-47 years. However, one participant who was 49 years at study entry was randomized.|participants|Number|0|0.0||||||
4111042|NCT00953056|3934966|B4|19 years to 49 years (adults)||Age, Customized|The inclusion criterion for Cohort I (adults) in this study was 19-47 years. However, one participant who was 49 years at study entry was randomized.|participants|Number|0|0.0||||||
4111043|NCT00953056|3934967|B3|19 years to 49 years (adults)||Age, Customized|The inclusion criterion for Cohort I (adults) in this study was 19-47 years. However, one participant who was 49 years at study entry was randomized.|participants|Number|0|0.0||||||
4111044|NCT00953056|3934968|B2|19 years to 49 years (adults)||Age, Customized|The inclusion criterion for Cohort I (adults) in this study was 19-47 years. However, one participant who was 49 years at study entry was randomized.|participants|Number|24|24.0||||||
4111045|NCT00953056|3934969|B1|19 years to 49 years (adults)||Age, Customized|The inclusion criterion for Cohort I (adults) in this study was 19-47 years. However, one participant who was 49 years at study entry was randomized.|participants|Number|24|24.0||||||
4111046|NCT00953056|3934963|B7|2 years to 5 years (children)||Age, Customized|The inclusion criterion for Cohort I (adults) in this study was 19-47 years. However, one participant who was 49 years at study entry was randomized.|participants|Number|48|48.0||||||
4111047|NCT00953056|3934964|B6|2 years to 5 years (children)||Age, Customized|The inclusion criterion for Cohort I (adults) in this study was 19-47 years. However, one participant who was 49 years at study entry was randomized.|participants|Number|0|0.0||||||
4111048|NCT00953056|3934965|B5|2 years to 5 years (children)||Age, Customized|The inclusion criterion for Cohort I (adults) in this study was 19-47 years. However, one participant who was 49 years at study entry was randomized.|participants|Number|0|0.0||||||
4111049|NCT00953056|3934966|B4|2 years to 5 years (children)||Age, Customized|The inclusion criterion for Cohort I (adults) in this study was 19-47 years. However, one participant who was 49 years at study entry was randomized.|participants|Number|24|24.0||||||
4111050|NCT00953056|3934967|B3|2 years to 5 years (children)||Age, Customized|The inclusion criterion for Cohort I (adults) in this study was 19-47 years. However, one participant who was 49 years at study entry was randomized.|participants|Number|24|24.0||||||
4111051|NCT00953056|3934968|B2|2 years to 5 years (children)||Age, Customized|The inclusion criterion for Cohort I (adults) in this study was 19-47 years. However, one participant who was 49 years at study entry was randomized.|participants|Number|0|0.0||||||
4111052|NCT00953056|3934969|B1|2 years to 5 years (children)||Age, Customized|The inclusion criterion for Cohort I (adults) in this study was 19-47 years. However, one participant who was 49 years at study entry was randomized.|participants|Number|0|0.0||||||
4111053|NCT00953056|3934963|B7|6 weeks to 12 weeks (infants)||Age, Customized|The inclusion criterion for Cohort I (adults) in this study was 19-47 years. However, one participant who was 49 years at study entry was randomized.|participants|Number|48|48.0||||||
4111054|NCT00953056|3934964|B6|6 weeks to 12 weeks (infants)||Age, Customized|The inclusion criterion for Cohort I (adults) in this study was 19-47 years. However, one participant who was 49 years at study entry was randomized.|participants|Number|24|24.0||||||
4111055|NCT00953056|3934965|B5|6 weeks to 12 weeks (infants)||Age, Customized|The inclusion criterion for Cohort I (adults) in this study was 19-47 years. However, one participant who was 49 years at study entry was randomized.|participants|Number|24|24.0||||||
4111056|NCT00953056|3934966|B4|6 weeks to 12 weeks (infants)||Age, Customized|The inclusion criterion for Cohort I (adults) in this study was 19-47 years. However, one participant who was 49 years at study entry was randomized.|participants|Number|0|0.0||||||
4111057|NCT00953056|3934967|B3|6 weeks to 12 weeks (infants)||Age, Customized|The inclusion criterion for Cohort I (adults) in this study was 19-47 years. However, one participant who was 49 years at study entry was randomized.|participants|Number|0|0.0||||||
4111058|NCT00953056|3934968|B2|6 weeks to 12 weeks (infants)||Age, Customized|The inclusion criterion for Cohort I (adults) in this study was 19-47 years. However, one participant who was 49 years at study entry was randomized.|participants|Number|0|0.0||||||
4111059|NCT00953056|3934969|B1|6 weeks to 12 weeks (infants)||Age, Customized|The inclusion criterion for Cohort I (adults) in this study was 19-47 years. However, one participant who was 49 years at study entry was randomized.|participants|Number|0|0.0||||||
4111060|NCT00953043|3934996|B3|||Body Mass Index (BMI)|Body mass index is defined as the individual's body weight divided by the square of his or her height.|kg/m^2|Mean|25.4|25.4|Standard Deviation|0.45|0.45|||
4111061|NCT00953043|3934997|B2|||Body Mass Index (BMI)|Body mass index is defined as the individual's body weight divided by the square of his or her height.|kg/m^2|Mean|25.5|25.5|Standard Deviation|0.74|0.74|||
4111062|NCT00953043|3934998|B1|||Body Mass Index (BMI)|Body mass index is defined as the individual's body weight divided by the square of his or her height.|kg/m^2|Mean|25.3|25.3|Standard Deviation|0.54|0.54|||
4111063|NCT00953043|3934996|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4111064|NCT00953043|3934997|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4111065|NCT00953043|3934998|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4111066|NCT00953043|3934996|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4111067|NCT00953043|3934997|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4111068|NCT00953043|3934998|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4111069|NCT00953043|3934996|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4111070|NCT00953043|3934997|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4111071|NCT00953043|3934998|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4111072|NCT00953043|3934996|B3|||Age||years|Mean|34.1|34.1|Standard Deviation|1.58|1.58|||
4111073|NCT00953043|3934997|B2|||Age||years|Mean|33.2|33.2|Standard Deviation|2.18|2.18|||
4111074|NCT00953043|3934998|B1|||Age||years|Mean|35.1|35.1|Standard Deviation|2.31|2.31|||
4111075|NCT00953017|3935019|B5|United States||Region of Enrollment||participants|Number|425|425.0||||||
4111076|NCT00953017|3935020|B4|United States||Region of Enrollment||participants|Number|106|106.0||||||
4111077|NCT00953017|3935021|B3|United States||Region of Enrollment||participants|Number|106|106.0||||||
4111078|NCT00953017|3935022|B2|United States||Region of Enrollment||participants|Number|107|107.0||||||
4111079|NCT00953017|3935023|B1|United States||Region of Enrollment||participants|Number|106|106.0||||||
4111080|NCT00953017|3935019|B5||Male|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
4111081|NCT00953017|3935020|B4||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4111082|NCT00953017|3935021|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4111083|NCT00953017|3935022|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4111084|NCT00953017|3935023|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4111085|NCT00953017|3935019|B5||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
4111086|NCT00953017|3935020|B4||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4111087|NCT00953017|3935021|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4111088|NCT00953017|3935022|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4111089|NCT00953017|3935023|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4111090|NCT00953017|3935019|B5|||Age||years|Mean|54|54.0|Standard Deviation|5.7|5.7|||
4111091|NCT00953017|3935020|B4|||Age||years|Mean|54.2|54.2|Standard Deviation|6.7|6.7|||
4111092|NCT00953017|3935021|B3|||Age||years|Mean|54.1|54.1|Standard Deviation|5.3|5.3|||
4111093|NCT00953017|3935022|B2|||Age||years|Mean|53.8|53.8|Standard Deviation|5.4|5.4|||
4111094|NCT00953017|3935023|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|5.7|5.7|||
4111095|NCT00953017|3935019|B5||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4111096|NCT00953017|3935020|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4111097|NCT00953017|3935021|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4111098|NCT00953017|3935022|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4111099|NCT00953017|3935023|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4111100|NCT00953017|3935019|B5||Between 18 and 65 years|Age||Participants|Count of Participants|421|421.0||||||
4111101|NCT00953017|3935020|B4||Between 18 and 65 years|Age||Participants|Count of Participants|104|104.0||||||
4111102|NCT00953017|3935021|B3||Between 18 and 65 years|Age||Participants|Count of Participants|106|106.0||||||
4111103|NCT00953017|3935022|B2||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
4111104|NCT00953017|3935023|B1||Between 18 and 65 years|Age||Participants|Count of Participants|104|104.0||||||
4111105|NCT00953017|3935019|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4111106|NCT00953017|3935020|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4111107|NCT00953017|3935021|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4111108|NCT00953017|3935022|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4111109|NCT00953017|3935023|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4111110|NCT00952848|3935048|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4111111|NCT00952848|3935048|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4111112|NCT00952848|3935048|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4111113|NCT00952848|3935048|B1|||Age||years|Mean|60|60.0|Standard Deviation|5|5.0|||
4111114|NCT00952848|3935048|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4111115|NCT00952848|3935048|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4111116|NCT00952848|3935048|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4111117|NCT00952822|3935055|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4111118|NCT00952822|3935055|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4111119|NCT00952822|3935055|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4111120|NCT00952822|3935055|B1|Adolescents/Adults||Age||years|Mean|26|26.0|Standard Deviation|10|10.0|||
4111121|NCT00952822|3935055|B1|Pediatrics||Age||years|Mean|6|6.0|Standard Deviation|3|3.0|||
4111122|NCT00952822|3935055|B1|≥16 to 65 years (Number Adults)||Age, Customized||participants|Number|24|24.0||||||
4111123|NCT00952822|3935055|B1|≥12 to <16 years (Number Adolescents)||Age, Customized||participants|Number|3|3.0||||||
4111124|NCT00952822|3935055|B1|≥2 to <12 years (Number Pediatrics)||Age, Customized||participants|Number|15|15.0||||||
4111125|NCT00952731|3935088|B3|Post-Menopausal||Menopausal status||participants|Number|20|20.0||||||
4111126|NCT00952731|3935089|B2|Post-Menopausal||Menopausal status||participants|Number|11|11.0||||||
4111127|NCT00952731|3935090|B1|Post-Menopausal||Menopausal status||participants|Number|9|9.0||||||
4111128|NCT00952731|3935088|B3|Pre-Menopausal||Menopausal status||participants|Number|7|7.0||||||
4111129|NCT00952731|3935089|B2|Pre-Menopausal||Menopausal status||participants|Number|3|3.0||||||
4111130|NCT00952731|3935090|B1|Pre-Menopausal||Menopausal status||participants|Number|4|4.0||||||
4111131|NCT00952731|3935088|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
4111132|NCT00952731|3935089|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4111133|NCT00952731|3935090|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4111134|NCT00952731|3935088|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4111135|NCT00952731|3935089|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4111136|NCT00952731|3935090|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111137|NCT00952731|3935088|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111138|NCT00952731|3935089|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111139|NCT00952731|3935090|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111140|NCT00952731|3935088|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4111141|NCT00952731|3935089|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4111142|NCT00952731|3935090|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4111143|NCT00952731|3935088|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4111144|NCT00952731|3935089|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4111145|NCT00952731|3935090|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4111146|NCT00952731|3935088|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111147|NCT00952731|3935089|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111148|NCT00952731|3935090|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111149|NCT00952731|3935088|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4111150|NCT00952731|3935089|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111151|NCT00952731|3935090|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4111152|NCT00952731|3935088|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111153|NCT00952731|3935089|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111154|NCT00952731|3935090|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111155|NCT00952731|3935088|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4111156|NCT00952731|3935089|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4111157|NCT00952731|3935090|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4111158|NCT00952731|3935088|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4111159|NCT00952731|3935089|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4111160|NCT00952731|3935090|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4111161|NCT00952731|3935088|B3|80-89 years||Age, Customized||participants|Number|2|2.0||||||
4111162|NCT00952731|3935089|B2|80-89 years||Age, Customized||participants|Number|0|0.0||||||
4111163|NCT00952731|3935090|B1|80-89 years||Age, Customized||participants|Number|2|2.0||||||
4111164|NCT00952731|3935088|B3|70-79 years||Age, Customized||participants|Number|1|1.0||||||
4111165|NCT00952731|3935089|B2|70-79 years||Age, Customized||participants|Number|1|1.0||||||
4111166|NCT00952731|3935090|B1|70-79 years||Age, Customized||participants|Number|0|0.0||||||
4111167|NCT00952731|3935088|B3|60-69 years||Age, Customized||participants|Number|10|10.0||||||
4111168|NCT00952731|3935089|B2|60-69 years||Age, Customized||participants|Number|4|4.0||||||
4111169|NCT00952731|3935090|B1|60-69 years||Age, Customized||participants|Number|6|6.0||||||
4111170|NCT00952731|3935088|B3|50-59 years||Age, Customized||participants|Number|11|11.0||||||
4111171|NCT00952731|3935089|B2|50-59 years||Age, Customized||participants|Number|7|7.0||||||
4111172|NCT00952731|3935090|B1|50-59 years||Age, Customized||participants|Number|4|4.0||||||
4111173|NCT00952731|3935088|B3|40-49 years||Age, Customized||participants|Number|3|3.0||||||
4111174|NCT00952731|3935089|B2|40-49 years||Age, Customized||participants|Number|2|2.0||||||
4111175|NCT00952731|3935090|B1|40-49 years||Age, Customized||participants|Number|1|1.0||||||
4111176|NCT00952705|3935107|B4||Male|Sex: Female, Male||Participants|Count of Participants|763|763.0||||||
4111177|NCT00952705|3935108|B3||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4111178|NCT00952705|3935109|B2||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4111179|NCT00952705|3935110|B1||Male|Sex: Female, Male||Participants|Count of Participants|501|501.0||||||
4111180|NCT00952705|3935107|B4||Female|Sex: Female, Male||Participants|Count of Participants|1037|1037.0||||||
4111181|NCT00952705|3935108|B3||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4111182|NCT00952705|3935109|B2||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4111183|NCT00952705|3935110|B1||Female|Sex: Female, Male||Participants|Count of Participants|701|701.0||||||
4111184|NCT00952705|3935107|B4|||Age||Years|Mean|33.9|33.9|Standard Deviation|9.3|9.3|||
4111185|NCT00952705|3935108|B3|||Age||Years|Mean|33.8|33.8|Standard Deviation|8.8|8.8|||
4111186|NCT00952705|3935109|B2|||Age||Years|Mean|34.0|34.0|Standard Deviation|9.1|9.1|||
4111187|NCT00952705|3935110|B1|||Age||Years|Mean|33.9|33.9|Standard Deviation|9.5|9.5|||
4111188|NCT00952653|3935174|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4111189|NCT00952653|3935174|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4111190|NCT00952653|3935174|B1|> 45 years||Age, Customized||participants|Number|4|4.0||||||
4111191|NCT00952653|3935174|B1|36 to 45 years||Age, Customized||participants|Number|13|13.0||||||
4111192|NCT00952653|3935174|B1|26 to 35 years||Age, Customized||participants|Number|9|9.0||||||
4111193|NCT00952653|3935174|B1|18 to 25 years||Age, Customized||participants|Number|2|2.0||||||
4111194|NCT00952614|3935199|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4111195|NCT00952614|3935199|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4111196|NCT00952614|3935199|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4111197|NCT00952614|3935199|B1|||Age||years|Mean|68|68.0|Standard Deviation|9.1|9.1|||
4111198|NCT00952588|3935204|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4111199|NCT00952588|3935205|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4111200|NCT00952588|3935206|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4111201|NCT00952588|3935204|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4111202|NCT00952588|3935205|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4111203|NCT00952588|3935206|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4111204|NCT00952588|3935204|B3|||Age||years|Mean|74.0|74.0|Standard Deviation|6.03|6.03|||
4111205|NCT00952588|3935205|B2|||Age||years|Mean|71.5|71.5|Standard Deviation|5.75|5.75|||
4111206|NCT00952588|3935206|B1|||Age||years|Mean|75.3|75.3|Standard Deviation|5.79|5.79|||
4111207|NCT00952523|3935225|B1|United States||Region of Enrollment||participants|Number|162|162.0||||||
4111208|NCT00952523|3935225|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4111209|NCT00952523|3935225|B1||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4111210|NCT00952523|3935225|B1|||Age||years|Mean|31|31.0|Standard Deviation|8.2|8.2|||
4111211|NCT00952484|3935231|B4|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4111212|NCT00952484|3935232|B3|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4111213|NCT00952484|3935233|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4111214|NCT00952484|3935234|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4111215|NCT00952484|3935231|B4|United States||Region of Enrollment||participants|Number|25|25.0||||||
4111216|NCT00952484|3935232|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4111217|NCT00952484|3935233|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4111218|NCT00952484|3935234|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4111219|NCT00952484|3935231|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4111220|NCT00952484|3935232|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4111221|NCT00952484|3935233|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4111222|NCT00952484|3935234|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4111223|NCT00952484|3935231|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4111224|NCT00952484|3935232|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4111225|NCT00952484|3935233|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4111226|NCT00952484|3935234|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4111227|NCT00952484|3935231|B4|||Age||years|Mean|7.3|7.3|Standard Deviation|2.4|2.4|||
4111228|NCT00952484|3935232|B3|||Age||years|Mean|6.0|6.0|Standard Deviation|1.78|1.78|||
4111229|NCT00952484|3935233|B2|||Age||years|Mean|9.1|9.1|Standard Deviation|2.3|2.3|||
4111230|NCT00952484|3935234|B1|||Age||years|Mean|8.4|8.4|Standard Deviation|2.2|2.2|||
4111231|NCT00952484|3935231|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4111232|NCT00952484|3935232|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4111233|NCT00952484|3935233|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4111234|NCT00952484|3935234|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4111235|NCT00952484|3935231|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4111236|NCT00952484|3935232|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4111237|NCT00952484|3935233|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4111238|NCT00952484|3935234|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4111239|NCT00952484|3935231|B4||<=18 years|Age||Participants|Count of Participants|29|29.0||||||
4111240|NCT00952484|3935232|B3||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4111241|NCT00952484|3935233|B2||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4111242|NCT00952484|3935234|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4111243|NCT00952419|3935260|B4|United States||Region of Enrollment||participants|Number|474|474.0||||||
4111244|NCT00952419|3935261|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
4111245|NCT00952419|3935262|B2|United States||Region of Enrollment||participants|Number|208|208.0||||||
4111246|NCT00952419|3935263|B1|United States||Region of Enrollment||participants|Number|215|215.0||||||
4111247|NCT00952419|3935260|B4||Male|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
4111248|NCT00952419|3935261|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4111249|NCT00952419|3935262|B2||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4111250|NCT00952419|3935263|B1||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4111251|NCT00952419|3935260|B4||Female|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
4111252|NCT00952419|3935261|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4111253|NCT00952419|3935262|B2||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4111254|NCT00952419|3935263|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4111255|NCT00952419|3935260|B4|||Age||Years|Mean|4.2|4.2|Standard Deviation|2.8|2.8|||
4111256|NCT00952419|3935261|B3|||Age||Years|Mean|3.7|3.7|Standard Deviation|2.7|2.7|||
4111257|NCT00952419|3935262|B2|||Age||Years|Mean|4.3|4.3|Standard Deviation|2.8|2.8|||
4111258|NCT00952419|3935263|B1|||Age||Years|Mean|4.1|4.1|Standard Deviation|2.8|2.8|||
4111259|NCT00952419|3935260|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4111260|NCT00952419|3935261|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4111261|NCT00952419|3935262|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4111262|NCT00952419|3935263|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4111263|NCT00952419|3935260|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4111264|NCT00952419|3935261|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4111265|NCT00952419|3935262|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4111266|NCT00952419|3935263|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4111267|NCT00952419|3935260|B4||<=18 years|Age||Participants|Count of Participants|474|474.0||||||
4111268|NCT00952419|3935261|B3||<=18 years|Age||Participants|Count of Participants|51|51.0||||||
4111269|NCT00952419|3935262|B2||<=18 years|Age||Participants|Count of Participants|208|208.0||||||
4111270|NCT00952419|3935263|B1||<=18 years|Age||Participants|Count of Participants|215|215.0||||||
4111271|NCT00952393|3935297|B1|United States||Region of Enrollment|This is the area from which all the subjects come.|participants|Number|10|10.0||||||
4111272|NCT00952393|3935297|B1||Unknown or Not Reported|Race (NIH/OMB)|We ask the subjects to report their ethnicity.|Participants|Count of Participants|0|0.0||||||
4111273|NCT00952393|3935297|B1||More than one race|Race (NIH/OMB)|We ask the subjects to report their ethnicity.|Participants|Count of Participants|0|0.0||||||
4111274|NCT00952393|3935297|B1||White|Race (NIH/OMB)|We ask the subjects to report their ethnicity.|Participants|Count of Participants|7|7.0||||||
4111275|NCT00952393|3935297|B1||Black or African American|Race (NIH/OMB)|We ask the subjects to report their ethnicity.|Participants|Count of Participants|2|2.0||||||
4111276|NCT00952393|3935297|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|We ask the subjects to report their ethnicity.|Participants|Count of Participants|0|0.0||||||
4111277|NCT00952393|3935297|B1||Asian|Race (NIH/OMB)|We ask the subjects to report their ethnicity.|Participants|Count of Participants|1|1.0||||||
4111278|NCT00952393|3935297|B1||American Indian or Alaska Native|Race (NIH/OMB)|We ask the subjects to report their ethnicity.|Participants|Count of Participants|0|0.0||||||
4111279|NCT00952393|3935297|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111280|NCT00952393|3935297|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4111281|NCT00952393|3935297|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4111282|NCT00952393|3935297|B1||Male|Sex: Female, Male|This is gender or sex as determined by inquiry from the subjects|Participants|Count of Participants|7|7.0||||||
4111283|NCT00952393|3935297|B1||Female|Sex: Female, Male|This is gender or sex as determined by inquiry from the subjects|Participants|Count of Participants|3|3.0||||||
4111284|NCT00952393|3935297|B1|||Age|Age in years as determine by asking the subject when their birthdate is.|years|Mean|31.7|31.7|Standard Deviation|13.5|13.5|||
4111285|NCT00952367|3935301|B1||Male|Sex: Female, Male||Participants|Count of Participants|1882|1882.0||||||
4111286|NCT00952367|3935301|B1||Female|Sex: Female, Male||Participants|Count of Participants|1718|1718.0||||||
4111287|NCT00952367|3935301|B1|||Age||months|Mean|14.9|14.9|Standard Deviation|2.1|2.1|||
4111288|NCT00952341|3935314|B3|China||Region of Enrollment||participants|Number|421|421.0||||||
4111289|NCT00952341|3935315|B2|China||Region of Enrollment||participants|Number|212|212.0||||||
4111290|NCT00952341|3935316|B1|China||Region of Enrollment||participants|Number|209|209.0||||||
4111291|NCT00952341|3935314|B3||Male|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
4111292|NCT00952341|3935315|B2||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4111293|NCT00952341|3935316|B1||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4111294|NCT00952341|3935314|B3||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4111295|NCT00952341|3935315|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4111296|NCT00952341|3935316|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4111297|NCT00952341|3935314|B3|||Age||years|Mean|53.4|53.4|Standard Deviation|10.3|10.3|||
4111298|NCT00952341|3935315|B2|||Age||years|Mean|53.6|53.6|Standard Deviation|10.6|10.6|||
4111299|NCT00952341|3935316|B1|||Age||years|Mean|53.1|53.1|Standard Deviation|10.1|10.1|||
4111300|NCT00952289|3935337|B3|Unknown/Missing||JAK2 V617F Mutation Status|JAK2V617F is a mutation in the pseudokinase domain of Janus Kinase 2 (JAK2) (at amino acid 617, valine to phenylalanine) that results in constitutive activation of JAK2. Mutation status was determined using a validated assay on bone marrow as well as peripheral blood.|participants|Number|6|6.0||||||
4111301|NCT00952289|3935338|B2|Unknown/Missing||JAK2 V617F Mutation Status|JAK2V617F is a mutation in the pseudokinase domain of Janus Kinase 2 (JAK2) (at amino acid 617, valine to phenylalanine) that results in constitutive activation of JAK2. Mutation status was determined using a validated assay on bone marrow as well as peripheral blood.|participants|Number|4|4.0||||||
4111302|NCT00952289|3935339|B1|Unknown/Missing||JAK2 V617F Mutation Status|JAK2V617F is a mutation in the pseudokinase domain of Janus Kinase 2 (JAK2) (at amino acid 617, valine to phenylalanine) that results in constitutive activation of JAK2. Mutation status was determined using a validated assay on bone marrow as well as peripheral blood.|participants|Number|2|2.0||||||
4111303|NCT00952289|3935337|B3|Negative||JAK2 V617F Mutation Status|JAK2V617F is a mutation in the pseudokinase domain of Janus Kinase 2 (JAK2) (at amino acid 617, valine to phenylalanine) that results in constitutive activation of JAK2. Mutation status was determined using a validated assay on bone marrow as well as peripheral blood.|participants|Number|67|67.0||||||
4111304|NCT00952289|3935338|B2|Negative||JAK2 V617F Mutation Status|JAK2V617F is a mutation in the pseudokinase domain of Janus Kinase 2 (JAK2) (at amino acid 617, valine to phenylalanine) that results in constitutive activation of JAK2. Mutation status was determined using a validated assay on bone marrow as well as peripheral blood.|participants|Number|27|27.0||||||
4111305|NCT00952289|3935339|B1|Negative||JAK2 V617F Mutation Status|JAK2V617F is a mutation in the pseudokinase domain of Janus Kinase 2 (JAK2) (at amino acid 617, valine to phenylalanine) that results in constitutive activation of JAK2. Mutation status was determined using a validated assay on bone marrow as well as peripheral blood.|participants|Number|40|40.0||||||
4111306|NCT00952289|3935337|B3|Positive||JAK2 V617F Mutation Status|JAK2V617F is a mutation in the pseudokinase domain of Janus Kinase 2 (JAK2) (at amino acid 617, valine to phenylalanine) that results in constitutive activation of JAK2. Mutation status was determined using a validated assay on bone marrow as well as peripheral blood.|participants|Number|236|236.0||||||
4111341|NCT00952289|3935339|B1|Male||Sex/Gender, Customized||participants|Number|79|79.0||||||
4111342|NCT00952289|3935337|B3|Female||Sex/Gender, Customized||participants|Number|141|141.0||||||
4111307|NCT00952289|3935338|B2|Positive||JAK2 V617F Mutation Status|JAK2V617F is a mutation in the pseudokinase domain of Janus Kinase 2 (JAK2) (at amino acid 617, valine to phenylalanine) that results in constitutive activation of JAK2. Mutation status was determined using a validated assay on bone marrow as well as peripheral blood.|participants|Number|123|123.0||||||
4111308|NCT00952289|3935339|B1|Positive||JAK2 V617F Mutation Status|JAK2V617F is a mutation in the pseudokinase domain of Janus Kinase 2 (JAK2) (at amino acid 617, valine to phenylalanine) that results in constitutive activation of JAK2. Mutation status was determined using a validated assay on bone marrow as well as peripheral blood.|participants|Number|113|113.0||||||
4111309|NCT00952289|3935337|B3|||Spleen volume|Spleen volume was measured by magnetic resonance imaging or computed tomography scans. Data for one patient in the placebo arm was not available because of loss of study data during a move by the clinical site.|cm˄3|Mean|2771.5|2771.5|Standard Deviation|1317.3|1317.3|||
4111310|NCT00952289|3935338|B2|||Spleen volume|Spleen volume was measured by magnetic resonance imaging or computed tomography scans. Data for one patient in the placebo arm was not available because of loss of study data during a move by the clinical site.|cm˄3|Mean|2797.6|2797.6|Standard Deviation|1388.5|1388.5|||
4111311|NCT00952289|3935339|B1|||Spleen volume|Spleen volume was measured by magnetic resonance imaging or computed tomography scans. Data for one patient in the placebo arm was not available because of loss of study data during a move by the clinical site.|cm˄3|Mean|2745.7|2745.7|Standard Deviation|1247.0|1247.0|||
4111312|NCT00952289|3935337|B3|Missing||Disease Subtype||participants|Number|1|1.0||||||
4111313|NCT00952289|3935338|B2|Missing||Disease Subtype||participants|Number|1|1.0||||||
4111314|NCT00952289|3935339|B1|Missing||Disease Subtype||participants|Number|0|0.0||||||
4111315|NCT00952289|3935337|B3|Post-essential thrombocythemia-myelofibrosis||Disease Subtype||participants|Number|57|57.0||||||
4111316|NCT00952289|3935338|B2|Post-essential thrombocythemia-myelofibrosis||Disease Subtype||participants|Number|22|22.0||||||
4111317|NCT00952289|3935339|B1|Post-essential thrombocythemia-myelofibrosis||Disease Subtype||participants|Number|35|35.0||||||
4111318|NCT00952289|3935337|B3|Post-polycythemia vera-myelofibrosis||Disease Subtype||participants|Number|97|97.0||||||
4111319|NCT00952289|3935338|B2|Post-polycythemia vera-myelofibrosis||Disease Subtype||participants|Number|47|47.0||||||
4111320|NCT00952289|3935339|B1|Post-polycythemia vera-myelofibrosis||Disease Subtype||participants|Number|50|50.0||||||
4111321|NCT00952289|3935337|B3|Primary myelofibrosis||Disease Subtype||participants|Number|154|154.0||||||
4111322|NCT00952289|3935338|B2|Primary myelofibrosis||Disease Subtype||participants|Number|84|84.0||||||
4111323|NCT00952289|3935339|B1|Primary myelofibrosis||Disease Subtype||participants|Number|70|70.0||||||
4111324|NCT00952289|3935337|B3|Other||Race/Ethnicity, Customized|Race data for one patient in the placebo arm was not available because of loss of study data during a move to a new location by the clinical site.|participants|Number|8|8.0||||||
4111325|NCT00952289|3935338|B2|Other||Race/Ethnicity, Customized|Race data for one patient in the placebo arm was not available because of loss of study data during a move to a new location by the clinical site.|participants|Number|3|3.0||||||
4111326|NCT00952289|3935339|B1|Other||Race/Ethnicity, Customized|Race data for one patient in the placebo arm was not available because of loss of study data during a move to a new location by the clinical site.|participants|Number|5|5.0||||||
4111327|NCT00952289|3935337|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Race data for one patient in the placebo arm was not available because of loss of study data during a move to a new location by the clinical site.|participants|Number|1|1.0||||||
4111328|NCT00952289|3935338|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Race data for one patient in the placebo arm was not available because of loss of study data during a move to a new location by the clinical site.|participants|Number|0|0.0||||||
4111329|NCT00952289|3935339|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Race data for one patient in the placebo arm was not available because of loss of study data during a move to a new location by the clinical site.|participants|Number|1|1.0||||||
4111330|NCT00952289|3935337|B3|Asian||Race/Ethnicity, Customized|Race data for one patient in the placebo arm was not available because of loss of study data during a move to a new location by the clinical site.|participants|Number|9|9.0||||||
4111331|NCT00952289|3935338|B2|Asian||Race/Ethnicity, Customized|Race data for one patient in the placebo arm was not available because of loss of study data during a move to a new location by the clinical site.|participants|Number|4|4.0||||||
4111332|NCT00952289|3935339|B1|Asian||Race/Ethnicity, Customized|Race data for one patient in the placebo arm was not available because of loss of study data during a move to a new location by the clinical site.|participants|Number|5|5.0||||||
4111333|NCT00952289|3935337|B3|White||Race/Ethnicity, Customized|Race data for one patient in the placebo arm was not available because of loss of study data during a move to a new location by the clinical site.|participants|Number|277|277.0||||||
4111334|NCT00952289|3935338|B2|White||Race/Ethnicity, Customized|Race data for one patient in the placebo arm was not available because of loss of study data during a move to a new location by the clinical site.|participants|Number|139|139.0||||||
4111335|NCT00952289|3935339|B1|White||Race/Ethnicity, Customized|Race data for one patient in the placebo arm was not available because of loss of study data during a move to a new location by the clinical site.|participants|Number|138|138.0||||||
4111336|NCT00952289|3935337|B3|Black or African American||Race/Ethnicity, Customized|Race data for one patient in the placebo arm was not available because of loss of study data during a move to a new location by the clinical site.|participants|Number|13|13.0||||||
4111337|NCT00952289|3935338|B2|Black or African American||Race/Ethnicity, Customized|Race data for one patient in the placebo arm was not available because of loss of study data during a move to a new location by the clinical site.|participants|Number|7|7.0||||||
4111338|NCT00952289|3935339|B1|Black or African American||Race/Ethnicity, Customized|Race data for one patient in the placebo arm was not available because of loss of study data during a move to a new location by the clinical site.|participants|Number|6|6.0||||||
4111339|NCT00952289|3935337|B3|Male||Sex/Gender, Customized||participants|Number|167|167.0||||||
4111340|NCT00952289|3935338|B2|Male||Sex/Gender, Customized||participants|Number|88|88.0||||||
4111343|NCT00952289|3935338|B2|Female||Sex/Gender, Customized||participants|Number|65|65.0||||||
4111344|NCT00952289|3935339|B1|Female||Sex/Gender, Customized||participants|Number|76|76.0||||||
4111345|NCT00952289|3935337|B3|||Age||years|Mean|67.7|67.7|Standard Deviation|8.78|8.78|||
4111346|NCT00952289|3935338|B2|||Age||years|Mean|68.7|68.7|Standard Deviation|8.66|8.66|||
4111347|NCT00952289|3935339|B1|||Age||years|Mean|66.7|66.7|Standard Deviation|8.82|8.82|||
4111348|NCT00952276|3935364|B6|United States||Region of Enrollment||Participants|Number|548|548.0||||||
4111349|NCT00952276|3935365|B5|United States||Region of Enrollment||Participants|Number|63|63.0||||||
4111350|NCT00952276|3935366|B4|United States||Region of Enrollment||Participants|Number|121|121.0||||||
4111351|NCT00952276|3935367|B3|United States||Region of Enrollment||Participants|Number|122|122.0||||||
4111352|NCT00952276|3935368|B2|United States||Region of Enrollment||Participants|Number|115|115.0||||||
4111353|NCT00952276|3935369|B1|United States||Region of Enrollment||Participants|Number|127|127.0||||||
4111354|NCT00952276|3935364|B6||Male|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
4111355|NCT00952276|3935365|B5||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4111356|NCT00952276|3935366|B4||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4111357|NCT00952276|3935367|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4111358|NCT00952276|3935368|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4111359|NCT00952276|3935369|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4111360|NCT00952276|3935364|B6||Female|Sex: Female, Male||Participants|Count of Participants|323|323.0||||||
4111361|NCT00952276|3935365|B5||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4111362|NCT00952276|3935366|B4||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4111363|NCT00952276|3935367|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4111364|NCT00952276|3935368|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4111365|NCT00952276|3935369|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4111366|NCT00952276|3935364|B6|Age Continuous||Age||Years|Mean|53.4|53.4|Standard Deviation|18.34|18.34|||
4111367|NCT00952276|3935365|B5|Age Continuous||Age||Years|Mean|54.7|54.7|Standard Deviation|16.7|16.7|||
4111368|NCT00952276|3935366|B4|Age Continuous||Age||Years|Mean|52.7|52.7|Standard Deviation|19.9|19.9|||
4111369|NCT00952276|3935367|B3|Age Continuous||Age||Years|Mean|51.9|51.9|Standard Deviation|18.0|18.0|||
4111370|NCT00952276|3935368|B2|Age Continuous||Age||Years|Mean|53.3|53.3|Standard Deviation|18.7|18.7|||
4111371|NCT00952276|3935369|B1|Age Continuous||Age||Years|Mean|54.0|54.0|Standard Deviation|18.4|18.4|||
4111372|NCT00952276|3935364|B6||>=65 years|Age||Participants|Count of Participants|222|222.0||||||
4111373|NCT00952276|3935365|B5||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4111374|NCT00952276|3935366|B4||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
4111375|NCT00952276|3935367|B3||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
4111376|NCT00952276|3935368|B2||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
4111377|NCT00952276|3935369|B1||>=65 years|Age||Participants|Count of Participants|52|52.0||||||
4111378|NCT00952276|3935364|B6||Between 18 and 65 years|Age||Participants|Count of Participants|326|326.0||||||
4111379|NCT00952276|3935365|B5||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4111380|NCT00952276|3935366|B4||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4111381|NCT00952276|3935367|B3||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4111382|NCT00952276|3935368|B2||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
4111383|NCT00952276|3935369|B1||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4111384|NCT00952276|3935364|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4111385|NCT00952276|3935365|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4111386|NCT00952276|3935366|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4111387|NCT00952276|3935367|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4111388|NCT00952276|3935368|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4111389|NCT00952276|3935369|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4111390|NCT00952211|3935420|B3|Male||Gender||participants|Number|1|1.0||||||
4111391|NCT00952211|3935422|B1|Male||Gender||participants|Number|1|1.0||||||
4111392|NCT00952211|3935420|B3|Female||Gender||participants|Number|2|2.0||||||
4111393|NCT00952211|3935422|B1|Female||Gender||participants|Number|2|2.0||||||
4111394|NCT00952211|3935420|B3|>=65 years||Age||participants|Number|1|1.0||||||
4111395|NCT00952211|3935422|B1|>=65 years||Age||participants|Number|1|1.0||||||
4111396|NCT00952211|3935420|B3|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
4111397|NCT00952211|3935422|B1|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
4111398|NCT00952211|3935420|B3|<=18 years||Age||participants|Number|0|0.0||||||
4111399|NCT00952211|3935422|B1|<=18 years||Age||participants|Number|0|0.0||||||
4111400|NCT00952133|3935431|B3|United States||Region of Enrollment||participants|Number|118|118.0||||||
4111401|NCT00952133|3935432|B2|United States||Region of Enrollment||participants|Number|59|59.0||||||
4111402|NCT00952133|3935433|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
4111403|NCT00952133|3935431|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4111404|NCT00952133|3935432|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4111405|NCT00952133|3935433|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4111406|NCT00952133|3935431|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4111407|NCT00952133|3935432|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4111408|NCT00952133|3935433|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4111409|NCT00952133|3935431|B3|||Age||years|Mean|35.7|35.7|Standard Deviation|8.4|8.4|||
4111410|NCT00952133|3935432|B2|||Age||years|Mean|36.2|36.2|Standard Deviation|8.1|8.1|||
4111411|NCT00952133|3935433|B1|||Age||years|Mean|35.2|35.2|Standard Deviation|8.8|8.8|||
4111412|NCT00952133|3935431|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4111413|NCT00952133|3935432|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4111414|NCT00952133|3935433|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4111415|NCT00952133|3935431|B3||Between 18 and 65 years|Age||Participants|Count of Participants|118|118.0||||||
4111416|NCT00952133|3935432|B2||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4111417|NCT00952133|3935433|B1||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4111418|NCT00952133|3935431|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4111419|NCT00952133|3935432|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4111420|NCT00952133|3935433|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4111421|NCT00952120|3935442|B4|United States||Region of Enrollment||participants|Number|104|104.0||||||
4111422|NCT00952120|3935443|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4111423|NCT00952120|3935444|B2|United States||Region of Enrollment||participants|Number|47|47.0||||||
4111424|NCT00952120|3935445|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
4111425|NCT00952120|3935442|B4||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4111426|NCT00952120|3935443|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4111427|NCT00952120|3935444|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4111428|NCT00952120|3935445|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4111429|NCT00952120|3935442|B4||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4111430|NCT00952120|3935443|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4111431|NCT00952120|3935444|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4111432|NCT00952120|3935445|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4111433|NCT00952120|3935442|B4|||Age||years|Mean|51.4|51.4|Standard Deviation|16.5|16.5|||
4111434|NCT00952120|3935443|B3|||Age||years|Mean|51.8|51.8|Standard Deviation|20.7|20.7|||
4111435|NCT00952120|3935444|B2|||Age||years|Mean|50.1|50.1|Standard Deviation|16.4|16.4|||
4111436|NCT00952120|3935445|B1|||Age||years|Mean|52.5|52.5|Standard Deviation|16.5|16.5|||
4111437|NCT00952081|3935455|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4111438|NCT00952081|3935455|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4111439|NCT00952081|3935455|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4111440|NCT00952081|3935455|B1|||Age||years|Mean|54|54.0|Standard Deviation|14.25|14.25|||
4111441|NCT00952081|3935455|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4111442|NCT00952081|3935455|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4111443|NCT00952081|3935455|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4111444|NCT00952068|3935459|B1|Romania||Region of Enrollment||participants|Number|47|47.0||||||
4111445|NCT00952068|3935459|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4111446|NCT00952068|3935459|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4111447|NCT00952068|3935459|B1|||Age||years|Mean|61.2|61.2|Standard Deviation|10.2|10.2|||
4111448|NCT00952068|3935459|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4111449|NCT00952068|3935459|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4111450|NCT00952068|3935459|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4111451|NCT00951912|3935467|B4|China||Region of Enrollment||participants|Number|165|165.0||||||
4111452|NCT00951912|3935468|B3|China||Region of Enrollment||participants|Number|56|56.0||||||
4111453|NCT00951912|3935469|B2|China||Region of Enrollment||participants|Number|55|55.0||||||
4111454|NCT00951912|3935470|B1|China||Region of Enrollment||participants|Number|54|54.0||||||
4111455|NCT00951912|3935467|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4111456|NCT00951912|3935468|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4111457|NCT00951912|3935469|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4111458|NCT00951912|3935470|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4111459|NCT00951912|3935467|B4||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4111460|NCT00951912|3935468|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4111461|NCT00951912|3935469|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4111462|NCT00951912|3935470|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4111463|NCT00951912|3935467|B4|||Age||years|Mean|56.57|56.57|Standard Deviation|10.17|10.17|||
4111464|NCT00951912|3935468|B3|||Age||years|Mean|57.02|57.02|Standard Deviation|9.68|9.68|||
4111465|NCT00951912|3935469|B2|||Age||years|Mean|56.36|56.36|Standard Deviation|9.90|9.9|||
4111466|NCT00951912|3935470|B1|||Age||years|Mean|56.31|56.31|Standard Deviation|11.07|11.07|||
4111467|NCT00951912|3935467|B4||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
4111468|NCT00951912|3935468|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4111469|NCT00951912|3935469|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4111470|NCT00951912|3935470|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4111471|NCT00951912|3935467|B4||Between 18 and 65 years|Age||Participants|Count of Participants|128|128.0||||||
4111472|NCT00951912|3935468|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4111473|NCT00951912|3935469|B2||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4111474|NCT00951912|3935470|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4111475|NCT00951912|3935467|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4111476|NCT00951912|3935468|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4111477|NCT00951912|3935469|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4111478|NCT00951912|3935470|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4111479|NCT00951899|3935522|B3|||Body Mass Index|Body Mass Index (BMI) is a health index for comparing weight to height. BMI is a person's weight in kilograms (kg) divided by his or her height in meters squared. The body mass index is an indication if a person is at a suitable weight for his height on an approximation of body fat.|kg/m^2|Mean|30.6|30.6|Standard Deviation|4.1|4.1|||
4111480|NCT00951899|3935523|B2|||Body Mass Index|Body Mass Index (BMI) is a health index for comparing weight to height. BMI is a person's weight in kilograms (kg) divided by his or her height in meters squared. The body mass index is an indication if a person is at a suitable weight for his height on an approximation of body fat.|kg/m^2|Mean|30.4|30.4|Standard Deviation|4.0|4.0|||
4111481|NCT00951899|3935524|B1|||Body Mass Index|Body Mass Index (BMI) is a health index for comparing weight to height. BMI is a person's weight in kilograms (kg) divided by his or her height in meters squared. The body mass index is an indication if a person is at a suitable weight for his height on an approximation of body fat.|kg/m^2|Mean|30.8|30.8|Standard Deviation|4.3|4.3|||
4111482|NCT00951899|3935522|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
4111483|NCT00951899|3935523|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4111484|NCT00951899|3935524|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4111485|NCT00951899|3935522|B3||Male|Sex: Female, Male|Gender reported for only the randomized subjects.|Participants|Count of Participants|26|26.0||||||
4111486|NCT00951899|3935523|B2||Male|Sex: Female, Male|Gender reported for only the randomized subjects.|Participants|Count of Participants|13|13.0||||||
4111487|NCT00951899|3935524|B1||Male|Sex: Female, Male|Gender reported for only the randomized subjects.|Participants|Count of Participants|13|13.0||||||
4111488|NCT00951899|3935522|B3||Female|Sex: Female, Male|Gender reported for only the randomized subjects.|Participants|Count of Participants|12|12.0||||||
4111489|NCT00951899|3935523|B2||Female|Sex: Female, Male|Gender reported for only the randomized subjects.|Participants|Count of Participants|6|6.0||||||
4111490|NCT00951899|3935524|B1||Female|Sex: Female, Male|Gender reported for only the randomized subjects.|Participants|Count of Participants|6|6.0||||||
4111491|NCT00951899|3935522|B3|||Age|Age is reported for the randomized subjects only.|years|Mean|61|61.0|Standard Deviation|6.1|6.1|||
4111492|NCT00951899|3935523|B2|||Age|Age is reported for the randomized subjects only.|years|Mean|60.2|60.2|Standard Deviation|6.3|6.3|||
4111493|NCT00951899|3935524|B1|||Age|Age is reported for the randomized subjects only.|years|Mean|62.6|62.6|Standard Deviation|5.9|5.9|||
4111494|NCT00951821|3935547|B3|||Beck Suicide Ideation Scale|Higher scores indicate greater suicidal ideation; full range 0 to 38|units on a scale|Mean|8.12|8.12|Full Range|||0.0|29.0|
4111495|NCT00951821|3935548|B2|||Beck Suicide Ideation Scale|Higher scores indicate greater suicidal ideation; full range 0 to 38|units on a scale|Mean|5.75|5.75|Full Range|||0.0|15.0|
4111496|NCT00951821|3935549|B1|||Beck Suicide Ideation Scale|Higher scores indicate greater suicidal ideation; full range 0 to 38|units on a scale|Mean|9.81|9.81|Full Range|||1.0|29.0|
4111497|NCT00951821|3935547|B3|||Beck Depression Inventory|Higher scores indicate greater depression; full range 0 to 60.|units on a scale|Mean|24.65|24.65|Full Range|||8.0|49.0|
4111498|NCT00951821|3935548|B2|||Beck Depression Inventory|Higher scores indicate greater depression; full range 0 to 60.|units on a scale|Mean|19.13|19.13|Full Range|||14.0|30.0|
4111499|NCT00951821|3935549|B1|||Beck Depression Inventory|Higher scores indicate greater depression; full range 0 to 60.|units on a scale|Mean|29.32|29.32|Full Range|||8.0|49.0|
4111500|NCT00951821|3935547|B3|United States||Region of Enrollment|Northeast|participants|Number|24|24.0||||||
4111501|NCT00951821|3935548|B2|United States||Region of Enrollment|Northeast|participants|Number|8|8.0||||||
4111502|NCT00951821|3935549|B1|United States||Region of Enrollment|Northeast|participants|Number|16|16.0||||||
4111503|NCT00951821|3935547|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)|A standard self-report form was used for adolescents to self-identify race and ethnicity|Participants|Count of Participants|0|0.0||||||
4111504|NCT00951821|3935548|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)|A standard self-report form was used for adolescents to self-identify race and ethnicity|Participants|Count of Participants|0|0.0||||||
4111505|NCT00951821|3935549|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|A standard self-report form was used for adolescents to self-identify race and ethnicity|Participants|Count of Participants|0|0.0||||||
4111506|NCT00951821|3935547|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)|A standard self-report form was used for adolescents to self-identify race and ethnicity|Participants|Count of Participants|22|22.0||||||
4111507|NCT00951821|3935548|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)|A standard self-report form was used for adolescents to self-identify race and ethnicity|Participants|Count of Participants|7|7.0||||||
4111508|NCT00951821|3935549|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|A standard self-report form was used for adolescents to self-identify race and ethnicity|Participants|Count of Participants|15|15.0||||||
4111509|NCT00951821|3935547|B3||Hispanic or Latino|Ethnicity (NIH/OMB)|A standard self-report form was used for adolescents to self-identify race and ethnicity|Participants|Count of Participants|2|2.0||||||
4111561|NCT00951665|3935567|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4111510|NCT00951821|3935548|B2||Hispanic or Latino|Ethnicity (NIH/OMB)|A standard self-report form was used for adolescents to self-identify race and ethnicity|Participants|Count of Participants|1|1.0||||||
4111511|NCT00951821|3935549|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|A standard self-report form was used for adolescents to self-identify race and ethnicity|Participants|Count of Participants|1|1.0||||||
4111512|NCT00951821|3935547|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4111513|NCT00951821|3935548|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4111514|NCT00951821|3935549|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4111515|NCT00951821|3935547|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4111516|NCT00951821|3935548|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4111517|NCT00951821|3935549|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4111518|NCT00951821|3935547|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4111519|NCT00951821|3935548|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4111520|NCT00951821|3935549|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4111521|NCT00951821|3935547|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4111522|NCT00951821|3935548|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111523|NCT00951821|3935549|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4111524|NCT00951821|3935547|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111525|NCT00951821|3935548|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111526|NCT00951821|3935549|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111527|NCT00951821|3935547|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111528|NCT00951821|3935548|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111529|NCT00951821|3935549|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111530|NCT00951821|3935547|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111531|NCT00951821|3935548|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111532|NCT00951821|3935549|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111533|NCT00951821|3935547|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4111534|NCT00951821|3935548|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4111535|NCT00951821|3935549|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4111536|NCT00951821|3935547|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4111537|NCT00951821|3935548|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4111538|NCT00951821|3935549|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4111539|NCT00951821|3935547|B3|||Age||years|Mean|14.45|14.45|Standard Deviation|1.72|1.72|||
4111540|NCT00951821|3935548|B2|||Age||years|Mean|14.0|14.0|Standard Deviation|1.69|1.69|||
4111541|NCT00951821|3935549|B1|||Age||years|Mean|14.69|14.69|Standard Deviation|1.78|1.78|||
4111542|NCT00951808|3935558|B1|Not applicable||Maximum secretory phospholipase A2 (sPLA2) value|Maximum secretory phospholipase A2 (sPLA2) value measured prior to acute chest syndrome (ACS) or discharge|participants|Number|34|34.0||||||
4111543|NCT00951808|3935558|B1|>200 - 800 ng/ml||Maximum secretory phospholipase A2 (sPLA2) value|Maximum secretory phospholipase A2 (sPLA2) value measured prior to acute chest syndrome (ACS) or discharge|participants|Number|28|28.0||||||
4111544|NCT00951808|3935558|B1|>100 - 200 ng/ml||Maximum secretory phospholipase A2 (sPLA2) value|Maximum secretory phospholipase A2 (sPLA2) value measured prior to acute chest syndrome (ACS) or discharge|participants|Number|13|13.0||||||
4111545|NCT00951808|3935558|B1|>50 - 100 ng/ml||Maximum secretory phospholipase A2 (sPLA2) value|Maximum secretory phospholipase A2 (sPLA2) value measured prior to acute chest syndrome (ACS) or discharge|participants|Number|22|22.0||||||
4111546|NCT00951808|3935558|B1|>25 - 50 ng/ml||Maximum secretory phospholipase A2 (sPLA2) value|Maximum secretory phospholipase A2 (sPLA2) value measured prior to acute chest syndrome (ACS) or discharge|participants|Number|34|34.0||||||
4111547|NCT00951808|3935558|B1|>0 - 25 ng/ml||Maximum secretory phospholipase A2 (sPLA2) value|Maximum secretory phospholipase A2 (sPLA2) value measured prior to acute chest syndrome (ACS) or discharge|participants|Number|106|106.0||||||
4111548|NCT00951808|3935558|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4111549|NCT00951808|3935558|B1|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4111550|NCT00951808|3935558|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|230|230.0||||||
4111551|NCT00951808|3935558|B1|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4111552|NCT00951808|3935558|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111553|NCT00951808|3935558|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|230|230.0||||||
4111554|NCT00951808|3935558|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4111555|NCT00951808|3935558|B1||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4111556|NCT00951808|3935558|B1||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4111557|NCT00951808|3935558|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4111558|NCT00951808|3935558|B1||Between 18 and 65 years|Age||Participants|Count of Participants|114|114.0||||||
4111559|NCT00951808|3935558|B1||<=18 years|Age||Participants|Count of Participants|122|122.0||||||
4111560|NCT00951665|3935566|B7||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4111562|NCT00951665|3935568|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4111563|NCT00951665|3935569|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4111564|NCT00951665|3935570|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4111565|NCT00951665|3935571|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4111566|NCT00951665|3935572|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4111567|NCT00951665|3935566|B7||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4111568|NCT00951665|3935567|B6||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4111569|NCT00951665|3935568|B5||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4111570|NCT00951665|3935569|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4111571|NCT00951665|3935570|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4111572|NCT00951665|3935571|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4111573|NCT00951665|3935572|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4111574|NCT00951665|3935566|B7|||Age||years|Mean|53.2|53.2|Standard Deviation|10.3|10.3|||
4111575|NCT00951665|3935567|B6|||Age||years|Mean|55.1|55.1|Standard Deviation|7.7|7.7|||
4111576|NCT00951665|3935568|B5|||Age||years|Mean|51.7|51.7|Standard Deviation|11.8|11.8|||
4111577|NCT00951665|3935569|B4|||Age||years|Mean|49.3|49.3|Standard Deviation|4.0|4.0|||
4111578|NCT00951665|3935570|B3|||Age||years|Mean|54.1|54.1|Standard Deviation|8.5|8.5|||
4111579|NCT00951665|3935571|B2|||Age||years|Mean|51.3|51.3|Standard Deviation|11.9|11.9|||
4111580|NCT00951665|3935572|B1|||Age||years|Mean|53.3|53.3|Standard Deviation|12.3|12.3|||
4111581|NCT00951561|3935678|B1|United States||Region of Enrollment||participants|Number|102|102.0||||||
4111582|NCT00951561|3935678|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4111583|NCT00951561|3935678|B1||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4111584|NCT00951561|3935678|B1|||Age||years|Mean|32.1|32.1|Standard Deviation|8.1|8.1|||
4111585|NCT00951561|3935678|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4111586|NCT00951561|3935678|B1||Between 18 and 65 years|Age||Participants|Count of Participants|102|102.0||||||
4111587|NCT00951561|3935678|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4111588|NCT00951509|3935686|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4111589|NCT00951509|3935686|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4111590|NCT00951509|3935686|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111591|NCT00951509|3935686|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4111592|NCT00951509|3935686|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4111593|NCT00951509|3935686|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111594|NCT00951509|3935686|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111595|NCT00951509|3935686|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111596|NCT00951509|3935686|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111597|NCT00951509|3935686|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4111598|NCT00951509|3935686|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4111599|NCT00951509|3935686|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4111600|NCT00951509|3935686|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4111601|NCT00951509|3935686|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4111602|NCT00951509|3935686|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4111603|NCT00951509|3935686|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4111604|NCT00951496|3935694|B4|Other/Not specified||Histology/Grade of tumor|The Histology/Grade lists how many participants entered the study with each type of tumor histology and the grade for the serous tumors. Histology is the type of tissue that the tumor is comprised of. The histologic types listed below include serous, endometrioid, clear cell, mucinous and other or not specified. Grading refers to (along with staging) describes the severity. Grade 1 tumor cells look a lot like normal ovarian cells. The outcome is good for grade I tumors. Grade 2 tumors are well differentiated. Grade 3 cells are more irregular and likely to metastasize.|Participants|Count of Participants|150|150.0||||||
4111605|NCT00951496|3935695|B3|Other/Not specified||Histology/Grade of tumor|The Histology/Grade lists how many participants entered the study with each type of tumor histology and the grade for the serous tumors. Histology is the type of tissue that the tumor is comprised of. The histologic types listed below include serous, endometrioid, clear cell, mucinous and other or not specified. Grading refers to (along with staging) describes the severity. Grade 1 tumor cells look a lot like normal ovarian cells. The outcome is good for grade I tumors. Grade 2 tumors are well differentiated. Grade 3 cells are more irregular and likely to metastasize.|Participants|Count of Participants|47|47.0||||||
4111606|NCT00951496|3935696|B2|Other/Not specified||Histology/Grade of tumor|The Histology/Grade lists how many participants entered the study with each type of tumor histology and the grade for the serous tumors. Histology is the type of tissue that the tumor is comprised of. The histologic types listed below include serous, endometrioid, clear cell, mucinous and other or not specified. Grading refers to (along with staging) describes the severity. Grade 1 tumor cells look a lot like normal ovarian cells. The outcome is good for grade I tumors. Grade 2 tumors are well differentiated. Grade 3 cells are more irregular and likely to metastasize.|Participants|Count of Participants|55|55.0||||||
4111677|NCT00951496|3935695|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4111678|NCT00951496|3935696|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4111607|NCT00951496|3935697|B1|Other/Not specified||Histology/Grade of tumor|The Histology/Grade lists how many participants entered the study with each type of tumor histology and the grade for the serous tumors. Histology is the type of tissue that the tumor is comprised of. The histologic types listed below include serous, endometrioid, clear cell, mucinous and other or not specified. Grading refers to (along with staging) describes the severity. Grade 1 tumor cells look a lot like normal ovarian cells. The outcome is good for grade I tumors. Grade 2 tumors are well differentiated. Grade 3 cells are more irregular and likely to metastasize.|Participants|Count of Participants|48|48.0||||||
4111608|NCT00951496|3935694|B4|Mucinous||Histology/Grade of tumor|The Histology/Grade lists how many participants entered the study with each type of tumor histology and the grade for the serous tumors. Histology is the type of tissue that the tumor is comprised of. The histologic types listed below include serous, endometrioid, clear cell, mucinous and other or not specified. Grading refers to (along with staging) describes the severity. Grade 1 tumor cells look a lot like normal ovarian cells. The outcome is good for grade I tumors. Grade 2 tumors are well differentiated. Grade 3 cells are more irregular and likely to metastasize.|Participants|Count of Participants|12|12.0||||||
4111609|NCT00951496|3935695|B3|Mucinous||Histology/Grade of tumor|The Histology/Grade lists how many participants entered the study with each type of tumor histology and the grade for the serous tumors. Histology is the type of tissue that the tumor is comprised of. The histologic types listed below include serous, endometrioid, clear cell, mucinous and other or not specified. Grading refers to (along with staging) describes the severity. Grade 1 tumor cells look a lot like normal ovarian cells. The outcome is good for grade I tumors. Grade 2 tumors are well differentiated. Grade 3 cells are more irregular and likely to metastasize.|Participants|Count of Participants|5|5.0||||||
4111610|NCT00951496|3935696|B2|Mucinous||Histology/Grade of tumor|The Histology/Grade lists how many participants entered the study with each type of tumor histology and the grade for the serous tumors. Histology is the type of tissue that the tumor is comprised of. The histologic types listed below include serous, endometrioid, clear cell, mucinous and other or not specified. Grading refers to (along with staging) describes the severity. Grade 1 tumor cells look a lot like normal ovarian cells. The outcome is good for grade I tumors. Grade 2 tumors are well differentiated. Grade 3 cells are more irregular and likely to metastasize.|Participants|Count of Participants|5|5.0||||||
4111611|NCT00951496|3935697|B1|Mucinous||Histology/Grade of tumor|The Histology/Grade lists how many participants entered the study with each type of tumor histology and the grade for the serous tumors. Histology is the type of tissue that the tumor is comprised of. The histologic types listed below include serous, endometrioid, clear cell, mucinous and other or not specified. Grading refers to (along with staging) describes the severity. Grade 1 tumor cells look a lot like normal ovarian cells. The outcome is good for grade I tumors. Grade 2 tumors are well differentiated. Grade 3 cells are more irregular and likely to metastasize.|Participants|Count of Participants|2|2.0||||||
4111612|NCT00951496|3935694|B4|Clear Cell||Histology/Grade of tumor|The Histology/Grade lists how many participants entered the study with each type of tumor histology and the grade for the serous tumors. Histology is the type of tissue that the tumor is comprised of. The histologic types listed below include serous, endometrioid, clear cell, mucinous and other or not specified. Grading refers to (along with staging) describes the severity. Grade 1 tumor cells look a lot like normal ovarian cells. The outcome is good for grade I tumors. Grade 2 tumors are well differentiated. Grade 3 cells are more irregular and likely to metastasize.|Participants|Count of Participants|87|87.0||||||
4111613|NCT00951496|3935695|B3|Clear Cell||Histology/Grade of tumor|The Histology/Grade lists how many participants entered the study with each type of tumor histology and the grade for the serous tumors. Histology is the type of tissue that the tumor is comprised of. The histologic types listed below include serous, endometrioid, clear cell, mucinous and other or not specified. Grading refers to (along with staging) describes the severity. Grade 1 tumor cells look a lot like normal ovarian cells. The outcome is good for grade I tumors. Grade 2 tumors are well differentiated. Grade 3 cells are more irregular and likely to metastasize.|Participants|Count of Participants|26|26.0||||||
4111614|NCT00951496|3935696|B2|Clear Cell||Histology/Grade of tumor|The Histology/Grade lists how many participants entered the study with each type of tumor histology and the grade for the serous tumors. Histology is the type of tissue that the tumor is comprised of. The histologic types listed below include serous, endometrioid, clear cell, mucinous and other or not specified. Grading refers to (along with staging) describes the severity. Grade 1 tumor cells look a lot like normal ovarian cells. The outcome is good for grade I tumors. Grade 2 tumors are well differentiated. Grade 3 cells are more irregular and likely to metastasize.|Participants|Count of Participants|29|29.0||||||
4111615|NCT00951496|3935697|B1|Clear Cell||Histology/Grade of tumor|The Histology/Grade lists how many participants entered the study with each type of tumor histology and the grade for the serous tumors. Histology is the type of tissue that the tumor is comprised of. The histologic types listed below include serous, endometrioid, clear cell, mucinous and other or not specified. Grading refers to (along with staging) describes the severity. Grade 1 tumor cells look a lot like normal ovarian cells. The outcome is good for grade I tumors. Grade 2 tumors are well differentiated. Grade 3 cells are more irregular and likely to metastasize.|Participants|Count of Participants|32|32.0||||||
4111616|NCT00951496|3935694|B4|Endometrioid||Histology/Grade of tumor|The Histology/Grade lists how many participants entered the study with each type of tumor histology and the grade for the serous tumors. Histology is the type of tissue that the tumor is comprised of. The histologic types listed below include serous, endometrioid, clear cell, mucinous and other or not specified. Grading refers to (along with staging) describes the severity. Grade 1 tumor cells look a lot like normal ovarian cells. The outcome is good for grade I tumors. Grade 2 tumors are well differentiated. Grade 3 cells are more irregular and likely to metastasize.|Participants|Count of Participants|11|11.0||||||
4111617|NCT00951496|3935695|B3|Endometrioid||Histology/Grade of tumor|The Histology/Grade lists how many participants entered the study with each type of tumor histology and the grade for the serous tumors. Histology is the type of tissue that the tumor is comprised of. The histologic types listed below include serous, endometrioid, clear cell, mucinous and other or not specified. Grading refers to (along with staging) describes the severity. Grade 1 tumor cells look a lot like normal ovarian cells. The outcome is good for grade I tumors. Grade 2 tumors are well differentiated. Grade 3 cells are more irregular and likely to metastasize.|Participants|Count of Participants|4|4.0||||||
4111679|NCT00951496|3935697|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4111618|NCT00951496|3935696|B2|Endometrioid||Histology/Grade of tumor|The Histology/Grade lists how many participants entered the study with each type of tumor histology and the grade for the serous tumors. Histology is the type of tissue that the tumor is comprised of. The histologic types listed below include serous, endometrioid, clear cell, mucinous and other or not specified. Grading refers to (along with staging) describes the severity. Grade 1 tumor cells look a lot like normal ovarian cells. The outcome is good for grade I tumors. Grade 2 tumors are well differentiated. Grade 3 cells are more irregular and likely to metastasize.|Participants|Count of Participants|2|2.0||||||
4111619|NCT00951496|3935697|B1|Endometrioid||Histology/Grade of tumor|The Histology/Grade lists how many participants entered the study with each type of tumor histology and the grade for the serous tumors. Histology is the type of tissue that the tumor is comprised of. The histologic types listed below include serous, endometrioid, clear cell, mucinous and other or not specified. Grading refers to (along with staging) describes the severity. Grade 1 tumor cells look a lot like normal ovarian cells. The outcome is good for grade I tumors. Grade 2 tumors are well differentiated. Grade 3 cells are more irregular and likely to metastasize.|Participants|Count of Participants|5|5.0||||||
4111620|NCT00951496|3935694|B4|Serous/Grade 3||Histology/Grade of tumor|The Histology/Grade lists how many participants entered the study with each type of tumor histology and the grade for the serous tumors. Histology is the type of tissue that the tumor is comprised of. The histologic types listed below include serous, endometrioid, clear cell, mucinous and other or not specified. Grading refers to (along with staging) describes the severity. Grade 1 tumor cells look a lot like normal ovarian cells. The outcome is good for grade I tumors. Grade 2 tumors are well differentiated. Grade 3 cells are more irregular and likely to metastasize.|Participants|Count of Participants|1126|1126.0||||||
4111621|NCT00951496|3935695|B3|Serous/Grade 3||Histology/Grade of tumor|The Histology/Grade lists how many participants entered the study with each type of tumor histology and the grade for the serous tumors. Histology is the type of tissue that the tumor is comprised of. The histologic types listed below include serous, endometrioid, clear cell, mucinous and other or not specified. Grading refers to (along with staging) describes the severity. Grade 1 tumor cells look a lot like normal ovarian cells. The outcome is good for grade I tumors. Grade 2 tumors are well differentiated. Grade 3 cells are more irregular and likely to metastasize.|Participants|Count of Participants|377|377.0||||||
4111622|NCT00951496|3935696|B2|Serous/Grade 3||Histology/Grade of tumor|The Histology/Grade lists how many participants entered the study with each type of tumor histology and the grade for the serous tumors. Histology is the type of tissue that the tumor is comprised of. The histologic types listed below include serous, endometrioid, clear cell, mucinous and other or not specified. Grading refers to (along with staging) describes the severity. Grade 1 tumor cells look a lot like normal ovarian cells. The outcome is good for grade I tumors. Grade 2 tumors are well differentiated. Grade 3 cells are more irregular and likely to metastasize.|Participants|Count of Participants|379|379.0||||||
4111623|NCT00951496|3935697|B1|Serous/Grade 3||Histology/Grade of tumor|The Histology/Grade lists how many participants entered the study with each type of tumor histology and the grade for the serous tumors. Histology is the type of tissue that the tumor is comprised of. The histologic types listed below include serous, endometrioid, clear cell, mucinous and other or not specified. Grading refers to (along with staging) describes the severity. Grade 1 tumor cells look a lot like normal ovarian cells. The outcome is good for grade I tumors. Grade 2 tumors are well differentiated. Grade 3 cells are more irregular and likely to metastasize.|Participants|Count of Participants|370|370.0||||||
4111624|NCT00951496|3935694|B4|Serous/Grade 2||Histology/Grade of tumor|The Histology/Grade lists how many participants entered the study with each type of tumor histology and the grade for the serous tumors. Histology is the type of tissue that the tumor is comprised of. The histologic types listed below include serous, endometrioid, clear cell, mucinous and other or not specified. Grading refers to (along with staging) describes the severity. Grade 1 tumor cells look a lot like normal ovarian cells. The outcome is good for grade I tumors. Grade 2 tumors are well differentiated. Grade 3 cells are more irregular and likely to metastasize.|Participants|Count of Participants|114|114.0||||||
4111625|NCT00951496|3935695|B3|Serous/Grade 2||Histology/Grade of tumor|The Histology/Grade lists how many participants entered the study with each type of tumor histology and the grade for the serous tumors. Histology is the type of tissue that the tumor is comprised of. The histologic types listed below include serous, endometrioid, clear cell, mucinous and other or not specified. Grading refers to (along with staging) describes the severity. Grade 1 tumor cells look a lot like normal ovarian cells. The outcome is good for grade I tumors. Grade 2 tumors are well differentiated. Grade 3 cells are more irregular and likely to metastasize.|Participants|Count of Participants|35|35.0||||||
4111626|NCT00951496|3935696|B2|Serous/Grade 2||Histology/Grade of tumor|The Histology/Grade lists how many participants entered the study with each type of tumor histology and the grade for the serous tumors. Histology is the type of tissue that the tumor is comprised of. The histologic types listed below include serous, endometrioid, clear cell, mucinous and other or not specified. Grading refers to (along with staging) describes the severity. Grade 1 tumor cells look a lot like normal ovarian cells. The outcome is good for grade I tumors. Grade 2 tumors are well differentiated. Grade 3 cells are more irregular and likely to metastasize.|Participants|Count of Participants|36|36.0||||||
4111627|NCT00951496|3935697|B1|Serous/Grade 2||Histology/Grade of tumor|The Histology/Grade lists how many participants entered the study with each type of tumor histology and the grade for the serous tumors. Histology is the type of tissue that the tumor is comprised of. The histologic types listed below include serous, endometrioid, clear cell, mucinous and other or not specified. Grading refers to (along with staging) describes the severity. Grade 1 tumor cells look a lot like normal ovarian cells. The outcome is good for grade I tumors. Grade 2 tumors are well differentiated. Grade 3 cells are more irregular and likely to metastasize.|Participants|Count of Participants|43|43.0||||||
4111628|NCT00951496|3935694|B4|Serous/Grade1||Histology/Grade of tumor|The Histology/Grade lists how many participants entered the study with each type of tumor histology and the grade for the serous tumors. Histology is the type of tissue that the tumor is comprised of. The histologic types listed below include serous, endometrioid, clear cell, mucinous and other or not specified. Grading refers to (along with staging) describes the severity. Grade 1 tumor cells look a lot like normal ovarian cells. The outcome is good for grade I tumors. Grade 2 tumors are well differentiated. Grade 3 cells are more irregular and likely to metastasize.|Participants|Count of Participants|59|59.0||||||
4111680|NCT00951496|3935694|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4111629|NCT00951496|3935695|B3|Serous/Grade1||Histology/Grade of tumor|The Histology/Grade lists how many participants entered the study with each type of tumor histology and the grade for the serous tumors. Histology is the type of tissue that the tumor is comprised of. The histologic types listed below include serous, endometrioid, clear cell, mucinous and other or not specified. Grading refers to (along with staging) describes the severity. Grade 1 tumor cells look a lot like normal ovarian cells. The outcome is good for grade I tumors. Grade 2 tumors are well differentiated. Grade 3 cells are more irregular and likely to metastasize.|Participants|Count of Participants|27|27.0||||||
4111630|NCT00951496|3935696|B2|Serous/Grade1||Histology/Grade of tumor|The Histology/Grade lists how many participants entered the study with each type of tumor histology and the grade for the serous tumors. Histology is the type of tissue that the tumor is comprised of. The histologic types listed below include serous, endometrioid, clear cell, mucinous and other or not specified. Grading refers to (along with staging) describes the severity. Grade 1 tumor cells look a lot like normal ovarian cells. The outcome is good for grade I tumors. Grade 2 tumors are well differentiated. Grade 3 cells are more irregular and likely to metastasize.|Participants|Count of Participants|12|12.0||||||
4111631|NCT00951496|3935697|B1|Serous/Grade1||Histology/Grade of tumor|The Histology/Grade lists how many participants entered the study with each type of tumor histology and the grade for the serous tumors. Histology is the type of tissue that the tumor is comprised of. The histologic types listed below include serous, endometrioid, clear cell, mucinous and other or not specified. Grading refers to (along with staging) describes the severity. Grade 1 tumor cells look a lot like normal ovarian cells. The outcome is good for grade I tumors. Grade 2 tumors are well differentiated. Grade 3 cells are more irregular and likely to metastasize.|Participants|Count of Participants|20|20.0||||||
4111632|NCT00951496|3935694|B4|> 1cm||Residual Disease Diameter||Participants|Count of Participants|108|108.0||||||
4111633|NCT00951496|3935695|B3|> 1cm||Residual Disease Diameter||Participants|Count of Participants|34|34.0||||||
4111634|NCT00951496|3935696|B2|> 1cm||Residual Disease Diameter||Participants|Count of Participants|32|32.0||||||
4111635|NCT00951496|3935697|B1|> 1cm||Residual Disease Diameter||Participants|Count of Participants|42|42.0||||||
4111636|NCT00951496|3935694|B4|0 < diameter <= 1cm||Residual Disease Diameter||Participants|Count of Participants|553|553.0||||||
4111637|NCT00951496|3935695|B3|0 < diameter <= 1cm||Residual Disease Diameter||Participants|Count of Participants|182|182.0||||||
4111638|NCT00951496|3935696|B2|0 < diameter <= 1cm||Residual Disease Diameter||Participants|Count of Participants|189|189.0||||||
4111639|NCT00951496|3935697|B1|0 < diameter <= 1cm||Residual Disease Diameter||Participants|Count of Participants|182|182.0||||||
4111640|NCT00951496|3935694|B4|Microscopic only||Residual Disease Diameter||Participants|Count of Participants|899|899.0||||||
4111641|NCT00951496|3935695|B3|Microscopic only||Residual Disease Diameter||Participants|Count of Participants|305|305.0||||||
4111642|NCT00951496|3935696|B2|Microscopic only||Residual Disease Diameter||Participants|Count of Participants|297|297.0||||||
4111643|NCT00951496|3935697|B1|Microscopic only||Residual Disease Diameter||Participants|Count of Participants|297|297.0||||||
4111644|NCT00951496|3935694|B4|Stage IV||FIGO Stage FIGO (International Federation of Gynecology & Obstetrics) Staging|FIGO staging of the Ovary was used. FIGO stage I includes all participants with disease confined to ovary. This stage has the best outcome, between 75 to 90% survival at 5 years. Stage II includes all participants with disease in ovaries and spread limited to pelvis (45 to 60% survival at 5 years). Stage III includes all participants with disease limited to abdomen. Stage IV disease includes all participants with distant metastasis outside the abdominal cavity. This stage has the worst outcome (<20% survival at 5 years)|Participants|Count of Participants|92|92.0||||||
4111645|NCT00951496|3935695|B3|Stage IV||FIGO Stage FIGO (International Federation of Gynecology & Obstetrics) Staging|FIGO staging of the Ovary was used. FIGO stage I includes all participants with disease confined to ovary. This stage has the best outcome, between 75 to 90% survival at 5 years. Stage II includes all participants with disease in ovaries and spread limited to pelvis (45 to 60% survival at 5 years). Stage III includes all participants with disease limited to abdomen. Stage IV disease includes all participants with distant metastasis outside the abdominal cavity. This stage has the worst outcome (<20% survival at 5 years)|Participants|Count of Participants|38|38.0||||||
4111646|NCT00951496|3935696|B2|Stage IV||FIGO Stage FIGO (International Federation of Gynecology & Obstetrics) Staging|FIGO staging of the Ovary was used. FIGO stage I includes all participants with disease confined to ovary. This stage has the best outcome, between 75 to 90% survival at 5 years. Stage II includes all participants with disease in ovaries and spread limited to pelvis (45 to 60% survival at 5 years). Stage III includes all participants with disease limited to abdomen. Stage IV disease includes all participants with distant metastasis outside the abdominal cavity. This stage has the worst outcome (<20% survival at 5 years)|Participants|Count of Participants|30|30.0||||||
4111647|NCT00951496|3935697|B1|Stage IV||FIGO Stage FIGO (International Federation of Gynecology & Obstetrics) Staging|FIGO staging of the Ovary was used. FIGO stage I includes all participants with disease confined to ovary. This stage has the best outcome, between 75 to 90% survival at 5 years. Stage II includes all participants with disease in ovaries and spread limited to pelvis (45 to 60% survival at 5 years). Stage III includes all participants with disease limited to abdomen. Stage IV disease includes all participants with distant metastasis outside the abdominal cavity. This stage has the worst outcome (<20% survival at 5 years)|Participants|Count of Participants|24|24.0||||||
4111648|NCT00951496|3935694|B4|Stage III||FIGO Stage FIGO (International Federation of Gynecology & Obstetrics) Staging|FIGO staging of the Ovary was used. FIGO stage I includes all participants with disease confined to ovary. This stage has the best outcome, between 75 to 90% survival at 5 years. Stage II includes all participants with disease in ovaries and spread limited to pelvis (45 to 60% survival at 5 years). Stage III includes all participants with disease limited to abdomen. Stage IV disease includes all participants with distant metastasis outside the abdominal cavity. This stage has the worst outcome (<20% survival at 5 years)|Participants|Count of Participants|1305|1305.0||||||
4111681|NCT00951496|3935695|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4111682|NCT00951496|3935696|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4111683|NCT00951496|3935697|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4111649|NCT00951496|3935695|B3|Stage III||FIGO Stage FIGO (International Federation of Gynecology & Obstetrics) Staging|FIGO staging of the Ovary was used. FIGO stage I includes all participants with disease confined to ovary. This stage has the best outcome, between 75 to 90% survival at 5 years. Stage II includes all participants with disease in ovaries and spread limited to pelvis (45 to 60% survival at 5 years). Stage III includes all participants with disease limited to abdomen. Stage IV disease includes all participants with distant metastasis outside the abdominal cavity. This stage has the worst outcome (<20% survival at 5 years)|Participants|Count of Participants|432|432.0||||||
4111650|NCT00951496|3935696|B2|Stage III||FIGO Stage FIGO (International Federation of Gynecology & Obstetrics) Staging|FIGO staging of the Ovary was used. FIGO stage I includes all participants with disease confined to ovary. This stage has the best outcome, between 75 to 90% survival at 5 years. Stage II includes all participants with disease in ovaries and spread limited to pelvis (45 to 60% survival at 5 years). Stage III includes all participants with disease limited to abdomen. Stage IV disease includes all participants with distant metastasis outside the abdominal cavity. This stage has the worst outcome (<20% survival at 5 years)|Participants|Count of Participants|432|432.0||||||
4111651|NCT00951496|3935697|B1|Stage III||FIGO Stage FIGO (International Federation of Gynecology & Obstetrics) Staging|FIGO staging of the Ovary was used. FIGO stage I includes all participants with disease confined to ovary. This stage has the best outcome, between 75 to 90% survival at 5 years. Stage II includes all participants with disease in ovaries and spread limited to pelvis (45 to 60% survival at 5 years). Stage III includes all participants with disease limited to abdomen. Stage IV disease includes all participants with distant metastasis outside the abdominal cavity. This stage has the worst outcome (<20% survival at 5 years)|Participants|Count of Participants|441|441.0||||||
4111652|NCT00951496|3935694|B4|Stage I-II||FIGO Stage FIGO (International Federation of Gynecology & Obstetrics) Staging|FIGO staging of the Ovary was used. FIGO stage I includes all participants with disease confined to ovary. This stage has the best outcome, between 75 to 90% survival at 5 years. Stage II includes all participants with disease in ovaries and spread limited to pelvis (45 to 60% survival at 5 years). Stage III includes all participants with disease limited to abdomen. Stage IV disease includes all participants with distant metastasis outside the abdominal cavity. This stage has the worst outcome (<20% survival at 5 years)|Participants|Count of Participants|163|163.0||||||
4111653|NCT00951496|3935695|B3|Stage I-II||FIGO Stage FIGO (International Federation of Gynecology & Obstetrics) Staging|FIGO staging of the Ovary was used. FIGO stage I includes all participants with disease confined to ovary. This stage has the best outcome, between 75 to 90% survival at 5 years. Stage II includes all participants with disease in ovaries and spread limited to pelvis (45 to 60% survival at 5 years). Stage III includes all participants with disease limited to abdomen. Stage IV disease includes all participants with distant metastasis outside the abdominal cavity. This stage has the worst outcome (<20% survival at 5 years)|Participants|Count of Participants|51|51.0||||||
4111654|NCT00951496|3935696|B2|Stage I-II||FIGO Stage FIGO (International Federation of Gynecology & Obstetrics) Staging|FIGO staging of the Ovary was used. FIGO stage I includes all participants with disease confined to ovary. This stage has the best outcome, between 75 to 90% survival at 5 years. Stage II includes all participants with disease in ovaries and spread limited to pelvis (45 to 60% survival at 5 years). Stage III includes all participants with disease limited to abdomen. Stage IV disease includes all participants with distant metastasis outside the abdominal cavity. This stage has the worst outcome (<20% survival at 5 years)|Participants|Count of Participants|56|56.0||||||
4111655|NCT00951496|3935697|B1|Stage I-II||FIGO Stage FIGO (International Federation of Gynecology & Obstetrics) Staging|FIGO staging of the Ovary was used. FIGO stage I includes all participants with disease confined to ovary. This stage has the best outcome, between 75 to 90% survival at 5 years. Stage II includes all participants with disease in ovaries and spread limited to pelvis (45 to 60% survival at 5 years). Stage III includes all participants with disease limited to abdomen. Stage IV disease includes all participants with distant metastasis outside the abdominal cavity. This stage has the worst outcome (<20% survival at 5 years)|Participants|Count of Participants|56|56.0||||||
4111656|NCT00951496|3935694|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4111657|NCT00951496|3935695|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4111658|NCT00951496|3935696|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4111659|NCT00951496|3935697|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4111660|NCT00951496|3935694|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111661|NCT00951496|3935695|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111662|NCT00951496|3935696|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111663|NCT00951496|3935697|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111664|NCT00951496|3935694|B4||White|Race (NIH/OMB)||Participants|Count of Participants|1427|1427.0||||||
4111665|NCT00951496|3935695|B3||White|Race (NIH/OMB)||Participants|Count of Participants|476|476.0||||||
4111666|NCT00951496|3935696|B2||White|Race (NIH/OMB)||Participants|Count of Participants|478|478.0||||||
4111667|NCT00951496|3935697|B1||White|Race (NIH/OMB)||Participants|Count of Participants|473|473.0||||||
4111668|NCT00951496|3935694|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4111669|NCT00951496|3935695|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4111670|NCT00951496|3935696|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4111671|NCT00951496|3935697|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4111672|NCT00951496|3935694|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4111673|NCT00951496|3935695|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111674|NCT00951496|3935696|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4111675|NCT00951496|3935697|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4111676|NCT00951496|3935694|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4111684|NCT00951496|3935694|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4111685|NCT00951496|3935695|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4111686|NCT00951496|3935696|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4111687|NCT00951496|3935697|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4111688|NCT00951496|3935694|B4||Female|Sex: Female, Male||Participants|Count of Participants|1560|1560.0||||||
4111689|NCT00951496|3935695|B3||Female|Sex: Female, Male||Participants|Count of Participants|521|521.0||||||
4111690|NCT00951496|3935696|B2||Female|Sex: Female, Male||Participants|Count of Participants|518|518.0||||||
4111691|NCT00951496|3935697|B1||Female|Sex: Female, Male||Participants|Count of Participants|521|521.0||||||
4111692|NCT00951496|3935694|B4|>79 years||Age, Customized||Participants|Count of Participants|13|13.0||||||
4111693|NCT00951496|3935695|B3|>79 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
4111694|NCT00951496|3935696|B2|>79 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
4111695|NCT00951496|3935697|B1|>79 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
4111696|NCT00951496|3935694|B4|70 - 79 years||Age, Customized||Participants|Count of Participants|168|168.0||||||
4111697|NCT00951496|3935695|B3|70 - 79 years||Age, Customized||Participants|Count of Participants|53|53.0||||||
4111698|NCT00951496|3935696|B2|70 - 79 years||Age, Customized||Participants|Count of Participants|64|64.0||||||
4111699|NCT00951496|3935697|B1|70 - 79 years||Age, Customized||Participants|Count of Participants|51|51.0||||||
4111700|NCT00951496|3935694|B4|60 -69 years||Age, Customized||Participants|Count of Participants|484|484.0||||||
4111701|NCT00951496|3935695|B3|60 -69 years||Age, Customized||Participants|Count of Participants|151|151.0||||||
4111702|NCT00951496|3935696|B2|60 -69 years||Age, Customized||Participants|Count of Participants|181|181.0||||||
4111703|NCT00951496|3935697|B1|60 -69 years||Age, Customized||Participants|Count of Participants|152|152.0||||||
4111704|NCT00951496|3935694|B4|50 - 59 years||Age, Customized||Participants|Count of Participants|564|564.0||||||
4111705|NCT00951496|3935695|B3|50 - 59 years||Age, Customized||Participants|Count of Participants|199|199.0||||||
4111706|NCT00951496|3935696|B2|50 - 59 years||Age, Customized||Participants|Count of Participants|178|178.0||||||
4111707|NCT00951496|3935697|B1|50 - 59 years||Age, Customized||Participants|Count of Participants|187|187.0||||||
4111708|NCT00951496|3935694|B4|40 - 49 years||Age, Customized||Participants|Count of Participants|273|273.0||||||
4111709|NCT00951496|3935695|B3|40 - 49 years||Age, Customized||Participants|Count of Participants|95|95.0||||||
4111710|NCT00951496|3935696|B2|40 - 49 years||Age, Customized||Participants|Count of Participants|77|77.0||||||
4111711|NCT00951496|3935697|B1|40 - 49 years||Age, Customized||Participants|Count of Participants|101|101.0||||||
4111712|NCT00951496|3935694|B4|<40 years||Age, Customized||Participants|Count of Participants|58|58.0||||||
4111713|NCT00951496|3935695|B3|<40 years||Age, Customized||Participants|Count of Participants|18|18.0||||||
4111714|NCT00951496|3935696|B2|<40 years||Age, Customized||Participants|Count of Participants|13|13.0||||||
4111715|NCT00951496|3935697|B1|<40 years||Age, Customized||Participants|Count of Participants|27|27.0||||||
4111716|NCT00951483|3935725|B3|||Perceived Stress Scale with 14 Items|The 14-item Perceived Stress Scale (PSS-14) is a subjective self-report assessment of stress. Each item is rated on a five point frequency scale ranging from 0 = never experiencing the stress symptom to 4 = Very often experiencing the stress symptom. Scores range from 0 to 56, where higher scores indicate higher stress.|units on a scale|Median|43.50|43.5|Inter-Quartile Range|||30.5|52.0|
4111717|NCT00951483|3935726|B2|||Perceived Stress Scale with 14 Items|The 14-item Perceived Stress Scale (PSS-14) is a subjective self-report assessment of stress. Each item is rated on a five point frequency scale ranging from 0 = never experiencing the stress symptom to 4 = Very often experiencing the stress symptom. Scores range from 0 to 56, where higher scores indicate higher stress.|units on a scale|Median|27.00|27.0|Inter-Quartile Range|||24.0|32.0|
4111718|NCT00951483|3935727|B1|||Perceived Stress Scale with 14 Items|The 14-item Perceived Stress Scale (PSS-14) is a subjective self-report assessment of stress. Each item is rated on a five point frequency scale ranging from 0 = never experiencing the stress symptom to 4 = Very often experiencing the stress symptom. Scores range from 0 to 56, where higher scores indicate higher stress.|units on a scale|Median|49.50|49.5|Inter-Quartile Range|||44.25|54.0|
4111719|NCT00951483|3935725|B3|||Baseline Beck Depression Inventory|The 21-item Beck Depression Inventory (BDI) is a subjective self-report assessment of depression. This version allows scores to range from 0 to 63, where higher scores indicate worsening mood.|units on a scale|Median|16.50|16.5|Inter-Quartile Range|||1.0|28.75|
4111720|NCT00951483|3935726|B2|||Baseline Beck Depression Inventory|The 21-item Beck Depression Inventory (BDI) is a subjective self-report assessment of depression. This version allows scores to range from 0 to 63, where higher scores indicate worsening mood.|units on a scale|Median|0|0.0|Inter-Quartile Range|||0.0|1.25|
4111721|NCT00951483|3935727|B1|||Baseline Beck Depression Inventory|The 21-item Beck Depression Inventory (BDI) is a subjective self-report assessment of depression. This version allows scores to range from 0 to 63, where higher scores indicate worsening mood.|units on a scale|Median|25.50|25.5|Inter-Quartile Range|||17.75|33.5|
4111722|NCT00951483|3935725|B3|||Baseline Hamilton Rating Scale for Anxiety|The 14-item Hamilton Rating Scale for Anxiety (HAM-A) is an objective assessment of anxiety administered by a trained rater. This version allows scores to range from 0 to 56, where higher scores indicate worsening anxiety.|units on a scale|Median|10|10.0|Inter-Quartile Range|||0.0|22.0|
4111723|NCT00951483|3935726|B2|||Baseline Hamilton Rating Scale for Anxiety|The 14-item Hamilton Rating Scale for Anxiety (HAM-A) is an objective assessment of anxiety administered by a trained rater. This version allows scores to range from 0 to 56, where higher scores indicate worsening anxiety.|units on a scale|Median|0|0.0|Inter-Quartile Range|||0.0|1.0|
4111724|NCT00951483|3935727|B1|||Baseline Hamilton Rating Scale for Anxiety|The 14-item Hamilton Rating Scale for Anxiety (HAM-A) is an objective assessment of anxiety administered by a trained rater. This version allows scores to range from 0 to 56, where higher scores indicate worsening anxiety.|units on a scale|Median|22|22.0|Inter-Quartile Range|||15.0|28.0|
4111725|NCT00951483|3935725|B3|||Baseline Hamilton Rating Scale for Depression with 21 Items|The 21-item Hamilton Rating Scale for Depression (HAMD-21) is an objective assessment of depression administered by a trained rater. This version allows scores to range from 0 to 63, where higher scores indicate worsening mood.|units on a scale|Median|18|18.0|Inter-Quartile Range|||0.0|27.0|
4111726|NCT00951483|3935726|B2|||Baseline Hamilton Rating Scale for Depression with 21 Items|The 21-item Hamilton Rating Scale for Depression (HAMD-21) is an objective assessment of depression administered by a trained rater. This version allows scores to range from 0 to 63, where higher scores indicate worsening mood.|units on a scale|Median|0|0.0|Inter-Quartile Range|||0.0|2.0|
4111727|NCT00951483|3935727|B1|||Baseline Hamilton Rating Scale for Depression with 21 Items|The 21-item Hamilton Rating Scale for Depression (HAMD-21) is an objective assessment of depression administered by a trained rater. This version allows scores to range from 0 to 63, where higher scores indicate worsening mood.|units on a scale|Median|27|27.0|Inter-Quartile Range|||23.0|32.0|
4111728|NCT00951483|3935725|B3|||Baseline Hamilton Rating Scale for Depression with 17 Items|The 17-item Hamilton Rating Scale for Depression (HAMD-17) is an objective assessment of depression administered by a trained rater. This version allows scores to range from 0 to 52, where higher scores indicate worsening mood.|units on a scale|Median|17|17.0|Inter-Quartile Range|||0.0|25.0|
4111729|NCT00951483|3935726|B2|||Baseline Hamilton Rating Scale for Depression with 17 Items|The 17-item Hamilton Rating Scale for Depression (HAMD-17) is an objective assessment of depression administered by a trained rater. This version allows scores to range from 0 to 52, where higher scores indicate worsening mood.|units on a scale|Median|0|0.0|Inter-Quartile Range|||0.0|2.0|
4111730|NCT00951483|3935727|B1|||Baseline Hamilton Rating Scale for Depression with 17 Items|The 17-item Hamilton Rating Scale for Depression (HAMD-17) is an objective assessment of depression administered by a trained rater. This version allows scores to range from 0 to 52, where higher scores indicate worsening mood.|units on a scale|Median|25|25.0|Inter-Quartile Range|||20.0|29.0|
4111731|NCT00951483|3935725|B3|||Baseline Hamilton Rating Scale for Depression with Seven Items|The seven item Hamilton Rating Scale for Depression (HAMD-7) is an objective assessment of depression administered by a trained rater. This version allows scores to range from 0 to 22, where higher scores indicate worsening mood.|units on a scale|Median|8|8.0|Inter-Quartile Range|||0.0|15.0|
4111732|NCT00951483|3935726|B2|||Baseline Hamilton Rating Scale for Depression with Seven Items|The seven item Hamilton Rating Scale for Depression (HAMD-7) is an objective assessment of depression administered by a trained rater. This version allows scores to range from 0 to 22, where higher scores indicate worsening mood.|units on a scale|Median|0|0.0|Inter-Quartile Range|||0.0|1.0|
4111733|NCT00951483|3935727|B1|||Baseline Hamilton Rating Scale for Depression with Seven Items|The seven item Hamilton Rating Scale for Depression (HAMD-7) is an objective assessment of depression administered by a trained rater. This version allows scores to range from 0 to 22, where higher scores indicate worsening mood.|units on a scale|Median|15|15.0|Inter-Quartile Range|||13.0|19.0|
4111734|NCT00951483|3935725|B3|Unknown||Family History of Alzheimer's Disease||participants|Number|12|12.0||||||
4111735|NCT00951483|3935726|B2|Unknown||Family History of Alzheimer's Disease||participants|Number|4|4.0||||||
4111736|NCT00951483|3935727|B1|Unknown||Family History of Alzheimer's Disease||participants|Number|8|8.0||||||
4111737|NCT00951483|3935725|B3|Yes||Family History of Alzheimer's Disease||participants|Number|25|25.0||||||
4111738|NCT00951483|3935726|B2|Yes||Family History of Alzheimer's Disease||participants|Number|4|4.0||||||
4111739|NCT00951483|3935727|B1|Yes||Family History of Alzheimer's Disease||participants|Number|21|21.0||||||
4111740|NCT00951483|3935725|B3|No||Family History of Alzheimer's Disease||participants|Number|54|54.0||||||
4111741|NCT00951483|3935726|B2|No||Family History of Alzheimer's Disease||participants|Number|36|36.0||||||
4111742|NCT00951483|3935727|B1|No||Family History of Alzheimer's Disease||participants|Number|18|18.0||||||
4111743|NCT00951483|3935725|B3|Unknown||Concomitant Psychiatric Medication||participants|Number|6|6.0||||||
4111744|NCT00951483|3935726|B2|Unknown||Concomitant Psychiatric Medication||participants|Number|1|1.0||||||
4111745|NCT00951483|3935727|B1|Unknown||Concomitant Psychiatric Medication||participants|Number|5|5.0||||||
4111746|NCT00951483|3935725|B3|No||Concomitant Psychiatric Medication||participants|Number|58|58.0||||||
4111747|NCT00951483|3935726|B2|No||Concomitant Psychiatric Medication||participants|Number|42|42.0||||||
4111748|NCT00951483|3935727|B1|No||Concomitant Psychiatric Medication||participants|Number|16|16.0||||||
4111749|NCT00951483|3935725|B3|Yes||Concomitant Psychiatric Medication||participants|Number|27|27.0||||||
4111750|NCT00951483|3935726|B2|Yes||Concomitant Psychiatric Medication||participants|Number|1|1.0||||||
4111751|NCT00951483|3935727|B1|Yes||Concomitant Psychiatric Medication||participants|Number|26|26.0||||||
4111752|NCT00951483|3935725|B3|Unknown||Family History of Depression||participants|Number|12|12.0||||||
4111753|NCT00951483|3935726|B2|Unknown||Family History of Depression||participants|Number|4|4.0||||||
4111754|NCT00951483|3935727|B1|Unknown||Family History of Depression||participants|Number|8|8.0||||||
4111755|NCT00951483|3935725|B3|Yes||Family History of Depression||participants|Number|24|24.0||||||
4111756|NCT00951483|3935726|B2|Yes||Family History of Depression||participants|Number|2|2.0||||||
4111757|NCT00951483|3935727|B1|Yes||Family History of Depression||participants|Number|22|22.0||||||
4111758|NCT00951483|3935725|B3|No||Family History of Depression||participants|Number|55|55.0||||||
4111759|NCT00951483|3935726|B2|No||Family History of Depression||participants|Number|38|38.0||||||
4111760|NCT00951483|3935727|B1|No||Family History of Depression||participants|Number|17|17.0||||||
4111761|NCT00951483|3935725|B3|Not Applicable (Males)||Menopausal Status||participants|Number|36|36.0||||||
4111762|NCT00951483|3935726|B2|Not Applicable (Males)||Menopausal Status||participants|Number|15|15.0||||||
4111763|NCT00951483|3935727|B1|Not Applicable (Males)||Menopausal Status||participants|Number|21|21.0||||||
4111764|NCT00951483|3935725|B3|Postmenopausal||Menopausal Status||participants|Number|13|13.0||||||
4111765|NCT00951483|3935726|B2|Postmenopausal||Menopausal Status||participants|Number|10|10.0||||||
4111766|NCT00951483|3935727|B1|Postmenopausal||Menopausal Status||participants|Number|3|3.0||||||
4111767|NCT00951483|3935725|B3|Premenopausal||Menopausal Status||participants|Number|42|42.0||||||
4111768|NCT00951483|3935726|B2|Premenopausal||Menopausal Status||participants|Number|19|19.0||||||
4111769|NCT00951483|3935727|B1|Premenopausal||Menopausal Status||participants|Number|23|23.0||||||
4111770|NCT00951483|3935725|B3|||Body Mass Index (BMI)||kg/m^2|Mean|29.36|29.36|Standard Deviation|6.84|6.84|||
4111771|NCT00951483|3935726|B2|||Body Mass Index (BMI)||kg/m^2|Mean|26.51|26.51|Standard Deviation|5.77|5.77|||
4111772|NCT00951483|3935727|B1|||Body Mass Index (BMI)||kg/m^2|Mean|31.98|31.98|Standard Deviation|6.76|6.76|||
4111773|NCT00951483|3935725|B3|||Weight|Weight was measured in kilograms|kilograms|Mean|81.86|81.86|Standard Deviation|21.31|21.31|||
4111774|NCT00951483|3935726|B2|||Weight|Weight was measured in kilograms|kilograms|Mean|74.59|74.59|Standard Deviation|15.45|15.45|||
4111775|NCT00951483|3935727|B1|||Weight|Weight was measured in kilograms|kilograms|Mean|88.50|88.5|Standard Deviation|23.8|23.8|||
4111776|NCT00951483|3935725|B3|||Height|Height was measured in meters|Meters|Mean|1.67|1.67|Standard Deviation|0.15|0.15|||
4111777|NCT00951483|3935726|B2|||Height|Height was measured in meters|Meters|Mean|1.68|1.68|Standard Deviation|0.10|0.1|||
4111778|NCT00951483|3935727|B1|||Height|Height was measured in meters|Meters|Mean|1.66|1.66|Standard Deviation|0.19|0.19|||
4111779|NCT00951483|3935725|B3|Unknown||Tobacco Use||Participants|Number|26|26.0||||||
4111780|NCT00951483|3935726|B2|Unknown||Tobacco Use||Participants|Number|1|1.0||||||
4111781|NCT00951483|3935727|B1|Unknown||Tobacco Use||Participants|Number|25|25.0||||||
4111782|NCT00951483|3935725|B3|Smoker||Tobacco Use||Participants|Number|3|3.0||||||
4111783|NCT00951483|3935726|B2|Smoker||Tobacco Use||Participants|Number|3|3.0||||||
4111784|NCT00951483|3935727|B1|Smoker||Tobacco Use||Participants|Number|0|0.0||||||
4111785|NCT00951483|3935725|B3|Non-Smoker||Tobacco Use||Participants|Number|62|62.0||||||
4111786|NCT00951483|3935726|B2|Non-Smoker||Tobacco Use||Participants|Number|40|40.0||||||
4111787|NCT00951483|3935727|B1|Non-Smoker||Tobacco Use||Participants|Number|22|22.0||||||
4111788|NCT00951483|3935725|B3|Hispanic White||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4111789|NCT00951483|3935726|B2|Hispanic White||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4111790|NCT00951483|3935727|B1|Hispanic White||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4111791|NCT00951483|3935725|B3|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4111792|NCT00951483|3935726|B2|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4111793|NCT00951483|3935727|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4111794|NCT00951483|3935725|B3|African American||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
4111795|NCT00951483|3935726|B2|African American||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4111796|NCT00951483|3935727|B1|African American||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4111797|NCT00951483|3935725|B3|Non-Hispanic White||Race/Ethnicity, Customized||Participants|Number|52|52.0||||||
4111798|NCT00951483|3935726|B2|Non-Hispanic White||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
4111799|NCT00951483|3935727|B1|Non-Hispanic White||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4111800|NCT00951483|3935725|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4111801|NCT00951483|3935726|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4111802|NCT00951483|3935727|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4111803|NCT00951483|3935725|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4111804|NCT00951483|3935726|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4111805|NCT00951483|3935727|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4111806|NCT00951483|3935725|B3|||Age||years|Mean|41.7|41.7|Standard Deviation|13.1|13.1|||
4111807|NCT00951483|3935726|B2|||Age||years|Mean|39.5|39.5|Standard Deviation|13.8|13.8|||
4111808|NCT00951483|3935727|B1|||Age||years|Mean|43.8|43.8|Standard Deviation|12.1|12.1|||
4111809|NCT00951379|3935746|B3|Never||Smoking Use at Baseline||participants|Number|21|21.0||||||
4111810|NCT00951379|3935747|B2|Never||Smoking Use at Baseline||participants|Number|12|12.0||||||
4111811|NCT00951379|3935748|B1|Never||Smoking Use at Baseline||participants|Number|9|9.0||||||
4111812|NCT00951379|3935746|B3|Former||Smoking Use at Baseline||participants|Number|19|19.0||||||
4111813|NCT00951379|3935747|B2|Former||Smoking Use at Baseline||participants|Number|7|7.0||||||
4111814|NCT00951379|3935748|B1|Former||Smoking Use at Baseline||participants|Number|12|12.0||||||
4111815|NCT00951379|3935746|B3|Current||Smoking Use at Baseline||participants|Number|12|12.0||||||
4111816|NCT00951379|3935747|B2|Current||Smoking Use at Baseline||participants|Number|6|6.0||||||
4111817|NCT00951379|3935748|B1|Current||Smoking Use at Baseline||participants|Number|6|6.0||||||
4111818|NCT00951379|3935746|B3|Non-Drinker||Alcohol Use at Baseline|Heavy drinkers are participants who drank every day; Light drinkers are participants who drank on some days; Non-drinkers are former drinkers or those who never drank alcohol.|participants|Number|13|13.0||||||
4111819|NCT00951379|3935747|B2|Non-Drinker||Alcohol Use at Baseline|Heavy drinkers are participants who drank every day; Light drinkers are participants who drank on some days; Non-drinkers are former drinkers or those who never drank alcohol.|participants|Number|5|5.0||||||
4111820|NCT00951379|3935748|B1|Non-Drinker||Alcohol Use at Baseline|Heavy drinkers are participants who drank every day; Light drinkers are participants who drank on some days; Non-drinkers are former drinkers or those who never drank alcohol.|participants|Number|8|8.0||||||
4111821|NCT00951379|3935746|B3|Light||Alcohol Use at Baseline|Heavy drinkers are participants who drank every day; Light drinkers are participants who drank on some days; Non-drinkers are former drinkers or those who never drank alcohol.|participants|Number|34|34.0||||||
4111874|NCT00951275|3935791|B1|||Age||years|Mean|55.0|55.0|Standard Deviation|12.8|12.8|||
4111822|NCT00951379|3935747|B2|Light||Alcohol Use at Baseline|Heavy drinkers are participants who drank every day; Light drinkers are participants who drank on some days; Non-drinkers are former drinkers or those who never drank alcohol.|participants|Number|17|17.0||||||
4111823|NCT00951379|3935748|B1|Light||Alcohol Use at Baseline|Heavy drinkers are participants who drank every day; Light drinkers are participants who drank on some days; Non-drinkers are former drinkers or those who never drank alcohol.|participants|Number|17|17.0||||||
4111824|NCT00951379|3935746|B3|Heavy||Alcohol Use at Baseline|Heavy drinkers are participants who drank every day; Light drinkers are participants who drank on some days; Non-drinkers are former drinkers or those who never drank alcohol.|participants|Number|5|5.0||||||
4111825|NCT00951379|3935747|B2|Heavy||Alcohol Use at Baseline|Heavy drinkers are participants who drank every day; Light drinkers are participants who drank on some days; Non-drinkers are former drinkers or those who never drank alcohol.|participants|Number|3|3.0||||||
4111826|NCT00951379|3935748|B1|Heavy||Alcohol Use at Baseline|Heavy drinkers are participants who drank every day; Light drinkers are participants who drank on some days; Non-drinkers are former drinkers or those who never drank alcohol.|participants|Number|2|2.0||||||
4111827|NCT00951379|3935746|B3|Italy||Region of Enrollment||participants|Number|7|7.0||||||
4111828|NCT00951379|3935747|B2|Italy||Region of Enrollment||participants|Number|3|3.0||||||
4111829|NCT00951379|3935748|B1|Italy||Region of Enrollment||participants|Number|4|4.0||||||
4111830|NCT00951379|3935746|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
4111831|NCT00951379|3935747|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4111832|NCT00951379|3935748|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4111833|NCT00951379|3935746|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111834|NCT00951379|3935747|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111835|NCT00951379|3935748|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111836|NCT00951379|3935746|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111837|NCT00951379|3935747|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111838|NCT00951379|3935748|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111839|NCT00951379|3935746|B3||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4111840|NCT00951379|3935747|B2||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4111841|NCT00951379|3935748|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4111842|NCT00951379|3935746|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111843|NCT00951379|3935747|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111844|NCT00951379|3935748|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111845|NCT00951379|3935746|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111846|NCT00951379|3935747|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111847|NCT00951379|3935748|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111848|NCT00951379|3935746|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4111849|NCT00951379|3935747|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4111850|NCT00951379|3935748|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4111851|NCT00951379|3935746|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111852|NCT00951379|3935747|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111853|NCT00951379|3935748|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111854|NCT00951379|3935746|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111855|NCT00951379|3935747|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111856|NCT00951379|3935748|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4111857|NCT00951379|3935746|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4111858|NCT00951379|3935747|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4111859|NCT00951379|3935748|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4111860|NCT00951379|3935746|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4111861|NCT00951379|3935747|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4111862|NCT00951379|3935748|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4111863|NCT00951379|3935746|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4111864|NCT00951379|3935747|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4111865|NCT00951379|3935748|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4111866|NCT00951379|3935746|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4111867|NCT00951379|3935747|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4111868|NCT00951379|3935748|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4111869|NCT00951379|3935746|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|9.2|9.2|||
4111870|NCT00951379|3935747|B2|||Age||years|Mean|59.0|59.0|Standard Deviation|10.3|10.3|||
4111871|NCT00951379|3935748|B1|||Age||years|Mean|59.9|59.9|Standard Deviation|8.3|8.3|||
4111872|NCT00951275|3935791|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4111873|NCT00951275|3935791|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4111875|NCT00951171|3935821|B3|United States||Region of Enrollment||participants|Number|95|95.0||||||
4111876|NCT00951171|3935822|B2|United States||Region of Enrollment||participants|Number|55|55.0||||||
4111877|NCT00951171|3935823|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4111878|NCT00951171|3935821|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4111879|NCT00951171|3935822|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4111880|NCT00951171|3935823|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4111881|NCT00951171|3935821|B3||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4111882|NCT00951171|3935822|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4111883|NCT00951171|3935823|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4111884|NCT00951171|3935821|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4111885|NCT00951171|3935822|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4111886|NCT00951171|3935823|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4111887|NCT00951171|3935821|B3||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
4111888|NCT00951171|3935822|B2||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4111889|NCT00951171|3935823|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4111890|NCT00951171|3935821|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4111891|NCT00951171|3935822|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4111892|NCT00951171|3935823|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4111893|NCT00951093|3935830|B1|Brazil||Region of Enrollment||participants|Number|53|53.0||||||
4111894|NCT00951093|3935830|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4111895|NCT00951093|3935830|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4111896|NCT00951093|3935830|B1|||Age||years|Mean|38.26|38.26|Standard Deviation|11.56|11.56|||
4111897|NCT00951093|3935830|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4111898|NCT00951093|3935830|B1||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4111899|NCT00951093|3935830|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4111900|NCT00951041|3935854|B3|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|130|130.0||||||
4111901|NCT00951041|3935855|B2|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|66|66.0||||||
4111902|NCT00951041|3935856|B1|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|64|64.0||||||
4111903|NCT00951041|3935854|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4111904|NCT00951041|3935855|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4111905|NCT00951041|3935856|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4111906|NCT00951041|3935854|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4111907|NCT00951041|3935855|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4111908|NCT00951041|3935856|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4111909|NCT00951041|3935854|B3|||Age||Years|Mean|39.60|39.6|Standard Deviation|12.43|12.43|||
4111910|NCT00951041|3935855|B2|||Age||Years|Mean|39.30|39.3|Standard Deviation|13.16|13.16|||
4111911|NCT00951041|3935856|B1|||Age||Years|Mean|39.90|39.9|Standard Deviation|11.72|11.72|||
4111912|NCT00951015|3935908|B5|Asian & White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4111913|NCT00951015|3935909|B4|Asian & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4111914|NCT00951015|3935910|B3|Asian & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4111915|NCT00951015|3935911|B2|Asian & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4111916|NCT00951015|3935912|B1|Asian & White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4111917|NCT00951015|3935908|B5|African American/African HER & White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4111918|NCT00951015|3935909|B4|African American/African HER & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4111919|NCT00951015|3935910|B3|African American/African HER & White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4111920|NCT00951015|3935911|B2|African American/African HER & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4111921|NCT00951015|3935912|B1|African American/African HER & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4111922|NCT00951015|3935908|B5|White||Race/Ethnicity, Customized||participants|Number|164|164.0||||||
4111923|NCT00951015|3935909|B4|White||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4111924|NCT00951015|3935910|B3|White||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4111925|NCT00951015|3935911|B2|White||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4111926|NCT00951015|3935912|B1|White||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4111927|NCT00951015|3935908|B5|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4111928|NCT00951015|3935909|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4111929|NCT00951015|3935910|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4111930|NCT00951015|3935911|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4111931|NCT00951015|3935912|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4111932|NCT00951015|3935908|B5|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4111933|NCT00951015|3935909|B4|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4111934|NCT00951015|3935910|B3|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4111935|NCT00951015|3935911|B2|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4111936|NCT00951015|3935912|B1|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4111937|NCT00951015|3935908|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4111938|NCT00951015|3935909|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4111939|NCT00951015|3935910|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4111940|NCT00951015|3935911|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4111941|NCT00951015|3935912|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4111942|NCT00951015|3935908|B5|African American/African Heritage (HER)||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4111943|NCT00951015|3935909|B4|African American/African Heritage (HER)||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4111944|NCT00951015|3935910|B3|African American/African Heritage (HER)||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4111945|NCT00951015|3935911|B2|African American/African Heritage (HER)||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4111946|NCT00951015|3935912|B1|African American/African Heritage (HER)||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4111947|NCT00951015|3935908|B5||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4111948|NCT00951015|3935909|B4||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4111949|NCT00951015|3935910|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4111950|NCT00951015|3935911|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4111951|NCT00951015|3935912|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4111952|NCT00951015|3935908|B5||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4111953|NCT00951015|3935909|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4111954|NCT00951015|3935910|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4111955|NCT00951015|3935911|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4111956|NCT00951015|3935912|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4111957|NCT00951015|3935908|B5|||Age||Years|Mean|37.2|37.2|Standard Deviation|10.00|10.0|||
4111958|NCT00951015|3935909|B4|||Age||Years|Mean|40.7|40.7|Standard Deviation|11.19|11.19|||
4111959|NCT00951015|3935910|B3|||Age||Years|Mean|37.0|37.0|Standard Deviation|8.89|8.89|||
4111960|NCT00951015|3935911|B2|||Age||Years|Mean|37.0|37.0|Standard Deviation|9.79|9.79|||
4111961|NCT00951015|3935912|B1|||Age||Years|Mean|34.2|34.2|Standard Deviation|9.25|9.25|||
4111962|NCT00950963|3936011|B3|United States||Region of Enrollment||participants|Number|762|762.0||||||
4111963|NCT00950963|3936012|B2|United States||Region of Enrollment||participants|Number|381|381.0||||||
4111964|NCT00950963|3936013|B1|United States||Region of Enrollment||participants|Number|381|381.0||||||
4111965|NCT00950963|3936011|B3||Male|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
4111966|NCT00950963|3936012|B2||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4111967|NCT00950963|3936013|B1||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4111968|NCT00950963|3936011|B3||Female|Sex: Female, Male||Participants|Count of Participants|462|462.0||||||
4111969|NCT00950963|3936012|B2||Female|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4111970|NCT00950963|3936013|B1||Female|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
4111971|NCT00950963|3936011|B3|||Age||years|Mean|58.4|58.4|Standard Deviation|12.3|12.3|||
4111972|NCT00950963|3936012|B2|||Age||years|Mean|58.3|58.3|Standard Deviation|12.1|12.1|||
4111973|NCT00950963|3936013|B1|||Age||years|Mean|58.5|58.5|Standard Deviation|12.5|12.5|||
4111974|NCT00950963|3936011|B3||>=65 years|Age||Participants|Count of Participants|249|249.0||||||
4111975|NCT00950963|3936012|B2||>=65 years|Age||Participants|Count of Participants|120|120.0||||||
4111976|NCT00950963|3936013|B1||>=65 years|Age||Participants|Count of Participants|129|129.0||||||
4111977|NCT00950963|3936011|B3||Between 18 and 65 years|Age||Participants|Count of Participants|513|513.0||||||
4111978|NCT00950963|3936012|B2||Between 18 and 65 years|Age||Participants|Count of Participants|261|261.0||||||
4111979|NCT00950963|3936013|B1||Between 18 and 65 years|Age||Participants|Count of Participants|252|252.0||||||
4111980|NCT00950963|3936011|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4111981|NCT00950963|3936012|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4111982|NCT00950963|3936013|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4111983|NCT00950937|3936028|B3|Brazil||Region of Enrollment||participants|Number|28.0|28.0||||||
4111984|NCT00950937|3936029|B2|Brazil||Region of Enrollment||participants|Number|14|14.0||||||
4111985|NCT00950937|3936030|B1|Brazil||Region of Enrollment||participants|Number|14|14.0||||||
4111986|NCT00950937|3936028|B3||Male|Sex: Female, Male||Participants|Count of Participants|14.0|14.0||||||
4111987|NCT00950937|3936029|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4111988|NCT00950937|3936030|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4111989|NCT00950937|3936028|B3||Female|Sex: Female, Male||Participants|Count of Participants|14.0|14.0||||||
4111990|NCT00950937|3936029|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4111991|NCT00950937|3936030|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4111992|NCT00950937|3936028|B3|||Age||years|Mean|37.5|37.5|Standard Deviation|9.5|9.5|||
4111993|NCT00950937|3936029|B2|||Age||years|Mean|36|36.0|Standard Deviation|10.6|10.6|||
4111994|NCT00950937|3936030|B1|||Age||years|Mean|39.2|39.2|Standard Deviation|8.7|8.7|||
4111995|NCT00950937|3936028|B3||>=65 years|Age||Participants|Count of Participants|0.0|0.0||||||
4111996|NCT00950937|3936029|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4111997|NCT00950937|3936030|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4111998|NCT00950937|3936028|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28.0|28.0||||||
4111999|NCT00950937|3936029|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4112000|NCT00950937|3936030|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4112001|NCT00950937|3936028|B3||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4112002|NCT00950937|3936029|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4112003|NCT00950937|3936030|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4112004|NCT00950911|3936047|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4112005|NCT00950911|3936048|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4112006|NCT00950911|3936049|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4112007|NCT00950911|3936047|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|34|34.0||||||
4112008|NCT00950911|3936048|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4112009|NCT00950911|3936049|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4112010|NCT00950911|3936047|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4112011|NCT00950911|3936048|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4112012|NCT00950911|3936049|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4112013|NCT00950911|3936047|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4112014|NCT00950911|3936048|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4112015|NCT00950911|3936049|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4112016|NCT00950911|3936047|B3|||Age||Years|Mean|61.3|61.3|Standard Deviation|11.9|11.9|||
4112017|NCT00950911|3936048|B2|||Age||Years|Mean|61.1|61.1|Standard Deviation|13.0|13.0|||
4112018|NCT00950911|3936049|B1|||Age||Years|Mean|61.6|61.6|Standard Deviation|11.1|11.1|||
4112019|NCT00950872|3936056|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4112020|NCT00950872|3936056|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4112021|NCT00950872|3936056|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112022|NCT00950872|3936056|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4112023|NCT00950872|3936056|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4112024|NCT00950872|3936056|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112025|NCT00950872|3936056|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112026|NCT00950872|3936056|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112027|NCT00950872|3936056|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4112028|NCT00950872|3936056|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4112029|NCT00950872|3936056|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4112030|NCT00950872|3936056|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4112031|NCT00950872|3936056|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4112032|NCT00950872|3936056|B1|||Age||years|Mean|42.2|42.2|Standard Deviation|11.3|11.3|||
4112033|NCT00950859|3936063|B3|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|41|41.0||||||
4112034|NCT00950859|3936064|B2|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4112035|NCT00950859|3936065|B1|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
4112036|NCT00950859|3936063|B3|White-Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4112037|NCT00950859|3936064|B2|White-Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4112038|NCT00950859|3936065|B1|White-Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4112039|NCT00950859|3936063|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4112040|NCT00950859|3936064|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4112041|NCT00950859|3936065|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4112042|NCT00950859|3936063|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4112043|NCT00950859|3936064|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4112044|NCT00950859|3936065|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4112045|NCT00950859|3936063|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4112046|NCT00950859|3936064|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4112047|NCT00950859|3936065|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4112048|NCT00950859|3936063|B3|Years||Age, Customized||Years|Median|47|47.0|Full Range|||19.0|68.0|
4112049|NCT00950859|3936064|B2|Years||Age, Customized||Years|Median|47|47.0|Full Range|||33.0|68.0|
4112050|NCT00950859|3936065|B1|Years||Age, Customized||Years|Median|48|48.0|Full Range|||19.0|61.0|
4112051|NCT00950833|3936106|B4|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4112052|NCT00950833|3936107|B3|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4112053|NCT00950833|3936108|B2|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4112054|NCT00950833|3936109|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4112055|NCT00950833|3936106|B4|White - Arabic / North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4112056|NCT00950833|3936107|B3|White - Arabic / North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4112057|NCT00950833|3936108|B2|White - Arabic / North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4112058|NCT00950833|3936109|B1|White - Arabic / North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4112059|NCT00950833|3936106|B4|White - Caucasian / European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|433|433.0||||||
4112060|NCT00950833|3936107|B3|White - Caucasian / European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|214|214.0||||||
4112061|NCT00950833|3936108|B2|White - Caucasian / European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|108|108.0||||||
4112062|NCT00950833|3936109|B1|White - Caucasian / European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|111|111.0||||||
4112063|NCT00950833|3936106|B4||Male|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
4112064|NCT00950833|3936107|B3||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4112065|NCT00950833|3936108|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4112066|NCT00950833|3936109|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4112067|NCT00950833|3936106|B4||Female|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4112068|NCT00950833|3936107|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4112069|NCT00950833|3936108|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4112070|NCT00950833|3936109|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4112071|NCT00950833|3936106|B4|||Age||Months|Mean|38.4|38.4|Standard Deviation|2.71|2.71|||
4112072|NCT00950833|3936107|B3|||Age||Months|Mean|37.7|37.7|Standard Deviation|3.36|3.36|||
4112073|NCT00950833|3936108|B2|||Age||Months|Mean|39.1|39.1|Standard Deviation|1.54|1.54|||
4112074|NCT00950833|3936109|B1|||Age||Months|Mean|39.2|39.2|Standard Deviation|1.53|1.53|||
4112075|NCT00950807|3936165|B1|White||Race/Ethnicity, Customized||Participants|Number|172|172.0||||||
4112076|NCT00950807|3936165|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4112077|NCT00950807|3936165|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4112078|NCT00950807|3936165|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4112079|NCT00950807|3936165|B1|||Age||Years|Mean|59.7|59.7|Standard Deviation|8.12|8.12|||
4112080|NCT00950755|3936216|B1|White||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4112081|NCT00950755|3936216|B1||Male|Gender||Participants|Count of Participants|20|20.0||||||
4112082|NCT00950755|3936216|B1||Female|Gender||Participants|Count of Participants|21|21.0||||||
4112083|NCT00950755|3936216|B1|||Age||Years|Mean|58.2|58.2|Standard Deviation|11.4|11.4|||
4112084|NCT00950742|3936240|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4112085|NCT00950742|3936241|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4112086|NCT00950742|3936242|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4112087|NCT00950742|3936240|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4112088|NCT00950742|3936241|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4112089|NCT00950742|3936242|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4112090|NCT00950742|3936240|B3|||Age||years|Mean|61.2|61.2|Standard Deviation|10.6|10.6|||
4112091|NCT00950742|3936241|B2|||Age||years|Mean|52.5|52.5|Standard Deviation|6.4|6.4|||
4112092|NCT00950742|3936242|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|10.6|10.6|||
4112093|NCT00950729|3936259|B1|Canada||Region of Enrollment||participants|Number|48|48.0||||||
4112094|NCT00950729|3936259|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4112095|NCT00950729|3936259|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4112096|NCT00950729|3936259|B1|||Age||years|Mean|42.27|42.27|Standard Deviation|10.06|10.06|||
4112097|NCT00950729|3936259|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4112098|NCT00950729|3936259|B1||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4112099|NCT00950729|3936259|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4112100|NCT00950690|3936264|B1|Unspecified||Sex/Gender, Customized||Participants|Number|42|42.0||||||
4112101|NCT00950690|3936264|B1|Female||Sex/Gender, Customized||Participants|Number|584|584.0||||||
4112102|NCT00950690|3936264|B1|Male||Sex/Gender, Customized||Participants|Number|723|723.0||||||
4112103|NCT00950690|3936264|B1|||Age||years|Mean|54.0|54.0|Standard Deviation|13.0|13.0|||
4112104|NCT00950664|3936269|B3|Korea, Republic of||Region of Enrollment||participants|Number|94|94.0||||||
4112105|NCT00950664|3936270|B2|Korea, Republic of||Region of Enrollment||participants|Number|48|48.0||||||
4112106|NCT00950664|3936271|B1|Korea, Republic of||Region of Enrollment||participants|Number|46|46.0||||||
4112107|NCT00950664|3936269|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4112108|NCT00950664|3936270|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4112109|NCT00950664|3936271|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4112110|NCT00950664|3936269|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4112111|NCT00950664|3936270|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4112112|NCT00950664|3936271|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4112113|NCT00950664|3936269|B3|||Age||years|Mean|53.29|53.29|Standard Deviation|10.76|10.76|||
4112114|NCT00950664|3936270|B2|||Age||years|Mean|53.35|53.35|Standard Deviation|10.18|10.18|||
4112115|NCT00950664|3936271|B1|||Age||years|Mean|53.24|53.24|Standard Deviation|11.44|11.44|||
4112116|NCT00950664|3936269|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4112117|NCT00950664|3936270|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4112118|NCT00950664|3936271|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4112119|NCT00950664|3936269|B3||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4112120|NCT00950664|3936270|B2||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4112121|NCT00950664|3936271|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4112122|NCT00950664|3936269|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4112123|NCT00950664|3936270|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4112124|NCT00950664|3936271|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4112125|NCT00950651|3936290|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4112126|NCT00950651|3936291|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4112127|NCT00950651|3936292|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4112128|NCT00950651|3936290|B3||Female|Sex: Female, Male||Participants|Count of Participants|357|357.0||||||
4112129|NCT00950651|3936291|B2||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4112130|NCT00950651|3936292|B1||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4112131|NCT00950651|3936290|B3|||Age||years|Mean|60.9|60.9|Standard Deviation|9.0|9.0|||
4112132|NCT00950651|3936291|B2|||Age||years|Mean|59.9|59.9|Standard Deviation|9.1|9.1|||
4112133|NCT00950651|3936292|B1|||Age||years|Mean|61.9|61.9|Standard Deviation|8.8|8.8|||
4112134|NCT00950651|3936290|B3||>=65 years|Age||Participants|Count of Participants|172|172.0||||||
4112135|NCT00950651|3936291|B2||>=65 years|Age||Participants|Count of Participants|78|78.0||||||
4112136|NCT00950651|3936292|B1||>=65 years|Age||Participants|Count of Participants|94|94.0||||||
4112137|NCT00950651|3936290|B3||Between 18 and 65 years|Age||Participants|Count of Participants|258|258.0||||||
4112138|NCT00950651|3936291|B2||Between 18 and 65 years|Age||Participants|Count of Participants|137|137.0||||||
4112139|NCT00950651|3936292|B1||Between 18 and 65 years|Age||Participants|Count of Participants|121|121.0||||||
4112140|NCT00950651|3936290|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4112141|NCT00950651|3936291|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4112142|NCT00950651|3936292|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4112143|NCT00950612|3936339|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4112144|NCT00950612|3936340|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4112145|NCT00950612|3936341|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4112146|NCT00950612|3936339|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4112147|NCT00950612|3936340|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4112148|NCT00950612|3936341|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4112149|NCT00950612|3936339|B3|||Age||Years|Mean|14.83|14.83|Standard Deviation|1.17|1.17|||
4112150|NCT00950612|3936340|B2|||Age||Years|Mean|14.9|14.9|Standard Deviation|1.12|1.12|||
4112151|NCT00950612|3936341|B1|||Age||Years|Mean|14.8|14.8|Standard Deviation|1.20|1.2|||
4112152|NCT00950599|3936378|B9||Male|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
4112153|NCT00950599|3936379|B8||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4112154|NCT00950599|3936380|B7||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4112155|NCT00950599|3936381|B6||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4112156|NCT00950599|3936382|B5||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4112157|NCT00950599|3936383|B4||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4112158|NCT00950599|3936384|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4112159|NCT00950599|3936385|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4112160|NCT00950599|3936386|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4112161|NCT00950599|3936378|B9||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4112162|NCT00950599|3936379|B8||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4112163|NCT00950599|3936380|B7||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4112164|NCT00950599|3936381|B6||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4112165|NCT00950599|3936382|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4112166|NCT00950599|3936383|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4112167|NCT00950599|3936384|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4112168|NCT00950599|3936385|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4112169|NCT00950599|3936386|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4112170|NCT00950599|3936378|B9|>= 65 years||Age, Customized||participants|Number|61|61.0||||||
4112171|NCT00950599|3936379|B8|>= 65 years||Age, Customized||participants|Number|6|6.0||||||
4112172|NCT00950599|3936380|B7|>= 65 years||Age, Customized||participants|Number|6|6.0||||||
4112173|NCT00950599|3936381|B6|>= 65 years||Age, Customized||participants|Number|12|12.0||||||
4112174|NCT00950599|3936382|B5|>= 65 years||Age, Customized||participants|Number|11|11.0||||||
4112175|NCT00950599|3936383|B4|>= 65 years||Age, Customized||participants|Number|4|4.0||||||
4112176|NCT00950599|3936384|B3|>= 65 years||Age, Customized||participants|Number|9|9.0||||||
4112177|NCT00950599|3936385|B2|>= 65 years||Age, Customized||participants|Number|8|8.0||||||
4112178|NCT00950599|3936386|B1|>= 65 years||Age, Customized||participants|Number|5|5.0||||||
4112179|NCT00950599|3936378|B9|<65 years||Age, Customized||participants|Number|362|362.0||||||
4112180|NCT00950599|3936379|B8|<65 years||Age, Customized||participants|Number|35|35.0||||||
4112181|NCT00950599|3936380|B7|<65 years||Age, Customized||participants|Number|38|38.0||||||
4112182|NCT00950599|3936381|B6|<65 years||Age, Customized||participants|Number|55|55.0||||||
4112183|NCT00950599|3936382|B5|<65 years||Age, Customized||participants|Number|41|41.0||||||
4112184|NCT00950599|3936383|B4|<65 years||Age, Customized||participants|Number|50|50.0||||||
4112185|NCT00950599|3936384|B3|<65 years||Age, Customized||participants|Number|54|54.0||||||
4112186|NCT00950599|3936385|B2|<65 years||Age, Customized||participants|Number|39|39.0||||||
4112187|NCT00950599|3936386|B1|<65 years||Age, Customized||participants|Number|50|50.0||||||
4112188|NCT00950352|3936957|B3|United States||Region of Enrollment||participants|Number|104|104.0||||||
4112189|NCT00950352|3936958|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
4112190|NCT00950352|3936959|B1|United States||Region of Enrollment||participants|Number|72|72.0||||||
4112191|NCT00950352|3936957|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4112192|NCT00950352|3936958|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4112193|NCT00950352|3936959|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4112194|NCT00950352|3936957|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4112195|NCT00950352|3936958|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4112196|NCT00950352|3936959|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4112197|NCT00950352|3936957|B3|||Age||years|Mean|32.4|32.4|Standard Deviation|6.89|6.89|||
4112198|NCT00950352|3936958|B2|||Age||years|Mean|31.4|31.4|Standard Deviation|7.1|7.1|||
4112199|NCT00950352|3936959|B1|||Age||years|Mean|32.9|32.9|Standard Deviation|6.8|6.8|||
4112200|NCT00950352|3936957|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4112201|NCT00950352|3936958|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4112202|NCT00950352|3936959|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4112203|NCT00950352|3936957|B3||Between 18 and 65 years|Age||Participants|Count of Participants|104|104.0||||||
4112204|NCT00950352|3936958|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4112205|NCT00950352|3936959|B1||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
4112206|NCT00950352|3936957|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4112207|NCT00950352|3936958|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4112208|NCT00950352|3936959|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4112209|NCT00950300|3936966|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4112210|NCT00950300|3936967|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4112211|NCT00950300|3936968|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4112212|NCT00950300|3936966|B3||Female|Sex: Female, Male||Participants|Count of Participants|591|591.0||||||
4112213|NCT00950300|3936967|B2||Female|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
4112214|NCT00950300|3936968|B1||Female|Sex: Female, Male||Participants|Count of Participants|297|297.0||||||
4112215|NCT00950300|3936966|B3|||Age||years|Mean|49.9|49.9|Standard Deviation|10.95|10.95|||
4112216|NCT00950300|3936967|B2|||Age||years|Mean|50.3|50.3|Standard Deviation|11.08|11.08|||
4112217|NCT00950300|3936968|B1|||Age||years|Mean|49.5|49.5|Standard Deviation|10.83|10.83|||
4112218|NCT00950235|3937016|B3|||Weight||kg|Mean|99.7|99.7|Standard Deviation|15.3|15.3|||
4112219|NCT00950235|3937017|B2|||Weight||kg|Mean|98.8|98.8|Standard Deviation|15.1|15.1|||
4112220|NCT00950235|3937018|B1|||Weight||kg|Mean|100.5|100.5|Standard Deviation|15.6|15.6|||
4112221|NCT00950235|3937016|B3|United States||Region of Enrollment||participants|Number|118|118.0||||||
4112222|NCT00950235|3937017|B2|United States||Region of Enrollment||participants|Number|58|58.0||||||
4112223|NCT00950235|3937018|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4112224|NCT00950235|3937016|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112225|NCT00950235|3937017|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112226|NCT00950235|3937018|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112227|NCT00950235|3937016|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4112228|NCT00950235|3937017|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4112229|NCT00950235|3937018|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4112230|NCT00950235|3937016|B3||White|Race (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
4112231|NCT00950235|3937017|B2||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4112232|NCT00950235|3937018|B1||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4112233|NCT00950235|3937016|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4112234|NCT00950235|3937017|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4112235|NCT00950235|3937018|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4112236|NCT00950235|3937016|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112237|NCT00950235|3937017|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112238|NCT00950235|3937018|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112239|NCT00950235|3937016|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4112240|NCT00950235|3937017|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4112241|NCT00950235|3937018|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4112242|NCT00950235|3937016|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4112243|NCT00950235|3937017|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4112244|NCT00950235|3937018|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4112245|NCT00950235|3937016|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4112246|NCT00950235|3937017|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4112247|NCT00950235|3937018|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4112248|NCT00950235|3937016|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
4112249|NCT00950235|3937017|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4112250|NCT00950235|3937018|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4112251|NCT00950235|3937016|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4112252|NCT00950235|3937017|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4112253|NCT00950235|3937018|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4112254|NCT00950235|3937016|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4112255|NCT00950235|3937017|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4112256|NCT00950235|3937018|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4112257|NCT00950235|3937016|B3||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4112258|NCT00950235|3937017|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4112259|NCT00950235|3937018|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4112260|NCT00950235|3937016|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4112261|NCT00950235|3937017|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4112262|NCT00950235|3937018|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4112263|NCT00950235|3937016|B3||Between 18 and 65 years|Age||Participants|Count of Participants|118|118.0||||||
4112264|NCT00950235|3937017|B2||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4112265|NCT00950235|3937018|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4112266|NCT00950235|3937016|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4112267|NCT00950235|3937017|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4112268|NCT00950235|3937018|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4112269|NCT00950183|3937029|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4112270|NCT00950183|3937029|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4112271|NCT00950183|3937029|B1|||Age||Years|Mean|56|56.0|Full Range|||25.0|75.0|
4112272|NCT00949975|3937037|B5||Male|Sex: Female, Male||Participants|Count of Participants|639|639.0||||||
4112273|NCT00949975|3937038|B4||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4112274|NCT00949975|3937039|B3||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4112275|NCT00949975|3937040|B2||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4112276|NCT00949975|3937041|B1||Male|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4112277|NCT00949975|3937037|B5||Female|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4112278|NCT00949975|3937038|B4||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4112279|NCT00949975|3937039|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4112280|NCT00949975|3937040|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4112281|NCT00949975|3937041|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4112282|NCT00949975|3937037|B5|||Age||Years|Mean|62|62.0|Full Range|||40.0|80.0|
4112283|NCT00949975|3937038|B4|||Age||Years|Mean|62|62.0|Full Range|||41.0|80.0|
4112284|NCT00949975|3937039|B3|||Age||Years|Mean|61|61.0|Full Range|||40.0|79.0|
4112285|NCT00949975|3937040|B2|||Age||Years|Mean|63|63.0|Full Range|||42.0|79.0|
4112286|NCT00949975|3937041|B1|||Age||Years|Mean|62|62.0|Full Range|||42.0|80.0|
4112287|NCT00949910|3937162|B1||Male|Sex: Female, Male||Participants|Count of Participants|3978|3978.0||||||
4112288|NCT00949910|3937162|B1||Female|Sex: Female, Male||Participants|Count of Participants|2608|2608.0||||||
4112289|NCT00949910|3937162|B1|||Age||years|Mean|62.4|62.4|Standard Deviation|11.24|11.24|||
4112290|NCT00949884|3937172|B4|||Pulse Rate||beats per minute|Mean|78.9|78.9|Standard Deviation|10.94|10.94|||
4112291|NCT00949884|3937173|B3|||Pulse Rate||beats per minute|Mean|78.5|78.5|Standard Deviation|10.59|10.59|||
4112292|NCT00949884|3937174|B2|||Pulse Rate||beats per minute|Mean|81.9|81.9|Standard Deviation|9.88|9.88|||
4112293|NCT00949884|3937175|B1|||Pulse Rate||beats per minute|Mean|78.8|78.8|Standard Deviation|11.41|11.41|||
4112294|NCT00949884|3937172|B4|||Diastolic Blood Pressure||mmHg|Mean|101.2|101.2|Standard Deviation|4.09|4.09|||
4112295|NCT00949884|3937173|B3|||Diastolic Blood Pressure||mmHg|Mean|101.3|101.3|Standard Deviation|4.14|4.14|||
4112296|NCT00949884|3937174|B2|||Diastolic Blood Pressure||mmHg|Mean|100.8|100.8|Standard Deviation|3.79|3.79|||
4112297|NCT00949884|3937175|B1|||Diastolic Blood Pressure||mmHg|Mean|101.1|101.1|Standard Deviation|4.07|4.07|||
4112298|NCT00949884|3937172|B4|||Systolic Blood Pressure||mmHg|Mean|158.3|158.3|Standard Deviation|10.29|10.29|||
4112299|NCT00949884|3937173|B3|||Systolic Blood Pressure||mmHg|Mean|158.3|158.3|Standard Deviation|10.24|10.24|||
4112300|NCT00949884|3937174|B2|||Systolic Blood Pressure||mmHg|Mean|157.9|157.9|Standard Deviation|10.05|10.05|||
4112301|NCT00949884|3937175|B1|||Systolic Blood Pressure||mmHg|Mean|158.3|158.3|Standard Deviation|10.41|10.41|||
4112302|NCT00949884|3937172|B4|||Body Mass Index||kilogram/meter^2|Mean|32.41|32.41|Standard Deviation|6.480|6.48|||
4112303|NCT00949884|3937173|B3|||Body Mass Index||kilogram/meter^2|Mean|32.28|32.28|Standard Deviation|6.619|6.619|||
4112304|NCT00949884|3937174|B2|||Body Mass Index||kilogram/meter^2|Mean|33.62|33.62|Standard Deviation|8.103|8.103|||
4112305|NCT00949884|3937175|B1|||Body Mass Index||kilogram/meter^2|Mean|32.41|32.41|Standard Deviation|6.089|6.089|||
4112306|NCT00949884|3937172|B4|||Weight||kilogram|Mean|94.01|94.01|Standard Deviation|20.810|20.81|||
4112307|NCT00949884|3937173|B3|||Weight||kilogram|Mean|94.02|94.02|Standard Deviation|21.647|21.647|||
4112308|NCT00949884|3937174|B2|||Weight||kilogram|Mean|96.14|96.14|Standard Deviation|22.611|22.611|||
4112309|NCT00949884|3937175|B1|||Weight||kilogram|Mean|93.73|93.73|Standard Deviation|19.627|19.627|||
4112310|NCT00949884|3937172|B4|||Height||centimeter|Mean|170.17|170.17|Standard Deviation|9.767|9.767|||
4112311|NCT00949884|3937173|B3|||Height||centimeter|Mean|170.47|170.47|Standard Deviation|9.906|9.906|||
4112312|NCT00949884|3937174|B2|||Height||centimeter|Mean|169.46|169.46|Standard Deviation|9.652|9.652|||
4112313|NCT00949884|3937175|B1|||Height||centimeter|Mean|169.92|169.92|Standard Deviation|9.635|9.635|||
4112314|NCT00949884|3937172|B4|Stage II||Hypertension stage|Hypertension stage was calculated using the baseline mean BP value. Stage I = systolic blood pressure of 140-159 mmHg and diastolic blood pressure 90-99 mmHg, Stage II = systolic blood pressure ≥160 mmHg or diastolic blood pressure ≥100 mmHg|participants|Number|664|664.0||||||
4112315|NCT00949884|3937173|B3|Stage II||Hypertension stage|Hypertension stage was calculated using the baseline mean BP value. Stage I = systolic blood pressure of 140-159 mmHg and diastolic blood pressure 90-99 mmHg, Stage II = systolic blood pressure ≥160 mmHg or diastolic blood pressure ≥100 mmHg|participants|Number|335|335.0||||||
4112316|NCT00949884|3937174|B2|Stage II||Hypertension stage|Hypertension stage was calculated using the baseline mean BP value. Stage I = systolic blood pressure of 140-159 mmHg and diastolic blood pressure 90-99 mmHg, Stage II = systolic blood pressure ≥160 mmHg or diastolic blood pressure ≥100 mmHg|participants|Number|29|29.0||||||
4112317|NCT00949884|3937175|B1|Stage II||Hypertension stage|Hypertension stage was calculated using the baseline mean BP value. Stage I = systolic blood pressure of 140-159 mmHg and diastolic blood pressure 90-99 mmHg, Stage II = systolic blood pressure ≥160 mmHg or diastolic blood pressure ≥100 mmHg|participants|Number|300|300.0||||||
4112318|NCT00949884|3937172|B4|Stage I||Hypertension stage|Hypertension stage was calculated using the baseline mean BP value. Stage I = systolic blood pressure of 140-159 mmHg and diastolic blood pressure 90-99 mmHg, Stage II = systolic blood pressure ≥160 mmHg or diastolic blood pressure ≥100 mmHg|participants|Number|277|277.0||||||
4112319|NCT00949884|3937173|B3|Stage I||Hypertension stage|Hypertension stage was calculated using the baseline mean BP value. Stage I = systolic blood pressure of 140-159 mmHg and diastolic blood pressure 90-99 mmHg, Stage II = systolic blood pressure ≥160 mmHg or diastolic blood pressure ≥100 mmHg|participants|Number|134|134.0||||||
4112320|NCT00949884|3937174|B2|Stage I||Hypertension stage|Hypertension stage was calculated using the baseline mean BP value. Stage I = systolic blood pressure of 140-159 mmHg and diastolic blood pressure 90-99 mmHg, Stage II = systolic blood pressure ≥160 mmHg or diastolic blood pressure ≥100 mmHg|participants|Number|23|23.0||||||
4112321|NCT00949884|3937175|B1|Stage I||Hypertension stage|Hypertension stage was calculated using the baseline mean BP value. Stage I = systolic blood pressure of 140-159 mmHg and diastolic blood pressure 90-99 mmHg, Stage II = systolic blood pressure ≥160 mmHg or diastolic blood pressure ≥100 mmHg|participants|Number|120|120.0||||||
4112322|NCT00949884|3937172|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4112323|NCT00949884|3937173|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4112324|NCT00949884|3937174|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4112325|NCT00949884|3937175|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112326|NCT00949884|3937172|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112327|NCT00949884|3937173|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112328|NCT00949884|3937174|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112329|NCT00949884|3937175|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112330|NCT00949884|3937172|B4||White|Race (NIH/OMB)||Participants|Count of Participants|610|610.0||||||
4112331|NCT00949884|3937173|B3||White|Race (NIH/OMB)||Participants|Count of Participants|304|304.0||||||
4112332|NCT00949884|3937174|B2||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4112333|NCT00949884|3937175|B1||White|Race (NIH/OMB)||Participants|Count of Participants|273|273.0||||||
4112334|NCT00949884|3937172|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|267|267.0||||||
4112335|NCT00949884|3937173|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|133|133.0||||||
4112336|NCT00949884|3937174|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4112337|NCT00949884|3937175|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|118|118.0||||||
4112338|NCT00949884|3937172|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4112339|NCT00949884|3937173|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4112340|NCT00949884|3937174|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112341|NCT00949884|3937175|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112342|NCT00949884|3937172|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4112343|NCT00949884|3937173|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4112344|NCT00949884|3937174|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4112345|NCT00949884|3937175|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4112346|NCT00949884|3937172|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4112347|NCT00949884|3937173|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4112348|NCT00949884|3937174|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112349|NCT00949884|3937175|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4112350|NCT00949884|3937172|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112351|NCT00949884|3937173|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112352|NCT00949884|3937174|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112353|NCT00949884|3937175|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112354|NCT00949884|3937172|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|821|821.0||||||
4112355|NCT00949884|3937173|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|408|408.0||||||
4112356|NCT00949884|3937174|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4112357|NCT00949884|3937175|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|368|368.0||||||
4112358|NCT00949884|3937172|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
4112359|NCT00949884|3937173|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4112360|NCT00949884|3937174|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4112361|NCT00949884|3937175|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4112362|NCT00949884|3937172|B4||Male|Sex: Female, Male||Participants|Count of Participants|513|513.0||||||
4112363|NCT00949884|3937173|B3||Male|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
4112364|NCT00949884|3937174|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4112365|NCT00949884|3937175|B1||Male|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4112366|NCT00949884|3937172|B4||Female|Sex: Female, Male||Participants|Count of Participants|428|428.0||||||
4112367|NCT00949884|3937173|B3||Female|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4112368|NCT00949884|3937174|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4112369|NCT00949884|3937175|B1||Female|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4112370|NCT00949884|3937172|B4|||Age||years|Mean|51.9|51.9|Standard Deviation|9.74|9.74|||
4112371|NCT00949884|3937173|B3|||Age||years|Mean|52.1|52.1|Standard Deviation|9.76|9.76|||
4112372|NCT00949884|3937174|B2|||Age||years|Mean|49.9|49.9|Standard Deviation|8.67|8.67|||
4112373|NCT00949884|3937175|B1|||Age||years|Mean|52.0|52.0|Standard Deviation|9.84|9.84|||
4112374|NCT00949884|3937172|B4||>=65 years|Age||Participants|Count of Participants|82|82.0||||||
4112375|NCT00949884|3937173|B3||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
4112376|NCT00949884|3937174|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4112377|NCT00949884|3937175|B1||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
4112378|NCT00949884|3937172|B4||Between 18 and 65 years|Age||Participants|Count of Participants|859|859.0||||||
4112379|NCT00949884|3937173|B3||Between 18 and 65 years|Age||Participants|Count of Participants|423|423.0||||||
4112380|NCT00949884|3937174|B2||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4112381|NCT00949884|3937175|B1||Between 18 and 65 years|Age||Participants|Count of Participants|385|385.0||||||
4112382|NCT00949884|3937172|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4112383|NCT00949884|3937173|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4112384|NCT00949884|3937174|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4112385|NCT00949884|3937175|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4112386|NCT00949715|3937230|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4112387|NCT00949715|3937231|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112388|NCT00949715|3937232|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4112389|NCT00949715|3937230|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112390|NCT00949715|3937231|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112391|NCT00949715|3937232|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112392|NCT00949715|3937230|B3||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4112393|NCT00949715|3937231|B2||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4112394|NCT00949715|3937232|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4112395|NCT00949715|3937230|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4112396|NCT00949715|3937231|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4112397|NCT00949715|3937232|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4112398|NCT00949715|3937230|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112399|NCT00949715|3937231|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112400|NCT00949715|3937232|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112401|NCT00949715|3937230|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112402|NCT00949715|3937231|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112403|NCT00949715|3937232|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112404|NCT00949715|3937230|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112405|NCT00949715|3937231|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112406|NCT00949715|3937232|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112407|NCT00949715|3937230|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4112408|NCT00949715|3937231|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4112409|NCT00949715|3937232|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4112410|NCT00949715|3937230|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4112411|NCT00949715|3937231|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4112412|NCT00949715|3937232|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4112413|NCT00949715|3937230|B3|||Age||years|Mean|74.4|74.4|Standard Deviation|9.3|9.3|||
4112414|NCT00949715|3937231|B2|||Age||years|Mean|73.3|73.3|Standard Deviation|10.6|10.6|||
4112415|NCT00949715|3937232|B1|||Age||years|Mean|75.6|75.6|Standard Deviation|7.6|7.6|||
4112416|NCT00949702|3937244|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4112417|NCT00949702|3937244|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4112418|NCT00949702|3937244|B1|||Age||years|Mean|50.3|50.3|Standard Deviation|14.70|14.7|||
4112419|NCT00949650|3937259|B3|ECOG PS 2 (baseline)||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|"ECOG PS measured on 6 point scale to assess participant's performance status. 0=Fully active, able to carry on all pre-disease activities without restriction.~Restricted in physically strenuous activity, but ambulatory and able to carry out light or sedentary work.~Ambulatory (>50 percent of waking hours), capable of all self-care, unable to carry out any work activities.~Capable of only limited self-care, confined to bed or chair more than 50 percent of waking hours.~Completely disabled, cannot carry on any self-care, totally confined to bed or chair.~Dead."|Participants|Number|1|1.0||||||
4112420|NCT00949650|3937260|B2|ECOG PS 2 (baseline)||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|"ECOG PS measured on 6 point scale to assess participant's performance status. 0=Fully active, able to carry on all pre-disease activities without restriction.~Restricted in physically strenuous activity, but ambulatory and able to carry out light or sedentary work.~Ambulatory (>50 percent of waking hours), capable of all self-care, unable to carry out any work activities.~Capable of only limited self-care, confined to bed or chair more than 50 percent of waking hours.~Completely disabled, cannot carry on any self-care, totally confined to bed or chair.~Dead."|Participants|Number|1|1.0||||||
4112421|NCT00949650|3937261|B1|ECOG PS 2 (baseline)||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|"ECOG PS measured on 6 point scale to assess participant's performance status. 0=Fully active, able to carry on all pre-disease activities without restriction.~Restricted in physically strenuous activity, but ambulatory and able to carry out light or sedentary work.~Ambulatory (>50 percent of waking hours), capable of all self-care, unable to carry out any work activities.~Capable of only limited self-care, confined to bed or chair more than 50 percent of waking hours.~Completely disabled, cannot carry on any self-care, totally confined to bed or chair.~Dead."|Participants|Number|0|0.0||||||
4112422|NCT00949650|3937259|B3|ECOG PS 1 (baseline)||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|"ECOG PS measured on 6 point scale to assess participant's performance status. 0=Fully active, able to carry on all pre-disease activities without restriction.~Restricted in physically strenuous activity, but ambulatory and able to carry out light or sedentary work.~Ambulatory (>50 percent of waking hours), capable of all self-care, unable to carry out any work activities.~Capable of only limited self-care, confined to bed or chair more than 50 percent of waking hours.~Completely disabled, cannot carry on any self-care, totally confined to bed or chair.~Dead."|Participants|Number|211|211.0||||||
4112423|NCT00949650|3937260|B2|ECOG PS 1 (baseline)||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|"ECOG PS measured on 6 point scale to assess participant's performance status. 0=Fully active, able to carry on all pre-disease activities without restriction.~Restricted in physically strenuous activity, but ambulatory and able to carry out light or sedentary work.~Ambulatory (>50 percent of waking hours), capable of all self-care, unable to carry out any work activities.~Capable of only limited self-care, confined to bed or chair more than 50 percent of waking hours.~Completely disabled, cannot carry on any self-care, totally confined to bed or chair.~Dead."|Participants|Number|73|73.0||||||
4112424|NCT00949650|3937261|B1|ECOG PS 1 (baseline)||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|"ECOG PS measured on 6 point scale to assess participant's performance status. 0=Fully active, able to carry on all pre-disease activities without restriction.~Restricted in physically strenuous activity, but ambulatory and able to carry out light or sedentary work.~Ambulatory (>50 percent of waking hours), capable of all self-care, unable to carry out any work activities.~Capable of only limited self-care, confined to bed or chair more than 50 percent of waking hours.~Completely disabled, cannot carry on any self-care, totally confined to bed or chair.~Dead."|Participants|Number|138|138.0||||||
4112425|NCT00949650|3937259|B3|ECOG PS 0 (baseline)||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|"ECOG PS measured on 6 point scale to assess participant's performance status. 0=Fully active, able to carry on all pre-disease activities without restriction.~Restricted in physically strenuous activity, but ambulatory and able to carry out light or sedentary work.~Ambulatory (>50 percent of waking hours), capable of all self-care, unable to carry out any work activities.~Capable of only limited self-care, confined to bed or chair more than 50 percent of waking hours.~Completely disabled, cannot carry on any self-care, totally confined to bed or chair.~Dead."|Participants|Number|133|133.0||||||
4112467|NCT00949234|3937313|B1|Black/AA||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4112426|NCT00949650|3937260|B2|ECOG PS 0 (baseline)||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|"ECOG PS measured on 6 point scale to assess participant's performance status. 0=Fully active, able to carry on all pre-disease activities without restriction.~Restricted in physically strenuous activity, but ambulatory and able to carry out light or sedentary work.~Ambulatory (>50 percent of waking hours), capable of all self-care, unable to carry out any work activities.~Capable of only limited self-care, confined to bed or chair more than 50 percent of waking hours.~Completely disabled, cannot carry on any self-care, totally confined to bed or chair.~Dead."|Participants|Number|41|41.0||||||
4112427|NCT00949650|3937261|B1|ECOG PS 0 (baseline)||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|"ECOG PS measured on 6 point scale to assess participant's performance status. 0=Fully active, able to carry on all pre-disease activities without restriction.~Restricted in physically strenuous activity, but ambulatory and able to carry out light or sedentary work.~Ambulatory (>50 percent of waking hours), capable of all self-care, unable to carry out any work activities.~Capable of only limited self-care, confined to bed or chair more than 50 percent of waking hours.~Completely disabled, cannot carry on any self-care, totally confined to bed or chair.~Dead."|Participants|Number|92|92.0||||||
4112428|NCT00949650|3937259|B3|EGFR mutation category: Other||Epidermal Growth Factor Receptor (EGFR) mutation group|EGFR mutation group (L858R/Deletion Exon 19/Other) was a stratification factor.|Participants|Number|38|38.0||||||
4112429|NCT00949650|3937260|B2|EGFR mutation category: Other||Epidermal Growth Factor Receptor (EGFR) mutation group|EGFR mutation group (L858R/Deletion Exon 19/Other) was a stratification factor.|Participants|Number|11|11.0||||||
4112430|NCT00949650|3937261|B1|EGFR mutation category: Other||Epidermal Growth Factor Receptor (EGFR) mutation group|EGFR mutation group (L858R/Deletion Exon 19/Other) was a stratification factor.|Participants|Number|27|27.0||||||
4112431|NCT00949650|3937259|B3|EGFR mutation category: Deletion Exon 19||Epidermal Growth Factor Receptor (EGFR) mutation group|EGFR mutation group (L858R/Deletion Exon 19/Other) was a stratification factor.|Participants|Number|169|169.0||||||
4112432|NCT00949650|3937260|B2|EGFR mutation category: Deletion Exon 19||Epidermal Growth Factor Receptor (EGFR) mutation group|EGFR mutation group (L858R/Deletion Exon 19/Other) was a stratification factor.|Participants|Number|57|57.0||||||
4112433|NCT00949650|3937261|B1|EGFR mutation category: Deletion Exon 19||Epidermal Growth Factor Receptor (EGFR) mutation group|EGFR mutation group (L858R/Deletion Exon 19/Other) was a stratification factor.|Participants|Number|112|112.0||||||
4112434|NCT00949650|3937259|B3|EGFR mutation category: L858R||Epidermal Growth Factor Receptor (EGFR) mutation group|EGFR mutation group (L858R/Deletion Exon 19/Other) was a stratification factor.|Participants|Number|138|138.0||||||
4112435|NCT00949650|3937260|B2|EGFR mutation category: L858R||Epidermal Growth Factor Receptor (EGFR) mutation group|EGFR mutation group (L858R/Deletion Exon 19/Other) was a stratification factor.|Participants|Number|47|47.0||||||
4112436|NCT00949650|3937261|B1|EGFR mutation category: L858R||Epidermal Growth Factor Receptor (EGFR) mutation group|EGFR mutation group (L858R/Deletion Exon 19/Other) was a stratification factor.|Participants|Number|91|91.0||||||
4112437|NCT00949650|3937259|B3|Non-Asian||Race/Ethnicity, Customized|Race (Asian/non-Asian) was a stratification factor.|Participants|Number|96|96.0||||||
4112438|NCT00949650|3937260|B2|Non-Asian||Race/Ethnicity, Customized|Race (Asian/non-Asian) was a stratification factor.|Participants|Number|32|32.0||||||
4112439|NCT00949650|3937261|B1|Non-Asian||Race/Ethnicity, Customized|Race (Asian/non-Asian) was a stratification factor.|Participants|Number|64|64.0||||||
4112440|NCT00949650|3937259|B3|Asian||Race/Ethnicity, Customized|Race (Asian/non-Asian) was a stratification factor.|Participants|Number|249|249.0||||||
4112441|NCT00949650|3937260|B2|Asian||Race/Ethnicity, Customized|Race (Asian/non-Asian) was a stratification factor.|Participants|Number|83|83.0||||||
4112442|NCT00949650|3937261|B1|Asian||Race/Ethnicity, Customized|Race (Asian/non-Asian) was a stratification factor.|Participants|Number|166|166.0||||||
4112443|NCT00949650|3937259|B3||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4112444|NCT00949650|3937260|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4112445|NCT00949650|3937261|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4112446|NCT00949650|3937259|B3||Female|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
4112447|NCT00949650|3937260|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4112448|NCT00949650|3937261|B1||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4112449|NCT00949650|3937259|B3|||Age||Years|Mean|60.3|60.3|Standard Deviation|10.1|10.1|||
4112450|NCT00949650|3937260|B2|||Age||Years|Mean|59.9|59.9|Standard Deviation|10.0|10.0|||
4112451|NCT00949650|3937261|B1|||Age||Years|Mean|60.5|60.5|Standard Deviation|10.1|10.1|||
4112452|NCT00949533|3937298|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4112453|NCT00949533|3937299|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4112454|NCT00949533|3937300|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4112455|NCT00949533|3937298|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4112456|NCT00949533|3937299|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4112457|NCT00949533|3937300|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4112458|NCT00949533|3937298|B3|||Age||years|Mean|21.8|21.8|Standard Deviation|11.7|11.7|||
4112459|NCT00949533|3937299|B2|||Age||years|Mean|22.0|22.0|Standard Deviation|12.7|12.7|||
4112460|NCT00949533|3937300|B1|||Age||years|Mean|21.6|21.6|Standard Deviation|11.0|11.0|||
4112461|NCT00949234|3937313|B1|United States||Region of Enrollment||participants|Number|267|267.0||||||
4112462|NCT00949234|3937313|B1|Other||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4112463|NCT00949234|3937313|B1|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4112464|NCT00949234|3937313|B1|Asian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4112465|NCT00949234|3937313|B1|Hispanic/Latino(a)||Race/Ethnicity, Customized||participants|Number|92|92.0||||||
4112466|NCT00949234|3937313|B1|White||Race/Ethnicity, Customized||participants|Number|128|128.0||||||
4112468|NCT00949234|3937313|B1|Transgender||Sex/Gender, Customized||participants|Number|3|3.0||||||
4112469|NCT00949234|3937313|B1|Female||Sex/Gender, Customized||participants|Number|11|11.0||||||
4112470|NCT00949234|3937313|B1|Male||Sex/Gender, Customized||participants|Number|253|253.0||||||
4112471|NCT00949234|3937313|B1|||Age||years|Median|32|32.0|Full Range|||19.0|66.0|
4112472|NCT00949234|3937313|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4112473|NCT00949234|3937313|B1||Between 18 and 65 years|Age||Participants|Count of Participants|266|266.0||||||
4112474|NCT00949234|3937313|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4112475|NCT00949117|3937317|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4112476|NCT00949117|3937318|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4112477|NCT00949117|3937319|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4112478|NCT00949117|3937317|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4112479|NCT00949117|3937318|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4112480|NCT00949117|3937319|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4112481|NCT00949117|3937317|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4112482|NCT00949117|3937318|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4112483|NCT00949117|3937319|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4112484|NCT00949117|3937317|B3|||Age||years|Mean|11.4|11.4|Standard Deviation|5.1|5.1|||
4112485|NCT00949117|3937318|B2|||Age||years|Mean|13.3|13.3|Standard Deviation|5.1|5.1|||
4112486|NCT00949117|3937319|B1|||Age||years|Mean|9.1|9.1|Standard Deviation|5.5|5.5|||
4112487|NCT00949117|3937317|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4112488|NCT00949117|3937318|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4112489|NCT00949117|3937319|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4112490|NCT00949117|3937317|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4112491|NCT00949117|3937318|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4112492|NCT00949117|3937319|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4112493|NCT00949117|3937317|B3||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4112494|NCT00949117|3937318|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4112495|NCT00949117|3937319|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4112496|NCT00949078|3937334|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4112497|NCT00949078|3937335|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4112498|NCT00949078|3937336|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4112499|NCT00949078|3937334|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4112500|NCT00949078|3937335|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4112501|NCT00949078|3937336|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4112502|NCT00949078|3937334|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4112503|NCT00949078|3937335|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4112504|NCT00949078|3937336|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4112505|NCT00949078|3937334|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4112506|NCT00949078|3937335|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4112507|NCT00949078|3937336|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4112508|NCT00949078|3937334|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4112509|NCT00949078|3937335|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4112510|NCT00949078|3937336|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4112511|NCT00949078|3937334|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4112512|NCT00949078|3937335|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4112513|NCT00949078|3937336|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4112514|NCT00948974|3937359|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112515|NCT00948974|3937360|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112516|NCT00948974|3937361|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112517|NCT00948974|3937359|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4112518|NCT00948974|3937360|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4112519|NCT00948974|3937361|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4112520|NCT00948974|3937359|B3||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4112521|NCT00948974|3937360|B2||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4112522|NCT00948974|3937361|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4112523|NCT00948974|3937359|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4112524|NCT00948974|3937360|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4112525|NCT00948974|3937361|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4112526|NCT00948974|3937359|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112527|NCT00948974|3937360|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112528|NCT00948974|3937361|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112529|NCT00948974|3937359|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4112530|NCT00948974|3937360|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4112531|NCT00948974|3937361|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4112532|NCT00948974|3937359|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112533|NCT00948974|3937360|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112534|NCT00948974|3937361|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112535|NCT00948974|3937359|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4112536|NCT00948974|3937360|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4112537|NCT00948974|3937361|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4112538|NCT00948974|3937359|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4112539|NCT00948974|3937360|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4112540|NCT00948974|3937361|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4112541|NCT00948974|3937359|B3|||Age||years|Mean|29.97|29.97|Standard Deviation|10.98|10.98|||
4112542|NCT00948974|3937360|B2|||Age||years|Mean|29.90|29.9|Standard Deviation|11.66|11.66|||
4112543|NCT00948974|3937361|B1|||Age||years|Mean|30.05|30.05|Standard Deviation|10.25|10.25|||
4112544|NCT00948922|3937372|B4|United States||Region of Enrollment||participants|Number|124|124.0||||||
4112545|NCT00948922|3937373|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
4112546|NCT00948922|3937374|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
4112547|NCT00948922|3937375|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4112548|NCT00948922|3937372|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4112549|NCT00948922|3937373|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4112550|NCT00948922|3937374|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4112551|NCT00948922|3937375|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112552|NCT00948922|3937372|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112553|NCT00948922|3937373|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112554|NCT00948922|3937374|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112555|NCT00948922|3937375|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112556|NCT00948922|3937372|B4||White|Race (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
4112557|NCT00948922|3937373|B3||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4112558|NCT00948922|3937374|B2||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4112559|NCT00948922|3937375|B1||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4112560|NCT00948922|3937372|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4112561|NCT00948922|3937373|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4112562|NCT00948922|3937374|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4112563|NCT00948922|3937375|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4112564|NCT00948922|3937372|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112565|NCT00948922|3937373|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112566|NCT00948922|3937374|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112567|NCT00948922|3937375|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112568|NCT00948922|3937372|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4112569|NCT00948922|3937373|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112570|NCT00948922|3937374|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4112571|NCT00948922|3937375|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4112572|NCT00948922|3937372|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4112573|NCT00948922|3937373|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4112574|NCT00948922|3937374|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112575|NCT00948922|3937375|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112576|NCT00948922|3937372|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4112577|NCT00948922|3937373|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4112578|NCT00948922|3937374|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112579|NCT00948922|3937375|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112580|NCT00948922|3937372|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
4112581|NCT00948922|3937373|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4112582|NCT00948922|3937374|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4112583|NCT00948922|3937375|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4112584|NCT00948922|3937372|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4112585|NCT00948922|3937373|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4112586|NCT00948922|3937374|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4112587|NCT00948922|3937375|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4112588|NCT00948922|3937372|B4||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4112589|NCT00948922|3937373|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4112590|NCT00948922|3937374|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4112591|NCT00948922|3937375|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4112592|NCT00948922|3937372|B4||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4112593|NCT00948922|3937373|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4112594|NCT00948922|3937374|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4112595|NCT00948922|3937375|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4112596|NCT00948922|3937372|B4|||Age||years|Mean|60|60.0|Full Range|||31.0|79.0|
4112597|NCT00948922|3937373|B3|||Age||years|Mean|62|62.0|Full Range|||39.0|78.0|
4112598|NCT00948922|3937374|B2|||Age||years|Mean|62|62.0|Full Range|||31.0|79.0|
4112599|NCT00948922|3937375|B1|||Age||years|Mean|53.5|53.5|Full Range|||32.0|76.0|
4112600|NCT00948896|3937385|B9|||Duration of follow-up||days|Median|546|546.0|Full Range|||7.0|580.0|
4112601|NCT00948896|3937386|B8|||Duration of follow-up||days|Median|409|409.0|Full Range|||31.0|535.0|
4112602|NCT00948896|3937387|B7|||Duration of follow-up||days|Median|346|346.0|Full Range|||88.0|505.0|
4112603|NCT00948896|3937388|B6|||Duration of follow-up||days|Median|420|420.0|Full Range|||127.0|524.0|
4112604|NCT00948896|3937389|B5|||Duration of follow-up||days|Median|427|427.0|Full Range|||88.0|549.0|
4112605|NCT00948896|3937390|B4|||Duration of follow-up||days|Median|547|547.0|Full Range|||7.0|569.0|
4112606|NCT00948896|3937391|B3|||Duration of follow-up||days|Median|547|547.0|Full Range|||58.0|564.0|
4112607|NCT00948896|3937392|B2|||Duration of follow-up||days|Median|547|547.0|Full Range|||63.0|550.0|
4112608|NCT00948896|3937393|B1|||Duration of follow-up||days|Median|547|547.0|Full Range|||53.0|580.0|
4112609|NCT00948896|3937385|B9|||Age at time of randomization||months|Median|6.0|6.0|Full Range|||6.0|20.0|
4112610|NCT00948896|3937386|B8|||Age at time of randomization||months|Median|10.3|10.3|Full Range|||6.5|20.0|
4112611|NCT00948896|3937387|B7|||Age at time of randomization||months|Median|11.6|11.6|Full Range|||6.2|18.7|
4112612|NCT00948896|3937388|B6|||Age at time of randomization||months|Median|9.3|9.3|Full Range|||6.5|18.8|
4112613|NCT00948896|3937389|B5|||Age at time of randomization||months|Median|10.0|10.0|Full Range|||6.0|18.0|
4112614|NCT00948896|3937390|B4|||Age at time of randomization||months|Median|6.0|6.0|Full Range|||6.0|6.5|
4112615|NCT00948896|3937391|B3|||Age at time of randomization||months|Median|6.0|6.0|Full Range|||6.0|6.3|
4112616|NCT00948896|3937392|B2|||Age at time of randomization||months|Median|6.0|6.0|Full Range|||6.0|6.5|
4112617|NCT00948896|3937393|B1|||Age at time of randomization||months|Median|6.0|6.0|Full Range|||6.0|6.5|
4112618|NCT00948896|3937385|B9|No||Taking TS prophylaxis|This measurement is only applicable for the HIV-exposed participants (n=186).|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4112619|NCT00948896|3937386|B8|No||Taking TS prophylaxis|This measurement is only applicable for the HIV-exposed participants (n=186).|participants|Number|38|38.0||||||
4112620|NCT00948896|3937387|B7|No||Taking TS prophylaxis|This measurement is only applicable for the HIV-exposed participants (n=186).|participants|Number|42|42.0||||||
4112621|NCT00948896|3937388|B6|No||Taking TS prophylaxis|This measurement is only applicable for the HIV-exposed participants (n=186).|participants|Number|39|39.0||||||
4112622|NCT00948896|3937389|B5|No||Taking TS prophylaxis|This measurement is only applicable for the HIV-exposed participants (n=186).|participants|Number|41|41.0||||||
4112623|NCT00948896|3937390|B4|No||Taking TS prophylaxis|This measurement is only applicable for the HIV-exposed participants (n=186).|participants|Number|NA|||||||Only applicable for HIV-exposed participants
4112624|NCT00948896|3937391|B3|No||Taking TS prophylaxis|This measurement is only applicable for the HIV-exposed participants (n=186).|participants|Number|NA|||||||Only applicable for HIV-exposed participants
4112625|NCT00948896|3937392|B2|No||Taking TS prophylaxis|This measurement is only applicable for the HIV-exposed participants (n=186).|participants|Number|NA|||||||Only applicable for HIV-exposed participants
4112626|NCT00948896|3937393|B1|No||Taking TS prophylaxis|This measurement is only applicable for the HIV-exposed participants (n=186).|participants|Number|NA|||||||Only applicable for HIV-exposed participants
4112627|NCT00948896|3937385|B9|Yes||Taking TS prophylaxis|This measurement is only applicable for the HIV-exposed participants (n=186).|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4112628|NCT00948896|3937386|B8|Yes||Taking TS prophylaxis|This measurement is only applicable for the HIV-exposed participants (n=186).|participants|Number|9|9.0||||||
4112629|NCT00948896|3937387|B7|Yes||Taking TS prophylaxis|This measurement is only applicable for the HIV-exposed participants (n=186).|participants|Number|5|5.0||||||
4112630|NCT00948896|3937388|B6|Yes||Taking TS prophylaxis|This measurement is only applicable for the HIV-exposed participants (n=186).|participants|Number|7|7.0||||||
4112631|NCT00948896|3937389|B5|Yes||Taking TS prophylaxis|This measurement is only applicable for the HIV-exposed participants (n=186).|participants|Number|5|5.0||||||
4112632|NCT00948896|3937390|B4|Yes||Taking TS prophylaxis|This measurement is only applicable for the HIV-exposed participants (n=186).|participants|Number|NA|||||||Only applicable for HIV-exposed participants
4112633|NCT00948896|3937391|B3|Yes||Taking TS prophylaxis|This measurement is only applicable for the HIV-exposed participants (n=186).|participants|Number|NA|||||||Only applicable for HIV-exposed participants
4112634|NCT00948896|3937392|B2|Yes||Taking TS prophylaxis|This measurement is only applicable for the HIV-exposed participants (n=186).|participants|Number|NA|||||||Only applicable for HIV-exposed participants
4112697|NCT00948896|3937392|B2|Yes||Stunted|Length-for-age z-score <-2|participants|Number|11|11.0||||||
4112635|NCT00948896|3937393|B1|Yes||Taking TS prophylaxis|This measurement is only applicable for the HIV-exposed participants (n=186).|participants|Number|NA|||||||Only applicable for HIV-exposed participants
4112636|NCT00948896|3937385|B9|No||Positive thick blood smear||participants|Number|459|459.0||||||
4112637|NCT00948896|3937386|B8|No||Positive thick blood smear||participants|Number|41|41.0||||||
4112638|NCT00948896|3937387|B7|No||Positive thick blood smear||participants|Number|39|39.0||||||
4112639|NCT00948896|3937388|B6|No||Positive thick blood smear||participants|Number|42|42.0||||||
4112640|NCT00948896|3937389|B5|No||Positive thick blood smear||participants|Number|38|38.0||||||
4112641|NCT00948896|3937390|B4|No||Positive thick blood smear||participants|Number|70|70.0||||||
4112642|NCT00948896|3937391|B3|No||Positive thick blood smear||participants|Number|82|82.0||||||
4112643|NCT00948896|3937392|B2|No||Positive thick blood smear||participants|Number|71|71.0||||||
4112644|NCT00948896|3937393|B1|No||Positive thick blood smear||participants|Number|76|76.0||||||
4112645|NCT00948896|3937385|B9|Yes||Positive thick blood smear||participants|Number|120|120.0||||||
4112646|NCT00948896|3937386|B8|Yes||Positive thick blood smear||participants|Number|6|6.0||||||
4112647|NCT00948896|3937387|B7|Yes||Positive thick blood smear||participants|Number|8|8.0||||||
4112648|NCT00948896|3937388|B6|Yes||Positive thick blood smear||participants|Number|4|4.0||||||
4112649|NCT00948896|3937389|B5|Yes||Positive thick blood smear||participants|Number|8|8.0||||||
4112650|NCT00948896|3937390|B4|Yes||Positive thick blood smear||participants|Number|28|28.0||||||
4112651|NCT00948896|3937391|B3|Yes||Positive thick blood smear||participants|Number|17|17.0||||||
4112652|NCT00948896|3937392|B2|Yes||Positive thick blood smear||participants|Number|27|27.0||||||
4112653|NCT00948896|3937393|B1|Yes||Positive thick blood smear||participants|Number|22|22.0||||||
4112654|NCT00948896|3937385|B9|||Hemoglobin||gm/dl|Mean|9.8|9.8|Standard Deviation|1.5|1.5|||
4112655|NCT00948896|3937386|B8|||Hemoglobin||gm/dl|Mean|10.5|10.5|Standard Deviation|1.5|1.5|||
4112656|NCT00948896|3937387|B7|||Hemoglobin||gm/dl|Mean|10.1|10.1|Standard Deviation|1.1|1.1|||
4112657|NCT00948896|3937388|B6|||Hemoglobin||gm/dl|Mean|10.0|10.0|Standard Deviation|1.4|1.4|||
4112658|NCT00948896|3937389|B5|||Hemoglobin||gm/dl|Mean|10.1|10.1|Standard Deviation|1.2|1.2|||
4112659|NCT00948896|3937390|B4|||Hemoglobin||gm/dl|Mean|9.5|9.5|Standard Deviation|1.5|1.5|||
4112660|NCT00948896|3937391|B3|||Hemoglobin||gm/dl|Mean|9.9|9.9|Standard Deviation|1.5|1.5|||
4112661|NCT00948896|3937392|B2|||Hemoglobin||gm/dl|Mean|9.6|9.6|Standard Deviation|1.8|1.8|||
4112662|NCT00948896|3937393|B1|||Hemoglobin||gm/dl|Mean|9.7|9.7|Standard Deviation|1.4|1.4|||
4112663|NCT00948896|3937385|B9|No||Wasted|Weight-for-age Z-score < -2|participants|Number|547|547.0||||||
4112664|NCT00948896|3937386|B8|No||Wasted|Weight-for-age Z-score < -2|participants|Number|43|43.0||||||
4112665|NCT00948896|3937387|B7|No||Wasted|Weight-for-age Z-score < -2|participants|Number|46|46.0||||||
4112666|NCT00948896|3937388|B6|No||Wasted|Weight-for-age Z-score < -2|participants|Number|42|42.0||||||
4112667|NCT00948896|3937389|B5|No||Wasted|Weight-for-age Z-score < -2|participants|Number|46|46.0||||||
4112668|NCT00948896|3937390|B4|No||Wasted|Weight-for-age Z-score < -2|participants|Number|93|93.0||||||
4112669|NCT00948896|3937391|B3|No||Wasted|Weight-for-age Z-score < -2|participants|Number|92|92.0||||||
4112670|NCT00948896|3937392|B2|No||Wasted|Weight-for-age Z-score < -2|participants|Number|91|91.0||||||
4112671|NCT00948896|3937393|B1|No||Wasted|Weight-for-age Z-score < -2|participants|Number|94|94.0||||||
4112672|NCT00948896|3937385|B9|Yes||Wasted|Weight-for-age Z-score < -2|participants|Number|32|32.0||||||
4112673|NCT00948896|3937386|B8|Yes||Wasted|Weight-for-age Z-score < -2|participants|Number|4|4.0||||||
4112674|NCT00948896|3937387|B7|Yes||Wasted|Weight-for-age Z-score < -2|participants|Number|1|1.0||||||
4112675|NCT00948896|3937388|B6|Yes||Wasted|Weight-for-age Z-score < -2|participants|Number|4|4.0||||||
4112676|NCT00948896|3937389|B5|Yes||Wasted|Weight-for-age Z-score < -2|participants|Number|0|0.0||||||
4112677|NCT00948896|3937390|B4|Yes||Wasted|Weight-for-age Z-score < -2|participants|Number|5|5.0||||||
4112678|NCT00948896|3937391|B3|Yes||Wasted|Weight-for-age Z-score < -2|participants|Number|7|7.0||||||
4112679|NCT00948896|3937392|B2|Yes||Wasted|Weight-for-age Z-score < -2|participants|Number|7|7.0||||||
4112680|NCT00948896|3937393|B1|Yes||Wasted|Weight-for-age Z-score < -2|participants|Number|4|4.0||||||
4112681|NCT00948896|3937385|B9|No||Stunted|Length-for-age z-score <-2|participants|Number|522|522.0||||||
4112682|NCT00948896|3937386|B8|No||Stunted|Length-for-age z-score <-2|participants|Number|40|40.0||||||
4112683|NCT00948896|3937387|B7|No||Stunted|Length-for-age z-score <-2|participants|Number|41|41.0||||||
4112684|NCT00948896|3937388|B6|No||Stunted|Length-for-age z-score <-2|participants|Number|39|39.0||||||
4112685|NCT00948896|3937389|B5|No||Stunted|Length-for-age z-score <-2|participants|Number|40|40.0||||||
4112686|NCT00948896|3937390|B4|No||Stunted|Length-for-age z-score <-2|participants|Number|94|94.0||||||
4112687|NCT00948896|3937391|B3|No||Stunted|Length-for-age z-score <-2|participants|Number|93|93.0||||||
4112688|NCT00948896|3937392|B2|No||Stunted|Length-for-age z-score <-2|participants|Number|87|87.0||||||
4112689|NCT00948896|3937393|B1|No||Stunted|Length-for-age z-score <-2|participants|Number|88|88.0||||||
4112690|NCT00948896|3937385|B9|Yes||Stunted|Length-for-age z-score <-2|participants|Number|57|57.0||||||
4112691|NCT00948896|3937386|B8|Yes||Stunted|Length-for-age z-score <-2|participants|Number|7|7.0||||||
4112692|NCT00948896|3937387|B7|Yes||Stunted|Length-for-age z-score <-2|participants|Number|6|6.0||||||
4112693|NCT00948896|3937388|B6|Yes||Stunted|Length-for-age z-score <-2|participants|Number|7|7.0||||||
4112694|NCT00948896|3937389|B5|Yes||Stunted|Length-for-age z-score <-2|participants|Number|6|6.0||||||
4112695|NCT00948896|3937390|B4|Yes||Stunted|Length-for-age z-score <-2|participants|Number|4|4.0||||||
4112696|NCT00948896|3937391|B3|Yes||Stunted|Length-for-age z-score <-2|participants|Number|6|6.0||||||
4112698|NCT00948896|3937393|B1|Yes||Stunted|Length-for-age z-score <-2|participants|Number|10|10.0||||||
4112699|NCT00948896|3937385|B9|No||Slept under ITN prior night||participants|Number|379|379.0||||||
4112700|NCT00948896|3937386|B8|No||Slept under ITN prior night||participants|Number|25|25.0||||||
4112701|NCT00948896|3937387|B7|No||Slept under ITN prior night||participants|Number|28|28.0||||||
4112702|NCT00948896|3937388|B6|No||Slept under ITN prior night||participants|Number|22|22.0||||||
4112703|NCT00948896|3937389|B5|No||Slept under ITN prior night||participants|Number|24|24.0||||||
4112704|NCT00948896|3937390|B4|No||Slept under ITN prior night||participants|Number|69|69.0||||||
4112705|NCT00948896|3937391|B3|No||Slept under ITN prior night||participants|Number|72|72.0||||||
4112706|NCT00948896|3937392|B2|No||Slept under ITN prior night||participants|Number|68|68.0||||||
4112707|NCT00948896|3937393|B1|No||Slept under ITN prior night||participants|Number|71|71.0||||||
4112708|NCT00948896|3937385|B9|Yes||Slept under ITN prior night||participants|Number|200|200.0||||||
4112709|NCT00948896|3937386|B8|Yes||Slept under ITN prior night||participants|Number|22|22.0||||||
4112710|NCT00948896|3937387|B7|Yes||Slept under ITN prior night||participants|Number|19|19.0||||||
4112711|NCT00948896|3937388|B6|Yes||Slept under ITN prior night||participants|Number|24|24.0||||||
4112712|NCT00948896|3937389|B5|Yes||Slept under ITN prior night||participants|Number|22|22.0||||||
4112713|NCT00948896|3937390|B4|Yes||Slept under ITN prior night||participants|Number|29|29.0||||||
4112714|NCT00948896|3937391|B3|Yes||Slept under ITN prior night||participants|Number|27|27.0||||||
4112715|NCT00948896|3937392|B2|Yes||Slept under ITN prior night||participants|Number|30|30.0||||||
4112716|NCT00948896|3937393|B1|Yes||Slept under ITN prior night||participants|Number|27|27.0||||||
4112717|NCT00948896|3937385|B9|No||Slept under any bednet prior night||participants|Number|301|301.0||||||
4112718|NCT00948896|3937386|B8|No||Slept under any bednet prior night||participants|Number|18|18.0||||||
4112719|NCT00948896|3937387|B7|No||Slept under any bednet prior night||participants|Number|21|21.0||||||
4112720|NCT00948896|3937388|B6|No||Slept under any bednet prior night||participants|Number|19|19.0||||||
4112721|NCT00948896|3937389|B5|No||Slept under any bednet prior night||participants|Number|19|19.0||||||
4112722|NCT00948896|3937390|B4|No||Slept under any bednet prior night||participants|Number|53|53.0||||||
4112723|NCT00948896|3937391|B3|No||Slept under any bednet prior night||participants|Number|59|59.0||||||
4112724|NCT00948896|3937392|B2|No||Slept under any bednet prior night||participants|Number|55|55.0||||||
4112725|NCT00948896|3937393|B1|No||Slept under any bednet prior night||participants|Number|57|57.0||||||
4112726|NCT00948896|3937385|B9|Yes||Slept under any bednet prior night||participants|Number|278|278.0||||||
4112727|NCT00948896|3937386|B8|Yes||Slept under any bednet prior night||participants|Number|29|29.0||||||
4112728|NCT00948896|3937387|B7|Yes||Slept under any bednet prior night||participants|Number|26|26.0||||||
4112729|NCT00948896|3937388|B6|Yes||Slept under any bednet prior night||participants|Number|27|27.0||||||
4112730|NCT00948896|3937389|B5|Yes||Slept under any bednet prior night||participants|Number|27|27.0||||||
4112731|NCT00948896|3937390|B4|Yes||Slept under any bednet prior night||participants|Number|45|45.0||||||
4112732|NCT00948896|3937391|B3|Yes||Slept under any bednet prior night||participants|Number|40|40.0||||||
4112733|NCT00948896|3937392|B2|Yes||Slept under any bednet prior night||participants|Number|43|43.0||||||
4112734|NCT00948896|3937393|B1|Yes||Slept under any bednet prior night||participants|Number|41|41.0||||||
4112735|NCT00948896|3937385|B9||Male|Sex: Female, Male||Participants|Count of Participants|292|292.0||||||
4112736|NCT00948896|3937386|B8||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4112737|NCT00948896|3937387|B7||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4112738|NCT00948896|3937388|B6||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4112739|NCT00948896|3937389|B5||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4112740|NCT00948896|3937390|B4||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4112741|NCT00948896|3937391|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4112742|NCT00948896|3937392|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4112743|NCT00948896|3937393|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4112744|NCT00948896|3937385|B9||Female|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
4112745|NCT00948896|3937386|B8||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4112746|NCT00948896|3937387|B7||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4112747|NCT00948896|3937388|B6||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4112748|NCT00948896|3937389|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4112749|NCT00948896|3937390|B4||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4112750|NCT00948896|3937391|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4112751|NCT00948896|3937392|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4112752|NCT00948896|3937393|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4112753|NCT00948896|3937385|B9|||Age|Age in months at time of enrollment|months|Mean|5.2|5.2|Standard Deviation|0.6|0.6|||
4112754|NCT00948896|3937386|B8|||Age|Age in months at time of enrollment|months|Mean|4.7|4.7|Standard Deviation|0.8|0.8|||
4112755|NCT00948896|3937387|B7|||Age|Age in months at time of enrollment|months|Mean|4.8|4.8|Standard Deviation|0.8|0.8|||
4112756|NCT00948896|3937388|B6|||Age|Age in months at time of enrollment|months|Mean|4.7|4.7|Standard Deviation|0.7|0.7|||
4112757|NCT00948896|3937389|B5|||Age|Age in months at time of enrollment|months|Mean|4.8|4.8|Standard Deviation|0.7|0.7|||
4112758|NCT00948896|3937390|B4|||Age|Age in months at time of enrollment|months|Mean|5.4|5.4|Standard Deviation|0.5|0.5|||
4112759|NCT00948896|3937391|B3|||Age|Age in months at time of enrollment|months|Mean|5.4|5.4|Standard Deviation|0.5|0.5|||
4112760|NCT00948896|3937392|B2|||Age|Age in months at time of enrollment|months|Mean|5.3|5.3|Standard Deviation|0.5|0.5|||
4112761|NCT00948896|3937393|B1|||Age|Age in months at time of enrollment|months|Mean|5.4|5.4|Standard Deviation|0.5|0.5|||
4112762|NCT00948857|3937434|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4112763|NCT00948857|3937435|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4112764|NCT00948857|3937436|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4112765|NCT00948857|3937434|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4112766|NCT00948857|3937435|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4112767|NCT00948857|3937436|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4112768|NCT00948857|3937434|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4112769|NCT00948857|3937435|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4112770|NCT00948857|3937436|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4112771|NCT00948857|3937434|B3|||Age||years|Mean|38|38.0|Standard Deviation|3|3.0|||
4112772|NCT00948857|3937435|B2|||Age||years|Mean|38|38.0|Standard Deviation|3|3.0|||
4112773|NCT00948857|3937436|B1|||Age||years|Mean|38|38.0|Standard Deviation|3|3.0|||
4112774|NCT00948857|3937434|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4112775|NCT00948857|3937435|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4112776|NCT00948857|3937436|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4112777|NCT00948857|3937434|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4112778|NCT00948857|3937435|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4112779|NCT00948857|3937436|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4112780|NCT00948857|3937434|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4112781|NCT00948857|3937435|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4112782|NCT00948857|3937436|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4112783|NCT00948818|3937443|B3|Canada||Region of Enrollment||participants|Number|61|61.0||||||
4112784|NCT00948818|3937444|B2|Canada||Region of Enrollment||participants|Number|32|32.0||||||
4112785|NCT00948818|3937445|B1|Canada||Region of Enrollment||participants|Number|29|29.0||||||
4112786|NCT00948818|3937443|B3|United States||Region of Enrollment||participants|Number|741|741.0||||||
4112787|NCT00948818|3937444|B2|United States||Region of Enrollment||participants|Number|374|374.0||||||
4112788|NCT00948818|3937445|B1|United States||Region of Enrollment||participants|Number|367|367.0||||||
4112789|NCT00948818|3937443|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4112790|NCT00948818|3937444|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4112791|NCT00948818|3937445|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4112792|NCT00948818|3937443|B3||Female|Sex: Female, Male||Participants|Count of Participants|726|726.0||||||
4112793|NCT00948818|3937444|B2||Female|Sex: Female, Male||Participants|Count of Participants|368|368.0||||||
4112794|NCT00948818|3937445|B1||Female|Sex: Female, Male||Participants|Count of Participants|358|358.0||||||
4112795|NCT00948818|3937443|B3|65 years and older||Age, Customized||participants|Number|45|45.0||||||
4112796|NCT00948818|3937444|B2|65 years and older||Age, Customized||participants|Number|19|19.0||||||
4112797|NCT00948818|3937445|B1|65 years and older||Age, Customized||participants|Number|26|26.0||||||
4112798|NCT00948818|3937443|B3|18 years to 64 years||Age, Customized||participants|Number|757|757.0||||||
4112799|NCT00948818|3937444|B2|18 years to 64 years||Age, Customized||participants|Number|387|387.0||||||
4112800|NCT00948818|3937445|B1|18 years to 64 years||Age, Customized||participants|Number|370|370.0||||||
4112801|NCT00948818|3937443|B3|||Age||years|Mean|43.5|43.5|Standard Deviation|12.8|12.8|||
4112802|NCT00948818|3937444|B2|||Age||years|Mean|43.3|43.3|Standard Deviation|12.7|12.7|||
4112803|NCT00948818|3937445|B1|||Age||years|Mean|43.7|43.7|Standard Deviation|12.9|12.9|||
4112804|NCT00948792|3937481|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4112805|NCT00948792|3937481|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4112806|NCT00948792|3937481|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4112807|NCT00948792|3937481|B1|||Age||Days|Median|26|26.0|Full Range|.09|0.09|1.0|63.0|
4112808|NCT00948792|3937481|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4112809|NCT00948792|3937481|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4112810|NCT00948792|3937481|B1||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
4112811|NCT00948766|3937491|B3||Male|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
4112812|NCT00948766|3937492|B2||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4112813|NCT00948766|3937493|B1||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4112814|NCT00948766|3937491|B3||Female|Sex: Female, Male||Participants|Count of Participants|461|461.0||||||
4112815|NCT00948766|3937492|B2||Female|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
4112816|NCT00948766|3937493|B1||Female|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
4112817|NCT00948766|3937491|B3|||Age||years|Mean|77.0|77.0|Standard Deviation|9.04|9.04|||
4112818|NCT00948766|3937492|B2|||Age||years|Mean|76.5|76.5|Standard Deviation|9.35|9.35|||
4112819|NCT00948766|3937493|B1|||Age||years|Mean|77.6|77.6|Standard Deviation|8.69|8.69|||
4112820|NCT00948688|3937510|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4112821|NCT00948688|3937510|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4112822|NCT00948688|3937510|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112823|NCT00948688|3937510|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4112824|NCT00948688|3937510|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112825|NCT00948688|3937510|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112826|NCT00948688|3937510|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112827|NCT00948688|3937510|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112828|NCT00948688|3937510|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112829|NCT00948688|3937510|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4112830|NCT00948688|3937510|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4112831|NCT00948688|3937510|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4112832|NCT00948688|3937510|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4112833|NCT00948688|3937510|B1|||Age||years|Median|60.7|60.7|Full Range|||48.2|78.7|
4112834|NCT00948688|3937510|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4112835|NCT00948688|3937510|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4112836|NCT00948688|3937510|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4112837|NCT00948675|3937523|B3|United States||Region of Enrollment||participants|Number|361|361.0||||||
4112838|NCT00948675|3937524|B2|United States||Region of Enrollment||participants|Number|179|179.0||||||
4112839|NCT00948675|3937525|B1|United States||Region of Enrollment||participants|Number|182|182.0||||||
4112840|NCT00948675|3937523|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112841|NCT00948675|3937524|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112842|NCT00948675|3937525|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112843|NCT00948675|3937523|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4112844|NCT00948675|3937524|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112845|NCT00948675|3937525|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4112846|NCT00948675|3937523|B3||White|Race (NIH/OMB)||Participants|Count of Participants|322|322.0||||||
4112847|NCT00948675|3937524|B2||White|Race (NIH/OMB)||Participants|Count of Participants|157|157.0||||||
4112848|NCT00948675|3937525|B1||White|Race (NIH/OMB)||Participants|Count of Participants|165|165.0||||||
4112849|NCT00948675|3937523|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4112850|NCT00948675|3937524|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4112851|NCT00948675|3937525|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4112852|NCT00948675|3937523|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112853|NCT00948675|3937524|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112854|NCT00948675|3937525|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112855|NCT00948675|3937523|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4112856|NCT00948675|3937524|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112857|NCT00948675|3937525|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4112858|NCT00948675|3937523|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4112859|NCT00948675|3937524|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4112860|NCT00948675|3937525|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112861|NCT00948675|3937523|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112862|NCT00948675|3937524|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112863|NCT00948675|3937525|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112864|NCT00948675|3937523|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|352|352.0||||||
4112865|NCT00948675|3937524|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|174|174.0||||||
4112866|NCT00948675|3937525|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|178|178.0||||||
4112867|NCT00948675|3937523|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4112868|NCT00948675|3937524|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4112869|NCT00948675|3937525|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4112870|NCT00948675|3937523|B3||Male|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4112871|NCT00948675|3937524|B2||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4112872|NCT00948675|3937525|B1||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4112873|NCT00948675|3937523|B3||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4112874|NCT00948675|3937524|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4112875|NCT00948675|3937525|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4112876|NCT00948675|3937523|B3|||Age||years|Mean|64.7|64.7|Standard Deviation|9.22|9.22|||
4112877|NCT00948675|3937524|B2|||Age||years|Mean|64.6|64.6|Standard Deviation|8.82|8.82|||
4112878|NCT00948675|3937525|B1|||Age||years|Mean|64.8|64.8|Standard Deviation|9.62|9.62|||
4112879|NCT00948610|3937540|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4112880|NCT00948610|3937541|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4112881|NCT00948610|3937542|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4112882|NCT00948610|3937540|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4112883|NCT00948610|3937541|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4112884|NCT00948610|3937542|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4112885|NCT00948610|3937540|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4112886|NCT00948610|3937541|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4112887|NCT00948610|3937542|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4112888|NCT00948610|3937540|B3|||Age||Years|Mean|51.5|51.5|Standard Deviation|13.8|13.8|||
4112889|NCT00948610|3937541|B2|||Age||Years|Mean|54.1|54.1|Standard Deviation|13.3|13.3|||
4112890|NCT00948610|3937542|B1|||Age||Years|Mean|48.8|48.8|Standard Deviation|14.0|14.0|||
4112891|NCT00948506|3937551|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4112892|NCT00948506|3937552|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4112893|NCT00948506|3937553|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4112894|NCT00948506|3937551|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4112895|NCT00948506|3937552|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4112896|NCT00948506|3937553|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4112897|NCT00948506|3937551|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4112898|NCT00948506|3937552|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4112899|NCT00948506|3937553|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4112900|NCT00948506|3937551|B3|||Age||years|Mean|34.25|34.25|Standard Deviation|10.20|10.2|||
4112901|NCT00948506|3937552|B2|||Age||years|Mean|31.44|31.44|Standard Deviation|12.02|12.02|||
4112902|NCT00948506|3937553|B1|||Age||years|Mean|36.55|36.55|Standard Deviation|8.32|8.32|||
4112903|NCT00948506|3937551|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4112904|NCT00948506|3937552|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4112905|NCT00948506|3937553|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4112906|NCT00948506|3937551|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4112907|NCT00948506|3937552|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4112908|NCT00948506|3937553|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4112909|NCT00948506|3937551|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4112910|NCT00948506|3937552|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4112911|NCT00948506|3937553|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4112912|NCT00948441|3937563|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4112913|NCT00948441|3937564|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4112914|NCT00948441|3937565|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4112915|NCT00948441|3937563|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112916|NCT00948441|3937564|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112917|NCT00948441|3937565|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112918|NCT00948441|3937563|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112919|NCT00948441|3937564|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112920|NCT00948441|3937565|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112921|NCT00948441|3937563|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4112922|NCT00948441|3937564|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4112923|NCT00948441|3937565|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4112924|NCT00948441|3937563|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4112925|NCT00948441|3937564|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4112926|NCT00948441|3937565|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4112927|NCT00948441|3937563|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112928|NCT00948441|3937564|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112929|NCT00948441|3937565|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112930|NCT00948441|3937563|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112931|NCT00948441|3937564|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112932|NCT00948441|3937565|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112933|NCT00948441|3937563|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112934|NCT00948441|3937564|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112935|NCT00948441|3937565|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4112936|NCT00948441|3937563|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4112937|NCT00948441|3937564|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4112938|NCT00948441|3937565|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4112939|NCT00948441|3937563|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4112940|NCT00948441|3937564|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4112941|NCT00948441|3937565|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4112942|NCT00948441|3937563|B3|||Age||years|Mean|4|4.0|Full Range|||1.2|13.5|
4112943|NCT00948441|3937564|B2|||Age||years|Mean|2|2.0|Full Range|||1.3|2.6|
4112944|NCT00948441|3937565|B1|||Age||years|Mean|4.99|4.99|Full Range|||1.2|13.5|
4112945|NCT00948389|3937574|B6|Grade 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria is used to assess disease progression and affects on daily living abilities and to determine appropriate treatment and prognosis. Grade 0=normal activity; Grade 1=Restricted physical activity but ambulatory and capable of light work; Grade 2=Ambulatory, capable of self care, but unable to carry out any work activities; Grade 3=Capable of limited self care, confined to bed or chair 50% or more of waking hours; Grade 4=Completely disabled, totally confined to bed or chair.|participants|Number|2|2.0||||||
4112946|NCT00948389|3937575|B5|Grade 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria is used to assess disease progression and affects on daily living abilities and to determine appropriate treatment and prognosis. Grade 0=normal activity; Grade 1=Restricted physical activity but ambulatory and capable of light work; Grade 2=Ambulatory, capable of self care, but unable to carry out any work activities; Grade 3=Capable of limited self care, confined to bed or chair 50% or more of waking hours; Grade 4=Completely disabled, totally confined to bed or chair.|participants|Number|0|0.0||||||
4112947|NCT00948389|3937576|B4|Grade 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria is used to assess disease progression and affects on daily living abilities and to determine appropriate treatment and prognosis. Grade 0=normal activity; Grade 1=Restricted physical activity but ambulatory and capable of light work; Grade 2=Ambulatory, capable of self care, but unable to carry out any work activities; Grade 3=Capable of limited self care, confined to bed or chair 50% or more of waking hours; Grade 4=Completely disabled, totally confined to bed or chair.|participants|Number|1|1.0||||||
4112948|NCT00948389|3937577|B3|Grade 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria is used to assess disease progression and affects on daily living abilities and to determine appropriate treatment and prognosis. Grade 0=normal activity; Grade 1=Restricted physical activity but ambulatory and capable of light work; Grade 2=Ambulatory, capable of self care, but unable to carry out any work activities; Grade 3=Capable of limited self care, confined to bed or chair 50% or more of waking hours; Grade 4=Completely disabled, totally confined to bed or chair.|participants|Number|1|1.0||||||
4112949|NCT00948389|3937578|B2|Grade 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria is used to assess disease progression and affects on daily living abilities and to determine appropriate treatment and prognosis. Grade 0=normal activity; Grade 1=Restricted physical activity but ambulatory and capable of light work; Grade 2=Ambulatory, capable of self care, but unable to carry out any work activities; Grade 3=Capable of limited self care, confined to bed or chair 50% or more of waking hours; Grade 4=Completely disabled, totally confined to bed or chair.|participants|Number|0|0.0||||||
4112950|NCT00948389|3937579|B1|Grade 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria is used to assess disease progression and affects on daily living abilities and to determine appropriate treatment and prognosis. Grade 0=normal activity; Grade 1=Restricted physical activity but ambulatory and capable of light work; Grade 2=Ambulatory, capable of self care, but unable to carry out any work activities; Grade 3=Capable of limited self care, confined to bed or chair 50% or more of waking hours; Grade 4=Completely disabled, totally confined to bed or chair.|participants|Number|0|0.0||||||
4112951|NCT00948389|3937574|B6|Grade 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria is used to assess disease progression and affects on daily living abilities and to determine appropriate treatment and prognosis. Grade 0=normal activity; Grade 1=Restricted physical activity but ambulatory and capable of light work; Grade 2=Ambulatory, capable of self care, but unable to carry out any work activities; Grade 3=Capable of limited self care, confined to bed or chair 50% or more of waking hours; Grade 4=Completely disabled, totally confined to bed or chair.|participants|Number|10|10.0||||||
4112952|NCT00948389|3937575|B5|Grade 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria is used to assess disease progression and affects on daily living abilities and to determine appropriate treatment and prognosis. Grade 0=normal activity; Grade 1=Restricted physical activity but ambulatory and capable of light work; Grade 2=Ambulatory, capable of self care, but unable to carry out any work activities; Grade 3=Capable of limited self care, confined to bed or chair 50% or more of waking hours; Grade 4=Completely disabled, totally confined to bed or chair.|participants|Number|0|0.0||||||
4112953|NCT00948389|3937576|B4|Grade 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria is used to assess disease progression and affects on daily living abilities and to determine appropriate treatment and prognosis. Grade 0=normal activity; Grade 1=Restricted physical activity but ambulatory and capable of light work; Grade 2=Ambulatory, capable of self care, but unable to carry out any work activities; Grade 3=Capable of limited self care, confined to bed or chair 50% or more of waking hours; Grade 4=Completely disabled, totally confined to bed or chair.|participants|Number|4|4.0||||||
4112954|NCT00948389|3937577|B3|Grade 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria is used to assess disease progression and affects on daily living abilities and to determine appropriate treatment and prognosis. Grade 0=normal activity; Grade 1=Restricted physical activity but ambulatory and capable of light work; Grade 2=Ambulatory, capable of self care, but unable to carry out any work activities; Grade 3=Capable of limited self care, confined to bed or chair 50% or more of waking hours; Grade 4=Completely disabled, totally confined to bed or chair.|participants|Number|5|5.0||||||
4112955|NCT00948389|3937578|B2|Grade 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria is used to assess disease progression and affects on daily living abilities and to determine appropriate treatment and prognosis. Grade 0=normal activity; Grade 1=Restricted physical activity but ambulatory and capable of light work; Grade 2=Ambulatory, capable of self care, but unable to carry out any work activities; Grade 3=Capable of limited self care, confined to bed or chair 50% or more of waking hours; Grade 4=Completely disabled, totally confined to bed or chair.|participants|Number|1|1.0||||||
4112956|NCT00948389|3937579|B1|Grade 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria is used to assess disease progression and affects on daily living abilities and to determine appropriate treatment and prognosis. Grade 0=normal activity; Grade 1=Restricted physical activity but ambulatory and capable of light work; Grade 2=Ambulatory, capable of self care, but unable to carry out any work activities; Grade 3=Capable of limited self care, confined to bed or chair 50% or more of waking hours; Grade 4=Completely disabled, totally confined to bed or chair.|participants|Number|0|0.0||||||
4112957|NCT00948389|3937574|B6|Grade 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria is used to assess disease progression and affects on daily living abilities and to determine appropriate treatment and prognosis. Grade 0=normal activity; Grade 1=Restricted physical activity but ambulatory and capable of light work; Grade 2=Ambulatory, capable of self care, but unable to carry out any work activities; Grade 3=Capable of limited self care, confined to bed or chair 50% or more of waking hours; Grade 4=Completely disabled, totally confined to bed or chair.|participants|Number|14|14.0||||||
4112958|NCT00948389|3937575|B5|Grade 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria is used to assess disease progression and affects on daily living abilities and to determine appropriate treatment and prognosis. Grade 0=normal activity; Grade 1=Restricted physical activity but ambulatory and capable of light work; Grade 2=Ambulatory, capable of self care, but unable to carry out any work activities; Grade 3=Capable of limited self care, confined to bed or chair 50% or more of waking hours; Grade 4=Completely disabled, totally confined to bed or chair.|participants|Number|1|1.0||||||
4112959|NCT00948389|3937576|B4|Grade 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria is used to assess disease progression and affects on daily living abilities and to determine appropriate treatment and prognosis. Grade 0=normal activity; Grade 1=Restricted physical activity but ambulatory and capable of light work; Grade 2=Ambulatory, capable of self care, but unable to carry out any work activities; Grade 3=Capable of limited self care, confined to bed or chair 50% or more of waking hours; Grade 4=Completely disabled, totally confined to bed or chair.|participants|Number|4|4.0||||||
4112960|NCT00948389|3937577|B3|Grade 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria is used to assess disease progression and affects on daily living abilities and to determine appropriate treatment and prognosis. Grade 0=normal activity; Grade 1=Restricted physical activity but ambulatory and capable of light work; Grade 2=Ambulatory, capable of self care, but unable to carry out any work activities; Grade 3=Capable of limited self care, confined to bed or chair 50% or more of waking hours; Grade 4=Completely disabled, totally confined to bed or chair.|participants|Number|1|1.0||||||
4112961|NCT00948389|3937578|B2|Grade 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria is used to assess disease progression and affects on daily living abilities and to determine appropriate treatment and prognosis. Grade 0=normal activity; Grade 1=Restricted physical activity but ambulatory and capable of light work; Grade 2=Ambulatory, capable of self care, but unable to carry out any work activities; Grade 3=Capable of limited self care, confined to bed or chair 50% or more of waking hours; Grade 4=Completely disabled, totally confined to bed or chair.|participants|Number|2|2.0||||||
4112962|NCT00948389|3937579|B1|Grade 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria is used to assess disease progression and affects on daily living abilities and to determine appropriate treatment and prognosis. Grade 0=normal activity; Grade 1=Restricted physical activity but ambulatory and capable of light work; Grade 2=Ambulatory, capable of self care, but unable to carry out any work activities; Grade 3=Capable of limited self care, confined to bed or chair 50% or more of waking hours; Grade 4=Completely disabled, totally confined to bed or chair.|participants|Number|6|6.0||||||
4112963|NCT00948389|3937574|B6|glioblastoma w/ oligodendroglial component||Histological Diagnosis of Primary Disease|by local pathologist|participants|Number|4|4.0||||||
4112964|NCT00948389|3937575|B5|glioblastoma w/ oligodendroglial component||Histological Diagnosis of Primary Disease|by local pathologist|participants|Number|0|0.0||||||
4112965|NCT00948389|3937576|B4|glioblastoma w/ oligodendroglial component||Histological Diagnosis of Primary Disease|by local pathologist|participants|Number|1|1.0||||||
4112966|NCT00948389|3937577|B3|glioblastoma w/ oligodendroglial component||Histological Diagnosis of Primary Disease|by local pathologist|participants|Number|2|2.0||||||
4112967|NCT00948389|3937578|B2|glioblastoma w/ oligodendroglial component||Histological Diagnosis of Primary Disease|by local pathologist|participants|Number|1|1.0||||||
4112968|NCT00948389|3937579|B1|glioblastoma w/ oligodendroglial component||Histological Diagnosis of Primary Disease|by local pathologist|participants|Number|0|0.0||||||
4112969|NCT00948389|3937574|B6|glioblastoma multiforme||Histological Diagnosis of Primary Disease|by local pathologist|participants|Number|22|22.0||||||
4112970|NCT00948389|3937575|B5|glioblastoma multiforme||Histological Diagnosis of Primary Disease|by local pathologist|participants|Number|1|1.0||||||
4112971|NCT00948389|3937576|B4|glioblastoma multiforme||Histological Diagnosis of Primary Disease|by local pathologist|participants|Number|8|8.0||||||
4112972|NCT00948389|3937577|B3|glioblastoma multiforme||Histological Diagnosis of Primary Disease|by local pathologist|participants|Number|5|5.0||||||
4112973|NCT00948389|3937578|B2|glioblastoma multiforme||Histological Diagnosis of Primary Disease|by local pathologist|participants|Number|2|2.0||||||
4112974|NCT00948389|3937579|B1|glioblastoma multiforme||Histological Diagnosis of Primary Disease|by local pathologist|participants|Number|6|6.0||||||
4112975|NCT00948389|3937574|B6||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4112976|NCT00948389|3937575|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4112977|NCT00948389|3937576|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4112978|NCT00948389|3937577|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4112979|NCT00948389|3937578|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4112980|NCT00948389|3937579|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4112981|NCT00948389|3937574|B6||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4112982|NCT00948389|3937575|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4112983|NCT00948389|3937576|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4112984|NCT00948389|3937577|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4112985|NCT00948389|3937578|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4112986|NCT00948389|3937579|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4112987|NCT00948389|3937574|B6|||Age||years|Median|54.8|54.8|Full Range|||38.8|70.7|
4112988|NCT00948389|3937575|B5|||Age||years|Median|51.1|51.1|Full Range|||51.1|51.1|
4112989|NCT00948389|3937576|B4|||Age||years|Median|49.7|49.7|Full Range|||38.8|66.8|
4112990|NCT00948389|3937577|B3|||Age||years|Median|53.6|53.6|Full Range|||42.4|64.0|
4112991|NCT00948389|3937578|B2|||Age||years|Median|57.7|57.7|Full Range|||48.9|57.7|
4112992|NCT00948389|3937579|B1|||Age||years|Median|58.8|58.8|Full Range|||41.3|70.7|
4112993|NCT00948298|3937620|B3|||Intact Parathyroid Hormone (PTH) Level||pmol/L|Mean|46.7|46.7|Standard Deviation|27.7|27.7|||
4112994|NCT00948298|3937621|B2|||Intact Parathyroid Hormone (PTH) Level||pmol/L|Mean|43.4|43.4|Standard Deviation|19.9|19.9|||
4112995|NCT00948298|3937622|B1|||Intact Parathyroid Hormone (PTH) Level||pmol/L|Mean|49.9|49.9|Standard Deviation|33.6|33.6|||
4112996|NCT00948298|3937620|B3|||Serum Calcium Level||mg/dl|Mean|9.4|9.4|Standard Deviation|0.4|0.4|||
4112997|NCT00948298|3937621|B2|||Serum Calcium Level||mg/dl|Mean|9.4|9.4|Standard Deviation|0.3|0.3|||
4112998|NCT00948298|3937622|B1|||Serum Calcium Level||mg/dl|Mean|9.3|9.3|Standard Deviation|0.4|0.4|||
4112999|NCT00948298|3937620|B3|||Serum 25(OH)D Level||nmol/L|Mean|16.8|16.8|Standard Deviation|5.1|5.1|||
4113000|NCT00948298|3937621|B2|||Serum 25(OH)D Level||nmol/L|Mean|17.0|17.0|Standard Deviation|5.2|5.2|||
4113001|NCT00948298|3937622|B1|||Serum 25(OH)D Level||nmol/L|Mean|16.5|16.5|Standard Deviation|5.0|5.0|||
4113002|NCT00948298|3937620|B3|||Urine Isoprostane||ng/mg|Mean|14.6|14.6|Standard Deviation|13.8|13.8|||
4113003|NCT00948298|3937621|B2|||Urine Isoprostane||ng/mg|Mean|14.4|14.4|Standard Deviation|11.6|11.6|||
4113004|NCT00948298|3937622|B1|||Urine Isoprostane||ng/mg|Mean|14.9|14.9|Standard Deviation|15.8|15.8|||
4113005|NCT00948298|3937620|B3|||Augmentation Index|Augmentation Index (Aix) is the percentage of central pulse pressure (central systolic minus diastolic pressure) attributable to the reflection of the pulse wave at arterial bifurcation points and interface of the large arteries and small resistance arteries. It is the index of aortic pressure wave reflection, defined as the ratio of augmented ascending aortic pressure (generated backward traveling pressure waves) to the central pulse pressure at the aortic root: where (Ps - Pi) / (Ps - Pd) Ps = peak systolic pressure, Pi = pressure at reflection point, and Pd = minimum diastolic pressure.|percentage of central pulse pressure|Mean|29.6|29.6|Standard Deviation|11.6|11.6|||
4113006|NCT00948298|3937621|B2|||Augmentation Index|Augmentation Index (Aix) is the percentage of central pulse pressure (central systolic minus diastolic pressure) attributable to the reflection of the pulse wave at arterial bifurcation points and interface of the large arteries and small resistance arteries. It is the index of aortic pressure wave reflection, defined as the ratio of augmented ascending aortic pressure (generated backward traveling pressure waves) to the central pulse pressure at the aortic root: where (Ps - Pi) / (Ps - Pd) Ps = peak systolic pressure, Pi = pressure at reflection point, and Pd = minimum diastolic pressure.|percentage of central pulse pressure|Mean|28.2|28.2|Standard Deviation|11.2|11.2|||
4113007|NCT00948298|3937622|B1|||Augmentation Index|Augmentation Index (Aix) is the percentage of central pulse pressure (central systolic minus diastolic pressure) attributable to the reflection of the pulse wave at arterial bifurcation points and interface of the large arteries and small resistance arteries. It is the index of aortic pressure wave reflection, defined as the ratio of augmented ascending aortic pressure (generated backward traveling pressure waves) to the central pulse pressure at the aortic root: where (Ps - Pi) / (Ps - Pd) Ps = peak systolic pressure, Pi = pressure at reflection point, and Pd = minimum diastolic pressure.|percentage of central pulse pressure|Mean|31.0|31.0|Standard Deviation|12.0|12.0|||
4113008|NCT00948298|3937620|B3|||Blood Pressure (Diastolic)||mmHg|Mean|82.7|82.7|Standard Deviation|11.1|11.1|||
4113009|NCT00948298|3937621|B2|||Blood Pressure (Diastolic)||mmHg|Mean|80.9|80.9|Standard Deviation|11.4|11.4|||
4113010|NCT00948298|3937622|B1|||Blood Pressure (Diastolic)||mmHg|Mean|84.5|84.5|Standard Deviation|10.5|10.5|||
4113011|NCT00948298|3937620|B3|||Blood Pressure (Systolic)||mmHg|Mean|126.8|126.8|Standard Deviation|15.7|15.7|||
4113012|NCT00948298|3937621|B2|||Blood Pressure (Systolic)||mmHg|Mean|125.2|125.2|Standard Deviation|16.1|16.1|||
4113013|NCT00948298|3937622|B1|||Blood Pressure (Systolic)||mmHg|Mean|128.5|128.5|Standard Deviation|15.2|15.2|||
4113014|NCT00948298|3937620|B3||High (>=102 cm for male and >=88 cm for female)|Waist Circumference Groups||Participants|Count of Participants|101|101.0||||||
4113015|NCT00948298|3937621|B2||High (>=102 cm for male and >=88 cm for female)|Waist Circumference Groups||Participants|Count of Participants|53|53.0||||||
4113016|NCT00948298|3937622|B1||High (>=102 cm for male and >=88 cm for female)|Waist Circumference Groups||Participants|Count of Participants|48|48.0||||||
4113017|NCT00948298|3937620|B3||Low (<102 cm for male and <88 cm for female)|Waist Circumference Groups||Participants|Count of Participants|29|29.0||||||
4113018|NCT00948298|3937621|B2||Low (<102 cm for male and <88 cm for female)|Waist Circumference Groups||Participants|Count of Participants|12|12.0||||||
4113019|NCT00948298|3937622|B1||Low (<102 cm for male and <88 cm for female)|Waist Circumference Groups||Participants|Count of Participants|17|17.0||||||
4113020|NCT00948298|3937620|B3||>30 kg/m^2|Body Mass Index, Categorical||Participants|Count of Participants|100|100.0||||||
4113021|NCT00948298|3937621|B2||>30 kg/m^2|Body Mass Index, Categorical||Participants|Count of Participants|53|53.0||||||
4113022|NCT00948298|3937622|B1||>30 kg/m^2|Body Mass Index, Categorical||Participants|Count of Participants|47|47.0||||||
4113023|NCT00948298|3937620|B3||25.0-29.9 kg/m^2|Body Mass Index, Categorical||Participants|Count of Participants|30|30.0||||||
4113024|NCT00948298|3937621|B2||25.0-29.9 kg/m^2|Body Mass Index, Categorical||Participants|Count of Participants|12|12.0||||||
4113025|NCT00948298|3937622|B1||25.0-29.9 kg/m^2|Body Mass Index, Categorical||Participants|Count of Participants|18|18.0||||||
4113026|NCT00948298|3937620|B3|United States||Region of Enrollment||Participants|Count of Participants|130|130.0||||||
4113027|NCT00948298|3937621|B2|United States||Region of Enrollment||Participants|Count of Participants|65|65.0||||||
4113028|NCT00948298|3937622|B1|United States||Region of Enrollment||Participants|Count of Participants|65|65.0||||||
4113029|NCT00948298|3937620|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4113030|NCT00948298|3937621|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4113031|NCT00948298|3937622|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4113032|NCT00948298|3937620|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4113033|NCT00948298|3937621|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4113034|NCT00948298|3937622|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4113035|NCT00948298|3937620|B3|60 years and above||Age, Customized||Participants|Count of Participants|18|18.0||||||
4113036|NCT00948298|3937621|B2|60 years and above||Age, Customized||Participants|Count of Participants|10|10.0||||||
4113037|NCT00948298|3937622|B1|60 years and above||Age, Customized||Participants|Count of Participants|8|8.0||||||
4113038|NCT00948298|3937620|B3|40-59 years||Age, Customized||Participants|Count of Participants|92|92.0||||||
4113039|NCT00948298|3937621|B2|40-59 years||Age, Customized||Participants|Count of Participants|45|45.0||||||
4113040|NCT00948298|3937622|B1|40-59 years||Age, Customized||Participants|Count of Participants|47|47.0||||||
4113041|NCT00948298|3937620|B3|18-39 years||Age, Customized||Participants|Count of Participants|20|20.0||||||
4113042|NCT00948298|3937621|B2|18-39 years||Age, Customized||Participants|Count of Participants|10|10.0||||||
4113043|NCT00948298|3937622|B1|18-39 years||Age, Customized||Participants|Count of Participants|10|10.0||||||
4113044|NCT00948246|3937631|B1|United Kingdom||Region of Enrollment||participants|Number|27|27.0||||||
4113045|NCT00948246|3937631|B1|Italy||Region of Enrollment||participants|Number|21|21.0||||||
4113046|NCT00948246|3937631|B1|Netherlands||Region of Enrollment||participants|Number|29|29.0||||||
4113047|NCT00948246|3937631|B1|Belgium||Region of Enrollment||participants|Number|33|33.0||||||
4113048|NCT00948246|3937631|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4113049|NCT00948246|3937631|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4113050|NCT00948246|3937631|B1|||Age||years|Mean|39.0|39.0|Standard Deviation|11.23|11.23|||
4113051|NCT00948246|3937631|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4113052|NCT00948246|3937631|B1||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
4113053|NCT00948246|3937631|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4113054|NCT00948155|3937638|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
4113055|NCT00948155|3937639|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4113056|NCT00948155|3937640|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4113057|NCT00948155|3937638|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4113058|NCT00948155|3937639|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4113059|NCT00948155|3937640|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4113060|NCT00948155|3937638|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4113061|NCT00948155|3937639|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4113062|NCT00948155|3937640|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4113063|NCT00948155|3937638|B3|||Age||years|Mean|39.9|39.9|Standard Deviation|13.3|13.3|||
4113064|NCT00948155|3937639|B2|||Age||years|Mean|37.6|37.6|Standard Deviation|12.8|12.8|||
4113065|NCT00948155|3937640|B1|||Age||years|Mean|42.6|42.6|Standard Deviation|13.7|13.7|||
4113066|NCT00948155|3937638|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4113067|NCT00948155|3937639|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4113068|NCT00948155|3937640|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4113069|NCT00948155|3937638|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4113070|NCT00948155|3937639|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4113071|NCT00948155|3937640|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4113072|NCT00948155|3937638|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4113073|NCT00948155|3937639|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4113074|NCT00948155|3937640|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4113075|NCT00948090|3937661|B3||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4113076|NCT00948090|3937662|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4113077|NCT00948090|3937663|B1||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4113078|NCT00948090|3937661|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4113079|NCT00948090|3937662|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4113080|NCT00948090|3937663|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4113081|NCT00948090|3937661|B3|Years||Age||Years|Mean|48.5|48.5|Standard Deviation|14|14.0|||
4113082|NCT00948090|3937662|B2|Years||Age||Years|Mean|68.5|68.5|Standard Deviation|2.3|2.3|||
4113083|NCT00948090|3937663|B1|Years||Age||Years|Mean|46.5|46.5|Standard Deviation|13.1|13.1|||
4113084|NCT00948064|3937685|B4|United States||Region of Enrollment||participants|Number|110|110.0||||||
4113085|NCT00948064|3937686|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
4113086|NCT00948064|3937687|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
4113087|NCT00948064|3937688|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4113088|NCT00948064|3937685|B4||Male|Gender||Participants|Count of Participants|77|77.0||||||
4113089|NCT00948064|3937686|B3||Male|Gender||Participants|Count of Participants|18|18.0||||||
4113090|NCT00948064|3937687|B2||Male|Gender||Participants|Count of Participants|37|37.0||||||
4113091|NCT00948064|3937688|B1||Male|Gender||Participants|Count of Participants|22|22.0||||||
4113092|NCT00948064|3937685|B4||Female|Gender||Participants|Count of Participants|33|33.0||||||
4113093|NCT00948064|3937686|B3||Female|Gender||Participants|Count of Participants|9|9.0||||||
4113094|NCT00948064|3937687|B2||Female|Gender||Participants|Count of Participants|15|15.0||||||
4113095|NCT00948064|3937688|B1||Female|Gender||Participants|Count of Participants|9|9.0||||||
4113096|NCT00948064|3937685|B4|||Age||years|Median|72|72.0|Full Range|||44.0|90.0|
4113097|NCT00948064|3937686|B3|||Age||years|Median|71|71.0|Full Range|||54.0|90.0|
4113098|NCT00948064|3937687|B2|||Age||years|Median|71|71.0|Full Range|||30.0|89.0|
4113099|NCT00948064|3937688|B1|||Age||years|Median|74|74.0|Full Range|||44.0|83.0|
4113100|NCT00947882|3937701|B5|||Baseline Maximum Urinary Flow (Qmax)|Uroflowmetry was used according to International Continence Society (ICS) recommendation.|mL/sec|Mean|10.3|10.3|Standard Deviation|3.05|3.05|||
4113101|NCT00947882|3937702|B4|||Baseline Maximum Urinary Flow (Qmax)|Uroflowmetry was used according to International Continence Society (ICS) recommendation.|mL/sec|Mean|10.2|10.2|Standard Deviation|2.44|2.44|||
4113102|NCT00947882|3937703|B3|||Baseline Maximum Urinary Flow (Qmax)|Uroflowmetry was used according to International Continence Society (ICS) recommendation.|mL/sec|Mean|10.6|10.6|Standard Deviation|4.58|4.58|||
4113103|NCT00947882|3937704|B2|||Baseline Maximum Urinary Flow (Qmax)|Uroflowmetry was used according to International Continence Society (ICS) recommendation.|mL/sec|Mean|10.3|10.3|Standard Deviation|2.65|2.65|||
4113104|NCT00947882|3937705|B1|||Baseline Maximum Urinary Flow (Qmax)|Uroflowmetry was used according to International Continence Society (ICS) recommendation.|mL/sec|Mean|10.2|10.2|Standard Deviation|2.51|2.51|||
4113105|NCT00947882|3937701|B5|||Baseline Total Prostate Volume (TPV)|TPV was measured directly by Trans-Rectal Ultrasound (TRUS).|mL|Mean|42.2|42.2|Standard Deviation|19.2|19.2|||
4113106|NCT00947882|3937702|B4|||Baseline Total Prostate Volume (TPV)|TPV was measured directly by Trans-Rectal Ultrasound (TRUS).|mL|Mean|42.1|42.1|Standard Deviation|20.2|20.2|||
4113107|NCT00947882|3937703|B3|||Baseline Total Prostate Volume (TPV)|TPV was measured directly by Trans-Rectal Ultrasound (TRUS).|mL|Mean|42.3|42.3|Standard Deviation|20.2|20.2|||
4113108|NCT00947882|3937704|B2|||Baseline Total Prostate Volume (TPV)|TPV was measured directly by Trans-Rectal Ultrasound (TRUS).|mL|Mean|42.9|42.9|Standard Deviation|18.8|18.8|||
4113109|NCT00947882|3937705|B1|||Baseline Total Prostate Volume (TPV)|TPV was measured directly by Trans-Rectal Ultrasound (TRUS).|mL|Mean|41.6|41.6|Standard Deviation|17.8|17.8|||
4113110|NCT00947882|3937701|B5|||Baseline International Prostate Symptom Scores (IPSS)|The IPSS questionnaire was used to assess the severity of Lower Urinary Tract Symptoms (LUTS). A detailed description of the questionnaire is provided in the Primary Outcome Measure section.|units on a scale|Mean|19.6|19.6|Standard Deviation|4.73|4.73|||
4113111|NCT00947882|3937702|B4|||Baseline International Prostate Symptom Scores (IPSS)|The IPSS questionnaire was used to assess the severity of Lower Urinary Tract Symptoms (LUTS). A detailed description of the questionnaire is provided in the Primary Outcome Measure section.|units on a scale|Mean|19.8|19.8|Standard Deviation|4.88|4.88|||
4113112|NCT00947882|3937703|B3|||Baseline International Prostate Symptom Scores (IPSS)|The IPSS questionnaire was used to assess the severity of Lower Urinary Tract Symptoms (LUTS). A detailed description of the questionnaire is provided in the Primary Outcome Measure section.|units on a scale|Mean|19.6|19.6|Standard Deviation|4.42|4.42|||
4113113|NCT00947882|3937704|B2|||Baseline International Prostate Symptom Scores (IPSS)|The IPSS questionnaire was used to assess the severity of Lower Urinary Tract Symptoms (LUTS). A detailed description of the questionnaire is provided in the Primary Outcome Measure section.|units on a scale|Mean|19.9|19.9|Standard Deviation|5.21|5.21|||
4113114|NCT00947882|3937705|B1|||Baseline International Prostate Symptom Scores (IPSS)|The IPSS questionnaire was used to assess the severity of Lower Urinary Tract Symptoms (LUTS). A detailed description of the questionnaire is provided in the Primary Outcome Measure section.|units on a scale|Mean|19.1|19.1|Standard Deviation|4.38|4.38|||
4113115|NCT00947882|3937701|B5|||Baseline Body Mass Index (BMI)||(kg/m^2)|Mean|28.2|28.2|Standard Deviation|4.08|4.08|||
4113116|NCT00947882|3937702|B4|||Baseline Body Mass Index (BMI)||(kg/m^2)|Mean|28.2|28.2|Standard Deviation|4.81|4.81|||
4113117|NCT00947882|3937703|B3|||Baseline Body Mass Index (BMI)||(kg/m^2)|Mean|27.9|27.9|Standard Deviation|3.84|3.84|||
4113118|NCT00947882|3937704|B2|||Baseline Body Mass Index (BMI)||(kg/m^2)|Mean|28.4|28.4|Standard Deviation|3.93|3.93|||
4113119|NCT00947882|3937705|B1|||Baseline Body Mass Index (BMI)||(kg/m^2)|Mean|28.5|28.5|Standard Deviation|3.66|3.66|||
4113120|NCT00947882|3937701|B5|Europe||Region of Enrollment||participants|Number|163|163.0||||||
4113121|NCT00947882|3937702|B4|Europe||Region of Enrollment||participants|Number|42|42.0||||||
4113122|NCT00947882|3937703|B3|Europe||Region of Enrollment||participants|Number|39|39.0||||||
4113123|NCT00947882|3937704|B2|Europe||Region of Enrollment||participants|Number|41|41.0||||||
4113124|NCT00947882|3937705|B1|Europe||Region of Enrollment||participants|Number|41|41.0||||||
4113125|NCT00947882|3937701|B5|North America||Region of Enrollment||participants|Number|240|240.0||||||
4113126|NCT00947882|3937702|B4|North America||Region of Enrollment||participants|Number|60|60.0||||||
4113127|NCT00947882|3937703|B3|North America||Region of Enrollment||participants|Number|61|61.0||||||
4113128|NCT00947882|3937704|B2|North America||Region of Enrollment||participants|Number|60|60.0||||||
4113129|NCT00947882|3937705|B1|North America||Region of Enrollment||participants|Number|59|59.0||||||
4113130|NCT00947882|3937701|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113131|NCT00947882|3937702|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113132|NCT00947882|3937703|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113133|NCT00947882|3937704|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113134|NCT00947882|3937705|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113135|NCT00947882|3937701|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113136|NCT00947882|3937702|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113137|NCT00947882|3937703|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113138|NCT00947882|3937704|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113139|NCT00947882|3937705|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113140|NCT00947882|3937701|B5||White|Race (NIH/OMB)||Participants|Count of Participants|384|384.0||||||
4113141|NCT00947882|3937702|B4||White|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4113142|NCT00947882|3937703|B3||White|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4113143|NCT00947882|3937704|B2||White|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4113144|NCT00947882|3937705|B1||White|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4113145|NCT00947882|3937701|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4113146|NCT00947882|3937702|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4113147|NCT00947882|3937703|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4113148|NCT00947882|3937704|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4113149|NCT00947882|3937705|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4113150|NCT00947882|3937701|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113151|NCT00947882|3937702|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113152|NCT00947882|3937703|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113153|NCT00947882|3937704|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113154|NCT00947882|3937705|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113155|NCT00947882|3937701|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4113156|NCT00947882|3937702|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4113157|NCT00947882|3937703|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4113158|NCT00947882|3937704|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4113159|NCT00947882|3937705|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113160|NCT00947882|3937701|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4113161|NCT00947882|3937702|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4113162|NCT00947882|3937703|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113163|NCT00947882|3937704|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4113164|NCT00947882|3937705|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113165|NCT00947882|3937701|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113166|NCT00947882|3937702|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113167|NCT00947882|3937703|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113168|NCT00947882|3937704|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113169|NCT00947882|3937705|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113170|NCT00947882|3937701|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|394|394.0||||||
4113171|NCT00947882|3937702|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
4113172|NCT00947882|3937703|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
4113173|NCT00947882|3937704|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
4113174|NCT00947882|3937705|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
4113175|NCT00947882|3937701|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4113176|NCT00947882|3937702|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4113177|NCT00947882|3937703|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113178|NCT00947882|3937704|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4113179|NCT00947882|3937705|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4113180|NCT00947882|3937701|B5||Male|Sex: Female, Male||Participants|Count of Participants|403|403.0||||||
4113181|NCT00947882|3937702|B4||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4113182|NCT00947882|3937703|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4113183|NCT00947882|3937704|B2||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4113184|NCT00947882|3937705|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4113185|NCT00947882|3937701|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4113186|NCT00947882|3937702|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4113187|NCT00947882|3937703|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4113188|NCT00947882|3937704|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4113189|NCT00947882|3937705|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4113190|NCT00947882|3937701|B5|||Age||years|Mean|65.3|65.3|Standard Deviation|7.59|7.59|||
4113191|NCT00947882|3937702|B4|||Age||years|Mean|65.4|65.4|Standard Deviation|7.56|7.56|||
4113192|NCT00947882|3937703|B3|||Age||years|Mean|65.7|65.7|Standard Deviation|7.12|7.12|||
4113193|NCT00947882|3937704|B2|||Age||years|Mean|64.9|64.9|Standard Deviation|7.89|7.89|||
4113194|NCT00947882|3937705|B1|||Age||years|Mean|65.2|65.2|Standard Deviation|7.86|7.86|||
4113195|NCT00947856|3937734|B3|Other||Disease diagnosis||participants|Number|5|5.0||||||
4113196|NCT00947856|3937735|B2|Other||Disease diagnosis||participants|Number|3|3.0||||||
4113197|NCT00947856|3937736|B1|Other||Disease diagnosis||participants|Number|2|2.0||||||
4113198|NCT00947856|3937734|B3|Systemic anaplastic large cell lymphoma (ALCL)||Disease diagnosis||participants|Number|16|16.0||||||
4113199|NCT00947856|3937735|B2|Systemic anaplastic large cell lymphoma (ALCL)||Disease diagnosis||participants|Number|8|8.0||||||
4113200|NCT00947856|3937736|B1|Systemic anaplastic large cell lymphoma (ALCL)||Disease diagnosis||participants|Number|8|8.0||||||
4113201|NCT00947856|3937734|B3|Hodgkin lymphoma (HL)||Disease diagnosis||participants|Number|89|89.0||||||
4113202|NCT00947856|3937735|B2|Hodgkin lymphoma (HL)||Disease diagnosis||participants|Number|21|21.0||||||
4113203|NCT00947856|3937736|B1|Hodgkin lymphoma (HL)||Disease diagnosis||participants|Number|68|68.0||||||
4113204|NCT00947856|3937734|B3|Missing||Eastern Cooperative Oncology Group Performance Status|"0 = Normal activity~= Symptoms but ambulatory~= In bed <50% of the time~= In bed >50% of the time~= 100% bedridden~= Dead"|participants|Number|1|1.0||||||
4113205|NCT00947856|3937735|B2|Missing||Eastern Cooperative Oncology Group Performance Status|"0 = Normal activity~= Symptoms but ambulatory~= In bed <50% of the time~= In bed >50% of the time~= 100% bedridden~= Dead"|participants|Number|0|0.0||||||
4113206|NCT00947856|3937736|B1|Missing||Eastern Cooperative Oncology Group Performance Status|"0 = Normal activity~= Symptoms but ambulatory~= In bed <50% of the time~= In bed >50% of the time~= 100% bedridden~= Dead"|participants|Number|1|1.0||||||
4113207|NCT00947856|3937734|B3|3-5||Eastern Cooperative Oncology Group Performance Status|"0 = Normal activity~= Symptoms but ambulatory~= In bed <50% of the time~= In bed >50% of the time~= 100% bedridden~= Dead"|participants|Number|0|0.0||||||
4113208|NCT00947856|3937735|B2|3-5||Eastern Cooperative Oncology Group Performance Status|"0 = Normal activity~= Symptoms but ambulatory~= In bed <50% of the time~= In bed >50% of the time~= 100% bedridden~= Dead"|participants|Number|0|0.0||||||
4113209|NCT00947856|3937736|B1|3-5||Eastern Cooperative Oncology Group Performance Status|"0 = Normal activity~= Symptoms but ambulatory~= In bed <50% of the time~= In bed >50% of the time~= 100% bedridden~= Dead"|participants|Number|0|0.0||||||
4113210|NCT00947856|3937734|B3|2||Eastern Cooperative Oncology Group Performance Status|"0 = Normal activity~= Symptoms but ambulatory~= In bed <50% of the time~= In bed >50% of the time~= 100% bedridden~= Dead"|participants|Number|2|2.0||||||
4113211|NCT00947856|3937735|B2|2||Eastern Cooperative Oncology Group Performance Status|"0 = Normal activity~= Symptoms but ambulatory~= In bed <50% of the time~= In bed >50% of the time~= 100% bedridden~= Dead"|participants|Number|2|2.0||||||
4113212|NCT00947856|3937736|B1|2||Eastern Cooperative Oncology Group Performance Status|"0 = Normal activity~= Symptoms but ambulatory~= In bed <50% of the time~= In bed >50% of the time~= 100% bedridden~= Dead"|participants|Number|0|0.0||||||
4113213|NCT00947856|3937734|B3|1||Eastern Cooperative Oncology Group Performance Status|"0 = Normal activity~= Symptoms but ambulatory~= In bed <50% of the time~= In bed >50% of the time~= 100% bedridden~= Dead"|participants|Number|48|48.0||||||
4113214|NCT00947856|3937735|B2|1||Eastern Cooperative Oncology Group Performance Status|"0 = Normal activity~= Symptoms but ambulatory~= In bed <50% of the time~= In bed >50% of the time~= 100% bedridden~= Dead"|participants|Number|18|18.0||||||
4113215|NCT00947856|3937736|B1|1||Eastern Cooperative Oncology Group Performance Status|"0 = Normal activity~= Symptoms but ambulatory~= In bed <50% of the time~= In bed >50% of the time~= 100% bedridden~= Dead"|participants|Number|30|30.0||||||
4113216|NCT00947856|3937734|B3|0||Eastern Cooperative Oncology Group Performance Status|"0 = Normal activity~= Symptoms but ambulatory~= In bed <50% of the time~= In bed >50% of the time~= 100% bedridden~= Dead"|participants|Number|59|59.0||||||
4113217|NCT00947856|3937735|B2|0||Eastern Cooperative Oncology Group Performance Status|"0 = Normal activity~= Symptoms but ambulatory~= In bed <50% of the time~= In bed >50% of the time~= 100% bedridden~= Dead"|participants|Number|12|12.0||||||
4113218|NCT00947856|3937736|B1|0||Eastern Cooperative Oncology Group Performance Status|"0 = Normal activity~= Symptoms but ambulatory~= In bed <50% of the time~= In bed >50% of the time~= 100% bedridden~= Dead"|participants|Number|47|47.0||||||
4113219|NCT00947856|3937734|B3|United States||Region of Enrollment||participants|Number|107|107.0||||||
4113220|NCT00947856|3937735|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4113221|NCT00947856|3937736|B1|United States||Region of Enrollment||participants|Number|78|78.0||||||
4113222|NCT00947856|3937734|B3|France||Region of Enrollment||participants|Number|3|3.0||||||
4113223|NCT00947856|3937735|B2|France||Region of Enrollment||participants|Number|3|3.0||||||
4113224|NCT00947856|3937736|B1|France||Region of Enrollment||participants|Number|0|0.0||||||
4113225|NCT00947856|3937734|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4113226|NCT00947856|3937735|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4113227|NCT00947856|3937736|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4113228|NCT00947856|3937734|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113229|NCT00947856|3937735|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113230|NCT00947856|3937736|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113231|NCT00947856|3937734|B3||White|Race (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
4113232|NCT00947856|3937735|B2||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4113233|NCT00947856|3937736|B1||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4113234|NCT00947856|3937734|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4113235|NCT00947856|3937735|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4113236|NCT00947856|3937736|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4113237|NCT00947856|3937734|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4113238|NCT00947856|3937735|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113239|NCT00947856|3937736|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4113240|NCT00947856|3937734|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4113241|NCT00947856|3937735|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113242|NCT00947856|3937736|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4113243|NCT00947856|3937734|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113244|NCT00947856|3937735|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113245|NCT00947856|3937736|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113246|NCT00947856|3937734|B3||Male|Gender||Participants|Count of Participants|58|58.0||||||
4113247|NCT00947856|3937735|B2||Male|Gender||Participants|Count of Participants|15|15.0||||||
4113248|NCT00947856|3937736|B1||Male|Gender||Participants|Count of Participants|43|43.0||||||
4113249|NCT00947856|3937734|B3||Female|Gender||Participants|Count of Participants|52|52.0||||||
4113250|NCT00947856|3937735|B2||Female|Gender||Participants|Count of Participants|17|17.0||||||
4113251|NCT00947856|3937736|B1||Female|Gender||Participants|Count of Participants|35|35.0||||||
4113252|NCT00947856|3937734|B3|||Age, Customized||years|Median|33.5|33.5|Full Range|||15.0|78.0|
4113253|NCT00947856|3937735|B2|||Age, Customized||years|Median|37|37.0|Full Range|||16.0|72.0|
4113254|NCT00947856|3937736|B1|||Age, Customized||years|Median|32|32.0|Full Range|||15.0|78.0|
4113255|NCT00947791|3937764|B3||Male|Sex: Female, Male||||0|0.0||||||
4113256|NCT00947791|3937764|B3||Female|Sex: Female, Male||||0|0.0||||||
4113257|NCT00947765|3937783|B3|||Pain: Visual Analogue Scale (0 to 10)|"PAIN SCORE; VISUAL ANALOGUE SCALE:~Pain of the participants will be assessed by most widely used and accepted “visual analogue scale”. It consists of a 10 centimeter line marked at one end with “no pain” and at other end with “worst pain ever”. Participant is asked to indicate where on the line he or she rates the pain on the day of presentation, 1, 4, 12weeks and 6 month of follow-ups. Numerical valve is then given to it simply by measuring length between “no pain” to patients mark.~No pain____1___2___3___4___5___6___7___8___9___10 worst pain ever."|Units on a scale|Mean|7.616|7.616|Standard Deviation|1.303|1.303|||
4113258|NCT00947765|3937784|B2|||Pain: Visual Analogue Scale (0 to 10)|"PAIN SCORE; VISUAL ANALOGUE SCALE:~Pain of the participants will be assessed by most widely used and accepted “visual analogue scale”. It consists of a 10 centimeter line marked at one end with “no pain” and at other end with “worst pain ever”. Participant is asked to indicate where on the line he or she rates the pain on the day of presentation, 1, 4, 12weeks and 6 month of follow-ups. Numerical valve is then given to it simply by measuring length between “no pain” to patients mark.~No pain____1___2___3___4___5___6___7___8___9___10 worst pain ever."|Units on a scale|Mean|7.533|7.533|Standard Deviation|1.2794|1.2794|||
4113259|NCT00947765|3937785|B1|||Pain: Visual Analogue Scale (0 to 10)|"PAIN SCORE; VISUAL ANALOGUE SCALE:~Pain of the participants will be assessed by most widely used and accepted “visual analogue scale”. It consists of a 10 centimeter line marked at one end with “no pain” and at other end with “worst pain ever”. Participant is asked to indicate where on the line he or she rates the pain on the day of presentation, 1, 4, 12weeks and 6 month of follow-ups. Numerical valve is then given to it simply by measuring length between “no pain” to patients mark.~No pain____1___2___3___4___5___6___7___8___9___10 worst pain ever."|Units on a scale|Mean|7.7|7.7|Standard Deviation|1.3429|1.3429|||
4113260|NCT00947765|3937783|B3|||Pain: Nirschl Staging (0 to 7)|"NIRSCHL STAGING:~phase1: mild pain with exercise; resolves within 24 hours phase2: pain after exercise; exceeds 48 hours phase3: pain with exercise; does not alter activity phase4: pain with exercise; alters activity phase5: pain with heavy activities of daily living phase6: pain with light activities of daily living; intermittent pain at rest phase7: constant pain at rest; disrupts sleeps No pain______1 ______ 2______ 3_______4______ 5______ 6 _____ 7 worst pain"|Units on a scale|Mean|5.315|5.315|Standard Deviation|1.049|1.049|||
4113261|NCT00947765|3937784|B2|||Pain: Nirschl Staging (0 to 7)|"NIRSCHL STAGING:~phase1: mild pain with exercise; resolves within 24 hours phase2: pain after exercise; exceeds 48 hours phase3: pain with exercise; does not alter activity phase4: pain with exercise; alters activity phase5: pain with heavy activities of daily living phase6: pain with light activities of daily living; intermittent pain at rest phase7: constant pain at rest; disrupts sleeps No pain______1 ______ 2______ 3_______4______ 5______ 6 _____ 7 worst pain"|Units on a scale|Mean|5.23|5.23|Standard Deviation|0.9714|0.9714|||
4113262|NCT00947765|3937785|B1|||Pain: Nirschl Staging (0 to 7)|"NIRSCHL STAGING:~phase1: mild pain with exercise; resolves within 24 hours phase2: pain after exercise; exceeds 48 hours phase3: pain with exercise; does not alter activity phase4: pain with exercise; alters activity phase5: pain with heavy activities of daily living phase6: pain with light activities of daily living; intermittent pain at rest phase7: constant pain at rest; disrupts sleeps No pain______1 ______ 2______ 3_______4______ 5______ 6 _____ 7 worst pain"|Units on a scale|Mean|5.4|5.4|Standard Deviation|1.1325|1.1325|||
4113263|NCT00947765|3937783|B3|Participants with Non-Dominant limb involved||Participants with Dominant and Non-Dominent limb involvement|Participants with Dominant limb involved / Participants with Non-Dominent limb involved|participants|Number|9|9.0||||||
4113264|NCT00947765|3937784|B2|Participants with Non-Dominant limb involved||Participants with Dominant and Non-Dominent limb involvement|Participants with Dominant limb involved / Participants with Non-Dominent limb involved|participants|Number|4|4.0||||||
4113265|NCT00947765|3937785|B1|Participants with Non-Dominant limb involved||Participants with Dominant and Non-Dominent limb involvement|Participants with Dominant limb involved / Participants with Non-Dominent limb involved|participants|Number|5|5.0||||||
4113266|NCT00947765|3937783|B3|Participants with Dominent limb involved||Participants with Dominant and Non-Dominent limb involvement|Participants with Dominant limb involved / Participants with Non-Dominent limb involved|participants|Number|51|51.0||||||
4113267|NCT00947765|3937784|B2|Participants with Dominent limb involved||Participants with Dominant and Non-Dominent limb involvement|Participants with Dominant limb involved / Participants with Non-Dominent limb involved|participants|Number|26|26.0||||||
4113268|NCT00947765|3937785|B1|Participants with Dominent limb involved||Participants with Dominant and Non-Dominent limb involvement|Participants with Dominant limb involved / Participants with Non-Dominent limb involved|participants|Number|25|25.0||||||
4113269|NCT00947765|3937783|B3|Participants with Left limb involved||Laterality of limb involved|Participants with Right limb involved / Participants with Left limb involved|participants|Number|14|14.0||||||
4113270|NCT00947765|3937784|B2|Participants with Left limb involved||Laterality of limb involved|Participants with Right limb involved / Participants with Left limb involved|participants|Number|7|7.0||||||
4113271|NCT00947765|3937785|B1|Participants with Left limb involved||Laterality of limb involved|Participants with Right limb involved / Participants with Left limb involved|participants|Number|7|7.0||||||
4113272|NCT00947765|3937783|B3|Participants with Right limb involved||Laterality of limb involved|Participants with Right limb involved / Participants with Left limb involved|participants|Number|46|46.0||||||
4113273|NCT00947765|3937784|B2|Participants with Right limb involved||Laterality of limb involved|Participants with Right limb involved / Participants with Left limb involved|participants|Number|23|23.0||||||
4113274|NCT00947765|3937785|B1|Participants with Right limb involved||Laterality of limb involved|Participants with Right limb involved / Participants with Left limb involved|participants|Number|23|23.0||||||
4113275|NCT00947765|3937783|B3|India||Region of Enrollment||participants|Number|60|60.0||||||
4113276|NCT00947765|3937784|B2|India||Region of Enrollment||participants|Number|30|30.0||||||
4113277|NCT00947765|3937785|B1|India||Region of Enrollment||participants|Number|30|30.0||||||
4113278|NCT00947765|3937783|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4113279|NCT00947765|3937784|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4113280|NCT00947765|3937785|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4113281|NCT00947765|3937783|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4113282|NCT00947765|3937784|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4113283|NCT00947765|3937785|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4113284|NCT00947765|3937783|B3|||Age||years|Mean|42.6|42.6|Standard Deviation|11.1678|11.1678|||
4113285|NCT00947765|3937784|B2|||Age||years|Mean|42.3|42.3|Standard Deviation|9.51|9.51|||
4113286|NCT00947765|3937785|B1|||Age||years|Mean|42.9|42.9|Standard Deviation|12.7721|12.7721|||
4113287|NCT00947765|3937783|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4113288|NCT00947765|3937784|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4113289|NCT00947765|3937785|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4113290|NCT00947765|3937783|B3||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4113291|NCT00947765|3937784|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4113292|NCT00947765|3937785|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4113293|NCT00947765|3937783|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4113294|NCT00947765|3937784|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4113295|NCT00947765|3937785|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4113296|NCT00947752|3937806|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4113297|NCT00947752|3937807|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4113298|NCT00947752|3937808|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4113299|NCT00947752|3937806|B3||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4113300|NCT00947752|3937807|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4113301|NCT00947752|3937808|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4113302|NCT00947752|3937806|B3|||Age||years|Mean|46.0|46.0|Standard Deviation|10.17|10.17|||
4113303|NCT00947752|3937807|B2|||Age||years|Mean|46.9|46.9|Standard Deviation|9.64|9.64|||
4113304|NCT00947752|3937808|B1|||Age||years|Mean|45.1|45.1|Standard Deviation|10.64|10.64|||
4113305|NCT00947752|3937806|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4113306|NCT00947752|3937807|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4113307|NCT00947752|3937808|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4113308|NCT00947752|3937806|B3||Between 18 and 65 years|Age||Participants|Count of Participants|144|144.0||||||
4113309|NCT00947752|3937807|B2||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4113310|NCT00947752|3937808|B1||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4113311|NCT00947752|3937806|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4113312|NCT00947752|3937807|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4113313|NCT00947752|3937808|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4113314|NCT00947661|3937817|B3||Male|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4113315|NCT00947661|3937818|B2||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4113316|NCT00947661|3937819|B1||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4113317|NCT00947661|3937817|B3||Female|Sex: Female, Male||Participants|Count of Participants|374|374.0||||||
4113318|NCT00947661|3937818|B2||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4113319|NCT00947661|3937819|B1||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4113320|NCT00947661|3937817|B3|||Age||years|Mean|63.4|63.4|Standard Deviation|10.36|10.36|||
4113321|NCT00947661|3937818|B2|||Age||years|Mean|63.8|63.8|Standard Deviation|11.08|11.08|||
4113322|NCT00947661|3937819|B1|||Age||years|Mean|63.1|63.1|Standard Deviation|9.59|9.59|||
4113323|NCT00947544|3937826|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4113324|NCT00947544|3937826|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4113325|NCT00947544|3937826|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
4113326|NCT00947544|3937826|B1||Female|Gender||Participants|Count of Participants|14|14.0||||||
4113327|NCT00947544|3937826|B1|||Age||years|Mean|10|10.0|Standard Deviation|3.482|3.482|||
4113328|NCT00947544|3937826|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4113329|NCT00947544|3937826|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4113330|NCT00947544|3937826|B1||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
4113331|NCT00947531|3937851|B3|Russian Federation||Region of Enrollment||participants|Number|242|242.0||||||
4113332|NCT00947531|3937852|B2|Russian Federation||Region of Enrollment||participants|Number|121|121.0||||||
4113333|NCT00947531|3937853|B1|Russian Federation||Region of Enrollment||participants|Number|121|121.0||||||
4113334|NCT00947531|3937851|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4113335|NCT00947531|3937852|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4113336|NCT00947531|3937853|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4113337|NCT00947531|3937851|B3||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4113338|NCT00947531|3937852|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4113339|NCT00947531|3937853|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4113340|NCT00947531|3937851|B3|||Age||years|Mean|67.3|67.3|Standard Deviation|8.0|8.0|||
4113341|NCT00947531|3937852|B2|||Age||years|Mean|67.6|67.6|Standard Deviation|8.0|8.0|||
4113342|NCT00947531|3937853|B1|||Age||years|Mean|67.1|67.1|Standard Deviation|8.0|8.0|||
4113343|NCT00947531|3937851|B3||>=65 years|Age||Participants|Count of Participants|165|165.0||||||
4113344|NCT00947531|3937852|B2||>=65 years|Age||Participants|Count of Participants|82|82.0||||||
4113345|NCT00947531|3937853|B1||>=65 years|Age||Participants|Count of Participants|83|83.0||||||
4113346|NCT00947531|3937851|B3||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
4113347|NCT00947531|3937852|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4113348|NCT00947531|3937853|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4113349|NCT00947531|3937851|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4113350|NCT00947531|3937852|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4113351|NCT00947531|3937853|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4113352|NCT00947518|3937860|B4|||Gestation (weeks)|Estimated gestational age in completed weeks|weeks|Median|33|33.0|Full Range|||28.0|36.0|
4113353|NCT00947518|3937861|B3|||Gestation (weeks)|Estimated gestational age in completed weeks|weeks|Median|32.5|32.5|Full Range|||28.0|36.0|
4113354|NCT00947518|3937862|B2|||Gestation (weeks)|Estimated gestational age in completed weeks|weeks|Median|33|33.0|Full Range|||28.0|36.0|
4113355|NCT00947518|3937863|B1|||Gestation (weeks)|Estimated gestational age in completed weeks|weeks|Median|33|33.0|Full Range|||28.0|36.0|
4113356|NCT00947518|3937860|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4113357|NCT00947518|3937861|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4113358|NCT00947518|3937862|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4113359|NCT00947518|3937863|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4113360|NCT00947518|3937860|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4113361|NCT00947518|3937861|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4113362|NCT00947518|3937862|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4113363|NCT00947518|3937863|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4113364|NCT00947518|3937860|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4113365|NCT00947518|3937861|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4113366|NCT00947518|3937862|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4113367|NCT00947518|3937863|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4113368|NCT00947518|3937860|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4113369|NCT00947518|3937861|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4113370|NCT00947518|3937862|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4113371|NCT00947518|3937863|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4113372|NCT00947518|3937860|B4||<=18 years|Age||Participants|Count of Participants|60|60.0||||||
4113373|NCT00947518|3937861|B3||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
4113374|NCT00947518|3937862|B2||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
4113375|NCT00947518|3937863|B1||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
4113376|NCT00947505|3937879|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4113377|NCT00947505|3937880|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4113378|NCT00947505|3937881|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4113379|NCT00947505|3937879|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4113380|NCT00947505|3937880|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4113381|NCT00947505|3937881|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4113382|NCT00947505|3937879|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4113383|NCT00947505|3937880|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4113384|NCT00947505|3937881|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4113385|NCT00947505|3937879|B3||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4113386|NCT00947505|3937880|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4113387|NCT00947505|3937881|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4113388|NCT00947505|3937879|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4113389|NCT00947505|3937880|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4113390|NCT00947505|3937881|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4113391|NCT00947427|3937888|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4113392|NCT00947427|3937889|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4113393|NCT00947427|3937890|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4113394|NCT00947427|3937888|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4113395|NCT00947427|3937889|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4113396|NCT00947427|3937890|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4113397|NCT00947427|3937888|B3|||Age||years|Mean|11.8|11.8|Standard Deviation|4.8|4.8|||
4113398|NCT00947427|3937889|B2|||Age||years|Mean|11.6|11.6|Standard Deviation|4.0|4.0|||
4113399|NCT00947427|3937890|B1|||Age||years|Mean|12.4|12.4|Standard Deviation|6.4|6.4|||
4113400|NCT00947349|3937897|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4113401|NCT00947349|3937898|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4113402|NCT00947349|3937899|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4113403|NCT00947349|3937900|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4113404|NCT00947349|3937901|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4113405|NCT00947349|3937897|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4113406|NCT00947349|3937898|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4113407|NCT00947349|3937899|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4113408|NCT00947349|3937900|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4113409|NCT00947349|3937901|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4113410|NCT00947349|3937897|B5|||Age||years|Mean|53.9|53.9|Standard Deviation|10.1|10.1|||
4113411|NCT00947349|3937898|B4|||Age||years|Mean|58.0|58.0|Standard Deviation|8.3|8.3|||
4113412|NCT00947349|3937899|B3|||Age||years|Mean|56.0|56.0|Standard Deviation|9.2|9.2|||
4113413|NCT00947349|3937900|B2|||Age||years|Mean|48.0|48.0|Standard Deviation|13.5|13.5|||
4113414|NCT00947349|3937901|B1|||Age||years|Mean|53.5|53.5|Standard Deviation|6.0|6.0|||
4113415|NCT00947310|3938036|B4|Israel||Region of Enrollment||participants|Number|104|104.0||||||
4113416|NCT00947310|3938037|B3|Israel||Region of Enrollment||participants|Number|34|34.0||||||
4113417|NCT00947310|3938038|B2|Israel||Region of Enrollment||participants|Number|36|36.0||||||
4113418|NCT00947310|3938039|B1|Israel||Region of Enrollment||participants|Number|34|34.0||||||
4113419|NCT00947310|3938036|B4|Canada||Region of Enrollment||participants|Number|35|35.0||||||
4113420|NCT00947310|3938037|B3|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4113421|NCT00947310|3938038|B2|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4113422|NCT00947310|3938039|B1|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4113423|NCT00947310|3938036|B4|Japan||Region of Enrollment||participants|Number|68|68.0||||||
4113424|NCT00947310|3938037|B3|Japan||Region of Enrollment||participants|Number|24|24.0||||||
4113425|NCT00947310|3938038|B2|Japan||Region of Enrollment||participants|Number|22|22.0||||||
4113426|NCT00947310|3938039|B1|Japan||Region of Enrollment||participants|Number|22|22.0||||||
4113427|NCT00947310|3938036|B4|Europe||Region of Enrollment||participants|Number|277|277.0||||||
4113428|NCT00947310|3938037|B3|Europe||Region of Enrollment||participants|Number|91|91.0||||||
4113429|NCT00947310|3938038|B2|Europe||Region of Enrollment||participants|Number|92|92.0||||||
4113430|NCT00947310|3938039|B1|Europe||Region of Enrollment||participants|Number|94|94.0||||||
4113431|NCT00947310|3938036|B4|United States||Region of Enrollment||participants|Number|1016|1016.0||||||
4113432|NCT00947310|3938037|B3|United States||Region of Enrollment||participants|Number|325|325.0||||||
4113433|NCT00947310|3938038|B2|United States||Region of Enrollment||participants|Number|338|338.0||||||
4113434|NCT00947310|3938039|B1|United States||Region of Enrollment||participants|Number|353|353.0||||||
4113435|NCT00947310|3938036|B4||Male|Sex: Female, Male||Participants|Count of Participants|1064|1064.0||||||
4113436|NCT00947310|3938037|B3||Male|Sex: Female, Male||Participants|Count of Participants|353|353.0||||||
4113437|NCT00947310|3938038|B2||Male|Sex: Female, Male||Participants|Count of Participants|354|354.0||||||
4113438|NCT00947310|3938039|B1||Male|Sex: Female, Male||Participants|Count of Participants|357|357.0||||||
4113439|NCT00947310|3938036|B4||Female|Sex: Female, Male||Participants|Count of Participants|436|436.0||||||
4113440|NCT00947310|3938037|B3||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4113441|NCT00947310|3938038|B2||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4113442|NCT00947310|3938039|B1||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4113443|NCT00947310|3938036|B4|||Age||years|Mean|63|63.0|Standard Deviation|12|12.0|||
4113444|NCT00947310|3938037|B3|||Age||years|Mean|62|62.0|Standard Deviation|12|12.0|||
4113445|NCT00947310|3938038|B2|||Age||years|Mean|63|63.0|Standard Deviation|12|12.0|||
4113446|NCT00947310|3938039|B1|||Age||years|Mean|63|63.0|Standard Deviation|11|11.0|||
4113447|NCT00947310|3938036|B4||>=65 years|Age||Participants|Count of Participants|749|749.0||||||
4113448|NCT00947310|3938037|B3||>=65 years|Age||Participants|Count of Participants|232|232.0||||||
4113449|NCT00947310|3938038|B2||>=65 years|Age||Participants|Count of Participants|255|255.0||||||
4113450|NCT00947310|3938039|B1||>=65 years|Age||Participants|Count of Participants|262|262.0||||||
4113451|NCT00947310|3938036|B4||Between 18 and 65 years|Age||Participants|Count of Participants|751|751.0||||||
4113452|NCT00947310|3938037|B3||Between 18 and 65 years|Age||Participants|Count of Participants|254|254.0||||||
4113453|NCT00947310|3938038|B2||Between 18 and 65 years|Age||Participants|Count of Participants|245|245.0||||||
4113454|NCT00947310|3938039|B1||Between 18 and 65 years|Age||Participants|Count of Participants|252|252.0||||||
4113455|NCT00947310|3938036|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4113456|NCT00947310|3938037|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4113457|NCT00947310|3938038|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4113458|NCT00947310|3938039|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4113459|NCT00947297|3938055|B1|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4113460|NCT00947297|3938055|B1|United States||Region of Enrollment||participants|Number|54|54.0||||||
4113461|NCT00947297|3938055|B1||Male|Gender||Participants|Count of Participants|19|19.0||||||
4113462|NCT00947297|3938055|B1||Female|Gender||Participants|Count of Participants|41|41.0||||||
4113463|NCT00947297|3938055|B1|||Age||years|Mean|28.83|28.83|Standard Deviation|13.933|13.933|||
4113464|NCT00947297|3938055|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4113465|NCT00947297|3938055|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4113466|NCT00947297|3938055|B1||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4113467|NCT00947284|3938062|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4113468|NCT00947284|3938062|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4113469|NCT00947284|3938062|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4113470|NCT00947284|3938062|B1|Unknown||Age, Customized|Demographic data not available due to death of investigator; co-investigators searched the computer of the deceased investigator and cannot find additional data|Participants|Number|3|3.0||||||
4113471|NCT00947271|3938067|B5|United States||Region of Enrollment||participants|Number|1010|1010.0||||||
4113472|NCT00947271|3938068|B4|United States||Region of Enrollment||participants|Number|250|250.0||||||
4113473|NCT00947271|3938069|B3|United States||Region of Enrollment||participants|Number|254|254.0||||||
4113474|NCT00947271|3938070|B2|United States||Region of Enrollment||participants|Number|252|252.0||||||
4113475|NCT00947271|3938071|B1|United States||Region of Enrollment||participants|Number|254|254.0||||||
4113476|NCT00947271|3938067|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4113477|NCT00947271|3938068|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4113478|NCT00947271|3938069|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113479|NCT00947271|3938070|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113480|NCT00947271|3938071|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113481|NCT00947271|3938067|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|927|927.0||||||
4113482|NCT00947271|3938068|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|225|225.0||||||
4113483|NCT00947271|3938069|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|237|237.0||||||
4113484|NCT00947271|3938070|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|236|236.0||||||
4113485|NCT00947271|3938071|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|229|229.0||||||
4113486|NCT00947271|3938067|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
4113487|NCT00947271|3938068|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4113488|NCT00947271|3938069|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4113489|NCT00947271|3938070|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4113490|NCT00947271|3938071|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4113491|NCT00947271|3938067|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4113492|NCT00947271|3938068|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4113493|NCT00947271|3938069|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4113494|NCT00947271|3938070|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4113495|NCT00947271|3938071|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4113496|NCT00947271|3938067|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4113497|NCT00947271|3938068|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4113498|NCT00947271|3938069|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4113499|NCT00947271|3938070|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4113500|NCT00947271|3938071|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4113501|NCT00947271|3938067|B5||White|Race (NIH/OMB)||Participants|Count of Participants|189|189.0||||||
4113502|NCT00947271|3938068|B4||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4113503|NCT00947271|3938069|B3||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4113504|NCT00947271|3938070|B2||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4113505|NCT00947271|3938071|B1||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4113506|NCT00947271|3938067|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|691|691.0||||||
4113507|NCT00947271|3938068|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|166|166.0||||||
4113508|NCT00947271|3938069|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|177|177.0||||||
4113509|NCT00947271|3938070|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|180|180.0||||||
4113510|NCT00947271|3938071|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|168|168.0||||||
4113511|NCT00947271|3938067|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4113512|NCT00947271|3938068|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113513|NCT00947271|3938069|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4113514|NCT00947271|3938070|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4113515|NCT00947271|3938071|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113516|NCT00947271|3938067|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4113517|NCT00947271|3938068|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113518|NCT00947271|3938069|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4113519|NCT00947271|3938070|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4113520|NCT00947271|3938071|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113521|NCT00947271|3938067|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4113522|NCT00947271|3938068|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4113523|NCT00947271|3938069|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4113524|NCT00947271|3938070|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4113525|NCT00947271|3938071|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4113526|NCT00947271|3938067|B5||Male|Sex: Female, Male||Participants|Count of Participants|567|567.0||||||
4113527|NCT00947271|3938068|B4||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4113528|NCT00947271|3938069|B3||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4113529|NCT00947271|3938070|B2||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4113530|NCT00947271|3938071|B1||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4113531|NCT00947271|3938067|B5||Female|Sex: Female, Male||Participants|Count of Participants|443|443.0||||||
4113532|NCT00947271|3938068|B4||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4113533|NCT00947271|3938069|B3||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4113534|NCT00947271|3938070|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4113535|NCT00947271|3938071|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4113536|NCT00947271|3938067|B5|||Age||years|Mean|28.5|28.5|Standard Deviation|9.5|9.5|||
4113537|NCT00947271|3938068|B4|||Age||years|Mean|28.9|28.9|Standard Deviation|10.0|10.0|||
4113538|NCT00947271|3938069|B3|||Age||years|Mean|28.0|28.0|Standard Deviation|9.2|9.2|||
4113539|NCT00947271|3938070|B2|||Age||years|Mean|29.3|29.3|Standard Deviation|9.7|9.7|||
4113540|NCT00947271|3938071|B1|||Age||years|Mean|27.9|27.9|Standard Deviation|8.9|8.9|||
4113541|NCT00947219|3938100|B4||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4113542|NCT00947219|3938101|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4113543|NCT00947219|3938102|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4113544|NCT00947219|3938103|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4113545|NCT00947219|3938100|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4113546|NCT00947219|3938101|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4113547|NCT00947219|3938102|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4113548|NCT00947219|3938103|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4113549|NCT00947219|3938100|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4113550|NCT00947219|3938101|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4113551|NCT00947219|3938102|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4113552|NCT00947219|3938103|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4113553|NCT00947219|3938100|B4||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
4113554|NCT00947219|3938101|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4113555|NCT00947219|3938102|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4113556|NCT00947219|3938103|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4113557|NCT00947219|3938100|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4113558|NCT00947219|3938101|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4113559|NCT00947219|3938102|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4113560|NCT00947219|3938103|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4113561|NCT00947167|3938113|B1||Male|Gender||Participants|Count of Participants|2|2.0||||||
4113562|NCT00947167|3938113|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
4113563|NCT00947167|3938113|B1|||Age||years|Mean|46.5|46.5|Full Range|||34.0|55.0|
4113564|NCT00947167|3938113|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4113565|NCT00947167|3938113|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4113566|NCT00947167|3938113|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4113567|NCT00947154|3938118|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4113568|NCT00947154|3938118|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4113569|NCT00947154|3938118|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4113570|NCT00947154|3938118|B1|||Age||years|Mean|34.0|34.0|Standard Deviation|10.4|10.4|||
4113571|NCT00947115|3938125|B4||Male|Gender|Data for Year 0 - Year 10|Participants|Count of Participants|0|0.0||||||
4113572|NCT00947115|3938126|B3||Male|Gender|Data for Year 0 - Year 10|Participants|Count of Participants|0|0.0||||||
4113573|NCT00947115|3938127|B2||Male|Gender|Data for Year 0 - Year 10|Participants|Count of Participants|0|0.0||||||
4113574|NCT00947115|3938128|B1||Male|Gender|Data for Year 0 - Year 10|Participants|Count of Participants|0|0.0||||||
4113575|NCT00947115|3938125|B4||Female|Gender|Data for Year 0 - Year 10|Participants|Count of Participants|524|524.0||||||
4113576|NCT00947115|3938126|B3||Female|Gender|Data for Year 0 - Year 10|Participants|Count of Participants|171|171.0||||||
4113577|NCT00947115|3938127|B2||Female|Gender|Data for Year 0 - Year 10|Participants|Count of Participants|194|194.0||||||
4113578|NCT00947115|3938128|B1||Female|Gender|Data for Year 0 - Year 10|Participants|Count of Participants|159|159.0||||||
4113579|NCT00947115|3938125|B4|Male||Sex/Gender, Customized|Data for Year 10|Subjects|Number|0|0.0||||||
4113580|NCT00947115|3938126|B3|Male||Sex/Gender, Customized|Data for Year 10|Subjects|Number|0|0.0||||||
4113581|NCT00947115|3938127|B2|Male||Sex/Gender, Customized|Data for Year 10|Subjects|Number|0|0.0||||||
4113582|NCT00947115|3938128|B1|Male||Sex/Gender, Customized|Data for Year 10|Subjects|Number|0|0.0||||||
4113583|NCT00947115|3938125|B4|Female||Sex/Gender, Customized|Data for Year 10|Subjects|Number|470|470.0||||||
4113584|NCT00947115|3938126|B3|Female||Sex/Gender, Customized|Data for Year 10|Subjects|Number|156|156.0||||||
4113585|NCT00947115|3938127|B2|Female||Sex/Gender, Customized|Data for Year 10|Subjects|Number|172|172.0||||||
4113586|NCT00947115|3938128|B1|Female||Sex/Gender, Customized|Data for Year 10|Subjects|Number|142|142.0||||||
4113587|NCT00947115|3938125|B4|Male||Sex/Gender, Customized|Data for Year 9|Subjects|Number|0|0.0||||||
4113588|NCT00947115|3938126|B3|Male||Sex/Gender, Customized|Data for Year 9|Subjects|Number|0|0.0||||||
4113589|NCT00947115|3938127|B2|Male||Sex/Gender, Customized|Data for Year 9|Subjects|Number|0|0.0||||||
4113590|NCT00947115|3938128|B1|Male||Sex/Gender, Customized|Data for Year 9|Subjects|Number|0|0.0||||||
4113591|NCT00947115|3938125|B4|Female||Sex/Gender, Customized|Data for Year 9|Subjects|Number|483|483.0||||||
4113592|NCT00947115|3938126|B3|Female||Sex/Gender, Customized|Data for Year 9|Subjects|Number|157|157.0||||||
4113593|NCT00947115|3938127|B2|Female||Sex/Gender, Customized|Data for Year 9|Subjects|Number|180|180.0||||||
4113594|NCT00947115|3938128|B1|Female||Sex/Gender, Customized|Data for Year 9|Subjects|Number|146|146.0||||||
4113595|NCT00947115|3938125|B4|Male||Sex/Gender, Customized|Data for Year 8|Subjects|Number|0|0.0||||||
4113596|NCT00947115|3938126|B3|Male||Sex/Gender, Customized|Data for Year 8|Subjects|Number|0|0.0||||||
4113597|NCT00947115|3938127|B2|Male||Sex/Gender, Customized|Data for Year 8|Subjects|Number|0|0.0||||||
4113598|NCT00947115|3938128|B1|Male||Sex/Gender, Customized|Data for Year 8|Subjects|Number|0|0.0||||||
4113599|NCT00947115|3938125|B4|Female||Sex/Gender, Customized|Data for Year 8|Subjects|Number|430|430.0||||||
4113600|NCT00947115|3938126|B3|Female||Sex/Gender, Customized|Data for Year 8|Subjects|Number|141|141.0||||||
4113601|NCT00947115|3938127|B2|Female||Sex/Gender, Customized|Data for Year 8|Subjects|Number|152|152.0||||||
4113602|NCT00947115|3938128|B1|Female||Sex/Gender, Customized|Data for Year 8|Subjects|Number|137|137.0||||||
4113603|NCT00947115|3938125|B4|Male||Sex/Gender, Customized|Data for Year 7|Subjects|Number|0|0.0||||||
4113604|NCT00947115|3938126|B3|Male||Sex/Gender, Customized|Data for Year 7|Subjects|Number|0|0.0||||||
4113605|NCT00947115|3938127|B2|Male||Sex/Gender, Customized|Data for Year 7|Subjects|Number|0|0.0||||||
4113606|NCT00947115|3938128|B1|Male||Sex/Gender, Customized|Data for Year 7|Subjects|Number|0|0.0||||||
4113607|NCT00947115|3938125|B4|Female||Sex/Gender, Customized|Data for Year 7|Subjects|Number|474|474.0||||||
4113608|NCT00947115|3938126|B3|Female||Sex/Gender, Customized|Data for Year 7|Subjects|Number|160|160.0||||||
4113609|NCT00947115|3938127|B2|Female||Sex/Gender, Customized|Data for Year 7|Subjects|Number|165|165.0||||||
4113610|NCT00947115|3938128|B1|Female||Sex/Gender, Customized|Data for Year 7|Subjects|Number|149|149.0||||||
4113611|NCT00947115|3938125|B4|Male||Sex/Gender, Customized|Data for Year 6|Subjects|Number|0|0.0||||||
4113612|NCT00947115|3938126|B3|Male||Sex/Gender, Customized|Data for Year 6|Subjects|Number|0|0.0||||||
4113613|NCT00947115|3938127|B2|Male||Sex/Gender, Customized|Data for Year 6|Subjects|Number|0|0.0||||||
4113614|NCT00947115|3938128|B1|Male||Sex/Gender, Customized|Data for Year 6|Subjects|Number|0|0.0||||||
4113615|NCT00947115|3938125|B4|Female||Sex/Gender, Customized|Data for Year 6|Subjects|Number|488|488.0||||||
4113616|NCT00947115|3938126|B3|Female||Sex/Gender, Customized|Data for Year 6|Subjects|Number|164|164.0||||||
4113617|NCT00947115|3938127|B2|Female||Sex/Gender, Customized|Data for Year 6|Subjects|Number|177|177.0||||||
4113618|NCT00947115|3938128|B1|Female||Sex/Gender, Customized|Data for Year 6|Subjects|Number|147|147.0||||||
4113619|NCT00947115|3938125|B4|Male||Sex/Gender, Customized|Data for Year 5|Subjects|Number|0|0.0||||||
4113620|NCT00947115|3938126|B3|Male||Sex/Gender, Customized|Data for Year 5|Subjects|Number|0|0.0||||||
4113621|NCT00947115|3938127|B2|Male||Sex/Gender, Customized|Data for Year 5|Subjects|Number|0|0.0||||||
4113622|NCT00947115|3938128|B1|Male||Sex/Gender, Customized|Data for Year 5|Subjects|Number|0|0.0||||||
4113623|NCT00947115|3938125|B4|Female||Sex/Gender, Customized|Data for Year 5|Subjects|Number|507|507.0||||||
4113624|NCT00947115|3938126|B3|Female||Sex/Gender, Customized|Data for Year 5|Subjects|Number|170|170.0||||||
4113625|NCT00947115|3938127|B2|Female||Sex/Gender, Customized|Data for Year 5|Subjects|Number|184|184.0||||||
4113626|NCT00947115|3938128|B1|Female||Sex/Gender, Customized|Data for Year 5|Subjects|Number|153|153.0||||||
4113627|NCT00947115|3938125|B4|||Age|Data for Year 0 - Year 10|Years|Mean|45.8|45.8|Standard Deviation|12.3|12.3|||
4113628|NCT00947115|3938126|B3|||Age|Data for Year 0 - Year 10|Years|Mean|59.6|59.6|Standard Deviation|2.8|2.8|||
4113629|NCT00947115|3938127|B2|||Age|Data for Year 0 - Year 10|Years|Mean|46.1|46.1|Standard Deviation|6.0|6.0|||
4113630|NCT00947115|3938128|B1|||Age|Data for Year 0 - Year 10|Years|Mean|30.6|30.6|Standard Deviation|2.8|2.8|||
4113631|NCT00947115|3938125|B4|||Age|Data for Year 10|Years|Mean|45.9|45.9|Standard Deviation|12.3|12.3|||
4113632|NCT00947115|3938126|B3|||Age|Data for Year 10|Years|Mean|59.6|59.6|Standard Deviation|2.8|2.8|||
4113633|NCT00947115|3938127|B2|||Age|Data for Year 10|Years|Mean|46.1|46.1|Standard Deviation|6.0|6.0|||
4113634|NCT00947115|3938128|B1|||Age|Data for Year 10|Years|Mean|30.6|30.6|Standard Deviation|2.8|2.8|||
4113635|NCT00947115|3938125|B4|||Age|Data for Year 9|Years|Mean|44.8|44.8|Standard Deviation|12.32|12.32|||
4113636|NCT00947115|3938126|B3|||Age|Data for Year 9|Years|Mean|58.6|58.6|Standard Deviation|2.9|2.9|||
4113637|NCT00947115|3938127|B2|||Age|Data for Year 9|Years|Mean|45.2|45.2|Standard Deviation|6.0|6.0|||
4113638|NCT00947115|3938128|B1|||Age|Data for Year 9|Years|Mean|29.5|29.5|Standard Deviation|2.8|2.8|||
4113639|NCT00947115|3938125|B4|||Age|Data for Year 8|Years|Mean|35.6|35.6|Standard Deviation|12.57|12.57|||
4113640|NCT00947115|3938126|B3|||Age|Data for Year 8|Years|Mean|57.6|57.6|Standard Deviation|2.9|2.9|||
4113641|NCT00947115|3938127|B2|||Age|Data for Year 8|Years|Mean|44.0|44.0|Standard Deviation|6.0|6.0|||
4113642|NCT00947115|3938128|B1|||Age|Data for Year 8|Years|Mean|28.3|28.3|Standard Deviation|2.8|2.8|||
4113643|NCT00947115|3938125|B4|||Age|Data for Year 7|Years|Mean|42.6|42.6|Standard Deviation|12.42|12.42|||
4113644|NCT00947115|3938126|B3|||Age|Data for Year 7|Years|Mean|56.4|56.4|Standard Deviation|3.23|3.23|||
4113645|NCT00947115|3938127|B2|||Age|Data for Year 7|Years|Mean|42.9|42.9|Standard Deviation|5.96|5.96|||
4113646|NCT00947115|3938128|B1|||Age|Data for Year 7|Years|Mean|27.5|27.5|Standard Deviation|2.78|2.78|||
4113647|NCT00947115|3938125|B4|||Age|Data for year 6|Years|Mean|41.8|41.8|Standard Deviation|12.28|12.28|||
4113648|NCT00947115|3938126|B3|||Age|Data for year 6|Years|Mean|55.4|55.4|Standard Deviation|3.20|3.2|||
4113649|NCT00947115|3938127|B2|||Age|Data for year 6|Years|Mean|41.8|41.8|Standard Deviation|6.05|6.05|||
4113650|NCT00947115|3938128|B1|||Age|Data for year 6|Years|Mean|26.6|26.6|Standard Deviation|2.85|2.85|||
4113651|NCT00947115|3938125|B4|||Age|Data for Year 5|Years|Mean|40.9|40.9|Standard Deviation|12.22|12.22|||
4113652|NCT00947115|3938126|B3|||Age|Data for Year 5|Years|Mean|54.4|54.4|Standard Deviation|3.15|3.15|||
4113653|NCT00947115|3938127|B2|||Age|Data for Year 5|Years|Mean|41.0|41.0|Standard Deviation|6.02|6.02|||
4113654|NCT00947115|3938128|B1|||Age|Data for Year 5|Years|Mean|25.7|25.7|Standard Deviation|2.82|2.82|||
4113655|NCT00947011|3938192|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4113656|NCT00947011|3938192|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4113657|NCT00947011|3938192|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4113658|NCT00947011|3938192|B1|>=21 and <=75||Age, Customized||participants|Number|12|12.0||||||
4113659|NCT00946998|3938200|B3|||16-item Quick Inventory of Depression Symptomatology Clinician-rated Score|The 16-item Quick Inventory of Depression Symptomatology measures depressive symptom severity. The range of final score is 0-27, with higher scores indicating more severe depression. A score of 0-5 corresponds to normal affect, 6-10 to mild, 11-15 to moderate, 16-20 to severe, and 21 to very severe depression.|units on a scale|Mean|14.0|14.0|Standard Deviation|2.4|2.4|||
4113660|NCT00946998|3938201|B2|||16-item Quick Inventory of Depression Symptomatology Clinician-rated Score|The 16-item Quick Inventory of Depression Symptomatology measures depressive symptom severity. The range of final score is 0-27, with higher scores indicating more severe depression. A score of 0-5 corresponds to normal affect, 6-10 to mild, 11-15 to moderate, 16-20 to severe, and 21 to very severe depression.|units on a scale|Mean|14.1|14.1|Standard Deviation|2.4|2.4|||
4113661|NCT00946998|3938202|B1|||16-item Quick Inventory of Depression Symptomatology Clinician-rated Score|The 16-item Quick Inventory of Depression Symptomatology measures depressive symptom severity. The range of final score is 0-27, with higher scores indicating more severe depression. A score of 0-5 corresponds to normal affect, 6-10 to mild, 11-15 to moderate, 16-20 to severe, and 21 to very severe depression.|units on a scale|Mean|14.0|14.0|Standard Deviation|2.4|2.4|||
4113662|NCT00946998|3938200|B3|||Estimated glomerular filtration rate||mL/min/1.73 m^2|Median|27.5|27.5|Inter-Quartile Range|||17.0|37.0|
4113663|NCT00946998|3938201|B2|||Estimated glomerular filtration rate||mL/min/1.73 m^2|Median|27.5|27.5|Inter-Quartile Range|||17.0|38.5|
4113664|NCT00946998|3938202|B1|||Estimated glomerular filtration rate||mL/min/1.73 m^2|Median|27.0|27.0|Inter-Quartile Range|||18.0|35.0|
4113665|NCT00946998|3938200|B3|||Diabetes Mellitus||Participants|Count of Participants|113|113.0||||||
4113666|NCT00946998|3938201|B2|||Diabetes Mellitus||Participants|Count of Participants|55|55.0||||||
4113667|NCT00946998|3938202|B1|||Diabetes Mellitus||Participants|Count of Participants|58|58.0||||||
4113668|NCT00946998|3938200|B3||CKD Stage 5|Chronic Kidney Disease Stage|Chronic kidney disease stages were categorized as follows: stage 3, estimated glomerular filtration rate (eGFR) of 30 to 59 mL/min/1.73 m^2; stage 4, eGFR of 15-29; and stage 5, eGFR<15, but not dialysis-dependent.|Participants|Count of Participants|33|33.0||||||
4113713|NCT00946998|3938200|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4113669|NCT00946998|3938201|B2||CKD Stage 5|Chronic Kidney Disease Stage|Chronic kidney disease stages were categorized as follows: stage 3, estimated glomerular filtration rate (eGFR) of 30 to 59 mL/min/1.73 m^2; stage 4, eGFR of 15-29; and stage 5, eGFR<15, but not dialysis-dependent.|Participants|Count of Participants|16|16.0||||||
4113670|NCT00946998|3938202|B1||CKD Stage 5|Chronic Kidney Disease Stage|Chronic kidney disease stages were categorized as follows: stage 3, estimated glomerular filtration rate (eGFR) of 30 to 59 mL/min/1.73 m^2; stage 4, eGFR of 15-29; and stage 5, eGFR<15, but not dialysis-dependent.|Participants|Count of Participants|17|17.0||||||
4113671|NCT00946998|3938200|B3||CKD Stage 4|Chronic Kidney Disease Stage|Chronic kidney disease stages were categorized as follows: stage 3, estimated glomerular filtration rate (eGFR) of 30 to 59 mL/min/1.73 m^2; stage 4, eGFR of 15-29; and stage 5, eGFR<15, but not dialysis-dependent.|Participants|Count of Participants|70|70.0||||||
4113672|NCT00946998|3938201|B2||CKD Stage 4|Chronic Kidney Disease Stage|Chronic kidney disease stages were categorized as follows: stage 3, estimated glomerular filtration rate (eGFR) of 30 to 59 mL/min/1.73 m^2; stage 4, eGFR of 15-29; and stage 5, eGFR<15, but not dialysis-dependent.|Participants|Count of Participants|36|36.0||||||
4113673|NCT00946998|3938202|B1||CKD Stage 4|Chronic Kidney Disease Stage|Chronic kidney disease stages were categorized as follows: stage 3, estimated glomerular filtration rate (eGFR) of 30 to 59 mL/min/1.73 m^2; stage 4, eGFR of 15-29; and stage 5, eGFR<15, but not dialysis-dependent.|Participants|Count of Participants|34|34.0||||||
4113674|NCT00946998|3938200|B3||CKD Stage 3|Chronic Kidney Disease Stage|Chronic kidney disease stages were categorized as follows: stage 3, estimated glomerular filtration rate (eGFR) of 30 to 59 mL/min/1.73 m^2; stage 4, eGFR of 15-29; and stage 5, eGFR<15, but not dialysis-dependent.|Participants|Count of Participants|90|90.0||||||
4113675|NCT00946998|3938201|B2||CKD Stage 3|Chronic Kidney Disease Stage|Chronic kidney disease stages were categorized as follows: stage 3, estimated glomerular filtration rate (eGFR) of 30 to 59 mL/min/1.73 m^2; stage 4, eGFR of 15-29; and stage 5, eGFR<15, but not dialysis-dependent.|Participants|Count of Participants|44|44.0||||||
4113676|NCT00946998|3938202|B1||CKD Stage 3|Chronic Kidney Disease Stage|Chronic kidney disease stages were categorized as follows: stage 3, estimated glomerular filtration rate (eGFR) of 30 to 59 mL/min/1.73 m^2; stage 4, eGFR of 15-29; and stage 5, eGFR<15, but not dialysis-dependent.|Participants|Count of Participants|46|46.0||||||
4113677|NCT00946998|3938200|B3|United States||Region of Enrollment||participants|Number|193|193.0||||||
4113678|NCT00946998|3938201|B2|United States||Region of Enrollment||participants|Number|96|96.0||||||
4113679|NCT00946998|3938202|B1|United States||Region of Enrollment||participants|Number|97|97.0||||||
4113680|NCT00946998|3938200|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113681|NCT00946998|3938201|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113682|NCT00946998|3938202|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113683|NCT00946998|3938200|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113684|NCT00946998|3938201|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113685|NCT00946998|3938202|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113686|NCT00946998|3938200|B3||White|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
4113687|NCT00946998|3938201|B2||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4113688|NCT00946998|3938202|B1||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4113689|NCT00946998|3938200|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
4113690|NCT00946998|3938201|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4113691|NCT00946998|3938202|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4113692|NCT00946998|3938200|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113693|NCT00946998|3938201|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113694|NCT00946998|3938202|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113695|NCT00946998|3938200|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113696|NCT00946998|3938201|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113697|NCT00946998|3938202|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113698|NCT00946998|3938200|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4113699|NCT00946998|3938201|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4113700|NCT00946998|3938202|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113701|NCT00946998|3938200|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113702|NCT00946998|3938201|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113703|NCT00946998|3938202|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113704|NCT00946998|3938200|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|158|158.0||||||
4113705|NCT00946998|3938201|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
4113706|NCT00946998|3938202|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
4113707|NCT00946998|3938200|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4113708|NCT00946998|3938201|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4113709|NCT00946998|3938202|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4113710|NCT00946998|3938200|B3||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4113711|NCT00946998|3938201|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4113712|NCT00946998|3938202|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4113714|NCT00946998|3938201|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4113715|NCT00946998|3938202|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4113716|NCT00946998|3938200|B3|||Age||years|Mean|58.4|58.4|Standard Deviation|13.4|13.4|||
4113717|NCT00946998|3938201|B2|||Age||years|Mean|59.1|59.1|Standard Deviation|12.2|12.2|||
4113718|NCT00946998|3938202|B1|||Age||years|Mean|57.7|57.7|Standard Deviation|14.5|14.5|||
4113719|NCT00946985|3938217|B1|Residual (295.60)||Current Schizophrenia Diagnosis|Per the Diagnostic and Statistical Manual for Mental Disorders fourth edition (DSM-IV) criteria.|participants|Number|1|1.0||||||
4113720|NCT00946985|3938217|B1|Undifferentiated (295.90)||Current Schizophrenia Diagnosis|Per the Diagnostic and Statistical Manual for Mental Disorders fourth edition (DSM-IV) criteria.|participants|Number|13|13.0||||||
4113721|NCT00946985|3938217|B1|Disorganized (295.10)||Current Schizophrenia Diagnosis|Per the Diagnostic and Statistical Manual for Mental Disorders fourth edition (DSM-IV) criteria.|participants|Number|6|6.0||||||
4113722|NCT00946985|3938217|B1|Paranoid (295.30)||Current Schizophrenia Diagnosis|Per the Diagnostic and Statistical Manual for Mental Disorders fourth edition (DSM-IV) criteria.|participants|Number|142|142.0||||||
4113723|NCT00946985|3938217|B1|||Age at First Diagnosis of Schizophrenia||years|Mean|24.1|24.1|Standard Deviation|4.61|4.61|||
4113724|NCT00946985|3938217|B1|||Clinical Global Impression of Severity (CGI-S)|"The Clinical Global Impression - Severity of Illness (CGI-S) is a clinician-rated subscale (low=0, high=7, higher score indicates increasing illness). The clinician rates the severity of symptoms in relation to the clinician's total experience with schizophrenia subjects using a 7-point scale (1=normal, not at all ill, 2= borderline ill, 3= mildly ill, 4=moderately ill, 5= markedly ill, 6= severely ill, 7= among the most extremely ill subjects) in response to the question Considering your total clinical experience with this particular population, how ill is the subject at this time?."|units on a scale|Mean|4.4|4.4|Standard Deviation|0.56|0.56|||
4113725|NCT00946985|3938217|B1|||Positive and Negative Syndrome Scale (PANSS) Total Score|Assesses the positive symptoms, negative symptoms, and general psychopathology specifically associated with schizophrenia. The scale consists of 30 items. Each item is rated on a scale from 1 (symptom not present) to 7 (symptoms extremely severe). Scores for PANSS positive and negative each range from 7 to 49. Scores for General Psychopathology range from 16 to 112. The sum of all 30 items is defined as the PANSS total score and ranges from 30 to 210.|units on a scale|Mean|85.9|85.9|Standard Deviation|13.65|13.65|||
4113726|NCT00946985|3938217|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4113727|NCT00946985|3938217|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4113728|NCT00946985|3938217|B1|30-35 years||Age, Customized||participants|Number|54|54.0||||||
4113729|NCT00946985|3938217|B1|24-29 years||Age, Customized||participants|Number|62|62.0||||||
4113730|NCT00946985|3938217|B1|18-23 years||Age, Customized||participants|Number|46|46.0||||||
4113731|NCT00946985|3938217|B1|||Age||years|Mean|27|27.0|Standard Deviation|4.55|4.55|||
4113732|NCT00946920|3938221|B3|||Baseline Total International Prostate Symptom Scores (IPSS)|IPSS is used to assess severity of lower urinary tract symptoms and to monitor the progress of symptoms once treatment has been initiated. It contains 7 questions regarding incomplete emptying, frequency, intermittency, urgency, weak stream, straining, and nocturia. Each question is assigned a score of 0-5 (i.e. the minimum total score is 0 and the maximum is 35). A score of “0” corresponds to a response of “not at all” for the first six symptoms and “none” for nocturia, and a score of 5 corresponds to a response of “almost always” for the first six symptoms and “5 times or more” for nocturia.|units on a scale|Mean|11.7|11.7|Standard Deviation|7.96|7.96|||
4113733|NCT00946920|3938222|B2|||Baseline Total International Prostate Symptom Scores (IPSS)|IPSS is used to assess severity of lower urinary tract symptoms and to monitor the progress of symptoms once treatment has been initiated. It contains 7 questions regarding incomplete emptying, frequency, intermittency, urgency, weak stream, straining, and nocturia. Each question is assigned a score of 0-5 (i.e. the minimum total score is 0 and the maximum is 35). A score of “0” corresponds to a response of “not at all” for the first six symptoms and “none” for nocturia, and a score of 5 corresponds to a response of “almost always” for the first six symptoms and “5 times or more” for nocturia.|units on a scale|Mean|11.6|11.6|Standard Deviation|8.02|8.02|||
4113734|NCT00946920|3938223|B1|||Baseline Total International Prostate Symptom Scores (IPSS)|IPSS is used to assess severity of lower urinary tract symptoms and to monitor the progress of symptoms once treatment has been initiated. It contains 7 questions regarding incomplete emptying, frequency, intermittency, urgency, weak stream, straining, and nocturia. Each question is assigned a score of 0-5 (i.e. the minimum total score is 0 and the maximum is 35). A score of “0” corresponds to a response of “not at all” for the first six symptoms and “none” for nocturia, and a score of 5 corresponds to a response of “almost always” for the first six symptoms and “5 times or more” for nocturia.|units on a scale|Mean|11.8|11.8|Standard Deviation|7.93|7.93|||
4113735|NCT00946920|3938221|B3|||Baseline Short Form-36 (SF-36) Total Scores|The SF-36 is a multi-purpose, short-form health survey with only 36 questions and with a minimum score of 0 and a maximum score of 100. The higher score the better health. It yields an 8-scale profile of functional health and well-being scores as well as psychometrically-based physical and mental health summary measures and a preference-based health utility index. The SF-36 has proven useful in surveys of general and specific populations, comparing the relative burden of diseases, and in differentiating the health benefits produced by a wide range of different treatments.|units on a scale|Mean|49.9|49.9|Standard Deviation|11.4|11.4|||
4113736|NCT00946920|3938222|B2|||Baseline Short Form-36 (SF-36) Total Scores|The SF-36 is a multi-purpose, short-form health survey with only 36 questions and with a minimum score of 0 and a maximum score of 100. The higher score the better health. It yields an 8-scale profile of functional health and well-being scores as well as psychometrically-based physical and mental health summary measures and a preference-based health utility index. The SF-36 has proven useful in surveys of general and specific populations, comparing the relative burden of diseases, and in differentiating the health benefits produced by a wide range of different treatments.|units on a scale|Mean|50.2|50.2|Standard Deviation|11.4|11.4|||
4113790|NCT00946530|3938272|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4113737|NCT00946920|3938223|B1|||Baseline Short Form-36 (SF-36) Total Scores|The SF-36 is a multi-purpose, short-form health survey with only 36 questions and with a minimum score of 0 and a maximum score of 100. The higher score the better health. It yields an 8-scale profile of functional health and well-being scores as well as psychometrically-based physical and mental health summary measures and a preference-based health utility index. The SF-36 has proven useful in surveys of general and specific populations, comparing the relative burden of diseases, and in differentiating the health benefits produced by a wide range of different treatments.|units on a scale|Mean|49.7|49.7|Standard Deviation|11.5|11.5|||
4113738|NCT00946920|3938221|B3|||Median Baseline Serum Prostate-specific Antigen Levels (ng/mL)||ng/mL|Median|19.0|19.0|Full Range|||0.01|12961.0|
4113739|NCT00946920|3938222|B2|||Median Baseline Serum Prostate-specific Antigen Levels (ng/mL)||ng/mL|Median|19.1|19.1|Full Range|||0.01|12961.0|
4113740|NCT00946920|3938223|B1|||Median Baseline Serum Prostate-specific Antigen Levels (ng/mL)||ng/mL|Median|19.0|19.0|Full Range|||0.26|8762.0|
4113741|NCT00946920|3938221|B3|||Median Baseline Serum Testosterone Levels (ng/mL)||ng/mL|Median|4.54|4.54|Full Range|||0.07|14.5|
4113742|NCT00946920|3938222|B2|||Median Baseline Serum Testosterone Levels (ng/mL)||ng/mL|Median|4.62|4.62|Full Range|||0.07|13.2|
4113743|NCT00946920|3938223|B1|||Median Baseline Serum Testosterone Levels (ng/mL)||ng/mL|Median|4.52|4.52|Full Range|||0.56|14.5|
4113744|NCT00946920|3938221|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113745|NCT00946920|3938222|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113746|NCT00946920|3938223|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113747|NCT00946920|3938221|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113748|NCT00946920|3938222|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113749|NCT00946920|3938223|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113750|NCT00946920|3938221|B3||White|Race (NIH/OMB)||Participants|Count of Participants|714|714.0||||||
4113751|NCT00946920|3938222|B2||White|Race (NIH/OMB)||Participants|Count of Participants|239|239.0||||||
4113752|NCT00946920|3938223|B1||White|Race (NIH/OMB)||Participants|Count of Participants|475|475.0||||||
4113753|NCT00946920|3938221|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4113754|NCT00946920|3938222|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4113755|NCT00946920|3938223|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4113756|NCT00946920|3938221|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4113757|NCT00946920|3938222|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4113758|NCT00946920|3938223|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113759|NCT00946920|3938221|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4113760|NCT00946920|3938222|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4113761|NCT00946920|3938223|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4113762|NCT00946920|3938221|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4113763|NCT00946920|3938222|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4113764|NCT00946920|3938223|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4113765|NCT00946920|3938221|B3||Male|Sex: Female, Male||Participants|Count of Participants|847|847.0||||||
4113766|NCT00946920|3938222|B2||Male|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
4113767|NCT00946920|3938223|B1||Male|Sex: Female, Male||Participants|Count of Participants|565|565.0||||||
4113768|NCT00946920|3938221|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4113769|NCT00946920|3938222|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4113770|NCT00946920|3938223|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4113771|NCT00946920|3938221|B3|||Age||years|Mean|71.6|71.6|Standard Deviation|8.2|8.2|||
4113772|NCT00946920|3938222|B2|||Age||years|Mean|71.1|71.1|Standard Deviation|7.9|7.9|||
4113773|NCT00946920|3938223|B1|||Age||years|Mean|71.9|71.9|Standard Deviation|8.3|8.3|||
4113774|NCT00946881|3938239|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4113775|NCT00946881|3938239|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4113776|NCT00946881|3938239|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4113777|NCT00946881|3938239|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|7.8|7.8|||
4113778|NCT00946881|3938239|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4113779|NCT00946881|3938239|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4113780|NCT00946881|3938239|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4113781|NCT00946530|3938268|B5|United States||Region of Enrollment||participants|Number|108|108.0||||||
4113782|NCT00946530|3938269|B4|United States||Region of Enrollment||participants|Number|23|23.0||||||
4113783|NCT00946530|3938270|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4113784|NCT00946530|3938271|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4113785|NCT00946530|3938272|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4113786|NCT00946530|3938268|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4113787|NCT00946530|3938269|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113788|NCT00946530|3938270|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4113789|NCT00946530|3938271|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113791|NCT00946530|3938268|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113792|NCT00946530|3938269|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113793|NCT00946530|3938270|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113794|NCT00946530|3938271|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113795|NCT00946530|3938272|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113796|NCT00946530|3938268|B5||White|Race (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
4113797|NCT00946530|3938269|B4||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4113798|NCT00946530|3938270|B3||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4113799|NCT00946530|3938271|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4113800|NCT00946530|3938272|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4113801|NCT00946530|3938268|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113802|NCT00946530|3938269|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113803|NCT00946530|3938270|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113804|NCT00946530|3938271|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113805|NCT00946530|3938272|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113806|NCT00946530|3938268|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113807|NCT00946530|3938269|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113808|NCT00946530|3938270|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113809|NCT00946530|3938271|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113810|NCT00946530|3938272|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113811|NCT00946530|3938268|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4113812|NCT00946530|3938269|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4113813|NCT00946530|3938270|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4113814|NCT00946530|3938271|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4113815|NCT00946530|3938272|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4113816|NCT00946530|3938268|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113817|NCT00946530|3938269|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113818|NCT00946530|3938270|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113819|NCT00946530|3938271|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113820|NCT00946530|3938272|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113821|NCT00946530|3938268|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113822|NCT00946530|3938269|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113823|NCT00946530|3938270|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113824|NCT00946530|3938271|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113825|NCT00946530|3938272|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113826|NCT00946530|3938268|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
4113827|NCT00946530|3938269|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4113828|NCT00946530|3938270|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4113829|NCT00946530|3938271|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4113830|NCT00946530|3938272|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4113831|NCT00946530|3938268|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4113832|NCT00946530|3938269|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113833|NCT00946530|3938270|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4113834|NCT00946530|3938271|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113835|NCT00946530|3938272|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4113836|NCT00946530|3938268|B5||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4113837|NCT00946530|3938269|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4113838|NCT00946530|3938270|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4113839|NCT00946530|3938271|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4113840|NCT00946530|3938272|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4113841|NCT00946530|3938268|B5||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4113842|NCT00946530|3938269|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4113843|NCT00946530|3938270|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4113844|NCT00946530|3938271|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4113845|NCT00946530|3938272|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4113846|NCT00946530|3938268|B5||>=65 years|Age||Participants|Count of Participants|108|108.0||||||
4113847|NCT00946530|3938269|B4||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4113848|NCT00946530|3938270|B3||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4113849|NCT00946530|3938271|B2||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4113850|NCT00946530|3938272|B1||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4113851|NCT00946530|3938268|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4113852|NCT00946530|3938269|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4113853|NCT00946530|3938270|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4113854|NCT00946530|3938271|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4113855|NCT00946530|3938272|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4113856|NCT00946530|3938268|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4113857|NCT00946530|3938269|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4113858|NCT00946530|3938270|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4113859|NCT00946530|3938271|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4113860|NCT00946530|3938272|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4113861|NCT00946478|3938289|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4113862|NCT00946478|3938290|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4113863|NCT00946478|3938291|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4113864|NCT00946478|3938289|B3|Unknown||Sex/Gender, Customized|Gender|participants|Number|11|11.0||||||
4113865|NCT00946478|3938290|B2|Unknown||Sex/Gender, Customized|Gender|participants|Number|7|7.0||||||
4113866|NCT00946478|3938291|B1|Unknown||Sex/Gender, Customized|Gender|participants|Number|4|4.0||||||
4113867|NCT00946478|3938289|B3|Female||Sex/Gender, Customized|Gender|participants|Number|14|14.0||||||
4113868|NCT00946478|3938290|B2|Female||Sex/Gender, Customized|Gender|participants|Number|7|7.0||||||
4113869|NCT00946478|3938291|B1|Female||Sex/Gender, Customized|Gender|participants|Number|7|7.0||||||
4113870|NCT00946478|3938289|B3|Male||Sex/Gender, Customized|Gender|participants|Number|15|15.0||||||
4113871|NCT00946478|3938290|B2|Male||Sex/Gender, Customized|Gender|participants|Number|6|6.0||||||
4113872|NCT00946478|3938291|B1|Male||Sex/Gender, Customized|Gender|participants|Number|9|9.0||||||
4113873|NCT00946478|3938289|B3|||Age||years|Mean|27.4|27.4|Standard Deviation|9|9.0|||
4113874|NCT00946478|3938290|B2|||Age||years|Mean|28.6|28.6|Standard Deviation|9.5|9.5|||
4113875|NCT00946478|3938291|B1|||Age||years|Mean|26.2|26.2|Standard Deviation|8.4|8.4|||
4113876|NCT00946478|3938289|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4113877|NCT00946478|3938290|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4113878|NCT00946478|3938291|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4113879|NCT00946478|3938289|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4113880|NCT00946478|3938290|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4113881|NCT00946478|3938291|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4113882|NCT00946478|3938289|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4113883|NCT00946478|3938290|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4113884|NCT00946478|3938291|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4113885|NCT00946348|3938298|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4113886|NCT00946348|3938299|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4113887|NCT00946348|3938300|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4113888|NCT00946348|3938298|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4113889|NCT00946348|3938299|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4113890|NCT00946348|3938300|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4113891|NCT00946348|3938298|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4113892|NCT00946348|3938299|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4113893|NCT00946348|3938300|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4113894|NCT00946348|3938298|B3|||Age||years|Mean|34.2|34.2|Standard Deviation|10.6|10.6|||
4113895|NCT00946348|3938299|B2|||Age||years|Mean|36.2|36.2|Standard Deviation|9.6|9.6|||
4113896|NCT00946348|3938300|B1|||Age||years|Mean|32.17|32.17|Standard Deviation|8.32|8.32|||
4113897|NCT00946348|3938298|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4113898|NCT00946348|3938299|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4113899|NCT00946348|3938300|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4113900|NCT00946348|3938298|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4113901|NCT00946348|3938299|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4113902|NCT00946348|3938300|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4113903|NCT00946348|3938298|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4113904|NCT00946348|3938299|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4113905|NCT00946348|3938300|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4113906|NCT00946322|3938307|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4113907|NCT00946322|3938307|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113908|NCT00946322|3938307|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113909|NCT00946322|3938307|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4113910|NCT00946322|3938307|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4113911|NCT00946322|3938307|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113912|NCT00946322|3938307|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113913|NCT00946322|3938307|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113914|NCT00946322|3938307|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4113915|NCT00946322|3938307|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4113916|NCT00946322|3938307|B1|||Age||years|Mean|42.22|42.22|Standard Deviation|16.14|16.14|||
4113917|NCT00946309|3938318|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
4113918|NCT00946309|3938319|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4113919|NCT00946309|3938320|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4113920|NCT00946309|3938318|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113921|NCT00946309|3938319|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113922|NCT00946309|3938320|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113923|NCT00946309|3938318|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4113924|NCT00946309|3938319|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113925|NCT00946309|3938320|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4113926|NCT00946309|3938318|B3||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4113927|NCT00946309|3938319|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4113928|NCT00946309|3938320|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4113929|NCT00946309|3938318|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4113930|NCT00946309|3938319|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4113931|NCT00946309|3938320|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4113932|NCT00946309|3938318|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4113933|NCT00946309|3938319|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113934|NCT00946309|3938320|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4113935|NCT00946309|3938318|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113936|NCT00946309|3938319|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113937|NCT00946309|3938320|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113938|NCT00946309|3938318|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113939|NCT00946309|3938319|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113940|NCT00946309|3938320|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113941|NCT00946309|3938318|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113942|NCT00946309|3938319|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113943|NCT00946309|3938320|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113944|NCT00946309|3938318|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4113945|NCT00946309|3938319|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4113946|NCT00946309|3938320|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4113947|NCT00946309|3938318|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4113948|NCT00946309|3938319|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4113949|NCT00946309|3938320|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4113950|NCT00946309|3938318|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4113951|NCT00946309|3938319|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4113952|NCT00946309|3938320|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4113953|NCT00946309|3938318|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4113954|NCT00946309|3938319|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4113955|NCT00946309|3938320|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4113956|NCT00946309|3938318|B3|||Age||years|Mean|62.7|62.7|Standard Deviation|4.8|4.8|||
4113957|NCT00946309|3938319|B2|||Age||years|Mean|62.8|62.8|Standard Deviation|4.3|4.3|||
4113958|NCT00946309|3938320|B1|||Age||years|Mean|62.6|62.6|Standard Deviation|5.4|5.4|||
4113959|NCT00946309|3938318|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4113960|NCT00946309|3938319|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4113961|NCT00946309|3938320|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4113962|NCT00946309|3938318|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4113963|NCT00946309|3938319|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4113964|NCT00946309|3938320|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4113965|NCT00946309|3938318|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4113966|NCT00946309|3938319|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4113967|NCT00946309|3938320|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4113968|NCT00946296|3938337|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4113969|NCT00946296|3938338|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4113970|NCT00946296|3938339|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4113971|NCT00946296|3938337|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4113972|NCT00946296|3938338|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4113973|NCT00946296|3938339|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4113974|NCT00946296|3938337|B3|||Age||years|Mean|40.25|40.25|Standard Deviation|11.44|11.44|||
4113975|NCT00946296|3938338|B2|||Age||years|Mean|41.07|41.07|Standard Deviation|10.62|10.62|||
4113976|NCT00946296|3938339|B1|||Age||years|Mean|39.44|39.44|Standard Deviation|12.27|12.27|||
4113977|NCT00946114|3938346|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4113978|NCT00946114|3938347|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4113979|NCT00946114|3938348|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4113980|NCT00946114|3938346|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4113981|NCT00946114|3938347|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4113982|NCT00946114|3938348|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4113983|NCT00946114|3938346|B3|>= 65 years||Age, Customized||participants|Number|2|2.0||||||
4113984|NCT00946114|3938347|B2|>= 65 years||Age, Customized||participants|Number|0|0.0||||||
4113985|NCT00946114|3938348|B1|>= 65 years||Age, Customized||participants|Number|2|2.0||||||
4113986|NCT00946114|3938346|B3|45 - 64 years||Age, Customized||participants|Number|14|14.0||||||
4113987|NCT00946114|3938347|B2|45 - 64 years||Age, Customized||participants|Number|6|6.0||||||
4113988|NCT00946114|3938348|B1|45 - 64 years||Age, Customized||participants|Number|8|8.0||||||
4113989|NCT00946114|3938346|B3|18 - 44 years||Age, Customized||participants|Number|16|16.0||||||
4113990|NCT00946114|3938347|B2|18 - 44 years||Age, Customized||participants|Number|6|6.0||||||
4113991|NCT00946114|3938348|B1|18 - 44 years||Age, Customized||participants|Number|10|10.0||||||
4113992|NCT00946101|3938355|B3|Other||Race (NIH/OMB)||participants|Number|9|9.0||||||
4113993|NCT00946101|3938356|B2|Other||Race (NIH/OMB)||participants|Number|5|5.0||||||
4113994|NCT00946101|3938357|B1|Other||Race (NIH/OMB)||participants|Number|4|4.0||||||
4113995|NCT00946101|3938355|B3|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4113996|NCT00946101|3938356|B2|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4113997|NCT00946101|3938357|B1|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4113998|NCT00946101|3938355|B3|More than one race||Race (NIH/OMB)||participants|Number|9|9.0||||||
4113999|NCT00946101|3938356|B2|More than one race||Race (NIH/OMB)||participants|Number|1|1.0||||||
4114000|NCT00946101|3938357|B1|More than one race||Race (NIH/OMB)||participants|Number|8|8.0||||||
4114001|NCT00946101|3938355|B3|White||Race (NIH/OMB)||participants|Number|241|241.0||||||
4114002|NCT00946101|3938356|B2|White||Race (NIH/OMB)||participants|Number|43|43.0||||||
4114003|NCT00946101|3938357|B1|White||Race (NIH/OMB)||participants|Number|198|198.0||||||
4114004|NCT00946101|3938355|B3|Black or African American||Race (NIH/OMB)||participants|Number|55|55.0||||||
4114005|NCT00946101|3938356|B2|Black or African American||Race (NIH/OMB)||participants|Number|12|12.0||||||
4114006|NCT00946101|3938357|B1|Black or African American||Race (NIH/OMB)||participants|Number|43|43.0||||||
4114007|NCT00946101|3938355|B3|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|2|2.0||||||
4114008|NCT00946101|3938356|B2|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4114009|NCT00946101|3938357|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|2|2.0||||||
4114010|NCT00946101|3938355|B3|Asian||Race (NIH/OMB)||participants|Number|6|6.0||||||
4114011|NCT00946101|3938356|B2|Asian||Race (NIH/OMB)||participants|Number|4|4.0||||||
4114012|NCT00946101|3938357|B1|Asian||Race (NIH/OMB)||participants|Number|2|2.0||||||
4114013|NCT00946101|3938355|B3|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|4|4.0||||||
4114014|NCT00946101|3938356|B2|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
4114015|NCT00946101|3938357|B1|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|4|4.0||||||
4114016|NCT00946101|3938355|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114017|NCT00946101|3938356|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114018|NCT00946101|3938357|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114019|NCT00946101|3938355|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|259|259.0||||||
4114020|NCT00946101|3938356|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4114021|NCT00946101|3938357|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|211|211.0||||||
4114022|NCT00946101|3938355|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4114023|NCT00946101|3938356|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4114024|NCT00946101|3938357|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4114025|NCT00946101|3938355|B3||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4114026|NCT00946101|3938356|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4114027|NCT00946101|3938357|B1||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4114028|NCT00946101|3938355|B3||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4114029|NCT00946101|3938356|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4114030|NCT00946101|3938357|B1||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4114031|NCT00946101|3938355|B3|||Age||years|Mean|9.0|9.0|Standard Deviation|4.3|4.3|||
4114032|NCT00946101|3938356|B2|||Age||years|Mean|9.2|9.2|Standard Deviation|4.3|4.3|||
4114033|NCT00946101|3938357|B1|||Age||years|Mean|8.9|8.9|Standard Deviation|4.3|4.3|||
4114034|NCT00946088|3938422|B3|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4114035|NCT00946088|3938423|B2|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4114036|NCT00946088|3938424|B1|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4114037|NCT00946088|3938422|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4114038|NCT00946088|3938423|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114039|NCT00946088|3938424|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4114040|NCT00946088|3938422|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114041|NCT00946088|3938423|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114042|NCT00946088|3938424|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114043|NCT00946088|3938422|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4114044|NCT00946088|3938423|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4114045|NCT00946088|3938424|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4114046|NCT00946088|3938422|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114047|NCT00946088|3938423|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114048|NCT00946088|3938424|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114049|NCT00946088|3938422|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114050|NCT00946088|3938423|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114051|NCT00946088|3938424|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114052|NCT00946088|3938422|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4114053|NCT00946088|3938423|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4114054|NCT00946088|3938424|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114055|NCT00946088|3938422|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114056|NCT00946088|3938423|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114057|NCT00946088|3938424|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114058|NCT00946088|3938422|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114059|NCT00946088|3938423|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114060|NCT00946088|3938424|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114061|NCT00946088|3938422|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114062|NCT00946088|3938423|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114063|NCT00946088|3938424|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114064|NCT00946088|3938422|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4114065|NCT00946088|3938423|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4114066|NCT00946088|3938424|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4114067|NCT00946088|3938422|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4114068|NCT00946088|3938423|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4114069|NCT00946088|3938424|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4114070|NCT00946088|3938422|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4114071|NCT00946088|3938423|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4114072|NCT00946088|3938424|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4114073|NCT00946088|3938422|B3|||Age||years|Mean|27.9|27.9|Full Range|||19.0|34.0|
4114074|NCT00946088|3938423|B2|||Age||years|Mean|27.0|27.0|Full Range|||19.0|34.0|
4114075|NCT00946088|3938424|B1|||Age||years|Mean|28.5|28.5|Full Range|||24.0|33.0|
4114076|NCT00946023|3938447|B1|United States||Region of Enrollment||participants|Number|83|83.0||||||
4114077|NCT00946023|3938447|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4114078|NCT00946023|3938447|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4114079|NCT00946023|3938447|B1|>= 60 years old||Age, Customized||Participants|Count of Participants|39|39.0||||||
4114080|NCT00946023|3938447|B1|||Age||years|Median|59|59.0|Full Range|||34.0|75.0|
4114081|NCT00945958|3938462|B1||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4114082|NCT00945958|3938462|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4114083|NCT00945958|3938462|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|9.4|9.4|||
4114084|NCT00945945|3938467|B3|Sweden||Region of Enrollment||participants|Number|35|35.0||||||
4114085|NCT00945945|3938468|B2|Sweden||Region of Enrollment||participants|Number|17|17.0||||||
4114086|NCT00945945|3938469|B1|Sweden||Region of Enrollment||participants|Number|18|18.0||||||
4114087|NCT00945945|3938467|B3|Germany||Region of Enrollment||participants|Number|37|37.0||||||
4114088|NCT00945945|3938468|B2|Germany||Region of Enrollment||participants|Number|19|19.0||||||
4114089|NCT00945945|3938469|B1|Germany||Region of Enrollment||participants|Number|18|18.0||||||
4114090|NCT00945945|3938467|B3|Russian Federation||Region of Enrollment||participants|Number|65|65.0||||||
4114091|NCT00945945|3938468|B2|Russian Federation||Region of Enrollment||participants|Number|32|32.0||||||
4114092|NCT00945945|3938469|B1|Russian Federation||Region of Enrollment||participants|Number|33|33.0||||||
4114093|NCT00945945|3938467|B3|Romania||Region of Enrollment||participants|Number|35|35.0||||||
4114094|NCT00945945|3938468|B2|Romania||Region of Enrollment||participants|Number|19|19.0||||||
4114095|NCT00945945|3938469|B1|Romania||Region of Enrollment||participants|Number|16|16.0||||||
4114096|NCT00945945|3938467|B3|Spain||Region of Enrollment||participants|Number|48|48.0||||||
4114097|NCT00945945|3938468|B2|Spain||Region of Enrollment||participants|Number|23|23.0||||||
4114098|NCT00945945|3938469|B1|Spain||Region of Enrollment||participants|Number|25|25.0||||||
4114099|NCT00945945|3938467|B3|Greece||Region of Enrollment||participants|Number|24|24.0||||||
4114100|NCT00945945|3938468|B2|Greece||Region of Enrollment||participants|Number|11|11.0||||||
4114101|NCT00945945|3938469|B1|Greece||Region of Enrollment||participants|Number|13|13.0||||||
4114102|NCT00945945|3938467|B3|Puerto Rico||Region of Enrollment||participants|Number|7|7.0||||||
4114103|NCT00945945|3938468|B2|Puerto Rico||Region of Enrollment||participants|Number|4|4.0||||||
4114104|NCT00945945|3938469|B1|Puerto Rico||Region of Enrollment||participants|Number|3|3.0||||||
4114105|NCT00945945|3938467|B3|United States||Region of Enrollment||participants|Number|173|173.0||||||
4114106|NCT00945945|3938468|B2|United States||Region of Enrollment||participants|Number|92|92.0||||||
4114107|NCT00945945|3938469|B1|United States||Region of Enrollment||participants|Number|81|81.0||||||
4114108|NCT00945945|3938467|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114109|NCT00945945|3938468|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114110|NCT00945945|3938469|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114111|NCT00945945|3938467|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4114112|NCT00945945|3938468|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4114113|NCT00945945|3938469|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114114|NCT00945945|3938467|B3||White|Race (NIH/OMB)||Participants|Count of Participants|399|399.0||||||
4114115|NCT00945945|3938468|B2||White|Race (NIH/OMB)||Participants|Count of Participants|203|203.0||||||
4114116|NCT00945945|3938469|B1||White|Race (NIH/OMB)||Participants|Count of Participants|196|196.0||||||
4114117|NCT00945945|3938467|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4114118|NCT00945945|3938468|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4114119|NCT00945945|3938469|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4114120|NCT00945945|3938467|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114121|NCT00945945|3938468|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114122|NCT00945945|3938469|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114123|NCT00945945|3938467|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4114124|NCT00945945|3938468|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114125|NCT00945945|3938469|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4114126|NCT00945945|3938467|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4114127|NCT00945945|3938468|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114128|NCT00945945|3938469|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4114129|NCT00945945|3938467|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114130|NCT00945945|3938468|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114131|NCT00945945|3938469|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114132|NCT00945945|3938467|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|371|371.0||||||
4114133|NCT00945945|3938468|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|190|190.0||||||
4114134|NCT00945945|3938469|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|181|181.0||||||
4114135|NCT00945945|3938467|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4114136|NCT00945945|3938468|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4114137|NCT00945945|3938469|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4114138|NCT00945945|3938467|B3||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4114139|NCT00945945|3938468|B2||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4114140|NCT00945945|3938469|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4114141|NCT00945945|3938467|B3||Female|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
4114142|NCT00945945|3938468|B2||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4114143|NCT00945945|3938469|B1||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4114144|NCT00945945|3938467|B3|||Age||years|Mean|63.80|63.8|Standard Deviation|9.97|9.97|||
4114145|NCT00945945|3938468|B2|||Age||years|Mean|64.18|64.18|Standard Deviation|10.06|10.06|||
4114146|NCT00945945|3938469|B1|||Age||years|Mean|63.40|63.4|Standard Deviation|9.90|9.9|||
4114147|NCT00945906|3938496|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4114148|NCT00945906|3938496|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4114149|NCT00945906|3938496|B1|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4114150|NCT00945906|3938496|B1|16 to < 65 years||Age, Customized||participants|Number|32|32.0||||||
4114151|NCT00945906|3938496|B1|< 16 years||Age, Customized||participants|Number|29|29.0||||||
4114152|NCT00945906|3938496|B1|||Age||years|Mean|18.5|18.5|Standard Deviation|12.48|12.48|||
4114153|NCT00945893|3938505|B3|Other||Race (NIH/OMB)||participants|Number|1|1.0||||||
4114154|NCT00945893|3938506|B2|Other||Race (NIH/OMB)||participants|Number|1|1.0||||||
4114155|NCT00945893|3938507|B1|Other||Race (NIH/OMB)||participants|Number|0|0.0||||||
4114156|NCT00945893|3938505|B3|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4114157|NCT00945893|3938506|B2|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4114158|NCT00945893|3938507|B1|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4114159|NCT00945893|3938505|B3|More than one race||Race (NIH/OMB)||participants|Number|1|1.0||||||
4114160|NCT00945893|3938506|B2|More than one race||Race (NIH/OMB)||participants|Number|1|1.0||||||
4114161|NCT00945893|3938507|B1|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4114162|NCT00945893|3938505|B3|White||Race (NIH/OMB)||participants|Number|246|246.0||||||
4114163|NCT00945893|3938506|B2|White||Race (NIH/OMB)||participants|Number|199|199.0||||||
4114164|NCT00945893|3938507|B1|White||Race (NIH/OMB)||participants|Number|47|47.0||||||
4114165|NCT00945893|3938505|B3|Black or African American||Race (NIH/OMB)||participants|Number|50|50.0||||||
4114166|NCT00945893|3938506|B2|Black or African American||Race (NIH/OMB)||participants|Number|37|37.0||||||
4114167|NCT00945893|3938507|B1|Black or African American||Race (NIH/OMB)||participants|Number|13|13.0||||||
4114168|NCT00945893|3938505|B3|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|1|1.0||||||
4114169|NCT00945893|3938506|B2|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|1|1.0||||||
4114170|NCT00945893|3938507|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4114171|NCT00945893|3938505|B3|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
4114172|NCT00945893|3938506|B2|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
4114173|NCT00945893|3938507|B1|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
4114174|NCT00945893|3938505|B3|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|1|1.0||||||
4114175|NCT00945893|3938506|B2|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|1|1.0||||||
4114176|NCT00945893|3938507|B1|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
4114177|NCT00945893|3938505|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114178|NCT00945893|3938506|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114179|NCT00945893|3938507|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114180|NCT00945893|3938505|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|187|187.0||||||
4114181|NCT00945893|3938506|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|145|145.0||||||
4114182|NCT00945893|3938507|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4114183|NCT00945893|3938505|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
4114184|NCT00945893|3938506|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
4114185|NCT00945893|3938507|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4114186|NCT00945893|3938505|B3||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4114187|NCT00945893|3938506|B2||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4114188|NCT00945893|3938507|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4114189|NCT00945893|3938505|B3||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4114190|NCT00945893|3938506|B2||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4114191|NCT00945893|3938507|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4114192|NCT00945893|3938505|B3|||Age||years|Mean|33.5|33.5|Standard Deviation|9.2|9.2|||
4114193|NCT00945893|3938506|B2|||Age||years|Mean|33.3|33.3|Standard Deviation|9.2|9.2|||
4114194|NCT00945893|3938507|B1|||Age||years|Mean|34.1|34.1|Standard Deviation|8.9|8.9|||
4114195|NCT00945854|3938572|B3|Italy||Region of Enrollment||participants|Number|60|60.0||||||
4114196|NCT00945854|3938573|B2|Italy||Region of Enrollment||participants|Number|30|30.0||||||
4114197|NCT00945854|3938574|B1|Italy||Region of Enrollment||participants|Number|30|30.0||||||
4114198|NCT00945854|3938572|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4114199|NCT00945854|3938573|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4114200|NCT00945854|3938574|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4114201|NCT00945854|3938572|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4114202|NCT00945854|3938573|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4114203|NCT00945854|3938574|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4114204|NCT00945854|3938572|B3|||Age||years|Mean|57.2|57.2|Standard Deviation|7.9|7.9|||
4114205|NCT00945854|3938573|B2|||Age||years|Mean|57.4|57.4|Standard Deviation|7.3|7.3|||
4114206|NCT00945854|3938574|B1|||Age||years|Mean|57.2|57.2|Standard Deviation|8.5|8.5|||
4114207|NCT00945815|3938585|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4114208|NCT00945815|3938585|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114209|NCT00945815|3938585|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4114210|NCT00945815|3938585|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4114211|NCT00945815|3938585|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114212|NCT00945815|3938585|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4114213|NCT00945815|3938585|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114214|NCT00945815|3938585|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4114215|NCT00945815|3938585|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4114216|NCT00945815|3938585|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4114217|NCT00945815|3938585|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4114218|NCT00945815|3938585|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4114219|NCT00945815|3938585|B1|||Age||years|Median|41|41.0|Full Range|||21.0|69.0|
4114220|NCT00945750|3938590|B7|||Weight||Pounds|Mean|157.4|157.4|Full Range|||106.9|205.9|
4114221|NCT00945750|3938591|B6|||Weight||Pounds|Mean|180.4|180.4|Full Range|||140.6|205.9|
4114222|NCT00945750|3938592|B5|||Weight||Pounds|Mean|142.6|142.6|Full Range|||113.9|185.1|
4114223|NCT00945750|3938593|B4|||Weight||Pounds|Mean|147.9|147.9|Full Range|||110.9|182.2|
4114224|NCT00945750|3938594|B3|||Weight||Pounds|Mean|175.4|175.4|Full Range|||139.6|195.0|
4114225|NCT00945750|3938595|B2|||Weight||Pounds|Mean|163.0|163.0|Full Range|||140.6|187.1|
4114226|NCT00945750|3938596|B1|||Weight||Pounds|Mean|137.6|137.6|Full Range|||106.9|158.4|
4114227|NCT00945750|3938590|B7||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4114228|NCT00945750|3938591|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4114229|NCT00945750|3938592|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4114230|NCT00945750|3938593|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4114231|NCT00945750|3938594|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4114232|NCT00945750|3938595|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4114233|NCT00945750|3938596|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4114234|NCT00945750|3938590|B7||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4114235|NCT00945750|3938591|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4114236|NCT00945750|3938592|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4114237|NCT00945750|3938593|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4114238|NCT00945750|3938594|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4114239|NCT00945750|3938595|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4114240|NCT00945750|3938596|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4114241|NCT00945750|3938590|B7|||Age||years|Mean|25.9|25.9|Standard Deviation|6.09|6.09|18.0|39.0|
4114242|NCT00945750|3938591|B6|||Age||years|Mean|25.6|25.6|Standard Deviation|6.50|6.5|22.0|37.0|
4114243|NCT00945750|3938592|B5|||Age||years|Mean|26.4|26.4|Standard Deviation|6.11|6.11|19.0|36.0|
4114244|NCT00945750|3938593|B4|||Age||years|Mean|22.6|22.6|Standard Deviation|3.51|3.51|19.0|28.0|
4114245|NCT00945750|3938594|B3|||Age||years|Mean|24.2|24.2|Standard Deviation|4.38|4.38|19.0|31.0|
4114246|NCT00945750|3938595|B2|||Age||years|Mean|24.0|24.0|Standard Deviation|7.38|7.38|18.0|36.0|
4114247|NCT00945750|3938596|B1|||Age||years|Mean|32.4|32.4|Standard Deviation|5.32|5.32|26.0|39.0|
4114248|NCT00945659|3938614|B4|||Glycated Hemoglobin Level (%)|Glycated hemoglobin level expressed as percentage of hemoglobin molecules bound to glucose molecules.|Percentage of hemoglobin|Mean|9.03|9.03|Standard Deviation|0.96|0.96|||
4114249|NCT00945659|3938615|B3|||Glycated Hemoglobin Level (%)|Glycated hemoglobin level expressed as percentage of hemoglobin molecules bound to glucose molecules.|Percentage of hemoglobin|Mean|9.24|9.24|Standard Deviation|0.83|0.83|||
4114250|NCT00945659|3938616|B2|||Glycated Hemoglobin Level (%)|Glycated hemoglobin level expressed as percentage of hemoglobin molecules bound to glucose molecules.|Percentage of hemoglobin|Mean|9.03|9.03|Standard Deviation|1.07|1.07|||
4114251|NCT00945659|3938617|B1|||Glycated Hemoglobin Level (%)|Glycated hemoglobin level expressed as percentage of hemoglobin molecules bound to glucose molecules.|Percentage of hemoglobin|Mean|8.84|8.84|Standard Deviation|0.95|0.95|||
4114252|NCT00945659|3938614|B4|United States||Region of Enrollment||Participants|Count of Participants|112|112.0||||||
4114253|NCT00945659|3938615|B3|United States||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
4114254|NCT00945659|3938616|B2|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
4114255|NCT00945659|3938617|B1|United States||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
4114256|NCT00945659|3938614|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4114257|NCT00945659|3938615|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4114258|NCT00945659|3938616|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4114259|NCT00945659|3938617|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4114260|NCT00945659|3938614|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114261|NCT00945659|3938615|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114262|NCT00945659|3938616|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114263|NCT00945659|3938617|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114264|NCT00945659|3938614|B4||White|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
4114265|NCT00945659|3938615|B3||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4114266|NCT00945659|3938616|B2||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4114267|NCT00945659|3938617|B1||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4114268|NCT00945659|3938614|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4114269|NCT00945659|3938615|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4114270|NCT00945659|3938616|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4114271|NCT00945659|3938617|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4114272|NCT00945659|3938614|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114273|NCT00945659|3938615|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114274|NCT00945659|3938616|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114275|NCT00945659|3938617|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114276|NCT00945659|3938614|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4114277|NCT00945659|3938615|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114278|NCT00945659|3938616|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114279|NCT00945659|3938617|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4114280|NCT00945659|3938614|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4114281|NCT00945659|3938615|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114282|NCT00945659|3938616|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4114283|NCT00945659|3938617|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114284|NCT00945659|3938614|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4114285|NCT00945659|3938615|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114286|NCT00945659|3938616|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4114287|NCT00945659|3938617|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4114288|NCT00945659|3938614|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
4114289|NCT00945659|3938615|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4114290|NCT00945659|3938616|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4114291|NCT00945659|3938617|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4114292|NCT00945659|3938614|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4114293|NCT00945659|3938615|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4114294|NCT00945659|3938616|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4114295|NCT00945659|3938617|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4114296|NCT00945659|3938614|B4||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4114297|NCT00945659|3938615|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4114298|NCT00945659|3938616|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4114299|NCT00945659|3938617|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4114300|NCT00945659|3938614|B4||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4114301|NCT00945659|3938615|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4114302|NCT00945659|3938616|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4114303|NCT00945659|3938617|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4114304|NCT00945659|3938614|B4|||Age|Adolescent Age in Years|years|Mean|13.56|13.56|Standard Deviation|1.83|1.83|||
4114305|NCT00945659|3938615|B3|||Age|Adolescent Age in Years|years|Mean|13.46|13.46|Standard Deviation|1.98|1.98|||
4114306|NCT00945659|3938616|B2|||Age|Adolescent Age in Years|years|Mean|13.62|13.62|Standard Deviation|1.82|1.82|||
4114307|NCT00945659|3938617|B1|||Age|Adolescent Age in Years|years|Mean|13.61|13.61|Standard Deviation|1.76|1.76|||
4114308|NCT00945555|3938663|B1||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4114309|NCT00945555|3938663|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4114310|NCT00945555|3938663|B1|||Age||years|Mean|42.41|42.41|Standard Deviation|16.46|16.46|||
4114311|NCT00945477|3938674|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4114312|NCT00945477|3938674|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4114313|NCT00945477|3938674|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4114314|NCT00945477|3938674|B1|||Age||years|Mean|68.5|68.5|Standard Deviation|14.5|14.5|||
4114315|NCT00945477|3938674|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4114316|NCT00945477|3938674|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4114317|NCT00945477|3938674|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4114318|NCT00945334|3938679|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4114319|NCT00945334|3938680|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4114320|NCT00945334|3938681|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4114321|NCT00945334|3938679|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4114322|NCT00945334|3938680|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4114323|NCT00945334|3938681|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4114324|NCT00945334|3938679|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4114325|NCT00945334|3938680|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4114326|NCT00945334|3938681|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4114327|NCT00945334|3938679|B3|||Age||years|Mean|42.8|42.8|Standard Deviation|15.6|15.6|||
4114328|NCT00945334|3938680|B2|||Age||years|Mean|45.5|45.5|Standard Deviation|16.9|16.9|||
4114329|NCT00945334|3938681|B1|||Age||years|Mean|40.4|40.4|Standard Deviation|14.3|14.3|||
4114330|NCT00945334|3938679|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4114331|NCT00945334|3938680|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4114332|NCT00945334|3938681|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4114333|NCT00945334|3938679|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4114334|NCT00945334|3938680|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4114335|NCT00945334|3938681|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4114336|NCT00945334|3938679|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4114337|NCT00945334|3938680|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4114338|NCT00945334|3938681|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4114339|NCT00945321|3938690|B1|||Weight||Kilograms|Mean|74.2|74.2|Full Range|||44.9|91.2|
4114340|NCT00945321|3938690|B1|||Height||Centimeters|Mean|172.9|172.9|Full Range|||151.1|190.5|
4114341|NCT00945321|3938690|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4114342|NCT00945321|3938690|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4114343|NCT00945321|3938690|B1|||Age||years|Mean|27.8|27.8|Full Range|||18.0|43.0|
4114344|NCT00945295|3938715|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4114345|NCT00945295|3938716|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4114346|NCT00945295|3938717|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4114347|NCT00945295|3938715|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4114348|NCT00945295|3938716|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4114349|NCT00945295|3938717|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4114350|NCT00945295|3938715|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4114351|NCT00945295|3938716|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4114352|NCT00945295|3938717|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4114353|NCT00945295|3938715|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|9.1|9.1|||
4114354|NCT00945295|3938716|B2|||Age||years|Mean|60.9|60.9|Standard Deviation|11.0|11.0|||
4114355|NCT00945295|3938717|B1|||Age||years|Mean|58.0|58.0|Standard Deviation|6.6|6.6|||
4114356|NCT00945295|3938715|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4114357|NCT00945295|3938716|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4114358|NCT00945295|3938717|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4114359|NCT00945295|3938715|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4114360|NCT00945295|3938716|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4114361|NCT00945295|3938717|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4114362|NCT00945295|3938715|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4114363|NCT00945295|3938716|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4114364|NCT00945295|3938717|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4114365|NCT00945282|3938726|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114366|NCT00945282|3938727|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114367|NCT00945282|3938728|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114368|NCT00945282|3938726|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114369|NCT00945282|3938727|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114370|NCT00945282|3938728|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114371|NCT00945282|3938726|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4114372|NCT00945282|3938727|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4114373|NCT00945282|3938728|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4114374|NCT00945282|3938726|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4114375|NCT00945282|3938727|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114376|NCT00945282|3938728|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4114377|NCT00945282|3938726|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114378|NCT00945282|3938727|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114379|NCT00945282|3938728|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114380|NCT00945282|3938726|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114381|NCT00945282|3938727|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114382|NCT00945282|3938728|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114383|NCT00945282|3938726|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114384|NCT00945282|3938727|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114385|NCT00945282|3938728|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114386|NCT00945282|3938726|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4114387|NCT00945282|3938727|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4114388|NCT00945282|3938728|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4114389|NCT00945282|3938726|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4114390|NCT00945282|3938727|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4114391|NCT00945282|3938728|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4114392|NCT00945282|3938726|B3|||Age||years|Mean|33.3|33.3|Standard Deviation|7.15|7.15|||
4114393|NCT00945282|3938727|B2|||Age||years|Mean|28.0|28.0|Standard Deviation|5.66|5.66|||
4114394|NCT00945282|3938728|B1|||Age||years|Mean|35.0|35.0|Standard Deviation|7.10|7.1|||
4114395|NCT00945256|3938807|B6|United States||Region of Enrollment||participants|Number|62|62.0||||||
4114396|NCT00945256|3938808|B5|United States||Region of Enrollment||participants|Number|8|8.0||||||
4114397|NCT00945256|3938809|B4|United States||Region of Enrollment||participants|Number|16|16.0||||||
4114398|NCT00945256|3938810|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4114399|NCT00945256|3938811|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4114400|NCT00945256|3938812|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4114401|NCT00945256|3938807|B6||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4114402|NCT00945256|3938808|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4114403|NCT00945256|3938809|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4114404|NCT00945256|3938810|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4114405|NCT00945256|3938811|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4114406|NCT00945256|3938812|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4114407|NCT00945256|3938807|B6||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4114408|NCT00945256|3938808|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4114409|NCT00945256|3938809|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4114410|NCT00945256|3938810|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4114411|NCT00945256|3938811|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4114412|NCT00945256|3938812|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4114413|NCT00945256|3938807|B6|||Age||years|Mean|49.2|49.2|Standard Deviation|21.2|21.2|||
4114414|NCT00945256|3938808|B5|||Age||years|Mean|67.1|67.1|Standard Deviation|4.4|4.4|||
4114415|NCT00945256|3938809|B4|||Age||years|Mean|68.1|68.1|Standard Deviation|5.9|5.9|||
4114416|NCT00945256|3938810|B3|||Age||years|Mean|26.4|26.4|Standard Deviation|5.0|5.0|||
4114417|NCT00945256|3938811|B2|||Age||years|Mean|67.4|67.4|Standard Deviation|5.1|5.1|||
4114418|NCT00945256|3938812|B1|||Age||years|Mean|27.2|27.2|Standard Deviation|5.9|5.9|||
4114419|NCT00945256|3938807|B6||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4114420|NCT00945256|3938808|B5||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4114421|NCT00945256|3938809|B4||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4114422|NCT00945256|3938810|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4114423|NCT00945256|3938811|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4114424|NCT00945256|3938812|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4114425|NCT00945256|3938807|B6||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4114426|NCT00945256|3938808|B5||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4114427|NCT00945256|3938809|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4114428|NCT00945256|3938810|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4114429|NCT00945256|3938811|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4114430|NCT00945256|3938812|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4114431|NCT00945256|3938807|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4114432|NCT00945256|3938808|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4114433|NCT00945256|3938809|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4114434|NCT00945256|3938810|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4114435|NCT00945256|3938811|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4114436|NCT00945256|3938812|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4114437|NCT00945243|3938828|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4114438|NCT00945243|3938828|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4114439|NCT00945243|3938828|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4114440|NCT00945243|3938828|B1|||Age||years|Mean|47.8|47.8|Standard Deviation|11.6|11.6|||
4114441|NCT00945139|3938834|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4114442|NCT00945139|3938834|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4114443|NCT00945139|3938834|B1||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4114444|NCT00945139|3938834|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4114445|NCT00945139|3938834|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4114446|NCT00945100|3938843|B3|||Refractive error in fellow eye at enrollment||Diopters|Mean|2.50|2.5|Standard Deviation|2.00|2.0|||
4114447|NCT00945100|3938844|B2|||Refractive error in fellow eye at enrollment||Diopters|Mean|2.89|2.89|Standard Deviation|2.06|2.06|||
4114448|NCT00945100|3938845|B1|||Refractive error in fellow eye at enrollment||Diopters|Mean|2.10|2.1|Standard Deviation|1.86|1.86|||
4114449|NCT00945100|3938843|B3|+4.00 D or more||Refractive error in fellow eye at enrollment||participants|Number|42|42.0||||||
4114450|NCT00945100|3938844|B2|+4.00 D or more||Refractive error in fellow eye at enrollment||participants|Number|26|26.0||||||
4114451|NCT00945100|3938845|B1|+4.00 D or more||Refractive error in fellow eye at enrollment||participants|Number|16|16.0||||||
4114452|NCT00945100|3938843|B3|+3.00 D to <+4.00 D||Refractive error in fellow eye at enrollment||participants|Number|16|16.0||||||
4114453|NCT00945100|3938844|B2|+3.00 D to <+4.00 D||Refractive error in fellow eye at enrollment||participants|Number|12|12.0||||||
4114454|NCT00945100|3938845|B1|+3.00 D to <+4.00 D||Refractive error in fellow eye at enrollment||participants|Number|4|4.0||||||
4114455|NCT00945100|3938843|B3|+2.00 D to <+3.00 D||Refractive error in fellow eye at enrollment||participants|Number|24|24.0||||||
4114456|NCT00945100|3938844|B2|+2.00 D to <+3.00 D||Refractive error in fellow eye at enrollment||participants|Number|14|14.0||||||
4114457|NCT00945100|3938845|B1|+2.00 D to <+3.00 D||Refractive error in fellow eye at enrollment||participants|Number|10|10.0||||||
4114458|NCT00945100|3938843|B3|+1.00 D to <+2.00 D||Refractive error in fellow eye at enrollment||participants|Number|49|49.0||||||
4114459|NCT00945100|3938844|B2|+1.00 D to <+2.00 D||Refractive error in fellow eye at enrollment||participants|Number|19|19.0||||||
4114460|NCT00945100|3938845|B1|+1.00 D to <+2.00 D||Refractive error in fellow eye at enrollment||participants|Number|30|30.0||||||
4114461|NCT00945100|3938843|B3|0 to <+1.00D||Refractive error in fellow eye at enrollment||participants|Number|36|36.0||||||
4114462|NCT00945100|3938844|B2|0 to <+1.00D||Refractive error in fellow eye at enrollment||participants|Number|14|14.0||||||
4114463|NCT00945100|3938845|B1|0 to <+1.00D||Refractive error in fellow eye at enrollment||participants|Number|22|22.0||||||
4114464|NCT00945100|3938843|B3|<0 D||Refractive error in fellow eye at enrollment||participants|Number|2|2.0||||||
4114465|NCT00945100|3938844|B2|<0 D||Refractive error in fellow eye at enrollment||participants|Number|1|1.0||||||
4114466|NCT00945100|3938845|B1|<0 D||Refractive error in fellow eye at enrollment||participants|Number|1|1.0||||||
4114467|NCT00945100|3938843|B3|||Refractive error in amblyopic eye at enrollment||Diopters|Mean|4.93|4.93|Standard Deviation|2.12|2.12|||
4114468|NCT00945100|3938844|B2|||Refractive error in amblyopic eye at enrollment||Diopters|Mean|5.27|5.27|Standard Deviation|1.94|1.94|||
4114469|NCT00945100|3938845|B1|||Refractive error in amblyopic eye at enrollment||Diopters|Mean|4.58|4.58|Standard Deviation|2.26|2.26|||
4114470|NCT00945100|3938843|B3|+4.00 D or more||Refractive error in amblyopic eye at enrollment||participants|Number|124|124.0||||||
4114471|NCT00945100|3938844|B2|+4.00 D or more||Refractive error in amblyopic eye at enrollment||participants|Number|70|70.0||||||
4114472|NCT00945100|3938845|B1|+4.00 D or more||Refractive error in amblyopic eye at enrollment||participants|Number|54|54.0||||||
4114473|NCT00945100|3938843|B3|+3.00 D to <+4.00 D||Refractive error in amblyopic eye at enrollment||participants|Number|19|19.0||||||
4114474|NCT00945100|3938844|B2|+3.00 D to <+4.00 D||Refractive error in amblyopic eye at enrollment||participants|Number|6|6.0||||||
4114475|NCT00945100|3938845|B1|+3.00 D to <+4.00 D||Refractive error in amblyopic eye at enrollment||participants|Number|13|13.0||||||
4114476|NCT00945100|3938843|B3|+2.00 D to <+3.00 D||Refractive error in amblyopic eye at enrollment||participants|Number|6|6.0||||||
4114477|NCT00945100|3938844|B2|+2.00 D to <+3.00 D||Refractive error in amblyopic eye at enrollment||participants|Number|4|4.0||||||
4114478|NCT00945100|3938845|B1|+2.00 D to <+3.00 D||Refractive error in amblyopic eye at enrollment||participants|Number|2|2.0||||||
4114479|NCT00945100|3938843|B3|+1.00 D to <+2.00 D||Refractive error in amblyopic eye at enrollment||participants|Number|8|8.0||||||
4114480|NCT00945100|3938844|B2|+1.00 D to <+2.00 D||Refractive error in amblyopic eye at enrollment||participants|Number|3|3.0||||||
4114481|NCT00945100|3938845|B1|+1.00 D to <+2.00 D||Refractive error in amblyopic eye at enrollment||participants|Number|5|5.0||||||
4114482|NCT00945100|3938843|B3|0 to <+1.00D||Refractive error in amblyopic eye at enrollment||participants|Number|12|12.0||||||
4114483|NCT00945100|3938844|B2|0 to <+1.00D||Refractive error in amblyopic eye at enrollment||participants|Number|3|3.0||||||
4114484|NCT00945100|3938845|B1|0 to <+1.00D||Refractive error in amblyopic eye at enrollment||participants|Number|9|9.0||||||
4114485|NCT00945100|3938843|B3|||Best interocular eye visual acuity difference at randomization|Best interocular eye visual acuity difference was computed as difference between the best amblyopic eye visual acuity and the best fellow eye visual acuity at randomization.|logMAR lines|Mean|4.5|4.5|Standard Deviation|1.7|1.7|||
4114486|NCT00945100|3938844|B2|||Best interocular eye visual acuity difference at randomization|Best interocular eye visual acuity difference was computed as difference between the best amblyopic eye visual acuity and the best fellow eye visual acuity at randomization.|logMAR lines|Mean|4.5|4.5|Standard Deviation|1.7|1.7|||
4114487|NCT00945100|3938845|B1|||Best interocular eye visual acuity difference at randomization|Best interocular eye visual acuity difference was computed as difference between the best amblyopic eye visual acuity and the best fellow eye visual acuity at randomization.|logMAR lines|Mean|4.4|4.4|Standard Deviation|1.6|1.6|||
4114488|NCT00945100|3938843|B3|||Best distance visual acuity in the fellow eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best fellow eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|logMAR|Mean|-0.01|-0.01|Standard Deviation|0.09|0.09|||
4114565|NCT00945100|3938845|B1|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4114566|NCT00945100|3938843|B3|United States||Region of Enrollment||participants|Number|162|162.0||||||
4114489|NCT00945100|3938844|B2|||Best distance visual acuity in the fellow eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best fellow eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|logMAR|Mean|0.00|0.0|Standard Deviation|0.09|0.09|||
4114490|NCT00945100|3938845|B1|||Best distance visual acuity in the fellow eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best fellow eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|logMAR|Mean|-0.01|-0.01|Standard Deviation|0.09|0.09|||
4114491|NCT00945100|3938843|B3|20/16||Best distance visual acuity in the fellow eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best fellow eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|participants|Number|68|68.0||||||
4114492|NCT00945100|3938844|B2|20/16||Best distance visual acuity in the fellow eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best fellow eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|participants|Number|34|34.0||||||
4114493|NCT00945100|3938845|B1|20/16||Best distance visual acuity in the fellow eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best fellow eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|participants|Number|34|34.0||||||
4114494|NCT00945100|3938843|B3|20/20||Best distance visual acuity in the fellow eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best fellow eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|participants|Number|53|53.0||||||
4114495|NCT00945100|3938844|B2|20/20||Best distance visual acuity in the fellow eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best fellow eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|participants|Number|26|26.0||||||
4114496|NCT00945100|3938845|B1|20/20||Best distance visual acuity in the fellow eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best fellow eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|participants|Number|27|27.0||||||
4114497|NCT00945100|3938843|B3|20/25||Best distance visual acuity in the fellow eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best fellow eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|participants|Number|38|38.0||||||
4114498|NCT00945100|3938844|B2|20/25||Best distance visual acuity in the fellow eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best fellow eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|participants|Number|21|21.0||||||
4114499|NCT00945100|3938845|B1|20/25||Best distance visual acuity in the fellow eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best fellow eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|participants|Number|17|17.0||||||
4114500|NCT00945100|3938843|B3|20/32||Best distance visual acuity in the fellow eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best fellow eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|participants|Number|10|10.0||||||
4114501|NCT00945100|3938844|B2|20/32||Best distance visual acuity in the fellow eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best fellow eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|participants|Number|5|5.0||||||
4114502|NCT00945100|3938845|B1|20/32||Best distance visual acuity in the fellow eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best fellow eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|participants|Number|5|5.0||||||
4114503|NCT00945100|3938843|B3|||Best distance visual acuity in the amblyopic eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best amblyopic eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|logMAR|Mean|0.44|0.44|Standard Deviation|0.16|0.16|||
4114504|NCT00945100|3938844|B2|||Best distance visual acuity in the amblyopic eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best amblyopic eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|logMAR|Mean|0.45|0.45|Standard Deviation|0.16|0.16|||
4114505|NCT00945100|3938845|B1|||Best distance visual acuity in the amblyopic eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best amblyopic eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|logMAR|Mean|0.43|0.43|Standard Deviation|0.15|0.15|||
4114506|NCT00945100|3938843|B3|20/32||Best distance visual acuity in the amblyopic eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best amblyopic eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|participants|Number|12|12.0||||||
4114507|NCT00945100|3938844|B2|20/32||Best distance visual acuity in the amblyopic eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best amblyopic eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|participants|Number|6|6.0||||||
4114508|NCT00945100|3938845|B1|20/32||Best distance visual acuity in the amblyopic eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best amblyopic eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|participants|Number|6|6.0||||||
4114509|NCT00945100|3938843|B3|20/40||Best distance visual acuity in the amblyopic eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best amblyopic eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|participants|Number|39|39.0||||||
4114510|NCT00945100|3938844|B2|20/40||Best distance visual acuity in the amblyopic eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best amblyopic eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|participants|Number|18|18.0||||||
4114511|NCT00945100|3938845|B1|20/40||Best distance visual acuity in the amblyopic eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best amblyopic eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|participants|Number|21|21.0||||||
4114512|NCT00945100|3938843|B3|20/50||Best distance visual acuity in the amblyopic eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best amblyopic eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|participants|Number|50|50.0||||||
4114513|NCT00945100|3938844|B2|20/50||Best distance visual acuity in the amblyopic eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best amblyopic eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|participants|Number|24|24.0||||||
4114514|NCT00945100|3938845|B1|20/50||Best distance visual acuity in the amblyopic eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best amblyopic eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|participants|Number|26|26.0||||||
4114515|NCT00945100|3938843|B3|20/63||Best distance visual acuity in the amblyopic eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best amblyopic eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|participants|Number|38|38.0||||||
4114516|NCT00945100|3938844|B2|20/63||Best distance visual acuity in the amblyopic eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best amblyopic eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|participants|Number|21|21.0||||||
4114517|NCT00945100|3938845|B1|20/63||Best distance visual acuity in the amblyopic eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best amblyopic eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|participants|Number|17|17.0||||||
4114518|NCT00945100|3938843|B3|20/80||Best distance visual acuity in the amblyopic eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best amblyopic eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|participants|Number|12|12.0||||||
4114519|NCT00945100|3938844|B2|20/80||Best distance visual acuity in the amblyopic eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best amblyopic eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|participants|Number|6|6.0||||||
4114520|NCT00945100|3938845|B1|20/80||Best distance visual acuity in the amblyopic eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best amblyopic eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|participants|Number|6|6.0||||||
4114521|NCT00945100|3938843|B3|20/100||Best distance visual acuity in the amblyopic eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best amblyopic eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|participants|Number|9|9.0||||||
4114522|NCT00945100|3938844|B2|20/100||Best distance visual acuity in the amblyopic eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best amblyopic eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|participants|Number|7|7.0||||||
4114523|NCT00945100|3938845|B1|20/100||Best distance visual acuity in the amblyopic eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best amblyopic eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|participants|Number|2|2.0||||||
4114524|NCT00945100|3938843|B3|20/125||Best distance visual acuity in the amblyopic eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best amblyopic eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|participants|Number|4|4.0||||||
4114525|NCT00945100|3938844|B2|20/125||Best distance visual acuity in the amblyopic eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best amblyopic eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|participants|Number|1|1.0||||||
4114526|NCT00945100|3938845|B1|20/125||Best distance visual acuity in the amblyopic eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best amblyopic eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|participants|Number|3|3.0||||||
4114527|NCT00945100|3938843|B3|20/160||Best distance visual acuity in the amblyopic eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best amblyopic eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|participants|Number|5|5.0||||||
4114528|NCT00945100|3938844|B2|20/160||Best distance visual acuity in the amblyopic eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best amblyopic eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|participants|Number|3|3.0||||||
4114529|NCT00945100|3938845|B1|20/160||Best distance visual acuity in the amblyopic eye at randomization|"Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction (if applicable) by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.~Best amblyopic eye visual acuity was computed as the better of the initial test and retest visual acuities at randomization."|participants|Number|2|2.0||||||
4114530|NCT00945100|3938843|B3|Strabismus and Anisometropia||Amblyopia Cause|"Amblyopia associated with strabismus (comitant or incomitant), anisometropia, or both:~Criteria for strabismus: At least one of the following:~Heterotropia at distance and/or near fixation on examination (with or without spectacles)~History of strabismus surgery~Documented history which is no longer present (which in the judgement of the investigator could have caused amblyopia)~Criteria for anisometropia: At least one of the following:~At least 0.50 D difference between eyes in spherical equivalent~At least 1.50 D different between eyes in astigmatism in any meridian"|participants|Number|62|62.0||||||
4114531|NCT00945100|3938844|B2|Strabismus and Anisometropia||Amblyopia Cause|"Amblyopia associated with strabismus (comitant or incomitant), anisometropia, or both:~Criteria for strabismus: At least one of the following:~Heterotropia at distance and/or near fixation on examination (with or without spectacles)~History of strabismus surgery~Documented history which is no longer present (which in the judgement of the investigator could have caused amblyopia)~Criteria for anisometropia: At least one of the following:~At least 0.50 D difference between eyes in spherical equivalent~At least 1.50 D different between eyes in astigmatism in any meridian"|participants|Number|36|36.0||||||
4114532|NCT00945100|3938845|B1|Strabismus and Anisometropia||Amblyopia Cause|"Amblyopia associated with strabismus (comitant or incomitant), anisometropia, or both:~Criteria for strabismus: At least one of the following:~Heterotropia at distance and/or near fixation on examination (with or without spectacles)~History of strabismus surgery~Documented history which is no longer present (which in the judgement of the investigator could have caused amblyopia)~Criteria for anisometropia: At least one of the following:~At least 0.50 D difference between eyes in spherical equivalent~At least 1.50 D different between eyes in astigmatism in any meridian"|participants|Number|26|26.0||||||
4114533|NCT00945100|3938843|B3|Anisometropia||Amblyopia Cause|"Amblyopia associated with strabismus (comitant or incomitant), anisometropia, or both:~Criteria for strabismus: At least one of the following:~Heterotropia at distance and/or near fixation on examination (with or without spectacles)~History of strabismus surgery~Documented history which is no longer present (which in the judgement of the investigator could have caused amblyopia)~Criteria for anisometropia: At least one of the following:~At least 0.50 D difference between eyes in spherical equivalent~At least 1.50 D different between eyes in astigmatism in any meridian"|participants|Number|75|75.0||||||
4114534|NCT00945100|3938844|B2|Anisometropia||Amblyopia Cause|"Amblyopia associated with strabismus (comitant or incomitant), anisometropia, or both:~Criteria for strabismus: At least one of the following:~Heterotropia at distance and/or near fixation on examination (with or without spectacles)~History of strabismus surgery~Documented history which is no longer present (which in the judgement of the investigator could have caused amblyopia)~Criteria for anisometropia: At least one of the following:~At least 0.50 D difference between eyes in spherical equivalent~At least 1.50 D different between eyes in astigmatism in any meridian"|participants|Number|34|34.0||||||
4114535|NCT00945100|3938845|B1|Anisometropia||Amblyopia Cause|"Amblyopia associated with strabismus (comitant or incomitant), anisometropia, or both:~Criteria for strabismus: At least one of the following:~Heterotropia at distance and/or near fixation on examination (with or without spectacles)~History of strabismus surgery~Documented history which is no longer present (which in the judgement of the investigator could have caused amblyopia)~Criteria for anisometropia: At least one of the following:~At least 0.50 D difference between eyes in spherical equivalent~At least 1.50 D different between eyes in astigmatism in any meridian"|participants|Number|41|41.0||||||
4114536|NCT00945100|3938843|B3|Strabismus||Amblyopia Cause|"Amblyopia associated with strabismus (comitant or incomitant), anisometropia, or both:~Criteria for strabismus: At least one of the following:~Heterotropia at distance and/or near fixation on examination (with or without spectacles)~History of strabismus surgery~Documented history which is no longer present (which in the judgement of the investigator could have caused amblyopia)~Criteria for anisometropia: At least one of the following:~At least 0.50 D difference between eyes in spherical equivalent~At least 1.50 D different between eyes in astigmatism in any meridian"|participants|Number|32|32.0||||||
4114537|NCT00945100|3938844|B2|Strabismus||Amblyopia Cause|"Amblyopia associated with strabismus (comitant or incomitant), anisometropia, or both:~Criteria for strabismus: At least one of the following:~Heterotropia at distance and/or near fixation on examination (with or without spectacles)~History of strabismus surgery~Documented history which is no longer present (which in the judgement of the investigator could have caused amblyopia)~Criteria for anisometropia: At least one of the following:~At least 0.50 D difference between eyes in spherical equivalent~At least 1.50 D different between eyes in astigmatism in any meridian"|participants|Number|16|16.0||||||
4114538|NCT00945100|3938845|B1|Strabismus||Amblyopia Cause|"Amblyopia associated with strabismus (comitant or incomitant), anisometropia, or both:~Criteria for strabismus: At least one of the following:~Heterotropia at distance and/or near fixation on examination (with or without spectacles)~History of strabismus surgery~Documented history which is no longer present (which in the judgement of the investigator could have caused amblyopia)~Criteria for anisometropia: At least one of the following:~At least 0.50 D difference between eyes in spherical equivalent~At least 1.50 D different between eyes in astigmatism in any meridian"|participants|Number|16|16.0||||||
4114539|NCT00945100|3938843|B3|||Duration of patching prior to randomization (weeks)||Weeks|Mean|24.4|24.4|Standard Deviation|11.3|11.3|||
4114540|NCT00945100|3938844|B2|||Duration of patching prior to randomization (weeks)||Weeks|Mean|24.4|24.4|Standard Deviation|11.9|11.9|||
4114541|NCT00945100|3938845|B1|||Duration of patching prior to randomization (weeks)||Weeks|Mean|24.5|24.5|Standard Deviation|10.7|10.7|||
4114542|NCT00945100|3938843|B3|25 weeks or more||Duration of patching prior to randomization (weeks)||participants|Number|64|64.0||||||
4114543|NCT00945100|3938844|B2|25 weeks or more||Duration of patching prior to randomization (weeks)||participants|Number|34|34.0||||||
4114544|NCT00945100|3938845|B1|25 weeks or more||Duration of patching prior to randomization (weeks)||participants|Number|30|30.0||||||
4114545|NCT00945100|3938843|B3|16 to <25 weeks||Duration of patching prior to randomization (weeks)||participants|Number|70|70.0||||||
4114546|NCT00945100|3938844|B2|16 to <25 weeks||Duration of patching prior to randomization (weeks)||participants|Number|31|31.0||||||
4114547|NCT00945100|3938845|B1|16 to <25 weeks||Duration of patching prior to randomization (weeks)||participants|Number|39|39.0||||||
4114548|NCT00945100|3938843|B3|12 to <16 weeks||Duration of patching prior to randomization (weeks)||participants|Number|35|35.0||||||
4114549|NCT00945100|3938844|B2|12 to <16 weeks||Duration of patching prior to randomization (weeks)||participants|Number|21|21.0||||||
4114550|NCT00945100|3938845|B1|12 to <16 weeks||Duration of patching prior to randomization (weeks)||participants|Number|14|14.0||||||
4114551|NCT00945100|3938843|B3|Ready for randomization||Enrollment Disposition|Participants were classified into 3 groups (no current treatment, on treatment, ready for randomization) according to their treatment disposition at enrollment.|participants|Number|36|36.0||||||
4114552|NCT00945100|3938844|B2|Ready for randomization||Enrollment Disposition|Participants were classified into 3 groups (no current treatment, on treatment, ready for randomization) according to their treatment disposition at enrollment.|participants|Number|19|19.0||||||
4114553|NCT00945100|3938845|B1|Ready for randomization||Enrollment Disposition|Participants were classified into 3 groups (no current treatment, on treatment, ready for randomization) according to their treatment disposition at enrollment.|participants|Number|17|17.0||||||
4114554|NCT00945100|3938843|B3|On treatment||Enrollment Disposition|Participants were classified into 3 groups (no current treatment, on treatment, ready for randomization) according to their treatment disposition at enrollment.|participants|Number|36|36.0||||||
4114555|NCT00945100|3938844|B2|On treatment||Enrollment Disposition|Participants were classified into 3 groups (no current treatment, on treatment, ready for randomization) according to their treatment disposition at enrollment.|participants|Number|18|18.0||||||
4114556|NCT00945100|3938845|B1|On treatment||Enrollment Disposition|Participants were classified into 3 groups (no current treatment, on treatment, ready for randomization) according to their treatment disposition at enrollment.|participants|Number|18|18.0||||||
4114557|NCT00945100|3938843|B3|No current treatment||Enrollment Disposition|Participants were classified into 3 groups (no current treatment, on treatment, ready for randomization) according to their treatment disposition at enrollment.|participants|Number|97|97.0||||||
4114558|NCT00945100|3938844|B2|No current treatment||Enrollment Disposition|Participants were classified into 3 groups (no current treatment, on treatment, ready for randomization) according to their treatment disposition at enrollment.|participants|Number|49|49.0||||||
4114559|NCT00945100|3938845|B1|No current treatment||Enrollment Disposition|Participants were classified into 3 groups (no current treatment, on treatment, ready for randomization) according to their treatment disposition at enrollment.|participants|Number|48|48.0||||||
4114560|NCT00945100|3938843|B3|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4114561|NCT00945100|3938844|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4114562|NCT00945100|3938845|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4114563|NCT00945100|3938843|B3|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4114564|NCT00945100|3938844|B2|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4114567|NCT00945100|3938844|B2|United States||Region of Enrollment||participants|Number|82|82.0||||||
4114568|NCT00945100|3938845|B1|United States||Region of Enrollment||participants|Number|80|80.0||||||
4114569|NCT00945100|3938843|B3|More than one race||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4114570|NCT00945100|3938844|B2|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4114571|NCT00945100|3938845|B1|More than one race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4114572|NCT00945100|3938843|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4114573|NCT00945100|3938844|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4114574|NCT00945100|3938845|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4114575|NCT00945100|3938843|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4114576|NCT00945100|3938844|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4114577|NCT00945100|3938845|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4114578|NCT00945100|3938843|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4114579|NCT00945100|3938844|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4114580|NCT00945100|3938845|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4114581|NCT00945100|3938843|B3|White||Race/Ethnicity, Customized||participants|Number|123|123.0||||||
4114582|NCT00945100|3938844|B2|White||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
4114583|NCT00945100|3938845|B1|White||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
4114584|NCT00945100|3938843|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4114585|NCT00945100|3938844|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4114586|NCT00945100|3938845|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4114587|NCT00945100|3938843|B3||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4114588|NCT00945100|3938844|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4114589|NCT00945100|3938845|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4114590|NCT00945100|3938843|B3|7 to 8 years||Age, Customized|"Baseline age reflects age at randomization.~The age eligibility requirement at enrollment was 3 to <8 years old, however, there were 7 participants who were enrolled into the run-in phase that were 8 years old by the time they were randomized."|participants|Number|38|38.0||||||
4114591|NCT00945100|3938844|B2|7 to 8 years||Age, Customized|"Baseline age reflects age at randomization.~The age eligibility requirement at enrollment was 3 to <8 years old, however, there were 7 participants who were enrolled into the run-in phase that were 8 years old by the time they were randomized."|participants|Number|19|19.0||||||
4114592|NCT00945100|3938845|B1|7 to 8 years||Age, Customized|"Baseline age reflects age at randomization.~The age eligibility requirement at enrollment was 3 to <8 years old, however, there were 7 participants who were enrolled into the run-in phase that were 8 years old by the time they were randomized."|participants|Number|19|19.0||||||
4114593|NCT00945100|3938843|B3|6 to <7 years||Age, Customized|"Baseline age reflects age at randomization.~The age eligibility requirement at enrollment was 3 to <8 years old, however, there were 7 participants who were enrolled into the run-in phase that were 8 years old by the time they were randomized."|participants|Number|42|42.0||||||
4114594|NCT00945100|3938844|B2|6 to <7 years||Age, Customized|"Baseline age reflects age at randomization.~The age eligibility requirement at enrollment was 3 to <8 years old, however, there were 7 participants who were enrolled into the run-in phase that were 8 years old by the time they were randomized."|participants|Number|25|25.0||||||
4114595|NCT00945100|3938845|B1|6 to <7 years||Age, Customized|"Baseline age reflects age at randomization.~The age eligibility requirement at enrollment was 3 to <8 years old, however, there were 7 participants who were enrolled into the run-in phase that were 8 years old by the time they were randomized."|participants|Number|17|17.0||||||
4114596|NCT00945100|3938843|B3|5 to <6 years||Age, Customized|"Baseline age reflects age at randomization.~The age eligibility requirement at enrollment was 3 to <8 years old, however, there were 7 participants who were enrolled into the run-in phase that were 8 years old by the time they were randomized."|participants|Number|46|46.0||||||
4114597|NCT00945100|3938844|B2|5 to <6 years||Age, Customized|"Baseline age reflects age at randomization.~The age eligibility requirement at enrollment was 3 to <8 years old, however, there were 7 participants who were enrolled into the run-in phase that were 8 years old by the time they were randomized."|participants|Number|19|19.0||||||
4114598|NCT00945100|3938845|B1|5 to <6 years||Age, Customized|"Baseline age reflects age at randomization.~The age eligibility requirement at enrollment was 3 to <8 years old, however, there were 7 participants who were enrolled into the run-in phase that were 8 years old by the time they were randomized."|participants|Number|27|27.0||||||
4114599|NCT00945100|3938843|B3|4 to <5 years||Age, Customized|"Baseline age reflects age at randomization.~The age eligibility requirement at enrollment was 3 to <8 years old, however, there were 7 participants who were enrolled into the run-in phase that were 8 years old by the time they were randomized."|participants|Number|30|30.0||||||
4114600|NCT00945100|3938844|B2|4 to <5 years||Age, Customized|"Baseline age reflects age at randomization.~The age eligibility requirement at enrollment was 3 to <8 years old, however, there were 7 participants who were enrolled into the run-in phase that were 8 years old by the time they were randomized."|participants|Number|15|15.0||||||
4114601|NCT00945100|3938845|B1|4 to <5 years||Age, Customized|"Baseline age reflects age at randomization.~The age eligibility requirement at enrollment was 3 to <8 years old, however, there were 7 participants who were enrolled into the run-in phase that were 8 years old by the time they were randomized."|participants|Number|15|15.0||||||
4114602|NCT00945100|3938843|B3|3 to <4 years||Age, Customized|"Baseline age reflects age at randomization.~The age eligibility requirement at enrollment was 3 to <8 years old, however, there were 7 participants who were enrolled into the run-in phase that were 8 years old by the time they were randomized."|participants|Number|13|13.0||||||
4114654|NCT00944710|3938926|B1|||Spherical Equivalent Refractive Error in Amblyopic Eye at Enrollment||diopters|Mean|5.73|5.73|Standard Deviation|1.62|1.62|||
4114603|NCT00945100|3938844|B2|3 to <4 years||Age, Customized|"Baseline age reflects age at randomization.~The age eligibility requirement at enrollment was 3 to <8 years old, however, there were 7 participants who were enrolled into the run-in phase that were 8 years old by the time they were randomized."|participants|Number|8|8.0||||||
4114604|NCT00945100|3938845|B1|3 to <4 years||Age, Customized|"Baseline age reflects age at randomization.~The age eligibility requirement at enrollment was 3 to <8 years old, however, there were 7 participants who were enrolled into the run-in phase that were 8 years old by the time they were randomized."|participants|Number|5|5.0||||||
4114605|NCT00945100|3938843|B3|||Age||years|Mean|5.9|5.9|Standard Deviation|1.3|1.3|||
4114606|NCT00945100|3938844|B2|||Age||years|Mean|5.9|5.9|Standard Deviation|1.2|1.2|||
4114607|NCT00945100|3938845|B1|||Age||years|Mean|5.9|5.9|Standard Deviation|1.3|1.3|||
4114608|NCT00945100|3938843|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4114609|NCT00945100|3938844|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4114610|NCT00945100|3938845|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4114611|NCT00945100|3938843|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4114612|NCT00945100|3938844|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4114613|NCT00945100|3938845|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4114614|NCT00945100|3938843|B3||<=18 years|Age||Participants|Count of Participants|169|169.0||||||
4114615|NCT00945100|3938844|B2||<=18 years|Age||Participants|Count of Participants|86|86.0||||||
4114616|NCT00945100|3938845|B1||<=18 years|Age||Participants|Count of Participants|83|83.0||||||
4114617|NCT00945035|3938910|B1|||Weight||Kilograms|Mean|75.2|75.2|Full Range|||50.5|99.1|
4114618|NCT00945035|3938910|B1|||Height||Centimeters|Mean|168.3|168.3|Full Range|||149.9|193.0|
4114619|NCT00945035|3938910|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4114620|NCT00945035|3938910|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4114621|NCT00945035|3938910|B1|||Age||Years|Mean|36.1|36.1|Full Range|||18.0|44.0|
4114622|NCT00944749|3938919|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4114623|NCT00944749|3938919|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4114624|NCT00944749|3938919|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4114625|NCT00944749|3938919|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4114626|NCT00944749|3938919|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114627|NCT00944749|3938919|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114628|NCT00944749|3938919|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114629|NCT00944749|3938919|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114630|NCT00944749|3938919|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4114631|NCT00944749|3938919|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4114632|NCT00944749|3938919|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4114633|NCT00944749|3938919|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4114634|NCT00944749|3938919|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4114635|NCT00944749|3938919|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4114636|NCT00944749|3938919|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4114637|NCT00944710|3938924|B3|||Spherical Equivalent Refractive Error in Fellow Eye at Enrollment||diopters|Mean|4.22|4.22|Standard Deviation|1.95|1.95|||
4114638|NCT00944710|3938925|B2|||Spherical Equivalent Refractive Error in Fellow Eye at Enrollment||diopters|Mean|4.55|4.55|Standard Deviation|2.28|2.28|||
4114639|NCT00944710|3938926|B1|||Spherical Equivalent Refractive Error in Fellow Eye at Enrollment||diopters|Mean|3.95|3.95|Standard Deviation|1.60|1.6|||
4114640|NCT00944710|3938924|B3|+4.00 D or more||Spherical Equivalent Refractive Error in Fellow Eye at Enrollment||participants|Number|39|39.0||||||
4114641|NCT00944710|3938925|B2|+4.00 D or more||Spherical Equivalent Refractive Error in Fellow Eye at Enrollment||participants|Number|17|17.0||||||
4114642|NCT00944710|3938926|B1|+4.00 D or more||Spherical Equivalent Refractive Error in Fellow Eye at Enrollment||participants|Number|22|22.0||||||
4114643|NCT00944710|3938924|B3|+3.00 to <+4.00 D||Spherical Equivalent Refractive Error in Fellow Eye at Enrollment||participants|Number|16|16.0||||||
4114644|NCT00944710|3938925|B2|+3.00 to <+4.00 D||Spherical Equivalent Refractive Error in Fellow Eye at Enrollment||participants|Number|9|9.0||||||
4114645|NCT00944710|3938926|B1|+3.00 to <+4.00 D||Spherical Equivalent Refractive Error in Fellow Eye at Enrollment||participants|Number|7|7.0||||||
4114646|NCT00944710|3938924|B3|+2.00 to <+3.00 D||Spherical Equivalent Refractive Error in Fellow Eye at Enrollment||participants|Number|8|8.0||||||
4114647|NCT00944710|3938925|B2|+2.00 to <+3.00 D||Spherical Equivalent Refractive Error in Fellow Eye at Enrollment||participants|Number|2|2.0||||||
4114648|NCT00944710|3938926|B1|+2.00 to <+3.00 D||Spherical Equivalent Refractive Error in Fellow Eye at Enrollment||participants|Number|6|6.0||||||
4114649|NCT00944710|3938924|B3|+1.50 to <+2.00 D||Spherical Equivalent Refractive Error in Fellow Eye at Enrollment||participants|Number|10|10.0||||||
4114650|NCT00944710|3938925|B2|+1.50 to <+2.00 D||Spherical Equivalent Refractive Error in Fellow Eye at Enrollment||participants|Number|5|5.0||||||
4114651|NCT00944710|3938926|B1|+1.50 to <+2.00 D||Spherical Equivalent Refractive Error in Fellow Eye at Enrollment||participants|Number|5|5.0||||||
4114652|NCT00944710|3938924|B3|||Spherical Equivalent Refractive Error in Amblyopic Eye at Enrollment||diopters|Mean|5.78|5.78|Standard Deviation|1.74|1.74|||
4114653|NCT00944710|3938925|B2|||Spherical Equivalent Refractive Error in Amblyopic Eye at Enrollment||diopters|Mean|5.84|5.84|Standard Deviation|1.89|1.89|||
4114655|NCT00944710|3938924|B3|+4.00 D or more||Spherical Equivalent Refractive Error in Amblyopic Eye at Enrollment||participants|Number|59|59.0||||||
4114656|NCT00944710|3938925|B2|+4.00 D or more||Spherical Equivalent Refractive Error in Amblyopic Eye at Enrollment||participants|Number|26|26.0||||||
4114657|NCT00944710|3938926|B1|+4.00 D or more||Spherical Equivalent Refractive Error in Amblyopic Eye at Enrollment||participants|Number|33|33.0||||||
4114658|NCT00944710|3938924|B3|+3.00 to <+4.00 D||Spherical Equivalent Refractive Error in Amblyopic Eye at Enrollment||participants|Number|11|11.0||||||
4114659|NCT00944710|3938925|B2|+3.00 to <+4.00 D||Spherical Equivalent Refractive Error in Amblyopic Eye at Enrollment||participants|Number|5|5.0||||||
4114660|NCT00944710|3938926|B1|+3.00 to <+4.00 D||Spherical Equivalent Refractive Error in Amblyopic Eye at Enrollment||participants|Number|6|6.0||||||
4114661|NCT00944710|3938924|B3|+2.00 to <+3.00 D||Spherical Equivalent Refractive Error in Amblyopic Eye at Enrollment||participants|Number|2|2.0||||||
4114662|NCT00944710|3938925|B2|+2.00 to <+3.00 D||Spherical Equivalent Refractive Error in Amblyopic Eye at Enrollment||participants|Number|1|1.0||||||
4114663|NCT00944710|3938926|B1|+2.00 to <+3.00 D||Spherical Equivalent Refractive Error in Amblyopic Eye at Enrollment||participants|Number|1|1.0||||||
4114664|NCT00944710|3938924|B3|+1.00 to <+2.00 D||Spherical Equivalent Refractive Error in Amblyopic Eye at Enrollment||participants|Number|1|1.0||||||
4114665|NCT00944710|3938925|B2|+1.00 to <+2.00 D||Spherical Equivalent Refractive Error in Amblyopic Eye at Enrollment||participants|Number|1|1.0||||||
4114666|NCT00944710|3938926|B1|+1.00 to <+2.00 D||Spherical Equivalent Refractive Error in Amblyopic Eye at Enrollment||participants|Number|0|0.0||||||
4114667|NCT00944710|3938924|B3|0 to <+1.00 D||Spherical Equivalent Refractive Error in Amblyopic Eye at Enrollment||participants|Number|0|0.0||||||
4114668|NCT00944710|3938925|B2|0 to <+1.00 D||Spherical Equivalent Refractive Error in Amblyopic Eye at Enrollment||participants|Number|0|0.0||||||
4114669|NCT00944710|3938926|B1|0 to <+1.00 D||Spherical Equivalent Refractive Error in Amblyopic Eye at Enrollment||participants|Number|0|0.0||||||
4114670|NCT00944710|3938924|B3|||Interocular Eye Visual Acuity Difference at Randomization||logMAR lines|Mean|4.4|4.4|Standard Deviation|1.7|1.7|||
4114671|NCT00944710|3938925|B2|||Interocular Eye Visual Acuity Difference at Randomization||logMAR lines|Mean|4.4|4.4|Standard Deviation|1.7|1.7|||
4114672|NCT00944710|3938926|B1|||Interocular Eye Visual Acuity Difference at Randomization||logMAR lines|Mean|4.4|4.4|Standard Deviation|1.8|1.8|||
4114673|NCT00944710|3938924|B3|||Distance Visual Acuity in the Fellow Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|logMAR|Mean|0.05|0.05|Standard Deviation|0.09|0.09|||
4114674|NCT00944710|3938925|B2|||Distance Visual Acuity in the Fellow Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|logMAR|Mean|0.05|0.05|Standard Deviation|0.10|0.1|||
4114675|NCT00944710|3938926|B1|||Distance Visual Acuity in the Fellow Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|logMAR|Mean|0.04|0.04|Standard Deviation|0.09|0.09|||
4114676|NCT00944710|3938924|B3|20/16||Distance Visual Acuity in the Fellow Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|participants|Number|11|11.0||||||
4114677|NCT00944710|3938925|B2|20/16||Distance Visual Acuity in the Fellow Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|participants|Number|5|5.0||||||
4114678|NCT00944710|3938926|B1|20/16||Distance Visual Acuity in the Fellow Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|participants|Number|6|6.0||||||
4114679|NCT00944710|3938924|B3|20/20||Distance Visual Acuity in the Fellow Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|participants|Number|29|29.0||||||
4114680|NCT00944710|3938925|B2|20/20||Distance Visual Acuity in the Fellow Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|participants|Number|13|13.0||||||
4114681|NCT00944710|3938926|B1|20/20||Distance Visual Acuity in the Fellow Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|participants|Number|16|16.0||||||
4114682|NCT00944710|3938924|B3|20/25||Distance Visual Acuity in the Fellow Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|participants|Number|22|22.0||||||
4114683|NCT00944710|3938925|B2|20/25||Distance Visual Acuity in the Fellow Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|participants|Number|9|9.0||||||
4114684|NCT00944710|3938926|B1|20/25||Distance Visual Acuity in the Fellow Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|participants|Number|13|13.0||||||
4114685|NCT00944710|3938924|B3|20/32||Distance Visual Acuity in the Fellow Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|participants|Number|11|11.0||||||
4114797|NCT00944697|3938984|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4114798|NCT00944697|3938985|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4114686|NCT00944710|3938925|B2|20/32||Distance Visual Acuity in the Fellow Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|participants|Number|6|6.0||||||
4114687|NCT00944710|3938926|B1|20/32||Distance Visual Acuity in the Fellow Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|participants|Number|5|5.0||||||
4114688|NCT00944710|3938924|B3|||Distance Visual Acuity in the Amblyopic Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|logMAR|Mean|0.48|0.48|Standard Deviation|0.18|0.18|||
4114689|NCT00944710|3938925|B2|||Distance Visual Acuity in the Amblyopic Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|logMAR|Mean|0.48|0.48|Standard Deviation|0.16|0.16|||
4114690|NCT00944710|3938926|B1|||Distance Visual Acuity in the Amblyopic Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|logMAR|Mean|0.48|0.48|Standard Deviation|0.19|0.19|||
4114691|NCT00944710|3938924|B3|20/32||Distance Visual Acuity in the Amblyopic Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|participants|Number|3|3.0||||||
4114692|NCT00944710|3938925|B2|20/32||Distance Visual Acuity in the Amblyopic Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|participants|Number|1|1.0||||||
4114693|NCT00944710|3938926|B1|20/32||Distance Visual Acuity in the Amblyopic Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|participants|Number|2|2.0||||||
4114694|NCT00944710|3938924|B3|20/40||Distance Visual Acuity in the Amblyopic Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|participants|Number|17|17.0||||||
4114695|NCT00944710|3938925|B2|20/40||Distance Visual Acuity in the Amblyopic Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|participants|Number|6|6.0||||||
4114696|NCT00944710|3938926|B1|20/40||Distance Visual Acuity in the Amblyopic Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|participants|Number|11|11.0||||||
4114697|NCT00944710|3938924|B3|20/50||Distance Visual Acuity in the Amblyopic Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|participants|Number|15|15.0||||||
4114698|NCT00944710|3938925|B2|20/50||Distance Visual Acuity in the Amblyopic Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|participants|Number|8|8.0||||||
4114699|NCT00944710|3938926|B1|20/50||Distance Visual Acuity in the Amblyopic Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|participants|Number|7|7.0||||||
4114700|NCT00944710|3938924|B3|20/63||Distance Visual Acuity in the Amblyopic Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|participants|Number|17|17.0||||||
4114701|NCT00944710|3938925|B2|20/63||Distance Visual Acuity in the Amblyopic Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|participants|Number|8|8.0||||||
4114702|NCT00944710|3938926|B1|20/63||Distance Visual Acuity in the Amblyopic Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|participants|Number|9|9.0||||||
4114703|NCT00944710|3938924|B3|20/80||Distance Visual Acuity in the Amblyopic Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|participants|Number|8|8.0||||||
4114704|NCT00944710|3938925|B2|20/80||Distance Visual Acuity in the Amblyopic Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|participants|Number|6|6.0||||||
4114705|NCT00944710|3938926|B1|20/80||Distance Visual Acuity in the Amblyopic Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|participants|Number|2|2.0||||||
4114706|NCT00944710|3938924|B3|20/100||Distance Visual Acuity in the Amblyopic Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|participants|Number|6|6.0||||||
4114707|NCT00944710|3938925|B2|20/100||Distance Visual Acuity in the Amblyopic Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|participants|Number|1|1.0||||||
4114799|NCT00944697|3938983|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4114708|NCT00944710|3938926|B1|20/100||Distance Visual Acuity in the Amblyopic Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|participants|Number|5|5.0||||||
4114709|NCT00944710|3938924|B3|20/125||Distance Visual Acuity in the Amblyopic Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|participants|Number|4|4.0||||||
4114710|NCT00944710|3938925|B2|20/125||Distance Visual Acuity in the Amblyopic Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|participants|Number|2|2.0||||||
4114711|NCT00944710|3938926|B1|20/125||Distance Visual Acuity in the Amblyopic Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|participants|Number|2|2.0||||||
4114712|NCT00944710|3938924|B3|20/160||Distance Visual Acuity in the Amblyopic Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|participants|Number|3|3.0||||||
4114713|NCT00944710|3938925|B2|20/160||Distance Visual Acuity in the Amblyopic Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|participants|Number|1|1.0||||||
4114714|NCT00944710|3938926|B1|20/160||Distance Visual Acuity in the Amblyopic Eye at Randomization|Visual acuity was measured without cycloplegia using the participant's optimal spectacle correction by a study-certified tester using the ATS-HOTV protocol on the Electronic Visual Acuity Tester.|participants|Number|2|2.0||||||
4114715|NCT00944710|3938924|B3|Strabismus and Anisometropia||Cause of Amblyopia|"Amblyopia associated with strabismus (comitant or incomitant), anisometropia, or both:~Criteria for strabismus: At least one of the following:~Heterotropia at distance and/or near fixation on examination (with or without spectacles)~History of strabismus surgery~Documented history which is no longer present (which in the judgement of the investigator could have caused amblyopia)~Criteria for anisometropia: At least one of the following:~At least 0.50 D difference between eyes in spherical equivalent~At least 1.50 D different between eyes in astigmatism in any meridian"|participants|Number|35|35.0||||||
4114716|NCT00944710|3938925|B2|Strabismus and Anisometropia||Cause of Amblyopia|"Amblyopia associated with strabismus (comitant or incomitant), anisometropia, or both:~Criteria for strabismus: At least one of the following:~Heterotropia at distance and/or near fixation on examination (with or without spectacles)~History of strabismus surgery~Documented history which is no longer present (which in the judgement of the investigator could have caused amblyopia)~Criteria for anisometropia: At least one of the following:~At least 0.50 D difference between eyes in spherical equivalent~At least 1.50 D different between eyes in astigmatism in any meridian"|participants|Number|14|14.0||||||
4114717|NCT00944710|3938926|B1|Strabismus and Anisometropia||Cause of Amblyopia|"Amblyopia associated with strabismus (comitant or incomitant), anisometropia, or both:~Criteria for strabismus: At least one of the following:~Heterotropia at distance and/or near fixation on examination (with or without spectacles)~History of strabismus surgery~Documented history which is no longer present (which in the judgement of the investigator could have caused amblyopia)~Criteria for anisometropia: At least one of the following:~At least 0.50 D difference between eyes in spherical equivalent~At least 1.50 D different between eyes in astigmatism in any meridian"|participants|Number|21|21.0||||||
4114718|NCT00944710|3938924|B3|Anisometropia||Cause of Amblyopia|"Amblyopia associated with strabismus (comitant or incomitant), anisometropia, or both:~Criteria for strabismus: At least one of the following:~Heterotropia at distance and/or near fixation on examination (with or without spectacles)~History of strabismus surgery~Documented history which is no longer present (which in the judgement of the investigator could have caused amblyopia)~Criteria for anisometropia: At least one of the following:~At least 0.50 D difference between eyes in spherical equivalent~At least 1.50 D different between eyes in astigmatism in any meridian"|participants|Number|16|16.0||||||
4114719|NCT00944710|3938925|B2|Anisometropia||Cause of Amblyopia|"Amblyopia associated with strabismus (comitant or incomitant), anisometropia, or both:~Criteria for strabismus: At least one of the following:~Heterotropia at distance and/or near fixation on examination (with or without spectacles)~History of strabismus surgery~Documented history which is no longer present (which in the judgement of the investigator could have caused amblyopia)~Criteria for anisometropia: At least one of the following:~At least 0.50 D difference between eyes in spherical equivalent~At least 1.50 D different between eyes in astigmatism in any meridian"|participants|Number|6|6.0||||||
4114720|NCT00944710|3938926|B1|Anisometropia||Cause of Amblyopia|"Amblyopia associated with strabismus (comitant or incomitant), anisometropia, or both:~Criteria for strabismus: At least one of the following:~Heterotropia at distance and/or near fixation on examination (with or without spectacles)~History of strabismus surgery~Documented history which is no longer present (which in the judgement of the investigator could have caused amblyopia)~Criteria for anisometropia: At least one of the following:~At least 0.50 D difference between eyes in spherical equivalent~At least 1.50 D different between eyes in astigmatism in any meridian"|participants|Number|10|10.0||||||
4114721|NCT00944710|3938924|B3|Strabismus||Cause of Amblyopia|"Amblyopia associated with strabismus (comitant or incomitant), anisometropia, or both:~Criteria for strabismus: At least one of the following:~Heterotropia at distance and/or near fixation on examination (with or without spectacles)~History of strabismus surgery~Documented history which is no longer present (which in the judgement of the investigator could have caused amblyopia)~Criteria for anisometropia: At least one of the following:~At least 0.50 D difference between eyes in spherical equivalent~At least 1.50 D different between eyes in astigmatism in any meridian"|participants|Number|22|22.0||||||
4114722|NCT00944710|3938925|B2|Strabismus||Cause of Amblyopia|"Amblyopia associated with strabismus (comitant or incomitant), anisometropia, or both:~Criteria for strabismus: At least one of the following:~Heterotropia at distance and/or near fixation on examination (with or without spectacles)~History of strabismus surgery~Documented history which is no longer present (which in the judgement of the investigator could have caused amblyopia)~Criteria for anisometropia: At least one of the following:~At least 0.50 D difference between eyes in spherical equivalent~At least 1.50 D different between eyes in astigmatism in any meridian"|participants|Number|13|13.0||||||
4114723|NCT00944710|3938926|B1|Strabismus||Cause of Amblyopia|"Amblyopia associated with strabismus (comitant or incomitant), anisometropia, or both:~Criteria for strabismus: At least one of the following:~Heterotropia at distance and/or near fixation on examination (with or without spectacles)~History of strabismus surgery~Documented history which is no longer present (which in the judgement of the investigator could have caused amblyopia)~Criteria for anisometropia: At least one of the following:~At least 0.50 D difference between eyes in spherical equivalent~At least 1.50 D different between eyes in astigmatism in any meridian"|participants|Number|9|9.0||||||
4114724|NCT00944710|3938924|B3|||Duration of Atropine Treatment Prior to Randomization||weeks|Mean|25.0|25.0|Standard Deviation|12.8|12.8|||
4114725|NCT00944710|3938925|B2|||Duration of Atropine Treatment Prior to Randomization||weeks|Mean|26.4|26.4|Standard Deviation|14.6|14.6|||
4114726|NCT00944710|3938926|B1|||Duration of Atropine Treatment Prior to Randomization||weeks|Mean|24.0|24.0|Standard Deviation|11.2|11.2|||
4114727|NCT00944710|3938924|B3|27 to 84 weeks||Duration of Atropine Treatment Prior to Randomization||participants|Number|20|20.0||||||
4114728|NCT00944710|3938925|B2|27 to 84 weeks||Duration of Atropine Treatment Prior to Randomization||participants|Number|10|10.0||||||
4114729|NCT00944710|3938926|B1|27 to 84 weeks||Duration of Atropine Treatment Prior to Randomization||participants|Number|10|10.0||||||
4114730|NCT00944710|3938924|B3|21 to <27 weeks||Duration of Atropine Treatment Prior to Randomization||participants|Number|22|22.0||||||
4114731|NCT00944710|3938925|B2|21 to <27 weeks||Duration of Atropine Treatment Prior to Randomization||participants|Number|9|9.0||||||
4114732|NCT00944710|3938926|B1|21 to <27 weeks||Duration of Atropine Treatment Prior to Randomization||participants|Number|13|13.0||||||
4114733|NCT00944710|3938924|B3|15 to <21 weeks||Duration of Atropine Treatment Prior to Randomization||participants|Number|15|15.0||||||
4114734|NCT00944710|3938925|B2|15 to <21 weeks||Duration of Atropine Treatment Prior to Randomization||participants|Number|9|9.0||||||
4114735|NCT00944710|3938926|B1|15 to <21 weeks||Duration of Atropine Treatment Prior to Randomization||participants|Number|6|6.0||||||
4114736|NCT00944710|3938924|B3|12 to <15 weeks||Duration of Atropine Treatment Prior to Randomization||participants|Number|16|16.0||||||
4114737|NCT00944710|3938925|B2|12 to <15 weeks||Duration of Atropine Treatment Prior to Randomization||participants|Number|5|5.0||||||
4114738|NCT00944710|3938926|B1|12 to <15 weeks||Duration of Atropine Treatment Prior to Randomization||participants|Number|11|11.0||||||
4114739|NCT00944710|3938924|B3|United States||Region of Enrollment||participants|Number|73|73.0||||||
4114740|NCT00944710|3938925|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4114741|NCT00944710|3938926|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4114742|NCT00944710|3938924|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4114743|NCT00944710|3938925|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4114744|NCT00944710|3938926|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4114745|NCT00944710|3938924|B3|African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4114746|NCT00944710|3938925|B2|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4114747|NCT00944710|3938926|B1|African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4114748|NCT00944710|3938924|B3|White||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
4114749|NCT00944710|3938925|B2|White||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4114750|NCT00944710|3938926|B1|White||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4114751|NCT00944710|3938924|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4114752|NCT00944710|3938925|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4114753|NCT00944710|3938926|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4114754|NCT00944710|3938924|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4114755|NCT00944710|3938925|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4114756|NCT00944710|3938926|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4114757|NCT00944710|3938924|B3|>=7 years||Age, Customized|"Baseline age reflects age at randomization.~The age eligibility requirement at enrollment was 3 to <8 years old; however, four participants (2 in each group) were <8 years old at time of enrollment into the run-in phase and ≥ 8 years old at time of randomization (8.0 and 8.1 in the atropine only group, and 8.1 and 8.3 in the atropine plus plano lens group)."|participants|Number|20|20.0||||||
4114758|NCT00944710|3938925|B2|>=7 years||Age, Customized|"Baseline age reflects age at randomization.~The age eligibility requirement at enrollment was 3 to <8 years old; however, four participants (2 in each group) were <8 years old at time of enrollment into the run-in phase and ≥ 8 years old at time of randomization (8.0 and 8.1 in the atropine only group, and 8.1 and 8.3 in the atropine plus plano lens group)."|participants|Number|9|9.0||||||
4114759|NCT00944710|3938926|B1|>=7 years||Age, Customized|"Baseline age reflects age at randomization.~The age eligibility requirement at enrollment was 3 to <8 years old; however, four participants (2 in each group) were <8 years old at time of enrollment into the run-in phase and ≥ 8 years old at time of randomization (8.0 and 8.1 in the atropine only group, and 8.1 and 8.3 in the atropine plus plano lens group)."|participants|Number|11|11.0||||||
4114760|NCT00944710|3938924|B3|6 to <7 years||Age, Customized|"Baseline age reflects age at randomization.~The age eligibility requirement at enrollment was 3 to <8 years old; however, four participants (2 in each group) were <8 years old at time of enrollment into the run-in phase and ≥ 8 years old at time of randomization (8.0 and 8.1 in the atropine only group, and 8.1 and 8.3 in the atropine plus plano lens group)."|participants|Number|12|12.0||||||
4114761|NCT00944710|3938925|B2|6 to <7 years||Age, Customized|"Baseline age reflects age at randomization.~The age eligibility requirement at enrollment was 3 to <8 years old; however, four participants (2 in each group) were <8 years old at time of enrollment into the run-in phase and ≥ 8 years old at time of randomization (8.0 and 8.1 in the atropine only group, and 8.1 and 8.3 in the atropine plus plano lens group)."|participants|Number|5|5.0||||||
4114800|NCT00944697|3938984|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4114762|NCT00944710|3938926|B1|6 to <7 years||Age, Customized|"Baseline age reflects age at randomization.~The age eligibility requirement at enrollment was 3 to <8 years old; however, four participants (2 in each group) were <8 years old at time of enrollment into the run-in phase and ≥ 8 years old at time of randomization (8.0 and 8.1 in the atropine only group, and 8.1 and 8.3 in the atropine plus plano lens group)."|participants|Number|7|7.0||||||
4114763|NCT00944710|3938924|B3|5 to <6 years||Age, Customized|"Baseline age reflects age at randomization.~The age eligibility requirement at enrollment was 3 to <8 years old; however, four participants (2 in each group) were <8 years old at time of enrollment into the run-in phase and ≥ 8 years old at time of randomization (8.0 and 8.1 in the atropine only group, and 8.1 and 8.3 in the atropine plus plano lens group)."|participants|Number|18|18.0||||||
4114764|NCT00944710|3938925|B2|5 to <6 years||Age, Customized|"Baseline age reflects age at randomization.~The age eligibility requirement at enrollment was 3 to <8 years old; however, four participants (2 in each group) were <8 years old at time of enrollment into the run-in phase and ≥ 8 years old at time of randomization (8.0 and 8.1 in the atropine only group, and 8.1 and 8.3 in the atropine plus plano lens group)."|participants|Number|9|9.0||||||
4114765|NCT00944710|3938926|B1|5 to <6 years||Age, Customized|"Baseline age reflects age at randomization.~The age eligibility requirement at enrollment was 3 to <8 years old; however, four participants (2 in each group) were <8 years old at time of enrollment into the run-in phase and ≥ 8 years old at time of randomization (8.0 and 8.1 in the atropine only group, and 8.1 and 8.3 in the atropine plus plano lens group)."|participants|Number|9|9.0||||||
4114766|NCT00944710|3938924|B3|4 to <5 years||Age, Customized|"Baseline age reflects age at randomization.~The age eligibility requirement at enrollment was 3 to <8 years old; however, four participants (2 in each group) were <8 years old at time of enrollment into the run-in phase and ≥ 8 years old at time of randomization (8.0 and 8.1 in the atropine only group, and 8.1 and 8.3 in the atropine plus plano lens group)."|participants|Number|14|14.0||||||
4114767|NCT00944710|3938925|B2|4 to <5 years||Age, Customized|"Baseline age reflects age at randomization.~The age eligibility requirement at enrollment was 3 to <8 years old; however, four participants (2 in each group) were <8 years old at time of enrollment into the run-in phase and ≥ 8 years old at time of randomization (8.0 and 8.1 in the atropine only group, and 8.1 and 8.3 in the atropine plus plano lens group)."|participants|Number|6|6.0||||||
4114768|NCT00944710|3938926|B1|4 to <5 years||Age, Customized|"Baseline age reflects age at randomization.~The age eligibility requirement at enrollment was 3 to <8 years old; however, four participants (2 in each group) were <8 years old at time of enrollment into the run-in phase and ≥ 8 years old at time of randomization (8.0 and 8.1 in the atropine only group, and 8.1 and 8.3 in the atropine plus plano lens group)."|participants|Number|8|8.0||||||
4114769|NCT00944710|3938924|B3|3 to <4 years||Age, Customized|"Baseline age reflects age at randomization.~The age eligibility requirement at enrollment was 3 to <8 years old; however, four participants (2 in each group) were <8 years old at time of enrollment into the run-in phase and ≥ 8 years old at time of randomization (8.0 and 8.1 in the atropine only group, and 8.1 and 8.3 in the atropine plus plano lens group)."|participants|Number|9|9.0||||||
4114770|NCT00944710|3938925|B2|3 to <4 years||Age, Customized|"Baseline age reflects age at randomization.~The age eligibility requirement at enrollment was 3 to <8 years old; however, four participants (2 in each group) were <8 years old at time of enrollment into the run-in phase and ≥ 8 years old at time of randomization (8.0 and 8.1 in the atropine only group, and 8.1 and 8.3 in the atropine plus plano lens group)."|participants|Number|4|4.0||||||
4114771|NCT00944710|3938926|B1|3 to <4 years||Age, Customized|"Baseline age reflects age at randomization.~The age eligibility requirement at enrollment was 3 to <8 years old; however, four participants (2 in each group) were <8 years old at time of enrollment into the run-in phase and ≥ 8 years old at time of randomization (8.0 and 8.1 in the atropine only group, and 8.1 and 8.3 in the atropine plus plano lens group)."|participants|Number|5|5.0||||||
4114772|NCT00944710|3938924|B3|||Age||years|Mean|5.8|5.8|Standard Deviation|1.4|1.4|||
4114773|NCT00944710|3938925|B2|||Age||years|Mean|5.8|5.8|Standard Deviation|1.4|1.4|||
4114774|NCT00944710|3938926|B1|||Age||years|Mean|5.8|5.8|Standard Deviation|1.5|1.5|||
4114775|NCT00944710|3938924|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4114776|NCT00944710|3938925|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4114777|NCT00944710|3938926|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4114778|NCT00944710|3938924|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4114779|NCT00944710|3938925|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4114780|NCT00944710|3938926|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4114781|NCT00944710|3938924|B3||<=18 years|Age||Participants|Count of Participants|73|73.0||||||
4114782|NCT00944710|3938925|B2||<=18 years|Age||Participants|Count of Participants|33|33.0||||||
4114783|NCT00944710|3938926|B1||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
4114784|NCT00944697|3938983|B3|Romania||Region of Enrollment||participants|Number|22|22.0||||||
4114785|NCT00944697|3938984|B2|Romania||Region of Enrollment||participants|Number|11|11.0||||||
4114786|NCT00944697|3938985|B1|Romania||Region of Enrollment||participants|Number|11|11.0||||||
4114787|NCT00944697|3938983|B3|Hungary||Region of Enrollment||participants|Number|22|22.0||||||
4114788|NCT00944697|3938984|B2|Hungary||Region of Enrollment||participants|Number|11|11.0||||||
4114789|NCT00944697|3938985|B1|Hungary||Region of Enrollment||participants|Number|11|11.0||||||
4114790|NCT00944697|3938983|B3|Germany||Region of Enrollment||participants|Number|14|14.0||||||
4114791|NCT00944697|3938984|B2|Germany||Region of Enrollment||participants|Number|7|7.0||||||
4114792|NCT00944697|3938985|B1|Germany||Region of Enrollment||participants|Number|7|7.0||||||
4114793|NCT00944697|3938983|B3|Czech Republic||Region of Enrollment||participants|Number|40|40.0||||||
4114794|NCT00944697|3938984|B2|Czech Republic||Region of Enrollment||participants|Number|19|19.0||||||
4114795|NCT00944697|3938985|B1|Czech Republic||Region of Enrollment||participants|Number|21|21.0||||||
4114796|NCT00944697|3938983|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4114801|NCT00944697|3938985|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4114802|NCT00944697|3938983|B3|||Age||years|Mean|60.63|60.63|Standard Deviation|9.80|9.8|||
4114803|NCT00944697|3938984|B2|||Age||years|Mean|58.96|58.96|Standard Deviation|10.03|10.03|||
4114804|NCT00944697|3938985|B1|||Age||years|Mean|62.24|62.24|Standard Deviation|9.39|9.39|||
4114805|NCT00944697|3938983|B3||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4114806|NCT00944697|3938984|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4114807|NCT00944697|3938985|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4114808|NCT00944697|3938983|B3||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
4114809|NCT00944697|3938984|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4114810|NCT00944697|3938985|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4114811|NCT00944697|3938983|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4114812|NCT00944697|3938984|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4114813|NCT00944697|3938985|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4114814|NCT00944671|3938992|B7|||Weight||Pounds|Mean|162.6|162.6|Full Range|||132.7|206.9|
4114815|NCT00944671|3938993|B6|||Weight||Pounds|Mean|165.3|165.3|Full Range|||134.6|206.9|
4114816|NCT00944671|3938994|B5|||Weight||Pounds|Mean|168.8|168.8|Full Range|||132.7|200.0|
4114817|NCT00944671|3938995|B4|||Weight||Pounds|Mean|164.8|164.8|Full Range|||148.5|175.2|
4114818|NCT00944671|3938996|B3|||Weight||Pounds|Mean|160.4|160.4|Full Range|||148.5|175.2|
4114819|NCT00944671|3938997|B2|||Weight||Pounds|Mean|152.2|152.2|Full Range|||137.6|182.2|
4114820|NCT00944671|3938998|B1|||Weight||Pounds|Mean|164.1|164.1|Full Range|||151.5|186.1|
4114821|NCT00944671|3938992|B7|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4114822|NCT00944671|3938993|B6|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4114823|NCT00944671|3938994|B5|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4114824|NCT00944671|3938995|B4|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4114825|NCT00944671|3938996|B3|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4114826|NCT00944671|3938997|B2|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4114827|NCT00944671|3938998|B1|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4114828|NCT00944671|3938992|B7|Caucasian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4114829|NCT00944671|3938993|B6|Caucasian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4114830|NCT00944671|3938994|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4114831|NCT00944671|3938995|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4114832|NCT00944671|3938996|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4114833|NCT00944671|3938997|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4114834|NCT00944671|3938998|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4114835|NCT00944671|3938992|B7|Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4114836|NCT00944671|3938993|B6|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4114837|NCT00944671|3938994|B5|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4114838|NCT00944671|3938995|B4|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4114839|NCT00944671|3938996|B3|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4114840|NCT00944671|3938997|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4114841|NCT00944671|3938998|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4114842|NCT00944671|3938992|B7||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4114843|NCT00944671|3938993|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4114844|NCT00944671|3938994|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4114845|NCT00944671|3938995|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4114846|NCT00944671|3938996|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4114847|NCT00944671|3938997|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4114848|NCT00944671|3938998|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4114849|NCT00944671|3938992|B7||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4114850|NCT00944671|3938993|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4114851|NCT00944671|3938994|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4114852|NCT00944671|3938995|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4114853|NCT00944671|3938996|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4114854|NCT00944671|3938997|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4114855|NCT00944671|3938998|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4114856|NCT00944671|3938992|B7|||Age||years|Mean|28.6|28.6|Full Range|||19.0|45.0|
4114857|NCT00944671|3938993|B6|||Age||years|Mean|25.0|25.0|Full Range|||20.0|39.0|
4114858|NCT00944671|3938994|B5|||Age||years|Mean|30.8|30.8|Full Range|||19.0|40.0|
4114859|NCT00944671|3938995|B4|||Age||years|Mean|26.3|26.3|Full Range|||22.0|38.0|
4114860|NCT00944671|3938996|B3|||Age||years|Mean|29.8|29.8|Full Range|||22.0|38.0|
4114861|NCT00944671|3938997|B2|||Age||years|Mean|30.0|30.0|Full Range|||20.0|45.0|
4114862|NCT00944671|3938998|B1|||Age||years|Mean|29.8|29.8|Full Range|||20.0|38.0|
4114863|NCT00944645|3939016|B1|||Weight||Kilograms|Mean|71.6|71.6|Full Range|||48.4|101.0|
4114864|NCT00944645|3939016|B1|||Height||Centimeters|Mean|166.6|166.6|Full Range|||140.0|190.0|
4114865|NCT00944645|3939016|B1||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4114866|NCT00944645|3939016|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4114867|NCT00944645|3939016|B1|||Age||years|Mean|38.5|38.5|Full Range|1|1.0|18.0|65.0|
4114868|NCT00944554|3939029|B3|United States||Region of Enrollment||participants|Number|104|104.0||||||
4114869|NCT00944554|3939030|B2|United States||Region of Enrollment||participants|Number|54|54.0||||||
4114870|NCT00944554|3939031|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4114871|NCT00944554|3939029|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
4114872|NCT00944554|3939030|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4114873|NCT00944554|3939031|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4114874|NCT00944554|3939029|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114875|NCT00944554|3939030|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114876|NCT00944554|3939031|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114877|NCT00944554|3939029|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114878|NCT00944554|3939030|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114879|NCT00944554|3939031|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114880|NCT00944554|3939029|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114881|NCT00944554|3939030|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114882|NCT00944554|3939031|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114883|NCT00944554|3939029|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114884|NCT00944554|3939030|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114885|NCT00944554|3939031|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114886|NCT00944554|3939029|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114887|NCT00944554|3939030|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114888|NCT00944554|3939031|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114889|NCT00944554|3939029|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114890|NCT00944554|3939030|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114891|NCT00944554|3939031|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114892|NCT00944554|3939029|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4114893|NCT00944554|3939030|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4114894|NCT00944554|3939031|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4114895|NCT00944554|3939029|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4114896|NCT00944554|3939030|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4114897|NCT00944554|3939031|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4114898|NCT00944554|3939029|B3|||Age||years|Mean|44|44.0|Standard Deviation|11|11.0|||
4114899|NCT00944554|3939030|B2|||Age||years|Mean|45|45.0|Standard Deviation|12|12.0|||
4114900|NCT00944554|3939031|B1|||Age||years|Mean|43|43.0|Standard Deviation|10|10.0|||
4114901|NCT00944450|3939038|B1|||Weight||Kilograms|Mean|75.3|75.3|Full Range|||56.6|88.3|
4114902|NCT00944450|3939038|B1|||Height||Centimeters|Mean|170.5|170.5|Full Range|||156.5|179.0|
4114903|NCT00944450|3939038|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4114904|NCT00944450|3939038|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4114905|NCT00944450|3939038|B1|||Age||years|Mean|45.3|45.3|Full Range|||41.0|54.0|
4114906|NCT00944229|3939047|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
4114907|NCT00944229|3939047|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4114908|NCT00944229|3939047|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4114909|NCT00944229|3939047|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4114910|NCT00944229|3939047|B1|African American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4114911|NCT00944229|3939047|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4114912|NCT00944229|3939047|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4114913|NCT00944229|3939047|B1|>=65 years||Age, Customized||participants|Number|8|8.0||||||
4114914|NCT00944229|3939047|B1|Between 18 and 65 years||Age, Customized||participants|Number|50|50.0||||||
4114915|NCT00944125|3939053|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4114916|NCT00944125|3939053|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114917|NCT00944125|3939053|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114918|NCT00944125|3939053|B1||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4114919|NCT00944125|3939053|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114920|NCT00944125|3939053|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114921|NCT00944125|3939053|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114922|NCT00944125|3939053|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114923|NCT00944125|3939053|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4114924|NCT00944125|3939053|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4114925|NCT00944125|3939053|B1|||Age||years|Mean|69.5|69.5|Standard Deviation|10.98|10.98|||
4114926|NCT00944073|3939060|B3|United States||Region of Enrollment||participants|Number|583|583.0||||||
4114927|NCT00944073|3939061|B2|United States||Region of Enrollment||participants|Number|291|291.0||||||
4114928|NCT00944073|3939062|B1|United States||Region of Enrollment||participants|Number|292|292.0||||||
4114929|NCT00944073|3939060|B3||Male|Sex: Female, Male||Participants|Count of Participants|317|317.0||||||
4114930|NCT00944073|3939061|B2||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4114931|NCT00944073|3939062|B1||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4114932|NCT00944073|3939060|B3||Female|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
4114933|NCT00944073|3939061|B2||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4114934|NCT00944073|3939062|B1||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4114935|NCT00944073|3939060|B3|||Age||years|Mean|7.5|7.5|Standard Deviation|5.3|5.3|||
4114936|NCT00944073|3939061|B2|||Age||years|Mean|7.3|7.3|Standard Deviation|5.2|5.2|||
4114937|NCT00944073|3939062|B1|||Age||years|Mean|7.6|7.6|Standard Deviation|5.5|5.5|||
4114938|NCT00944073|3939060|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4114939|NCT00944073|3939061|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4114940|NCT00944073|3939062|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4114941|NCT00944073|3939060|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4114942|NCT00944073|3939061|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4114943|NCT00944073|3939062|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4114944|NCT00944073|3939060|B3||<=18 years|Age||Participants|Count of Participants|583|583.0||||||
4114945|NCT00944073|3939061|B2||<=18 years|Age||Participants|Count of Participants|291|291.0||||||
4114946|NCT00944073|3939062|B1||<=18 years|Age||Participants|Count of Participants|292|292.0||||||
4114947|NCT00944047|3939141|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4114948|NCT00944047|3939141|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114949|NCT00944047|3939141|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4114950|NCT00944047|3939141|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4114951|NCT00944047|3939141|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114952|NCT00944047|3939141|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114953|NCT00944047|3939141|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4114954|NCT00944047|3939141|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4114955|NCT00944047|3939141|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4114956|NCT00944047|3939141|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4114957|NCT00944047|3939141|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4114958|NCT00944047|3939141|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4114959|NCT00944034|3939145|B13||Male|Sex: Female, Male||Participants|Count of Participants|826|826.0||||||
4114960|NCT00944034|3939146|B12||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4114961|NCT00944034|3939147|B11||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4114962|NCT00944034|3939148|B10||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4114963|NCT00944034|3939149|B9||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4114964|NCT00944034|3939150|B8||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4114965|NCT00944034|3939151|B7||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4114966|NCT00944034|3939152|B6||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4114967|NCT00944034|3939153|B5||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4114968|NCT00944034|3939154|B4||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4114969|NCT00944034|3939155|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4114970|NCT00944034|3939156|B2||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4114971|NCT00944034|3939157|B1||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4114972|NCT00944034|3939145|B13||Female|Sex: Female, Male||Participants|Count of Participants|762|762.0||||||
4114973|NCT00944034|3939146|B12||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4114974|NCT00944034|3939147|B11||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4114975|NCT00944034|3939148|B10||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4114976|NCT00944034|3939149|B9||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4114977|NCT00944034|3939150|B8||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4114978|NCT00944034|3939151|B7||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4114979|NCT00944034|3939152|B6||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4114980|NCT00944034|3939153|B5||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4114981|NCT00944034|3939154|B4||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4114982|NCT00944034|3939155|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4114983|NCT00944034|3939156|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4114984|NCT00944034|3939157|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4114985|NCT00944034|3939145|B13|||Age||months|Mean|17.1|17.1|Standard Deviation|4.7|4.7|||
4114986|NCT00944034|3939146|B12|||Age||months|Mean|24|24.0|Standard Deviation|0.2|0.2|||
4114987|NCT00944034|3939147|B11|||Age||months|Mean|18|18.0|Standard Deviation|0.2|0.2|||
4114988|NCT00944034|3939148|B10|||Age||months|Mean|12.6|12.6|Standard Deviation|1.3|1.3|||
4114989|NCT00944034|3939149|B9|||Age||months|Mean|24|24.0|Standard Deviation|0.5|0.5|||
4114990|NCT00944034|3939150|B8|||Age||months|Mean|18|18.0|Standard Deviation|0.4|0.4|||
4114991|NCT00944034|3939151|B7|||Age||months|Mean|12.8|12.8|Standard Deviation|1.4|1.4|||
4114992|NCT00944034|3939152|B6|||Age||months|Mean|24|24.0|Standard Deviation|0.3|0.3|||
4114993|NCT00944034|3939153|B5|||Age||months|Mean|18.1|18.1|Standard Deviation|0.5|0.5|||
4114994|NCT00944034|3939154|B4|||Age||months|Mean|12.7|12.7|Standard Deviation|0.9|0.9|||
4114995|NCT00944034|3939155|B3|||Age||months|Mean|24|24.0|Standard Deviation|0.4|0.4|||
4114996|NCT00944034|3939156|B2|||Age||months|Mean|18.1|18.1|Standard Deviation|0.6|0.6|||
4114997|NCT00944034|3939157|B1|||Age||months|Mean|12.6|12.6|Standard Deviation|1.2|1.2|||
4114998|NCT00944034|3939145|B13||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4114999|NCT00944034|3939146|B12||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4115000|NCT00944034|3939147|B11||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4115001|NCT00944034|3939148|B10||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4115002|NCT00944034|3939149|B9||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4115003|NCT00944034|3939150|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4115004|NCT00944034|3939151|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4115005|NCT00944034|3939152|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4115006|NCT00944034|3939153|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4115007|NCT00944034|3939154|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4115008|NCT00944034|3939155|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4115009|NCT00944034|3939156|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4115010|NCT00944034|3939157|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4115011|NCT00944034|3939145|B13||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4115012|NCT00944034|3939146|B12||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4115013|NCT00944034|3939147|B11||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4115014|NCT00944034|3939148|B10||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4115015|NCT00944034|3939149|B9||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4115016|NCT00944034|3939150|B8||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4115017|NCT00944034|3939151|B7||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4115018|NCT00944034|3939152|B6||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4115019|NCT00944034|3939153|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4115020|NCT00944034|3939154|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4115021|NCT00944034|3939155|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4115022|NCT00944034|3939156|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4115023|NCT00944034|3939157|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4115024|NCT00944034|3939145|B13||<=18 years|Age||Participants|Count of Participants|1588|1588.0||||||
4115025|NCT00944034|3939146|B12||<=18 years|Age||Participants|Count of Participants|56|56.0||||||
4115026|NCT00944034|3939147|B11||<=18 years|Age||Participants|Count of Participants|51|51.0||||||
4115027|NCT00944034|3939148|B10||<=18 years|Age||Participants|Count of Participants|246|246.0||||||
4115028|NCT00944034|3939149|B9||<=18 years|Age||Participants|Count of Participants|73|73.0||||||
4115029|NCT00944034|3939150|B8||<=18 years|Age||Participants|Count of Participants|78|78.0||||||
4115030|NCT00944034|3939151|B7||<=18 years|Age||Participants|Count of Participants|106|106.0||||||
4115031|NCT00944034|3939152|B6||<=18 years|Age||Participants|Count of Participants|143|143.0||||||
4115032|NCT00944034|3939153|B5||<=18 years|Age||Participants|Count of Participants|164|164.0||||||
4115033|NCT00944034|3939154|B4||<=18 years|Age||Participants|Count of Participants|174|174.0||||||
4115034|NCT00944034|3939155|B3||<=18 years|Age||Participants|Count of Participants|152|152.0||||||
4115035|NCT00944034|3939156|B2||<=18 years|Age||Participants|Count of Participants|157|157.0||||||
4115036|NCT00944034|3939157|B1||<=18 years|Age||Participants|Count of Participants|188|188.0||||||
4115037|NCT00944021|3939233|B6|South Africa||Region of Enrollment||participants|Number|69|69.0||||||
4115038|NCT00944021|3939234|B5|South Africa||Region of Enrollment||participants|Number|8|8.0||||||
4115039|NCT00944021|3939235|B4|South Africa||Region of Enrollment||participants|Number|16|16.0||||||
4115040|NCT00944021|3939236|B3|South Africa||Region of Enrollment||participants|Number|15|15.0||||||
4115041|NCT00944021|3939237|B2|South Africa||Region of Enrollment||participants|Number|15|15.0||||||
4115042|NCT00944021|3939238|B1|South Africa||Region of Enrollment||participants|Number|15|15.0||||||
4115043|NCT00944021|3939233|B6||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4115044|NCT00944021|3939234|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4115045|NCT00944021|3939235|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4115046|NCT00944021|3939236|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4115047|NCT00944021|3939237|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4115048|NCT00944021|3939238|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4115049|NCT00944021|3939233|B6||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4115050|NCT00944021|3939234|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4115051|NCT00944021|3939235|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4115052|NCT00944021|3939236|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4115053|NCT00944021|3939237|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4115054|NCT00944021|3939238|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4115055|NCT00944021|3939233|B6|||Age||years|Mean|28.6|28.6|Standard Deviation|9.45|9.45|||
4115056|NCT00944021|3939234|B5|||Age||years|Mean|33.3|33.3|Standard Deviation|14.09|14.09|||
4115057|NCT00944021|3939235|B4|||Age||years|Mean|25.3|25.3|Standard Deviation|6.18|6.18|||
4115058|NCT00944021|3939236|B3|||Age||years|Mean|26.9|26.9|Standard Deviation|8.91|8.91|||
4115059|NCT00944021|3939237|B2|||Age||years|Mean|29.6|29.6|Standard Deviation|9.28|9.28|||
4115060|NCT00944021|3939238|B1|||Age||years|Mean|30.5|30.5|Standard Deviation|9.76|9.76|||
4115061|NCT00944021|3939233|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4115062|NCT00944021|3939234|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4115063|NCT00944021|3939235|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4115064|NCT00944021|3939236|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4115065|NCT00944021|3939237|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4115066|NCT00944021|3939238|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4115067|NCT00944021|3939233|B6||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
4115068|NCT00944021|3939234|B5||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4115069|NCT00944021|3939235|B4||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4115070|NCT00944021|3939236|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4115071|NCT00944021|3939237|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4115072|NCT00944021|3939238|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4115073|NCT00944021|3939233|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4115074|NCT00944021|3939234|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4115075|NCT00944021|3939235|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4115076|NCT00944021|3939236|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4115077|NCT00944021|3939237|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4115078|NCT00944021|3939238|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4115079|NCT00943917|3939299|B16|United States||Region of Enrollment||participants|Number|155|155.0||||||
4115080|NCT00943917|3939312|B3|United States||Region of Enrollment||participants|Number|53|53.0||||||
4115081|NCT00943917|3939313|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
4115082|NCT00943917|3939314|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4115083|NCT00943917|3939299|B16|Male||Gender||participants|Number|77|77.0||||||
4115084|NCT00943917|3939312|B3|Male||Gender||participants|Number|29|29.0||||||
4115085|NCT00943917|3939313|B2|Male||Gender||participants|Number|23|23.0||||||
4115086|NCT00943917|3939314|B1|Male||Gender||participants|Number|25|25.0||||||
4115087|NCT00943917|3939299|B16|Female||Gender||participants|Number|78|78.0||||||
4115088|NCT00943917|3939312|B3|Female||Gender||participants|Number|24|24.0||||||
4115089|NCT00943917|3939313|B2|Female||Gender||participants|Number|28|28.0||||||
4115090|NCT00943917|3939314|B1|Female||Gender||participants|Number|26|26.0||||||
4115091|NCT00943917|3939299|B16|>=60 years||Age, Customized||participants|Number|38|38.0||||||
4115092|NCT00943917|3939312|B3|>=60 years||Age, Customized||participants|Number|14|14.0||||||
4115093|NCT00943917|3939313|B2|>=60 years||Age, Customized||participants|Number|14|14.0||||||
4115094|NCT00943917|3939314|B1|>=60 years||Age, Customized||participants|Number|10|10.0||||||
4115095|NCT00943917|3939299|B16|Between 18 and 60 years||Age, Customized||participants|Number|117|117.0||||||
4115096|NCT00943917|3939312|B3|Between 18 and 60 years||Age, Customized||participants|Number|39|39.0||||||
4115097|NCT00943917|3939313|B2|Between 18 and 60 years||Age, Customized||participants|Number|37|37.0||||||
4115098|NCT00943917|3939314|B1|Between 18 and 60 years||Age, Customized||participants|Number|41|41.0||||||
4115099|NCT00943917|3939299|B16|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4115100|NCT00943917|3939312|B3|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4115101|NCT00943917|3939313|B2|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4115102|NCT00943917|3939314|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4115103|NCT00943917|3939299|B16|||Age||years|Mean|53.7|53.7|Standard Deviation|8.9|8.9|||
4115104|NCT00943917|3939312|B3|||Age||years|Mean|53.8|53.8|Standard Deviation|9.6|9.6|||
4115105|NCT00943917|3939313|B2|||Age||years|Mean|53.3|53.3|Standard Deviation|8.9|8.9|||
4115106|NCT00943917|3939314|B1|||Age||years|Mean|54.0|54.0|Standard Deviation|8.3|8.3|||
4115107|NCT00943878|3939375|B5|United States||Region of Enrollment||participants|Number|805|805.0||||||
4115108|NCT00943878|3939376|B4|United States||Region of Enrollment||participants|Number|200|200.0||||||
4115109|NCT00943878|3939377|B3|United States||Region of Enrollment||participants|Number|203|203.0||||||
4115110|NCT00943878|3939378|B2|United States||Region of Enrollment||participants|Number|200|200.0||||||
4115111|NCT00943878|3939379|B1|United States||Region of Enrollment||participants|Number|202|202.0||||||
4115112|NCT00943878|3939375|B5||Male|Sex: Female, Male||Participants|Count of Participants|361|361.0||||||
4115113|NCT00943878|3939376|B4||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4115114|NCT00943878|3939377|B3||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4115115|NCT00943878|3939378|B2||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4115116|NCT00943878|3939379|B1||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4115117|NCT00943878|3939375|B5||Female|Sex: Female, Male||Participants|Count of Participants|444|444.0||||||
4115118|NCT00943878|3939376|B4||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4115119|NCT00943878|3939377|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4115120|NCT00943878|3939378|B2||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4115121|NCT00943878|3939379|B1||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4115122|NCT00943878|3939375|B5|||Age||years|Mean|58.8|58.8|Standard Deviation|16.2|16.2|||
4115123|NCT00943878|3939376|B4|||Age||years|Mean|59.1|59.1|Standard Deviation|15.3|15.3|||
4115124|NCT00943878|3939377|B3|||Age||years|Mean|58.5|58.5|Standard Deviation|16.6|16.6|||
4115125|NCT00943878|3939378|B2|||Age||years|Mean|58.4|58.4|Standard Deviation|16.7|16.7|||
4115126|NCT00943878|3939379|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|16.2|16.2|||
4115127|NCT00943878|3939375|B5||>=65 years|Age||Participants|Count of Participants|397|397.0||||||
4115128|NCT00943878|3939376|B4||>=65 years|Age||Participants|Count of Participants|98|98.0||||||
4115129|NCT00943878|3939377|B3||>=65 years|Age||Participants|Count of Participants|101|101.0||||||
4115130|NCT00943878|3939378|B2||>=65 years|Age||Participants|Count of Participants|97|97.0||||||
4115131|NCT00943878|3939379|B1||>=65 years|Age||Participants|Count of Participants|101|101.0||||||
4115132|NCT00943878|3939375|B5||Between 18 and 65 years|Age||Participants|Count of Participants|408|408.0||||||
4115133|NCT00943878|3939376|B4||Between 18 and 65 years|Age||Participants|Count of Participants|102|102.0||||||
4115134|NCT00943878|3939377|B3||Between 18 and 65 years|Age||Participants|Count of Participants|102|102.0||||||
4115135|NCT00943878|3939378|B2||Between 18 and 65 years|Age||Participants|Count of Participants|103|103.0||||||
4115136|NCT00943878|3939379|B1||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
4115137|NCT00943878|3939375|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4115138|NCT00943878|3939376|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4115139|NCT00943878|3939377|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4115140|NCT00943878|3939378|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4115141|NCT00943878|3939379|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4115142|NCT00943852|3939504|B1|||Systolic Blood Pressure||mm Hg|Mean|141.5|141.5|Full Range|||114.0|165.0|
4115143|NCT00943852|3939504|B1|||Heart Rate||Beats per Minute|Mean|75.4|75.4|Full Range|||48.0|99.0|
4115144|NCT00943852|3939504|B1|||Diastolic Blood Pressure||mm Hg|Mean|90.6|90.6|Full Range|||77.0|103.0|
4115145|NCT00943852|3939504|B1|No||Exclusionary Medication Washout||participants|Number|10|10.0||||||
4115146|NCT00943852|3939504|B1|Yes||Exclusionary Medication Washout||participants|Number|3|3.0||||||
4115147|NCT00943852|3939504|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4115148|NCT00943852|3939504|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4115149|NCT00943852|3939504|B1|||Age||years|Mean|57.2|57.2|Full Range|||46.0|67.0|
4115150|NCT00943826|3939524|B3||Male|Sex: Female, Male||Participants|Count of Participants|580|580.0||||||
4115151|NCT00943826|3939525|B2||Male|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
4115152|NCT00943826|3939526|B1||Male|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
4115153|NCT00943826|3939524|B3||Female|Sex: Female, Male||Participants|Count of Participants|341|341.0||||||
4115154|NCT00943826|3939525|B2||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4115155|NCT00943826|3939526|B1||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4115156|NCT00943826|3939524|B3|||Age||years|Mean|55.9|55.9|Full Range|||18.0|84.0|
4115157|NCT00943826|3939525|B2|||Age||years|Mean|55.9|55.9|Full Range|||18.0|79.0|
4115158|NCT00943826|3939526|B1|||Age||years|Mean|55.9|55.9|Full Range|||20.0|84.0|
4115159|NCT00943787|3939545|B1|||Glycosylated hembglobin (HbA1c)||percent|Mean|7.6|7.6|Standard Deviation|0.21|0.21|||
4115160|NCT00943787|3939545|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4115161|NCT00943787|3939545|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4115162|NCT00943787|3939545|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4115163|NCT00943787|3939545|B1|||Age||years|Mean|37|37.0|Standard Deviation|2.1|2.1|||
4115164|NCT00943787|3939545|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4115165|NCT00943787|3939545|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4115166|NCT00943787|3939545|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4115167|NCT00943761|3939550|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4115168|NCT00943761|3939551|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4115169|NCT00943761|3939552|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4115170|NCT00943761|3939550|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4115171|NCT00943761|3939551|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4115172|NCT00943761|3939552|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4115173|NCT00943761|3939550|B3|||Age||Years|Mean|50.2|50.2|Standard Deviation|8.1|8.1|||
4115174|NCT00943761|3939551|B2|||Age||Years|Mean|48.1|48.1|Standard Deviation|8.4|8.4|||
4115175|NCT00943761|3939552|B1|||Age||Years|Mean|52.5|52.5|Standard Deviation|7.4|7.4|||
4115176|NCT00943735|3939565|B1||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4115177|NCT00943735|3939565|B1||Female|Sex: Female, Male||Participants|Count of Participants|593|593.0||||||
4115178|NCT00943735|3939565|B1|≥ 65 years||Age, Customized||participants|Number|325|325.0||||||
4115179|NCT00943735|3939565|B1|45 to 64 years||Age, Customized||participants|Number|325|325.0||||||
4115180|NCT00943735|3939565|B1|25 to 44 years||Age, Customized||participants|Number|119|119.0||||||
4115181|NCT00943735|3939565|B1|18 to 24 years||Age, Customized||participants|Number|5|5.0||||||
4115182|NCT00943722|3939598|B6||Male|Sex: Female, Male||Participants|Count of Participants|669|669.0||||||
4115183|NCT00943722|3939599|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4115184|NCT00943722|3939600|B4||Male|Sex: Female, Male||Participants|Count of Participants|669|669.0||||||
4115185|NCT00943722|3939601|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4115186|NCT00943722|3939602|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4115187|NCT00943722|3939603|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4115188|NCT00943722|3939598|B6||Female|Sex: Female, Male||Participants|Count of Participants|2405|2405.0||||||
4115189|NCT00943722|3939599|B5||Female|Sex: Female, Male||Participants|Count of Participants|470|470.0||||||
4115190|NCT00943722|3939600|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4115191|NCT00943722|3939601|B3||Female|Sex: Female, Male||Participants|Count of Participants|644|644.0||||||
4115192|NCT00943722|3939602|B2||Female|Sex: Female, Male||Participants|Count of Participants|643|643.0||||||
4115193|NCT00943722|3939603|B1||Female|Sex: Female, Male||Participants|Count of Participants|648|648.0||||||
4115194|NCT00943722|3939598|B6|16 to 26 years||Age, Customized||Participants|Number|470|470.0||||||
4115195|NCT00943722|3939599|B5|16 to 26 years||Age, Customized||Participants|Number|470|470.0||||||
4115196|NCT00943722|3939600|B4|16 to 26 years||Age, Customized||Participants|Number|0|0.0||||||
4115197|NCT00943722|3939601|B3|16 to 26 years||Age, Customized||Participants|Number|0|0.0||||||
4115198|NCT00943722|3939602|B2|16 to 26 years||Age, Customized||Participants|Number|0|0.0||||||
4115199|NCT00943722|3939603|B1|16 to 26 years||Age, Customized||Participants|Number|0|0.0||||||
4115200|NCT00943722|3939598|B6|13 to 15 years||Age, Customized||Participants|Number|850|850.0||||||
4115201|NCT00943722|3939599|B5|13 to 15 years||Age, Customized||Participants|Number|0|0.0||||||
4115202|NCT00943722|3939600|B4|13 to 15 years||Age, Customized||Participants|Number|219|219.0||||||
4115203|NCT00943722|3939601|B3|13 to 15 years||Age, Customized||Participants|Number|212|212.0||||||
4115204|NCT00943722|3939602|B2|13 to 15 years||Age, Customized||Participants|Number|211|211.0||||||
4115205|NCT00943722|3939603|B1|13 to 15 years||Age, Customized||Participants|Number|208|208.0||||||
4115206|NCT00943722|3939598|B6|9 to 12 years||Age, Customized||Participants|Number|1754|1754.0||||||
4115207|NCT00943722|3939599|B5|9 to 12 years||Age, Customized||Participants|Number|0|0.0||||||
4115208|NCT00943722|3939600|B4|9 to 12 years||Age, Customized||Participants|Number|450|450.0||||||
4115209|NCT00943722|3939601|B3|9 to 12 years||Age, Customized||Participants|Number|432|432.0||||||
4115210|NCT00943722|3939602|B2|9 to 12 years||Age, Customized||Participants|Number|432|432.0||||||
4115211|NCT00943722|3939603|B1|9 to 12 years||Age, Customized||Participants|Number|440|440.0||||||
4115212|NCT00943683|3939635|B3||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4115213|NCT00943683|3939636|B2||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4115214|NCT00943683|3939637|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4115215|NCT00943683|3939635|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4115216|NCT00943683|3939636|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4115217|NCT00943683|3939637|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4115218|NCT00943683|3939635|B3|||Age||Months|Mean|14.63|14.63|Standard Deviation|4.87|4.87|||
4115219|NCT00943683|3939636|B2|||Age||Months|Mean|14.90|14.9|Standard Deviation|4.70|4.7|||
4115220|NCT00943683|3939637|B1|||Age||Months|Mean|14.05|14.05|Standard Deviation|5.22|5.22|||
4115221|NCT00943670|3939644|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4115222|NCT00943670|3939644|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4115223|NCT00943670|3939644|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4115224|NCT00943670|3939644|B1|||Age||years|Mean|53.5|53.5|Standard Deviation|11.4|11.4|||
4115225|NCT00943631|3939678|B3|United States||Region of Enrollment||participants|Number|406|406.0||||||
4115226|NCT00943631|3939679|B2|United States||Region of Enrollment||participants|Number|204|204.0||||||
4115227|NCT00943631|3939680|B1|United States||Region of Enrollment||participants|Number|202|202.0||||||
4115228|NCT00943631|3939678|B3||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4115229|NCT00943631|3939679|B2||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4115230|NCT00943631|3939680|B1||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4115231|NCT00943631|3939678|B3||Female|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
4115232|NCT00943631|3939679|B2||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4115233|NCT00943631|3939680|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4115234|NCT00943631|3939678|B3|||Age||years|Mean|59.1|59.1|Standard Deviation|16.7|16.7|||
4115235|NCT00943631|3939679|B2|||Age||years|Mean|59.6|59.6|Standard Deviation|16.4|16.4|||
4115236|NCT00943631|3939680|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|17.1|17.1|||
4115237|NCT00943631|3939678|B3||>=65 years|Age||Participants|Count of Participants|204|204.0||||||
4115238|NCT00943631|3939679|B2||>=65 years|Age||Participants|Count of Participants|104|104.0||||||
4115239|NCT00943631|3939680|B1||>=65 years|Age||Participants|Count of Participants|100|100.0||||||
4115240|NCT00943631|3939678|B3||Between 18 and 65 years|Age||Participants|Count of Participants|202|202.0||||||
4115241|NCT00943631|3939679|B2||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4115242|NCT00943631|3939680|B1||Between 18 and 65 years|Age||Participants|Count of Participants|102|102.0||||||
4115243|NCT00943631|3939678|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4115244|NCT00943631|3939679|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4115245|NCT00943631|3939680|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4115246|NCT00943605|3939731|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4115247|NCT00943605|3939732|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4115248|NCT00943605|3939733|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4115249|NCT00943605|3939731|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4115250|NCT00943605|3939732|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4115251|NCT00943605|3939733|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4115252|NCT00943605|3939731|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4115253|NCT00943605|3939732|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4115254|NCT00943605|3939733|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4115255|NCT00943605|3939731|B3|20 to 70 years||Age, Customized|An integrity audit found that the data for this study could not be analyzed owing to unverifiable source documentation. The protocol-specified age range is used for this baseline measure.|participants|Number|60|60.0||||||
4115256|NCT00943605|3939732|B2|20 to 70 years||Age, Customized|An integrity audit found that the data for this study could not be analyzed owing to unverifiable source documentation. The protocol-specified age range is used for this baseline measure.|participants|Number|30|30.0||||||
4115257|NCT00943605|3939733|B1|20 to 70 years||Age, Customized|An integrity audit found that the data for this study could not be analyzed owing to unverifiable source documentation. The protocol-specified age range is used for this baseline measure.|participants|Number|30|30.0||||||
4115258|NCT00943592|3939744|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4115259|NCT00943592|3939744|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4115260|NCT00943592|3939744|B1|||Age||years|Median|54|54.0|Full Range|||21.0|73.0|
4115261|NCT00943579|3939755|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
4115262|NCT00943579|3939756|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4115263|NCT00943579|3939757|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4115264|NCT00943579|3939755|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4115265|NCT00943579|3939756|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4115266|NCT00943579|3939757|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4115267|NCT00943579|3939755|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4115268|NCT00943579|3939756|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4115269|NCT00943579|3939757|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4115270|NCT00943579|3939755|B3|||Age||years|Mean|5|5.0|Standard Deviation|1|1.0|||
4115271|NCT00943579|3939756|B2|||Age||years|Mean|5|5.0|Standard Deviation|1|1.0|||
4115272|NCT00943579|3939757|B1|||Age||years|Mean|5|5.0|Standard Deviation|1|1.0|||
4115273|NCT00943579|3939755|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4115274|NCT00943579|3939756|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4115275|NCT00943579|3939757|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4115276|NCT00943579|3939755|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4115277|NCT00943579|3939756|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4115278|NCT00943579|3939757|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4115279|NCT00943579|3939755|B3||<=18 years|Age||Participants|Count of Participants|41|41.0||||||
4115280|NCT00943579|3939756|B2||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
4115281|NCT00943579|3939757|B1||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
4115282|NCT00943488|3939777|B3|United States||Region of Enrollment||participants|Number|408|408.0||||||
4115283|NCT00943488|3939778|B2|United States||Region of Enrollment||participants|Number|204|204.0||||||
4115284|NCT00943488|3939779|B1|United States||Region of Enrollment||participants|Number|204|204.0||||||
4115285|NCT00943488|3939777|B3||Male|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4115286|NCT00943488|3939778|B2||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4115287|NCT00943488|3939779|B1||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4115288|NCT00943488|3939777|B3||Female|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
4115289|NCT00943488|3939778|B2||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4115290|NCT00943488|3939779|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4115291|NCT00943488|3939777|B3|||Age||years|Mean|58.7|58.7|Standard Deviation|16.5|16.5|||
4115292|NCT00943488|3939778|B2|||Age||years|Mean|59.5|59.5|Standard Deviation|15.9|15.9|||
4115293|NCT00943488|3939779|B1|||Age||years|Mean|57.9|57.9|Standard Deviation|17.1|17.1|||
4115294|NCT00943488|3939777|B3||>=65 years|Age||Participants|Count of Participants|208|208.0||||||
4115295|NCT00943488|3939778|B2||>=65 years|Age||Participants|Count of Participants|106|106.0||||||
4115296|NCT00943488|3939779|B1||>=65 years|Age||Participants|Count of Participants|102|102.0||||||
4115297|NCT00943488|3939777|B3||Between 18 and 65 years|Age||Participants|Count of Participants|200|200.0||||||
4115298|NCT00943488|3939778|B2||Between 18 and 65 years|Age||Participants|Count of Participants|98|98.0||||||
4115299|NCT00943488|3939779|B1||Between 18 and 65 years|Age||Participants|Count of Participants|102|102.0||||||
4115300|NCT00943488|3939777|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4115301|NCT00943488|3939778|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4115302|NCT00943488|3939779|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4115303|NCT00943436|3939834|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4115304|NCT00943436|3939835|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4115305|NCT00943436|3939836|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4115306|NCT00943436|3939834|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4115307|NCT00943436|3939835|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4115308|NCT00943436|3939836|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4115309|NCT00943436|3939834|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4115310|NCT00943436|3939835|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4115311|NCT00943436|3939836|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4115312|NCT00943436|3939834|B3|||Age||years|Mean|21.15|21.15|Standard Deviation|2.000|2.0|||
4115313|NCT00943436|3939835|B2|||Age||years|Mean|20.90|20.9|Standard Deviation|1.792|1.792|||
4115314|NCT00943436|3939836|B1|||Age||years|Mean|21.40|21.4|Standard Deviation|2.066|2.066|||
4115315|NCT00943436|3939834|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4115316|NCT00943436|3939835|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4115317|NCT00943436|3939836|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4115318|NCT00943436|3939834|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4115319|NCT00943436|3939835|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4115320|NCT00943436|3939836|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4115321|NCT00943436|3939834|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4115322|NCT00943436|3939835|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4115323|NCT00943436|3939836|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4115324|NCT00943397|3939857|B3||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4115325|NCT00943397|3939858|B2||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4115326|NCT00943397|3939859|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4115327|NCT00943397|3939857|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4115328|NCT00943397|3939858|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4115329|NCT00943397|3939859|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4115330|NCT00943397|3939857|B3|||Age||Months|Mean|16.49|16.49|Standard Deviation|7.36|7.36|||
4115331|NCT00943397|3939858|B2|||Age||Months|Mean|16.45|16.45|Standard Deviation|7.41|7.41|||
4115332|NCT00943397|3939859|B1|||Age||Months|Mean|16.69|16.69|Standard Deviation|7.22|7.22|||
4115333|NCT00943384|3939866|B1|Two-level, L4-S1||Level(s) treated|Subjects were treated at one or two contiguous levels from L2 through S1|participants|Number|26|26.0||||||
4115334|NCT00943384|3939866|B1|Two-level, L3-5||Level(s) treated|Subjects were treated at one or two contiguous levels from L2 through S1|participants|Number|8|8.0||||||
4115335|NCT00943384|3939866|B1|One-level, L5-S1||Level(s) treated|Subjects were treated at one or two contiguous levels from L2 through S1|participants|Number|18|18.0||||||
4115336|NCT00943384|3939866|B1|One level, L4-5||Level(s) treated|Subjects were treated at one or two contiguous levels from L2 through S1|participants|Number|22|22.0||||||
4115337|NCT00943384|3939866|B1|One-level, L3-4||Level(s) treated|Subjects were treated at one or two contiguous levels from L2 through S1|participants|Number|1|1.0||||||
4115338|NCT00943384|3939866|B1|One-level, L2-3||Level(s) treated|Subjects were treated at one or two contiguous levels from L2 through S1|participants|Number|1|1.0||||||
4115339|NCT00943384|3939866|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4115340|NCT00943384|3939866|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4115341|NCT00943384|3939866|B1|||Age||years|Mean|50.1|50.1|Standard Deviation|10.37|10.37|||
4115342|NCT00943306|3939880|B1|Italy||Region of Enrollment||participants|Number|5|5.0||||||
4115343|NCT00943306|3939880|B1|South Africa||Region of Enrollment||participants|Number|9|9.0||||||
4115344|NCT00943306|3939880|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4115345|NCT00943306|3939880|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4115346|NCT00943306|3939880|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4115347|NCT00943306|3939880|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115348|NCT00943306|3939880|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4115349|NCT00943306|3939880|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115350|NCT00943306|3939880|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115351|NCT00943306|3939880|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4115352|NCT00943306|3939880|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115353|NCT00943306|3939880|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4115354|NCT00943306|3939880|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4115355|NCT00943306|3939880|B1|||Age||years|Mean|30.4|30.4|Standard Deviation|11.74|11.74|||
4115356|NCT00943306|3939880|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4115357|NCT00943306|3939880|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4115358|NCT00943306|3939880|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4115359|NCT00943202|3939937|B5|United States||Region of Enrollment||participants|Number|531|531.0||||||
4115360|NCT00943202|3939938|B4|United States||Region of Enrollment||participants|Number|132|132.0||||||
4115361|NCT00943202|3939939|B3|United States||Region of Enrollment||participants|Number|133|133.0||||||
4115362|NCT00943202|3939940|B2|United States||Region of Enrollment||participants|Number|133|133.0||||||
4115363|NCT00943202|3939941|B1|United States||Region of Enrollment||participants|Number|133|133.0||||||
4115364|NCT00943202|3939937|B5||Male|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
4115365|NCT00943202|3939938|B4||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4115366|NCT00943202|3939939|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4115367|NCT00943202|3939940|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4115368|NCT00943202|3939941|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4115369|NCT00943202|3939937|B5||Female|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
4115370|NCT00943202|3939938|B4||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4115371|NCT00943202|3939939|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4115372|NCT00943202|3939940|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4115373|NCT00943202|3939941|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4115374|NCT00943202|3939937|B5|||Age||years|Mean|8.1|8.1|Standard Deviation|5.1|5.1|||
4115375|NCT00943202|3939938|B4|||Age||years|Mean|8.5|8.5|Standard Deviation|5.0|5.0|||
4115376|NCT00943202|3939939|B3|||Age||years|Mean|7.9|7.9|Standard Deviation|5.3|5.3|||
4115377|NCT00943202|3939940|B2|||Age||years|Mean|8.2|8.2|Standard Deviation|5.3|5.3|||
4115378|NCT00943202|3939941|B1|||Age||years|Mean|8.0|8.0|Standard Deviation|5.0|5.0|||
4115379|NCT00943202|3939937|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4115380|NCT00943202|3939938|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4115381|NCT00943202|3939939|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4115382|NCT00943202|3939940|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4115383|NCT00943202|3939941|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4115384|NCT00943202|3939937|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4115385|NCT00943202|3939938|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4115386|NCT00943202|3939939|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4115387|NCT00943202|3939940|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4115388|NCT00943202|3939941|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4115389|NCT00943202|3939937|B5||<=18 years|Age||Participants|Count of Participants|531|531.0||||||
4115390|NCT00943202|3939938|B4||<=18 years|Age||Participants|Count of Participants|132|132.0||||||
4115391|NCT00943202|3939939|B3||<=18 years|Age||Participants|Count of Participants|133|133.0||||||
4115392|NCT00943202|3939940|B2||<=18 years|Age||Participants|Count of Participants|133|133.0||||||
4115393|NCT00943202|3939941|B1||<=18 years|Age||Participants|Count of Participants|133|133.0||||||
4115394|NCT00943150|3940158|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4115395|NCT00943150|3940159|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4115396|NCT00943150|3940160|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4115397|NCT00943150|3940158|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4115398|NCT00943150|3940159|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4115399|NCT00943150|3940160|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4115400|NCT00943150|3940158|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4115401|NCT00943150|3940159|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4115402|NCT00943150|3940160|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4115403|NCT00943150|3940158|B3|||Age||years|Mean|43.26|43.26|Full Range|||28.0|58.0|
4115404|NCT00943150|3940159|B2|||Age||years|Mean|44.40|44.4|Full Range|10.72|10.72|28.0|58.0|
4115405|NCT00943150|3940160|B1|||Age||years|Mean|42.11|42.11|Full Range|9.41|9.41|28.0|56.0|
4115406|NCT00943124|3940182|B1|||Weight||Kilograms|Mean|72.99|72.99|Full Range|||43.6|111.2|
4115407|NCT00943124|3940182|B1|||Height||Centimeters|Mean|169.58|169.58|Full Range|||147.0|193.0|
4115408|NCT00943124|3940182|B1||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4115409|NCT00943124|3940182|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4115410|NCT00943124|3940182|B1|||Age||years|Mean|35.11|35.11|Full Range|||18.0|65.0|
4115411|NCT00943111|3940203|B3|||Height||centimeter (cm)|Mean|167.1|167.1|Standard Deviation|9.79|9.79|||
4115412|NCT00943111|3940204|B2|||Height||centimeter (cm)|Mean|166.2|166.2|Standard Deviation|9.56|9.56|||
4115413|NCT00943111|3940205|B1|||Height||centimeter (cm)|Mean|167.6|167.6|Standard Deviation|9.92|9.92|||
4115414|NCT00943111|3940203|B3|||Weight||kilogram (kg)|Mean|69.8|69.8|Standard Deviation|16.08|16.08|||
4115415|NCT00943111|3940204|B2|||Weight||kilogram (kg)|Mean|67.8|67.8|Standard Deviation|14.44|14.44|||
4115416|NCT00943111|3940205|B1|||Weight||kilogram (kg)|Mean|70.8|70.8|Standard Deviation|16.82|16.82|||
4115721|NCT00942578|3940404|B4||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4115417|NCT00943111|3940203|B3|||Body Mass Index (BMI)|BMI was calculated as ([weight in kg] divided by [height in cm multiplied by 0.01]^2).|kilogram per square meter (kg/m^2)|Mean|24.9|24.9|Standard Deviation|5.01|5.01|||
4115418|NCT00943111|3940204|B2|||Body Mass Index (BMI)|BMI was calculated as ([weight in kg] divided by [height in cm multiplied by 0.01]^2).|kilogram per square meter (kg/m^2)|Mean|24.5|24.5|Standard Deviation|4.51|4.51|||
4115419|NCT00943111|3940205|B1|||Body Mass Index (BMI)|BMI was calculated as ([weight in kg] divided by [height in cm multiplied by 0.01]^2).|kilogram per square meter (kg/m^2)|Mean|25.2|25.2|Standard Deviation|5.24|5.24|||
4115420|NCT00943111|3940203|B3|Ethnicity: Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|98|98.0||||||
4115421|NCT00943111|3940204|B2|Ethnicity: Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4115422|NCT00943111|3940205|B1|Ethnicity: Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|64|64.0||||||
4115423|NCT00943111|3940203|B3|Ethnicity: Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
4115424|NCT00943111|3940204|B2|Ethnicity: Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4115425|NCT00943111|3940205|B1|Ethnicity: Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4115426|NCT00943111|3940203|B3|Race: White/American Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4115427|NCT00943111|3940204|B2|Race: White/American Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4115428|NCT00943111|3940205|B1|Race: White/American Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4115429|NCT00943111|3940203|B3|Race: Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4115430|NCT00943111|3940204|B2|Race: Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4115431|NCT00943111|3940205|B1|Race: Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4115432|NCT00943111|3940203|B3|Race: Black or African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4115433|NCT00943111|3940204|B2|Race: Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4115434|NCT00943111|3940205|B1|Race: Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4115435|NCT00943111|3940203|B3|Race: White||Race/Ethnicity, Customized||participants|Number|146|146.0||||||
4115436|NCT00943111|3940204|B2|Race: White||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
4115437|NCT00943111|3940205|B1|Race: White||Race/Ethnicity, Customized||participants|Number|98|98.0||||||
4115438|NCT00943111|3940203|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4115439|NCT00943111|3940204|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4115440|NCT00943111|3940205|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4115441|NCT00943111|3940203|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4115442|NCT00943111|3940204|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4115443|NCT00943111|3940205|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4115444|NCT00943111|3940203|B3|||Age||years|Mean|37.5|37.5|Standard Deviation|14.37|14.37|||
4115445|NCT00943111|3940204|B2|||Age||years|Mean|37.5|37.5|Standard Deviation|14.92|14.92|||
4115446|NCT00943111|3940205|B1|||Age||years|Mean|37.6|37.6|Standard Deviation|14.17|14.17|||
4115447|NCT00943098|3940238|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4115448|NCT00943098|3940239|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4115449|NCT00943098|3940240|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4115450|NCT00943098|3940238|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4115451|NCT00943098|3940239|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4115452|NCT00943098|3940240|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4115453|NCT00943098|3940238|B3|||Age||years|Mean|28.49|28.49|Standard Deviation|6.96|6.96|||
4115454|NCT00943098|3940239|B2|||Age||years|Mean|28.7|28.7|Standard Deviation|7.08|7.08|||
4115455|NCT00943098|3940240|B1|||Age||years|Mean|28.1|28.1|Standard Deviation|6.88|6.88|||
4115456|NCT00943072|3940273|B3|Missing||Time Since Central Retinal Vein Occlusion (CRVO) Diagnosis||participants|Number|1|1.0||||||
4115457|NCT00943072|3940274|B2|Missing||Time Since Central Retinal Vein Occlusion (CRVO) Diagnosis||participants|Number|0|0.0||||||
4115458|NCT00943072|3940275|B1|Missing||Time Since Central Retinal Vein Occlusion (CRVO) Diagnosis||participants|Number|1|1.0||||||
4115459|NCT00943072|3940273|B3|> 2 Months||Time Since Central Retinal Vein Occlusion (CRVO) Diagnosis||participants|Number|70|70.0||||||
4115460|NCT00943072|3940274|B2|> 2 Months||Time Since Central Retinal Vein Occlusion (CRVO) Diagnosis||participants|Number|21|21.0||||||
4115461|NCT00943072|3940275|B1|> 2 Months||Time Since Central Retinal Vein Occlusion (CRVO) Diagnosis||participants|Number|49|49.0||||||
4115462|NCT00943072|3940273|B3|</= 2 Months||Time Since Central Retinal Vein Occlusion (CRVO) Diagnosis||participants|Number|117|117.0||||||
4115463|NCT00943072|3940274|B2|</= 2 Months||Time Since Central Retinal Vein Occlusion (CRVO) Diagnosis||participants|Number|53|53.0||||||
4115464|NCT00943072|3940275|B1|</= 2 Months||Time Since Central Retinal Vein Occlusion (CRVO) Diagnosis||participants|Number|64|64.0||||||
4115465|NCT00943072|3940273|B3|||Baseline Best Corrected Visual Acuity (BCVA) Letter Score|Only participants with an ETDRS (Early Treatment Diabetic Retinopathy Study) Best Corrected Visual Acuity letter score of 73 to 25 (= Acuity of 20/40 to 20/320) in the study eye at 4 meters were included; a higher score represents better functioning.|letters correctly read|Mean|49.9|49.9|Standard Deviation|14.10|14.1|||
4115466|NCT00943072|3940274|B2|||Baseline Best Corrected Visual Acuity (BCVA) Letter Score|Only participants with an ETDRS (Early Treatment Diabetic Retinopathy Study) Best Corrected Visual Acuity letter score of 73 to 25 (= Acuity of 20/40 to 20/320) in the study eye at 4 meters were included; a higher score represents better functioning.|letters correctly read|Mean|48.7|48.7|Standard Deviation|14.41|14.41|||
4115467|NCT00943072|3940275|B1|||Baseline Best Corrected Visual Acuity (BCVA) Letter Score|Only participants with an ETDRS (Early Treatment Diabetic Retinopathy Study) Best Corrected Visual Acuity letter score of 73 to 25 (= Acuity of 20/40 to 20/320) in the study eye at 4 meters were included; a higher score represents better functioning.|letters correctly read|Mean|50.7|50.7|Standard Deviation|13.90|13.9|||
4115468|NCT00943072|3940273|B3|Indeterminate||Number of Participants with Retinal Perfusion at Baseline|"Retinal Perfusion defined as less than 10 disc areas of capillary non-perfusion using fluorescein angiography (FA).~Non-Perfused defined as greater than or equal to 10 disc areas of non-perfusion.~Indeterminate defined as not able to be determined by the reading center; for the purposes of analysis, indeterminate patients were considered non-perfused."|participants|Number|32|32.0||||||
4115469|NCT00943072|3940274|B2|Indeterminate||Number of Participants with Retinal Perfusion at Baseline|"Retinal Perfusion defined as less than 10 disc areas of capillary non-perfusion using fluorescein angiography (FA).~Non-Perfused defined as greater than or equal to 10 disc areas of non-perfusion.~Indeterminate defined as not able to be determined by the reading center; for the purposes of analysis, indeterminate patients were considered non-perfused."|participants|Number|12|12.0||||||
4115470|NCT00943072|3940275|B1|Indeterminate||Number of Participants with Retinal Perfusion at Baseline|"Retinal Perfusion defined as less than 10 disc areas of capillary non-perfusion using fluorescein angiography (FA).~Non-Perfused defined as greater than or equal to 10 disc areas of non-perfusion.~Indeterminate defined as not able to be determined by the reading center; for the purposes of analysis, indeterminate patients were considered non-perfused."|participants|Number|20|20.0||||||
4115471|NCT00943072|3940273|B3|Non-Perfused||Number of Participants with Retinal Perfusion at Baseline|"Retinal Perfusion defined as less than 10 disc areas of capillary non-perfusion using fluorescein angiography (FA).~Non-Perfused defined as greater than or equal to 10 disc areas of non-perfusion.~Indeterminate defined as not able to be determined by the reading center; for the purposes of analysis, indeterminate patients were considered non-perfused."|participants|Number|29|29.0||||||
4115472|NCT00943072|3940274|B2|Non-Perfused||Number of Participants with Retinal Perfusion at Baseline|"Retinal Perfusion defined as less than 10 disc areas of capillary non-perfusion using fluorescein angiography (FA).~Non-Perfused defined as greater than or equal to 10 disc areas of non-perfusion.~Indeterminate defined as not able to be determined by the reading center; for the purposes of analysis, indeterminate patients were considered non-perfused."|participants|Number|12|12.0||||||
4115473|NCT00943072|3940275|B1|Non-Perfused||Number of Participants with Retinal Perfusion at Baseline|"Retinal Perfusion defined as less than 10 disc areas of capillary non-perfusion using fluorescein angiography (FA).~Non-Perfused defined as greater than or equal to 10 disc areas of non-perfusion.~Indeterminate defined as not able to be determined by the reading center; for the purposes of analysis, indeterminate patients were considered non-perfused."|participants|Number|17|17.0||||||
4115474|NCT00943072|3940273|B3|Perfused||Number of Participants with Retinal Perfusion at Baseline|"Retinal Perfusion defined as less than 10 disc areas of capillary non-perfusion using fluorescein angiography (FA).~Non-Perfused defined as greater than or equal to 10 disc areas of non-perfusion.~Indeterminate defined as not able to be determined by the reading center; for the purposes of analysis, indeterminate patients were considered non-perfused."|participants|Number|127|127.0||||||
4115475|NCT00943072|3940274|B2|Perfused||Number of Participants with Retinal Perfusion at Baseline|"Retinal Perfusion defined as less than 10 disc areas of capillary non-perfusion using fluorescein angiography (FA).~Non-Perfused defined as greater than or equal to 10 disc areas of non-perfusion.~Indeterminate defined as not able to be determined by the reading center; for the purposes of analysis, indeterminate patients were considered non-perfused."|participants|Number|50|50.0||||||
4115476|NCT00943072|3940275|B1|Perfused||Number of Participants with Retinal Perfusion at Baseline|"Retinal Perfusion defined as less than 10 disc areas of capillary non-perfusion using fluorescein angiography (FA).~Non-Perfused defined as greater than or equal to 10 disc areas of non-perfusion.~Indeterminate defined as not able to be determined by the reading center; for the purposes of analysis, indeterminate patients were considered non-perfused."|participants|Number|77|77.0||||||
4115477|NCT00943072|3940273|B3|||Baseline Intraocular Pressure||millimeters of mercury (mmHg)|Mean|15.1|15.1|Standard Deviation|3.09|3.09|||
4115478|NCT00943072|3940274|B2|||Baseline Intraocular Pressure||millimeters of mercury (mmHg)|Mean|15.0|15.0|Standard Deviation|2.83|2.83|||
4115479|NCT00943072|3940275|B1|||Baseline Intraocular Pressure||millimeters of mercury (mmHg)|Mean|15.1|15.1|Standard Deviation|3.26|3.26|||
4115480|NCT00943072|3940273|B3|||Baseline National Eye Institute 25-item Visual Function Questionnaire (NEI VFQ-25) Total Score|The NEI VFQ-25 total score ranges from 0-100 with a score of 0 being the worst outcome and 100 being the best outcome. The NEI VFQ questionnaire is organized as a collection of subscales which are all scored from 0-100. To reach the overall composite score, each sub-scale score is averaged in order to give each sub-scale equal weight.|scores on a scale|Mean|77.81|77.81|Standard Deviation|16.04|16.04|||
4115481|NCT00943072|3940274|B2|||Baseline National Eye Institute 25-item Visual Function Questionnaire (NEI VFQ-25) Total Score|The NEI VFQ-25 total score ranges from 0-100 with a score of 0 being the worst outcome and 100 being the best outcome. The NEI VFQ questionnaire is organized as a collection of subscales which are all scored from 0-100. To reach the overall composite score, each sub-scale score is averaged in order to give each sub-scale equal weight.|scores on a scale|Mean|78.01|78.01|Standard Deviation|16.26|16.26|||
4115482|NCT00943072|3940275|B1|||Baseline National Eye Institute 25-item Visual Function Questionnaire (NEI VFQ-25) Total Score|The NEI VFQ-25 total score ranges from 0-100 with a score of 0 being the worst outcome and 100 being the best outcome. The NEI VFQ questionnaire is organized as a collection of subscales which are all scored from 0-100. To reach the overall composite score, each sub-scale score is averaged in order to give each sub-scale equal weight.|scores on a scale|Mean|77.67|77.67|Standard Deviation|15.96|15.96|||
4115483|NCT00943072|3940273|B3|||Baseline Retinal Thickness by Optical Coherence Tomography (OCT)||microns|Mean|668.1|668.1|Standard Deviation|241.23|241.23|||
4115484|NCT00943072|3940274|B2|||Baseline Retinal Thickness by Optical Coherence Tomography (OCT)||microns|Mean|678.4|678.4|Standard Deviation|248.66|248.66|||
4115485|NCT00943072|3940275|B1|||Baseline Retinal Thickness by Optical Coherence Tomography (OCT)||microns|Mean|661.7|661.7|Standard Deviation|237.37|237.37|||
4115486|NCT00943072|3940273|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115487|NCT00943072|3940274|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115488|NCT00943072|3940275|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115489|NCT00943072|3940273|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4115490|NCT00943072|3940274|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4115491|NCT00943072|3940275|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4115492|NCT00943072|3940273|B3||White|Race (NIH/OMB)||Participants|Count of Participants|148|148.0||||||
4115493|NCT00943072|3940274|B2||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4115494|NCT00943072|3940275|B1||White|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
4115495|NCT00943072|3940273|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4115496|NCT00943072|3940274|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4115497|NCT00943072|3940275|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4115498|NCT00943072|3940273|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4115499|NCT00943072|3940274|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4115500|NCT00943072|3940275|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115501|NCT00943072|3940273|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4115502|NCT00943072|3940274|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4115503|NCT00943072|3940275|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4115504|NCT00943072|3940273|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4115505|NCT00943072|3940274|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115506|NCT00943072|3940275|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4115507|NCT00943072|3940273|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115508|NCT00943072|3940274|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115509|NCT00943072|3940275|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115510|NCT00943072|3940273|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|158|158.0||||||
4115511|NCT00943072|3940274|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4115512|NCT00943072|3940275|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4115513|NCT00943072|3940273|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4115514|NCT00943072|3940274|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4115515|NCT00943072|3940275|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4115516|NCT00943072|3940273|B3||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4115517|NCT00943072|3940274|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4115518|NCT00943072|3940275|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4115519|NCT00943072|3940273|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4115520|NCT00943072|3940274|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4115521|NCT00943072|3940275|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4115522|NCT00943072|3940273|B3|||Age||years|Mean|66.3|66.3|Standard Deviation|13.83|13.83|||
4115523|NCT00943072|3940274|B2|||Age||years|Mean|67.5|67.5|Standard Deviation|14.22|14.22|||
4115524|NCT00943072|3940275|B1|||Age||years|Mean|65.5|65.5|Standard Deviation|13.57|13.57|||
4115525|NCT00942994|3940292|B3||Male|Sex: Female, Male|Baseline characteristics are given for Safety Set. The Safety Set included all patients who received at least one dose of double-blind trial medication. One patient was excluded from the Safety Set because the patient was withdrawn from the study without receiving any dose of study medication.|Participants|Count of Participants|204|204.0||||||
4115526|NCT00942994|3940293|B2||Male|Sex: Female, Male|Baseline characteristics are given for Safety Set. The Safety Set included all patients who received at least one dose of double-blind trial medication. One patient was excluded from the Safety Set because the patient was withdrawn from the study without receiving any dose of study medication.|Participants|Count of Participants|109|109.0||||||
4115527|NCT00942994|3940294|B1||Male|Sex: Female, Male|Baseline characteristics are given for Safety Set. The Safety Set included all patients who received at least one dose of double-blind trial medication. One patient was excluded from the Safety Set because the patient was withdrawn from the study without receiving any dose of study medication.|Participants|Count of Participants|95|95.0||||||
4115528|NCT00942994|3940292|B3||Female|Sex: Female, Male|Baseline characteristics are given for Safety Set. The Safety Set included all patients who received at least one dose of double-blind trial medication. One patient was excluded from the Safety Set because the patient was withdrawn from the study without receiving any dose of study medication.|Participants|Count of Participants|207|207.0||||||
4115529|NCT00942994|3940293|B2||Female|Sex: Female, Male|Baseline characteristics are given for Safety Set. The Safety Set included all patients who received at least one dose of double-blind trial medication. One patient was excluded from the Safety Set because the patient was withdrawn from the study without receiving any dose of study medication.|Participants|Count of Participants|100|100.0||||||
4115530|NCT00942994|3940294|B1||Female|Sex: Female, Male|Baseline characteristics are given for Safety Set. The Safety Set included all patients who received at least one dose of double-blind trial medication. One patient was excluded from the Safety Set because the patient was withdrawn from the study without receiving any dose of study medication.|Participants|Count of Participants|107|107.0||||||
4115722|NCT00942578|3940405|B3||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4115531|NCT00942994|3940292|B3|||Age|Baseline characteristics are given for Safety Set. The Safety Set included all patients who received at least one dose of double-blind trial medication. One patient was excluded from the Safety Set because the patient was withdrawn from the study without receiving any dose of study medication.|years|Mean|55.2|55.2|Standard Deviation|10.00|10.0|||
4115532|NCT00942994|3940293|B2|||Age|Baseline characteristics are given for Safety Set. The Safety Set included all patients who received at least one dose of double-blind trial medication. One patient was excluded from the Safety Set because the patient was withdrawn from the study without receiving any dose of study medication.|years|Mean|54.7|54.7|Standard Deviation|10.19|10.19|||
4115533|NCT00942994|3940294|B1|||Age|Baseline characteristics are given for Safety Set. The Safety Set included all patients who received at least one dose of double-blind trial medication. One patient was excluded from the Safety Set because the patient was withdrawn from the study without receiving any dose of study medication.|years|Mean|55.7|55.7|Standard Deviation|9.79|9.79|||
4115534|NCT00942968|3940311|B1||Male|Gender||Participants|Count of Participants|163|163.0||||||
4115535|NCT00942968|3940311|B1||Female|Gender||Participants|Count of Participants|171|171.0||||||
4115536|NCT00942968|3940311|B1|||Age||years|Mean|63.8|63.8|Standard Deviation|10.63|10.63|||
4115537|NCT00942903|3940332|B1|Netherlands||Region of Enrollment||patients|Number|20|20.0||||||
4115538|NCT00942903|3940332|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4115539|NCT00942903|3940332|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4115540|NCT00942903|3940332|B1|||Age||years|Mean|66.4|66.4|Standard Deviation|9.07|9.07|||
4115541|NCT00942903|3940332|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4115542|NCT00942903|3940332|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4115543|NCT00942903|3940332|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4115544|NCT00942890|3940337|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
4115545|NCT00942890|3940338|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4115546|NCT00942890|3940339|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4115547|NCT00942890|3940337|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4115548|NCT00942890|3940338|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4115549|NCT00942890|3940339|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4115550|NCT00942890|3940337|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4115551|NCT00942890|3940338|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4115552|NCT00942890|3940339|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4115553|NCT00942890|3940337|B3|||Age||years|Mean|26.5|26.5|Standard Deviation|5.9|5.9|||
4115554|NCT00942890|3940338|B2|||Age||years|Mean|26.5|26.5|Standard Deviation|5.9|5.9|||
4115555|NCT00942890|3940339|B1|||Age||years|Mean|27.1|27.1|Standard Deviation|6.3|6.3|||
4115556|NCT00942890|3940337|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4115557|NCT00942890|3940338|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4115558|NCT00942890|3940339|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4115559|NCT00942890|3940337|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4115560|NCT00942890|3940338|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4115561|NCT00942890|3940339|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4115562|NCT00942890|3940337|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4115563|NCT00942890|3940338|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4115564|NCT00942890|3940339|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4115565|NCT00942851|3940360|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4115566|NCT00942851|3940361|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4115567|NCT00942851|3940362|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4115568|NCT00942851|3940360|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4115569|NCT00942851|3940361|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4115570|NCT00942851|3940362|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4115571|NCT00942851|3940360|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4115572|NCT00942851|3940361|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4115573|NCT00942851|3940362|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4115574|NCT00942851|3940360|B3|||Age||years|Mean|56.73|56.73|Standard Deviation|8.22|8.22|||
4115575|NCT00942851|3940361|B2|||Age||years|Mean|55.87|55.87|Standard Deviation|8.25|8.25|||
4115576|NCT00942851|3940362|B1|||Age||years|Mean|57.59|57.59|Standard Deviation|8.46|8.46|||
4115577|NCT00942851|3940360|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4115578|NCT00942851|3940361|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4115579|NCT00942851|3940362|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4115580|NCT00942851|3940360|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4115581|NCT00942851|3940361|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4115582|NCT00942851|3940362|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4115583|NCT00942851|3940360|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4115584|NCT00942851|3940361|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4115585|NCT00942851|3940362|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4115586|NCT00942825|3940373|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4115587|NCT00942825|3940374|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4115588|NCT00942825|3940375|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4115589|NCT00942825|3940373|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115590|NCT00942825|3940374|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115591|NCT00942825|3940375|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115592|NCT00942825|3940373|B3||White|Race (NIH/OMB)||Participants|Count of Participants|163|163.0||||||
4115593|NCT00942825|3940374|B2||White|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
4115594|NCT00942825|3940375|B1||White|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4115595|NCT00942825|3940373|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4115596|NCT00942825|3940374|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4115597|NCT00942825|3940375|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4115598|NCT00942825|3940373|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115599|NCT00942825|3940374|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115600|NCT00942825|3940375|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115601|NCT00942825|3940373|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4115602|NCT00942825|3940374|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4115603|NCT00942825|3940375|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4115604|NCT00942825|3940373|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115605|NCT00942825|3940374|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115606|NCT00942825|3940375|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115607|NCT00942825|3940373|B3||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4115608|NCT00942825|3940374|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4115609|NCT00942825|3940375|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4115610|NCT00942825|3940373|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4115611|NCT00942825|3940374|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4115612|NCT00942825|3940375|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4115613|NCT00942825|3940373|B3|||Age||years|Mean|60.6|60.6|Standard Deviation|8.82|8.82|||
4115614|NCT00942825|3940374|B2|||Age||years|Mean|60.6|60.6|Standard Deviation|9.03|9.03|||
4115615|NCT00942825|3940375|B1|||Age||years|Mean|60.5|60.5|Standard Deviation|8.66|8.66|||
4115616|NCT00942786|3940382|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4115617|NCT00942786|3940382|B1||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4115618|NCT00942786|3940382|B1|||Age||years|Mean|74|74.0|Full Range|||51.0|103.0|
4115619|NCT00942734|3940389|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4115620|NCT00942734|3940389|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4115621|NCT00942734|3940389|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4115622|NCT00942734|3940389|B1|||Age||years|Median|61|61.0|Full Range|||38.0|75.0|
4115623|NCT00942604|3940393|B3|United States||Region of Enrollment||participants|Number|203|203.0||||||
4115624|NCT00942604|3940394|B2|United States||Region of Enrollment||participants|Number|103|103.0||||||
4115625|NCT00942604|3940395|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
4115626|NCT00942604|3940393|B3||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4115627|NCT00942604|3940394|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4115628|NCT00942604|3940395|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4115629|NCT00942604|3940393|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4115630|NCT00942604|3940394|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4115631|NCT00942604|3940395|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4115632|NCT00942604|3940393|B3||>=65 years|Age||Participants|Count of Participants|103|103.0||||||
4115633|NCT00942604|3940394|B2||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
4115634|NCT00942604|3940395|B1||>=65 years|Age||Participants|Count of Participants|52|52.0||||||
4115635|NCT00942604|3940393|B3||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4115636|NCT00942604|3940394|B2||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4115637|NCT00942604|3940395|B1||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4115638|NCT00942604|3940393|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4115639|NCT00942604|3940394|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4115640|NCT00942604|3940395|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4115641|NCT00942578|3940404|B4|||Hemoglobin|Hemoglobin is a protein in the blood that carries oxygen and the normal range for men is 13.5 to 17.5 g/dL.|g/dL|Median|12.0|12.0|Full Range|||7.4|14.8|
4115642|NCT00942578|3940405|B3|||Hemoglobin|Hemoglobin is a protein in the blood that carries oxygen and the normal range for men is 13.5 to 17.5 g/dL.|g/dL|Median|11.9|11.9|Full Range|||7.4|14.8|
4115643|NCT00942578|3940406|B2|||Hemoglobin|Hemoglobin is a protein in the blood that carries oxygen and the normal range for men is 13.5 to 17.5 g/dL.|g/dL|Median|12.1|12.1|Full Range|||12.0|13.2|
4115716|NCT00942578|3940407|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115644|NCT00942578|3940407|B1|||Hemoglobin|Hemoglobin is a protein in the blood that carries oxygen and the normal range for men is 13.5 to 17.5 g/dL.|g/dL|Median|12.85|12.85|Full Range|||8.5|14.5|
4115645|NCT00942578|3940404|B4|||Prostatic Specific Antigen (PSA)|Prostatic Specific Antigen (PSA) is a test to assess prostate cancer and the normal values are 4.0 ng/mL and lower.|U/L|Median|78.7|78.7|Full Range|||0.14|3520.0|
4115646|NCT00942578|3940405|B3|||Prostatic Specific Antigen (PSA)|Prostatic Specific Antigen (PSA) is a test to assess prostate cancer and the normal values are 4.0 ng/mL and lower.|U/L|Median|85.15|85.15|Full Range|||0.014|3520.0|
4115647|NCT00942578|3940406|B2|||Prostatic Specific Antigen (PSA)|Prostatic Specific Antigen (PSA) is a test to assess prostate cancer and the normal values are 4.0 ng/mL and lower.|U/L|Median|61.6|61.6|Full Range|||19.3|95.3|
4115648|NCT00942578|3940407|B1|||Prostatic Specific Antigen (PSA)|Prostatic Specific Antigen (PSA) is a test to assess prostate cancer and the normal values are 4.0 ng/mL and lower.|U/L|Median|61.33|61.33|Full Range|||0.48|1452.0|
4115649|NCT00942578|3940404|B4|Lactate dehydrogenase||Alkaline Phosphatase & Lactate Dehydrogenase|Alkaline phosphatase is a test to assess liver disease and the normal range is 44 to 147 U/L.|U/L|Median|206|206.0|Full Range|||127.0|2305.0|
4115650|NCT00942578|3940405|B3|Lactate dehydrogenase||Alkaline Phosphatase & Lactate Dehydrogenase|Alkaline phosphatase is a test to assess liver disease and the normal range is 44 to 147 U/L.|U/L|Median|206.5|206.5|Full Range|||127.0|2305.0|
4115651|NCT00942578|3940406|B2|Lactate dehydrogenase||Alkaline Phosphatase & Lactate Dehydrogenase|Alkaline phosphatase is a test to assess liver disease and the normal range is 44 to 147 U/L.|U/L|Median|177|177.0|Full Range|||152.0|193.0|
4115652|NCT00942578|3940407|B1|Lactate dehydrogenase||Alkaline Phosphatase & Lactate Dehydrogenase|Alkaline phosphatase is a test to assess liver disease and the normal range is 44 to 147 U/L.|U/L|Median|209|209.0|Full Range|||174.0|624.0|
4115653|NCT00942578|3940404|B4|Alkaline phosphatase||Alkaline Phosphatase & Lactate Dehydrogenase|Alkaline phosphatase is a test to assess liver disease and the normal range is 44 to 147 U/L.|U/L|Median|125|125.0|Full Range|||53.0|956.0|
4115654|NCT00942578|3940405|B3|Alkaline phosphatase||Alkaline Phosphatase & Lactate Dehydrogenase|Alkaline phosphatase is a test to assess liver disease and the normal range is 44 to 147 U/L.|U/L|Median|127|127.0|Full Range|||53.0|956.0|
4115655|NCT00942578|3940406|B2|Alkaline phosphatase||Alkaline Phosphatase & Lactate Dehydrogenase|Alkaline phosphatase is a test to assess liver disease and the normal range is 44 to 147 U/L.|U/L|Median|84|84.0|Full Range|||71.0|121.0|
4115656|NCT00942578|3940407|B1|Alkaline phosphatase||Alkaline Phosphatase & Lactate Dehydrogenase|Alkaline phosphatase is a test to assess liver disease and the normal range is 44 to 147 U/L.|U/L|Median|124|124.0|Full Range|||53.0|702.0|
4115657|NCT00942578|3940404|B4|Visceral alone ( bladder and lung)||Location of Disease||Participants|Count of Participants|2|2.0||||||
4115658|NCT00942578|3940405|B3|Visceral alone ( bladder and lung)||Location of Disease||Participants|Count of Participants|1|1.0||||||
4115659|NCT00942578|3940406|B2|Visceral alone ( bladder and lung)||Location of Disease||Participants|Count of Participants|0|0.0||||||
4115660|NCT00942578|3940407|B1|Visceral alone ( bladder and lung)||Location of Disease||Participants|Count of Participants|1|1.0||||||
4115661|NCT00942578|3940404|B4|Lymph node alone||Location of Disease||Participants|Count of Participants|3|3.0||||||
4115662|NCT00942578|3940405|B3|Lymph node alone||Location of Disease||Participants|Count of Participants|2|2.0||||||
4115663|NCT00942578|3940406|B2|Lymph node alone||Location of Disease||Participants|Count of Participants|0|0.0||||||
4115664|NCT00942578|3940407|B1|Lymph node alone||Location of Disease||Participants|Count of Participants|1|1.0||||||
4115665|NCT00942578|3940404|B4|Bone and visceral (3 hepatic)||Location of Disease||Participants|Count of Participants|7|7.0||||||
4115666|NCT00942578|3940405|B3|Bone and visceral (3 hepatic)||Location of Disease||Participants|Count of Participants|3|3.0||||||
4115667|NCT00942578|3940406|B2|Bone and visceral (3 hepatic)||Location of Disease||Participants|Count of Participants|0|0.0||||||
4115668|NCT00942578|3940407|B1|Bone and visceral (3 hepatic)||Location of Disease||Participants|Count of Participants|4|4.0||||||
4115669|NCT00942578|3940404|B4|Bone and lymph nodes||Location of Disease||Participants|Count of Participants|27|27.0||||||
4115670|NCT00942578|3940405|B3|Bone and lymph nodes||Location of Disease||Participants|Count of Participants|24|24.0||||||
4115671|NCT00942578|3940406|B2|Bone and lymph nodes||Location of Disease||Participants|Count of Participants|2|2.0||||||
4115672|NCT00942578|3940407|B1|Bone and lymph nodes||Location of Disease||Participants|Count of Participants|1|1.0||||||
4115673|NCT00942578|3940404|B4|Bone only||Location of Disease||Participants|Count of Participants|24|24.0||||||
4115674|NCT00942578|3940405|B3|Bone only||Location of Disease||Participants|Count of Participants|16|16.0||||||
4115675|NCT00942578|3940406|B2|Bone only||Location of Disease||Participants|Count of Participants|1|1.0||||||
4115676|NCT00942578|3940407|B1|Bone only||Location of Disease||Participants|Count of Participants|7|7.0||||||
4115677|NCT00942578|3940404|B4|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG 0 is defined as normal activity, fully active, able to carry on all pre-disease performance without restriction. ECOG 1 is defined as symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g. light housework. ECOG 2 is defined as in bed <50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hours.|Participants|Count of Participants|3|3.0||||||
4115678|NCT00942578|3940405|B3|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG 0 is defined as normal activity, fully active, able to carry on all pre-disease performance without restriction. ECOG 1 is defined as symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g. light housework. ECOG 2 is defined as in bed <50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hours.|Participants|Count of Participants|3|3.0||||||
4115717|NCT00942578|3940404|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115718|NCT00942578|3940405|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115723|NCT00942578|3940406|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4115679|NCT00942578|3940406|B2|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG 0 is defined as normal activity, fully active, able to carry on all pre-disease performance without restriction. ECOG 1 is defined as symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g. light housework. ECOG 2 is defined as in bed <50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hours.|Participants|Count of Participants|0|0.0||||||
4115680|NCT00942578|3940407|B1|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG 0 is defined as normal activity, fully active, able to carry on all pre-disease performance without restriction. ECOG 1 is defined as symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g. light housework. ECOG 2 is defined as in bed <50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hours.|Participants|Count of Participants|0|0.0||||||
4115681|NCT00942578|3940404|B4|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG 0 is defined as normal activity, fully active, able to carry on all pre-disease performance without restriction. ECOG 1 is defined as symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g. light housework. ECOG 2 is defined as in bed <50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hours.|Participants|Count of Participants|50|50.0||||||
4115682|NCT00942578|3940405|B3|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG 0 is defined as normal activity, fully active, able to carry on all pre-disease performance without restriction. ECOG 1 is defined as symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g. light housework. ECOG 2 is defined as in bed <50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hours.|Participants|Count of Participants|36|36.0||||||
4115683|NCT00942578|3940406|B2|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG 0 is defined as normal activity, fully active, able to carry on all pre-disease performance without restriction. ECOG 1 is defined as symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g. light housework. ECOG 2 is defined as in bed <50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hours.|Participants|Count of Participants|3|3.0||||||
4115684|NCT00942578|3940407|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG 0 is defined as normal activity, fully active, able to carry on all pre-disease performance without restriction. ECOG 1 is defined as symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g. light housework. ECOG 2 is defined as in bed <50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hours.|Participants|Count of Participants|11|11.0||||||
4115685|NCT00942578|3940404|B4|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG 0 is defined as normal activity, fully active, able to carry on all pre-disease performance without restriction. ECOG 1 is defined as symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g. light housework. ECOG 2 is defined as in bed <50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hours.|Participants|Count of Participants|10|10.0||||||
4115686|NCT00942578|3940405|B3|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG 0 is defined as normal activity, fully active, able to carry on all pre-disease performance without restriction. ECOG 1 is defined as symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g. light housework. ECOG 2 is defined as in bed <50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hours.|Participants|Count of Participants|7|7.0||||||
4115687|NCT00942578|3940406|B2|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG 0 is defined as normal activity, fully active, able to carry on all pre-disease performance without restriction. ECOG 1 is defined as symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g. light housework. ECOG 2 is defined as in bed <50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hours.|Participants|Count of Participants|0|0.0||||||
4115688|NCT00942578|3940407|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG 0 is defined as normal activity, fully active, able to carry on all pre-disease performance without restriction. ECOG 1 is defined as symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g. light housework. ECOG 2 is defined as in bed <50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hours.|Participants|Count of Participants|3|3.0||||||
4115689|NCT00942578|3940404|B4|10||Gleason Score|The Gleason score helps the physician determine whether prostate tissue is normal or different than normal. The Gleason score ranges from 2-10. The lower number means the prostate tissue is normal tissue. The higher number means the prostate tissue is not normal tissue and may be cancer.|Participants|Count of Participants|6|6.0||||||
4115690|NCT00942578|3940405|B3|10||Gleason Score|The Gleason score helps the physician determine whether prostate tissue is normal or different than normal. The Gleason score ranges from 2-10. The lower number means the prostate tissue is normal tissue. The higher number means the prostate tissue is not normal tissue and may be cancer.|Participants|Count of Participants|4|4.0||||||
4115691|NCT00942578|3940406|B2|10||Gleason Score|The Gleason score helps the physician determine whether prostate tissue is normal or different than normal. The Gleason score ranges from 2-10. The lower number means the prostate tissue is normal tissue. The higher number means the prostate tissue is not normal tissue and may be cancer.|Participants|Count of Participants|0|0.0||||||
4115719|NCT00942578|3940406|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115720|NCT00942578|3940407|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115692|NCT00942578|3940407|B1|10||Gleason Score|The Gleason score helps the physician determine whether prostate tissue is normal or different than normal. The Gleason score ranges from 2-10. The lower number means the prostate tissue is normal tissue. The higher number means the prostate tissue is not normal tissue and may be cancer.|Participants|Count of Participants|2|2.0||||||
4115693|NCT00942578|3940404|B4|9||Gleason Score|The Gleason score helps the physician determine whether prostate tissue is normal or different than normal. The Gleason score ranges from 2-10. The lower number means the prostate tissue is normal tissue. The higher number means the prostate tissue is not normal tissue and may be cancer.|Participants|Count of Participants|23|23.0||||||
4115694|NCT00942578|3940405|B3|9||Gleason Score|The Gleason score helps the physician determine whether prostate tissue is normal or different than normal. The Gleason score ranges from 2-10. The lower number means the prostate tissue is normal tissue. The higher number means the prostate tissue is not normal tissue and may be cancer.|Participants|Count of Participants|18|18.0||||||
4115695|NCT00942578|3940406|B2|9||Gleason Score|The Gleason score helps the physician determine whether prostate tissue is normal or different than normal. The Gleason score ranges from 2-10. The lower number means the prostate tissue is normal tissue. The higher number means the prostate tissue is not normal tissue and may be cancer.|Participants|Count of Participants|1|1.0||||||
4115696|NCT00942578|3940407|B1|9||Gleason Score|The Gleason score helps the physician determine whether prostate tissue is normal or different than normal. The Gleason score ranges from 2-10. The lower number means the prostate tissue is normal tissue. The higher number means the prostate tissue is not normal tissue and may be cancer.|Participants|Count of Participants|4|4.0||||||
4115697|NCT00942578|3940404|B4|8||Gleason Score|The Gleason score helps the physician determine whether prostate tissue is normal or different than normal. The Gleason score ranges from 2-10. The lower number means the prostate tissue is normal tissue. The higher number means the prostate tissue is not normal tissue and may be cancer.|Participants|Count of Participants|15|15.0||||||
4115698|NCT00942578|3940405|B3|8||Gleason Score|The Gleason score helps the physician determine whether prostate tissue is normal or different than normal. The Gleason score ranges from 2-10. The lower number means the prostate tissue is normal tissue. The higher number means the prostate tissue is not normal tissue and may be cancer.|Participants|Count of Participants|10|10.0||||||
4115699|NCT00942578|3940406|B2|8||Gleason Score|The Gleason score helps the physician determine whether prostate tissue is normal or different than normal. The Gleason score ranges from 2-10. The lower number means the prostate tissue is normal tissue. The higher number means the prostate tissue is not normal tissue and may be cancer.|Participants|Count of Participants|1|1.0||||||
4115700|NCT00942578|3940407|B1|8||Gleason Score|The Gleason score helps the physician determine whether prostate tissue is normal or different than normal. The Gleason score ranges from 2-10. The lower number means the prostate tissue is normal tissue. The higher number means the prostate tissue is not normal tissue and may be cancer.|Participants|Count of Participants|4|4.0||||||
4115701|NCT00942578|3940404|B4|7||Gleason Score|The Gleason score helps the physician determine whether prostate tissue is normal or different than normal. The Gleason score ranges from 2-10. The lower number means the prostate tissue is normal tissue. The higher number means the prostate tissue is not normal tissue and may be cancer.|Participants|Count of Participants|15|15.0||||||
4115702|NCT00942578|3940405|B3|7||Gleason Score|The Gleason score helps the physician determine whether prostate tissue is normal or different than normal. The Gleason score ranges from 2-10. The lower number means the prostate tissue is normal tissue. The higher number means the prostate tissue is not normal tissue and may be cancer.|Participants|Count of Participants|11|11.0||||||
4115703|NCT00942578|3940406|B2|7||Gleason Score|The Gleason score helps the physician determine whether prostate tissue is normal or different than normal. The Gleason score ranges from 2-10. The lower number means the prostate tissue is normal tissue. The higher number means the prostate tissue is not normal tissue and may be cancer.|Participants|Count of Participants|1|1.0||||||
4115704|NCT00942578|3940407|B1|7||Gleason Score|The Gleason score helps the physician determine whether prostate tissue is normal or different than normal. The Gleason score ranges from 2-10. The lower number means the prostate tissue is normal tissue. The higher number means the prostate tissue is not normal tissue and may be cancer.|Participants|Count of Participants|3|3.0||||||
4115705|NCT00942578|3940404|B4|≤6||Gleason Score|The Gleason score helps the physician determine whether prostate tissue is normal or different than normal. The Gleason score ranges from 2-10. The lower number means the prostate tissue is normal tissue. The higher number means the prostate tissue is not normal tissue and may be cancer.|Participants|Count of Participants|4|4.0||||||
4115706|NCT00942578|3940405|B3|≤6||Gleason Score|The Gleason score helps the physician determine whether prostate tissue is normal or different than normal. The Gleason score ranges from 2-10. The lower number means the prostate tissue is normal tissue. The higher number means the prostate tissue is not normal tissue and may be cancer.|Participants|Count of Participants|3|3.0||||||
4115707|NCT00942578|3940406|B2|≤6||Gleason Score|The Gleason score helps the physician determine whether prostate tissue is normal or different than normal. The Gleason score ranges from 2-10. The lower number means the prostate tissue is normal tissue. The higher number means the prostate tissue is not normal tissue and may be cancer.|Participants|Count of Participants|0|0.0||||||
4115708|NCT00942578|3940407|B1|≤6||Gleason Score|The Gleason score helps the physician determine whether prostate tissue is normal or different than normal. The Gleason score ranges from 2-10. The lower number means the prostate tissue is normal tissue. The higher number means the prostate tissue is not normal tissue and may be cancer.|Participants|Count of Participants|1|1.0||||||
4115709|NCT00942578|3940404|B4|United States||Region of Enrollment||Participants|Count of Participants|63|63.0||||||
4115710|NCT00942578|3940405|B3|United States||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
4115711|NCT00942578|3940406|B2|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4115712|NCT00942578|3940407|B1|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4115713|NCT00942578|3940404|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115714|NCT00942578|3940405|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115715|NCT00942578|3940406|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115724|NCT00942578|3940407|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4115725|NCT00942578|3940404|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4115726|NCT00942578|3940405|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4115727|NCT00942578|3940406|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4115728|NCT00942578|3940407|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4115729|NCT00942578|3940404|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4115730|NCT00942578|3940405|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4115731|NCT00942578|3940406|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115732|NCT00942578|3940407|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115733|NCT00942578|3940404|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4115734|NCT00942578|3940405|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4115735|NCT00942578|3940406|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115736|NCT00942578|3940407|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115737|NCT00942578|3940404|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115738|NCT00942578|3940405|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115739|NCT00942578|3940406|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115740|NCT00942578|3940407|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115741|NCT00942578|3940404|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115742|NCT00942578|3940405|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115743|NCT00942578|3940406|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115744|NCT00942578|3940407|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115745|NCT00942578|3940404|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4115746|NCT00942578|3940405|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4115747|NCT00942578|3940406|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4115748|NCT00942578|3940407|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4115749|NCT00942578|3940404|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4115750|NCT00942578|3940405|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4115751|NCT00942578|3940406|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115752|NCT00942578|3940407|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115753|NCT00942578|3940404|B4||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4115754|NCT00942578|3940405|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4115755|NCT00942578|3940406|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4115756|NCT00942578|3940407|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4115757|NCT00942578|3940404|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4115758|NCT00942578|3940405|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4115759|NCT00942578|3940406|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4115760|NCT00942578|3940407|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4115761|NCT00942578|3940404|B4|||Age||years|Mean|64.51|64.51|Standard Deviation|6.29|6.29|||
4115762|NCT00942578|3940405|B3|||Age||years|Mean|66.07|66.07|Standard Deviation|8.02|8.02|||
4115763|NCT00942578|3940406|B2|||Age||years|Mean|63.2|63.2|Standard Deviation|4.95|4.95|||
4115764|NCT00942578|3940407|B1|||Age||years|Mean|64.25|64.25|Standard Deviation|5.9|5.9|||
4115765|NCT00942578|3940404|B4||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
4115766|NCT00942578|3940405|B3||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4115767|NCT00942578|3940406|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4115768|NCT00942578|3940407|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4115769|NCT00942578|3940404|B4||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4115770|NCT00942578|3940405|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4115771|NCT00942578|3940406|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4115772|NCT00942578|3940407|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4115773|NCT00942578|3940404|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4115774|NCT00942578|3940405|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4115775|NCT00942578|3940406|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4115776|NCT00942578|3940407|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4115777|NCT00942448|3940435|B5||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4115778|NCT00942448|3940436|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4115779|NCT00942448|3940437|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4115780|NCT00942448|3940438|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4115781|NCT00942448|3940439|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4115782|NCT00942448|3940435|B5||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4115783|NCT00942448|3940436|B4||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4115784|NCT00942448|3940437|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4115785|NCT00942448|3940438|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4115786|NCT00942448|3940439|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4115787|NCT00942448|3940435|B5|||Age||years|Mean|30.56|30.56|Standard Deviation|9.79|9.79|||
4115788|NCT00942448|3940436|B4|||Age||years|Mean|31.9|31.9|Standard Deviation|11.3|11.3|||
4115789|NCT00942448|3940437|B3|||Age||years|Mean|30.2|30.2|Standard Deviation|8.76|8.76|||
4115790|NCT00942448|3940438|B2|||Age||years|Mean|29.5|29.5|Standard Deviation|8.68|8.68|||
4115791|NCT00942448|3940439|B1|||Age||years|Mean|30.7|30.7|Standard Deviation|10.3|10.3|||
4115792|NCT00942422|3940504|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4115793|NCT00942422|3940504|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4115794|NCT00942422|3940504|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4115795|NCT00942422|3940504|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4115796|NCT00942422|3940504|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4115797|NCT00942422|3940504|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4115798|NCT00942409|3940508|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4115799|NCT00942409|3940508|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4115800|NCT00942409|3940508|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4115801|NCT00942409|3940508|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4115802|NCT00942409|3940508|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4115803|NCT00942409|3940508|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4115804|NCT00942357|3940512|B3|Other||Endometrial Cancer Grades|Grade 1 is 5% or less of a non-squamous or non-morular solid growth pattern. Grade 2 is 6 through 50% of a non squamous or non-morular solid growth pattern. Grade 3 is more than 50% of a non-squamous or non-morular solid growth pattern. Generally the higher the stage the worse the outcome.|Participants|Count of Participants|68|68.0||||||
4115805|NCT00942357|3940513|B2|Other||Endometrial Cancer Grades|Grade 1 is 5% or less of a non-squamous or non-morular solid growth pattern. Grade 2 is 6 through 50% of a non squamous or non-morular solid growth pattern. Grade 3 is more than 50% of a non-squamous or non-morular solid growth pattern. Generally the higher the stage the worse the outcome.|Participants|Count of Participants|30|30.0||||||
4115806|NCT00942357|3940514|B1|Other||Endometrial Cancer Grades|Grade 1 is 5% or less of a non-squamous or non-morular solid growth pattern. Grade 2 is 6 through 50% of a non squamous or non-morular solid growth pattern. Grade 3 is more than 50% of a non-squamous or non-morular solid growth pattern. Generally the higher the stage the worse the outcome.|Participants|Count of Participants|38|38.0||||||
4115807|NCT00942357|3940512|B3|Clear Cell||Endometrial Cancer Grades|Grade 1 is 5% or less of a non-squamous or non-morular solid growth pattern. Grade 2 is 6 through 50% of a non squamous or non-morular solid growth pattern. Grade 3 is more than 50% of a non-squamous or non-morular solid growth pattern. Generally the higher the stage the worse the outcome.|Participants|Count of Participants|22|22.0||||||
4115808|NCT00942357|3940513|B2|Clear Cell||Endometrial Cancer Grades|Grade 1 is 5% or less of a non-squamous or non-morular solid growth pattern. Grade 2 is 6 through 50% of a non squamous or non-morular solid growth pattern. Grade 3 is more than 50% of a non-squamous or non-morular solid growth pattern. Generally the higher the stage the worse the outcome.|Participants|Count of Participants|12|12.0||||||
4115809|NCT00942357|3940514|B1|Clear Cell||Endometrial Cancer Grades|Grade 1 is 5% or less of a non-squamous or non-morular solid growth pattern. Grade 2 is 6 through 50% of a non squamous or non-morular solid growth pattern. Grade 3 is more than 50% of a non-squamous or non-morular solid growth pattern. Generally the higher the stage the worse the outcome.|Participants|Count of Participants|10|10.0||||||
4115810|NCT00942357|3940512|B3|Serous||Endometrial Cancer Grades|Grade 1 is 5% or less of a non-squamous or non-morular solid growth pattern. Grade 2 is 6 through 50% of a non squamous or non-morular solid growth pattern. Grade 3 is more than 50% of a non-squamous or non-morular solid growth pattern. Generally the higher the stage the worse the outcome.|Participants|Count of Participants|131|131.0||||||
4115811|NCT00942357|3940513|B2|Serous||Endometrial Cancer Grades|Grade 1 is 5% or less of a non-squamous or non-morular solid growth pattern. Grade 2 is 6 through 50% of a non squamous or non-morular solid growth pattern. Grade 3 is more than 50% of a non-squamous or non-morular solid growth pattern. Generally the higher the stage the worse the outcome.|Participants|Count of Participants|65|65.0||||||
4115812|NCT00942357|3940514|B1|Serous||Endometrial Cancer Grades|Grade 1 is 5% or less of a non-squamous or non-morular solid growth pattern. Grade 2 is 6 through 50% of a non squamous or non-morular solid growth pattern. Grade 3 is more than 50% of a non-squamous or non-morular solid growth pattern. Generally the higher the stage the worse the outcome.|Participants|Count of Participants|66|66.0||||||
4115813|NCT00942357|3940512|B3|Endometrioid Grade 3||Endometrial Cancer Grades|Grade 1 is 5% or less of a non-squamous or non-morular solid growth pattern. Grade 2 is 6 through 50% of a non squamous or non-morular solid growth pattern. Grade 3 is more than 50% of a non-squamous or non-morular solid growth pattern. Generally the higher the stage the worse the outcome.|Participants|Count of Participants|128|128.0||||||
4115814|NCT00942357|3940513|B2|Endometrioid Grade 3||Endometrial Cancer Grades|Grade 1 is 5% or less of a non-squamous or non-morular solid growth pattern. Grade 2 is 6 through 50% of a non squamous or non-morular solid growth pattern. Grade 3 is more than 50% of a non-squamous or non-morular solid growth pattern. Generally the higher the stage the worse the outcome.|Participants|Count of Participants|62|62.0||||||
4115815|NCT00942357|3940514|B1|Endometrioid Grade 3||Endometrial Cancer Grades|Grade 1 is 5% or less of a non-squamous or non-morular solid growth pattern. Grade 2 is 6 through 50% of a non squamous or non-morular solid growth pattern. Grade 3 is more than 50% of a non-squamous or non-morular solid growth pattern. Generally the higher the stage the worse the outcome.|Participants|Count of Participants|66|66.0||||||
4115816|NCT00942357|3940512|B3|Endometrioid Grade 2||Endometrial Cancer Grades|Grade 1 is 5% or less of a non-squamous or non-morular solid growth pattern. Grade 2 is 6 through 50% of a non squamous or non-morular solid growth pattern. Grade 3 is more than 50% of a non-squamous or non-morular solid growth pattern. Generally the higher the stage the worse the outcome.|Participants|Count of Participants|221|221.0||||||
4115817|NCT00942357|3940513|B2|Endometrioid Grade 2||Endometrial Cancer Grades|Grade 1 is 5% or less of a non-squamous or non-morular solid growth pattern. Grade 2 is 6 through 50% of a non squamous or non-morular solid growth pattern. Grade 3 is more than 50% of a non-squamous or non-morular solid growth pattern. Generally the higher the stage the worse the outcome.|Participants|Count of Participants|118|118.0||||||
4115818|NCT00942357|3940514|B1|Endometrioid Grade 2||Endometrial Cancer Grades|Grade 1 is 5% or less of a non-squamous or non-morular solid growth pattern. Grade 2 is 6 through 50% of a non squamous or non-morular solid growth pattern. Grade 3 is more than 50% of a non-squamous or non-morular solid growth pattern. Generally the higher the stage the worse the outcome.|Participants|Count of Participants|103|103.0||||||
4115819|NCT00942357|3940512|B3|Endometrioid Grade 1||Endometrial Cancer Grades|Grade 1 is 5% or less of a non-squamous or non-morular solid growth pattern. Grade 2 is 6 through 50% of a non squamous or non-morular solid growth pattern. Grade 3 is more than 50% of a non-squamous or non-morular solid growth pattern. Generally the higher the stage the worse the outcome.|Participants|Count of Participants|166|166.0||||||
4115820|NCT00942357|3940513|B2|Endometrioid Grade 1||Endometrial Cancer Grades|Grade 1 is 5% or less of a non-squamous or non-morular solid growth pattern. Grade 2 is 6 through 50% of a non squamous or non-morular solid growth pattern. Grade 3 is more than 50% of a non-squamous or non-morular solid growth pattern. Generally the higher the stage the worse the outcome.|Participants|Count of Participants|79|79.0||||||
4115821|NCT00942357|3940514|B1|Endometrioid Grade 1||Endometrial Cancer Grades|Grade 1 is 5% or less of a non-squamous or non-morular solid growth pattern. Grade 2 is 6 through 50% of a non squamous or non-morular solid growth pattern. Grade 3 is more than 50% of a non-squamous or non-morular solid growth pattern. Generally the higher the stage the worse the outcome.|Participants|Count of Participants|87|87.0||||||
4115822|NCT00942357|3940512|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4115823|NCT00942357|3940513|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4115824|NCT00942357|3940514|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4115825|NCT00942357|3940512|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115826|NCT00942357|3940513|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115827|NCT00942357|3940514|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4115828|NCT00942357|3940512|B3||White|Race (NIH/OMB)||Participants|Count of Participants|570|570.0||||||
4115829|NCT00942357|3940513|B2||White|Race (NIH/OMB)||Participants|Count of Participants|279|279.0||||||
4115830|NCT00942357|3940514|B1||White|Race (NIH/OMB)||Participants|Count of Participants|291|291.0||||||
4115831|NCT00942357|3940512|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
4115832|NCT00942357|3940513|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4115833|NCT00942357|3940514|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4115834|NCT00942357|3940512|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4115835|NCT00942357|3940513|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4115836|NCT00942357|3940514|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4115837|NCT00942357|3940512|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4115838|NCT00942357|3940513|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4115839|NCT00942357|3940514|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4115840|NCT00942357|3940512|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4115841|NCT00942357|3940513|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4115842|NCT00942357|3940514|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4115843|NCT00942357|3940512|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4115844|NCT00942357|3940513|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4115845|NCT00942357|3940514|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4115846|NCT00942357|3940512|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|662|662.0||||||
4115847|NCT00942357|3940513|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|324|324.0||||||
4115848|NCT00942357|3940514|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|338|338.0||||||
4115849|NCT00942357|3940512|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4115850|NCT00942357|3940513|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4115851|NCT00942357|3940514|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4115852|NCT00942357|3940512|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4115853|NCT00942357|3940513|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4115854|NCT00942357|3940514|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4115855|NCT00942357|3940512|B3||Female|Sex: Female, Male||Participants|Count of Participants|736|736.0||||||
4115856|NCT00942357|3940513|B2||Female|Sex: Female, Male||Participants|Count of Participants|366|366.0||||||
4115857|NCT00942357|3940514|B1||Female|Sex: Female, Male||Participants|Count of Participants|370|370.0||||||
4115858|NCT00942357|3940512|B3|80-89 years||Age, Customized||Participants|Count of Participants|16|16.0||||||
4115859|NCT00942357|3940513|B2|80-89 years||Age, Customized||Participants|Count of Participants|8|8.0||||||
4115860|NCT00942357|3940514|B1|80-89 years||Age, Customized||Participants|Count of Participants|8|8.0||||||
4115861|NCT00942357|3940512|B3|70-79 years||Age, Customized||Participants|Count of Participants|106|106.0||||||
4115862|NCT00942357|3940513|B2|70-79 years||Age, Customized||Participants|Count of Participants|51|51.0||||||
4115863|NCT00942357|3940514|B1|70-79 years||Age, Customized||Participants|Count of Participants|55|55.0||||||
4115864|NCT00942357|3940512|B3|60-69 years||Age, Customized||Participants|Count of Participants|263|263.0||||||
4115865|NCT00942357|3940513|B2|60-69 years||Age, Customized||Participants|Count of Participants|130|130.0||||||
4115866|NCT00942357|3940514|B1|60-69 years||Age, Customized||Participants|Count of Participants|133|133.0||||||
4115867|NCT00942357|3940512|B3|50-59 years||Age, Customized||Participants|Count of Participants|268|268.0||||||
4115868|NCT00942357|3940513|B2|50-59 years||Age, Customized||Participants|Count of Participants|136|136.0||||||
4115869|NCT00942357|3940514|B1|50-59 years||Age, Customized||Participants|Count of Participants|132|132.0||||||
4115870|NCT00942357|3940512|B3|40-49 years||Age, Customized||Participants|Count of Participants|67|67.0||||||
4115871|NCT00942357|3940513|B2|40-49 years||Age, Customized||Participants|Count of Participants|31|31.0||||||
4115872|NCT00942357|3940514|B1|40-49 years||Age, Customized||Participants|Count of Participants|36|36.0||||||
4115873|NCT00942357|3940512|B3|30-39 years||Age, Customized||Participants|Count of Participants|16|16.0||||||
4115874|NCT00942357|3940513|B2|30-39 years||Age, Customized||Participants|Count of Participants|10|10.0||||||
4115875|NCT00942357|3940514|B1|30-39 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
4115876|NCT00942357|3940512|B3|20-29 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4115877|NCT00942357|3940513|B2|20-29 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4115878|NCT00942357|3940514|B1|20-29 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4115879|NCT00942266|3940529|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4115880|NCT00942266|3940530|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4115881|NCT00942266|3940531|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4115882|NCT00942266|3940529|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4115883|NCT00942266|3940530|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4115884|NCT00942266|3940531|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4115885|NCT00942266|3940529|B3||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4115886|NCT00942266|3940530|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4115887|NCT00942266|3940531|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4115888|NCT00942266|3940529|B3||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4115889|NCT00942266|3940530|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4115890|NCT00942266|3940531|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4115891|NCT00942266|3940529|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4115892|NCT00942266|3940530|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4115893|NCT00942266|3940531|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4115894|NCT00942266|3940529|B3|||Age||years|Mean|60.6|60.6|Standard Deviation|10.1|10.1|||
4115895|NCT00942266|3940530|B2|||Age||years|Mean|61.1|61.1|Standard Deviation|10.5|10.5|||
4115896|NCT00942266|3940531|B1|||Age||years|Mean|60.5|60.5|Standard Deviation|10.3|10.3|||
4115897|NCT00942188|3940550|B5|Sufonylureas||Number of Participants on Anti-diabetic Medications|The number of participants on anti-diabetic medications does not equal the total number of participants because some participants reported taking more than 1 anti-diabetic medication.|Participants|Count of Participants|26|26.0||||||
4115898|NCT00942188|3940551|B4|Sufonylureas||Number of Participants on Anti-diabetic Medications|The number of participants on anti-diabetic medications does not equal the total number of participants because some participants reported taking more than 1 anti-diabetic medication.|Participants|Count of Participants|6|6.0||||||
4115899|NCT00942188|3940552|B3|Sufonylureas||Number of Participants on Anti-diabetic Medications|The number of participants on anti-diabetic medications does not equal the total number of participants because some participants reported taking more than 1 anti-diabetic medication.|Participants|Count of Participants|5|5.0||||||
4115900|NCT00942188|3940553|B2|Sufonylureas||Number of Participants on Anti-diabetic Medications|The number of participants on anti-diabetic medications does not equal the total number of participants because some participants reported taking more than 1 anti-diabetic medication.|Participants|Count of Participants|7|7.0||||||
4115901|NCT00942188|3940554|B1|Sufonylureas||Number of Participants on Anti-diabetic Medications|The number of participants on anti-diabetic medications does not equal the total number of participants because some participants reported taking more than 1 anti-diabetic medication.|Participants|Count of Participants|8|8.0||||||
4115902|NCT00942188|3940550|B5|Enhancers of Insulin Effects||Number of Participants on Anti-diabetic Medications|The number of participants on anti-diabetic medications does not equal the total number of participants because some participants reported taking more than 1 anti-diabetic medication.|Participants|Count of Participants|1|1.0||||||
4115903|NCT00942188|3940551|B4|Enhancers of Insulin Effects||Number of Participants on Anti-diabetic Medications|The number of participants on anti-diabetic medications does not equal the total number of participants because some participants reported taking more than 1 anti-diabetic medication.|Participants|Count of Participants|0|0.0||||||
4115904|NCT00942188|3940552|B3|Enhancers of Insulin Effects||Number of Participants on Anti-diabetic Medications|The number of participants on anti-diabetic medications does not equal the total number of participants because some participants reported taking more than 1 anti-diabetic medication.|Participants|Count of Participants|0|0.0||||||
4115905|NCT00942188|3940553|B2|Enhancers of Insulin Effects||Number of Participants on Anti-diabetic Medications|The number of participants on anti-diabetic medications does not equal the total number of participants because some participants reported taking more than 1 anti-diabetic medication.|Participants|Count of Participants|1|1.0||||||
4115906|NCT00942188|3940554|B1|Enhancers of Insulin Effects||Number of Participants on Anti-diabetic Medications|The number of participants on anti-diabetic medications does not equal the total number of participants because some participants reported taking more than 1 anti-diabetic medication.|Participants|Count of Participants|0|0.0||||||
4115907|NCT00942188|3940550|B5|DPP-4 Inhibitors||Number of Participants on Anti-diabetic Medications|The number of participants on anti-diabetic medications does not equal the total number of participants because some participants reported taking more than 1 anti-diabetic medication.|Participants|Count of Participants|4|4.0||||||
4115908|NCT00942188|3940551|B4|DPP-4 Inhibitors||Number of Participants on Anti-diabetic Medications|The number of participants on anti-diabetic medications does not equal the total number of participants because some participants reported taking more than 1 anti-diabetic medication.|Participants|Count of Participants|0|0.0||||||
4115909|NCT00942188|3940552|B3|DPP-4 Inhibitors||Number of Participants on Anti-diabetic Medications|The number of participants on anti-diabetic medications does not equal the total number of participants because some participants reported taking more than 1 anti-diabetic medication.|Participants|Count of Participants|4|4.0||||||
4115910|NCT00942188|3940553|B2|DPP-4 Inhibitors||Number of Participants on Anti-diabetic Medications|The number of participants on anti-diabetic medications does not equal the total number of participants because some participants reported taking more than 1 anti-diabetic medication.|Participants|Count of Participants|0|0.0||||||
4115911|NCT00942188|3940554|B1|DPP-4 Inhibitors||Number of Participants on Anti-diabetic Medications|The number of participants on anti-diabetic medications does not equal the total number of participants because some participants reported taking more than 1 anti-diabetic medication.|Participants|Count of Participants|0|0.0||||||
4115912|NCT00942188|3940550|B5|Glucagon-like Peptide (GLP) Analogs and Agonists||Number of Participants on Anti-diabetic Medications|The number of participants on anti-diabetic medications does not equal the total number of participants because some participants reported taking more than 1 anti-diabetic medication.|Participants|Count of Participants|1|1.0||||||
4115913|NCT00942188|3940551|B4|Glucagon-like Peptide (GLP) Analogs and Agonists||Number of Participants on Anti-diabetic Medications|The number of participants on anti-diabetic medications does not equal the total number of participants because some participants reported taking more than 1 anti-diabetic medication.|Participants|Count of Participants|0|0.0||||||
4115914|NCT00942188|3940552|B3|Glucagon-like Peptide (GLP) Analogs and Agonists||Number of Participants on Anti-diabetic Medications|The number of participants on anti-diabetic medications does not equal the total number of participants because some participants reported taking more than 1 anti-diabetic medication.|Participants|Count of Participants|0|0.0||||||
4115915|NCT00942188|3940553|B2|Glucagon-like Peptide (GLP) Analogs and Agonists||Number of Participants on Anti-diabetic Medications|The number of participants on anti-diabetic medications does not equal the total number of participants because some participants reported taking more than 1 anti-diabetic medication.|Participants|Count of Participants|0|0.0||||||
4115916|NCT00942188|3940554|B1|Glucagon-like Peptide (GLP) Analogs and Agonists||Number of Participants on Anti-diabetic Medications|The number of participants on anti-diabetic medications does not equal the total number of participants because some participants reported taking more than 1 anti-diabetic medication.|Participants|Count of Participants|1|1.0||||||
4115917|NCT00942188|3940550|B5|Biguanides||Number of Participants on Anti-diabetic Medications|The number of participants on anti-diabetic medications does not equal the total number of participants because some participants reported taking more than 1 anti-diabetic medication.|Participants|Count of Participants|85|85.0||||||
4115918|NCT00942188|3940551|B4|Biguanides||Number of Participants on Anti-diabetic Medications|The number of participants on anti-diabetic medications does not equal the total number of participants because some participants reported taking more than 1 anti-diabetic medication.|Participants|Count of Participants|20|20.0||||||
4115919|NCT00942188|3940552|B3|Biguanides||Number of Participants on Anti-diabetic Medications|The number of participants on anti-diabetic medications does not equal the total number of participants because some participants reported taking more than 1 anti-diabetic medication.|Participants|Count of Participants|22|22.0||||||
4115920|NCT00942188|3940553|B2|Biguanides||Number of Participants on Anti-diabetic Medications|The number of participants on anti-diabetic medications does not equal the total number of participants because some participants reported taking more than 1 anti-diabetic medication.|Participants|Count of Participants|23|23.0||||||
4115921|NCT00942188|3940554|B1|Biguanides||Number of Participants on Anti-diabetic Medications|The number of participants on anti-diabetic medications does not equal the total number of participants because some participants reported taking more than 1 anti-diabetic medication.|Participants|Count of Participants|20|20.0||||||
4115922|NCT00942188|3940550|B5|Diet and Exercise Only - No||Number of Participants on Diet and Exercise Only||Participants|Count of Participants|87|87.0||||||
4115923|NCT00942188|3940551|B4|Diet and Exercise Only - No||Number of Participants on Diet and Exercise Only||Participants|Count of Participants|20|20.0||||||
4115924|NCT00942188|3940552|B3|Diet and Exercise Only - No||Number of Participants on Diet and Exercise Only||Participants|Count of Participants|23|23.0||||||
4115925|NCT00942188|3940553|B2|Diet and Exercise Only - No||Number of Participants on Diet and Exercise Only||Participants|Count of Participants|23|23.0||||||
4115926|NCT00942188|3940554|B1|Diet and Exercise Only - No||Number of Participants on Diet and Exercise Only||Participants|Count of Participants|21|21.0||||||
4115927|NCT00942188|3940550|B5|Diet and Exercise Only - Yes||Number of Participants on Diet and Exercise Only||Participants|Count of Participants|19|19.0||||||
4115928|NCT00942188|3940551|B4|Diet and Exercise Only - Yes||Number of Participants on Diet and Exercise Only||Participants|Count of Participants|7|7.0||||||
4115929|NCT00942188|3940552|B3|Diet and Exercise Only - Yes||Number of Participants on Diet and Exercise Only||Participants|Count of Participants|4|4.0||||||
4115930|NCT00942188|3940553|B2|Diet and Exercise Only - Yes||Number of Participants on Diet and Exercise Only||Participants|Count of Participants|3|3.0||||||
4116038|NCT00942149|3940719|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4115931|NCT00942188|3940554|B1|Diet and Exercise Only - Yes||Number of Participants on Diet and Exercise Only||Participants|Count of Participants|5|5.0||||||
4115932|NCT00942188|3940550|B5|||Body Mass Index (BMI)||kilograms per square meter (kg/m^2)|Mean|33.1|33.1|Standard Deviation|4.01|4.01|||
4115933|NCT00942188|3940551|B4|||Body Mass Index (BMI)||kilograms per square meter (kg/m^2)|Mean|32.5|32.5|Standard Deviation|4.62|4.62|||
4115934|NCT00942188|3940552|B3|||Body Mass Index (BMI)||kilograms per square meter (kg/m^2)|Mean|33.1|33.1|Standard Deviation|4.02|4.02|||
4115935|NCT00942188|3940553|B2|||Body Mass Index (BMI)||kilograms per square meter (kg/m^2)|Mean|33.7|33.7|Standard Deviation|3.72|3.72|||
4115936|NCT00942188|3940554|B1|||Body Mass Index (BMI)||kilograms per square meter (kg/m^2)|Mean|33.0|33.0|Standard Deviation|3.73|3.73|||
4115937|NCT00942188|3940550|B5|||High-sensitivity C-reactive Protein (hsCRP)||milligrams per liter (mg/L)|Mean|6.373|6.373|Standard Deviation|5.5685|5.5685|||
4115938|NCT00942188|3940551|B4|||High-sensitivity C-reactive Protein (hsCRP)||milligrams per liter (mg/L)|Mean|6.093|6.093|Standard Deviation|4.5289|4.5289|||
4115939|NCT00942188|3940552|B3|||High-sensitivity C-reactive Protein (hsCRP)||milligrams per liter (mg/L)|Mean|7.183|7.183|Standard Deviation|6.9691|6.9691|||
4115940|NCT00942188|3940553|B2|||High-sensitivity C-reactive Protein (hsCRP)||milligrams per liter (mg/L)|Mean|6.024|6.024|Standard Deviation|4.4956|4.4956|||
4115941|NCT00942188|3940554|B1|||High-sensitivity C-reactive Protein (hsCRP)||milligrams per liter (mg/L)|Mean|6.214|6.214|Standard Deviation|6.2179|6.2179|||
4115942|NCT00942188|3940550|B5|||Fasting Insulin||microinternational units per milliliter|Mean|14.821|14.821|Standard Deviation|11.7856|11.7856|||
4115943|NCT00942188|3940551|B4|||Fasting Insulin||microinternational units per milliliter|Mean|15.120|15.12|Standard Deviation|12.5253|12.5253|||
4115944|NCT00942188|3940552|B3|||Fasting Insulin||microinternational units per milliliter|Mean|13.989|13.989|Standard Deviation|14.4076|14.4076|||
4115945|NCT00942188|3940553|B2|||Fasting Insulin||microinternational units per milliliter|Mean|15.034|15.034|Standard Deviation|6.9383|6.9383|||
4115946|NCT00942188|3940554|B1|||Fasting Insulin||microinternational units per milliliter|Mean|15.083|15.083|Standard Deviation|12.0562|12.0562|||
4115947|NCT00942188|3940550|B5|||Fasting Glucose||millimoles per liter (mmol/L)|Mean|9.208|9.208|Standard Deviation|2.0688|2.0688|||
4115948|NCT00942188|3940551|B4|||Fasting Glucose||millimoles per liter (mmol/L)|Mean|9.339|9.339|Standard Deviation|1.7315|1.7315|||
4115949|NCT00942188|3940552|B3|||Fasting Glucose||millimoles per liter (mmol/L)|Mean|10.300|10.3|Standard Deviation|2.1440|2.144|||
4115950|NCT00942188|3940553|B2|||Fasting Glucose||millimoles per liter (mmol/L)|Mean|9.106|9.106|Standard Deviation|2.2001|2.2001|||
4115951|NCT00942188|3940554|B1|||Fasting Glucose||millimoles per liter (mmol/L)|Mean|8.152|8.152|Standard Deviation|1.8154|1.8154|||
4115952|NCT00942188|3940550|B5|||Percentage of Glycosylated Fraction of Hemoglobin (HbA1c)|HbA1c: Hemoglobin A1c, glycosylated fraction of hemoglobin A (%)|percentage of glycosylated hemoglobin|Mean|7.882|7.882|Standard Deviation|0.7544|0.7544|||
4115953|NCT00942188|3940551|B4|||Percentage of Glycosylated Fraction of Hemoglobin (HbA1c)|HbA1c: Hemoglobin A1c, glycosylated fraction of hemoglobin A (%)|percentage of glycosylated hemoglobin|Mean|7.824|7.824|Standard Deviation|0.6557|0.6557|||
4115954|NCT00942188|3940552|B3|||Percentage of Glycosylated Fraction of Hemoglobin (HbA1c)|HbA1c: Hemoglobin A1c, glycosylated fraction of hemoglobin A (%)|percentage of glycosylated hemoglobin|Mean|8.271|8.271|Standard Deviation|0.9380|0.938|||
4115955|NCT00942188|3940553|B2|||Percentage of Glycosylated Fraction of Hemoglobin (HbA1c)|HbA1c: Hemoglobin A1c, glycosylated fraction of hemoglobin A (%)|percentage of glycosylated hemoglobin|Mean|7.950|7.95|Standard Deviation|0.7002|0.7002|||
4115956|NCT00942188|3940554|B1|||Percentage of Glycosylated Fraction of Hemoglobin (HbA1c)|HbA1c: Hemoglobin A1c, glycosylated fraction of hemoglobin A (%)|percentage of glycosylated hemoglobin|Mean|7.540|7.54|Standard Deviation|0.5596|0.5596|||
4115957|NCT00942188|3940550|B5|United States||Region of Enrollment||Participants|Count of Participants|106|106.0||||||
4115958|NCT00942188|3940551|B4|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
4115959|NCT00942188|3940552|B3|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
4115960|NCT00942188|3940553|B2|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
4115961|NCT00942188|3940554|B1|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
4115962|NCT00942188|3940550|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4115963|NCT00942188|3940551|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4115964|NCT00942188|3940552|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4115965|NCT00942188|3940553|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4115966|NCT00942188|3940554|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4115967|NCT00942188|3940550|B5|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4115968|NCT00942188|3940551|B4|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4115969|NCT00942188|3940552|B3|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4115970|NCT00942188|3940553|B2|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4115971|NCT00942188|3940554|B1|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4115972|NCT00942188|3940550|B5|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|49|49.0||||||
4115973|NCT00942188|3940551|B4|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4115974|NCT00942188|3940552|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4115975|NCT00942188|3940553|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4115976|NCT00942188|3940554|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
4115977|NCT00942188|3940550|B5|African||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
4115978|NCT00942188|3940551|B4|African||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4115979|NCT00942188|3940552|B3|African||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4115980|NCT00942188|3940553|B2|African||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4115981|NCT00942188|3940554|B1|African||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4115982|NCT00942188|3940550|B5|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
4115983|NCT00942188|3940551|B4|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4115984|NCT00942188|3940552|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4115985|NCT00942188|3940553|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4115986|NCT00942188|3940554|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4115987|NCT00942188|3940550|B5||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4115988|NCT00942188|3940551|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4115989|NCT00942188|3940552|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4115990|NCT00942188|3940553|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4115991|NCT00942188|3940554|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4115992|NCT00942188|3940550|B5||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4115993|NCT00942188|3940551|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4115994|NCT00942188|3940552|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4115995|NCT00942188|3940553|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4115996|NCT00942188|3940554|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4115997|NCT00942188|3940550|B5|||Age||years|Mean|52.7|52.7|Standard Deviation|9.05|9.05|||
4115998|NCT00942188|3940551|B4|||Age||years|Mean|52.9|52.9|Standard Deviation|9.41|9.41|||
4115999|NCT00942188|3940552|B3|||Age||years|Mean|51.3|51.3|Standard Deviation|9.17|9.17|||
4116000|NCT00942188|3940553|B2|||Age||years|Mean|53.7|53.7|Standard Deviation|10.74|10.74|||
4116001|NCT00942188|3940554|B1|||Age||years|Mean|52.9|52.9|Standard Deviation|6.75|6.75|||
4116002|NCT00942175|3940592|B5||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4116003|NCT00942175|3940593|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4116004|NCT00942175|3940594|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4116005|NCT00942175|3940595|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4116006|NCT00942175|3940596|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4116007|NCT00942175|3940592|B5||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4116008|NCT00942175|3940593|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4116009|NCT00942175|3940594|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4116010|NCT00942175|3940595|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4116011|NCT00942175|3940596|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4116012|NCT00942175|3940592|B5|||Age||years|Mean|33.9|33.9|Standard Deviation|7.26|7.26|||
4116013|NCT00942175|3940593|B4|||Age||years|Mean|33.3|33.3|Standard Deviation|7.10|7.1|||
4116014|NCT00942175|3940594|B3|||Age||years|Mean|34.0|34.0|Standard Deviation|7.40|7.4|||
4116015|NCT00942175|3940595|B2|||Age||years|Mean|35.7|35.7|Standard Deviation|7.92|7.92|||
4116016|NCT00942175|3940596|B1|||Age||years|Mean|32.8|32.8|Standard Deviation|6.48|6.48|||
4116017|NCT00942162|3940649|B4|White – Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|123|123.0||||||
4116018|NCT00942162|3940650|B3|White – Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4116019|NCT00942162|3940651|B2|White – Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
4116020|NCT00942162|3940652|B1|White – Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|71|71.0||||||
4116021|NCT00942162|3940649|B4||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4116022|NCT00942162|3940650|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4116023|NCT00942162|3940651|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4116024|NCT00942162|3940652|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4116025|NCT00942162|3940649|B4||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4116026|NCT00942162|3940650|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4116027|NCT00942162|3940651|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4116028|NCT00942162|3940652|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4116029|NCT00942162|3940649|B4|||Age||Years|Mean|64.9|64.9|Standard Deviation|13.45|13.45|||
4116030|NCT00942162|3940650|B3|||Age||Years|Mean|60.5|60.5|Standard Deviation|6.36|6.36|||
4116031|NCT00942162|3940651|B2|||Age||Years|Mean|62.1|62.1|Standard Deviation|12.6|12.6|||
4116032|NCT00942162|3940652|B1|||Age||Years|Mean|66.9|66.9|Standard Deviation|13.9|13.9|||
4116033|NCT00942149|3940719|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4116034|NCT00942149|3940719|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4116035|NCT00942149|3940719|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4116036|NCT00942149|3940719|B1|||Age||years|Mean|0.1|0.1|Standard Deviation|0.1|0.1|||
4116037|NCT00942149|3940719|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4116039|NCT00942149|3940719|B1||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
4116040|NCT00942084|3940723|B1|||Birthweight||grams|Median|1295|1295.0|Full Range|||420.0|4840.0|
4116041|NCT00942084|3940723|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4116042|NCT00942084|3940723|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116043|NCT00942084|3940723|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116044|NCT00942084|3940723|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4116045|NCT00942084|3940723|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4116046|NCT00942084|3940723|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116047|NCT00942084|3940723|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4116048|NCT00942084|3940723|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116049|NCT00942084|3940723|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116050|NCT00942084|3940723|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4116051|NCT00942084|3940723|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4116052|NCT00942084|3940723|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4116053|NCT00942084|3940723|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4116054|NCT00942084|3940723|B1|Gestational Age (weeks)||Age||weeks|Median|30.5|30.5|Full Range|||23.0|40.0|
4116055|NCT00942084|3940723|B1|Postnatal Age (days)||Age||days|Median|3.0|3.0|Full Range|||0.0|30.0|
4116056|NCT00941993|3940732|B1|United States||Region of Enrollment||participants|Number|109|109.0||||||
4116057|NCT00941993|3940732|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4116058|NCT00941993|3940732|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4116059|NCT00941993|3940732|B1|||Age||years|Mean|18.0|18.0|Standard Deviation|22.0|22.0|||
4116060|NCT00941928|3940740|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4116061|NCT00941928|3940740|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4116062|NCT00941928|3940740|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4116063|NCT00941928|3940740|B1|||Age||years|Mean|11|11.0|Full Range|||6.0|16.0|
4116064|NCT00941889|3940744|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4116065|NCT00941889|3940745|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4116066|NCT00941889|3940746|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4116067|NCT00941889|3940744|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4116068|NCT00941889|3940745|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4116069|NCT00941889|3940746|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4116070|NCT00941889|3940744|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4116071|NCT00941889|3940745|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4116072|NCT00941889|3940746|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4116073|NCT00941889|3940744|B3|||Age||years|Mean|37|37.0|Standard Deviation|11|11.0|||
4116074|NCT00941889|3940745|B2|||Age||years|Mean|37|37.0|Standard Deviation|13|13.0|||
4116075|NCT00941889|3940746|B1|||Age||years|Mean|36|36.0|Standard Deviation|10|10.0|||
4116076|NCT00941889|3940744|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4116077|NCT00941889|3940745|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4116078|NCT00941889|3940746|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4116079|NCT00941889|3940744|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4116080|NCT00941889|3940745|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4116081|NCT00941889|3940746|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4116082|NCT00941889|3940744|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116083|NCT00941889|3940745|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116084|NCT00941889|3940746|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116085|NCT00941863|3940753|B6|Other||Site of primary lesion|Tumor response was assessed using Response Evaluation Criteria in Solid Tumors (RECIST) criteria.|participants|Number|7|7.0||||||
4116086|NCT00941863|3940754|B5|Other||Site of primary lesion|Tumor response was assessed using Response Evaluation Criteria in Solid Tumors (RECIST) criteria.|participants|Number|2|2.0||||||
4116087|NCT00941863|3940755|B4|Other||Site of primary lesion|Tumor response was assessed using Response Evaluation Criteria in Solid Tumors (RECIST) criteria.|participants|Number|2|2.0||||||
4116088|NCT00941863|3940756|B3|Other||Site of primary lesion|Tumor response was assessed using Response Evaluation Criteria in Solid Tumors (RECIST) criteria.|participants|Number|0|0.0||||||
4116089|NCT00941863|3940757|B2|Other||Site of primary lesion|Tumor response was assessed using Response Evaluation Criteria in Solid Tumors (RECIST) criteria.|participants|Number|1|1.0||||||
4116090|NCT00941863|3940758|B1|Other||Site of primary lesion|Tumor response was assessed using Response Evaluation Criteria in Solid Tumors (RECIST) criteria.|participants|Number|2|2.0||||||
4116091|NCT00941863|3940753|B6|Renal||Site of primary lesion|Tumor response was assessed using Response Evaluation Criteria in Solid Tumors (RECIST) criteria.|participants|Number|23|23.0||||||
4116092|NCT00941863|3940754|B5|Renal||Site of primary lesion|Tumor response was assessed using Response Evaluation Criteria in Solid Tumors (RECIST) criteria.|participants|Number|21|21.0||||||
4116093|NCT00941863|3940755|B4|Renal||Site of primary lesion|Tumor response was assessed using Response Evaluation Criteria in Solid Tumors (RECIST) criteria.|participants|Number|1|1.0||||||
4116094|NCT00941863|3940756|B3|Renal||Site of primary lesion|Tumor response was assessed using Response Evaluation Criteria in Solid Tumors (RECIST) criteria.|participants|Number|0|0.0||||||
4116095|NCT00941863|3940757|B2|Renal||Site of primary lesion|Tumor response was assessed using Response Evaluation Criteria in Solid Tumors (RECIST) criteria.|participants|Number|1|1.0||||||
4116096|NCT00941863|3940758|B1|Renal||Site of primary lesion|Tumor response was assessed using Response Evaluation Criteria in Solid Tumors (RECIST) criteria.|participants|Number|0|0.0||||||
4116097|NCT00941863|3940753|B6|Ovarian||Site of primary lesion|Tumor response was assessed using Response Evaluation Criteria in Solid Tumors (RECIST) criteria.|participants|Number|3|3.0||||||
4116098|NCT00941863|3940754|B5|Ovarian||Site of primary lesion|Tumor response was assessed using Response Evaluation Criteria in Solid Tumors (RECIST) criteria.|participants|Number|3|3.0||||||
4116099|NCT00941863|3940755|B4|Ovarian||Site of primary lesion|Tumor response was assessed using Response Evaluation Criteria in Solid Tumors (RECIST) criteria.|participants|Number|0|0.0||||||
4116100|NCT00941863|3940756|B3|Ovarian||Site of primary lesion|Tumor response was assessed using Response Evaluation Criteria in Solid Tumors (RECIST) criteria.|participants|Number|0|0.0||||||
4116101|NCT00941863|3940757|B2|Ovarian||Site of primary lesion|Tumor response was assessed using Response Evaluation Criteria in Solid Tumors (RECIST) criteria.|participants|Number|0|0.0||||||
4116102|NCT00941863|3940758|B1|Ovarian||Site of primary lesion|Tumor response was assessed using Response Evaluation Criteria in Solid Tumors (RECIST) criteria.|participants|Number|0|0.0||||||
4116103|NCT00941863|3940753|B6|Non Small Cell Lung||Site of primary lesion|Tumor response was assessed using Response Evaluation Criteria in Solid Tumors (RECIST) criteria.|participants|Number|15|15.0||||||
4116104|NCT00941863|3940754|B5|Non Small Cell Lung||Site of primary lesion|Tumor response was assessed using Response Evaluation Criteria in Solid Tumors (RECIST) criteria.|participants|Number|11|11.0||||||
4116105|NCT00941863|3940755|B4|Non Small Cell Lung||Site of primary lesion|Tumor response was assessed using Response Evaluation Criteria in Solid Tumors (RECIST) criteria.|participants|Number|2|2.0||||||
4116106|NCT00941863|3940756|B3|Non Small Cell Lung||Site of primary lesion|Tumor response was assessed using Response Evaluation Criteria in Solid Tumors (RECIST) criteria.|participants|Number|1|1.0||||||
4116107|NCT00941863|3940757|B2|Non Small Cell Lung||Site of primary lesion|Tumor response was assessed using Response Evaluation Criteria in Solid Tumors (RECIST) criteria.|participants|Number|0|0.0||||||
4116108|NCT00941863|3940758|B1|Non Small Cell Lung||Site of primary lesion|Tumor response was assessed using Response Evaluation Criteria in Solid Tumors (RECIST) criteria.|participants|Number|1|1.0||||||
4116109|NCT00941863|3940753|B6|Malignant Melanoma||Site of primary lesion|Tumor response was assessed using Response Evaluation Criteria in Solid Tumors (RECIST) criteria.|participants|Number|105|105.0||||||
4116110|NCT00941863|3940754|B5|Malignant Melanoma||Site of primary lesion|Tumor response was assessed using Response Evaluation Criteria in Solid Tumors (RECIST) criteria.|participants|Number|81|81.0||||||
4116111|NCT00941863|3940755|B4|Malignant Melanoma||Site of primary lesion|Tumor response was assessed using Response Evaluation Criteria in Solid Tumors (RECIST) criteria.|participants|Number|10|10.0||||||
4116112|NCT00941863|3940756|B3|Malignant Melanoma||Site of primary lesion|Tumor response was assessed using Response Evaluation Criteria in Solid Tumors (RECIST) criteria.|participants|Number|10|10.0||||||
4116113|NCT00941863|3940757|B2|Malignant Melanoma||Site of primary lesion|Tumor response was assessed using Response Evaluation Criteria in Solid Tumors (RECIST) criteria.|participants|Number|1|1.0||||||
4116114|NCT00941863|3940758|B1|Malignant Melanoma||Site of primary lesion|Tumor response was assessed using Response Evaluation Criteria in Solid Tumors (RECIST) criteria.|participants|Number|3|3.0||||||
4116115|NCT00941863|3940753|B6|Colon||Site of primary lesion|Tumor response was assessed using Response Evaluation Criteria in Solid Tumors (RECIST) criteria.|participants|Number|5|5.0||||||
4116116|NCT00941863|3940754|B5|Colon||Site of primary lesion|Tumor response was assessed using Response Evaluation Criteria in Solid Tumors (RECIST) criteria.|participants|Number|1|1.0||||||
4116117|NCT00941863|3940755|B4|Colon||Site of primary lesion|Tumor response was assessed using Response Evaluation Criteria in Solid Tumors (RECIST) criteria.|participants|Number|2|2.0||||||
4116118|NCT00941863|3940756|B3|Colon||Site of primary lesion|Tumor response was assessed using Response Evaluation Criteria in Solid Tumors (RECIST) criteria.|participants|Number|1|1.0||||||
4116119|NCT00941863|3940757|B2|Colon||Site of primary lesion|Tumor response was assessed using Response Evaluation Criteria in Solid Tumors (RECIST) criteria.|participants|Number|0|0.0||||||
4116120|NCT00941863|3940758|B1|Colon||Site of primary lesion|Tumor response was assessed using Response Evaluation Criteria in Solid Tumors (RECIST) criteria.|participants|Number|1|1.0||||||
4116121|NCT00941863|3940753|B6|hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4116122|NCT00941863|3940754|B5|hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4116123|NCT00941863|3940755|B4|hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4116124|NCT00941863|3940756|B3|hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4116125|NCT00941863|3940757|B2|hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4116126|NCT00941863|3940758|B1|hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4116127|NCT00941863|3940753|B6|asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4116128|NCT00941863|3940754|B5|asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4116129|NCT00941863|3940755|B4|asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4116130|NCT00941863|3940756|B3|asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4116131|NCT00941863|3940757|B2|asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4116132|NCT00941863|3940758|B1|asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4116133|NCT00941863|3940753|B6|black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4116134|NCT00941863|3940754|B5|black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4116135|NCT00941863|3940755|B4|black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4116136|NCT00941863|3940756|B3|black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4116137|NCT00941863|3940757|B2|black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4116138|NCT00941863|3940758|B1|black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4116139|NCT00941863|3940753|B6|white||Race/Ethnicity, Customized||participants|Number|150|150.0||||||
4116140|NCT00941863|3940754|B5|white||Race/Ethnicity, Customized||participants|Number|113|113.0||||||
4116141|NCT00941863|3940755|B4|white||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4116142|NCT00941863|3940756|B3|white||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4116143|NCT00941863|3940757|B2|white||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4116144|NCT00941863|3940758|B1|white||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4116145|NCT00941863|3940753|B6||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4116146|NCT00941863|3940754|B5||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4116147|NCT00941863|3940755|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4116148|NCT00941863|3940756|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4116149|NCT00941863|3940757|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4116150|NCT00941863|3940758|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4116151|NCT00941863|3940753|B6||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4116152|NCT00941863|3940754|B5||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4116153|NCT00941863|3940755|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4116154|NCT00941863|3940756|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4116155|NCT00941863|3940757|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4116156|NCT00941863|3940758|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4116157|NCT00941863|3940753|B6|||Age||years|Mean|52.5|52.5|Standard Deviation|12.6|12.6|||
4116158|NCT00941863|3940754|B5|||Age||years|Mean|52.8|52.8|Standard Deviation|12.6|12.6|||
4116159|NCT00941863|3940755|B4|||Age||years|Mean|52.8|52.8|Standard Deviation|10.5|10.5|||
4116160|NCT00941863|3940756|B3|||Age||years|Mean|52.0|52.0|Standard Deviation|14.4|14.4|||
4116161|NCT00941863|3940757|B2|||Age||years|Mean|52.0|52.0|Standard Deviation|12.0|12.0|||
4116162|NCT00941863|3940758|B1|||Age||years|Mean|49.3|49.3|Standard Deviation|17.9|17.9|||
4116163|NCT00941798|3940787|B3||Male|Sex: Female, Male||Participants|Count of Participants|623|623.0||||||
4116164|NCT00941798|3940788|B2||Male|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
4116165|NCT00941798|3940789|B1||Male|Sex: Female, Male||Participants|Count of Participants|313|313.0||||||
4116166|NCT00941798|3940787|B3||Female|Sex: Female, Male||Participants|Count of Participants|885|885.0||||||
4116167|NCT00941798|3940788|B2||Female|Sex: Female, Male||Participants|Count of Participants|449|449.0||||||
4116168|NCT00941798|3940789|B1||Female|Sex: Female, Male||Participants|Count of Participants|436|436.0||||||
4116169|NCT00941798|3940787|B3|||Age||years|Mean|42.3|42.3|Standard Deviation|14.66|14.66|||
4116170|NCT00941798|3940788|B2|||Age||years|Mean|42.3|42.3|Standard Deviation|14.58|14.58|||
4116171|NCT00941798|3940789|B1|||Age||years|Mean|42.4|42.4|Standard Deviation|14.75|14.75|||
4116172|NCT00941733|3940818|B3|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
4116173|NCT00941733|3940819|B2|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4116174|NCT00941733|3940820|B1|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
4116175|NCT00941733|3940818|B3|Italy||Region of Enrollment||participants|Number|39|39.0||||||
4116176|NCT00941733|3940819|B2|Italy||Region of Enrollment||participants|Number|13|13.0||||||
4116177|NCT00941733|3940820|B1|Italy||Region of Enrollment||participants|Number|26|26.0||||||
4116178|NCT00941733|3940818|B3|Austria||Region of Enrollment||participants|Number|72|72.0||||||
4116179|NCT00941733|3940819|B2|Austria||Region of Enrollment||participants|Number|25|25.0||||||
4116180|NCT00941733|3940820|B1|Austria||Region of Enrollment||participants|Number|47|47.0||||||
4116181|NCT00941733|3940818|B3|Belgium||Region of Enrollment||participants|Number|91|91.0||||||
4116182|NCT00941733|3940819|B2|Belgium||Region of Enrollment||participants|Number|31|31.0||||||
4116183|NCT00941733|3940820|B1|Belgium||Region of Enrollment||participants|Number|60|60.0||||||
4116184|NCT00941733|3940818|B3|Switzerland||Region of Enrollment||participants|Number|46|46.0||||||
4116185|NCT00941733|3940819|B2|Switzerland||Region of Enrollment||participants|Number|15|15.0||||||
4116186|NCT00941733|3940820|B1|Switzerland||Region of Enrollment||participants|Number|31|31.0||||||
4116187|NCT00941733|3940818|B3|Germany||Region of Enrollment||participants|Number|108|108.0||||||
4116188|NCT00941733|3940819|B2|Germany||Region of Enrollment||participants|Number|35|35.0||||||
4116189|NCT00941733|3940820|B1|Germany||Region of Enrollment||participants|Number|73|73.0||||||
4116190|NCT00941733|3940818|B3||Male|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
4116191|NCT00941733|3940819|B2||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4116192|NCT00941733|3940820|B1||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4116193|NCT00941733|3940818|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4116194|NCT00941733|3940819|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4116195|NCT00941733|3940820|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4116196|NCT00941733|3940818|B3|||Age||years|Mean|72.5|72.5|Standard Deviation|9.05|9.05|||
4116197|NCT00941733|3940819|B2|||Age||years|Mean|71.7|71.7|Standard Deviation|9.9|9.9|||
4116198|NCT00941733|3940820|B1|||Age||years|Mean|73.3|73.3|Standard Deviation|8.2|8.2|||
4116199|NCT00941720|3940861|B1|United States||Region of Enrollment||participants|Number|57|57.0||||||
4116261|NCT00941668|3940897|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116200|NCT00941720|3940861|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116201|NCT00941720|3940861|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4116202|NCT00941720|3940861|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116203|NCT00941720|3940861|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116204|NCT00941720|3940861|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116205|NCT00941720|3940861|B1||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4116206|NCT00941720|3940861|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4116207|NCT00941720|3940861|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116208|NCT00941720|3940861|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4116209|NCT00941720|3940861|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116210|NCT00941720|3940861|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4116211|NCT00941720|3940861|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4116212|NCT00941720|3940861|B1|||Age||years|Mean|58|58.0|Standard Deviation|8|8.0|||
4116213|NCT00941681|3940867|B4|Georgia||Region of Enrollment||participants|Number|35|35.0||||||
4116214|NCT00941681|3940868|B3|Georgia||Region of Enrollment||participants|Number|12|12.0||||||
4116215|NCT00941681|3940869|B2|Georgia||Region of Enrollment||participants|Number|11|11.0||||||
4116216|NCT00941681|3940870|B1|Georgia||Region of Enrollment||participants|Number|12|12.0||||||
4116217|NCT00941681|3940867|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4116218|NCT00941681|3940868|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4116219|NCT00941681|3940869|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4116220|NCT00941681|3940870|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4116221|NCT00941681|3940867|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4116222|NCT00941681|3940868|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4116223|NCT00941681|3940869|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4116224|NCT00941681|3940870|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4116225|NCT00941681|3940867|B4|||Age||years|Mean|62.6|62.6|Standard Deviation|9.08|9.08|||
4116226|NCT00941681|3940868|B3|||Age||years|Mean|62.4|62.4|Standard Deviation|11.51|11.51|||
4116227|NCT00941681|3940869|B2|||Age||years|Mean|61.1|61.1|Standard Deviation|7.97|7.97|||
4116228|NCT00941681|3940870|B1|||Age||years|Mean|64.1|64.1|Standard Deviation|7.74|7.74|||
4116229|NCT00941681|3940867|B4||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4116230|NCT00941681|3940868|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4116231|NCT00941681|3940869|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4116232|NCT00941681|3940870|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4116233|NCT00941681|3940867|B4||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4116234|NCT00941681|3940868|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4116235|NCT00941681|3940869|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4116236|NCT00941681|3940870|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4116237|NCT00941681|3940867|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116238|NCT00941681|3940868|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116239|NCT00941681|3940869|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116240|NCT00941681|3940870|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116241|NCT00941668|3940895|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
4116242|NCT00941668|3940896|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4116243|NCT00941668|3940897|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4116244|NCT00941668|3940895|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4116245|NCT00941668|3940896|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4116246|NCT00941668|3940897|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4116247|NCT00941668|3940895|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4116248|NCT00941668|3940896|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4116249|NCT00941668|3940897|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4116250|NCT00941668|3940895|B3|||Age||years|Mean|36.25|36.25|Standard Deviation|12.2|12.2|||
4116251|NCT00941668|3940896|B2|||Age||years|Mean|34|34.0|Standard Deviation|12.1|12.1|||
4116252|NCT00941668|3940897|B1|||Age||years|Mean|39.9|39.9|Standard Deviation|12.5|12.5|||
4116253|NCT00941668|3940895|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4116254|NCT00941668|3940896|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4116255|NCT00941668|3940897|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4116256|NCT00941668|3940895|B3||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4116257|NCT00941668|3940896|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4116258|NCT00941668|3940897|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4116259|NCT00941668|3940895|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116260|NCT00941668|3940896|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116262|NCT00941655|3940906|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4116263|NCT00941655|3940907|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4116264|NCT00941655|3940908|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4116265|NCT00941655|3940906|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4116266|NCT00941655|3940907|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116267|NCT00941655|3940908|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4116268|NCT00941655|3940906|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116269|NCT00941655|3940907|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116270|NCT00941655|3940908|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116271|NCT00941655|3940906|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4116272|NCT00941655|3940907|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4116273|NCT00941655|3940908|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4116274|NCT00941655|3940906|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116275|NCT00941655|3940907|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116276|NCT00941655|3940908|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116277|NCT00941655|3940906|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116278|NCT00941655|3940907|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116279|NCT00941655|3940908|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116280|NCT00941655|3940906|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4116281|NCT00941655|3940907|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4116282|NCT00941655|3940908|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116283|NCT00941655|3940906|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116284|NCT00941655|3940907|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116285|NCT00941655|3940908|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116286|NCT00941655|3940906|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116287|NCT00941655|3940907|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116288|NCT00941655|3940908|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116289|NCT00941655|3940906|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4116290|NCT00941655|3940907|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4116291|NCT00941655|3940908|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4116292|NCT00941655|3940906|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4116293|NCT00941655|3940907|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116294|NCT00941655|3940908|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4116295|NCT00941655|3940906|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4116296|NCT00941655|3940907|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4116297|NCT00941655|3940908|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4116298|NCT00941655|3940906|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4116299|NCT00941655|3940907|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4116300|NCT00941655|3940908|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4116301|NCT00941655|3940906|B3|||Age||years|Mean|49.33|49.33|Standard Deviation|13.44|13.44|||
4116302|NCT00941655|3940907|B2|||Age||years|Mean|52.94|52.94|Standard Deviation|11.67|11.67|||
4116303|NCT00941655|3940908|B1|||Age||years|Mean|45.73|45.73|Standard Deviation|14.88|14.88|||
4116304|NCT00941655|3940906|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4116305|NCT00941655|3940907|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4116306|NCT00941655|3940908|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4116307|NCT00941655|3940906|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4116308|NCT00941655|3940907|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4116309|NCT00941655|3940908|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4116310|NCT00941655|3940906|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116311|NCT00941655|3940907|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116312|NCT00941655|3940908|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116313|NCT00941603|3940928|B7||Male|Sex: Female, Male||Participants|Count of Participants|319|319.0||||||
4116314|NCT00941603|3940929|B6||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4116315|NCT00941603|3940930|B5||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4116316|NCT00941603|3940931|B4||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4116317|NCT00941603|3940932|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4116318|NCT00941603|3940933|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4116319|NCT00941603|3940934|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4116320|NCT00941603|3940928|B7||Female|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
4116321|NCT00941603|3940929|B6||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4116322|NCT00941603|3940930|B5||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4116323|NCT00941603|3940931|B4||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4116324|NCT00941603|3940932|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4116325|NCT00941603|3940933|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4116326|NCT00941603|3940934|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4116327|NCT00941603|3940928|B7|||Age||Years|Mean|56.5|56.5|Standard Deviation|9.7|9.7|||
4116328|NCT00941603|3940929|B6|||Age||Years|Mean|55.2|55.2|Standard Deviation|9.5|9.5|||
4116329|NCT00941603|3940930|B5|||Age||Years|Mean|57.5|57.5|Standard Deviation|9.4|9.4|||
4116330|NCT00941603|3940931|B4|||Age||Years|Mean|56.5|56.5|Standard Deviation|8.7|8.7|||
4116331|NCT00941603|3940932|B3|||Age||Years|Mean|56.1|56.1|Standard Deviation|10.3|10.3|||
4116332|NCT00941603|3940933|B2|||Age||Years|Mean|56.0|56.0|Standard Deviation|10.8|10.8|||
4116333|NCT00941603|3940934|B1|||Age||Years|Mean|57.5|57.5|Standard Deviation|9.5|9.5|||
4116334|NCT00941330|3940959|B3|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
4116335|NCT00941330|3940960|B2|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4116336|NCT00941330|3940961|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4116337|NCT00941330|3940959|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4116338|NCT00941330|3940960|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4116339|NCT00941330|3940961|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4116340|NCT00941330|3940959|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4116341|NCT00941330|3940960|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4116342|NCT00941330|3940961|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4116343|NCT00941330|3940959|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4116344|NCT00941330|3940960|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4116345|NCT00941330|3940961|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4116346|NCT00941330|3940959|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4116347|NCT00941330|3940960|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4116348|NCT00941330|3940961|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4116349|NCT00941330|3940959|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116350|NCT00941330|3940960|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116351|NCT00941330|3940961|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116352|NCT00941304|3940970|B6||Male|Gender||Participants|Count of Participants|57|57.0||||||
4116353|NCT00941304|3940971|B5||Male|Gender||Participants|Count of Participants|15|15.0||||||
4116354|NCT00941304|3940972|B4||Male|Gender||Participants|Count of Participants|12|12.0||||||
4116355|NCT00941304|3940973|B3||Male|Gender||Participants|Count of Participants|11|11.0||||||
4116356|NCT00941304|3940974|B2||Male|Gender||Participants|Count of Participants|10|10.0||||||
4116357|NCT00941304|3940975|B1||Male|Gender||Participants|Count of Participants|9|9.0||||||
4116358|NCT00941304|3940970|B6||Female|Gender||Participants|Count of Participants|96|96.0||||||
4116359|NCT00941304|3940971|B5||Female|Gender||Participants|Count of Participants|16|16.0||||||
4116360|NCT00941304|3940972|B4||Female|Gender||Participants|Count of Participants|18|18.0||||||
4116361|NCT00941304|3940973|B3||Female|Gender||Participants|Count of Participants|20|20.0||||||
4116362|NCT00941304|3940974|B2||Female|Gender||Participants|Count of Participants|20|20.0||||||
4116363|NCT00941304|3940975|B1||Female|Gender||Participants|Count of Participants|22|22.0||||||
4116364|NCT00941304|3940970|B6|||Age||years|Median|21.0|21.0|Full Range|||18.0|30.0|
4116365|NCT00941304|3940971|B5|||Age||years|Median|21.0|21.0|Full Range|||18.0|29.0|
4116366|NCT00941304|3940972|B4|||Age||years|Median|22.0|22.0|Full Range|||18.0|28.0|
4116367|NCT00941304|3940973|B3|||Age||years|Median|21.0|21.0|Full Range|||18.0|27.0|
4116368|NCT00941304|3940974|B2|||Age||years|Median|21.0|21.0|Full Range|||18.0|30.0|
4116369|NCT00941304|3940975|B1|||Age||years|Median|21.0|21.0|Full Range|||18.0|30.0|
4116370|NCT00941070|3941041|B1|HPV-naive||HPV Genotyping|Cervical cancer genotyping|participants|Number|6|6.0||||||
4116371|NCT00941070|3941041|B1|HPV 18||HPV Genotyping|Cervical cancer genotyping|participants|Number|4|4.0||||||
4116372|NCT00941070|3941041|B1|HPV 16||HPV Genotyping|Cervical cancer genotyping|participants|Number|15|15.0||||||
4116373|NCT00941070|3941041|B1|Vagina IVA||International Federation of Gynecology and Obstetrics (FIGO) Stage|One patient was non-compliant and received no therapy. Patient was excluded from study specific baseline characteristics.|participants|Number|1|1.0||||||
4116374|NCT00941070|3941041|B1|Vagina II||International Federation of Gynecology and Obstetrics (FIGO) Stage|One patient was non-compliant and received no therapy. Patient was excluded from study specific baseline characteristics.|participants|Number|2|2.0||||||
4116375|NCT00941070|3941041|B1|Cervix IVB||International Federation of Gynecology and Obstetrics (FIGO) Stage|One patient was non-compliant and received no therapy. Patient was excluded from study specific baseline characteristics.|participants|Number|2|2.0||||||
4116376|NCT00941070|3941041|B1|Cervix IIIB||International Federation of Gynecology and Obstetrics (FIGO) Stage|One patient was non-compliant and received no therapy. Patient was excluded from study specific baseline characteristics.|participants|Number|10|10.0||||||
4116420|NCT00941031|3941057|B5||White|Race (NIH/OMB)||Participants|Count of Participants|353|353.0||||||
4116377|NCT00941070|3941041|B1|Cervix IIB||International Federation of Gynecology and Obstetrics (FIGO) Stage|One patient was non-compliant and received no therapy. Patient was excluded from study specific baseline characteristics.|participants|Number|1|1.0||||||
4116378|NCT00941070|3941041|B1|Cervix IIA||International Federation of Gynecology and Obstetrics (FIGO) Stage|One patient was non-compliant and received no therapy. Patient was excluded from study specific baseline characteristics.|participants|Number|4|4.0||||||
4116379|NCT00941070|3941041|B1|Cervix IB2 Node Positive||International Federation of Gynecology and Obstetrics (FIGO) Stage|One patient was non-compliant and received no therapy. Patient was excluded from study specific baseline characteristics.|participants|Number|4|4.0||||||
4116380|NCT00941070|3941041|B1|Cervix IB2 Node Negative||International Federation of Gynecology and Obstetrics (FIGO) Stage|One patient was non-compliant and received no therapy. Patient was excluded from study specific baseline characteristics.|participants|Number|1|1.0||||||
4116381|NCT00941070|3941041|B1|Present||Lymphovascular invasion|One patient was non-compliant and received no therapy. Patient was excluded from study specific baseline characteristics.|participants|Number|18|18.0||||||
4116382|NCT00941070|3941041|B1|Absent||Lymphovascular invasion|One patient was non-compliant and received no therapy. Patient was excluded from study specific baseline characteristics.|participants|Number|7|7.0||||||
4116383|NCT00941070|3941041|B1|2/3rds or greater invasion||Cervical Stromal Invasion|One patient was non-compliant and received no therapy. Patient was excluded from study specific baseline characteristics.|participants|Number|22|22.0||||||
4116384|NCT00941070|3941041|B1|Less than 2/3rds invasion||Cervical Stromal Invasion|One patient was non-compliant and received no therapy. Patient was excluded from study specific baseline characteristics.|participants|Number|3|3.0||||||
4116385|NCT00941070|3941041|B1|Grade 3||Tumor Grade|One patient was non-compliant and received no therapy. Patient was excluded from study specific baseline characteristics.|participants|Number|12|12.0||||||
4116386|NCT00941070|3941041|B1|Grade 2||Tumor Grade|One patient was non-compliant and received no therapy. Patient was excluded from study specific baseline characteristics.|participants|Number|13|13.0||||||
4116387|NCT00941070|3941041|B1|Adenocarcinoma||Histopathology|One patient was non-compliant and received no therapy. Patient was excluded from study specific baseline characteristics.|participants|Number|1|1.0||||||
4116388|NCT00941070|3941041|B1|Adenosquamous carcinoma||Histopathology|One patient was non-compliant and received no therapy. Patient was excluded from study specific baseline characteristics.|participants|Number|1|1.0||||||
4116389|NCT00941070|3941041|B1|Squamous cell carcinoma||Histopathology|One patient was non-compliant and received no therapy. Patient was excluded from study specific baseline characteristics.|participants|Number|23|23.0||||||
4116390|NCT00941070|3941041|B1|1||GOG Performance Status|One patient was non-compliant and received no therapy. Patient was excluded from study specific baseline characteristics. The Gynecologic Oncology Group (GOG) performance status reflects individual daily living activities on a scale of 0 (fully active with symptoms) to 5 (dead).|participants|Number|2|2.0||||||
4116391|NCT00941070|3941041|B1|0||GOG Performance Status|One patient was non-compliant and received no therapy. Patient was excluded from study specific baseline characteristics. The Gynecologic Oncology Group (GOG) performance status reflects individual daily living activities on a scale of 0 (fully active with symptoms) to 5 (dead).|participants|Number|23|23.0||||||
4116392|NCT00941070|3941041|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4116393|NCT00941070|3941041|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116394|NCT00941070|3941041|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4116395|NCT00941070|3941041|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4116396|NCT00941070|3941041|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4116397|NCT00941070|3941041|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116398|NCT00941070|3941041|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116399|NCT00941070|3941041|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116400|NCT00941070|3941041|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116401|NCT00941070|3941041|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4116402|NCT00941070|3941041|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4116403|NCT00941070|3941041|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4116404|NCT00941070|3941041|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4116405|NCT00941070|3941041|B1|70-79||Age, Customized||participants|Number|1|1.0||||||
4116406|NCT00941070|3941041|B1|60-69||Age, Customized||participants|Number|6|6.0||||||
4116407|NCT00941070|3941041|B1|50-59||Age, Customized||participants|Number|11|11.0||||||
4116408|NCT00941070|3941041|B1|40-49||Age, Customized||participants|Number|7|7.0||||||
4116409|NCT00941070|3941041|B1|30-39||Age, Customized||participants|Number|1|1.0||||||
4116410|NCT00941031|3941057|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4116411|NCT00941031|3941058|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4116412|NCT00941031|3941059|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4116413|NCT00941031|3941060|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116414|NCT00941031|3941061|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116415|NCT00941031|3941057|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116416|NCT00941031|3941058|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116417|NCT00941031|3941059|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116418|NCT00941031|3941060|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116419|NCT00941031|3941061|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116421|NCT00941031|3941058|B4||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4116422|NCT00941031|3941059|B3||White|Race (NIH/OMB)||Participants|Count of Participants|118|118.0||||||
4116423|NCT00941031|3941060|B2||White|Race (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
4116424|NCT00941031|3941061|B1||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4116425|NCT00941031|3941057|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4116426|NCT00941031|3941058|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4116427|NCT00941031|3941059|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116428|NCT00941031|3941060|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4116429|NCT00941031|3941061|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116430|NCT00941031|3941057|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4116431|NCT00941031|3941058|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4116432|NCT00941031|3941059|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116433|NCT00941031|3941060|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116434|NCT00941031|3941061|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116435|NCT00941031|3941057|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4116436|NCT00941031|3941058|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4116437|NCT00941031|3941059|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4116438|NCT00941031|3941060|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4116439|NCT00941031|3941061|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4116440|NCT00941031|3941057|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116441|NCT00941031|3941058|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116442|NCT00941031|3941059|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116443|NCT00941031|3941060|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116444|NCT00941031|3941061|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116445|NCT00941031|3941057|B5||Male|Sex: Female, Male||Participants|Count of Participants|306|306.0||||||
4116446|NCT00941031|3941058|B4||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4116447|NCT00941031|3941059|B3||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4116448|NCT00941031|3941060|B2||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4116449|NCT00941031|3941061|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4116450|NCT00941031|3941057|B5||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4116451|NCT00941031|3941058|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4116452|NCT00941031|3941059|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4116453|NCT00941031|3941060|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4116454|NCT00941031|3941061|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4116455|NCT00941031|3941057|B5|||Age||Years|Mean|44.1|44.1|Standard Deviation|12.44|12.44|||
4116456|NCT00941031|3941058|B4|||Age||Years|Mean|44.2|44.2|Standard Deviation|12.59|12.59|||
4116457|NCT00941031|3941059|B3|||Age||Years|Mean|44.5|44.5|Standard Deviation|12.45|12.45|||
4116458|NCT00941031|3941060|B2|||Age||Years|Mean|44.2|44.2|Standard Deviation|12.96|12.96|||
4116459|NCT00941031|3941061|B1|||Age||Years|Mean|42.7|42.7|Standard Deviation|11.32|11.32|||
4116460|NCT00940992|3941090|B4|||number of inflammatory lesions|minimum of 12 inflammatory lesions|number of inflammatory lesion|Mean|23.9|23.9|Standard Deviation|19.76|19.76|||
4116461|NCT00940992|3941091|B3|||number of inflammatory lesions|minimum of 12 inflammatory lesions|number of inflammatory lesion|Mean|22.9|22.9|Standard Deviation|16.89|16.89|||
4116462|NCT00940992|3941092|B2|||number of inflammatory lesions|minimum of 12 inflammatory lesions|number of inflammatory lesion|Mean|19.9|19.9|Standard Deviation|8.64|8.64|||
4116463|NCT00940992|3941093|B1|||number of inflammatory lesions|minimum of 12 inflammatory lesions|number of inflammatory lesion|Mean|28.6|28.6|Standard Deviation|27.76|27.76|||
4116464|NCT00940992|3941090|B4|United States||Region of Enrollment||participants|Number|92|92.0||||||
4116465|NCT00940992|3941091|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4116466|NCT00940992|3941092|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4116467|NCT00940992|3941093|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4116468|NCT00940992|3941090|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4116469|NCT00940992|3941091|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4116470|NCT00940992|3941092|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4116471|NCT00940992|3941093|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4116472|NCT00940992|3941090|B4||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4116473|NCT00940992|3941091|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4116474|NCT00940992|3941092|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4116475|NCT00940992|3941093|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4116476|NCT00940992|3941090|B4|||Age||years|Mean|51.2|51.2|Standard Deviation|12.80|12.8|||
4116477|NCT00940992|3941091|B3|||Age||years|Mean|52.2|52.2|Standard Deviation|12.66|12.66|||
4116478|NCT00940992|3941092|B2|||Age||years|Mean|50.5|50.5|Standard Deviation|12.56|12.56|||
4116479|NCT00940992|3941093|B1|||Age||years|Mean|51.0|51.0|Standard Deviation|13.50|13.5|||
4116480|NCT00940927|3941106|B1|United States||Region of Enrollment||participants|Number|81|81.0||||||
4116481|NCT00940927|3941106|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4116482|NCT00940927|3941106|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4116483|NCT00940927|3941106|B1|||Age||years|Mean|30.2|30.2|Standard Deviation|17.4|17.4|||
4116484|NCT00940927|3941106|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4116485|NCT00940927|3941106|B1||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4116486|NCT00940927|3941106|B1||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
4116487|NCT00940901|3941111|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4116488|NCT00940901|3941112|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4116489|NCT00940901|3941113|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4116490|NCT00940901|3941111|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4116491|NCT00940901|3941112|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4116492|NCT00940901|3941113|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4116493|NCT00940901|3941111|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4116494|NCT00940901|3941112|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4116495|NCT00940901|3941113|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4116496|NCT00940901|3941111|B3|||Age||years|Mean|22.5|22.5|Standard Deviation|7.0|7.0|||
4116497|NCT00940901|3941112|B2|||Age||years|Mean|23.0|23.0|Standard Deviation|8.7|8.7|||
4116498|NCT00940901|3941113|B1|||Age||years|Mean|21.7|21.7|Standard Deviation|5.3|5.3|||
4116499|NCT00940888|3941124|B1|Not Available||Primary Indication for Device Implant||participants|Number|1|1.0||||||
4116500|NCT00940888|3941124|B1|VT||Primary Indication for Device Implant||participants|Number|164|164.0||||||
4116501|NCT00940888|3941124|B1|VF||Primary Indication for Device Implant||participants|Number|83|83.0||||||
4116502|NCT00940888|3941124|B1|Syncope||Primary Indication for Device Implant||participants|Number|39|39.0||||||
4116503|NCT00940888|3941124|B1|SCD-HeFT||Primary Indication for Device Implant||participants|Number|409|409.0||||||
4116504|NCT00940888|3941124|B1|Physician Designated||Primary Indication for Device Implant||participants|Number|19|19.0||||||
4116505|NCT00940888|3941124|B1|PAVE||Primary Indication for Device Implant||participants|Number|14|14.0||||||
4116506|NCT00940888|3941124|B1|MADIT II||Primary Indication for Device Implant||participants|Number|228|228.0||||||
4116507|NCT00940888|3941124|B1|ICD Upgrade||Primary Indication for Device Implant||participants|Number|44|44.0||||||
4116508|NCT00940888|3941124|B1|HF Without Sinus Rhythm||Primary Indication for Device Implant||participants|Number|70|70.0||||||
4116509|NCT00940888|3941124|B1|HF Without QRS||Primary Indication for Device Implant||participants|Number|45|45.0||||||
4116510|NCT00940888|3941124|B1|HF With Wide QRS||Primary Indication for Device Implant||participants|Number|484|484.0||||||
4116511|NCT00940888|3941124|B1|Familial Condition||Primary Indication for Device Implant||participants|Number|31|31.0||||||
4116512|NCT00940888|3941124|B1|DEFINITE||Primary Indication for Device Implant||participants|Number|5|5.0||||||
4116513|NCT00940888|3941124|B1|CRT-D Upgrade||Primary Indication for Device Implant||participants|Number|65|65.0||||||
4116514|NCT00940888|3941124|B1|||Left Ventricular (LV) Ejection Fraction (%)||Percentage|Mean|29|29.0|Standard Deviation|12|12.0|||
4116515|NCT00940888|3941124|B1|Not Available||New York Heart Association (NYHA) Class|NHYA classification:Class I-no limitation of physical activity, ordinary physical activity doesn't cause undue breathlessness, fatigue, or palpitations, Class II-slight limitation of physical activity;comfortable at rest; ordinary physical activity results in fatigue, palpitation, dyspnea, Class III-marked limitation of physical activity;comfortable at rest;less than ordinary activity causes fatigue, palpitation, or dyspnea, class IV-Unable to carry on any physical activity without discomfort; symptoms at rest can be present; if any physical activity is undertaken, discomfort is increased.|participants|Number|221|221.0||||||
4116516|NCT00940888|3941124|B1|Class 4||New York Heart Association (NYHA) Class|NHYA classification:Class I-no limitation of physical activity, ordinary physical activity doesn't cause undue breathlessness, fatigue, or palpitations, Class II-slight limitation of physical activity;comfortable at rest; ordinary physical activity results in fatigue, palpitation, dyspnea, Class III-marked limitation of physical activity;comfortable at rest;less than ordinary activity causes fatigue, palpitation, or dyspnea, class IV-Unable to carry on any physical activity without discomfort; symptoms at rest can be present; if any physical activity is undertaken, discomfort is increased.|participants|Number|29|29.0||||||
4116517|NCT00940888|3941124|B1|Class 3||New York Heart Association (NYHA) Class|NHYA classification:Class I-no limitation of physical activity, ordinary physical activity doesn't cause undue breathlessness, fatigue, or palpitations, Class II-slight limitation of physical activity;comfortable at rest; ordinary physical activity results in fatigue, palpitation, dyspnea, Class III-marked limitation of physical activity;comfortable at rest;less than ordinary activity causes fatigue, palpitation, or dyspnea, class IV-Unable to carry on any physical activity without discomfort; symptoms at rest can be present; if any physical activity is undertaken, discomfort is increased.|participants|Number|816|816.0||||||
4116518|NCT00940888|3941124|B1|Class 2||New York Heart Association (NYHA) Class|NHYA classification:Class I-no limitation of physical activity, ordinary physical activity doesn't cause undue breathlessness, fatigue, or palpitations, Class II-slight limitation of physical activity;comfortable at rest; ordinary physical activity results in fatigue, palpitation, dyspnea, Class III-marked limitation of physical activity;comfortable at rest;less than ordinary activity causes fatigue, palpitation, or dyspnea, class IV-Unable to carry on any physical activity without discomfort; symptoms at rest can be present; if any physical activity is undertaken, discomfort is increased.|participants|Number|541|541.0||||||
4116567|NCT00940823|3941152|B1||White|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4116519|NCT00940888|3941124|B1|Class 1||New York Heart Association (NYHA) Class|NHYA classification:Class I-no limitation of physical activity, ordinary physical activity doesn't cause undue breathlessness, fatigue, or palpitations, Class II-slight limitation of physical activity;comfortable at rest; ordinary physical activity results in fatigue, palpitation, dyspnea, Class III-marked limitation of physical activity;comfortable at rest;less than ordinary activity causes fatigue, palpitation, or dyspnea, class IV-Unable to carry on any physical activity without discomfort; symptoms at rest can be present; if any physical activity is undertaken, discomfort is increased.|participants|Number|94|94.0||||||
4116520|NCT00940888|3941124|B1|United States||Region of Enrollment||participants|Number|1701|1701.0||||||
4116521|NCT00940888|3941124|B1|Hispanic/ Black (Puerto Rican)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4116522|NCT00940888|3941124|B1|White||Race/Ethnicity, Customized||participants|Number|1382|1382.0||||||
4116523|NCT00940888|3941124|B1|Persian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4116524|NCT00940888|3941124|B1|Other- Non Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4116525|NCT00940888|3941124|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4116526|NCT00940888|3941124|B1|Middle Eastern||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4116527|NCT00940888|3941124|B1|Iranian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4116528|NCT00940888|3941124|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
4116529|NCT00940888|3941124|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|235|235.0||||||
4116530|NCT00940888|3941124|B1|Asian||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4116531|NCT00940888|3941124|B1|American Indian Or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4116532|NCT00940888|3941124|B1||Male|Sex: Female, Male||Participants|Count of Participants|1219|1219.0||||||
4116533|NCT00940888|3941124|B1||Female|Sex: Female, Male||Participants|Count of Participants|482|482.0||||||
4116534|NCT00940888|3941124|B1|||Age||years|Mean|65|65.0|Standard Deviation|13|13.0|||
4116535|NCT00940875|3941129|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4116536|NCT00940875|3941130|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4116537|NCT00940875|3941131|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4116538|NCT00940875|3941129|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4116539|NCT00940875|3941130|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4116540|NCT00940875|3941131|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4116541|NCT00940875|3941129|B3|||Age||years|Mean|73.8|73.8|Standard Deviation|8.32|8.32|||
4116542|NCT00940875|3941130|B2|||Age||years|Mean|72.8|72.8|Standard Deviation|7.91|7.91|||
4116543|NCT00940875|3941131|B1|||Age||years|Mean|74.8|74.8|Standard Deviation|8.72|8.72|||
4116544|NCT00940823|3941150|B3|||Mean logMAR (converted) Visual Acuity|"LogMAR Visual Acuity is calculated by taking the log(Snellen Acuity/20). Normal vision (20/20) corresponds to 0 and complete blindness (no light perception, designated as 20/64000) corresponds to 3.5.~Hence, the lower the logMAR value, the better the vision."|units on a scale|Mean|1.3|1.3|Standard Deviation|1.1|1.1|||
4116545|NCT00940823|3941151|B2|||Mean logMAR (converted) Visual Acuity|"LogMAR Visual Acuity is calculated by taking the log(Snellen Acuity/20). Normal vision (20/20) corresponds to 0 and complete blindness (no light perception, designated as 20/64000) corresponds to 3.5.~Hence, the lower the logMAR value, the better the vision."|units on a scale|Mean|1.3|1.3|Standard Deviation|1.1|1.1|||
4116546|NCT00940823|3941152|B1|||Mean logMAR (converted) Visual Acuity|"LogMAR Visual Acuity is calculated by taking the log(Snellen Acuity/20). Normal vision (20/20) corresponds to 0 and complete blindness (no light perception, designated as 20/64000) corresponds to 3.5.~Hence, the lower the logMAR value, the better the vision."|units on a scale|Mean|1.3|1.3|Standard Deviation|1.0|1.0|||
4116547|NCT00940823|3941150|B3|||Prior Ocular Surgeries||Ocular Surgeries|Mean|1.7|1.7|Standard Deviation|1.2|1.2|||
4116548|NCT00940823|3941151|B2|||Prior Ocular Surgeries||Ocular Surgeries|Mean|1.6|1.6|Standard Deviation|1.1|1.1|||
4116549|NCT00940823|3941152|B1|||Prior Ocular Surgeries||Ocular Surgeries|Mean|1.8|1.8|Standard Deviation|1.3|1.3|||
4116550|NCT00940823|3941150|B3|||Prior Laser Therapies||laser procedures|Mean|0.9|0.9|Standard Deviation|1.1|1.1|||
4116551|NCT00940823|3941151|B2|||Prior Laser Therapies||laser procedures|Mean|1.0|1.0|Standard Deviation|1.1|1.1|||
4116552|NCT00940823|3941152|B1|||Prior Laser Therapies||laser procedures|Mean|0.8|0.8|Standard Deviation|1.1|1.1|||
4116553|NCT00940823|3941150|B3|||Glaucoma Medication Use||medications|Mean|3.1|3.1|Standard Deviation|1.0|1.0|||
4116554|NCT00940823|3941151|B2|||Glaucoma Medication Use||medications|Mean|3.1|3.1|Standard Deviation|1.1|1.1|||
4116555|NCT00940823|3941152|B1|||Glaucoma Medication Use||medications|Mean|3.1|3.1|Standard Deviation|1.0|1.0|||
4116556|NCT00940823|3941150|B3|||Intraocular Pressure||mmHg|Mean|31.4|31.4|Standard Deviation|10.8|10.8|||
4116557|NCT00940823|3941151|B2|||Intraocular Pressure||mmHg|Mean|31.7|31.7|Standard Deviation|11.1|11.1|||
4116558|NCT00940823|3941152|B1|||Intraocular Pressure||mmHg|Mean|31.1|31.1|Standard Deviation|10.5|10.5|||
4116559|NCT00940823|3941150|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116560|NCT00940823|3941151|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116561|NCT00940823|3941152|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116562|NCT00940823|3941150|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116563|NCT00940823|3941151|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116564|NCT00940823|3941152|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116565|NCT00940823|3941150|B3||White|Race (NIH/OMB)||Participants|Count of Participants|182|182.0||||||
4116566|NCT00940823|3941151|B2||White|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4116568|NCT00940823|3941150|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4116569|NCT00940823|3941151|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4116570|NCT00940823|3941152|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4116571|NCT00940823|3941150|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116572|NCT00940823|3941151|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116573|NCT00940823|3941152|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116574|NCT00940823|3941150|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4116575|NCT00940823|3941151|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4116576|NCT00940823|3941152|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4116577|NCT00940823|3941150|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116578|NCT00940823|3941151|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116579|NCT00940823|3941152|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116580|NCT00940823|3941150|B3||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4116581|NCT00940823|3941151|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4116582|NCT00940823|3941152|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4116583|NCT00940823|3941150|B3||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4116584|NCT00940823|3941151|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4116585|NCT00940823|3941152|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4116586|NCT00940823|3941150|B3|||Age||years|Mean|66|66.0|Standard Deviation|16|16.0|||
4116587|NCT00940823|3941151|B2|||Age||years|Mean|67|67.0|Standard Deviation|15|15.0|||
4116588|NCT00940823|3941152|B1|||Age||years|Mean|65|65.0|Standard Deviation|17|17.0|||
4116589|NCT00940589|3941169|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4116590|NCT00940589|3941170|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4116591|NCT00940589|3941171|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4116592|NCT00940589|3941169|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4116593|NCT00940589|3941170|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4116594|NCT00940589|3941171|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4116595|NCT00940589|3941169|B3|||Age||years|Mean|75.4|75.4|Standard Deviation|7.6|7.6|||
4116596|NCT00940589|3941170|B2|||Age||years|Mean|77.3|77.3|Standard Deviation|6.6|6.6|||
4116597|NCT00940589|3941171|B1|||Age||years|Mean|73.5|73.5|Standard Deviation|8.6|8.6|||
4116598|NCT00940576|3941182|B1|Germany||Region of Enrollment||participants|Number|17|17.0||||||
4116599|NCT00940576|3941182|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4116600|NCT00940576|3941182|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4116601|NCT00940576|3941182|B1|||Age||years|Mean|19.0|19.0|Standard Deviation|8.4|8.4|||
4116602|NCT00940576|3941182|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4116603|NCT00940576|3941182|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4116604|NCT00940576|3941182|B1||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4116605|NCT00940537|3941190|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4116606|NCT00940537|3941191|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4116607|NCT00940537|3941192|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4116608|NCT00940537|3941190|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4116609|NCT00940537|3941191|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4116610|NCT00940537|3941192|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4116611|NCT00940537|3941190|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4116612|NCT00940537|3941191|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4116613|NCT00940537|3941192|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4116614|NCT00940537|3941190|B3|||Age||years|Mean|45|45.0|Standard Deviation|12|12.0|||
4116615|NCT00940537|3941191|B2|||Age||years|Mean|46|46.0|Standard Deviation|12|12.0|||
4116616|NCT00940537|3941192|B1|||Age||years|Mean|43|43.0|Standard Deviation|13|13.0|||
4116617|NCT00940537|3941190|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4116618|NCT00940537|3941191|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4116619|NCT00940537|3941192|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4116620|NCT00940537|3941190|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4116621|NCT00940537|3941191|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4116622|NCT00940537|3941192|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4116623|NCT00940537|3941190|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116624|NCT00940537|3941191|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116625|NCT00940537|3941192|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116626|NCT00940498|3941202|B9||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4116627|NCT00940498|3941203|B8||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4116628|NCT00940498|3941204|B7||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4116629|NCT00940498|3941205|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4116630|NCT00940498|3941206|B5||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4116631|NCT00940498|3941207|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4116632|NCT00940498|3941208|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4116633|NCT00940498|3941209|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4116634|NCT00940498|3941210|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4116635|NCT00940498|3941202|B9||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4116636|NCT00940498|3941203|B8||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4116637|NCT00940498|3941204|B7||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4116638|NCT00940498|3941205|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4116639|NCT00940498|3941206|B5||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4116640|NCT00940498|3941207|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4116641|NCT00940498|3941208|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4116642|NCT00940498|3941209|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4116643|NCT00940498|3941210|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4116644|NCT00940498|3941202|B9||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4116645|NCT00940498|3941203|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4116646|NCT00940498|3941204|B7||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4116647|NCT00940498|3941205|B6||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4116648|NCT00940498|3941206|B5||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4116649|NCT00940498|3941207|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4116650|NCT00940498|3941208|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4116651|NCT00940498|3941209|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4116652|NCT00940498|3941210|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4116653|NCT00940498|3941202|B9||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4116654|NCT00940498|3941203|B8||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4116655|NCT00940498|3941204|B7||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4116656|NCT00940498|3941205|B6||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4116657|NCT00940498|3941206|B5||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4116658|NCT00940498|3941207|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4116659|NCT00940498|3941208|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4116660|NCT00940498|3941209|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4116661|NCT00940498|3941210|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4116662|NCT00940498|3941202|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116663|NCT00940498|3941203|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116664|NCT00940498|3941204|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116665|NCT00940498|3941205|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116666|NCT00940498|3941206|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116667|NCT00940498|3941207|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116668|NCT00940498|3941208|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116669|NCT00940498|3941209|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116670|NCT00940498|3941210|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116671|NCT00940485|3941333|B3||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4116672|NCT00940485|3941334|B2||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4116673|NCT00940485|3941335|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4116674|NCT00940485|3941333|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4116675|NCT00940485|3941334|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4116676|NCT00940485|3941335|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4116677|NCT00940485|3941333|B3|||Age||years|Mean|33.3|33.3|Standard Deviation|8.6|8.6|||
4116678|NCT00940485|3941334|B2|||Age||years|Mean|33.28|33.28|Standard Deviation|8.95|8.95|||
4116679|NCT00940485|3941335|B1|||Age||years|Mean|33.38|33.38|Standard Deviation|8.25|8.25|||
4116680|NCT00940446|3941360|B3|||Number of staples placed|we counted the number of staples used, collectively for all participants. This is a baseline number used for outcomes comparisons.|staples|Number|1062|1062.0||||||
4116681|NCT00940446|3941361|B2|||Number of staples placed|we counted the number of staples used, collectively for all participants. This is a baseline number used for outcomes comparisons.|staples|Number|597|597.0||||||
4116682|NCT00940446|3941362|B1|||Number of staples placed|we counted the number of staples used, collectively for all participants. This is a baseline number used for outcomes comparisons.|staples|Number|465|465.0||||||
4116683|NCT00940446|3941360|B3||Male|Sex: Female, Male|number and sex of study participants|Participants|Count of Participants|25|25.0||||||
4116684|NCT00940446|3941361|B2||Male|Sex: Female, Male|number and sex of study participants|Participants|Count of Participants|10|10.0||||||
4116685|NCT00940446|3941362|B1||Male|Sex: Female, Male|number and sex of study participants|Participants|Count of Participants|15|15.0||||||
4116686|NCT00940446|3941360|B3||Female|Sex: Female, Male|number and sex of study participants|Participants|Count of Participants|35|35.0||||||
4116687|NCT00940446|3941361|B2||Female|Sex: Female, Male|number and sex of study participants|Participants|Count of Participants|20|20.0||||||
4116688|NCT00940446|3941362|B1||Female|Sex: Female, Male|number and sex of study participants|Participants|Count of Participants|15|15.0||||||
4116689|NCT00940446|3941360|B3|||Age||years|Median|61.9|61.9|Full Range|||41.0|82.0|
4116690|NCT00940446|3941361|B2|||Age||years|Median|61.9|61.9|Full Range|||41.0|82.0|
4116691|NCT00940446|3941362|B1|||Age||years|Median|62.3|62.3|Full Range|||45.0|82.0|
4116692|NCT00940342|3941371|B4|United States||Region of Enrollment||participants|Number|130|130.0||||||
4116693|NCT00940342|3941372|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4116694|NCT00940342|3941373|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4116695|NCT00940342|3941374|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4116696|NCT00940342|3941371|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116697|NCT00940342|3941372|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116698|NCT00940342|3941373|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116699|NCT00940342|3941374|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116700|NCT00940342|3941371|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116701|NCT00940342|3941372|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116702|NCT00940342|3941373|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116703|NCT00940342|3941374|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116704|NCT00940342|3941371|B4||White|Race (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
4116705|NCT00940342|3941372|B3||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4116706|NCT00940342|3941373|B2||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4116707|NCT00940342|3941374|B1||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4116708|NCT00940342|3941371|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4116709|NCT00940342|3941372|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4116710|NCT00940342|3941373|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4116711|NCT00940342|3941374|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4116712|NCT00940342|3941371|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116713|NCT00940342|3941372|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116714|NCT00940342|3941373|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116715|NCT00940342|3941374|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116716|NCT00940342|3941371|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116717|NCT00940342|3941372|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116718|NCT00940342|3941373|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116719|NCT00940342|3941374|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116720|NCT00940342|3941371|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116721|NCT00940342|3941372|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116722|NCT00940342|3941373|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116723|NCT00940342|3941374|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116724|NCT00940342|3941371|B4||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4116725|NCT00940342|3941372|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4116726|NCT00940342|3941373|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4116727|NCT00940342|3941374|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4116728|NCT00940342|3941371|B4||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4116729|NCT00940342|3941372|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4116730|NCT00940342|3941373|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4116731|NCT00940342|3941374|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4116732|NCT00940342|3941371|B4|||Age||years|Median|69|69.0|Full Range|||34.0|84.0|
4116733|NCT00940342|3941372|B3|||Age||years|Median|73|73.0|Full Range|||70.0|83.0|
4116734|NCT00940342|3941373|B2|||Age||years|Median|56.5|56.5|Full Range|||34.0|70.0|
4116735|NCT00940342|3941374|B1|||Age||years|Median|68|68.0|Full Range|||41.0|84.0|
4116736|NCT00940342|3941371|B4||>=65 years|Age||Participants|Count of Participants|74|74.0||||||
4116737|NCT00940342|3941372|B3||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
4116738|NCT00940342|3941373|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4116739|NCT00940342|3941374|B1||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4116740|NCT00940342|3941371|B4||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4116741|NCT00940342|3941372|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4116742|NCT00940342|3941373|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4116743|NCT00940342|3941374|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4116744|NCT00940342|3941371|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116745|NCT00940342|3941372|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116746|NCT00940342|3941373|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116747|NCT00940342|3941374|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116748|NCT00940290|3941384|B5|Years of practice||Years of practice||Years|Median|5|5.0|Inter-Quartile Range|||2.0|18.0|
4116749|NCT00940290|3941385|B4|Years of practice||Years of practice||Years|Median|9|9.0|Inter-Quartile Range|||2.0|20.0|
4116750|NCT00940290|3941386|B3|Years of practice||Years of practice||Years|Median|4|4.0|Inter-Quartile Range|||2.0|12.0|
4116751|NCT00940290|3941387|B2|Years of practice||Years of practice||Years|Median|5|5.0|Inter-Quartile Range|||2.0|18.0|
4116752|NCT00940290|3941388|B1|Years of practice||Years of practice||Years|Median|4|4.0|Inter-Quartile Range|||2.0|19.0|
4116753|NCT00940290|3941384|B5||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4116754|NCT00940290|3941385|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4116755|NCT00940290|3941386|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4116756|NCT00940290|3941387|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4116757|NCT00940290|3941388|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4116758|NCT00940290|3941384|B5||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4116759|NCT00940290|3941385|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4116760|NCT00940290|3941386|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4116761|NCT00940290|3941387|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4116762|NCT00940290|3941388|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4116763|NCT00940290|3941384|B5|||Age||years|Median|32|32.0|Inter-Quartile Range|||28.0|46.0|
4116764|NCT00940290|3941385|B4|||Age||years|Median|38|38.0|Inter-Quartile Range|||28.0|49.0|
4116765|NCT00940290|3941386|B3|||Age||years|Median|31|31.0|Inter-Quartile Range|||28.0|40.0|
4116766|NCT00940290|3941387|B2|||Age||years|Median|34|34.0|Inter-Quartile Range|||28.0|47.0|
4116767|NCT00940290|3941388|B1|||Age||years|Median|30|30.0|Inter-Quartile Range|||28.0|47.0|
4116768|NCT00940108|3941401|B5||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4116769|NCT00940108|3941402|B4||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4116770|NCT00940108|3941403|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4116771|NCT00940108|3941404|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4116772|NCT00940108|3941405|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4116773|NCT00940108|3941401|B5||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4116774|NCT00940108|3941402|B4||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4116775|NCT00940108|3941403|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4116776|NCT00940108|3941404|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4116777|NCT00940108|3941405|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4116778|NCT00940108|3941401|B5|||Age||years|Mean|3.96|3.96|Standard Deviation|2.42|2.42|||
4116779|NCT00940108|3941402|B4|||Age||years|Mean|5.66|5.66|Standard Deviation|1.74|1.74|||
4116780|NCT00940108|3941403|B3|||Age||years|Mean|5.78|5.78|Standard Deviation|1.69|1.69|||
4116781|NCT00940108|3941404|B2|||Age||years|Mean|1.73|1.73|Standard Deviation|0.74|0.74|||
4116782|NCT00940108|3941405|B1|||Age||years|Mean|1.68|1.68|Standard Deviation|0.67|0.67|||
4116783|NCT00940017|3941458|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4116784|NCT00940017|3941458|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4116785|NCT00940017|3941458|B1|||Age||years|Mean|27.3|27.3|Standard Deviation|7.8|7.8|||
4116786|NCT00939991|3941477|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4116787|NCT00939991|3941478|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4116788|NCT00939991|3941479|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4116789|NCT00939991|3941477|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4116790|NCT00939991|3941478|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4116791|NCT00939991|3941479|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4116792|NCT00939991|3941477|B3|||Age||years|Mean|50|50.0|Standard Deviation|12|12.0|||
4116793|NCT00939991|3941478|B2|||Age||years|Mean|51|51.0|Standard Deviation|11|11.0|||
4116794|NCT00939991|3941479|B1|||Age||years|Mean|47|47.0|Standard Deviation|14|14.0|||
4116795|NCT00939952|3941490|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4116796|NCT00939952|3941490|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4116797|NCT00939952|3941490|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4116798|NCT00939952|3941490|B1|||Age||years|Mean|55.14|55.14|Standard Deviation|17|17.0|||
4116799|NCT00939952|3941490|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4116800|NCT00939952|3941490|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4116801|NCT00939952|3941490|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116802|NCT00939900|3941500|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4116803|NCT00939900|3941501|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4116804|NCT00939900|3941502|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4116805|NCT00939900|3941500|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4116806|NCT00939900|3941501|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4116807|NCT00939900|3941502|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4116808|NCT00939900|3941500|B3|||Age||years|Mean|44.5|44.5|Standard Deviation|11.5|11.5|||
4116809|NCT00939900|3941501|B2|||Age||years|Mean|45.2|45.2|Standard Deviation|11.6|11.6|||
4116810|NCT00939900|3941502|B1|||Age||years|Mean|43.8|43.8|Standard Deviation|11.8|11.8|||
4116811|NCT00939874|3941509|B1|Australia||Region of Enrollment||participants|Number|37|37.0||||||
4116812|NCT00939874|3941509|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4116813|NCT00939874|3941509|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4116814|NCT00939874|3941509|B1|||Age||years|Mean|50|50.0|Full Range|||30.0|70.0|
4116815|NCT00939874|3941509|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4116816|NCT00939874|3941509|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4116817|NCT00939874|3941509|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116818|NCT00939809|3941514|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4116819|NCT00939809|3941514|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4116820|NCT00939809|3941514|B1|70-79 years||Age, Customized||participants|Number|2|2.0||||||
4116821|NCT00939809|3941514|B1|60-69 years||Age, Customized||participants|Number|17|17.0||||||
4116822|NCT00939809|3941514|B1|50-59 years||Age, Customized||participants|Number|11|11.0||||||
4116823|NCT00939809|3941514|B1|40-49 years||Age, Customized||participants|Number|1|1.0||||||
4116824|NCT00939796|3941523|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4116825|NCT00939796|3941523|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4116826|NCT00939796|3941523|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4116827|NCT00939796|3941523|B1|>5 years||Age, Customized||participants|Number|2|2.0||||||
4116828|NCT00939796|3941523|B1|<=5 years||Age, Customized||participants|Number|14|14.0||||||
4116829|NCT00939783|3941529|B1||Male|Sex: Female, Male||Participants|Count of Participants|306|306.0||||||
4116830|NCT00939783|3941529|B1||Female|Sex: Female, Male||Participants|Count of Participants|342|342.0||||||
4116831|NCT00939783|3941529|B1|Greater than 85 years||Age, Customized||Participants|Number|60|60.0||||||
4116832|NCT00939783|3941529|B1|80 to 85 years||Age, Customized||Participants|Number|187|187.0||||||
4116833|NCT00939783|3941529|B1|70 to 79 years||Age, Customized||Participants|Number|269|269.0||||||
4116834|NCT00939783|3941529|B1|60 to 69 years||Age, Customized||Participants|Number|100|100.0||||||
4116835|NCT00939783|3941529|B1|50 to 59 years||Age, Customized||Participants|Number|32|32.0||||||
4116836|NCT00939731|3941536|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4116837|NCT00939731|3941536|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4116838|NCT00939731|3941536|B1|||Age||years|Mean|32.1|32.1|Standard Deviation|9.3|9.3|||
4116839|NCT00939705|3941555|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4116840|NCT00939705|3941556|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4116841|NCT00939705|3941557|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4116842|NCT00939705|3941555|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4116843|NCT00939705|3941556|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4116844|NCT00939705|3941557|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4116845|NCT00939705|3941555|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4116846|NCT00939705|3941556|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4116847|NCT00939705|3941557|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4116848|NCT00939705|3941555|B3|||Age||years|Mean|32.4|32.4|Standard Deviation|10.8|10.8|||
4116849|NCT00939705|3941556|B2|||Age||years|Mean|32.4|32.4|Standard Deviation|10.8|10.8|||
4116850|NCT00939705|3941557|B1|||Age||years|Mean|32.4|32.4|Standard Deviation|10.8|10.8|||
4116851|NCT00939705|3941555|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4116852|NCT00939705|3941556|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4116853|NCT00939705|3941557|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4116854|NCT00939705|3941555|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4116855|NCT00939705|3941556|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4116856|NCT00939705|3941557|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4116857|NCT00939705|3941555|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116858|NCT00939705|3941556|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116859|NCT00939705|3941557|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116860|NCT00939692|3941568|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4116861|NCT00939692|3941569|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4116862|NCT00939692|3941570|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4116863|NCT00939692|3941568|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4116864|NCT00939692|3941569|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4116865|NCT00939692|3941570|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4116866|NCT00939692|3941568|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4116867|NCT00939692|3941569|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4116868|NCT00939692|3941570|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4116869|NCT00939692|3941568|B3|||Age||years|Mean|30.3|30.3|Standard Deviation|10.9|10.9|||
4116870|NCT00939692|3941569|B2|||Age||years|Mean|30.3|30.3|Standard Deviation|10.9|10.9|||
4116871|NCT00939692|3941570|B1|||Age||years|Mean|30.3|30.3|Standard Deviation|10.9|10.9|||
4116872|NCT00939692|3941568|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4116873|NCT00939692|3941569|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4116874|NCT00939692|3941570|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4116875|NCT00939692|3941568|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4116876|NCT00939692|3941569|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4116877|NCT00939692|3941570|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4116878|NCT00939692|3941568|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116879|NCT00939692|3941569|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116880|NCT00939692|3941570|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116881|NCT00939640|3941581|B1|||Participants on 3 or more antihypertensive medications||Participants|Count of Participants|10|10.0||||||
4116882|NCT00939640|3941581|B1|||Participants on chronic loop diuretics||Participants|Count of Participants|11|11.0||||||
4116883|NCT00939640|3941581|B1|||Participants with prior hospitalization due to heart failure||Participants|Count of Participants|10|10.0||||||
4116884|NCT00939640|3941581|B1|NYHA Class II||New York Heart Assocation Classification|"NYHA class:~I No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea (shortness of breath).~II Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea~III Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~IV Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases."|Participants|Count of Participants|2|2.0||||||
4116885|NCT00939640|3941581|B1|NYHA Class III||New York Heart Assocation Classification|"NYHA class:~I No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea (shortness of breath).~II Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea~III Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~IV Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases."|Participants|Count of Participants|12|12.0||||||
4116886|NCT00939640|3941581|B1|||Participants wtih Anemia||Participants|Count of Participants|6|6.0||||||
4116887|NCT00939640|3941581|B1|||Participants wtih Diabetes Mellitus||Participants|Count of Participants|6|6.0||||||
4116888|NCT00939640|3941581|B1|||Coronary Artery Disease||Participants|Count of Participants|5|5.0||||||
4116889|NCT00939640|3941581|B1|||Participants with Chronic Kidney Disease||Participants|Count of Participants|14|14.0||||||
4116890|NCT00939640|3941581|B1|||Hypertension||Participants|Count of Participants|14|14.0||||||
4116891|NCT00939640|3941581|B1|||Body mass index||kg/m^2|Mean|35.5|35.5|Standard Deviation|7.9|7.9|||
4116892|NCT00939640|3941581|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4116893|NCT00939640|3941581|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4116894|NCT00939640|3941581|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4116895|NCT00939640|3941581|B1|||Age||years|Mean|72|72.0|Standard Deviation|10|10.0|||
4116896|NCT00939640|3941581|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4116897|NCT00939640|3941581|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4116898|NCT00939640|3941581|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116899|NCT00939627|3941602|B3|United States||Region of Enrollment||participants|Number|55|55.0||||||
4116900|NCT00939627|3941603|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4116901|NCT00939627|3941604|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4116902|NCT00939627|3941602|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4116903|NCT00939627|3941603|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4116904|NCT00939627|3941604|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4116905|NCT00939627|3941602|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4116906|NCT00939627|3941603|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4116907|NCT00939627|3941604|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4116908|NCT00939627|3941602|B3|||Age, Customized||years|Median|59|59.0|Full Range|||26.0|74.0|
4116909|NCT00939627|3941603|B2|||Age, Customized||years|Median|60|60.0|Full Range|||42.0|71.0|
4116910|NCT00939627|3941604|B1|||Age, Customized||years|Median|59|59.0|Full Range|||26.0|74.0|
4116911|NCT00939627|3941602|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4116912|NCT00939627|3941603|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4116913|NCT00939627|3941604|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4116914|NCT00939627|3941602|B3||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4116915|NCT00939627|3941603|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4116916|NCT00939627|3941604|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4116917|NCT00939627|3941602|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116918|NCT00939627|3941603|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116919|NCT00939627|3941604|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116920|NCT00939562|3941624|B1|Asian||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4116921|NCT00939562|3941624|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4116922|NCT00939562|3941624|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4116923|NCT00939562|3941624|B1|> = 65 years||Age, Customized||participants|Number|0|0.0||||||
4116924|NCT00939562|3941624|B1|45 to 64 years||Age, Customized||participants|Number|0|0.0||||||
4116925|NCT00939562|3941624|B1|18 to 44 years||Age, Customized||participants|Number|24|24.0||||||
4116926|NCT00939562|3941624|B1|< 18 years||Age, Customized||participants|Number|0|0.0||||||
4116927|NCT00939536|3941633|B3|India||Region of Enrollment||participants|Number|24|24.0||||||
4116928|NCT00939536|3941634|B2|India||Region of Enrollment||participants|Number|12|12.0||||||
4116929|NCT00939536|3941635|B1|India||Region of Enrollment||participants|Number|12|12.0||||||
4116930|NCT00939536|3941633|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4116931|NCT00939536|3941634|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4116932|NCT00939536|3941635|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4116933|NCT00939536|3941633|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4116934|NCT00939536|3941634|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4116935|NCT00939536|3941635|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4116936|NCT00939536|3941633|B3|||Age||years|Mean|28.2|28.2|Standard Deviation|6.7|6.7|||
4116937|NCT00939536|3941634|B2|||Age||years|Mean|28.2|28.2|Standard Deviation|6.7|6.7|||
4116938|NCT00939536|3941635|B1|||Age||years|Mean|28.2|28.2|Standard Deviation|6.7|6.7|||
4116939|NCT00939536|3941633|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4116940|NCT00939536|3941634|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4116941|NCT00939536|3941635|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4116942|NCT00939536|3941633|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4116943|NCT00939536|3941634|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4116944|NCT00939536|3941635|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4116945|NCT00939536|3941633|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116946|NCT00939536|3941634|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116947|NCT00939536|3941635|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4116948|NCT00939510|3941646|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4116949|NCT00939510|3941646|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4116950|NCT00939510|3941646|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116951|NCT00939510|3941646|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4116952|NCT00939510|3941646|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4116953|NCT00939510|3941646|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116954|NCT00939510|3941646|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116955|NCT00939510|3941646|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116956|NCT00939510|3941646|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4116957|NCT00939510|3941646|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4116958|NCT00939510|3941646|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116959|NCT00939510|3941646|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4116960|NCT00939510|3941646|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4116961|NCT00939510|3941646|B1|||Age||years|Mean|68.7|68.7|Standard Deviation|7.3|7.3|||
4116962|NCT00939484|3941652|B4|Primitive neuroectodermal tumor||Diagnosis||participants|Number|1|1.0||||||
4116963|NCT00939484|3941653|B3|Primitive neuroectodermal tumor||Diagnosis||participants|Number|0|0.0||||||
4116964|NCT00939484|3941654|B2|Primitive neuroectodermal tumor||Diagnosis||participants|Number|1|1.0||||||
4116965|NCT00939484|3941655|B1|Primitive neuroectodermal tumor||Diagnosis||participants|Number|0|0.0||||||
4116966|NCT00939484|3941652|B4|Medulloblastoma, NOS||Diagnosis||participants|Number|29|29.0||||||
4116967|NCT00939484|3941653|B3|Medulloblastoma, NOS||Diagnosis||participants|Number|3|3.0||||||
4116968|NCT00939484|3941654|B2|Medulloblastoma, NOS||Diagnosis||participants|Number|18|18.0||||||
4116969|NCT00939484|3941655|B1|Medulloblastoma, NOS||Diagnosis||participants|Number|8|8.0||||||
4116970|NCT00939484|3941652|B4|Desmoplastic medulloblastoma||Diagnosis||participants|Number|1|1.0||||||
4116971|NCT00939484|3941653|B3|Desmoplastic medulloblastoma||Diagnosis||participants|Number|0|0.0||||||
4116972|NCT00939484|3941654|B2|Desmoplastic medulloblastoma||Diagnosis||participants|Number|1|1.0||||||
4116973|NCT00939484|3941655|B1|Desmoplastic medulloblastoma||Diagnosis||participants|Number|0|0.0||||||
4116974|NCT00939484|3941652|B4|United States||Region of Enrollment||participants|Number|31|31.0||||||
4116975|NCT00939484|3941653|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4116976|NCT00939484|3941654|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4116977|NCT00939484|3941655|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4116978|NCT00939484|3941652|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4116979|NCT00939484|3941653|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116980|NCT00939484|3941654|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4116981|NCT00939484|3941655|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4116982|NCT00939484|3941652|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116983|NCT00939484|3941653|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116984|NCT00939484|3941654|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116985|NCT00939484|3941655|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116986|NCT00939484|3941652|B4||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4116987|NCT00939484|3941653|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4116988|NCT00939484|3941654|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4116989|NCT00939484|3941655|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4116990|NCT00939484|3941652|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4116991|NCT00939484|3941653|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116992|NCT00939484|3941654|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4116993|NCT00939484|3941655|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116994|NCT00939484|3941652|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116995|NCT00939484|3941653|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116996|NCT00939484|3941654|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116997|NCT00939484|3941655|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116998|NCT00939484|3941652|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4116999|NCT00939484|3941653|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117000|NCT00939484|3941654|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117001|NCT00939484|3941655|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117002|NCT00939484|3941652|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117003|NCT00939484|3941653|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117004|NCT00939484|3941654|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117005|NCT00939484|3941655|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117006|NCT00939484|3941652|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4117007|NCT00939484|3941653|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117008|NCT00939484|3941654|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4117009|NCT00939484|3941655|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4117010|NCT00939484|3941652|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4117011|NCT00939484|3941653|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4117012|NCT00939484|3941654|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4117013|NCT00939484|3941655|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4117014|NCT00939484|3941652|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4117015|NCT00939484|3941653|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4117016|NCT00939484|3941654|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4117017|NCT00939484|3941655|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117018|NCT00939484|3941652|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4117019|NCT00939484|3941653|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4117020|NCT00939484|3941654|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4117021|NCT00939484|3941655|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4117022|NCT00939484|3941652|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4117023|NCT00939484|3941653|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4117024|NCT00939484|3941654|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4117025|NCT00939484|3941655|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4117026|NCT00939484|3941652|B4|||Age|Age at study enrollment|years|Median|30.3|30.3|Full Range|||22.4|51.9|
4117027|NCT00939484|3941653|B3|||Age|Age at study enrollment|years|Median|32.9|32.9|Full Range|||25.3|38.6|
4117028|NCT00939484|3941654|B2|||Age|Age at study enrollment|years|Median|32.0|32.0|Full Range|||23.5|51.9|
4117029|NCT00939484|3941655|B1|||Age|Age at study enrollment|years|Median|23.8|23.8|Full Range|||22.4|40.6|
4117030|NCT00939471|3941670|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4117031|NCT00939471|3941670|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4117032|NCT00939471|3941670|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4117033|NCT00939471|3941670|B1|||Age||years|Mean|8.14|8.14|Standard Deviation|3.99|3.99|||
4117034|NCT00939471|3941670|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4117035|NCT00939471|3941670|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4117036|NCT00939471|3941670|B1||<=18 years|Age||Participants|Count of Participants|44|44.0||||||
4117037|NCT00939393|3941681|B3|United States||Region of Enrollment||participants|Number|72|72.0||||||
4117038|NCT00939393|3941682|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
4117039|NCT00939393|3941683|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4117040|NCT00939393|3941681|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4117041|NCT00939393|3941682|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4117042|NCT00939393|3941683|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4117043|NCT00939393|3941681|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4117044|NCT00939393|3941682|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4117045|NCT00939393|3941683|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4117046|NCT00939393|3941681|B3|||Age||years|Mean|51.2|51.2|Standard Deviation|14.2|14.2|||
4117047|NCT00939393|3941682|B2|||Age||years|Mean|47.5|47.5|Standard Deviation|15.1|15.1|||
4117048|NCT00939393|3941683|B1|||Age||years|Mean|54.6|54.6|Standard Deviation|12.5|12.5|||
4117049|NCT00939367|3941704|B1|India||Region of Enrollment||participants|Number|30|30.0||||||
4117050|NCT00939367|3941704|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4117051|NCT00939367|3941704|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4117052|NCT00939367|3941704|B1|||Age||years|Mean|27.6|27.6|Standard Deviation|7.48|7.48|||
4117053|NCT00939367|3941704|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4117054|NCT00939367|3941704|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4117055|NCT00939367|3941704|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4117056|NCT00939341|3941715|B1||Male|Sex: Female, Male||Participants|Count of Participants|407|407.0||||||
4117057|NCT00939341|3941715|B1||Female|Sex: Female, Male||Participants|Count of Participants|455|455.0||||||
4117058|NCT00939341|3941715|B1|All Participants||Age||Years|Mean|13.7|13.7|Standard Deviation|44.7|44.7|||
4117059|NCT00939211|3941735|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4117060|NCT00939211|3941735|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4117061|NCT00939211|3941735|B1|||Age||years|Mean|64.2|64.2|Full Range|||51.0|71.0|
4117062|NCT00939198|3941797|B1|Brazil||Region of Enrollment||Participants|Count of Participants|87|87.0||||||
4117063|NCT00939198|3941797|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117064|NCT00939198|3941797|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117065|NCT00939198|3941797|B1||White|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
4117066|NCT00939198|3941797|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117067|NCT00939198|3941797|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117068|NCT00939198|3941797|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117069|NCT00939198|3941797|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117070|NCT00939198|3941797|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4117071|NCT00939198|3941797|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4117072|NCT00939198|3941797|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4117073|NCT00939198|3941797|B1||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
4117074|NCT00939198|3941797|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4117075|NCT00939185|3941802|B1||Male|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4117076|NCT00939185|3941802|B1||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4117077|NCT00939185|3941802|B1|Unspecified||Age, Customized||participants|Number|4|4.0||||||
4117078|NCT00939185|3941802|B1|> 18 years||Age, Customized||participants|Number|0|0.0||||||
4117079|NCT00939185|3941802|B1|> 12 years to 18 years||Age, Customized||participants|Number|10|10.0||||||
4117080|NCT00939185|3941802|B1|> 2 years to 12 years||Age, Customized||participants|Number|292|292.0||||||
4117081|NCT00939185|3941802|B1|> 1 month to 2 years||Age, Customized||participants|Number|82|82.0||||||
4117082|NCT00939185|3941802|B1|Birth to 1 month||Age, Customized||participants|Number|2|2.0||||||
4117083|NCT00939159|3941809|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4117084|NCT00939159|3941809|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4117085|NCT00939159|3941809|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4117086|NCT00939159|3941809|B1|||Age||years|Median|70|70.0|Full Range|||47.0|84.0|
4117087|NCT00939120|3941813|B3|||Urinary frequency|Participant reported urinary frequency episodes during a 24-hour period.|frequency episodes|Mean|11.3|11.3|Standard Deviation|2.2|2.2|||
4117088|NCT00939120|3941814|B2|||Urinary frequency|Participant reported urinary frequency episodes during a 24-hour period.|frequency episodes|Mean|11.4|11.4|Standard Deviation|2.2|2.2|||
4117089|NCT00939120|3941815|B1|||Urinary frequency|Participant reported urinary frequency episodes during a 24-hour period.|frequency episodes|Mean|11.3|11.3|Standard Deviation|2.2|2.2|||
4117090|NCT00939120|3941813|B3|||Urinary urgency|Patient reported number of urgency episodes during a 24-hour period.|urgency episodes|Mean|7.7|7.7|Standard Deviation|3.6|3.6|||
4117091|NCT00939120|3941814|B2|||Urinary urgency|Patient reported number of urgency episodes during a 24-hour period.|urgency episodes|Mean|8.6|8.6|Standard Deviation|3.5|3.5|||
4117092|NCT00939120|3941815|B1|||Urinary urgency|Patient reported number of urgency episodes during a 24-hour period.|urgency episodes|Mean|6.7|6.7|Standard Deviation|3.5|3.5|||
4117093|NCT00939120|3941813|B3|||International prostate symptoms score, storage subscore|"The IPSS is based on the answers to 7 questions concerning urinary symptoms. Each question is assigned points from 0 to 5 indicating increasing severity of the particular symptom. The total score can therefore range from 0 to 35 (asymptomatic to very symptomatic).~Storage sub-component is 3/7 questions, thus ranging from 0-15."|units on a scale|Mean|8.8|8.8|Standard Deviation|2.4|2.4|||
4117114|NCT00939120|3941813|B3|||Voided volume|Voided urinary volume via uroflowmetry.|mL|Mean|238.1|238.1|Standard Deviation|153.2|153.2|||
4117115|NCT00939120|3941814|B2|||Voided volume|Voided urinary volume via uroflowmetry.|mL|Mean|273.7|273.7|Standard Deviation|189.9|189.9|||
4117094|NCT00939120|3941814|B2|||International prostate symptoms score, storage subscore|"The IPSS is based on the answers to 7 questions concerning urinary symptoms. Each question is assigned points from 0 to 5 indicating increasing severity of the particular symptom. The total score can therefore range from 0 to 35 (asymptomatic to very symptomatic).~Storage sub-component is 3/7 questions, thus ranging from 0-15."|units on a scale|Mean|8.7|8.7|Standard Deviation|2.2|2.2|||
4117095|NCT00939120|3941815|B1|||International prostate symptoms score, storage subscore|"The IPSS is based on the answers to 7 questions concerning urinary symptoms. Each question is assigned points from 0 to 5 indicating increasing severity of the particular symptom. The total score can therefore range from 0 to 35 (asymptomatic to very symptomatic).~Storage sub-component is 3/7 questions, thus ranging from 0-15."|units on a scale|Mean|8.9|8.9|Standard Deviation|2.7|2.7|||
4117096|NCT00939120|3941813|B3|||International prostate symptoms score, voiding subscore|"The IPSS is based on the answers to 7 questions concerning urinary symptoms. Each question is assigned points from 0 to 5 indicating increasing severity of the particular symptom. The total score can therefore range from 0 to 35 (asymptomatic to very symptomatic).~Voiding sub-component is 4/7 questions, thus ranging from 0-20."|units on a scale|Mean|9.1|9.1|Standard Deviation|4.0|4.0|||
4117097|NCT00939120|3941814|B2|||International prostate symptoms score, voiding subscore|"The IPSS is based on the answers to 7 questions concerning urinary symptoms. Each question is assigned points from 0 to 5 indicating increasing severity of the particular symptom. The total score can therefore range from 0 to 35 (asymptomatic to very symptomatic).~Voiding sub-component is 4/7 questions, thus ranging from 0-20."|units on a scale|Mean|9.0|9.0|Standard Deviation|3.8|3.8|||
4117098|NCT00939120|3941815|B1|||International prostate symptoms score, voiding subscore|"The IPSS is based on the answers to 7 questions concerning urinary symptoms. Each question is assigned points from 0 to 5 indicating increasing severity of the particular symptom. The total score can therefore range from 0 to 35 (asymptomatic to very symptomatic).~Voiding sub-component is 4/7 questions, thus ranging from 0-20."|units on a scale|Mean|9.1|9.1|Standard Deviation|4.3|4.3|||
4117099|NCT00939120|3941813|B3|||International prostate symptoms score, total|The IPSS is based on the answers to 7 questions concerning urinary symptoms. Each question is assigned points from 0 to 5 indicating increasing severity of the particular symptom. The total score can therefore range from 0 to 35 (asymptomatic to very symptomatic).|units on a scale|Mean|17.9|17.9|Standard Deviation|5.4|5.4|||
4117100|NCT00939120|3941814|B2|||International prostate symptoms score, total|The IPSS is based on the answers to 7 questions concerning urinary symptoms. Each question is assigned points from 0 to 5 indicating increasing severity of the particular symptom. The total score can therefore range from 0 to 35 (asymptomatic to very symptomatic).|units on a scale|Mean|17.7|17.7|Standard Deviation|4.5|4.5|||
4117101|NCT00939120|3941815|B1|||International prostate symptoms score, total|The IPSS is based on the answers to 7 questions concerning urinary symptoms. Each question is assigned points from 0 to 5 indicating increasing severity of the particular symptom. The total score can therefore range from 0 to 35 (asymptomatic to very symptomatic).|units on a scale|Mean|18.0|18.0|Standard Deviation|6.2|6.2|||
4117102|NCT00939120|3941813|B3|||Patient's perception of bladder condition|Patient-reported scores on a scale of 1-6 indicating how their bladder condition affects them. Scores are as follows: 1 = Does not cause me any problems at all; 2 = Causes me some very minor problems; 3 = Causes me some minor problems; 4 = Causes me (some) moderate problems; 5 = Causes me severe problems; 6 = Causes me many severe problems.|units on a scale|Mean|3.7|3.7|Standard Deviation|0.9|0.9|||
4117103|NCT00939120|3941814|B2|||Patient's perception of bladder condition|Patient-reported scores on a scale of 1-6 indicating how their bladder condition affects them. Scores are as follows: 1 = Does not cause me any problems at all; 2 = Causes me some very minor problems; 3 = Causes me some minor problems; 4 = Causes me (some) moderate problems; 5 = Causes me severe problems; 6 = Causes me many severe problems.|units on a scale|Mean|3.7|3.7|Standard Deviation|1.0|1.0|||
4117104|NCT00939120|3941815|B1|||Patient's perception of bladder condition|Patient-reported scores on a scale of 1-6 indicating how their bladder condition affects them. Scores are as follows: 1 = Does not cause me any problems at all; 2 = Causes me some very minor problems; 3 = Causes me some minor problems; 4 = Causes me (some) moderate problems; 5 = Causes me severe problems; 6 = Causes me many severe problems.|units on a scale|Mean|3.7|3.7|Standard Deviation|0.9|0.9|||
4117105|NCT00939120|3941813|B3|||Overactive bladder questionnaire|The Overactive Bladder Questionnaire score is based on the answers to 33 questions concerning bladder symptoms. Each question is assigned points from 1 to 6 indicating increasing severity of the particular symptom. The total score can therefore range from 33 to 198 (asymptomatic to very symptomatic).|units on a scale|Mean|86.3|86.3|Standard Deviation|26.1|26.1|||
4117106|NCT00939120|3941814|B2|||Overactive bladder questionnaire|The Overactive Bladder Questionnaire score is based on the answers to 33 questions concerning bladder symptoms. Each question is assigned points from 1 to 6 indicating increasing severity of the particular symptom. The total score can therefore range from 33 to 198 (asymptomatic to very symptomatic).|units on a scale|Mean|86.1|86.1|Standard Deviation|29.9|29.9|||
4117107|NCT00939120|3941815|B1|||Overactive bladder questionnaire|The Overactive Bladder Questionnaire score is based on the answers to 33 questions concerning bladder symptoms. Each question is assigned points from 1 to 6 indicating increasing severity of the particular symptom. The total score can therefore range from 33 to 198 (asymptomatic to very symptomatic).|units on a scale|Mean|86.4|86.4|Standard Deviation|22.3|22.3|||
4117108|NCT00939120|3941813|B3|||Post-void residual volume|Post-voiding residual volume (PVR) measured in each participant via ultrasound.|mL|Mean|87.3|87.3|Standard Deviation|64.6|64.6|||
4117109|NCT00939120|3941814|B2|||Post-void residual volume|Post-voiding residual volume (PVR) measured in each participant via ultrasound.|mL|Mean|81.6|81.6|Standard Deviation|60.7|60.7|||
4117110|NCT00939120|3941815|B1|||Post-void residual volume|Post-voiding residual volume (PVR) measured in each participant via ultrasound.|mL|Mean|93.0|93.0|Standard Deviation|69.2|69.2|||
4117111|NCT00939120|3941813|B3|||Maximum flow rate|Maximum urine flow rate (Qmax) measured via uroflowmetry.|mL/sec|Mean|11.7|11.7|Standard Deviation|4.2|4.2|||
4117112|NCT00939120|3941814|B2|||Maximum flow rate|Maximum urine flow rate (Qmax) measured via uroflowmetry.|mL/sec|Mean|12.4|12.4|Standard Deviation|4.8|4.8|||
4117113|NCT00939120|3941815|B1|||Maximum flow rate|Maximum urine flow rate (Qmax) measured via uroflowmetry.|mL/sec|Mean|11.1|11.1|Standard Deviation|3.5|3.5|||
4117116|NCT00939120|3941815|B1|||Voided volume|Voided urinary volume via uroflowmetry.|mL|Mean|202.5|202.5|Standard Deviation|96.5|96.5|||
4117117|NCT00939120|3941813|B3|||Prostate specific antigen|Prostate specific antigen measured via blood test.|ng/mL|Mean|4.6|4.6|Standard Deviation|6.4|6.4|||
4117118|NCT00939120|3941814|B2|||Prostate specific antigen|Prostate specific antigen measured via blood test.|ng/mL|Mean|5.3|5.3|Standard Deviation|8.8|8.8|||
4117119|NCT00939120|3941815|B1|||Prostate specific antigen|Prostate specific antigen measured via blood test.|ng/mL|Mean|4.0|4.0|Standard Deviation|2.1|2.1|||
4117120|NCT00939120|3941813|B3|||Prostate volume|Prostate volume measured by transrectal ultrasound, age-adjusted for this study.|mL|Mean|43.5|43.5|Standard Deviation|15.7|15.7|||
4117121|NCT00939120|3941814|B2|||Prostate volume|Prostate volume measured by transrectal ultrasound, age-adjusted for this study.|mL|Mean|43.1|43.1|Standard Deviation|16.0|16.0|||
4117122|NCT00939120|3941815|B1|||Prostate volume|Prostate volume measured by transrectal ultrasound, age-adjusted for this study.|mL|Mean|43.9|43.9|Standard Deviation|15.8|15.8|||
4117123|NCT00939120|3941813|B3|United States||Region of Enrollment|Region in which participant was enrolled.|participants|Number|46|46.0||||||
4117124|NCT00939120|3941814|B2|United States||Region of Enrollment|Region in which participant was enrolled.|participants|Number|23|23.0||||||
4117125|NCT00939120|3941815|B1|United States||Region of Enrollment|Region in which participant was enrolled.|participants|Number|23|23.0||||||
4117126|NCT00939120|3941813|B3||Unknown or Not Reported|Race (NIH/OMB)|Race of the participant.|Participants|Count of Participants|0|0.0||||||
4117127|NCT00939120|3941814|B2||Unknown or Not Reported|Race (NIH/OMB)|Race of the participant.|Participants|Count of Participants|0|0.0||||||
4117128|NCT00939120|3941815|B1||Unknown or Not Reported|Race (NIH/OMB)|Race of the participant.|Participants|Count of Participants|0|0.0||||||
4117129|NCT00939120|3941813|B3||More than one race|Race (NIH/OMB)|Race of the participant.|Participants|Count of Participants|0|0.0||||||
4117130|NCT00939120|3941814|B2||More than one race|Race (NIH/OMB)|Race of the participant.|Participants|Count of Participants|0|0.0||||||
4117131|NCT00939120|3941815|B1||More than one race|Race (NIH/OMB)|Race of the participant.|Participants|Count of Participants|0|0.0||||||
4117132|NCT00939120|3941813|B3||White|Race (NIH/OMB)|Race of the participant.|Participants|Count of Participants|45|45.0||||||
4117133|NCT00939120|3941814|B2||White|Race (NIH/OMB)|Race of the participant.|Participants|Count of Participants|22|22.0||||||
4117134|NCT00939120|3941815|B1||White|Race (NIH/OMB)|Race of the participant.|Participants|Count of Participants|23|23.0||||||
4117135|NCT00939120|3941813|B3||Black or African American|Race (NIH/OMB)|Race of the participant.|Participants|Count of Participants|1|1.0||||||
4117136|NCT00939120|3941814|B2||Black or African American|Race (NIH/OMB)|Race of the participant.|Participants|Count of Participants|1|1.0||||||
4117137|NCT00939120|3941815|B1||Black or African American|Race (NIH/OMB)|Race of the participant.|Participants|Count of Participants|0|0.0||||||
4117138|NCT00939120|3941813|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race of the participant.|Participants|Count of Participants|0|0.0||||||
4117139|NCT00939120|3941814|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race of the participant.|Participants|Count of Participants|0|0.0||||||
4117140|NCT00939120|3941815|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race of the participant.|Participants|Count of Participants|0|0.0||||||
4117141|NCT00939120|3941813|B3||Asian|Race (NIH/OMB)|Race of the participant.|Participants|Count of Participants|0|0.0||||||
4117142|NCT00939120|3941814|B2||Asian|Race (NIH/OMB)|Race of the participant.|Participants|Count of Participants|0|0.0||||||
4117143|NCT00939120|3941815|B1||Asian|Race (NIH/OMB)|Race of the participant.|Participants|Count of Participants|0|0.0||||||
4117144|NCT00939120|3941813|B3||American Indian or Alaska Native|Race (NIH/OMB)|Race of the participant.|Participants|Count of Participants|0|0.0||||||
4117145|NCT00939120|3941814|B2||American Indian or Alaska Native|Race (NIH/OMB)|Race of the participant.|Participants|Count of Participants|0|0.0||||||
4117146|NCT00939120|3941815|B1||American Indian or Alaska Native|Race (NIH/OMB)|Race of the participant.|Participants|Count of Participants|0|0.0||||||
4117147|NCT00939120|3941813|B3||Male|Sex: Female, Male|Gender of participant.|Participants|Count of Participants|46|46.0||||||
4117148|NCT00939120|3941814|B2||Male|Sex: Female, Male|Gender of participant.|Participants|Count of Participants|23|23.0||||||
4117149|NCT00939120|3941815|B1||Male|Sex: Female, Male|Gender of participant.|Participants|Count of Participants|23|23.0||||||
4117150|NCT00939120|3941813|B3||Female|Sex: Female, Male|Gender of participant.|Participants|Count of Participants|0|0.0||||||
4117151|NCT00939120|3941814|B2||Female|Sex: Female, Male|Gender of participant.|Participants|Count of Participants|0|0.0||||||
4117152|NCT00939120|3941815|B1||Female|Sex: Female, Male|Gender of participant.|Participants|Count of Participants|0|0.0||||||
4117153|NCT00939120|3941813|B3|||Age|Age of patient at enrollment|years|Mean|68.2|68.2|Standard Deviation|8.4|8.4|||
4117154|NCT00939120|3941814|B2|||Age|Age of patient at enrollment|years|Mean|67.7|67.7|Standard Deviation|7.4|7.4|||
4117155|NCT00939120|3941815|B1|||Age|Age of patient at enrollment|years|Mean|68.6|68.6|Standard Deviation|9.5|9.5|||
4117156|NCT00939107|3941838|B3|||Duration of pain||Weeks|Mean|95|95.0|Standard Deviation|210|210.0|||
4117157|NCT00939107|3941839|B2|||Duration of pain||Weeks|Mean|94|94.0|Standard Deviation|181|181.0|||
4117158|NCT00939107|3941840|B1|||Duration of pain||Weeks|Mean|97|97.0|Standard Deviation|230|230.0|||
4117159|NCT00939107|3941838|B3|Number of patients not on sick leave due to LBP||Number sick-listed||participants|Number|238|238.0||||||
4117160|NCT00939107|3941839|B2|Number of patients not on sick leave due to LBP||Number sick-listed||participants|Number|128|128.0||||||
4117161|NCT00939107|3941840|B1|Number of patients not on sick leave due to LBP||Number sick-listed||participants|Number|110|110.0||||||
4117162|NCT00939107|3941838|B3|Number of patients on sick leave due to LBP||Number sick-listed||participants|Number|112|112.0||||||
4117163|NCT00939107|3941839|B2|Number of patients on sick leave due to LBP||Number sick-listed||participants|Number|47|47.0||||||
4117340|NCT00938717|3942049|B2|18 years 64 years||Age, Customized||Participants|Number|379|379.0||||||
4117164|NCT00939107|3941840|B1|Number of patients on sick leave due to LBP||Number sick-listed||participants|Number|65|65.0||||||
4117165|NCT00939107|3941838|B3|Denmark||Region of Enrollment||participants|Number|350|350.0||||||
4117166|NCT00939107|3941839|B2|Denmark||Region of Enrollment||participants|Number|175|175.0||||||
4117167|NCT00939107|3941840|B1|Denmark||Region of Enrollment||participants|Number|175|175.0||||||
4117168|NCT00939107|3941838|B3||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4117169|NCT00939107|3941839|B2||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4117170|NCT00939107|3941840|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4117171|NCT00939107|3941838|B3||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4117172|NCT00939107|3941839|B2||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4117173|NCT00939107|3941840|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4117174|NCT00939107|3941838|B3|||Age||years|Mean|37|37.0|Standard Deviation|6.5|6.5|||
4117175|NCT00939107|3941839|B2|||Age||years|Mean|37|37.0|Standard Deviation|9.4|9.4|||
4117176|NCT00939107|3941840|B1|||Age||years|Mean|38|38.0|Standard Deviation|10.4|10.4|||
4117177|NCT00939107|3941838|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4117178|NCT00939107|3941839|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4117179|NCT00939107|3941840|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4117180|NCT00939107|3941838|B3||Between 18 and 65 years|Age||Participants|Count of Participants|350|350.0||||||
4117181|NCT00939107|3941839|B2||Between 18 and 65 years|Age||Participants|Count of Participants|175|175.0||||||
4117182|NCT00939107|3941840|B1||Between 18 and 65 years|Age||Participants|Count of Participants|175|175.0||||||
4117183|NCT00939107|3941838|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4117184|NCT00939107|3941839|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4117185|NCT00939107|3941840|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4117186|NCT00939094|3941853|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4117187|NCT00939094|3941854|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4117188|NCT00939094|3941855|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4117189|NCT00939094|3941853|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4117190|NCT00939094|3941854|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4117191|NCT00939094|3941855|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4117192|NCT00939094|3941853|B3|||Age||years|Mean|58.7|58.7|Standard Deviation|12.8|12.8|||
4117193|NCT00939094|3941854|B2|||Age||years|Mean|59.3|59.3|Standard Deviation|14.31|14.31|||
4117194|NCT00939094|3941855|B1|||Age||years|Mean|58.1|58.1|Standard Deviation|9.25|9.25|||
4117195|NCT00939055|3941876|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4117196|NCT00939055|3941877|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4117197|NCT00939055|3941878|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4117198|NCT00939055|3941876|B3||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4117199|NCT00939055|3941877|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4117200|NCT00939055|3941878|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4117201|NCT00939055|3941876|B3|||Age||years|Mean|49|49.0|Standard Deviation|8.15|8.15|||
4117202|NCT00939055|3941877|B2|||Age||years|Mean|49|49.0|Standard Deviation|7.35|7.35|||
4117203|NCT00939055|3941878|B1|||Age||years|Mean|49|49.0|Standard Deviation|8.62|8.62|||
4117204|NCT00939029|3941887|B3|||Smokeless tobacco use|Average cans/pouches of smokeless tobacco used per week over the last month prior to the baseline visit|cans or pouches per week|Mean|4.3|4.3|Standard Deviation|1.6|1.6|||
4117205|NCT00939029|3941888|B2|||Smokeless tobacco use|Average cans/pouches of smokeless tobacco used per week over the last month prior to the baseline visit|cans or pouches per week|Mean|4.0|4.0|Standard Deviation|1.3|1.3|||
4117206|NCT00939029|3941889|B1|||Smokeless tobacco use|Average cans/pouches of smokeless tobacco used per week over the last month prior to the baseline visit|cans or pouches per week|Mean|4.6|4.6|Standard Deviation|1.8|1.8|||
4117207|NCT00939029|3941887|B3|Caucasian, Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4117208|NCT00939029|3941888|B2|Caucasian, Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4117209|NCT00939029|3941889|B1|Caucasian, Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4117210|NCT00939029|3941887|B3|Caucasian, non-Hispanic||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4117211|NCT00939029|3941888|B2|Caucasian, non-Hispanic||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4117212|NCT00939029|3941889|B1|Caucasian, non-Hispanic||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4117213|NCT00939029|3941887|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4117214|NCT00939029|3941888|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4117215|NCT00939029|3941889|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4117216|NCT00939029|3941887|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4117217|NCT00939029|3941888|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4117218|NCT00939029|3941889|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4117219|NCT00939029|3941887|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4117220|NCT00939029|3941888|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4117221|NCT00939029|3941889|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4117222|NCT00939029|3941887|B3||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4117223|NCT00939029|3941888|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4117224|NCT00939029|3941889|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4117225|NCT00939029|3941887|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4117226|NCT00939029|3941888|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4117227|NCT00939029|3941889|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4117228|NCT00939029|3941887|B3|||Age||years|Mean|37.2|37.2|Standard Deviation|9.4|9.4|||
4117229|NCT00939029|3941888|B2|||Age||years|Mean|35.3|35.3|Standard Deviation|9.5|9.5|||
4117230|NCT00939029|3941889|B1|||Age||years|Mean|39.2|39.2|Standard Deviation|9.1|9.1|||
4117231|NCT00939003|3941900|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4117232|NCT00939003|3941901|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4117233|NCT00939003|3941902|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4117234|NCT00939003|3941900|B3||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4117235|NCT00939003|3941901|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4117236|NCT00939003|3941902|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4117237|NCT00939003|3941900|B3|||Age||years|Mean|38.0|38.0|Standard Deviation|10.82|10.82|||
4117238|NCT00939003|3941901|B2|||Age||years|Mean|37.6|37.6|Standard Deviation|11.29|11.29|||
4117239|NCT00939003|3941902|B1|||Age||years|Mean|38.4|38.4|Standard Deviation|10.39|10.39|||
4117240|NCT00938964|3941938|B3|United States||Region of Enrollment||Participants|Count of Participants|420|420.0||||||
4117241|NCT00938964|3941939|B2|United States||Region of Enrollment||Participants|Count of Participants|209|209.0||||||
4117242|NCT00938964|3941940|B1|United States||Region of Enrollment||Participants|Count of Participants|211|211.0||||||
4117243|NCT00938964|3941938|B3||Male|Sex: Female, Male||Participants|Count of Participants|311|311.0||||||
4117244|NCT00938964|3941939|B2||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4117245|NCT00938964|3941940|B1||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4117246|NCT00938964|3941938|B3||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4117247|NCT00938964|3941939|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4117248|NCT00938964|3941940|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4117249|NCT00938964|3941938|B3|||Age||years|Mean|66.7|66.7|Standard Deviation|9.3|9.3|||
4117250|NCT00938964|3941939|B2|||Age||years|Mean|66.5|66.5|Standard Deviation|9.5|9.5|||
4117251|NCT00938964|3941940|B1|||Age||years|Mean|66.9|66.9|Standard Deviation|9.1|9.1|||
4117252|NCT00938886|3942003|B3|||Fagerstrom Test for Nicotine Dependence|Scale ranges from 0 to 10 where higher values indicates higher levels of nicotine dependence.|units on a scale|Mean|5.3|5.3|Standard Deviation|2.3|2.3|||
4117253|NCT00938886|3942004|B2|||Fagerstrom Test for Nicotine Dependence|Scale ranges from 0 to 10 where higher values indicates higher levels of nicotine dependence.|units on a scale|Mean|5.4|5.4|Standard Deviation|2.3|2.3|||
4117254|NCT00938886|3942005|B1|||Fagerstrom Test for Nicotine Dependence|Scale ranges from 0 to 10 where higher values indicates higher levels of nicotine dependence.|units on a scale|Mean|5.3|5.3|Standard Deviation|2.2|2.2|||
4117255|NCT00938886|3942003|B3|||Current Alcohol Dependence||Participants|Count of Participants|42|42.0||||||
4117256|NCT00938886|3942004|B2|||Current Alcohol Dependence||Participants|Count of Participants|19|19.0||||||
4117257|NCT00938886|3942005|B1|||Current Alcohol Dependence||Participants|Count of Participants|23|23.0||||||
4117258|NCT00938886|3942003|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4117259|NCT00938886|3942004|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4117260|NCT00938886|3942005|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4117261|NCT00938886|3942003|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4117262|NCT00938886|3942004|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4117263|NCT00938886|3942005|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4117264|NCT00938886|3942003|B3||White|Race (NIH/OMB)||Participants|Count of Participants|109|109.0||||||
4117265|NCT00938886|3942004|B2||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4117266|NCT00938886|3942005|B1||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4117267|NCT00938886|3942003|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4117268|NCT00938886|3942004|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4117269|NCT00938886|3942005|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4117270|NCT00938886|3942003|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117271|NCT00938886|3942004|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117272|NCT00938886|3942005|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117273|NCT00938886|3942003|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4117274|NCT00938886|3942004|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4117275|NCT00938886|3942005|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4117276|NCT00938886|3942003|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4117277|NCT00938886|3942004|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4117278|NCT00938886|3942005|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117279|NCT00938886|3942003|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4117280|NCT00938886|3942004|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4117281|NCT00938886|3942005|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117282|NCT00938886|3942003|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
4117283|NCT00938886|3942004|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4117284|NCT00938886|3942005|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
4117285|NCT00938886|3942003|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4117286|NCT00938886|3942004|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4117287|NCT00938886|3942005|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4117288|NCT00938886|3942003|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4117289|NCT00938886|3942004|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4117290|NCT00938886|3942005|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4117291|NCT00938886|3942003|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4117292|NCT00938886|3942004|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4117293|NCT00938886|3942005|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4117294|NCT00938886|3942003|B3|||Age||years|Mean|42.1|42.1|Standard Deviation|12.7|12.7|||
4117295|NCT00938886|3942004|B2|||Age||years|Mean|41.8|41.8|Standard Deviation|12.9|12.9|||
4117296|NCT00938886|3942005|B1|||Age||years|Mean|42.3|42.3|Standard Deviation|12.7|12.7|||
4117297|NCT00938860|3942014|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4117298|NCT00938860|3942015|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4117299|NCT00938860|3942016|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4117300|NCT00938860|3942014|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4117301|NCT00938860|3942015|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4117302|NCT00938860|3942016|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4117303|NCT00938860|3942014|B3|||Age||Years|Mean|54.6|54.6|Standard Deviation|6.53|6.53|||
4117304|NCT00938860|3942015|B2|||Age||Years|Mean|55.0|55.0|Standard Deviation|6.84|6.84|||
4117305|NCT00938860|3942016|B1|||Age||Years|Mean|54.2|54.2|Standard Deviation|6.30|6.3|||
4117306|NCT00938782|3942039|B3|United States||Region of Enrollment||participants|Number|67|67.0||||||
4117307|NCT00938782|3942040|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
4117308|NCT00938782|3942041|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4117309|NCT00938782|3942039|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4117310|NCT00938782|3942040|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4117311|NCT00938782|3942041|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4117312|NCT00938782|3942039|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4117313|NCT00938782|3942040|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4117314|NCT00938782|3942041|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4117315|NCT00938782|3942039|B3|||Age||years|Mean|74.8|74.8|Standard Deviation|6.2|6.2|||
4117316|NCT00938782|3942040|B2|||Age||years|Mean|74.5|74.5|Standard Deviation|6.7|6.7|||
4117317|NCT00938782|3942041|B1|||Age||years|Mean|75|75.0|Standard Deviation|5.7|5.7|||
4117318|NCT00938782|3942039|B3||>=65 years|Age||Participants|Count of Participants|67|67.0||||||
4117319|NCT00938782|3942040|B2||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
4117320|NCT00938782|3942041|B1||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4117321|NCT00938782|3942039|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4117322|NCT00938782|3942040|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4117323|NCT00938782|3942041|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4117324|NCT00938782|3942039|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4117325|NCT00938782|3942040|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4117326|NCT00938782|3942041|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4117327|NCT00938717|3942048|B3|United States||Region of Enrollment||participants|Number|805|805.0||||||
4117328|NCT00938717|3942049|B2|United States||Region of Enrollment||participants|Number|402|402.0||||||
4117329|NCT00938717|3942050|B1|United States||Region of Enrollment||participants|Number|403|403.0||||||
4117330|NCT00938717|3942048|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4117331|NCT00938717|3942049|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4117332|NCT00938717|3942050|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4117333|NCT00938717|3942048|B3||Female|Sex: Female, Male||Participants|Count of Participants|721|721.0||||||
4117334|NCT00938717|3942049|B2||Female|Sex: Female, Male||Participants|Count of Participants|369|369.0||||||
4117335|NCT00938717|3942050|B1||Female|Sex: Female, Male||Participants|Count of Participants|352|352.0||||||
4117336|NCT00938717|3942048|B3|65 years and older||Age, Customized||Participants|Number|40|40.0||||||
4117337|NCT00938717|3942049|B2|65 years and older||Age, Customized||Participants|Number|23|23.0||||||
4117338|NCT00938717|3942050|B1|65 years and older||Age, Customized||Participants|Number|17|17.0||||||
4117339|NCT00938717|3942048|B3|18 years 64 years||Age, Customized||Participants|Number|765|765.0||||||
4117341|NCT00938717|3942050|B1|18 years 64 years||Age, Customized||Participants|Number|386|386.0||||||
4117342|NCT00938717|3942048|B3|||Age||years|Mean|44.3|44.3|Standard Deviation|13.3|13.3|||
4117343|NCT00938717|3942049|B2|||Age||years|Mean|44.7|44.7|Standard Deviation|13.1|13.1|||
4117344|NCT00938717|3942050|B1|||Age||years|Mean|44.0|44.0|Standard Deviation|13.4|13.4|||
4117345|NCT00938704|3942083|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4117346|NCT00938704|3942084|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4117347|NCT00938704|3942085|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4117348|NCT00938704|3942083|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4117349|NCT00938704|3942084|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4117350|NCT00938704|3942085|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4117351|NCT00938704|3942083|B3|||Age||years|Mean|51.5865|51.5865|Full Range|||18.942|87.485|
4117352|NCT00938704|3942084|B2|||Age||years|Mean|48.787|48.787|Full Range|||18.942|84.482|
4117353|NCT00938704|3942085|B1|||Age||years|Mean|54.386|54.386|Full Range|||20.277|87.485|
4117354|NCT00938639|3942100|B3||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4117355|NCT00938639|3942101|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4117356|NCT00938639|3942102|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4117357|NCT00938639|3942100|B3||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4117358|NCT00938639|3942101|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4117359|NCT00938639|3942102|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4117360|NCT00938639|3942100|B3|||Age||years|Mean|43.7|43.7|Standard Deviation|15.25|15.25|||
4117361|NCT00938639|3942101|B2|||Age||years|Mean|42.9|42.9|Standard Deviation|15.39|15.39|||
4117362|NCT00938639|3942102|B1|||Age||years|Mean|44.6|44.6|Standard Deviation|15.12|15.12|||
4117363|NCT00938548|3942171|B3|Korea, Republic of||Region of Enrollment||participants|Number|70|70.0||||||
4117364|NCT00938548|3942172|B2|Korea, Republic of||Region of Enrollment||participants|Number|35|35.0||||||
4117365|NCT00938548|3942173|B1|Korea, Republic of||Region of Enrollment||participants|Number|35|35.0||||||
4117366|NCT00938548|3942171|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4117367|NCT00938548|3942172|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4117368|NCT00938548|3942173|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4117369|NCT00938548|3942171|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4117370|NCT00938548|3942172|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4117371|NCT00938548|3942173|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4117372|NCT00938548|3942171|B3|||Age||years|Mean|50|50.0|Standard Deviation|8|8.0|||
4117373|NCT00938548|3942172|B2|||Age||years|Mean|51|51.0|Standard Deviation|9|9.0|||
4117374|NCT00938548|3942173|B1|||Age||years|Mean|49|49.0|Standard Deviation|8|8.0|||
4117375|NCT00938548|3942171|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4117376|NCT00938548|3942172|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4117377|NCT00938548|3942173|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4117378|NCT00938548|3942171|B3||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
4117379|NCT00938548|3942172|B2||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4117380|NCT00938548|3942173|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4117381|NCT00938548|3942171|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4117382|NCT00938548|3942172|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4117383|NCT00938548|3942173|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4117384|NCT00938470|3942184|B3||No|Measurable Disease||Participants|Count of Participants|33|33.0||||||
4117385|NCT00938470|3942185|B2||No|Measurable Disease||Participants|Count of Participants|16|16.0||||||
4117386|NCT00938470|3942186|B1||No|Measurable Disease||Participants|Count of Participants|17|17.0||||||
4117387|NCT00938470|3942184|B3||Yes|Measurable Disease||Participants|Count of Participants|22|22.0||||||
4117388|NCT00938470|3942185|B2||Yes|Measurable Disease||Participants|Count of Participants|11|11.0||||||
4117389|NCT00938470|3942186|B1||Yes|Measurable Disease||Participants|Count of Participants|11|11.0||||||
4117390|NCT00938470|3942184|B3||Gastric Cardia|Site of Tumor||Participants|Count of Participants|2|2.0||||||
4117391|NCT00938470|3942185|B2||Gastric Cardia|Site of Tumor||Participants|Count of Participants|2|2.0||||||
4117392|NCT00938470|3942186|B1||Gastric Cardia|Site of Tumor||Participants|Count of Participants|0|0.0||||||
4117393|NCT00938470|3942184|B3||Gastroesophageal Junction|Site of Tumor||Participants|Count of Participants|26|26.0||||||
4117394|NCT00938470|3942185|B2||Gastroesophageal Junction|Site of Tumor||Participants|Count of Participants|14|14.0||||||
4117395|NCT00938470|3942186|B1||Gastroesophageal Junction|Site of Tumor||Participants|Count of Participants|12|12.0||||||
4117396|NCT00938470|3942184|B3||Esophagus|Site of Tumor||Participants|Count of Participants|27|27.0||||||
4117397|NCT00938470|3942185|B2||Esophagus|Site of Tumor||Participants|Count of Participants|11|11.0||||||
4117398|NCT00938470|3942186|B1||Esophagus|Site of Tumor||Participants|Count of Participants|16|16.0||||||
4117432|NCT00938431|3942214|B4|Other/ Mixed||Racial Group||participants|Number|8|8.0||||||
4117433|NCT00938431|3942215|B3|Other/ Mixed||Racial Group||participants|Number|1|1.0||||||
4117434|NCT00938431|3942216|B2|Other/ Mixed||Racial Group||participants|Number|0|0.0||||||
4117435|NCT00938431|3942217|B1|Other/ Mixed||Racial Group||participants|Number|7|7.0||||||
4117436|NCT00938431|3942214|B4|White||Racial Group||participants|Number|30|30.0||||||
4117399|NCT00938470|3942184|B3||III|Tumor Stage|"Staging group was defined by primary tumor (T), regional (N) and distant metastasis (M).~II= T2N0M0, T3N0M0 or T1-2, N1M0; III= T1-2,N2M0 or T3N1M0, T4aN0M0 or T3N2M0 or T4a,N1-2, M0 or T4b, Any N, M0 or Any T, N3, M0~M0=No M N0=No N M N1=M in 1-2 N N2=M in 3-6 N N3=M in >=7 N NX=N cannot be assessed (NA) T1=Invades lamina propria, muscularis mucosae, or submucosa T2=Invades muscularis propria T3=Invades adventitia T4=Invades adjacent structures T4a=Resectable T invading pleura, pericardium, or diaphragm T4b=Unresectable T invading other adjacent structures TX=T NA"|Participants|Count of Participants|40|40.0||||||
4117400|NCT00938470|3942185|B2||III|Tumor Stage|"Staging group was defined by primary tumor (T), regional (N) and distant metastasis (M).~II= T2N0M0, T3N0M0 or T1-2, N1M0; III= T1-2,N2M0 or T3N1M0, T4aN0M0 or T3N2M0 or T4a,N1-2, M0 or T4b, Any N, M0 or Any T, N3, M0~M0=No M N0=No N M N1=M in 1-2 N N2=M in 3-6 N N3=M in >=7 N NX=N cannot be assessed (NA) T1=Invades lamina propria, muscularis mucosae, or submucosa T2=Invades muscularis propria T3=Invades adventitia T4=Invades adjacent structures T4a=Resectable T invading pleura, pericardium, or diaphragm T4b=Unresectable T invading other adjacent structures TX=T NA"|Participants|Count of Participants|18|18.0||||||
4117401|NCT00938470|3942186|B1||III|Tumor Stage|"Staging group was defined by primary tumor (T), regional (N) and distant metastasis (M).~II= T2N0M0, T3N0M0 or T1-2, N1M0; III= T1-2,N2M0 or T3N1M0, T4aN0M0 or T3N2M0 or T4a,N1-2, M0 or T4b, Any N, M0 or Any T, N3, M0~M0=No M N0=No N M N1=M in 1-2 N N2=M in 3-6 N N3=M in >=7 N NX=N cannot be assessed (NA) T1=Invades lamina propria, muscularis mucosae, or submucosa T2=Invades muscularis propria T3=Invades adventitia T4=Invades adjacent structures T4a=Resectable T invading pleura, pericardium, or diaphragm T4b=Unresectable T invading other adjacent structures TX=T NA"|Participants|Count of Participants|22|22.0||||||
4117402|NCT00938470|3942184|B3||II|Tumor Stage|"Staging group was defined by primary tumor (T), regional (N) and distant metastasis (M).~II= T2N0M0, T3N0M0 or T1-2, N1M0; III= T1-2,N2M0 or T3N1M0, T4aN0M0 or T3N2M0 or T4a,N1-2, M0 or T4b, Any N, M0 or Any T, N3, M0~M0=No M N0=No N M N1=M in 1-2 N N2=M in 3-6 N N3=M in >=7 N NX=N cannot be assessed (NA) T1=Invades lamina propria, muscularis mucosae, or submucosa T2=Invades muscularis propria T3=Invades adventitia T4=Invades adjacent structures T4a=Resectable T invading pleura, pericardium, or diaphragm T4b=Unresectable T invading other adjacent structures TX=T NA"|Participants|Count of Participants|15|15.0||||||
4117403|NCT00938470|3942185|B2||II|Tumor Stage|"Staging group was defined by primary tumor (T), regional (N) and distant metastasis (M).~II= T2N0M0, T3N0M0 or T1-2, N1M0; III= T1-2,N2M0 or T3N1M0, T4aN0M0 or T3N2M0 or T4a,N1-2, M0 or T4b, Any N, M0 or Any T, N3, M0~M0=No M N0=No N M N1=M in 1-2 N N2=M in 3-6 N N3=M in >=7 N NX=N cannot be assessed (NA) T1=Invades lamina propria, muscularis mucosae, or submucosa T2=Invades muscularis propria T3=Invades adventitia T4=Invades adjacent structures T4a=Resectable T invading pleura, pericardium, or diaphragm T4b=Unresectable T invading other adjacent structures TX=T NA"|Participants|Count of Participants|9|9.0||||||
4117404|NCT00938470|3942186|B1||II|Tumor Stage|"Staging group was defined by primary tumor (T), regional (N) and distant metastasis (M).~II= T2N0M0, T3N0M0 or T1-2, N1M0; III= T1-2,N2M0 or T3N1M0, T4aN0M0 or T3N2M0 or T4a,N1-2, M0 or T4b, Any N, M0 or Any T, N3, M0~M0=No M N0=No N M N1=M in 1-2 N N2=M in 3-6 N N3=M in >=7 N NX=N cannot be assessed (NA) T1=Invades lamina propria, muscularis mucosae, or submucosa T2=Invades muscularis propria T3=Invades adventitia T4=Invades adjacent structures T4a=Resectable T invading pleura, pericardium, or diaphragm T4b=Unresectable T invading other adjacent structures TX=T NA"|Participants|Count of Participants|6|6.0||||||
4117405|NCT00938470|3942184|B3|||ECOG Performance Status 0-1|"Eastern Cooperative Oncology Group (ECOG) Performance Status:~0=Asymptomatic and fully active~1=Symptomatic and fully ambulatory"|Participants|Count of Participants|55|55.0||||||
4117406|NCT00938470|3942185|B2|||ECOG Performance Status 0-1|"Eastern Cooperative Oncology Group (ECOG) Performance Status:~0=Asymptomatic and fully active~1=Symptomatic and fully ambulatory"|Participants|Count of Participants|27|27.0||||||
4117407|NCT00938470|3942186|B1|||ECOG Performance Status 0-1|"Eastern Cooperative Oncology Group (ECOG) Performance Status:~0=Asymptomatic and fully active~1=Symptomatic and fully ambulatory"|Participants|Count of Participants|28|28.0||||||
4117408|NCT00938470|3942184|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|55|55.0||||||
4117409|NCT00938470|3942185|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
4117410|NCT00938470|3942186|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
4117411|NCT00938470|3942184|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4117412|NCT00938470|3942185|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4117413|NCT00938470|3942186|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4117414|NCT00938470|3942184|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4117415|NCT00938470|3942185|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4117416|NCT00938470|3942186|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4117417|NCT00938470|3942184|B3|||Age||years|Median|63|63.0|Full Range|||38.0|88.0|
4117418|NCT00938470|3942185|B2|||Age||years|Median|65|65.0|Full Range|||44.0|88.0|
4117419|NCT00938470|3942186|B1|||Age||years|Median|62.5|62.5|Full Range|||38.0|78.0|
4117420|NCT00938457|3942201|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4117421|NCT00938457|3942201|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4117422|NCT00938457|3942201|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4117423|NCT00938457|3942201|B1|||Age||years|Median|60|60.0|Full Range|||43.0|67.0|
4117424|NCT00938431|3942214|B4|Not Hispanic or Latino||Ethnicity||participants|Number|26|26.0||||||
4117425|NCT00938431|3942215|B3|Not Hispanic or Latino||Ethnicity||participants|Number|6|6.0||||||
4117426|NCT00938431|3942216|B2|Not Hispanic or Latino||Ethnicity||participants|Number|16|16.0||||||
4117427|NCT00938431|3942217|B1|Not Hispanic or Latino||Ethnicity||participants|Number|4|4.0||||||
4117428|NCT00938431|3942214|B4|Hispanic or Latino||Ethnicity||participants|Number|21|21.0||||||
4117429|NCT00938431|3942215|B3|Hispanic or Latino||Ethnicity||participants|Number|3|3.0||||||
4117430|NCT00938431|3942216|B2|Hispanic or Latino||Ethnicity||participants|Number|7|7.0||||||
4117431|NCT00938431|3942217|B1|Hispanic or Latino||Ethnicity||participants|Number|11|11.0||||||
4117437|NCT00938431|3942215|B3|White||Racial Group||participants|Number|5|5.0||||||
4117438|NCT00938431|3942216|B2|White||Racial Group||participants|Number|18|18.0||||||
4117439|NCT00938431|3942217|B1|White||Racial Group||participants|Number|7|7.0||||||
4117440|NCT00938431|3942214|B4|Black||Racial Group||participants|Number|7|7.0||||||
4117441|NCT00938431|3942215|B3|Black||Racial Group||participants|Number|3|3.0||||||
4117442|NCT00938431|3942216|B2|Black||Racial Group||participants|Number|4|4.0||||||
4117443|NCT00938431|3942217|B1|Black||Racial Group||participants|Number|0|0.0||||||
4117444|NCT00938431|3942214|B4|Asian||Racial Group||participants|Number|2|2.0||||||
4117445|NCT00938431|3942215|B3|Asian||Racial Group||participants|Number|0|0.0||||||
4117446|NCT00938431|3942216|B2|Asian||Racial Group||participants|Number|1|1.0||||||
4117447|NCT00938431|3942217|B1|Asian||Racial Group||participants|Number|1|1.0||||||
4117448|NCT00938431|3942214|B4|||BMI||kg/m^2|Mean|17.48|17.48|Standard Deviation|3.37|3.37|||
4117449|NCT00938431|3942215|B3|||BMI||kg/m^2|Mean|21.38|21.38|Standard Deviation|3.12|3.12|||
4117450|NCT00938431|3942216|B2|||BMI||kg/m^2|Mean|17.39|17.39|Standard Deviation|2.68|2.68|||
4117451|NCT00938431|3942217|B1|||BMI||kg/m^2|Mean|15.27|15.27|Standard Deviation|2.33|2.33|||
4117452|NCT00938431|3942214|B4|||Height||centimeters|Mean|115.46|115.46|Standard Deviation|31.23|31.23|||
4117453|NCT00938431|3942215|B3|||Height||centimeters|Mean|158.93|158.93|Standard Deviation|11.43|11.43|||
4117454|NCT00938431|3942216|B2|||Height||centimeters|Mean|121.81|121.81|Standard Deviation|14.86|14.86|||
4117455|NCT00938431|3942217|B1|||Height||centimeters|Mean|79.64|79.64|Standard Deviation|11.22|11.22|||
4117456|NCT00938431|3942214|B4|||Weight||kilograms|Mean|26.60|26.6|Standard Deviation|17.64|17.64|||
4117457|NCT00938431|3942215|B3|||Weight||kilograms|Mean|54.10|54.1|Standard Deviation|10.49|10.49|||
4117458|NCT00938431|3942216|B2|||Weight||kilograms|Mean|26.73|26.73|Standard Deviation|10.20|10.2|||
4117459|NCT00938431|3942217|B1|||Weight||kilograms|Mean|9.90|9.9|Standard Deviation|3.31|3.31|||
4117460|NCT00938431|3942214|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4117461|NCT00938431|3942215|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4117462|NCT00938431|3942216|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4117463|NCT00938431|3942217|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4117464|NCT00938431|3942214|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4117465|NCT00938431|3942215|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4117466|NCT00938431|3942216|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4117467|NCT00938431|3942217|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4117468|NCT00938431|3942214|B4|Age (years)||Age||years|Mean|7.03|7.03|Standard Deviation|5.12|5.12|||
4117469|NCT00938431|3942215|B3|Age (years)||Age||years|Mean|15.15|15.15|Standard Deviation|1.50|1.5|||
4117470|NCT00938431|3942216|B2|Age (years)||Age||years|Mean|7.41|7.41|Standard Deviation|2.44|2.44|||
4117471|NCT00938431|3942217|B1|Age (years)||Age||years|Mean|1.58|1.58|Standard Deviation|1.02|1.02|||
4117472|NCT00938392|3942244|B3||Male|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
4117473|NCT00938392|3942245|B2||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4117474|NCT00938392|3942246|B1||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4117475|NCT00938392|3942244|B3||Female|Sex: Female, Male||Participants|Count of Participants|482|482.0||||||
4117476|NCT00938392|3942245|B2||Female|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
4117477|NCT00938392|3942246|B1||Female|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
4117478|NCT00938392|3942244|B3|||Age||Years|Mean|73.4|73.4|Standard Deviation|6.22|6.22|||
4117479|NCT00938392|3942245|B2|||Age||Years|Mean|73.5|73.5|Standard Deviation|6.36|6.36|||
4117480|NCT00938392|3942246|B1|||Age||Years|Mean|73.3|73.3|Standard Deviation|6.09|6.09|||
4117481|NCT00938366|3942271|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4117482|NCT00938366|3942272|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4117483|NCT00938366|3942273|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4117484|NCT00938366|3942271|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4117485|NCT00938366|3942272|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4117486|NCT00938366|3942273|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4117487|NCT00938366|3942271|B3|||Age||years|Mean|45.72|45.72|Standard Deviation|9.95|9.95|||
4117488|NCT00938366|3942272|B2|||Age||years|Mean|46.89|46.89|Standard Deviation|8.31|8.31|||
4117489|NCT00938366|3942273|B1|||Age||years|Mean|44.56|44.56|Standard Deviation|11.75|11.75|||
4117490|NCT00938340|3942294|B1|||Framingham reactive hyperemia index (fRHI)|fRHI is an alternative calculation derived from the same raw data (as RHI) and differs in that it uses the period from 90 to 120 s of postocclusion hyperemia, does not incorporate a baseline correction factor, and has a natural log transformation applied to the resulting ratio.|ln(ratio)|Mean|0.43|0.43|Standard Deviation|0.39|0.39|||
4117491|NCT00938340|3942294|B1|||Reactive hyperemia index (RHI)|RHI was calculated as the ratio of the average pulse wave amplitude during hyperemia (60 to 120 s of the post occlusion period) to the average pulse wave amplitude during baseline in the occluded hand divided by the same values in the control hand and then multiplied by a baseline correction factor.|ratio|Mean|2.0|2.0|Standard Deviation|0.6|0.6|||
4117492|NCT00938340|3942294|B1|||Malondialdehyde (MDA)||umol/L|Mean|0.75|0.75|Standard Deviation|0.32|0.32|||
4117493|NCT00938340|3942294|B1|||Total thiols||mmol/L|Mean|0.40|0.4|Standard Deviation|0.11|0.11|||
4117494|NCT00938340|3942294|B1|||Ferric reducing antioxidant potential (FRAP)||umol TE/L|Mean|1148|1148.0|Standard Deviation|195|195.0|||
4117495|NCT00938340|3942294|B1|||Triglycerides||mmol/L|Mean|1.2|1.2|Standard Deviation|0.5|0.5|||
4117496|NCT00938340|3942294|B1|||HDL-cholesterol||mmol/L|Mean|1.1|1.1|Standard Deviation|0.3|0.3|||
4117497|NCT00938340|3942294|B1|||LDL-cholesterol||mmol/L|Mean|3.4|3.4|Standard Deviation|0.6|0.6|||
4117498|NCT00938340|3942294|B1|||Total cholesterol||mmol/L|Mean|5.0|5.0|Standard Deviation|0.7|0.7|||
4117499|NCT00938340|3942294|B1|||Diastolic blood pressure||mm Hg|Mean|76|76.0|Standard Deviation|9|9.0|||
4117500|NCT00938340|3942294|B1|||Systolic blood pressure||mm Hg|Mean|119|119.0|Standard Deviation|10|10.0|||
4117501|NCT00938340|3942294|B1|||Body mass index||kg/m^2|Mean|29|29.0|Standard Deviation|4|4.0|||
4117502|NCT00938340|3942294|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4117503|NCT00938340|3942294|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4117504|NCT00938340|3942294|B1|||Age||years|Mean|49|49.0|Standard Deviation|9|9.0|||
4117505|NCT00938327|3942424|B1||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4117506|NCT00938327|3942424|B1||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4117507|NCT00938327|3942424|B1|||Age||weeks|Mean|10.4|10.4|Standard Deviation|4.27|4.27|||
4117508|NCT00938314|3942431|B5|India||Region of Enrollment||participants|Number|94|94.0||||||
4117509|NCT00938314|3942432|B4|India||Region of Enrollment||participants|Number|24|24.0||||||
4117510|NCT00938314|3942433|B3|India||Region of Enrollment||participants|Number|24|24.0||||||
4117511|NCT00938314|3942434|B2|India||Region of Enrollment||participants|Number|22|22.0||||||
4117512|NCT00938314|3942435|B1|India||Region of Enrollment||participants|Number|24|24.0||||||
4117513|NCT00938314|3942431|B5|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4117514|NCT00938314|3942432|B4|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4117515|NCT00938314|3942433|B3|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4117516|NCT00938314|3942434|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4117517|NCT00938314|3942435|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4117518|NCT00938314|3942431|B5||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4117519|NCT00938314|3942432|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4117520|NCT00938314|3942433|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4117521|NCT00938314|3942434|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4117522|NCT00938314|3942435|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4117523|NCT00938314|3942431|B5||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4117524|NCT00938314|3942432|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4117525|NCT00938314|3942433|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4117526|NCT00938314|3942434|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4117527|NCT00938314|3942435|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4117528|NCT00938314|3942431|B5|||Age||years|Mean|58.13|58.13|Standard Deviation|12.39|12.39|||
4117529|NCT00938314|3942432|B4|||Age||years|Mean|61.67|61.67|Standard Deviation|12.38|12.38|||
4117530|NCT00938314|3942433|B3|||Age||years|Mean|54.83|54.83|Standard Deviation|12.98|12.98|||
4117531|NCT00938314|3942434|B2|||Age||years|Mean|58.58|58.58|Standard Deviation|13.32|13.32|||
4117532|NCT00938314|3942435|B1|||Age||years|Mean|57.42|57.42|Standard Deviation|10.49|10.49|||
4117533|NCT00938314|3942431|B5||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4117534|NCT00938314|3942432|B4||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4117535|NCT00938314|3942433|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4117536|NCT00938314|3942434|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4117537|NCT00938314|3942435|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4117538|NCT00938314|3942431|B5||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
4117539|NCT00938314|3942432|B4||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4117540|NCT00938314|3942433|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4117541|NCT00938314|3942434|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4117542|NCT00938314|3942435|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4117543|NCT00938314|3942431|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4117544|NCT00938314|3942432|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4117545|NCT00938314|3942433|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4117546|NCT00938314|3942434|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4117547|NCT00938314|3942435|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4117548|NCT00938041|3942492|B1|White||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
4117549|NCT00938041|3942492|B1||Male|Gender||Participants|Count of Participants|19|19.0||||||
4117550|NCT00938041|3942492|B1||Female|Gender||Participants|Count of Participants|13|13.0||||||
4117551|NCT00938041|3942492|B1|||Age||Years|Mean|58.1|58.1|Standard Deviation|12.5|12.5|||
4117552|NCT00938015|3942501|B1||Male|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4117553|NCT00938015|3942501|B1||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4117554|NCT00938015|3942501|B1|||Age||Years|Mean|48.29|48.29|Standard Deviation|10.83|10.83|||
4117555|NCT00937950|3942517|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4117556|NCT00937950|3942517|B1||Female|Sex: Female, Male||Participants|Count of Participants|2003|2003.0||||||
4117557|NCT00937950|3942517|B1|||Age||Years|Mean|24.3|24.3|Standard Deviation|3.06|3.06|||
4117558|NCT00937937|3942533|B1|Unknown primary||Primary Type|Primary type of melanoma of 72 patients who have received Dinaciclib.|participants|Number|9|9.0||||||
4117559|NCT00937937|3942533|B1|Mucosal||Primary Type|Primary type of melanoma of 72 patients who have received Dinaciclib.|participants|Number|8|8.0||||||
4117560|NCT00937937|3942533|B1|Cutaneous||Primary Type|Primary type of melanoma of 72 patients who have received Dinaciclib.|participants|Number|55|55.0||||||
4117561|NCT00937937|3942533|B1|Yes||Elevated LDH|Whether elevated LDH or not of 72 patients who have received Dinaciclib.|participants|Number|31|31.0||||||
4117562|NCT00937937|3942533|B1|No||Elevated LDH|Whether elevated LDH or not of 72 patients who have received Dinaciclib.|participants|Number|41|41.0||||||
4117563|NCT00937937|3942533|B1|Other non-visceral||Site(s) of Metastases|Sites of metastases of 72 patients who have received Dinaciclib.|participants|Number|14|14.0||||||
4117564|NCT00937937|3942533|B1|Other visceral||Site(s) of Metastases|Sites of metastases of 72 patients who have received Dinaciclib.|participants|Number|17|17.0||||||
4117565|NCT00937937|3942533|B1|Lung||Site(s) of Metastases|Sites of metastases of 72 patients who have received Dinaciclib.|participants|Number|41|41.0||||||
4117566|NCT00937937|3942533|B1|Lymph node, soft tissue, skin||Site(s) of Metastases|Sites of metastases of 72 patients who have received Dinaciclib.|participants|Number|41|41.0||||||
4117567|NCT00937937|3942533|B1|Liver||Site(s) of Metastases|Sites of metastases of 72 patients who have received Dinaciclib.|participants|Number|23|23.0||||||
4117568|NCT00937937|3942533|B1|Brain||Site(s) of Metastases|Sites of metastases of 72 patients who have received Dinaciclib.|participants|Number|0|0.0||||||
4117569|NCT00937937|3942533|B1|Bone||Site(s) of Metastases|Sites of metastases of 72 patients who have received Dinaciclib.|participants|Number|18|18.0||||||
4117570|NCT00937937|3942533|B1|1||Performance Status|"The performance status of 72 patients who have received Dinaciclib. Only performance status 0 or 1 are included in the study.~Performance status 0: Fully active, able to carry on all pre-disease performance without restriction.~Performance status 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work.~The higher score, the worse outcomes."|participants|Number|34|34.0||||||
4117571|NCT00937937|3942533|B1|0||Performance Status|"The performance status of 72 patients who have received Dinaciclib. Only performance status 0 or 1 are included in the study.~Performance status 0: Fully active, able to carry on all pre-disease performance without restriction.~Performance status 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work.~The higher score, the worse outcomes."|participants|Number|38|38.0||||||
4117572|NCT00937937|3942533|B1|Unknown||Hispanic|The hispanic or non-hispanic summary of 72 patients who have received Dinaciclib.|participants|Number|1|1.0||||||
4117573|NCT00937937|3942533|B1|No||Hispanic|The hispanic or non-hispanic summary of 72 patients who have received Dinaciclib.|participants|Number|69|69.0||||||
4117574|NCT00937937|3942533|B1|Yes||Hispanic|The hispanic or non-hispanic summary of 72 patients who have received Dinaciclib.|participants|Number|2|2.0||||||
4117575|NCT00937937|3942533|B1|Pacific Islander||Race/Ethnicity, Customized|The race summary of 72 patients who have received Dinaciclib.|participants|Number|1|1.0||||||
4117576|NCT00937937|3942533|B1|Asian||Race/Ethnicity, Customized|The race summary of 72 patients who have received Dinaciclib.|participants|Number|2|2.0||||||
4117577|NCT00937937|3942533|B1|White||Race/Ethnicity, Customized|The race summary of 72 patients who have received Dinaciclib.|participants|Number|69|69.0||||||
4117578|NCT00937937|3942533|B1||Male|Sex: Female, Male|The gender summary of those 72 patients who have received Dinaciclib.|Participants|Count of Participants|52|52.0||||||
4117579|NCT00937937|3942533|B1||Female|Sex: Female, Male|The gender summary of those 72 patients who have received Dinaciclib.|Participants|Count of Participants|20|20.0||||||
4117580|NCT00937937|3942533|B1|||Age|The median ans full range of those 72 patients' ages.|years|Median|65.4|65.4|Full Range|||28.6|90.4|
4117581|NCT00937833|3942540|B3||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4117582|NCT00937833|3942541|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4117583|NCT00937833|3942542|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4117584|NCT00937833|3942540|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4117585|NCT00937833|3942541|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4117586|NCT00937833|3942542|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4117587|NCT00937833|3942540|B3|||Age||years|Mean|60.8|60.8|Standard Deviation|6.6|6.6|||
4117588|NCT00937833|3942541|B2|||Age||years|Mean|60.6|60.6|Standard Deviation|7.1|7.1|||
4117589|NCT00937833|3942542|B1|||Age||years|Mean|60.9|60.9|Standard Deviation|6.1|6.1|||
4117590|NCT00937794|3942549|B1|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
4117591|NCT00937794|3942549|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4117592|NCT00937794|3942549|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4117593|NCT00937794|3942549|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4117594|NCT00937794|3942549|B1|||Age||years|Mean|6.42|6.42|Standard Deviation|2.841|2.841|||
4117595|NCT00937794|3942549|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4117596|NCT00937794|3942549|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4117597|NCT00937794|3942549|B1||<=18 years|Age||Participants|Count of Participants|33|33.0||||||
4117598|NCT00937768|3942554|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4117599|NCT00937768|3942555|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4117600|NCT00937768|3942556|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4117601|NCT00937768|3942554|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4117602|NCT00937768|3942555|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4117603|NCT00937768|3942556|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4117604|NCT00937768|3942554|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4117605|NCT00937768|3942555|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4117606|NCT00937768|3942556|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4117607|NCT00937768|3942554|B3|||Age||years|Mean|62.0|62.0|Standard Deviation|7.8|7.8|||
4117608|NCT00937768|3942555|B2|||Age||years|Mean|62.8|62.8|Standard Deviation|7.4|7.4|||
4117609|NCT00937768|3942556|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|8.6|8.6|||
4117610|NCT00937560|3942563|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4117611|NCT00937560|3942563|B1||Female|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4117612|NCT00937560|3942563|B1|||Age||years|Median|55|55.0|Full Range|||24.0|79.0|
4117613|NCT00937547|3942571|B4|Venezuela||Region of Enrollment||participants|Number|329|329.0||||||
4117614|NCT00937547|3942572|B3|Venezuela||Region of Enrollment||participants|Number|84|84.0||||||
4117615|NCT00937547|3942573|B2|Venezuela||Region of Enrollment||participants|Number|149|149.0||||||
4117616|NCT00937547|3942574|B1|Venezuela||Region of Enrollment||participants|Number|96|96.0||||||
4117617|NCT00937547|3942571|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4117618|NCT00937547|3942572|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4117619|NCT00937547|3942573|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4117620|NCT00937547|3942574|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4117621|NCT00937547|3942571|B4||Female|Sex: Female, Male||Participants|Count of Participants|329|329.0||||||
4117622|NCT00937547|3942572|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4117623|NCT00937547|3942573|B2||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4117624|NCT00937547|3942574|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4117625|NCT00937547|3942571|B4|||Age||years|Mean|39.27|39.27|Standard Deviation|11.12|11.12|||
4117626|NCT00937547|3942572|B3|||Age||years|Mean|36.9|36.9|Standard Deviation|9.34|9.34|||
4117627|NCT00937547|3942573|B2|||Age||years|Mean|37.6|37.6|Standard Deviation|10.42|10.42|||
4117628|NCT00937547|3942574|B1|||Age||years|Mean|44.5|44.5|Standard Deviation|12.04|12.04|||
4117629|NCT00937547|3942571|B4||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4117630|NCT00937547|3942572|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4117631|NCT00937547|3942573|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4117632|NCT00937547|3942574|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4117633|NCT00937547|3942571|B4||Between 18 and 65 years|Age||Participants|Count of Participants|317|317.0||||||
4117634|NCT00937547|3942572|B3||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
4117635|NCT00937547|3942573|B2||Between 18 and 65 years|Age||Participants|Count of Participants|146|146.0||||||
4117636|NCT00937547|3942574|B1||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
4117637|NCT00937547|3942571|B4||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4117638|NCT00937547|3942572|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4117639|NCT00937547|3942573|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4117640|NCT00937547|3942574|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4117641|NCT00937521|3942605|B9||Male|Sex: Female, Male||Participants|Count of Participants|808|808.0||||||
4117642|NCT00937521|3942606|B8||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4117643|NCT00937521|3942607|B7||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4117644|NCT00937521|3942608|B6||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4117645|NCT00937521|3942609|B5||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4117646|NCT00937521|3942610|B4||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4117647|NCT00937521|3942611|B3||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4117648|NCT00937521|3942612|B2||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4117649|NCT00937521|3942613|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4117650|NCT00937521|3942605|B9||Female|Sex: Female, Male||Participants|Count of Participants|699|699.0||||||
4117651|NCT00937521|3942606|B8||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4117652|NCT00937521|3942607|B7||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4117653|NCT00937521|3942608|B6||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4117654|NCT00937521|3942609|B5||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4117655|NCT00937521|3942610|B4||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4117656|NCT00937521|3942611|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4117657|NCT00937521|3942612|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4117658|NCT00937521|3942613|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4117659|NCT00937521|3942605|B9||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4117660|NCT00937521|3942606|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4117661|NCT00937521|3942607|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4117662|NCT00937521|3942608|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4117663|NCT00937521|3942609|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4117664|NCT00937521|3942610|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4117665|NCT00937521|3942611|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4117666|NCT00937521|3942612|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4117667|NCT00937521|3942613|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4117668|NCT00937521|3942605|B9||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4117669|NCT00937521|3942606|B8||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4117670|NCT00937521|3942607|B7||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4117671|NCT00937521|3942608|B6||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4117672|NCT00937521|3942609|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4117673|NCT00937521|3942610|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4117674|NCT00937521|3942611|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4117675|NCT00937521|3942612|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4117676|NCT00937521|3942613|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4117677|NCT00937521|3942605|B9||<=18 years|Age||Participants|Count of Participants|1507|1507.0||||||
4117678|NCT00937521|3942606|B8||<=18 years|Age||Participants|Count of Participants|184|184.0||||||
4117679|NCT00937521|3942607|B7||<=18 years|Age||Participants|Count of Participants|186|186.0||||||
4117680|NCT00937521|3942608|B6||<=18 years|Age||Participants|Count of Participants|188|188.0||||||
4117681|NCT00937521|3942609|B5||<=18 years|Age||Participants|Count of Participants|191|191.0||||||
4117682|NCT00937521|3942610|B4||<=18 years|Age||Participants|Count of Participants|188|188.0||||||
4117683|NCT00937521|3942611|B3||<=18 years|Age||Participants|Count of Participants|192|192.0||||||
4117684|NCT00937521|3942612|B2||<=18 years|Age||Participants|Count of Participants|190|190.0||||||
4117685|NCT00937521|3942613|B1||<=18 years|Age||Participants|Count of Participants|188|188.0||||||
4117686|NCT00937495|3942726|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4117687|NCT00937495|3942726|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4117688|NCT00937495|3942726|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4117689|NCT00937495|3942726|B1|||Age||years|Median|62|62.0|Full Range|||34.0|81.0|
4117690|NCT00937404|3942732|B1|Asian-Chinese Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
4117691|NCT00937404|3942732|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4117692|NCT00937404|3942732|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4117693|NCT00937404|3942732|B1|||Age||Weeks|Mean|9.6|9.6|Standard Deviation|1.38|1.38|||
4117694|NCT00937391|3942739|B3|||Body Weight||kg|Mean|8.1|8.1|Standard Deviation|2.2|2.2|||
4117695|NCT00937391|3942740|B2|||Body Weight||kg|Mean|8.0|8.0|Standard Deviation|2.0|2.0|||
4117696|NCT00937391|3942741|B1|||Body Weight||kg|Mean|8.4|8.4|Standard Deviation|2.6|2.6|||
4117697|NCT00937391|3942739|B3|Multiple||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4117698|NCT00937391|3942740|B2|Multiple||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4117699|NCT00937391|3942741|B1|Multiple||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4117700|NCT00937391|3942739|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4117701|NCT00937391|3942740|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4117702|NCT00937391|3942741|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4117703|NCT00937391|3942739|B3|White||Race/Ethnicity, Customized||Participants|Number|52|52.0||||||
4117704|NCT00937391|3942740|B2|White||Race/Ethnicity, Customized||Participants|Number|33|33.0||||||
4117705|NCT00937391|3942741|B1|White||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4117706|NCT00937391|3942739|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4117707|NCT00937391|3942740|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4117708|NCT00937391|3942741|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4117709|NCT00937391|3942739|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4117710|NCT00937391|3942740|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4117711|NCT00937391|3942741|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4117712|NCT00937391|3942739|B3|12 months to 2 years||Age, Customized||Participants|Number|20|20.0||||||
4117713|NCT00937391|3942740|B2|12 months to 2 years||Age, Customized||Participants|Number|12|12.0||||||
4117714|NCT00937391|3942741|B1|12 months to 2 years||Age, Customized||Participants|Number|8|8.0||||||
4117715|NCT00937391|3942739|B3|6 to 12 months||Age, Customized||Participants|Number|17|17.0||||||
4117716|NCT00937391|3942740|B2|6 to 12 months||Age, Customized||Participants|Number|11|11.0||||||
4117717|NCT00937391|3942741|B1|6 to 12 months||Age, Customized||Participants|Number|6|6.0||||||
4117718|NCT00937391|3942739|B3|2 to 6 months||Age, Customized||Participants|Number|17|17.0||||||
4117719|NCT00937391|3942740|B2|2 to 6 months||Age, Customized||Participants|Number|11|11.0||||||
4117720|NCT00937391|3942741|B1|2 to 6 months||Age, Customized||Participants|Number|6|6.0||||||
4117721|NCT00937326|3942792|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117722|NCT00937326|3942793|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117723|NCT00937326|3942794|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117724|NCT00937326|3942795|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117725|NCT00937326|3942796|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117726|NCT00937326|3942797|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117727|NCT00937326|3942792|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117728|NCT00937326|3942793|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117729|NCT00937326|3942794|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117730|NCT00937326|3942795|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117731|NCT00937326|3942796|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117732|NCT00937326|3942797|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117733|NCT00937326|3942792|B6||White|Race (NIH/OMB)||Participants|Count of Participants|225|225.0||||||
4117734|NCT00937326|3942793|B5||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4117735|NCT00937326|3942794|B4||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4117736|NCT00937326|3942795|B3||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4117737|NCT00937326|3942796|B2||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4117738|NCT00937326|3942797|B1||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4117739|NCT00937326|3942792|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4117740|NCT00937326|3942793|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117741|NCT00937326|3942794|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117742|NCT00937326|3942795|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117743|NCT00937326|3942796|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117744|NCT00937326|3942797|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4117745|NCT00937326|3942792|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117746|NCT00937326|3942793|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117747|NCT00937326|3942794|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117748|NCT00937326|3942795|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117749|NCT00937326|3942796|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117750|NCT00937326|3942797|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117751|NCT00937326|3942792|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4117752|NCT00937326|3942793|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4117753|NCT00937326|3942794|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117754|NCT00937326|3942795|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117755|NCT00937326|3942796|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117756|NCT00937326|3942797|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117757|NCT00937326|3942792|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117758|NCT00937326|3942793|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117759|NCT00937326|3942794|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117760|NCT00937326|3942795|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117761|NCT00937326|3942796|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117762|NCT00937326|3942797|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117763|NCT00937326|3942792|B6||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4117764|NCT00937326|3942793|B5||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4117765|NCT00937326|3942794|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4117766|NCT00937326|3942795|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4117767|NCT00937326|3942796|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4117768|NCT00937326|3942797|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4117769|NCT00937326|3942792|B6||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4117770|NCT00937326|3942793|B5||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4117771|NCT00937326|3942794|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4117772|NCT00937326|3942795|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4117773|NCT00937326|3942796|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4117774|NCT00937326|3942797|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4117775|NCT00937326|3942792|B6|||Age||Years|Mean|57.0|57.0|Standard Deviation|8.67|8.67|||
4117776|NCT00937326|3942793|B5|||Age||Years|Mean|55.9|55.9|Standard Deviation|9.03|9.03|||
4117777|NCT00937326|3942794|B4|||Age||Years|Mean|57.3|57.3|Standard Deviation|8.95|8.95|||
4117778|NCT00937326|3942795|B3|||Age||Years|Mean|57.7|57.7|Standard Deviation|9.00|9.0|||
4117779|NCT00937326|3942796|B2|||Age||Years|Mean|58.2|58.2|Standard Deviation|8.04|8.04|||
4117780|NCT00937326|3942797|B1|||Age||Years|Mean|55.8|55.8|Standard Deviation|8.40|8.4|||
4117781|NCT00937235|3943027|B3|United States||Region of Enrollment||participants|Number|142|142.0||||||
4117782|NCT00937235|3943028|B2|United States||Region of Enrollment||participants|Number|70|70.0||||||
4117783|NCT00937235|3943029|B1|United States||Region of Enrollment||participants|Number|72|72.0||||||
4117784|NCT00937235|3943027|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4117785|NCT00937235|3943028|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4117786|NCT00937235|3943029|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4117787|NCT00937235|3943027|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4117788|NCT00937235|3943028|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4117789|NCT00937235|3943029|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4117790|NCT00937235|3943027|B3|||Age||years|Mean|42.7|42.7|Standard Deviation|9.9|9.9|||
4117791|NCT00937235|3943028|B2|||Age||years|Mean|42.6|42.6|Standard Deviation|10.2|10.2|||
4117792|NCT00937235|3943029|B1|||Age||years|Mean|42.8|42.8|Standard Deviation|9.7|9.7|||
4117793|NCT00937235|3943027|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4117794|NCT00937235|3943028|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4117795|NCT00937235|3943029|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4117796|NCT00937235|3943027|B3||Between 18 and 65 years|Age||Participants|Count of Participants|142|142.0||||||
4117797|NCT00937235|3943028|B2||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4117798|NCT00937235|3943029|B1||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
4117799|NCT00937235|3943027|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4117800|NCT00937235|3943028|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4117801|NCT00937235|3943029|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4117802|NCT00937157|3943050|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4117803|NCT00937157|3943050|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4117804|NCT00937157|3943050|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4117805|NCT00937157|3943050|B1|||Age||years|Mean|43|43.0|Standard Deviation|7.823|7.823|||
4117806|NCT00937157|3943050|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4117807|NCT00937157|3943050|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4117808|NCT00937157|3943050|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4117809|NCT00937118|3943054|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4117810|NCT00937118|3943054|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4117811|NCT00937118|3943054|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4117812|NCT00937118|3943054|B1|||Age||years|Mean|34|34.0|Standard Deviation|18|18.0|||
4117813|NCT00937105|3943061|B3|United States||Region of Enrollment||participants|Number|218|218.0||||||
4117814|NCT00937105|3943062|B2|United States||Region of Enrollment||participants|Number|109|109.0||||||
4117815|NCT00937105|3943063|B1|United States||Region of Enrollment||participants|Number|109|109.0||||||
4117816|NCT00937105|3943061|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4117817|NCT00937105|3943062|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4117818|NCT00937105|3943063|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4117819|NCT00937105|3943061|B3||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4117820|NCT00937105|3943062|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4117821|NCT00937105|3943063|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4117822|NCT00937105|3943061|B3|||Age||years|Mean|34.7|34.7|Standard Deviation|11.4|11.4|||
4117823|NCT00937105|3943062|B2|||Age||years|Mean|34.9|34.9|Standard Deviation|11.5|11.5|||
4117824|NCT00937105|3943063|B1|||Age||years|Mean|34.4|34.4|Standard Deviation|11.3|11.3|||
4117825|NCT00937105|3943061|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4117826|NCT00937105|3943062|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4117827|NCT00937105|3943063|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4117828|NCT00937105|3943061|B3||Between 18 and 65 years|Age||Participants|Count of Participants|215|215.0||||||
4117829|NCT00937105|3943062|B2||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
4117830|NCT00937105|3943063|B1||Between 18 and 65 years|Age||Participants|Count of Participants|108|108.0||||||
4117831|NCT00937105|3943061|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4117832|NCT00937105|3943062|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4117833|NCT00937105|3943063|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4117834|NCT00937040|3943079|B3|USA||Region of Enrollment||participants|Number|357|357.0||||||
4117835|NCT00937040|3943080|B2|USA||Region of Enrollment||participants|Number|178|178.0||||||
4117836|NCT00937040|3943081|B1|USA||Region of Enrollment||participants|Number|179|179.0||||||
4117837|NCT00937040|3943079|B3||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4117838|NCT00937040|3943080|B2||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4117839|NCT00937040|3943081|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4117840|NCT00937040|3943079|B3||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4117841|NCT00937040|3943080|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4117842|NCT00937040|3943081|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4117843|NCT00937040|3943079|B3|||Age||years|Mean|35.7|35.7|Standard Deviation|11.73|11.73|||
4117844|NCT00937040|3943080|B2|||Age||years|Mean|36.8|36.8|Standard Deviation|11.87|11.87|||
4117845|NCT00937040|3943081|B1|||Age||years|Mean|34.6|34.6|Standard Deviation|11.53|11.53|||
4117846|NCT00937040|3943079|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4117847|NCT00937040|3943080|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4117848|NCT00937040|3943081|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4117849|NCT00937040|3943079|B3||Between 18 and 65 years|Age||Participants|Count of Participants|348|348.0||||||
4117850|NCT00937040|3943080|B2||Between 18 and 65 years|Age||Participants|Count of Participants|173|173.0||||||
4117851|NCT00937040|3943081|B1||Between 18 and 65 years|Age||Participants|Count of Participants|175|175.0||||||
4117852|NCT00937040|3943079|B3||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4117853|NCT00937040|3943080|B2||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4117854|NCT00937040|3943081|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4117855|NCT00936975|3943124|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4117856|NCT00936975|3943124|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117857|NCT00936975|3943124|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117858|NCT00936975|3943124|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4117859|NCT00936975|3943124|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4117860|NCT00936975|3943124|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117861|NCT00936975|3943124|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117862|NCT00936975|3943124|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117863|NCT00936975|3943124|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4117864|NCT00936975|3943124|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4117865|NCT00936975|3943124|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117866|NCT00936975|3943124|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4117867|NCT00936975|3943124|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4117868|NCT00936975|3943124|B1|||Age||years|Median|69|69.0|Full Range|||48.0|86.0|
4117869|NCT00936910|3943133|B1|||All patients with fungal catheter-related blood stream infections were potential study subjects||participants|Number|13|13.0||||||
4117870|NCT00936910|3943133|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4117871|NCT00936910|3943133|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4117872|NCT00936910|3943133|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4117873|NCT00936910|3943133|B1|||Age||years|Mean|7.8|7.8|Full Range|||0.92|18.58|
4117874|NCT00936897|3943140|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4117875|NCT00936897|3943141|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4117876|NCT00936897|3943142|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4117877|NCT00936897|3943140|B3|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4117878|NCT00936897|3943141|B2|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4117879|NCT00936897|3943142|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4117880|NCT00936897|3943140|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4117881|NCT00936897|3943141|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4117882|NCT00936897|3943142|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4117883|NCT00936897|3943140|B3|Asian||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4117884|NCT00936897|3943141|B2|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4117885|NCT00936897|3943142|B1|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4117886|NCT00936897|3943140|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|96|96.0||||||
4117887|NCT00936897|3943141|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|42|42.0||||||
4117888|NCT00936897|3943142|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|54|54.0||||||
4117889|NCT00936897|3943140|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4117890|NCT00936897|3943141|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4117891|NCT00936897|3943142|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4117892|NCT00936897|3943140|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|709|709.0||||||
4117893|NCT00936897|3943141|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|361|361.0||||||
4117894|NCT00936897|3943142|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|348|348.0||||||
4117895|NCT00936897|3943140|B3|Male||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4117896|NCT00936897|3943141|B2|Male||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4117897|NCT00936897|3943142|B1|Male||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4117898|NCT00936897|3943140|B3|Female||Sex/Gender, Customized||Participants|Number|833|833.0||||||
4117899|NCT00936897|3943141|B2|Female||Sex/Gender, Customized||Participants|Number|416|416.0||||||
4117900|NCT00936897|3943142|B1|Female||Sex/Gender, Customized||Participants|Number|417|417.0||||||
4117901|NCT00936897|3943140|B3|||Age||Years|Mean|66.7|66.7|Standard Deviation|8|8.0|||
4117902|NCT00936897|3943141|B2|||Age||Years|Mean|66.2|66.2|Standard Deviation|7.8|7.8|||
4117903|NCT00936897|3943142|B1|||Age||Years|Mean|67.2|67.2|Standard Deviation|8.1|8.1|||
4117904|NCT00936741|3943155|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4117905|NCT00936741|3943155|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4117906|NCT00936741|3943155|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4117907|NCT00936741|3943155|B1|||Age||years|Mean|46.1|46.1|Standard Deviation|11.74|11.74|||
4117908|NCT00936741|3943155|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4117909|NCT00936741|3943155|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4117910|NCT00936741|3943155|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4117911|NCT00936715|3943160|B1|Not Permitted||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4117912|NCT00936715|3943160|B1|Non-Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4117913|NCT00936715|3943160|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4117914|NCT00936715|3943160|B1|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4117915|NCT00936715|3943160|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4117916|NCT00936715|3943160|B1|Black or American African||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4117917|NCT00936715|3943160|B1|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4117918|NCT00936715|3943160|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4117919|NCT00936715|3943160|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4117920|NCT00936715|3943160|B1|||Age||years|Mean|58.3|58.3|Standard Deviation|10.52|10.52|||
4117921|NCT00936702|3943164|B1||Other|Predominant location of disease||Participants|Count of Participants|6|6.0||||||
4117922|NCT00936702|3943164|B1||Bone|Predominant location of disease||Participants|Count of Participants|3|3.0||||||
4117923|NCT00936702|3943164|B1||Soft tissue|Predominant location of disease||Participants|Count of Participants|9|9.0||||||
4117924|NCT00936702|3943164|B1||Lung|Predominant location of disease||Participants|Count of Participants|10|10.0||||||
4117925|NCT00936702|3943164|B1||Liver|Predominant location of disease||Participants|Count of Participants|18|18.0||||||
4117926|NCT00936702|3943164|B1||Not Available|Histologic grade||Participants|Count of Participants|1|1.0||||||
4117927|NCT00936702|3943164|B1||Undifferentiated, anaplastic|Histologic grade||Participants|Count of Participants|8|8.0||||||
4117928|NCT00936702|3943164|B1||Poor|Histologic grade||Participants|Count of Participants|28|28.0||||||
4117929|NCT00936702|3943164|B1||Moderate|Histologic grade||Participants|Count of Participants|8|8.0||||||
4117930|NCT00936702|3943164|B1||Well|Histologic grade||Participants|Count of Participants|1|1.0||||||
4117931|NCT00936702|3943164|B1||Other|Histologic diagnosis||Participants|Count of Participants|4|4.0||||||
4117932|NCT00936702|3943164|B1||Poorly differentiated squamous carcinoma|Histologic diagnosis||Participants|Count of Participants|1|1.0||||||
4117933|NCT00936702|3943164|B1||Poorly differentiated nonsmall-cell carcinoma|Histologic diagnosis||Participants|Count of Participants|5|5.0||||||
4117934|NCT00936702|3943164|B1||Adenocarcinoma|Histologic diagnosis||Participants|Count of Participants|36|36.0||||||
4117935|NCT00936702|3943164|B1||2=Symptomatic and ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|6|6.0||||||
4117936|NCT00936702|3943164|B1||1=Symptomatic and fully ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|15|15.0||||||
4117937|NCT00936702|3943164|B1||0=Asymptomatic and fully active|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|25|25.0||||||
4117938|NCT00936702|3943164|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4117939|NCT00936702|3943164|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4117940|NCT00936702|3943164|B1|||Age||years|Median|61|61.0|Full Range|||32.0|79.0|
4117941|NCT00936663|3943172|B3|||AUC C peptide||ng*hr/ml|Mean|26.8|26.8|Standard Deviation|0|0.0|||
4117942|NCT00936663|3943173|B2|||AUC C peptide||ng*hr/ml|Mean|26.8|26.8|Standard Deviation|0|0.0|||
4117943|NCT00936663|3943172|B3|||AUC Proinsulin||pmol*hr/L|Mean|52.5|52.5|Standard Deviation|0|0.0|||
4117944|NCT00936663|3943173|B2|||AUC Proinsulin||pmol*hr/L|Mean|52.5|52.5|Standard Deviation|0|0.0|||
4117945|NCT00936663|3943172|B3|||AUC for Insulin||mciu*hr/ml|Mean|101.5|101.5|Standard Deviation|0|0.0|||
4117946|NCT00936663|3943173|B2|||AUC for Insulin||mciu*hr/ml|Mean|101.5|101.5|Standard Deviation|0|0.0|||
4117947|NCT00936663|3943172|B3|||Area Under the Curve (AUC) for glucose||mg*hr/dl|Mean|408|408.0|Standard Deviation|0|0.0|||
4117948|NCT00936663|3943173|B2|||Area Under the Curve (AUC) for glucose||mg*hr/dl|Mean|408|408.0|Standard Deviation|0|0.0|||
4117949|NCT00936663|3943172|B3|||estimated glomerular filtration rate (eGFR)||mL/min/1.73 m²|Mean|37.3|37.3|Standard Deviation|11.6|11.6|||
4117950|NCT00936663|3943173|B2|||estimated glomerular filtration rate (eGFR)||mL/min/1.73 m²|Mean|32|32.0|Standard Deviation|9.9|9.9|||
4117951|NCT00936663|3943174|B1|||estimated glomerular filtration rate (eGFR)||mL/min/1.73 m²|Mean|48|48.0|Standard Deviation|0|0.0|||
4117952|NCT00936663|3943172|B3|||Fasting Blood Glucose||mg/dl|Mean|118.3|118.3|Standard Deviation|21.3|21.3|||
4117953|NCT00936663|3943173|B2|||Fasting Blood Glucose||mg/dl|Mean|125|125.0|Standard Deviation|25.5|25.5|||
4117954|NCT00936663|3943174|B1|||Fasting Blood Glucose||mg/dl|Mean|105|105.0|Standard Deviation|0|0.0|||
4117955|NCT00936663|3943172|B3|||HbA1c||percentage of glycated haemoglobin|Mean|5.7|5.7|Standard Deviation|1.0|1.0|||
4117956|NCT00936663|3943173|B2|||HbA1c||percentage of glycated haemoglobin|Mean|5.8|5.8|Standard Deviation|1.5|1.5|||
4117957|NCT00936663|3943174|B1|||HbA1c||percentage of glycated haemoglobin|Mean|5.6|5.6|Standard Deviation|0|0.0|||
4117958|NCT00936663|3943172|B3|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4117959|NCT00936663|3943173|B2|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4117960|NCT00936663|3943174|B1|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4117961|NCT00936663|3943172|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117962|NCT00936663|3943173|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117963|NCT00936663|3943174|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117964|NCT00936663|3943172|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117965|NCT00936663|3943173|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117966|NCT00936663|3943174|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117967|NCT00936663|3943172|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4117968|NCT00936663|3943173|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4117969|NCT00936663|3943174|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4117970|NCT00936663|3943172|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117971|NCT00936663|3943173|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117972|NCT00936663|3943174|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117973|NCT00936663|3943172|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117974|NCT00936663|3943173|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117975|NCT00936663|3943174|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117976|NCT00936663|3943172|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117977|NCT00936663|3943173|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117978|NCT00936663|3943174|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117979|NCT00936663|3943172|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117980|NCT00936663|3943173|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117981|NCT00936663|3943174|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117982|NCT00936663|3943172|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117983|NCT00936663|3943173|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117984|NCT00936663|3943174|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117985|NCT00936663|3943172|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4117986|NCT00936663|3943173|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4117987|NCT00936663|3943174|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4117988|NCT00936663|3943172|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117989|NCT00936663|3943173|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117990|NCT00936663|3943174|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4117991|NCT00936663|3943172|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4117992|NCT00936663|3943173|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4117993|NCT00936663|3943174|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4117994|NCT00936663|3943172|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4117995|NCT00936663|3943173|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4117996|NCT00936663|3943174|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4117997|NCT00936663|3943172|B3|||Age||years|Mean|41|41.0|Standard Deviation|14|14.0|||
4117998|NCT00936663|3943173|B2|||Age||years|Mean|34|34.0|Standard Deviation|9.9|9.9|||
4117999|NCT00936663|3943174|B1|||Age||years|Mean|55|55.0|Standard Deviation|0|0.0|||
4118000|NCT00936663|3943172|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4118001|NCT00936663|3943173|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4118002|NCT00936663|3943174|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4118003|NCT00936663|3943172|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4118004|NCT00936663|3943173|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4118005|NCT00936663|3943174|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4118006|NCT00936663|3943172|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118007|NCT00936663|3943173|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118008|NCT00936663|3943174|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118009|NCT00936598|3943195|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4118010|NCT00936598|3943196|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4118011|NCT00936598|3943197|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4118012|NCT00936598|3943195|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4118013|NCT00936598|3943196|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4118014|NCT00936598|3943197|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4118015|NCT00936598|3943195|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4118016|NCT00936598|3943196|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4118017|NCT00936598|3943197|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4118018|NCT00936598|3943195|B3|||Age||years|Mean|54.4|54.4|Standard Deviation|18.2|18.2|||
4118019|NCT00936598|3943196|B2|||Age||years|Mean|60|60.0|Standard Deviation|0|0.0|||
4118020|NCT00936598|3943197|B1|||Age||years|Mean|53|53.0|Standard Deviation|20.7|20.7|||
4118021|NCT00936598|3943195|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4118022|NCT00936598|3943196|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4118023|NCT00936598|3943197|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4118024|NCT00936598|3943195|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4118025|NCT00936598|3943196|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4118026|NCT00936598|3943197|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4118027|NCT00936598|3943195|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118028|NCT00936598|3943196|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118029|NCT00936598|3943197|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118030|NCT00936585|3943208|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4118031|NCT00936585|3943208|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4118032|NCT00936585|3943208|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4118033|NCT00936585|3943208|B1|||Age||years|Mean|44.5|44.5|Standard Deviation|0.71|0.71|||
4118034|NCT00936585|3943208|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4118035|NCT00936585|3943208|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4118036|NCT00936585|3943208|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118037|NCT00936481|3943212|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
4118038|NCT00936481|3943213|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4118039|NCT00936481|3943214|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4118040|NCT00936481|3943212|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4118041|NCT00936481|3943213|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4118042|NCT00936481|3943214|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4118043|NCT00936481|3943212|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4118044|NCT00936481|3943213|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4118045|NCT00936481|3943214|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4118046|NCT00936481|3943212|B3|||Age||years|Mean|43|43.0|Standard Deviation|11|11.0|||
4118047|NCT00936481|3943213|B2|||Age||years|Mean|49|49.0|Standard Deviation|11|11.0|||
4118048|NCT00936481|3943214|B1|||Age||years|Mean|37|37.0|Standard Deviation|11|11.0|||
4118049|NCT00936481|3943212|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4118050|NCT00936481|3943213|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4118051|NCT00936481|3943214|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4118052|NCT00936481|3943212|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4118053|NCT00936481|3943213|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4118054|NCT00936481|3943214|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4118055|NCT00936481|3943212|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118056|NCT00936481|3943213|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118057|NCT00936481|3943214|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118058|NCT00936455|3943223|B3|United States||Region of Enrollment||participants|Number|75|75.0||||||
4118059|NCT00936455|3943224|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
4118060|NCT00936455|3943225|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4118061|NCT00936455|3943223|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4118062|NCT00936455|3943224|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4118063|NCT00936455|3943225|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4118064|NCT00936455|3943223|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4118065|NCT00936455|3943224|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4118066|NCT00936455|3943225|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4118067|NCT00936455|3943223|B3|||Age||years|Mean|67|67.0|Standard Deviation|13|13.0|||
4118068|NCT00936455|3943224|B2|||Age||years|Mean|67|67.0|Standard Deviation|13|13.0|||
4118069|NCT00936455|3943225|B1|||Age||years|Mean|68|68.0|Standard Deviation|13|13.0|||
4118070|NCT00936377|3943238|B4|||Time from Study Qualification to Study Drug Start||hours|Median|14|14.0|Inter-Quartile Range|||1.7|33.7|
4118071|NCT00936377|3943239|B3|||Time from Study Qualification to Study Drug Start||hours|Median|10.4|10.4|Inter-Quartile Range|||1.7|19.9|
4118072|NCT00936377|3943240|B2|||Time from Study Qualification to Study Drug Start||hours|Median|13.5|13.5|Inter-Quartile Range|||3.4|27.0|
4118073|NCT00936377|3943241|B1|||Time from Study Qualification to Study Drug Start||hours|Median|17.1|17.1|Inter-Quartile Range|||6.5|33.7|
4118074|NCT00936377|3943238|B4|||Lorazepam requirement 24 Hour Prior to Study Entry||mg|Mean|69.3|69.3|Inter-Quartile Range|||28.0|190.0|
4118075|NCT00936377|3943239|B3|||Lorazepam requirement 24 Hour Prior to Study Entry||mg|Mean|39|39.0|Inter-Quartile Range|||31.0|91.0|
4118076|NCT00936377|3943240|B2|||Lorazepam requirement 24 Hour Prior to Study Entry||mg|Mean|75|75.0|Inter-Quartile Range|||28.0|190.0|
4118077|NCT00936377|3943241|B1|||Lorazepam requirement 24 Hour Prior to Study Entry||mg|Mean|94|94.0|Inter-Quartile Range|||52.0|148.0|
4118078|NCT00936377|3943238|B4|||Child-Pugh Score|The Child-Pugh score is used to assess the prognosis of chronic liver disease. The point score is calculated from the summation of points assigned for total bilirubin (serum), albumin (serum), prothrombin time, and the presence of ascites and encephalopathy. The range is from 0 to 15. Grade A liver disease (scores of 5-6) predict two-year survival of 85%. Grade B liver disease (scores of 7-9) predict two-year survival of 55%. Grade C liver disease (scores of 10-15) predict two-year survival of 35%.|units on a scale|Mean|6.3|6.3|Full Range|||5.0|11.0|
4118110|NCT00936377|3943238|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4118111|NCT00936377|3943239|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4118079|NCT00936377|3943239|B3|||Child-Pugh Score|The Child-Pugh score is used to assess the prognosis of chronic liver disease. The point score is calculated from the summation of points assigned for total bilirubin (serum), albumin (serum), prothrombin time, and the presence of ascites and encephalopathy. The range is from 0 to 15. Grade A liver disease (scores of 5-6) predict two-year survival of 85%. Grade B liver disease (scores of 7-9) predict two-year survival of 55%. Grade C liver disease (scores of 10-15) predict two-year survival of 35%.|units on a scale|Mean|6|6.0|Full Range|||5.0|11.0|
4118080|NCT00936377|3943240|B2|||Child-Pugh Score|The Child-Pugh score is used to assess the prognosis of chronic liver disease. The point score is calculated from the summation of points assigned for total bilirubin (serum), albumin (serum), prothrombin time, and the presence of ascites and encephalopathy. The range is from 0 to 15. Grade A liver disease (scores of 5-6) predict two-year survival of 85%. Grade B liver disease (scores of 7-9) predict two-year survival of 55%. Grade C liver disease (scores of 10-15) predict two-year survival of 35%.|units on a scale|Mean|6|6.0|Full Range|||6.0|9.0|
4118081|NCT00936377|3943241|B1|||Child-Pugh Score|The Child-Pugh score is used to assess the prognosis of chronic liver disease. The point score is calculated from the summation of points assigned for total bilirubin (serum), albumin (serum), prothrombin time, and the presence of ascites and encephalopathy. The range is from 0 to 15. Grade A liver disease (scores of 5-6) predict two-year survival of 85%. Grade B liver disease (scores of 7-9) predict two-year survival of 55%. Grade C liver disease (scores of 10-15) predict two-year survival of 35%.|units on a scale|Mean|7|7.0|Full Range|||6.0|9.0|
4118082|NCT00936377|3943238|B4|Not intubated||Endotracheal Intubation at Study Entry||participants|Number|11|11.0||||||
4118083|NCT00936377|3943239|B3|Not intubated||Endotracheal Intubation at Study Entry||participants|Number|3|3.0||||||
4118084|NCT00936377|3943240|B2|Not intubated||Endotracheal Intubation at Study Entry||participants|Number|5|5.0||||||
4118085|NCT00936377|3943241|B1|Not intubated||Endotracheal Intubation at Study Entry||participants|Number|3|3.0||||||
4118086|NCT00936377|3943238|B4|Intubated||Endotracheal Intubation at Study Entry||participants|Number|13|13.0||||||
4118087|NCT00936377|3943239|B3|Intubated||Endotracheal Intubation at Study Entry||participants|Number|5|5.0||||||
4118088|NCT00936377|3943240|B2|Intubated||Endotracheal Intubation at Study Entry||participants|Number|3|3.0||||||
4118089|NCT00936377|3943241|B1|Intubated||Endotracheal Intubation at Study Entry||participants|Number|5|5.0||||||
4118090|NCT00936377|3943238|B4|||Acute Physiologic And Chronic Health Evaluation (APACHE) III|APACHE III measures the severity of disease for adult patients admitted to intensive care units. The point score is calculated as a summation from scores assigned to a patient's age, primary comorbidity, preexisting comorbidities, location prior to ICU admission, Glasgow Coma Scale, and 20 routine physiological measurements. APACHE III scores range from 0 to 299. This provides an initial risk classification of severely ill hospitalized patients in defined groups with higher scores indicating greater disease severity and correlated to higher mortality risk.|units on a scale|Mean|58.5|58.5|Inter-Quartile Range|||30.0|72.0|
4118091|NCT00936377|3943239|B3|||Acute Physiologic And Chronic Health Evaluation (APACHE) III|APACHE III measures the severity of disease for adult patients admitted to intensive care units. The point score is calculated as a summation from scores assigned to a patient's age, primary comorbidity, preexisting comorbidities, location prior to ICU admission, Glasgow Coma Scale, and 20 routine physiological measurements. APACHE III scores range from 0 to 299. This provides an initial risk classification of severely ill hospitalized patients in defined groups with higher scores indicating greater disease severity and correlated to higher mortality risk.|units on a scale|Mean|49.5|49.5|Inter-Quartile Range|||30.0|68.0|
4118092|NCT00936377|3943240|B2|||Acute Physiologic And Chronic Health Evaluation (APACHE) III|APACHE III measures the severity of disease for adult patients admitted to intensive care units. The point score is calculated as a summation from scores assigned to a patient's age, primary comorbidity, preexisting comorbidities, location prior to ICU admission, Glasgow Coma Scale, and 20 routine physiological measurements. APACHE III scores range from 0 to 299. This provides an initial risk classification of severely ill hospitalized patients in defined groups with higher scores indicating greater disease severity and correlated to higher mortality risk.|units on a scale|Mean|56.5|56.5|Inter-Quartile Range|||43.0|64.0|
4118093|NCT00936377|3943241|B1|||Acute Physiologic And Chronic Health Evaluation (APACHE) III|APACHE III measures the severity of disease for adult patients admitted to intensive care units. The point score is calculated as a summation from scores assigned to a patient's age, primary comorbidity, preexisting comorbidities, location prior to ICU admission, Glasgow Coma Scale, and 20 routine physiological measurements. APACHE III scores range from 0 to 299. This provides an initial risk classification of severely ill hospitalized patients in defined groups with higher scores indicating greater disease severity and correlated to higher mortality risk.|units on a scale|Mean|69.5|69.5|Inter-Quartile Range|||65.0|72.0|
4118094|NCT00936377|3943238|B4|||Weight||kg|Mean|84.4|84.4|Full Range|||44.5|126.0|
4118095|NCT00936377|3943239|B3|||Weight||kg|Mean|81.5|81.5|Full Range|||58.0|98.0|
4118096|NCT00936377|3943240|B2|||Weight||kg|Mean|84.5|84.5|Full Range|||60.0|126.0|
4118097|NCT00936377|3943241|B1|||Weight||kg|Mean|87.1|87.1|Full Range|||44.5|126.0|
4118098|NCT00936377|3943238|B4|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4118099|NCT00936377|3943239|B3|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4118100|NCT00936377|3943240|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4118101|NCT00936377|3943241|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4118102|NCT00936377|3943238|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4118103|NCT00936377|3943239|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4118104|NCT00936377|3943240|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4118105|NCT00936377|3943241|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4118106|NCT00936377|3943238|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4118107|NCT00936377|3943239|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4118108|NCT00936377|3943240|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4118109|NCT00936377|3943241|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4118112|NCT00936377|3943240|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4118113|NCT00936377|3943241|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4118114|NCT00936377|3943238|B4|||Age||years|Mean|49.3|49.3|Full Range|||28.0|61.0|
4118115|NCT00936377|3943239|B3|||Age||years|Mean|51|51.0|Full Range|||30.0|61.0|
4118116|NCT00936377|3943240|B2|||Age||years|Mean|50|50.0|Full Range|||30.0|56.0|
4118117|NCT00936377|3943241|B1|||Age||years|Mean|47|47.0|Full Range|||28.0|60.0|
4118118|NCT00936351|3943272|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
4118119|NCT00936351|3943273|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4118120|NCT00936351|3943274|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4118121|NCT00936351|3943272|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4118122|NCT00936351|3943273|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4118123|NCT00936351|3943274|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4118124|NCT00936351|3943272|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4118125|NCT00936351|3943273|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4118126|NCT00936351|3943274|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4118127|NCT00936351|3943272|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4118128|NCT00936351|3943273|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4118129|NCT00936351|3943274|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4118130|NCT00936351|3943272|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4118131|NCT00936351|3943273|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4118132|NCT00936351|3943274|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4118133|NCT00936351|3943272|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4118134|NCT00936351|3943273|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4118135|NCT00936351|3943274|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4118136|NCT00936351|3943272|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4118137|NCT00936351|3943273|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4118138|NCT00936351|3943274|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4118139|NCT00936351|3943272|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4118140|NCT00936351|3943273|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4118141|NCT00936351|3943274|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4118142|NCT00936351|3943272|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4118143|NCT00936351|3943273|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4118144|NCT00936351|3943274|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4118145|NCT00936351|3943272|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4118146|NCT00936351|3943273|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4118147|NCT00936351|3943274|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4118148|NCT00936351|3943272|B3|||Age, Customized||years|Mean|51.7|51.7|Standard Deviation|8.51|8.51|||
4118149|NCT00936351|3943273|B2|||Age, Customized||years|Mean|50.1|50.1|Standard Deviation|10.6|10.6|||
4118150|NCT00936351|3943274|B1|||Age, Customized||years|Mean|53.2|53.2|Standard Deviation|6.1|6.1|||
4118151|NCT00936221|3943285|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4118152|NCT00936221|3943286|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4118153|NCT00936221|3943287|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4118154|NCT00936221|3943285|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4118155|NCT00936221|3943286|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4118156|NCT00936221|3943287|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4118157|NCT00936221|3943285|B3|||Age||Years|Mean|53.6|53.6|Standard Deviation|15.62|15.62|||
4118158|NCT00936221|3943286|B2|||Age||Years|Mean|51.6|51.6|Standard Deviation|16.21|16.21|||
4118159|NCT00936221|3943287|B1|||Age||Years|Mean|55.7|55.7|Standard Deviation|14.89|14.89|||
4118160|NCT00936208|3943300|B3|||International Renal Interest Society (IRIS) II score at baseline|The baseline IRIS II score was given for 1122 patients in the Micardis 80mg group and for 1314 patients in the Micardis Plus 80/12.5mg group. The score represent the risk for vascular complication in type to diabetes mellitus and ranges from 0 (no risk) to 100% (complete risk).|Units on a scale|Mean|36.1|36.1|Standard Deviation|32.9|32.9|||
4118161|NCT00936208|3943301|B2|||International Renal Interest Society (IRIS) II score at baseline|The baseline IRIS II score was given for 1122 patients in the Micardis 80mg group and for 1314 patients in the Micardis Plus 80/12.5mg group. The score represent the risk for vascular complication in type to diabetes mellitus and ranges from 0 (no risk) to 100% (complete risk).|Units on a scale|Mean|37.1|37.1|Standard Deviation|32.2|32.2|||
4118162|NCT00936208|3943302|B1|||International Renal Interest Society (IRIS) II score at baseline|The baseline IRIS II score was given for 1122 patients in the Micardis 80mg group and for 1314 patients in the Micardis Plus 80/12.5mg group. The score represent the risk for vascular complication in type to diabetes mellitus and ranges from 0 (no risk) to 100% (complete risk).|Units on a scale|Mean|35.8|35.8|Standard Deviation|33.8|33.8|||
4118204|NCT00935883|3943437|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4118163|NCT00936208|3943300|B3|||Framingham score at baseline|The baseline Framingham score was given for 1349 patients in the Micardis 80mg group and for 1482 patients in the Micardis Plus 80/12.5mg group. The score represent the cardiovascular risk and ranges from 0 (no risk) to 100% (complete risk).|Units on a scale|Mean|18.6|18.6|Standard Deviation|12.6|12.6|||
4118164|NCT00936208|3943301|B2|||Framingham score at baseline|The baseline Framingham score was given for 1349 patients in the Micardis 80mg group and for 1482 patients in the Micardis Plus 80/12.5mg group. The score represent the cardiovascular risk and ranges from 0 (no risk) to 100% (complete risk).|Units on a scale|Mean|20.6|20.6|Standard Deviation|12.5|12.5|||
4118165|NCT00936208|3943302|B1|||Framingham score at baseline|The baseline Framingham score was given for 1349 patients in the Micardis 80mg group and for 1482 patients in the Micardis Plus 80/12.5mg group. The score represent the cardiovascular risk and ranges from 0 (no risk) to 100% (complete risk).|Units on a scale|Mean|15.7|15.7|Standard Deviation|12.3|12.3|||
4118166|NCT00936208|3943300|B3|Male||Gender|Gender was given for 1431 patients in the Micardis 80mg group and for 1547 patients in the Micardis Plus 80/12.5mg group.|participants|Number|2044|2044.0||||||
4118167|NCT00936208|3943301|B2|Male||Gender|Gender was given for 1431 patients in the Micardis 80mg group and for 1547 patients in the Micardis Plus 80/12.5mg group.|participants|Number|1113|1113.0||||||
4118168|NCT00936208|3943302|B1|Male||Gender|Gender was given for 1431 patients in the Micardis 80mg group and for 1547 patients in the Micardis Plus 80/12.5mg group.|participants|Number|931|931.0||||||
4118169|NCT00936208|3943300|B3|Female||Gender|Gender was given for 1431 patients in the Micardis 80mg group and for 1547 patients in the Micardis Plus 80/12.5mg group.|participants|Number|934|934.0||||||
4118170|NCT00936208|3943301|B2|Female||Gender|Gender was given for 1431 patients in the Micardis 80mg group and for 1547 patients in the Micardis Plus 80/12.5mg group.|participants|Number|434|434.0||||||
4118171|NCT00936208|3943302|B1|Female||Gender|Gender was given for 1431 patients in the Micardis 80mg group and for 1547 patients in the Micardis Plus 80/12.5mg group.|participants|Number|500|500.0||||||
4118172|NCT00936208|3943300|B3|||Age|Age was given for 1457 patients in the Micardis 80mg group and for 1569 patients in the Micardis Plus 80/12.5mg group.|years|Mean|51.5|51.5|Standard Deviation|10.2|10.2|||
4118173|NCT00936208|3943301|B2|||Age|Age was given for 1457 patients in the Micardis 80mg group and for 1569 patients in the Micardis Plus 80/12.5mg group.|years|Mean|53.1|53.1|Standard Deviation|9.8|9.8|||
4118174|NCT00936208|3943302|B1|||Age|Age was given for 1457 patients in the Micardis 80mg group and for 1569 patients in the Micardis Plus 80/12.5mg group.|years|Mean|49.8|49.8|Standard Deviation|10.4|10.4|||
4118175|NCT00936117|3943321|B1|Miscellaneous*||Chemotherapy Received|Participant's first induction chemotherapy, either with a clofarabine-based regimen or a cytarabine-based regimen. Exception listed as miscellaneous chemotherapy treatment, and include AZD1152 (an experimental aurora kinase inhibitor) alone (1 participant) or in combination with low-dose cytarabine (2 participants).|participants|Number|3|3.0||||||
4118176|NCT00936117|3943321|B1|Clofarabine-containing regimen||Chemotherapy Received|Participant's first induction chemotherapy, either with a clofarabine-based regimen or a cytarabine-based regimen. Exception listed as miscellaneous chemotherapy treatment, and include AZD1152 (an experimental aurora kinase inhibitor) alone (1 participant) or in combination with low-dose cytarabine (2 participants).|participants|Number|8|8.0||||||
4118177|NCT00936117|3943321|B1|Cytarabine-containing regimen||Chemotherapy Received|Participant's first induction chemotherapy, either with a clofarabine-based regimen or a cytarabine-based regimen. Exception listed as miscellaneous chemotherapy treatment, and include AZD1152 (an experimental aurora kinase inhibitor) alone (1 participant) or in combination with low-dose cytarabine (2 participants).|participants|Number|9|9.0||||||
4118178|NCT00936117|3943321|B1|AML, Relapse||Participant Diagnosis||participants|Number|1|1.0||||||
4118179|NCT00936117|3943321|B1|AML, Induction||Participant Diagnosis||participants|Number|19|19.0||||||
4118180|NCT00936117|3943321|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4118181|NCT00936117|3943321|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4118182|NCT00936117|3943321|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4118183|NCT00936117|3943321|B1|||Age||years|Median|65|65.0|Full Range|||34.0|78.0|
4118184|NCT00936065|3943326|B4||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4118185|NCT00936065|3943327|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4118186|NCT00936065|3943328|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4118187|NCT00936065|3943329|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4118188|NCT00936065|3943326|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4118189|NCT00936065|3943327|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4118190|NCT00936065|3943328|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4118191|NCT00936065|3943329|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4118192|NCT00936065|3943326|B4|||Age||years|Mean|38.78|38.78|Standard Deviation|10.31|10.31|||
4118193|NCT00936065|3943327|B3|||Age||years|Mean|42.39|42.39|Standard Deviation|11.95|11.95|||
4118194|NCT00936065|3943328|B2|||Age||years|Mean|35.5|35.5|Standard Deviation|8.75|8.75|||
4118195|NCT00936065|3943329|B1|||Age||years|Mean|38.57|38.57|Standard Deviation|9.53|9.53|||
4118196|NCT00935883|3943435|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4118197|NCT00935883|3943436|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4118198|NCT00935883|3943437|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4118199|NCT00935883|3943435|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4118200|NCT00935883|3943436|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4118201|NCT00935883|3943437|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4118202|NCT00935883|3943435|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4118203|NCT00935883|3943436|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4118205|NCT00935883|3943435|B3|||Age||years|Mean|75.3|75.3|Standard Deviation|8.2|8.2|||
4118206|NCT00935883|3943436|B2|||Age||years|Mean|75.1|75.1|Standard Deviation|8.0|8.0|||
4118207|NCT00935883|3943437|B1|||Age||years|Mean|75.7|75.7|Standard Deviation|8.64|8.64|||
4118208|NCT00935883|3943435|B3||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
4118209|NCT00935883|3943436|B2||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
4118210|NCT00935883|3943437|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4118211|NCT00935883|3943435|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4118212|NCT00935883|3943436|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4118213|NCT00935883|3943437|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4118214|NCT00935883|3943435|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118215|NCT00935883|3943436|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118216|NCT00935883|3943437|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118217|NCT00935857|3943450|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4118218|NCT00935857|3943451|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4118219|NCT00935857|3943452|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4118220|NCT00935857|3943450|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4118221|NCT00935857|3943451|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4118222|NCT00935857|3943452|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4118223|NCT00935857|3943450|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4118224|NCT00935857|3943451|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4118225|NCT00935857|3943452|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4118226|NCT00935857|3943450|B3|||Age||years|Mean|59.2|59.2|Standard Deviation|11|11.0|||
4118227|NCT00935857|3943451|B2|||Age||years|Mean|59.9|59.9|Standard Deviation|10.0|10.0|||
4118228|NCT00935857|3943452|B1|||Age||years|Mean|58.5|58.5|Standard Deviation|12.5|12.5|||
4118229|NCT00935857|3943450|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4118230|NCT00935857|3943451|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4118231|NCT00935857|3943452|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4118232|NCT00935857|3943450|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4118233|NCT00935857|3943451|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4118234|NCT00935857|3943452|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4118235|NCT00935857|3943450|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118236|NCT00935857|3943451|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118237|NCT00935857|3943452|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118238|NCT00935818|3943463|B3|||smoking rate||cigarettes per day|Mean|19.6|19.6|Standard Deviation|7.6|7.6|||
4118239|NCT00935818|3943464|B2|||smoking rate||cigarettes per day|Mean|19.7|19.7|Standard Deviation|7.9|7.9|||
4118240|NCT00935818|3943465|B1|||smoking rate||cigarettes per day|Mean|19.5|19.5|Standard Deviation|7.3|7.3|||
4118241|NCT00935818|3943463|B3|other||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4118242|NCT00935818|3943464|B2|other||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4118243|NCT00935818|3943465|B1|other||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4118244|NCT00935818|3943463|B3|White, non-hispanic||Race/Ethnicity, Customized||participants|Number|474|474.0||||||
4118245|NCT00935818|3943464|B2|White, non-hispanic||Race/Ethnicity, Customized||participants|Number|240|240.0||||||
4118246|NCT00935818|3943465|B1|White, non-hispanic||Race/Ethnicity, Customized||participants|Number|234|234.0||||||
4118247|NCT00935818|3943463|B3||Male|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
4118248|NCT00935818|3943464|B2||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4118249|NCT00935818|3943465|B1||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4118250|NCT00935818|3943463|B3||Female|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
4118251|NCT00935818|3943464|B2||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4118252|NCT00935818|3943465|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4118253|NCT00935818|3943463|B3|||Age||years|Mean|42.1|42.1|Standard Deviation|12.4|12.4|||
4118254|NCT00935818|3943464|B2|||Age||years|Mean|41.9|41.9|Standard Deviation|12.7|12.7|||
4118255|NCT00935818|3943465|B1|||Age||years|Mean|42.2|42.2|Standard Deviation|12.2|12.2|||
4118256|NCT00935818|3943463|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4118257|NCT00935818|3943464|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4118258|NCT00935818|3943465|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4118259|NCT00935818|3943463|B3||Between 18 and 65 years|Age||Participants|Count of Participants|487|487.0||||||
4118260|NCT00935818|3943464|B2||Between 18 and 65 years|Age||Participants|Count of Participants|253|253.0||||||
4118261|NCT00935818|3943465|B1||Between 18 and 65 years|Age||Participants|Count of Participants|234|234.0||||||
4118262|NCT00935818|3943463|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4118263|NCT00935818|3943464|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118264|NCT00935818|3943465|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4118265|NCT00935792|3943484|B4|||Previouse number of regimens||regimens|Median|3|3.0|Full Range|||1.0|10.0|
4118266|NCT00935792|3943485|B3|||Previouse number of regimens||regimens|Median|3|3.0|Full Range|||1.0|10.0|
4118267|NCT00935792|3943486|B2|||Previouse number of regimens||regimens|Median|3.5|3.5|Full Range|||1.0|5.0|
4118268|NCT00935792|3943487|B1|||Previouse number of regimens||regimens|Median|2|2.0|Full Range|||1.0|6.0|
4118269|NCT00935792|3943484|B4|United States||Region of Enrollment||participants|Number|24|24.0||||||
4118270|NCT00935792|3943485|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4118271|NCT00935792|3943486|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4118272|NCT00935792|3943487|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4118273|NCT00935792|3943484|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4118274|NCT00935792|3943485|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4118275|NCT00935792|3943486|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4118276|NCT00935792|3943487|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4118277|NCT00935792|3943484|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4118278|NCT00935792|3943485|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4118279|NCT00935792|3943486|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4118280|NCT00935792|3943487|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4118281|NCT00935792|3943484|B4|||Age||years|Median|72|72.0|Full Range|||54.0|82.0|
4118282|NCT00935792|3943485|B3|||Age||years|Median|71|71.0|Full Range|||61.0|82.0|
4118283|NCT00935792|3943486|B2|||Age||years|Median|73|73.0|Full Range|||54.0|82.0|
4118284|NCT00935792|3943487|B1|||Age||years|Median|72.5|72.5|Full Range|||66.0|78.0|
4118285|NCT00935766|3943504|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
4118286|NCT00935766|3943505|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4118287|NCT00935766|3943506|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4118288|NCT00935766|3943504|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4118289|NCT00935766|3943505|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4118290|NCT00935766|3943506|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4118291|NCT00935766|3943504|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4118292|NCT00935766|3943505|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4118293|NCT00935766|3943506|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4118294|NCT00935766|3943504|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4118295|NCT00935766|3943505|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4118296|NCT00935766|3943506|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4118297|NCT00935766|3943504|B3||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4118298|NCT00935766|3943505|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4118299|NCT00935766|3943506|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4118300|NCT00935766|3943504|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118301|NCT00935766|3943505|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118302|NCT00935766|3943506|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118303|NCT00935766|3943504|B3|||Age||years|Mean|61.1|61.1|Standard Deviation|10.3|10.3|||
4118304|NCT00935766|3943505|B2|||Age||years|Mean|62.3|62.3|Standard Deviation|9.7|9.7|||
4118305|NCT00935766|3943506|B1|||Age||years|Mean|60.2|60.2|Standard Deviation|10.8|10.8|||
4118306|NCT00935701|3943517|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4118307|NCT00935701|3943517|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4118308|NCT00935701|3943517|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4118309|NCT00935701|3943517|B1|||Age||years|Mean|6.2|6.2|Standard Deviation|2.4|2.4|||
4118310|NCT00935701|3943517|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4118311|NCT00935701|3943517|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4118312|NCT00935701|3943517|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4118313|NCT00935649|3943524|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4118314|NCT00935649|3943524|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4118315|NCT00935649|3943524|B1|||Age||years|Mean|52.1|52.1|Standard Deviation|13.7|13.7|||
4118316|NCT00935584|3943532|B3|United States||Region of Enrollment||participants|Number|149|149.0||||||
4118317|NCT00935584|3943533|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4118318|NCT00935584|3943534|B1|United States||Region of Enrollment||participants|Number|126|126.0||||||
4118319|NCT00935584|3943532|B3||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4118320|NCT00935584|3943533|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4118321|NCT00935584|3943534|B1||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4118322|NCT00935584|3943532|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4118323|NCT00935584|3943533|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4118324|NCT00935584|3943534|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4118325|NCT00935584|3943532|B3|||Age||years|Mean|NA||Standard Deviation|NA||||Only provider gender and location was recorded.
4118326|NCT00935584|3943533|B2|||Age||years|Mean|NA||Standard Deviation|NA||||Only provider gender and location was recorded.
4118327|NCT00935584|3943534|B1|||Age||years|Mean|60.5|60.5|Standard Deviation|13.4|13.4|||
4118328|NCT00935532|3943545|B3|BG+Thiazolidine Derivative (TZD)||Background Oral Antidiabetic Agent (OAD)||participants|Number|140|140.0||||||
4118329|NCT00935532|3943546|B2|BG+Thiazolidine Derivative (TZD)||Background Oral Antidiabetic Agent (OAD)||participants|Number|70|70.0||||||
4118330|NCT00935532|3943547|B1|BG+Thiazolidine Derivative (TZD)||Background Oral Antidiabetic Agent (OAD)||participants|Number|70|70.0||||||
4118331|NCT00935532|3943545|B3|Biguanide (BG)||Background Oral Antidiabetic Agent (OAD)||participants|Number|287|287.0||||||
4118332|NCT00935532|3943546|B2|Biguanide (BG)||Background Oral Antidiabetic Agent (OAD)||participants|Number|142|142.0||||||
4118333|NCT00935532|3943547|B1|Biguanide (BG)||Background Oral Antidiabetic Agent (OAD)||participants|Number|145|145.0||||||
4118334|NCT00935532|3943545|B3|||Weight||kg|Mean|70.49|70.49|Standard Deviation|13.586|13.586|||
4118335|NCT00935532|3943546|B2|||Weight||kg|Mean|71.03|71.03|Standard Deviation|13.932|13.932|||
4118336|NCT00935532|3943547|B1|||Weight||kg|Mean|69.95|69.95|Standard Deviation|13.246|13.246|||
4118337|NCT00935532|3943545|B3|||Glycosylated hemoglobin (HbA1c)||percentage of total hemoglobin|Mean|8.50|8.5|Standard Deviation|0.806|0.806|||
4118338|NCT00935532|3943546|B2|||Glycosylated hemoglobin (HbA1c)||percentage of total hemoglobin|Mean|8.50|8.5|Standard Deviation|0.791|0.791|||
4118339|NCT00935532|3943547|B1|||Glycosylated hemoglobin (HbA1c)||percentage of total hemoglobin|Mean|8.51|8.51|Standard Deviation|0.823|0.823|||
4118340|NCT00935532|3943545|B3||Male|Sex: Female, Male||Participants|Count of Participants|290|290.0||||||
4118341|NCT00935532|3943546|B2||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4118342|NCT00935532|3943547|B1||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4118343|NCT00935532|3943545|B3||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4118344|NCT00935532|3943546|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4118345|NCT00935532|3943547|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4118346|NCT00935532|3943545|B3|||Age||years|Mean|56.8|56.8|Standard Deviation|10.80|10.8|||
4118347|NCT00935532|3943546|B2|||Age||years|Mean|56.4|56.4|Standard Deviation|11.16|11.16|||
4118348|NCT00935532|3943547|B1|||Age||years|Mean|57.1|57.1|Standard Deviation|10.44|10.44|||
4118349|NCT00935532|3943545|B3||>=65 years|Age||Participants|Count of Participants|111|111.0||||||
4118350|NCT00935532|3943546|B2||>=65 years|Age||Participants|Count of Participants|56|56.0||||||
4118351|NCT00935532|3943547|B1||>=65 years|Age||Participants|Count of Participants|55|55.0||||||
4118352|NCT00935532|3943545|B3||Between 18 and 65 years|Age||Participants|Count of Participants|316|316.0||||||
4118353|NCT00935532|3943546|B2||Between 18 and 65 years|Age||Participants|Count of Participants|156|156.0||||||
4118354|NCT00935532|3943547|B1||Between 18 and 65 years|Age||Participants|Count of Participants|160|160.0||||||
4118355|NCT00935532|3943545|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118356|NCT00935532|3943546|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118357|NCT00935532|3943547|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118358|NCT00935493|3943574|B4||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4118359|NCT00935493|3943575|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4118360|NCT00935493|3943576|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4118361|NCT00935493|3943577|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4118362|NCT00935493|3943574|B4||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4118363|NCT00935493|3943575|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4118364|NCT00935493|3943576|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4118365|NCT00935493|3943577|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4118366|NCT00935493|3943574|B4|||Age||years|Mean|80.2|80.2|Standard Deviation|4.0|4.0|||
4118367|NCT00935493|3943575|B3|||Age||years|Mean|80.5|80.5|Standard Deviation|4.0|4.0|||
4118368|NCT00935493|3943576|B2|||Age||years|Mean|80.1|80.1|Standard Deviation|4.0|4.0|||
4118369|NCT00935493|3943577|B1|||Age||years|Mean|80.0|80.0|Standard Deviation|4.0|4.0|||
4118370|NCT00935311|3943593|B4||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4118371|NCT00935311|3943594|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4118372|NCT00935311|3943595|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4118373|NCT00935311|3943596|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4118374|NCT00935311|3943593|B4||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4118375|NCT00935311|3943594|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4118376|NCT00935311|3943595|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4118377|NCT00935311|3943596|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4118378|NCT00935311|3943593|B4|||Age||years|Mean|22.2|22.2|Standard Deviation|3.70|3.7|||
4118379|NCT00935311|3943594|B3|||Age||years|Mean|23.0|23.0|Standard Deviation|4.73|4.73|||
4118380|NCT00935311|3943595|B2|||Age||years|Mean|21.4|21.4|Standard Deviation|3.20|3.2|||
4118381|NCT00935311|3943596|B1|||Age||years|Mean|22.1|22.1|Standard Deviation|2.83|2.83|||
4118382|NCT00935272|3943615|B3|United States||Region of Enrollment||participants|Number|180|180.0||||||
4118383|NCT00935272|3943616|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
4118384|NCT00935272|3943617|B1|United States||Region of Enrollment||participants|Number|135|135.0||||||
4118385|NCT00935272|3943615|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4118386|NCT00935272|3943616|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4118387|NCT00935272|3943617|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4118388|NCT00935272|3943615|B3||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4118389|NCT00935272|3943616|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4118390|NCT00935272|3943617|B1||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4118391|NCT00935272|3943615|B3|||Age||years|Mean|47.6|47.6|Standard Deviation|10.6|10.6|||
4118392|NCT00935272|3943616|B2|||Age||years|Mean|47.2|47.2|Standard Deviation|10.9|10.9|||
4118393|NCT00935272|3943617|B1|||Age||years|Mean|47.8|47.8|Standard Deviation|10.5|10.5|||
4118394|NCT00935272|3943615|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4118395|NCT00935272|3943616|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4118396|NCT00935272|3943617|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4118397|NCT00935272|3943615|B3||Between 18 and 65 years|Age||Participants|Count of Participants|177|177.0||||||
4118398|NCT00935272|3943616|B2||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4118399|NCT00935272|3943617|B1||Between 18 and 65 years|Age||Participants|Count of Participants|133|133.0||||||
4118400|NCT00935272|3943615|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4118401|NCT00935272|3943616|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118402|NCT00935272|3943617|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4118403|NCT00935259|3943627|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4118404|NCT00935259|3943627|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4118405|NCT00935259|3943627|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4118406|NCT00935259|3943627|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4118407|NCT00935259|3943627|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118408|NCT00935220|3943642|B1|||Body mass index (BMI) continuous||kg/m^2|Mean|30.93|30.93|Standard Deviation|3.90|3.9|||
4118409|NCT00935220|3943642|B1|Black / African American||Race/Ethnicity, Customized||Participants|Number|41|41.0||||||
4118410|NCT00935220|3943642|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4118411|NCT00935220|3943642|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4118412|NCT00935220|3943642|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4118413|NCT00935220|3943642|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4118414|NCT00935220|3943642|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4118415|NCT00935220|3943642|B1|||Age||Years|Mean|50.5|50.5|Standard Deviation|9.8|9.8|||
4118416|NCT00935064|3943654|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4118417|NCT00935064|3943655|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4118418|NCT00935064|3943656|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4118419|NCT00935064|3943654|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4118420|NCT00935064|3943655|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4118421|NCT00935064|3943656|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4118422|NCT00935064|3943654|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4118423|NCT00935064|3943655|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4118424|NCT00935064|3943656|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4118425|NCT00935064|3943654|B3|||Age||years|Mean|51|51.0|Standard Deviation|12|12.0|||
4118426|NCT00935064|3943655|B2|||Age||years|Mean|53|53.0|Standard Deviation|12|12.0|||
4118427|NCT00935064|3943656|B1|||Age||years|Mean|49|49.0|Standard Deviation|12|12.0|||
4118428|NCT00935064|3943654|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4118429|NCT00935064|3943655|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4118430|NCT00935064|3943656|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4118431|NCT00935064|3943654|B3||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4118432|NCT00935064|3943655|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4118433|NCT00935064|3943656|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4118434|NCT00935064|3943654|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118435|NCT00935064|3943655|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118436|NCT00935064|3943656|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118437|NCT00934947|3943671|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
4118438|NCT00934947|3943672|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4118439|NCT00934947|3943673|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4118440|NCT00934947|3943671|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4118441|NCT00934947|3943672|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4118442|NCT00934947|3943673|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4118443|NCT00934947|3943671|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4118444|NCT00934947|3943672|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4118445|NCT00934947|3943673|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4118446|NCT00934947|3943671|B3|||Age||years|Mean|32|32.0|Standard Deviation|10|10.0|||
4118447|NCT00934947|3943672|B2|||Age||years|Mean|31|31.0|Standard Deviation|9|9.0|||
4118448|NCT00934947|3943673|B1|||Age||years|Mean|32|32.0|Standard Deviation|11|11.0|||
4118449|NCT00934947|3943671|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4118450|NCT00934947|3943672|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4118451|NCT00934947|3943673|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4118452|NCT00934947|3943671|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4118453|NCT00934947|3943672|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4118454|NCT00934947|3943673|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4118455|NCT00934947|3943671|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118456|NCT00934947|3943672|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118457|NCT00934947|3943673|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118458|NCT00934921|3943686|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4118459|NCT00934921|3943687|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4118460|NCT00934921|3943688|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4118461|NCT00934921|3943686|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4118462|NCT00934921|3943687|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4118463|NCT00934921|3943688|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4118464|NCT00934921|3943686|B3|Biracial||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4118465|NCT00934921|3943687|B2|Biracial||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4118466|NCT00934921|3943688|B1|Biracial||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4118467|NCT00934921|3943686|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4118468|NCT00934921|3943687|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4118469|NCT00934921|3943688|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4118470|NCT00934921|3943686|B3|Black||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4118471|NCT00934921|3943687|B2|Black||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4118472|NCT00934921|3943688|B1|Black||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4118473|NCT00934921|3943686|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4118474|NCT00934921|3943687|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4118475|NCT00934921|3943688|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4118476|NCT00934921|3943686|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4118477|NCT00934921|3943687|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4118478|NCT00934921|3943688|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4118479|NCT00934921|3943686|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4118480|NCT00934921|3943687|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4118481|NCT00934921|3943688|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4118482|NCT00934921|3943686|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4118483|NCT00934921|3943687|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4118484|NCT00934921|3943688|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4118485|NCT00934921|3943686|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118486|NCT00934921|3943687|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118487|NCT00934921|3943688|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118488|NCT00934856|3943697|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4118489|NCT00934856|3943698|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4118490|NCT00934856|3943699|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4118491|NCT00934856|3943700|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4118492|NCT00934856|3943701|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4118493|NCT00934856|3943702|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4118494|NCT00934856|3943703|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4118495|NCT00934856|3943697|B7||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4118496|NCT00934856|3943698|B6||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4118497|NCT00934856|3943699|B5||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4118498|NCT00934856|3943700|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4118499|NCT00934856|3943701|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4118500|NCT00934856|3943702|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4118501|NCT00934856|3943703|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4118502|NCT00934856|3943697|B7|||Age||years|Mean|50.4|50.4|Standard Deviation|10.39|10.39|||
4118503|NCT00934856|3943698|B6|||Age||years|Mean|54.2|54.2|Standard Deviation|11.43|11.43|||
4118504|NCT00934856|3943699|B5|||Age||years|Mean|48.6|48.6|Standard Deviation|9.73|9.73|||
4118505|NCT00934856|3943700|B4|||Age||years|Mean|48|48.0|Standard Deviation|9.39|9.39|||
4118506|NCT00934856|3943701|B3|||Age||years|Mean|57|57.0|Standard Deviation|12.12|12.12|||
4118507|NCT00934856|3943702|B2|||Age||years|Mean|50.7|50.7|Standard Deviation|4.84|4.84|||
4118508|NCT00934856|3943703|B1|||Age||years|Mean|43|43.0|Standard Deviation|7.16|7.16|||
4118509|NCT00934843|3943804|B3|United States||Region of Enrollment||participants|Number|77|77.0||||||
4118510|NCT00934843|3943805|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4118511|NCT00934843|3943806|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4118512|NCT00934843|3943804|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4118513|NCT00934843|3943805|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4118514|NCT00934843|3943806|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4118515|NCT00934843|3943804|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4118516|NCT00934843|3943805|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4118517|NCT00934843|3943806|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4118518|NCT00934843|3943804|B3|||Age||days|Mean|8.8|8.8|Standard Deviation|5.7|5.7|||
4118519|NCT00934843|3943805|B2|||Age||days|Mean|9.4|9.4|Standard Deviation|6.3|6.3|||
4118520|NCT00934843|3943806|B1|||Age||days|Mean|8.2|8.2|Standard Deviation|5.0|5.0|||
4118521|NCT00934843|3943804|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4118522|NCT00934843|3943805|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4118523|NCT00934843|3943806|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4118524|NCT00934843|3943804|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4118525|NCT00934843|3943805|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4118526|NCT00934843|3943806|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4118527|NCT00934843|3943804|B3||<=18 years|Age||Participants|Count of Participants|77|77.0||||||
4118528|NCT00934843|3943805|B2||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
4118529|NCT00934843|3943806|B1||<=18 years|Age||Participants|Count of Participants|37|37.0||||||
4118530|NCT00934791|3943821|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4118531|NCT00934791|3943823|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4118532|NCT00934791|3943821|B3|Male||Gender||participants|Number|1|1.0||||||
4118533|NCT00934791|3943823|B1|Male||Gender||participants|Number|1|1.0||||||
4118534|NCT00934791|3943821|B3|Female||Gender||participants|Number|0|0.0||||||
4118535|NCT00934791|3943823|B1|Female||Gender||participants|Number|0|0.0||||||
4118536|NCT00934791|3943821|B3|>=65 years||Age||participants|Number|0|0.0||||||
4118537|NCT00934791|3943823|B1|>=65 years||Age||participants|Number|0|0.0||||||
4118538|NCT00934791|3943821|B3|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
4118539|NCT00934791|3943823|B1|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
4118540|NCT00934791|3943821|B3|<=18 years||Age||participants|Number|0|0.0||||||
4118541|NCT00934791|3943823|B1|<=18 years||Age||participants|Number|0|0.0||||||
4118542|NCT00934661|3943830|B3|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
4118543|NCT00934661|3943831|B2|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4118544|NCT00934661|3943832|B1|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4118545|NCT00934661|3943830|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4118546|NCT00934661|3943831|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4118547|NCT00934661|3943832|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4118548|NCT00934661|3943830|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4118549|NCT00934661|3943831|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4118550|NCT00934661|3943832|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4118551|NCT00934661|3943830|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4118552|NCT00934661|3943831|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4118553|NCT00934661|3943832|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4118554|NCT00934661|3943830|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4118555|NCT00934661|3943831|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4118556|NCT00934661|3943832|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4118557|NCT00934661|3943830|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118558|NCT00934661|3943831|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118559|NCT00934661|3943832|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118560|NCT00934648|3943853|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4118561|NCT00934648|3943853|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4118562|NCT00934648|3943853|B1|||Age||years|Mean|37|37.0|Standard Deviation|12|12.0|||
4118563|NCT00934635|3943860|B10|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4118564|NCT00934635|3943861|B9|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4118565|NCT00934635|3943868|B2|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4118566|NCT00934635|3943860|B10|Male||Gender||participants|Number|1|1.0||||||
4118567|NCT00934635|3943861|B9|Male||Gender||participants|Number|0|0.0||||||
4118568|NCT00934635|3943868|B2|Male||Gender||participants|Number|1|1.0||||||
4118569|NCT00934635|3943860|B10|Female||Gender||participants|Number|1|1.0||||||
4118570|NCT00934635|3943861|B9|Female||Gender||participants|Number|1|1.0||||||
4118571|NCT00934635|3943868|B2|Female||Gender||participants|Number|0|0.0||||||
4118572|NCT00934635|3943860|B10|19 years of age||Age, Customized||years|Number|1|1.0||||||
4118573|NCT00934635|3943861|B9|19 years of age||Age, Customized||years|Number|1|1.0||||||
4118574|NCT00934635|3943868|B2|19 years of age||Age, Customized||years|Number|0|0.0||||||
4118575|NCT00934635|3943860|B10|27 years of age||Age, Customized||years|Number|1|1.0||||||
4118576|NCT00934635|3943861|B9|27 years of age||Age, Customized||years|Number|0|0.0||NA||||
4118577|NCT00934635|3943868|B2|27 years of age||Age, Customized||years|Number|1|1.0||NA||||
4118578|NCT00934635|3943860|B10|>=65 years||Age||participants|Number|0|0.0||||||
4118579|NCT00934635|3943861|B9|>=65 years||Age||participants|Number|0|0.0||||||
4118580|NCT00934635|3943868|B2|>=65 years||Age||participants|Number|0|0.0||||||
4118581|NCT00934635|3943860|B10|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
4118582|NCT00934635|3943861|B9|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
4118583|NCT00934635|3943868|B2|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
4118584|NCT00934635|3943860|B10|<=18 years||Age||participants|Number|0|0.0||||||
4118585|NCT00934635|3943861|B9|<=18 years||Age||participants|Number|0|0.0||||||
4118586|NCT00934635|3943868|B2|<=18 years||Age||participants|Number|0|0.0||||||
4118587|NCT00934622|3943897|B1|Male||Gender|Gender data not collected for 1 patient.|participants|Number|27|27.0||||||
4118588|NCT00934622|3943897|B1|Female||Gender|Gender data not collected for 1 patient.|participants|Number|48|48.0||||||
4118589|NCT00934622|3943897|B1||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
4118590|NCT00934622|3943897|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4118591|NCT00934622|3943897|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118592|NCT00934596|3943902|B3|Sweden||Region of Enrollment||participants|Number|20|20.0||||||
4118593|NCT00934596|3943903|B2|Sweden||Region of Enrollment||participants|Number|10|10.0||||||
4118594|NCT00934596|3943904|B1|Sweden||Region of Enrollment||participants|Number|10|10.0||||||
4118595|NCT00934596|3943902|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4118596|NCT00934596|3943903|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4118597|NCT00934596|3943904|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4118598|NCT00934596|3943902|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4118599|NCT00934596|3943903|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4118600|NCT00934596|3943904|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4118601|NCT00934596|3943902|B3|||Age||years|Mean|68|68.0|Standard Deviation|12|12.0|||
4118602|NCT00934596|3943903|B2|||Age||years|Mean|68|68.0|Standard Deviation|13|13.0|||
4118603|NCT00934596|3943904|B1|||Age||years|Mean|68|68.0|Standard Deviation|11|11.0|||
4118604|NCT00934596|3943902|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4118605|NCT00934596|3943903|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4118606|NCT00934596|3943904|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4118607|NCT00934596|3943902|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4118608|NCT00934596|3943903|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4118609|NCT00934596|3943904|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4118610|NCT00934596|3943902|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118611|NCT00934596|3943903|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118612|NCT00934596|3943904|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118613|NCT00934544|3943933|B3|Post-essential thrombocythemia-myelofibrosis||Disease Profile - Type of Myelofibrosis (MF)|Disease characteristics at baseline. Overall, (primary myelofibrosis (PMF), post-polycythemia vera-myelofibrosis(PPV-MF) and post-essential thrombocythemia-myelofibrosis (PET-MF) were diagnose in participants. The frequency of PMF was similar between ruxolitinib and BAT arms. In addition, the frequencies of PPV-MF and PET-MF were also similar between both treatment arms.|Participants|Number|35|35.0||||||
4118614|NCT00934544|3943934|B2|Post-essential thrombocythemia-myelofibrosis||Disease Profile - Type of Myelofibrosis (MF)|Disease characteristics at baseline. Overall, (primary myelofibrosis (PMF), post-polycythemia vera-myelofibrosis(PPV-MF) and post-essential thrombocythemia-myelofibrosis (PET-MF) were diagnose in participants. The frequency of PMF was similar between ruxolitinib and BAT arms. In addition, the frequencies of PPV-MF and PET-MF were also similar between both treatment arms.|Participants|Number|14|14.0||||||
4118615|NCT00934544|3943935|B1|Post-essential thrombocythemia-myelofibrosis||Disease Profile - Type of Myelofibrosis (MF)|Disease characteristics at baseline. Overall, (primary myelofibrosis (PMF), post-polycythemia vera-myelofibrosis(PPV-MF) and post-essential thrombocythemia-myelofibrosis (PET-MF) were diagnose in participants. The frequency of PMF was similar between ruxolitinib and BAT arms. In addition, the frequencies of PPV-MF and PET-MF were also similar between both treatment arms.|Participants|Number|21|21.0||||||
4118616|NCT00934544|3943933|B3|Post-polycythemia vera-myelofibrosis||Disease Profile - Type of Myelofibrosis (MF)|Disease characteristics at baseline. Overall, (primary myelofibrosis (PMF), post-polycythemia vera-myelofibrosis(PPV-MF) and post-essential thrombocythemia-myelofibrosis (PET-MF) were diagnose in participants. The frequency of PMF was similar between ruxolitinib and BAT arms. In addition, the frequencies of PPV-MF and PET-MF were also similar between both treatment arms.|Participants|Number|68|68.0||||||
4118617|NCT00934544|3943934|B2|Post-polycythemia vera-myelofibrosis||Disease Profile - Type of Myelofibrosis (MF)|Disease characteristics at baseline. Overall, (primary myelofibrosis (PMF), post-polycythemia vera-myelofibrosis(PPV-MF) and post-essential thrombocythemia-myelofibrosis (PET-MF) were diagnose in participants. The frequency of PMF was similar between ruxolitinib and BAT arms. In addition, the frequencies of PPV-MF and PET-MF were also similar between both treatment arms.|Participants|Number|20|20.0||||||
4118618|NCT00934544|3943935|B1|Post-polycythemia vera-myelofibrosis||Disease Profile - Type of Myelofibrosis (MF)|Disease characteristics at baseline. Overall, (primary myelofibrosis (PMF), post-polycythemia vera-myelofibrosis(PPV-MF) and post-essential thrombocythemia-myelofibrosis (PET-MF) were diagnose in participants. The frequency of PMF was similar between ruxolitinib and BAT arms. In addition, the frequencies of PPV-MF and PET-MF were also similar between both treatment arms.|Participants|Number|48|48.0||||||
4118667|NCT00934362|3943966|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4118668|NCT00934362|3943964|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4118669|NCT00934362|3943965|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4118670|NCT00934362|3943966|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4118619|NCT00934544|3943933|B3|Primary Myelofibrosis||Disease Profile - Type of Myelofibrosis (MF)|Disease characteristics at baseline. Overall, (primary myelofibrosis (PMF), post-polycythemia vera-myelofibrosis(PPV-MF) and post-essential thrombocythemia-myelofibrosis (PET-MF) were diagnose in participants. The frequency of PMF was similar between ruxolitinib and BAT arms. In addition, the frequencies of PPV-MF and PET-MF were also similar between both treatment arms.|Participants|Number|116|116.0||||||
4118620|NCT00934544|3943934|B2|Primary Myelofibrosis||Disease Profile - Type of Myelofibrosis (MF)|Disease characteristics at baseline. Overall, (primary myelofibrosis (PMF), post-polycythemia vera-myelofibrosis(PPV-MF) and post-essential thrombocythemia-myelofibrosis (PET-MF) were diagnose in participants. The frequency of PMF was similar between ruxolitinib and BAT arms. In addition, the frequencies of PPV-MF and PET-MF were also similar between both treatment arms.|Participants|Number|39|39.0||||||
4118621|NCT00934544|3943935|B1|Primary Myelofibrosis||Disease Profile - Type of Myelofibrosis (MF)|Disease characteristics at baseline. Overall, (primary myelofibrosis (PMF), post-polycythemia vera-myelofibrosis(PPV-MF) and post-essential thrombocythemia-myelofibrosis (PET-MF) were diagnose in participants. The frequency of PMF was similar between ruxolitinib and BAT arms. In addition, the frequencies of PPV-MF and PET-MF were also similar between both treatment arms.|Participants|Number|77|77.0||||||
4118622|NCT00934544|3943933|B3||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4118623|NCT00934544|3943934|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4118624|NCT00934544|3943935|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4118625|NCT00934544|3943933|B3||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4118626|NCT00934544|3943934|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4118627|NCT00934544|3943935|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4118628|NCT00934544|3943933|B3|||Age||years|Mean|65.2|65.2|Standard Deviation|9.89|9.89|||
4118629|NCT00934544|3943934|B2|||Age||years|Mean|65.2|65.2|Standard Deviation|10.27|10.27|||
4118630|NCT00934544|3943935|B1|||Age||years|Mean|65.1|65.1|Standard Deviation|9.74|9.74|||
4118631|NCT00934440|3943950|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4118632|NCT00934440|3943950|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4118633|NCT00934440|3943950|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4118634|NCT00934440|3943950|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4118635|NCT00934440|3943950|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4118636|NCT00934440|3943950|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4118637|NCT00934440|3943950|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4118638|NCT00934440|3943950|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4118639|NCT00934440|3943950|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4118640|NCT00934440|3943950|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4118641|NCT00934440|3943950|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4118642|NCT00934440|3943950|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4118643|NCT00934440|3943950|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4118644|NCT00934440|3943950|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4118645|NCT00934440|3943950|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4118646|NCT00934440|3943950|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118647|NCT00934375|3943955|B3|United States||Region of Enrollment||participants|Number|145|145.0||||||
4118648|NCT00934375|3943956|B2|United States||Region of Enrollment||participants|Number|77|77.0||||||
4118649|NCT00934375|3943957|B1|United States||Region of Enrollment||participants|Number|68|68.0||||||
4118650|NCT00934375|3943955|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4118651|NCT00934375|3943956|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4118652|NCT00934375|3943957|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4118653|NCT00934375|3943955|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4118654|NCT00934375|3943956|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4118655|NCT00934375|3943957|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4118656|NCT00934375|3943955|B3|||Age||years|Mean|72.6|72.6|Standard Deviation|8.62|8.62|||
4118657|NCT00934375|3943956|B2|||Age||years|Mean|73.4|73.4|Standard Deviation|8.73|8.73|||
4118658|NCT00934375|3943957|B1|||Age||years|Mean|71.7|71.7|Standard Deviation|8.46|8.46|||
4118659|NCT00934362|3943964|B3|||Baseline Mucociliary Clearance Rate|Radiolabeled particle clearance through 60 minutes (post inhalation) is averaged as index of clearance.|Percentage Clearance|Mean|10.5|10.5|Standard Deviation|8.1|8.1|||
4118660|NCT00934362|3943965|B2|||Baseline Mucociliary Clearance Rate|Radiolabeled particle clearance through 60 minutes (post inhalation) is averaged as index of clearance.|Percentage Clearance|Mean|12.0|12.0|Standard Deviation|10.5|10.5|||
4118661|NCT00934362|3943966|B1|||Baseline Mucociliary Clearance Rate|Radiolabeled particle clearance through 60 minutes (post inhalation) is averaged as index of clearance.|Percentage Clearance|Mean|9.2|9.2|Standard Deviation|4.8|4.8|||
4118662|NCT00934362|3943964|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4118663|NCT00934362|3943965|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4118664|NCT00934362|3943966|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4118665|NCT00934362|3943964|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4118666|NCT00934362|3943965|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4118671|NCT00934362|3943964|B3|||Age||years|Mean|27.1|27.1|Standard Deviation|7.5|7.5|||
4118672|NCT00934362|3943965|B2|||Age||years|Mean|25.9|25.9|Standard Deviation|6.4|6.4|||
4118673|NCT00934362|3943966|B1|||Age||years|Mean|28.3|28.3|Standard Deviation|8.8|8.8|||
4118674|NCT00934362|3943964|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4118675|NCT00934362|3943965|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4118676|NCT00934362|3943966|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4118677|NCT00934362|3943964|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4118678|NCT00934362|3943965|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4118679|NCT00934362|3943966|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4118680|NCT00934362|3943964|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4118681|NCT00934362|3943965|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4118682|NCT00934362|3943966|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118683|NCT00934180|3943975|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4118684|NCT00934180|3943976|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4118685|NCT00934180|3943977|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4118686|NCT00934180|3943975|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4118687|NCT00934180|3943976|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4118688|NCT00934180|3943977|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4118689|NCT00934180|3943975|B3|Black||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4118690|NCT00934180|3943976|B2|Black||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4118691|NCT00934180|3943977|B1|Black||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4118692|NCT00934180|3943975|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4118693|NCT00934180|3943976|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4118694|NCT00934180|3943977|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4118695|NCT00934180|3943975|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4118696|NCT00934180|3943976|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4118697|NCT00934180|3943977|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4118698|NCT00934180|3943975|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4118699|NCT00934180|3943976|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4118700|NCT00934180|3943977|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4118701|NCT00934180|3943975|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4118702|NCT00934180|3943976|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4118703|NCT00934180|3943977|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4118704|NCT00934180|3943975|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4118705|NCT00934180|3943976|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4118706|NCT00934180|3943977|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4118707|NCT00934180|3943975|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118708|NCT00934180|3943976|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118709|NCT00934180|3943977|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118710|NCT00934141|3943986|B5|||Rating of management quality|The management score resulted from a telephone interview of a senior leader at each clinic that assessed management quality across 14 subscales grouped into four areas: intake and retention; quality monitoring and reviewing, including performance tracking and review; (3) targets, including the realism and transparency of program goals; and (4) employee incentives, which includes promotion criteria, pay and bonuses. Each subscale was rated between 1 and 5, with a higher score indicating better management. Subscales were averaged together for an overall management rating ranging from 1-5.|Units on a scale between 1 and 5|Mean|2.98|2.98|Standard Deviation|0.62|0.62|||
4118711|NCT00934141|3943987|B4|||Rating of management quality|The management score resulted from a telephone interview of a senior leader at each clinic that assessed management quality across 14 subscales grouped into four areas: intake and retention; quality monitoring and reviewing, including performance tracking and review; (3) targets, including the realism and transparency of program goals; and (4) employee incentives, which includes promotion criteria, pay and bonuses. Each subscale was rated between 1 and 5, with a higher score indicating better management. Subscales were averaged together for an overall management rating ranging from 1-5.|Units on a scale between 1 and 5|Mean|2.95|2.95|Standard Deviation|0.73|0.73|||
4118712|NCT00934141|3943988|B3|||Rating of management quality|The management score resulted from a telephone interview of a senior leader at each clinic that assessed management quality across 14 subscales grouped into four areas: intake and retention; quality monitoring and reviewing, including performance tracking and review; (3) targets, including the realism and transparency of program goals; and (4) employee incentives, which includes promotion criteria, pay and bonuses. Each subscale was rated between 1 and 5, with a higher score indicating better management. Subscales were averaged together for an overall management rating ranging from 1-5.|Units on a scale between 1 and 5|Mean|2.99|2.99|Standard Deviation|0.57|0.57|||
4118713|NCT00934141|3943989|B2|||Rating of management quality|The management score resulted from a telephone interview of a senior leader at each clinic that assessed management quality across 14 subscales grouped into four areas: intake and retention; quality monitoring and reviewing, including performance tracking and review; (3) targets, including the realism and transparency of program goals; and (4) employee incentives, which includes promotion criteria, pay and bonuses. Each subscale was rated between 1 and 5, with a higher score indicating better management. Subscales were averaged together for an overall management rating ranging from 1-5.|Units on a scale between 1 and 5|Mean|2.97|2.97|Standard Deviation|0.64|0.64|||
4118714|NCT00934141|3943990|B1|||Rating of management quality|The management score resulted from a telephone interview of a senior leader at each clinic that assessed management quality across 14 subscales grouped into four areas: intake and retention; quality monitoring and reviewing, including performance tracking and review; (3) targets, including the realism and transparency of program goals; and (4) employee incentives, which includes promotion criteria, pay and bonuses. Each subscale was rated between 1 and 5, with a higher score indicating better management. Subscales were averaged together for an overall management rating ranging from 1-5.|Units on a scale between 1 and 5|Mean|3.02|3.02|Standard Deviation|0.54|0.54|||
4118715|NCT00934141|3943986|B5|||Clinics' annual number of patient admissions per year|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are average annual number of new patient admissions, per clinic. Standard deviation reflects differences in patient volume between clinics in the same group, as measured by annual admission counts.|Patients per year|Mean|559.25|559.25|Standard Deviation|659.25|659.25|||
4118716|NCT00934141|3943987|B4|||Clinics' annual number of patient admissions per year|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are average annual number of new patient admissions, per clinic. Standard deviation reflects differences in patient volume between clinics in the same group, as measured by annual admission counts.|Patients per year|Mean|671|671.0|Standard Deviation|1031|1031.0|||
4118717|NCT00934141|3943988|B3|||Clinics' annual number of patient admissions per year|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are average annual number of new patient admissions, per clinic. Standard deviation reflects differences in patient volume between clinics in the same group, as measured by annual admission counts.|Patients per year|Mean|488|488.0|Standard Deviation|437|437.0|||
4118718|NCT00934141|3943989|B2|||Clinics' annual number of patient admissions per year|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are average annual number of new patient admissions, per clinic. Standard deviation reflects differences in patient volume between clinics in the same group, as measured by annual admission counts.|Patients per year|Mean|578|578.0|Standard Deviation|684|684.0|||
4118719|NCT00934141|3943990|B1|||Clinics' annual number of patient admissions per year|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are average annual number of new patient admissions, per clinic. Standard deviation reflects differences in patient volume between clinics in the same group, as measured by annual admission counts.|Patients per year|Mean|500|500.0|Standard Deviation|485|485.0|||
4118720|NCT00934141|3943986|B5|Other or unreported||Primary setting||participants|Number|18|18.0||||||
4118721|NCT00934141|3943987|B4|Other or unreported||Primary setting||participants|Number|4|4.0||||||
4118722|NCT00934141|3943988|B3|Other or unreported||Primary setting||participants|Number|7|7.0||||||
4118723|NCT00934141|3943989|B2|Other or unreported||Primary setting||participants|Number|2|2.0||||||
4118724|NCT00934141|3943990|B1|Other or unreported||Primary setting||participants|Number|5|5.0||||||
4118725|NCT00934141|3943986|B5|Corrections||Primary setting||participants|Number|5|5.0||||||
4118726|NCT00934141|3943987|B4|Corrections||Primary setting||participants|Number|1|1.0||||||
4118727|NCT00934141|3943988|B3|Corrections||Primary setting||participants|Number|1|1.0||||||
4118728|NCT00934141|3943989|B2|Corrections||Primary setting||participants|Number|0|0.0||||||
4118729|NCT00934141|3943990|B1|Corrections||Primary setting||participants|Number|3|3.0||||||
4118730|NCT00934141|3943986|B5|Social services agency||Primary setting||participants|Number|8|8.0||||||
4118731|NCT00934141|3943987|B4|Social services agency||Primary setting||participants|Number|2|2.0||||||
4118732|NCT00934141|3943988|B3|Social services agency||Primary setting||participants|Number|3|3.0||||||
4118733|NCT00934141|3943989|B2|Social services agency||Primary setting||participants|Number|2|2.0||||||
4118734|NCT00934141|3943990|B1|Social services agency||Primary setting||participants|Number|1|1.0||||||
4118735|NCT00934141|3943986|B5|Family or children's service agency||Primary setting||participants|Number|8|8.0||||||
4118736|NCT00934141|3943987|B4|Family or children's service agency||Primary setting||participants|Number|2|2.0||||||
4118737|NCT00934141|3943988|B3|Family or children's service agency||Primary setting||participants|Number|1|1.0||||||
4118738|NCT00934141|3943989|B2|Family or children's service agency||Primary setting||participants|Number|2|2.0||||||
4118739|NCT00934141|3943990|B1|Family or children's service agency||Primary setting||participants|Number|3|3.0||||||
4118740|NCT00934141|3943986|B5|Free-standing alcohol or drug treatment clinic||Primary setting||participants|Number|109|109.0||||||
4118741|NCT00934141|3943987|B4|Free-standing alcohol or drug treatment clinic||Primary setting||participants|Number|32|32.0||||||
4118742|NCT00934141|3943988|B3|Free-standing alcohol or drug treatment clinic||Primary setting||participants|Number|26|26.0||||||
4118743|NCT00934141|3943989|B2|Free-standing alcohol or drug treatment clinic||Primary setting||participants|Number|25|25.0||||||
4118744|NCT00934141|3943990|B1|Free-standing alcohol or drug treatment clinic||Primary setting||participants|Number|26|26.0||||||
4118745|NCT00934141|3943986|B5|Community mental health clinic||Primary setting||participants|Number|35|35.0||||||
4118746|NCT00934141|3943987|B4|Community mental health clinic||Primary setting||participants|Number|10|10.0||||||
4118747|NCT00934141|3943988|B3|Community mental health clinic||Primary setting||participants|Number|5|5.0||||||
4118748|NCT00934141|3943989|B2|Community mental health clinic||Primary setting||participants|Number|13|13.0||||||
4118749|NCT00934141|3943990|B1|Community mental health clinic||Primary setting||participants|Number|7|7.0||||||
4118750|NCT00934141|3943986|B5|Hospital/Health Center (including primary setting)||Primary setting||participants|Number|18|18.0||||||
4118751|NCT00934141|3943987|B4|Hospital/Health Center (including primary setting)||Primary setting||participants|Number|3|3.0||||||
4118752|NCT00934141|3943988|B3|Hospital/Health Center (including primary setting)||Primary setting||participants|Number|5|5.0||||||
4118753|NCT00934141|3943989|B2|Hospital/Health Center (including primary setting)||Primary setting||participants|Number|6|6.0||||||
4118870|NCT00934102|3944026|B1|||Age||years|Mean|23.23|23.23|Standard Deviation|4.04|4.04|||
4118754|NCT00934141|3943990|B1|Hospital/Health Center (including primary setting)||Primary setting||participants|Number|4|4.0||||||
4118755|NCT00934141|3943986|B5|Unit of other government||Organizational structure||participants|Number|17|17.0||||||
4118756|NCT00934141|3943987|B4|Unit of other government||Organizational structure||participants|Number|3|3.0||||||
4118757|NCT00934141|3943988|B3|Unit of other government||Organizational structure||participants|Number|1|1.0||||||
4118758|NCT00934141|3943989|B2|Unit of other government||Organizational structure||participants|Number|6|6.0||||||
4118759|NCT00934141|3943990|B1|Unit of other government||Organizational structure||participants|Number|7|7.0||||||
4118760|NCT00934141|3943986|B5|Unit of tribal government||Organizational structure||participants|Number|7|7.0||||||
4118761|NCT00934141|3943987|B4|Unit of tribal government||Organizational structure||participants|Number|2|2.0||||||
4118762|NCT00934141|3943988|B3|Unit of tribal government||Organizational structure||participants|Number|2|2.0||||||
4118763|NCT00934141|3943989|B2|Unit of tribal government||Organizational structure||participants|Number|2|2.0||||||
4118764|NCT00934141|3943990|B1|Unit of tribal government||Organizational structure||participants|Number|1|1.0||||||
4118765|NCT00934141|3943986|B5|Unit of state government||Organizational structure||participants|Number|12|12.0||||||
4118766|NCT00934141|3943987|B4|Unit of state government||Organizational structure||participants|Number|3|3.0||||||
4118767|NCT00934141|3943988|B3|Unit of state government||Organizational structure||participants|Number|4|4.0||||||
4118768|NCT00934141|3943989|B2|Unit of state government||Organizational structure||participants|Number|1|1.0||||||
4118769|NCT00934141|3943990|B1|Unit of state government||Organizational structure||participants|Number|4|4.0||||||
4118770|NCT00934141|3943986|B5|Private not-for-profit||Organizational structure||participants|Number|162|162.0||||||
4118771|NCT00934141|3943987|B4|Private not-for-profit||Organizational structure||participants|Number|43|43.0||||||
4118772|NCT00934141|3943988|B3|Private not-for-profit||Organizational structure||participants|Number|41|41.0||||||
4118773|NCT00934141|3943989|B2|Private not-for-profit||Organizational structure||participants|Number|41|41.0||||||
4118774|NCT00934141|3943990|B1|Private not-for-profit||Organizational structure||participants|Number|37|37.0||||||
4118775|NCT00934141|3943986|B5|Private for-profit||Organizational structure||participants|Number|3|3.0||||||
4118776|NCT00934141|3943987|B4|Private for-profit||Organizational structure||participants|Number|3|3.0||||||
4118777|NCT00934141|3943988|B3|Private for-profit||Organizational structure||participants|Number|0|0.0||||||
4118778|NCT00934141|3943989|B2|Private for-profit||Organizational structure||participants|Number|0|0.0||||||
4118779|NCT00934141|3943990|B1|Private for-profit||Organizational structure||participants|Number|0|0.0||||||
4118780|NCT00934141|3943986|B5|United States||Region of Enrollment||participants|Number|201|201.0||||||
4118781|NCT00934141|3943987|B4|United States||Region of Enrollment||participants|Number|54|54.0||||||
4118782|NCT00934141|3943988|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
4118783|NCT00934141|3943989|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
4118784|NCT00934141|3943990|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
4118785|NCT00934141|3943986|B5|Unknown or Not Reported||Race/Ethnicity, Customized|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of minority (Non-white or Hispanic) patients adjusted to the clinic level, based on the percentage of minority patients in each clinic. This adjustment is required to match participant totals between tables.|Non-white or Hispanic participants|Number|201|201.0||||||
4118786|NCT00934141|3943987|B4|Unknown or Not Reported||Race/Ethnicity, Customized|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of minority (Non-white or Hispanic) patients adjusted to the clinic level, based on the percentage of minority patients in each clinic. This adjustment is required to match participant totals between tables.|Non-white or Hispanic participants|Number|54|54.0||||||
4118787|NCT00934141|3943988|B3|Unknown or Not Reported||Race/Ethnicity, Customized|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of minority (Non-white or Hispanic) patients adjusted to the clinic level, based on the percentage of minority patients in each clinic. This adjustment is required to match participant totals between tables.|Non-white or Hispanic participants|Number|48|48.0||||||
4118788|NCT00934141|3943989|B2|Unknown or Not Reported||Race/Ethnicity, Customized|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of minority (Non-white or Hispanic) patients adjusted to the clinic level, based on the percentage of minority patients in each clinic. This adjustment is required to match participant totals between tables.|Non-white or Hispanic participants|Number|50|50.0||||||
4118789|NCT00934141|3943990|B1|Unknown or Not Reported||Race/Ethnicity, Customized|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of minority (Non-white or Hispanic) patients adjusted to the clinic level, based on the percentage of minority patients in each clinic. This adjustment is required to match participant totals between tables.|Non-white or Hispanic participants|Number|49|49.0||||||
4118790|NCT00934141|3943986|B5|More than one race||Race/Ethnicity, Customized|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of minority (Non-white or Hispanic) patients adjusted to the clinic level, based on the percentage of minority patients in each clinic. This adjustment is required to match participant totals between tables.|Non-white or Hispanic participants|Number|0|0.0||||||
4118791|NCT00934141|3943987|B4|More than one race||Race/Ethnicity, Customized|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of minority (Non-white or Hispanic) patients adjusted to the clinic level, based on the percentage of minority patients in each clinic. This adjustment is required to match participant totals between tables.|Non-white or Hispanic participants|Number|0|0.0||||||
4118871|NCT00934050|3944036|B7|North America||Region of Enrollment||participants|Number|103|103.0||||||
4118872|NCT00934050|3944037|B6|North America||Region of Enrollment||participants|Number|27|27.0||||||
4118792|NCT00934141|3943988|B3|More than one race||Race/Ethnicity, Customized|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of minority (Non-white or Hispanic) patients adjusted to the clinic level, based on the percentage of minority patients in each clinic. This adjustment is required to match participant totals between tables.|Non-white or Hispanic participants|Number|0|0.0||||||
4118793|NCT00934141|3943989|B2|More than one race||Race/Ethnicity, Customized|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of minority (Non-white or Hispanic) patients adjusted to the clinic level, based on the percentage of minority patients in each clinic. This adjustment is required to match participant totals between tables.|Non-white or Hispanic participants|Number|0|0.0||||||
4118794|NCT00934141|3943990|B1|More than one race||Race/Ethnicity, Customized|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of minority (Non-white or Hispanic) patients adjusted to the clinic level, based on the percentage of minority patients in each clinic. This adjustment is required to match participant totals between tables.|Non-white or Hispanic participants|Number|0|0.0||||||
4118795|NCT00934141|3943986|B5|White||Race/Ethnicity, Customized|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of minority (Non-white or Hispanic) patients adjusted to the clinic level, based on the percentage of minority patients in each clinic. This adjustment is required to match participant totals between tables.|Non-white or Hispanic participants|Number|0|0.0||||||
4118796|NCT00934141|3943987|B4|White||Race/Ethnicity, Customized|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of minority (Non-white or Hispanic) patients adjusted to the clinic level, based on the percentage of minority patients in each clinic. This adjustment is required to match participant totals between tables.|Non-white or Hispanic participants|Number|0|0.0||||||
4118797|NCT00934141|3943988|B3|White||Race/Ethnicity, Customized|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of minority (Non-white or Hispanic) patients adjusted to the clinic level, based on the percentage of minority patients in each clinic. This adjustment is required to match participant totals between tables.|Non-white or Hispanic participants|Number|0|0.0||||||
4118798|NCT00934141|3943989|B2|White||Race/Ethnicity, Customized|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of minority (Non-white or Hispanic) patients adjusted to the clinic level, based on the percentage of minority patients in each clinic. This adjustment is required to match participant totals between tables.|Non-white or Hispanic participants|Number|0|0.0||||||
4118799|NCT00934141|3943990|B1|White||Race/Ethnicity, Customized|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of minority (Non-white or Hispanic) patients adjusted to the clinic level, based on the percentage of minority patients in each clinic. This adjustment is required to match participant totals between tables.|Non-white or Hispanic participants|Number|0|0.0||||||
4118800|NCT00934141|3943986|B5|Black or African American||Race/Ethnicity, Customized|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of minority (Non-white or Hispanic) patients adjusted to the clinic level, based on the percentage of minority patients in each clinic. This adjustment is required to match participant totals between tables.|Non-white or Hispanic participants|Number|0|0.0||||||
4118801|NCT00934141|3943987|B4|Black or African American||Race/Ethnicity, Customized|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of minority (Non-white or Hispanic) patients adjusted to the clinic level, based on the percentage of minority patients in each clinic. This adjustment is required to match participant totals between tables.|Non-white or Hispanic participants|Number|0|0.0||||||
4118802|NCT00934141|3943988|B3|Black or African American||Race/Ethnicity, Customized|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of minority (Non-white or Hispanic) patients adjusted to the clinic level, based on the percentage of minority patients in each clinic. This adjustment is required to match participant totals between tables.|Non-white or Hispanic participants|Number|0|0.0||||||
4118803|NCT00934141|3943989|B2|Black or African American||Race/Ethnicity, Customized|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of minority (Non-white or Hispanic) patients adjusted to the clinic level, based on the percentage of minority patients in each clinic. This adjustment is required to match participant totals between tables.|Non-white or Hispanic participants|Number|0|0.0||||||
4118804|NCT00934141|3943990|B1|Black or African American||Race/Ethnicity, Customized|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of minority (Non-white or Hispanic) patients adjusted to the clinic level, based on the percentage of minority patients in each clinic. This adjustment is required to match participant totals between tables.|Non-white or Hispanic participants|Number|0|0.0||||||
4118805|NCT00934141|3943986|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of minority (Non-white or Hispanic) patients adjusted to the clinic level, based on the percentage of minority patients in each clinic. This adjustment is required to match participant totals between tables.|Non-white or Hispanic participants|Number|0|0.0||||||
4118806|NCT00934141|3943987|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of minority (Non-white or Hispanic) patients adjusted to the clinic level, based on the percentage of minority patients in each clinic. This adjustment is required to match participant totals between tables.|Non-white or Hispanic participants|Number|0|0.0||||||
4118807|NCT00934141|3943988|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of minority (Non-white or Hispanic) patients adjusted to the clinic level, based on the percentage of minority patients in each clinic. This adjustment is required to match participant totals between tables.|Non-white or Hispanic participants|Number|0|0.0||||||
4118873|NCT00934050|3944038|B5|North America||Region of Enrollment||participants|Number|26|26.0||||||
4118808|NCT00934141|3943989|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of minority (Non-white or Hispanic) patients adjusted to the clinic level, based on the percentage of minority patients in each clinic. This adjustment is required to match participant totals between tables.|Non-white or Hispanic participants|Number|0|0.0||||||
4118809|NCT00934141|3943990|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of minority (Non-white or Hispanic) patients adjusted to the clinic level, based on the percentage of minority patients in each clinic. This adjustment is required to match participant totals between tables.|Non-white or Hispanic participants|Number|0|0.0||||||
4118810|NCT00934141|3943986|B5|Asian||Race/Ethnicity, Customized|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of minority (Non-white or Hispanic) patients adjusted to the clinic level, based on the percentage of minority patients in each clinic. This adjustment is required to match participant totals between tables.|Non-white or Hispanic participants|Number|0|0.0||||||
4118811|NCT00934141|3943987|B4|Asian||Race/Ethnicity, Customized|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of minority (Non-white or Hispanic) patients adjusted to the clinic level, based on the percentage of minority patients in each clinic. This adjustment is required to match participant totals between tables.|Non-white or Hispanic participants|Number|0|0.0||||||
4118812|NCT00934141|3943988|B3|Asian||Race/Ethnicity, Customized|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of minority (Non-white or Hispanic) patients adjusted to the clinic level, based on the percentage of minority patients in each clinic. This adjustment is required to match participant totals between tables.|Non-white or Hispanic participants|Number|0|0.0||||||
4118813|NCT00934141|3943989|B2|Asian||Race/Ethnicity, Customized|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of minority (Non-white or Hispanic) patients adjusted to the clinic level, based on the percentage of minority patients in each clinic. This adjustment is required to match participant totals between tables.|Non-white or Hispanic participants|Number|0|0.0||||||
4118814|NCT00934141|3943990|B1|Asian||Race/Ethnicity, Customized|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of minority (Non-white or Hispanic) patients adjusted to the clinic level, based on the percentage of minority patients in each clinic. This adjustment is required to match participant totals between tables.|Non-white or Hispanic participants|Number|0|0.0||||||
4118815|NCT00934141|3943986|B5|American Indian or Alaska Native||Race/Ethnicity, Customized|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of minority (Non-white or Hispanic) patients adjusted to the clinic level, based on the percentage of minority patients in each clinic. This adjustment is required to match participant totals between tables.|Non-white or Hispanic participants|Number|0|0.0||||||
4118816|NCT00934141|3943987|B4|American Indian or Alaska Native||Race/Ethnicity, Customized|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of minority (Non-white or Hispanic) patients adjusted to the clinic level, based on the percentage of minority patients in each clinic. This adjustment is required to match participant totals between tables.|Non-white or Hispanic participants|Number|0|0.0||||||
4118817|NCT00934141|3943988|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of minority (Non-white or Hispanic) patients adjusted to the clinic level, based on the percentage of minority patients in each clinic. This adjustment is required to match participant totals between tables.|Non-white or Hispanic participants|Number|0|0.0||||||
4118818|NCT00934141|3943989|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of minority (Non-white or Hispanic) patients adjusted to the clinic level, based on the percentage of minority patients in each clinic. This adjustment is required to match participant totals between tables.|Non-white or Hispanic participants|Number|0|0.0||||||
4118819|NCT00934141|3943990|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of minority (Non-white or Hispanic) patients adjusted to the clinic level, based on the percentage of minority patients in each clinic. This adjustment is required to match participant totals between tables.|Non-white or Hispanic participants|Number|0|0.0||||||
4118820|NCT00934141|3943986|B5||Male|Sex: Female, Male|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of gender and adjusted to the clinic level, based on the percentage of male/female patients in each clinic. This adjustment is required to match participant totals between tables.|Participants|Count of Participants|135|135.0||||||
4118821|NCT00934141|3943987|B4||Male|Sex: Female, Male|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of gender and adjusted to the clinic level, based on the percentage of male/female patients in each clinic. This adjustment is required to match participant totals between tables.|Participants|Count of Participants|37|37.0||||||
4118822|NCT00934141|3943988|B3||Male|Sex: Female, Male|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of gender and adjusted to the clinic level, based on the percentage of male/female patients in each clinic. This adjustment is required to match participant totals between tables.|Participants|Count of Participants|32|32.0||||||
4118823|NCT00934141|3943989|B2||Male|Sex: Female, Male|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of gender and adjusted to the clinic level, based on the percentage of male/female patients in each clinic. This adjustment is required to match participant totals between tables.|Participants|Count of Participants|33|33.0||||||
4118874|NCT00934050|3944039|B4|North America||Region of Enrollment||participants|Number|14|14.0||||||
4118875|NCT00934050|3944040|B3|North America||Region of Enrollment||participants|Number|12|12.0||||||
4118824|NCT00934141|3943990|B1||Male|Sex: Female, Male|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of gender and adjusted to the clinic level, based on the percentage of male/female patients in each clinic. This adjustment is required to match participant totals between tables.|Participants|Count of Participants|33|33.0||||||
4118825|NCT00934141|3943986|B5||Female|Sex: Female, Male|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of gender and adjusted to the clinic level, based on the percentage of male/female patients in each clinic. This adjustment is required to match participant totals between tables.|Participants|Count of Participants|66|66.0||||||
4118826|NCT00934141|3943987|B4||Female|Sex: Female, Male|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of gender and adjusted to the clinic level, based on the percentage of male/female patients in each clinic. This adjustment is required to match participant totals between tables.|Participants|Count of Participants|17|17.0||||||
4118827|NCT00934141|3943988|B3||Female|Sex: Female, Male|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of gender and adjusted to the clinic level, based on the percentage of male/female patients in each clinic. This adjustment is required to match participant totals between tables.|Participants|Count of Participants|16|16.0||||||
4118828|NCT00934141|3943989|B2||Female|Sex: Female, Male|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of gender and adjusted to the clinic level, based on the percentage of male/female patients in each clinic. This adjustment is required to match participant totals between tables.|Participants|Count of Participants|17|17.0||||||
4118829|NCT00934141|3943990|B1||Female|Sex: Female, Male|Note: unit of randomization and analysis is the clinic, not the individual patient. Figures reported are proportional estimates of gender and adjusted to the clinic level, based on the percentage of male/female patients in each clinic. This adjustment is required to match participant totals between tables.|Participants|Count of Participants|16|16.0||||||
4118830|NCT00934141|3943986|B5|||Age||years|Mean|32.53|32.53|Standard Deviation|11.96|11.96|||
4118831|NCT00934141|3943987|B4|||Age||years|Mean|32.08|32.08|Standard Deviation|12.19|12.19|||
4118832|NCT00934141|3943988|B3|||Age||years|Mean|32.71|32.71|Standard Deviation|11.81|11.81|||
4118833|NCT00934141|3943989|B2|||Age||years|Mean|31.89|31.89|Standard Deviation|12.02|12.02|||
4118834|NCT00934141|3943990|B1|||Age||years|Mean|33.36|33.36|Standard Deviation|11.81|11.81|||
4118835|NCT00934128|3944015|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4118836|NCT00934128|3944016|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4118837|NCT00934128|3944017|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4118838|NCT00934128|3944015|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4118839|NCT00934128|3944016|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4118840|NCT00934128|3944017|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4118841|NCT00934128|3944015|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4118842|NCT00934128|3944016|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4118843|NCT00934128|3944017|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4118844|NCT00934128|3944015|B3||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4118845|NCT00934128|3944016|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4118846|NCT00934128|3944017|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4118847|NCT00934128|3944015|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4118848|NCT00934128|3944016|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4118849|NCT00934128|3944017|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4118850|NCT00934128|3944015|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4118851|NCT00934128|3944016|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4118852|NCT00934128|3944017|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4118853|NCT00934128|3944015|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4118854|NCT00934128|3944016|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4118855|NCT00934128|3944017|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4118856|NCT00934128|3944015|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4118857|NCT00934128|3944016|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4118858|NCT00934128|3944017|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4118859|NCT00934128|3944015|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4118860|NCT00934128|3944016|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4118861|NCT00934128|3944017|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4118862|NCT00934128|3944015|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4118863|NCT00934128|3944016|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4118864|NCT00934128|3944017|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4118865|NCT00934128|3944015|B3|||Age||years|Mean|61|61.0|Full Range|||29.0|79.0|
4118866|NCT00934128|3944016|B2|||Age||years|Mean|59|59.0|Full Range|||29.0|79.0|
4118867|NCT00934128|3944017|B1|||Age||years|Mean|63|63.0|Full Range|||47.0|79.0|
4118868|NCT00934102|3944026|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4118869|NCT00934102|3944026|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4118876|NCT00934050|3944041|B2|North America||Region of Enrollment||participants|Number|12|12.0||||||
4118877|NCT00934050|3944042|B1|North America||Region of Enrollment||participants|Number|12|12.0||||||
4118878|NCT00934050|3944036|B7|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|101|101.0||||||
4118879|NCT00934050|3944037|B6|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4118880|NCT00934050|3944038|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4118881|NCT00934050|3944039|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4118882|NCT00934050|3944040|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4118883|NCT00934050|3944041|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4118884|NCT00934050|3944042|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4118885|NCT00934050|3944036|B7|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4118886|NCT00934050|3944037|B6|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4118887|NCT00934050|3944038|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4118888|NCT00934050|3944039|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4118889|NCT00934050|3944040|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4118890|NCT00934050|3944041|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4118891|NCT00934050|3944042|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4118892|NCT00934050|3944036|B7||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4118893|NCT00934050|3944037|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4118894|NCT00934050|3944038|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4118895|NCT00934050|3944039|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4118896|NCT00934050|3944040|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4118897|NCT00934050|3944041|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4118898|NCT00934050|3944042|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4118899|NCT00934050|3944036|B7||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4118900|NCT00934050|3944037|B6||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4118901|NCT00934050|3944038|B5||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4118902|NCT00934050|3944039|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4118903|NCT00934050|3944040|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4118904|NCT00934050|3944041|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4118905|NCT00934050|3944042|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4118906|NCT00934050|3944036|B7|Participants enrolled after 15 Dec 2009||Age||Years|Mean|72.2|72.2|Standard Deviation|8.12|8.12|||
4118907|NCT00934050|3944037|B6|Participants enrolled after 15 Dec 2009||Age||Years|Mean|73.0|73.0|Standard Deviation|7.53|7.53|||
4118908|NCT00934050|3944038|B5|Participants enrolled after 15 Dec 2009||Age||Years|Mean|71.4|71.4|Standard Deviation|8.77|8.77|||
4118909|NCT00934050|3944039|B4|Participants enrolled after 15 Dec 2009||Age||Years|Mean|NA||Standard Deviation|NA||||All participants enrolled prior to 15 Dec 2009
4118910|NCT00934050|3944040|B3|Participants enrolled after 15 Dec 2009||Age||Years|Mean|NA||Standard Deviation|NA||||All participants enrolled prior to 15 Dec 2009
4118911|NCT00934050|3944041|B2|Participants enrolled after 15 Dec 2009||Age||Years|Mean|NA||Standard Deviation|NA||||All participants enrolled prior to 15 Dec 2009
4118912|NCT00934050|3944042|B1|Participants enrolled after 15 Dec 2009||Age||Years|Mean|NA||Standard Deviation|NA||||All participants enrolled prior to 15 Dec 2009
4118913|NCT00934050|3944036|B7|Enrolled prior to 15 Dec 2009||Age||Years|Mean|74.7|74.7|Standard Deviation|7.73|7.73|||
4118914|NCT00934050|3944037|B6|Enrolled prior to 15 Dec 2009||Age||Years|Mean|NA||Standard Deviation|NA||||All participants enrolled after 15 Dec 2009
4118915|NCT00934050|3944038|B5|Enrolled prior to 15 Dec 2009||Age||Years|Mean|NA||Standard Deviation|NA||||All participants enrolled after 15 Dec 2009
4118916|NCT00934050|3944039|B4|Enrolled prior to 15 Dec 2009||Age||Years|Mean|69.2|69.2|Standard Deviation|8.51|8.51|||
4118917|NCT00934050|3944040|B3|Enrolled prior to 15 Dec 2009||Age||Years|Mean|76.9|76.9|Standard Deviation|6.92|6.92|||
4118918|NCT00934050|3944041|B2|Enrolled prior to 15 Dec 2009||Age||Years|Mean|77.0|77.0|Standard Deviation|6.98|6.98|||
4118919|NCT00934050|3944042|B1|Enrolled prior to 15 Dec 2009||Age||Years|Mean|76.8|76.8|Standard Deviation|5.51|5.51|||
4118920|NCT00934024|3944057|B3|||cigarettes per day||Cigarettes per day|Mean|18.86|18.86|Standard Deviation|5.06|5.06|||
4118921|NCT00934024|3944058|B2|||cigarettes per day||Cigarettes per day|Mean|17.27|17.27|Standard Deviation|4.29|4.29|||
4118922|NCT00934024|3944059|B1|||cigarettes per day||Cigarettes per day|Mean|20.45|20.45|Standard Deviation|5.83|5.83|||
4118923|NCT00934024|3944057|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4118924|NCT00934024|3944058|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4118925|NCT00934024|3944059|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4118926|NCT00934024|3944057|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4118927|NCT00934024|3944058|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4118928|NCT00934024|3944059|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4118929|NCT00934024|3944057|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4118930|NCT00934024|3944058|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4118931|NCT00934024|3944059|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4118932|NCT00934024|3944057|B3|||Age||Years|Mean|30.18|30.18|Standard Deviation|12.4|12.4|||
4118933|NCT00934024|3944058|B2|||Age||Years|Mean|35.55|35.55|Standard Deviation|11.72|11.72|||
4118934|NCT00934024|3944059|B1|||Age||Years|Mean|24.8|24.8|Standard Deviation|13.07|13.07|||
4118935|NCT00934024|3944057|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4118936|NCT00934024|3944058|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4118937|NCT00934024|3944059|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4118938|NCT00934024|3944057|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4118939|NCT00934024|3944058|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4118940|NCT00934024|3944059|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4118941|NCT00934024|3944057|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118942|NCT00934024|3944058|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118943|NCT00934024|3944059|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4118944|NCT00933933|3944065|B6|Cameroon||Region of Enrollment||Participants|Number|1|1.0||||||
4118945|NCT00933933|3944066|B5|Cameroon||Region of Enrollment||Participants|Number|0|0.0||||||
4118946|NCT00933933|3944067|B4|Cameroon||Region of Enrollment||Participants|Number|0|0.0||||||
4118947|NCT00933933|3944068|B3|Cameroon||Region of Enrollment||Participants|Number|0|0.0||||||
4118948|NCT00933933|3944069|B2|Cameroon||Region of Enrollment||Participants|Number|1|1.0||||||
4118949|NCT00933933|3944070|B1|Cameroon||Region of Enrollment||Participants|Number|0|0.0||||||
4118950|NCT00933933|3944065|B6|South Africa||Region of Enrollment||Participants|Number|4|4.0||||||
4118951|NCT00933933|3944066|B5|South Africa||Region of Enrollment||Participants|Number|0|0.0||||||
4118952|NCT00933933|3944067|B4|South Africa||Region of Enrollment||Participants|Number|0|0.0||||||
4118953|NCT00933933|3944068|B3|South Africa||Region of Enrollment||Participants|Number|0|0.0||||||
4118954|NCT00933933|3944069|B2|South Africa||Region of Enrollment||Participants|Number|4|4.0||||||
4118955|NCT00933933|3944070|B1|South Africa||Region of Enrollment||Participants|Number|0|0.0||||||
4118956|NCT00933933|3944065|B6|Côte D'Ivoire||Region of Enrollment||Participants|Number|714|714.0||||||
4118957|NCT00933933|3944066|B5|Côte D'Ivoire||Region of Enrollment||Participants|Number|513|513.0||||||
4118958|NCT00933933|3944067|B4|Côte D'Ivoire||Region of Enrollment||Participants|Number|201|201.0||||||
4118959|NCT00933933|3944068|B3|Côte D'Ivoire||Region of Enrollment||Participants|Number|0|0.0||||||
4118960|NCT00933933|3944069|B2|Côte D'Ivoire||Region of Enrollment||Participants|Number|0|0.0||||||
4118961|NCT00933933|3944070|B1|Côte D'Ivoire||Region of Enrollment||Participants|Number|0|0.0||||||
4118962|NCT00933933|3944065|B6|United States||Region of Enrollment||Participants|Number|8347|8347.0||||||
4118963|NCT00933933|3944066|B5|United States||Region of Enrollment||Participants|Number|896|896.0||||||
4118964|NCT00933933|3944067|B4|United States||Region of Enrollment||Participants|Number|0|0.0||||||
4118965|NCT00933933|3944068|B3|United States||Region of Enrollment||Participants|Number|1121|1121.0||||||
4118966|NCT00933933|3944069|B2|United States||Region of Enrollment||Participants|Number|78|78.0||||||
4118967|NCT00933933|3944070|B1|United States||Region of Enrollment||Participants|Number|6252|6252.0||||||
4118968|NCT00933933|3944065|B6|Not collected||Sex/Gender, Customized||participants|Number|284|284.0||||||
4118969|NCT00933933|3944066|B5|Not collected||Sex/Gender, Customized||participants|Number|0|0.0||||||
4118970|NCT00933933|3944067|B4|Not collected||Sex/Gender, Customized||participants|Number|201|201.0||||||
4118971|NCT00933933|3944068|B3|Not collected||Sex/Gender, Customized||participants|Number|0|0.0||||||
4118972|NCT00933933|3944069|B2|Not collected||Sex/Gender, Customized||participants|Number|83|83.0||||||
4118973|NCT00933933|3944070|B1|Not collected||Sex/Gender, Customized||participants|Number|0|0.0||||||
4118974|NCT00933933|3944065|B6|Male||Sex/Gender, Customized||participants|Number|3856|3856.0||||||
4118975|NCT00933933|3944066|B5|Male||Sex/Gender, Customized||participants|Number|879|879.0||||||
4118976|NCT00933933|3944067|B4|Male||Sex/Gender, Customized||participants|Number|0|0.0||||||
4118977|NCT00933933|3944068|B3|Male||Sex/Gender, Customized||participants|Number|890|890.0||||||
4118978|NCT00933933|3944069|B2|Male||Sex/Gender, Customized||participants|Number|0|0.0||||||
4118979|NCT00933933|3944070|B1|Male||Sex/Gender, Customized||participants|Number|2087|2087.0||||||
4118980|NCT00933933|3944065|B6|Female||Sex/Gender, Customized||participants|Number|4926|4926.0||||||
4118981|NCT00933933|3944066|B5|Female||Sex/Gender, Customized||participants|Number|530|530.0||||||
4118982|NCT00933933|3944067|B4|Female||Sex/Gender, Customized||participants|Number|0|0.0||||||
4118983|NCT00933933|3944068|B3|Female||Sex/Gender, Customized||participants|Number|231|231.0||||||
4118984|NCT00933933|3944069|B2|Female||Sex/Gender, Customized||participants|Number|0|0.0||||||
4118985|NCT00933933|3944070|B1|Female||Sex/Gender, Customized||participants|Number|4165|4165.0||||||
4118986|NCT00933933|3944065|B6|Not collected||Age, Customized||participants|Number|329|329.0||||||
4118987|NCT00933933|3944066|B5|Not collected||Age, Customized||participants|Number|44|44.0||||||
4118988|NCT00933933|3944067|B4|Not collected||Age, Customized||participants|Number|201|201.0||||||
4118989|NCT00933933|3944068|B3|Not collected||Age, Customized||participants|Number|0|0.0||||||
4118990|NCT00933933|3944069|B2|Not collected||Age, Customized||participants|Number|83|83.0||||||
4118991|NCT00933933|3944070|B1|Not collected||Age, Customized||participants|Number|1|1.0||||||
4118992|NCT00933933|3944065|B6|>= 21 years||Age, Customized||participants|Number|8024|8024.0||||||
4118993|NCT00933933|3944066|B5|>= 21 years||Age, Customized||participants|Number|1304|1304.0||||||
4118994|NCT00933933|3944067|B4|>= 21 years||Age, Customized||participants|Number|0|0.0||||||
4118995|NCT00933933|3944068|B3|>= 21 years||Age, Customized||participants|Number|1057|1057.0||||||
4118996|NCT00933933|3944069|B2|>= 21 years||Age, Customized||participants|Number|0|0.0||||||
4118997|NCT00933933|3944070|B1|>= 21 years||Age, Customized||participants|Number|5663|5663.0||||||
4118998|NCT00933933|3944065|B6|between 2 and 21 years||Age, Customized||participants|Number|713|713.0||||||
4118999|NCT00933933|3944066|B5|between 2 and 21 years||Age, Customized||participants|Number|61|61.0||||||
4119000|NCT00933933|3944067|B4|between 2 and 21 years||Age, Customized||participants|Number|0|0.0||||||
4119001|NCT00933933|3944068|B3|between 2 and 21 years||Age, Customized||participants|Number|64|64.0||||||
4119002|NCT00933933|3944069|B2|between 2 and 21 years||Age, Customized||participants|Number|0|0.0||||||
4119003|NCT00933933|3944070|B1|between 2 and 21 years||Age, Customized||participants|Number|588|588.0||||||
4119004|NCT00933686|3944088|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119005|NCT00933686|3944089|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119006|NCT00933686|3944090|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119007|NCT00933686|3944088|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4119008|NCT00933686|3944089|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4119009|NCT00933686|3944090|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4119010|NCT00933686|3944088|B3|||Age||years|Mean|50.1|50.1|Standard Deviation|9.5|9.5|||
4119011|NCT00933686|3944089|B2|||Age||years|Mean|50.3|50.3|Standard Deviation|9.6|9.6|||
4119012|NCT00933686|3944090|B1|||Age||years|Mean|49.9|49.9|Standard Deviation|9.5|9.5|||
4119013|NCT00933608|3944109|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4119014|NCT00933608|3944110|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4119015|NCT00933608|3944111|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4119016|NCT00933608|3944109|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4119017|NCT00933608|3944110|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4119018|NCT00933608|3944111|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4119019|NCT00933608|3944109|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4119020|NCT00933608|3944110|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4119021|NCT00933608|3944111|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4119022|NCT00933608|3944109|B3|||Age||years|Mean|69.7|69.7|Standard Deviation|7.1|7.1|||
4119023|NCT00933608|3944110|B2|||Age||years|Mean|69.7|69.7|Standard Deviation|8.2|8.2|||
4119024|NCT00933608|3944111|B1|||Age||years|Mean|69.7|69.7|Standard Deviation|5.7|5.7|||
4119025|NCT00933608|3944109|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4119026|NCT00933608|3944110|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4119027|NCT00933608|3944111|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4119028|NCT00933608|3944109|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4119029|NCT00933608|3944110|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4119030|NCT00933608|3944111|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4119031|NCT00933608|3944109|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4119032|NCT00933608|3944110|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4119033|NCT00933608|3944111|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4119034|NCT00933543|3944118|B3|Mild dryness||Patients with dryness|The investigator assess the dryness using a scale from 0 to 3 (0=absence, 1=mild, 2=moderate, 3=severe).|Number of patients|Number|16|16.0||||||
4119035|NCT00933543|3944119|B2|Mild dryness||Patients with dryness|The investigator assess the dryness using a scale from 0 to 3 (0=absence, 1=mild, 2=moderate, 3=severe).|Number of patients|Number|7|7.0||||||
4119036|NCT00933543|3944120|B1|Mild dryness||Patients with dryness|The investigator assess the dryness using a scale from 0 to 3 (0=absence, 1=mild, 2=moderate, 3=severe).|Number of patients|Number|9|9.0||||||
4119037|NCT00933543|3944118|B3|No dryness||Patients with dryness|The investigator assess the dryness using a scale from 0 to 3 (0=absence, 1=mild, 2=moderate, 3=severe).|Number of patients|Number|91|91.0||||||
4119038|NCT00933543|3944119|B2|No dryness||Patients with dryness|The investigator assess the dryness using a scale from 0 to 3 (0=absence, 1=mild, 2=moderate, 3=severe).|Number of patients|Number|46|46.0||||||
4119039|NCT00933543|3944120|B1|No dryness||Patients with dryness|The investigator assess the dryness using a scale from 0 to 3 (0=absence, 1=mild, 2=moderate, 3=severe).|Number of patients|Number|45|45.0||||||
4119040|NCT00933543|3944118|B3|Patients with very severe scarring||Scarring|"The investigator assess the scarring using a scale called SCAR-S. Clear 0: No visible scars from acne. Almost clear 1: Hardly visible scars from 2.5 meters away. Mild 2: Easily recognizable, less than ½ the affected area (eg. face, back or chest) involved.~Moderate 3: More than ½ affected area (eg. face, back or chest) involved. Severe 4: Entire area involved. Very severe 5: Entire area with prominent atrophic or hypertrophic scars."|number of patients|Number|1|1.0||||||
4119041|NCT00933543|3944119|B2|Patients with very severe scarring||Scarring|"The investigator assess the scarring using a scale called SCAR-S. Clear 0: No visible scars from acne. Almost clear 1: Hardly visible scars from 2.5 meters away. Mild 2: Easily recognizable, less than ½ the affected area (eg. face, back or chest) involved.~Moderate 3: More than ½ affected area (eg. face, back or chest) involved. Severe 4: Entire area involved. Very severe 5: Entire area with prominent atrophic or hypertrophic scars."|number of patients|Number|1|1.0||||||
4119042|NCT00933543|3944120|B1|Patients with very severe scarring||Scarring|"The investigator assess the scarring using a scale called SCAR-S. Clear 0: No visible scars from acne. Almost clear 1: Hardly visible scars from 2.5 meters away. Mild 2: Easily recognizable, less than ½ the affected area (eg. face, back or chest) involved.~Moderate 3: More than ½ affected area (eg. face, back or chest) involved. Severe 4: Entire area involved. Very severe 5: Entire area with prominent atrophic or hypertrophic scars."|number of patients|Number|0|0.0||||||
4119043|NCT00933543|3944118|B3|Patients with severe scarring||Scarring|"The investigator assess the scarring using a scale called SCAR-S. Clear 0: No visible scars from acne. Almost clear 1: Hardly visible scars from 2.5 meters away. Mild 2: Easily recognizable, less than ½ the affected area (eg. face, back or chest) involved.~Moderate 3: More than ½ affected area (eg. face, back or chest) involved. Severe 4: Entire area involved. Very severe 5: Entire area with prominent atrophic or hypertrophic scars."|number of patients|Number|4|4.0||||||
4119044|NCT00933543|3944119|B2|Patients with severe scarring||Scarring|"The investigator assess the scarring using a scale called SCAR-S. Clear 0: No visible scars from acne. Almost clear 1: Hardly visible scars from 2.5 meters away. Mild 2: Easily recognizable, less than ½ the affected area (eg. face, back or chest) involved.~Moderate 3: More than ½ affected area (eg. face, back or chest) involved. Severe 4: Entire area involved. Very severe 5: Entire area with prominent atrophic or hypertrophic scars."|number of patients|Number|1|1.0||||||
4119045|NCT00933543|3944120|B1|Patients with severe scarring||Scarring|"The investigator assess the scarring using a scale called SCAR-S. Clear 0: No visible scars from acne. Almost clear 1: Hardly visible scars from 2.5 meters away. Mild 2: Easily recognizable, less than ½ the affected area (eg. face, back or chest) involved.~Moderate 3: More than ½ affected area (eg. face, back or chest) involved. Severe 4: Entire area involved. Very severe 5: Entire area with prominent atrophic or hypertrophic scars."|number of patients|Number|3|3.0||||||
4119046|NCT00933543|3944118|B3|Patients with moderate scarring||Scarring|"The investigator assess the scarring using a scale called SCAR-S. Clear 0: No visible scars from acne. Almost clear 1: Hardly visible scars from 2.5 meters away. Mild 2: Easily recognizable, less than ½ the affected area (eg. face, back or chest) involved.~Moderate 3: More than ½ affected area (eg. face, back or chest) involved. Severe 4: Entire area involved. Very severe 5: Entire area with prominent atrophic or hypertrophic scars."|number of patients|Number|12|12.0||||||
4119047|NCT00933543|3944119|B2|Patients with moderate scarring||Scarring|"The investigator assess the scarring using a scale called SCAR-S. Clear 0: No visible scars from acne. Almost clear 1: Hardly visible scars from 2.5 meters away. Mild 2: Easily recognizable, less than ½ the affected area (eg. face, back or chest) involved.~Moderate 3: More than ½ affected area (eg. face, back or chest) involved. Severe 4: Entire area involved. Very severe 5: Entire area with prominent atrophic or hypertrophic scars."|number of patients|Number|6|6.0||||||
4119048|NCT00933543|3944120|B1|Patients with moderate scarring||Scarring|"The investigator assess the scarring using a scale called SCAR-S. Clear 0: No visible scars from acne. Almost clear 1: Hardly visible scars from 2.5 meters away. Mild 2: Easily recognizable, less than ½ the affected area (eg. face, back or chest) involved.~Moderate 3: More than ½ affected area (eg. face, back or chest) involved. Severe 4: Entire area involved. Very severe 5: Entire area with prominent atrophic or hypertrophic scars."|number of patients|Number|6|6.0||||||
4119049|NCT00933543|3944118|B3|Patients with mild scarring||Scarring|"The investigator assess the scarring using a scale called SCAR-S. Clear 0: No visible scars from acne. Almost clear 1: Hardly visible scars from 2.5 meters away. Mild 2: Easily recognizable, less than ½ the affected area (eg. face, back or chest) involved.~Moderate 3: More than ½ affected area (eg. face, back or chest) involved. Severe 4: Entire area involved. Very severe 5: Entire area with prominent atrophic or hypertrophic scars."|number of patients|Number|24|24.0||||||
4119050|NCT00933543|3944119|B2|Patients with mild scarring||Scarring|"The investigator assess the scarring using a scale called SCAR-S. Clear 0: No visible scars from acne. Almost clear 1: Hardly visible scars from 2.5 meters away. Mild 2: Easily recognizable, less than ½ the affected area (eg. face, back or chest) involved.~Moderate 3: More than ½ affected area (eg. face, back or chest) involved. Severe 4: Entire area involved. Very severe 5: Entire area with prominent atrophic or hypertrophic scars."|number of patients|Number|9|9.0||||||
4119051|NCT00933543|3944120|B1|Patients with mild scarring||Scarring|"The investigator assess the scarring using a scale called SCAR-S. Clear 0: No visible scars from acne. Almost clear 1: Hardly visible scars from 2.5 meters away. Mild 2: Easily recognizable, less than ½ the affected area (eg. face, back or chest) involved.~Moderate 3: More than ½ affected area (eg. face, back or chest) involved. Severe 4: Entire area involved. Very severe 5: Entire area with prominent atrophic or hypertrophic scars."|number of patients|Number|15|15.0||||||
4119052|NCT00933543|3944118|B3|Patients with almost clear scarring||Scarring|"The investigator assess the scarring using a scale called SCAR-S. Clear 0: No visible scars from acne. Almost clear 1: Hardly visible scars from 2.5 meters away. Mild 2: Easily recognizable, less than ½ the affected area (eg. face, back or chest) involved.~Moderate 3: More than ½ affected area (eg. face, back or chest) involved. Severe 4: Entire area involved. Very severe 5: Entire area with prominent atrophic or hypertrophic scars."|number of patients|Number|19|19.0||||||
4119053|NCT00933543|3944119|B2|Patients with almost clear scarring||Scarring|"The investigator assess the scarring using a scale called SCAR-S. Clear 0: No visible scars from acne. Almost clear 1: Hardly visible scars from 2.5 meters away. Mild 2: Easily recognizable, less than ½ the affected area (eg. face, back or chest) involved.~Moderate 3: More than ½ affected area (eg. face, back or chest) involved. Severe 4: Entire area involved. Very severe 5: Entire area with prominent atrophic or hypertrophic scars."|number of patients|Number|10|10.0||||||
4119054|NCT00933543|3944120|B1|Patients with almost clear scarring||Scarring|"The investigator assess the scarring using a scale called SCAR-S. Clear 0: No visible scars from acne. Almost clear 1: Hardly visible scars from 2.5 meters away. Mild 2: Easily recognizable, less than ½ the affected area (eg. face, back or chest) involved.~Moderate 3: More than ½ affected area (eg. face, back or chest) involved. Severe 4: Entire area involved. Very severe 5: Entire area with prominent atrophic or hypertrophic scars."|number of patients|Number|9|9.0||||||
4119055|NCT00933543|3944118|B3|Patients with no scarring||Scarring|"The investigator assess the scarring using a scale called SCAR-S. Clear 0: No visible scars from acne. Almost clear 1: Hardly visible scars from 2.5 meters away. Mild 2: Easily recognizable, less than ½ the affected area (eg. face, back or chest) involved.~Moderate 3: More than ½ affected area (eg. face, back or chest) involved. Severe 4: Entire area involved. Very severe 5: Entire area with prominent atrophic or hypertrophic scars."|number of patients|Number|47|47.0||||||
4119056|NCT00933543|3944119|B2|Patients with no scarring||Scarring|"The investigator assess the scarring using a scale called SCAR-S. Clear 0: No visible scars from acne. Almost clear 1: Hardly visible scars from 2.5 meters away. Mild 2: Easily recognizable, less than ½ the affected area (eg. face, back or chest) involved.~Moderate 3: More than ½ affected area (eg. face, back or chest) involved. Severe 4: Entire area involved. Very severe 5: Entire area with prominent atrophic or hypertrophic scars."|number of patients|Number|26|26.0||||||
4119057|NCT00933543|3944120|B1|Patients with no scarring||Scarring|"The investigator assess the scarring using a scale called SCAR-S. Clear 0: No visible scars from acne. Almost clear 1: Hardly visible scars from 2.5 meters away. Mild 2: Easily recognizable, less than ½ the affected area (eg. face, back or chest) involved.~Moderate 3: More than ½ affected area (eg. face, back or chest) involved. Severe 4: Entire area involved. Very severe 5: Entire area with prominent atrophic or hypertrophic scars."|number of patients|Number|21|21.0||||||
4119058|NCT00933543|3944118|B3|Skin type VI||Fitzpatrick Skin type|I: White; very fair; red or blond hair; blue eyes; freckles Always burns, never tans II: White; fair; red or blond hair; blue, hazel or green eyes Usually burns, tans with difficulty III: Cream white; fair with any eye or hair color; very common Sometimes mild burn, gradually tans IV: Brown; typical Mediterranean Caucasian skin Rarely burns, tans with ease V: Dark brown; Middle Eastern skin types Very rarely burns, tans very easily VI: Black Never burns, tans very easily|participants|Number|5|5.0||||||
4119059|NCT00933543|3944119|B2|Skin type VI||Fitzpatrick Skin type|I: White; very fair; red or blond hair; blue eyes; freckles Always burns, never tans II: White; fair; red or blond hair; blue, hazel or green eyes Usually burns, tans with difficulty III: Cream white; fair with any eye or hair color; very common Sometimes mild burn, gradually tans IV: Brown; typical Mediterranean Caucasian skin Rarely burns, tans with ease V: Dark brown; Middle Eastern skin types Very rarely burns, tans very easily VI: Black Never burns, tans very easily|participants|Number|3|3.0||||||
4119060|NCT00933543|3944120|B1|Skin type VI||Fitzpatrick Skin type|I: White; very fair; red or blond hair; blue eyes; freckles Always burns, never tans II: White; fair; red or blond hair; blue, hazel or green eyes Usually burns, tans with difficulty III: Cream white; fair with any eye or hair color; very common Sometimes mild burn, gradually tans IV: Brown; typical Mediterranean Caucasian skin Rarely burns, tans with ease V: Dark brown; Middle Eastern skin types Very rarely burns, tans very easily VI: Black Never burns, tans very easily|participants|Number|2|2.0||||||
4119061|NCT00933543|3944118|B3|Skin type V||Fitzpatrick Skin type|I: White; very fair; red or blond hair; blue eyes; freckles Always burns, never tans II: White; fair; red or blond hair; blue, hazel or green eyes Usually burns, tans with difficulty III: Cream white; fair with any eye or hair color; very common Sometimes mild burn, gradually tans IV: Brown; typical Mediterranean Caucasian skin Rarely burns, tans with ease V: Dark brown; Middle Eastern skin types Very rarely burns, tans very easily VI: Black Never burns, tans very easily|participants|Number|7|7.0||||||
4119062|NCT00933543|3944119|B2|Skin type V||Fitzpatrick Skin type|I: White; very fair; red or blond hair; blue eyes; freckles Always burns, never tans II: White; fair; red or blond hair; blue, hazel or green eyes Usually burns, tans with difficulty III: Cream white; fair with any eye or hair color; very common Sometimes mild burn, gradually tans IV: Brown; typical Mediterranean Caucasian skin Rarely burns, tans with ease V: Dark brown; Middle Eastern skin types Very rarely burns, tans very easily VI: Black Never burns, tans very easily|participants|Number|2|2.0||||||
4119063|NCT00933543|3944120|B1|Skin type V||Fitzpatrick Skin type|I: White; very fair; red or blond hair; blue eyes; freckles Always burns, never tans II: White; fair; red or blond hair; blue, hazel or green eyes Usually burns, tans with difficulty III: Cream white; fair with any eye or hair color; very common Sometimes mild burn, gradually tans IV: Brown; typical Mediterranean Caucasian skin Rarely burns, tans with ease V: Dark brown; Middle Eastern skin types Very rarely burns, tans very easily VI: Black Never burns, tans very easily|participants|Number|5|5.0||||||
4119064|NCT00933543|3944118|B3|Skin type IV||Fitzpatrick Skin type|I: White; very fair; red or blond hair; blue eyes; freckles Always burns, never tans II: White; fair; red or blond hair; blue, hazel or green eyes Usually burns, tans with difficulty III: Cream white; fair with any eye or hair color; very common Sometimes mild burn, gradually tans IV: Brown; typical Mediterranean Caucasian skin Rarely burns, tans with ease V: Dark brown; Middle Eastern skin types Very rarely burns, tans very easily VI: Black Never burns, tans very easily|participants|Number|10|10.0||||||
4119065|NCT00933543|3944119|B2|Skin type IV||Fitzpatrick Skin type|I: White; very fair; red or blond hair; blue eyes; freckles Always burns, never tans II: White; fair; red or blond hair; blue, hazel or green eyes Usually burns, tans with difficulty III: Cream white; fair with any eye or hair color; very common Sometimes mild burn, gradually tans IV: Brown; typical Mediterranean Caucasian skin Rarely burns, tans with ease V: Dark brown; Middle Eastern skin types Very rarely burns, tans very easily VI: Black Never burns, tans very easily|participants|Number|6|6.0||||||
4119066|NCT00933543|3944120|B1|Skin type IV||Fitzpatrick Skin type|I: White; very fair; red or blond hair; blue eyes; freckles Always burns, never tans II: White; fair; red or blond hair; blue, hazel or green eyes Usually burns, tans with difficulty III: Cream white; fair with any eye or hair color; very common Sometimes mild burn, gradually tans IV: Brown; typical Mediterranean Caucasian skin Rarely burns, tans with ease V: Dark brown; Middle Eastern skin types Very rarely burns, tans very easily VI: Black Never burns, tans very easily|participants|Number|4|4.0||||||
4119067|NCT00933543|3944118|B3|Skin type III||Fitzpatrick Skin type|I: White; very fair; red or blond hair; blue eyes; freckles Always burns, never tans II: White; fair; red or blond hair; blue, hazel or green eyes Usually burns, tans with difficulty III: Cream white; fair with any eye or hair color; very common Sometimes mild burn, gradually tans IV: Brown; typical Mediterranean Caucasian skin Rarely burns, tans with ease V: Dark brown; Middle Eastern skin types Very rarely burns, tans very easily VI: Black Never burns, tans very easily|participants|Number|45|45.0||||||
4119068|NCT00933543|3944119|B2|Skin type III||Fitzpatrick Skin type|I: White; very fair; red or blond hair; blue eyes; freckles Always burns, never tans II: White; fair; red or blond hair; blue, hazel or green eyes Usually burns, tans with difficulty III: Cream white; fair with any eye or hair color; very common Sometimes mild burn, gradually tans IV: Brown; typical Mediterranean Caucasian skin Rarely burns, tans with ease V: Dark brown; Middle Eastern skin types Very rarely burns, tans very easily VI: Black Never burns, tans very easily|participants|Number|21|21.0||||||
4119069|NCT00933543|3944120|B1|Skin type III||Fitzpatrick Skin type|I: White; very fair; red or blond hair; blue eyes; freckles Always burns, never tans II: White; fair; red or blond hair; blue, hazel or green eyes Usually burns, tans with difficulty III: Cream white; fair with any eye or hair color; very common Sometimes mild burn, gradually tans IV: Brown; typical Mediterranean Caucasian skin Rarely burns, tans with ease V: Dark brown; Middle Eastern skin types Very rarely burns, tans very easily VI: Black Never burns, tans very easily|participants|Number|24|24.0||||||
4119105|NCT00933543|3944120|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4119106|NCT00933543|3944118|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4119070|NCT00933543|3944118|B3|Skin type II||Fitzpatrick Skin type|I: White; very fair; red or blond hair; blue eyes; freckles Always burns, never tans II: White; fair; red or blond hair; blue, hazel or green eyes Usually burns, tans with difficulty III: Cream white; fair with any eye or hair color; very common Sometimes mild burn, gradually tans IV: Brown; typical Mediterranean Caucasian skin Rarely burns, tans with ease V: Dark brown; Middle Eastern skin types Very rarely burns, tans very easily VI: Black Never burns, tans very easily|participants|Number|29|29.0||||||
4119071|NCT00933543|3944119|B2|Skin type II||Fitzpatrick Skin type|I: White; very fair; red or blond hair; blue eyes; freckles Always burns, never tans II: White; fair; red or blond hair; blue, hazel or green eyes Usually burns, tans with difficulty III: Cream white; fair with any eye or hair color; very common Sometimes mild burn, gradually tans IV: Brown; typical Mediterranean Caucasian skin Rarely burns, tans with ease V: Dark brown; Middle Eastern skin types Very rarely burns, tans very easily VI: Black Never burns, tans very easily|participants|Number|15|15.0||||||
4119072|NCT00933543|3944120|B1|Skin type II||Fitzpatrick Skin type|I: White; very fair; red or blond hair; blue eyes; freckles Always burns, never tans II: White; fair; red or blond hair; blue, hazel or green eyes Usually burns, tans with difficulty III: Cream white; fair with any eye or hair color; very common Sometimes mild burn, gradually tans IV: Brown; typical Mediterranean Caucasian skin Rarely burns, tans with ease V: Dark brown; Middle Eastern skin types Very rarely burns, tans very easily VI: Black Never burns, tans very easily|participants|Number|14|14.0||||||
4119073|NCT00933543|3944118|B3|Skin type I||Fitzpatrick Skin type|I: White; very fair; red or blond hair; blue eyes; freckles Always burns, never tans II: White; fair; red or blond hair; blue, hazel or green eyes Usually burns, tans with difficulty III: Cream white; fair with any eye or hair color; very common Sometimes mild burn, gradually tans IV: Brown; typical Mediterranean Caucasian skin Rarely burns, tans with ease V: Dark brown; Middle Eastern skin types Very rarely burns, tans very easily VI: Black Never burns, tans very easily|participants|Number|11|11.0||||||
4119074|NCT00933543|3944119|B2|Skin type I||Fitzpatrick Skin type|I: White; very fair; red or blond hair; blue eyes; freckles Always burns, never tans II: White; fair; red or blond hair; blue, hazel or green eyes Usually burns, tans with difficulty III: Cream white; fair with any eye or hair color; very common Sometimes mild burn, gradually tans IV: Brown; typical Mediterranean Caucasian skin Rarely burns, tans with ease V: Dark brown; Middle Eastern skin types Very rarely burns, tans very easily VI: Black Never burns, tans very easily|participants|Number|6|6.0||||||
4119075|NCT00933543|3944120|B1|Skin type I||Fitzpatrick Skin type|I: White; very fair; red or blond hair; blue eyes; freckles Always burns, never tans II: White; fair; red or blond hair; blue, hazel or green eyes Usually burns, tans with difficulty III: Cream white; fair with any eye or hair color; very common Sometimes mild burn, gradually tans IV: Brown; typical Mediterranean Caucasian skin Rarely burns, tans with ease V: Dark brown; Middle Eastern skin types Very rarely burns, tans very easily VI: Black Never burns, tans very easily|participants|Number|5|5.0||||||
4119076|NCT00933543|3944118|B3|IGA 4 (Severe acne)||Investigator Global Assessment (IGA) Score||participants|Number|18|18.0||||||
4119077|NCT00933543|3944119|B2|IGA 4 (Severe acne)||Investigator Global Assessment (IGA) Score||participants|Number|8|8.0||||||
4119078|NCT00933543|3944120|B1|IGA 4 (Severe acne)||Investigator Global Assessment (IGA) Score||participants|Number|10|10.0||||||
4119079|NCT00933543|3944118|B3|IGA 3 (Moderate acne)||Investigator Global Assessment (IGA) Score||participants|Number|89|89.0||||||
4119080|NCT00933543|3944119|B2|IGA 3 (Moderate acne)||Investigator Global Assessment (IGA) Score||participants|Number|45|45.0||||||
4119081|NCT00933543|3944120|B1|IGA 3 (Moderate acne)||Investigator Global Assessment (IGA) Score||participants|Number|44|44.0||||||
4119082|NCT00933543|3944118|B3|Severe hyperpigmentation||Patients with mild and moderate hyperpigmentation||number of patients|Number|3|3.0||||||
4119083|NCT00933543|3944119|B2|Severe hyperpigmentation||Patients with mild and moderate hyperpigmentation||number of patients|Number|1|1.0||||||
4119084|NCT00933543|3944120|B1|Severe hyperpigmentation||Patients with mild and moderate hyperpigmentation||number of patients|Number|2|2.0||||||
4119085|NCT00933543|3944118|B3|Moderate hyperpigmentation||Patients with mild and moderate hyperpigmentation||number of patients|Number|16|16.0||||||
4119086|NCT00933543|3944119|B2|Moderate hyperpigmentation||Patients with mild and moderate hyperpigmentation||number of patients|Number|8|8.0||||||
4119087|NCT00933543|3944120|B1|Moderate hyperpigmentation||Patients with mild and moderate hyperpigmentation||number of patients|Number|8|8.0||||||
4119088|NCT00933543|3944118|B3|Mild hyperpigmentation||Patients with mild and moderate hyperpigmentation||number of patients|Number|15|15.0||||||
4119089|NCT00933543|3944119|B2|Mild hyperpigmentation||Patients with mild and moderate hyperpigmentation||number of patients|Number|10|10.0||||||
4119090|NCT00933543|3944120|B1|Mild hyperpigmentation||Patients with mild and moderate hyperpigmentation||number of patients|Number|5|5.0||||||
4119091|NCT00933543|3944118|B3|No hyperpigmentation||Patients with mild and moderate hyperpigmentation||number of patients|Number|73|73.0||||||
4119092|NCT00933543|3944119|B2|No hyperpigmentation||Patients with mild and moderate hyperpigmentation||number of patients|Number|34|34.0||||||
4119093|NCT00933543|3944120|B1|No hyperpigmentation||Patients with mild and moderate hyperpigmentation||number of patients|Number|39|39.0||||||
4119094|NCT00933543|3944118|B3|United States||Region of Enrollment||participants|Number|74|74.0||||||
4119095|NCT00933543|3944119|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4119096|NCT00933543|3944120|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4119097|NCT00933543|3944118|B3|Canada||Region of Enrollment||participants|Number|33|33.0||||||
4119098|NCT00933543|3944119|B2|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4119099|NCT00933543|3944120|B1|Canada||Region of Enrollment||participants|Number|17|17.0||||||
4119100|NCT00933543|3944118|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4119101|NCT00933543|3944119|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4119102|NCT00933543|3944120|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4119103|NCT00933543|3944118|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4119104|NCT00933543|3944119|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4119107|NCT00933543|3944119|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4119108|NCT00933543|3944120|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4119109|NCT00933543|3944118|B3||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4119110|NCT00933543|3944119|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4119111|NCT00933543|3944120|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4119112|NCT00933543|3944118|B3||<=18 years|Age||Participants|Count of Participants|69|69.0||||||
4119113|NCT00933543|3944119|B2||<=18 years|Age||Participants|Count of Participants|34|34.0||||||
4119114|NCT00933543|3944120|B1||<=18 years|Age||Participants|Count of Participants|35|35.0||||||
4119115|NCT00933491|3944177|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4119116|NCT00933491|3944178|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4119117|NCT00933491|3944179|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4119118|NCT00933491|3944177|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4119119|NCT00933491|3944178|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4119120|NCT00933491|3944179|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4119121|NCT00933491|3944177|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4119122|NCT00933491|3944178|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4119123|NCT00933491|3944179|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4119124|NCT00933491|3944177|B3|||Age||years|Mean|64.5|64.5|Full Range|||48.0|80.0|
4119125|NCT00933491|3944178|B2|||Age||years|Mean|64|64.0|Full Range|||48.0|75.0|
4119126|NCT00933491|3944179|B1|||Age||years|Mean|65|65.0|Full Range|||51.0|80.0|
4119127|NCT00933491|3944177|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4119128|NCT00933491|3944178|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4119129|NCT00933491|3944179|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4119130|NCT00933491|3944177|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4119131|NCT00933491|3944178|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4119132|NCT00933491|3944179|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4119133|NCT00933491|3944177|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4119134|NCT00933491|3944178|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4119135|NCT00933491|3944179|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4119136|NCT00933335|3944188|B3|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4119137|NCT00933335|3944189|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4119138|NCT00933335|3944190|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4119139|NCT00933335|3944188|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4119140|NCT00933335|3944189|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4119141|NCT00933335|3944190|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4119142|NCT00933335|3944188|B3|White||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4119143|NCT00933335|3944189|B2|White||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4119144|NCT00933335|3944190|B1|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4119145|NCT00933335|3944188|B3||Male|Gender||Participants|Count of Participants|21|21.0||||||
4119146|NCT00933335|3944189|B2||Male|Gender||Participants|Count of Participants|20|20.0||||||
4119147|NCT00933335|3944190|B1||Male|Gender||Participants|Count of Participants|1|1.0||||||
4119148|NCT00933335|3944188|B3||Female|Gender||Participants|Count of Participants|17|17.0||||||
4119149|NCT00933335|3944189|B2||Female|Gender||Participants|Count of Participants|16|16.0||||||
4119150|NCT00933335|3944190|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
4119151|NCT00933335|3944188|B3|||Age||Years|Mean|51.7|51.7|Standard Deviation|13.4|13.4|||
4119152|NCT00933335|3944189|B2|||Age||Years|Mean|51.2|51.2|Standard Deviation|13.4|13.4|||
4119153|NCT00933335|3944190|B1|||Age||Years|Mean|61.0|61.0|Standard Deviation|11.3|11.3|||
4119154|NCT00933270|3944261|B1|United States||Region of Enrollment||participants|Number|264|264.0||||||
4119155|NCT00933270|3944261|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4119156|NCT00933270|3944261|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119157|NCT00933270|3944261|B1||White|Race (NIH/OMB)||Participants|Count of Participants|221|221.0||||||
4119158|NCT00933270|3944261|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4119159|NCT00933270|3944261|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119160|NCT00933270|3944261|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4119161|NCT00933270|3944261|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119162|NCT00933270|3944261|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|244|244.0||||||
4119163|NCT00933270|3944261|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119164|NCT00933270|3944261|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4119165|NCT00933270|3944261|B1||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4119166|NCT00933270|3944261|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4119167|NCT00933270|3944261|B1|ITT population||Age||years|Mean|68.7|68.7|Standard Deviation|10.0|10.0|||
4119168|NCT00933244|3944352|B4|United States||Region of Enrollment||participants|Number|230|230.0||||||
4119169|NCT00933244|3944353|B3|United States||Region of Enrollment||participants|Number|76|76.0||||||
4119170|NCT00933244|3944354|B2|United States||Region of Enrollment||participants|Number|75|75.0||||||
4119171|NCT00933244|3944355|B1|United States||Region of Enrollment||participants|Number|79|79.0||||||
4119172|NCT00933244|3944352|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119173|NCT00933244|3944353|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119174|NCT00933244|3944354|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119175|NCT00933244|3944355|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119176|NCT00933244|3944352|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119177|NCT00933244|3944353|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119178|NCT00933244|3944354|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119179|NCT00933244|3944355|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119180|NCT00933244|3944352|B4||White|Race (NIH/OMB)||Participants|Count of Participants|209|209.0||||||
4119181|NCT00933244|3944353|B3||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
4119182|NCT00933244|3944354|B2||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4119183|NCT00933244|3944355|B1||White|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
4119184|NCT00933244|3944352|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4119185|NCT00933244|3944353|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4119186|NCT00933244|3944354|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4119187|NCT00933244|3944355|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4119188|NCT00933244|3944352|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119189|NCT00933244|3944353|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119190|NCT00933244|3944354|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119191|NCT00933244|3944355|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119192|NCT00933244|3944352|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4119193|NCT00933244|3944353|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4119194|NCT00933244|3944354|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4119195|NCT00933244|3944355|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4119196|NCT00933244|3944352|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4119197|NCT00933244|3944353|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119198|NCT00933244|3944354|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119199|NCT00933244|3944355|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4119200|NCT00933244|3944352|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119201|NCT00933244|3944353|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119202|NCT00933244|3944354|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119203|NCT00933244|3944355|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119204|NCT00933244|3944352|B4||Female|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4119205|NCT00933244|3944353|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4119206|NCT00933244|3944354|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4119207|NCT00933244|3944355|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4119208|NCT00933244|3944352|B4|||Age||years|Mean|61|61.0|Standard Deviation|6|6.0|||
4119209|NCT00933244|3944353|B3|||Age||years|Mean|61|61.0|Standard Deviation|6|6.0|||
4119210|NCT00933244|3944354|B2|||Age||years|Mean|60|60.0|Standard Deviation|6|6.0|||
4119211|NCT00933244|3944355|B1|||Age||years|Mean|60|60.0|Standard Deviation|5|5.0|||
4119212|NCT00933166|3944374|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4119213|NCT00933166|3944374|B1||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4119214|NCT00933166|3944374|B1|||Age||years|Mean|37.3|37.3|Standard Deviation|12.1|12.1|||
4119215|NCT00932893|3944378|B3||Male|Gender||Participants|Count of Participants|154|154.0||||||
4119216|NCT00932893|3944379|B2||Male|Gender||Participants|Count of Participants|79|79.0||||||
4119217|NCT00932893|3944380|B1||Male|Gender||Participants|Count of Participants|75|75.0||||||
4119218|NCT00932893|3944378|B3||Female|Gender||Participants|Count of Participants|193|193.0||||||
4119219|NCT00932893|3944379|B2||Female|Gender||Participants|Count of Participants|95|95.0||||||
4119220|NCT00932893|3944380|B1||Female|Gender||Participants|Count of Participants|98|98.0||||||
4119221|NCT00932893|3944378|B3|||Age||years|Mean|50.0|50.0|Standard Deviation|13.0|13.0|||
4119222|NCT00932893|3944379|B2|||Age||years|Mean|49.8|49.8|Standard Deviation|13.0|13.0|||
4119223|NCT00932893|3944380|B1|||Age||years|Mean|50.3|50.3|Standard Deviation|13.1|13.1|||
4119224|NCT00932828|3944412|B1|||Peanut skin prick test (SPT)|Epicutaneous skin prick test applied using the Greer pick and measured after 15 minutes. Cross diameters of the raised wheal skin response are averaged and reported as the average wheal size in mm.|mm wheal size|Median|11.5|11.5|Inter-Quartile Range|||8.0|16.5|
4119225|NCT00932828|3944412|B1|||Peanut immunoglobin E (IgE)||kUA/L|Median|14.4|14.4|Inter-Quartile Range|||3.4|48.6|
4119226|NCT00932828|3944412|B1|United States||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
4119227|NCT00932828|3944412|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119228|NCT00932828|3944412|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119229|NCT00932828|3944412|B1||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4119230|NCT00932828|3944412|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4119231|NCT00932828|3944412|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119232|NCT00932828|3944412|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4119233|NCT00932828|3944412|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119234|NCT00932828|3944412|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4119235|NCT00932828|3944412|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4119236|NCT00932828|3944412|B1|||Age||months|Median|28.5|28.5|Inter-Quartile Range|||22.0|35.0|
4119237|NCT00932828|3944412|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4119238|NCT00932828|3944412|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4119239|NCT00932828|3944412|B1||<=18 years|Age||Participants|Count of Participants|37|37.0||||||
4119240|NCT00932659|3944418|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4119241|NCT00932659|3944418|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4119242|NCT00932659|3944418|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4119243|NCT00932659|3944418|B1|||Age||years|Mean|55|55.0|Standard Deviation|3|3.0|||
4119244|NCT00932659|3944418|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4119245|NCT00932659|3944418|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4119246|NCT00932659|3944418|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4119247|NCT00932646|3944423|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4119248|NCT00932646|3944423|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4119249|NCT00932646|3944423|B1|||Age||years|Mean|63.5|63.5|Standard Deviation|8.2|8.2|||
4119250|NCT00932620|3944480|B3|Greece||Region of Enrollment||participants|Number|100|100.0||||||
4119251|NCT00932620|3944481|B2|Greece||Region of Enrollment||participants|Number|50|50.0||||||
4119252|NCT00932620|3944482|B1|Greece||Region of Enrollment||participants|Number|50|50.0||||||
4119253|NCT00932620|3944480|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4119254|NCT00932620|3944481|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4119255|NCT00932620|3944482|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4119256|NCT00932620|3944480|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4119257|NCT00932620|3944481|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4119258|NCT00932620|3944482|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4119259|NCT00932620|3944480|B3|||Age||years|Mean|58|58.0|Standard Deviation|9|9.0|||
4119260|NCT00932620|3944481|B2|||Age||years|Mean|59|59.0|Standard Deviation|9|9.0|||
4119261|NCT00932620|3944482|B1|||Age||years|Mean|57|57.0|Standard Deviation|10|10.0|||
4119262|NCT00932620|3944480|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4119263|NCT00932620|3944481|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4119264|NCT00932620|3944482|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4119265|NCT00932620|3944480|B3||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
4119266|NCT00932620|3944481|B2||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4119267|NCT00932620|3944482|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4119268|NCT00932620|3944480|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4119269|NCT00932620|3944481|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4119270|NCT00932620|3944482|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4119271|NCT00932477|3944491|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4119272|NCT00932477|3944491|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4119273|NCT00932477|3944491|B1|>=40 years||Age, Customized||participants|Number|40|40.0||||||
4119274|NCT00932477|3944491|B1|<40 years||Age, Customized||participants|Number|7|7.0||||||
4119275|NCT00932451|3944513|B1|Other-Asian||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4119276|NCT00932451|3944513|B1|Other||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4119277|NCT00932451|3944513|B1|Black||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4119278|NCT00932451|3944513|B1|White||Race/Ethnicity, Customized||participants|Number|532|532.0||||||
4119279|NCT00932451|3944513|B1|Korean||Race/Ethnicity, Customized||participants|Number|144|144.0||||||
4119280|NCT00932451|3944513|B1|Japanese||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
4119281|NCT00932451|3944513|B1|Chinese||Race/Ethnicity, Customized||participants|Number|252|252.0||||||
4119282|NCT00932451|3944513|B1||Male|Gender||Participants|Count of Participants|465|465.0||||||
4119283|NCT00932451|3944513|B1||Female|Gender||Participants|Count of Participants|601|601.0||||||
4119284|NCT00932451|3944513|B1|>=65 years||Age, Customized||Participants|Number|172|172.0||||||
4119285|NCT00932451|3944513|B1|< 65 years||Age, Customized||Participants|Number|894|894.0||||||
4119286|NCT00932451|3944513|B1|||Age||Years|Mean|52.2|52.2|Standard Deviation|12.33|12.33|||
4119287|NCT00932425|3944535|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4119288|NCT00932425|3944536|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4119289|NCT00932425|3944537|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4119290|NCT00932425|3944535|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4119291|NCT00932425|3944536|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4119292|NCT00932425|3944537|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4119293|NCT00932425|3944535|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4119294|NCT00932425|3944536|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4119295|NCT00932425|3944537|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4119296|NCT00932425|3944535|B3|||Age||years|Mean|67|67.0|Standard Deviation|12|12.0|||
4119297|NCT00932425|3944536|B2|||Age||years|Mean|69|69.0|Standard Deviation|9|9.0|||
4119298|NCT00932425|3944537|B1|||Age||years|Mean|65|65.0|Standard Deviation|15|15.0|||
4119299|NCT00932399|3944551|B3||Male|Sex: Female, Male||Participants|Count of Participants|4549|4549.0||||||
4119300|NCT00932399|3944552|B2||Male|Sex: Female, Male||Participants|Count of Participants|3790|3790.0||||||
4119301|NCT00932399|3944553|B1||Male|Sex: Female, Male||Participants|Count of Participants|759|759.0||||||
4119302|NCT00932399|3944551|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119303|NCT00932399|3944552|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119304|NCT00932399|3944553|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119305|NCT00932399|3944551|B3|75-89 years||Age, Customized||participants|Number|744|744.0||||||
4119306|NCT00932399|3944552|B2|75-89 years||Age, Customized||participants|Number|620|620.0||||||
4119307|NCT00932399|3944553|B1|75-89 years||Age, Customized||participants|Number|124|124.0||||||
4119308|NCT00932399|3944551|B3|65-74 years||Age, Customized||participants|Number|1195|1195.0||||||
4119309|NCT00932399|3944552|B2|65-74 years||Age, Customized||participants|Number|995|995.0||||||
4119310|NCT00932399|3944553|B1|65-74 years||Age, Customized||participants|Number|200|200.0||||||
4119311|NCT00932399|3944551|B3|55-64 years||Age, Customized||participants|Number|1764|1764.0||||||
4119312|NCT00932399|3944552|B2|55-64 years||Age, Customized||participants|Number|1470|1470.0||||||
4119313|NCT00932399|3944553|B1|55-64 years||Age, Customized||participants|Number|294|294.0||||||
4119314|NCT00932399|3944551|B3|<55 years||Age, Customized||participants|Number|846|846.0||||||
4119315|NCT00932399|3944552|B2|<55 years||Age, Customized||participants|Number|705|705.0||||||
4119316|NCT00932399|3944553|B1|<55 years||Age, Customized||participants|Number|141|141.0||||||
4119317|NCT00932373|3944560|B12|United States||Region of Enrollment||participants|Number|52|52.0||||||
4119318|NCT00932373|3944561|B11|United States||Region of Enrollment||participants|Number|3|3.0||||||
4119319|NCT00932373|3944562|B10|United States||Region of Enrollment||participants|Number|16|16.0||||||
4119320|NCT00932373|3944563|B9|United States||Region of Enrollment||participants|Number|3|3.0||||||
4119321|NCT00932373|3944564|B8|United States||Region of Enrollment||participants|Number|3|3.0||||||
4119322|NCT00932373|3944565|B7|United States||Region of Enrollment||participants|Number|3|3.0||||||
4119323|NCT00932373|3944566|B6|United States||Region of Enrollment||participants|Number|3|3.0||||||
4119324|NCT00932373|3944567|B5|United States||Region of Enrollment||participants|Number|15|15.0||||||
4119325|NCT00932373|3944568|B4|United States||Region of Enrollment||participants|Number|1|1.0||||||
4119326|NCT00932373|3944569|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4119327|NCT00932373|3944570|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4119328|NCT00932373|3944571|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4119329|NCT00932373|3944560|B12||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119330|NCT00932373|3944561|B11||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119331|NCT00932373|3944562|B10||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119332|NCT00932373|3944563|B9||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119333|NCT00932373|3944564|B8||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119334|NCT00932373|3944565|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119335|NCT00932373|3944566|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119336|NCT00932373|3944567|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119337|NCT00932373|3944568|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119338|NCT00932373|3944569|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119339|NCT00932373|3944570|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119340|NCT00932373|3944571|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119341|NCT00932373|3944560|B12||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4119342|NCT00932373|3944561|B11||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4119343|NCT00932373|3944562|B10||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4119344|NCT00932373|3944563|B9||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4119345|NCT00932373|3944564|B8||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4119346|NCT00932373|3944565|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4119347|NCT00932373|3944566|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4119348|NCT00932373|3944567|B5||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4119349|NCT00932373|3944568|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4119350|NCT00932373|3944569|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4119351|NCT00932373|3944570|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4119352|NCT00932373|3944571|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4119353|NCT00932373|3944560|B12|||Age||Years|Mean|52.9|52.9|Standard Deviation|10.7|10.7|||
4119354|NCT00932373|3944561|B11|||Age||Years|Mean|58.3|58.3|Standard Deviation|11.0|11.0|||
4119355|NCT00932373|3944562|B10|||Age||Years|Mean|50.9|50.9|Standard Deviation|14.0|14.0|||
4119356|NCT00932373|3944563|B9|||Age||Years|Mean|55.3|55.3|Standard Deviation|3.2|3.2|||
4119357|NCT00932373|3944564|B8|||Age||Years|Mean|53.0|53.0|Standard Deviation|6.1|6.1|||
4119358|NCT00932373|3944565|B7|||Age||Years|Mean|55.3|55.3|Standard Deviation|10.0|10.0|||
4119359|NCT00932373|3944566|B6|||Age||Years|Mean|48.0|48.0|Standard Deviation|6.0|6.0|||
4119360|NCT00932373|3944567|B5|||Age||Years|Mean|52.1|52.1|Standard Deviation|10.3|10.3|||
4119361|NCT00932373|3944568|B4|||Age||Years|Mean|58.0|58.0|Standard Deviation|0|0.0|||
4119362|NCT00932373|3944569|B3|||Age||Years|Mean|61.0|61.0|Standard Deviation|0|0.0|||
4119363|NCT00932373|3944570|B2|||Age||Years|Mean|47.0|47.0|Standard Deviation|0|0.0|||
4119364|NCT00932373|3944571|B1|||Age||Years|Mean|60.7|60.7|Standard Deviation|10.1|10.1|||
4119365|NCT00932321|3944681|B3|United States||Region of Enrollment||participants|Number|938|938.0||||||
4119366|NCT00932321|3944682|B2|United States||Region of Enrollment||participants|Number|187|187.0||||||
4119367|NCT00932321|3944683|B1|United States||Region of Enrollment||participants|Number|751|751.0||||||
4119368|NCT00932321|3944681|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119369|NCT00932321|3944682|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119370|NCT00932321|3944683|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119371|NCT00932321|3944681|B3||Female|Sex: Female, Male||Participants|Count of Participants|938|938.0||||||
4119372|NCT00932321|3944682|B2||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4119373|NCT00932321|3944683|B1||Female|Sex: Female, Male||Participants|Count of Participants|751|751.0||||||
4119374|NCT00932321|3944681|B3|> 35 years||Age, Customized|MITT (Modified Intent to Treat) Population|Participants|Number|154|154.0||||||
4119375|NCT00932321|3944682|B2|> 35 years||Age, Customized|MITT (Modified Intent to Treat) Population|Participants|Number|29|29.0||||||
4119376|NCT00932321|3944683|B1|> 35 years||Age, Customized|MITT (Modified Intent to Treat) Population|Participants|Number|125|125.0||||||
4119377|NCT00932321|3944681|B3|18-35 years||Age, Customized|MITT (Modified Intent to Treat) Population|Participants|Number|730|730.0||||||
4119378|NCT00932321|3944682|B2|18-35 years||Age, Customized|MITT (Modified Intent to Treat) Population|Participants|Number|151|151.0||||||
4119379|NCT00932321|3944683|B1|18-35 years||Age, Customized|MITT (Modified Intent to Treat) Population|Participants|Number|579|579.0||||||
4119380|NCT00932321|3944681|B3|Age, Unknown||Age, Customized|MITT (Modified Intent to Treat) Population|Participants|Number|2|2.0||||||
4119381|NCT00932321|3944682|B2|Age, Unknown||Age, Customized|MITT (Modified Intent to Treat) Population|Participants|Number|1|1.0||||||
4119382|NCT00932321|3944683|B1|Age, Unknown||Age, Customized|MITT (Modified Intent to Treat) Population|Participants|Number|1|1.0||||||
4119383|NCT00932282|3944692|B3|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4119384|NCT00932282|3944693|B2|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4119385|NCT00932282|3944694|B1|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4119386|NCT00932282|3944692|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4119387|NCT00932282|3944693|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4119388|NCT00932282|3944694|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4119389|NCT00932282|3944692|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4119390|NCT00932282|3944693|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4119391|NCT00932282|3944694|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4119392|NCT00932282|3944692|B3|||Age||years|Median|14.4|14.4|Full Range|||12.6|19.9|
4119393|NCT00932282|3944693|B2|||Age||years|Median|14.1|14.1|Full Range|||12.8|16.1|
4119394|NCT00932282|3944694|B1|||Age||years|Median|14.4|14.4|Full Range|||12.6|19.9|
4119395|NCT00932282|3944692|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4119396|NCT00932282|3944693|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4119397|NCT00932282|3944694|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4119398|NCT00932282|3944692|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4119399|NCT00932282|3944693|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4119400|NCT00932282|3944694|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4119401|NCT00932282|3944692|B3||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4119402|NCT00932282|3944693|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4119403|NCT00932282|3944694|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4119404|NCT00932165|3944709|B1|Japan||Region of Enrollment||participants|Number|450|450.0||||||
4119405|NCT00932165|3944709|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119406|NCT00932165|3944709|B1||Female|Sex: Female, Male||Participants|Count of Participants|450|450.0||||||
4119407|NCT00932165|3944709|B1|||Age||years|Mean|62.67|62.67|Standard Deviation|9.83|9.83|||
4119408|NCT00932165|3944709|B1||>=65 years|Age||Participants|Count of Participants|181|181.0||||||
4119409|NCT00932165|3944709|B1||Between 18 and 65 years|Age||Participants|Count of Participants|269|269.0||||||
4119410|NCT00932165|3944709|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4119411|NCT00932152|3944720|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119412|NCT00932152|3944721|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119413|NCT00932152|3944722|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119414|NCT00932152|3944720|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4119415|NCT00932152|3944721|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4119416|NCT00932152|3944722|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4119417|NCT00932152|3944720|B3|||Age||years|Mean|67|67.0|Full Range|||58.0|77.0|
4119418|NCT00932152|3944721|B2|||Age||years|Mean|67.5|67.5|Full Range|||58.0|77.0|
4119419|NCT00932152|3944722|B1|||Age||years|Mean|67|67.0|Full Range|||67.0|67.0|
4119420|NCT00932126|3944733|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4119421|NCT00932126|3944733|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4119422|NCT00932126|3944733|B1|>=65 years||Age, Customized||participants|Number|14|14.0||||||
4119423|NCT00932126|3944733|B1|45 - 64 years||Age, Customized||participants|Number|15|15.0||||||
4119424|NCT00932126|3944733|B1|18 - 44 years||Age, Customized||participants|Number|6|6.0||||||
4119425|NCT00932126|3944733|B1|<18 years||Age, Customized||participants|Number|0|0.0||||||
4119426|NCT00932113|3944776|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4119427|NCT00932113|3944777|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4119428|NCT00932113|3944778|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4119429|NCT00932113|3944776|B3|hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4119430|NCT00932113|3944777|B2|hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4119431|NCT00932113|3944778|B1|hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4119432|NCT00932113|3944776|B3|unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4119433|NCT00932113|3944777|B2|unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4119434|NCT00932113|3944778|B1|unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4119435|NCT00932113|3944776|B3|african american||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4119436|NCT00932113|3944777|B2|african american||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4119437|NCT00932113|3944778|B1|african american||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4119438|NCT00932113|3944776|B3|caucasian||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4119439|NCT00932113|3944777|B2|caucasian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4119440|NCT00932113|3944778|B1|caucasian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4119441|NCT00932113|3944776|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4119442|NCT00932113|3944777|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4119443|NCT00932113|3944778|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4119444|NCT00932113|3944776|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4119445|NCT00932113|3944777|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4119446|NCT00932113|3944778|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4119447|NCT00932113|3944776|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4119448|NCT00932113|3944777|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4119449|NCT00932113|3944778|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4119450|NCT00932113|3944776|B3|||Age||years|Mean|50.4|50.4|Full Range|||22.0|69.0|
4119451|NCT00932113|3944777|B2|||Age||years|Mean|50.3|50.3|Full Range|||22.0|69.0|
4119452|NCT00932113|3944778|B1|||Age||years|Mean|50.5|50.5|Full Range|||22.0|69.0|
4119453|NCT00932113|3944776|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4119454|NCT00932113|3944777|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4119455|NCT00932113|3944778|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4119456|NCT00932113|3944776|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4119457|NCT00932113|3944777|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4119458|NCT00932113|3944778|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4119459|NCT00932113|3944776|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4119460|NCT00932113|3944777|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4119461|NCT00932113|3944778|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4119462|NCT00932035|3944795|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
4119463|NCT00932035|3944796|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4119464|NCT00932035|3944797|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4119465|NCT00932035|3944795|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119466|NCT00932035|3944796|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119467|NCT00932035|3944797|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119468|NCT00932035|3944795|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4119469|NCT00932035|3944796|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4119470|NCT00932035|3944797|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4119471|NCT00932035|3944795|B3|||Age||years|Median|50|50.0|Full Range|||28.0|81.0|
4119472|NCT00932035|3944796|B2|||Age||years|Median|47|47.0|Full Range|||32.0|73.0|
4119473|NCT00932035|3944797|B1|||Age||years|Median|52|52.0|Full Range|||28.0|81.0|
4119474|NCT00932022|3944808|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119475|NCT00932022|3944809|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119476|NCT00932022|3944810|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119477|NCT00932022|3944808|B3||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4119478|NCT00932022|3944809|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4119479|NCT00932022|3944810|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4119480|NCT00932022|3944808|B3|>75 years||Age, Customized||Participants|Number|0|0.0||||||
4119481|NCT00932022|3944809|B2|>75 years||Age, Customized||Participants|Number|0|0.0||||||
4119482|NCT00932022|3944810|B1|>75 years||Age, Customized||Participants|Number|0|0.0||||||
4119483|NCT00932022|3944808|B3|18 to 75 years||Age, Customized||Participants|Number|127|127.0||||||
4119484|NCT00932022|3944809|B2|18 to 75 years||Age, Customized||Participants|Number|63|63.0||||||
4119485|NCT00932022|3944810|B1|18 to 75 years||Age, Customized||Participants|Number|64|64.0||||||
4119486|NCT00932022|3944808|B3|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4119487|NCT00932022|3944809|B2|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4119488|NCT00932022|3944810|B1|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4119489|NCT00931996|3944825|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4119490|NCT00931996|3944825|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4119491|NCT00931996|3944825|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4119492|NCT00931996|3944825|B1|||Age||years|Mean|22.3|22.3|Standard Deviation|7.1|7.1|||
4119493|NCT00931996|3944825|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4119494|NCT00931996|3944825|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4119495|NCT00931996|3944825|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4119496|NCT00931918|3944829|B3|||Body Surface Area|Body Surface Area (m²) is calculated based on patient’s height and weight, and is defined as ([Height(cm) x Weight (kg)]/3600). Body Surface Area data is available for n=99, 99 participants respectively.|m^2|Mean|1.986|1.986|Standard Deviation|0.2934|0.2934|||
4119497|NCT00931918|3944830|B2|||Body Surface Area|Body Surface Area (m²) is calculated based on patient’s height and weight, and is defined as ([Height(cm) x Weight (kg)]/3600). Body Surface Area data is available for n=99, 99 participants respectively.|m^2|Mean|1.970|1.97|Standard Deviation|0.3040|0.304|||
4119498|NCT00931918|3944831|B1|||Body Surface Area|Body Surface Area (m²) is calculated based on patient’s height and weight, and is defined as ([Height(cm) x Weight (kg)]/3600). Body Surface Area data is available for n=99, 99 participants respectively.|m^2|Mean|2.002|2.002|Standard Deviation|0.2830|0.283|||
4119499|NCT00931918|3944829|B3|||Weight||kg|Mean|84.02|84.02|Standard Deviation|21.203|21.203|||
4119500|NCT00931918|3944830|B2|||Weight||kg|Mean|82.86|82.86|Standard Deviation|21.745|21.745|||
4119501|NCT00931918|3944831|B1|||Weight||kg|Mean|85.19|85.19|Standard Deviation|20.684|20.684|||
4119502|NCT00931918|3944829|B3|||Height|Height data is available for n=99, 99 participants, respectively.|cm|Mean|170.7|170.7|Standard Deviation|11.37|11.37|||
4119503|NCT00931918|3944830|B2|||Height|Height data is available for n=99, 99 participants, respectively.|cm|Mean|170.3|170.3|Standard Deviation|11.48|11.48|||
4119504|NCT00931918|3944831|B1|||Height|Height data is available for n=99, 99 participants, respectively.|cm|Mean|171.1|171.1|Standard Deviation|11.30|11.3|||
4119505|NCT00931918|3944829|B3|United States||Region of Enrollment||participants|Number|201|201.0||||||
4119506|NCT00931918|3944830|B2|United States||Region of Enrollment||participants|Number|101|101.0||||||
4119507|NCT00931918|3944831|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
4119508|NCT00931918|3944829|B3|Not Reported||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4119509|NCT00931918|3944830|B2|Not Reported||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4119510|NCT00931918|3944831|B1|Not Reported||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4119511|NCT00931918|3944829|B3|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4119512|NCT00931918|3944830|B2|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4119513|NCT00931918|3944831|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4119514|NCT00931918|3944829|B3|Asian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4119515|NCT00931918|3944830|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4119516|NCT00931918|3944831|B1|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4119517|NCT00931918|3944829|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4119518|NCT00931918|3944830|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4119519|NCT00931918|3944831|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4119520|NCT00931918|3944829|B3|White||Race/Ethnicity, Customized||participants|Number|156|156.0||||||
4119521|NCT00931918|3944830|B2|White||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
4119522|NCT00931918|3944831|B1|White||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
4119523|NCT00931918|3944829|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4119524|NCT00931918|3944830|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4119525|NCT00931918|3944831|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4119526|NCT00931918|3944829|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|172|172.0||||||
4119527|NCT00931918|3944830|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
4119528|NCT00931918|3944831|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4119529|NCT00931918|3944829|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4119530|NCT00931918|3944830|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4119531|NCT00931918|3944831|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4119532|NCT00931918|3944829|B3||Male|Gender||Participants|Count of Participants|107|107.0||||||
4119533|NCT00931918|3944830|B2||Male|Gender||Participants|Count of Participants|50|50.0||||||
4119534|NCT00931918|3944831|B1||Male|Gender||Participants|Count of Participants|57|57.0||||||
4119535|NCT00931918|3944829|B3||Female|Gender||Participants|Count of Participants|94|94.0||||||
4119536|NCT00931918|3944830|B2||Female|Gender||Participants|Count of Participants|51|51.0||||||
4119537|NCT00931918|3944831|B1||Female|Gender||Participants|Count of Participants|43|43.0||||||
4119538|NCT00931918|3944829|B3|> 65 years||Age, Customized||participants|Number|88|88.0||||||
4119539|NCT00931918|3944830|B2|> 65 years||Age, Customized||participants|Number|46|46.0||||||
4119540|NCT00931918|3944831|B1|> 65 years||Age, Customized||participants|Number|42|42.0||||||
4119541|NCT00931918|3944829|B3|≤ 65 years||Age, Customized||participants|Number|113|113.0||||||
4119542|NCT00931918|3944830|B2|≤ 65 years||Age, Customized||participants|Number|55|55.0||||||
4119543|NCT00931918|3944831|B1|≤ 65 years||Age, Customized||participants|Number|58|58.0||||||
4119544|NCT00931918|3944829|B3|||Age||years|Mean|60.9|60.9|Standard Deviation|14.21|14.21|||
4119545|NCT00931918|3944830|B2|||Age||years|Mean|61.9|61.9|Standard Deviation|13.81|13.81|||
4119546|NCT00931918|3944831|B1|||Age||years|Mean|59.8|59.8|Standard Deviation|14.60|14.6|||
4119547|NCT00931879|3944856|B3|||Insulin (uIU/mL)||(uIU/mL)|Mean|32.88|32.88|Standard Deviation|6.96|6.96|||
4119548|NCT00931879|3944857|B2|||Insulin (uIU/mL)||(uIU/mL)|Mean|26.23|26.23|Standard Deviation|5.88|5.88|||
4119549|NCT00931879|3944858|B1|||Insulin (uIU/mL)||(uIU/mL)|Mean|39.54|39.54|Standard Deviation|12.63|12.63|||
4119550|NCT00931879|3944856|B3|||C-peptide (ng/mL)||(ng/mL)|Mean|4.61|4.61|Standard Deviation|0.30|0.3|||
4119551|NCT00931879|3944857|B2|||C-peptide (ng/mL)||(ng/mL)|Mean|4.56|4.56|Standard Deviation|0.45|0.45|||
4119552|NCT00931879|3944858|B1|||C-peptide (ng/mL)||(ng/mL)|Mean|4.66|4.66|Standard Deviation|0.40|0.4|||
4119553|NCT00931879|3944856|B3|||Alkaline phosphatase (u/L)||(u/L)|Mean|74.63|74.63|Standard Deviation|4.62|4.62|||
4119554|NCT00931879|3944857|B2|||Alkaline phosphatase (u/L)||(u/L)|Mean|70.11|70.11|Standard Deviation|4.40|4.4|||
4119555|NCT00931879|3944858|B1|||Alkaline phosphatase (u/L)||(u/L)|Mean|77.89|77.89|Standard Deviation|6.55|6.55|||
4119556|NCT00931879|3944856|B3|||serum glutamate pyruvate transaminase (ALT) (u/L)||(u/L)|Mean|30.71|30.71|Standard Deviation|2.20|2.2|||
4119557|NCT00931879|3944857|B2|||serum glutamate pyruvate transaminase (ALT) (u/L)||(u/L)|Mean|31.05|31.05|Standard Deviation|3.84|3.84|||
4119558|NCT00931879|3944858|B1|||serum glutamate pyruvate transaminase (ALT) (u/L)||(u/L)|Mean|28.79|28.79|Standard Deviation|2.63|2.63|||
4119559|NCT00931879|3944856|B3|||serum glutamate oxaloacetate transaminase(AST) (u/L)||(u/L)|Mean|24.00|24.0|Standard Deviation|8.44|8.44|||
4119560|NCT00931879|3944857|B2|||serum glutamate oxaloacetate transaminase(AST) (u/L)||(u/L)|Mean|24.11|24.11|Standard Deviation|2.28|2.28|||
4119561|NCT00931879|3944858|B1|||serum glutamate oxaloacetate transaminase(AST) (u/L)||(u/L)|Mean|22.16|22.16|Standard Deviation|1.50|1.5|||
4119562|NCT00931879|3944856|B3|||Fasting glucose (mg/dL)||(mg/dL)|Mean|156.55|156.55|Standard Deviation|7.49|7.49|||
4119563|NCT00931879|3944857|B2|||Fasting glucose (mg/dL)||(mg/dL)|Mean|157.21|157.21|Standard Deviation|12.09|12.09|||
4119564|NCT00931879|3944858|B1|||Fasting glucose (mg/dL)||(mg/dL)|Mean|155.89|155.89|Standard Deviation|9.18|9.18|||
4119565|NCT00931879|3944856|B3|||HbA1c (%)||%|Mean|7.73|7.73|Standard Deviation|0.21|0.21|||
4119566|NCT00931879|3944857|B2|||HbA1c (%)||%|Mean|7.66|7.66|Standard Deviation|0.23|0.23|||
4119567|NCT00931879|3944858|B1|||HbA1c (%)||%|Mean|7.82|7.82|Standard Deviation|0.35|0.35|||
4119568|NCT00931879|3944856|B3|||LDL cholesterol (mg/dL)||(mg/dL)|Mean|88.30|88.3|Standard Deviation|5.01|5.01|||
4119569|NCT00931879|3944857|B2|||LDL cholesterol (mg/dL)||(mg/dL)|Mean|101.44|101.44|Standard Deviation|7.21|7.21|||
4119570|NCT00931879|3944858|B1|||LDL cholesterol (mg/dL)||(mg/dL)|Mean|75.84|75.84|Standard Deviation|5.80|5.8|||
4119571|NCT00931879|3944856|B3|||HDL cholesterol (mg/dL)||(mg/dL)|Mean|41.58|41.58|Standard Deviation|1.80|1.8|||
4119572|NCT00931879|3944857|B2|||HDL cholesterol (mg/dL)||(mg/dL)|Mean|43.32|43.32|Standard Deviation|2.81|2.81|||
4119573|NCT00931879|3944858|B1|||HDL cholesterol (mg/dL)||(mg/dL)|Mean|39.84|39.84|Standard Deviation|2.27|2.27|||
4119574|NCT00931879|3944856|B3|||Total cholesterol (mg/dL)||(mg/dL)|Mean|170.84|170.84|Standard Deviation|6.51|6.51|||
4119575|NCT00931879|3944857|B2|||Total cholesterol (mg/dL)||(mg/dL)|Mean|189.42|189.42|Standard Deviation|9.63|9.63|||
4119576|NCT00931879|3944858|B1|||Total cholesterol (mg/dL)||(mg/dL)|Mean|152.26|152.26|Standard Deviation|6.56|6.56|||
4119577|NCT00931879|3944856|B3|||Qualifying triglyceride level (mg/dL)||mg/dL|Mean|237.48|237.48|Standard Deviation|24.42|24.42|||
4119578|NCT00931879|3944857|B2|||Qualifying triglyceride level (mg/dL)||mg/dL|Mean|261.17|261.17|Standard Deviation|50.73|50.73|||
4119579|NCT00931879|3944858|B1|||Qualifying triglyceride level (mg/dL)||mg/dL|Mean|215.05|215.05|Standard Deviation|12.51|12.51|||
4119580|NCT00931879|3944856|B3|||BMI kg/m^2||kg/m^2|Mean|34.10|34.1|Standard Deviation|1.11|1.11|||
4119581|NCT00931879|3944857|B2|||BMI kg/m^2||kg/m^2|Mean|34.37|34.37|Standard Deviation|1.83|1.83|||
4119582|NCT00931879|3944858|B1|||BMI kg/m^2||kg/m^2|Mean|34.04|34.04|Standard Deviation|1.17|1.17|||
4119583|NCT00931879|3944856|B3|||Weight (lbs)||lbs|Mean|215.71|215.71|Standard Deviation|7.25|7.25|||
4119584|NCT00931879|3944857|B2|||Weight (lbs)||lbs|Mean|215.16|215.16|Standard Deviation|10.38|10.38|||
4119585|NCT00931879|3944858|B1|||Weight (lbs)||lbs|Mean|217.03|217.03|Standard Deviation|9.62|9.62|||
4119586|NCT00931879|3944856|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4119587|NCT00931879|3944857|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119588|NCT00931879|3944858|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4119589|NCT00931879|3944856|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119590|NCT00931879|3944857|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119591|NCT00931879|3944858|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119592|NCT00931879|3944856|B3||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4119593|NCT00931879|3944857|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4119594|NCT00931879|3944858|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4119595|NCT00931879|3944856|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4119596|NCT00931879|3944857|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4119597|NCT00931879|3944858|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4119598|NCT00931879|3944856|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119599|NCT00931879|3944857|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119600|NCT00931879|3944858|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119601|NCT00931879|3944856|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119602|NCT00931879|3944857|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119603|NCT00931879|3944858|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119604|NCT00931879|3944856|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119605|NCT00931879|3944857|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119606|NCT00931879|3944858|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119607|NCT00931879|3944856|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4119608|NCT00931879|3944857|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4119609|NCT00931879|3944858|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4119610|NCT00931879|3944856|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4119611|NCT00931879|3944857|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4119612|NCT00931879|3944858|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4119613|NCT00931879|3944856|B3|||Age||years|Mean|59.39|59.39|Standard Deviation|1.33|1.33|||
4119614|NCT00931879|3944857|B2|||Age||years|Mean|58.21|58.21|Standard Deviation|1.70|1.7|||
4119615|NCT00931879|3944858|B1|||Age||years|Mean|60.58|60.58|Standard Deviation|2.06|2.06|||
4119616|NCT00931801|3944881|B4|||Mean CD4||cells/mm3|Mean|532.0|532.0|Standard Deviation|193.8|193.8|||
4119617|NCT00931801|3944882|B3|||Mean CD4||cells/mm3|Mean|533.9|533.9|Standard Deviation|198.3|198.3|||
4119618|NCT00931801|3944883|B2|||Mean CD4||cells/mm3|Mean|518.5|518.5|Standard Deviation|198.9|198.9|||
4119619|NCT00931801|3944884|B1|||Mean CD4||cells/mm3|Mean|544.6|544.6|Standard Deviation|197.7|197.7|||
4119620|NCT00931801|3944881|B4|United States||Region of Enrollment||participants|Number|43|43.0||||||
4119621|NCT00931801|3944882|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4119622|NCT00931801|3944883|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4119623|NCT00931801|3944884|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4119624|NCT00931801|3944881|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4119625|NCT00931801|3944882|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119626|NCT00931801|3944883|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119627|NCT00931801|3944884|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4119628|NCT00931801|3944881|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119629|NCT00931801|3944882|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119630|NCT00931801|3944883|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119631|NCT00931801|3944884|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119632|NCT00931801|3944881|B4||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4119633|NCT00931801|3944882|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4119634|NCT00931801|3944883|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4119635|NCT00931801|3944884|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4119636|NCT00931801|3944881|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4119637|NCT00931801|3944882|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4119638|NCT00931801|3944883|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4119639|NCT00931801|3944884|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4119640|NCT00931801|3944881|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119641|NCT00931801|3944882|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119642|NCT00931801|3944883|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119643|NCT00931801|3944884|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119644|NCT00931801|3944881|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4119645|NCT00931801|3944882|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119646|NCT00931801|3944883|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119647|NCT00931801|3944884|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4119648|NCT00931801|3944881|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119649|NCT00931801|3944882|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119650|NCT00931801|3944883|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119651|NCT00931801|3944884|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119652|NCT00931801|3944881|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119653|NCT00931801|3944882|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119654|NCT00931801|3944883|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119655|NCT00931801|3944884|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119656|NCT00931801|3944881|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4119657|NCT00931801|3944882|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4119658|NCT00931801|3944883|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4119659|NCT00931801|3944884|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4119660|NCT00931801|3944881|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4119661|NCT00931801|3944882|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4119662|NCT00931801|3944883|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4119663|NCT00931801|3944884|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4119664|NCT00931801|3944881|B4||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4119665|NCT00931801|3944882|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4119666|NCT00931801|3944883|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4119667|NCT00931801|3944884|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4119668|NCT00931801|3944881|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4119669|NCT00931801|3944882|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4119670|NCT00931801|3944883|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4119671|NCT00931801|3944884|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4119672|NCT00931801|3944881|B4|||Age||years|Mean|45.9|45.9|Standard Deviation|10.1|10.1|||
4119673|NCT00931801|3944882|B3|||Age||years|Mean|46.6|46.6|Standard Deviation|6.6|6.6|||
4119674|NCT00931801|3944883|B2|||Age||years|Mean|47.6|47.6|Standard Deviation|11.5|11.5|||
4119675|NCT00931801|3944884|B1|||Age||years|Mean|43.5|43.5|Standard Deviation|11.6|11.6|||
4119676|NCT00931723|3944907|B3||Male|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4119677|NCT00931723|3944908|B2||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4119678|NCT00931723|3944909|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4119679|NCT00931723|3944907|B3||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4119680|NCT00931723|3944908|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4119681|NCT00931723|3944909|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4119682|NCT00931723|3944907|B3|||Age||Years|Mean|38.3|38.3|Standard Deviation|12.39|12.39|||
4119683|NCT00931723|3944908|B2|||Age||Years|Mean|38.8|38.8|Standard Deviation|12.09|12.09|||
4119684|NCT00931723|3944909|B1|||Age||Years|Mean|37.9|37.9|Standard Deviation|12.71|12.71|||
4119685|NCT00931710|3944956|B3||Male|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4119686|NCT00931710|3944957|B2||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4119687|NCT00931710|3944958|B1||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4119688|NCT00931710|3944956|B3||Female|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
4119689|NCT00931710|3944957|B2||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4119690|NCT00931710|3944958|B1||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4119691|NCT00931710|3944956|B3|||Age||years|Mean|56.1|56.1|Standard Deviation|9.81|9.81|||
4119692|NCT00931710|3944957|B2|||Age||years|Mean|57.1|57.1|Standard Deviation|9.69|9.69|||
4119693|NCT00931710|3944958|B1|||Age||years|Mean|55.0|55.0|Standard Deviation|9.83|9.83|||
4119694|NCT00931632|3944975|B3|Canada||Region of Enrollment||participants|Number|39|39.0||||||
4119695|NCT00931632|3944976|B2|Canada||Region of Enrollment||participants|Number|19|19.0||||||
4119696|NCT00931632|3944977|B1|Canada||Region of Enrollment||participants|Number|20|20.0||||||
4119697|NCT00931632|3944975|B3|United States||Region of Enrollment||participants|Number|412|412.0||||||
4119698|NCT00931632|3944976|B2|United States||Region of Enrollment||participants|Number|203|203.0||||||
4119699|NCT00931632|3944977|B1|United States||Region of Enrollment||participants|Number|209|209.0||||||
4119700|NCT00931632|3944975|B3|Other||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4119701|NCT00931632|3944976|B2|Other||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4119702|NCT00931632|3944977|B1|Other||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4119703|NCT00931632|3944975|B3|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4119704|NCT00931632|3944976|B2|Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4119705|NCT00931632|3944977|B1|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4119706|NCT00931632|3944975|B3|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4119707|NCT00931632|3944976|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4119708|NCT00931632|3944977|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4119709|NCT00931632|3944975|B3|American Indian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4119710|NCT00931632|3944976|B2|American Indian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4119711|NCT00931632|3944977|B1|American Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4119712|NCT00931632|3944975|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|88|88.0||||||
4119713|NCT00931632|3944976|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
4119714|NCT00931632|3944977|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4119715|NCT00931632|3944975|B3|Black||Race/Ethnicity, Customized||participants|Number|117|117.0||||||
4119716|NCT00931632|3944976|B2|Black||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
4119717|NCT00931632|3944977|B1|Black||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
4119718|NCT00931632|3944975|B3|White||Race/Ethnicity, Customized||participants|Number|205|205.0||||||
4119719|NCT00931632|3944976|B2|White||Race/Ethnicity, Customized||participants|Number|85|85.0||||||
4119720|NCT00931632|3944977|B1|White||Race/Ethnicity, Customized||participants|Number|120|120.0||||||
4119721|NCT00931632|3944975|B3||Male|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
4119722|NCT00931632|3944976|B2||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4119723|NCT00931632|3944977|B1||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4119724|NCT00931632|3944975|B3||Female|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
4119725|NCT00931632|3944976|B2||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4119726|NCT00931632|3944977|B1||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4119727|NCT00931632|3944975|B3|||Age, Customized|Preterm infants < 30 weeks Gestational Age (GA)|participants|Number|451|451.0||||||
4119728|NCT00931632|3944976|B2|||Age, Customized|Preterm infants < 30 weeks Gestational Age (GA)|participants|Number|222|222.0||||||
4119729|NCT00931632|3944977|B1|||Age, Customized|Preterm infants < 30 weeks Gestational Age (GA)|participants|Number|229|229.0||||||
4119730|NCT00931528|3944998|B3||Male|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
4119731|NCT00931528|3944999|B2||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4119732|NCT00931528|3945000|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4119733|NCT00931528|3944998|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119734|NCT00931528|3944999|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119735|NCT00931528|3945000|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119736|NCT00931528|3944998|B3|||Age||years|Median|63|63.0|Full Range|||45.0|80.0|
4119737|NCT00931528|3944999|B2|||Age||years|Median|63|63.0|Full Range|||48.0|79.0|
4119738|NCT00931528|3945000|B1|||Age||years|Median|63|63.0|Full Range|||45.0|80.0|
4119739|NCT00931515|3945019|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4119740|NCT00931515|3945020|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4119741|NCT00931515|3945021|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4119742|NCT00931515|3945019|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4119743|NCT00931515|3945020|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4119744|NCT00931515|3945021|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4119745|NCT00931515|3945019|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4119746|NCT00931515|3945020|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4119747|NCT00931515|3945021|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4119748|NCT00931515|3945019|B3|||Age||years|Mean|42.05|42.05|Standard Deviation|11.2|11.2|||
4119749|NCT00931515|3945020|B2|||Age||years|Mean|40.1|40.1|Standard Deviation|11.2|11.2|||
4119750|NCT00931515|3945021|B1|||Age||years|Mean|44.0|44.0|Standard Deviation|11.2|11.2|||
4119751|NCT00931515|3945019|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4119752|NCT00931515|3945020|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4119753|NCT00931515|3945021|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4119754|NCT00931515|3945019|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4119755|NCT00931515|3945020|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4119756|NCT00931515|3945021|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4119757|NCT00931515|3945019|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4119758|NCT00931515|3945020|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4119759|NCT00931515|3945021|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4119760|NCT00931489|3945028|B6||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4119761|NCT00931489|3945029|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4119762|NCT00931489|3945030|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4119763|NCT00931489|3945031|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4119764|NCT00931489|3945032|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4119765|NCT00931489|3945033|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4119766|NCT00931489|3945028|B6||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4119767|NCT00931489|3945029|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4119768|NCT00931489|3945030|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4119769|NCT00931489|3945031|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4119770|NCT00931489|3945032|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4119771|NCT00931489|3945033|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4119772|NCT00931489|3945028|B6|||Age||Years|Mean|75.60|75.6|Standard Deviation|10.15|10.15|||
4119773|NCT00931489|3945029|B5|||Age||Years|Mean|82.86|82.86|Standard Deviation|8.41|8.41|||
4119774|NCT00931489|3945030|B4|||Age||Years|Mean|77.08|77.08|Standard Deviation|9.50|9.5|||
4119775|NCT00931489|3945031|B3|||Age||Years|Mean|78.20|78.2|Standard Deviation|8.41|8.41|||
4119776|NCT00931489|3945032|B2|||Age||Years|Mean|67.82|67.82|Standard Deviation|7.39|7.39|||
4119777|NCT00931489|3945033|B1|||Age||Years|Mean|80.35|80.35|Standard Deviation|9.24|9.24|||
4119778|NCT00931463|3945050|B3|South America||Region of Enrollment||participants|Number|112|112.0||||||
4119779|NCT00931463|3945051|B2|South America||Region of Enrollment||participants|Number|59|59.0||||||
4119780|NCT00931463|3945052|B1|South America||Region of Enrollment||participants|Number|53|53.0||||||
4119781|NCT00931463|3945050|B3|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4119782|NCT00931463|3945051|B2|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4119783|NCT00931463|3945052|B1|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4119784|NCT00931463|3945050|B3|Europe||Region of Enrollment||participants|Number|3|3.0||||||
4119785|NCT00931463|3945051|B2|Europe||Region of Enrollment||participants|Number|2|2.0||||||
4119786|NCT00931463|3945052|B1|Europe||Region of Enrollment||participants|Number|1|1.0||||||
4119787|NCT00931463|3945050|B3|Southeast Asia||Region of Enrollment||participants|Number|229|229.0||||||
4119788|NCT00931463|3945051|B2|Southeast Asia||Region of Enrollment||participants|Number|113|113.0||||||
4119789|NCT00931463|3945052|B1|Southeast Asia||Region of Enrollment||participants|Number|116|116.0||||||
4119790|NCT00931463|3945050|B3|Africa||Region of Enrollment||participants|Number|196|196.0||||||
4119791|NCT00931463|3945051|B2|Africa||Region of Enrollment||participants|Number|96|96.0||||||
4119792|NCT00931463|3945052|B1|Africa||Region of Enrollment||participants|Number|100|100.0||||||
4119793|NCT00931463|3945050|B3||Male|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
4119794|NCT00931463|3945051|B2||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4119795|NCT00931463|3945052|B1||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4119796|NCT00931463|3945050|B3||Female|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
4119797|NCT00931463|3945051|B2||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4119798|NCT00931463|3945052|B1||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4119799|NCT00931463|3945050|B3|||Age||years|Mean|38.78|38.78|Standard Deviation|8.82|8.82|||
4119800|NCT00931463|3945051|B2|||Age||years|Mean|38.55|38.55|Standard Deviation|8.84|8.84|||
4119801|NCT00931463|3945052|B1|||Age||years|Mean|39|39.0|Standard Deviation|8.81|8.81|||
4119802|NCT00931411|3945067|B3|||Quality of Life Questionnaire|The effect of formulation 609580 20 to improve quality of life compared to formulation 609209 as measured by changes in the quality of life questionnaire score from Day 0 to Day 42. Scale from -46 (worse) to 46 (better).|Units on a scale|Mean|7.1|7.1|Standard Deviation|11.4|11.4|||
4119803|NCT00931411|3945068|B2|||Quality of Life Questionnaire|The effect of formulation 609580 20 to improve quality of life compared to formulation 609209 as measured by changes in the quality of life questionnaire score from Day 0 to Day 42. Scale from -46 (worse) to 46 (better).|Units on a scale|Mean|9.25|9.25|Standard Deviation|12.2|12.2|||
4119804|NCT00931411|3945069|B1|||Quality of Life Questionnaire|The effect of formulation 609580 20 to improve quality of life compared to formulation 609209 as measured by changes in the quality of life questionnaire score from Day 0 to Day 42. Scale from -46 (worse) to 46 (better).|Units on a scale|Mean|4.75|4.75|Standard Deviation|10.2|10.2|||
4119805|NCT00931411|3945067|B3|||SCORAD - Score Atopic Dermatitis|"SCORAD - Score Atopic Dermatis measures intensity of erythema/darkening, edema/papulation, oosing/crust, excoriation, lichenfinication/prurigo and dryness on a scale from 0-3 for a total of 18 points. This score is multiplided by 3.5 and added to 1/5 of the affected percent body surface area. The final score is added to the score from a 10-point pruritus visual analog scale (VAS) and a 10-point loss of sleep VAS. Best score is 0, worst score is 103.~Example:~18 * 3.5 = 63~63 + 20 = 83~83 + 10 + 10 = 103"|Units on a scale|Mean|21.3|21.3|Standard Deviation|5.0|5.0|||
4119806|NCT00931411|3945068|B2|||SCORAD - Score Atopic Dermatitis|"SCORAD - Score Atopic Dermatis measures intensity of erythema/darkening, edema/papulation, oosing/crust, excoriation, lichenfinication/prurigo and dryness on a scale from 0-3 for a total of 18 points. This score is multiplided by 3.5 and added to 1/5 of the affected percent body surface area. The final score is added to the score from a 10-point pruritus visual analog scale (VAS) and a 10-point loss of sleep VAS. Best score is 0, worst score is 103.~Example:~18 * 3.5 = 63~63 + 20 = 83~83 + 10 + 10 = 103"|Units on a scale|Mean|21.2|21.2|Standard Deviation|5.2|5.2|||
4119807|NCT00931411|3945069|B1|||SCORAD - Score Atopic Dermatitis|"SCORAD - Score Atopic Dermatis measures intensity of erythema/darkening, edema/papulation, oosing/crust, excoriation, lichenfinication/prurigo and dryness on a scale from 0-3 for a total of 18 points. This score is multiplided by 3.5 and added to 1/5 of the affected percent body surface area. The final score is added to the score from a 10-point pruritus visual analog scale (VAS) and a 10-point loss of sleep VAS. Best score is 0, worst score is 103.~Example:~18 * 3.5 = 63~63 + 20 = 83~83 + 10 + 10 = 103"|Units on a scale|Mean|21.5|21.5|Standard Deviation|4.8|4.8|||
4119808|NCT00931411|3945067|B3|Canada||Region of Enrollment||participants|Number|73|73.0||||||
4119809|NCT00931411|3945068|B2|Canada||Region of Enrollment||participants|Number|38|38.0||||||
4119810|NCT00931411|3945069|B1|Canada||Region of Enrollment||participants|Number|35|35.0||||||
4119811|NCT00931411|3945067|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4119812|NCT00931411|3945068|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4119813|NCT00931411|3945069|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4119814|NCT00931411|3945067|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4119815|NCT00931411|3945068|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4119816|NCT00931411|3945069|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4119817|NCT00931411|3945067|B3|||Age||years|Mean|6.88|6.88|Standard Deviation|2.59|2.59|||
4119818|NCT00931411|3945068|B2|||Age||years|Mean|6.66|6.66|Standard Deviation|2.36|2.36|||
4119819|NCT00931411|3945069|B1|||Age||years|Mean|7.11|7.11|Standard Deviation|2.83|2.83|||
4119820|NCT00931411|3945067|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4119821|NCT00931411|3945068|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4119822|NCT00931411|3945069|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4119823|NCT00931411|3945067|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4119824|NCT00931411|3945068|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4119825|NCT00931411|3945069|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4119826|NCT00931411|3945067|B3||<=18 years|Age||Participants|Count of Participants|73|73.0||||||
4119827|NCT00931411|3945068|B2||<=18 years|Age||Participants|Count of Participants|38|38.0||||||
4119828|NCT00931411|3945069|B1||<=18 years|Age||Participants|Count of Participants|35|35.0||||||
4119829|NCT00931385|3945091|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4119830|NCT00931385|3945091|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4119831|NCT00931385|3945091|B1|||Age||years|Mean|61.8|61.8|Standard Deviation|8.9|8.9|||
4119832|NCT00931359|3945148|B3|United States||Region of Enrollment||participants|Number|120|120.0||||||
4119833|NCT00931359|3945149|B2|United States||Region of Enrollment||participants|Number|81|81.0||||||
4119834|NCT00931359|3945150|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4119835|NCT00931359|3945148|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4119836|NCT00931359|3945149|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4119837|NCT00931359|3945150|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4119838|NCT00931359|3945148|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4119839|NCT00931359|3945149|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4119840|NCT00931359|3945150|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4119841|NCT00931359|3945148|B3|||Age||years|Mean|32.8|32.8|Standard Deviation|10.8|10.8|||
4119842|NCT00931359|3945149|B2|||Age||years|Mean|32.2|32.2|Standard Deviation|10.7|10.7|||
4119843|NCT00931359|3945150|B1|||Age||years|Mean|34.1|34.1|Standard Deviation|11.2|11.2|||
4119844|NCT00931359|3945148|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4119845|NCT00931359|3945149|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4119846|NCT00931359|3945150|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4119847|NCT00931359|3945148|B3||Between 18 and 65 years|Age||Participants|Count of Participants|119|119.0||||||
4119848|NCT00931359|3945149|B2||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4119849|NCT00931359|3945150|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4119850|NCT00931359|3945148|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4119851|NCT00931359|3945149|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4119852|NCT00931359|3945150|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4119853|NCT00931307|3945163|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4119854|NCT00931307|3945163|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4119855|NCT00931307|3945163|B1|||Age||years|Mean|32.4|32.4|Standard Deviation|10.0|10.0|||
4119856|NCT00931268|3945167|B1|France||Region of Enrollment||participants|Number|10|10.0||||||
4119857|NCT00931268|3945167|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4119858|NCT00931268|3945167|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4119859|NCT00931268|3945167|B1|||Age||years|Mean|44.6|44.6|Standard Deviation|3.7|3.7|||
4119860|NCT00931268|3945167|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4119861|NCT00931268|3945167|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4119862|NCT00931268|3945167|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4119863|NCT00931255|3945177|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4119864|NCT00931255|3945178|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4119865|NCT00931255|3945179|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4119866|NCT00931255|3945177|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4119867|NCT00931255|3945178|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4119868|NCT00931255|3945179|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4119869|NCT00931255|3945177|B3|||Age||years|Mean|51.7|51.7|Standard Deviation|9.9|9.9|||
4119870|NCT00931255|3945178|B2|||Age||years|Mean|49.9|49.9|Standard Deviation|10.1|10.1|||
4119871|NCT00931255|3945179|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|9.7|9.7|||
4119872|NCT00931242|3945202|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4119873|NCT00931242|3945203|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4119874|NCT00931242|3945204|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4119875|NCT00931242|3945202|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4119876|NCT00931242|3945203|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119877|NCT00931242|3945204|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4119878|NCT00931242|3945202|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4119879|NCT00931242|3945203|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4119880|NCT00931242|3945204|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4119881|NCT00931242|3945202|B3|||Age||years|Mean|45|45.0|Standard Deviation|13.0384048|13.0384048|||
4119882|NCT00931242|3945203|B2|||Age||years|Mean|53.4|53.4|Standard Deviation|4.5|4.5|||
4119883|NCT00931242|3945204|B1|||Age||years|Mean|43.3|43.3|Standard Deviation|14.2442971|14.2442971|||
4119884|NCT00931242|3945202|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4119885|NCT00931242|3945203|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4119886|NCT00931242|3945204|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4119887|NCT00931242|3945202|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4119888|NCT00931242|3945203|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4119889|NCT00931242|3945204|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4119890|NCT00931242|3945202|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4119891|NCT00931242|3945203|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4119892|NCT00931242|3945204|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4119893|NCT00931164|3945211|B1|Ireland||Region of Enrollment||participants|Number|1|1.0||||||
4119894|NCT00931164|3945211|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4119895|NCT00931164|3945211|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4119896|NCT00931164|3945211|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4119897|NCT00931164|3945211|B1|||Age||years|Mean|6.4|6.4|Full Range|||1.1|11.2|
4119898|NCT00931164|3945211|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4119899|NCT00931164|3945211|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4119900|NCT00931164|3945211|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4119901|NCT00930982|3945215|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4119902|NCT00930982|3945216|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4119903|NCT00930982|3945217|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4119904|NCT00930982|3945215|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4119905|NCT00930982|3945216|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4119906|NCT00930982|3945217|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4119907|NCT00930982|3945215|B3|||Age||Years|Mean|63.0|63.0|Standard Deviation|11.9|11.9|||
4119908|NCT00930982|3945216|B2|||Age||Years|Mean|61.4|61.4|Standard Deviation|11.9|11.9|||
4119909|NCT00930982|3945217|B1|||Age||Years|Mean|64.7|64.7|Standard Deviation|11.8|11.8|||
4119910|NCT00930969|3945252|B1|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4119911|NCT00930969|3945252|B1|Germany||Region of Enrollment||participants|Number|3|3.0||||||
4119912|NCT00930969|3945252|B1|Netherlands||Region of Enrollment||participants|Number|11|11.0||||||
4119913|NCT00930969|3945252|B1|Norway||Region of Enrollment||participants|Number|3|3.0||||||
4119914|NCT00930969|3945252|B1|South Africa||Region of Enrollment||participants|Number|0|0.0||||||
4119915|NCT00930969|3945252|B1|Austria||Region of Enrollment||participants|Number|10|10.0||||||
4119916|NCT00930969|3945252|B1|Denmark||Region of Enrollment||participants|Number|13|13.0||||||
4119917|NCT00930969|3945252|B1|United States||Region of Enrollment||participants|Number|134|134.0||||||
4119918|NCT00930969|3945252|B1||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4119919|NCT00930969|3945252|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4119920|NCT00930969|3945252|B1|||Age||years|Mean|60|60.0|Standard Deviation|10|10.0|||
4119921|NCT00930969|3945252|B1||>=65 years|Age||Participants|Count of Participants|57|57.0||||||
4119922|NCT00930969|3945252|B1||Between 18 and 65 years|Age||Participants|Count of Participants|118|118.0||||||
4119923|NCT00930969|3945252|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4119924|NCT00930930|3945260|B3|United States||Region of Enrollment||participants|Number|145|145.0||||||
4119925|NCT00930930|3945261|B2|United States||Region of Enrollment||participants|Number|49|49.0||||||
4119926|NCT00930930|3945262|B1|United States||Region of Enrollment||participants|Number|96|96.0||||||
4119927|NCT00930930|3945260|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119928|NCT00930930|3945261|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119929|NCT00930930|3945262|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4119930|NCT00930930|3945260|B3||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4119931|NCT00930930|3945261|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4119932|NCT00930930|3945262|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4119933|NCT00930930|3945260|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4119934|NCT00930930|3945261|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4119935|NCT00930930|3945262|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4119936|NCT00930930|3945260|B3||Between 18 and 65 years|Age||Participants|Count of Participants|133|133.0||||||
4119937|NCT00930930|3945261|B2||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4119938|NCT00930930|3945262|B1||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
4119939|NCT00930930|3945260|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4119940|NCT00930930|3945261|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4119941|NCT00930930|3945262|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4119942|NCT00930930|3945260|B3|||Age||years|Median|52|52.0|Inter-Quartile Range|||43.0|58.0|
4119943|NCT00930930|3945261|B2|||Age||years|Median|52|52.0|Inter-Quartile Range|||43.0|58.0|
4119944|NCT00930930|3945262|B1|||Age||years|Median|52|52.0|Inter-Quartile Range|||42.8|57.2|
4119945|NCT00930813|3945275|B3|5 (Minor tissue loss)||Rutherford Class||participants|Number|4|4.0||||||
4119946|NCT00930813|3945276|B2|5 (Minor tissue loss)||Rutherford Class||participants|Number|2|2.0||||||
4119947|NCT00930813|3945277|B1|5 (Minor tissue loss)||Rutherford Class||participants|Number|2|2.0||||||
4119948|NCT00930813|3945275|B3|4 (Ischemia rest pain)||Rutherford Class||participants|Number|3|3.0||||||
4119949|NCT00930813|3945276|B2|4 (Ischemia rest pain)||Rutherford Class||participants|Number|2|2.0||||||
4119950|NCT00930813|3945277|B1|4 (Ischemia rest pain)||Rutherford Class||participants|Number|1|1.0||||||
4119951|NCT00930813|3945275|B3|3 (Severe claudication)||Rutherford Class||participants|Number|72|72.0||||||
4119952|NCT00930813|3945276|B2|3 (Severe claudication)||Rutherford Class||participants|Number|37|37.0||||||
4119953|NCT00930813|3945277|B1|3 (Severe claudication)||Rutherford Class||participants|Number|35|35.0||||||
4119954|NCT00930813|3945275|B3|2 (Moderate claudication)||Rutherford Class||participants|Number|22|22.0||||||
4119955|NCT00930813|3945276|B2|2 (Moderate claudication)||Rutherford Class||participants|Number|11|11.0||||||
4119956|NCT00930813|3945277|B1|2 (Moderate claudication)||Rutherford Class||participants|Number|11|11.0||||||
4119957|NCT00930813|3945275|B3|No||Lesion totally occluded||participants|Number|59|59.0||||||
4119958|NCT00930813|3945276|B2|No||Lesion totally occluded||participants|Number|30|30.0||||||
4119959|NCT00930813|3945277|B1|No||Lesion totally occluded||participants|Number|29|29.0||||||
4119960|NCT00930813|3945275|B3|Yes||Lesion totally occluded||participants|Number|42|42.0||||||
4119961|NCT00930813|3945276|B2|Yes||Lesion totally occluded||participants|Number|22|22.0||||||
4119962|NCT00930813|3945277|B1|Yes||Lesion totally occluded||participants|Number|20|20.0||||||
4119963|NCT00930813|3945275|B3|||Lesion Length||mm|Mean|81|81.0|Standard Deviation|38|38.0|||
4119964|NCT00930813|3945276|B2|||Lesion Length||mm|Mean|80|80.0|Standard Deviation|38|38.0|||
4119965|NCT00930813|3945277|B1|||Lesion Length||mm|Mean|81|81.0|Standard Deviation|37|37.0|||
4119966|NCT00930813|3945275|B3|Popliteal||Lesion location||participants|Number|7|7.0||||||
4119967|NCT00930813|3945276|B2|Popliteal||Lesion location||participants|Number|3|3.0||||||
4119968|NCT00930813|3945277|B1|Popliteal||Lesion location||participants|Number|4|4.0||||||
4119969|NCT00930813|3945275|B3|SFA||Lesion location||participants|Number|94|94.0||||||
4119970|NCT00930813|3945276|B2|SFA||Lesion location||participants|Number|49|49.0||||||
4119971|NCT00930813|3945277|B1|SFA||Lesion location||participants|Number|45|45.0||||||
4119972|NCT00930813|3945275|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4119973|NCT00930813|3945276|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4119974|NCT00930813|3945277|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4119975|NCT00930813|3945275|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4119976|NCT00930813|3945276|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4119977|NCT00930813|3945277|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4119978|NCT00930813|3945275|B3|||Age||years|Mean|68|68.0|Standard Deviation|9|9.0|||
4119979|NCT00930813|3945276|B2|||Age||years|Mean|70|70.0|Standard Deviation|10|10.0|||
4119980|NCT00930813|3945277|B1|||Age||years|Mean|67|67.0|Standard Deviation|8|8.0|||
4119981|NCT00930787|3945286|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4119982|NCT00930787|3945287|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4119983|NCT00930787|3945288|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4119984|NCT00930787|3945286|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4119985|NCT00930787|3945287|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4119986|NCT00930787|3945288|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4119987|NCT00930787|3945286|B3|||Age||years|Mean|56|56.0|Standard Deviation|12|12.0|||
4119988|NCT00930787|3945287|B2|||Age||years|Mean|52.7|52.7|Standard Deviation|13.54|13.54|||
4119989|NCT00930787|3945288|B1|||Age||years|Mean|58.2|58.2|Standard Deviation|11.47|11.47|||
4119990|NCT00930774|3945295|B5|||Word recognition score|Assessment of ability to repeat back simple words presented at 40 decibels above threshold|percent correct|Mean|95.9|95.9|Standard Deviation|4.7|4.7|||
4119991|NCT00930774|3945296|B4|||Word recognition score|Assessment of ability to repeat back simple words presented at 40 decibels above threshold|percent correct|Mean|95.6|95.6|Standard Deviation|3.9|3.9|||
4119992|NCT00930774|3945297|B3|||Word recognition score|Assessment of ability to repeat back simple words presented at 40 decibels above threshold|percent correct|Mean|97.3|97.3|Standard Deviation|2.8|2.8|||
4119993|NCT00930774|3945298|B2|||Word recognition score|Assessment of ability to repeat back simple words presented at 40 decibels above threshold|percent correct|Mean|95.2|95.2|Standard Deviation|5.4|5.4|||
4119994|NCT00930774|3945299|B1|||Word recognition score|Assessment of ability to repeat back simple words presented at 40 decibels above threshold|percent correct|Mean|95.5|95.5|Standard Deviation|5.8|5.8|||
4120047|NCT00930774|3945297|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4119995|NCT00930774|3945295|B5|||Pure tone sensitivity|Assessment of hearing ability at threshold for frequencies between 250 hertz and 8000 hertz|Decibels hearing level|Mean|12.2|12.2|Standard Deviation|5.1|5.1|||
4119996|NCT00930774|3945296|B4|||Pure tone sensitivity|Assessment of hearing ability at threshold for frequencies between 250 hertz and 8000 hertz|Decibels hearing level|Mean|12.1|12.1|Standard Deviation|4.4|4.4|||
4119997|NCT00930774|3945297|B3|||Pure tone sensitivity|Assessment of hearing ability at threshold for frequencies between 250 hertz and 8000 hertz|Decibels hearing level|Mean|12.9|12.9|Standard Deviation|5.4|5.4|||
4119998|NCT00930774|3945298|B2|||Pure tone sensitivity|Assessment of hearing ability at threshold for frequencies between 250 hertz and 8000 hertz|Decibels hearing level|Mean|12.0|12.0|Standard Deviation|5.3|5.3|||
4119999|NCT00930774|3945299|B1|||Pure tone sensitivity|Assessment of hearing ability at threshold for frequencies between 250 hertz and 8000 hertz|Decibels hearing level|Mean|12.3|12.3|Standard Deviation|6.1|6.1|||
4120000|NCT00930774|3945295|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4120001|NCT00930774|3945296|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120002|NCT00930774|3945297|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120003|NCT00930774|3945298|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4120004|NCT00930774|3945299|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4120005|NCT00930774|3945295|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
4120006|NCT00930774|3945296|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4120007|NCT00930774|3945297|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4120008|NCT00930774|3945298|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4120009|NCT00930774|3945299|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4120010|NCT00930774|3945295|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4120011|NCT00930774|3945296|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4120012|NCT00930774|3945297|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4120013|NCT00930774|3945298|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4120014|NCT00930774|3945299|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4120015|NCT00930774|3945295|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4120016|NCT00930774|3945296|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120017|NCT00930774|3945297|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120018|NCT00930774|3945298|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4120019|NCT00930774|3945299|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4120020|NCT00930774|3945295|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4120021|NCT00930774|3945296|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120022|NCT00930774|3945297|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4120023|NCT00930774|3945298|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120024|NCT00930774|3945299|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120025|NCT00930774|3945295|B5||White|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
4120026|NCT00930774|3945296|B4||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4120027|NCT00930774|3945297|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4120028|NCT00930774|3945298|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4120029|NCT00930774|3945299|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4120030|NCT00930774|3945295|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4120031|NCT00930774|3945296|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4120032|NCT00930774|3945297|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4120033|NCT00930774|3945298|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4120034|NCT00930774|3945299|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4120035|NCT00930774|3945295|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120036|NCT00930774|3945296|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120037|NCT00930774|3945297|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120038|NCT00930774|3945298|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120039|NCT00930774|3945299|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120040|NCT00930774|3945295|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4120041|NCT00930774|3945296|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120042|NCT00930774|3945297|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4120043|NCT00930774|3945298|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120044|NCT00930774|3945299|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120045|NCT00930774|3945295|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4120046|NCT00930774|3945296|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120048|NCT00930774|3945298|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120049|NCT00930774|3945299|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4120050|NCT00930774|3945295|B5||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4120051|NCT00930774|3945296|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4120052|NCT00930774|3945297|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4120053|NCT00930774|3945298|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4120054|NCT00930774|3945299|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4120055|NCT00930774|3945295|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4120056|NCT00930774|3945296|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4120057|NCT00930774|3945297|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4120058|NCT00930774|3945298|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4120059|NCT00930774|3945299|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4120060|NCT00930774|3945295|B5|||Age||years|Mean|34.0|34.0|Standard Deviation|8.1|8.1|||
4120061|NCT00930774|3945296|B4|||Age||years|Mean|33.7|33.7|Standard Deviation|8.0|8.0|||
4120062|NCT00930774|3945297|B3|||Age||years|Mean|33.9|33.9|Standard Deviation|7.7|7.7|||
4120063|NCT00930774|3945298|B2|||Age||years|Mean|33.9|33.9|Standard Deviation|9.2|9.2|||
4120064|NCT00930774|3945299|B1|||Age||years|Mean|34.4|34.4|Standard Deviation|7.8|7.8|||
4120065|NCT00930761|3945340|B3|Brazil||Region of Enrollment||participants|Number|101|101.0||||||
4120066|NCT00930761|3945341|B2|Brazil||Region of Enrollment||participants|Number|51|51.0||||||
4120067|NCT00930761|3945342|B1|Brazil||Region of Enrollment||participants|Number|50|50.0||||||
4120068|NCT00930761|3945340|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4120069|NCT00930761|3945341|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4120070|NCT00930761|3945342|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4120071|NCT00930761|3945340|B3||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4120072|NCT00930761|3945341|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4120073|NCT00930761|3945342|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4120074|NCT00930761|3945340|B3|> 40 years||Age, Customized|12-20 years; 21-30 years; 31-40 years; > 40 years|participants|Number|5|5.0||||||
4120075|NCT00930761|3945341|B2|> 40 years||Age, Customized|12-20 years; 21-30 years; 31-40 years; > 40 years|participants|Number|2|2.0||||||
4120076|NCT00930761|3945342|B1|> 40 years||Age, Customized|12-20 years; 21-30 years; 31-40 years; > 40 years|participants|Number|3|3.0||||||
4120077|NCT00930761|3945340|B3|31-40 years||Age, Customized|12-20 years; 21-30 years; 31-40 years; > 40 years|participants|Number|21|21.0||||||
4120078|NCT00930761|3945341|B2|31-40 years||Age, Customized|12-20 years; 21-30 years; 31-40 years; > 40 years|participants|Number|9|9.0||||||
4120079|NCT00930761|3945342|B1|31-40 years||Age, Customized|12-20 years; 21-30 years; 31-40 years; > 40 years|participants|Number|12|12.0||||||
4120080|NCT00930761|3945340|B3|21-30 years||Age, Customized|12-20 years; 21-30 years; 31-40 years; > 40 years|participants|Number|49|49.0||||||
4120081|NCT00930761|3945341|B2|21-30 years||Age, Customized|12-20 years; 21-30 years; 31-40 years; > 40 years|participants|Number|27|27.0||||||
4120082|NCT00930761|3945342|B1|21-30 years||Age, Customized|12-20 years; 21-30 years; 31-40 years; > 40 years|participants|Number|22|22.0||||||
4120083|NCT00930761|3945340|B3|12-20 years||Age, Customized|12-20 years; 21-30 years; 31-40 years; > 40 years|participants|Number|26|26.0||||||
4120084|NCT00930761|3945341|B2|12-20 years||Age, Customized|12-20 years; 21-30 years; 31-40 years; > 40 years|participants|Number|13|13.0||||||
4120085|NCT00930761|3945342|B1|12-20 years||Age, Customized|12-20 years; 21-30 years; 31-40 years; > 40 years|participants|Number|13|13.0||||||
4120086|NCT00930722|3945355|B1||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4120087|NCT00930722|3945355|B1||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4120088|NCT00930722|3945355|B1|||Age||Years|Mean|52.5|52.5|Standard Deviation|10.7|10.7|||
4120089|NCT00930644|3945370|B1|||Prescribed weekly number of days on PN/IV||days|Mean|5.6|5.6|Standard Deviation|1.68|1.68|||
4120090|NCT00930644|3945370|B1|||Prescribed weekly PN/IV volume||Liters|Mean|12.07|12.07|Standard Deviation|7.56|7.56|||
4120091|NCT00930644|3945370|B1|||Years since start of PN/IV dependecy||years|Mean|6.41|6.41|Standard Deviation|6.272|6.272|||
4120092|NCT00930644|3945370|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4120093|NCT00930644|3945370|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4120094|NCT00930644|3945370|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4120095|NCT00930644|3945370|B1||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4120096|NCT00930644|3945370|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4120097|NCT00930553|3945383|B1||Male|Sex: Female, Male||Participants|Count of Participants|457|457.0||||||
4120098|NCT00930553|3945383|B1||Female|Sex: Female, Male||Participants|Count of Participants|857|857.0||||||
4120099|NCT00930553|3945383|B1|||Age||years|Mean|36.7|36.7|Standard Deviation|8.51|8.51|||
4120100|NCT00930293|3945449|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4120101|NCT00930293|3945450|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4120102|NCT00930293|3945451|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4120103|NCT00930293|3945449|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4120104|NCT00930293|3945450|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4120105|NCT00930293|3945451|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4120106|NCT00930293|3945449|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4120107|NCT00930293|3945450|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4120108|NCT00930293|3945451|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4120109|NCT00930293|3945449|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4120110|NCT00930293|3945450|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4120111|NCT00930293|3945451|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4120112|NCT00930293|3945449|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4120113|NCT00930293|3945450|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4120114|NCT00930293|3945451|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4120115|NCT00930293|3945449|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4120116|NCT00930293|3945450|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4120117|NCT00930293|3945451|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4120118|NCT00930293|3945449|B3|||Age||years|Mean|30.74|30.74|Standard Deviation|10.72|10.72|||
4120119|NCT00930293|3945450|B2|||Age||years|Mean|31.09|31.09|Standard Deviation|10.27|10.27|||
4120120|NCT00930293|3945451|B1|||Age||years|Mean|30.37|30.37|Standard Deviation|11.41|11.41|||
4120121|NCT00930176|3945460|B1|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4120122|NCT00930176|3945460|B1|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4120123|NCT00930176|3945460|B1|Turkey||Region of Enrollment||participants|Number|6|6.0||||||
4120124|NCT00930176|3945460|B1|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4120125|NCT00930176|3945460|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4120126|NCT00930176|3945460|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4120127|NCT00930176|3945460|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4120128|NCT00930176|3945460|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4120129|NCT00930176|3945460|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4120130|NCT00930176|3945460|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4120131|NCT00929981|3945465|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4120132|NCT00929981|3945465|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4120133|NCT00929981|3945465|B1|||Age||Years|Mean|41.2|41.2|Standard Deviation|12.9|12.9|||
4120134|NCT00929864|3945475|B3|South America||Region of Enrollment||participants|Number|181|181.0||||||
4120135|NCT00929864|3945476|B2|South America||Region of Enrollment||participants|Number|93|93.0||||||
4120136|NCT00929864|3945477|B1|South America||Region of Enrollment||participants|Number|88|88.0||||||
4120137|NCT00929864|3945475|B3|North America||Region of Enrollment||participants|Number|465|465.0||||||
4120138|NCT00929864|3945476|B2|North America||Region of Enrollment||participants|Number|235|235.0||||||
4120139|NCT00929864|3945477|B1|North America||Region of Enrollment||participants|Number|230|230.0||||||
4120140|NCT00929864|3945475|B3||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4120141|NCT00929864|3945476|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4120142|NCT00929864|3945477|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4120143|NCT00929864|3945475|B3||Female|Sex: Female, Male||Participants|Count of Participants|529|529.0||||||
4120144|NCT00929864|3945476|B2||Female|Sex: Female, Male||Participants|Count of Participants|270|270.0||||||
4120145|NCT00929864|3945477|B1||Female|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
4120146|NCT00929864|3945475|B3|||Age||years|Mean|51.2|51.2|Standard Deviation|12.7|12.7|19.0|85.0|
4120147|NCT00929864|3945476|B2|||Age||years|Mean|51.0|51.0|Standard Deviation|12.8|12.8|19.0|85.0|
4120148|NCT00929864|3945477|B1|||Age||years|Mean|51.4|51.4|Standard Deviation|12.6|12.6|19.0|83.0|
4120149|NCT00929773|3945496|B3|||Duration of Pain||months|Mean|48.15|48.15|Standard Deviation|97.64|97.64|||
4120150|NCT00929773|3945497|B2|||Duration of Pain||months|Mean|40.25|40.25|Standard Deviation|71.13|71.13|||
4120151|NCT00929773|3945498|B1|||Duration of Pain||months|Mean|57.11|57.11|Standard Deviation|121.40|121.4|||
4120152|NCT00929773|3945496|B3|||Pain Rating on the Visual Analog Scale (VAS)|The Visual Analog Scale (VAS) is used as a self-reported measure of current pain level. Participants mark the spot on the line scale that shows the level of their pain at that time. The scale ranges fron '0: no pain at all' to '100: worst pain imaginable.' The scale is a straight line of 100mm. The point marked by the participant is measured as their current pain level. The higher the number, the greater the pain level. To qualify to be in the study, participants needed to record a Baseline pain level on the VAS of 30 or greater.|units on a scale|Mean|50.10|50.1|Standard Deviation|18.00|18.0|||
4120153|NCT00929773|3945497|B2|||Pain Rating on the Visual Analog Scale (VAS)|The Visual Analog Scale (VAS) is used as a self-reported measure of current pain level. Participants mark the spot on the line scale that shows the level of their pain at that time. The scale ranges fron '0: no pain at all' to '100: worst pain imaginable.' The scale is a straight line of 100mm. The point marked by the participant is measured as their current pain level. The higher the number, the greater the pain level. To qualify to be in the study, participants needed to record a Baseline pain level on the VAS of 30 or greater.|units on a scale|Mean|49.06|49.06|Standard Deviation|19.48|19.48|||
4120209|NCT00929734|3945515|B3|No||Inhaled corticosteroids|including long acting beta agonists (LABA)|participants|Number|24|24.0||||||
4120210|NCT00929734|3945516|B2|No||Inhaled corticosteroids|including long acting beta agonists (LABA)|participants|Number|13|13.0||||||
4120211|NCT00929734|3945517|B1|No||Inhaled corticosteroids|including long acting beta agonists (LABA)|participants|Number|11|11.0||||||
4120154|NCT00929773|3945498|B1|||Pain Rating on the Visual Analog Scale (VAS)|The Visual Analog Scale (VAS) is used as a self-reported measure of current pain level. Participants mark the spot on the line scale that shows the level of their pain at that time. The scale ranges fron '0: no pain at all' to '100: worst pain imaginable.' The scale is a straight line of 100mm. The point marked by the participant is measured as their current pain level. The higher the number, the greater the pain level. To qualify to be in the study, participants needed to record a Baseline pain level on the VAS of 30 or greater.|units on a scale|Mean|51.14|51.14|Standard Deviation|16.50|16.5|||
4120155|NCT00929773|3945496|B3|Acute||Type of Pain||participants|Number|13|13.0||||||
4120156|NCT00929773|3945497|B2|Acute||Type of Pain||participants|Number|6|6.0||||||
4120157|NCT00929773|3945498|B1|Acute||Type of Pain||participants|Number|7|7.0||||||
4120158|NCT00929773|3945496|B3|Chronic||Type of Pain||participants|Number|87|87.0||||||
4120159|NCT00929773|3945497|B2|Chronic||Type of Pain||participants|Number|44|44.0||||||
4120160|NCT00929773|3945498|B1|Chronic||Type of Pain||participants|Number|43|43.0||||||
4120161|NCT00929773|3945496|B3|Neck & Shoulders||Location of Pain|Subject report of pain located in the neck, shoulder or both regions.|participants|Number|49|49.0||||||
4120162|NCT00929773|3945497|B2|Neck & Shoulders||Location of Pain|Subject report of pain located in the neck, shoulder or both regions.|participants|Number|22|22.0||||||
4120163|NCT00929773|3945498|B1|Neck & Shoulders||Location of Pain|Subject report of pain located in the neck, shoulder or both regions.|participants|Number|27|27.0||||||
4120164|NCT00929773|3945496|B3|Neck||Location of Pain|Subject report of pain located in the neck, shoulder or both regions.|participants|Number|27|27.0||||||
4120165|NCT00929773|3945497|B2|Neck||Location of Pain|Subject report of pain located in the neck, shoulder or both regions.|participants|Number|14|14.0||||||
4120166|NCT00929773|3945498|B1|Neck||Location of Pain|Subject report of pain located in the neck, shoulder or both regions.|participants|Number|13|13.0||||||
4120167|NCT00929773|3945496|B3|Shoulders||Location of Pain|Subject report of pain located in the neck, shoulder or both regions.|participants|Number|24|24.0||||||
4120168|NCT00929773|3945497|B2|Shoulders||Location of Pain|Subject report of pain located in the neck, shoulder or both regions.|participants|Number|14|14.0||||||
4120169|NCT00929773|3945498|B1|Shoulders||Location of Pain|Subject report of pain located in the neck, shoulder or both regions.|participants|Number|10|10.0||||||
4120170|NCT00929773|3945496|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4120171|NCT00929773|3945497|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4120172|NCT00929773|3945498|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4120173|NCT00929773|3945496|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4120174|NCT00929773|3945497|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4120175|NCT00929773|3945498|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4120176|NCT00929773|3945496|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4120177|NCT00929773|3945497|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4120178|NCT00929773|3945498|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4120179|NCT00929773|3945496|B3||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4120180|NCT00929773|3945497|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4120181|NCT00929773|3945498|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4120182|NCT00929773|3945496|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4120183|NCT00929773|3945497|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4120184|NCT00929773|3945498|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4120185|NCT00929734|3945515|B3|No||Oestrogen treatment||participants|Number|87|87.0||||||
4120186|NCT00929734|3945516|B2|No||Oestrogen treatment||participants|Number|44|44.0||||||
4120187|NCT00929734|3945517|B1|No||Oestrogen treatment||participants|Number|43|43.0||||||
4120188|NCT00929734|3945515|B3|Yes||Oestrogen treatment||participants|Number|7|7.0||||||
4120189|NCT00929734|3945516|B2|Yes||Oestrogen treatment||participants|Number|3|3.0||||||
4120190|NCT00929734|3945517|B1|Yes||Oestrogen treatment||participants|Number|4|4.0||||||
4120191|NCT00929734|3945515|B3|No||Anti-inflammatory treatment||participants|Number|92|92.0||||||
4120192|NCT00929734|3945516|B2|No||Anti-inflammatory treatment||participants|Number|47|47.0||||||
4120193|NCT00929734|3945517|B1|No||Anti-inflammatory treatment||participants|Number|45|45.0||||||
4120194|NCT00929734|3945515|B3|Yes||Anti-inflammatory treatment||participants|Number|2|2.0||||||
4120195|NCT00929734|3945516|B2|Yes||Anti-inflammatory treatment||participants|Number|0|0.0||||||
4120196|NCT00929734|3945517|B1|Yes||Anti-inflammatory treatment||participants|Number|2|2.0||||||
4120197|NCT00929734|3945515|B3|No||Long acting muscarinic antagonists||participants|Number|37|37.0||||||
4120198|NCT00929734|3945516|B2|No||Long acting muscarinic antagonists||participants|Number|20|20.0||||||
4120199|NCT00929734|3945517|B1|No||Long acting muscarinic antagonists||participants|Number|17|17.0||||||
4120200|NCT00929734|3945515|B3|Yes||Long acting muscarinic antagonists||participants|Number|57|57.0||||||
4120201|NCT00929734|3945516|B2|Yes||Long acting muscarinic antagonists||participants|Number|27|27.0||||||
4120202|NCT00929734|3945517|B1|Yes||Long acting muscarinic antagonists||participants|Number|30|30.0||||||
4120203|NCT00929734|3945515|B3|No||Long acting beta agonists||participants|Number|89|89.0||||||
4120204|NCT00929734|3945516|B2|No||Long acting beta agonists||participants|Number|44|44.0||||||
4120205|NCT00929734|3945517|B1|No||Long acting beta agonists||participants|Number|45|45.0||||||
4120206|NCT00929734|3945515|B3|Yes||Long acting beta agonists||participants|Number|5|5.0||||||
4120207|NCT00929734|3945516|B2|Yes||Long acting beta agonists||participants|Number|3|3.0||||||
4120208|NCT00929734|3945517|B1|Yes||Long acting beta agonists||participants|Number|2|2.0||||||
4120212|NCT00929734|3945515|B3|Yes||Inhaled corticosteroids|including long acting beta agonists (LABA)|participants|Number|70|70.0||||||
4120213|NCT00929734|3945516|B2|Yes||Inhaled corticosteroids|including long acting beta agonists (LABA)|participants|Number|34|34.0||||||
4120214|NCT00929734|3945517|B1|Yes||Inhaled corticosteroids|including long acting beta agonists (LABA)|participants|Number|36|36.0||||||
4120215|NCT00929734|3945515|B3|No||Antihypertensive treatment||participants|Number|72|72.0||||||
4120216|NCT00929734|3945516|B2|No||Antihypertensive treatment||participants|Number|37|37.0||||||
4120217|NCT00929734|3945517|B1|No||Antihypertensive treatment||participants|Number|35|35.0||||||
4120218|NCT00929734|3945515|B3|Yes||Antihypertensive treatment||participants|Number|22|22.0||||||
4120219|NCT00929734|3945516|B2|Yes||Antihypertensive treatment||participants|Number|10|10.0||||||
4120220|NCT00929734|3945517|B1|Yes||Antihypertensive treatment||participants|Number|12|12.0||||||
4120221|NCT00929734|3945515|B3|||FEV1/FVC|Forced vital capacity (FVC)|Percent of FVC|Mean|48|48.0|Standard Deviation|12.8|12.8|||
4120222|NCT00929734|3945516|B2|||FEV1/FVC|Forced vital capacity (FVC)|Percent of FVC|Mean|49|49.0|Standard Deviation|11.8|11.8|||
4120223|NCT00929734|3945517|B1|||FEV1/FVC|Forced vital capacity (FVC)|Percent of FVC|Mean|47|47.0|Standard Deviation|13.8|13.8|||
4120224|NCT00929734|3945515|B3|||FEV1, % of predicted||Percent predicted value|Mean|50.2|50.2|Standard Deviation|18.9|18.9|||
4120225|NCT00929734|3945516|B2|||FEV1, % of predicted||Percent predicted value|Mean|52.1|52.1|Standard Deviation|18.8|18.8|||
4120226|NCT00929734|3945517|B1|||FEV1, % of predicted||Percent predicted value|Mean|48.3|48.3|Standard Deviation|18.9|18.9|||
4120227|NCT00929734|3945515|B3|||Forced expiratory volume at one second (FEV1)||Liter|Mean|1.4|1.4|Standard Deviation|0.6|0.6|||
4120228|NCT00929734|3945516|B2|||Forced expiratory volume at one second (FEV1)||Liter|Mean|1.5|1.5|Standard Deviation|0.7|0.7|||
4120229|NCT00929734|3945517|B1|||Forced expiratory volume at one second (FEV1)||Liter|Mean|1.4|1.4|Standard Deviation|0.6|0.6|||
4120230|NCT00929734|3945515|B3|||Triglycerides||mmol/L|Mean|1.1|1.1|Standard Deviation|0.4|0.4|||
4120231|NCT00929734|3945516|B2|||Triglycerides||mmol/L|Mean|1.1|1.1|Standard Deviation|0.5|0.5|||
4120232|NCT00929734|3945517|B1|||Triglycerides||mmol/L|Mean|1.0|1.0|Standard Deviation|0.4|0.4|||
4120233|NCT00929734|3945515|B3|||HDL-C||mmol/L|Mean|1.8|1.8|Standard Deviation|0.5|0.5|||
4120234|NCT00929734|3945516|B2|||HDL-C||mmol/L|Mean|1.8|1.8|Standard Deviation|0.1|0.1|||
4120235|NCT00929734|3945517|B1|||HDL-C||mmol/L|Mean|1.8|1.8|Standard Deviation|0.1|0.1|||
4120236|NCT00929734|3945515|B3|||LDL-C||mmol/L|Mean|3.4|3.4|Standard Deviation|0.9|0.9|||
4120237|NCT00929734|3945516|B2|||LDL-C||mmol/L|Mean|3.5|3.5|Standard Deviation|0.9|0.9|||
4120238|NCT00929734|3945517|B1|||LDL-C||mmol/L|Mean|3.3|3.3|Standard Deviation|0.8|0.8|||
4120239|NCT00929734|3945515|B3|||Cholesterol||mmol/L|Mean|5.6|5.6|Standard Deviation|1.0|1.0|||
4120240|NCT00929734|3945516|B2|||Cholesterol||mmol/L|Mean|5.7|5.7|Standard Deviation|1.1|1.1|||
4120241|NCT00929734|3945517|B1|||Cholesterol||mmol/L|Mean|5.5|5.5|Standard Deviation|0.9|0.9|||
4120242|NCT00929734|3945515|B3|||Glucose||mmol/L|Mean|5.0|5.0|Standard Deviation|0.6|0.6|||
4120243|NCT00929734|3945516|B2|||Glucose||mmol/L|Mean|5.1|5.1|Standard Deviation|0.7|0.7|||
4120244|NCT00929734|3945517|B1|||Glucose||mmol/L|Mean|5.0|5.0|Standard Deviation|0.6|0.6|||
4120245|NCT00929734|3945515|B3|||Interleukin 6||pg/mL|Median|3.7|3.7|Inter-Quartile Range|||2.7|5.1|
4120246|NCT00929734|3945516|B2|||Interleukin 6||pg/mL|Median|3.4|3.4|Inter-Quartile Range|||2.7|4.7|
4120247|NCT00929734|3945517|B1|||Interleukin 6||pg/mL|Median|4.1|4.1|Inter-Quartile Range|||2.9|5.3|
4120248|NCT00929734|3945515|B3|||High-sensitivity C-reactive protein|Acute-phase reactant used in cardiovascular risk assessment|mg/L|Median|1.7|1.7|Inter-Quartile Range|||0.8|3.8|
4120249|NCT00929734|3945516|B2|||High-sensitivity C-reactive protein|Acute-phase reactant used in cardiovascular risk assessment|mg/L|Median|1.8|1.8|Inter-Quartile Range|||1.0|4.4|
4120250|NCT00929734|3945517|B1|||High-sensitivity C-reactive protein|Acute-phase reactant used in cardiovascular risk assessment|mg/L|Median|1.4|1.4|Inter-Quartile Range|||0.8|3.7|
4120251|NCT00929734|3945515|B3|||Leucocyte count||cells*10^9/L|Mean|6.7|6.7|Standard Deviation|1.6|1.6|||
4120252|NCT00929734|3945516|B2|||Leucocyte count||cells*10^9/L|Mean|6.9|6.9|Standard Deviation|1.7|1.7|||
4120253|NCT00929734|3945517|B1|||Leucocyte count||cells*10^9/L|Mean|6.6|6.6|Standard Deviation|1.4|1.4|||
4120254|NCT00929734|3945515|B3|||Estimated Glomerular Filtration Rate (eGFR)|Renal function as calculated by the Cockcroft-Gault formula ((140- age) × bodyweight/serum creatinine) (× 0.85 for women))|ml/min|Mean|86.2|86.2|Standard Deviation|25.1|25.1|||
4120255|NCT00929734|3945516|B2|||Estimated Glomerular Filtration Rate (eGFR)|Renal function as calculated by the Cockcroft-Gault formula ((140- age) × bodyweight/serum creatinine) (× 0.85 for women))|ml/min|Mean|90.1|90.1|Standard Deviation|29.4|29.4|||
4120256|NCT00929734|3945517|B1|||Estimated Glomerular Filtration Rate (eGFR)|Renal function as calculated by the Cockcroft-Gault formula ((140- age) × bodyweight/serum creatinine) (× 0.85 for women))|ml/min|Mean|82.4|82.4|Standard Deviation|19.6|19.6|||
4120257|NCT00929734|3945515|B3|||Haemoglobin||g/dl|Mean|14.0|14.0|Standard Deviation|1.2|1.2|||
4120258|NCT00929734|3945516|B2|||Haemoglobin||g/dl|Mean|14.0|14.0|Standard Deviation|0.2|0.2|||
4120259|NCT00929734|3945517|B1|||Haemoglobin||g/dl|Mean|14.1|14.1|Standard Deviation|1.4|1.4|||
4120260|NCT00929734|3945515|B3|No||Current smoking||participants|Number|59|59.0||||||
4120261|NCT00929734|3945516|B2|No||Current smoking||participants|Number|24|24.0||||||
4120262|NCT00929734|3945517|B1|No||Current smoking||participants|Number|35|35.0||||||
4120263|NCT00929734|3945515|B3|Yes||Current smoking||participants|Number|35|35.0||||||
4120264|NCT00929734|3945516|B2|Yes||Current smoking||participants|Number|23|23.0||||||
4120265|NCT00929734|3945517|B1|Yes||Current smoking||participants|Number|12|12.0||||||
4120266|NCT00929734|3945515|B3|||Pack-years|Number of packs of cigarettes smoked per day by the number of years the person has smoked|pack-years|Mean|37|37.0|Standard Deviation|15.8|15.8|||
4120267|NCT00929734|3945516|B2|||Pack-years|Number of packs of cigarettes smoked per day by the number of years the person has smoked|pack-years|Mean|35|35.0|Standard Deviation|15.5|15.5|||
4120268|NCT00929734|3945517|B1|||Pack-years|Number of packs of cigarettes smoked per day by the number of years the person has smoked|pack-years|Mean|39|39.0|Standard Deviation|16.1|16.1|||
4120269|NCT00929734|3945515|B3|No||History of asthma||participants|Number|72|72.0||||||
4120270|NCT00929734|3945516|B2|No||History of asthma||participants|Number|34|34.0||||||
4120271|NCT00929734|3945517|B1|No||History of asthma||participants|Number|38|38.0||||||
4120272|NCT00929734|3945515|B3|Yes||History of asthma||participants|Number|22|22.0||||||
4120273|NCT00929734|3945516|B2|Yes||History of asthma||participants|Number|13|13.0||||||
4120274|NCT00929734|3945517|B1|Yes||History of asthma||participants|Number|9|9.0||||||
4120275|NCT00929734|3945515|B3|No||History of hypertension||participants|Number|71|71.0||||||
4120276|NCT00929734|3945516|B2|No||History of hypertension||participants|Number|36|36.0||||||
4120277|NCT00929734|3945517|B1|No||History of hypertension||participants|Number|35|35.0||||||
4120278|NCT00929734|3945515|B3|Yes||History of hypertension||participants|Number|23|23.0||||||
4120279|NCT00929734|3945516|B2|Yes||History of hypertension||participants|Number|11|11.0||||||
4120280|NCT00929734|3945517|B1|Yes||History of hypertension||participants|Number|12|12.0||||||
4120281|NCT00929734|3945515|B3|||Heart rate||beats/min|Mean|67|67.0|Standard Deviation|11.0|11.0|||
4120282|NCT00929734|3945516|B2|||Heart rate||beats/min|Mean|67|67.0|Standard Deviation|10.9|10.9|||
4120283|NCT00929734|3945517|B1|||Heart rate||beats/min|Mean|68|68.0|Standard Deviation|11.2|11.2|||
4120284|NCT00929734|3945515|B3|||Diastolic blood pressure||mmHg|Mean|80|80.0|Standard Deviation|9.4|9.4|||
4120285|NCT00929734|3945516|B2|||Diastolic blood pressure||mmHg|Mean|80|80.0|Standard Deviation|10.3|10.3|||
4120286|NCT00929734|3945517|B1|||Diastolic blood pressure||mmHg|Mean|79|79.0|Standard Deviation|8.4|8.4|||
4120287|NCT00929734|3945515|B3|||Systolic blood pressure||mmHg|Mean|133|133.0|Standard Deviation|18.9|18.9|||
4120288|NCT00929734|3945516|B2|||Systolic blood pressure||mmHg|Mean|135|135.0|Standard Deviation|20.1|20.1|||
4120289|NCT00929734|3945517|B1|||Systolic blood pressure||mmHg|Mean|131|131.0|Standard Deviation|17.7|17.7|||
4120290|NCT00929734|3945515|B3|||BMI||kg/m^2|Mean|24|24.0|Standard Deviation|3.9|3.9|||
4120291|NCT00929734|3945516|B2|||BMI||kg/m^2|Mean|24|24.0|Standard Deviation|4.1|4.1|||
4120292|NCT00929734|3945517|B1|||BMI||kg/m^2|Mean|23|23.0|Standard Deviation|3.8|3.8|||
4120293|NCT00929734|3945515|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4120294|NCT00929734|3945516|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4120295|NCT00929734|3945517|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4120296|NCT00929734|3945515|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4120297|NCT00929734|3945516|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4120298|NCT00929734|3945517|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4120299|NCT00929734|3945515|B3|||Age||years|Mean|65|65.0|Standard Deviation|6.1|6.1|||
4120300|NCT00929734|3945516|B2|||Age||years|Mean|63|63.0|Standard Deviation|6.6|6.6|||
4120301|NCT00929734|3945517|B1|||Age||years|Mean|66|66.0|Standard Deviation|5.5|5.5|||
4120302|NCT00929708|3945530|B6||Male|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
4120303|NCT00929708|3945531|B5||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4120304|NCT00929708|3945532|B4||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4120305|NCT00929708|3945533|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4120306|NCT00929708|3945534|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4120307|NCT00929708|3945535|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4120308|NCT00929708|3945530|B6||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4120309|NCT00929708|3945531|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4120310|NCT00929708|3945532|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4120311|NCT00929708|3945533|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4120312|NCT00929708|3945534|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4120313|NCT00929708|3945535|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4120314|NCT00929708|3945530|B6|||Age||Years|Mean|63.85|63.85|Full Range|||62.4|65.3|
4120315|NCT00929708|3945531|B5|||Age||Years|Mean|64.8|64.8|Full Range|||46.0|84.0|
4120316|NCT00929708|3945532|B4|||Age||Years|Mean|64.1|64.1|Full Range|||47.0|77.0|
4120317|NCT00929708|3945533|B3|||Age||Years|Mean|65.3|65.3|Full Range|||41.0|92.0|
4120318|NCT00929708|3945534|B2|||Age||Years|Mean|63.8|63.8|Full Range|||40.0|82.0|
4120319|NCT00929708|3945535|B1|||Age||Years|Mean|62.4|62.4|Full Range|||45.0|81.0|
4120320|NCT00929695|3945591|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4120321|NCT00929695|3945592|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4120322|NCT00929695|3945593|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4120323|NCT00929695|3945591|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4120324|NCT00929695|3945592|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4120325|NCT00929695|3945593|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4120326|NCT00929695|3945591|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4120327|NCT00929695|3945592|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4120328|NCT00929695|3945593|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4120329|NCT00929695|3945591|B3||Between 18 and 65 years|Age||Participants|Count of Participants|115|115.0||||||
4120330|NCT00929695|3945592|B2||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4120331|NCT00929695|3945593|B1||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4120332|NCT00929695|3945591|B3||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
4120333|NCT00929695|3945592|B2||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4120334|NCT00929695|3945593|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4120335|NCT00929669|3945624|B1|||patients with a gonadotroph adenoma||participants|Number|2|2.0||||||
4120336|NCT00929669|3945624|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4120337|NCT00929669|3945624|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4120338|NCT00929669|3945624|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4120339|NCT00929669|3945624|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4120340|NCT00929669|3945624|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4120341|NCT00929669|3945624|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4120342|NCT00929656|3945629|B3|||Time Post-Stroke|The amount of time, in months, between stroke onset and entrance into the study.|months|Mean|39.6|39.6|Standard Deviation|74.2|74.2|||
4120343|NCT00929656|3945630|B2|||Time Post-Stroke|The amount of time, in months, between stroke onset and entrance into the study.|months|Mean|33.3|33.3|Standard Deviation|25.9|25.9|||
4120344|NCT00929656|3945631|B1|||Time Post-Stroke|The amount of time, in months, between stroke onset and entrance into the study.|months|Mean|44.0|44.0|Standard Deviation|95.6|95.6|||
4120345|NCT00929656|3945629|B3|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4120346|NCT00929656|3945630|B2|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4120347|NCT00929656|3945631|B1|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4120348|NCT00929656|3945629|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120349|NCT00929656|3945630|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120350|NCT00929656|3945631|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120351|NCT00929656|3945629|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120352|NCT00929656|3945630|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120353|NCT00929656|3945631|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120354|NCT00929656|3945629|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4120355|NCT00929656|3945630|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4120356|NCT00929656|3945631|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4120357|NCT00929656|3945629|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4120358|NCT00929656|3945630|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4120359|NCT00929656|3945631|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4120360|NCT00929656|3945629|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120361|NCT00929656|3945630|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120362|NCT00929656|3945631|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120363|NCT00929656|3945629|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120364|NCT00929656|3945630|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120365|NCT00929656|3945631|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120366|NCT00929656|3945629|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120367|NCT00929656|3945630|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120368|NCT00929656|3945631|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120369|NCT00929656|3945629|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4120370|NCT00929656|3945630|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4120371|NCT00929656|3945631|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4120372|NCT00929656|3945629|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4120373|NCT00929656|3945630|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4120374|NCT00929656|3945631|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4120375|NCT00929656|3945629|B3|||Age||years|Mean|60.5|60.5|Standard Deviation|9.1|9.1|||
4120376|NCT00929656|3945630|B2|||Age||years|Mean|59.4|59.4|Standard Deviation|8.2|8.2|||
4120377|NCT00929656|3945631|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|10.0|10.0|||
4120378|NCT00929656|3945629|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4120379|NCT00929656|3945630|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4120380|NCT00929656|3945631|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4120381|NCT00929656|3945629|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4120382|NCT00929656|3945630|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4120383|NCT00929656|3945631|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4120384|NCT00929656|3945629|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4120385|NCT00929656|3945630|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4120386|NCT00929656|3945631|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4120387|NCT00929643|3945646|B1||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4120388|NCT00929643|3945646|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4120389|NCT00929643|3945646|B1|||Age||Years|Mean|57.4|57.4|Standard Deviation|19.7|19.7|||
4120390|NCT00929578|3945655|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4120391|NCT00929578|3945655|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4120392|NCT00929578|3945655|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4120393|NCT00929578|3945655|B1|||Age||years|Mean|51.5|51.5|Standard Deviation|12.5|12.5|||
4120394|NCT00929578|3945655|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4120395|NCT00929578|3945655|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4120396|NCT00929578|3945655|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4120397|NCT00929526|3945666|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4120398|NCT00929526|3945667|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4120399|NCT00929526|3945668|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4120400|NCT00929526|3945666|B3||Female|Sex: Female, Male||Participants|Count of Participants|752|752.0||||||
4120401|NCT00929526|3945667|B2||Female|Sex: Female, Male||Participants|Count of Participants|377|377.0||||||
4120402|NCT00929526|3945668|B1||Female|Sex: Female, Male||Participants|Count of Participants|375|375.0||||||
4120403|NCT00929526|3945666|B3|||Age|Japanase women aged 20 to 25 years at the time of first vaccination in the primary study NCT00316693|Years|Mean|25.5|25.5|Standard Deviation|1.72|1.72|||
4120404|NCT00929526|3945667|B2|||Age|Japanase women aged 20 to 25 years at the time of first vaccination in the primary study NCT00316693|Years|Mean|25.5|25.5|Standard Deviation|1.72|1.72|||
4120405|NCT00929526|3945668|B1|||Age|Japanase women aged 20 to 25 years at the time of first vaccination in the primary study NCT00316693|Years|Mean|25.4|25.4|Standard Deviation|1.72|1.72|||
4120406|NCT00929500|3945703|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4120407|NCT00929500|3945704|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4120408|NCT00929500|3945705|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4120409|NCT00929500|3945703|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4120410|NCT00929500|3945704|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4120411|NCT00929500|3945705|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4120412|NCT00929500|3945703|B3|||Age||years|Mean|58|58.0|Standard Deviation|7.4|7.4|||
4120413|NCT00929500|3945704|B2|||Age||years|Mean|55.75|55.75|Standard Deviation|6.07|6.07|||
4120414|NCT00929500|3945705|B1|||Age||years|Mean|60.25|60.25|Standard Deviation|8.9|8.9|||
4120415|NCT00929500|3945703|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4120416|NCT00929500|3945704|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4120417|NCT00929500|3945705|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4120418|NCT00929500|3945703|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4120419|NCT00929500|3945704|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4120420|NCT00929500|3945705|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4120421|NCT00929500|3945703|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4120422|NCT00929500|3945704|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4120423|NCT00929500|3945705|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4120424|NCT00929474|3945718|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4120425|NCT00929474|3945719|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4120426|NCT00929474|3945720|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4120427|NCT00929474|3945718|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4120428|NCT00929474|3945719|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4120429|NCT00929474|3945720|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4120430|NCT00929474|3945718|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4120431|NCT00929474|3945719|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4120432|NCT00929474|3945720|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4120433|NCT00929474|3945718|B3|||Age||years|Mean|76|76.0|Standard Deviation|9.8|9.8|||
4120434|NCT00929474|3945719|B2|||Age||years|Mean|77.7|77.7|Standard Deviation|9.8|9.8|||
4120435|NCT00929474|3945720|B1|||Age||years|Mean|74.2|74.2|Standard Deviation|10.2|10.2|||
4120436|NCT00929474|3945718|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4120437|NCT00929474|3945719|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4120438|NCT00929474|3945720|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4120439|NCT00929474|3945718|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4120440|NCT00929474|3945719|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4120441|NCT00929474|3945720|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4120442|NCT00929474|3945718|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4120443|NCT00929474|3945719|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4120444|NCT00929474|3945720|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4120445|NCT00929383|3945727|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4120446|NCT00929383|3945727|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4120447|NCT00929383|3945727|B1|||Age||years|Mean|64.23|64.23|Standard Deviation|10.78|10.78|||
4120448|NCT00929357|3945735|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4120449|NCT00929357|3945736|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4120450|NCT00929357|3945737|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4120451|NCT00929357|3945735|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4120452|NCT00929357|3945736|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4120453|NCT00929357|3945737|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4120454|NCT00929357|3945735|B3|||Age, Customized||years|Mean|60.5|60.5|Standard Deviation|12.8|12.8|||
4120455|NCT00929357|3945736|B2|||Age, Customized||years|Mean|58.9|58.9|Standard Deviation|13.1|13.1|||
4120456|NCT00929357|3945737|B1|||Age, Customized||years|Mean|61.6|61.6|Standard Deviation|12.6|12.6|||
4120457|NCT00929344|3945758|B4||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4120458|NCT00929344|3945759|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4120459|NCT00929344|3945760|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4120460|NCT00929344|3945761|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4120461|NCT00929344|3945758|B4||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4120462|NCT00929344|3945759|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4120463|NCT00929344|3945760|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4120464|NCT00929344|3945761|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4120465|NCT00929344|3945758|B4|||Age||years|Mean|44.32|44.32|Standard Deviation|10.82|10.82|||
4120466|NCT00929344|3945759|B3|||Age||years|Mean|43.54|43.54|Standard Deviation|10.52|10.52|||
4120467|NCT00929344|3945760|B2|||Age||years|Mean|44.56|44.56|Standard Deviation|11.55|11.55|||
4120468|NCT00929344|3945761|B1|||Age||years|Mean|44.86|44.86|Standard Deviation|10.53|10.53|||
4120469|NCT00929331|3945777|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4120470|NCT00929331|3945778|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4120471|NCT00929331|3945779|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4120472|NCT00929331|3945777|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4120473|NCT00929331|3945778|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4120474|NCT00929331|3945779|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4120475|NCT00929331|3945777|B3|||Age||years|Mean|51.0|51.0|Standard Deviation|19.26|19.26|||
4120476|NCT00929331|3945778|B2|||Age||years|Mean|66.8|66.8|Standard Deviation|4.10|4.1|||
4120477|NCT00929331|3945779|B1|||Age||years|Mean|35.1|35.1|Standard Deviation|14.83|14.83|||
4120478|NCT00929305|3945812|B3|||Duration of Pain|Duration in months of chronic pain in the neck and/or shoulder region.|months|Mean|72.35|72.35|Standard Deviation|82.01|82.01|||
4120479|NCT00929305|3945813|B2|||Duration of Pain|Duration in months of chronic pain in the neck and/or shoulder region.|months|Mean|61.74|61.74|Standard Deviation|77.21|77.21|||
4120480|NCT00929305|3945814|B1|||Duration of Pain|Duration in months of chronic pain in the neck and/or shoulder region.|months|Mean|82.95|82.95|Standard Deviation|86.14|86.14|||
4120481|NCT00929305|3945812|B3|||Baseline Visual Analog Scale (VAS) pain rating|Participants recorded a self-rating of their degree of pain in the neck-shoulder area before the study treatment was administered on the 0-100 standardized Visual Analog Scale (VAS). The VAS is a 100mm long horizontal line ranging from '0: no pain at all' on one end to '100: worst pain imaginable' on the other end. The participant marked the point along the scale that best represented the level of pain they experienced at that time in the neck-shoulder area. The higher the number marked, the greater the pain level.|units on a scale|Mean|60.10|60.1|Standard Deviation|9.19|9.19|||
4120482|NCT00929305|3945813|B2|||Baseline Visual Analog Scale (VAS) pain rating|Participants recorded a self-rating of their degree of pain in the neck-shoulder area before the study treatment was administered on the 0-100 standardized Visual Analog Scale (VAS). The VAS is a 100mm long horizontal line ranging from '0: no pain at all' on one end to '100: worst pain imaginable' on the other end. The participant marked the point along the scale that best represented the level of pain they experienced at that time in the neck-shoulder area. The higher the number marked, the greater the pain level.|units on a scale|Mean|60.21|60.21|Standard Deviation|9.84|9.84|||
4120483|NCT00929305|3945814|B1|||Baseline Visual Analog Scale (VAS) pain rating|Participants recorded a self-rating of their degree of pain in the neck-shoulder area before the study treatment was administered on the 0-100 standardized Visual Analog Scale (VAS). The VAS is a 100mm long horizontal line ranging from '0: no pain at all' on one end to '100: worst pain imaginable' on the other end. The participant marked the point along the scale that best represented the level of pain they experienced at that time in the neck-shoulder area. The higher the number marked, the greater the pain level.|units on a scale|Mean|60.00|60.0|Standard Deviation|8.60|8.6|||
4120484|NCT00929305|3945812|B3|osteoarthritis||Origin of Pain|Pain originating from one or more of three etiologies: osteoarthritis; muscle spasms, sprain strain.|participants|Number|14|14.0||||||
4120485|NCT00929305|3945813|B2|osteoarthritis||Origin of Pain|Pain originating from one or more of three etiologies: osteoarthritis; muscle spasms, sprain strain.|participants|Number|7|7.0||||||
4120486|NCT00929305|3945814|B1|osteoarthritis||Origin of Pain|Pain originating from one or more of three etiologies: osteoarthritis; muscle spasms, sprain strain.|participants|Number|7|7.0||||||
4120487|NCT00929305|3945812|B3|muscle spasms only||Origin of Pain|Pain originating from one or more of three etiologies: osteoarthritis; muscle spasms, sprain strain.|participants|Number|15|15.0||||||
4120488|NCT00929305|3945813|B2|muscle spasms only||Origin of Pain|Pain originating from one or more of three etiologies: osteoarthritis; muscle spasms, sprain strain.|participants|Number|5|5.0||||||
4120489|NCT00929305|3945814|B1|muscle spasms only||Origin of Pain|Pain originating from one or more of three etiologies: osteoarthritis; muscle spasms, sprain strain.|participants|Number|10|10.0||||||
4120490|NCT00929305|3945812|B3|muscle spasms and sprain strain||Origin of Pain|Pain originating from one or more of three etiologies: osteoarthritis; muscle spasms, sprain strain.|participants|Number|57|57.0||||||
4120491|NCT00929305|3945813|B2|muscle spasms and sprain strain||Origin of Pain|Pain originating from one or more of three etiologies: osteoarthritis; muscle spasms, sprain strain.|participants|Number|31|31.0||||||
4120492|NCT00929305|3945814|B1|muscle spasms and sprain strain||Origin of Pain|Pain originating from one or more of three etiologies: osteoarthritis; muscle spasms, sprain strain.|participants|Number|26|26.0||||||
4120493|NCT00929305|3945812|B3|Both Neck & Shoulder||Location of Pain|Pain on the right and/or left sides of the neck and/or shoulders, or both.|participants|Number|46|46.0||||||
4120494|NCT00929305|3945813|B2|Both Neck & Shoulder||Location of Pain|Pain on the right and/or left sides of the neck and/or shoulders, or both.|participants|Number|23|23.0||||||
4120495|NCT00929305|3945814|B1|Both Neck & Shoulder||Location of Pain|Pain on the right and/or left sides of the neck and/or shoulders, or both.|participants|Number|23|23.0||||||
4120496|NCT00929305|3945812|B3|Shoulder only||Location of Pain|Pain on the right and/or left sides of the neck and/or shoulders, or both.|participants|Number|11|11.0||||||
4120497|NCT00929305|3945813|B2|Shoulder only||Location of Pain|Pain on the right and/or left sides of the neck and/or shoulders, or both.|participants|Number|7|7.0||||||
4120498|NCT00929305|3945814|B1|Shoulder only||Location of Pain|Pain on the right and/or left sides of the neck and/or shoulders, or both.|participants|Number|4|4.0||||||
4120499|NCT00929305|3945812|B3|Neck only||Location of Pain|Pain on the right and/or left sides of the neck and/or shoulders, or both.|participants|Number|29|29.0||||||
4120500|NCT00929305|3945813|B2|Neck only||Location of Pain|Pain on the right and/or left sides of the neck and/or shoulders, or both.|participants|Number|13|13.0||||||
4120501|NCT00929305|3945814|B1|Neck only||Location of Pain|Pain on the right and/or left sides of the neck and/or shoulders, or both.|participants|Number|16|16.0||||||
4120502|NCT00929305|3945812|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4120503|NCT00929305|3945813|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4120504|NCT00929305|3945814|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4120505|NCT00929305|3945812|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4120506|NCT00929305|3945813|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4120507|NCT00929305|3945814|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4120508|NCT00929305|3945812|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4120509|NCT00929305|3945813|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4120510|NCT00929305|3945814|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4120511|NCT00929305|3945812|B3||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
4120512|NCT00929305|3945813|B2||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4120513|NCT00929305|3945814|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4120514|NCT00929305|3945812|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4120515|NCT00929305|3945813|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4120516|NCT00929305|3945814|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4120517|NCT00929240|3945823|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4120518|NCT00929240|3945823|B1||Female|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
4120519|NCT00929240|3945823|B1|||Age||years|Mean|52.5|52.5|Standard Deviation|11.8|11.8|||
4120520|NCT00929201|3945852|B1|||Weight||Kilograms|Mean|73.0|73.0|Full Range|||45.9|102.3|
4120521|NCT00929201|3945852|B1|||Height||Centimeters|Mean|164.9|164.9|Full Range|||150.0|184.0|
4120522|NCT00929201|3945852|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4120523|NCT00929201|3945852|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4120524|NCT00929201|3945852|B1|||Age||Years|Mean|32.4|32.4|Full Range|||18.0|45.0|
4120525|NCT00929162|3945861|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4120526|NCT00929162|3945862|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4120527|NCT00929162|3945863|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4120528|NCT00929162|3945861|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4120529|NCT00929162|3945862|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4120530|NCT00929162|3945863|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4120531|NCT00929162|3945861|B3|Overall||Age||Years|Mean|57.0|57.0|Standard Deviation|11.49|11.49|||
4120532|NCT00929162|3945862|B2|Overall||Age||Years|Mean|56.6|56.6|Standard Deviation|11.07|11.07|||
4120533|NCT00929162|3945863|B1|Overall||Age||Years|Mean|57.4|57.4|Standard Deviation|11.98|11.98|||
4120534|NCT00929110|3945874|B4||Male|Sex: Female, Male|Demographic data are based on the safety population which was defined as all patients who received at least 1 dose of study medication whether they were randomized or not. The number of patients in the safety population was less than the number of randomized patients, ie, some randomized patients did not receive study medication (4 in the glycopyrronium bromide group, 1 in the placebo group, and 1 in the tiotropium group).|Participants|Count of Participants|680|680.0||||||
4120535|NCT00929110|3945875|B3||Male|Sex: Female, Male|Demographic data are based on the safety population which was defined as all patients who received at least 1 dose of study medication whether they were randomized or not. The number of patients in the safety population was less than the number of randomized patients, ie, some randomized patients did not receive study medication (4 in the glycopyrronium bromide group, 1 in the placebo group, and 1 in the tiotropium group).|Participants|Count of Participants|168|168.0||||||
4120565|NCT00928889|3945962|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4120536|NCT00929110|3945876|B2||Male|Sex: Female, Male|Demographic data are based on the safety population which was defined as all patients who received at least 1 dose of study medication whether they were randomized or not. The number of patients in the safety population was less than the number of randomized patients, ie, some randomized patients did not receive study medication (4 in the glycopyrronium bromide group, 1 in the placebo group, and 1 in the tiotropium group).|Participants|Count of Participants|173|173.0||||||
4120537|NCT00929110|3945877|B1||Male|Sex: Female, Male|Demographic data are based on the safety population which was defined as all patients who received at least 1 dose of study medication whether they were randomized or not. The number of patients in the safety population was less than the number of randomized patients, ie, some randomized patients did not receive study medication (4 in the glycopyrronium bromide group, 1 in the placebo group, and 1 in the tiotropium group).|Participants|Count of Participants|339|339.0||||||
4120538|NCT00929110|3945874|B4||Female|Sex: Female, Male|Demographic data are based on the safety population which was defined as all patients who received at least 1 dose of study medication whether they were randomized or not. The number of patients in the safety population was less than the number of randomized patients, ie, some randomized patients did not receive study medication (4 in the glycopyrronium bromide group, 1 in the placebo group, and 1 in the tiotropium group).|Participants|Count of Participants|380|380.0||||||
4120539|NCT00929110|3945875|B3||Female|Sex: Female, Male|Demographic data are based on the safety population which was defined as all patients who received at least 1 dose of study medication whether they were randomized or not. The number of patients in the safety population was less than the number of randomized patients, ie, some randomized patients did not receive study medication (4 in the glycopyrronium bromide group, 1 in the placebo group, and 1 in the tiotropium group).|Participants|Count of Participants|99|99.0||||||
4120540|NCT00929110|3945876|B2||Female|Sex: Female, Male|Demographic data are based on the safety population which was defined as all patients who received at least 1 dose of study medication whether they were randomized or not. The number of patients in the safety population was less than the number of randomized patients, ie, some randomized patients did not receive study medication (4 in the glycopyrronium bromide group, 1 in the placebo group, and 1 in the tiotropium group).|Participants|Count of Participants|95|95.0||||||
4120541|NCT00929110|3945877|B1||Female|Sex: Female, Male|Demographic data are based on the safety population which was defined as all patients who received at least 1 dose of study medication whether they were randomized or not. The number of patients in the safety population was less than the number of randomized patients, ie, some randomized patients did not receive study medication (4 in the glycopyrronium bromide group, 1 in the placebo group, and 1 in the tiotropium group).|Participants|Count of Participants|186|186.0||||||
4120542|NCT00929110|3945874|B4|||Age|Demographic data are based on the safety population which was defined as all patients who received at least 1 dose of study medication whether they were randomized or not. The number of patients in the safety population was less than the number of randomized patients, ie, some randomized patients did not receive study medication (4 in the glycopyrronium bromide group, 1 in the placebo group, and 1 in the tiotropium group).|years|Mean|63.6|63.6|Standard Deviation|8.87|8.87|||
4120543|NCT00929110|3945875|B3|||Age|Demographic data are based on the safety population which was defined as all patients who received at least 1 dose of study medication whether they were randomized or not. The number of patients in the safety population was less than the number of randomized patients, ie, some randomized patients did not receive study medication (4 in the glycopyrronium bromide group, 1 in the placebo group, and 1 in the tiotropium group).|years|Mean|63.9|63.9|Standard Deviation|8.25|8.25|||
4120544|NCT00929110|3945876|B2|||Age|Demographic data are based on the safety population which was defined as all patients who received at least 1 dose of study medication whether they were randomized or not. The number of patients in the safety population was less than the number of randomized patients, ie, some randomized patients did not receive study medication (4 in the glycopyrronium bromide group, 1 in the placebo group, and 1 in the tiotropium group).|years|Mean|63.6|63.6|Standard Deviation|9.14|9.14|||
4120545|NCT00929110|3945877|B1|||Age|Demographic data are based on the safety population which was defined as all patients who received at least 1 dose of study medication whether they were randomized or not. The number of patients in the safety population was less than the number of randomized patients, ie, some randomized patients did not receive study medication (4 in the glycopyrronium bromide group, 1 in the placebo group, and 1 in the tiotropium group).|years|Mean|63.5|63.5|Standard Deviation|9.05|9.05|||
4120546|NCT00929071|3945944|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4120547|NCT00929071|3945944|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4120548|NCT00929071|3945944|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4120549|NCT00929071|3945944|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|9.4|9.4|||
4120550|NCT00929071|3945944|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4120551|NCT00929071|3945944|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4120552|NCT00929071|3945944|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4120553|NCT00928954|3945951|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4120554|NCT00928954|3945951|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4120555|NCT00928954|3945951|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4120556|NCT00928954|3945951|B1|||Age||years|Mean|43.5|43.5|Standard Deviation|14.9|14.9|||
4120557|NCT00928954|3945951|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4120558|NCT00928954|3945951|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4120559|NCT00928954|3945951|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4120560|NCT00928889|3945960|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4120561|NCT00928889|3945961|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4120562|NCT00928889|3945962|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4120563|NCT00928889|3945960|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4120564|NCT00928889|3945961|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4120566|NCT00928889|3945960|B3|||Age||years|Mean|52.5|52.5|Standard Deviation|10.87|10.87|||
4120567|NCT00928889|3945961|B2|||Age||years|Mean|51.9|51.9|Standard Deviation|10.82|10.82|||
4120568|NCT00928889|3945962|B1|||Age||years|Mean|53.1|53.1|Standard Deviation|10.95|10.95|||
4120569|NCT00928772|3945987|B4|United States||Region of Enrollment||Participants|Count of Participants|115|115.0||||||
4120570|NCT00928772|3945988|B3|United States||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
4120571|NCT00928772|3945989|B2|United States||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
4120572|NCT00928772|3945990|B1|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
4120573|NCT00928772|3945987|B4||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4120574|NCT00928772|3945988|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4120575|NCT00928772|3945989|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4120576|NCT00928772|3945990|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4120577|NCT00928772|3945987|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4120578|NCT00928772|3945988|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4120579|NCT00928772|3945989|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4120580|NCT00928772|3945990|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4120581|NCT00928772|3945987|B4|50-90 years||Age, Customized||Participants|Count of Participants|115|115.0||||||
4120582|NCT00928772|3945988|B3|50-90 years||Age, Customized||Participants|Count of Participants|38|38.0||||||
4120583|NCT00928772|3945989|B2|50-90 years||Age, Customized||Participants|Count of Participants|38|38.0||||||
4120584|NCT00928772|3945990|B1|50-90 years||Age, Customized||Participants|Count of Participants|39|39.0||||||
4120585|NCT00928746|3946009|B1|||Weight||kilograms|Mean|88.8|88.8|Standard Deviation|27.7|27.7|||
4120586|NCT00928746|3946009|B1|||Height||centimeters|Mean|167.2|167.2|Standard Deviation|15.7|15.7|||
4120587|NCT00928746|3946009|B1|Currently smoke||Smoking history||participants|Number|80|80.0||||||
4120588|NCT00928746|3946009|B1|Ex-smoker||Smoking history||participants|Number|62|62.0||||||
4120589|NCT00928746|3946009|B1|Drinks alcohol - should not interfere with trial||Alcohol status||participants|Number|48|48.0||||||
4120590|NCT00928746|3946009|B1|Does not drink alcohol||Alcohol status||participants|Number|94|94.0||||||
4120591|NCT00928746|3946009|B1|White||Race/Ethnicity, Customized||participants|Number|122|122.0||||||
4120592|NCT00928746|3946009|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4120593|NCT00928746|3946009|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4120594|NCT00928746|3946009|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4120595|NCT00928746|3946009|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|9.2|9.2|||
4120596|NCT00928720|3946029|B4|||Daily stress impact|The Daily Stress Inventory is a 58-item measure designed to quantify individuals’ perceived daily stress by rating the stressfulness of the events identified on a Likert-type scale from 1 to 7. Three daily scores are derived for each individual: (1) number of events that are scored as having occurred (Frequency), (2) sum of the total of the impact rating of these events (Summary, and (3) average impact rating of the events (the AIR, which is obtained by dividing the Summary score by the Frequency Score). Scores range from 1 to 58, with higher scores indicating higher levels of stress.|units on a scale|Mean|3.44|3.44|Standard Deviation|1.3|1.3|||
4120597|NCT00928720|3946030|B3|||Daily stress impact|The Daily Stress Inventory is a 58-item measure designed to quantify individuals’ perceived daily stress by rating the stressfulness of the events identified on a Likert-type scale from 1 to 7. Three daily scores are derived for each individual: (1) number of events that are scored as having occurred (Frequency), (2) sum of the total of the impact rating of these events (Summary, and (3) average impact rating of the events (the AIR, which is obtained by dividing the Summary score by the Frequency Score). Scores range from 1 to 58, with higher scores indicating higher levels of stress.|units on a scale|Mean|3.39|3.39|Standard Deviation|1.3|1.3|||
4120598|NCT00928720|3946031|B2|||Daily stress impact|The Daily Stress Inventory is a 58-item measure designed to quantify individuals’ perceived daily stress by rating the stressfulness of the events identified on a Likert-type scale from 1 to 7. Three daily scores are derived for each individual: (1) number of events that are scored as having occurred (Frequency), (2) sum of the total of the impact rating of these events (Summary, and (3) average impact rating of the events (the AIR, which is obtained by dividing the Summary score by the Frequency Score). Scores range from 1 to 58, with higher scores indicating higher levels of stress.|units on a scale|Mean|3.05|3.05|Standard Deviation|1.1|1.1|||
4120599|NCT00928720|3946032|B1|||Daily stress impact|The Daily Stress Inventory is a 58-item measure designed to quantify individuals’ perceived daily stress by rating the stressfulness of the events identified on a Likert-type scale from 1 to 7. Three daily scores are derived for each individual: (1) number of events that are scored as having occurred (Frequency), (2) sum of the total of the impact rating of these events (Summary, and (3) average impact rating of the events (the AIR, which is obtained by dividing the Summary score by the Frequency Score). Scores range from 1 to 58, with higher scores indicating higher levels of stress.|units on a scale|Mean|3.86|3.86|Standard Deviation|1.2|1.2|||
4120600|NCT00928720|3946029|B4|||General sleep disturbance|The General Sleep Disturbance Scale (GSDS) is a subjective measure of sleep disturbance that contains 21 items rating the frequency of specific sleep problems during the past week from 0 to 7. Each item is rated on a numeric rating scale ranging from 0 to 7 and the total 21 items are summed to calculate total score ranging from 0 (no disturbance) to 147 (extreme disturbance); higher scores indicate greater sleep disturbances.|units on a scale|Mean|3.8|3.8|Standard Deviation|0.87|0.87|||
4120617|NCT00928720|3946030|B3|||Pain Numeric Rating Scale|A Numeric Rating Scale to capture average pain. The scales ranges from 0 (no pain) to 10 (worst pain imaginable).|units on a scale|Mean|6.0|6.0|Standard Deviation|2.1|2.1|||
4120618|NCT00928720|3946031|B2|||Pain Numeric Rating Scale|A Numeric Rating Scale to capture average pain. The scales ranges from 0 (no pain) to 10 (worst pain imaginable).|units on a scale|Mean|5.7|5.7|Standard Deviation|1.6|1.6|||
4120601|NCT00928720|3946030|B3|||General sleep disturbance|The General Sleep Disturbance Scale (GSDS) is a subjective measure of sleep disturbance that contains 21 items rating the frequency of specific sleep problems during the past week from 0 to 7. Each item is rated on a numeric rating scale ranging from 0 to 7 and the total 21 items are summed to calculate total score ranging from 0 (no disturbance) to 147 (extreme disturbance); higher scores indicate greater sleep disturbances.|units on a scale|Mean|3.6|3.6|Standard Deviation|0.86|0.86|||
4120602|NCT00928720|3946031|B2|||General sleep disturbance|The General Sleep Disturbance Scale (GSDS) is a subjective measure of sleep disturbance that contains 21 items rating the frequency of specific sleep problems during the past week from 0 to 7. Each item is rated on a numeric rating scale ranging from 0 to 7 and the total 21 items are summed to calculate total score ranging from 0 (no disturbance) to 147 (extreme disturbance); higher scores indicate greater sleep disturbances.|units on a scale|Mean|4.01|4.01|Standard Deviation|0.80|0.8|||
4120603|NCT00928720|3946032|B1|||General sleep disturbance|The General Sleep Disturbance Scale (GSDS) is a subjective measure of sleep disturbance that contains 21 items rating the frequency of specific sleep problems during the past week from 0 to 7. Each item is rated on a numeric rating scale ranging from 0 to 7 and the total 21 items are summed to calculate total score ranging from 0 (no disturbance) to 147 (extreme disturbance); higher scores indicate greater sleep disturbances.|units on a scale|Mean|3.75|3.75|Standard Deviation|0.94|0.94|||
4120604|NCT00928720|3946029|B4|||Depression|The Center for Epidemiological Studies-Depression (CES-D) scale is a 20-item measure that asks the individual to rate how often over the past week s/he has experienced symptoms associated with depression, such as restless sleep, poor appetite, and feeling lonely. Response options range from 0 to 3 for each item. Scores range from 0 to 60, with high scores indicating greater depressive symptoms. The CES-D also provides cutoff scores (e.g., 16 or greater) that aid in identifying individuals at risk for clinical depression.|units on a scale|Mean|26.0|26.0|Standard Deviation|13.3|13.3|||
4120605|NCT00928720|3946030|B3|||Depression|The Center for Epidemiological Studies-Depression (CES-D) scale is a 20-item measure that asks the individual to rate how often over the past week s/he has experienced symptoms associated with depression, such as restless sleep, poor appetite, and feeling lonely. Response options range from 0 to 3 for each item. Scores range from 0 to 60, with high scores indicating greater depressive symptoms. The CES-D also provides cutoff scores (e.g., 16 or greater) that aid in identifying individuals at risk for clinical depression.|units on a scale|Mean|24.1|24.1|Standard Deviation|14.2|14.2|||
4120606|NCT00928720|3946031|B2|||Depression|The Center for Epidemiological Studies-Depression (CES-D) scale is a 20-item measure that asks the individual to rate how often over the past week s/he has experienced symptoms associated with depression, such as restless sleep, poor appetite, and feeling lonely. Response options range from 0 to 3 for each item. Scores range from 0 to 60, with high scores indicating greater depressive symptoms. The CES-D also provides cutoff scores (e.g., 16 or greater) that aid in identifying individuals at risk for clinical depression.|units on a scale|Mean|29.5|29.5|Standard Deviation|13.7|13.7|||
4120607|NCT00928720|3946032|B1|||Depression|The Center for Epidemiological Studies-Depression (CES-D) scale is a 20-item measure that asks the individual to rate how often over the past week s/he has experienced symptoms associated with depression, such as restless sleep, poor appetite, and feeling lonely. Response options range from 0 to 3 for each item. Scores range from 0 to 60, with high scores indicating greater depressive symptoms. The CES-D also provides cutoff scores (e.g., 16 or greater) that aid in identifying individuals at risk for clinical depression.|units on a scale|Mean|23.9|23.9|Standard Deviation|11.8|11.8|||
4120608|NCT00928720|3946029|B4|||Fibromyalgia impact|The Fibromyalgia Impact Questionnaire is a brief assessment and evaluation instrument consisting of 19 items to measure patient status, progress, and outcomes of patients with fibromyalgia over the past week. The measure is self-administered and takes approximately 5 minutes to complete. Total scores range from 0 to 80, with 0 indicating no impact and 80 indicating maximum impact, thus a higher score indicating more negative impact.|units on a scale|Mean|64.51|64.51|Standard Deviation|17.5|17.5|||
4120609|NCT00928720|3946030|B3|||Fibromyalgia impact|The Fibromyalgia Impact Questionnaire is a brief assessment and evaluation instrument consisting of 19 items to measure patient status, progress, and outcomes of patients with fibromyalgia over the past week. The measure is self-administered and takes approximately 5 minutes to complete. Total scores range from 0 to 80, with 0 indicating no impact and 80 indicating maximum impact, thus a higher score indicating more negative impact.|units on a scale|Mean|66.31|66.31|Standard Deviation|16.9|16.9|||
4120610|NCT00928720|3946031|B2|||Fibromyalgia impact|The Fibromyalgia Impact Questionnaire is a brief assessment and evaluation instrument consisting of 19 items to measure patient status, progress, and outcomes of patients with fibromyalgia over the past week. The measure is self-administered and takes approximately 5 minutes to complete. Total scores range from 0 to 80, with 0 indicating no impact and 80 indicating maximum impact, thus a higher score indicating more negative impact.|units on a scale|Mean|65.98|65.98|Standard Deviation|17.9|17.9|||
4120611|NCT00928720|3946032|B1|||Fibromyalgia impact|The Fibromyalgia Impact Questionnaire is a brief assessment and evaluation instrument consisting of 19 items to measure patient status, progress, and outcomes of patients with fibromyalgia over the past week. The measure is self-administered and takes approximately 5 minutes to complete. Total scores range from 0 to 80, with 0 indicating no impact and 80 indicating maximum impact, thus a higher score indicating more negative impact.|units on a scale|Mean|61.36|61.36|Standard Deviation|18.2|18.2|||
4120612|NCT00928720|3946029|B4|||Fatigue|A Numeric Rating Scale to capture present fatigue. The scales ranges from 0 (no fatigue) to 10 (worst fatigue imaginable).|units on a scale|Mean|6.53|6.53|Standard Deviation|1.89|1.89|||
4120613|NCT00928720|3946030|B3|||Fatigue|A Numeric Rating Scale to capture present fatigue. The scales ranges from 0 (no fatigue) to 10 (worst fatigue imaginable).|units on a scale|Mean|6.85|6.85|Standard Deviation|1.74|1.74|||
4120614|NCT00928720|3946031|B2|||Fatigue|A Numeric Rating Scale to capture present fatigue. The scales ranges from 0 (no fatigue) to 10 (worst fatigue imaginable).|units on a scale|Mean|6.66|6.66|Standard Deviation|2.0|2.0|||
4120615|NCT00928720|3946032|B1|||Fatigue|A Numeric Rating Scale to capture present fatigue. The scales ranges from 0 (no fatigue) to 10 (worst fatigue imaginable).|units on a scale|Mean|6.12|6.12|Standard Deviation|1.89|1.89|||
4120616|NCT00928720|3946029|B4|||Pain Numeric Rating Scale|A Numeric Rating Scale to capture average pain. The scales ranges from 0 (no pain) to 10 (worst pain imaginable).|units on a scale|Mean|5.8|5.8|Standard Deviation|1.8|1.8|||
4120619|NCT00928720|3946032|B1|||Pain Numeric Rating Scale|A Numeric Rating Scale to capture average pain. The scales ranges from 0 (no pain) to 10 (worst pain imaginable).|units on a scale|Mean|5.8|5.8|Standard Deviation|1.9|1.9|||
4120620|NCT00928720|3946029|B4|United States||Region of Enrollment||participants|Number|46|46.0||||||
4120621|NCT00928720|3946030|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4120622|NCT00928720|3946031|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4120623|NCT00928720|3946032|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4120624|NCT00928720|3946029|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4120625|NCT00928720|3946030|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4120626|NCT00928720|3946031|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4120627|NCT00928720|3946032|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4120628|NCT00928720|3946029|B4||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4120629|NCT00928720|3946030|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4120630|NCT00928720|3946031|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4120631|NCT00928720|3946032|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4120632|NCT00928720|3946029|B4|||Age||years|Mean|50.8|50.8|Standard Deviation|10.4|10.4|||
4120633|NCT00928720|3946030|B3|||Age||years|Mean|48.6|48.6|Standard Deviation|9.8|9.8|||
4120634|NCT00928720|3946031|B2|||Age||years|Mean|51.5|51.5|Standard Deviation|10.9|10.9|||
4120635|NCT00928720|3946032|B1|||Age||years|Mean|51.9|51.9|Standard Deviation|10.6|10.6|||
4120636|NCT00928694|3946057|B1|||Weight||Kilograms|Mean|73.94|73.94|Full Range|||51.71|93.9|
4120637|NCT00928694|3946057|B1|||Height||Centimeters|Mean|169.64|169.64|Full Range|||154.94|187.96|
4120638|NCT00928694|3946057|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4120639|NCT00928694|3946057|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4120640|NCT00928694|3946057|B1|||Age||years|Mean|36.7|36.7|Full Range|||23.0|45.0|
4120641|NCT00928668|3946066|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4120642|NCT00928668|3946066|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4120643|NCT00928668|3946066|B1|||Age||years|Mean|28.9|28.9|Standard Deviation|9.2|9.2|||
4120644|NCT00928642|3946112|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4120645|NCT00928642|3946112|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4120646|NCT00928642|3946112|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4120647|NCT00928642|3946112|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|7.3|7.3|||
4120648|NCT00928642|3946112|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4120649|NCT00928642|3946112|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4120650|NCT00928642|3946112|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4120651|NCT00928512|3946121|B6|||BMI (body mass index)||kg/m^2|Mean|27.52|27.52|Standard Deviation|5.693|5.693|||
4120652|NCT00928512|3946122|B5|||BMI (body mass index)||kg/m^2|Mean|24.47|24.47|Standard Deviation|5.229|5.229|||
4120653|NCT00928512|3946123|B4|||BMI (body mass index)||kg/m^2|Mean|26.69|26.69|Standard Deviation|4.768|4.768|||
4120654|NCT00928512|3946124|B3|||BMI (body mass index)||kg/m^2|Mean|27.03|27.03|Standard Deviation|4.936|4.936|||
4120655|NCT00928512|3946125|B2|||BMI (body mass index)||kg/m^2|Mean|27.32|27.32|Standard Deviation|4.673|4.673|||
4120656|NCT00928512|3946126|B1|||BMI (body mass index)||kg/m^2|Mean|29.48|29.48|Standard Deviation|8.383|8.383|||
4120657|NCT00928512|3946121|B6|||Height||cm|Mean|164.0|164.0|Standard Deviation|9.06|9.06|||
4120658|NCT00928512|3946122|B5|||Height||cm|Mean|166.1|166.1|Standard Deviation|7.62|7.62|||
4120659|NCT00928512|3946123|B4|||Height||cm|Mean|163.2|163.2|Standard Deviation|7.07|7.07|||
4120660|NCT00928512|3946124|B3|||Height||cm|Mean|165.4|165.4|Standard Deviation|9.52|9.52|||
4120661|NCT00928512|3946125|B2|||Height||cm|Mean|161.9|161.9|Standard Deviation|10.84|10.84|||
4120662|NCT00928512|3946126|B1|||Height||cm|Mean|163.3|163.3|Standard Deviation|10.03|10.03|||
4120663|NCT00928512|3946121|B6|>=90 kg||Weight Group||Participants|Number|40|40.0||||||
4120664|NCT00928512|3946122|B5|>=90 kg||Weight Group||Participants|Number|10|10.0||||||
4120665|NCT00928512|3946123|B4|>=90 kg||Weight Group||Participants|Number|4|4.0||||||
4120666|NCT00928512|3946124|B3|>=90 kg||Weight Group||Participants|Number|9|9.0||||||
4120667|NCT00928512|3946125|B2|>=90 kg||Weight Group||Participants|Number|8|8.0||||||
4120668|NCT00928512|3946126|B1|>=90 kg||Weight Group||Participants|Number|9|9.0||||||
4120669|NCT00928512|3946121|B6|<90 kg||Weight Group||Participants|Number|197|197.0||||||
4120670|NCT00928512|3946122|B5|<90 kg||Weight Group||Participants|Number|40|40.0||||||
4120671|NCT00928512|3946123|B4|<90 kg||Weight Group||Participants|Number|50|50.0||||||
4120672|NCT00928512|3946124|B3|<90 kg||Weight Group||Participants|Number|40|40.0||||||
4120673|NCT00928512|3946125|B2|<90 kg||Weight Group||Participants|Number|35|35.0||||||
4120674|NCT00928512|3946126|B1|<90 kg||Weight Group||Participants|Number|32|32.0||||||
4120675|NCT00928512|3946121|B6|||Weight||kg|Mean|74.3|74.3|Standard Deviation|17.27|17.27|||
4120676|NCT00928512|3946122|B5|||Weight||kg|Mean|75.9|75.9|Standard Deviation|15.61|15.61|||
4120677|NCT00928512|3946123|B4|||Weight||kg|Mean|71.3|71.3|Standard Deviation|14.16|14.16|||
4120678|NCT00928512|3946124|B3|||Weight||kg|Mean|74.3|74.3|Standard Deviation|15.70|15.7|||
4120679|NCT00928512|3946125|B2|||Weight||kg|Mean|72.1|72.1|Standard Deviation|16.52|16.52|||
4120680|NCT00928512|3946126|B1|||Weight||kg|Mean|78.9|78.9|Standard Deviation|23.91|23.91|||
4120681|NCT00928512|3946121|B6|Class IV||Functional Status|ACR classification criteria of functional status in rheumatoid arthritis: Class l: completely able to perform usual activities of daily living (self-care, vocational & avocational); Class ll: able to perform usual self-care and vocational activities but limited in avocational activities; Class lll: able to perform usual self-care activities but limited in vocational and avocational activities; Class IV: limited ability to perform usual self-care, vocational and avocational activities.|Participants|Number|0|0.0||||||
4120682|NCT00928512|3946122|B5|Class IV||Functional Status|ACR classification criteria of functional status in rheumatoid arthritis: Class l: completely able to perform usual activities of daily living (self-care, vocational & avocational); Class ll: able to perform usual self-care and vocational activities but limited in avocational activities; Class lll: able to perform usual self-care activities but limited in vocational and avocational activities; Class IV: limited ability to perform usual self-care, vocational and avocational activities.|Participants|Number|0|0.0||||||
4120683|NCT00928512|3946123|B4|Class IV||Functional Status|ACR classification criteria of functional status in rheumatoid arthritis: Class l: completely able to perform usual activities of daily living (self-care, vocational & avocational); Class ll: able to perform usual self-care and vocational activities but limited in avocational activities; Class lll: able to perform usual self-care activities but limited in vocational and avocational activities; Class IV: limited ability to perform usual self-care, vocational and avocational activities.|Participants|Number|0|0.0||||||
4120684|NCT00928512|3946124|B3|Class IV||Functional Status|ACR classification criteria of functional status in rheumatoid arthritis: Class l: completely able to perform usual activities of daily living (self-care, vocational & avocational); Class ll: able to perform usual self-care and vocational activities but limited in avocational activities; Class lll: able to perform usual self-care activities but limited in vocational and avocational activities; Class IV: limited ability to perform usual self-care, vocational and avocational activities.|Participants|Number|0|0.0||||||
4120685|NCT00928512|3946125|B2|Class IV||Functional Status|ACR classification criteria of functional status in rheumatoid arthritis: Class l: completely able to perform usual activities of daily living (self-care, vocational & avocational); Class ll: able to perform usual self-care and vocational activities but limited in avocational activities; Class lll: able to perform usual self-care activities but limited in vocational and avocational activities; Class IV: limited ability to perform usual self-care, vocational and avocational activities.|Participants|Number|0|0.0||||||
4120686|NCT00928512|3946126|B1|Class IV||Functional Status|ACR classification criteria of functional status in rheumatoid arthritis: Class l: completely able to perform usual activities of daily living (self-care, vocational & avocational); Class ll: able to perform usual self-care and vocational activities but limited in avocational activities; Class lll: able to perform usual self-care activities but limited in vocational and avocational activities; Class IV: limited ability to perform usual self-care, vocational and avocational activities.|Participants|Number|0|0.0||||||
4120687|NCT00928512|3946121|B6|Class lll||Functional Status|ACR classification criteria of functional status in rheumatoid arthritis: Class l: completely able to perform usual activities of daily living (self-care, vocational & avocational); Class ll: able to perform usual self-care and vocational activities but limited in avocational activities; Class lll: able to perform usual self-care activities but limited in vocational and avocational activities; Class IV: limited ability to perform usual self-care, vocational and avocational activities.|Participants|Number|64|64.0||||||
4120688|NCT00928512|3946122|B5|Class lll||Functional Status|ACR classification criteria of functional status in rheumatoid arthritis: Class l: completely able to perform usual activities of daily living (self-care, vocational & avocational); Class ll: able to perform usual self-care and vocational activities but limited in avocational activities; Class lll: able to perform usual self-care activities but limited in vocational and avocational activities; Class IV: limited ability to perform usual self-care, vocational and avocational activities.|Participants|Number|12|12.0||||||
4120689|NCT00928512|3946123|B4|Class lll||Functional Status|ACR classification criteria of functional status in rheumatoid arthritis: Class l: completely able to perform usual activities of daily living (self-care, vocational & avocational); Class ll: able to perform usual self-care and vocational activities but limited in avocational activities; Class lll: able to perform usual self-care activities but limited in vocational and avocational activities; Class IV: limited ability to perform usual self-care, vocational and avocational activities.|Participants|Number|12|12.0||||||
4120690|NCT00928512|3946124|B3|Class lll||Functional Status|ACR classification criteria of functional status in rheumatoid arthritis: Class l: completely able to perform usual activities of daily living (self-care, vocational & avocational); Class ll: able to perform usual self-care and vocational activities but limited in avocational activities; Class lll: able to perform usual self-care activities but limited in vocational and avocational activities; Class IV: limited ability to perform usual self-care, vocational and avocational activities.|Participants|Number|16|16.0||||||
4120691|NCT00928512|3946125|B2|Class lll||Functional Status|ACR classification criteria of functional status in rheumatoid arthritis: Class l: completely able to perform usual activities of daily living (self-care, vocational & avocational); Class ll: able to perform usual self-care and vocational activities but limited in avocational activities; Class lll: able to perform usual self-care activities but limited in vocational and avocational activities; Class IV: limited ability to perform usual self-care, vocational and avocational activities.|Participants|Number|13|13.0||||||
4120692|NCT00928512|3946126|B1|Class lll||Functional Status|ACR classification criteria of functional status in rheumatoid arthritis: Class l: completely able to perform usual activities of daily living (self-care, vocational & avocational); Class ll: able to perform usual self-care and vocational activities but limited in avocational activities; Class lll: able to perform usual self-care activities but limited in vocational and avocational activities; Class IV: limited ability to perform usual self-care, vocational and avocational activities.|Participants|Number|11|11.0||||||
4120693|NCT00928512|3946121|B6|Class ll||Functional Status|ACR classification criteria of functional status in rheumatoid arthritis: Class l: completely able to perform usual activities of daily living (self-care, vocational & avocational); Class ll: able to perform usual self-care and vocational activities but limited in avocational activities; Class lll: able to perform usual self-care activities but limited in vocational and avocational activities; Class IV: limited ability to perform usual self-care, vocational and avocational activities.|Participants|Number|157|157.0||||||
4120715|NCT00928512|3946125|B2|East Asia||Geographical Region||Participants|Number|11|11.0||||||
4120694|NCT00928512|3946122|B5|Class ll||Functional Status|ACR classification criteria of functional status in rheumatoid arthritis: Class l: completely able to perform usual activities of daily living (self-care, vocational & avocational); Class ll: able to perform usual self-care and vocational activities but limited in avocational activities; Class lll: able to perform usual self-care activities but limited in vocational and avocational activities; Class IV: limited ability to perform usual self-care, vocational and avocational activities.|Participants|Number|34|34.0||||||
4120695|NCT00928512|3946123|B4|Class ll||Functional Status|ACR classification criteria of functional status in rheumatoid arthritis: Class l: completely able to perform usual activities of daily living (self-care, vocational & avocational); Class ll: able to perform usual self-care and vocational activities but limited in avocational activities; Class lll: able to perform usual self-care activities but limited in vocational and avocational activities; Class IV: limited ability to perform usual self-care, vocational and avocational activities.|Participants|Number|37|37.0||||||
4120696|NCT00928512|3946124|B3|Class ll||Functional Status|ACR classification criteria of functional status in rheumatoid arthritis: Class l: completely able to perform usual activities of daily living (self-care, vocational & avocational); Class ll: able to perform usual self-care and vocational activities but limited in avocational activities; Class lll: able to perform usual self-care activities but limited in vocational and avocational activities; Class IV: limited ability to perform usual self-care, vocational and avocational activities.|Participants|Number|31|31.0||||||
4120697|NCT00928512|3946125|B2|Class ll||Functional Status|ACR classification criteria of functional status in rheumatoid arthritis: Class l: completely able to perform usual activities of daily living (self-care, vocational & avocational); Class ll: able to perform usual self-care and vocational activities but limited in avocational activities; Class lll: able to perform usual self-care activities but limited in vocational and avocational activities; Class IV: limited ability to perform usual self-care, vocational and avocational activities.|Participants|Number|27|27.0||||||
4120698|NCT00928512|3946126|B1|Class ll||Functional Status|ACR classification criteria of functional status in rheumatoid arthritis: Class l: completely able to perform usual activities of daily living (self-care, vocational & avocational); Class ll: able to perform usual self-care and vocational activities but limited in avocational activities; Class lll: able to perform usual self-care activities but limited in vocational and avocational activities; Class IV: limited ability to perform usual self-care, vocational and avocational activities.|Participants|Number|28|28.0||||||
4120699|NCT00928512|3946121|B6|Class l||Functional Status|ACR classification criteria of functional status in rheumatoid arthritis: Class l: completely able to perform usual activities of daily living (self-care, vocational & avocational); Class ll: able to perform usual self-care and vocational activities but limited in avocational activities; Class lll: able to perform usual self-care activities but limited in vocational and avocational activities; Class IV: limited ability to perform usual self-care, vocational and avocational activities.|Participants|Number|16|16.0||||||
4120700|NCT00928512|3946122|B5|Class l||Functional Status|ACR classification criteria of functional status in rheumatoid arthritis: Class l: completely able to perform usual activities of daily living (self-care, vocational & avocational); Class ll: able to perform usual self-care and vocational activities but limited in avocational activities; Class lll: able to perform usual self-care activities but limited in vocational and avocational activities; Class IV: limited ability to perform usual self-care, vocational and avocational activities.|Participants|Number|4|4.0||||||
4120701|NCT00928512|3946123|B4|Class l||Functional Status|ACR classification criteria of functional status in rheumatoid arthritis: Class l: completely able to perform usual activities of daily living (self-care, vocational & avocational); Class ll: able to perform usual self-care and vocational activities but limited in avocational activities; Class lll: able to perform usual self-care activities but limited in vocational and avocational activities; Class IV: limited ability to perform usual self-care, vocational and avocational activities.|Participants|Number|5|5.0||||||
4120702|NCT00928512|3946124|B3|Class l||Functional Status|ACR classification criteria of functional status in rheumatoid arthritis: Class l: completely able to perform usual activities of daily living (self-care, vocational & avocational); Class ll: able to perform usual self-care and vocational activities but limited in avocational activities; Class lll: able to perform usual self-care activities but limited in vocational and avocational activities; Class IV: limited ability to perform usual self-care, vocational and avocational activities.|Participants|Number|2|2.0||||||
4120703|NCT00928512|3946125|B2|Class l||Functional Status|ACR classification criteria of functional status in rheumatoid arthritis: Class l: completely able to perform usual activities of daily living (self-care, vocational & avocational); Class ll: able to perform usual self-care and vocational activities but limited in avocational activities; Class lll: able to perform usual self-care activities but limited in vocational and avocational activities; Class IV: limited ability to perform usual self-care, vocational and avocational activities.|Participants|Number|3|3.0||||||
4120704|NCT00928512|3946126|B1|Class l||Functional Status|ACR classification criteria of functional status in rheumatoid arthritis: Class l: completely able to perform usual activities of daily living (self-care, vocational & avocational); Class ll: able to perform usual self-care and vocational activities but limited in avocational activities; Class lll: able to perform usual self-care activities but limited in vocational and avocational activities; Class IV: limited ability to perform usual self-care, vocational and avocational activities.|Participants|Number|2|2.0||||||
4120705|NCT00928512|3946121|B6|Non-East Asia||Geographical Region||Participants|Number|188|188.0||||||
4120706|NCT00928512|3946122|B5|Non-East Asia||Geographical Region||Participants|Number|42|42.0||||||
4120707|NCT00928512|3946123|B4|Non-East Asia||Geographical Region||Participants|Number|41|41.0||||||
4120708|NCT00928512|3946124|B3|Non-East Asia||Geographical Region||Participants|Number|40|40.0||||||
4120709|NCT00928512|3946125|B2|Non-East Asia||Geographical Region||Participants|Number|32|32.0||||||
4120710|NCT00928512|3946126|B1|Non-East Asia||Geographical Region||Participants|Number|33|33.0||||||
4120711|NCT00928512|3946121|B6|East Asia||Geographical Region||Participants|Number|49|49.0||||||
4120712|NCT00928512|3946122|B5|East Asia||Geographical Region||Participants|Number|8|8.0||||||
4120713|NCT00928512|3946123|B4|East Asia||Geographical Region||Participants|Number|13|13.0||||||
4120714|NCT00928512|3946124|B3|East Asia||Geographical Region||Participants|Number|9|9.0||||||
4120716|NCT00928512|3946126|B1|East Asia||Geographical Region||Participants|Number|8|8.0||||||
4120717|NCT00928512|3946121|B6|Other||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4120718|NCT00928512|3946122|B5|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4120719|NCT00928512|3946123|B4|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4120720|NCT00928512|3946124|B3|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4120721|NCT00928512|3946125|B2|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4120722|NCT00928512|3946126|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4120723|NCT00928512|3946121|B6|Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4120724|NCT00928512|3946122|B5|Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4120725|NCT00928512|3946123|B4|Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4120726|NCT00928512|3946124|B3|Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4120727|NCT00928512|3946125|B2|Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4120728|NCT00928512|3946126|B1|Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4120729|NCT00928512|3946121|B6|Native American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4120730|NCT00928512|3946122|B5|Native American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4120731|NCT00928512|3946123|B4|Native American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4120732|NCT00928512|3946124|B3|Native American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4120733|NCT00928512|3946125|B2|Native American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4120734|NCT00928512|3946126|B1|Native American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4120735|NCT00928512|3946121|B6|Asian||Race/Ethnicity, Customized||Participants|Number|50|50.0||||||
4120736|NCT00928512|3946122|B5|Asian||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4120737|NCT00928512|3946123|B4|Asian||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4120738|NCT00928512|3946124|B3|Asian||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4120739|NCT00928512|3946125|B2|Asian||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4120740|NCT00928512|3946126|B1|Asian||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4120741|NCT00928512|3946121|B6|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4120742|NCT00928512|3946122|B5|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4120743|NCT00928512|3946123|B4|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4120744|NCT00928512|3946124|B3|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4120745|NCT00928512|3946125|B2|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4120746|NCT00928512|3946126|B1|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4120747|NCT00928512|3946121|B6|Caucasian||Race/Ethnicity, Customized||Participants|Number|176|176.0||||||
4120748|NCT00928512|3946122|B5|Caucasian||Race/Ethnicity, Customized||Participants|Number|39|39.0||||||
4120749|NCT00928512|3946123|B4|Caucasian||Race/Ethnicity, Customized||Participants|Number|38|38.0||||||
4120750|NCT00928512|3946124|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
4120751|NCT00928512|3946125|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
4120752|NCT00928512|3946126|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
4120753|NCT00928512|3946121|B6||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4120754|NCT00928512|3946122|B5||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4120755|NCT00928512|3946123|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4120756|NCT00928512|3946124|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4120757|NCT00928512|3946125|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4120758|NCT00928512|3946126|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4120759|NCT00928512|3946121|B6||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4120760|NCT00928512|3946122|B5||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4120761|NCT00928512|3946123|B4||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4120762|NCT00928512|3946124|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4120763|NCT00928512|3946125|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4120764|NCT00928512|3946126|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4120765|NCT00928512|3946121|B6|>=75 years||Age, Customized||Participants|Number|5|5.0||||||
4120766|NCT00928512|3946122|B5|>=75 years||Age, Customized||Participants|Number|1|1.0||||||
4120767|NCT00928512|3946123|B4|>=75 years||Age, Customized||Participants|Number|1|1.0||||||
4120768|NCT00928512|3946124|B3|>=75 years||Age, Customized||Participants|Number|0|0.0||||||
4120769|NCT00928512|3946125|B2|>=75 years||Age, Customized||Participants|Number|2|2.0||||||
4120770|NCT00928512|3946126|B1|>=75 years||Age, Customized||Participants|Number|1|1.0||||||
4120771|NCT00928512|3946121|B6|>=65 - < 75 years||Age, Customized||Participants|Number|41|41.0||||||
4120772|NCT00928512|3946122|B5|>=65 - < 75 years||Age, Customized||Participants|Number|9|9.0||||||
4120773|NCT00928512|3946123|B4|>=65 - < 75 years||Age, Customized||Participants|Number|6|6.0||||||
4120774|NCT00928512|3946124|B3|>=65 - < 75 years||Age, Customized||Participants|Number|8|8.0||||||
4120775|NCT00928512|3946125|B2|>=65 - < 75 years||Age, Customized||Participants|Number|11|11.0||||||
4120776|NCT00928512|3946126|B1|>=65 - < 75 years||Age, Customized||Participants|Number|7|7.0||||||
4120777|NCT00928512|3946121|B6|>=41 - < 65 years||Age, Customized||Participants|Number|169|169.0||||||
4120778|NCT00928512|3946122|B5|>=41 - < 65 years||Age, Customized||Participants|Number|34|34.0||||||
4120779|NCT00928512|3946123|B4|>=41 - < 65 years||Age, Customized||Participants|Number|41|41.0||||||
4120780|NCT00928512|3946124|B3|>=41 - < 65 years||Age, Customized||Participants|Number|37|37.0||||||
4120781|NCT00928512|3946125|B2|>=41 - < 65 years||Age, Customized||Participants|Number|27|27.0||||||
4120782|NCT00928512|3946126|B1|>=41 - < 65 years||Age, Customized||Participants|Number|30|30.0||||||
4120783|NCT00928512|3946121|B6|>=18 - < 41 years||Age, Customized||Participants|Number|22|22.0||||||
4120784|NCT00928512|3946122|B5|>=18 - < 41 years||Age, Customized||Participants|Number|6|6.0||||||
4120785|NCT00928512|3946123|B4|>=18 - < 41 years||Age, Customized||Participants|Number|6|6.0||||||
4120786|NCT00928512|3946124|B3|>=18 - < 41 years||Age, Customized||Participants|Number|4|4.0||||||
4120787|NCT00928512|3946125|B2|>=18 - < 41 years||Age, Customized||Participants|Number|3|3.0||||||
4120788|NCT00928512|3946126|B1|>=18 - < 41 years||Age, Customized||Participants|Number|3|3.0||||||
4120789|NCT00928512|3946121|B6|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4120790|NCT00928512|3946122|B5|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4120791|NCT00928512|3946123|B4|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4120792|NCT00928512|3946124|B3|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4120793|NCT00928512|3946125|B2|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4120794|NCT00928512|3946126|B1|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4120795|NCT00928512|3946121|B6|||Age||years|Mean|54.9|54.9|Standard Deviation|10.75|10.75|||
4120796|NCT00928512|3946122|B5|||Age||years|Mean|55.0|55.0|Standard Deviation|10.46|10.46|||
4120797|NCT00928512|3946123|B4|||Age||years|Mean|53.3|53.3|Standard Deviation|11.44|11.44|||
4120798|NCT00928512|3946124|B3|||Age||years|Mean|54.3|54.3|Standard Deviation|9.84|9.84|||
4120799|NCT00928512|3946125|B2|||Age||years|Mean|57.8|57.8|Standard Deviation|11.23|11.23|||
4120800|NCT00928512|3946126|B1|||Age||years|Mean|54.7|54.7|Standard Deviation|10.61|10.61|||
4120801|NCT00928486|3946231|B1|Japan||Region of Enrollment||participants|Number|25|25.0||||||
4120802|NCT00928486|3946231|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4120803|NCT00928486|3946231|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4120804|NCT00928486|3946231|B1|||Age||years|Mean|62.1|62.1|Standard Deviation|9.99|9.99|||
4120805|NCT00928434|3946237|B4|||Testosterone||ng/mL|Mean|3.73|3.73|Standard Deviation|1.52|1.52|||
4120806|NCT00928434|3946238|B3|||Testosterone||ng/mL|Mean|3.76|3.76|Standard Deviation|1.58|1.58|||
4120807|NCT00928434|3946239|B2|||Testosterone||ng/mL|Mean|3.90|3.9|Standard Deviation|1.59|1.59|||
4120808|NCT00928434|3946240|B1|||Testosterone||ng/mL|Mean|3.65|3.65|Standard Deviation|1.43|1.43|||
4120809|NCT00928434|3946237|B4|||Prostate Specific Antigen (PSA)||ng/mL|Mean|13.8|13.8|Standard Deviation|48|48.0|||
4120810|NCT00928434|3946238|B3|||Prostate Specific Antigen (PSA)||ng/mL|Mean|10.7|10.7|Standard Deviation|24.4|24.4|||
4120811|NCT00928434|3946239|B2|||Prostate Specific Antigen (PSA)||ng/mL|Mean|15.6|15.6|Standard Deviation|32.2|32.2|||
4120812|NCT00928434|3946240|B1|||Prostate Specific Antigen (PSA)||ng/mL|Mean|16.4|16.4|Standard Deviation|66.3|66.3|||
4120813|NCT00928434|3946237|B4|||Body Mass Index (BMI)||Kg/m^2|Mean|29.2|29.2|Standard Deviation|5.16|5.16|||
4120814|NCT00928434|3946238|B3|||Body Mass Index (BMI)||Kg/m^2|Mean|29.6|29.6|Standard Deviation|4.94|4.94|||
4120815|NCT00928434|3946239|B2|||Body Mass Index (BMI)||Kg/m^2|Mean|29.2|29.2|Standard Deviation|4.89|4.89|||
4120816|NCT00928434|3946240|B1|||Body Mass Index (BMI)||Kg/m^2|Mean|28.9|28.9|Standard Deviation|5.45|5.45|||
4120817|NCT00928434|3946237|B4|||Weight||Kg|Mean|90.8|90.8|Standard Deviation|17.9|17.9|||
4120818|NCT00928434|3946238|B3|||Weight||Kg|Mean|91.9|91.9|Standard Deviation|16.9|16.9|||
4120819|NCT00928434|3946239|B2|||Weight||Kg|Mean|88.4|88.4|Standard Deviation|15.8|15.8|||
4120820|NCT00928434|3946240|B1|||Weight||Kg|Mean|90.3|90.3|Standard Deviation|19.4|19.4|||
4120821|NCT00928434|3946237|B4|||Height||Meter|Mean|1.76|1.76|Standard Deviation|0.085|0.085|||
4120822|NCT00928434|3946238|B3|||Height||Meter|Mean|1.76|1.76|Standard Deviation|0.080|0.08|||
4120823|NCT00928434|3946239|B2|||Height||Meter|Mean|1.74|1.74|Standard Deviation|0.089|0.089|||
4120824|NCT00928434|3946240|B1|||Height||Meter|Mean|1.77|1.77|Standard Deviation|0.089|0.089|||
4120825|NCT00928434|3946237|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4120826|NCT00928434|3946238|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120827|NCT00928434|3946239|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120828|NCT00928434|3946240|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4120829|NCT00928434|3946237|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120830|NCT00928434|3946238|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120831|NCT00928434|3946239|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120832|NCT00928434|3946240|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120833|NCT00928434|3946237|B4||White|Race (NIH/OMB)||Participants|Count of Participants|316|316.0||||||
4120834|NCT00928434|3946238|B3||White|Race (NIH/OMB)||Participants|Count of Participants|137|137.0||||||
4120835|NCT00928434|3946239|B2||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4120836|NCT00928434|3946240|B1||White|Race (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
4120837|NCT00928434|3946237|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
4120838|NCT00928434|3946238|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4120839|NCT00928434|3946239|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4120840|NCT00928434|3946240|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4120841|NCT00928434|3946237|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120842|NCT00928434|3946238|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120843|NCT00928434|3946239|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120844|NCT00928434|3946240|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120845|NCT00928434|3946237|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4120846|NCT00928434|3946238|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4120847|NCT00928434|3946239|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4120848|NCT00928434|3946240|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120849|NCT00928434|3946237|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4120850|NCT00928434|3946238|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4120851|NCT00928434|3946239|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4120852|NCT00928434|3946240|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4120853|NCT00928434|3946237|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120854|NCT00928434|3946238|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120855|NCT00928434|3946239|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120856|NCT00928434|3946240|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120857|NCT00928434|3946237|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|368|368.0||||||
4120858|NCT00928434|3946238|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|164|164.0||||||
4120859|NCT00928434|3946239|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4120860|NCT00928434|3946240|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|158|158.0||||||
4120861|NCT00928434|3946237|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4120862|NCT00928434|3946238|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4120863|NCT00928434|3946239|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4120864|NCT00928434|3946240|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4120865|NCT00928434|3946237|B4||Male|Sex: Female, Male||Participants|Count of Participants|403|403.0||||||
4120866|NCT00928434|3946238|B3||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4120867|NCT00928434|3946239|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4120868|NCT00928434|3946240|B1||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4120869|NCT00928434|3946237|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4120870|NCT00928434|3946238|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4120871|NCT00928434|3946239|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4120872|NCT00928434|3946240|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4120873|NCT00928434|3946237|B4|||Age||Years|Mean|71.5|71.5|Standard Deviation|8.59|8.59|||
4120874|NCT00928434|3946238|B3|||Age||Years|Mean|71.0|71.0|Standard Deviation|8.44|8.44|||
4120875|NCT00928434|3946239|B2|||Age||Years|Mean|71.7|71.7|Standard Deviation|8.14|8.14|||
4120876|NCT00928434|3946240|B1|||Age||Years|Mean|71.9|71.9|Standard Deviation|8.89|8.89|||
4120877|NCT00928421|3946314|B1|||Body Mass Index||kg/m^2|Mean|29.0|29.0|Standard Deviation|6.73|6.73|||
4120878|NCT00928421|3946314|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120879|NCT00928421|3946314|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4120880|NCT00928421|3946314|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4120881|NCT00928421|3946314|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120882|NCT00928421|3946314|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4120883|NCT00928421|3946314|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120884|NCT00928421|3946314|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120885|NCT00928421|3946314|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4120886|NCT00928421|3946314|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4120887|NCT00928421|3946314|B1|||Age||years|Mean|52.9|52.9|Standard Deviation|10.44|10.44|||
4120888|NCT00928408|3946318|B1|White or Caucasion||Race/Ethnicity, Customized||Participants|Number|199|199.0||||||
4120889|NCT00928408|3946318|B1|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|104|104.0||||||
4120890|NCT00928408|3946318|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4120891|NCT00928408|3946318|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4120892|NCT00928408|3946318|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4120893|NCT00928408|3946318|B1||Female|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
4120894|NCT00928408|3946318|B1|||Age||Years|Mean|67.4|67.4|Standard Deviation|13.0|13.0|||
4120895|NCT00928395|3946347|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4120896|NCT00928395|3946347|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4120897|NCT00928395|3946347|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4120898|NCT00928395|3946347|B1|||Age||years|Mean|60.5|60.5|Standard Deviation|15.5|15.5|||
4120899|NCT00928395|3946347|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4120900|NCT00928395|3946347|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4120901|NCT00928395|3946347|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4120902|NCT00928304|3946351|B1|United States||Region of Enrollment||participants|Number|109|109.0||||||
4120903|NCT00928304|3946351|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4120904|NCT00928304|3946351|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4120905|NCT00928304|3946351|B1|Healthy Volunteer Group||Age||years|Mean|27.7|27.7|Standard Deviation|5.1|5.1|||
4120906|NCT00928304|3946351|B1|Down Syndrome Group||Age||years|Mean|46.3|46.3|Standard Deviation|4.7|4.7|||
4120907|NCT00928304|3946351|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4120908|NCT00928304|3946351|B1||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
4120909|NCT00928304|3946351|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4120910|NCT00928252|3946364|B1|United States||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
4120911|NCT00928252|3946364|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4120912|NCT00928252|3946364|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4120913|NCT00928252|3946364|B1|||Age||Years|Mean|73|73.0|Full Range|||70.0|75.0|
4120914|NCT00928252|3946364|B1||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
4120915|NCT00928252|3946364|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4120916|NCT00928252|3946364|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4120917|NCT00928187|3946370|B4|||CD4 cells count||cells/mm3|Median|183|183.0|Inter-Quartile Range|||87.0|290.0|
4120918|NCT00928187|3946371|B3|||CD4 cells count||cells/mm3|Median|153|153.0|Inter-Quartile Range|||81.0|261.0|
4120919|NCT00928187|3946372|B2|||CD4 cells count||cells/mm3|Median|195|195.0|Inter-Quartile Range|||100.0|288.0|
4120920|NCT00928187|3946373|B1|||CD4 cells count||cells/mm3|Median|199|199.0|Inter-Quartile Range|||92.0|318.0|
4120921|NCT00928187|3946370|B4|||Resistance to the three first-line drugs||participants|Number|249|249.0||||||
4120922|NCT00928187|3946371|B3|||Resistance to the three first-line drugs||participants|Number|88|88.0||||||
4120923|NCT00928187|3946372|B2|||Resistance to the three first-line drugs||participants|Number|77|77.0||||||
4120924|NCT00928187|3946373|B1|||Resistance to the three first-line drugs||participants|Number|84|84.0||||||
4120925|NCT00928187|3946370|B4|||HIV RNA Viral Load||log10 (copies/ml)|Median|4.5|4.5|Inter-Quartile Range|||4.0|5.1|
4120926|NCT00928187|3946371|B3|||HIV RNA Viral Load||log10 (copies/ml)|Median|4.5|4.5|Inter-Quartile Range|||4.0|5.1|
4120927|NCT00928187|3946372|B2|||HIV RNA Viral Load||log10 (copies/ml)|Median|4.6|4.6|Inter-Quartile Range|||4.1|5.1|
4120928|NCT00928187|3946373|B1|||HIV RNA Viral Load||log10 (copies/ml)|Median|4.4|4.4|Inter-Quartile Range|||4.0|5.0|
4120929|NCT00928187|3946370|B4|Senegal||Region of Enrollment||participants|Number|59|59.0||||||
4120930|NCT00928187|3946371|B3|Senegal||Region of Enrollment||participants|Number|20|20.0||||||
4120931|NCT00928187|3946372|B2|Senegal||Region of Enrollment||participants|Number|18|18.0||||||
4120932|NCT00928187|3946373|B1|Senegal||Region of Enrollment||participants|Number|21|21.0||||||
4120933|NCT00928187|3946370|B4|Burkina Faso||Region of Enrollment||participants|Number|90|90.0||||||
4120934|NCT00928187|3946371|B3|Burkina Faso||Region of Enrollment||participants|Number|32|32.0||||||
4120935|NCT00928187|3946372|B2|Burkina Faso||Region of Enrollment||participants|Number|28|28.0||||||
4120936|NCT00928187|3946373|B1|Burkina Faso||Region of Enrollment||participants|Number|30|30.0||||||
4120937|NCT00928187|3946370|B4|Cameroon||Region of Enrollment||participants|Number|302|302.0||||||
4120938|NCT00928187|3946371|B3|Cameroon||Region of Enrollment||participants|Number|102|102.0||||||
4120939|NCT00928187|3946372|B2|Cameroon||Region of Enrollment||participants|Number|99|99.0||||||
4120940|NCT00928187|3946373|B1|Cameroon||Region of Enrollment||participants|Number|101|101.0||||||
4120941|NCT00928187|3946370|B4||Male|Gender||Participants|Count of Participants|127|127.0||||||
4120942|NCT00928187|3946371|B3||Male|Gender||Participants|Count of Participants|48|48.0||||||
4120943|NCT00928187|3946372|B2||Male|Gender||Participants|Count of Participants|40|40.0||||||
4120944|NCT00928187|3946373|B1||Male|Gender||Participants|Count of Participants|39|39.0||||||
4120945|NCT00928187|3946370|B4||Female|Gender||Participants|Count of Participants|324|324.0||||||
4120946|NCT00928187|3946371|B3||Female|Gender||Participants|Count of Participants|106|106.0||||||
4120947|NCT00928187|3946372|B2||Female|Gender||Participants|Count of Participants|105|105.0||||||
4120948|NCT00928187|3946373|B1||Female|Gender||Participants|Count of Participants|113|113.0||||||
4120949|NCT00928187|3946370|B4|||Age||years|Median|38|38.0|Inter-Quartile Range|||32.0|46.0|
4120950|NCT00928187|3946371|B3|||Age||years|Median|36|36.0|Inter-Quartile Range|||32.0|45.0|
4120951|NCT00928187|3946372|B2|||Age||years|Median|38|38.0|Inter-Quartile Range|||33.0|47.0|
4120952|NCT00928187|3946373|B1|||Age||years|Median|38|38.0|Inter-Quartile Range|||34.0|45.0|
4120953|NCT00928174|3946419|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4120954|NCT00928174|3946419|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4120955|NCT00928174|3946419|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120956|NCT00928174|3946419|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4120957|NCT00928174|3946419|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120958|NCT00928174|3946419|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4120959|NCT00928174|3946419|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4120960|NCT00928174|3946419|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4120961|NCT00928174|3946419|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4120962|NCT00928174|3946419|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4120963|NCT00928174|3946419|B1|80-89 years||Age, Customized|Age (10-year groupings)|participants|Number|13|13.0||||||
4120964|NCT00928174|3946419|B1|70-79 years||Age, Customized|Age (10-year groupings)|participants|Number|4|4.0||||||
4120965|NCT00928174|3946419|B1|60-69 years||Age, Customized|Age (10-year groupings)|participants|Number|9|9.0||||||
4120966|NCT00928174|3946419|B1|50-59 years||Age, Customized|Age (10-year groupings)|participants|Number|1|1.0||||||
4120967|NCT00928174|3946419|B1|40-49 years||Age, Customized|Age (10-year groupings)|participants|Number|0|0.0||||||
4120968|NCT00928174|3946419|B1|<40||Age, Customized|Age (10-year groupings)|participants|Number|0|0.0||||||
4120969|NCT00928083|3946423|B4|United States||Region of Enrollment||participants|Number|63|63.0||||||
4120970|NCT00928083|3946424|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4120971|NCT00928083|3946425|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4120972|NCT00928083|3946426|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4120973|NCT00928083|3946423|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4120974|NCT00928083|3946424|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4120975|NCT00928083|3946425|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4120976|NCT00928083|3946426|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4120977|NCT00928083|3946423|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4120978|NCT00928083|3946424|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4120979|NCT00928083|3946425|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4120980|NCT00928083|3946426|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4120981|NCT00928083|3946423|B4|||Age||years|Mean|36.5|36.5|Standard Deviation|9.67|9.67|||
4120982|NCT00928083|3946424|B3|||Age||years|Mean|40.1|40.1|Standard Deviation|10.17|10.17|||
4120983|NCT00928083|3946425|B2|||Age||years|Mean|33.7|33.7|Standard Deviation|8.49|8.49|||
4120984|NCT00928083|3946426|B1|||Age||years|Mean|35.6|35.6|Standard Deviation|10.35|10.35|||
4120985|NCT00928070|3946543|B3||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4120986|NCT00928070|3946544|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4120987|NCT00928070|3946545|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4120988|NCT00928070|3946543|B3||Female|Sex: Female, Male||Participants|Count of Participants|461|461.0||||||
4120989|NCT00928070|3946544|B2||Female|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
4120990|NCT00928070|3946545|B1||Female|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
4120991|NCT00928070|3946543|B3|At least 85 years||Age, Customized||participants|Number|59|59.0||||||
4120992|NCT00928070|3946544|B2|At least 85 years||Age, Customized||participants|Number|30|30.0||||||
4120993|NCT00928070|3946545|B1|At least 85 years||Age, Customized||participants|Number|29|29.0||||||
4120994|NCT00928070|3946543|B3|75 to 84 years||Age, Customized||participants|Number|224|224.0||||||
4120995|NCT00928070|3946544|B2|75 to 84 years||Age, Customized||participants|Number|106|106.0||||||
4120996|NCT00928070|3946545|B1|75 to 84 years||Age, Customized||participants|Number|118|118.0||||||
4120997|NCT00928070|3946543|B3|65 to 74 years||Age, Customized||participants|Number|279|279.0||||||
4120998|NCT00928070|3946544|B2|65 to 74 years||Age, Customized||participants|Number|145|145.0||||||
4120999|NCT00928070|3946545|B1|65 to 74 years||Age, Customized||participants|Number|134|134.0||||||
4121000|NCT00928057|3946602|B3|||Serum Fructosamine Concentration|A blood sample was collected at baseline (Visit 2).|umol/L|Mean|299.9|299.9|Standard Deviation|55.1|55.1|||
4121001|NCT00928057|3946603|B2|||Serum Fructosamine Concentration|A blood sample was collected at baseline (Visit 2).|umol/L|Mean|301.5|301.5|Standard Deviation|61.0|61.0|||
4121002|NCT00928057|3946604|B1|||Serum Fructosamine Concentration|A blood sample was collected at baseline (Visit 2).|umol/L|Mean|298.3|298.3|Standard Deviation|48.4|48.4|||
4121003|NCT00928057|3946602|B3|||Single Largest Daily Insulin Dose|At baseline, subjects described their current insulin regimen, including the largest single daily insulin dose self-administered with a pen needle.|Units|Mean|20.5|20.5|Full Range|||2.0|40.0|
4121004|NCT00928057|3946603|B2|||Single Largest Daily Insulin Dose|At baseline, subjects described their current insulin regimen, including the largest single daily insulin dose self-administered with a pen needle.|Units|Mean|21.3|21.3|Full Range|||2.0|40.0|
4121005|NCT00928057|3946604|B1|||Single Largest Daily Insulin Dose|At baseline, subjects described their current insulin regimen, including the largest single daily insulin dose self-administered with a pen needle.|Units|Mean|19.6|19.6|Full Range|||2.0|40.0|
4121006|NCT00928057|3946602|B3|Regular Dose||Insulin Dose Group|Subjects were assigned to an insulin dosing group (Low or Regular) based on their baseline regimen to help ensure balance among treatment arms. Low Dose: largest single dose of insulin a day, with a pen device, was <=20 units. Regular Dose: largest single dose of insulin a day, with a pen device, 21-40 units.|participants|Number|76|76.0||||||
4121007|NCT00928057|3946603|B2|Regular Dose||Insulin Dose Group|Subjects were assigned to an insulin dosing group (Low or Regular) based on their baseline regimen to help ensure balance among treatment arms. Low Dose: largest single dose of insulin a day, with a pen device, was <=20 units. Regular Dose: largest single dose of insulin a day, with a pen device, 21-40 units.|participants|Number|40|40.0||||||
4121059|NCT00928018|3946630|B1|||Age||years|Median|58|58.0|Full Range|||23.0|70.0|
4121008|NCT00928057|3946604|B1|Regular Dose||Insulin Dose Group|Subjects were assigned to an insulin dosing group (Low or Regular) based on their baseline regimen to help ensure balance among treatment arms. Low Dose: largest single dose of insulin a day, with a pen device, was <=20 units. Regular Dose: largest single dose of insulin a day, with a pen device, 21-40 units.|participants|Number|36|36.0||||||
4121009|NCT00928057|3946602|B3|Low Dose||Insulin Dose Group|Subjects were assigned to an insulin dosing group (Low or Regular) based on their baseline regimen to help ensure balance among treatment arms. Low Dose: largest single dose of insulin a day, with a pen device, was <=20 units. Regular Dose: largest single dose of insulin a day, with a pen device, 21-40 units.|participants|Number|97|97.0||||||
4121010|NCT00928057|3946603|B2|Low Dose||Insulin Dose Group|Subjects were assigned to an insulin dosing group (Low or Regular) based on their baseline regimen to help ensure balance among treatment arms. Low Dose: largest single dose of insulin a day, with a pen device, was <=20 units. Regular Dose: largest single dose of insulin a day, with a pen device, 21-40 units.|participants|Number|49|49.0||||||
4121011|NCT00928057|3946604|B1|Low Dose||Insulin Dose Group|Subjects were assigned to an insulin dosing group (Low or Regular) based on their baseline regimen to help ensure balance among treatment arms. Low Dose: largest single dose of insulin a day, with a pen device, was <=20 units. Regular Dose: largest single dose of insulin a day, with a pen device, 21-40 units.|participants|Number|48|48.0||||||
4121012|NCT00928057|3946602|B3|||Hemoglobin A1c (HbA1c)|A blood sample for HbA1c was collected at screening|percent|Mean|7.5|7.5|Standard Deviation|1.0|1.0|||
4121013|NCT00928057|3946603|B2|||Hemoglobin A1c (HbA1c)|A blood sample for HbA1c was collected at screening|percent|Mean|7.6|7.6|Standard Deviation|1.0|1.0|||
4121014|NCT00928057|3946604|B1|||Hemoglobin A1c (HbA1c)|A blood sample for HbA1c was collected at screening|percent|Mean|7.4|7.4|Standard Deviation|1.0|1.0|||
4121015|NCT00928057|3946602|B3|||Body Mass Index (BMI)||kg/m²|Mean|30.5|30.5|Full Range|||20.0|49.0|
4121016|NCT00928057|3946603|B2|||Body Mass Index (BMI)||kg/m²|Mean|30.9|30.9|Full Range|||21.0|48.0|
4121017|NCT00928057|3946604|B1|||Body Mass Index (BMI)||kg/m²|Mean|30.1|30.1|Full Range|||20.0|49.0|
4121018|NCT00928057|3946602|B3|Type 2 diabetes||Diabetes Type||Participants|Number|109|109.0||||||
4121019|NCT00928057|3946603|B2|Type 2 diabetes||Diabetes Type||Participants|Number|55|55.0||||||
4121020|NCT00928057|3946604|B1|Type 2 diabetes||Diabetes Type||Participants|Number|54|54.0||||||
4121021|NCT00928057|3946602|B3|Type 1 diabetes||Diabetes Type||Participants|Number|64|64.0||||||
4121022|NCT00928057|3946603|B2|Type 1 diabetes||Diabetes Type||Participants|Number|34|34.0||||||
4121023|NCT00928057|3946604|B1|Type 1 diabetes||Diabetes Type||Participants|Number|30|30.0||||||
4121024|NCT00928057|3946602|B3|More than one race||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4121025|NCT00928057|3946603|B2|More than one race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4121026|NCT00928057|3946604|B1|More than one race||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4121027|NCT00928057|3946602|B3|Asian||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4121028|NCT00928057|3946603|B2|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4121029|NCT00928057|3946604|B1|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4121030|NCT00928057|3946602|B3|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4121031|NCT00928057|3946603|B2|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4121032|NCT00928057|3946604|B1|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4121033|NCT00928057|3946602|B3|Black/African American||Race/Ethnicity, Customized||Participants|Number|26|26.0||||||
4121034|NCT00928057|3946603|B2|Black/African American||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4121035|NCT00928057|3946604|B1|Black/African American||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4121036|NCT00928057|3946602|B3|White/Caucasian||Race/Ethnicity, Customized||Participants|Number|133|133.0||||||
4121037|NCT00928057|3946603|B2|White/Caucasian||Race/Ethnicity, Customized||Participants|Number|66|66.0||||||
4121038|NCT00928057|3946604|B1|White/Caucasian||Race/Ethnicity, Customized||Participants|Number|67|67.0||||||
4121039|NCT00928057|3946602|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4121040|NCT00928057|3946603|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4121041|NCT00928057|3946604|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4121042|NCT00928057|3946602|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4121043|NCT00928057|3946603|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4121044|NCT00928057|3946604|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4121045|NCT00928057|3946602|B3|||Age||years|Mean|52.6|52.6|Full Range|||18.1|76.2|
4121046|NCT00928057|3946603|B2|||Age||years|Mean|53.8|53.8|Full Range|||22.3|76.2|
4121047|NCT00928057|3946604|B1|||Age||years|Mean|51.3|51.3|Full Range|||18.1|76.0|
4121048|NCT00928018|3946628|B3|United States||Region of Enrollment||participants|Number|139|139.0||||||
4121049|NCT00928018|3946629|B2|United States||Region of Enrollment||participants|Number|73|73.0||||||
4121050|NCT00928018|3946630|B1|United States||Region of Enrollment||participants|Number|66|66.0||||||
4121051|NCT00928018|3946628|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4121052|NCT00928018|3946629|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4121053|NCT00928018|3946630|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4121054|NCT00928018|3946628|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4121055|NCT00928018|3946629|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4121056|NCT00928018|3946630|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4121057|NCT00928018|3946628|B3|||Age||years|Median|57|57.0|Full Range|||23.0|70.0|
4121058|NCT00928018|3946629|B2|||Age||years|Median|57|57.0|Full Range|||23.0|69.0|
4121060|NCT00927992|3946649|B1|Type B||Number of participants with Type A and B Hemophilia||participants|Number|2|2.0||||||
4121061|NCT00927992|3946649|B1|Type A||Number of participants with Type A and B Hemophilia||participants|Number|9|9.0||||||
4121062|NCT00927992|3946649|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4121063|NCT00927992|3946649|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4121064|NCT00927992|3946649|B1|||Age||years|Mean|45.45|45.45|Standard Deviation|15.38|15.38|||
4121065|NCT00927953|3946659|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4121066|NCT00927953|3946660|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4121067|NCT00927953|3946661|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4121068|NCT00927953|3946659|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4121069|NCT00927953|3946660|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4121070|NCT00927953|3946661|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4121071|NCT00927953|3946659|B3|||Age||years|Mean|43.5|43.5|Standard Deviation|19.3|19.3|||
4121072|NCT00927953|3946660|B2|||Age||years|Mean|38.9|38.9|Standard Deviation|18.07|18.07|||
4121073|NCT00927953|3946661|B1|||Age||years|Mean|48.8|48.8|Standard Deviation|20.84|20.84|||
4121074|NCT00927953|3946659|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4121075|NCT00927953|3946660|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4121076|NCT00927953|3946661|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4121077|NCT00927953|3946659|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4121078|NCT00927953|3946660|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4121079|NCT00927953|3946661|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4121080|NCT00927953|3946659|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4121081|NCT00927953|3946660|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4121082|NCT00927953|3946661|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4121083|NCT00927940|3946676|B1|Japan||Region of Enrollment||participants|Number|100|100.0||||||
4121084|NCT00927940|3946676|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4121085|NCT00927940|3946676|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4121086|NCT00927940|3946676|B1|||Age||years|Mean|67.7|67.7|Standard Deviation|10.4|10.4|||
4121087|NCT00927940|3946676|B1||>=65 years|Age||Participants|Count of Participants|61|61.0||||||
4121088|NCT00927940|3946676|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4121089|NCT00927940|3946676|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4121090|NCT00927927|3946681|B16||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4121091|NCT00927927|3946682|B15||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4121092|NCT00927927|3946683|B14||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4121093|NCT00927927|3946684|B13||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4121094|NCT00927927|3946685|B12||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4121095|NCT00927927|3946686|B11||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4121096|NCT00927927|3946687|B10||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4121097|NCT00927927|3946688|B9||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4121098|NCT00927927|3946689|B8||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4121099|NCT00927927|3946690|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4121100|NCT00927927|3946691|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4121101|NCT00927927|3946692|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4121102|NCT00927927|3946693|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4121103|NCT00927927|3946694|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4121104|NCT00927927|3946695|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4121105|NCT00927927|3946696|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4121106|NCT00927927|3946681|B16||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4121107|NCT00927927|3946682|B15||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4121108|NCT00927927|3946683|B14||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4121109|NCT00927927|3946684|B13||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4121110|NCT00927927|3946685|B12||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4121111|NCT00927927|3946686|B11||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4121112|NCT00927927|3946687|B10||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4121113|NCT00927927|3946688|B9||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4121114|NCT00927927|3946689|B8||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4121115|NCT00927927|3946690|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4121116|NCT00927927|3946691|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4121117|NCT00927927|3946692|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4121118|NCT00927927|3946693|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4121119|NCT00927927|3946694|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4121120|NCT00927927|3946695|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4121121|NCT00927927|3946696|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4121122|NCT00927927|3946681|B16|||Age||participants|Mean|56.0|56.0|Standard Deviation|9.8|9.8|||
4121123|NCT00927927|3946682|B15|||Age||participants|Mean|53.7|53.7|Standard Deviation|11.0|11.0|||
4121124|NCT00927927|3946683|B14|||Age||participants|Mean|48.2|48.2|Standard Deviation|7.7|7.7|||
4121125|NCT00927927|3946684|B13|||Age||participants|Mean|53.0|53.0|Standard Deviation|17.9|17.9|||
4121126|NCT00927927|3946685|B12|||Age||participants|Mean|58.4|58.4|Standard Deviation|5.5|5.5|||
4121127|NCT00927927|3946686|B11|||Age||participants|Mean|56.4|56.4|Standard Deviation|9.4|9.4|||
4121128|NCT00927927|3946687|B10|||Age||participants|Mean|55.3|55.3|Standard Deviation|5.0|5.0|||
4121129|NCT00927927|3946688|B9|||Age||participants|Mean|52.8|52.8|Standard Deviation|7.8|7.8|||
4121130|NCT00927927|3946689|B8|||Age||participants|Mean|69.0|69.0|Standard Deviation|4.6|4.6|||
4121131|NCT00927927|3946690|B7|||Age||participants|Mean|49.0|49.0|Standard Deviation|10.8|10.8|||
4121132|NCT00927927|3946691|B6|||Age||participants|Mean|52.7|52.7|Standard Deviation|11.0|11.0|||
4121133|NCT00927927|3946692|B5|||Age||participants|Mean|58.7|58.7|Standard Deviation|3.1|3.1|||
4121134|NCT00927927|3946693|B4|||Age||participants|Mean|58.3|58.3|Standard Deviation|5.1|5.1|||
4121135|NCT00927927|3946694|B3|||Age||participants|Mean|66.7|66.7|Standard Deviation|8.1|8.1|||
4121136|NCT00927927|3946695|B2|||Age||participants|Mean|60.7|60.7|Standard Deviation|8.1|8.1|||
4121137|NCT00927927|3946696|B1|||Age||participants|Mean|63.0|63.0|Standard Deviation|7.9|7.9|||
4121138|NCT00927901|3946757|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4121139|NCT00927901|3946757|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4121140|NCT00927901|3946757|B1|||Age||years|Mean|50|50.0|Standard Deviation|12.3|12.3|||
4121141|NCT00927888|3946788|B3|United States||Region of Enrollment||participants|Number|56|56.0||||||
4121142|NCT00927888|3946789|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4121143|NCT00927888|3946790|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4121144|NCT00927888|3946788|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4121145|NCT00927888|3946789|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4121146|NCT00927888|3946790|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4121147|NCT00927888|3946788|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4121148|NCT00927888|3946789|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4121149|NCT00927888|3946790|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4121150|NCT00927888|3946788|B3|||Age||years|Mean|45|45.0|Full Range|||18.0|75.0|
4121151|NCT00927888|3946789|B2|||Age||years|Mean|42|42.0|Full Range|||18.0|67.0|
4121152|NCT00927888|3946790|B1|||Age||years|Mean|49|49.0|Full Range|||18.0|75.0|
4121153|NCT00927888|3946788|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4121154|NCT00927888|3946789|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4121155|NCT00927888|3946790|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4121156|NCT00927888|3946788|B3||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4121157|NCT00927888|3946789|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4121158|NCT00927888|3946790|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4121159|NCT00927888|3946788|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4121160|NCT00927888|3946789|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4121161|NCT00927888|3946790|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4121162|NCT00927862|3946799|B3|United States||Region of Enrollment||participants|Number|2415|2415.0||||||
4121163|NCT00927862|3946800|B2|United States||Region of Enrollment||participants|Number|1911|1911.0||||||
4121164|NCT00927862|3946801|B1|United States||Region of Enrollment||participants|Number|504|504.0||||||
4121165|NCT00927862|3946799|B3||Male|Sex: Female, Male||Participants|Count of Participants|1163|1163.0||||||
4121166|NCT00927862|3946800|B2||Male|Sex: Female, Male||Participants|Count of Participants|927|927.0||||||
4121167|NCT00927862|3946801|B1||Male|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
4121168|NCT00927862|3946799|B3||Female|Sex: Female, Male||Participants|Count of Participants|1252|1252.0||||||
4121169|NCT00927862|3946800|B2||Female|Sex: Female, Male||Participants|Count of Participants|984|984.0||||||
4121170|NCT00927862|3946801|B1||Female|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
4121171|NCT00927862|3946799|B3|||Age||years|Mean|58.0|58.0|Standard Deviation|16.8|16.8|||
4121172|NCT00927862|3946800|B2|||Age||years|Mean|57.3|57.3|Standard Deviation|17.5|17.5|||
4121173|NCT00927862|3946801|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|14.6|14.6|||
4121174|NCT00927862|3946799|B3||>=65 years|Age||Participants|Count of Participants|913|913.0||||||
4121175|NCT00927862|3946800|B2||>=65 years|Age||Participants|Count of Participants|697|697.0||||||
4121176|NCT00927862|3946801|B1||>=65 years|Age||Participants|Count of Participants|216|216.0||||||
4121177|NCT00927862|3946799|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1502|1502.0||||||
4121178|NCT00927862|3946800|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1214|1214.0||||||
4121179|NCT00927862|3946801|B1||Between 18 and 65 years|Age||Participants|Count of Participants|288|288.0||||||
4121180|NCT00927862|3946799|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4121181|NCT00927862|3946800|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4121182|NCT00927862|3946801|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4121183|NCT00927849|3946824|B4|Egypt||Region of Enrollment||participants|Number|63.0|63.0||||||
4121184|NCT00927849|3946825|B3|Egypt||Region of Enrollment||participants|Number|21|21.0||||||
4121185|NCT00927849|3946826|B2|Egypt||Region of Enrollment||participants|Number|21|21.0||||||
4121186|NCT00927849|3946827|B1|Egypt||Region of Enrollment||participants|Number|21|21.0||||||
4121187|NCT00927849|3946824|B4||Male|Sex: Female, Male||Participants|Count of Participants|16.0|16.0||||||
4121188|NCT00927849|3946825|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4121189|NCT00927849|3946826|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4121190|NCT00927849|3946827|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4121191|NCT00927849|3946824|B4||Female|Sex: Female, Male||Participants|Count of Participants|47.0|47.0||||||
4121192|NCT00927849|3946825|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4121193|NCT00927849|3946826|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4121194|NCT00927849|3946827|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4121195|NCT00927849|3946824|B4|||Age||years|Mean|41|41.0|Standard Deviation|6.5|6.5|||
4121196|NCT00927849|3946825|B3|||Age||years|Mean|40.5|40.5|Standard Deviation|3.5|3.5|||
4121197|NCT00927849|3946826|B2|||Age||years|Mean|40|40.0|Standard Deviation|7.5|7.5|||
4121198|NCT00927849|3946827|B1|||Age||years|Mean|41|41.0|Standard Deviation|5.5|5.5|||
4121199|NCT00927849|3946824|B4||>=65 years|Age||Participants|Count of Participants|0.0|0.0||||||
4121200|NCT00927849|3946825|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4121201|NCT00927849|3946826|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4121202|NCT00927849|3946827|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4121203|NCT00927849|3946824|B4||Between 18 and 65 years|Age||Participants|Count of Participants|59.0|59.0||||||
4121204|NCT00927849|3946825|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4121205|NCT00927849|3946826|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4121206|NCT00927849|3946827|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4121207|NCT00927849|3946824|B4||<=18 years|Age||Participants|Count of Participants|4.0|4.0||||||
4121208|NCT00927849|3946825|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4121209|NCT00927849|3946826|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4121210|NCT00927849|3946827|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4121211|NCT00927823|3946837|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4121212|NCT00927823|3946837|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4121213|NCT00927823|3946837|B1|||Age||years|Mean|59.6|59.6|Standard Deviation|10.5|10.5|||
4121214|NCT00927758|3946904|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4121215|NCT00927758|3946904|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4121216|NCT00927758|3946904|B1|||Age||Years|Mean|29.86|29.86|Standard Deviation|10.40|10.4|||
4121217|NCT00927589|3946917|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4121218|NCT00927589|3946917|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4121219|NCT00927589|3946917|B1|||Age||years|Mean|59.0|59.0|Standard Deviation|12.1|12.1|||
4121220|NCT00927576|3946939|B3|United States||Region of Enrollment|Subjects from the San Francisco Bay Area|participants|Number|265|265.0||||||
4121221|NCT00927576|3946940|B2|United States||Region of Enrollment|Subjects from the San Francisco Bay Area|participants|Number|28|28.0||||||
4121222|NCT00927576|3946941|B1|United States||Region of Enrollment|Subjects from the San Francisco Bay Area|participants|Number|237|237.0||||||
4121223|NCT00927576|3946939|B3||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4121224|NCT00927576|3946940|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4121225|NCT00927576|3946941|B1||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4121226|NCT00927576|3946939|B3||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4121227|NCT00927576|3946940|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4121228|NCT00927576|3946941|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4121229|NCT00927576|3946939|B3|||Age||years|Mean|41.8|41.8|Standard Deviation|14.4|14.4|||
4121230|NCT00927576|3946940|B2|||Age||years|Mean|42.4|42.4|Standard Deviation|10.3|10.3|||
4121231|NCT00927576|3946941|B1|||Age||years|Mean|41.0|41.0|Standard Deviation|21.3|21.3|||
4121232|NCT00927576|3946939|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4121233|NCT00927576|3946940|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4121234|NCT00927576|3946941|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4121235|NCT00927576|3946939|B3||Between 18 and 65 years|Age||Participants|Count of Participants|250|250.0||||||
4121236|NCT00927576|3946940|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4121237|NCT00927576|3946941|B1||Between 18 and 65 years|Age||Participants|Count of Participants|222|222.0||||||
4121238|NCT00927576|3946939|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4121239|NCT00927576|3946940|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4121240|NCT00927576|3946941|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4121241|NCT00927563|3946947|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4121242|NCT00927563|3946947|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4121243|NCT00927563|3946947|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4121244|NCT00927563|3946947|B1|||Age||years|Mean|48.9|48.9|Standard Deviation|12.9|12.9|||
4121245|NCT00927563|3946947|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4121246|NCT00927563|3946947|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4121247|NCT00927563|3946947|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4121248|NCT00927472|3946953|B3|United States||Region of Enrollment||participants|Number|254|254.0||||||
4121249|NCT00927472|3946954|B2|United States||Region of Enrollment||participants|Number|128|128.0||||||
4121250|NCT00927472|3946955|B1|United States||Region of Enrollment||participants|Number|126|126.0||||||
4121251|NCT00927472|3946953|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4121252|NCT00927472|3946954|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4121253|NCT00927472|3946955|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4121254|NCT00927472|3946953|B3||Female|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4121255|NCT00927472|3946954|B2||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4121256|NCT00927472|3946955|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4121257|NCT00927472|3946953|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4121258|NCT00927472|3946954|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4121259|NCT00927472|3946955|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4121260|NCT00927472|3946953|B3||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4121261|NCT00927472|3946954|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4121262|NCT00927472|3946955|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4121263|NCT00927472|3946953|B3||<=18 years|Age||Participants|Count of Participants|192|192.0||||||
4121264|NCT00927472|3946954|B2||<=18 years|Age||Participants|Count of Participants|97|97.0||||||
4121265|NCT00927472|3946955|B1||<=18 years|Age||Participants|Count of Participants|95|95.0||||||
4121266|NCT00927472|3946953|B3|||Age||years|Mean|13.96|13.96|Standard Deviation|11.68|11.68|||
4121267|NCT00927472|3946954|B2|||Age||years|Mean|14.02|14.02|Standard Deviation|11.88|11.88|||
4121268|NCT00927472|3946955|B1|||Age||years|Mean|13.91|13.91|Standard Deviation|11.79|11.79|||
4121269|NCT00927394|3946980|B3||Male|Sex: Female, Male||Participants|Count of Participants|662|662.0||||||
4121270|NCT00927394|3946981|B2||Male|Sex: Female, Male||Participants|Count of Participants|321|321.0||||||
4121271|NCT00927394|3946982|B1||Male|Sex: Female, Male||Participants|Count of Participants|341|341.0||||||
4121272|NCT00927394|3946980|B3||Female|Sex: Female, Male||Participants|Count of Participants|477|477.0||||||
4121273|NCT00927394|3946981|B2||Female|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
4121274|NCT00927394|3946982|B1||Female|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
4121275|NCT00927394|3946980|B3|||Age|Demographic measures were based on Safety set.|years|Mean|55.1|55.1|Standard Deviation|9.44|9.44|||
4121276|NCT00927394|3946981|B2|||Age|Demographic measures were based on Safety set.|years|Mean|55.2|55.2|Standard Deviation|9.60|9.6|||
4121277|NCT00927394|3946982|B1|||Age|Demographic measures were based on Safety set.|years|Mean|55.0|55.0|Standard Deviation|9.30|9.3|||
4121278|NCT00927368|3947011|B4||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4121279|NCT00927368|3947012|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4121280|NCT00927368|3947013|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4121281|NCT00927368|3947014|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4121282|NCT00927368|3947011|B4||Female|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
4121283|NCT00927368|3947012|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4121284|NCT00927368|3947013|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4121285|NCT00927368|3947014|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4121286|NCT00927368|3947011|B4|||Age||years|Mean|62|62.0|Standard Deviation|10|10.0|||
4121287|NCT00927368|3947012|B3|||Age||years|Mean|63|63.0|Standard Deviation|9|9.0|||
4121288|NCT00927368|3947013|B2|||Age||years|Mean|61|61.0|Standard Deviation|13|13.0|||
4121289|NCT00927368|3947014|B1|||Age||years|Mean|62|62.0|Standard Deviation|9|9.0|||
4121290|NCT00927355|3947033|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4121291|NCT00927355|3947034|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4121292|NCT00927355|3947035|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4121293|NCT00927355|3947033|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4121294|NCT00927355|3947034|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4121295|NCT00927355|3947035|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4121296|NCT00927355|3947033|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4121297|NCT00927355|3947034|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4121298|NCT00927355|3947035|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4121299|NCT00927355|3947033|B3|||Age||years|Mean|55|55.0|Standard Deviation|5|5.0|||
4121300|NCT00927355|3947034|B2|||Age||years|Mean|60|60.0|Standard Deviation|6|6.0|||
4121301|NCT00927355|3947035|B1|||Age||years|Mean|52|52.0|Standard Deviation|10|10.0|||
4121302|NCT00927355|3947033|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4121303|NCT00927355|3947034|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4121304|NCT00927355|3947035|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4121305|NCT00927355|3947033|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4121306|NCT00927355|3947034|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4121307|NCT00927355|3947035|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4121308|NCT00927355|3947033|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4121309|NCT00927355|3947034|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4121310|NCT00927355|3947035|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4121311|NCT00927264|3947054|B3|United States||Region of Enrollment|Participant unit of measure is child + consented caregiver|participants|Number|330|330.0||||||
4121312|NCT00927264|3947055|B2|United States||Region of Enrollment|Participant unit of measure is child + consented caregiver|participants|Number|165|165.0||||||
4121313|NCT00927264|3947056|B1|United States||Region of Enrollment|Participant unit of measure is child + consented caregiver|participants|Number|165|165.0||||||
4121314|NCT00927264|3947054|B3||Unknown or Not Reported|Race (NIH/OMB)|Race of child enrolled in study|Participants|Count of Participants|0|0.0||||||
4121315|NCT00927264|3947055|B2||Unknown or Not Reported|Race (NIH/OMB)|Race of child enrolled in study|Participants|Count of Participants|0|0.0||||||
4121316|NCT00927264|3947056|B1||Unknown or Not Reported|Race (NIH/OMB)|Race of child enrolled in study|Participants|Count of Participants|0|0.0||||||
4121317|NCT00927264|3947054|B3||More than one race|Race (NIH/OMB)|Race of child enrolled in study|Participants|Count of Participants|9|9.0||||||
4121318|NCT00927264|3947055|B2||More than one race|Race (NIH/OMB)|Race of child enrolled in study|Participants|Count of Participants|7|7.0||||||
4121319|NCT00927264|3947056|B1||More than one race|Race (NIH/OMB)|Race of child enrolled in study|Participants|Count of Participants|2|2.0||||||
4121320|NCT00927264|3947054|B3||White|Race (NIH/OMB)|Race of child enrolled in study|Participants|Count of Participants|19|19.0||||||
4121321|NCT00927264|3947055|B2||White|Race (NIH/OMB)|Race of child enrolled in study|Participants|Count of Participants|9|9.0||||||
4121322|NCT00927264|3947056|B1||White|Race (NIH/OMB)|Race of child enrolled in study|Participants|Count of Participants|10|10.0||||||
4121323|NCT00927264|3947054|B3||Black or African American|Race (NIH/OMB)|Race of child enrolled in study|Participants|Count of Participants|302|302.0||||||
4121324|NCT00927264|3947055|B2||Black or African American|Race (NIH/OMB)|Race of child enrolled in study|Participants|Count of Participants|149|149.0||||||
4121325|NCT00927264|3947056|B1||Black or African American|Race (NIH/OMB)|Race of child enrolled in study|Participants|Count of Participants|153|153.0||||||
4121326|NCT00927264|3947054|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race of child enrolled in study|Participants|Count of Participants|0|0.0||||||
4121327|NCT00927264|3947055|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race of child enrolled in study|Participants|Count of Participants|0|0.0||||||
4121328|NCT00927264|3947056|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race of child enrolled in study|Participants|Count of Participants|0|0.0||||||
4121329|NCT00927264|3947054|B3||Asian|Race (NIH/OMB)|Race of child enrolled in study|Participants|Count of Participants|0|0.0||||||
4121330|NCT00927264|3947055|B2||Asian|Race (NIH/OMB)|Race of child enrolled in study|Participants|Count of Participants|0|0.0||||||
4121331|NCT00927264|3947056|B1||Asian|Race (NIH/OMB)|Race of child enrolled in study|Participants|Count of Participants|0|0.0||||||
4121332|NCT00927264|3947054|B3||American Indian or Alaska Native|Race (NIH/OMB)|Race of child enrolled in study|Participants|Count of Participants|0|0.0||||||
4121333|NCT00927264|3947055|B2||American Indian or Alaska Native|Race (NIH/OMB)|Race of child enrolled in study|Participants|Count of Participants|0|0.0||||||
4121334|NCT00927264|3947056|B1||American Indian or Alaska Native|Race (NIH/OMB)|Race of child enrolled in study|Participants|Count of Participants|0|0.0||||||
4121335|NCT00927264|3947054|B3|Caregiver Gender|Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4121336|NCT00927264|3947055|B2|Caregiver Gender|Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4121337|NCT00927264|3947056|B1|Caregiver Gender|Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4121338|NCT00927264|3947054|B3|Caregiver Gender|Female|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
4121339|NCT00927264|3947055|B2|Caregiver Gender|Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4121340|NCT00927264|3947056|B1|Caregiver Gender|Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4121341|NCT00927264|3947054|B3|Child Gender|Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4121342|NCT00927264|3947055|B2|Child Gender|Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4121343|NCT00927264|3947056|B1|Child Gender|Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4121344|NCT00927264|3947054|B3|Child Gender|Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4121345|NCT00927264|3947055|B2|Child Gender|Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4121346|NCT00927264|3947056|B1|Child Gender|Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4121347|NCT00927264|3947054|B3|caregiver age||Age||years|Mean|32.09|32.09|Standard Deviation|8.87|8.87|||
4121348|NCT00927264|3947055|B2|caregiver age||Age||years|Mean|32.12|32.12|Standard Deviation|9.18|9.18|||
4121349|NCT00927264|3947056|B1|caregiver age||Age||years|Mean|32.07|32.07|Standard Deviation|8.6|8.6|||
4121350|NCT00927264|3947054|B3|child age||Age||years|Mean|3.76|3.76|Standard Deviation|0.82|0.82|||
4121351|NCT00927264|3947055|B2|child age||Age||years|Mean|3.71|3.71|Standard Deviation|.82|0.82|||
4121352|NCT00927264|3947056|B1|child age||Age||years|Mean|3.81|3.81|Standard Deviation|0.81|0.81|||
4121353|NCT00927251|3947071|B1|||QRS Duration||milliseconds|Mean|159.0|159.0|Standard Deviation|21.1|21.1|||
4121354|NCT00927251|3947071|B1|||Left Ventricular Ejection Fraction|The Left Ventricular Ejection fraction is the percentage of blood ejected from the left ventricle with each heart beat.|Percentage (%)|Mean|25.6|25.6|Standard Deviation|6.5|6.5|||
4121382|NCT00927186|3947076|B2|||Femoral Neck T-Score|The T-score at femoral neck is a comparison of a participant's bone mineral density (BMD) to that of the mean BMD for a healthy population of women at peak bone mass (30 years). A normal T-score has a value of -1.0 or higher. Osteoporosis is defined as a T-score of -2.5 or lower, meaning a bone mineral density that is two and a half standard deviations below the mean BMD of a healthy population of women at peak bone mass (30 years).|T-Score|Mean|-2.29|-2.29|Standard Deviation|0.74|0.74|||
4121355|NCT00927251|3947071|B1|NYHA Class IV||New York Heart Association Functional Classification|"Class I No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, or dyspnea.~Class II Slight limitation of physical activity. Comfortable at rest, but ordinary physical activity results in fatigue, palpitation, or dyspnea.~Class III Marked limitation of physical activity. Comfortable at rest, but less than ordinary activity causes fatigue, palpitation, or dyspnea.~Class IV Unable to carry out any physical activity without discomfort. Symptoms of cardiac insufficiency at rest. If any physical activity is undertaken, discomfort is increased."|participants|Number|1|1.0||||||
4121356|NCT00927251|3947071|B1|NYHA Class III||New York Heart Association Functional Classification|"Class I No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, or dyspnea.~Class II Slight limitation of physical activity. Comfortable at rest, but ordinary physical activity results in fatigue, palpitation, or dyspnea.~Class III Marked limitation of physical activity. Comfortable at rest, but less than ordinary activity causes fatigue, palpitation, or dyspnea.~Class IV Unable to carry out any physical activity without discomfort. Symptoms of cardiac insufficiency at rest. If any physical activity is undertaken, discomfort is increased."|participants|Number|86|86.0||||||
4121357|NCT00927251|3947071|B1|NYHA Class II||New York Heart Association Functional Classification|"Class I No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, or dyspnea.~Class II Slight limitation of physical activity. Comfortable at rest, but ordinary physical activity results in fatigue, palpitation, or dyspnea.~Class III Marked limitation of physical activity. Comfortable at rest, but less than ordinary activity causes fatigue, palpitation, or dyspnea.~Class IV Unable to carry out any physical activity without discomfort. Symptoms of cardiac insufficiency at rest. If any physical activity is undertaken, discomfort is increased."|participants|Number|3|3.0||||||
4121358|NCT00927251|3947071|B1|India||Region of Enrollment||participants|Number|0|0.0||||||
4121359|NCT00927251|3947071|B1|Italy||Region of Enrollment||participants|Number|9|9.0||||||
4121360|NCT00927251|3947071|B1|Germany||Region of Enrollment||participants|Number|43|43.0||||||
4121361|NCT00927251|3947071|B1|Netherlands||Region of Enrollment||participants|Number|14|14.0||||||
4121362|NCT00927251|3947071|B1|Norway||Region of Enrollment||participants|Number|3|3.0||||||
4121363|NCT00927251|3947071|B1|Austria||Region of Enrollment||participants|Number|11|11.0||||||
4121364|NCT00927251|3947071|B1|Finland||Region of Enrollment||participants|Number|0|0.0||||||
4121365|NCT00927251|3947071|B1|Slovakia||Region of Enrollment||participants|Number|10|10.0||||||
4121366|NCT00927251|3947071|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4121367|NCT00927251|3947071|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4121368|NCT00927251|3947071|B1|||Age||years|Mean|67.0|67.0|Standard Deviation|8.8|8.8|||
4121369|NCT00927186|3947075|B3|||Serum Osteocalcin|A measure of osteoblast function.|microgram/Liter (µg/L)|Mean|24.98|24.98|Standard Deviation|8.39|8.39|||
4121370|NCT00927186|3947076|B2|||Serum Osteocalcin|A measure of osteoblast function.|microgram/Liter (µg/L)|Mean|24.92|24.92|Standard Deviation|8.53|8.53|||
4121371|NCT00927186|3947077|B1|||Serum Osteocalcin|A measure of osteoblast function.|microgram/Liter (µg/L)|Mean|25.05|25.05|Standard Deviation|8.37|8.37|||
4121372|NCT00927186|3947075|B3|||Serum Carboxyterminal Cross-Linking Telopeptide of Collagen Type I (CTX)|A measure of bone resorption.|nanogram/milliliter (ng/mL)|Mean|0.43|0.43|Standard Deviation|0.21|0.21|||
4121373|NCT00927186|3947076|B2|||Serum Carboxyterminal Cross-Linking Telopeptide of Collagen Type I (CTX)|A measure of bone resorption.|nanogram/milliliter (ng/mL)|Mean|0.42|0.42|Standard Deviation|0.19|0.19|||
4121374|NCT00927186|3947077|B1|||Serum Carboxyterminal Cross-Linking Telopeptide of Collagen Type I (CTX)|A measure of bone resorption.|nanogram/milliliter (ng/mL)|Mean|0.43|0.43|Standard Deviation|0.23|0.23|||
4121375|NCT00927186|3947075|B3|||Serum Procollagen Type I N-Terminal Propeptide (PINP)|A measure of bone formation.|microgram/Liter (µg/L)|Mean|51.03|51.03|Standard Deviation|18.81|18.81|||
4121376|NCT00927186|3947076|B2|||Serum Procollagen Type I N-Terminal Propeptide (PINP)|A measure of bone formation.|microgram/Liter (µg/L)|Mean|52.88|52.88|Standard Deviation|19.43|19.43|||
4121377|NCT00927186|3947077|B1|||Serum Procollagen Type I N-Terminal Propeptide (PINP)|A measure of bone formation.|microgram/Liter (µg/L)|Mean|49.18|49.18|Standard Deviation|18.28|18.28|||
4121378|NCT00927186|3947075|B3|||Total Hip T-Score|The T-score at total hip is a comparison of a participant's bone mineral density (BMD) to that of the mean BMD for a healthy population of women at peak bone mass (30 years). A normal T-score has a value of -1.0 or higher. Osteoporosis is defined as a T-score of -2.5 or lower, meaning a bone mineral density that is two and a half standard deviations below the mean BMD of a healthy population of women at peak bone mass (30 years).|T-Score|Mean|-1.83|-1.83|Standard Deviation|0.84|0.84|||
4121379|NCT00927186|3947076|B2|||Total Hip T-Score|The T-score at total hip is a comparison of a participant's bone mineral density (BMD) to that of the mean BMD for a healthy population of women at peak bone mass (30 years). A normal T-score has a value of -1.0 or higher. Osteoporosis is defined as a T-score of -2.5 or lower, meaning a bone mineral density that is two and a half standard deviations below the mean BMD of a healthy population of women at peak bone mass (30 years).|T-Score|Mean|-1.88|-1.88|Standard Deviation|0.91|0.91|||
4121380|NCT00927186|3947077|B1|||Total Hip T-Score|The T-score at total hip is a comparison of a participant's bone mineral density (BMD) to that of the mean BMD for a healthy population of women at peak bone mass (30 years). A normal T-score has a value of -1.0 or higher. Osteoporosis is defined as a T-score of -2.5 or lower, meaning a bone mineral density that is two and a half standard deviations below the mean BMD of a healthy population of women at peak bone mass (30 years).|T-Score|Mean|-1.78|-1.78|Standard Deviation|0.78|0.78|||
4121381|NCT00927186|3947075|B3|||Femoral Neck T-Score|The T-score at femoral neck is a comparison of a participant's bone mineral density (BMD) to that of the mean BMD for a healthy population of women at peak bone mass (30 years). A normal T-score has a value of -1.0 or higher. Osteoporosis is defined as a T-score of -2.5 or lower, meaning a bone mineral density that is two and a half standard deviations below the mean BMD of a healthy population of women at peak bone mass (30 years).|T-Score|Mean|-2.27|-2.27|Standard Deviation|0.70|0.7|||
4121429|NCT00927186|3947075|B3|||Height||centimeters (cm)|Mean|159.64|159.64|Standard Deviation|6.66|6.66|||
4121383|NCT00927186|3947077|B1|||Femoral Neck T-Score|The T-score at femoral neck is a comparison of a participant's bone mineral density (BMD) to that of the mean BMD for a healthy population of women at peak bone mass (30 years). A normal T-score has a value of -1.0 or higher. Osteoporosis is defined as a T-score of -2.5 or lower, meaning a bone mineral density that is two and a half standard deviations below the mean BMD of a healthy population of women at peak bone mass (30 years).|T-Score|Mean|-2.25|-2.25|Standard Deviation|0.68|0.68|||
4121384|NCT00927186|3947075|B3|||Lumbar Spine T-Score|The T-score at lumbar spine is a comparison of a participant's bone mineral density (BMD) to that of the mean BMD for a healthy population of women at peak bone mass (30 years). A normal T-score has a value of -1.0 or higher. Osteoporosis is defined as a T-score of -2.5 or lower, meaning a bone mineral density that is two and a half standard deviations below the mean BMD of a healthy population of women at peak bone mass (30 years).|T-Score|Mean|-2.86|-2.86|Standard Deviation|0.79|0.79|||
4121385|NCT00927186|3947076|B2|||Lumbar Spine T-Score|The T-score at lumbar spine is a comparison of a participant's bone mineral density (BMD) to that of the mean BMD for a healthy population of women at peak bone mass (30 years). A normal T-score has a value of -1.0 or higher. Osteoporosis is defined as a T-score of -2.5 or lower, meaning a bone mineral density that is two and a half standard deviations below the mean BMD of a healthy population of women at peak bone mass (30 years).|T-Score|Mean|-2.93|-2.93|Standard Deviation|0.75|0.75|||
4121386|NCT00927186|3947077|B1|||Lumbar Spine T-Score|The T-score at lumbar spine is a comparison of a participant's bone mineral density (BMD) to that of the mean BMD for a healthy population of women at peak bone mass (30 years). A normal T-score has a value of -1.0 or higher. Osteoporosis is defined as a T-score of -2.5 or lower, meaning a bone mineral density that is two and a half standard deviations below the mean BMD of a healthy population of women at peak bone mass (30 years).|T-Score|Mean|-2.79|-2.79|Standard Deviation|0.83|0.83|||
4121387|NCT00927186|3947075|B3|No||Fracture Status|Yes means a participant has already had fracture before study entry.|participants|Number|38|38.0||||||
4121388|NCT00927186|3947076|B2|No||Fracture Status|Yes means a participant has already had fracture before study entry.|participants|Number|18|18.0||||||
4121389|NCT00927186|3947077|B1|No||Fracture Status|Yes means a participant has already had fracture before study entry.|participants|Number|20|20.0||||||
4121390|NCT00927186|3947075|B3|Yes||Fracture Status|Yes means a participant has already had fracture before study entry.|participants|Number|31|31.0||||||
4121391|NCT00927186|3947076|B2|Yes||Fracture Status|Yes means a participant has already had fracture before study entry.|participants|Number|17|17.0||||||
4121392|NCT00927186|3947077|B1|Yes||Fracture Status|Yes means a participant has already had fracture before study entry.|participants|Number|14|14.0||||||
4121393|NCT00927186|3947075|B3|No||Previous Osteoporosis Therapy||participants|Number|31|31.0||||||
4121394|NCT00927186|3947076|B2|No||Previous Osteoporosis Therapy||participants|Number|14|14.0||||||
4121395|NCT00927186|3947077|B1|No||Previous Osteoporosis Therapy||participants|Number|17|17.0||||||
4121396|NCT00927186|3947075|B3|Yes||Previous Osteoporosis Therapy||participants|Number|38|38.0||||||
4121397|NCT00927186|3947076|B2|Yes||Previous Osteoporosis Therapy||participants|Number|21|21.0||||||
4121398|NCT00927186|3947077|B1|Yes||Previous Osteoporosis Therapy||participants|Number|17|17.0||||||
4121399|NCT00927186|3947075|B3|No||Caffeine or Xanthine Use||participants|Number|10|10.0||||||
4121400|NCT00927186|3947076|B2|No||Caffeine or Xanthine Use||participants|Number|5|5.0||||||
4121401|NCT00927186|3947077|B1|No||Caffeine or Xanthine Use||participants|Number|5|5.0||||||
4121402|NCT00927186|3947075|B3|Yes||Caffeine or Xanthine Use||participants|Number|59|59.0||||||
4121403|NCT00927186|3947076|B2|Yes||Caffeine or Xanthine Use||participants|Number|30|30.0||||||
4121404|NCT00927186|3947077|B1|Yes||Caffeine or Xanthine Use||participants|Number|29|29.0||||||
4121405|NCT00927186|3947075|B3|No||Tobacco Use||participants|Number|59|59.0||||||
4121406|NCT00927186|3947076|B2|No||Tobacco Use||participants|Number|30|30.0||||||
4121407|NCT00927186|3947077|B1|No||Tobacco Use||participants|Number|29|29.0||||||
4121408|NCT00927186|3947075|B3|Yes||Tobacco Use||participants|Number|10|10.0||||||
4121409|NCT00927186|3947076|B2|Yes||Tobacco Use||participants|Number|5|5.0||||||
4121410|NCT00927186|3947077|B1|Yes||Tobacco Use||participants|Number|5|5.0||||||
4121411|NCT00927186|3947075|B3|No||Alcohol Use||participants|Number|31|31.0||||||
4121412|NCT00927186|3947076|B2|No||Alcohol Use||participants|Number|18|18.0||||||
4121413|NCT00927186|3947077|B1|No||Alcohol Use||participants|Number|13|13.0||||||
4121414|NCT00927186|3947075|B3|Yes||Alcohol Use||participants|Number|38|38.0||||||
4121415|NCT00927186|3947076|B2|Yes||Alcohol Use||participants|Number|17|17.0||||||
4121416|NCT00927186|3947077|B1|Yes||Alcohol Use||participants|Number|21|21.0||||||
4121417|NCT00927186|3947075|B3|||Blood Pressure - Diastolic||mmHg|Mean|74.38|74.38|Standard Deviation|9.20|9.2|||
4121418|NCT00927186|3947076|B2|||Blood Pressure - Diastolic||mmHg|Mean|73.97|73.97|Standard Deviation|10.15|10.15|||
4121419|NCT00927186|3947077|B1|||Blood Pressure - Diastolic||mmHg|Mean|74.79|74.79|Standard Deviation|8.24|8.24|||
4121420|NCT00927186|3947075|B3|||Blood Pressure - Systolic||millimeters of mercury (mmHg)|Mean|124.07|124.07|Standard Deviation|16.18|16.18|||
4121421|NCT00927186|3947076|B2|||Blood Pressure - Systolic||millimeters of mercury (mmHg)|Mean|122.49|122.49|Standard Deviation|16.25|16.25|||
4121422|NCT00927186|3947077|B1|||Blood Pressure - Systolic||millimeters of mercury (mmHg)|Mean|125.71|125.71|Standard Deviation|16.19|16.19|||
4121423|NCT00927186|3947075|B3|||Pulse||beats per minute (bpm)|Mean|69.03|69.03|Standard Deviation|8.13|8.13|||
4121424|NCT00927186|3947076|B2|||Pulse||beats per minute (bpm)|Mean|70.60|70.6|Standard Deviation|8.79|8.79|||
4121425|NCT00927186|3947077|B1|||Pulse||beats per minute (bpm)|Mean|67.41|67.41|Standard Deviation|7.15|7.15|||
4121426|NCT00927186|3947075|B3|||Weight||kilograms (kg)|Mean|63.03|63.03|Standard Deviation|10.60|10.6|||
4121427|NCT00927186|3947076|B2|||Weight||kilograms (kg)|Mean|64.75|64.75|Standard Deviation|11.66|11.66|||
4121428|NCT00927186|3947077|B1|||Weight||kilograms (kg)|Mean|61.25|61.25|Standard Deviation|9.21|9.21|||
4121492|NCT00927082|3947219|B4|||Age||years|Mean|34.2|34.2|Standard Deviation|10.78|10.78|||
4121430|NCT00927186|3947076|B2|||Height||centimeters (cm)|Mean|160.00|160.0|Standard Deviation|7.38|7.38|||
4121431|NCT00927186|3947077|B1|||Height||centimeters (cm)|Mean|159.28|159.28|Standard Deviation|5.92|5.92|||
4121432|NCT00927186|3947075|B3|Canada||Region of Enrollment||participants|Number|23|23.0||||||
4121433|NCT00927186|3947076|B2|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4121434|NCT00927186|3947077|B1|Canada||Region of Enrollment||participants|Number|13|13.0||||||
4121435|NCT00927186|3947075|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
4121436|NCT00927186|3947076|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4121437|NCT00927186|3947077|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4121438|NCT00927186|3947075|B3|White||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
4121439|NCT00927186|3947076|B2|White||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4121440|NCT00927186|3947077|B1|White||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4121441|NCT00927186|3947075|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4121442|NCT00927186|3947076|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4121443|NCT00927186|3947077|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4121444|NCT00927186|3947075|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4121445|NCT00927186|3947076|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4121446|NCT00927186|3947077|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4121447|NCT00927186|3947075|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4121448|NCT00927186|3947076|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4121449|NCT00927186|3947077|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4121450|NCT00927186|3947075|B3|||Age||years|Mean|64.84|64.84|Standard Deviation|6.44|6.44|||
4121451|NCT00927186|3947076|B2|||Age||years|Mean|64.20|64.2|Standard Deviation|5.96|5.96|||
4121452|NCT00927186|3947077|B1|||Age||years|Mean|65.49|65.49|Standard Deviation|6.93|6.93|||
4121453|NCT00927160|3947194|B3|United States||Region of Enrollment||participants|Number|346|346.0||||||
4121454|NCT00927160|3947195|B2|United States||Region of Enrollment||participants|Number|173|173.0||||||
4121455|NCT00927160|3947196|B1|United States||Region of Enrollment||participants|Number|173|173.0||||||
4121456|NCT00927160|3947194|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4121457|NCT00927160|3947195|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4121458|NCT00927160|3947196|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4121459|NCT00927160|3947194|B3||Female|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
4121460|NCT00927160|3947195|B2||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4121461|NCT00927160|3947196|B1||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4121462|NCT00927160|3947194|B3|||Age||years|Mean|85.0|85.0|Standard Deviation|5.4|5.4|||
4121463|NCT00927160|3947195|B2|||Age||years|Mean|84.7|84.7|Standard Deviation|5.4|5.4|||
4121464|NCT00927160|3947196|B1|||Age||years|Mean|85.2|85.2|Standard Deviation|5.3|5.3|||
4121465|NCT00927095|3947205|B4|United States||Region of Enrollment||participants|Number|67|67.0||||||
4121466|NCT00927095|3947206|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4121467|NCT00927095|3947207|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4121468|NCT00927095|3947208|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4121469|NCT00927095|3947205|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4121470|NCT00927095|3947206|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4121471|NCT00927095|3947207|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4121472|NCT00927095|3947208|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4121473|NCT00927095|3947205|B4||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4121474|NCT00927095|3947206|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4121475|NCT00927095|3947207|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4121476|NCT00927095|3947208|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4121477|NCT00927095|3947205|B4|||Age||years|Mean|32.5|32.5|Standard Deviation|7.7|7.7|||
4121478|NCT00927095|3947206|B3|||Age||years|Mean|32.1|32.1|Standard Deviation|6.7|6.7|||
4121479|NCT00927095|3947207|B2|||Age||years|Mean|32.2|32.2|Standard Deviation|8.6|8.6|||
4121480|NCT00927095|3947208|B1|||Age||years|Mean|33.2|33.2|Standard Deviation|8.1|8.1|||
4121481|NCT00927082|3947218|B5||Male|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
4121482|NCT00927082|3947219|B4||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4121483|NCT00927082|3947220|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4121484|NCT00927082|3947221|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4121485|NCT00927082|3947222|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4121486|NCT00927082|3947218|B5||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4121487|NCT00927082|3947219|B4||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4121488|NCT00927082|3947220|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4121489|NCT00927082|3947221|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4121490|NCT00927082|3947222|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4121491|NCT00927082|3947218|B5|||Age||years|Mean|33.9|33.9|Standard Deviation|10.49|10.49|||
4121493|NCT00927082|3947220|B3|||Age||years|Mean|34.3|34.3|Standard Deviation|10.82|10.82|||
4121494|NCT00927082|3947221|B2|||Age||years|Mean|34.5|34.5|Standard Deviation|10.54|10.54|||
4121495|NCT00927082|3947222|B1|||Age||years|Mean|32.5|32.5|Standard Deviation|9.73|9.73|||
4121496|NCT00927069|3947287|B3|Canada||Region of Enrollment||participants|Number|85|85.0||||||
4121497|NCT00927069|3947288|B2|Canada||Region of Enrollment||participants|Number|35|35.0||||||
4121498|NCT00927069|3947289|B1|Canada||Region of Enrollment||participants|Number|50|50.0||||||
4121499|NCT00927069|3947287|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4121500|NCT00927069|3947288|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4121501|NCT00927069|3947289|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4121502|NCT00927069|3947287|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4121503|NCT00927069|3947288|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4121504|NCT00927069|3947289|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4121505|NCT00927069|3947287|B3|||Age||years|Mean|47.91|47.91|Standard Deviation|11.21|11.21|||
4121506|NCT00927069|3947288|B2|||Age||years|Mean|46.17|46.17|Standard Deviation|11.2|11.2|||
4121507|NCT00927069|3947289|B1|||Age||years|Mean|49.12|49.12|Standard Deviation|11.18|11.18|||
4121508|NCT00927069|3947287|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4121509|NCT00927069|3947288|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4121510|NCT00927069|3947289|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4121511|NCT00927069|3947287|B3||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
4121512|NCT00927069|3947288|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4121513|NCT00927069|3947289|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4121514|NCT00927069|3947287|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4121515|NCT00927069|3947288|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4121516|NCT00927069|3947289|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4121517|NCT00926952|3947302|B1|||Descriptive Scale - Mean Mottled Hyperpigmentation|"This factor represents a visual assessment of light, patchy, mottled hyperpigmentation and solar freckling (including melasma) based on quantitative criteria such as the area/density of pigment, color intensity (dark vs. light), and uniformity of distribution (i.e. the more uneven or blotchy, the greater the score), Lentigines, nevi, and other pigmented lesions are not to be included in this assessment.~Rating Category~0 None~1-3 Mild~4-6 Moderate~7-9 Severe"|Units on a scale|Mean|4.45|4.45|Standard Deviation|2.14|2.14|||
4121518|NCT00926952|3947302|B1|||Descriptive Scale - Mean Sallowness|"This factor represents a visual assessment of color tone from very pink or rosy (0) to very sallow or pale (9).~Rating Category~0 None~1-3 Mild~4-6 Moderate~7-9 Severe"|Units on a scale|Mean|3.60|3.6|Standard Deviation|2.37|2.37|||
4121519|NCT00926952|3947302|B1|||Descriptive Scale - Mean Coarse Wrinkling|"This factor represents a visual assessment of the number and depth of coarse wrinkles (i.e. deep lines, furrows, or creases). Coarse wrinkles appear on the forehead, glabella, chin, and nasolabial and periorbital areas, and they tend to be located closer to the eyes and mouth than fine wrinkles.~Rating Category~0 None~1-3 Mild~4-6 Moderate~7-9 Severe"|Units on a scale|Mean|5.00|5.0|Standard Deviation|2.20|2.2|||
4121520|NCT00926952|3947302|B1|||Descriptive Scale -Mean Fine Wrinkling|"This factor represents a visual assessment of the number and depth of superficial wrinkles (i.e. shallow indentations or lines). Fine wrinkles typically appear in periorbital and perioral regions and are usually found further from the eyes and mouth than are coarse wrinkles.~Rating Category~0 None~1-3 Mild~4-6 Moderate~7-9 Severe"|Units on a scale|Mean|5.40|5.4|Standard Deviation|1.76|1.76|||
4121521|NCT00926952|3947302|B1|||Mean Griffiths Photonumeric Scale for Photodamage Score|Griffiths photonumeric scale was evaluated by the dermatologist. Patients were placed under natural daylight or fluorescent lighting for grading. A direct comparison was then made between the subjects and photographic standards (provided in reference 1). If an exact match could not be made to a grade then an inter-grade number was used used, for example 1, 3, 5, or 7. Zero (0) is the least amount of photodamage, 8 is the most amount of photodamage.|Units on a scale.|Mean|5.40|5.4|Standard Deviation|1.60|1.6|||
4121522|NCT00926952|3947302|B1|||Mean Number of Actinic Keratosis lesions on face||Lesions|Mean|9.85|9.85|Standard Deviation|7.88|7.88|||
4121523|NCT00926952|3947302|B1|Canada||Region of Enrollment||participants|Number|20|20.0||||||
4121524|NCT00926952|3947302|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4121525|NCT00926952|3947302|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4121526|NCT00926952|3947302|B1|||Age||years|Mean|65.25|65.25|Standard Deviation|10.73|10.73|||
4121527|NCT00926952|3947302|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4121528|NCT00926952|3947302|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4121529|NCT00926952|3947302|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4121530|NCT00926887|3947314|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4121531|NCT00926887|3947315|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4121532|NCT00926887|3947316|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4121533|NCT00926887|3947314|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4121534|NCT00926887|3947315|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4121535|NCT00926887|3947316|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4121536|NCT00926887|3947314|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4121537|NCT00926887|3947315|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4121538|NCT00926887|3947316|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4121539|NCT00926887|3947314|B3||Between 18 and 65 years|Age||Participants|Count of Participants|104|104.0||||||
4121540|NCT00926887|3947315|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4121541|NCT00926887|3947316|B1||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4121542|NCT00926887|3947314|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4121543|NCT00926887|3947315|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4121544|NCT00926887|3947316|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4121545|NCT00926848|3947327|B3|United States||Region of Enrollment||participants|Number|68|68.0||||||
4121546|NCT00926848|3947328|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
4121547|NCT00926848|3947329|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4121548|NCT00926848|3947327|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121549|NCT00926848|3947328|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121550|NCT00926848|3947329|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121551|NCT00926848|3947327|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121552|NCT00926848|3947328|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121553|NCT00926848|3947329|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121554|NCT00926848|3947327|B3||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4121555|NCT00926848|3947328|B2||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4121556|NCT00926848|3947329|B1||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4121557|NCT00926848|3947327|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121558|NCT00926848|3947328|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121559|NCT00926848|3947329|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121560|NCT00926848|3947327|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121561|NCT00926848|3947328|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121562|NCT00926848|3947329|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121563|NCT00926848|3947327|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121564|NCT00926848|3947328|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121565|NCT00926848|3947329|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121566|NCT00926848|3947327|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121567|NCT00926848|3947328|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121568|NCT00926848|3947329|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121569|NCT00926848|3947327|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121570|NCT00926848|3947328|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121571|NCT00926848|3947329|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121572|NCT00926848|3947327|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4121573|NCT00926848|3947328|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4121574|NCT00926848|3947329|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4121575|NCT00926848|3947327|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4121576|NCT00926848|3947328|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4121577|NCT00926848|3947329|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4121578|NCT00926848|3947327|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4121579|NCT00926848|3947328|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4121580|NCT00926848|3947329|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4121581|NCT00926848|3947327|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4121582|NCT00926848|3947328|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4121583|NCT00926848|3947329|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4121584|NCT00926848|3947327|B3|||Age||years|Mean|60.4|60.4|Standard Deviation|12.2|12.2|||
4121585|NCT00926848|3947328|B2|||Age||years|Mean|59.5|59.5|Standard Deviation|14.1|14.1|||
4121586|NCT00926848|3947329|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|10.3|10.3|||
4121587|NCT00926796|3947346|B3|United States||Region of Enrollment||participants|Number|401|401.0||||||
4121588|NCT00926796|3947347|B2|United States||Region of Enrollment||participants|Number|199|199.0||||||
4121589|NCT00926796|3947348|B1|United States||Region of Enrollment||participants|Number|202|202.0||||||
4121590|NCT00926796|3947346|B3||Male|Sex: Female, Male||Participants|Count of Participants|361|361.0||||||
4121591|NCT00926796|3947347|B2||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4121592|NCT00926796|3947348|B1||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4121593|NCT00926796|3947346|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4121594|NCT00926796|3947347|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4121595|NCT00926796|3947348|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4121596|NCT00926796|3947346|B3|||Age||years|Mean|30|30.0|Standard Deviation|9.8|9.8|||
4121597|NCT00926796|3947347|B2|||Age||years|Mean|30|30.0|Standard Deviation|9.6|9.6|||
4121598|NCT00926796|3947348|B1|||Age||years|Mean|30|30.0|Standard Deviation|9.9|9.9|||
4121599|NCT00926796|3947346|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4121600|NCT00926796|3947347|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4121601|NCT00926796|3947348|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4121602|NCT00926796|3947346|B3||Between 18 and 65 years|Age||Participants|Count of Participants|392|392.0||||||
4121603|NCT00926796|3947347|B2||Between 18 and 65 years|Age||Participants|Count of Participants|196|196.0||||||
4121604|NCT00926796|3947348|B1||Between 18 and 65 years|Age||Participants|Count of Participants|196|196.0||||||
4121605|NCT00926796|3947346|B3||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4121606|NCT00926796|3947347|B2||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4121607|NCT00926796|3947348|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4121608|NCT00926783|3947368|B3|||Duration of Atrial fibrillation diagnosis (Year)||years|Mean|5.5|5.5|Standard Deviation|5.4|5.4|||
4121609|NCT00926783|3947369|B2|||Duration of Atrial fibrillation diagnosis (Year)||years|Mean|5.2|5.2|Standard Deviation|5.2|5.2|||
4121610|NCT00926783|3947370|B1|||Duration of Atrial fibrillation diagnosis (Year)||years|Mean|5.8|5.8|Standard Deviation|5.7|5.7|||
4121611|NCT00926783|3947368|B3|Persistent||Atrial fibrillation type||participants|Number|52|52.0||||||
4121612|NCT00926783|3947369|B2|Persistent||Atrial fibrillation type||participants|Number|21|21.0||||||
4121613|NCT00926783|3947370|B1|Persistent||Atrial fibrillation type||participants|Number|31|31.0||||||
4121614|NCT00926783|3947368|B3|High Burden Paroxysmal||Atrial fibrillation type||participants|Number|30|30.0||||||
4121615|NCT00926783|3947369|B2|High Burden Paroxysmal||Atrial fibrillation type||participants|Number|19|19.0||||||
4121616|NCT00926783|3947370|B1|High Burden Paroxysmal||Atrial fibrillation type||participants|Number|11|11.0||||||
4121617|NCT00926783|3947368|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4121618|NCT00926783|3947369|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4121619|NCT00926783|3947370|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4121620|NCT00926783|3947368|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121621|NCT00926783|3947369|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121622|NCT00926783|3947370|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121623|NCT00926783|3947368|B3||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
4121624|NCT00926783|3947369|B2||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4121625|NCT00926783|3947370|B1||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4121626|NCT00926783|3947368|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121627|NCT00926783|3947369|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121628|NCT00926783|3947370|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121629|NCT00926783|3947368|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121630|NCT00926783|3947369|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121631|NCT00926783|3947370|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121632|NCT00926783|3947368|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4121633|NCT00926783|3947369|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4121634|NCT00926783|3947370|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121635|NCT00926783|3947368|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121636|NCT00926783|3947369|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121637|NCT00926783|3947370|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121638|NCT00926783|3947368|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4121639|NCT00926783|3947369|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4121640|NCT00926783|3947370|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4121641|NCT00926783|3947368|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4121642|NCT00926783|3947369|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4121643|NCT00926783|3947370|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4121644|NCT00926783|3947368|B3|||Age||years|Mean|61.6|61.6|Standard Deviation|9.4|9.4|||
4121645|NCT00926783|3947369|B2|||Age||years|Mean|61.5|61.5|Standard Deviation|9.2|9.2|||
4121646|NCT00926783|3947370|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|9.8|9.8|||
4121647|NCT00926588|3947387|B3|United States||Region of Enrollment||participants|Number|250|250.0||||||
4121648|NCT00926588|3947388|B2|United States||Region of Enrollment||participants|Number|126|126.0||||||
4121649|NCT00926588|3947389|B1|United States||Region of Enrollment||participants|Number|124|124.0||||||
4121650|NCT00926588|3947387|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4121651|NCT00926588|3947388|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4121652|NCT00926588|3947389|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4121653|NCT00926588|3947387|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121654|NCT00926588|3947388|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121655|NCT00926588|3947389|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121656|NCT00926588|3947387|B3||White|Race (NIH/OMB)||Participants|Count of Participants|192|192.0||||||
4121657|NCT00926588|3947388|B2||White|Race (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
4121658|NCT00926588|3947389|B1||White|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
4121659|NCT00926588|3947387|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4121660|NCT00926588|3947388|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4121661|NCT00926588|3947389|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4121662|NCT00926588|3947387|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121663|NCT00926588|3947388|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121664|NCT00926588|3947389|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121665|NCT00926588|3947387|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4121666|NCT00926588|3947388|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4121667|NCT00926588|3947389|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121668|NCT00926588|3947387|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4121669|NCT00926588|3947388|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4121670|NCT00926588|3947389|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4121671|NCT00926588|3947387|B3||Male|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4121672|NCT00926588|3947388|B2||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4121673|NCT00926588|3947389|B1||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4121674|NCT00926588|3947387|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4121675|NCT00926588|3947388|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4121676|NCT00926588|3947389|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4121677|NCT00926588|3947387|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4121678|NCT00926588|3947388|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4121679|NCT00926588|3947389|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4121680|NCT00926588|3947387|B3||Between 18 and 65 years|Age||Participants|Count of Participants|250|250.0||||||
4121681|NCT00926588|3947388|B2||Between 18 and 65 years|Age||Participants|Count of Participants|126|126.0||||||
4121682|NCT00926588|3947389|B1||Between 18 and 65 years|Age||Participants|Count of Participants|124|124.0||||||
4121683|NCT00926588|3947387|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4121684|NCT00926588|3947388|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4121685|NCT00926588|3947389|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4121686|NCT00926575|3947396|B3||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4121687|NCT00926575|3947397|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4121688|NCT00926575|3947398|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4121689|NCT00926575|3947396|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4121690|NCT00926575|3947397|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4121691|NCT00926575|3947398|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4121692|NCT00926575|3947396|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4121693|NCT00926575|3947397|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4121694|NCT00926575|3947398|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4121695|NCT00926575|3947396|B3||Between 18 and 65 years|Age||Participants|Count of Participants|128|128.0||||||
4121696|NCT00926575|3947397|B2||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4121697|NCT00926575|3947398|B1||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4121698|NCT00926575|3947396|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4121699|NCT00926575|3947397|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4121700|NCT00926575|3947398|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4121701|NCT00926536|3947409|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4121702|NCT00926536|3947410|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4121703|NCT00926536|3947411|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4121704|NCT00926536|3947409|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4121705|NCT00926536|3947410|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4121706|NCT00926536|3947411|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4121707|NCT00926536|3947409|B3|Over 18 years old||Age, Customized||participants|Number|84|84.0||||||
4121708|NCT00926536|3947410|B2|Over 18 years old||Age, Customized||participants|Number|41|41.0||||||
4121709|NCT00926536|3947411|B1|Over 18 years old||Age, Customized||participants|Number|43|43.0||||||
4121710|NCT00926536|3947409|B3|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4121711|NCT00926536|3947410|B2|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4121712|NCT00926536|3947411|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4121713|NCT00926497|3947420|B3|Switzerland||Region of Enrollment||participants|Number|121|121.0||||||
4121714|NCT00926497|3947421|B2|Switzerland||Region of Enrollment||participants|Number|61|61.0||||||
4121715|NCT00926497|3947422|B1|Switzerland||Region of Enrollment||participants|Number|60|60.0||||||
4121716|NCT00926497|3947420|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4121717|NCT00926497|3947421|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4121718|NCT00926497|3947422|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4121719|NCT00926497|3947420|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4121720|NCT00926497|3947421|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4121721|NCT00926497|3947422|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4121722|NCT00926497|3947420|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4121723|NCT00926497|3947421|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4121724|NCT00926497|3947422|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4121725|NCT00926497|3947420|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4121726|NCT00926497|3947421|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4121727|NCT00926497|3947422|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4121728|NCT00926497|3947420|B3||<=18 years|Age||Participants|Count of Participants|121|121.0||||||
4121729|NCT00926497|3947421|B2||<=18 years|Age||Participants|Count of Participants|61|61.0||||||
4121730|NCT00926497|3947422|B1||<=18 years|Age||Participants|Count of Participants|60|60.0||||||
4121731|NCT00926393|3947431|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4121732|NCT00926393|3947432|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4121733|NCT00926393|3947433|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4121734|NCT00926393|3947431|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4121735|NCT00926393|3947432|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4121736|NCT00926393|3947433|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4121737|NCT00926393|3947431|B3|40-50||Age, Customized||Participants|Number|80|80.0||||||
4121738|NCT00926393|3947432|B2|40-50||Age, Customized||Participants|Number|39|39.0||||||
4121739|NCT00926393|3947433|B1|40-50||Age, Customized||Participants|Number|41|41.0||||||
4121740|NCT00926393|3947431|B3|18-39||Age, Customized||Participants|Number|59|59.0||||||
4121741|NCT00926393|3947432|B2|18-39||Age, Customized||Participants|Number|31|31.0||||||
4121742|NCT00926393|3947433|B1|18-39||Age, Customized||Participants|Number|28|28.0||||||
4121743|NCT00926380|3947464|B4|||DXA Bone Density (g/cm^2) (Distal 1/3 of the radius shaft)||g/cm^2|Mean|0.609|0.609|Standard Deviation|0.073|0.073|||
4121744|NCT00926380|3947465|B3|||DXA Bone Density (g/cm^2) (Distal 1/3 of the radius shaft)||g/cm^2|Mean|0.613|0.613|Standard Deviation|0.070|0.07|||
4121745|NCT00926380|3947466|B2|||DXA Bone Density (g/cm^2) (Distal 1/3 of the radius shaft)||g/cm^2|Mean|0.612|0.612|Standard Deviation|0.069|0.069|||
4121746|NCT00926380|3947467|B1|||DXA Bone Density (g/cm^2) (Distal 1/3 of the radius shaft)||g/cm^2|Mean|0.602|0.602|Standard Deviation|0.082|0.082|||
4121747|NCT00926380|3947464|B4|||DXA Bone Density (g/cm^2) (Total hip)||g/cm^2|Mean|0.761|0.761|Standard Deviation|0.081|0.081|||
4121748|NCT00926380|3947465|B3|||DXA Bone Density (g/cm^2) (Total hip)||g/cm^2|Mean|0.759|0.759|Standard Deviation|0.073|0.073|||
4121749|NCT00926380|3947466|B2|||DXA Bone Density (g/cm^2) (Total hip)||g/cm^2|Mean|0.757|0.757|Standard Deviation|0.068|0.068|||
4121750|NCT00926380|3947467|B1|||DXA Bone Density (g/cm^2) (Total hip)||g/cm^2|Mean|0.766|0.766|Standard Deviation|0.100|0.1|||
4121751|NCT00926380|3947464|B4|||DXA Bone Density (g/cm^2) (Femoral neck)||g/cm^2|Mean|0.642|0.642|Standard Deviation|0.071|0.071|||
4121752|NCT00926380|3947465|B3|||DXA Bone Density (g/cm^2) (Femoral neck)||g/cm^2|Mean|0.642|0.642|Standard Deviation|0.067|0.067|||
4121753|NCT00926380|3947466|B2|||DXA Bone Density (g/cm^2) (Femoral neck)||g/cm^2|Mean|0.643|0.643|Standard Deviation|0.061|0.061|||
4121754|NCT00926380|3947467|B1|||DXA Bone Density (g/cm^2) (Femoral neck)||g/cm^2|Mean|0.641|0.641|Standard Deviation|0.086|0.086|||
4121755|NCT00926380|3947464|B4|||DXA Bone Density (g/cm^2) (Posterior-anterior lumbar spine)||g/cm^2|Mean|0.848|0.848|Standard Deviation|0.112|0.112|||
4121756|NCT00926380|3947465|B3|||DXA Bone Density (g/cm^2) (Posterior-anterior lumbar spine)||g/cm^2|Mean|0.856|0.856|Standard Deviation|0.131|0.131|||
4121757|NCT00926380|3947466|B2|||DXA Bone Density (g/cm^2) (Posterior-anterior lumbar spine)||g/cm^2|Mean|0.823|0.823|Standard Deviation|0.111|0.111|||
4121758|NCT00926380|3947467|B1|||DXA Bone Density (g/cm^2) (Posterior-anterior lumbar spine)||g/cm^2|Mean|0.866|0.866|Standard Deviation|0.088|0.088|||
4121759|NCT00926380|3947464|B4|||Serum β-C-terminal telopeptide of type 1 collagen (CTX) (ng/mL)||ng/mL|Mean|0.39|0.39|Standard Deviation|0.18|0.18|||
4121760|NCT00926380|3947465|B3|||Serum β-C-terminal telopeptide of type 1 collagen (CTX) (ng/mL)||ng/mL|Mean|0.43|0.43|Standard Deviation|0.17|0.17|||
4121761|NCT00926380|3947466|B2|||Serum β-C-terminal telopeptide of type 1 collagen (CTX) (ng/mL)||ng/mL|Mean|0.36|0.36|Standard Deviation|0.15|0.15|||
4121762|NCT00926380|3947467|B1|||Serum β-C-terminal telopeptide of type 1 collagen (CTX) (ng/mL)||ng/mL|Mean|0.39|0.39|Standard Deviation|0.21|0.21|||
4121763|NCT00926380|3947464|B4|||Serum amino-terminal propeptide of type 1 procollagen (P1NP) (µg/L)||µg/L|Mean|47.1|47.1|Standard Deviation|19.0|19.0|||
4121764|NCT00926380|3947465|B3|||Serum amino-terminal propeptide of type 1 procollagen (P1NP) (µg/L)||µg/L|Mean|49.3|49.3|Standard Deviation|20.9|20.9|||
4121765|NCT00926380|3947466|B2|||Serum amino-terminal propeptide of type 1 procollagen (P1NP) (µg/L)||µg/L|Mean|46.0|46.0|Standard Deviation|19.5|19.5|||
4121766|NCT00926380|3947467|B1|||Serum amino-terminal propeptide of type 1 procollagen (P1NP) (µg/L)||µg/L|Mean|45.7|45.7|Standard Deviation|16.7|16.7|||
4121767|NCT00926380|3947464|B4|||Osteocalcin (ng/mL)||ng/mL|Mean|47.8|47.8|Standard Deviation|26.2|26.2|||
4121768|NCT00926380|3947465|B3|||Osteocalcin (ng/mL)||ng/mL|Mean|52.2|52.2|Standard Deviation|29.9|29.9|||
4121769|NCT00926380|3947466|B2|||Osteocalcin (ng/mL)||ng/mL|Mean|49.0|49.0|Standard Deviation|28.8|28.8|||
4121770|NCT00926380|3947467|B1|||Osteocalcin (ng/mL)||ng/mL|Mean|42.9|42.9|Standard Deviation|19.4|19.4|||
4121771|NCT00926380|3947464|B4|||Alkaline phosphatase concentration in serum (U/L)||U/L|Mean|79.6|79.6|Standard Deviation|18.4|18.4|||
4121772|NCT00926380|3947465|B3|||Alkaline phosphatase concentration in serum (U/L)||U/L|Mean|84.2|84.2|Standard Deviation|20.8|20.8|||
4121773|NCT00926380|3947466|B2|||Alkaline phosphatase concentration in serum (U/L)||U/L|Mean|75.8|75.8|Standard Deviation|16.8|16.8|||
4121774|NCT00926380|3947467|B1|||Alkaline phosphatase concentration in serum (U/L)||U/L|Mean|78.8|78.8|Standard Deviation|16.8|16.8|||
4121775|NCT00926380|3947464|B4|||25-Hydroxyvitamin D (ng/mL)||ng/mL|Mean|33.5|33.5|Standard Deviation|10.5|10.5|||
4121776|NCT00926380|3947465|B3|||25-Hydroxyvitamin D (ng/mL)||ng/mL|Mean|33.9|33.9|Standard Deviation|11.8|11.8|||
4121777|NCT00926380|3947466|B2|||25-Hydroxyvitamin D (ng/mL)||ng/mL|Mean|31.2|31.2|Standard Deviation|8.5|8.5|||
4121778|NCT00926380|3947467|B1|||25-Hydroxyvitamin D (ng/mL)||ng/mL|Mean|35.3|35.3|Standard Deviation|10.5|10.5|||
4121779|NCT00926380|3947464|B4|||Previous oral bisphosphonate use||Participants|Count of Participants|35|35.0||||||
4121780|NCT00926380|3947465|B3|||Previous oral bisphosphonate use||Participants|Count of Participants|10|10.0||||||
4121781|NCT00926380|3947466|B2|||Previous oral bisphosphonate use||Participants|Count of Participants|13|13.0||||||
4121782|NCT00926380|3947467|B1|||Previous oral bisphosphonate use||Participants|Count of Participants|12|12.0||||||
4121783|NCT00926380|3947464|B4|||History of fragility fracture||Participants|Count of Participants|38|38.0||||||
4121784|NCT00926380|3947465|B3|||History of fragility fracture||Participants|Count of Participants|10|10.0||||||
4121785|NCT00926380|3947466|B2|||History of fragility fracture||Participants|Count of Participants|16|16.0||||||
4121786|NCT00926380|3947467|B1|||History of fragility fracture||Participants|Count of Participants|12|12.0||||||
4121787|NCT00926380|3947464|B4|||Body-mass index||kg/m^2|Mean|25.0|25.0|Standard Deviation|4.2|4.2|||
4121788|NCT00926380|3947465|B3|||Body-mass index||kg/m^2|Mean|25.4|25.4|Standard Deviation|4.9|4.9|||
4121789|NCT00926380|3947466|B2|||Body-mass index||kg/m^2|Mean|25.5|25.5|Standard Deviation|3.8|3.8|||
4121790|NCT00926380|3947467|B1|||Body-mass index||kg/m^2|Mean|24.1|24.1|Standard Deviation|3.9|3.9|||
4121791|NCT00926380|3947464|B4|United States||Region of Enrollment||Participants|Count of Participants|94|94.0||||||
4121792|NCT00926380|3947465|B3|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4121793|NCT00926380|3947466|B2|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
4121794|NCT00926380|3947467|B1|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
4121795|NCT00926380|3947464|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121796|NCT00926380|3947465|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121797|NCT00926380|3947466|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121798|NCT00926380|3947467|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121799|NCT00926380|3947464|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121800|NCT00926380|3947465|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121801|NCT00926380|3947466|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121802|NCT00926380|3947467|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121803|NCT00926380|3947464|B4||White|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4121804|NCT00926380|3947465|B3||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4121805|NCT00926380|3947466|B2||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4121806|NCT00926380|3947467|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4121807|NCT00926380|3947464|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4121808|NCT00926380|3947465|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4121809|NCT00926380|3947466|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121810|NCT00926380|3947467|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4121811|NCT00926380|3947464|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121812|NCT00926380|3947465|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121813|NCT00926380|3947466|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121814|NCT00926380|3947467|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121815|NCT00926380|3947464|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4121816|NCT00926380|3947465|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121817|NCT00926380|3947466|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121818|NCT00926380|3947467|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4121819|NCT00926380|3947464|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121820|NCT00926380|3947465|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121821|NCT00926380|3947466|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121822|NCT00926380|3947467|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121823|NCT00926380|3947464|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121824|NCT00926380|3947465|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121825|NCT00926380|3947466|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121826|NCT00926380|3947467|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121888|NCT00926289|3947533|B1||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4121827|NCT00926380|3947464|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
4121828|NCT00926380|3947465|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4121829|NCT00926380|3947466|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4121830|NCT00926380|3947467|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4121831|NCT00926380|3947464|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4121832|NCT00926380|3947465|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4121833|NCT00926380|3947466|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4121834|NCT00926380|3947467|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4121835|NCT00926380|3947464|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4121836|NCT00926380|3947465|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4121837|NCT00926380|3947466|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4121838|NCT00926380|3947467|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4121839|NCT00926380|3947464|B4||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4121840|NCT00926380|3947465|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4121841|NCT00926380|3947466|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4121842|NCT00926380|3947467|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4121843|NCT00926380|3947464|B4|||Age||years|Mean|65.9|65.9|Standard Deviation|8.3|8.3|||
4121844|NCT00926380|3947465|B3|||Age||years|Mean|65.9|65.9|Standard Deviation|9.0|9.0|||
4121845|NCT00926380|3947466|B2|||Age||years|Mean|65.5|65.5|Standard Deviation|7.9|7.9|||
4121846|NCT00926380|3947467|B1|||Age||years|Mean|66.3|66.3|Standard Deviation|8.3|8.3|||
4121847|NCT00926367|3947477|B3|United States||Region of Enrollment||participants|Number|52|52.0||||||
4121848|NCT00926367|3947478|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4121849|NCT00926367|3947479|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4121850|NCT00926367|3947477|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4121851|NCT00926367|3947478|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4121852|NCT00926367|3947479|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4121853|NCT00926367|3947477|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4121854|NCT00926367|3947478|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4121855|NCT00926367|3947479|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4121856|NCT00926367|3947477|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4121857|NCT00926367|3947478|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4121858|NCT00926367|3947479|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4121859|NCT00926367|3947477|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4121860|NCT00926367|3947478|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4121861|NCT00926367|3947479|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4121862|NCT00926367|3947477|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4121863|NCT00926367|3947478|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4121864|NCT00926367|3947479|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4121865|NCT00926328|3947520|B3|Spain||Region of Enrollment||participants|Number|120|120.0||||||
4121866|NCT00926328|3947521|B2|Spain||Region of Enrollment||participants|Number|60|60.0||||||
4121867|NCT00926328|3947522|B1|Spain||Region of Enrollment||participants|Number|60|60.0||||||
4121868|NCT00926328|3947520|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4121869|NCT00926328|3947521|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4121870|NCT00926328|3947522|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4121871|NCT00926328|3947520|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4121872|NCT00926328|3947521|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4121873|NCT00926328|3947522|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4121874|NCT00926328|3947520|B3|||Age||years|Mean|35.33|35.33|Standard Deviation|9.39|9.39|||
4121875|NCT00926328|3947521|B2|||Age||years|Mean|35.95|35.95|Standard Deviation|10.24|10.24|||
4121876|NCT00926328|3947522|B1|||Age||years|Mean|34.72|34.72|Standard Deviation|8.51|8.51|||
4121877|NCT00926328|3947520|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4121878|NCT00926328|3947521|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4121879|NCT00926328|3947522|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4121880|NCT00926328|3947520|B3||Between 18 and 65 years|Age||Participants|Count of Participants|116|116.0||||||
4121881|NCT00926328|3947521|B2||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4121882|NCT00926328|3947522|B1||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4121883|NCT00926328|3947520|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4121884|NCT00926328|3947521|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4121885|NCT00926328|3947522|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4121886|NCT00926289|3947531|B3||Male|Sex: Female, Male||Participants|Count of Participants|478|478.0||||||
4121887|NCT00926289|3947532|B2||Male|Sex: Female, Male||Participants|Count of Participants|309|309.0||||||
4121889|NCT00926289|3947531|B3||Female|Sex: Female, Male||Participants|Count of Participants|410|410.0||||||
4121890|NCT00926289|3947532|B2||Female|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
4121891|NCT00926289|3947533|B1||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4121892|NCT00926289|3947531|B3|||Age||Years|Mean|57.0|57.0|Standard Deviation|11.5|11.5|||
4121893|NCT00926289|3947532|B2|||Age||Years|Mean|56.8|56.8|Standard Deviation|11.3|11.3|||
4121894|NCT00926289|3947533|B1|||Age||Years|Mean|57.6|57.6|Standard Deviation|11.9|11.9|||
4121895|NCT00926263|3947568|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4121896|NCT00926263|3947569|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4121897|NCT00926263|3947570|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4121898|NCT00926263|3947568|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4121899|NCT00926263|3947569|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4121900|NCT00926263|3947570|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4121901|NCT00926263|3947568|B3|Black||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4121902|NCT00926263|3947569|B2|Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4121903|NCT00926263|3947570|B1|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4121904|NCT00926263|3947568|B3|White||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4121905|NCT00926263|3947569|B2|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4121906|NCT00926263|3947570|B1|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4121907|NCT00926263|3947568|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4121908|NCT00926263|3947569|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4121909|NCT00926263|3947570|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4121910|NCT00926263|3947568|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4121911|NCT00926263|3947569|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4121912|NCT00926263|3947570|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4121913|NCT00926263|3947568|B3|||Age||years|Mean|30.6|30.6|Standard Deviation|6.8|6.8|||
4121914|NCT00926263|3947569|B2|||Age||years|Mean|30.3|30.3|Standard Deviation|7.7|7.7|||
4121915|NCT00926263|3947570|B1|||Age||years|Mean|30.9|30.9|Standard Deviation|6.3|6.3|||
4121916|NCT00926211|3947602|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4121917|NCT00926211|3947602|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4121918|NCT00926211|3947602|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4121919|NCT00926211|3947602|B1|||Age||years|Mean|48.6|48.6|Standard Deviation|7.5|7.5|||
4121920|NCT00926211|3947602|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4121921|NCT00926211|3947602|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4121922|NCT00926211|3947602|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4121923|NCT00926185|3947609|B5||Male|Gender||Participants|Count of Participants|51|51.0||||||
4121924|NCT00926185|3947610|B4||Male|Gender||Participants|Count of Participants|13|13.0||||||
4121925|NCT00926185|3947611|B3||Male|Gender||Participants|Count of Participants|11|11.0||||||
4121926|NCT00926185|3947612|B2||Male|Gender||Participants|Count of Participants|17|17.0||||||
4121927|NCT00926185|3947613|B1||Male|Gender||Participants|Count of Participants|10|10.0||||||
4121928|NCT00926185|3947609|B5||Female|Gender||Participants|Count of Participants|179|179.0||||||
4121929|NCT00926185|3947610|B4||Female|Gender||Participants|Count of Participants|45|45.0||||||
4121930|NCT00926185|3947611|B3||Female|Gender||Participants|Count of Participants|47|47.0||||||
4121931|NCT00926185|3947612|B2||Female|Gender||Participants|Count of Participants|40|40.0||||||
4121932|NCT00926185|3947613|B1||Female|Gender||Participants|Count of Participants|47|47.0||||||
4121933|NCT00926185|3947609|B5|||Age||years|Mean|62.34|62.34|Standard Deviation|12.523|12.523|||
4121934|NCT00926185|3947610|B4|||Age||years|Mean|60.38|60.38|Standard Deviation|12.930|12.93|||
4121935|NCT00926185|3947611|B3|||Age||years|Mean|62.26|62.26|Standard Deviation|12.220|12.22|||
4121936|NCT00926185|3947612|B2|||Age||years|Mean|63.63|63.63|Standard Deviation|11.883|11.883|||
4121937|NCT00926185|3947613|B1|||Age||years|Mean|63.14|63.14|Standard Deviation|13.100|13.1|||
4121938|NCT00926029|3947630|B4|United States||Region of Enrollment||participants|Number|102.0|102.0||||||
4121939|NCT00926029|3947631|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
4121940|NCT00926029|3947632|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
4121941|NCT00926029|3947633|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4121942|NCT00926029|3947630|B4||Male|Sex: Female, Male||Participants|Count of Participants|22.0|22.0||||||
4121943|NCT00926029|3947631|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4121944|NCT00926029|3947632|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4121945|NCT00926029|3947633|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4121946|NCT00926029|3947630|B4||Female|Sex: Female, Male||Participants|Count of Participants|80.0|80.0||||||
4121947|NCT00926029|3947631|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4121948|NCT00926029|3947632|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4121949|NCT00926029|3947633|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4121950|NCT00926029|3947630|B4|||Age||years|Mean|47.4|47.4|Standard Deviation|10.4|10.4|||
4121951|NCT00926029|3947631|B3|||Age||years|Mean|48.9|48.9|Standard Deviation|9.5|9.5|||
4121952|NCT00926029|3947632|B2|||Age||years|Mean|46.4|46.4|Standard Deviation|10.5|10.5|||
4121953|NCT00926029|3947633|B1|||Age||years|Mean|46.7|46.7|Standard Deviation|11.2|11.2|||
4121954|NCT00926029|3947630|B4||>=65 years|Age||Participants|Count of Participants|0.0|0.0||||||
4121955|NCT00926029|3947631|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4121956|NCT00926029|3947632|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4121957|NCT00926029|3947633|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4121958|NCT00926029|3947630|B4||Between 18 and 65 years|Age||Participants|Count of Participants|102.0|102.0||||||
4121959|NCT00926029|3947631|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4121960|NCT00926029|3947632|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4121961|NCT00926029|3947633|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4121962|NCT00926029|3947630|B4||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4121963|NCT00926029|3947631|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4121964|NCT00926029|3947632|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4121965|NCT00926029|3947633|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4121966|NCT00925990|3947646|B3|Puerto Rico||Region of Enrollment||participants|Number|5|5.0||||||
4121967|NCT00925990|3947647|B2|Puerto Rico||Region of Enrollment||participants|Number|4|4.0||||||
4121968|NCT00925990|3947648|B1|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
4121969|NCT00925990|3947646|B3|United States||Region of Enrollment||participants|Number|65|65.0||||||
4121970|NCT00925990|3947647|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
4121971|NCT00925990|3947648|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4121972|NCT00925990|3947646|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4121973|NCT00925990|3947647|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4121974|NCT00925990|3947648|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4121975|NCT00925990|3947646|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4121976|NCT00925990|3947647|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4121977|NCT00925990|3947648|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4121978|NCT00925990|3947646|B3|||Age||years|Mean|51.2|51.2|Standard Deviation|8.1|8.1|||
4121979|NCT00925990|3947647|B2|||Age||years|Mean|49.7|49.7|Standard Deviation|9.1|9.1|||
4121980|NCT00925990|3947648|B1|||Age||years|Mean|52.6|52.6|Standard Deviation|6.8|6.8|||
4121981|NCT00925990|3947646|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4121982|NCT00925990|3947647|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4121983|NCT00925990|3947648|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4121984|NCT00925990|3947646|B3||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
4121985|NCT00925990|3947647|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4121986|NCT00925990|3947648|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4121987|NCT00925990|3947646|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4121988|NCT00925990|3947647|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4121989|NCT00925990|3947648|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4121990|NCT00925938|3947657|B4|United States||Region of Enrollment||participants|Number|51|51.0||||||
4121991|NCT00925938|3947658|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4121992|NCT00925938|3947659|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4121993|NCT00925938|3947660|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4121994|NCT00925938|3947657|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4121995|NCT00925938|3947658|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4121996|NCT00925938|3947659|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4121997|NCT00925938|3947660|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4121998|NCT00925938|3947657|B4||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4121999|NCT00925938|3947658|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4122000|NCT00925938|3947659|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4122001|NCT00925938|3947660|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4122002|NCT00925938|3947657|B4|||Age||years|Mean|41.5|41.5|Standard Deviation|6.05|6.05|||
4122003|NCT00925938|3947658|B3|||Age||years|Mean|42.0|42.0|Standard Deviation|5.86|5.86|||
4122004|NCT00925938|3947659|B2|||Age||years|Mean|41.5|41.5|Standard Deviation|6.21|6.21|||
4122005|NCT00925938|3947660|B1|||Age||years|Mean|40.8|40.8|Standard Deviation|6.57|6.57|||
4122006|NCT00925938|3947657|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4122007|NCT00925938|3947658|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4122008|NCT00925938|3947659|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4122009|NCT00925938|3947660|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4122010|NCT00925938|3947657|B4||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4122011|NCT00925938|3947658|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4122012|NCT00925938|3947659|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4122013|NCT00925938|3947660|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4122014|NCT00925938|3947657|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4122015|NCT00925938|3947658|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4122016|NCT00925938|3947659|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4122017|NCT00925938|3947660|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4122018|NCT00925899|3947682|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4122019|NCT00925899|3947683|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4122020|NCT00925899|3947684|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4122021|NCT00925899|3947682|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4122022|NCT00925899|3947683|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4122023|NCT00925899|3947684|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4122024|NCT00925899|3947682|B3|||Age||years|Mean|63|63.0|Full Range|||33.0|89.0|
4122025|NCT00925899|3947683|B2|||Age||years|Mean|62|62.0|Full Range|||33.0|89.0|
4122026|NCT00925899|3947684|B1|||Age||years|Mean|65|65.0|Full Range|||35.0|84.0|
4122027|NCT00925782|3947703|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4122028|NCT00925782|3947703|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4122029|NCT00925782|3947703|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4122030|NCT00925782|3947703|B1|||Age||years|Mean|57|57.0|Standard Deviation|5|5.0|||
4122031|NCT00925782|3947703|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4122032|NCT00925782|3947703|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4122033|NCT00925782|3947703|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4122034|NCT00925769|3947713|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4122035|NCT00925769|3947713|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4122036|NCT00925769|3947713|B1|||Age||years|Mean|63.9|63.9|Standard Deviation|8.4|8.4|||
4122037|NCT00925704|3947780|B7|United States||Region of Enrollment||participants|Number|41|41.0||||||
4122038|NCT00925704|3947781|B6|United States||Region of Enrollment||participants|Number|7|7.0||||||
4122039|NCT00925704|3947782|B5|United States||Region of Enrollment||participants|Number|7|7.0||||||
4122040|NCT00925704|3947783|B4|United States||Region of Enrollment||participants|Number|7|7.0||||||
4122041|NCT00925704|3947784|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4122042|NCT00925704|3947785|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4122043|NCT00925704|3947786|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4122044|NCT00925704|3947780|B7||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4122045|NCT00925704|3947781|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4122046|NCT00925704|3947782|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4122047|NCT00925704|3947783|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4122048|NCT00925704|3947784|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4122049|NCT00925704|3947785|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4122050|NCT00925704|3947786|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4122051|NCT00925704|3947780|B7||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4122052|NCT00925704|3947781|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4122053|NCT00925704|3947782|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4122054|NCT00925704|3947783|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4122055|NCT00925704|3947784|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4122056|NCT00925704|3947785|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4122057|NCT00925704|3947786|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4122058|NCT00925704|3947780|B7|||Age||years|Mean|29.8|29.8|Standard Deviation|7.55|7.55|||
4122059|NCT00925704|3947781|B6|||Age||years|Mean|30.4|30.4|Standard Deviation|10.41|10.41|||
4122060|NCT00925704|3947782|B5|||Age||years|Mean|31.0|31.0|Standard Deviation|8.52|8.52|||
4122061|NCT00925704|3947783|B4|||Age||years|Mean|28.4|28.4|Standard Deviation|7.28|7.28|||
4122062|NCT00925704|3947784|B3|||Age||years|Mean|30.9|30.9|Standard Deviation|5.52|5.52|||
4122063|NCT00925704|3947785|B2|||Age||years|Mean|30.0|30.0|Standard Deviation|6.24|6.24|||
4122064|NCT00925704|3947786|B1|||Age||years|Mean|27.7|27.7|Standard Deviation|8.94|8.94|||
4122065|NCT00925704|3947780|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4122066|NCT00925704|3947781|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4122067|NCT00925704|3947782|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4122068|NCT00925704|3947783|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4122069|NCT00925704|3947784|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4122070|NCT00925704|3947785|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4122071|NCT00925704|3947786|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4122072|NCT00925704|3947780|B7||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4122073|NCT00925704|3947781|B6||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4122074|NCT00925704|3947782|B5||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4122075|NCT00925704|3947783|B4||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4122076|NCT00925704|3947784|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4122077|NCT00925704|3947785|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4122078|NCT00925704|3947786|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4122079|NCT00925704|3947780|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4122080|NCT00925704|3947781|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4122081|NCT00925704|3947782|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4122082|NCT00925704|3947783|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4122083|NCT00925704|3947784|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4122084|NCT00925704|3947785|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4122085|NCT00925704|3947786|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4122086|NCT00925600|3947802|B3|No||Participant-reported History of Cataract|Participant-reported history of cataracts was a study stratification factor.|participants|Number|699|699.0||||||
4122087|NCT00925600|3947803|B2|No||Participant-reported History of Cataract|Participant-reported history of cataracts was a study stratification factor.|participants|Number|348|348.0||||||
4122088|NCT00925600|3947804|B1|No||Participant-reported History of Cataract|Participant-reported history of cataracts was a study stratification factor.|participants|Number|351|351.0||||||
4122089|NCT00925600|3947802|B3|Yes||Participant-reported History of Cataract|Participant-reported history of cataracts was a study stratification factor.|participants|Number|70|70.0||||||
4122090|NCT00925600|3947803|B2|Yes||Participant-reported History of Cataract|Participant-reported history of cataracts was a study stratification factor.|participants|Number|35|35.0||||||
4122091|NCT00925600|3947804|B1|Yes||Participant-reported History of Cataract|Participant-reported history of cataracts was a study stratification factor.|participants|Number|35|35.0||||||
4122092|NCT00925600|3947802|B3|≥ 3.0 at any of these sites||Screening Lens Opacities Classification System (LOCS) III Status|The Lens Opacities Classification System III (LOCS III) is a slit lamp based opacification grading method. Photographs of slit lamp cross-sections of the lens are used as references for grading nuclear opalescence (NO) and nuclear color (NC), and photographs of the lens seen by retroillumination are used as references for grading cortical (C) and posterior subcapsular (P) cataract. Opacification severity is graded on a decimal scale, scores can range from 0.1 to 6.9 for NO and NC and from 0.1 to 5.9 for C and P. For each opacification type the higher grading scores indicate greater severity.|participants|Number|171|171.0||||||
4122093|NCT00925600|3947803|B2|≥ 3.0 at any of these sites||Screening Lens Opacities Classification System (LOCS) III Status|The Lens Opacities Classification System III (LOCS III) is a slit lamp based opacification grading method. Photographs of slit lamp cross-sections of the lens are used as references for grading nuclear opalescence (NO) and nuclear color (NC), and photographs of the lens seen by retroillumination are used as references for grading cortical (C) and posterior subcapsular (P) cataract. Opacification severity is graded on a decimal scale, scores can range from 0.1 to 6.9 for NO and NC and from 0.1 to 5.9 for C and P. For each opacification type the higher grading scores indicate greater severity.|participants|Number|84|84.0||||||
4122094|NCT00925600|3947804|B1|≥ 3.0 at any of these sites||Screening Lens Opacities Classification System (LOCS) III Status|The Lens Opacities Classification System III (LOCS III) is a slit lamp based opacification grading method. Photographs of slit lamp cross-sections of the lens are used as references for grading nuclear opalescence (NO) and nuclear color (NC), and photographs of the lens seen by retroillumination are used as references for grading cortical (C) and posterior subcapsular (P) cataract. Opacification severity is graded on a decimal scale, scores can range from 0.1 to 6.9 for NO and NC and from 0.1 to 5.9 for C and P. For each opacification type the higher grading scores indicate greater severity.|participants|Number|87|87.0||||||
4122095|NCT00925600|3947802|B3|< 3.0 at all sites [P, C, and NO]||Screening Lens Opacities Classification System (LOCS) III Status|The Lens Opacities Classification System III (LOCS III) is a slit lamp based opacification grading method. Photographs of slit lamp cross-sections of the lens are used as references for grading nuclear opalescence (NO) and nuclear color (NC), and photographs of the lens seen by retroillumination are used as references for grading cortical (C) and posterior subcapsular (P) cataract. Opacification severity is graded on a decimal scale, scores can range from 0.1 to 6.9 for NO and NC and from 0.1 to 5.9 for C and P. For each opacification type the higher grading scores indicate greater severity.|participants|Number|598|598.0||||||
4122096|NCT00925600|3947803|B2|< 3.0 at all sites [P, C, and NO]||Screening Lens Opacities Classification System (LOCS) III Status|The Lens Opacities Classification System III (LOCS III) is a slit lamp based opacification grading method. Photographs of slit lamp cross-sections of the lens are used as references for grading nuclear opalescence (NO) and nuclear color (NC), and photographs of the lens seen by retroillumination are used as references for grading cortical (C) and posterior subcapsular (P) cataract. Opacification severity is graded on a decimal scale, scores can range from 0.1 to 6.9 for NO and NC and from 0.1 to 5.9 for C and P. For each opacification type the higher grading scores indicate greater severity.|participants|Number|299|299.0||||||
4122097|NCT00925600|3947804|B1|< 3.0 at all sites [P, C, and NO]||Screening Lens Opacities Classification System (LOCS) III Status|The Lens Opacities Classification System III (LOCS III) is a slit lamp based opacification grading method. Photographs of slit lamp cross-sections of the lens are used as references for grading nuclear opalescence (NO) and nuclear color (NC), and photographs of the lens seen by retroillumination are used as references for grading cortical (C) and posterior subcapsular (P) cataract. Opacification severity is graded on a decimal scale, scores can range from 0.1 to 6.9 for NO and NC and from 0.1 to 5.9 for C and P. For each opacification type the higher grading scores indicate greater severity.|participants|Number|299|299.0||||||
4122098|NCT00925600|3947802|B3|No||Orchiectomy (Surgical Castration)||participants|Number|660|660.0||||||
4122099|NCT00925600|3947803|B2|No||Orchiectomy (Surgical Castration)||participants|Number|332|332.0||||||
4122100|NCT00925600|3947804|B1|No||Orchiectomy (Surgical Castration)||participants|Number|328|328.0||||||
4122101|NCT00925600|3947802|B3|Yes||Orchiectomy (Surgical Castration)||participants|Number|109|109.0||||||
4122102|NCT00925600|3947803|B2|Yes||Orchiectomy (Surgical Castration)||participants|Number|51|51.0||||||
4122103|NCT00925600|3947804|B1|Yes||Orchiectomy (Surgical Castration)||participants|Number|58|58.0||||||
4122104|NCT00925600|3947802|B3|No||Received Androgen-deprivation Therapy (ADT)||participants|Number|66|66.0||||||
4122105|NCT00925600|3947803|B2|No||Received Androgen-deprivation Therapy (ADT)||participants|Number|30|30.0||||||
4122106|NCT00925600|3947804|B1|No||Received Androgen-deprivation Therapy (ADT)||participants|Number|36|36.0||||||
4122107|NCT00925600|3947802|B3|Yes||Received Androgen-deprivation Therapy (ADT)||participants|Number|703|703.0||||||
4122108|NCT00925600|3947803|B2|Yes||Received Androgen-deprivation Therapy (ADT)||participants|Number|353|353.0||||||
4122109|NCT00925600|3947804|B1|Yes||Received Androgen-deprivation Therapy (ADT)||participants|Number|350|350.0||||||
4122110|NCT00925600|3947802|B3|No||Presence of Diabetes|From baseline medical history|participants|Number|638|638.0||||||
4122111|NCT00925600|3947803|B2|No||Presence of Diabetes|From baseline medical history|participants|Number|322|322.0||||||
4122112|NCT00925600|3947804|B1|No||Presence of Diabetes|From baseline medical history|participants|Number|316|316.0||||||
4122113|NCT00925600|3947802|B3|Yes||Presence of Diabetes|From baseline medical history|participants|Number|131|131.0||||||
4122114|NCT00925600|3947803|B2|Yes||Presence of Diabetes|From baseline medical history|participants|Number|61|61.0||||||
4122115|NCT00925600|3947804|B1|Yes||Presence of Diabetes|From baseline medical history|participants|Number|70|70.0||||||
4122116|NCT00925600|3947802|B3|No||Presence of Cataract(s)|From baseline medical history|participants|Number|647|647.0||||||
4122117|NCT00925600|3947803|B2|No||Presence of Cataract(s)|From baseline medical history|participants|Number|320|320.0||||||
4122118|NCT00925600|3947804|B1|No||Presence of Cataract(s)|From baseline medical history|participants|Number|327|327.0||||||
4122119|NCT00925600|3947802|B3|Yes||Presence of Cataract(s)|From baseline medical history|participants|Number|122|122.0||||||
4122120|NCT00925600|3947803|B2|Yes||Presence of Cataract(s)|From baseline medical history|participants|Number|63|63.0||||||
4122121|NCT00925600|3947804|B1|Yes||Presence of Cataract(s)|From baseline medical history|participants|Number|59|59.0||||||
4122122|NCT00925600|3947802|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4122123|NCT00925600|3947803|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4122124|NCT00925600|3947804|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4122125|NCT00925600|3947802|B3|Japanese||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4122126|NCT00925600|3947803|B2|Japanese||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4122127|NCT00925600|3947804|B1|Japanese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4122128|NCT00925600|3947802|B3|Asian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4122129|NCT00925600|3947803|B2|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4122130|NCT00925600|3947804|B1|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4122131|NCT00925600|3947802|B3|Other||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4122132|NCT00925600|3947803|B2|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4122133|NCT00925600|3947804|B1|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4122134|NCT00925600|3947802|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4122135|NCT00925600|3947803|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4122136|NCT00925600|3947804|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4122137|NCT00925600|3947802|B3|Black (or African American)||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4122138|NCT00925600|3947803|B2|Black (or African American)||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4122139|NCT00925600|3947804|B1|Black (or African American)||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4122140|NCT00925600|3947802|B3|White||Race/Ethnicity, Customized||participants|Number|705|705.0||||||
4122141|NCT00925600|3947803|B2|White||Race/Ethnicity, Customized||participants|Number|346|346.0||||||
4122142|NCT00925600|3947804|B1|White||Race/Ethnicity, Customized||participants|Number|359|359.0||||||
4122143|NCT00925600|3947802|B3||Male|Sex: Female, Male||Participants|Count of Participants|769|769.0||||||
4122144|NCT00925600|3947803|B2||Male|Sex: Female, Male||Participants|Count of Participants|383|383.0||||||
4122145|NCT00925600|3947804|B1||Male|Sex: Female, Male||Participants|Count of Participants|386|386.0||||||
4122146|NCT00925600|3947802|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4122147|NCT00925600|3947803|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4122148|NCT00925600|3947804|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4122149|NCT00925600|3947802|B3|≥ 85 years||Age, Customized||participants|Number|12|12.0||||||
4122150|NCT00925600|3947803|B2|≥ 85 years||Age, Customized||participants|Number|7|7.0||||||
4122151|NCT00925600|3947804|B1|≥ 85 years||Age, Customized||participants|Number|5|5.0||||||
4122152|NCT00925600|3947802|B3|75 - 84 years||Age, Customized||participants|Number|235|235.0||||||
4122153|NCT00925600|3947803|B2|75 - 84 years||Age, Customized||participants|Number|116|116.0||||||
4122154|NCT00925600|3947804|B1|75 - 84 years||Age, Customized||participants|Number|119|119.0||||||
4122155|NCT00925600|3947802|B3|65 - 74 years||Age, Customized||participants|Number|383|383.0||||||
4122156|NCT00925600|3947803|B2|65 - 74 years||Age, Customized||participants|Number|194|194.0||||||
4122157|NCT00925600|3947804|B1|65 - 74 years||Age, Customized||participants|Number|189|189.0||||||
4122158|NCT00925600|3947802|B3|18 - 64 years||Age, Customized||participants|Number|139|139.0||||||
4122159|NCT00925600|3947803|B2|18 - 64 years||Age, Customized||participants|Number|66|66.0||||||
4122160|NCT00925600|3947804|B1|18 - 64 years||Age, Customized||participants|Number|73|73.0||||||
4122161|NCT00925600|3947802|B3|||Age||years|Mean|71.0|71.0|Standard Deviation|7.1|7.1|||
4122162|NCT00925600|3947803|B2|||Age||years|Mean|71.1|71.1|Standard Deviation|7.2|7.2|||
4122163|NCT00925600|3947804|B1|||Age||years|Mean|71.0|71.0|Standard Deviation|7.0|7.0|||
4122164|NCT00925587|3947825|B3|||Baseline Hemoglobin||g/dL|Mean|9.12|9.12|Standard Deviation|0.65|0.65|||
4122165|NCT00925587|3947826|B2|||Baseline Hemoglobin||g/dL|Mean|9.11|9.11|Standard Deviation|0.70|0.7|||
4122166|NCT00925587|3947827|B1|||Baseline Hemoglobin||g/dL|Mean|9.13|9.13|Standard Deviation|0.61|0.61|||
4122167|NCT00925587|3947825|B3|Other||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
4122168|NCT00925587|3947826|B2|Other||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4122169|NCT00925587|3947827|B1|Other||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4122170|NCT00925587|3947825|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|329|329.0||||||
4122171|NCT00925587|3947826|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|163|163.0||||||
4122172|NCT00925587|3947827|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|166|166.0||||||
4122173|NCT00925587|3947825|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4122174|NCT00925587|3947826|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4122175|NCT00925587|3947827|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4122176|NCT00925587|3947825|B3||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4122177|NCT00925587|3947826|B2||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4122178|NCT00925587|3947827|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4122179|NCT00925587|3947825|B3||Female|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4122180|NCT00925587|3947826|B2||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4122181|NCT00925587|3947827|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4122182|NCT00925587|3947825|B3|>=75 years||Age, Customized||Participants|Number|132|132.0||||||
4122183|NCT00925587|3947826|B2|>=75 years||Age, Customized||Participants|Number|59|59.0||||||
4122184|NCT00925587|3947827|B1|>=75 years||Age, Customized||Participants|Number|73|73.0||||||
4122185|NCT00925587|3947825|B3|>=65-<75 years||Age, Customized||Participants|Number|96|96.0||||||
4122186|NCT00925587|3947826|B2|>=65-<75 years||Age, Customized||Participants|Number|54|54.0||||||
4122187|NCT00925587|3947827|B1|>=65-<75 years||Age, Customized||Participants|Number|42|42.0||||||
4122188|NCT00925587|3947825|B3|<65 years||Age, Customized||Participants|Number|127|127.0||||||
4122189|NCT00925587|3947826|B2|<65 years||Age, Customized||Participants|Number|67|67.0||||||
4122190|NCT00925587|3947827|B1|<65 years||Age, Customized||Participants|Number|60|60.0||||||
4122191|NCT00925587|3947825|B3|||Age||years|Mean|67.3|67.3|Standard Deviation|14.7|14.7|||
4122192|NCT00925587|3947826|B2|||Age||years|Mean|66.3|66.3|Standard Deviation|15.2|15.2|||
4122193|NCT00925587|3947827|B1|||Age||years|Mean|68.4|68.4|Standard Deviation|14.1|14.1|||
4122194|NCT00925548|3947940|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4122195|NCT00925548|3947941|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4122196|NCT00925548|3947942|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4122197|NCT00925548|3947940|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4122198|NCT00925548|3947941|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4122199|NCT00925548|3947942|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4122200|NCT00925548|3947940|B3|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|9|9.0||||||
4122201|NCT00925548|3947941|B2|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|3|3.0||||||
4122202|NCT00925548|3947942|B1|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|6|6.0||||||
4122203|NCT00925548|3947940|B3|Less than (<) 65 years||Age, Customized||participants|Number|7|7.0||||||
4122204|NCT00925548|3947941|B2|Less than (<) 65 years||Age, Customized||participants|Number|2|2.0||||||
4122205|NCT00925548|3947942|B1|Less than (<) 65 years||Age, Customized||participants|Number|5|5.0||||||
4122206|NCT00925522|3947969|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4122207|NCT00925522|3947969|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4122208|NCT00925522|3947969|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4122209|NCT00925522|3947969|B1|||Age||years|Mean|66.8|66.8|Standard Deviation|10.5|10.5|||
4122210|NCT00925522|3947969|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4122211|NCT00925522|3947969|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4122212|NCT00925522|3947969|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4122213|NCT00925353|3947973|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4122214|NCT00925353|3947973|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4122215|NCT00925353|3947973|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4122216|NCT00925353|3947973|B1|||Age||years|Mean|53.9|53.9|Standard Deviation|9.8|9.8|||
4122217|NCT00925353|3947973|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4122218|NCT00925353|3947973|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4122219|NCT00925353|3947973|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4122220|NCT00925301|3947977|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4122221|NCT00925301|3947978|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4122222|NCT00925301|3947979|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4122223|NCT00925301|3947977|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4122224|NCT00925301|3947978|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4122225|NCT00925301|3947979|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4122226|NCT00925301|3947977|B3|||Age||years|Mean|42.2|42.2|Standard Deviation|11.99|11.99|||
4122227|NCT00925301|3947978|B2|||Age||years|Mean|44.5|44.5|Standard Deviation|10.18|10.18|||
4122228|NCT00925301|3947979|B1|||Age||years|Mean|40.0|40.0|Standard Deviation|13.29|13.29|||
4122229|NCT00925288|3947996|B3|Peru||Region of Enrollment||participants|Number|200|200.0||||||
4122230|NCT00925288|3947997|B2|Peru||Region of Enrollment||participants|Number|100|100.0||||||
4122231|NCT00925288|3947998|B1|Peru||Region of Enrollment||participants|Number|100|100.0||||||
4122232|NCT00925288|3947996|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4122233|NCT00925288|3947997|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4122234|NCT00925288|3947998|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4122235|NCT00925288|3947996|B3||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4122236|NCT00925288|3947997|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4122237|NCT00925288|3947998|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4122238|NCT00925288|3947996|B3|||Age||years|Mean|22.92|22.92|Standard Deviation|3.18|3.18|||
4122239|NCT00925288|3947997|B2|||Age||years|Mean|22.97|22.97|Standard Deviation|2.17|2.17|||
4122240|NCT00925288|3947998|B1|||Age||years|Mean|22.86|22.86|Standard Deviation|2.33|2.33|||
4122241|NCT00925288|3947996|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4122242|NCT00925288|3947997|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4122243|NCT00925288|3947998|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4122244|NCT00925288|3947996|B3||Between 18 and 65 years|Age||Participants|Count of Participants|200|200.0||||||
4122245|NCT00925288|3947997|B2||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4122246|NCT00925288|3947998|B1||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4122247|NCT00925288|3947996|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4122248|NCT00925288|3947997|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4122249|NCT00925288|3947998|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4122250|NCT00925132|3948011|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4122251|NCT00925132|3948011|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4122252|NCT00925132|3948011|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4122253|NCT00925132|3948011|B1||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4122254|NCT00925132|3948011|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4122255|NCT00925132|3948011|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4122256|NCT00925132|3948011|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4122257|NCT00925132|3948011|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4122258|NCT00925132|3948011|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4122259|NCT00925132|3948011|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4122260|NCT00925132|3948011|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4122261|NCT00925132|3948011|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4122262|NCT00925132|3948011|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4122263|NCT00925119|3948021|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4122264|NCT00925119|3948021|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4122265|NCT00925119|3948021|B1|||Age||years|Mean|57|57.0|Standard Deviation|11|11.0|||
4122266|NCT00925015|3948031|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4122267|NCT00925015|3948032|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4122268|NCT00925015|3948033|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4122269|NCT00925015|3948034|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4122270|NCT00925015|3948031|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4122271|NCT00925015|3948032|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4122272|NCT00925015|3948033|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4122273|NCT00925015|3948034|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4122274|NCT00925015|3948031|B4|||Age||Years|Mean|60.6|60.6|Standard Deviation|6.0|6.0|||
4122275|NCT00925015|3948032|B3|||Age||Years|Mean|59.7|59.7|Standard Deviation|8.5|8.5|||
4122276|NCT00925015|3948033|B2|||Age||Years|Mean|59.3|59.3|Standard Deviation|3.6|3.6|||
4122277|NCT00925015|3948034|B1|||Age||Years|Mean|62.3|62.3|Standard Deviation|5.6|5.6|||
4122278|NCT00924950|3948092|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4122279|NCT00924950|3948092|B1||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Gender was not measured in each arm
4122280|NCT00924950|3948092|B1||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Gender was not measured in each arm
4122281|NCT00924950|3948092|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4122282|NCT00924950|3948092|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4122283|NCT00924950|3948092|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4122284|NCT00924898|3948097|B1|||sexually transmitted diseases within 8 weeks prior to diagnosis|Diagnosis of sexually transmitted disease within the 8 weeks prior to diagnosis with acute HIV|Participants|Count of Participants|14|14.0||||||
4122285|NCT00924898|3948097|B1|Men who have sex with men||Sexual risk group||Participants|Count of Participants|72|72.0||||||
4122286|NCT00924898|3948097|B1|Heterosexual Male||Sexual risk group||Participants|Count of Participants|9|9.0||||||
4122287|NCT00924898|3948097|B1|Female||Sexual risk group||Participants|Count of Participants|11|11.0||||||
4122288|NCT00924898|3948097|B1|||HIV RNA level|baseline HIV RNA level|copies/mL|Median|614898|614898.0|Full Range|||615.0|29807640.0|
4122289|NCT00924898|3948097|B1|||CD4 cell count|Baseline CD4 cell count|cells/mm^3|Median|487|487.0|Full Range|||13.0|1316.0|
4122290|NCT00924898|3948097|B1|United States||Region of Enrollment|All participants were enrolled at either The University of North Carolina or Duke University.|Participants|Count of Participants|92|92.0||||||
4122291|NCT00924898|3948097|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4122292|NCT00924898|3948097|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4122293|NCT00924898|3948097|B1||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4122294|NCT00924898|3948097|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4122295|NCT00924898|3948097|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4122296|NCT00924898|3948097|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4122297|NCT00924898|3948097|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4122298|NCT00924898|3948097|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4122299|NCT00924898|3948097|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4122300|NCT00924898|3948097|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4122301|NCT00924898|3948097|B1||Male|Sex: Female, Male|Gender at birth was determined at screening.|Participants|Count of Participants|81|81.0||||||
4122302|NCT00924898|3948097|B1||Female|Sex: Female, Male|Gender at birth was determined at screening.|Participants|Count of Participants|11|11.0||||||
4122303|NCT00924898|3948097|B1|||Age|Age at enrollment|years|Median|27|27.0|Full Range|||18.0|66.0|
4122304|NCT00924898|3948097|B1||>=65 years|Age|age (years) at time of acute HIV diagnosis|Participants|Count of Participants|1|1.0||||||
4122305|NCT00924898|3948097|B1||Between 18 and 65 years|Age|age (years) at time of acute HIV diagnosis|Participants|Count of Participants|91|91.0||||||
4122306|NCT00924898|3948097|B1||<=18 years|Age|age (years) at time of acute HIV diagnosis|Participants|Count of Participants|0|0.0||||||
4122307|NCT00924833|3948106|B4|Italy||Region of Enrollment||participants|Number|27|27.0||||||
4122308|NCT00924833|3948107|B3|Italy||Region of Enrollment||participants|Number|9|9.0||||||
4122309|NCT00924833|3948108|B2|Italy||Region of Enrollment||participants|Number|9|9.0||||||
4122310|NCT00924833|3948109|B1|Italy||Region of Enrollment||participants|Number|9|9.0||||||
4122311|NCT00924833|3948106|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4122312|NCT00924833|3948107|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4122313|NCT00924833|3948108|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4122314|NCT00924833|3948109|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4122315|NCT00924833|3948106|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4122316|NCT00924833|3948107|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4122317|NCT00924833|3948108|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4122318|NCT00924833|3948109|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4122319|NCT00924833|3948106|B4|||Age||years|Mean|38.5|38.5|Standard Deviation|12.9|12.9|||
4122320|NCT00924833|3948107|B3|||Age||years|Mean|32.7|32.7|Standard Deviation|10.0|10.0|||
4122321|NCT00924833|3948108|B2|||Age||years|Mean|39.22|39.22|Standard Deviation|11.4|11.4|||
4122322|NCT00924833|3948109|B1|||Age||years|Mean|44.1|44.1|Standard Deviation|15.9|15.9|||
4122323|NCT00924833|3948106|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4122324|NCT00924833|3948107|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4122325|NCT00924833|3948108|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4122326|NCT00924833|3948109|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4122327|NCT00924833|3948106|B4||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4122328|NCT00924833|3948107|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4122329|NCT00924833|3948108|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4122330|NCT00924833|3948109|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4122331|NCT00924833|3948106|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4122332|NCT00924833|3948107|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4122333|NCT00924833|3948108|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4122334|NCT00924833|3948109|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4122335|NCT00924807|3948125|B1|||Gleason 7 histology, or PSA 10-20|"Prostate cancers are commonly graded using Gleason score or pattern. Gleason grading is based on a 5-component system, based on 5 histologic patterns.~Cancers with a Gleason score of 7 may be called moderately differentiated or intermediate grade.~Prostate-Specific Antigen (PSA) a protein that is produced by the prostate gland. The higher a man’s PSA level, the more likely it is that he has prostate cancer. Most doctors considered PSA levels of 4.0 ng/mL and lower as normal."|participants|Number|4|4.0||||||
4122336|NCT00924807|3948125|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4122337|NCT00924807|3948125|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4122338|NCT00924807|3948125|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4122339|NCT00924807|3948125|B1|||Age||years|Mean|66.25|66.25|Full Range|||61.0|72.0|
4122340|NCT00924807|3948125|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4122341|NCT00924807|3948125|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4122342|NCT00924807|3948125|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4122343|NCT00924781|3948130|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4122344|NCT00924781|3948131|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4122345|NCT00924781|3948132|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4122346|NCT00924781|3948133|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4122347|NCT00924781|3948134|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4122348|NCT00924781|3948130|B5||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4122349|NCT00924781|3948131|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4122350|NCT00924781|3948132|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4122351|NCT00924781|3948133|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4122352|NCT00924781|3948134|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4122353|NCT00924781|3948130|B5|||Age||years|Mean|51.0|51.0|Standard Deviation|12.30|12.3|||
4122354|NCT00924781|3948131|B4|||Age||years|Mean|60.5|60.5|Standard Deviation|4.51|4.51|||
4122355|NCT00924781|3948132|B3|||Age||years|Mean|58.0|58.0|Standard Deviation|8.91|8.91|||
4122356|NCT00924781|3948133|B2|||Age||years|Mean|51.7|51.7|Standard Deviation|10.22|10.22|||
4122357|NCT00924781|3948134|B1|||Age||years|Mean|46.3|46.3|Standard Deviation|14.29|14.29|||
4122358|NCT00924729|3948167|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4122359|NCT00924729|3948168|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4122360|NCT00924729|3948169|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4122361|NCT00924729|3948167|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4122362|NCT00924729|3948168|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4122363|NCT00924729|3948169|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4122364|NCT00924729|3948167|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4122365|NCT00924729|3948168|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4122366|NCT00924729|3948169|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4122367|NCT00924729|3948167|B3|||Age||years|Mean|71.0|71.0|Standard Deviation|12.0|12.0|||
4122368|NCT00924729|3948168|B2|||Age||years|Mean|68.0|68.0|Standard Deviation|14.0|14.0|||
4122369|NCT00924729|3948169|B1|||Age||years|Mean|74.0|74.0|Standard Deviation|8.90|8.9|||
4122370|NCT00924729|3948167|B3||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
4122371|NCT00924729|3948168|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4122372|NCT00924729|3948169|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4122373|NCT00924729|3948167|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4122374|NCT00924729|3948168|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4122375|NCT00924729|3948169|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4122376|NCT00924729|3948167|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4122377|NCT00924729|3948168|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4122378|NCT00924729|3948169|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4122379|NCT00924651|3948178|B3||Exercising and have been for more than 6 months|Exercise Stages of Change||Participants|Count of Participants|0|0.0||||||
4122380|NCT00924651|3948179|B2||Exercising and have been for more than 6 months|Exercise Stages of Change||Participants|Count of Participants|0|0.0||||||
4122381|NCT00924651|3948180|B1||Exercising and have been for more than 6 months|Exercise Stages of Change||Participants|Count of Participants|0|0.0||||||
4122382|NCT00924651|3948178|B3||Exercising and have been for less than 6 months|Exercise Stages of Change||Participants|Count of Participants|1|1.0||||||
4122383|NCT00924651|3948179|B2||Exercising and have been for less than 6 months|Exercise Stages of Change||Participants|Count of Participants|1|1.0||||||
4122384|NCT00924651|3948180|B1||Exercising and have been for less than 6 months|Exercise Stages of Change||Participants|Count of Participants|0|0.0||||||
4122385|NCT00924651|3948178|B3||Not exercising but intend to in next 30 days|Exercise Stages of Change||Participants|Count of Participants|391|391.0||||||
4122386|NCT00924651|3948179|B2||Not exercising but intend to in next 30 days|Exercise Stages of Change||Participants|Count of Participants|192|192.0||||||
4122387|NCT00924651|3948180|B1||Not exercising but intend to in next 30 days|Exercise Stages of Change||Participants|Count of Participants|199|199.0||||||
4122388|NCT00924651|3948178|B3||Not exercising but do intend to in next 6 months|Exercise Stages of Change||Participants|Count of Participants|172|172.0||||||
4122389|NCT00924651|3948179|B2||Not exercising but do intend to in next 6 months|Exercise Stages of Change||Participants|Count of Participants|83|83.0||||||
4122390|NCT00924651|3948180|B1||Not exercising but do intend to in next 6 months|Exercise Stages of Change||Participants|Count of Participants|89|89.0||||||
4122391|NCT00924651|3948178|B3||Not exercising and don't intend to in next 6 month|Exercise Stages of Change||Participants|Count of Participants|79|79.0||||||
4122392|NCT00924651|3948179|B2||Not exercising and don't intend to in next 6 month|Exercise Stages of Change||Participants|Count of Participants|36|36.0||||||
4122393|NCT00924651|3948180|B1||Not exercising and don't intend to in next 6 month|Exercise Stages of Change||Participants|Count of Participants|43|43.0||||||
4122394|NCT00924651|3948178|B3|||Karnofsky Performance Status (KPS)|Measure Description: The Karnofsky Performance Scale (KPS) Index allows patients to be classified as to their functional impairment. Essentially as used in oncology, the KPS is a measure of time to death. A higher score is favorable. There are 3 general categories which are broken down into 11 specific criteria. Scale range is from 0 (Dead) to 100 (Normal, no complaints, no evidence of disease). The scale increases in units of 10.|Karnofsky Performance Scale|Mean|94.5|94.5|Standard Deviation|7.0|7.0|||
4122440|NCT00924651|3948179|B2||Other|Cancer Type||Participants|Count of Participants|14|14.0||||||
4122441|NCT00924651|3948180|B1||Other|Cancer Type||Participants|Count of Participants|17|17.0||||||
4122395|NCT00924651|3948179|B2|||Karnofsky Performance Status (KPS)|Measure Description: The Karnofsky Performance Scale (KPS) Index allows patients to be classified as to their functional impairment. Essentially as used in oncology, the KPS is a measure of time to death. A higher score is favorable. There are 3 general categories which are broken down into 11 specific criteria. Scale range is from 0 (Dead) to 100 (Normal, no complaints, no evidence of disease). The scale increases in units of 10.|Karnofsky Performance Scale|Mean|94.8|94.8|Standard Deviation|6.8|6.8|||
4122396|NCT00924651|3948180|B1|||Karnofsky Performance Status (KPS)|Measure Description: The Karnofsky Performance Scale (KPS) Index allows patients to be classified as to their functional impairment. Essentially as used in oncology, the KPS is a measure of time to death. A higher score is favorable. There are 3 general categories which are broken down into 11 specific criteria. Scale range is from 0 (Dead) to 100 (Normal, no complaints, no evidence of disease). The scale increases in units of 10.|Karnofsky Performance Scale|Mean|94.2|94.2|Standard Deviation|7.1|7.1|||
4122397|NCT00924651|3948178|B3|||Time since end of first cancer treatment, weeks||weeks|Mean|10.8|10.8|Standard Deviation|55.2|55.2|||
4122398|NCT00924651|3948179|B2|||Time since end of first cancer treatment, weeks||weeks|Mean|6.8|6.8|Standard Deviation|23.7|23.7|||
4122399|NCT00924651|3948180|B1|||Time since end of first cancer treatment, weeks||weeks|Mean|14.5|14.5|Standard Deviation|72.9|72.9|||
4122400|NCT00924651|3948178|B3||No|Previous Treatment - Hormone Therapy||Participants|Count of Participants|622|622.0||||||
4122401|NCT00924651|3948179|B2||No|Previous Treatment - Hormone Therapy||Participants|Count of Participants|304|304.0||||||
4122402|NCT00924651|3948180|B1||No|Previous Treatment - Hormone Therapy||Participants|Count of Participants|318|318.0||||||
4122403|NCT00924651|3948178|B3||Yes|Previous Treatment - Hormone Therapy||Participants|Count of Participants|21|21.0||||||
4122404|NCT00924651|3948179|B2||Yes|Previous Treatment - Hormone Therapy||Participants|Count of Participants|8|8.0||||||
4122405|NCT00924651|3948180|B1||Yes|Previous Treatment - Hormone Therapy||Participants|Count of Participants|13|13.0||||||
4122406|NCT00924651|3948178|B3||No|Previous Treatment - Radiation Therapy||Participants|Count of Participants|629|629.0||||||
4122407|NCT00924651|3948179|B2||No|Previous Treatment - Radiation Therapy||Participants|Count of Participants|306|306.0||||||
4122408|NCT00924651|3948180|B1||No|Previous Treatment - Radiation Therapy||Participants|Count of Participants|323|323.0||||||
4122409|NCT00924651|3948178|B3||Yes|Previous Treatment - Radiation Therapy||Participants|Count of Participants|14|14.0||||||
4122410|NCT00924651|3948179|B2||Yes|Previous Treatment - Radiation Therapy||Participants|Count of Participants|6|6.0||||||
4122411|NCT00924651|3948180|B1||Yes|Previous Treatment - Radiation Therapy||Participants|Count of Participants|8|8.0||||||
4122412|NCT00924651|3948178|B3||No|Previous Treatment - Chemotherapy||Participants|Count of Participants|637|637.0||||||
4122413|NCT00924651|3948179|B2||No|Previous Treatment - Chemotherapy||Participants|Count of Participants|308|308.0||||||
4122414|NCT00924651|3948180|B1||No|Previous Treatment - Chemotherapy||Participants|Count of Participants|329|329.0||||||
4122415|NCT00924651|3948178|B3||Yes|Previous Treatment - Chemotherapy||Participants|Count of Participants|6|6.0||||||
4122416|NCT00924651|3948179|B2||Yes|Previous Treatment - Chemotherapy||Participants|Count of Participants|4|4.0||||||
4122417|NCT00924651|3948180|B1||Yes|Previous Treatment - Chemotherapy||Participants|Count of Participants|2|2.0||||||
4122418|NCT00924651|3948178|B3||No|Previous Treatment - Surgery||Participants|Count of Participants|72|72.0||||||
4122419|NCT00924651|3948179|B2||No|Previous Treatment - Surgery||Participants|Count of Participants|37|37.0||||||
4122420|NCT00924651|3948180|B1||No|Previous Treatment - Surgery||Participants|Count of Participants|35|35.0||||||
4122421|NCT00924651|3948178|B3||Yes|Previous Treatment - Surgery||Participants|Count of Participants|571|571.0||||||
4122422|NCT00924651|3948179|B2||Yes|Previous Treatment - Surgery||Participants|Count of Participants|275|275.0||||||
4122423|NCT00924651|3948180|B1||Yes|Previous Treatment - Surgery||Participants|Count of Participants|296|296.0||||||
4122424|NCT00924651|3948178|B3||Unknown|Cancer Stage|"Stage I.This stage is usually a small cancer or tumor that has not grown deeply into nearby tissues. It also has not spread to the lymph nodes or other parts of the body.~Stage II and III.These stages indicate larger cancers or tumors that have grown more deeply into nearby tissue. They may have also spread to lymph nodes but not other parts of the body.~Stage IV.This stage means that the cancer has spread to other organs or parts of the body. It may also be called metastatic cancer.~Unknown Stage. There is not enough information to determine stage.~Stage I is best, Stage IV is worst."|Participants|Count of Participants|18|18.0||||||
4122425|NCT00924651|3948179|B2||Unknown|Cancer Stage|"Stage I.This stage is usually a small cancer or tumor that has not grown deeply into nearby tissues. It also has not spread to the lymph nodes or other parts of the body.~Stage II and III.These stages indicate larger cancers or tumors that have grown more deeply into nearby tissue. They may have also spread to lymph nodes but not other parts of the body.~Stage IV.This stage means that the cancer has spread to other organs or parts of the body. It may also be called metastatic cancer.~Unknown Stage. There is not enough information to determine stage.~Stage I is best, Stage IV is worst."|Participants|Count of Participants|7|7.0||||||
4122426|NCT00924651|3948180|B1||Unknown|Cancer Stage|"Stage I.This stage is usually a small cancer or tumor that has not grown deeply into nearby tissues. It also has not spread to the lymph nodes or other parts of the body.~Stage II and III.These stages indicate larger cancers or tumors that have grown more deeply into nearby tissue. They may have also spread to lymph nodes but not other parts of the body.~Stage IV.This stage means that the cancer has spread to other organs or parts of the body. It may also be called metastatic cancer.~Unknown Stage. There is not enough information to determine stage.~Stage I is best, Stage IV is worst."|Participants|Count of Participants|11|11.0||||||
4122427|NCT00924651|3948178|B3||Stage IV|Cancer Stage|"Stage I.This stage is usually a small cancer or tumor that has not grown deeply into nearby tissues. It also has not spread to the lymph nodes or other parts of the body.~Stage II and III.These stages indicate larger cancers or tumors that have grown more deeply into nearby tissue. They may have also spread to lymph nodes but not other parts of the body.~Stage IV.This stage means that the cancer has spread to other organs or parts of the body. It may also be called metastatic cancer.~Unknown Stage. There is not enough information to determine stage.~Stage I is best, Stage IV is worst."|Participants|Count of Participants|11|11.0||||||
4122428|NCT00924651|3948179|B2||Stage IV|Cancer Stage|"Stage I.This stage is usually a small cancer or tumor that has not grown deeply into nearby tissues. It also has not spread to the lymph nodes or other parts of the body.~Stage II and III.These stages indicate larger cancers or tumors that have grown more deeply into nearby tissue. They may have also spread to lymph nodes but not other parts of the body.~Stage IV.This stage means that the cancer has spread to other organs or parts of the body. It may also be called metastatic cancer.~Unknown Stage. There is not enough information to determine stage.~Stage I is best, Stage IV is worst."|Participants|Count of Participants|5|5.0||||||
4122429|NCT00924651|3948180|B1||Stage IV|Cancer Stage|"Stage I.This stage is usually a small cancer or tumor that has not grown deeply into nearby tissues. It also has not spread to the lymph nodes or other parts of the body.~Stage II and III.These stages indicate larger cancers or tumors that have grown more deeply into nearby tissue. They may have also spread to lymph nodes but not other parts of the body.~Stage IV.This stage means that the cancer has spread to other organs or parts of the body. It may also be called metastatic cancer.~Unknown Stage. There is not enough information to determine stage.~Stage I is best, Stage IV is worst."|Participants|Count of Participants|6|6.0||||||
4122430|NCT00924651|3948178|B3||Stage III|Cancer Stage|"Stage I.This stage is usually a small cancer or tumor that has not grown deeply into nearby tissues. It also has not spread to the lymph nodes or other parts of the body.~Stage II and III.These stages indicate larger cancers or tumors that have grown more deeply into nearby tissue. They may have also spread to lymph nodes but not other parts of the body.~Stage IV.This stage means that the cancer has spread to other organs or parts of the body. It may also be called metastatic cancer.~Unknown Stage. There is not enough information to determine stage.~Stage I is best, Stage IV is worst."|Participants|Count of Participants|161|161.0||||||
4122431|NCT00924651|3948179|B2||Stage III|Cancer Stage|"Stage I.This stage is usually a small cancer or tumor that has not grown deeply into nearby tissues. It also has not spread to the lymph nodes or other parts of the body.~Stage II and III.These stages indicate larger cancers or tumors that have grown more deeply into nearby tissue. They may have also spread to lymph nodes but not other parts of the body.~Stage IV.This stage means that the cancer has spread to other organs or parts of the body. It may also be called metastatic cancer.~Unknown Stage. There is not enough information to determine stage.~Stage I is best, Stage IV is worst."|Participants|Count of Participants|77|77.0||||||
4122432|NCT00924651|3948180|B1||Stage III|Cancer Stage|"Stage I.This stage is usually a small cancer or tumor that has not grown deeply into nearby tissues. It also has not spread to the lymph nodes or other parts of the body.~Stage II and III.These stages indicate larger cancers or tumors that have grown more deeply into nearby tissue. They may have also spread to lymph nodes but not other parts of the body.~Stage IV.This stage means that the cancer has spread to other organs or parts of the body. It may also be called metastatic cancer.~Unknown Stage. There is not enough information to determine stage.~Stage I is best, Stage IV is worst."|Participants|Count of Participants|84|84.0||||||
4122433|NCT00924651|3948178|B3||Stage II|Cancer Stage|"Stage I.This stage is usually a small cancer or tumor that has not grown deeply into nearby tissues. It also has not spread to the lymph nodes or other parts of the body.~Stage II and III.These stages indicate larger cancers or tumors that have grown more deeply into nearby tissue. They may have also spread to lymph nodes but not other parts of the body.~Stage IV.This stage means that the cancer has spread to other organs or parts of the body. It may also be called metastatic cancer.~Unknown Stage. There is not enough information to determine stage.~Stage I is best, Stage IV is worst."|Participants|Count of Participants|289|289.0||||||
4122434|NCT00924651|3948179|B2||Stage II|Cancer Stage|"Stage I.This stage is usually a small cancer or tumor that has not grown deeply into nearby tissues. It also has not spread to the lymph nodes or other parts of the body.~Stage II and III.These stages indicate larger cancers or tumors that have grown more deeply into nearby tissue. They may have also spread to lymph nodes but not other parts of the body.~Stage IV.This stage means that the cancer has spread to other organs or parts of the body. It may also be called metastatic cancer.~Unknown Stage. There is not enough information to determine stage.~Stage I is best, Stage IV is worst."|Participants|Count of Participants|139|139.0||||||
4122435|NCT00924651|3948180|B1||Stage II|Cancer Stage|"Stage I.This stage is usually a small cancer or tumor that has not grown deeply into nearby tissues. It also has not spread to the lymph nodes or other parts of the body.~Stage II and III.These stages indicate larger cancers or tumors that have grown more deeply into nearby tissue. They may have also spread to lymph nodes but not other parts of the body.~Stage IV.This stage means that the cancer has spread to other organs or parts of the body. It may also be called metastatic cancer.~Unknown Stage. There is not enough information to determine stage.~Stage I is best, Stage IV is worst."|Participants|Count of Participants|150|150.0||||||
4122436|NCT00924651|3948178|B3||Stage I|Cancer Stage|"Stage I.This stage is usually a small cancer or tumor that has not grown deeply into nearby tissues. It also has not spread to the lymph nodes or other parts of the body.~Stage II and III.These stages indicate larger cancers or tumors that have grown more deeply into nearby tissue. They may have also spread to lymph nodes but not other parts of the body.~Stage IV.This stage means that the cancer has spread to other organs or parts of the body. It may also be called metastatic cancer.~Unknown Stage. There is not enough information to determine stage.~Stage I is best, Stage IV is worst."|Participants|Count of Participants|164|164.0||||||
4122437|NCT00924651|3948179|B2||Stage I|Cancer Stage|"Stage I.This stage is usually a small cancer or tumor that has not grown deeply into nearby tissues. It also has not spread to the lymph nodes or other parts of the body.~Stage II and III.These stages indicate larger cancers or tumors that have grown more deeply into nearby tissue. They may have also spread to lymph nodes but not other parts of the body.~Stage IV.This stage means that the cancer has spread to other organs or parts of the body. It may also be called metastatic cancer.~Unknown Stage. There is not enough information to determine stage.~Stage I is best, Stage IV is worst."|Participants|Count of Participants|84|84.0||||||
4122438|NCT00924651|3948180|B1||Stage I|Cancer Stage|"Stage I.This stage is usually a small cancer or tumor that has not grown deeply into nearby tissues. It also has not spread to the lymph nodes or other parts of the body.~Stage II and III.These stages indicate larger cancers or tumors that have grown more deeply into nearby tissue. They may have also spread to lymph nodes but not other parts of the body.~Stage IV.This stage means that the cancer has spread to other organs or parts of the body. It may also be called metastatic cancer.~Unknown Stage. There is not enough information to determine stage.~Stage I is best, Stage IV is worst."|Participants|Count of Participants|80|80.0||||||
4122439|NCT00924651|3948178|B3||Other|Cancer Type||Participants|Count of Participants|31|31.0||||||
4122442|NCT00924651|3948178|B3||Lung|Cancer Type||Participants|Count of Participants|15|15.0||||||
4122443|NCT00924651|3948179|B2||Lung|Cancer Type||Participants|Count of Participants|9|9.0||||||
4122444|NCT00924651|3948180|B1||Lung|Cancer Type||Participants|Count of Participants|6|6.0||||||
4122445|NCT00924651|3948178|B3||Colon|Cancer Type||Participants|Count of Participants|35|35.0||||||
4122446|NCT00924651|3948179|B2||Colon|Cancer Type||Participants|Count of Participants|15|15.0||||||
4122447|NCT00924651|3948180|B1||Colon|Cancer Type||Participants|Count of Participants|20|20.0||||||
4122448|NCT00924651|3948178|B3||Lymphoma|Cancer Type||Participants|Count of Participants|24|24.0||||||
4122449|NCT00924651|3948179|B2||Lymphoma|Cancer Type||Participants|Count of Participants|7|7.0||||||
4122450|NCT00924651|3948180|B1||Lymphoma|Cancer Type||Participants|Count of Participants|17|17.0||||||
4122451|NCT00924651|3948178|B3||Breast|Cancer Type||Participants|Count of Participants|538|538.0||||||
4122452|NCT00924651|3948179|B2||Breast|Cancer Type||Participants|Count of Participants|267|267.0||||||
4122453|NCT00924651|3948180|B1||Breast|Cancer Type||Participants|Count of Participants|271|271.0||||||
4122454|NCT00924651|3948178|B3||Unknown|Education||Participants|Count of Participants|2|2.0||||||
4122455|NCT00924651|3948179|B2||Unknown|Education||Participants|Count of Participants|1|1.0||||||
4122456|NCT00924651|3948180|B1||Unknown|Education||Participants|Count of Participants|1|1.0||||||
4122457|NCT00924651|3948178|B3||No high school or GED degree|Education||Participants|Count of Participants|24|24.0||||||
4122458|NCT00924651|3948179|B2||No high school or GED degree|Education||Participants|Count of Participants|14|14.0||||||
4122459|NCT00924651|3948180|B1||No high school or GED degree|Education||Participants|Count of Participants|10|10.0||||||
4122460|NCT00924651|3948178|B3||High school / GED degree|Education||Participants|Count of Participants|174|174.0||||||
4122461|NCT00924651|3948179|B2||High school / GED degree|Education||Participants|Count of Participants|86|86.0||||||
4122462|NCT00924651|3948180|B1||High school / GED degree|Education||Participants|Count of Participants|88|88.0||||||
4122463|NCT00924651|3948178|B3||2 or 4 degree or Some college|Education||Participants|Count of Participants|330|330.0||||||
4122464|NCT00924651|3948179|B2||2 or 4 degree or Some college|Education||Participants|Count of Participants|165|165.0||||||
4122465|NCT00924651|3948180|B1||2 or 4 degree or Some college|Education||Participants|Count of Participants|165|165.0||||||
4122466|NCT00924651|3948178|B3||Graduate degree|Education||Participants|Count of Participants|113|113.0||||||
4122467|NCT00924651|3948179|B2||Graduate degree|Education||Participants|Count of Participants|46|46.0||||||
4122468|NCT00924651|3948180|B1||Graduate degree|Education||Participants|Count of Participants|67|67.0||||||
4122469|NCT00924651|3948178|B3||Widowed|Marital Status||Participants|Count of Participants|49|49.0||||||
4122470|NCT00924651|3948179|B2||Widowed|Marital Status||Participants|Count of Participants|22|22.0||||||
4122471|NCT00924651|3948180|B1||Widowed|Marital Status||Participants|Count of Participants|27|27.0||||||
4122472|NCT00924651|3948178|B3||Single|Marital Status||Participants|Count of Participants|80|80.0||||||
4122473|NCT00924651|3948179|B2||Single|Marital Status||Participants|Count of Participants|36|36.0||||||
4122474|NCT00924651|3948180|B1||Single|Marital Status||Participants|Count of Participants|44|44.0||||||
4122475|NCT00924651|3948178|B3||Divorced or separated|Marital Status||Participants|Count of Participants|64|64.0||||||
4122476|NCT00924651|3948179|B2||Divorced or separated|Marital Status||Participants|Count of Participants|40|40.0||||||
4122477|NCT00924651|3948180|B1||Divorced or separated|Marital Status||Participants|Count of Participants|24|24.0||||||
4122478|NCT00924651|3948178|B3||Married or long-term committed relationship|Marital Status||Participants|Count of Participants|450|450.0||||||
4122479|NCT00924651|3948179|B2||Married or long-term committed relationship|Marital Status||Participants|Count of Participants|214|214.0||||||
4122480|NCT00924651|3948180|B1||Married or long-term committed relationship|Marital Status||Participants|Count of Participants|236|236.0||||||
4122481|NCT00924651|3948178|B3||Unemployed|Currently Employed||Participants|Count of Participants|193|193.0||||||
4122482|NCT00924651|3948179|B2||Unemployed|Currently Employed||Participants|Count of Participants|89|89.0||||||
4122483|NCT00924651|3948180|B1||Unemployed|Currently Employed||Participants|Count of Participants|104|104.0||||||
4122484|NCT00924651|3948178|B3||Home-Maker with >= 1 dependents|Currently Employed||Participants|Count of Participants|55|55.0||||||
4122485|NCT00924651|3948179|B2||Home-Maker with >= 1 dependents|Currently Employed||Participants|Count of Participants|23|23.0||||||
4122486|NCT00924651|3948180|B1||Home-Maker with >= 1 dependents|Currently Employed||Participants|Count of Participants|32|32.0||||||
4122487|NCT00924651|3948178|B3||Self-Employed|Currently Employed||Participants|Count of Participants|27|27.0||||||
4122488|NCT00924651|3948179|B2||Self-Employed|Currently Employed||Participants|Count of Participants|16|16.0||||||
4122489|NCT00924651|3948180|B1||Self-Employed|Currently Employed||Participants|Count of Participants|11|11.0||||||
4122490|NCT00924651|3948178|B3||Employed outside the house|Currently Employed||Participants|Count of Participants|368|368.0||||||
4122491|NCT00924651|3948179|B2||Employed outside the house|Currently Employed||Participants|Count of Participants|184|184.0||||||
4122492|NCT00924651|3948180|B1||Employed outside the house|Currently Employed||Participants|Count of Participants|184|184.0||||||
4122493|NCT00924651|3948178|B3|||Body Mass Index (BMI)|"Measure Description: Body Mass Index (BMI) is a person's weight in kilograms divided by the square of height in meters. Values below 18.5 represent Underweight, 18.5 to 24.9 represent Normal or Healthy Weight, 25.0 to 29.9 represent Overweight and 30.0 and above represent Obese."|kg / m^2|Mean|30.1|30.1|Standard Deviation|6.5|6.5|||
4122494|NCT00924651|3948179|B2|||Body Mass Index (BMI)|"Measure Description: Body Mass Index (BMI) is a person's weight in kilograms divided by the square of height in meters. Values below 18.5 represent Underweight, 18.5 to 24.9 represent Normal or Healthy Weight, 25.0 to 29.9 represent Overweight and 30.0 and above represent Obese."|kg / m^2|Mean|30.2|30.2|Standard Deviation|6.4|6.4|||
4122495|NCT00924651|3948180|B1|||Body Mass Index (BMI)|"Measure Description: Body Mass Index (BMI) is a person's weight in kilograms divided by the square of height in meters. Values below 18.5 represent Underweight, 18.5 to 24.9 represent Normal or Healthy Weight, 25.0 to 29.9 represent Overweight and 30.0 and above represent Obese."|kg / m^2|Mean|30.1|30.1|Standard Deviation|6.7|6.7|||
4122496|NCT00924651|3948178|B3|Race/Ethnicity, Customized|Other|Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
4122497|NCT00924651|3948179|B2|Race/Ethnicity, Customized|Other|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4122498|NCT00924651|3948180|B1|Race/Ethnicity, Customized|Other|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
4122499|NCT00924651|3948178|B3|Race/Ethnicity, Customized|Black|Race/Ethnicity, Customized||Participants|Count of Participants|60|60.0||||||
4122500|NCT00924651|3948179|B2|Race/Ethnicity, Customized|Black|Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
4122501|NCT00924651|3948180|B1|Race/Ethnicity, Customized|Black|Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
4122502|NCT00924651|3948178|B3|Race/Ethnicity, Customized|White|Race/Ethnicity, Customized||Participants|Count of Participants|550|550.0||||||
4122503|NCT00924651|3948179|B2|Race/Ethnicity, Customized|White|Race/Ethnicity, Customized||Participants|Count of Participants|265|265.0||||||
4122504|NCT00924651|3948180|B1|Race/Ethnicity, Customized|White|Race/Ethnicity, Customized||Participants|Count of Participants|285|285.0||||||
4122505|NCT00924651|3948178|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4122506|NCT00924651|3948179|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4122507|NCT00924651|3948180|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4122508|NCT00924651|3948178|B3||Female|Sex: Female, Male||Participants|Count of Participants|604|604.0||||||
4122509|NCT00924651|3948179|B2||Female|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
4122510|NCT00924651|3948180|B1||Female|Sex: Female, Male||Participants|Count of Participants|306|306.0||||||
4122511|NCT00924651|3948178|B3|||Age||years|Mean|56.8|56.8|Standard Deviation|11.1|11.1|||
4122512|NCT00924651|3948179|B2|||Age||years|Mean|56.4|56.4|Standard Deviation|10.1|10.1|||
4122513|NCT00924651|3948180|B1|||Age||years|Mean|57.1|57.1|Standard Deviation|11.9|11.9|||
4122514|NCT00924638|3948187|B3|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
4122515|NCT00924638|3948188|B2|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
4122516|NCT00924638|3948189|B1|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
4122517|NCT00924638|3948187|B3|Netherlands||Region of Enrollment||participants|Number|23|23.0||||||
4122518|NCT00924638|3948188|B2|Netherlands||Region of Enrollment||participants|Number|11|11.0||||||
4122519|NCT00924638|3948189|B1|Netherlands||Region of Enrollment||participants|Number|12|12.0||||||
4122520|NCT00924638|3948187|B3|Germany||Region of Enrollment||participants|Number|71|71.0||||||
4122521|NCT00924638|3948188|B2|Germany||Region of Enrollment||participants|Number|32|32.0||||||
4122522|NCT00924638|3948189|B1|Germany||Region of Enrollment||participants|Number|39|39.0||||||
4122523|NCT00924638|3948187|B3|Denmark||Region of Enrollment||participants|Number|6|6.0||||||
4122524|NCT00924638|3948188|B2|Denmark||Region of Enrollment||participants|Number|3|3.0||||||
4122525|NCT00924638|3948189|B1|Denmark||Region of Enrollment||participants|Number|3|3.0||||||
4122526|NCT00924638|3948187|B3|Belgium||Region of Enrollment||participants|Number|41|41.0||||||
4122527|NCT00924638|3948188|B2|Belgium||Region of Enrollment||participants|Number|27|27.0||||||
4122528|NCT00924638|3948189|B1|Belgium||Region of Enrollment||participants|Number|14|14.0||||||
4122529|NCT00924638|3948187|B3|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4122530|NCT00924638|3948188|B2|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4122531|NCT00924638|3948189|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4122532|NCT00924638|3948187|B3|France||Region of Enrollment||participants|Number|34|34.0||||||
4122533|NCT00924638|3948188|B2|France||Region of Enrollment||participants|Number|17|17.0||||||
4122534|NCT00924638|3948189|B1|France||Region of Enrollment||participants|Number|17|17.0||||||
4122535|NCT00924638|3948187|B3|Italy||Region of Enrollment||participants|Number|59|59.0||||||
4122536|NCT00924638|3948188|B2|Italy||Region of Enrollment||participants|Number|31|31.0||||||
4122537|NCT00924638|3948189|B1|Italy||Region of Enrollment||participants|Number|28|28.0||||||
4122538|NCT00924638|3948187|B3|Austria||Region of Enrollment||participants|Number|39|39.0||||||
4122539|NCT00924638|3948188|B2|Austria||Region of Enrollment||participants|Number|16|16.0||||||
4122540|NCT00924638|3948189|B1|Austria||Region of Enrollment||participants|Number|23|23.0||||||
4122541|NCT00924638|3948187|B3|Spain||Region of Enrollment||participants|Number|5|5.0||||||
4122542|NCT00924638|3948188|B2|Spain||Region of Enrollment||participants|Number|5|5.0||||||
4122543|NCT00924638|3948189|B1|Spain||Region of Enrollment||participants|Number|0|0.0||||||
4122544|NCT00924638|3948187|B3|Finland||Region of Enrollment||participants|Number|2|2.0||||||
4122545|NCT00924638|3948188|B2|Finland||Region of Enrollment||participants|Number|2|2.0||||||
4122546|NCT00924638|3948189|B1|Finland||Region of Enrollment||participants|Number|0|0.0||||||
4122547|NCT00924638|3948187|B3|Greece||Region of Enrollment||participants|Number|1|1.0||||||
4122548|NCT00924638|3948188|B2|Greece||Region of Enrollment||participants|Number|0|0.0||||||
4122549|NCT00924638|3948189|B1|Greece||Region of Enrollment||participants|Number|1|1.0||||||
4122550|NCT00924638|3948187|B3|Slovakia||Region of Enrollment||participants|Number|4|4.0||||||
4122551|NCT00924638|3948188|B2|Slovakia||Region of Enrollment||participants|Number|3|3.0||||||
4122552|NCT00924638|3948189|B1|Slovakia||Region of Enrollment||participants|Number|1|1.0||||||
4122553|NCT00924638|3948187|B3|United States||Region of Enrollment||participants|Number|146|146.0||||||
4122554|NCT00924638|3948188|B2|United States||Region of Enrollment||participants|Number|66|66.0||||||
4122555|NCT00924638|3948189|B1|United States||Region of Enrollment||participants|Number|80|80.0||||||
4122556|NCT00924638|3948187|B3||Male|Sex: Female, Male||Participants|Count of Participants|280|280.0||||||
4122557|NCT00924638|3948188|B2||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4122558|NCT00924638|3948189|B1||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4122559|NCT00924638|3948187|B3||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4122560|NCT00924638|3948188|B2||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4122561|NCT00924638|3948189|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4122562|NCT00924638|3948187|B3|||Age||years|Mean|61.5|61.5|Standard Deviation|11.3|11.3|||
4122563|NCT00924638|3948188|B2|||Age||years|Mean|61.4|61.4|Standard Deviation|11.3|11.3|||
4122564|NCT00924638|3948189|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|11.4|11.4|||
4122565|NCT00924560|3948209|B4|Other||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4122566|NCT00924560|3948210|B3|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4122567|NCT00924560|3948211|B2|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4122568|NCT00924560|3948212|B1|Other||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4122569|NCT00924560|3948209|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|292|292.0||||||
4122570|NCT00924560|3948210|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|111|111.0||||||
4122571|NCT00924560|3948211|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
4122572|NCT00924560|3948212|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|102|102.0||||||
4122573|NCT00924560|3948209|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|771|771.0||||||
4122574|NCT00924560|3948210|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|255|255.0||||||
4122575|NCT00924560|3948211|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|265|265.0||||||
4122576|NCT00924560|3948212|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|251|251.0||||||
4122577|NCT00924560|3948209|B4|Asian||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4122578|NCT00924560|3948210|B3|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4122579|NCT00924560|3948211|B2|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4122580|NCT00924560|3948212|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4122581|NCT00924560|3948209|B4|African-American||Race/Ethnicity, Customized||participants|Number|246|246.0||||||
4122582|NCT00924560|3948210|B3|African-American||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
4122583|NCT00924560|3948211|B2|African-American||Race/Ethnicity, Customized||participants|Number|87|87.0||||||
4122584|NCT00924560|3948212|B1|African-American||Race/Ethnicity, Customized||participants|Number|87|87.0||||||
4122585|NCT00924560|3948209|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4122586|NCT00924560|3948210|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4122587|NCT00924560|3948211|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4122588|NCT00924560|3948212|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4122589|NCT00924560|3948209|B4||Female|Sex: Female, Male||Participants|Count of Participants|1361|1361.0||||||
4122590|NCT00924560|3948210|B3||Female|Sex: Female, Male||Participants|Count of Participants|455|455.0||||||
4122591|NCT00924560|3948211|B2||Female|Sex: Female, Male||Participants|Count of Participants|448|448.0||||||
4122592|NCT00924560|3948212|B1||Female|Sex: Female, Male||Participants|Count of Participants|458|458.0||||||
4122593|NCT00924560|3948209|B4|||Age||years|Mean|15.6|15.6|Standard Deviation|1.77|1.77|||
4122594|NCT00924560|3948210|B3|||Age||years|Mean|14.8|14.8|Standard Deviation|1.72|1.72|||
4122595|NCT00924560|3948211|B2|||Age||years|Mean|15.9|15.9|Standard Deviation|1.71|1.71|||
4122596|NCT00924560|3948212|B1|||Age||years|Mean|16.0|16.0|Standard Deviation|1.61|1.61|||
4122597|NCT00924508|3948258|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4122598|NCT00924508|3948258|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4122599|NCT00924508|3948258|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4122600|NCT00924508|3948258|B1|||Age||years|Mean|45.6|45.6|Standard Deviation|19.2|19.2|||
4122601|NCT00924482|3948265|B1|||Ejection Fraction||percent|Mean|56|56.0|Standard Deviation|12|12.0|||
4122602|NCT00924482|3948265|B1|||Body Surface Area||meters^2|Mean|2.1|2.1|Standard Deviation|0.2|0.2|||
4122603|NCT00924482|3948265|B1|||Height||cm|Mean|175|175.0|Standard Deviation|8|8.0|||
4122604|NCT00924482|3948265|B1|||Weight||kg|Mean|91|91.0|Standard Deviation|19|19.0|||
4122605|NCT00924482|3948265|B1|United States||Region of Enrollment||participants|Number|101|101.0||||||
4122606|NCT00924482|3948265|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4122607|NCT00924482|3948265|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4122608|NCT00924482|3948265|B1|||Age||years|Mean|64|64.0|Standard Deviation|9|9.0|||
4122609|NCT00924469|3948270|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4122610|NCT00924469|3948271|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4122611|NCT00924469|3948272|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4122612|NCT00924469|3948270|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4122613|NCT00924469|3948271|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4122614|NCT00924469|3948272|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4122615|NCT00924469|3948270|B3|||Age||years|Mean|59.0|59.0|Standard Deviation|6.35|6.35|||
4122616|NCT00924469|3948271|B2|||Age||years|Mean|56.9|56.9|Standard Deviation|5.30|5.3|||
4122617|NCT00924469|3948272|B1|||Age||years|Mean|61.0|61.0|Standard Deviation|6.67|6.67|||
4122618|NCT00924443|3948295|B1|Missing||Karnofsky Performance Status|"Karnofsky performance scale is used by doctors to classify patient's functional impairment level. The lower the number the higher the impairment in typical daily activities by the disease.~Typical classification examples: 100% normal with no evidence of disease, 90% able to carry on normal activity with minor signs of illness, 80% normal activity but requiring effort, 70% able to care for self but unable to work or carry on other normal activities, 60% able to care for most needs but requires occasional assistance, 50% considerable assistance and frequent medical care required, etc.."|participants|Number|3|3.0||||||
4122619|NCT00924443|3948295|B1|20%||Karnofsky Performance Status|"Karnofsky performance scale is used by doctors to classify patient's functional impairment level. The lower the number the higher the impairment in typical daily activities by the disease.~Typical classification examples: 100% normal with no evidence of disease, 90% able to carry on normal activity with minor signs of illness, 80% normal activity but requiring effort, 70% able to care for self but unable to work or carry on other normal activities, 60% able to care for most needs but requires occasional assistance, 50% considerable assistance and frequent medical care required, etc.."|participants|Number|2|2.0||||||
4122620|NCT00924443|3948295|B1|50%||Karnofsky Performance Status|"Karnofsky performance scale is used by doctors to classify patient's functional impairment level. The lower the number the higher the impairment in typical daily activities by the disease.~Typical classification examples: 100% normal with no evidence of disease, 90% able to carry on normal activity with minor signs of illness, 80% normal activity but requiring effort, 70% able to care for self but unable to work or carry on other normal activities, 60% able to care for most needs but requires occasional assistance, 50% considerable assistance and frequent medical care required, etc.."|participants|Number|5|5.0||||||
4122621|NCT00924443|3948295|B1|60%||Karnofsky Performance Status|"Karnofsky performance scale is used by doctors to classify patient's functional impairment level. The lower the number the higher the impairment in typical daily activities by the disease.~Typical classification examples: 100% normal with no evidence of disease, 90% able to carry on normal activity with minor signs of illness, 80% normal activity but requiring effort, 70% able to care for self but unable to work or carry on other normal activities, 60% able to care for most needs but requires occasional assistance, 50% considerable assistance and frequent medical care required, etc.."|participants|Number|2|2.0||||||
4122622|NCT00924443|3948295|B1|70%||Karnofsky Performance Status|"Karnofsky performance scale is used by doctors to classify patient's functional impairment level. The lower the number the higher the impairment in typical daily activities by the disease.~Typical classification examples: 100% normal with no evidence of disease, 90% able to carry on normal activity with minor signs of illness, 80% normal activity but requiring effort, 70% able to care for self but unable to work or carry on other normal activities, 60% able to care for most needs but requires occasional assistance, 50% considerable assistance and frequent medical care required, etc.."|participants|Number|9|9.0||||||
4122623|NCT00924443|3948295|B1|80%||Karnofsky Performance Status|"Karnofsky performance scale is used by doctors to classify patient's functional impairment level. The lower the number the higher the impairment in typical daily activities by the disease.~Typical classification examples: 100% normal with no evidence of disease, 90% able to carry on normal activity with minor signs of illness, 80% normal activity but requiring effort, 70% able to care for self but unable to work or carry on other normal activities, 60% able to care for most needs but requires occasional assistance, 50% considerable assistance and frequent medical care required, etc.."|participants|Number|24|24.0||||||
4122624|NCT00924443|3948295|B1|90%||Karnofsky Performance Status|"Karnofsky performance scale is used by doctors to classify patient's functional impairment level. The lower the number the higher the impairment in typical daily activities by the disease.~Typical classification examples: 100% normal with no evidence of disease, 90% able to carry on normal activity with minor signs of illness, 80% normal activity but requiring effort, 70% able to care for self but unable to work or carry on other normal activities, 60% able to care for most needs but requires occasional assistance, 50% considerable assistance and frequent medical care required, etc.."|participants|Number|13|13.0||||||
4122625|NCT00924443|3948295|B1|100%||Karnofsky Performance Status|"Karnofsky performance scale is used by doctors to classify patient's functional impairment level. The lower the number the higher the impairment in typical daily activities by the disease.~Typical classification examples: 100% normal with no evidence of disease, 90% able to carry on normal activity with minor signs of illness, 80% normal activity but requiring effort, 70% able to care for self but unable to work or carry on other normal activities, 60% able to care for most needs but requires occasional assistance, 50% considerable assistance and frequent medical care required, etc.."|participants|Number|8|8.0||||||
4122626|NCT00924443|3948295|B1|>1||Number of Co-morbidities||participants|Number|26|26.0||||||
4122627|NCT00924443|3948295|B1|1||Number of Co-morbidities||participants|Number|23|23.0||||||
4122628|NCT00924443|3948295|B1|0||Number of Co-morbidities||participants|Number|17|17.0||||||
4122629|NCT00924443|3948295|B1|>50||Glomerular Filtration Rate (mL/min/1.73m^2)||participants|Number|51|51.0||||||
4122630|NCT00924443|3948295|B1|<=50||Glomerular Filtration Rate (mL/min/1.73m^2)||participants|Number|15|15.0||||||
4122631|NCT00924443|3948295|B1|>=100||White Blood Cell Count (10^9/L)||participants|Number|3|3.0||||||
4122632|NCT00924443|3948295|B1|25-99.9||White Blood Cell Count (10^9/L)||participants|Number|6|6.0||||||
4122633|NCT00924443|3948295|B1|<25||White Blood Cell Count (10^9/L)||participants|Number|57|57.0||||||
4122634|NCT00924443|3948295|B1|Missing/Unknown||Type of Acute Myeloid Leukemia (AML)||participants|Number|2|2.0||||||
4122635|NCT00924443|3948295|B1|Secondary||Type of Acute Myeloid Leukemia (AML)||participants|Number|16|16.0||||||
4122636|NCT00924443|3948295|B1|De Novo||Type of Acute Myeloid Leukemia (AML)||participants|Number|48|48.0||||||
4122637|NCT00924443|3948295|B1|Missing/Unknown||Cytogenetics (2001)|Diagnostic criteria of Grimwade for older patients|participants|Number|4|4.0||||||
4122638|NCT00924443|3948295|B1|Adverse||Cytogenetics (2001)|Diagnostic criteria of Grimwade for older patients|participants|Number|14|14.0||||||
4122639|NCT00924443|3948295|B1|Intermediate||Cytogenetics (2001)|Diagnostic criteria of Grimwade for older patients|participants|Number|48|48.0||||||
4122640|NCT00924443|3948295|B1|Favourable||Cytogenetics (2001)|Diagnostic criteria of Grimwade for older patients|participants|Number|0|0.0||||||
4122641|NCT00924443|3948295|B1|Missing/Unknown||Cytogenetics (1998)|Diagnostic criteria of Grimwade for younger patients|participants|Number|4|4.0||||||
4122642|NCT00924443|3948295|B1|Adverse||Cytogenetics (1998)|Diagnostic criteria of Grimwade for younger patients|participants|Number|19|19.0||||||
4122643|NCT00924443|3948295|B1|Intermediate||Cytogenetics (1998)|Diagnostic criteria of Grimwade for younger patients|participants|Number|43|43.0||||||
4122644|NCT00924443|3948295|B1|Favourable||Cytogenetics (1998)|Diagnostic criteria of Grimwade for younger patients|participants|Number|0|0.0||||||
4122645|NCT00924443|3948295|B1|United Kingdom||Region of Enrollment||participants|Number|55|55.0||||||
4122646|NCT00924443|3948295|B1|Italy||Region of Enrollment||participants|Number|8|8.0||||||
4122647|NCT00924443|3948295|B1|Ireland||Region of Enrollment||participants|Number|3|3.0||||||
4122648|NCT00924443|3948295|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4122649|NCT00924443|3948295|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4122650|NCT00924443|3948295|B1||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4122651|NCT00924443|3948295|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4122652|NCT00924443|3948295|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4122653|NCT00924443|3948295|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4122654|NCT00924443|3948295|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4122655|NCT00924443|3948295|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4122656|NCT00924443|3948295|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4122657|NCT00924443|3948295|B1|||Age||years|Mean|71.5|71.5|Standard Deviation|4.65|4.65|||
4122658|NCT00924404|3948303|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4122659|NCT00924404|3948304|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4122660|NCT00924404|3948305|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4122661|NCT00924404|3948303|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4122662|NCT00924404|3948304|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4122663|NCT00924404|3948305|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4122664|NCT00924404|3948303|B3|||Age||years|Mean|54|54.0|Standard Deviation|16|16.0|||
4122665|NCT00924404|3948304|B2|||Age||years|Mean|55|55.0|Standard Deviation|17|17.0|||
4122666|NCT00924404|3948305|B1|||Age||years|Mean|51|51.0|Standard Deviation|14|14.0|||
4122667|NCT00924352|3948314|B1|United States||Region of Enrollment||participants|Number|56|56.0||||||
4122668|NCT00924352|3948314|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4122669|NCT00924352|3948314|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4122670|NCT00924352|3948314|B1||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4122671|NCT00924352|3948314|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4122672|NCT00924352|3948314|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4122673|NCT00924352|3948314|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4122674|NCT00924352|3948314|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4122675|NCT00924352|3948314|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4122676|NCT00924352|3948314|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4122677|NCT00924352|3948314|B1|||Age||years|Mean|53.7|53.7|Standard Deviation|9.29|9.29|||
4122678|NCT00924313|3948328|B1|||Days to Radical Prostatectomy|Radical prostatectomy is removal of the entire prostate gland. and additional tissue|Days|Mean|10.5|10.5|Full Range|||1.0|34.0|
4122679|NCT00924313|3948328|B1|||Interval Between Magnetic Resonance Imaging and Prostatectomy|Prostatectomy is a partial or total removal of the prostate gland.|Days|Mean|54|54.0|Full Range|||2.0|155.0|
4122680|NCT00924313|3948328|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4122681|NCT00924313|3948328|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4122682|NCT00924313|3948328|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4122683|NCT00924313|3948328|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4122684|NCT00924313|3948328|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4122685|NCT00924313|3948328|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4122686|NCT00924313|3948328|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4122687|NCT00924313|3948328|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4122688|NCT00924313|3948328|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4122689|NCT00924313|3948328|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4122690|NCT00924313|3948328|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4122691|NCT00924313|3948328|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4122692|NCT00924313|3948328|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4122693|NCT00924313|3948328|B1|||Age||years|Mean|58.97|58.97|Standard Deviation|6.11|6.11|||
4122694|NCT00924313|3948328|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4122695|NCT00924313|3948328|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4122696|NCT00924313|3948328|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4122697|NCT00924287|3948340|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4122698|NCT00924287|3948340|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4122699|NCT00924287|3948340|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4122700|NCT00924287|3948340|B1|||Age||years|Mean|39.0|39.0|Standard Deviation|||||
4122701|NCT00924287|3948340|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4122702|NCT00924287|3948340|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4122703|NCT00924287|3948340|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4122704|NCT00924209|3948346|B1|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4122705|NCT00924209|3948346|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4122706|NCT00924209|3948346|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4122707|NCT00924209|3948346|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4122708|NCT00924209|3948346|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4122709|NCT00924209|3948346|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4122710|NCT00924209|3948346|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4122711|NCT00924209|3948346|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4122712|NCT00924209|3948346|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4122713|NCT00924209|3948346|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4122714|NCT00924209|3948346|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4122715|NCT00924209|3948346|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4122716|NCT00924209|3948346|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4122717|NCT00924209|3948346|B1|||Age||years|Mean|55.76|55.76|Standard Deviation|6.03|6.03|||
4122718|NCT00924209|3948346|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4122719|NCT00924209|3948346|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4122720|NCT00924209|3948346|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4122721|NCT00924170|3948354|B3|20, 1.8 cm tumor||Maximum tumor size|Maximum tumor size is listed, respectively, with the maximum spleen diameter.|Participants|Count of Participants|1|1.0||||||
4122722|NCT00924170|3948355|B2|20, 1.8 cm tumor||Maximum tumor size|Maximum tumor size is listed, respectively, with the maximum spleen diameter.|Participants|Count of Participants|0|0.0||||||
4122723|NCT00924170|3948356|B1|20, 1.8 cm tumor||Maximum tumor size|Maximum tumor size is listed, respectively, with the maximum spleen diameter.|Participants|Count of Participants|1|1.0||||||
4122724|NCT00924170|3948354|B3|18.5, 1.7 cm tumor||Maximum tumor size|Maximum tumor size is listed, respectively, with the maximum spleen diameter.|Participants|Count of Participants|1|1.0||||||
4122725|NCT00924170|3948355|B2|18.5, 1.7 cm tumor||Maximum tumor size|Maximum tumor size is listed, respectively, with the maximum spleen diameter.|Participants|Count of Participants|0|0.0||||||
4122726|NCT00924170|3948356|B1|18.5, 1.7 cm tumor||Maximum tumor size|Maximum tumor size is listed, respectively, with the maximum spleen diameter.|Participants|Count of Participants|1|1.0||||||
4122727|NCT00924170|3948354|B3|17.5 cm tumor||Maximum tumor size|Maximum tumor size is listed, respectively, with the maximum spleen diameter.|Participants|Count of Participants|1|1.0||||||
4122728|NCT00924170|3948355|B2|17.5 cm tumor||Maximum tumor size|Maximum tumor size is listed, respectively, with the maximum spleen diameter.|Participants|Count of Participants|0|0.0||||||
4122729|NCT00924170|3948356|B1|17.5 cm tumor||Maximum tumor size|Maximum tumor size is listed, respectively, with the maximum spleen diameter.|Participants|Count of Participants|1|1.0||||||
4122730|NCT00924170|3948354|B3|17 cm tumor||Maximum tumor size|Maximum tumor size is listed, respectively, with the maximum spleen diameter.|Participants|Count of Participants|1|1.0||||||
4122731|NCT00924170|3948355|B2|17 cm tumor||Maximum tumor size|Maximum tumor size is listed, respectively, with the maximum spleen diameter.|Participants|Count of Participants|0|0.0||||||
4122732|NCT00924170|3948356|B1|17 cm tumor||Maximum tumor size|Maximum tumor size is listed, respectively, with the maximum spleen diameter.|Participants|Count of Participants|1|1.0||||||
4122733|NCT00924170|3948354|B3|15, 2.5 cm tumor||Maximum tumor size|Maximum tumor size is listed, respectively, with the maximum spleen diameter.|Participants|Count of Participants|1|1.0||||||
4122734|NCT00924170|3948355|B2|15, 2.5 cm tumor||Maximum tumor size|Maximum tumor size is listed, respectively, with the maximum spleen diameter.|Participants|Count of Participants|1|1.0||||||
4122735|NCT00924170|3948356|B1|15, 2.5 cm tumor||Maximum tumor size|Maximum tumor size is listed, respectively, with the maximum spleen diameter.|Participants|Count of Participants|0|0.0||||||
4122736|NCT00924170|3948354|B3|9 cm tumor||Maximum tumor size|Maximum tumor size is listed, respectively, with the maximum spleen diameter.|Participants|Count of Participants|1|1.0||||||
4122737|NCT00924170|3948355|B2|9 cm tumor||Maximum tumor size|Maximum tumor size is listed, respectively, with the maximum spleen diameter.|Participants|Count of Participants|1|1.0||||||
4122738|NCT00924170|3948356|B1|9 cm tumor||Maximum tumor size|Maximum tumor size is listed, respectively, with the maximum spleen diameter.|Participants|Count of Participants|0|0.0||||||
4122739|NCT00924170|3948354|B3|6 cm tumor||Maximum tumor size|Maximum tumor size is listed, respectively, with the maximum spleen diameter.|Participants|Count of Participants|1|1.0||||||
4122740|NCT00924170|3948355|B2|6 cm tumor||Maximum tumor size|Maximum tumor size is listed, respectively, with the maximum spleen diameter.|Participants|Count of Participants|1|1.0||||||
4122741|NCT00924170|3948356|B1|6 cm tumor||Maximum tumor size|Maximum tumor size is listed, respectively, with the maximum spleen diameter.|Participants|Count of Participants|0|0.0||||||
4122742|NCT00924170|3948354|B3|5.8 cm tumor||Maximum tumor size|Maximum tumor size is listed, respectively, with the maximum spleen diameter.|Participants|Count of Participants|1|1.0||||||
4122743|NCT00924170|3948355|B2|5.8 cm tumor||Maximum tumor size|Maximum tumor size is listed, respectively, with the maximum spleen diameter.|Participants|Count of Participants|1|1.0||||||
4122744|NCT00924170|3948356|B1|5.8 cm tumor||Maximum tumor size|Maximum tumor size is listed, respectively, with the maximum spleen diameter.|Participants|Count of Participants|0|0.0||||||
4122745|NCT00924170|3948354|B3|5.6 cm tumor||Maximum tumor size|Maximum tumor size is listed, respectively, with the maximum spleen diameter.|Participants|Count of Participants|1|1.0||||||
4122746|NCT00924170|3948355|B2|5.6 cm tumor||Maximum tumor size|Maximum tumor size is listed, respectively, with the maximum spleen diameter.|Participants|Count of Participants|0|0.0||||||
4122747|NCT00924170|3948356|B1|5.6 cm tumor||Maximum tumor size|Maximum tumor size is listed, respectively, with the maximum spleen diameter.|Participants|Count of Participants|1|1.0||||||
4122748|NCT00924170|3948354|B3|2.2 cm tumor||Maximum tumor size|Maximum tumor size is listed, respectively, with the maximum spleen diameter.|Participants|Count of Participants|1|1.0||||||
4122749|NCT00924170|3948355|B2|2.2 cm tumor||Maximum tumor size|Maximum tumor size is listed, respectively, with the maximum spleen diameter.|Participants|Count of Participants|1|1.0||||||
4122750|NCT00924170|3948356|B1|2.2 cm tumor||Maximum tumor size|Maximum tumor size is listed, respectively, with the maximum spleen diameter.|Participants|Count of Participants|0|0.0||||||
4122751|NCT00924170|3948354|B3|2 cm tumor||Maximum tumor size|Maximum tumor size is listed, respectively, with the maximum spleen diameter.|Participants|Count of Participants|1|1.0||||||
4122752|NCT00924170|3948355|B2|2 cm tumor||Maximum tumor size|Maximum tumor size is listed, respectively, with the maximum spleen diameter.|Participants|Count of Participants|0|0.0||||||
4122753|NCT00924170|3948356|B1|2 cm tumor||Maximum tumor size|Maximum tumor size is listed, respectively, with the maximum spleen diameter.|Participants|Count of Participants|1|1.0||||||
4122754|NCT00924170|3948354|B3|1.9 cm tumor||Maximum tumor size|Maximum tumor size is listed, respectively, with the maximum spleen diameter.|Participants|Count of Participants|1|1.0||||||
4122755|NCT00924170|3948355|B2|1.9 cm tumor||Maximum tumor size|Maximum tumor size is listed, respectively, with the maximum spleen diameter.|Participants|Count of Participants|1|1.0||||||
4122756|NCT00924170|3948356|B1|1.9 cm tumor||Maximum tumor size|Maximum tumor size is listed, respectively, with the maximum spleen diameter.|Participants|Count of Participants|0|0.0||||||
4122757|NCT00924170|3948354|B3|<1 cm tumor||Maximum tumor size|Maximum tumor size is listed, respectively, with the maximum spleen diameter.|Participants|Count of Participants|5|5.0||||||
4122758|NCT00924170|3948355|B2|<1 cm tumor||Maximum tumor size|Maximum tumor size is listed, respectively, with the maximum spleen diameter.|Participants|Count of Participants|1|1.0||||||
4122759|NCT00924170|3948356|B1|<1 cm tumor||Maximum tumor size|Maximum tumor size is listed, respectively, with the maximum spleen diameter.|Participants|Count of Participants|4|4.0||||||
4122760|NCT00924170|3948354|B3|213,000 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|1|1.0||||||
4122761|NCT00924170|3948355|B2|213,000 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|1|1.0||||||
4122762|NCT00924170|3948356|B1|213,000 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|0|0.0||||||
4122763|NCT00924170|3948354|B3|210,000 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|1|1.0||||||
4122764|NCT00924170|3948355|B2|210,000 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|0|0.0||||||
4122765|NCT00924170|3948356|B1|210,000 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|1|1.0||||||
4122766|NCT00924170|3948354|B3|24,112 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|1|1.0||||||
4122767|NCT00924170|3948355|B2|24,112 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|0|0.0||||||
4122768|NCT00924170|3948356|B1|24,112 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|1|1.0||||||
4122769|NCT00924170|3948354|B3|13,153 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|1|1.0||||||
4122770|NCT00924170|3948355|B2|13,153 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|0|0.0||||||
4122771|NCT00924170|3948356|B1|13,153 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|1|1.0||||||
4122772|NCT00924170|3948354|B3|8,216 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|1|1.0||||||
4122773|NCT00924170|3948355|B2|8,216 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|0|0.0||||||
4122774|NCT00924170|3948356|B1|8,216 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|1|1.0||||||
4122775|NCT00924170|3948354|B3|7,737 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|1|1.0||||||
4122776|NCT00924170|3948355|B2|7,737 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|1|1.0||||||
4122777|NCT00924170|3948356|B1|7,737 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|0|0.0||||||
4122778|NCT00924170|3948354|B3|5,604 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|1|1.0||||||
4122779|NCT00924170|3948355|B2|5,604 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|0|0.0||||||
4122780|NCT00924170|3948356|B1|5,604 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|1|1.0||||||
4122781|NCT00924170|3948354|B3|687 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|1|1.0||||||
4122782|NCT00924170|3948355|B2|687 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|0|0.0||||||
4122783|NCT00924170|3948356|B1|687 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|1|1.0||||||
4122784|NCT00924170|3948354|B3|450 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|1|1.0||||||
4122785|NCT00924170|3948355|B2|450 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|1|1.0||||||
4122786|NCT00924170|3948356|B1|450 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|0|0.0||||||
4122787|NCT00924170|3948354|B3|408 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|1|1.0||||||
4122788|NCT00924170|3948355|B2|408 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|0|0.0||||||
4122789|NCT00924170|3948356|B1|408 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|1|1.0||||||
4122790|NCT00924170|3948354|B3|246 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|1|1.0||||||
4122791|NCT00924170|3948355|B2|246 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|0|0.0||||||
4122792|NCT00924170|3948356|B1|246 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|1|1.0||||||
4122793|NCT00924170|3948354|B3|206 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|1|1.0||||||
4122794|NCT00924170|3948355|B2|206 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|0|0.0||||||
4122795|NCT00924170|3948356|B1|206 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|1|1.0||||||
4122796|NCT00924170|3948354|B3|80 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|1|1.0||||||
4122797|NCT00924170|3948355|B2|80 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|0|0.0||||||
4122798|NCT00924170|3948356|B1|80 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|1|1.0||||||
4122799|NCT00924170|3948354|B3|1 cell||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|1|1.0||||||
4122800|NCT00924170|3948355|B2|1 cell||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|1|1.0||||||
4122801|NCT00924170|3948356|B1|1 cell||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|0|0.0||||||
4122802|NCT00924170|3948354|B3|0 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|3|3.0||||||
4122803|NCT00924170|3948355|B2|0 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|3|3.0||||||
4122804|NCT00924170|3948356|B1|0 cells||Adult T-cell Leukemia (ATL) cells/mm^3 in the Peripheral Blood||Participants|Count of Participants|0|0.0||||||
4122805|NCT00924170|3948354|B3|No||Participants with High Calcium++|High Calcium++ is a corrected calcium > 2.74|Participants|Count of Participants|10|10.0||||||
4122806|NCT00924170|3948355|B2|No||Participants with High Calcium++|High Calcium++ is a corrected calcium > 2.74|Participants|Count of Participants|5|5.0||||||
4122807|NCT00924170|3948356|B1|No||Participants with High Calcium++|High Calcium++ is a corrected calcium > 2.74|Participants|Count of Participants|5|5.0||||||
4122808|NCT00924170|3948354|B3|Yes||Participants with High Calcium++|High Calcium++ is a corrected calcium > 2.74|Participants|Count of Participants|7|7.0||||||
4122809|NCT00924170|3948355|B2|Yes||Participants with High Calcium++|High Calcium++ is a corrected calcium > 2.74|Participants|Count of Participants|2|2.0||||||
4122810|NCT00924170|3948356|B1|Yes||Participants with High Calcium++|High Calcium++ is a corrected calcium > 2.74|Participants|Count of Participants|5|5.0||||||
4122811|NCT00924170|3948354|B3|No||Participants with High Lactate Hydrogenase (LDH)|High LDH is > 400 u/L.|Participants|Count of Participants|0|0.0||||||
4122812|NCT00924170|3948355|B2|No||Participants with High Lactate Hydrogenase (LDH)|High LDH is > 400 u/L.|Participants|Count of Participants|0|0.0||||||
4122813|NCT00924170|3948356|B1|No||Participants with High Lactate Hydrogenase (LDH)|High LDH is > 400 u/L.|Participants|Count of Participants|0|0.0||||||
4122814|NCT00924170|3948354|B3|Yes||Participants with High Lactate Hydrogenase (LDH)|High LDH is > 400 u/L.|Participants|Count of Participants|17|17.0||||||
4122815|NCT00924170|3948355|B2|Yes||Participants with High Lactate Hydrogenase (LDH)|High LDH is > 400 u/L.|Participants|Count of Participants|7|7.0||||||
4122816|NCT00924170|3948356|B1|Yes||Participants with High Lactate Hydrogenase (LDH)|High LDH is > 400 u/L.|Participants|Count of Participants|10|10.0||||||
4122817|NCT00924170|3948354|B3|Spleen||Extravascular sites||Participants|Count of Participants|2|2.0||||||
4122818|NCT00924170|3948355|B2|Spleen||Extravascular sites||Participants|Count of Participants|0|0.0||||||
4122819|NCT00924170|3948356|B1|Spleen||Extravascular sites||Participants|Count of Participants|2|2.0||||||
4122820|NCT00924170|3948354|B3|Bone, subcutaneous||Extravascular sites||Participants|Count of Participants|1|1.0||||||
4122821|NCT00924170|3948355|B2|Bone, subcutaneous||Extravascular sites||Participants|Count of Participants|1|1.0||||||
4122822|NCT00924170|3948356|B1|Bone, subcutaneous||Extravascular sites||Participants|Count of Participants|0|0.0||||||
4122823|NCT00924170|3948354|B3|None||Extravascular sites||Participants|Count of Participants|1|1.0||||||
4122824|NCT00924170|3948355|B2|None||Extravascular sites||Participants|Count of Participants|0|0.0||||||
4122825|NCT00924170|3948356|B1|None||Extravascular sites||Participants|Count of Participants|1|1.0||||||
4122826|NCT00924170|3948354|B3|Subcutaneous||Extravascular sites||Participants|Count of Participants|2|2.0||||||
4122827|NCT00924170|3948355|B2|Subcutaneous||Extravascular sites||Participants|Count of Participants|1|1.0||||||
4122828|NCT00924170|3948356|B1|Subcutaneous||Extravascular sites||Participants|Count of Participants|1|1.0||||||
4122829|NCT00924170|3948354|B3|Spleen, LN||Extravascular sites||Participants|Count of Participants|3|3.0||||||
4122830|NCT00924170|3948355|B2|Spleen, LN||Extravascular sites||Participants|Count of Participants|1|1.0||||||
4122831|NCT00924170|3948356|B1|Spleen, LN||Extravascular sites||Participants|Count of Participants|2|2.0||||||
4122832|NCT00924170|3948354|B3|Lymph node (LN)||Extravascular sites||Participants|Count of Participants|3|3.0||||||
4122833|NCT00924170|3948355|B2|Lymph node (LN)||Extravascular sites||Participants|Count of Participants|2|2.0||||||
4122834|NCT00924170|3948356|B1|Lymph node (LN)||Extravascular sites||Participants|Count of Participants|1|1.0||||||
4122835|NCT00924170|3948354|B3|Skin||Extravascular sites||Participants|Count of Participants|1|1.0||||||
4122836|NCT00924170|3948355|B2|Skin||Extravascular sites||Participants|Count of Participants|0|0.0||||||
4122837|NCT00924170|3948356|B1|Skin||Extravascular sites||Participants|Count of Participants|1|1.0||||||
4122838|NCT00924170|3948354|B3|Muscle||Extravascular sites||Participants|Count of Participants|1|1.0||||||
4122839|NCT00924170|3948355|B2|Muscle||Extravascular sites||Participants|Count of Participants|0|0.0||||||
4122840|NCT00924170|3948356|B1|Muscle||Extravascular sites||Participants|Count of Participants|1|1.0||||||
4122841|NCT00924170|3948354|B3|Pelvis||Extravascular sites||Participants|Count of Participants|1|1.0||||||
4122842|NCT00924170|3948355|B2|Pelvis||Extravascular sites||Participants|Count of Participants|0|0.0||||||
4122843|NCT00924170|3948356|B1|Pelvis||Extravascular sites||Participants|Count of Participants|1|1.0||||||
4122844|NCT00924170|3948354|B3|Thigh (skin)||Extravascular sites||Participants|Count of Participants|1|1.0||||||
4122845|NCT00924170|3948355|B2|Thigh (skin)||Extravascular sites||Participants|Count of Participants|1|1.0||||||
4122846|NCT00924170|3948356|B1|Thigh (skin)||Extravascular sites||Participants|Count of Participants|0|0.0||||||
4122847|NCT00924170|3948354|B3|Bone, lung, skin||Extravascular sites||Participants|Count of Participants|1|1.0||||||
4122848|NCT00924170|3948355|B2|Bone, lung, skin||Extravascular sites||Participants|Count of Participants|1|1.0||||||
4122849|NCT00924170|3948356|B1|Bone, lung, skin||Extravascular sites||Participants|Count of Participants|0|0.0||||||
4122850|NCT00924170|3948354|B3|Lymphoma||Type of Leukemia||Participants|Count of Participants|4|4.0||||||
4122851|NCT00924170|3948355|B2|Lymphoma||Type of Leukemia||Participants|Count of Participants|4|4.0||||||
4122852|NCT00924170|3948356|B1|Lymphoma||Type of Leukemia||Participants|Count of Participants|0|0.0||||||
4122853|NCT00924170|3948354|B3|Acute||Type of Leukemia||Participants|Count of Participants|13|13.0||||||
4122854|NCT00924170|3948355|B2|Acute||Type of Leukemia||Participants|Count of Participants|3|3.0||||||
4122855|NCT00924170|3948356|B1|Acute||Type of Leukemia||Participants|Count of Participants|10|10.0||||||
4122856|NCT00924170|3948354|B3|LSG-15, radiation||Prior Treatment|Prior treatments included cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP), these 4 agents with etoposide (EPOCH) and campath (C or alemtuzumab, together EPOCH-C), etoposide, methylprednisolone, cytarabine, and cisplatin (ESHAP), pralatrexate (PTX), gemcitabine (Gem), siplizumab (Medi507), denileukin diftitox (Ontak), daclizumab or humanized anti-Tac (HAT) and EPOCH with rituximab and siplizumab (EPOCH-RS). The LSG-15 regimen includes prednisone, adriamycin, carmustine, etoposide, carboplatin, and vinorelbine.|Participants|Count of Participants|1|1.0||||||
4122857|NCT00924170|3948355|B2|LSG-15, radiation||Prior Treatment|Prior treatments included cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP), these 4 agents with etoposide (EPOCH) and campath (C or alemtuzumab, together EPOCH-C), etoposide, methylprednisolone, cytarabine, and cisplatin (ESHAP), pralatrexate (PTX), gemcitabine (Gem), siplizumab (Medi507), denileukin diftitox (Ontak), daclizumab or humanized anti-Tac (HAT) and EPOCH with rituximab and siplizumab (EPOCH-RS). The LSG-15 regimen includes prednisone, adriamycin, carmustine, etoposide, carboplatin, and vinorelbine.|Participants|Count of Participants|1|1.0||||||
4122858|NCT00924170|3948356|B1|LSG-15, radiation||Prior Treatment|Prior treatments included cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP), these 4 agents with etoposide (EPOCH) and campath (C or alemtuzumab, together EPOCH-C), etoposide, methylprednisolone, cytarabine, and cisplatin (ESHAP), pralatrexate (PTX), gemcitabine (Gem), siplizumab (Medi507), denileukin diftitox (Ontak), daclizumab or humanized anti-Tac (HAT) and EPOCH with rituximab and siplizumab (EPOCH-RS). The LSG-15 regimen includes prednisone, adriamycin, carmustine, etoposide, carboplatin, and vinorelbine.|Participants|Count of Participants|0|0.0||||||
4122859|NCT00924170|3948354|B3|CHOP, Hydroxyurea||Prior Treatment|Prior treatments included cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP), these 4 agents with etoposide (EPOCH) and campath (C or alemtuzumab, together EPOCH-C), etoposide, methylprednisolone, cytarabine, and cisplatin (ESHAP), pralatrexate (PTX), gemcitabine (Gem), siplizumab (Medi507), denileukin diftitox (Ontak), daclizumab or humanized anti-Tac (HAT) and EPOCH with rituximab and siplizumab (EPOCH-RS). The LSG-15 regimen includes prednisone, adriamycin, carmustine, etoposide, carboplatin, and vinorelbine.|Participants|Count of Participants|1|1.0||||||
4122860|NCT00924170|3948355|B2|CHOP, Hydroxyurea||Prior Treatment|Prior treatments included cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP), these 4 agents with etoposide (EPOCH) and campath (C or alemtuzumab, together EPOCH-C), etoposide, methylprednisolone, cytarabine, and cisplatin (ESHAP), pralatrexate (PTX), gemcitabine (Gem), siplizumab (Medi507), denileukin diftitox (Ontak), daclizumab or humanized anti-Tac (HAT) and EPOCH with rituximab and siplizumab (EPOCH-RS). The LSG-15 regimen includes prednisone, adriamycin, carmustine, etoposide, carboplatin, and vinorelbine.|Participants|Count of Participants|0|0.0||||||
4122861|NCT00924170|3948356|B1|CHOP, Hydroxyurea||Prior Treatment|Prior treatments included cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP), these 4 agents with etoposide (EPOCH) and campath (C or alemtuzumab, together EPOCH-C), etoposide, methylprednisolone, cytarabine, and cisplatin (ESHAP), pralatrexate (PTX), gemcitabine (Gem), siplizumab (Medi507), denileukin diftitox (Ontak), daclizumab or humanized anti-Tac (HAT) and EPOCH with rituximab and siplizumab (EPOCH-RS). The LSG-15 regimen includes prednisone, adriamycin, carmustine, etoposide, carboplatin, and vinorelbine.|Participants|Count of Participants|1|1.0||||||
4122862|NCT00924170|3948354|B3|Hydroxyurea||Prior Treatment|Prior treatments included cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP), these 4 agents with etoposide (EPOCH) and campath (C or alemtuzumab, together EPOCH-C), etoposide, methylprednisolone, cytarabine, and cisplatin (ESHAP), pralatrexate (PTX), gemcitabine (Gem), siplizumab (Medi507), denileukin diftitox (Ontak), daclizumab or humanized anti-Tac (HAT) and EPOCH with rituximab and siplizumab (EPOCH-RS). The LSG-15 regimen includes prednisone, adriamycin, carmustine, etoposide, carboplatin, and vinorelbine.|Participants|Count of Participants|2|2.0||||||
4122891|NCT00924170|3948356|B1|American, from Ghana, Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4122863|NCT00924170|3948355|B2|Hydroxyurea||Prior Treatment|Prior treatments included cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP), these 4 agents with etoposide (EPOCH) and campath (C or alemtuzumab, together EPOCH-C), etoposide, methylprednisolone, cytarabine, and cisplatin (ESHAP), pralatrexate (PTX), gemcitabine (Gem), siplizumab (Medi507), denileukin diftitox (Ontak), daclizumab or humanized anti-Tac (HAT) and EPOCH with rituximab and siplizumab (EPOCH-RS). The LSG-15 regimen includes prednisone, adriamycin, carmustine, etoposide, carboplatin, and vinorelbine.|Participants|Count of Participants|1|1.0||||||
4122864|NCT00924170|3948356|B1|Hydroxyurea||Prior Treatment|Prior treatments included cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP), these 4 agents with etoposide (EPOCH) and campath (C or alemtuzumab, together EPOCH-C), etoposide, methylprednisolone, cytarabine, and cisplatin (ESHAP), pralatrexate (PTX), gemcitabine (Gem), siplizumab (Medi507), denileukin diftitox (Ontak), daclizumab or humanized anti-Tac (HAT) and EPOCH with rituximab and siplizumab (EPOCH-RS). The LSG-15 regimen includes prednisone, adriamycin, carmustine, etoposide, carboplatin, and vinorelbine.|Participants|Count of Participants|1|1.0||||||
4122865|NCT00924170|3948354|B3|None||Prior Treatment|Prior treatments included cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP), these 4 agents with etoposide (EPOCH) and campath (C or alemtuzumab, together EPOCH-C), etoposide, methylprednisolone, cytarabine, and cisplatin (ESHAP), pralatrexate (PTX), gemcitabine (Gem), siplizumab (Medi507), denileukin diftitox (Ontak), daclizumab or humanized anti-Tac (HAT) and EPOCH with rituximab and siplizumab (EPOCH-RS). The LSG-15 regimen includes prednisone, adriamycin, carmustine, etoposide, carboplatin, and vinorelbine.|Participants|Count of Participants|1|1.0||||||
4122866|NCT00924170|3948355|B2|None||Prior Treatment|Prior treatments included cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP), these 4 agents with etoposide (EPOCH) and campath (C or alemtuzumab, together EPOCH-C), etoposide, methylprednisolone, cytarabine, and cisplatin (ESHAP), pralatrexate (PTX), gemcitabine (Gem), siplizumab (Medi507), denileukin diftitox (Ontak), daclizumab or humanized anti-Tac (HAT) and EPOCH with rituximab and siplizumab (EPOCH-RS). The LSG-15 regimen includes prednisone, adriamycin, carmustine, etoposide, carboplatin, and vinorelbine.|Participants|Count of Participants|0|0.0||||||
4122867|NCT00924170|3948356|B1|None||Prior Treatment|Prior treatments included cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP), these 4 agents with etoposide (EPOCH) and campath (C or alemtuzumab, together EPOCH-C), etoposide, methylprednisolone, cytarabine, and cisplatin (ESHAP), pralatrexate (PTX), gemcitabine (Gem), siplizumab (Medi507), denileukin diftitox (Ontak), daclizumab or humanized anti-Tac (HAT) and EPOCH with rituximab and siplizumab (EPOCH-RS). The LSG-15 regimen includes prednisone, adriamycin, carmustine, etoposide, carboplatin, and vinorelbine.|Participants|Count of Participants|1|1.0||||||
4122868|NCT00924170|3948354|B3|EPOCH-RS||Prior Treatment|Prior treatments included cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP), these 4 agents with etoposide (EPOCH) and campath (C or alemtuzumab, together EPOCH-C), etoposide, methylprednisolone, cytarabine, and cisplatin (ESHAP), pralatrexate (PTX), gemcitabine (Gem), siplizumab (Medi507), denileukin diftitox (Ontak), daclizumab or humanized anti-Tac (HAT) and EPOCH with rituximab and siplizumab (EPOCH-RS). The LSG-15 regimen includes prednisone, adriamycin, carmustine, etoposide, carboplatin, and vinorelbine.|Participants|Count of Participants|2|2.0||||||
4122869|NCT00924170|3948355|B2|EPOCH-RS||Prior Treatment|Prior treatments included cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP), these 4 agents with etoposide (EPOCH) and campath (C or alemtuzumab, together EPOCH-C), etoposide, methylprednisolone, cytarabine, and cisplatin (ESHAP), pralatrexate (PTX), gemcitabine (Gem), siplizumab (Medi507), denileukin diftitox (Ontak), daclizumab or humanized anti-Tac (HAT) and EPOCH with rituximab and siplizumab (EPOCH-RS). The LSG-15 regimen includes prednisone, adriamycin, carmustine, etoposide, carboplatin, and vinorelbine.|Participants|Count of Participants|1|1.0||||||
4122870|NCT00924170|3948356|B1|EPOCH-RS||Prior Treatment|Prior treatments included cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP), these 4 agents with etoposide (EPOCH) and campath (C or alemtuzumab, together EPOCH-C), etoposide, methylprednisolone, cytarabine, and cisplatin (ESHAP), pralatrexate (PTX), gemcitabine (Gem), siplizumab (Medi507), denileukin diftitox (Ontak), daclizumab or humanized anti-Tac (HAT) and EPOCH with rituximab and siplizumab (EPOCH-RS). The LSG-15 regimen includes prednisone, adriamycin, carmustine, etoposide, carboplatin, and vinorelbine.|Participants|Count of Participants|1|1.0||||||
4122871|NCT00924170|3948354|B3|CHOP, C||Prior Treatment|Prior treatments included cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP), these 4 agents with etoposide (EPOCH) and campath (C or alemtuzumab, together EPOCH-C), etoposide, methylprednisolone, cytarabine, and cisplatin (ESHAP), pralatrexate (PTX), gemcitabine (Gem), siplizumab (Medi507), denileukin diftitox (Ontak), daclizumab or humanized anti-Tac (HAT) and EPOCH with rituximab and siplizumab (EPOCH-RS). The LSG-15 regimen includes prednisone, adriamycin, carmustine, etoposide, carboplatin, and vinorelbine.|Participants|Count of Participants|2|2.0||||||
4122872|NCT00924170|3948355|B2|CHOP, C||Prior Treatment|Prior treatments included cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP), these 4 agents with etoposide (EPOCH) and campath (C or alemtuzumab, together EPOCH-C), etoposide, methylprednisolone, cytarabine, and cisplatin (ESHAP), pralatrexate (PTX), gemcitabine (Gem), siplizumab (Medi507), denileukin diftitox (Ontak), daclizumab or humanized anti-Tac (HAT) and EPOCH with rituximab and siplizumab (EPOCH-RS). The LSG-15 regimen includes prednisone, adriamycin, carmustine, etoposide, carboplatin, and vinorelbine.|Participants|Count of Participants|0|0.0||||||
4122873|NCT00924170|3948356|B1|CHOP, C||Prior Treatment|Prior treatments included cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP), these 4 agents with etoposide (EPOCH) and campath (C or alemtuzumab, together EPOCH-C), etoposide, methylprednisolone, cytarabine, and cisplatin (ESHAP), pralatrexate (PTX), gemcitabine (Gem), siplizumab (Medi507), denileukin diftitox (Ontak), daclizumab or humanized anti-Tac (HAT) and EPOCH with rituximab and siplizumab (EPOCH-RS). The LSG-15 regimen includes prednisone, adriamycin, carmustine, etoposide, carboplatin, and vinorelbine.|Participants|Count of Participants|2|2.0||||||
4122874|NCT00924170|3948354|B3|Medi507, Ontak, HAT||Prior Treatment|Prior treatments included cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP), these 4 agents with etoposide (EPOCH) and campath (C or alemtuzumab, together EPOCH-C), etoposide, methylprednisolone, cytarabine, and cisplatin (ESHAP), pralatrexate (PTX), gemcitabine (Gem), siplizumab (Medi507), denileukin diftitox (Ontak), daclizumab or humanized anti-Tac (HAT) and EPOCH with rituximab and siplizumab (EPOCH-RS). The LSG-15 regimen includes prednisone, adriamycin, carmustine, etoposide, carboplatin, and vinorelbine.|Participants|Count of Participants|1|1.0||||||
4122949|NCT00924118|3948395|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4122875|NCT00924170|3948355|B2|Medi507, Ontak, HAT||Prior Treatment|Prior treatments included cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP), these 4 agents with etoposide (EPOCH) and campath (C or alemtuzumab, together EPOCH-C), etoposide, methylprednisolone, cytarabine, and cisplatin (ESHAP), pralatrexate (PTX), gemcitabine (Gem), siplizumab (Medi507), denileukin diftitox (Ontak), daclizumab or humanized anti-Tac (HAT) and EPOCH with rituximab and siplizumab (EPOCH-RS). The LSG-15 regimen includes prednisone, adriamycin, carmustine, etoposide, carboplatin, and vinorelbine.|Participants|Count of Participants|0|0.0||||||
4122876|NCT00924170|3948356|B1|Medi507, Ontak, HAT||Prior Treatment|Prior treatments included cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP), these 4 agents with etoposide (EPOCH) and campath (C or alemtuzumab, together EPOCH-C), etoposide, methylprednisolone, cytarabine, and cisplatin (ESHAP), pralatrexate (PTX), gemcitabine (Gem), siplizumab (Medi507), denileukin diftitox (Ontak), daclizumab or humanized anti-Tac (HAT) and EPOCH with rituximab and siplizumab (EPOCH-RS). The LSG-15 regimen includes prednisone, adriamycin, carmustine, etoposide, carboplatin, and vinorelbine.|Participants|Count of Participants|1|1.0||||||
4122877|NCT00924170|3948354|B3|C, ESHAP, PTX, Gem||Prior Treatment|Prior treatments included cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP), these 4 agents with etoposide (EPOCH) and campath (C or alemtuzumab, together EPOCH-C), etoposide, methylprednisolone, cytarabine, and cisplatin (ESHAP), pralatrexate (PTX), gemcitabine (Gem), siplizumab (Medi507), denileukin diftitox (Ontak), daclizumab or humanized anti-Tac (HAT) and EPOCH with rituximab and siplizumab (EPOCH-RS). The LSG-15 regimen includes prednisone, adriamycin, carmustine, etoposide, carboplatin, and vinorelbine.|Participants|Count of Participants|1|1.0||||||
4122878|NCT00924170|3948355|B2|C, ESHAP, PTX, Gem||Prior Treatment|Prior treatments included cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP), these 4 agents with etoposide (EPOCH) and campath (C or alemtuzumab, together EPOCH-C), etoposide, methylprednisolone, cytarabine, and cisplatin (ESHAP), pralatrexate (PTX), gemcitabine (Gem), siplizumab (Medi507), denileukin diftitox (Ontak), daclizumab or humanized anti-Tac (HAT) and EPOCH with rituximab and siplizumab (EPOCH-RS). The LSG-15 regimen includes prednisone, adriamycin, carmustine, etoposide, carboplatin, and vinorelbine.|Participants|Count of Participants|0|0.0||||||
4122879|NCT00924170|3948356|B1|C, ESHAP, PTX, Gem||Prior Treatment|Prior treatments included cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP), these 4 agents with etoposide (EPOCH) and campath (C or alemtuzumab, together EPOCH-C), etoposide, methylprednisolone, cytarabine, and cisplatin (ESHAP), pralatrexate (PTX), gemcitabine (Gem), siplizumab (Medi507), denileukin diftitox (Ontak), daclizumab or humanized anti-Tac (HAT) and EPOCH with rituximab and siplizumab (EPOCH-RS). The LSG-15 regimen includes prednisone, adriamycin, carmustine, etoposide, carboplatin, and vinorelbine.|Participants|Count of Participants|1|1.0||||||
4122880|NCT00924170|3948354|B3|EPOCH-C||Prior Treatment|Prior treatments included cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP), these 4 agents with etoposide (EPOCH) and campath (C or alemtuzumab, together EPOCH-C), etoposide, methylprednisolone, cytarabine, and cisplatin (ESHAP), pralatrexate (PTX), gemcitabine (Gem), siplizumab (Medi507), denileukin diftitox (Ontak), daclizumab or humanized anti-Tac (HAT) and EPOCH with rituximab and siplizumab (EPOCH-RS). The LSG-15 regimen includes prednisone, adriamycin, carmustine, etoposide, carboplatin, and vinorelbine.|Participants|Count of Participants|1|1.0||||||
4122881|NCT00924170|3948355|B2|EPOCH-C||Prior Treatment|Prior treatments included cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP), these 4 agents with etoposide (EPOCH) and campath (C or alemtuzumab, together EPOCH-C), etoposide, methylprednisolone, cytarabine, and cisplatin (ESHAP), pralatrexate (PTX), gemcitabine (Gem), siplizumab (Medi507), denileukin diftitox (Ontak), daclizumab or humanized anti-Tac (HAT) and EPOCH with rituximab and siplizumab (EPOCH-RS). The LSG-15 regimen includes prednisone, adriamycin, carmustine, etoposide, carboplatin, and vinorelbine.|Participants|Count of Participants|1|1.0||||||
4122882|NCT00924170|3948356|B1|EPOCH-C||Prior Treatment|Prior treatments included cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP), these 4 agents with etoposide (EPOCH) and campath (C or alemtuzumab, together EPOCH-C), etoposide, methylprednisolone, cytarabine, and cisplatin (ESHAP), pralatrexate (PTX), gemcitabine (Gem), siplizumab (Medi507), denileukin diftitox (Ontak), daclizumab or humanized anti-Tac (HAT) and EPOCH with rituximab and siplizumab (EPOCH-RS). The LSG-15 regimen includes prednisone, adriamycin, carmustine, etoposide, carboplatin, and vinorelbine.|Participants|Count of Participants|0|0.0||||||
4122883|NCT00924170|3948354|B3|CHOP||Prior Treatment|Prior treatments included cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP), these 4 agents with etoposide (EPOCH) and campath (C or alemtuzumab, together EPOCH-C), etoposide, methylprednisolone, cytarabine, and cisplatin (ESHAP), pralatrexate (PTX), gemcitabine (Gem), siplizumab (Medi507), denileukin diftitox (Ontak), daclizumab or humanized anti-Tac (HAT) and EPOCH with rituximab and siplizumab (EPOCH-RS). The LSG-15 regimen includes prednisone, adriamycin, carmustine, etoposide, carboplatin, and vinorelbine.|Participants|Count of Participants|5|5.0||||||
4122884|NCT00924170|3948355|B2|CHOP||Prior Treatment|Prior treatments included cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP), these 4 agents with etoposide (EPOCH) and campath (C or alemtuzumab, together EPOCH-C), etoposide, methylprednisolone, cytarabine, and cisplatin (ESHAP), pralatrexate (PTX), gemcitabine (Gem), siplizumab (Medi507), denileukin diftitox (Ontak), daclizumab or humanized anti-Tac (HAT) and EPOCH with rituximab and siplizumab (EPOCH-RS). The LSG-15 regimen includes prednisone, adriamycin, carmustine, etoposide, carboplatin, and vinorelbine.|Participants|Count of Participants|3|3.0||||||
4122885|NCT00924170|3948356|B1|CHOP||Prior Treatment|Prior treatments included cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP), these 4 agents with etoposide (EPOCH) and campath (C or alemtuzumab, together EPOCH-C), etoposide, methylprednisolone, cytarabine, and cisplatin (ESHAP), pralatrexate (PTX), gemcitabine (Gem), siplizumab (Medi507), denileukin diftitox (Ontak), daclizumab or humanized anti-Tac (HAT) and EPOCH with rituximab and siplizumab (EPOCH-RS). The LSG-15 regimen includes prednisone, adriamycin, carmustine, etoposide, carboplatin, and vinorelbine.|Participants|Count of Participants|2|2.0||||||
4122886|NCT00924170|3948354|B3|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4122887|NCT00924170|3948355|B2|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4122888|NCT00924170|3948356|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4122889|NCT00924170|3948354|B3|American, from Ghana, Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4122890|NCT00924170|3948355|B2|American, from Ghana, Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4122892|NCT00924170|3948354|B3|Barbados, Black||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4122893|NCT00924170|3948355|B2|Barbados, Black||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4122894|NCT00924170|3948356|B1|Barbados, Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4122895|NCT00924170|3948354|B3|Jamaican||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4122896|NCT00924170|3948355|B2|Jamaican||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4122897|NCT00924170|3948356|B1|Jamaican||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4122898|NCT00924170|3948354|B3|Ethiopian, Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4122899|NCT00924170|3948355|B2|Ethiopian, Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4122900|NCT00924170|3948356|B1|Ethiopian, Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4122901|NCT00924170|3948354|B3|Jamaican, Black||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4122902|NCT00924170|3948355|B2|Jamaican, Black||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4122903|NCT00924170|3948356|B1|Jamaican, Black||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4122904|NCT00924170|3948354|B3|American from Jamaica, Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4122905|NCT00924170|3948355|B2|American from Jamaica, Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4122906|NCT00924170|3948356|B1|American from Jamaica, Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4122907|NCT00924170|3948354|B3|Peruvian, Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4122908|NCT00924170|3948355|B2|Peruvian, Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4122909|NCT00924170|3948356|B1|Peruvian, Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4122910|NCT00924170|3948354|B3|Tabago, Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4122911|NCT00924170|3948355|B2|Tabago, Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4122912|NCT00924170|3948356|B1|Tabago, Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4122913|NCT00924170|3948354|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4122914|NCT00924170|3948355|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4122915|NCT00924170|3948356|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4122916|NCT00924170|3948354|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4122917|NCT00924170|3948355|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4122918|NCT00924170|3948356|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4122919|NCT00924170|3948354|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4122920|NCT00924170|3948355|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4122921|NCT00924170|3948356|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4122922|NCT00924170|3948354|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4122923|NCT00924170|3948355|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4122924|NCT00924170|3948356|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4122925|NCT00924170|3948354|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4122926|NCT00924170|3948355|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4122927|NCT00924170|3948356|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4122928|NCT00924170|3948354|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4122929|NCT00924170|3948355|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4122930|NCT00924170|3948356|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4122931|NCT00924170|3948354|B3|||Age||years|Mean|40.9|40.9|Standard Deviation|12.51|12.51|||
4122932|NCT00924170|3948355|B2|||Age||years|Mean|39.8|39.8|Standard Deviation|10.77|10.77|||
4122933|NCT00924170|3948356|B1|||Age||years|Mean|42|42.0|Standard Deviation|14.25|14.25|||
4122934|NCT00924170|3948354|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4122935|NCT00924170|3948355|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4122936|NCT00924170|3948356|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4122937|NCT00924170|3948354|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4122938|NCT00924170|3948355|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4122939|NCT00924170|3948356|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4122940|NCT00924170|3948354|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4122941|NCT00924170|3948355|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4122942|NCT00924170|3948356|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4122943|NCT00924118|3948395|B3|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4122944|NCT00924118|3948396|B2|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4122945|NCT00924118|3948397|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4122946|NCT00924118|3948395|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4122947|NCT00924118|3948396|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4122948|NCT00924118|3948397|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4122950|NCT00924118|3948396|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4122951|NCT00924118|3948397|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4122952|NCT00924118|3948395|B3|||Age||years|Mean|59.4|59.4|Full Range|||44.0|76.0|
4122953|NCT00924118|3948396|B2|||Age||years|Mean|59.2|59.2|Full Range|||46.0|72.0|
4122954|NCT00924118|3948397|B1|||Age||years|Mean|59.6|59.6|Full Range|||44.0|76.0|
4122955|NCT00924118|3948395|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4122956|NCT00924118|3948396|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4122957|NCT00924118|3948397|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4122958|NCT00924118|3948395|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4122959|NCT00924118|3948396|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4122960|NCT00924118|3948397|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4122961|NCT00924118|3948395|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4122962|NCT00924118|3948396|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4122963|NCT00924118|3948397|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4122964|NCT00924066|3948406|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4122965|NCT00924066|3948406|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4122966|NCT00924066|3948406|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4122967|NCT00924066|3948406|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4122968|NCT00924066|3948406|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4122969|NCT00924066|3948406|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4122970|NCT00924066|3948406|B1||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4122971|NCT00924066|3948406|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4122972|NCT00924066|3948406|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4122973|NCT00924066|3948406|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4122974|NCT00924066|3948406|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4122975|NCT00924066|3948406|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4122976|NCT00924066|3948406|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4122977|NCT00924066|3948406|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4122978|NCT00924066|3948406|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4122979|NCT00924066|3948406|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4122980|NCT00924066|3948406|B1|||Age||years|Mean|46.79|46.79|Standard Deviation|9.17|9.17|||
4122981|NCT00924053|3948411|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4122982|NCT00924053|3948412|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4122983|NCT00924053|3948413|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4122984|NCT00924053|3948414|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4122985|NCT00924053|3948415|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4122986|NCT00924053|3948411|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4122987|NCT00924053|3948412|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4122988|NCT00924053|3948413|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4122989|NCT00924053|3948414|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4122990|NCT00924053|3948415|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4122991|NCT00924053|3948411|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4122992|NCT00924053|3948412|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4122993|NCT00924053|3948413|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4122994|NCT00924053|3948414|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4122995|NCT00924053|3948415|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4122996|NCT00924053|3948411|B5||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4122997|NCT00924053|3948412|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4122998|NCT00924053|3948413|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4122999|NCT00924053|3948414|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4123000|NCT00924053|3948415|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4123001|NCT00924053|3948411|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123002|NCT00924053|3948412|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123003|NCT00924053|3948413|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123004|NCT00924053|3948414|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123005|NCT00924053|3948415|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123006|NCT00924040|3948464|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4123007|NCT00924040|3948464|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123008|NCT00924040|3948464|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123009|NCT00924040|3948464|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123010|NCT00924040|3948464|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123011|NCT00924040|3948464|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123012|NCT00924040|3948464|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123013|NCT00924040|3948464|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123014|NCT00924040|3948464|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123015|NCT00924040|3948464|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123016|NCT00924040|3948464|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123017|NCT00924040|3948464|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4123018|NCT00924040|3948464|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4123019|NCT00924040|3948464|B1|||Age||years|Mean|65.2|65.2|Standard Deviation|0|0.0|||
4123020|NCT00924040|3948464|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4123021|NCT00924040|3948464|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4123022|NCT00924040|3948464|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123023|NCT00924001|3948476|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4123024|NCT00924001|3948476|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123025|NCT00924001|3948476|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123026|NCT00924001|3948476|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123027|NCT00924001|3948476|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123028|NCT00924001|3948476|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123029|NCT00924001|3948476|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123030|NCT00924001|3948476|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123031|NCT00924001|3948476|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123032|NCT00924001|3948476|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123033|NCT00924001|3948476|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123034|NCT00924001|3948476|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4123035|NCT00924001|3948476|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4123036|NCT00924001|3948476|B1|||Age||years|Mean|32.0|32.0|Standard Deviation|||||
4123037|NCT00924001|3948476|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4123038|NCT00924001|3948476|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4123039|NCT00924001|3948476|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123040|NCT00923975|3948482|B1|United States||Region of Enrollment|Baseline measures were analyzed using only data for the young adults (18-24 years of age) and parents/guardians (18 to 47 years of age) of children with diabetes, not healthcare professionals. Data was not used from one subject withdrawn from the study because the subject did not meet inclusion criteria.|participants|Number|47|47.0||||||
4123041|NCT00923975|3948482|B1||Male|Sex: Female, Male|Baseline measures were analyzed using only data for the young adults (18-24 years of age) and parents/guardians (18 to 47 years of age) of children with diabetes, not healthcare professionals. Data was not used from one subject withdrawn from the study because the subject did not meet inclusion criteria.|Participants|Count of Participants|18|18.0||||||
4123042|NCT00923975|3948482|B1||Female|Sex: Female, Male|Baseline measures were analyzed using only data for the young adults (18-24 years of age) and parents/guardians (18 to 47 years of age) of children with diabetes, not healthcare professionals. Data was not used from one subject withdrawn from the study because the subject did not meet inclusion criteria.|Participants|Count of Participants|29|29.0||||||
4123043|NCT00923975|3948482|B1|||Age|Baseline participants included young adults with diabetes (age 18 to 24)and parents/guardians (age 18 to 47) of children with diabetes; note healthcare professionals were not included in this measure. One young adult subject was withdrawn from the study (did not meet inclusion criteria) and the data was not used in the analysis.|years|Median|26.9|26.9|Full Range|||18.0|47.0|
4123044|NCT00923949|3948489|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4123045|NCT00923949|3948489|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123046|NCT00923949|3948489|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123047|NCT00923949|3948489|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123048|NCT00923949|3948489|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123049|NCT00923949|3948489|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123050|NCT00923949|3948489|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123051|NCT00923949|3948489|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123052|NCT00923949|3948489|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123053|NCT00923949|3948489|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123054|NCT00923949|3948489|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123055|NCT00923949|3948489|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4123056|NCT00923949|3948489|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4123057|NCT00923949|3948489|B1|||Age||years|Mean|74.5|74.5|Standard Deviation|0|0.0|||
4123058|NCT00923949|3948489|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4123059|NCT00923949|3948489|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4123060|NCT00923949|3948489|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123061|NCT00923936|3948499|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4123062|NCT00923936|3948500|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4123063|NCT00923936|3948501|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4123064|NCT00923936|3948499|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4123065|NCT00923936|3948500|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123066|NCT00923936|3948501|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123067|NCT00923936|3948499|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4123068|NCT00923936|3948500|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123069|NCT00923936|3948501|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123070|NCT00923936|3948499|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4123071|NCT00923936|3948500|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123072|NCT00923936|3948501|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4123073|NCT00923936|3948499|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4123074|NCT00923936|3948500|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4123075|NCT00923936|3948501|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4123076|NCT00923936|3948499|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123077|NCT00923936|3948500|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123078|NCT00923936|3948501|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123079|NCT00923936|3948499|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123080|NCT00923936|3948500|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123081|NCT00923936|3948501|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123082|NCT00923936|3948499|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123083|NCT00923936|3948500|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123084|NCT00923936|3948501|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123085|NCT00923936|3948499|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123086|NCT00923936|3948500|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123087|NCT00923936|3948501|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123088|NCT00923936|3948499|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4123089|NCT00923936|3948500|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4123090|NCT00923936|3948501|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4123091|NCT00923936|3948499|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4123092|NCT00923936|3948500|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4123093|NCT00923936|3948501|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4123094|NCT00923936|3948499|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4123095|NCT00923936|3948500|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4123096|NCT00923936|3948501|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4123097|NCT00923936|3948499|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4123098|NCT00923936|3948500|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4123099|NCT00923936|3948501|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4123100|NCT00923936|3948499|B3|||Age||years|Mean|45.95|45.95|Full Range|||24.8|57.9|
4123101|NCT00923936|3948500|B2|||Age||years|Mean|40.85|40.85|Full Range|||32.0|57.9|
4123102|NCT00923936|3948501|B1|||Age||years|Mean|50.85|50.85|Full Range|||24.8|57.1|
4123103|NCT00923936|3948499|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4123104|NCT00923936|3948500|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4123105|NCT00923936|3948501|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4123106|NCT00923936|3948499|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4123107|NCT00923936|3948500|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4123108|NCT00923936|3948501|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4123109|NCT00923936|3948499|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123110|NCT00923936|3948500|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123111|NCT00923936|3948501|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123112|NCT00923910|3948516|B3|Patient 5||Time to First Vaccine (from day 0 of HCT), mo||Months|Number|15|15.0||||||
4123113|NCT00923910|3948517|B2|Patient 5||Time to First Vaccine (from day 0 of HCT), mo||Months|Number|15|15.0||||||
4123114|NCT00923910|3948516|B3|Patient 4||Time to First Vaccine (from day 0 of HCT), mo||Months|Number|29|29.0||||||
4123115|NCT00923910|3948517|B2|Patient 4||Time to First Vaccine (from day 0 of HCT), mo||Months|Number|29|29.0||||||
4123116|NCT00923910|3948516|B3|Patient 3||Time to First Vaccine (from day 0 of HCT), mo||Months|Number|14|14.0||||||
4123117|NCT00923910|3948517|B2|Patient 3||Time to First Vaccine (from day 0 of HCT), mo||Months|Number|14|14.0||||||
4123118|NCT00923910|3948516|B3|Patient 2||Time to First Vaccine (from day 0 of HCT), mo||Months|Number|32|32.0||||||
4123119|NCT00923910|3948517|B2|Patient 2||Time to First Vaccine (from day 0 of HCT), mo||Months|Number|32|32.0||||||
4123120|NCT00923910|3948516|B3|Patient 1||Time to First Vaccine (from day 0 of HCT), mo||Months|Number|14|14.0||||||
4123121|NCT00923910|3948517|B2|Patient 1||Time to First Vaccine (from day 0 of HCT), mo||Months|Number|14|14.0||||||
4123122|NCT00923910|3948516|B3|Patient 5||Time to HCT to Relapse, mo||Months|Number|12|12.0||||||
4123123|NCT00923910|3948517|B2|Patient 5||Time to HCT to Relapse, mo||Months|Number|12|12.0||||||
4123124|NCT00923910|3948516|B3|Patient 4||Time to HCT to Relapse, mo||Months|Number|11|11.0||||||
4123125|NCT00923910|3948517|B2|Patient 4||Time to HCT to Relapse, mo||Months|Number|11|11.0||||||
4123126|NCT00923910|3948516|B3|Patient 3||Time to HCT to Relapse, mo||Months|Number|12|12.0||||||
4123127|NCT00923910|3948517|B2|Patient 3||Time to HCT to Relapse, mo||Months|Number|12|12.0||||||
4123128|NCT00923910|3948516|B3|Patient 2||Time to HCT to Relapse, mo||Months|Number|1|1.0||||||
4123129|NCT00923910|3948517|B2|Patient 2||Time to HCT to Relapse, mo||Months|Number|1|1.0||||||
4123130|NCT00923910|3948516|B3|Patient 1||Time to HCT to Relapse, mo||Months|Number|8|8.0||||||
4123131|NCT00923910|3948517|B2|Patient 1||Time to HCT to Relapse, mo||Months|Number|8|8.0||||||
4123132|NCT00923910|3948516|B3|5% blasts||Pre-Enrollment Disease Status||participants|Number|1|1.0||||||
4123133|NCT00923910|3948517|B2|5% blasts||Pre-Enrollment Disease Status||participants|Number|1|1.0||||||
4123134|NCT00923910|3948516|B3|2% blasts||Pre-Enrollment Disease Status||participants|Number|1|1.0||||||
4123135|NCT00923910|3948517|B2|2% blasts||Pre-Enrollment Disease Status||participants|Number|1|1.0||||||
4123136|NCT00923910|3948516|B3|5%-10% blasts||Pre-Enrollment Disease Status||participants|Number|1|1.0||||||
4123137|NCT00923910|3948517|B2|5%-10% blasts||Pre-Enrollment Disease Status||participants|Number|1|1.0||||||
4123138|NCT00923910|3948516|B3|Multiple 1-2cm lymph nodes||Pre-Enrollment Disease Status||participants|Number|1|1.0||||||
4123139|NCT00923910|3948517|B2|Multiple 1-2cm lymph nodes||Pre-Enrollment Disease Status||participants|Number|1|1.0||||||
4123140|NCT00923910|3948516|B3|6%-8% blasts||Pre-Enrollment Disease Status||participants|Number|1|1.0||||||
4123141|NCT00923910|3948517|B2|6%-8% blasts||Pre-Enrollment Disease Status||participants|Number|1|1.0||||||
4123142|NCT00923910|3948516|B3|Patient 5||Time Off Immunosuppression before Protocol Enrollment||Months|Number|9|9.0||||||
4123143|NCT00923910|3948517|B2|Patient 5||Time Off Immunosuppression before Protocol Enrollment||Months|Number|9|9.0||||||
4123144|NCT00923910|3948516|B3|Patient 4||Time Off Immunosuppression before Protocol Enrollment||Months|Number|23|23.0||||||
4123145|NCT00923910|3948517|B2|Patient 4||Time Off Immunosuppression before Protocol Enrollment||Months|Number|23|23.0||||||
4123146|NCT00923910|3948516|B3|Patient 3||Time Off Immunosuppression before Protocol Enrollment||Months|Number|11|11.0||||||
4123147|NCT00923910|3948517|B2|Patient 3||Time Off Immunosuppression before Protocol Enrollment||Months|Number|11|11.0||||||
4123148|NCT00923910|3948516|B3|Patient 2||Time Off Immunosuppression before Protocol Enrollment||Months|Number|28|28.0||||||
4123149|NCT00923910|3948517|B2|Patient 2||Time Off Immunosuppression before Protocol Enrollment||Months|Number|28|28.0||||||
4123150|NCT00923910|3948516|B3|Patient 1||Time Off Immunosuppression before Protocol Enrollment||Months|Number|10|10.0||||||
4123151|NCT00923910|3948517|B2|Patient 1||Time Off Immunosuppression before Protocol Enrollment||Months|Number|10|10.0||||||
4123152|NCT00923910|3948516|B3|None after second BMT||Immunosuppression|BMT, bone marrow transplant|participants|Number|1|1.0||||||
4123153|NCT00923910|3948517|B2|None after second BMT||Immunosuppression|BMT, bone marrow transplant|participants|Number|1|1.0||||||
4123154|NCT00923910|3948516|B3|Sirolimus/tacrolimus, methotrexate||Immunosuppression|BMT, bone marrow transplant|participants|Number|1|1.0||||||
4123155|NCT00923910|3948517|B2|Sirolimus/tacrolimus, methotrexate||Immunosuppression|BMT, bone marrow transplant|participants|Number|1|1.0||||||
4123156|NCT00923910|3948516|B3|Cyclosporine||Immunosuppression|BMT, bone marrow transplant|participants|Number|3|3.0||||||
4123157|NCT00923910|3948517|B2|Cyclosporine||Immunosuppression|BMT, bone marrow transplant|participants|Number|3|3.0||||||
4123158|NCT00923910|3948516|B3|Cyclophosphamide, TBI||Conditioning Regimen|TBI, total body irradiation; cyclo, cyclophosphamide; etop, etoposide; HSCT, hematopoietic stem cell transplant|participants|Number|1|1.0||||||
4123159|NCT00923910|3948517|B2|Cyclophosphamide, TBI||Conditioning Regimen|TBI, total body irradiation; cyclo, cyclophosphamide; etop, etoposide; HSCT, hematopoietic stem cell transplant|participants|Number|1|1.0||||||
4123160|NCT00923910|3948516|B3|HSCT1:cyclo,TBI;HSCT2:busulfan, melphalan, etop||Conditioning Regimen|TBI, total body irradiation; cyclo, cyclophosphamide; etop, etoposide; HSCT, hematopoietic stem cell transplant|participants|Number|1|1.0||||||
4123161|NCT00923910|3948517|B2|HSCT1:cyclo,TBI;HSCT2:busulfan, melphalan, etop||Conditioning Regimen|TBI, total body irradiation; cyclo, cyclophosphamide; etop, etoposide; HSCT, hematopoietic stem cell transplant|participants|Number|1|1.0||||||
4123162|NCT00923910|3948516|B3|Cyclophosphamide, TBI, thiotepa||Conditioning Regimen|TBI, total body irradiation; cyclo, cyclophosphamide; etop, etoposide; HSCT, hematopoietic stem cell transplant|participants|Number|1|1.0||||||
4123163|NCT00923910|3948517|B2|Cyclophosphamide, TBI, thiotepa||Conditioning Regimen|TBI, total body irradiation; cyclo, cyclophosphamide; etop, etoposide; HSCT, hematopoietic stem cell transplant|participants|Number|1|1.0||||||
4123164|NCT00923910|3948516|B3|Fludarabine/cyclophosphamide||Conditioning Regimen|TBI, total body irradiation; cyclo, cyclophosphamide; etop, etoposide; HSCT, hematopoietic stem cell transplant|participants|Number|2|2.0||||||
4123165|NCT00923910|3948517|B2|Fludarabine/cyclophosphamide||Conditioning Regimen|TBI, total body irradiation; cyclo, cyclophosphamide; etop, etoposide; HSCT, hematopoietic stem cell transplant|participants|Number|2|2.0||||||
4123166|NCT00923910|3948516|B3|MUD||Donors|MSD, matched sibling donor; MRD*, matched related donor. MRD* was a 10/10 matched related parent for both transplantations. the first used marrow and the second used peripheral blood stem cells.; MUD, matched unrelated donor.|participants|Number|1|1.0||||||
4123208|NCT00923910|3948516|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123167|NCT00923910|3948518|B1|MUD||Donors|MSD, matched sibling donor; MRD*, matched related donor. MRD* was a 10/10 matched related parent for both transplantations. the first used marrow and the second used peripheral blood stem cells.; MUD, matched unrelated donor.|participants|Number|1|1.0||||||
4123168|NCT00923910|3948516|B3|MRD*||Donors|MSD, matched sibling donor; MRD*, matched related donor. MRD* was a 10/10 matched related parent for both transplantations. the first used marrow and the second used peripheral blood stem cells.; MUD, matched unrelated donor.|participants|Number|1|1.0||||||
4123169|NCT00923910|3948518|B1|MRD*||Donors|MSD, matched sibling donor; MRD*, matched related donor. MRD* was a 10/10 matched related parent for both transplantations. the first used marrow and the second used peripheral blood stem cells.; MUD, matched unrelated donor.|participants|Number|1|1.0||||||
4123170|NCT00923910|3948516|B3|MSD||Donors|MSD, matched sibling donor; MRD*, matched related donor. MRD* was a 10/10 matched related parent for both transplantations. the first used marrow and the second used peripheral blood stem cells.; MUD, matched unrelated donor.|participants|Number|3|3.0||||||
4123171|NCT00923910|3948518|B1|MSD||Donors|MSD, matched sibling donor; MRD*, matched related donor. MRD* was a 10/10 matched related parent for both transplantations. the first used marrow and the second used peripheral blood stem cells.; MUD, matched unrelated donor.|participants|Number|3|3.0||||||
4123172|NCT00923910|3948516|B3|MA x 2||Transplantation Type|NMA, nonmyeloablative; MA, myeloablative; MAx2, myeloablative conditioning. This is standard terminology in the transplant field and refers to pre-transplant chemotherapy/radiation doses that require stem cell rescue.|participants|Number|1|1.0||||||
4123173|NCT00923910|3948517|B2|MA x 2||Transplantation Type|NMA, nonmyeloablative; MA, myeloablative; MAx2, myeloablative conditioning. This is standard terminology in the transplant field and refers to pre-transplant chemotherapy/radiation doses that require stem cell rescue.|participants|Number|1|1.0||||||
4123174|NCT00923910|3948516|B3|MA||Transplantation Type|NMA, nonmyeloablative; MA, myeloablative; MAx2, myeloablative conditioning. This is standard terminology in the transplant field and refers to pre-transplant chemotherapy/radiation doses that require stem cell rescue.|participants|Number|2|2.0||||||
4123175|NCT00923910|3948517|B2|MA||Transplantation Type|NMA, nonmyeloablative; MA, myeloablative; MAx2, myeloablative conditioning. This is standard terminology in the transplant field and refers to pre-transplant chemotherapy/radiation doses that require stem cell rescue.|participants|Number|2|2.0||||||
4123176|NCT00923910|3948516|B3|NMA||Transplantation Type|NMA, nonmyeloablative; MA, myeloablative; MAx2, myeloablative conditioning. This is standard terminology in the transplant field and refers to pre-transplant chemotherapy/radiation doses that require stem cell rescue.|participants|Number|2|2.0||||||
4123177|NCT00923910|3948517|B2|NMA||Transplantation Type|NMA, nonmyeloablative; MA, myeloablative; MAx2, myeloablative conditioning. This is standard terminology in the transplant field and refers to pre-transplant chemotherapy/radiation doses that require stem cell rescue.|participants|Number|2|2.0||||||
4123178|NCT00923910|3948516|B3|AML||Disease|ALL, acute lymphocytic leukemia; AML, acute myeloid leukemia.|participants|Number|1|1.0||||||
4123179|NCT00923910|3948517|B2|AML||Disease|ALL, acute lymphocytic leukemia; AML, acute myeloid leukemia.|participants|Number|1|1.0||||||
4123180|NCT00923910|3948516|B3|ALL||Disease|ALL, acute lymphocytic leukemia; AML, acute myeloid leukemia.|participants|Number|3|3.0||||||
4123181|NCT00923910|3948517|B2|ALL||Disease|ALL, acute lymphocytic leukemia; AML, acute myeloid leukemia.|participants|Number|3|3.0||||||
4123182|NCT00923910|3948516|B3|Hodgkin||Disease|ALL, acute lymphocytic leukemia; AML, acute myeloid leukemia.|participants|Number|1|1.0||||||
4123183|NCT00923910|3948517|B2|Hodgkin||Disease|ALL, acute lymphocytic leukemia; AML, acute myeloid leukemia.|participants|Number|1|1.0||||||
4123184|NCT00923910|3948516|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4123185|NCT00923910|3948517|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4123186|NCT00923910|3948518|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4123187|NCT00923910|3948516|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123188|NCT00923910|3948517|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123189|NCT00923910|3948518|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123190|NCT00923910|3948516|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123191|NCT00923910|3948517|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123192|NCT00923910|3948518|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123193|NCT00923910|3948516|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4123194|NCT00923910|3948517|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4123195|NCT00923910|3948518|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4123196|NCT00923910|3948516|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123197|NCT00923910|3948517|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123198|NCT00923910|3948518|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123199|NCT00923910|3948516|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123200|NCT00923910|3948517|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123201|NCT00923910|3948518|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123202|NCT00923910|3948516|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123203|NCT00923910|3948517|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123204|NCT00923910|3948518|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123205|NCT00923910|3948516|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123206|NCT00923910|3948517|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123207|NCT00923910|3948518|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123209|NCT00923910|3948517|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123210|NCT00923910|3948518|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123211|NCT00923910|3948516|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4123212|NCT00923910|3948517|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4123213|NCT00923910|3948518|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4123214|NCT00923910|3948516|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4123215|NCT00923910|3948517|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123216|NCT00923910|3948518|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123217|NCT00923910|3948516|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4123218|NCT00923910|3948517|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4123219|NCT00923910|3948518|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4123220|NCT00923910|3948516|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4123221|NCT00923910|3948517|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4123222|NCT00923910|3948518|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4123223|NCT00923910|3948516|B3|||Age||years|Median|19|19.0|Standard Deviation|8.72|8.72|||
4123224|NCT00923910|3948517|B2|||Age||years|Median|17|17.0|Standard Deviation|3.71|3.71|||
4123225|NCT00923910|3948518|B1|||Age||years|Median|21|21.0|Standard Deviation|9.17|9.17|||
4123226|NCT00923910|3948516|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4123227|NCT00923910|3948517|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4123228|NCT00923910|3948518|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4123229|NCT00923910|3948516|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4123230|NCT00923910|3948517|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4123231|NCT00923910|3948518|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4123232|NCT00923910|3948516|B3||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4123233|NCT00923910|3948517|B2||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4123234|NCT00923910|3948518|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4123235|NCT00923845|3948529|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4123236|NCT00923845|3948530|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4123237|NCT00923845|3948531|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4123238|NCT00923845|3948529|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123239|NCT00923845|3948530|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123240|NCT00923845|3948531|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123241|NCT00923845|3948529|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123242|NCT00923845|3948530|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123243|NCT00923845|3948531|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123244|NCT00923845|3948529|B3||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4123245|NCT00923845|3948530|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4123246|NCT00923845|3948531|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4123247|NCT00923845|3948529|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4123248|NCT00923845|3948530|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123249|NCT00923845|3948531|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123250|NCT00923845|3948529|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123251|NCT00923845|3948530|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123252|NCT00923845|3948531|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123253|NCT00923845|3948529|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123254|NCT00923845|3948530|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123255|NCT00923845|3948531|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123256|NCT00923845|3948529|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123257|NCT00923845|3948530|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123258|NCT00923845|3948531|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123259|NCT00923845|3948529|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4123260|NCT00923845|3948530|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123261|NCT00923845|3948531|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4123262|NCT00923845|3948529|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4123263|NCT00923845|3948530|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4123264|NCT00923845|3948531|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4123265|NCT00923845|3948529|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123615|NCT00923130|3948821|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4123266|NCT00923845|3948530|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123267|NCT00923845|3948531|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123268|NCT00923845|3948529|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4123269|NCT00923845|3948530|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4123270|NCT00923845|3948531|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4123271|NCT00923845|3948529|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4123272|NCT00923845|3948530|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4123273|NCT00923845|3948531|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4123274|NCT00923845|3948529|B3|||Age||years|Mean|55.48|55.48|Standard Deviation|8.75|8.75|||
4123275|NCT00923845|3948530|B2|||Age||years|Mean|58.03|58.03|Standard Deviation|8.01|8.01|||
4123276|NCT00923845|3948531|B1|||Age||years|Mean|53.14|53.14|Standard Deviation|9.06|9.06|||
4123277|NCT00923845|3948529|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4123278|NCT00923845|3948530|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4123279|NCT00923845|3948531|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4123280|NCT00923845|3948529|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4123281|NCT00923845|3948530|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4123282|NCT00923845|3948531|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4123283|NCT00923845|3948529|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123284|NCT00923845|3948530|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123285|NCT00923845|3948531|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123286|NCT00923481|3948553|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4123287|NCT00923481|3948553|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123288|NCT00923481|3948553|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123289|NCT00923481|3948553|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4123290|NCT00923481|3948553|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4123291|NCT00923481|3948553|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123292|NCT00923481|3948553|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4123293|NCT00923481|3948553|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123294|NCT00923481|3948553|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123295|NCT00923481|3948553|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4123296|NCT00923481|3948553|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123297|NCT00923481|3948553|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4123298|NCT00923481|3948553|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4123299|NCT00923481|3948553|B1|||Age||years|Mean|57.73|57.73|Standard Deviation|9.59|9.59|||
4123300|NCT00923481|3948553|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4123301|NCT00923481|3948553|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4123302|NCT00923481|3948553|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123303|NCT00923364|3948558|B1|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4123304|NCT00923364|3948558|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123305|NCT00923364|3948558|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123306|NCT00923364|3948558|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4123307|NCT00923364|3948558|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4123308|NCT00923364|3948558|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123309|NCT00923364|3948558|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4123310|NCT00923364|3948558|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123311|NCT00923364|3948558|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123312|NCT00923364|3948558|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4123313|NCT00923364|3948558|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4123314|NCT00923364|3948558|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4123315|NCT00923364|3948558|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4123316|NCT00923364|3948558|B1|||Age||years|Mean|30.21|30.21|Standard Deviation|7.61|7.61|||
4123317|NCT00923364|3948558|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4123318|NCT00923364|3948558|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4123319|NCT00923364|3948558|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4123320|NCT00923351|3948569|B3|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
4123321|NCT00923351|3948570|B2|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
4123322|NCT00923351|3948571|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4123323|NCT00923351|3948569|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4123324|NCT00923351|3948570|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4123325|NCT00923351|3948571|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4123326|NCT00923351|3948569|B3|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4123327|NCT00923351|3948570|B2|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4123328|NCT00923351|3948571|B1|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4123329|NCT00923351|3948569|B3|More than one race||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4123330|NCT00923351|3948570|B2|More than one race||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4123331|NCT00923351|3948571|B1|More than one race||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4123332|NCT00923351|3948569|B3|White (non-Hispanic)||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
4123333|NCT00923351|3948570|B2|White (non-Hispanic)||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
4123334|NCT00923351|3948571|B1|White (non-Hispanic)||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4123335|NCT00923351|3948569|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4123336|NCT00923351|3948570|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4123337|NCT00923351|3948571|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4123338|NCT00923351|3948569|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4123339|NCT00923351|3948570|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4123340|NCT00923351|3948571|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4123341|NCT00923351|3948569|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4123342|NCT00923351|3948570|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4123343|NCT00923351|3948571|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4123344|NCT00923351|3948569|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4123345|NCT00923351|3948570|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4123346|NCT00923351|3948571|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4123347|NCT00923351|3948569|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4123348|NCT00923351|3948570|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4123349|NCT00923351|3948571|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123350|NCT00923351|3948569|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4123351|NCT00923351|3948570|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4123352|NCT00923351|3948571|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4123353|NCT00923351|3948569|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4123354|NCT00923351|3948570|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4123355|NCT00923351|3948571|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123356|NCT00923351|3948569|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4123357|NCT00923351|3948570|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4123358|NCT00923351|3948571|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4123359|NCT00923351|3948569|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4123360|NCT00923351|3948570|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4123361|NCT00923351|3948571|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4123362|NCT00923351|3948569|B3|||Age||years|Mean|21.0|21.0|Standard Deviation|8.04|8.04|||
4123363|NCT00923351|3948570|B2|||Age||years|Mean|20.96|20.96|Standard Deviation|8.19|8.19|||
4123364|NCT00923351|3948571|B1|||Age||years|Mean|21.6|21.6|Standard Deviation|7.56|7.56|||
4123365|NCT00923351|3948569|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4123366|NCT00923351|3948570|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4123367|NCT00923351|3948571|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4123368|NCT00923351|3948569|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4123369|NCT00923351|3948570|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4123370|NCT00923351|3948571|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4123371|NCT00923351|3948569|B3||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
4123372|NCT00923351|3948570|B2||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4123373|NCT00923351|3948571|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4123374|NCT00923273|3948583|B6|United States||Region of Enrollment||participants|Number|42|42.0||||||
4123375|NCT00923273|3948584|B5|United States||Region of Enrollment||participants|Number|5|5.0||||||
4123376|NCT00923273|3948585|B4|United States||Region of Enrollment||participants|Number|27|27.0||||||
4123377|NCT00923273|3948586|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4123378|NCT00923273|3948587|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4123379|NCT00923273|3948588|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4123380|NCT00923273|3948583|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4123381|NCT00923273|3948584|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123382|NCT00923273|3948585|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123383|NCT00923273|3948586|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123384|NCT00923273|3948587|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123385|NCT00923273|3948588|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123386|NCT00923273|3948583|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123387|NCT00923273|3948584|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123388|NCT00923273|3948585|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123389|NCT00923273|3948586|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123390|NCT00923273|3948587|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123391|NCT00923273|3948588|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123392|NCT00923273|3948583|B6||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4123393|NCT00923273|3948584|B5||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4123394|NCT00923273|3948585|B4||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4123395|NCT00923273|3948586|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123396|NCT00923273|3948587|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123397|NCT00923273|3948588|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4123398|NCT00923273|3948583|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4123399|NCT00923273|3948584|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123400|NCT00923273|3948585|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4123401|NCT00923273|3948586|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123402|NCT00923273|3948587|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123403|NCT00923273|3948588|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123404|NCT00923273|3948583|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123405|NCT00923273|3948584|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123406|NCT00923273|3948585|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123407|NCT00923273|3948586|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123408|NCT00923273|3948587|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123409|NCT00923273|3948588|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123410|NCT00923273|3948583|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4123411|NCT00923273|3948584|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123412|NCT00923273|3948585|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4123413|NCT00923273|3948586|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123414|NCT00923273|3948587|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123415|NCT00923273|3948588|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123416|NCT00923273|3948583|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123417|NCT00923273|3948584|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123418|NCT00923273|3948585|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123419|NCT00923273|3948586|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123420|NCT00923273|3948587|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123421|NCT00923273|3948588|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123422|NCT00923273|3948583|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123423|NCT00923273|3948584|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123424|NCT00923273|3948585|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123425|NCT00923273|3948586|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123426|NCT00923273|3948587|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123427|NCT00923273|3948588|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123428|NCT00923273|3948583|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4123429|NCT00923273|3948584|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4123430|NCT00923273|3948585|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4123431|NCT00923273|3948586|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4123432|NCT00923273|3948587|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4123433|NCT00923273|3948588|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4123434|NCT00923273|3948583|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4123435|NCT00923273|3948584|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123673|NCT00923117|3948839|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4123436|NCT00923273|3948585|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4123437|NCT00923273|3948586|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123438|NCT00923273|3948587|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123439|NCT00923273|3948588|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123440|NCT00923273|3948583|B6||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4123441|NCT00923273|3948584|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4123442|NCT00923273|3948585|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4123443|NCT00923273|3948586|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4123444|NCT00923273|3948587|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4123445|NCT00923273|3948588|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4123446|NCT00923273|3948583|B6||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4123447|NCT00923273|3948584|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4123448|NCT00923273|3948585|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4123449|NCT00923273|3948586|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4123450|NCT00923273|3948587|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4123451|NCT00923273|3948588|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4123452|NCT00923273|3948583|B6|||Age||years|Mean|60.6|60.6|Standard Deviation|11.99|11.99|||
4123453|NCT00923273|3948584|B5|||Age||years|Mean|56.08|56.08|Standard Deviation|10.75|10.75|||
4123454|NCT00923273|3948585|B4|||Age||years|Mean|59.5|59.5|Standard Deviation|11.48|11.48|||
4123455|NCT00923273|3948586|B3|||Age||years|Mean|61.7|61.7|Standard Deviation|24.74|24.74|||
4123456|NCT00923273|3948587|B2|||Age||years|Mean|71.57|71.57|Standard Deviation|3.76|3.76|||
4123457|NCT00923273|3948588|B1|||Age||years|Mean|64.65|64.65|Standard Deviation|7.84|7.84|||
4123458|NCT00923273|3948583|B6||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4123459|NCT00923273|3948584|B5||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4123460|NCT00923273|3948585|B4||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4123461|NCT00923273|3948586|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4123462|NCT00923273|3948587|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4123463|NCT00923273|3948588|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4123464|NCT00923273|3948583|B6||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4123465|NCT00923273|3948584|B5||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4123466|NCT00923273|3948585|B4||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4123467|NCT00923273|3948586|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4123468|NCT00923273|3948587|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4123469|NCT00923273|3948588|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4123470|NCT00923273|3948583|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123471|NCT00923273|3948584|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123472|NCT00923273|3948585|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123473|NCT00923273|3948586|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123474|NCT00923273|3948587|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123475|NCT00923273|3948588|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123476|NCT00923260|3948615|B3|Mexico||Region of Enrollment||participants|Number|24|24.0||||||
4123477|NCT00923260|3948616|B2|Mexico||Region of Enrollment||participants|Number|12|12.0||||||
4123478|NCT00923260|3948617|B1|Mexico||Region of Enrollment||participants|Number|12|12.0||||||
4123479|NCT00923260|3948615|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4123480|NCT00923260|3948616|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4123481|NCT00923260|3948617|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4123482|NCT00923260|3948615|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4123483|NCT00923260|3948616|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4123484|NCT00923260|3948617|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4123485|NCT00923260|3948615|B3|||Age||years|Mean|38.3|38.3|Standard Deviation|11.9|11.9|||
4123486|NCT00923260|3948616|B2|||Age||years|Mean|39.8|39.8|Standard Deviation|11.1|11.1|||
4123487|NCT00923260|3948617|B1|||Age||years|Mean|36.8|36.8|Standard Deviation|12.9|12.9|||
4123488|NCT00923260|3948615|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4123489|NCT00923260|3948616|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4123490|NCT00923260|3948617|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4123491|NCT00923260|3948615|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4123492|NCT00923260|3948616|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4123493|NCT00923260|3948617|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4123494|NCT00923260|3948615|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123495|NCT00923260|3948616|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123496|NCT00923260|3948617|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123497|NCT00923247|3948750|B3|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4123498|NCT00923247|3948751|B2|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4123499|NCT00923247|3948752|B1|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
4123500|NCT00923247|3948750|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123501|NCT00923247|3948751|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123502|NCT00923247|3948752|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123503|NCT00923247|3948750|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123504|NCT00923247|3948751|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123505|NCT00923247|3948752|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123506|NCT00923247|3948750|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4123507|NCT00923247|3948751|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123508|NCT00923247|3948752|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4123509|NCT00923247|3948750|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4123510|NCT00923247|3948751|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123511|NCT00923247|3948752|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4123512|NCT00923247|3948750|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123513|NCT00923247|3948751|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123514|NCT00923247|3948752|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123515|NCT00923247|3948750|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123516|NCT00923247|3948751|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123517|NCT00923247|3948752|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123518|NCT00923247|3948750|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123519|NCT00923247|3948751|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123520|NCT00923247|3948752|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123521|NCT00923247|3948750|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123522|NCT00923247|3948751|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123523|NCT00923247|3948752|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123524|NCT00923247|3948750|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4123525|NCT00923247|3948751|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123526|NCT00923247|3948752|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4123527|NCT00923247|3948750|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123528|NCT00923247|3948751|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123529|NCT00923247|3948752|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123530|NCT00923247|3948750|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4123531|NCT00923247|3948751|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4123532|NCT00923247|3948752|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4123533|NCT00923247|3948750|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4123534|NCT00923247|3948751|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4123535|NCT00923247|3948752|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4123536|NCT00923247|3948750|B3|||Age||years|Mean|55.34|55.34|Standard Deviation|10.58|10.58|||
4123537|NCT00923247|3948751|B2|||Age||years|Mean|39.8|39.8|Standard Deviation|0|0.0|||
4123538|NCT00923247|3948752|B1|||Age||years|Mean|56.07|56.07|Standard Deviation|10|10.0|||
4123539|NCT00923247|3948750|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4123540|NCT00923247|3948751|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4123541|NCT00923247|3948752|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4123542|NCT00923247|3948750|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4123543|NCT00923247|3948751|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4123544|NCT00923247|3948752|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4123545|NCT00923247|3948750|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123546|NCT00923247|3948751|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123547|NCT00923247|3948752|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123548|NCT00923195|3948779|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4123549|NCT00923195|3948780|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4123550|NCT00923195|3948781|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4123551|NCT00923195|3948779|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123552|NCT00923195|3948780|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123553|NCT00923195|3948781|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123554|NCT00923195|3948779|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123555|NCT00923195|3948780|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123556|NCT00923195|3948781|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123557|NCT00923195|3948779|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4123558|NCT00923195|3948780|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4123559|NCT00923195|3948781|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4123560|NCT00923195|3948779|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123561|NCT00923195|3948780|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123562|NCT00923195|3948781|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123563|NCT00923195|3948779|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123564|NCT00923195|3948780|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123565|NCT00923195|3948781|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123566|NCT00923195|3948779|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123567|NCT00923195|3948780|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123568|NCT00923195|3948781|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123569|NCT00923195|3948779|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123570|NCT00923195|3948780|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123571|NCT00923195|3948781|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123572|NCT00923195|3948779|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123573|NCT00923195|3948780|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123574|NCT00923195|3948781|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123575|NCT00923195|3948779|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4123576|NCT00923195|3948780|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4123577|NCT00923195|3948781|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4123578|NCT00923195|3948779|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123579|NCT00923195|3948780|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123580|NCT00923195|3948781|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123581|NCT00923195|3948779|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4123582|NCT00923195|3948780|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4123583|NCT00923195|3948781|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4123584|NCT00923195|3948779|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4123585|NCT00923195|3948780|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4123586|NCT00923195|3948781|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4123587|NCT00923195|3948779|B3|||Age||years|Mean|48.0|48.0|Standard Deviation|7.5|7.5|||
4123588|NCT00923195|3948780|B2|||Age||years|Mean|47.5|47.5|Standard Deviation|12.0|12.0|||
4123589|NCT00923195|3948781|B1|||Age||years|Mean|48.5|48.5|Standard Deviation|4.9|4.9|||
4123590|NCT00923195|3948779|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4123591|NCT00923195|3948780|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4123592|NCT00923195|3948781|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4123593|NCT00923195|3948779|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4123594|NCT00923195|3948780|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4123595|NCT00923195|3948781|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4123596|NCT00923195|3948779|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123597|NCT00923195|3948780|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123598|NCT00923195|3948781|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123599|NCT00923156|3948790|B4||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4123600|NCT00923156|3948791|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4123601|NCT00923156|3948792|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4123602|NCT00923156|3948793|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4123603|NCT00923156|3948790|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4123604|NCT00923156|3948791|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4123605|NCT00923156|3948792|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4123606|NCT00923156|3948793|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4123607|NCT00923156|3948790|B4|||Age||years|Mean|62.6|62.6|Standard Deviation|9.83|9.83|||
4123608|NCT00923156|3948791|B3|||Age||years|Mean|62.0|62.0|Standard Deviation|10.47|10.47|||
4123609|NCT00923156|3948792|B2|||Age||years|Mean|64.3|64.3|Standard Deviation|9.91|9.91|||
4123610|NCT00923156|3948793|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|9.00|9.0|||
4123611|NCT00923130|3948821|B1|||Prior Therapies||therapies|Median|2|2.0|Full Range|||1.0|5.0|
4123612|NCT00923130|3948821|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4123613|NCT00923130|3948821|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123614|NCT00923130|3948821|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123616|NCT00923130|3948821|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4123617|NCT00923130|3948821|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123618|NCT00923130|3948821|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123619|NCT00923130|3948821|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123620|NCT00923130|3948821|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123621|NCT00923130|3948821|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4123622|NCT00923130|3948821|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4123623|NCT00923130|3948821|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4123624|NCT00923130|3948821|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4123625|NCT00923130|3948821|B1|||Age||years|Mean|61.17|61.17|Standard Deviation|9.08|9.08|||
4123626|NCT00923130|3948821|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4123627|NCT00923130|3948821|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4123628|NCT00923130|3948821|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123629|NCT00923117|3948837|B3|United States||Region of Enrollment||participants|Number|87|87.0||||||
4123630|NCT00923117|3948838|B2|United States||Region of Enrollment||participants|Number|43|43.0||||||
4123631|NCT00923117|3948839|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4123632|NCT00923117|3948837|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4123633|NCT00923117|3948838|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4123634|NCT00923117|3948839|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4123635|NCT00923117|3948837|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123636|NCT00923117|3948838|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123637|NCT00923117|3948839|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123638|NCT00923117|3948837|B3||White|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
4123639|NCT00923117|3948838|B2||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4123640|NCT00923117|3948839|B1||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4123641|NCT00923117|3948837|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4123642|NCT00923117|3948838|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123643|NCT00923117|3948839|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4123644|NCT00923117|3948837|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123645|NCT00923117|3948838|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123646|NCT00923117|3948839|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123647|NCT00923117|3948837|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123648|NCT00923117|3948838|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123649|NCT00923117|3948839|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123650|NCT00923117|3948837|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123651|NCT00923117|3948838|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123652|NCT00923117|3948839|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123653|NCT00923117|3948837|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123654|NCT00923117|3948838|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123655|NCT00923117|3948839|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123656|NCT00923117|3948837|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4123657|NCT00923117|3948838|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4123658|NCT00923117|3948839|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4123659|NCT00923117|3948837|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123660|NCT00923117|3948838|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123661|NCT00923117|3948839|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123662|NCT00923117|3948837|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4123663|NCT00923117|3948838|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4123664|NCT00923117|3948839|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4123665|NCT00923117|3948837|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4123666|NCT00923117|3948838|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4123667|NCT00923117|3948839|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4123668|NCT00923117|3948837|B3|||Age||years|Mean|51.01|51.01|Standard Deviation|13.07|13.07|||
4123669|NCT00923117|3948838|B2|||Age||years|Mean|50.38|50.38|Standard Deviation|13.88|13.88|||
4123670|NCT00923117|3948839|B1|||Age||years|Mean|51.63|51.63|Standard Deviation|12.36|12.36|||
4123671|NCT00923117|3948837|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4123672|NCT00923117|3948838|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4123674|NCT00923117|3948837|B3||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
4123675|NCT00923117|3948838|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4123676|NCT00923117|3948839|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4123677|NCT00923117|3948837|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123678|NCT00923117|3948838|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123679|NCT00923117|3948839|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123680|NCT00923091|3948848|B9|Europe||Region of Enrollment||Participants|Number|2689|2689.0||||||
4123681|NCT00923091|3948849|B8|Europe||Region of Enrollment||Participants|Number|336|336.0||||||
4123682|NCT00923091|3948850|B7|Europe||Region of Enrollment||Participants|Number|337|337.0||||||
4123683|NCT00923091|3948851|B6|Europe||Region of Enrollment||Participants|Number|337|337.0||||||
4123684|NCT00923091|3948852|B5|Europe||Region of Enrollment||Participants|Number|336|336.0||||||
4123685|NCT00923091|3948853|B4|Europe||Region of Enrollment||Participants|Number|336|336.0||||||
4123686|NCT00923091|3948854|B3|Europe||Region of Enrollment||Participants|Number|336|336.0||||||
4123687|NCT00923091|3948855|B2|Europe||Region of Enrollment||Participants|Number|336|336.0||||||
4123688|NCT00923091|3948856|B1|Europe||Region of Enrollment||Participants|Number|335|335.0||||||
4123689|NCT00923091|3948848|B9|White||Race/Ethnicity, Customized||Participants|Number|2685|2685.0||||||
4123690|NCT00923091|3948849|B8|White||Race/Ethnicity, Customized||Participants|Number|335|335.0||||||
4123691|NCT00923091|3948850|B7|White||Race/Ethnicity, Customized||Participants|Number|337|337.0||||||
4123692|NCT00923091|3948851|B6|White||Race/Ethnicity, Customized||Participants|Number|337|337.0||||||
4123693|NCT00923091|3948852|B5|White||Race/Ethnicity, Customized||Participants|Number|336|336.0||||||
4123694|NCT00923091|3948853|B4|White||Race/Ethnicity, Customized||Participants|Number|335|335.0||||||
4123695|NCT00923091|3948854|B3|White||Race/Ethnicity, Customized||Participants|Number|335|335.0||||||
4123696|NCT00923091|3948855|B2|White||Race/Ethnicity, Customized||Participants|Number|336|336.0||||||
4123697|NCT00923091|3948856|B1|White||Race/Ethnicity, Customized||Participants|Number|334|334.0||||||
4123698|NCT00923091|3948848|B9|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4123699|NCT00923091|3948849|B8|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4123700|NCT00923091|3948850|B7|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4123701|NCT00923091|3948851|B6|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4123702|NCT00923091|3948852|B5|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4123703|NCT00923091|3948853|B4|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4123704|NCT00923091|3948854|B3|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4123705|NCT00923091|3948855|B2|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4123706|NCT00923091|3948856|B1|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4123707|NCT00923091|3948848|B9|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4123708|NCT00923091|3948849|B8|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4123709|NCT00923091|3948850|B7|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4123710|NCT00923091|3948851|B6|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4123711|NCT00923091|3948852|B5|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4123712|NCT00923091|3948853|B4|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4123713|NCT00923091|3948854|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4123714|NCT00923091|3948855|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4123715|NCT00923091|3948856|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4123716|NCT00923091|3948848|B9||Male|Sex: Female, Male||Participants|Count of Participants|1246|1246.0||||||
4123717|NCT00923091|3948849|B8||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4123718|NCT00923091|3948850|B7||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4123719|NCT00923091|3948851|B6||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4123720|NCT00923091|3948852|B5||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4123721|NCT00923091|3948853|B4||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4123722|NCT00923091|3948854|B3||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4123723|NCT00923091|3948855|B2||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4123724|NCT00923091|3948856|B1||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4123725|NCT00923091|3948848|B9||Female|Sex: Female, Male||Participants|Count of Participants|1443|1443.0||||||
4123726|NCT00923091|3948849|B8||Female|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4123727|NCT00923091|3948850|B7||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4123728|NCT00923091|3948851|B6||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4123729|NCT00923091|3948852|B5||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4123730|NCT00923091|3948853|B4||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4123731|NCT00923091|3948854|B3||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4123732|NCT00923091|3948855|B2||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4123733|NCT00923091|3948856|B1||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4123734|NCT00923091|3948848|B9|||Age||years|Mean|56.5|56.5|Standard Deviation|10.53|10.53|||
4123735|NCT00923091|3948849|B8|||Age||years|Mean|57.0|57.0|Standard Deviation|9.70|9.7|||
4123736|NCT00923091|3948850|B7|||Age||years|Mean|56.4|56.4|Standard Deviation|10.4|10.4|||
4123737|NCT00923091|3948851|B6|||Age||years|Mean|56.1|56.1|Standard Deviation|10.22|10.22|||
4123738|NCT00923091|3948852|B5|||Age||years|Mean|55.9|55.9|Standard Deviation|11.08|11.08|||
4123739|NCT00923091|3948853|B4|||Age||years|Mean|57.0|57.0|Standard Deviation|10.72|10.72|||
4123740|NCT00923091|3948854|B3|||Age||years|Mean|56.5|56.5|Standard Deviation|10.92|10.92|||
4123741|NCT00923091|3948855|B2|||Age||years|Mean|56.8|56.8|Standard Deviation|10.36|10.36|||
4123742|NCT00923091|3948856|B1|||Age||years|Mean|56.0|56.0|Standard Deviation|10.81|10.81|||
4123743|NCT00923078|3948915|B4|||Positive and Negative Syndrome Scale (PANSS)|Clinical interview rating of schizophrenia symptom severity. The PANSS has a possible score range of 30-210 across 30 items, with higher scores indicating greater symptom distress. Per test literature, stable outpatients typically score between 60-80, and inpatient cases seldom exceed 80-150 at highest severity.|units on a scale|Mean|56.8|56.8|Standard Deviation|13.25|13.25|||
4123744|NCT00923078|3948917|B2|||Positive and Negative Syndrome Scale (PANSS)|Clinical interview rating of schizophrenia symptom severity. The PANSS has a possible score range of 30-210 across 30 items, with higher scores indicating greater symptom distress. Per test literature, stable outpatients typically score between 60-80, and inpatient cases seldom exceed 80-150 at highest severity.|units on a scale|Mean|56.8|56.8|Standard Deviation|13.94|13.94|||
4123745|NCT00923078|3948918|B1|||Positive and Negative Syndrome Scale (PANSS)|Clinical interview rating of schizophrenia symptom severity. The PANSS has a possible score range of 30-210 across 30 items, with higher scores indicating greater symptom distress. Per test literature, stable outpatients typically score between 60-80, and inpatient cases seldom exceed 80-150 at highest severity.|units on a scale|Mean|56.8|56.8|Standard Deviation|12.89|12.89|||
4123746|NCT00923078|3948915|B4|||Cognitive Composite Score|MATRICS Consensus Cognitive Battery (MCCB) cognitive composite score, reported as age- and gender-corrected t-score (M=50, SD =10) with higher score indicating better cognitive ability|t-score|Mean|37.57|37.57|Standard Deviation|14.45|14.45|||
4123747|NCT00923078|3948916|B3|||Cognitive Composite Score|MATRICS Consensus Cognitive Battery (MCCB) cognitive composite score, reported as age- and gender-corrected t-score (M=50, SD =10) with higher score indicating better cognitive ability|t-score|Mean|45.95|45.95|Standard Deviation|13.70|13.7|||
4123748|NCT00923078|3948917|B2|||Cognitive Composite Score|MATRICS Consensus Cognitive Battery (MCCB) cognitive composite score, reported as age- and gender-corrected t-score (M=50, SD =10) with higher score indicating better cognitive ability|t-score|Mean|30.40|30.4|Standard Deviation|12.87|12.87|||
4123749|NCT00923078|3948918|B1|||Cognitive Composite Score|MATRICS Consensus Cognitive Battery (MCCB) cognitive composite score, reported as age- and gender-corrected t-score (M=50, SD =10) with higher score indicating better cognitive ability|t-score|Mean|36.35|36.35|Standard Deviation|12.86|12.86|||
4123750|NCT00923078|3948915|B4|||IQ|Estimated IQ derived from age, gender, race normative performance of the Wechsler Test of Adult Reading (WTAR). IQ scores reported in standard form with M = 100, SD = 15|units on a scale|Mean|95.25|95.25|Standard Deviation|14.90|14.9|||
4123751|NCT00923078|3948916|B3|||IQ|Estimated IQ derived from age, gender, race normative performance of the Wechsler Test of Adult Reading (WTAR). IQ scores reported in standard form with M = 100, SD = 15|units on a scale|Mean|103.26|103.26|Standard Deviation|13.86|13.86|||
4123752|NCT00923078|3948917|B2|||IQ|Estimated IQ derived from age, gender, race normative performance of the Wechsler Test of Adult Reading (WTAR). IQ scores reported in standard form with M = 100, SD = 15|units on a scale|Mean|87.70|87.7|Standard Deviation|12.32|12.32|||
4123753|NCT00923078|3948918|B1|||IQ|Estimated IQ derived from age, gender, race normative performance of the Wechsler Test of Adult Reading (WTAR). IQ scores reported in standard form with M = 100, SD = 15|units on a scale|Mean|95.20|95.2|Standard Deviation|14.83|14.83|||
4123754|NCT00923078|3948915|B4|United States||Region of Enrollment||participants|Number|60|60.0||||||
4123755|NCT00923078|3948916|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4123756|NCT00923078|3948917|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4123757|NCT00923078|3948918|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4123758|NCT00923078|3948915|B4||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4123759|NCT00923078|3948916|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4123760|NCT00923078|3948917|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4123761|NCT00923078|3948918|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4123762|NCT00923078|3948915|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4123763|NCT00923078|3948916|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4123764|NCT00923078|3948917|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4123765|NCT00923078|3948918|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4123766|NCT00923078|3948915|B4|||Age||years|Mean|43.78|43.78|Standard Deviation|13.05|13.05|||
4123767|NCT00923078|3948916|B3|||Age||years|Mean|39.15|39.15|Standard Deviation|13.39|13.39|||
4123768|NCT00923078|3948917|B2|||Age||years|Mean|46.55|46.55|Standard Deviation|12.85|12.85|||
4123769|NCT00923078|3948918|B1|||Age||years|Mean|45.65|45.65|Standard Deviation|12.26|12.26|||
4123770|NCT00923078|3948915|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4123771|NCT00923078|3948916|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4123772|NCT00923078|3948917|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4123773|NCT00923078|3948918|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4123774|NCT00923078|3948915|B4||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4123775|NCT00923078|3948916|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4123776|NCT00923078|3948917|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4123777|NCT00923078|3948918|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4123778|NCT00923078|3948915|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123779|NCT00923078|3948916|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123780|NCT00923078|3948917|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123781|NCT00923078|3948918|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123782|NCT00922987|3948939|B1|||28-Day partial seizure frequency|The partial seizure frequency for the baseline period was the total number of partial seizures recorded for that period at Visit 0 (week 0). This was evaluated for 264 participants.|seizures|Mean|2.31|2.31|Standard Deviation|1.33|1.33|||
4123783|NCT00922987|3948939|B1|Zentronal||Prior anti-epileptic medications||Participants|Number|1|1.0||||||
4123784|NCT00922987|3948939|B1|Vigabatrin||Prior anti-epileptic medications||Participants|Number|1|1.0||||||
4123785|NCT00922987|3948939|B1|Valproic acid||Prior anti-epileptic medications||Participants|Number|66|66.0||||||
4123786|NCT00922987|3948939|B1|Valproate sodium||Prior anti-epileptic medications||Participants|Number|24|24.0||||||
4123787|NCT00922987|3948939|B1|Topiramate||Prior anti-epileptic medications||Participants|Number|40|40.0||||||
4123788|NCT00922987|3948939|B1|Sultiame||Prior anti-epileptic medications||Participants|Number|1|1.0||||||
4123789|NCT00922987|3948939|B1|Primidone||Prior anti-epileptic medications||Participants|Number|1|1.0||||||
4123790|NCT00922987|3948939|B1|Pregabalin||Prior anti-epileptic medications||Participants|Number|15|15.0||||||
4123791|NCT00922987|3948939|B1|Phenytoin||Prior anti-epileptic medications||Participants|Number|14|14.0||||||
4123792|NCT00922987|3948939|B1|Phenobarbital||Prior anti-epileptic medications||Participants|Number|2|2.0||||||
4123793|NCT00922987|3948939|B1|Oxcarbazepine||Prior anti-epileptic medications||Participants|Number|12|12.0||||||
4123794|NCT00922987|3948939|B1|Levetiracetam||Prior anti-epileptic medications||Participants|Number|30|30.0||||||
4123795|NCT00922987|3948939|B1|Lamotrigine||Prior anti-epileptic medications||Participants|Number|57|57.0||||||
4123796|NCT00922987|3948939|B1|Lacosamide||Prior anti-epileptic medications||Participants|Number|4|4.0||||||
4123797|NCT00922987|3948939|B1|Gabapentin||Prior anti-epileptic medications||Participants|Number|2|2.0||||||
4123798|NCT00922987|3948939|B1|Ergenyl chrono||Prior anti-epileptic medications||Participants|Number|27|27.0||||||
4123799|NCT00922987|3948939|B1|Clonazepam||Prior anti-epileptic medications||Participants|Number|7|7.0||||||
4123800|NCT00922987|3948939|B1|Cinolazepam||Prior anti-epileptic medications||Participants|Number|1|1.0||||||
4123801|NCT00922987|3948939|B1|Carbamazepine||Prior anti-epileptic medications||Participants|Number|135|135.0||||||
4123802|NCT00922987|3948939|B1|Hypertension||Comorbidities in the past||Participants|Number|2|2.0||||||
4123803|NCT00922987|3948939|B1|Subdural haematoma evacuation||Comorbidities in the past||Participants|Number|1|1.0||||||
4123804|NCT00922987|3948939|B1|Strabismus correction||Comorbidities in the past||Participants|Number|1|1.0||||||
4123805|NCT00922987|3948939|B1|Spinal laminectomy||Comorbidities in the past||Participants|Number|1|1.0||||||
4123806|NCT00922987|3948939|B1|Spinal anaesthesia||Comorbidities in the past||Participants|Number|1|1.0||||||
4123807|NCT00922987|3948939|B1|Meningioma surgery||Comorbidities in the past||Participants|Number|1|1.0||||||
4123808|NCT00922987|3948939|B1|Inguinal hernia repair||Comorbidities in the past||Participants|Number|1|1.0||||||
4123809|NCT00922987|3948939|B1|Hysterectomy||Comorbidities in the past||Participants|Number|1|1.0||||||
4123810|NCT00922987|3948939|B1|Glaucoma surgery||Comorbidities in the past||Participants|Number|1|1.0||||||
4123811|NCT00922987|3948939|B1|Craniotomy||Comorbidities in the past||Participants|Number|1|1.0||||||
4123812|NCT00922987|3948939|B1|Cholecystectomy||Comorbidities in the past||Participants|Number|1|1.0||||||
4123813|NCT00922987|3948939|B1|Appendicectomy||Comorbidities in the past||Participants|Number|1|1.0||||||
4123814|NCT00922987|3948939|B1|Pulmonary embolism||Comorbidities in the past||Participants|Number|1|1.0||||||
4123815|NCT00922987|3948939|B1|Neonatal asphyxia||Comorbidities in the past||Participants|Number|1|1.0||||||
4123816|NCT00922987|3948939|B1|Psychotic disorder||Comorbidities in the past||Participants|Number|1|1.0||||||
4123817|NCT00922987|3948939|B1|Depression||Comorbidities in the past||Participants|Number|2|2.0||||||
4123818|NCT00922987|3948939|B1|Alcohol abuse||Comorbidities in the past||Participants|Number|1|1.0||||||
4123819|NCT00922987|3948939|B1|Delivery||Comorbidities in the past||Participants|Number|1|1.0||||||
4123820|NCT00922987|3948939|B1|Neuritis||Comorbidities in the past||Participants|Number|1|1.0||||||
4123821|NCT00922987|3948939|B1|Hypoxic encephalopathy||Comorbidities in the past||Participants|Number|1|1.0||||||
4123822|NCT00922987|3948939|B1|Hypotonia||Comorbidities in the past||Participants|Number|1|1.0||||||
4123823|NCT00922987|3948939|B1|Headache||Comorbidities in the past||Participants|Number|1|1.0||||||
4123824|NCT00922987|3948939|B1|Epilepsy||Comorbidities in the past||Participants|Number|1|1.0||||||
4123825|NCT00922987|3948939|B1|Encephalopathy||Comorbidities in the past||Participants|Number|3|3.0||||||
4123826|NCT00922987|3948939|B1|Encephalomalacia||Comorbidities in the past||Participants|Number|1|1.0||||||
4123827|NCT00922987|3948939|B1|Encephalitis||Comorbidities in the past||Participants|Number|3|3.0||||||
4123828|NCT00922987|3948939|B1|Demyelination||Comorbidities in the past||Participants|Number|1|1.0||||||
4123829|NCT00922987|3948939|B1|Convulsion||Comorbidities in the past||Participants|Number|1|1.0||||||
4123830|NCT00922987|3948939|B1|Cerebrovascular accident||Comorbidities in the past||Participants|Number|3|3.0||||||
4123831|NCT00922987|3948939|B1|Cerebral hemorrhage||Comorbidities in the past||Participants|Number|1|1.0||||||
4123832|NCT00922987|3948939|B1|Central nervous system lesion||Comorbidities in the past||Participants|Number|1|1.0||||||
4123833|NCT00922987|3948939|B1|Pleura carcinoma||Comorbidities in the past||Participants|Number|1|1.0||||||
4123834|NCT00922987|3948939|B1|Meningioma||Comorbidities in the past||Participants|Number|5|5.0||||||
4123835|NCT00922987|3948939|B1|Brain neoplasm||Comorbidities in the past||Participants|Number|2|2.0||||||
4123836|NCT00922987|3948939|B1|Muscle spasms||Comorbidities in the past||Participants|Number|1|1.0||||||
4123837|NCT00922987|3948939|B1|Back pain||Comorbidities in the past||Participants|Number|1|1.0||||||
4123838|NCT00922987|3948939|B1|Hepatitis B surface antigen positive||Comorbidities in the past||Participants|Number|1|1.0||||||
4123839|NCT00922987|3948939|B1|Traumatic brain injury||Comorbidities in the past||Participants|Number|5|5.0||||||
4123840|NCT00922987|3948939|B1|Subdural haematoma||Comorbidities in the past||Participants|Number|1|1.0||||||
4123841|NCT00922987|3948939|B1|Head injury||Comorbidities in the past||Participants|Number|2|2.0||||||
4123842|NCT00922987|3948939|B1|Femur fracture||Comorbidities in the past||Participants|Number|1|1.0||||||
4123843|NCT00922987|3948939|B1|Extradural haematoma||Comorbidities in the past||Participants|Number|1|1.0||||||
4123844|NCT00922987|3948939|B1|Concussion||Comorbidities in the past||Participants|Number|2|2.0||||||
4123845|NCT00922987|3948939|B1|Brain contusion||Comorbidities in the past||Participants|Number|4|4.0||||||
4123846|NCT00922987|3948939|B1|Meningitis||Comorbidities in the past||Participants|Number|1|1.0||||||
4123847|NCT00922987|3948939|B1|Herpes zoster||Comorbidities in the past||Participants|Number|1|1.0||||||
4123848|NCT00922987|3948939|B1|Hepatitis non-A non-B||Comorbidities in the past||Participants|Number|1|1.0||||||
4123849|NCT00922987|3948939|B1|Hepatitis toxic||Comorbidities in the past||Participants|Number|1|1.0||||||
4123850|NCT00922987|3948939|B1|Pyrexia||Comorbidities in the past||Participants|Number|1|1.0||||||
4123851|NCT00922987|3948939|B1|Ill-defined disorder||Comorbidities in the past||Participants|Number|4|4.0||||||
4123852|NCT00922987|3948939|B1|Gastric ulcer||Comorbidities in the past||Participants|Number|1|1.0||||||
4123853|NCT00922987|3948939|B1|Dyspepsia||Comorbidities in the past||Participants|Number|1|1.0||||||
4123854|NCT00922987|3948939|B1|Hypothyroidism||Comorbidities in the past||Participants|Number|1|1.0||||||
4123855|NCT00922987|3948939|B1|Transposition of great vessels||Comorbidities in the past||Participants|Number|1|1.0||||||
4123856|NCT00922987|3948939|B1|Hypercoagulation||Comorbidities in the past||Participants|Number|1|1.0||||||
4123857|NCT00922987|3948939|B1|Unspecified||Sex/Gender, Customized||participants|Number|2|2.0||||||
4123858|NCT00922987|3948939|B1|Female||Sex/Gender, Customized||participants|Number|142|142.0||||||
4123859|NCT00922987|3948939|B1|Male||Sex/Gender, Customized||participants|Number|137|137.0||||||
4123860|NCT00922987|3948939|B1|||Age||years|Mean|43.7|43.7|Standard Deviation|13.7|13.7|||
4123861|NCT00922935|3948951|B4|Sweden||Region of Enrollment||participants|Number|36|36.0||||||
4123862|NCT00922935|3948952|B3|Sweden||Region of Enrollment||participants|Number|10|10.0||||||
4123863|NCT00922935|3948953|B2|Sweden||Region of Enrollment||participants|Number|16|16.0||||||
4123864|NCT00922935|3948954|B1|Sweden||Region of Enrollment||participants|Number|10|10.0||||||
4123865|NCT00922935|3948951|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4123866|NCT00922935|3948952|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4123867|NCT00922935|3948953|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4123868|NCT00922935|3948954|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4123869|NCT00922935|3948951|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4123870|NCT00922935|3948952|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4123871|NCT00922935|3948953|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4123872|NCT00922935|3948954|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4123873|NCT00922935|3948951|B4|||Age||years|Mean|65.1|65.1|Standard Deviation|9.9|9.9|||
4123874|NCT00922935|3948952|B3|||Age||years|Mean|67.1|67.1|Standard Deviation|7|7.0|||
4123875|NCT00922935|3948953|B2|||Age||years|Mean|64.2|64.2|Standard Deviation|10.7|10.7|||
4123876|NCT00922935|3948954|B1|||Age||years|Mean|64.1|64.1|Standard Deviation|12.2|12.2|||
4123877|NCT00922935|3948951|B4||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4123878|NCT00922935|3948952|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4123879|NCT00922935|3948953|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4123880|NCT00922935|3948954|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4123881|NCT00922935|3948951|B4||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4123882|NCT00922935|3948952|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4123883|NCT00922935|3948953|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4123884|NCT00922935|3948954|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4123885|NCT00922935|3948951|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123886|NCT00922935|3948952|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123887|NCT00922935|3948953|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123888|NCT00922935|3948954|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4123889|NCT00922883|3948964|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4123890|NCT00922883|3948964|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4123891|NCT00922883|3948964|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4123892|NCT00922883|3948964|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4123893|NCT00922883|3948964|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123894|NCT00922883|3948964|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123895|NCT00922883|3948964|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123896|NCT00922883|3948964|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123897|NCT00922883|3948964|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4123898|NCT00922883|3948964|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4123899|NCT00922883|3948964|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4123900|NCT00922883|3948964|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4123901|NCT00922883|3948964|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4123902|NCT00922883|3948964|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4123903|NCT00922883|3948964|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4123904|NCT00922779|3948968|B1|Missing||Sex/Gender, Customized||Participants|Number|15|15.0||||||
4123905|NCT00922779|3948968|B1|Female||Sex/Gender, Customized||Participants|Number|2250|2250.0||||||
4123906|NCT00922779|3948968|B1|Male||Sex/Gender, Customized||Participants|Number|4396|4396.0||||||
4123907|NCT00922779|3948968|B1|||Age|"Here, number of participants analyzed for baseline measure age was 6622."|Years|Mean|34.21|34.21|Standard Deviation|9.81|9.81|||
4123908|NCT00922766|3948975|B1||Male|Sex: Female, Male||Participants|Count of Participants|368|368.0||||||
4123909|NCT00922766|3948975|B1||Female|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
4123910|NCT00922766|3948975|B1|||Age||years|Mean|57.5|57.5|Standard Deviation|12.6|12.6|||
4123911|NCT00922701|3948984|B1|||Ultrafiltration|Ultrafiltration measured at the end of the long dwell (nocturnal) exchange|milliliters|Mean|1987|1987.0|Standard Deviation|192|192.0|||
4123912|NCT00922701|3948984|B1|Italy||Region of Enrollment||participants|Number|4|4.0||||||
4123913|NCT00922701|3948984|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4123914|NCT00922701|3948984|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4123915|NCT00922701|3948984|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|11.9|11.9|||
4123916|NCT00922636|3948988|B6|United States||Region of Enrollment||participants|Number|290|290.0||||||
4123917|NCT00922636|3948989|B5|United States||Region of Enrollment||participants|Number|63|63.0||||||
4123918|NCT00922636|3948990|B4|United States||Region of Enrollment||participants|Number|65|65.0||||||
4123919|NCT00922636|3948991|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
4123920|NCT00922636|3948992|B2|United States||Region of Enrollment||participants|Number|67|67.0||||||
4123921|NCT00922636|3948993|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4123922|NCT00922636|3948988|B6|Taiwan||Region of Enrollment||participants|Number|16|16.0||||||
4123923|NCT00922636|3948989|B5|Taiwan||Region of Enrollment||participants|Number|4|4.0||||||
4123924|NCT00922636|3948990|B4|Taiwan||Region of Enrollment||participants|Number|3|3.0||||||
4123925|NCT00922636|3948991|B3|Taiwan||Region of Enrollment||participants|Number|5|5.0||||||
4123926|NCT00922636|3948992|B2|Taiwan||Region of Enrollment||participants|Number|4|4.0||||||
4123927|NCT00922636|3948993|B1|Taiwan||Region of Enrollment||participants|Number|0|0.0||||||
4123928|NCT00922636|3948988|B6|Puerto Rico||Region of Enrollment||participants|Number|14|14.0||||||
4123929|NCT00922636|3948989|B5|Puerto Rico||Region of Enrollment||participants|Number|3|3.0||||||
4123930|NCT00922636|3948990|B4|Puerto Rico||Region of Enrollment||participants|Number|2|2.0||||||
4123931|NCT00922636|3948991|B3|Puerto Rico||Region of Enrollment||participants|Number|4|4.0||||||
4123932|NCT00922636|3948992|B2|Puerto Rico||Region of Enrollment||participants|Number|3|3.0||||||
4123933|NCT00922636|3948993|B1|Puerto Rico||Region of Enrollment||participants|Number|2|2.0||||||
4123934|NCT00922636|3948988|B6|Mexico||Region of Enrollment||participants|Number|2|2.0||||||
4123935|NCT00922636|3948989|B5|Mexico||Region of Enrollment||participants|Number|1|1.0||||||
4123936|NCT00922636|3948990|B4|Mexico||Region of Enrollment||participants|Number|0|0.0||||||
4123937|NCT00922636|3948991|B3|Mexico||Region of Enrollment||participants|Number|1|1.0||||||
4123938|NCT00922636|3948992|B2|Mexico||Region of Enrollment||participants|Number|0|0.0||||||
4123939|NCT00922636|3948993|B1|Mexico||Region of Enrollment||participants|Number|0|0.0||||||
4123940|NCT00922636|3948988|B6|Canada||Region of Enrollment||participants|Number|18|18.0||||||
4123941|NCT00922636|3948989|B5|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4123942|NCT00922636|3948990|B4|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4123943|NCT00922636|3948991|B3|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4123944|NCT00922636|3948992|B2|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4123945|NCT00922636|3948993|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4123946|NCT00922636|3948988|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123947|NCT00922636|3948989|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123948|NCT00922636|3948990|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123949|NCT00922636|3948991|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123950|NCT00922636|3948992|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123951|NCT00922636|3948993|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123952|NCT00922636|3948988|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4123953|NCT00922636|3948989|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4123954|NCT00922636|3948990|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4123955|NCT00922636|3948991|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4123956|NCT00922636|3948992|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4123957|NCT00922636|3948993|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4123958|NCT00922636|3948988|B6||White|Race (NIH/OMB)||Participants|Count of Participants|247|247.0||||||
4123959|NCT00922636|3948989|B5||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4123960|NCT00922636|3948990|B4||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4123961|NCT00922636|3948991|B3||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4123962|NCT00922636|3948992|B2||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4123963|NCT00922636|3948993|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4123964|NCT00922636|3948988|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4123965|NCT00922636|3948989|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4123966|NCT00922636|3948990|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4123967|NCT00922636|3948991|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4123968|NCT00922636|3948992|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4123969|NCT00922636|3948993|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4123970|NCT00922636|3948988|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123971|NCT00922636|3948989|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123972|NCT00922636|3948990|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123973|NCT00922636|3948991|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123974|NCT00922636|3948992|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123975|NCT00922636|3948993|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123976|NCT00922636|3948988|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4123977|NCT00922636|3948989|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4123978|NCT00922636|3948990|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4123979|NCT00922636|3948991|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4123980|NCT00922636|3948992|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4123981|NCT00922636|3948993|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123982|NCT00922636|3948988|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4123983|NCT00922636|3948989|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123984|NCT00922636|3948990|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4123985|NCT00922636|3948991|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4123986|NCT00922636|3948992|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123987|NCT00922636|3948993|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123988|NCT00922636|3948988|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123989|NCT00922636|3948989|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123990|NCT00922636|3948990|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123991|NCT00922636|3948991|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123992|NCT00922636|3948992|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123993|NCT00922636|3948993|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4123994|NCT00922636|3948988|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|251|251.0||||||
4123995|NCT00922636|3948989|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4123996|NCT00922636|3948990|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4123997|NCT00922636|3948991|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4123998|NCT00922636|3948992|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4123999|NCT00922636|3948993|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4124000|NCT00922636|3948988|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
4124001|NCT00922636|3948989|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4124002|NCT00922636|3948990|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4124003|NCT00922636|3948991|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4124004|NCT00922636|3948992|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4124005|NCT00922636|3948993|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4124006|NCT00922636|3948988|B6||Male|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
4124007|NCT00922636|3948989|B5||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4124008|NCT00922636|3948990|B4||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4124009|NCT00922636|3948991|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4124010|NCT00922636|3948992|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4124011|NCT00922636|3948993|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4124012|NCT00922636|3948988|B6||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4124013|NCT00922636|3948989|B5||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4124014|NCT00922636|3948990|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4124015|NCT00922636|3948991|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4124016|NCT00922636|3948992|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4124017|NCT00922636|3948993|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4124018|NCT00922636|3948988|B6|||Age||years|Mean|11.63|11.63|Standard Deviation|3.07|3.07|||
4124019|NCT00922636|3948989|B5|||Age||years|Mean|11.47|11.47|Standard Deviation|3.10|3.1|||
4124020|NCT00922636|3948990|B4|||Age||years|Mean|12.59|12.59|Standard Deviation|2.81|2.81|||
4124021|NCT00922636|3948991|B3|||Age||years|Mean|11.90|11.9|Standard Deviation|3.03|3.03|||
4124022|NCT00922636|3948992|B2|||Age||years|Mean|11.37|11.37|Standard Deviation|3.07|3.07|||
4124023|NCT00922636|3948993|B1|||Age||years|Mean|9.92|9.92|Standard Deviation|2.94|2.94|||
4124024|NCT00922623|3949144|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4124025|NCT00922623|3949144|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|90|90.0||||||
4124026|NCT00922623|3949144|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4124027|NCT00922623|3949144|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4124028|NCT00922623|3949144|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4124029|NCT00922623|3949144|B1|||Age||years|Mean|51.5|51.5|Standard Deviation|10.1|10.1|||
4124030|NCT00922623|3949144|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4124031|NCT00922623|3949144|B1||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
4124032|NCT00922623|3949144|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4124033|NCT00922480|3949150|B3||Male|Sex: Female, Male||Participants|Count of Participants|335|335.0||||||
4124034|NCT00922480|3949151|B2||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4124035|NCT00922480|3949152|B1||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4124036|NCT00922480|3949150|B3||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4124037|NCT00922480|3949151|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4124038|NCT00922480|3949152|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4124039|NCT00922480|3949150|B3|||Age||years|Mean|53.77|53.77|Standard Deviation|9.19|9.19|||
4124040|NCT00922480|3949151|B2|||Age||years|Mean|53.96|53.96|Standard Deviation|8.79|8.79|||
4124041|NCT00922480|3949152|B1|||Age||years|Mean|53.58|53.58|Standard Deviation|9.61|9.61|||
4124042|NCT00922441|3949161|B4||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4124043|NCT00922441|3949162|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4124044|NCT00922441|3949163|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4124045|NCT00922441|3949164|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4124046|NCT00922441|3949161|B4||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4124047|NCT00922441|3949162|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4124048|NCT00922441|3949163|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4124049|NCT00922441|3949164|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4124050|NCT00922441|3949161|B4|||Age||years|Mean|54.09|54.09|Standard Deviation|8.18|8.18|||
4124051|NCT00922441|3949162|B3|||Age||years|Mean|56.00|56.0|Standard Deviation|7.15|7.15|||
4124052|NCT00922441|3949163|B2|||Age||years|Mean|54.07|54.07|Standard Deviation|8.79|8.79|||
4124053|NCT00922441|3949164|B1|||Age||years|Mean|52.07|52.07|Standard Deviation|8.36|8.36|||
4124054|NCT00922428|3949174|B1|Germany||Region of Enrollment||participants|Number|1374|1374.0||||||
4124055|NCT00922428|3949174|B1|unknown||Sex/Gender, Customized|gender of the patients|participants|Number|11|11.0||||||
4124056|NCT00922428|3949174|B1|female||Sex/Gender, Customized|gender of the patients|participants|Number|926|926.0||||||
4124057|NCT00922428|3949174|B1|male||Sex/Gender, Customized|gender of the patients|participants|Number|437|437.0||||||
4124058|NCT00922428|3949174|B1|||Age||years|Mean|59.9|59.9|Standard Deviation|15.5|15.5|||
4124059|NCT00922428|3949174|B1||>=65 years|Age||Participants|Count of Participants|580|580.0||||||
4124060|NCT00922428|3949174|B1||Between 18 and 65 years|Age||Participants|Count of Participants|791|791.0||||||
4124061|NCT00922428|3949174|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4124062|NCT00922272|3949203|B1|United States||Region of Enrollment||participants|Number|92|92.0||||||
4124063|NCT00922272|3949203|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4124064|NCT00922272|3949203|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4124065|NCT00922272|3949203|B1|>55 years||Age, Customized||participants|Number|0|0.0||||||
4124066|NCT00922272|3949203|B1|Between 18 and 55 years||Age, Customized||participants|Number|92|92.0||||||
4124067|NCT00922272|3949203|B1|<18 years||Age, Customized||participants|Number|0|0.0||||||
4124068|NCT00922272|3949203|B1|||Age||years|Mean|42.3|42.3|Standard Deviation|9.11|9.11|||
4124069|NCT00922233|3949260|B1|Africa||Region of Enrollment||participants|Number|72|72.0||||||
4124070|NCT00922233|3949260|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4124071|NCT00922233|3949260|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4124072|NCT00922233|3949260|B1|||Age||years|Mean|32.4|32.4|Standard Deviation|6.9|6.9|||
4124073|NCT00922207|3949266|B4||Male|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4124074|NCT00922207|3949267|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4124075|NCT00922207|3949268|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4124076|NCT00922207|3949269|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4124077|NCT00922207|3949266|B4||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4124078|NCT00922207|3949267|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4124079|NCT00922207|3949268|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4124080|NCT00922207|3949269|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4124081|NCT00922207|3949266|B4|||Age||years|Mean|38.2|38.2|Standard Deviation|9.8|9.8|||
4124082|NCT00922207|3949267|B3|||Age||years|Mean|38.2|38.2|Standard Deviation|9.7|9.7|||
4124083|NCT00922207|3949268|B2|||Age||years|Mean|37.7|37.7|Standard Deviation|10.0|10.0|||
4124084|NCT00922207|3949269|B1|||Age||years|Mean|38.7|38.7|Standard Deviation|9.7|9.7|||
4124085|NCT00922194|3949297|B1|India||Region of Enrollment||participants|Number|102|102.0||||||
4124086|NCT00922194|3949297|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4124087|NCT00922194|3949297|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4124088|NCT00922194|3949297|B1|||Age||years|Mean|51.16|51.16|Standard Deviation|9.75|9.75|||
4124089|NCT00922194|3949297|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4124090|NCT00922194|3949297|B1||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
4124091|NCT00922194|3949297|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4124092|NCT00922116|3949307|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4124093|NCT00922116|3949307|B1||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4124094|NCT00922116|3949307|B1|||Age||years|Mean|60.4|60.4|Standard Deviation|12.9|12.9|||
4124095|NCT00921947|3949316|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4124096|NCT00921947|3949317|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4124097|NCT00921947|3949318|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4124098|NCT00921947|3949316|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4124099|NCT00921947|3949317|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4124100|NCT00921947|3949318|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4124101|NCT00921947|3949316|B3|||Age||years|Mean|27|27.0|Standard Deviation|8.14|8.14|||
4124102|NCT00921947|3949317|B2|||Age||years|Mean|26.7|26.7|Standard Deviation|8.74|8.74|||
4124103|NCT00921947|3949318|B1|||Age||years|Mean|27.3|27.3|Standard Deviation|7.64|7.64|||
4124104|NCT00921934|3949329|B1|Strong||Common symptoms at baseline impaired concentration||participants|Number|3|3.0||||||
4124105|NCT00921934|3949329|B1|Moderate||Common symptoms at baseline impaired concentration||participants|Number|17|17.0||||||
4124106|NCT00921934|3949329|B1|Mild||Common symptoms at baseline impaired concentration||participants|Number|24|24.0||||||
4124107|NCT00921934|3949329|B1|Not present||Common symptoms at baseline impaired concentration||participants|Number|24|24.0||||||
4124108|NCT00921934|3949329|B1|Strong||Common symptoms at baseline gerneral fatigue||participants|Number|5|5.0||||||
4124109|NCT00921934|3949329|B1|Moderate||Common symptoms at baseline gerneral fatigue||participants|Number|20|20.0||||||
4124110|NCT00921934|3949329|B1|Mild||Common symptoms at baseline gerneral fatigue||participants|Number|30|30.0||||||
4124111|NCT00921934|3949329|B1|Not present||Common symptoms at baseline gerneral fatigue||participants|Number|13|13.0||||||
4124112|NCT00921934|3949329|B1|4||Number of concomitant medications for the inclusion diagnosis||participants|Number|3|3.0||||||
4124113|NCT00921934|3949329|B1|3||Number of concomitant medications for the inclusion diagnosis||participants|Number|2|2.0||||||
4124114|NCT00921934|3949329|B1|2||Number of concomitant medications for the inclusion diagnosis||participants|Number|15|15.0||||||
4124115|NCT00921934|3949329|B1|1||Number of concomitant medications for the inclusion diagnosis||participants|Number|24|24.0||||||
4124116|NCT00921934|3949329|B1|None||Number of concomitant medications for the inclusion diagnosis||participants|Number|24|24.0||||||
4124117|NCT00921934|3949329|B1|> 6 weeks||Duration of Herpes Zoster-specific complaints (separated into groups)||participants|Number|7|7.0||||||
4124118|NCT00921934|3949329|B1|2 to 6 weeks||Duration of Herpes Zoster-specific complaints (separated into groups)||participants|Number|30|30.0||||||
4124119|NCT00921934|3949329|B1|0 to 14 days||Duration of Herpes Zoster-specific complaints (separated into groups)||participants|Number|31|31.0||||||
4124120|NCT00921934|3949329|B1|no||Concomitant immunosuppressive disease|Immunosuppressive conditions = malignant neoformation of the mammae, diabetes mellitus, bronchial asthma, neurodermatitis, malignant neoformation, chemotherapy, breast ablation, hyperthyreosis, B-cell lymphoma, laryngeal cancer, pernicious anaemia, hepatitis, non-Hodgkin lymphoma, immunoglobulin-G deficiency, pneumoconiosis.|participants|Number|57|57.0||||||
4124121|NCT00921934|3949329|B1|yes||Concomitant immunosuppressive disease|Immunosuppressive conditions = malignant neoformation of the mammae, diabetes mellitus, bronchial asthma, neurodermatitis, malignant neoformation, chemotherapy, breast ablation, hyperthyreosis, B-cell lymphoma, laryngeal cancer, pernicious anaemia, hepatitis, non-Hodgkin lymphoma, immunoglobulin-G deficiency, pneumoconiosis.|participants|Number|11|11.0||||||
4124122|NCT00921934|3949329|B1|Total||Weihgt, kg||kg|Mean|73.1|73.1|Standard Deviation|14.3|14.3|||
4124123|NCT00921934|3949329|B1|Male||Weihgt, kg||kg|Mean|83.3|83.3|Standard Deviation|12.4|12.4|||
4124124|NCT00921934|3949329|B1|Female||Weihgt, kg||kg|Mean|65.6|65.6|Standard Deviation|10.6|10.6|||
4124125|NCT00921934|3949329|B1|Total||Body mass index||kg/m^2|Mean|25.8|25.8|Standard Deviation|4.6|4.6|||
4124126|NCT00921934|3949329|B1|Male||Body mass index||kg/m^2|Mean|27.6|27.6|Standard Deviation|4.9|4.9|||
4124127|NCT00921934|3949329|B1|Female||Body mass index||kg/m^2|Mean|24.4|24.4|Standard Deviation|3.9|3.9|||
4124128|NCT00921934|3949329|B1|Germany||Region of Enrollment||participants|Number|68|68.0||||||
4124129|NCT00921934|3949329|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4124130|NCT00921934|3949329|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4124131|NCT00921934|3949329|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4124132|NCT00921934|3949329|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4124133|NCT00921934|3949329|B1||<=18 years|Age||Participants|Count of Participants|NA|||||||zero patients were analyzed in this age group
4124134|NCT00921934|3949329|B1|>=65 years||Age, Customized||years|Mean|67.7|67.7|Standard Deviation|8.2|8.2|||
4124135|NCT00921934|3949329|B1|Between 18 and 65 years||Age, Customized||years|Mean|43.6|43.6|Standard Deviation|14.5|14.5|||
4124136|NCT00921895|3949333|B1|United States||Region of Enrollment||participants|Number|128|128.0||||||
4124137|NCT00921895|3949333|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4124138|NCT00921895|3949333|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4124139|NCT00921895|3949333|B1|||Age, Customized||years|Median|43|43.0|Full Range|||5.0|90.0|
4124140|NCT00921687|3949338|B3|Stage V||Stage of chronic kidney disease|Stage III - estimated glomerular filtration rate (eGFR) <60 and >=30 Stage IV - eGFR <30 and >=15 Stage V - eGFR <15 Stage V is the worst clinical stage (lower eGFR indicates worse kidney function).|participants|Number|5|5.0||||||
4124141|NCT00921687|3949339|B2|Stage V||Stage of chronic kidney disease|Stage III - estimated glomerular filtration rate (eGFR) <60 and >=30 Stage IV - eGFR <30 and >=15 Stage V - eGFR <15 Stage V is the worst clinical stage (lower eGFR indicates worse kidney function).|participants|Number|2|2.0||||||
4124142|NCT00921687|3949340|B1|Stage V||Stage of chronic kidney disease|Stage III - estimated glomerular filtration rate (eGFR) <60 and >=30 Stage IV - eGFR <30 and >=15 Stage V - eGFR <15 Stage V is the worst clinical stage (lower eGFR indicates worse kidney function).|participants|Number|3|3.0||||||
4124143|NCT00921687|3949338|B3|Stage IV||Stage of chronic kidney disease|Stage III - estimated glomerular filtration rate (eGFR) <60 and >=30 Stage IV - eGFR <30 and >=15 Stage V - eGFR <15 Stage V is the worst clinical stage (lower eGFR indicates worse kidney function).|participants|Number|68|68.0||||||
4124144|NCT00921687|3949339|B2|Stage IV||Stage of chronic kidney disease|Stage III - estimated glomerular filtration rate (eGFR) <60 and >=30 Stage IV - eGFR <30 and >=15 Stage V - eGFR <15 Stage V is the worst clinical stage (lower eGFR indicates worse kidney function).|participants|Number|36|36.0||||||
4124145|NCT00921687|3949340|B1|Stage IV||Stage of chronic kidney disease|Stage III - estimated glomerular filtration rate (eGFR) <60 and >=30 Stage IV - eGFR <30 and >=15 Stage V - eGFR <15 Stage V is the worst clinical stage (lower eGFR indicates worse kidney function).|participants|Number|32|32.0||||||
4124146|NCT00921687|3949338|B3|Stage III||Stage of chronic kidney disease|Stage III - estimated glomerular filtration rate (eGFR) <60 and >=30 Stage IV - eGFR <30 and >=15 Stage V - eGFR <15 Stage V is the worst clinical stage (lower eGFR indicates worse kidney function).|participants|Number|708|708.0||||||
4124147|NCT00921687|3949339|B2|Stage III||Stage of chronic kidney disease|Stage III - estimated glomerular filtration rate (eGFR) <60 and >=30 Stage IV - eGFR <30 and >=15 Stage V - eGFR <15 Stage V is the worst clinical stage (lower eGFR indicates worse kidney function).|participants|Number|325|325.0||||||
4124148|NCT00921687|3949340|B1|Stage III||Stage of chronic kidney disease|Stage III - estimated glomerular filtration rate (eGFR) <60 and >=30 Stage IV - eGFR <30 and >=15 Stage V - eGFR <15 Stage V is the worst clinical stage (lower eGFR indicates worse kidney function).|participants|Number|383|383.0||||||
4124149|NCT00921687|3949338|B3|No||Hypertension||participants|Number|40|40.0||||||
4124150|NCT00921687|3949339|B2|No||Hypertension||participants|Number|11|11.0||||||
4124151|NCT00921687|3949340|B1|No||Hypertension||participants|Number|29|29.0||||||
4124152|NCT00921687|3949338|B3|Yes||Hypertension||participants|Number|741|741.0||||||
4124153|NCT00921687|3949339|B2|Yes||Hypertension||participants|Number|352|352.0||||||
4124154|NCT00921687|3949340|B1|Yes||Hypertension||participants|Number|389|389.0||||||
4124155|NCT00921687|3949338|B3|No||Diabetes||participants|Number|408|408.0||||||
4124156|NCT00921687|3949339|B2|No||Diabetes||participants|Number|200|200.0||||||
4124157|NCT00921687|3949340|B1|No||Diabetes||participants|Number|208|208.0||||||
4124158|NCT00921687|3949338|B3|Yes||Diabetes||participants|Number|373|373.0||||||
4124159|NCT00921687|3949339|B2|Yes||Diabetes||participants|Number|163|163.0||||||
4124160|NCT00921687|3949340|B1|Yes||Diabetes||participants|Number|210|210.0||||||
4124161|NCT00921687|3949338|B3||Male|Sex: Female, Male||Participants|Count of Participants|744|744.0||||||
4124162|NCT00921687|3949339|B2||Male|Sex: Female, Male||Participants|Count of Participants|343|343.0||||||
4124163|NCT00921687|3949340|B1||Male|Sex: Female, Male||Participants|Count of Participants|401|401.0||||||
4124164|NCT00921687|3949338|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4124165|NCT00921687|3949339|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4124166|NCT00921687|3949340|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4124167|NCT00921687|3949338|B3|||Age||years|Mean|71|71.0|Standard Deviation|10|10.0|||
4124168|NCT00921687|3949339|B2|||Age||years|Mean|71|71.0|Standard Deviation|10.7|10.7|||
4124169|NCT00921687|3949340|B1|||Age||years|Mean|71|71.0|Standard Deviation|10.3|10.3|||
4124170|NCT00921557|3949349|B4|||Whole body (with head) BMD (g/cm^2)||g/cm^2|Median|0.87|0.87|Full Range|||0.62|1.08|
4124171|NCT00921557|3949350|B3|||Whole body (with head) BMD (g/cm^2)||g/cm^2|Median|0.86|0.86|Full Range|||0.69|1.08|
4124172|NCT00921557|3949351|B2|||Whole body (with head) BMD (g/cm^2)||g/cm^2|Median|0.91|0.91|Full Range|||0.62|1.08|
4124173|NCT00921557|3949352|B1|||Whole body (with head) BMD (g/cm^2)||g/cm^2|Median|0.87|0.87|Full Range|||0.68|1.05|
4124174|NCT00921557|3949349|B4|||Lumbar spine BMD (g/cm^2)||g/cm^2|Median|0.70|0.7|Full Range|||0.47|0.93|
4124175|NCT00921557|3949350|B3|||Lumbar spine BMD (g/cm^2)||g/cm^2|Median|0.66|0.66|Full Range|||0.5|0.88|
4124176|NCT00921557|3949351|B2|||Lumbar spine BMD (g/cm^2)||g/cm^2|Median|0.73|0.73|Full Range|||0.5|0.89|
4124177|NCT00921557|3949352|B1|||Lumbar spine BMD (g/cm^2)||g/cm^2|Median|0.64|0.64|Full Range|||0.47|0.93|
4124178|NCT00921557|3949349|B4|>= 30||25-OH Vitamin D (ng/mL)||Participants|Count of Participants|23|23.0||||||
4124179|NCT00921557|3949350|B3|>= 30||25-OH Vitamin D (ng/mL)||Participants|Count of Participants|12|12.0||||||
4124180|NCT00921557|3949351|B2|>= 30||25-OH Vitamin D (ng/mL)||Participants|Count of Participants|4|4.0||||||
4124181|NCT00921557|3949352|B1|>= 30||25-OH Vitamin D (ng/mL)||Participants|Count of Participants|7|7.0||||||
4124182|NCT00921557|3949349|B4|20 - < 30||25-OH Vitamin D (ng/mL)||Participants|Count of Participants|21|21.0||||||
4124183|NCT00921557|3949350|B3|20 - < 30||25-OH Vitamin D (ng/mL)||Participants|Count of Participants|6|6.0||||||
4124184|NCT00921557|3949351|B2|20 - < 30||25-OH Vitamin D (ng/mL)||Participants|Count of Participants|8|8.0||||||
4124185|NCT00921557|3949352|B1|20 - < 30||25-OH Vitamin D (ng/mL)||Participants|Count of Participants|7|7.0||||||
4124186|NCT00921557|3949349|B4|10 - < 20||25-OH Vitamin D (ng/mL)||Participants|Count of Participants|6|6.0||||||
4124187|NCT00921557|3949350|B3|10 - < 20||25-OH Vitamin D (ng/mL)||Participants|Count of Participants|0|0.0||||||
4124188|NCT00921557|3949351|B2|10 - < 20||25-OH Vitamin D (ng/mL)||Participants|Count of Participants|5|5.0||||||
4124189|NCT00921557|3949352|B1|10 - < 20||25-OH Vitamin D (ng/mL)||Participants|Count of Participants|1|1.0||||||
4124190|NCT00921557|3949349|B4|>= 1000||CD4 cell count (cells/mm^3)||Participants|Count of Participants|12|12.0||||||
4124191|NCT00921557|3949350|B3|>= 1000||CD4 cell count (cells/mm^3)||Participants|Count of Participants|6|6.0||||||
4124192|NCT00921557|3949351|B2|>= 1000||CD4 cell count (cells/mm^3)||Participants|Count of Participants|4|4.0||||||
4124193|NCT00921557|3949352|B1|>= 1000||CD4 cell count (cells/mm^3)||Participants|Count of Participants|2|2.0||||||
4124194|NCT00921557|3949349|B4|500 - < 1000||CD4 cell count (cells/mm^3)||Participants|Count of Participants|30|30.0||||||
4124195|NCT00921557|3949350|B3|500 - < 1000||CD4 cell count (cells/mm^3)||Participants|Count of Participants|10|10.0||||||
4124196|NCT00921557|3949351|B2|500 - < 1000||CD4 cell count (cells/mm^3)||Participants|Count of Participants|10|10.0||||||
4124197|NCT00921557|3949352|B1|500 - < 1000||CD4 cell count (cells/mm^3)||Participants|Count of Participants|10|10.0||||||
4124198|NCT00921557|3949349|B4|200 - <500||CD4 cell count (cells/mm^3)||Participants|Count of Participants|8|8.0||||||
4124199|NCT00921557|3949350|B3|200 - <500||CD4 cell count (cells/mm^3)||Participants|Count of Participants|2|2.0||||||
4124200|NCT00921557|3949351|B2|200 - <500||CD4 cell count (cells/mm^3)||Participants|Count of Participants|3|3.0||||||
4124201|NCT00921557|3949352|B1|200 - <500||CD4 cell count (cells/mm^3)||Participants|Count of Participants|3|3.0||||||
4124202|NCT00921557|3949349|B4|>400||HIV-1 RNA (copies/ml)||Participants|Count of Participants|9|9.0||||||
4124203|NCT00921557|3949350|B3|>400||HIV-1 RNA (copies/ml)||Participants|Count of Participants|3|3.0||||||
4124204|NCT00921557|3949351|B2|>400||HIV-1 RNA (copies/ml)||Participants|Count of Participants|1|1.0||||||
4124205|NCT00921557|3949352|B1|>400||HIV-1 RNA (copies/ml)||Participants|Count of Participants|5|5.0||||||
4124206|NCT00921557|3949349|B4|<= 400||HIV-1 RNA (copies/ml)||Participants|Count of Participants|41|41.0||||||
4124207|NCT00921557|3949350|B3|<= 400||HIV-1 RNA (copies/ml)||Participants|Count of Participants|15|15.0||||||
4124208|NCT00921557|3949351|B2|<= 400||HIV-1 RNA (copies/ml)||Participants|Count of Participants|16|16.0||||||
4124209|NCT00921557|3949352|B1|<= 400||HIV-1 RNA (copies/ml)||Participants|Count of Participants|10|10.0||||||
4124210|NCT00921557|3949349|B4|C/3||CDC HIV disease category|Severity of HIV disease was classified using the Centers for Disease Control (CDC) 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults (https://www.cdc.gov/mmwr/preview/mmwrhtml/00018871.htm). Disease category C/3 is the most advanced.|Participants|Count of Participants|38|38.0||||||
4124211|NCT00921557|3949350|B3|C/3||CDC HIV disease category|Severity of HIV disease was classified using the Centers for Disease Control (CDC) 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults (https://www.cdc.gov/mmwr/preview/mmwrhtml/00018871.htm). Disease category C/3 is the most advanced.|Participants|Count of Participants|9|9.0||||||
4124212|NCT00921557|3949351|B2|C/3||CDC HIV disease category|Severity of HIV disease was classified using the Centers for Disease Control (CDC) 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults (https://www.cdc.gov/mmwr/preview/mmwrhtml/00018871.htm). Disease category C/3 is the most advanced.|Participants|Count of Participants|16|16.0||||||
4124213|NCT00921557|3949352|B1|C/3||CDC HIV disease category|Severity of HIV disease was classified using the Centers for Disease Control (CDC) 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults (https://www.cdc.gov/mmwr/preview/mmwrhtml/00018871.htm). Disease category C/3 is the most advanced.|Participants|Count of Participants|13|13.0||||||
4124214|NCT00921557|3949349|B4|B/2||CDC HIV disease category|Severity of HIV disease was classified using the Centers for Disease Control (CDC) 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults (https://www.cdc.gov/mmwr/preview/mmwrhtml/00018871.htm). Disease category C/3 is the most advanced.|Participants|Count of Participants|8|8.0||||||
4124215|NCT00921557|3949350|B3|B/2||CDC HIV disease category|Severity of HIV disease was classified using the Centers for Disease Control (CDC) 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults (https://www.cdc.gov/mmwr/preview/mmwrhtml/00018871.htm). Disease category C/3 is the most advanced.|Participants|Count of Participants|6|6.0||||||
4124216|NCT00921557|3949351|B2|B/2||CDC HIV disease category|Severity of HIV disease was classified using the Centers for Disease Control (CDC) 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults (https://www.cdc.gov/mmwr/preview/mmwrhtml/00018871.htm). Disease category C/3 is the most advanced.|Participants|Count of Participants|0|0.0||||||
4124217|NCT00921557|3949352|B1|B/2||CDC HIV disease category|Severity of HIV disease was classified using the Centers for Disease Control (CDC) 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults (https://www.cdc.gov/mmwr/preview/mmwrhtml/00018871.htm). Disease category C/3 is the most advanced.|Participants|Count of Participants|2|2.0||||||
4124218|NCT00921557|3949349|B4|A/1||CDC HIV disease category|Severity of HIV disease was classified using the Centers for Disease Control (CDC) 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults (https://www.cdc.gov/mmwr/preview/mmwrhtml/00018871.htm). Disease category C/3 is the most advanced.|Participants|Count of Participants|4|4.0||||||
4124219|NCT00921557|3949350|B3|A/1||CDC HIV disease category|Severity of HIV disease was classified using the Centers for Disease Control (CDC) 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults (https://www.cdc.gov/mmwr/preview/mmwrhtml/00018871.htm). Disease category C/3 is the most advanced.|Participants|Count of Participants|3|3.0||||||
4124220|NCT00921557|3949351|B2|A/1||CDC HIV disease category|Severity of HIV disease was classified using the Centers for Disease Control (CDC) 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults (https://www.cdc.gov/mmwr/preview/mmwrhtml/00018871.htm). Disease category C/3 is the most advanced.|Participants|Count of Participants|1|1.0||||||
4124221|NCT00921557|3949352|B1|A/1||CDC HIV disease category|Severity of HIV disease was classified using the Centers for Disease Control (CDC) 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults (https://www.cdc.gov/mmwr/preview/mmwrhtml/00018871.htm). Disease category C/3 is the most advanced.|Participants|Count of Participants|0|0.0||||||
4124222|NCT00921557|3949349|B4|No||Use of tenofovir|Tenofovir disoproxil is a drug used to treat HIV|Participants|Count of Participants|27|27.0||||||
4124223|NCT00921557|3949350|B3|No||Use of tenofovir|Tenofovir disoproxil is a drug used to treat HIV|Participants|Count of Participants|9|9.0||||||
4124224|NCT00921557|3949351|B2|No||Use of tenofovir|Tenofovir disoproxil is a drug used to treat HIV|Participants|Count of Participants|10|10.0||||||
4124225|NCT00921557|3949352|B1|No||Use of tenofovir|Tenofovir disoproxil is a drug used to treat HIV|Participants|Count of Participants|8|8.0||||||
4124226|NCT00921557|3949349|B4|Yes||Use of tenofovir|Tenofovir disoproxil is a drug used to treat HIV|Participants|Count of Participants|23|23.0||||||
4124227|NCT00921557|3949350|B3|Yes||Use of tenofovir|Tenofovir disoproxil is a drug used to treat HIV|Participants|Count of Participants|9|9.0||||||
4124228|NCT00921557|3949351|B2|Yes||Use of tenofovir|Tenofovir disoproxil is a drug used to treat HIV|Participants|Count of Participants|7|7.0||||||
4124229|NCT00921557|3949352|B1|Yes||Use of tenofovir|Tenofovir disoproxil is a drug used to treat HIV|Participants|Count of Participants|7|7.0||||||
4124230|NCT00921557|3949349|B4|||Bone age||years|Median|15|15.0|Full Range|||10.0|23.0|
4124231|NCT00921557|3949350|B3|||Bone age||years|Median|15|15.0|Full Range|||11.0|21.0|
4124232|NCT00921557|3949351|B2|||Bone age||years|Median|16|16.0|Full Range|||11.0|23.0|
4124233|NCT00921557|3949352|B1|||Bone age||years|Median|14|14.0|Full Range|||10.0|22.0|
4124234|NCT00921557|3949349|B4|No||Smoker||Participants|Count of Participants|47|47.0||||||
4124235|NCT00921557|3949350|B3|No||Smoker||Participants|Count of Participants|17|17.0||||||
4124236|NCT00921557|3949351|B2|No||Smoker||Participants|Count of Participants|15|15.0||||||
4124237|NCT00921557|3949352|B1|No||Smoker||Participants|Count of Participants|15|15.0||||||
4124238|NCT00921557|3949349|B4|Yes||Smoker||Participants|Count of Participants|3|3.0||||||
4124239|NCT00921557|3949350|B3|Yes||Smoker||Participants|Count of Participants|1|1.0||||||
4124240|NCT00921557|3949351|B2|Yes||Smoker||Participants|Count of Participants|2|2.0||||||
4124241|NCT00921557|3949352|B1|Yes||Smoker||Participants|Count of Participants|0|0.0||||||
4124242|NCT00921557|3949349|B4|5||Tanner stage|Tanner stage represents the extent of physical development in children, adolescents and adults. It is based on external physical characteristics such as the size of breasts, genitals and pubic hair. Before puberty children are Tanner 1. Adults are Tanner 5. Study participants were classified as the most advanced stage of breasts and pubic hair (females) and genitals and pubic hair (males).|Participants|Count of Participants|17|17.0||||||
4124243|NCT00921557|3949350|B3|5||Tanner stage|Tanner stage represents the extent of physical development in children, adolescents and adults. It is based on external physical characteristics such as the size of breasts, genitals and pubic hair. Before puberty children are Tanner 1. Adults are Tanner 5. Study participants were classified as the most advanced stage of breasts and pubic hair (females) and genitals and pubic hair (males).|Participants|Count of Participants|6|6.0||||||
4124244|NCT00921557|3949351|B2|5||Tanner stage|Tanner stage represents the extent of physical development in children, adolescents and adults. It is based on external physical characteristics such as the size of breasts, genitals and pubic hair. Before puberty children are Tanner 1. Adults are Tanner 5. Study participants were classified as the most advanced stage of breasts and pubic hair (females) and genitals and pubic hair (males).|Participants|Count of Participants|6|6.0||||||
4124245|NCT00921557|3949352|B1|5||Tanner stage|Tanner stage represents the extent of physical development in children, adolescents and adults. It is based on external physical characteristics such as the size of breasts, genitals and pubic hair. Before puberty children are Tanner 1. Adults are Tanner 5. Study participants were classified as the most advanced stage of breasts and pubic hair (females) and genitals and pubic hair (males).|Participants|Count of Participants|5|5.0||||||
4124246|NCT00921557|3949349|B4|4||Tanner stage|Tanner stage represents the extent of physical development in children, adolescents and adults. It is based on external physical characteristics such as the size of breasts, genitals and pubic hair. Before puberty children are Tanner 1. Adults are Tanner 5. Study participants were classified as the most advanced stage of breasts and pubic hair (females) and genitals and pubic hair (males).|Participants|Count of Participants|15|15.0||||||
4124247|NCT00921557|3949350|B3|4||Tanner stage|Tanner stage represents the extent of physical development in children, adolescents and adults. It is based on external physical characteristics such as the size of breasts, genitals and pubic hair. Before puberty children are Tanner 1. Adults are Tanner 5. Study participants were classified as the most advanced stage of breasts and pubic hair (females) and genitals and pubic hair (males).|Participants|Count of Participants|6|6.0||||||
4124268|NCT00921557|3949351|B2|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4124269|NCT00921557|3949352|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4124248|NCT00921557|3949351|B2|4||Tanner stage|Tanner stage represents the extent of physical development in children, adolescents and adults. It is based on external physical characteristics such as the size of breasts, genitals and pubic hair. Before puberty children are Tanner 1. Adults are Tanner 5. Study participants were classified as the most advanced stage of breasts and pubic hair (females) and genitals and pubic hair (males).|Participants|Count of Participants|8|8.0||||||
4124249|NCT00921557|3949352|B1|4||Tanner stage|Tanner stage represents the extent of physical development in children, adolescents and adults. It is based on external physical characteristics such as the size of breasts, genitals and pubic hair. Before puberty children are Tanner 1. Adults are Tanner 5. Study participants were classified as the most advanced stage of breasts and pubic hair (females) and genitals and pubic hair (males).|Participants|Count of Participants|1|1.0||||||
4124250|NCT00921557|3949349|B4|3||Tanner stage|Tanner stage represents the extent of physical development in children, adolescents and adults. It is based on external physical characteristics such as the size of breasts, genitals and pubic hair. Before puberty children are Tanner 1. Adults are Tanner 5. Study participants were classified as the most advanced stage of breasts and pubic hair (females) and genitals and pubic hair (males).|Participants|Count of Participants|8|8.0||||||
4124251|NCT00921557|3949350|B3|3||Tanner stage|Tanner stage represents the extent of physical development in children, adolescents and adults. It is based on external physical characteristics such as the size of breasts, genitals and pubic hair. Before puberty children are Tanner 1. Adults are Tanner 5. Study participants were classified as the most advanced stage of breasts and pubic hair (females) and genitals and pubic hair (males).|Participants|Count of Participants|2|2.0||||||
4124252|NCT00921557|3949351|B2|3||Tanner stage|Tanner stage represents the extent of physical development in children, adolescents and adults. It is based on external physical characteristics such as the size of breasts, genitals and pubic hair. Before puberty children are Tanner 1. Adults are Tanner 5. Study participants were classified as the most advanced stage of breasts and pubic hair (females) and genitals and pubic hair (males).|Participants|Count of Participants|1|1.0||||||
4124253|NCT00921557|3949352|B1|3||Tanner stage|Tanner stage represents the extent of physical development in children, adolescents and adults. It is based on external physical characteristics such as the size of breasts, genitals and pubic hair. Before puberty children are Tanner 1. Adults are Tanner 5. Study participants were classified as the most advanced stage of breasts and pubic hair (females) and genitals and pubic hair (males).|Participants|Count of Participants|5|5.0||||||
4124254|NCT00921557|3949349|B4|2||Tanner stage|Tanner stage represents the extent of physical development in children, adolescents and adults. It is based on external physical characteristics such as the size of breasts, genitals and pubic hair. Before puberty children are Tanner 1. Adults are Tanner 5. Study participants were classified as the most advanced stage of breasts and pubic hair (females) and genitals and pubic hair (males).|Participants|Count of Participants|7|7.0||||||
4124255|NCT00921557|3949350|B3|2||Tanner stage|Tanner stage represents the extent of physical development in children, adolescents and adults. It is based on external physical characteristics such as the size of breasts, genitals and pubic hair. Before puberty children are Tanner 1. Adults are Tanner 5. Study participants were classified as the most advanced stage of breasts and pubic hair (females) and genitals and pubic hair (males).|Participants|Count of Participants|2|2.0||||||
4124256|NCT00921557|3949351|B2|2||Tanner stage|Tanner stage represents the extent of physical development in children, adolescents and adults. It is based on external physical characteristics such as the size of breasts, genitals and pubic hair. Before puberty children are Tanner 1. Adults are Tanner 5. Study participants were classified as the most advanced stage of breasts and pubic hair (females) and genitals and pubic hair (males).|Participants|Count of Participants|2|2.0||||||
4124257|NCT00921557|3949352|B1|2||Tanner stage|Tanner stage represents the extent of physical development in children, adolescents and adults. It is based on external physical characteristics such as the size of breasts, genitals and pubic hair. Before puberty children are Tanner 1. Adults are Tanner 5. Study participants were classified as the most advanced stage of breasts and pubic hair (females) and genitals and pubic hair (males).|Participants|Count of Participants|3|3.0||||||
4124258|NCT00921557|3949349|B4|1||Tanner stage|Tanner stage represents the extent of physical development in children, adolescents and adults. It is based on external physical characteristics such as the size of breasts, genitals and pubic hair. Before puberty children are Tanner 1. Adults are Tanner 5. Study participants were classified as the most advanced stage of breasts and pubic hair (females) and genitals and pubic hair (males).|Participants|Count of Participants|3|3.0||||||
4124259|NCT00921557|3949350|B3|1||Tanner stage|Tanner stage represents the extent of physical development in children, adolescents and adults. It is based on external physical characteristics such as the size of breasts, genitals and pubic hair. Before puberty children are Tanner 1. Adults are Tanner 5. Study participants were classified as the most advanced stage of breasts and pubic hair (females) and genitals and pubic hair (males).|Participants|Count of Participants|2|2.0||||||
4124260|NCT00921557|3949351|B2|1||Tanner stage|Tanner stage represents the extent of physical development in children, adolescents and adults. It is based on external physical characteristics such as the size of breasts, genitals and pubic hair. Before puberty children are Tanner 1. Adults are Tanner 5. Study participants were classified as the most advanced stage of breasts and pubic hair (females) and genitals and pubic hair (males).|Participants|Count of Participants|0|0.0||||||
4124261|NCT00921557|3949352|B1|1||Tanner stage|Tanner stage represents the extent of physical development in children, adolescents and adults. It is based on external physical characteristics such as the size of breasts, genitals and pubic hair. Before puberty children are Tanner 1. Adults are Tanner 5. Study participants were classified as the most advanced stage of breasts and pubic hair (females) and genitals and pubic hair (males).|Participants|Count of Participants|1|1.0||||||
4124262|NCT00921557|3949349|B4|Brazil||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
4124263|NCT00921557|3949350|B3|Brazil||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4124264|NCT00921557|3949351|B2|Brazil||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4124265|NCT00921557|3949352|B1|Brazil||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4124266|NCT00921557|3949349|B4|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
4124267|NCT00921557|3949350|B3|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4124270|NCT00921557|3949349|B4|Hispanic (regardless of race)||Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
4124271|NCT00921557|3949350|B3|Hispanic (regardless of race)||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
4124272|NCT00921557|3949351|B2|Hispanic (regardless of race)||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4124273|NCT00921557|3949352|B1|Hispanic (regardless of race)||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4124274|NCT00921557|3949349|B4|Black non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4124275|NCT00921557|3949350|B3|Black non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4124276|NCT00921557|3949351|B2|Black non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4124277|NCT00921557|3949352|B1|Black non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4124278|NCT00921557|3949349|B4|White non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4124279|NCT00921557|3949350|B3|White non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4124280|NCT00921557|3949351|B2|White non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4124281|NCT00921557|3949352|B1|White non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4124282|NCT00921557|3949349|B4||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4124283|NCT00921557|3949350|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4124284|NCT00921557|3949351|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4124285|NCT00921557|3949352|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4124286|NCT00921557|3949349|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4124287|NCT00921557|3949350|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4124288|NCT00921557|3949351|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4124289|NCT00921557|3949352|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4124290|NCT00921557|3949349|B4|>= 19 years||Age, Customized||Participants|Count of Participants|10|10.0||||||
4124291|NCT00921557|3949350|B3|>= 19 years||Age, Customized||Participants|Count of Participants|4|4.0||||||
4124292|NCT00921557|3949351|B2|>= 19 years||Age, Customized||Participants|Count of Participants|4|4.0||||||
4124293|NCT00921557|3949352|B1|>= 19 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
4124294|NCT00921557|3949349|B4|15 - < 19 years||Age, Customized||Participants|Count of Participants|23|23.0||||||
4124295|NCT00921557|3949350|B3|15 - < 19 years||Age, Customized||Participants|Count of Participants|8|8.0||||||
4124296|NCT00921557|3949351|B2|15 - < 19 years||Age, Customized||Participants|Count of Participants|9|9.0||||||
4124297|NCT00921557|3949352|B1|15 - < 19 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
4124298|NCT00921557|3949349|B4|11 - < 15 years||Age, Customized||Participants|Count of Participants|17|17.0||||||
4124299|NCT00921557|3949350|B3|11 - < 15 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
4124300|NCT00921557|3949351|B2|11 - < 15 years||Age, Customized||Participants|Count of Participants|4|4.0||||||
4124301|NCT00921557|3949352|B1|11 - < 15 years||Age, Customized||Participants|Count of Participants|7|7.0||||||
4124302|NCT00921557|3949349|B4|||Age||years|Median|16|16.0|Full Range|||11.0|23.0|
4124303|NCT00921557|3949350|B3|||Age||years|Median|16|16.0|Full Range|||11.0|22.0|
4124304|NCT00921557|3949351|B2|||Age||years|Median|16|16.0|Full Range|||12.0|23.0|
4124305|NCT00921557|3949352|B1|||Age||years|Median|16|16.0|Full Range|||11.0|23.0|
4124306|NCT00921518|3949412|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4124307|NCT00921518|3949413|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4124308|NCT00921518|3949414|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4124309|NCT00921518|3949412|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4124310|NCT00921518|3949413|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4124311|NCT00921518|3949414|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4124312|NCT00921518|3949412|B3|||Age||years|Mean|72|72.0|Standard Deviation|11|11.0|||
4124313|NCT00921518|3949413|B2|||Age||years|Mean|72|72.0|Standard Deviation|11|11.0|||
4124314|NCT00921518|3949414|B1|||Age||years|Mean|73|73.0|Standard Deviation|11|11.0|||
4124315|NCT00921310|3949421|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4124316|NCT00921310|3949422|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4124317|NCT00921310|3949423|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4124318|NCT00921310|3949421|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4124319|NCT00921310|3949422|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4124320|NCT00921310|3949423|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4124321|NCT00921310|3949421|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4124322|NCT00921310|3949422|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4124323|NCT00921310|3949423|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4124324|NCT00921310|3949421|B3|||Age||years|Median|62.5|62.5|Full Range|||49.0|76.0|
4124325|NCT00921310|3949422|B2|||Age||years|Median|67.5|67.5|Full Range|||62.0|70.0|
4124326|NCT00921310|3949423|B1|||Age||years|Median|58.5|58.5|Full Range|||49.0|76.0|
4124327|NCT00921115|3949450|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4124328|NCT00921115|3949450|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4124329|NCT00921115|3949450|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4124330|NCT00921115|3949450|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4124331|NCT00921115|3949450|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4124332|NCT00921115|3949450|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4124333|NCT00921024|3949454|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4124334|NCT00921024|3949455|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4124335|NCT00921024|3949456|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4124336|NCT00921024|3949454|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4124337|NCT00921024|3949455|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4124338|NCT00921024|3949456|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4124339|NCT00921024|3949454|B3|||Age||years|Mean|58.8|58.8|Standard Deviation|19.88|19.88|||
4124340|NCT00921024|3949455|B2|||Age||years|Mean|62.7|62.7|Standard Deviation|19.74|19.74|||
4124341|NCT00921024|3949456|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|19.78|19.78|||
4124342|NCT00920907|3949465|B3|ECOG=1||Eastern Cooperative Oncology Group (ECOG)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|29|29.0||||||
4124343|NCT00920907|3949466|B2|ECOG=1||Eastern Cooperative Oncology Group (ECOG)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|17|17.0||||||
4124344|NCT00920907|3949467|B1|ECOG=1||Eastern Cooperative Oncology Group (ECOG)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|12|12.0||||||
4124345|NCT00920907|3949465|B3|ECOG=0||Eastern Cooperative Oncology Group (ECOG)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|46|46.0||||||
4124346|NCT00920907|3949466|B2|ECOG=0||Eastern Cooperative Oncology Group (ECOG)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|21|21.0||||||
4124347|NCT00920907|3949467|B1|ECOG=0||Eastern Cooperative Oncology Group (ECOG)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|25|25.0||||||
4124348|NCT00920907|3949465|B3|||Body Weight|Body weight measured in kilograms (kg).|kg|Mean|81.0|81.0|Standard Deviation|13.3|13.3|||
4124349|NCT00920907|3949466|B2|||Body Weight|Body weight measured in kilograms (kg).|kg|Mean|80.7|80.7|Standard Deviation|13.3|13.3|||
4124350|NCT00920907|3949467|B1|||Body Weight|Body weight measured in kilograms (kg).|kg|Mean|81.3|81.3|Standard Deviation|13.4|13.4|||
4124351|NCT00920907|3949465|B3|United States||Region of Enrollment||participants|Number|75|75.0||||||
4124352|NCT00920907|3949466|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
4124353|NCT00920907|3949467|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4124354|NCT00920907|3949465|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4124355|NCT00920907|3949466|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4124356|NCT00920907|3949467|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4124357|NCT00920907|3949465|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4124358|NCT00920907|3949466|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4124359|NCT00920907|3949467|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4124360|NCT00920907|3949465|B3|||Age||years|Mean|58|58.0|Standard Deviation|13|13.0|||
4124361|NCT00920907|3949466|B2|||Age||years|Mean|59|59.0|Standard Deviation|12|12.0|||
4124362|NCT00920907|3949467|B1|||Age||years|Mean|57|57.0|Standard Deviation|14|14.0|||
4124363|NCT00920907|3949465|B3||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4124364|NCT00920907|3949466|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4124365|NCT00920907|3949467|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4124366|NCT00920907|3949465|B3||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4124367|NCT00920907|3949466|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4124368|NCT00920907|3949467|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4124369|NCT00920907|3949465|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4124370|NCT00920907|3949466|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4124371|NCT00920907|3949467|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4124372|NCT00920855|3949506|B4|||Body Surface Area (BSA)||m^2|Mean|1.87|1.87|Standard Deviation|0.254|0.254|||
4124373|NCT00920855|3949507|B3|||Body Surface Area (BSA)||m^2|Mean|1.90|1.9|Standard Deviation|0.265|0.265|||
4124374|NCT00920855|3949508|B2|||Body Surface Area (BSA)||m^2|Mean|1.81|1.81|Standard Deviation|0.177|0.177|||
4124375|NCT00920855|3949509|B1|||Body Surface Area (BSA)||m^2|Mean|1.76|1.76|Standard Deviation|0.234|0.234|||
4124376|NCT00920855|3949506|B4|United States||Region of Enrollment||participants|Number|40|40.0||||||
4124377|NCT00920855|3949507|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4124378|NCT00920855|3949508|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4124379|NCT00920855|3949509|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4124380|NCT00920855|3949506|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4124381|NCT00920855|3949507|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4124382|NCT00920855|3949508|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4124383|NCT00920855|3949509|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4124384|NCT00920855|3949506|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4124385|NCT00920855|3949507|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4124386|NCT00920855|3949508|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4124387|NCT00920855|3949509|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4124388|NCT00920855|3949506|B4|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4124389|NCT00920855|3949507|B3|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4124390|NCT00920855|3949508|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4124391|NCT00920855|3949509|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4124392|NCT00920855|3949506|B4|White||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4124393|NCT00920855|3949507|B3|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4124394|NCT00920855|3949508|B2|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4124395|NCT00920855|3949509|B1|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4124396|NCT00920855|3949506|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4124397|NCT00920855|3949507|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4124398|NCT00920855|3949508|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4124399|NCT00920855|3949509|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4124400|NCT00920855|3949506|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4124401|NCT00920855|3949507|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4124402|NCT00920855|3949508|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4124403|NCT00920855|3949509|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4124404|NCT00920855|3949506|B4|||Age||years|Mean|64.6|64.6|Standard Deviation|11.38|11.38|||
4124405|NCT00920855|3949507|B3|||Age||years|Mean|64.5|64.5|Standard Deviation|10.68|10.68|||
4124406|NCT00920855|3949508|B2|||Age||years|Mean|67.0|67.0|Standard Deviation|9.49|9.49|||
4124407|NCT00920855|3949509|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|18.17|18.17|||
4124408|NCT00920829|3949533|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124409|NCT00920829|3949534|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124410|NCT00920829|3949535|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124411|NCT00920829|3949536|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124412|NCT00920829|3949537|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124413|NCT00920829|3949533|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4124414|NCT00920829|3949534|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4124415|NCT00920829|3949535|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124416|NCT00920829|3949536|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124417|NCT00920829|3949537|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124418|NCT00920829|3949533|B5||White|Race (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
4124419|NCT00920829|3949534|B4||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4124420|NCT00920829|3949535|B3||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4124421|NCT00920829|3949536|B2||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4124422|NCT00920829|3949537|B1||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4124423|NCT00920829|3949533|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124424|NCT00920829|3949534|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124425|NCT00920829|3949535|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124426|NCT00920829|3949536|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124427|NCT00920829|3949537|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124428|NCT00920829|3949533|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124429|NCT00920829|3949534|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124430|NCT00920829|3949535|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124431|NCT00920829|3949536|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124432|NCT00920829|3949537|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124433|NCT00920829|3949533|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124434|NCT00920829|3949534|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124435|NCT00920829|3949535|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124436|NCT00920829|3949536|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124437|NCT00920829|3949537|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124438|NCT00920829|3949533|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4124439|NCT00920829|3949534|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124440|NCT00920829|3949535|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124441|NCT00920829|3949536|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124442|NCT00920829|3949537|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4124443|NCT00920829|3949533|B5||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4124444|NCT00920829|3949534|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4124445|NCT00920829|3949535|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4124446|NCT00920829|3949536|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4124447|NCT00920829|3949537|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4124448|NCT00920829|3949533|B5||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4124449|NCT00920829|3949534|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4124450|NCT00920829|3949535|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4124451|NCT00920829|3949536|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4124452|NCT00920829|3949537|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4124453|NCT00920829|3949533|B5|||Age||years|Mean|49.3|49.3|Standard Deviation|10.1|10.1|||
4124454|NCT00920829|3949534|B4|||Age||years|Mean|49.7|49.7|Standard Deviation|10.6|10.6|||
4124455|NCT00920829|3949535|B3|||Age||years|Mean|50.3|50.3|Standard Deviation|10.2|10.2|||
4124456|NCT00920829|3949536|B2|||Age||years|Mean|46.3|46.3|Standard Deviation|10.8|10.8|||
4124457|NCT00920829|3949537|B1|||Age||years|Mean|51.1|51.1|Standard Deviation|8.2|8.2|||
4124458|NCT00920816|3949550|B5||Male|Sex: Female, Male||Participants|Count of Participants|351|351.0||||||
4124459|NCT00920816|3949551|B4||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4124460|NCT00920816|3949552|B3||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4124461|NCT00920816|3949553|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4124462|NCT00920816|3949554|B1||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4124463|NCT00920816|3949550|B5||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4124464|NCT00920816|3949551|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4124465|NCT00920816|3949552|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4124466|NCT00920816|3949553|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4124467|NCT00920816|3949554|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4124468|NCT00920816|3949550|B5|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|107|107.0||||||
4124469|NCT00920816|3949551|B4|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|13|13.0||||||
4124470|NCT00920816|3949552|B3|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|25|25.0||||||
4124471|NCT00920816|3949553|B2|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|19|19.0||||||
4124472|NCT00920816|3949554|B1|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|50|50.0||||||
4124473|NCT00920816|3949550|B5|Less than (<) 65 years||Age, Customized||participants|Number|385|385.0||||||
4124474|NCT00920816|3949551|B4|Less than (<) 65 years||Age, Customized||participants|Number|56|56.0||||||
4124475|NCT00920816|3949552|B3|Less than (<) 65 years||Age, Customized||participants|Number|110|110.0||||||
4124476|NCT00920816|3949553|B2|Less than (<) 65 years||Age, Customized||participants|Number|77|77.0||||||
4124477|NCT00920816|3949554|B1|Less than (<) 65 years||Age, Customized||participants|Number|142|142.0||||||
4124478|NCT00920790|3949595|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4124479|NCT00920790|3949595|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4124480|NCT00920790|3949595|B1|||Age||years|Median|64|64.0|Full Range|7.5|7.5|49.0|83.0|
4124481|NCT00920699|3949604|B4|United States||Region of Enrollment||Participants|Count of Participants|90|90.0||||||
4124482|NCT00920699|3949605|B3|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
4124483|NCT00920699|3949606|B2|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
4124484|NCT00920699|3949607|B1|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
4124485|NCT00920699|3949604|B4||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4124486|NCT00920699|3949605|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4124487|NCT00920699|3949606|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4124488|NCT00920699|3949607|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4124489|NCT00920699|3949604|B4||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4124490|NCT00920699|3949605|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4124491|NCT00920699|3949606|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4124492|NCT00920699|3949607|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4124493|NCT00920699|3949604|B4|||Age||years|Mean|39.5|39.5|Standard Deviation|10.9|10.9|||
4124494|NCT00920699|3949605|B3|||Age||years|Mean|39.8|39.8|Standard Deviation|11.6|11.6|||
4124495|NCT00920699|3949606|B2|||Age||years|Mean|39.3|39.3|Standard Deviation|11.5|11.5|||
4124496|NCT00920699|3949607|B1|||Age||years|Mean|39.2|39.2|Standard Deviation|9.8|9.8|||
4124497|NCT00920686|3949623|B4|||Number of Previous Migraines per month|Number of Previous Migraines for each subject was based on the total number of migraine entries reported on the Migraine History CRF.|migraines per month|Mean|1.5|1.5|Standard Deviation|0.53|0.53|||
4124498|NCT00920686|3949624|B3|||Number of Previous Migraines per month|Number of Previous Migraines for each subject was based on the total number of migraine entries reported on the Migraine History CRF.|migraines per month|Mean|1.5|1.5|Standard Deviation|0.50|0.5|||
4124499|NCT00920686|3949625|B2|||Number of Previous Migraines per month|Number of Previous Migraines for each subject was based on the total number of migraine entries reported on the Migraine History CRF.|migraines per month|Mean|1.5|1.5|Standard Deviation|0.50|0.5|||
4124500|NCT00920686|3949626|B1|||Number of Previous Migraines per month|Number of Previous Migraines for each subject was based on the total number of migraine entries reported on the Migraine History CRF.|migraines per month|Mean|1.6|1.6|Standard Deviation|0.59|0.59|||
4124501|NCT00920686|3949623|B4|With Aura||Type of Migraine|Subjects are counted once within each type where at least one migraine is recorded.|Participants|Number|182|182.0||||||
4124502|NCT00920686|3949624|B3|With Aura||Type of Migraine|Subjects are counted once within each type where at least one migraine is recorded.|Participants|Number|62|62.0||||||
4124503|NCT00920686|3949625|B2|With Aura||Type of Migraine|Subjects are counted once within each type where at least one migraine is recorded.|Participants|Number|59|59.0||||||
4124504|NCT00920686|3949626|B1|With Aura||Type of Migraine|Subjects are counted once within each type where at least one migraine is recorded.|Participants|Number|61|61.0||||||
4124505|NCT00920686|3949623|B4|Without Aura||Type of Migraine|Subjects are counted once within each type where at least one migraine is recorded.|Participants|Number|95|95.0||||||
4124506|NCT00920686|3949624|B3|Without Aura||Type of Migraine|Subjects are counted once within each type where at least one migraine is recorded.|Participants|Number|29|29.0||||||
4124507|NCT00920686|3949625|B2|Without Aura||Type of Migraine|Subjects are counted once within each type where at least one migraine is recorded.|Participants|Number|31|31.0||||||
4124508|NCT00920686|3949626|B1|Without Aura||Type of Migraine|Subjects are counted once within each type where at least one migraine is recorded.|Participants|Number|35|35.0||||||
4124509|NCT00920686|3949623|B4|Dysphasia (speech disturbance)||Applicable Aura Symptoms for Qualifying Migraine|"Safety Population - included all subjects who were randomized and dosed with study drug.~Subject may have reported more than one aura symptom."|Participants|Number|20|20.0||||||
4124510|NCT00920686|3949624|B3|Dysphasia (speech disturbance)||Applicable Aura Symptoms for Qualifying Migraine|"Safety Population - included all subjects who were randomized and dosed with study drug.~Subject may have reported more than one aura symptom."|Participants|Number|7|7.0||||||
4124511|NCT00920686|3949625|B2|Dysphasia (speech disturbance)||Applicable Aura Symptoms for Qualifying Migraine|"Safety Population - included all subjects who were randomized and dosed with study drug.~Subject may have reported more than one aura symptom."|Participants|Number|6|6.0||||||
4124512|NCT00920686|3949626|B1|Dysphasia (speech disturbance)||Applicable Aura Symptoms for Qualifying Migraine|"Safety Population - included all subjects who were randomized and dosed with study drug.~Subject may have reported more than one aura symptom."|Participants|Number|7|7.0||||||
4124513|NCT00920686|3949623|B4|Numbness||Applicable Aura Symptoms for Qualifying Migraine|"Safety Population - included all subjects who were randomized and dosed with study drug.~Subject may have reported more than one aura symptom."|Participants|Number|28|28.0||||||
4124514|NCT00920686|3949624|B3|Numbness||Applicable Aura Symptoms for Qualifying Migraine|"Safety Population - included all subjects who were randomized and dosed with study drug.~Subject may have reported more than one aura symptom."|Participants|Number|11|11.0||||||
4124515|NCT00920686|3949625|B2|Numbness||Applicable Aura Symptoms for Qualifying Migraine|"Safety Population - included all subjects who were randomized and dosed with study drug.~Subject may have reported more than one aura symptom."|Participants|Number|10|10.0||||||
4124516|NCT00920686|3949626|B1|Numbness||Applicable Aura Symptoms for Qualifying Migraine|"Safety Population - included all subjects who were randomized and dosed with study drug.~Subject may have reported more than one aura symptom."|Participants|Number|7|7.0||||||
4124517|NCT00920686|3949623|B4|Pins and needles||Applicable Aura Symptoms for Qualifying Migraine|"Safety Population - included all subjects who were randomized and dosed with study drug.~Subject may have reported more than one aura symptom."|Participants|Number|35|35.0||||||
4124518|NCT00920686|3949624|B3|Pins and needles||Applicable Aura Symptoms for Qualifying Migraine|"Safety Population - included all subjects who were randomized and dosed with study drug.~Subject may have reported more than one aura symptom."|Participants|Number|9|9.0||||||
4124519|NCT00920686|3949625|B2|Pins and needles||Applicable Aura Symptoms for Qualifying Migraine|"Safety Population - included all subjects who were randomized and dosed with study drug.~Subject may have reported more than one aura symptom."|Participants|Number|15|15.0||||||
4124520|NCT00920686|3949626|B1|Pins and needles||Applicable Aura Symptoms for Qualifying Migraine|"Safety Population - included all subjects who were randomized and dosed with study drug.~Subject may have reported more than one aura symptom."|Participants|Number|11|11.0||||||
4124521|NCT00920686|3949623|B4|Loss of Vision||Applicable Aura Symptoms for Qualifying Migraine|"Safety Population - included all subjects who were randomized and dosed with study drug.~Subject may have reported more than one aura symptom."|Participants|Number|62|62.0||||||
4124522|NCT00920686|3949624|B3|Loss of Vision||Applicable Aura Symptoms for Qualifying Migraine|"Safety Population - included all subjects who were randomized and dosed with study drug.~Subject may have reported more than one aura symptom."|Participants|Number|22|22.0||||||
4124523|NCT00920686|3949625|B2|Loss of Vision||Applicable Aura Symptoms for Qualifying Migraine|"Safety Population - included all subjects who were randomized and dosed with study drug.~Subject may have reported more than one aura symptom."|Participants|Number|18|18.0||||||
4124524|NCT00920686|3949626|B1|Loss of Vision||Applicable Aura Symptoms for Qualifying Migraine|"Safety Population - included all subjects who were randomized and dosed with study drug.~Subject may have reported more than one aura symptom."|Participants|Number|22|22.0||||||
4124525|NCT00920686|3949623|B4|Lines||Applicable Aura Symptoms for Qualifying Migraine|"Safety Population - included all subjects who were randomized and dosed with study drug.~Subject may have reported more than one aura symptom."|Participants|Number|36|36.0||||||
4124526|NCT00920686|3949624|B3|Lines||Applicable Aura Symptoms for Qualifying Migraine|"Safety Population - included all subjects who were randomized and dosed with study drug.~Subject may have reported more than one aura symptom."|Participants|Number|11|11.0||||||
4124527|NCT00920686|3949625|B2|Lines||Applicable Aura Symptoms for Qualifying Migraine|"Safety Population - included all subjects who were randomized and dosed with study drug.~Subject may have reported more than one aura symptom."|Participants|Number|12|12.0||||||
4124528|NCT00920686|3949626|B1|Lines||Applicable Aura Symptoms for Qualifying Migraine|"Safety Population - included all subjects who were randomized and dosed with study drug.~Subject may have reported more than one aura symptom."|Participants|Number|13|13.0||||||
4124529|NCT00920686|3949623|B4|Spots||Applicable Aura Symptoms for Qualifying Migraine|"Safety Population - included all subjects who were randomized and dosed with study drug.~Subject may have reported more than one aura symptom."|Participants|Number|129|129.0||||||
4124530|NCT00920686|3949624|B3|Spots||Applicable Aura Symptoms for Qualifying Migraine|"Safety Population - included all subjects who were randomized and dosed with study drug.~Subject may have reported more than one aura symptom."|Participants|Number|43|43.0||||||
4124531|NCT00920686|3949625|B2|Spots||Applicable Aura Symptoms for Qualifying Migraine|"Safety Population - included all subjects who were randomized and dosed with study drug.~Subject may have reported more than one aura symptom."|Participants|Number|43|43.0||||||
4124532|NCT00920686|3949626|B1|Spots||Applicable Aura Symptoms for Qualifying Migraine|"Safety Population - included all subjects who were randomized and dosed with study drug.~Subject may have reported more than one aura symptom."|Participants|Number|43|43.0||||||
4124533|NCT00920686|3949623|B4|Flickering lights||Applicable Aura Symptoms for Qualifying Migraine|"Safety Population - included all subjects who were randomized and dosed with study drug.~Subject may have reported more than one aura symptom."|Participants|Number|112|112.0||||||
4124534|NCT00920686|3949624|B3|Flickering lights||Applicable Aura Symptoms for Qualifying Migraine|"Safety Population - included all subjects who were randomized and dosed with study drug.~Subject may have reported more than one aura symptom."|Participants|Number|39|39.0||||||
4124535|NCT00920686|3949625|B2|Flickering lights||Applicable Aura Symptoms for Qualifying Migraine|"Safety Population - included all subjects who were randomized and dosed with study drug.~Subject may have reported more than one aura symptom."|Participants|Number|40|40.0||||||
4124536|NCT00920686|3949626|B1|Flickering lights||Applicable Aura Symptoms for Qualifying Migraine|"Safety Population - included all subjects who were randomized and dosed with study drug.~Subject may have reported more than one aura symptom."|Participants|Number|33|33.0||||||
4124537|NCT00920686|3949623|B4|||Body Mass Index (BMI)|Safety Population - included all subjects who were randomized and dosed with study drug.|kg/m^2|Mean|26.8|26.8|Standard Deviation|4.76|4.76|||
4124538|NCT00920686|3949624|B3|||Body Mass Index (BMI)|Safety Population - included all subjects who were randomized and dosed with study drug.|kg/m^2|Mean|26.9|26.9|Standard Deviation|4.48|4.48|||
4124539|NCT00920686|3949625|B2|||Body Mass Index (BMI)|Safety Population - included all subjects who were randomized and dosed with study drug.|kg/m^2|Mean|27.0|27.0|Standard Deviation|5.31|5.31|||
4124540|NCT00920686|3949626|B1|||Body Mass Index (BMI)|Safety Population - included all subjects who were randomized and dosed with study drug.|kg/m^2|Mean|26.5|26.5|Standard Deviation|4.54|4.54|||
4124541|NCT00920686|3949623|B4|||Height|Safety Population - included all subjects who were randomized and dosed with study drug.|cm|Mean|167.9|167.9|Standard Deviation|8.89|8.89|||
4124542|NCT00920686|3949624|B3|||Height|Safety Population - included all subjects who were randomized and dosed with study drug.|cm|Mean|166.3|166.3|Standard Deviation|8.82|8.82|||
4124543|NCT00920686|3949625|B2|||Height|Safety Population - included all subjects who were randomized and dosed with study drug.|cm|Mean|167.8|167.8|Standard Deviation|8.67|8.67|||
4124544|NCT00920686|3949626|B1|||Height|Safety Population - included all subjects who were randomized and dosed with study drug.|cm|Mean|169.5|169.5|Standard Deviation|9.01|9.01|||
4124545|NCT00920686|3949623|B4|||Weight|Safety Population - included all subjects who were randomized and dosed with study drug.|kg|Mean|75.7|75.7|Standard Deviation|16.00|16.0|||
4124546|NCT00920686|3949624|B3|||Weight|Safety Population - included all subjects who were randomized and dosed with study drug.|kg|Mean|74.2|74.2|Standard Deviation|14.50|14.5|||
4124547|NCT00920686|3949625|B2|||Weight|Safety Population - included all subjects who were randomized and dosed with study drug.|kg|Mean|76.3|76.3|Standard Deviation|16.61|16.61|||
4124548|NCT00920686|3949626|B1|||Weight|Safety Population - included all subjects who were randomized and dosed with study drug.|kg|Mean|76.6|76.6|Standard Deviation|16.95|16.95|||
4124549|NCT00920686|3949623|B4||Unknown or Not Reported|Race (NIH/OMB)|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|0|0.0||||||
4124550|NCT00920686|3949624|B3||Unknown or Not Reported|Race (NIH/OMB)|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|0|0.0||||||
4124551|NCT00920686|3949625|B2||Unknown or Not Reported|Race (NIH/OMB)|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|0|0.0||||||
4124552|NCT00920686|3949626|B1||Unknown or Not Reported|Race (NIH/OMB)|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|0|0.0||||||
4124553|NCT00920686|3949623|B4||More than one race|Race (NIH/OMB)|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|1|1.0||||||
4124554|NCT00920686|3949624|B3||More than one race|Race (NIH/OMB)|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|0|0.0||||||
4124555|NCT00920686|3949625|B2||More than one race|Race (NIH/OMB)|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|1|1.0||||||
4124556|NCT00920686|3949626|B1||More than one race|Race (NIH/OMB)|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|0|0.0||||||
4124557|NCT00920686|3949623|B4||White|Race (NIH/OMB)|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|154|154.0||||||
4124558|NCT00920686|3949624|B3||White|Race (NIH/OMB)|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|54|54.0||||||
4124559|NCT00920686|3949625|B2||White|Race (NIH/OMB)|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|47|47.0||||||
4124560|NCT00920686|3949626|B1||White|Race (NIH/OMB)|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|53|53.0||||||
4124561|NCT00920686|3949623|B4||Black or African American|Race (NIH/OMB)|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|27|27.0||||||
4124562|NCT00920686|3949624|B3||Black or African American|Race (NIH/OMB)|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|8|8.0||||||
4124563|NCT00920686|3949625|B2||Black or African American|Race (NIH/OMB)|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|10|10.0||||||
4124564|NCT00920686|3949626|B1||Black or African American|Race (NIH/OMB)|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|9|9.0||||||
4124565|NCT00920686|3949623|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|1|1.0||||||
4124566|NCT00920686|3949624|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|0|0.0||||||
4124567|NCT00920686|3949625|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|1|1.0||||||
4124568|NCT00920686|3949626|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|0|0.0||||||
4124569|NCT00920686|3949623|B4||Asian|Race (NIH/OMB)|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|1|1.0||||||
4124570|NCT00920686|3949624|B3||Asian|Race (NIH/OMB)|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|0|0.0||||||
4124571|NCT00920686|3949625|B2||Asian|Race (NIH/OMB)|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|1|1.0||||||
4124572|NCT00920686|3949626|B1||Asian|Race (NIH/OMB)|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|0|0.0||||||
4124573|NCT00920686|3949623|B4||American Indian or Alaska Native|Race (NIH/OMB)|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|1|1.0||||||
4124574|NCT00920686|3949624|B3||American Indian or Alaska Native|Race (NIH/OMB)|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|0|0.0||||||
4124575|NCT00920686|3949625|B2||American Indian or Alaska Native|Race (NIH/OMB)|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|0|0.0||||||
4124576|NCT00920686|3949626|B1||American Indian or Alaska Native|Race (NIH/OMB)|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|1|1.0||||||
4124577|NCT00920686|3949623|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|0|0.0||||||
4124578|NCT00920686|3949624|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|0|0.0||||||
4124579|NCT00920686|3949625|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|0|0.0||||||
4124580|NCT00920686|3949626|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|0|0.0||||||
4124581|NCT00920686|3949623|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|173|173.0||||||
4124582|NCT00920686|3949624|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|59|59.0||||||
4124583|NCT00920686|3949625|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|54|54.0||||||
4124584|NCT00920686|3949626|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|60|60.0||||||
4124585|NCT00920686|3949623|B4||Hispanic or Latino|Ethnicity (NIH/OMB)|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|12|12.0||||||
4124638|NCT00920647|3949650|B3||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4124586|NCT00920686|3949624|B3||Hispanic or Latino|Ethnicity (NIH/OMB)|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|3|3.0||||||
4124587|NCT00920686|3949625|B2||Hispanic or Latino|Ethnicity (NIH/OMB)|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|6|6.0||||||
4124588|NCT00920686|3949626|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|3|3.0||||||
4124589|NCT00920686|3949623|B4||Male|Sex: Female, Male|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|84|84.0||||||
4124590|NCT00920686|3949624|B3||Male|Sex: Female, Male|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|53|53.0||||||
4124591|NCT00920686|3949625|B2||Male|Sex: Female, Male|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|11|11.0||||||
4124592|NCT00920686|3949626|B1||Male|Sex: Female, Male|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|20|20.0||||||
4124593|NCT00920686|3949623|B4||Female|Sex: Female, Male|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|101|101.0||||||
4124594|NCT00920686|3949624|B3||Female|Sex: Female, Male|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|9|9.0||||||
4124595|NCT00920686|3949625|B2||Female|Sex: Female, Male|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|49|49.0||||||
4124596|NCT00920686|3949626|B1||Female|Sex: Female, Male|Safety Population - included all subjects who were randomized and dosed with study drug.|Participants|Count of Participants|43|43.0||||||
4124597|NCT00920686|3949623|B4|||Age|Safety Population - included all subjects who were randomized and dosed with study drug.|years|Mean|39.9|39.9|Standard Deviation|12.10|12.1|||
4124598|NCT00920686|3949624|B3|||Age|Safety Population - included all subjects who were randomized and dosed with study drug.|years|Mean|41.2|41.2|Standard Deviation|12.03|12.03|||
4124599|NCT00920686|3949625|B2|||Age|Safety Population - included all subjects who were randomized and dosed with study drug.|years|Mean|41.4|41.4|Standard Deviation|13.02|13.02|||
4124600|NCT00920686|3949626|B1|||Age|Safety Population - included all subjects who were randomized and dosed with study drug.|years|Mean|37.2|37.2|Standard Deviation|10.90|10.9|||
4124601|NCT00920647|3949648|B5|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4124602|NCT00920647|3949649|B4|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4124603|NCT00920647|3949650|B3|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4124604|NCT00920647|3949651|B2|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4124605|NCT00920647|3949652|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4124606|NCT00920647|3949648|B5|United States||Region of Enrollment||participants|Number|11|11.0||||||
4124607|NCT00920647|3949649|B4|United States||Region of Enrollment||participants|Number|2|2.0||||||
4124608|NCT00920647|3949650|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4124609|NCT00920647|3949651|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4124610|NCT00920647|3949652|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4124611|NCT00920647|3949648|B5||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4124612|NCT00920647|3949649|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4124613|NCT00920647|3949650|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4124614|NCT00920647|3949651|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4124615|NCT00920647|3949652|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4124616|NCT00920647|3949648|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4124617|NCT00920647|3949649|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4124618|NCT00920647|3949650|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4124619|NCT00920647|3949651|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4124620|NCT00920647|3949652|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4124621|NCT00920647|3949648|B5|||Age||years|Mean|6.38|6.38|Standard Deviation|2.294|2.294|||
4124622|NCT00920647|3949649|B4|||Age||years|Mean|6.91|6.91|Standard Deviation|1.678|1.678|||
4124623|NCT00920647|3949650|B3|||Age||years|Mean|4.34|4.34|Standard Deviation|0.829|0.829|||
4124624|NCT00920647|3949651|B2|||Age||years|Mean|5.61|5.61|Standard Deviation|1.799|1.799|||
4124625|NCT00920647|3949652|B1|||Age||years|Mean|8.64|8.64|Standard Deviation|2.462|2.462|||
4124626|NCT00920647|3949648|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4124627|NCT00920647|3949649|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4124628|NCT00920647|3949650|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4124629|NCT00920647|3949651|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4124630|NCT00920647|3949652|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4124631|NCT00920647|3949648|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4124632|NCT00920647|3949649|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4124633|NCT00920647|3949650|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4124634|NCT00920647|3949651|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4124635|NCT00920647|3949652|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4124636|NCT00920647|3949648|B5||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4124637|NCT00920647|3949649|B4||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4124639|NCT00920647|3949651|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4124640|NCT00920647|3949652|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4124641|NCT00920621|3949703|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|297|297.0||||||
4124642|NCT00920621|3949704|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|80|80.0||||||
4124643|NCT00920621|3949705|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|71|71.0||||||
4124644|NCT00920621|3949706|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|69|69.0||||||
4124645|NCT00920621|3949707|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|77|77.0||||||
4124646|NCT00920621|3949703|B5|White non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|391|391.0||||||
4124647|NCT00920621|3949704|B4|White non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|79|79.0||||||
4124648|NCT00920621|3949705|B3|White non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|82|82.0||||||
4124649|NCT00920621|3949706|B2|White non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|116|116.0||||||
4124650|NCT00920621|3949707|B1|White non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|114|114.0||||||
4124651|NCT00920621|3949703|B5|White Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|224|224.0||||||
4124652|NCT00920621|3949704|B4|White Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
4124653|NCT00920621|3949705|B3|White Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|53|53.0||||||
4124654|NCT00920621|3949706|B2|White Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|61|61.0||||||
4124655|NCT00920621|3949707|B1|White Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|59|59.0||||||
4124656|NCT00920621|3949703|B5|Black||Race/Ethnicity, Customized||Participants|Count of Participants|770|770.0||||||
4124657|NCT00920621|3949704|B4|Black||Race/Ethnicity, Customized||Participants|Count of Participants|191|191.0||||||
4124658|NCT00920621|3949705|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|199|199.0||||||
4124659|NCT00920621|3949706|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|190|190.0||||||
4124660|NCT00920621|3949707|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|190|190.0||||||
4124661|NCT00920621|3949703|B5||Male|Sex: Female, Male||Participants|Count of Participants|421|421.0||||||
4124662|NCT00920621|3949704|B4||Male|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
4124663|NCT00920621|3949705|B3||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4124664|NCT00920621|3949706|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4124665|NCT00920621|3949707|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4124666|NCT00920621|3949703|B5||Female|Sex: Female, Male||Participants|Count of Participants|1261|1261.0||||||
4124667|NCT00920621|3949704|B4||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4124668|NCT00920621|3949705|B3||Female|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4124669|NCT00920621|3949706|B2||Female|Sex: Female, Male||Participants|Count of Participants|436|436.0||||||
4124670|NCT00920621|3949707|B1||Female|Sex: Female, Male||Participants|Count of Participants|440|440.0||||||
4124671|NCT00920621|3949703|B5|||Age||years|Mean|27.4|27.4|Standard Deviation|5.6|5.6|||
4124672|NCT00920621|3949704|B4|||Age||years|Mean|0|0.0|Standard Deviation|0|0.0|||
4124673|NCT00920621|3949705|B3|||Age||years|Mean|0|0.0|Standard Deviation|0|0.0|||
4124674|NCT00920621|3949706|B2|||Age||years|Mean|27.3|27.3|Standard Deviation|5.6|5.6|||
4124675|NCT00920621|3949707|B1|||Age||years|Mean|27.5|27.5|Standard Deviation|5.5|5.5|||
4124676|NCT00920439|3949734|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4124677|NCT00920439|3949734|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4124678|NCT00920439|3949734|B1|||Age||Months|Mean|20.3|20.3|Standard Deviation|1.49|1.49|||
4124679|NCT00920426|3949741|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124680|NCT00920426|3949742|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124681|NCT00920426|3949743|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124682|NCT00920426|3949744|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124683|NCT00920426|3949741|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124684|NCT00920426|3949742|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124685|NCT00920426|3949743|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124686|NCT00920426|3949744|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124687|NCT00920426|3949741|B4||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4124688|NCT00920426|3949742|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4124689|NCT00920426|3949743|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4124690|NCT00920426|3949744|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4124691|NCT00920426|3949741|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4124692|NCT00920426|3949742|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124693|NCT00920426|3949743|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4124694|NCT00920426|3949744|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124695|NCT00920426|3949741|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124696|NCT00920426|3949742|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124697|NCT00920426|3949743|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124698|NCT00920426|3949744|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124699|NCT00920426|3949741|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124700|NCT00920426|3949742|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124701|NCT00920426|3949743|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124702|NCT00920426|3949744|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124703|NCT00920426|3949741|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124704|NCT00920426|3949742|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124705|NCT00920426|3949743|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124706|NCT00920426|3949744|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124707|NCT00920426|3949741|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4124708|NCT00920426|3949742|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4124709|NCT00920426|3949743|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4124710|NCT00920426|3949744|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4124711|NCT00920426|3949741|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4124712|NCT00920426|3949742|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4124713|NCT00920426|3949743|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4124714|NCT00920426|3949744|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4124715|NCT00920426|3949741|B4|27 to 51 Years||Age, Customized||Participants|Count of Participants|17|17.0||||||
4124716|NCT00920426|3949742|B3|27 to 51 Years||Age, Customized||Participants|Count of Participants|2|2.0||||||
4124717|NCT00920426|3949743|B2|27 to 51 Years||Age, Customized||Participants|Count of Participants|7|7.0||||||
4124718|NCT00920426|3949744|B1|27 to 51 Years||Age, Customized||Participants|Count of Participants|8|8.0||||||
4124719|NCT00920374|3949814|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4124720|NCT00920374|3949815|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4124721|NCT00920374|3949816|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4124722|NCT00920374|3949814|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4124723|NCT00920374|3949815|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4124724|NCT00920374|3949816|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4124725|NCT00920374|3949814|B3|||Age||years|Mean|53.6|53.6|Standard Deviation|17.82|17.82|||
4124726|NCT00920374|3949815|B2|||Age||years|Mean|68.9|68.9|Standard Deviation|6.57|6.57|||
4124727|NCT00920374|3949816|B1|||Age||years|Mean|39.3|39.3|Standard Deviation|12.18|12.18|||
4124728|NCT00920309|3949841|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4124729|NCT00920309|3949842|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4124730|NCT00920309|3949843|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4124731|NCT00920309|3949841|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4124732|NCT00920309|3949842|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4124733|NCT00920309|3949843|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4124734|NCT00920309|3949841|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4124735|NCT00920309|3949842|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4124736|NCT00920309|3949843|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4124737|NCT00920309|3949841|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4124738|NCT00920309|3949842|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4124739|NCT00920309|3949843|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4124740|NCT00920309|3949841|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4124741|NCT00920309|3949842|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4124742|NCT00920309|3949843|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4124743|NCT00920231|3949852|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4124744|NCT00920231|3949853|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4124745|NCT00920231|3949854|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4124746|NCT00920231|3949852|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4124747|NCT00920231|3949853|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4124748|NCT00920231|3949854|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4124749|NCT00920231|3949852|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4124750|NCT00920231|3949853|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4124751|NCT00920231|3949854|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4124752|NCT00920231|3949852|B3|||Age|Initial system: 8 subjects with age range from 21 to 66; Modified system: 8 subjects with age range from 39 to 70|years|Mean|48|48.0|Full Range|||21.0|70.0|
4124753|NCT00920231|3949853|B2|||Age|Initial system: 8 subjects with age range from 21 to 66; Modified system: 8 subjects with age range from 39 to 70|years|Mean|52|52.0|Full Range|||39.0|70.0|
4124754|NCT00920231|3949854|B1|||Age|Initial system: 8 subjects with age range from 21 to 66; Modified system: 8 subjects with age range from 39 to 70|years|Mean|43|43.0|Full Range|||21.0|66.0|
4124755|NCT00920231|3949852|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4124756|NCT00920231|3949853|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4124757|NCT00920231|3949854|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4124758|NCT00920231|3949852|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4124759|NCT00920231|3949853|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4124760|NCT00920231|3949854|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4124761|NCT00920231|3949852|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4124762|NCT00920231|3949853|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4124763|NCT00920231|3949854|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4124764|NCT00920218|3949863|B5|Race/Ethnicity|White-Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|100|100.0||||||
4124765|NCT00920218|3949864|B4|Race/Ethnicity|White-Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
4124766|NCT00920218|3949865|B3|Race/Ethnicity|White-Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
4124767|NCT00920218|3949866|B2|Race/Ethnicity|White-Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
4124768|NCT00920218|3949867|B1|Race/Ethnicity|White-Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
4124769|NCT00920218|3949863|B5|Race/Ethnicity|White-Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4124770|NCT00920218|3949864|B4|Race/Ethnicity|White-Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4124771|NCT00920218|3949865|B3|Race/Ethnicity|White-Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4124772|NCT00920218|3949866|B2|Race/Ethnicity|White-Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4124773|NCT00920218|3949867|B1|Race/Ethnicity|White-Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4124774|NCT00920218|3949863|B5|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4124775|NCT00920218|3949864|B4|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4124776|NCT00920218|3949865|B3|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4124777|NCT00920218|3949866|B2|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4124778|NCT00920218|3949867|B1|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4124779|NCT00920218|3949863|B5|Race/Ethnicity|Asian-Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4124780|NCT00920218|3949864|B4|Race/Ethnicity|Asian-Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4124781|NCT00920218|3949865|B3|Race/Ethnicity|Asian-Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4124782|NCT00920218|3949866|B2|Race/Ethnicity|Asian-Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4124783|NCT00920218|3949867|B1|Race/Ethnicity|Asian-Japanese Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4124784|NCT00920218|3949863|B5|Race/Ethnicity|Asian-East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4124785|NCT00920218|3949864|B4|Race/Ethnicity|Asian-East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4124786|NCT00920218|3949865|B3|Race/Ethnicity|Asian-East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4124787|NCT00920218|3949866|B2|Race/Ethnicity|Asian-East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4124788|NCT00920218|3949867|B1|Race/Ethnicity|Asian-East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4124789|NCT00920218|3949863|B5|Race/Ethnicity|Asian-Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4124790|NCT00920218|3949864|B4|Race/Ethnicity|Asian-Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4124791|NCT00920218|3949865|B3|Race/Ethnicity|Asian-Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4124792|NCT00920218|3949866|B2|Race/Ethnicity|Asian-Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4124793|NCT00920218|3949867|B1|Race/Ethnicity|Asian-Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4124794|NCT00920218|3949863|B5|Race/Ethnicity|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4124795|NCT00920218|3949864|B4|Race/Ethnicity|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4124796|NCT00920218|3949865|B3|Race/Ethnicity|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4124797|NCT00920218|3949866|B2|Race/Ethnicity|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4124798|NCT00920218|3949867|B1|Race/Ethnicity|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4124799|NCT00920218|3949863|B5|Race/Ethnicity|African Heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4124800|NCT00920218|3949864|B4|Race/Ethnicity|African Heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4124801|NCT00920218|3949865|B3|Race/Ethnicity|African Heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4124802|NCT00920218|3949866|B2|Race/Ethnicity|African Heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4124803|NCT00920218|3949867|B1|Race/Ethnicity|African Heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4124804|NCT00920218|3949863|B5||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4124805|NCT00920218|3949864|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4124806|NCT00920218|3949865|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4124807|NCT00920218|3949866|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4124808|NCT00920218|3949867|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4124809|NCT00920218|3949863|B5||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4124810|NCT00920218|3949864|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4124811|NCT00920218|3949865|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4124812|NCT00920218|3949866|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4124813|NCT00920218|3949867|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4124814|NCT00920218|3949863|B5|||Age||Years|Mean|56.1|56.1|Standard Deviation|10.0|10.0|||
4124815|NCT00920218|3949864|B4|||Age||Years|Mean|57.3|57.3|Standard Deviation|8.6|8.6|||
4124816|NCT00920218|3949865|B3|||Age||Years|Mean|57.8|57.8|Standard Deviation|6.8|6.8|||
4124817|NCT00920218|3949866|B2|||Age||Years|Mean|56.0|56.0|Standard Deviation|11.4|11.4|||
4124818|NCT00920218|3949867|B1|||Age||Years|Mean|53.1|53.1|Standard Deviation|12.2|12.2|||
4124819|NCT00920140|3949968|B6|Missing||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4124820|NCT00920140|3949969|B5|Missing||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4124821|NCT00920140|3949970|B4|Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4124822|NCT00920140|3949971|B3|Missing||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4124823|NCT00920140|3949972|B2|Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4124824|NCT00920140|3949973|B1|Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4124825|NCT00920140|3949968|B6|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4124826|NCT00920140|3949969|B5|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4124827|NCT00920140|3949970|B4|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4124828|NCT00920140|3949971|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4124829|NCT00920140|3949972|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4124830|NCT00920140|3949973|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4124831|NCT00920140|3949968|B6|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4124832|NCT00920140|3949969|B5|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4124833|NCT00920140|3949970|B4|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4124834|NCT00920140|3949971|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4124835|NCT00920140|3949972|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4124836|NCT00920140|3949973|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4124837|NCT00920140|3949968|B6|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4124838|NCT00920140|3949969|B5|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4124839|NCT00920140|3949970|B4|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4124840|NCT00920140|3949971|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4124841|NCT00920140|3949972|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4124842|NCT00920140|3949973|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4124843|NCT00920140|3949968|B6|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|80|80.0||||||
4124844|NCT00920140|3949969|B5|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4124845|NCT00920140|3949970|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4124846|NCT00920140|3949971|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
4124847|NCT00920140|3949972|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4124848|NCT00920140|3949973|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4124849|NCT00920140|3949968|B6|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4124850|NCT00920140|3949969|B5|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4124851|NCT00920140|3949970|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4124852|NCT00920140|3949971|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4124853|NCT00920140|3949972|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4124854|NCT00920140|3949973|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4124855|NCT00920140|3949968|B6||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4124856|NCT00920140|3949969|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4124857|NCT00920140|3949970|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4124858|NCT00920140|3949971|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4124859|NCT00920140|3949972|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4124860|NCT00920140|3949973|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4124861|NCT00920140|3949968|B6||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4124862|NCT00920140|3949969|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4124863|NCT00920140|3949970|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4124864|NCT00920140|3949971|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4124865|NCT00920140|3949972|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4124866|NCT00920140|3949973|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4124867|NCT00920140|3949968|B6|||Age||Years|Mean|64.2|64.2|Standard Deviation|13.69|13.69|||
4124868|NCT00920140|3949969|B5|||Age||Years|Mean|67.7|67.7|Standard Deviation|6.87|6.87|||
4124869|NCT00920140|3949970|B4|||Age||Years|Mean|59.6|59.6|Standard Deviation|18.89|18.89|||
4124870|NCT00920140|3949971|B3|||Age||Years|Mean|65.6|65.6|Standard Deviation|10.71|10.71|||
4124871|NCT00920140|3949972|B2|||Age||Years|Mean|60.2|60.2|Standard Deviation|15.86|15.86|||
4124872|NCT00920140|3949973|B1|||Age||Years|Mean|70.4|70.4|Standard Deviation|15.71|15.71|||
4124873|NCT00920075|3950015|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4124874|NCT00920075|3950015|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4124875|NCT00920075|3950015|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4124876|NCT00920075|3950015|B1|||Age||years|Mean|12.9|12.9|Standard Deviation|2.7|2.7|||
4124877|NCT00920075|3950015|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4124878|NCT00920075|3950015|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4124879|NCT00920075|3950015|B1||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4124880|NCT00920023|3950021|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4124881|NCT00920023|3950021|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4124882|NCT00920023|3950021|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4124883|NCT00920023|3950021|B1|||Age||years|Mean|64.8|64.8|Standard Deviation|13.04|13.04|||
4124884|NCT00919932|3950026|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4124885|NCT00919932|3950027|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4124886|NCT00919932|3950028|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4124887|NCT00919932|3950026|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4124888|NCT00919932|3950027|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4124889|NCT00919932|3950028|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4124890|NCT00919932|3950026|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4124891|NCT00919932|3950027|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4124892|NCT00919932|3950028|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4124893|NCT00919932|3950026|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4124894|NCT00919932|3950027|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4124895|NCT00919932|3950028|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4124896|NCT00919932|3950026|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4124897|NCT00919932|3950027|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4124898|NCT00919932|3950028|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4124899|NCT00919932|3950026|B3||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4124900|NCT00919932|3950027|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4124901|NCT00919932|3950028|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4124902|NCT00919893|3950037|B3|Germany||Region of Enrollment||participants|Number|139|139.0||||||
4124903|NCT00919893|3950038|B2|Germany||Region of Enrollment||participants|Number|69|69.0||||||
4124904|NCT00919893|3950039|B1|Germany||Region of Enrollment||participants|Number|70|70.0||||||
4124905|NCT00919893|3950037|B3||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4124906|NCT00919893|3950038|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4124907|NCT00919893|3950039|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4124908|NCT00919893|3950037|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4124909|NCT00919893|3950038|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4124910|NCT00919893|3950039|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4124911|NCT00919893|3950037|B3|||Age||years|Mean|39.5|39.5|Standard Deviation|8.1|8.1|||
4124912|NCT00919893|3950038|B2|||Age||years|Mean|39.3|39.3|Standard Deviation|9.1|9.1|||
4124913|NCT00919893|3950039|B1|||Age||years|Mean|39.7|39.7|Standard Deviation|7.2|7.2|||
4124914|NCT00919893|3950037|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4124915|NCT00919893|3950038|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4124916|NCT00919893|3950039|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4124917|NCT00919893|3950037|B3||Between 18 and 65 years|Age||Participants|Count of Participants|139|139.0||||||
4124918|NCT00919893|3950038|B2||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
4124919|NCT00919893|3950039|B1||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4124920|NCT00919893|3950037|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4124921|NCT00919893|3950038|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4124922|NCT00919893|3950039|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4124923|NCT00919867|3950046|B7|United States||Region of Enrollment||participants|Number|42|42.0||||||
4124924|NCT00919867|3950047|B6|United States||Region of Enrollment||participants|Number|7|7.0||||||
4124925|NCT00919867|3950048|B5|United States||Region of Enrollment||participants|Number|7|7.0||||||
4124926|NCT00919867|3950049|B4|United States||Region of Enrollment||participants|Number|7|7.0||||||
4124927|NCT00919867|3950050|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4124928|NCT00919867|3950051|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4124929|NCT00919867|3950052|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4124930|NCT00919867|3950046|B7||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4124931|NCT00919867|3950047|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4124932|NCT00919867|3950048|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4124933|NCT00919867|3950049|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4124934|NCT00919867|3950050|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4124935|NCT00919867|3950051|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4124936|NCT00919867|3950052|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4124937|NCT00919867|3950046|B7||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4124938|NCT00919867|3950047|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4124939|NCT00919867|3950048|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4124940|NCT00919867|3950049|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4124941|NCT00919867|3950050|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4124942|NCT00919867|3950051|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4124943|NCT00919867|3950052|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4124944|NCT00919867|3950046|B7|||Age||years|Mean|30.5|30.5|Standard Deviation|7.41|7.41|||
4124945|NCT00919867|3950047|B6|||Age||years|Mean|31.1|31.1|Standard Deviation|4.18|4.18|||
4124946|NCT00919867|3950048|B5|||Age||years|Mean|31.9|31.9|Standard Deviation|8.19|8.19|||
4124947|NCT00919867|3950049|B4|||Age||years|Mean|26.0|26.0|Standard Deviation|5.29|5.29|||
4124948|NCT00919867|3950050|B3|||Age||years|Mean|34.6|34.6|Standard Deviation|10.18|10.18|||
4124949|NCT00919867|3950051|B2|||Age||years|Mean|28.7|28.7|Standard Deviation|8.44|8.44|||
4124950|NCT00919867|3950052|B1|||Age||years|Mean|30.9|30.9|Standard Deviation|6.20|6.2|||
4124951|NCT00919867|3950046|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4124952|NCT00919867|3950047|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4124953|NCT00919867|3950048|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4124954|NCT00919867|3950049|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4124955|NCT00919867|3950050|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4124956|NCT00919867|3950051|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4124957|NCT00919867|3950052|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4124958|NCT00919867|3950046|B7||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4124959|NCT00919867|3950047|B6||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4124960|NCT00919867|3950048|B5||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4124961|NCT00919867|3950049|B4||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4124962|NCT00919867|3950050|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4124963|NCT00919867|3950051|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4124964|NCT00919867|3950052|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4124965|NCT00919867|3950046|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4124966|NCT00919867|3950047|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4124967|NCT00919867|3950048|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4124968|NCT00919867|3950049|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4124969|NCT00919867|3950050|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4124970|NCT00919867|3950051|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4124971|NCT00919867|3950052|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4124972|NCT00919854|3950078|B1|||Body Mass Index (BMI)||kg/m^2|Mean|15.1|15.1|Standard Deviation|1.51|1.51|||
4124973|NCT00919854|3950078|B1|South Africa||Region of Enrollment||participants|Number|10|10.0||||||
4124974|NCT00919854|3950078|B1|India||Region of Enrollment||participants|Number|1|1.0||||||
4124975|NCT00919854|3950078|B1|Brazil||Region of Enrollment||participants|Number|6|6.0||||||
4124976|NCT00919854|3950078|B1|Argentina||Region of Enrollment||participants|Number|4|4.0||||||
4124977|NCT00919854|3950078|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4124978|NCT00919854|3950078|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4124979|NCT00919854|3950078|B1|||Age||years|Median|4.6|4.6|Full Range|0.89|0.89|3.2|5.9|
4124980|NCT00919802|3950087|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4124981|NCT00919802|3950087|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124982|NCT00919802|3950087|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124983|NCT00919802|3950087|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4124984|NCT00919802|3950087|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4124985|NCT00919802|3950087|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124986|NCT00919802|3950087|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124987|NCT00919802|3950087|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4124988|NCT00919802|3950087|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124989|NCT00919802|3950087|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4124990|NCT00919802|3950087|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4124991|NCT00919802|3950087|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4124992|NCT00919802|3950087|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4124993|NCT00919802|3950087|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4124994|NCT00919802|3950087|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4124995|NCT00919802|3950087|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4124996|NCT00919763|3950096|B3|United States||Region of Enrollment||participants|Number|102|102.0||||||
4124997|NCT00919763|3950097|B2|United States||Region of Enrollment||participants|Number|49|49.0||||||
4124998|NCT00919763|3950098|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
4124999|NCT00919763|3950096|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4125000|NCT00919763|3950097|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4125001|NCT00919763|3950098|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4125002|NCT00919763|3950096|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4125003|NCT00919763|3950097|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4125004|NCT00919763|3950098|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4125005|NCT00919763|3950096|B3|||Age||years|Mean|39.3|39.3|Standard Deviation|14.3|14.3|||
4125006|NCT00919763|3950097|B2|||Age||years|Mean|40.3|40.3|Standard Deviation|13.8|13.8|||
4125007|NCT00919763|3950098|B1|||Age||years|Mean|38.3|38.3|Standard Deviation|14.9|14.9|||
4125008|NCT00919763|3950096|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4125009|NCT00919763|3950097|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4125010|NCT00919763|3950098|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4125011|NCT00919763|3950096|B3||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
4125012|NCT00919763|3950097|B2||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4125013|NCT00919763|3950098|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4125014|NCT00919763|3950096|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4125015|NCT00919763|3950097|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4125016|NCT00919763|3950098|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4125017|NCT00919724|3950105|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125018|NCT00919724|3950106|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125019|NCT00919724|3950107|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125020|NCT00919724|3950105|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125021|NCT00919724|3950106|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125022|NCT00919724|3950107|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125023|NCT00919724|3950105|B3||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4125024|NCT00919724|3950106|B2||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4125025|NCT00919724|3950107|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4125026|NCT00919724|3950105|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4125027|NCT00919724|3950106|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4125028|NCT00919724|3950107|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4125029|NCT00919724|3950105|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125030|NCT00919724|3950106|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125031|NCT00919724|3950107|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125032|NCT00919724|3950105|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125033|NCT00919724|3950106|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125034|NCT00919724|3950107|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125035|NCT00919724|3950105|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125036|NCT00919724|3950106|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125037|NCT00919724|3950107|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125038|NCT00919724|3950105|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4125039|NCT00919724|3950106|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4125040|NCT00919724|3950107|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4125041|NCT00919724|3950105|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4125042|NCT00919724|3950106|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4125043|NCT00919724|3950107|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4125044|NCT00919724|3950105|B3|||Age||years|Median|35|35.0|Inter-Quartile Range|||26.0|45.0|
4125045|NCT00919724|3950106|B2|||Age||years|Median|35|35.0|Inter-Quartile Range|||25.0|45.0|
4125046|NCT00919724|3950107|B1|||Age||years|Median|35|35.0|Inter-Quartile Range|||27.0|44.0|
4125047|NCT00919711|3950114|B3|Japanese||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4125048|NCT00919711|3950115|B2|Japanese||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4125049|NCT00919711|3950116|B1|Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4125050|NCT00919711|3950114|B3|Asian||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4125051|NCT00919711|3950115|B2|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4125052|NCT00919711|3950116|B1|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4125053|NCT00919711|3950114|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4125054|NCT00919711|3950115|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4125055|NCT00919711|3950116|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4125056|NCT00919711|3950114|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|849|849.0||||||
4125057|NCT00919711|3950115|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|424|424.0||||||
4125058|NCT00919711|3950116|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|425|425.0||||||
4125059|NCT00919711|3950114|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4125060|NCT00919711|3950115|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4125061|NCT00919711|3950116|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4125062|NCT00919711|3950114|B3||Female|Sex: Female, Male||Participants|Count of Participants|870|870.0||||||
4125063|NCT00919711|3950115|B2||Female|Sex: Female, Male||Participants|Count of Participants|435|435.0||||||
4125064|NCT00919711|3950116|B1||Female|Sex: Female, Male||Participants|Count of Participants|435|435.0||||||
4125065|NCT00919711|3950114|B3|||Age||Years|Mean|67.7|67.7|Standard Deviation|6.9|6.9|||
4125066|NCT00919711|3950115|B2|||Age||Years|Mean|67.8|67.8|Standard Deviation|7.0|7.0|||
4125067|NCT00919711|3950116|B1|||Age||Years|Mean|67.7|67.7|Standard Deviation|6.8|6.8|||
4125068|NCT00919633|3950129|B5|1b||Hepatitis C Genotype|1a, 1b|participants|Number|21|21.0||||||
4125069|NCT00919633|3950130|B4|1b||Hepatitis C Genotype|1a, 1b|participants|Number|7|7.0||||||
4125070|NCT00919633|3950131|B3|1b||Hepatitis C Genotype|1a, 1b|participants|Number|4|4.0||||||
4125071|NCT00919633|3950132|B2|1b||Hepatitis C Genotype|1a, 1b|participants|Number|6|6.0||||||
4125072|NCT00919633|3950133|B1|1b||Hepatitis C Genotype|1a, 1b|participants|Number|4|4.0||||||
4125073|NCT00919633|3950129|B5|1a||Hepatitis C Genotype|1a, 1b|participants|Number|85|85.0||||||
4125074|NCT00919633|3950130|B4|1a||Hepatitis C Genotype|1a, 1b|participants|Number|19|19.0||||||
4125075|NCT00919633|3950131|B3|1a||Hepatitis C Genotype|1a, 1b|participants|Number|23|23.0||||||
4125076|NCT00919633|3950132|B2|1a||Hepatitis C Genotype|1a, 1b|participants|Number|19|19.0||||||
4125077|NCT00919633|3950133|B1|1a||Hepatitis C Genotype|1a, 1b|participants|Number|24|24.0||||||
4125078|NCT00919633|3950129|B5|United States||Region of Enrollment||participants|Number|106|106.0||||||
4125079|NCT00919633|3950130|B4|United States||Region of Enrollment||participants|Number|26|26.0||||||
4125080|NCT00919633|3950131|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
4125081|NCT00919633|3950132|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4125082|NCT00919633|3950133|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4125083|NCT00919633|3950129|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125084|NCT00919633|3950130|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125085|NCT00919633|3950131|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125086|NCT00919633|3950132|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125087|NCT00919633|3950133|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125088|NCT00919633|3950129|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4125089|NCT00919633|3950130|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4125090|NCT00919633|3950131|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125091|NCT00919633|3950132|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125092|NCT00919633|3950133|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4125093|NCT00919633|3950129|B5||White|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
4125094|NCT00919633|3950130|B4||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4125095|NCT00919633|3950131|B3||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4125096|NCT00919633|3950132|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4125097|NCT00919633|3950133|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4125098|NCT00919633|3950129|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4125099|NCT00919633|3950130|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4125100|NCT00919633|3950131|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4125101|NCT00919633|3950132|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4125102|NCT00919633|3950133|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4125103|NCT00919633|3950129|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4125104|NCT00919633|3950130|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125105|NCT00919633|3950131|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4125106|NCT00919633|3950132|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125107|NCT00919633|3950133|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125108|NCT00919633|3950129|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125109|NCT00919633|3950130|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125110|NCT00919633|3950131|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125111|NCT00919633|3950132|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125112|NCT00919633|3950133|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125113|NCT00919633|3950129|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4125114|NCT00919633|3950130|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4125115|NCT00919633|3950131|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125116|NCT00919633|3950132|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125117|NCT00919633|3950133|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4125118|NCT00919633|3950129|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125119|NCT00919633|3950130|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125120|NCT00919633|3950131|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125121|NCT00919633|3950132|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125122|NCT00919633|3950133|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125123|NCT00919633|3950129|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
4125124|NCT00919633|3950130|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4125125|NCT00919633|3950131|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4125126|NCT00919633|3950132|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4125127|NCT00919633|3950133|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4125128|NCT00919633|3950129|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4125129|NCT00919633|3950130|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4125130|NCT00919633|3950131|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4125131|NCT00919633|3950132|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4125132|NCT00919633|3950133|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4125133|NCT00919633|3950129|B5||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4125134|NCT00919633|3950130|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4125135|NCT00919633|3950131|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4125136|NCT00919633|3950132|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4125137|NCT00919633|3950133|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4125138|NCT00919633|3950129|B5||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4125139|NCT00919633|3950130|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4125140|NCT00919633|3950131|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4125141|NCT00919633|3950132|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4125142|NCT00919633|3950133|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4125143|NCT00919633|3950129|B5|||Age||years|Median|51.2|51.2|Inter-Quartile Range|||44.6|56.1|
4125144|NCT00919633|3950130|B4|||Age||years|Median|49.1|49.1|Inter-Quartile Range|||44.6|53.2|
4125145|NCT00919633|3950131|B3|||Age||years|Median|51.3|51.3|Inter-Quartile Range|||46.7|55.5|
4125146|NCT00919633|3950132|B2|||Age||years|Median|51.5|51.5|Inter-Quartile Range|||47.0|56.1|
4125147|NCT00919633|3950133|B1|||Age||years|Median|51.2|51.2|Inter-Quartile Range|||48.5|53.8|
4125148|NCT00919633|3950129|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4125149|NCT00919633|3950130|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4125150|NCT00919633|3950131|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4125151|NCT00919633|3950132|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4125152|NCT00919633|3950133|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4125153|NCT00919633|3950129|B5||Between 18 and 65 years|Age||Participants|Count of Participants|106|106.0||||||
4125154|NCT00919633|3950130|B4||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4125155|NCT00919633|3950131|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4125156|NCT00919633|3950132|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4125157|NCT00919633|3950133|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4125158|NCT00919633|3950129|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4125159|NCT00919633|3950130|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4125160|NCT00919633|3950131|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4125161|NCT00919633|3950132|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4125162|NCT00919633|3950133|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4125163|NCT00919191|3950154|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4125164|NCT00919191|3950154|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4125165|NCT00919191|3950154|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4125166|NCT00919191|3950154|B1|||Age||years|Mean|29.1|29.1|Standard Deviation|5.8|5.8|||
4125167|NCT00919191|3950154|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4125168|NCT00919191|3950154|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4125169|NCT00919191|3950154|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4125170|NCT00919126|3950161|B4|Yes||Pre-Operative Serum Creatinine >2.0 mg/dL||participants|Number|12|12.0||||||
4125171|NCT00919126|3950162|B3|Yes||Pre-Operative Serum Creatinine >2.0 mg/dL||participants|Number|5|5.0||||||
4125172|NCT00919126|3950163|B2|Yes||Pre-Operative Serum Creatinine >2.0 mg/dL||participants|Number|4|4.0||||||
4125173|NCT00919126|3950164|B1|Yes||Pre-Operative Serum Creatinine >2.0 mg/dL||participants|Number|3|3.0||||||
4125174|NCT00919126|3950161|B4|No||Pre-Operative Serum Creatinine >2.0 mg/dL||participants|Number|90|90.0||||||
4125175|NCT00919126|3950162|B3|No||Pre-Operative Serum Creatinine >2.0 mg/dL||participants|Number|28|28.0||||||
4125176|NCT00919126|3950163|B2|No||Pre-Operative Serum Creatinine >2.0 mg/dL||participants|Number|33|33.0||||||
4125177|NCT00919126|3950164|B1|No||Pre-Operative Serum Creatinine >2.0 mg/dL||participants|Number|29|29.0||||||
4125178|NCT00919126|3950161|B4|Yes||Pre-Operative Treatment With Insulin or Antidiabetics||participants|Number|33|33.0||||||
4125179|NCT00919126|3950162|B3|Yes||Pre-Operative Treatment With Insulin or Antidiabetics||participants|Number|8|8.0||||||
4125180|NCT00919126|3950163|B2|Yes||Pre-Operative Treatment With Insulin or Antidiabetics||participants|Number|13|13.0||||||
4125181|NCT00919126|3950164|B1|Yes||Pre-Operative Treatment With Insulin or Antidiabetics||participants|Number|12|12.0||||||
4125182|NCT00919126|3950161|B4|No||Pre-Operative Treatment With Insulin or Antidiabetics||participants|Number|69|69.0||||||
4125183|NCT00919126|3950162|B3|No||Pre-Operative Treatment With Insulin or Antidiabetics||participants|Number|25|25.0||||||
4125184|NCT00919126|3950163|B2|No||Pre-Operative Treatment With Insulin or Antidiabetics||participants|Number|24|24.0||||||
4125185|NCT00919126|3950164|B1|No||Pre-Operative Treatment With Insulin or Antidiabetics||participants|Number|20|20.0||||||
4125186|NCT00919126|3950161|B4|Yes||History of Cerebrovascular Disease||participants|Number|27|27.0||||||
4125187|NCT00919126|3950162|B3|Yes||History of Cerebrovascular Disease||participants|Number|12|12.0||||||
4125188|NCT00919126|3950163|B2|Yes||History of Cerebrovascular Disease||participants|Number|10|10.0||||||
4125189|NCT00919126|3950164|B1|Yes||History of Cerebrovascular Disease||participants|Number|5|5.0||||||
4125190|NCT00919126|3950161|B4|No||History of Cerebrovascular Disease||participants|Number|75|75.0||||||
4125191|NCT00919126|3950162|B3|No||History of Cerebrovascular Disease||participants|Number|21|21.0||||||
4125192|NCT00919126|3950163|B2|No||History of Cerebrovascular Disease||participants|Number|27|27.0||||||
4125193|NCT00919126|3950164|B1|No||History of Cerebrovascular Disease||participants|Number|27|27.0||||||
4125194|NCT00919126|3950161|B4|Yes||History of Congestive Heart Failure||participants|Number|29|29.0||||||
4125195|NCT00919126|3950162|B3|Yes||History of Congestive Heart Failure||participants|Number|11|11.0||||||
4125196|NCT00919126|3950163|B2|Yes||History of Congestive Heart Failure||participants|Number|9|9.0||||||
4125197|NCT00919126|3950164|B1|Yes||History of Congestive Heart Failure||participants|Number|9|9.0||||||
4125198|NCT00919126|3950161|B4|No||History of Congestive Heart Failure||participants|Number|73|73.0||||||
4125199|NCT00919126|3950162|B3|No||History of Congestive Heart Failure||participants|Number|22|22.0||||||
4125200|NCT00919126|3950163|B2|No||History of Congestive Heart Failure||participants|Number|28|28.0||||||
4125201|NCT00919126|3950164|B1|No||History of Congestive Heart Failure||participants|Number|23|23.0||||||
4125202|NCT00919126|3950161|B4|Yes||History of Ischemic Heart Disease||participants|Number|68|68.0||||||
4125203|NCT00919126|3950162|B3|Yes||History of Ischemic Heart Disease||participants|Number|22|22.0||||||
4125204|NCT00919126|3950163|B2|Yes||History of Ischemic Heart Disease||participants|Number|23|23.0||||||
4125205|NCT00919126|3950164|B1|Yes||History of Ischemic Heart Disease||participants|Number|23|23.0||||||
4125206|NCT00919126|3950161|B4|No||History of Ischemic Heart Disease||participants|Number|34|34.0||||||
4125207|NCT00919126|3950162|B3|No||History of Ischemic Heart Disease||participants|Number|11|11.0||||||
4125208|NCT00919126|3950163|B2|No||History of Ischemic Heart Disease||participants|Number|14|14.0||||||
4125209|NCT00919126|3950164|B1|No||History of Ischemic Heart Disease||participants|Number|9|9.0||||||
4125210|NCT00919126|3950161|B4|Yes||Planned High-Risk Surgical Procedures||participants|Number|90|90.0||||||
4125211|NCT00919126|3950162|B3|Yes||Planned High-Risk Surgical Procedures||participants|Number|29|29.0||||||
4125212|NCT00919126|3950163|B2|Yes||Planned High-Risk Surgical Procedures||participants|Number|33|33.0||||||
4125213|NCT00919126|3950164|B1|Yes||Planned High-Risk Surgical Procedures||participants|Number|28|28.0||||||
4125214|NCT00919126|3950161|B4|No||Planned High-Risk Surgical Procedures||participants|Number|12|12.0||||||
4125215|NCT00919126|3950162|B3|No||Planned High-Risk Surgical Procedures||participants|Number|4|4.0||||||
4125216|NCT00919126|3950163|B2|No||Planned High-Risk Surgical Procedures||participants|Number|4|4.0||||||
4125217|NCT00919126|3950164|B1|No||Planned High-Risk Surgical Procedures||participants|Number|4|4.0||||||
4125218|NCT00919126|3950161|B4|||Body Mass Index||Kg/m2|Mean|28.51|28.51|Standard Deviation|6.05|6.05|||
4125219|NCT00919126|3950162|B3|||Body Mass Index||Kg/m2|Mean|28.39|28.39|Standard Deviation|5.98|5.98|||
4125220|NCT00919126|3950163|B2|||Body Mass Index||Kg/m2|Mean|28.43|28.43|Standard Deviation|6.09|6.09|||
4125283|NCT00919100|3950222|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4125221|NCT00919126|3950164|B1|||Body Mass Index||Kg/m2|Mean|28.71|28.71|Standard Deviation|6.26|6.26|||
4125222|NCT00919126|3950161|B4|||Body Surface Area||m2|Mean|1.935|1.935|Standard Deviation|0.235|0.235|||
4125223|NCT00919126|3950162|B3|||Body Surface Area||m2|Mean|1.943|1.943|Standard Deviation|0.228|0.228|||
4125224|NCT00919126|3950163|B2|||Body Surface Area||m2|Mean|1.926|1.926|Standard Deviation|0.251|0.251|||
4125225|NCT00919126|3950164|B1|||Body Surface Area||m2|Mean|1.938|1.938|Standard Deviation|0.228|0.228|||
4125226|NCT00919126|3950161|B4|||Height||cm|Mean|168.5|168.5|Standard Deviation|9.1|9.1|||
4125227|NCT00919126|3950162|B3|||Height||cm|Mean|169.2|169.2|Standard Deviation|9.8|9.8|||
4125228|NCT00919126|3950163|B2|||Height||cm|Mean|168.0|168.0|Standard Deviation|8.9|8.9|||
4125229|NCT00919126|3950164|B1|||Height||cm|Mean|168.4|168.4|Standard Deviation|8.8|8.8|||
4125230|NCT00919126|3950161|B4|||Weight||kg|Mean|80.88|80.88|Standard Deviation|17.85|17.85|||
4125231|NCT00919126|3950162|B3|||Weight||kg|Mean|81.12|81.12|Standard Deviation|16.74|16.74|||
4125232|NCT00919126|3950163|B2|||Weight||kg|Mean|80.41|80.41|Standard Deviation|19.61|19.61|||
4125233|NCT00919126|3950164|B1|||Weight||kg|Mean|81.18|81.18|Standard Deviation|17.39|17.39|||
4125234|NCT00919126|3950161|B4||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4125235|NCT00919126|3950162|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4125236|NCT00919126|3950163|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4125237|NCT00919126|3950164|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4125238|NCT00919126|3950161|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4125239|NCT00919126|3950162|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4125240|NCT00919126|3950163|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4125241|NCT00919126|3950164|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4125242|NCT00919126|3950161|B4|||Age||years|Mean|70.3|70.3|Standard Deviation|8.3|8.3|||
4125243|NCT00919126|3950162|B3|||Age||years|Mean|71.1|71.1|Standard Deviation|6.9|6.9|||
4125244|NCT00919126|3950163|B2|||Age||years|Mean|70.0|70.0|Standard Deviation|9.7|9.7|||
4125245|NCT00919126|3950164|B1|||Age||years|Mean|69.8|69.8|Standard Deviation|8.2|8.2|||
4125246|NCT00919113|3950210|B3|United States||Region of Enrollment||participants|Number|98|98.0||||||
4125247|NCT00919113|3950211|B2|United States||Region of Enrollment||participants|Number|49|49.0||||||
4125248|NCT00919113|3950212|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
4125249|NCT00919113|3950210|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4125250|NCT00919113|3950211|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4125251|NCT00919113|3950212|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4125252|NCT00919113|3950210|B3||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4125253|NCT00919113|3950211|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4125254|NCT00919113|3950212|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4125255|NCT00919113|3950210|B3|||Age||years|Mean|45.6|45.6|Standard Deviation|14.3|14.3|||
4125256|NCT00919113|3950211|B2|||Age||years|Mean|46.8|46.8|Standard Deviation|14.1|14.1|||
4125257|NCT00919113|3950212|B1|||Age||years|Mean|44.4|44.4|Standard Deviation|14.6|14.6|||
4125258|NCT00919113|3950210|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4125259|NCT00919113|3950211|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4125260|NCT00919113|3950212|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4125261|NCT00919113|3950210|B3||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
4125262|NCT00919113|3950211|B2||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4125263|NCT00919113|3950212|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4125264|NCT00919113|3950210|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4125265|NCT00919113|3950211|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4125266|NCT00919113|3950212|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4125267|NCT00919100|3950221|B3|United States||Region of Enrollment||Participants|Count of Participants|81|81.0||||||
4125268|NCT00919100|3950222|B2|United States||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
4125269|NCT00919100|3950223|B1|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
4125270|NCT00919100|3950221|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4125271|NCT00919100|3950222|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4125272|NCT00919100|3950223|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4125273|NCT00919100|3950221|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4125274|NCT00919100|3950222|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4125275|NCT00919100|3950223|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4125276|NCT00919100|3950221|B3|||Age||years|Median|10.0|10.0|Full Range|||6.68|11.99|
4125277|NCT00919100|3950222|B2|||Age||years|Median|10.10|10.1|Full Range|||8.91|11.99|
4125278|NCT00919100|3950223|B1|||Age||years|Median|9.91|9.91|Full Range|||6.68|11.08|
4125279|NCT00919100|3950221|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4125280|NCT00919100|3950222|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4125281|NCT00919100|3950223|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4125282|NCT00919100|3950221|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4125284|NCT00919100|3950223|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4125285|NCT00919100|3950221|B3||<=18 years|Age||Participants|Count of Participants|81|81.0||||||
4125286|NCT00919100|3950222|B2||<=18 years|Age||Participants|Count of Participants|41|41.0||||||
4125287|NCT00919100|3950223|B1||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
4125288|NCT00919061|3950234|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4125289|NCT00919061|3950234|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4125290|NCT00919061|3950234|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4125291|NCT00919061|3950234|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4125292|NCT00919061|3950234|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4125293|NCT00919061|3950234|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4125294|NCT00919035|3950239|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4125295|NCT00919035|3950239|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4125296|NCT00919035|3950239|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4125297|NCT00919035|3950239|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4125298|NCT00919035|3950239|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4125299|NCT00919035|3950239|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4125300|NCT00918957|3950245|B3|||Baseline P. aeruginosa sputum density|"Overall density, defined as the sum of biotypes (mucoid, dry and small colony variant).~Baseline is defined as the latest measurement prior to first dosing of study medication.~If sub-isolates existed for CFU biotype mucoid or dry, then the sum of sub-isolates is analyzed."|Log10 CFU (colony forming unit)|Mean|7.4|7.4|Standard Deviation|1.52|1.52|||
4125301|NCT00918957|3950246|B2|||Baseline P. aeruginosa sputum density|"Overall density, defined as the sum of biotypes (mucoid, dry and small colony variant).~Baseline is defined as the latest measurement prior to first dosing of study medication.~If sub-isolates existed for CFU biotype mucoid or dry, then the sum of sub-isolates is analyzed."|Log10 CFU (colony forming unit)|Mean|7.4|7.4|Standard Deviation|1.55|1.55|||
4125302|NCT00918957|3950247|B1|||Baseline P. aeruginosa sputum density|"Overall density, defined as the sum of biotypes (mucoid, dry and small colony variant).~Baseline is defined as the latest measurement prior to first dosing of study medication.~If sub-isolates existed for CFU biotype mucoid or dry, then the sum of sub-isolates is analyzed."|Log10 CFU (colony forming unit)|Mean|7.4|7.4|Standard Deviation|1.53|1.53|||
4125303|NCT00918957|3950245|B3|||Baseline Forced Expiratory Volume in one second (FEV1) percentage predicted|"Any spirometry values that are listed as missing at Screening and/or Baseline FEV1 % predicted can include data that was captured but identified as technically unacceptable.~Baseline is defined as the latest measurement prior to first dosing of study medication."|Percentage|Mean|59.2|59.2|Standard Deviation|17.25|17.25|||
4125304|NCT00918957|3950246|B2|||Baseline Forced Expiratory Volume in one second (FEV1) percentage predicted|"Any spirometry values that are listed as missing at Screening and/or Baseline FEV1 % predicted can include data that was captured but identified as technically unacceptable.~Baseline is defined as the latest measurement prior to first dosing of study medication."|Percentage|Mean|59.3|59.3|Standard Deviation|16.61|16.61|||
4125305|NCT00918957|3950247|B1|||Baseline Forced Expiratory Volume in one second (FEV1) percentage predicted|"Any spirometry values that are listed as missing at Screening and/or Baseline FEV1 % predicted can include data that was captured but identified as technically unacceptable.~Baseline is defined as the latest measurement prior to first dosing of study medication."|Percentage|Mean|59.1|59.1|Standard Deviation|18.18|18.18|||
4125306|NCT00918957|3950245|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4125307|NCT00918957|3950246|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4125308|NCT00918957|3950247|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4125309|NCT00918957|3950245|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4125310|NCT00918957|3950246|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4125311|NCT00918957|3950247|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4125312|NCT00918957|3950245|B3|>= 13 years||Age, Customized||participants|Number|32|32.0||||||
4125313|NCT00918957|3950246|B2|>= 13 years||Age, Customized||participants|Number|17|17.0||||||
4125314|NCT00918957|3950247|B1|>= 13 years||Age, Customized||participants|Number|15|15.0||||||
4125315|NCT00918957|3950245|B3|<13 years||Age, Customized||participants|Number|30|30.0||||||
4125316|NCT00918957|3950246|B2|<13 years||Age, Customized||participants|Number|15|15.0||||||
4125317|NCT00918957|3950247|B1|<13 years||Age, Customized||participants|Number|15|15.0||||||
4125318|NCT00918957|3950245|B3|||Age||years|Mean|12.9|12.9|Standard Deviation|4.44|4.44|||
4125319|NCT00918957|3950246|B2|||Age||years|Mean|12.9|12.9|Standard Deviation|4.68|4.68|||
4125320|NCT00918957|3950247|B1|||Age||years|Mean|12.9|12.9|Standard Deviation|4.25|4.25|||
4125321|NCT00918931|3950275|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4125322|NCT00918931|3950275|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4125323|NCT00918931|3950275|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4125324|NCT00918931|3950275|B1|||Age||years|Median|75|75.0|Full Range|||60.0|79.0|
4125325|NCT00918879|3950279|B3||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4125326|NCT00918879|3950280|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4125327|NCT00918879|3950281|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4125328|NCT00918879|3950279|B3||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4125329|NCT00918879|3950280|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4125330|NCT00918879|3950281|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4125331|NCT00918879|3950279|B3|||Age||Years|Mean|48.68|48.68|Standard Deviation|9.17|9.17|||
4125332|NCT00918879|3950280|B2|||Age||Years|Mean|48.29|48.29|Standard Deviation|9.59|9.59|||
4125333|NCT00918879|3950281|B1|||Age||Years|Mean|49.07|49.07|Standard Deviation|8.77|8.77|||
4125334|NCT00918866|3950294|B3|||Pulmonary artery pressure 1 minute pre-dose||mm Hg|Mean|40.7|40.7|Standard Deviation|12.89|12.89|||
4125335|NCT00918866|3950295|B2|||Pulmonary artery pressure 1 minute pre-dose||mm Hg|Mean|50.9|50.9|Standard Deviation|10.31|10.31|||
4125336|NCT00918866|3950296|B1|||Pulmonary artery pressure 1 minute pre-dose||mm Hg|Mean|30.4|30.4|Standard Deviation|3.38|3.38|||
4125337|NCT00918866|3950294|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4125338|NCT00918866|3950295|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4125339|NCT00918866|3950296|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4125340|NCT00918866|3950294|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4125341|NCT00918866|3950295|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4125342|NCT00918866|3950296|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4125343|NCT00918866|3950294|B3|||Age||years|Mean|57.2|57.2|Standard Deviation|12.9|12.9|||
4125344|NCT00918866|3950295|B2|||Age||years|Mean|57.4|57.4|Standard Deviation|15.1|15.1|||
4125345|NCT00918866|3950296|B1|||Age||years|Mean|56.9|56.9|Standard Deviation|10.8|10.8|||
4125346|NCT00918749|3950311|B4|United States||Region of Enrollment||participants|Number|205|205.0||||||
4125347|NCT00918749|3950312|B3|United States||Region of Enrollment||participants|Number|69|69.0||||||
4125348|NCT00918749|3950313|B2|United States||Region of Enrollment||participants|Number|66|66.0||||||
4125349|NCT00918749|3950314|B1|United States||Region of Enrollment||participants|Number|70|70.0||||||
4125350|NCT00918749|3950311|B4|Hawaiian/Pacific Islander||Race/Ethnicity, Customized|ITT Population|Participants|Number|2|2.0||||||
4125351|NCT00918749|3950312|B3|Hawaiian/Pacific Islander||Race/Ethnicity, Customized|ITT Population|Participants|Number|1|1.0||||||
4125352|NCT00918749|3950313|B2|Hawaiian/Pacific Islander||Race/Ethnicity, Customized|ITT Population|Participants|Number|0|0.0||||||
4125353|NCT00918749|3950314|B1|Hawaiian/Pacific Islander||Race/Ethnicity, Customized|ITT Population|Participants|Number|1|1.0||||||
4125354|NCT00918749|3950311|B4|Multi-Racial||Race/Ethnicity, Customized|ITT Population|Participants|Number|5|5.0||||||
4125355|NCT00918749|3950312|B3|Multi-Racial||Race/Ethnicity, Customized|ITT Population|Participants|Number|1|1.0||||||
4125356|NCT00918749|3950313|B2|Multi-Racial||Race/Ethnicity, Customized|ITT Population|Participants|Number|3|3.0||||||
4125357|NCT00918749|3950314|B1|Multi-Racial||Race/Ethnicity, Customized|ITT Population|Participants|Number|1|1.0||||||
4125358|NCT00918749|3950311|B4|Caucasian||Race/Ethnicity, Customized|ITT Population|Participants|Number|174|174.0||||||
4125359|NCT00918749|3950312|B3|Caucasian||Race/Ethnicity, Customized|ITT Population|Participants|Number|61|61.0||||||
4125360|NCT00918749|3950313|B2|Caucasian||Race/Ethnicity, Customized|ITT Population|Participants|Number|53|53.0||||||
4125361|NCT00918749|3950314|B1|Caucasian||Race/Ethnicity, Customized|ITT Population|Participants|Number|60|60.0||||||
4125362|NCT00918749|3950311|B4|Black||Race/Ethnicity, Customized|ITT Population|Participants|Number|7|7.0||||||
4125363|NCT00918749|3950312|B3|Black||Race/Ethnicity, Customized|ITT Population|Participants|Number|3|3.0||||||
4125364|NCT00918749|3950313|B2|Black||Race/Ethnicity, Customized|ITT Population|Participants|Number|4|4.0||||||
4125365|NCT00918749|3950314|B1|Black||Race/Ethnicity, Customized|ITT Population|Participants|Number|0|0.0||||||
4125366|NCT00918749|3950311|B4|Asian (Oriental)||Race/Ethnicity, Customized|ITT Population|Participants|Number|16|16.0||||||
4125367|NCT00918749|3950312|B3|Asian (Oriental)||Race/Ethnicity, Customized|ITT Population|Participants|Number|3|3.0||||||
4125368|NCT00918749|3950313|B2|Asian (Oriental)||Race/Ethnicity, Customized|ITT Population|Participants|Number|6|6.0||||||
4125369|NCT00918749|3950314|B1|Asian (Oriental)||Race/Ethnicity, Customized|ITT Population|Participants|Number|7|7.0||||||
4125370|NCT00918749|3950311|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4125371|NCT00918749|3950312|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4125372|NCT00918749|3950313|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4125373|NCT00918749|3950314|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4125374|NCT00918749|3950311|B4||Female|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4125375|NCT00918749|3950312|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4125376|NCT00918749|3950313|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4125377|NCT00918749|3950314|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4125378|NCT00918749|3950311|B4|>= 75 years||Age, Customized|ITT Population - Total 204|participants|Number|4|4.0||||||
4125379|NCT00918749|3950312|B3|>= 75 years||Age, Customized|ITT Population - Total 204|participants|Number|1|1.0||||||
4125380|NCT00918749|3950313|B2|>= 75 years||Age, Customized|ITT Population - Total 204|participants|Number|1|1.0||||||
4125381|NCT00918749|3950314|B1|>= 75 years||Age, Customized|ITT Population - Total 204|participants|Number|2|2.0||||||
4125382|NCT00918749|3950311|B4|65 years thru <75 years||Age, Customized|ITT Population - Total 204|participants|Number|35|35.0||||||
4125383|NCT00918749|3950312|B3|65 years thru <75 years||Age, Customized|ITT Population - Total 204|participants|Number|13|13.0||||||
4125384|NCT00918749|3950313|B2|65 years thru <75 years||Age, Customized|ITT Population - Total 204|participants|Number|12|12.0||||||
4125385|NCT00918749|3950314|B1|65 years thru <75 years||Age, Customized|ITT Population - Total 204|participants|Number|10|10.0||||||
4125386|NCT00918749|3950311|B4|< 65 years||Age, Customized|ITT Population - Total 204|participants|Number|165|165.0||||||
4125387|NCT00918749|3950312|B3|< 65 years||Age, Customized|ITT Population - Total 204|participants|Number|55|55.0||||||
4125388|NCT00918749|3950313|B2|< 65 years||Age, Customized|ITT Population - Total 204|participants|Number|53|53.0||||||
4125389|NCT00918749|3950314|B1|< 65 years||Age, Customized|ITT Population - Total 204|participants|Number|57|57.0||||||
4125390|NCT00918749|3950311|B4|||Age|ITT Population|years|Mean|58.0|58.0|Standard Deviation|7.1|7.1|||
4125391|NCT00918749|3950312|B3|||Age|ITT Population|years|Mean|57.5|57.5|Standard Deviation|7.0|7.0|||
4125392|NCT00918749|3950313|B2|||Age|ITT Population|years|Mean|58.2|58.2|Standard Deviation|7.2|7.2|||
4125393|NCT00918749|3950314|B1|||Age|ITT Population|years|Mean|58.3|58.3|Standard Deviation|7.2|7.2|||
4125394|NCT00918736|3950348|B1|Taiwan||Region of Enrollment||participants|Number|50|50.0||||||
4125395|NCT00918736|3950348|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4125396|NCT00918736|3950348|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4125397|NCT00918736|3950348|B1|||Age||years|Mean|51.7|51.7|Standard Deviation|14.4|14.4|||
4125398|NCT00918736|3950348|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4125399|NCT00918736|3950348|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4125400|NCT00918736|3950348|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4125401|NCT00918723|3950352|B1|||High ZAP-70 (> 20%) (Cytogenetics/immunophenotypic characteristics)||Participants|Count of Participants|14|14.0||||||
4125402|NCT00918723|3950352|B1|||High CD38 expression (> 30%) (Cytogenetics/immunophenotypic characteristics)||Participants|Count of Participants|20|20.0||||||
4125403|NCT00918723|3950352|B1|||Other chromosomal abnormalities (Cytogenetics/immunophenotypic characteristics)||Participants|Count of Participants|6|6.0||||||
4125404|NCT00918723|3950352|B1|||Normal cytogenetic (Cytogenetics/immunophenotypic characteristics)||Participants|Count of Participants|14|14.0||||||
4125405|NCT00918723|3950352|B1|||del 13q (Cytogenetics/immunophenotypic characteristics)||Participants|Count of Participants|3|3.0||||||
4125406|NCT00918723|3950352|B1|||Trisomy 12 (Cytogenetics/immunophenotypic characteristics)||Participants|Count of Participants|4|4.0||||||
4125407|NCT00918723|3950352|B1|||del 11q (Cytogenetics/immunophenotypic characteristics)||Participants|Count of Participants|2|2.0||||||
4125408|NCT00918723|3950352|B1|||del 17p (Cytogenetics/immunophenotypic characteristics)||Participants|Count of Participants|2|2.0||||||
4125409|NCT00918723|3950352|B1|||B symptoms|B symptoms include weight loss, extreme fatigue, fevers, night sweats|Participants|Count of Participants|13|13.0||||||
4125410|NCT00918723|3950352|B1|||Time to treatment||months|Mean|27|27.0|Full Range|||0.0|102.0|
4125411|NCT00918723|3950352|B1||Rai stage III/IV|Rai stage at the time of treatment|Rai stage 0: Lymphocytosis in blood or bone marrow Rai stage I: Lymphocytosis + enlarged lymph nodes. Rai stage II: Lymphocytosis + enlarged liver or spleen with or without lymphadenopathy Rai stage III: Lymphocytosis + anemia (Hgb <11 g/dL) with or without enlarged liver, spleen, or lymph nodes Rai stage IV: Lymphocytosis + thrombocytopenia (platelet count <100,000/microL) with or without anemia or enlarged liver, spleen, or lymph nodes Low risk: Rai stage 0 Intermediate risk: Rai stages I and II High risk: Rai stages III and IV With higher risk, median survival outlook declines.|Participants|Count of Participants|17|17.0||||||
4125412|NCT00918723|3950352|B1||Rai stage I/II|Rai stage at the time of treatment|Rai stage 0: Lymphocytosis in blood or bone marrow Rai stage I: Lymphocytosis + enlarged lymph nodes. Rai stage II: Lymphocytosis + enlarged liver or spleen with or without lymphadenopathy Rai stage III: Lymphocytosis + anemia (Hgb <11 g/dL) with or without enlarged liver, spleen, or lymph nodes Rai stage IV: Lymphocytosis + thrombocytopenia (platelet count <100,000/microL) with or without anemia or enlarged liver, spleen, or lymph nodes Low risk: Rai stage 0 Intermediate risk: Rai stages I and II High risk: Rai stages III and IV With higher risk, median survival outlook declines.|Participants|Count of Participants|23|23.0||||||
4125413|NCT00918723|3950352|B1||Rai stage 0|Rai stage at the time of treatment|Rai stage 0: Lymphocytosis in blood or bone marrow Rai stage I: Lymphocytosis + enlarged lymph nodes. Rai stage II: Lymphocytosis + enlarged liver or spleen with or without lymphadenopathy Rai stage III: Lymphocytosis + anemia (Hgb <11 g/dL) with or without enlarged liver, spleen, or lymph nodes Rai stage IV: Lymphocytosis + thrombocytopenia (platelet count <100,000/microL) with or without anemia or enlarged liver, spleen, or lymph nodes Low risk: Rai stage 0 Intermediate risk: Rai stages I and II High risk: Rai stages III and IV With higher risk, median survival outlook declines.|Participants|Count of Participants|0|0.0||||||
4125414|NCT00918723|3950352|B1||Rai stage III/IV|Rai stage at the time of diagnosis|Rai stage 0: Lymphocytosis in blood or bone marrow Rai stage I: Lymphocytosis + enlarged lymph nodes. Rai stage II: Lymphocytosis + enlarged liver or spleen with or without lymphadenopathy Rai stage III: Lymphocytosis + anemia (Hgb <11 g/dL) with or without enlarged liver, spleen, or lymph nodes Rai stage IV: Lymphocytosis + thrombocytopenia (platelet count <100,000/microL) with or without anemia or enlarged liver, spleen, or lymph nodes Low risk: Rai stage 0 Intermediate risk: Rai stages I and II High risk: Rai stages III and IV With higher risk, median survival outlook declines.|Participants|Count of Participants|6|6.0||||||
4125415|NCT00918723|3950352|B1||Rai stage I/II|Rai stage at the time of diagnosis|Rai stage 0: Lymphocytosis in blood or bone marrow Rai stage I: Lymphocytosis + enlarged lymph nodes. Rai stage II: Lymphocytosis + enlarged liver or spleen with or without lymphadenopathy Rai stage III: Lymphocytosis + anemia (Hgb <11 g/dL) with or without enlarged liver, spleen, or lymph nodes Rai stage IV: Lymphocytosis + thrombocytopenia (platelet count <100,000/microL) with or without anemia or enlarged liver, spleen, or lymph nodes Low risk: Rai stage 0 Intermediate risk: Rai stages I and II High risk: Rai stages III and IV With higher risk, median survival outlook declines.|Participants|Count of Participants|19|19.0||||||
4125416|NCT00918723|3950352|B1||Rai stage 0|Rai stage at the time of diagnosis|Rai stage 0: Lymphocytosis in blood or bone marrow Rai stage I: Lymphocytosis + enlarged lymph nodes. Rai stage II: Lymphocytosis + enlarged liver or spleen with or without lymphadenopathy Rai stage III: Lymphocytosis + anemia (Hgb <11 g/dL) with or without enlarged liver, spleen, or lymph nodes Rai stage IV: Lymphocytosis + thrombocytopenia (platelet count <100,000/microL) with or without anemia or enlarged liver, spleen, or lymph nodes Low risk: Rai stage 0 Intermediate risk: Rai stages I and II High risk: Rai stages III and IV With higher risk, median survival outlook declines.|Participants|Count of Participants|15|15.0||||||
4125417|NCT00918723|3950352|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4125418|NCT00918723|3950352|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4125419|NCT00918723|3950352|B1|||Age||years|Mean|58|58.0|Full Range|||36.0|72.0|
4125420|NCT00918684|3950361|B1|||Stroop Color-Word Test|Stroop Color-Word total scores can range from 0-100. Higher scores indicate better memory functioning (no cognitive impairment). Total scores are reported with no subscales.|units on a scale|Mean|32.77|32.77|Standard Deviation|10.63|10.63|||
4125421|NCT00918684|3950361|B1|||WHODAS-II Disability Score|WHODAS II total scores can range from 0-100. Higher scores indicate greater severity of disability. Total scores are reported with no subscales.|units on a scale|Mean|34.64|34.64|Standard Deviation|10.56|10.56|||
4125422|NCT00918684|3950361|B1|||Mini Mental Status Examination (MMSE)|MMSE total scores range from 0-30. Higher scores indicate better memory functioning (no cognitive impairment). Total scores are reported with no subscales.|units on a scale|Mean|28.08|28.08|Standard Deviation|1.64|1.64|||
4125423|NCT00918684|3950361|B1|||Hamilton Scale for Depression|The Hamilton Scale for Depression 24 item total scores range from 0-76. Higher scores indicate greater severity of depression. Total scores are reported with no subscales.|units on a scale|Mean|21.21|21.21|Standard Deviation|4.51|4.51|||
4125424|NCT00918684|3950361|B1|United States||Region of Enrollment||Participants|Count of Participants|90|90.0||||||
4125425|NCT00918684|3950361|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125426|NCT00918684|3950361|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125427|NCT00918684|3950361|B1||White|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4125428|NCT00918684|3950361|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4125429|NCT00918684|3950361|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4125430|NCT00918684|3950361|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4125431|NCT00918684|3950361|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125432|NCT00918684|3950361|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125433|NCT00918684|3950361|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
4125434|NCT00918684|3950361|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4125435|NCT00918684|3950361|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4125436|NCT00918684|3950361|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4125437|NCT00918684|3950361|B1|||Age||Years|Mean|70.82|70.82|Standard Deviation|6.76|6.76|||
4125438|NCT00918684|3950361|B1||>=65 years|Age||Participants|Count of Participants|69|69.0||||||
4125439|NCT00918684|3950361|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4125440|NCT00918684|3950361|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4125441|NCT00918671|3950367|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4125442|NCT00918671|3950367|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4125443|NCT00918671|3950367|B1|||Age||years|Mean|40.6|40.6|Standard Deviation|10.96|10.96|||
4125444|NCT00918671|3950367|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4125445|NCT00918671|3950367|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4125446|NCT00918671|3950367|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4125447|NCT00918645|3950372|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125448|NCT00918645|3950372|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125449|NCT00918645|3950372|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4125450|NCT00918645|3950372|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125451|NCT00918645|3950372|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125452|NCT00918645|3950372|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125453|NCT00918645|3950372|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125454|NCT00918645|3950372|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125455|NCT00918645|3950372|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4125456|NCT00918645|3950372|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125457|NCT00918645|3950372|B1|Male||Sex/Gender, Customized||Participants|Count of Participants|13|13.0||||||
4125458|NCT00918645|3950372|B1|||Age||Years|Mean|73.2|73.2|Full Range|||65.0|86.1|
4125459|NCT00918645|3950372|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4125460|NCT00918645|3950372|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4125461|NCT00918645|3950372|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4125462|NCT00918580|3950378|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4125463|NCT00918580|3950378|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4125464|NCT00918580|3950378|B1|||Age||years|Mean|13.3|13.3|Standard Deviation|3.08|3.08|||
4125465|NCT00918463|3950396|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4125466|NCT00918463|3950396|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125467|NCT00918463|3950396|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4125468|NCT00918463|3950396|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125469|NCT00918463|3950396|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125470|NCT00918463|3950396|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125471|NCT00918463|3950396|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125472|NCT00918463|3950396|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4125473|NCT00918463|3950396|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4125474|NCT00918463|3950396|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125475|NCT00918463|3950396|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4125476|NCT00918463|3950396|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4125477|NCT00918463|3950396|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4125478|NCT00918463|3950396|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4125479|NCT00918463|3950396|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4125480|NCT00918385|3950402|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4125481|NCT00918385|3950403|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4125482|NCT00918385|3950404|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4125483|NCT00918385|3950402|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125484|NCT00918385|3950403|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125485|NCT00918385|3950404|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125486|NCT00918385|3950402|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125487|NCT00918385|3950403|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125488|NCT00918385|3950404|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125489|NCT00918385|3950402|B3||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4125490|NCT00918385|3950403|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4125491|NCT00918385|3950404|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4125492|NCT00918385|3950402|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4125493|NCT00918385|3950403|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4125494|NCT00918385|3950404|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4125495|NCT00918385|3950402|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125496|NCT00918385|3950403|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125497|NCT00918385|3950404|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125498|NCT00918385|3950402|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125499|NCT00918385|3950403|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125500|NCT00918385|3950404|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125501|NCT00918385|3950402|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125502|NCT00918385|3950403|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125503|NCT00918385|3950404|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125504|NCT00918385|3950402|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4125505|NCT00918385|3950403|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4125506|NCT00918385|3950404|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4125507|NCT00918385|3950402|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4125508|NCT00918385|3950403|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4125509|NCT00918385|3950404|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4125510|NCT00918385|3950402|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4125511|NCT00918385|3950403|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4125512|NCT00918385|3950404|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4125513|NCT00918385|3950402|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4125514|NCT00918385|3950403|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4125515|NCT00918385|3950404|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4125516|NCT00918385|3950402|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4125517|NCT00918385|3950403|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4125518|NCT00918385|3950404|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4125519|NCT00918346|3950414|B1|Left eye||Central corneal thickness||micrometer|Mean|547.0|547.0|Standard Deviation|45.4|45.4|||
4125520|NCT00918346|3950414|B1|Right eye||Central corneal thickness||micrometer|Mean|548.7|548.7|Standard Deviation|42.8|42.8|||
4125521|NCT00918346|3950414|B1|Ocular Hypertension||Diagnosis - worse eyes|Worse eye: If both eyes satisfied the inclusion criteria, then the worse eye was the eye with the higher intraocular pressure at the 8:00 IOP measurement at the first baseline visit. In case both eyes had the same IOP, then the right eye was designated as the worse eye. If only one eye satisfied the inclusion criteria, then that eye was considered to be the worse eye.|eyes|Number|12|12.0||||||
4125522|NCT00918346|3950414|B1|Capsular Glaucoma||Diagnosis - worse eyes|Worse eye: If both eyes satisfied the inclusion criteria, then the worse eye was the eye with the higher intraocular pressure at the 8:00 IOP measurement at the first baseline visit. In case both eyes had the same IOP, then the right eye was designated as the worse eye. If only one eye satisfied the inclusion criteria, then that eye was considered to be the worse eye.|eyes|Number|3|3.0||||||
4125581|NCT00918203|3950496|B2|Non-Squamous Cell Carcinoma||Stratification Factor Case Report Form (CRF)||participants|Number|48|48.0||||||
4125523|NCT00918346|3950414|B1|Primary Open Angle Glaucoma||Diagnosis - worse eyes|Worse eye: If both eyes satisfied the inclusion criteria, then the worse eye was the eye with the higher intraocular pressure at the 8:00 IOP measurement at the first baseline visit. In case both eyes had the same IOP, then the right eye was designated as the worse eye. If only one eye satisfied the inclusion criteria, then that eye was considered to be the worse eye.|eyes|Number|28|28.0||||||
4125524|NCT00918346|3950414|B1|Finland||Region of Enrollment||participants|Number|11|11.0||||||
4125525|NCT00918346|3950414|B1|Germany||Region of Enrollment||participants|Number|32|32.0||||||
4125526|NCT00918346|3950414|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4125527|NCT00918346|3950414|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4125528|NCT00918346|3950414|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4125529|NCT00918346|3950414|B1|||Age||years|Mean|65.3|65.3|Standard Deviation|10.1|10.1|||
4125530|NCT00918333|3950429|B3|United States||Region of Enrollment||Participants|Count of Participants|116|116.0||||||
4125531|NCT00918333|3950430|B2|United States||Region of Enrollment||Participants|Count of Participants|93|93.0||||||
4125532|NCT00918333|3950431|B1|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4125533|NCT00918333|3950429|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4125534|NCT00918333|3950430|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4125535|NCT00918333|3950431|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4125536|NCT00918333|3950429|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4125537|NCT00918333|3950430|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4125538|NCT00918333|3950431|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4125539|NCT00918333|3950429|B3|||Age||years|Median|59.5|59.5|Full Range|||20.0|84.0|
4125540|NCT00918333|3950430|B2|||Age||years|Median|59.0|59.0|Full Range|||20.0|84.0|
4125541|NCT00918333|3950431|B1|||Age||years|Median|61.0|61.0|Full Range|||24.0|73.0|
4125542|NCT00918281|3950452|B1|United Kingdom||Region of Enrollment||participants|Number|19|19.0||||||
4125543|NCT00918281|3950452|B1|Sweden||Region of Enrollment||participants|Number|4|4.0||||||
4125544|NCT00918281|3950452|B1|Korea, Republic of||Region of Enrollment||participants|Number|8|8.0||||||
4125545|NCT00918281|3950452|B1|India||Region of Enrollment||participants|Number|18|18.0||||||
4125546|NCT00918281|3950452|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4125547|NCT00918281|3950452|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4125548|NCT00918281|3950452|B1|||Age||years|Mean|59.9|59.9|Standard Deviation|12.71|12.71|||
4125549|NCT00918281|3950452|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4125550|NCT00918281|3950452|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4125551|NCT00918281|3950452|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4125552|NCT00918255|3950459|B4|Europe||Region of Enrollment||participants|Number|38|38.0||||||
4125553|NCT00918255|3950460|B3|Europe||Region of Enrollment||participants|Number|15|15.0||||||
4125554|NCT00918255|3950461|B2|Europe||Region of Enrollment||participants|Number|13|13.0||||||
4125555|NCT00918255|3950462|B1|Europe||Region of Enrollment||participants|Number|10|10.0||||||
4125556|NCT00918255|3950459|B4|United States||Region of Enrollment||participants|Number|116|116.0||||||
4125557|NCT00918255|3950460|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4125558|NCT00918255|3950461|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
4125559|NCT00918255|3950462|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4125560|NCT00918255|3950459|B4||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4125561|NCT00918255|3950460|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4125562|NCT00918255|3950461|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4125563|NCT00918255|3950462|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4125564|NCT00918255|3950459|B4||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4125565|NCT00918255|3950460|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4125566|NCT00918255|3950461|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4125567|NCT00918255|3950462|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4125568|NCT00918255|3950459|B4|||Age||years|Mean|36.3|36.3|Standard Deviation|11.76|11.76|||
4125569|NCT00918255|3950460|B3|||Age||years|Mean|37.8|37.8|Standard Deviation|12.10|12.1|||
4125570|NCT00918255|3950461|B2|||Age||years|Mean|36.1|36.1|Standard Deviation|12.50|12.5|||
4125571|NCT00918255|3950462|B1|||Age||years|Mean|35.1|35.1|Standard Deviation|10.69|10.69|||
4125572|NCT00918229|3950490|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4125573|NCT00918229|3950490|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4125574|NCT00918229|3950490|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4125575|NCT00918229|3950490|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4125576|NCT00918229|3950490|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4125577|NCT00918203|3950495|B3|Squamous Cell Carcinoma||Stratification Factor Case Report Form (CRF)||participants|Number|35|35.0||||||
4125578|NCT00918203|3950496|B2|Squamous Cell Carcinoma||Stratification Factor Case Report Form (CRF)||participants|Number|16|16.0||||||
4125579|NCT00918203|3950497|B1|Squamous Cell Carcinoma||Stratification Factor Case Report Form (CRF)||participants|Number|19|19.0||||||
4125580|NCT00918203|3950495|B3|Non-Squamous Cell Carcinoma||Stratification Factor Case Report Form (CRF)||participants|Number|96|96.0||||||
4125681|NCT00918138|3950530|B1|White||Race/Ethnicity, Customized||Participant|Number|43|43.0||||||
4125582|NCT00918203|3950497|B1|Non-Squamous Cell Carcinoma||Stratification Factor Case Report Form (CRF)||participants|Number|48|48.0||||||
4125583|NCT00918203|3950495|B3|ECOG PS 1||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|ECOG performance status classified participants according to their functional impairment. Scores ranged from 0 (fully active) to 5 (death).|participants|Number|90|90.0||||||
4125584|NCT00918203|3950496|B2|ECOG PS 1||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|ECOG performance status classified participants according to their functional impairment. Scores ranged from 0 (fully active) to 5 (death).|participants|Number|48|48.0||||||
4125585|NCT00918203|3950497|B1|ECOG PS 1||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|ECOG performance status classified participants according to their functional impairment. Scores ranged from 0 (fully active) to 5 (death).|participants|Number|42|42.0||||||
4125586|NCT00918203|3950495|B3|ECOG PS 0||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|ECOG performance status classified participants according to their functional impairment. Scores ranged from 0 (fully active) to 5 (death).|participants|Number|41|41.0||||||
4125587|NCT00918203|3950496|B2|ECOG PS 0||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|ECOG performance status classified participants according to their functional impairment. Scores ranged from 0 (fully active) to 5 (death).|participants|Number|16|16.0||||||
4125588|NCT00918203|3950497|B1|ECOG PS 0||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|ECOG performance status classified participants according to their functional impairment. Scores ranged from 0 (fully active) to 5 (death).|participants|Number|25|25.0||||||
4125589|NCT00918203|3950495|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125590|NCT00918203|3950496|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125591|NCT00918203|3950497|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125592|NCT00918203|3950495|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4125593|NCT00918203|3950496|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125594|NCT00918203|3950497|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4125595|NCT00918203|3950495|B3||White|Race (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
4125596|NCT00918203|3950496|B2||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4125597|NCT00918203|3950497|B1||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4125598|NCT00918203|3950495|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4125599|NCT00918203|3950496|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4125600|NCT00918203|3950497|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4125601|NCT00918203|3950495|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4125602|NCT00918203|3950496|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4125603|NCT00918203|3950497|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4125604|NCT00918203|3950495|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4125605|NCT00918203|3950496|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4125606|NCT00918203|3950497|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4125607|NCT00918203|3950495|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125608|NCT00918203|3950496|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125609|NCT00918203|3950497|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125610|NCT00918203|3950495|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125611|NCT00918203|3950496|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125612|NCT00918203|3950497|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125613|NCT00918203|3950495|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
4125614|NCT00918203|3950496|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4125615|NCT00918203|3950497|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4125616|NCT00918203|3950495|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4125617|NCT00918203|3950496|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4125618|NCT00918203|3950497|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4125619|NCT00918203|3950495|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4125620|NCT00918203|3950496|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4125621|NCT00918203|3950497|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4125622|NCT00918203|3950495|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4125623|NCT00918203|3950496|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4125624|NCT00918203|3950497|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4125625|NCT00918203|3950495|B3|||Age||years|Mean|63.7|63.7|Standard Deviation|10.21|10.21|||
4125626|NCT00918203|3950496|B2|||Age||years|Mean|63.8|63.8|Standard Deviation|9.67|9.67|||
4125627|NCT00918203|3950497|B1|||Age||years|Mean|63.6|63.6|Standard Deviation|10.77|10.77|||
4125628|NCT00918138|3950528|B3|||120-minute postprandial glucose (PPG)|The 120-minute value is collected 120 minutes after start of evening meal|mg/dL|Mean|282.3|282.3|Standard Deviation|59.08|59.08|||
4125629|NCT00918138|3950529|B2|||120-minute postprandial glucose (PPG)|The 120-minute value is collected 120 minutes after start of evening meal|mg/dL|Mean|283.3|283.3|Standard Deviation|66.14|66.14|||
4125630|NCT00918138|3950530|B1|||120-minute postprandial glucose (PPG)|The 120-minute value is collected 120 minutes after start of evening meal|mg/dL|Mean|281.3|281.3|Standard Deviation|51.59|51.59|||
4125631|NCT00918138|3950528|B3|>= 220 mg/dL to < 300 mg/dL||FPG Categorization|The fasting value is collected at time -30 minutes prior to morning meal|participants|Number|7|7.0||||||
4125632|NCT00918138|3950529|B2|>= 220 mg/dL to < 300 mg/dL||FPG Categorization|The fasting value is collected at time -30 minutes prior to morning meal|participants|Number|5|5.0||||||
4125633|NCT00918138|3950530|B1|>= 220 mg/dL to < 300 mg/dL||FPG Categorization|The fasting value is collected at time -30 minutes prior to morning meal|participants|Number|2|2.0||||||
4125634|NCT00918138|3950528|B3|>= 150 mg/dL to < 220 mg/dL||FPG Categorization|The fasting value is collected at time -30 minutes prior to morning meal|participants|Number|51|51.0||||||
4125635|NCT00918138|3950529|B2|>= 150 mg/dL to < 220 mg/dL||FPG Categorization|The fasting value is collected at time -30 minutes prior to morning meal|participants|Number|23|23.0||||||
4125636|NCT00918138|3950530|B1|>= 150 mg/dL to < 220 mg/dL||FPG Categorization|The fasting value is collected at time -30 minutes prior to morning meal|participants|Number|28|28.0||||||
4125637|NCT00918138|3950528|B3|>= 126 mg/dL to < 150 mg/dL||FPG Categorization|The fasting value is collected at time -30 minutes prior to morning meal|participants|Number|25|25.0||||||
4125638|NCT00918138|3950529|B2|>= 126 mg/dL to < 150 mg/dL||FPG Categorization|The fasting value is collected at time -30 minutes prior to morning meal|participants|Number|14|14.0||||||
4125639|NCT00918138|3950530|B1|>= 126 mg/dL to < 150 mg/dL||FPG Categorization|The fasting value is collected at time -30 minutes prior to morning meal|participants|Number|11|11.0||||||
4125640|NCT00918138|3950528|B3|< 126 mg/dL||FPG Categorization|The fasting value is collected at time -30 minutes prior to morning meal|participants|Number|10|10.0||||||
4125641|NCT00918138|3950529|B2|< 126 mg/dL||FPG Categorization|The fasting value is collected at time -30 minutes prior to morning meal|participants|Number|5|5.0||||||
4125642|NCT00918138|3950530|B1|< 126 mg/dL||FPG Categorization|The fasting value is collected at time -30 minutes prior to morning meal|participants|Number|5|5.0||||||
4125643|NCT00918138|3950528|B3|||Fasting Plasma Glucose (FPG)|The fasting value is collected at time -30 minutes prior to morning meal|mg/dL|Mean|163.8|163.8|Standard Deviation|34.16|34.16|||
4125644|NCT00918138|3950529|B2|||Fasting Plasma Glucose (FPG)|The fasting value is collected at time -30 minutes prior to morning meal|mg/dL|Mean|164.2|164.2|Standard Deviation|36.21|36.21|||
4125645|NCT00918138|3950530|B1|||Fasting Plasma Glucose (FPG)|The fasting value is collected at time -30 minutes prior to morning meal|mg/dL|Mean|163.5|163.5|Standard Deviation|32.32|32.32|||
4125646|NCT00918138|3950528|B3|||Glycosylated Hemoglobin (A1C)||percentage|Mean|8.5|8.5|Standard Deviation|0.9|0.9|||
4125647|NCT00918138|3950529|B2|||Glycosylated Hemoglobin (A1C)||percentage|Mean|8.4|8.4|Standard Deviation|0.9|0.9|||
4125648|NCT00918138|3950530|B1|||Glycosylated Hemoglobin (A1C)||percentage|Mean|8.6|8.6|Standard Deviation|0.9|0.9|||
4125649|NCT00918138|3950528|B3|>= 30 kg/m^2||BMI Categorization||Participants|Number|60|60.0||||||
4125650|NCT00918138|3950529|B2|>= 30 kg/m^2||BMI Categorization||Participants|Number|30|30.0||||||
4125651|NCT00918138|3950530|B1|>= 30 kg/m^2||BMI Categorization||Participants|Number|30|30.0||||||
4125652|NCT00918138|3950528|B3|< 30 kg/m^2||BMI Categorization||Participants|Number|33|33.0||||||
4125653|NCT00918138|3950529|B2|< 30 kg/m^2||BMI Categorization||Participants|Number|17|17.0||||||
4125654|NCT00918138|3950530|B1|< 30 kg/m^2||BMI Categorization||Participants|Number|16|16.0||||||
4125655|NCT00918138|3950528|B3|||Body Mass Index (BMI)||kg/m^2|Mean|31.75|31.75|Standard Deviation|4.72|4.72|||
4125656|NCT00918138|3950529|B2|||Body Mass Index (BMI)||kg/m^2|Mean|31.06|31.06|Standard Deviation|4.28|4.28|||
4125657|NCT00918138|3950530|B1|||Body Mass Index (BMI)||kg/m^2|Mean|32.45|32.45|Standard Deviation|5.08|5.08|||
4125658|NCT00918138|3950528|B3|||Weight||kg|Mean|89.09|89.09|Standard Deviation|16.94|16.94|||
4125659|NCT00918138|3950529|B2|||Weight||kg|Mean|86.94|86.94|Standard Deviation|15.24|15.24|||
4125660|NCT00918138|3950530|B1|||Weight||kg|Mean|91.27|91.27|Standard Deviation|18.43|18.43|||
4125661|NCT00918138|3950528|B3|> 50 years||Age categorization Females Only||participants|Number|32|32.0||||||
4125662|NCT00918138|3950529|B2|> 50 years||Age categorization Females Only||participants|Number|16|16.0||||||
4125663|NCT00918138|3950530|B1|> 50 years||Age categorization Females Only||participants|Number|16|16.0||||||
4125664|NCT00918138|3950528|B3|<= 50 years||Age categorization Females Only||participants|Number|14|14.0||||||
4125665|NCT00918138|3950529|B2|<= 50 years||Age categorization Females Only||participants|Number|9|9.0||||||
4125666|NCT00918138|3950530|B1|<= 50 years||Age categorization Females Only||participants|Number|5|5.0||||||
4125667|NCT00918138|3950528|B3|Not Reported||Race/Ethnicity, Customized||Participant|Number|44|44.0||||||
4125668|NCT00918138|3950529|B2|Not Reported||Race/Ethnicity, Customized||Participant|Number|22|22.0||||||
4125669|NCT00918138|3950530|B1|Not Reported||Race/Ethnicity, Customized||Participant|Number|22|22.0||||||
4125670|NCT00918138|3950528|B3|Not Hispanic/ Not Latino||Race/Ethnicity, Customized||Participant|Number|16|16.0||||||
4125671|NCT00918138|3950529|B2|Not Hispanic/ Not Latino||Race/Ethnicity, Customized||Participant|Number|8|8.0||||||
4125672|NCT00918138|3950530|B1|Not Hispanic/ Not Latino||Race/Ethnicity, Customized||Participant|Number|8|8.0||||||
4125673|NCT00918138|3950528|B3|Hispanic/Latino||Race/Ethnicity, Customized||Participant|Number|33|33.0||||||
4125674|NCT00918138|3950529|B2|Hispanic/Latino||Race/Ethnicity, Customized||Participant|Number|17|17.0||||||
4125675|NCT00918138|3950530|B1|Hispanic/Latino||Race/Ethnicity, Customized||Participant|Number|16|16.0||||||
4125676|NCT00918138|3950528|B3|Black/African American||Race/Ethnicity, Customized||Participant|Number|5|5.0||||||
4125677|NCT00918138|3950529|B2|Black/African American||Race/Ethnicity, Customized||Participant|Number|2|2.0||||||
4125678|NCT00918138|3950530|B1|Black/African American||Race/Ethnicity, Customized||Participant|Number|3|3.0||||||
4125679|NCT00918138|3950528|B3|White||Race/Ethnicity, Customized||Participant|Number|88|88.0||||||
4125680|NCT00918138|3950529|B2|White||Race/Ethnicity, Customized||Participant|Number|45|45.0||||||
4125682|NCT00918138|3950528|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4125683|NCT00918138|3950529|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4125684|NCT00918138|3950530|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4125685|NCT00918138|3950528|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4125686|NCT00918138|3950529|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4125687|NCT00918138|3950530|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4125688|NCT00918138|3950528|B3|>=65 years||Age, Customized||participants|Number|8|8.0||||||
4125689|NCT00918138|3950529|B2|>=65 years||Age, Customized||participants|Number|2|2.0||||||
4125690|NCT00918138|3950530|B1|>=65 years||Age, Customized||participants|Number|6|6.0||||||
4125691|NCT00918138|3950528|B3|<65 years||Age, Customized||participants|Number|85|85.0||||||
4125692|NCT00918138|3950529|B2|<65 years||Age, Customized||participants|Number|45|45.0||||||
4125693|NCT00918138|3950530|B1|<65 years||Age, Customized||participants|Number|40|40.0||||||
4125694|NCT00918138|3950528|B3|||Age||years|Mean|52.25|52.25|Standard Deviation|9.66|9.66|||
4125695|NCT00918138|3950529|B2|||Age||years|Mean|50.64|50.64|Standard Deviation|9.74|9.74|||
4125696|NCT00918138|3950530|B1|||Age||years|Mean|53.89|53.89|Standard Deviation|9.41|9.41|||
4125697|NCT00918125|3950545|B3|Usual Care||Randomization Allocation|Patients were randomized into three study arms, stratified by race: white video, black video or usual care|participants|Number|20|20.0||||||
4125698|NCT00918125|3950546|B2|Usual Care||Randomization Allocation|Patients were randomized into three study arms, stratified by race: white video, black video or usual care|participants|Number|13|13.0||||||
4125699|NCT00918125|3950547|B1|Usual Care||Randomization Allocation|Patients were randomized into three study arms, stratified by race: white video, black video or usual care|participants|Number|7|7.0||||||
4125700|NCT00918125|3950545|B3|Video||Randomization Allocation|Patients were randomized into three study arms, stratified by race: white video, black video or usual care|participants|Number|39|39.0||||||
4125701|NCT00918125|3950546|B2|Video||Randomization Allocation|Patients were randomized into three study arms, stratified by race: white video, black video or usual care|participants|Number|24|24.0||||||
4125702|NCT00918125|3950547|B1|Video||Randomization Allocation|Patients were randomized into three study arms, stratified by race: white video, black video or usual care|participants|Number|15|15.0||||||
4125703|NCT00918125|3950545|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4125704|NCT00918125|3950546|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4125705|NCT00918125|3950547|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4125706|NCT00918125|3950545|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4125707|NCT00918125|3950546|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4125708|NCT00918125|3950547|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4125709|NCT00918125|3950545|B3|||Age||Years|Mean|58.2|58.2|Standard Deviation|16.0|16.0|||
4125710|NCT00918125|3950546|B2|||Age||Years|Mean|61.7|61.7|Standard Deviation|17.5|17.5|||
4125711|NCT00918125|3950547|B1|||Age||Years|Mean|52.4|52.4|Standard Deviation|11.4|11.4|||
4125712|NCT00917865|3950559|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4125713|NCT00917865|3950559|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4125714|NCT00917865|3950559|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4125715|NCT00917865|3950559|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|6.3|6.3|||
4125716|NCT00917865|3950559|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4125717|NCT00917865|3950559|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4125718|NCT00917865|3950559|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4125719|NCT00917852|3950570|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4125720|NCT00917852|3950570|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4125721|NCT00917852|3950570|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4125722|NCT00917852|3950570|B1|||Age||years|Mean|44.1|44.1|Standard Deviation|19.9|19.9|||
4125723|NCT00917735|3950575|B3|||Waist-to-hip ratio||Ratio|Mean|0.83|0.83|Standard Deviation|0.07|0.07|||
4125724|NCT00917735|3950576|B2|||Waist-to-hip ratio||Ratio|Mean|0.83|0.83|Standard Deviation|0.1|0.1|||
4125725|NCT00917735|3950577|B1|||Waist-to-hip ratio||Ratio|Mean|0.84|0.84|Standard Deviation|0.1|0.1|||
4125726|NCT00917735|3950575|B3|||Weight||kg|Mean|67.4|67.4|Standard Deviation|10.5|10.5|||
4125727|NCT00917735|3950576|B2|||Weight||kg|Mean|67.9|67.9|Standard Deviation|10.5|10.5|||
4125728|NCT00917735|3950577|B1|||Weight||kg|Mean|67.4|67.4|Standard Deviation|10.6|10.6|||
4125729|NCT00917735|3950575|B3|||Height||cm|Mean|163.9|163.9|Standard Deviation|6.2|6.2|||
4125730|NCT00917735|3950576|B2|||Height||cm|Mean|164.3|164.3|Standard Deviation|6.2|6.2|||
4125731|NCT00917735|3950577|B1|||Height||cm|Mean|163.5|163.5|Standard Deviation|6.3|6.3|||
4125732|NCT00917735|3950575|B3|United States||Region of Enrollment||participants|Number|1075|1075.0||||||
4125733|NCT00917735|3950576|B2|United States||Region of Enrollment||participants|Number|537|537.0||||||
4125734|NCT00917735|3950577|B1|United States||Region of Enrollment||participants|Number|538|538.0||||||
4125735|NCT00917735|3950575|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4125736|NCT00917735|3950576|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4125737|NCT00917735|3950577|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4125738|NCT00917735|3950575|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4125739|NCT00917735|3950576|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4125740|NCT00917735|3950577|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4125741|NCT00917735|3950575|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1020|1020.0||||||
4125742|NCT00917735|3950576|B2||White|Race (NIH/OMB)||Participants|Count of Participants|505|505.0||||||
4125743|NCT00917735|3950577|B1||White|Race (NIH/OMB)||Participants|Count of Participants|515|515.0||||||
4125744|NCT00917735|3950575|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4125745|NCT00917735|3950576|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4125746|NCT00917735|3950577|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4125747|NCT00917735|3950575|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125748|NCT00917735|3950576|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125749|NCT00917735|3950577|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125750|NCT00917735|3950575|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4125751|NCT00917735|3950576|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4125752|NCT00917735|3950577|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4125753|NCT00917735|3950575|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125754|NCT00917735|3950576|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125755|NCT00917735|3950577|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125756|NCT00917735|3950575|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4125757|NCT00917735|3950576|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4125758|NCT00917735|3950577|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4125759|NCT00917735|3950575|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1026|1026.0||||||
4125760|NCT00917735|3950576|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|510|510.0||||||
4125761|NCT00917735|3950577|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|516|516.0||||||
4125762|NCT00917735|3950575|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4125763|NCT00917735|3950576|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4125764|NCT00917735|3950577|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4125765|NCT00917735|3950575|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4125766|NCT00917735|3950576|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4125767|NCT00917735|3950577|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4125768|NCT00917735|3950575|B3||Female|Sex: Female, Male||Participants|Count of Participants|1075|1075.0||||||
4125769|NCT00917735|3950576|B2||Female|Sex: Female, Male||Participants|Count of Participants|537|537.0||||||
4125770|NCT00917735|3950577|B1||Female|Sex: Female, Male||Participants|Count of Participants|538|538.0||||||
4125771|NCT00917735|3950575|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|5.02|5.02|||
4125772|NCT00917735|3950576|B2|||Age||years|Mean|59.6|59.6|Standard Deviation|5.1|5.1|||
4125773|NCT00917735|3950577|B1|||Age||years|Mean|59.9|59.9|Standard Deviation|5.0|5.0|||
4125774|NCT00917644|3950588|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4125775|NCT00917644|3950588|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4125776|NCT00917644|3950588|B1|||Age||years|Mean|41.0|41.0|Standard Deviation|9.0|9.0|||
4125777|NCT00917579|3950603|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4125778|NCT00917579|3950603|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4125779|NCT00917579|3950603|B1|45-64 years||Age, Customized||participants|Number|17|17.0||||||
4125780|NCT00917579|3950603|B1|18-44 years||Age, Customized||participants|Number|59|59.0||||||
4125781|NCT00917553|3950618|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
4125782|NCT00917553|3950619|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4125783|NCT00917553|3950620|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4125784|NCT00917553|3950618|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125785|NCT00917553|3950619|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125786|NCT00917553|3950620|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125787|NCT00917553|3950618|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125788|NCT00917553|3950619|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125789|NCT00917553|3950620|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125790|NCT00917553|3950618|B3||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4125791|NCT00917553|3950619|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4125792|NCT00917553|3950620|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4125793|NCT00917553|3950618|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125794|NCT00917553|3950619|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125795|NCT00917553|3950620|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125796|NCT00917553|3950618|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125797|NCT00917553|3950619|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125798|NCT00917553|3950620|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125799|NCT00917553|3950618|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125800|NCT00917553|3950619|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125801|NCT00917553|3950620|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125802|NCT00917553|3950618|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4125803|NCT00917553|3950619|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4125804|NCT00917553|3950620|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125805|NCT00917553|3950618|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4125806|NCT00917553|3950619|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4125807|NCT00917553|3950620|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4125808|NCT00917553|3950618|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4125809|NCT00917553|3950619|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4125810|NCT00917553|3950620|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4125811|NCT00917553|3950618|B3|||Age||years|Mean|57.57|57.57|Standard Deviation|10.41|10.41|||
4125812|NCT00917553|3950619|B2|||Age||years|Mean|58.44|58.44|Standard Deviation|12.96|12.96|||
4125813|NCT00917553|3950620|B1|||Age||years|Mean|56.76|56.76|Standard Deviation|7.61|7.61|||
4125814|NCT00917501|3950635|B3|United States||Region of Enrollment||participants|Number|55|55.0||||||
4125815|NCT00917501|3950636|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4125816|NCT00917501|3950637|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4125817|NCT00917501|3950635|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4125818|NCT00917501|3950636|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4125819|NCT00917501|3950637|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4125820|NCT00917501|3950635|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4125821|NCT00917501|3950636|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4125822|NCT00917501|3950637|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4125823|NCT00917501|3950635|B3|||Age||Years|Mean|13.2|13.2|Standard Deviation|3.9|3.9|||
4125824|NCT00917501|3950636|B2|||Age||Years|Mean|13|13.0|Standard Deviation|4.5|4.5|||
4125825|NCT00917501|3950637|B1|||Age||Years|Mean|13.4|13.4|Standard Deviation|3.3|3.3|||
4125826|NCT00917384|3950644|B3|Other||Race||participants|Number|21|21.0||||||
4125827|NCT00917384|3950645|B2|Other||Race||participants|Number|7|7.0||||||
4125828|NCT00917384|3950646|B1|Other||Race||participants|Number|14|14.0||||||
4125829|NCT00917384|3950644|B3|Black||Race||participants|Number|6|6.0||||||
4125830|NCT00917384|3950645|B2|Black||Race||participants|Number|2|2.0||||||
4125831|NCT00917384|3950646|B1|Black||Race||participants|Number|4|4.0||||||
4125832|NCT00917384|3950644|B3|Asian||Race||participants|Number|56|56.0||||||
4125833|NCT00917384|3950645|B2|Asian||Race||participants|Number|17|17.0||||||
4125834|NCT00917384|3950646|B1|Asian||Race||participants|Number|39|39.0||||||
4125835|NCT00917384|3950644|B3|White||Race||participants|Number|272|272.0||||||
4125836|NCT00917384|3950645|B2|White||Race||participants|Number|91|91.0||||||
4125837|NCT00917384|3950646|B1|White||Race||participants|Number|181|181.0||||||
4125838|NCT00917384|3950644|B3|South Africa||Region of Enrollment||participants|Number|1|1.0||||||
4125839|NCT00917384|3950645|B2|South Africa||Region of Enrollment||participants|Number|1|1.0||||||
4125840|NCT00917384|3950646|B1|South Africa||Region of Enrollment||participants|Number|0|0.0||||||
4125841|NCT00917384|3950644|B3|United States||Region of Enrollment||participants|Number|43|43.0||||||
4125842|NCT00917384|3950645|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4125843|NCT00917384|3950646|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4125844|NCT00917384|3950644|B3|Taiwan||Region of Enrollment||participants|Number|3|3.0||||||
4125845|NCT00917384|3950645|B2|Taiwan||Region of Enrollment||participants|Number|0|0.0||||||
4125846|NCT00917384|3950646|B1|Taiwan||Region of Enrollment||participants|Number|3|3.0||||||
4125847|NCT00917384|3950644|B3|Turkey||Region of Enrollment||participants|Number|6|6.0||||||
4125848|NCT00917384|3950645|B2|Turkey||Region of Enrollment||participants|Number|1|1.0||||||
4125849|NCT00917384|3950646|B1|Turkey||Region of Enrollment||participants|Number|5|5.0||||||
4125850|NCT00917384|3950644|B3|Thailand||Region of Enrollment||participants|Number|1|1.0||||||
4125851|NCT00917384|3950645|B2|Thailand||Region of Enrollment||participants|Number|0|0.0||||||
4125852|NCT00917384|3950646|B1|Thailand||Region of Enrollment||participants|Number|1|1.0||||||
4125853|NCT00917384|3950644|B3|Russian Federation||Region of Enrollment||participants|Number|22|22.0||||||
4125854|NCT00917384|3950645|B2|Russian Federation||Region of Enrollment||participants|Number|8|8.0||||||
4125855|NCT00917384|3950646|B1|Russian Federation||Region of Enrollment||participants|Number|14|14.0||||||
4125856|NCT00917384|3950644|B3|Romania||Region of Enrollment||participants|Number|17|17.0||||||
4125857|NCT00917384|3950645|B2|Romania||Region of Enrollment||participants|Number|4|4.0||||||
4125858|NCT00917384|3950646|B1|Romania||Region of Enrollment||participants|Number|13|13.0||||||
4125859|NCT00917384|3950644|B3|Poland||Region of Enrollment||participants|Number|13|13.0||||||
4125860|NCT00917384|3950645|B2|Poland||Region of Enrollment||participants|Number|4|4.0||||||
4125861|NCT00917384|3950646|B1|Poland||Region of Enrollment||participants|Number|9|9.0||||||
4125862|NCT00917384|3950644|B3|Philippines||Region of Enrollment||participants|Number|2|2.0||||||
4125863|NCT00917384|3950645|B2|Philippines||Region of Enrollment||participants|Number|1|1.0||||||
4125864|NCT00917384|3950646|B1|Philippines||Region of Enrollment||participants|Number|1|1.0||||||
4125865|NCT00917384|3950644|B3|New Zealand||Region of Enrollment||participants|Number|2|2.0||||||
4125866|NCT00917384|3950645|B2|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
4125867|NCT00917384|3950646|B1|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
4125868|NCT00917384|3950644|B3|Malta||Region of Enrollment||participants|Number|5|5.0||||||
4125869|NCT00917384|3950645|B2|Malta||Region of Enrollment||participants|Number|3|3.0||||||
4125870|NCT00917384|3950646|B1|Malta||Region of Enrollment||participants|Number|2|2.0||||||
4125871|NCT00917384|3950644|B3|Lebanon||Region of Enrollment||participants|Number|1|1.0||||||
4125872|NCT00917384|3950645|B2|Lebanon||Region of Enrollment||participants|Number|0|0.0||||||
4125873|NCT00917384|3950646|B1|Lebanon||Region of Enrollment||participants|Number|1|1.0||||||
4125874|NCT00917384|3950644|B3|Korea, Republic of||Region of Enrollment||participants|Number|17|17.0||||||
4125875|NCT00917384|3950645|B2|Korea, Republic of||Region of Enrollment||participants|Number|6|6.0||||||
4125876|NCT00917384|3950646|B1|Korea, Republic of||Region of Enrollment||participants|Number|11|11.0||||||
4125877|NCT00917384|3950644|B3|Italy||Region of Enrollment||participants|Number|34|34.0||||||
4125878|NCT00917384|3950645|B2|Italy||Region of Enrollment||participants|Number|11|11.0||||||
4125879|NCT00917384|3950646|B1|Italy||Region of Enrollment||participants|Number|23|23.0||||||
4125880|NCT00917384|3950644|B3|India||Region of Enrollment||participants|Number|24|24.0||||||
4125881|NCT00917384|3950645|B2|India||Region of Enrollment||participants|Number|8|8.0||||||
4125882|NCT00917384|3950646|B1|India||Region of Enrollment||participants|Number|16|16.0||||||
4125883|NCT00917384|3950644|B3|Indonesia||Region of Enrollment||participants|Number|3|3.0||||||
4125884|NCT00917384|3950645|B2|Indonesia||Region of Enrollment||participants|Number|1|1.0||||||
4125885|NCT00917384|3950646|B1|Indonesia||Region of Enrollment||participants|Number|2|2.0||||||
4125886|NCT00917384|3950644|B3|Croatia||Region of Enrollment||participants|Number|7|7.0||||||
4125887|NCT00917384|3950645|B2|Croatia||Region of Enrollment||participants|Number|0|0.0||||||
4125888|NCT00917384|3950646|B1|Croatia||Region of Enrollment||participants|Number|7|7.0||||||
4125889|NCT00917384|3950644|B3|Guatemala||Region of Enrollment||participants|Number|8|8.0||||||
4125890|NCT00917384|3950645|B2|Guatemala||Region of Enrollment||participants|Number|2|2.0||||||
4125891|NCT00917384|3950646|B1|Guatemala||Region of Enrollment||participants|Number|6|6.0||||||
4125892|NCT00917384|3950644|B3|United Kingdom||Region of Enrollment||participants|Number|17|17.0||||||
4125893|NCT00917384|3950645|B2|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4125894|NCT00917384|3950646|B1|United Kingdom||Region of Enrollment||participants|Number|13|13.0||||||
4125895|NCT00917384|3950644|B3|Spain||Region of Enrollment||participants|Number|16|16.0||||||
4125896|NCT00917384|3950645|B2|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4125897|NCT00917384|3950646|B1|Spain||Region of Enrollment||participants|Number|12|12.0||||||
4125898|NCT00917384|3950644|B3|Egypt||Region of Enrollment||participants|Number|1|1.0||||||
4125899|NCT00917384|3950645|B2|Egypt||Region of Enrollment||participants|Number|0|0.0||||||
4125900|NCT00917384|3950646|B1|Egypt||Region of Enrollment||participants|Number|1|1.0||||||
4125901|NCT00917384|3950644|B3|Czech Republic||Region of Enrollment||participants|Number|37|37.0||||||
4125902|NCT00917384|3950645|B2|Czech Republic||Region of Enrollment||participants|Number|13|13.0||||||
4125903|NCT00917384|3950646|B1|Czech Republic||Region of Enrollment||participants|Number|24|24.0||||||
4125904|NCT00917384|3950644|B3|Colombia||Region of Enrollment||participants|Number|3|3.0||||||
4125905|NCT00917384|3950645|B2|Colombia||Region of Enrollment||participants|Number|1|1.0||||||
4125906|NCT00917384|3950646|B1|Colombia||Region of Enrollment||participants|Number|2|2.0||||||
4125907|NCT00917384|3950644|B3|Chile||Region of Enrollment||participants|Number|2|2.0||||||
4125908|NCT00917384|3950645|B2|Chile||Region of Enrollment||participants|Number|1|1.0||||||
4125909|NCT00917384|3950646|B1|Chile||Region of Enrollment||participants|Number|1|1.0||||||
4125910|NCT00917384|3950644|B3|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4125911|NCT00917384|3950645|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4125912|NCT00917384|3950646|B1|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4125913|NCT00917384|3950644|B3|Brazil||Region of Enrollment||participants|Number|38|38.0||||||
4125914|NCT00917384|3950645|B2|Brazil||Region of Enrollment||participants|Number|14|14.0||||||
4125915|NCT00917384|3950646|B1|Brazil||Region of Enrollment||participants|Number|24|24.0||||||
4125916|NCT00917384|3950644|B3|Bosnia and Herzegovina||Region of Enrollment||participants|Number|4|4.0||||||
4125917|NCT00917384|3950645|B2|Bosnia and Herzegovina||Region of Enrollment||participants|Number|3|3.0||||||
4125918|NCT00917384|3950646|B1|Bosnia and Herzegovina||Region of Enrollment||participants|Number|1|1.0||||||
4125919|NCT00917384|3950644|B3|Australia||Region of Enrollment||participants|Number|12|12.0||||||
4125920|NCT00917384|3950645|B2|Australia||Region of Enrollment||participants|Number|4|4.0||||||
4125921|NCT00917384|3950646|B1|Australia||Region of Enrollment||participants|Number|8|8.0||||||
4125922|NCT00917384|3950644|B3|Argentina||Region of Enrollment||participants|Number|6|6.0||||||
4125923|NCT00917384|3950645|B2|Argentina||Region of Enrollment||participants|Number|2|2.0||||||
4125924|NCT00917384|3950646|B1|Argentina||Region of Enrollment||participants|Number|4|4.0||||||
4125925|NCT00917384|3950644|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125926|NCT00917384|3950645|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125927|NCT00917384|3950646|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4125928|NCT00917384|3950644|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|295|295.0||||||
4125929|NCT00917384|3950645|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
4125930|NCT00917384|3950646|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|197|197.0||||||
4125931|NCT00917384|3950644|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4125932|NCT00917384|3950645|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4125933|NCT00917384|3950646|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4125934|NCT00917384|3950644|B3||Male|Gender||Participants|Count of Participants|248|248.0||||||
4125935|NCT00917384|3950645|B2||Male|Gender||Participants|Count of Participants|79|79.0||||||
4125936|NCT00917384|3950646|B1||Male|Gender||Participants|Count of Participants|169|169.0||||||
4125937|NCT00917384|3950644|B3||Female|Gender||Participants|Count of Participants|107|107.0||||||
4125938|NCT00917384|3950645|B2||Female|Gender||Participants|Count of Participants|38|38.0||||||
4125939|NCT00917384|3950646|B1||Female|Gender||Participants|Count of Participants|69|69.0||||||
4125940|NCT00917384|3950644|B3|||Age||years|Median|60.0|60.0|Full Range|||24.0|87.0|
4125941|NCT00917384|3950645|B2|||Age||years|Median|60.0|60.0|Full Range|||24.0|87.0|
4125942|NCT00917384|3950646|B1|||Age||years|Median|60.0|60.0|Full Range|||30.0|86.0|
4125943|NCT00917267|3950669|B3|TZD||Background Oral Antidiabetic Agent (OAD)||participants|Number|4|4.0||||||
4125944|NCT00917267|3950670|B2|TZD||Background Oral Antidiabetic Agent (OAD)||participants|Number|2|2.0||||||
4125945|NCT00917267|3950671|B1|TZD||Background Oral Antidiabetic Agent (OAD)||participants|Number|2|2.0||||||
4125946|NCT00917267|3950669|B3|SU+TZD||Background Oral Antidiabetic Agent (OAD)||participants|Number|30|30.0||||||
4125947|NCT00917267|3950670|B2|SU+TZD||Background Oral Antidiabetic Agent (OAD)||participants|Number|12|12.0||||||
4125948|NCT00917267|3950671|B1|SU+TZD||Background Oral Antidiabetic Agent (OAD)||participants|Number|18|18.0||||||
4125949|NCT00917267|3950669|B3|SU||Background Oral Antidiabetic Agent (OAD)||participants|Number|59|59.0||||||
4125950|NCT00917267|3950670|B2|SU||Background Oral Antidiabetic Agent (OAD)||participants|Number|29|29.0||||||
4125951|NCT00917267|3950671|B1|SU||Background Oral Antidiabetic Agent (OAD)||participants|Number|30|30.0||||||
4125952|NCT00917267|3950669|B3|MET+TZD||Background Oral Antidiabetic Agent (OAD)||participants|Number|21|21.0||||||
4125953|NCT00917267|3950670|B2|MET+TZD||Background Oral Antidiabetic Agent (OAD)||participants|Number|9|9.0||||||
4125954|NCT00917267|3950671|B1|MET+TZD||Background Oral Antidiabetic Agent (OAD)||participants|Number|12|12.0||||||
4125955|NCT00917267|3950669|B3|MET+SU+Thiazolidinedione (TZD)||Background Oral Antidiabetic Agent (OAD)||participants|Number|16|16.0||||||
4125956|NCT00917267|3950670|B2|MET+SU+Thiazolidinedione (TZD)||Background Oral Antidiabetic Agent (OAD)||participants|Number|10|10.0||||||
4125957|NCT00917267|3950671|B1|MET+SU+Thiazolidinedione (TZD)||Background Oral Antidiabetic Agent (OAD)||participants|Number|6|6.0||||||
4125958|NCT00917267|3950669|B3|MET+Sulfonylurea (SU)||Background Oral Antidiabetic Agent (OAD)||participants|Number|426|426.0||||||
4125959|NCT00917267|3950670|B2|MET+Sulfonylurea (SU)||Background Oral Antidiabetic Agent (OAD)||participants|Number|216|216.0||||||
4125960|NCT00917267|3950671|B1|MET+Sulfonylurea (SU)||Background Oral Antidiabetic Agent (OAD)||participants|Number|210|210.0||||||
4125961|NCT00917267|3950669|B3|Metformin (MET)||Background Oral Antidiabetic Agent (OAD)||participants|Number|122|122.0||||||
4125962|NCT00917267|3950670|B2|Metformin (MET)||Background Oral Antidiabetic Agent (OAD)||participants|Number|60|60.0||||||
4125963|NCT00917267|3950671|B1|Metformin (MET)||Background Oral Antidiabetic Agent (OAD)||participants|Number|62|62.0||||||
4125964|NCT00917267|3950669|B3|||Weight||kg|Mean|70.0|70.0|Standard Deviation|12.26|12.26|||
4125965|NCT00917267|3950670|B2|||Weight||kg|Mean|70.4|70.4|Standard Deviation|12.09|12.09|||
4125966|NCT00917267|3950671|B1|||Weight||kg|Mean|69.6|69.6|Standard Deviation|12.44|12.44|||
4125967|NCT00917267|3950669|B3|||Glycosylated hemoglobin (HbA1c)||percentage of total hemoglobin|Mean|8.7|8.7|Standard Deviation|1.03|1.03|||
4125968|NCT00917267|3950670|B2|||Glycosylated hemoglobin (HbA1c)||percentage of total hemoglobin|Mean|8.7|8.7|Standard Deviation|1.03|1.03|||
4125969|NCT00917267|3950671|B1|||Glycosylated hemoglobin (HbA1c)||percentage of total hemoglobin|Mean|8.7|8.7|Standard Deviation|1.04|1.04|||
4125970|NCT00917267|3950669|B3||Male|Sex: Female, Male||Participants|Count of Participants|367|367.0||||||
4125971|NCT00917267|3950670|B2||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4125972|NCT00917267|3950671|B1||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4125973|NCT00917267|3950669|B3||Female|Sex: Female, Male||Participants|Count of Participants|311|311.0||||||
4125974|NCT00917267|3950670|B2||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4125975|NCT00917267|3950671|B1||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4125976|NCT00917267|3950669|B3|||Age||years|Mean|55.8|55.8|Standard Deviation|10.30|10.3|||
4125977|NCT00917267|3950670|B2|||Age||years|Mean|56.2|56.2|Standard Deviation|9.99|9.99|||
4125978|NCT00917267|3950671|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|10.59|10.59|||
4125979|NCT00917267|3950669|B3||>=65 years|Age||Participants|Count of Participants|129|129.0||||||
4125980|NCT00917267|3950670|B2||>=65 years|Age||Participants|Count of Participants|64|64.0||||||
4125981|NCT00917267|3950671|B1||>=65 years|Age||Participants|Count of Participants|65|65.0||||||
4125982|NCT00917267|3950669|B3||Between 18 and 65 years|Age||Participants|Count of Participants|549|549.0||||||
4125983|NCT00917267|3950670|B2||Between 18 and 65 years|Age||Participants|Count of Participants|274|274.0||||||
4125984|NCT00917267|3950671|B1||Between 18 and 65 years|Age||Participants|Count of Participants|275|275.0||||||
4125985|NCT00917267|3950669|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4125986|NCT00917267|3950670|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4125987|NCT00917267|3950671|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4125988|NCT00917124|3950698|B3|||Aortic cross-clamp time||minutes|Mean|63|63.0|Standard Deviation|25|25.0|||
4125989|NCT00917124|3950699|B2|||Aortic cross-clamp time||minutes|Mean|63|63.0|Standard Deviation|23|23.0|||
4125990|NCT00917124|3950700|B1|||Aortic cross-clamp time||minutes|Mean|62|62.0|Standard Deviation|26|26.0|||
4125991|NCT00917124|3950698|B3|||Bypass time||minutes|Mean|90|90.0|Standard Deviation|31|31.0|||
4125992|NCT00917124|3950699|B2|||Bypass time||minutes|Mean|91|91.0|Standard Deviation|31|31.0|||
4125993|NCT00917124|3950700|B1|||Bypass time||minutes|Mean|89|89.0|Standard Deviation|32|32.0|||
4125994|NCT00917124|3950698|B3|Without atrial fibrillation||Comorbidity - Atrial fibrillation before operation||participants|Number|181|181.0||||||
4125995|NCT00917124|3950699|B2|Without atrial fibrillation||Comorbidity - Atrial fibrillation before operation||participants|Number|90|90.0||||||
4125996|NCT00917124|3950700|B1|Without atrial fibrillation||Comorbidity - Atrial fibrillation before operation||participants|Number|91|91.0||||||
4125997|NCT00917124|3950698|B3|Atrial fibrillation||Comorbidity - Atrial fibrillation before operation||participants|Number|9|9.0||||||
4125998|NCT00917124|3950699|B2|Atrial fibrillation||Comorbidity - Atrial fibrillation before operation||participants|Number|4|4.0||||||
4125999|NCT00917124|3950700|B1|Atrial fibrillation||Comorbidity - Atrial fibrillation before operation||participants|Number|5|5.0||||||
4126000|NCT00917124|3950698|B3|Without preoperative myocardial infarction||Comorbidity - Myocardial infarction within 1 month before operation||participants|Number|170|170.0||||||
4126001|NCT00917124|3950699|B2|Without preoperative myocardial infarction||Comorbidity - Myocardial infarction within 1 month before operation||participants|Number|86|86.0||||||
4126002|NCT00917124|3950700|B1|Without preoperative myocardial infarction||Comorbidity - Myocardial infarction within 1 month before operation||participants|Number|84|84.0||||||
4126003|NCT00917124|3950698|B3|With preoperative myocardial infarction||Comorbidity - Myocardial infarction within 1 month before operation||participants|Number|20|20.0||||||
4126004|NCT00917124|3950699|B2|With preoperative myocardial infarction||Comorbidity - Myocardial infarction within 1 month before operation||participants|Number|8|8.0||||||
4126005|NCT00917124|3950700|B1|With preoperative myocardial infarction||Comorbidity - Myocardial infarction within 1 month before operation||participants|Number|12|12.0||||||
4126006|NCT00917124|3950698|B3|Without hypertension||Comorbidity - hypertension||participants|Number|26|26.0||||||
4126007|NCT00917124|3950699|B2|Without hypertension||Comorbidity - hypertension||participants|Number|15|15.0||||||
4126008|NCT00917124|3950700|B1|Without hypertension||Comorbidity - hypertension||participants|Number|11|11.0||||||
4126009|NCT00917124|3950698|B3|Hypertension||Comorbidity - hypertension||participants|Number|164|164.0||||||
4126010|NCT00917124|3950699|B2|Hypertension||Comorbidity - hypertension||participants|Number|79|79.0||||||
4126011|NCT00917124|3950700|B1|Hypertension||Comorbidity - hypertension||participants|Number|85|85.0||||||
4126012|NCT00917124|3950698|B3|Without diabetes||Comorbidity - diabetes||participants|Number|129|129.0||||||
4126013|NCT00917124|3950699|B2|Without diabetes||Comorbidity - diabetes||participants|Number|66|66.0||||||
4126014|NCT00917124|3950700|B1|Without diabetes||Comorbidity - diabetes||participants|Number|63|63.0||||||
4126015|NCT00917124|3950698|B3|Diabetes||Comorbidity - diabetes||participants|Number|61|61.0||||||
4126016|NCT00917124|3950699|B2|Diabetes||Comorbidity - diabetes||participants|Number|28|28.0||||||
4126017|NCT00917124|3950700|B1|Diabetes||Comorbidity - diabetes||participants|Number|33|33.0||||||
4126018|NCT00917124|3950698|B3|||Years of education||years|Mean|11.2|11.2|Standard Deviation|3.3|3.3|||
4126019|NCT00917124|3950699|B2|||Years of education||years|Mean|11.3|11.3|Standard Deviation|3.4|3.4|||
4126020|NCT00917124|3950700|B1|||Years of education||years|Mean|11.2|11.2|Standard Deviation|3.2|3.2|||
4126021|NCT00917124|3950698|B3|||Ejection fraction||%|Mean|56|56.0|Standard Deviation|9.8|9.8|||
4126022|NCT00917124|3950699|B2|||Ejection fraction||%|Mean|56|56.0|Standard Deviation|9.7|9.7|||
4126023|NCT00917124|3950700|B1|||Ejection fraction||%|Mean|56|56.0|Standard Deviation|9.9|9.9|||
4126024|NCT00917124|3950698|B3|||EuroSCORE|EuroSCORE (European system for cardiac operative risk evaluation) is a method of calculating predicted operative mortality for patients undergoing cardiac surgery. The outcome (survival or death) was related to the preoperative risk factors. If a risk factor is present in a patient, the weights are added to give an approximate percent predicted mortality. Two online risk calculators are available: the simple additive EuroSCORE and the logistic EuroSCORE. We used the logistic version of EuroSCORE which provides more accurate predicted mortality according to the logistic regression equation.|% - predicted mortality|Mean|2.3|2.3|Standard Deviation|1.7|1.7|||
4126025|NCT00917124|3950699|B2|||EuroSCORE|EuroSCORE (European system for cardiac operative risk evaluation) is a method of calculating predicted operative mortality for patients undergoing cardiac surgery. The outcome (survival or death) was related to the preoperative risk factors. If a risk factor is present in a patient, the weights are added to give an approximate percent predicted mortality. Two online risk calculators are available: the simple additive EuroSCORE and the logistic EuroSCORE. We used the logistic version of EuroSCORE which provides more accurate predicted mortality according to the logistic regression equation.|% - predicted mortality|Mean|2.2|2.2|Standard Deviation|1.7|1.7|||
4126084|NCT00916721|3950720|B3||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
4126085|NCT00916721|3950721|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4126086|NCT00916721|3950722|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4126087|NCT00916721|3950720|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126026|NCT00917124|3950700|B1|||EuroSCORE|EuroSCORE (European system for cardiac operative risk evaluation) is a method of calculating predicted operative mortality for patients undergoing cardiac surgery. The outcome (survival or death) was related to the preoperative risk factors. If a risk factor is present in a patient, the weights are added to give an approximate percent predicted mortality. Two online risk calculators are available: the simple additive EuroSCORE and the logistic EuroSCORE. We used the logistic version of EuroSCORE which provides more accurate predicted mortality according to the logistic regression equation.|% - predicted mortality|Mean|2.4|2.4|Standard Deviation|1.7|1.7|||
4126027|NCT00917124|3950698|B3|Croatia||Region of Enrollment||participants|Number|190|190.0||||||
4126028|NCT00917124|3950699|B2|Croatia||Region of Enrollment||participants|Number|94|94.0||||||
4126029|NCT00917124|3950700|B1|Croatia||Region of Enrollment||participants|Number|96|96.0||||||
4126030|NCT00917124|3950698|B3||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4126031|NCT00917124|3950699|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4126032|NCT00917124|3950700|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4126033|NCT00917124|3950698|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4126034|NCT00917124|3950699|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4126035|NCT00917124|3950700|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4126036|NCT00917124|3950698|B3|||Age||years|Mean|62.4|62.4|Standard Deviation|9.1|9.1|||
4126037|NCT00917124|3950699|B2|||Age||years|Mean|61.9|61.9|Standard Deviation|7.1|7.1|||
4126038|NCT00917124|3950700|B1|||Age||years|Mean|63.4|63.4|Standard Deviation|8.8|8.8|||
4126039|NCT00917124|3950698|B3||>=65 years|Age||Participants|Count of Participants|78|78.0||||||
4126040|NCT00917124|3950699|B2||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4126041|NCT00917124|3950700|B1||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4126042|NCT00917124|3950698|B3||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
4126043|NCT00917124|3950699|B2||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4126044|NCT00917124|3950700|B1||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4126045|NCT00917124|3950698|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126046|NCT00917124|3950699|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126047|NCT00917124|3950700|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126048|NCT00916929|3950709|B3|United States||Region of Enrollment||participants|Number|162|162.0||||||
4126049|NCT00916929|3950710|B2|United States||Region of Enrollment||participants|Number|82|82.0||||||
4126050|NCT00916929|3950711|B1|United States||Region of Enrollment||participants|Number|80|80.0||||||
4126051|NCT00916929|3950709|B3||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4126052|NCT00916929|3950710|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4126053|NCT00916929|3950711|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4126054|NCT00916929|3950709|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4126055|NCT00916929|3950710|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4126056|NCT00916929|3950711|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4126057|NCT00916929|3950709|B3|||Age||years|Mean|64|64.0|Standard Deviation|13|13.0|||
4126058|NCT00916929|3950710|B2|||Age||years|Mean|66|66.0|Standard Deviation|13|13.0|||
4126059|NCT00916929|3950711|B1|||Age||years|Mean|61|61.0|Standard Deviation|14|14.0|||
4126060|NCT00916929|3950709|B3||>=65 years|Age||Participants|Count of Participants|82|82.0||||||
4126061|NCT00916929|3950710|B2||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
4126062|NCT00916929|3950711|B1||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4126063|NCT00916929|3950709|B3||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4126064|NCT00916929|3950710|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4126065|NCT00916929|3950711|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4126066|NCT00916929|3950709|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126067|NCT00916929|3950710|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126068|NCT00916929|3950711|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126069|NCT00916721|3950720|B3|United States||Region of Enrollment||participants|Number|74|74.0||||||
4126070|NCT00916721|3950721|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
4126071|NCT00916721|3950722|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4126072|NCT00916721|3950720|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4126073|NCT00916721|3950721|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4126074|NCT00916721|3950722|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4126075|NCT00916721|3950720|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4126076|NCT00916721|3950721|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4126077|NCT00916721|3950722|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4126078|NCT00916721|3950720|B3|||Age||years|Mean|42.1|42.1|Standard Deviation|10.23|10.23|||
4126079|NCT00916721|3950721|B2|||Age||years|Mean|42.5|42.5|Standard Deviation|9.84|9.84|||
4126080|NCT00916721|3950722|B1|||Age||years|Mean|41.6|41.6|Standard Deviation|10.9|10.9|||
4126081|NCT00916721|3950720|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4126082|NCT00916721|3950721|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4126083|NCT00916721|3950722|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4126088|NCT00916721|3950721|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126089|NCT00916721|3950722|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126090|NCT00916643|3950735|B1|United States||Region of Enrollment||participants|Number|113|113.0||||||
4126091|NCT00916643|3950735|B1|Male||Gender|Not all site collected this information.|participants|Number|34|34.0||||||
4126092|NCT00916643|3950735|B1|Female||Gender|Not all site collected this information.|participants|Number|56|56.0||||||
4126093|NCT00916643|3950735|B1|>=65 years||Age|Not all sites collected this information.|participants|Number|13|13.0||||||
4126094|NCT00916643|3950735|B1|Between 18 and 65 years||Age|Not all sites collected this information.|participants|Number|80|80.0||||||
4126095|NCT00916643|3950735|B1|<=18 years||Age|Not all sites collected this information.|participants|Number|0|0.0||||||
4126096|NCT00916617|3950742|B5||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4126097|NCT00916617|3950743|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4126098|NCT00916617|3950744|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4126099|NCT00916617|3950745|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4126100|NCT00916617|3950746|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4126101|NCT00916617|3950742|B5||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4126102|NCT00916617|3950743|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4126103|NCT00916617|3950744|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4126104|NCT00916617|3950745|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4126105|NCT00916617|3950746|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4126106|NCT00916617|3950742|B5|Greater than or equal to (>=) 65 years||Age, Customized||Participants|Number|52|52.0||||||
4126107|NCT00916617|3950743|B4|Greater than or equal to (>=) 65 years||Age, Customized||Participants|Number|5|5.0||||||
4126108|NCT00916617|3950744|B3|Greater than or equal to (>=) 65 years||Age, Customized||Participants|Number|10|10.0||||||
4126109|NCT00916617|3950745|B2|Greater than or equal to (>=) 65 years||Age, Customized||Participants|Number|18|18.0||||||
4126110|NCT00916617|3950746|B1|Greater than or equal to (>=) 65 years||Age, Customized||Participants|Number|19|19.0||||||
4126111|NCT00916617|3950742|B5|Less than (<) 65 years||Age, Customized||Participants|Number|9|9.0||||||
4126112|NCT00916617|3950743|B4|Less than (<) 65 years||Age, Customized||Participants|Number|2|2.0||||||
4126113|NCT00916617|3950744|B3|Less than (<) 65 years||Age, Customized||Participants|Number|0|0.0||||||
4126114|NCT00916617|3950745|B2|Less than (<) 65 years||Age, Customized||Participants|Number|3|3.0||||||
4126115|NCT00916617|3950746|B1|Less than (<) 65 years||Age, Customized||Participants|Number|4|4.0||||||
4126116|NCT00916617|3950742|B5|||Age||Years|Mean|73.9|73.9|Standard Deviation|9.10|9.1|||
4126117|NCT00916617|3950743|B4|||Age||Years|Mean|70.3|70.3|Standard Deviation|10.13|10.13|||
4126118|NCT00916617|3950744|B3|||Age||Years|Mean|80.4|80.4|Standard Deviation|5.54|5.54|||
4126119|NCT00916617|3950745|B2|||Age||Years|Mean|74.0|74.0|Standard Deviation|9.34|9.34|||
4126120|NCT00916617|3950746|B1|||Age||Years|Mean|72.2|72.2|Standard Deviation|8.92|8.92|||
4126121|NCT00916578|3950763|B1|||Patients enrolled were female gender over the age of 18.|Number of patients enrolled into the protocol were eligible patients who were women over the age of 18.|participants|Number|33|33.0||||||
4126122|NCT00916578|3950763|B1|Norway||Region of Enrollment||participants|Number|1|1.0||||||
4126123|NCT00916578|3950763|B1|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
4126124|NCT00916578|3950763|B1|Hungary||Region of Enrollment||participants|Number|1|1.0||||||
4126125|NCT00916578|3950763|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4126126|NCT00916578|3950763|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4126127|NCT00916578|3950763|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4126128|NCT00916578|3950763|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4126129|NCT00916578|3950763|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4126130|NCT00916578|3950763|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4126131|NCT00916578|3950763|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4126132|NCT00916578|3950763|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4126133|NCT00916578|3950763|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4126134|NCT00916578|3950763|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4126135|NCT00916578|3950763|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4126136|NCT00916578|3950763|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4126137|NCT00916578|3950763|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4126138|NCT00916578|3950763|B1|||Age||years|Mean|49|49.0|Standard Deviation|12.02326|12.02326|||
4126139|NCT00916578|3950763|B1||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4126140|NCT00916578|3950763|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4126141|NCT00916578|3950763|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126142|NCT00916539|3950767|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
4126143|NCT00916539|3950768|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
4126144|NCT00916539|3950769|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4126145|NCT00916539|3950767|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4126146|NCT00916539|3950768|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4126147|NCT00916539|3950769|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4126148|NCT00916539|3950767|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4126149|NCT00916539|3950768|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4126150|NCT00916539|3950769|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4126151|NCT00916539|3950767|B3|||Age||years|Mean|37.5|37.5|Standard Deviation|17.0|17.0|||
4126152|NCT00916539|3950768|B2|||Age||years|Mean|42|42.0|Standard Deviation|18|18.0|||
4126153|NCT00916539|3950769|B1|||Age||years|Mean|33|33.0|Standard Deviation|14|14.0|||
4126154|NCT00916383|3950792|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4126155|NCT00916383|3950792|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4126156|NCT00916383|3950792|B1|All Participants||Age||Years|Mean|79.5|79.5|Standard Deviation|6.47|6.47|||
4126157|NCT00916370|3950818|B3|Australia||Region of Enrollment||participants|Number|33|33.0||||||
4126158|NCT00916370|3950819|B2|Australia||Region of Enrollment||participants|Number|8|8.0||||||
4126159|NCT00916370|3950820|B1|Australia||Region of Enrollment||participants|Number|25|25.0||||||
4126160|NCT00916370|3950818|B3|United States||Region of Enrollment||participants|Number|472|472.0||||||
4126161|NCT00916370|3950819|B2|United States||Region of Enrollment||participants|Number|96|96.0||||||
4126162|NCT00916370|3950820|B1|United States||Region of Enrollment||participants|Number|376|376.0||||||
4126163|NCT00916370|3950818|B3||Male|Sex: Female, Male||Participants|Count of Participants|347|347.0||||||
4126164|NCT00916370|3950819|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4126165|NCT00916370|3950820|B1||Male|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
4126166|NCT00916370|3950818|B3||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4126167|NCT00916370|3950819|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4126168|NCT00916370|3950820|B1||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4126169|NCT00916370|3950818|B3|||Age||years|Mean|62.86|62.86|Standard Deviation|10.07|10.07|||
4126170|NCT00916370|3950819|B2|||Age||years|Mean|63.46|63.46|Standard Deviation|9.44|9.44|||
4126171|NCT00916370|3950820|B1|||Age||years|Mean|62.70|62.7|Standard Deviation|10.23|10.23|||
4126172|NCT00916370|3950818|B3||>=65 years|Age||Participants|Count of Participants|215|215.0||||||
4126173|NCT00916370|3950819|B2||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4126174|NCT00916370|3950820|B1||>=65 years|Age||Participants|Count of Participants|167|167.0||||||
4126175|NCT00916370|3950818|B3||Between 18 and 65 years|Age||Participants|Count of Participants|290|290.0||||||
4126176|NCT00916370|3950819|B2||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4126177|NCT00916370|3950820|B1||Between 18 and 65 years|Age||Participants|Count of Participants|234|234.0||||||
4126178|NCT00916370|3950818|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126179|NCT00916370|3950819|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126180|NCT00916370|3950820|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126181|NCT00916357|3950995|B1|United States||Region of Enrollment||Participants|Number|23|23.0||||||
4126182|NCT00916357|3950995|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4126183|NCT00916357|3950995|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4126184|NCT00916357|3950995|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4126185|NCT00916357|3950995|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4126186|NCT00916357|3950995|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4126187|NCT00916357|3950995|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4126188|NCT00916357|3950995|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4126189|NCT00916357|3950995|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4126190|NCT00916357|3950995|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4126191|NCT00916357|3950995|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4126192|NCT00916357|3950995|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4126193|NCT00916357|3950995|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4126194|NCT00916357|3950995|B1|||Age||Years (yr)|Mean|52.2|52.2|Standard Deviation|8.07|8.07|||
4126195|NCT00916344|3951038|B1|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4126196|NCT00916344|3951038|B1|Sweden||Region of Enrollment||participants|Number|4|4.0||||||
4126197|NCT00916344|3951038|B1|Spain||Region of Enrollment||participants|Number|16|16.0||||||
4126198|NCT00916344|3951038|B1|Germany||Region of Enrollment||participants|Number|93|93.0||||||
4126199|NCT00916344|3951038|B1|France||Region of Enrollment||participants|Number|9|9.0||||||
4126200|NCT00916344|3951038|B1|Denmark||Region of Enrollment||participants|Number|19|19.0||||||
4126201|NCT00916344|3951038|B1|Austria||Region of Enrollment||participants|Number|32|32.0||||||
4126202|NCT00916344|3951038|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4126203|NCT00916344|3951038|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4126204|NCT00916344|3951038|B1|Between 34 and 93 years||Age, Customized||participants|Number|175|175.0||||||
4126205|NCT00916344|3951038|B1|||Age||years|Mean|74|74.0|Standard Deviation|10.5|10.5|||
4126206|NCT00916305|3951043|B3|Male/Female||Sex/Gender, Customized|Per-arm data are not available. A total of 51 (78.5%) participants were female and a total of 14 (21.5%) participants were Male|Participants|Number|65|65.0||||||
4126262|NCT00916149|3951064|B2|||Age||years|Mean|35.8|35.8|Full Range|||22.0|50.0|
4126207|NCT00916305|3951044|B2|Male/Female||Sex/Gender, Customized|Per-arm data are not available. A total of 51 (78.5%) participants were female and a total of 14 (21.5%) participants were Male|Participants|Number|37|37.0||||||
4126208|NCT00916305|3951045|B1|Male/Female||Sex/Gender, Customized|Per-arm data are not available. A total of 51 (78.5%) participants were female and a total of 14 (21.5%) participants were Male|Participants|Number|28|28.0||||||
4126209|NCT00916305|3951043|B3|18-25 years||Age, Customized||participants|Number|65|65.0||||||
4126210|NCT00916305|3951044|B2|18-25 years||Age, Customized||participants|Number|37|37.0||||||
4126211|NCT00916305|3951045|B1|18-25 years||Age, Customized||participants|Number|28|28.0||||||
4126212|NCT00916279|3951054|B1|RCA||Target Lesion Location|Target coronary vessel(s) treated: circumflex (CFX), left anterior descending (LAD), right coronary artery (RCA).|participants|Number|11|11.0||||||
4126213|NCT00916279|3951054|B1|LAD||Target Lesion Location|Target coronary vessel(s) treated: circumflex (CFX), left anterior descending (LAD), right coronary artery (RCA).|participants|Number|13|13.0||||||
4126214|NCT00916279|3951054|B1|CFX||Target Lesion Location|Target coronary vessel(s) treated: circumflex (CFX), left anterior descending (LAD), right coronary artery (RCA).|participants|Number|17|17.0||||||
4126215|NCT00916279|3951054|B1|Germany||Region of Enrollment||participants|Number|36|36.0||||||
4126216|NCT00916279|3951054|B1|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
4126217|NCT00916279|3951054|B1|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4126218|NCT00916279|3951054|B1||Male|Gender||Participants|Count of Participants|31|31.0||||||
4126219|NCT00916279|3951054|B1||Female|Gender||Participants|Count of Participants|10|10.0||||||
4126220|NCT00916279|3951054|B1|||Age||Years|Mean|64.4|64.4|Standard Deviation|11.0|11.0|||
4126221|NCT00916279|3951054|B1||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4126222|NCT00916279|3951054|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4126223|NCT00916279|3951054|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126224|NCT00916149|3951062|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4126225|NCT00916149|3951063|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4126226|NCT00916149|3951064|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4126227|NCT00916149|3951065|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4126228|NCT00916149|3951062|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4126229|NCT00916149|3951063|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4126230|NCT00916149|3951064|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4126231|NCT00916149|3951065|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4126232|NCT00916149|3951062|B4||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4126233|NCT00916149|3951063|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4126234|NCT00916149|3951064|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4126235|NCT00916149|3951065|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4126236|NCT00916149|3951062|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4126237|NCT00916149|3951063|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4126238|NCT00916149|3951064|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4126239|NCT00916149|3951065|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4126240|NCT00916149|3951062|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4126241|NCT00916149|3951063|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4126242|NCT00916149|3951064|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4126243|NCT00916149|3951065|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4126244|NCT00916149|3951062|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4126245|NCT00916149|3951063|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4126246|NCT00916149|3951064|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4126247|NCT00916149|3951065|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4126248|NCT00916149|3951062|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4126249|NCT00916149|3951063|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4126250|NCT00916149|3951064|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4126251|NCT00916149|3951065|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4126252|NCT00916149|3951062|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4126253|NCT00916149|3951063|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4126254|NCT00916149|3951064|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4126255|NCT00916149|3951065|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4126256|NCT00916149|3951062|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4126257|NCT00916149|3951063|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4126258|NCT00916149|3951064|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4126259|NCT00916149|3951065|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4126260|NCT00916149|3951062|B4|||Age||years|Mean|35.3|35.3|Full Range|||18.0|55.0|
4126261|NCT00916149|3951063|B3|||Age||years|Mean|31.4|31.4|Full Range|||18.0|43.0|
4126263|NCT00916149|3951065|B1|||Age||years|Mean|31.4|31.4|Full Range|||18.0|43.0|
4126264|NCT00916136|3951136|B3|United States||Region of Enrollment||participants|Number|66|66.0||||||
4126265|NCT00916136|3951137|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4126266|NCT00916136|3951138|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4126267|NCT00916136|3951136|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4126268|NCT00916136|3951137|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4126269|NCT00916136|3951138|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4126270|NCT00916136|3951136|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4126271|NCT00916136|3951137|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4126272|NCT00916136|3951138|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4126273|NCT00916136|3951136|B3|||Age||years|Mean|27|27.0|Standard Deviation|13.1|13.1|||
4126274|NCT00916136|3951137|B2|||Age||years|Mean|28.0|28.0|Standard Deviation|13.5|13.5|||
4126275|NCT00916136|3951138|B1|||Age||years|Mean|25.6|25.6|Standard Deviation|12.75|12.75|||
4126276|NCT00916136|3951136|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4126277|NCT00916136|3951137|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4126278|NCT00916136|3951138|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4126279|NCT00916136|3951136|B3||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4126280|NCT00916136|3951137|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4126281|NCT00916136|3951138|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4126282|NCT00916136|3951136|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126283|NCT00916136|3951137|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126284|NCT00916136|3951138|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126285|NCT00916032|3951147|B1|Russian Federation||Region of Enrollment||participants|Number|9|9.0||||||
4126286|NCT00916032|3951147|B1|Bulgaria||Region of Enrollment||participants|Number|14|14.0||||||
4126287|NCT00916032|3951147|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4126288|NCT00916032|3951147|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4126289|NCT00916032|3951147|B1|||Age||years|Mean|36.5|36.5|Standard Deviation|13.2|13.2|||
4126290|NCT00916006|3951188|B3|Australia||Region of Enrollment||participants|Number|18|18.0||||||
4126291|NCT00916006|3951189|B2|Australia||Region of Enrollment||participants|Number|8|8.0||||||
4126292|NCT00916006|3951190|B1|Australia||Region of Enrollment||participants|Number|10|10.0||||||
4126293|NCT00916006|3951188|B3|United States||Region of Enrollment||participants|Number|251|251.0||||||
4126294|NCT00916006|3951189|B2|United States||Region of Enrollment||participants|Number|126|126.0||||||
4126295|NCT00916006|3951190|B1|United States||Region of Enrollment||participants|Number|125|125.0||||||
4126296|NCT00916006|3951188|B3||Male|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
4126297|NCT00916006|3951189|B2||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4126298|NCT00916006|3951190|B1||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4126299|NCT00916006|3951188|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4126300|NCT00916006|3951189|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4126301|NCT00916006|3951190|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4126302|NCT00916006|3951188|B3||>=65 years|Age||Participants|Count of Participants|121|121.0||||||
4126303|NCT00916006|3951189|B2||>=65 years|Age||Participants|Count of Participants|57|57.0||||||
4126304|NCT00916006|3951190|B1||>=65 years|Age||Participants|Count of Participants|64|64.0||||||
4126305|NCT00916006|3951188|B3||Between 18 and 65 years|Age||Participants|Count of Participants|148|148.0||||||
4126306|NCT00916006|3951189|B2||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
4126307|NCT00916006|3951190|B1||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4126308|NCT00916006|3951188|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126309|NCT00916006|3951189|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126310|NCT00916006|3951190|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126311|NCT00915902|3951199|B3|||Triglyceride (mg/dL||mg/dL|Mean|270|270.0|Standard Deviation|24|24.0|||
4126312|NCT00915902|3951200|B2|||Triglyceride (mg/dL||mg/dL|Mean|280|280.0|Standard Deviation|25|25.0|||
4126313|NCT00915902|3951201|B1|||Triglyceride (mg/dL||mg/dL|Mean|260|260.0|Standard Deviation|22|22.0|||
4126314|NCT00915902|3951199|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4126315|NCT00915902|3951200|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4126316|NCT00915902|3951201|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4126317|NCT00915902|3951199|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4126318|NCT00915902|3951200|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4126319|NCT00915902|3951201|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4126320|NCT00915902|3951199|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4126321|NCT00915902|3951200|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4126322|NCT00915902|3951201|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4126323|NCT00915902|3951199|B3|||Age||years|Mean|14.1|14.1|Standard Deviation|0.5|0.5|||
4126324|NCT00915902|3951200|B2|||Age||years|Mean|14.2|14.2|Standard Deviation|0.5|0.5|||
4126325|NCT00915902|3951201|B1|||Age||years|Mean|14|14.0|Standard Deviation|0.4|0.4|||
4126326|NCT00915876|3951210|B3|||estimated glomerular filtration rate||mL/min/1.73m2|Mean|35|35.0|Standard Deviation|10|10.0|||
4126327|NCT00915876|3951211|B2|||estimated glomerular filtration rate||mL/min/1.73m2|Mean|30|30.0|Standard Deviation|9|9.0|||
4126328|NCT00915876|3951212|B1|||estimated glomerular filtration rate||mL/min/1.73m2|Mean|36|36.0|Standard Deviation|11|11.0|||
4126329|NCT00915876|3951210|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4126330|NCT00915876|3951211|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4126331|NCT00915876|3951212|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4126332|NCT00915876|3951210|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4126333|NCT00915876|3951211|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4126334|NCT00915876|3951212|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4126335|NCT00915876|3951210|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4126336|NCT00915876|3951211|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4126337|NCT00915876|3951212|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4126338|NCT00915876|3951210|B3|||Age||years|Mean|66|66.0|Standard Deviation|13|13.0|||
4126339|NCT00915876|3951211|B2|||Age||years|Mean|64|64.0|Standard Deviation|14|14.0|||
4126340|NCT00915876|3951212|B1|||Age||years|Mean|67|67.0|Standard Deviation|11|11.0|||
4126341|NCT00915798|3951219|B5|United States||Region of Enrollment||Participants|Count of Participants|89|89.0||||||
4126342|NCT00915798|3951220|B4|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
4126343|NCT00915798|3951221|B3|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4126344|NCT00915798|3951222|B2|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
4126345|NCT00915798|3951223|B1|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4126346|NCT00915798|3951219|B5||Male|Gender||Participants|Count of Participants|59|59.0||||||
4126347|NCT00915798|3951220|B4||Male|Gender||Participants|Count of Participants|8|8.0||||||
4126348|NCT00915798|3951221|B3||Male|Gender||Participants|Count of Participants|19|19.0||||||
4126349|NCT00915798|3951222|B2||Male|Gender||Participants|Count of Participants|15|15.0||||||
4126350|NCT00915798|3951223|B1||Male|Gender||Participants|Count of Participants|17|17.0||||||
4126351|NCT00915798|3951219|B5||Female|Gender||Participants|Count of Participants|30|30.0||||||
4126352|NCT00915798|3951220|B4||Female|Gender||Participants|Count of Participants|18|18.0||||||
4126353|NCT00915798|3951221|B3||Female|Gender||Participants|Count of Participants|4|4.0||||||
4126354|NCT00915798|3951222|B2||Female|Gender||Participants|Count of Participants|6|6.0||||||
4126355|NCT00915798|3951223|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
4126356|NCT00915798|3951219|B5|||Age||years|Mean|24.44|24.44|Standard Deviation|4.88|4.88|||
4126357|NCT00915798|3951220|B4|||Age||years|Mean|22.69|22.69|Standard Deviation|1.85|1.85|||
4126358|NCT00915798|3951221|B3|||Age||years|Mean|25.04|25.04|Standard Deviation|4.29|4.29|||
4126359|NCT00915798|3951222|B2|||Age||years|Mean|27.24|27.24|Standard Deviation|7.96|7.96|||
4126360|NCT00915798|3951223|B1|||Age||years|Mean|23.00|23.0|Standard Deviation|1.70|1.7|||
4126361|NCT00915772|3951246|B4|||Fasting plasma glucose (FPG) at baseline|Based upon non-missing data, n=544 (6:10:6 missing in each of the groups respectively)|mg/dL|Mean|159.868|159.868|Standard Deviation|41.206|41.206|||
4126362|NCT00915772|3951247|B3|||Fasting plasma glucose (FPG) at baseline|Based upon non-missing data, n=544 (6:10:6 missing in each of the groups respectively)|mg/dL|Mean|153.721|153.721|Standard Deviation|37.128|37.128|||
4126363|NCT00915772|3951248|B2|||Fasting plasma glucose (FPG) at baseline|Based upon non-missing data, n=544 (6:10:6 missing in each of the groups respectively)|mg/dL|Mean|167.088|167.088|Standard Deviation|44.633|44.633|||
4126364|NCT00915772|3951249|B1|||Fasting plasma glucose (FPG) at baseline|Based upon non-missing data, n=544 (6:10:6 missing in each of the groups respectively)|mg/dL|Mean|156.585|156.585|Standard Deviation|39.194|39.194|||
4126365|NCT00915772|3951246|B4|||Baseline Glycosylated haemoglobin (HbA1c) at baseline|Based upon non-missing data, n=559 (5:1:1 missing in each of the groups respectively)|percent|Mean|7.50|7.5|Standard Deviation|1.06|1.06|||
4126366|NCT00915772|3951247|B3|||Baseline Glycosylated haemoglobin (HbA1c) at baseline|Based upon non-missing data, n=559 (5:1:1 missing in each of the groups respectively)|percent|Mean|7.35|7.35|Standard Deviation|1.12|1.12|||
4126367|NCT00915772|3951248|B2|||Baseline Glycosylated haemoglobin (HbA1c) at baseline|Based upon non-missing data, n=559 (5:1:1 missing in each of the groups respectively)|percent|Mean|7.64|7.64|Standard Deviation|1.04|1.04|||
4126368|NCT00915772|3951249|B1|||Baseline Glycosylated haemoglobin (HbA1c) at baseline|Based upon non-missing data, n=559 (5:1:1 missing in each of the groups respectively)|percent|Mean|7.48|7.48|Standard Deviation|0.99|0.99|||
4126369|NCT00915772|3951246|B4|||Baseline weight||kg|Mean|79.58|79.58|Standard Deviation|18.25|18.25|||
4126370|NCT00915772|3951247|B3|||Baseline weight||kg|Mean|78.62|78.62|Standard Deviation|16.86|16.86|||
4126371|NCT00915772|3951248|B2|||Baseline weight||kg|Mean|79.17|79.17|Standard Deviation|18.75|18.75|||
4126372|NCT00915772|3951249|B1|||Baseline weight||kg|Mean|81.09|81.09|Standard Deviation|18.92|18.92|||
4126373|NCT00915772|3951246|B4|||Body Mass Index (BMI) continuous||kg/m2|Mean|29.01|29.01|Standard Deviation|4.98|4.98|||
4126374|NCT00915772|3951247|B3|||Body Mass Index (BMI) continuous||kg/m2|Mean|28.64|28.64|Standard Deviation|4.79|4.79|||
4126375|NCT00915772|3951248|B2|||Body Mass Index (BMI) continuous||kg/m2|Mean|29.06|29.06|Standard Deviation|4.95|4.95|||
4126376|NCT00915772|3951249|B1|||Body Mass Index (BMI) continuous||kg/m2|Mean|29.33|29.33|Standard Deviation|5.22|5.22|||
4126377|NCT00915772|3951246|B4||Male|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
4126378|NCT00915772|3951247|B3||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4126379|NCT00915772|3951248|B2||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4126380|NCT00915772|3951249|B1||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4126381|NCT00915772|3951246|B4||Female|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
4126382|NCT00915772|3951247|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4126383|NCT00915772|3951248|B2||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4126384|NCT00915772|3951249|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4126385|NCT00915772|3951246|B4|||Age||Years|Mean|55.8|55.8|Standard Deviation|10.7|10.7|||
4126386|NCT00915772|3951247|B3|||Age||Years|Mean|55.7|55.7|Standard Deviation|10.8|10.8|||
4126387|NCT00915772|3951248|B2|||Age||Years|Mean|56.0|56.0|Standard Deviation|10.7|10.7|||
4126388|NCT00915772|3951249|B1|||Age||Years|Mean|55.6|55.6|Standard Deviation|10.7|10.7|||
4126389|NCT00915759|3951296|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4126390|NCT00915759|3951296|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4126391|NCT00915759|3951296|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4126392|NCT00915759|3951296|B1|||Age||years|Mean|30.1|30.1|Standard Deviation|6.8|6.8|||
4126393|NCT00915759|3951296|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4126394|NCT00915759|3951296|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4126395|NCT00915759|3951296|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126396|NCT00915655|3951306|B1|||Percentile for Weight||Weight Percentile|Median|51.6|51.6|Full Range|||8.6|79.0|
4126397|NCT00915655|3951306|B1|||Percentile for BMI||BMI Percentile|Median|47.5|47.5|Full Range|||13.3|85.9|
4126398|NCT00915655|3951306|B1|||Percentile for Height||Height Percentile|Median|27.2|27.2|Full Range|||0.5|94.1|
4126399|NCT00915655|3951306|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4126400|NCT00915655|3951306|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4126401|NCT00915655|3951306|B1|||Age||years|Mean|14.7|14.7|Standard Deviation|1.69|1.69|||
4126402|NCT00915603|3951311|B3|United States||Region of Enrollment||participants|Number|113|113.0||||||
4126403|NCT00915603|3951312|B2|United States||Region of Enrollment||participants|Number|56|56.0||||||
4126404|NCT00915603|3951313|B1|United States||Region of Enrollment||participants|Number|57|57.0||||||
4126405|NCT00915603|3951311|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4126406|NCT00915603|3951312|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4126407|NCT00915603|3951313|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4126408|NCT00915603|3951311|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4126409|NCT00915603|3951312|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4126410|NCT00915603|3951313|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4126411|NCT00915603|3951311|B3|||Age||Years|Median|58|58.0|Full Range|||25.0|79.0|
4126412|NCT00915603|3951312|B2|||Age||Years|Median|61|61.0|Full Range|||30.0|77.0|
4126413|NCT00915603|3951313|B1|||Age||Years|Median|57|57.0|Full Range|||25.0|79.0|
4126414|NCT00915590|3951328|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4126415|NCT00915590|3951329|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4126416|NCT00915590|3951330|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4126417|NCT00915590|3951328|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4126418|NCT00915590|3951329|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4126419|NCT00915590|3951330|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4126420|NCT00915590|3951328|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4126421|NCT00915590|3951329|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4126422|NCT00915590|3951330|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4126423|NCT00915590|3951328|B3|||Age||years|Mean|56|56.0|Standard Deviation|22|22.0|||
4126424|NCT00915590|3951329|B2|||Age||years|Mean|66|66.0|Standard Deviation|19|19.0|||
4126425|NCT00915590|3951330|B1|||Age||years|Mean|53|53.0|Standard Deviation|24|24.0|||
4126426|NCT00915590|3951328|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4126427|NCT00915590|3951329|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4126428|NCT00915590|3951330|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4126429|NCT00915590|3951328|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4126430|NCT00915590|3951329|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4126431|NCT00915590|3951330|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4126432|NCT00915590|3951328|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126433|NCT00915590|3951329|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126434|NCT00915590|3951330|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126435|NCT00915551|3951348|B3|Australia||Region of Enrollment||participants|Number|23|23.0||||||
4126436|NCT00915551|3951349|B2|Australia||Region of Enrollment||participants|Number|12|12.0||||||
4126437|NCT00915551|3951350|B1|Australia||Region of Enrollment||participants|Number|11|11.0||||||
4126438|NCT00915551|3951348|B3|United States||Region of Enrollment||participants|Number|255|255.0||||||
4126439|NCT00915551|3951349|B2|United States||Region of Enrollment||participants|Number|124|124.0||||||
4126440|NCT00915551|3951350|B1|United States||Region of Enrollment||participants|Number|131|131.0||||||
4126441|NCT00915551|3951348|B3||Male|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4126442|NCT00915551|3951349|B2||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4126443|NCT00915551|3951350|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4126444|NCT00915551|3951348|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4126445|NCT00915551|3951349|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4126446|NCT00915551|3951350|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4126447|NCT00915551|3951348|B3||>=65 years|Age||Participants|Count of Participants|142|142.0||||||
4126448|NCT00915551|3951349|B2||>=65 years|Age||Participants|Count of Participants|73|73.0||||||
4126449|NCT00915551|3951350|B1||>=65 years|Age||Participants|Count of Participants|69|69.0||||||
4126450|NCT00915551|3951348|B3||Between 18 and 65 years|Age||Participants|Count of Participants|136|136.0||||||
4126451|NCT00915551|3951349|B2||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4126452|NCT00915551|3951350|B1||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4126453|NCT00915551|3951348|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126454|NCT00915551|3951349|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126455|NCT00915551|3951350|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126456|NCT00915525|3951359|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4126457|NCT00915525|3951360|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4126458|NCT00915525|3951361|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4126459|NCT00915525|3951359|B3||Female|Sex: Female, Male||Participants|Count of Participants|749|749.0||||||
4126460|NCT00915525|3951360|B2||Female|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
4126461|NCT00915525|3951361|B1||Female|Sex: Female, Male||Participants|Count of Participants|493|493.0||||||
4126462|NCT00915525|3951359|B3|≥75 years||Age, Customized||Participants|Number|114|114.0||||||
4126463|NCT00915525|3951360|B2|≥75 years||Age, Customized||Participants|Number|42|42.0||||||
4126464|NCT00915525|3951361|B1|≥75 years||Age, Customized||Participants|Number|72|72.0||||||
4126465|NCT00915525|3951359|B3|65 to 74 years||Age, Customized||Participants|Number|230|230.0||||||
4126466|NCT00915525|3951360|B2|65 to 74 years||Age, Customized||Participants|Number|74|74.0||||||
4126467|NCT00915525|3951361|B1|65 to 74 years||Age, Customized||Participants|Number|156|156.0||||||
4126468|NCT00915525|3951359|B3|40 to 64 years||Age, Customized||Participants|Number|423|423.0||||||
4126469|NCT00915525|3951360|B2|40 to 64 years||Age, Customized||Participants|Number|147|147.0||||||
4126470|NCT00915525|3951361|B1|40 to 64 years||Age, Customized||Participants|Number|276|276.0||||||
4126471|NCT00915525|3951359|B3|<40 years||Age, Customized||Participants|Number|62|62.0||||||
4126472|NCT00915525|3951360|B2|<40 years||Age, Customized||Participants|Number|23|23.0||||||
4126473|NCT00915525|3951361|B1|<40 years||Age, Customized||Participants|Number|39|39.0||||||
4126474|NCT00915499|3951463|B3|United States||Region of Enrollment||participants|Number|66|66.0||||||
4126475|NCT00915499|3951464|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4126476|NCT00915499|3951465|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4126477|NCT00915499|3951463|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4126478|NCT00915499|3951464|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4126479|NCT00915499|3951465|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4126480|NCT00915499|3951463|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4126481|NCT00915499|3951464|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4126482|NCT00915499|3951465|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4126483|NCT00915499|3951463|B3|||Age||years|Mean|59.2|59.2|Standard Deviation|12.9|12.9|||
4126484|NCT00915499|3951464|B2|||Age||years|Mean|59.4|59.4|Standard Deviation|11.7|11.7|||
4126485|NCT00915499|3951465|B1|||Age||years|Mean|59.1|59.1|Standard Deviation|14.2|14.2|||
4126486|NCT00915499|3951463|B3||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4126487|NCT00915499|3951464|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4126488|NCT00915499|3951465|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4126489|NCT00915499|3951463|B3||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4126490|NCT00915499|3951464|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4126491|NCT00915499|3951465|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4126492|NCT00915499|3951463|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126493|NCT00915499|3951464|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126494|NCT00915499|3951465|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126495|NCT00915473|3951474|B3|United States||Region of Enrollment||participants|Number|70|70.0||||||
4126496|NCT00915473|3951475|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
4126497|NCT00915473|3951476|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4126498|NCT00915473|3951474|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4126499|NCT00915473|3951475|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4126500|NCT00915473|3951476|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4126501|NCT00915473|3951474|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4126502|NCT00915473|3951475|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4126503|NCT00915473|3951476|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4126504|NCT00915473|3951474|B3|||Age||years|Mean|43|43.0|Standard Deviation|14|14.0|||
4126505|NCT00915473|3951475|B2|||Age||years|Mean|43|43.0|Standard Deviation|15|15.0|||
4126506|NCT00915473|3951476|B1|||Age||years|Mean|44|44.0|Standard Deviation|11|11.0|||
4126507|NCT00915356|3951489|B6||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4126508|NCT00915356|3951490|B5||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4126509|NCT00915356|3951491|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4126510|NCT00915356|3951492|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4126511|NCT00915356|3951493|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4126512|NCT00915356|3951494|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4126513|NCT00915356|3951489|B6||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4126514|NCT00915356|3951490|B5||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4126515|NCT00915356|3951491|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4126516|NCT00915356|3951492|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4126517|NCT00915356|3951493|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4126518|NCT00915356|3951494|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4126519|NCT00915356|3951489|B6|Age (years)||Age||Years|Mean|65|65.0|Standard Deviation|8|8.0|||
4126520|NCT00915356|3951490|B5|Age (years)||Age||Years|Mean|66|66.0|Standard Deviation|9|9.0|||
4126521|NCT00915356|3951491|B4|Age (years)||Age||Years|Mean|66|66.0|Standard Deviation|7|7.0|||
4126522|NCT00915356|3951492|B3|Age (years)||Age||Years|Mean|64|64.0|Standard Deviation|10|10.0|||
4126523|NCT00915356|3951493|B2|Age (years)||Age||Years|Mean|65|65.0|Standard Deviation|7|7.0|||
4126524|NCT00915356|3951494|B1|Age (years)||Age||Years|Mean|65|65.0|Standard Deviation|9|9.0|||
4126525|NCT00915343|3951560|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4126526|NCT00915343|3951560|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4126527|NCT00915343|3951560|B1|||Age||years|Mean|47.3|47.3|Standard Deviation|13.7|13.7|||
4126528|NCT00915278|3951641|B7||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4126529|NCT00915278|3951642|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4126530|NCT00915278|3951643|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4126531|NCT00915278|3951644|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4126532|NCT00915278|3951645|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4126533|NCT00915278|3951646|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4126534|NCT00915278|3951647|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4126535|NCT00915278|3951641|B7||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4126536|NCT00915278|3951642|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4126537|NCT00915278|3951643|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4126538|NCT00915278|3951644|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4126539|NCT00915278|3951645|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4126540|NCT00915278|3951646|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4126541|NCT00915278|3951647|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4126542|NCT00915278|3951641|B7|||Age||Years|Mean|56.4|56.4|Standard Deviation|10.9|10.9|||
4126543|NCT00915278|3951642|B6|||Age||Years|Mean|59.3|59.3|Standard Deviation|13.6|13.6|||
4126544|NCT00915278|3951643|B5|||Age||Years|Mean|60.7|60.7|Standard Deviation|12.5|12.5|||
4126545|NCT00915278|3951644|B4|||Age||Years|Mean|51.8|51.8|Standard Deviation|7.2|7.2|||
4126546|NCT00915278|3951645|B3|||Age||Years|Mean|61.3|61.3|Standard Deviation|5.5|5.5|||
4126547|NCT00915278|3951646|B2|||Age||Years|Mean|54.2|54.2|Standard Deviation|12.2|12.2|||
4126548|NCT00915278|3951647|B1|||Age||Years|Mean|54|54.0|Standard Deviation|10.3|10.3|||
4126549|NCT00915148|3951798|B1|Norway||Region of Enrollment||participants|Number|110|110.0||||||
4126550|NCT00915148|3951798|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4126551|NCT00915148|3951798|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4126552|NCT00915148|3951798|B1|||Age||years|Median|29|29.0|Full Range|||18.0|41.0|
4126553|NCT00915148|3951798|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4126554|NCT00915148|3951798|B1||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
4126555|NCT00915148|3951798|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126556|NCT00915018|3951803|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4126557|NCT00915018|3951804|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4126558|NCT00915018|3951805|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4126559|NCT00915018|3951803|B3||Female|Sex: Female, Male||Participants|Count of Participants|479|479.0||||||
4126560|NCT00915018|3951804|B2||Female|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
4126561|NCT00915018|3951805|B1||Female|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
4126562|NCT00915018|3951803|B3|||Age||years|Mean|54.1|54.1|Standard Deviation|11.3|11.3|||
4126563|NCT00915018|3951804|B2|||Age||years|Mean|54.3|54.3|Standard Deviation|11.0|11.0|||
4126564|NCT00915018|3951805|B1|||Age||years|Mean|54.0|54.0|Standard Deviation|11.6|11.6|||
4126565|NCT00915018|3951803|B3||>=65 years|Age||Participants|Count of Participants|87|87.0||||||
4126566|NCT00915018|3951804|B2||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
4126567|NCT00915018|3951805|B1||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
4126568|NCT00915018|3951803|B3||Between 18 and 65 years|Age||Participants|Count of Participants|392|392.0||||||
4126569|NCT00915018|3951804|B2||Between 18 and 65 years|Age||Participants|Count of Participants|193|193.0||||||
4126570|NCT00915018|3951805|B1||Between 18 and 65 years|Age||Participants|Count of Participants|199|199.0||||||
4126571|NCT00915018|3951803|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126572|NCT00915018|3951804|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126573|NCT00915018|3951805|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126574|NCT00914966|3951820|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4126575|NCT00914966|3951820|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4126576|NCT00914966|3951820|B1|||Age||years|Mean|41.7|41.7|Standard Deviation|15.28|15.28|||
4126577|NCT00914927|3951832|B8||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4126578|NCT00914927|3951833|B7||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4126579|NCT00914927|3951834|B6||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4126580|NCT00914927|3951835|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4126581|NCT00914927|3951836|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4126582|NCT00914927|3951837|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4126583|NCT00914927|3951838|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4126584|NCT00914927|3951839|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4126585|NCT00914927|3951832|B8||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4126586|NCT00914927|3951833|B7||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4126587|NCT00914927|3951834|B6||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4126588|NCT00914927|3951835|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4126589|NCT00914927|3951836|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4126590|NCT00914927|3951837|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4126591|NCT00914927|3951838|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4126592|NCT00914927|3951839|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4126593|NCT00914927|3951832|B8|||Age||Years|Mean|54.8|54.8|Standard Deviation|6.56|6.56|||
4126594|NCT00914927|3951833|B7|||Age||Years|Mean|55.6|55.6|Standard Deviation|6.52|6.52|||
4126595|NCT00914927|3951834|B6|||Age||Years|Mean|56.8|56.8|Standard Deviation|6.46|6.46|||
4126596|NCT00914927|3951835|B5|||Age||Years|Mean|53.9|53.9|Standard Deviation|5.48|5.48|||
4126597|NCT00914927|3951836|B4|||Age||Years|Mean|54.2|54.2|Standard Deviation|6.87|6.87|||
4126598|NCT00914927|3951837|B3|||Age||Years|Mean|55.2|55.2|Standard Deviation|5.96|5.96|||
4126599|NCT00914927|3951838|B2|||Age||Years|Mean|52.8|52.8|Standard Deviation|7.78|7.78|||
4126600|NCT00914927|3951839|B1|||Age||Years|Mean|55.3|55.3|Standard Deviation|7.16|7.16|||
4126601|NCT00914862|3951889|B6|||Body Mass Index (BMI)||kg/m^2|Mean|22.6|22.6|Standard Deviation|4.29|4.29|||
4126602|NCT00914862|3951890|B5|||Body Mass Index (BMI)||kg/m^2|Mean|25.1|25.1|Standard Deviation|3.05|3.05|||
4126603|NCT00914862|3951891|B4|||Body Mass Index (BMI)||kg/m^2|Mean|22.9|22.9|Standard Deviation|2.94|2.94|||
4126604|NCT00914862|3951892|B3|||Body Mass Index (BMI)||kg/m^2|Mean|21.7|21.7|Standard Deviation|2.53|2.53|||
4126605|NCT00914862|3951893|B2|||Body Mass Index (BMI)||kg/m^2|Mean|17.6|17.6|Standard Deviation|3.75|3.75|||
4126606|NCT00914862|3951894|B1|||Body Mass Index (BMI)||kg/m^2|Mean|16.5|16.5|Standard Deviation|2.19|2.19|||
4126607|NCT00914862|3951889|B6|||Height||cm|Mean|164|164.0|Standard Deviation|19.5|19.5|||
4126608|NCT00914862|3951890|B5|||Height||cm|Mean|174|174.0|Standard Deviation|11.7|11.7|||
4126609|NCT00914862|3951891|B4|||Height||cm|Mean|170|170.0|Standard Deviation|12.8|12.8|||
4126610|NCT00914862|3951892|B3|||Height||cm|Mean|168|168.0|Standard Deviation|11.2|11.2|||
4126611|NCT00914862|3951893|B2|||Height||cm|Mean|141|141.0|Standard Deviation|11.9|11.9|||
4126612|NCT00914862|3951894|B1|||Height||cm|Mean|128|128.0|Standard Deviation|11.8|11.8|||
4126613|NCT00914862|3951889|B6|||Weight||kg|Mean|63.6|63.6|Standard Deviation|21.40|21.4|||
4126614|NCT00914862|3951890|B5|||Weight||kg|Mean|76.8|76.8|Standard Deviation|13.85|13.85|||
4126615|NCT00914862|3951891|B4|||Weight||kg|Mean|66.4|66.4|Standard Deviation|12.99|12.99|||
4126616|NCT00914862|3951892|B3|||Weight||kg|Mean|61.4|61.4|Standard Deviation|11.14|11.14|||
4126617|NCT00914862|3951893|B2|||Weight||kg|Mean|36.6|36.6|Standard Deviation|12.24|12.24|||
4126618|NCT00914862|3951894|B1|||Weight||kg|Mean|28.1|28.1|Standard Deviation|7.40|7.4|||
4126619|NCT00914862|3951889|B6|United States||Region of Enrollment||participants|Number|56|56.0||||||
4126620|NCT00914862|3951890|B5|United States||Region of Enrollment||participants|Number|28|28.0||||||
4126621|NCT00914862|3951891|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
4126622|NCT00914862|3951892|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4126623|NCT00914862|3951893|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4126624|NCT00914862|3951894|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4126625|NCT00914862|3951889|B6|Multiracial||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4126626|NCT00914862|3951890|B5|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4126627|NCT00914862|3951891|B4|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4126628|NCT00914862|3951892|B3|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4126629|NCT00914862|3951893|B2|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4126630|NCT00914862|3951894|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4126631|NCT00914862|3951889|B6|White||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4126632|NCT00914862|3951890|B5|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4126633|NCT00914862|3951891|B4|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4126634|NCT00914862|3951892|B3|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4126635|NCT00914862|3951893|B2|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4126636|NCT00914862|3951894|B1|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4126637|NCT00914862|3951889|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4126638|NCT00914862|3951890|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4126639|NCT00914862|3951891|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4126640|NCT00914862|3951892|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4126641|NCT00914862|3951893|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4126642|NCT00914862|3951894|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4126643|NCT00914862|3951889|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4126644|NCT00914862|3951890|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4126645|NCT00914862|3951891|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4126646|NCT00914862|3951892|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4126647|NCT00914862|3951893|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4126648|NCT00914862|3951894|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4126649|NCT00914862|3951889|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4126650|NCT00914862|3951890|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4126651|NCT00914862|3951891|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4126652|NCT00914862|3951892|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4126653|NCT00914862|3951893|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4126654|NCT00914862|3951894|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4126655|NCT00914862|3951889|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4126656|NCT00914862|3951890|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4126657|NCT00914862|3951891|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4126658|NCT00914862|3951892|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4126659|NCT00914862|3951893|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4126660|NCT00914862|3951894|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4126661|NCT00914862|3951889|B6||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4126662|NCT00914862|3951890|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4126663|NCT00914862|3951891|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4126664|NCT00914862|3951892|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4126665|NCT00914862|3951893|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4126666|NCT00914862|3951894|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4126667|NCT00914862|3951889|B6||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4126668|NCT00914862|3951890|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4126669|NCT00914862|3951891|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4126670|NCT00914862|3951892|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4126671|NCT00914862|3951893|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4126672|NCT00914862|3951894|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4126673|NCT00914862|3951889|B6|||Age||years|Mean|21.7|21.7|Standard Deviation|12.00|12.0|||
4126674|NCT00914862|3951890|B5|||Age||years|Mean|30.9|30.9|Standard Deviation|10.17|10.17|||
4126675|NCT00914862|3951891|B4|||Age||years|Mean|15.5|15.5|Standard Deviation|1.93|1.93|||
4126676|NCT00914862|3951892|B3|||Age||years|Mean|15.8|15.8|Standard Deviation|1.67|1.67|||
4126677|NCT00914862|3951893|B2|||Age||years|Mean|9.2|9.2|Standard Deviation|1.47|1.47|||
4126678|NCT00914862|3951894|B1|||Age||years|Mean|7.8|7.8|Standard Deviation|1.72|1.72|||
4126679|NCT00914849|3951970|B3|United States||Region of Enrollment||participants|Number|67|67.0||||||
4126680|NCT00914849|3951971|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4126681|NCT00914849|3951972|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4126682|NCT00914849|3951970|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4126683|NCT00914849|3951971|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4126684|NCT00914849|3951972|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4126685|NCT00914849|3951970|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4126686|NCT00914849|3951971|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4126687|NCT00914849|3951972|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4126688|NCT00914849|3951970|B3|||Age||years|Median|52|52.0|Full Range|||25.0|68.0|
4126689|NCT00914849|3951971|B2|||Age||years|Median|54|54.0|Full Range|||25.0|68.0|
4126690|NCT00914849|3951972|B1|||Age||years|Median|50|50.0|Full Range|||28.0|65.0|
4126691|NCT00914810|3952005|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
4126692|NCT00914810|3952006|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4126693|NCT00914810|3952007|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4126694|NCT00914810|3952005|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4126695|NCT00914810|3952006|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4126696|NCT00914810|3952007|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4126697|NCT00914810|3952005|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4126698|NCT00914810|3952006|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4126699|NCT00914810|3952007|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4126700|NCT00914810|3952005|B3|Age||Age||years|Mean|68|68.0|Standard Deviation|8|8.0|||
4126701|NCT00914810|3952006|B2|Age||Age||years|Mean|67.6|67.6|Standard Deviation|7|7.0|||
4126702|NCT00914810|3952007|B1|Age||Age||years|Mean|68|68.0|Standard Deviation|8|8.0|||
4126703|NCT00914589|3952016|B4||Male|Sex: Female, Male||Participants|Count of Participants|336|336.0||||||
4126704|NCT00914589|3952017|B3||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4126705|NCT00914589|3952018|B2||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4126706|NCT00914589|3952019|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4126707|NCT00914589|3952016|B4||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4126708|NCT00914589|3952017|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4126709|NCT00914589|3952018|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4126710|NCT00914589|3952019|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4126711|NCT00914589|3952016|B4|||Age||years|Mean|68.8|68.8|Standard Deviation|8.4|8.4|||
4126712|NCT00914589|3952017|B3|||Age||years|Mean|69.0|69.0|Standard Deviation|7.9|7.9|||
4126713|NCT00914589|3952018|B2|||Age||years|Mean|68.7|68.7|Standard Deviation|9.0|9.0|||
4126714|NCT00914589|3952019|B1|||Age||years|Mean|68.8|68.8|Standard Deviation|8.4|8.4|||
4126715|NCT00914485|3952041|B1|Other Race/Ethnicity||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4126716|NCT00914485|3952041|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4126717|NCT00914485|3952041|B1|White||Race/Ethnicity, Customized||participants|Number|129|129.0||||||
4126718|NCT00914485|3952041|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|207|207.0||||||
4126719|NCT00914485|3952041|B1||Male|Sex: Female, Male||Participants|Count of Participants|338|338.0||||||
4126720|NCT00914485|3952041|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4126721|NCT00914485|3952041|B1||>=65 years|Age||Participants|Count of Participants|114|114.0||||||
4126722|NCT00914485|3952041|B1||Between 18 and 65 years|Age||Participants|Count of Participants|255|255.0||||||
4126723|NCT00914485|3952041|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126724|NCT00914459|3952045|B3||Male|Gender||Participants|Count of Participants|37|37.0||||||
4126725|NCT00914459|3952046|B2||Male|Gender||Participants|Count of Participants|19|19.0||||||
4126726|NCT00914459|3952047|B1||Male|Gender||Participants|Count of Participants|18|18.0||||||
4126727|NCT00914459|3952045|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
4126728|NCT00914459|3952046|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
4126729|NCT00914459|3952047|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
4126730|NCT00914459|3952045|B3|||Age||years|Mean|6.5|6.5|Standard Deviation|3.20|3.2|||
4126731|NCT00914459|3952046|B2|||Age||years|Mean|9.2|9.2|Standard Deviation|1.47|1.47|||
4126732|NCT00914459|3952047|B1|||Age||years|Mean|3.6|3.6|Standard Deviation|1.42|1.42|||
4126733|NCT00914316|3952074|B5|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4126734|NCT00914316|3952075|B4|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4126735|NCT00914316|3952076|B3|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4126736|NCT00914316|3952077|B2|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4126737|NCT00914316|3952078|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4126738|NCT00914316|3952074|B5||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4126739|NCT00914316|3952075|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4126740|NCT00914316|3952076|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4126741|NCT00914316|3952077|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4126742|NCT00914316|3952078|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4126743|NCT00914316|3952074|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4126744|NCT00914316|3952075|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4126745|NCT00914316|3952076|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4126746|NCT00914316|3952077|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4126747|NCT00914316|3952078|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4126748|NCT00914316|3952074|B5|||Age||years|Mean|70.1|70.1|Standard Deviation|11.3|11.3|||
4126749|NCT00914316|3952075|B4|||Age||years|Mean|65.8|65.8|Standard Deviation|14.9|14.9|||
4126750|NCT00914316|3952076|B3|||Age||years|Mean|77.0|77.0|Standard Deviation|10.5|10.5|||
4126751|NCT00914316|3952077|B2|||Age||years|Mean|69.7|69.7|Standard Deviation|6.9|6.9|||
4126752|NCT00914316|3952078|B1|||Age||years|Mean|69.0|69.0|Standard Deviation|3.6|3.6|||
4126753|NCT00914316|3952074|B5||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4126754|NCT00914316|3952075|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4126755|NCT00914316|3952076|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4126756|NCT00914316|3952077|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4126757|NCT00914316|3952078|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4126758|NCT00914316|3952074|B5||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4126759|NCT00914316|3952075|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4126760|NCT00914316|3952076|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4126761|NCT00914316|3952077|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4126762|NCT00914316|3952078|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4126763|NCT00914316|3952074|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126764|NCT00914316|3952075|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126765|NCT00914316|3952076|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126766|NCT00914316|3952077|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126767|NCT00914316|3952078|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126768|NCT00914186|3952095|B5|United States||Region of Enrollment||participants|Number|122|122.0||||||
4126769|NCT00914186|3952096|B4|United States||Region of Enrollment||participants|Number|30|30.0||||||
4126770|NCT00914186|3952097|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4126771|NCT00914186|3952098|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4126772|NCT00914186|3952099|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4126773|NCT00914186|3952095|B5||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4126774|NCT00914186|3952096|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4126775|NCT00914186|3952097|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4126776|NCT00914186|3952098|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4126777|NCT00914186|3952099|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4126778|NCT00914186|3952095|B5||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4126779|NCT00914186|3952096|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4126780|NCT00914186|3952097|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4126781|NCT00914186|3952098|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4126782|NCT00914186|3952099|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4126783|NCT00914186|3952095|B5|||Age||years|Mean|36.4|36.4|Standard Deviation|13.23|13.23|||
4126784|NCT00914186|3952096|B4|||Age||years|Mean|39.0|39.0|Standard Deviation|13.89|13.89|||
4126785|NCT00914186|3952097|B3|||Age||years|Mean|35.1|35.1|Standard Deviation|13.78|13.78|||
4126786|NCT00914186|3952098|B2|||Age||years|Mean|38.0|38.0|Standard Deviation|11.63|11.63|||
4126787|NCT00914186|3952099|B1|||Age||years|Mean|37.5|37.5|Standard Deviation|13.53|13.53|||
4126788|NCT00914186|3952095|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4126789|NCT00914186|3952096|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4126790|NCT00914186|3952097|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4126791|NCT00914186|3952098|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4126792|NCT00914186|3952099|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4126793|NCT00914186|3952095|B5||Between 18 and 65 years|Age||Participants|Count of Participants|122|122.0||||||
4126794|NCT00914186|3952096|B4||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4126795|NCT00914186|3952097|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4126796|NCT00914186|3952098|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4126797|NCT00914186|3952099|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4126798|NCT00914186|3952095|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126799|NCT00914186|3952096|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126800|NCT00914186|3952097|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126801|NCT00914186|3952098|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126802|NCT00914186|3952099|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126803|NCT00914069|3952134|B3|Other||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4126804|NCT00914069|3952135|B2|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4126805|NCT00914069|3952136|B1|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4126806|NCT00914069|3952134|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4126807|NCT00914069|3952135|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4126808|NCT00914069|3952136|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4126809|NCT00914069|3952134|B3|Asian||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4126810|NCT00914069|3952135|B2|Asian||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4126811|NCT00914069|3952136|B1|Asian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4126812|NCT00914069|3952134|B3|Black||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4126813|NCT00914069|3952135|B2|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4126814|NCT00914069|3952136|B1|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4126815|NCT00914069|3952134|B3|White||Race/Ethnicity, Customized||participants|Number|86|86.0||||||
4126816|NCT00914069|3952135|B2|White||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4126817|NCT00914069|3952136|B1|White||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4126818|NCT00914069|3952134|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4126819|NCT00914069|3952135|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4126820|NCT00914069|3952136|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4126821|NCT00914069|3952134|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4126822|NCT00914069|3952135|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4126823|NCT00914069|3952136|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4126824|NCT00914069|3952134|B3|||Age||years|Mean|66.7|66.7|Standard Deviation|10.2|10.2|||
4126825|NCT00914069|3952135|B2|||Age||years|Mean|67.2|67.2|Standard Deviation|10.9|10.9|||
4126826|NCT00914069|3952136|B1|||Age||years|Mean|66.1|66.1|Standard Deviation|9.4|9.4|||
4126827|NCT00913913|3952151|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4126828|NCT00913913|3952151|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4126829|NCT00913913|3952151|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4126830|NCT00913913|3952151|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4126831|NCT00913913|3952151|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4126832|NCT00913913|3952151|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126833|NCT00913913|3952151|B1|||Age|Age is the mean of the age of the 8 patients at time of consent for study participation.|years|Mean|55|55.0|Full Range|||50.0|70.0|
4126834|NCT00913835|3952158|B3|Platinum Resistant||Stratification Factor|Participants reaction to prior platinum treatment.|Participants|Count of Participants|92|92.0||||||
4126835|NCT00913835|3952159|B2|Platinum Resistant||Stratification Factor|Participants reaction to prior platinum treatment.|Participants|Count of Participants|45|45.0||||||
4126836|NCT00913835|3952160|B1|Platinum Resistant||Stratification Factor|Participants reaction to prior platinum treatment.|Participants|Count of Participants|47|47.0||||||
4126837|NCT00913835|3952158|B3|Platinum Refractory||Stratification Factor|Participants reaction to prior platinum treatment.|Participants|Count of Participants|31|31.0||||||
4126838|NCT00913835|3952159|B2|Platinum Refractory||Stratification Factor|Participants reaction to prior platinum treatment.|Participants|Count of Participants|16|16.0||||||
4126839|NCT00913835|3952160|B1|Platinum Refractory||Stratification Factor|Participants reaction to prior platinum treatment.|Participants|Count of Participants|15|15.0||||||
4126840|NCT00913835|3952158|B3|1-ambulatory, able to do light/sedentary nature||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG PS classified participants according to their functional impairment.|Participants|Count of Participants|55|55.0||||||
4126841|NCT00913835|3952159|B2|1-ambulatory, able to do light/sedentary nature||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG PS classified participants according to their functional impairment.|Participants|Count of Participants|30|30.0||||||
4126842|NCT00913835|3952160|B1|1-ambulatory, able to do light/sedentary nature||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG PS classified participants according to their functional impairment.|Participants|Count of Participants|25|25.0||||||
4126843|NCT00913835|3952158|B3|0-Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG PS classified participants according to their functional impairment.|Participants|Count of Participants|68|68.0||||||
4126844|NCT00913835|3952159|B2|0-Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG PS classified participants according to their functional impairment.|Participants|Count of Participants|31|31.0||||||
4126845|NCT00913835|3952160|B1|0-Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG PS classified participants according to their functional impairment.|Participants|Count of Participants|37|37.0||||||
4126846|NCT00913835|3952158|B3|Spain||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4126847|NCT00913835|3952159|B2|Spain||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4126848|NCT00913835|3952160|B1|Spain||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4126849|NCT00913835|3952158|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
4126850|NCT00913835|3952159|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4126851|NCT00913835|3952160|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
4126852|NCT00913835|3952158|B3|United States||Region of Enrollment||Participants|Count of Participants|73|73.0||||||
4126853|NCT00913835|3952159|B2|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
4126854|NCT00913835|3952160|B1|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
4126855|NCT00913835|3952158|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4126856|NCT00913835|3952159|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4126857|NCT00913835|3952160|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4126858|NCT00913835|3952158|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|108|108.0||||||
4126859|NCT00913835|3952159|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|54|54.0||||||
4126860|NCT00913835|3952160|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|54|54.0||||||
4126861|NCT00913835|3952158|B3|Native Hawaiian of Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4126862|NCT00913835|3952159|B2|Native Hawaiian of Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4126863|NCT00913835|3952160|B1|Native Hawaiian of Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4126864|NCT00913835|3952158|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4126865|NCT00913835|3952159|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4126866|NCT00913835|3952160|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4126867|NCT00913835|3952158|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4126868|NCT00913835|3952159|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4126869|NCT00913835|3952160|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4126870|NCT00913835|3952158|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4126871|NCT00913835|3952159|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4126872|NCT00913835|3952160|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4126873|NCT00913835|3952158|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
4126874|NCT00913835|3952159|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4126875|NCT00913835|3952160|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4126876|NCT00913835|3952158|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4126877|NCT00913835|3952159|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4126878|NCT00913835|3952160|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4126879|NCT00913835|3952158|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4126880|NCT00913835|3952159|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4126881|NCT00913835|3952160|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4126882|NCT00913835|3952158|B3||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4126883|NCT00913835|3952159|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4126884|NCT00913835|3952160|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4126885|NCT00913835|3952158|B3|||Age||years|Mean|59.3|59.3|Standard Deviation|9.86|9.86|||
4126886|NCT00913835|3952159|B2|||Age||years|Mean|59.8|59.8|Standard Deviation|9.70|9.7|||
4126887|NCT00913835|3952160|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|10.07|10.07|||
4126888|NCT00913770|3952197|B4||Male|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4126889|NCT00913770|3952198|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4126890|NCT00913770|3952199|B2||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4126891|NCT00913770|3952200|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4126892|NCT00913770|3952197|B4||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4126893|NCT00913770|3952198|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4126894|NCT00913770|3952199|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4126895|NCT00913770|3952200|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4126896|NCT00913770|3952197|B4|||Age||years|Mean|31.4|31.4|Standard Deviation|10.6|10.6|||
4126897|NCT00913770|3952198|B3|||Age||years|Mean|31|31.0|Standard Deviation|9.8|9.8|||
4126898|NCT00913770|3952199|B2|||Age||years|Mean|31.9|31.9|Standard Deviation|9.7|9.7|||
4126899|NCT00913770|3952200|B1|||Age||years|Mean|31.4|31.4|Standard Deviation|10.6|10.6|||
4126900|NCT00913744|3952213|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4126901|NCT00913744|3952214|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4126902|NCT00913744|3952215|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4126903|NCT00913744|3952213|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4126904|NCT00913744|3952214|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4126905|NCT00913744|3952215|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4126906|NCT00913744|3952213|B3|||Age||years|Mean|74.6|74.6|Standard Deviation|7.86|7.86|||
4126907|NCT00913744|3952214|B2|||Age||years|Mean|74.7|74.7|Standard Deviation|7.16|7.16|||
4126908|NCT00913744|3952215|B1|||Age||years|Mean|74.5|74.5|Standard Deviation|8.13|8.13|||
4126909|NCT00913692|3952222|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4126910|NCT00913692|3952222|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4126911|NCT00913692|3952222|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4126912|NCT00913692|3952222|B1|||Age||years|Mean|38|38.0|Standard Deviation|10.97|10.97|||
4126913|NCT00913692|3952222|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4126914|NCT00913692|3952222|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4126915|NCT00913692|3952222|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4126916|NCT00913627|3952232|B5|||Pain intensity|"Visual Analogue Scale (VAS) rated baseline pain intensity. Participants asked to Draw a single vertical line on the scale that shows how much pain you have at this time. Scores measured to nearest millimeter (mm), ranged from 0 to 100 mm. Minimum 50 mm score required to verify participant had at least moderate pain at baseline."|mm|Mean|75.37|75.37|Standard Deviation|12.44|12.44|||
4126948|NCT00913523|3952315|B2|2 to 34 Years, inclusive||Years of Tampon Use||Participants|Number|158|158.0||||||
4126949|NCT00913523|3952316|B1|2 to 34 Years, inclusive||Years of Tampon Use||Participants|Number|161|161.0||||||
4126950|NCT00913523|3952313|B4|1 Year||Years of Tampon Use||Participants|Number|2|2.0||||||
4126917|NCT00913627|3952233|B4|||Pain intensity|"Visual Analogue Scale (VAS) rated baseline pain intensity. Participants asked to Draw a single vertical line on the scale that shows how much pain you have at this time. Scores measured to nearest millimeter (mm), ranged from 0 to 100 mm. Minimum 50 mm score required to verify participant had at least moderate pain at baseline."|mm|Mean|75.12|75.12|Standard Deviation|12.30|12.3|||
4126918|NCT00913627|3952234|B3|||Pain intensity|"Visual Analogue Scale (VAS) rated baseline pain intensity. Participants asked to Draw a single vertical line on the scale that shows how much pain you have at this time. Scores measured to nearest millimeter (mm), ranged from 0 to 100 mm. Minimum 50 mm score required to verify participant had at least moderate pain at baseline."|mm|Mean|74.80|74.8|Standard Deviation|12.40|12.4|||
4126919|NCT00913627|3952235|B2|||Pain intensity|"Visual Analogue Scale (VAS) rated baseline pain intensity. Participants asked to Draw a single vertical line on the scale that shows how much pain you have at this time. Scores measured to nearest millimeter (mm), ranged from 0 to 100 mm. Minimum 50 mm score required to verify participant had at least moderate pain at baseline."|mm|Mean|77.06|77.06|Standard Deviation|13.23|13.23|||
4126920|NCT00913627|3952236|B1|||Pain intensity|"Visual Analogue Scale (VAS) rated baseline pain intensity. Participants asked to Draw a single vertical line on the scale that shows how much pain you have at this time. Scores measured to nearest millimeter (mm), ranged from 0 to 100 mm. Minimum 50 mm score required to verify participant had at least moderate pain at baseline."|mm|Mean|73.90|73.9|Standard Deviation|11.60|11.6|||
4126921|NCT00913627|3952232|B5|Severe||Pain severity|"A 4-point categorical pain intensity rating scale was used to rate the severity of baseline pain in response to the query,  My starting pain is: Range of scale: None, Mild, Moderate, Severe. A baseline pain intensity score of at least moderate was required for study enrollment."|participants|Number|82|82.0||||||
4126922|NCT00913627|3952233|B4|Severe||Pain severity|"A 4-point categorical pain intensity rating scale was used to rate the severity of baseline pain in response to the query,  My starting pain is: Range of scale: None, Mild, Moderate, Severe. A baseline pain intensity score of at least moderate was required for study enrollment."|participants|Number|24|24.0||||||
4126923|NCT00913627|3952234|B3|Severe||Pain severity|"A 4-point categorical pain intensity rating scale was used to rate the severity of baseline pain in response to the query,  My starting pain is: Range of scale: None, Mild, Moderate, Severe. A baseline pain intensity score of at least moderate was required for study enrollment."|participants|Number|23|23.0||||||
4126924|NCT00913627|3952235|B2|Severe||Pain severity|"A 4-point categorical pain intensity rating scale was used to rate the severity of baseline pain in response to the query,  My starting pain is: Range of scale: None, Mild, Moderate, Severe. A baseline pain intensity score of at least moderate was required for study enrollment."|participants|Number|24|24.0||||||
4126925|NCT00913627|3952236|B1|Severe||Pain severity|"A 4-point categorical pain intensity rating scale was used to rate the severity of baseline pain in response to the query,  My starting pain is: Range of scale: None, Mild, Moderate, Severe. A baseline pain intensity score of at least moderate was required for study enrollment."|participants|Number|11|11.0||||||
4126926|NCT00913627|3952232|B5|Moderate||Pain severity|"A 4-point categorical pain intensity rating scale was used to rate the severity of baseline pain in response to the query,  My starting pain is: Range of scale: None, Mild, Moderate, Severe. A baseline pain intensity score of at least moderate was required for study enrollment."|participants|Number|114|114.0||||||
4126927|NCT00913627|3952233|B4|Moderate||Pain severity|"A 4-point categorical pain intensity rating scale was used to rate the severity of baseline pain in response to the query,  My starting pain is: Range of scale: None, Mild, Moderate, Severe. A baseline pain intensity score of at least moderate was required for study enrollment."|participants|Number|34|34.0||||||
4126928|NCT00913627|3952234|B3|Moderate||Pain severity|"A 4-point categorical pain intensity rating scale was used to rate the severity of baseline pain in response to the query,  My starting pain is: Range of scale: None, Mild, Moderate, Severe. A baseline pain intensity score of at least moderate was required for study enrollment."|participants|Number|33|33.0||||||
4126929|NCT00913627|3952235|B2|Moderate||Pain severity|"A 4-point categorical pain intensity rating scale was used to rate the severity of baseline pain in response to the query,  My starting pain is: Range of scale: None, Mild, Moderate, Severe. A baseline pain intensity score of at least moderate was required for study enrollment."|participants|Number|29|29.0||||||
4126930|NCT00913627|3952236|B1|Moderate||Pain severity|"A 4-point categorical pain intensity rating scale was used to rate the severity of baseline pain in response to the query,  My starting pain is: Range of scale: None, Mild, Moderate, Severe. A baseline pain intensity score of at least moderate was required for study enrollment."|participants|Number|18|18.0||||||
4126931|NCT00913627|3952232|B5||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4126932|NCT00913627|3952233|B4||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4126933|NCT00913627|3952234|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4126934|NCT00913627|3952235|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4126935|NCT00913627|3952236|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4126936|NCT00913627|3952232|B5||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4126937|NCT00913627|3952233|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4126938|NCT00913627|3952234|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4126939|NCT00913627|3952235|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4126940|NCT00913627|3952236|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4126941|NCT00913627|3952232|B5|||Age||years|Mean|18.5|18.5|Standard Deviation|2.5|2.5|||
4126942|NCT00913627|3952233|B4|||Age||years|Mean|18.3|18.3|Standard Deviation|2.6|2.6|||
4126943|NCT00913627|3952234|B3|||Age||years|Mean|18.7|18.7|Standard Deviation|2.7|2.7|||
4126944|NCT00913627|3952235|B2|||Age||years|Mean|18.6|18.6|Standard Deviation|2.4|2.4|||
4126945|NCT00913627|3952236|B1|||Age||years|Mean|18.1|18.1|Standard Deviation|2.1|2.1|||
4126946|NCT00913523|3952313|B4|2 to 34 Years, inclusive||Years of Tampon Use||Participants|Number|479|479.0||||||
4126947|NCT00913523|3952314|B3|2 to 34 Years, inclusive||Years of Tampon Use||Participants|Number|160|160.0||||||
4126951|NCT00913523|3952314|B3|1 Year||Years of Tampon Use||Participants|Number|0|0.0||||||
4126952|NCT00913523|3952315|B2|1 Year||Years of Tampon Use||Participants|Number|1|1.0||||||
4126953|NCT00913523|3952316|B1|1 Year||Years of Tampon Use||Participants|Number|1|1.0||||||
4126954|NCT00913523|3952313|B4|Less than 1 Year||Years of Tampon Use||Participants|Number|1|1.0||||||
4126955|NCT00913523|3952314|B3|Less than 1 Year||Years of Tampon Use||Participants|Number|1|1.0||||||
4126956|NCT00913523|3952315|B2|Less than 1 Year||Years of Tampon Use||Participants|Number|0|0.0||||||
4126957|NCT00913523|3952316|B1|Less than 1 Year||Years of Tampon Use||Participants|Number|0|0.0||||||
4126958|NCT00913523|3952313|B4|||Number of Pregnancies Less than 14||Participants|Number|482|482.0||||||
4126959|NCT00913523|3952314|B3|||Number of Pregnancies Less than 14||Participants|Number|161|161.0||||||
4126960|NCT00913523|3952315|B2|||Number of Pregnancies Less than 14||Participants|Number|159|159.0||||||
4126961|NCT00913523|3952316|B1|||Number of Pregnancies Less than 14||Participants|Number|162|162.0||||||
4126962|NCT00913523|3952313|B4|More than 10 Days||Average Flow 3-10 Days, inclusive|Average Days of Flow in the past 4-6 months|Participants|Number|0|0.0||||||
4126963|NCT00913523|3952314|B3|More than 10 Days||Average Flow 3-10 Days, inclusive|Average Days of Flow in the past 4-6 months|Participants|Number|0|0.0||||||
4126964|NCT00913523|3952315|B2|More than 10 Days||Average Flow 3-10 Days, inclusive|Average Days of Flow in the past 4-6 months|Participants|Number|0|0.0||||||
4126965|NCT00913523|3952316|B1|More than 10 Days||Average Flow 3-10 Days, inclusive|Average Days of Flow in the past 4-6 months|Participants|Number|0|0.0||||||
4126966|NCT00913523|3952313|B4|3 to 10 Days, inclusive||Average Flow 3-10 Days, inclusive|Average Days of Flow in the past 4-6 months|Participants|Number|482|482.0||||||
4126967|NCT00913523|3952314|B3|3 to 10 Days, inclusive||Average Flow 3-10 Days, inclusive|Average Days of Flow in the past 4-6 months|Participants|Number|161|161.0||||||
4126968|NCT00913523|3952315|B2|3 to 10 Days, inclusive||Average Flow 3-10 Days, inclusive|Average Days of Flow in the past 4-6 months|Participants|Number|159|159.0||||||
4126969|NCT00913523|3952316|B1|3 to 10 Days, inclusive||Average Flow 3-10 Days, inclusive|Average Days of Flow in the past 4-6 months|Participants|Number|162|162.0||||||
4126970|NCT00913523|3952313|B4|Less than 3 Days||Average Flow 3-10 Days, inclusive|Average Days of Flow in the past 4-6 months|Participants|Number|0|0.0||||||
4126971|NCT00913523|3952314|B3|Less than 3 Days||Average Flow 3-10 Days, inclusive|Average Days of Flow in the past 4-6 months|Participants|Number|0|0.0||||||
4126972|NCT00913523|3952315|B2|Less than 3 Days||Average Flow 3-10 Days, inclusive|Average Days of Flow in the past 4-6 months|Participants|Number|0|0.0||||||
4126973|NCT00913523|3952316|B1|Less than 3 Days||Average Flow 3-10 Days, inclusive|Average Days of Flow in the past 4-6 months|Participants|Number|0|0.0||||||
4126974|NCT00913523|3952313|B4|||Average Cycle 17-35 Days, inclusive|Average Days per Cycle in the past 4-6 months|Participants|Number|482|482.0||||||
4126975|NCT00913523|3952314|B3|||Average Cycle 17-35 Days, inclusive|Average Days per Cycle in the past 4-6 months|Participants|Number|161|161.0||||||
4126976|NCT00913523|3952315|B2|||Average Cycle 17-35 Days, inclusive|Average Days per Cycle in the past 4-6 months|Participants|Number|159|159.0||||||
4126977|NCT00913523|3952316|B1|||Average Cycle 17-35 Days, inclusive|Average Days per Cycle in the past 4-6 months|Participants|Number|162|162.0||||||
4126978|NCT00913523|3952313|B4|||Body Mass Index 15-54, inclusive||Participants|Number|482|482.0||||||
4126979|NCT00913523|3952314|B3|||Body Mass Index 15-54, inclusive||Participants|Number|161|161.0||||||
4126980|NCT00913523|3952315|B2|||Body Mass Index 15-54, inclusive||Participants|Number|159|159.0||||||
4126981|NCT00913523|3952316|B1|||Body Mass Index 15-54, inclusive||Participants|Number|162|162.0||||||
4126982|NCT00913523|3952313|B4|||Height 143-148 cm, inclusive||Participants|Number|482|482.0||||||
4126983|NCT00913523|3952314|B3|||Height 143-148 cm, inclusive||Participants|Number|161|161.0||||||
4126984|NCT00913523|3952315|B2|||Height 143-148 cm, inclusive||Participants|Number|159|159.0||||||
4126985|NCT00913523|3952316|B1|||Height 143-148 cm, inclusive||Participants|Number|162|162.0||||||
4126986|NCT00913523|3952313|B4|||Weight 39-169 kg, inclusive||Participants|Number|482|482.0||||||
4126987|NCT00913523|3952314|B3|||Weight 39-169 kg, inclusive||Participants|Number|161|161.0||||||
4126988|NCT00913523|3952315|B2|||Weight 39-169 kg, inclusive||Participants|Number|159|159.0||||||
4126989|NCT00913523|3952316|B1|||Weight 39-169 kg, inclusive||Participants|Number|162|162.0||||||
4126990|NCT00913523|3952313|B4|United States||Region of Enrollment||participants|Number|482|482.0||||||
4126991|NCT00913523|3952314|B3|United States||Region of Enrollment||participants|Number|161|161.0||||||
4126992|NCT00913523|3952315|B2|United States||Region of Enrollment||participants|Number|159|159.0||||||
4126993|NCT00913523|3952316|B1|United States||Region of Enrollment||participants|Number|162|162.0||||||
4126994|NCT00913523|3952313|B4|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4126995|NCT00913523|3952314|B3|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4126996|NCT00913523|3952315|B2|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4126997|NCT00913523|3952316|B1|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4126998|NCT00913523|3952313|B4|White||Race/Ethnicity, Customized||Participants|Number|412|412.0||||||
4126999|NCT00913523|3952314|B3|White||Race/Ethnicity, Customized||Participants|Number|133|133.0||||||
4127000|NCT00913523|3952315|B2|White||Race/Ethnicity, Customized||Participants|Number|138|138.0||||||
4127001|NCT00913523|3952316|B1|White||Race/Ethnicity, Customized||Participants|Number|141|141.0||||||
4127002|NCT00913523|3952313|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|50|50.0||||||
4127003|NCT00913523|3952314|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
4127004|NCT00913523|3952315|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4127005|NCT00913523|3952316|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4127006|NCT00913523|3952313|B4|Asian||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4127007|NCT00913523|3952314|B3|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4127008|NCT00913523|3952315|B2|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4127009|NCT00913523|3952316|B1|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4127010|NCT00913523|3952313|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4127011|NCT00913523|3952314|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4127012|NCT00913523|3952315|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4127013|NCT00913523|3952316|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4127014|NCT00913523|3952313|B4|H/L & NH/OPI||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4127015|NCT00913523|3952314|B3|H/L & NH/OPI||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4127016|NCT00913523|3952315|B2|H/L & NH/OPI||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4127017|NCT00913523|3952316|B1|H/L & NH/OPI||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4127018|NCT00913523|3952313|B4|Native Hawaiian/Other Pacific Islander (NH/OPI)||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4127019|NCT00913523|3952314|B3|Native Hawaiian/Other Pacific Islander (NH/OPI)||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4127020|NCT00913523|3952315|B2|Native Hawaiian/Other Pacific Islander (NH/OPI)||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4127021|NCT00913523|3952316|B1|Native Hawaiian/Other Pacific Islander (NH/OPI)||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4127022|NCT00913523|3952313|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|430|430.0||||||
4127023|NCT00913523|3952314|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|148|148.0||||||
4127024|NCT00913523|3952315|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|142|142.0||||||
4127025|NCT00913523|3952316|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|140|140.0||||||
4127026|NCT00913523|3952313|B4|Hispanic or Latino (H/L)||Race/Ethnicity, Customized||Participants|Number|46|46.0||||||
4127027|NCT00913523|3952314|B3|Hispanic or Latino (H/L)||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4127028|NCT00913523|3952315|B2|Hispanic or Latino (H/L)||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4127029|NCT00913523|3952316|B1|Hispanic or Latino (H/L)||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4127030|NCT00913523|3952313|B4|Female||Sex/Gender, Customized||participants|Number|482|482.0||||||
4127031|NCT00913523|3952314|B3|Female||Sex/Gender, Customized||participants|Number|161|161.0||||||
4127032|NCT00913523|3952315|B2|Female||Sex/Gender, Customized||participants|Number|159|159.0||||||
4127033|NCT00913523|3952316|B1|Female||Sex/Gender, Customized||participants|Number|162|162.0||||||
4127034|NCT00913523|3952313|B4|>=65 years||Age, Customized||Participants|Number|0|0.0||||||
4127035|NCT00913523|3952314|B3|>=65 years||Age, Customized||Participants|Number|0|0.0||||||
4127036|NCT00913523|3952315|B2|>=65 years||Age, Customized||Participants|Number|0|0.0||||||
4127037|NCT00913523|3952316|B1|>=65 years||Age, Customized||Participants|Number|0|0.0||||||
4127038|NCT00913523|3952313|B4|18 to 64 years, inclusive||Age, Customized||Participants|Number|482|482.0||||||
4127039|NCT00913523|3952314|B3|18 to 64 years, inclusive||Age, Customized||Participants|Number|161|161.0||||||
4127040|NCT00913523|3952315|B2|18 to 64 years, inclusive||Age, Customized||Participants|Number|159|159.0||||||
4127041|NCT00913523|3952316|B1|18 to 64 years, inclusive||Age, Customized||Participants|Number|162|162.0||||||
4127042|NCT00913523|3952313|B4|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4127043|NCT00913523|3952314|B3|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4127044|NCT00913523|3952315|B2|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4127045|NCT00913523|3952316|B1|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4127046|NCT00913510|3952341|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4127047|NCT00913510|3952342|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4127048|NCT00913510|3952343|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4127049|NCT00913510|3952341|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4127050|NCT00913510|3952342|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4127051|NCT00913510|3952343|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4127052|NCT00913510|3952341|B3|||Age||years|Mean|44.85|44.85|Standard Deviation|12.38|12.38|||
4127053|NCT00913510|3952342|B2|||Age||years|Mean|51.71|51.71|Standard Deviation|8.34|8.34|||
4127054|NCT00913510|3952343|B1|||Age||years|Mean|41.15|41.15|Standard Deviation|12.86|12.86|||
4127055|NCT00913458|3952350|B1||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4127056|NCT00913458|3952350|B1||Female|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
4127057|NCT00913458|3952350|B1|||Age||Years|Mean|49.94|49.94|Standard Deviation|13.70|13.7|||
4127058|NCT00913380|3952447|B3|Non-abdominal radiologist||Radiologist||participants|Number|449|449.0||||||
4127059|NCT00913380|3952448|B2|Non-abdominal radiologist||Radiologist||participants|Number|222|222.0||||||
4127060|NCT00913380|3952449|B1|Non-abdominal radiologist||Radiologist||participants|Number|227|227.0||||||
4127061|NCT00913380|3952447|B3|Abdominal radiologist||Radiologist||participants|Number|442|442.0||||||
4127062|NCT00913380|3952448|B2|Abdominal radiologist||Radiologist||participants|Number|225|225.0||||||
4127063|NCT00913380|3952449|B1|Abdominal radiologist||Radiologist||participants|Number|217|217.0||||||
4127064|NCT00913380|3952447|B3|256-detector CT||CT scanner||participants|Number|225|225.0||||||
4127065|NCT00913380|3952448|B2|256-detector CT||CT scanner||participants|Number|112|112.0||||||
4127066|NCT00913380|3952449|B1|256-detector CT||CT scanner||participants|Number|113|113.0||||||
4127067|NCT00913380|3952447|B3|64-detector CT||CT scanner||participants|Number|298|298.0||||||
4127068|NCT00913380|3952448|B2|64-detector CT||CT scanner||participants|Number|144|144.0||||||
4127069|NCT00913380|3952449|B1|64-detector CT||CT scanner||participants|Number|154|154.0||||||
4127070|NCT00913380|3952447|B3|16-detector CT||CT scanner||participants|Number|368|368.0||||||
4127071|NCT00913380|3952448|B2|16-detector CT||CT scanner||participants|Number|191|191.0||||||
4127072|NCT00913380|3952449|B1|16-detector CT||CT scanner||participants|Number|177|177.0||||||
4127073|NCT00913380|3952447|B3|||C-reactive protein||mg/dL|Median|0.6|0.6|Inter-Quartile Range|||0.3|3.1|
4127074|NCT00913380|3952448|B2|||C-reactive protein||mg/dL|Median|0.7|0.7|Inter-Quartile Range|||0.3|3.3|
4127075|NCT00913380|3952449|B1|||C-reactive protein||mg/dL|Median|0.5|0.5|Inter-Quartile Range|||0.3|2.5|
4127076|NCT00913380|3952447|B3|||Segmented neutrophil||Percentage of peripheral Leukocytes|Median|77.3|77.3|Inter-Quartile Range|||65.7|84.6|
4127077|NCT00913380|3952448|B2|||Segmented neutrophil||Percentage of peripheral Leukocytes|Median|77.3|77.3|Inter-Quartile Range|||65.5|83.9|
4127078|NCT00913380|3952449|B1|||Segmented neutrophil||Percentage of peripheral Leukocytes|Median|77.0|77.0|Inter-Quartile Range|||65.8|85.2|
4127079|NCT00913380|3952447|B3|||White blood cell||x10^3/mm^3|Median|10.8|10.8|Inter-Quartile Range|||7.9|14.2|
4127080|NCT00913380|3952448|B2|||White blood cell||x10^3/mm^3|Median|10.8|10.8|Inter-Quartile Range|||8.0|14.3|
4127081|NCT00913380|3952449|B1|||White blood cell||x10^3/mm^3|Median|10.7|10.7|Inter-Quartile Range|||7.8|14.1|
4127082|NCT00913380|3952447|B3|≥ 25.0 (overweight to extremely obese)||Body mass index||kg/m^2|Number|156|156.0||||||
4127083|NCT00913380|3952448|B2|≥ 25.0 (overweight to extremely obese)||Body mass index||kg/m^2|Number|86|86.0||||||
4127084|NCT00913380|3952449|B1|≥ 25.0 (overweight to extremely obese)||Body mass index||kg/m^2|Number|70|70.0||||||
4127085|NCT00913380|3952447|B3|18.5-24.9 (normal)||Body mass index||kg/m^2|Number|613|613.0||||||
4127086|NCT00913380|3952448|B2|18.5-24.9 (normal)||Body mass index||kg/m^2|Number|301|301.0||||||
4127087|NCT00913380|3952449|B1|18.5-24.9 (normal)||Body mass index||kg/m^2|Number|312|312.0||||||
4127088|NCT00913380|3952447|B3|< 18.5 (underweight)||Body mass index||kg/m^2|Number|122|122.0||||||
4127089|NCT00913380|3952448|B2|< 18.5 (underweight)||Body mass index||kg/m^2|Number|60|60.0||||||
4127090|NCT00913380|3952449|B1|< 18.5 (underweight)||Body mass index||kg/m^2|Number|62|62.0||||||
4127091|NCT00913380|3952447|B3|Non-Korean||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4127092|NCT00913380|3952448|B2|Non-Korean||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4127093|NCT00913380|3952449|B1|Non-Korean||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4127094|NCT00913380|3952447|B3|Korean||Race/Ethnicity, Customized||participants|Number|886|886.0||||||
4127095|NCT00913380|3952448|B2|Korean||Race/Ethnicity, Customized||participants|Number|445|445.0||||||
4127096|NCT00913380|3952449|B1|Korean||Race/Ethnicity, Customized||participants|Number|441|441.0||||||
4127097|NCT00913380|3952447|B3||Male|Sex: Female, Male||Participants|Count of Participants|352|352.0||||||
4127098|NCT00913380|3952448|B2||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4127099|NCT00913380|3952449|B1||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4127100|NCT00913380|3952447|B3||Female|Sex: Female, Male||Participants|Count of Participants|539|539.0||||||
4127101|NCT00913380|3952448|B2||Female|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
4127102|NCT00913380|3952449|B1||Female|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
4127103|NCT00913380|3952447|B3|Age (year)||Age||year|Median|30|30.0|Inter-Quartile Range|||22.0|37.0|
4127104|NCT00913380|3952448|B2|Age (year)||Age||year|Median|30|30.0|Inter-Quartile Range|||22.0|37.0|
4127105|NCT00913380|3952449|B1|Age (year)||Age||year|Median|29|29.0|Inter-Quartile Range|||21.5|36.0|
4127106|NCT00913263|3952476|B1|Finland||Region of Enrollment||participants|Number|24|24.0||||||
4127107|NCT00913263|3952476|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4127108|NCT00913263|3952476|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4127109|NCT00913263|3952476|B1|||Age||years|Mean|68|68.0|Standard Deviation|5|5.0|||
4127110|NCT00913263|3952476|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4127111|NCT00913263|3952476|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4127112|NCT00913263|3952476|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4127113|NCT00913133|3952485|B1|United States||Region of Enrollment||participants|Number|516|516.0||||||
4127114|NCT00913133|3952485|B1||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4127115|NCT00913133|3952485|B1||Female|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
4127116|NCT00913133|3952485|B1|||Age||years|Mean|59|59.0|Standard Deviation|14.7|14.7|||
4127117|NCT00913133|3952485|B1||>=65 years|Age||Participants|Count of Participants|129|129.0||||||
4127118|NCT00913133|3952485|B1||Between 18 and 65 years|Age||Participants|Count of Participants|387|387.0||||||
4127119|NCT00913133|3952485|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4127120|NCT00913081|3952490|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127121|NCT00913081|3952490|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127122|NCT00913081|3952490|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4127123|NCT00913081|3952490|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4127124|NCT00913081|3952490|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127125|NCT00913081|3952490|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127126|NCT00913081|3952490|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127127|NCT00913081|3952490|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127128|NCT00913081|3952490|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4127129|NCT00913081|3952490|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4127130|NCT00913081|3952490|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4127131|NCT00913081|3952490|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4127132|NCT00913081|3952490|B1|||Age||years|Mean|38.1|38.1|Standard Deviation|13.0|13.0|||
4127133|NCT00913003|3952500|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4127134|NCT00913003|3952501|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4127135|NCT00913003|3952502|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4127136|NCT00913003|3952500|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4127137|NCT00913003|3952501|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4127138|NCT00913003|3952502|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4127139|NCT00913003|3952500|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4127140|NCT00913003|3952501|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4127141|NCT00913003|3952502|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4127142|NCT00913003|3952500|B3|||Age||Years|Mean|49.5|49.5|Standard Deviation|9.1|9.1|||
4127143|NCT00913003|3952501|B2|||Age||Years|Mean|48.5|48.5|Standard Deviation|7.9|7.9|||
4127144|NCT00913003|3952502|B1|||Age||Years|Mean|50.4|50.4|Standard Deviation|10.1|10.1|||
4127145|NCT00912964|3952513|B4|||Mean number of pads used per 24 hours|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|pads|Mean|0.85|0.85|Standard Deviation|1.666|1.666|||
4127146|NCT00912964|3952514|B3|||Mean number of pads used per 24 hours|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|pads|Mean|0.84|0.84|Standard Deviation|1.700|1.7|||
4127147|NCT00912964|3952515|B2|||Mean number of pads used per 24 hours|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|pads|Mean|0.79|0.79|Standard Deviation|1.449|1.449|||
4127148|NCT00912964|3952516|B1|||Mean number of pads used per 24 hours|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|pads|Mean|0.91|0.91|Standard Deviation|1.786|1.786|||
4127149|NCT00912964|3952513|B4|||Mean number of nocturia episodes per 24 hours|The average number of times a patient woke at night to urinate (excluding incontinence only episodes) recorded for 3 days prior to the Baseline visit in the patient micturition diary.|nocturia episodes|Mean|1.93|1.93|Standard Deviation|1.465|1.465|||
4127150|NCT00912964|3952514|B3|||Mean number of nocturia episodes per 24 hours|The average number of times a patient woke at night to urinate (excluding incontinence only episodes) recorded for 3 days prior to the Baseline visit in the patient micturition diary.|nocturia episodes|Mean|2.03|2.03|Standard Deviation|1.528|1.528|||
4127151|NCT00912964|3952515|B2|||Mean number of nocturia episodes per 24 hours|The average number of times a patient woke at night to urinate (excluding incontinence only episodes) recorded for 3 days prior to the Baseline visit in the patient micturition diary.|nocturia episodes|Mean|1.94|1.94|Standard Deviation|1.552|1.552|||
4127152|NCT00912964|3952516|B1|||Mean number of nocturia episodes per 24 hours|The average number of times a patient woke at night to urinate (excluding incontinence only episodes) recorded for 3 days prior to the Baseline visit in the patient micturition diary.|nocturia episodes|Mean|1.82|1.82|Standard Deviation|1.332|1.332|||
4127153|NCT00912964|3952513|B4|||Mean level of urgency|Average of patients’ ratings on the degree of associated urgency for each micturition and/or incontinence episode recorded in a 3-day micturition diary according to the following 5-point categorical scale (Patient Perception of Intensity of Urgency Scale): 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet.|scores on a scale|Mean|2.38|2.38|Standard Deviation|0.560|0.56|||
4127154|NCT00912964|3952514|B3|||Mean level of urgency|Average of patients’ ratings on the degree of associated urgency for each micturition and/or incontinence episode recorded in a 3-day micturition diary according to the following 5-point categorical scale (Patient Perception of Intensity of Urgency Scale): 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet.|scores on a scale|Mean|2.41|2.41|Standard Deviation|0.556|0.556|||
4127155|NCT00912964|3952515|B2|||Mean level of urgency|Average of patients’ ratings on the degree of associated urgency for each micturition and/or incontinence episode recorded in a 3-day micturition diary according to the following 5-point categorical scale (Patient Perception of Intensity of Urgency Scale): 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet.|scores on a scale|Mean|2.37|2.37|Standard Deviation|0.573|0.573|||
4127156|NCT00912964|3952516|B1|||Mean level of urgency|Average of patients’ ratings on the degree of associated urgency for each micturition and/or incontinence episode recorded in a 3-day micturition diary according to the following 5-point categorical scale (Patient Perception of Intensity of Urgency Scale): 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet.|scores on a scale|Mean|2.36|2.36|Standard Deviation|0.550|0.55|||
4127157|NCT00912964|3952513|B4|||Mean number of urgency episodes (grade 3 or 4) per 24 hours|Urgency episodes were those classified by the patient in a 3-day micturition diary as 3 or 4 on the Patient Perception of Intensity of Urgency (PPIUS) scale: 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet.|urgency episodes|Mean|5.60|5.6|Standard Deviation|3.508|3.508|||
4127158|NCT00912964|3952514|B3|||Mean number of urgency episodes (grade 3 or 4) per 24 hours|Urgency episodes were those classified by the patient in a 3-day micturition diary as 3 or 4 on the Patient Perception of Intensity of Urgency (PPIUS) scale: 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet.|urgency episodes|Mean|5.81|5.81|Standard Deviation|3.559|3.559|||
4127159|NCT00912964|3952515|B2|||Mean number of urgency episodes (grade 3 or 4) per 24 hours|Urgency episodes were those classified by the patient in a 3-day micturition diary as 3 or 4 on the Patient Perception of Intensity of Urgency (PPIUS) scale: 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet.|urgency episodes|Mean|5.54|5.54|Standard Deviation|3.622|3.622|||
4127160|NCT00912964|3952516|B1|||Mean number of urgency episodes (grade 3 or 4) per 24 hours|Urgency episodes were those classified by the patient in a 3-day micturition diary as 3 or 4 on the Patient Perception of Intensity of Urgency (PPIUS) scale: 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet.|urgency episodes|Mean|5.43|5.43|Standard Deviation|3.335|3.335|||
4127161|NCT00912964|3952513|B4|||Mean volume voided per micturition|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|mL|Mean|162.4|162.4|Standard Deviation|55.33|55.33|||
4127162|NCT00912964|3952514|B3|||Mean volume voided per micturition|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|mL|Mean|158.4|158.4|Standard Deviation|52.17|52.17|||
4127163|NCT00912964|3952515|B2|||Mean volume voided per micturition|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|mL|Mean|165.4|165.4|Standard Deviation|57.24|57.24|||
4127164|NCT00912964|3952516|B1|||Mean volume voided per micturition|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|mL|Mean|163.5|163.5|Standard Deviation|56.39|56.39|||
4127165|NCT00912964|3952513|B4|||Mean number of micturitions per 24 hours|The average number of micturitions (urinations) recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|micturitions|Mean|11.63|11.63|Standard Deviation|3.108|3.108|||
4127166|NCT00912964|3952514|B3|||Mean number of micturitions per 24 hours|The average number of micturitions (urinations) recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|micturitions|Mean|11.69|11.69|Standard Deviation|3.227|3.227|||
4127167|NCT00912964|3952515|B2|||Mean number of micturitions per 24 hours|The average number of micturitions (urinations) recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|micturitions|Mean|11.66|11.66|Standard Deviation|3.117|3.117|||
4127168|NCT00912964|3952516|B1|||Mean number of micturitions per 24 hours|The average number of micturitions (urinations) recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|micturitions|Mean|11.54|11.54|Standard Deviation|2.979|2.979|||
4127169|NCT00912964|3952513|B4|||Duration of OAB symptoms||months|Mean|93.4|93.4|Standard Deviation|103.02|103.02|||
4127170|NCT00912964|3952514|B3|||Duration of OAB symptoms||months|Mean|92.7|92.7|Standard Deviation|97.88|97.88|||
4127171|NCT00912964|3952515|B2|||Duration of OAB symptoms||months|Mean|96.3|96.3|Standard Deviation|113.77|113.77|||
4127172|NCT00912964|3952516|B1|||Duration of OAB symptoms||months|Mean|91.3|91.3|Standard Deviation|96.82|96.82|||
4127173|NCT00912964|3952513|B4|Frequency||Type of overactive bladder (OAB)||participants|Number|414|414.0||||||
4127174|NCT00912964|3952514|B3|Frequency||Type of overactive bladder (OAB)||participants|Number|117|117.0||||||
4127175|NCT00912964|3952515|B2|Frequency||Type of overactive bladder (OAB)||participants|Number|135|135.0||||||
4127176|NCT00912964|3952516|B1|Frequency||Type of overactive bladder (OAB)||participants|Number|162|162.0||||||
4127177|NCT00912964|3952513|B4|Mixed||Type of overactive bladder (OAB)||participants|Number|428|428.0||||||
4127178|NCT00912964|3952514|B3|Mixed||Type of overactive bladder (OAB)||participants|Number|154|154.0||||||
4127179|NCT00912964|3952515|B2|Mixed||Type of overactive bladder (OAB)||participants|Number|129|129.0||||||
4127180|NCT00912964|3952516|B1|Mixed||Type of overactive bladder (OAB)||participants|Number|145|145.0||||||
4127181|NCT00912964|3952513|B4|Urge Incontinence||Type of overactive bladder (OAB)||participants|Number|463|463.0||||||
4127182|NCT00912964|3952514|B3|Urge Incontinence||Type of overactive bladder (OAB)||participants|Number|169|169.0||||||
4127183|NCT00912964|3952515|B2|Urge Incontinence||Type of overactive bladder (OAB)||participants|Number|168|168.0||||||
4127184|NCT00912964|3952516|B1|Urge Incontinence||Type of overactive bladder (OAB)||participants|Number|126|126.0||||||
4127185|NCT00912964|3952513|B4|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4127186|NCT00912964|3952514|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4127187|NCT00912964|3952515|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4127188|NCT00912964|3952516|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4127189|NCT00912964|3952513|B4|Asian||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4127190|NCT00912964|3952514|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4127191|NCT00912964|3952515|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4127192|NCT00912964|3952516|B1|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4127193|NCT00912964|3952513|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|100|100.0||||||
4127194|NCT00912964|3952514|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4127195|NCT00912964|3952515|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4127196|NCT00912964|3952516|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4127197|NCT00912964|3952513|B4|White||Race/Ethnicity, Customized||participants|Number|1183|1183.0||||||
4127198|NCT00912964|3952514|B3|White||Race/Ethnicity, Customized||participants|Number|400|400.0||||||
4127199|NCT00912964|3952515|B2|White||Race/Ethnicity, Customized||participants|Number|394|394.0||||||
4127200|NCT00912964|3952516|B1|White||Race/Ethnicity, Customized||participants|Number|389|389.0||||||
4127201|NCT00912964|3952513|B4||Male|Sex: Female, Male||Participants|Count of Participants|408|408.0||||||
4127202|NCT00912964|3952514|B3||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4127203|NCT00912964|3952515|B2||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4127204|NCT00912964|3952516|B1||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4127205|NCT00912964|3952513|B4||Female|Sex: Female, Male||Participants|Count of Participants|897|897.0||||||
4127206|NCT00912964|3952514|B3||Female|Sex: Female, Male||Participants|Count of Participants|303|303.0||||||
4127207|NCT00912964|3952515|B2||Female|Sex: Female, Male||Participants|Count of Participants|293|293.0||||||
4127208|NCT00912964|3952516|B1||Female|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
4127209|NCT00912964|3952513|B4|||Age|Baseline Measure data are provided for all randomized patients who took at least 1 dose of double-blind study drug (Safety Analysis Set).|years|Mean|59.0|59.0|Standard Deviation|12.97|12.97|||
4127210|NCT00912964|3952514|B3|||Age|Baseline Measure data are provided for all randomized patients who took at least 1 dose of double-blind study drug (Safety Analysis Set).|years|Mean|60.3|60.3|Standard Deviation|12.22|12.22|||
4127211|NCT00912964|3952515|B2|||Age|Baseline Measure data are provided for all randomized patients who took at least 1 dose of double-blind study drug (Safety Analysis Set).|years|Mean|58.5|58.5|Standard Deviation|12.85|12.85|||
4127212|NCT00912964|3952516|B1|||Age|Baseline Measure data are provided for all randomized patients who took at least 1 dose of double-blind study drug (Safety Analysis Set).|years|Mean|58.2|58.2|Standard Deviation|13.73|13.73|||
4127213|NCT00912925|3952640|B3|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4127214|NCT00912925|3952641|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4127215|NCT00912925|3952642|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4127216|NCT00912925|3952640|B3|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4127217|NCT00912925|3952641|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4127218|NCT00912925|3952642|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4127219|NCT00912925|3952640|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4127220|NCT00912925|3952641|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4127221|NCT00912925|3952642|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4127222|NCT00912925|3952640|B3|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4127223|NCT00912925|3952641|B2|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4127224|NCT00912925|3952642|B1|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4127225|NCT00912925|3952640|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
4127226|NCT00912925|3952641|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4127227|NCT00912925|3952642|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
4127228|NCT00912925|3952640|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4127229|NCT00912925|3952641|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4127230|NCT00912925|3952642|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4127231|NCT00912925|3952640|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4127232|NCT00912925|3952641|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4127233|NCT00912925|3952642|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4127234|NCT00912925|3952640|B3|||Age||years|Mean|15.5|15.5|Standard Deviation|8.04|8.04|||
4127235|NCT00912925|3952641|B2|||Age||years|Mean|15.6|15.6|Standard Deviation|8.63|8.63|||
4127236|NCT00912925|3952642|B1|||Age||years|Mean|15.4|15.4|Standard Deviation|7.63|7.63|||
4127237|NCT00912925|3952640|B3|19 to less than or equal to 65 years||Age, Customized||participants|Number|12|12.0||||||
4127238|NCT00912925|3952641|B2|19 to less than or equal to 65 years||Age, Customized||participants|Number|7|7.0||||||
4127239|NCT00912925|3952642|B1|19 to less than or equal to 65 years||Age, Customized||participants|Number|5|5.0||||||
4127240|NCT00912925|3952640|B3|13 to less than or equal to 18 years||Age, Customized||participants|Number|11|11.0||||||
4127241|NCT00912925|3952641|B2|13 to less than or equal to 18 years||Age, Customized||participants|Number|3|3.0||||||
4127242|NCT00912925|3952642|B1|13 to less than or equal to 18 years||Age, Customized||participants|Number|8|8.0||||||
4127243|NCT00912925|3952640|B3|less than or equal to 12 years||Age, Customized||participants|Number|22|22.0||||||
4127244|NCT00912925|3952641|B2|less than or equal to 12 years||Age, Customized||participants|Number|12|12.0||||||
4127245|NCT00912925|3952642|B1|less than or equal to 12 years||Age, Customized||participants|Number|10|10.0||||||
4127246|NCT00912912|3952661|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4127247|NCT00912912|3952661|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127248|NCT00912912|3952661|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127249|NCT00912912|3952661|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4127250|NCT00912912|3952661|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4127251|NCT00912912|3952661|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127252|NCT00912912|3952661|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4127253|NCT00912912|3952661|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127254|NCT00912912|3952661|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4127255|NCT00912912|3952661|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4127256|NCT00912912|3952661|B1|||Age||years|Median|29|29.0|Full Range|||17.0|36.0|
4127257|NCT00912808|3952665|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4127258|NCT00912808|3952666|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4127259|NCT00912808|3952667|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4127260|NCT00912808|3952665|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4127261|NCT00912808|3952666|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4127262|NCT00912808|3952667|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4127263|NCT00912808|3952665|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4127264|NCT00912808|3952666|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4127265|NCT00912808|3952667|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4127266|NCT00912808|3952665|B3|||Age||years|Mean|68.4|68.4|Standard Deviation|10.9|10.9|||
4127267|NCT00912808|3952666|B2|||Age||years|Mean|66.4|66.4|Standard Deviation|11.5|11.5|||
4127268|NCT00912808|3952667|B1|||Age||years|Mean|71.5|71.5|Standard Deviation|10.2|10.2|||
4127269|NCT00912808|3952665|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4127270|NCT00912808|3952666|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4127271|NCT00912808|3952667|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4127272|NCT00912808|3952665|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4127273|NCT00912808|3952666|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4127274|NCT00912808|3952667|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4127275|NCT00912808|3952665|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4127276|NCT00912808|3952666|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4127277|NCT00912808|3952667|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4127278|NCT00912795|3952676|B3|||Number of quit attempts in the past year||number of quit attempts|Mean|2.4|2.4|Standard Deviation|1.5|1.5|||
4127279|NCT00912795|3952677|B2|||Number of quit attempts in the past year||number of quit attempts|Mean|2.4|2.4|Standard Deviation|1.5|1.5|||
4127280|NCT00912795|3952678|B1|||Number of quit attempts in the past year||number of quit attempts|Mean|2.4|2.4|Standard Deviation|1.5|1.5|||
4127281|NCT00912795|3952676|B3|||Confidence in one's ability to quit|This measure has scores possibly ranging form 0 to 10 with higher scores reflecting more confidence|score|Mean|6.0|6.0|Standard Deviation|2.5|2.5|||
4127282|NCT00912795|3952677|B2|||Confidence in one's ability to quit|This measure has scores possibly ranging form 0 to 10 with higher scores reflecting more confidence|score|Mean|6.0|6.0|Standard Deviation|2.5|2.5|||
4127283|NCT00912795|3952678|B1|||Confidence in one's ability to quit|This measure has scores possibly ranging form 0 to 10 with higher scores reflecting more confidence|score|Mean|6.0|6.0|Standard Deviation|2.4|2.4|||
4127284|NCT00912795|3952676|B3|||Importance of quitting to self|This measure has scores possibly ranging form 4 to 10 with higher scores reflecting more importance|score|Mean|8.9|8.9|Standard Deviation|1.5|1.5|||
4127285|NCT00912795|3952677|B2|||Importance of quitting to self|This measure has scores possibly ranging form 4 to 10 with higher scores reflecting more importance|score|Mean|9.0|9.0|Standard Deviation|1.4|1.4|||
4127286|NCT00912795|3952678|B1|||Importance of quitting to self|This measure has scores possibly ranging form 4 to 10 with higher scores reflecting more importance|score|Mean|8.9|8.9|Standard Deviation|1.6|1.6|||
4127287|NCT00912795|3952676|B3|||Fagerström score|Tobacco dependence was assessed using the Fagerström Test of Nicotine Dependence (FTND). Scores range from 0-10. A score of 0-2 indicates low dependence, 3-4 indicates low to moderate dependence, 5-7 indicates moderate dependence, and 8-10 indicates high dependence.|score|Mean|4.8|4.8|Standard Deviation|2.4|2.4|||
4127288|NCT00912795|3952677|B2|||Fagerström score|Tobacco dependence was assessed using the Fagerström Test of Nicotine Dependence (FTND). Scores range from 0-10. A score of 0-2 indicates low dependence, 3-4 indicates low to moderate dependence, 5-7 indicates moderate dependence, and 8-10 indicates high dependence.|score|Mean|4.9|4.9|Standard Deviation|2.5|2.5|||
4127289|NCT00912795|3952678|B1|||Fagerström score|Tobacco dependence was assessed using the Fagerström Test of Nicotine Dependence (FTND). Scores range from 0-10. A score of 0-2 indicates low dependence, 3-4 indicates low to moderate dependence, 5-7 indicates moderate dependence, and 8-10 indicates high dependence.|score|Mean|4.8|4.8|Standard Deviation|2.3|2.3|||
4127290|NCT00912795|3952676|B3|||Age at first cigarette||years|Mean|17.3|17.3|Standard Deviation|3.6|3.6|||
4127291|NCT00912795|3952677|B2|||Age at first cigarette||years|Mean|17.1|17.1|Standard Deviation|3.6|3.6|||
4127292|NCT00912795|3952678|B1|||Age at first cigarette||years|Mean|17.5|17.5|Standard Deviation|3.7|3.7|||
4127293|NCT00912795|3952676|B3|||Average Number of cigarettes smoked per day||number of cigarettes per day|Mean|19.53|19.53|Standard Deviation|8.27|8.27|||
4127294|NCT00912795|3952677|B2|||Average Number of cigarettes smoked per day||number of cigarettes per day|Mean|20.4|20.4|Standard Deviation|9.2|9.2|||
4127295|NCT00912795|3952678|B1|||Average Number of cigarettes smoked per day||number of cigarettes per day|Mean|18.7|18.7|Standard Deviation|7.2|7.2|||
4127296|NCT00912795|3952676|B3|Post graduate degree||Educational attainment||participants|Number|12|12.0||||||
4127297|NCT00912795|3952677|B2|Post graduate degree||Educational attainment||participants|Number|4|4.0||||||
4127298|NCT00912795|3952678|B1|Post graduate degree||Educational attainment||participants|Number|8|8.0||||||
4127299|NCT00912795|3952676|B3|University degree||Educational attainment||participants|Number|50|50.0||||||
4127300|NCT00912795|3952677|B2|University degree||Educational attainment||participants|Number|23|23.0||||||
4127301|NCT00912795|3952678|B1|University degree||Educational attainment||participants|Number|27|27.0||||||
4127302|NCT00912795|3952676|B3|Two-year college||Educational attainment||participants|Number|23|23.0||||||
4127303|NCT00912795|3952677|B2|Two-year college||Educational attainment||participants|Number|10|10.0||||||
4127304|NCT00912795|3952678|B1|Two-year college||Educational attainment||participants|Number|13|13.0||||||
4127305|NCT00912795|3952676|B3|High school or less||Educational attainment||participants|Number|66|66.0||||||
4127306|NCT00912795|3952677|B2|High school or less||Educational attainment||participants|Number|38|38.0||||||
4127307|NCT00912795|3952678|B1|High school or less||Educational attainment||participants|Number|28|28.0||||||
4127308|NCT00912795|3952676|B3|Widowed||Martial status||participants|Number|1|1.0||||||
4127309|NCT00912795|3952677|B2|Widowed||Martial status||participants|Number|1|1.0||||||
4127310|NCT00912795|3952678|B1|Widowed||Martial status||participants|Number|0|0.0||||||
4127311|NCT00912795|3952676|B3|Divorced||Martial status||participants|Number|4|4.0||||||
4127312|NCT00912795|3952677|B2|Divorced||Martial status||participants|Number|0|0.0||||||
4127313|NCT00912795|3952678|B1|Divorced||Martial status||participants|Number|4|4.0||||||
4127314|NCT00912795|3952676|B3|Single||Martial status||participants|Number|55|55.0||||||
4127315|NCT00912795|3952677|B2|Single||Martial status||participants|Number|25|25.0||||||
4127316|NCT00912795|3952678|B1|Single||Martial status||participants|Number|30|30.0||||||
4127317|NCT00912795|3952676|B3|Married||Martial status||participants|Number|91|91.0||||||
4127318|NCT00912795|3952677|B2|Married||Martial status||participants|Number|49|49.0||||||
4127319|NCT00912795|3952678|B1|Married||Martial status||participants|Number|42|42.0||||||
4127320|NCT00912795|3952676|B3|Do not want to answer||Income||participants|Number|4|4.0||||||
4127321|NCT00912795|3952677|B2|Do not want to answer||Income||participants|Number|1|1.0||||||
4127322|NCT00912795|3952678|B1|Do not want to answer||Income||participants|Number|3|3.0||||||
4127323|NCT00912795|3952676|B3|More than 4000 Turkish lira per month||Income||participants|Number|25|25.0||||||
4127324|NCT00912795|3952677|B2|More than 4000 Turkish lira per month||Income||participants|Number|9|9.0||||||
4127325|NCT00912795|3952678|B1|More than 4000 Turkish lira per month||Income||participants|Number|16|16.0||||||
4127326|NCT00912795|3952676|B3|2000 - 4000 Turkish lira per month||Income||participants|Number|62|62.0||||||
4127327|NCT00912795|3952677|B2|2000 - 4000 Turkish lira per month||Income||participants|Number|28|28.0||||||
4127328|NCT00912795|3952678|B1|2000 - 4000 Turkish lira per month||Income||participants|Number|34|34.0||||||
4127329|NCT00912795|3952676|B3|Less than 2000 Turkish lira per month||Income||participants|Number|60|60.0||||||
4127330|NCT00912795|3952677|B2|Less than 2000 Turkish lira per month||Income||participants|Number|37|37.0||||||
4127331|NCT00912795|3952678|B1|Less than 2000 Turkish lira per month||Income||participants|Number|23|23.0||||||
4127332|NCT00912795|3952676|B3||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4127333|NCT00912795|3952677|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4127334|NCT00912795|3952678|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4127335|NCT00912795|3952676|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4127336|NCT00912795|3952677|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4127337|NCT00912795|3952678|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4127338|NCT00912795|3952676|B3|||Age||years|Mean|35.89|35.89|Standard Deviation|9.89|9.89|||
4127339|NCT00912795|3952677|B2|||Age||years|Mean|36.1|36.1|Standard Deviation|9.5|9.5|||
4127340|NCT00912795|3952678|B1|||Age||years|Mean|35.6|35.6|Standard Deviation|10.3|10.3|||
4127341|NCT00912782|3952691|B3|United States||Region of Enrollment||participants|Number|52|52.0||||||
4127342|NCT00912782|3952692|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4127343|NCT00912782|3952693|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4127344|NCT00912782|3952691|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4127345|NCT00912782|3952692|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4127346|NCT00912782|3952693|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4127347|NCT00912782|3952691|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127348|NCT00912782|3952692|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127349|NCT00912782|3952693|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127350|NCT00912782|3952691|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127351|NCT00912782|3952692|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127352|NCT00912782|3952693|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127353|NCT00912782|3952691|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4127354|NCT00912782|3952692|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4127355|NCT00912782|3952693|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4127356|NCT00912782|3952691|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127357|NCT00912782|3952692|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127358|NCT00912782|3952693|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127359|NCT00912782|3952691|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127360|NCT00912782|3952692|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127361|NCT00912782|3952693|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127362|NCT00912782|3952691|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127363|NCT00912782|3952692|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127364|NCT00912782|3952693|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127365|NCT00912782|3952691|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4127366|NCT00912782|3952692|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4127367|NCT00912782|3952693|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4127368|NCT00912782|3952691|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4127369|NCT00912782|3952692|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4127370|NCT00912782|3952693|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4127371|NCT00912782|3952691|B3|||Age||years|Mean|51.1|51.1|Standard Deviation|13.2|13.2|||
4127372|NCT00912782|3952692|B2|||Age||years|Mean|49.9|49.9|Standard Deviation|10.9|10.9|||
4127373|NCT00912782|3952693|B1|||Age||years|Mean|52.1|52.1|Standard Deviation|14.9|14.9|||
4127374|NCT00912743|3952702|B3|Other||Race/Ethnicity, Customized|Race|Participants|Number|2|2.0||||||
4127375|NCT00912743|3952703|B2|Other||Race/Ethnicity, Customized|Race|Participants|Number|1|1.0||||||
4127376|NCT00912743|3952704|B1|Other||Race/Ethnicity, Customized|Race|Participants|Number|1|1.0||||||
4127377|NCT00912743|3952702|B3|Asian||Race/Ethnicity, Customized|Race|Participants|Number|1|1.0||||||
4127378|NCT00912743|3952703|B2|Asian||Race/Ethnicity, Customized|Race|Participants|Number|0|0.0||||||
4127379|NCT00912743|3952704|B1|Asian||Race/Ethnicity, Customized|Race|Participants|Number|1|1.0||||||
4127380|NCT00912743|3952702|B3|Black or African American||Race/Ethnicity, Customized|Race|Participants|Number|1|1.0||||||
4127381|NCT00912743|3952703|B2|Black or African American||Race/Ethnicity, Customized|Race|Participants|Number|0|0.0||||||
4127382|NCT00912743|3952704|B1|Black or African American||Race/Ethnicity, Customized|Race|Participants|Number|1|1.0||||||
4127383|NCT00912743|3952702|B3|White||Race/Ethnicity, Customized|Race|Participants|Number|29|29.0||||||
4127384|NCT00912743|3952703|B2|White||Race/Ethnicity, Customized|Race|Participants|Number|19|19.0||||||
4127385|NCT00912743|3952704|B1|White||Race/Ethnicity, Customized|Race|Participants|Number|10|10.0||||||
4127386|NCT00912743|3952702|B3||Male|Sex: Female, Male|Gender, Male/Female|Participants|Count of Participants|18|18.0||||||
4127387|NCT00912743|3952703|B2||Male|Sex: Female, Male|Gender, Male/Female|Participants|Count of Participants|11|11.0||||||
4127388|NCT00912743|3952704|B1||Male|Sex: Female, Male|Gender, Male/Female|Participants|Count of Participants|7|7.0||||||
4127389|NCT00912743|3952702|B3||Female|Sex: Female, Male|Gender, Male/Female|Participants|Count of Participants|15|15.0||||||
4127390|NCT00912743|3952703|B2||Female|Sex: Female, Male|Gender, Male/Female|Participants|Count of Participants|9|9.0||||||
4127391|NCT00912743|3952704|B1||Female|Sex: Female, Male|Gender, Male/Female|Participants|Count of Participants|6|6.0||||||
4127392|NCT00912743|3952702|B3|||Age|Age (years) at screening|years|Mean|57.85|57.85|Standard Deviation|11.65|11.65|||
4127393|NCT00912743|3952703|B2|||Age|Age (years) at screening|years|Mean|61.80|61.8|Standard Deviation|11.46|11.46|||
4127394|NCT00912743|3952704|B1|||Age|Age (years) at screening|years|Mean|51.77|51.77|Standard Deviation|9.37|9.37|||
4127395|NCT00912509|3952715|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4127396|NCT00912509|3952716|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4127397|NCT00912509|3952717|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4127398|NCT00912509|3952715|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4127399|NCT00912509|3952716|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4127400|NCT00912509|3952717|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4127401|NCT00912509|3952715|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4127402|NCT00912509|3952716|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4127403|NCT00912509|3952717|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4127404|NCT00912509|3952715|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4127405|NCT00912509|3952716|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4127406|NCT00912509|3952717|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4127407|NCT00912509|3952715|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4127408|NCT00912509|3952716|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4127409|NCT00912509|3952717|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4127410|NCT00912405|3952726|B1|||Proportion of Patients Undergoing Revision Surgery||participants|Number|14|14.0||||||
4127411|NCT00912405|3952726|B1|||Proportion of Patients with Polyps||participants|Number|33|33.0||||||
4127412|NCT00912405|3952726|B1|||Lund MacKay CT Stage|The Lund Mackay CT Staging system is a scale ranging from 0 to 24, where lower scores represent a better condition. each sinus is scored 0, 1 or 2, where 0=no opacification, 1=partial opacification and 2=complete opacification. 12 areas of the anatomy are evaluated, resulting in the scale ranging from 0 to 24.|units on a scale|Mean|11.2|11.2|Standard Deviation|5.5|5.5|||
4127413|NCT00912405|3952726|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4127414|NCT00912405|3952726|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4127415|NCT00912405|3952726|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4127416|NCT00912405|3952726|B1|||Age||years|Mean|44.2|44.2|Standard Deviation|13.1|13.1|||
4127417|NCT00912340|3952733|B4|United States||Region of Enrollment||participants|Number|0|0.0||||||
4127418|NCT00912340|3952734|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4127419|NCT00912340|3952735|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4127420|NCT00912340|3952736|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4127421|NCT00912340|3952733|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4127422|NCT00912340|3952734|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127423|NCT00912340|3952735|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4127424|NCT00912340|3952736|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127425|NCT00912340|3952733|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127426|NCT00912340|3952734|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127427|NCT00912340|3952735|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127428|NCT00912340|3952736|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127429|NCT00912340|3952733|B4||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4127430|NCT00912340|3952734|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4127431|NCT00912340|3952735|B2||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4127432|NCT00912340|3952736|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4127433|NCT00912340|3952733|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4127434|NCT00912340|3952734|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4127435|NCT00912340|3952735|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4127436|NCT00912340|3952736|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4127437|NCT00912340|3952733|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127438|NCT00912340|3952734|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127439|NCT00912340|3952735|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127440|NCT00912340|3952736|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127441|NCT00912340|3952733|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4127442|NCT00912340|3952734|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4127443|NCT00912340|3952735|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127444|NCT00912340|3952736|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127445|NCT00912340|3952733|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127446|NCT00912340|3952734|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127447|NCT00912340|3952735|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127448|NCT00912340|3952736|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127449|NCT00912340|3952733|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4127450|NCT00912340|3952734|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127451|NCT00912340|3952735|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4127452|NCT00912340|3952736|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4127453|NCT00912340|3952733|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4127454|NCT00912340|3952734|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4127455|NCT00912340|3952735|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4127456|NCT00912340|3952736|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4127457|NCT00912340|3952733|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4127458|NCT00912340|3952734|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127459|NCT00912340|3952735|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4127460|NCT00912340|3952736|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127461|NCT00912340|3952733|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4127462|NCT00912340|3952734|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4127463|NCT00912340|3952735|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4127464|NCT00912340|3952736|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4127465|NCT00912340|3952733|B4||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4127466|NCT00912340|3952734|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4127467|NCT00912340|3952735|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4127468|NCT00912340|3952736|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4127469|NCT00912340|3952733|B4|Age range 81-89||Age, Customized||Participants|Count of Participants|1|1.0||||||
4127470|NCT00912340|3952734|B3|Age range 81-89||Age, Customized||Participants|Count of Participants|0|0.0||||||
4127471|NCT00912340|3952735|B2|Age range 81-89||Age, Customized||Participants|Count of Participants|1|1.0||||||
4127472|NCT00912340|3952736|B1|Age range 81-89||Age, Customized||Participants|Count of Participants|0|0.0||||||
4127473|NCT00912340|3952733|B4|Age range 70-79||Age, Customized||Participants|Count of Participants|14|14.0||||||
4127474|NCT00912340|3952734|B3|Age range 70-79||Age, Customized||Participants|Count of Participants|0|0.0||||||
4127475|NCT00912340|3952735|B2|Age range 70-79||Age, Customized||Participants|Count of Participants|7|7.0||||||
4127476|NCT00912340|3952736|B1|Age range 70-79||Age, Customized||Participants|Count of Participants|7|7.0||||||
4127477|NCT00912340|3952733|B4|Age range 60-69||Age, Customized||Participants|Count of Participants|17|17.0||||||
4127478|NCT00912340|3952734|B3|Age range 60-69||Age, Customized||Participants|Count of Participants|4|4.0||||||
4127479|NCT00912340|3952735|B2|Age range 60-69||Age, Customized||Participants|Count of Participants|9|9.0||||||
4127480|NCT00912340|3952736|B1|Age range 60-69||Age, Customized||Participants|Count of Participants|4|4.0||||||
4127481|NCT00912340|3952733|B4|Age range 50-59||Age, Customized||Participants|Count of Participants|17|17.0||||||
4127482|NCT00912340|3952734|B3|Age range 50-59||Age, Customized||Participants|Count of Participants|0|0.0||||||
4127483|NCT00912340|3952735|B2|Age range 50-59||Age, Customized||Participants|Count of Participants|8|8.0||||||
4127484|NCT00912340|3952736|B1|Age range 50-59||Age, Customized||Participants|Count of Participants|9|9.0||||||
4127485|NCT00912340|3952733|B4|Age range 40-49||Age, Customized||Participants|Count of Participants|7|7.0||||||
4127486|NCT00912340|3952734|B3|Age range 40-49||Age, Customized||Participants|Count of Participants|0|0.0||||||
4127487|NCT00912340|3952735|B2|Age range 40-49||Age, Customized||Participants|Count of Participants|5|5.0||||||
4127488|NCT00912340|3952736|B1|Age range 40-49||Age, Customized||Participants|Count of Participants|2|2.0||||||
4127489|NCT00912340|3952733|B4|Age range 30-39||Age, Customized||Participants|Count of Participants|2|2.0||||||
4127490|NCT00912340|3952734|B3|Age range 30-39||Age, Customized||Participants|Count of Participants|0|0.0||||||
4127491|NCT00912340|3952735|B2|Age range 30-39||Age, Customized||Participants|Count of Participants|0|0.0||||||
4127492|NCT00912340|3952736|B1|Age range 30-39||Age, Customized||Participants|Count of Participants|2|2.0||||||
4127493|NCT00912301|3952749|B4|United States||Region of Enrollment||participants|Number|36|36.0||||||
4127494|NCT00912301|3952750|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4127495|NCT00912301|3952751|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4127496|NCT00912301|3952752|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4127497|NCT00912301|3952749|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4127498|NCT00912301|3952750|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4127499|NCT00912301|3952751|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4127500|NCT00912301|3952752|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4127501|NCT00912301|3952749|B4||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4127502|NCT00912301|3952750|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4127503|NCT00912301|3952751|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4127504|NCT00912301|3952752|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4127505|NCT00912301|3952749|B4|||Age||years|Mean|42|42.0|Standard Deviation|10|10.0|||
4127506|NCT00912301|3952750|B3|||Age||years|Mean|40.8|40.8|Standard Deviation|2.3|2.3|||
4127507|NCT00912301|3952751|B2|||Age||years|Mean|46.1|46.1|Standard Deviation|2.6|2.6|||
4127508|NCT00912301|3952752|B1|||Age||years|Mean|38.3|38.3|Standard Deviation|3.3|3.3|||
4127509|NCT00912288|3952774|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4127510|NCT00912288|3952775|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4127511|NCT00912288|3952776|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4127512|NCT00912288|3952774|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4127513|NCT00912288|3952775|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4127514|NCT00912288|3952776|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4127515|NCT00912288|3952774|B3|Greater than 85 years||Age, Customized||Participants|Number|11|11.0||||||
4127516|NCT00912288|3952775|B2|Greater than 85 years||Age, Customized||Participants|Number|8|8.0||||||
4127517|NCT00912288|3952776|B1|Greater than 85 years||Age, Customized||Participants|Number|3|3.0||||||
4127518|NCT00912288|3952774|B3|80 to 85 years||Age, Customized||Participants|Number|19|19.0||||||
4127519|NCT00912288|3952775|B2|80 to 85 years||Age, Customized||Participants|Number|9|9.0||||||
4127520|NCT00912288|3952776|B1|80 to 85 years||Age, Customized||Participants|Number|10|10.0||||||
4127521|NCT00912288|3952774|B3|70 to 79 years||Age, Customized||Participants|Number|36|36.0||||||
4127522|NCT00912288|3952775|B2|70 to 79 years||Age, Customized||Participants|Number|16|16.0||||||
4127523|NCT00912288|3952776|B1|70 to 79 years||Age, Customized||Participants|Number|20|20.0||||||
4127524|NCT00912288|3952774|B3|60 to 69 years||Age, Customized||Participants|Number|17|17.0||||||
4127525|NCT00912288|3952775|B2|60 to 69 years||Age, Customized||Participants|Number|8|8.0||||||
4127526|NCT00912288|3952776|B1|60 to 69 years||Age, Customized||Participants|Number|9|9.0||||||
4127527|NCT00912288|3952774|B3|50 to 59 years||Age, Customized||Participants|Number|3|3.0||||||
4127528|NCT00912288|3952775|B2|50 to 59 years||Age, Customized||Participants|Number|1|1.0||||||
4127529|NCT00912288|3952776|B1|50 to 59 years||Age, Customized||Participants|Number|2|2.0||||||
4127530|NCT00912223|3952799|B1|Negative||Recipient Cytomegalovirus Status||participants|Number|27|27.0||||||
4127531|NCT00912223|3952799|B1|Positive||Recipient Cytomegalovirus Status||participants|Number|35|35.0||||||
4127532|NCT00912223|3952799|B1|Matched Unrelated Donor (8/8 allele)||Donor Type (HLA match)||participants|Number|29|29.0||||||
4127533|NCT00912223|3952799|B1|Matched Related Donor (6/6 allele)||Donor Type (HLA match)||participants|Number|33|33.0||||||
4127534|NCT00912223|3952799|B1|≥ 5||Number of Prior Chemotherapy Regimens||participants|Number|20|20.0||||||
4127535|NCT00912223|3952799|B1|4||Number of Prior Chemotherapy Regimens||participants|Number|12|12.0||||||
4127536|NCT00912223|3952799|B1|3||Number of Prior Chemotherapy Regimens||participants|Number|16|16.0||||||
4127537|NCT00912223|3952799|B1|2||Number of Prior Chemotherapy Regimens||participants|Number|14|14.0||||||
4127575|NCT00912158|3952815|B4||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4127538|NCT00912223|3952799|B1|Unknown||Disease Status|Disease status is categorized best to worst by second/subsequent complete remission (CR2), first partial remission (PR1), second partial remission (PR2). Complete remission criteria is disappearance of all evidence of disease and partial remission criteria is regression of measurable disease and no new sites.|participants|Number|6|6.0||||||
4127539|NCT00912223|3952799|B1|Stable Disease||Disease Status|Disease status is categorized best to worst by second/subsequent complete remission (CR2), first partial remission (PR1), second partial remission (PR2). Complete remission criteria is disappearance of all evidence of disease and partial remission criteria is regression of measurable disease and no new sites.|participants|Number|2|2.0||||||
4127540|NCT00912223|3952799|B1|≥ PR2||Disease Status|Disease status is categorized best to worst by second/subsequent complete remission (CR2), first partial remission (PR1), second partial remission (PR2). Complete remission criteria is disappearance of all evidence of disease and partial remission criteria is regression of measurable disease and no new sites.|participants|Number|16|16.0||||||
4127541|NCT00912223|3952799|B1|PR1||Disease Status|Disease status is categorized best to worst by second/subsequent complete remission (CR2), first partial remission (PR1), second partial remission (PR2). Complete remission criteria is disappearance of all evidence of disease and partial remission criteria is regression of measurable disease and no new sites.|participants|Number|6|6.0||||||
4127542|NCT00912223|3952799|B1|CR2||Disease Status|Disease status is categorized best to worst by second/subsequent complete remission (CR2), first partial remission (PR1), second partial remission (PR2). Complete remission criteria is disappearance of all evidence of disease and partial remission criteria is regression of measurable disease and no new sites.|participants|Number|32|32.0||||||
4127543|NCT00912223|3952799|B1|>3||Comorbidity Index Score|Comorbidity is graded on a scale of 0 to 6 based on the adjusted risk of mortality and the sum of scores result in a single comorbidity index score for a participant. A score of zero indicates that no comorbidities were found. The higher the score, the more likely the predicted outcome will result in mortality.|participants|Number|15|15.0||||||
4127544|NCT00912223|3952799|B1|1-2||Comorbidity Index Score|Comorbidity is graded on a scale of 0 to 6 based on the adjusted risk of mortality and the sum of scores result in a single comorbidity index score for a participant. A score of zero indicates that no comorbidities were found. The higher the score, the more likely the predicted outcome will result in mortality.|participants|Number|16|16.0||||||
4127545|NCT00912223|3952799|B1|0||Comorbidity Index Score|Comorbidity is graded on a scale of 0 to 6 based on the adjusted risk of mortality and the sum of scores result in a single comorbidity index score for a participant. A score of zero indicates that no comorbidities were found. The higher the score, the more likely the predicted outcome will result in mortality.|participants|Number|31|31.0||||||
4127546|NCT00912223|3952799|B1|80||Karnofsky Performance Score|Assesses patient self-perceived global quality of life and functioning on a scale of 0 - 100; where 100 equals normal quality of life with no evidence of disease, 90 equals ability to carry on normal activity with minor signs/symptoms of disease, and 80 equals normal activity with effort and some signs/symptoms of disease.|participants|Number|5|5.0||||||
4127547|NCT00912223|3952799|B1|90||Karnofsky Performance Score|Assesses patient self-perceived global quality of life and functioning on a scale of 0 - 100; where 100 equals normal quality of life with no evidence of disease, 90 equals ability to carry on normal activity with minor signs/symptoms of disease, and 80 equals normal activity with effort and some signs/symptoms of disease.|participants|Number|28|28.0||||||
4127548|NCT00912223|3952799|B1|100||Karnofsky Performance Score|Assesses patient self-perceived global quality of life and functioning on a scale of 0 - 100; where 100 equals normal quality of life with no evidence of disease, 90 equals ability to carry on normal activity with minor signs/symptoms of disease, and 80 equals normal activity with effort and some signs/symptoms of disease.|participants|Number|29|29.0||||||
4127549|NCT00912223|3952799|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127550|NCT00912223|3952799|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4127551|NCT00912223|3952799|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4127552|NCT00912223|3952799|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4127553|NCT00912223|3952799|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4127554|NCT00912223|3952799|B1|||Age||years|Median|55|55.0|Full Range|||29.0|74.0|
4127555|NCT00912158|3952815|B4|Egypt||Region of Enrollment||participants|Number|129|129.0||||||
4127556|NCT00912158|3952816|B3|Egypt||Region of Enrollment||participants|Number|41|41.0||||||
4127557|NCT00912158|3952817|B2|Egypt||Region of Enrollment||participants|Number|44|44.0||||||
4127558|NCT00912158|3952818|B1|Egypt||Region of Enrollment||participants|Number|44|44.0||||||
4127559|NCT00912158|3952815|B4||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4127560|NCT00912158|3952816|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4127561|NCT00912158|3952817|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4127562|NCT00912158|3952818|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4127563|NCT00912158|3952815|B4||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4127564|NCT00912158|3952816|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4127565|NCT00912158|3952817|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4127566|NCT00912158|3952818|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4127567|NCT00912158|3952815|B4|||Age||years|Mean|67|67.0|Standard Deviation|4.8|4.8|||
4127568|NCT00912158|3952816|B3|||Age||years|Mean|69|69.0|Standard Deviation|5.8|5.8|||
4127569|NCT00912158|3952817|B2|||Age||years|Mean|68|68.0|Standard Deviation|3.8|3.8|||
4127570|NCT00912158|3952818|B1|||Age||years|Mean|66|66.0|Standard Deviation|6.9|6.9|||
4127571|NCT00912158|3952815|B4||>=65 years|Age||Participants|Count of Participants|93|93.0||||||
4127572|NCT00912158|3952816|B3||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4127573|NCT00912158|3952817|B2||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4127574|NCT00912158|3952818|B1||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4127576|NCT00912158|3952816|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4127577|NCT00912158|3952817|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4127578|NCT00912158|3952818|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4127579|NCT00912158|3952815|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4127580|NCT00912158|3952816|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4127581|NCT00912158|3952817|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4127582|NCT00912158|3952818|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4127583|NCT00912093|3952825|B6|>100 kg||Weight (kg)||participants|Number|22|22.0||||||
4127584|NCT00912093|3952826|B5|>100 kg||Weight (kg)||participants|Number|2|2.0||||||
4127585|NCT00912093|3952827|B4|>100 kg||Weight (kg)||participants|Number|0|0.0||||||
4127586|NCT00912093|3952828|B3|>100 kg||Weight (kg)||participants|Number|1|1.0||||||
4127587|NCT00912093|3952829|B2|>100 kg||Weight (kg)||participants|Number|10|10.0||||||
4127588|NCT00912093|3952830|B1|>100 kg||Weight (kg)||participants|Number|9|9.0||||||
4127589|NCT00912093|3952825|B6|>75-100 kg||Weight (kg)||participants|Number|31|31.0||||||
4127590|NCT00912093|3952826|B5|>75-100 kg||Weight (kg)||participants|Number|3|3.0||||||
4127591|NCT00912093|3952827|B4|>75-100 kg||Weight (kg)||participants|Number|0|0.0||||||
4127592|NCT00912093|3952828|B3|>75-100 kg||Weight (kg)||participants|Number|1|1.0||||||
4127593|NCT00912093|3952829|B2|>75-100 kg||Weight (kg)||participants|Number|13|13.0||||||
4127594|NCT00912093|3952830|B1|>75-100 kg||Weight (kg)||participants|Number|14|14.0||||||
4127595|NCT00912093|3952825|B6|>50-75 kg||Weight (kg)||participants|Number|39|39.0||||||
4127596|NCT00912093|3952826|B5|>50-75 kg||Weight (kg)||participants|Number|0|0.0||||||
4127597|NCT00912093|3952827|B4|>50-75 kg||Weight (kg)||participants|Number|2|2.0||||||
4127598|NCT00912093|3952828|B3|>50-75 kg||Weight (kg)||participants|Number|1|1.0||||||
4127599|NCT00912093|3952829|B2|>50-75 kg||Weight (kg)||participants|Number|20|20.0||||||
4127600|NCT00912093|3952830|B1|>50-75 kg||Weight (kg)||participants|Number|16|16.0||||||
4127601|NCT00912093|3952825|B6|<= 50 kg||Weight (kg)||participants|Number|6|6.0||||||
4127602|NCT00912093|3952826|B5|<= 50 kg||Weight (kg)||participants|Number|0|0.0||||||
4127603|NCT00912093|3952827|B4|<= 50 kg||Weight (kg)||participants|Number|0|0.0||||||
4127604|NCT00912093|3952828|B3|<= 50 kg||Weight (kg)||participants|Number|0|0.0||||||
4127605|NCT00912093|3952829|B2|<= 50 kg||Weight (kg)||participants|Number|2|2.0||||||
4127606|NCT00912093|3952830|B1|<= 50 kg||Weight (kg)||participants|Number|4|4.0||||||
4127607|NCT00912093|3952825|B6|Israel||Region of Enrollment||participants|Number|10|10.0||||||
4127608|NCT00912093|3952826|B5|Israel||Region of Enrollment||participants|Number|1|1.0||||||
4127609|NCT00912093|3952827|B4|Israel||Region of Enrollment||participants|Number|0|0.0||||||
4127610|NCT00912093|3952828|B3|Israel||Region of Enrollment||participants|Number|0|0.0||||||
4127611|NCT00912093|3952829|B2|Israel||Region of Enrollment||participants|Number|5|5.0||||||
4127612|NCT00912093|3952830|B1|Israel||Region of Enrollment||participants|Number|4|4.0||||||
4127613|NCT00912093|3952825|B6|South Africa||Region of Enrollment||participants|Number|4|4.0||||||
4127614|NCT00912093|3952826|B5|South Africa||Region of Enrollment||participants|Number|1|1.0||||||
4127615|NCT00912093|3952827|B4|South Africa||Region of Enrollment||participants|Number|0|0.0||||||
4127616|NCT00912093|3952828|B3|South Africa||Region of Enrollment||participants|Number|0|0.0||||||
4127617|NCT00912093|3952829|B2|South Africa||Region of Enrollment||participants|Number|1|1.0||||||
4127618|NCT00912093|3952830|B1|South Africa||Region of Enrollment||participants|Number|2|2.0||||||
4127619|NCT00912093|3952825|B6|Russian Federation||Region of Enrollment||participants|Number|3|3.0||||||
4127620|NCT00912093|3952826|B5|Russian Federation||Region of Enrollment||participants|Number|0|0.0||||||
4127621|NCT00912093|3952827|B4|Russian Federation||Region of Enrollment||participants|Number|0|0.0||||||
4127622|NCT00912093|3952828|B3|Russian Federation||Region of Enrollment||participants|Number|0|0.0||||||
4127623|NCT00912093|3952829|B2|Russian Federation||Region of Enrollment||participants|Number|1|1.0||||||
4127624|NCT00912093|3952830|B1|Russian Federation||Region of Enrollment||participants|Number|2|2.0||||||
4127625|NCT00912093|3952825|B6|Australia||Region of Enrollment||participants|Number|5|5.0||||||
4127626|NCT00912093|3952826|B5|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4127627|NCT00912093|3952827|B4|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4127628|NCT00912093|3952828|B3|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4127629|NCT00912093|3952829|B2|Australia||Region of Enrollment||participants|Number|3|3.0||||||
4127630|NCT00912093|3952830|B1|Australia||Region of Enrollment||participants|Number|2|2.0||||||
4127631|NCT00912093|3952825|B6|Romania||Region of Enrollment||participants|Number|5|5.0||||||
4127632|NCT00912093|3952826|B5|Romania||Region of Enrollment||participants|Number|0|0.0||||||
4127633|NCT00912093|3952827|B4|Romania||Region of Enrollment||participants|Number|0|0.0||||||
4127634|NCT00912093|3952828|B3|Romania||Region of Enrollment||participants|Number|1|1.0||||||
4127635|NCT00912093|3952829|B2|Romania||Region of Enrollment||participants|Number|1|1.0||||||
4127636|NCT00912093|3952830|B1|Romania||Region of Enrollment||participants|Number|3|3.0||||||
4127637|NCT00912093|3952825|B6|Ukraine||Region of Enrollment||participants|Number|1|1.0||||||
4127638|NCT00912093|3952826|B5|Ukraine||Region of Enrollment||participants|Number|0|0.0||||||
4127639|NCT00912093|3952827|B4|Ukraine||Region of Enrollment||participants|Number|0|0.0||||||
4127640|NCT00912093|3952828|B3|Ukraine||Region of Enrollment||participants|Number|0|0.0||||||
4127641|NCT00912093|3952829|B2|Ukraine||Region of Enrollment||participants|Number|1|1.0||||||
4127642|NCT00912093|3952830|B1|Ukraine||Region of Enrollment||participants|Number|0|0.0||||||
4127643|NCT00912093|3952825|B6|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4127644|NCT00912093|3952826|B5|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4127645|NCT00912093|3952827|B4|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4127646|NCT00912093|3952828|B3|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4127647|NCT00912093|3952829|B2|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4127648|NCT00912093|3952830|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4127649|NCT00912093|3952825|B6|Hungary||Region of Enrollment||participants|Number|4|4.0||||||
4127650|NCT00912093|3952826|B5|Hungary||Region of Enrollment||participants|Number|0|0.0||||||
4127651|NCT00912093|3952827|B4|Hungary||Region of Enrollment||participants|Number|0|0.0||||||
4127652|NCT00912093|3952828|B3|Hungary||Region of Enrollment||participants|Number|0|0.0||||||
4127653|NCT00912093|3952829|B2|Hungary||Region of Enrollment||participants|Number|1|1.0||||||
4127654|NCT00912093|3952830|B1|Hungary||Region of Enrollment||participants|Number|3|3.0||||||
4127655|NCT00912093|3952825|B6|United States||Region of Enrollment||participants|Number|65|65.0||||||
4127656|NCT00912093|3952826|B5|United States||Region of Enrollment||participants|Number|3|3.0||||||
4127657|NCT00912093|3952827|B4|United States||Region of Enrollment||participants|Number|2|2.0||||||
4127658|NCT00912093|3952828|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4127659|NCT00912093|3952829|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
4127660|NCT00912093|3952830|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4127661|NCT00912093|3952825|B6|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4127662|NCT00912093|3952826|B5|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4127663|NCT00912093|3952827|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4127664|NCT00912093|3952828|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4127665|NCT00912093|3952829|B2|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4127666|NCT00912093|3952830|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4127667|NCT00912093|3952825|B6|White||Race/Ethnicity, Customized||participants|Number|87|87.0||||||
4127668|NCT00912093|3952826|B5|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4127669|NCT00912093|3952827|B4|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4127670|NCT00912093|3952828|B3|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4127671|NCT00912093|3952829|B2|White||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4127672|NCT00912093|3952830|B1|White||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4127673|NCT00912093|3952825|B6|Native Hawaiian or Other Pacific||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4127674|NCT00912093|3952826|B5|Native Hawaiian or Other Pacific||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4127675|NCT00912093|3952827|B4|Native Hawaiian or Other Pacific||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4127676|NCT00912093|3952828|B3|Native Hawaiian or Other Pacific||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4127677|NCT00912093|3952829|B2|Native Hawaiian or Other Pacific||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4127678|NCT00912093|3952830|B1|Native Hawaiian or Other Pacific||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4127679|NCT00912093|3952825|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4127680|NCT00912093|3952826|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4127681|NCT00912093|3952827|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4127682|NCT00912093|3952828|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4127683|NCT00912093|3952829|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4127684|NCT00912093|3952830|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4127685|NCT00912093|3952825|B6|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4127686|NCT00912093|3952826|B5|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4127687|NCT00912093|3952827|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4127688|NCT00912093|3952828|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4127689|NCT00912093|3952829|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4127690|NCT00912093|3952830|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4127691|NCT00912093|3952825|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4127692|NCT00912093|3952826|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4127693|NCT00912093|3952827|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4127694|NCT00912093|3952828|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4127695|NCT00912093|3952829|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4127696|NCT00912093|3952830|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4127697|NCT00912093|3952825|B6||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4127698|NCT00912093|3952826|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4127699|NCT00912093|3952827|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4127700|NCT00912093|3952828|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4127701|NCT00912093|3952829|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4127702|NCT00912093|3952830|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4127703|NCT00912093|3952825|B6||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4127704|NCT00912093|3952826|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4127705|NCT00912093|3952827|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4127706|NCT00912093|3952828|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4127707|NCT00912093|3952829|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4127708|NCT00912093|3952830|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4127709|NCT00912093|3952825|B6|||Age||years|Mean|37.0|37.0|Standard Deviation|12.46|12.46|||
4127710|NCT00912093|3952826|B5|||Age||years|Mean|41.6|41.6|Standard Deviation|11.78|11.78|||
4127711|NCT00912093|3952827|B4|||Age||years|Mean|50.0|50.0|Standard Deviation|22.63|22.63|||
4127712|NCT00912093|3952828|B3|||Age||years|Mean|40.3|40.3|Standard Deviation|6.66|6.66|||
4127713|NCT00912093|3952829|B2|||Age||years|Mean|36.6|36.6|Standard Deviation|11.18|11.18|||
4127714|NCT00912093|3952830|B1|||Age||years|Mean|36.1|36.1|Standard Deviation|13.69|13.69|||
4127715|NCT00912028|3952850|B4|Brazil||Region of Enrollment||participants|Number|59|59.0||||||
4127716|NCT00912028|3952851|B3|Brazil||Region of Enrollment||participants|Number|16|16.0||||||
4127717|NCT00912028|3952852|B2|Brazil||Region of Enrollment||participants|Number|13|13.0||||||
4127718|NCT00912028|3952853|B1|Brazil||Region of Enrollment||participants|Number|30|30.0||||||
4127719|NCT00912028|3952850|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4127720|NCT00912028|3952851|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4127721|NCT00912028|3952852|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4127722|NCT00912028|3952853|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4127723|NCT00912028|3952850|B4||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4127724|NCT00912028|3952851|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4127725|NCT00912028|3952852|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4127726|NCT00912028|3952853|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4127727|NCT00912028|3952850|B4|||Age||years|Mean|24.5|24.5|Standard Deviation|4.2|4.2|||
4127728|NCT00912028|3952851|B3|||Age||years|Mean|27.0|27.0|Standard Deviation|4.2|4.2|||
4127729|NCT00912028|3952852|B2|||Age||years|Mean|22.7|22.7|Standard Deviation|3.5|3.5|||
4127730|NCT00912028|3952853|B1|||Age||years|Mean|23.9|23.9|Standard Deviation|3.9|3.9|||
4127731|NCT00912015|3952882|B5||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4127732|NCT00912015|3952883|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4127733|NCT00912015|3952884|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4127734|NCT00912015|3952885|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4127735|NCT00912015|3952886|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4127736|NCT00912015|3952882|B5||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4127737|NCT00912015|3952883|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4127738|NCT00912015|3952884|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4127739|NCT00912015|3952885|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4127740|NCT00912015|3952886|B1||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4127741|NCT00912015|3952882|B5|||Age||years|Mean|60.0|60.0|Standard Deviation|9.3|9.3|||
4127742|NCT00912015|3952883|B4|||Age||years|Mean|56.0|56.0|Standard Deviation|5.7|5.7|||
4127743|NCT00912015|3952884|B3|||Age||years|Mean|58.5|58.5|Standard Deviation|10.8|10.8|||
4127744|NCT00912015|3952885|B2|||Age||years|Mean|60.5|60.5|Standard Deviation|8.8|8.8|||
4127745|NCT00912015|3952886|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|9.3|9.3|||
4127746|NCT00912015|3952882|B5||>=65 years|Age||Participants|Count of Participants|91|91.0||||||
4127747|NCT00912015|3952883|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4127748|NCT00912015|3952884|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4127749|NCT00912015|3952885|B2||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4127750|NCT00912015|3952886|B1||>=65 years|Age||Participants|Count of Participants|54|54.0||||||
4127751|NCT00912015|3952882|B5||Between 18 and 65 years|Age||Participants|Count of Participants|147|147.0||||||
4127752|NCT00912015|3952883|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4127753|NCT00912015|3952884|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4127754|NCT00912015|3952885|B2||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4127755|NCT00912015|3952886|B1||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
4127756|NCT00912015|3952882|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4127757|NCT00912015|3952883|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4127758|NCT00912015|3952884|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4127759|NCT00912015|3952885|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4127760|NCT00912015|3952886|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4127761|NCT00912002|3952899|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4127762|NCT00912002|3952899|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4127763|NCT00912002|3952899|B1|>55 years||Age, Customized||participants|Number|0|0.0||||||
4127764|NCT00912002|3952899|B1|29 years to 55 years||Age, Customized||participants|Number|6|6.0||||||
4127765|NCT00912002|3952899|B1|<29 years||Age, Customized||participants|Number|0|0.0||||||
4127766|NCT00911989|3952905|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4127767|NCT00911989|3952905|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4127768|NCT00911989|3952905|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4127769|NCT00911989|3952905|B1|||Age||years|Mean|48.3|48.3|Standard Deviation|11.64|11.64|||
4127770|NCT00911989|3952905|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4127771|NCT00911989|3952905|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4127772|NCT00911989|3952905|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4127773|NCT00911937|3952909|B3||Male|Sex: Female, Male||Participants|Count of Participants|312|312.0||||||
4127774|NCT00911937|3952910|B2||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4127775|NCT00911937|3952911|B1||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4127776|NCT00911937|3952909|B3||Female|Sex: Female, Male||Participants|Count of Participants|625|625.0||||||
4127777|NCT00911937|3952910|B2||Female|Sex: Female, Male||Participants|Count of Participants|313|313.0||||||
4127778|NCT00911937|3952911|B1||Female|Sex: Female, Male||Participants|Count of Participants|312|312.0||||||
4127779|NCT00911937|3952909|B3|At least 65 years||Age, Customized||participants|Number|308|308.0||||||
4127780|NCT00911937|3952910|B2|At least 65 years||Age, Customized||participants|Number|165|165.0||||||
4127781|NCT00911937|3952911|B1|At least 65 years||Age, Customized||participants|Number|143|143.0||||||
4127782|NCT00911937|3952909|B3|45 to 64 years||Age, Customized||participants|Number|471|471.0||||||
4127783|NCT00911937|3952910|B2|45 to 64 years||Age, Customized||participants|Number|214|214.0||||||
4127784|NCT00911937|3952911|B1|45 to 64 years||Age, Customized||participants|Number|257|257.0||||||
4127785|NCT00911937|3952909|B3|18 to 44 years||Age, Customized||participants|Number|158|158.0||||||
4127786|NCT00911937|3952910|B2|18 to 44 years||Age, Customized||participants|Number|84|84.0||||||
4127787|NCT00911937|3952911|B1|18 to 44 years||Age, Customized||participants|Number|74|74.0||||||
4127788|NCT00911898|3952972|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4127789|NCT00911898|3952972|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4127790|NCT00911898|3952972|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4127791|NCT00911898|3952972|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4127792|NCT00911898|3952972|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4127793|NCT00911898|3952972|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4127794|NCT00911898|3952972|B1|||Age||years|Median|61.0|61.0|Full Range|||30.0|82.0|
4127795|NCT00911859|3952976|B4|UNITED STATES||Region of Enrollment||participants|Number|5|5.0||||||
4127796|NCT00911859|3952977|B3|UNITED STATES||Region of Enrollment||participants|Number|2|2.0||||||
4127797|NCT00911859|3952978|B2|UNITED STATES||Region of Enrollment||participants|Number|3|3.0||||||
4127798|NCT00911859|3952979|B1|UNITED STATES||Region of Enrollment||participants|Number|0|0.0||||||
4127799|NCT00911859|3952976|B4|SPAIN||Region of Enrollment||participants|Number|24|24.0||||||
4127800|NCT00911859|3952977|B3|SPAIN||Region of Enrollment||participants|Number|7|7.0||||||
4127801|NCT00911859|3952978|B2|SPAIN||Region of Enrollment||participants|Number|5|5.0||||||
4127802|NCT00911859|3952979|B1|SPAIN||Region of Enrollment||participants|Number|12|12.0||||||
4127803|NCT00911859|3952976|B4|SOUTH KOREA||Region of Enrollment||participants|Number|15|15.0||||||
4127804|NCT00911859|3952977|B3|SOUTH KOREA||Region of Enrollment||participants|Number|8|8.0||||||
4127805|NCT00911859|3952978|B2|SOUTH KOREA||Region of Enrollment||participants|Number|7|7.0||||||
4127806|NCT00911859|3952979|B1|SOUTH KOREA||Region of Enrollment||participants|Number|0|0.0||||||
4127807|NCT00911859|3952976|B4|SINGAPORE||Region of Enrollment||participants|Number|5|5.0||||||
4127808|NCT00911859|3952977|B3|SINGAPORE||Region of Enrollment||participants|Number|2|2.0||||||
4127809|NCT00911859|3952978|B2|SINGAPORE||Region of Enrollment||participants|Number|3|3.0||||||
4127810|NCT00911859|3952979|B1|SINGAPORE||Region of Enrollment||participants|Number|0|0.0||||||
4127811|NCT00911859|3952976|B4|RUSSIAN FEDERATION||Region of Enrollment||participants|Number|20|20.0||||||
4127812|NCT00911859|3952977|B3|RUSSIAN FEDERATION||Region of Enrollment||participants|Number|10|10.0||||||
4127813|NCT00911859|3952978|B2|RUSSIAN FEDERATION||Region of Enrollment||participants|Number|10|10.0||||||
4127814|NCT00911859|3952979|B1|RUSSIAN FEDERATION||Region of Enrollment||participants|Number|0|0.0||||||
4127815|NCT00911859|3952976|B4|ROMANIA||Region of Enrollment||participants|Number|2|2.0||||||
4127816|NCT00911859|3952977|B3|ROMANIA||Region of Enrollment||participants|Number|0|0.0||||||
4127817|NCT00911859|3952978|B2|ROMANIA||Region of Enrollment||participants|Number|2|2.0||||||
4127818|NCT00911859|3952979|B1|ROMANIA||Region of Enrollment||participants|Number|0|0.0||||||
4127819|NCT00911859|3952976|B4|POLAND||Region of Enrollment||participants|Number|16|16.0||||||
4127820|NCT00911859|3952977|B3|POLAND||Region of Enrollment||participants|Number|11|11.0||||||
4127821|NCT00911859|3952978|B2|POLAND||Region of Enrollment||participants|Number|5|5.0||||||
4127822|NCT00911859|3952979|B1|POLAND||Region of Enrollment||participants|Number|0|0.0||||||
4127823|NCT00911859|3952976|B4|ITALY||Region of Enrollment||participants|Number|4|4.0||||||
4127824|NCT00911859|3952977|B3|ITALY||Region of Enrollment||participants|Number|2|2.0||||||
4127825|NCT00911859|3952978|B2|ITALY||Region of Enrollment||participants|Number|2|2.0||||||
4127826|NCT00911859|3952979|B1|ITALY||Region of Enrollment||participants|Number|0|0.0||||||
4127827|NCT00911859|3952976|B4|ISRAEL||Region of Enrollment||participants|Number|12|12.0||||||
4127828|NCT00911859|3952977|B3|ISRAEL||Region of Enrollment||participants|Number|5|5.0||||||
4127829|NCT00911859|3952978|B2|ISRAEL||Region of Enrollment||participants|Number|7|7.0||||||
4127830|NCT00911859|3952979|B1|ISRAEL||Region of Enrollment||participants|Number|0|0.0||||||
4127831|NCT00911859|3952976|B4|INDIA||Region of Enrollment||participants|Number|4|4.0||||||
4127832|NCT00911859|3952977|B3|INDIA||Region of Enrollment||participants|Number|1|1.0||||||
4127833|NCT00911859|3952978|B2|INDIA||Region of Enrollment||participants|Number|3|3.0||||||
4127834|NCT00911859|3952979|B1|INDIA||Region of Enrollment||participants|Number|0|0.0||||||
4127835|NCT00911859|3952976|B4|FRANCE||Region of Enrollment||participants|Number|7|7.0||||||
4127836|NCT00911859|3952977|B3|FRANCE||Region of Enrollment||participants|Number|2|2.0||||||
4127837|NCT00911859|3952978|B2|FRANCE||Region of Enrollment||participants|Number|5|5.0||||||
4127838|NCT00911859|3952979|B1|FRANCE||Region of Enrollment||participants|Number|0|0.0||||||
4127839|NCT00911859|3952976|B4|AUSTRALIA||Region of Enrollment||participants|Number|4|4.0||||||
4127840|NCT00911859|3952977|B3|AUSTRALIA||Region of Enrollment||participants|Number|2|2.0||||||
4127841|NCT00911859|3952978|B2|AUSTRALIA||Region of Enrollment||participants|Number|2|2.0||||||
4127842|NCT00911859|3952979|B1|AUSTRALIA||Region of Enrollment||participants|Number|0|0.0||||||
4127843|NCT00911859|3952976|B4||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4127844|NCT00911859|3952977|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4127845|NCT00911859|3952978|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4127846|NCT00911859|3952979|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4127847|NCT00911859|3952976|B4||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4127848|NCT00911859|3952977|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4127849|NCT00911859|3952978|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4127850|NCT00911859|3952979|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4127851|NCT00911859|3952976|B4|||Age||years|Mean|71.2|71.2|Standard Deviation|6.21|6.21|||
4127852|NCT00911859|3952977|B3|||Age||years|Mean|71.6|71.6|Standard Deviation|4.76|4.76|||
4127853|NCT00911859|3952978|B2|||Age||years|Mean|70.3|70.3|Standard Deviation|7.27|7.27|||
4127854|NCT00911859|3952979|B1|||Age||years|Mean|73.6|73.6|Standard Deviation|6.3|6.3|||
4127855|NCT00911820|3953005|B3|Gastric||Tumor Location||Participants|Count of Participants|27|27.0||||||
4127856|NCT00911820|3953006|B2|Gastric||Tumor Location||Participants|Count of Participants|12|12.0||||||
4127857|NCT00911820|3953007|B1|Gastric||Tumor Location||Participants|Count of Participants|15|15.0||||||
4127858|NCT00911820|3953005|B3|GE Junction||Tumor Location||Participants|Count of Participants|21|21.0||||||
4127859|NCT00911820|3953006|B2|GE Junction||Tumor Location||Participants|Count of Participants|12|12.0||||||
4127860|NCT00911820|3953007|B1|GE Junction||Tumor Location||Participants|Count of Participants|9|9.0||||||
4127861|NCT00911820|3953005|B3|Esophagus||Tumor Location||Participants|Count of Participants|37|37.0||||||
4127862|NCT00911820|3953006|B2|Esophagus||Tumor Location||Participants|Count of Participants|17|17.0||||||
4127863|NCT00911820|3953007|B1|Esophagus||Tumor Location||Participants|Count of Participants|20|20.0||||||
4127864|NCT00911820|3953005|B3|ECOG PS 2||ECOG Performance Status (PS)|ECOG PS0: Fully active, able to carry on all pre-disease performance without restriction ECOG PS1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature ECOG PS2: Ambulatory and capable of all self-care but unable to carry out any work activities; Up and about more than 50% of waking hours|Participants|Count of Participants|2|2.0||||||
4127865|NCT00911820|3953006|B2|ECOG PS 2||ECOG Performance Status (PS)|ECOG PS0: Fully active, able to carry on all pre-disease performance without restriction ECOG PS1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature ECOG PS2: Ambulatory and capable of all self-care but unable to carry out any work activities; Up and about more than 50% of waking hours|Participants|Count of Participants|1|1.0||||||
4127866|NCT00911820|3953007|B1|ECOG PS 2||ECOG Performance Status (PS)|ECOG PS0: Fully active, able to carry on all pre-disease performance without restriction ECOG PS1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature ECOG PS2: Ambulatory and capable of all self-care but unable to carry out any work activities; Up and about more than 50% of waking hours|Participants|Count of Participants|1|1.0||||||
4127867|NCT00911820|3953005|B3|ECOG PS 0/1||ECOG Performance Status (PS)|ECOG PS0: Fully active, able to carry on all pre-disease performance without restriction ECOG PS1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature ECOG PS2: Ambulatory and capable of all self-care but unable to carry out any work activities; Up and about more than 50% of waking hours|Participants|Count of Participants|83|83.0||||||
4127868|NCT00911820|3953006|B2|ECOG PS 0/1||ECOG Performance Status (PS)|ECOG PS0: Fully active, able to carry on all pre-disease performance without restriction ECOG PS1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature ECOG PS2: Ambulatory and capable of all self-care but unable to carry out any work activities; Up and about more than 50% of waking hours|Participants|Count of Participants|40|40.0||||||
4127869|NCT00911820|3953007|B1|ECOG PS 0/1||ECOG Performance Status (PS)|ECOG PS0: Fully active, able to carry on all pre-disease performance without restriction ECOG PS1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature ECOG PS2: Ambulatory and capable of all self-care but unable to carry out any work activities; Up and about more than 50% of waking hours|Participants|Count of Participants|43|43.0||||||
4127870|NCT00911820|3953005|B3|United States||Region of Enrollment||Participants|Count of Participants|85|85.0||||||
4127871|NCT00911820|3953006|B2|United States||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
4127872|NCT00911820|3953007|B1|United States||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
4127873|NCT00911820|3953005|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4127874|NCT00911820|3953006|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4127875|NCT00911820|3953007|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4127876|NCT00911820|3953005|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127877|NCT00911820|3953006|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127878|NCT00911820|3953007|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127879|NCT00911820|3953005|B3||White|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
4127880|NCT00911820|3953006|B2||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4127881|NCT00911820|3953007|B1||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4127882|NCT00911820|3953005|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4127883|NCT00911820|3953006|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127884|NCT00911820|3953007|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4127885|NCT00911820|3953005|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127886|NCT00911820|3953006|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127887|NCT00911820|3953007|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127888|NCT00911820|3953005|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127889|NCT00911820|3953006|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127890|NCT00911820|3953007|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127891|NCT00911820|3953005|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127892|NCT00911820|3953006|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127893|NCT00911820|3953007|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127894|NCT00911820|3953005|B3||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4127895|NCT00911820|3953006|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4127896|NCT00911820|3953007|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4127897|NCT00911820|3953005|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4127898|NCT00911820|3953006|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4127899|NCT00911820|3953007|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4127900|NCT00911820|3953005|B3|||Age||years|Median|60|60.0|Full Range|||40.0|85.0|
4127901|NCT00911820|3953006|B2|||Age||years|Median|61|61.0|Full Range|||40.0|85.0|
4127902|NCT00911820|3953007|B1|||Age||years|Median|59|59.0|Full Range|||41.0|79.0|
4127903|NCT00911807|3953022|B4|Spain||Region of Enrollment||participants|Number|217.0|217.0||||||
4127904|NCT00911807|3953023|B3|Spain||Region of Enrollment||participants|Number|75|75.0||||||
4127905|NCT00911807|3953024|B2|Spain||Region of Enrollment||participants|Number|70|70.0||||||
4127906|NCT00911807|3953025|B1|Spain||Region of Enrollment||participants|Number|72|72.0||||||
4127907|NCT00911807|3953022|B4||Male|Sex: Female, Male||Participants|Count of Participants|48.0|48.0||||||
4127908|NCT00911807|3953023|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4127909|NCT00911807|3953024|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4127910|NCT00911807|3953025|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4127911|NCT00911807|3953022|B4||Female|Sex: Female, Male||Participants|Count of Participants|169.0|169.0||||||
4127912|NCT00911807|3953023|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4127913|NCT00911807|3953024|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4127914|NCT00911807|3953025|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4127915|NCT00911807|3953022|B4|||Age||years|Mean|75.2|75.2|Standard Deviation|7.9|7.9|||
4127916|NCT00911807|3953023|B3|||Age||years|Mean|76.0|76.0|Standard Deviation|7.7|7.7|||
4127917|NCT00911807|3953024|B2|||Age||years|Mean|75.1|75.1|Standard Deviation|7.6|7.6|||
4127918|NCT00911807|3953025|B1|||Age||years|Mean|74.5|74.5|Standard Deviation|8.3|8.3|||
4127919|NCT00911807|3953022|B4||>=65 years|Age||Participants|Count of Participants|193.0|193.0||||||
4127920|NCT00911807|3953023|B3||>=65 years|Age||Participants|Count of Participants|69|69.0||||||
4127921|NCT00911807|3953024|B2||>=65 years|Age||Participants|Count of Participants|61|61.0||||||
4127922|NCT00911807|3953025|B1||>=65 years|Age||Participants|Count of Participants|63|63.0||||||
4127923|NCT00911807|3953022|B4||Between 18 and 65 years|Age||Participants|Count of Participants|24.0|24.0||||||
4127924|NCT00911807|3953023|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4127925|NCT00911807|3953024|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4127926|NCT00911807|3953025|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4127927|NCT00911807|3953022|B4||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4127928|NCT00911807|3953023|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4127929|NCT00911807|3953024|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4127930|NCT00911807|3953025|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4127931|NCT00911768|3953035|B3|Korea, Republic of||Region of Enrollment||participants|Number|100.0|100.0||||||
4127932|NCT00911768|3953036|B2|Korea, Republic of||Region of Enrollment||participants|Number|50|50.0||||||
4127933|NCT00911768|3953037|B1|Korea, Republic of||Region of Enrollment||participants|Number|50|50.0||||||
4127934|NCT00911768|3953035|B3||Male|Sex: Female, Male||Participants|Count of Participants|46.0|46.0||||||
4127935|NCT00911768|3953036|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4127936|NCT00911768|3953037|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4127937|NCT00911768|3953035|B3||Female|Sex: Female, Male||Participants|Count of Participants|54.0|54.0||||||
4127938|NCT00911768|3953036|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4127939|NCT00911768|3953037|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4127940|NCT00911768|3953035|B3|||Age||years|Mean|47.1|47.1|Standard Deviation|16.0|16.0|||
4127941|NCT00911768|3953036|B2|||Age||years|Mean|46.02|46.02|Standard Deviation|16.14|16.14|||
4127942|NCT00911768|3953037|B1|||Age||years|Mean|48.14|48.14|Standard Deviation|15.97|15.97|||
4127943|NCT00911768|3953035|B3||>=65 years|Age||Participants|Count of Participants|11.0|11.0||||||
4127944|NCT00911768|3953036|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4127945|NCT00911768|3953037|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4127946|NCT00911768|3953035|B3||Between 18 and 65 years|Age||Participants|Count of Participants|89.0|89.0||||||
4127947|NCT00911768|3953036|B2||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4127948|NCT00911768|3953037|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4127949|NCT00911768|3953035|B3||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4127950|NCT00911768|3953036|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4127951|NCT00911768|3953037|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4127952|NCT00911742|3953048|B3||Male|Sex: Female, Male||Participants|Count of Participants|13.0|13.0||||||
4127953|NCT00911742|3953049|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4127954|NCT00911742|3953050|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4127955|NCT00911742|3953048|B3||Female|Sex: Female, Male||Participants|Count of Participants|13.0|13.0||||||
4127956|NCT00911742|3953049|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4127957|NCT00911742|3953050|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4127958|NCT00911742|3953048|B3||>=65 years|Age||Participants|Count of Participants|0.0|0.0||||||
4127959|NCT00911742|3953049|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4127960|NCT00911742|3953050|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4127961|NCT00911742|3953048|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26.0|26.0||||||
4127962|NCT00911742|3953049|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4127963|NCT00911742|3953050|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4127964|NCT00911742|3953048|B3||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4127965|NCT00911742|3953049|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4127966|NCT00911742|3953050|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4127967|NCT00911625|3953065|B3|||Total home daily insulin dose||units of insulin|Mean|52.0|52.0|Standard Deviation|43.0|43.0|||
4127968|NCT00911625|3953066|B2|||Total home daily insulin dose||units of insulin|Mean|51.6|51.6|Standard Deviation|46.3|46.3|||
4127969|NCT00911625|3953067|B1|||Total home daily insulin dose||units of insulin|Mean|54.3|54.3|Standard Deviation|40.7|40.7|||
4127970|NCT00911625|3953065|B3||No insulin before admission|Insulin therapy before admission||Participants|Count of Participants|26|26.0||||||
4127971|NCT00911625|3953066|B2||No insulin before admission|Insulin therapy before admission||Participants|Count of Participants|15|15.0||||||
4127972|NCT00911625|3953067|B1||No insulin before admission|Insulin therapy before admission||Participants|Count of Participants|11|11.0||||||
4127973|NCT00911625|3953065|B3||Insulin before admission|Insulin therapy before admission||Participants|Count of Participants|81|81.0||||||
4127974|NCT00911625|3953066|B2||Insulin before admission|Insulin therapy before admission||Participants|Count of Participants|42|42.0||||||
4127975|NCT00911625|3953067|B1||Insulin before admission|Insulin therapy before admission||Participants|Count of Participants|39|39.0||||||
4127976|NCT00911625|3953065|B3|||Glycated hemoglobin||Percentage (%)|Mean|8.0|8.0|Standard Deviation|2.0|2.0|||
4127977|NCT00911625|3953066|B2|||Glycated hemoglobin||Percentage (%)|Mean|7.9|7.9|Standard Deviation|1.9|1.9|||
4127978|NCT00911625|3953067|B1|||Glycated hemoglobin||Percentage (%)|Mean|8.2|8.2|Standard Deviation|2.1|2.1|||
4127979|NCT00911625|3953065|B3|||Years of Diabetes||years|Mean|17.6|17.6|Standard Deviation|10.0|10.0|||
4127980|NCT00911625|3953066|B2|||Years of Diabetes||years|Mean|16.6|16.6|Standard Deviation|9.9|9.9|||
4127981|NCT00911625|3953067|B1|||Years of Diabetes||years|Mean|18.6|18.6|Standard Deviation|8.8|8.8|||
4127982|NCT00911625|3953065|B3|||Glomerular filtration rate||mL/min/1.73 squared meters|Mean|29.9|29.9|Standard Deviation|9.0|9.0|||
4127983|NCT00911625|3953066|B2|||Glomerular filtration rate||mL/min/1.73 squared meters|Mean|29.6|29.6|Standard Deviation|10|10.0|||
4127984|NCT00911625|3953067|B1|||Glomerular filtration rate||mL/min/1.73 squared meters|Mean|30.4|30.4|Standard Deviation|8.3|8.3|||
4127985|NCT00911625|3953065|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127986|NCT00911625|3953066|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127987|NCT00911625|3953067|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127988|NCT00911625|3953065|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4127989|NCT00911625|3953066|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4127990|NCT00911625|3953067|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4127991|NCT00911625|3953065|B3||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4127992|NCT00911625|3953066|B2||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4127993|NCT00911625|3953067|B1||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4127994|NCT00911625|3953065|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4127995|NCT00911625|3953066|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4127996|NCT00911625|3953067|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4127997|NCT00911625|3953065|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127998|NCT00911625|3953066|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4127999|NCT00911625|3953067|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4128000|NCT00911625|3953065|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4128001|NCT00911625|3953066|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4128002|NCT00911625|3953067|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4128003|NCT00911625|3953065|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4128004|NCT00911625|3953066|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4128005|NCT00911625|3953067|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4128006|NCT00911625|3953065|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4128007|NCT00911625|3953066|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4128008|NCT00911625|3953067|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4128009|NCT00911625|3953065|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4128010|NCT00911625|3953066|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4128011|NCT00911625|3953067|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4128012|NCT00911625|3953065|B3|||Age||years|Mean|64.0|64.0|Standard Deviation|11.0|11.0|||
4128013|NCT00911625|3953066|B2|||Age||years|Mean|63.7|63.7|Standard Deviation|13.0|13.0|||
4128014|NCT00911625|3953067|B1|||Age||years|Mean|65.3|65.3|Standard Deviation|10.6|10.6|||
4128015|NCT00911612|3953076|B3|||Fasting Serum 7 alpha-HCO|The measurement of serum 7 alpha-hydroxy-4-cholesten-3-one (7 alpha-HCO) is a measurement of hepatic cholesterol synthesis, is closely related to the fecal loss of bile acids, and is a validated method for screening for bile acid malabsorption (BAM).|ng/mL|Mean|35.0|35.0|Standard Deviation|36.5|36.5|||
4128016|NCT00911612|3953077|B2|||Fasting Serum 7 alpha-HCO|The measurement of serum 7 alpha-hydroxy-4-cholesten-3-one (7 alpha-HCO) is a measurement of hepatic cholesterol synthesis, is closely related to the fecal loss of bile acids, and is a validated method for screening for bile acid malabsorption (BAM).|ng/mL|Mean|38.2|38.2|Standard Deviation|14.7|14.7|||
4128017|NCT00911612|3953078|B1|||Fasting Serum 7 alpha-HCO|The measurement of serum 7 alpha-hydroxy-4-cholesten-3-one (7 alpha-HCO) is a measurement of hepatic cholesterol synthesis, is closely related to the fecal loss of bile acids, and is a validated method for screening for bile acid malabsorption (BAM).|ng/mL|Mean|31.8|31.8|Standard Deviation|5.9|5.9|||
4128018|NCT00911612|3953076|B3|||Baseline Colonic Geometric Center at 24 hours|The scintigraphic method is used to measure colonic transit. An isotope is adsorbed on activated charcoal particles and delivered to the colon in a delayed release capsule. Anterior and posterior gamma images are taken hourly. The geometric center (GC) is the weighted average of counts in the different colonic regions. The scale ranges from 1 to 5; a high GC implies faster colonic transit. A GC of 1 implies all isotope is in the ascending colon, and a GC of 5 implies all isotope is in the stool.|units on a scale|Mean|3.4|3.4|Standard Deviation|0.2|0.2|||
4128019|NCT00911612|3953077|B2|||Baseline Colonic Geometric Center at 24 hours|The scintigraphic method is used to measure colonic transit. An isotope is adsorbed on activated charcoal particles and delivered to the colon in a delayed release capsule. Anterior and posterior gamma images are taken hourly. The geometric center (GC) is the weighted average of counts in the different colonic regions. The scale ranges from 1 to 5; a high GC implies faster colonic transit. A GC of 1 implies all isotope is in the ascending colon, and a GC of 5 implies all isotope is in the stool.|units on a scale|Mean|3.4|3.4|Standard Deviation|0.3|0.3|||
4128020|NCT00911612|3953078|B1|||Baseline Colonic Geometric Center at 24 hours|The scintigraphic method is used to measure colonic transit. An isotope is adsorbed on activated charcoal particles and delivered to the colon in a delayed release capsule. Anterior and posterior gamma images are taken hourly. The geometric center (GC) is the weighted average of counts in the different colonic regions. The scale ranges from 1 to 5; a high GC implies faster colonic transit. A GC of 1 implies all isotope is in the ascending colon, and a GC of 5 implies all isotope is in the stool.|units on a scale|Mean|3.4|3.4|Standard Deviation|0.3|0.3|||
4128021|NCT00911612|3953076|B3|||Body Mass Index||kg/m^2|Mean|30.4|30.4|Standard Deviation|5.7|5.7|||
4128022|NCT00911612|3953077|B2|||Body Mass Index||kg/m^2|Mean|28.9|28.9|Standard Deviation|1.8|1.8|||
4128023|NCT00911612|3953078|B1|||Body Mass Index||kg/m^2|Mean|31.8|31.8|Standard Deviation|1.5|1.5|||
4128024|NCT00911612|3953076|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4128025|NCT00911612|3953077|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4128026|NCT00911612|3953078|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4128027|NCT00911612|3953076|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4128028|NCT00911612|3953077|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4128029|NCT00911612|3953078|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4128030|NCT00911612|3953076|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4128031|NCT00911612|3953077|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4128032|NCT00911612|3953078|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4128033|NCT00911612|3953076|B3|||Age||years|Mean|42.8|42.8|Standard Deviation|13.0|13.0|||
4128034|NCT00911612|3953077|B2|||Age||years|Mean|43.3|43.3|Standard Deviation|3.7|3.7|||
4128035|NCT00911612|3953078|B1|||Age||years|Mean|42.1|42.1|Standard Deviation|4.0|4.0|||
4128036|NCT00911547|3953093|B5|||Total daily Beta-agonist use|Number of inhalations (Puffs) of beta-agonist medication|Puffs|Mean|3.53|3.53|Standard Deviation|2.39|2.39|||
4128037|NCT00911547|3953094|B4|||Total daily Beta-agonist use|Number of inhalations (Puffs) of beta-agonist medication|Puffs|Mean|3.41|3.41|Standard Deviation|2.17|2.17|||
4128038|NCT00911547|3953095|B3|||Total daily Beta-agonist use|Number of inhalations (Puffs) of beta-agonist medication|Puffs|Mean|3.51|3.51|Standard Deviation|2.47|2.47|||
4128039|NCT00911547|3953096|B2|||Total daily Beta-agonist use|Number of inhalations (Puffs) of beta-agonist medication|Puffs|Mean|3.52|3.52|Standard Deviation|2.34|2.34|||
4128040|NCT00911547|3953097|B1|||Total daily Beta-agonist use|Number of inhalations (Puffs) of beta-agonist medication|Puffs|Mean|4.16|4.16|Standard Deviation|3.02|3.02|||
4128041|NCT00911547|3953093|B5|||Nocturnal asthma score|"Nocturnal asthma score: The patient scored his/her symptoms [from 0 (best)~to 3 (worst)] on a daily basis."|Units on a Scale|Mean|0.41|0.41|Standard Deviation|0.46|0.46|||
4128042|NCT00911547|3953094|B4|||Nocturnal asthma score|"Nocturnal asthma score: The patient scored his/her symptoms [from 0 (best)~to 3 (worst)] on a daily basis."|Units on a Scale|Mean|0.43|0.43|Standard Deviation|0.47|0.47|||
4128043|NCT00911547|3953095|B3|||Nocturnal asthma score|"Nocturnal asthma score: The patient scored his/her symptoms [from 0 (best)~to 3 (worst)] on a daily basis."|Units on a Scale|Mean|0.35|0.35|Standard Deviation|0.44|0.44|||
4128044|NCT00911547|3953096|B2|||Nocturnal asthma score|"Nocturnal asthma score: The patient scored his/her symptoms [from 0 (best)~to 3 (worst)] on a daily basis."|Units on a Scale|Mean|0.41|0.41|Standard Deviation|0.45|0.45|||
4128045|NCT00911547|3953097|B1|||Nocturnal asthma score|"Nocturnal asthma score: The patient scored his/her symptoms [from 0 (best)~to 3 (worst)] on a daily basis."|Units on a Scale|Mean|0.57|0.57|Standard Deviation|0.46|0.46|||
4128046|NCT00911547|3953093|B5|||Morning peak flow rate (PEFR)||Liters/minute|Mean|411.42|411.42|Standard Deviation|88.92|88.92|||
4128047|NCT00911547|3953094|B4|||Morning peak flow rate (PEFR)||Liters/minute|Mean|412.46|412.46|Standard Deviation|91.15|91.15|||
4128048|NCT00911547|3953095|B3|||Morning peak flow rate (PEFR)||Liters/minute|Mean|402.91|402.91|Standard Deviation|86.19|86.19|||
4128049|NCT00911547|3953096|B2|||Morning peak flow rate (PEFR)||Liters/minute|Mean|419.94|419.94|Standard Deviation|92.47|92.47|||
4128050|NCT00911547|3953097|B1|||Morning peak flow rate (PEFR)||Liters/minute|Mean|406.80|406.8|Standard Deviation|73.47|73.47|||
4128051|NCT00911547|3953093|B5|||Forced expiratory volume in 1 second (FEV1)||Liters|Mean|2.57|2.57|Standard Deviation|0.70|0.7|||
4128052|NCT00911547|3953094|B4|||Forced expiratory volume in 1 second (FEV1)||Liters|Mean|2.61|2.61|Standard Deviation|0.68|0.68|||
4128053|NCT00911547|3953095|B3|||Forced expiratory volume in 1 second (FEV1)||Liters|Mean|2.53|2.53|Standard Deviation|0.68|0.68|||
4128054|NCT00911547|3953096|B2|||Forced expiratory volume in 1 second (FEV1)||Liters|Mean|2.61|2.61|Standard Deviation|0.74|0.74|||
4128055|NCT00911547|3953097|B1|||Forced expiratory volume in 1 second (FEV1)||Liters|Mean|2.45|2.45|Standard Deviation|0.69|0.69|||
4128056|NCT00911547|3953093|B5|||Daytime symptom score|"Daytime symptom score: The patient scored his/her symptoms [from 0~(best) to 6 (worst)] on a daily basis."|Units on a Scale|Mean|2.18|2.18|Standard Deviation|0.82|0.82|||
4128057|NCT00911547|3953094|B4|||Daytime symptom score|"Daytime symptom score: The patient scored his/her symptoms [from 0~(best) to 6 (worst)] on a daily basis."|Units on a Scale|Mean|2.17|2.17|Standard Deviation|0.84|0.84|||
4128058|NCT00911547|3953095|B3|||Daytime symptom score|"Daytime symptom score: The patient scored his/her symptoms [from 0~(best) to 6 (worst)] on a daily basis."|Units on a Scale|Mean|2.17|2.17|Standard Deviation|0.82|0.82|||
4128059|NCT00911547|3953096|B2|||Daytime symptom score|"Daytime symptom score: The patient scored his/her symptoms [from 0~(best) to 6 (worst)] on a daily basis."|Units on a Scale|Mean|2.14|2.14|Standard Deviation|0.83|0.83|||
4128060|NCT00911547|3953097|B1|||Daytime symptom score|"Daytime symptom score: The patient scored his/her symptoms [from 0~(best) to 6 (worst)] on a daily basis."|Units on a Scale|Mean|2.36|2.36|Standard Deviation|0.68|0.68|||
4128061|NCT00911547|3953093|B5|Other||Race/Ethnicity||participants|Number|22|22.0||||||
4128062|NCT00911547|3953094|B4|Other||Race/Ethnicity||participants|Number|5|5.0||||||
4128063|NCT00911547|3953095|B3|Other||Race/Ethnicity||participants|Number|11|11.0||||||
4128064|NCT00911547|3953096|B2|Other||Race/Ethnicity||participants|Number|4|4.0||||||
4128065|NCT00911547|3953097|B1|Other||Race/Ethnicity||participants|Number|2|2.0||||||
4128066|NCT00911547|3953093|B5|Hispanic||Race/Ethnicity||participants|Number|14|14.0||||||
4128067|NCT00911547|3953094|B4|Hispanic||Race/Ethnicity||participants|Number|6|6.0||||||
4128068|NCT00911547|3953095|B3|Hispanic||Race/Ethnicity||participants|Number|1|1.0||||||
4128069|NCT00911547|3953096|B2|Hispanic||Race/Ethnicity||participants|Number|5|5.0||||||
4128070|NCT00911547|3953097|B1|Hispanic||Race/Ethnicity||participants|Number|2|2.0||||||
4128071|NCT00911547|3953093|B5|Black||Race/Ethnicity||participants|Number|16|16.0||||||
4128072|NCT00911547|3953094|B4|Black||Race/Ethnicity||participants|Number|5|5.0||||||
4128073|NCT00911547|3953095|B3|Black||Race/Ethnicity||participants|Number|4|4.0||||||
4128074|NCT00911547|3953096|B2|Black||Race/Ethnicity||participants|Number|3|3.0||||||
4128075|NCT00911547|3953097|B1|Black||Race/Ethnicity||participants|Number|4|4.0||||||
4128076|NCT00911547|3953093|B5|Caucasian||Race/Ethnicity||participants|Number|590|590.0||||||
4128077|NCT00911547|3953094|B4|Caucasian||Race/Ethnicity||participants|Number|177|177.0||||||
4128078|NCT00911547|3953095|B3|Caucasian||Race/Ethnicity||participants|Number|184|184.0||||||
4128079|NCT00911547|3953096|B2|Caucasian||Race/Ethnicity||participants|Number|189|189.0||||||
4128080|NCT00911547|3953097|B1|Caucasian||Race/Ethnicity||participants|Number|40|40.0||||||
4128081|NCT00911547|3953093|B5||Male|Sex: Female, Male||Participants|Count of Participants|330|330.0||||||
4128082|NCT00911547|3953094|B4||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4128083|NCT00911547|3953095|B3||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4128084|NCT00911547|3953096|B2||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4128085|NCT00911547|3953097|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4128086|NCT00911547|3953093|B5||Female|Sex: Female, Male||Participants|Count of Participants|312|312.0||||||
4128087|NCT00911547|3953094|B4||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4128088|NCT00911547|3953095|B3||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4128089|NCT00911547|3953096|B2||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4128090|NCT00911547|3953097|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4128091|NCT00911547|3953093|B5|||Age||years|Mean|39.00|39.0|Full Range|||15.0|78.0|
4128092|NCT00911547|3953094|B4|||Age||years|Mean|40.00|40.0|Full Range|||15.0|76.0|
4128093|NCT00911547|3953095|B3|||Age||years|Mean|39.00|39.0|Full Range|||15.0|78.0|
4128094|NCT00911547|3953096|B2|||Age||years|Mean|38.00|38.0|Full Range|||15.0|75.0|
4128095|NCT00911547|3953097|B1|||Age||years|Mean|40.50|40.5|Full Range|||15.0|75.0|
4128096|NCT00911534|3953126|B3||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4128097|NCT00911534|3953127|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4128098|NCT00911534|3953128|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4128099|NCT00911534|3953126|B3||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4128100|NCT00911534|3953127|B2||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4128101|NCT00911534|3953128|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4128102|NCT00911534|3953126|B3|||Age||Years|Mean|44.1|44.1|Standard Deviation|12.82|12.82|||
4128103|NCT00911534|3953127|B2|||Age||Years|Mean|43.8|43.8|Standard Deviation|12.35|12.35|||
4128104|NCT00911534|3953128|B1|||Age||Years|Mean|44.4|44.4|Standard Deviation|13.32|13.32|||
4128105|NCT00911495|3953141|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4128106|NCT00911495|3953141|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4128107|NCT00911495|3953141|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4128108|NCT00911495|3953141|B1|||Age||years|Median|28|28.0|Full Range|||19.0|50.0|
4128109|NCT00911443|3953149|B6|Italy||Region of Enrollment||participants|Number|153.0|153.0||||||
4128110|NCT00911443|3953150|B5|Italy||Region of Enrollment||participants|Number|28|28.0||||||
4128111|NCT00911443|3953151|B4|Italy||Region of Enrollment||participants|Number|31|31.0||||||
4128112|NCT00911443|3953152|B3|Italy||Region of Enrollment||participants|Number|27|27.0||||||
4128113|NCT00911443|3953153|B2|Italy||Region of Enrollment||participants|Number|34|34.0||||||
4128114|NCT00911443|3953154|B1|Italy||Region of Enrollment||participants|Number|33|33.0||||||
4128115|NCT00911443|3953149|B6|Switzerland||Region of Enrollment||participants|Number|1.0|1.0||||||
4128116|NCT00911443|3953150|B5|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
4128117|NCT00911443|3953151|B4|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4128118|NCT00911443|3953152|B3|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
4128119|NCT00911443|3953153|B2|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
4128120|NCT00911443|3953154|B1|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
4128121|NCT00911443|3953149|B6|Germany||Region of Enrollment||participants|Number|85.0|85.0||||||
4128122|NCT00911443|3953150|B5|Germany||Region of Enrollment||participants|Number|11|11.0||||||
4128123|NCT00911443|3953151|B4|Germany||Region of Enrollment||participants|Number|10|10.0||||||
4128124|NCT00911443|3953152|B3|Germany||Region of Enrollment||participants|Number|25|25.0||||||
4128125|NCT00911443|3953153|B2|Germany||Region of Enrollment||participants|Number|22|22.0||||||
4128126|NCT00911443|3953154|B1|Germany||Region of Enrollment||participants|Number|17|17.0||||||
4128127|NCT00911443|3953149|B6|Poland||Region of Enrollment||participants|Number|159.0|159.0||||||
4128128|NCT00911443|3953150|B5|Poland||Region of Enrollment||participants|Number|37|37.0||||||
4128129|NCT00911443|3953151|B4|Poland||Region of Enrollment||participants|Number|36|36.0||||||
4128130|NCT00911443|3953152|B3|Poland||Region of Enrollment||participants|Number|32|32.0||||||
4128131|NCT00911443|3953153|B2|Poland||Region of Enrollment||participants|Number|28|28.0||||||
4128132|NCT00911443|3953154|B1|Poland||Region of Enrollment||participants|Number|26|26.0||||||
4128133|NCT00911443|3953149|B6|Spain||Region of Enrollment||participants|Number|27.0|27.0||||||
4128134|NCT00911443|3953150|B5|Spain||Region of Enrollment||participants|Number|6|6.0||||||
4128135|NCT00911443|3953151|B4|Spain||Region of Enrollment||participants|Number|13|13.0||||||
4128136|NCT00911443|3953152|B3|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4128137|NCT00911443|3953153|B2|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4128138|NCT00911443|3953154|B1|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4128139|NCT00911443|3953149|B6|Hungary||Region of Enrollment||participants|Number|19.0|19.0||||||
4128140|NCT00911443|3953150|B5|Hungary||Region of Enrollment||participants|Number|9|9.0||||||
4128141|NCT00911443|3953151|B4|Hungary||Region of Enrollment||participants|Number|2|2.0||||||
4128142|NCT00911443|3953152|B3|Hungary||Region of Enrollment||participants|Number|1|1.0||||||
4128143|NCT00911443|3953153|B2|Hungary||Region of Enrollment||participants|Number|4|4.0||||||
4128144|NCT00911443|3953154|B1|Hungary||Region of Enrollment||participants|Number|3|3.0||||||
4128145|NCT00911443|3953149|B6|Portugal||Region of Enrollment||participants|Number|1.0|1.0||||||
4128146|NCT00911443|3953150|B5|Portugal||Region of Enrollment||participants|Number|1|1.0||||||
4128147|NCT00911443|3953151|B4|Portugal||Region of Enrollment||participants|Number|0|0.0||||||
4128148|NCT00911443|3953152|B3|Portugal||Region of Enrollment||participants|Number|0|0.0||||||
4128149|NCT00911443|3953153|B2|Portugal||Region of Enrollment||participants|Number|0|0.0||||||
4128150|NCT00911443|3953154|B1|Portugal||Region of Enrollment||participants|Number|0|0.0||||||
4128151|NCT00911443|3953149|B6|France||Region of Enrollment||participants|Number|43.0|43.0||||||
4128152|NCT00911443|3953150|B5|France||Region of Enrollment||participants|Number|5|5.0||||||
4128153|NCT00911443|3953151|B4|France||Region of Enrollment||participants|Number|6|6.0||||||
4128154|NCT00911443|3953152|B3|France||Region of Enrollment||participants|Number|11|11.0||||||
4128155|NCT00911443|3953153|B2|France||Region of Enrollment||participants|Number|7|7.0||||||
4128156|NCT00911443|3953154|B1|France||Region of Enrollment||participants|Number|14|14.0||||||
4128157|NCT00911443|3953149|B6||Male|Sex: Female, Male||Participants|Count of Participants|262.0|262.0||||||
4128158|NCT00911443|3953150|B5||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4128159|NCT00911443|3953151|B4||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4128160|NCT00911443|3953152|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4128161|NCT00911443|3953153|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4128162|NCT00911443|3953154|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4128163|NCT00911443|3953149|B6||Female|Sex: Female, Male||Participants|Count of Participants|226.0|226.0||||||
4128164|NCT00911443|3953150|B5||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4128165|NCT00911443|3953151|B4||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4128166|NCT00911443|3953152|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4128167|NCT00911443|3953153|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4128168|NCT00911443|3953154|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4128169|NCT00911443|3953149|B6|||Age||years|Mean|55|55.0|Standard Deviation|13|13.0|||
4128170|NCT00911443|3953150|B5|||Age||years|Mean|57|57.0|Standard Deviation|12|12.0|||
4128171|NCT00911443|3953151|B4|||Age||years|Mean|56|56.0|Standard Deviation|11|11.0|||
4128172|NCT00911443|3953152|B3|||Age||years|Mean|56|56.0|Standard Deviation|13|13.0|||
4128173|NCT00911443|3953153|B2|||Age||years|Mean|54|54.0|Standard Deviation|14|14.0|||
4128174|NCT00911443|3953154|B1|||Age||years|Mean|54|54.0|Standard Deviation|14|14.0|||
4128175|NCT00911443|3953149|B6||>=65 years|Age||Participants|Count of Participants|142.0|142.0||||||
4128176|NCT00911443|3953150|B5||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4128177|NCT00911443|3953151|B4||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4128178|NCT00911443|3953152|B3||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4128179|NCT00911443|3953153|B2||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4128180|NCT00911443|3953154|B1||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4128181|NCT00911443|3953149|B6||Between 18 and 65 years|Age||Participants|Count of Participants|346.0|346.0||||||
4128182|NCT00911443|3953150|B5||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
4128183|NCT00911443|3953151|B4||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4128184|NCT00911443|3953152|B3||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
4128185|NCT00911443|3953153|B2||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
4128186|NCT00911443|3953154|B1||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
4128187|NCT00911443|3953149|B6||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4128188|NCT00911443|3953150|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4128189|NCT00911443|3953151|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4128190|NCT00911443|3953152|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4128191|NCT00911443|3953153|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4128192|NCT00911443|3953154|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4128193|NCT00911326|3953175|B1|Retromolar gingiva||Tumor location||participants|Number|4|4.0||||||
4128194|NCT00911326|3953175|B1|Oral tongue||Tumor location||participants|Number|43|43.0||||||
4128195|NCT00911326|3953175|B1|Mucosal lip||Tumor location||participants|Number|1|1.0||||||
4128196|NCT00911326|3953175|B1|Lower alveolar ridge||Tumor location||participants|Number|3|3.0||||||
4128197|NCT00911326|3953175|B1|Floor of the mouth||Tumor location||participants|Number|20|20.0||||||
4128198|NCT00911326|3953175|B1|Cutaneous||Tumor location||participants|Number|6|6.0||||||
4128199|NCT00911326|3953175|B1|Buccal mucosa||Tumor location||participants|Number|8|8.0||||||
4128200|NCT00911326|3953175|B1|T4||Clinical tumor stage|"From the American Joint Committee on Cancer, Manual for Staging of Cancer 6th Edition.~T1: tumor 2 cm or less in greatest dimension; T2: tumor more than 2 cm but not more than 4 cm (for lip and oral cavity SCC) or 5 cm (for cutaneous SCC) in greatest dimension; T3: tumor more than 4 cm (for lip and oral cavity SCC) or 5 cm (for cutaneous SCC) in greatest dimension; T4: tumor invades adjacent structures (for lip and oral cavity SCC) or deep extradermal structures (for cutaneous SCC)."|participants|Number|6|6.0||||||
4128201|NCT00911326|3953175|B1|T3||Clinical tumor stage|"From the American Joint Committee on Cancer, Manual for Staging of Cancer 6th Edition.~T1: tumor 2 cm or less in greatest dimension; T2: tumor more than 2 cm but not more than 4 cm (for lip and oral cavity SCC) or 5 cm (for cutaneous SCC) in greatest dimension; T3: tumor more than 4 cm (for lip and oral cavity SCC) or 5 cm (for cutaneous SCC) in greatest dimension; T4: tumor invades adjacent structures (for lip and oral cavity SCC) or deep extradermal structures (for cutaneous SCC)."|participants|Number|7|7.0||||||
4128240|NCT00911274|3953211|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4128241|NCT00911274|3953209|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4128242|NCT00911274|3953210|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4128243|NCT00911274|3953211|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4128202|NCT00911326|3953175|B1|T2||Clinical tumor stage|"From the American Joint Committee on Cancer, Manual for Staging of Cancer 6th Edition.~T1: tumor 2 cm or less in greatest dimension; T2: tumor more than 2 cm but not more than 4 cm (for lip and oral cavity SCC) or 5 cm (for cutaneous SCC) in greatest dimension; T3: tumor more than 4 cm (for lip and oral cavity SCC) or 5 cm (for cutaneous SCC) in greatest dimension; T4: tumor invades adjacent structures (for lip and oral cavity SCC) or deep extradermal structures (for cutaneous SCC)."|participants|Number|46|46.0||||||
4128203|NCT00911326|3953175|B1|T1||Clinical tumor stage|"From the American Joint Committee on Cancer, Manual for Staging of Cancer 6th Edition.~T1: tumor 2 cm or less in greatest dimension; T2: tumor more than 2 cm but not more than 4 cm (for lip and oral cavity SCC) or 5 cm (for cutaneous SCC) in greatest dimension; T3: tumor more than 4 cm (for lip and oral cavity SCC) or 5 cm (for cutaneous SCC) in greatest dimension; T4: tumor invades adjacent structures (for lip and oral cavity SCC) or deep extradermal structures (for cutaneous SCC)."|participants|Number|26|26.0||||||
4128204|NCT00911326|3953175|B1|United States||Region of Enrollment||participants|Number|85|85.0||||||
4128205|NCT00911326|3953175|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4128206|NCT00911326|3953175|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4128207|NCT00911326|3953175|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|12.8|12.8|||
4128208|NCT00911326|3953175|B1||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4128209|NCT00911326|3953175|B1||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4128210|NCT00911326|3953175|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4128211|NCT00911300|3953182|B3||Male|Sex: Female, Male|Baseline characteristic data were collected in members of the Modified Intent-to-Treat (mITT) Population, comprised of all randomized participants receiving at least one dose of study medication and for whom any post-baseline value was available.|Participants|Count of Participants|215|215.0||||||
4128212|NCT00911300|3953183|B2||Male|Sex: Female, Male|Baseline characteristic data were collected in members of the Modified Intent-to-Treat (mITT) Population, comprised of all randomized participants receiving at least one dose of study medication and for whom any post-baseline value was available.|Participants|Count of Participants|110|110.0||||||
4128213|NCT00911300|3953184|B1||Male|Sex: Female, Male|Baseline characteristic data were collected in members of the Modified Intent-to-Treat (mITT) Population, comprised of all randomized participants receiving at least one dose of study medication and for whom any post-baseline value was available.|Participants|Count of Participants|105|105.0||||||
4128214|NCT00911300|3953182|B3||Female|Sex: Female, Male|Baseline characteristic data were collected in members of the Modified Intent-to-Treat (mITT) Population, comprised of all randomized participants receiving at least one dose of study medication and for whom any post-baseline value was available.|Participants|Count of Participants|129|129.0||||||
4128215|NCT00911300|3953183|B2||Female|Sex: Female, Male|Baseline characteristic data were collected in members of the Modified Intent-to-Treat (mITT) Population, comprised of all randomized participants receiving at least one dose of study medication and for whom any post-baseline value was available.|Participants|Count of Participants|60|60.0||||||
4128216|NCT00911300|3953184|B1||Female|Sex: Female, Male|Baseline characteristic data were collected in members of the Modified Intent-to-Treat (mITT) Population, comprised of all randomized participants receiving at least one dose of study medication and for whom any post-baseline value was available.|Participants|Count of Participants|69|69.0||||||
4128217|NCT00911300|3953182|B3|||Age|Baseline characteristic data were collected in members of the Modified Intent-to-Treat (mITT) Population, comprised of all randomized participants receiving at least one dose of study medication and for whom any post-baseline value was available.|Years|Mean|67.52|67.52|Standard Deviation|11.52|11.52|||
4128218|NCT00911300|3953183|B2|||Age|Baseline characteristic data were collected in members of the Modified Intent-to-Treat (mITT) Population, comprised of all randomized participants receiving at least one dose of study medication and for whom any post-baseline value was available.|Years|Mean|66.78|66.78|Standard Deviation|11.93|11.93|||
4128219|NCT00911300|3953184|B1|||Age|Baseline characteristic data were collected in members of the Modified Intent-to-Treat (mITT) Population, comprised of all randomized participants receiving at least one dose of study medication and for whom any post-baseline value was available.|Years|Mean|68.24|68.24|Standard Deviation|11.09|11.09|||
4128220|NCT00911274|3953209|B3|United States||Region of Enrollment||participants|Number|53|53.0||||||
4128221|NCT00911274|3953210|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4128222|NCT00911274|3953211|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4128223|NCT00911274|3953209|B3|American Indian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4128224|NCT00911274|3953210|B2|American Indian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4128225|NCT00911274|3953211|B1|American Indian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4128226|NCT00911274|3953209|B3|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4128227|NCT00911274|3953210|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4128228|NCT00911274|3953211|B1|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4128229|NCT00911274|3953209|B3|Black||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4128230|NCT00911274|3953210|B2|Black||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4128231|NCT00911274|3953211|B1|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4128232|NCT00911274|3953209|B3|White||Race/Ethnicity, Customized||Participants|Number|41|41.0||||||
4128233|NCT00911274|3953210|B2|White||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
4128234|NCT00911274|3953211|B1|White||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
4128235|NCT00911274|3953209|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4128236|NCT00911274|3953210|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4128237|NCT00911274|3953211|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4128238|NCT00911274|3953209|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4128239|NCT00911274|3953210|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4128244|NCT00911274|3953209|B3||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4128245|NCT00911274|3953210|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4128246|NCT00911274|3953211|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4128247|NCT00911274|3953209|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4128248|NCT00911274|3953210|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4128249|NCT00911274|3953211|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4128250|NCT00911170|3953220|B3|Rectum||Primary Tumor Diagnosis||participants|Number|271|271.0||||||
4128251|NCT00911170|3953221|B2|Rectum||Primary Tumor Diagnosis||participants|Number|132|132.0||||||
4128252|NCT00911170|3953222|B1|Rectum||Primary Tumor Diagnosis||participants|Number|139|139.0||||||
4128253|NCT00911170|3953220|B3|Colon||Primary Tumor Diagnosis||participants|Number|574|574.0||||||
4128254|NCT00911170|3953221|B2|Colon||Primary Tumor Diagnosis||participants|Number|290|290.0||||||
4128255|NCT00911170|3953222|B1|Colon||Primary Tumor Diagnosis||participants|Number|284|284.0||||||
4128256|NCT00911170|3953220|B3|Metastatic||Disease Status||participants|Number|809|809.0||||||
4128257|NCT00911170|3953221|B2|Metastatic||Disease Status||participants|Number|404|404.0||||||
4128258|NCT00911170|3953222|B1|Metastatic||Disease Status||participants|Number|405|405.0||||||
4128259|NCT00911170|3953220|B3|Locally Advanced||Disease Status||participants|Number|36|36.0||||||
4128260|NCT00911170|3953221|B2|Locally Advanced||Disease Status||participants|Number|18|18.0||||||
4128261|NCT00911170|3953222|B1|Locally Advanced||Disease Status||participants|Number|18|18.0||||||
4128262|NCT00911170|3953220|B3|Rest of World||Region|North America (Canada and the US) and the Rest of World (Australia, Belgium, Bulgaria, Czech Republic, France, Hungary, Ireland, Italy, Latvia, Mexico, Poland, Romania, Russian Federation, Slovakia, and Ukraine)|participants|Number|689|689.0||||||
4128263|NCT00911170|3953221|B2|Rest of World||Region|North America (Canada and the US) and the Rest of World (Australia, Belgium, Bulgaria, Czech Republic, France, Hungary, Ireland, Italy, Latvia, Mexico, Poland, Romania, Russian Federation, Slovakia, and Ukraine)|participants|Number|345|345.0||||||
4128264|NCT00911170|3953222|B1|Rest of World||Region|North America (Canada and the US) and the Rest of World (Australia, Belgium, Bulgaria, Czech Republic, France, Hungary, Ireland, Italy, Latvia, Mexico, Poland, Romania, Russian Federation, Slovakia, and Ukraine)|participants|Number|344|344.0||||||
4128265|NCT00911170|3953220|B3|North America||Region|North America (Canada and the US) and the Rest of World (Australia, Belgium, Bulgaria, Czech Republic, France, Hungary, Ireland, Italy, Latvia, Mexico, Poland, Romania, Russian Federation, Slovakia, and Ukraine)|participants|Number|156|156.0||||||
4128266|NCT00911170|3953221|B2|North America||Region|North America (Canada and the US) and the Rest of World (Australia, Belgium, Bulgaria, Czech Republic, France, Hungary, Ireland, Italy, Latvia, Mexico, Poland, Romania, Russian Federation, Slovakia, and Ukraine)|participants|Number|77|77.0||||||
4128267|NCT00911170|3953222|B1|North America||Region|North America (Canada and the US) and the Rest of World (Australia, Belgium, Bulgaria, Czech Republic, France, Hungary, Ireland, Italy, Latvia, Mexico, Poland, Romania, Russian Federation, Slovakia, and Ukraine)|participants|Number|79|79.0||||||
4128268|NCT00911170|3953220|B3|FOLFIRI||Chemotherapy Regimen||participants|Number|431|431.0||||||
4128269|NCT00911170|3953221|B2|FOLFIRI||Chemotherapy Regimen||participants|Number|215|215.0||||||
4128270|NCT00911170|3953222|B1|FOLFIRI||Chemotherapy Regimen||participants|Number|216|216.0||||||
4128271|NCT00911170|3953220|B3|FOLFOX||Chemotherapy Regimen||participants|Number|414|414.0||||||
4128272|NCT00911170|3953221|B2|FOLFOX||Chemotherapy Regimen||participants|Number|207|207.0||||||
4128273|NCT00911170|3953222|B1|FOLFOX||Chemotherapy Regimen||participants|Number|207|207.0||||||
4128274|NCT00911170|3953220|B3|White||Race/Ethnicity, Customized||participants|Number|806|806.0||||||
4128275|NCT00911170|3953221|B2|White||Race/Ethnicity, Customized||participants|Number|402|402.0||||||
4128276|NCT00911170|3953222|B1|White||Race/Ethnicity, Customized||participants|Number|404|404.0||||||
4128277|NCT00911170|3953220|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4128278|NCT00911170|3953221|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4128279|NCT00911170|3953222|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4128280|NCT00911170|3953220|B3|Japanese||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4128281|NCT00911170|3953221|B2|Japanese||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4128282|NCT00911170|3953222|B1|Japanese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4128283|NCT00911170|3953220|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4128284|NCT00911170|3953221|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4128285|NCT00911170|3953222|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4128286|NCT00911170|3953220|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4128287|NCT00911170|3953221|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4128288|NCT00911170|3953222|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4128289|NCT00911170|3953220|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4128290|NCT00911170|3953221|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4128291|NCT00911170|3953222|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4128292|NCT00911170|3953220|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4128293|NCT00911170|3953221|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4128294|NCT00911170|3953222|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4128295|NCT00911170|3953220|B3||Male|Sex: Female, Male||Participants|Count of Participants|512|512.0||||||
4128296|NCT00911170|3953221|B2||Male|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
4128297|NCT00911170|3953222|B1||Male|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
4128298|NCT00911170|3953220|B3||Female|Sex: Female, Male||Participants|Count of Participants|333|333.0||||||
4128299|NCT00911170|3953221|B2||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4128300|NCT00911170|3953222|B1||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4128301|NCT00911170|3953220|B3|||Age||years|Mean|60.6|60.6|Standard Deviation|10.5|10.5|||
4128302|NCT00911170|3953221|B2|||Age||years|Mean|60.6|60.6|Standard Deviation|10.4|10.4|||
4128303|NCT00911170|3953222|B1|||Age||years|Mean|60.7|60.7|Standard Deviation|10.7|10.7|||
4128304|NCT00911157|3953245|B3|>100 kg||Number of Participants with the Indicated Body Weight|Participants were weighed at Screening (within 10 days before randomization). FAS|participants|Number|0|0.0||||||
4128305|NCT00911157|3953246|B2|>100 kg||Number of Participants with the Indicated Body Weight|Participants were weighed at Screening (within 10 days before randomization). FAS|participants|Number|0|0.0||||||
4128306|NCT00911157|3953247|B1|>100 kg||Number of Participants with the Indicated Body Weight|Participants were weighed at Screening (within 10 days before randomization). FAS|participants|Number|0|0.0||||||
4128307|NCT00911157|3953245|B3|50-100 kg||Number of Participants with the Indicated Body Weight|Participants were weighed at Screening (within 10 days before randomization). FAS|participants|Number|26|26.0||||||
4128308|NCT00911157|3953246|B2|50-100 kg||Number of Participants with the Indicated Body Weight|Participants were weighed at Screening (within 10 days before randomization). FAS|participants|Number|6|6.0||||||
4128309|NCT00911157|3953247|B1|50-100 kg||Number of Participants with the Indicated Body Weight|Participants were weighed at Screening (within 10 days before randomization). FAS|participants|Number|20|20.0||||||
4128310|NCT00911157|3953245|B3|<50 kg||Number of Participants with the Indicated Body Weight|Participants were weighed at Screening (within 10 days before randomization). FAS|participants|Number|11|11.0||||||
4128311|NCT00911157|3953246|B2|<50 kg||Number of Participants with the Indicated Body Weight|Participants were weighed at Screening (within 10 days before randomization). FAS|participants|Number|3|3.0||||||
4128312|NCT00911157|3953247|B1|<50 kg||Number of Participants with the Indicated Body Weight|Participants were weighed at Screening (within 10 days before randomization). FAS|participants|Number|8|8.0||||||
4128313|NCT00911157|3953245|B3|Asian-Japanese||Race/Ethnicity, Customized|FAS|participants|Number|37|37.0||||||
4128314|NCT00911157|3953246|B2|Asian-Japanese||Race/Ethnicity, Customized|FAS|participants|Number|9|9.0||||||
4128315|NCT00911157|3953247|B1|Asian-Japanese||Race/Ethnicity, Customized|FAS|participants|Number|28|28.0||||||
4128316|NCT00911157|3953245|B3||Male|Sex: Female, Male|FAS|Participants|Count of Participants|13|13.0||||||
4128317|NCT00911157|3953246|B2||Male|Sex: Female, Male|FAS|Participants|Count of Participants|0|0.0||||||
4128318|NCT00911157|3953247|B1||Male|Sex: Female, Male|FAS|Participants|Count of Participants|13|13.0||||||
4128319|NCT00911157|3953245|B3||Female|Sex: Female, Male|FAS|Participants|Count of Participants|24|24.0||||||
4128320|NCT00911157|3953246|B2||Female|Sex: Female, Male|FAS|Participants|Count of Participants|9|9.0||||||
4128321|NCT00911157|3953247|B1||Female|Sex: Female, Male|FAS|Participants|Count of Participants|15|15.0||||||
4128322|NCT00911157|3953245|B3|||Age|Full Analysis Set (FAS): 29 and 10 participants, respectively. One participant in each group whose data for the primary efficacy endpoint (contrast-enhanced MDCT) were missing were excluded.|years|Mean|67.3|67.3|Standard Deviation|18.7|18.7|||
4128323|NCT00911157|3953246|B2|||Age|Full Analysis Set (FAS): 29 and 10 participants, respectively. One participant in each group whose data for the primary efficacy endpoint (contrast-enhanced MDCT) were missing were excluded.|years|Mean|76.1|76.1|Standard Deviation|12.2|12.2|||
4128324|NCT00911157|3953247|B1|||Age|Full Analysis Set (FAS): 29 and 10 participants, respectively. One participant in each group whose data for the primary efficacy endpoint (contrast-enhanced MDCT) were missing were excluded.|years|Mean|64.5|64.5|Standard Deviation|19.7|19.7|||
4128325|NCT00911144|3953262|B3||Male|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
4128326|NCT00911144|3953263|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4128327|NCT00911144|3953264|B1||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4128328|NCT00911144|3953262|B3||Female|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
4128329|NCT00911144|3953263|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4128330|NCT00911144|3953264|B1||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4128331|NCT00911144|3953262|B3|||Age||months|Mean|13.6|13.6|Standard Deviation|1.05|1.05|||
4128332|NCT00911144|3953263|B2|||Age||months|Mean|13.7|13.7|Standard Deviation|1.00|1.0|||
4128333|NCT00911144|3953264|B1|||Age||months|Mean|13.6|13.6|Standard Deviation|1.07|1.07|||
4128334|NCT00910988|3953289|B5|||Fasting Insulin|Completer Sample (eg, completed both clamps)|uIU/mL|Mean|16.2|16.2|Standard Deviation|9.3|9.3|||
4128335|NCT00910988|3953290|B4|||Fasting Insulin|Completer Sample (eg, completed both clamps)|uIU/mL|Mean|17.0|17.0|Standard Deviation|10.4|10.4|||
4128336|NCT00910988|3953291|B3|||Fasting Insulin|Completer Sample (eg, completed both clamps)|uIU/mL|Mean|20.0|20.0|Standard Deviation|9.5|9.5|||
4128337|NCT00910988|3953292|B2|||Fasting Insulin|Completer Sample (eg, completed both clamps)|uIU/mL|Mean|13.6|13.6|Standard Deviation|5.5|5.5|||
4128338|NCT00910988|3953293|B1|||Fasting Insulin|Completer Sample (eg, completed both clamps)|uIU/mL|Mean|16.6|16.6|Standard Deviation|11.5|11.5|||
4128339|NCT00910988|3953289|B5|||Fasting Insulin|Intent-To-Treat (eg, completed at least one clamp)|uIU/mL|Mean|16.2|16.2|Standard Deviation|8.7|8.7|||
4128340|NCT00910988|3953290|B4|||Fasting Insulin|Intent-To-Treat (eg, completed at least one clamp)|uIU/mL|Mean|17.0|17.0|Standard Deviation|10.4|10.4|||
4128341|NCT00910988|3953291|B3|||Fasting Insulin|Intent-To-Treat (eg, completed at least one clamp)|uIU/mL|Mean|21.1|21.1|Standard Deviation|7.6|7.6|||
4128565|NCT00910962|3953341|B1||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4128342|NCT00910988|3953292|B2|||Fasting Insulin|Intent-To-Treat (eg, completed at least one clamp)|uIU/mL|Mean|13.4|13.4|Standard Deviation|5.1|5.1|||
4128343|NCT00910988|3953293|B1|||Fasting Insulin|Intent-To-Treat (eg, completed at least one clamp)|uIU/mL|Mean|16.3|16.3|Standard Deviation|10.8|10.8|||
4128344|NCT00910988|3953289|B5|||Fasting LDL Cholesterol|Completer Sample (eg, completed both clamps)|mg/dL|Mean|111.6|111.6|Standard Deviation|30.4|30.4|||
4128345|NCT00910988|3953290|B4|||Fasting LDL Cholesterol|Completer Sample (eg, completed both clamps)|mg/dL|Mean|116.3|116.3|Standard Deviation|27.2|27.2|||
4128346|NCT00910988|3953291|B3|||Fasting LDL Cholesterol|Completer Sample (eg, completed both clamps)|mg/dL|Mean|104.2|104.2|Standard Deviation|38.5|38.5|||
4128347|NCT00910988|3953292|B2|||Fasting LDL Cholesterol|Completer Sample (eg, completed both clamps)|mg/dL|Mean|105.2|105.2|Standard Deviation|26.3|26.3|||
4128348|NCT00910988|3953293|B1|||Fasting LDL Cholesterol|Completer Sample (eg, completed both clamps)|mg/dL|Mean|117.9|117.9|Standard Deviation|33.5|33.5|||
4128349|NCT00910988|3953289|B5|||Fasting LDL Cholesterol|Intent-To-Treat (eg, completed at least one clamp)|mg/dL|Mean|112.2|112.2|Standard Deviation|30.0|30.0|||
4128350|NCT00910988|3953290|B4|||Fasting LDL Cholesterol|Intent-To-Treat (eg, completed at least one clamp)|mg/dL|Mean|116.3|116.3|Standard Deviation|27.2|27.2|||
4128351|NCT00910988|3953291|B3|||Fasting LDL Cholesterol|Intent-To-Treat (eg, completed at least one clamp)|mg/dL|Mean|104.1|104.1|Standard Deviation|30.4|30.4|||
4128352|NCT00910988|3953292|B2|||Fasting LDL Cholesterol|Intent-To-Treat (eg, completed at least one clamp)|mg/dL|Mean|106.7|106.7|Standard Deviation|28.0|28.0|||
4128353|NCT00910988|3953293|B1|||Fasting LDL Cholesterol|Intent-To-Treat (eg, completed at least one clamp)|mg/dL|Mean|120.1|120.1|Standard Deviation|33.2|33.2|||
4128354|NCT00910988|3953289|B5|||Fasting Triglycerides|Completer Sample (eg, completed both clamps)|mg/dL|Mean|142.5|142.5|Standard Deviation|61.3|61.3|||
4128355|NCT00910988|3953290|B4|||Fasting Triglycerides|Completer Sample (eg, completed both clamps)|mg/dL|Mean|171.0|171.0|Standard Deviation|55.2|55.2|||
4128356|NCT00910988|3953291|B3|||Fasting Triglycerides|Completer Sample (eg, completed both clamps)|mg/dL|Mean|128.6|128.6|Standard Deviation|79.3|79.3|||
4128357|NCT00910988|3953292|B2|||Fasting Triglycerides|Completer Sample (eg, completed both clamps)|mg/dL|Mean|122.0|122.0|Standard Deviation|62.1|62.1|||
4128358|NCT00910988|3953293|B1|||Fasting Triglycerides|Completer Sample (eg, completed both clamps)|mg/dL|Mean|152.8|152.8|Standard Deviation|55.5|55.5|||
4128359|NCT00910988|3953289|B5|||Fasting Triglycerides|Intent-To-Treat (eg, completed at least one clamp)|mg/dL|Mean|140.3|140.3|Standard Deviation|57.9|57.9|||
4128360|NCT00910988|3953290|B4|||Fasting Triglycerides|Intent-To-Treat (eg, completed at least one clamp)|mg/dL|Mean|171.0|171.0|Standard Deviation|55.2|55.2|||
4128361|NCT00910988|3953291|B3|||Fasting Triglycerides|Intent-To-Treat (eg, completed at least one clamp)|mg/dL|Mean|121.2|121.2|Standard Deviation|64.0|64.0|||
4128362|NCT00910988|3953292|B2|||Fasting Triglycerides|Intent-To-Treat (eg, completed at least one clamp)|mg/dL|Mean|125.9|125.9|Standard Deviation|58.7|58.7|||
4128363|NCT00910988|3953293|B1|||Fasting Triglycerides|Intent-To-Treat (eg, completed at least one clamp)|mg/dL|Mean|152.8|152.8|Standard Deviation|52.4|52.4|||
4128364|NCT00910988|3953289|B5|||Fasting HDL Cholesterol|Completer Sample (eg, completed both clamps)|mg/dL|Mean|39.2|39.2|Standard Deviation|13.3|13.3|||
4128365|NCT00910988|3953290|B4|||Fasting HDL Cholesterol|Completer Sample (eg, completed both clamps)|mg/dL|Mean|29.2|29.2|Standard Deviation|6.5|6.5|||
4128366|NCT00910988|3953291|B3|||Fasting HDL Cholesterol|Completer Sample (eg, completed both clamps)|mg/dL|Mean|43.4|43.4|Standard Deviation|11.1|11.1|||
4128367|NCT00910988|3953292|B2|||Fasting HDL Cholesterol|Completer Sample (eg, completed both clamps)|mg/dL|Mean|38.9|38.9|Standard Deviation|9.6|9.6|||
4128368|NCT00910988|3953293|B1|||Fasting HDL Cholesterol|Completer Sample (eg, completed both clamps)|mg/dL|Mean|42.3|42.3|Standard Deviation|17.1|17.1|||
4128369|NCT00910988|3953289|B5|||Fasting HDL Cholesterol|Intent-To-Treat (eg, completed at least one clamp)|mg/dL|Mean|38.7|38.7|Standard Deviation|12.3|12.3|||
4128370|NCT00910988|3953290|B4|||Fasting HDL Cholesterol|Intent-To-Treat (eg, completed at least one clamp)|mg/dL|Mean|29.2|29.2|Standard Deviation|6.5|6.5|||
4128371|NCT00910988|3953291|B3|||Fasting HDL Cholesterol|Intent-To-Treat (eg, completed at least one clamp)|mg/dL|Mean|40.5|40.5|Standard Deviation|10.5|10.5|||
4128372|NCT00910988|3953292|B2|||Fasting HDL Cholesterol|Intent-To-Treat (eg, completed at least one clamp)|mg/dL|Mean|38.9|38.9|Standard Deviation|9.0|9.0|||
4128373|NCT00910988|3953293|B1|||Fasting HDL Cholesterol|Intent-To-Treat (eg, completed at least one clamp)|mg/dL|Mean|41.1|41.1|Standard Deviation|16.3|16.3|||
4128374|NCT00910988|3953289|B5|||Fasting Cholesterol|Completer Sample (eg, completed both clamps)|mg/dL|Mean|179.9|179.9|Standard Deviation|37.3|37.3|||
4128375|NCT00910988|3953290|B4|||Fasting Cholesterol|Completer Sample (eg, completed both clamps)|mg/dL|Mean|175.3|175.3|Standard Deviation|24.2|24.2|||
4128376|NCT00910988|3953291|B3|||Fasting Cholesterol|Completer Sample (eg, completed both clamps)|mg/dL|Mean|176.8|176.8|Standard Deviation|38.4|38.4|||
4128377|NCT00910988|3953292|B2|||Fasting Cholesterol|Completer Sample (eg, completed both clamps)|mg/dL|Mean|169.6|169.6|Standard Deviation|37.6|37.6|||
4128378|NCT00910988|3953293|B1|||Fasting Cholesterol|Completer Sample (eg, completed both clamps)|mg/dL|Mean|191.9|191.9|Standard Deviation|41.4|41.4|||
4128379|NCT00910988|3953289|B5|||Fasting Cholesterol|Intent-To-Treat (eg, completed at least one clamp)|mg/dL|Mean|179.8|179.8|Standard Deviation|36.6|36.6|||
4128380|NCT00910988|3953290|B4|||Fasting Cholesterol|Intent-To-Treat (eg, completed at least one clamp)|mg/dL|Mean|175.3|175.3|Standard Deviation|24.2|24.2|||
4128381|NCT00910988|3953291|B3|||Fasting Cholesterol|Intent-To-Treat (eg, completed at least one clamp)|mg/dL|Mean|171.6|171.6|Standard Deviation|32.1|32.1|||
4128382|NCT00910988|3953292|B2|||Fasting Cholesterol|Intent-To-Treat (eg, completed at least one clamp)|mg/dL|Mean|171.9|171.9|Standard Deviation|37.7|37.7|||
4128383|NCT00910988|3953293|B1|||Fasting Cholesterol|Intent-To-Treat (eg, completed at least one clamp)|mg/dL|Mean|193.6|193.6|Standard Deviation|40.3|40.3|||
4128566|NCT00910962|3953338|B4||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4128384|NCT00910988|3953289|B5|||Heart Rate|Completer Sample (eg, completed both clamps)|beats per minute|Mean|67|67.0|Standard Deviation|11|11.0|||
4128385|NCT00910988|3953290|B4|||Heart Rate|Completer Sample (eg, completed both clamps)|beats per minute|Mean|66|66.0|Standard Deviation|7|7.0|||
4128386|NCT00910988|3953291|B3|||Heart Rate|Completer Sample (eg, completed both clamps)|beats per minute|Mean|57|57.0|Standard Deviation|5|5.0|||
4128387|NCT00910988|3953292|B2|||Heart Rate|Completer Sample (eg, completed both clamps)|beats per minute|Mean|71|71.0|Standard Deviation|11|11.0|||
4128388|NCT00910988|3953293|B1|||Heart Rate|Completer Sample (eg, completed both clamps)|beats per minute|Mean|67|67.0|Standard Deviation|12|12.0|||
4128389|NCT00910988|3953289|B5|||Heart Rate|Intent-To-Treat (eg, completed at least one clamp)|beats per minute|Mean|67|67.0|Standard Deviation|11|11.0|||
4128390|NCT00910988|3953290|B4|||Heart Rate|Intent-To-Treat (eg, completed at least one clamp)|beats per minute|Mean|66|66.0|Standard Deviation|7|7.0|||
4128391|NCT00910988|3953291|B3|||Heart Rate|Intent-To-Treat (eg, completed at least one clamp)|beats per minute|Mean|62|62.0|Standard Deviation|9|9.0|||
4128392|NCT00910988|3953292|B2|||Heart Rate|Intent-To-Treat (eg, completed at least one clamp)|beats per minute|Mean|70|70.0|Standard Deviation|11|11.0|||
4128393|NCT00910988|3953293|B1|||Heart Rate|Intent-To-Treat (eg, completed at least one clamp)|beats per minute|Mean|66|66.0|Standard Deviation|11|11.0|||
4128394|NCT00910988|3953289|B5|||Diastolic Blood Pressure|Completer Sample (eg, completed both clamps)|mmHg|Mean|78|78.0|Standard Deviation|9|9.0|||
4128395|NCT00910988|3953290|B4|||Diastolic Blood Pressure|Completer Sample (eg, completed both clamps)|mmHg|Mean|71|71.0|Standard Deviation|10|10.0|||
4128396|NCT00910988|3953291|B3|||Diastolic Blood Pressure|Completer Sample (eg, completed both clamps)|mmHg|Mean|82|82.0|Standard Deviation|15|15.0|||
4128397|NCT00910988|3953292|B2|||Diastolic Blood Pressure|Completer Sample (eg, completed both clamps)|mmHg|Mean|77|77.0|Standard Deviation|6|6.0|||
4128398|NCT00910988|3953293|B1|||Diastolic Blood Pressure|Completer Sample (eg, completed both clamps)|mmHg|Mean|80|80.0|Standard Deviation|8|8.0|||
4128399|NCT00910988|3953289|B5|||Diastolic Blood Pressure|Intent-To-Treat (eg, completed at least one clamp)|mmHg|Mean|76|76.0|Standard Deviation|11|11.0|||
4128400|NCT00910988|3953290|B4|||Diastolic Blood Pressure|Intent-To-Treat (eg, completed at least one clamp)|mmHg|Mean|71|71.0|Standard Deviation|10|10.0|||
4128401|NCT00910988|3953291|B3|||Diastolic Blood Pressure|Intent-To-Treat (eg, completed at least one clamp)|mmHg|Mean|81|81.0|Standard Deviation|13|13.0|||
4128402|NCT00910988|3953292|B2|||Diastolic Blood Pressure|Intent-To-Treat (eg, completed at least one clamp)|mmHg|Mean|74|74.0|Standard Deviation|11|11.0|||
4128403|NCT00910988|3953293|B1|||Diastolic Blood Pressure|Intent-To-Treat (eg, completed at least one clamp)|mmHg|Mean|78|78.0|Standard Deviation|9|9.0|||
4128404|NCT00910988|3953289|B5|||Systolic Blood Pressure|Completer Sample (eg, completed both clamps)|mmHg|Mean|131|131.0|Standard Deviation|10|10.0|||
4128405|NCT00910988|3953290|B4|||Systolic Blood Pressure|Completer Sample (eg, completed both clamps)|mmHg|Mean|130|130.0|Standard Deviation|10|10.0|||
4128406|NCT00910988|3953291|B3|||Systolic Blood Pressure|Completer Sample (eg, completed both clamps)|mmHg|Mean|134|134.0|Standard Deviation|17|17.0|||
4128407|NCT00910988|3953292|B2|||Systolic Blood Pressure|Completer Sample (eg, completed both clamps)|mmHg|Mean|130|130.0|Standard Deviation|7|7.0|||
4128408|NCT00910988|3953293|B1|||Systolic Blood Pressure|Completer Sample (eg, completed both clamps)|mmHg|Mean|130|130.0|Standard Deviation|10|10.0|||
4128409|NCT00910988|3953289|B5|||Systolic Blood Pressure|Intent-To-Treat (eg, completed at least one clamp)|mmHg|Mean|130|130.0|Standard Deviation|10|10.0|||
4128410|NCT00910988|3953290|B4|||Systolic Blood Pressure|Intent-To-Treat (eg, completed at least one clamp)|mmHg|Mean|130|130.0|Standard Deviation|10|10.0|||
4128411|NCT00910988|3953291|B3|||Systolic Blood Pressure|Intent-To-Treat (eg, completed at least one clamp)|mmHg|Mean|135|135.0|Standard Deviation|14|14.0|||
4128412|NCT00910988|3953292|B2|||Systolic Blood Pressure|Intent-To-Treat (eg, completed at least one clamp)|mmHg|Mean|127|127.0|Standard Deviation|9|9.0|||
4128413|NCT00910988|3953293|B1|||Systolic Blood Pressure|Intent-To-Treat (eg, completed at least one clamp)|mmHg|Mean|130|130.0|Standard Deviation|9|9.0|||
4128414|NCT00910988|3953289|B5|||DEXA Total Fat|Completer Sample (eg, completed both clamps)|kilograms|Mean|27.1|27.1|Standard Deviation|6.9|6.9|||
4128415|NCT00910988|3953290|B4|||DEXA Total Fat|Completer Sample (eg, completed both clamps)|kilograms|Mean|27.8|27.8|Standard Deviation|5.5|5.5|||
4128416|NCT00910988|3953291|B3|||DEXA Total Fat|Completer Sample (eg, completed both clamps)|kilograms|Mean|30.4|30.4|Standard Deviation|6.9|6.9|||
4128417|NCT00910988|3953292|B2|||DEXA Total Fat|Completer Sample (eg, completed both clamps)|kilograms|Mean|26.9|26.9|Standard Deviation|7.4|7.4|||
4128418|NCT00910988|3953293|B1|||DEXA Total Fat|Completer Sample (eg, completed both clamps)|kilograms|Mean|25.8|25.8|Standard Deviation|7.3|7.3|||
4128419|NCT00910988|3953289|B5|||DEXA Total Fat|Intent-To-Treat (eg, completed at least one clamp)|kilograms|Mean|27.6|27.6|Standard Deviation|7.3|7.3|||
4128420|NCT00910988|3953290|B4|||DEXA Total Fat|Intent-To-Treat (eg, completed at least one clamp)|kilograms|Mean|27.8|27.8|Standard Deviation|5.5|5.5|||
4128421|NCT00910988|3953291|B3|||DEXA Total Fat|Intent-To-Treat (eg, completed at least one clamp)|kilograms|Mean|32.2|32.2|Standard Deviation|5.9|5.9|||
4128422|NCT00910988|3953292|B2|||DEXA Total Fat|Intent-To-Treat (eg, completed at least one clamp)|kilograms|Mean|27.4|27.4|Standard Deviation|8.3|8.3|||
4128423|NCT00910988|3953293|B1|||DEXA Total Fat|Intent-To-Treat (eg, completed at least one clamp)|kilograms|Mean|25.3|25.3|Standard Deviation|7.0|7.0|||
4128424|NCT00910988|3953289|B5|||Waist Circumference|Completer Sample (eg, completed both clamps)|centimeters|Mean|104.7|104.7|Standard Deviation|9.0|9.0|||
4128425|NCT00910988|3953290|B4|||Waist Circumference|Completer Sample (eg, completed both clamps)|centimeters|Mean|106.2|106.2|Standard Deviation|8.7|8.7|||
4128426|NCT00910988|3953291|B3|||Waist Circumference|Completer Sample (eg, completed both clamps)|centimeters|Mean|111.4|111.4|Standard Deviation|4.2|4.2|||
4128427|NCT00910988|3953292|B2|||Waist Circumference|Completer Sample (eg, completed both clamps)|centimeters|Mean|104.3|104.3|Standard Deviation|10.7|10.7|||
4128428|NCT00910988|3953293|B1|||Waist Circumference|Completer Sample (eg, completed both clamps)|centimeters|Mean|102.0|102.0|Standard Deviation|8.3|8.3|||
4128429|NCT00910988|3953289|B5|||Waist Circumference|Intent-To-Treat (eg, completed at least one clamp)|centimeters|Mean|104.9|104.9|Standard Deviation|9.7|9.7|||
4128430|NCT00910988|3953290|B4|||Waist Circumference|Intent-To-Treat (eg, completed at least one clamp)|centimeters|Mean|106.2|106.2|Standard Deviation|8.7|8.7|||
4128431|NCT00910988|3953291|B3|||Waist Circumference|Intent-To-Treat (eg, completed at least one clamp)|centimeters|Mean|112.5|112.5|Standard Deviation|5.0|5.0|||
4128432|NCT00910988|3953292|B2|||Waist Circumference|Intent-To-Treat (eg, completed at least one clamp)|centimeters|Mean|103.9|103.9|Standard Deviation|11.8|11.8|||
4128433|NCT00910988|3953293|B1|||Waist Circumference|Intent-To-Treat (eg, completed at least one clamp)|centimeters|Mean|101.5|101.5|Standard Deviation|8.0|8.0|||
4128434|NCT00910988|3953289|B5|||Body Mass Index (BMI)|Completer Sample (eg, completed both clamps)|kg/m^2|Mean|30.69|30.69|Standard Deviation|2.44|2.44|||
4128435|NCT00910988|3953290|B4|||Body Mass Index (BMI)|Completer Sample (eg, completed both clamps)|kg/m^2|Mean|30.84|30.84|Standard Deviation|1.45|1.45|||
4128436|NCT00910988|3953291|B3|||Body Mass Index (BMI)|Completer Sample (eg, completed both clamps)|kg/m^2|Mean|33.18|33.18|Standard Deviation|1.56|1.56|||
4128437|NCT00910988|3953292|B2|||Body Mass Index (BMI)|Completer Sample (eg, completed both clamps)|kg/m^2|Mean|30.86|30.86|Standard Deviation|2.82|2.82|||
4128438|NCT00910988|3953293|B1|||Body Mass Index (BMI)|Completer Sample (eg, completed both clamps)|kg/m^2|Mean|29.60|29.6|Standard Deviation|2.13|2.13|||
4128439|NCT00910988|3953289|B5|||Body Mass Index (BMI)|Intent-To-Treat (eg, completed at least one clamp)|kg/m^2|Mean|30.89|30.89|Standard Deviation|2.85|2.85|||
4128440|NCT00910988|3953290|B4|||Body Mass Index (BMI)|Intent-To-Treat (eg, completed at least one clamp)|kg/m^2|Mean|30.84|30.84|Standard Deviation|1.45|1.45|||
4128441|NCT00910988|3953291|B3|||Body Mass Index (BMI)|Intent-To-Treat (eg, completed at least one clamp)|kg/m^2|Mean|33.83|33.83|Standard Deviation|1.90|1.9|||
4128442|NCT00910988|3953292|B2|||Body Mass Index (BMI)|Intent-To-Treat (eg, completed at least one clamp)|kg/m^2|Mean|30.85|30.85|Standard Deviation|3.34|3.34|||
4128443|NCT00910988|3953293|B1|||Body Mass Index (BMI)|Intent-To-Treat (eg, completed at least one clamp)|kg/m^2|Mean|29.49|29.49|Standard Deviation|2.02|2.02|||
4128444|NCT00910988|3953289|B5|||Weight|Completer Sample (eg, completed both clamps)|kilograms|Mean|98.0|98.0|Standard Deviation|11.4|11.4|||
4128445|NCT00910988|3953290|B4|||Weight|Completer Sample (eg, completed both clamps)|kilograms|Mean|96.2|96.2|Standard Deviation|6.0|6.0|||
4128446|NCT00910988|3953291|B3|||Weight|Completer Sample (eg, completed both clamps)|kilograms|Mean|113.1|113.1|Standard Deviation|9.4|9.4|||
4128447|NCT00910988|3953292|B2|||Weight|Completer Sample (eg, completed both clamps)|kilograms|Mean|96.7|96.7|Standard Deviation|10.7|10.7|||
4128448|NCT00910988|3953293|B1|||Weight|Completer Sample (eg, completed both clamps)|kilograms|Mean|94.6|94.6|Standard Deviation|10.9|10.9|||
4128449|NCT00910988|3953289|B5|||Weight|Intent-To-Treat (eg, completed at least one clamp)|kilograms|Mean|98.9|98.9|Standard Deviation|13.6|13.6|||
4128450|NCT00910988|3953290|B4|||Weight|Intent-To-Treat (eg, completed at least one clamp)|kilograms|Mean|96.2|96.2|Standard Deviation|6.0|6.0|||
4128451|NCT00910988|3953291|B3|||Weight|Intent-To-Treat (eg, completed at least one clamp)|kilograms|Mean|114.1|114.1|Standard Deviation|10.0|10.0|||
4128452|NCT00910988|3953292|B2|||Weight|Intent-To-Treat (eg, completed at least one clamp)|kilograms|Mean|97.4|97.4|Standard Deviation|15.1|15.1|||
4128453|NCT00910988|3953293|B1|||Weight|Intent-To-Treat (eg, completed at least one clamp)|kilograms|Mean|93.7|93.7|Standard Deviation|10.5|10.5|||
4128454|NCT00910988|3953289|B5|Other||Race/Ethnicity, Customized|Intent-To-Treat (eg, completed at least one clamp)|participants|Number|1|1.0||||||
4128455|NCT00910988|3953290|B4|Other||Race/Ethnicity, Customized|Intent-To-Treat (eg, completed at least one clamp)|participants|Number|0|0.0||||||
4128456|NCT00910988|3953291|B3|Other||Race/Ethnicity, Customized|Intent-To-Treat (eg, completed at least one clamp)|participants|Number|0|0.0||||||
4128457|NCT00910988|3953292|B2|Other||Race/Ethnicity, Customized|Intent-To-Treat (eg, completed at least one clamp)|participants|Number|1|1.0||||||
4128458|NCT00910988|3953293|B1|Other||Race/Ethnicity, Customized|Intent-To-Treat (eg, completed at least one clamp)|participants|Number|0|0.0||||||
4128459|NCT00910988|3953289|B5|Native American||Race/Ethnicity, Customized|Intent-To-Treat (eg, completed at least one clamp)|participants|Number|2|2.0||||||
4128460|NCT00910988|3953290|B4|Native American||Race/Ethnicity, Customized|Intent-To-Treat (eg, completed at least one clamp)|participants|Number|0|0.0||||||
4128461|NCT00910988|3953291|B3|Native American||Race/Ethnicity, Customized|Intent-To-Treat (eg, completed at least one clamp)|participants|Number|0|0.0||||||
4128462|NCT00910988|3953292|B2|Native American||Race/Ethnicity, Customized|Intent-To-Treat (eg, completed at least one clamp)|participants|Number|1|1.0||||||
4128463|NCT00910988|3953293|B1|Native American||Race/Ethnicity, Customized|Intent-To-Treat (eg, completed at least one clamp)|participants|Number|1|1.0||||||
4128464|NCT00910988|3953289|B5|Asian||Race/Ethnicity, Customized|Intent-To-Treat (eg, completed at least one clamp)|participants|Number|2|2.0||||||
4128465|NCT00910988|3953290|B4|Asian||Race/Ethnicity, Customized|Intent-To-Treat (eg, completed at least one clamp)|participants|Number|0|0.0||||||
4128466|NCT00910988|3953291|B3|Asian||Race/Ethnicity, Customized|Intent-To-Treat (eg, completed at least one clamp)|participants|Number|0|0.0||||||
4128467|NCT00910988|3953292|B2|Asian||Race/Ethnicity, Customized|Intent-To-Treat (eg, completed at least one clamp)|participants|Number|1|1.0||||||
4128468|NCT00910988|3953293|B1|Asian||Race/Ethnicity, Customized|Intent-To-Treat (eg, completed at least one clamp)|participants|Number|1|1.0||||||
4128469|NCT00910988|3953289|B5|African American||Race/Ethnicity, Customized|Intent-To-Treat (eg, completed at least one clamp)|participants|Number|24|24.0||||||
4128470|NCT00910988|3953290|B4|African American||Race/Ethnicity, Customized|Intent-To-Treat (eg, completed at least one clamp)|participants|Number|2|2.0||||||
4128471|NCT00910988|3953291|B3|African American||Race/Ethnicity, Customized|Intent-To-Treat (eg, completed at least one clamp)|participants|Number|7|7.0||||||
4128472|NCT00910988|3953292|B2|African American||Race/Ethnicity, Customized|Intent-To-Treat (eg, completed at least one clamp)|participants|Number|6|6.0||||||
4128473|NCT00910988|3953293|B1|African American||Race/Ethnicity, Customized|Intent-To-Treat (eg, completed at least one clamp)|participants|Number|9|9.0||||||
4128474|NCT00910988|3953289|B5|Caucasian||Race/Ethnicity, Customized|Intent-To-Treat (eg, completed at least one clamp)|participants|Number|17|17.0||||||
4128475|NCT00910988|3953290|B4|Caucasian||Race/Ethnicity, Customized|Intent-To-Treat (eg, completed at least one clamp)|participants|Number|4|4.0||||||
4128476|NCT00910988|3953291|B3|Caucasian||Race/Ethnicity, Customized|Intent-To-Treat (eg, completed at least one clamp)|participants|Number|1|1.0||||||
4128477|NCT00910988|3953292|B2|Caucasian||Race/Ethnicity, Customized|Intent-To-Treat (eg, completed at least one clamp)|participants|Number|7|7.0||||||
4128478|NCT00910988|3953293|B1|Caucasian||Race/Ethnicity, Customized|Intent-To-Treat (eg, completed at least one clamp)|participants|Number|5|5.0||||||
4128479|NCT00910988|3953289|B5|Other||Race/Ethnicity, Customized|Completer Sample (eg, completed both clamps), which includes 37 subjects|participants|Number|1|1.0||||||
4128480|NCT00910988|3953290|B4|Other||Race/Ethnicity, Customized|Completer Sample (eg, completed both clamps), which includes 37 subjects|participants|Number|0|0.0||||||
4128481|NCT00910988|3953291|B3|Other||Race/Ethnicity, Customized|Completer Sample (eg, completed both clamps), which includes 37 subjects|participants|Number|0|0.0||||||
4128482|NCT00910988|3953292|B2|Other||Race/Ethnicity, Customized|Completer Sample (eg, completed both clamps), which includes 37 subjects|participants|Number|1|1.0||||||
4128483|NCT00910988|3953293|B1|Other||Race/Ethnicity, Customized|Completer Sample (eg, completed both clamps), which includes 37 subjects|participants|Number|0|0.0||||||
4128484|NCT00910988|3953289|B5|Native American||Race/Ethnicity, Customized|Completer Sample (eg, completed both clamps), which includes 37 subjects|participants|Number|2|2.0||||||
4128485|NCT00910988|3953290|B4|Native American||Race/Ethnicity, Customized|Completer Sample (eg, completed both clamps), which includes 37 subjects|participants|Number|0|0.0||||||
4128486|NCT00910988|3953291|B3|Native American||Race/Ethnicity, Customized|Completer Sample (eg, completed both clamps), which includes 37 subjects|participants|Number|0|0.0||||||
4128487|NCT00910988|3953292|B2|Native American||Race/Ethnicity, Customized|Completer Sample (eg, completed both clamps), which includes 37 subjects|participants|Number|1|1.0||||||
4128488|NCT00910988|3953293|B1|Native American||Race/Ethnicity, Customized|Completer Sample (eg, completed both clamps), which includes 37 subjects|participants|Number|1|1.0||||||
4128489|NCT00910988|3953289|B5|Asian||Race/Ethnicity, Customized|Completer Sample (eg, completed both clamps), which includes 37 subjects|participants|Number|1|1.0||||||
4128490|NCT00910988|3953290|B4|Asian||Race/Ethnicity, Customized|Completer Sample (eg, completed both clamps), which includes 37 subjects|participants|Number|0|0.0||||||
4128491|NCT00910988|3953291|B3|Asian||Race/Ethnicity, Customized|Completer Sample (eg, completed both clamps), which includes 37 subjects|participants|Number|0|0.0||||||
4128492|NCT00910988|3953292|B2|Asian||Race/Ethnicity, Customized|Completer Sample (eg, completed both clamps), which includes 37 subjects|participants|Number|0|0.0||||||
4128493|NCT00910988|3953293|B1|Asian||Race/Ethnicity, Customized|Completer Sample (eg, completed both clamps), which includes 37 subjects|participants|Number|1|1.0||||||
4128494|NCT00910988|3953289|B5|African American||Race/Ethnicity, Customized|Completer Sample (eg, completed both clamps), which includes 37 subjects|participants|Number|18|18.0||||||
4128495|NCT00910988|3953290|B4|African American||Race/Ethnicity, Customized|Completer Sample (eg, completed both clamps), which includes 37 subjects|participants|Number|2|2.0||||||
4128496|NCT00910988|3953291|B3|African American||Race/Ethnicity, Customized|Completer Sample (eg, completed both clamps), which includes 37 subjects|participants|Number|4|4.0||||||
4128497|NCT00910988|3953292|B2|African American||Race/Ethnicity, Customized|Completer Sample (eg, completed both clamps), which includes 37 subjects|participants|Number|5|5.0||||||
4128498|NCT00910988|3953293|B1|African American||Race/Ethnicity, Customized|Completer Sample (eg, completed both clamps), which includes 37 subjects|participants|Number|7|7.0||||||
4128499|NCT00910988|3953289|B5|Caucasian||Race/Ethnicity, Customized|Completer Sample (eg, completed both clamps), which includes 37 subjects|participants|Number|15|15.0||||||
4128500|NCT00910988|3953290|B4|Caucasian||Race/Ethnicity, Customized|Completer Sample (eg, completed both clamps), which includes 37 subjects|participants|Number|4|4.0||||||
4128501|NCT00910988|3953291|B3|Caucasian||Race/Ethnicity, Customized|Completer Sample (eg, completed both clamps), which includes 37 subjects|participants|Number|1|1.0||||||
4128502|NCT00910988|3953292|B2|Caucasian||Race/Ethnicity, Customized|Completer Sample (eg, completed both clamps), which includes 37 subjects|participants|Number|5|5.0||||||
4128503|NCT00910988|3953293|B1|Caucasian||Race/Ethnicity, Customized|Completer Sample (eg, completed both clamps), which includes 37 subjects|participants|Number|5|5.0||||||
4128504|NCT00910988|3953289|B5|Male||Sex/Gender, Customized|Completer Sample (eg, completed both clamps), which includes 37 subjects|participants|Number|37|37.0||||||
4128505|NCT00910988|3953290|B4|Male||Sex/Gender, Customized|Completer Sample (eg, completed both clamps), which includes 37 subjects|participants|Number|6|6.0||||||
4128506|NCT00910988|3953291|B3|Male||Sex/Gender, Customized|Completer Sample (eg, completed both clamps), which includes 37 subjects|participants|Number|5|5.0||||||
4128507|NCT00910988|3953292|B2|Male||Sex/Gender, Customized|Completer Sample (eg, completed both clamps), which includes 37 subjects|participants|Number|12|12.0||||||
4128508|NCT00910988|3953293|B1|Male||Sex/Gender, Customized|Completer Sample (eg, completed both clamps), which includes 37 subjects|participants|Number|14|14.0||||||
4128509|NCT00910988|3953289|B5|Female||Sex/Gender, Customized|Completer Sample (eg, completed both clamps), which includes 37 subjects|participants|Number|0|0.0||||||
4128510|NCT00910988|3953290|B4|Female||Sex/Gender, Customized|Completer Sample (eg, completed both clamps), which includes 37 subjects|participants|Number|0|0.0||||||
4128511|NCT00910988|3953291|B3|Female||Sex/Gender, Customized|Completer Sample (eg, completed both clamps), which includes 37 subjects|participants|Number|0|0.0||||||
4128512|NCT00910988|3953292|B2|Female||Sex/Gender, Customized|Completer Sample (eg, completed both clamps), which includes 37 subjects|participants|Number|0|0.0||||||
4128513|NCT00910988|3953293|B1|Female||Sex/Gender, Customized|Completer Sample (eg, completed both clamps), which includes 37 subjects|participants|Number|0|0.0||||||
4128514|NCT00910988|3953289|B5||Male|Sex: Female, Male|Intent-To-Treat (eg, completed at least one clamp)|Participants|Count of Participants|46|46.0||||||
4128515|NCT00910988|3953290|B4||Male|Sex: Female, Male|Intent-To-Treat (eg, completed at least one clamp)|Participants|Count of Participants|6|6.0||||||
4128516|NCT00910988|3953291|B3||Male|Sex: Female, Male|Intent-To-Treat (eg, completed at least one clamp)|Participants|Count of Participants|8|8.0||||||
4128517|NCT00910988|3953292|B2||Male|Sex: Female, Male|Intent-To-Treat (eg, completed at least one clamp)|Participants|Count of Participants|16|16.0||||||
4128518|NCT00910988|3953293|B1||Male|Sex: Female, Male|Intent-To-Treat (eg, completed at least one clamp)|Participants|Count of Participants|16|16.0||||||
4128519|NCT00910988|3953289|B5||Female|Sex: Female, Male|Intent-To-Treat (eg, completed at least one clamp)|Participants|Count of Participants|0|0.0||||||
4128520|NCT00910988|3953290|B4||Female|Sex: Female, Male|Intent-To-Treat (eg, completed at least one clamp)|Participants|Count of Participants|0|0.0||||||
4128521|NCT00910988|3953291|B3||Female|Sex: Female, Male|Intent-To-Treat (eg, completed at least one clamp)|Participants|Count of Participants|0|0.0||||||
4128522|NCT00910988|3953292|B2||Female|Sex: Female, Male|Intent-To-Treat (eg, completed at least one clamp)|Participants|Count of Participants|0|0.0||||||
4128523|NCT00910988|3953293|B1||Female|Sex: Female, Male|Intent-To-Treat (eg, completed at least one clamp)|Participants|Count of Participants|0|0.0||||||
4128524|NCT00910988|3953289|B5|||Age|Completer Sample (eg, completed both clamps)|years|Mean|33.5|33.5|Standard Deviation|8.5|8.5|||
4128525|NCT00910988|3953290|B4|||Age|Completer Sample (eg, completed both clamps)|years|Mean|29.7|29.7|Standard Deviation|8.7|8.7|||
4128526|NCT00910988|3953291|B3|||Age|Completer Sample (eg, completed both clamps)|years|Mean|37.0|37.0|Standard Deviation|5.6|5.6|||
4128527|NCT00910988|3953292|B2|||Age|Completer Sample (eg, completed both clamps)|years|Mean|32.9|32.9|Standard Deviation|9.0|9.0|||
4128528|NCT00910988|3953293|B1|||Age|Completer Sample (eg, completed both clamps)|years|Mean|34.5|34.5|Standard Deviation|9.1|9.1|||
4128529|NCT00910988|3953289|B5|||Age|Intent-To-Treat (eg, completed at least one clamp)|years|Mean|33.1|33.1|Standard Deviation|8.6|8.6|||
4128530|NCT00910988|3953290|B4|||Age|Intent-To-Treat (eg, completed at least one clamp)|years|Mean|29.7|29.7|Standard Deviation|8.7|8.7|||
4128531|NCT00910988|3953291|B3|||Age|Intent-To-Treat (eg, completed at least one clamp)|years|Mean|31.9|31.9|Standard Deviation|8.7|8.7|||
4128532|NCT00910988|3953292|B2|||Age|Intent-To-Treat (eg, completed at least one clamp)|years|Mean|33.2|33.2|Standard Deviation|8.7|8.7|||
4128533|NCT00910988|3953293|B1|||Age|Intent-To-Treat (eg, completed at least one clamp)|years|Mean|34.9|34.9|Standard Deviation|8.9|8.9|||
4128534|NCT00910962|3953338|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4128535|NCT00910962|3953339|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4128536|NCT00910962|3953340|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4128537|NCT00910962|3953341|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4128538|NCT00910962|3953338|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4128539|NCT00910962|3953339|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4128540|NCT00910962|3953340|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4128541|NCT00910962|3953341|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4128542|NCT00910962|3953338|B4||White|Race (NIH/OMB)||Participants|Count of Participants|485|485.0||||||
4128543|NCT00910962|3953339|B3||White|Race (NIH/OMB)||Participants|Count of Participants|174|174.0||||||
4128544|NCT00910962|3953340|B2||White|Race (NIH/OMB)||Participants|Count of Participants|183|183.0||||||
4128545|NCT00910962|3953341|B1||White|Race (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
4128546|NCT00910962|3953338|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4128547|NCT00910962|3953339|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4128548|NCT00910962|3953340|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4128549|NCT00910962|3953341|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4128550|NCT00910962|3953338|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4128551|NCT00910962|3953339|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4128552|NCT00910962|3953340|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4128553|NCT00910962|3953341|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4128554|NCT00910962|3953338|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4128555|NCT00910962|3953339|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4128556|NCT00910962|3953340|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4128557|NCT00910962|3953341|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4128558|NCT00910962|3953338|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4128559|NCT00910962|3953339|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4128560|NCT00910962|3953340|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4128561|NCT00910962|3953341|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4128562|NCT00910962|3953338|B4||Male|Sex: Female, Male||Participants|Count of Participants|377|377.0||||||
4128563|NCT00910962|3953339|B3||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4128564|NCT00910962|3953340|B2||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4128567|NCT00910962|3953339|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4128568|NCT00910962|3953340|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4128569|NCT00910962|3953341|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4128570|NCT00910962|3953338|B4|||Age||Years|Mean|63.5|63.5|Standard Deviation|10.66|10.66|||
4128571|NCT00910962|3953339|B3|||Age||Years|Mean|64.6|64.6|Standard Deviation|10.50|10.5|||
4128572|NCT00910962|3953340|B2|||Age||Years|Mean|62.6|62.6|Standard Deviation|11.03|11.03|||
4128573|NCT00910962|3953341|B1|||Age||Years|Mean|63.4|63.4|Standard Deviation|10.29|10.29|||
4128574|NCT00910910|3953433|B3||Male|Sex: Female, Male|The Intent-to-Treat (ITT) population was defined as all participants who were randomized, independent of whether they received study treatment or not.|Participants|Count of Participants|274|274.0||||||
4128575|NCT00910910|3953434|B2||Male|Sex: Female, Male|The Intent-to-Treat (ITT) population was defined as all participants who were randomized, independent of whether they received study treatment or not.|Participants|Count of Participants|142|142.0||||||
4128576|NCT00910910|3953435|B1||Male|Sex: Female, Male|The Intent-to-Treat (ITT) population was defined as all participants who were randomized, independent of whether they received study treatment or not.|Participants|Count of Participants|132|132.0||||||
4128577|NCT00910910|3953433|B3||Female|Sex: Female, Male|The Intent-to-Treat (ITT) population was defined as all participants who were randomized, independent of whether they received study treatment or not.|Participants|Count of Participants|176|176.0||||||
4128578|NCT00910910|3953434|B2||Female|Sex: Female, Male|The Intent-to-Treat (ITT) population was defined as all participants who were randomized, independent of whether they received study treatment or not.|Participants|Count of Participants|83|83.0||||||
4128579|NCT00910910|3953435|B1||Female|Sex: Female, Male|The Intent-to-Treat (ITT) population was defined as all participants who were randomized, independent of whether they received study treatment or not.|Participants|Count of Participants|93|93.0||||||
4128580|NCT00910910|3953433|B3|||Age||years|Mean|73.1|73.1|Standard Deviation|5.72|5.72|||
4128581|NCT00910910|3953434|B2|||Age||years|Mean|73.3|73.3|Standard Deviation|5.72|5.72|||
4128582|NCT00910910|3953435|B1|||Age||years|Mean|73.0|73.0|Standard Deviation|5.72|5.72|||
4128583|NCT00910871|3953470|B1||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4128584|NCT00910871|3953470|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4128585|NCT00910871|3953470|B1|||Age||years|Mean|34.6|34.6|Standard Deviation|12.1|12.1|||
4128586|NCT00910858|3953475|B4|Missing||Serum erythropoietin level||participants|Number|10|10.0||||||
4128587|NCT00910858|3953476|B3|Missing||Serum erythropoietin level||participants|Number|0|0.0||||||
4128588|NCT00910858|3953477|B2|Missing||Serum erythropoietin level||participants|Number|9|9.0||||||
4128589|NCT00910858|3953478|B1|Missing||Serum erythropoietin level||participants|Number|1|1.0||||||
4128590|NCT00910858|3953475|B4|≥ 500 mIU/mL||Serum erythropoietin level||participants|Number|14|14.0||||||
4128591|NCT00910858|3953476|B3|≥ 500 mIU/mL||Serum erythropoietin level||participants|Number|5|5.0||||||
4128592|NCT00910858|3953477|B2|≥ 500 mIU/mL||Serum erythropoietin level||participants|Number|2|2.0||||||
4128593|NCT00910858|3953478|B1|≥ 500 mIU/mL||Serum erythropoietin level||participants|Number|7|7.0||||||
4128594|NCT00910858|3953475|B4|< 500 mIU/mL||Serum erythropoietin level||participants|Number|15|15.0||||||
4128595|NCT00910858|3953476|B3|< 500 mIU/mL||Serum erythropoietin level||participants|Number|2|2.0||||||
4128596|NCT00910858|3953477|B2|< 500 mIU/mL||Serum erythropoietin level||participants|Number|4|4.0||||||
4128597|NCT00910858|3953478|B1|< 500 mIU/mL||Serum erythropoietin level||participants|Number|9|9.0||||||
4128598|NCT00910858|3953475|B4|Other||French-American-British (FAB) classification of MDS|"Refractory anemia: characterized by less than 5% primitive blood cells (myeloblasts) in the bone marrow and pathological abnormalities primarily seen in red cell precursors; RARS: distinguished by the presence of 15% or greater red cell precursors in the marrow being abnormal iron-stuffed cells called ringed sideroblasts; RAEB: characterized by 5-20% myeloblasts in the marrow; RAEB-1: characterized by 5% to 9% blasts in the bone marrow and less than 5% blasts in the blood."|participants|Number|4|4.0||||||
4128599|NCT00910858|3953476|B3|Other||French-American-British (FAB) classification of MDS|"Refractory anemia: characterized by less than 5% primitive blood cells (myeloblasts) in the bone marrow and pathological abnormalities primarily seen in red cell precursors; RARS: distinguished by the presence of 15% or greater red cell precursors in the marrow being abnormal iron-stuffed cells called ringed sideroblasts; RAEB: characterized by 5-20% myeloblasts in the marrow; RAEB-1: characterized by 5% to 9% blasts in the bone marrow and less than 5% blasts in the blood."|participants|Number|1|1.0||||||
4128600|NCT00910858|3953477|B2|Other||French-American-British (FAB) classification of MDS|"Refractory anemia: characterized by less than 5% primitive blood cells (myeloblasts) in the bone marrow and pathological abnormalities primarily seen in red cell precursors; RARS: distinguished by the presence of 15% or greater red cell precursors in the marrow being abnormal iron-stuffed cells called ringed sideroblasts; RAEB: characterized by 5-20% myeloblasts in the marrow; RAEB-1: characterized by 5% to 9% blasts in the bone marrow and less than 5% blasts in the blood."|participants|Number|0|0.0||||||
4128601|NCT00910858|3953478|B1|Other||French-American-British (FAB) classification of MDS|"Refractory anemia: characterized by less than 5% primitive blood cells (myeloblasts) in the bone marrow and pathological abnormalities primarily seen in red cell precursors; RARS: distinguished by the presence of 15% or greater red cell precursors in the marrow being abnormal iron-stuffed cells called ringed sideroblasts; RAEB: characterized by 5-20% myeloblasts in the marrow; RAEB-1: characterized by 5% to 9% blasts in the bone marrow and less than 5% blasts in the blood."|participants|Number|3|3.0||||||
4128635|NCT00910858|3953476|B3|Low risk (0)||International Prognostic Scoring System (IPSS) Score|The MDS IPSS score = sum of marrow blast + karyotype + cytopenia score. Score ranges from 0 (low risk) to 3.5 (high risk).|participants|Number|2|2.0||||||
4128636|NCT00910858|3953477|B2|Low risk (0)||International Prognostic Scoring System (IPSS) Score|The MDS IPSS score = sum of marrow blast + karyotype + cytopenia score. Score ranges from 0 (low risk) to 3.5 (high risk).|participants|Number|8|8.0||||||
4128602|NCT00910858|3953475|B4|Refractory anemia with excess blasts -1 (RAEB-1)||French-American-British (FAB) classification of MDS|"Refractory anemia: characterized by less than 5% primitive blood cells (myeloblasts) in the bone marrow and pathological abnormalities primarily seen in red cell precursors; RARS: distinguished by the presence of 15% or greater red cell precursors in the marrow being abnormal iron-stuffed cells called ringed sideroblasts; RAEB: characterized by 5-20% myeloblasts in the marrow; RAEB-1: characterized by 5% to 9% blasts in the bone marrow and less than 5% blasts in the blood."|participants|Number|1|1.0||||||
4128603|NCT00910858|3953476|B3|Refractory anemia with excess blasts -1 (RAEB-1)||French-American-British (FAB) classification of MDS|"Refractory anemia: characterized by less than 5% primitive blood cells (myeloblasts) in the bone marrow and pathological abnormalities primarily seen in red cell precursors; RARS: distinguished by the presence of 15% or greater red cell precursors in the marrow being abnormal iron-stuffed cells called ringed sideroblasts; RAEB: characterized by 5-20% myeloblasts in the marrow; RAEB-1: characterized by 5% to 9% blasts in the bone marrow and less than 5% blasts in the blood."|participants|Number|0|0.0||||||
4128604|NCT00910858|3953477|B2|Refractory anemia with excess blasts -1 (RAEB-1)||French-American-British (FAB) classification of MDS|"Refractory anemia: characterized by less than 5% primitive blood cells (myeloblasts) in the bone marrow and pathological abnormalities primarily seen in red cell precursors; RARS: distinguished by the presence of 15% or greater red cell precursors in the marrow being abnormal iron-stuffed cells called ringed sideroblasts; RAEB: characterized by 5-20% myeloblasts in the marrow; RAEB-1: characterized by 5% to 9% blasts in the bone marrow and less than 5% blasts in the blood."|participants|Number|1|1.0||||||
4128605|NCT00910858|3953478|B1|Refractory anemia with excess blasts -1 (RAEB-1)||French-American-British (FAB) classification of MDS|"Refractory anemia: characterized by less than 5% primitive blood cells (myeloblasts) in the bone marrow and pathological abnormalities primarily seen in red cell precursors; RARS: distinguished by the presence of 15% or greater red cell precursors in the marrow being abnormal iron-stuffed cells called ringed sideroblasts; RAEB: characterized by 5-20% myeloblasts in the marrow; RAEB-1: characterized by 5% to 9% blasts in the bone marrow and less than 5% blasts in the blood."|participants|Number|0|0.0||||||
4128606|NCT00910858|3953475|B4|Refractory anemia with excess blasts (RAEB)||French-American-British (FAB) classification of MDS|"Refractory anemia: characterized by less than 5% primitive blood cells (myeloblasts) in the bone marrow and pathological abnormalities primarily seen in red cell precursors; RARS: distinguished by the presence of 15% or greater red cell precursors in the marrow being abnormal iron-stuffed cells called ringed sideroblasts; RAEB: characterized by 5-20% myeloblasts in the marrow; RAEB-1: characterized by 5% to 9% blasts in the bone marrow and less than 5% blasts in the blood."|participants|Number|8|8.0||||||
4128607|NCT00910858|3953476|B3|Refractory anemia with excess blasts (RAEB)||French-American-British (FAB) classification of MDS|"Refractory anemia: characterized by less than 5% primitive blood cells (myeloblasts) in the bone marrow and pathological abnormalities primarily seen in red cell precursors; RARS: distinguished by the presence of 15% or greater red cell precursors in the marrow being abnormal iron-stuffed cells called ringed sideroblasts; RAEB: characterized by 5-20% myeloblasts in the marrow; RAEB-1: characterized by 5% to 9% blasts in the bone marrow and less than 5% blasts in the blood."|participants|Number|4|4.0||||||
4128608|NCT00910858|3953477|B2|Refractory anemia with excess blasts (RAEB)||French-American-British (FAB) classification of MDS|"Refractory anemia: characterized by less than 5% primitive blood cells (myeloblasts) in the bone marrow and pathological abnormalities primarily seen in red cell precursors; RARS: distinguished by the presence of 15% or greater red cell precursors in the marrow being abnormal iron-stuffed cells called ringed sideroblasts; RAEB: characterized by 5-20% myeloblasts in the marrow; RAEB-1: characterized by 5% to 9% blasts in the bone marrow and less than 5% blasts in the blood."|participants|Number|1|1.0||||||
4128609|NCT00910858|3953478|B1|Refractory anemia with excess blasts (RAEB)||French-American-British (FAB) classification of MDS|"Refractory anemia: characterized by less than 5% primitive blood cells (myeloblasts) in the bone marrow and pathological abnormalities primarily seen in red cell precursors; RARS: distinguished by the presence of 15% or greater red cell precursors in the marrow being abnormal iron-stuffed cells called ringed sideroblasts; RAEB: characterized by 5-20% myeloblasts in the marrow; RAEB-1: characterized by 5% to 9% blasts in the bone marrow and less than 5% blasts in the blood."|participants|Number|3|3.0||||||
4128610|NCT00910858|3953475|B4|Refractory anemia with ringed sideroblasts (RARS)||French-American-British (FAB) classification of MDS|"Refractory anemia: characterized by less than 5% primitive blood cells (myeloblasts) in the bone marrow and pathological abnormalities primarily seen in red cell precursors; RARS: distinguished by the presence of 15% or greater red cell precursors in the marrow being abnormal iron-stuffed cells called ringed sideroblasts; RAEB: characterized by 5-20% myeloblasts in the marrow; RAEB-1: characterized by 5% to 9% blasts in the bone marrow and less than 5% blasts in the blood."|participants|Number|11|11.0||||||
4128611|NCT00910858|3953476|B3|Refractory anemia with ringed sideroblasts (RARS)||French-American-British (FAB) classification of MDS|"Refractory anemia: characterized by less than 5% primitive blood cells (myeloblasts) in the bone marrow and pathological abnormalities primarily seen in red cell precursors; RARS: distinguished by the presence of 15% or greater red cell precursors in the marrow being abnormal iron-stuffed cells called ringed sideroblasts; RAEB: characterized by 5-20% myeloblasts in the marrow; RAEB-1: characterized by 5% to 9% blasts in the bone marrow and less than 5% blasts in the blood."|participants|Number|0|0.0||||||
4128612|NCT00910858|3953477|B2|Refractory anemia with ringed sideroblasts (RARS)||French-American-British (FAB) classification of MDS|"Refractory anemia: characterized by less than 5% primitive blood cells (myeloblasts) in the bone marrow and pathological abnormalities primarily seen in red cell precursors; RARS: distinguished by the presence of 15% or greater red cell precursors in the marrow being abnormal iron-stuffed cells called ringed sideroblasts; RAEB: characterized by 5-20% myeloblasts in the marrow; RAEB-1: characterized by 5% to 9% blasts in the bone marrow and less than 5% blasts in the blood."|participants|Number|6|6.0||||||
4128613|NCT00910858|3953478|B1|Refractory anemia with ringed sideroblasts (RARS)||French-American-British (FAB) classification of MDS|"Refractory anemia: characterized by less than 5% primitive blood cells (myeloblasts) in the bone marrow and pathological abnormalities primarily seen in red cell precursors; RARS: distinguished by the presence of 15% or greater red cell precursors in the marrow being abnormal iron-stuffed cells called ringed sideroblasts; RAEB: characterized by 5-20% myeloblasts in the marrow; RAEB-1: characterized by 5% to 9% blasts in the bone marrow and less than 5% blasts in the blood."|participants|Number|5|5.0||||||
4128614|NCT00910858|3953475|B4|Refractory anemia (RA)||French-American-British (FAB) classification of MDS|"Refractory anemia: characterized by less than 5% primitive blood cells (myeloblasts) in the bone marrow and pathological abnormalities primarily seen in red cell precursors; RARS: distinguished by the presence of 15% or greater red cell precursors in the marrow being abnormal iron-stuffed cells called ringed sideroblasts; RAEB: characterized by 5-20% myeloblasts in the marrow; RAEB-1: characterized by 5% to 9% blasts in the bone marrow and less than 5% blasts in the blood."|participants|Number|15|15.0||||||
4128615|NCT00910858|3953476|B3|Refractory anemia (RA)||French-American-British (FAB) classification of MDS|"Refractory anemia: characterized by less than 5% primitive blood cells (myeloblasts) in the bone marrow and pathological abnormalities primarily seen in red cell precursors; RARS: distinguished by the presence of 15% or greater red cell precursors in the marrow being abnormal iron-stuffed cells called ringed sideroblasts; RAEB: characterized by 5-20% myeloblasts in the marrow; RAEB-1: characterized by 5% to 9% blasts in the bone marrow and less than 5% blasts in the blood."|participants|Number|2|2.0||||||
4128616|NCT00910858|3953477|B2|Refractory anemia (RA)||French-American-British (FAB) classification of MDS|"Refractory anemia: characterized by less than 5% primitive blood cells (myeloblasts) in the bone marrow and pathological abnormalities primarily seen in red cell precursors; RARS: distinguished by the presence of 15% or greater red cell precursors in the marrow being abnormal iron-stuffed cells called ringed sideroblasts; RAEB: characterized by 5-20% myeloblasts in the marrow; RAEB-1: characterized by 5% to 9% blasts in the bone marrow and less than 5% blasts in the blood."|participants|Number|7|7.0||||||
4128617|NCT00910858|3953478|B1|Refractory anemia (RA)||French-American-British (FAB) classification of MDS|"Refractory anemia: characterized by less than 5% primitive blood cells (myeloblasts) in the bone marrow and pathological abnormalities primarily seen in red cell precursors; RARS: distinguished by the presence of 15% or greater red cell precursors in the marrow being abnormal iron-stuffed cells called ringed sideroblasts; RAEB: characterized by 5-20% myeloblasts in the marrow; RAEB-1: characterized by 5% to 9% blasts in the bone marrow and less than 5% blasts in the blood."|participants|Number|6|6.0||||||
4128618|NCT00910858|3953475|B4|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status: 0 = Fully active, no restrictions; 1 = Restricted but ambulatory and capable of light work; 2 = Ambulatory and capable of self-care but unable to work.|participants|Number|1|1.0||||||
4128619|NCT00910858|3953476|B3|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status: 0 = Fully active, no restrictions; 1 = Restricted but ambulatory and capable of light work; 2 = Ambulatory and capable of self-care but unable to work.|participants|Number|0|0.0||||||
4128620|NCT00910858|3953477|B2|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status: 0 = Fully active, no restrictions; 1 = Restricted but ambulatory and capable of light work; 2 = Ambulatory and capable of self-care but unable to work.|participants|Number|0|0.0||||||
4128621|NCT00910858|3953478|B1|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status: 0 = Fully active, no restrictions; 1 = Restricted but ambulatory and capable of light work; 2 = Ambulatory and capable of self-care but unable to work.|participants|Number|1|1.0||||||
4128622|NCT00910858|3953475|B4|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status: 0 = Fully active, no restrictions; 1 = Restricted but ambulatory and capable of light work; 2 = Ambulatory and capable of self-care but unable to work.|participants|Number|31|31.0||||||
4128623|NCT00910858|3953476|B3|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status: 0 = Fully active, no restrictions; 1 = Restricted but ambulatory and capable of light work; 2 = Ambulatory and capable of self-care but unable to work.|participants|Number|6|6.0||||||
4128624|NCT00910858|3953477|B2|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status: 0 = Fully active, no restrictions; 1 = Restricted but ambulatory and capable of light work; 2 = Ambulatory and capable of self-care but unable to work.|participants|Number|11|11.0||||||
4128625|NCT00910858|3953478|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status: 0 = Fully active, no restrictions; 1 = Restricted but ambulatory and capable of light work; 2 = Ambulatory and capable of self-care but unable to work.|participants|Number|14|14.0||||||
4128626|NCT00910858|3953475|B4|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status: 0 = Fully active, no restrictions; 1 = Restricted but ambulatory and capable of light work; 2 = Ambulatory and capable of self-care but unable to work.|participants|Number|7|7.0||||||
4128627|NCT00910858|3953476|B3|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status: 0 = Fully active, no restrictions; 1 = Restricted but ambulatory and capable of light work; 2 = Ambulatory and capable of self-care but unable to work.|participants|Number|1|1.0||||||
4128628|NCT00910858|3953477|B2|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status: 0 = Fully active, no restrictions; 1 = Restricted but ambulatory and capable of light work; 2 = Ambulatory and capable of self-care but unable to work.|participants|Number|4|4.0||||||
4128629|NCT00910858|3953478|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status: 0 = Fully active, no restrictions; 1 = Restricted but ambulatory and capable of light work; 2 = Ambulatory and capable of self-care but unable to work.|participants|Number|2|2.0||||||
4128630|NCT00910858|3953475|B4|Intermediate-1 (0.5-1.0)||International Prognostic Scoring System (IPSS) Score|The MDS IPSS score = sum of marrow blast + karyotype + cytopenia score. Score ranges from 0 (low risk) to 3.5 (high risk).|participants|Number|21|21.0||||||
4128631|NCT00910858|3953476|B3|Intermediate-1 (0.5-1.0)||International Prognostic Scoring System (IPSS) Score|The MDS IPSS score = sum of marrow blast + karyotype + cytopenia score. Score ranges from 0 (low risk) to 3.5 (high risk).|participants|Number|5|5.0||||||
4128632|NCT00910858|3953477|B2|Intermediate-1 (0.5-1.0)||International Prognostic Scoring System (IPSS) Score|The MDS IPSS score = sum of marrow blast + karyotype + cytopenia score. Score ranges from 0 (low risk) to 3.5 (high risk).|participants|Number|7|7.0||||||
4128633|NCT00910858|3953478|B1|Intermediate-1 (0.5-1.0)||International Prognostic Scoring System (IPSS) Score|The MDS IPSS score = sum of marrow blast + karyotype + cytopenia score. Score ranges from 0 (low risk) to 3.5 (high risk).|participants|Number|9|9.0||||||
4128634|NCT00910858|3953475|B4|Low risk (0)||International Prognostic Scoring System (IPSS) Score|The MDS IPSS score = sum of marrow blast + karyotype + cytopenia score. Score ranges from 0 (low risk) to 3.5 (high risk).|participants|Number|18|18.0||||||
4128637|NCT00910858|3953478|B1|Low risk (0)||International Prognostic Scoring System (IPSS) Score|The MDS IPSS score = sum of marrow blast + karyotype + cytopenia score. Score ranges from 0 (low risk) to 3.5 (high risk).|participants|Number|8|8.0||||||
4128638|NCT00910858|3953475|B4|||Duration of MDS||years|Mean|3.0|3.0|Standard Deviation|2.81|2.81|||
4128639|NCT00910858|3953476|B3|||Duration of MDS||years|Mean|4.2|4.2|Standard Deviation|4.74|4.74|||
4128640|NCT00910858|3953477|B2|||Duration of MDS||years|Mean|2.6|2.6|Standard Deviation|2.22|2.22|||
4128641|NCT00910858|3953478|B1|||Duration of MDS||years|Mean|2.8|2.8|Standard Deviation|2.28|2.28|||
4128642|NCT00910858|3953475|B4|Other||Race/Ethnicity, Customized|Participants could select more than 1 race option.|participants|Number|2|2.0||||||
4128643|NCT00910858|3953476|B3|Other||Race/Ethnicity, Customized|Participants could select more than 1 race option.|participants|Number|0|0.0||||||
4128644|NCT00910858|3953477|B2|Other||Race/Ethnicity, Customized|Participants could select more than 1 race option.|participants|Number|1|1.0||||||
4128645|NCT00910858|3953478|B1|Other||Race/Ethnicity, Customized|Participants could select more than 1 race option.|participants|Number|1|1.0||||||
4128646|NCT00910858|3953475|B4|Hispanic||Race/Ethnicity, Customized|Participants could select more than 1 race option.|participants|Number|2|2.0||||||
4128647|NCT00910858|3953476|B3|Hispanic||Race/Ethnicity, Customized|Participants could select more than 1 race option.|participants|Number|0|0.0||||||
4128648|NCT00910858|3953477|B2|Hispanic||Race/Ethnicity, Customized|Participants could select more than 1 race option.|participants|Number|1|1.0||||||
4128649|NCT00910858|3953478|B1|Hispanic||Race/Ethnicity, Customized|Participants could select more than 1 race option.|participants|Number|1|1.0||||||
4128650|NCT00910858|3953475|B4|White||Race/Ethnicity, Customized|Participants could select more than 1 race option.|participants|Number|37|37.0||||||
4128651|NCT00910858|3953476|B3|White||Race/Ethnicity, Customized|Participants could select more than 1 race option.|participants|Number|7|7.0||||||
4128652|NCT00910858|3953477|B2|White||Race/Ethnicity, Customized|Participants could select more than 1 race option.|participants|Number|13|13.0||||||
4128653|NCT00910858|3953478|B1|White||Race/Ethnicity, Customized|Participants could select more than 1 race option.|participants|Number|17|17.0||||||
4128654|NCT00910858|3953475|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4128655|NCT00910858|3953476|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4128656|NCT00910858|3953477|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4128657|NCT00910858|3953478|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4128658|NCT00910858|3953475|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4128659|NCT00910858|3953476|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4128660|NCT00910858|3953477|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4128661|NCT00910858|3953478|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4128662|NCT00910858|3953475|B4|||Age||years|Mean|70.8|70.8|Standard Deviation|9.07|9.07|||
4128663|NCT00910858|3953476|B3|||Age||years|Mean|72.6|72.6|Standard Deviation|7.39|7.39|||
4128664|NCT00910858|3953477|B2|||Age||years|Mean|73.4|73.4|Standard Deviation|6.51|6.51|||
4128665|NCT00910858|3953478|B1|||Age||years|Mean|67.8|67.8|Standard Deviation|10.96|10.96|||
4128666|NCT00910845|3953503|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4128667|NCT00910845|3953504|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4128668|NCT00910845|3953505|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4128669|NCT00910845|3953503|B3||Female|Sex: Female, Male||Participants|Count of Participants|497|497.0||||||
4128670|NCT00910845|3953504|B2||Female|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4128671|NCT00910845|3953505|B1||Female|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
4128672|NCT00910845|3953503|B3|≥ 75 years||Age, Customized||Participants|Number|90|90.0||||||
4128673|NCT00910845|3953504|B2|≥ 75 years||Age, Customized||Participants|Number|44|44.0||||||
4128674|NCT00910845|3953505|B1|≥ 75 years||Age, Customized||Participants|Number|46|46.0||||||
4128675|NCT00910845|3953503|B3|Between 65 and 74 years||Age, Customized||Participants|Number|148|148.0||||||
4128676|NCT00910845|3953504|B2|Between 65 and 74 years||Age, Customized||Participants|Number|73|73.0||||||
4128677|NCT00910845|3953505|B1|Between 65 and 74 years||Age, Customized||Participants|Number|75|75.0||||||
4128678|NCT00910845|3953503|B3|Between 40 and 64 years||Age, Customized||Participants|Number|293|293.0||||||
4128679|NCT00910845|3953504|B2|Between 40 and 64 years||Age, Customized||Participants|Number|143|143.0||||||
4128680|NCT00910845|3953505|B1|Between 40 and 64 years||Age, Customized||Participants|Number|150|150.0||||||
4128681|NCT00910845|3953503|B3|< 40 years||Age, Customized||Participants|Number|26|26.0||||||
4128682|NCT00910845|3953504|B2|< 40 years||Age, Customized||Participants|Number|17|17.0||||||
4128683|NCT00910845|3953505|B1|< 40 years||Age, Customized||Participants|Number|9|9.0||||||
4128684|NCT00910728|3953516|B10||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4128685|NCT00910728|3953517|B9||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4128686|NCT00910728|3953518|B8||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4128687|NCT00910728|3953519|B7||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4128688|NCT00910728|3953520|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4128689|NCT00910728|3953521|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4128690|NCT00910728|3953522|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4128691|NCT00910728|3953523|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4128692|NCT00910728|3953524|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4128693|NCT00910728|3953525|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4128694|NCT00910728|3953516|B10||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4128695|NCT00910728|3953517|B9||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4128696|NCT00910728|3953518|B8||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4128697|NCT00910728|3953519|B7||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4128698|NCT00910728|3953520|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4128699|NCT00910728|3953521|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4128700|NCT00910728|3953522|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4128701|NCT00910728|3953523|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4128702|NCT00910728|3953524|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4128703|NCT00910728|3953525|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4128704|NCT00910728|3953516|B10|||Age||years|Mean|65.1|65.1|Standard Deviation|10.6|10.6|||
4128705|NCT00910728|3953517|B9|||Age||years|Mean|75.7|75.7|Standard Deviation|3.8|3.8|||
4128706|NCT00910728|3953518|B8|||Age||years|Mean|65.3|65.3|Standard Deviation|11.3|11.3|||
4128707|NCT00910728|3953519|B7|||Age||years|Mean|69.3|69.3|Standard Deviation|3.8|3.8|||
4128708|NCT00910728|3953520|B6|||Age||years|Mean|49.3|49.3|Standard Deviation|4.2|4.2|||
4128709|NCT00910728|3953521|B5|||Age||years|Mean|66.5|66.5|Standard Deviation|10.3|10.3|||
4128710|NCT00910728|3953522|B4|||Age||years|Mean|56.0|56.0|Standard Deviation|0|0.0|||
4128711|NCT00910728|3953523|B3|||Age||years|Mean|76.7|76.7|Standard Deviation|10.5|10.5|||
4128712|NCT00910728|3953524|B2|||Age||years|Mean|66.3|66.3|Standard Deviation|9.6|9.6|||
4128713|NCT00910728|3953525|B1|||Age||years|Mean|57.5|57.5|Standard Deviation|7.7|7.7|||
4128714|NCT00910715|3953652|B4|Slovenia||Region of Enrollment||participants|Number|225|225.0||||||
4128715|NCT00910715|3953654|B2|Slovenia||Region of Enrollment||participants|Number|117|117.0||||||
4128716|NCT00910715|3953655|B1|Slovenia||Region of Enrollment||participants|Number|108|108.0||||||
4128717|NCT00910715|3953652|B4||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4128718|NCT00910715|3953654|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4128719|NCT00910715|3953655|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4128720|NCT00910715|3953652|B4||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4128721|NCT00910715|3953654|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4128722|NCT00910715|3953655|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4128723|NCT00910715|3953652|B4|||Age||years|Mean|50.4|50.4|Standard Deviation|14.9|14.9|||
4128724|NCT00910715|3953654|B2|||Age||years|Mean|49.6|49.6|Standard Deviation|14.0|14.0|||
4128725|NCT00910715|3953655|B1|||Age||years|Mean|52.5|52.5|Standard Deviation|14.3|14.3|||
4128726|NCT00910715|3953652|B4||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4128727|NCT00910715|3953654|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4128728|NCT00910715|3953655|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4128729|NCT00910715|3953652|B4||Between 18 and 65 years|Age||Participants|Count of Participants|189|189.0||||||
4128730|NCT00910715|3953654|B2||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
4128731|NCT00910715|3953655|B1||Between 18 and 65 years|Age||Participants|Count of Participants|88|88.0||||||
4128732|NCT00910715|3953652|B4||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4128733|NCT00910715|3953654|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4128734|NCT00910715|3953655|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4128735|NCT00910689|3953667|B5|United States||Region of Enrollment||participants|Number|232|232.0||||||
4128736|NCT00910689|3953668|B4|United States||Region of Enrollment||participants|Number|69|69.0||||||
4128737|NCT00910689|3953669|B3|United States||Region of Enrollment||participants|Number|55|55.0||||||
4128738|NCT00910689|3953670|B2|United States||Region of Enrollment||participants|Number|53|53.0||||||
4128739|NCT00910689|3953671|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4128740|NCT00910689|3953667|B5||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4128741|NCT00910689|3953668|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4128742|NCT00910689|3953669|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4128743|NCT00910689|3953670|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4128744|NCT00910689|3953671|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4128745|NCT00910689|3953667|B5||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4128746|NCT00910689|3953668|B4||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4128747|NCT00910689|3953669|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4128748|NCT00910689|3953670|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4128749|NCT00910689|3953671|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4128750|NCT00910689|3953667|B5|||Age||years|Mean|38.2|38.2|Standard Deviation|10.2|10.2|||
4128751|NCT00910689|3953668|B4|||Age||years|Mean|38.3|38.3|Standard Deviation|10.9|10.9|||
4128752|NCT00910689|3953669|B3|||Age||years|Mean|37.1|37.1|Standard Deviation|9.4|9.4|||
4128753|NCT00910689|3953670|B2|||Age||years|Mean|37.7|37.7|Standard Deviation|10.1|10.1|||
4128754|NCT00910689|3953671|B1|||Age||years|Mean|39.5|39.5|Standard Deviation|10.2|10.2|||
4128755|NCT00910689|3953667|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4128756|NCT00910689|3953668|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4128757|NCT00910689|3953669|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4128758|NCT00910689|3953670|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4128759|NCT00910689|3953671|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4128760|NCT00910689|3953667|B5||Between 18 and 65 years|Age||Participants|Count of Participants|232|232.0||||||
4128761|NCT00910689|3953668|B4||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
4128762|NCT00910689|3953669|B3||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4128763|NCT00910689|3953670|B2||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4128764|NCT00910689|3953671|B1||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4128765|NCT00910689|3953667|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4128766|NCT00910689|3953668|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4128767|NCT00910689|3953669|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4128768|NCT00910689|3953670|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4128769|NCT00910689|3953671|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4128770|NCT00910663|3953704|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4128771|NCT00910663|3953705|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4128772|NCT00910663|3953706|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4128773|NCT00910663|3953704|B3|American Indian||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4128774|NCT00910663|3953705|B2|American Indian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4128775|NCT00910663|3953706|B1|American Indian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4128776|NCT00910663|3953704|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4128777|NCT00910663|3953705|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4128778|NCT00910663|3953706|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4128779|NCT00910663|3953704|B3|Black||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4128780|NCT00910663|3953705|B2|Black||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4128781|NCT00910663|3953706|B1|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4128782|NCT00910663|3953704|B3|White||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
4128783|NCT00910663|3953705|B2|White||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4128784|NCT00910663|3953706|B1|White||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4128785|NCT00910663|3953704|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4128786|NCT00910663|3953705|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4128787|NCT00910663|3953706|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4128788|NCT00910663|3953704|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4128789|NCT00910663|3953705|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4128790|NCT00910663|3953706|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4128791|NCT00910663|3953704|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4128792|NCT00910663|3953705|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4128793|NCT00910663|3953706|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4128794|NCT00910663|3953704|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4128795|NCT00910663|3953705|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4128796|NCT00910663|3953706|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4128797|NCT00910663|3953704|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4128798|NCT00910663|3953705|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4128799|NCT00910663|3953706|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4128800|NCT00910624|3953717|B5||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4128801|NCT00910624|3953718|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4128802|NCT00910624|3953719|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4128803|NCT00910624|3953720|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4128804|NCT00910624|3953721|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4128805|NCT00910624|3953717|B5||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4128806|NCT00910624|3953718|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4128807|NCT00910624|3953719|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4128808|NCT00910624|3953720|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4128809|NCT00910624|3953721|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4128810|NCT00910624|3953717|B5|||Age||years|Mean|52.3|52.3|Standard Deviation|7.8|7.8|||
4128811|NCT00910624|3953718|B4|||Age||years|Mean|52.0|52.0|Standard Deviation|1.4|1.4|||
4128812|NCT00910624|3953719|B3|||Age||years|Mean|53.6|53.6|Standard Deviation|6.4|6.4|||
4128813|NCT00910624|3953720|B2|||Age||years|Mean|52.6|52.6|Standard Deviation|8.4|8.4|||
4128814|NCT00910624|3953721|B1|||Age||years|Mean|51.3|51.3|Standard Deviation|7.7|7.7|||
4128815|NCT00910520|3953736|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4128816|NCT00910520|3953737|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4128817|NCT00910520|3953738|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4128818|NCT00910520|3953736|B3||Female|Sex: Female, Male||Participants|Count of Participants|473|473.0||||||
4128819|NCT00910520|3953737|B2||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4128820|NCT00910520|3953738|B1||Female|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
4128821|NCT00910520|3953736|B3|≥ 75 years||Age, Customized||Participants|Number|77|77.0||||||
4128822|NCT00910520|3953737|B2|≥ 75 years||Age, Customized||Participants|Number|35|35.0||||||
4128823|NCT00910520|3953738|B1|≥ 75 years||Age, Customized||Participants|Number|42|42.0||||||
4128824|NCT00910520|3953736|B3|Between 65 and 74 years||Age, Customized||Participants|Number|155|155.0||||||
4128825|NCT00910520|3953737|B2|Between 65 and 74 years||Age, Customized||Participants|Number|73|73.0||||||
4128826|NCT00910520|3953738|B1|Between 65 and 74 years||Age, Customized||Participants|Number|82|82.0||||||
4128827|NCT00910520|3953736|B3|Between 40 and 64 years||Age, Customized||Participants|Number|254|254.0||||||
4128828|NCT00910520|3953737|B2|Between 40 and 64 years||Age, Customized||Participants|Number|139|139.0||||||
4128829|NCT00910520|3953738|B1|Between 40 and 64 years||Age, Customized||Participants|Number|115|115.0||||||
4128830|NCT00910520|3953736|B3|< 40 years||Age, Customized||Participants|Number|62|62.0||||||
4128831|NCT00910520|3953737|B2|< 40 years||Age, Customized||Participants|Number|24|24.0||||||
4128832|NCT00910520|3953738|B1|< 40 years||Age, Customized||Participants|Number|38|38.0||||||
4128833|NCT00910299|3953749|B3|Germany||Region of Enrollment||participants|Number|398|398.0||||||
4128834|NCT00910299|3953750|B2|Germany||Region of Enrollment||participants|Number|198|198.0||||||
4128835|NCT00910299|3953751|B1|Germany||Region of Enrollment||participants|Number|200|200.0||||||
4128836|NCT00910299|3953749|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4128837|NCT00910299|3953750|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4128838|NCT00910299|3953751|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4128839|NCT00910299|3953749|B3|White||Race/Ethnicity, Customized||participants|Number|418|418.0||||||
4128840|NCT00910299|3953750|B2|White||Race/Ethnicity, Customized||participants|Number|207|207.0||||||
4128841|NCT00910299|3953751|B1|White||Race/Ethnicity, Customized||participants|Number|211|211.0||||||
4128842|NCT00910299|3953749|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4128843|NCT00910299|3953750|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4128844|NCT00910299|3953751|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4128845|NCT00910299|3953749|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4128846|NCT00910299|3953750|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4128847|NCT00910299|3953751|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4128848|NCT00910299|3953749|B3||Male|Sex: Female, Male||Participants|Count of Participants|307|307.0||||||
4128849|NCT00910299|3953750|B2||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4128850|NCT00910299|3953751|B1||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4128851|NCT00910299|3953749|B3||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4128852|NCT00910299|3953750|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4128853|NCT00910299|3953751|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4128854|NCT00910299|3953749|B3|||Age||years|Mean|66.1|66.1|Standard Deviation|8.4|8.4|||
4128855|NCT00910299|3953750|B2|||Age||years|Mean|66.3|66.3|Standard Deviation|8.6|8.6|||
4128856|NCT00910299|3953751|B1|||Age||years|Mean|65.8|65.8|Standard Deviation|8.3|8.3|||
4128857|NCT00910273|3953762|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4128858|NCT00910273|3953763|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4128859|NCT00910273|3953764|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4128860|NCT00910273|3953762|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4128861|NCT00910273|3953763|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4128862|NCT00910273|3953764|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4128863|NCT00910273|3953762|B3|||Age||years|Mean|42.93|42.93|Standard Deviation|11.46|11.46|||
4128864|NCT00910273|3953763|B2|||Age||years|Mean|46.83|46.83|Standard Deviation|13.14|13.14|||
4128865|NCT00910273|3953764|B1|||Age||years|Mean|39.47|39.47|Standard Deviation|8.69|8.69|||
4128866|NCT00910247|3953815|B1|Serbia||Region of Enrollment||participants|Number|2|2.0||||||
4128867|NCT00910247|3953815|B1|Bulgaria||Region of Enrollment||participants|Number|18|18.0||||||
4128868|NCT00910247|3953815|B1|Ukraine||Region of Enrollment||participants|Number|57|57.0||||||
4128869|NCT00910247|3953815|B1|Czechia||Region of Enrollment||participants|Number|27|27.0||||||
4128870|NCT00910247|3953815|B1|United States||Region of Enrollment||participants|Number|167|167.0||||||
4128871|NCT00910247|3953815|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4128872|NCT00910247|3953815|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4128873|NCT00910247|3953815|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4128874|NCT00910247|3953815|B1||White|Race (NIH/OMB)||Participants|Count of Participants|229|229.0||||||
4128875|NCT00910247|3953815|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4128876|NCT00910247|3953815|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4128877|NCT00910247|3953815|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4128878|NCT00910247|3953815|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4128879|NCT00910247|3953815|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4128931|NCT00910091|3953836|B2|Czech Republic||Region of Enrollment||Participants|Number|5|5.0||||||
4128880|NCT00910247|3953815|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|246|246.0||||||
4128881|NCT00910247|3953815|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4128882|NCT00910247|3953815|B1||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4128883|NCT00910247|3953815|B1||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4128884|NCT00910247|3953815|B1|||Age||years|Mean|37.9|37.9|Standard Deviation|12.70|12.7|||
4128885|NCT00910247|3953815|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4128886|NCT00910247|3953815|B1||Between 18 and 65 years|Age||Participants|Count of Participants|258|258.0||||||
4128887|NCT00910247|3953815|B1||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4128888|NCT00910091|3953835|B3|||Eastern Cooperative Oncology Group(ECOG) Performance Status Score|ECOG score ranges from 0 to 5, where 0: Asymptomatic, 1: Symptomatic but completely ambulatory, 2: Symptomatic (<50% in bed during the day - ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours), 3: Symptomatic (>50% in bed, but not bedbound - capable of only limited self-care, confined to bed or chair 50% or more of waking hours), 4: Bedbound (Completely disabled- cannot carry on any self-care) and 5: Death.|Units on a scale|Mean|0.7|0.7|Standard Deviation|0.7|0.7|||
4128889|NCT00910091|3953836|B2|||Eastern Cooperative Oncology Group(ECOG) Performance Status Score|ECOG score ranges from 0 to 5, where 0: Asymptomatic, 1: Symptomatic but completely ambulatory, 2: Symptomatic (<50% in bed during the day - ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours), 3: Symptomatic (>50% in bed, but not bedbound - capable of only limited self-care, confined to bed or chair 50% or more of waking hours), 4: Bedbound (Completely disabled- cannot carry on any self-care) and 5: Death.|Units on a scale|Mean|0.7|0.7|Standard Deviation|0.7|0.7|||
4128890|NCT00910091|3953837|B1|||Eastern Cooperative Oncology Group(ECOG) Performance Status Score|ECOG score ranges from 0 to 5, where 0: Asymptomatic, 1: Symptomatic but completely ambulatory, 2: Symptomatic (<50% in bed during the day - ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours), 3: Symptomatic (>50% in bed, but not bedbound - capable of only limited self-care, confined to bed or chair 50% or more of waking hours), 4: Bedbound (Completely disabled- cannot carry on any self-care) and 5: Death.|Units on a scale|Mean|0.8|0.8|Standard Deviation|0.6|0.6|||
4128891|NCT00910091|3953835|B3|Caucasian / White||Race||Subjects|Number|72|72.0||||||
4128892|NCT00910091|3953836|B2|Caucasian / White||Race||Subjects|Number|36|36.0||||||
4128893|NCT00910091|3953837|B1|Caucasian / White||Race||Subjects|Number|36|36.0||||||
4128894|NCT00910091|3953835|B3|Black / African American||Race||Subjects|Number|1|1.0||||||
4128895|NCT00910091|3953836|B2|Black / African American||Race||Subjects|Number|1|1.0||||||
4128896|NCT00910091|3953837|B1|Black / African American||Race||Subjects|Number|0|0.0||||||
4128897|NCT00910091|3953835|B3|Missing||BMI (Body Mass Index)||Participants|Number|5|5.0||||||
4128898|NCT00910091|3953836|B2|Missing||BMI (Body Mass Index)||Participants|Number|2|2.0||||||
4128899|NCT00910091|3953837|B1|Missing||BMI (Body Mass Index)||Participants|Number|3|3.0||||||
4128900|NCT00910091|3953835|B3|>30 kg/m2||BMI (Body Mass Index)||Participants|Number|29|29.0||||||
4128901|NCT00910091|3953836|B2|>30 kg/m2||BMI (Body Mass Index)||Participants|Number|17|17.0||||||
4128902|NCT00910091|3953837|B1|>30 kg/m2||BMI (Body Mass Index)||Participants|Number|12|12.0||||||
4128903|NCT00910091|3953835|B3|>25 - 30 kg/m2||BMI (Body Mass Index)||Participants|Number|18|18.0||||||
4128904|NCT00910091|3953836|B2|>25 - 30 kg/m2||BMI (Body Mass Index)||Participants|Number|8|8.0||||||
4128905|NCT00910091|3953837|B1|>25 - 30 kg/m2||BMI (Body Mass Index)||Participants|Number|10|10.0||||||
4128906|NCT00910091|3953835|B3|18.5 - 25 kg/m2||BMI (Body Mass Index)||Participants|Number|20|20.0||||||
4128907|NCT00910091|3953836|B2|18.5 - 25 kg/m2||BMI (Body Mass Index)||Participants|Number|10|10.0||||||
4128908|NCT00910091|3953837|B1|18.5 - 25 kg/m2||BMI (Body Mass Index)||Participants|Number|10|10.0||||||
4128909|NCT00910091|3953835|B3|<18.5 kg/m2||BMI (Body Mass Index)||Participants|Number|1|1.0||||||
4128910|NCT00910091|3953836|B2|<18.5 kg/m2||BMI (Body Mass Index)||Participants|Number|0|0.0||||||
4128911|NCT00910091|3953837|B1|<18.5 kg/m2||BMI (Body Mass Index)||Participants|Number|1|1.0||||||
4128912|NCT00910091|3953835|B3|Moldova, Republic of||Region of Enrollment||Participants|Number|1|1.0||||||
4128913|NCT00910091|3953836|B2|Moldova, Republic of||Region of Enrollment||Participants|Number|1|1.0||||||
4128914|NCT00910091|3953837|B1|Moldova, Republic of||Region of Enrollment||Participants|Number|0|0.0||||||
4128915|NCT00910091|3953835|B3|Latvia||Region of Enrollment||Participants|Number|1|1.0||||||
4128916|NCT00910091|3953836|B2|Latvia||Region of Enrollment||Participants|Number|1|1.0||||||
4128917|NCT00910091|3953837|B1|Latvia||Region of Enrollment||Participants|Number|0|0.0||||||
4128918|NCT00910091|3953835|B3|Spain||Region of Enrollment||Participants|Number|2|2.0||||||
4128919|NCT00910091|3953836|B2|Spain||Region of Enrollment||Participants|Number|1|1.0||||||
4128920|NCT00910091|3953837|B1|Spain||Region of Enrollment||Participants|Number|1|1.0||||||
4128921|NCT00910091|3953835|B3|Lithuania||Region of Enrollment||Participants|Number|2|2.0||||||
4128922|NCT00910091|3953836|B2|Lithuania||Region of Enrollment||Participants|Number|1|1.0||||||
4128923|NCT00910091|3953837|B1|Lithuania||Region of Enrollment||Participants|Number|1|1.0||||||
4128924|NCT00910091|3953835|B3|Ukraine||Region of Enrollment||Participants|Number|4|4.0||||||
4128925|NCT00910091|3953836|B2|Ukraine||Region of Enrollment||Participants|Number|2|2.0||||||
4128926|NCT00910091|3953837|B1|Ukraine||Region of Enrollment||Participants|Number|2|2.0||||||
4128927|NCT00910091|3953835|B3|Poland||Region of Enrollment||Participants|Number|4|4.0||||||
4128928|NCT00910091|3953836|B2|Poland||Region of Enrollment||Participants|Number|2|2.0||||||
4128929|NCT00910091|3953837|B1|Poland||Region of Enrollment||Participants|Number|2|2.0||||||
4128930|NCT00910091|3953835|B3|Czech Republic||Region of Enrollment||Participants|Number|8|8.0||||||
4128932|NCT00910091|3953837|B1|Czech Republic||Region of Enrollment||Participants|Number|3|3.0||||||
4128933|NCT00910091|3953835|B3|Russian Federation||Region of Enrollment||Participants|Number|14|14.0||||||
4128934|NCT00910091|3953836|B2|Russian Federation||Region of Enrollment||Participants|Number|8|8.0||||||
4128935|NCT00910091|3953837|B1|Russian Federation||Region of Enrollment||Participants|Number|6|6.0||||||
4128936|NCT00910091|3953835|B3|Belgium||Region of Enrollment||Participants|Number|8|8.0||||||
4128937|NCT00910091|3953836|B2|Belgium||Region of Enrollment||Participants|Number|2|2.0||||||
4128938|NCT00910091|3953837|B1|Belgium||Region of Enrollment||Participants|Number|6|6.0||||||
4128939|NCT00910091|3953835|B3|United Kingdom||Region of Enrollment||Participants|Number|14|14.0||||||
4128940|NCT00910091|3953836|B2|United Kingdom||Region of Enrollment||Participants|Number|7|7.0||||||
4128941|NCT00910091|3953837|B1|United Kingdom||Region of Enrollment||Participants|Number|7|7.0||||||
4128942|NCT00910091|3953835|B3|France||Region of Enrollment||Participants|Number|15|15.0||||||
4128943|NCT00910091|3953836|B2|France||Region of Enrollment||Participants|Number|7|7.0||||||
4128944|NCT00910091|3953837|B1|France||Region of Enrollment||Participants|Number|8|8.0||||||
4128945|NCT00910091|3953835|B3|Female||Sex/Gender, Customized||Participants|Number|73|73.0||||||
4128946|NCT00910091|3953836|B2|Female||Sex/Gender, Customized||Participants|Number|37|37.0||||||
4128947|NCT00910091|3953837|B1|Female||Sex/Gender, Customized||Participants|Number|36|36.0||||||
4128948|NCT00910091|3953835|B3|>75 years||Age, Customized||Participants|Number|17|17.0||||||
4128949|NCT00910091|3953836|B2|>75 years||Age, Customized||Participants|Number|6|6.0||||||
4128950|NCT00910091|3953837|B1|>75 years||Age, Customized||Participants|Number|11|11.0||||||
4128951|NCT00910091|3953835|B3|65-75 years||Age, Customized||Participants|Number|28|28.0||||||
4128952|NCT00910091|3953836|B2|65-75 years||Age, Customized||Participants|Number|15|15.0||||||
4128953|NCT00910091|3953837|B1|65-75 years||Age, Customized||Participants|Number|13|13.0||||||
4128954|NCT00910091|3953835|B3|18-64 years||Age, Customized||Participants|Number|28|28.0||||||
4128955|NCT00910091|3953836|B2|18-64 years||Age, Customized||Participants|Number|16|16.0||||||
4128956|NCT00910091|3953837|B1|18-64 years||Age, Customized||Participants|Number|12|12.0||||||
4128957|NCT00910091|3953835|B3|||Age||Years|Median|67.7|67.7|Standard Deviation|10.0|10.0|||
4128958|NCT00910091|3953836|B2|||Age||Years|Median|67.4|67.4|Standard Deviation|8.6|8.6|||
4128959|NCT00910091|3953837|B1|||Age||Years|Median|68.1|68.1|Standard Deviation|11.4|11.4|||
4128960|NCT00910039|3953866|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4128961|NCT00910039|3953866|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4128962|NCT00910039|3953866|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4128963|NCT00910039|3953866|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4128964|NCT00910039|3953866|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4128965|NCT00910039|3953866|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4128966|NCT00910039|3953866|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4128967|NCT00910039|3953866|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4128968|NCT00910039|3953866|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4128969|NCT00910039|3953866|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4128970|NCT00910039|3953866|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4128971|NCT00910039|3953866|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4128972|NCT00910039|3953866|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4128973|NCT00910039|3953866|B1|||Age||years|Median|59|59.0|Full Range|||46.0|80.0|
4128974|NCT00910000|3953877|B7|United States||Region of Enrollment||participants|Number|15|15.0||||||
4128975|NCT00910000|3953878|B6|United States||Region of Enrollment||participants|Number|1|1.0||||||
4128976|NCT00910000|3953879|B5|United States||Region of Enrollment||participants|Number|3|3.0||||||
4128977|NCT00910000|3953880|B4|United States||Region of Enrollment||participants|Number|2|2.0||||||
4128978|NCT00910000|3953881|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4128979|NCT00910000|3953882|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4128980|NCT00910000|3953883|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4128981|NCT00910000|3953877|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4128982|NCT00910000|3953878|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4128983|NCT00910000|3953879|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4128984|NCT00910000|3953880|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4128985|NCT00910000|3953881|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4128986|NCT00910000|3953882|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4128987|NCT00910000|3953883|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4128988|NCT00910000|3953877|B7||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4128989|NCT00910000|3953878|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4128990|NCT00910000|3953879|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4128991|NCT00910000|3953880|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4128992|NCT00910000|3953881|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4128993|NCT00910000|3953882|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4128994|NCT00910000|3953883|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4128995|NCT00910000|3953877|B7|Age||Age, Customized||years|Mean|60|60.0|Full Range|||51.0|75.0|
4128996|NCT00910000|3953878|B6|Age||Age, Customized||years|Mean|63|63.0|Full Range|||0.0|0.0|There is only 1 patient in this cohort.
4128997|NCT00910000|3953879|B5|Age||Age, Customized||years|Mean|67|67.0|Full Range|||58.0|75.0|
4128998|NCT00910000|3953880|B4|Age||Age, Customized||years|Mean|54.5|54.5|Full Range|||52.0|57.0|
4128999|NCT00910000|3953881|B3|Age||Age, Customized||years|Mean|59|59.0|Full Range|||54.0|66.0|
4129000|NCT00910000|3953882|B2|Age||Age, Customized||years|Mean|63|63.0|Full Range|||61.0|65.0|
4129001|NCT00910000|3953883|B1|Age||Age, Customized||years|Mean|59|59.0|Full Range|||51.0|68.0|
4129002|NCT00909870|3953904|B3|||Ulcer Duration||days|Median|214|214.0|Full Range|||1.0|18157.0|
4129003|NCT00909870|3953905|B2|||Ulcer Duration||days|Median|228|228.0|Full Range|||23.0|3834.0|
4129004|NCT00909870|3953906|B1|||Ulcer Duration||days|Median|206|206.0|Full Range|||1.0|18157.0|
4129005|NCT00909870|3953904|B3|||Ulcer Size||centimeters-squared|Median|5.9|5.9|Full Range|||1.5|24.8|
4129006|NCT00909870|3953905|B2|||Ulcer Size||centimeters-squared|Median|5.90|5.9|Full Range|||2.0|24.8|
4129007|NCT00909870|3953906|B1|||Ulcer Size||centimeters-squared|Median|5.75|5.75|Full Range|||1.5|19.3|
4129008|NCT00909870|3953904|B3|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
4129009|NCT00909870|3953905|B2|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
4129010|NCT00909870|3953906|B1|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
4129011|NCT00909870|3953904|B3|United Kingdom||Region of Enrollment||participants|Number|13|13.0||||||
4129012|NCT00909870|3953905|B2|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
4129013|NCT00909870|3953906|B1|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4129014|NCT00909870|3953904|B3|Germany||Region of Enrollment||participants|Number|16|16.0||||||
4129015|NCT00909870|3953905|B2|Germany||Region of Enrollment||participants|Number|8|8.0||||||
4129016|NCT00909870|3953906|B1|Germany||Region of Enrollment||participants|Number|8|8.0||||||
4129017|NCT00909870|3953904|B3|South Africa||Region of Enrollment||participants|Number|144|144.0||||||
4129018|NCT00909870|3953905|B2|South Africa||Region of Enrollment||participants|Number|71|71.0||||||
4129019|NCT00909870|3953906|B1|South Africa||Region of Enrollment||participants|Number|73|73.0||||||
4129020|NCT00909870|3953904|B3|Poland||Region of Enrollment||participants|Number|155|155.0||||||
4129021|NCT00909870|3953905|B2|Poland||Region of Enrollment||participants|Number|74|74.0||||||
4129022|NCT00909870|3953906|B1|Poland||Region of Enrollment||participants|Number|81|81.0||||||
4129023|NCT00909870|3953904|B3|Estonia||Region of Enrollment||participants|Number|19|19.0||||||
4129024|NCT00909870|3953905|B2|Estonia||Region of Enrollment||participants|Number|9|9.0||||||
4129025|NCT00909870|3953906|B1|Estonia||Region of Enrollment||participants|Number|10|10.0||||||
4129026|NCT00909870|3953904|B3|United States||Region of Enrollment||participants|Number|187|187.0||||||
4129027|NCT00909870|3953905|B2|United States||Region of Enrollment||participants|Number|93|93.0||||||
4129028|NCT00909870|3953906|B1|United States||Region of Enrollment||participants|Number|94|94.0||||||
4129029|NCT00909870|3953904|B3||Male|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
4129030|NCT00909870|3953905|B2||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4129031|NCT00909870|3953906|B1||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4129032|NCT00909870|3953904|B3||Female|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
4129033|NCT00909870|3953905|B2||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4129034|NCT00909870|3953906|B1||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4129035|NCT00909870|3953904|B3|||Age||Years|Mean|63.1|63.1|Standard Deviation|13.74|13.74|||
4129036|NCT00909870|3953905|B2|||Age||Years|Mean|63.2|63.2|Standard Deviation|14.46|14.46|||
4129037|NCT00909870|3953906|B1|||Age||Years|Mean|63.1|63.1|Standard Deviation|13.04|13.04|||
4129038|NCT00909857|3953917|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4129039|NCT00909857|3953918|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4129040|NCT00909857|3953919|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4129041|NCT00909857|3953917|B3||Female|Sex: Female, Male||Participants|Count of Participants|464|464.0||||||
4129042|NCT00909857|3953918|B2||Female|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4129043|NCT00909857|3953919|B1||Female|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
4129044|NCT00909857|3953917|B3|18 years of age or older||Age, Customized||Participants|Number|440|440.0||||||
4129045|NCT00909857|3953918|B2|18 years of age or older||Age, Customized||Participants|Number|217|217.0||||||
4129046|NCT00909857|3953919|B1|18 years of age or older||Age, Customized||Participants|Number|223|223.0||||||
4129047|NCT00909857|3953917|B3|less than 18 years of age||Age, Customized||Participants|Number|24|24.0||||||
4129048|NCT00909857|3953918|B2|less than 18 years of age||Age, Customized||Participants|Number|13|13.0||||||
4129049|NCT00909857|3953919|B1|less than 18 years of age||Age, Customized||Participants|Number|11|11.0||||||
4129050|NCT00909857|3953917|B3|||Age||Years|Mean|27.8|27.8|Standard Deviation|7.9|7.9|||
4129051|NCT00909857|3953918|B2|||Age||Years|Mean|27.6|27.6|Standard Deviation|8.0|8.0|||
4129052|NCT00909857|3953919|B1|||Age||Years|Mean|28.0|28.0|Standard Deviation|7.9|7.9|||
4129053|NCT00909844|3954060|B1|||Weight at Pretreatment||kilogram (kg)|Mean|32.4|32.4|Standard Deviation|6.9|6.9|||
4129054|NCT00909844|3954060|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4129055|NCT00909844|3954060|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4129056|NCT00909844|3954060|B1|||Age||years|Mean|8.73|8.73|Standard Deviation|1.07|1.07|||
4129057|NCT00909792|3954078|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4129058|NCT00909792|3954078|B1||Female|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4129059|NCT00909792|3954078|B1|||Age||Years|Mean|45.5|45.5|Standard Deviation|4.3|4.3|||
4129060|NCT00909779|3954085|B3|Yes||Baseline Oxygen Therapy Use|Oxygen therapy use at baseline|participants|Number|177|177.0||21.0|21.0|||
4129061|NCT00909779|3954086|B2|Yes||Baseline Oxygen Therapy Use|Oxygen therapy use at baseline|participants|Number|86|86.0||20.5|20.5|||
4129062|NCT00909779|3954087|B1|Yes||Baseline Oxygen Therapy Use|Oxygen therapy use at baseline|participants|Number|91|91.0||21.6|21.6|||
4129063|NCT00909779|3954085|B3|No||Baseline Oxygen Therapy Use|Oxygen therapy use at baseline|participants|Number|664|664.0||79.0|79.0|||
4129064|NCT00909779|3954086|B2|No||Baseline Oxygen Therapy Use|Oxygen therapy use at baseline|participants|Number|334|334.0||79.5|79.5|||
4129065|NCT00909779|3954087|B1|No||Baseline Oxygen Therapy Use|Oxygen therapy use at baseline|participants|Number|330|330.0||78.4|78.4|||
4129066|NCT00909779|3954085|B3|Yes||Baseline Oral/Inhaled Corticosteroid Use|Oral or inhaled corticosteroid use|participants|Number|437|437.0||52.0|52.0|||
4129067|NCT00909779|3954086|B2|Yes||Baseline Oral/Inhaled Corticosteroid Use|Oral or inhaled corticosteroid use|participants|Number|218|218.0||51.9|51.9|||
4129068|NCT00909779|3954087|B1|Yes||Baseline Oral/Inhaled Corticosteroid Use|Oral or inhaled corticosteroid use|participants|Number|219|219.0||52.0|52.0|||
4129069|NCT00909779|3954085|B3|No||Baseline Oral/Inhaled Corticosteroid Use|Oral or inhaled corticosteroid use|participants|Number|404|404.0||48.0|48.0|||
4129070|NCT00909779|3954086|B2|No||Baseline Oral/Inhaled Corticosteroid Use|Oral or inhaled corticosteroid use|participants|Number|202|202.0||48.1|48.1|||
4129071|NCT00909779|3954087|B1|No||Baseline Oral/Inhaled Corticosteroid Use|Oral or inhaled corticosteroid use|participants|Number|202|202.0||48.0|48.0|||
4129072|NCT00909779|3954085|B3|≥ 30||Number of pack-years smoked|Number of pack-years smoked was defined as the number of cigarette packs smoked per day times the number of years smoked.|Pack-years|Number|695|695.0||82.6|82.6|||
4129073|NCT00909779|3954086|B2|≥ 30||Number of pack-years smoked|Number of pack-years smoked was defined as the number of cigarette packs smoked per day times the number of years smoked.|Pack-years|Number|351|351.0||83.6|83.6|||
4129074|NCT00909779|3954087|B1|≥ 30||Number of pack-years smoked|Number of pack-years smoked was defined as the number of cigarette packs smoked per day times the number of years smoked.|Pack-years|Number|344|344.0||81.7|81.7|||
4129075|NCT00909779|3954085|B3|≥ 25 - < 30||Number of pack-years smoked|Number of pack-years smoked was defined as the number of cigarette packs smoked per day times the number of years smoked.|Pack-years|Number|65|65.0||7.7|7.7|||
4129076|NCT00909779|3954086|B2|≥ 25 - < 30||Number of pack-years smoked|Number of pack-years smoked was defined as the number of cigarette packs smoked per day times the number of years smoked.|Pack-years|Number|29|29.0||6.9|6.9|||
4129077|NCT00909779|3954087|B1|≥ 25 - < 30||Number of pack-years smoked|Number of pack-years smoked was defined as the number of cigarette packs smoked per day times the number of years smoked.|Pack-years|Number|36|36.0||8.6|8.6|||
4129078|NCT00909779|3954085|B3|≥ 15 - < 25||Number of pack-years smoked|Number of pack-years smoked was defined as the number of cigarette packs smoked per day times the number of years smoked.|Pack-years|Number|81|81.0||9.6|9.6|||
4129079|NCT00909779|3954086|B2|≥ 15 - < 25||Number of pack-years smoked|Number of pack-years smoked was defined as the number of cigarette packs smoked per day times the number of years smoked.|Pack-years|Number|40|40.0||9.5|9.5|||
4129080|NCT00909779|3954087|B1|≥ 15 - < 25||Number of pack-years smoked|Number of pack-years smoked was defined as the number of cigarette packs smoked per day times the number of years smoked.|Pack-years|Number|41|41.0||9.7|9.7|||
4129081|NCT00909779|3954085|B3|Former||Baseline smoking status|Smoking status was recorded at each visit. At baseline, a subject was only defined as a former smoker if they had given up smoking at least 6 calendar months prior to the Visit 1 (screening) date based on the smoking cessation date. Otherwise, they were classified as a current smoker.|Current|Number|409|409.0||||||
4129082|NCT00909779|3954086|B2|Former||Baseline smoking status|Smoking status was recorded at each visit. At baseline, a subject was only defined as a former smoker if they had given up smoking at least 6 calendar months prior to the Visit 1 (screening) date based on the smoking cessation date. Otherwise, they were classified as a current smoker.|Current|Number|206|206.0||||||
4129083|NCT00909779|3954087|B1|Former||Baseline smoking status|Smoking status was recorded at each visit. At baseline, a subject was only defined as a former smoker if they had given up smoking at least 6 calendar months prior to the Visit 1 (screening) date based on the smoking cessation date. Otherwise, they were classified as a current smoker.|Current|Number|203|203.0||||||
4129084|NCT00909779|3954085|B3|Current||Baseline smoking status|Smoking status was recorded at each visit. At baseline, a subject was only defined as a former smoker if they had given up smoking at least 6 calendar months prior to the Visit 1 (screening) date based on the smoking cessation date. Otherwise, they were classified as a current smoker.|Current|Number|432|432.0||||||
4129085|NCT00909779|3954086|B2|Current||Baseline smoking status|Smoking status was recorded at each visit. At baseline, a subject was only defined as a former smoker if they had given up smoking at least 6 calendar months prior to the Visit 1 (screening) date based on the smoking cessation date. Otherwise, they were classified as a current smoker.|Current|Number|214|214.0||||||
4129086|NCT00909779|3954087|B1|Current||Baseline smoking status|Smoking status was recorded at each visit. At baseline, a subject was only defined as a former smoker if they had given up smoking at least 6 calendar months prior to the Visit 1 (screening) date based on the smoking cessation date. Otherwise, they were classified as a current smoker.|Current|Number|218|218.0||||||
4129087|NCT00909779|3954085|B3|||Percent predicted FEV1 (%)|Best FEV1 percent predicted was measured at Visit 1 (screening), pre-dose at Visits 2 through 5, and at Visit 6/EOS, as described for FEV1.|Percentage (%)|Mean|39.5|39.5|Standard Deviation|13.5|13.5|||
4129088|NCT00909779|3954086|B2|||Percent predicted FEV1 (%)|Best FEV1 percent predicted was measured at Visit 1 (screening), pre-dose at Visits 2 through 5, and at Visit 6/EOS, as described for FEV1.|Percentage (%)|Mean|39.7|39.7|Standard Deviation|13.2|13.2|||
4129089|NCT00909779|3954087|B1|||Percent predicted FEV1 (%)|Best FEV1 percent predicted was measured at Visit 1 (screening), pre-dose at Visits 2 through 5, and at Visit 6/EOS, as described for FEV1.|Percentage (%)|Mean|39.4|39.4|Standard Deviation|13.9|13.9|||
4129090|NCT00909779|3954085|B3|||FEV1|FEV1: Forced expiratory volume in one second. FEV1 was measured at Visit 1 (screening), pre- and post-albuterol administration for reversibility testing, pre-dose at Visits 2 through 5, and at Visit 6/EOS. The best FEV1 from at least 3 acceptable maneuvers was recorded. Study baseline was defined as the Visit 2 pre-dose value. If the Visit 2 pre-dose value was missing, the last FEV1 value obtained prior to first treatment was used for baseline.|Liter|Mean|1.177|1.177|Standard Deviation|0.485|0.485|||
4129091|NCT00909779|3954086|B2|||FEV1|FEV1: Forced expiratory volume in one second. FEV1 was measured at Visit 1 (screening), pre- and post-albuterol administration for reversibility testing, pre-dose at Visits 2 through 5, and at Visit 6/EOS. The best FEV1 from at least 3 acceptable maneuvers was recorded. Study baseline was defined as the Visit 2 pre-dose value. If the Visit 2 pre-dose value was missing, the last FEV1 value obtained prior to first treatment was used for baseline.|Liter|Mean|1.176|1.176|Standard Deviation|0.482|0.482|||
4129092|NCT00909779|3954087|B1|||FEV1|FEV1: Forced expiratory volume in one second. FEV1 was measured at Visit 1 (screening), pre- and post-albuterol administration for reversibility testing, pre-dose at Visits 2 through 5, and at Visit 6/EOS. The best FEV1 from at least 3 acceptable maneuvers was recorded. Study baseline was defined as the Visit 2 pre-dose value. If the Visit 2 pre-dose value was missing, the last FEV1 value obtained prior to first treatment was used for baseline.|Liter|Mean|1.178|1.178|Standard Deviation|0.487|0.487|||
4129093|NCT00909779|3954085|B3|||Number of COPD exacerbations in last year|The average number of COPD exacerbations during the previous year|Number of occurrences|Mean|0.9|0.9|Standard Deviation|1.3|1.3|||
4129094|NCT00909779|3954086|B2|||Number of COPD exacerbations in last year|The average number of COPD exacerbations during the previous year|Number of occurrences|Mean|1.0|1.0|Standard Deviation|1.4|1.4|||
4129095|NCT00909779|3954087|B1|||Number of COPD exacerbations in last year|The average number of COPD exacerbations during the previous year|Number of occurrences|Mean|0.8|0.8|Standard Deviation|1.1|1.1|||
4129096|NCT00909779|3954085|B3|United States||Region of Enrollment||participants|Number|841|841.0||||||
4129097|NCT00909779|3954086|B2|United States||Region of Enrollment||participants|Number|420|420.0||||||
4129098|NCT00909779|3954087|B1|United States||Region of Enrollment||participants|Number|421|421.0||||||
4129099|NCT00909779|3954085|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4129100|NCT00909779|3954086|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4129101|NCT00909779|3954087|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4129102|NCT00909779|3954085|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4129103|NCT00909779|3954086|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4129104|NCT00909779|3954087|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4129105|NCT00909779|3954085|B3||White|Race (NIH/OMB)||Participants|Count of Participants|746|746.0||||||
4129106|NCT00909779|3954086|B2||White|Race (NIH/OMB)||Participants|Count of Participants|372|372.0||||||
4129107|NCT00909779|3954087|B1||White|Race (NIH/OMB)||Participants|Count of Participants|374|374.0||||||
4129108|NCT00909779|3954085|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
4129109|NCT00909779|3954086|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4129110|NCT00909779|3954087|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4129111|NCT00909779|3954085|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4129112|NCT00909779|3954086|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4129113|NCT00909779|3954087|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4129114|NCT00909779|3954085|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4129115|NCT00909779|3954086|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4129116|NCT00909779|3954087|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4129117|NCT00909779|3954085|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4129118|NCT00909779|3954086|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4129119|NCT00909779|3954087|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4129120|NCT00909779|3954085|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4129121|NCT00909779|3954086|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4129122|NCT00909779|3954087|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4129123|NCT00909779|3954085|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|813|813.0||||||
4129124|NCT00909779|3954086|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|411|411.0||||||
4129125|NCT00909779|3954087|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|402|402.0||||||
4129126|NCT00909779|3954085|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4129127|NCT00909779|3954086|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4129128|NCT00909779|3954087|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4129129|NCT00909779|3954085|B3|Undifferentiated||Sex/Gender, Customized||participants|Number|1|1.0||||||
4129130|NCT00909779|3954086|B2|Undifferentiated||Sex/Gender, Customized||participants|Number|1|1.0||||||
4129131|NCT00909779|3954087|B1|Undifferentiated||Sex/Gender, Customized||participants|Number|0|0.0||||||
4129132|NCT00909779|3954085|B3|Male||Sex/Gender, Customized||participants|Number|479|479.0||||||
4129133|NCT00909779|3954086|B2|Male||Sex/Gender, Customized||participants|Number|236|236.0||||||
4129134|NCT00909779|3954087|B1|Male||Sex/Gender, Customized||participants|Number|243|243.0||||||
4129135|NCT00909779|3954085|B3|Female||Sex/Gender, Customized||participants|Number|361|361.0||||||
4129136|NCT00909779|3954086|B2|Female||Sex/Gender, Customized||participants|Number|183|183.0||||||
4129137|NCT00909779|3954087|B1|Female||Sex/Gender, Customized||participants|Number|178|178.0||||||
4129138|NCT00909779|3954085|B3|||Age||years|Mean|63.8|63.8|Standard Deviation|9.4|9.4|||
4129139|NCT00909779|3954086|B2|||Age||years|Mean|64.2|64.2|Standard Deviation|9.3|9.3|||
4129140|NCT00909779|3954087|B1|||Age||years|Mean|63.3|63.3|Standard Deviation|9.5|9.5|||
4129141|NCT00909779|3954085|B3||>=65 years|Age||Participants|Count of Participants|415|415.0||||||
4129142|NCT00909779|3954086|B2||>=65 years|Age||Participants|Count of Participants|216|216.0||||||
4129143|NCT00909779|3954087|B1||>=65 years|Age||Participants|Count of Participants|199|199.0||||||
4129144|NCT00909779|3954085|B3||Between 18 and 65 years|Age||Participants|Count of Participants|426|426.0||||||
4129145|NCT00909779|3954086|B2||Between 18 and 65 years|Age||Participants|Count of Participants|204|204.0||||||
4129146|NCT00909779|3954087|B1||Between 18 and 65 years|Age||Participants|Count of Participants|222|222.0||||||
4129147|NCT00909779|3954085|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4129148|NCT00909779|3954086|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4129149|NCT00909779|3954087|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4129150|NCT00909753|3954110|B3|Canada||Region of Enrollment||participants|Number|92|92.0||||||
4129151|NCT00909753|3954111|B2|Canada||Region of Enrollment||participants|Number|46|46.0||||||
4129152|NCT00909753|3954112|B1|Canada||Region of Enrollment||participants|Number|46|46.0||||||
4129153|NCT00909753|3954110|B3|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4129154|NCT00909753|3954111|B2|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4129155|NCT00909753|3954112|B1|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4129156|NCT00909753|3954110|B3|Black||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
4129157|NCT00909753|3954111|B2|Black||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4129158|NCT00909753|3954112|B1|Black||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4129159|NCT00909753|3954110|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|64|64.0||||||
4129160|NCT00909753|3954111|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|33|33.0||||||
4129161|NCT00909753|3954112|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|31|31.0||||||
4129162|NCT00909753|3954110|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4129163|NCT00909753|3954111|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4129164|NCT00909753|3954112|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4129165|NCT00909753|3954110|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4129166|NCT00909753|3954111|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4129167|NCT00909753|3954112|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4129168|NCT00909753|3954110|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4129169|NCT00909753|3954111|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4129170|NCT00909753|3954112|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4129171|NCT00909753|3954110|B3||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
4129172|NCT00909753|3954111|B2||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4129173|NCT00909753|3954112|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4129174|NCT00909753|3954110|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4129175|NCT00909753|3954111|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4129176|NCT00909753|3954112|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4129177|NCT00909727|3954131|B3|||Percent Predicted Forced Expiratory Volume in 1 Second (FEV1)|Percent predicted for age, gender, and height|percentage|Mean|84.2|84.2|Standard Deviation|18.07|18.07|||
4129178|NCT00909727|3954132|B2|||Percent Predicted Forced Expiratory Volume in 1 Second (FEV1)|Percent predicted for age, gender, and height|percentage|Mean|84.7|84.7|Standard Deviation|15.83|15.83|||
4129179|NCT00909727|3954133|B1|||Percent Predicted Forced Expiratory Volume in 1 Second (FEV1)|Percent predicted for age, gender, and height|percentage|Mean|83.7|83.7|Standard Deviation|20.37|20.37|||
4129180|NCT00909727|3954131|B3|> 90%||Percent Predicted Forced Expiratory Volume in 1 Second (FEV1)|Percent predicted for age, gender, and height|participants|Number|22|22.0||||||
4129181|NCT00909727|3954132|B2|> 90%||Percent Predicted Forced Expiratory Volume in 1 Second (FEV1)|Percent predicted for age, gender, and height|participants|Number|10|10.0||||||
4129182|NCT00909727|3954133|B1|> 90%||Percent Predicted Forced Expiratory Volume in 1 Second (FEV1)|Percent predicted for age, gender, and height|participants|Number|12|12.0||||||
4129183|NCT00909727|3954131|B3|≥ 70% to ≤ 90%||Percent Predicted Forced Expiratory Volume in 1 Second (FEV1)|Percent predicted for age, gender, and height|participants|Number|18|18.0||||||
4129184|NCT00909727|3954132|B2|≥ 70% to ≤ 90%||Percent Predicted Forced Expiratory Volume in 1 Second (FEV1)|Percent predicted for age, gender, and height|participants|Number|12|12.0||||||
4129185|NCT00909727|3954133|B1|≥ 70% to ≤ 90%||Percent Predicted Forced Expiratory Volume in 1 Second (FEV1)|Percent predicted for age, gender, and height|participants|Number|6|6.0||||||
4129186|NCT00909727|3954131|B3|< 70%||Percent Predicted Forced Expiratory Volume in 1 Second (FEV1)|Percent predicted for age, gender, and height|participants|Number|12|12.0||||||
4129187|NCT00909727|3954132|B2|< 70%||Percent Predicted Forced Expiratory Volume in 1 Second (FEV1)|Percent predicted for age, gender, and height|participants|Number|4|4.0||||||
4129247|NCT00909649|3954149|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4129188|NCT00909727|3954133|B1|< 70%||Percent Predicted Forced Expiratory Volume in 1 Second (FEV1)|Percent predicted for age, gender, and height|participants|Number|8|8.0||||||
4129189|NCT00909727|3954131|B3|||Sweat Chloride||millimoles per liter|Mean|104.6|104.6|Standard Deviation|11.92|11.92|||
4129190|NCT00909727|3954132|B2|||Sweat Chloride||millimoles per liter|Mean|104.3|104.3|Standard Deviation|14.54|14.54|||
4129191|NCT00909727|3954133|B1|||Sweat Chloride||millimoles per liter|Mean|104.8|104.8|Standard Deviation|8.87|8.87|||
4129192|NCT00909727|3954131|B3|||Body Mass Index||kilograms per square meter|Mean|17.0|17.0|Standard Deviation|2.21|2.21|||
4129193|NCT00909727|3954132|B2|||Body Mass Index||kilograms per square meter|Mean|17.1|17.1|Standard Deviation|2.61|2.61|||
4129194|NCT00909727|3954133|B1|||Body Mass Index||kilograms per square meter|Mean|16.8|16.8|Standard Deviation|1.75|1.75|||
4129195|NCT00909727|3954131|B3|||Weight||kilograms|Mean|30.9|30.9|Standard Deviation|8.63|8.63|||
4129196|NCT00909727|3954132|B2|||Weight||kilograms|Mean|31.8|31.8|Standard Deviation|9.95|9.95|||
4129197|NCT00909727|3954133|B1|||Weight||kilograms|Mean|30.0|30.0|Standard Deviation|7.16|7.16|||
4129198|NCT00909727|3954131|B3|Australia||Region of Enrollment||participants|Number|14|14.0||||||
4129199|NCT00909727|3954132|B2|Australia||Region of Enrollment||participants|Number|8|8.0||||||
4129200|NCT00909727|3954133|B1|Australia||Region of Enrollment||participants|Number|6|6.0||||||
4129201|NCT00909727|3954131|B3|Europe||Region of Enrollment||participants|Number|11|11.0||||||
4129202|NCT00909727|3954132|B2|Europe||Region of Enrollment||participants|Number|6|6.0||||||
4129203|NCT00909727|3954133|B1|Europe||Region of Enrollment||participants|Number|5|5.0||||||
4129204|NCT00909727|3954131|B3|North America||Region of Enrollment||participants|Number|27|27.0||||||
4129205|NCT00909727|3954132|B2|North America||Region of Enrollment||participants|Number|12|12.0||||||
4129206|NCT00909727|3954133|B1|North America||Region of Enrollment||participants|Number|15|15.0||||||
4129207|NCT00909727|3954131|B3|Not Allowed to Ask Per Local Regulations||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4129208|NCT00909727|3954132|B2|Not Allowed to Ask Per Local Regulations||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4129209|NCT00909727|3954133|B1|Not Allowed to Ask Per Local Regulations||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4129210|NCT00909727|3954131|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4129211|NCT00909727|3954132|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4129212|NCT00909727|3954133|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4129213|NCT00909727|3954131|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4129214|NCT00909727|3954132|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4129215|NCT00909727|3954133|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4129216|NCT00909727|3954131|B3|Not Allowed to Ask Per Local Regulations||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4129217|NCT00909727|3954132|B2|Not Allowed to Ask Per Local Regulations||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4129218|NCT00909727|3954133|B1|Not Allowed to Ask Per Local Regulations||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4129219|NCT00909727|3954131|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4129220|NCT00909727|3954132|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4129221|NCT00909727|3954133|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4129222|NCT00909727|3954131|B3|White||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4129223|NCT00909727|3954132|B2|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4129224|NCT00909727|3954133|B1|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4129225|NCT00909727|3954131|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4129226|NCT00909727|3954132|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4129227|NCT00909727|3954133|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4129228|NCT00909727|3954131|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4129229|NCT00909727|3954132|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4129230|NCT00909727|3954133|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4129231|NCT00909727|3954131|B3|> 11 Years||Age, Customized||participants|Number|4|4.0||||||
4129232|NCT00909727|3954132|B2|> 11 Years||Age, Customized||participants|Number|3|3.0||||||
4129233|NCT00909727|3954133|B1|> 11 Years||Age, Customized||participants|Number|1|1.0||||||
4129234|NCT00909727|3954131|B3|9 to 11 Years||Age, Customized||participants|Number|23|23.0||||||
4129235|NCT00909727|3954132|B2|9 to 11 Years||Age, Customized||participants|Number|11|11.0||||||
4129236|NCT00909727|3954133|B1|9 to 11 Years||Age, Customized||participants|Number|12|12.0||||||
4129237|NCT00909727|3954131|B3|6 to 8 Years||Age, Customized||participants|Number|25|25.0||||||
4129238|NCT00909727|3954132|B2|6 to 8 Years||Age, Customized||participants|Number|12|12.0||||||
4129239|NCT00909727|3954133|B1|6 to 8 Years||Age, Customized||participants|Number|13|13.0||||||
4129240|NCT00909727|3954131|B3|||Age||years|Mean|8.9|8.9|Standard Deviation|1.91|1.91|||
4129241|NCT00909727|3954132|B2|||Age||years|Mean|8.9|8.9|Standard Deviation|2.00|2.0|||
4129242|NCT00909727|3954133|B1|||Age||years|Mean|8.9|8.9|Standard Deviation|1.86|1.86|||
4129243|NCT00909649|3954148|B3|Egypt||Region of Enrollment||participants|Number|50.0|50.0||||||
4129244|NCT00909649|3954149|B2|Egypt||Region of Enrollment||participants|Number|25|25.0||||||
4129245|NCT00909649|3954150|B1|Egypt||Region of Enrollment||participants|Number|25|25.0||||||
4129246|NCT00909649|3954148|B3||Male|Sex: Female, Male||Participants|Count of Participants|0.0|0.0||||||
4129248|NCT00909649|3954150|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4129249|NCT00909649|3954148|B3||Female|Sex: Female, Male||Participants|Count of Participants|50.0|50.0||||||
4129250|NCT00909649|3954149|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4129251|NCT00909649|3954150|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4129252|NCT00909649|3954148|B3|||Age||years|Mean|51.9|51.9|Standard Deviation|10.7|10.7|||
4129253|NCT00909649|3954149|B2|||Age||years|Mean|51.6|51.6|Standard Deviation|10.8|10.8|||
4129254|NCT00909649|3954150|B1|||Age||years|Mean|52.2|52.2|Standard Deviation|11.5|11.5|||
4129255|NCT00909649|3954148|B3||>=65 years|Age||Participants|Count of Participants|6.0|6.0||||||
4129256|NCT00909649|3954149|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4129257|NCT00909649|3954150|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4129258|NCT00909649|3954148|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44.0|44.0||||||
4129259|NCT00909649|3954149|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4129260|NCT00909649|3954150|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4129261|NCT00909649|3954148|B3||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4129262|NCT00909649|3954149|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4129263|NCT00909649|3954150|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4129264|NCT00909610|3954155|B3|Canada||Region of Enrollment||participants|Number|80|80.0||||||
4129265|NCT00909610|3954156|B2|Canada||Region of Enrollment||participants|Number|40|40.0||||||
4129266|NCT00909610|3954157|B1|Canada||Region of Enrollment||participants|Number|40|40.0||||||
4129267|NCT00909610|3954155|B3|Black||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
4129268|NCT00909610|3954156|B2|Black||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4129269|NCT00909610|3954157|B1|Black||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4129270|NCT00909610|3954155|B3|Asian||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4129271|NCT00909610|3954156|B2|Asian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4129272|NCT00909610|3954157|B1|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4129273|NCT00909610|3954155|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|49|49.0||||||
4129274|NCT00909610|3954156|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
4129275|NCT00909610|3954157|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|26|26.0||||||
4129276|NCT00909610|3954155|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4129277|NCT00909610|3954156|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4129278|NCT00909610|3954157|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4129279|NCT00909610|3954155|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4129280|NCT00909610|3954156|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4129281|NCT00909610|3954157|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4129282|NCT00909610|3954155|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4129283|NCT00909610|3954156|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4129284|NCT00909610|3954157|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4129285|NCT00909610|3954155|B3||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4129286|NCT00909610|3954156|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4129287|NCT00909610|3954157|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4129288|NCT00909610|3954155|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4129289|NCT00909610|3954156|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4129290|NCT00909610|3954157|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4129291|NCT00909545|3954176|B5|Supine||Vital Signs: Pulse||Beats per minute|Mean|67.2|67.2|Standard Deviation|9.6|9.6|||
4129292|NCT00909545|3954177|B4|Supine||Vital Signs: Pulse||Beats per minute|Mean|66.33|66.33|Standard Deviation|9.71|9.71|||
4129293|NCT00909545|3954178|B3|Supine||Vital Signs: Pulse||Beats per minute|Mean|67.08|67.08|Standard Deviation|8.39|8.39|||
4129294|NCT00909545|3954179|B2|Supine||Vital Signs: Pulse||Beats per minute|Mean|67.43|67.43|Standard Deviation|10.28|10.28|||
4129295|NCT00909545|3954180|B1|Supine||Vital Signs: Pulse||Beats per minute|Mean|68.00|68.0|Standard Deviation|10.63|10.63|||
4129296|NCT00909545|3954176|B5|Standing||Vital Signs: Pulse||Beats per minute|Mean|74.5|74.5|Standard Deviation|11.6|11.6|||
4129297|NCT00909545|3954177|B4|Standing||Vital Signs: Pulse||Beats per minute|Mean|72.33|72.33|Standard Deviation|11.43|11.43|||
4129298|NCT00909545|3954178|B3|Standing||Vital Signs: Pulse||Beats per minute|Mean|75.50|75.5|Standard Deviation|12.27|12.27|||
4129299|NCT00909545|3954179|B2|Standing||Vital Signs: Pulse||Beats per minute|Mean|77.35|77.35|Standard Deviation|10.70|10.7|||
4129300|NCT00909545|3954180|B1|Standing||Vital Signs: Pulse||Beats per minute|Mean|72.92|72.92|Standard Deviation|11.90|11.9|||
4129301|NCT00909545|3954176|B5|Supine||Vital Signs: Diastolic||mm Hg|Mean|79.1|79.1|Standard Deviation|10.5|10.5|||
4129302|NCT00909545|3954177|B4|Supine||Vital Signs: Diastolic||mm Hg|Mean|79.63|79.63|Standard Deviation|10.43|10.43|||
4129303|NCT00909545|3954178|B3|Supine||Vital Signs: Diastolic||mm Hg|Mean|76.88|76.88|Standard Deviation|10.95|10.95|||
4129304|NCT00909545|3954179|B2|Supine||Vital Signs: Diastolic||mm Hg|Mean|79.22|79.22|Standard Deviation|9.50|9.5|||
4129305|NCT00909545|3954180|B1|Supine||Vital Signs: Diastolic||mm Hg|Mean|80.69|80.69|Standard Deviation|11.34|11.34|||
4129306|NCT00909545|3954176|B5|Standing||Vital Signs: Diastolic||mm Hg|Mean|82.3|82.3|Standard Deviation|11.4|11.4|||
4129397|NCT00909545|3954177|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4129307|NCT00909545|3954177|B4|Standing||Vital Signs: Diastolic||mm Hg|Mean|81.29|81.29|Standard Deviation|11.02|11.02|||
4129308|NCT00909545|3954178|B3|Standing||Vital Signs: Diastolic||mm Hg|Mean|80.04|80.04|Standard Deviation|9.73|9.73|||
4129309|NCT00909545|3954179|B2|Standing||Vital Signs: Diastolic||mm Hg|Mean|84.43|84.43|Standard Deviation|12.22|12.22|||
4129310|NCT00909545|3954180|B1|Standing||Vital Signs: Diastolic||mm Hg|Mean|83.73|83.73|Standard Deviation|12.74|12.74|||
4129311|NCT00909545|3954176|B5|Supine||Vital Signs: Systolic||mm Hg|Mean|130.0|130.0|Standard Deviation|15.6|15.6|||
4129312|NCT00909545|3954177|B4|Supine||Vital Signs: Systolic||mm Hg|Mean|129.1|129.1|Standard Deviation|13.69|13.69|||
4129313|NCT00909545|3954178|B3|Supine||Vital Signs: Systolic||mm Hg|Mean|131.3|131.3|Standard Deviation|19.00|19.0|||
4129314|NCT00909545|3954179|B2|Supine||Vital Signs: Systolic||mm Hg|Mean|128.5|128.5|Standard Deviation|13.60|13.6|||
4129315|NCT00909545|3954180|B1|Supine||Vital Signs: Systolic||mm Hg|Mean|130.9|130.9|Standard Deviation|16.04|16.04|||
4129316|NCT00909545|3954176|B5|Standing||Vital Signs: Systolic||mm Hg|Mean|128.4|128.4|Standard Deviation|16.3|16.3|||
4129317|NCT00909545|3954177|B4|Standing||Vital Signs: Systolic||mm Hg|Mean|125.8|125.8|Standard Deviation|11.96|11.96|||
4129318|NCT00909545|3954178|B3|Standing||Vital Signs: Systolic||mm Hg|Mean|130.4|130.4|Standard Deviation|17.76|17.76|||
4129319|NCT00909545|3954179|B2|Standing||Vital Signs: Systolic||mm Hg|Mean|127.3|127.3|Standard Deviation|17.03|17.03|||
4129320|NCT00909545|3954180|B1|Standing||Vital Signs: Systolic||mm Hg|Mean|130.0|130.0|Standard Deviation|18.12|18.12|||
4129321|NCT00909545|3954176|B5|||PD Qualify of Life Scale|Higher score indicates higher disability.|Unit of PDQ-39|Mean|9.7|9.7|Standard Deviation|2.3|2.3|||
4129322|NCT00909545|3954177|B4|||PD Qualify of Life Scale|Higher score indicates higher disability.|Unit of PDQ-39|Mean|10.45|10.45|Standard Deviation|8.06|8.06|||
4129323|NCT00909545|3954178|B3|||PD Qualify of Life Scale|Higher score indicates higher disability.|Unit of PDQ-39|Mean|8.39|8.39|Standard Deviation|5.82|5.82|||
4129324|NCT00909545|3954179|B2|||PD Qualify of Life Scale|Higher score indicates higher disability.|Unit of PDQ-39|Mean|9.69|9.69|Standard Deviation|6.88|6.88|||
4129325|NCT00909545|3954180|B1|||PD Qualify of Life Scale|Higher score indicates higher disability.|Unit of PDQ-39|Mean|10.28|10.28|Standard Deviation|8.55|8.55|||
4129326|NCT00909545|3954176|B5|||Montreal Cognitive Assessment|Lower score indicates more severe disability.|Unit of MoCA|Mean|27.4|27.4|Standard Deviation|2.2|2.2|||
4129327|NCT00909545|3954177|B4|||Montreal Cognitive Assessment|Lower score indicates more severe disability.|Unit of MoCA|Mean|27.79|27.79|Standard Deviation|1.89|1.89|||
4129328|NCT00909545|3954178|B3|||Montreal Cognitive Assessment|Lower score indicates more severe disability.|Unit of MoCA|Mean|26.92|26.92|Standard Deviation|2.36|2.36|||
4129329|NCT00909545|3954179|B2|||Montreal Cognitive Assessment|Lower score indicates more severe disability.|Unit of MoCA|Mean|27.96|27.96|Standard Deviation|1.97|1.97|||
4129330|NCT00909545|3954180|B1|||Montreal Cognitive Assessment|Lower score indicates more severe disability.|Unit of MoCA|Mean|26.96|26.96|Standard Deviation|2.58|2.58|||
4129331|NCT00909545|3954176|B5|||Modified Schwab & England Independence Scale|Higher score indicates higher independence.|Percentage scale|Mean|92.0|92.0|Standard Deviation|5.0|5.0|||
4129332|NCT00909545|3954177|B4|||Modified Schwab & England Independence Scale|Higher score indicates higher independence.|Percentage scale|Mean|91.04|91.04|Standard Deviation|5.10|5.1|||
4129333|NCT00909545|3954178|B3|||Modified Schwab & England Independence Scale|Higher score indicates higher independence.|Percentage scale|Mean|93.08|93.08|Standard Deviation|5.11|5.11|||
4129334|NCT00909545|3954179|B2|||Modified Schwab & England Independence Scale|Higher score indicates higher independence.|Percentage scale|Mean|93.48|93.48|Standard Deviation|4.632|4.632|||
4129335|NCT00909545|3954180|B1|||Modified Schwab & England Independence Scale|Higher score indicates higher independence.|Percentage scale|Mean|93.08|93.08|Standard Deviation|5.11|5.11|||
4129336|NCT00909545|3954176|B5|H/Y Stage: 2.5||Hoehn & Yahr Scale|Higher stage indicates more severe disability.|Participants|Number|2|2.0||||||
4129337|NCT00909545|3954177|B4|H/Y Stage: 2.5||Hoehn & Yahr Scale|Higher stage indicates more severe disability.|Participants|Number|1|1.0||||||
4129338|NCT00909545|3954178|B3|H/Y Stage: 2.5||Hoehn & Yahr Scale|Higher stage indicates more severe disability.|Participants|Number|0|0.0||||||
4129339|NCT00909545|3954179|B2|H/Y Stage: 2.5||Hoehn & Yahr Scale|Higher stage indicates more severe disability.|Participants|Number|0|0.0||||||
4129340|NCT00909545|3954180|B1|H/Y Stage: 2.5||Hoehn & Yahr Scale|Higher stage indicates more severe disability.|Participants|Number|1|1.0||||||
4129341|NCT00909545|3954176|B5|H/Y Stage: 2||Hoehn & Yahr Scale|Higher stage indicates more severe disability.|Participants|Number|61|61.0||||||
4129342|NCT00909545|3954177|B4|H/Y Stage: 2||Hoehn & Yahr Scale|Higher stage indicates more severe disability.|Participants|Number|11|11.0||||||
4129343|NCT00909545|3954178|B3|H/Y Stage: 2||Hoehn & Yahr Scale|Higher stage indicates more severe disability.|Participants|Number|18|18.0||||||
4129344|NCT00909545|3954179|B2|H/Y Stage: 2||Hoehn & Yahr Scale|Higher stage indicates more severe disability.|Participants|Number|16|16.0||||||
4129345|NCT00909545|3954180|B1|H/Y Stage: 2||Hoehn & Yahr Scale|Higher stage indicates more severe disability.|Participants|Number|16|16.0||||||
4129346|NCT00909545|3954176|B5|H/Y Stage: 1.5||Hoehn & Yahr Scale|Higher stage indicates more severe disability.|Participants|Number|6|6.0||||||
4129347|NCT00909545|3954177|B4|H/Y Stage: 1.5||Hoehn & Yahr Scale|Higher stage indicates more severe disability.|Participants|Number|1|1.0||||||
4129348|NCT00909545|3954178|B3|H/Y Stage: 1.5||Hoehn & Yahr Scale|Higher stage indicates more severe disability.|Participants|Number|0|0.0||||||
4129349|NCT00909545|3954179|B2|H/Y Stage: 1.5||Hoehn & Yahr Scale|Higher stage indicates more severe disability.|Participants|Number|3|3.0||||||
4129350|NCT00909545|3954180|B1|H/Y Stage: 1.5||Hoehn & Yahr Scale|Higher stage indicates more severe disability.|Participants|Number|2|2.0||||||
4129351|NCT00909545|3954176|B5|H/Y Stage: 1||Hoehn & Yahr Scale|Higher stage indicates more severe disability.|Participants|Number|30|30.0||||||
4129352|NCT00909545|3954177|B4|H/Y Stage: 1||Hoehn & Yahr Scale|Higher stage indicates more severe disability.|Participants|Number|11|11.0||||||
4129353|NCT00909545|3954178|B3|H/Y Stage: 1||Hoehn & Yahr Scale|Higher stage indicates more severe disability.|Participants|Number|8|8.0||||||
4129354|NCT00909545|3954179|B2|H/Y Stage: 1||Hoehn & Yahr Scale|Higher stage indicates more severe disability.|Participants|Number|4|4.0||||||
4129355|NCT00909545|3954180|B1|H/Y Stage: 1||Hoehn & Yahr Scale|Higher stage indicates more severe disability.|Participants|Number|7|7.0||||||
4129356|NCT00909545|3954176|B5|||Unified Parkinson's Disease Rating Scale (UPDRS) Motor|Higher score indicates more severe disability.|Unit of UPDRS scales|Mean|18.0|18.0|Standard Deviation|7.8|7.8|||
4129357|NCT00909545|3954177|B4|||Unified Parkinson's Disease Rating Scale (UPDRS) Motor|Higher score indicates more severe disability.|Unit of UPDRS scales|Mean|17.13|17.13|Standard Deviation|8.26|8.26|||
4129358|NCT00909545|3954178|B3|||Unified Parkinson's Disease Rating Scale (UPDRS) Motor|Higher score indicates more severe disability.|Unit of UPDRS scales|Mean|16.85|16.85|Standard Deviation|7.88|7.88|||
4129359|NCT00909545|3954179|B2|||Unified Parkinson's Disease Rating Scale (UPDRS) Motor|Higher score indicates more severe disability.|Unit of UPDRS scales|Mean|19.30|19.3|Standard Deviation|8.02|8.02|||
4129360|NCT00909545|3954180|B1|||Unified Parkinson's Disease Rating Scale (UPDRS) Motor|Higher score indicates more severe disability.|Unit of UPDRS scales|Mean|18.96|18.96|Standard Deviation|7.27|7.27|||
4129361|NCT00909545|3954176|B5|||Unified Parkinson's Disease Rating Scale (UPDRS) Activities of Daily Living (ADL)|Higher score indicates more severe disability.|Unit of UPDRS scales|Mean|6.1|6.1|Standard Deviation|3.0|3.0|||
4129362|NCT00909545|3954177|B4|||Unified Parkinson's Disease Rating Scale (UPDRS) Activities of Daily Living (ADL)|Higher score indicates more severe disability.|Unit of UPDRS scales|Mean|6.58|6.58|Standard Deviation|3.03|3.03|||
4129363|NCT00909545|3954178|B3|||Unified Parkinson's Disease Rating Scale (UPDRS) Activities of Daily Living (ADL)|Higher score indicates more severe disability.|Unit of UPDRS scales|Mean|6.15|6.15|Standard Deviation|3.03|3.03|||
4129364|NCT00909545|3954179|B2|||Unified Parkinson's Disease Rating Scale (UPDRS) Activities of Daily Living (ADL)|Higher score indicates more severe disability.|Unit of UPDRS scales|Mean|5.83|5.83|Standard Deviation|3.02|3.02|||
4129365|NCT00909545|3954180|B1|||Unified Parkinson's Disease Rating Scale (UPDRS) Activities of Daily Living (ADL)|Higher score indicates more severe disability.|Unit of UPDRS scales|Mean|5.85|5.85|Standard Deviation|2.98|2.98|||
4129366|NCT00909545|3954176|B5|||Unified Parkinson's Disease Rating Scale (UPDRS) Mental|Higher score indicates more severe disability.|Unit of UPDRS scales|Mean|0.9|0.9|Standard Deviation|1.3|1.3|||
4129367|NCT00909545|3954177|B4|||Unified Parkinson's Disease Rating Scale (UPDRS) Mental|Higher score indicates more severe disability.|Unit of UPDRS scales|Mean|0.96|0.96|Standard Deviation|1.12|1.12|||
4129368|NCT00909545|3954178|B3|||Unified Parkinson's Disease Rating Scale (UPDRS) Mental|Higher score indicates more severe disability.|Unit of UPDRS scales|Mean|0.65|0.65|Standard Deviation|0.98|0.98|||
4129369|NCT00909545|3954179|B2|||Unified Parkinson's Disease Rating Scale (UPDRS) Mental|Higher score indicates more severe disability.|Unit of UPDRS scales|Mean|1.30|1.3|Standard Deviation|1.79|1.79|||
4129370|NCT00909545|3954180|B1|||Unified Parkinson's Disease Rating Scale (UPDRS) Mental|Higher score indicates more severe disability.|Unit of UPDRS scales|Mean|0.65|0.65|Standard Deviation|1.06|1.06|||
4129371|NCT00909545|3954176|B5|||Unified Parkinson's Disease Rating Scale (UPDRS) Total|Higher score indicates more severe disability.|Unit of UPDRS scales|Mean|25.0|25.0|Standard Deviation|9.9|9.9|||
4129372|NCT00909545|3954177|B4|||Unified Parkinson's Disease Rating Scale (UPDRS) Total|Higher score indicates more severe disability.|Unit of UPDRS scales|Mean|24.67|24.67|Standard Deviation|10.77|10.77|||
4129373|NCT00909545|3954178|B3|||Unified Parkinson's Disease Rating Scale (UPDRS) Total|Higher score indicates more severe disability.|Unit of UPDRS scales|Mean|23.65|23.65|Standard Deviation|9.97|9.97|||
4129374|NCT00909545|3954179|B2|||Unified Parkinson's Disease Rating Scale (UPDRS) Total|Higher score indicates more severe disability.|Unit of UPDRS scales|Mean|26.43|26.43|Standard Deviation|9.69|9.69|||
4129375|NCT00909545|3954180|B1|||Unified Parkinson's Disease Rating Scale (UPDRS) Total|Higher score indicates more severe disability.|Unit of UPDRS scales|Mean|25.46|25.46|Standard Deviation|9.39|9.39|||
4129376|NCT00909545|3954176|B5|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4129377|NCT00909545|3954177|B4|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4129378|NCT00909545|3954178|B3|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4129379|NCT00909545|3954179|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4129380|NCT00909545|3954180|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4129381|NCT00909545|3954176|B5|United States||Region of Enrollment||participants|Number|90|90.0||||||
4129382|NCT00909545|3954177|B4|United States||Region of Enrollment||participants|Number|21|21.0||||||
4129383|NCT00909545|3954178|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4129384|NCT00909545|3954179|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4129385|NCT00909545|3954180|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4129386|NCT00909545|3954176|B5|Other race||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4129387|NCT00909545|3954177|B4|Other race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4129388|NCT00909545|3954178|B3|Other race||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4129389|NCT00909545|3954179|B2|Other race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4129390|NCT00909545|3954180|B1|Other race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4129391|NCT00909545|3954176|B5|White||Race/Ethnicity, Customized||participants|Number|91|91.0||||||
4129392|NCT00909545|3954177|B4|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4129393|NCT00909545|3954178|B3|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4129394|NCT00909545|3954179|B2|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4129395|NCT00909545|3954180|B1|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4129396|NCT00909545|3954176|B5||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4129398|NCT00909545|3954178|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4129399|NCT00909545|3954179|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4129400|NCT00909545|3954180|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4129401|NCT00909545|3954176|B5||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4129402|NCT00909545|3954177|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4129403|NCT00909545|3954178|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4129404|NCT00909545|3954179|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4129405|NCT00909545|3954180|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4129406|NCT00909545|3954176|B5|>=65 years||Age, Customized||participants|Number|27|27.0||||||
4129407|NCT00909545|3954177|B4|>=65 years||Age, Customized||participants|Number|5|5.0||||||
4129408|NCT00909545|3954178|B3|>=65 years||Age, Customized||participants|Number|8|8.0||||||
4129409|NCT00909545|3954179|B2|>=65 years||Age, Customized||participants|Number|5|5.0||||||
4129410|NCT00909545|3954180|B1|>=65 years||Age, Customized||participants|Number|9|9.0||||||
4129411|NCT00909545|3954176|B5|Between 30 and 65 years||Age, Customized||participants|Number|72|72.0||||||
4129412|NCT00909545|3954177|B4|Between 30 and 65 years||Age, Customized||participants|Number|19|19.0||||||
4129413|NCT00909545|3954178|B3|Between 30 and 65 years||Age, Customized||participants|Number|18|18.0||||||
4129414|NCT00909545|3954179|B2|Between 30 and 65 years||Age, Customized||participants|Number|18|18.0||||||
4129415|NCT00909545|3954180|B1|Between 30 and 65 years||Age, Customized||participants|Number|17|17.0||||||
4129416|NCT00909545|3954176|B5|||Age||years|Mean|59.1|59.1|Standard Deviation|9.8|9.8|||
4129417|NCT00909545|3954177|B4|||Age||years|Mean|59.8|59.8|Standard Deviation|8.9|8.9|||
4129418|NCT00909545|3954178|B3|||Age||years|Mean|58.5|58.5|Standard Deviation|11.6|11.6|||
4129419|NCT00909545|3954179|B2|||Age||years|Mean|57.7|57.7|Standard Deviation|8.3|8.3|||
4129420|NCT00909545|3954180|B1|||Age||years|Mean|60.2|60.2|Standard Deviation|10.1|10.1|||
4129421|NCT00909532|3954317|B3|||Sweat Chloride||millimoles per liter|Mean|100.2|100.2|Standard Deviation|10.28|10.28|||
4129422|NCT00909532|3954318|B2|||Sweat Chloride||millimoles per liter|Mean|100.4|100.4|Standard Deviation|10.00|10.0|||
4129423|NCT00909532|3954319|B1|||Sweat Chloride||millimoles per liter|Mean|100.1|100.1|Standard Deviation|10.63|10.63|||
4129424|NCT00909532|3954317|B3|||Body Mass Index||kilograms per square meter|Mean|21.8|21.8|Standard Deviation|3.56|3.56|||
4129425|NCT00909532|3954318|B2|||Body Mass Index||kilograms per square meter|Mean|21.7|21.7|Standard Deviation|3.65|3.65|||
4129426|NCT00909532|3954319|B1|||Body Mass Index||kilograms per square meter|Mean|21.9|21.9|Standard Deviation|3.49|3.49|||
4129427|NCT00909532|3954317|B3|||Weight||kilograms|Mean|61.5|61.5|Standard Deviation|14.06|14.06|||
4129428|NCT00909532|3954318|B2|||Weight||kilograms|Mean|61.7|61.7|Standard Deviation|14.26|14.26|||
4129429|NCT00909532|3954319|B1|||Weight||kilograms|Mean|61.2|61.2|Standard Deviation|13.93|13.93|||
4129430|NCT00909532|3954317|B3|≥ 70% predicted FEV1||Percent Predicted FEV1, Categorical|Percent predicted for age, gender, and height.|participants|Number|67|67.0||||||
4129431|NCT00909532|3954318|B2|≥ 70% predicted FEV1||Percent Predicted FEV1, Categorical|Percent predicted for age, gender, and height.|participants|Number|34|34.0||||||
4129432|NCT00909532|3954319|B1|≥ 70% predicted FEV1||Percent Predicted FEV1, Categorical|Percent predicted for age, gender, and height.|participants|Number|33|33.0||||||
4129433|NCT00909532|3954317|B3|< 70% predicted FEV1||Percent Predicted FEV1, Categorical|Percent predicted for age, gender, and height.|participants|Number|94|94.0||||||
4129434|NCT00909532|3954318|B2|< 70% predicted FEV1||Percent Predicted FEV1, Categorical|Percent predicted for age, gender, and height.|participants|Number|49|49.0||||||
4129435|NCT00909532|3954319|B1|< 70% predicted FEV1||Percent Predicted FEV1, Categorical|Percent predicted for age, gender, and height.|participants|Number|45|45.0||||||
4129436|NCT00909532|3954317|B3|||Percent Predicted Forced Expiratory Volume in 1 Second (FEV1), Continuous|Percent predicted for age, gender, and height.|percentage|Mean|63.6|63.6|Standard Deviation|16.43|16.43|||
4129437|NCT00909532|3954318|B2|||Percent Predicted Forced Expiratory Volume in 1 Second (FEV1), Continuous|Percent predicted for age, gender, and height.|percentage|Mean|63.5|63.5|Standard Deviation|16.14|16.14|||
4129438|NCT00909532|3954319|B1|||Percent Predicted Forced Expiratory Volume in 1 Second (FEV1), Continuous|Percent predicted for age, gender, and height.|percentage|Mean|63.7|63.7|Standard Deviation|16.83|16.83|||
4129439|NCT00909532|3954317|B3|Australia||Region of Enrollment||participants|Number|19|19.0||||||
4129440|NCT00909532|3954318|B2|Australia||Region of Enrollment||participants|Number|10|10.0||||||
4129441|NCT00909532|3954319|B1|Australia||Region of Enrollment||participants|Number|9|9.0||||||
4129442|NCT00909532|3954317|B3|Europe||Region of Enrollment||participants|Number|42|42.0||||||
4129443|NCT00909532|3954318|B2|Europe||Region of Enrollment||participants|Number|23|23.0||||||
4129444|NCT00909532|3954319|B1|Europe||Region of Enrollment||participants|Number|19|19.0||||||
4129445|NCT00909532|3954317|B3|North America||Region of Enrollment||participants|Number|100|100.0||||||
4129446|NCT00909532|3954318|B2|North America||Region of Enrollment||participants|Number|50|50.0||||||
4129447|NCT00909532|3954319|B1|North America||Region of Enrollment||participants|Number|50|50.0||||||
4129448|NCT00909532|3954317|B3|Not Allowed to Ask Per Local Regulations||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4129449|NCT00909532|3954318|B2|Not Allowed to Ask Per Local Regulations||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4129450|NCT00909532|3954319|B1|Not Allowed to Ask Per Local Regulations||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4129451|NCT00909532|3954317|B3|White||Race/Ethnicity, Customized||participants|Number|158|158.0||||||
4129452|NCT00909532|3954318|B2|White||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
4129453|NCT00909532|3954319|B1|White||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
4129454|NCT00909532|3954317|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4129455|NCT00909532|3954318|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4129456|NCT00909532|3954319|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4129457|NCT00909532|3954317|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|158|158.0||||||
4129458|NCT00909532|3954318|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
4129459|NCT00909532|3954319|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
4129460|NCT00909532|3954317|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4129461|NCT00909532|3954318|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4129462|NCT00909532|3954319|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4129463|NCT00909532|3954317|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4129464|NCT00909532|3954318|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4129465|NCT00909532|3954319|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4129466|NCT00909532|3954317|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4129467|NCT00909532|3954318|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4129468|NCT00909532|3954319|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4129469|NCT00909532|3954317|B3|||Age||years|Mean|25.5|25.5|Standard Deviation|9.54|9.54|||
4129470|NCT00909532|3954318|B2|||Age||years|Mean|26.2|26.2|Standard Deviation|9.85|9.85|||
4129471|NCT00909532|3954319|B1|||Age||years|Mean|24.7|24.7|Standard Deviation|9.21|9.21|||
4129472|NCT00909532|3954317|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4129473|NCT00909532|3954318|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4129474|NCT00909532|3954319|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4129475|NCT00909532|3954317|B3||Between 18 and 65 years|Age||Participants|Count of Participants|125|125.0||||||
4129476|NCT00909532|3954318|B2||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4129477|NCT00909532|3954319|B1||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4129478|NCT00909532|3954317|B3||<=18 years|Age||Participants|Count of Participants|36|36.0||||||
4129479|NCT00909532|3954318|B2||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
4129480|NCT00909532|3954319|B1||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
4129481|NCT00909480|3954336|B3|||Diabetes History||years|Mean|8.22|8.22|Standard Deviation|6.08|6.08|||
4129482|NCT00909480|3954337|B2|||Diabetes History||years|Mean|8.44|8.44|Standard Deviation|6.56|6.56|||
4129483|NCT00909480|3954338|B1|||Diabetes History||years|Mean|7.99|7.99|Standard Deviation|5.56|5.56|||
4129484|NCT00909480|3954336|B3|Metformin monotherapy||Stratification||participants|Number|124|124.0||||||
4129485|NCT00909480|3954337|B2|Metformin monotherapy||Stratification||participants|Number|62|62.0||||||
4129486|NCT00909480|3954338|B1|Metformin monotherapy||Stratification||participants|Number|62|62.0||||||
4129487|NCT00909480|3954336|B3|Metformin + other OAD other than TZD||Stratification||participants|Number|299|299.0||||||
4129488|NCT00909480|3954337|B2|Metformin + other OAD other than TZD||Stratification||participants|Number|150|150.0||||||
4129489|NCT00909480|3954338|B1|Metformin + other OAD other than TZD||Stratification||participants|Number|149|149.0||||||
4129490|NCT00909480|3954336|B3|Metformin+thiazolidinedione (TZD)||Stratification||participants|Number|30|30.0||||||
4129491|NCT00909480|3954337|B2|Metformin+thiazolidinedione (TZD)||Stratification||participants|Number|15|15.0||||||
4129492|NCT00909480|3954338|B1|Metformin+thiazolidinedione (TZD)||Stratification||participants|Number|15|15.0||||||
4129493|NCT00909480|3954336|B3|||Height||meters|Mean|1.68|1.68|Standard Deviation|0.11|0.11|||
4129494|NCT00909480|3954337|B2|||Height||meters|Mean|1.67|1.67|Standard Deviation|0.1|0.1|||
4129495|NCT00909480|3954338|B1|||Height||meters|Mean|1.69|1.69|Standard Deviation|0.11|0.11|||
4129496|NCT00909480|3954336|B3|United States||Region of Enrolment||participants|Number|322|322.0||||||
4129497|NCT00909480|3954337|B2|United States||Region of Enrolment||participants|Number|159|159.0||||||
4129498|NCT00909480|3954338|B1|United States||Region of Enrolment||participants|Number|163|163.0||||||
4129499|NCT00909480|3954336|B3|Thailand||Region of Enrolment||participants|Number|33|33.0||||||
4129500|NCT00909480|3954337|B2|Thailand||Region of Enrolment||participants|Number|16|16.0||||||
4129501|NCT00909480|3954338|B1|Thailand||Region of Enrolment||participants|Number|17|17.0||||||
4129502|NCT00909480|3954336|B3|Korea, Republic of||Region of Enrolment||participants|Number|26|26.0||||||
4129503|NCT00909480|3954337|B2|Korea, Republic of||Region of Enrolment||participants|Number|10|10.0||||||
4129504|NCT00909480|3954338|B1|Korea, Republic of||Region of Enrolment||participants|Number|16|16.0||||||
4129505|NCT00909480|3954336|B3|India||Region of Enrolment||participants|Number|51|51.0||||||
4129506|NCT00909480|3954337|B2|India||Region of Enrolment||participants|Number|32|32.0||||||
4129507|NCT00909480|3954338|B1|India||Region of Enrolment||participants|Number|19|19.0||||||
4129508|NCT00909480|3954336|B3|Argentina||Region of Enrolment||participants|Number|21|21.0||||||
4129509|NCT00909480|3954337|B2|Argentina||Region of Enrolment||participants|Number|10|10.0||||||
4129510|NCT00909480|3954338|B1|Argentina||Region of Enrolment||participants|Number|11|11.0||||||
4129511|NCT00909480|3954336|B3|||Fasting Plasma Glucose (FPG)||mmol/L|Mean|8.56|8.56|Standard Deviation|2.24|2.24|||
4129512|NCT00909480|3954337|B2|||Fasting Plasma Glucose (FPG)||mmol/L|Mean|8.46|8.46|Standard Deviation|2.21|2.21|||
4129513|NCT00909480|3954338|B1|||Fasting Plasma Glucose (FPG)||mmol/L|Mean|8.66|8.66|Standard Deviation|2.26|2.26|||
4129514|NCT00909480|3954336|B3|||HbA1c (Glycosylated haemoglobin A1c)||Percent (%) glycosylated haemoglobin|Mean|7.91|7.91|Standard Deviation|0.6|0.6|||
4129515|NCT00909480|3954337|B2|||HbA1c (Glycosylated haemoglobin A1c)||Percent (%) glycosylated haemoglobin|Mean|7.86|7.86|Standard Deviation|0.58|0.58|||
4129516|NCT00909480|3954338|B1|||HbA1c (Glycosylated haemoglobin A1c)||Percent (%) glycosylated haemoglobin|Mean|7.96|7.96|Standard Deviation|0.62|0.62|||
4129517|NCT00909480|3954336|B3|||Body Mass Index (BMI)||kg/m^2|Mean|28.96|28.96|Standard Deviation|3.93|3.93|||
4129518|NCT00909480|3954337|B2|||Body Mass Index (BMI)||kg/m^2|Mean|29.06|29.06|Standard Deviation|3.9|3.9|||
4129519|NCT00909480|3954338|B1|||Body Mass Index (BMI)||kg/m^2|Mean|28.86|28.86|Standard Deviation|3.96|3.96|||
4129520|NCT00909480|3954336|B3|||Weight||kg|Mean|82.3|82.3|Standard Deviation|16.7|16.7|||
4129521|NCT00909480|3954337|B2|||Weight||kg|Mean|81.7|81.7|Standard Deviation|16.2|16.2|||
4129522|NCT00909480|3954338|B1|||Weight||kg|Mean|82.8|82.8|Standard Deviation|17.2|17.2|||
4129523|NCT00909480|3954336|B3|Not Applicable||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4129524|NCT00909480|3954337|B2|Not Applicable||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4129525|NCT00909480|3954338|B1|Not Applicable||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4129526|NCT00909480|3954336|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|314|314.0||||||
4129527|NCT00909480|3954337|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|150|150.0||||||
4129528|NCT00909480|3954338|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|164|164.0||||||
4129529|NCT00909480|3954336|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|107|107.0||||||
4129530|NCT00909480|3954337|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
4129531|NCT00909480|3954338|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4129532|NCT00909480|3954336|B3|Other||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4129533|NCT00909480|3954337|B2|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4129534|NCT00909480|3954338|B1|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4129535|NCT00909480|3954336|B3|White||Race/Ethnicity, Customized||participants|Number|267|267.0||||||
4129536|NCT00909480|3954337|B2|White||Race/Ethnicity, Customized||participants|Number|129|129.0||||||
4129537|NCT00909480|3954338|B1|White||Race/Ethnicity, Customized||participants|Number|138|138.0||||||
4129538|NCT00909480|3954336|B3|Native Hawaiian or pacific islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4129539|NCT00909480|3954337|B2|Native Hawaiian or pacific islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4129540|NCT00909480|3954338|B1|Native Hawaiian or pacific islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4129541|NCT00909480|3954336|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
4129542|NCT00909480|3954337|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4129543|NCT00909480|3954338|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4129544|NCT00909480|3954336|B3|Asian||Race/Ethnicity, Customized||participants|Number|116|116.0||||||
4129545|NCT00909480|3954337|B2|Asian||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
4129546|NCT00909480|3954338|B1|Asian||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
4129547|NCT00909480|3954336|B3|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4129548|NCT00909480|3954337|B2|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4129549|NCT00909480|3954338|B1|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4129550|NCT00909480|3954336|B3||Male|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
4129551|NCT00909480|3954337|B2||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4129552|NCT00909480|3954338|B1||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4129553|NCT00909480|3954336|B3||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4129554|NCT00909480|3954337|B2||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4129555|NCT00909480|3954338|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4129556|NCT00909480|3954336|B3|||Age||years|Mean|57.3|57.3|Standard Deviation|10.2|10.2|||
4129557|NCT00909480|3954337|B2|||Age||years|Mean|57.3|57.3|Standard Deviation|10.3|10.3|||
4129558|NCT00909480|3954338|B1|||Age||years|Mean|57.3|57.3|Standard Deviation|10.2|10.2|||
4129559|NCT00909428|3954371|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4129560|NCT00909428|3954372|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4129561|NCT00909428|3954373|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4129562|NCT00909428|3954374|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4129563|NCT00909428|3954371|B4||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4129564|NCT00909428|3954372|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4129565|NCT00909428|3954373|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4129566|NCT00909428|3954374|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4129567|NCT00909428|3954371|B4||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4129568|NCT00909428|3954372|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4129569|NCT00909428|3954373|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4129570|NCT00909428|3954374|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4129571|NCT00909428|3954371|B4||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4129572|NCT00909428|3954372|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4129573|NCT00909428|3954373|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4129574|NCT00909428|3954374|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4129575|NCT00909428|3954371|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4129576|NCT00909428|3954372|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4129577|NCT00909428|3954373|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4129578|NCT00909428|3954374|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4129579|NCT00909389|3954383|B1||Male|Sex: Female, Male||Participants|Count of Participants|2348|2348.0||||||
4129580|NCT00909389|3954383|B1||Female|Sex: Female, Male||Participants|Count of Participants|2400|2400.0||||||
4129581|NCT00909389|3954383|B1|||Age||years|Mean|55.53|55.53|Standard Deviation|11.71|11.71|||
4129582|NCT00909324|3954387|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4129583|NCT00909324|3954388|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4129584|NCT00909324|3954389|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4129585|NCT00909324|3954387|B3||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4129586|NCT00909324|3954388|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4129587|NCT00909324|3954389|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4129588|NCT00909324|3954387|B3|||Age||Years|Mean|26.10|26.1|Standard Deviation|4.93|4.93|||
4129589|NCT00909324|3954388|B2|||Age||Years|Mean|25.99|25.99|Standard Deviation|5.06|5.06|||
4129590|NCT00909324|3954389|B1|||Age||Years|Mean|26.24|26.24|Standard Deviation|4.81|4.81|||
4129591|NCT00909220|3954400|B3|United States||Region of Enrollment||participants|Number|77|77.0||||||
4129592|NCT00909220|3954401|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
4129593|NCT00909220|3954402|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4129594|NCT00909220|3954400|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4129595|NCT00909220|3954401|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4129596|NCT00909220|3954402|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4129597|NCT00909220|3954400|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4129598|NCT00909220|3954401|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4129599|NCT00909220|3954402|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4129600|NCT00909220|3954400|B3|||Age||years|Mean|35|35.0|Standard Deviation|13|13.0|||
4129601|NCT00909220|3954401|B2|||Age||years|Mean|35|35.0|Standard Deviation|14|14.0|||
4129602|NCT00909220|3954402|B1|||Age||years|Mean|36|36.0|Standard Deviation|12|12.0|||
4129603|NCT00909220|3954400|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4129604|NCT00909220|3954401|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4129605|NCT00909220|3954402|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4129606|NCT00909220|3954400|B3||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
4129607|NCT00909220|3954401|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4129608|NCT00909220|3954402|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4129609|NCT00909220|3954400|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4129610|NCT00909220|3954401|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4129611|NCT00909220|3954402|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4129612|NCT00909181|3954414|B4|||Number of incontinent episodes at baseline||Episodes|Mean|46.5|46.5|Standard Deviation|29.3|29.3|||
4129613|NCT00909181|3954415|B3|||Number of incontinent episodes at baseline||Episodes|Mean|45.8|45.8|Standard Deviation|28.9|28.9|||
4129614|NCT00909181|3954416|B2|||Number of incontinent episodes at baseline||Episodes|Mean|43.6|43.6|Standard Deviation|27.5|27.5|||
4129615|NCT00909181|3954417|B1|||Number of incontinent episodes at baseline||Episodes|Mean|50.1|50.1|Standard Deviation|32.5|32.5|||
4129616|NCT00909181|3954414|B4|United States||Region of Enrollment||participants|Number|626|626.0||||||
4129617|NCT00909181|3954415|B3|United States||Region of Enrollment||participants|Number|202|202.0||||||
4129618|NCT00909181|3954416|B2|United States||Region of Enrollment||participants|Number|214|214.0||||||
4129619|NCT00909181|3954417|B1|United States||Region of Enrollment||participants|Number|210|210.0||||||
4129620|NCT00909181|3954414|B4||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4129621|NCT00909181|3954415|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4129622|NCT00909181|3954416|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4129623|NCT00909181|3954417|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4129624|NCT00909181|3954414|B4||Female|Sex: Female, Male||Participants|Count of Participants|542|542.0||||||
4129625|NCT00909181|3954415|B3||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4129626|NCT00909181|3954416|B2||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4129627|NCT00909181|3954417|B1||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4129628|NCT00909181|3954414|B4|||Age||years|Mean|58.8|58.8|Standard Deviation|13.1|13.1|||
4129629|NCT00909181|3954415|B3|||Age||years|Mean|57.8|57.8|Standard Deviation|13.3|13.3|||
4129630|NCT00909181|3954416|B2|||Age||years|Mean|59.1|59.1|Standard Deviation|13.3|13.3|||
4129631|NCT00909181|3954417|B1|||Age||years|Mean|59.4|59.4|Standard Deviation|12.6|12.6|||
4129632|NCT00909181|3954414|B4||>=65 years|Age||Participants|Count of Participants|264|264.0||||||
4129633|NCT00909181|3954415|B3||>=65 years|Age||Participants|Count of Participants|82|82.0||||||
4129634|NCT00909181|3954416|B2||>=65 years|Age||Participants|Count of Participants|92|92.0||||||
4129635|NCT00909181|3954417|B1||>=65 years|Age||Participants|Count of Participants|90|90.0||||||
4129636|NCT00909181|3954414|B4||Between 18 and 65 years|Age||Participants|Count of Participants|362|362.0||||||
4129637|NCT00909181|3954415|B3||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
4129638|NCT00909181|3954416|B2||Between 18 and 65 years|Age||Participants|Count of Participants|122|122.0||||||
4129639|NCT00909181|3954417|B1||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
4129640|NCT00909181|3954414|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4129641|NCT00909181|3954415|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4129642|NCT00909181|3954416|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4129643|NCT00909181|3954417|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4129644|NCT00909155|3954427|B4|United States||Region of Enrollment||participants|Number|50|50.0||||||
4129645|NCT00909155|3954428|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4129646|NCT00909155|3954429|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4129647|NCT00909155|3954430|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4129648|NCT00909155|3954427|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4129649|NCT00909155|3954428|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4129650|NCT00909155|3954429|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4129651|NCT00909155|3954430|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4129652|NCT00909155|3954427|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4129653|NCT00909155|3954428|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4129654|NCT00909155|3954429|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4129655|NCT00909155|3954430|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4129656|NCT00909155|3954427|B4|||Age|Data from the fluoxetine and venlafaxine groups were combined for analysis as individual groups not large enough to provide sufficient statistical power to identify treatment differences between groups.|years|Mean|31.65|31.65|Standard Deviation|12.31|12.31|||
4129657|NCT00909155|3954428|B3|||Age|Data from the fluoxetine and venlafaxine groups were combined for analysis as individual groups not large enough to provide sufficient statistical power to identify treatment differences between groups.|years|Mean|31.31|31.31|Standard Deviation|14.22|14.22|||
4129658|NCT00909155|3954429|B2|||Age|Data from the fluoxetine and venlafaxine groups were combined for analysis as individual groups not large enough to provide sufficient statistical power to identify treatment differences between groups.|years|Mean|33.14|33.14|Standard Deviation|10.71|10.71|||
4129659|NCT00909155|3954430|B1|||Age|Data from the fluoxetine and venlafaxine groups were combined for analysis as individual groups not large enough to provide sufficient statistical power to identify treatment differences between groups.|years|Mean|30.74|30.74|Standard Deviation|11.46|11.46|||
4129660|NCT00909155|3954427|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4129661|NCT00909155|3954428|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4129662|NCT00909155|3954429|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4129663|NCT00909155|3954430|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4129664|NCT00909155|3954427|B4||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4129665|NCT00909155|3954428|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4129666|NCT00909155|3954429|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4129667|NCT00909155|3954430|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4129668|NCT00909155|3954427|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4129669|NCT00909155|3954428|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4129670|NCT00909155|3954429|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4129671|NCT00909155|3954430|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4129672|NCT00909064|3954443|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4129673|NCT00909064|3954443|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4129674|NCT00909064|3954443|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|9.4|9.4|||
4129675|NCT00909038|3954449|B1|HDL-Cholesterol ≤ 0.4 g/L||Cardiovascular risk factors (including the existence of a metabolic syndrome)|Number of Patients used in the analysis for Cardiovascular risk factors (including the existence of a metabolic syndrome) were 322 Participants with existence of a metabolic syndrome|Percentage of participants|Number|20.5|20.5||||||
4129676|NCT00909038|3954449|B1|LDL-Cholesterol ≥ 1.6 g/L||Cardiovascular risk factors (including the existence of a metabolic syndrome)|Number of Patients used in the analysis for Cardiovascular risk factors (including the existence of a metabolic syndrome) were 322 Participants with existence of a metabolic syndrome|Percentage of participants|Number|72.4|72.4||||||
4129677|NCT00909038|3954449|B1|Diabetes||Cardiovascular risk factors (including the existence of a metabolic syndrome)|Number of Patients used in the analysis for Cardiovascular risk factors (including the existence of a metabolic syndrome) were 322 Participants with existence of a metabolic syndrome|Percentage of participants|Number|54.3|54.3||||||
4129678|NCT00909038|3954449|B1|Family History||Cardiovascular risk factors (including the existence of a metabolic syndrome)|Number of Patients used in the analysis for Cardiovascular risk factors (including the existence of a metabolic syndrome) were 322 Participants with existence of a metabolic syndrome|Percentage of participants|Number|28.9|28.9||||||
4129679|NCT00909038|3954449|B1|Smoking||Cardiovascular risk factors (including the existence of a metabolic syndrome)|Number of Patients used in the analysis for Cardiovascular risk factors (including the existence of a metabolic syndrome) were 322 Participants with existence of a metabolic syndrome|Percentage of participants|Number|23.9|23.9||||||
4129680|NCT00909038|3954449|B1|Age (male>50 or female>60)||Cardiovascular risk factors (including the existence of a metabolic syndrome)|Number of Patients used in the analysis for Cardiovascular risk factors (including the existence of a metabolic syndrome) were 322 Participants with existence of a metabolic syndrome|Percentage of participants|Number|82.0|82.0||||||
4129681|NCT00909038|3954449|B1|To decrease the number of treatment||Conditions for prescribing 80 mg telmisartan in fixed combination with 25 mg HCTZ|"Conditions for prescribing 80 mg telmisartan in fixed combination with 25 mg HCTZ were ,~Lack of efficacy of previous treatments and To decrease the number of treatment administration throughout the day"|Percentage of participants|Number|33.1|33.1||||||
4129682|NCT00909038|3954449|B1|Lack of efficacy||Conditions for prescribing 80 mg telmisartan in fixed combination with 25 mg HCTZ|"Conditions for prescribing 80 mg telmisartan in fixed combination with 25 mg HCTZ were ,~Lack of efficacy of previous treatments and To decrease the number of treatment administration throughout the day"|Percentage of participants|Number|53.8|53.8||||||
4129683|NCT00909038|3954449|B1|Beta-blocker||Hypertension treatments prescribed prior to initiation of treatment|Hypertension treatments prescribed prior to initiation of treatment with telmisartan 80mg in a FDC with HCTZ 25 mg|Percentage of participants|Number|20.5|20.5||||||
4129684|NCT00909038|3954449|B1|Calcium channel blocker||Hypertension treatments prescribed prior to initiation of treatment|Hypertension treatments prescribed prior to initiation of treatment with telmisartan 80mg in a FDC with HCTZ 25 mg|Percentage of participants|Number|23.3|23.3||||||
4129685|NCT00909038|3954449|B1|Diuretic||Hypertension treatments prescribed prior to initiation of treatment|Hypertension treatments prescribed prior to initiation of treatment with telmisartan 80mg in a FDC with HCTZ 25 mg|Percentage of participants|Number|64.3|64.3||||||
4129686|NCT00909038|3954449|B1|Angiotensin II antagonist||Hypertension treatments prescribed prior to initiation of treatment|Hypertension treatments prescribed prior to initiation of treatment with telmisartan 80mg in a FDC with HCTZ 25 mg|Percentage of participants|Number|71.8|71.8||||||
4129687|NCT00909038|3954449|B1||Male|Sex: Female, Male||Participants|Count of Participants|1159|1159.0||||||
4129688|NCT00909038|3954449|B1||Female|Sex: Female, Male||Participants|Count of Participants|835|835.0||||||
4129689|NCT00909038|3954449|B1|||Age||years|Mean|63.5|63.5|Standard Deviation|10.6|10.6|||
4129690|NCT00908960|3954458|B4|United States||Region of Enrollment||Participants|Count of Participants|66|66.0||||||
4129691|NCT00908960|3954459|B3|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
4129692|NCT00908960|3954460|B2|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4129693|NCT00908960|3954461|B1|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4129694|NCT00908960|3954458|B4||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4129695|NCT00908960|3954459|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4129696|NCT00908960|3954460|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4129697|NCT00908960|3954461|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4129698|NCT00908960|3954458|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4129699|NCT00908960|3954459|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4129700|NCT00908960|3954460|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4129701|NCT00908960|3954461|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4129702|NCT00908960|3954458|B4|||Age||years|Mean|64.0|64.0|Standard Deviation|11.8|11.8|||
4129703|NCT00908960|3954459|B3|||Age||years|Mean|63.3|63.3|Standard Deviation|11.7|11.7|||
4129704|NCT00908960|3954460|B2|||Age||years|Mean|63.4|63.4|Standard Deviation|15.0|15.0|||
4129705|NCT00908960|3954461|B1|||Age||years|Mean|65.3|65.3|Standard Deviation|10.5|10.5|||
4129706|NCT00908960|3954458|B4||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
4129707|NCT00908960|3954459|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4129708|NCT00908960|3954460|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4129709|NCT00908960|3954461|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4129710|NCT00908960|3954458|B4||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4129711|NCT00908960|3954459|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4129712|NCT00908960|3954460|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4129713|NCT00908960|3954461|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4129714|NCT00908960|3954458|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4129715|NCT00908960|3954459|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4129716|NCT00908960|3954460|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4129717|NCT00908960|3954461|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4129718|NCT00908908|3954477|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4129719|NCT00908908|3954477|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4129720|NCT00908908|3954477|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4129721|NCT00908908|3954477|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4129722|NCT00908908|3954477|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4129723|NCT00908908|3954477|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4129724|NCT00908908|3954477|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4129725|NCT00908908|3954477|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4129726|NCT00908908|3954477|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4129727|NCT00908908|3954477|B1|||Age||years|Mean|57.5|57.5|Standard Deviation|13.4|13.4|||
4129728|NCT00908895|3954483|B3|Canada||Region of Enrollment||participants|Number|120|120.0||||||
4129729|NCT00908895|3954484|B2|Canada||Region of Enrollment||participants|Number|63|63.0||||||
4129730|NCT00908895|3954485|B1|Canada||Region of Enrollment||participants|Number|57|57.0||||||
4129731|NCT00908895|3954483|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4129732|NCT00908895|3954484|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4129733|NCT00908895|3954485|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4129734|NCT00908895|3954483|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4129735|NCT00908895|3954484|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4129736|NCT00908895|3954485|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4129737|NCT00908895|3954483|B3|||Age||years|Mean|55.6|55.6|Standard Deviation|18|18.0|||
4129738|NCT00908895|3954484|B2|||Age||years|Mean|54|54.0|Standard Deviation|16|16.0|||
4129739|NCT00908895|3954485|B1|||Age||years|Mean|57|57.0|Standard Deviation|19|19.0|||
4129740|NCT00908895|3954483|B3||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4129741|NCT00908895|3954484|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4129742|NCT00908895|3954485|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4129743|NCT00908895|3954483|B3||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
4129744|NCT00908895|3954484|B2||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4129745|NCT00908895|3954485|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4129746|NCT00908895|3954483|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4129747|NCT00908895|3954484|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4129748|NCT00908895|3954485|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4129749|NCT00908882|3954494|B3|||Fagerstrom Test of Nicotine Dependence|0-3 low dependence 4-6 medium dependence 7-10 high dependence|units on a scale|Mean|5.3|5.3|Standard Deviation|2.2|2.2|||
4129750|NCT00908882|3954495|B2|||Fagerstrom Test of Nicotine Dependence|0-3 low dependence 4-6 medium dependence 7-10 high dependence|units on a scale|Mean|5|5.0|Standard Deviation|2.3|2.3|||
4129751|NCT00908882|3954496|B1|||Fagerstrom Test of Nicotine Dependence|0-3 low dependence 4-6 medium dependence 7-10 high dependence|units on a scale|Mean|5.4|5.4|Standard Deviation|2|2.0|||
4129752|NCT00908882|3954494|B3|||Geriatric Depression Scale|Range 1-15; > 6 indicates probably depression|units on a scale|Mean|9.1|9.1|Standard Deviation|3.7|3.7|||
4129753|NCT00908882|3954495|B2|||Geriatric Depression Scale|Range 1-15; > 6 indicates probably depression|units on a scale|Mean|9.2|9.2|Standard Deviation|3.8|3.8|||
4129754|NCT00908882|3954496|B1|||Geriatric Depression Scale|Range 1-15; > 6 indicates probably depression|units on a scale|Mean|8.9|8.9|Standard Deviation|3.7|3.7|||
4129755|NCT00908882|3954494|B3|||Post Traumatic Stress Disorder Checklist|Range 17-85; > 50 indicates PTSD diagnosis|units on a scale|Mean|58.8|58.8|Standard Deviation|11.5|11.5|||
4129756|NCT00908882|3954495|B2|||Post Traumatic Stress Disorder Checklist|Range 17-85; > 50 indicates PTSD diagnosis|units on a scale|Mean|60|60.0|Standard Deviation|11|11.0|||
4129757|NCT00908882|3954496|B1|||Post Traumatic Stress Disorder Checklist|Range 17-85; > 50 indicates PTSD diagnosis|units on a scale|Mean|57|57.0|Standard Deviation|11.9|11.9|||
4129758|NCT00908882|3954494|B3|United States||Region of Enrollment||participants|Number|175|175.0||||||
4129759|NCT00908882|3954495|B2|United States||Region of Enrollment||participants|Number|86|86.0||||||
4129760|NCT00908882|3954496|B1|United States||Region of Enrollment||participants|Number|89|89.0||||||
4129761|NCT00908882|3954494|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4129762|NCT00908882|3954495|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4129763|NCT00908882|3954496|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4129764|NCT00908882|3954494|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4129765|NCT00908882|3954495|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4129766|NCT00908882|3954496|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4129767|NCT00908882|3954494|B3||White|Race (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
4129768|NCT00908882|3954495|B2||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4129769|NCT00908882|3954496|B1||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4129770|NCT00908882|3954494|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4129771|NCT00908882|3954495|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4129772|NCT00908882|3954496|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4129773|NCT00908882|3954494|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4129774|NCT00908882|3954495|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4129775|NCT00908882|3954496|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4129776|NCT00908882|3954494|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4129777|NCT00908882|3954495|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4129778|NCT00908882|3954496|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4129779|NCT00908882|3954494|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4129780|NCT00908882|3954495|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4129781|NCT00908882|3954496|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4129782|NCT00908882|3954494|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4129783|NCT00908882|3954495|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4129784|NCT00908882|3954496|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4129785|NCT00908882|3954494|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|154|154.0||||||
4129786|NCT00908882|3954495|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
4129787|NCT00908882|3954496|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
4129788|NCT00908882|3954494|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4129789|NCT00908882|3954495|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4129790|NCT00908882|3954496|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4129791|NCT00908882|3954494|B3||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4129792|NCT00908882|3954495|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4129793|NCT00908882|3954496|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4129794|NCT00908882|3954494|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4129795|NCT00908882|3954495|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4129796|NCT00908882|3954496|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4129797|NCT00908882|3954494|B3|||Age||years|Mean|55.6|55.6|Standard Deviation|11.0|11.0|||
4129798|NCT00908882|3954495|B2|||Age||years|Mean|57|57.0|Standard Deviation|10.8|10.8|||
4129799|NCT00908882|3954496|B1|||Age||years|Mean|55|55.0|Standard Deviation|11.2|11.2|||
4129800|NCT00908830|3954521|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4129801|NCT00908830|3954522|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4129802|NCT00908830|3954523|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4129803|NCT00908830|3954521|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4129804|NCT00908830|3954522|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4129805|NCT00908830|3954523|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4129806|NCT00908830|3954521|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4129807|NCT00908830|3954522|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4129808|NCT00908830|3954523|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4129809|NCT00908830|3954521|B3|||Age||years|Mean|45.0|45.0|Standard Deviation|16.9|16.9|||
4129810|NCT00908830|3954522|B2|||Age||years|Mean|59.4|59.4|Standard Deviation|9.0|9.0|||
4129811|NCT00908830|3954523|B1|||Age||years|Mean|30.6|30.6|Standard Deviation|6.8|6.8|||
4129812|NCT00908687|3954532|B7||Male|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4129813|NCT00908687|3954533|B6||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4129814|NCT00908687|3954534|B5||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4129815|NCT00908687|3954535|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4129816|NCT00908687|3954536|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4129817|NCT00908687|3954537|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4129818|NCT00908687|3954538|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4129819|NCT00908687|3954532|B7||Female|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
4129820|NCT00908687|3954533|B6||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4129821|NCT00908687|3954534|B5||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4129822|NCT00908687|3954535|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4129823|NCT00908687|3954536|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4129824|NCT00908687|3954537|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4129825|NCT00908687|3954538|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4129826|NCT00908687|3954532|B7|||Age||years|Mean|30.1|30.1|Standard Deviation|9.2|9.2|||
4129827|NCT00908687|3954533|B6|||Age||years|Mean|30.8|30.8|Standard Deviation|8.3|8.3|||
4129828|NCT00908687|3954534|B5|||Age||years|Mean|28.1|28.1|Standard Deviation|8.2|8.2|||
4129829|NCT00908687|3954535|B4|||Age||years|Mean|30.5|30.5|Standard Deviation|8.7|8.7|||
4129830|NCT00908687|3954536|B3|||Age||years|Mean|31.3|31.3|Standard Deviation|10.4|10.4|||
4129831|NCT00908687|3954537|B2|||Age||years|Mean|29.8|29.8|Standard Deviation|9.6|9.6|||
4129832|NCT00908687|3954538|B1|||Age||years|Mean|30.9|30.9|Standard Deviation|9.7|9.7|||
4129833|NCT00908648|3954557|B3||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4129834|NCT00908648|3954558|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4129835|NCT00908648|3954559|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4129836|NCT00908648|3954557|B3||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4129837|NCT00908648|3954558|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4129838|NCT00908648|3954559|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4129839|NCT00908648|3954557|B3|||Age||years|Mean|60.8|60.8|Standard Deviation|5.4|5.4|||
4129840|NCT00908648|3954558|B2|||Age||years|Mean|59.6|59.6|Standard Deviation|5.3|5.3|||
4129841|NCT00908648|3954559|B1|||Age||years|Mean|61.1|61.1|Standard Deviation|5.8|5.8|||
4129842|NCT00908648|3954557|B3||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
4129843|NCT00908648|3954558|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4129844|NCT00908648|3954559|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4129845|NCT00908648|3954557|B3||Between 18 and 65 years|Age||Participants|Count of Participants|178|178.0||||||
4129846|NCT00908648|3954558|B2||Between 18 and 65 years|Age||Participants|Count of Participants|88|88.0||||||
4129847|NCT00908648|3954559|B1||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
4129848|NCT00908648|3954557|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4129849|NCT00908648|3954558|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4129850|NCT00908648|3954559|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4129851|NCT00908596|3954566|B5|other||Race/Ethnicity, Customized||Participants|Number|47|47.0||||||
4129852|NCT00908596|3954567|B4|other||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4129853|NCT00908596|3954568|B3|other||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
4129854|NCT00908596|3954569|B2|other||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4129855|NCT00908596|3954570|B1|other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4129856|NCT00908596|3954566|B5|Asian||Race/Ethnicity, Customized||Participants|Number|107|107.0||||||
4129857|NCT00908596|3954567|B4|Asian||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4129858|NCT00908596|3954568|B3|Asian||Race/Ethnicity, Customized||Participants|Number|56|56.0||||||
4129859|NCT00908596|3954569|B2|Asian||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4129860|NCT00908596|3954570|B1|Asian||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
4129861|NCT00908596|3954566|B5|Hispanic||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4129862|NCT00908596|3954567|B4|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4129863|NCT00908596|3954568|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4129864|NCT00908596|3954569|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4129865|NCT00908596|3954570|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4129866|NCT00908596|3954566|B5|Black||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4129867|NCT00908596|3954567|B4|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4129868|NCT00908596|3954568|B3|Black||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4129869|NCT00908596|3954569|B2|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4129870|NCT00908596|3954570|B1|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4129871|NCT00908596|3954566|B5|Caucasian||Race/Ethnicity, Customized||Participants|Number|188|188.0||||||
4129872|NCT00908596|3954567|B4|Caucasian||Race/Ethnicity, Customized||Participants|Number|63|63.0||||||
4129873|NCT00908596|3954568|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|101|101.0||||||
4129874|NCT00908596|3954569|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4129875|NCT00908596|3954570|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4129876|NCT00908596|3954566|B5||Male|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
4129877|NCT00908596|3954567|B4||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4129878|NCT00908596|3954568|B3||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4129879|NCT00908596|3954569|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4129880|NCT00908596|3954570|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4129881|NCT00908596|3954566|B5||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4129882|NCT00908596|3954567|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4129883|NCT00908596|3954568|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4129884|NCT00908596|3954569|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4129885|NCT00908596|3954570|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4129886|NCT00908596|3954566|B5|||Age||Years|Mean|64.7|64.7|Standard Deviation|11.56|11.56|||
4129887|NCT00908596|3954567|B4|||Age||Years|Mean|62.2|62.2|Standard Deviation|13.83|13.83|||
4129888|NCT00908596|3954568|B3|||Age||Years|Mean|65.5|65.5|Standard Deviation|10.88|10.88|||
4129889|NCT00908596|3954569|B2|||Age||Years|Mean|65.3|65.3|Standard Deviation|12.03|12.03|||
4129890|NCT00908596|3954570|B1|||Age||Years|Mean|65.3|65.3|Standard Deviation|9.55|9.55|||
4129891|NCT00908583|3954603|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4129892|NCT00908583|3954603|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4129893|NCT00908583|3954603|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4129894|NCT00908583|3954603|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4129895|NCT00908583|3954603|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4129896|NCT00908583|3954603|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4129897|NCT00908583|3954603|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4129898|NCT00908583|3954603|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4129899|NCT00908583|3954603|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4129900|NCT00908583|3954603|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4129901|NCT00908583|3954603|B1|||Age||years|Mean|45.2|45.2|Standard Deviation|10.2|10.2|||
4129902|NCT00908466|3954621|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4129903|NCT00908466|3954622|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4129904|NCT00908466|3954623|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4129905|NCT00908466|3954621|B3|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4129906|NCT00908466|3954622|B2|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4129907|NCT00908466|3954623|B1|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4129908|NCT00908466|3954621|B3|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4129909|NCT00908466|3954622|B2|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4129910|NCT00908466|3954623|B1|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4129911|NCT00908466|3954621|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4129912|NCT00908466|3954622|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4129913|NCT00908466|3954623|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4129914|NCT00908466|3954621|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4129915|NCT00908466|3954622|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4129916|NCT00908466|3954623|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4129917|NCT00908466|3954621|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4129918|NCT00908466|3954622|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4129919|NCT00908466|3954623|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4129920|NCT00908466|3954621|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4129921|NCT00908466|3954622|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4129922|NCT00908466|3954623|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4129923|NCT00908466|3954621|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4129924|NCT00908466|3954622|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4129925|NCT00908466|3954623|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4129926|NCT00908466|3954621|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4129927|NCT00908466|3954622|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4129928|NCT00908466|3954623|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4129929|NCT00908466|3954621|B3|||Age||years|Mean|47|47.0|Standard Deviation|18.8|18.8|||
4129930|NCT00908466|3954622|B2|||Age||years|Mean|48|48.0|Standard Deviation|18.2|18.2|||
4129931|NCT00908466|3954623|B1|||Age||years|Mean|45|45.0|Standard Deviation|19.8|19.8|||
4129932|NCT00908388|3954630|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4129933|NCT00908388|3954630|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4129934|NCT00908388|3954630|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4129935|NCT00908388|3954630|B1|||Age||years|Mean|57.1|57.1|Standard Deviation|11.6|11.6|||
4129936|NCT00908375|3954638|B3|||Pain Score (Numeric Rating Scale , 0-10)|Numeric Rating Pain scale ranging from 0 (no pain) to 10 (worst pain imaginable).|units on a scale|Median|6|6.0|Inter-Quartile Range|||4.0|7.0|
4129937|NCT00908375|3954639|B2|||Pain Score (Numeric Rating Scale , 0-10)|Numeric Rating Pain scale ranging from 0 (no pain) to 10 (worst pain imaginable).|units on a scale|Median|6|6.0|Inter-Quartile Range|||3.0|7.0|
4129938|NCT00908375|3954640|B1|||Pain Score (Numeric Rating Scale , 0-10)|Numeric Rating Pain scale ranging from 0 (no pain) to 10 (worst pain imaginable).|units on a scale|Median|6.5|6.5|Inter-Quartile Range|||4.5|7.0|
4129939|NCT00908375|3954638|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4129940|NCT00908375|3954639|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4129941|NCT00908375|3954640|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4129942|NCT00908375|3954638|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4129943|NCT00908375|3954639|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4129944|NCT00908375|3954640|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4129945|NCT00908375|3954638|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4129946|NCT00908375|3954639|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4129947|NCT00908375|3954640|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4129948|NCT00908375|3954638|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4129949|NCT00908375|3954639|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4129950|NCT00908375|3954640|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4129951|NCT00908375|3954638|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4129952|NCT00908375|3954639|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4129953|NCT00908375|3954640|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4129954|NCT00908375|3954638|B3|||Age||years|Mean|45|45.0|Standard Deviation|11.78|11.78|||
4129955|NCT00908375|3954639|B2|||Age||years|Mean|44|44.0|Standard Deviation|13.38|13.38|||
4129956|NCT00908375|3954640|B1|||Age||years|Mean|47|47.0|Standard Deviation|10.17|10.17|||
4129957|NCT00908349|3954651|B1|Bulgaria||Region of Enrollment||participants|Number|26|26.0||||||
4129958|NCT00908349|3954651|B1|Russian Federation||Region of Enrollment||participants|Number|64|64.0||||||
4129959|NCT00908349|3954651|B1|Croatia||Region of Enrollment||participants|Number|6|6.0||||||
4129960|NCT00908349|3954651|B1|Romania||Region of Enrollment||participants|Number|12|12.0||||||
4129961|NCT00908349|3954651|B1|Poland||Region of Enrollment||participants|Number|31|31.0||||||
4129962|NCT00908349|3954651|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4129963|NCT00908349|3954651|B1|Mexico||Region of Enrollment||participants|Number|30|30.0||||||
4129964|NCT00908349|3954651|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4129965|NCT00908349|3954651|B1||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4129966|NCT00908349|3954651|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4129967|NCT00908349|3954651|B1|||Age||Years|Mean|37.4|37.4|Full Range|||18.0|67.0|
4129968|NCT00908310|3954655|B1|Taiwan||Region of Enrollment||participants|Number|77|77.0||||||
4129969|NCT00908310|3954655|B1|Spain||Region of Enrollment||participants|Number|12|12.0||||||
4129970|NCT00908310|3954655|B1|India||Region of Enrollment||participants|Number|10|10.0||||||
4129971|NCT00908310|3954655|B1|China||Region of Enrollment||participants|Number|62|62.0||||||
4129972|NCT00908310|3954655|B1|Canada||Region of Enrollment||participants|Number|28|28.0||||||
4129973|NCT00908310|3954655|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4129974|NCT00908310|3954655|B1||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4129975|NCT00908310|3954655|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4129976|NCT00908310|3954655|B1||>=65 years|Age||Participants|Count of Participants|118|118.0||||||
4129977|NCT00908310|3954655|B1||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
4129978|NCT00908310|3954655|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4129979|NCT00908310|3954655|B1|||Age||years|Mean|67.2|67.2|Standard Deviation|12.41|12.41|||
4129980|NCT00908232|3954659|B1|United Kingdom||Region of Enrollment||participants|Number|21|21.0||||||
4129981|NCT00908232|3954659|B1|Turkey||Region of Enrollment||participants|Number|19|19.0||||||
4129982|NCT00908232|3954659|B1|Spain||Region of Enrollment||participants|Number|20|20.0||||||
4129983|NCT00908232|3954659|B1|Serbia||Region of Enrollment||participants|Number|15|15.0||||||
4129984|NCT00908232|3954659|B1|Poland||Region of Enrollment||participants|Number|19|19.0||||||
4129985|NCT00908232|3954659|B1|Lithuania||Region of Enrollment||participants|Number|9|9.0||||||
4129986|NCT00908232|3954659|B1|Hungary||Region of Enrollment||participants|Number|2|2.0||||||
4129987|NCT00908232|3954659|B1|Greece||Region of Enrollment||participants|Number|23|23.0||||||
4129988|NCT00908232|3954659|B1|Germany||Region of Enrollment||participants|Number|15|15.0||||||
4129989|NCT00908232|3954659|B1|France||Region of Enrollment||participants|Number|20|20.0||||||
4129990|NCT00908232|3954659|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4129991|NCT00908232|3954659|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4129992|NCT00908232|3954659|B1|||Age||years|Mean|63.7|63.7|Standard Deviation|11.04|11.04|||
4129993|NCT00908141|3954678|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4129994|NCT00908141|3954679|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4129995|NCT00908141|3954680|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4129996|NCT00908141|3954678|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4129997|NCT00908141|3954679|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4129998|NCT00908141|3954680|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4129999|NCT00908141|3954678|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4130000|NCT00908141|3954679|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4130001|NCT00908141|3954680|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4130002|NCT00908141|3954678|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4130003|NCT00908141|3954679|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4130004|NCT00908141|3954680|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4130005|NCT00908141|3954678|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4130006|NCT00908141|3954679|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4130007|NCT00908141|3954680|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4130008|NCT00908141|3954678|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4130009|NCT00908141|3954679|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4130010|NCT00908141|3954680|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4130011|NCT00908141|3954678|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4130012|NCT00908141|3954679|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4130013|NCT00908141|3954680|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4130014|NCT00908141|3954678|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4130015|NCT00908141|3954679|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4130016|NCT00908141|3954680|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4130017|NCT00908141|3954678|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4130018|NCT00908141|3954679|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4130019|NCT00908141|3954680|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4130020|NCT00908141|3954678|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4130021|NCT00908141|3954679|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4130022|NCT00908141|3954680|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4130023|NCT00908141|3954678|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4130024|NCT00908141|3954679|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4130025|NCT00908141|3954680|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4130026|NCT00908141|3954678|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4130027|NCT00908141|3954679|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4130028|NCT00908141|3954680|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4130029|NCT00908141|3954678|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4130030|NCT00908141|3954679|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4130031|NCT00908141|3954680|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4130032|NCT00908141|3954678|B3|70-79 years||Age, Customized||participants|Number|6|6.0||||||
4130033|NCT00908141|3954679|B2|70-79 years||Age, Customized||participants|Number|3|3.0||||||
4130034|NCT00908141|3954680|B1|70-79 years||Age, Customized||participants|Number|3|3.0||||||
4130035|NCT00908141|3954678|B3|60-69 years||Age, Customized||participants|Number|6|6.0||||||
4130036|NCT00908141|3954679|B2|60-69 years||Age, Customized||participants|Number|4|4.0||||||
4130037|NCT00908141|3954680|B1|60-69 years||Age, Customized||participants|Number|2|2.0||||||
4130038|NCT00908141|3954678|B3|50-59 years||Age, Customized||participants|Number|4|4.0||||||
4130039|NCT00908141|3954679|B2|50-59 years||Age, Customized||participants|Number|2|2.0||||||
4130040|NCT00908141|3954680|B1|50-59 years||Age, Customized||participants|Number|2|2.0||||||
4130041|NCT00908141|3954678|B3|40-49 years||Age, Customized||participants|Number|1|1.0||||||
4130042|NCT00908141|3954679|B2|40-49 years||Age, Customized||participants|Number|0|0.0||||||
4130043|NCT00908141|3954680|B1|40-49 years||Age, Customized||participants|Number|1|1.0||||||
4130044|NCT00908128|3954687|B3|Canada||Region of Enrollment||participants|Number|40|40.0||||||
4130045|NCT00908128|3954688|B2|Canada||Region of Enrollment||participants|Number|20|20.0||||||
4130046|NCT00908128|3954689|B1|Canada||Region of Enrollment||participants|Number|20|20.0||||||
4130047|NCT00908128|3954687|B3|Asian||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4130048|NCT00908128|3954688|B2|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4130049|NCT00908128|3954689|B1|Asian||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4130050|NCT00908128|3954687|B3|Black||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4130051|NCT00908128|3954688|B2|Black||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4130052|NCT00908128|3954689|B1|Black||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4130053|NCT00908128|3954687|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
4130054|NCT00908128|3954688|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4130055|NCT00908128|3954689|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4130056|NCT00908128|3954687|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4130057|NCT00908128|3954688|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4130058|NCT00908128|3954689|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4130059|NCT00908128|3954687|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4130060|NCT00908128|3954688|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4130061|NCT00908128|3954689|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4130062|NCT00908128|3954687|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4130063|NCT00908128|3954688|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4130064|NCT00908128|3954689|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4130065|NCT00908128|3954687|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4130066|NCT00908128|3954688|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4130067|NCT00908128|3954689|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4130068|NCT00908128|3954687|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4130069|NCT00908128|3954688|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4130070|NCT00908128|3954689|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4130071|NCT00908115|3954698|B1||Male|Sex: Female, Male||Participants|Count of Participants|643|643.0||||||
4130072|NCT00908115|3954698|B1||Female|Sex: Female, Male||Participants|Count of Participants|615|615.0||||||
4130073|NCT00908115|3954698|B1|||Age||months|Mean|5.0|5.0|Standard Deviation|8.44|8.44|||
4130074|NCT00908076|3954704|B3|||PD duration||years|Mean|9.2|9.2|Standard Deviation|6.3|6.3|||
4130075|NCT00908076|3954705|B2|||PD duration||years|Mean|9.5|9.5|Standard Deviation|6.3|6.3|||
4130076|NCT00908076|3954706|B1|||PD duration||years|Mean|8.9|8.9|Standard Deviation|6.3|6.3|||
4130077|NCT00908076|3954704|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
4130078|NCT00908076|3954705|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4130079|NCT00908076|3954706|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4130080|NCT00908076|3954704|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4130081|NCT00908076|3954705|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4130082|NCT00908076|3954706|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4130083|NCT00908076|3954704|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4130084|NCT00908076|3954705|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4130085|NCT00908076|3954706|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4130086|NCT00908076|3954704|B3|||Age||years|Mean|68.0|68.0|Standard Deviation|10.15|10.15|||
4130087|NCT00908076|3954705|B2|||Age||years|Mean|70.1|70.1|Standard Deviation|12.2|12.2|||
4130088|NCT00908076|3954706|B1|||Age||years|Mean|67.3|67.3|Standard Deviation|8.1|8.1|||
4130089|NCT00908037|3954713|B8|Mixed Race||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4130090|NCT00908037|3954714|B7|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4130091|NCT00908037|3954715|B6|Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4130092|NCT00908037|3954716|B5|Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4130093|NCT00908037|3954717|B4|Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4130094|NCT00908037|3954718|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4130095|NCT00908037|3954719|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4130096|NCT00908037|3954720|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4130097|NCT00908037|3954713|B8|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4130098|NCT00908037|3954714|B7|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4130099|NCT00908037|3954715|B6|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4130100|NCT00908037|3954716|B5|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4130101|NCT00908037|3954717|B4|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4130102|NCT00908037|3954718|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4130103|NCT00908037|3954719|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4130104|NCT00908037|3954720|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4130105|NCT00908037|3954713|B8|Unknown||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4130106|NCT00908037|3954714|B7|Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4130107|NCT00908037|3954715|B6|Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4130108|NCT00908037|3954716|B5|Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4130109|NCT00908037|3954717|B4|Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4130110|NCT00908037|3954718|B3|Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4130111|NCT00908037|3954719|B2|Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4130112|NCT00908037|3954720|B1|Unknown||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4130113|NCT00908037|3954713|B8|White – White/Caucasian/European||Race/Ethnicity, Customized||Participants|Number|67|67.0||||||
4130114|NCT00908037|3954714|B7|White – White/Caucasian/European||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4130115|NCT00908037|3954715|B6|White – White/Caucasian/European||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4130116|NCT00908037|3954716|B5|White – White/Caucasian/European||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4130117|NCT00908037|3954717|B4|White – White/Caucasian/European||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4130118|NCT00908037|3954718|B3|White – White/Caucasian/European||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4130119|NCT00908037|3954719|B2|White – White/Caucasian/European||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4130120|NCT00908037|3954720|B1|White – White/Caucasian/European||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4130121|NCT00908037|3954713|B8|Asian – Japanese/East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4130122|NCT00908037|3954714|B7|Asian – Japanese/East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4130123|NCT00908037|3954715|B6|Asian – Japanese/East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4130124|NCT00908037|3954716|B5|Asian – Japanese/East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4130125|NCT00908037|3954717|B4|Asian – Japanese/East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4130126|NCT00908037|3954718|B3|Asian – Japanese/East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4130127|NCT00908037|3954719|B2|Asian – Japanese/East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4130128|NCT00908037|3954720|B1|Asian – Japanese/East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4130129|NCT00908037|3954713|B8|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4130130|NCT00908037|3954714|B7|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4130131|NCT00908037|3954715|B6|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4130132|NCT00908037|3954716|B5|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4130133|NCT00908037|3954717|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4130134|NCT00908037|3954718|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4130135|NCT00908037|3954719|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4130136|NCT00908037|3954720|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4130137|NCT00908037|3954713|B8||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4130138|NCT00908037|3954714|B7||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4130139|NCT00908037|3954715|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4130140|NCT00908037|3954716|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4130141|NCT00908037|3954717|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4130142|NCT00908037|3954718|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4130143|NCT00908037|3954719|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4130144|NCT00908037|3954720|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4130145|NCT00908037|3954713|B8||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4130146|NCT00908037|3954714|B7||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4130147|NCT00908037|3954715|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4130148|NCT00908037|3954716|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4130149|NCT00908037|3954717|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4130150|NCT00908037|3954718|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4130151|NCT00908037|3954719|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4130152|NCT00908037|3954720|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4130153|NCT00908037|3954713|B8|||Age||Years|Mean|9.3|9.3|Standard Deviation|4.49|4.49|||
4130154|NCT00908037|3954714|B7|||Age||Years|Mean|3.3|3.3|Standard Deviation|1.34|1.34|||
4130155|NCT00908037|3954715|B6|||Age||Years|Mean|3.6|3.6|Standard Deviation|1.34|1.34|||
4130156|NCT00908037|3954716|B5|||Age||Years|Mean|8.2|8.2|Standard Deviation|1.87|1.87|||
4130157|NCT00908037|3954717|B4|||Age||Years|Mean|8.6|8.6|Standard Deviation|2.24|2.24|||
4130158|NCT00908037|3954718|B3|||Age||Years|Mean|13.7|13.7|Standard Deviation|1.58|1.58|||
4130159|NCT00908037|3954719|B2|||Age||Years|Mean|14.6|14.6|Standard Deviation|1.69|1.69|||
4130160|NCT00908037|3954720|B1|||Age||Years|Mean|9.1|9.1|Standard Deviation|4.61|4.61|||
4130161|NCT00908011|3954878|B3|Canada||Region of Enrollment||participants|Number|43|43.0||||||
4130162|NCT00908011|3954879|B2|Canada||Region of Enrollment||participants|Number|20|20.0||||||
4130163|NCT00908011|3954880|B1|Canada||Region of Enrollment||participants|Number|23|23.0||||||
4130164|NCT00908011|3954878|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4130165|NCT00908011|3954879|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4130166|NCT00908011|3954880|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4130167|NCT00908011|3954878|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4130168|NCT00908011|3954879|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4130169|NCT00908011|3954880|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4130170|NCT00908011|3954878|B3|||Age||Years|Mean|57|57.0|Standard Deviation|8.6|8.6|||
4130171|NCT00908011|3954879|B2|||Age||Years|Mean|57.0|57.0|Standard Deviation|9.9|9.9|||
4130172|NCT00908011|3954880|B1|||Age||Years|Mean|56.5|56.5|Standard Deviation|7.4|7.4|||
4130173|NCT00908011|3954878|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4130174|NCT00908011|3954879|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4130175|NCT00908011|3954880|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4130176|NCT00908011|3954878|B3||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4130177|NCT00908011|3954879|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4130178|NCT00908011|3954880|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4130179|NCT00908011|3954878|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4130180|NCT00908011|3954879|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4130181|NCT00908011|3954880|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4130182|NCT00907907|3954887|B3|Canada||Region of Enrollment||participants|Number|40|40.0||||||
4130183|NCT00907907|3954888|B2|Canada||Region of Enrollment||participants|Number|20|20.0||||||
4130184|NCT00907907|3954889|B1|Canada||Region of Enrollment||participants|Number|20|20.0||||||
4130185|NCT00907907|3954887|B3|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4130186|NCT00907907|3954888|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4130187|NCT00907907|3954889|B1|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4130188|NCT00907907|3954887|B3|Black||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4130189|NCT00907907|3954888|B2|Black||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4130190|NCT00907907|3954889|B1|Black||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4130191|NCT00907907|3954887|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
4130192|NCT00907907|3954888|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4130193|NCT00907907|3954889|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4130194|NCT00907907|3954887|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4130195|NCT00907907|3954888|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4130196|NCT00907907|3954889|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4130197|NCT00907907|3954887|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4130198|NCT00907907|3954888|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4130199|NCT00907907|3954889|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4130200|NCT00907907|3954887|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4130201|NCT00907907|3954888|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4130202|NCT00907907|3954889|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4130203|NCT00907907|3954887|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4130204|NCT00907907|3954888|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4130205|NCT00907907|3954889|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4130206|NCT00907907|3954887|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4130207|NCT00907907|3954888|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4130208|NCT00907907|3954889|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4130209|NCT00907881|3954898|B1|India||Region of Enrollment||participants|Number|1069|1069.0||||||
4130210|NCT00907881|3954898|B1|Missing||Sex/Gender, Customized||participants|Number|8|8.0||||||
4130211|NCT00907881|3954898|B1|Male||Sex/Gender, Customized||participants|Number|589|589.0||||||
4130212|NCT00907881|3954898|B1|Female||Sex/Gender, Customized||participants|Number|472|472.0||||||
4130213|NCT00907881|3954898|B1|||Age|Age was missing for 1 participant; therefore, the population for age included 1068 participants.|years|Mean|52.21|52.21|Standard Deviation|10.70|10.7|||
4130214|NCT00907803|3954905|B4|United States||Region of Enrollment||participants|Number|107|107.0||||||
4130215|NCT00907803|3954906|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4130216|NCT00907803|3954907|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
4130217|NCT00907803|3954908|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4130218|NCT00907803|3954905|B4||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4130219|NCT00907803|3954906|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4130220|NCT00907803|3954907|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4130221|NCT00907803|3954908|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4130222|NCT00907803|3954905|B4||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4130223|NCT00907803|3954906|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4130224|NCT00907803|3954907|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4130225|NCT00907803|3954908|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4130226|NCT00907803|3954905|B4|||Age||years|Mean|42.5|42.5|Standard Deviation|15.64|15.64|||
4130227|NCT00907803|3954906|B3|||Age||years|Mean|42.5|42.5|Standard Deviation|17.03|17.03|||
4130228|NCT00907803|3954907|B2|||Age||years|Mean|43.7|43.7|Standard Deviation|15.81|15.81|||
4130229|NCT00907803|3954908|B1|||Age||years|Mean|41.3|41.3|Standard Deviation|15.22|15.22|||
4130230|NCT00907803|3954905|B4||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4130231|NCT00907803|3954906|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4130232|NCT00907803|3954907|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4130233|NCT00907803|3954908|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4130234|NCT00907803|3954905|B4||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
4130235|NCT00907803|3954906|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4130236|NCT00907803|3954907|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4130237|NCT00907803|3954908|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4130238|NCT00907803|3954905|B4||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4130239|NCT00907803|3954906|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4130240|NCT00907803|3954907|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4130241|NCT00907803|3954908|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4130242|NCT00907777|3954939|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4130243|NCT00907777|3954940|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4130244|NCT00907777|3954941|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4130245|NCT00907777|3954939|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4130246|NCT00907777|3954940|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4130247|NCT00907777|3954941|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4130248|NCT00907777|3954939|B3|||Age||Months|Mean|46.65|46.65|Standard Deviation|0.81|0.81|||
4130249|NCT00907777|3954940|B2|||Age||Months|Mean|46.7|46.7|Standard Deviation|0.72|0.72|||
4130250|NCT00907777|3954941|B1|||Age||Months|Mean|46.6|46.6|Standard Deviation|0.91|0.91|||
4130251|NCT00907738|3954964|B6||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4130252|NCT00907738|3954965|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4130253|NCT00907738|3954966|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4130254|NCT00907738|3954967|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4130255|NCT00907738|3954968|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4130256|NCT00907738|3954969|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4130257|NCT00907738|3954964|B6||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4130258|NCT00907738|3954965|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4130259|NCT00907738|3954966|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4130260|NCT00907738|3954967|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4130261|NCT00907738|3954968|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4130262|NCT00907738|3954969|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4130263|NCT00907738|3954964|B6|||Age, Customized|All participants were at least 18 years of age.|Participants|Number|27|27.0||||||
4130264|NCT00907738|3954965|B5|||Age, Customized|All participants were at least 18 years of age.|Participants|Number|2|2.0||||||
4130265|NCT00907738|3954966|B4|||Age, Customized|All participants were at least 18 years of age.|Participants|Number|4|4.0||||||
4130266|NCT00907738|3954967|B3|||Age, Customized|All participants were at least 18 years of age.|Participants|Number|7|7.0||||||
4130267|NCT00907738|3954968|B2|||Age, Customized|All participants were at least 18 years of age.|Participants|Number|1|1.0||||||
4130268|NCT00907738|3954969|B1|||Age, Customized|All participants were at least 18 years of age.|Participants|Number|13|13.0||||||
4130269|NCT00907621|3954989|B3|||baseline crying time in minutes|Daily accumulative crying time pr 24 hours as measured in a crying registration diary by the parents and returned to the investigators after the registration period.|crying time in minutes|Mean|216|216.0|Full Range|||0.0|394.0|
4130270|NCT00907621|3954990|B2|||baseline crying time in minutes|Daily accumulative crying time pr 24 hours as measured in a crying registration diary by the parents and returned to the investigators after the registration period.|crying time in minutes|Mean|212|212.0|Full Range|||0.0|353.0|
4130271|NCT00907621|3954991|B1|||baseline crying time in minutes|Daily accumulative crying time pr 24 hours as measured in a crying registration diary by the parents and returned to the investigators after the registration period.|crying time in minutes|Mean|220|220.0|Full Range|||80.0|394.0|
4130272|NCT00907621|3954989|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4130273|NCT00907621|3954990|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4130274|NCT00907621|3954991|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4130275|NCT00907621|3954989|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4130276|NCT00907621|3954990|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4130277|NCT00907621|3954991|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4130278|NCT00907621|3954989|B3|||Age||weeks|Mean|6|6.0|Full Range|||3.0|13.0|
4130279|NCT00907621|3954990|B2|||Age||weeks|Mean|6|6.0|Full Range|||3.0|9.0|
4130280|NCT00907621|3954991|B1|||Age||weeks|Mean|6|6.0|Full Range|||3.0|13.0|
4130281|NCT00907517|3955000|B6||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4130282|NCT00907517|3955001|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4130283|NCT00907517|3955002|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4130284|NCT00907517|3955003|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4130285|NCT00907517|3955004|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4130286|NCT00907517|3955005|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4130287|NCT00907517|3955000|B6||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4130288|NCT00907517|3955001|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4130289|NCT00907517|3955002|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4130290|NCT00907517|3955003|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4130291|NCT00907517|3955004|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4130292|NCT00907517|3955005|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4130293|NCT00907517|3955000|B6|||Age||Years|Mean|53.9|53.9|Standard Deviation|14.0|14.0|||
4130294|NCT00907517|3955001|B5|||Age||Years|Mean|56.3|56.3|Standard Deviation|13.5|13.5|||
4130295|NCT00907517|3955002|B4|||Age||Years|Mean|57.5|57.5|Standard Deviation|18.3|18.3|||
4130296|NCT00907517|3955003|B3|||Age||Years|Mean|44.2|44.2|Standard Deviation|14.2|14.2|||
4130297|NCT00907517|3955004|B2|||Age||Years|Mean|55.7|55.7|Standard Deviation|1.5|1.5|||
4130298|NCT00907517|3955005|B1|||Age||Years|Mean|59.3|59.3|Standard Deviation|9.1|9.1|||
4130299|NCT00907478|3955031|B4|Yes||Any Prior History of Bone Marrow Abnormalities||participants|Number|10|10.0||||||
4130300|NCT00907478|3955032|B3|Yes||Any Prior History of Bone Marrow Abnormalities||participants|Number|5|5.0||||||
4130301|NCT00907478|3955033|B2|Yes||Any Prior History of Bone Marrow Abnormalities||participants|Number|3|3.0||||||
4130302|NCT00907478|3955034|B1|Yes||Any Prior History of Bone Marrow Abnormalities||participants|Number|2|2.0||||||
4130303|NCT00907478|3955031|B4|No||Any Prior History of Bone Marrow Abnormalities||participants|Number|159|159.0||||||
4130304|NCT00907478|3955032|B3|No||Any Prior History of Bone Marrow Abnormalities||participants|Number|64|64.0||||||
4130305|NCT00907478|3955033|B2|No||Any Prior History of Bone Marrow Abnormalities||participants|Number|47|47.0||||||
4130306|NCT00907478|3955034|B1|No||Any Prior History of Bone Marrow Abnormalities||participants|Number|48|48.0||||||
4130307|NCT00907478|3955031|B4|Yes||Had Splenectomy||participants|Number|60|60.0||||||
4130308|NCT00907478|3955032|B3|Yes||Had Splenectomy||participants|Number|23|23.0||||||
4130309|NCT00907478|3955033|B2|Yes||Had Splenectomy||participants|Number|15|15.0||||||
4130310|NCT00907478|3955034|B1|Yes||Had Splenectomy||participants|Number|22|22.0||||||
4130311|NCT00907478|3955031|B4|No||Had Splenectomy||participants|Number|109|109.0||||||
4130312|NCT00907478|3955032|B3|No||Had Splenectomy||participants|Number|46|46.0||||||
4130313|NCT00907478|3955033|B2|No||Had Splenectomy||participants|Number|35|35.0||||||
4130314|NCT00907478|3955034|B1|No||Had Splenectomy||participants|Number|28|28.0||||||
4130315|NCT00907478|3955031|B4|≥ 4||Number of Prior ITP Therapies||participants|Number|35|35.0||||||
4130316|NCT00907478|3955032|B3|≥ 4||Number of Prior ITP Therapies||participants|Number|10|10.0||||||
4130317|NCT00907478|3955033|B2|≥ 4||Number of Prior ITP Therapies||participants|Number|10|10.0||||||
4130318|NCT00907478|3955034|B1|≥ 4||Number of Prior ITP Therapies||participants|Number|15|15.0||||||
4130319|NCT00907478|3955031|B4|3||Number of Prior ITP Therapies||participants|Number|27|27.0||||||
4130320|NCT00907478|3955032|B3|3||Number of Prior ITP Therapies||participants|Number|10|10.0||||||
4130321|NCT00907478|3955033|B2|3||Number of Prior ITP Therapies||participants|Number|9|9.0||||||
4130322|NCT00907478|3955034|B1|3||Number of Prior ITP Therapies||participants|Number|8|8.0||||||
4130323|NCT00907478|3955031|B4|2||Number of Prior ITP Therapies||participants|Number|46|46.0||||||
4130324|NCT00907478|3955032|B3|2||Number of Prior ITP Therapies||participants|Number|20|20.0||||||
4130325|NCT00907478|3955033|B2|2||Number of Prior ITP Therapies||participants|Number|15|15.0||||||
4130326|NCT00907478|3955034|B1|2||Number of Prior ITP Therapies||participants|Number|11|11.0||||||
4130327|NCT00907478|3955031|B4|1||Number of Prior ITP Therapies||participants|Number|61|61.0||||||
4130328|NCT00907478|3955032|B3|1||Number of Prior ITP Therapies||participants|Number|29|29.0||||||
4130329|NCT00907478|3955033|B2|1||Number of Prior ITP Therapies||participants|Number|16|16.0||||||
4130330|NCT00907478|3955034|B1|1||Number of Prior ITP Therapies||participants|Number|16|16.0||||||
4130331|NCT00907478|3955031|B4|0||Number of Prior ITP Therapies||participants|Number|0|0.0||||||
4130332|NCT00907478|3955032|B3|0||Number of Prior ITP Therapies||participants|Number|0|0.0||||||
4130333|NCT00907478|3955033|B2|0||Number of Prior ITP Therapies||participants|Number|0|0.0||||||
4130334|NCT00907478|3955034|B1|0||Number of Prior ITP Therapies||participants|Number|0|0.0||||||
4130335|NCT00907478|3955031|B4|||Time Since ITP Diagnosis||years|Mean|8.24|8.24|Standard Deviation|9.72|9.72|||
4130336|NCT00907478|3955032|B3|||Time Since ITP Diagnosis||years|Mean|5.36|5.36|Standard Deviation|6.41|6.41|||
4130337|NCT00907478|3955033|B2|||Time Since ITP Diagnosis||years|Mean|10.50|10.5|Standard Deviation|11.87|11.87|||
4130338|NCT00907478|3955034|B1|||Time Since ITP Diagnosis||years|Mean|9.94|9.94|Standard Deviation|10.29|10.29|||
4130339|NCT00907478|3955031|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4130340|NCT00907478|3955032|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4130341|NCT00907478|3955033|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4130342|NCT00907478|3955034|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4130343|NCT00907478|3955031|B4|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4130344|NCT00907478|3955032|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4130345|NCT00907478|3955033|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4130346|NCT00907478|3955034|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4130347|NCT00907478|3955031|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4130348|NCT00907478|3955032|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4130349|NCT00907478|3955033|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4130350|NCT00907478|3955034|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4130351|NCT00907478|3955031|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4130352|NCT00907478|3955032|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4130353|NCT00907478|3955033|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4130354|NCT00907478|3955034|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4130355|NCT00907478|3955031|B4|White or Caucasian||Race/Ethnicity, Customized||participants|Number|154|154.0||||||
4130356|NCT00907478|3955032|B3|White or Caucasian||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
4130357|NCT00907478|3955033|B2|White or Caucasian||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4130358|NCT00907478|3955034|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
4130359|NCT00907478|3955031|B4||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4130360|NCT00907478|3955032|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4130361|NCT00907478|3955033|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4130362|NCT00907478|3955034|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4130363|NCT00907478|3955031|B4||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4130364|NCT00907478|3955032|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4130365|NCT00907478|3955033|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4130366|NCT00907478|3955034|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4130367|NCT00907478|3955031|B4|||Age||years|Mean|49.8|49.8|Standard Deviation|16.9|16.9|||
4130368|NCT00907478|3955032|B3|||Age||years|Mean|46.6|46.6|Standard Deviation|16.3|16.3|||
4130369|NCT00907478|3955033|B2|||Age||years|Mean|48.6|48.6|Standard Deviation|16.5|16.5|||
4130370|NCT00907478|3955034|B1|||Age||years|Mean|55.5|55.5|Standard Deviation|17.1|17.1|||
4130371|NCT00907426|3955064|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4130372|NCT00907426|3955065|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4130373|NCT00907426|3955066|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4130374|NCT00907426|3955067|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4130375|NCT00907426|3955064|B4||Female|Sex: Female, Male||Participants|Count of Participants|364|364.0||||||
4130376|NCT00907426|3955065|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4130377|NCT00907426|3955066|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4130378|NCT00907426|3955067|B1||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4130379|NCT00907426|3955064|B4|>65 Years||Age, Customized||Participants|Number|24|24.0||||||
4130380|NCT00907426|3955065|B3|>65 Years||Age, Customized||Participants|Number|9|9.0||||||
4130381|NCT00907426|3955066|B2|>65 Years||Age, Customized||Participants|Number|7|7.0||||||
4130382|NCT00907426|3955067|B1|>65 Years||Age, Customized||Participants|Number|8|8.0||||||
4130383|NCT00907426|3955064|B4|Between 45 and 65 years||Age, Customized||Participants|Number|239|239.0||||||
4130384|NCT00907426|3955065|B3|Between 45 and 65 years||Age, Customized||Participants|Number|53|53.0||||||
4130385|NCT00907426|3955066|B2|Between 45 and 65 years||Age, Customized||Participants|Number|35|35.0||||||
4130386|NCT00907426|3955067|B1|Between 45 and 65 years||Age, Customized||Participants|Number|151|151.0||||||
4130387|NCT00907426|3955064|B4|<45 Years||Age, Customized||Participants|Number|105|105.0||||||
4130388|NCT00907426|3955065|B3|<45 Years||Age, Customized||Participants|Number|31|31.0||||||
4130389|NCT00907426|3955066|B2|<45 Years||Age, Customized||Participants|Number|18|18.0||||||
4130390|NCT00907426|3955067|B1|<45 Years||Age, Customized||Participants|Number|56|56.0||||||
4130391|NCT00907374|3955084|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
4130392|NCT00907374|3955085|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4130393|NCT00907374|3955086|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4130394|NCT00907374|3955084|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4130395|NCT00907374|3955085|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4130396|NCT00907374|3955086|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4130397|NCT00907374|3955084|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4130398|NCT00907374|3955085|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4130399|NCT00907374|3955086|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4130400|NCT00907374|3955084|B3|||Age||years|Mean|53.0|53.0|Standard Deviation|5.5|5.5|||
4130401|NCT00907374|3955085|B2|||Age||years|Mean|51.6|51.6|Standard Deviation|5.9|5.9|||
4130402|NCT00907374|3955086|B1|||Age||years|Mean|54.4|54.4|Standard Deviation|6.7|6.7|||
4130403|NCT00907374|3955084|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4130404|NCT00907374|3955085|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4130405|NCT00907374|3955086|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4130406|NCT00907374|3955084|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4130407|NCT00907374|3955085|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4130408|NCT00907374|3955086|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4130409|NCT00907374|3955084|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4130410|NCT00907374|3955085|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4130411|NCT00907374|3955086|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4130412|NCT00907335|3955099|B3|VI||Fitzpatrick Score|Skin type is categorized according to the Fitzpatrick skin type scale, which ranges from very fair (skin type I) to very dark (skin type VI).|Participants|Number|5|5.0||||||
4130413|NCT00907335|3955100|B2|VI||Fitzpatrick Score|Skin type is categorized according to the Fitzpatrick skin type scale, which ranges from very fair (skin type I) to very dark (skin type VI).|Participants|Number|2|2.0||||||
4130414|NCT00907335|3955101|B1|VI||Fitzpatrick Score|Skin type is categorized according to the Fitzpatrick skin type scale, which ranges from very fair (skin type I) to very dark (skin type VI).|Participants|Number|3|3.0||||||
4130415|NCT00907335|3955099|B3|V||Fitzpatrick Score|Skin type is categorized according to the Fitzpatrick skin type scale, which ranges from very fair (skin type I) to very dark (skin type VI).|Participants|Number|17|17.0||||||
4130416|NCT00907335|3955100|B2|V||Fitzpatrick Score|Skin type is categorized according to the Fitzpatrick skin type scale, which ranges from very fair (skin type I) to very dark (skin type VI).|Participants|Number|9|9.0||||||
4130417|NCT00907335|3955101|B1|V||Fitzpatrick Score|Skin type is categorized according to the Fitzpatrick skin type scale, which ranges from very fair (skin type I) to very dark (skin type VI).|Participants|Number|8|8.0||||||
4130418|NCT00907335|3955099|B3|IV||Fitzpatrick Score|Skin type is categorized according to the Fitzpatrick skin type scale, which ranges from very fair (skin type I) to very dark (skin type VI).|Participants|Number|29|29.0||||||
4130419|NCT00907335|3955100|B2|IV||Fitzpatrick Score|Skin type is categorized according to the Fitzpatrick skin type scale, which ranges from very fair (skin type I) to very dark (skin type VI).|Participants|Number|15|15.0||||||
4130420|NCT00907335|3955101|B1|IV||Fitzpatrick Score|Skin type is categorized according to the Fitzpatrick skin type scale, which ranges from very fair (skin type I) to very dark (skin type VI).|Participants|Number|14|14.0||||||
4130421|NCT00907335|3955099|B3|III||Fitzpatrick Score|Skin type is categorized according to the Fitzpatrick skin type scale, which ranges from very fair (skin type I) to very dark (skin type VI).|Participants|Number|27|27.0||||||
4130422|NCT00907335|3955100|B2|III||Fitzpatrick Score|Skin type is categorized according to the Fitzpatrick skin type scale, which ranges from very fair (skin type I) to very dark (skin type VI).|Participants|Number|16|16.0||||||
4130423|NCT00907335|3955101|B1|III||Fitzpatrick Score|Skin type is categorized according to the Fitzpatrick skin type scale, which ranges from very fair (skin type I) to very dark (skin type VI).|Participants|Number|11|11.0||||||
4130424|NCT00907335|3955099|B3|II||Fitzpatrick Score|Skin type is categorized according to the Fitzpatrick skin type scale, which ranges from very fair (skin type I) to very dark (skin type VI).|Participants|Number|29|29.0||||||
4130425|NCT00907335|3955100|B2|II||Fitzpatrick Score|Skin type is categorized according to the Fitzpatrick skin type scale, which ranges from very fair (skin type I) to very dark (skin type VI).|Participants|Number|12|12.0||||||
4130426|NCT00907335|3955101|B1|II||Fitzpatrick Score|Skin type is categorized according to the Fitzpatrick skin type scale, which ranges from very fair (skin type I) to very dark (skin type VI).|Participants|Number|17|17.0||||||
4130427|NCT00907335|3955099|B3|I||Fitzpatrick Score|Skin type is categorized according to the Fitzpatrick skin type scale, which ranges from very fair (skin type I) to very dark (skin type VI).|Participants|Number|3|3.0||||||
4130428|NCT00907335|3955100|B2|I||Fitzpatrick Score|Skin type is categorized according to the Fitzpatrick skin type scale, which ranges from very fair (skin type I) to very dark (skin type VI).|Participants|Number|1|1.0||||||
4130429|NCT00907335|3955101|B1|I||Fitzpatrick Score|Skin type is categorized according to the Fitzpatrick skin type scale, which ranges from very fair (skin type I) to very dark (skin type VI).|Participants|Number|2|2.0||||||
4130430|NCT00907335|3955099|B3|No||Subject Reached Puberty||Participants|Number|72|72.0||||||
4130431|NCT00907335|3955100|B2|No||Subject Reached Puberty||Participants|Number|34|34.0||||||
4130432|NCT00907335|3955101|B1|No||Subject Reached Puberty||Participants|Number|38|38.0||||||
4130433|NCT00907335|3955099|B3|Yes||Subject Reached Puberty||Participants|Number|38|38.0||||||
4130434|NCT00907335|3955100|B2|Yes||Subject Reached Puberty||Participants|Number|21|21.0||||||
4130435|NCT00907335|3955101|B1|Yes||Subject Reached Puberty||Participants|Number|17|17.0||||||
4130436|NCT00907335|3955099|B3|United States||Region of Enrollment||participants|Number|110|110.0||||||
4130437|NCT00907335|3955100|B2|United States||Region of Enrollment||participants|Number|55|55.0||||||
4130438|NCT00907335|3955101|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4130439|NCT00907335|3955099|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4130440|NCT00907335|3955100|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4130441|NCT00907335|3955101|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4130442|NCT00907335|3955099|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4130443|NCT00907335|3955100|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4130444|NCT00907335|3955101|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4130445|NCT00907335|3955099|B3|11 Years||Age, Customized||participants|Number|63|63.0||||||
4130446|NCT00907335|3955100|B2|11 Years||Age, Customized||participants|Number|34|34.0||||||
4130447|NCT00907335|3955101|B1|11 Years||Age, Customized||participants|Number|29|29.0||||||
4130448|NCT00907335|3955099|B3|10 Years||Age, Customized||participants|Number|38|38.0||||||
4130449|NCT00907335|3955100|B2|10 Years||Age, Customized||participants|Number|17|17.0||||||
4130450|NCT00907335|3955101|B1|10 Years||Age, Customized||participants|Number|21|21.0||||||
4130451|NCT00907335|3955099|B3|9 years||Age, Customized||participants|Number|9|9.0||||||
4130452|NCT00907335|3955100|B2|9 years||Age, Customized||participants|Number|4|4.0||||||
4130453|NCT00907335|3955101|B1|9 years||Age, Customized||participants|Number|5|5.0||||||
4130454|NCT00907257|3955118|B3|VI||Fitzpatrick Score|Skin type is categorized according to the Fitzpatrick skin type scale, which ranges from very fair (skin type I) to very dark (skin type VI).|Participants|Number|12|12.0||||||
4130455|NCT00907257|3955119|B2|VI||Fitzpatrick Score|Skin type is categorized according to the Fitzpatrick skin type scale, which ranges from very fair (skin type I) to very dark (skin type VI).|Participants|Number|4|4.0||||||
4130456|NCT00907257|3955120|B1|VI||Fitzpatrick Score|Skin type is categorized according to the Fitzpatrick skin type scale, which ranges from very fair (skin type I) to very dark (skin type VI).|Participants|Number|8|8.0||||||
4130457|NCT00907257|3955118|B3|V||Fitzpatrick Score|Skin type is categorized according to the Fitzpatrick skin type scale, which ranges from very fair (skin type I) to very dark (skin type VI).|Participants|Number|20|20.0||||||
4130458|NCT00907257|3955119|B2|V||Fitzpatrick Score|Skin type is categorized according to the Fitzpatrick skin type scale, which ranges from very fair (skin type I) to very dark (skin type VI).|Participants|Number|12|12.0||||||
4130459|NCT00907257|3955120|B1|V||Fitzpatrick Score|Skin type is categorized according to the Fitzpatrick skin type scale, which ranges from very fair (skin type I) to very dark (skin type VI).|Participants|Number|8|8.0||||||
4130460|NCT00907257|3955118|B3|IV||Fitzpatrick Score|Skin type is categorized according to the Fitzpatrick skin type scale, which ranges from very fair (skin type I) to very dark (skin type VI).|Participants|Number|46|46.0||||||
4130461|NCT00907257|3955119|B2|IV||Fitzpatrick Score|Skin type is categorized according to the Fitzpatrick skin type scale, which ranges from very fair (skin type I) to very dark (skin type VI).|Participants|Number|22|22.0||||||
4130462|NCT00907257|3955120|B1|IV||Fitzpatrick Score|Skin type is categorized according to the Fitzpatrick skin type scale, which ranges from very fair (skin type I) to very dark (skin type VI).|Participants|Number|24|24.0||||||
4130463|NCT00907257|3955118|B3|III||Fitzpatrick Score|Skin type is categorized according to the Fitzpatrick skin type scale, which ranges from very fair (skin type I) to very dark (skin type VI).|Participants|Number|96|96.0||||||
4130464|NCT00907257|3955119|B2|III||Fitzpatrick Score|Skin type is categorized according to the Fitzpatrick skin type scale, which ranges from very fair (skin type I) to very dark (skin type VI).|Participants|Number|52|52.0||||||
4130465|NCT00907257|3955120|B1|III||Fitzpatrick Score|Skin type is categorized according to the Fitzpatrick skin type scale, which ranges from very fair (skin type I) to very dark (skin type VI).|Participants|Number|44|44.0||||||
4130466|NCT00907257|3955118|B3|II||Fitzpatrick Score|Skin type is categorized according to the Fitzpatrick skin type scale, which ranges from very fair (skin type I) to very dark (skin type VI).|Participants|Number|60|60.0||||||
4130467|NCT00907257|3955119|B2|II||Fitzpatrick Score|Skin type is categorized according to the Fitzpatrick skin type scale, which ranges from very fair (skin type I) to very dark (skin type VI).|Participants|Number|29|29.0||||||
4130468|NCT00907257|3955120|B1|II||Fitzpatrick Score|Skin type is categorized according to the Fitzpatrick skin type scale, which ranges from very fair (skin type I) to very dark (skin type VI).|Participants|Number|31|31.0||||||
4130469|NCT00907257|3955118|B3|I||Fitzpatrick Score|Skin type is categorized according to the Fitzpatrick skin type scale, which ranges from very fair (skin type I) to very dark (skin type VI).|Participants|Number|13|13.0||||||
4130470|NCT00907257|3955119|B2|I||Fitzpatrick Score|Skin type is categorized according to the Fitzpatrick skin type scale, which ranges from very fair (skin type I) to very dark (skin type VI).|Participants|Number|5|5.0||||||
4130471|NCT00907257|3955120|B1|I||Fitzpatrick Score|Skin type is categorized according to the Fitzpatrick skin type scale, which ranges from very fair (skin type I) to very dark (skin type VI).|Participants|Number|8|8.0||||||
4130472|NCT00907257|3955118|B3|United States||Region of Enrollment||participants|Number|247|247.0||||||
4130473|NCT00907257|3955119|B2|United States||Region of Enrollment||participants|Number|124|124.0||||||
4130474|NCT00907257|3955120|B1|United States||Region of Enrollment||participants|Number|123|123.0||||||
4130475|NCT00907257|3955118|B3||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4130476|NCT00907257|3955119|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4130477|NCT00907257|3955120|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4130478|NCT00907257|3955118|B3||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4130479|NCT00907257|3955119|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4130480|NCT00907257|3955120|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4130481|NCT00907257|3955118|B3|||Age||years|Mean|18.5|18.5|Standard Deviation|6.89|6.89|||
4130482|NCT00907257|3955119|B2|||Age||years|Mean|18.6|18.6|Standard Deviation|6.94|6.94|||
4130483|NCT00907257|3955120|B1|||Age||years|Mean|18.5|18.5|Standard Deviation|6.86|6.86|||
4130484|NCT00907218|3955131|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4130485|NCT00907218|3955131|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4130486|NCT00907218|3955131|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4130487|NCT00907218|3955131|B1|||Age||years|Mean|37.5|37.5|Standard Deviation|17|17.0|||
4130488|NCT00907218|3955131|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4130489|NCT00907218|3955131|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4130490|NCT00907218|3955131|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4130491|NCT00907153|3955141|B3|||Free testosterone||ng/dL|Mean|16.89|16.89|Standard Deviation|13.33|13.33|||
4130492|NCT00907153|3955142|B2|||Free testosterone||ng/dL|Mean|14.00|14.0|Standard Deviation|10.88|10.88|||
4130493|NCT00907153|3955143|B1|||Free testosterone||ng/dL|Mean|19.08|19.08|Standard Deviation|15.79|15.79|||
4130494|NCT00907153|3955141|B3|||Total testosterone||ng/dL|Mean|48.48|48.48|Standard Deviation|23.03|23.03|||
4130495|NCT00907153|3955142|B2|||Total testosterone||ng/dL|Mean|41.27|41.27|Standard Deviation|17.29|17.29|||
4130496|NCT00907153|3955143|B1|||Total testosterone||ng/dL|Mean|54.23|54.23|Standard Deviation|28.16|28.16|||
4130497|NCT00907153|3955141|B3|||High sensitive C-reactive protein (hsCRP)||mg/L|Mean|6.1|6.1|Standard Deviation|5.0|5.0|||
4130498|NCT00907153|3955142|B2|||High sensitive C-reactive protein (hsCRP)||mg/L|Mean|4.42|4.42|Standard Deviation|4.34|4.34|||
4130499|NCT00907153|3955143|B1|||High sensitive C-reactive protein (hsCRP)||mg/L|Mean|7.95|7.95|Standard Deviation|5.24|5.24|||
4130500|NCT00907153|3955141|B3|||Triglyecrides||mg/dL|Mean|144.64|144.64|Standard Deviation|78.07|78.07|||
4130501|NCT00907153|3955142|B2|||Triglyecrides||mg/dL|Mean|149.47|149.47|Standard Deviation|85.46|85.46|||
4130502|NCT00907153|3955143|B1|||Triglyecrides||mg/dL|Mean|139.08|139.08|Standard Deviation|71.61|71.61|||
4130503|NCT00907153|3955141|B3|||LDL cholesterol||mg/dL|Mean|108.64|108.64|Standard Deviation|33.47|33.47|||
4130504|NCT00907153|3955142|B2|||LDL cholesterol||mg/dL|Mean|117.33|117.33|Standard Deviation|28.56|28.56|||
4130505|NCT00907153|3955143|B1|||LDL cholesterol||mg/dL|Mean|98.62|98.62|Standard Deviation|36.96|36.96|||
4130506|NCT00907153|3955141|B3|||HDL cholesterol||mg/dL|Mean|40.96|40.96|Standard Deviation|14.74|14.74|||
4130507|NCT00907153|3955142|B2|||HDL cholesterol||mg/dL|Mean|37.00|37.0|Standard Deviation|10.83|10.83|||
4130508|NCT00907153|3955143|B1|||HDL cholesterol||mg/dL|Mean|45.54|45.54|Standard Deviation|17.60|17.6|||
4130509|NCT00907153|3955141|B3|||Total cholesterol||mg/dL|Mean|178.57|178.57|Standard Deviation|37.38|37.38|||
4130510|NCT00907153|3955142|B2|||Total cholesterol||mg/dL|Mean|184.27|184.27|Standard Deviation|32.52|32.52|||
4130511|NCT00907153|3955143|B1|||Total cholesterol||mg/dL|Mean|172.00|172.0|Standard Deviation|42.70|42.7|||
4130512|NCT00907153|3955141|B3|||Homeostatic Model Assessment of Insulin Resistance (HOMA-IR)|HOMA-IR is calculated as the product of fasting glucose and insulin divided by 22.5.|units on a scale|Mean|5.65|5.65|Standard Deviation|2.93|2.93|||
4130513|NCT00907153|3955142|B2|||Homeostatic Model Assessment of Insulin Resistance (HOMA-IR)|HOMA-IR is calculated as the product of fasting glucose and insulin divided by 22.5.|units on a scale|Mean|5.80|5.8|Standard Deviation|3.90|3.9|||
4130514|NCT00907153|3955143|B1|||Homeostatic Model Assessment of Insulin Resistance (HOMA-IR)|HOMA-IR is calculated as the product of fasting glucose and insulin divided by 22.5.|units on a scale|Mean|5.47|5.47|Standard Deviation|1.82|1.82|||
4130515|NCT00907153|3955141|B3|||Quantitative Insulin Sensitivity Check Index (QUICKI)|The primary outcome was quantitative insulin sensitivity check index (QUICKI), a validated measure of insulin sensitivity based on fasting insulin and glucose. Quantitative insulin sensitivity check index (QUICKI) = 1/[log(I(0)) + log(G(0))]).|units on a scale|Mean|0.305|0.305|Standard Deviation|0.022|0.022|||
4130516|NCT00907153|3955142|B2|||Quantitative Insulin Sensitivity Check Index (QUICKI)|The primary outcome was quantitative insulin sensitivity check index (QUICKI), a validated measure of insulin sensitivity based on fasting insulin and glucose. Quantitative insulin sensitivity check index (QUICKI) = 1/[log(I(0)) + log(G(0))]).|units on a scale|Mean|0.307|0.307|Standard Deviation|0.029|0.029|||
4130517|NCT00907153|3955143|B1|||Quantitative Insulin Sensitivity Check Index (QUICKI)|The primary outcome was quantitative insulin sensitivity check index (QUICKI), a validated measure of insulin sensitivity based on fasting insulin and glucose. Quantitative insulin sensitivity check index (QUICKI) = 1/[log(I(0)) + log(G(0))]).|units on a scale|Mean|0.302|0.302|Standard Deviation|0.014|0.014|||
4130518|NCT00907153|3955141|B3|||Insulin sensitivity index 0,120|Participants underwent a 75-g oral glucose tolerance test, in which blood samples for glucose and insulin were obtained at 0 and 120 minutes and used to calculate the insulin sensitivity index (ISI0,120). The ISI 0,120 = the glucose uptake rate divided by the mean plasma glucose divided by the log(mean serum insulin).|mg·l^2/mmol·mU·min|Mean|59.84|59.84|Standard Deviation|19.57|19.57|||
4130519|NCT00907153|3955142|B2|||Insulin sensitivity index 0,120|Participants underwent a 75-g oral glucose tolerance test, in which blood samples for glucose and insulin were obtained at 0 and 120 minutes and used to calculate the insulin sensitivity index (ISI0,120). The ISI 0,120 = the glucose uptake rate divided by the mean plasma glucose divided by the log(mean serum insulin).|mg·l^2/mmol·mU·min|Mean|63.56|63.56|Standard Deviation|16.37|16.37|||
4130574|NCT00907153|3955143|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4130520|NCT00907153|3955143|B1|||Insulin sensitivity index 0,120|Participants underwent a 75-g oral glucose tolerance test, in which blood samples for glucose and insulin were obtained at 0 and 120 minutes and used to calculate the insulin sensitivity index (ISI0,120). The ISI 0,120 = the glucose uptake rate divided by the mean plasma glucose divided by the log(mean serum insulin).|mg·l^2/mmol·mU·min|Mean|55.55|55.55|Standard Deviation|23.26|23.26|||
4130521|NCT00907153|3955141|B3|||2-hour insulin||uU/mL|Mean|157.04|157.04|Standard Deviation|118.72|118.72|||
4130522|NCT00907153|3955142|B2|||2-hour insulin||uU/mL|Mean|107.07|107.07|Standard Deviation|55.20|55.2|||
4130523|NCT00907153|3955143|B1|||2-hour insulin||uU/mL|Mean|214.69|214.69|Standard Deviation|146.41|146.41|||
4130524|NCT00907153|3955141|B3|||2-hour glucose||mg/dL|Mean|115.64|115.64|Standard Deviation|30.22|30.22|||
4130525|NCT00907153|3955142|B2|||2-hour glucose||mg/dL|Mean|110.07|110.07|Standard Deviation|23.68|23.68|||
4130526|NCT00907153|3955143|B1|||2-hour glucose||mg/dL|Mean|122.08|122.08|Standard Deviation|36.29|36.29|||
4130527|NCT00907153|3955141|B3|||Fasting insulin||uU/mL|Mean|26.75|26.75|Standard Deviation|13.05|13.05|||
4130528|NCT00907153|3955142|B2|||Fasting insulin||uU/mL|Mean|27.13|27.13|Standard Deviation|15.79|15.79|||
4130529|NCT00907153|3955143|B1|||Fasting insulin||uU/mL|Mean|26.31|26.31|Standard Deviation|9.60|9.6|||
4130530|NCT00907153|3955141|B3|||Fasting glucose||mg/dL|Mean|84.29|84.29|Standard Deviation|9.23|9.23|||
4130531|NCT00907153|3955142|B2|||Fasting glucose||mg/dL|Mean|83.73|83.73|Standard Deviation|9.33|9.33|||
4130532|NCT00907153|3955143|B1|||Fasting glucose||mg/dL|Mean|84.92|84.92|Standard Deviation|9.46|9.46|||
4130533|NCT00907153|3955141|B3|||Intact parathyroid hormone (i-PTH)||pg/mL|Mean|36.72|36.72|Standard Deviation|22.19|22.19|||
4130534|NCT00907153|3955142|B2|||Intact parathyroid hormone (i-PTH)||pg/mL|Mean|33.17|33.17|Standard Deviation|17.73|17.73|||
4130535|NCT00907153|3955143|B1|||Intact parathyroid hormone (i-PTH)||pg/mL|Mean|40.81|40.81|Standard Deviation|27.34|27.34|||
4130536|NCT00907153|3955141|B3|||Vitamin D binding protein||mg/dL|Mean|31.34|31.34|Standard Deviation|8.04|8.04|||
4130537|NCT00907153|3955142|B2|||Vitamin D binding protein||mg/dL|Mean|31.95|31.95|Standard Deviation|7.54|7.54|||
4130538|NCT00907153|3955143|B1|||Vitamin D binding protein||mg/dL|Mean|30.46|30.46|Standard Deviation|8.53|8.53|||
4130539|NCT00907153|3955141|B3|||25-hydroxyvitamin D||ng/mL|Mean|21.15|21.15|Standard Deviation|8.10|8.1|||
4130540|NCT00907153|3955142|B2|||25-hydroxyvitamin D||ng/mL|Mean|22.20|22.2|Standard Deviation|6.86|6.86|||
4130541|NCT00907153|3955143|B1|||25-hydroxyvitamin D||ng/mL|Mean|19.95|19.95|Standard Deviation|9.47|9.47|||
4130542|NCT00907153|3955141|B3|||Diastolic blood pressure||mm hg|Mean|76.83|76.83|Standard Deviation|7.98|7.98|||
4130543|NCT00907153|3955142|B2|||Diastolic blood pressure||mm hg|Mean|74.88|74.88|Standard Deviation|7.72|7.72|||
4130544|NCT00907153|3955143|B1|||Diastolic blood pressure||mm hg|Mean|79.08|79.08|Standard Deviation|8.28|8.28|||
4130545|NCT00907153|3955141|B3|||Systolic blood pressure||mm Hg|Mean|115.56|115.56|Standard Deviation|10.11|10.11|||
4130546|NCT00907153|3955142|B2|||Systolic blood pressure||mm Hg|Mean|113.91|113.91|Standard Deviation|10.21|10.21|||
4130547|NCT00907153|3955143|B1|||Systolic blood pressure||mm Hg|Mean|117.46|117.46|Standard Deviation|10.00|10.0|||
4130548|NCT00907153|3955141|B3|||Body Mass Index (BMI)||kg/m2|Mean|36.1|36.1|Standard Deviation|7.8|7.8|||
4130549|NCT00907153|3955142|B2|||Body Mass Index (BMI)||kg/m2|Mean|35.09|35.09|Standard Deviation|9.81|9.81|||
4130550|NCT00907153|3955143|B1|||Body Mass Index (BMI)||kg/m2|Mean|37.20|37.2|Standard Deviation|4.53|4.53|||
4130551|NCT00907153|3955141|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
4130552|NCT00907153|3955142|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4130553|NCT00907153|3955143|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4130554|NCT00907153|3955141|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4130555|NCT00907153|3955142|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4130556|NCT00907153|3955143|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4130557|NCT00907153|3955141|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4130558|NCT00907153|3955142|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4130559|NCT00907153|3955143|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4130560|NCT00907153|3955141|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4130561|NCT00907153|3955142|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4130562|NCT00907153|3955143|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4130563|NCT00907153|3955141|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4130564|NCT00907153|3955142|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4130565|NCT00907153|3955143|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4130566|NCT00907153|3955141|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4130567|NCT00907153|3955142|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4130568|NCT00907153|3955143|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4130569|NCT00907153|3955141|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4130570|NCT00907153|3955142|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4130571|NCT00907153|3955143|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4130572|NCT00907153|3955141|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4130573|NCT00907153|3955142|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4130575|NCT00907153|3955141|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4130576|NCT00907153|3955142|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4130577|NCT00907153|3955143|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4130578|NCT00907153|3955141|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4130579|NCT00907153|3955142|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4130580|NCT00907153|3955143|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4130581|NCT00907153|3955141|B3|||Age||years|Mean|28.5|28.5|Standard Deviation|5.3|5.3|||
4130582|NCT00907153|3955142|B2|||Age||years|Mean|28.7|28.7|Standard Deviation|5.6|5.6|||
4130583|NCT00907153|3955143|B1|||Age||years|Mean|28.2|28.2|Standard Deviation|5.2|5.2|||
4130584|NCT00907101|3955186|B1|VI||Fitzpatrick Skin Type|"Investigator assessment based on the standard Fitzpatrick Skin Type Scale (I to VI).~TYPE 1: Highly sensitive, always burns, never tans. TYP E 2: Very sun sensitive, burns easily, tans minimally. TYPE 3: Sun sensitive skin, sometimes burns, slowly tans to light brown. TYPE 4: Minimally sun sensitive, burns minimally, always tans to moderate brown.~TYPE 5: Sun insensitive skin, rarely burns, tans well. TYPE 6: Sun insensitive, never burns, deeply pigmented."|participants|Number|0|0.0||||||
4130585|NCT00907101|3955186|B1|V||Fitzpatrick Skin Type|"Investigator assessment based on the standard Fitzpatrick Skin Type Scale (I to VI).~TYPE 1: Highly sensitive, always burns, never tans. TYP E 2: Very sun sensitive, burns easily, tans minimally. TYPE 3: Sun sensitive skin, sometimes burns, slowly tans to light brown. TYPE 4: Minimally sun sensitive, burns minimally, always tans to moderate brown.~TYPE 5: Sun insensitive skin, rarely burns, tans well. TYPE 6: Sun insensitive, never burns, deeply pigmented."|participants|Number|3|3.0||||||
4130586|NCT00907101|3955186|B1|IV||Fitzpatrick Skin Type|"Investigator assessment based on the standard Fitzpatrick Skin Type Scale (I to VI).~TYPE 1: Highly sensitive, always burns, never tans. TYP E 2: Very sun sensitive, burns easily, tans minimally. TYPE 3: Sun sensitive skin, sometimes burns, slowly tans to light brown. TYPE 4: Minimally sun sensitive, burns minimally, always tans to moderate brown.~TYPE 5: Sun insensitive skin, rarely burns, tans well. TYPE 6: Sun insensitive, never burns, deeply pigmented."|participants|Number|12|12.0||||||
4130587|NCT00907101|3955186|B1|III||Fitzpatrick Skin Type|"Investigator assessment based on the standard Fitzpatrick Skin Type Scale (I to VI).~TYPE 1: Highly sensitive, always burns, never tans. TYP E 2: Very sun sensitive, burns easily, tans minimally. TYPE 3: Sun sensitive skin, sometimes burns, slowly tans to light brown. TYPE 4: Minimally sun sensitive, burns minimally, always tans to moderate brown.~TYPE 5: Sun insensitive skin, rarely burns, tans well. TYPE 6: Sun insensitive, never burns, deeply pigmented."|participants|Number|12|12.0||||||
4130588|NCT00907101|3955186|B1|II||Fitzpatrick Skin Type|"Investigator assessment based on the standard Fitzpatrick Skin Type Scale (I to VI).~TYPE 1: Highly sensitive, always burns, never tans. TYP E 2: Very sun sensitive, burns easily, tans minimally. TYPE 3: Sun sensitive skin, sometimes burns, slowly tans to light brown. TYPE 4: Minimally sun sensitive, burns minimally, always tans to moderate brown.~TYPE 5: Sun insensitive skin, rarely burns, tans well. TYPE 6: Sun insensitive, never burns, deeply pigmented."|participants|Number|3|3.0||||||
4130589|NCT00907101|3955186|B1|I||Fitzpatrick Skin Type|"Investigator assessment based on the standard Fitzpatrick Skin Type Scale (I to VI).~TYPE 1: Highly sensitive, always burns, never tans. TYP E 2: Very sun sensitive, burns easily, tans minimally. TYPE 3: Sun sensitive skin, sometimes burns, slowly tans to light brown. TYPE 4: Minimally sun sensitive, burns minimally, always tans to moderate brown.~TYPE 5: Sun insensitive skin, rarely burns, tans well. TYPE 6: Sun insensitive, never burns, deeply pigmented."|participants|Number|0|0.0||||||
4130590|NCT00907101|3955186|B1|Combination||Skin Type||participants|Number|11|11.0||||||
4130591|NCT00907101|3955186|B1|Oily||Skin Type||participants|Number|5|5.0||||||
4130592|NCT00907101|3955186|B1|Normal||Skin Type||participants|Number|11|11.0||||||
4130593|NCT00907101|3955186|B1|Dry||Skin Type||participants|Number|3|3.0||||||
4130594|NCT00907101|3955186|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4130595|NCT00907101|3955186|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4130596|NCT00907101|3955186|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4130597|NCT00907101|3955186|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4130598|NCT00907101|3955186|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4130599|NCT00907101|3955186|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4130600|NCT00907101|3955186|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4130601|NCT00907101|3955186|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4130602|NCT00907101|3955186|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4130603|NCT00907101|3955186|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4130604|NCT00907101|3955186|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4130605|NCT00907101|3955186|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4130606|NCT00907101|3955186|B1|||Age||years|Mean|36.0|36.0|Standard Deviation|12.51|12.51|||
4130607|NCT00907088|3955194|B3|No Information Available||Plan to bottle-wean by 2 years old||participants|Number|121|121.0||||||
4130608|NCT00907088|3955195|B2|No Information Available||Plan to bottle-wean by 2 years old||participants|Number|66|66.0||||||
4130609|NCT00907088|3955196|B1|No Information Available||Plan to bottle-wean by 2 years old||participants|Number|55|55.0||||||
4130610|NCT00907088|3955194|B3|Plan to Bottle Wean By 2 Years Old||Plan to bottle-wean by 2 years old||participants|Number|130|130.0||||||
4130611|NCT00907088|3955195|B2|Plan to Bottle Wean By 2 Years Old||Plan to bottle-wean by 2 years old||participants|Number|63|63.0||||||
4130612|NCT00907088|3955196|B1|Plan to Bottle Wean By 2 Years Old||Plan to bottle-wean by 2 years old||participants|Number|67|67.0||||||
4130613|NCT00907088|3955194|B3|Information Not Available||Bottle use||participants|Number|5|5.0||||||
4130614|NCT00907088|3955195|B2|Information Not Available||Bottle use||participants|Number|4|4.0||||||
4130615|NCT00907088|3955196|B1|Information Not Available||Bottle use||participants|Number|1|1.0||||||
4130616|NCT00907088|3955194|B3|Breast and Bottle||Bottle use||participants|Number|41|41.0||||||
4130617|NCT00907088|3955195|B2|Breast and Bottle||Bottle use||participants|Number|26|26.0||||||
4130618|NCT00907088|3955196|B1|Breast and Bottle||Bottle use||participants|Number|15|15.0||||||
4130619|NCT00907088|3955194|B3|Bottle Only||Bottle use||participants|Number|121|121.0||||||
4130620|NCT00907088|3955195|B2|Bottle Only||Bottle use||participants|Number|61|61.0||||||
4130621|NCT00907088|3955196|B1|Bottle Only||Bottle use||participants|Number|60|60.0||||||
4130622|NCT00907088|3955194|B3|Breast Only||Bottle use||participants|Number|84|84.0||||||
4130623|NCT00907088|3955195|B2|Breast Only||Bottle use||participants|Number|38|38.0||||||
4130624|NCT00907088|3955196|B1|Breast Only||Bottle use||participants|Number|46|46.0||||||
4130625|NCT00907088|3955194|B3|Black||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4130626|NCT00907088|3955195|B2|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4130627|NCT00907088|3955196|B1|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4130628|NCT00907088|3955194|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4130629|NCT00907088|3955195|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4130630|NCT00907088|3955196|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4130631|NCT00907088|3955194|B3|Asian||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4130632|NCT00907088|3955195|B2|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4130633|NCT00907088|3955196|B1|Asian||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4130634|NCT00907088|3955194|B3|White||Race/Ethnicity, Customized||participants|Number|177|177.0||||||
4130635|NCT00907088|3955195|B2|White||Race/Ethnicity, Customized||participants|Number|92|92.0||||||
4130636|NCT00907088|3955196|B1|White||Race/Ethnicity, Customized||participants|Number|85|85.0||||||
4130637|NCT00907088|3955194|B3||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4130638|NCT00907088|3955195|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4130639|NCT00907088|3955196|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4130640|NCT00907088|3955194|B3||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4130641|NCT00907088|3955195|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4130642|NCT00907088|3955196|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4130643|NCT00907088|3955194|B3||>=65 years|Age|All participants were 9 months of age.|Participants|Count of Participants|0|0.0||||||
4130644|NCT00907088|3955195|B2||>=65 years|Age|All participants were 9 months of age.|Participants|Count of Participants|0|0.0||||||
4130645|NCT00907088|3955196|B1||>=65 years|Age|All participants were 9 months of age.|Participants|Count of Participants|0|0.0||||||
4130646|NCT00907088|3955194|B3||Between 18 and 65 years|Age|All participants were 9 months of age.|Participants|Count of Participants|0|0.0||||||
4130647|NCT00907088|3955195|B2||Between 18 and 65 years|Age|All participants were 9 months of age.|Participants|Count of Participants|0|0.0||||||
4130648|NCT00907088|3955196|B1||Between 18 and 65 years|Age|All participants were 9 months of age.|Participants|Count of Participants|0|0.0||||||
4130649|NCT00907088|3955194|B3||<=18 years|Age|All participants were 9 months of age.|Participants|Count of Participants|251|251.0||||||
4130650|NCT00907088|3955195|B2||<=18 years|Age|All participants were 9 months of age.|Participants|Count of Participants|129|129.0||||||
4130651|NCT00907088|3955196|B1||<=18 years|Age|All participants were 9 months of age.|Participants|Count of Participants|122|122.0||||||
4130652|NCT00906971|3955203|B3|||Retentive fecal incontinence||days/week|Mean|3.5|3.5|Standard Deviation|2.7|2.7|||
4130653|NCT00906971|3955204|B2|||Retentive fecal incontinence||days/week|Mean|3.6|3.6|Standard Deviation|2.8|2.8|||
4130654|NCT00906971|3955205|B1|||Retentive fecal incontinence||days/week|Mean|3.5|3.5|Standard Deviation|2.6|2.6|||
4130655|NCT00906971|3955203|B3|||Frequency of defecations||days/week|Mean|2.9|2.9|Standard Deviation|2.2|2.2|||
4130656|NCT00906971|3955204|B2|||Frequency of defecations||days/week|Mean|2.9|2.9|Standard Deviation|2.3|2.3|||
4130657|NCT00906971|3955205|B1|||Frequency of defecations||days/week|Mean|2.9|2.9|Standard Deviation|2.0|2.0|||
4130658|NCT00906971|3955203|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4130659|NCT00906971|3955204|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4130660|NCT00906971|3955205|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4130661|NCT00906971|3955203|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4130662|NCT00906971|3955204|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4130663|NCT00906971|3955205|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4130664|NCT00906971|3955203|B3|11 >= 18 years||Age, Customized||participants|Number|27|27.0||||||
4130665|NCT00906971|3955204|B2|11 >= 18 years||Age, Customized||participants|Number|11|11.0||||||
4130666|NCT00906971|3955205|B1|11 >= 18 years||Age, Customized||participants|Number|16|16.0||||||
4130667|NCT00906971|3955203|B3|4 >= 10 years||Age, Customized||participants|Number|45|45.0||||||
4130668|NCT00906971|3955204|B2|4 >= 10 years||Age, Customized||participants|Number|25|25.0||||||
4130669|NCT00906971|3955205|B1|4 >= 10 years||Age, Customized||participants|Number|20|20.0||||||
4130670|NCT00906945|3955214|B6|United States||Region of Enrollment||participants|Number|35|35.0||||||
4130671|NCT00906945|3955215|B5|United States||Region of Enrollment||participants|Number|20|20.0||||||
4130672|NCT00906945|3955216|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
4130673|NCT00906945|3955217|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4130674|NCT00906945|3955218|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4130675|NCT00906945|3955219|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4130676|NCT00906945|3955214|B6||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4130677|NCT00906945|3955215|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4130678|NCT00906945|3955216|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4130679|NCT00906945|3955217|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4130680|NCT00906945|3955218|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4130681|NCT00906945|3955219|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4130682|NCT00906945|3955214|B6||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4130683|NCT00906945|3955215|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4130684|NCT00906945|3955216|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4130685|NCT00906945|3955217|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4130686|NCT00906945|3955218|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4130687|NCT00906945|3955219|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4130688|NCT00906945|3955214|B6|||Age||years|Median|56|56.0|Full Range|||24.0|70.0|
4130689|NCT00906945|3955215|B5|||Age||years|Median|56|56.0|Full Range|||29.0|70.0|
4130690|NCT00906945|3955216|B4|||Age||years|Median|54|54.0|Full Range|||34.0|59.0|
4130691|NCT00906945|3955217|B3|||Age||years|Median|64|64.0|Full Range|||24.0|67.0|
4130692|NCT00906945|3955218|B2|||Age||years|Median|47|47.0|Full Range|||43.0|50.0|
4130693|NCT00906945|3955219|B1|||Age||years|Median|63|63.0|Full Range|||59.0|65.0|
4130694|NCT00906789|3955251|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4130695|NCT00906789|3955251|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4130696|NCT00906789|3955251|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4130697|NCT00906789|3955251|B1|number of participants||Age, Customized|>= 25 years old|participants|Number|15|15.0||||||
4130698|NCT00906776|3955259|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4130699|NCT00906776|3955260|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4130700|NCT00906776|3955261|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4130701|NCT00906776|3955259|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4130702|NCT00906776|3955260|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4130703|NCT00906776|3955261|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4130704|NCT00906776|3955259|B3|||Age||years|Mean|34.8|34.8|Standard Deviation|8.6|8.6|||
4130705|NCT00906776|3955260|B2|||Age||years|Mean|31.9|31.9|Standard Deviation|8.6|8.6|||
4130706|NCT00906776|3955261|B1|||Age||years|Mean|36.9|36.9|Standard Deviation|8.9|8.9|||
4130707|NCT00906698|3955278|B7||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4130708|NCT00906698|3955279|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4130709|NCT00906698|3955280|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4130710|NCT00906698|3955281|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4130711|NCT00906698|3955282|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4130712|NCT00906698|3955283|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4130713|NCT00906698|3955284|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4130714|NCT00906698|3955278|B7||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4130715|NCT00906698|3955279|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4130716|NCT00906698|3955280|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4130717|NCT00906698|3955281|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4130718|NCT00906698|3955282|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4130719|NCT00906698|3955283|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4130720|NCT00906698|3955284|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4130721|NCT00906698|3955278|B7|||Age||years|Mean|54.4|54.4|Standard Deviation|9.0|9.0|||
4130722|NCT00906698|3955279|B6|||Age||years|Mean|51.0|51.0|Standard Deviation|8.3|8.3|||
4130723|NCT00906698|3955280|B5|||Age||years|Mean|50.9|50.9|Standard Deviation|9.5|9.5|||
4130724|NCT00906698|3955281|B4|||Age||years|Mean|55.3|55.3|Standard Deviation|6.2|6.2|||
4130725|NCT00906698|3955282|B3|||Age||years|Mean|61.7|61.7|Standard Deviation|5.0|5.0|||
4130726|NCT00906698|3955283|B2|||Age||years|Mean|55.3|55.3|Standard Deviation|8.0|8.0|||
4130727|NCT00906698|3955284|B1|||Age||years|Mean|59.7|59.7|Standard Deviation|15.3|15.3|||
4130728|NCT00906503|3955371|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4130729|NCT00906503|3955371|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4130730|NCT00906503|3955371|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4130731|NCT00906503|3955371|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4130732|NCT00906503|3955371|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4130733|NCT00906503|3955371|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4130734|NCT00906425|3955375|B3|Sweden||Region of Enrollment||participants|Number|11|11.0||||||
4130735|NCT00906425|3955376|B2|Sweden||Region of Enrollment||participants|Number|5|5.0||||||
4130736|NCT00906425|3955377|B1|Sweden||Region of Enrollment||participants|Number|6|6.0||||||
4130737|NCT00906425|3955375|B3|Italy||Region of Enrollment||participants|Number|12|12.0||||||
4130738|NCT00906425|3955376|B2|Italy||Region of Enrollment||participants|Number|6|6.0||||||
4130739|NCT00906425|3955377|B1|Italy||Region of Enrollment||participants|Number|6|6.0||||||
4130740|NCT00906425|3955375|B3|Switzerland||Region of Enrollment||participants|Number|14|14.0||||||
4130741|NCT00906425|3955376|B2|Switzerland||Region of Enrollment||participants|Number|7|7.0||||||
4130742|NCT00906425|3955377|B1|Switzerland||Region of Enrollment||participants|Number|7|7.0||||||
4130743|NCT00906425|3955375|B3|Germany||Region of Enrollment||participants|Number|32|32.0||||||
4130744|NCT00906425|3955376|B2|Germany||Region of Enrollment||participants|Number|14|14.0||||||
4130745|NCT00906425|3955377|B1|Germany||Region of Enrollment||participants|Number|18|18.0||||||
4130746|NCT00906425|3955375|B3|Australia||Region of Enrollment||participants|Number|19|19.0||||||
4130747|NCT00906425|3955376|B2|Australia||Region of Enrollment||participants|Number|9|9.0||||||
4130748|NCT00906425|3955377|B1|Australia||Region of Enrollment||participants|Number|10|10.0||||||
4130749|NCT00906425|3955375|B3|Spain||Region of Enrollment||participants|Number|24|24.0||||||
4130750|NCT00906425|3955376|B2|Spain||Region of Enrollment||participants|Number|12|12.0||||||
4130751|NCT00906425|3955377|B1|Spain||Region of Enrollment||participants|Number|12|12.0||||||
4130752|NCT00906425|3955375|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
4130753|NCT00906425|3955376|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4130754|NCT00906425|3955377|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4130755|NCT00906425|3955375|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4130756|NCT00906425|3955376|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4130757|NCT00906425|3955377|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4130758|NCT00906425|3955375|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4130759|NCT00906425|3955376|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4130760|NCT00906425|3955377|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4130761|NCT00906425|3955375|B3||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4130762|NCT00906425|3955376|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4130763|NCT00906425|3955377|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4130764|NCT00906425|3955375|B3||Between 18 and 65 years|Age||Participants|Count of Participants|121|121.0||||||
4130765|NCT00906425|3955376|B2||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4130766|NCT00906425|3955377|B1||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4130767|NCT00906425|3955375|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4130768|NCT00906425|3955376|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4130769|NCT00906425|3955377|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4130770|NCT00906399|3955388|B4|||Expanded Disability Status Scale (EDSS)|The EDSS measures the disability status of people with multiple sclerosis (MS) on a scale that ranges from 0 to 10. The range of main categories include 0 (normal neurologic exam), to 5 (ambulatory without aid or rest for 200 meters/disability severe enough to impair full daily activities), to 10 (death due to MS).|units on a scale|Mean|2.46|2.46|Standard Deviation|1.226|1.226|||
4130771|NCT00906399|3955389|B3|||Expanded Disability Status Scale (EDSS)|The EDSS measures the disability status of people with multiple sclerosis (MS) on a scale that ranges from 0 to 10. The range of main categories include 0 (normal neurologic exam), to 5 (ambulatory without aid or rest for 200 meters/disability severe enough to impair full daily activities), to 10 (death due to MS).|units on a scale|Mean|2.47|2.47|Standard Deviation|1.255|1.255|||
4130772|NCT00906399|3955390|B2|||Expanded Disability Status Scale (EDSS)|The EDSS measures the disability status of people with multiple sclerosis (MS) on a scale that ranges from 0 to 10. The range of main categories include 0 (normal neurologic exam), to 5 (ambulatory without aid or rest for 200 meters/disability severe enough to impair full daily activities), to 10 (death due to MS).|units on a scale|Mean|2.48|2.48|Standard Deviation|1.244|1.244|||
4130773|NCT00906399|3955391|B1|||Expanded Disability Status Scale (EDSS)|The EDSS measures the disability status of people with multiple sclerosis (MS) on a scale that ranges from 0 to 10. The range of main categories include 0 (normal neurologic exam), to 5 (ambulatory without aid or rest for 200 meters/disability severe enough to impair full daily activities), to 10 (death due to MS).|units on a scale|Mean|2.44|2.44|Standard Deviation|1.180|1.18|||
4130774|NCT00906399|3955388|B4||Male|Sex: Female, Male||Participants|Count of Participants|441|441.0||||||
4130775|NCT00906399|3955389|B3||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4130776|NCT00906399|3955390|B2||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4130777|NCT00906399|3955391|B1||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4130778|NCT00906399|3955388|B4||Female|Sex: Female, Male||Participants|Count of Participants|1071|1071.0||||||
4130779|NCT00906399|3955389|B3||Female|Sex: Female, Male||Participants|Count of Participants|361|361.0||||||
4130780|NCT00906399|3955390|B2||Female|Sex: Female, Male||Participants|Count of Participants|352|352.0||||||
4130781|NCT00906399|3955391|B1||Female|Sex: Female, Male||Participants|Count of Participants|358|358.0||||||
4130782|NCT00906399|3955388|B4|||Age||years|Mean|36.5|36.5|Standard Deviation|9.80|9.8|||
4130783|NCT00906399|3955389|B3|||Age||years|Mean|36.9|36.9|Standard Deviation|9.79|9.79|||
4130784|NCT00906399|3955390|B2|||Age||years|Mean|36.4|36.4|Standard Deviation|9.87|9.87|||
4130785|NCT00906399|3955391|B1|||Age||years|Mean|36.3|36.3|Standard Deviation|9.74|9.74|||
4130786|NCT00906373|3955418|B3|United States||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
4130787|NCT00906373|3955419|B2|United States||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
4130939|NCT00906178|3955513|B2|No||Ever had a boyfriend/girlfriend||participants|Number|46|46.0||||||
4130788|NCT00906373|3955420|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4130789|NCT00906373|3955418|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4130790|NCT00906373|3955419|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4130791|NCT00906373|3955420|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4130792|NCT00906373|3955418|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
4130793|NCT00906373|3955419|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
4130794|NCT00906373|3955420|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4130795|NCT00906373|3955418|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4130796|NCT00906373|3955419|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4130797|NCT00906373|3955420|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4130798|NCT00906373|3955418|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4130799|NCT00906373|3955419|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4130800|NCT00906373|3955420|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4130801|NCT00906373|3955418|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4130802|NCT00906373|3955419|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4130803|NCT00906373|3955420|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4130804|NCT00906373|3955418|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4130805|NCT00906373|3955419|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4130806|NCT00906373|3955420|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4130807|NCT00906373|3955418|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4130808|NCT00906373|3955419|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4130809|NCT00906373|3955420|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4130810|NCT00906373|3955418|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4130811|NCT00906373|3955419|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4130812|NCT00906373|3955420|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4130813|NCT00906373|3955418|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4130814|NCT00906373|3955419|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4130815|NCT00906373|3955420|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4130816|NCT00906373|3955418|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4130817|NCT00906373|3955419|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4130818|NCT00906373|3955420|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4130819|NCT00906373|3955418|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4130820|NCT00906373|3955419|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4130821|NCT00906373|3955420|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4130822|NCT00906373|3955418|B3|||Age||years|Mean|64.2|64.2|Standard Deviation|9.05|9.05|||
4130823|NCT00906373|3955419|B2|||Age||years|Mean|63.7|63.7|Standard Deviation|8.79|8.79|||
4130824|NCT00906373|3955420|B1|||Age||years|Mean|67.3|67.3|Standard Deviation|11.06|11.06|||
4130825|NCT00906347|3955458|B3|United States||Region of Enrollment||participants|Number|350|350.0||||||
4130826|NCT00906347|3955459|B2|United States||Region of Enrollment||participants|Number|174|174.0||||||
4130827|NCT00906347|3955460|B1|United States||Region of Enrollment||participants|Number|176|176.0||||||
4130828|NCT00906347|3955458|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4130829|NCT00906347|3955459|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4130830|NCT00906347|3955460|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4130831|NCT00906347|3955458|B3||Female|Sex: Female, Male||Participants|Count of Participants|350|350.0||||||
4130832|NCT00906347|3955459|B2||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4130833|NCT00906347|3955460|B1||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4130834|NCT00906347|3955458|B3|||Age, Customized||years|Mean|24.5|24.5|Standard Deviation|5.6|5.6|||
4130835|NCT00906347|3955459|B2|||Age, Customized||years|Mean|24.1|24.1|Standard Deviation|5.3|5.3|||
4130836|NCT00906347|3955460|B1|||Age, Customized||years|Mean|24.9|24.9|Standard Deviation|5.8|5.8|||
4130837|NCT00906282|3955481|B1|Stage IIIB||Clinical Stage of Cancer|Number of patients based on clinical stage of disease at study entry.|participants|Number|1|1.0||||||
4130838|NCT00906282|3955481|B1|Stage IIIA||Clinical Stage of Cancer|Number of patients based on clinical stage of disease at study entry.|participants|Number|23|23.0||||||
4130839|NCT00906282|3955481|B1|Stage IIA/II/B||Clinical Stage of Cancer|Number of patients based on clinical stage of disease at study entry.|participants|Number|17|17.0||||||
4130840|NCT00906282|3955481|B1|Stage 1B||Clinical Stage of Cancer|Number of patients based on clinical stage of disease at study entry.|participants|Number|5|5.0||||||
4130841|NCT00906282|3955481|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4130842|NCT00906282|3955481|B1|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4130843|NCT00906282|3955481|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
4130844|NCT00906282|3955481|B1||Male|Gender||Participants|Count of Participants|18|18.0||||||
4130845|NCT00906282|3955481|B1||Female|Gender||Participants|Count of Participants|28|28.0||||||
4130846|NCT00906282|3955481|B1|||Age||years|Median|65|65.0|Full Range|||42.0|82.0|
4130847|NCT00906243|3955489|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4130848|NCT00906243|3955489|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4130849|NCT00906243|3955489|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4130850|NCT00906243|3955489|B1|||Age||years|Mean|69.1|69.1|Standard Deviation|9.58|9.58|||
4130851|NCT00906243|3955489|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4130852|NCT00906243|3955489|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4130853|NCT00906243|3955489|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4130854|NCT00906204|3955493|B3|Deceased donor||Type of kidney donor||participants|Number|40|40.0||||||
4130855|NCT00906204|3955494|B2|Deceased donor||Type of kidney donor||participants|Number|22|22.0||||||
4130856|NCT00906204|3955495|B1|Deceased donor||Type of kidney donor||participants|Number|18|18.0||||||
4130857|NCT00906204|3955493|B3|Living donor||Type of kidney donor||participants|Number|55|55.0||||||
4130858|NCT00906204|3955494|B2|Living donor||Type of kidney donor||participants|Number|29|29.0||||||
4130859|NCT00906204|3955495|B1|Living donor||Type of kidney donor||participants|Number|26|26.0||||||
4130860|NCT00906204|3955493|B3|United States||Region of Enrollment||participants|Number|95|95.0||||||
4130861|NCT00906204|3955494|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
4130862|NCT00906204|3955495|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4130863|NCT00906204|3955493|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4130864|NCT00906204|3955494|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4130865|NCT00906204|3955495|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4130866|NCT00906204|3955493|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4130867|NCT00906204|3955494|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4130868|NCT00906204|3955495|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4130869|NCT00906204|3955493|B3|||Age||years|Mean|48.5|48.5|Standard Deviation|12.1|12.1|||
4130870|NCT00906204|3955494|B2|||Age||years|Mean|49.0|49.0|Standard Deviation|12.4|12.4|||
4130871|NCT00906204|3955495|B1|||Age||years|Mean|48.0|48.0|Standard Deviation|11.8|11.8|||
4130872|NCT00906204|3955493|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4130873|NCT00906204|3955494|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4130874|NCT00906204|3955495|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4130875|NCT00906204|3955493|B3||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
4130876|NCT00906204|3955494|B2||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4130877|NCT00906204|3955495|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4130878|NCT00906204|3955493|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4130879|NCT00906204|3955494|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4130880|NCT00906204|3955495|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4130881|NCT00906178|3955512|B3|||Behavioral Skills|This measure has scores possibly ranging form 1 to 5 with higher scores reflecting more skills|units on a scale|Mean|2.9|2.9|Standard Deviation|.7|0.7|||
4130882|NCT00906178|3955513|B2|||Behavioral Skills|This measure has scores possibly ranging form 1 to 5 with higher scores reflecting more skills|units on a scale|Mean|2.9|2.9|Standard Deviation|.7|0.7|||
4130883|NCT00906178|3955514|B1|||Behavioral Skills|This measure has scores possibly ranging form 1 to 5 with higher scores reflecting more skills|units on a scale|Mean|2.9|2.9|Standard Deviation|.7|0.7|||
4130884|NCT00906178|3955512|B3|||Motivation: Behavioral intentions for HIV prevention|This measure has scores possibly ranging form 1 to 5 with higher scores reflecting more motivation|units on a scale|Mean|3.5|3.5|Standard Deviation|.9|0.9|||
4130885|NCT00906178|3955513|B2|||Motivation: Behavioral intentions for HIV prevention|This measure has scores possibly ranging form 1 to 5 with higher scores reflecting more motivation|units on a scale|Mean|3.5|3.5|Standard Deviation|.9|0.9|||
4130886|NCT00906178|3955514|B1|||Motivation: Behavioral intentions for HIV prevention|This measure has scores possibly ranging form 1 to 5 with higher scores reflecting more motivation|units on a scale|Mean|3.5|3.5|Standard Deviation|.9|0.9|||
4130887|NCT00906178|3955512|B3|||Motivation: Subjective norms regarding HIV preventive acts|This measure has scores possibly ranging form 1 to 5 with higher scores reflecting more motivation|units on a scale|Mean|3.6|3.6|Standard Deviation|.9|0.9|||
4130888|NCT00906178|3955513|B2|||Motivation: Subjective norms regarding HIV preventive acts|This measure has scores possibly ranging form 1 to 5 with higher scores reflecting more motivation|units on a scale|Mean|3.5|3.5|Standard Deviation|.9|0.9|||
4130889|NCT00906178|3955514|B1|||Motivation: Subjective norms regarding HIV preventive acts|This measure has scores possibly ranging form 1 to 5 with higher scores reflecting more motivation|units on a scale|Mean|3.6|3.6|Standard Deviation|.9|0.9|||
4130890|NCT00906178|3955512|B3|||Motivation: Attitudes towards HIV preventive acts|This measure has scores possibly ranging form 1 to 5 with higher scores reflecting more motivation|units on a scale|Mean|3.6|3.6|Standard Deviation|.9|0.9|||
4130891|NCT00906178|3955513|B2|||Motivation: Attitudes towards HIV preventive acts|This measure has scores possibly ranging form 1 to 5 with higher scores reflecting more motivation|units on a scale|Mean|3.5|3.5|Standard Deviation|.9|0.9|||
4130892|NCT00906178|3955514|B1|||Motivation: Attitudes towards HIV preventive acts|This measure has scores possibly ranging form 1 to 5 with higher scores reflecting more motivation|units on a scale|Mean|3.6|3.6|Standard Deviation|.9|0.9|||
4130893|NCT00906178|3955512|B3|No||Information|80% or more answers about HIV correct|participants|Number|183|183.0||||||
4130894|NCT00906178|3955513|B2|No||Information|80% or more answers about HIV correct|participants|Number|86|86.0||||||
4130895|NCT00906178|3955514|B1|No||Information|80% or more answers about HIV correct|participants|Number|97|97.0||||||
4130896|NCT00906178|3955512|B3|Yes||Information|80% or more answers about HIV correct|participants|Number|183|183.0||||||
4130897|NCT00906178|3955513|B2|Yes||Information|80% or more answers about HIV correct|participants|Number|97|97.0||||||
4130898|NCT00906178|3955514|B1|Yes||Information|80% or more answers about HIV correct|participants|Number|86|86.0||||||
4130899|NCT00906178|3955512|B3|||The Multidimensional Scale of Perceived Social Support: Social support from family|This measure has scores possibly ranging form 1 to 20 with higher scores reflecting more support|units on a scale|Mean|17.4|17.4|Standard Deviation|3.1|3.1|||
4130900|NCT00906178|3955513|B2|||The Multidimensional Scale of Perceived Social Support: Social support from family|This measure has scores possibly ranging form 1 to 20 with higher scores reflecting more support|units on a scale|Mean|17.7|17.7|Standard Deviation|3.0|3.0|||
4130901|NCT00906178|3955514|B1|||The Multidimensional Scale of Perceived Social Support: Social support from family|This measure has scores possibly ranging form 1 to 20 with higher scores reflecting more support|units on a scale|Mean|17.1|17.1|Standard Deviation|3.1|3.1|||
4130902|NCT00906178|3955512|B3|||"The Multidimensional Scale of Perceived Social Support : Social support from special person"|This measure has scores possibly ranging form 1 to 20 with higher scores reflecting more support|units on a scale|Mean|16.5|16.5|Standard Deviation|4.0|4.0|||
4130903|NCT00906178|3955513|B2|||"The Multidimensional Scale of Perceived Social Support : Social support from special person"|This measure has scores possibly ranging form 1 to 20 with higher scores reflecting more support|units on a scale|Mean|16.2|16.2|Standard Deviation|4.1|4.1|||
4130904|NCT00906178|3955514|B1|||"The Multidimensional Scale of Perceived Social Support : Social support from special person"|This measure has scores possibly ranging form 1 to 20 with higher scores reflecting more support|units on a scale|Mean|16.7|16.7|Standard Deviation|2.8|2.8|||
4130905|NCT00906178|3955512|B3|No||Wish to have more self-respect||participants|Number|73|73.0||||||
4130906|NCT00906178|3955513|B2|No||Wish to have more self-respect||participants|Number|39|39.0||||||
4130907|NCT00906178|3955514|B1|No||Wish to have more self-respect||participants|Number|34|34.0||||||
4130908|NCT00906178|3955512|B3|Yes||Wish to have more self-respect||participants|Number|293|293.0||||||
4130909|NCT00906178|3955513|B2|Yes||Wish to have more self-respect||participants|Number|144|144.0||||||
4130910|NCT00906178|3955514|B1|Yes||Wish to have more self-respect||participants|Number|149|149.0||||||
4130911|NCT00906178|3955512|B3|No||Bright future somewhat/very unlikely|subject chose between somewhat likely and very likely|participants|Number|331|331.0||||||
4130912|NCT00906178|3955513|B2|No||Bright future somewhat/very unlikely|subject chose between somewhat likely and very likely|participants|Number|168|168.0||||||
4130913|NCT00906178|3955514|B1|No||Bright future somewhat/very unlikely|subject chose between somewhat likely and very likely|participants|Number|163|163.0||||||
4130914|NCT00906178|3955512|B3|Yes||Bright future somewhat/very unlikely|subject chose between somewhat likely and very likely|participants|Number|35|35.0||||||
4130915|NCT00906178|3955513|B2|Yes||Bright future somewhat/very unlikely|subject chose between somewhat likely and very likely|participants|Number|15|15.0||||||
4130916|NCT00906178|3955514|B1|Yes||Bright future somewhat/very unlikely|subject chose between somewhat likely and very likely|participants|Number|20|20.0||||||
4130917|NCT00906178|3955512|B3|No||Fair or poor health||participants|Number|307|307.0||||||
4130918|NCT00906178|3955513|B2|No||Fair or poor health||participants|Number|159|159.0||||||
4130919|NCT00906178|3955514|B1|No||Fair or poor health||participants|Number|148|148.0||||||
4130920|NCT00906178|3955512|B3|Yes||Fair or poor health||participants|Number|59|59.0||||||
4130921|NCT00906178|3955513|B2|Yes||Fair or poor health||participants|Number|24|24.0||||||
4130922|NCT00906178|3955514|B1|Yes||Fair or poor health||participants|Number|35|35.0||||||
4130923|NCT00906178|3955512|B3|||Beliefs consistent with female empowerment in relationships|This measure has scores that can range from 2 to 10 with higher scores being higher in these beliefs|units on a scale|Mean|8.1|8.1|Standard Deviation|2.8|2.8|||
4130924|NCT00906178|3955513|B2|||Beliefs consistent with female empowerment in relationships|This measure has scores that can range from 2 to 10 with higher scores being higher in these beliefs|units on a scale|Mean|8.0|8.0|Standard Deviation|2.8|2.8|||
4130925|NCT00906178|3955514|B1|||Beliefs consistent with female empowerment in relationships|This measure has scores that can range from 2 to 10 with higher scores being higher in these beliefs|units on a scale|Mean|8.2|8.2|Standard Deviation|2.8|2.8|||
4130926|NCT00906178|3955512|B3|No||Ever been a perpetrator of teen dating violence||participants|Number|301|301.0||||||
4130927|NCT00906178|3955513|B2|No||Ever been a perpetrator of teen dating violence||participants|Number|146|146.0||||||
4130928|NCT00906178|3955514|B1|No||Ever been a perpetrator of teen dating violence||participants|Number|155|155.0||||||
4130929|NCT00906178|3955512|B3|Yes||Ever been a perpetrator of teen dating violence||participants|Number|65|65.0||||||
4130930|NCT00906178|3955513|B2|Yes||Ever been a perpetrator of teen dating violence||participants|Number|37|37.0||||||
4130931|NCT00906178|3955514|B1|Yes||Ever been a perpetrator of teen dating violence||participants|Number|28|28.0||||||
4130932|NCT00906178|3955512|B3|No||Ever been a victim of teen dating violence||participants|Number|288|288.0||||||
4130933|NCT00906178|3955513|B2|No||Ever been a victim of teen dating violence||participants|Number|140|140.0||||||
4130934|NCT00906178|3955514|B1|No||Ever been a victim of teen dating violence||participants|Number|148|148.0||||||
4130935|NCT00906178|3955512|B3|Yes||Ever been a victim of teen dating violence||participants|Number|78|78.0||||||
4130936|NCT00906178|3955513|B2|Yes||Ever been a victim of teen dating violence||participants|Number|43|43.0||||||
4130937|NCT00906178|3955514|B1|Yes||Ever been a victim of teen dating violence||participants|Number|35|35.0||||||
4130938|NCT00906178|3955512|B3|No||Ever had a boyfriend/girlfriend||participants|Number|88|88.0||||||
4130940|NCT00906178|3955514|B1|No||Ever had a boyfriend/girlfriend||participants|Number|42|42.0||||||
4130941|NCT00906178|3955512|B3|Yes||Ever had a boyfriend/girlfriend||participants|Number|278|278.0||||||
4130942|NCT00906178|3955513|B2|Yes||Ever had a boyfriend/girlfriend||participants|Number|137|137.0||||||
4130943|NCT00906178|3955514|B1|Yes||Ever had a boyfriend/girlfriend||participants|Number|141|141.0||||||
4130944|NCT00906178|3955512|B3|||Beliefs supportive of HIV Stigma|This measure has a range from 0 to 4 with higher scores reflecting greater HIV stigma|units on a scale|Mean|1.1|1.1|Standard Deviation|1.0|1.0|||
4130945|NCT00906178|3955513|B2|||Beliefs supportive of HIV Stigma|This measure has a range from 0 to 4 with higher scores reflecting greater HIV stigma|units on a scale|Mean|1.2|1.2|Standard Deviation|1.1|1.1|||
4130946|NCT00906178|3955514|B1|||Beliefs supportive of HIV Stigma|This measure has a range from 0 to 4 with higher scores reflecting greater HIV stigma|units on a scale|Mean|1.1|1.1|Standard Deviation|.9|0.9|||
4130947|NCT00906178|3955512|B3|No||Above average change of getting HIV|Self-appraisal of one's likelihood of getting HIV|participants|Number|342|342.0||||||
4130948|NCT00906178|3955513|B2|No||Above average change of getting HIV|Self-appraisal of one's likelihood of getting HIV|participants|Number|171|171.0||||||
4130949|NCT00906178|3955514|B1|No||Above average change of getting HIV|Self-appraisal of one's likelihood of getting HIV|participants|Number|171|171.0||||||
4130950|NCT00906178|3955512|B3|Yes||Above average change of getting HIV|Self-appraisal of one's likelihood of getting HIV|participants|Number|24|24.0||||||
4130951|NCT00906178|3955513|B2|Yes||Above average change of getting HIV|Self-appraisal of one's likelihood of getting HIV|participants|Number|12|12.0||||||
4130952|NCT00906178|3955514|B1|Yes||Above average change of getting HIV|Self-appraisal of one's likelihood of getting HIV|participants|Number|12|12.0||||||
4130953|NCT00906178|3955512|B3|Do not Somewhat/strongly agree||Tired of hearing about HIV prevention information||participants|Number|272|272.0||||||
4130954|NCT00906178|3955513|B2|Do not Somewhat/strongly agree||Tired of hearing about HIV prevention information||participants|Number|134|134.0||||||
4130955|NCT00906178|3955514|B1|Do not Somewhat/strongly agree||Tired of hearing about HIV prevention information||participants|Number|138|138.0||||||
4130956|NCT00906178|3955512|B3|Somewhat/strongly agree||Tired of hearing about HIV prevention information||participants|Number|94|94.0||||||
4130957|NCT00906178|3955513|B2|Somewhat/strongly agree||Tired of hearing about HIV prevention information||participants|Number|49|49.0||||||
4130958|NCT00906178|3955514|B1|Somewhat/strongly agree||Tired of hearing about HIV prevention information||participants|Number|45|45.0||||||
4130959|NCT00906178|3955512|B3|No||Ever known someone who died from AIDS||participants|Number|228|228.0||||||
4130960|NCT00906178|3955513|B2|No||Ever known someone who died from AIDS||participants|Number|112|112.0||||||
4130961|NCT00906178|3955514|B1|No||Ever known someone who died from AIDS||participants|Number|116|116.0||||||
4130962|NCT00906178|3955512|B3|Yes||Ever known someone who died from AIDS||participants|Number|138|138.0||||||
4130963|NCT00906178|3955513|B2|Yes||Ever known someone who died from AIDS||participants|Number|71|71.0||||||
4130964|NCT00906178|3955514|B1|Yes||Ever known someone who died from AIDS||participants|Number|67|67.0||||||
4130965|NCT00906178|3955512|B3|No||Ever Been Tested for HIV||participants|Number|227|227.0||||||
4130966|NCT00906178|3955513|B2|No||Ever Been Tested for HIV||participants|Number|119|119.0||||||
4130967|NCT00906178|3955514|B1|No||Ever Been Tested for HIV||participants|Number|108|108.0||||||
4130968|NCT00906178|3955512|B3|Yes||Ever Been Tested for HIV||participants|Number|139|139.0||||||
4130969|NCT00906178|3955513|B2|Yes||Ever Been Tested for HIV||participants|Number|64|64.0||||||
4130970|NCT00906178|3955514|B1|Yes||Ever Been Tested for HIV||participants|Number|75|75.0||||||
4130971|NCT00906178|3955512|B3|No||Ever Had Anal Sex||participants|Number|357|357.0||||||
4130972|NCT00906178|3955513|B2|No||Ever Had Anal Sex||participants|Number|178|178.0||||||
4130973|NCT00906178|3955514|B1|No||Ever Had Anal Sex||participants|Number|179|179.0||||||
4130974|NCT00906178|3955512|B3|Yes||Ever Had Anal Sex||participants|Number|9|9.0||||||
4130975|NCT00906178|3955513|B2|Yes||Ever Had Anal Sex||participants|Number|5|5.0||||||
4130976|NCT00906178|3955514|B1|Yes||Ever Had Anal Sex||participants|Number|4|4.0||||||
4130977|NCT00906178|3955512|B3|No||Ever Had Vaginal Sex||participants|Number|253|253.0||||||
4130978|NCT00906178|3955513|B2|No||Ever Had Vaginal Sex||participants|Number|128|128.0||||||
4130979|NCT00906178|3955514|B1|No||Ever Had Vaginal Sex||participants|Number|125|125.0||||||
4130980|NCT00906178|3955512|B3|Yes||Ever Had Vaginal Sex||participants|Number|113|113.0||||||
4130981|NCT00906178|3955513|B2|Yes||Ever Had Vaginal Sex||participants|Number|55|55.0||||||
4130982|NCT00906178|3955514|B1|Yes||Ever Had Vaginal Sex||participants|Number|58|58.0||||||
4130983|NCT00906178|3955512|B3|No||Ever Had Oral Sex||participants|Number|330|330.0||||||
4130984|NCT00906178|3955513|B2|No||Ever Had Oral Sex||participants|Number|166|166.0||||||
4130985|NCT00906178|3955514|B1|No||Ever Had Oral Sex||participants|Number|164|164.0||||||
4130986|NCT00906178|3955512|B3|Yes||Ever Had Oral Sex||participants|Number|36|36.0||||||
4130987|NCT00906178|3955513|B2|Yes||Ever Had Oral Sex||participants|Number|17|17.0||||||
4130988|NCT00906178|3955514|B1|Yes||Ever Had Oral Sex||participants|Number|19|19.0||||||
4130989|NCT00906178|3955512|B3|Frequent||Internet Use||participants|Number|163|163.0||||||
4130990|NCT00906178|3955513|B2|Frequent||Internet Use||participants|Number|81|81.0||||||
4130991|NCT00906178|3955514|B1|Frequent||Internet Use||participants|Number|82|82.0||||||
4130992|NCT00906178|3955512|B3|Infrequent||Internet Use||participants|Number|203|203.0||||||
4130993|NCT00906178|3955513|B2|Infrequent||Internet Use||participants|Number|102|102.0||||||
4130994|NCT00906178|3955514|B1|Infrequent||Internet Use||participants|Number|101|101.0||||||
4130995|NCT00906178|3955512|B3|More Than Primary School||Paternal Education||participants|Number|268|268.0||||||
4130996|NCT00906178|3955513|B2|More Than Primary School||Paternal Education||participants|Number|133|133.0||||||
4130997|NCT00906178|3955514|B1|More Than Primary School||Paternal Education||participants|Number|135|135.0||||||
4130998|NCT00906178|3955512|B3|Primary School or Less/Don't Know||Paternal Education||participants|Number|98|98.0||||||
4130999|NCT00906178|3955513|B2|Primary School or Less/Don't Know||Paternal Education||participants|Number|50|50.0||||||
4131000|NCT00906178|3955514|B1|Primary School or Less/Don't Know||Paternal Education||participants|Number|48|48.0||||||
4131001|NCT00906178|3955512|B3|More Than Primary School||Maternal Education||participants|Number|243|243.0||||||
4131002|NCT00906178|3955513|B2|More Than Primary School||Maternal Education||participants|Number|120|120.0||||||
4131003|NCT00906178|3955514|B1|More Than Primary School||Maternal Education||participants|Number|123|123.0||||||
4131004|NCT00906178|3955512|B3|Primary School or Less/Don't Know||Maternal Education||participants|Number|123|123.0||||||
4131005|NCT00906178|3955513|B2|Primary School or Less/Don't Know||Maternal Education||participants|Number|63|63.0||||||
4131006|NCT00906178|3955514|B1|Primary School or Less/Don't Know||Maternal Education||participants|Number|60|60.0||||||
4131007|NCT00906178|3955512|B3|Secondary 4||Grade||participants|Number|138|138.0||||||
4131008|NCT00906178|3955513|B2|Secondary 4||Grade||participants|Number|75|75.0||||||
4131009|NCT00906178|3955514|B1|Secondary 4||Grade||participants|Number|63|63.0||||||
4131010|NCT00906178|3955512|B3|Secondary 3||Grade||participants|Number|131|131.0||||||
4131011|NCT00906178|3955513|B2|Secondary 3||Grade||participants|Number|58|58.0||||||
4131012|NCT00906178|3955514|B1|Secondary 3||Grade||participants|Number|73|73.0||||||
4131013|NCT00906178|3955512|B3|Secondary 2||Grade||participants|Number|97|97.0||||||
4131014|NCT00906178|3955513|B2|Secondary 2||Grade||participants|Number|50|50.0||||||
4131015|NCT00906178|3955514|B1|Secondary 2||Grade||participants|Number|47|47.0||||||
4131016|NCT00906178|3955512|B3||Male|Sex: Female, Male||Participants|Count of Participants|307|307.0||||||
4131017|NCT00906178|3955513|B2||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4131018|NCT00906178|3955514|B1||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4131019|NCT00906178|3955512|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4131020|NCT00906178|3955513|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4131021|NCT00906178|3955514|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4131022|NCT00906178|3955512|B3|||Age||years|Mean|16.1|16.1|Standard Deviation|1.4|1.4|||
4131023|NCT00906178|3955513|B2|||Age||years|Mean|16.2|16.2|Standard Deviation|1.5|1.5|||
4131024|NCT00906178|3955514|B1|||Age||years|Mean|16.0|16.0|Standard Deviation|1.4|1.4|||
4131025|NCT00906087|3955527|B1|After 4 week washout||Intraocular pressure left eye||mmHg|Mean|20.4|20.4|Standard Deviation|5.57|5.57|||
4131026|NCT00906087|3955527|B1|Baseline at initial visit||Intraocular pressure left eye||mmHg|Mean|16.4|16.4|Standard Deviation|3.61|3.61|||
4131027|NCT00906087|3955527|B1|After 4 week washout||Intraocular pressure right eye|Baseline intraocular pressure = on current treatment|mmHg|Mean|19.9|19.9|Standard Deviation|4.33|4.33|||
4131028|NCT00906087|3955527|B1|Baseline at initial visit||Intraocular pressure right eye|Baseline intraocular pressure = on current treatment|mmHg|Mean|15.6|15.6|Standard Deviation|2.10|2.1|||
4131029|NCT00906087|3955527|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4131030|NCT00906087|3955527|B1||Male|Sex: Female, Male|Number of males and females|Participants|Count of Participants|10|10.0||||||
4131031|NCT00906087|3955527|B1||Female|Sex: Female, Male|Number of males and females|Participants|Count of Participants|4|4.0||||||
4131032|NCT00906087|3955527|B1|||Age||years|Mean|60|60.0|Standard Deviation|19.5|19.5|||
4131033|NCT00906074|3955534|B3||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4131034|NCT00906074|3955535|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4131035|NCT00906074|3955536|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4131036|NCT00906074|3955534|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4131037|NCT00906074|3955535|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4131038|NCT00906074|3955536|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4131039|NCT00906074|3955534|B3|||Age||years|Mean|60.47|60.47|Standard Deviation|18.44|18.44|||
4131040|NCT00906074|3955535|B2|||Age||years|Mean|58.46|58.46|Standard Deviation|20.40|20.4|||
4131041|NCT00906074|3955536|B1|||Age||years|Mean|62.49|62.49|Standard Deviation|16.11|16.11|||
4131042|NCT00906035|3955561|B4|United States||Region of Enrollment||participants|Number|25|25.0||||||
4131043|NCT00906035|3955562|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4131044|NCT00906035|3955563|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4131045|NCT00906035|3955564|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4131046|NCT00906035|3955561|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4131047|NCT00906035|3955562|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4131048|NCT00906035|3955563|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4131049|NCT00906035|3955564|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4131050|NCT00906035|3955561|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4131051|NCT00906035|3955562|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4131052|NCT00906035|3955563|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4131053|NCT00906035|3955564|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4131054|NCT00906035|3955561|B4||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4131055|NCT00906035|3955562|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4131056|NCT00906035|3955563|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4131057|NCT00906035|3955564|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4131058|NCT00906035|3955561|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4131059|NCT00906035|3955562|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4131060|NCT00906035|3955563|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4131061|NCT00906035|3955564|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4131062|NCT00906035|3955561|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131063|NCT00906035|3955562|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131064|NCT00906035|3955563|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131065|NCT00906035|3955564|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131066|NCT00905840|3955580|B1|Switzerland||Region of Enrollment||participants|Number|20|20.0||||||
4131067|NCT00905840|3955580|B1|Italy||Region of Enrollment||participants|Number|14|14.0||||||
4131068|NCT00905840|3955580|B1|Germany||Region of Enrollment||participants|Number|28|28.0||||||
4131069|NCT00905840|3955580|B1|Netherlands||Region of Enrollment||participants|Number|12|12.0||||||
4131070|NCT00905840|3955580|B1|Belgium||Region of Enrollment||participants|Number|17|17.0||||||
4131071|NCT00905840|3955580|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4131072|NCT00905840|3955580|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4131073|NCT00905840|3955580|B1||>=65 years|Age||Participants|Count of Participants|47|47.0||||||
4131074|NCT00905840|3955580|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4131075|NCT00905840|3955580|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131076|NCT00905827|3955589|B4|Midlevel Provider||Profession||participants|Number|129|129.0||||||
4131077|NCT00905827|3955590|B3|Midlevel Provider||Profession||participants|Number|43|43.0||||||
4131078|NCT00905827|3955591|B2|Midlevel Provider||Profession||participants|Number|44|44.0||||||
4131079|NCT00905827|3955592|B1|Midlevel Provider||Profession||participants|Number|42|42.0||||||
4131080|NCT00905827|3955589|B4|Psychologist||Profession||participants|Number|47|47.0||||||
4131081|NCT00905827|3955590|B3|Psychologist||Profession||participants|Number|18|18.0||||||
4131082|NCT00905827|3955591|B2|Psychologist||Profession||participants|Number|13|13.0||||||
4131083|NCT00905827|3955592|B1|Psychologist||Profession||participants|Number|16|16.0||||||
4131084|NCT00905827|3955589|B4|Psychiatrist||Profession||participants|Number|36|36.0||||||
4131085|NCT00905827|3955590|B3|Psychiatrist||Profession||participants|Number|12|12.0||||||
4131086|NCT00905827|3955591|B2|Psychiatrist||Profession||participants|Number|12|12.0||||||
4131087|NCT00905827|3955592|B1|Psychiatrist||Profession||participants|Number|12|12.0||||||
4131088|NCT00905827|3955589|B4|Other||Race/Ethnicity, Customized|Not all participants reported race, hence there may be differences in overall number|participants|Number|11|11.0||||||
4131089|NCT00905827|3955590|B3|Other||Race/Ethnicity, Customized|Not all participants reported race, hence there may be differences in overall number|participants|Number|4|4.0||||||
4131090|NCT00905827|3955591|B2|Other||Race/Ethnicity, Customized|Not all participants reported race, hence there may be differences in overall number|participants|Number|1|1.0||||||
4131091|NCT00905827|3955592|B1|Other||Race/Ethnicity, Customized|Not all participants reported race, hence there may be differences in overall number|participants|Number|6|6.0||||||
4131092|NCT00905827|3955589|B4|Hispanic||Race/Ethnicity, Customized|Not all participants reported race, hence there may be differences in overall number|participants|Number|3|3.0||||||
4131093|NCT00905827|3955590|B3|Hispanic||Race/Ethnicity, Customized|Not all participants reported race, hence there may be differences in overall number|participants|Number|1|1.0||||||
4131094|NCT00905827|3955591|B2|Hispanic||Race/Ethnicity, Customized|Not all participants reported race, hence there may be differences in overall number|participants|Number|2|2.0||||||
4131095|NCT00905827|3955592|B1|Hispanic||Race/Ethnicity, Customized|Not all participants reported race, hence there may be differences in overall number|participants|Number|0|0.0||||||
4131096|NCT00905827|3955589|B4|African American||Race/Ethnicity, Customized|Not all participants reported race, hence there may be differences in overall number|participants|Number|48|48.0||||||
4131097|NCT00905827|3955590|B3|African American||Race/Ethnicity, Customized|Not all participants reported race, hence there may be differences in overall number|participants|Number|14|14.0||||||
4131098|NCT00905827|3955591|B2|African American||Race/Ethnicity, Customized|Not all participants reported race, hence there may be differences in overall number|participants|Number|19|19.0||||||
4131099|NCT00905827|3955592|B1|African American||Race/Ethnicity, Customized|Not all participants reported race, hence there may be differences in overall number|participants|Number|15|15.0||||||
4131100|NCT00905827|3955589|B4|White||Race/Ethnicity, Customized|Not all participants reported race, hence there may be differences in overall number|participants|Number|136|136.0||||||
4131101|NCT00905827|3955590|B3|White||Race/Ethnicity, Customized|Not all participants reported race, hence there may be differences in overall number|participants|Number|46|46.0||||||
4131102|NCT00905827|3955591|B2|White||Race/Ethnicity, Customized|Not all participants reported race, hence there may be differences in overall number|participants|Number|45|45.0||||||
4131103|NCT00905827|3955592|B1|White||Race/Ethnicity, Customized|Not all participants reported race, hence there may be differences in overall number|participants|Number|45|45.0||||||
4131104|NCT00905827|3955589|B4||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4131105|NCT00905827|3955590|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4131106|NCT00905827|3955591|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4131107|NCT00905827|3955592|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4131108|NCT00905827|3955589|B4||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4131109|NCT00905827|3955590|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4131110|NCT00905827|3955591|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4131111|NCT00905827|3955592|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4131112|NCT00905827|3955589|B4|60-69 years||Age, Customized||participants|Number|22|22.0||||||
4131113|NCT00905827|3955590|B3|60-69 years||Age, Customized||participants|Number|4|4.0||||||
4131114|NCT00905827|3955591|B2|60-69 years||Age, Customized||participants|Number|8|8.0||||||
4131115|NCT00905827|3955592|B1|60-69 years||Age, Customized||participants|Number|10|10.0||||||
4131116|NCT00905827|3955589|B4|50-59 years||Age, Customized||participants|Number|59|59.0||||||
4131117|NCT00905827|3955590|B3|50-59 years||Age, Customized||participants|Number|18|18.0||||||
4131118|NCT00905827|3955591|B2|50-59 years||Age, Customized||participants|Number|22|22.0||||||
4131119|NCT00905827|3955592|B1|50-59 years||Age, Customized||participants|Number|19|19.0||||||
4131120|NCT00905827|3955589|B4|40-49 years||Age, Customized||participants|Number|50|50.0||||||
4131121|NCT00905827|3955590|B3|40-49 years||Age, Customized||participants|Number|22|22.0||||||
4131122|NCT00905827|3955591|B2|40-49 years||Age, Customized||participants|Number|13|13.0||||||
4131123|NCT00905827|3955592|B1|40-49 years||Age, Customized||participants|Number|15|15.0||||||
4131124|NCT00905827|3955589|B4|30-39 years||Age, Customized||participants|Number|67|67.0||||||
4131125|NCT00905827|3955590|B3|30-39 years||Age, Customized||participants|Number|23|23.0||||||
4131126|NCT00905827|3955591|B2|30-39 years||Age, Customized||participants|Number|22|22.0||||||
4131127|NCT00905827|3955592|B1|30-39 years||Age, Customized||participants|Number|22|22.0||||||
4131128|NCT00905827|3955589|B4|20-29 years||Age, Customized||participants|Number|14|14.0||||||
4131129|NCT00905827|3955590|B3|20-29 years||Age, Customized||participants|Number|6|6.0||||||
4131130|NCT00905827|3955591|B2|20-29 years||Age, Customized||participants|Number|4|4.0||||||
4131131|NCT00905827|3955592|B1|20-29 years||Age, Customized||participants|Number|4|4.0||||||
4131132|NCT00905632|3955604|B8||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4131133|NCT00905632|3955605|B7||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4131134|NCT00905632|3955606|B6||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4131135|NCT00905632|3955607|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4131136|NCT00905632|3955608|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4131137|NCT00905632|3955609|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4131138|NCT00905632|3955610|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4131139|NCT00905632|3955611|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4131140|NCT00905632|3955604|B8||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4131141|NCT00905632|3955605|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4131142|NCT00905632|3955606|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4131143|NCT00905632|3955607|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4131144|NCT00905632|3955608|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4131145|NCT00905632|3955609|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4131146|NCT00905632|3955610|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4131147|NCT00905632|3955611|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4131148|NCT00905632|3955604|B8|||Age||years|Mean|48.930|48.93|Standard Deviation|10.863|10.863|||
4131149|NCT00905632|3955605|B7|||Age||years|Mean|53.727|53.727|Standard Deviation|10.287|10.287|||
4131150|NCT00905632|3955606|B6|||Age||years|Mean|50.889|50.889|Standard Deviation|11.252|11.252|||
4131151|NCT00905632|3955607|B5|||Age||years|Mean|49.200|49.2|Standard Deviation|5.996|5.996|||
4131152|NCT00905632|3955608|B4|||Age||years|Mean|46.167|46.167|Standard Deviation|13.963|13.963|||
4131153|NCT00905632|3955609|B3|||Age||years|Mean|42.571|42.571|Standard Deviation|11.731|11.731|||
4131154|NCT00905632|3955610|B2|||Age||years|Mean|43.833|43.833|Standard Deviation|15.459|15.459|||
4131155|NCT00905632|3955611|B1|||Age||years|Mean|51.250|51.25|Standard Deviation|7.573|7.573|||
4131156|NCT00905606|3955753|B3|Canada||Region of Enrollment||participants|Number|30|30.0||||||
4131157|NCT00905606|3955754|B2|Canada||Region of Enrollment||participants|Number|15|15.0||||||
4131158|NCT00905606|3955755|B1|Canada||Region of Enrollment||participants|Number|15|15.0||||||
4131159|NCT00905606|3955753|B3|American Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4131160|NCT00905606|3955754|B2|American Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4131161|NCT00905606|3955755|B1|American Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4131162|NCT00905606|3955753|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
4131163|NCT00905606|3955754|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4131164|NCT00905606|3955755|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4131165|NCT00905606|3955753|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4131166|NCT00905606|3955754|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4131167|NCT00905606|3955755|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4131168|NCT00905606|3955753|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4131169|NCT00905606|3955754|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4131170|NCT00905606|3955755|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4131171|NCT00905606|3955753|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4131172|NCT00905606|3955754|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4131173|NCT00905606|3955755|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4131174|NCT00905606|3955753|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4131175|NCT00905606|3955754|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4131176|NCT00905606|3955755|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4131177|NCT00905606|3955753|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131178|NCT00905606|3955754|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131179|NCT00905606|3955755|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131180|NCT00905580|3955764|B3|Korea, Republic of||Region of Enrollment||participants|Number|99|99.0||||||
4131181|NCT00905580|3955765|B2|Korea, Republic of||Region of Enrollment||participants|Number|50|50.0||||||
4131182|NCT00905580|3955766|B1|Korea, Republic of||Region of Enrollment||participants|Number|49|49.0||||||
4131183|NCT00905580|3955764|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4131184|NCT00905580|3955765|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4131185|NCT00905580|3955766|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4131186|NCT00905580|3955764|B3||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4131187|NCT00905580|3955765|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4131188|NCT00905580|3955766|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4131189|NCT00905580|3955764|B3|||Age||years|Mean|38.2|38.2|Standard Deviation|8.9|8.9|||
4131190|NCT00905580|3955765|B2|||Age||years|Mean|38.0|38.0|Standard Deviation|8.2|8.2|||
4131191|NCT00905580|3955766|B1|||Age||years|Mean|38.5|38.5|Standard Deviation|9.5|9.5|||
4131192|NCT00905580|3955764|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4131193|NCT00905580|3955765|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4131194|NCT00905580|3955766|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4131195|NCT00905580|3955764|B3||Between 18 and 65 years|Age||Participants|Count of Participants|99|99.0||||||
4131196|NCT00905580|3955765|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4131197|NCT00905580|3955766|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4131198|NCT00905580|3955764|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131199|NCT00905580|3955765|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131200|NCT00905580|3955766|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131201|NCT00905567|3955779|B3|Canada||Region of Enrollment||participants|Number|24|24.0||||||
4131202|NCT00905567|3955780|B2|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4131203|NCT00905567|3955781|B1|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4131204|NCT00905567|3955779|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
4131205|NCT00905567|3955780|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4131206|NCT00905567|3955781|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4131207|NCT00905567|3955779|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4131208|NCT00905567|3955780|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4131209|NCT00905567|3955781|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4131210|NCT00905567|3955779|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4131211|NCT00905567|3955780|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4131212|NCT00905567|3955781|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4131213|NCT00905567|3955779|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4131214|NCT00905567|3955780|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4131215|NCT00905567|3955781|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4131216|NCT00905567|3955779|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4131217|NCT00905567|3955780|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4131218|NCT00905567|3955781|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4131219|NCT00905567|3955779|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131220|NCT00905567|3955780|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131221|NCT00905567|3955781|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131222|NCT00905554|3955790|B3|Italy||Region of Enrollment||participants|Number|230|230.0||||||
4131223|NCT00905554|3955791|B2|Italy||Region of Enrollment||participants|Number|114|114.0||||||
4131224|NCT00905554|3955792|B1|Italy||Region of Enrollment||participants|Number|116|116.0||||||
4131225|NCT00905554|3955790|B3||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4131226|NCT00905554|3955791|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4131227|NCT00905554|3955792|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4131228|NCT00905554|3955790|B3||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4131229|NCT00905554|3955791|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4131230|NCT00905554|3955792|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4131231|NCT00905554|3955790|B3|||Age||years|Mean|58.4|58.4|Standard Deviation|12.1|12.1|||
4131232|NCT00905554|3955791|B2|||Age||years|Mean|58.8|58.8|Standard Deviation|13.3|13.3|||
4131233|NCT00905554|3955792|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|11.5|11.5|||
4131234|NCT00905554|3955790|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4131235|NCT00905554|3955791|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4131236|NCT00905554|3955792|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4131237|NCT00905554|3955790|B3||Between 18 and 65 years|Age||Participants|Count of Participants|217|217.0||||||
4131238|NCT00905554|3955791|B2||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
4131239|NCT00905554|3955792|B1||Between 18 and 65 years|Age||Participants|Count of Participants|108|108.0||||||
4131240|NCT00905554|3955790|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4131241|NCT00905554|3955791|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4131242|NCT00905554|3955792|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4131243|NCT00905515|3955801|B4|United States||Region of Enrollment||participants|Number|63|63.0||||||
4131244|NCT00905515|3955802|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4131245|NCT00905515|3955803|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4131246|NCT00905515|3955804|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4131247|NCT00905515|3955801|B4||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4131248|NCT00905515|3955802|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4131249|NCT00905515|3955803|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4131250|NCT00905515|3955804|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4131251|NCT00905515|3955801|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4131252|NCT00905515|3955802|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4131253|NCT00905515|3955803|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4131254|NCT00905515|3955804|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4131255|NCT00905515|3955801|B4|||Age||years|Mean|58.48|58.48|Standard Deviation|11.196|11.196|||
4131256|NCT00905515|3955802|B3|||Age||years|Mean|59.14|59.14|Standard Deviation|10.011|10.011|||
4131257|NCT00905515|3955803|B2|||Age||years|Mean|58.57|58.57|Standard Deviation|12.023|12.023|||
4131258|NCT00905515|3955804|B1|||Age||years|Mean|57.65|57.65|Standard Deviation|12.036|12.036|||
4131259|NCT00905515|3955801|B4||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4131260|NCT00905515|3955802|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4131261|NCT00905515|3955803|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4131262|NCT00905515|3955804|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4131263|NCT00905515|3955801|B4||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4131264|NCT00905515|3955802|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4131265|NCT00905515|3955803|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4131266|NCT00905515|3955804|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4131267|NCT00905515|3955801|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131268|NCT00905515|3955802|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131269|NCT00905515|3955803|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131270|NCT00905515|3955804|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131271|NCT00905489|3955814|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4131272|NCT00905489|3955814|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4131273|NCT00905489|3955814|B1|||Age||years|Mean|9.3|9.3|Standard Deviation|4.6|4.6|||
4131274|NCT00905437|3955861|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4131275|NCT00905437|3955862|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4131276|NCT00905437|3955863|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4131277|NCT00905437|3955861|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4131278|NCT00905437|3955862|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4131279|NCT00905437|3955863|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4131280|NCT00905437|3955861|B3|||Age||years|Mean|48.0|48.0|Standard Deviation|13.3|13.3|||
4131281|NCT00905437|3955862|B2|||Age||years|Mean|48.9|48.9|Standard Deviation|13.3|13.3|||
4131282|NCT00905437|3955863|B1|||Age||years|Mean|47.1|47.1|Standard Deviation|13.5|13.5|||
4131283|NCT00905424|3955882|B3|United States||Region of Enrollment|177 subjects were randomized. However, 4 withdrew before receiving any randomized augmentation treatment. Therefore, 173 subjects were included in the Randomized Safety Analysis Set defined as all subjects who took at least 1 dose of randomized augmentation treatment and at least 1 follow-up safety assessment.|participants|Number|173|173.0||||||
4131284|NCT00905424|3955883|B2|United States||Region of Enrollment|177 subjects were randomized. However, 4 withdrew before receiving any randomized augmentation treatment. Therefore, 173 subjects were included in the Randomized Safety Analysis Set defined as all subjects who took at least 1 dose of randomized augmentation treatment and at least 1 follow-up safety assessment.|participants|Number|85|85.0||||||
4131285|NCT00905424|3955884|B1|United States||Region of Enrollment|177 subjects were randomized. However, 4 withdrew before receiving any randomized augmentation treatment. Therefore, 173 subjects were included in the Randomized Safety Analysis Set defined as all subjects who took at least 1 dose of randomized augmentation treatment and at least 1 follow-up safety assessment.|participants|Number|88|88.0||||||
4131286|NCT00905424|3955882|B3||Male|Sex: Female, Male|177 subjects were randomized. However, 4 withdrew before receiving any randomized augmentation treatment. Therefore, 173 subjects were included in the Randomized Safety Analysis Set defined as all subjects who took at least 1 dose of randomized augmentation treatment and at least 1 follow-up safety assessment.|Participants|Count of Participants|66|66.0||||||
4131316|NCT00905346|3955962|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
4131317|NCT00905346|3955963|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4131287|NCT00905424|3955883|B2||Male|Sex: Female, Male|177 subjects were randomized. However, 4 withdrew before receiving any randomized augmentation treatment. Therefore, 173 subjects were included in the Randomized Safety Analysis Set defined as all subjects who took at least 1 dose of randomized augmentation treatment and at least 1 follow-up safety assessment.|Participants|Count of Participants|31|31.0||||||
4131288|NCT00905424|3955884|B1||Male|Sex: Female, Male|177 subjects were randomized. However, 4 withdrew before receiving any randomized augmentation treatment. Therefore, 173 subjects were included in the Randomized Safety Analysis Set defined as all subjects who took at least 1 dose of randomized augmentation treatment and at least 1 follow-up safety assessment.|Participants|Count of Participants|35|35.0||||||
4131289|NCT00905424|3955882|B3||Female|Sex: Female, Male|177 subjects were randomized. However, 4 withdrew before receiving any randomized augmentation treatment. Therefore, 173 subjects were included in the Randomized Safety Analysis Set defined as all subjects who took at least 1 dose of randomized augmentation treatment and at least 1 follow-up safety assessment.|Participants|Count of Participants|107|107.0||||||
4131290|NCT00905424|3955883|B2||Female|Sex: Female, Male|177 subjects were randomized. However, 4 withdrew before receiving any randomized augmentation treatment. Therefore, 173 subjects were included in the Randomized Safety Analysis Set defined as all subjects who took at least 1 dose of randomized augmentation treatment and at least 1 follow-up safety assessment.|Participants|Count of Participants|54|54.0||||||
4131291|NCT00905424|3955884|B1||Female|Sex: Female, Male|177 subjects were randomized. However, 4 withdrew before receiving any randomized augmentation treatment. Therefore, 173 subjects were included in the Randomized Safety Analysis Set defined as all subjects who took at least 1 dose of randomized augmentation treatment and at least 1 follow-up safety assessment.|Participants|Count of Participants|53|53.0||||||
4131292|NCT00905424|3955882|B3|41-55 years||Age, Customized|177 subjects were randomized. However, 4 withdrew before receiving any randomized augmentation treatment. Therefore, 173 subjects were included in the Randomized Safety Analysis Set defined as all subjects who took at least 1 dose of randomized augmentation treatment and at least 1 follow-up safety assessment.|participants|Number|80|80.0||||||
4131293|NCT00905424|3955883|B2|41-55 years||Age, Customized|177 subjects were randomized. However, 4 withdrew before receiving any randomized augmentation treatment. Therefore, 173 subjects were included in the Randomized Safety Analysis Set defined as all subjects who took at least 1 dose of randomized augmentation treatment and at least 1 follow-up safety assessment.|participants|Number|36|36.0||||||
4131294|NCT00905424|3955884|B1|41-55 years||Age, Customized|177 subjects were randomized. However, 4 withdrew before receiving any randomized augmentation treatment. Therefore, 173 subjects were included in the Randomized Safety Analysis Set defined as all subjects who took at least 1 dose of randomized augmentation treatment and at least 1 follow-up safety assessment.|participants|Number|44|44.0||||||
4131295|NCT00905424|3955882|B3|18-40 years||Age, Customized|177 subjects were randomized. However, 4 withdrew before receiving any randomized augmentation treatment. Therefore, 173 subjects were included in the Randomized Safety Analysis Set defined as all subjects who took at least 1 dose of randomized augmentation treatment and at least 1 follow-up safety assessment.|participants|Number|93|93.0||||||
4131296|NCT00905424|3955883|B2|18-40 years||Age, Customized|177 subjects were randomized. However, 4 withdrew before receiving any randomized augmentation treatment. Therefore, 173 subjects were included in the Randomized Safety Analysis Set defined as all subjects who took at least 1 dose of randomized augmentation treatment and at least 1 follow-up safety assessment.|participants|Number|49|49.0||||||
4131297|NCT00905424|3955884|B1|18-40 years||Age, Customized|177 subjects were randomized. However, 4 withdrew before receiving any randomized augmentation treatment. Therefore, 173 subjects were included in the Randomized Safety Analysis Set defined as all subjects who took at least 1 dose of randomized augmentation treatment and at least 1 follow-up safety assessment.|participants|Number|44|44.0||||||
4131298|NCT00905424|3955882|B3|||Age|177 subjects were randomized. However, 4 withdrew before receiving any randomized augmentation treatment. Therefore, 173 subjects were included in the Randomized Safety Analysis Set defined as all subjects who took at least 1 dose of randomized augmentation treatment and at least 1 follow-up safety assessment.|years|Mean|39.0|39.0|Standard Deviation|9.99|9.99|||
4131299|NCT00905424|3955883|B2|||Age|177 subjects were randomized. However, 4 withdrew before receiving any randomized augmentation treatment. Therefore, 173 subjects were included in the Randomized Safety Analysis Set defined as all subjects who took at least 1 dose of randomized augmentation treatment and at least 1 follow-up safety assessment.|years|Mean|38.6|38.6|Standard Deviation|10.38|10.38|||
4131300|NCT00905424|3955884|B1|||Age|177 subjects were randomized. However, 4 withdrew before receiving any randomized augmentation treatment. Therefore, 173 subjects were included in the Randomized Safety Analysis Set defined as all subjects who took at least 1 dose of randomized augmentation treatment and at least 1 follow-up safety assessment.|years|Mean|39.4|39.4|Standard Deviation|9.65|9.65|||
4131301|NCT00905359|3955925|B3|||BMI||kg/m^2|Mean|28.31|28.31|Standard Deviation|3.51|3.51|||
4131302|NCT00905359|3955926|B2|||BMI||kg/m^2|Mean|28.07|28.07|Standard Deviation|3.54|3.54|||
4131303|NCT00905359|3955927|B1|||BMI||kg/m^2|Mean|28.54|28.54|Standard Deviation|3.50|3.5|||
4131304|NCT00905359|3955925|B3||Male|Gender||Participants|Count of Participants|74|74.0||||||
4131305|NCT00905359|3955926|B2||Male|Gender||Participants|Count of Participants|38|38.0||||||
4131306|NCT00905359|3955927|B1||Male|Gender||Participants|Count of Participants|36|36.0||||||
4131307|NCT00905359|3955925|B3||Female|Gender||Participants|Count of Participants|78|78.0||||||
4131308|NCT00905359|3955926|B2||Female|Gender||Participants|Count of Participants|37|37.0||||||
4131309|NCT00905359|3955927|B1||Female|Gender||Participants|Count of Participants|41|41.0||||||
4131310|NCT00905359|3955925|B3|||Age||years|Mean|64.94|64.94|Standard Deviation|10.55|10.55|||
4131311|NCT00905359|3955926|B2|||Age||years|Mean|64.59|64.59|Standard Deviation|10.22|10.22|||
4131312|NCT00905359|3955927|B1|||Age||years|Mean|65.29|65.29|Standard Deviation|10.91|10.91|||
4131313|NCT00905346|3955962|B3|Canada||Region of Enrollment||participants|Number|24|24.0||||||
4131314|NCT00905346|3955963|B2|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4131315|NCT00905346|3955964|B1|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4131318|NCT00905346|3955964|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4131319|NCT00905346|3955962|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4131320|NCT00905346|3955963|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4131321|NCT00905346|3955964|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4131322|NCT00905346|3955962|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4131323|NCT00905346|3955963|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4131324|NCT00905346|3955964|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4131325|NCT00905346|3955962|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4131326|NCT00905346|3955963|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4131327|NCT00905346|3955964|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4131328|NCT00905346|3955962|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4131329|NCT00905346|3955963|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4131330|NCT00905346|3955964|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4131331|NCT00905346|3955962|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131332|NCT00905346|3955963|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131333|NCT00905346|3955964|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131334|NCT00905307|3955973|B7||Male|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
4131335|NCT00905307|3955974|B6||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4131336|NCT00905307|3955975|B5||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4131337|NCT00905307|3955976|B4||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4131338|NCT00905307|3955977|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4131339|NCT00905307|3955978|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4131340|NCT00905307|3955979|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4131341|NCT00905307|3955973|B7||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4131342|NCT00905307|3955974|B6||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4131343|NCT00905307|3955975|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4131344|NCT00905307|3955976|B4||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4131345|NCT00905307|3955977|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4131346|NCT00905307|3955978|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4131347|NCT00905307|3955979|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4131348|NCT00905307|3955973|B7|||Age||Years|Mean|39.1|39.1|Standard Deviation|10.6|10.6|||
4131349|NCT00905307|3955974|B6|||Age||Years|Mean|38.8|38.8|Standard Deviation|11.4|11.4|||
4131350|NCT00905307|3955975|B5|||Age||Years|Mean|40.8|40.8|Standard Deviation|11|11.0|||
4131351|NCT00905307|3955976|B4|||Age||Years|Mean|39.5|39.5|Standard Deviation|11.1|11.1|||
4131352|NCT00905307|3955977|B3|||Age||Years|Mean|37.4|37.4|Standard Deviation|11.1|11.1|||
4131353|NCT00905307|3955978|B2|||Age||Years|Mean|39.2|39.2|Standard Deviation|10.3|10.3|||
4131354|NCT00905307|3955979|B1|||Age||Years|Mean|40.4|40.4|Standard Deviation|9.1|9.1|||
4131355|NCT00905268|3956040|B5|Netherlands||Region of Enrollment|The Intent-To-Treat (ITT) population included all randomized subjects who received at least one dose of the study medication and had a confirmed diagnosis of FRDA, did not take idebenone within one month pre-Screening or between Screening and Visit 1, and were not under idebenone treatment at Baseline according to available PK results at Visit 1. The subjects were analyzed as randomized regardless of protocol deviations|participants|Number|12|12.0||||||
4131356|NCT00905268|3956041|B4|Netherlands||Region of Enrollment|The Intent-To-Treat (ITT) population included all randomized subjects who received at least one dose of the study medication and had a confirmed diagnosis of FRDA, did not take idebenone within one month pre-Screening or between Screening and Visit 1, and were not under idebenone treatment at Baseline according to available PK results at Visit 1. The subjects were analyzed as randomized regardless of protocol deviations|participants|Number|3|3.0||||||
4131357|NCT00905268|3956042|B3|Netherlands||Region of Enrollment|The Intent-To-Treat (ITT) population included all randomized subjects who received at least one dose of the study medication and had a confirmed diagnosis of FRDA, did not take idebenone within one month pre-Screening or between Screening and Visit 1, and were not under idebenone treatment at Baseline according to available PK results at Visit 1. The subjects were analyzed as randomized regardless of protocol deviations|participants|Number|3|3.0||||||
4131358|NCT00905268|3956043|B2|Netherlands||Region of Enrollment|The Intent-To-Treat (ITT) population included all randomized subjects who received at least one dose of the study medication and had a confirmed diagnosis of FRDA, did not take idebenone within one month pre-Screening or between Screening and Visit 1, and were not under idebenone treatment at Baseline according to available PK results at Visit 1. The subjects were analyzed as randomized regardless of protocol deviations|participants|Number|3|3.0||||||
4131359|NCT00905268|3956044|B1|Netherlands||Region of Enrollment|The Intent-To-Treat (ITT) population included all randomized subjects who received at least one dose of the study medication and had a confirmed diagnosis of FRDA, did not take idebenone within one month pre-Screening or between Screening and Visit 1, and were not under idebenone treatment at Baseline according to available PK results at Visit 1. The subjects were analyzed as randomized regardless of protocol deviations|participants|Number|3|3.0||||||
4131360|NCT00905268|3956040|B5|France||Region of Enrollment|The Intent-To-Treat (ITT) population included all randomized subjects who received at least one dose of the study medication and had a confirmed diagnosis of FRDA, did not take idebenone within one month pre-Screening or between Screening and Visit 1, and were not under idebenone treatment at Baseline according to available PK results at Visit 1. The subjects were analyzed as randomized regardless of protocol deviations|participants|Number|17|17.0||||||
4131361|NCT00905268|3956041|B4|France||Region of Enrollment|The Intent-To-Treat (ITT) population included all randomized subjects who received at least one dose of the study medication and had a confirmed diagnosis of FRDA, did not take idebenone within one month pre-Screening or between Screening and Visit 1, and were not under idebenone treatment at Baseline according to available PK results at Visit 1. The subjects were analyzed as randomized regardless of protocol deviations|participants|Number|6|6.0||||||
4131362|NCT00905268|3956042|B3|France||Region of Enrollment|The Intent-To-Treat (ITT) population included all randomized subjects who received at least one dose of the study medication and had a confirmed diagnosis of FRDA, did not take idebenone within one month pre-Screening or between Screening and Visit 1, and were not under idebenone treatment at Baseline according to available PK results at Visit 1. The subjects were analyzed as randomized regardless of protocol deviations|participants|Number|4|4.0||||||
4131363|NCT00905268|3956043|B2|France||Region of Enrollment|The Intent-To-Treat (ITT) population included all randomized subjects who received at least one dose of the study medication and had a confirmed diagnosis of FRDA, did not take idebenone within one month pre-Screening or between Screening and Visit 1, and were not under idebenone treatment at Baseline according to available PK results at Visit 1. The subjects were analyzed as randomized regardless of protocol deviations|participants|Number|2|2.0||||||
4131364|NCT00905268|3956044|B1|France||Region of Enrollment|The Intent-To-Treat (ITT) population included all randomized subjects who received at least one dose of the study medication and had a confirmed diagnosis of FRDA, did not take idebenone within one month pre-Screening or between Screening and Visit 1, and were not under idebenone treatment at Baseline according to available PK results at Visit 1. The subjects were analyzed as randomized regardless of protocol deviations|participants|Number|5|5.0||||||
4131365|NCT00905268|3956040|B5|Belgium||Region of Enrollment|The Intent-To-Treat (ITT) population included all randomized subjects who received at least one dose of the study medication and had a confirmed diagnosis of FRDA, did not take idebenone within one month pre-Screening or between Screening and Visit 1, and were not under idebenone treatment at Baseline according to available PK results at Visit 1. The subjects were analyzed as randomized regardless of protocol deviations|participants|Number|13|13.0||||||
4131366|NCT00905268|3956041|B4|Belgium||Region of Enrollment|The Intent-To-Treat (ITT) population included all randomized subjects who received at least one dose of the study medication and had a confirmed diagnosis of FRDA, did not take idebenone within one month pre-Screening or between Screening and Visit 1, and were not under idebenone treatment at Baseline according to available PK results at Visit 1. The subjects were analyzed as randomized regardless of protocol deviations|participants|Number|4|4.0||||||
4131367|NCT00905268|3956042|B3|Belgium||Region of Enrollment|The Intent-To-Treat (ITT) population included all randomized subjects who received at least one dose of the study medication and had a confirmed diagnosis of FRDA, did not take idebenone within one month pre-Screening or between Screening and Visit 1, and were not under idebenone treatment at Baseline according to available PK results at Visit 1. The subjects were analyzed as randomized regardless of protocol deviations|participants|Number|5|5.0||||||
4131368|NCT00905268|3956043|B2|Belgium||Region of Enrollment|The Intent-To-Treat (ITT) population included all randomized subjects who received at least one dose of the study medication and had a confirmed diagnosis of FRDA, did not take idebenone within one month pre-Screening or between Screening and Visit 1, and were not under idebenone treatment at Baseline according to available PK results at Visit 1. The subjects were analyzed as randomized regardless of protocol deviations|participants|Number|1|1.0||||||
4131369|NCT00905268|3956044|B1|Belgium||Region of Enrollment|The Intent-To-Treat (ITT) population included all randomized subjects who received at least one dose of the study medication and had a confirmed diagnosis of FRDA, did not take idebenone within one month pre-Screening or between Screening and Visit 1, and were not under idebenone treatment at Baseline according to available PK results at Visit 1. The subjects were analyzed as randomized regardless of protocol deviations|participants|Number|3|3.0||||||
4131370|NCT00905268|3956040|B5|Austria||Region of Enrollment|The Intent-To-Treat (ITT) population included all randomized subjects who received at least one dose of the study medication and had a confirmed diagnosis of FRDA, did not take idebenone within one month pre-Screening or between Screening and Visit 1, and were not under idebenone treatment at Baseline according to available PK results at Visit 1. The subjects were analyzed as randomized regardless of protocol deviations|participants|Number|13|13.0||||||
4131371|NCT00905268|3956041|B4|Austria||Region of Enrollment|The Intent-To-Treat (ITT) population included all randomized subjects who received at least one dose of the study medication and had a confirmed diagnosis of FRDA, did not take idebenone within one month pre-Screening or between Screening and Visit 1, and were not under idebenone treatment at Baseline according to available PK results at Visit 1. The subjects were analyzed as randomized regardless of protocol deviations|participants|Number|5|5.0||||||
4131372|NCT00905268|3956042|B3|Austria||Region of Enrollment|The Intent-To-Treat (ITT) population included all randomized subjects who received at least one dose of the study medication and had a confirmed diagnosis of FRDA, did not take idebenone within one month pre-Screening or between Screening and Visit 1, and were not under idebenone treatment at Baseline according to available PK results at Visit 1. The subjects were analyzed as randomized regardless of protocol deviations|participants|Number|2|2.0||||||
4131373|NCT00905268|3956043|B2|Austria||Region of Enrollment|The Intent-To-Treat (ITT) population included all randomized subjects who received at least one dose of the study medication and had a confirmed diagnosis of FRDA, did not take idebenone within one month pre-Screening or between Screening and Visit 1, and were not under idebenone treatment at Baseline according to available PK results at Visit 1. The subjects were analyzed as randomized regardless of protocol deviations|participants|Number|4|4.0||||||
4131374|NCT00905268|3956044|B1|Austria||Region of Enrollment|The Intent-To-Treat (ITT) population included all randomized subjects who received at least one dose of the study medication and had a confirmed diagnosis of FRDA, did not take idebenone within one month pre-Screening or between Screening and Visit 1, and were not under idebenone treatment at Baseline according to available PK results at Visit 1. The subjects were analyzed as randomized regardless of protocol deviations|participants|Number|2|2.0||||||
4131403|NCT00905255|3956077|B3|||Body Mass Index (BMI)|BMI was calculated by dividing body weight by the height squared.|kilogram per square meter (kg/m^2)|Mean|24.98|24.98|Standard Deviation|4.48|4.48|||
4131404|NCT00905255|3956078|B2|||Body Mass Index (BMI)|BMI was calculated by dividing body weight by the height squared.|kilogram per square meter (kg/m^2)|Mean|24.81|24.81|Standard Deviation|3.68|3.68|||
4131375|NCT00905268|3956040|B5|United Kingdom||Region of Enrollment|The Intent-To-Treat (ITT) population included all randomized subjects who received at least one dose of the study medication and had a confirmed diagnosis of FRDA, did not take idebenone within one month pre-Screening or between Screening and Visit 1, and were not under idebenone treatment at Baseline according to available PK results at Visit 1. The subjects were analyzed as randomized regardless of protocol deviations|participants|Number|21|21.0||||||
4131376|NCT00905268|3956041|B4|United Kingdom||Region of Enrollment|The Intent-To-Treat (ITT) population included all randomized subjects who received at least one dose of the study medication and had a confirmed diagnosis of FRDA, did not take idebenone within one month pre-Screening or between Screening and Visit 1, and were not under idebenone treatment at Baseline according to available PK results at Visit 1. The subjects were analyzed as randomized regardless of protocol deviations|participants|Number|5|5.0||||||
4131377|NCT00905268|3956042|B3|United Kingdom||Region of Enrollment|The Intent-To-Treat (ITT) population included all randomized subjects who received at least one dose of the study medication and had a confirmed diagnosis of FRDA, did not take idebenone within one month pre-Screening or between Screening and Visit 1, and were not under idebenone treatment at Baseline according to available PK results at Visit 1. The subjects were analyzed as randomized regardless of protocol deviations|participants|Number|6|6.0||||||
4131378|NCT00905268|3956043|B2|United Kingdom||Region of Enrollment|The Intent-To-Treat (ITT) population included all randomized subjects who received at least one dose of the study medication and had a confirmed diagnosis of FRDA, did not take idebenone within one month pre-Screening or between Screening and Visit 1, and were not under idebenone treatment at Baseline according to available PK results at Visit 1. The subjects were analyzed as randomized regardless of protocol deviations|participants|Number|6|6.0||||||
4131379|NCT00905268|3956044|B1|United Kingdom||Region of Enrollment|The Intent-To-Treat (ITT) population included all randomized subjects who received at least one dose of the study medication and had a confirmed diagnosis of FRDA, did not take idebenone within one month pre-Screening or between Screening and Visit 1, and were not under idebenone treatment at Baseline according to available PK results at Visit 1. The subjects were analyzed as randomized regardless of protocol deviations|participants|Number|4|4.0||||||
4131380|NCT00905268|3956040|B5|Germany||Region of Enrollment|The Intent-To-Treat (ITT) population included all randomized subjects who received at least one dose of the study medication and had a confirmed diagnosis of FRDA, did not take idebenone within one month pre-Screening or between Screening and Visit 1, and were not under idebenone treatment at Baseline according to available PK results at Visit 1. The subjects were analyzed as randomized regardless of protocol deviations|participants|Number|156|156.0||||||
4131381|NCT00905268|3956041|B4|Germany||Region of Enrollment|The Intent-To-Treat (ITT) population included all randomized subjects who received at least one dose of the study medication and had a confirmed diagnosis of FRDA, did not take idebenone within one month pre-Screening or between Screening and Visit 1, and were not under idebenone treatment at Baseline according to available PK results at Visit 1. The subjects were analyzed as randomized regardless of protocol deviations|participants|Number|36|36.0||||||
4131382|NCT00905268|3956042|B3|Germany||Region of Enrollment|The Intent-To-Treat (ITT) population included all randomized subjects who received at least one dose of the study medication and had a confirmed diagnosis of FRDA, did not take idebenone within one month pre-Screening or between Screening and Visit 1, and were not under idebenone treatment at Baseline according to available PK results at Visit 1. The subjects were analyzed as randomized regardless of protocol deviations|participants|Number|39|39.0||||||
4131383|NCT00905268|3956043|B2|Germany||Region of Enrollment|The Intent-To-Treat (ITT) population included all randomized subjects who received at least one dose of the study medication and had a confirmed diagnosis of FRDA, did not take idebenone within one month pre-Screening or between Screening and Visit 1, and were not under idebenone treatment at Baseline according to available PK results at Visit 1. The subjects were analyzed as randomized regardless of protocol deviations|participants|Number|41|41.0||||||
4131384|NCT00905268|3956044|B1|Germany||Region of Enrollment|The Intent-To-Treat (ITT) population included all randomized subjects who received at least one dose of the study medication and had a confirmed diagnosis of FRDA, did not take idebenone within one month pre-Screening or between Screening and Visit 1, and were not under idebenone treatment at Baseline according to available PK results at Visit 1. The subjects were analyzed as randomized regardless of protocol deviations|participants|Number|40|40.0||||||
4131385|NCT00905268|3956040|B5||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4131386|NCT00905268|3956041|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4131387|NCT00905268|3956042|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4131388|NCT00905268|3956043|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4131389|NCT00905268|3956044|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4131390|NCT00905268|3956040|B5||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4131391|NCT00905268|3956041|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4131392|NCT00905268|3956042|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4131393|NCT00905268|3956043|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4131394|NCT00905268|3956044|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4131395|NCT00905268|3956040|B5|||Age||years|Mean|30.9|30.9|Standard Deviation|13.3|13.3|||
4131396|NCT00905268|3956041|B4|||Age||years|Mean|30.4|30.4|Standard Deviation|13.3|13.3|||
4131397|NCT00905268|3956042|B3|||Age||years|Mean|30.9|30.9|Standard Deviation|13.6|13.6|||
4131398|NCT00905268|3956043|B2|||Age||years|Mean|31.6|31.6|Standard Deviation|13.1|13.1|||
4131399|NCT00905268|3956044|B1|||Age||years|Mean|30.9|30.9|Standard Deviation|13.7|13.7|||
4131400|NCT00905255|3956077|B3|||Duration of Diabetes|Duration of diabetes is reported at screening.|years|Mean|8.56|8.56|Standard Deviation|7.16|7.16|||
4131401|NCT00905255|3956078|B2|||Duration of Diabetes|Duration of diabetes is reported at screening.|years|Mean|9.03|9.03|Standard Deviation|7.87|7.87|||
4131402|NCT00905255|3956079|B1|||Duration of Diabetes|Duration of diabetes is reported at screening.|years|Mean|8.05|8.05|Standard Deviation|6.38|6.38|||
4131405|NCT00905255|3956079|B1|||Body Mass Index (BMI)|BMI was calculated by dividing body weight by the height squared.|kilogram per square meter (kg/m^2)|Mean|25.16|25.16|Standard Deviation|5.27|5.27|||
4131406|NCT00905255|3956077|B3|||Body Weight||kilogram (kg)|Mean|68.66|68.66|Standard Deviation|15.54|15.54|||
4131407|NCT00905255|3956078|B2|||Body Weight||kilogram (kg)|Mean|66.74|66.74|Standard Deviation|11.14|11.14|||
4131408|NCT00905255|3956079|B1|||Body Weight||kilogram (kg)|Mean|70.75|70.75|Standard Deviation|19.21|19.21|||
4131409|NCT00905255|3956077|B3|||Fasting Plasma Glucose (FPG)||millimole per liter (mmol/L)|Mean|9.52|9.52|Standard Deviation|1.94|1.94|||
4131410|NCT00905255|3956078|B2|||Fasting Plasma Glucose (FPG)||millimole per liter (mmol/L)|Mean|9.16|9.16|Standard Deviation|1.92|1.92|||
4131411|NCT00905255|3956079|B1|||Fasting Plasma Glucose (FPG)||millimole per liter (mmol/L)|Mean|9.91|9.91|Standard Deviation|1.91|1.91|||
4131412|NCT00905255|3956077|B3|||Glycosylated Hemoglobin (HbA1c)||percentage of hemoglobin|Mean|8.23|8.23|Standard Deviation|0.76|0.76|||
4131413|NCT00905255|3956078|B2|||Glycosylated Hemoglobin (HbA1c)||percentage of hemoglobin|Mean|8.12|8.12|Standard Deviation|0.68|0.68|||
4131414|NCT00905255|3956079|B1|||Glycosylated Hemoglobin (HbA1c)||percentage of hemoglobin|Mean|8.35|8.35|Standard Deviation|0.82|0.82|||
4131415|NCT00905255|3956077|B3|Ethnicity: Non Hispanic||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
4131416|NCT00905255|3956078|B2|Ethnicity: Non Hispanic||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4131417|NCT00905255|3956079|B1|Ethnicity: Non Hispanic||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4131418|NCT00905255|3956077|B3|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
4131419|NCT00905255|3956078|B2|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4131420|NCT00905255|3956079|B1|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4131421|NCT00905255|3956077|B3||Male|Gender||Participants|Count of Participants|58|58.0||||||
4131422|NCT00905255|3956078|B2||Male|Gender||Participants|Count of Participants|28|28.0||||||
4131423|NCT00905255|3956079|B1||Male|Gender||Participants|Count of Participants|30|30.0||||||
4131424|NCT00905255|3956077|B3||Female|Gender||Participants|Count of Participants|11|11.0||||||
4131425|NCT00905255|3956078|B2||Female|Gender||Participants|Count of Participants|8|8.0||||||
4131426|NCT00905255|3956079|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
4131427|NCT00905255|3956077|B3|||Age||years|Mean|58.7|58.7|Standard Deviation|8.7|8.7|||
4131428|NCT00905255|3956078|B2|||Age||years|Mean|60.4|60.4|Standard Deviation|8.2|8.2|||
4131429|NCT00905255|3956079|B1|||Age||years|Mean|56.9|56.9|Standard Deviation|9.0|9.0|||
4131430|NCT00905164|3956096|B3|Canada||Region of Enrollment||participants|Number|24|24.0||||||
4131431|NCT00905164|3956097|B2|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4131432|NCT00905164|3956098|B1|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4131433|NCT00905164|3956096|B3|American Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4131434|NCT00905164|3956097|B2|American Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4131435|NCT00905164|3956098|B1|American Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4131436|NCT00905164|3956096|B3|Black||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4131437|NCT00905164|3956097|B2|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4131438|NCT00905164|3956098|B1|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4131439|NCT00905164|3956096|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4131440|NCT00905164|3956097|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4131441|NCT00905164|3956098|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4131442|NCT00905164|3956096|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4131443|NCT00905164|3956097|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4131444|NCT00905164|3956098|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4131445|NCT00905164|3956096|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4131446|NCT00905164|3956097|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4131447|NCT00905164|3956098|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4131448|NCT00905164|3956096|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4131449|NCT00905164|3956097|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4131450|NCT00905164|3956098|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4131451|NCT00905164|3956096|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4131452|NCT00905164|3956097|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4131453|NCT00905164|3956098|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4131454|NCT00905164|3956096|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131455|NCT00905164|3956097|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131456|NCT00905164|3956098|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131457|NCT00905151|3956107|B1||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4131458|NCT00905151|3956107|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4131459|NCT00905151|3956107|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4131460|NCT00905151|3956107|B1||Between 18 and 65 years|Age||Participants|Count of Participants|194|194.0||||||
4131461|NCT00905151|3956107|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131462|NCT00905125|3956111|B3|United States||Region of Enrollment||participants|Number|102|102.0||||||
4131463|NCT00905125|3956112|B2|United States||Region of Enrollment||participants|Number|56|56.0||||||
4131464|NCT00905125|3956113|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4131465|NCT00905125|3956111|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4131466|NCT00905125|3956112|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4131467|NCT00905125|3956113|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4131468|NCT00905125|3956111|B3||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4131469|NCT00905125|3956112|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4131470|NCT00905125|3956113|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4131471|NCT00905125|3956111|B3|||Age||years|Mean|28.2|28.2|Standard Deviation|5.4|5.4|||
4131472|NCT00905125|3956112|B2|||Age||years|Mean|28.4|28.4|Standard Deviation|5.0|5.0|||
4131473|NCT00905125|3956113|B1|||Age||years|Mean|28.0|28.0|Standard Deviation|5.9|5.9|||
4131474|NCT00905125|3956111|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4131475|NCT00905125|3956112|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4131476|NCT00905125|3956113|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4131477|NCT00905125|3956111|B3||Between 18 and 65 years|Age||Participants|Count of Participants|102|102.0||||||
4131478|NCT00905125|3956112|B2||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4131479|NCT00905125|3956113|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4131480|NCT00905125|3956111|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131481|NCT00905125|3956112|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131482|NCT00905125|3956113|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131483|NCT00905034|3956146|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4131484|NCT00905034|3956146|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4131485|NCT00905034|3956146|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4131486|NCT00905034|3956146|B1|||Age||years|Mean|42|42.0|Full Range|||22.0|69.0|
4131487|NCT00905021|3956150|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4131488|NCT00905021|3956150|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4131489|NCT00905021|3956150|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4131490|NCT00905021|3956150|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4131491|NCT00905021|3956150|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131492|NCT00904995|3956155|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4131493|NCT00904995|3956156|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4131494|NCT00904995|3956157|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4131495|NCT00904995|3956155|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4131496|NCT00904995|3956156|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4131497|NCT00904995|3956157|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4131498|NCT00904995|3956155|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4131499|NCT00904995|3956156|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4131500|NCT00904995|3956157|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4131501|NCT00904995|3956155|B3|||Age||years|Median|56|56.0|Full Range|||20.0|78.0|
4131502|NCT00904995|3956156|B2|||Age||years|Median|61|61.0|Full Range|||20.0|76.0|
4131503|NCT00904995|3956157|B1|||Age||years|Median|52|52.0|Full Range|||25.0|78.0|
4131504|NCT00904982|3956164|B5|United States||Region of Enrollment||participants|Number|270|270.0||||||
4131505|NCT00904982|3956165|B4|United States||Region of Enrollment||participants|Number|68|68.0||||||
4131506|NCT00904982|3956166|B3|United States||Region of Enrollment||participants|Number|67|67.0||||||
4131507|NCT00904982|3956167|B2|United States||Region of Enrollment||participants|Number|67|67.0||||||
4131508|NCT00904982|3956168|B1|United States||Region of Enrollment||participants|Number|68|68.0||||||
4131509|NCT00904982|3956164|B5||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4131510|NCT00904982|3956165|B4||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4131511|NCT00904982|3956166|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4131512|NCT00904982|3956167|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4131513|NCT00904982|3956168|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4131514|NCT00904982|3956164|B5||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4131515|NCT00904982|3956165|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4131516|NCT00904982|3956166|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4131517|NCT00904982|3956167|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4131518|NCT00904982|3956168|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4131519|NCT00904982|3956164|B5|||Age||years|Median|62|62.0|Inter-Quartile Range|||54.0|69.0|
4131520|NCT00904982|3956165|B4|||Age||years|Median|61.5|61.5|Inter-Quartile Range|||51.5|68.5|
4131521|NCT00904982|3956166|B3|||Age||years|Median|62|62.0|Inter-Quartile Range|||51.0|68.0|
4131522|NCT00904982|3956167|B2|||Age||years|Median|62|62.0|Inter-Quartile Range|||55.0|67.0|
4131523|NCT00904982|3956168|B1|||Age||years|Median|64|64.0|Inter-Quartile Range|||60.0|71.0|
4131524|NCT00904969|3956181|B1|||Duration of Incontinence Symptoms||months|Mean|57.2|57.2|Standard Deviation|76.5|76.5|||
4131525|NCT00904969|3956181|B1|2006||Years Since Surgery||participants|Number|3|3.0||||||
4131526|NCT00904969|3956181|B1|2005||Years Since Surgery||participants|Number|8|8.0||||||
4131527|NCT00904969|3956181|B1|2002-2004||Years Since Surgery||participants|Number|18|18.0||||||
4131528|NCT00904969|3956181|B1|1996 - 2001||Years Since Surgery||participants|Number|14|14.0||||||
4131529|NCT00904969|3956181|B1|<=1995||Years Since Surgery||participants|Number|7|7.0||||||
4131530|NCT00904969|3956181|B1|Radical Prostatectomy||Primary etiology of intrinsic sphincter deficiency (ISD)||participants|Number|47|47.0||||||
4131531|NCT00904969|3956181|B1|Post-Transurethral Resection of Prostate (TURP)||Primary etiology of intrinsic sphincter deficiency (ISD)||participants|Number|3|3.0||||||
4131532|NCT00904969|3956181|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4131533|NCT00904969|3956181|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4131534|NCT00904969|3956181|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4131535|NCT00904969|3956181|B1|African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4131536|NCT00904969|3956181|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4131537|NCT00904969|3956181|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4131538|NCT00904969|3956181|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4131539|NCT00904969|3956181|B1|||Age||years|Mean|64.6|64.6|Standard Deviation|8.7|8.7|||
4131540|NCT00904943|3956231|B3|Canada||Region of Enrollment||participants|Number|18|18.0||||||
4131541|NCT00904943|3956232|B2|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4131542|NCT00904943|3956233|B1|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4131543|NCT00904943|3956231|B3|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4131544|NCT00904943|3956232|B2|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4131545|NCT00904943|3956233|B1|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4131546|NCT00904943|3956231|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4131547|NCT00904943|3956232|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4131548|NCT00904943|3956233|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4131549|NCT00904943|3956231|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4131550|NCT00904943|3956232|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4131551|NCT00904943|3956233|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4131552|NCT00904943|3956231|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4131553|NCT00904943|3956232|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4131554|NCT00904943|3956233|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4131555|NCT00904943|3956231|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4131556|NCT00904943|3956232|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4131557|NCT00904943|3956233|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4131558|NCT00904943|3956231|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4131559|NCT00904943|3956232|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4131560|NCT00904943|3956233|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4131561|NCT00904943|3956231|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131562|NCT00904943|3956232|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131563|NCT00904943|3956233|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131564|NCT00904917|3956242|B5|United States||Region of Enrollment||participants|Number|34|34.0||||||
4131565|NCT00904917|3956243|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
4131566|NCT00904917|3956244|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4131567|NCT00904917|3956245|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4131568|NCT00904917|3956246|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4131569|NCT00904917|3956242|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4131570|NCT00904917|3956243|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4131571|NCT00904917|3956244|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4131572|NCT00904917|3956245|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4131573|NCT00904917|3956246|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4131574|NCT00904917|3956242|B5||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4131575|NCT00904917|3956243|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4131576|NCT00904917|3956244|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4131577|NCT00904917|3956245|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4131578|NCT00904917|3956246|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4131579|NCT00904917|3956242|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4131580|NCT00904917|3956243|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4131581|NCT00904917|3956244|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4131582|NCT00904917|3956245|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4131583|NCT00904917|3956246|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4131584|NCT00904917|3956242|B5||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4131585|NCT00904917|3956243|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4131586|NCT00904917|3956244|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4131587|NCT00904917|3956245|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4131588|NCT00904917|3956246|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4131589|NCT00904917|3956242|B5||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
4131590|NCT00904917|3956243|B4||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4131591|NCT00904917|3956244|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131592|NCT00904917|3956245|B2||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4131593|NCT00904917|3956246|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131594|NCT00904839|3956265|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4131595|NCT00904839|3956266|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4131596|NCT00904839|3956267|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4131597|NCT00904839|3956265|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4131598|NCT00904839|3956266|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4131599|NCT00904839|3956267|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4131600|NCT00904839|3956265|B3|||Age||years|Mean|62.8|62.8|Standard Deviation|9.64|9.64|||
4131601|NCT00904839|3956266|B2|||Age||years|Mean|63.0|63.0|Standard Deviation|9.36|9.36|||
4131602|NCT00904839|3956267|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|9.83|9.83|||
4131603|NCT00904826|3956303|B1|||Expanded Disability Status Scale (EDSS) Score|The EDSS is an ordinal clinical rating scale ranging from 0 (normal neurologic examination) to 10 (death) in half-point increments.|units on a scale|Mean|4.8|4.8|Full Range|||2.0|8.0|
4131604|NCT00904826|3956303|B1|||Number of previous attacks per subject||attacks per subject|Mean|5.5|5.5|Full Range|||2.0|10.0|
4131605|NCT00904826|3956303|B1|Other multifocal||Type of previous attacks at enrollment||attacks|Number|2|2.0||||||
4131606|NCT00904826|3956303|B1|Multifocal optic neuritis and transverse myelitis||Type of previous attacks at enrollment||attacks|Number|3|3.0||||||
4131607|NCT00904826|3956303|B1|Brainstem||Type of previous attacks at enrollment||attacks|Number|1|1.0||||||
4131608|NCT00904826|3956303|B1|Transverse myelitis||Type of previous attacks at enrollment||attacks|Number|52|52.0||||||
4131609|NCT00904826|3956303|B1|Optic neuritis||Type of previous attacks at enrollment||attacks|Number|28|28.0||||||
4131610|NCT00904826|3956303|B1|No coexisting autoimmune disease||Coexisting autoimmune diseases||participants|Number|10|10.0||||||
4131611|NCT00904826|3956303|B1|Mixed connective tissue disease||Coexisting autoimmune diseases||participants|Number|2|2.0||||||
4131612|NCT00904826|3956303|B1|Idiopathic thrombocytopenic purpura||Coexisting autoimmune diseases||participants|Number|2|2.0||||||
4131613|NCT00904826|3956303|B1|Myasthenia gravis||Coexisting autoimmune diseases||participants|Number|2|2.0||||||
4131614|NCT00904826|3956303|B1|Relapsing transverse myelitis||Diagnosis||participants|Number|4|4.0||||||
4131615|NCT00904826|3956303|B1|Relapsing optic neuritis||Diagnosis||participants|Number|2|2.0||||||
4131616|NCT00904826|3956303|B1|Neuromyelitis optica||Diagnosis||participants|Number|8|8.0||||||
4131617|NCT00904826|3956303|B1|White||Ethnic origin||participants|Number|9|9.0||||||
4131618|NCT00904826|3956303|B1|Hispanic||Ethnic origin||participants|Number|3|3.0||||||
4131619|NCT00904826|3956303|B1|African American||Ethnic origin||participants|Number|2|2.0||||||
4131620|NCT00904826|3956303|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4131621|NCT00904826|3956303|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4131622|NCT00904826|3956303|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4131623|NCT00904826|3956303|B1|||Age||years|Mean|41.1|41.1|Full Range|||18.4|67.6|
4131624|NCT00904748|3956315|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4131625|NCT00904748|3956315|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4131626|NCT00904748|3956315|B1|||Age||years|Mean|29.3|29.3|Full Range|||18.0|45.0|
4131627|NCT00904722|3956344|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4131628|NCT00904722|3956344|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4131629|NCT00904722|3956344|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4131630|NCT00904722|3956344|B1|||Age||years|Median|61|61.0|Full Range|||35.0|79.0|
4131631|NCT00904670|3956349|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4131632|NCT00904670|3956349|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4131633|NCT00904670|3956349|B1|||Age||years|Mean|8.8|8.8|Standard Deviation|1.69|1.69|||
4131634|NCT00904618|3956371|B1|Canada||Region of Enrollment||participants|Number|48|48.0||||||
4131635|NCT00904618|3956371|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4131636|NCT00904618|3956371|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4131637|NCT00904618|3956371|B1|||Age||years|Mean|58|58.0|Standard Deviation|11|11.0|||
4131638|NCT00904618|3956371|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4131639|NCT00904618|3956371|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4131640|NCT00904618|3956371|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131641|NCT00904488|3956379|B3|||Brain Natriuretic Peptide (BNP) at admission||pg/ml|Mean|6201.00|6201.0|Standard Deviation|7313.54|7313.54|||
4131642|NCT00904488|3956380|B2|||Brain Natriuretic Peptide (BNP) at admission||pg/ml|Mean|5401.33|5401.33|Standard Deviation|4183.06|4183.06|||
4131643|NCT00904488|3956381|B1|||Brain Natriuretic Peptide (BNP) at admission||pg/ml|Mean|6800.75|6800.75|Standard Deviation|10330.95|10330.95|||
4131644|NCT00904488|3956379|B3|Potassium supplement||Medication||participants|Number|4|4.0||||||
4131645|NCT00904488|3956380|B2|Potassium supplement||Medication||participants|Number|3|3.0||||||
4131646|NCT00904488|3956381|B1|Potassium supplement||Medication||participants|Number|1|1.0||||||
4131647|NCT00904488|3956379|B3|Aspirin||Medication||participants|Number|7|7.0||||||
4131648|NCT00904488|3956380|B2|Aspirin||Medication||participants|Number|5|5.0||||||
4131649|NCT00904488|3956381|B1|Aspirin||Medication||participants|Number|2|2.0||||||
4131650|NCT00904488|3956379|B3|Anticoagulant||Medication||participants|Number|5|5.0||||||
4131651|NCT00904488|3956380|B2|Anticoagulant||Medication||participants|Number|3|3.0||||||
4131652|NCT00904488|3956381|B1|Anticoagulant||Medication||participants|Number|2|2.0||||||
4131653|NCT00904488|3956379|B3|Statin||Medication||participants|Number|9|9.0||||||
4131654|NCT00904488|3956380|B2|Statin||Medication||participants|Number|4|4.0||||||
4131655|NCT00904488|3956381|B1|Statin||Medication||participants|Number|5|5.0||||||
4131656|NCT00904488|3956379|B3|Hydralazine||Medication||participants|Number|5|5.0||||||
4131657|NCT00904488|3956380|B2|Hydralazine||Medication||participants|Number|1|1.0||||||
4131658|NCT00904488|3956381|B1|Hydralazine||Medication||participants|Number|4|4.0||||||
4131659|NCT00904488|3956379|B3|Isosorbide Dinitrate||Medication||participants|Number|2|2.0||||||
4131660|NCT00904488|3956380|B2|Isosorbide Dinitrate||Medication||participants|Number|1|1.0||||||
4131661|NCT00904488|3956381|B1|Isosorbide Dinitrate||Medication||participants|Number|1|1.0||||||
4131662|NCT00904488|3956379|B3|Calcium Channel Blocker||Medication||participants|Number|3|3.0||||||
4131663|NCT00904488|3956380|B2|Calcium Channel Blocker||Medication||participants|Number|1|1.0||||||
4131664|NCT00904488|3956381|B1|Calcium Channel Blocker||Medication||participants|Number|2|2.0||||||
4131665|NCT00904488|3956379|B3|Digoxin||Medication||participants|Number|2|2.0||||||
4131666|NCT00904488|3956380|B2|Digoxin||Medication||participants|Number|0|0.0||||||
4131667|NCT00904488|3956381|B1|Digoxin||Medication||participants|Number|2|2.0||||||
4131668|NCT00904488|3956379|B3|Aldosterone Antagonist||Medication||participants|Number|1|1.0||||||
4131669|NCT00904488|3956380|B2|Aldosterone Antagonist||Medication||participants|Number|1|1.0||||||
4131670|NCT00904488|3956381|B1|Aldosterone Antagonist||Medication||participants|Number|0|0.0||||||
4131671|NCT00904488|3956379|B3|Loop Diuretic||Medication||participants|Number|9|9.0||||||
4131672|NCT00904488|3956380|B2|Loop Diuretic||Medication||participants|Number|5|5.0||||||
4131673|NCT00904488|3956381|B1|Loop Diuretic||Medication||participants|Number|4|4.0||||||
4131674|NCT00904488|3956379|B3|Angiotensin Receptor Blockers||Medication||participants|Number|0|0.0||||||
4131675|NCT00904488|3956380|B2|Angiotensin Receptor Blockers||Medication||participants|Number|0|0.0||||||
4131676|NCT00904488|3956381|B1|Angiotensin Receptor Blockers||Medication||participants|Number|0|0.0||||||
4131677|NCT00904488|3956379|B3|Angiotensin-converting-enzyme inhibitor||Medication||participants|Number|10|10.0||||||
4131678|NCT00904488|3956380|B2|Angiotensin-converting-enzyme inhibitor||Medication||participants|Number|6|6.0||||||
4131679|NCT00904488|3956381|B1|Angiotensin-converting-enzyme inhibitor||Medication||participants|Number|4|4.0||||||
4131680|NCT00904488|3956379|B3|Beta Blocker||Medication||participants|Number|8|8.0||||||
4131681|NCT00904488|3956380|B2|Beta Blocker||Medication||participants|Number|4|4.0||||||
4131682|NCT00904488|3956381|B1|Beta Blocker||Medication||participants|Number|4|4.0||||||
4131683|NCT00904488|3956379|B3|Obstructive Sleep Apnea||Comorbidities||participants|Number|4|4.0||||||
4131684|NCT00904488|3956380|B2|Obstructive Sleep Apnea||Comorbidities||participants|Number|2|2.0||||||
4131685|NCT00904488|3956381|B1|Obstructive Sleep Apnea||Comorbidities||participants|Number|2|2.0||||||
4131686|NCT00904488|3956379|B3|Obesity||Comorbidities||participants|Number|3|3.0||||||
4131687|NCT00904488|3956380|B2|Obesity||Comorbidities||participants|Number|1|1.0||||||
4131688|NCT00904488|3956381|B1|Obesity||Comorbidities||participants|Number|2|2.0||||||
4131689|NCT00904488|3956379|B3|Hypertension||Comorbidities||participants|Number|8|8.0||||||
4131690|NCT00904488|3956380|B2|Hypertension||Comorbidities||participants|Number|4|4.0||||||
4131691|NCT00904488|3956381|B1|Hypertension||Comorbidities||participants|Number|4|4.0||||||
4131692|NCT00904488|3956379|B3|Myocardial infarction (MI)||Comorbidities||participants|Number|2|2.0||||||
4131693|NCT00904488|3956380|B2|Myocardial infarction (MI)||Comorbidities||participants|Number|1|1.0||||||
4131694|NCT00904488|3956381|B1|Myocardial infarction (MI)||Comorbidities||participants|Number|1|1.0||||||
4131695|NCT00904488|3956379|B3|Human immunodeficiency virus (HIV)||Comorbidities||participants|Number|1|1.0||||||
4131696|NCT00904488|3956380|B2|Human immunodeficiency virus (HIV)||Comorbidities||participants|Number|0|0.0||||||
4131697|NCT00904488|3956381|B1|Human immunodeficiency virus (HIV)||Comorbidities||participants|Number|1|1.0||||||
4131698|NCT00904488|3956379|B3|Gout||Comorbidities||participants|Number|2|2.0||||||
4131699|NCT00904488|3956380|B2|Gout||Comorbidities||participants|Number|1|1.0||||||
4131700|NCT00904488|3956381|B1|Gout||Comorbidities||participants|Number|1|1.0||||||
4131701|NCT00904488|3956379|B3|Gastroesophageal reflux disease (GERD)||Comorbidities||participants|Number|1|1.0||||||
4131702|NCT00904488|3956380|B2|Gastroesophageal reflux disease (GERD)||Comorbidities||participants|Number|0|0.0||||||
4131703|NCT00904488|3956381|B1|Gastroesophageal reflux disease (GERD)||Comorbidities||participants|Number|1|1.0||||||
4131704|NCT00904488|3956379|B3|Dyslipidemia||Comorbidities||participants|Number|6|6.0||||||
4131705|NCT00904488|3956380|B2|Dyslipidemia||Comorbidities||participants|Number|2|2.0||||||
4131706|NCT00904488|3956381|B1|Dyslipidemia||Comorbidities||participants|Number|4|4.0||||||
4131707|NCT00904488|3956379|B3|Diabetes||Comorbidities||participants|Number|7|7.0||||||
4131708|NCT00904488|3956380|B2|Diabetes||Comorbidities||participants|Number|3|3.0||||||
4131709|NCT00904488|3956381|B1|Diabetes||Comorbidities||participants|Number|4|4.0||||||
4131710|NCT00904488|3956379|B3|Cerebrovascular accident (CVA)||Comorbidities||participants|Number|3|3.0||||||
4131711|NCT00904488|3956380|B2|Cerebrovascular accident (CVA)||Comorbidities||participants|Number|2|2.0||||||
4131712|NCT00904488|3956381|B1|Cerebrovascular accident (CVA)||Comorbidities||participants|Number|1|1.0||||||
4131820|NCT00904189|3956441|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4131713|NCT00904488|3956379|B3|Chronic obstructive pulmonary disease (COPD)||Comorbidities||participants|Number|2|2.0||||||
4131714|NCT00904488|3956380|B2|Chronic obstructive pulmonary disease (COPD)||Comorbidities||participants|Number|2|2.0||||||
4131715|NCT00904488|3956381|B1|Chronic obstructive pulmonary disease (COPD)||Comorbidities||participants|Number|0|0.0||||||
4131716|NCT00904488|3956379|B3|Coronary artery disease (CAD)||Comorbidities||participants|Number|4|4.0||||||
4131717|NCT00904488|3956380|B2|Coronary artery disease (CAD)||Comorbidities||participants|Number|3|3.0||||||
4131718|NCT00904488|3956381|B1|Coronary artery disease (CAD)||Comorbidities||participants|Number|1|1.0||||||
4131719|NCT00904488|3956379|B3|Anemia||Comorbidities||participants|Number|2|2.0||||||
4131720|NCT00904488|3956380|B2|Anemia||Comorbidities||participants|Number|0|0.0||||||
4131721|NCT00904488|3956381|B1|Anemia||Comorbidities||participants|Number|2|2.0||||||
4131722|NCT00904488|3956379|B3||Not Reported|New York Heart Association (NYHA) Class on Admission|"ClassI No limitation of physical activity. Best outcome.~ClassII Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~ClassIII Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~ClassIV Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases. Worst outcome"|Participants|Count of Participants|6|6.0||||||
4131723|NCT00904488|3956380|B2||Not Reported|New York Heart Association (NYHA) Class on Admission|"ClassI No limitation of physical activity. Best outcome.~ClassII Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~ClassIII Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~ClassIV Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases. Worst outcome"|Participants|Count of Participants|2|2.0||||||
4131724|NCT00904488|3956381|B1||Not Reported|New York Heart Association (NYHA) Class on Admission|"ClassI No limitation of physical activity. Best outcome.~ClassII Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~ClassIII Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~ClassIV Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases. Worst outcome"|Participants|Count of Participants|4|4.0||||||
4131725|NCT00904488|3956379|B3||Class IV|New York Heart Association (NYHA) Class on Admission|"ClassI No limitation of physical activity. Best outcome.~ClassII Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~ClassIII Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~ClassIV Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases. Worst outcome"|Participants|Count of Participants|2|2.0||||||
4131726|NCT00904488|3956380|B2||Class IV|New York Heart Association (NYHA) Class on Admission|"ClassI No limitation of physical activity. Best outcome.~ClassII Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~ClassIII Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~ClassIV Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases. Worst outcome"|Participants|Count of Participants|1|1.0||||||
4131727|NCT00904488|3956381|B1||Class IV|New York Heart Association (NYHA) Class on Admission|"ClassI No limitation of physical activity. Best outcome.~ClassII Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~ClassIII Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~ClassIV Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases. Worst outcome"|Participants|Count of Participants|1|1.0||||||
4131728|NCT00904488|3956379|B3||Class III|New York Heart Association (NYHA) Class on Admission|"ClassI No limitation of physical activity. Best outcome.~ClassII Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~ClassIII Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~ClassIV Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases. Worst outcome"|Participants|Count of Participants|3|3.0||||||
4131729|NCT00904488|3956380|B2||Class III|New York Heart Association (NYHA) Class on Admission|"ClassI No limitation of physical activity. Best outcome.~ClassII Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~ClassIII Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~ClassIV Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases. Worst outcome"|Participants|Count of Participants|3|3.0||||||
4131730|NCT00904488|3956381|B1||Class III|New York Heart Association (NYHA) Class on Admission|"ClassI No limitation of physical activity. Best outcome.~ClassII Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~ClassIII Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~ClassIV Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases. Worst outcome"|Participants|Count of Participants|0|0.0||||||
4131764|NCT00904488|3956379|B3|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4131765|NCT00904488|3956380|B2|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4131766|NCT00904488|3956381|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4131731|NCT00904488|3956379|B3||Class II|New York Heart Association (NYHA) Class on Admission|"ClassI No limitation of physical activity. Best outcome.~ClassII Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~ClassIII Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~ClassIV Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases. Worst outcome"|Participants|Count of Participants|0|0.0||||||
4131732|NCT00904488|3956380|B2||Class II|New York Heart Association (NYHA) Class on Admission|"ClassI No limitation of physical activity. Best outcome.~ClassII Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~ClassIII Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~ClassIV Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases. Worst outcome"|Participants|Count of Participants|0|0.0||||||
4131733|NCT00904488|3956381|B1||Class II|New York Heart Association (NYHA) Class on Admission|"ClassI No limitation of physical activity. Best outcome.~ClassII Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~ClassIII Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~ClassIV Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases. Worst outcome"|Participants|Count of Participants|0|0.0||||||
4131734|NCT00904488|3956379|B3||Class I|New York Heart Association (NYHA) Class on Admission|"ClassI No limitation of physical activity. Best outcome.~ClassII Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~ClassIII Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~ClassIV Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases. Worst outcome"|Participants|Count of Participants|0|0.0||||||
4131735|NCT00904488|3956380|B2||Class I|New York Heart Association (NYHA) Class on Admission|"ClassI No limitation of physical activity. Best outcome.~ClassII Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~ClassIII Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~ClassIV Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases. Worst outcome"|Participants|Count of Participants|0|0.0||||||
4131736|NCT00904488|3956381|B1||Class I|New York Heart Association (NYHA) Class on Admission|"ClassI No limitation of physical activity. Best outcome.~ClassII Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~ClassIII Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~ClassIV Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases. Worst outcome"|Participants|Count of Participants|0|0.0||||||
4131737|NCT00904488|3956379|B3||Not reported|Afib on Admission||Participants|Count of Participants|3|3.0||||||
4131738|NCT00904488|3956380|B2||Not reported|Afib on Admission||Participants|Count of Participants|1|1.0||||||
4131739|NCT00904488|3956381|B1||Not reported|Afib on Admission||Participants|Count of Participants|2|2.0||||||
4131740|NCT00904488|3956379|B3||Absent|Afib on Admission||Participants|Count of Participants|8|8.0||||||
4131741|NCT00904488|3956380|B2||Absent|Afib on Admission||Participants|Count of Participants|5|5.0||||||
4131742|NCT00904488|3956381|B1||Absent|Afib on Admission||Participants|Count of Participants|3|3.0||||||
4131743|NCT00904488|3956379|B3||Present|Afib on Admission||Participants|Count of Participants|0|0.0||||||
4131744|NCT00904488|3956380|B2||Present|Afib on Admission||Participants|Count of Participants|0|0.0||||||
4131745|NCT00904488|3956381|B1||Present|Afib on Admission||Participants|Count of Participants|0|0.0||||||
4131746|NCT00904488|3956379|B3|Fluid Overload||Chief Complaints||participants|Number|2|2.0||||||
4131747|NCT00904488|3956380|B2|Fluid Overload||Chief Complaints||participants|Number|2|2.0||||||
4131748|NCT00904488|3956381|B1|Fluid Overload||Chief Complaints||participants|Number|1|1.0||||||
4131749|NCT00904488|3956379|B3|Weight Gain||Chief Complaints||participants|Number|1|1.0||||||
4131750|NCT00904488|3956380|B2|Weight Gain||Chief Complaints||participants|Number|1|1.0||||||
4131751|NCT00904488|3956381|B1|Weight Gain||Chief Complaints||participants|Number|0|0.0||||||
4131752|NCT00904488|3956379|B3|Shortness of Breath (SOB)||Chief Complaints||participants|Number|3|3.0||||||
4131753|NCT00904488|3956380|B2|Shortness of Breath (SOB)||Chief Complaints||participants|Number|2|2.0||||||
4131754|NCT00904488|3956381|B1|Shortness of Breath (SOB)||Chief Complaints||participants|Number|2|2.0||||||
4131755|NCT00904488|3956379|B3||Severe (5-15%)|Baseline Ejection Fraction (EF) (%)||Participants|Count of Participants|2|2.0||||||
4131756|NCT00904488|3956380|B2||Severe (5-15%)|Baseline Ejection Fraction (EF) (%)||Participants|Count of Participants|0|0.0||||||
4131757|NCT00904488|3956381|B1||Severe (5-15%)|Baseline Ejection Fraction (EF) (%)||Participants|Count of Participants|2|2.0||||||
4131758|NCT00904488|3956379|B3||Moderate (20-40%)|Baseline Ejection Fraction (EF) (%)||Participants|Count of Participants|6|6.0||||||
4131759|NCT00904488|3956380|B2||Moderate (20-40%)|Baseline Ejection Fraction (EF) (%)||Participants|Count of Participants|5|5.0||||||
4131760|NCT00904488|3956381|B1||Moderate (20-40%)|Baseline Ejection Fraction (EF) (%)||Participants|Count of Participants|1|1.0||||||
4131761|NCT00904488|3956379|B3||Mild (55-60%)|Baseline Ejection Fraction (EF) (%)||Participants|Count of Participants|3|3.0||||||
4131762|NCT00904488|3956380|B2||Mild (55-60%)|Baseline Ejection Fraction (EF) (%)||Participants|Count of Participants|1|1.0||||||
4131763|NCT00904488|3956381|B1||Mild (55-60%)|Baseline Ejection Fraction (EF) (%)||Participants|Count of Participants|2|2.0||||||
4131767|NCT00904488|3956379|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4131768|NCT00904488|3956380|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131769|NCT00904488|3956381|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4131770|NCT00904488|3956379|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131771|NCT00904488|3956380|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131772|NCT00904488|3956381|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131773|NCT00904488|3956379|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4131774|NCT00904488|3956380|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4131775|NCT00904488|3956381|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4131776|NCT00904488|3956379|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4131777|NCT00904488|3956380|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4131778|NCT00904488|3956381|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4131779|NCT00904488|3956379|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131780|NCT00904488|3956380|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131781|NCT00904488|3956381|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131782|NCT00904488|3956379|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131783|NCT00904488|3956380|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131784|NCT00904488|3956381|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131785|NCT00904488|3956379|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131786|NCT00904488|3956380|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131787|NCT00904488|3956381|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131788|NCT00904488|3956379|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4131789|NCT00904488|3956380|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4131790|NCT00904488|3956381|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4131791|NCT00904488|3956379|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4131792|NCT00904488|3956380|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4131793|NCT00904488|3956381|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4131794|NCT00904488|3956379|B3|||Age||years|Mean|56.6|56.6|Standard Deviation|15.3|15.3|||
4131795|NCT00904488|3956380|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|16.2|16.2|||
4131796|NCT00904488|3956381|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|16.0|16.0|||
4131797|NCT00904423|3956412|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131798|NCT00904423|3956412|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131799|NCT00904423|3956412|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4131800|NCT00904423|3956412|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131801|NCT00904423|3956412|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131802|NCT00904423|3956412|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4131803|NCT00904423|3956412|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131804|NCT00904423|3956412|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4131805|NCT00904423|3956412|B1||Female|Gender||Participants|Count of Participants|8|8.0||||||
4131806|NCT00904423|3956412|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4131807|NCT00904423|3956412|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4131808|NCT00904423|3956412|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131809|NCT00904371|3956420|B1|Other||Additional antihypertensive treatment at baseline|Participants may have taken more than one antihypertensive treatment, so the percentages will not add to 100 percent.|Percentage of participants|Number|7.6|7.6||||||
4131810|NCT00904371|3956420|B1|Beta Blockers||Additional antihypertensive treatment at baseline|Participants may have taken more than one antihypertensive treatment, so the percentages will not add to 100 percent.|Percentage of participants|Number|39.3|39.3||||||
4131811|NCT00904371|3956420|B1|Calcium Channel Blockers||Additional antihypertensive treatment at baseline|Participants may have taken more than one antihypertensive treatment, so the percentages will not add to 100 percent.|Percentage of participants|Number|26.5|26.5||||||
4131812|NCT00904371|3956420|B1|Diuretics||Additional antihypertensive treatment at baseline|Participants may have taken more than one antihypertensive treatment, so the percentages will not add to 100 percent.|Percentage of participants|Number|15.2|15.2||||||
4131813|NCT00904371|3956420|B1|ACE inhibitors||Additional antihypertensive treatment at baseline|Participants may have taken more than one antihypertensive treatment, so the percentages will not add to 100 percent.|Percentage of participants|Number|19|19.0||||||
4131814|NCT00904371|3956420|B1|Male||Gender|There were only 203 patients with non-missing gender|Participants|Number|113|113.0||||||
4131815|NCT00904371|3956420|B1|Female||Gender|There were only 203 patients with non-missing gender|Participants|Number|90|90.0||||||
4131816|NCT00904371|3956420|B1|||Age||years|Mean|64.4|64.4|Standard Deviation|10.4|10.4|||
4131817|NCT00904215|3956434|B1||Male|Sex: Female, Male||Participants|Count of Participants|531|531.0||||||
4131818|NCT00904215|3956434|B1||Female|Sex: Female, Male||Participants|Count of Participants|494|494.0||||||
4131819|NCT00904215|3956434|B1|||Age||years|Mean|57|57.0|Standard Deviation|12|12.0|||
4131821|NCT00904189|3956441|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4131822|NCT00904189|3956441|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4131823|NCT00904189|3956441|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4131824|NCT00904189|3956441|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131825|NCT00904150|3956446|B3|Australia||Region of Enrollment||participants|Number|145|145.0||||||
4131826|NCT00904150|3956447|B2|Australia||Region of Enrollment||participants|Number|145|145.0||||||
4131827|NCT00904150|3956448|B1|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4131828|NCT00904150|3956446|B3|United Kingdom||Region of Enrollment||participants|Number|440|440.0||||||
4131829|NCT00904150|3956447|B2|United Kingdom||Region of Enrollment||participants|Number|155|155.0||||||
4131830|NCT00904150|3956448|B1|United Kingdom||Region of Enrollment||participants|Number|285|285.0||||||
4131831|NCT00904150|3956446|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4131832|NCT00904150|3956447|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4131833|NCT00904150|3956448|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4131834|NCT00904150|3956446|B3||Female|Sex: Female, Male||Participants|Count of Participants|585|585.0||||||
4131835|NCT00904150|3956447|B2||Female|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
4131836|NCT00904150|3956448|B1||Female|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
4131837|NCT00904150|3956446|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4131838|NCT00904150|3956447|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4131839|NCT00904150|3956448|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4131840|NCT00904150|3956446|B3||Between 18 and 65 years|Age||Participants|Count of Participants|585|585.0||||||
4131841|NCT00904150|3956447|B2||Between 18 and 65 years|Age||Participants|Count of Participants|300|300.0||||||
4131842|NCT00904150|3956448|B1||Between 18 and 65 years|Age||Participants|Count of Participants|285|285.0||||||
4131843|NCT00904150|3956446|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131844|NCT00904150|3956447|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131845|NCT00904150|3956448|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131846|NCT00904007|3956467|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4131847|NCT00904007|3956468|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4131848|NCT00904007|3956469|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4131849|NCT00904007|3956467|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4131850|NCT00904007|3956468|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4131851|NCT00904007|3956469|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4131852|NCT00904007|3956467|B3|||Age||years|Mean|51.8|51.8|Standard Deviation|9.2|9.2|||
4131853|NCT00904007|3956468|B2|||Age||years|Mean|53.1|53.1|Standard Deviation|8.5|8.5|||
4131854|NCT00904007|3956469|B1|||Age||years|Mean|50.5|50.5|Standard Deviation|9.7|9.7|||
4131855|NCT00903968|3956476|B3|United States||Region of Enrollment||Participants|Count of Participants|58|58.0||||||
4131856|NCT00903968|3956477|B2|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
4131857|NCT00903968|3956478|B1|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4131858|NCT00903968|3956476|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4131859|NCT00903968|3956477|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131860|NCT00903968|3956478|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4131861|NCT00903968|3956476|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131862|NCT00903968|3956477|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131863|NCT00903968|3956478|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131864|NCT00903968|3956476|B3||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4131865|NCT00903968|3956477|B2||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4131866|NCT00903968|3956478|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4131867|NCT00903968|3956476|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4131868|NCT00903968|3956477|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4131869|NCT00903968|3956478|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4131870|NCT00903968|3956476|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131871|NCT00903968|3956477|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131872|NCT00903968|3956478|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131873|NCT00903968|3956476|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4131874|NCT00903968|3956477|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4131875|NCT00903968|3956478|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131876|NCT00903968|3956476|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4131877|NCT00903968|3956477|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4131878|NCT00903968|3956478|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131879|NCT00903968|3956476|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4131880|NCT00903968|3956477|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4131881|NCT00903968|3956478|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131882|NCT00903968|3956476|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4131883|NCT00903968|3956477|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4131884|NCT00903968|3956478|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4131885|NCT00903968|3956476|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4131886|NCT00903968|3956477|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4131887|NCT00903968|3956478|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131888|NCT00903968|3956476|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4131889|NCT00903968|3956477|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4131890|NCT00903968|3956478|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4131891|NCT00903968|3956476|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4131892|NCT00903968|3956477|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4131893|NCT00903968|3956478|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4131894|NCT00903968|3956476|B3|||Age||years|Median|63|63.0|Full Range|||43.0|85.0|
4131895|NCT00903968|3956477|B2|||Age||years|Median|63|63.0|Full Range|||46.0|83.0|
4131896|NCT00903968|3956478|B1|||Age||years|Median|59|59.0|Full Range|||43.0|85.0|
4131897|NCT00903929|3956515|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4131898|NCT00903929|3956515|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4131899|NCT00903929|3956515|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4131900|NCT00903929|3956515|B1|||Age||years|Median|52|52.0|Full Range|||20.0|69.0|
4131901|NCT00903877|3956524|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4131902|NCT00903877|3956524|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4131903|NCT00903877|3956524|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4131904|NCT00903877|3956524|B1|||Age||years|Mean|35.35|35.35|Standard Deviation|7.76|7.76|||
4131905|NCT00903877|3956524|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4131906|NCT00903877|3956524|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4131907|NCT00903877|3956524|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4131908|NCT00903786|3956528|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4131909|NCT00903786|3956528|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4131910|NCT00903786|3956528|B1|||Age||Years|Mean|36.5|36.5|Standard Deviation|11.02|11.02|||
4131911|NCT00903760|3956536|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
4131912|NCT00903760|3956537|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4131913|NCT00903760|3956538|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4131914|NCT00903760|3956536|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4131915|NCT00903760|3956537|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131916|NCT00903760|3956538|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4131917|NCT00903760|3956536|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131918|NCT00903760|3956537|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131919|NCT00903760|3956538|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131920|NCT00903760|3956536|B3||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4131921|NCT00903760|3956537|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4131922|NCT00903760|3956538|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4131923|NCT00903760|3956536|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4131924|NCT00903760|3956537|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4131925|NCT00903760|3956538|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4131926|NCT00903760|3956536|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131927|NCT00903760|3956537|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131928|NCT00903760|3956538|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131929|NCT00903760|3956536|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131930|NCT00903760|3956537|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131931|NCT00903760|3956538|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131932|NCT00903760|3956536|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131933|NCT00903760|3956537|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131934|NCT00903760|3956538|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131935|NCT00903760|3956536|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4131936|NCT00903760|3956537|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4131937|NCT00903760|3956538|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4131938|NCT00903760|3956536|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4131939|NCT00903760|3956537|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4131940|NCT00903760|3956538|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4131941|NCT00903760|3956536|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4131942|NCT00903760|3956537|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4131943|NCT00903760|3956538|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4131944|NCT00903760|3956536|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4131945|NCT00903760|3956537|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4131946|NCT00903760|3956538|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4131947|NCT00903760|3956536|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4131948|NCT00903760|3956537|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4131949|NCT00903760|3956538|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4131950|NCT00903760|3956536|B3|>=80||Age, Customized||participants|Number|1|1.0||||||
4131951|NCT00903760|3956537|B2|>=80||Age, Customized||participants|Number|1|1.0||||||
4131952|NCT00903760|3956538|B1|>=80||Age, Customized||participants|Number|0|0.0||||||
4131953|NCT00903760|3956536|B3|70-79||Age, Customized||participants|Number|17|17.0||||||
4131954|NCT00903760|3956537|B2|70-79||Age, Customized||participants|Number|8|8.0||||||
4131955|NCT00903760|3956538|B1|70-79||Age, Customized||participants|Number|9|9.0||||||
4131956|NCT00903760|3956536|B3|60-69||Age, Customized||participants|Number|11|11.0||||||
4131957|NCT00903760|3956537|B2|60-69||Age, Customized||participants|Number|7|7.0||||||
4131958|NCT00903760|3956538|B1|60-69||Age, Customized||participants|Number|4|4.0||||||
4131959|NCT00903760|3956536|B3|50-59||Age, Customized||participants|Number|4|4.0||||||
4131960|NCT00903760|3956537|B2|50-59||Age, Customized||participants|Number|1|1.0||||||
4131961|NCT00903760|3956538|B1|50-59||Age, Customized||participants|Number|3|3.0||||||
4131962|NCT00903760|3956536|B3|40-49||Age, Customized||participants|Number|1|1.0||||||
4131963|NCT00903760|3956537|B2|40-49||Age, Customized||participants|Number|0|0.0||||||
4131964|NCT00903760|3956538|B1|40-49||Age, Customized||participants|Number|1|1.0||||||
4131965|NCT00903760|3956536|B3|30-39||Age, Customized||participants|Number|1|1.0||||||
4131966|NCT00903760|3956537|B2|30-39||Age, Customized||participants|Number|1|1.0||||||
4131967|NCT00903760|3956538|B1|30-39||Age, Customized||participants|Number|0|0.0||||||
4131968|NCT00903760|3956536|B3|<=29||Age, Customized||participants|Number|2|2.0||||||
4131969|NCT00903760|3956537|B2|<=29||Age, Customized||participants|Number|0|0.0||||||
4131970|NCT00903760|3956538|B1|<=29||Age, Customized||participants|Number|2|2.0||||||
4131971|NCT00903695|3956547|B3|||Clock Drawing Test|Clock Drawing Test is a cognitive screening instrument in which subjects are asked to draw a traditional clock and place the hands at a specified time. Scoring in this version used 8 indicators of accuracy and skill, with higher scores showing more competence (0-8 pts possible).|initial total raw score by group|Mean|6.8|6.8|Standard Deviation|0.9|0.9|||
4131972|NCT00903695|3956548|B2|||Clock Drawing Test|Clock Drawing Test is a cognitive screening instrument in which subjects are asked to draw a traditional clock and place the hands at a specified time. Scoring in this version used 8 indicators of accuracy and skill, with higher scores showing more competence (0-8 pts possible).|initial total raw score by group|Mean|7.0|7.0|Standard Deviation|0.7|0.7|||
4131973|NCT00903695|3956549|B1|||Clock Drawing Test|Clock Drawing Test is a cognitive screening instrument in which subjects are asked to draw a traditional clock and place the hands at a specified time. Scoring in this version used 8 indicators of accuracy and skill, with higher scores showing more competence (0-8 pts possible).|initial total raw score by group|Mean|6.7|6.7|Standard Deviation|0.3|0.3|||
4131974|NCT00903695|3956547|B3|||Instrumental Activities of Daily Living (IADL)|IADL is a behavior rating scale with 9 domains, and 3 incremental scores ( 1, 2, 3). Total scores can range from 9 to 27, with higher scores indicating more pathology.|total initial scores by study group|Mean|14.0|14.0|Standard Deviation|4.9|4.9|||
4131975|NCT00903695|3956548|B2|||Instrumental Activities of Daily Living (IADL)|IADL is a behavior rating scale with 9 domains, and 3 incremental scores ( 1, 2, 3). Total scores can range from 9 to 27, with higher scores indicating more pathology.|total initial scores by study group|Mean|13.0|13.0|Standard Deviation|3.7|3.7|||
4131976|NCT00903695|3956549|B1|||Instrumental Activities of Daily Living (IADL)|IADL is a behavior rating scale with 9 domains, and 3 incremental scores ( 1, 2, 3). Total scores can range from 9 to 27, with higher scores indicating more pathology.|total initial scores by study group|Mean|14.2|14.2|Standard Deviation|1.8|1.8|||
4131977|NCT00903695|3956547|B3|||Activities of Daily Living (ADL)|ADL is a behavior rating scale with 6 domains of self-care (feeding, toileting, etc.), with 3 incremental scores (1, 2, 3) in which higher scores mean more pathology (total scores of 6 to 18 points).|total initial raw scores by group|Mean|6.6|6.6|Standard Deviation|1.2|1.2|||
4131978|NCT00903695|3956548|B2|||Activities of Daily Living (ADL)|ADL is a behavior rating scale with 6 domains of self-care (feeding, toileting, etc.), with 3 incremental scores (1, 2, 3) in which higher scores mean more pathology (total scores of 6 to 18 points).|total initial raw scores by group|Mean|8.0|8.0|Standard Deviation|0.7|0.7|||
4131979|NCT00903695|3956549|B1|||Activities of Daily Living (ADL)|ADL is a behavior rating scale with 6 domains of self-care (feeding, toileting, etc.), with 3 incremental scores (1, 2, 3) in which higher scores mean more pathology (total scores of 6 to 18 points).|total initial raw scores by group|Mean|6.3|6.3|Standard Deviation|0.4|0.4|||
4132018|NCT00903682|3956572|B1|Spain||Region of Enrollment||participants|Number|12|12.0||||||
4132019|NCT00903682|3956570|B3|Russia||Region of Enrollment||participants|Number|17|17.0||||||
4132020|NCT00903682|3956571|B2|Russia||Region of Enrollment||participants|Number|8|8.0||||||
4131980|NCT00903695|3956547|B3|||Modified Clinical Dementia Rating scale (CDR)|Modified CDR is a behavior rating scale of 8 domains, with 5 incremental scores for each domain (0, 0.5, 1, 2, 3). Total raw score of 0 means patient is healthy; raw score of 1 to <8 points from the 8 domains earns subject a CDR scale score of 0.5 (Mild Cognitive Impairment, no dementia). Total scaled score of 1 = mild dementia; 2 = moderate dementia; 3 = severe dementia.|total raw scores by study group|Mean|5.8|5.8|Standard Deviation|3.8|3.8|||
4131981|NCT00903695|3956548|B2|||Modified Clinical Dementia Rating scale (CDR)|Modified CDR is a behavior rating scale of 8 domains, with 5 incremental scores for each domain (0, 0.5, 1, 2, 3). Total raw score of 0 means patient is healthy; raw score of 1 to <8 points from the 8 domains earns subject a CDR scale score of 0.5 (Mild Cognitive Impairment, no dementia). Total scaled score of 1 = mild dementia; 2 = moderate dementia; 3 = severe dementia.|total raw scores by study group|Mean|6.5|6.5|Standard Deviation|2.8|2.8|||
4131982|NCT00903695|3956549|B1|||Modified Clinical Dementia Rating scale (CDR)|Modified CDR is a behavior rating scale of 8 domains, with 5 incremental scores for each domain (0, 0.5, 1, 2, 3). Total raw score of 0 means patient is healthy; raw score of 1 to <8 points from the 8 domains earns subject a CDR scale score of 0.5 (Mild Cognitive Impairment, no dementia). Total scaled score of 1 = mild dementia; 2 = moderate dementia; 3 = severe dementia.|total raw scores by study group|Mean|5.6|5.6|Standard Deviation|1.4|1.4|||
4131983|NCT00903695|3956547|B3|||Neuropsychiatric Inventory NPI)|Neuropsychiatric Inventory (NPI) behavior rating scale includes 12 domains; higher numbers mean more psychiatric pathology (0 to 36 points).|total raw scores by group|Mean|3.5|3.5|Standard Deviation|3.4|3.4|||
4131984|NCT00903695|3956548|B2|||Neuropsychiatric Inventory NPI)|Neuropsychiatric Inventory (NPI) behavior rating scale includes 12 domains; higher numbers mean more psychiatric pathology (0 to 36 points).|total raw scores by group|Mean|3.0|3.0|Standard Deviation|2.6|2.6|||
4131985|NCT00903695|3956549|B1|||Neuropsychiatric Inventory NPI)|Neuropsychiatric Inventory (NPI) behavior rating scale includes 12 domains; higher numbers mean more psychiatric pathology (0 to 36 points).|total raw scores by group|Mean|3.6|3.6|Standard Deviation|1.3|1.3|||
4131986|NCT00903695|3956547|B3|||MiniMental State Exam (MMSE)|MiniMental State Exam (MMSE) is a cognitive screening device with possible 30 points; higher scores mean more competence, and scores can range from 0-30 points.|total 1st MMSE score parameters|Mean|27.7|27.7|Standard Deviation|2.1|2.1|||
4131987|NCT00903695|3956548|B2|||MiniMental State Exam (MMSE)|MiniMental State Exam (MMSE) is a cognitive screening device with possible 30 points; higher scores mean more competence, and scores can range from 0-30 points.|total 1st MMSE score parameters|Mean|28.5|28.5|Standard Deviation|1.5|1.5|||
4131988|NCT00903695|3956549|B1|||MiniMental State Exam (MMSE)|MiniMental State Exam (MMSE) is a cognitive screening device with possible 30 points; higher scores mean more competence, and scores can range from 0-30 points.|total 1st MMSE score parameters|Mean|27.5|27.5|Standard Deviation|0.8|0.8|||
4131989|NCT00903695|3956547|B3|||Dementia Rating Scale|Dementia Rating Scale (DRS) = cognitive test with 5 domains; raw scores can be converted to percentiles for age/education levels. Higher scores mean more competence (range = 0 to 180 points).|total raw score points for 5 domains|Mean|132|132.0|Standard Deviation|7.5|7.5|||
4131990|NCT00903695|3956548|B2|||Dementia Rating Scale|Dementia Rating Scale (DRS) = cognitive test with 5 domains; raw scores can be converted to percentiles for age/education levels. Higher scores mean more competence (range = 0 to 180 points).|total raw score points for 5 domains|Mean|140|140.0|Standard Deviation|4.7|4.7|||
4131991|NCT00903695|3956549|B1|||Dementia Rating Scale|Dementia Rating Scale (DRS) = cognitive test with 5 domains; raw scores can be converted to percentiles for age/education levels. Higher scores mean more competence (range = 0 to 180 points).|total raw score points for 5 domains|Mean|130|130.0|Standard Deviation|2.3|2.3|||
4131992|NCT00903695|3956547|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4131993|NCT00903695|3956548|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4131994|NCT00903695|3956549|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4131995|NCT00903695|3956547|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4131996|NCT00903695|3956548|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4131997|NCT00903695|3956549|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4131998|NCT00903695|3956547|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4131999|NCT00903695|3956548|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4132000|NCT00903695|3956549|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4132001|NCT00903695|3956547|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4132002|NCT00903695|3956548|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4132003|NCT00903695|3956549|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4132004|NCT00903695|3956547|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4132005|NCT00903695|3956548|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4132006|NCT00903695|3956549|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4132007|NCT00903695|3956547|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132008|NCT00903695|3956548|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132009|NCT00903695|3956549|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132010|NCT00903682|3956570|B3|UK||Region of Enrollment||participants|Number|11|11.0||||||
4132011|NCT00903682|3956571|B2|UK||Region of Enrollment||participants|Number|6|6.0||||||
4132012|NCT00903682|3956572|B1|UK||Region of Enrollment||participants|Number|5|5.0||||||
4132013|NCT00903682|3956570|B3|Switzerland||Region of Enrollment||participants|Number|4|4.0||||||
4132014|NCT00903682|3956571|B2|Switzerland||Region of Enrollment||participants|Number|3|3.0||||||
4132015|NCT00903682|3956572|B1|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4132016|NCT00903682|3956570|B3|Spain||Region of Enrollment||participants|Number|21|21.0||||||
4132017|NCT00903682|3956571|B2|Spain||Region of Enrollment||participants|Number|9|9.0||||||
4132021|NCT00903682|3956572|B1|Russia||Region of Enrollment||participants|Number|9|9.0||||||
4132022|NCT00903682|3956570|B3|Romania||Region of Enrollment||participants|Number|16|16.0||||||
4132023|NCT00903682|3956571|B2|Romania||Region of Enrollment||participants|Number|10|10.0||||||
4132024|NCT00903682|3956572|B1|Romania||Region of Enrollment||participants|Number|6|6.0||||||
4132025|NCT00903682|3956570|B3|Italy||Region of Enrollment||participants|Number|15|15.0||||||
4132026|NCT00903682|3956571|B2|Italy||Region of Enrollment||participants|Number|6|6.0||||||
4132027|NCT00903682|3956572|B1|Italy||Region of Enrollment||participants|Number|9|9.0||||||
4132028|NCT00903682|3956570|B3|Israel||Region of Enrollment||participants|Number|9|9.0||||||
4132029|NCT00903682|3956571|B2|Israel||Region of Enrollment||participants|Number|5|5.0||||||
4132030|NCT00903682|3956572|B1|Israel||Region of Enrollment||participants|Number|4|4.0||||||
4132031|NCT00903682|3956570|B3|Hungary||Region of Enrollment||participants|Number|8|8.0||||||
4132032|NCT00903682|3956571|B2|Hungary||Region of Enrollment||participants|Number|3|3.0||||||
4132033|NCT00903682|3956572|B1|Hungary||Region of Enrollment||participants|Number|5|5.0||||||
4132034|NCT00903682|3956570|B3|Germany||Region of Enrollment||participants|Number|29|29.0||||||
4132035|NCT00903682|3956571|B2|Germany||Region of Enrollment||participants|Number|13|13.0||||||
4132036|NCT00903682|3956572|B1|Germany||Region of Enrollment||participants|Number|16|16.0||||||
4132037|NCT00903682|3956570|B3|France||Region of Enrollment||participants|Number|18|18.0||||||
4132038|NCT00903682|3956571|B2|France||Region of Enrollment||participants|Number|9|9.0||||||
4132039|NCT00903682|3956572|B1|France||Region of Enrollment||participants|Number|9|9.0||||||
4132040|NCT00903682|3956570|B3|Denmark||Region of Enrollment||participants|Number|2|2.0||||||
4132041|NCT00903682|3956571|B2|Denmark||Region of Enrollment||participants|Number|2|2.0||||||
4132042|NCT00903682|3956572|B1|Denmark||Region of Enrollment||participants|Number|0|0.0||||||
4132043|NCT00903682|3956570|B3|Austria||Region of Enrollment||participants|Number|7|7.0||||||
4132044|NCT00903682|3956571|B2|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4132045|NCT00903682|3956572|B1|Austria||Region of Enrollment||participants|Number|3|3.0||||||
4132046|NCT00903682|3956570|B3||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4132047|NCT00903682|3956571|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4132048|NCT00903682|3956572|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4132049|NCT00903682|3956570|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4132050|NCT00903682|3956571|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4132051|NCT00903682|3956572|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4132052|NCT00903682|3956570|B3|||Age||years|Mean|37.6|37.6|Standard Deviation|9.64|9.64|||
4132053|NCT00903682|3956571|B2|||Age||years|Mean|37.6|37.6|Standard Deviation|9.82|9.82|||
4132054|NCT00903682|3956572|B1|||Age||years|Mean|37.7|37.7|Standard Deviation|9.52|9.52|||
4132055|NCT00903682|3956570|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4132056|NCT00903682|3956571|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4132057|NCT00903682|3956572|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4132058|NCT00903682|3956570|B3||Between 18 and 65 years|Age||Participants|Count of Participants|155|155.0||||||
4132059|NCT00903682|3956571|B2||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
4132060|NCT00903682|3956572|B1||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
4132061|NCT00903682|3956570|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4132062|NCT00903682|3956571|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132063|NCT00903682|3956572|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4132064|NCT00903630|3956591|B4|United States||Region of Enrollment||participants|Number|15|15.0||||||
4132065|NCT00903630|3956592|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4132066|NCT00903630|3956593|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4132067|NCT00903630|3956594|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4132068|NCT00903630|3956591|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4132069|NCT00903630|3956592|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4132070|NCT00903630|3956593|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4132071|NCT00903630|3956594|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4132072|NCT00903630|3956591|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4132073|NCT00903630|3956592|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4132074|NCT00903630|3956593|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4132075|NCT00903630|3956594|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4132076|NCT00903630|3956591|B4||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4132077|NCT00903630|3956592|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4132078|NCT00903630|3956593|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4132079|NCT00903630|3956594|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4132080|NCT00903630|3956591|B4||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4132081|NCT00903630|3956592|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4132082|NCT00903630|3956593|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4132083|NCT00903630|3956594|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4132084|NCT00903630|3956591|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132085|NCT00903630|3956592|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132086|NCT00903630|3956593|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132087|NCT00903630|3956594|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132088|NCT00903617|3956610|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132089|NCT00903617|3956611|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132090|NCT00903617|3956612|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132091|NCT00903617|3956613|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132092|NCT00903617|3956614|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132093|NCT00903617|3956610|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132094|NCT00903617|3956611|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132095|NCT00903617|3956612|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132096|NCT00903617|3956613|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132097|NCT00903617|3956614|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132098|NCT00903617|3956610|B5||White|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
4132099|NCT00903617|3956611|B4||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4132100|NCT00903617|3956612|B3||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4132101|NCT00903617|3956613|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4132102|NCT00903617|3956614|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4132103|NCT00903617|3956610|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4132104|NCT00903617|3956611|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4132105|NCT00903617|3956612|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4132106|NCT00903617|3956613|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4132107|NCT00903617|3956614|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4132108|NCT00903617|3956610|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132109|NCT00903617|3956611|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132110|NCT00903617|3956612|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132111|NCT00903617|3956613|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132112|NCT00903617|3956614|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132113|NCT00903617|3956610|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132114|NCT00903617|3956611|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132115|NCT00903617|3956612|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132116|NCT00903617|3956613|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132117|NCT00903617|3956614|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132118|NCT00903617|3956610|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4132119|NCT00903617|3956611|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4132120|NCT00903617|3956612|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132121|NCT00903617|3956613|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132122|NCT00903617|3956614|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132123|NCT00903617|3956610|B5||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4132124|NCT00903617|3956611|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4132125|NCT00903617|3956612|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4132126|NCT00903617|3956613|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4132127|NCT00903617|3956614|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4132128|NCT00903617|3956610|B5||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4132129|NCT00903617|3956611|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4132130|NCT00903617|3956612|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4132131|NCT00903617|3956613|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4132132|NCT00903617|3956614|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4132133|NCT00903617|3956610|B5|||Age||Years|Mean|56.7|56.7|Standard Deviation|9.80|9.8|||
4132134|NCT00903617|3956611|B4|||Age||Years|Mean|57.7|57.7|Standard Deviation|10.15|10.15|||
4132135|NCT00903617|3956612|B3|||Age||Years|Mean|57.0|57.0|Standard Deviation|10.75|10.75|||
4132136|NCT00903617|3956613|B2|||Age||Years|Mean|53.8|53.8|Standard Deviation|9.77|9.77|||
4132137|NCT00903617|3956614|B1|||Age||Years|Mean|58.3|58.3|Standard Deviation|8.43|8.43|||
4132138|NCT00903448|3956711|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4132139|NCT00903448|3956711|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4132140|NCT00903448|3956711|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4132141|NCT00903448|3956711|B1|||Age||years|Mean|28|28.0|Standard Deviation|6.65|6.65|||
4132142|NCT00903448|3956711|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4132143|NCT00903448|3956711|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4132144|NCT00903448|3956711|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132145|NCT00903409|3956718|B3|Hispanic or Latino||Race/Ethnicity, Customized||Number of participants|Number|2|2.0||||||
4132146|NCT00903409|3956719|B2|Hispanic or Latino||Race/Ethnicity, Customized||Number of participants|Number|1|1.0||||||
4132147|NCT00903409|3956720|B1|Hispanic or Latino||Race/Ethnicity, Customized||Number of participants|Number|1|1.0||||||
4132148|NCT00903409|3956718|B3|Black or African American||Race/Ethnicity, Customized||Number of participants|Number|3|3.0||||||
4132149|NCT00903409|3956719|B2|Black or African American||Race/Ethnicity, Customized||Number of participants|Number|1|1.0||||||
4132150|NCT00903409|3956720|B1|Black or African American||Race/Ethnicity, Customized||Number of participants|Number|2|2.0||||||
4132151|NCT00903409|3956718|B3|Asian||Race/Ethnicity, Customized||Number of participants|Number|2|2.0||||||
4132152|NCT00903409|3956719|B2|Asian||Race/Ethnicity, Customized||Number of participants|Number|0|0.0||||||
4132153|NCT00903409|3956720|B1|Asian||Race/Ethnicity, Customized||Number of participants|Number|2|2.0||||||
4132154|NCT00903409|3956718|B3|White||Race/Ethnicity, Customized||Number of participants|Number|175|175.0||||||
4132155|NCT00903409|3956719|B2|White||Race/Ethnicity, Customized||Number of participants|Number|95|95.0||||||
4132156|NCT00903409|3956720|B1|White||Race/Ethnicity, Customized||Number of participants|Number|80|80.0||||||
4132157|NCT00903409|3956718|B3||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4132158|NCT00903409|3956719|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4132159|NCT00903409|3956720|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4132160|NCT00903409|3956718|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4132161|NCT00903409|3956719|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4132162|NCT00903409|3956720|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4132163|NCT00903409|3956718|B3|||Age||years|Mean|59.9|59.9|Standard Deviation|10.55|10.55|||
4132164|NCT00903409|3956719|B2|||Age||years|Mean|60.0|60.0|Standard Deviation|10.80|10.8|||
4132165|NCT00903409|3956720|B1|||Age||years|Mean|59.7|59.7|Standard Deviation|10.32|10.32|||
4132166|NCT00903383|3956768|B5||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4132167|NCT00903383|3956769|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4132168|NCT00903383|3956770|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4132169|NCT00903383|3956771|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4132170|NCT00903383|3956772|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4132171|NCT00903383|3956768|B5||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4132172|NCT00903383|3956769|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4132173|NCT00903383|3956770|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4132174|NCT00903383|3956771|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4132175|NCT00903383|3956772|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4132176|NCT00903383|3956768|B5|||Age||years|Mean|56.5|56.5|Standard Deviation|9.83|9.83|||
4132177|NCT00903383|3956769|B4|||Age||years|Mean|57.5|57.5|Standard Deviation|10.19|10.19|||
4132178|NCT00903383|3956770|B3|||Age||years|Mean|56.4|56.4|Standard Deviation|10.89|10.89|||
4132179|NCT00903383|3956771|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|9.20|9.2|||
4132180|NCT00903383|3956772|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|9.25|9.25|||
4132181|NCT00903370|3956805|B3|United States||Region of Enrollment||participants|Number|217|217.0||||||
4132182|NCT00903370|3956806|B2|United States||Region of Enrollment||participants|Number|111|111.0||||||
4132183|NCT00903370|3956807|B1|United States||Region of Enrollment||participants|Number|106|106.0||||||
4132184|NCT00903370|3956805|B3|Canada||Region of Enrollment||participants|Number|43|43.0||||||
4132185|NCT00903370|3956806|B2|Canada||Region of Enrollment||participants|Number|22|22.0||||||
4132186|NCT00903370|3956807|B1|Canada||Region of Enrollment||participants|Number|21|21.0||||||
4132187|NCT00903370|3956805|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132188|NCT00903370|3956806|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132189|NCT00903370|3956807|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132190|NCT00903370|3956805|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132191|NCT00903370|3956806|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132192|NCT00903370|3956807|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132193|NCT00903370|3956805|B3||White|Race (NIH/OMB)||Participants|Count of Participants|228|228.0||||||
4132194|NCT00903370|3956806|B2||White|Race (NIH/OMB)||Participants|Count of Participants|116|116.0||||||
4132195|NCT00903370|3956807|B1||White|Race (NIH/OMB)||Participants|Count of Participants|112|112.0||||||
4132196|NCT00903370|3956805|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4132197|NCT00903370|3956806|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4132198|NCT00903370|3956807|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4132199|NCT00903370|3956805|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132200|NCT00903370|3956806|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132201|NCT00903370|3956807|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132202|NCT00903370|3956805|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4132203|NCT00903370|3956806|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4132204|NCT00903370|3956807|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4132205|NCT00903370|3956805|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132206|NCT00903370|3956806|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132207|NCT00903370|3956807|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132208|NCT00903370|3956805|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132209|NCT00903370|3956806|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132210|NCT00903370|3956807|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132211|NCT00903370|3956805|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|242|242.0||||||
4132212|NCT00903370|3956806|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
4132213|NCT00903370|3956807|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
4132214|NCT00903370|3956805|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4132215|NCT00903370|3956806|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4132216|NCT00903370|3956807|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4132217|NCT00903370|3956805|B3||Male|Gender||Participants|Count of Participants|140|140.0||||||
4132218|NCT00903370|3956806|B2||Male|Gender||Participants|Count of Participants|76|76.0||||||
4132219|NCT00903370|3956807|B1||Male|Gender||Participants|Count of Participants|64|64.0||||||
4132220|NCT00903370|3956805|B3||Female|Gender||Participants|Count of Participants|120|120.0||||||
4132221|NCT00903370|3956806|B2||Female|Gender||Participants|Count of Participants|57|57.0||||||
4132222|NCT00903370|3956807|B1||Female|Gender||Participants|Count of Participants|63|63.0||||||
4132223|NCT00903370|3956805|B3|||Age||years|Mean|69.6|69.6|Standard Deviation|10.2|10.2|||
4132224|NCT00903370|3956806|B2|||Age||years|Mean|69.7|69.7|Standard Deviation|10.4|10.4|||
4132225|NCT00903370|3956807|B1|||Age||years|Mean|69.4|69.4|Standard Deviation|10|10.0|||
4132226|NCT00903357|3956816|B1|severe||Severity of atopic dermatitis|Severity of atopic dermatitis using SCORAD index. Moderate : 15~40, Severe : >40.|participants|Number|28|28.0||||||
4132227|NCT00903357|3956816|B1|moderate||Severity of atopic dermatitis|Severity of atopic dermatitis using SCORAD index. Moderate : 15~40, Severe : >40.|participants|Number|26|26.0||||||
4132228|NCT00903357|3956816|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4132229|NCT00903357|3956816|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4132230|NCT00903357|3956816|B1|||Age||months|Mean|46.0|46.0|Standard Deviation|16.1|16.1|||
4132231|NCT00903344|3956827|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4132232|NCT00903344|3956828|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4132233|NCT00903344|3956829|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4132234|NCT00903344|3956827|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4132235|NCT00903344|3956828|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4132236|NCT00903344|3956829|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4132237|NCT00903344|3956827|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4132238|NCT00903344|3956828|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4132239|NCT00903344|3956829|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4132240|NCT00903344|3956827|B3|||Age||years|Mean|30|30.0|Standard Deviation|4.64|4.64|||
4132241|NCT00903344|3956828|B2|||Age||years|Mean|32|32.0|Standard Deviation|3|3.0|||
4132242|NCT00903344|3956829|B1|||Age||years|Mean|29|29.0|Standard Deviation|6|6.0|||
4132243|NCT00903331|3956846|B3|United States||Region of Enrollment||participants|Number|55|55.0||||||
4132244|NCT00903331|3956847|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4132245|NCT00903331|3956848|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4132246|NCT00903331|3956846|B3|Turkey||Region of Enrollment||participants|Number|11|11.0||||||
4132247|NCT00903331|3956847|B2|Turkey||Region of Enrollment||participants|Number|8|8.0||||||
4132248|NCT00903331|3956848|B1|Turkey||Region of Enrollment||participants|Number|3|3.0||||||
4132249|NCT00903331|3956846|B3|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
4132250|NCT00903331|3956847|B2|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
4132251|NCT00903331|3956848|B1|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
4132252|NCT00903331|3956846|B3|Spain||Region of Enrollment||participants|Number|11|11.0||||||
4132253|NCT00903331|3956847|B2|Spain||Region of Enrollment||participants|Number|7|7.0||||||
4132254|NCT00903331|3956848|B1|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4132255|NCT00903331|3956846|B3|South Africa||Region of Enrollment||participants|Number|2|2.0||||||
4132256|NCT00903331|3956847|B2|South Africa||Region of Enrollment||participants|Number|1|1.0||||||
4132257|NCT00903331|3956848|B1|South Africa||Region of Enrollment||participants|Number|1|1.0||||||
4132258|NCT00903331|3956846|B3|Slovenia||Region of Enrollment||participants|Number|2|2.0||||||
4132259|NCT00903331|3956847|B2|Slovenia||Region of Enrollment||participants|Number|1|1.0||||||
4132260|NCT00903331|3956848|B1|Slovenia||Region of Enrollment||participants|Number|1|1.0||||||
4132261|NCT00903331|3956846|B3|Italy||Region of Enrollment||participants|Number|8|8.0||||||
4132262|NCT00903331|3956847|B2|Italy||Region of Enrollment||participants|Number|7|7.0||||||
4132263|NCT00903331|3956848|B1|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4132264|NCT00903331|3956846|B3|Israel||Region of Enrollment||participants|Number|7|7.0||||||
4132265|NCT00903331|3956847|B2|Israel||Region of Enrollment||participants|Number|5|5.0||||||
4132266|NCT00903331|3956848|B1|Israel||Region of Enrollment||participants|Number|2|2.0||||||
4132267|NCT00903331|3956846|B3|Germany||Region of Enrollment||participants|Number|13|13.0||||||
4132268|NCT00903331|3956847|B2|Germany||Region of Enrollment||participants|Number|8|8.0||||||
4132269|NCT00903331|3956848|B1|Germany||Region of Enrollment||participants|Number|5|5.0||||||
4132270|NCT00903331|3956846|B3|France||Region of Enrollment||participants|Number|26|26.0||||||
4132271|NCT00903331|3956847|B2|France||Region of Enrollment||participants|Number|16|16.0||||||
4132272|NCT00903331|3956848|B1|France||Region of Enrollment||participants|Number|10|10.0||||||
4132273|NCT00903331|3956846|B3|Canada||Region of Enrollment||participants|Number|15|15.0||||||
4132274|NCT00903331|3956847|B2|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4132275|NCT00903331|3956848|B1|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4132276|NCT00903331|3956846|B3|Australia||Region of Enrollment||participants|Number|27|27.0||||||
4132277|NCT00903331|3956847|B2|Australia||Region of Enrollment||participants|Number|18|18.0||||||
4132278|NCT00903331|3956848|B1|Australia||Region of Enrollment||participants|Number|9|9.0||||||
4132279|NCT00903331|3956846|B3||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4132280|NCT00903331|3956847|B2||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4132281|NCT00903331|3956848|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4132282|NCT00903331|3956846|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4132283|NCT00903331|3956847|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4132284|NCT00903331|3956848|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4132285|NCT00903331|3956846|B3|||Age||years|Mean|64.9|64.9|Standard Deviation|7.37|7.37|||
4132286|NCT00903331|3956847|B2|||Age||years|Mean|65.1|65.1|Standard Deviation|7.85|7.85|||
4132287|NCT00903331|3956848|B1|||Age||years|Mean|64.5|64.5|Standard Deviation|6.32|6.32|||
4132288|NCT00903201|3956857|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132289|NCT00903201|3956858|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132290|NCT00903201|3956859|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132291|NCT00903201|3956860|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132292|NCT00903201|3956857|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4132293|NCT00903201|3956858|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132294|NCT00903201|3956859|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4132295|NCT00903201|3956860|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132296|NCT00903201|3956857|B4||White|Race (NIH/OMB)||Participants|Count of Participants|143|143.0||||||
4132297|NCT00903201|3956858|B3||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4132298|NCT00903201|3956859|B2||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4132299|NCT00903201|3956860|B1||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4132300|NCT00903201|3956857|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4132301|NCT00903201|3956858|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132302|NCT00903201|3956859|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132303|NCT00903201|3956860|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4132304|NCT00903201|3956857|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132305|NCT00903201|3956858|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132306|NCT00903201|3956859|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132307|NCT00903201|3956860|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132308|NCT00903201|3956857|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132309|NCT00903201|3956858|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132310|NCT00903201|3956859|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132311|NCT00903201|3956860|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132312|NCT00903201|3956857|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132313|NCT00903201|3956858|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132314|NCT00903201|3956859|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132315|NCT00903201|3956860|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132316|NCT00903201|3956857|B4||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4132317|NCT00903201|3956858|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4132318|NCT00903201|3956859|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4132319|NCT00903201|3956860|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4132320|NCT00903201|3956857|B4||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4132321|NCT00903201|3956858|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4132322|NCT00903201|3956859|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4132323|NCT00903201|3956860|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4132324|NCT00903201|3956857|B4|||Age||Years|Mean|31.0|31.0|Standard Deviation|10.59|10.59|||
4132325|NCT00903201|3956858|B3|||Age||Years|Mean|31.3|31.3|Standard Deviation|12.12|12.12|||
4132326|NCT00903201|3956859|B2|||Age||Years|Mean|32.9|32.9|Standard Deviation|11.65|11.65|||
4132327|NCT00903201|3956860|B1|||Age||Years|Mean|29.5|29.5|Standard Deviation|8.41|8.41|||
4132328|NCT00903175|3956918|B3|Male||Sex/Gender, Customized||Participants|Number|342|342.0||||||
4132329|NCT00903175|3956919|B2|Male||Sex/Gender, Customized||Participants|Number|176|176.0||||||
4132330|NCT00903175|3956920|B1|Male||Sex/Gender, Customized||Participants|Number|166|166.0||||||
4132331|NCT00903175|3956918|B3|Female||Sex/Gender, Customized||Participants|Number|129|129.0||||||
4132332|NCT00903175|3956919|B2|Female||Sex/Gender, Customized||Participants|Number|57|57.0||||||
4132333|NCT00903175|3956920|B1|Female||Sex/Gender, Customized||Participants|Number|72|72.0||||||
4132334|NCT00903175|3956918|B3|||Age||years|Mean|61.10|61.1|Standard Deviation|11.860|11.86|||
4132335|NCT00903175|3956919|B2|||Age||years|Mean|60.84|60.84|Standard Deviation|11.627|11.627|||
4132336|NCT00903175|3956920|B1|||Age||years|Mean|61.36|61.36|Standard Deviation|12.102|12.102|||
4132337|NCT00903162|3956951|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4132338|NCT00903162|3956951|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4132339|NCT00903162|3956951|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4132340|NCT00903162|3956951|B1|||Age||years|Mean|45.1|45.1|Standard Deviation|3.7|3.7|||
4132341|NCT00903162|3956951|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4132342|NCT00903162|3956951|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4132343|NCT00903162|3956951|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132344|NCT00903032|3956957|B3|United States||Region of Enrollment||participants|Number|241|241.0||||||
4132345|NCT00903032|3956958|B2|United States||Region of Enrollment||participants|Number|119|119.0||||||
4132346|NCT00903032|3956959|B1|United States||Region of Enrollment||participants|Number|122|122.0||||||
4132347|NCT00903032|3956957|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4132348|NCT00903032|3956958|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4132349|NCT00903032|3956959|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4132350|NCT00903032|3956957|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132351|NCT00903032|3956958|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132352|NCT00903032|3956959|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132353|NCT00903032|3956957|B3||White|Race (NIH/OMB)||Participants|Count of Participants|170|170.0||||||
4132354|NCT00903032|3956958|B2||White|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
4132355|NCT00903032|3956959|B1||White|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
4132356|NCT00903032|3956957|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4132357|NCT00903032|3956958|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4132358|NCT00903032|3956959|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4132359|NCT00903032|3956957|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132360|NCT00903032|3956958|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132361|NCT00903032|3956959|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132362|NCT00903032|3956957|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4132363|NCT00903032|3956958|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4132364|NCT00903032|3956959|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4132365|NCT00903032|3956957|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4132366|NCT00903032|3956958|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4132367|NCT00903032|3956959|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132368|NCT00903032|3956957|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4132369|NCT00903032|3956958|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4132370|NCT00903032|3956959|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4132371|NCT00903032|3956957|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|170|170.0||||||
4132372|NCT00903032|3956958|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
4132373|NCT00903032|3956959|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4132374|NCT00903032|3956957|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4132375|NCT00903032|3956958|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4132376|NCT00903032|3956959|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4132377|NCT00903032|3956957|B3||Male|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
4132378|NCT00903032|3956958|B2||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4132379|NCT00903032|3956959|B1||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4132380|NCT00903032|3956957|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4132381|NCT00903032|3956958|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4132382|NCT00903032|3956959|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4132383|NCT00903032|3956957|B3|||Age||years|Mean|64|64.0|Standard Deviation|9|9.0|||
4132384|NCT00903032|3956958|B2|||Age||years|Mean|63.8|63.8|Standard Deviation|9.25|9.25|||
4132385|NCT00903032|3956959|B1|||Age||years|Mean|64|64.0|Standard Deviation|8.57|8.57|||
4132386|NCT00903032|3956957|B3||>=65 years|Age||Participants|Count of Participants|91|91.0||||||
4132387|NCT00903032|3956958|B2||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
4132388|NCT00903032|3956959|B1||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
4132389|NCT00903032|3956957|B3||Between 18 and 65 years|Age||Participants|Count of Participants|150|150.0||||||
4132390|NCT00903032|3956958|B2||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4132391|NCT00903032|3956959|B1||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
4132392|NCT00903032|3956957|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132393|NCT00903032|3956958|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132394|NCT00903032|3956959|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132395|NCT00903006|3956966|B5|United States||Region of Enrollment||participants|Number|6|6.0||||||
4132396|NCT00903006|3956968|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4132397|NCT00903006|3956969|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4132398|NCT00903006|3956970|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4132399|NCT00903006|3956966|B5|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4132400|NCT00903006|3956968|B3|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4132401|NCT00903006|3956969|B2|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4132402|NCT00903006|3956970|B1|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4132403|NCT00903006|3956966|B5|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4132404|NCT00903006|3956968|B3|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4132405|NCT00903006|3956969|B2|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4132406|NCT00903006|3956970|B1|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4132407|NCT00903006|3956966|B5|White||Race (NIH/OMB)||participants|Number|5|5.0||||||
4132408|NCT00903006|3956968|B3|White||Race (NIH/OMB)||participants|Number|1|1.0||||||
4132409|NCT00903006|3956969|B2|White||Race (NIH/OMB)||participants|Number|3|3.0||||||
4132410|NCT00903006|3956970|B1|White||Race (NIH/OMB)||participants|Number|1|1.0||||||
4132411|NCT00903006|3956966|B5|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
4132412|NCT00903006|3956968|B3|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
4132413|NCT00903006|3956969|B2|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
4132414|NCT00903006|3956970|B1|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
4132415|NCT00903006|3956966|B5|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4132416|NCT00903006|3956968|B3|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4132417|NCT00903006|3956969|B2|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4132418|NCT00903006|3956970|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4132419|NCT00903006|3956966|B5|Asian||Race (NIH/OMB)||participants|Number|1|1.0||||||
4132420|NCT00903006|3956968|B3|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
4132421|NCT00903006|3956969|B2|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
4132422|NCT00903006|3956970|B1|Asian||Race (NIH/OMB)||participants|Number|1|1.0||||||
4132423|NCT00903006|3956966|B5|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
4132424|NCT00903006|3956968|B3|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
4132425|NCT00903006|3956969|B2|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
4132426|NCT00903006|3956970|B1|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
4132427|NCT00903006|3956966|B5|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
4132428|NCT00903006|3956968|B3|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
4132429|NCT00903006|3956969|B2|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
4132430|NCT00903006|3956970|B1|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
4132431|NCT00903006|3956966|B5|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|4|4.0||||||
4132432|NCT00903006|3956968|B3|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
4132433|NCT00903006|3956969|B2|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|2|2.0||||||
4132434|NCT00903006|3956970|B1|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|2|2.0||||||
4132435|NCT00903006|3956966|B5|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|2|2.0||||||
4132436|NCT00903006|3956968|B3|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|1|1.0||||||
4132437|NCT00903006|3956969|B2|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|1|1.0||||||
4132438|NCT00903006|3956970|B1|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
4132439|NCT00903006|3956966|B5|Male||Gender||participants|Number|0|0.0||||||
4132440|NCT00903006|3956968|B3|Male||Gender||participants|Number|0|0.0||||||
4132441|NCT00903006|3956969|B2|Male||Gender||participants|Number|0|0.0||||||
4132442|NCT00903006|3956970|B1|Male||Gender||participants|Number|0|0.0||||||
4132443|NCT00903006|3956966|B5|Female||Gender||participants|Number|6|6.0||||||
4132444|NCT00903006|3956968|B3|Female||Gender||participants|Number|1|1.0||||||
4132445|NCT00903006|3956969|B2|Female||Gender||participants|Number|3|3.0||||||
4132446|NCT00903006|3956970|B1|Female||Gender||participants|Number|2|2.0||||||
4132447|NCT00903006|3956966|B5|||Age||years|Median|57.5|57.5|Full Range|||36.0|72.0|
4132448|NCT00903006|3956968|B3|||Age||years|Median|36|36.0|Full Range|||36.0|36.0|
4132449|NCT00903006|3956969|B2|||Age||years|Median|63|63.0|Full Range|||53.0|72.0|
4132450|NCT00903006|3956970|B1|||Age||years|Median|51|51.0|Full Range|||40.0|62.0|
4132451|NCT00903006|3956966|B5|>=65 years||Age||participants|Number|1|1.0||||||
4132452|NCT00903006|3956968|B3|>=65 years||Age||participants|Number|0|0.0||||||
4132453|NCT00903006|3956969|B2|>=65 years||Age||participants|Number|1|1.0||||||
4132454|NCT00903006|3956970|B1|>=65 years||Age||participants|Number|0|0.0||||||
4132455|NCT00903006|3956966|B5|Between 18 and 65 years||Age||participants|Number|5|5.0||||||
4132456|NCT00903006|3956968|B3|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
4132457|NCT00903006|3956969|B2|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
4132458|NCT00903006|3956970|B1|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
4132459|NCT00903006|3956966|B5|<=18 years||Age||participants|Number|0|0.0||||||
4132460|NCT00903006|3956968|B3|<=18 years||Age||participants|Number|0|0.0||||||
4132461|NCT00903006|3956969|B2|<=18 years||Age||participants|Number|0|0.0||||||
4132462|NCT00903006|3956970|B1|<=18 years||Age||participants|Number|0|0.0||||||
4132463|NCT00902850|3956983|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
4132464|NCT00902850|3956984|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4132465|NCT00902850|3956985|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4132466|NCT00902850|3956983|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4132467|NCT00902850|3956984|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4132468|NCT00902850|3956985|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4132469|NCT00902850|3956983|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4132470|NCT00902850|3956984|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4132471|NCT00902850|3956985|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4132472|NCT00902850|3956983|B3|||Age||years|Median|40|40.0|Full Range|||24.0|59.0|
4132473|NCT00902850|3956984|B2|||Age||years|Median|40|40.0|Full Range|||24.0|59.0|
4132474|NCT00902850|3956985|B1|||Age||years|Median|40|40.0|Full Range|||24.0|59.0|
4132475|NCT00902746|3956992|B1|||Visual Analogue Scale||units on a scale|Mean|53.1|53.1|Standard Deviation|21.49|21.49|||
4132476|NCT00902746|3956992|B1|||Total Dysmenorrhea Score (VRS; Verbal Rating Scale)||units on a scale|Mean|4.1|4.1|Standard Deviation|0.99|0.99|||
4132477|NCT00902746|3956992|B1|Female||Sex/Gender, Customized||participants|Number|147|147.0||||||
4132478|NCT00902746|3956992|B1|30 year of age and older||Age, Customized||participants|Number|96|96.0||||||
4132479|NCT00902746|3956992|B1|Under 30 years of age||Age, Customized||participants|Number|51|51.0||||||
4132480|NCT00902746|3956992|B1|||Age||years|Mean|33.2|33.2|Standard Deviation|7.12|7.12|||
4132481|NCT00902668|3956997|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4132482|NCT00902668|3956997|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4132483|NCT00902668|3956997|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4132484|NCT00902668|3956997|B1|||Age||years|Mean|63|63.0|Standard Deviation|2|2.0|||
4132485|NCT00902668|3956997|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4132486|NCT00902668|3956997|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4132487|NCT00902668|3956997|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132488|NCT00902564|3957001|B1|||Sheehan Disability Scale (SDS) Social|The SDS comprises self-rated items designed to measure impairment. The patient rates the extent to which his or her (1) work, (2) social life or leisure activities and (3) home life or family responsibilities are impaired on a 10-point visual analogue scale, on which 0 = normal functioning and 10 = severe functional impairment.|scores on a scale|Mean|6.8|6.8|Standard Deviation|2.5|2.5|||
4132489|NCT00902564|3957001|B1|||Sheehan Disability Scale (SDS) Family|The SDS comprises self-rated items designed to measure impairment. The patient rates the extent to which his or her (1) work, (2) social life or leisure activities and (3) home life or family responsibilities are impaired on a 10-point visual analogue scale, on which 0 = normal functioning and 10 = severe functional impairment.|scores on a scale|Mean|6.1|6.1|Standard Deviation|2.0|2.0|||
4132490|NCT00902564|3957001|B1|||Sheehan Disability Scale (SDS) Work|The SDS comprises self-rated items designed to measure impairment. The patient rates the extent to which his or her (1) work, (2) social life or leisure activities and (3) home life or family responsibilities are impaired on a 10-point visual analogue scale, on which 0 = normal functioning and 10 = severe functional impairment.|scores on a scale|Mean|6.8|6.8|Standard Deviation|1.6|1.6|||
4132491|NCT00902564|3957001|B1|||Clinical Global Impression Severity (CGI-S)|The CGI-S provides the clinician's impression of the patient's current state of mental illness. The clinician uses his or her clinical experience of this patient population to rate the severity of the patient's current mental illness on a 7-point scale ranging from 1 (Normal - not at all ill) to 7 (among the most extremely ill patients).|scores on a scale|Mean|4.5|4.5|Standard Deviation|0.6|0.6|||
4132492|NCT00902564|3957001|B1|||Hamilton Anxiety Scale (HAMA)|The HAMA is a 14-item rating scale designed to assess global anxiety symptoms. Each symptom is rated from 0 (absent) to 4 (severe). The total score of the 14 items ranges from 0 to 56.|scores on a scale|Mean|31.1|31.1|Standard Deviation|5.3|5.3|||
4132493|NCT00902564|3957001|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4132494|NCT00902564|3957001|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4132495|NCT00902564|3957001|B1|||Age||years|Mean|37.3|37.3|Standard Deviation|12|12.0|||
4132496|NCT00902564|3957001|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4132497|NCT00902564|3957001|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4132498|NCT00902564|3957001|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132499|NCT00902538|3957013|B4|Body Mass Index >= 30 kg/m^2||Obesity|Number of participants whose Body Mass Index (BMI) is <30 kg/m^2 or whose number is >=30 kg/m^2. Only 806 participants had their BMI measured.|Participants|Number|393|393.0||||||
4132500|NCT00902538|3957014|B3|Body Mass Index >= 30 kg/m^2||Obesity|Number of participants whose Body Mass Index (BMI) is <30 kg/m^2 or whose number is >=30 kg/m^2. Only 806 participants had their BMI measured.|Participants|Number|137|137.0||||||
4132501|NCT00902538|3957015|B2|Body Mass Index >= 30 kg/m^2||Obesity|Number of participants whose Body Mass Index (BMI) is <30 kg/m^2 or whose number is >=30 kg/m^2. Only 806 participants had their BMI measured.|Participants|Number|125|125.0||||||
4132502|NCT00902538|3957016|B1|Body Mass Index >= 30 kg/m^2||Obesity|Number of participants whose Body Mass Index (BMI) is <30 kg/m^2 or whose number is >=30 kg/m^2. Only 806 participants had their BMI measured.|Participants|Number|131|131.0||||||
4132503|NCT00902538|3957013|B4|Body Mass Index < 30 kg/m^2||Obesity|Number of participants whose Body Mass Index (BMI) is <30 kg/m^2 or whose number is >=30 kg/m^2. Only 806 participants had their BMI measured.|Participants|Number|413|413.0||||||
4132504|NCT00902538|3957014|B3|Body Mass Index < 30 kg/m^2||Obesity|Number of participants whose Body Mass Index (BMI) is <30 kg/m^2 or whose number is >=30 kg/m^2. Only 806 participants had their BMI measured.|Participants|Number|133|133.0||||||
4132505|NCT00902538|3957015|B2|Body Mass Index < 30 kg/m^2||Obesity|Number of participants whose Body Mass Index (BMI) is <30 kg/m^2 or whose number is >=30 kg/m^2. Only 806 participants had their BMI measured.|Participants|Number|142|142.0||||||
4132506|NCT00902538|3957016|B1|Body Mass Index < 30 kg/m^2||Obesity|Number of participants whose Body Mass Index (BMI) is <30 kg/m^2 or whose number is >=30 kg/m^2. Only 806 participants had their BMI measured.|Participants|Number|138|138.0||||||
4132507|NCT00902538|3957013|B4|||Body Mass Index||kg/m^2|Mean|30.34|30.34|Standard Deviation|4.80|4.8|||
4132508|NCT00902538|3957014|B3|||Body Mass Index||kg/m^2|Mean|30.44|30.44|Standard Deviation|4.87|4.87|||
4132509|NCT00902538|3957015|B2|||Body Mass Index||kg/m^2|Mean|30.30|30.3|Standard Deviation|4.65|4.65|||
4132510|NCT00902538|3957016|B1|||Body Mass Index||kg/m^2|Mean|30.27|30.27|Standard Deviation|4.90|4.9|||
4132511|NCT00902538|3957013|B4|||Height||cm|Mean|170.3|170.3|Standard Deviation|9.27|9.27|||
4132512|NCT00902538|3957014|B3|||Height||cm|Mean|170.4|170.4|Standard Deviation|8.98|8.98|||
4132513|NCT00902538|3957015|B2|||Height||cm|Mean|170.5|170.5|Standard Deviation|9.11|9.11|||
4132514|NCT00902538|3957016|B1|||Height||cm|Mean|169.9|169.9|Standard Deviation|9.74|9.74|||
4132515|NCT00902538|3957013|B4|||Weight||kg|Mean|88.2|88.2|Standard Deviation|16.83|16.83|||
4132516|NCT00902538|3957014|B3|||Weight||kg|Mean|88.5|88.5|Standard Deviation|16.28|16.28|||
4132517|NCT00902538|3957015|B2|||Weight||kg|Mean|88.2|88.2|Standard Deviation|16.03|16.03|||
4132518|NCT00902538|3957016|B1|||Weight||kg|Mean|87.8|87.8|Standard Deviation|18.14|18.14|||
4132519|NCT00902538|3957013|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132520|NCT00902538|3957014|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132521|NCT00902538|3957015|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132522|NCT00902538|3957016|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132523|NCT00902538|3957013|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132524|NCT00902538|3957014|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132525|NCT00902538|3957015|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132526|NCT00902538|3957016|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132527|NCT00902538|3957013|B4||White|Race (NIH/OMB)||Participants|Count of Participants|807|807.0||||||
4132528|NCT00902538|3957014|B3||White|Race (NIH/OMB)||Participants|Count of Participants|269|269.0||||||
4132529|NCT00902538|3957015|B2||White|Race (NIH/OMB)||Participants|Count of Participants|269|269.0||||||
4132530|NCT00902538|3957016|B1||White|Race (NIH/OMB)||Participants|Count of Participants|269|269.0||||||
4132531|NCT00902538|3957013|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132532|NCT00902538|3957014|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132533|NCT00902538|3957015|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132534|NCT00902538|3957016|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132535|NCT00902538|3957013|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132536|NCT00902538|3957014|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132537|NCT00902538|3957015|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132538|NCT00902538|3957016|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132539|NCT00902538|3957013|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4132540|NCT00902538|3957014|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4132541|NCT00902538|3957015|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132542|NCT00902538|3957016|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132543|NCT00902538|3957013|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132544|NCT00902538|3957014|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132545|NCT00902538|3957015|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132546|NCT00902538|3957016|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132547|NCT00902538|3957013|B4||Male|Sex: Female, Male||Participants|Count of Participants|469|469.0||||||
4132548|NCT00902538|3957014|B3||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4132549|NCT00902538|3957015|B2||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4132550|NCT00902538|3957016|B1||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4132551|NCT00902538|3957013|B4||Female|Sex: Female, Male||Participants|Count of Participants|339|339.0||||||
4132552|NCT00902538|3957014|B3||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4132553|NCT00902538|3957015|B2||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4132554|NCT00902538|3957016|B1||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4132555|NCT00902538|3957013|B4|||Age||years|Mean|55.8|55.8|Standard Deviation|10.42|10.42|||
4132556|NCT00902538|3957014|B3|||Age||years|Mean|54.9|54.9|Standard Deviation|10.44|10.44|||
4132557|NCT00902538|3957015|B2|||Age||years|Mean|56.5|56.5|Standard Deviation|10.25|10.25|||
4132558|NCT00902538|3957016|B1|||Age||years|Mean|55.9|55.9|Standard Deviation|10.56|10.56|||
4132559|NCT00902486|3957051|B5||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4132560|NCT00902486|3957052|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4132561|NCT00902486|3957053|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4132562|NCT00902486|3957054|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4132563|NCT00902486|3957055|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4132564|NCT00902486|3957051|B5||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4132565|NCT00902486|3957052|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4132566|NCT00902486|3957053|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4132567|NCT00902486|3957054|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4132568|NCT00902486|3957055|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4132569|NCT00902486|3957051|B5|||Age||years|Mean|55.8|55.8|Standard Deviation|10.92|10.92|||
4132570|NCT00902486|3957052|B4|||Age||years|Mean|55.2|55.2|Standard Deviation|10.09|10.09|||
4132571|NCT00902486|3957053|B3|||Age||years|Mean|57.3|57.3|Standard Deviation|10.38|10.38|||
4132572|NCT00902486|3957054|B2|||Age||years|Mean|53.7|53.7|Standard Deviation|10.92|10.92|||
4132573|NCT00902486|3957055|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|12.28|12.28|||
4132574|NCT00902330|3957196|B3|Phase III||Stage of Disease|Staged with TNM classifications. The TNM system is based on the size and/or extent (reach) of the primary tumor (T), the amount of spread to nearby lymph nodes (N), and the presence of metastasis (M) or secondary tumors formed by the spread of cancer cells to other parts of the body.|participants|Number|24|24.0||||||
4132575|NCT00902330|3957197|B2|Phase III||Stage of Disease|Staged with TNM classifications. The TNM system is based on the size and/or extent (reach) of the primary tumor (T), the amount of spread to nearby lymph nodes (N), and the presence of metastasis (M) or secondary tumors formed by the spread of cancer cells to other parts of the body.|participants|Number|14|14.0||||||
4132576|NCT00902330|3957198|B1|Phase III||Stage of Disease|Staged with TNM classifications. The TNM system is based on the size and/or extent (reach) of the primary tumor (T), the amount of spread to nearby lymph nodes (N), and the presence of metastasis (M) or secondary tumors formed by the spread of cancer cells to other parts of the body.|participants|Number|10|10.0||||||
4132577|NCT00902330|3957196|B3|Phase II||Stage of Disease|Staged with TNM classifications. The TNM system is based on the size and/or extent (reach) of the primary tumor (T), the amount of spread to nearby lymph nodes (N), and the presence of metastasis (M) or secondary tumors formed by the spread of cancer cells to other parts of the body.|participants|Number|94|94.0||||||
4132578|NCT00902330|3957197|B2|Phase II||Stage of Disease|Staged with TNM classifications. The TNM system is based on the size and/or extent (reach) of the primary tumor (T), the amount of spread to nearby lymph nodes (N), and the presence of metastasis (M) or secondary tumors formed by the spread of cancer cells to other parts of the body.|participants|Number|43|43.0||||||
4132579|NCT00902330|3957198|B1|Phase II||Stage of Disease|Staged with TNM classifications. The TNM system is based on the size and/or extent (reach) of the primary tumor (T), the amount of spread to nearby lymph nodes (N), and the presence of metastasis (M) or secondary tumors formed by the spread of cancer cells to other parts of the body.|participants|Number|51|51.0||||||
4132580|NCT00902330|3957196|B3|Phase I||Stage of Disease|Staged with TNM classifications. The TNM system is based on the size and/or extent (reach) of the primary tumor (T), the amount of spread to nearby lymph nodes (N), and the presence of metastasis (M) or secondary tumors formed by the spread of cancer cells to other parts of the body.|participants|Number|34|34.0||||||
4132581|NCT00902330|3957197|B2|Phase I||Stage of Disease|Staged with TNM classifications. The TNM system is based on the size and/or extent (reach) of the primary tumor (T), the amount of spread to nearby lymph nodes (N), and the presence of metastasis (M) or secondary tumors formed by the spread of cancer cells to other parts of the body.|participants|Number|18|18.0||||||
4132582|NCT00902330|3957198|B1|Phase I||Stage of Disease|Staged with TNM classifications. The TNM system is based on the size and/or extent (reach) of the primary tumor (T), the amount of spread to nearby lymph nodes (N), and the presence of metastasis (M) or secondary tumors formed by the spread of cancer cells to other parts of the body.|participants|Number|16|16.0||||||
4132583|NCT00902330|3957196|B3|United States||Region of Enrollment||participants|Number|152|152.0||||||
4132584|NCT00902330|3957197|B2|United States||Region of Enrollment||participants|Number|75|75.0||||||
4132585|NCT00902330|3957198|B1|United States||Region of Enrollment||participants|Number|77|77.0||||||
4132586|NCT00902330|3957196|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4132587|NCT00902330|3957197|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4132588|NCT00902330|3957198|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4132589|NCT00902330|3957196|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132590|NCT00902330|3957197|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132591|NCT00902330|3957198|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132592|NCT00902330|3957196|B3||White|Race (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
4132593|NCT00902330|3957197|B2||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4132594|NCT00902330|3957198|B1||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4132595|NCT00902330|3957196|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4132596|NCT00902330|3957197|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4132597|NCT00902330|3957198|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4132598|NCT00902330|3957196|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132599|NCT00902330|3957197|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132600|NCT00902330|3957198|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132601|NCT00902330|3957196|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132602|NCT00902330|3957197|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132603|NCT00902330|3957198|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132604|NCT00902330|3957196|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132605|NCT00902330|3957197|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132606|NCT00902330|3957198|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132607|NCT00902330|3957196|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4132608|NCT00902330|3957197|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4132609|NCT00902330|3957198|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4132610|NCT00902330|3957196|B3||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4132611|NCT00902330|3957197|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4132612|NCT00902330|3957198|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4132613|NCT00902330|3957196|B3|||Age||years|Median|51.22|51.22|Standard Deviation|9.805|9.805|||
4132614|NCT00902330|3957197|B2|||Age||years|Median|51.41|51.41|Standard Deviation|8.55|8.55|||
4132615|NCT00902330|3957198|B1|||Age||years|Median|51.03|51.03|Standard Deviation|11.06|11.06|||
4132616|NCT00902304|3957233|B4||Male|Sex: Female, Male||Participants|Count of Participants|963|963.0||||||
4132617|NCT00902304|3957234|B3||Male|Sex: Female, Male||Participants|Count of Participants|418|418.0||||||
4132618|NCT00902304|3957235|B2||Male|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4132619|NCT00902304|3957236|B1||Male|Sex: Female, Male||Participants|Count of Participants|323|323.0||||||
4132620|NCT00902304|3957233|B4||Female|Sex: Female, Male||Participants|Count of Participants|599|599.0||||||
4132621|NCT00902304|3957234|B3||Female|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
4132622|NCT00902304|3957235|B2||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4132623|NCT00902304|3957236|B1||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4132624|NCT00902304|3957233|B4|||Age||years|Mean|59|59.0|Standard Deviation|12|12.0|||
4132625|NCT00902304|3957234|B3|||Age||years|Mean|59|59.0|Standard Deviation|12|12.0|||
4132626|NCT00902304|3957235|B2|||Age||years|Mean|59|59.0|Standard Deviation|12|12.0|||
4132627|NCT00902304|3957236|B1|||Age||years|Mean|59|59.0|Standard Deviation|12|12.0|||
4132628|NCT00902278|3957283|B6|United States||Region of Enrollment||participants|Number|193|193.0||||||
4132629|NCT00902278|3957284|B5|United States||Region of Enrollment||participants|Number|37|37.0||||||
4132630|NCT00902278|3957285|B4|United States||Region of Enrollment||participants|Number|12|12.0||||||
4132631|NCT00902278|3957286|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
4132632|NCT00902278|3957287|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
4132633|NCT00902278|3957288|B1|United States||Region of Enrollment||participants|Number|54|54.0||||||
4132634|NCT00902278|3957283|B6||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4132635|NCT00902278|3957284|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4132636|NCT00902278|3957285|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4132637|NCT00902278|3957286|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4132638|NCT00902278|3957287|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4132639|NCT00902278|3957288|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4132640|NCT00902278|3957283|B6||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4132641|NCT00902278|3957284|B5||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4132642|NCT00902278|3957285|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4132643|NCT00902278|3957286|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4132644|NCT00902278|3957287|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4132645|NCT00902278|3957288|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4132646|NCT00902278|3957283|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4132647|NCT00902278|3957284|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4132648|NCT00902278|3957285|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4132649|NCT00902278|3957286|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4132650|NCT00902278|3957287|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4132651|NCT00902278|3957288|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4132652|NCT00902278|3957283|B6||Between 18 and 65 years|Age||Participants|Count of Participants|193|193.0||||||
4132653|NCT00902278|3957284|B5||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4132654|NCT00902278|3957285|B4||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4132655|NCT00902278|3957286|B3||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4132656|NCT00902278|3957287|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4132657|NCT00902278|3957288|B1||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4132658|NCT00902278|3957283|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132659|NCT00902278|3957284|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132660|NCT00902278|3957285|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132661|NCT00902278|3957286|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132662|NCT00902278|3957287|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132663|NCT00902278|3957288|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132664|NCT00902265|3957309|B1|Germany||Region of Enrollment||participants|Number|137|137.0||||||
4132665|NCT00902265|3957309|B1||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4132666|NCT00902265|3957309|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4132667|NCT00902265|3957309|B1|||Age||years|Mean|62.6|62.6|Standard Deviation|7.8|7.8|||
4132668|NCT00902226|3957321|B1|||Sheehan Disability Scale (SDS) Social|The SDS comprises self-rated items designed to measure impairment. The patient rates the extent to which his or her (1) work, (2) social life or leisure activities and (3) home life or family responsibilities are impaired on a 10-point visual analogue scales, on which 0 = normal functioning and 10 = severe functional impairment.|scores on a scale|Mean|7.0|7.0|Standard Deviation|1.5|1.5|||
4132669|NCT00902226|3957321|B1|||Sheehan Disability Scale (SDS) Family|The SDS comprises self-rated items designed to measure impairment. The patient rates the extent to which his or her (1) work, (2) social life or leisure activities and (3) home life or family responsibilities are impaired on a 10-point visual analogue scales, on which 0 = normal functioning and 10 = severe functional impairment.|scores on a scale|Mean|4.3|4.3|Standard Deviation|2.1|2.1|||
4132670|NCT00902226|3957321|B1|||Sheehan Disability Scale (SDS) Work|The SDS comprises self-rated items designed to measure impairment. The patient rates the extent to which his or her (1) work, (2) social life or leisure activities and (3) home life or family responsibilities are impaired on a 10-point visual analogue scales, on which 0 = normal functioning and 10 = severe functional impairment.|scores on a scale|Mean|6.9|6.9|Standard Deviation|1.5|1.5|||
4132671|NCT00902226|3957321|B1|||CGI Severity Score|The CGI-S provides the clinician's impression of the patient's current state of mental illness. The clinician uses his or her clinical experience of this patient population to rate the severity of the patient's current mental illness on a 7-point scale ranging from 1 (Normal - not at all ill) to 7 (among the most extremely ill patients).|scores on a scale|Mean|4.3|4.3|Standard Deviation|1.0|1.0|||
4132672|NCT00902226|3957321|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4132673|NCT00902226|3957321|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4132674|NCT00902226|3957321|B1|||Age||years|Mean|36.3|36.3|Standard Deviation|12.5|12.5|||
4132675|NCT00902226|3957321|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4132676|NCT00902226|3957321|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4132677|NCT00902226|3957321|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132678|NCT00902174|3957331|B3|Male||Gender|One participant was randomized to placebo but did not receive study drug.|participants|Number|39|39.0||||||
4132679|NCT00902174|3957332|B2|Male||Gender|One participant was randomized to placebo but did not receive study drug.|participants|Number|19|19.0||||||
4132680|NCT00902174|3957333|B1|Male||Gender|One participant was randomized to placebo but did not receive study drug.|participants|Number|20|20.0||||||
4132681|NCT00902174|3957331|B3|Female||Gender|One participant was randomized to placebo but did not receive study drug.|participants|Number|162|162.0||||||
4132682|NCT00902174|3957332|B2|Female||Gender|One participant was randomized to placebo but did not receive study drug.|participants|Number|79|79.0||||||
4132683|NCT00902174|3957333|B1|Female||Gender|One participant was randomized to placebo but did not receive study drug.|participants|Number|83|83.0||||||
4132684|NCT00902174|3957331|B3|||Age||years|Mean|48.3|48.3|Standard Deviation|14.59|14.59|||
4132685|NCT00902174|3957332|B2|||Age||years|Mean|46.5|46.5|Standard Deviation|13.60|13.6|||
4132686|NCT00902174|3957333|B1|||Age||years|Mean|50.0|50.0|Standard Deviation|15.33|15.33|||
4132687|NCT00902161|3957370|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4132688|NCT00902161|3957371|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4132689|NCT00902161|3957372|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4132690|NCT00902161|3957370|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4132691|NCT00902161|3957371|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4132692|NCT00902161|3957372|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4132693|NCT00902161|3957370|B3|||Age||years|Mean|50.0|50.0|Standard Deviation|6.26|6.26|||
4132694|NCT00902161|3957371|B2|||Age||years|Mean|48.5|48.5|Standard Deviation|6.88|6.88|||
4132695|NCT00902161|3957372|B1|||Age||years|Mean|51.3|51.3|Standard Deviation|5.66|5.66|||
4132696|NCT00901901|3957389|B3||No|Extrahepatic spread||Participants|Count of Participants|296|296.0||||||
4132697|NCT00901901|3957390|B2||No|Extrahepatic spread||Participants|Count of Participants|139|139.0||||||
4132698|NCT00901901|3957391|B1||No|Extrahepatic spread||Participants|Count of Participants|157|157.0||||||
4132699|NCT00901901|3957389|B3||Yes|Extrahepatic spread||Participants|Count of Participants|424|424.0||||||
4132700|NCT00901901|3957390|B2||Yes|Extrahepatic spread||Participants|Count of Participants|219|219.0||||||
4132701|NCT00901901|3957391|B1||Yes|Extrahepatic spread||Participants|Count of Participants|205|205.0||||||
4132702|NCT00901901|3957389|B3||No|Macroscopic vascular invasion||Participants|Count of Participants|429|429.0||||||
4132703|NCT00901901|3957390|B2||No|Macroscopic vascular invasion||Participants|Count of Participants|205|205.0||||||
4132704|NCT00901901|3957391|B1||No|Macroscopic vascular invasion||Participants|Count of Participants|224|224.0||||||
4132705|NCT00901901|3957389|B3||Yes|Macroscopic vascular invasion||Participants|Count of Participants|291|291.0||||||
4132706|NCT00901901|3957390|B2||Yes|Macroscopic vascular invasion||Participants|Count of Participants|153|153.0||||||
4132707|NCT00901901|3957391|B1||Yes|Macroscopic vascular invasion||Participants|Count of Participants|138|138.0||||||
4132708|NCT00901901|3957389|B3||1|ECOG stratification group|Eastern Cooperative Oncology Group (ECOG) grade 0 = fully active; grade 1 = restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature.|Participants|Count of Participants|282|282.0||||||
4132709|NCT00901901|3957390|B2||1|ECOG stratification group|Eastern Cooperative Oncology Group (ECOG) grade 0 = fully active; grade 1 = restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature.|Participants|Count of Participants|142|142.0||||||
4132710|NCT00901901|3957391|B1||1|ECOG stratification group|Eastern Cooperative Oncology Group (ECOG) grade 0 = fully active; grade 1 = restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature.|Participants|Count of Participants|140|140.0||||||
4132711|NCT00901901|3957389|B3||0|ECOG stratification group|Eastern Cooperative Oncology Group (ECOG) grade 0 = fully active; grade 1 = restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature.|Participants|Count of Participants|438|438.0||||||
4132712|NCT00901901|3957390|B2||0|ECOG stratification group|Eastern Cooperative Oncology Group (ECOG) grade 0 = fully active; grade 1 = restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature.|Participants|Count of Participants|216|216.0||||||
4132713|NCT00901901|3957391|B1||0|ECOG stratification group|Eastern Cooperative Oncology Group (ECOG) grade 0 = fully active; grade 1 = restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature.|Participants|Count of Participants|222|222.0||||||
4132714|NCT00901901|3957389|B3||current smoker|Smoking status||Participants|Count of Participants|241|241.0||||||
4132715|NCT00901901|3957390|B2||current smoker|Smoking status||Participants|Count of Participants|123|123.0||||||
4132716|NCT00901901|3957391|B1||current smoker|Smoking status||Participants|Count of Participants|118|118.0||||||
4132717|NCT00901901|3957389|B3||former smoker|Smoking status||Participants|Count of Participants|260|260.0||||||
4132718|NCT00901901|3957390|B2||former smoker|Smoking status||Participants|Count of Participants|128|128.0||||||
4132719|NCT00901901|3957391|B1||former smoker|Smoking status||Participants|Count of Participants|132|132.0||||||
4132720|NCT00901901|3957389|B3||non-smoker|Smoking status||Participants|Count of Participants|219|219.0||||||
4132721|NCT00901901|3957390|B2||non-smoker|Smoking status||Participants|Count of Participants|107|107.0||||||
4132722|NCT00901901|3957391|B1||non-smoker|Smoking status||Participants|Count of Participants|112|112.0||||||
4132723|NCT00901901|3957389|B3||Male|Sex: Female, Male||Participants|Count of Participants|581|581.0||||||
4132724|NCT00901901|3957390|B2||Male|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
4132725|NCT00901901|3957391|B1||Male|Sex: Female, Male||Participants|Count of Participants|295|295.0||||||
4132726|NCT00901901|3957389|B3||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4132727|NCT00901901|3957390|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4132728|NCT00901901|3957391|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4132729|NCT00901901|3957389|B3|||Age||Years|Mean|59.9|59.9|Standard Deviation|12.4|12.4|||
4132730|NCT00901901|3957390|B2|||Age||Years|Mean|59.5|59.5|Standard Deviation|13.0|13.0|||
4132731|NCT00901901|3957391|B1|||Age||Years|Mean|60.3|60.3|Standard Deviation|11.8|11.8|||
4132732|NCT00901628|3957412|B3|Korea, Republic of||Region of Enrollment||participants|Number|101|101.0||||||
4132733|NCT00901628|3957413|B2|Korea, Republic of||Region of Enrollment||participants|Number|52|52.0||||||
4132734|NCT00901628|3957414|B1|Korea, Republic of||Region of Enrollment||participants|Number|49|49.0||||||
4132735|NCT00901628|3957412|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4132736|NCT00901628|3957413|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4132737|NCT00901628|3957414|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4132738|NCT00901628|3957412|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4132739|NCT00901628|3957413|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4132740|NCT00901628|3957414|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4132741|NCT00901628|3957412|B3|||Age||years|Mean|70.1|70.1|Standard Deviation|6.1|6.1|||
4132742|NCT00901628|3957413|B2|||Age||years|Mean|70.1|70.1|Standard Deviation|4.9|4.9|||
4132743|NCT00901628|3957414|B1|||Age||years|Mean|70.2|70.2|Standard Deviation|7.1|7.1|||
4132744|NCT00901628|3957412|B3||>=65 years|Age||Participants|Count of Participants|84|84.0||||||
4132745|NCT00901628|3957413|B2||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
4132746|NCT00901628|3957414|B1||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
4132747|NCT00901628|3957412|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4132748|NCT00901628|3957413|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4132749|NCT00901628|3957414|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4132750|NCT00901628|3957412|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132751|NCT00901628|3957413|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132752|NCT00901628|3957414|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132753|NCT00901576|3957431|B7|United States||Region of Enrollment||participants|Number|38|38.0||||||
4132754|NCT00901576|3957432|B6|United States||Region of Enrollment||participants|Number|6|6.0||||||
4132755|NCT00901576|3957433|B5|United States||Region of Enrollment||participants|Number|6|6.0||||||
4132756|NCT00901576|3957434|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
4132757|NCT00901576|3957435|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4132758|NCT00901576|3957436|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4132759|NCT00901576|3957437|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4132760|NCT00901576|3957431|B7||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4132761|NCT00901576|3957432|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4132762|NCT00901576|3957433|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4132763|NCT00901576|3957434|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4132764|NCT00901576|3957435|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4132765|NCT00901576|3957436|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4132766|NCT00901576|3957437|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4132767|NCT00901576|3957431|B7||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4132768|NCT00901576|3957432|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4132769|NCT00901576|3957433|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4132770|NCT00901576|3957434|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4132771|NCT00901576|3957435|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4132772|NCT00901576|3957436|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4132773|NCT00901576|3957437|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4132774|NCT00901576|3957431|B7|||Age||years|Mean|30.8|30.8|Standard Deviation|6.28|6.28|||
4132775|NCT00901576|3957432|B6|||Age||years|Mean|30.3|30.3|Standard Deviation|5.68|5.68|||
4132776|NCT00901576|3957433|B5|||Age||years|Mean|29.8|29.8|Standard Deviation|2.64|2.64|||
4132777|NCT00901576|3957434|B4|||Age||years|Mean|31.5|31.5|Standard Deviation|8.41|8.41|||
4132778|NCT00901576|3957435|B3|||Age||years|Mean|32.1|32.1|Standard Deviation|8.01|8.01|||
4132779|NCT00901576|3957436|B2|||Age||years|Mean|32.6|32.6|Standard Deviation|6.70|6.7|||
4132780|NCT00901576|3957437|B1|||Age||years|Mean|27.7|27.7|Standard Deviation|5.54|5.54|||
4132781|NCT00901576|3957431|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4132782|NCT00901576|3957432|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4132783|NCT00901576|3957433|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4132784|NCT00901576|3957434|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4132785|NCT00901576|3957435|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4132786|NCT00901576|3957436|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4132787|NCT00901576|3957437|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4132788|NCT00901576|3957431|B7||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4132789|NCT00901576|3957432|B6||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4132790|NCT00901576|3957433|B5||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4132791|NCT00901576|3957434|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4132792|NCT00901576|3957435|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4132793|NCT00901576|3957436|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4132794|NCT00901576|3957437|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4132795|NCT00901576|3957431|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132796|NCT00901576|3957432|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132797|NCT00901576|3957433|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132798|NCT00901576|3957434|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132799|NCT00901576|3957435|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132800|NCT00901576|3957436|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132801|NCT00901576|3957437|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132802|NCT00901459|3957463|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4132803|NCT00901459|3957463|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4132804|NCT00901459|3957463|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4132805|NCT00901459|3957463|B1|||Age||years|Mean|39.9|39.9|Standard Deviation|8.88|8.88|||
4132806|NCT00901459|3957463|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4132807|NCT00901459|3957463|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4132808|NCT00901459|3957463|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132836|NCT00901316|3957478|B3||Female|Sex: Female, Male||Participants|Count of Participants|529|529.0||||||
4132809|NCT00901342|3957474|B1|Gleason Score Missing||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|2|2.0||||||
4132810|NCT00901342|3957474|B1|Gleason Score ≥ 8||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|51|51.0||||||
4132811|NCT00901342|3957474|B1|Gleason Score = 7||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|35|35.0||||||
4132812|NCT00901342|3957474|B1|Gleason Score ≤ 6||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|16|16.0||||||
4132813|NCT00901342|3957474|B1|ECOG 2=Ambulatory, capable of self-care; no work||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|3|3.0||||||
4132814|NCT00901342|3957474|B1|ECOG 1= Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|35|35.0||||||
4132815|NCT00901342|3957474|B1|ECOG 0=Fully Active; No restrictions.||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|66|66.0||||||
4132816|NCT00901342|3957474|B1|United States||Region of Enrollment||Participants|Count of Participants|104|104.0||||||
4132817|NCT00901342|3957474|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4132818|NCT00901342|3957474|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132819|NCT00901342|3957474|B1||White|Race (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
4132820|NCT00901342|3957474|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4132821|NCT00901342|3957474|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4132822|NCT00901342|3957474|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4132823|NCT00901342|3957474|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132824|NCT00901342|3957474|B1||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4132825|NCT00901342|3957474|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4132826|NCT00901342|3957474|B1|||Age||years|Mean|69.2|69.2|Full Range|||46.0|91.0|
4132827|NCT00901342|3957474|B1||>=65 years|Age||Participants|Count of Participants|73|73.0||||||
4132828|NCT00901342|3957474|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4132829|NCT00901342|3957474|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132830|NCT00901316|3957478|B3|United States||Region of Enrollment||participants|Number|987|987.0||||||
4132831|NCT00901316|3957479|B2|United States||Region of Enrollment||participants|Number|495|495.0||||||
4132832|NCT00901316|3957480|B1|United States||Region of Enrollment||participants|Number|492|492.0||||||
4132833|NCT00901316|3957478|B3||Male|Sex: Female, Male||Participants|Count of Participants|458|458.0||||||
4132834|NCT00901316|3957479|B2||Male|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
4132835|NCT00901316|3957480|B1||Male|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
4132837|NCT00901316|3957479|B2||Female|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
4132838|NCT00901316|3957480|B1||Female|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
4132839|NCT00901316|3957478|B3|||Age||years|Median|1.85|1.85|Full Range|||0.26|18.8|
4132840|NCT00901316|3957479|B2|||Age||years|Median|1.8|1.8|Full Range|||0.27|17.9|
4132841|NCT00901316|3957480|B1|||Age||years|Median|1.92|1.92|Full Range|||0.26|18.8|
4132842|NCT00901316|3957478|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4132843|NCT00901316|3957479|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4132844|NCT00901316|3957480|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4132845|NCT00901316|3957478|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4132846|NCT00901316|3957479|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4132847|NCT00901316|3957480|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4132848|NCT00901316|3957478|B3||<=18 years|Age||Participants|Count of Participants|987|987.0||||||
4132849|NCT00901316|3957479|B2||<=18 years|Age||Participants|Count of Participants|495|495.0||||||
4132850|NCT00901316|3957480|B1||<=18 years|Age||Participants|Count of Participants|492|492.0||||||
4132851|NCT00901303|3957487|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4132852|NCT00901303|3957488|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4132853|NCT00901303|3957489|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4132854|NCT00901303|3957487|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132855|NCT00901303|3957488|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132856|NCT00901303|3957489|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132857|NCT00901303|3957487|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132858|NCT00901303|3957488|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132859|NCT00901303|3957489|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132860|NCT00901303|3957487|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4132861|NCT00901303|3957488|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4132862|NCT00901303|3957489|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4132863|NCT00901303|3957487|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4132864|NCT00901303|3957488|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132865|NCT00901303|3957489|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4132866|NCT00901303|3957487|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132867|NCT00901303|3957488|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132868|NCT00901303|3957489|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132869|NCT00901303|3957487|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132870|NCT00901303|3957488|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132871|NCT00901303|3957489|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132872|NCT00901303|3957487|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132873|NCT00901303|3957488|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132874|NCT00901303|3957489|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132875|NCT00901303|3957487|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132876|NCT00901303|3957488|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132877|NCT00901303|3957489|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132878|NCT00901303|3957487|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4132879|NCT00901303|3957488|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4132880|NCT00901303|3957489|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4132881|NCT00901303|3957487|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132882|NCT00901303|3957488|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132883|NCT00901303|3957489|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4132884|NCT00901303|3957487|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4132885|NCT00901303|3957488|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4132886|NCT00901303|3957489|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4132887|NCT00901303|3957487|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4132888|NCT00901303|3957488|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4132889|NCT00901303|3957489|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4132890|NCT00901303|3957487|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4132891|NCT00901303|3957488|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4132892|NCT00901303|3957489|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4132893|NCT00901303|3957487|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4132894|NCT00901303|3957488|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4132895|NCT00901303|3957489|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4132896|NCT00901303|3957487|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132897|NCT00901303|3957488|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132898|NCT00901303|3957489|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132899|NCT00901225|3957496|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4132900|NCT00901225|3957496|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4132901|NCT00901225|3957496|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4132902|NCT00901225|3957496|B1|||Age||years|Mean|61|61.0|Standard Deviation|9|9.0|||
4132903|NCT00901225|3957496|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4132904|NCT00901225|3957496|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4132905|NCT00901225|3957496|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132906|NCT00901186|3957505|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4132907|NCT00901186|3957506|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4132908|NCT00901186|3957507|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4132909|NCT00901186|3957505|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4132910|NCT00901186|3957506|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4132911|NCT00901186|3957507|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4132912|NCT00901186|3957505|B3|||Age||Years|Mean|63.49|63.49|Standard Deviation|9.36|9.36|||
4132913|NCT00901186|3957506|B2|||Age||Years|Mean|65.47|65.47|Standard Deviation|9.40|9.4|||
4132914|NCT00901186|3957507|B1|||Age||Years|Mean|61.31|61.31|Standard Deviation|8.94|8.94|||
4132915|NCT00901017|3957524|B1|Belgium||Region of Enrollment||participants|Number|14|14.0||||||
4132916|NCT00901017|3957524|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4132917|NCT00901017|3957524|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4132918|NCT00901017|3957524|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|9.9|9.9|||
4132919|NCT00901017|3957524|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4132920|NCT00901017|3957524|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4132921|NCT00901017|3957524|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132922|NCT00900822|3957538|B1|Sweden||Region of Enrollment||participants|Number|11|11.0||||||
4132923|NCT00900822|3957538|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4132924|NCT00900822|3957538|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4132925|NCT00900822|3957538|B1|||Age||years|Mean|65.27|65.27|Standard Deviation|9.06|9.06|||
4132926|NCT00900822|3957538|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4132927|NCT00900822|3957538|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4132928|NCT00900822|3957538|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132929|NCT00900796|3957548|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4132930|NCT00900796|3957548|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4132931|NCT00900796|3957548|B1|||Age||years|Mean|42.7|42.7|Standard Deviation|11.6|11.6|||
4132932|NCT00900757|3957558|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4132933|NCT00900757|3957558|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4132934|NCT00900757|3957558|B1|||Age||years|Mean|58.9|58.9|Standard Deviation|9.5|9.5|||
4132935|NCT00900731|3957566|B3||Male|Sex: Female, Male||Participants|Count of Participants|1093|1093.0||||||
4132936|NCT00900731|3957567|B2||Male|Sex: Female, Male||Participants|Count of Participants|538|538.0||||||
4132937|NCT00900731|3957568|B1||Male|Sex: Female, Male||Participants|Count of Participants|555|555.0||||||
4132938|NCT00900731|3957566|B3||Female|Sex: Female, Male||Participants|Count of Participants|500|500.0||||||
4132939|NCT00900731|3957567|B2||Female|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
4132940|NCT00900731|3957568|B1||Female|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
4132941|NCT00900731|3957566|B3|||Age|Baseline Measures used the safety population that consisted of all participants who received at least one dose of study drug.|years|Mean|63.5|63.5|Standard Deviation|8.45|8.45|||
4132942|NCT00900731|3957567|B2|||Age|Baseline Measures used the safety population that consisted of all participants who received at least one dose of study drug.|years|Mean|63.4|63.4|Standard Deviation|8.29|8.29|||
4132943|NCT00900731|3957568|B1|||Age|Baseline Measures used the safety population that consisted of all participants who received at least one dose of study drug.|years|Mean|63.6|63.6|Standard Deviation|8.60|8.6|||
4132944|NCT00900666|3957589|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4132945|NCT00900666|3957590|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4132946|NCT00900666|3957591|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4132947|NCT00900666|3957589|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4132948|NCT00900666|3957590|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4132949|NCT00900666|3957591|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4132950|NCT00900666|3957589|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4132951|NCT00900666|3957590|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4132952|NCT00900666|3957591|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4132953|NCT00900666|3957589|B3|||Age||years|Mean|48.9|48.9|Standard Deviation|16.2|16.2|||
4132954|NCT00900666|3957590|B2|||Age||years|Mean|49.8|49.8|Standard Deviation|15.6|15.6|||
4132955|NCT00900666|3957591|B1|||Age||years|Mean|48|48.0|Standard Deviation|17.5|17.5|||
4132956|NCT00900666|3957589|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4132957|NCT00900666|3957590|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4132958|NCT00900666|3957591|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4132959|NCT00900666|3957589|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4132960|NCT00900666|3957590|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4132961|NCT00900666|3957591|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4132962|NCT00900666|3957589|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132963|NCT00900666|3957590|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132964|NCT00900666|3957591|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4132965|NCT00900627|3957600|B7|Prior chemotherapy: No||Stratification: Prior chemotherapy (This stratification information iis based on CRF data).|Prior chemotherapy for locally advanced (not amenable to surgery) or metastatic breast cancer|Participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4132966|NCT00900627|3957601|B6|Prior chemotherapy: No||Stratification: Prior chemotherapy (This stratification information iis based on CRF data).|Prior chemotherapy for locally advanced (not amenable to surgery) or metastatic breast cancer|Participants|Number|78|78.0||||||
4132967|NCT00900627|3957602|B5|Prior chemotherapy: No||Stratification: Prior chemotherapy (This stratification information iis based on CRF data).|Prior chemotherapy for locally advanced (not amenable to surgery) or metastatic breast cancer|Participants|Number|79|79.0||||||
4132968|NCT00900627|3957603|B4|Prior chemotherapy: No||Stratification: Prior chemotherapy (This stratification information iis based on CRF data).|Prior chemotherapy for locally advanced (not amenable to surgery) or metastatic breast cancer|Participants|Number|NA|||||||Not applicable for Part A
4132969|NCT00900627|3957604|B3|Prior chemotherapy: No||Stratification: Prior chemotherapy (This stratification information iis based on CRF data).|Prior chemotherapy for locally advanced (not amenable to surgery) or metastatic breast cancer|Participants|Number|NA|||||||Not applicable for Part A
4132970|NCT00900627|3957605|B2|Prior chemotherapy: No||Stratification: Prior chemotherapy (This stratification information iis based on CRF data).|Prior chemotherapy for locally advanced (not amenable to surgery) or metastatic breast cancer|Participants|Number|NA|||||||Not applicable for Part A
4132971|NCT00900627|3957606|B1|Prior chemotherapy: No||Stratification: Prior chemotherapy (This stratification information iis based on CRF data).|Prior chemotherapy for locally advanced (not amenable to surgery) or metastatic breast cancer|Participants|Number|NA|||||||Not applicable for Part A
4132972|NCT00900627|3957600|B7|Prior chemotherapy: Yes||Stratification: Prior chemotherapy (This stratification information iis based on CRF data).|Prior chemotherapy for locally advanced (not amenable to surgery) or metastatic breast cancer|Participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4132973|NCT00900627|3957601|B6|Prior chemotherapy: Yes||Stratification: Prior chemotherapy (This stratification information iis based on CRF data).|Prior chemotherapy for locally advanced (not amenable to surgery) or metastatic breast cancer|Participants|Number|18|18.0||||||
4132974|NCT00900627|3957602|B5|Prior chemotherapy: Yes||Stratification: Prior chemotherapy (This stratification information iis based on CRF data).|Prior chemotherapy for locally advanced (not amenable to surgery) or metastatic breast cancer|Participants|Number|15|15.0||||||
4132975|NCT00900627|3957603|B4|Prior chemotherapy: Yes||Stratification: Prior chemotherapy (This stratification information iis based on CRF data).|Prior chemotherapy for locally advanced (not amenable to surgery) or metastatic breast cancer|Participants|Number|NA|||||||Not applicable for Part A
4132976|NCT00900627|3957604|B3|Prior chemotherapy: Yes||Stratification: Prior chemotherapy (This stratification information iis based on CRF data).|Prior chemotherapy for locally advanced (not amenable to surgery) or metastatic breast cancer|Participants|Number|NA|||||||Not applicable for Part A
4132977|NCT00900627|3957605|B2|Prior chemotherapy: Yes||Stratification: Prior chemotherapy (This stratification information iis based on CRF data).|Prior chemotherapy for locally advanced (not amenable to surgery) or metastatic breast cancer|Participants|Number|NA|||||||Not applicable for Part A
4132978|NCT00900627|3957606|B1|Prior chemotherapy: Yes||Stratification: Prior chemotherapy (This stratification information iis based on CRF data).|Prior chemotherapy for locally advanced (not amenable to surgery) or metastatic breast cancer|Participants|Number|NA|||||||Not applicable for Part A
4132979|NCT00900627|3957600|B7|Hormone receptor status Negative [ER-/PgR-]||Stratification: Hormone receptor status (This stratification information iis based on CRF data).|Hormone receptor status|Participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4132980|NCT00900627|3957601|B6|Hormone receptor status Negative [ER-/PgR-]||Stratification: Hormone receptor status (This stratification information iis based on CRF data).|Hormone receptor status|Participants|Number|21|21.0||||||
4132981|NCT00900627|3957602|B5|Hormone receptor status Negative [ER-/PgR-]||Stratification: Hormone receptor status (This stratification information iis based on CRF data).|Hormone receptor status|Participants|Number|18|18.0||||||
4132982|NCT00900627|3957603|B4|Hormone receptor status Negative [ER-/PgR-]||Stratification: Hormone receptor status (This stratification information iis based on CRF data).|Hormone receptor status|Participants|Number|NA|||||||Not applicable for Part A
4132983|NCT00900627|3957604|B3|Hormone receptor status Negative [ER-/PgR-]||Stratification: Hormone receptor status (This stratification information iis based on CRF data).|Hormone receptor status|Participants|Number|NA|||||||Not applicable for Part A
4132984|NCT00900627|3957605|B2|Hormone receptor status Negative [ER-/PgR-]||Stratification: Hormone receptor status (This stratification information iis based on CRF data).|Hormone receptor status|Participants|Number|NA|||||||Not applicable for Part A
4132985|NCT00900627|3957606|B1|Hormone receptor status Negative [ER-/PgR-]||Stratification: Hormone receptor status (This stratification information iis based on CRF data).|Hormone receptor status|Participants|Number|NA|||||||Not applicable for Part A
4132986|NCT00900627|3957600|B7|Hormone receptor status Positive [ER+ and/or PgR+]||Stratification: Hormone receptor status (This stratification information iis based on CRF data).|Hormone receptor status|Participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4133028|NCT00900627|3957600|B7|Ethnicity: Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4132987|NCT00900627|3957601|B6|Hormone receptor status Positive [ER+ and/or PgR+]||Stratification: Hormone receptor status (This stratification information iis based on CRF data).|Hormone receptor status|Participants|Number|75|75.0||||||
4132988|NCT00900627|3957602|B5|Hormone receptor status Positive [ER+ and/or PgR+]||Stratification: Hormone receptor status (This stratification information iis based on CRF data).|Hormone receptor status|Participants|Number|76|76.0||||||
4132989|NCT00900627|3957603|B4|Hormone receptor status Positive [ER+ and/or PgR+]||Stratification: Hormone receptor status (This stratification information iis based on CRF data).|Hormone receptor status|Participants|Number|NA|||||||Not applicable for Part A
4132990|NCT00900627|3957604|B3|Hormone receptor status Positive [ER+ and/or PgR+]||Stratification: Hormone receptor status (This stratification information iis based on CRF data).|Hormone receptor status|Participants|Number|NA|||||||Not applicable for Part A
4132991|NCT00900627|3957605|B2|Hormone receptor status Positive [ER+ and/or PgR+]||Stratification: Hormone receptor status (This stratification information iis based on CRF data).|Hormone receptor status|Participants|Number|NA|||||||Not applicable for Part A
4132992|NCT00900627|3957606|B1|Hormone receptor status Positive [ER+ and/or PgR+]||Stratification: Hormone receptor status (This stratification information iis based on CRF data).|Hormone receptor status|Participants|Number|NA|||||||Not applicable for Part A
4132993|NCT00900627|3957600|B7|Prior taxane: No||Stratification: Prior taxane (This stratification information iis based on CRF data).|Prior taxane in adjuvant setting|Participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4132994|NCT00900627|3957601|B6|Prior taxane: No||Stratification: Prior taxane (This stratification information iis based on CRF data).|Prior taxane in adjuvant setting|Participants|Number|75|75.0||||||
4132995|NCT00900627|3957602|B5|Prior taxane: No||Stratification: Prior taxane (This stratification information iis based on CRF data).|Prior taxane in adjuvant setting|Participants|Number|74|74.0||||||
4132996|NCT00900627|3957603|B4|Prior taxane: No||Stratification: Prior taxane (This stratification information iis based on CRF data).|Prior taxane in adjuvant setting|Participants|Number|NA|||||||Not applicable for Part A
4132997|NCT00900627|3957604|B3|Prior taxane: No||Stratification: Prior taxane (This stratification information iis based on CRF data).|Prior taxane in adjuvant setting|Participants|Number|NA|||||||Not applicable for Part A
4132998|NCT00900627|3957605|B2|Prior taxane: No||Stratification: Prior taxane (This stratification information iis based on CRF data).|Prior taxane in adjuvant setting|Participants|Number|NA|||||||Not applicable for Part A
4132999|NCT00900627|3957606|B1|Prior taxane: No||Stratification: Prior taxane (This stratification information iis based on CRF data).|Prior taxane in adjuvant setting|Participants|Number|NA|||||||Not applicable for Part A
4133000|NCT00900627|3957600|B7|Prior taxane: Yes||Stratification: Prior taxane (This stratification information iis based on CRF data).|Prior taxane in adjuvant setting|Participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4133001|NCT00900627|3957601|B6|Prior taxane: Yes||Stratification: Prior taxane (This stratification information iis based on CRF data).|Prior taxane in adjuvant setting|Participants|Number|21|21.0||||||
4133002|NCT00900627|3957602|B5|Prior taxane: Yes||Stratification: Prior taxane (This stratification information iis based on CRF data).|Prior taxane in adjuvant setting|Participants|Number|20|20.0||||||
4133003|NCT00900627|3957603|B4|Prior taxane: Yes||Stratification: Prior taxane (This stratification information iis based on CRF data).|Prior taxane in adjuvant setting|Participants|Number|NA|||||||Not applicable for Part A
4133004|NCT00900627|3957604|B3|Prior taxane: Yes||Stratification: Prior taxane (This stratification information iis based on CRF data).|Prior taxane in adjuvant setting|Participants|Number|NA|||||||Not applicable for Part A
4133005|NCT00900627|3957605|B2|Prior taxane: Yes||Stratification: Prior taxane (This stratification information iis based on CRF data).|Prior taxane in adjuvant setting|Participants|Number|NA|||||||Not applicable for Part A
4133006|NCT00900627|3957606|B1|Prior taxane: Yes||Stratification: Prior taxane (This stratification information iis based on CRF data).|Prior taxane in adjuvant setting|Participants|Number|NA|||||||Not applicable for Part A
4133007|NCT00900627|3957600|B7|Ethnicity: Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133008|NCT00900627|3957601|B6|Ethnicity: Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133009|NCT00900627|3957602|B5|Ethnicity: Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133010|NCT00900627|3957603|B4|Ethnicity: Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133011|NCT00900627|3957604|B3|Ethnicity: Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133012|NCT00900627|3957605|B2|Ethnicity: Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133013|NCT00900627|3957606|B1|Ethnicity: Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133014|NCT00900627|3957600|B7|Ethnicity: Other||Race/Ethnicity, Customized||Participants|Number|26|26.0||||||
4133015|NCT00900627|3957601|B6|Ethnicity: Other||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4133016|NCT00900627|3957602|B5|Ethnicity: Other||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4133017|NCT00900627|3957603|B4|Ethnicity: Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133018|NCT00900627|3957604|B3|Ethnicity: Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133019|NCT00900627|3957605|B2|Ethnicity: Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133020|NCT00900627|3957606|B1|Ethnicity: Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133021|NCT00900627|3957600|B7|Ethnicity: Not Applicable||Race/Ethnicity, Customized||Participants|Number|96|96.0||||||
4133022|NCT00900627|3957601|B6|Ethnicity: Not Applicable||Race/Ethnicity, Customized||Participants|Number|49|49.0||||||
4133023|NCT00900627|3957602|B5|Ethnicity: Not Applicable||Race/Ethnicity, Customized||Participants|Number|47|47.0||||||
4133024|NCT00900627|3957603|B4|Ethnicity: Not Applicable||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133025|NCT00900627|3957604|B3|Ethnicity: Not Applicable||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133026|NCT00900627|3957605|B2|Ethnicity: Not Applicable||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133027|NCT00900627|3957606|B1|Ethnicity: Not Applicable||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133029|NCT00900627|3957601|B6|Ethnicity: Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133030|NCT00900627|3957602|B5|Ethnicity: Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133031|NCT00900627|3957603|B4|Ethnicity: Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133032|NCT00900627|3957604|B3|Ethnicity: Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133033|NCT00900627|3957605|B2|Ethnicity: Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133034|NCT00900627|3957606|B1|Ethnicity: Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133035|NCT00900627|3957600|B7|Ethnicity: Chinese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133036|NCT00900627|3957601|B6|Ethnicity: Chinese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133037|NCT00900627|3957602|B5|Ethnicity: Chinese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133038|NCT00900627|3957603|B4|Ethnicity: Chinese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133039|NCT00900627|3957604|B3|Ethnicity: Chinese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133040|NCT00900627|3957605|B2|Ethnicity: Chinese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133041|NCT00900627|3957606|B1|Ethnicity: Chinese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133042|NCT00900627|3957600|B7|Ethnicity: Asian (other than Chinese and Japanese)||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4133043|NCT00900627|3957601|B6|Ethnicity: Asian (other than Chinese and Japanese)||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4133044|NCT00900627|3957602|B5|Ethnicity: Asian (other than Chinese and Japanese)||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133045|NCT00900627|3957603|B4|Ethnicity: Asian (other than Chinese and Japanese)||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133046|NCT00900627|3957604|B3|Ethnicity: Asian (other than Chinese and Japanese)||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133047|NCT00900627|3957605|B2|Ethnicity: Asian (other than Chinese and Japanese)||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133048|NCT00900627|3957606|B1|Ethnicity: Asian (other than Chinese and Japanese)||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133049|NCT00900627|3957600|B7|Ethnicity: African-Caribbean||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4133050|NCT00900627|3957601|B6|Ethnicity: African-Caribbean||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4133051|NCT00900627|3957602|B5|Ethnicity: African-Caribbean||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133052|NCT00900627|3957603|B4|Ethnicity: African-Caribbean||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133053|NCT00900627|3957604|B3|Ethnicity: African-Caribbean||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133054|NCT00900627|3957605|B2|Ethnicity: African-Caribbean||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133055|NCT00900627|3957606|B1|Ethnicity: African-Caribbean||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133056|NCT00900627|3957600|B7|Ethnicity: African-American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133057|NCT00900627|3957601|B6|Ethnicity: African-American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133058|NCT00900627|3957602|B5|Ethnicity: African-American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133059|NCT00900627|3957603|B4|Ethnicity: African-American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133060|NCT00900627|3957604|B3|Ethnicity: African-American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133061|NCT00900627|3957605|B2|Ethnicity: African-American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133062|NCT00900627|3957606|B1|Ethnicity: African-American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133063|NCT00900627|3957600|B7|Ethnicity: African||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133064|NCT00900627|3957601|B6|Ethnicity: African||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133065|NCT00900627|3957602|B5|Ethnicity: African||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133066|NCT00900627|3957603|B4|Ethnicity: African||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133067|NCT00900627|3957604|B3|Ethnicity: African||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133068|NCT00900627|3957605|B2|Ethnicity: African||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133069|NCT00900627|3957606|B1|Ethnicity: African||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133070|NCT00900627|3957600|B7|Ethnicity: Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133071|NCT00900627|3957601|B6|Ethnicity: Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133072|NCT00900627|3957602|B5|Ethnicity: Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133073|NCT00900627|3957603|B4|Ethnicity: Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133074|NCT00900627|3957604|B3|Ethnicity: Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133075|NCT00900627|3957605|B2|Ethnicity: Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133076|NCT00900627|3957606|B1|Ethnicity: Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133077|NCT00900627|3957600|B7|Ethnicity: Native Alaskan/Inuit||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133078|NCT00900627|3957601|B6|Ethnicity: Native Alaskan/Inuit||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133079|NCT00900627|3957602|B5|Ethnicity: Native Alaskan/Inuit||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133080|NCT00900627|3957603|B4|Ethnicity: Native Alaskan/Inuit||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133081|NCT00900627|3957604|B3|Ethnicity: Native Alaskan/Inuit||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133082|NCT00900627|3957605|B2|Ethnicity: Native Alaskan/Inuit||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133083|NCT00900627|3957606|B1|Ethnicity: Native Alaskan/Inuit||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133084|NCT00900627|3957600|B7|Ethnicity: Native American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133085|NCT00900627|3957601|B6|Ethnicity: Native American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133086|NCT00900627|3957602|B5|Ethnicity: Native American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133087|NCT00900627|3957603|B4|Ethnicity: Native American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133088|NCT00900627|3957604|B3|Ethnicity: Native American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133089|NCT00900627|3957605|B2|Ethnicity: Native American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133090|NCT00900627|3957606|B1|Ethnicity: Native American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133091|NCT00900627|3957600|B7|Ethnicity: Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|86|86.0||||||
4133092|NCT00900627|3957601|B6|Ethnicity: Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|31|31.0||||||
4133093|NCT00900627|3957602|B5|Ethnicity: Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
4133094|NCT00900627|3957603|B4|Ethnicity: Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4133095|NCT00900627|3957604|B3|Ethnicity: Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4133096|NCT00900627|3957605|B2|Ethnicity: Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4133097|NCT00900627|3957606|B1|Ethnicity: Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4133098|NCT00900627|3957600|B7|Race: Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133099|NCT00900627|3957601|B6|Race: Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133100|NCT00900627|3957602|B5|Race: Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133101|NCT00900627|3957603|B4|Race: Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133102|NCT00900627|3957604|B3|Race: Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133103|NCT00900627|3957605|B2|Race: Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133104|NCT00900627|3957606|B1|Race: Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133105|NCT00900627|3957600|B7|Race: Other||Race/Ethnicity, Customized||Participants|Number|31|31.0||||||
4133106|NCT00900627|3957601|B6|Race: Other||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4133107|NCT00900627|3957602|B5|Race: Other||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4133108|NCT00900627|3957603|B4|Race: Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133109|NCT00900627|3957604|B3|Race: Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133110|NCT00900627|3957605|B2|Race: Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133111|NCT00900627|3957606|B1|Race: Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133112|NCT00900627|3957600|B7|Race: White||Race/Ethnicity, Customized||Participants|Number|169|169.0||||||
4133113|NCT00900627|3957601|B6|Race: White||Race/Ethnicity, Customized||Participants|Number|74|74.0||||||
4133114|NCT00900627|3957602|B5|Race: White||Race/Ethnicity, Customized||Participants|Number|75|75.0||||||
4133115|NCT00900627|3957603|B4|Race: White||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4133116|NCT00900627|3957604|B3|Race: White||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4133117|NCT00900627|3957605|B2|Race: White||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4133118|NCT00900627|3957606|B1|Race: White||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4133119|NCT00900627|3957600|B7|Race: Native Haiwaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133120|NCT00900627|3957601|B6|Race: Native Haiwaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133121|NCT00900627|3957602|B5|Race: Native Haiwaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133122|NCT00900627|3957603|B4|Race: Native Haiwaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133123|NCT00900627|3957604|B3|Race: Native Haiwaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133124|NCT00900627|3957605|B2|Race: Native Haiwaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133125|NCT00900627|3957606|B1|Race: Native Haiwaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133126|NCT00900627|3957600|B7|Race: Black or African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4133127|NCT00900627|3957601|B6|Race: Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4133128|NCT00900627|3957602|B5|Race: Black or African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4133129|NCT00900627|3957603|B4|Race: Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133130|NCT00900627|3957604|B3|Race: Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133131|NCT00900627|3957605|B2|Race: Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133132|NCT00900627|3957606|B1|Race: Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133133|NCT00900627|3957600|B7|Race: Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4133134|NCT00900627|3957601|B6|Race: Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4133135|NCT00900627|3957602|B5|Race: Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133136|NCT00900627|3957603|B4|Race: Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133137|NCT00900627|3957604|B3|Race: Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133138|NCT00900627|3957605|B2|Race: Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133139|NCT00900627|3957606|B1|Race: Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133140|NCT00900627|3957600|B7|Race: American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4133141|NCT00900627|3957601|B6|Race: American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4133142|NCT00900627|3957602|B5|Race: American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4133143|NCT00900627|3957603|B4|Race: American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133144|NCT00900627|3957604|B3|Race: American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133145|NCT00900627|3957605|B2|Race: American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133146|NCT00900627|3957606|B1|Race: American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4133147|NCT00900627|3957600|B7||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4133148|NCT00900627|3957601|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4133149|NCT00900627|3957602|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4133150|NCT00900627|3957603|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4133151|NCT00900627|3957604|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4133152|NCT00900627|3957605|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4133153|NCT00900627|3957606|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4133154|NCT00900627|3957600|B7||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
4133155|NCT00900627|3957601|B6||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4133156|NCT00900627|3957602|B5||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4133157|NCT00900627|3957603|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4133158|NCT00900627|3957604|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4133159|NCT00900627|3957605|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4133160|NCT00900627|3957606|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4133161|NCT00900627|3957600|B7|>= 75 years||Age, Customized|Age in years|Participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4133162|NCT00900627|3957601|B6|>= 75 years||Age, Customized|Age in years|Participants|Number|1|1.0||||||
4133163|NCT00900627|3957602|B5|>= 75 years||Age, Customized|Age in years|Participants|Number|4|4.0||||||
4133164|NCT00900627|3957603|B4|>= 75 years||Age, Customized|Age in years|Participants|Number|NA|||||||Customized age tables were not presented for Part A
4133165|NCT00900627|3957604|B3|>= 75 years||Age, Customized|Age in years|Participants|Number|NA|||||||Customized age tables were not presented for Part A
4133166|NCT00900627|3957605|B2|>= 75 years||Age, Customized|Age in years|Participants|Number|NA|||||||Customized age tables were not presented for Part A
4133167|NCT00900627|3957606|B1|>= 75 years||Age, Customized|Age in years|Participants|Number|NA|||||||Customized age tables were not presented for Part A
4133168|NCT00900627|3957600|B7|>65 - <75 years||Age, Customized|Age in years|Participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4133169|NCT00900627|3957601|B6|>65 - <75 years||Age, Customized|Age in years|Participants|Number|11|11.0||||||
4133170|NCT00900627|3957602|B5|>65 - <75 years||Age, Customized|Age in years|Participants|Number|18|18.0||||||
4133171|NCT00900627|3957603|B4|>65 - <75 years||Age, Customized|Age in years|Participants|Number|NA|||||||Customized age tables were not presented for Part A
4133172|NCT00900627|3957604|B3|>65 - <75 years||Age, Customized|Age in years|Participants|Number|NA|||||||Customized age tables were not presented for Part A
4133173|NCT00900627|3957605|B2|>65 - <75 years||Age, Customized|Age in years|Participants|Number|NA|||||||Customized age tables were not presented for Part A
4133174|NCT00900627|3957606|B1|>65 - <75 years||Age, Customized|Age in years|Participants|Number|NA|||||||Customized age tables were not presented for Part A
4133175|NCT00900627|3957600|B7|50 - <=65 years||Age, Customized|Age in years|Participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4133176|NCT00900627|3957601|B6|50 - <=65 years||Age, Customized|Age in years|Participants|Number|46|46.0||||||
4133177|NCT00900627|3957602|B5|50 - <=65 years||Age, Customized|Age in years|Participants|Number|38|38.0||||||
4133178|NCT00900627|3957603|B4|50 - <=65 years||Age, Customized|Age in years|Participants|Number|NA|||||||Customized age tables were not presented for Part A
4133179|NCT00900627|3957604|B3|50 - <=65 years||Age, Customized|Age in years|Participants|Number|NA|||||||Customized age tables were not presented for Part A
4133180|NCT00900627|3957605|B2|50 - <=65 years||Age, Customized|Age in years|Participants|Number|NA|||||||Customized age tables were not presented for Part A
4133181|NCT00900627|3957606|B1|50 - <=65 years||Age, Customized|Age in years|Participants|Number|NA|||||||Customized age tables were not presented for Part A
4133182|NCT00900627|3957600|B7|18 - <50 years||Age, Customized|Age in years|Participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4133183|NCT00900627|3957601|B6|18 - <50 years||Age, Customized|Age in years|Participants|Number|38|38.0||||||
4133184|NCT00900627|3957602|B5|18 - <50 years||Age, Customized|Age in years|Participants|Number|34|34.0||||||
4133185|NCT00900627|3957603|B4|18 - <50 years||Age, Customized|Age in years|Participants|Number|NA|||||||Customized age tables were not presented for Part A
4133186|NCT00900627|3957604|B3|18 - <50 years||Age, Customized|Age in years|Participants|Number|NA|||||||Customized age tables were not presented for Part A
4133187|NCT00900627|3957605|B2|18 - <50 years||Age, Customized|Age in years|Participants|Number|NA|||||||Customized age tables were not presented for Part A
4133188|NCT00900627|3957606|B1|18 - <50 years||Age, Customized|Age in years|Participants|Number|NA|||||||Customized age tables were not presented for Part A
4133189|NCT00900627|3957600|B7|> 65 years||Age, Customized|Age in years|Participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4133190|NCT00900627|3957601|B6|> 65 years||Age, Customized|Age in years|Participants|Number|12|12.0||||||
4133191|NCT00900627|3957602|B5|> 65 years||Age, Customized|Age in years|Participants|Number|22|22.0||||||
4133192|NCT00900627|3957603|B4|> 65 years||Age, Customized|Age in years|Participants|Number|NA|||||||Customized age tables were not presented for Part A
4133193|NCT00900627|3957604|B3|> 65 years||Age, Customized|Age in years|Participants|Number|NA|||||||Customized age tables were not presented for Part A
4133194|NCT00900627|3957605|B2|> 65 years||Age, Customized|Age in years|Participants|Number|NA|||||||Customized age tables were not presented for Part A
4133195|NCT00900627|3957606|B1|> 65 years||Age, Customized|Age in years|Participants|Number|NA|||||||Customized age tables were not presented for Part A
4133196|NCT00900627|3957600|B7|< = 65 years||Age, Customized|Age in years|Participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4133197|NCT00900627|3957601|B6|< = 65 years||Age, Customized|Age in years|Participants|Number|84|84.0||||||
4133198|NCT00900627|3957602|B5|< = 65 years||Age, Customized|Age in years|Participants|Number|72|72.0||||||
4133199|NCT00900627|3957603|B4|< = 65 years||Age, Customized|Age in years|Participants|Number|NA|||||||Customized age tables were not presented for Part A
4133200|NCT00900627|3957604|B3|< = 65 years||Age, Customized|Age in years|Participants|Number|NA|||||||Customized age tables were not presented for Part A
4133201|NCT00900627|3957605|B2|< = 65 years||Age, Customized|Age in years|Participants|Number|NA|||||||Customized age tables were not presented for Part A
4133202|NCT00900627|3957606|B1|< = 65 years||Age, Customized|Age in years|Participants|Number|NA|||||||Customized age tables were not presented for Part A
4133203|NCT00900627|3957600|B7|Age for Part B||Age|Age at informed consent date|Years|Mean|53.8|53.8|Standard Deviation|11.26|11.26|||
4133204|NCT00900627|3957601|B6|Age for Part B||Age|Age at informed consent date|Years|Mean|53.1|53.1|Standard Deviation|10.64|10.64|||
4133205|NCT00900627|3957602|B5|Age for Part B||Age|Age at informed consent date|Years|Mean|54.5|54.5|Standard Deviation|11.87|11.87|||
4133206|NCT00900627|3957603|B4|Age for Part B||Age|Age at informed consent date|Years|Mean|NA||Standard Deviation|NA||||Treatment in Part A only
4133207|NCT00900627|3957604|B3|Age for Part B||Age|Age at informed consent date|Years|Mean|NA||Standard Deviation|NA||||Treatment in Part A only
4133208|NCT00900627|3957605|B2|Age for Part B||Age|Age at informed consent date|Years|Mean|NA||Standard Deviation|NA||||Treatment in Part A only
4133209|NCT00900627|3957606|B1|Age for Part B||Age|Age at informed consent date|Years|Mean|NA||Standard Deviation|NA||||Treatment in Part A only
4133210|NCT00900627|3957600|B7|Age for Part A||Age|Age at informed consent date|Years|Mean|52.6|52.6|Standard Deviation|10.63|10.63|||
4133211|NCT00900627|3957601|B6|Age for Part A||Age|Age at informed consent date|Years|Mean|NA||Standard Deviation|NA||||Treatment in Part B only
4133212|NCT00900627|3957602|B5|Age for Part A||Age|Age at informed consent date|Years|Mean|NA||Standard Deviation|NA||||Treatment in Part B only
4133213|NCT00900627|3957603|B4|Age for Part A||Age|Age at informed consent date|Years|Mean|54.8|54.8|Standard Deviation|11.07|11.07|||
4133214|NCT00900627|3957604|B3|Age for Part A||Age|Age at informed consent date|Years|Mean|47.2|47.2|Standard Deviation|5.85|5.85|||
4133215|NCT00900627|3957605|B2|Age for Part A||Age|Age at informed consent date|Years|Mean|62.0|62.0|Standard Deviation|16.97|16.97|||
4133216|NCT00900627|3957606|B1|Age for Part A||Age|Age at informed consent date|Years|Mean|52.7|52.7|Standard Deviation|11.78|11.78|||
4133217|NCT00900601|3957629|B1||Bilateral pain|Unilateral/Bilateral||Participants|Count of Participants|8|8.0||||||
4133218|NCT00900601|3957629|B1||Unilateral pain|Unilateral/Bilateral||Participants|Count of Participants|1|1.0||||||
4133219|NCT00900601|3957629|B1||Trauma|Etiology||Participants|Count of Participants|2|2.0||||||
4133220|NCT00900601|3957629|B1||Post preganancy|Etiology||Participants|Count of Participants|7|7.0||||||
4133221|NCT00900601|3957629|B1|||BMI||kg/m2|Median|25|25.0|Full Range|||20.0|30.0|
4133222|NCT00900601|3957629|B1|||Duration of pain||years|Median|11|11.0|Full Range|||2.0|25.0|
4133223|NCT00900601|3957629|B1|Norway||Region of Enrollment||participants|Number|9|9.0||||||
4133224|NCT00900601|3957629|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133225|NCT00900601|3957629|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133226|NCT00900601|3957629|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4133227|NCT00900601|3957629|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133228|NCT00900601|3957629|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133229|NCT00900601|3957629|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133230|NCT00900601|3957629|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133231|NCT00900601|3957629|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4133232|NCT00900601|3957629|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4133233|NCT00900601|3957629|B1|||Age||years|Median|40|40.0|Full Range|||33.0|47.0|
4133234|NCT00900237|3957635|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4133235|NCT00900237|3957636|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4133236|NCT00900237|3957637|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4133237|NCT00900237|3957635|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4133238|NCT00900237|3957636|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4133239|NCT00900237|3957637|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4133240|NCT00900237|3957635|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4133241|NCT00900237|3957636|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4133242|NCT00900237|3957637|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4133243|NCT00900237|3957635|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4133244|NCT00900237|3957636|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4133245|NCT00900237|3957637|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4133246|NCT00900237|3957635|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4133247|NCT00900237|3957636|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4133248|NCT00900237|3957637|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4133249|NCT00900159|3957646|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4133250|NCT00900159|3957647|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4133251|NCT00900159|3957648|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4133252|NCT00900159|3957646|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4133253|NCT00900159|3957647|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4133254|NCT00900159|3957648|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4133255|NCT00900159|3957646|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4133256|NCT00900159|3957647|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4133257|NCT00900159|3957648|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4133258|NCT00900159|3957646|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4133259|NCT00900159|3957647|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4133260|NCT00900159|3957648|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4133261|NCT00900159|3957646|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4133262|NCT00900159|3957647|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4133263|NCT00900159|3957648|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4133264|NCT00900159|3957646|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4133265|NCT00900159|3957647|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4133266|NCT00900159|3957648|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4133267|NCT00900146|3957663|B6||Male|Sex: Female, Male||Participants|Count of Participants|311|311.0||||||
4133268|NCT00900146|3957664|B5||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4133269|NCT00900146|3957665|B4||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4133270|NCT00900146|3957666|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4133271|NCT00900146|3957667|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4133272|NCT00900146|3957668|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4133273|NCT00900146|3957663|B6||Female|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
4133274|NCT00900146|3957664|B5||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4133275|NCT00900146|3957665|B4||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4133276|NCT00900146|3957666|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4133277|NCT00900146|3957667|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4133278|NCT00900146|3957668|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4133279|NCT00900146|3957663|B6|||Age|Baseline measures were based on the full analysis set (FAS) which included all randomized patients except for mis-randomized patients. Mis-randomized patients referred to patients who are not qualified for randomization but who were inadvertently randomized into the study and did not receive study drug.|years|Mean|54.1|54.1|Standard Deviation|9.99|9.99|||
4133280|NCT00900146|3957664|B5|||Age|Baseline measures were based on the full analysis set (FAS) which included all randomized patients except for mis-randomized patients. Mis-randomized patients referred to patients who are not qualified for randomization but who were inadvertently randomized into the study and did not receive study drug.|years|Mean|54.3|54.3|Standard Deviation|10.15|10.15|||
4133281|NCT00900146|3957665|B4|||Age|Baseline measures were based on the full analysis set (FAS) which included all randomized patients except for mis-randomized patients. Mis-randomized patients referred to patients who are not qualified for randomization but who were inadvertently randomized into the study and did not receive study drug.|years|Mean|53.7|53.7|Standard Deviation|10.36|10.36|||
4133282|NCT00900146|3957666|B3|||Age|Baseline measures were based on the full analysis set (FAS) which included all randomized patients except for mis-randomized patients. Mis-randomized patients referred to patients who are not qualified for randomization but who were inadvertently randomized into the study and did not receive study drug.|years|Mean|53.0|53.0|Standard Deviation|9.29|9.29|||
4133283|NCT00900146|3957667|B2|||Age|Baseline measures were based on the full analysis set (FAS) which included all randomized patients except for mis-randomized patients. Mis-randomized patients referred to patients who are not qualified for randomization but who were inadvertently randomized into the study and did not receive study drug.|years|Mean|55.5|55.5|Standard Deviation|9.70|9.7|||
4133284|NCT00900146|3957668|B1|||Age|Baseline measures were based on the full analysis set (FAS) which included all randomized patients except for mis-randomized patients. Mis-randomized patients referred to patients who are not qualified for randomization but who were inadvertently randomized into the study and did not receive study drug.|years|Mean|53.5|53.5|Standard Deviation|10.27|10.27|||
4133285|NCT00900029|3957784|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4133286|NCT00900029|3957785|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4133287|NCT00900029|3957786|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4133288|NCT00900029|3957787|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4133289|NCT00900029|3957788|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4133290|NCT00900029|3957789|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4133291|NCT00900029|3957784|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133292|NCT00900029|3957785|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133293|NCT00900029|3957786|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133294|NCT00900029|3957787|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133295|NCT00900029|3957788|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133296|NCT00900029|3957789|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133297|NCT00900029|3957784|B6||White|Race (NIH/OMB)||Participants|Count of Participants|147|147.0||||||
4133298|NCT00900029|3957785|B5||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4133299|NCT00900029|3957786|B4||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4133300|NCT00900029|3957787|B3||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4133301|NCT00900029|3957788|B2||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4133302|NCT00900029|3957789|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4133303|NCT00900029|3957784|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4133304|NCT00900029|3957785|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4133305|NCT00900029|3957786|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4133306|NCT00900029|3957787|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4133307|NCT00900029|3957788|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4133308|NCT00900029|3957789|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4133309|NCT00900029|3957784|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133310|NCT00900029|3957785|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133311|NCT00900029|3957786|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133312|NCT00900029|3957787|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133313|NCT00900029|3957788|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133314|NCT00900029|3957789|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133315|NCT00900029|3957784|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4133316|NCT00900029|3957785|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4133317|NCT00900029|3957786|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133318|NCT00900029|3957787|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133319|NCT00900029|3957788|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133320|NCT00900029|3957789|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133321|NCT00900029|3957784|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4133322|NCT00900029|3957785|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133323|NCT00900029|3957786|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133324|NCT00900029|3957787|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133325|NCT00900029|3957788|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133326|NCT00900029|3957789|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4133327|NCT00900029|3957784|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133328|NCT00900029|3957785|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133329|NCT00900029|3957786|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133330|NCT00900029|3957787|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133331|NCT00900029|3957788|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133332|NCT00900029|3957789|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133333|NCT00900029|3957784|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|158|158.0||||||
4133334|NCT00900029|3957785|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4133335|NCT00900029|3957786|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4133336|NCT00900029|3957787|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4133337|NCT00900029|3957788|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4133338|NCT00900029|3957789|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4133339|NCT00900029|3957784|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4133340|NCT00900029|3957785|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4133341|NCT00900029|3957786|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4133342|NCT00900029|3957787|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4133343|NCT00900029|3957788|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4133344|NCT00900029|3957789|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4133345|NCT00900029|3957784|B6||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4133346|NCT00900029|3957785|B5||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4133347|NCT00900029|3957786|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4133348|NCT00900029|3957787|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4133349|NCT00900029|3957788|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4133350|NCT00900029|3957789|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4133351|NCT00900029|3957784|B6||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4133352|NCT00900029|3957785|B5||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4133353|NCT00900029|3957786|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4133354|NCT00900029|3957787|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4133355|NCT00900029|3957788|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4133356|NCT00900029|3957789|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4133357|NCT00900029|3957784|B6|60+ years||Age, Customized||participants|Number|119|119.0||||||
4133358|NCT00900029|3957785|B5|60+ years||Age, Customized||participants|Number|26|26.0||||||
4133359|NCT00900029|3957786|B4|60+ years||Age, Customized||participants|Number|24|24.0||||||
4133360|NCT00900029|3957787|B3|60+ years||Age, Customized||participants|Number|24|24.0||||||
4133361|NCT00900029|3957788|B2|60+ years||Age, Customized||participants|Number|21|21.0||||||
4133362|NCT00900029|3957789|B1|60+ years||Age, Customized||participants|Number|24|24.0||||||
4133363|NCT00900029|3957784|B6|50-59 years||Age, Customized||participants|Number|42|42.0||||||
4133364|NCT00900029|3957785|B5|50-59 years||Age, Customized||participants|Number|6|6.0||||||
4133365|NCT00900029|3957786|B4|50-59 years||Age, Customized||participants|Number|8|8.0||||||
4133366|NCT00900029|3957787|B3|50-59 years||Age, Customized||participants|Number|10|10.0||||||
4133367|NCT00900029|3957788|B2|50-59 years||Age, Customized||participants|Number|7|7.0||||||
4133368|NCT00900029|3957789|B1|50-59 years||Age, Customized||participants|Number|11|11.0||||||
4133369|NCT00900029|3957784|B6|40-49 years||Age, Customized||participants|Number|30|30.0||||||
4133370|NCT00900029|3957785|B5|40-49 years||Age, Customized||participants|Number|6|6.0||||||
4133371|NCT00900029|3957786|B4|40-49 years||Age, Customized||participants|Number|6|6.0||||||
4133372|NCT00900029|3957787|B3|40-49 years||Age, Customized||participants|Number|4|4.0||||||
4133373|NCT00900029|3957788|B2|40-49 years||Age, Customized||participants|Number|6|6.0||||||
4133374|NCT00900029|3957789|B1|40-49 years||Age, Customized||participants|Number|8|8.0||||||
4133375|NCT00900029|3957784|B6|18-39 years||Age, Customized||participants|Number|15|15.0||||||
4133376|NCT00900029|3957785|B5|18-39 years||Age, Customized||participants|Number|4|4.0||||||
4133377|NCT00900029|3957786|B4|18-39 years||Age, Customized||participants|Number|3|3.0||||||
4133378|NCT00900029|3957787|B3|18-39 years||Age, Customized||participants|Number|3|3.0||||||
4133379|NCT00900029|3957788|B2|18-39 years||Age, Customized||participants|Number|4|4.0||||||
4133380|NCT00900029|3957789|B1|18-39 years||Age, Customized||participants|Number|1|1.0||||||
4133381|NCT00899847|3957810|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133382|NCT00899847|3957810|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133383|NCT00899847|3957810|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4133384|NCT00899847|3957810|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133385|NCT00899847|3957810|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133386|NCT00899847|3957810|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133387|NCT00899847|3957810|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133388|NCT00899847|3957810|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133389|NCT00899847|3957810|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4133390|NCT00899847|3957810|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4133391|NCT00899847|3957810|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4133392|NCT00899847|3957810|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4133393|NCT00899847|3957810|B1|||Age||years|Median|54|54.0|Full Range|||33.0|59.0|
4133394|NCT00899847|3957810|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4133395|NCT00899847|3957810|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4133396|NCT00899847|3957810|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4133397|NCT00899717|3957821|B3|Spain||Region of Enrollment||participants|Number|21|21.0||||||
4133398|NCT00899717|3957822|B2|Spain||Region of Enrollment||participants|Number|11|11.0||||||
4133399|NCT00899717|3957823|B1|Spain||Region of Enrollment||participants|Number|10|10.0||||||
4133400|NCT00899717|3957821|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4133401|NCT00899717|3957822|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4133402|NCT00899717|3957823|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4133403|NCT00899717|3957821|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4133404|NCT00899717|3957822|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4133405|NCT00899717|3957823|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4133406|NCT00899717|3957821|B3|||Age||years|Mean|32.1|32.1|Standard Deviation|11.34|11.34|||
4133407|NCT00899717|3957822|B2|||Age||years|Mean|29.73|29.73|Standard Deviation|8.61|8.61|||
4133408|NCT00899717|3957823|B1|||Age||years|Mean|34.7|34.7|Standard Deviation|13.7|13.7|||
4133409|NCT00899717|3957821|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4133410|NCT00899717|3957822|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4133411|NCT00899717|3957823|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4133412|NCT00899717|3957821|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4133413|NCT00899717|3957822|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4133414|NCT00899717|3957823|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4133415|NCT00899717|3957821|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4133416|NCT00899717|3957822|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4133417|NCT00899717|3957823|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4133418|NCT00899678|3957838|B4|||Body Surface Area (BSA)||square meter|Mean|1.43|1.43|Standard Deviation|0.283|0.283|||
4133419|NCT00899678|3957839|B3|||Body Surface Area (BSA)||square meter|Mean|1.47|1.47|Standard Deviation|0.319|0.319|||
4133420|NCT00899678|3957840|B2|||Body Surface Area (BSA)||square meter|Mean|1.39|1.39|Standard Deviation|0.272|0.272|||
4133421|NCT00899678|3957841|B1|||Body Surface Area (BSA)||square meter|Mean|1.42|1.42|Standard Deviation|0.250|0.25|||
4133422|NCT00899678|3957838|B4|||Body Mass Index (BMI)||kilogram per square meter|Mean|18.93|18.93|Standard Deviation|3.869|3.869|||
4133423|NCT00899678|3957839|B3|||Body Mass Index (BMI)||kilogram per square meter|Mean|19.79|19.79|Standard Deviation|4.897|4.897|||
4133424|NCT00899678|3957840|B2|||Body Mass Index (BMI)||kilogram per square meter|Mean|18.51|18.51|Standard Deviation|3.531|3.531|||
4133425|NCT00899678|3957841|B1|||Body Mass Index (BMI)||kilogram per square meter|Mean|18.39|18.39|Standard Deviation|2.504|2.504|||
4133426|NCT00899678|3957838|B4|||Height||centimeter|Mean|156.57|156.57|Standard Deviation|13.460|13.46|||
4133427|NCT00899678|3957839|B3|||Height||centimeter|Mean|157.22|157.22|Standard Deviation|13.320|13.32|||
4133428|NCT00899678|3957840|B2|||Height||centimeter|Mean|155.32|155.32|Standard Deviation|13.589|13.589|||
4133429|NCT00899678|3957841|B1|||Height||centimeter|Mean|157.46|157.46|Standard Deviation|13.841|13.841|||
4133430|NCT00899678|3957838|B4|||Weight||kilogram|Mean|47.55|47.55|Standard Deviation|15.642|15.642|||
4133431|NCT00899678|3957839|B3|||Weight||kilogram|Mean|50.35|50.35|Standard Deviation|18.569|18.569|||
4133432|NCT00899678|3957840|B2|||Weight||kilogram|Mean|45.67|45.67|Standard Deviation|14.638|14.638|||
4133433|NCT00899678|3957841|B1|||Weight||kilogram|Mean|46.50|46.5|Standard Deviation|12.565|12.565|||
4133434|NCT00899678|3957838|B4|Other / Mixed||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4133435|NCT00899678|3957839|B3|Other / Mixed||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4133436|NCT00899678|3957840|B2|Other / Mixed||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4133437|NCT00899678|3957841|B1|Other / Mixed||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4133438|NCT00899678|3957838|B4|White||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
4133439|NCT00899678|3957839|B3|White||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4133440|NCT00899678|3957840|B2|White||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4133441|NCT00899678|3957841|B1|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4133442|NCT00899678|3957838|B4|Native Hawaiian or other Pacific islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4133443|NCT00899678|3957839|B3|Native Hawaiian or other Pacific islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4133444|NCT00899678|3957840|B2|Native Hawaiian or other Pacific islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4133445|NCT00899678|3957841|B1|Native Hawaiian or other Pacific islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4133446|NCT00899678|3957838|B4|Black||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4133447|NCT00899678|3957839|B3|Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4133448|NCT00899678|3957840|B2|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4133449|NCT00899678|3957841|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4133450|NCT00899678|3957838|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4133451|NCT00899678|3957839|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4133452|NCT00899678|3957840|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4133453|NCT00899678|3957841|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4133454|NCT00899678|3957838|B4|American Indian / Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4133455|NCT00899678|3957839|B3|American Indian / Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4133456|NCT00899678|3957840|B2|American Indian / Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4133457|NCT00899678|3957841|B1|American Indian / Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4133458|NCT00899678|3957838|B4||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4133459|NCT00899678|3957839|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4133460|NCT00899678|3957840|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4133461|NCT00899678|3957841|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4133462|NCT00899678|3957838|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4133463|NCT00899678|3957839|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4133464|NCT00899678|3957840|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4133465|NCT00899678|3957841|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4133466|NCT00899678|3957838|B4|12-17 years||Age, Customized||participants|Number|76|76.0||||||
4133467|NCT00899678|3957839|B3|12-17 years||Age, Customized||participants|Number|27|27.0||||||
4133468|NCT00899678|3957840|B2|12-17 years||Age, Customized||participants|Number|28|28.0||||||
4133469|NCT00899678|3957841|B1|12-17 years||Age, Customized||participants|Number|21|21.0||||||
4133470|NCT00899678|3957838|B4|6-11 years||Age, Customized||participants|Number|23|23.0||||||
4133471|NCT00899678|3957839|B3|6-11 years||Age, Customized||participants|Number|8|8.0||||||
4133472|NCT00899678|3957840|B2|6-11 years||Age, Customized||participants|Number|9|9.0||||||
4133473|NCT00899678|3957841|B1|6-11 years||Age, Customized||participants|Number|6|6.0||||||
4133474|NCT00899678|3957838|B4|||Age||years|Mean|13.4|13.4|Standard Deviation|2.48|2.48|||
4133475|NCT00899678|3957839|B3|||Age||years|Mean|13.4|13.4|Standard Deviation|2.46|2.46|||
4133476|NCT00899678|3957840|B2|||Age||years|Mean|13.2|13.2|Standard Deviation|2.41|2.41|||
4133477|NCT00899678|3957841|B1|||Age||years|Mean|13.8|13.8|Standard Deviation|2.67|2.67|||
4133478|NCT00899600|3957871|B3|United States||Region of Enrollment||participants|Number|102|102.0||||||
4133479|NCT00899600|3957872|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
4133480|NCT00899600|3957873|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4133481|NCT00899600|3957871|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4133482|NCT00899600|3957872|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4133483|NCT00899600|3957873|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4133484|NCT00899600|3957871|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4133485|NCT00899600|3957872|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4133486|NCT00899600|3957873|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4133487|NCT00899600|3957871|B3|||Age||years|Mean|51.6|51.6|Standard Deviation|14.3|14.3|||
4133488|NCT00899600|3957872|B2|||Age||years|Mean|51.7|51.7|Standard Deviation|14.2|14.2|||
4133489|NCT00899600|3957873|B1|||Age||years|Mean|51.4|51.4|Standard Deviation|14.4|14.4|||
4133490|NCT00899600|3957871|B3||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4133491|NCT00899600|3957872|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4133492|NCT00899600|3957873|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4133493|NCT00899600|3957871|B3||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
4133494|NCT00899600|3957872|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4133495|NCT00899600|3957873|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4133496|NCT00899600|3957871|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4133497|NCT00899600|3957872|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4133498|NCT00899600|3957873|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4133499|NCT00899574|3957888|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4133500|NCT00899574|3957888|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4133501|NCT00899574|3957888|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4133502|NCT00899574|3957888|B1|||Age||years|Median|50|50.0|Full Range|||44.0|71.0|
4133503|NCT00899574|3957888|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4133504|NCT00899574|3957888|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4133505|NCT00899574|3957888|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4133506|NCT00899470|3957893|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4133507|NCT00899470|3957893|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4133508|NCT00899470|3957893|B1|||Age||years|Mean|28|28.0|Standard Deviation|7|7.0|||
4133509|NCT00899392|3957972|B3||Male|Sex: Female, Male|EAC population are subjects that used web based education module|Participants|Count of Participants|32|32.0||||||
4133510|NCT00899392|3957973|B2||Male|Sex: Female, Male|EAC population are subjects that used web based education module|Participants|Count of Participants|14|14.0||||||
4133511|NCT00899392|3957974|B1||Male|Sex: Female, Male|EAC population are subjects that used web based education module|Participants|Count of Participants|18|18.0||||||
4133512|NCT00899392|3957972|B3||Female|Sex: Female, Male|EAC population are subjects that used web based education module|Participants|Count of Participants|110|110.0||||||
4133513|NCT00899392|3957973|B2||Female|Sex: Female, Male|EAC population are subjects that used web based education module|Participants|Count of Participants|60|60.0||||||
4133514|NCT00899392|3957974|B1||Female|Sex: Female, Male|EAC population are subjects that used web based education module|Participants|Count of Participants|50|50.0||||||
4133515|NCT00899392|3957972|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4133516|NCT00899392|3957973|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4133517|NCT00899392|3957974|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4133518|NCT00899392|3957972|B3||Between 18 and 65 years|Age||Participants|Count of Participants|142|142.0||||||
4133519|NCT00899392|3957973|B2||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
4133520|NCT00899392|3957974|B1||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
4133521|NCT00899392|3957972|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4133522|NCT00899392|3957973|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4133523|NCT00899392|3957974|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4133524|NCT00899379|3957987|B6|Grade 3: Severe||Baseline Severity (First Attack)|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain)|Participants|Number|100|100.0||||||
4133569|NCT00899379|3957990|B3|Oriental||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4133525|NCT00899379|3957988|B5|Grade 3: Severe||Baseline Severity (First Attack)|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain)|Participants|Number|17|17.0||||||
4133526|NCT00899379|3957989|B4|Grade 3: Severe||Baseline Severity (First Attack)|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain)|Participants|Number|29|29.0||||||
4133527|NCT00899379|3957990|B3|Grade 3: Severe||Baseline Severity (First Attack)|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain)|Participants|Number|15|15.0||||||
4133528|NCT00899379|3957991|B2|Grade 3: Severe||Baseline Severity (First Attack)|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain)|Participants|Number|15|15.0||||||
4133529|NCT00899379|3957992|B1|Grade 3: Severe||Baseline Severity (First Attack)|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain)|Participants|Number|24|24.0||||||
4133530|NCT00899379|3957987|B6|Grade 2: Moderate||Baseline Severity (First Attack)|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain)|Participants|Number|303|303.0||||||
4133531|NCT00899379|3957988|B5|Grade 2: Moderate||Baseline Severity (First Attack)|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain)|Participants|Number|64|64.0||||||
4133532|NCT00899379|3957989|B4|Grade 2: Moderate||Baseline Severity (First Attack)|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain)|Participants|Number|46|46.0||||||
4133533|NCT00899379|3957990|B3|Grade 2: Moderate||Baseline Severity (First Attack)|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain)|Participants|Number|69|69.0||||||
4133534|NCT00899379|3957991|B2|Grade 2: Moderate||Baseline Severity (First Attack)|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain)|Participants|Number|66|66.0||||||
4133535|NCT00899379|3957992|B1|Grade 2: Moderate||Baseline Severity (First Attack)|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain)|Participants|Number|58|58.0||||||
4133536|NCT00899379|3957987|B6|Grades 0, 1: No pain, Mild, or Missing||Baseline Severity (First Attack)|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain)|Participants|Number|4|4.0||||||
4133537|NCT00899379|3957988|B5|Grades 0, 1: No pain, Mild, or Missing||Baseline Severity (First Attack)|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain)|Participants|Number|0|0.0||||||
4133538|NCT00899379|3957989|B4|Grades 0, 1: No pain, Mild, or Missing||Baseline Severity (First Attack)|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain)|Participants|Number|2|2.0||||||
4133539|NCT00899379|3957990|B3|Grades 0, 1: No pain, Mild, or Missing||Baseline Severity (First Attack)|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain)|Participants|Number|0|0.0||||||
4133540|NCT00899379|3957991|B2|Grades 0, 1: No pain, Mild, or Missing||Baseline Severity (First Attack)|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain)|Participants|Number|1|1.0||||||
4133541|NCT00899379|3957992|B1|Grades 0, 1: No pain, Mild, or Missing||Baseline Severity (First Attack)|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain)|Participants|Number|1|1.0||||||
4133542|NCT00899379|3957987|B6|Other||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4133543|NCT00899379|3957988|B5|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4133544|NCT00899379|3957989|B4|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4133545|NCT00899379|3957990|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4133546|NCT00899379|3957991|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4133547|NCT00899379|3957992|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4133548|NCT00899379|3957987|B6|Thai||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4133549|NCT00899379|3957988|B5|Thai||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4133550|NCT00899379|3957989|B4|Thai||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4133551|NCT00899379|3957990|B3|Thai||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4133552|NCT00899379|3957991|B2|Thai||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4133553|NCT00899379|3957992|B1|Thai||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4133554|NCT00899379|3957987|B6|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4133555|NCT00899379|3957988|B5|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4133556|NCT00899379|3957989|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4133557|NCT00899379|3957990|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4133558|NCT00899379|3957991|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4133559|NCT00899379|3957992|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4133560|NCT00899379|3957987|B6|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4133561|NCT00899379|3957988|B5|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4133562|NCT00899379|3957989|B4|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4133563|NCT00899379|3957990|B3|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4133564|NCT00899379|3957991|B2|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4133565|NCT00899379|3957992|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4133566|NCT00899379|3957987|B6|Oriental||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4133567|NCT00899379|3957988|B5|Oriental||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4133568|NCT00899379|3957989|B4|Oriental||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4133570|NCT00899379|3957991|B2|Oriental||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4133571|NCT00899379|3957992|B1|Oriental||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4133572|NCT00899379|3957987|B6|Caucasian||Race/Ethnicity, Customized||participants|Number|382|382.0||||||
4133573|NCT00899379|3957988|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
4133574|NCT00899379|3957989|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
4133575|NCT00899379|3957990|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|80|80.0||||||
4133576|NCT00899379|3957991|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|75|75.0||||||
4133577|NCT00899379|3957992|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
4133578|NCT00899379|3957987|B6||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4133579|NCT00899379|3957988|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4133580|NCT00899379|3957989|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4133581|NCT00899379|3957990|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4133582|NCT00899379|3957991|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4133583|NCT00899379|3957992|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4133584|NCT00899379|3957987|B6||Female|Sex: Female, Male||Participants|Count of Participants|341|341.0||||||
4133585|NCT00899379|3957988|B5||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4133586|NCT00899379|3957989|B4||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4133587|NCT00899379|3957990|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4133588|NCT00899379|3957991|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4133589|NCT00899379|3957992|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4133590|NCT00899379|3957987|B6|||Age||years|Mean|40.6|40.6|Standard Deviation|10.2|10.2|||
4133591|NCT00899379|3957988|B5|||Age||years|Mean|38.9|38.9|Standard Deviation|10.8|10.8|||
4133592|NCT00899379|3957989|B4|||Age||years|Mean|39.5|39.5|Standard Deviation|10.1|10.1|||
4133593|NCT00899379|3957990|B3|||Age||years|Mean|42.3|42.3|Standard Deviation|10.6|10.6|||
4133594|NCT00899379|3957991|B2|||Age||years|Mean|41.0|41.0|Standard Deviation|9.8|9.8|||
4133595|NCT00899379|3957992|B1|||Age||years|Mean|41.1|41.1|Standard Deviation|9.6|9.6|||
4133596|NCT00899353|3958008|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4133597|NCT00899353|3958008|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4133598|NCT00899353|3958008|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4133599|NCT00899353|3958008|B1|||Age||years|Mean|68|68.0|Standard Deviation|7|7.0|||
4133600|NCT00899353|3958008|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4133601|NCT00899353|3958008|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4133602|NCT00899353|3958008|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4133603|NCT00898937|3958029|B4|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4133604|NCT00898937|3958029|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4133605|NCT00898937|3958030|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4133606|NCT00898937|3958031|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4133607|NCT00898937|3958032|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4133608|NCT00898937|3958029|B4||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4133609|NCT00898937|3958030|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4133610|NCT00898937|3958031|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4133611|NCT00898937|3958032|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4133612|NCT00898937|3958029|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4133613|NCT00898937|3958030|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4133614|NCT00898937|3958031|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4133615|NCT00898937|3958032|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4133616|NCT00898937|3958029|B4||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4133617|NCT00898937|3958030|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4133618|NCT00898937|3958031|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4133619|NCT00898937|3958032|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4133620|NCT00898937|3958029|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4133621|NCT00898937|3958030|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4133622|NCT00898937|3958031|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4133623|NCT00898937|3958032|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4133624|NCT00898807|3958042|B3|Canada||Region of Enrollment||participants|Number|25|25.0||||||
4133625|NCT00898807|3958043|B2|Canada||Region of Enrollment||participants|Number|13|13.0||||||
4133626|NCT00898807|3958044|B1|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4133627|NCT00898807|3958042|B3|United States||Region of Enrollment||participants|Number|161|161.0||||||
4133628|NCT00898807|3958043|B2|United States||Region of Enrollment||participants|Number|79|79.0||||||
4133629|NCT00898807|3958044|B1|United States||Region of Enrollment||participants|Number|82|82.0||||||
4133630|NCT00898807|3958042|B3||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4133631|NCT00898807|3958043|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4133632|NCT00898807|3958044|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4133633|NCT00898807|3958042|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4133634|NCT00898807|3958043|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4133635|NCT00898807|3958044|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4133636|NCT00898807|3958042|B3|||Age||years|Mean|78|78.0|Standard Deviation|8|8.0|||
4133637|NCT00898807|3958043|B2|||Age||years|Mean|79|79.0|Standard Deviation|8|8.0|||
4133638|NCT00898807|3958044|B1|||Age||years|Mean|78|78.0|Standard Deviation|9|9.0|||
4133639|NCT00898807|3958042|B3||>=65 years|Age||Participants|Count of Participants|173|173.0||||||
4133640|NCT00898807|3958043|B2||>=65 years|Age||Participants|Count of Participants|85|85.0||||||
4133641|NCT00898807|3958044|B1||>=65 years|Age||Participants|Count of Participants|88|88.0||||||
4133642|NCT00898807|3958042|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4133643|NCT00898807|3958043|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4133644|NCT00898807|3958044|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4133645|NCT00898807|3958042|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4133646|NCT00898807|3958043|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4133647|NCT00898807|3958044|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4133648|NCT00898677|3958057|B5|Asian/Caucasian||Race/Ethnicity||participants|Number|1|1.0||||||
4133649|NCT00898677|3958058|B4|Asian/Caucasian||Race/Ethnicity||participants|Number|0|0.0||||||
4133650|NCT00898677|3958059|B3|Asian/Caucasian||Race/Ethnicity||participants|Number|0|0.0||||||
4133651|NCT00898677|3958060|B2|Asian/Caucasian||Race/Ethnicity||participants|Number|0|0.0||||||
4133652|NCT00898677|3958061|B1|Asian/Caucasian||Race/Ethnicity||participants|Number|1|1.0||||||
4133653|NCT00898677|3958057|B5|Mixed||Race/Ethnicity||participants|Number|5|5.0||||||
4133654|NCT00898677|3958058|B4|Mixed||Race/Ethnicity||participants|Number|1|1.0||||||
4133655|NCT00898677|3958059|B3|Mixed||Race/Ethnicity||participants|Number|0|0.0||||||
4133656|NCT00898677|3958060|B2|Mixed||Race/Ethnicity||participants|Number|2|2.0||||||
4133657|NCT00898677|3958061|B1|Mixed||Race/Ethnicity||participants|Number|2|2.0||||||
4133658|NCT00898677|3958057|B5|Mexican/Hispanic||Race/Ethnicity||participants|Number|1|1.0||||||
4133659|NCT00898677|3958058|B4|Mexican/Hispanic||Race/Ethnicity||participants|Number|0|0.0||||||
4133660|NCT00898677|3958059|B3|Mexican/Hispanic||Race/Ethnicity||participants|Number|0|0.0||||||
4133661|NCT00898677|3958060|B2|Mexican/Hispanic||Race/Ethnicity||participants|Number|0|0.0||||||
4133662|NCT00898677|3958061|B1|Mexican/Hispanic||Race/Ethnicity||participants|Number|1|1.0||||||
4133663|NCT00898677|3958057|B5|Colored||Race/Ethnicity||participants|Number|1|1.0||||||
4133664|NCT00898677|3958058|B4|Colored||Race/Ethnicity||participants|Number|0|0.0||||||
4133665|NCT00898677|3958059|B3|Colored||Race/Ethnicity||participants|Number|1|1.0||||||
4133666|NCT00898677|3958060|B2|Colored||Race/Ethnicity||participants|Number|0|0.0||||||
4133667|NCT00898677|3958061|B1|Colored||Race/Ethnicity||participants|Number|0|0.0||||||
4133668|NCT00898677|3958057|B5|Mexican||Race/Ethnicity||participants|Number|4|4.0||||||
4133669|NCT00898677|3958058|B4|Mexican||Race/Ethnicity||participants|Number|0|0.0||||||
4133670|NCT00898677|3958059|B3|Mexican||Race/Ethnicity||participants|Number|2|2.0||||||
4133671|NCT00898677|3958060|B2|Mexican||Race/Ethnicity||participants|Number|2|2.0||||||
4133672|NCT00898677|3958061|B1|Mexican||Race/Ethnicity||participants|Number|0|0.0||||||
4133673|NCT00898677|3958057|B5|Mestizo||Race/Ethnicity||participants|Number|53|53.0||||||
4133674|NCT00898677|3958058|B4|Mestizo||Race/Ethnicity||participants|Number|7|7.0||||||
4133675|NCT00898677|3958059|B3|Mestizo||Race/Ethnicity||participants|Number|22|22.0||||||
4133676|NCT00898677|3958060|B2|Mestizo||Race/Ethnicity||participants|Number|15|15.0||||||
4133677|NCT00898677|3958061|B1|Mestizo||Race/Ethnicity||participants|Number|9|9.0||||||
4133678|NCT00898677|3958057|B5|Hispanic||Race/Ethnicity||participants|Number|222|222.0||||||
4133679|NCT00898677|3958058|B4|Hispanic||Race/Ethnicity||participants|Number|32|32.0||||||
4133680|NCT00898677|3958059|B3|Hispanic||Race/Ethnicity||participants|Number|77|77.0||||||
4133681|NCT00898677|3958060|B2|Hispanic||Race/Ethnicity||participants|Number|80|80.0||||||
4133682|NCT00898677|3958061|B1|Hispanic||Race/Ethnicity||participants|Number|33|33.0||||||
4133683|NCT00898677|3958057|B5|Asian||Race/Ethnicity||participants|Number|3|3.0||||||
4133684|NCT00898677|3958058|B4|Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4133685|NCT00898677|3958059|B3|Asian||Race/Ethnicity||participants|Number|2|2.0||||||
4133686|NCT00898677|3958060|B2|Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4133687|NCT00898677|3958061|B1|Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4133688|NCT00898677|3958057|B5|Black||Race/Ethnicity||participants|Number|9|9.0||||||
4133689|NCT00898677|3958058|B4|Black||Race/Ethnicity||participants|Number|0|0.0||||||
4133690|NCT00898677|3958059|B3|Black||Race/Ethnicity||participants|Number|3|3.0||||||
4133691|NCT00898677|3958060|B2|Black||Race/Ethnicity||participants|Number|5|5.0||||||
4133692|NCT00898677|3958061|B1|Black||Race/Ethnicity||participants|Number|1|1.0||||||
4133693|NCT00898677|3958057|B5|Caucasian||Race/Ethnicity||participants|Number|800|800.0||||||
4133694|NCT00898677|3958058|B4|Caucasian||Race/Ethnicity||participants|Number|120|120.0||||||
4133695|NCT00898677|3958059|B3|Caucasian||Race/Ethnicity||participants|Number|281|281.0||||||
4133696|NCT00898677|3958060|B2|Caucasian||Race/Ethnicity||participants|Number|282|282.0||||||
4133697|NCT00898677|3958061|B1|Caucasian||Race/Ethnicity||participants|Number|117|117.0||||||
4133744|NCT00898443|3958102|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4133698|NCT00898677|3958057|B5|Grade 3: Severe||Baseline Headache Severity|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain).|participants|Number|585|585.0||||||
4133699|NCT00898677|3958058|B4|Grade 3: Severe||Baseline Headache Severity|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain).|participants|Number|84|84.0||||||
4133700|NCT00898677|3958059|B3|Grade 3: Severe||Baseline Headache Severity|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain).|participants|Number|196|196.0||||||
4133701|NCT00898677|3958060|B2|Grade 3: Severe||Baseline Headache Severity|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain).|participants|Number|213|213.0||||||
4133702|NCT00898677|3958061|B1|Grade 3: Severe||Baseline Headache Severity|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain).|participants|Number|92|92.0||||||
4133703|NCT00898677|3958057|B5|Grade 2: Moderate||Baseline Headache Severity|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain).|participants|Number|512|512.0||||||
4133704|NCT00898677|3958058|B4|Grade 2: Moderate||Baseline Headache Severity|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain).|participants|Number|75|75.0||||||
4133705|NCT00898677|3958059|B3|Grade 2: Moderate||Baseline Headache Severity|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain).|participants|Number|191|191.0||||||
4133706|NCT00898677|3958060|B2|Grade 2: Moderate||Baseline Headache Severity|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain).|participants|Number|174|174.0||||||
4133707|NCT00898677|3958061|B1|Grade 2: Moderate||Baseline Headache Severity|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain).|participants|Number|72|72.0||||||
4133708|NCT00898677|3958057|B5|Grades 1, 0: Mild, no pain, or missing||Baseline Headache Severity|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain).|participants|Number|2|2.0||||||
4133709|NCT00898677|3958058|B4|Grades 1, 0: Mild, no pain, or missing||Baseline Headache Severity|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain).|participants|Number|1|1.0||||||
4133710|NCT00898677|3958059|B3|Grades 1, 0: Mild, no pain, or missing||Baseline Headache Severity|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain).|participants|Number|1|1.0||||||
4133711|NCT00898677|3958060|B2|Grades 1, 0: Mild, no pain, or missing||Baseline Headache Severity|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain).|participants|Number|0|0.0||||||
4133712|NCT00898677|3958061|B1|Grades 1, 0: Mild, no pain, or missing||Baseline Headache Severity|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain).|participants|Number|0|0.0||||||
4133713|NCT00898677|3958057|B5||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4133714|NCT00898677|3958058|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4133715|NCT00898677|3958059|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4133716|NCT00898677|3958060|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4133717|NCT00898677|3958061|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4133718|NCT00898677|3958057|B5||Female|Sex: Female, Male||Participants|Count of Participants|898|898.0||||||
4133719|NCT00898677|3958058|B4||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4133720|NCT00898677|3958059|B3||Female|Sex: Female, Male||Participants|Count of Participants|309|309.0||||||
4133721|NCT00898677|3958060|B2||Female|Sex: Female, Male||Participants|Count of Participants|319|319.0||||||
4133722|NCT00898677|3958061|B1||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4133723|NCT00898677|3958057|B5|||Age||years|Mean|38.2|38.2|Standard Deviation|10.2|10.2|||
4133724|NCT00898677|3958058|B4|||Age||years|Mean|38.3|38.3|Standard Deviation|10.3|10.3|||
4133725|NCT00898677|3958059|B3|||Age||years|Mean|39.2|39.2|Standard Deviation|10.1|10.1|||
4133726|NCT00898677|3958060|B2|||Age||years|Mean|37.0|37.0|Standard Deviation|10.0|10.0|||
4133727|NCT00898677|3958061|B1|||Age||years|Mean|38.3|38.3|Standard Deviation|10.3|10.3|||
4133728|NCT00898560|3958090|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4133729|NCT00898560|3958090|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4133730|NCT00898560|3958090|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4133731|NCT00898560|3958090|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4133732|NCT00898560|3958090|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4133733|NCT00898443|3958100|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4133734|NCT00898443|3958101|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4133735|NCT00898443|3958102|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4133736|NCT00898443|3958100|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4133737|NCT00898443|3958101|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4133738|NCT00898443|3958102|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4133739|NCT00898443|3958100|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4133740|NCT00898443|3958101|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4133741|NCT00898443|3958102|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4133742|NCT00898443|3958100|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4133743|NCT00898443|3958101|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4133745|NCT00898443|3958100|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4133746|NCT00898443|3958101|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4133747|NCT00898443|3958102|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4133748|NCT00898443|3958100|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4133749|NCT00898443|3958101|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4133750|NCT00898443|3958102|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4133751|NCT00898222|3958111|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4133752|NCT00898222|3958111|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4133753|NCT00898222|3958111|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4133754|NCT00898222|3958111|B1|||Age||years|Mean|26|26.0|Standard Deviation|2.94|2.94|||
4133755|NCT00898222|3958111|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4133756|NCT00898222|3958111|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4133757|NCT00898222|3958111|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4133758|NCT00897949|3958115|B4|Grade 3: Severe||Baseline Headache Severity|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain)|Participants|Number|378|378.0||||||
4133759|NCT00897949|3958116|B3|Grade 3: Severe||Baseline Headache Severity|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain)|Participants|Number|95|95.0||||||
4133760|NCT00897949|3958117|B2|Grade 3: Severe||Baseline Headache Severity|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain)|Participants|Number|131|131.0||||||
4133761|NCT00897949|3958118|B1|Grade 3: Severe||Baseline Headache Severity|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain)|Participants|Number|152|152.0||||||
4133762|NCT00897949|3958115|B4|Grade 2: Moderate||Baseline Headache Severity|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain)|Participants|Number|816|816.0||||||
4133763|NCT00897949|3958116|B3|Grade 2: Moderate||Baseline Headache Severity|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain)|Participants|Number|202|202.0||||||
4133764|NCT00897949|3958117|B2|Grade 2: Moderate||Baseline Headache Severity|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain)|Participants|Number|316|316.0||||||
4133765|NCT00897949|3958118|B1|Grade 2: Moderate||Baseline Headache Severity|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain)|Participants|Number|298|298.0||||||
4133766|NCT00897949|3958115|B4|Grade 0, 1: No pain, Mild, or missing||Baseline Headache Severity|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain)|Participants|Number|24|24.0||||||
4133767|NCT00897949|3958116|B3|Grade 0, 1: No pain, Mild, or missing||Baseline Headache Severity|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain)|Participants|Number|7|7.0||||||
4133768|NCT00897949|3958117|B2|Grade 0, 1: No pain, Mild, or missing||Baseline Headache Severity|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain)|Participants|Number|9|9.0||||||
4133769|NCT00897949|3958118|B1|Grade 0, 1: No pain, Mild, or missing||Baseline Headache Severity|Each patient rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain)|Participants|Number|8|8.0||||||
4133770|NCT00897949|3958115|B4|Other||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4133771|NCT00897949|3958116|B3|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4133772|NCT00897949|3958117|B2|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4133773|NCT00897949|3958118|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4133774|NCT00897949|3958115|B4|Mixed||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4133775|NCT00897949|3958116|B3|Mixed||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4133776|NCT00897949|3958117|B2|Mixed||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4133777|NCT00897949|3958118|B1|Mixed||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4133778|NCT00897949|3958115|B4|Anglo-Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4133779|NCT00897949|3958116|B3|Anglo-Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4133780|NCT00897949|3958117|B2|Anglo-Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4133781|NCT00897949|3958118|B1|Anglo-Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4133782|NCT00897949|3958115|B4|Syrian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4133783|NCT00897949|3958116|B3|Syrian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4133784|NCT00897949|3958117|B2|Syrian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4133785|NCT00897949|3958118|B1|Syrian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4133786|NCT00897949|3958115|B4|Mexican-American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4133787|NCT00897949|3958116|B3|Mexican-American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4133788|NCT00897949|3958117|B2|Mexican-American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4133789|NCT00897949|3958118|B1|Mexican-American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4133790|NCT00897949|3958115|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4133791|NCT00897949|3958116|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4133792|NCT00897949|3958117|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4133793|NCT00897949|3958118|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4133794|NCT00897949|3958115|B4|Asian||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4133795|NCT00897949|3958116|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4133796|NCT00897949|3958117|B2|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4133797|NCT00897949|3958118|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4133798|NCT00897949|3958115|B4|Black||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4133799|NCT00897949|3958116|B3|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4133800|NCT00897949|3958117|B2|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4133801|NCT00897949|3958118|B1|Black||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4133802|NCT00897949|3958115|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|1138|1138.0||||||
4133803|NCT00897949|3958116|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|286|286.0||||||
4133804|NCT00897949|3958117|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|422|422.0||||||
4133805|NCT00897949|3958118|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|430|430.0||||||
4133806|NCT00897949|3958115|B4||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4133807|NCT00897949|3958116|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4133808|NCT00897949|3958117|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4133809|NCT00897949|3958118|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4133810|NCT00897949|3958115|B4||Female|Sex: Female, Male||Participants|Count of Participants|1055|1055.0||||||
4133811|NCT00897949|3958116|B3||Female|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
4133812|NCT00897949|3958117|B2||Female|Sex: Female, Male||Participants|Count of Participants|402|402.0||||||
4133813|NCT00897949|3958118|B1||Female|Sex: Female, Male||Participants|Count of Participants|394|394.0||||||
4133814|NCT00897949|3958115|B4|||Age||years|Mean|40.6|40.6|Standard Deviation|9.9|9.9|||
4133815|NCT00897949|3958116|B3|||Age||years|Mean|40.6|40.6|Standard Deviation|10.5|10.5|||
4133816|NCT00897949|3958117|B2|||Age||years|Mean|40.7|40.7|Standard Deviation|9.6|9.6|||
4133817|NCT00897949|3958118|B1|||Age||years|Mean|40.5|40.5|Standard Deviation|9.6|9.6|||
4133818|NCT00897910|3958143|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4133819|NCT00897910|3958143|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4133820|NCT00897910|3958143|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4133821|NCT00897910|3958143|B1|||Age||years|Mean|53|53.0|Standard Deviation|0|0.0|||
4133822|NCT00897897|3958147|B1|Korea, Republic of||Region of Enrollment||participants|Number|10|10.0||||||
4133823|NCT00897897|3958147|B1|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
4133824|NCT00897897|3958147|B1|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4133825|NCT00897897|3958147|B1|France||Region of Enrollment||participants|Number|16|16.0||||||
4133826|NCT00897897|3958147|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4133827|NCT00897897|3958147|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4133828|NCT00897897|3958147|B1|||Age||years|Mean|44.8|44.8|Standard Deviation|5.2|5.2|||
4133829|NCT00897897|3958147|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4133830|NCT00897897|3958147|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4133831|NCT00897897|3958147|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4133832|NCT00897715|3958152|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4133833|NCT00897715|3958153|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4133834|NCT00897715|3958154|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4133835|NCT00897715|3958152|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133836|NCT00897715|3958153|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133837|NCT00897715|3958154|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133838|NCT00897715|3958152|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133839|NCT00897715|3958153|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133840|NCT00897715|3958154|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133841|NCT00897715|3958152|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4133842|NCT00897715|3958153|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4133843|NCT00897715|3958154|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4133844|NCT00897715|3958152|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4133845|NCT00897715|3958153|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4133846|NCT00897715|3958154|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133847|NCT00897715|3958152|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133848|NCT00897715|3958153|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133849|NCT00897715|3958154|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133850|NCT00897715|3958152|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133851|NCT00897715|3958153|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133852|NCT00897715|3958154|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133853|NCT00897715|3958152|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133854|NCT00897715|3958153|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134093|NCT00896532|3958314|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4133855|NCT00897715|3958154|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133856|NCT00897715|3958152|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133857|NCT00897715|3958153|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133858|NCT00897715|3958154|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133859|NCT00897715|3958152|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4133860|NCT00897715|3958153|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4133861|NCT00897715|3958154|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4133862|NCT00897715|3958152|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4133863|NCT00897715|3958153|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4133864|NCT00897715|3958154|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4133865|NCT00897715|3958152|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4133866|NCT00897715|3958153|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4133867|NCT00897715|3958154|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4133868|NCT00897715|3958152|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4133869|NCT00897715|3958153|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4133870|NCT00897715|3958154|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4133871|NCT00897715|3958152|B3|||Age||years|Mean|64|64.0|Standard Deviation|9.4|9.4|||
4133872|NCT00897715|3958153|B2|||Age||years|Mean|67|67.0|Standard Deviation|6.2|6.2|||
4133873|NCT00897715|3958154|B1|||Age||years|Mean|62|62.0|Standard Deviation|11.5|11.5|||
4133874|NCT00897676|3958163|B1|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4133875|NCT00897676|3958163|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133876|NCT00897676|3958163|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133877|NCT00897676|3958163|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4133878|NCT00897676|3958163|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4133879|NCT00897676|3958163|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133880|NCT00897676|3958163|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133881|NCT00897676|3958163|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4133882|NCT00897676|3958163|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4133883|NCT00897676|3958163|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4133884|NCT00897676|3958163|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4133885|NCT00897676|3958163|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4133886|NCT00897676|3958163|B1||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4133887|NCT00897390|3958180|B1|||weight||kg|Mean|79.9|79.9|Standard Deviation|15.0|15.0|||
4133888|NCT00897390|3958180|B1|||Body Mass Index||kg/m^2|Mean|26.5|26.5|Standard Deviation|3.8|3.8|||
4133889|NCT00897390|3958180|B1|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4133890|NCT00897390|3958180|B1|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4133891|NCT00897390|3958180|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4133892|NCT00897390|3958180|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4133893|NCT00897390|3958180|B1|||Age||years|Mean|30|30.0|Standard Deviation|6|6.0|||
4133894|NCT00897104|3958267|B4|Grade 3: Severe||Baseline Headache Severity|Each participant rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain).|Participants|Number|290|290.0||||||
4133895|NCT00897104|3958268|B3|Grade 3: Severe||Baseline Headache Severity|Each participant rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain).|Participants|Number|29|29.0||||||
4133896|NCT00897104|3958269|B2|Grade 3: Severe||Baseline Headache Severity|Each participant rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain).|Participants|Number|128|128.0||||||
4133897|NCT00897104|3958270|B1|Grade 3: Severe||Baseline Headache Severity|Each participant rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain).|Participants|Number|133|133.0||||||
4133898|NCT00897104|3958267|B4|Grade 2: Moderate||Baseline Headache Severity|Each participant rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain).|Participants|Number|488|488.0||||||
4133899|NCT00897104|3958268|B3|Grade 2: Moderate||Baseline Headache Severity|Each participant rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain).|Participants|Number|51|51.0||||||
4133900|NCT00897104|3958269|B2|Grade 2: Moderate||Baseline Headache Severity|Each participant rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain).|Participants|Number|221|221.0||||||
4133901|NCT00897104|3958270|B1|Grade 2: Moderate||Baseline Headache Severity|Each participant rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain).|Participants|Number|216|216.0||||||
4133902|NCT00897104|3958267|B4|Grades 0,1: no pain, Mild, or missing||Baseline Headache Severity|Each participant rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain).|Participants|Number|14|14.0||||||
4133903|NCT00897104|3958268|B3|Grades 0,1: no pain, Mild, or missing||Baseline Headache Severity|Each participant rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain).|Participants|Number|0|0.0||||||
4133904|NCT00897104|3958269|B2|Grades 0,1: no pain, Mild, or missing||Baseline Headache Severity|Each participant rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain).|Participants|Number|8|8.0||||||
4133905|NCT00897104|3958270|B1|Grades 0,1: no pain, Mild, or missing||Baseline Headache Severity|Each participant rated headache severity on a 4-grade scale (0 = no headache; 1 = mild pain; 2 = moderate pain; 3 = severe pain).|Participants|Number|6|6.0||||||
4133906|NCT00897104|3958267|B4|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4133907|NCT00897104|3958268|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4133908|NCT00897104|3958269|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4133909|NCT00897104|3958270|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4133910|NCT00897104|3958267|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|788|788.0||||||
4133911|NCT00897104|3958268|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|80|80.0||||||
4133912|NCT00897104|3958269|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|356|356.0||||||
4133913|NCT00897104|3958270|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|352|352.0||||||
4133914|NCT00897104|3958267|B4||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4133915|NCT00897104|3958268|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4133916|NCT00897104|3958269|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4133917|NCT00897104|3958270|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4133918|NCT00897104|3958267|B4||Female|Sex: Female, Male||Participants|Count of Participants|652|652.0||||||
4133919|NCT00897104|3958268|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4133920|NCT00897104|3958269|B2||Female|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
4133921|NCT00897104|3958270|B1||Female|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
4133922|NCT00897104|3958267|B4|||Age||years|Mean|41.2|41.2|Standard Deviation|10.3|10.3|||
4133923|NCT00897104|3958268|B3|||Age||years|Mean|44.3|44.3|Standard Deviation|10.5|10.5|||
4133924|NCT00897104|3958269|B2|||Age||years|Mean|41.8|41.8|Standard Deviation|10.1|10.1|||
4133925|NCT00897104|3958270|B1|||Age||years|Mean|39.9|39.9|Standard Deviation|10.3|10.3|||
4133926|NCT00896779|3958298|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4133927|NCT00896779|3958299|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4133928|NCT00896779|3958300|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4133929|NCT00896779|3958298|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4133930|NCT00896779|3958299|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4133931|NCT00896779|3958300|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4133932|NCT00896779|3958298|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4133933|NCT00896779|3958299|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4133934|NCT00896779|3958300|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4133935|NCT00896779|3958298|B3|||Age||years|Mean|83|83.0|Full Range|||68.0|97.0|
4133936|NCT00896779|3958299|B2|||Age||years|Mean|84|84.0|Full Range|||71.0|97.0|
4133937|NCT00896779|3958300|B1|||Age||years|Mean|81|81.0|Full Range|||68.0|94.0|
4133938|NCT00896779|3958298|B3||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4133939|NCT00896779|3958299|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4133940|NCT00896779|3958300|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4133941|NCT00896779|3958298|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4133942|NCT00896779|3958299|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4133943|NCT00896779|3958300|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4133944|NCT00896779|3958298|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4133945|NCT00896779|3958299|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4133946|NCT00896779|3958300|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4133947|NCT00896649|3958307|B1|||No prior history of cancer in previous 5 years||participants|Number|193|193.0||||||
4133948|NCT00896649|3958307|B1|pregnant status||Pregnancy status|Only non-pregnant patients are allowed to participate.|Participants|Count of Participants|1|1.0||||||
4133949|NCT00896649|3958307|B1|negative pregnancy status||Pregnancy status|Only non-pregnant patients are allowed to participate.|Participants|Count of Participants|192|192.0||||||
4133950|NCT00896649|3958307|B1|United States||Region of Enrollment|Boston, Massachusetts, USA|Participants|Count of Participants|193|193.0||||||
4133951|NCT00896649|3958307|B1||Unknown or Not Reported|Race (NIH/OMB)|Caucasian African American|Participants|Count of Participants|0|0.0||||||
4133952|NCT00896649|3958307|B1||More than one race|Race (NIH/OMB)|Caucasian African American|Participants|Count of Participants|0|0.0||||||
4133953|NCT00896649|3958307|B1||White|Race (NIH/OMB)|Caucasian African American|Participants|Count of Participants|80|80.0||||||
4133954|NCT00896649|3958307|B1||Black or African American|Race (NIH/OMB)|Caucasian African American|Participants|Count of Participants|113|113.0||||||
4133955|NCT00896649|3958307|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Caucasian African American|Participants|Count of Participants|0|0.0||||||
4133956|NCT00896649|3958307|B1||Asian|Race (NIH/OMB)|Caucasian African American|Participants|Count of Participants|0|0.0||||||
4133957|NCT00896649|3958307|B1||American Indian or Alaska Native|Race (NIH/OMB)|Caucasian African American|Participants|Count of Participants|0|0.0||||||
4133958|NCT00896649|3958307|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|Hispanic/Non-Hispanic eligible|Participants|Count of Participants|0|0.0||||||
4133959|NCT00896649|3958307|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Hispanic/Non-Hispanic eligible|Participants|Count of Participants|185|185.0||||||
4133960|NCT00896649|3958307|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|Hispanic/Non-Hispanic eligible|Participants|Count of Participants|8|8.0||||||
4133961|NCT00896649|3958307|B1|Female||Sex/Gender, Customized|The gender of the patient must be female per protocol.|Participants|Count of Participants|193|193.0||||||
4133962|NCT00896649|3958307|B1||>=65 years|Age|Age of the subjects must be greater than or equal to 18 years of age.|Participants|Count of Participants|11|11.0||||||
4133963|NCT00896649|3958307|B1||Between 18 and 65 years|Age|Age of the subjects must be greater than or equal to 18 years of age.|Participants|Count of Participants|182|182.0||||||
4133964|NCT00896649|3958307|B1||<=18 years|Age|Age of the subjects must be greater than or equal to 18 years of age.|Participants|Count of Participants|0|0.0||||||
4133965|NCT00896532|3958312|B9|||Bone-specific Alkaline Phosphatase (BSAP)||μg/L|Median|12.44|12.44|Inter-Quartile Range|||10.06|15.3|
4133966|NCT00896532|3958313|B8|||Bone-specific Alkaline Phosphatase (BSAP)||μg/L|Median|12.37|12.37|Inter-Quartile Range|||10.16|15.9|
4133967|NCT00896532|3958314|B7|||Bone-specific Alkaline Phosphatase (BSAP)||μg/L|Median|12.61|12.61|Inter-Quartile Range|||10.06|14.04|
4133968|NCT00896532|3958315|B6|||Bone-specific Alkaline Phosphatase (BSAP)||μg/L|Median|11.78|11.78|Inter-Quartile Range|||9.44|14.6|
4133969|NCT00896532|3958316|B5|||Bone-specific Alkaline Phosphatase (BSAP)||μg/L|Median|13.19|13.19|Inter-Quartile Range|||10.1|15.68|
4133970|NCT00896532|3958317|B4|||Bone-specific Alkaline Phosphatase (BSAP)||μg/L|Median|11.82|11.82|Inter-Quartile Range|||10.66|15.34|
4133971|NCT00896532|3958318|B3|||Bone-specific Alkaline Phosphatase (BSAP)||μg/L|Median|13.34|13.34|Inter-Quartile Range|||10.04|16.39|
4133972|NCT00896532|3958319|B2|||Bone-specific Alkaline Phosphatase (BSAP)||μg/L|Median|12.93|12.93|Inter-Quartile Range|||10.48|15.52|
4133973|NCT00896532|3958320|B1|||Bone-specific Alkaline Phosphatase (BSAP)||μg/L|Median|11.79|11.79|Inter-Quartile Range|||9.75|13.53|
4133974|NCT00896532|3958312|B9|||Osteocalcin||ng/mL|Median|18.84|18.84|Inter-Quartile Range|||15.13|24.16|
4133975|NCT00896532|3958313|B8|||Osteocalcin||ng/mL|Median|18.36|18.36|Inter-Quartile Range|||16.15|28.32|
4133976|NCT00896532|3958314|B7|||Osteocalcin||ng/mL|Median|17.72|17.72|Inter-Quartile Range|||13.61|23.16|
4133977|NCT00896532|3958315|B6|||Osteocalcin||ng/mL|Median|18.56|18.56|Inter-Quartile Range|||15.2|21.92|
4133978|NCT00896532|3958316|B5|||Osteocalcin||ng/mL|Median|19.93|19.93|Inter-Quartile Range|||14.92|26.72|
4133979|NCT00896532|3958317|B4|||Osteocalcin||ng/mL|Median|19.03|19.03|Inter-Quartile Range|||15.1|23.63|
4133980|NCT00896532|3958318|B3|||Osteocalcin||ng/mL|Median|19.47|19.47|Inter-Quartile Range|||15.93|26.14|
4133981|NCT00896532|3958319|B2|||Osteocalcin||ng/mL|Median|19.37|19.37|Inter-Quartile Range|||14.69|24.78|
4133982|NCT00896532|3958320|B1|||Osteocalcin||ng/mL|Median|17.95|17.95|Inter-Quartile Range|||15.78|23.62|
4133983|NCT00896532|3958312|B9|||Serum Procollagen Type 1 N-telopeptide (P1NP)||μg/L|Median|49.37|49.37|Inter-Quartile Range|||39.57|61.86|
4133984|NCT00896532|3958313|B8|||Serum Procollagen Type 1 N-telopeptide (P1NP)||μg/L|Median|52.58|52.58|Inter-Quartile Range|||42.47|63.91|
4133985|NCT00896532|3958314|B7|||Serum Procollagen Type 1 N-telopeptide (P1NP)||μg/L|Median|49.24|49.24|Inter-Quartile Range|||39.57|62.16|
4133986|NCT00896532|3958315|B6|||Serum Procollagen Type 1 N-telopeptide (P1NP)||μg/L|Median|48.13|48.13|Inter-Quartile Range|||38.45|56.3|
4133987|NCT00896532|3958316|B5|||Serum Procollagen Type 1 N-telopeptide (P1NP)||μg/L|Median|48.63|48.63|Inter-Quartile Range|||37.55|67.47|
4133988|NCT00896532|3958317|B4|||Serum Procollagen Type 1 N-telopeptide (P1NP)||μg/L|Median|50.36|50.36|Inter-Quartile Range|||36.43|61.39|
4133989|NCT00896532|3958318|B3|||Serum Procollagen Type 1 N-telopeptide (P1NP)||μg/L|Median|48.78|48.78|Inter-Quartile Range|||42.45|66.98|
4133990|NCT00896532|3958319|B2|||Serum Procollagen Type 1 N-telopeptide (P1NP)||μg/L|Median|49.25|49.25|Inter-Quartile Range|||40.05|57.73|
4133991|NCT00896532|3958320|B1|||Serum Procollagen Type 1 N-telopeptide (P1NP)||μg/L|Median|47.76|47.76|Inter-Quartile Range|||37.92|59.12|
4133992|NCT00896532|3958312|B9|||Serum Type 1 Collagen C-telopeptide (CTX)||ng/L|Median|501.5|501.5|Inter-Quartile Range|||379.0|649.0|
4133993|NCT00896532|3958313|B8|||Serum Type 1 Collagen C-telopeptide (CTX)||ng/L|Median|519.0|519.0|Inter-Quartile Range|||405.0|642.0|
4133994|NCT00896532|3958314|B7|||Serum Type 1 Collagen C-telopeptide (CTX)||ng/L|Median|478.0|478.0|Inter-Quartile Range|||362.0|695.0|
4133995|NCT00896532|3958315|B6|||Serum Type 1 Collagen C-telopeptide (CTX)||ng/L|Median|532.0|532.0|Inter-Quartile Range|||363.0|621.5|
4133996|NCT00896532|3958316|B5|||Serum Type 1 Collagen C-telopeptide (CTX)||ng/L|Median|525.0|525.0|Inter-Quartile Range|||358.0|714.0|
4133997|NCT00896532|3958317|B4|||Serum Type 1 Collagen C-telopeptide (CTX)||ng/L|Median|486.0|486.0|Inter-Quartile Range|||374.0|627.0|
4133998|NCT00896532|3958318|B3|||Serum Type 1 Collagen C-telopeptide (CTX)||ng/L|Median|505.5|505.5|Inter-Quartile Range|||410.0|690.0|
4133999|NCT00896532|3958319|B2|||Serum Type 1 Collagen C-telopeptide (CTX)||ng/L|Median|494.0|494.0|Inter-Quartile Range|||373.0|614.0|
4134000|NCT00896532|3958320|B1|||Serum Type 1 Collagen C-telopeptide (CTX)||ng/L|Median|481.0|481.0|Inter-Quartile Range|||347.0|673.0|
4134001|NCT00896532|3958312|B9|||Distal 1/3 Radius BMD T-score||T-score|Mean|-2.01|-2.01|Standard Deviation|1.08|1.08|||
4134002|NCT00896532|3958313|B8|||Distal 1/3 Radius BMD T-score||T-score|Mean|-2.03|-2.03|Standard Deviation|0.99|0.99|||
4134003|NCT00896532|3958314|B7|||Distal 1/3 Radius BMD T-score||T-score|Mean|-1.98|-1.98|Standard Deviation|1.04|1.04|||
4134004|NCT00896532|3958315|B6|||Distal 1/3 Radius BMD T-score||T-score|Mean|-2.11|-2.11|Standard Deviation|1.12|1.12|||
4134005|NCT00896532|3958316|B5|||Distal 1/3 Radius BMD T-score||T-score|Mean|-2.24|-2.24|Standard Deviation|1.06|1.06|||
4134006|NCT00896532|3958317|B4|||Distal 1/3 Radius BMD T-score||T-score|Mean|-1.78|-1.78|Standard Deviation|1.14|1.14|||
4134007|NCT00896532|3958318|B3|||Distal 1/3 Radius BMD T-score||T-score|Mean|-2.05|-2.05|Standard Deviation|1.21|1.21|||
4134008|NCT00896532|3958319|B2|||Distal 1/3 Radius BMD T-score||T-score|Mean|-2.08|-2.08|Standard Deviation|0.99|0.99|||
4134094|NCT00896532|3958315|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4134009|NCT00896532|3958320|B1|||Distal 1/3 Radius BMD T-score||T-score|Mean|-1.85|-1.85|Standard Deviation|1.04|1.04|||
4134010|NCT00896532|3958312|B9|||Femoral Neck BMD T-score||T-score|Mean|-1.93|-1.93|Standard Deviation|0.59|0.59|||
4134011|NCT00896532|3958313|B8|||Femoral Neck BMD T-score||T-score|Mean|-1.87|-1.87|Standard Deviation|0.58|0.58|||
4134012|NCT00896532|3958314|B7|||Femoral Neck BMD T-score||T-score|Mean|-2.02|-2.02|Standard Deviation|0.57|0.57|||
4134013|NCT00896532|3958315|B6|||Femoral Neck BMD T-score||T-score|Mean|-2.03|-2.03|Standard Deviation|0.58|0.58|||
4134014|NCT00896532|3958316|B5|||Femoral Neck BMD T-score||T-score|Mean|-2.00|-2.0|Standard Deviation|0.54|0.54|||
4134015|NCT00896532|3958317|B4|||Femoral Neck BMD T-score||T-score|Mean|-2.06|-2.06|Standard Deviation|0.55|0.55|||
4134016|NCT00896532|3958318|B3|||Femoral Neck BMD T-score||T-score|Mean|-1.79|-1.79|Standard Deviation|0.67|0.67|||
4134017|NCT00896532|3958319|B2|||Femoral Neck BMD T-score||T-score|Mean|-1.91|-1.91|Standard Deviation|0.61|0.61|||
4134018|NCT00896532|3958320|B1|||Femoral Neck BMD T-score||T-score|Mean|-1.76|-1.76|Standard Deviation|0.56|0.56|||
4134019|NCT00896532|3958312|B9|||Total Hip BMD T-score||T-score|Mean|-1.53|-1.53|Standard Deviation|0.66|0.66|||
4134020|NCT00896532|3958313|B8|||Total Hip BMD T-score||T-score|Mean|-1.45|-1.45|Standard Deviation|0.65|0.65|||
4134021|NCT00896532|3958314|B7|||Total Hip BMD T-score||T-score|Mean|-1.65|-1.65|Standard Deviation|0.63|0.63|||
4134022|NCT00896532|3958315|B6|||Total Hip BMD T-score||T-score|Mean|-1.67|-1.67|Standard Deviation|0.65|0.65|||
4134023|NCT00896532|3958316|B5|||Total Hip BMD T-score||T-score|Mean|-1.58|-1.58|Standard Deviation|0.51|0.51|||
4134024|NCT00896532|3958317|B4|||Total Hip BMD T-score||T-score|Mean|-1.69|-1.69|Standard Deviation|0.67|0.67|||
4134025|NCT00896532|3958318|B3|||Total Hip BMD T-score||T-score|Mean|-1.32|-1.32|Standard Deviation|0.78|0.78|||
4134026|NCT00896532|3958319|B2|||Total Hip BMD T-score||T-score|Mean|-1.55|-1.55|Standard Deviation|0.68|0.68|||
4134027|NCT00896532|3958320|B1|||Total Hip BMD T-score||T-score|Mean|-1.35|-1.35|Standard Deviation|0.67|0.67|||
4134028|NCT00896532|3958312|B9|||Lumbar Spine Bone Mineral Density (BMD) T-score|The T-score is the bone mineral density (BMD) at the site when compared to that of a healthy thirty-year-old. A normal T-score is −1.0 or higher; Osteopenia is defined as between −1.0 and −2.5; Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a thirty-year-old man/woman.|T-score|Mean|-2.29|-2.29|Standard Deviation|0.68|0.68|||
4134029|NCT00896532|3958313|B8|||Lumbar Spine Bone Mineral Density (BMD) T-score|The T-score is the bone mineral density (BMD) at the site when compared to that of a healthy thirty-year-old. A normal T-score is −1.0 or higher; Osteopenia is defined as between −1.0 and −2.5; Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a thirty-year-old man/woman.|T-score|Mean|-2.33|-2.33|Standard Deviation|0.57|0.57|||
4134030|NCT00896532|3958314|B7|||Lumbar Spine Bone Mineral Density (BMD) T-score|The T-score is the bone mineral density (BMD) at the site when compared to that of a healthy thirty-year-old. A normal T-score is −1.0 or higher; Osteopenia is defined as between −1.0 and −2.5; Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a thirty-year-old man/woman.|T-score|Mean|-2.21|-2.21|Standard Deviation|0.69|0.69|||
4134031|NCT00896532|3958315|B6|||Lumbar Spine Bone Mineral Density (BMD) T-score|The T-score is the bone mineral density (BMD) at the site when compared to that of a healthy thirty-year-old. A normal T-score is −1.0 or higher; Osteopenia is defined as between −1.0 and −2.5; Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a thirty-year-old man/woman.|T-score|Mean|-2.27|-2.27|Standard Deviation|0.77|0.77|||
4134032|NCT00896532|3958316|B5|||Lumbar Spine Bone Mineral Density (BMD) T-score|The T-score is the bone mineral density (BMD) at the site when compared to that of a healthy thirty-year-old. A normal T-score is −1.0 or higher; Osteopenia is defined as between −1.0 and −2.5; Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a thirty-year-old man/woman.|T-score|Mean|-2.44|-2.44|Standard Deviation|0.70|0.7|||
4134033|NCT00896532|3958317|B4|||Lumbar Spine Bone Mineral Density (BMD) T-score|The T-score is the bone mineral density (BMD) at the site when compared to that of a healthy thirty-year-old. A normal T-score is −1.0 or higher; Osteopenia is defined as between −1.0 and −2.5; Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a thirty-year-old man/woman.|T-score|Mean|-2.35|-2.35|Standard Deviation|0.79|0.79|||
4134034|NCT00896532|3958318|B3|||Lumbar Spine Bone Mineral Density (BMD) T-score|The T-score is the bone mineral density (BMD) at the site when compared to that of a healthy thirty-year-old. A normal T-score is −1.0 or higher; Osteopenia is defined as between −1.0 and −2.5; Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a thirty-year-old man/woman.|T-score|Mean|-2.29|-2.29|Standard Deviation|0.57|0.57|||
4134035|NCT00896532|3958319|B2|||Lumbar Spine Bone Mineral Density (BMD) T-score|The T-score is the bone mineral density (BMD) at the site when compared to that of a healthy thirty-year-old. A normal T-score is −1.0 or higher; Osteopenia is defined as between −1.0 and −2.5; Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a thirty-year-old man/woman.|T-score|Mean|-2.08|-2.08|Standard Deviation|0.69|0.69|||
4134036|NCT00896532|3958320|B1|||Lumbar Spine Bone Mineral Density (BMD) T-score|The T-score is the bone mineral density (BMD) at the site when compared to that of a healthy thirty-year-old. A normal T-score is −1.0 or higher; Osteopenia is defined as between −1.0 and −2.5; Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a thirty-year-old man/woman.|T-score|Mean|-2.29|-2.29|Standard Deviation|0.66|0.66|||
4134037|NCT00896532|3958312|B9||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4134038|NCT00896532|3958313|B8||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4134039|NCT00896532|3958314|B7||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4134040|NCT00896532|3958315|B6||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4134041|NCT00896532|3958316|B5||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4134042|NCT00896532|3958317|B4||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4134043|NCT00896532|3958318|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4134044|NCT00896532|3958319|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4134045|NCT00896532|3958320|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4134046|NCT00896532|3958312|B9||Japanese|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4134047|NCT00896532|3958313|B8||Japanese|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4134048|NCT00896532|3958314|B7||Japanese|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4134049|NCT00896532|3958315|B6||Japanese|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4134050|NCT00896532|3958316|B5||Japanese|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4134051|NCT00896532|3958317|B4||Japanese|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4134052|NCT00896532|3958318|B3||Japanese|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4134053|NCT00896532|3958319|B2||Japanese|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4134054|NCT00896532|3958320|B1||Japanese|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4134055|NCT00896532|3958312|B9||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4134056|NCT00896532|3958313|B8||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4134057|NCT00896532|3958314|B7||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4134058|NCT00896532|3958315|B6||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4134059|NCT00896532|3958316|B5||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4134060|NCT00896532|3958317|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4134061|NCT00896532|3958318|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4134062|NCT00896532|3958319|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4134063|NCT00896532|3958320|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4134064|NCT00896532|3958312|B9||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
4134065|NCT00896532|3958313|B8||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4134066|NCT00896532|3958314|B7||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4134067|NCT00896532|3958315|B6||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4134068|NCT00896532|3958316|B5||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4134069|NCT00896532|3958317|B4||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4134070|NCT00896532|3958318|B3||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4134071|NCT00896532|3958319|B2||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4134072|NCT00896532|3958320|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4134073|NCT00896532|3958312|B9||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4134074|NCT00896532|3958313|B8||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4134075|NCT00896532|3958314|B7||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4134076|NCT00896532|3958315|B6||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4134077|NCT00896532|3958316|B5||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4134078|NCT00896532|3958317|B4||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4134079|NCT00896532|3958318|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4134080|NCT00896532|3958319|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4134081|NCT00896532|3958320|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4134082|NCT00896532|3958312|B9||White or Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|362|362.0||||||
4134083|NCT00896532|3958313|B8||White or Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
4134084|NCT00896532|3958314|B7||White or Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
4134085|NCT00896532|3958315|B6||White or Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
4134086|NCT00896532|3958316|B5||White or Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
4134087|NCT00896532|3958317|B4||White or Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
4134088|NCT00896532|3958318|B3||White or Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
4134089|NCT00896532|3958319|B2||White or Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
4134090|NCT00896532|3958320|B1||White or Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
4134091|NCT00896532|3958312|B9||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4134092|NCT00896532|3958313|B8||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4134095|NCT00896532|3958316|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4134096|NCT00896532|3958317|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4134097|NCT00896532|3958318|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4134098|NCT00896532|3958319|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4134099|NCT00896532|3958320|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4134100|NCT00896532|3958312|B9||Female|Sex: Female, Male||Participants|Count of Participants|419|419.0||||||
4134101|NCT00896532|3958313|B8||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4134102|NCT00896532|3958314|B7||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4134103|NCT00896532|3958315|B6||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4134104|NCT00896532|3958316|B5||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4134105|NCT00896532|3958317|B4||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4134106|NCT00896532|3958318|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4134107|NCT00896532|3958319|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4134108|NCT00896532|3958320|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4134109|NCT00896532|3958312|B9||≥ 65 years|Age, Customized||Participants|Count of Participants|265|265.0||||||
4134110|NCT00896532|3958313|B8||≥ 65 years|Age, Customized||Participants|Count of Participants|34|34.0||||||
4134111|NCT00896532|3958314|B7||≥ 65 years|Age, Customized||Participants|Count of Participants|29|29.0||||||
4134112|NCT00896532|3958315|B6||≥ 65 years|Age, Customized||Participants|Count of Participants|39|39.0||||||
4134113|NCT00896532|3958316|B5||≥ 65 years|Age, Customized||Participants|Count of Participants|34|34.0||||||
4134114|NCT00896532|3958317|B4||≥ 65 years|Age, Customized||Participants|Count of Participants|30|30.0||||||
4134115|NCT00896532|3958318|B3||≥ 65 years|Age, Customized||Participants|Count of Participants|34|34.0||||||
4134116|NCT00896532|3958319|B2||≥ 65 years|Age, Customized||Participants|Count of Participants|33|33.0||||||
4134117|NCT00896532|3958320|B1||≥ 65 years|Age, Customized||Participants|Count of Participants|32|32.0||||||
4134118|NCT00896532|3958312|B9||< 65 years|Age, Customized||Participants|Count of Participants|154|154.0||||||
4134119|NCT00896532|3958313|B8||< 65 years|Age, Customized||Participants|Count of Participants|18|18.0||||||
4134120|NCT00896532|3958314|B7||< 65 years|Age, Customized||Participants|Count of Participants|24|24.0||||||
4134121|NCT00896532|3958315|B6||< 65 years|Age, Customized||Participants|Count of Participants|12|12.0||||||
4134122|NCT00896532|3958316|B5||< 65 years|Age, Customized||Participants|Count of Participants|20|20.0||||||
4134123|NCT00896532|3958317|B4||< 65 years|Age, Customized||Participants|Count of Participants|21|21.0||||||
4134124|NCT00896532|3958318|B3||< 65 years|Age, Customized||Participants|Count of Participants|21|21.0||||||
4134125|NCT00896532|3958319|B2||< 65 years|Age, Customized||Participants|Count of Participants|18|18.0||||||
4134126|NCT00896532|3958320|B1||< 65 years|Age, Customized||Participants|Count of Participants|20|20.0||||||
4134127|NCT00896532|3958312|B9|||Age||years|Mean|66.8|66.8|Standard Deviation|6.4|6.4|||
4134128|NCT00896532|3958313|B8|||Age||years|Mean|66.3|66.3|Standard Deviation|6.5|6.5|||
4134129|NCT00896532|3958314|B7|||Age||years|Mean|66.1|66.1|Standard Deviation|7.3|7.3|||
4134130|NCT00896532|3958315|B6|||Age||years|Mean|67.8|67.8|Standard Deviation|6.2|6.2|||
4134131|NCT00896532|3958316|B5|||Age||years|Mean|67.3|67.3|Standard Deviation|6.7|6.7|||
4134132|NCT00896532|3958317|B4|||Age||years|Mean|65.8|65.8|Standard Deviation|6.1|6.1|||
4134133|NCT00896532|3958318|B3|||Age||years|Mean|66.8|66.8|Standard Deviation|5.7|5.7|||
4134134|NCT00896532|3958319|B2|||Age||years|Mean|67.1|67.1|Standard Deviation|5.8|5.8|||
4134135|NCT00896532|3958320|B1|||Age||years|Mean|67.0|67.0|Standard Deviation|6.5|6.5|||
4134136|NCT00896454|3958469|B1|||Calcium (corrected)||mg/dL|Mean|13.89|13.89|Standard Deviation|1.27|1.27|||
4134137|NCT00896454|3958469|B1|Weight loss||Baseline Hypercalcemia of Malignancy (HCM) Symptoms|Participants may have had more than one symptom|participants|Number|1|1.0||||||
4134138|NCT00896454|3958469|B1|Urinary frequency||Baseline Hypercalcemia of Malignancy (HCM) Symptoms|Participants may have had more than one symptom|participants|Number|1|1.0||||||
4134139|NCT00896454|3958469|B1|Retching||Baseline Hypercalcemia of Malignancy (HCM) Symptoms|Participants may have had more than one symptom|participants|Number|1|1.0||||||
4134140|NCT00896454|3958469|B1|Psychomotor retardation||Baseline Hypercalcemia of Malignancy (HCM) Symptoms|Participants may have had more than one symptom|participants|Number|1|1.0||||||
4134141|NCT00896454|3958469|B1|Polyuro-polydipsic syndrome||Baseline Hypercalcemia of Malignancy (HCM) Symptoms|Participants may have had more than one symptom|participants|Number|1|1.0||||||
4134142|NCT00896454|3958469|B1|Listlessness/muscle weakness||Baseline Hypercalcemia of Malignancy (HCM) Symptoms|Participants may have had more than one symptom|participants|Number|1|1.0||||||
4134143|NCT00896454|3958469|B1|Light headedness (dizziness)||Baseline Hypercalcemia of Malignancy (HCM) Symptoms|Participants may have had more than one symptom|participants|Number|1|1.0||||||
4134144|NCT00896454|3958469|B1|Insomnolence||Baseline Hypercalcemia of Malignancy (HCM) Symptoms|Participants may have had more than one symptom|participants|Number|1|1.0||||||
4134145|NCT00896454|3958469|B1|General weakness||Baseline Hypercalcemia of Malignancy (HCM) Symptoms|Participants may have had more than one symptom|participants|Number|1|1.0||||||
4134146|NCT00896454|3958469|B1|Dyspnea||Baseline Hypercalcemia of Malignancy (HCM) Symptoms|Participants may have had more than one symptom|participants|Number|1|1.0||||||
4134147|NCT00896454|3958469|B1|Decreased mental acuity||Baseline Hypercalcemia of Malignancy (HCM) Symptoms|Participants may have had more than one symptom|participants|Number|1|1.0||||||
4134148|NCT00896454|3958469|B1|Abdominal pain||Baseline Hypercalcemia of Malignancy (HCM) Symptoms|Participants may have had more than one symptom|participants|Number|1|1.0||||||
4134149|NCT00896454|3958469|B1|Polyuria||Baseline Hypercalcemia of Malignancy (HCM) Symptoms|Participants may have had more than one symptom|participants|Number|2|2.0||||||
4134150|NCT00896454|3958469|B1|Confusion||Baseline Hypercalcemia of Malignancy (HCM) Symptoms|Participants may have had more than one symptom|participants|Number|3|3.0||||||
4134151|NCT00896454|3958469|B1|Lethargy||Baseline Hypercalcemia of Malignancy (HCM) Symptoms|Participants may have had more than one symptom|participants|Number|4|4.0||||||
4134152|NCT00896454|3958469|B1|Constipation||Baseline Hypercalcemia of Malignancy (HCM) Symptoms|Participants may have had more than one symptom|participants|Number|4|4.0||||||
4134153|NCT00896454|3958469|B1|Dry mouth||Baseline Hypercalcemia of Malignancy (HCM) Symptoms|Participants may have had more than one symptom|participants|Number|1|1.0||||||
4134154|NCT00896454|3958469|B1|Vomiting||Baseline Hypercalcemia of Malignancy (HCM) Symptoms|Participants may have had more than one symptom|participants|Number|2|2.0||||||
4134155|NCT00896454|3958469|B1|Depressed level of consciousness||Baseline Hypercalcemia of Malignancy (HCM) Symptoms|Participants may have had more than one symptom|participants|Number|2|2.0||||||
4134156|NCT00896454|3958469|B1|Nausea||Baseline Hypercalcemia of Malignancy (HCM) Symptoms|Participants may have had more than one symptom|participants|Number|4|4.0||||||
4134157|NCT00896454|3958469|B1|Anorexia||Baseline Hypercalcemia of Malignancy (HCM) Symptoms|Participants may have had more than one symptom|participants|Number|5|5.0||||||
4134158|NCT00896454|3958469|B1|Fatigue||Baseline Hypercalcemia of Malignancy (HCM) Symptoms|Participants may have had more than one symptom|participants|Number|9|9.0||||||
4134159|NCT00896454|3958469|B1|No||Presence of bone metastatic disease at enrollment||participants|Number|20|20.0||||||
4134160|NCT00896454|3958469|B1|Yes||Presence of bone metastatic disease at enrollment||participants|Number|13|13.0||||||
4134161|NCT00896454|3958469|B1|No||Presence of metastatic disease at enrollment||participants|Number|3|3.0||||||
4134162|NCT00896454|3958469|B1|Yes||Presence of metastatic disease at enrollment||participants|Number|30|30.0||||||
4134163|NCT00896454|3958469|B1|||Time from initial cancer diagnosis to enrollment||months|Mean|56.9|56.9|Standard Deviation|68.8|68.8|||
4134164|NCT00896454|3958469|B1|Myeloma||Primary Tumor Type||participants|Number|1|1.0||||||
4134165|NCT00896454|3958469|B1|IGG kappa multiple myeloma||Primary Tumor Type||participants|Number|1|1.0||||||
4134166|NCT00896454|3958469|B1|Chronic lymphocytic leukemia||Primary Tumor Type||participants|Number|2|2.0||||||
4134167|NCT00896454|3958469|B1|Multiple myeloma||Primary Tumor Type||participants|Number|3|3.0||||||
4134168|NCT00896454|3958469|B1|Unknown (primary tumor)||Primary Tumor Type||participants|Number|1|1.0||||||
4134169|NCT00896454|3958469|B1|Soft tissue sarcoma||Primary Tumor Type||participants|Number|1|1.0||||||
4134170|NCT00896454|3958469|B1|Small cell lung cancer||Primary Tumor Type||participants|Number|1|1.0||||||
4134171|NCT00896454|3958469|B1|Renal||Primary Tumor Type||participants|Number|3|3.0||||||
4134172|NCT00896454|3958469|B1|Ovarian||Primary Tumor Type||participants|Number|1|1.0||||||
4134173|NCT00896454|3958469|B1|Non-small cell lung cancer||Primary Tumor Type||participants|Number|3|3.0||||||
4134174|NCT00896454|3958469|B1|Non-hodgkin's||Primary Tumor Type||participants|Number|2|2.0||||||
4134175|NCT00896454|3958469|B1|Neuroendocrine/carcinoid||Primary Tumor Type||participants|Number|4|4.0||||||
4134176|NCT00896454|3958469|B1|Liver||Primary Tumor Type||participants|Number|1|1.0||||||
4134177|NCT00896454|3958469|B1|Head and neck||Primary Tumor Type||participants|Number|2|2.0||||||
4134178|NCT00896454|3958469|B1|Breast||Primary Tumor Type||participants|Number|6|6.0||||||
4134179|NCT00896454|3958469|B1|Bladder||Primary Tumor Type||participants|Number|1|1.0||||||
4134180|NCT00896454|3958469|B1|4||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|3|3.0||||||
4134181|NCT00896454|3958469|B1|3||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|8|8.0||||||
4134182|NCT00896454|3958469|B1|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|14|14.0||||||
4134183|NCT00896454|3958469|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|7|7.0||||||
4134238|NCT00896363|3958507|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134336|NCT00896051|3958703|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4134184|NCT00896454|3958469|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|1|1.0||||||
4134185|NCT00896454|3958469|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4134186|NCT00896454|3958469|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4134187|NCT00896454|3958469|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4134188|NCT00896454|3958469|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4134189|NCT00896454|3958469|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4134190|NCT00896454|3958469|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4134191|NCT00896454|3958469|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4134192|NCT00896454|3958469|B1|||Age||years|Mean|60.3|60.3|Standard Deviation|14.8|14.8|||
4134193|NCT00896441|3958481|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4134194|NCT00896441|3958482|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4134195|NCT00896441|3958483|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4134196|NCT00896441|3958481|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4134197|NCT00896441|3958482|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4134198|NCT00896441|3958483|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4134199|NCT00896441|3958481|B3|||Age||years|Mean|36.50|36.5|Standard Deviation|12.6|12.6|||
4134200|NCT00896441|3958482|B2|||Age||years|Mean|31.92|31.92|Standard Deviation|11.2|11.2|||
4134201|NCT00896441|3958483|B1|||Age||years|Mean|40.00|40.0|Standard Deviation|12.6|12.6|||
4134202|NCT00896389|3958491|B1|||creatinine||mg/dL|Mean|0.74|0.74|Standard Deviation|0.12|0.12|||
4134203|NCT00896389|3958491|B1|||BMI||kg/m2|Mean|26.1|26.1|Standard Deviation|2.8|2.8|||
4134204|NCT00896389|3958491|B1|HCTZ||Diastolic blood pressure||mmHg|Mean|80|80.0|Standard Deviation|7|7.0|||
4134205|NCT00896389|3958491|B1|Salt Loading||Diastolic blood pressure||mmHg|Mean|71|71.0|Standard Deviation|7|7.0|||
4134206|NCT00896389|3958491|B1|HCTZ||Systolic blood pressure||mmHg|Mean|126|126.0|Standard Deviation|10|10.0|||
4134207|NCT00896389|3958491|B1|Salt loading||Systolic blood pressure||mmHg|Mean|114|114.0|Standard Deviation|11|11.0|||
4134208|NCT00896389|3958491|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4134209|NCT00896389|3958491|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4134210|NCT00896389|3958491|B1|saline infusion and HCTZ||Age||years|Mean|53|53.0|Standard Deviation|9|9.0|||
4134211|NCT00896389|3958491|B1|Saline infusion only||Age||years|Mean|50|50.0|Standard Deviation|7|7.0|||
4134212|NCT00896363|3958505|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134213|NCT00896363|3958506|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134214|NCT00896363|3958507|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134215|NCT00896363|3958508|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134216|NCT00896363|3958505|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134217|NCT00896363|3958506|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134218|NCT00896363|3958507|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134219|NCT00896363|3958508|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134220|NCT00896363|3958505|B4||White|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
4134221|NCT00896363|3958506|B3||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4134222|NCT00896363|3958507|B2||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4134223|NCT00896363|3958508|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4134224|NCT00896363|3958505|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134225|NCT00896363|3958506|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134226|NCT00896363|3958507|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134227|NCT00896363|3958508|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134228|NCT00896363|3958505|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134229|NCT00896363|3958506|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134230|NCT00896363|3958507|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134231|NCT00896363|3958508|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134232|NCT00896363|3958505|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4134233|NCT00896363|3958506|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134234|NCT00896363|3958507|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134235|NCT00896363|3958508|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4134236|NCT00896363|3958505|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134237|NCT00896363|3958506|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134239|NCT00896363|3958508|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134240|NCT00896363|3958505|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4134241|NCT00896363|3958506|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4134242|NCT00896363|3958507|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4134243|NCT00896363|3958508|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4134244|NCT00896363|3958505|B4||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4134245|NCT00896363|3958506|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4134246|NCT00896363|3958507|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4134247|NCT00896363|3958508|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4134248|NCT00896363|3958505|B4|||Age||Years|Mean|43.4|43.4|Standard Deviation|12.60|12.6|||
4134249|NCT00896363|3958506|B3|||Age||Years|Mean|47.3|47.3|Standard Deviation|10.84|10.84|||
4134250|NCT00896363|3958507|B2|||Age||Years|Mean|42.2|42.2|Standard Deviation|14.57|14.57|||
4134251|NCT00896363|3958508|B1|||Age||Years|Mean|40.7|40.7|Standard Deviation|11.12|11.12|||
4134252|NCT00896337|3958562|B1|Aneurysm||Lesion Characteristics|These data are reported per lesion. A participant could have more than one lesion; therefore, the number of lesions reported for this baseline measure does not equal the total number of participants in the group. The same participant’s lesion may also be included in more than one category or not all participants may contribute to a category.|Lesions|Number|10|10.0||||||
4134253|NCT00896337|3958562|B1|Total Occlusion||Lesion Characteristics|These data are reported per lesion. A participant could have more than one lesion; therefore, the number of lesions reported for this baseline measure does not equal the total number of participants in the group. The same participant’s lesion may also be included in more than one category or not all participants may contribute to a category.|Lesions|Number|26|26.0||||||
4134254|NCT00896337|3958562|B1|Ulcerated||Lesion Characteristics|These data are reported per lesion. A participant could have more than one lesion; therefore, the number of lesions reported for this baseline measure does not equal the total number of participants in the group. The same participant’s lesion may also be included in more than one category or not all participants may contribute to a category.|Lesions|Number|29|29.0||||||
4134255|NCT00896337|3958562|B1|Calcification, Severe||Lesion Characteristics|These data are reported per lesion. A participant could have more than one lesion; therefore, the number of lesions reported for this baseline measure does not equal the total number of participants in the group. The same participant’s lesion may also be included in more than one category or not all participants may contribute to a category.|Lesions|Number|78|78.0||||||
4134256|NCT00896337|3958562|B1|Calcification, Moderate||Lesion Characteristics|These data are reported per lesion. A participant could have more than one lesion; therefore, the number of lesions reported for this baseline measure does not equal the total number of participants in the group. The same participant’s lesion may also be included in more than one category or not all participants may contribute to a category.|Lesions|Number|45|45.0||||||
4134257|NCT00896337|3958562|B1|Calcification, Non/Mild||Lesion Characteristics|These data are reported per lesion. A participant could have more than one lesion; therefore, the number of lesions reported for this baseline measure does not equal the total number of participants in the group. The same participant’s lesion may also be included in more than one category or not all participants may contribute to a category.|Lesions|Number|37|37.0||||||
4134258|NCT00896337|3958562|B1|Thrombus||Lesion Characteristics|These data are reported per lesion. A participant could have more than one lesion; therefore, the number of lesions reported for this baseline measure does not equal the total number of participants in the group. The same participant’s lesion may also be included in more than one category or not all participants may contribute to a category.|Lesions|Number|0|0.0||||||
4134259|NCT00896337|3958562|B1|> 90 Degree Bend||Lesion Characteristics|These data are reported per lesion. A participant could have more than one lesion; therefore, the number of lesions reported for this baseline measure does not equal the total number of participants in the group. The same participant’s lesion may also be included in more than one category or not all participants may contribute to a category.|Lesions|Number|0|0.0||||||
4134260|NCT00896337|3958562|B1|> 45 Degree Bend||Lesion Characteristics|These data are reported per lesion. A participant could have more than one lesion; therefore, the number of lesions reported for this baseline measure does not equal the total number of participants in the group. The same participant’s lesion may also be included in more than one category or not all participants may contribute to a category.|Lesions|Number|1|1.0||||||
4134261|NCT00896337|3958562|B1|Eccentric Lesion||Lesion Characteristics|These data are reported per lesion. A participant could have more than one lesion; therefore, the number of lesions reported for this baseline measure does not equal the total number of participants in the group. The same participant’s lesion may also be included in more than one category or not all participants may contribute to a category.|Lesions|Number|88|88.0||||||
4134262|NCT00896337|3958562|B1|Concentric Lesion||Lesion Characteristics|These data are reported per lesion. A participant could have more than one lesion; therefore, the number of lesions reported for this baseline measure does not equal the total number of participants in the group. The same participant’s lesion may also be included in more than one category or not all participants may contribute to a category.|Lesions|Number|72|72.0||||||
4134263|NCT00896337|3958562|B1|||Lesion Characteristic: Diameter Stenosis|These data are reported per lesion. A participant could have more than one lesion, therefore, the number of lesions reported for this baseline measure does not equal the total number of participants in the group.|percent|Mean|71.51|71.51|Standard Deviation|16.27|16.27|||
4134264|NCT00896337|3958562|B1|Lesion Length||Lesion Characteristics: Size|These data are reported per lesion.|millimeters|Mean|31.04|31.04|Standard Deviation|22.13|22.13|||
4134265|NCT00896337|3958562|B1|Minimum Lumen Diameter||Lesion Characteristics: Size|These data are reported per lesion.|millimeters|Mean|2.20|2.2|Standard Deviation|1.34|1.34|||
4134266|NCT00896337|3958562|B1|Reference Vessel Diameter||Lesion Characteristics: Size|These data are reported per lesion.|millimeters|Mean|7.69|7.69|Standard Deviation|1.79|1.79|||
4134335|NCT00896051|3958702|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4134267|NCT00896337|3958562|B1|Distal||Lesion Characteristic: Lesion Location|These data are reported per lesion. A participant could have more than one lesion, therefore, the number of lesions reported for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|13|13.0||||||
4134268|NCT00896337|3958562|B1|Mid||Lesion Characteristic: Lesion Location|These data are reported per lesion. A participant could have more than one lesion, therefore, the number of lesions reported for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|12|12.0||||||
4134269|NCT00896337|3958562|B1|Proximal||Lesion Characteristic: Lesion Location|These data are reported per lesion. A participant could have more than one lesion, therefore, the number of lesions reported for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|35|35.0||||||
4134270|NCT00896337|3958562|B1|Ostial||Lesion Characteristic: Lesion Location|These data are reported per lesion. A participant could have more than one lesion, therefore, the number of lesions reported for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|100|100.0||||||
4134271|NCT00896337|3958562|B1|Right External Iliac Artery||Lesion Characteristic: Target Lesion Vessel|These data are reported per lesion. A participant could have more than one lesion, therefore, the number of lesions reported for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|28|28.0||||||
4134272|NCT00896337|3958562|B1|Right Common Iliac Artery||Lesion Characteristic: Target Lesion Vessel|These data are reported per lesion. A participant could have more than one lesion, therefore, the number of lesions reported for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|58|58.0||||||
4134273|NCT00896337|3958562|B1|Left External Iliac Artery||Lesion Characteristic: Target Lesion Vessel|These data are reported per lesion. A participant could have more than one lesion, therefore, the number of lesions reported for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|16|16.0||||||
4134274|NCT00896337|3958562|B1|Left Common Iliac Artery||Lesion Characteristic: Target Lesion Vessel|These data are reported per lesion. A participant could have more than one lesion, therefore, the number of lesions reported for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|58|58.0||||||
4134275|NCT00896337|3958562|B1|History of Renal Percutaneous Intervention||Neurologic/Renal History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|6|6.0||||||
4134276|NCT00896337|3958562|B1|History of Renal Insufficiency||Neurologic/Renal History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|9|9.0||||||
4134277|NCT00896337|3958562|B1|History of Cerebrovascular Accident||Neurologic/Renal History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|7|7.0||||||
4134278|NCT00896337|3958562|B1|History of Transient Ischemic Attack||Neurologic/Renal History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|5|5.0||||||
4134279|NCT00896337|3958562|B1|History of Claudication||Peripheral Vascular History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|116|116.0||||||
4134280|NCT00896337|3958562|B1|History of Other Peripheral Endovascular Intervent||Peripheral Vascular History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|25|25.0||||||
4134281|NCT00896337|3958562|B1|History of Peripheral Vascular Surgery||Peripheral Vascular History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|10|10.0||||||
4134282|NCT00896337|3958562|B1|Previous Coronary Artery Bypass Graft||Cardiac History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|22|22.0||||||
4134283|NCT00896337|3958562|B1|Previous Percutaneous Coronary Intervention||Cardiac History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|46|46.0||||||
4134284|NCT00896337|3958562|B1|Silent Ischemia||Cardiac History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|0|0.0||||||
4134285|NCT00896337|3958562|B1|Unstable Angina||Cardiac History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|1|1.0||||||
4134286|NCT00896337|3958562|B1|Stable Angina||Cardiac History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|15|15.0||||||
4134287|NCT00896337|3958562|B1|History of Congestive Heart Failure||Cardiac History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|10|10.0||||||
4134288|NCT00896337|3958562|B1|History of Myocardial Infarction||Cardiac History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|36|36.0||||||
4134289|NCT00896337|3958562|B1|History of Coronary Artery Disease||Cardiac History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|73|73.0||||||
4134290|NCT00896337|3958562|B1|History of Chronic Obstructive Pulmonary Disease||General Medical History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|31|31.0||||||
4134291|NCT00896337|3958562|B1|Hypertension Requiring Medication||General Medical History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|95|95.0||||||
4134292|NCT00896337|3958562|B1|Hyperlipidemia Requiring Medication||General Medical History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|98|98.0||||||
4134293|NCT00896337|3958562|B1|Medically Treated Diabetes||General Medical History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|42|42.0||||||
4134294|NCT00896337|3958562|B1|Smoking, Ever||General Medical History|The same participant may be included in more than one category or not all participants may contribute to a category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|121|121.0||||||
4134295|NCT00896337|3958562|B1|United States||Region of Enrollment||participants|Number|125|125.0||||||
4134296|NCT00896337|3958562|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4134297|NCT00896337|3958562|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4134298|NCT00896337|3958562|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4134299|NCT00896337|3958562|B1|Black of African heritage||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4134300|NCT00896337|3958562|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|112|112.0||||||
4134301|NCT00896337|3958562|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4134302|NCT00896337|3958562|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4134303|NCT00896337|3958562|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4134304|NCT00896337|3958562|B1|||Age||years|Mean|61.1|61.1|Standard Deviation|9.3|9.3|||
4134305|NCT00896337|3958562|B1||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
4134306|NCT00896337|3958562|B1||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4134307|NCT00896337|3958562|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4134308|NCT00896233|3958629|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4134309|NCT00896233|3958629|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4134310|NCT00896233|3958629|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|12.9|12.9|||
4134311|NCT00896168|3958640|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4134312|NCT00896168|3958641|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4134313|NCT00896168|3958642|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4134314|NCT00896168|3958640|B3||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4134315|NCT00896168|3958641|B2||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4134316|NCT00896168|3958642|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4134317|NCT00896168|3958640|B3|||Age||Years|Mean|44.92|44.92|Standard Deviation|11.84|11.84|||
4134318|NCT00896168|3958641|B2|||Age||Years|Mean|46.62|46.62|Standard Deviation|11.39|11.39|||
4134319|NCT00896168|3958642|B1|||Age||Years|Mean|42.83|42.83|Standard Deviation|12.05|12.05|||
4134320|NCT00896064|3958671|B3|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
4134321|NCT00896064|3958672|B2|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
4134322|NCT00896064|3958673|B1|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
4134323|NCT00896064|3958671|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4134324|NCT00896064|3958672|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4134325|NCT00896064|3958673|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4134326|NCT00896064|3958671|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4134327|NCT00896064|3958672|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4134328|NCT00896064|3958673|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4134329|NCT00896064|3958671|B3|||Age||Years|Mean|25.33|25.33|Standard Deviation|4.64|4.64|||
4134330|NCT00896064|3958672|B2|||Age||Years|Mean|23.9|23.9|Standard Deviation|4.11|4.11|||
4134331|NCT00896064|3958673|B1|||Age||Years|Mean|26.7|26.7|Standard Deviation|4.80|4.8|||
4134332|NCT00896051|3958702|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4134333|NCT00896051|3958703|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4134334|NCT00896051|3958704|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4134337|NCT00896051|3958704|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4134338|NCT00896051|3958702|B3|||Age||years|Mean|40.5|40.5|Standard Deviation|9.85|9.85|||
4134339|NCT00896051|3958703|B2|||Age||years|Mean|39.8|39.8|Standard Deviation|9.37|9.37|||
4134340|NCT00896051|3958704|B1|||Age||years|Mean|41.2|41.2|Standard Deviation|10.44|10.44|||
4134341|NCT00896051|3958702|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4134342|NCT00896051|3958703|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4134343|NCT00896051|3958704|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4134344|NCT00896051|3958702|B3||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4134345|NCT00896051|3958703|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4134346|NCT00896051|3958704|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4134347|NCT00896051|3958702|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4134348|NCT00896051|3958703|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4134349|NCT00896051|3958704|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4134350|NCT00896038|3958745|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4134351|NCT00896038|3958746|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4134352|NCT00896038|3958747|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134353|NCT00896038|3958745|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134354|NCT00896038|3958746|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134355|NCT00896038|3958747|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134356|NCT00896038|3958745|B3||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4134357|NCT00896038|3958746|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4134358|NCT00896038|3958747|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4134359|NCT00896038|3958745|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4134360|NCT00896038|3958746|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4134361|NCT00896038|3958747|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4134362|NCT00896038|3958745|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134363|NCT00896038|3958746|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134364|NCT00896038|3958747|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134365|NCT00896038|3958745|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134366|NCT00896038|3958746|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134367|NCT00896038|3958747|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134368|NCT00896038|3958745|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4134369|NCT00896038|3958746|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4134370|NCT00896038|3958747|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134371|NCT00896038|3958745|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134372|NCT00896038|3958746|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134373|NCT00896038|3958747|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134374|NCT00896038|3958745|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4134375|NCT00896038|3958746|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4134376|NCT00896038|3958747|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4134377|NCT00896038|3958745|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4134378|NCT00896038|3958746|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4134379|NCT00896038|3958747|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134380|NCT00896038|3958745|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4134381|NCT00896038|3958746|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4134382|NCT00896038|3958747|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4134383|NCT00896038|3958745|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4134384|NCT00896038|3958746|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4134385|NCT00896038|3958747|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4134386|NCT00896038|3958745|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4134387|NCT00896038|3958746|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4134388|NCT00896038|3958747|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4134389|NCT00896038|3958745|B3||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4134390|NCT00896038|3958746|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4134391|NCT00896038|3958747|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4134392|NCT00896038|3958745|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4134393|NCT00896038|3958746|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4134394|NCT00896038|3958747|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4134395|NCT00896025|3958786|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4134396|NCT00896025|3958786|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4134397|NCT00896025|3958786|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4134398|NCT00896025|3958786|B1|||Age||years|Median|46|46.0|Full Range|||23.0|67.0|
4134399|NCT00896025|3958786|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4134400|NCT00896025|3958786|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4134401|NCT00896025|3958786|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4134402|NCT00895947|3958790|B3|Australia||Region of Enrollment||participants|Number|200|200.0||||||
4134403|NCT00895947|3958791|B2|Australia||Region of Enrollment||participants|Number|100|100.0||||||
4134404|NCT00895947|3958792|B1|Australia||Region of Enrollment||participants|Number|100|100.0||||||
4134405|NCT00895947|3958790|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4134406|NCT00895947|3958791|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4134407|NCT00895947|3958792|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4134408|NCT00895947|3958790|B3||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4134409|NCT00895947|3958791|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4134410|NCT00895947|3958792|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4134411|NCT00895947|3958790|B3|||Age||years|Mean|46.2|46.2|Standard Deviation|14.2|14.2|||
4134412|NCT00895947|3958791|B2|||Age||years|Mean|47.3|47.3|Standard Deviation|13.2|13.2|||
4134413|NCT00895947|3958792|B1|||Age||years|Mean|45.0|45.0|Standard Deviation|14.4|14.4|||
4134414|NCT00895947|3958790|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4134415|NCT00895947|3958791|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4134416|NCT00895947|3958792|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4134417|NCT00895947|3958790|B3||Between 18 and 65 years|Age||Participants|Count of Participants|186|186.0||||||
4134418|NCT00895947|3958791|B2||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
4134419|NCT00895947|3958792|B1||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
4134420|NCT00895947|3958790|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4134421|NCT00895947|3958791|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4134422|NCT00895947|3958792|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4134423|NCT00895934|3958809|B3|United States||Region of Enrollment||participants|Number|53|53.0||||||
4134424|NCT00895934|3958810|B2|United States||Region of Enrollment||participants|Number|43|43.0||||||
4134425|NCT00895934|3958811|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4134426|NCT00895934|3958809|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4134427|NCT00895934|3958810|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4134428|NCT00895934|3958811|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134429|NCT00895934|3958809|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4134430|NCT00895934|3958810|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4134431|NCT00895934|3958811|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4134432|NCT00895934|3958809|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4134433|NCT00895934|3958810|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4134434|NCT00895934|3958811|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4134435|NCT00895934|3958809|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4134436|NCT00895934|3958810|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4134437|NCT00895934|3958811|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134438|NCT00895934|3958809|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134439|NCT00895934|3958810|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134440|NCT00895934|3958811|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134441|NCT00895934|3958809|B3||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4134442|NCT00895934|3958810|B2||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4134443|NCT00895934|3958811|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4134444|NCT00895934|3958809|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4134445|NCT00895934|3958810|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4134446|NCT00895934|3958811|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134447|NCT00895934|3958809|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134448|NCT00895934|3958810|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134449|NCT00895934|3958811|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134450|NCT00895934|3958809|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4134451|NCT00895934|3958810|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4134452|NCT00895934|3958811|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134453|NCT00895934|3958809|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4134454|NCT00895934|3958810|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134455|NCT00895934|3958811|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4134456|NCT00895934|3958809|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4134457|NCT00895934|3958810|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4134458|NCT00895934|3958811|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4134459|NCT00895934|3958809|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4134460|NCT00895934|3958810|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4134461|NCT00895934|3958811|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4134462|NCT00895934|3958809|B3||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4134463|NCT00895934|3958810|B2||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4134464|NCT00895934|3958811|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4134465|NCT00895934|3958809|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4134466|NCT00895934|3958810|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4134467|NCT00895934|3958811|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4134468|NCT00895934|3958809|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4134469|NCT00895934|3958810|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4134470|NCT00895934|3958811|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4134471|NCT00895895|3958818|B6||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4134472|NCT00895895|3958819|B5||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4134473|NCT00895895|3958820|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4134474|NCT00895895|3958821|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4134475|NCT00895895|3958822|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4134476|NCT00895895|3958823|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4134477|NCT00895895|3958818|B6||Female|Sex: Female, Male||Participants|Count of Participants|356|356.0||||||
4134478|NCT00895895|3958819|B5||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4134479|NCT00895895|3958820|B4||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4134480|NCT00895895|3958821|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4134481|NCT00895895|3958822|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4134482|NCT00895895|3958823|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4134483|NCT00895895|3958818|B6|greater than 80 years||Age, Customized||participants|Number|117|117.0||||||
4134484|NCT00895895|3958819|B5|greater than 80 years||Age, Customized||participants|Number|18|18.0||||||
4134485|NCT00895895|3958820|B4|greater than 80 years||Age, Customized||participants|Number|19|19.0||||||
4134486|NCT00895895|3958821|B3|greater than 80 years||Age, Customized||participants|Number|30|30.0||||||
4134487|NCT00895895|3958822|B2|greater than 80 years||Age, Customized||participants|Number|25|25.0||||||
4134488|NCT00895895|3958823|B1|greater than 80 years||Age, Customized||participants|Number|25|25.0||||||
4134489|NCT00895895|3958818|B6|66 to 80 years||Age, Customized||participants|Number|305|305.0||||||
4134490|NCT00895895|3958819|B5|66 to 80 years||Age, Customized||participants|Number|66|66.0||||||
4134491|NCT00895895|3958820|B4|66 to 80 years||Age, Customized||participants|Number|66|66.0||||||
4134492|NCT00895895|3958821|B3|66 to 80 years||Age, Customized||participants|Number|54|54.0||||||
4134493|NCT00895895|3958822|B2|66 to 80 years||Age, Customized||participants|Number|60|60.0||||||
4134494|NCT00895895|3958823|B1|66 to 80 years||Age, Customized||participants|Number|59|59.0||||||
4134495|NCT00895895|3958818|B6|50 to 65 years||Age, Customized||participants|Number|96|96.0||||||
4134496|NCT00895895|3958819|B5|50 to 65 years||Age, Customized||participants|Number|20|20.0||||||
4134497|NCT00895895|3958820|B4|50 to 65 years||Age, Customized||participants|Number|18|18.0||||||
4134498|NCT00895895|3958821|B3|50 to 65 years||Age, Customized||participants|Number|19|19.0||||||
4134499|NCT00895895|3958822|B2|50 to 65 years||Age, Customized||participants|Number|17|17.0||||||
4134500|NCT00895895|3958823|B1|50 to 65 years||Age, Customized||participants|Number|22|22.0||||||
4134501|NCT00895843|3958939|B3|United Kingdom||Region of Enrollment||participants|Number|122.0|122.0||||||
4134502|NCT00895843|3958940|B2|United Kingdom||Region of Enrollment||participants|Number|62|62.0||||||
4134503|NCT00895843|3958941|B1|United Kingdom||Region of Enrollment||participants|Number|60|60.0||||||
4134504|NCT00895843|3958939|B3||Male|Sex: Female, Male||Participants|Count of Participants|66.0|66.0||||||
4134505|NCT00895843|3958940|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4134506|NCT00895843|3958941|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4134507|NCT00895843|3958939|B3||Female|Sex: Female, Male||Participants|Count of Participants|56.0|56.0||||||
4134508|NCT00895843|3958940|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4134509|NCT00895843|3958941|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4134510|NCT00895843|3958939|B3|||Age||years|Mean|28.77|28.77|Standard Deviation|6.013|6.013|||
4134511|NCT00895843|3958940|B2|||Age||years|Mean|28.82|28.82|Standard Deviation|6.262|6.262|||
4134512|NCT00895843|3958941|B1|||Age||years|Mean|28.71|28.71|Standard Deviation|5.809|5.809|||
4134513|NCT00895843|3958939|B3||>=65 years|Age||Participants|Count of Participants|0.0|0.0||||||
4134514|NCT00895843|3958940|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4134515|NCT00895843|3958941|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4134516|NCT00895843|3958939|B3||Between 18 and 65 years|Age||Participants|Count of Participants|122.0|122.0||||||
4134517|NCT00895843|3958940|B2||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4134518|NCT00895843|3958941|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4134519|NCT00895843|3958939|B3||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4134520|NCT00895843|3958940|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4134521|NCT00895843|3958941|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4134522|NCT00895830|3958948|B6|Switzerland||Region of Enrollment||participants|Number|3|3.0||||||
4134523|NCT00895830|3958949|B5|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4134524|NCT00895830|3958950|B4|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4134525|NCT00895830|3958951|B3|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
4134526|NCT00895830|3958952|B2|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
4134527|NCT00895830|3958953|B1|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4134528|NCT00895830|3958948|B6|Germany||Region of Enrollment||participants|Number|138|138.0||||||
4134529|NCT00895830|3958949|B5|Germany||Region of Enrollment||participants|Number|29|29.0||||||
4134530|NCT00895830|3958950|B4|Germany||Region of Enrollment||participants|Number|29|29.0||||||
4134531|NCT00895830|3958951|B3|Germany||Region of Enrollment||participants|Number|26|26.0||||||
4134532|NCT00895830|3958952|B2|Germany||Region of Enrollment||participants|Number|28|28.0||||||
4134533|NCT00895830|3958953|B1|Germany||Region of Enrollment||participants|Number|26|26.0||||||
4134534|NCT00895830|3958948|B6|France||Region of Enrollment||participants|Number|77|77.0||||||
4134535|NCT00895830|3958949|B5|France||Region of Enrollment||participants|Number|16|16.0||||||
4134536|NCT00895830|3958950|B4|France||Region of Enrollment||participants|Number|16|16.0||||||
4134537|NCT00895830|3958951|B3|France||Region of Enrollment||participants|Number|14|14.0||||||
4134538|NCT00895830|3958952|B2|France||Region of Enrollment||participants|Number|15|15.0||||||
4134539|NCT00895830|3958953|B1|France||Region of Enrollment||participants|Number|16|16.0||||||
4134540|NCT00895830|3958948|B6|United States||Region of Enrollment||participants|Number|39|39.0||||||
4134541|NCT00895830|3958949|B5|United States||Region of Enrollment||participants|Number|9|9.0||||||
4134542|NCT00895830|3958950|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
4134543|NCT00895830|3958951|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4134544|NCT00895830|3958952|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4134545|NCT00895830|3958953|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4134546|NCT00895830|3958948|B6||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4134547|NCT00895830|3958949|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4134548|NCT00895830|3958950|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4134549|NCT00895830|3958951|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4134550|NCT00895830|3958952|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4134551|NCT00895830|3958953|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4134552|NCT00895830|3958948|B6||Female|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
4134553|NCT00895830|3958949|B5||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4134554|NCT00895830|3958950|B4||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4134555|NCT00895830|3958951|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4134556|NCT00895830|3958952|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4134557|NCT00895830|3958953|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4134558|NCT00895830|3958948|B6|||Age||years|Mean|50.55|50.55|Standard Deviation|14.198|14.198|||
4134559|NCT00895830|3958949|B5|||Age||years|Mean|50.3|50.3|Standard Deviation|13.599|13.599|||
4134560|NCT00895830|3958950|B4|||Age||years|Mean|52.3|52.3|Standard Deviation|16.191|16.191|||
4134561|NCT00895830|3958951|B3|||Age||years|Mean|49.5|49.5|Standard Deviation|13.949|13.949|||
4134562|NCT00895830|3958952|B2|||Age||years|Mean|49.4|49.4|Standard Deviation|13.575|13.575|||
4134563|NCT00895830|3958953|B1|||Age||years|Mean|51.2|51.2|Standard Deviation|13.828|13.828|||
4134564|NCT00895817|3958969|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4134565|NCT00895817|3958970|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4134566|NCT00895817|3958971|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4134567|NCT00895817|3958969|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4134568|NCT00895817|3958970|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4134569|NCT00895817|3958971|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4134570|NCT00895817|3958969|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4134571|NCT00895817|3958970|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4134572|NCT00895817|3958971|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4134573|NCT00895817|3958969|B3|||Age||years|Mean|38|38.0|Standard Deviation|19|19.0|||
4134574|NCT00895817|3958970|B2|||Age||years|Mean|38|38.0|Standard Deviation|10|10.0|||
4134575|NCT00895817|3958971|B1|||Age||years|Mean|38|38.0|Standard Deviation|10|10.0|||
4134576|NCT00895817|3958969|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4134577|NCT00895817|3958970|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4134578|NCT00895817|3958971|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4134579|NCT00895817|3958969|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4134580|NCT00895817|3958970|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4134581|NCT00895817|3958971|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4134582|NCT00895817|3958969|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4134583|NCT00895817|3958970|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4134584|NCT00895817|3958971|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4134585|NCT00895752|3958978|B1|||Children's Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders|The Children’s Yale-Brown Obsessive Compulsive Scales-Modified (CY-BOCS) is a 5-item, semi-structured clinician rating scale modified designed to rate the current severity of repetitive behavior in children and adolescents with PDD. Once the current repetitive behaviors are identified, they are separately rated on 5 items: Time Spent, Interference, Distress, Resistance, and Control. Each of these items is scored on a 5-point scale form 0 (least symptomatic) to 4 (most symptomatic). The CY-BOCS yields a Total Score from 0 to 20 and is sensitive to change.|units on a scale|Mean|11.2|11.2|Standard Deviation|3.2|3.2|||
4134586|NCT00895752|3958978|B1|||Social Reciprocity Scale|The 65-item SRS is a standardized measure of the core symptoms of autism. Each item is scored on a 4-point Likert scale. The score of each individual item is summed to create a total raw score. A total scores results are as follows: 0-62: Within normal limits 63-79: Mild range of impairment 80-108: Moderate range of impairment 109-149: Severe range of impairment|units on a scale|Mean|114.7|114.7|Standard Deviation|23.6|23.6|||
4134587|NCT00895752|3958978|B1|||Peabody Picture Vocabulary Test|The Peabody Picture Vocabulary Test is one of the most commonly used assessment tests that measure verbal ability in standard American English vocabulary. This test has been nationally standardized using examinees from various age groups, from children to adults. Thus, the raw scores are equated to mental age, using the norms obtained from standardization. The total standard scores range from 40 (worse receptive vocabulary) to 160 (better receptive vocabulary). The scores can also be converted to percentile rank.|units on a scale|Mean|116.8|116.8|Standard Deviation|40.2|40.2|||
4134588|NCT00895752|3958978|B1|||Clinical Global Improvement-Severity|The Clinical Global Impression – Severity scale (CGI-S) is a 7-point scale that requires the clinician to rate the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis. Considering total clinical experience, a patient is assessed on severity of mental illness at the time of rating 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|units on a scale|Mean|4.3|4.3|Standard Deviation|0.5|0.5|||
4134589|NCT00895752|3958978|B1|||ADHD rating scale|The ADHD Rating Scale is an 18-item scale directly derived from DSM-IV criteria for Attention Deficit Hyperactivity Disorder. The ADHD Rating Scale-IV is completed by the parent and scored by a clinician. The scale consists of 2 subscales: inattention (9 items) and hyperactivity-impulsivity (9 items). If 3 or more items are skipped, the clinician should use extreme caution in interpreting the scale. The total score can range from 0 to 54, with a higher score indicating greater severity.|units on a scale|Mean|24.3|24.3|Standard Deviation|8.4|8.4|||
4134590|NCT00895752|3958978|B1|ABC Inappropriate Speech||Aberrant Behavior Checklist|The Aberrant Behavior Checklist (ABC) is a 58-item measure of maladaptive behaviors and is used as a measure of drug effects. The ABC has 5 subscales: Social Withdrawal (16 items) ranging from 0 (not at all) to 48 (severe), Irritability (15 items) ranging from 0 (not at all) to 45 (severe), Inappropriate Speech (4 items) ranging from 0 (not at all) to 12 (severe), Hyperactivity (16 items) ranging from 0 (not at all) to 48 (severe), and Stereotypy (7 items) ranging from 0 (not at all) to 21 (severe). Items are rated from 0 (not at all) to 3 (severe).|units on a scale|Mean|8.5|8.5|Standard Deviation|2.7|2.7|||
4134591|NCT00895752|3958978|B1|ABC Hyperactivity||Aberrant Behavior Checklist|The Aberrant Behavior Checklist (ABC) is a 58-item measure of maladaptive behaviors and is used as a measure of drug effects. The ABC has 5 subscales: Social Withdrawal (16 items) ranging from 0 (not at all) to 48 (severe), Irritability (15 items) ranging from 0 (not at all) to 45 (severe), Inappropriate Speech (4 items) ranging from 0 (not at all) to 12 (severe), Hyperactivity (16 items) ranging from 0 (not at all) to 48 (severe), and Stereotypy (7 items) ranging from 0 (not at all) to 21 (severe). Items are rated from 0 (not at all) to 3 (severe).|units on a scale|Mean|19.5|19.5|Standard Deviation|8.3|8.3|||
4134592|NCT00895752|3958978|B1|ABC Stereotypy||Aberrant Behavior Checklist|The Aberrant Behavior Checklist (ABC) is a 58-item measure of maladaptive behaviors and is used as a measure of drug effects. The ABC has 5 subscales: Social Withdrawal (16 items) ranging from 0 (not at all) to 48 (severe), Irritability (15 items) ranging from 0 (not at all) to 45 (severe), Inappropriate Speech (4 items) ranging from 0 (not at all) to 12 (severe), Hyperactivity (16 items) ranging from 0 (not at all) to 48 (severe), and Stereotypy (7 items) ranging from 0 (not at all) to 21 (severe). Items are rated from 0 (not at all) to 3 (severe).|units on a scale|Mean|8.3|8.3|Standard Deviation|7.8|7.8|||
4134593|NCT00895752|3958978|B1|ABC Social Withdrawal||Aberrant Behavior Checklist|The Aberrant Behavior Checklist (ABC) is a 58-item measure of maladaptive behaviors and is used as a measure of drug effects. The ABC has 5 subscales: Social Withdrawal (16 items) ranging from 0 (not at all) to 48 (severe), Irritability (15 items) ranging from 0 (not at all) to 45 (severe), Inappropriate Speech (4 items) ranging from 0 (not at all) to 12 (severe), Hyperactivity (16 items) ranging from 0 (not at all) to 48 (severe), and Stereotypy (7 items) ranging from 0 (not at all) to 21 (severe). Items are rated from 0 (not at all) to 3 (severe).|units on a scale|Mean|15.8|15.8|Standard Deviation|11.0|11.0|||
4134594|NCT00895752|3958978|B1|ABC Irritability||Aberrant Behavior Checklist|The Aberrant Behavior Checklist (ABC) is a 58-item measure of maladaptive behaviors and is used as a measure of drug effects. The ABC has 5 subscales: Social Withdrawal (16 items) ranging from 0 (not at all) to 48 (severe), Irritability (15 items) ranging from 0 (not at all) to 45 (severe), Inappropriate Speech (4 items) ranging from 0 (not at all) to 12 (severe), Hyperactivity (16 items) ranging from 0 (not at all) to 48 (severe), and Stereotypy (7 items) ranging from 0 (not at all) to 21 (severe). Items are rated from 0 (not at all) to 3 (severe).|units on a scale|Mean|15.2|15.2|Standard Deviation|11.4|11.4|||
4134595|NCT00895752|3958978|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4134596|NCT00895752|3958978|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4134597|NCT00895752|3958978|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4134598|NCT00895752|3958978|B1|||Age||years|Mean|22.5|22.5|Full Range|||19.0|24.0|
4134599|NCT00895752|3958978|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4134600|NCT00895752|3958978|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4134601|NCT00895752|3958978|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4134602|NCT00895661|3958989|B1||FLIPI score not available|Follicular lymphoma prognostic index (FLIPI)||Participants|Count of Participants|2|2.0||||||
4134603|NCT00895661|3958989|B1||High risk|Follicular lymphoma prognostic index (FLIPI)||Participants|Count of Participants|17|17.0||||||
4134604|NCT00895661|3958989|B1||Intermediate risk|Follicular lymphoma prognostic index (FLIPI)||Participants|Count of Participants|15|15.0||||||
4134605|NCT00895661|3958989|B1||Low risk|Follicular lymphoma prognostic index (FLIPI)||Participants|Count of Participants|6|6.0||||||
4134606|NCT00895661|3958989|B1|||elevated LDH (Lactate dehydrogenase)||Participants|Count of Participants|11|11.0||||||
4134607|NCT00895661|3958989|B1|||Hgb<12 g/dL||Participants|Count of Participants|9|9.0||||||
4134608|NCT00895661|3958989|B1|||Involvement of >4 nodal sites||Participants|Count of Participants|17|17.0||||||
4134609|NCT00895661|3958989|B1||Indolent B cell, not otherwise specified|Lymphoma type||Participants|Count of Participants|2|2.0||||||
4134610|NCT00895661|3958989|B1||Small lymphocytic|Lymphoma type||Participants|Count of Participants|3|3.0||||||
4134611|NCT00895661|3958989|B1||Marginal zone|Lymphoma type||Participants|Count of Participants|4|4.0||||||
4134612|NCT00895661|3958989|B1||Follicular|Lymphoma type||Participants|Count of Participants|31|31.0||||||
4134613|NCT00895661|3958989|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4134614|NCT00895661|3958989|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4134615|NCT00895661|3958989|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4134616|NCT00895661|3958989|B1|||Age||years|Median|60|60.0|Full Range|||36.0|88.0|
4134617|NCT00895622|3958996|B4||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4134618|NCT00895622|3958997|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4134619|NCT00895622|3958998|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4134620|NCT00895622|3958999|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4134621|NCT00895622|3958996|B4||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4134622|NCT00895622|3958997|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4134623|NCT00895622|3958998|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4134624|NCT00895622|3958999|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4134625|NCT00895622|3958996|B4|||Age||years|Median|56|56.0|Full Range|||18.0|94.0|
4134626|NCT00895622|3958997|B3|||Age||years|Median|62|62.0|Full Range|||19.0|94.0|
4134627|NCT00895622|3958998|B2|||Age||years|Median|53|53.0|Full Range|||18.0|73.0|
4134628|NCT00895622|3958999|B1|||Age||years|Median|56|56.0|Full Range|||31.0|79.0|
4134629|NCT00895583|3959022|B3||Male|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4134630|NCT00895583|3959023|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4134631|NCT00895583|3959024|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4134632|NCT00895583|3959022|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4134633|NCT00895583|3959023|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4134634|NCT00895583|3959024|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4134635|NCT00895583|3959022|B3|||Age||years|Mean|51.5|51.5|Standard Deviation|12.57|12.57|||
4134636|NCT00895583|3959023|B2|||Age||years|Mean|52.4|52.4|Standard Deviation|12.05|12.05|||
4134637|NCT00895583|3959024|B1|||Age||years|Mean|50.7|50.7|Standard Deviation|13.03|13.03|||
4134638|NCT00895531|3959103|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4134639|NCT00895531|3959103|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4134640|NCT00895531|3959104|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4134641|NCT00895531|3959105|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4134642|NCT00895531|3959103|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4134643|NCT00895531|3959104|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4134644|NCT00895531|3959105|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4134645|NCT00895531|3959103|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4134646|NCT00895531|3959104|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4134647|NCT00895531|3959105|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4134648|NCT00895531|3959103|B3||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4134649|NCT00895531|3959104|B2||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4134650|NCT00895531|3959105|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4134651|NCT00895531|3959103|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4134652|NCT00895531|3959104|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4134653|NCT00895531|3959105|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4134654|NCT00895453|3959112|B4|Austria||Region of Enrollment||participants|Number|144|144.0||||||
4134655|NCT00895453|3959113|B3|Austria||Region of Enrollment||participants|Number|46|46.0||||||
4134656|NCT00895453|3959114|B2|Austria||Region of Enrollment||participants|Number|50|50.0||||||
4134657|NCT00895453|3959115|B1|Austria||Region of Enrollment||participants|Number|48|48.0||||||
4134658|NCT00895453|3959112|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4134659|NCT00895453|3959113|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4134660|NCT00895453|3959114|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4134661|NCT00895453|3959115|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4134662|NCT00895453|3959112|B4||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4134663|NCT00895453|3959113|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4134664|NCT00895453|3959114|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4134665|NCT00895453|3959115|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4134666|NCT00895453|3959112|B4|||Age||years|Mean|30.4|30.4|Standard Deviation|7.4|7.4|||
4134667|NCT00895453|3959113|B3|||Age||years|Mean|30.3|30.3|Standard Deviation|8.0|8.0|||
4134668|NCT00895453|3959114|B2|||Age||years|Mean|30.4|30.4|Standard Deviation|7.4|7.4|||
4134669|NCT00895453|3959115|B1|||Age||years|Mean|30.5|30.5|Standard Deviation|7.8|7.8|||
4134670|NCT00895453|3959112|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4134671|NCT00895453|3959113|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4134672|NCT00895453|3959114|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4134673|NCT00895453|3959115|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4134674|NCT00895453|3959112|B4||Between 18 and 65 years|Age||Participants|Count of Participants|144|144.0||||||
4134675|NCT00895453|3959113|B3||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4134676|NCT00895453|3959114|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4134677|NCT00895453|3959115|B1||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4134678|NCT00895453|3959112|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4134679|NCT00895453|3959113|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4134680|NCT00895453|3959114|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4134681|NCT00895453|3959115|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4134682|NCT00895310|3959125|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4134683|NCT00895310|3959125|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4134684|NCT00895310|3959125|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4134685|NCT00895310|3959125|B1|||Age||years|Median|72|72.0|Full Range|||55.0|86.0|
4134686|NCT00895284|3959132|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4134687|NCT00895284|3959134|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4134688|NCT00895284|3959132|B3|Male||Gender||participants|Number|0|0.0||||||
4134689|NCT00895284|3959134|B1|Male||Gender||participants|Number|0|0.0||||||
4134690|NCT00895284|3959132|B3|Female||Gender||participants|Number|3|3.0||||||
4134691|NCT00895284|3959134|B1|Female||Gender||participants|Number|3|3.0||||||
4134692|NCT00895284|3959132|B3|>=65 years||Age||participants|Number|0|0.0||||||
4134693|NCT00895284|3959134|B1|>=65 years||Age||participants|Number|0|0.0||||||
4134694|NCT00895284|3959132|B3|Between 18 and 65 years||Age||participants|Number|3|3.0||||||
4134695|NCT00895284|3959134|B1|Between 18 and 65 years||Age||participants|Number|3|3.0||||||
4134696|NCT00895284|3959132|B3|<=18 years||Age||participants|Number|0|0.0||||||
4134697|NCT00895284|3959134|B1|<=18 years||Age||participants|Number|0|0.0||||||
4134698|NCT00895245|3959141|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4134699|NCT00895245|3959141|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4134700|NCT00895245|3959141|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4134701|NCT00895245|3959141|B1|||Age||years|Median|41|41.0|Full Range|||39.0|51.0|
4134702|NCT00895245|3959141|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4134703|NCT00895245|3959141|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4134704|NCT00895245|3959141|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4134705|NCT00895232|3959148|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4134706|NCT00895232|3959149|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4134707|NCT00895232|3959150|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4134708|NCT00895232|3959151|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4134709|NCT00895232|3959148|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4134710|NCT00895232|3959149|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4134711|NCT00895232|3959150|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4134712|NCT00895232|3959151|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4134713|NCT00895232|3959148|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4134714|NCT00895232|3959149|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4134715|NCT00895232|3959150|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4134716|NCT00895232|3959151|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4134717|NCT00895232|3959148|B4||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4134718|NCT00895232|3959149|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4134719|NCT00895232|3959150|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4134720|NCT00895232|3959151|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4134721|NCT00895232|3959148|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4134722|NCT00895232|3959149|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4134723|NCT00895232|3959150|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4134724|NCT00895232|3959151|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4134725|NCT00895193|3959167|B5|||Waist Circumference||inches|Mean|35|35.0|Standard Deviation|5.65|5.65|||
4134726|NCT00895193|3959168|B4|||Waist Circumference||inches|Mean|35|35.0|Standard Deviation|5.3|5.3|||
4134727|NCT00895193|3959169|B3|||Waist Circumference||inches|Mean|34|34.0|Standard Deviation|5.0|5.0|||
4134728|NCT00895193|3959170|B2|||Waist Circumference||inches|Mean|36|36.0|Standard Deviation|6.3|6.3|||
4134729|NCT00895193|3959171|B1|||Waist Circumference||inches|Mean|35|35.0|Standard Deviation|6.1|6.1|||
4134730|NCT00895193|3959167|B5|||Body Mass Index||kg/m2|Mean|26.4|26.4|Standard Deviation|5.4|5.4|||
4134731|NCT00895193|3959168|B4|||Body Mass Index||kg/m2|Mean|26|26.0|Standard Deviation|5.0|5.0|||
4134732|NCT00895193|3959169|B3|||Body Mass Index||kg/m2|Mean|26|26.0|Standard Deviation|5.3|5.3|||
4134733|NCT00895193|3959170|B2|||Body Mass Index||kg/m2|Mean|27|27.0|Standard Deviation|6.2|6.2|||
4134734|NCT00895193|3959171|B1|||Body Mass Index||kg/m2|Mean|26|26.0|Standard Deviation|5.5|5.5|||
4134735|NCT00895193|3959167|B5|United States||Region of Enrollment||participants|Number|100|100.0||||||
4134736|NCT00895193|3959168|B4|United States||Region of Enrollment||participants|Number|25|25.0||||||
4134737|NCT00895193|3959169|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4134738|NCT00895193|3959170|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4134739|NCT00895193|3959171|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4134740|NCT00895193|3959167|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4134741|NCT00895193|3959168|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134742|NCT00895193|3959169|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134743|NCT00895193|3959170|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4134744|NCT00895193|3959171|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4134745|NCT00895193|3959167|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134746|NCT00895193|3959168|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134747|NCT00895193|3959169|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134748|NCT00895193|3959170|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134749|NCT00895193|3959171|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134750|NCT00895193|3959167|B5||White|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
4134751|NCT00895193|3959168|B4||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4134752|NCT00895193|3959169|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4134753|NCT00895193|3959170|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4134754|NCT00895193|3959171|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4134755|NCT00895193|3959167|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4134756|NCT00895193|3959168|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4134757|NCT00895193|3959169|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4134758|NCT00895193|3959170|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4134759|NCT00895193|3959171|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4134760|NCT00895193|3959167|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134761|NCT00895193|3959168|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134762|NCT00895193|3959169|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134763|NCT00895193|3959170|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134764|NCT00895193|3959171|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134765|NCT00895193|3959167|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134766|NCT00895193|3959168|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134767|NCT00895193|3959169|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134768|NCT00895193|3959170|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134769|NCT00895193|3959171|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134770|NCT00895193|3959167|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134771|NCT00895193|3959168|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134772|NCT00895193|3959169|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134773|NCT00895193|3959170|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134774|NCT00895193|3959171|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134775|NCT00895193|3959167|B5||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4134776|NCT00895193|3959168|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4134777|NCT00895193|3959169|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4134778|NCT00895193|3959170|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4134779|NCT00895193|3959171|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4134780|NCT00895193|3959167|B5||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4134781|NCT00895193|3959168|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4134782|NCT00895193|3959169|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4134783|NCT00895193|3959170|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4134784|NCT00895193|3959171|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4134785|NCT00895193|3959167|B5|||Age||years|Mean|38.2|38.2|Standard Deviation|12.5|12.5|||
4134786|NCT00895193|3959168|B4|||Age||years|Mean|38|38.0|Standard Deviation|12.7|12.7|||
4134787|NCT00895193|3959169|B3|||Age||years|Mean|40|40.0|Standard Deviation|12.3|12.3|||
4134788|NCT00895193|3959170|B2|||Age||years|Mean|40|40.0|Standard Deviation|13.3|13.3|||
4134789|NCT00895193|3959171|B1|||Age||years|Mean|34|34.0|Standard Deviation|11.5|11.5|||
4134790|NCT00895180|3959196|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
4134791|NCT00895180|3959197|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4134792|NCT00895180|3959198|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4134793|NCT00895180|3959196|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134794|NCT00895180|3959197|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134795|NCT00895180|3959198|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134796|NCT00895180|3959196|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4134797|NCT00895180|3959197|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4134798|NCT00895180|3959198|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134799|NCT00895180|3959196|B3||White|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4134800|NCT00895180|3959197|B2||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4134801|NCT00895180|3959198|B1||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4134802|NCT00895180|3959196|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4134803|NCT00895180|3959197|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4134804|NCT00895180|3959198|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4134805|NCT00895180|3959196|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134806|NCT00895180|3959197|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134807|NCT00895180|3959198|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134808|NCT00895180|3959196|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4134809|NCT00895180|3959197|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134810|NCT00895180|3959198|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4134811|NCT00895180|3959196|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134812|NCT00895180|3959197|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134813|NCT00895180|3959198|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134814|NCT00895180|3959196|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134815|NCT00895180|3959197|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134816|NCT00895180|3959198|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4134817|NCT00895180|3959196|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
4134818|NCT00895180|3959197|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4134819|NCT00895180|3959198|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4134820|NCT00895180|3959196|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4134821|NCT00895180|3959197|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4134822|NCT00895180|3959198|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4134823|NCT00895180|3959196|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4134824|NCT00895180|3959197|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4134825|NCT00895180|3959198|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4134826|NCT00895180|3959196|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4134827|NCT00895180|3959197|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4134828|NCT00895180|3959198|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4134829|NCT00895180|3959196|B3|||Age||years|Mean|51.5|51.5|Standard Deviation|11.98|11.98|||
4134830|NCT00895180|3959197|B2|||Age||years|Mean|51.6|51.6|Standard Deviation|11.81|11.81|||
4134831|NCT00895180|3959198|B1|||Age||years|Mean|51.4|51.4|Standard Deviation|12.29|12.29|||
4134832|NCT00895037|3959217|B4||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4134833|NCT00895037|3959218|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4134834|NCT00895037|3959219|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4134835|NCT00895037|3959220|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4134836|NCT00895037|3959217|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4134837|NCT00895037|3959218|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4134838|NCT00895037|3959219|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4134839|NCT00895037|3959220|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4134840|NCT00895037|3959217|B4|||Age||Years|Mean|22.7|22.7|Standard Deviation|16.6|16.6|||
4134841|NCT00895037|3959218|B3|||Age||Years|Mean|62.0|62.0|Standard Deviation|7.1|7.1|||
4134842|NCT00895037|3959219|B2|||Age||Years|Mean|18.5|18.5|Standard Deviation|12.4|12.4|||
4134843|NCT00895037|3959220|B1|||Age||Years|Mean|34.0|34.0|Standard Deviation|20.2|20.2|||
4134844|NCT00895011|3959250|B4|United States||Region of Enrollment||participants|Number|298|298.0||||||
4134845|NCT00895011|3959251|B3|United States||Region of Enrollment||participants|Number|99|99.0||||||
4134846|NCT00895011|3959252|B2|United States||Region of Enrollment||participants|Number|99|99.0||||||
4134847|NCT00895011|3959253|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
4134848|NCT00895011|3959250|B4||Male|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
4134849|NCT00895011|3959251|B3||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4134850|NCT00895011|3959252|B2||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4134851|NCT00895011|3959253|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4134852|NCT00895011|3959250|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4134853|NCT00895011|3959251|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4134854|NCT00895011|3959252|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4134855|NCT00895011|3959253|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4134856|NCT00895011|3959250|B4|||Age||years|Mean|58.4|58.4|Standard Deviation|6.13|6.13|||
4134857|NCT00895011|3959251|B3|||Age||years|Mean|57.7|57.7|Standard Deviation|6.60|6.6|||
4134858|NCT00895011|3959252|B2|||Age||years|Mean|58.9|58.9|Standard Deviation|5.88|5.88|||
4134859|NCT00895011|3959253|B1|||Age||years|Mean|58.6|58.6|Standard Deviation|5.87|5.87|||
4134860|NCT00895011|3959250|B4||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4134861|NCT00895011|3959251|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4134862|NCT00895011|3959252|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4134863|NCT00895011|3959253|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4134864|NCT00895011|3959250|B4||Between 18 and 65 years|Age||Participants|Count of Participants|250|250.0||||||
4134865|NCT00895011|3959251|B3||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
4134866|NCT00895011|3959252|B2||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
4134867|NCT00895011|3959253|B1||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
4134868|NCT00895011|3959250|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4134869|NCT00895011|3959251|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4134870|NCT00895011|3959252|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4134871|NCT00895011|3959253|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4134872|NCT00894933|3959269|B1|||Prostate size (g) via TRUS||grams|Mean|33.7|33.7|Standard Deviation|7.9|7.9|||
4134873|NCT00894933|3959269|B1|||History of smoking||Participants|Count of Participants|19|19.0||||||
4134874|NCT00894933|3959269|B1|||Body Mass Index||kg/m2|Mean|27.3|27.3|Standard Deviation|3.0|3.0|||
4134875|NCT00894933|3959269|B1|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
4134876|NCT00894933|3959269|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4134877|NCT00894933|3959269|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4134878|NCT00894933|3959269|B1|||Age||years|Mean|58.6|58.6|Standard Deviation|7.8|7.8|||
4134879|NCT00894803|3959285|B3|5||Modified Rankin Score (mRS)|modified Rankin Score (mRS), 6 point ordinal scale, measuring functional status. 0 (no symptoms at all), 5 (severe disability; bedridden, incontinent, and requiring constant nursing care)|participants|Number|0|0.0||||||
4134880|NCT00894803|3959286|B2|5||Modified Rankin Score (mRS)|modified Rankin Score (mRS), 6 point ordinal scale, measuring functional status. 0 (no symptoms at all), 5 (severe disability; bedridden, incontinent, and requiring constant nursing care)|participants|Number|0|0.0||||||
4134881|NCT00894803|3959287|B1|5||Modified Rankin Score (mRS)|modified Rankin Score (mRS), 6 point ordinal scale, measuring functional status. 0 (no symptoms at all), 5 (severe disability; bedridden, incontinent, and requiring constant nursing care)|participants|Number|0|0.0||||||
4134882|NCT00894803|3959285|B3|4||Modified Rankin Score (mRS)|modified Rankin Score (mRS), 6 point ordinal scale, measuring functional status. 0 (no symptoms at all), 5 (severe disability; bedridden, incontinent, and requiring constant nursing care)|participants|Number|5|5.0||||||
4134883|NCT00894803|3959286|B2|4||Modified Rankin Score (mRS)|modified Rankin Score (mRS), 6 point ordinal scale, measuring functional status. 0 (no symptoms at all), 5 (severe disability; bedridden, incontinent, and requiring constant nursing care)|participants|Number|5|5.0||||||
4134884|NCT00894803|3959287|B1|4||Modified Rankin Score (mRS)|modified Rankin Score (mRS), 6 point ordinal scale, measuring functional status. 0 (no symptoms at all), 5 (severe disability; bedridden, incontinent, and requiring constant nursing care)|participants|Number|0|0.0||||||
4134885|NCT00894803|3959285|B3|3||Modified Rankin Score (mRS)|modified Rankin Score (mRS), 6 point ordinal scale, measuring functional status. 0 (no symptoms at all), 5 (severe disability; bedridden, incontinent, and requiring constant nursing care)|participants|Number|8|8.0||||||
4134886|NCT00894803|3959286|B2|3||Modified Rankin Score (mRS)|modified Rankin Score (mRS), 6 point ordinal scale, measuring functional status. 0 (no symptoms at all), 5 (severe disability; bedridden, incontinent, and requiring constant nursing care)|participants|Number|4|4.0||||||
4134887|NCT00894803|3959287|B1|3||Modified Rankin Score (mRS)|modified Rankin Score (mRS), 6 point ordinal scale, measuring functional status. 0 (no symptoms at all), 5 (severe disability; bedridden, incontinent, and requiring constant nursing care)|participants|Number|4|4.0||||||
4134888|NCT00894803|3959285|B3|2||Modified Rankin Score (mRS)|modified Rankin Score (mRS), 6 point ordinal scale, measuring functional status. 0 (no symptoms at all), 5 (severe disability; bedridden, incontinent, and requiring constant nursing care)|participants|Number|10|10.0||||||
4134889|NCT00894803|3959286|B2|2||Modified Rankin Score (mRS)|modified Rankin Score (mRS), 6 point ordinal scale, measuring functional status. 0 (no symptoms at all), 5 (severe disability; bedridden, incontinent, and requiring constant nursing care)|participants|Number|7|7.0||||||
4134890|NCT00894803|3959287|B1|2||Modified Rankin Score (mRS)|modified Rankin Score (mRS), 6 point ordinal scale, measuring functional status. 0 (no symptoms at all), 5 (severe disability; bedridden, incontinent, and requiring constant nursing care)|participants|Number|3|3.0||||||
4134891|NCT00894803|3959285|B3|1||Modified Rankin Score (mRS)|modified Rankin Score (mRS), 6 point ordinal scale, measuring functional status. 0 (no symptoms at all), 5 (severe disability; bedridden, incontinent, and requiring constant nursing care)|participants|Number|13|13.0||||||
4134892|NCT00894803|3959286|B2|1||Modified Rankin Score (mRS)|modified Rankin Score (mRS), 6 point ordinal scale, measuring functional status. 0 (no symptoms at all), 5 (severe disability; bedridden, incontinent, and requiring constant nursing care)|participants|Number|11|11.0||||||
4134893|NCT00894803|3959287|B1|1||Modified Rankin Score (mRS)|modified Rankin Score (mRS), 6 point ordinal scale, measuring functional status. 0 (no symptoms at all), 5 (severe disability; bedridden, incontinent, and requiring constant nursing care)|participants|Number|2|2.0||||||
4134894|NCT00894803|3959285|B3|0||Modified Rankin Score (mRS)|modified Rankin Score (mRS), 6 point ordinal scale, measuring functional status. 0 (no symptoms at all), 5 (severe disability; bedridden, incontinent, and requiring constant nursing care)|participants|Number|90|90.0||||||
4134895|NCT00894803|3959286|B2|0||Modified Rankin Score (mRS)|modified Rankin Score (mRS), 6 point ordinal scale, measuring functional status. 0 (no symptoms at all), 5 (severe disability; bedridden, incontinent, and requiring constant nursing care)|participants|Number|74|74.0||||||
4134896|NCT00894803|3959287|B1|0||Modified Rankin Score (mRS)|modified Rankin Score (mRS), 6 point ordinal scale, measuring functional status. 0 (no symptoms at all), 5 (severe disability; bedridden, incontinent, and requiring constant nursing care)|participants|Number|16|16.0||||||
4134897|NCT00894803|3959285|B3|||Stroke symptom onset to intravenous rt-PA start|Tme from stroke symptom onset to intravenous rt-PA start|minutes|Median|116|116.0|Inter-Quartile Range|||97.0|138.0|
4134898|NCT00894803|3959286|B2|||Stroke symptom onset to intravenous rt-PA start|Tme from stroke symptom onset to intravenous rt-PA start|minutes|Median|113|113.0|Inter-Quartile Range|||99.0|135.0|
4134899|NCT00894803|3959287|B1|||Stroke symptom onset to intravenous rt-PA start|Tme from stroke symptom onset to intravenous rt-PA start|minutes|Median|129|129.0|Inter-Quartile Range|||90.0|141.0|
4134900|NCT00894803|3959285|B3|> 3 hours||Stroke symptom onset to intravenous rt-PA start|Time from stroke symptom onset to intravenous rt-PA start|Participants|Number|3|3.0||||||
4134901|NCT00894803|3959286|B2|> 3 hours||Stroke symptom onset to intravenous rt-PA start|Time from stroke symptom onset to intravenous rt-PA start|Participants|Number|2|2.0||||||
4134902|NCT00894803|3959287|B1|> 3 hours||Stroke symptom onset to intravenous rt-PA start|Time from stroke symptom onset to intravenous rt-PA start|Participants|Number|1|1.0||||||
4134903|NCT00894803|3959285|B3|>2 to 3 hours||Stroke symptom onset to intravenous rt-PA start|Time from stroke symptom onset to intravenous rt-PA start|Participants|Number|55|55.0||||||
4134904|NCT00894803|3959286|B2|>2 to 3 hours||Stroke symptom onset to intravenous rt-PA start|Time from stroke symptom onset to intravenous rt-PA start|Participants|Number|42|42.0||||||
4134905|NCT00894803|3959287|B1|>2 to 3 hours||Stroke symptom onset to intravenous rt-PA start|Time from stroke symptom onset to intravenous rt-PA start|Participants|Number|13|13.0||||||
4134906|NCT00894803|3959285|B3|1 to 2 hours||Stroke symptom onset to intravenous rt-PA start|Time from stroke symptom onset to intravenous rt-PA start|Participants|Number|67|67.0||||||
4134907|NCT00894803|3959286|B2|1 to 2 hours||Stroke symptom onset to intravenous rt-PA start|Time from stroke symptom onset to intravenous rt-PA start|Participants|Number|56|56.0||||||
4134908|NCT00894803|3959287|B1|1 to 2 hours||Stroke symptom onset to intravenous rt-PA start|Time from stroke symptom onset to intravenous rt-PA start|Participants|Number|11|11.0||||||
4134909|NCT00894803|3959285|B3|< 1 hour||Stroke symptom onset to intravenous rt-PA start|Time from stroke symptom onset to intravenous rt-PA start|Participants|Number|1|1.0||||||
4134910|NCT00894803|3959286|B2|< 1 hour||Stroke symptom onset to intravenous rt-PA start|Time from stroke symptom onset to intravenous rt-PA start|Participants|Number|1|1.0||||||
4134911|NCT00894803|3959287|B1|< 1 hour||Stroke symptom onset to intravenous rt-PA start|Time from stroke symptom onset to intravenous rt-PA start|Participants|Number|0|0.0||||||
4134912|NCT00894803|3959285|B3|||National Institutes of Health Stroke Scale Score (NIHSS)|National Institutes of Health Stroke Scale Score (NIHSS), 43 point ordinal scale (0 to 42), measuring severity of stroke. 0 (no measurable effect), 42 (dead).|units on a scale|Median|12|12.0|Inter-Quartile Range|||9.0|20.0|
4134913|NCT00894803|3959286|B2|||National Institutes of Health Stroke Scale Score (NIHSS)|National Institutes of Health Stroke Scale Score (NIHSS), 43 point ordinal scale (0 to 42), measuring severity of stroke. 0 (no measurable effect), 42 (dead).|units on a scale|Median|12|12.0|Inter-Quartile Range|||9.0|20.0|
4134914|NCT00894803|3959287|B1|||National Institutes of Health Stroke Scale Score (NIHSS)|National Institutes of Health Stroke Scale Score (NIHSS), 43 point ordinal scale (0 to 42), measuring severity of stroke. 0 (no measurable effect), 42 (dead).|units on a scale|Median|17|17.0|Inter-Quartile Range|||11.0|22.0|
4134915|NCT00894803|3959285|B3|||National Institutes of Health Stroke Scale Score (NIHSS)|National Institutes of Health Stroke Scale Score (NIHSS), 43 point ordinal scale (0 to 42), measuring severity of stroke. 0 (no measurable effect), 42 (dead).|units on a scale|Mean|14.6|14.6|Standard Deviation|6.9|6.9|||
4134916|NCT00894803|3959286|B2|||National Institutes of Health Stroke Scale Score (NIHSS)|National Institutes of Health Stroke Scale Score (NIHSS), 43 point ordinal scale (0 to 42), measuring severity of stroke. 0 (no measurable effect), 42 (dead).|units on a scale|Mean|14.1|14.1|Standard Deviation|6.9|6.9|||
4134917|NCT00894803|3959287|B1|||National Institutes of Health Stroke Scale Score (NIHSS)|National Institutes of Health Stroke Scale Score (NIHSS), 43 point ordinal scale (0 to 42), measuring severity of stroke. 0 (no measurable effect), 42 (dead).|units on a scale|Mean|16.4|16.4|Standard Deviation|6.7|6.7|||
4134918|NCT00894803|3959285|B3|NIHSS >12||National Institutes of Health Stroke Scale Score (NIHSS)|National Institutes of Health Stroke Scale Score (NIHSS), 43 point ordinal scale (0 to 42), measuring severity of stroke. 0 (no measurable effect), 42 (dead).|Participants|Number|60|60.0||||||
4134919|NCT00894803|3959286|B2|NIHSS >12||National Institutes of Health Stroke Scale Score (NIHSS)|National Institutes of Health Stroke Scale Score (NIHSS), 43 point ordinal scale (0 to 42), measuring severity of stroke. 0 (no measurable effect), 42 (dead).|Participants|Number|45|45.0||||||
4134920|NCT00894803|3959287|B1|NIHSS >12||National Institutes of Health Stroke Scale Score (NIHSS)|National Institutes of Health Stroke Scale Score (NIHSS), 43 point ordinal scale (0 to 42), measuring severity of stroke. 0 (no measurable effect), 42 (dead).|Participants|Number|15|15.0||||||
4134921|NCT00894803|3959285|B3|NIHSS <=12||National Institutes of Health Stroke Scale Score (NIHSS)|National Institutes of Health Stroke Scale Score (NIHSS), 43 point ordinal scale (0 to 42), measuring severity of stroke. 0 (no measurable effect), 42 (dead).|Participants|Number|66|66.0||||||
4134922|NCT00894803|3959286|B2|NIHSS <=12||National Institutes of Health Stroke Scale Score (NIHSS)|National Institutes of Health Stroke Scale Score (NIHSS), 43 point ordinal scale (0 to 42), measuring severity of stroke. 0 (no measurable effect), 42 (dead).|Participants|Number|56|56.0||||||
4134923|NCT00894803|3959287|B1|NIHSS <=12||National Institutes of Health Stroke Scale Score (NIHSS)|National Institutes of Health Stroke Scale Score (NIHSS), 43 point ordinal scale (0 to 42), measuring severity of stroke. 0 (no measurable effect), 42 (dead).|Participants|Number|10|10.0||||||
4134924|NCT00894803|3959285|B3|United States||Region of Enrollment||participants|Number|126|126.0||||||
4134925|NCT00894803|3959286|B2|United States||Region of Enrollment||participants|Number|101|101.0||||||
4134926|NCT00894803|3959287|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4134927|NCT00894803|3959285|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4134928|NCT00894803|3959286|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4134929|NCT00894803|3959287|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4134930|NCT00894803|3959285|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4134931|NCT00894803|3959286|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4134932|NCT00894803|3959287|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4134933|NCT00894803|3959285|B3|||Age||Years|Median|74.2|74.2|Inter-Quartile Range|||58.1|81.5|
4134934|NCT00894803|3959286|B2|||Age||Years|Median|71.6|71.6|Inter-Quartile Range|||58.1|81.5|
4134935|NCT00894803|3959287|B1|||Age||Years|Median|75.5|75.5|Inter-Quartile Range|||60.5|81.4|
4134936|NCT00894803|3959285|B3|||Age||years|Mean|69.3|69.3|Standard Deviation|13.4|13.4|||
4134937|NCT00894803|3959286|B2|||Age||years|Mean|69.0|69.0|Standard Deviation|13.6|13.6|||
4134938|NCT00894803|3959287|B1|||Age||years|Mean|70.9|70.9|Standard Deviation|13.0|13.0|||
4134939|NCT00894803|3959285|B3||>=65 years|Age||Participants|Count of Participants|82|82.0||||||
4134940|NCT00894803|3959286|B2||>=65 years|Age||Participants|Count of Participants|64|64.0||||||
4134941|NCT00894803|3959287|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4134942|NCT00894803|3959285|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4134943|NCT00894803|3959286|B2||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4134944|NCT00894803|3959287|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4134945|NCT00894803|3959285|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4134946|NCT00894803|3959286|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4134947|NCT00894803|3959287|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4134948|NCT00894790|3959322|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4134949|NCT00894790|3959323|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4134950|NCT00894790|3959324|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4134951|NCT00894790|3959322|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4134952|NCT00894790|3959323|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4134953|NCT00894790|3959324|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4134954|NCT00894790|3959322|B3|45 to 64 years||Age, Customized||participants|Number|4|4.0||||||
4134955|NCT00894790|3959323|B2|45 to 64 years||Age, Customized||participants|Number|2|2.0||||||
4134956|NCT00894790|3959324|B1|45 to 64 years||Age, Customized||participants|Number|2|2.0||||||
4134957|NCT00894790|3959322|B3|18 to 44 years||Age, Customized||participants|Number|4|4.0||||||
4134958|NCT00894790|3959323|B2|18 to 44 years||Age, Customized||participants|Number|2|2.0||||||
4134959|NCT00894790|3959324|B1|18 to 44 years||Age, Customized||participants|Number|2|2.0||||||
4134960|NCT00894699|3959347|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4134961|NCT00894699|3959348|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4134962|NCT00894699|3959349|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4134963|NCT00894699|3959347|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4134964|NCT00894699|3959348|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4134965|NCT00894699|3959349|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4134966|NCT00894699|3959347|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4134967|NCT00894699|3959348|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4134968|NCT00894699|3959349|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4134969|NCT00894699|3959347|B3|||Age||years|Mean|36.7|36.7|Standard Deviation|8.8|8.8|||
4134970|NCT00894699|3959348|B2|||Age||years|Mean|37.3|37.3|Standard Deviation|7.7|7.7|||
4134971|NCT00894699|3959349|B1|||Age||years|Mean|36.1|36.1|Standard Deviation|9.8|9.8|||
4134972|NCT00894699|3959347|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4134973|NCT00894699|3959348|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4134974|NCT00894699|3959349|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4134975|NCT00894699|3959347|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4134976|NCT00894699|3959348|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4134977|NCT00894699|3959349|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4134978|NCT00894699|3959347|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4134979|NCT00894699|3959348|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4134980|NCT00894699|3959349|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4134981|NCT00894686|3959356|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4134982|NCT00894686|3959356|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4134983|NCT00894686|3959356|B1|||Age||Years|Mean|15.1|15.1|Standard Deviation|4.4|4.4|||
4134984|NCT00894647|3959378|B3|Canada||Region of Enrollment||participants|Number|66|66.0||||||
4134985|NCT00894647|3959379|B2|Canada||Region of Enrollment||participants|Number|35|35.0||||||
4134986|NCT00894647|3959380|B1|Canada||Region of Enrollment||participants|Number|31|31.0||||||
4134987|NCT00894647|3959378|B3|United States||Region of Enrollment||participants|Number|181|181.0||||||
4134988|NCT00894647|3959379|B2|United States||Region of Enrollment||participants|Number|91|91.0||||||
4134989|NCT00894647|3959380|B1|United States||Region of Enrollment||participants|Number|90|90.0||||||
4134990|NCT00894647|3959378|B3||Male|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4134991|NCT00894647|3959379|B2||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4134992|NCT00894647|3959380|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4134993|NCT00894647|3959378|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4134994|NCT00894647|3959379|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4134995|NCT00894647|3959380|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4134996|NCT00894647|3959378|B3|||Age||years|Mean|66.7|66.7|Standard Deviation|9.77|9.77|||
4134997|NCT00894647|3959379|B2|||Age||years|Mean|66.0|66.0|Standard Deviation|9.49|9.49|||
4134998|NCT00894647|3959380|B1|||Age||years|Mean|67.3|67.3|Standard Deviation|10.05|10.05|||
4134999|NCT00894647|3959378|B3||>=65 years|Age||Participants|Count of Participants|136|136.0||||||
4135000|NCT00894647|3959379|B2||>=65 years|Age||Participants|Count of Participants|63|63.0||||||
4135001|NCT00894647|3959380|B1||>=65 years|Age||Participants|Count of Participants|73|73.0||||||
4135002|NCT00894647|3959378|B3||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
4135003|NCT00894647|3959379|B2||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4135004|NCT00894647|3959380|B1||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4135005|NCT00894647|3959378|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4135006|NCT00894647|3959379|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4135007|NCT00894647|3959380|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4135008|NCT00894556|3959391|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135009|NCT00894556|3959392|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135010|NCT00894556|3959393|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135011|NCT00894556|3959394|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135012|NCT00894556|3959391|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4135013|NCT00894556|3959392|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4135014|NCT00894556|3959393|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4135015|NCT00894556|3959394|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4135016|NCT00894556|3959391|B4||White|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
4135017|NCT00894556|3959392|B3||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4135018|NCT00894556|3959393|B2||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4135019|NCT00894556|3959394|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4135020|NCT00894556|3959391|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4135021|NCT00894556|3959392|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4135022|NCT00894556|3959393|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4135023|NCT00894556|3959394|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4135024|NCT00894556|3959391|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135025|NCT00894556|3959392|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135026|NCT00894556|3959393|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135027|NCT00894556|3959394|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135028|NCT00894556|3959391|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135029|NCT00894556|3959392|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135030|NCT00894556|3959393|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135031|NCT00894556|3959394|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135032|NCT00894556|3959391|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4135033|NCT00894556|3959392|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4135034|NCT00894556|3959393|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135035|NCT00894556|3959394|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135036|NCT00894556|3959391|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135037|NCT00894556|3959392|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135038|NCT00894556|3959393|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135039|NCT00894556|3959394|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135040|NCT00894556|3959391|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
4135041|NCT00894556|3959392|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4135042|NCT00894556|3959393|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4135043|NCT00894556|3959394|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4135044|NCT00894556|3959391|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4135045|NCT00894556|3959392|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4135046|NCT00894556|3959393|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4135047|NCT00894556|3959394|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4135048|NCT00894556|3959391|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4135049|NCT00894556|3959392|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4135050|NCT00894556|3959393|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4135051|NCT00894556|3959394|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4135052|NCT00894556|3959391|B4||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4135053|NCT00894556|3959392|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4135054|NCT00894556|3959393|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4135055|NCT00894556|3959394|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4135056|NCT00894556|3959391|B4|||Age||years|Mean|43.1|43.1|Standard Deviation|10.9|10.9|||
4135057|NCT00894556|3959392|B3|||Age||years|Mean|43.5|43.5|Standard Deviation|10.2|10.2|||
4135058|NCT00894556|3959393|B2|||Age||years|Mean|43.6|43.6|Standard Deviation|8.9|8.9|||
4135059|NCT00894556|3959394|B1|||Age||years|Mean|42.2|42.2|Standard Deviation|13.4|13.4|||
4135060|NCT00894543|3959406|B3|Don't know||Hysterectomy||participants|Number|1|1.0||||||
4135061|NCT00894543|3959407|B2|Don't know||Hysterectomy||participants|Number|1|1.0||||||
4135062|NCT00894543|3959408|B1|Don't know||Hysterectomy||participants|Number|0|0.0||||||
4135063|NCT00894543|3959406|B3|None||Hysterectomy||participants|Number|155|155.0||||||
4135064|NCT00894543|3959407|B2|None||Hysterectomy||participants|Number|78|78.0||||||
4135065|NCT00894543|3959408|B1|None||Hysterectomy||participants|Number|77|77.0||||||
4135066|NCT00894543|3959406|B3|Oophorectomy only||Hysterectomy||participants|Number|4|4.0||||||
4135067|NCT00894543|3959407|B2|Oophorectomy only||Hysterectomy||participants|Number|1|1.0||||||
4135068|NCT00894543|3959408|B1|Oophorectomy only||Hysterectomy||participants|Number|3|3.0||||||
4135069|NCT00894543|3959406|B3|Hysterectomy and oophorectomy||Hysterectomy||participants|Number|19|19.0||||||
4135070|NCT00894543|3959407|B2|Hysterectomy and oophorectomy||Hysterectomy||participants|Number|8|8.0||||||
4135071|NCT00894543|3959408|B1|Hysterectomy and oophorectomy||Hysterectomy||participants|Number|11|11.0||||||
4135072|NCT00894543|3959406|B3|Hysterectomy||Hysterectomy||participants|Number|26|26.0||||||
4135073|NCT00894543|3959407|B2|Hysterectomy||Hysterectomy||participants|Number|13|13.0||||||
4135074|NCT00894543|3959408|B1|Hysterectomy||Hysterectomy||participants|Number|13|13.0||||||
4135075|NCT00894543|3959406|B3|Missing data||Body Mass Index (BMI)|BMI calculated as (body weight in kilograms) divided by (body height in meters squared) (kg/m^2)|participants|Number|1|1.0||||||
4135076|NCT00894543|3959407|B2|Missing data||Body Mass Index (BMI)|BMI calculated as (body weight in kilograms) divided by (body height in meters squared) (kg/m^2)|participants|Number|1|1.0||||||
4135077|NCT00894543|3959408|B1|Missing data||Body Mass Index (BMI)|BMI calculated as (body weight in kilograms) divided by (body height in meters squared) (kg/m^2)|participants|Number|0|0.0||||||
4135078|NCT00894543|3959406|B3|>=30, kg/m^2||Body Mass Index (BMI)|BMI calculated as (body weight in kilograms) divided by (body height in meters squared) (kg/m^2)|participants|Number|78|78.0||||||
4135079|NCT00894543|3959407|B2|>=30, kg/m^2||Body Mass Index (BMI)|BMI calculated as (body weight in kilograms) divided by (body height in meters squared) (kg/m^2)|participants|Number|40|40.0||||||
4135080|NCT00894543|3959408|B1|>=30, kg/m^2||Body Mass Index (BMI)|BMI calculated as (body weight in kilograms) divided by (body height in meters squared) (kg/m^2)|participants|Number|38|38.0||||||
4135081|NCT00894543|3959406|B3|25-<30, kg/m^2||Body Mass Index (BMI)|BMI calculated as (body weight in kilograms) divided by (body height in meters squared) (kg/m^2)|participants|Number|72|72.0||||||
4135082|NCT00894543|3959407|B2|25-<30, kg/m^2||Body Mass Index (BMI)|BMI calculated as (body weight in kilograms) divided by (body height in meters squared) (kg/m^2)|participants|Number|38|38.0||||||
4135083|NCT00894543|3959408|B1|25-<30, kg/m^2||Body Mass Index (BMI)|BMI calculated as (body weight in kilograms) divided by (body height in meters squared) (kg/m^2)|participants|Number|34|34.0||||||
4135084|NCT00894543|3959406|B3|<25, kg/m^2||Body Mass Index (BMI)|BMI calculated as (body weight in kilograms) divided by (body height in meters squared) (kg/m^2)|participants|Number|54|54.0||||||
4135085|NCT00894543|3959407|B2|<25, kg/m^2||Body Mass Index (BMI)|BMI calculated as (body weight in kilograms) divided by (body height in meters squared) (kg/m^2)|participants|Number|22|22.0||||||
4135086|NCT00894543|3959408|B1|<25, kg/m^2||Body Mass Index (BMI)|BMI calculated as (body weight in kilograms) divided by (body height in meters squared) (kg/m^2)|participants|Number|32|32.0||||||
4135087|NCT00894543|3959406|B3|Early transition||Menopausal Status||participants|Number|6|6.0||||||
4135088|NCT00894543|3959407|B2|Early transition||Menopausal Status||participants|Number|3|3.0||||||
4135089|NCT00894543|3959408|B1|Early transition||Menopausal Status||participants|Number|3|3.0||||||
4135090|NCT00894543|3959406|B3|Late transition||Menopausal Status||participants|Number|32|32.0||||||
4135091|NCT00894543|3959407|B2|Late transition||Menopausal Status||participants|Number|15|15.0||||||
4135092|NCT00894543|3959408|B1|Late transition||Menopausal Status||participants|Number|17|17.0||||||
4135093|NCT00894543|3959406|B3|Postmenopause||Menopausal Status||participants|Number|167|167.0||||||
4135094|NCT00894543|3959407|B2|Postmenopause||Menopausal Status||participants|Number|83|83.0||||||
4135095|NCT00894543|3959408|B1|Postmenopause||Menopausal Status||participants|Number|84|84.0||||||
4135096|NCT00894543|3959406|B3|United States||Region of Enrollment||participants|Number|205|205.0||||||
4135097|NCT00894543|3959407|B2|United States||Region of Enrollment||participants|Number|101|101.0||||||
4135098|NCT00894543|3959408|B1|United States||Region of Enrollment||participants|Number|104|104.0||||||
4135099|NCT00894543|3959406|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4135100|NCT00894543|3959407|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4135101|NCT00894543|3959408|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4135102|NCT00894543|3959406|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135103|NCT00894543|3959407|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135104|NCT00894543|3959408|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135105|NCT00894543|3959406|B3||White|Race (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
4135106|NCT00894543|3959407|B2||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4135107|NCT00894543|3959408|B1||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4135108|NCT00894543|3959406|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
4135109|NCT00894543|3959407|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4135110|NCT00894543|3959408|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4135111|NCT00894543|3959406|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135112|NCT00894543|3959407|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135113|NCT00894543|3959408|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135114|NCT00894543|3959406|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135115|NCT00894543|3959407|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135116|NCT00894543|3959408|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135117|NCT00894543|3959406|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135118|NCT00894543|3959407|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135119|NCT00894543|3959408|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135120|NCT00894543|3959406|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4135121|NCT00894543|3959407|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4135122|NCT00894543|3959408|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4135123|NCT00894543|3959406|B3||Female|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4135124|NCT00894543|3959407|B2||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4135125|NCT00894543|3959408|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4135126|NCT00894543|3959406|B3|||Age||years|Mean|53.9|53.9|Standard Deviation|4.0|4.0|||
4135127|NCT00894543|3959407|B2|||Age||years|Mean|54.36|54.36|Standard Deviation|3.86|3.86|||
4135128|NCT00894543|3959408|B1|||Age||years|Mean|53.45|53.45|Standard Deviation|4.20|4.2|||
4135129|NCT00894543|3959406|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4135130|NCT00894543|3959407|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4135131|NCT00894543|3959408|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4135132|NCT00894543|3959406|B3||Between 18 and 65 years|Age||Participants|Count of Participants|205|205.0||||||
4135133|NCT00894543|3959407|B2||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
4135134|NCT00894543|3959408|B1||Between 18 and 65 years|Age||Participants|Count of Participants|104|104.0||||||
4135135|NCT00894543|3959406|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4135136|NCT00894543|3959407|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4135137|NCT00894543|3959408|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4135138|NCT00894517|3959431|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4135139|NCT00894517|3959432|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4135140|NCT00894517|3959433|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4135141|NCT00894517|3959431|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4135142|NCT00894517|3959432|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4135143|NCT00894517|3959433|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4135144|NCT00894517|3959431|B3|> 60 years||Age, Customized||Participants|Number|16|16.0||||||
4135145|NCT00894517|3959432|B2|> 60 years||Age, Customized||Participants|Number|6|6.0||||||
4135146|NCT00894517|3959433|B1|> 60 years||Age, Customized||Participants|Number|10|10.0||||||
4135147|NCT00894517|3959431|B3|45 to 60 years||Age, Customized||Participants|Number|45|45.0||||||
4135148|NCT00894517|3959432|B2|45 to 60 years||Age, Customized||Participants|Number|25|25.0||||||
4135149|NCT00894517|3959433|B1|45 to 60 years||Age, Customized||Participants|Number|20|20.0||||||
4135150|NCT00894504|3959448|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
4135151|NCT00894504|3959448|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4135152|NCT00894504|3959448|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4135153|NCT00894504|3959448|B1|||Age||Years|Median|54|54.0|Full Range|||32.0|85.0|
4135154|NCT00894465|3959462|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
4135155|NCT00894465|3959463|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4135156|NCT00894465|3959464|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4135157|NCT00894465|3959462|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4135158|NCT00894465|3959463|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4135159|NCT00894465|3959464|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4135160|NCT00894465|3959462|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4135161|NCT00894465|3959463|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4135162|NCT00894465|3959464|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4135163|NCT00894465|3959462|B3|||Age||years|Mean|3.52|3.52|Standard Deviation|1.15|1.15|||
4135164|NCT00894465|3959463|B2|||Age||years|Mean|3.45|3.45|Standard Deviation|1.4|1.4|||
4135165|NCT00894465|3959464|B1|||Age||years|Mean|3.59|3.59|Standard Deviation|0.9|0.9|||
4135166|NCT00894465|3959462|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4135167|NCT00894465|3959463|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4135168|NCT00894465|3959464|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4135169|NCT00894465|3959462|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4135170|NCT00894465|3959463|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4135171|NCT00894465|3959464|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4135172|NCT00894465|3959462|B3||<=18 years|Age||Participants|Count of Participants|44|44.0||||||
4135173|NCT00894465|3959463|B2||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
4135174|NCT00894465|3959464|B1||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
4135175|NCT00894387|3959473|B3||Male|Sex: Female, Male||Participants|Count of Participants|1247|1247.0||||||
4135176|NCT00894387|3959474|B2||Male|Sex: Female, Male||Participants|Count of Participants|610|610.0||||||
4135177|NCT00894387|3959475|B1||Male|Sex: Female, Male||Participants|Count of Participants|637|637.0||||||
4135178|NCT00894387|3959473|B3||Female|Sex: Female, Male||Participants|Count of Participants|368|368.0||||||
4135179|NCT00894387|3959474|B2||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4135180|NCT00894387|3959475|B1||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4135181|NCT00894387|3959473|B3|||Age||years|Mean|64.6|64.6|Standard Deviation|12.16|12.16|||
4135182|NCT00894387|3959474|B2|||Age||years|Mean|64.5|64.5|Standard Deviation|11.88|11.88|||
4135183|NCT00894387|3959475|B1|||Age||years|Mean|64.7|64.7|Standard Deviation|12.44|12.44|||
4135184|NCT00894361|3959494|B3|||range of motion of knee||degrees|Mean|112.8|112.8|Standard Deviation|1.2|1.2|||
4135185|NCT00894361|3959495|B2|||range of motion of knee||degrees|Mean|111.9|111.9|Standard Deviation|1.1|1.1|||
4135186|NCT00894361|3959496|B1|||range of motion of knee||degrees|Mean|113.7|113.7|Standard Deviation|1.0|1.0|||
4135187|NCT00894361|3959494|B3|United States||Region of Enrollment||participants|Number|400|400.0||||||
4135188|NCT00894361|3959495|B2|United States||Region of Enrollment||participants|Number|200|200.0||||||
4135189|NCT00894361|3959496|B1|United States||Region of Enrollment||participants|Number|200|200.0||||||
4135190|NCT00894361|3959494|B3||Male|Sex: Female, Male||Participants|Count of Participants|388|388.0||||||
4135191|NCT00894361|3959495|B2||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4135192|NCT00894361|3959496|B1||Male|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4135193|NCT00894361|3959494|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4135194|NCT00894361|3959495|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4135195|NCT00894361|3959496|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4135196|NCT00894361|3959494|B3||>=65 years|Age||Participants|Count of Participants|247|247.0||||||
4135197|NCT00894361|3959495|B2||>=65 years|Age||Participants|Count of Participants|126|126.0||||||
4135198|NCT00894361|3959496|B1||>=65 years|Age||Participants|Count of Participants|121|121.0||||||
4135199|NCT00894361|3959494|B3||Between 18 and 65 years|Age||Participants|Count of Participants|153|153.0||||||
4135200|NCT00894361|3959495|B2||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
4135201|NCT00894361|3959496|B1||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
4135202|NCT00894361|3959494|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4135203|NCT00894361|3959495|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4135204|NCT00894361|3959496|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4135205|NCT00894322|3959503|B4|||Body Mass Index (BMI)|BMI was measured in kilograms (kg) of body weight per meter (m) of height, squared.|kg/m^2|Mean|35.1|35.1|Standard Deviation|6.1|6.1|||
4135206|NCT00894322|3959504|B3|||Body Mass Index (BMI)|BMI was measured in kilograms (kg) of body weight per meter (m) of height, squared.|kg/m^2|Mean|34.9|34.9|Standard Deviation|4.9|4.9|||
4135207|NCT00894322|3959505|B2|||Body Mass Index (BMI)|BMI was measured in kilograms (kg) of body weight per meter (m) of height, squared.|kg/m^2|Mean|35.3|35.3|Standard Deviation|6.7|6.7|||
4135208|NCT00894322|3959506|B1|||Body Mass Index (BMI)|BMI was measured in kilograms (kg) of body weight per meter (m) of height, squared.|kg/m^2|Mean|28.5|28.5|Standard Deviation|3.5|3.5|||
4135209|NCT00894322|3959503|B4|||Body Weight||kilograms|Mean|104.7|104.7|Standard Deviation|22.0|22.0|||
4135210|NCT00894322|3959504|B3|||Body Weight||kilograms|Mean|104.4|104.4|Standard Deviation|20.3|20.3|||
4135211|NCT00894322|3959505|B2|||Body Weight||kilograms|Mean|104.9|104.9|Standard Deviation|23.2|23.2|||
4135212|NCT00894322|3959506|B1|||Body Weight||kilograms|Mean|85.9|85.9|Standard Deviation|15.5|15.5|||
4135213|NCT00894322|3959503|B4|United States||Region of Enrollment||participants|Number|65|65.0||||||
4135214|NCT00894322|3959504|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4135215|NCT00894322|3959505|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4135216|NCT00894322|3959506|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4135217|NCT00894322|3959503|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4135218|NCT00894322|3959504|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135219|NCT00894322|3959505|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4135220|NCT00894322|3959506|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4135221|NCT00894322|3959503|B4|Native American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4135222|NCT00894322|3959504|B3|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135223|NCT00894322|3959505|B2|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4135224|NCT00894322|3959506|B1|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4135225|NCT00894322|3959503|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4135226|NCT00894322|3959504|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4135227|NCT00894322|3959505|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135228|NCT00894322|3959506|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135229|NCT00894322|3959503|B4|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4135230|NCT00894322|3959504|B3|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135231|NCT00894322|3959505|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4135232|NCT00894322|3959506|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4135233|NCT00894322|3959503|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
4135234|NCT00894322|3959504|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4135235|NCT00894322|3959505|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4135236|NCT00894322|3959506|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4135237|NCT00894322|3959503|B4||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4135238|NCT00894322|3959504|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4135239|NCT00894322|3959505|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4135240|NCT00894322|3959506|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4135241|NCT00894322|3959503|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4135242|NCT00894322|3959504|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4135243|NCT00894322|3959505|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4135244|NCT00894322|3959506|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4135245|NCT00894322|3959503|B4|||Age||years|Mean|52.4|52.4|Standard Deviation|10.7|10.7|||
4135246|NCT00894322|3959504|B3|||Age||years|Mean|52.0|52.0|Standard Deviation|9.3|9.3|||
4135247|NCT00894322|3959505|B2|||Age||years|Mean|52.7|52.7|Standard Deviation|11.6|11.6|||
4135248|NCT00894322|3959506|B1|||Age||years|Mean|41.2|41.2|Standard Deviation|14.4|14.4|||
4135249|NCT00894244|3959547|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4135250|NCT00894244|3959547|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4135251|NCT00894244|3959547|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4135252|NCT00894244|3959547|B1|||Age||years|Mean|56|56.0|Standard Deviation|1.78|1.78|||
4135253|NCT00894244|3959547|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4135254|NCT00894244|3959547|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4135255|NCT00894244|3959547|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4135256|NCT00894166|3959551|B9|United States||Region of Enrollment||participants|Number|606|606.0||||||
4135257|NCT00894166|3959552|B8|United States||Region of Enrollment||participants|Number|34|34.0||||||
4135258|NCT00894166|3959553|B7|United States||Region of Enrollment||participants|Number|35|35.0||||||
4135259|NCT00894166|3959554|B6|United States||Region of Enrollment||participants|Number|36|36.0||||||
4135260|NCT00894166|3959555|B5|United States||Region of Enrollment||participants|Number|34|34.0||||||
4135261|NCT00894166|3959556|B4|United States||Region of Enrollment||participants|Number|114|114.0||||||
4135262|NCT00894166|3959557|B3|United States||Region of Enrollment||participants|Number|112|112.0||||||
4135263|NCT00894166|3959558|B2|United States||Region of Enrollment||participants|Number|109|109.0||||||
4135264|NCT00894166|3959559|B1|United States||Region of Enrollment||participants|Number|132|132.0||||||
4135265|NCT00894166|3959551|B9||Male|Sex: Female, Male||Participants|Count of Participants|306|306.0||||||
4135266|NCT00894166|3959552|B8||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4135267|NCT00894166|3959553|B7||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4135268|NCT00894166|3959554|B6||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4135269|NCT00894166|3959555|B5||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4135270|NCT00894166|3959556|B4||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4135271|NCT00894166|3959557|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4135272|NCT00894166|3959558|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4135273|NCT00894166|3959559|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4135274|NCT00894166|3959551|B9||Female|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
4135275|NCT00894166|3959552|B8||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4135276|NCT00894166|3959553|B7||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4135277|NCT00894166|3959554|B6||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4135278|NCT00894166|3959555|B5||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4135279|NCT00894166|3959556|B4||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4135280|NCT00894166|3959557|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4135281|NCT00894166|3959558|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4135282|NCT00894166|3959559|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4135283|NCT00894166|3959551|B9|||Age||years|Mean|44.3|44.3|Standard Deviation|10.8|10.8|||
4135284|NCT00894166|3959552|B8|||Age||years|Mean|40.7|40.7|Standard Deviation|10.1|10.1|||
4135285|NCT00894166|3959553|B7|||Age||years|Mean|40.8|40.8|Standard Deviation|12.8|12.8|||
4135286|NCT00894166|3959554|B6|||Age||years|Mean|44.1|44.1|Standard Deviation|11.2|11.2|||
4135287|NCT00894166|3959555|B5|||Age||years|Mean|43.1|43.1|Standard Deviation|11.6|11.6|||
4135288|NCT00894166|3959556|B4|||Age||years|Mean|44.3|44.3|Standard Deviation|10.8|10.8|||
4135289|NCT00894166|3959557|B3|||Age||years|Mean|44.7|44.7|Standard Deviation|10.7|10.7|||
4135290|NCT00894166|3959558|B2|||Age||years|Mean|46.0|46.0|Standard Deviation|10.8|10.8|||
4135291|NCT00894166|3959559|B1|||Age||years|Mean|43.6|43.6|Standard Deviation|10.2|10.2|||
4135292|NCT00894166|3959551|B9||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4135293|NCT00894166|3959552|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4135294|NCT00894166|3959553|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4135295|NCT00894166|3959554|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4135296|NCT00894166|3959555|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4135297|NCT00894166|3959556|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4135298|NCT00894166|3959557|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4135299|NCT00894166|3959558|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4135300|NCT00894166|3959559|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4135301|NCT00894166|3959551|B9||Between 18 and 65 years|Age||Participants|Count of Participants|601|601.0||||||
4135302|NCT00894166|3959552|B8||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4135303|NCT00894166|3959553|B7||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4135304|NCT00894166|3959554|B6||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4135305|NCT00894166|3959555|B5||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4135306|NCT00894166|3959556|B4||Between 18 and 65 years|Age||Participants|Count of Participants|113|113.0||||||
4135307|NCT00894166|3959557|B3||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
4135308|NCT00894166|3959558|B2||Between 18 and 65 years|Age||Participants|Count of Participants|108|108.0||||||
4135309|NCT00894166|3959559|B1||Between 18 and 65 years|Age||Participants|Count of Participants|129|129.0||||||
4135310|NCT00894166|3959551|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4135311|NCT00894166|3959552|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4135312|NCT00894166|3959553|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4135313|NCT00894166|3959554|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4135314|NCT00894166|3959555|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4135315|NCT00894166|3959556|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4135316|NCT00894166|3959557|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4135317|NCT00894166|3959558|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4135318|NCT00894166|3959559|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4135319|NCT00894127|3959596|B1|United States||Region of Enrollment||participants|Number|128|128.0||||||
4135320|NCT00894127|3959596|B1||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4135321|NCT00894127|3959596|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4135322|NCT00894127|3959596|B1|cohort 2 n=26||Age, Customized||years|Mean|61.5|61.5|Standard Deviation|9.3|9.3|||
4135323|NCT00894127|3959596|B1|cohort 1 n=102||Age, Customized||years|Mean|57.2|57.2|Standard Deviation|11.6|11.6|||
4135324|NCT00893997|3959600|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4135325|NCT00893997|3959600|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4135326|NCT00893997|3959600|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4135327|NCT00893997|3959600|B1|||Age||years|Median|64|64.0|Full Range|||46.0|84.0|
4135328|NCT00893971|3959605|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4135329|NCT00893971|3959605|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4135330|NCT00893971|3959605|B1|||Age||Years|Mean|27.4|27.4|Standard Deviation|10.1|10.1|||
4135331|NCT00893789|3959719|B5|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4135332|NCT00893789|3959720|B4|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135333|NCT00893789|3959721|B3|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135334|NCT00893789|3959722|B2|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4135335|NCT00893789|3959723|B1|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135336|NCT00893789|3959719|B5|White||Race/Ethnicity, Customized||participants|Number|99|99.0||||||
4135337|NCT00893789|3959720|B4|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4135338|NCT00893789|3959721|B3|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4135339|NCT00893789|3959722|B2|White||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4135340|NCT00893789|3959723|B1|White||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4135341|NCT00893789|3959719|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4135342|NCT00893789|3959720|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4135343|NCT00893789|3959721|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4135344|NCT00893789|3959722|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4135345|NCT00893789|3959723|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4135346|NCT00893789|3959719|B5|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4135347|NCT00893789|3959720|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4135348|NCT00893789|3959721|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135349|NCT00893789|3959722|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135350|NCT00893789|3959723|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4135351|NCT00893789|3959719|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4135352|NCT00893789|3959720|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135353|NCT00893789|3959721|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4135354|NCT00893789|3959722|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135355|NCT00893789|3959723|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135356|NCT00893789|3959719|B5||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4135357|NCT00893789|3959720|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4135358|NCT00893789|3959721|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4135359|NCT00893789|3959722|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4135360|NCT00893789|3959723|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4135361|NCT00893789|3959719|B5||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4135362|NCT00893789|3959720|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4135363|NCT00893789|3959721|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4135364|NCT00893789|3959722|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4135365|NCT00893789|3959723|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4135366|NCT00893789|3959719|B5|||Age||years|Mean|31.3|31.3|Standard Deviation|10.54|10.54|||
4135367|NCT00893789|3959720|B4|||Age||years|Mean|29.4|29.4|Standard Deviation|11.07|11.07|||
4135368|NCT00893789|3959721|B3|||Age||years|Mean|32.3|32.3|Standard Deviation|10.81|10.81|||
4135369|NCT00893789|3959722|B2|||Age||years|Mean|33.2|33.2|Standard Deviation|9.31|9.31|||
4135370|NCT00893789|3959723|B1|||Age||years|Mean|30.2|30.2|Standard Deviation|11.02|11.02|||
4135371|NCT00893763|3959808|B3|United States||Region of Enrollment||participants|Number|314|314.0||||||
4135372|NCT00893763|3959809|B2|United States||Region of Enrollment||participants|Number|157|157.0||||||
4135373|NCT00893763|3959810|B1|United States||Region of Enrollment||participants|Number|157|157.0||||||
4135374|NCT00893763|3959808|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135375|NCT00893763|3959809|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135376|NCT00893763|3959810|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135377|NCT00893763|3959808|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4135378|NCT00893763|3959809|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4135379|NCT00893763|3959810|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4135380|NCT00893763|3959808|B3||White|Race (NIH/OMB)||Participants|Count of Participants|202|202.0||||||
4135381|NCT00893763|3959809|B2||White|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4135382|NCT00893763|3959810|B1||White|Race (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
4135383|NCT00893763|3959808|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
4135384|NCT00893763|3959809|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4135385|NCT00893763|3959810|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4135386|NCT00893763|3959808|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135387|NCT00893763|3959809|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135388|NCT00893763|3959810|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135389|NCT00893763|3959808|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135390|NCT00893763|3959809|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135391|NCT00893763|3959810|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135392|NCT00893763|3959808|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135393|NCT00893763|3959809|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135394|NCT00893763|3959810|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135395|NCT00893763|3959808|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135396|NCT00893763|3959809|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135397|NCT00893763|3959810|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135398|NCT00893763|3959808|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|305|305.0||||||
4135399|NCT00893763|3959809|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|153|153.0||||||
4135400|NCT00893763|3959810|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|152|152.0||||||
4135401|NCT00893763|3959808|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4135402|NCT00893763|3959809|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4135403|NCT00893763|3959810|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4135404|NCT00893763|3959808|B3||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4135405|NCT00893763|3959809|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4135406|NCT00893763|3959810|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4135407|NCT00893763|3959808|B3||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4135408|NCT00893763|3959809|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4135409|NCT00893763|3959810|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4135410|NCT00893763|3959808|B3|||Age||years|Mean|58.12|58.12|Standard Deviation|16.01|16.01|||
4135411|NCT00893763|3959809|B2|||Age||years|Mean|58.20|58.2|Standard Deviation|16.19|16.19|||
4135412|NCT00893763|3959810|B1|||Age||years|Mean|58.08|58.08|Standard Deviation|15.85|15.85|||
4135413|NCT00893737|3959819|B1|United States||Region of Enrollment||participants|Number|147|147.0||||||
4135414|NCT00893737|3959819|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4135415|NCT00893737|3959819|B1||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4135416|NCT00893737|3959819|B1|||Age||years|Mean|44.3|44.3|Standard Deviation|11.0|11.0|||
4135417|NCT00893737|3959819|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4135418|NCT00893737|3959819|B1||Between 18 and 65 years|Age||Participants|Count of Participants|145|145.0||||||
4135419|NCT00893737|3959819|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4135420|NCT00893464|3959825|B9|||Time Since Primary Diagnosis to First Dose||months|Mean|72.8|72.8|Standard Deviation|65.22|65.22|||
4135421|NCT00893464|3959826|B8|||Time Since Primary Diagnosis to First Dose||months|Mean|113.8|113.8|Standard Deviation|89.85|89.85|||
4135422|NCT00893464|3959827|B7|||Time Since Primary Diagnosis to First Dose||months|Mean|57.2|57.2|Standard Deviation|63.50|63.5|||
4135423|NCT00893464|3959828|B6|||Time Since Primary Diagnosis to First Dose||months|Mean|51.9|51.9|Standard Deviation|36.95|36.95|||
4135424|NCT00893464|3959829|B5|||Time Since Primary Diagnosis to First Dose||months|Mean|105.0|105.0|Standard Deviation|95.81|95.81|||
4135425|NCT00893464|3959830|B4|||Time Since Primary Diagnosis to First Dose||months|Mean|82.0|82.0|Standard Deviation|||||
4135426|NCT00893464|3959831|B3|||Time Since Primary Diagnosis to First Dose||months|Mean|75.0|75.0|Standard Deviation|||||
4135427|NCT00893464|3959832|B2|||Time Since Primary Diagnosis to First Dose||months|Mean|50.0|50.0|Standard Deviation|||||
4135428|NCT00893464|3959833|B1|||Time Since Primary Diagnosis to First Dose||months|Mean|53.0|53.0|Standard Deviation|||||
4135429|NCT00893464|3959825|B9|Cutaneous T-cell lymphoma||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|2|2.0||||||
4135430|NCT00893464|3959826|B8|Cutaneous T-cell lymphoma||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|1|1.0||||||
4135431|NCT00893464|3959827|B7|Cutaneous T-cell lymphoma||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|0|0.0||||||
4135432|NCT00893464|3959828|B6|Cutaneous T-cell lymphoma||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|0|0.0||||||
4135433|NCT00893464|3959829|B5|Cutaneous T-cell lymphoma||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|0|0.0||||||
4135434|NCT00893464|3959830|B4|Cutaneous T-cell lymphoma||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|0|0.0||||||
4135435|NCT00893464|3959831|B3|Cutaneous T-cell lymphoma||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|0|0.0||||||
4135582|NCT00893464|3959825|B9|United States||Region of Enrollment||participants|Number|18|18.0||||||
4135436|NCT00893464|3959832|B2|Cutaneous T-cell lymphoma||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|0|0.0||||||
4135437|NCT00893464|3959833|B1|Cutaneous T-cell lymphoma||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|1|1.0||||||
4135438|NCT00893464|3959825|B9|Others||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|3|3.0||||||
4135439|NCT00893464|3959826|B8|Others||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|0|0.0||||||
4135440|NCT00893464|3959827|B7|Others||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|1|1.0||||||
4135441|NCT00893464|3959828|B6|Others||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|0|0.0||||||
4135442|NCT00893464|3959829|B5|Others||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|1|1.0||||||
4135443|NCT00893464|3959830|B4|Others||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|0|0.0||||||
4135444|NCT00893464|3959831|B3|Others||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|1|1.0||||||
4135445|NCT00893464|3959832|B2|Others||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|0|0.0||||||
4135446|NCT00893464|3959833|B1|Others||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|0|0.0||||||
4135447|NCT00893464|3959825|B9|Hodgkin’s lymphoma||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|3|3.0||||||
4135448|NCT00893464|3959826|B8|Hodgkin’s lymphoma||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|0|0.0||||||
4135449|NCT00893464|3959827|B7|Hodgkin’s lymphoma||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|0|0.0||||||
4135450|NCT00893464|3959828|B6|Hodgkin’s lymphoma||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|3|3.0||||||
4135451|NCT00893464|3959829|B5|Hodgkin’s lymphoma||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|0|0.0||||||
4135452|NCT00893464|3959830|B4|Hodgkin’s lymphoma||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|0|0.0||||||
4135453|NCT00893464|3959831|B3|Hodgkin’s lymphoma||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|0|0.0||||||
4135454|NCT00893464|3959832|B2|Hodgkin’s lymphoma||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|0|0.0||||||
4135455|NCT00893464|3959833|B1|Hodgkin’s lymphoma||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|0|0.0||||||
4135456|NCT00893464|3959825|B9|Peripheral T-cell lymphoma not otherwise specified||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|4|4.0||||||
4135457|NCT00893464|3959826|B8|Peripheral T-cell lymphoma not otherwise specified||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|0|0.0||||||
4135458|NCT00893464|3959827|B7|Peripheral T-cell lymphoma not otherwise specified||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|4|4.0||||||
4135459|NCT00893464|3959828|B6|Peripheral T-cell lymphoma not otherwise specified||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|0|0.0||||||
4135460|NCT00893464|3959829|B5|Peripheral T-cell lymphoma not otherwise specified||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|0|0.0||||||
4135461|NCT00893464|3959830|B4|Peripheral T-cell lymphoma not otherwise specified||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|0|0.0||||||
4135462|NCT00893464|3959831|B3|Peripheral T-cell lymphoma not otherwise specified||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|0|0.0||||||
4135463|NCT00893464|3959832|B2|Peripheral T-cell lymphoma not otherwise specified||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|0|0.0||||||
4135464|NCT00893464|3959833|B1|Peripheral T-cell lymphoma not otherwise specified||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|0|0.0||||||
4135465|NCT00893464|3959825|B9|Diffused large B-cell lymphoma||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|5|5.0||||||
4135466|NCT00893464|3959826|B8|Diffused large B-cell lymphoma||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|1|1.0||||||
4135467|NCT00893464|3959827|B7|Diffused large B-cell lymphoma||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|1|1.0||||||
4135468|NCT00893464|3959828|B6|Diffused large B-cell lymphoma||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|2|2.0||||||
4135469|NCT00893464|3959829|B5|Diffused large B-cell lymphoma||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|1|1.0||||||
4135470|NCT00893464|3959830|B4|Diffused large B-cell lymphoma||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|0|0.0||||||
4135471|NCT00893464|3959831|B3|Diffused large B-cell lymphoma||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|0|0.0||||||
4135472|NCT00893464|3959832|B2|Diffused large B-cell lymphoma||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|0|0.0||||||
4135473|NCT00893464|3959833|B1|Diffused large B-cell lymphoma||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|0|0.0||||||
4135474|NCT00893464|3959825|B9|Follicular lymphoma||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|11|11.0||||||
4135475|NCT00893464|3959826|B8|Follicular lymphoma||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|2|2.0||||||
4135476|NCT00893464|3959827|B7|Follicular lymphoma||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|3|3.0||||||
4135477|NCT00893464|3959828|B6|Follicular lymphoma||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|2|2.0||||||
4135478|NCT00893464|3959829|B5|Follicular lymphoma||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|2|2.0||||||
4135479|NCT00893464|3959830|B4|Follicular lymphoma||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|1|1.0||||||
4135480|NCT00893464|3959831|B3|Follicular lymphoma||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|0|0.0||||||
4135481|NCT00893464|3959832|B2|Follicular lymphoma||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|1|1.0||||||
4135482|NCT00893464|3959833|B1|Follicular lymphoma||Disease Histological Class|For this outcome measure, number of participants evaluable were 1, 1, 1, 1, 4, 7, 9 and 4 for each arm, respectively.|participants|Number|0|0.0||||||
4135483|NCT00893464|3959825|B9|Not Applicable||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|4|4.0||||||
4135484|NCT00893464|3959826|B8|Not Applicable||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|2|2.0||||||
4135485|NCT00893464|3959827|B7|Not Applicable||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|1|1.0||||||
4135486|NCT00893464|3959828|B6|Not Applicable||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|1|1.0||||||
4135487|NCT00893464|3959829|B5|Not Applicable||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|0|0.0||||||
4135583|NCT00893464|3959826|B8|United States||Region of Enrollment||participants|Number|3|3.0||||||
4135584|NCT00893464|3959827|B7|United States||Region of Enrollment||participants|Number|5|5.0||||||
4135488|NCT00893464|3959830|B4|Not Applicable||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|0|0.0||||||
4135489|NCT00893464|3959831|B3|Not Applicable||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|0|0.0||||||
4135490|NCT00893464|3959832|B2|Not Applicable||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|0|0.0||||||
4135491|NCT00893464|3959833|B1|Not Applicable||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|0|0.0||||||
4135492|NCT00893464|3959825|B9|Unknown||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|4|4.0||||||
4135493|NCT00893464|3959826|B8|Unknown||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|2|2.0||||||
4135494|NCT00893464|3959827|B7|Unknown||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|1|1.0||||||
4135495|NCT00893464|3959828|B6|Unknown||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|0|0.0||||||
4135496|NCT00893464|3959829|B5|Unknown||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|0|0.0||||||
4135497|NCT00893464|3959830|B4|Unknown||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|0|0.0||||||
4135498|NCT00893464|3959831|B3|Unknown||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|1|1.0||||||
4135585|NCT00893464|3959828|B6|United States||Region of Enrollment||participants|Number|2|2.0||||||
4135499|NCT00893464|3959832|B2|Unknown||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|0|0.0||||||
4135500|NCT00893464|3959833|B1|Unknown||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|0|0.0||||||
4135501|NCT00893464|3959825|B9|IV||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|10|10.0||||||
4135502|NCT00893464|3959826|B8|IV||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|0|0.0||||||
4135503|NCT00893464|3959827|B7|IV||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|4|4.0||||||
4135504|NCT00893464|3959828|B6|IV||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|4|4.0||||||
4135505|NCT00893464|3959829|B5|IV||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|1|1.0||||||
4135506|NCT00893464|3959830|B4|IV||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|1|1.0||||||
4135507|NCT00893464|3959831|B3|IV||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|0|0.0||||||
4135508|NCT00893464|3959832|B2|IV||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|0|0.0||||||
4135509|NCT00893464|3959833|B1|IV||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|0|0.0||||||
4135586|NCT00893464|3959829|B5|United States||Region of Enrollment||participants|Number|4|4.0||||||
4135587|NCT00893464|3959830|B4|United States||Region of Enrollment||participants|Number|1|1.0||||||
4135510|NCT00893464|3959825|B9|III||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|4|4.0||||||
4135511|NCT00893464|3959826|B8|III||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|0|0.0||||||
4135512|NCT00893464|3959827|B7|III||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|2|2.0||||||
4135513|NCT00893464|3959828|B6|III||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|1|1.0||||||
4135514|NCT00893464|3959829|B5|III||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|1|1.0||||||
4135515|NCT00893464|3959830|B4|III||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|0|0.0||||||
4135516|NCT00893464|3959831|B3|III||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|0|0.0||||||
4135517|NCT00893464|3959832|B2|III||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|0|0.0||||||
4135518|NCT00893464|3959833|B1|III||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|0|0.0||||||
4135519|NCT00893464|3959825|B9|II||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|6|6.0||||||
4135520|NCT00893464|3959826|B8|II||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|1|1.0||||||
4135588|NCT00893464|3959831|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4135589|NCT00893464|3959832|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4135521|NCT00893464|3959827|B7|II||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|1|1.0||||||
4135522|NCT00893464|3959828|B6|II||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|1|1.0||||||
4135523|NCT00893464|3959829|B5|II||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|1|1.0||||||
4135524|NCT00893464|3959830|B4|II||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|0|0.0||||||
4135525|NCT00893464|3959831|B3|II||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|0|0.0||||||
4135526|NCT00893464|3959832|B2|II||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|1|1.0||||||
4135527|NCT00893464|3959833|B1|II||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|1|1.0||||||
4135528|NCT00893464|3959825|B9|I||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|2|2.0||||||
4135529|NCT00893464|3959826|B8|I||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|0|0.0||||||
4135530|NCT00893464|3959827|B7|I||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|1|1.0||||||
4135531|NCT00893464|3959828|B6|I||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|0|0.0||||||
4135590|NCT00893464|3959833|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4135591|NCT00893464|3959825|B9|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4135532|NCT00893464|3959829|B5|I||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|1|1.0||||||
4135533|NCT00893464|3959830|B4|I||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|0|0.0||||||
4135534|NCT00893464|3959831|B3|I||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|0|0.0||||||
4135535|NCT00893464|3959832|B2|I||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|0|0.0||||||
4135536|NCT00893464|3959833|B1|I||Ann Arbor Stage|Ann Arbor staging is staging system for lymphomas. The stage is determined by location of tumor. Stage I (located in a single region, usually 1 lymph node and surrounding area), Stage II (located in 2 separate regions, an affected lymph node or organ and a second affected area, and both affected areas are confined to 1 side of diaphragm), Stage III (spread to both sides of diaphragm, including organ/area near lymph nodes/spleen), Stage IV (diffuse or disseminated involvement of 1 or more extra lymphatic organs, including any involvement of liver, bone marrow or nodular involvement of lungs).|participants|Number|0|0.0||||||
4135537|NCT00893464|3959825|B9|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|17|17.0||||||
4135538|NCT00893464|3959826|B8|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|2|2.0||||||
4135539|NCT00893464|3959827|B7|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|9|9.0||||||
4135540|NCT00893464|3959828|B6|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|2|2.0||||||
4135541|NCT00893464|3959829|B5|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|2|2.0||||||
4135542|NCT00893464|3959830|B4|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|0|0.0||||||
4135543|NCT00893464|3959831|B3|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|1|1.0||||||
4135544|NCT00893464|3959832|B2|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|1|1.0||||||
4135545|NCT00893464|3959833|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|0|0.0||||||
4135592|NCT00893464|3959826|B8|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4135546|NCT00893464|3959825|B9|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|13|13.0||||||
4135547|NCT00893464|3959826|B8|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|3|3.0||||||
4135548|NCT00893464|3959827|B7|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|1|1.0||||||
4135549|NCT00893464|3959828|B6|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|5|5.0||||||
4135550|NCT00893464|3959829|B5|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|2|2.0||||||
4135551|NCT00893464|3959830|B4|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|1|1.0||||||
4135552|NCT00893464|3959831|B3|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|0|0.0||||||
4135553|NCT00893464|3959832|B2|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|0|0.0||||||
4135554|NCT00893464|3959833|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status is used to assess how the disease affects the daily living abilities of the participant. It ranges on the scale from 0-5 (0= normal activity; 1= symptoms but ambulatory; 2= in bed for less than (<) 50 percent (%) of the time; 3= in bed for greater than (>) 50% of the time; 4= 100% bedridden; 5= dead.|participants|Number|1|1.0||||||
4135555|NCT00893464|3959825|B9|||Weight||kilogram (kg)|Mean|78.57|78.57|Standard Deviation|17.558|17.558|||
4135556|NCT00893464|3959826|B8|||Weight||kilogram (kg)|Mean|79.84|79.84|Standard Deviation|11.436|11.436|||
4135557|NCT00893464|3959827|B7|||Weight||kilogram (kg)|Mean|73.85|73.85|Standard Deviation|15.321|15.321|||
4135558|NCT00893464|3959828|B6|||Weight||kilogram (kg)|Mean|70.70|70.7|Standard Deviation|13.860|13.86|||
4135559|NCT00893464|3959829|B5|||Weight||kilogram (kg)|Mean|92.60|92.6|Standard Deviation|24.148|24.148|||
4135560|NCT00893464|3959830|B4|||Weight||kilogram (kg)|Mean|83.30|83.3|Standard Deviation|||||
4135561|NCT00893464|3959831|B3|||Weight||kilogram (kg)|Mean|121.00|121.0|Standard Deviation|||||
4135562|NCT00893464|3959832|B2|||Weight||kilogram (kg)|Mean|67.80|67.8|Standard Deviation|||||
4135563|NCT00893464|3959833|B1|||Weight||kilogram (kg)|Mean|82.00|82.0|Standard Deviation|||||
4135564|NCT00893464|3959825|B9|||Height||centimeter (cm)|Mean|169.0|169.0|Standard Deviation|11.26|11.26|||
4135565|NCT00893464|3959826|B8|||Height||centimeter (cm)|Mean|174.2|174.2|Standard Deviation|9.63|9.63|||
4135566|NCT00893464|3959827|B7|||Height||centimeter (cm)|Mean|164.5|164.5|Standard Deviation|12.87|12.87|||
4135567|NCT00893464|3959828|B6|||Height||centimeter (cm)|Mean|168.1|168.1|Standard Deviation|9.48|9.48|||
4135568|NCT00893464|3959829|B5|||Height||centimeter (cm)|Mean|172.8|172.8|Standard Deviation|13.67|13.67|||
4135569|NCT00893464|3959830|B4|||Height||centimeter (cm)|Mean|173.0|173.0|Standard Deviation|||||
4135570|NCT00893464|3959831|B3|||Height||centimeter (cm)|Mean|175.0|175.0|Standard Deviation|||||
4135571|NCT00893464|3959832|B2|||Height||centimeter (cm)|Mean|180.0|180.0|Standard Deviation|||||
4135572|NCT00893464|3959833|B1|||Height||centimeter (cm)|Mean|157.0|157.0|Standard Deviation|||||
4135573|NCT00893464|3959825|B9|||Body surface area (BSA)||square meter|Mean|1.911|1.911|Standard Deviation|0.2534|0.2534|||
4135574|NCT00893464|3959826|B8|||Body surface area (BSA)||square meter|Mean|1.960|1.96|Standard Deviation|0.1785|0.1785|||
4135575|NCT00893464|3959827|B7|||Body surface area (BSA)||square meter|Mean|1.830|1.83|Standard Deviation|0.2403|0.2403|||
4135576|NCT00893464|3959828|B6|||Body surface area (BSA)||square meter|Mean|1.811|1.811|Standard Deviation|0.2183|0.2183|||
4135577|NCT00893464|3959829|B5|||Body surface area (BSA)||square meter|Mean|2.100|2.1|Standard Deviation|0.3445|0.3445|||
4135578|NCT00893464|3959830|B4|||Body surface area (BSA)||square meter|Mean|2.000|2.0|Standard Deviation|||||
4135579|NCT00893464|3959831|B3|||Body surface area (BSA)||square meter|Mean|2.430|2.43|Standard Deviation|||||
4135580|NCT00893464|3959832|B2|||Body surface area (BSA)||square meter|Mean|1.840|1.84|Standard Deviation|||||
4135581|NCT00893464|3959833|B1|||Body surface area (BSA)||square meter|Mean|1.890|1.89|Standard Deviation|||||
4135593|NCT00893464|3959827|B7|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4135594|NCT00893464|3959828|B6|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4135595|NCT00893464|3959829|B5|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4135596|NCT00893464|3959830|B4|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4135597|NCT00893464|3959831|B3|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4135598|NCT00893464|3959832|B2|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4135599|NCT00893464|3959833|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4135600|NCT00893464|3959825|B9|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4135601|NCT00893464|3959826|B8|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4135602|NCT00893464|3959827|B7|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4135603|NCT00893464|3959828|B6|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4135604|NCT00893464|3959829|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4135605|NCT00893464|3959830|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4135606|NCT00893464|3959831|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4135607|NCT00893464|3959832|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4135608|NCT00893464|3959833|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4135609|NCT00893464|3959825|B9|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135610|NCT00893464|3959826|B8|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135611|NCT00893464|3959827|B7|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135612|NCT00893464|3959828|B6|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135613|NCT00893464|3959829|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135614|NCT00893464|3959830|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135615|NCT00893464|3959831|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135616|NCT00893464|3959832|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135617|NCT00893464|3959833|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135618|NCT00893464|3959825|B9|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4135619|NCT00893464|3959826|B8|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135620|NCT00893464|3959827|B7|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4135621|NCT00893464|3959828|B6|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135622|NCT00893464|3959829|B5|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135623|NCT00893464|3959830|B4|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135624|NCT00893464|3959831|B3|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135625|NCT00893464|3959832|B2|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135626|NCT00893464|3959833|B1|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135627|NCT00893464|3959825|B9|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4135628|NCT00893464|3959826|B8|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4135629|NCT00893464|3959827|B7|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135630|NCT00893464|3959828|B6|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4135631|NCT00893464|3959829|B5|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135632|NCT00893464|3959830|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135633|NCT00893464|3959831|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135634|NCT00893464|3959832|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135635|NCT00893464|3959833|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135636|NCT00893464|3959825|B9|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4135637|NCT00893464|3959826|B8|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135638|NCT00893464|3959827|B7|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135639|NCT00893464|3959828|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4135640|NCT00893464|3959829|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135641|NCT00893464|3959830|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135642|NCT00893464|3959831|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4135643|NCT00893464|3959832|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135644|NCT00893464|3959833|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4135645|NCT00893464|3959825|B9|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4135646|NCT00893464|3959826|B8|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4135647|NCT00893464|3959827|B7|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4135648|NCT00893464|3959828|B6|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4135649|NCT00893464|3959829|B5|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4135650|NCT00893464|3959830|B4|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4135651|NCT00893464|3959831|B3|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135652|NCT00893464|3959832|B2|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4135653|NCT00893464|3959833|B1|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135654|NCT00893464|3959825|B9||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4135655|NCT00893464|3959826|B8||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4135656|NCT00893464|3959827|B7||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4135657|NCT00893464|3959828|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4135658|NCT00893464|3959829|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4135659|NCT00893464|3959830|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4135660|NCT00893464|3959831|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4135661|NCT00893464|3959832|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4135662|NCT00893464|3959833|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4135663|NCT00893464|3959825|B9||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4135664|NCT00893464|3959826|B8||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4135665|NCT00893464|3959827|B7||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4135666|NCT00893464|3959828|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4135667|NCT00893464|3959829|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4135668|NCT00893464|3959830|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4135669|NCT00893464|3959831|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4135670|NCT00893464|3959832|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4135671|NCT00893464|3959833|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4135672|NCT00893464|3959825|B9|||Age||years|Mean|57.1|57.1|Standard Deviation|15.02|15.02|||
4135673|NCT00893464|3959826|B8|||Age||years|Mean|53.2|53.2|Standard Deviation|18.51|18.51|||
4135674|NCT00893464|3959827|B7|||Age||years|Mean|64.2|64.2|Standard Deviation|9.51|9.51|||
4135675|NCT00893464|3959828|B6|||Age||years|Mean|44.7|44.7|Standard Deviation|16.52|16.52|||
4135676|NCT00893464|3959829|B5|||Age||years|Mean|69.8|69.8|Standard Deviation|6.18|6.18|||
4135677|NCT00893464|3959830|B4|||Age||years|Mean|53.0|53.0|Standard Deviation|||||
4135678|NCT00893464|3959831|B3|||Age||years|Mean|65.0|65.0|Standard Deviation|||||
4135679|NCT00893464|3959832|B2|||Age||years|Mean|43.0|43.0|Standard Deviation|||||
4135680|NCT00893464|3959833|B1|||Age||years|Mean|51.0|51.0|Standard Deviation|||||
4135681|NCT00893152|3959956|B3|United States||Region of Enrollment||participants|Number|83|83.0||||||
4135682|NCT00893152|3959957|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
4135683|NCT00893152|3959958|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
4135684|NCT00893152|3959956|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4135685|NCT00893152|3959957|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4135686|NCT00893152|3959958|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4135687|NCT00893152|3959956|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4135688|NCT00893152|3959957|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4135689|NCT00893152|3959958|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4135690|NCT00893152|3959956|B3|||Age||years|Mean|38.2|38.2|Standard Deviation|11.7|11.7|||
4135691|NCT00893152|3959957|B2|||Age||years|Mean|39.1|39.1|Standard Deviation|13.1|13.1|||
4135692|NCT00893152|3959958|B1|||Age||years|Mean|37.3|37.3|Standard Deviation|10.9|10.9|||
4135693|NCT00893113|3959965|B3|United States||Region of Enrollment||participants|Number|74|74.0||||||
4135694|NCT00893113|3959966|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
4135695|NCT00893113|3959967|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4135696|NCT00893113|3959965|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4135697|NCT00893113|3959966|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4135698|NCT00893113|3959967|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4135699|NCT00893113|3959965|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4135700|NCT00893113|3959966|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4135701|NCT00893113|3959967|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4135702|NCT00893113|3959965|B3|||Age||years|Mean|54|54.0|Full Range|||36.0|69.0|
4135703|NCT00893113|3959966|B2|||Age||years|Mean|53|53.0|Full Range|||38.0|68.0|
4135704|NCT00893113|3959967|B1|||Age||years|Mean|55|55.0|Full Range|||36.0|69.0|
4135705|NCT00893113|3959965|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4135706|NCT00893113|3959966|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4135707|NCT00893113|3959967|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4135708|NCT00893113|3959965|B3||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
4135709|NCT00893113|3959966|B2||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4135710|NCT00893113|3959967|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4135711|NCT00893113|3959965|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4135712|NCT00893113|3959966|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4135713|NCT00893113|3959967|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4135714|NCT00893074|3959978|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4135715|NCT00893074|3959978|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135716|NCT00893074|3959978|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135717|NCT00893074|3959978|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4135718|NCT00893074|3959978|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4135719|NCT00893074|3959978|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135720|NCT00893074|3959978|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135721|NCT00893074|3959978|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135722|NCT00893074|3959978|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135723|NCT00893074|3959978|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4135724|NCT00893074|3959978|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135725|NCT00893074|3959978|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4135726|NCT00893074|3959978|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4135727|NCT00893074|3959978|B1|||Age||years|Mean|32|32.0|Standard Deviation|8|8.0|||
4135728|NCT00892957|3959996|B3|United States||Region of Enrollment||participants|Number|140|140.0||||||
4135729|NCT00892957|3959997|B2|United States||Region of Enrollment||participants|Number|70|70.0||||||
4135730|NCT00892957|3959998|B1|United States||Region of Enrollment||participants|Number|70|70.0||||||
4135731|NCT00892957|3959996|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4135732|NCT00892957|3959997|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4135733|NCT00892957|3959998|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4135734|NCT00892957|3959996|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4135735|NCT00892957|3959997|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4135736|NCT00892957|3959998|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4135737|NCT00892957|3959996|B3|||Age||years|Mean|64.4|64.4|Standard Deviation|12.2|12.2|||
4135738|NCT00892957|3959997|B2|||Age||years|Mean|66.3|66.3|Standard Deviation|11.5|11.5|||
4135739|NCT00892957|3959998|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|12.6|12.6|||
4135740|NCT00892775|3960085|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4135741|NCT00892775|3960086|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4135742|NCT00892775|3960087|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4135743|NCT00892775|3960085|B3|White - caucasian / european heritage||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4135744|NCT00892775|3960086|B2|White - caucasian / european heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4135745|NCT00892775|3960087|B1|White - caucasian / european heritage||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4135746|NCT00892775|3960085|B3|Asian - south east asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|243|243.0||||||
4135747|NCT00892775|3960086|B2|Asian - south east asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|81|81.0||||||
4135748|NCT00892775|3960087|B1|Asian - south east asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|162|162.0||||||
4135749|NCT00892775|3960085|B3|Asian - East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|248|248.0||||||
4135750|NCT00892775|3960086|B2|Asian - East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|83|83.0||||||
4135751|NCT00892775|3960087|B1|Asian - East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|165|165.0||||||
4135752|NCT00892775|3960085|B3|Male||Sex/Gender, Customized||Participants|Count of Participants|248|248.0||||||
4135753|NCT00892775|3960086|B2|Male||Sex/Gender, Customized||Participants|Count of Participants|82|82.0||||||
4135754|NCT00892775|3960087|B1|Male||Sex/Gender, Customized||Participants|Count of Participants|166|166.0||||||
4135755|NCT00892775|3960085|B3|Female||Sex/Gender, Customized||Participants|Count of Participants|250|250.0||||||
4135756|NCT00892775|3960086|B2|Female||Sex/Gender, Customized||Participants|Count of Participants|84|84.0||||||
4135757|NCT00892775|3960087|B1|Female||Sex/Gender, Customized||Participants|Count of Participants|166|166.0||||||
4135758|NCT00892775|3960085|B3|||Age||Months|Mean|12.97|12.97|Standard Deviation|1.86|1.86|||
4135759|NCT00892775|3960086|B2|||Age||Months|Mean|12.9|12.9|Standard Deviation|1.7|1.7|||
4135760|NCT00892775|3960087|B1|||Age||Months|Mean|13|13.0|Standard Deviation|1.94|1.94|||
4135761|NCT00892723|3960112|B4|United States||Region of Enrollment||participants|Number|59|59.0||||||
4135762|NCT00892723|3960113|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4135763|NCT00892723|3960114|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4135764|NCT00892723|3960115|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4135765|NCT00892723|3960112|B4||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4135766|NCT00892723|3960113|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4135767|NCT00892723|3960114|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4135768|NCT00892723|3960115|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4135769|NCT00892723|3960112|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4135770|NCT00892723|3960113|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4135771|NCT00892723|3960114|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4135772|NCT00892723|3960115|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4135773|NCT00892723|3960112|B4|||Age||years|Mean|36.9|36.9|Standard Deviation|11.2|11.2|||
4135774|NCT00892723|3960113|B3|||Age||years|Mean|37.5|37.5|Standard Deviation|12.4|12.4|||
4135775|NCT00892723|3960114|B2|||Age||years|Mean|36.1|36.1|Standard Deviation|10.9|10.9|||
4135776|NCT00892723|3960115|B1|||Age||years|Mean|37.1|37.1|Standard Deviation|11|11.0|||
4135777|NCT00892723|3960112|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4135778|NCT00892723|3960113|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4135779|NCT00892723|3960114|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4135780|NCT00892723|3960115|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4135781|NCT00892723|3960112|B4||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4135782|NCT00892723|3960113|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4135783|NCT00892723|3960114|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4135784|NCT00892723|3960115|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4135785|NCT00892723|3960112|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4135786|NCT00892723|3960113|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4135787|NCT00892723|3960114|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4135788|NCT00892723|3960115|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4135789|NCT00892710|3960158|B4|United States||Region of Enrollment||participants|Number|172|172.0||||||
4135790|NCT00892710|3960159|B3|United States||Region of Enrollment||participants|Number|61|61.0||||||
4135791|NCT00892710|3960160|B2|United States||Region of Enrollment||participants|Number|63|63.0||||||
4135792|NCT00892710|3960161|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4135793|NCT00892710|3960158|B4||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4135794|NCT00892710|3960159|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4135795|NCT00892710|3960160|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4135796|NCT00892710|3960161|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4135797|NCT00892710|3960158|B4||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4135798|NCT00892710|3960159|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4135799|NCT00892710|3960160|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4135800|NCT00892710|3960161|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4135801|NCT00892710|3960158|B4|||Age||years|Median|72|72.0|Full Range|||48.0|90.0|
4135802|NCT00892710|3960159|B3|||Age||years|Median|73|73.0|Full Range|||48.0|90.0|
4135803|NCT00892710|3960160|B2|||Age||years|Median|72|72.0|Full Range|||50.0|90.0|
4135804|NCT00892710|3960161|B1|||Age||years|Median|72|72.0|Full Range|||51.0|84.0|
4135805|NCT00892697|3960186|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4135806|NCT00892697|3960186|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4135807|NCT00892697|3960186|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4135808|NCT00892697|3960186|B1|||Age||years|Median|50|50.0|Inter-Quartile Range|||46.5|58.0|
4135809|NCT00892697|3960186|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4135810|NCT00892697|3960186|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4135811|NCT00892697|3960186|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4135812|NCT00892606|3960191|B3|United States||Region of Enrollment||participants|Number|75|75.0||||||
4135813|NCT00892606|3960192|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4135814|NCT00892606|3960193|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4135815|NCT00892606|3960191|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4135816|NCT00892606|3960192|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4135817|NCT00892606|3960193|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4135818|NCT00892606|3960191|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4135819|NCT00892606|3960192|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4135820|NCT00892606|3960193|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4135821|NCT00892606|3960191|B3|||Age||years|Mean|36|36.0|Standard Deviation|12|12.0|||
4135822|NCT00892606|3960192|B2|||Age||years|Mean|35|35.0|Standard Deviation|12|12.0|||
4135823|NCT00892606|3960193|B1|||Age||years|Mean|37|37.0|Standard Deviation|13|13.0|||
4135824|NCT00892437|3960204|B3|Positive||Chronic Hepatitis C Infection Status||participants|Number|0|0.0||||||
4135825|NCT00892437|3960205|B2|Positive||Chronic Hepatitis C Infection Status||participants|Number|0|0.0||||||
4135826|NCT00892437|3960206|B1|Positive||Chronic Hepatitis C Infection Status||participants|Number|0|0.0||||||
4135827|NCT00892437|3960204|B3|Negative||Chronic Hepatitis C Infection Status||participants|Number|79|79.0||||||
4135828|NCT00892437|3960205|B2|Negative||Chronic Hepatitis C Infection Status||participants|Number|29|29.0||||||
4135829|NCT00892437|3960206|B1|Negative||Chronic Hepatitis C Infection Status||participants|Number|50|50.0||||||
4135830|NCT00892437|3960204|B3|Positive||Chronic Hepatitis B Infection Status||participants|Number|0|0.0||||||
4135831|NCT00892437|3960205|B2|Positive||Chronic Hepatitis B Infection Status||participants|Number|0|0.0||||||
4135832|NCT00892437|3960206|B1|Positive||Chronic Hepatitis B Infection Status||participants|Number|0|0.0||||||
4135833|NCT00892437|3960204|B3|Negative||Chronic Hepatitis B Infection Status||participants|Number|79|79.0||||||
4135834|NCT00892437|3960205|B2|Negative||Chronic Hepatitis B Infection Status||participants|Number|29|29.0||||||
4135835|NCT00892437|3960206|B1|Negative||Chronic Hepatitis B Infection Status||participants|Number|50|50.0||||||
4135836|NCT00892437|3960204|B3|AIDS||HIV Disease Status||participants|Number|11|11.0||||||
4135837|NCT00892437|3960205|B2|AIDS||HIV Disease Status||participants|Number|3|3.0||||||
4135838|NCT00892437|3960206|B1|AIDS||HIV Disease Status||participants|Number|8|8.0||||||
4135839|NCT00892437|3960204|B3|Symptomatic HIV Infections||HIV Disease Status||participants|Number|2|2.0||||||
4135840|NCT00892437|3960205|B2|Symptomatic HIV Infections||HIV Disease Status||participants|Number|1|1.0||||||
4135841|NCT00892437|3960206|B1|Symptomatic HIV Infections||HIV Disease Status||participants|Number|1|1.0||||||
4135842|NCT00892437|3960204|B3|Asymptomatic||HIV Disease Status||participants|Number|66|66.0||||||
4135843|NCT00892437|3960205|B2|Asymptomatic||HIV Disease Status||participants|Number|25|25.0||||||
4135844|NCT00892437|3960206|B1|Asymptomatic||HIV Disease Status||participants|Number|41|41.0||||||
4135845|NCT00892437|3960204|B3|> 500 cells/μL||CD4 Cell Count Category||participants|Number|11|11.0||||||
4135846|NCT00892437|3960205|B2|> 500 cells/μL||CD4 Cell Count Category||participants|Number|4|4.0||||||
4135847|NCT00892437|3960206|B1|> 500 cells/μL||CD4 Cell Count Category||participants|Number|7|7.0||||||
4135848|NCT00892437|3960204|B3|351 to ≤ 500 cells/μL||CD4 Cell Count Category||participants|Number|28|28.0||||||
4135849|NCT00892437|3960205|B2|351 to ≤ 500 cells/μL||CD4 Cell Count Category||participants|Number|11|11.0||||||
4135850|NCT00892437|3960206|B1|351 to ≤ 500 cells/μL||CD4 Cell Count Category||participants|Number|17|17.0||||||
4135851|NCT00892437|3960204|B3|201 to ≤ 350 cells/μL||CD4 Cell Count Category||participants|Number|23|23.0||||||
4135852|NCT00892437|3960205|B2|201 to ≤ 350 cells/μL||CD4 Cell Count Category||participants|Number|7|7.0||||||
4135853|NCT00892437|3960206|B1|201 to ≤ 350 cells/μL||CD4 Cell Count Category||participants|Number|16|16.0||||||
4135854|NCT00892437|3960204|B3|51 to ≤ 200 cells/μL||CD4 Cell Count Category||participants|Number|15|15.0||||||
4135855|NCT00892437|3960205|B2|51 to ≤ 200 cells/μL||CD4 Cell Count Category||participants|Number|6|6.0||||||
4135856|NCT00892437|3960206|B1|51 to ≤ 200 cells/μL||CD4 Cell Count Category||participants|Number|9|9.0||||||
4135857|NCT00892437|3960204|B3|≤ 50 cells/μL||CD4 Cell Count Category||participants|Number|2|2.0||||||
4135858|NCT00892437|3960205|B2|≤ 50 cells/μL||CD4 Cell Count Category||participants|Number|1|1.0||||||
4135859|NCT00892437|3960206|B1|≤ 50 cells/μL||CD4 Cell Count Category||participants|Number|1|1.0||||||
4135860|NCT00892437|3960204|B3|||Cluster of differentiation (CD4) Cell Count||cells/uL|Mean|357|357.0|Standard Deviation|192.2|192.2|||
4135861|NCT00892437|3960205|B2|||Cluster of differentiation (CD4) Cell Count||cells/uL|Mean|343|343.0|Standard Deviation|178.1|178.1|||
4135862|NCT00892437|3960206|B1|||Cluster of differentiation (CD4) Cell Count||cells/uL|Mean|365|365.0|Standard Deviation|201.3|201.3|||
4135863|NCT00892437|3960204|B3|> 100,000 copies/mL||HIV-1 RNA Category||participants|Number|23|23.0||||||
4135864|NCT00892437|3960205|B2|> 100,000 copies/mL||HIV-1 RNA Category||participants|Number|11|11.0||||||
4135865|NCT00892437|3960206|B1|> 100,000 copies/mL||HIV-1 RNA Category||participants|Number|12|12.0||||||
4135866|NCT00892437|3960204|B3|≤ 100,000 copies/mL||HIV-1 RNA Category||participants|Number|56|56.0||||||
4135867|NCT00892437|3960205|B2|≤ 100,000 copies/mL||HIV-1 RNA Category||participants|Number|18|18.0||||||
4135868|NCT00892437|3960206|B1|≤ 100,000 copies/mL||HIV-1 RNA Category||participants|Number|38|38.0||||||
4135869|NCT00892437|3960204|B3|||HIV-1 RNA||log_10 copies/mL|Mean|4.61|4.61|Standard Deviation|0.614|0.614|||
4135870|NCT00892437|3960205|B2|||HIV-1 RNA||log_10 copies/mL|Mean|4.69|4.69|Standard Deviation|0.530|0.53|||
4135871|NCT00892437|3960206|B1|||HIV-1 RNA||log_10 copies/mL|Mean|4.56|4.56|Standard Deviation|0.657|0.657|||
4135872|NCT00892437|3960204|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4135873|NCT00892437|3960205|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4135874|NCT00892437|3960206|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4135875|NCT00892437|3960204|B3|White||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4135876|NCT00892437|3960205|B2|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4135877|NCT00892437|3960206|B1|White||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4135878|NCT00892437|3960204|B3|Black||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4135879|NCT00892437|3960205|B2|Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4135880|NCT00892437|3960206|B1|Black||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4135881|NCT00892437|3960204|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4135882|NCT00892437|3960205|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4135883|NCT00892437|3960206|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4135884|NCT00892437|3960204|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135885|NCT00892437|3960205|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135886|NCT00892437|3960206|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135887|NCT00892437|3960204|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4135888|NCT00892437|3960205|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4135889|NCT00892437|3960206|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4135890|NCT00892437|3960204|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4135891|NCT00892437|3960205|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4135892|NCT00892437|3960206|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4135893|NCT00892437|3960204|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4135894|NCT00892437|3960205|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4135895|NCT00892437|3960206|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4135896|NCT00892437|3960204|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4135897|NCT00892437|3960205|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4135898|NCT00892437|3960206|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4135899|NCT00892437|3960204|B3|||Age||years|Mean|36|36.0|Standard Deviation|9.8|9.8|||
4135900|NCT00892437|3960205|B2|||Age||years|Mean|34|34.0|Standard Deviation|10.1|10.1|||
4135901|NCT00892437|3960206|B1|||Age||years|Mean|37|37.0|Standard Deviation|9.6|9.6|||
4135902|NCT00892281|3960224|B3||Male|Sex: Female, Male||Participants|Count of Participants|414|414.0||||||
4135903|NCT00892281|3960225|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4135904|NCT00892281|3960226|B1||Male|Sex: Female, Male||Participants|Count of Participants|344|344.0||||||
4135905|NCT00892281|3960224|B3||Female|Sex: Female, Male||Participants|Count of Participants|1007|1007.0||||||
4135906|NCT00892281|3960225|B2||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4135907|NCT00892281|3960226|B1||Female|Sex: Female, Male||Participants|Count of Participants|853|853.0||||||
4135908|NCT00892281|3960224|B3|>=18 years||Age||years|Mean|50.7|50.7|Standard Deviation|13.4|13.4|||
4135909|NCT00892281|3960225|B2|>=18 years||Age||years|Mean|53.4|53.4|Standard Deviation|12.9|12.9|||
4135910|NCT00892281|3960226|B1|>=18 years||Age||years|Mean|50.2|50.2|Standard Deviation|13.9|13.9|||
4135911|NCT00892177|3960237|B4|United States||Region of Enrollment||Participants|Count of Participants|137|137.0||||||
4135912|NCT00892177|3960238|B3|United States||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
4135913|NCT00892177|3960239|B2|United States||Region of Enrollment||Participants|Count of Participants|83|83.0||||||
4135914|NCT00892177|3960240|B1|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4135915|NCT00892177|3960237|B4||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4135916|NCT00892177|3960238|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4135917|NCT00892177|3960239|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4135918|NCT00892177|3960240|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4135919|NCT00892177|3960237|B4||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4135920|NCT00892177|3960238|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4135921|NCT00892177|3960239|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4135922|NCT00892177|3960240|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4135923|NCT00892177|3960237|B4|||Age||years|Median|57|57.0|Full Range|||18.0|79.0|
4135924|NCT00892177|3960238|B3|||Age||years|Median|56.5|56.5|Full Range|||18.0|71.0|
4135925|NCT00892177|3960239|B2|||Age||years|Median|58|58.0|Full Range|||29.0|79.0|
4135926|NCT00892177|3960240|B1|||Age||years|Median|46.5|46.5|Full Range|||28.0|68.0|
4135927|NCT00892151|3960270|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4135928|NCT00892151|3960270|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4135929|NCT00892151|3960270|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4135930|NCT00892151|3960270|B1|||Age, Customized|Baseline measures apply to lay persons (n=40) not healthcare professionals in the study. Ages ranged from 18 to 67 years.|years|Median|36|36.0|Full Range|||18.0|67.0|
4135931|NCT00892099|3960276|B4|||25(OH) vitamin D||ng/ml|Mean|21.9|21.9|Standard Deviation|6.9|6.9|||
4135932|NCT00892099|3960277|B3|||25(OH) vitamin D||ng/ml|Mean|21.7|21.7|Standard Deviation|7.3|7.3|||
4135933|NCT00892099|3960278|B2|||25(OH) vitamin D||ng/ml|Mean|22.3|22.3|Standard Deviation|6.5|6.5|||
4135934|NCT00892099|3960279|B1|||25(OH) vitamin D||ng/ml|Mean|21.8|21.8|Standard Deviation|7|7.0|||
4135935|NCT00892099|3960276|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135936|NCT00892099|3960277|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135937|NCT00892099|3960278|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135938|NCT00892099|3960279|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135939|NCT00892099|3960276|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4135940|NCT00892099|3960277|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4135941|NCT00892099|3960278|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4135942|NCT00892099|3960279|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135943|NCT00892099|3960276|B4||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4135944|NCT00892099|3960277|B3||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4135945|NCT00892099|3960278|B2||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4135946|NCT00892099|3960279|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4135947|NCT00892099|3960276|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4135948|NCT00892099|3960277|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4135949|NCT00892099|3960278|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4135950|NCT00892099|3960279|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4135951|NCT00892099|3960276|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135952|NCT00892099|3960277|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135953|NCT00892099|3960278|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135954|NCT00892099|3960279|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135955|NCT00892099|3960276|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4135956|NCT00892099|3960277|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4135957|NCT00892099|3960278|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4135958|NCT00892099|3960279|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135959|NCT00892099|3960276|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135960|NCT00892099|3960277|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135961|NCT00892099|3960278|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135962|NCT00892099|3960279|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135963|NCT00892099|3960276|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135964|NCT00892099|3960277|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135965|NCT00892099|3960278|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135966|NCT00892099|3960279|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4135967|NCT00892099|3960276|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4135968|NCT00892099|3960277|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4135969|NCT00892099|3960278|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4135970|NCT00892099|3960279|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4135971|NCT00892099|3960276|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4135972|NCT00892099|3960277|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4135973|NCT00892099|3960278|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4135974|NCT00892099|3960279|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4135975|NCT00892099|3960276|B4||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4135976|NCT00892099|3960277|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4135977|NCT00892099|3960278|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4135978|NCT00892099|3960279|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4135979|NCT00892099|3960276|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4135980|NCT00892099|3960277|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4135981|NCT00892099|3960278|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4135982|NCT00892099|3960279|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4135983|NCT00892099|3960276|B4|||Age||years|Mean|57|57.0|Standard Deviation|17|17.0|||
4135984|NCT00892099|3960277|B3|||Age||years|Mean|59|59.0|Standard Deviation|17|17.0|||
4135985|NCT00892099|3960278|B2|||Age||years|Mean|58|58.0|Standard Deviation|16|16.0|||
4135986|NCT00892099|3960279|B1|||Age||years|Mean|53|53.0|Standard Deviation|17|17.0|||
4135987|NCT00892047|3960304|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4135988|NCT00892047|3960305|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4135989|NCT00892047|3960306|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4135990|NCT00892047|3960304|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4135991|NCT00892047|3960305|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4135992|NCT00892047|3960306|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4135993|NCT00892047|3960304|B3|||Age||years|Median|66.0|66.0|Inter-Quartile Range|||62.8|70.5|
4135994|NCT00892047|3960305|B2|||Age||years|Median|65.7|65.7|Inter-Quartile Range|||62.8|69.8|
4135995|NCT00892047|3960306|B1|||Age||years|Median|66.4|66.4|Inter-Quartile Range|||62.8|71.6|
4135996|NCT00892008|3960323|B1|unspecified||Sex/Gender, Customized||participants|Number|22|22.0||||||
4135997|NCT00892008|3960323|B1|male||Sex/Gender, Customized||participants|Number|932|932.0||||||
4135998|NCT00892008|3960323|B1|female||Sex/Gender, Customized||participants|Number|1324|1324.0||||||
4135999|NCT00892008|3960323|B1|unspecified||Age, Customized||participants|Number|191|191.0||||||
4136000|NCT00892008|3960323|B1|≥ 65 years||Age, Customized||participants|Number|451|451.0||||||
4136001|NCT00892008|3960323|B1|45-64 years||Age, Customized||participants|Number|1054|1054.0||||||
4136002|NCT00892008|3960323|B1|18-44 years||Age, Customized||participants|Number|582|582.0||||||
4136003|NCT00891995|3960337|B3|Unknown||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4136004|NCT00891995|3960338|B2|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4136005|NCT00891995|3960339|B1|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4136006|NCT00891995|3960337|B3|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4136007|NCT00891995|3960338|B2|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4136008|NCT00891995|3960339|B1|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4136009|NCT00891995|3960337|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4136010|NCT00891995|3960338|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4136011|NCT00891995|3960339|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4136012|NCT00891995|3960337|B3|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4136013|NCT00891995|3960338|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4136014|NCT00891995|3960339|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4136015|NCT00891995|3960337|B3|White||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
4136016|NCT00891995|3960338|B2|White||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4136017|NCT00891995|3960339|B1|White||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4136018|NCT00891995|3960337|B3||Male|Gender||Participants|Count of Participants|44|44.0||||||
4136019|NCT00891995|3960338|B2||Male|Gender||Participants|Count of Participants|13|13.0||||||
4136020|NCT00891995|3960339|B1||Male|Gender||Participants|Count of Participants|31|31.0||||||
4136021|NCT00891995|3960337|B3||Female|Gender||Participants|Count of Participants|24|24.0||||||
4136022|NCT00891995|3960338|B2||Female|Gender||Participants|Count of Participants|7|7.0||||||
4136023|NCT00891995|3960339|B1||Female|Gender||Participants|Count of Participants|17|17.0||||||
4136024|NCT00891995|3960337|B3|||Age||years|Mean|13.3|13.3|Standard Deviation|5.7|5.7|||
4136025|NCT00891995|3960338|B2|||Age||years|Mean|14.7|14.7|Standard Deviation|7.6|7.6|||
4136026|NCT00891995|3960339|B1|||Age||years|Mean|12.7|12.7|Standard Deviation|4.7|4.7|||
4136027|NCT00891995|3960337|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4136028|NCT00891995|3960338|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4136029|NCT00891995|3960339|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4136030|NCT00891995|3960337|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4136031|NCT00891995|3960338|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4136032|NCT00891995|3960339|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4136033|NCT00891995|3960337|B3||<=18 years|Age||Participants|Count of Participants|65|65.0||||||
4136034|NCT00891995|3960338|B2||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
4136035|NCT00891995|3960339|B1||<=18 years|Age||Participants|Count of Participants|46|46.0||||||
4136036|NCT00891982|3960362|B3|Grade 4||ISGA|Investigator's Static Global Assessment measured on a 6 point scale where 0=normal, clear skin; 1 = skin almost clear; 2 = Some noninflammatory lesions are present, with few inflammatory lesions; 3 = Noninflammatory lesions predominate, with multiple inflammatory lesions evident; 4 = Inflammatory lesions are more apparent: many comedones and papules/pustules,there may or may not be a few nodulocystic lesions; and 5=highly inflammatory lesions predominate.|participants|Number|8|8.0||||||
4136037|NCT00891982|3960363|B2|Grade 4||ISGA|Investigator's Static Global Assessment measured on a 6 point scale where 0=normal, clear skin; 1 = skin almost clear; 2 = Some noninflammatory lesions are present, with few inflammatory lesions; 3 = Noninflammatory lesions predominate, with multiple inflammatory lesions evident; 4 = Inflammatory lesions are more apparent: many comedones and papules/pustules,there may or may not be a few nodulocystic lesions; and 5=highly inflammatory lesions predominate.|participants|Number|5|5.0||||||
4136038|NCT00891982|3960364|B1|Grade 4||ISGA|Investigator's Static Global Assessment measured on a 6 point scale where 0=normal, clear skin; 1 = skin almost clear; 2 = Some noninflammatory lesions are present, with few inflammatory lesions; 3 = Noninflammatory lesions predominate, with multiple inflammatory lesions evident; 4 = Inflammatory lesions are more apparent: many comedones and papules/pustules,there may or may not be a few nodulocystic lesions; and 5=highly inflammatory lesions predominate.|participants|Number|3|3.0||||||
4136039|NCT00891982|3960362|B3|Grade 3||ISGA|Investigator's Static Global Assessment measured on a 6 point scale where 0=normal, clear skin; 1 = skin almost clear; 2 = Some noninflammatory lesions are present, with few inflammatory lesions; 3 = Noninflammatory lesions predominate, with multiple inflammatory lesions evident; 4 = Inflammatory lesions are more apparent: many comedones and papules/pustules,there may or may not be a few nodulocystic lesions; and 5=highly inflammatory lesions predominate.|participants|Number|33|33.0||||||
4136040|NCT00891982|3960363|B2|Grade 3||ISGA|Investigator's Static Global Assessment measured on a 6 point scale where 0=normal, clear skin; 1 = skin almost clear; 2 = Some noninflammatory lesions are present, with few inflammatory lesions; 3 = Noninflammatory lesions predominate, with multiple inflammatory lesions evident; 4 = Inflammatory lesions are more apparent: many comedones and papules/pustules,there may or may not be a few nodulocystic lesions; and 5=highly inflammatory lesions predominate.|participants|Number|15|15.0||||||
4136041|NCT00891982|3960364|B1|Grade 3||ISGA|Investigator's Static Global Assessment measured on a 6 point scale where 0=normal, clear skin; 1 = skin almost clear; 2 = Some noninflammatory lesions are present, with few inflammatory lesions; 3 = Noninflammatory lesions predominate, with multiple inflammatory lesions evident; 4 = Inflammatory lesions are more apparent: many comedones and papules/pustules,there may or may not be a few nodulocystic lesions; and 5=highly inflammatory lesions predominate.|participants|Number|18|18.0||||||
4136042|NCT00891982|3960362|B3|Grade 2||ISGA|Investigator's Static Global Assessment measured on a 6 point scale where 0=normal, clear skin; 1 = skin almost clear; 2 = Some noninflammatory lesions are present, with few inflammatory lesions; 3 = Noninflammatory lesions predominate, with multiple inflammatory lesions evident; 4 = Inflammatory lesions are more apparent: many comedones and papules/pustules,there may or may not be a few nodulocystic lesions; and 5=highly inflammatory lesions predominate.|participants|Number|20|20.0||||||
4136043|NCT00891982|3960363|B2|Grade 2||ISGA|Investigator's Static Global Assessment measured on a 6 point scale where 0=normal, clear skin; 1 = skin almost clear; 2 = Some noninflammatory lesions are present, with few inflammatory lesions; 3 = Noninflammatory lesions predominate, with multiple inflammatory lesions evident; 4 = Inflammatory lesions are more apparent: many comedones and papules/pustules,there may or may not be a few nodulocystic lesions; and 5=highly inflammatory lesions predominate.|participants|Number|11|11.0||||||
4136044|NCT00891982|3960364|B1|Grade 2||ISGA|Investigator's Static Global Assessment measured on a 6 point scale where 0=normal, clear skin; 1 = skin almost clear; 2 = Some noninflammatory lesions are present, with few inflammatory lesions; 3 = Noninflammatory lesions predominate, with multiple inflammatory lesions evident; 4 = Inflammatory lesions are more apparent: many comedones and papules/pustules,there may or may not be a few nodulocystic lesions; and 5=highly inflammatory lesions predominate.|participants|Number|9|9.0||||||
4136045|NCT00891982|3960362|B3|United States||Region of Enrollment||participants|Number|61|61.0||||||
4136046|NCT00891982|3960363|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
4136047|NCT00891982|3960364|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4136048|NCT00891982|3960362|B3|More than one race||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4136049|NCT00891982|3960363|B2|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4136050|NCT00891982|3960364|B1|More than one race||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4136051|NCT00891982|3960362|B3|White||Race/Ethnicity, Customized||Participants|Number|52|52.0||||||
4136052|NCT00891982|3960363|B2|White||Race/Ethnicity, Customized||Participants|Number|28|28.0||||||
4136053|NCT00891982|3960364|B1|White||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
4136054|NCT00891982|3960362|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4136055|NCT00891982|3960363|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4136056|NCT00891982|3960364|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4136057|NCT00891982|3960362|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136058|NCT00891982|3960363|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136059|NCT00891982|3960364|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136060|NCT00891982|3960362|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4136061|NCT00891982|3960363|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4136062|NCT00891982|3960364|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4136063|NCT00891982|3960362|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4136064|NCT00891982|3960363|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4136065|NCT00891982|3960364|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4136066|NCT00891982|3960362|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4136067|NCT00891982|3960363|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4136068|NCT00891982|3960364|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4136069|NCT00891982|3960362|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4136070|NCT00891982|3960363|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4136071|NCT00891982|3960364|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4136072|NCT00891982|3960362|B3|Between 18 and 45 years||Age, Customized||participants|Number|31|31.0||||||
4136073|NCT00891982|3960363|B2|Between 18 and 45 years||Age, Customized||participants|Number|17|17.0||||||
4136074|NCT00891982|3960364|B1|Between 18 and 45 years||Age, Customized||participants|Number|14|14.0||||||
4136075|NCT00891982|3960362|B3|<18 years||Age, Customized||participants|Number|30|30.0||||||
4136076|NCT00891982|3960363|B2|<18 years||Age, Customized||participants|Number|14|14.0||||||
4136077|NCT00891982|3960364|B1|<18 years||Age, Customized||participants|Number|16|16.0||||||
4136078|NCT00891930|3960409|B1|Rectal Cancer||Primary Diagnosis||participants|Number|27|27.0||||||
4136079|NCT00891930|3960409|B1|Colon Cancer||Primary Diagnosis||participants|Number|49|49.0||||||
4136080|NCT00891930|3960409|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4136081|NCT00891930|3960409|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|75|75.0||||||
4136082|NCT00891930|3960409|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4136083|NCT00891930|3960409|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4136084|NCT00891930|3960409|B1|||Age||years|Mean|62.4|62.4|Standard Deviation|9.9|9.9|||
4136085|NCT00891904|3960430|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4136086|NCT00891904|3960430|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4136087|NCT00891904|3960430|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4136088|NCT00891904|3960430|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4136089|NCT00891904|3960430|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4136090|NCT00891904|3960430|B1|||Age||years|Mean|67|67.0|Standard Deviation|2.8|2.8|||
4136091|NCT00891878|3960437|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136092|NCT00891878|3960438|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136093|NCT00891878|3960439|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136094|NCT00891878|3960437|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4136095|NCT00891878|3960438|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4136096|NCT00891878|3960439|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4136097|NCT00891878|3960437|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136098|NCT00891878|3960438|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136099|NCT00891878|3960439|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136100|NCT00891878|3960437|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4136101|NCT00891878|3960438|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4136102|NCT00891878|3960439|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4136103|NCT00891878|3960437|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4136104|NCT00891878|3960438|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4136105|NCT00891878|3960439|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4136106|NCT00891878|3960437|B3|||Age||years|Median|73|73.0|Full Range|||47.0|82.0|
4136107|NCT00891878|3960438|B2|||Age||years|Median|73|73.0|Full Range|||47.0|80.0|
4136108|NCT00891878|3960439|B1|||Age||years|Median|74.5|74.5|Full Range|||56.0|82.0|
4136109|NCT00891839|3960456|B1|Absent||B-Symptoms|"The presence of B symptoms is a marker for more advanced disease with systemic, rather than merely local, involvement.~B symptoms include:~Fever greater than 38 °C. Pel-Ebstein fever, the classic intermittent fever associated with Hodgkin disease, occurs at variable intervals of days to weeks and lasts for 1–2 weeks before resolving. However, fever associated with lymphoma can follow virtually any pattern.~Drenching sweats, especially at night.~Unintentional weight loss of >10% of normal body weight over a period of 6 months or less."|participants|Number|36|36.0||||||
4136110|NCT00891839|3960456|B1|Present||B-Symptoms|"The presence of B symptoms is a marker for more advanced disease with systemic, rather than merely local, involvement.~B symptoms include:~Fever greater than 38 °C. Pel-Ebstein fever, the classic intermittent fever associated with Hodgkin disease, occurs at variable intervals of days to weeks and lasts for 1–2 weeks before resolving. However, fever associated with lymphoma can follow virtually any pattern.~Drenching sweats, especially at night.~Unintentional weight loss of >10% of normal body weight over a period of 6 months or less."|participants|Number|9|9.0||||||
4136111|NCT00891839|3960456|B1|Stage IV||Ann Arbor Staging System of Lymphoma|"Stage I indicates that the cancer is located in a single region.~Stage II indicates that the cancer is located in two separate regions, and that both affected areas are confined to one side of the diaphragm.~Stage III indicates that the cancer has spread to both sides of the diaphragm, including one organ or area near the lymph nodes or the spleen.~Stage IV indicates diffuse or disseminated involvement of one or more extralymphatic organs, including any involvement of the liver, bone marrow, or nodular involvement of the lungs"|participants|Number|37|37.0||||||
4136112|NCT00891839|3960456|B1|Stage III||Ann Arbor Staging System of Lymphoma|"Stage I indicates that the cancer is located in a single region.~Stage II indicates that the cancer is located in two separate regions, and that both affected areas are confined to one side of the diaphragm.~Stage III indicates that the cancer has spread to both sides of the diaphragm, including one organ or area near the lymph nodes or the spleen.~Stage IV indicates diffuse or disseminated involvement of one or more extralymphatic organs, including any involvement of the liver, bone marrow, or nodular involvement of the lungs"|participants|Number|4|4.0||||||
4136113|NCT00891839|3960456|B1|Stage II||Ann Arbor Staging System of Lymphoma|"Stage I indicates that the cancer is located in a single region.~Stage II indicates that the cancer is located in two separate regions, and that both affected areas are confined to one side of the diaphragm.~Stage III indicates that the cancer has spread to both sides of the diaphragm, including one organ or area near the lymph nodes or the spleen.~Stage IV indicates diffuse or disseminated involvement of one or more extralymphatic organs, including any involvement of the liver, bone marrow, or nodular involvement of the lungs"|participants|Number|4|4.0||||||
4136114|NCT00891839|3960456|B1|Stage I||Ann Arbor Staging System of Lymphoma|"Stage I indicates that the cancer is located in a single region.~Stage II indicates that the cancer is located in two separate regions, and that both affected areas are confined to one side of the diaphragm.~Stage III indicates that the cancer has spread to both sides of the diaphragm, including one organ or area near the lymph nodes or the spleen.~Stage IV indicates diffuse or disseminated involvement of one or more extralymphatic organs, including any involvement of the liver, bone marrow, or nodular involvement of the lungs"|participants|Number|0|0.0||||||
4136115|NCT00891839|3960456|B1|||Body Surface Area (BSA)||m^2|Mean|1.9|1.9|Standard Deviation|0.20|0.2|||
4136116|NCT00891839|3960456|B1|||Height||cm|Mean|172.7|172.7|Standard Deviation|9.87|9.87|||
4136117|NCT00891839|3960456|B1|||Weight||kg|Mean|80.3|80.3|Standard Deviation|13.59|13.59|||
4136118|NCT00891839|3960456|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4136119|NCT00891839|3960456|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136120|NCT00891839|3960456|B1||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4136121|NCT00891839|3960456|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4136122|NCT00891839|3960456|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136123|NCT00891839|3960456|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4136124|NCT00891839|3960456|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136125|NCT00891839|3960456|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136126|NCT00891839|3960456|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4136127|NCT00891839|3960456|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4136128|NCT00891839|3960456|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4136129|NCT00891839|3960456|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4136130|NCT00891839|3960456|B1|||Age||years|Mean|69.5|69.5|Standard Deviation|8.02|8.02|||
4136131|NCT00891813|3960465|B1|Peru||Region of Enrollment||participants|Number|100|100.0||||||
4136132|NCT00891813|3960465|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4136133|NCT00891813|3960465|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4136134|NCT00891813|3960465|B1|||Age||years|Mean|46|46.0|Standard Deviation|12|12.0|||
4136135|NCT00891774|3960471|B1|VI (Dark Brown/Black)||Fitzpatrick Skin Tone||Participants|Number|52|52.0||||||
4136136|NCT00891774|3960471|B1|V (Brown)||Fitzpatrick Skin Tone||Participants|Number|66|66.0||||||
4136137|NCT00891774|3960471|B1|IV (Light Brown)||Fitzpatrick Skin Tone||Participants|Number|54|54.0||||||
4136138|NCT00891774|3960471|B1|United States||Region of Enrollment||participants|Number|172|172.0||||||
4136139|NCT00891774|3960471|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4136140|NCT00891774|3960471|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136141|NCT00891774|3960471|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4136142|NCT00891774|3960471|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|135|135.0||||||
4136143|NCT00891774|3960471|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136144|NCT00891774|3960471|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4136145|NCT00891774|3960471|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4136146|NCT00891774|3960471|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136147|NCT00891774|3960471|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|154|154.0||||||
4136148|NCT00891774|3960471|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4136149|NCT00891774|3960471|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4136150|NCT00891774|3960471|B1||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4136151|NCT00891774|3960471|B1|||Age||years|Mean|51.4|51.4|Standard Deviation|10.28|10.28|||
4136152|NCT00891735|3960475|B5||Male|Sex: Female, Male||Participants|Count of Participants|446|446.0||||||
4136153|NCT00891735|3960476|B4||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4136154|NCT00891735|3960477|B3||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4136155|NCT00891735|3960478|B2||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4136156|NCT00891735|3960479|B1||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4136157|NCT00891735|3960475|B5||Female|Sex: Female, Male||Participants|Count of Participants|651|651.0||||||
4136158|NCT00891735|3960476|B4||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4136159|NCT00891735|3960477|B3||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4136160|NCT00891735|3960478|B2||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4136161|NCT00891735|3960479|B1||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4136162|NCT00891735|3960475|B5|||Age||years|Mean|78.7|78.7|Standard Deviation|8.3|8.3|||
4136163|NCT00891735|3960476|B4|||Age||years|Mean|78.3|78.3|Standard Deviation|8.3|8.3|||
4136164|NCT00891735|3960477|B3|||Age||years|Mean|78.5|78.5|Standard Deviation|8.3|8.3|||
4136165|NCT00891735|3960478|B2|||Age||years|Mean|79.3|79.3|Standard Deviation|8.3|8.3|||
4136166|NCT00891735|3960479|B1|||Age||years|Mean|78.8|78.8|Standard Deviation|8.4|8.4|||
4136167|NCT00891657|3960520|B3|Germany||Region of Enrollment||participants|Number|15|15.0||||||
4136168|NCT00891657|3960521|B2|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4136169|NCT00891657|3960522|B1|Germany||Region of Enrollment||participants|Number|9|9.0||||||
4136170|NCT00891657|3960520|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4136171|NCT00891657|3960521|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4136172|NCT00891657|3960522|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4136173|NCT00891657|3960520|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4136174|NCT00891657|3960521|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4136175|NCT00891657|3960522|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4136176|NCT00891657|3960520|B3|||Age||years|Mean|39.2|39.2|Standard Deviation|5.9|5.9|||
4136177|NCT00891657|3960521|B2|||Age||years|Mean|44.3|44.3|Standard Deviation|3.3|3.3|||
4136178|NCT00891657|3960522|B1|||Age||years|Mean|35.8|35.8|Standard Deviation|4.6|4.6|||
4136179|NCT00891657|3960520|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4136180|NCT00891657|3960521|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4136181|NCT00891657|3960522|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4136182|NCT00891657|3960520|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4136183|NCT00891657|3960521|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4136184|NCT00891657|3960522|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4136185|NCT00891657|3960520|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4136186|NCT00891657|3960521|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4136187|NCT00891657|3960522|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4136188|NCT00891618|3960535|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4136189|NCT00891618|3960535|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4136190|NCT00891618|3960535|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4136191|NCT00891618|3960535|B1|||Age||years|Median|64|64.0|Full Range|||46.0|79.0|
4136192|NCT00891527|3960539|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4136193|NCT00891527|3960539|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4136194|NCT00891527|3960539|B1|>/= 12 months||Age, Customized||Participants|Count of Participants|13|13.0||||||
4136195|NCT00891527|3960539|B1|6 to <12 months||Age, Customized||Participants|Count of Participants|17|17.0||||||
4136196|NCT00891527|3960539|B1|3 to <6 months||Age, Customized||Participants|Count of Participants|15|15.0||||||
4136197|NCT00891527|3960539|B1|<3 months||Age, Customized||Participants|Count of Participants|3|3.0||||||
4136198|NCT00891462|3960545|B4|Canada||Region of Enrollment||participants|Number|37|37.0||||||
4136199|NCT00891462|3960546|B3|Canada||Region of Enrollment||participants|Number|13|13.0||||||
4136200|NCT00891462|3960547|B2|Canada||Region of Enrollment||participants|Number|14|14.0||||||
4136201|NCT00891462|3960548|B1|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4136202|NCT00891462|3960545|B4|United States||Region of Enrollment||participants|Number|523|523.0||||||
4136203|NCT00891462|3960546|B3|United States||Region of Enrollment||participants|Number|177|177.0||||||
4136204|NCT00891462|3960547|B2|United States||Region of Enrollment||participants|Number|170|170.0||||||
4136205|NCT00891462|3960548|B1|United States||Region of Enrollment||participants|Number|176|176.0||||||
4136206|NCT00891462|3960545|B4||Male|Gender||Participants|Count of Participants|297|297.0||||||
4136207|NCT00891462|3960546|B3||Male|Gender||Participants|Count of Participants|100|100.0||||||
4136208|NCT00891462|3960547|B2||Male|Gender||Participants|Count of Participants|101|101.0||||||
4136209|NCT00891462|3960548|B1||Male|Gender||Participants|Count of Participants|96|96.0||||||
4136210|NCT00891462|3960545|B4||Female|Gender||Participants|Count of Participants|263|263.0||||||
4136211|NCT00891462|3960546|B3||Female|Gender||Participants|Count of Participants|90|90.0||||||
4136212|NCT00891462|3960547|B2||Female|Gender||Participants|Count of Participants|83|83.0||||||
4136213|NCT00891462|3960548|B1||Female|Gender||Participants|Count of Participants|90|90.0||||||
4136214|NCT00891462|3960545|B4|≥ 70 years||Age, Customized||participants|Number|162|162.0||||||
4136215|NCT00891462|3960546|B3|≥ 70 years||Age, Customized||participants|Number|59|59.0||||||
4136216|NCT00891462|3960547|B2|≥ 70 years||Age, Customized||participants|Number|48|48.0||||||
4136217|NCT00891462|3960548|B1|≥ 70 years||Age, Customized||participants|Number|55|55.0||||||
4136218|NCT00891462|3960545|B4|≥ 60 to < 70 years||Age, Customized||participants|Number|244|244.0||||||
4136219|NCT00891462|3960546|B3|≥ 60 to < 70 years||Age, Customized||participants|Number|87|87.0||||||
4136220|NCT00891462|3960547|B2|≥ 60 to < 70 years||Age, Customized||participants|Number|72|72.0||||||
4136221|NCT00891462|3960548|B1|≥ 60 to < 70 years||Age, Customized||participants|Number|85|85.0||||||
4136222|NCT00891462|3960545|B4|≥ 40 to < 60 years||Age, Customized||participants|Number|154|154.0||||||
4136223|NCT00891462|3960546|B3|≥ 40 to < 60 years||Age, Customized||participants|Number|44|44.0||||||
4136224|NCT00891462|3960547|B2|≥ 40 to < 60 years||Age, Customized||participants|Number|64|64.0||||||
4136225|NCT00891462|3960548|B1|≥ 40 to < 60 years||Age, Customized||participants|Number|46|46.0||||||
4136226|NCT00891462|3960545|B4|||Age||years|Mean|64.3|64.3|Standard Deviation|9.4|9.4|||
4136227|NCT00891462|3960546|B3|||Age||years|Mean|64.9|64.9|Standard Deviation|9.5|9.5|||
4136228|NCT00891462|3960547|B2|||Age||years|Mean|63.1|63.1|Standard Deviation|9.5|9.5|||
4136229|NCT00891462|3960548|B1|||Age||years|Mean|65.1|65.1|Standard Deviation|9.2|9.2|||
4136230|NCT00891436|3960561|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4136231|NCT00891436|3960562|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4136232|NCT00891436|3960563|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4136233|NCT00891436|3960561|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4136234|NCT00891436|3960562|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4136235|NCT00891436|3960563|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4136236|NCT00891436|3960561|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4136237|NCT00891436|3960562|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4136238|NCT00891436|3960563|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4136239|NCT00891436|3960561|B3|||Age||years|Mean|30|30.0|Standard Deviation|7.6|7.6|||
4136240|NCT00891436|3960562|B2|||Age||years|Mean|29|29.0|Standard Deviation|8.0|8.0|||
4136241|NCT00891436|3960563|B1|||Age||years|Mean|32|32.0|Standard Deviation|7.3|7.3|||
4136242|NCT00891436|3960561|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4136243|NCT00891436|3960562|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4136244|NCT00891436|3960563|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4136245|NCT00891436|3960561|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4136246|NCT00891436|3960562|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4136247|NCT00891436|3960563|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4136248|NCT00891436|3960561|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4136249|NCT00891436|3960562|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4136250|NCT00891436|3960563|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4136251|NCT00891371|3960572|B1|||Mean Number of Stools||Number of Stools|Mean|5.5|5.5|Standard Deviation|2.3|2.3|||
4136252|NCT00891371|3960572|B1|||Score of Stool Consistency (Bristol Stool Form Scale)|Each patient scored his/her stool on the Bristol Stool Form Scale: Type 1 - Separate hard lumps, like nuts (hard to pass); Type 2 - Sausage-shaped but lumpy; Type 3 - Like a sausage but with cracks on its surface; Type 4 - Like a sausage or snake, smooth and soft; Type 5 - Soft blobs with clear-cut edges (passed easily); Type 6 - Fluffy pieces with ragged edges, a mushy stool; Type 7 - Water no solid pieces, Entirely liquid|units on a scale|Median|6.0|6.0|Full Range|||5.0|7.0|
4136253|NCT00891371|3960572|B1|IBS QOL: Total Score||Quality Of Life (QOL) - Scales|"SF36 QOL includes 1 multi-item scale measuring each of 8 health concepts. These scores are summed to produce raw scale scores for each health concept which are transformed to a 0–100 scale. There is in addition a single-item measure of Health Transition~IBS-QOL is a self-report QOL measure specific to IBS that can be used to assess impact of IBS and its treatment. This consists of 34 items,each with a 5 point response scale.Individual responses to 34 items are summed and averaged for a total score and transformed to a 0-100 scale with higher scores indicating better IBS specific QOL"|units on a scale|Mean|47.4|47.4|Standard Deviation|18.5|18.5|||
4136275|NCT00891319|3960581|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136276|NCT00891319|3960582|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136277|NCT00891319|3960583|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136278|NCT00891319|3960581|B3||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4136254|NCT00891371|3960572|B1|SF36 QOL: General Health||Quality Of Life (QOL) - Scales|"SF36 QOL includes 1 multi-item scale measuring each of 8 health concepts. These scores are summed to produce raw scale scores for each health concept which are transformed to a 0–100 scale. There is in addition a single-item measure of Health Transition~IBS-QOL is a self-report QOL measure specific to IBS that can be used to assess impact of IBS and its treatment. This consists of 34 items,each with a 5 point response scale.Individual responses to 34 items are summed and averaged for a total score and transformed to a 0-100 scale with higher scores indicating better IBS specific QOL"|units on a scale|Mean|43.9|43.9|Standard Deviation|22.8|22.8|||
4136255|NCT00891371|3960572|B1|SF36 QOL: Bodily Pain||Quality Of Life (QOL) - Scales|"SF36 QOL includes 1 multi-item scale measuring each of 8 health concepts. These scores are summed to produce raw scale scores for each health concept which are transformed to a 0–100 scale. There is in addition a single-item measure of Health Transition~IBS-QOL is a self-report QOL measure specific to IBS that can be used to assess impact of IBS and its treatment. This consists of 34 items,each with a 5 point response scale.Individual responses to 34 items are summed and averaged for a total score and transformed to a 0-100 scale with higher scores indicating better IBS specific QOL"|units on a scale|Mean|48.7|48.7|Standard Deviation|30.4|30.4|||
4136256|NCT00891371|3960572|B1|SF36 QOL: Social Functioning||Quality Of Life (QOL) - Scales|"SF36 QOL includes 1 multi-item scale measuring each of 8 health concepts. These scores are summed to produce raw scale scores for each health concept which are transformed to a 0–100 scale. There is in addition a single-item measure of Health Transition~IBS-QOL is a self-report QOL measure specific to IBS that can be used to assess impact of IBS and its treatment. This consists of 34 items,each with a 5 point response scale.Individual responses to 34 items are summed and averaged for a total score and transformed to a 0-100 scale with higher scores indicating better IBS specific QOL"|units on a scale|Mean|41.1|41.1|Standard Deviation|31.2|31.2|||
4136257|NCT00891371|3960572|B1|SF36 QOL: Mental Health||Quality Of Life (QOL) - Scales|"SF36 QOL includes 1 multi-item scale measuring each of 8 health concepts. These scores are summed to produce raw scale scores for each health concept which are transformed to a 0–100 scale. There is in addition a single-item measure of Health Transition~IBS-QOL is a self-report QOL measure specific to IBS that can be used to assess impact of IBS and its treatment. This consists of 34 items,each with a 5 point response scale.Individual responses to 34 items are summed and averaged for a total score and transformed to a 0-100 scale with higher scores indicating better IBS specific QOL"|units on a scale|Mean|47.6|47.6|Standard Deviation|23.1|23.1|||
4136258|NCT00891371|3960572|B1|SF36 QOL: Vitality||Quality Of Life (QOL) - Scales|"SF36 QOL includes 1 multi-item scale measuring each of 8 health concepts. These scores are summed to produce raw scale scores for each health concept which are transformed to a 0–100 scale. There is in addition a single-item measure of Health Transition~IBS-QOL is a self-report QOL measure specific to IBS that can be used to assess impact of IBS and its treatment. This consists of 34 items,each with a 5 point response scale.Individual responses to 34 items are summed and averaged for a total score and transformed to a 0-100 scale with higher scores indicating better IBS specific QOL"|units on a scale|Mean|38.8|38.8|Standard Deviation|24.1|24.1|||
4136259|NCT00891371|3960572|B1|SF36 QOL: Role Emotional||Quality Of Life (QOL) - Scales|"SF36 QOL includes 1 multi-item scale measuring each of 8 health concepts. These scores are summed to produce raw scale scores for each health concept which are transformed to a 0–100 scale. There is in addition a single-item measure of Health Transition~IBS-QOL is a self-report QOL measure specific to IBS that can be used to assess impact of IBS and its treatment. This consists of 34 items,each with a 5 point response scale.Individual responses to 34 items are summed and averaged for a total score and transformed to a 0-100 scale with higher scores indicating better IBS specific QOL"|units on a scale|Mean|52.8|52.8|Standard Deviation|38.7|38.7|||
4136260|NCT00891371|3960572|B1|SF36 QOL: Role Physical||Quality Of Life (QOL) - Scales|"SF36 QOL includes 1 multi-item scale measuring each of 8 health concepts. These scores are summed to produce raw scale scores for each health concept which are transformed to a 0–100 scale. There is in addition a single-item measure of Health Transition~IBS-QOL is a self-report QOL measure specific to IBS that can be used to assess impact of IBS and its treatment. This consists of 34 items,each with a 5 point response scale.Individual responses to 34 items are summed and averaged for a total score and transformed to a 0-100 scale with higher scores indicating better IBS specific QOL"|units on a scale|Mean|39.6|39.6|Standard Deviation|30.9|30.9|||
4136261|NCT00891371|3960572|B1|SF36 QOL: Physical Functioning||Quality Of Life (QOL) - Scales|"SF36 QOL includes 1 multi-item scale measuring each of 8 health concepts. These scores are summed to produce raw scale scores for each health concept which are transformed to a 0–100 scale. There is in addition a single-item measure of Health Transition~IBS-QOL is a self-report QOL measure specific to IBS that can be used to assess impact of IBS and its treatment. This consists of 34 items,each with a 5 point response scale.Individual responses to 34 items are summed and averaged for a total score and transformed to a 0-100 scale with higher scores indicating better IBS specific QOL"|units on a scale|Mean|60.5|60.5|Standard Deviation|29.1|29.1|||
4136262|NCT00891371|3960572|B1|||Race [Caucasian / White]||Participants|Number|36|36.0||||||
4136263|NCT00891371|3960572|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4136264|NCT00891371|3960572|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4136265|NCT00891371|3960572|B1|>=65 years||Age, Customized||participants|Number|12|12.0||||||
4136266|NCT00891371|3960572|B1|>=30 to <65 years||Age, Customized||participants|Number|22|22.0||||||
4136267|NCT00891371|3960572|B1|<30 years||Age, Customized||participants|Number|2|2.0||||||
4136268|NCT00891371|3960572|B1|||Age||Years|Mean|55.2|55.2|Standard Deviation|16.4|16.4|||
4136269|NCT00891319|3960581|B3|||Years Since Stroke||years since stroke|Median|1.6|1.6|Inter-Quartile Range|||0.9|4.0|
4136270|NCT00891319|3960582|B2|||Years Since Stroke||years since stroke|Median|1.6|1.6|Inter-Quartile Range|||1.0|6.0|
4136271|NCT00891319|3960583|B1|||Years Since Stroke||years since stroke|Median|1.8|1.8|Inter-Quartile Range|||0.8|3.5|
4136272|NCT00891319|3960581|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136273|NCT00891319|3960582|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136274|NCT00891319|3960583|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136279|NCT00891319|3960582|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4136280|NCT00891319|3960583|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4136281|NCT00891319|3960581|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4136282|NCT00891319|3960582|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4136283|NCT00891319|3960583|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4136284|NCT00891319|3960581|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136285|NCT00891319|3960582|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136286|NCT00891319|3960583|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136287|NCT00891319|3960581|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136288|NCT00891319|3960582|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136289|NCT00891319|3960583|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136290|NCT00891319|3960581|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136291|NCT00891319|3960582|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136292|NCT00891319|3960583|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136293|NCT00891319|3960581|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4136294|NCT00891319|3960582|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4136295|NCT00891319|3960583|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4136296|NCT00891319|3960581|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4136297|NCT00891319|3960582|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4136298|NCT00891319|3960583|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4136299|NCT00891319|3960581|B3|||Age||years|Median|56.2|56.2|Inter-Quartile Range|||51.0|65.7|
4136300|NCT00891319|3960582|B2|||Age||years|Median|56.3|56.3|Inter-Quartile Range|||51.9|65.2|
4136301|NCT00891319|3960583|B1|||Age||years|Median|55.4|55.4|Inter-Quartile Range|||48.1|66.2|
4136302|NCT00891293|3960594|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4136303|NCT00891293|3960594|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4136304|NCT00891293|3960594|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4136305|NCT00891293|3960594|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4136306|NCT00891293|3960594|B1|White||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
4136307|NCT00891293|3960594|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4136308|NCT00891293|3960594|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4136309|NCT00891293|3960594|B1|||Age||years|Mean|52.4|52.4|Standard Deviation|9.99|9.99|||
4136310|NCT00891228|3960606|B4|United States||Region of Enrollment||participants|Number|99|99.0||||||
4136311|NCT00891228|3960607|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
4136312|NCT00891228|3960608|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4136313|NCT00891228|3960609|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4136314|NCT00891228|3960606|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4136315|NCT00891228|3960607|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4136316|NCT00891228|3960608|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4136317|NCT00891228|3960609|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4136318|NCT00891228|3960606|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136319|NCT00891228|3960607|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136320|NCT00891228|3960608|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136321|NCT00891228|3960609|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136322|NCT00891228|3960606|B4||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4136323|NCT00891228|3960607|B3||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4136324|NCT00891228|3960608|B2||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4136325|NCT00891228|3960609|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4136326|NCT00891228|3960606|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4136327|NCT00891228|3960607|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4136328|NCT00891228|3960608|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4136329|NCT00891228|3960609|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4136330|NCT00891228|3960606|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4136331|NCT00891228|3960607|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136332|NCT00891228|3960608|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4136333|NCT00891228|3960609|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4136334|NCT00891228|3960606|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4136335|NCT00891228|3960607|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4136336|NCT00891228|3960608|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4136337|NCT00891228|3960609|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4136338|NCT00891228|3960606|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4136339|NCT00891228|3960607|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136340|NCT00891228|3960608|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4136341|NCT00891228|3960609|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136342|NCT00891228|3960606|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136343|NCT00891228|3960607|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136344|NCT00891228|3960608|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136345|NCT00891228|3960609|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136346|NCT00891228|3960606|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4136347|NCT00891228|3960607|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4136348|NCT00891228|3960608|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4136349|NCT00891228|3960609|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4136350|NCT00891228|3960606|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4136351|NCT00891228|3960607|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4136352|NCT00891228|3960608|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4136353|NCT00891228|3960609|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4136354|NCT00891228|3960606|B4||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4136355|NCT00891228|3960607|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4136356|NCT00891228|3960608|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4136357|NCT00891228|3960609|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4136358|NCT00891228|3960606|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4136359|NCT00891228|3960607|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4136360|NCT00891228|3960608|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4136361|NCT00891228|3960609|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4136362|NCT00891228|3960606|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4136363|NCT00891228|3960607|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4136364|NCT00891228|3960608|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4136365|NCT00891228|3960609|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4136366|NCT00891228|3960606|B4||Between 18 and 65 years|Age||Participants|Count of Participants|99|99.0||||||
4136367|NCT00891228|3960607|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4136368|NCT00891228|3960608|B2||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4136369|NCT00891228|3960609|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4136370|NCT00891228|3960606|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4136371|NCT00891228|3960607|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4136372|NCT00891228|3960608|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4136373|NCT00891228|3960609|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4136374|NCT00891202|3960631|B3|||Height||centimeter (cm)|Mean|168.1|168.1|Standard Deviation|11.05|11.05|||
4136375|NCT00891202|3960632|B2|||Height||centimeter (cm)|Mean|170.0|170.0|Standard Deviation|12.02|12.02|||
4136376|NCT00891202|3960633|B1|||Height||centimeter (cm)|Mean|166.2|166.2|Standard Deviation|9.91|9.91|||
4136377|NCT00891202|3960631|B3|||Weight||kilogram (kg)|Mean|66.7|66.7|Standard Deviation|14.65|14.65|||
4136378|NCT00891202|3960632|B2|||Weight||kilogram (kg)|Mean|68.6|68.6|Standard Deviation|17.17|17.17|||
4136379|NCT00891202|3960633|B1|||Weight||kilogram (kg)|Mean|64.8|64.8|Standard Deviation|11.74|11.74|||
4136380|NCT00891202|3960631|B3|||Body Mass Index (BMI)|BMI was calculated as ([weight in kg] divided by [height in cm multiplied by 0.01]^2).|kilogram per square meter (kg/m^2)|Mean|23.4|23.4|Standard Deviation|3.13|3.13|||
4136381|NCT00891202|3960632|B2|||Body Mass Index (BMI)|BMI was calculated as ([weight in kg] divided by [height in cm multiplied by 0.01]^2).|kilogram per square meter (kg/m^2)|Mean|23.4|23.4|Standard Deviation|3.54|3.54|||
4136382|NCT00891202|3960633|B1|||Body Mass Index (BMI)|BMI was calculated as ([weight in kg] divided by [height in cm multiplied by 0.01]^2).|kilogram per square meter (kg/m^2)|Mean|23.3|23.3|Standard Deviation|2.74|2.74|||
4136383|NCT00891202|3960631|B3|Ethnicity: Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4136384|NCT00891202|3960632|B2|Ethnicity: Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4136385|NCT00891202|3960633|B1|Ethnicity: Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4136386|NCT00891202|3960631|B3|Ethnicity: Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4136387|NCT00891202|3960632|B2|Ethnicity: Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4136388|NCT00891202|3960633|B1|Ethnicity: Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4136389|NCT00891202|3960631|B3|Race: Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4136390|NCT00891202|3960632|B2|Race: Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4136391|NCT00891202|3960633|B1|Race: Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4136392|NCT00891202|3960631|B3|Race: White||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4136393|NCT00891202|3960632|B2|Race: White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4136394|NCT00891202|3960633|B1|Race: White||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4136395|NCT00891202|3960631|B3||Male|Gender||Participants|Count of Participants|20|20.0||||||
4136396|NCT00891202|3960632|B2||Male|Gender||Participants|Count of Participants|12|12.0||||||
4136397|NCT00891202|3960633|B1||Male|Gender||Participants|Count of Participants|8|8.0||||||
4136398|NCT00891202|3960631|B3||Female|Gender||Participants|Count of Participants|20|20.0||||||
4136399|NCT00891202|3960632|B2||Female|Gender||Participants|Count of Participants|8|8.0||||||
4136400|NCT00891202|3960633|B1||Female|Gender||Participants|Count of Participants|12|12.0||||||
4136401|NCT00891202|3960631|B3|||Age||years|Mean|31.8|31.8|Standard Deviation|11.26|11.26|||
4136402|NCT00891202|3960632|B2|||Age||years|Mean|32.1|32.1|Standard Deviation|11.26|11.26|||
4136403|NCT00891202|3960633|B1|||Age||years|Mean|31.6|31.6|Standard Deviation|11.55|11.55|||
4136404|NCT00891176|3960658|B5||Male|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
4136405|NCT00891176|3960659|B4||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4136406|NCT00891176|3960660|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4136407|NCT00891176|3960661|B2||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4136408|NCT00891176|3960662|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4136409|NCT00891176|3960658|B5||Female|Sex: Female, Male||Participants|Count of Participants|293|293.0||||||
4136410|NCT00891176|3960659|B4||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4136411|NCT00891176|3960660|B3||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4136412|NCT00891176|3960661|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4136413|NCT00891176|3960662|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4136414|NCT00891176|3960658|B5|||Age||Months|Mean|37.2|37.2|Standard Deviation|1.21|1.21|||
4136415|NCT00891176|3960659|B4|||Age||Months|Mean|37.3|37.3|Standard Deviation|1.28|1.28|||
4136416|NCT00891176|3960660|B3|||Age||Months|Mean|37.3|37.3|Standard Deviation|1.18|1.18|||
4136417|NCT00891176|3960661|B2|||Age||Months|Mean|37.2|37.2|Standard Deviation|1.20|1.2|||
4136418|NCT00891176|3960662|B1|||Age||Months|Mean|37.1|37.1|Standard Deviation|1.17|1.17|||
4136419|NCT00891046|3960807|B6||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4136420|NCT00891046|3960808|B5||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4136421|NCT00891046|3960809|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4136422|NCT00891046|3960810|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4136423|NCT00891046|3960811|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4136424|NCT00891046|3960812|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4136425|NCT00891046|3960807|B6||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4136426|NCT00891046|3960808|B5||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4136427|NCT00891046|3960809|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4136428|NCT00891046|3960810|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4136429|NCT00891046|3960811|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4136430|NCT00891046|3960812|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4136431|NCT00891046|3960807|B6|≥ 20 years||Age, Customized||participants|Number|2|2.0||||||
4136432|NCT00891046|3960808|B5|≥ 20 years||Age, Customized||participants|Number|0|0.0||||||
4136433|NCT00891046|3960809|B4|≥ 20 years||Age, Customized||participants|Number|0|0.0||||||
4136434|NCT00891046|3960810|B3|≥ 20 years||Age, Customized||participants|Number|0|0.0||||||
4136435|NCT00891046|3960811|B2|≥ 20 years||Age, Customized||participants|Number|2|2.0||||||
4136436|NCT00891046|3960812|B1|≥ 20 years||Age, Customized||participants|Number|0|0.0||||||
4136437|NCT00891046|3960807|B6|12 ­- <20 years||Age, Customized||participants|Number|80|80.0||||||
4136438|NCT00891046|3960808|B5|12 ­- <20 years||Age, Customized||participants|Number|40|40.0||||||
4136439|NCT00891046|3960809|B4|12 ­- <20 years||Age, Customized||participants|Number|2|2.0||||||
4136440|NCT00891046|3960810|B3|12 ­- <20 years||Age, Customized||participants|Number|10|10.0||||||
4136441|NCT00891046|3960811|B2|12 ­- <20 years||Age, Customized||participants|Number|17|17.0||||||
4136442|NCT00891046|3960812|B1|12 ­- <20 years||Age, Customized||participants|Number|11|11.0||||||
4136443|NCT00891046|3960807|B6|6 ­- <12 years||Age, Customized||participants|Number|122|122.0||||||
4136444|NCT00891046|3960808|B5|6 ­- <12 years||Age, Customized||participants|Number|50|50.0||||||
4136445|NCT00891046|3960809|B4|6 ­- <12 years||Age, Customized||participants|Number|3|3.0||||||
4136446|NCT00891046|3960810|B3|6 ­- <12 years||Age, Customized||participants|Number|21|21.0||||||
4136447|NCT00891046|3960811|B2|6 ­- <12 years||Age, Customized||participants|Number|32|32.0||||||
4136448|NCT00891046|3960812|B1|6 ­- <12 years||Age, Customized||participants|Number|16|16.0||||||
4136449|NCT00891046|3960807|B6|4 ­- <6 years||Age, Customized||participants|Number|42|42.0||||||
4136450|NCT00891046|3960808|B5|4 ­- <6 years||Age, Customized||participants|Number|15|15.0||||||
4136451|NCT00891046|3960809|B4|4 ­- <6 years||Age, Customized||participants|Number|5|5.0||||||
4136452|NCT00891046|3960810|B3|4 ­- <6 years||Age, Customized||participants|Number|6|6.0||||||
4136453|NCT00891046|3960811|B2|4 ­- <6 years||Age, Customized||participants|Number|10|10.0||||||
4136454|NCT00891046|3960812|B1|4 ­- <6 years||Age, Customized||participants|Number|6|6.0||||||
4136455|NCT00891046|3960807|B6|2 ­- <4 years||Age, Customized||participants|Number|24|24.0||||||
4136456|NCT00891046|3960808|B5|2 ­- <4 years||Age, Customized||participants|Number|18|18.0||||||
4136457|NCT00891046|3960809|B4|2 ­- <4 years||Age, Customized||participants|Number|1|1.0||||||
4136458|NCT00891046|3960810|B3|2 ­- <4 years||Age, Customized||participants|Number|3|3.0||||||
4136459|NCT00891046|3960811|B2|2 ­- <4 years||Age, Customized||participants|Number|2|2.0||||||
4136460|NCT00891046|3960812|B1|2 ­- <4 years||Age, Customized||participants|Number|0|0.0||||||
4136461|NCT00891020|3960889|B4||Male|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4136462|NCT00891020|3960890|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4136463|NCT00891020|3960891|B2||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4136464|NCT00891020|3960892|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4136465|NCT00891020|3960889|B4||Female|Sex: Female, Male||Participants|Count of Participants|679|679.0||||||
4136466|NCT00891020|3960890|B3||Female|Sex: Female, Male||Participants|Count of Participants|296|296.0||||||
4136467|NCT00891020|3960891|B2||Female|Sex: Female, Male||Participants|Count of Participants|273|273.0||||||
4136468|NCT00891020|3960892|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4136469|NCT00891020|3960889|B4|||Age|Baseline measures are based on the number of participants in the Safety Population who received at least one dose of study drug and who had at least one post baseline safety assessment.|years|Mean|54.6|54.6|Standard Deviation|12.13|12.13|||
4136470|NCT00891020|3960890|B3|||Age|Baseline measures are based on the number of participants in the Safety Population who received at least one dose of study drug and who had at least one post baseline safety assessment.|years|Mean|54.0|54.0|Standard Deviation|12.11|12.11|||
4136471|NCT00891020|3960891|B2|||Age|Baseline measures are based on the number of participants in the Safety Population who received at least one dose of study drug and who had at least one post baseline safety assessment.|years|Mean|55.6|55.6|Standard Deviation|11.92|11.92|||
4136472|NCT00891020|3960892|B1|||Age|Baseline measures are based on the number of participants in the Safety Population who received at least one dose of study drug and who had at least one post baseline safety assessment.|years|Mean|53.5|53.5|Standard Deviation|12.63|12.63|||
4136473|NCT00890981|3960925|B3|||Months since last dose in 20050179||Months|Mean|32.1|32.1|Standard Deviation|2.6|2.6|||
4136474|NCT00890981|3960926|B2|||Months since last dose in 20050179||Months|Mean|32.2|32.2|Standard Deviation|2.7|2.7|||
4136475|NCT00890981|3960927|B1|||Months since last dose in 20050179||Months|Mean|32.1|32.1|Standard Deviation|2.5|2.5|||
4136476|NCT00890981|3960925|B3|||Race/Ethnicity, Customized||Participants|Number|79|79.0||||||
4136477|NCT00890981|3960926|B2|||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
4136478|NCT00890981|3960927|B1|||Race/Ethnicity, Customized||Participants|Number|39|39.0||||||
4136479|NCT00890981|3960925|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4136480|NCT00890981|3960926|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4136481|NCT00890981|3960927|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4136482|NCT00890981|3960925|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4136483|NCT00890981|3960926|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4136484|NCT00890981|3960927|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4136485|NCT00890981|3960925|B3|||Age||Years|Mean|63.7|63.7|Standard Deviation|6.1|6.1|||
4136486|NCT00890981|3960926|B2|||Age||Years|Mean|63.4|63.4|Standard Deviation|6.5|6.5|||
4136487|NCT00890981|3960927|B1|||Age||Years|Mean|63.9|63.9|Standard Deviation|5.8|5.8|||
4136488|NCT00890929|3960958|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4136489|NCT00890929|3960958|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4136490|NCT00890929|3960958|B1|||Age||years|Median|74|74.0|Full Range|||62.0|86.0|
4136491|NCT00890916|3960970|B1|||Grasp-Release Test|The Grasp and Release Test (GRT) [Wuolle, 1994; Smith et al., 1996; Carroll et al., 2000; Peckham, 2001; Taylor et al., 2002; Mulcahey et al., 2004], is a pick-and-place test requires the participant to unilaterally acquire, move, and release six objects varying in weight and size. The objects are: 1) a small peg, 2) a wooden cube, 3) a small juice can, 4) a videotape, 5) a paperweight and a simulated fork task. The number of objects that the participant can successfully manipulate are scored.|Number of Completions|Median|2|2.0|Full Range|||0.0|4.0|
4136492|NCT00890916|3960970|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4136493|NCT00890916|3960970|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4136494|NCT00890916|3960970|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4136495|NCT00890916|3960970|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4136496|NCT00890916|3960970|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4136497|NCT00890825|3960974|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|70|70.0||||||
4136498|NCT00890825|3960975|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
4136499|NCT00890825|3960976|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
4136500|NCT00890825|3960974|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4136501|NCT00890825|3960975|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4136502|NCT00890825|3960976|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4136503|NCT00890825|3960974|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4136504|NCT00890825|3960975|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4136505|NCT00890825|3960976|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4136506|NCT00890825|3960974|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4136507|NCT00890825|3960975|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4136508|NCT00890825|3960976|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4136509|NCT00890825|3960974|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|81|81.0||||||
4136510|NCT00890825|3960975|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
4136511|NCT00890825|3960976|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
4136512|NCT00890825|3960974|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4136513|NCT00890825|3960975|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4136514|NCT00890825|3960976|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4136515|NCT00890825|3960974|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4136516|NCT00890825|3960975|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4136517|NCT00890825|3960976|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4136518|NCT00890825|3960974|B3|Age group : >55 years||Age, Customized||Participants|Count of Participants|57|57.0||||||
4136519|NCT00890825|3960975|B2|Age group : >55 years||Age, Customized||Participants|Count of Participants|28|28.0||||||
4136520|NCT00890825|3960976|B1|Age group : >55 years||Age, Customized||Participants|Count of Participants|29|29.0||||||
4136521|NCT00890825|3960974|B3|Age group : <=55 years||Age, Customized||Participants|Count of Participants|30|30.0||||||
4136522|NCT00890825|3960975|B2|Age group : <=55 years||Age, Customized||Participants|Count of Participants|15|15.0||||||
4136523|NCT00890825|3960976|B1|Age group : <=55 years||Age, Customized||Participants|Count of Participants|15|15.0||||||
4136524|NCT00890825|3960974|B3|||Age||Years|Mean|58.4|58.4|Standard Deviation|8.77|8.77|||
4136525|NCT00890825|3960975|B2|||Age||Years|Mean|58.6|58.6|Standard Deviation|8.38|8.38|||
4136526|NCT00890825|3960976|B1|||Age||Years|Mean|58.2|58.2|Standard Deviation|9.22|9.22|||
4136527|NCT00890721|3960995|B3|Georgia||Region of Enrollment||participants|Number|67|67.0||||||
4136528|NCT00890721|3960996|B2|Georgia||Region of Enrollment||participants|Number|33|33.0||||||
4136529|NCT00890721|3960997|B1|Georgia||Region of Enrollment||participants|Number|34|34.0||||||
4136530|NCT00890721|3960995|B3|Serbia||Region of Enrollment||participants|Number|50|50.0||||||
4136531|NCT00890721|3960996|B2|Serbia||Region of Enrollment||participants|Number|25|25.0||||||
4136532|NCT00890721|3960997|B1|Serbia||Region of Enrollment||participants|Number|25|25.0||||||
4136533|NCT00890721|3960995|B3|Poland||Region of Enrollment||participants|Number|72|72.0||||||
4136534|NCT00890721|3960996|B2|Poland||Region of Enrollment||participants|Number|36|36.0||||||
4136535|NCT00890721|3960997|B1|Poland||Region of Enrollment||participants|Number|36|36.0||||||
4136536|NCT00890721|3960995|B3||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4136537|NCT00890721|3960996|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4136538|NCT00890721|3960997|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4136539|NCT00890721|3960995|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4136540|NCT00890721|3960996|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4136541|NCT00890721|3960997|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4136542|NCT00890721|3960995|B3|||Age||years|Mean|48.4|48.4|Standard Deviation|12|12.0|||
4136543|NCT00890721|3960996|B2|||Age||years|Mean|48.7|48.7|Standard Deviation|12|12.0|||
4136544|NCT00890721|3960997|B1|||Age||years|Mean|48|48.0|Standard Deviation|12.2|12.2|||
4136545|NCT00890721|3960995|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4136546|NCT00890721|3960996|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4136547|NCT00890721|3960997|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4136548|NCT00890721|3960995|B3||Between 18 and 65 years|Age||Participants|Count of Participants|172|172.0||||||
4136549|NCT00890721|3960996|B2||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
4136550|NCT00890721|3960997|B1||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
4136551|NCT00890721|3960995|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4136552|NCT00890721|3960996|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4136553|NCT00890721|3960997|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4136554|NCT00890695|3961004|B3|Kenya||Region of Enrollment||participants|Number|64|64.0||||||
4136555|NCT00890695|3961005|B2|Kenya||Region of Enrollment||participants|Number|33|33.0||||||
4136556|NCT00890695|3961006|B1|Kenya||Region of Enrollment||participants|Number|31|31.0||||||
4136557|NCT00890695|3961004|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4136558|NCT00890695|3961005|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4136559|NCT00890695|3961006|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4136560|NCT00890695|3961004|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4136561|NCT00890695|3961005|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4136562|NCT00890695|3961006|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4136563|NCT00890695|3961004|B3|||Age||years|Mean|1.18|1.18|Standard Deviation|0.50|0.5|||
4136564|NCT00890695|3961005|B2|||Age||years|Mean|1.15|1.15|Standard Deviation|0.46|0.46|||
4136565|NCT00890695|3961006|B1|||Age||years|Mean|1.21|1.21|Standard Deviation|0.55|0.55|||
4136566|NCT00890695|3961004|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4136567|NCT00890695|3961005|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4136568|NCT00890695|3961006|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4136569|NCT00890695|3961004|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4136570|NCT00890695|3961005|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4136571|NCT00890695|3961006|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4136572|NCT00890695|3961004|B3||<=18 years|Age||Participants|Count of Participants|64|64.0||||||
4136573|NCT00890695|3961005|B2||<=18 years|Age||Participants|Count of Participants|33|33.0||||||
4136574|NCT00890695|3961006|B1||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
4136575|NCT00890682|3961023|B3|United States||Region of Enrollment||participants|Number|193|193.0||||||
4136576|NCT00890682|3961024|B2|United States||Region of Enrollment||participants|Number|96|96.0||||||
4136577|NCT00890682|3961025|B1|United States||Region of Enrollment||participants|Number|97|97.0||||||
4136578|NCT00890682|3961023|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4136579|NCT00890682|3961024|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4136580|NCT00890682|3961025|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4136581|NCT00890682|3961023|B3||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4136582|NCT00890682|3961024|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4136583|NCT00890682|3961025|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4136584|NCT00890682|3961023|B3|||Age||years|Mean|42.8|42.8|Standard Deviation|13.0|13.0|||
4136585|NCT00890682|3961024|B2|||Age||years|Mean|43.2|43.2|Standard Deviation|13.3|13.3|||
4136586|NCT00890682|3961025|B1|||Age||years|Mean|42.4|42.4|Standard Deviation|12.6|12.6|||
4136587|NCT00890682|3961023|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4136588|NCT00890682|3961024|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4136589|NCT00890682|3961025|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4136590|NCT00890682|3961023|B3||Between 18 and 65 years|Age||Participants|Count of Participants|189|189.0||||||
4136591|NCT00890682|3961024|B2||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
4136592|NCT00890682|3961025|B1||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
4136593|NCT00890682|3961023|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4136594|NCT00890682|3961024|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4136595|NCT00890682|3961025|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4136596|NCT00890656|3961032|B1|United States||Region of Enrollment||participants|Number|90|90.0||||||
4136597|NCT00890656|3961032|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4136598|NCT00890656|3961032|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4136599|NCT00890656|3961032|B1|||Age||years|Median|34|34.0|Full Range|||14.0|70.0|
4136600|NCT00890591|3961036|B1|Brazil||Region of Enrollment||participants|Number|144|144.0||||||
4136601|NCT00890591|3961036|B1|Other||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
4136602|NCT00890591|3961036|B1|Asian||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4136603|NCT00890591|3961036|B1|White||Race/Ethnicity, Customized||Participants|Number|83|83.0||||||
4136604|NCT00890591|3961036|B1|Black||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
4136605|NCT00890591|3961036|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4136606|NCT00890591|3961036|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4136607|NCT00890591|3961036|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4136608|NCT00890591|3961036|B1||Between 18 and 65 years|Age||Participants|Count of Participants|132|132.0||||||
4136609|NCT00890591|3961036|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4136610|NCT00890552|3961042|B1|Lambda free light chain (%)||Hematologic disease burden||Percentage of participants|Number|80|80.0||||||
4136611|NCT00890552|3961042|B1|Kappa free light chain (%)||Hematologic disease burden||Percentage of participants|Number|20|20.0||||||
4136612|NCT00890552|3961042|B1|ECOG PS 3||ECOG Performance Status (PS)|"ECOG Performance Status. PS 0 = Fully active, able to carry on all pre-disease performance without restriction.~PS 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work.~PS 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours. PS 3 = Capable of only limited self-care, confined to bed or chair more than 50% of waking hours.."|participants|Number|4|4.0||||||
4136613|NCT00890552|3961042|B1|ECOG PS 2||ECOG Performance Status (PS)|"ECOG Performance Status. PS 0 = Fully active, able to carry on all pre-disease performance without restriction.~PS 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work.~PS 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours. PS 3 = Capable of only limited self-care, confined to bed or chair more than 50% of waking hours.."|participants|Number|9|9.0||||||
4136614|NCT00890552|3961042|B1|ECOG PS 1||ECOG Performance Status (PS)|"ECOG Performance Status. PS 0 = Fully active, able to carry on all pre-disease performance without restriction.~PS 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work.~PS 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours. PS 3 = Capable of only limited self-care, confined to bed or chair more than 50% of waking hours.."|participants|Number|12|12.0||||||
4136615|NCT00890552|3961042|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4136616|NCT00890552|3961042|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136617|NCT00890552|3961042|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4136618|NCT00890552|3961042|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136619|NCT00890552|3961042|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136620|NCT00890552|3961042|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4136621|NCT00890552|3961042|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136622|NCT00890552|3961042|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4136623|NCT00890552|3961042|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4136624|NCT00890552|3961042|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4136625|NCT00890552|3961042|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4136626|NCT00890552|3961042|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4136627|NCT00890552|3961042|B1|||Age||years|Median|67|67.0|Full Range|||52.0|84.0|
4136628|NCT00890409|3961049|B3||Male|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4136629|NCT00890409|3961050|B2||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4136630|NCT00890409|3961051|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4136631|NCT00890409|3961049|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4136632|NCT00890409|3961050|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4136633|NCT00890409|3961051|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4136634|NCT00890409|3961049|B3|<=6 hours||Age, Customized||hour|Mean|4.07|4.07|Standard Deviation|1.38|1.38|||
4136635|NCT00890409|3961050|B2|<=6 hours||Age, Customized||hour|Mean|4.12|4.12|Standard Deviation|1.59|1.59|||
4136636|NCT00890409|3961051|B1|<=6 hours||Age, Customized||hour|Mean|4.03|4.03|Standard Deviation|1.21|1.21|||
4136637|NCT00890201|3961060|B3|Chile||Region of Enrollment||participants|Number|197|197.0||||||
4136638|NCT00890201|3961061|B2|Chile||Region of Enrollment||participants|Number|159|159.0||||||
4136639|NCT00890201|3961062|B1|Chile||Region of Enrollment||participants|Number|38|38.0||||||
4136640|NCT00890201|3961060|B3||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4136641|NCT00890201|3961061|B2||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4136642|NCT00890201|3961062|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4136643|NCT00890201|3961060|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4136644|NCT00890201|3961061|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4136645|NCT00890201|3961062|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4136646|NCT00890201|3961060|B3|||Age||years|Mean|46.3|46.3|Standard Deviation|13|13.0|||
4136647|NCT00890201|3961061|B2|||Age||years|Mean|43.4|43.4|Standard Deviation|12.6|12.6|||
4136648|NCT00890201|3961062|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|10|10.0|||
4136649|NCT00890201|3961060|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4136650|NCT00890201|3961061|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4136651|NCT00890201|3961062|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4136652|NCT00890201|3961060|B3||Between 18 and 65 years|Age||Participants|Count of Participants|182|182.0||||||
4136653|NCT00890201|3961061|B2||Between 18 and 65 years|Age||Participants|Count of Participants|149|149.0||||||
4136654|NCT00890201|3961062|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4136655|NCT00890201|3961060|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4136656|NCT00890201|3961061|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4136657|NCT00890201|3961062|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4136658|NCT00890097|3961069|B4|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4136659|NCT00890097|3961070|B3|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4136660|NCT00890097|3961071|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4136661|NCT00890097|3961072|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4136662|NCT00890097|3961069|B4|Portugal||Region of Enrollment||participants|Number|7|7.0||||||
4136663|NCT00890097|3961070|B3|Portugal||Region of Enrollment||participants|Number|2|2.0||||||
4136664|NCT00890097|3961071|B2|Portugal||Region of Enrollment||participants|Number|3|3.0||||||
4136665|NCT00890097|3961072|B1|Portugal||Region of Enrollment||participants|Number|2|2.0||||||
4136666|NCT00890097|3961069|B4|Japan||Region of Enrollment||participants|Number|8|8.0||||||
4136667|NCT00890097|3961070|B3|Japan||Region of Enrollment||participants|Number|3|3.0||||||
4136668|NCT00890097|3961071|B2|Japan||Region of Enrollment||participants|Number|2|2.0||||||
4136669|NCT00890097|3961072|B1|Japan||Region of Enrollment||participants|Number|3|3.0||||||
4136670|NCT00890097|3961069|B4|Ireland||Region of Enrollment||participants|Number|9|9.0||||||
4136671|NCT00890097|3961070|B3|Ireland||Region of Enrollment||participants|Number|3|3.0||||||
4136672|NCT00890097|3961071|B2|Ireland||Region of Enrollment||participants|Number|3|3.0||||||
4136673|NCT00890097|3961072|B1|Ireland||Region of Enrollment||participants|Number|3|3.0||||||
4136674|NCT00890097|3961069|B4|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
4136675|NCT00890097|3961070|B3|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4136676|NCT00890097|3961071|B2|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4136677|NCT00890097|3961072|B1|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4136678|NCT00890097|3961069|B4|Belgium||Region of Enrollment||participants|Number|19|19.0||||||
4136679|NCT00890097|3961070|B3|Belgium||Region of Enrollment||participants|Number|6|6.0||||||
4136680|NCT00890097|3961071|B2|Belgium||Region of Enrollment||participants|Number|6|6.0||||||
4136681|NCT00890097|3961072|B1|Belgium||Region of Enrollment||participants|Number|7|7.0||||||
4136682|NCT00890097|3961069|B4|Austria||Region of Enrollment||participants|Number|40|40.0||||||
4136683|NCT00890097|3961070|B3|Austria||Region of Enrollment||participants|Number|14|14.0||||||
4136684|NCT00890097|3961071|B2|Austria||Region of Enrollment||participants|Number|13|13.0||||||
4136685|NCT00890097|3961072|B1|Austria||Region of Enrollment||participants|Number|13|13.0||||||
4136686|NCT00890097|3961069|B4|Italy||Region of Enrollment||participants|Number|41|41.0||||||
4136687|NCT00890097|3961070|B3|Italy||Region of Enrollment||participants|Number|14|14.0||||||
4136688|NCT00890097|3961071|B2|Italy||Region of Enrollment||participants|Number|15|15.0||||||
4136689|NCT00890097|3961072|B1|Italy||Region of Enrollment||participants|Number|12|12.0||||||
4136690|NCT00890097|3961069|B4|Israel||Region of Enrollment||participants|Number|43|43.0||||||
4136691|NCT00890097|3961070|B3|Israel||Region of Enrollment||participants|Number|15|15.0||||||
4136692|NCT00890097|3961071|B2|Israel||Region of Enrollment||participants|Number|15|15.0||||||
4136693|NCT00890097|3961072|B1|Israel||Region of Enrollment||participants|Number|13|13.0||||||
4136694|NCT00890097|3961069|B4|Australia||Region of Enrollment||participants|Number|50|50.0||||||
4136695|NCT00890097|3961070|B3|Australia||Region of Enrollment||participants|Number|16|16.0||||||
4136696|NCT00890097|3961071|B2|Australia||Region of Enrollment||participants|Number|18|18.0||||||
4136697|NCT00890097|3961072|B1|Australia||Region of Enrollment||participants|Number|16|16.0||||||
4136698|NCT00890097|3961069|B4|Germany||Region of Enrollment||participants|Number|57|57.0||||||
4136699|NCT00890097|3961070|B3|Germany||Region of Enrollment||participants|Number|19|19.0||||||
4136700|NCT00890097|3961071|B2|Germany||Region of Enrollment||participants|Number|20|20.0||||||
4136701|NCT00890097|3961072|B1|Germany||Region of Enrollment||participants|Number|18|18.0||||||
4136702|NCT00890097|3961069|B4|Switzerland||Region of Enrollment||participants|Number|63|63.0||||||
4136703|NCT00890097|3961070|B3|Switzerland||Region of Enrollment||participants|Number|21|21.0||||||
4136704|NCT00890097|3961071|B2|Switzerland||Region of Enrollment||participants|Number|21|21.0||||||
4136705|NCT00890097|3961072|B1|Switzerland||Region of Enrollment||participants|Number|21|21.0||||||
4136706|NCT00890097|3961069|B4|France||Region of Enrollment||participants|Number|84|84.0||||||
4136707|NCT00890097|3961070|B3|France||Region of Enrollment||participants|Number|29|29.0||||||
4136708|NCT00890097|3961071|B2|France||Region of Enrollment||participants|Number|27|27.0||||||
4136709|NCT00890097|3961072|B1|France||Region of Enrollment||participants|Number|28|28.0||||||
4136710|NCT00890097|3961069|B4|United States||Region of Enrollment||participants|Number|339|339.0||||||
4136711|NCT00890097|3961070|B3|United States||Region of Enrollment||participants|Number|116|116.0||||||
4136712|NCT00890097|3961071|B2|United States||Region of Enrollment||participants|Number|112|112.0||||||
4136713|NCT00890097|3961072|B1|United States||Region of Enrollment||participants|Number|111|111.0||||||
4136714|NCT00890097|3961069|B4||Male|Sex: Female, Male||Participants|Count of Participants|333|333.0||||||
4136715|NCT00890097|3961070|B3||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4136716|NCT00890097|3961071|B2||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4136717|NCT00890097|3961072|B1||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4136718|NCT00890097|3961069|B4||Female|Sex: Female, Male||Participants|Count of Participants|439|439.0||||||
4136719|NCT00890097|3961070|B3||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4136720|NCT00890097|3961071|B2||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4136721|NCT00890097|3961072|B1||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4136722|NCT00890097|3961069|B4|||Age||years|Mean|78.3|78.3|Standard Deviation|7.6|7.6|||
4136723|NCT00890097|3961070|B3|||Age||years|Mean|78.8|78.8|Standard Deviation|7.1|7.1|||
4136724|NCT00890097|3961071|B2|||Age||years|Mean|78.3|78.3|Standard Deviation|7.7|7.7|||
4136725|NCT00890097|3961072|B1|||Age||years|Mean|77.9|77.9|Standard Deviation|8.0|8.0|||
4136726|NCT00890084|3961082|B1|Diastolic Blood Pressure||Systolic and diastolic blood pressure||mm Hg|Mean|91.9|91.9|Standard Deviation|8.64|8.64|||
4136727|NCT00890084|3961082|B1|Systolic Blood Pressure||Systolic and diastolic blood pressure||mm Hg|Mean|156.1|156.1|Standard Deviation|12.9|12.9|||
4136728|NCT00890084|3961082|B1|Male||Sex/Gender, Customized||percentage of participants|Number|51.2|51.2||||||
4136729|NCT00890084|3961082|B1|Female||Sex/Gender, Customized||percentage of participants|Number|48.8|48.8||||||
4136730|NCT00890084|3961082|B1|||Age, Customized||years|Mean|64.4|64.4|Standard Deviation|12.6|12.6|||
4136731|NCT00889928|3961093|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4136732|NCT00889928|3961093|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4136733|NCT00889928|3961093|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4136734|NCT00889928|3961093|B1|||Age||years|Mean|37.7|37.7|Standard Deviation|6.26|6.26|||
4136735|NCT00889928|3961093|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4136736|NCT00889928|3961093|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4136737|NCT00889928|3961093|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4136738|NCT00889915|3961097|B5|United States||Region of Enrollment||participants|Number|228|228.0||||||
4136739|NCT00889915|3961098|B4|United States||Region of Enrollment||participants|Number|48|48.0||||||
4136740|NCT00889915|3961099|B3|United States||Region of Enrollment||participants|Number|67|67.0||||||
4136741|NCT00889915|3961100|B2|United States||Region of Enrollment||participants|Number|76|76.0||||||
4136742|NCT00889915|3961101|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4136743|NCT00889915|3961097|B5||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4136744|NCT00889915|3961098|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4136745|NCT00889915|3961099|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4136746|NCT00889915|3961100|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4136747|NCT00889915|3961101|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4136748|NCT00889915|3961097|B5||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4136749|NCT00889915|3961098|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4136750|NCT00889915|3961099|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4136751|NCT00889915|3961100|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4136752|NCT00889915|3961101|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4136753|NCT00889915|3961097|B5|||Age||years|Mean|10.3|10.3|Standard Deviation|3.1|3.1|||
4136754|NCT00889915|3961098|B4|||Age||years|Mean|10.4|10.4|Standard Deviation|3.0|3.0|||
4136755|NCT00889915|3961099|B3|||Age||years|Mean|10.0|10.0|Standard Deviation|3.2|3.2|||
4136756|NCT00889915|3961100|B2|||Age||years|Mean|10.6|10.6|Standard Deviation|3.1|3.1|||
4136757|NCT00889915|3961101|B1|||Age||years|Mean|10.3|10.3|Standard Deviation|3.2|3.2|||
4136758|NCT00889915|3961097|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4136759|NCT00889915|3961098|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4136760|NCT00889915|3961099|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4136761|NCT00889915|3961100|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4136762|NCT00889915|3961101|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4136763|NCT00889915|3961097|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4136764|NCT00889915|3961098|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4136765|NCT00889915|3961099|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4136766|NCT00889915|3961100|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4136767|NCT00889915|3961101|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4136768|NCT00889915|3961097|B5||<=18 years|Age||Participants|Count of Participants|228|228.0||||||
4136769|NCT00889915|3961098|B4||<=18 years|Age||Participants|Count of Participants|48|48.0||||||
4136770|NCT00889915|3961099|B3||<=18 years|Age||Participants|Count of Participants|67|67.0||||||
4136771|NCT00889915|3961100|B2||<=18 years|Age||Participants|Count of Participants|76|76.0||||||
4136772|NCT00889915|3961101|B1||<=18 years|Age||Participants|Count of Participants|37|37.0||||||
4136773|NCT00889863|3961122|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4136774|NCT00889863|3961122|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4136775|NCT00889863|3961122|B1|||Age||years|Mean|8.7|8.7|Standard Deviation|4.46|4.46|||
4136776|NCT00889824|3961145|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4136777|NCT00889824|3961145|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4136778|NCT00889824|3961145|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4136779|NCT00889824|3961145|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4136780|NCT00889824|3961145|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4136781|NCT00889824|3961145|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4136782|NCT00889720|3961149|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4136783|NCT00889720|3961149|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4136784|NCT00889720|3961149|B1|>= 65 years||Age, Customized||Participants|Number|3|3.0||||||
4136785|NCT00889720|3961149|B1|Between 45 and 64 years||Age, Customized||Participants|Number|7|7.0||||||
4136786|NCT00889720|3961149|B1|Between 18 and 44 years||Age, Customized||Participants|Number|6|6.0||||||
4136787|NCT00889707|3961174|B3|Canada||Region of Enrollment||participants|Number|92|92.0||||||
4136788|NCT00889707|3961175|B2|Canada||Region of Enrollment||participants|Number|31|31.0||||||
4136789|NCT00889707|3961176|B1|Canada||Region of Enrollment||participants|Number|61|61.0||||||
4136790|NCT00889707|3961174|B3||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4136791|NCT00889707|3961175|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4136792|NCT00889707|3961176|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4136793|NCT00889707|3961174|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4136794|NCT00889707|3961175|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4136795|NCT00889707|3961176|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4136796|NCT00889707|3961174|B3|||Age||years|Mean|63.6|63.6|Standard Deviation|8.57|8.57|||
4136797|NCT00889707|3961175|B2|||Age||years|Mean|63.5|63.5|Standard Deviation|8.36|8.36|||
4136798|NCT00889707|3961176|B1|||Age||years|Mean|63.7|63.7|Standard Deviation|8.74|8.74|||
4136799|NCT00889707|3961174|B3||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
4136800|NCT00889707|3961175|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4136801|NCT00889707|3961176|B1||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4136802|NCT00889707|3961174|B3||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4136803|NCT00889707|3961175|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4136804|NCT00889707|3961176|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4136805|NCT00889707|3961174|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4136806|NCT00889707|3961175|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4136807|NCT00889707|3961176|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4136808|NCT00889681|3961185|B1|United States||Region of Enrollment||participants|Number|81|81.0||||||
4136809|NCT00889681|3961185|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4136810|NCT00889681|3961185|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4136811|NCT00889681|3961185|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|10.4|10.4|||
4136812|NCT00889681|3961185|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4136813|NCT00889681|3961185|B1||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4136814|NCT00889681|3961185|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4136815|NCT00889603|3961192|B1||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4136816|NCT00889603|3961192|B1||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4136817|NCT00889603|3961192|B1|Greater than or equal to 85 years||Age, Customized||Participants|Number|27|27.0||||||
4136818|NCT00889603|3961192|B1|75 to 84 years||Age, Customized||Participants|Number|142|142.0||||||
4136819|NCT00889603|3961192|B1|65 to 74 years||Age, Customized||Participants|Number|130|130.0||||||
4136820|NCT00889603|3961192|B1|Less than 65 years||Age, Customized||Participants|Number|71|71.0||||||
4136821|NCT00889512|3961205|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4136822|NCT00889512|3961206|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4136823|NCT00889512|3961207|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4136824|NCT00889512|3961205|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4136825|NCT00889512|3961206|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4136826|NCT00889512|3961207|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4136827|NCT00889512|3961205|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4136828|NCT00889512|3961206|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4136829|NCT00889512|3961207|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4136830|NCT00889512|3961205|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4136831|NCT00889512|3961206|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4136832|NCT00889512|3961207|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4136833|NCT00889512|3961205|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4136834|NCT00889512|3961206|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4136835|NCT00889512|3961207|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4136836|NCT00889421|3961214|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4136837|NCT00889421|3961214|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4136838|NCT00889421|3961214|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4136839|NCT00889421|3961214|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4136840|NCT00889421|3961214|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4136841|NCT00889421|3961214|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4136842|NCT00889330|3961222|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4136843|NCT00889330|3961223|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4136844|NCT00889330|3961224|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4136845|NCT00889330|3961222|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4136846|NCT00889330|3961223|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4136847|NCT00889330|3961224|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4136848|NCT00889330|3961222|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4136849|NCT00889330|3961223|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4136850|NCT00889330|3961224|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4136851|NCT00889330|3961222|B3|||Age||years|Mean|36.1|36.1|Standard Deviation|40|40.0|||
4136852|NCT00889330|3961223|B2|||Age||years|Mean|34.3|34.3|Standard Deviation|15.64|15.64|||
4136853|NCT00889330|3961224|B1|||Age||years|Mean|37.8|37.8|Standard Deviation|13.52|13.52|||
4136854|NCT00889265|3961255|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4136855|NCT00889265|3961255|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4136856|NCT00889265|3961255|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4136857|NCT00889265|3961255|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4136858|NCT00889265|3961255|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4136859|NCT00889265|3961255|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4136860|NCT00889265|3961255|B1|||Age||years|Mean|49|49.0|Standard Deviation|15|15.0|||
4136861|NCT00889252|3961260|B3|United States||Region of Enrollment||participants|Number|250|250.0||||||
4136862|NCT00889252|3961261|B2|United States||Region of Enrollment||participants|Number|82|82.0||||||
4136863|NCT00889252|3961262|B1|United States||Region of Enrollment||participants|Number|168|168.0||||||
4136864|NCT00889252|3961260|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4136865|NCT00889252|3961261|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4136866|NCT00889252|3961262|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4136867|NCT00889252|3961260|B3||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4136868|NCT00889252|3961261|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4136869|NCT00889252|3961262|B1||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4136870|NCT00889252|3961260|B3|||Age||years|Mean|31.5|31.5|Standard Deviation|12.03|12.03|||
4136871|NCT00889252|3961261|B2|||Age||years|Mean|29.3|29.3|Standard Deviation|10.77|10.77|||
4136872|NCT00889252|3961262|B1|||Age||years|Mean|32.6|32.6|Standard Deviation|12.48|12.48|||
4136873|NCT00889200|3961305|B1|||Insomnia Severity Index|Self report measure of Insomnia. Subjects had to have a total score >10 to enroll. The range of the scales is from 0 (no insomnia symptoms) to 28 (severe insomnia symptoms).|units on a scale|Mean|15.23|15.23|Standard Deviation|2.93|2.93|||
4136874|NCT00889200|3961305|B1|||plasma cortisol response to standardized dexamethasone/Corticotropin Releasing Hormone (DEX/CRH)|"Cortisol assays were performed on plasma samples from 2:59 PM (baseline), 3:30 PM, 3:45 PM, 4:00 PM, 4:15 PM, and 5:00 PM. Radioimmunoassay (RIA) used to measure cortisol in duplicate at each time point; intra-assay and inter-assay coefficients of variation observed for quality assessment samples (5 and 20 nmol/L) were <5% and 10%, respectively. Cortisol responsewas summarized by absolute change from pre-CRH infusion (time point 0) to peak level after CRH infusion."|nmol/L|Mean|146.23|146.23|Standard Deviation|161.85|161.85|||
4136875|NCT00889200|3961305|B1|||Depressive Symptoms|Inventory for Depressive Symptomology-Self Report version (IDS-SR), total score calculated without 4 items pertaining to sleep. Range of scores on this version of the IDSSR are 0 (best outcome; no symptoms) to 69 (worst outcome; severe symptoms).|scores on a scale|Mean|13.83|13.83|Standard Deviation|8.24|8.24|||
4136876|NCT00889200|3961305|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4136877|NCT00889200|3961305|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4136878|NCT00889200|3961305|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4136879|NCT00889200|3961305|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4136880|NCT00889200|3961305|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4136881|NCT00889187|3961309|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4136882|NCT00889187|3961309|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4136883|NCT00889187|3961309|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4136884|NCT00889187|3961309|B1|||Age||years|Median|62.6|62.6|Full Range|||57.0|75.0|
4136885|NCT00889005|3961327|B3|Israel||Region of Enrollment||participants|Number|139|139.0||||||
4136886|NCT00889005|3961328|B2|Israel||Region of Enrollment||participants|Number|74|74.0||||||
4136887|NCT00889005|3961329|B1|Israel||Region of Enrollment||participants|Number|65|65.0||||||
4136888|NCT00889005|3961327|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136889|NCT00889005|3961328|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136890|NCT00889005|3961329|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136891|NCT00889005|3961327|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136892|NCT00889005|3961328|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136893|NCT00889005|3961329|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136894|NCT00889005|3961327|B3||White|Race (NIH/OMB)||Participants|Count of Participants|139|139.0||||||
4136895|NCT00889005|3961328|B2||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4136896|NCT00889005|3961329|B1||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4136897|NCT00889005|3961327|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136898|NCT00889005|3961328|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136899|NCT00889005|3961329|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136900|NCT00889005|3961327|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136901|NCT00889005|3961328|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136902|NCT00889005|3961329|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136903|NCT00889005|3961327|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136904|NCT00889005|3961328|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136905|NCT00889005|3961329|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136906|NCT00889005|3961327|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136907|NCT00889005|3961328|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136908|NCT00889005|3961329|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136909|NCT00889005|3961327|B3|Male||Sex/Gender, Customized||participants|Number|62|62.0||||||
4136910|NCT00889005|3961328|B2|Male||Sex/Gender, Customized||participants|Number|32|32.0||||||
4136911|NCT00889005|3961329|B1|Male||Sex/Gender, Customized||participants|Number|30|30.0||||||
4136912|NCT00889005|3961327|B3|Female||Sex/Gender, Customized||participants|Number|77|77.0||||||
4136913|NCT00889005|3961328|B2|Female||Sex/Gender, Customized||participants|Number|42|42.0||||||
4136914|NCT00889005|3961329|B1|Female||Sex/Gender, Customized||participants|Number|35|35.0||||||
4136915|NCT00889005|3961327|B3|||Age||years|Mean|37.89|37.89|Standard Deviation|10.4|10.4|||
4136916|NCT00889005|3961328|B2|||Age||years|Mean|37.95|37.95|Standard Deviation|12.71|12.71|||
4136917|NCT00889005|3961329|B1|||Age||years|Mean|37.83|37.83|Standard Deviation|12.2|12.2|||
4136918|NCT00888979|3961336|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4136919|NCT00888979|3961336|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4136920|NCT00888979|3961336|B1||Female|Gender||Participants|Count of Participants|8|8.0||||||
4136921|NCT00888979|3961336|B1|||Age||years|Mean|26|26.0|Full Range|||19.0|38.0|
4136922|NCT00888979|3961336|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4136923|NCT00888979|3961336|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4136924|NCT00888979|3961336|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4136925|NCT00888940|3961342|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136926|NCT00888940|3961343|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136927|NCT00888940|3961344|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136928|NCT00888940|3961342|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136929|NCT00888940|3961343|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136930|NCT00888940|3961344|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136931|NCT00888940|3961342|B3||White|Race (NIH/OMB)||Participants|Count of Participants|242|242.0||||||
4136932|NCT00888940|3961343|B2||White|Race (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
4136933|NCT00888940|3961344|B1||White|Race (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
4136934|NCT00888940|3961342|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136935|NCT00888940|3961343|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136936|NCT00888940|3961344|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136937|NCT00888940|3961342|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136938|NCT00888940|3961343|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136939|NCT00888940|3961344|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136940|NCT00888940|3961342|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136941|NCT00888940|3961343|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136942|NCT00888940|3961344|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136943|NCT00888940|3961342|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136944|NCT00888940|3961343|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136945|NCT00888940|3961344|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136946|NCT00888940|3961342|B3||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4136947|NCT00888940|3961343|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4136948|NCT00888940|3961344|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4136949|NCT00888940|3961342|B3||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4136950|NCT00888940|3961343|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4136951|NCT00888940|3961344|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4136952|NCT00888940|3961342|B3|||Age||years|Mean|68.2|68.2|Standard Deviation|9.65|9.65|||
4136953|NCT00888940|3961343|B2|||Age||years|Mean|66.9|66.9|Standard Deviation|10.88|10.88|||
4136954|NCT00888940|3961344|B1|||Age||years|Mean|69.6|69.6|Standard Deviation|8.02|8.02|||
4136955|NCT00888849|3961353|B3|India||Region of Enrollment||participants|Number|280|280.0||||||
4136956|NCT00888849|3961354|B2|India||Region of Enrollment||participants|Number|138|138.0||||||
4136957|NCT00888849|3961355|B1|India||Region of Enrollment||participants|Number|142|142.0||||||
4136958|NCT00888849|3961353|B3||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4136959|NCT00888849|3961354|B2||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4136960|NCT00888849|3961355|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4136961|NCT00888849|3961353|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4136962|NCT00888849|3961354|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4136963|NCT00888849|3961355|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4136964|NCT00888849|3961353|B3|||Age||years|Mean|43.8|43.8|Standard Deviation|14.86|14.86|||
4136965|NCT00888849|3961354|B2|||Age||years|Mean|43.7|43.7|Standard Deviation|15.87|15.87|||
4136966|NCT00888849|3961355|B1|||Age||years|Mean|43.8|43.8|Standard Deviation|13.81|13.81|||
4136967|NCT00888849|3961353|B3||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4136968|NCT00888849|3961354|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4136969|NCT00888849|3961355|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4136970|NCT00888849|3961353|B3||Between 18 and 65 years|Age||Participants|Count of Participants|252|252.0||||||
4136971|NCT00888849|3961354|B2||Between 18 and 65 years|Age||Participants|Count of Participants|128|128.0||||||
4136972|NCT00888849|3961355|B1||Between 18 and 65 years|Age||Participants|Count of Participants|124|124.0||||||
4136973|NCT00888849|3961353|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4136974|NCT00888849|3961354|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4136975|NCT00888849|3961355|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4136976|NCT00888654|3961366|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4136977|NCT00888654|3961366|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4136978|NCT00888654|3961366|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4136979|NCT00888654|3961366|B1|||Age||years|Median|58|58.0|Full Range|||20.0|70.0|
4136980|NCT00888628|3961372|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4136981|NCT00888628|3961372|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136982|NCT00888628|3961372|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136983|NCT00888628|3961372|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4136984|NCT00888628|3961372|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136985|NCT00888628|3961372|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136986|NCT00888628|3961372|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136987|NCT00888628|3961372|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136988|NCT00888628|3961372|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136989|NCT00888628|3961372|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4136990|NCT00888628|3961372|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4136991|NCT00888628|3961372|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4136992|NCT00888628|3961372|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4136993|NCT00888628|3961372|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4136994|NCT00888628|3961372|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4136995|NCT00888628|3961372|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4136996|NCT00888459|3961384|B3|||Smokeless tobacco||cans/week|Mean|3.8|3.8|Standard Deviation|2.6|2.6|||
4136997|NCT00888459|3961385|B2|||Smokeless tobacco||cans/week|Mean|3.7|3.7|Standard Deviation|2.1|2.1|||
4136998|NCT00888459|3961386|B1|||Smokeless tobacco||cans/week|Mean|3.9|3.9|Standard Deviation|3.1|3.1|||
4136999|NCT00888459|3961384|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4137000|NCT00888459|3961385|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4137001|NCT00888459|3961386|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4137002|NCT00888459|3961384|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4137003|NCT00888459|3961385|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4137004|NCT00888459|3961386|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4137005|NCT00888459|3961384|B3|||Age||years|Mean|43.0|43.0|Standard Deviation|13.9|13.9|||
4137006|NCT00888459|3961385|B2|||Age||years|Mean|42.4|42.4|Standard Deviation|11.7|11.7|||
4137007|NCT00888459|3961386|B1|||Age||years|Mean|43.6|43.6|Standard Deviation|16.0|16.0|||
4137008|NCT00888433|3961393|B3|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
4137009|NCT00888433|3961394|B2|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4137010|NCT00888433|3961395|B1|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4137011|NCT00888433|3961393|B3|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4137012|NCT00888433|3961394|B2|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4137013|NCT00888433|3961395|B1|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
4137014|NCT00888433|3961393|B3|Germany||Region of Enrollment||participants|Number|61|61.0||||||
4137015|NCT00888433|3961394|B2|Germany||Region of Enrollment||participants|Number|29|29.0||||||
4137016|NCT00888433|3961395|B1|Germany||Region of Enrollment||participants|Number|32|32.0||||||
4137017|NCT00888433|3961393|B3|Latvia||Region of Enrollment||participants|Number|7|7.0||||||
4137018|NCT00888433|3961394|B2|Latvia||Region of Enrollment||participants|Number|4|4.0||||||
4137019|NCT00888433|3961395|B1|Latvia||Region of Enrollment||participants|Number|3|3.0||||||
4137020|NCT00888433|3961393|B3|Austria||Region of Enrollment||participants|Number|3|3.0||||||
4137021|NCT00888433|3961394|B2|Austria||Region of Enrollment||participants|Number|2|2.0||||||
4137022|NCT00888433|3961395|B1|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4137023|NCT00888433|3961393|B3|Australia||Region of Enrollment||participants|Number|10|10.0||||||
4137024|NCT00888433|3961394|B2|Australia||Region of Enrollment||participants|Number|5|5.0||||||
4137025|NCT00888433|3961395|B1|Australia||Region of Enrollment||participants|Number|5|5.0||||||
4137026|NCT00888433|3961393|B3|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4137027|NCT00888433|3961394|B2|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4137028|NCT00888433|3961395|B1|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4137029|NCT00888433|3961393|B3|Belgium||Region of Enrollment||participants|Number|6|6.0||||||
4137030|NCT00888433|3961394|B2|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
4137031|NCT00888433|3961395|B1|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
4137032|NCT00888433|3961393|B3|Poland||Region of Enrollment||participants|Number|2|2.0||||||
4137033|NCT00888433|3961394|B2|Poland||Region of Enrollment||participants|Number|1|1.0||||||
4137034|NCT00888433|3961395|B1|Poland||Region of Enrollment||participants|Number|1|1.0||||||
4137035|NCT00888433|3961393|B3|France||Region of Enrollment||participants|Number|4|4.0||||||
4137036|NCT00888433|3961394|B2|France||Region of Enrollment||participants|Number|3|3.0||||||
4137037|NCT00888433|3961395|B1|France||Region of Enrollment||participants|Number|1|1.0||||||
4137038|NCT00888433|3961393|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4137039|NCT00888433|3961394|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4137040|NCT00888433|3961395|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4137041|NCT00888433|3961393|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4137042|NCT00888433|3961394|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4137043|NCT00888433|3961395|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4137044|NCT00888433|3961393|B3|||Age||years|Mean|58.2|58.2|Standard Deviation|12.0|12.0|||
4137045|NCT00888433|3961394|B2|||Age||years|Mean|58.3|58.3|Standard Deviation|12.3|12.3|||
4137046|NCT00888433|3961395|B1|||Age||years|Mean|58.2|58.2|Standard Deviation|11.9|11.9|||
4137047|NCT00888381|3961402|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4137048|NCT00888381|3961403|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4137049|NCT00888381|3961404|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4137050|NCT00888381|3961402|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4137051|NCT00888381|3961403|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4137052|NCT00888381|3961404|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4137053|NCT00888381|3961402|B3|||Age||years|Mean|50.7|50.7|Standard Deviation|18.24|18.24|||
4137054|NCT00888381|3961403|B2|||Age||years|Mean|66.2|66.2|Standard Deviation|5.92|5.92|||
4137055|NCT00888381|3961404|B1|||Age||years|Mean|35.3|35.3|Standard Deviation|12.31|12.31|||
4137056|NCT00888355|3961421|B5|||Sitting Diastolic Blood Pressure (SiDBP)||mm Hg|Mean|101.9|101.9|Standard Deviation|5.6|5.6|||
4137057|NCT00888355|3961422|B4|||Sitting Diastolic Blood Pressure (SiDBP)||mm Hg|Mean|102.0|102.0|Standard Deviation|5.3|5.3|||
4137058|NCT00888355|3961423|B3|||Sitting Diastolic Blood Pressure (SiDBP)||mm Hg|Mean|102.4|102.4|Standard Deviation|6.4|6.4|||
4137059|NCT00888355|3961424|B2|||Sitting Diastolic Blood Pressure (SiDBP)||mm Hg|Mean|101.8|101.8|Standard Deviation|5.5|5.5|||
4137060|NCT00888355|3961425|B1|||Sitting Diastolic Blood Pressure (SiDBP)||mm Hg|Mean|101.5|101.5|Standard Deviation|5.1|5.1|||
4137061|NCT00888355|3961421|B5|Vietnamese||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4137062|NCT00888355|3961422|B4|Vietnamese||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4137063|NCT00888355|3961423|B3|Vietnamese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4137064|NCT00888355|3961424|B2|Vietnamese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4137065|NCT00888355|3961425|B1|Vietnamese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4137066|NCT00888355|3961421|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4137067|NCT00888355|3961422|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4137068|NCT00888355|3961423|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4137069|NCT00888355|3961424|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4137070|NCT00888355|3961425|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4137071|NCT00888355|3961421|B5|Black||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
4137072|NCT00888355|3961422|B4|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4137073|NCT00888355|3961423|B3|Black||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4137074|NCT00888355|3961424|B2|Black||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4137075|NCT00888355|3961425|B1|Black||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4137076|NCT00888355|3961421|B5|Latin American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4137077|NCT00888355|3961422|B4|Latin American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4137078|NCT00888355|3961423|B3|Latin American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4137079|NCT00888355|3961424|B2|Latin American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4137080|NCT00888355|3961425|B1|Latin American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4137081|NCT00888355|3961421|B5|Oriental||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4137082|NCT00888355|3961422|B4|Oriental||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4137083|NCT00888355|3961423|B3|Oriental||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4137084|NCT00888355|3961424|B2|Oriental||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4137085|NCT00888355|3961425|B1|Oriental||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4137086|NCT00888355|3961421|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|334|334.0||||||
4137087|NCT00888355|3961422|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|89|89.0||||||
4137088|NCT00888355|3961423|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
4137089|NCT00888355|3961424|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
4137090|NCT00888355|3961425|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|84|84.0||||||
4137091|NCT00888355|3961421|B5||Male|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
4137092|NCT00888355|3961422|B4||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4137093|NCT00888355|3961423|B3||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4137094|NCT00888355|3961424|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4137095|NCT00888355|3961425|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4137096|NCT00888355|3961421|B5||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4137097|NCT00888355|3961422|B4||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4137098|NCT00888355|3961423|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4137099|NCT00888355|3961424|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4137100|NCT00888355|3961425|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4137101|NCT00888355|3961421|B5|||Age||years|Mean|53.5|53.5|Standard Deviation|10.4|10.4|||
4137102|NCT00888355|3961422|B4|||Age||years|Mean|52.4|52.4|Standard Deviation|10.1|10.1|||
4137103|NCT00888355|3961423|B3|||Age||years|Mean|54.0|54.0|Standard Deviation|10.1|10.1|||
4137104|NCT00888355|3961424|B2|||Age||years|Mean|53.0|53.0|Standard Deviation|10.7|10.7|||
4137105|NCT00888355|3961425|B1|||Age||years|Mean|54.6|54.6|Standard Deviation|10.6|10.6|||
4137106|NCT00888329|3961482|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4137107|NCT00888329|3961483|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4137108|NCT00888329|3961484|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4137109|NCT00888329|3961482|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4137110|NCT00888329|3961483|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4137111|NCT00888329|3961484|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4137112|NCT00888329|3961482|B3|||Age||years|Mean|56|56.0|Standard Deviation|12|12.0|||
4137113|NCT00888329|3961483|B2|||Age||years|Mean|53|53.0|Standard Deviation|12|12.0|||
4137114|NCT00888329|3961484|B1|||Age||years|Mean|60|60.0|Standard Deviation|12|12.0|||
4137115|NCT00888238|3961491|B1|||Body Mass Index||kg/m2|Mean|20.5|20.5|Standard Deviation|1.3|1.3|||
4137116|NCT00888238|3961491|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4137117|NCT00888238|3961491|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4137118|NCT00888238|3961491|B1|||Age||years|Mean|26.8|26.8|Standard Deviation|6.4|6.4|||
4137119|NCT00888173|3961501|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4137120|NCT00888173|3961501|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4137121|NCT00888173|3961501|B1|80-89 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
4137122|NCT00888173|3961501|B1|70-79 years||Age, Customized||Participants|Count of Participants|11|11.0||||||
4137123|NCT00888173|3961501|B1|60-69 years||Age, Customized||Participants|Count of Participants|15|15.0||||||
4137124|NCT00888173|3961501|B1|50-59 years||Age, Customized||Participants|Count of Participants|12|12.0||||||
4137125|NCT00888173|3961501|B1|40-49 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
4137126|NCT00888173|3961501|B1|30-39 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4137127|NCT00888173|3961501|B1|20-29 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4137128|NCT00888173|3961501|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|9.5|9.5|||
4137129|NCT00888134|3961509|B1|Other cancer||Type of cancer||participants|Number|4|4.0||||||
4137130|NCT00888134|3961509|B1|Colon cancer||Type of cancer||participants|Number|10|10.0||||||
4137131|NCT00888134|3961509|B1|Non small-cell lung cancer||Type of cancer||participants|Number|14|14.0||||||
4137132|NCT00888134|3961509|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4137133|NCT00888134|3961509|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137134|NCT00888134|3961509|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137135|NCT00888134|3961509|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4137136|NCT00888134|3961509|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4137137|NCT00888134|3961509|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137138|NCT00888134|3961509|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137139|NCT00888134|3961509|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137140|NCT00888134|3961509|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4137141|NCT00888134|3961509|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4137142|NCT00888134|3961509|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137143|NCT00888134|3961509|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4137144|NCT00888134|3961509|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4137145|NCT00888134|3961509|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4137146|NCT00888134|3961509|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4137147|NCT00888134|3961509|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137148|NCT00887978|3961517|B3|||Time since PAH diagnosis||years|Mean|2.9|2.9|Standard Deviation|3.4|3.4|||
4137149|NCT00887978|3961518|B2|||Time since PAH diagnosis||years|Mean|3.3|3.3|Standard Deviation|4.1|4.1|||
4137150|NCT00887978|3961519|B1|||Time since PAH diagnosis||years|Mean|2.5|2.5|Standard Deviation|2.6|2.6|||
4137151|NCT00887978|3961517|B3|PDE-5i + ERA||Background PAH therapy|Eligible subjects were receiving background PAH therapy of either a phosphodiesterase-5 inhibitor (PDE-5i) and/or endothelin receptor antagonist (ERA)|participants|Number|125|125.0||||||
4137152|NCT00887978|3961518|B2|PDE-5i + ERA||Background PAH therapy|Eligible subjects were receiving background PAH therapy of either a phosphodiesterase-5 inhibitor (PDE-5i) and/or endothelin receptor antagonist (ERA)|participants|Number|60|60.0||||||
4137153|NCT00887978|3961519|B1|PDE-5i + ERA||Background PAH therapy|Eligible subjects were receiving background PAH therapy of either a phosphodiesterase-5 inhibitor (PDE-5i) and/or endothelin receptor antagonist (ERA)|participants|Number|65|65.0||||||
4137154|NCT00887978|3961517|B3|ERA||Background PAH therapy|Eligible subjects were receiving background PAH therapy of either a phosphodiesterase-5 inhibitor (PDE-5i) and/or endothelin receptor antagonist (ERA)|participants|Number|53|53.0||||||
4137155|NCT00887978|3961518|B2|ERA||Background PAH therapy|Eligible subjects were receiving background PAH therapy of either a phosphodiesterase-5 inhibitor (PDE-5i) and/or endothelin receptor antagonist (ERA)|participants|Number|28|28.0||||||
4137156|NCT00887978|3961519|B1|ERA||Background PAH therapy|Eligible subjects were receiving background PAH therapy of either a phosphodiesterase-5 inhibitor (PDE-5i) and/or endothelin receptor antagonist (ERA)|participants|Number|25|25.0||||||
4137157|NCT00887978|3961517|B3|PDE-5i||Background PAH therapy|Eligible subjects were receiving background PAH therapy of either a phosphodiesterase-5 inhibitor (PDE-5i) and/or endothelin receptor antagonist (ERA)|participants|Number|132|132.0||||||
4137158|NCT00887978|3961518|B2|PDE-5i||Background PAH therapy|Eligible subjects were receiving background PAH therapy of either a phosphodiesterase-5 inhibitor (PDE-5i) and/or endothelin receptor antagonist (ERA)|participants|Number|65|65.0||||||
4137159|NCT00887978|3961519|B1|PDE-5i||Background PAH therapy|Eligible subjects were receiving background PAH therapy of either a phosphodiesterase-5 inhibitor (PDE-5i) and/or endothelin receptor antagonist (ERA)|participants|Number|67|67.0||||||
4137160|NCT00887978|3961517|B3|||Baseline Six-minute walk distance||meters|Mean|333|333.0|Standard Deviation|66.4|66.4|||
4137161|NCT00887978|3961518|B2|||Baseline Six-minute walk distance||meters|Mean|336.8|336.8|Standard Deviation|63.5|63.5|||
4137162|NCT00887978|3961519|B1|||Baseline Six-minute walk distance||meters|Mean|329.4|329.4|Standard Deviation|69.2|69.2|||
4137163|NCT00887978|3961517|B3|Unknown||World Health Organization (WHO) Functional Class|Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Inability to carry out any physical activity without symptoms.|Participants|Number|2|2.0||||||
4137164|NCT00887978|3961518|B2|Unknown||World Health Organization (WHO) Functional Class|Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Inability to carry out any physical activity without symptoms.|Participants|Number|1|1.0||||||
4137165|NCT00887978|3961519|B1|Unknown||World Health Organization (WHO) Functional Class|Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Inability to carry out any physical activity without symptoms.|Participants|Number|1|1.0||||||
4137166|NCT00887978|3961517|B3|Class IV||World Health Organization (WHO) Functional Class|Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Inability to carry out any physical activity without symptoms.|Participants|Number|3|3.0||||||
4137167|NCT00887978|3961518|B2|Class IV||World Health Organization (WHO) Functional Class|Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Inability to carry out any physical activity without symptoms.|Participants|Number|0|0.0||||||
4137168|NCT00887978|3961519|B1|Class IV||World Health Organization (WHO) Functional Class|Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Inability to carry out any physical activity without symptoms.|Participants|Number|3|3.0||||||
4137169|NCT00887978|3961517|B3|Class III||World Health Organization (WHO) Functional Class|Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Inability to carry out any physical activity without symptoms.|Participants|Number|225|225.0||||||
4137170|NCT00887978|3961518|B2|Class III||World Health Organization (WHO) Functional Class|Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Inability to carry out any physical activity without symptoms.|Participants|Number|115|115.0||||||
4137171|NCT00887978|3961519|B1|Class III||World Health Organization (WHO) Functional Class|Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Inability to carry out any physical activity without symptoms.|Participants|Number|110|110.0||||||
4137172|NCT00887978|3961517|B3|Class II||World Health Organization (WHO) Functional Class|Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Inability to carry out any physical activity without symptoms.|Participants|Number|80|80.0||||||
4137173|NCT00887978|3961518|B2|Class II||World Health Organization (WHO) Functional Class|Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Inability to carry out any physical activity without symptoms.|Participants|Number|37|37.0||||||
4137174|NCT00887978|3961519|B1|Class II||World Health Organization (WHO) Functional Class|Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Inability to carry out any physical activity without symptoms.|Participants|Number|43|43.0||||||
4137175|NCT00887978|3961517|B3|Repaired congenital heart disease||PAH Etiology||participants|Number|4|4.0||||||
4137176|NCT00887978|3961518|B2|Repaired congenital heart disease||PAH Etiology||participants|Number|1|1.0||||||
4137177|NCT00887978|3961519|B1|Repaired congenital heart disease||PAH Etiology||participants|Number|3|3.0||||||
4137178|NCT00887978|3961517|B3|HIV infection||PAH Etiology||participants|Number|6|6.0||||||
4137179|NCT00887978|3961518|B2|HIV infection||PAH Etiology||participants|Number|4|4.0||||||
4137180|NCT00887978|3961519|B1|HIV infection||PAH Etiology||participants|Number|2|2.0||||||
4137181|NCT00887978|3961517|B3|Collagen vascular disease||PAH Etiology||participants|Number|97|97.0||||||
4137182|NCT00887978|3961518|B2|Collagen vascular disease||PAH Etiology||participants|Number|49|49.0||||||
4137183|NCT00887978|3961519|B1|Collagen vascular disease||PAH Etiology||participants|Number|48|48.0||||||
4137184|NCT00887978|3961517|B3|Idiopathic or familial||PAH Etiology||participants|Number|203|203.0||||||
4137185|NCT00887978|3961518|B2|Idiopathic or familial||PAH Etiology||participants|Number|99|99.0||||||
4137186|NCT00887978|3961519|B1|Idiopathic or familial||PAH Etiology||participants|Number|104|104.0||||||
4137187|NCT00887978|3961517|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4137188|NCT00887978|3961518|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4137189|NCT00887978|3961519|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4137190|NCT00887978|3961517|B3||Female|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
4137191|NCT00887978|3961518|B2||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4137192|NCT00887978|3961519|B1||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4137193|NCT00887978|3961517|B3|||Age||years|Mean|51.0|51.0|Full Range|||18.0|76.0|
4137194|NCT00887978|3961518|B2|||Age||years|Mean|50.4|50.4|Full Range|14.5|14.5|20.0|75.0|
4137195|NCT00887978|3961519|B1|||Age||years|Mean|51.5|51.5|Full Range|15|15.0|18.0|76.0|
4137196|NCT00887978|3961517|B3||>=65 years|Age||Participants|Count of Participants|69|69.0||||||
4137197|NCT00887978|3961518|B2||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4137198|NCT00887978|3961519|B1||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4137199|NCT00887978|3961517|B3||Between 18 and 65 years|Age||Participants|Count of Participants|241|241.0||||||
4137200|NCT00887978|3961518|B2||Between 18 and 65 years|Age||Participants|Count of Participants|122|122.0||||||
4137201|NCT00887978|3961519|B1||Between 18 and 65 years|Age||Participants|Count of Participants|119|119.0||||||
4137202|NCT00887978|3961517|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137203|NCT00887978|3961518|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137204|NCT00887978|3961519|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137205|NCT00887965|3961556|B1|||Ethnic group: White or Caucasian||Participants|Number|15|15.0||||||
4137206|NCT00887965|3961556|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4137207|NCT00887965|3961556|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4137208|NCT00887965|3961556|B1|||Age||Years|Mean|62.1|62.1|Standard Deviation|5.9|5.9|||
4137209|NCT00887913|3961586|B1|Canada||Region of Enrollment||participants|Number|24|24.0||||||
4137210|NCT00887913|3961586|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4137211|NCT00887913|3961586|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4137212|NCT00887913|3961586|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4137213|NCT00887913|3961586|B1|||Age||years|Mean|51.02|51.02|Standard Deviation|8.28|8.28|||
4137214|NCT00887913|3961586|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4137215|NCT00887913|3961586|B1||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4137216|NCT00887913|3961586|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137217|NCT00887822|3961592|B3||Male|Gender||Participants|Count of Participants|142|142.0||||||
4137218|NCT00887822|3961593|B2||Male|Gender||Participants|Count of Participants|74|74.0||||||
4137219|NCT00887822|3961594|B1||Male|Gender||Participants|Count of Participants|68|68.0||||||
4137220|NCT00887822|3961592|B3||Female|Gender||Participants|Count of Participants|60|60.0||||||
4137221|NCT00887822|3961593|B2||Female|Gender||Participants|Count of Participants|28|28.0||||||
4137222|NCT00887822|3961594|B1||Female|Gender||Participants|Count of Participants|32|32.0||||||
4137223|NCT00887822|3961592|B3|||Age||years|Mean|54.9|54.9|Standard Deviation|11.89|11.89|||
4137224|NCT00887822|3961593|B2|||Age||years|Mean|55.5|55.5|Standard Deviation|12.14|12.14|||
4137225|NCT00887822|3961594|B1|||Age||years|Mean|54.2|54.2|Standard Deviation|11.66|11.66|||
4137226|NCT00887809|3961625|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4137227|NCT00887809|3961626|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4137228|NCT00887809|3961627|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4137229|NCT00887809|3961625|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4137230|NCT00887809|3961626|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4137231|NCT00887809|3961627|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4137232|NCT00887809|3961625|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4137233|NCT00887809|3961626|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4137234|NCT00887809|3961627|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4137235|NCT00887809|3961625|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4137236|NCT00887809|3961626|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4137237|NCT00887809|3961627|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4137238|NCT00887809|3961625|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137239|NCT00887809|3961626|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137240|NCT00887809|3961627|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137241|NCT00887744|3961634|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4137242|NCT00887744|3961634|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4137243|NCT00887744|3961634|B1|||Age||years|Mean|65|65.0|Standard Deviation|11.93|11.93|||
4137244|NCT00887679|3961643|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4137245|NCT00887679|3961643|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4137246|NCT00887679|3961643|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4137247|NCT00887679|3961643|B1|||Age||years|Mean|43.6|43.6|Standard Deviation|8.12|8.12|||
4137248|NCT00887679|3961643|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4137249|NCT00887679|3961643|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4137250|NCT00887679|3961643|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137251|NCT00887653|3961652|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4137252|NCT00887653|3961652|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4137253|NCT00887653|3961652|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137254|NCT00887653|3961652|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4137255|NCT00887653|3961652|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4137256|NCT00887653|3961652|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137257|NCT00887653|3961652|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137258|NCT00887653|3961652|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137259|NCT00887653|3961652|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4137260|NCT00887653|3961652|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4137261|NCT00887653|3961652|B1|||Age||years|Median|52|52.0|Full Range|||40.0|67.0|
4137262|NCT00887640|3961658|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4137263|NCT00887640|3961658|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4137264|NCT00887640|3961658|B1|||Age||years|Median|61|61.0|Full Range|||36.0|78.0|
4137265|NCT00887588|3961671|B3||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4137266|NCT00887588|3961672|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4137267|NCT00887588|3961673|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4137268|NCT00887588|3961671|B3||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4137269|NCT00887588|3961672|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4137270|NCT00887588|3961673|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4137271|NCT00887588|3961671|B3|||Age||Years|Mean|71.0|71.0|Standard Deviation|9.15|9.15|||
4137272|NCT00887588|3961672|B2|||Age||Years|Mean|71.2|71.2|Standard Deviation|8.94|8.94|||
4137273|NCT00887588|3961673|B1|||Age||Years|Mean|70.9|70.9|Standard Deviation|9.38|9.38|||
4137274|NCT00887575|3961726|B1|Premenopausal||Menopausal Status||Participants|Number|16|16.0||||||
4137275|NCT00887575|3961726|B1|Postmenopausal||Menopausal Status||Participants|Number|34|34.0||||||
4137276|NCT00887575|3961726|B1|ECOG Performance Status = 1||Baseline ECOG Performance Status|"ECOG Performance Status = 0 – Asymptomatic (Fully active, able to carry on all predisease activities without restriction)~ECOG Performance Status = 1 – Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. For example, light housework, office work)"|participants|Number|5|5.0||||||
4137277|NCT00887575|3961726|B1|ECOG Performance Status = 0||Baseline ECOG Performance Status|"ECOG Performance Status = 0 – Asymptomatic (Fully active, able to carry on all predisease activities without restriction)~ECOG Performance Status = 1 – Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. For example, light housework, office work)"|participants|Number|45|45.0||||||
4137278|NCT00887575|3961726|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4137279|NCT00887575|3961726|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4137280|NCT00887575|3961726|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137281|NCT00887575|3961726|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4137282|NCT00887575|3961726|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4137283|NCT00887575|3961726|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137284|NCT00887575|3961726|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4137285|NCT00887575|3961726|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137286|NCT00887575|3961726|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4137287|NCT00887575|3961726|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4137288|NCT00887575|3961726|B1|||Age||Years|Median|53|53.0|Full Range|||32.0|78.0|
4137289|NCT00887562|3961736|B4|United States||Region of Enrollment||participants|Number|27|27.0||||||
4137290|NCT00887562|3961737|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4137291|NCT00887562|3961738|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4137292|NCT00887562|3961739|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4137293|NCT00887562|3961736|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137294|NCT00887562|3961737|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137295|NCT00887562|3961738|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137296|NCT00887562|3961739|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137297|NCT00887562|3961736|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137298|NCT00887562|3961737|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137299|NCT00887562|3961738|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137300|NCT00887562|3961739|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137301|NCT00887562|3961736|B4||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4137302|NCT00887562|3961737|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4137303|NCT00887562|3961738|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4137304|NCT00887562|3961739|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4137305|NCT00887562|3961736|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137306|NCT00887562|3961737|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137307|NCT00887562|3961738|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137308|NCT00887562|3961739|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137309|NCT00887562|3961736|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137310|NCT00887562|3961737|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137311|NCT00887562|3961738|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137312|NCT00887562|3961739|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137313|NCT00887562|3961736|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4137314|NCT00887562|3961737|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137315|NCT00887562|3961738|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4137316|NCT00887562|3961739|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137317|NCT00887562|3961736|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4137318|NCT00887562|3961737|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137319|NCT00887562|3961738|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137320|NCT00887562|3961739|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4137321|NCT00887562|3961736|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4137322|NCT00887562|3961737|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4137323|NCT00887562|3961738|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4137324|NCT00887562|3961739|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4137325|NCT00887562|3961736|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4137326|NCT00887562|3961737|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4137327|NCT00887562|3961738|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4137328|NCT00887562|3961739|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4137329|NCT00887562|3961736|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4137330|NCT00887562|3961737|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4137331|NCT00887562|3961738|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4137332|NCT00887562|3961739|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4137333|NCT00887562|3961736|B4||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4137334|NCT00887562|3961737|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4137335|NCT00887562|3961738|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4137336|NCT00887562|3961739|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4137337|NCT00887562|3961736|B4||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4137338|NCT00887562|3961737|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137339|NCT00887562|3961738|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137340|NCT00887562|3961739|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4137341|NCT00887549|3961755|B1|Ever used tobacco products||Past and Current Tobacco Usage||participants|Number|64|64.0||||||
4137342|NCT00887549|3961755|B1|Never used tobacco products||Past and Current Tobacco Usage||participants|Number|6|6.0||||||
4137343|NCT00887549|3961755|B1|Carcinoma, undifferentiated||Pathological Diagnosis||participants|Number|1|1.0||||||
4137344|NCT00887549|3961755|B1|Carcinoma, NSC, Poorly Differentiated, Lung||Pathological Diagnosis||participants|Number|5|5.0||||||
4137345|NCT00887549|3961755|B1|Carcinoma, Non-Small Cell, Lung (NSCL), (NOS)||Pathological Diagnosis||participants|Number|3|3.0||||||
4137346|NCT00887549|3961755|B1|Bronchioalveolar Carcinoma||Pathological Diagnosis||participants|Number|6|6.0||||||
4137347|NCT00887549|3961755|B1|Adenocarcinoma, poorly differentiated||Pathological Diagnosis||participants|Number|20|20.0||||||
4137348|NCT00887549|3961755|B1|Adenocarcinoma, acinar||Pathological Diagnosis||participants|Number|1|1.0||||||
4137349|NCT00887549|3961755|B1|Adenocarcinoma, not otherwise specified (NOS)||Pathological Diagnosis||participants|Number|34|34.0||||||
4137350|NCT00887549|3961755|B1|1- Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|46|46.0||||||
4137351|NCT00887549|3961755|B1|0- Fully active||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|24|24.0||||||
4137352|NCT00887549|3961755|B1|United Kingdom||Region of Enrollment||participants|Number|66|66.0||||||
4137353|NCT00887549|3961755|B1|Ireland||Region of Enrollment||participants|Number|4|4.0||||||
4137354|NCT00887549|3961755|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4137355|NCT00887549|3961755|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
4137356|NCT00887549|3961755|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4137357|NCT00887549|3961755|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4137358|NCT00887549|3961755|B1|||Age||years|Mean|63.0|63.0|Standard Deviation|9.42|9.42|||
4137359|NCT00887510|3961762|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4137360|NCT00887510|3961763|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4137361|NCT00887510|3961764|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4137362|NCT00887510|3961762|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4137363|NCT00887510|3961763|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4137364|NCT00887510|3961764|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4137365|NCT00887510|3961762|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4137366|NCT00887510|3961763|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4137367|NCT00887510|3961764|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4137368|NCT00887510|3961762|B3|||Age||years|Mean|44.5|44.5|Standard Deviation|10.1|10.1|||
4137369|NCT00887510|3961763|B2|||Age||years|Mean|45.7|45.7|Standard Deviation|10.6|10.6|||
4137370|NCT00887510|3961764|B1|||Age||years|Mean|43.4|43.4|Standard Deviation|9.6|9.6|||
4137371|NCT00887484|3961773|B1|||Total Acne Lesion Count|Total acne lesion count (includes inflammatory and non-inflammatory lesions)|Acne lesions|Mean|39.1|39.1|Standard Deviation|13.0|13.0|||
4137372|NCT00887484|3961773|B1|||Non-Inflammatory Acne Lesion Count|Non-Inflammatory acne lesion count at baseline (number of whiteheads and blackheads)|Non-Infammatory acne lesions|Mean|24.8|24.8|Standard Deviation|12.8|12.8|||
4137373|NCT00887484|3961773|B1|||Inflammatory Acne Lesion Count|Inflammatory acne lesion count at baseline (number of pustules and papules).|Inflammatory lesions|Mean|14.2|14.2|Standard Deviation|9.1|9.1|||
4137374|NCT00887484|3961773|B1|Severe||Investigators Static Global Assessment (ISGA)|The investigator rated the participants’ skin using the 6-point ISGA: 0=clear, clear skin with no inflammatory lesions (ILs) or non-ILs; 1=almost clear, rare non-ILs with no more than one small IL; 2=mild, some non-ILs with no more than a few ILs (papules/pustules only, no nodular lesions [NLs]); 3=moderate, up to many non-ILs and may have some ILs, but no more than one small NL; 4=severe, up to many non-IL and ILs, but no more than a few NLs; 5=many non-IL and ILs and more than a few NLs. May have cystic lesions. Participants with grades of 2-4 were eligible for enrollment in this study.|Participants|Number|3|3.0||||||
4137375|NCT00887484|3961773|B1|Moderate||Investigators Static Global Assessment (ISGA)|The investigator rated the participants’ skin using the 6-point ISGA: 0=clear, clear skin with no inflammatory lesions (ILs) or non-ILs; 1=almost clear, rare non-ILs with no more than one small IL; 2=mild, some non-ILs with no more than a few ILs (papules/pustules only, no nodular lesions [NLs]); 3=moderate, up to many non-ILs and may have some ILs, but no more than one small NL; 4=severe, up to many non-IL and ILs, but no more than a few NLs; 5=many non-IL and ILs and more than a few NLs. May have cystic lesions. Participants with grades of 2-4 were eligible for enrollment in this study.|Participants|Number|31|31.0||||||
4137376|NCT00887484|3961773|B1|Mild||Investigators Static Global Assessment (ISGA)|The investigator rated the participants’ skin using the 6-point ISGA: 0=clear, clear skin with no inflammatory lesions (ILs) or non-ILs; 1=almost clear, rare non-ILs with no more than one small IL; 2=mild, some non-ILs with no more than a few ILs (papules/pustules only, no nodular lesions [NLs]); 3=moderate, up to many non-ILs and may have some ILs, but no more than one small NL; 4=severe, up to many non-IL and ILs, but no more than a few NLs; 5=many non-IL and ILs and more than a few NLs. May have cystic lesions. Participants with grades of 2-4 were eligible for enrollment in this study.|Participants|Number|14|14.0||||||
4137377|NCT00887484|3961773|B1|Argentina||Region of Enrollment||participants|Number|48|48.0||||||
4137378|NCT00887484|3961773|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137379|NCT00887484|3961773|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137380|NCT00887484|3961773|B1||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4137381|NCT00887484|3961773|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137382|NCT00887484|3961773|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137383|NCT00887484|3961773|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137384|NCT00887484|3961773|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137385|NCT00887484|3961773|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137386|NCT00887484|3961773|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4137387|NCT00887484|3961773|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4137388|NCT00887484|3961773|B1||Male|Gender||Participants|Count of Participants|38|38.0||||||
4137389|NCT00887484|3961773|B1||Female|Gender||Participants|Count of Participants|10|10.0||||||
4137390|NCT00887484|3961773|B1|||Age||years|Mean|27.6|27.6|Standard Deviation|5.5|5.5|||
4137391|NCT00887471|3961837|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4137392|NCT00887471|3961838|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4137393|NCT00887471|3961839|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4137394|NCT00887471|3961837|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4137395|NCT00887471|3961838|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4137396|NCT00887471|3961839|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4137397|NCT00887471|3961837|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4137398|NCT00887471|3961838|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4137399|NCT00887471|3961839|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4137400|NCT00887471|3961837|B3|||Age||years|Mean|5.74|5.74|Standard Deviation|3.44|3.44|||
4137401|NCT00887471|3961838|B2|||Age||years|Mean|6.15|6.15|Standard Deviation|3.29|3.29|||
4137402|NCT00887471|3961839|B1|||Age||years|Mean|5.33|5.33|Standard Deviation|3.65|3.65|||
4137403|NCT00887471|3961837|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4137404|NCT00887471|3961838|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4137405|NCT00887471|3961839|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4137406|NCT00887471|3961837|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4137407|NCT00887471|3961838|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4137408|NCT00887471|3961839|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4137409|NCT00887471|3961837|B3||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4137410|NCT00887471|3961838|B2||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4137411|NCT00887471|3961839|B1||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4137412|NCT00887458|3961848|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
4137413|NCT00887458|3961849|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4137414|NCT00887458|3961850|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4137415|NCT00887458|3961848|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4137416|NCT00887458|3961849|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4137417|NCT00887458|3961850|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4137418|NCT00887458|3961848|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4137419|NCT00887458|3961849|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4137420|NCT00887458|3961850|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4137421|NCT00887458|3961848|B3||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4137422|NCT00887458|3961849|B2||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4137423|NCT00887458|3961850|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4137424|NCT00887458|3961848|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4137425|NCT00887458|3961849|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4137426|NCT00887458|3961850|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4137427|NCT00887458|3961848|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137428|NCT00887458|3961849|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137429|NCT00887458|3961850|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137430|NCT00887458|3961848|B3|||Age||years|Median|73|73.0|Full Range|||52.0|89.0|
4137431|NCT00887458|3961849|B2|||Age||years|Median|71|71.0|Full Range|||52.0|89.0|
4137432|NCT00887458|3961850|B1|||Age||years|Median|73|73.0|Full Range|||60.0|81.0|
4137433|NCT00887354|3961859|B3|Sweden||Region of Enrollment||participants|Number|5|5.0||||||
4137434|NCT00887354|3961860|B2|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
4137435|NCT00887354|3961861|B1|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
4137436|NCT00887354|3961859|B3|Ireland||Region of Enrollment||participants|Number|1|1.0||||||
4137437|NCT00887354|3961860|B2|Ireland||Region of Enrollment||participants|Number|0|0.0||||||
4137438|NCT00887354|3961861|B1|Ireland||Region of Enrollment||participants|Number|1|1.0||||||
4137439|NCT00887354|3961859|B3|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4137440|NCT00887354|3961860|B2|Austria||Region of Enrollment||participants|Number|0|0.0||||||
4137441|NCT00887354|3961861|B1|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4137442|NCT00887354|3961859|B3|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4137443|NCT00887354|3961860|B2|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4137444|NCT00887354|3961861|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4137445|NCT00887354|3961859|B3|Spain||Region of Enrollment||participants|Number|40|40.0||||||
4137446|NCT00887354|3961860|B2|Spain||Region of Enrollment||participants|Number|19|19.0||||||
4137447|NCT00887354|3961861|B1|Spain||Region of Enrollment||participants|Number|21|21.0||||||
4137448|NCT00887354|3961859|B3|Germany||Region of Enrollment||participants|Number|3|3.0||||||
4137449|NCT00887354|3961860|B2|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4137450|NCT00887354|3961861|B1|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4137451|NCT00887354|3961859|B3|France||Region of Enrollment||participants|Number|13|13.0||||||
4137452|NCT00887354|3961860|B2|France||Region of Enrollment||participants|Number|8|8.0||||||
4137453|NCT00887354|3961861|B1|France||Region of Enrollment||participants|Number|5|5.0||||||
4137454|NCT00887354|3961859|B3|Mexico||Region of Enrollment||participants|Number|18|18.0||||||
4137455|NCT00887354|3961860|B2|Mexico||Region of Enrollment||participants|Number|12|12.0||||||
4137456|NCT00887354|3961861|B1|Mexico||Region of Enrollment||participants|Number|6|6.0||||||
4137457|NCT00887354|3961859|B3|Italy||Region of Enrollment||participants|Number|26|26.0||||||
4137458|NCT00887354|3961860|B2|Italy||Region of Enrollment||participants|Number|10|10.0||||||
4137459|NCT00887354|3961861|B1|Italy||Region of Enrollment||participants|Number|16|16.0||||||
4137460|NCT00887354|3961859|B3|Denmark||Region of Enrollment||participants|Number|22|22.0||||||
4137461|NCT00887354|3961860|B2|Denmark||Region of Enrollment||participants|Number|9|9.0||||||
4137462|NCT00887354|3961861|B1|Denmark||Region of Enrollment||participants|Number|13|13.0||||||
4137463|NCT00887354|3961859|B3|Norway||Region of Enrollment||participants|Number|7|7.0||||||
4137464|NCT00887354|3961860|B2|Norway||Region of Enrollment||participants|Number|2|2.0||||||
4137465|NCT00887354|3961861|B1|Norway||Region of Enrollment||participants|Number|5|5.0||||||
4137466|NCT00887354|3961859|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4137467|NCT00887354|3961860|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4137468|NCT00887354|3961861|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4137469|NCT00887354|3961859|B3|Czech Republic||Region of Enrollment||participants|Number|20|20.0||||||
4137470|NCT00887354|3961860|B2|Czech Republic||Region of Enrollment||participants|Number|12|12.0||||||
4137471|NCT00887354|3961861|B1|Czech Republic||Region of Enrollment||participants|Number|8|8.0||||||
4137472|NCT00887354|3961859|B3|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4137473|NCT00887354|3961860|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4137474|NCT00887354|3961861|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4137475|NCT00887354|3961859|B3|Greece||Region of Enrollment||participants|Number|7|7.0||||||
4137476|NCT00887354|3961860|B2|Greece||Region of Enrollment||participants|Number|4|4.0||||||
4137477|NCT00887354|3961861|B1|Greece||Region of Enrollment||participants|Number|3|3.0||||||
4137478|NCT00887354|3961859|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137479|NCT00887354|3961860|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137480|NCT00887354|3961861|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137481|NCT00887354|3961859|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137482|NCT00887354|3961860|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137483|NCT00887354|3961861|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137484|NCT00887354|3961859|B3||White|Race (NIH/OMB)||Participants|Count of Participants|171|171.0||||||
4137485|NCT00887354|3961860|B2||White|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
4137486|NCT00887354|3961861|B1||White|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4137487|NCT00887354|3961859|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137488|NCT00887354|3961860|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137489|NCT00887354|3961861|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137490|NCT00887354|3961859|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137491|NCT00887354|3961860|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137492|NCT00887354|3961861|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137493|NCT00887354|3961859|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137494|NCT00887354|3961860|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137495|NCT00887354|3961861|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137496|NCT00887354|3961859|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137497|NCT00887354|3961860|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137498|NCT00887354|3961861|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137499|NCT00887354|3961859|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4137500|NCT00887354|3961860|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4137501|NCT00887354|3961861|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4137502|NCT00887354|3961859|B3||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4137503|NCT00887354|3961860|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4137504|NCT00887354|3961861|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4137505|NCT00887354|3961859|B3|||Age||years|Mean|76.8|76.8|Standard Deviation|7.71|7.71|||
4137506|NCT00887354|3961860|B2|||Age||years|Mean|76.4|76.4|Standard Deviation|7.47|7.47|||
4137507|NCT00887354|3961861|B1|||Age||years|Mean|77.2|77.2|Standard Deviation|7.96|7.96|||
4137508|NCT00887341|3961880|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4137509|NCT00887341|3961881|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4137510|NCT00887341|3961882|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4137511|NCT00887341|3961880|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4137512|NCT00887341|3961881|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4137513|NCT00887341|3961882|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4137514|NCT00887341|3961880|B3|||Age||years|Mean|52.55|52.55|Standard Deviation|11.54|11.54|||
4137515|NCT00887341|3961881|B2|||Age||years|Mean|52.46|52.46|Standard Deviation|10.47|10.47|||
4137516|NCT00887341|3961882|B1|||Age||years|Mean|52.65|52.65|Standard Deviation|12.71|12.71|||
4137517|NCT00887315|3961917|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4137518|NCT00887315|3961918|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4137519|NCT00887315|3961919|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4137520|NCT00887315|3961917|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4137521|NCT00887315|3961918|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4137522|NCT00887315|3961919|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4137523|NCT00887315|3961917|B3|||Age||years|Mean|69.1|69.1|Standard Deviation|9.2|9.2|||
4137524|NCT00887315|3961918|B2|||Age||years|Mean|74|74.0|Standard Deviation|3.2|3.2|||
4137525|NCT00887315|3961919|B1|||Age||years|Mean|66.4|66.4|Standard Deviation|10.6|10.6|||
4137526|NCT00887315|3961917|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4137527|NCT00887315|3961918|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4137528|NCT00887315|3961919|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4137529|NCT00887315|3961917|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4137530|NCT00887315|3961918|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4137531|NCT00887315|3961919|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4137532|NCT00887315|3961917|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137533|NCT00887315|3961918|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137534|NCT00887315|3961919|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137535|NCT00887289|3961928|B1|Male||Gender||participants|Number|490|490.0||||||
4137536|NCT00887289|3961928|B1|Female||Gender||participants|Number|1008|1008.0||||||
4137537|NCT00887289|3961928|B1|||Age||Years|Mean|65.0|65.0|Standard Deviation|13.0|13.0|||
4137538|NCT00887250|3961937|B4|||Sitting Diastolic Blood Pressure (SiDBP)||mm Hg|Mean|101.9|101.9|Full Range|||95.0|114.0|
4137539|NCT00887250|3961938|B3|||Sitting Diastolic Blood Pressure (SiDBP)||mm Hg|Mean|102.2|102.2|Full Range|||95.0|114.0|
4137540|NCT00887250|3961939|B2|||Sitting Diastolic Blood Pressure (SiDBP)||mm Hg|Mean|102.2|102.2|Full Range|||95.0|113.0|
4137541|NCT00887250|3961940|B1|||Sitting Diastolic Blood Pressure (SiDBP)||mm Hg|Mean|101.3|101.3|Full Range|||95.0|115.0|
4137542|NCT00887250|3961937|B4|Oriental||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4137543|NCT00887250|3961938|B3|Oriental||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4137544|NCT00887250|3961939|B2|Oriental||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4137545|NCT00887250|3961940|B1|Oriental||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4137546|NCT00887250|3961937|B4|Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4137547|NCT00887250|3961938|B3|Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4137548|NCT00887250|3961939|B2|Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4137549|NCT00887250|3961940|B1|Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4137550|NCT00887250|3961937|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4137551|NCT00887250|3961938|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4137552|NCT00887250|3961939|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4137553|NCT00887250|3961940|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4137554|NCT00887250|3961937|B4|Black||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4137555|NCT00887250|3961938|B3|Black||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4137556|NCT00887250|3961939|B2|Black||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4137557|NCT00887250|3961940|B1|Black||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4137558|NCT00887250|3961937|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|297|297.0||||||
4137559|NCT00887250|3961938|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|101|101.0||||||
4137560|NCT00887250|3961939|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|104|104.0||||||
4137561|NCT00887250|3961940|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|92|92.0||||||
4137562|NCT00887250|3961937|B4||Male|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4137563|NCT00887250|3961938|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4137564|NCT00887250|3961939|B2||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4137565|NCT00887250|3961940|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4137566|NCT00887250|3961937|B4||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4137567|NCT00887250|3961938|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4137568|NCT00887250|3961939|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4137569|NCT00887250|3961940|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4137570|NCT00887250|3961937|B4|||Age||years|Mean|54.0|54.0|Full Range|||26.0|78.0|
4137571|NCT00887250|3961938|B3|||Age||years|Mean|55.1|55.1|Full Range|||28.0|76.0|
4137572|NCT00887250|3961939|B2|||Age||years|Mean|53.2|53.2|Full Range|||28.0|75.0|
4137573|NCT00887250|3961940|B1|||Age||years|Mean|53.8|53.8|Full Range|||26.0|78.0|
4137574|NCT00887224|3961962|B4|Remission=Yes||Number of participants with remission based on HAM-D17 score|HAM-D17: standardized, clinician-administered rating scale that assesses 17 items associated with major depression (such as depressed mood, guilty feelings, suicide, sleep disturbances, anxiety levels, and weight loss). Nine items scored on 3 point scale (0=none/absent to 2=most severe) and 8 items scored on 5 point scale (0=none/absent to 4=most severe) for maximum total score of 50; higher score indicates more depression. Remission (Yes or No) based on HAMD-17 total score ≤7. Outcome measure HAM-D17 Remission results reported for DB phase; HAM-D17 Remission baseline=DB baseline.|participants|Number|450|450.0||||||
4137575|NCT00887224|3961963|B3|Remission=Yes||Number of participants with remission based on HAM-D17 score|HAM-D17: standardized, clinician-administered rating scale that assesses 17 items associated with major depression (such as depressed mood, guilty feelings, suicide, sleep disturbances, anxiety levels, and weight loss). Nine items scored on 3 point scale (0=none/absent to 2=most severe) and 8 items scored on 5 point scale (0=none/absent to 4=most severe) for maximum total score of 50; higher score indicates more depression. Remission (Yes or No) based on HAMD-17 total score ≤7. Outcome measure HAM-D17 Remission results reported for DB phase; HAM-D17 Remission baseline=DB baseline.|participants|Number|220|220.0||||||
4137576|NCT00887224|3961964|B2|Remission=Yes||Number of participants with remission based on HAM-D17 score|HAM-D17: standardized, clinician-administered rating scale that assesses 17 items associated with major depression (such as depressed mood, guilty feelings, suicide, sleep disturbances, anxiety levels, and weight loss). Nine items scored on 3 point scale (0=none/absent to 2=most severe) and 8 items scored on 5 point scale (0=none/absent to 4=most severe) for maximum total score of 50; higher score indicates more depression. Remission (Yes or No) based on HAMD-17 total score ≤7. Outcome measure HAM-D17 Remission results reported for DB phase; HAM-D17 Remission baseline=DB baseline.|participants|Number|230|230.0||||||
4137577|NCT00887224|3961965|B1|Remission=Yes||Number of participants with remission based on HAM-D17 score|HAM-D17: standardized, clinician-administered rating scale that assesses 17 items associated with major depression (such as depressed mood, guilty feelings, suicide, sleep disturbances, anxiety levels, and weight loss). Nine items scored on 3 point scale (0=none/absent to 2=most severe) and 8 items scored on 5 point scale (0=none/absent to 4=most severe) for maximum total score of 50; higher score indicates more depression. Remission (Yes or No) based on HAMD-17 total score ≤7. Outcome measure HAM-D17 Remission results reported for DB phase; HAM-D17 Remission baseline=DB baseline.|participants|Number|0|0.0||||||
4137631|NCT00887198|3961994|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
4137632|NCT00887198|3961992|B3|Sweden||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
4137578|NCT00887224|3961962|B4|Remission=No||Number of participants with remission based on HAM-D17 score|HAM-D17: standardized, clinician-administered rating scale that assesses 17 items associated with major depression (such as depressed mood, guilty feelings, suicide, sleep disturbances, anxiety levels, and weight loss). Nine items scored on 3 point scale (0=none/absent to 2=most severe) and 8 items scored on 5 point scale (0=none/absent to 4=most severe) for maximum total score of 50; higher score indicates more depression. Remission (Yes or No) based on HAMD-17 total score ≤7. Outcome measure HAM-D17 Remission results reported for DB phase; HAM-D17 Remission baseline=DB baseline.|participants|Number|98|98.0||||||
4137579|NCT00887224|3961963|B3|Remission=No||Number of participants with remission based on HAM-D17 score|HAM-D17: standardized, clinician-administered rating scale that assesses 17 items associated with major depression (such as depressed mood, guilty feelings, suicide, sleep disturbances, anxiety levels, and weight loss). Nine items scored on 3 point scale (0=none/absent to 2=most severe) and 8 items scored on 5 point scale (0=none/absent to 4=most severe) for maximum total score of 50; higher score indicates more depression. Remission (Yes or No) based on HAMD-17 total score ≤7. Outcome measure HAM-D17 Remission results reported for DB phase; HAM-D17 Remission baseline=DB baseline.|participants|Number|52|52.0||||||
4137580|NCT00887224|3961964|B2|Remission=No||Number of participants with remission based on HAM-D17 score|HAM-D17: standardized, clinician-administered rating scale that assesses 17 items associated with major depression (such as depressed mood, guilty feelings, suicide, sleep disturbances, anxiety levels, and weight loss). Nine items scored on 3 point scale (0=none/absent to 2=most severe) and 8 items scored on 5 point scale (0=none/absent to 4=most severe) for maximum total score of 50; higher score indicates more depression. Remission (Yes or No) based on HAMD-17 total score ≤7. Outcome measure HAM-D17 Remission results reported for DB phase; HAM-D17 Remission baseline=DB baseline.|participants|Number|46|46.0||||||
4137581|NCT00887224|3961965|B1|Remission=No||Number of participants with remission based on HAM-D17 score|HAM-D17: standardized, clinician-administered rating scale that assesses 17 items associated with major depression (such as depressed mood, guilty feelings, suicide, sleep disturbances, anxiety levels, and weight loss). Nine items scored on 3 point scale (0=none/absent to 2=most severe) and 8 items scored on 5 point scale (0=none/absent to 4=most severe) for maximum total score of 50; higher score indicates more depression. Remission (Yes or No) based on HAMD-17 total score ≤7. Outcome measure HAM-D17 Remission results reported for DB phase; HAM-D17 Remission baseline=DB baseline.|participants|Number|0|0.0||||||
4137582|NCT00887224|3961962|B4|||Hamilton Psychiatric Scale for Depression-17 Item (HAM-D17) Total Score|HAM-D17 is a standardized, clinician-administered rating scale that assesses 17 items characteristically associated with major depression (symptoms such as depressed mood, guilty feelings, suicide, sleep disturbances, anxiety levels, and weight loss). Nine items are scored on a 3 point scale (0=none/absent to 2=most severe) and 8 items are scored on a 5 point scale (0=none/absent to 4=most severe) for a maximum total score of 50; higher score indicates more depression.|scores on a scale|Mean|4.64|4.64|Standard Deviation|2.99|2.99|||
4137583|NCT00887224|3961963|B3|||Hamilton Psychiatric Scale for Depression-17 Item (HAM-D17) Total Score|HAM-D17 is a standardized, clinician-administered rating scale that assesses 17 items characteristically associated with major depression (symptoms such as depressed mood, guilty feelings, suicide, sleep disturbances, anxiety levels, and weight loss). Nine items are scored on a 3 point scale (0=none/absent to 2=most severe) and 8 items are scored on a 5 point scale (0=none/absent to 4=most severe) for a maximum total score of 50; higher score indicates more depression.|scores on a scale|Mean|4.69|4.69|Standard Deviation|2.97|2.97|||
4137584|NCT00887224|3961964|B2|||Hamilton Psychiatric Scale for Depression-17 Item (HAM-D17) Total Score|HAM-D17 is a standardized, clinician-administered rating scale that assesses 17 items characteristically associated with major depression (symptoms such as depressed mood, guilty feelings, suicide, sleep disturbances, anxiety levels, and weight loss). Nine items are scored on a 3 point scale (0=none/absent to 2=most severe) and 8 items are scored on a 5 point scale (0=none/absent to 4=most severe) for a maximum total score of 50; higher score indicates more depression.|scores on a scale|Mean|4.58|4.58|Standard Deviation|3.02|3.02|||
4137585|NCT00887224|3961965|B1|||Hamilton Psychiatric Scale for Depression-17 Item (HAM-D17) Total Score|HAM-D17 is a standardized, clinician-administered rating scale that assesses 17 items characteristically associated with major depression (symptoms such as depressed mood, guilty feelings, suicide, sleep disturbances, anxiety levels, and weight loss). Nine items are scored on a 3 point scale (0=none/absent to 2=most severe) and 8 items are scored on a 5 point scale (0=none/absent to 4=most severe) for a maximum total score of 50; higher score indicates more depression.|scores on a scale|Mean|NA||Standard Deviation|NA||||Outcome measure HAM-D17 results reported for DB phase; HAM-D17 baseline=DB baseline.
4137586|NCT00887224|3961962|B4|7=very much worse||Number of participants per categorical score on Clinical Global Impression-Improvement (CGI-I) scale|CGI-I is a 7-point clinician rated scale ranging from 1 (very much improved) to 7 (very much worse). Improvement defined as a score of 1 (very much improved), 2 (much improved), or 3 (minimally improved) on the scale. Outcome measure CGI-I results reported for DB phase; CGI-I baseline=DB baseline.|participants|Number|0|0.0||||||
4137587|NCT00887224|3961963|B3|7=very much worse||Number of participants per categorical score on Clinical Global Impression-Improvement (CGI-I) scale|CGI-I is a 7-point clinician rated scale ranging from 1 (very much improved) to 7 (very much worse). Improvement defined as a score of 1 (very much improved), 2 (much improved), or 3 (minimally improved) on the scale. Outcome measure CGI-I results reported for DB phase; CGI-I baseline=DB baseline.|participants|Number|0|0.0||||||
4137588|NCT00887224|3961964|B2|7=very much worse||Number of participants per categorical score on Clinical Global Impression-Improvement (CGI-I) scale|CGI-I is a 7-point clinician rated scale ranging from 1 (very much improved) to 7 (very much worse). Improvement defined as a score of 1 (very much improved), 2 (much improved), or 3 (minimally improved) on the scale. Outcome measure CGI-I results reported for DB phase; CGI-I baseline=DB baseline.|participants|Number|0|0.0||||||
4137589|NCT00887224|3961965|B1|7=very much worse||Number of participants per categorical score on Clinical Global Impression-Improvement (CGI-I) scale|CGI-I is a 7-point clinician rated scale ranging from 1 (very much improved) to 7 (very much worse). Improvement defined as a score of 1 (very much improved), 2 (much improved), or 3 (minimally improved) on the scale. Outcome measure CGI-I results reported for DB phase; CGI-I baseline=DB baseline.|participants|Number|0|0.0||||||
4137633|NCT00887198|3961993|B2|Sweden||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4137590|NCT00887224|3961962|B4|6=much worse||Number of participants per categorical score on Clinical Global Impression-Improvement (CGI-I) scale|CGI-I is a 7-point clinician rated scale ranging from 1 (very much improved) to 7 (very much worse). Improvement defined as a score of 1 (very much improved), 2 (much improved), or 3 (minimally improved) on the scale. Outcome measure CGI-I results reported for DB phase; CGI-I baseline=DB baseline.|participants|Number|0|0.0||||||
4137591|NCT00887224|3961963|B3|6=much worse||Number of participants per categorical score on Clinical Global Impression-Improvement (CGI-I) scale|CGI-I is a 7-point clinician rated scale ranging from 1 (very much improved) to 7 (very much worse). Improvement defined as a score of 1 (very much improved), 2 (much improved), or 3 (minimally improved) on the scale. Outcome measure CGI-I results reported for DB phase; CGI-I baseline=DB baseline.|participants|Number|0|0.0||||||
4137592|NCT00887224|3961964|B2|6=much worse||Number of participants per categorical score on Clinical Global Impression-Improvement (CGI-I) scale|CGI-I is a 7-point clinician rated scale ranging from 1 (very much improved) to 7 (very much worse). Improvement defined as a score of 1 (very much improved), 2 (much improved), or 3 (minimally improved) on the scale. Outcome measure CGI-I results reported for DB phase; CGI-I baseline=DB baseline.|participants|Number|0|0.0||||||
4137593|NCT00887224|3961965|B1|6=much worse||Number of participants per categorical score on Clinical Global Impression-Improvement (CGI-I) scale|CGI-I is a 7-point clinician rated scale ranging from 1 (very much improved) to 7 (very much worse). Improvement defined as a score of 1 (very much improved), 2 (much improved), or 3 (minimally improved) on the scale. Outcome measure CGI-I results reported for DB phase; CGI-I baseline=DB baseline.|participants|Number|0|0.0||||||
4137594|NCT00887224|3961962|B4|5=minimally worse||Number of participants per categorical score on Clinical Global Impression-Improvement (CGI-I) scale|CGI-I is a 7-point clinician rated scale ranging from 1 (very much improved) to 7 (very much worse). Improvement defined as a score of 1 (very much improved), 2 (much improved), or 3 (minimally improved) on the scale. Outcome measure CGI-I results reported for DB phase; CGI-I baseline=DB baseline.|participants|Number|0|0.0||||||
4137595|NCT00887224|3961963|B3|5=minimally worse||Number of participants per categorical score on Clinical Global Impression-Improvement (CGI-I) scale|CGI-I is a 7-point clinician rated scale ranging from 1 (very much improved) to 7 (very much worse). Improvement defined as a score of 1 (very much improved), 2 (much improved), or 3 (minimally improved) on the scale. Outcome measure CGI-I results reported for DB phase; CGI-I baseline=DB baseline.|participants|Number|0|0.0||||||
4137596|NCT00887224|3961964|B2|5=minimally worse||Number of participants per categorical score on Clinical Global Impression-Improvement (CGI-I) scale|CGI-I is a 7-point clinician rated scale ranging from 1 (very much improved) to 7 (very much worse). Improvement defined as a score of 1 (very much improved), 2 (much improved), or 3 (minimally improved) on the scale. Outcome measure CGI-I results reported for DB phase; CGI-I baseline=DB baseline.|participants|Number|0|0.0||||||
4137597|NCT00887224|3961965|B1|5=minimally worse||Number of participants per categorical score on Clinical Global Impression-Improvement (CGI-I) scale|CGI-I is a 7-point clinician rated scale ranging from 1 (very much improved) to 7 (very much worse). Improvement defined as a score of 1 (very much improved), 2 (much improved), or 3 (minimally improved) on the scale. Outcome measure CGI-I results reported for DB phase; CGI-I baseline=DB baseline.|participants|Number|0|0.0||||||
4137598|NCT00887224|3961962|B4|4=no change||Number of participants per categorical score on Clinical Global Impression-Improvement (CGI-I) scale|CGI-I is a 7-point clinician rated scale ranging from 1 (very much improved) to 7 (very much worse). Improvement defined as a score of 1 (very much improved), 2 (much improved), or 3 (minimally improved) on the scale. Outcome measure CGI-I results reported for DB phase; CGI-I baseline=DB baseline.|participants|Number|0|0.0||||||
4137599|NCT00887224|3961963|B3|4=no change||Number of participants per categorical score on Clinical Global Impression-Improvement (CGI-I) scale|CGI-I is a 7-point clinician rated scale ranging from 1 (very much improved) to 7 (very much worse). Improvement defined as a score of 1 (very much improved), 2 (much improved), or 3 (minimally improved) on the scale. Outcome measure CGI-I results reported for DB phase; CGI-I baseline=DB baseline.|participants|Number|0|0.0||||||
4137600|NCT00887224|3961964|B2|4=no change||Number of participants per categorical score on Clinical Global Impression-Improvement (CGI-I) scale|CGI-I is a 7-point clinician rated scale ranging from 1 (very much improved) to 7 (very much worse). Improvement defined as a score of 1 (very much improved), 2 (much improved), or 3 (minimally improved) on the scale. Outcome measure CGI-I results reported for DB phase; CGI-I baseline=DB baseline.|participants|Number|0|0.0||||||
4137601|NCT00887224|3961965|B1|4=no change||Number of participants per categorical score on Clinical Global Impression-Improvement (CGI-I) scale|CGI-I is a 7-point clinician rated scale ranging from 1 (very much improved) to 7 (very much worse). Improvement defined as a score of 1 (very much improved), 2 (much improved), or 3 (minimally improved) on the scale. Outcome measure CGI-I results reported for DB phase; CGI-I baseline=DB baseline.|participants|Number|0|0.0||||||
4137602|NCT00887224|3961962|B4|3=minimally improved||Number of participants per categorical score on Clinical Global Impression-Improvement (CGI-I) scale|CGI-I is a 7-point clinician rated scale ranging from 1 (very much improved) to 7 (very much worse). Improvement defined as a score of 1 (very much improved), 2 (much improved), or 3 (minimally improved) on the scale. Outcome measure CGI-I results reported for DB phase; CGI-I baseline=DB baseline.|participants|Number|1|1.0||||||
4137603|NCT00887224|3961963|B3|3=minimally improved||Number of participants per categorical score on Clinical Global Impression-Improvement (CGI-I) scale|CGI-I is a 7-point clinician rated scale ranging from 1 (very much improved) to 7 (very much worse). Improvement defined as a score of 1 (very much improved), 2 (much improved), or 3 (minimally improved) on the scale. Outcome measure CGI-I results reported for DB phase; CGI-I baseline=DB baseline.|participants|Number|0|0.0||||||
4137604|NCT00887224|3961964|B2|3=minimally improved||Number of participants per categorical score on Clinical Global Impression-Improvement (CGI-I) scale|CGI-I is a 7-point clinician rated scale ranging from 1 (very much improved) to 7 (very much worse). Improvement defined as a score of 1 (very much improved), 2 (much improved), or 3 (minimally improved) on the scale. Outcome measure CGI-I results reported for DB phase; CGI-I baseline=DB baseline.|participants|Number|1|1.0||||||
4137634|NCT00887198|3961994|B1|Sweden||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4137635|NCT00887198|3961992|B3|Spain||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
4137636|NCT00887198|3961993|B2|Spain||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4137605|NCT00887224|3961965|B1|3=minimally improved||Number of participants per categorical score on Clinical Global Impression-Improvement (CGI-I) scale|CGI-I is a 7-point clinician rated scale ranging from 1 (very much improved) to 7 (very much worse). Improvement defined as a score of 1 (very much improved), 2 (much improved), or 3 (minimally improved) on the scale. Outcome measure CGI-I results reported for DB phase; CGI-I baseline=DB baseline.|participants|Number|0|0.0||||||
4137606|NCT00887224|3961962|B4|2=much improved||Number of participants per categorical score on Clinical Global Impression-Improvement (CGI-I) scale|CGI-I is a 7-point clinician rated scale ranging from 1 (very much improved) to 7 (very much worse). Improvement defined as a score of 1 (very much improved), 2 (much improved), or 3 (minimally improved) on the scale. Outcome measure CGI-I results reported for DB phase; CGI-I baseline=DB baseline.|participants|Number|85|85.0||||||
4137607|NCT00887224|3961963|B3|2=much improved||Number of participants per categorical score on Clinical Global Impression-Improvement (CGI-I) scale|CGI-I is a 7-point clinician rated scale ranging from 1 (very much improved) to 7 (very much worse). Improvement defined as a score of 1 (very much improved), 2 (much improved), or 3 (minimally improved) on the scale. Outcome measure CGI-I results reported for DB phase; CGI-I baseline=DB baseline.|participants|Number|49|49.0||||||
4137608|NCT00887224|3961964|B2|2=much improved||Number of participants per categorical score on Clinical Global Impression-Improvement (CGI-I) scale|CGI-I is a 7-point clinician rated scale ranging from 1 (very much improved) to 7 (very much worse). Improvement defined as a score of 1 (very much improved), 2 (much improved), or 3 (minimally improved) on the scale. Outcome measure CGI-I results reported for DB phase; CGI-I baseline=DB baseline.|participants|Number|36|36.0||||||
4137609|NCT00887224|3961965|B1|2=much improved||Number of participants per categorical score on Clinical Global Impression-Improvement (CGI-I) scale|CGI-I is a 7-point clinician rated scale ranging from 1 (very much improved) to 7 (very much worse). Improvement defined as a score of 1 (very much improved), 2 (much improved), or 3 (minimally improved) on the scale. Outcome measure CGI-I results reported for DB phase; CGI-I baseline=DB baseline.|participants|Number|0|0.0||||||
4137610|NCT00887224|3961962|B4|1=very much improved||Number of participants per categorical score on Clinical Global Impression-Improvement (CGI-I) scale|CGI-I is a 7-point clinician rated scale ranging from 1 (very much improved) to 7 (very much worse). Improvement defined as a score of 1 (very much improved), 2 (much improved), or 3 (minimally improved) on the scale. Outcome measure CGI-I results reported for DB phase; CGI-I baseline=DB baseline.|participants|Number|462|462.0||||||
4137611|NCT00887224|3961963|B3|1=very much improved||Number of participants per categorical score on Clinical Global Impression-Improvement (CGI-I) scale|CGI-I is a 7-point clinician rated scale ranging from 1 (very much improved) to 7 (very much worse). Improvement defined as a score of 1 (very much improved), 2 (much improved), or 3 (minimally improved) on the scale. Outcome measure CGI-I results reported for DB phase; CGI-I baseline=DB baseline.|participants|Number|223|223.0||||||
4137612|NCT00887224|3961964|B2|1=very much improved||Number of participants per categorical score on Clinical Global Impression-Improvement (CGI-I) scale|CGI-I is a 7-point clinician rated scale ranging from 1 (very much improved) to 7 (very much worse). Improvement defined as a score of 1 (very much improved), 2 (much improved), or 3 (minimally improved) on the scale. Outcome measure CGI-I results reported for DB phase; CGI-I baseline=DB baseline.|participants|Number|239|239.0||||||
4137613|NCT00887224|3961965|B1|1=very much improved||Number of participants per categorical score on Clinical Global Impression-Improvement (CGI-I) scale|CGI-I is a 7-point clinician rated scale ranging from 1 (very much improved) to 7 (very much worse). Improvement defined as a score of 1 (very much improved), 2 (much improved), or 3 (minimally improved) on the scale. Outcome measure CGI-I results reported for DB phase; CGI-I baseline=DB baseline.|participants|Number|0|0.0||||||
4137614|NCT00887224|3961962|B4|Male||Gender|OL Baseline All Enrolled Population. Baseline Gender reported for participants entering the Open-label phase at study start.|participants|Number|266|266.0||||||
4137615|NCT00887224|3961963|B3|Male||Gender|OL Baseline All Enrolled Population. Baseline Gender reported for participants entering the Open-label phase at study start.|participants|Number|0|0.0||||||
4137616|NCT00887224|3961964|B2|Male||Gender|OL Baseline All Enrolled Population. Baseline Gender reported for participants entering the Open-label phase at study start.|participants|Number|0|0.0||||||
4137617|NCT00887224|3961965|B1|Male||Gender|OL Baseline All Enrolled Population. Baseline Gender reported for participants entering the Open-label phase at study start.|participants|Number|266|266.0||||||
4137618|NCT00887224|3961962|B4|Female||Gender|OL Baseline All Enrolled Population. Baseline Gender reported for participants entering the Open-label phase at study start.|participants|Number|608|608.0||||||
4137619|NCT00887224|3961963|B3|Female||Gender|OL Baseline All Enrolled Population. Baseline Gender reported for participants entering the Open-label phase at study start.|participants|Number|0|0.0||||||
4137620|NCT00887224|3961964|B2|Female||Gender|OL Baseline All Enrolled Population. Baseline Gender reported for participants entering the Open-label phase at study start.|participants|Number|0|0.0||||||
4137621|NCT00887224|3961965|B1|Female||Gender|OL Baseline All Enrolled Population. Baseline Gender reported for participants entering the Open-label phase at study start.|participants|Number|608|608.0||||||
4137622|NCT00887224|3961962|B4|||Age|OL Baseline All Enrolled Population|years|Mean|44.98|44.98|Standard Deviation|13.25|13.25|||
4137623|NCT00887224|3961963|B3|||Age|OL Baseline All Enrolled Population|years|Mean|NA||Standard Deviation|NA||||Baseline Age reported for participants entering the Open-label phase at study start.
4137624|NCT00887224|3961964|B2|||Age|OL Baseline All Enrolled Population|years|Mean|NA||Standard Deviation|NA||||Baseline Age reported for participants entering the Open-label phase at study start.
4137625|NCT00887224|3961965|B1|||Age|OL Baseline All Enrolled Population|years|Mean|44.98|44.98|Standard Deviation|13.25|13.25|||
4137626|NCT00887198|3961992|B3|United States||Region of Enrollment||Participants|Count of Participants|472|472.0||||||
4137627|NCT00887198|3961993|B2|United States||Region of Enrollment||Participants|Count of Participants|238|238.0||||||
4137628|NCT00887198|3961994|B1|United States||Region of Enrollment||Participants|Count of Participants|234|234.0||||||
4137629|NCT00887198|3961992|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|98|98.0||||||
4137630|NCT00887198|3961993|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|56|56.0||||||
4137698|NCT00886834|3962056|B3|United States||Region of Enrollment||participants|Number|108|108.0||||||
4137637|NCT00887198|3961994|B1|Spain||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4137638|NCT00887198|3961992|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4137639|NCT00887198|3961993|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4137640|NCT00887198|3961994|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4137641|NCT00887198|3961992|B3|Italy||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4137642|NCT00887198|3961993|B2|Italy||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4137643|NCT00887198|3961994|B1|Italy||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4137644|NCT00887198|3961992|B3|Greece||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4137645|NCT00887198|3961993|B2|Greece||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4137646|NCT00887198|3961994|B1|Greece||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4137647|NCT00887198|3961992|B3|Germany||Region of Enrollment||Participants|Count of Participants|78|78.0||||||
4137648|NCT00887198|3961993|B2|Germany||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
4137649|NCT00887198|3961994|B1|Germany||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
4137650|NCT00887198|3961992|B3|France||Region of Enrollment||Participants|Count of Participants|53|53.0||||||
4137651|NCT00887198|3961993|B2|France||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
4137652|NCT00887198|3961994|B1|France||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
4137653|NCT00887198|3961992|B3|Canada||Region of Enrollment||Participants|Count of Participants|100|100.0||||||
4137654|NCT00887198|3961993|B2|Canada||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
4137655|NCT00887198|3961994|B1|Canada||Region of Enrollment||Participants|Count of Participants|63|63.0||||||
4137656|NCT00887198|3961992|B3|Belgium||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
4137657|NCT00887198|3961993|B2|Belgium||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
4137658|NCT00887198|3961994|B1|Belgium||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4137659|NCT00887198|3961992|B3|Australia||Region of Enrollment||Participants|Count of Participants|132|132.0||||||
4137660|NCT00887198|3961993|B2|Australia||Region of Enrollment||Participants|Count of Participants|72|72.0||||||
4137661|NCT00887198|3961994|B1|Australia||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
4137662|NCT00887198|3961992|B3||Male|Sex: Female, Male||Participants|Count of Participants|1088|1088.0||||||
4137663|NCT00887198|3961993|B2||Male|Sex: Female, Male||Participants|Count of Participants|542|542.0||||||
4137664|NCT00887198|3961994|B1||Male|Sex: Female, Male||Participants|Count of Participants|546|546.0||||||
4137665|NCT00887198|3961992|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4137666|NCT00887198|3961993|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4137667|NCT00887198|3961994|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4137668|NCT00887198|3961992|B3|||Age||years|Mean|70.3|70.3|Standard Deviation|8.76|8.76|||
4137669|NCT00887198|3961993|B2|||Age||years|Mean|70.1|70.1|Standard Deviation|8.72|8.72|||
4137670|NCT00887198|3961994|B1|||Age||years|Mean|70.5|70.5|Standard Deviation|8.8|8.8|||
4137671|NCT00887159|3962024|B4|United States||Region of Enrollment||participants|Number|152|152.0||||||
4137672|NCT00887159|3962025|B3|United States||Region of Enrollment||participants|Number|52|52.0||||||
4137673|NCT00887159|3962026|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
4137674|NCT00887159|3962027|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4137675|NCT00887159|3962024|B4||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4137676|NCT00887159|3962025|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4137677|NCT00887159|3962026|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4137678|NCT00887159|3962027|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4137679|NCT00887159|3962024|B4||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4137680|NCT00887159|3962025|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4137681|NCT00887159|3962026|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4137682|NCT00887159|3962027|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4137683|NCT00887159|3962024|B4|||Age||years|Median|63|63.0|Full Range|||38.0|87.0|
4137684|NCT00887159|3962025|B3|||Age||years|Median|64|64.0|Full Range|||45.0|83.0|
4137685|NCT00887159|3962026|B2|||Age||years|Median|64|64.0|Full Range|||52.0|87.0|
4137686|NCT00887159|3962027|B1|||Age||years|Median|61|61.0|Full Range|||38.0|77.0|
4137687|NCT00886938|3962045|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4137688|NCT00886938|3962045|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4137689|NCT00886938|3962045|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4137690|NCT00886938|3962045|B1|||Age||years|Mean|51|51.0|Full Range|||45.0|57.0|
4137691|NCT00886938|3962045|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4137692|NCT00886938|3962045|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4137693|NCT00886938|3962045|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137694|NCT00886899|3962049|B1|United States||Region of Enrollment||participants|Number|147|147.0||||||
4137695|NCT00886899|3962049|B1||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4137696|NCT00886899|3962049|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4137697|NCT00886899|3962049|B1|||Age||years|Mean|63.3|63.3|Standard Deviation|9.1|9.1|||
4137699|NCT00886834|3962057|B2|United States||Region of Enrollment||participants|Number|54|54.0||||||
4137700|NCT00886834|3962058|B1|United States||Region of Enrollment||participants|Number|54|54.0||||||
4137701|NCT00886834|3962056|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4137702|NCT00886834|3962057|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4137703|NCT00886834|3962058|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4137704|NCT00886834|3962056|B3||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4137705|NCT00886834|3962057|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4137706|NCT00886834|3962058|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4137707|NCT00886834|3962056|B3|||Age||years|Mean|24.7|24.7|Standard Deviation|4.0|4.0|||
4137708|NCT00886834|3962057|B2|||Age||years|Mean|24.8|24.8|Standard Deviation|4.2|4.2|||
4137709|NCT00886834|3962058|B1|||Age||years|Mean|24.6|24.6|Standard Deviation|3.8|3.8|||
4137710|NCT00886834|3962056|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4137711|NCT00886834|3962057|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4137712|NCT00886834|3962058|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4137713|NCT00886834|3962056|B3||Between 18 and 65 years|Age||Participants|Count of Participants|108|108.0||||||
4137714|NCT00886834|3962057|B2||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4137715|NCT00886834|3962058|B1||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4137716|NCT00886834|3962056|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137717|NCT00886834|3962057|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137718|NCT00886834|3962058|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137719|NCT00886821|3962067|B15||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4137720|NCT00886821|3962068|B14||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4137721|NCT00886821|3962069|B13||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4137722|NCT00886821|3962070|B12||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4137723|NCT00886821|3962071|B11||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4137724|NCT00886821|3962072|B10||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4137725|NCT00886821|3962073|B9||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4137726|NCT00886821|3962074|B8||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4137727|NCT00886821|3962075|B7||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4137728|NCT00886821|3962076|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4137729|NCT00886821|3962077|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4137730|NCT00886821|3962078|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4137731|NCT00886821|3962079|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4137732|NCT00886821|3962080|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4137733|NCT00886821|3962081|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4137734|NCT00886821|3962067|B15||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4137735|NCT00886821|3962068|B14||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4137736|NCT00886821|3962069|B13||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4137737|NCT00886821|3962070|B12||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4137738|NCT00886821|3962071|B11||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4137739|NCT00886821|3962072|B10||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4137740|NCT00886821|3962073|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4137741|NCT00886821|3962074|B8||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4137742|NCT00886821|3962075|B7||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4137743|NCT00886821|3962076|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4137744|NCT00886821|3962077|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4137745|NCT00886821|3962078|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4137746|NCT00886821|3962079|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4137747|NCT00886821|3962080|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4137748|NCT00886821|3962081|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4137749|NCT00886821|3962067|B15||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4137750|NCT00886821|3962068|B14||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4137751|NCT00886821|3962069|B13||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4137752|NCT00886821|3962070|B12||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4137753|NCT00886821|3962071|B11||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4137754|NCT00886821|3962072|B10||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4137755|NCT00886821|3962073|B9||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4137756|NCT00886821|3962074|B8||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4137757|NCT00886821|3962075|B7||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4137758|NCT00886821|3962076|B6||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4137759|NCT00886821|3962077|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4137760|NCT00886821|3962078|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4137761|NCT00886821|3962079|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4137762|NCT00886821|3962080|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4137763|NCT00886821|3962081|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4137764|NCT00886821|3962067|B15||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
4137765|NCT00886821|3962068|B14||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4137766|NCT00886821|3962069|B13||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4137767|NCT00886821|3962070|B12||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4137768|NCT00886821|3962071|B11||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4137769|NCT00886821|3962072|B10||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4137770|NCT00886821|3962073|B9||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4137771|NCT00886821|3962074|B8||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4137772|NCT00886821|3962075|B7||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4137773|NCT00886821|3962076|B6||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4137774|NCT00886821|3962077|B5||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4137775|NCT00886821|3962078|B4||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4137776|NCT00886821|3962079|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4137777|NCT00886821|3962080|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4137778|NCT00886821|3962081|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4137779|NCT00886821|3962067|B15||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137780|NCT00886821|3962068|B14||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137781|NCT00886821|3962069|B13||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137782|NCT00886821|3962070|B12||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137783|NCT00886821|3962071|B11||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137784|NCT00886821|3962072|B10||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137785|NCT00886821|3962073|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137786|NCT00886821|3962074|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137787|NCT00886821|3962075|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137788|NCT00886821|3962076|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137789|NCT00886821|3962077|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137790|NCT00886821|3962078|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137791|NCT00886821|3962079|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137792|NCT00886821|3962080|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137793|NCT00886821|3962081|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137794|NCT00886795|3962319|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4137795|NCT00886795|3962319|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4137796|NCT00886795|3962319|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4137797|NCT00886795|3962319|B1|||Age||years|Mean|43|43.0|Standard Deviation|7.29|7.29|||
4137798|NCT00886769|3962324|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4137799|NCT00886769|3962325|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4137800|NCT00886769|3962326|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4137801|NCT00886769|3962324|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4137802|NCT00886769|3962325|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4137803|NCT00886769|3962326|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4137804|NCT00886769|3962324|B3|||Age||years|Mean|9.0|9.0|Standard Deviation|4.75|4.75|||
4137805|NCT00886769|3962325|B2|||Age||years|Mean|9.7|9.7|Standard Deviation|4.32|4.32|||
4137806|NCT00886769|3962326|B1|||Age||years|Mean|8.3|8.3|Standard Deviation|5.08|5.08|||
4137807|NCT00886743|3962351|B1|||Body Mass Index||Kilograms/meters^2|Mean|26.7|26.7|Standard Deviation|7.9|7.9|||
4137808|NCT00886743|3962351|B1|||Weight||Kilograms|Mean|76.9|76.9|Standard Deviation|25.7|25.7|||
4137809|NCT00886743|3962351|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4137810|NCT00886743|3962351|B1|White||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4137811|NCT00886743|3962351|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4137812|NCT00886743|3962351|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4137813|NCT00886743|3962351|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4137814|NCT00886743|3962351|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4137815|NCT00886743|3962351|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4137816|NCT00886743|3962351|B1|||Age||Years|Mean|49.5|49.5|Standard Deviation|9.60|9.6|||
4137817|NCT00886704|3962359|B3|Germany||Region of Enrollment||participants|Number|50|50.0||||||
4137818|NCT00886704|3962360|B2|Germany||Region of Enrollment||participants|Number|10|10.0||||||
4137819|NCT00886704|3962361|B1|Germany||Region of Enrollment||participants|Number|40|40.0||||||
4137820|NCT00886704|3962359|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4137821|NCT00886704|3962360|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4137822|NCT00886704|3962361|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4137823|NCT00886704|3962359|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4137824|NCT00886704|3962360|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4137825|NCT00886704|3962361|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4137826|NCT00886704|3962359|B3|||Age||years|Mean|64.8|64.8|Standard Deviation|6.0|6.0|||
4137827|NCT00886704|3962360|B2|||Age||years|Mean|64.5|64.5|Standard Deviation|5.9|5.9|||
4137828|NCT00886704|3962361|B1|||Age||years|Mean|65.1|65.1|Standard Deviation|6.1|6.1|||
4137829|NCT00886704|3962359|B3||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4137830|NCT00886704|3962360|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4137831|NCT00886704|3962361|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4137832|NCT00886704|3962359|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4137833|NCT00886704|3962360|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4137834|NCT00886704|3962361|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4137835|NCT00886704|3962359|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137836|NCT00886704|3962360|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137837|NCT00886704|3962361|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137838|NCT00886691|3962370|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4137839|NCT00886691|3962371|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4137840|NCT00886691|3962372|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4137841|NCT00886691|3962370|B3||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4137842|NCT00886691|3962371|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4137843|NCT00886691|3962372|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4137844|NCT00886691|3962370|B3|>=80 years||Age, Customized||Participants|Count of Participants|7|7.0||||||
4137845|NCT00886691|3962371|B2|>=80 years||Age, Customized||Participants|Count of Participants|4|4.0||||||
4137846|NCT00886691|3962372|B1|>=80 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
4137847|NCT00886691|3962370|B3|70-79 years||Age, Customized||Participants|Count of Participants|25|25.0||||||
4137848|NCT00886691|3962371|B2|70-79 years||Age, Customized||Participants|Count of Participants|13|13.0||||||
4137849|NCT00886691|3962372|B1|70-79 years||Age, Customized||Participants|Count of Participants|12|12.0||||||
4137850|NCT00886691|3962370|B3|60-69 years||Age, Customized||Participants|Count of Participants|61|61.0||||||
4137851|NCT00886691|3962371|B2|60-69 years||Age, Customized||Participants|Count of Participants|28|28.0||||||
4137852|NCT00886691|3962372|B1|60-69 years||Age, Customized||Participants|Count of Participants|33|33.0||||||
4137853|NCT00886691|3962370|B3|50-59 years||Age, Customized||Participants|Count of Participants|37|37.0||||||
4137854|NCT00886691|3962371|B2|50-59 years||Age, Customized||Participants|Count of Participants|21|21.0||||||
4137855|NCT00886691|3962372|B1|50-59 years||Age, Customized||Participants|Count of Participants|16|16.0||||||
4137856|NCT00886691|3962370|B3|40-49 years||Age, Customized||Participants|Count of Participants|17|17.0||||||
4137857|NCT00886691|3962371|B2|40-49 years||Age, Customized||Participants|Count of Participants|8|8.0||||||
4137858|NCT00886691|3962372|B1|40-49 years||Age, Customized||Participants|Count of Participants|9|9.0||||||
4137859|NCT00886691|3962370|B3|30-39 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
4137860|NCT00886691|3962371|B2|30-39 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
4137861|NCT00886691|3962372|B1|30-39 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
4137862|NCT00886691|3962370|B3|20-29 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
4137863|NCT00886691|3962371|B2|20-29 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4137864|NCT00886691|3962372|B1|20-29 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
4137865|NCT00886639|3962389|B1|||Forced expiratory volume in 1 second (FEV1%pred.)|in percentage of predicted value|percentage of predicted value|Mean|35.5|35.5|Standard Deviation|11.5|11.5|||
4137866|NCT00886639|3962389|B1|Germany||Region of Enrollment||participants|Number|127|127.0||||||
4137867|NCT00886639|3962389|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4137868|NCT00886639|3962389|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4137869|NCT00886639|3962389|B1|||Age||years|Mean|63.7|63.7|Standard Deviation|8.74|8.74|||
4137870|NCT00886639|3962389|B1||>=65 years|Age||Participants|Count of Participants|67|67.0||||||
4137871|NCT00886639|3962389|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4137872|NCT00886639|3962389|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137873|NCT00886626|3962393|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4137874|NCT00886626|3962393|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4137875|NCT00886626|3962393|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4137876|NCT00886626|3962393|B1|||Age||years|Mean|12.7|12.7|Standard Deviation|2.1|2.1|||
4137877|NCT00886626|3962393|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4137878|NCT00886626|3962393|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4137879|NCT00886626|3962393|B1||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4137880|NCT00886613|3962400|B4|United States||Region of Enrollment||participants|Number|120|120.0||||||
4137881|NCT00886613|3962401|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4137882|NCT00886613|3962402|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
4137883|NCT00886613|3962403|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4137884|NCT00886613|3962400|B4||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4137885|NCT00886613|3962401|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4137886|NCT00886613|3962402|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4137887|NCT00886613|3962403|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4137888|NCT00886613|3962400|B4||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4137889|NCT00886613|3962401|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4137890|NCT00886613|3962402|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4137891|NCT00886613|3962403|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4137892|NCT00886613|3962400|B4|Between 60 and 88 years||Age, Customized||participants|Number|120|120.0||||||
4137893|NCT00886613|3962401|B3|Between 60 and 88 years||Age, Customized||participants|Number|40|40.0||||||
4137894|NCT00886613|3962402|B2|Between 60 and 88 years||Age, Customized||participants|Number|39|39.0||||||
4137895|NCT00886613|3962403|B1|Between 60 and 88 years||Age, Customized||participants|Number|41|41.0||||||
4137896|NCT00886600|3962423|B5|||Sitting Diastolic Blood Pressure (SiDBP)||mm Hg|Mean|100.9|100.9|Standard Deviation|4.6|4.6|||
4137897|NCT00886600|3962424|B4|||Sitting Diastolic Blood Pressure (SiDBP)||mm Hg|Mean|101.2|101.2|Standard Deviation|4.8|4.8|||
4137898|NCT00886600|3962425|B3|||Sitting Diastolic Blood Pressure (SiDBP)||mm Hg|Mean|101.5|101.5|Standard Deviation|5.1|5.1|||
4137899|NCT00886600|3962426|B2|||Sitting Diastolic Blood Pressure (SiDBP)||mm Hg|Mean|100.0|100.0|Standard Deviation|4.6|4.6|||
4137900|NCT00886600|3962427|B1|||Sitting Diastolic Blood Pressure (SiDBP)||mm Hg|Mean|100.7|100.7|Standard Deviation|4.0|4.0|||
4137901|NCT00886600|3962423|B5|||Diastolic 24-hr mean ambulatory blood pressure monitoring (ABPM)||mm Hg|Mean|94.2|94.2|Standard Deviation|6.4|6.4|||
4137902|NCT00886600|3962424|B4|||Diastolic 24-hr mean ambulatory blood pressure monitoring (ABPM)||mm Hg|Mean|94.4|94.4|Standard Deviation|6.9|6.9|||
4137903|NCT00886600|3962425|B3|||Diastolic 24-hr mean ambulatory blood pressure monitoring (ABPM)||mm Hg|Mean|93.8|93.8|Standard Deviation|6.0|6.0|||
4137904|NCT00886600|3962426|B2|||Diastolic 24-hr mean ambulatory blood pressure monitoring (ABPM)||mm Hg|Mean|94.0|94.0|Standard Deviation|6.9|6.9|||
4137905|NCT00886600|3962427|B1|||Diastolic 24-hr mean ambulatory blood pressure monitoring (ABPM)||mm Hg|Mean|94.8|94.8|Standard Deviation|5.9|5.9|||
4137906|NCT00886600|3962423|B5|Indian||Race/Ethnicity||participants|Number|1|1.0||||||
4137907|NCT00886600|3962424|B4|Indian||Race/Ethnicity||participants|Number|0|0.0||||||
4137908|NCT00886600|3962425|B3|Indian||Race/Ethnicity||participants|Number|0|0.0||||||
4137909|NCT00886600|3962426|B2|Indian||Race/Ethnicity||participants|Number|0|0.0||||||
4137910|NCT00886600|3962427|B1|Indian||Race/Ethnicity||participants|Number|1|1.0||||||
4137911|NCT00886600|3962423|B5|Filipino||Race/Ethnicity||participants|Number|1|1.0||||||
4137912|NCT00886600|3962424|B4|Filipino||Race/Ethnicity||participants|Number|0|0.0||||||
4137913|NCT00886600|3962425|B3|Filipino||Race/Ethnicity||participants|Number|0|0.0||||||
4137914|NCT00886600|3962426|B2|Filipino||Race/Ethnicity||participants|Number|0|0.0||||||
4137915|NCT00886600|3962427|B1|Filipino||Race/Ethnicity||participants|Number|1|1.0||||||
4137916|NCT00886600|3962423|B5|Oriental||Race/Ethnicity||participants|Number|1|1.0||||||
4137917|NCT00886600|3962424|B4|Oriental||Race/Ethnicity||participants|Number|1|1.0||||||
4137918|NCT00886600|3962425|B3|Oriental||Race/Ethnicity||participants|Number|0|0.0||||||
4137919|NCT00886600|3962426|B2|Oriental||Race/Ethnicity||participants|Number|0|0.0||||||
4137920|NCT00886600|3962427|B1|Oriental||Race/Ethnicity||participants|Number|0|0.0||||||
4137921|NCT00886600|3962423|B5|Caucasian||Race/Ethnicity||participants|Number|119|119.0||||||
4137922|NCT00886600|3962424|B4|Caucasian||Race/Ethnicity||participants|Number|30|30.0||||||
4137923|NCT00886600|3962425|B3|Caucasian||Race/Ethnicity||participants|Number|30|30.0||||||
4137924|NCT00886600|3962426|B2|Caucasian||Race/Ethnicity||participants|Number|29|29.0||||||
4137925|NCT00886600|3962427|B1|Caucasian||Race/Ethnicity||participants|Number|30|30.0||||||
4137926|NCT00886600|3962423|B5||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4137927|NCT00886600|3962424|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4137928|NCT00886600|3962425|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4137929|NCT00886600|3962426|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4137930|NCT00886600|3962427|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4137931|NCT00886600|3962423|B5||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4137932|NCT00886600|3962424|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4137933|NCT00886600|3962425|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4137934|NCT00886600|3962426|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4137935|NCT00886600|3962427|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4137936|NCT00886600|3962423|B5|||Age||years|Mean|53.5|53.5|Standard Deviation|10.8|10.8|||
4137937|NCT00886600|3962424|B4|||Age||years|Mean|54.1|54.1|Standard Deviation|9.0|9.0|||
4137938|NCT00886600|3962425|B3|||Age||years|Mean|51.2|51.2|Standard Deviation|9.6|9.6|||
4137939|NCT00886600|3962426|B2|||Age||years|Mean|56.8|56.8|Standard Deviation|12.1|12.1|||
4137940|NCT00886600|3962427|B1|||Age||years|Mean|52.2|52.2|Standard Deviation|12.0|12.0|||
4137941|NCT00886587|3962452|B3|United States||Region of Enrollment||participants|Number|82|82.0||||||
4137942|NCT00886587|3962453|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
4137943|NCT00886587|3962454|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4137944|NCT00886587|3962452|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4137945|NCT00886587|3962453|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4137946|NCT00886587|3962454|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4137947|NCT00886587|3962452|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4137948|NCT00886587|3962453|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4137949|NCT00886587|3962454|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4137950|NCT00886587|3962452|B3|||Age||years|Mean|5.96|5.96|Standard Deviation|2.88|2.88|||
4137951|NCT00886587|3962453|B2|||Age||years|Mean|5.56|5.56|Standard Deviation|2.84|2.84|||
4137952|NCT00886587|3962454|B1|||Age||years|Mean|6.37|6.37|Standard Deviation|2.90|2.9|||
4137953|NCT00886483|3962467|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
4137954|NCT00886483|3962468|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4137955|NCT00886483|3962469|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4137956|NCT00886483|3962467|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4137957|NCT00886483|3962468|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4137958|NCT00886483|3962469|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4137959|NCT00886483|3962467|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4137960|NCT00886483|3962468|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4137961|NCT00886483|3962469|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4137962|NCT00886483|3962467|B3|||Age||years|Mean|8.9|8.9|Standard Deviation|1.8|1.8|||
4137963|NCT00886483|3962468|B2|||Age||years|Mean|8.7|8.7|Standard Deviation|2.1|2.1|||
4137964|NCT00886483|3962469|B1|||Age||years|Mean|9.0|9.0|Standard Deviation|1.5|1.5|||
4137965|NCT00886483|3962467|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4137966|NCT00886483|3962468|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4137967|NCT00886483|3962469|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4137968|NCT00886483|3962467|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4137969|NCT00886483|3962468|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4137970|NCT00886483|3962469|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4137971|NCT00886483|3962467|B3||<=18 years|Age||Participants|Count of Participants|39|39.0||||||
4137972|NCT00886483|3962468|B2||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4137973|NCT00886483|3962469|B1||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
4137974|NCT00886340|3962486|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4137975|NCT00886340|3962487|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4137976|NCT00886340|3962488|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4137977|NCT00886340|3962486|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4137978|NCT00886340|3962487|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4137979|NCT00886340|3962488|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4137980|NCT00886340|3962486|B3|||Age||years|Mean|45.7|45.7|Standard Deviation|12.7|12.7|||
4137981|NCT00886340|3962487|B2|||Age||years|Mean|48.2|48.2|Standard Deviation|12.4|12.4|||
4137982|NCT00886340|3962488|B1|||Age||years|Mean|43.2|43.2|Standard Deviation|13.2|13.2|||
4137983|NCT00886340|3962486|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4137984|NCT00886340|3962487|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4137985|NCT00886340|3962488|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4137986|NCT00886340|3962486|B3||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4137987|NCT00886340|3962487|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4137988|NCT00886340|3962488|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4137989|NCT00886340|3962486|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137990|NCT00886340|3962487|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137991|NCT00886340|3962488|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4137992|NCT00886288|3962495|B3||Male|Sex: Female, Male||Participants|Count of Participants|1416|1416.0||||||
4137993|NCT00886288|3962496|B2||Male|Sex: Female, Male||Participants|Count of Participants|355|355.0||||||
4137994|NCT00886288|3962497|B1||Male|Sex: Female, Male||Participants|Count of Participants|1061|1061.0||||||
4137995|NCT00886288|3962495|B3||Female|Sex: Female, Male||Participants|Count of Participants|1295|1295.0||||||
4137996|NCT00886288|3962496|B2||Female|Sex: Female, Male||Participants|Count of Participants|329|329.0||||||
4137997|NCT00886288|3962497|B1||Female|Sex: Female, Male||Participants|Count of Participants|966|966.0||||||
4137998|NCT00886288|3962495|B3|||Age||years|Mean|63.8|63.8|Standard Deviation|11.8|11.8|||
4137999|NCT00886288|3962496|B2|||Age||years|Mean|65.9|65.9|Standard Deviation|11.9|11.9|||
4138000|NCT00886288|3962497|B1|||Age||years|Mean|63|63.0|Standard Deviation|11.7|11.7|||
4138001|NCT00886262|3962514|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4138002|NCT00886262|3962515|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4138003|NCT00886262|3962516|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4138004|NCT00886262|3962514|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4138005|NCT00886262|3962515|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4138006|NCT00886262|3962516|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4138007|NCT00886262|3962514|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4138008|NCT00886262|3962515|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4138009|NCT00886262|3962516|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4138010|NCT00886262|3962514|B3|||Age||years|Mean|56.4|56.4|Full Range|||30.0|69.0|
4138011|NCT00886262|3962515|B2|||Age||years|Mean|55.1|55.1|Full Range|||30.0|69.0|
4138012|NCT00886262|3962516|B1|||Age||years|Mean|58|58.0|Full Range|||36.0|68.0|
4138013|NCT00886262|3962514|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4138014|NCT00886262|3962515|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4138015|NCT00886262|3962516|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4138016|NCT00886262|3962514|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4138017|NCT00886262|3962515|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4138018|NCT00886262|3962516|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4138019|NCT00886262|3962514|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4138020|NCT00886262|3962515|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4138021|NCT00886262|3962516|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4138022|NCT00886236|3962529|B4|United States||Region of Enrollment||participants|Number|62|62.0||||||
4138023|NCT00886236|3962530|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4138024|NCT00886236|3962531|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4138025|NCT00886236|3962532|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4138026|NCT00886236|3962529|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4138027|NCT00886236|3962530|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4138028|NCT00886236|3962531|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4138029|NCT00886236|3962532|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4138030|NCT00886236|3962529|B4||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4138031|NCT00886236|3962530|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4138032|NCT00886236|3962531|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4138033|NCT00886236|3962532|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4138034|NCT00886236|3962529|B4|||Age||years|Mean|47|47.0|Full Range|||22.0|75.0|
4138035|NCT00886236|3962530|B3|||Age||years|Mean|46|46.0|Full Range|||24.0|75.0|
4138036|NCT00886236|3962531|B2|||Age||years|Mean|47|47.0|Full Range|||22.0|67.0|
4138037|NCT00886236|3962532|B1|||Age||years|Mean|47|47.0|Full Range|||30.0|64.0|
4138038|NCT00886236|3962529|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4138039|NCT00886236|3962530|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4138040|NCT00886236|3962531|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4138041|NCT00886236|3962532|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4138042|NCT00886236|3962529|B4||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4138043|NCT00886236|3962530|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4138044|NCT00886236|3962531|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4138045|NCT00886236|3962532|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4138046|NCT00886236|3962529|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4138047|NCT00886236|3962530|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4138048|NCT00886236|3962531|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4138049|NCT00886236|3962532|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4138050|NCT00886145|3962548|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4138051|NCT00886145|3962548|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4138052|NCT00886145|3962548|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4138053|NCT00886145|3962548|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4138054|NCT00886145|3962548|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4138055|NCT00886119|3962554|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4138056|NCT00886119|3962554|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4138057|NCT00886119|3962554|B1|||Age||years|Mean|49.3|49.3|Standard Deviation|4.6|4.6|||
4138058|NCT00886015|3962561|B3|severe||Trichiasis|mild, moderate, severe|eyelids|Number|1819|1819.0||||||
4138059|NCT00886015|3962562|B2|severe||Trichiasis|mild, moderate, severe|eyelids|Number|945|945.0||||||
4138060|NCT00886015|3962563|B1|severe||Trichiasis|mild, moderate, severe|eyelids|Number|874|874.0||||||
4138061|NCT00886015|3962561|B3|moderate||Trichiasis|mild, moderate, severe|eyelids|Number|876|876.0||||||
4138062|NCT00886015|3962562|B2|moderate||Trichiasis|mild, moderate, severe|eyelids|Number|423|423.0||||||
4138063|NCT00886015|3962563|B1|moderate||Trichiasis|mild, moderate, severe|eyelids|Number|453|453.0||||||
4138064|NCT00886015|3962561|B3|mild||Trichiasis|mild, moderate, severe|eyelids|Number|650|650.0||||||
4138065|NCT00886015|3962562|B2|mild||Trichiasis|mild, moderate, severe|eyelids|Number|303|303.0||||||
4138066|NCT00886015|3962563|B1|mild||Trichiasis|mild, moderate, severe|eyelids|Number|347|347.0||||||
4138067|NCT00886015|3962561|B3|Tanzania||Region of Enrollment||participants|Number|1917|1917.0||||||
4138068|NCT00886015|3962562|B2|Tanzania||Region of Enrollment||participants|Number|957|957.0||||||
4138069|NCT00886015|3962563|B1|Tanzania||Region of Enrollment||participants|Number|960|960.0||||||
4138070|NCT00886015|3962561|B3|Male||Sex/Gender, Customized||participants|Number|490|490.0||||||
4138071|NCT00886015|3962562|B2|Male||Sex/Gender, Customized||participants|Number|252|252.0||||||
4138072|NCT00886015|3962563|B1|Male||Sex/Gender, Customized||participants|Number|238|238.0||||||
4138073|NCT00886015|3962561|B3|Female||Sex/Gender, Customized||participants|Number|1427|1427.0||||||
4138074|NCT00886015|3962562|B2|Female||Sex/Gender, Customized||participants|Number|705|705.0||||||
4138075|NCT00886015|3962563|B1|Female||Sex/Gender, Customized||participants|Number|722|722.0||||||
4138076|NCT00886015|3962561|B3|||Age||years|Mean|55.2|55.2|Standard Deviation|13.3|13.3|||
4138077|NCT00886015|3962562|B2|||Age||years|Mean|54.9|54.9|Standard Deviation|13.5|13.5|||
4138078|NCT00886015|3962563|B1|||Age||years|Mean|55.6|55.6|Standard Deviation|13.1|13.1|||
4138079|NCT00885846|3962580|B4|United States||Region of Enrollment||participants|Number|32.0|32.0||||||
4138080|NCT00885846|3962581|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4138081|NCT00885846|3962582|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4138082|NCT00885846|3962583|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4138083|NCT00885846|3962580|B4||Male|Sex: Female, Male||Participants|Count of Participants|13.0|13.0||||||
4138084|NCT00885846|3962581|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4138085|NCT00885846|3962582|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4138086|NCT00885846|3962583|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4138087|NCT00885846|3962580|B4||Female|Sex: Female, Male||Participants|Count of Participants|19.0|19.0||||||
4138088|NCT00885846|3962581|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4138089|NCT00885846|3962582|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4138090|NCT00885846|3962583|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4138091|NCT00885846|3962580|B4|||Age||years|Mean|56.3|56.3|Standard Deviation|8.1|8.1|||
4138092|NCT00885846|3962581|B3|||Age||years|Mean|60.2|60.2|Standard Deviation|6.3|6.3|||
4138093|NCT00885846|3962582|B2|||Age||years|Mean|52.8|52.8|Standard Deviation|9.9|9.9|||
4138094|NCT00885846|3962583|B1|||Age||years|Mean|56.2|56.2|Standard Deviation|7.5|7.5|||
4138095|NCT00885846|3962580|B4||>=65 years|Age||Participants|Count of Participants|5.0|5.0||||||
4138096|NCT00885846|3962581|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4138097|NCT00885846|3962582|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4138098|NCT00885846|3962583|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4138099|NCT00885846|3962580|B4||Between 18 and 65 years|Age||Participants|Count of Participants|27.0|27.0||||||
4138100|NCT00885846|3962581|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4138101|NCT00885846|3962582|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4138102|NCT00885846|3962583|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4138103|NCT00885846|3962580|B4||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4138104|NCT00885846|3962581|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4138105|NCT00885846|3962582|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4138106|NCT00885846|3962583|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4138107|NCT00885768|3962593|B1|||the patients with coronary artery disease||participants|Number|146|146.0||||||
4138108|NCT00885768|3962593|B1|>=65 years||the adult patients with coronary artry disease|when the reffered patients for coronary angiography have been proved to have significant coronary artery stenosis then the angiography of renal artery were performed.|participants|Number|19|19.0||||||
4138109|NCT00885768|3962593|B1|Between 18 and 65 years||the adult patients with coronary artry disease|when the reffered patients for coronary angiography have been proved to have significant coronary artery stenosis then the angiography of renal artery were performed.|participants|Number|127|127.0||||||
4138110|NCT00885768|3962593|B1|<=18 years||the adult patients with coronary artry disease|when the reffered patients for coronary angiography have been proved to have significant coronary artery stenosis then the angiography of renal artery were performed.|participants|Number|0|0.0||||||
4138111|NCT00885768|3962593|B1|Iran, Islamic Republic of||Region of Enrollment||participants|Number|146|146.0||||||
4138112|NCT00885768|3962593|B1||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4138113|NCT00885768|3962593|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4138114|NCT00885768|3962593|B1|||Age||years|Mean|61.17|61.17|Standard Deviation|9.47|9.47|||
4138115|NCT00885755|3962597|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4138116|NCT00885755|3962598|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4138117|NCT00885755|3962599|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4138118|NCT00885755|3962600|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4138119|NCT00885755|3962597|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4138120|NCT00885755|3962598|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4138121|NCT00885755|3962599|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4138122|NCT00885755|3962600|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4138123|NCT00885755|3962597|B4|||Age||years|Mean|55.9|55.9|Standard Deviation|12.91|12.91|||
4138124|NCT00885755|3962598|B3|||Age||years|Mean|85.0|85.0|Standard Deviation|NA||||Standard deviation was not available since there was only 1 participant.
4138125|NCT00885755|3962599|B2|||Age||years|Mean|37.0|37.0|Standard Deviation|NA||||Standard deviation was not available since there was only 1 participant.
4138126|NCT00885755|3962600|B1|||Age||years|Mean|55.5|55.5|Standard Deviation|11.73|11.73|||
4138127|NCT00885742|3962627|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4138128|NCT00885742|3962627|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4138129|NCT00885742|3962627|B1|≥ 65 years||Age, Customized||participants|Number|0|0.0||||||
4138130|NCT00885742|3962627|B1|16 to < 65 years||Age, Customized||participants|Number|23|23.0||||||
4138131|NCT00885742|3962627|B1|< 16 years||Age, Customized||participants|Number|18|18.0||||||
4138132|NCT00885742|3962627|B1|||Age||years|Mean|20.1|20.1|Standard Deviation|11.20|11.2|||
4138133|NCT00885703|3962638|B8|||Cryptococcal Antigen (CrAG) Titer||titers|Median|452.5|452.5|Inter-Quartile Range|||32.0|2405.0|
4138134|NCT00885703|3962639|B7|||Cryptococcal Antigen (CrAG) Titer||titers|Median|416|416.0|Inter-Quartile Range|||128.0|4096.0|
4138135|NCT00885703|3962640|B6|||Cryptococcal Antigen (CrAG) Titer||titers|Median|128|128.0|Inter-Quartile Range|||16.0|2048.0|
4138136|NCT00885703|3962641|B5|||Cryptococcal Antigen (CrAG) Titer||titers|Median|256|256.0|Inter-Quartile Range|||20.0|1024.0|
4138137|NCT00885703|3962642|B4|||Cryptococcal Antigen (CrAG) Titer||titers|Median|1050|1050.0|Inter-Quartile Range|||160.0|4096.0|
4138138|NCT00885703|3962643|B3|||Cryptococcal Antigen (CrAG) Titer||titers|Median|815.5|815.5|Inter-Quartile Range|||125.0|8192.0|
4138139|NCT00885703|3962644|B2|||Cryptococcal Antigen (CrAG) Titer||titers|Median|128|128.0|Inter-Quartile Range|||32.0|1024.0|
4138140|NCT00885703|3962645|B1|||Cryptococcal Antigen (CrAG) Titer||titers|Median|756|756.0|Inter-Quartile Range|||256.0|8192.0|
4138141|NCT00885703|3962638|B8|||Creatinine Clearance||mL/min|Mean|95.0|95.0|Inter-Quartile Range|||75.0|113.3|
4138142|NCT00885703|3962639|B7|||Creatinine Clearance||mL/min|Mean|94.4|94.4|Inter-Quartile Range|||77.6|113.5|
4138143|NCT00885703|3962640|B6|||Creatinine Clearance||mL/min|Mean|98.8|98.8|Inter-Quartile Range|||67.3|121.8|
4138144|NCT00885703|3962641|B5|||Creatinine Clearance||mL/min|Mean|94.0|94.0|Inter-Quartile Range|||68.2|104.0|
4138145|NCT00885703|3962642|B4|||Creatinine Clearance||mL/min|Mean|102.3|102.3|Inter-Quartile Range|||81.9|135.5|
4138146|NCT00885703|3962643|B3|||Creatinine Clearance||mL/min|Mean|94.2|94.2|Inter-Quartile Range|||72.7|115.2|
4138147|NCT00885703|3962644|B2|||Creatinine Clearance||mL/min|Mean|94.5|94.5|Inter-Quartile Range|||79.3|106.3|
4138148|NCT00885703|3962645|B1|||Creatinine Clearance||mL/min|Mean|94.2|94.2|Inter-Quartile Range|||79.5|112.1|
4138149|NCT00885703|3962638|B8|||ALT (Alanine Aminotransferase)||U/L|Median|20.6|20.6|Inter-Quartile Range|||14.0|32.6|
4138150|NCT00885703|3962639|B7|||ALT (Alanine Aminotransferase)||U/L|Median|18.1|18.1|Inter-Quartile Range|||14.5|35.3|
4138151|NCT00885703|3962640|B6|||ALT (Alanine Aminotransferase)||U/L|Median|24.1|24.1|Inter-Quartile Range|||14.5|32.1|
4138152|NCT00885703|3962641|B5|||ALT (Alanine Aminotransferase)||U/L|Median|25.2|25.2|Inter-Quartile Range|||17.4|38.0|
4138153|NCT00885703|3962642|B4|||ALT (Alanine Aminotransferase)||U/L|Median|21.5|21.5|Inter-Quartile Range|||11.7|32.7|
4138154|NCT00885703|3962643|B3|||ALT (Alanine Aminotransferase)||U/L|Median|24.7|24.7|Inter-Quartile Range|||14.0|41.8|
4138155|NCT00885703|3962644|B2|||ALT (Alanine Aminotransferase)||U/L|Median|19.0|19.0|Inter-Quartile Range|||13.0|29.2|
4138156|NCT00885703|3962645|B1|||ALT (Alanine Aminotransferase)||U/L|Median|15.7|15.7|Inter-Quartile Range|||11.0|22.8|
4138157|NCT00885703|3962638|B8|||Albumin||g/dL|Median|3.2|3.2|Inter-Quartile Range|||2.8|3.5|
4138158|NCT00885703|3962639|B7|||Albumin||g/dL|Median|3.1|3.1|Inter-Quartile Range|||2.7|3.6|
4138159|NCT00885703|3962640|B6|||Albumin||g/dL|Median|3.1|3.1|Inter-Quartile Range|||2.7|3.6|
4138160|NCT00885703|3962641|B5|||Albumin||g/dL|Median|3.1|3.1|Inter-Quartile Range|||2.8|3.2|
4138161|NCT00885703|3962642|B4|||Albumin||g/dL|Median|3.2|3.2|Inter-Quartile Range|||2.8|3.6|
4138162|NCT00885703|3962643|B3|||Albumin||g/dL|Median|3.3|3.3|Inter-Quartile Range|||2.9|3.6|
4138163|NCT00885703|3962644|B2|||Albumin||g/dL|Median|3.2|3.2|Inter-Quartile Range|||3.1|3.6|
4138164|NCT00885703|3962645|B1|||Albumin||g/dL|Median|3.0|3.0|Inter-Quartile Range|||2.6|3.3|
4138165|NCT00885703|3962638|B8|||White Blood Cell count (from CSF)||cells/mm^3|Median|19|19.0|Inter-Quartile Range|||9.0|100.0|
4138166|NCT00885703|3962639|B7|||White Blood Cell count (from CSF)||cells/mm^3|Median|13|13.0|Inter-Quartile Range|||8.0|53.0|
4138167|NCT00885703|3962640|B6|||White Blood Cell count (from CSF)||cells/mm^3|Median|16|16.0|Inter-Quartile Range|||12.0|89.0|
4138168|NCT00885703|3962641|B5|||White Blood Cell count (from CSF)||cells/mm^3|Median|19|19.0|Inter-Quartile Range|||8.0|33.0|
4138169|NCT00885703|3962642|B4|||White Blood Cell count (from CSF)||cells/mm^3|Median|26|26.0|Inter-Quartile Range|||15.0|133.0|
4138170|NCT00885703|3962643|B3|||White Blood Cell count (from CSF)||cells/mm^3|Median|17|17.0|Inter-Quartile Range|||9.0|310.0|
4138171|NCT00885703|3962644|B2|||White Blood Cell count (from CSF)||cells/mm^3|Median|30|30.0|Inter-Quartile Range|||4.0|100.0|
4138172|NCT00885703|3962645|B1|||White Blood Cell count (from CSF)||cells/mm^3|Median|80|80.0|Inter-Quartile Range|||30.0|500.0|
4138173|NCT00885703|3962638|B8|||Opening Pressure (from Lumbar Pucture)||mm H20|Median|210|210.0|Inter-Quartile Range|||141.0|320.0|
4138174|NCT00885703|3962639|B7|||Opening Pressure (from Lumbar Pucture)||mm H20|Median|303|303.0|Inter-Quartile Range|||250.0|485.0|
4138175|NCT00885703|3962640|B6|||Opening Pressure (from Lumbar Pucture)||mm H20|Median|190|190.0|Inter-Quartile Range|||120.0|235.0|
4138176|NCT00885703|3962641|B5|||Opening Pressure (from Lumbar Pucture)||mm H20|Median|200|200.0|Inter-Quartile Range|||150.0|254.0|
4138177|NCT00885703|3962642|B4|||Opening Pressure (from Lumbar Pucture)||mm H20|Median|190|190.0|Inter-Quartile Range|||120.0|300.0|
4138178|NCT00885703|3962643|B3|||Opening Pressure (from Lumbar Pucture)||mm H20|Median|350|350.0|Inter-Quartile Range|||180.0|550.0|
4138179|NCT00885703|3962644|B2|||Opening Pressure (from Lumbar Pucture)||mm H20|Median|200|200.0|Inter-Quartile Range|||150.0|290.0|
4138180|NCT00885703|3962645|B1|||Opening Pressure (from Lumbar Pucture)||mm H20|Median|200|200.0|Inter-Quartile Range|||105.0|300.0|
4138225|NCT00885703|3962642|B4|||Quantitative Cryptococcal Meningitis Culture||Log10 CFU/mL|Median|4.37|4.37|Inter-Quartile Range|||3.33|5.23|
4138181|NCT00885703|3962638|B8|||Mini Mental Status|The Mini Mental Status is a 26-point questionnaire that is used to measure cognitive impairment. Scale is 0=worst to 26=best.|Scores on a scale|Median|26|26.0|Inter-Quartile Range|||22.0|26.0|
4138182|NCT00885703|3962639|B7|||Mini Mental Status|The Mini Mental Status is a 26-point questionnaire that is used to measure cognitive impairment. Scale is 0=worst to 26=best.|Scores on a scale|Median|25.5|25.5|Inter-Quartile Range|||20.0|26.0|
4138183|NCT00885703|3962640|B6|||Mini Mental Status|The Mini Mental Status is a 26-point questionnaire that is used to measure cognitive impairment. Scale is 0=worst to 26=best.|Scores on a scale|Median|26|26.0|Inter-Quartile Range|||19.0|26.0|
4138184|NCT00885703|3962641|B5|||Mini Mental Status|The Mini Mental Status is a 26-point questionnaire that is used to measure cognitive impairment. Scale is 0=worst to 26=best.|Scores on a scale|Median|26|26.0|Inter-Quartile Range|||21.0|26.0|
4138185|NCT00885703|3962642|B4|||Mini Mental Status|The Mini Mental Status is a 26-point questionnaire that is used to measure cognitive impairment. Scale is 0=worst to 26=best.|Scores on a scale|Median|26|26.0|Inter-Quartile Range|||24.0|26.0|
4138186|NCT00885703|3962643|B3|||Mini Mental Status|The Mini Mental Status is a 26-point questionnaire that is used to measure cognitive impairment. Scale is 0=worst to 26=best.|Scores on a scale|Median|26|26.0|Inter-Quartile Range|||22.0|26.0|
4138187|NCT00885703|3962644|B2|||Mini Mental Status|The Mini Mental Status is a 26-point questionnaire that is used to measure cognitive impairment. Scale is 0=worst to 26=best.|Scores on a scale|Median|25|25.0|Inter-Quartile Range|||23.0|26.0|
4138188|NCT00885703|3962645|B1|||Mini Mental Status|The Mini Mental Status is a 26-point questionnaire that is used to measure cognitive impairment. Scale is 0=worst to 26=best.|Scores on a scale|Median|26|26.0|Inter-Quartile Range|||23.0|26.0|
4138189|NCT00885703|3962638|B8||No opportunistic infections|Opportunistic Infections||Participants|Count of Participants|100|100.0||||||
4138190|NCT00885703|3962639|B7||No opportunistic infections|Opportunistic Infections||Participants|Count of Participants|14|14.0||||||
4138191|NCT00885703|3962640|B6||No opportunistic infections|Opportunistic Infections||Participants|Count of Participants|15|15.0||||||
4138192|NCT00885703|3962641|B5||No opportunistic infections|Opportunistic Infections||Participants|Count of Participants|13|13.0||||||
4138193|NCT00885703|3962642|B4||No opportunistic infections|Opportunistic Infections||Participants|Count of Participants|14|14.0||||||
4138194|NCT00885703|3962643|B3||No opportunistic infections|Opportunistic Infections||Participants|Count of Participants|13|13.0||||||
4138195|NCT00885703|3962644|B2||No opportunistic infections|Opportunistic Infections||Participants|Count of Participants|19|19.0||||||
4138196|NCT00885703|3962645|B1||No opportunistic infections|Opportunistic Infections||Participants|Count of Participants|12|12.0||||||
4138197|NCT00885703|3962638|B8||One or more opportunistic infections|Opportunistic Infections||Participants|Count of Participants|68|68.0||||||
4138198|NCT00885703|3962639|B7||One or more opportunistic infections|Opportunistic Infections||Participants|Count of Participants|10|10.0||||||
4138199|NCT00885703|3962640|B6||One or more opportunistic infections|Opportunistic Infections||Participants|Count of Participants|9|9.0||||||
4138200|NCT00885703|3962641|B5||One or more opportunistic infections|Opportunistic Infections||Participants|Count of Participants|11|11.0||||||
4138201|NCT00885703|3962642|B4||One or more opportunistic infections|Opportunistic Infections||Participants|Count of Participants|10|10.0||||||
4138202|NCT00885703|3962643|B3||One or more opportunistic infections|Opportunistic Infections||Participants|Count of Participants|11|11.0||||||
4138203|NCT00885703|3962644|B2||One or more opportunistic infections|Opportunistic Infections||Participants|Count of Participants|7|7.0||||||
4138204|NCT00885703|3962645|B1||One or more opportunistic infections|Opportunistic Infections||Participants|Count of Participants|10|10.0||||||
4138205|NCT00885703|3962638|B8||Not on ART|Anti-Retroviral Therapy (ART) Status||Participants|Count of Participants|137|137.0||||||
4138206|NCT00885703|3962639|B7||Not on ART|Anti-Retroviral Therapy (ART) Status||Participants|Count of Participants|13|13.0||||||
4138207|NCT00885703|3962640|B6||Not on ART|Anti-Retroviral Therapy (ART) Status||Participants|Count of Participants|12|12.0||||||
4138208|NCT00885703|3962641|B5||Not on ART|Anti-Retroviral Therapy (ART) Status||Participants|Count of Participants|16|16.0||||||
4138209|NCT00885703|3962642|B4||Not on ART|Anti-Retroviral Therapy (ART) Status||Participants|Count of Participants|24|24.0||||||
4138210|NCT00885703|3962643|B3||Not on ART|Anti-Retroviral Therapy (ART) Status||Participants|Count of Participants|24|24.0||||||
4138211|NCT00885703|3962644|B2||Not on ART|Anti-Retroviral Therapy (ART) Status||Participants|Count of Participants|26|26.0||||||
4138212|NCT00885703|3962645|B1||Not on ART|Anti-Retroviral Therapy (ART) Status||Participants|Count of Participants|22|22.0||||||
4138213|NCT00885703|3962638|B8||On ART|Anti-Retroviral Therapy (ART) Status||Participants|Count of Participants|31|31.0||||||
4138214|NCT00885703|3962639|B7||On ART|Anti-Retroviral Therapy (ART) Status||Participants|Count of Participants|11|11.0||||||
4138215|NCT00885703|3962640|B6||On ART|Anti-Retroviral Therapy (ART) Status||Participants|Count of Participants|12|12.0||||||
4138216|NCT00885703|3962641|B5||On ART|Anti-Retroviral Therapy (ART) Status||Participants|Count of Participants|8|8.0||||||
4138217|NCT00885703|3962642|B4||On ART|Anti-Retroviral Therapy (ART) Status||Participants|Count of Participants|0|0.0||||||
4138218|NCT00885703|3962643|B3||On ART|Anti-Retroviral Therapy (ART) Status||Participants|Count of Participants|0|0.0||||||
4138219|NCT00885703|3962644|B2||On ART|Anti-Retroviral Therapy (ART) Status||Participants|Count of Participants|0|0.0||||||
4138220|NCT00885703|3962645|B1||On ART|Anti-Retroviral Therapy (ART) Status||Participants|Count of Participants|0|0.0||||||
4138221|NCT00885703|3962638|B8|||Quantitative Cryptococcal Meningitis Culture||Log10 CFU/mL|Median|5.04|5.04|Inter-Quartile Range|||3.8|5.42|
4138222|NCT00885703|3962639|B7|||Quantitative Cryptococcal Meningitis Culture||Log10 CFU/mL|Median|5.14|5.14|Inter-Quartile Range|||3.4|5.42|
4138223|NCT00885703|3962640|B6|||Quantitative Cryptococcal Meningitis Culture||Log10 CFU/mL|Median|4.29|4.29|Inter-Quartile Range|||2.05|5.32|
4138224|NCT00885703|3962641|B5|||Quantitative Cryptococcal Meningitis Culture||Log10 CFU/mL|Median|5.34|5.34|Inter-Quartile Range|||4.31|5.47|
4138226|NCT00885703|3962643|B3|||Quantitative Cryptococcal Meningitis Culture||Log10 CFU/mL|Median|5.15|5.15|Inter-Quartile Range|||4.25|5.8|
4138227|NCT00885703|3962644|B2|||Quantitative Cryptococcal Meningitis Culture||Log10 CFU/mL|Median|4.45|4.45|Inter-Quartile Range|||3.98|5.09|
4138228|NCT00885703|3962645|B1|||Quantitative Cryptococcal Meningitis Culture||Log10 CFU/mL|Median|5.18|5.18|Inter-Quartile Range|||4.23|6.02|
4138229|NCT00885703|3962638|B8||GCS =15|Glasgow Coma Score|The Glasgow Coma Score provides an assessment of impairment of conscious level in response to defined stimuli. The GCS is on a scale from 0=worst to 15=best.|Participants|Count of Participants|151|151.0||||||
4138230|NCT00885703|3962639|B7||GCS =15|Glasgow Coma Score|The Glasgow Coma Score provides an assessment of impairment of conscious level in response to defined stimuli. The GCS is on a scale from 0=worst to 15=best.|Participants|Count of Participants|24|24.0||||||
4138231|NCT00885703|3962640|B6||GCS =15|Glasgow Coma Score|The Glasgow Coma Score provides an assessment of impairment of conscious level in response to defined stimuli. The GCS is on a scale from 0=worst to 15=best.|Participants|Count of Participants|23|23.0||||||
4138232|NCT00885703|3962641|B5||GCS =15|Glasgow Coma Score|The Glasgow Coma Score provides an assessment of impairment of conscious level in response to defined stimuli. The GCS is on a scale from 0=worst to 15=best.|Participants|Count of Participants|22|22.0||||||
4138233|NCT00885703|3962642|B4||GCS =15|Glasgow Coma Score|The Glasgow Coma Score provides an assessment of impairment of conscious level in response to defined stimuli. The GCS is on a scale from 0=worst to 15=best.|Participants|Count of Participants|23|23.0||||||
4138234|NCT00885703|3962643|B3||GCS =15|Glasgow Coma Score|The Glasgow Coma Score provides an assessment of impairment of conscious level in response to defined stimuli. The GCS is on a scale from 0=worst to 15=best.|Participants|Count of Participants|19|19.0||||||
4138235|NCT00885703|3962644|B2||GCS =15|Glasgow Coma Score|The Glasgow Coma Score provides an assessment of impairment of conscious level in response to defined stimuli. The GCS is on a scale from 0=worst to 15=best.|Participants|Count of Participants|23|23.0||||||
4138236|NCT00885703|3962645|B1||GCS =15|Glasgow Coma Score|The Glasgow Coma Score provides an assessment of impairment of conscious level in response to defined stimuli. The GCS is on a scale from 0=worst to 15=best.|Participants|Count of Participants|17|17.0||||||
4138237|NCT00885703|3962638|B8||GCS <15|Glasgow Coma Score|The Glasgow Coma Score provides an assessment of impairment of conscious level in response to defined stimuli. The GCS is on a scale from 0=worst to 15=best.|Participants|Count of Participants|16|16.0||||||
4138238|NCT00885703|3962639|B7||GCS <15|Glasgow Coma Score|The Glasgow Coma Score provides an assessment of impairment of conscious level in response to defined stimuli. The GCS is on a scale from 0=worst to 15=best.|Participants|Count of Participants|0|0.0||||||
4138239|NCT00885703|3962640|B6||GCS <15|Glasgow Coma Score|The Glasgow Coma Score provides an assessment of impairment of conscious level in response to defined stimuli. The GCS is on a scale from 0=worst to 15=best.|Participants|Count of Participants|0|0.0||||||
4138240|NCT00885703|3962641|B5||GCS <15|Glasgow Coma Score|The Glasgow Coma Score provides an assessment of impairment of conscious level in response to defined stimuli. The GCS is on a scale from 0=worst to 15=best.|Participants|Count of Participants|2|2.0||||||
4138241|NCT00885703|3962642|B4||GCS <15|Glasgow Coma Score|The Glasgow Coma Score provides an assessment of impairment of conscious level in response to defined stimuli. The GCS is on a scale from 0=worst to 15=best.|Participants|Count of Participants|1|1.0||||||
4138242|NCT00885703|3962643|B3||GCS <15|Glasgow Coma Score|The Glasgow Coma Score provides an assessment of impairment of conscious level in response to defined stimuli. The GCS is on a scale from 0=worst to 15=best.|Participants|Count of Participants|5|5.0||||||
4138243|NCT00885703|3962644|B2||GCS <15|Glasgow Coma Score|The Glasgow Coma Score provides an assessment of impairment of conscious level in response to defined stimuli. The GCS is on a scale from 0=worst to 15=best.|Participants|Count of Participants|3|3.0||||||
4138244|NCT00885703|3962645|B1||GCS <15|Glasgow Coma Score|The Glasgow Coma Score provides an assessment of impairment of conscious level in response to defined stimuli. The GCS is on a scale from 0=worst to 15=best.|Participants|Count of Participants|5|5.0||||||
4138245|NCT00885703|3962638|B8|||HIV-1 RNA||log10(copies/mL)|Median|5.3|5.3|Inter-Quartile Range|||4.7|5.7|
4138246|NCT00885703|3962639|B7|||HIV-1 RNA||log10(copies/mL)|Median|4.6|4.6|Inter-Quartile Range|||3.5|5.5|
4138247|NCT00885703|3962640|B6|||HIV-1 RNA||log10(copies/mL)|Median|4.9|4.9|Inter-Quartile Range|||2.8|5.4|
4138248|NCT00885703|3962641|B5|||HIV-1 RNA||log10(copies/mL)|Median|5.2|5.2|Inter-Quartile Range|||4.9|5.5|
4138249|NCT00885703|3962642|B4|||HIV-1 RNA||log10(copies/mL)|Median|5.4|5.4|Inter-Quartile Range|||5.2|5.7|
4138250|NCT00885703|3962643|B3|||HIV-1 RNA||log10(copies/mL)|Median|5.5|5.5|Inter-Quartile Range|||5.2|5.9|
4138251|NCT00885703|3962644|B2|||HIV-1 RNA||log10(copies/mL)|Median|5.6|5.6|Inter-Quartile Range|||5.1|5.8|
4138252|NCT00885703|3962645|B1|||HIV-1 RNA||log10(copies/mL)|Median|5.3|5.3|Inter-Quartile Range|||5.1|6.0|
4138253|NCT00885703|3962638|B8||200+ cells/mm^3|CD4+||Participants|Count of Participants|5|5.0||||||
4138254|NCT00885703|3962639|B7||200+ cells/mm^3|CD4+||Participants|Count of Participants|0|0.0||||||
4138255|NCT00885703|3962640|B6||200+ cells/mm^3|CD4+||Participants|Count of Participants|0|0.0||||||
4138256|NCT00885703|3962641|B5||200+ cells/mm^3|CD4+||Participants|Count of Participants|1|1.0||||||
4138257|NCT00885703|3962642|B4||200+ cells/mm^3|CD4+||Participants|Count of Participants|1|1.0||||||
4138258|NCT00885703|3962643|B3||200+ cells/mm^3|CD4+||Participants|Count of Participants|0|0.0||||||
4138259|NCT00885703|3962644|B2||200+ cells/mm^3|CD4+||Participants|Count of Participants|3|3.0||||||
4138260|NCT00885703|3962645|B1||200+ cells/mm^3|CD4+||Participants|Count of Participants|0|0.0||||||
4138261|NCT00885703|3962638|B8||100 - <200 cells/mm^3|CD4+||Participants|Count of Participants|15|15.0||||||
4138262|NCT00885703|3962639|B7||100 - <200 cells/mm^3|CD4+||Participants|Count of Participants|2|2.0||||||
4138263|NCT00885703|3962640|B6||100 - <200 cells/mm^3|CD4+||Participants|Count of Participants|3|3.0||||||
4138264|NCT00885703|3962641|B5||100 - <200 cells/mm^3|CD4+||Participants|Count of Participants|0|0.0||||||
4138265|NCT00885703|3962642|B4||100 - <200 cells/mm^3|CD4+||Participants|Count of Participants|2|2.0||||||
4138266|NCT00885703|3962643|B3||100 - <200 cells/mm^3|CD4+||Participants|Count of Participants|3|3.0||||||
4138267|NCT00885703|3962644|B2||100 - <200 cells/mm^3|CD4+||Participants|Count of Participants|4|4.0||||||
4138268|NCT00885703|3962645|B1||100 - <200 cells/mm^3|CD4+||Participants|Count of Participants|1|1.0||||||
4138269|NCT00885703|3962638|B8||50 - <100 cells/mm^3|CD4+||Participants|Count of Participants|36|36.0||||||
4138270|NCT00885703|3962639|B7||50 - <100 cells/mm^3|CD4+||Participants|Count of Participants|5|5.0||||||
4138271|NCT00885703|3962640|B6||50 - <100 cells/mm^3|CD4+||Participants|Count of Participants|5|5.0||||||
4138272|NCT00885703|3962641|B5||50 - <100 cells/mm^3|CD4+||Participants|Count of Participants|3|3.0||||||
4138273|NCT00885703|3962642|B4||50 - <100 cells/mm^3|CD4+||Participants|Count of Participants|4|4.0||||||
4138274|NCT00885703|3962643|B3||50 - <100 cells/mm^3|CD4+||Participants|Count of Participants|4|4.0||||||
4138275|NCT00885703|3962644|B2||50 - <100 cells/mm^3|CD4+||Participants|Count of Participants|9|9.0||||||
4138276|NCT00885703|3962645|B1||50 - <100 cells/mm^3|CD4+||Participants|Count of Participants|6|6.0||||||
4138277|NCT00885703|3962638|B8||< 50 cells/mm^3|CD4+||Participants|Count of Participants|112|112.0||||||
4138278|NCT00885703|3962639|B7||< 50 cells/mm^3|CD4+||Participants|Count of Participants|17|17.0||||||
4138279|NCT00885703|3962640|B6||< 50 cells/mm^3|CD4+||Participants|Count of Participants|16|16.0||||||
4138280|NCT00885703|3962641|B5||< 50 cells/mm^3|CD4+||Participants|Count of Participants|20|20.0||||||
4138281|NCT00885703|3962642|B4||< 50 cells/mm^3|CD4+||Participants|Count of Participants|17|17.0||||||
4138282|NCT00885703|3962643|B3||< 50 cells/mm^3|CD4+||Participants|Count of Participants|17|17.0||||||
4138283|NCT00885703|3962644|B2||< 50 cells/mm^3|CD4+||Participants|Count of Participants|10|10.0||||||
4138284|NCT00885703|3962645|B1||< 50 cells/mm^3|CD4+||Participants|Count of Participants|15|15.0||||||
4138285|NCT00885703|3962638|B8|||BMI (Body Mass Index)||kg/m^2|Median|18.9|18.9|Inter-Quartile Range|||16.9|21.9|
4138286|NCT00885703|3962639|B7|||BMI (Body Mass Index)||kg/m^2|Median|19.6|19.6|Inter-Quartile Range|||17.5|22.9|
4138287|NCT00885703|3962640|B6|||BMI (Body Mass Index)||kg/m^2|Median|19.8|19.8|Inter-Quartile Range|||18.6|22.5|
4138288|NCT00885703|3962641|B5|||BMI (Body Mass Index)||kg/m^2|Median|18.7|18.7|Inter-Quartile Range|||17.1|20.3|
4138289|NCT00885703|3962642|B4|||BMI (Body Mass Index)||kg/m^2|Median|19.8|19.8|Inter-Quartile Range|||16.3|24.3|
4138290|NCT00885703|3962643|B3|||BMI (Body Mass Index)||kg/m^2|Median|18.3|18.3|Inter-Quartile Range|||17.2|22.7|
4138291|NCT00885703|3962644|B2|||BMI (Body Mass Index)||kg/m^2|Median|19.6|19.6|Inter-Quartile Range|||17.3|21.8|
4138292|NCT00885703|3962645|B1|||BMI (Body Mass Index)||kg/m^2|Median|17.2|17.2|Inter-Quartile Range|||15.6|19.6|
4138293|NCT00885703|3962638|B8|||Weight||kilograms|Median|52.0|52.0|Inter-Quartile Range|||44.7|59.3|
4138294|NCT00885703|3962639|B7|||Weight||kilograms|Median|52.5|52.5|Inter-Quartile Range|||48.5|60.1|
4138295|NCT00885703|3962640|B6|||Weight||kilograms|Median|55.0|55.0|Inter-Quartile Range|||51.6|59.1|
4138296|NCT00885703|3962641|B5|||Weight||kilograms|Median|49.8|49.8|Inter-Quartile Range|||44.5|60.0|
4138297|NCT00885703|3962642|B4|||Weight||kilograms|Median|56.8|56.8|Inter-Quartile Range|||47.5|64.1|
4138298|NCT00885703|3962643|B3|||Weight||kilograms|Median|51.9|51.9|Inter-Quartile Range|||43.5|58.5|
4138299|NCT00885703|3962644|B2|||Weight||kilograms|Median|50.5|50.5|Inter-Quartile Range|||44.0|65.0|
4138300|NCT00885703|3962645|B1|||Weight||kilograms|Median|46.5|46.5|Inter-Quartile Range|||42.0|52.2|
4138301|NCT00885703|3962638|B8|India||Region of Enrollment||participants|Number|9|9.0||||||
4138302|NCT00885703|3962639|B7|India||Region of Enrollment||participants|Number|0|0.0||||||
4138303|NCT00885703|3962640|B6|India||Region of Enrollment||participants|Number|0|0.0||||||
4138304|NCT00885703|3962641|B5|India||Region of Enrollment||participants|Number|0|0.0||||||
4138305|NCT00885703|3962642|B4|India||Region of Enrollment||participants|Number|3|3.0||||||
4138306|NCT00885703|3962643|B3|India||Region of Enrollment||participants|Number|0|0.0||||||
4138307|NCT00885703|3962644|B2|India||Region of Enrollment||participants|Number|1|1.0||||||
4138308|NCT00885703|3962645|B1|India||Region of Enrollment||participants|Number|5|5.0||||||
4138309|NCT00885703|3962638|B8|Peru||Region of Enrollment||participants|Number|6|6.0||||||
4138310|NCT00885703|3962639|B7|Peru||Region of Enrollment||participants|Number|1|1.0||||||
4138311|NCT00885703|3962640|B6|Peru||Region of Enrollment||participants|Number|1|1.0||||||
4138312|NCT00885703|3962641|B5|Peru||Region of Enrollment||participants|Number|0|0.0||||||
4138313|NCT00885703|3962642|B4|Peru||Region of Enrollment||participants|Number|0|0.0||||||
4138314|NCT00885703|3962643|B3|Peru||Region of Enrollment||participants|Number|0|0.0||||||
4138315|NCT00885703|3962644|B2|Peru||Region of Enrollment||participants|Number|4|4.0||||||
4138316|NCT00885703|3962645|B1|Peru||Region of Enrollment||participants|Number|0|0.0||||||
4138317|NCT00885703|3962638|B8|Thailand||Region of Enrollment||participants|Number|6|6.0||||||
4138318|NCT00885703|3962639|B7|Thailand||Region of Enrollment||participants|Number|0|0.0||||||
4138319|NCT00885703|3962640|B6|Thailand||Region of Enrollment||participants|Number|0|0.0||||||
4138320|NCT00885703|3962641|B5|Thailand||Region of Enrollment||participants|Number|0|0.0||||||
4138321|NCT00885703|3962642|B4|Thailand||Region of Enrollment||participants|Number|1|1.0||||||
4138322|NCT00885703|3962643|B3|Thailand||Region of Enrollment||participants|Number|0|0.0||||||
4138323|NCT00885703|3962644|B2|Thailand||Region of Enrollment||participants|Number|0|0.0||||||
4138324|NCT00885703|3962645|B1|Thailand||Region of Enrollment||participants|Number|5|5.0||||||
4138325|NCT00885703|3962638|B8|Kenya||Region of Enrollment||participants|Number|42|42.0||||||
4138326|NCT00885703|3962639|B7|Kenya||Region of Enrollment||participants|Number|2|2.0||||||
4138327|NCT00885703|3962640|B6|Kenya||Region of Enrollment||participants|Number|6|6.0||||||
4138328|NCT00885703|3962641|B5|Kenya||Region of Enrollment||participants|Number|4|4.0||||||
4138329|NCT00885703|3962642|B4|Kenya||Region of Enrollment||participants|Number|6|6.0||||||
4138330|NCT00885703|3962643|B3|Kenya||Region of Enrollment||participants|Number|7|7.0||||||
4138331|NCT00885703|3962644|B2|Kenya||Region of Enrollment||participants|Number|9|9.0||||||
4138332|NCT00885703|3962645|B1|Kenya||Region of Enrollment||participants|Number|8|8.0||||||
4138333|NCT00885703|3962638|B8|Zimbabwe||Region of Enrollment||participants|Number|18|18.0||||||
4138334|NCT00885703|3962639|B7|Zimbabwe||Region of Enrollment||participants|Number|3|3.0||||||
4138335|NCT00885703|3962640|B6|Zimbabwe||Region of Enrollment||participants|Number|1|1.0||||||
4138336|NCT00885703|3962641|B5|Zimbabwe||Region of Enrollment||participants|Number|4|4.0||||||
4138337|NCT00885703|3962642|B4|Zimbabwe||Region of Enrollment||participants|Number|3|3.0||||||
4138338|NCT00885703|3962643|B3|Zimbabwe||Region of Enrollment||participants|Number|1|1.0||||||
4138339|NCT00885703|3962644|B2|Zimbabwe||Region of Enrollment||participants|Number|4|4.0||||||
4138340|NCT00885703|3962645|B1|Zimbabwe||Region of Enrollment||participants|Number|2|2.0||||||
4138341|NCT00885703|3962638|B8|Uganda||Region of Enrollment||participants|Number|57|57.0||||||
4138342|NCT00885703|3962639|B7|Uganda||Region of Enrollment||participants|Number|12|12.0||||||
4138343|NCT00885703|3962640|B6|Uganda||Region of Enrollment||participants|Number|13|13.0||||||
4138344|NCT00885703|3962641|B5|Uganda||Region of Enrollment||participants|Number|14|14.0||||||
4138345|NCT00885703|3962642|B4|Uganda||Region of Enrollment||participants|Number|5|5.0||||||
4138346|NCT00885703|3962643|B3|Uganda||Region of Enrollment||participants|Number|11|11.0||||||
4138347|NCT00885703|3962644|B2|Uganda||Region of Enrollment||participants|Number|2|2.0||||||
4138348|NCT00885703|3962645|B1|Uganda||Region of Enrollment||participants|Number|0|0.0||||||
4138349|NCT00885703|3962638|B8|South Africa||Region of Enrollment||participants|Number|26|26.0||||||
4138350|NCT00885703|3962639|B7|South Africa||Region of Enrollment||participants|Number|6|6.0||||||
4138351|NCT00885703|3962640|B6|South Africa||Region of Enrollment||participants|Number|3|3.0||||||
4138352|NCT00885703|3962641|B5|South Africa||Region of Enrollment||participants|Number|2|2.0||||||
4138353|NCT00885703|3962642|B4|South Africa||Region of Enrollment||participants|Number|5|5.0||||||
4138354|NCT00885703|3962643|B3|South Africa||Region of Enrollment||participants|Number|3|3.0||||||
4138355|NCT00885703|3962644|B2|South Africa||Region of Enrollment||participants|Number|6|6.0||||||
4138356|NCT00885703|3962645|B1|South Africa||Region of Enrollment||participants|Number|1|1.0||||||
4138357|NCT00885703|3962638|B8|United States||Region of Enrollment||participants|Number|4|4.0||||||
4138358|NCT00885703|3962639|B7|United States||Region of Enrollment||participants|Number|0|0.0||||||
4138359|NCT00885703|3962640|B6|United States||Region of Enrollment||participants|Number|0|0.0||||||
4138360|NCT00885703|3962641|B5|United States||Region of Enrollment||participants|Number|0|0.0||||||
4138361|NCT00885703|3962642|B4|United States||Region of Enrollment||participants|Number|1|1.0||||||
4138362|NCT00885703|3962643|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4138363|NCT00885703|3962644|B2|United States||Region of Enrollment||participants|Number|0|0.0||||||
4138364|NCT00885703|3962645|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4138365|NCT00885703|3962638|B8|Asian, Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
4138366|NCT00885703|3962639|B7|Asian, Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4138367|NCT00885703|3962640|B6|Asian, Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4138368|NCT00885703|3962641|B5|Asian, Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4138369|NCT00885703|3962642|B4|Asian, Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4138370|NCT00885703|3962643|B3|Asian, Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4138371|NCT00885703|3962644|B2|Asian, Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4138372|NCT00885703|3962645|B1|Asian, Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4138373|NCT00885703|3962638|B8|Hispanic (regardless of Race)||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4138374|NCT00885703|3962639|B7|Hispanic (regardless of Race)||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4138375|NCT00885703|3962640|B6|Hispanic (regardless of Race)||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4138376|NCT00885703|3962641|B5|Hispanic (regardless of Race)||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4138377|NCT00885703|3962642|B4|Hispanic (regardless of Race)||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4138378|NCT00885703|3962643|B3|Hispanic (regardless of Race)||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4138379|NCT00885703|3962644|B2|Hispanic (regardless of Race)||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4138380|NCT00885703|3962645|B1|Hispanic (regardless of Race)||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4138381|NCT00885703|3962638|B8|Black Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|143|143.0||||||
4138382|NCT00885703|3962639|B7|Black Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
4138383|NCT00885703|3962640|B6|Black Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
4138384|NCT00885703|3962641|B5|Black Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
4138385|NCT00885703|3962642|B4|Black Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
4138386|NCT00885703|3962643|B3|Black Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
4138387|NCT00885703|3962644|B2|Black Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
4138388|NCT00885703|3962645|B1|Black Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4138389|NCT00885703|3962638|B8||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4138390|NCT00885703|3962639|B7||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4138391|NCT00885703|3962640|B6||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4138392|NCT00885703|3962641|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4138393|NCT00885703|3962642|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4138394|NCT00885703|3962643|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4138395|NCT00885703|3962644|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4138396|NCT00885703|3962645|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4138397|NCT00885703|3962638|B8||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4138398|NCT00885703|3962639|B7||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4138399|NCT00885703|3962640|B6||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4138400|NCT00885703|3962641|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4138401|NCT00885703|3962642|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4138402|NCT00885703|3962643|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4138403|NCT00885703|3962644|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4138404|NCT00885703|3962645|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4138405|NCT00885703|3962638|B8|||Age||years|Median|36|36.0|Inter-Quartile Range|||30.0|41.0|
4138406|NCT00885703|3962639|B7|||Age||years|Median|37.5|37.5|Inter-Quartile Range|||34.0|40.0|
4138407|NCT00885703|3962640|B6|||Age||years|Median|33.5|33.5|Inter-Quartile Range|||29.0|38.0|
4138408|NCT00885703|3962641|B5|||Age||years|Median|32.5|32.5|Inter-Quartile Range|||29.5|35.5|
4138409|NCT00885703|3962642|B4|||Age||years|Median|35.5|35.5|Inter-Quartile Range|||30.0|41.0|
4138410|NCT00885703|3962643|B3|||Age||years|Median|38|38.0|Inter-Quartile Range|||31.0|48.0|
4138411|NCT00885703|3962644|B2|||Age||years|Median|33|33.0|Inter-Quartile Range|||28.0|39.0|
4138412|NCT00885703|3962645|B1|||Age||years|Median|40.5|40.5|Inter-Quartile Range|||36.0|47.0|
4138413|NCT00885677|3962707|B3|||LVEF||%|Mean|27.3|27.3|Standard Deviation|6.3|6.3|||
4138414|NCT00885677|3962708|B2|||LVEF||%|Mean|27.4|27.4|Standard Deviation|6.0|6.0|||
4138415|NCT00885677|3962709|B1|||LVEF||%|Mean|27.3|27.3|Standard Deviation|6.6|6.6|||
4138416|NCT00885677|3962707|B3|Missing||History of Myocardial Infarction||participants|Number|14|14.0||||||
4138417|NCT00885677|3962708|B2|Missing||History of Myocardial Infarction||participants|Number|3|3.0||||||
4138418|NCT00885677|3962709|B1|Missing||History of Myocardial Infarction||participants|Number|11|11.0||||||
4138419|NCT00885677|3962707|B3|Without History of Myocardial Infarction||History of Myocardial Infarction||participants|Number|514|514.0||||||
4138420|NCT00885677|3962708|B2|Without History of Myocardial Infarction||History of Myocardial Infarction||participants|Number|252|252.0||||||
4138421|NCT00885677|3962709|B1|Without History of Myocardial Infarction||History of Myocardial Infarction||participants|Number|262|262.0||||||
4138422|NCT00885677|3962707|B3|With History of Myocardial Infarction||History of Myocardial Infarction||participants|Number|337|337.0||||||
4138423|NCT00885677|3962708|B2|With History of Myocardial Infarction||History of Myocardial Infarction||participants|Number|173|173.0||||||
4138424|NCT00885677|3962709|B1|With History of Myocardial Infarction||History of Myocardial Infarction||participants|Number|164|164.0||||||
4138425|NCT00885677|3962707|B3|Missing||History of AF||participants|Number|13|13.0||||||
4138426|NCT00885677|3962708|B2|Missing||History of AF||participants|Number|5|5.0||||||
4138427|NCT00885677|3962709|B1|Missing||History of AF||participants|Number|8|8.0||||||
4138428|NCT00885677|3962707|B3|No History of AF||History of AF||participants|Number|701|701.0||||||
4138429|NCT00885677|3962708|B2|No History of AF||History of AF||participants|Number|361|361.0||||||
4138430|NCT00885677|3962709|B1|No History of AF||History of AF||participants|Number|340|340.0||||||
4138431|NCT00885677|3962707|B3|History of AF||History of AF||participants|Number|151|151.0||||||
4138432|NCT00885677|3962708|B2|History of AF||History of AF||participants|Number|62|62.0||||||
4138433|NCT00885677|3962709|B1|History of AF||History of AF||participants|Number|89|89.0||||||
4138434|NCT00885677|3962707|B3|Spain||Region of Enrollment||participants|Number|89|89.0||||||
4138435|NCT00885677|3962708|B2|Spain||Region of Enrollment||participants|Number|43|43.0||||||
4138436|NCT00885677|3962709|B1|Spain||Region of Enrollment||participants|Number|46|46.0||||||
4138437|NCT00885677|3962707|B3|Switzerland||Region of Enrollment||participants|Number|68|68.0||||||
4138438|NCT00885677|3962708|B2|Switzerland||Region of Enrollment||participants|Number|33|33.0||||||
4138439|NCT00885677|3962709|B1|Switzerland||Region of Enrollment||participants|Number|35|35.0||||||
4138440|NCT00885677|3962707|B3|France||Region of Enrollment||participants|Number|162|162.0||||||
4138441|NCT00885677|3962708|B2|France||Region of Enrollment||participants|Number|77|77.0||||||
4138442|NCT00885677|3962709|B1|France||Region of Enrollment||participants|Number|85|85.0||||||
4138443|NCT00885677|3962707|B3|Slovakia||Region of Enrollment||participants|Number|23|23.0||||||
4138444|NCT00885677|3962708|B2|Slovakia||Region of Enrollment||participants|Number|11|11.0||||||
4138445|NCT00885677|3962709|B1|Slovakia||Region of Enrollment||participants|Number|12|12.0||||||
4138446|NCT00885677|3962707|B3|Israel||Region of Enrollment||participants|Number|6|6.0||||||
4138447|NCT00885677|3962708|B2|Israel||Region of Enrollment||participants|Number|3|3.0||||||
4138448|NCT00885677|3962709|B1|Israel||Region of Enrollment||participants|Number|3|3.0||||||
4138449|NCT00885677|3962707|B3|Italy||Region of Enrollment||participants|Number|456|456.0||||||
4138450|NCT00885677|3962708|B2|Italy||Region of Enrollment||participants|Number|231|231.0||||||
4138451|NCT00885677|3962709|B1|Italy||Region of Enrollment||participants|Number|225|225.0||||||
4138452|NCT00885677|3962707|B3|Hungary||Region of Enrollment||participants|Number|12|12.0||||||
4138453|NCT00885677|3962708|B2|Hungary||Region of Enrollment||participants|Number|6|6.0||||||
4138454|NCT00885677|3962709|B1|Hungary||Region of Enrollment||participants|Number|6|6.0||||||
4138455|NCT00885677|3962707|B3|Netherlands||Region of Enrollment||participants|Number|9|9.0||||||
4138456|NCT00885677|3962708|B2|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
4138457|NCT00885677|3962709|B1|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
4138458|NCT00885677|3962707|B3|Greece||Region of Enrollment||participants|Number|40|40.0||||||
4138459|NCT00885677|3962708|B2|Greece||Region of Enrollment||participants|Number|19|19.0||||||
4138460|NCT00885677|3962709|B1|Greece||Region of Enrollment||participants|Number|21|21.0||||||
4138461|NCT00885677|3962707|B3||Male|Sex: Female, Male||Participants|Count of Participants|654|654.0||||||
4138462|NCT00885677|3962708|B2||Male|Sex: Female, Male||Participants|Count of Participants|312|312.0||||||
4138463|NCT00885677|3962709|B1||Male|Sex: Female, Male||Participants|Count of Participants|342|342.0||||||
4138464|NCT00885677|3962707|B3||Female|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4138465|NCT00885677|3962708|B2||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4138466|NCT00885677|3962709|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4138467|NCT00885677|3962707|B3|||Age||years|Mean|66|66.0|Standard Deviation|10|10.0|||
4138468|NCT00885677|3962708|B2|||Age||years|Mean|67|67.0|Standard Deviation|10|10.0|||
4138469|NCT00885677|3962709|B1|||Age||years|Mean|66|66.0|Standard Deviation|11|11.0|||
4138470|NCT00885638|3962718|B1|Sweden||Region of Enrollment||participants|Number|12|12.0||||||
4138471|NCT00885638|3962718|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4138472|NCT00885638|3962718|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4138473|NCT00885638|3962718|B1|||Age||years|Mean|22.5|22.5|Standard Deviation|1.9|1.9|||
4138474|NCT00885638|3962718|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4138475|NCT00885638|3962718|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4138476|NCT00885638|3962718|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4138477|NCT00885534|3962726|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4138478|NCT00885534|3962726|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4138479|NCT00885534|3962726|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4138480|NCT00885534|3962726|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4138481|NCT00885534|3962726|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4138482|NCT00885482|3962730|B1|Italy||Region of Enrollment||participants|Number|40|40.0||||||
4138483|NCT00885482|3962730|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4138484|NCT00885482|3962730|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4138485|NCT00885482|3962730|B1|||Age||years|Mean|47|47.0|Standard Deviation|9|9.0|||
4138486|NCT00885482|3962730|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4138487|NCT00885482|3962730|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4138488|NCT00885482|3962730|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4138489|NCT00885378|3962734|B3|||Mean Metformin Dose at Baseline||mg|Mean|1881.6|1881.6|Standard Deviation|352.38|352.38|||
4138490|NCT00885378|3962735|B2|||Mean Metformin Dose at Baseline||mg|Mean|1855.8|1855.8|Standard Deviation|330.19|330.19|||
4138491|NCT00885378|3962736|B1|||Mean Metformin Dose at Baseline||mg|Mean|1911.5|1911.5|Standard Deviation|376.59|376.59|||
4138492|NCT00885378|3962734|B3|||Mean Duration of Type 2 Diabetes Mellitus|Mean time since the time of diagnosis of Type 2 Diabetes Mellitus.|Years|Mean|6.00|6.0|Standard Deviation|5.30|5.3|||
4138493|NCT00885378|3962735|B2|||Mean Duration of Type 2 Diabetes Mellitus|Mean time since the time of diagnosis of Type 2 Diabetes Mellitus.|Years|Mean|6.17|6.17|Standard Deviation|4.21|4.21|||
4138494|NCT00885378|3962736|B1|||Mean Duration of Type 2 Diabetes Mellitus|Mean time since the time of diagnosis of Type 2 Diabetes Mellitus.|Years|Mean|5.81|5.81|Standard Deviation|6.37|6.37|||
4138495|NCT00885378|3962734|B3|>= 30 kg / m^2||Participant Body Mass Index||Participants|Number|106|106.0||||||
4138496|NCT00885378|3962735|B2|>= 30 kg / m^2||Participant Body Mass Index||Participants|Number|51|51.0||||||
4138497|NCT00885378|3962736|B1|>= 30 kg / m^2||Participant Body Mass Index||Participants|Number|55|55.0||||||
4138498|NCT00885378|3962734|B3|< 30 kg / m^2||Participant Body Mass Index||Participants|Number|54|54.0||||||
4138499|NCT00885378|3962735|B2|< 30 kg / m^2||Participant Body Mass Index||Participants|Number|35|35.0||||||
4138500|NCT00885378|3962736|B1|< 30 kg / m^2||Participant Body Mass Index||Participants|Number|19|19.0||||||
4138501|NCT00885378|3962734|B3|||Mean Body Mass Index (BMI)||kg / m^2|Mean|33.05|33.05|Standard Deviation|6.08|6.08|||
4138502|NCT00885378|3962735|B2|||Mean Body Mass Index (BMI)||kg / m^2|Mean|32.51|32.51|Standard Deviation|6.18|6.18|||
4138503|NCT00885378|3962736|B1|||Mean Body Mass Index (BMI)||kg / m^2|Mean|33.68|33.68|Standard Deviation|5.94|5.94|||
4138504|NCT00885378|3962734|B3|||Mean Weight||kg|Mean|93.64|93.64|Standard Deviation|20.63|20.63|||
4138505|NCT00885378|3962735|B2|||Mean Weight||kg|Mean|91.74|91.74|Standard Deviation|19.87|19.87|||
4138506|NCT00885378|3962736|B1|||Mean Weight||kg|Mean|95.85|95.85|Standard Deviation|21.40|21.4|||
4138507|NCT00885378|3962734|B3|||Mean Height||cm|Mean|168.05|168.05|Standard Deviation|9.23|9.23|||
4138508|NCT00885378|3962735|B2|||Mean Height||cm|Mean|167.77|167.77|Standard Deviation|8.99|8.99|||
4138509|NCT00885378|3962736|B1|||Mean Height||cm|Mean|168.38|168.38|Standard Deviation|9.56|9.56|||
4138510|NCT00885378|3962734|B3|Germany||Region of Enrollment||participants|Number|21|21.0||||||
4138511|NCT00885378|3962735|B2|Germany||Region of Enrollment||participants|Number|12|12.0||||||
4138512|NCT00885378|3962736|B1|Germany||Region of Enrollment||participants|Number|9|9.0||||||
4138513|NCT00885378|3962734|B3|Puerto Rico||Region of Enrollment||participants|Number|18|18.0||||||
4138514|NCT00885378|3962735|B2|Puerto Rico||Region of Enrollment||participants|Number|10|10.0||||||
4138515|NCT00885378|3962736|B1|Puerto Rico||Region of Enrollment||participants|Number|8|8.0||||||
4138516|NCT00885378|3962734|B3|Hungary||Region of Enrollment||participants|Number|16|16.0||||||
4138517|NCT00885378|3962735|B2|Hungary||Region of Enrollment||participants|Number|8|8.0||||||
4138518|NCT00885378|3962736|B1|Hungary||Region of Enrollment||participants|Number|8|8.0||||||
4138519|NCT00885378|3962734|B3|United States||Region of Enrollment||participants|Number|105|105.0||||||
4138520|NCT00885378|3962735|B2|United States||Region of Enrollment||participants|Number|56|56.0||||||
4138521|NCT00885378|3962736|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
4138522|NCT00885378|3962734|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4138523|NCT00885378|3962735|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4138524|NCT00885378|3962736|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4138525|NCT00885378|3962734|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4138526|NCT00885378|3962735|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4138527|NCT00885378|3962736|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4138528|NCT00885378|3962734|B3||White|Race (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
4138529|NCT00885378|3962735|B2||White|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
4138530|NCT00885378|3962736|B1||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4138531|NCT00885378|3962734|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4138532|NCT00885378|3962735|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4138533|NCT00885378|3962736|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4138534|NCT00885378|3962734|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4138535|NCT00885378|3962735|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4138536|NCT00885378|3962736|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4138537|NCT00885378|3962734|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4138538|NCT00885378|3962735|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4138539|NCT00885378|3962736|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4138540|NCT00885378|3962734|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4138541|NCT00885378|3962735|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4138542|NCT00885378|3962736|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4138543|NCT00885378|3962734|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4138544|NCT00885378|3962735|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4138545|NCT00885378|3962736|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4138546|NCT00885378|3962734|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4138547|NCT00885378|3962735|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4138548|NCT00885378|3962736|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4138549|NCT00885378|3962734|B3|||Age||years|Mean|55.4|55.4|Standard Deviation|10.20|10.2|||
4138550|NCT00885378|3962735|B2|||Age||years|Mean|56.60|56.6|Standard Deviation|9.97|9.97|||
4138551|NCT00885378|3962736|B1|||Age||years|Mean|53.90|53.9|Standard Deviation|10.35|10.35|||
4138552|NCT00885365|3962765|B3|No||Use of rhDNase|Baseline use of rhDNase is set to 'Yes' if a patient has used rhDNase on the same date or within the 10 days prior to start of study drug administration. If the timing of rhDNase use cannot be identified because of missing date, then the use of rhDNase at baseline is considered as 'Yes'.|participants|Number|95|95.0||||||
4138553|NCT00885365|3962766|B2|No||Use of rhDNase|Baseline use of rhDNase is set to 'Yes' if a patient has used rhDNase on the same date or within the 10 days prior to start of study drug administration. If the timing of rhDNase use cannot be identified because of missing date, then the use of rhDNase at baseline is considered as 'Yes'.|participants|Number|49|49.0||||||
4138554|NCT00885365|3962767|B1|No||Use of rhDNase|Baseline use of rhDNase is set to 'Yes' if a patient has used rhDNase on the same date or within the 10 days prior to start of study drug administration. If the timing of rhDNase use cannot be identified because of missing date, then the use of rhDNase at baseline is considered as 'Yes'.|participants|Number|46|46.0||||||
4138555|NCT00885365|3962765|B3|Yes||Use of rhDNase|Baseline use of rhDNase is set to 'Yes' if a patient has used rhDNase on the same date or within the 10 days prior to start of study drug administration. If the timing of rhDNase use cannot be identified because of missing date, then the use of rhDNase at baseline is considered as 'Yes'.|participants|Number|229|229.0||||||
4138556|NCT00885365|3962766|B2|Yes||Use of rhDNase|Baseline use of rhDNase is set to 'Yes' if a patient has used rhDNase on the same date or within the 10 days prior to start of study drug administration. If the timing of rhDNase use cannot be identified because of missing date, then the use of rhDNase at baseline is considered as 'Yes'.|participants|Number|119|119.0||||||
4138604|NCT00885365|3962766|B2|6-12 years||Age, Customized||participants|Number|54|54.0||||||
4138605|NCT00885365|3962767|B1|6-12 years||Age, Customized||participants|Number|49|49.0||||||
4138557|NCT00885365|3962767|B1|Yes||Use of rhDNase|Baseline use of rhDNase is set to 'Yes' if a patient has used rhDNase on the same date or within the 10 days prior to start of study drug administration. If the timing of rhDNase use cannot be identified because of missing date, then the use of rhDNase at baseline is considered as 'Yes'.|participants|Number|110|110.0||||||
4138558|NCT00885365|3962765|B3|>=50 % predicted||Forced Expiratory Volume in 1 second (FEV1)||participants|Number|249|249.0||||||
4138559|NCT00885365|3962766|B2|>=50 % predicted||Forced Expiratory Volume in 1 second (FEV1)||participants|Number|130|130.0||||||
4138560|NCT00885365|3962767|B1|>=50 % predicted||Forced Expiratory Volume in 1 second (FEV1)||participants|Number|119|119.0||||||
4138561|NCT00885365|3962765|B3|<50 % predicted||Forced Expiratory Volume in 1 second (FEV1)||participants|Number|75|75.0||||||
4138562|NCT00885365|3962766|B2|<50 % predicted||Forced Expiratory Volume in 1 second (FEV1)||participants|Number|38|38.0||||||
4138563|NCT00885365|3962767|B1|<50 % predicted||Forced Expiratory Volume in 1 second (FEV1)||participants|Number|37|37.0||||||
4138564|NCT00885365|3962765|B3|Missing||Tobramycin Minimal Inhibitory Concentration (MIC) value|MIC is the lowest concentration of tobramycin that completely inhibits visible growth of a micro-organism.|participants|Number|1|1.0||||||
4138565|NCT00885365|3962766|B2|Missing||Tobramycin Minimal Inhibitory Concentration (MIC) value|MIC is the lowest concentration of tobramycin that completely inhibits visible growth of a micro-organism.|participants|Number|1|1.0||||||
4138566|NCT00885365|3962767|B1|Missing||Tobramycin Minimal Inhibitory Concentration (MIC) value|MIC is the lowest concentration of tobramycin that completely inhibits visible growth of a micro-organism.|participants|Number|0|0.0||||||
4138567|NCT00885365|3962765|B3|>=16 mcg/mL||Tobramycin Minimal Inhibitory Concentration (MIC) value|MIC is the lowest concentration of tobramycin that completely inhibits visible growth of a micro-organism.|participants|Number|21|21.0||||||
4138568|NCT00885365|3962766|B2|>=16 mcg/mL||Tobramycin Minimal Inhibitory Concentration (MIC) value|MIC is the lowest concentration of tobramycin that completely inhibits visible growth of a micro-organism.|participants|Number|8|8.0||||||
4138569|NCT00885365|3962767|B1|>=16 mcg/mL||Tobramycin Minimal Inhibitory Concentration (MIC) value|MIC is the lowest concentration of tobramycin that completely inhibits visible growth of a micro-organism.|participants|Number|13|13.0||||||
4138570|NCT00885365|3962765|B3|<16 mcg/mL||Tobramycin Minimal Inhibitory Concentration (MIC) value|MIC is the lowest concentration of tobramycin that completely inhibits visible growth of a micro-organism.|participants|Number|302|302.0||||||
4138571|NCT00885365|3962766|B2|<16 mcg/mL||Tobramycin Minimal Inhibitory Concentration (MIC) value|MIC is the lowest concentration of tobramycin that completely inhibits visible growth of a micro-organism.|participants|Number|159|159.0||||||
4138572|NCT00885365|3962767|B1|<16 mcg/mL||Tobramycin Minimal Inhibitory Concentration (MIC) value|MIC is the lowest concentration of tobramycin that completely inhibits visible growth of a micro-organism.|participants|Number|143|143.0||||||
4138573|NCT00885365|3962765|B3|||Time from first Cystic Fibrosis diagnosis||years|Mean|11.94|11.94|Standard Deviation|6.34|6.34|||
4138574|NCT00885365|3962766|B2|||Time from first Cystic Fibrosis diagnosis||years|Mean|11.74|11.74|Standard Deviation|6.55|6.55|||
4138575|NCT00885365|3962767|B1|||Time from first Cystic Fibrosis diagnosis||years|Mean|12.16|12.16|Standard Deviation|6.13|6.13|||
4138576|NCT00885365|3962765|B3|||Time from diagnosis of chronic colonization of P. aeruginosa||years|Mean|2.31|2.31|Standard Deviation|4.22|4.22|||
4138577|NCT00885365|3962766|B2|||Time from diagnosis of chronic colonization of P. aeruginosa||years|Mean|2.36|2.36|Standard Deviation|4.23|4.23|||
4138578|NCT00885365|3962767|B1|||Time from diagnosis of chronic colonization of P. aeruginosa||years|Mean|2.27|2.27|Standard Deviation|4.22|4.22|||
4138579|NCT00885365|3962765|B3|||Body Mass Index||kilograms/meters^2|Mean|17.68|17.68|Standard Deviation|3.22|3.22|||
4138580|NCT00885365|3962766|B2|||Body Mass Index||kilograms/meters^2|Mean|17.79|17.79|Standard Deviation|3.32|3.32|||
4138581|NCT00885365|3962767|B1|||Body Mass Index||kilograms/meters^2|Mean|17.55|17.55|Standard Deviation|3.12|3.12|||
4138582|NCT00885365|3962765|B3|||Weight||kilograms|Mean|43.25|43.25|Standard Deviation|15.69|15.69|||
4138583|NCT00885365|3962766|B2|||Weight||kilograms|Mean|43.81|43.81|Standard Deviation|16.39|16.39|||
4138584|NCT00885365|3962767|B1|||Weight||kilograms|Mean|42.64|42.64|Standard Deviation|14.92|14.92|||
4138585|NCT00885365|3962765|B3|||Height||centimeters|Mean|153.24|153.24|Standard Deviation|18.66|18.66|||
4138586|NCT00885365|3962766|B2|||Height||centimeters|Mean|153.41|153.41|Standard Deviation|19.88|19.88|||
4138587|NCT00885365|3962767|B1|||Height||centimeters|Mean|153.05|153.05|Standard Deviation|17.31|17.31|||
4138588|NCT00885365|3962765|B3|White||Race/Ethnicity, Customized||participants|Number|324|324.0||||||
4138589|NCT00885365|3962766|B2|White||Race/Ethnicity, Customized||participants|Number|168|168.0||||||
4138590|NCT00885365|3962767|B1|White||Race/Ethnicity, Customized||participants|Number|156|156.0||||||
4138591|NCT00885365|3962765|B3||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4138592|NCT00885365|3962766|B2||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4138593|NCT00885365|3962767|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4138594|NCT00885365|3962765|B3||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4138595|NCT00885365|3962766|B2||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4138596|NCT00885365|3962767|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4138597|NCT00885365|3962765|B3|> 17 years||Age, Customized||participants|Number|109|109.0||||||
4138598|NCT00885365|3962766|B2|> 17 years||Age, Customized||participants|Number|52|52.0||||||
4138599|NCT00885365|3962767|B1|> 17 years||Age, Customized||participants|Number|57|57.0||||||
4138600|NCT00885365|3962765|B3|13-17 years||Age, Customized||participants|Number|112|112.0||||||
4138601|NCT00885365|3962766|B2|13-17 years||Age, Customized||participants|Number|62|62.0||||||
4138602|NCT00885365|3962767|B1|13-17 years||Age, Customized||participants|Number|50|50.0||||||
4138603|NCT00885365|3962765|B3|6-12 years||Age, Customized||participants|Number|103|103.0||||||
4138606|NCT00885365|3962765|B3|||Age||years|Mean|15.84|15.84|Standard Deviation|6.99|6.99|||
4138607|NCT00885365|3962766|B2|||Age||years|Mean|15.74|15.74|Standard Deviation|7.24|7.24|||
4138608|NCT00885365|3962767|B1|||Age||years|Mean|15.95|15.95|Standard Deviation|6.74|6.74|||
4138609|NCT00885352|3962802|B3|||Fasting plasma glucose (FPG)||mg/dL|Mean|176.5|176.5|Standard Deviation|41.7|41.7|||
4138610|NCT00885352|3962803|B2|||Fasting plasma glucose (FPG)||mg/dL|Mean|173.6|173.6|Standard Deviation|38.9|38.9|||
4138611|NCT00885352|3962804|B1|||Fasting plasma glucose (FPG)||mg/dL|Mean|179.3|179.3|Standard Deviation|44.3|44.3|||
4138612|NCT00885352|3962802|B3|||2-hour post-meal glucose (PMG)|Participant population included 147 sitagliptin participants and 147 placebo participants.|mg/dL|Mean|270.8|270.8|Standard Deviation|64.5|64.5|||
4138613|NCT00885352|3962803|B2|||2-hour post-meal glucose (PMG)|Participant population included 147 sitagliptin participants and 147 placebo participants.|mg/dL|Mean|266.0|266.0|Standard Deviation|62.4|62.4|||
4138614|NCT00885352|3962804|B1|||2-hour post-meal glucose (PMG)|Participant population included 147 sitagliptin participants and 147 placebo participants.|mg/dL|Mean|275.5|275.5|Standard Deviation|66.4|66.4|||
4138615|NCT00885352|3962802|B3|||Hemoglobin A1c (A1C)||Percent of gylcosylated hemoglobin|Mean|8.7|8.7|Standard Deviation|1.0|1.0|||
4138616|NCT00885352|3962803|B2|||Hemoglobin A1c (A1C)||Percent of gylcosylated hemoglobin|Mean|8.7|8.7|Standard Deviation|1.0|1.0|||
4138617|NCT00885352|3962804|B1|||Hemoglobin A1c (A1C)||Percent of gylcosylated hemoglobin|Mean|8.8|8.8|Standard Deviation|1.0|1.0|||
4138618|NCT00885352|3962802|B3||Male|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4138619|NCT00885352|3962803|B2||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4138620|NCT00885352|3962804|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4138621|NCT00885352|3962802|B3||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4138622|NCT00885352|3962803|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4138623|NCT00885352|3962804|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4138624|NCT00885352|3962802|B3|||Age||years|Mean|56.1|56.1|Standard Deviation|9.0|9.0|||
4138625|NCT00885352|3962803|B2|||Age||years|Mean|56.4|56.4|Standard Deviation|9.4|9.4|||
4138626|NCT00885352|3962804|B1|||Age||years|Mean|55.7|55.7|Standard Deviation|8.7|8.7|||
4138627|NCT00885170|3962815|B3|||Urine N-Telopeptides/Creatinine Ratio|u-NTx/Cr (nmol/mmol), Odanacatib 50 mg N=115, Placebo N=114, Total N=229|nmol/mmol|Mean|26.17|26.17|Standard Deviation|21.08|21.08|||
4138628|NCT00885170|3962816|B2|||Urine N-Telopeptides/Creatinine Ratio|u-NTx/Cr (nmol/mmol), Odanacatib 50 mg N=115, Placebo N=114, Total N=229|nmol/mmol|Mean|26.35|26.35|Standard Deviation|18.08|18.08|||
4138629|NCT00885170|3962817|B1|||Urine N-Telopeptides/Creatinine Ratio|u-NTx/Cr (nmol/mmol), Odanacatib 50 mg N=115, Placebo N=114, Total N=229|nmol/mmol|Mean|26.00|26.0|Standard Deviation|23.76|23.76|||
4138630|NCT00885170|3962815|B3|Serum N-propeptide, T1 collagen (115, 117, 232)||Baseline Biochemical Markers of Bone Resorption and Bone Formation||ng/mL|Mean|28.63|28.63|Standard Deviation|25.03|25.03|||
4138631|NCT00885170|3962816|B2|Serum N-propeptide, T1 collagen (115, 117, 232)||Baseline Biochemical Markers of Bone Resorption and Bone Formation||ng/mL|Mean|27.79|27.79|Standard Deviation|21.58|21.58|||
4138632|NCT00885170|3962817|B1|Serum N-propeptide, T1 collagen (115, 117, 232)||Baseline Biochemical Markers of Bone Resorption and Bone Formation||ng/mL|Mean|29.48|29.48|Standard Deviation|28.18|28.18|||
4138633|NCT00885170|3962815|B3|Serum bone specific alk. phosphatase (115,117,232)||Baseline Biochemical Markers of Bone Resorption and Bone Formation||ng/mL|Mean|9.35|9.35|Standard Deviation|4.39|4.39|||
4138634|NCT00885170|3962816|B2|Serum bone specific alk. phosphatase (115,117,232)||Baseline Biochemical Markers of Bone Resorption and Bone Formation||ng/mL|Mean|9.41|9.41|Standard Deviation|4.16|4.16|||
4138635|NCT00885170|3962817|B1|Serum bone specific alk. phosphatase (115,117,232)||Baseline Biochemical Markers of Bone Resorption and Bone Formation||ng/mL|Mean|9.28|9.28|Standard Deviation|4.63|4.63|||
4138636|NCT00885170|3962815|B3|C-telopeptides of Type 1 collage (116, 117,233)||Baseline Biochemical Markers of Bone Resorption and Bone Formation||ng/mL|Mean|0.19|0.19|Standard Deviation|0.19|0.19|||
4138637|NCT00885170|3962816|B2|C-telopeptides of Type 1 collage (116, 117,233)||Baseline Biochemical Markers of Bone Resorption and Bone Formation||ng/mL|Mean|0.18|0.18|Standard Deviation|0.14|0.14|||
4138638|NCT00885170|3962817|B1|C-telopeptides of Type 1 collage (116, 117,233)||Baseline Biochemical Markers of Bone Resorption and Bone Formation||ng/mL|Mean|0.19|0.19|Standard Deviation|0.22|0.22|||
4138639|NCT00885170|3962815|B3|1/3 Distal Forearm BMD T-score (114, 113, 227)||Baseline DEXA Areal Bone Mineral Density T-score|Dual-energy X-ray absorptiometry (DEXA), Bone Mineral Density (BMD), T-score. T-Score is the difference between the BMD value and the average bone mass for sex-matched, healthy young adults; the difference being expressed in number of standard deviations; T-score based upon the normative database in use by the manufactures. A T-score of -1.0 or above is considered normal. More negative numbers are more indicative of osteoporosis.|T-score|Mean|-2.65|-2.65|Standard Deviation|1.18|1.18|||
4138640|NCT00885170|3962816|B2|1/3 Distal Forearm BMD T-score (114, 113, 227)||Baseline DEXA Areal Bone Mineral Density T-score|Dual-energy X-ray absorptiometry (DEXA), Bone Mineral Density (BMD), T-score. T-Score is the difference between the BMD value and the average bone mass for sex-matched, healthy young adults; the difference being expressed in number of standard deviations; T-score based upon the normative database in use by the manufactures. A T-score of -1.0 or above is considered normal. More negative numbers are more indicative of osteoporosis.|T-score|Mean|-2.69|-2.69|Standard Deviation|1.10|1.1|||
4138641|NCT00885170|3962817|B1|1/3 Distal Forearm BMD T-score (114, 113, 227)||Baseline DEXA Areal Bone Mineral Density T-score|Dual-energy X-ray absorptiometry (DEXA), Bone Mineral Density (BMD), T-score. T-Score is the difference between the BMD value and the average bone mass for sex-matched, healthy young adults; the difference being expressed in number of standard deviations; T-score based upon the normative database in use by the manufactures. A T-score of -1.0 or above is considered normal. More negative numbers are more indicative of osteoporosis.|T-score|Mean|-2.62|-2.62|Standard Deviation|1.26|1.26|||
4138656|NCT00885170|3962817|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4138642|NCT00885170|3962815|B3|Lumbar Spine BMD T-score (113, 116, 229)||Baseline DEXA Areal Bone Mineral Density T-score|Dual-energy X-ray absorptiometry (DEXA), Bone Mineral Density (BMD), T-score. T-Score is the difference between the BMD value and the average bone mass for sex-matched, healthy young adults; the difference being expressed in number of standard deviations; T-score based upon the normative database in use by the manufactures. A T-score of -1.0 or above is considered normal. More negative numbers are more indicative of osteoporosis.|T-score|Mean|-2.41|-2.41|Standard Deviation|1.12|1.12|||
4138643|NCT00885170|3962816|B2|Lumbar Spine BMD T-score (113, 116, 229)||Baseline DEXA Areal Bone Mineral Density T-score|Dual-energy X-ray absorptiometry (DEXA), Bone Mineral Density (BMD), T-score. T-Score is the difference between the BMD value and the average bone mass for sex-matched, healthy young adults; the difference being expressed in number of standard deviations; T-score based upon the normative database in use by the manufactures. A T-score of -1.0 or above is considered normal. More negative numbers are more indicative of osteoporosis.|T-score|Mean|-2.49|-2.49|Standard Deviation|1.14|1.14|||
4138644|NCT00885170|3962817|B1|Lumbar Spine BMD T-score (113, 116, 229)||Baseline DEXA Areal Bone Mineral Density T-score|Dual-energy X-ray absorptiometry (DEXA), Bone Mineral Density (BMD), T-score. T-Score is the difference between the BMD value and the average bone mass for sex-matched, healthy young adults; the difference being expressed in number of standard deviations; T-score based upon the normative database in use by the manufactures. A T-score of -1.0 or above is considered normal. More negative numbers are more indicative of osteoporosis.|T-score|Mean|-2.34|-2.34|Standard Deviation|1.10|1.1|||
4138645|NCT00885170|3962815|B3|Total Hip BMD T-score (122, 121, 243)||Baseline DEXA Areal Bone Mineral Density T-score|Dual-energy X-ray absorptiometry (DEXA), Bone Mineral Density (BMD), T-score. T-Score is the difference between the BMD value and the average bone mass for sex-matched, healthy young adults; the difference being expressed in number of standard deviations; T-score based upon the normative database in use by the manufactures. A T-score of -1.0 or above is considered normal. More negative numbers are more indicative of osteoporosis.|T-score|Mean|-1.98|-1.98|Standard Deviation|0.65|0.65|||
4138646|NCT00885170|3962816|B2|Total Hip BMD T-score (122, 121, 243)||Baseline DEXA Areal Bone Mineral Density T-score|Dual-energy X-ray absorptiometry (DEXA), Bone Mineral Density (BMD), T-score. T-Score is the difference between the BMD value and the average bone mass for sex-matched, healthy young adults; the difference being expressed in number of standard deviations; T-score based upon the normative database in use by the manufactures. A T-score of -1.0 or above is considered normal. More negative numbers are more indicative of osteoporosis.|T-score|Mean|-2.05|-2.05|Standard Deviation|0.68|0.68|||
4138647|NCT00885170|3962817|B1|Total Hip BMD T-score (122, 121, 243)||Baseline DEXA Areal Bone Mineral Density T-score|Dual-energy X-ray absorptiometry (DEXA), Bone Mineral Density (BMD), T-score. T-Score is the difference between the BMD value and the average bone mass for sex-matched, healthy young adults; the difference being expressed in number of standard deviations; T-score based upon the normative database in use by the manufactures. A T-score of -1.0 or above is considered normal. More negative numbers are more indicative of osteoporosis.|T-score|Mean|-1.91|-1.91|Standard Deviation|0.62|0.62|||
4138648|NCT00885170|3962815|B3|Hip Trochanter BMD T-score (122, 121, 243)||Baseline DEXA Areal Bone Mineral Density T-score|Dual-energy X-ray absorptiometry (DEXA), Bone Mineral Density (BMD), T-score. T-Score is the difference between the BMD value and the average bone mass for sex-matched, healthy young adults; the difference being expressed in number of standard deviations; T-score based upon the normative database in use by the manufactures. A T-score of -1.0 or above is considered normal. More negative numbers are more indicative of osteoporosis.|T-score|Mean|-2.00|-2.0|Standard Deviation|0.75|0.75|||
4138649|NCT00885170|3962816|B2|Hip Trochanter BMD T-score (122, 121, 243)||Baseline DEXA Areal Bone Mineral Density T-score|Dual-energy X-ray absorptiometry (DEXA), Bone Mineral Density (BMD), T-score. T-Score is the difference between the BMD value and the average bone mass for sex-matched, healthy young adults; the difference being expressed in number of standard deviations; T-score based upon the normative database in use by the manufactures. A T-score of -1.0 or above is considered normal. More negative numbers are more indicative of osteoporosis.|T-score|Mean|-2.10|-2.1|Standard Deviation|0.79|0.79|||
4138650|NCT00885170|3962817|B1|Hip Trochanter BMD T-score (122, 121, 243)||Baseline DEXA Areal Bone Mineral Density T-score|Dual-energy X-ray absorptiometry (DEXA), Bone Mineral Density (BMD), T-score. T-Score is the difference between the BMD value and the average bone mass for sex-matched, healthy young adults; the difference being expressed in number of standard deviations; T-score based upon the normative database in use by the manufactures. A T-score of -1.0 or above is considered normal. More negative numbers are more indicative of osteoporosis.|T-score|Mean|-1.91|-1.91|Standard Deviation|0.70|0.7|||
4138651|NCT00885170|3962815|B3|Femoral Neck BMD T-score (122, 121, 243)||Baseline DEXA Areal Bone Mineral Density T-score|Dual-energy X-ray absorptiometry (DEXA), Bone Mineral Density (BMD), T-score. T-Score is the difference between the BMD value and the average bone mass for sex-matched, healthy young adults; the difference being expressed in number of standard deviations; T-score based upon the normative database in use by the manufactures. A T-score of -1.0 or above is considered normal. More negative numbers are more indicative of osteoporosis.|T-score|Mean|-2.36|-2.36|Standard Deviation|0.50|0.5|||
4138652|NCT00885170|3962816|B2|Femoral Neck BMD T-score (122, 121, 243)||Baseline DEXA Areal Bone Mineral Density T-score|Dual-energy X-ray absorptiometry (DEXA), Bone Mineral Density (BMD), T-score. T-Score is the difference between the BMD value and the average bone mass for sex-matched, healthy young adults; the difference being expressed in number of standard deviations; T-score based upon the normative database in use by the manufactures. A T-score of -1.0 or above is considered normal. More negative numbers are more indicative of osteoporosis.|T-score|Mean|-2.38|-2.38|Standard Deviation|0.48|0.48|||
4138653|NCT00885170|3962817|B1|Femoral Neck BMD T-score (122, 121, 243)||Baseline DEXA Areal Bone Mineral Density T-score|Dual-energy X-ray absorptiometry (DEXA), Bone Mineral Density (BMD), T-score. T-Score is the difference between the BMD value and the average bone mass for sex-matched, healthy young adults; the difference being expressed in number of standard deviations; T-score based upon the normative database in use by the manufactures. A T-score of -1.0 or above is considered normal. More negative numbers are more indicative of osteoporosis.|T-score|Mean|-2.35|-2.35|Standard Deviation|0.52|0.52|||
4138654|NCT00885170|3962815|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4138655|NCT00885170|3962816|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4138657|NCT00885170|3962815|B3||Female|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
4138658|NCT00885170|3962816|B2||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4138659|NCT00885170|3962817|B1||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4138660|NCT00885170|3962815|B3|||Age||Years|Mean|71.3|71.3|Standard Deviation|6.8|6.8|||
4138661|NCT00885170|3962816|B2|||Age||Years|Mean|71.1|71.1|Standard Deviation|6.8|6.8|||
4138662|NCT00885170|3962817|B1|||Age||Years|Mean|71.5|71.5|Standard Deviation|6.7|6.7|||
4138663|NCT00885118|3962872|B6||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4138664|NCT00885118|3962873|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4138665|NCT00885118|3962874|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4138666|NCT00885118|3962875|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4138667|NCT00885118|3962876|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4138668|NCT00885118|3962877|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4138669|NCT00885118|3962872|B6||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4138670|NCT00885118|3962873|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4138671|NCT00885118|3962874|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4138672|NCT00885118|3962875|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4138673|NCT00885118|3962876|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4138674|NCT00885118|3962877|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4138675|NCT00885118|3962872|B6|||Age||years|Mean|57.2|57.2|Standard Deviation|9.2|9.2|||
4138676|NCT00885118|3962873|B5|||Age||years|Mean|60.8|60.8|Standard Deviation|8.7|8.7|||
4138677|NCT00885118|3962874|B4|||Age||years|Mean|55.8|55.8|Standard Deviation|8.0|8.0|||
4138678|NCT00885118|3962875|B3|||Age||years|Mean|53.9|53.9|Standard Deviation|9.9|9.9|||
4138679|NCT00885118|3962876|B2|||Age||years|Mean|58.6|58.6|Standard Deviation|8.2|8.2|||
4138680|NCT00885118|3962877|B1|||Age||years|Mean|57.2|57.2|Standard Deviation|10.0|10.0|||
4138681|NCT00885105|3963018|B3|United States||Region of Enrollment||participants|Number|242|242.0||||||
4138682|NCT00885105|3963019|B2|United States||Region of Enrollment||participants|Number|130|130.0||||||
4138683|NCT00885105|3963020|B1|United States||Region of Enrollment||participants|Number|112|112.0||||||
4138684|NCT00885105|3963018|B3||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4138685|NCT00885105|3963019|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4138686|NCT00885105|3963020|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4138687|NCT00885105|3963018|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4138688|NCT00885105|3963019|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4138689|NCT00885105|3963020|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4138690|NCT00885105|3963018|B3|||Age||Months|Mean|7.28|7.28|Standard Deviation|1.3|1.3|||
4138691|NCT00885105|3963019|B2|||Age||Months|Mean|7.28|7.28|Standard Deviation|1.47|1.47|||
4138692|NCT00885105|3963020|B1|||Age||Months|Mean|7.29|7.29|Standard Deviation|1.1|1.1|||
4138693|NCT00885105|3963018|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4138694|NCT00885105|3963019|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4138695|NCT00885105|3963020|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4138696|NCT00885105|3963018|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4138697|NCT00885105|3963019|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4138698|NCT00885105|3963020|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4138699|NCT00885105|3963018|B3||<=18 years|Age||Participants|Count of Participants|242|242.0||||||
4138700|NCT00885105|3963019|B2||<=18 years|Age||Participants|Count of Participants|130|130.0||||||
4138701|NCT00885105|3963020|B1||<=18 years|Age||Participants|Count of Participants|112|112.0||||||
4138702|NCT00885092|3963037|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4138703|NCT00885092|3963038|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4138704|NCT00885092|3963039|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4138705|NCT00885092|3963037|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4138706|NCT00885092|3963038|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4138707|NCT00885092|3963039|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4138708|NCT00885092|3963037|B3|||Age||years|Mean|42.6|42.6|Standard Deviation|10.0|10.0|||
4138709|NCT00885092|3963038|B2|||Age||years|Mean|42.4|42.4|Standard Deviation|10.0|10.0|||
4138710|NCT00885092|3963039|B1|||Age||years|Mean|42.9|42.9|Standard Deviation|10.1|10.1|||
4138711|NCT00885079|3963050|B3|Japan||Region of Enrollment||participants|Number|188|188.0||||||
4138712|NCT00885079|3963051|B2|Japan||Region of Enrollment||participants|Number|95|95.0||||||
4138713|NCT00885079|3963052|B1|Japan||Region of Enrollment||participants|Number|93|93.0||||||
4138714|NCT00885079|3963050|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4138715|NCT00885079|3963051|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4138716|NCT00885079|3963052|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4138717|NCT00885079|3963050|B3||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4138718|NCT00885079|3963051|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4138719|NCT00885079|3963052|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4138720|NCT00885079|3963050|B3|||Age||years|Mean|56.6|56.6|Standard Deviation|17.4|17.4|||
4138721|NCT00885079|3963051|B2|||Age||years|Mean|55.2|55.2|Standard Deviation|16.9|16.9|||
4138722|NCT00885079|3963052|B1|||Age||years|Mean|58.0|58.0|Standard Deviation|17.7|17.7|||
4138723|NCT00885079|3963050|B3||>=65 years|Age||Participants|Count of Participants|74|74.0||||||
4138724|NCT00885079|3963051|B2||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4138725|NCT00885079|3963052|B1||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4138726|NCT00885079|3963050|B3||Between 18 and 65 years|Age||Participants|Count of Participants|114|114.0||||||
4138727|NCT00885079|3963051|B2||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4138728|NCT00885079|3963052|B1||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4138729|NCT00885079|3963050|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4138730|NCT00885079|3963051|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4138731|NCT00885079|3963052|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4138732|NCT00884949|3963061|B1|United Kingdom||Region of Enrollment||participants|Number|20|20.0||||||
4138733|NCT00884949|3963061|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4138734|NCT00884949|3963061|B1|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4138735|NCT00884949|3963061|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4138736|NCT00884949|3963061|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4138737|NCT00884949|3963061|B1|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4138738|NCT00884949|3963061|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4138739|NCT00884949|3963061|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4138740|NCT00884949|3963061|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4138741|NCT00884949|3963061|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4138742|NCT00884949|3963061|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4138743|NCT00884949|3963061|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4138744|NCT00884949|3963061|B1|>=10 to <=18 years||Age, Customized||participants|Number|4|4.0||||||
4138745|NCT00884949|3963061|B1|>=8 to <10 years||Age, Customized||participants|Number|6|6.0||||||
4138746|NCT00884949|3963061|B1|>=4 to <8 years||Age, Customized||participants|Number|10|10.0||||||
4138747|NCT00884949|3963061|B1|||Age||years|Mean|8.0|8.0|Standard Deviation|2.89|2.89|||
4138748|NCT00884910|3963078|B1|Netherlands||Region of Enrollment||patients|Number|33|33.0||||||
4138749|NCT00884910|3963078|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4138750|NCT00884910|3963078|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4138751|NCT00884910|3963078|B1|||Age||years|Mean|66.42|66.42|Standard Deviation|12.6|12.6|||
4138752|NCT00884910|3963078|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4138753|NCT00884910|3963078|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4138754|NCT00884910|3963078|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4138755|NCT00884897|3963083|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
4138756|NCT00884897|3963084|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4138757|NCT00884897|3963085|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4138758|NCT00884897|3963083|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4138759|NCT00884897|3963084|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4138760|NCT00884897|3963085|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4138761|NCT00884897|3963083|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4138762|NCT00884897|3963084|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4138763|NCT00884897|3963085|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4138764|NCT00884897|3963083|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4138765|NCT00884897|3963084|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4138766|NCT00884897|3963085|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4138767|NCT00884897|3963083|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4138768|NCT00884897|3963084|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4138769|NCT00884897|3963085|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4138770|NCT00884897|3963083|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4138771|NCT00884897|3963084|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4138772|NCT00884897|3963085|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4138773|NCT00884897|3963083|B3|||Age||Years|Mean|39.6|39.6|Standard Deviation|11.0|11.0|||
4138774|NCT00884897|3963084|B2|||Age||Years|Mean|35.07|35.07|Standard Deviation|8.21|8.21|||
4138775|NCT00884897|3963085|B1|||Age||Years|Mean|44.74|44.74|Standard Deviation|11.74|11.74|||
4138776|NCT00884832|3963094|B3|Subjects without diarrhea||Functional diarrhea or Diarrhea-predominant Irritable Bowel Syndrome (IBS)||participants|Number|22|22.0||||||
4138777|NCT00884832|3963095|B2|Subjects without diarrhea||Functional diarrhea or Diarrhea-predominant Irritable Bowel Syndrome (IBS)||participants|Number|9|9.0||||||
4138778|NCT00884832|3963096|B1|Subjects without diarrhea||Functional diarrhea or Diarrhea-predominant Irritable Bowel Syndrome (IBS)||participants|Number|13|13.0||||||
4138779|NCT00884832|3963094|B3|Subjects with diarrhea||Functional diarrhea or Diarrhea-predominant Irritable Bowel Syndrome (IBS)||participants|Number|22|22.0||||||
4138780|NCT00884832|3963095|B2|Subjects with diarrhea||Functional diarrhea or Diarrhea-predominant Irritable Bowel Syndrome (IBS)||participants|Number|13|13.0||||||
4138781|NCT00884832|3963096|B1|Subjects with diarrhea||Functional diarrhea or Diarrhea-predominant Irritable Bowel Syndrome (IBS)||participants|Number|9|9.0||||||
4138782|NCT00884832|3963094|B3|No Hysterectomy||Hysterectomy|Number of participants who had previously had a hysterectomy at baseline.|participants|Number|24|24.0||||||
4138783|NCT00884832|3963095|B2|No Hysterectomy||Hysterectomy|Number of participants who had previously had a hysterectomy at baseline.|participants|Number|11|11.0||||||
4138784|NCT00884832|3963096|B1|No Hysterectomy||Hysterectomy|Number of participants who had previously had a hysterectomy at baseline.|participants|Number|13|13.0||||||
4138785|NCT00884832|3963094|B3|Hysterectomy||Hysterectomy|Number of participants who had previously had a hysterectomy at baseline.|participants|Number|20|20.0||||||
4138786|NCT00884832|3963095|B2|Hysterectomy||Hysterectomy|Number of participants who had previously had a hysterectomy at baseline.|participants|Number|11|11.0||||||
4138787|NCT00884832|3963096|B1|Hysterectomy||Hysterectomy|Number of participants who had previously had a hysterectomy at baseline.|participants|Number|9|9.0||||||
4138788|NCT00884832|3963094|B3|||Body Mass Index||kg/m^2|Mean|29.14|29.14|Standard Deviation|5.81|5.81|||
4138789|NCT00884832|3963095|B2|||Body Mass Index||kg/m^2|Mean|28.0|28.0|Standard Deviation|6.35|6.35|||
4138790|NCT00884832|3963096|B1|||Body Mass Index||kg/m^2|Mean|30.3|30.3|Standard Deviation|1.09|1.09|||
4138791|NCT00884832|3963094|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
4138792|NCT00884832|3963095|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4138793|NCT00884832|3963096|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4138794|NCT00884832|3963094|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4138795|NCT00884832|3963095|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4138796|NCT00884832|3963096|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4138797|NCT00884832|3963094|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4138798|NCT00884832|3963095|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4138799|NCT00884832|3963096|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4138800|NCT00884832|3963094|B3|||Age||years|Mean|57.38|57.38|Standard Deviation|11.26|11.26|||
4138801|NCT00884832|3963095|B2|||Age||years|Mean|57|57.0|Standard Deviation|11.86|11.86|||
4138802|NCT00884832|3963096|B1|||Age||years|Mean|58|58.0|Standard Deviation|10.88|10.88|||
4138803|NCT00884806|3963127|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4138804|NCT00884806|3963127|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4138805|NCT00884806|3963127|B1|||Age||years|Mean|33.1|33.1|Standard Deviation|11.1|11.1|||
4138806|NCT00884793|3963132|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4138807|NCT00884793|3963132|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4138808|NCT00884793|3963132|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4138809|NCT00884793|3963132|B1|||Age||years|Mean|48.9|48.9|Standard Deviation|11.5|11.5|||
4138810|NCT00884793|3963132|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4138811|NCT00884793|3963132|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4138812|NCT00884793|3963132|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4138813|NCT00884754|3963139|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4138814|NCT00884754|3963140|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4138815|NCT00884754|3963141|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4138816|NCT00884754|3963139|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4138817|NCT00884754|3963140|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4138818|NCT00884754|3963141|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4138819|NCT00884754|3963139|B3|Over 18 years||Age||participants|Number|60|60.0||||||
4138820|NCT00884754|3963140|B2|Over 18 years||Age||participants|Number|30|30.0||||||
4138821|NCT00884754|3963141|B1|Over 18 years||Age||participants|Number|30|30.0||||||
4138822|NCT00884741|3963148|B4||Male|Sex: Female, Male||Participants|Count of Participants|390|390.0||||||
4138823|NCT00884741|3963149|B3||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4138824|NCT00884741|3963150|B2||Male|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4138825|NCT00884741|3963151|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4138826|NCT00884741|3963148|B4||Female|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
4138827|NCT00884741|3963149|B3||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4138828|NCT00884741|3963150|B2||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4138829|NCT00884741|3963151|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4138830|NCT00884741|3963148|B4|||Age||years|Median|58|58.0|Full Range|||19.0|82.0|
4138831|NCT00884741|3963149|B3|||Age||years|Median|59|59.0|Full Range|||21.0|82.0|
4138832|NCT00884741|3963150|B2|||Age||years|Median|57|57.0|Full Range|||19.0|82.0|
4138833|NCT00884741|3963151|B1|||Age||years|Median|58|58.0|Full Range|||25.0|75.0|
4138834|NCT00884611|3963165|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4138835|NCT00884611|3963165|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4138836|NCT00884611|3963165|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4138837|NCT00884611|3963165|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4138838|NCT00884611|3963165|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4138839|NCT00884585|3963187|B3||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4138840|NCT00884585|3963188|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4138841|NCT00884585|3963189|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4138842|NCT00884585|3963187|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4138843|NCT00884585|3963188|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4138844|NCT00884585|3963189|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4138845|NCT00884585|3963187|B3|>=65 years||Age, Customized||Participants|Number|14|14.0||||||
4138846|NCT00884585|3963188|B2|>=65 years||Age, Customized||Participants|Number|6|6.0||||||
4138847|NCT00884585|3963189|B1|>=65 years||Age, Customized||Participants|Number|8|8.0||||||
4138848|NCT00884585|3963187|B3|50 to <65 years||Age, Customized||Participants|Number|49|49.0||||||
4138849|NCT00884585|3963188|B2|50 to <65 years||Age, Customized||Participants|Number|22|22.0||||||
4138850|NCT00884585|3963189|B1|50 to <65 years||Age, Customized||Participants|Number|27|27.0||||||
4138851|NCT00884585|3963187|B3|30 to <50 years||Age, Customized||Participants|Number|70|70.0||||||
4138852|NCT00884585|3963188|B2|30 to <50 years||Age, Customized||Participants|Number|38|38.0||||||
4138853|NCT00884585|3963189|B1|30 to <50 years||Age, Customized||Participants|Number|32|32.0||||||
4138854|NCT00884585|3963187|B3|18 to <30 years||Age, Customized||Participants|Number|28|28.0||||||
4138855|NCT00884585|3963188|B2|18 to <30 years||Age, Customized||Participants|Number|13|13.0||||||
4138856|NCT00884585|3963189|B1|18 to <30 years||Age, Customized||Participants|Number|15|15.0||||||
4138857|NCT00884585|3963187|B3|<18 years||Age, Customized||Participants|Number|15|15.0||||||
4138858|NCT00884585|3963188|B2|<18 years||Age, Customized||Participants|Number|8|8.0||||||
4138859|NCT00884585|3963189|B1|<18 years||Age, Customized||Participants|Number|7|7.0||||||
4138860|NCT00884390|3963202|B3||Male|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4138861|NCT00884390|3963203|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4138862|NCT00884390|3963204|B1||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4138863|NCT00884390|3963202|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4138864|NCT00884390|3963203|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4138865|NCT00884390|3963204|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4138866|NCT00884390|3963202|B3|18-65 years||Age, Customized||participants|Number|166|166.0||||||
4138867|NCT00884390|3963203|B2|18-65 years||Age, Customized||participants|Number|53|53.0||||||
4138868|NCT00884390|3963204|B1|18-65 years||Age, Customized||participants|Number|113|113.0||||||
4138869|NCT00884390|3963202|B3|12-17 years||Age, Customized||participants|Number|42|42.0||||||
4138870|NCT00884390|3963203|B2|12-17 years||Age, Customized||participants|Number|9|9.0||||||
4138871|NCT00884390|3963204|B1|12-17 years||Age, Customized||participants|Number|33|33.0||||||
4138872|NCT00884377|3963221|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4138873|NCT00884377|3963222|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4138874|NCT00884377|3963223|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4138875|NCT00884377|3963221|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4138876|NCT00884377|3963222|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4138877|NCT00884377|3963223|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4138878|NCT00884377|3963221|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4138879|NCT00884377|3963222|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4138880|NCT00884377|3963223|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4138881|NCT00884377|3963221|B3|||Age||years|Mean|27.9|27.9|Standard Deviation|9.0|9.0|||
4138882|NCT00884377|3963222|B2|||Age||years|Mean|28.9|28.9|Standard Deviation|8.3|8.3|||
4138883|NCT00884377|3963223|B1|||Age||years|Mean|27.0|27.0|Standard Deviation|9.7|9.7|||
4138884|NCT00884377|3963221|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4138885|NCT00884377|3963222|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4138886|NCT00884377|3963223|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4138887|NCT00884377|3963221|B3||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4138888|NCT00884377|3963222|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4138889|NCT00884377|3963223|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4138890|NCT00884377|3963221|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4138891|NCT00884377|3963222|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4138892|NCT00884377|3963223|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4138893|NCT00884325|3963244|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4138894|NCT00884325|3963245|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4138895|NCT00884325|3963246|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4138896|NCT00884325|3963244|B3|Male||Gender|gender data was missing for one participant|participants|Number|13|13.0||||||
4138897|NCT00884325|3963245|B2|Male||Gender|gender data was missing for one participant|participants|Number|7|7.0||||||
4138898|NCT00884325|3963246|B1|Male||Gender|gender data was missing for one participant|participants|Number|6|6.0||||||
4138899|NCT00884325|3963244|B3|Female||Gender|gender data was missing for one participant|participants|Number|26|26.0||||||
4138900|NCT00884325|3963245|B2|Female||Gender|gender data was missing for one participant|participants|Number|12|12.0||||||
4139113|NCT00884221|3963315|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4138901|NCT00884325|3963246|B1|Female||Gender|gender data was missing for one participant|participants|Number|14|14.0||||||
4138902|NCT00884325|3963244|B3|||Age|Age data was missing for one placebo participant|years|Mean|41.1|41.1|Full Range|14.6|14.6|19.5|68.1|
4138903|NCT00884325|3963245|B2|||Age|Age data was missing for one placebo participant|years|Mean|41.1|41.1|Full Range|14.8|14.8|19.8|68.1|
4138904|NCT00884325|3963246|B1|||Age|Age data was missing for one placebo participant|years|Mean|41.1|41.1|Full Range|14.6|14.6|19.5|64.6|
4138905|NCT00884325|3963244|B3|>=65 years||Age|Age data was unknown for one placebo participant|participants|Number|2|2.0||||||
4138906|NCT00884325|3963245|B2|>=65 years||Age|Age data was unknown for one placebo participant|participants|Number|1|1.0||||||
4138907|NCT00884325|3963246|B1|>=65 years||Age|Age data was unknown for one placebo participant|participants|Number|1|1.0||||||
4138908|NCT00884325|3963244|B3|Between 18 and 65 years||Age|Age data was unknown for one placebo participant|participants|Number|37|37.0||||||
4138909|NCT00884325|3963245|B2|Between 18 and 65 years||Age|Age data was unknown for one placebo participant|participants|Number|18|18.0||||||
4138910|NCT00884325|3963246|B1|Between 18 and 65 years||Age|Age data was unknown for one placebo participant|participants|Number|19|19.0||||||
4138911|NCT00884325|3963244|B3|<=18 years||Age|Age data was unknown for one placebo participant|participants|Number|0|0.0||||||
4138912|NCT00884325|3963245|B2|<=18 years||Age|Age data was unknown for one placebo participant|participants|Number|0|0.0||||||
4138913|NCT00884325|3963246|B1|<=18 years||Age|Age data was unknown for one placebo participant|participants|Number|0|0.0||||||
4138914|NCT00884312|3963255|B3||2 (Ambulatory but unable to work)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|10|10.0||||||
4138915|NCT00884312|3963256|B2||2 (Ambulatory but unable to work)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|10|10.0||||||
4138916|NCT00884312|3963257|B1||2 (Ambulatory but unable to work)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|0|0.0||||||
4138917|NCT00884312|3963255|B3||1 (Restricted but ambulatory)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|45|45.0||||||
4138918|NCT00884312|3963256|B2||1 (Restricted but ambulatory)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|42|42.0||||||
4138919|NCT00884312|3963257|B1||1 (Restricted but ambulatory)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|3|3.0||||||
4138920|NCT00884312|3963255|B3||0 (Fully active)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|45|45.0||||||
4138921|NCT00884312|3963256|B2||0 (Fully active)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|39|39.0||||||
4138974|NCT00884286|3963272|B3|Between 50 and 69 years||Age, Customized|A 17 year-old patient was included and it was considered by the Sponsor as a non-clinically relevant protocol deviation.|Participants|Count of Participants|33|33.0||||||
4138922|NCT00884312|3963257|B1||0 (Fully active)|Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|Participants|Count of Participants|6|6.0||||||
4138923|NCT00884312|3963255|B3||Asian/Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4138924|NCT00884312|3963256|B2||Asian/Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4138925|NCT00884312|3963257|B1||Asian/Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4138926|NCT00884312|3963255|B3||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4138927|NCT00884312|3963256|B2||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4138928|NCT00884312|3963257|B1||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4138929|NCT00884312|3963255|B3||Black|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4138930|NCT00884312|3963256|B2||Black|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4138931|NCT00884312|3963257|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4138932|NCT00884312|3963255|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|80|80.0||||||
4138933|NCT00884312|3963256|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|71|71.0||||||
4138934|NCT00884312|3963257|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4138935|NCT00884312|3963255|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4138936|NCT00884312|3963256|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4138937|NCT00884312|3963257|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4138938|NCT00884312|3963255|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4138939|NCT00884312|3963256|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4138940|NCT00884312|3963257|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4138941|NCT00884312|3963255|B3||≥ 65 years|Age, Customized||Participants|Count of Participants|48|48.0||||||
4138942|NCT00884312|3963256|B2||≥ 65 years|Age, Customized||Participants|Count of Participants|44|44.0||||||
4138943|NCT00884312|3963257|B1||≥ 65 years|Age, Customized||Participants|Count of Participants|4|4.0||||||
4138944|NCT00884312|3963255|B3||< 65 years|Age, Customized||Participants|Count of Participants|52|52.0||||||
4138945|NCT00884312|3963256|B2||< 65 years|Age, Customized||Participants|Count of Participants|47|47.0||||||
4138946|NCT00884312|3963257|B1||< 65 years|Age, Customized||Participants|Count of Participants|5|5.0||||||
4138947|NCT00884312|3963255|B3|||Age||years|Mean|63.0|63.0|Standard Deviation|10.05|10.05|||
4138948|NCT00884312|3963256|B2|||Age||years|Mean|63.2|63.2|Standard Deviation|9.82|9.82|||
4138949|NCT00884312|3963257|B1|||Age||years|Mean|61.2|61.2|Standard Deviation|12.75|12.75|||
4138950|NCT00884286|3963272|B3|Spain||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4138951|NCT00884286|3963273|B2|Spain||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4138952|NCT00884286|3963274|B1|Spain||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4138953|NCT00884286|3963272|B3|Peru||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4138954|NCT00884286|3963273|B2|Peru||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4138955|NCT00884286|3963274|B1|Peru||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4138956|NCT00884286|3963272|B3|Switzerland||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4138957|NCT00884286|3963273|B2|Switzerland||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4138958|NCT00884286|3963274|B1|Switzerland||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4138959|NCT00884286|3963272|B3|France||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
4138960|NCT00884286|3963273|B2|France||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4138961|NCT00884286|3963274|B1|France||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4138962|NCT00884286|3963272|B3|Italy||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4138963|NCT00884286|3963273|B2|Italy||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4138964|NCT00884286|3963274|B1|Italy||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4138965|NCT00884286|3963272|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4138966|NCT00884286|3963273|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4138967|NCT00884286|3963274|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4138968|NCT00884286|3963272|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4138969|NCT00884286|3963273|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4138970|NCT00884286|3963274|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4138971|NCT00884286|3963272|B3|>= 70 years||Age, Customized|A 17 year-old patient was included and it was considered by the Sponsor as a non-clinically relevant protocol deviation.|Participants|Count of Participants|16|16.0||||||
4138972|NCT00884286|3963273|B2|>= 70 years||Age, Customized|A 17 year-old patient was included and it was considered by the Sponsor as a non-clinically relevant protocol deviation.|Participants|Count of Participants|10|10.0||||||
4138973|NCT00884286|3963274|B1|>= 70 years||Age, Customized|A 17 year-old patient was included and it was considered by the Sponsor as a non-clinically relevant protocol deviation.|Participants|Count of Participants|6|6.0||||||
4138975|NCT00884286|3963273|B2|Between 50 and 69 years||Age, Customized|A 17 year-old patient was included and it was considered by the Sponsor as a non-clinically relevant protocol deviation.|Participants|Count of Participants|19|19.0||||||
4138976|NCT00884286|3963274|B1|Between 50 and 69 years||Age, Customized|A 17 year-old patient was included and it was considered by the Sponsor as a non-clinically relevant protocol deviation.|Participants|Count of Participants|14|14.0||||||
4138977|NCT00884286|3963272|B3|Between 18 and 49 years||Age, Customized|A 17 year-old patient was included and it was considered by the Sponsor as a non-clinically relevant protocol deviation.|Participants|Count of Participants|17|17.0||||||
4138978|NCT00884286|3963273|B2|Between 18 and 49 years||Age, Customized|A 17 year-old patient was included and it was considered by the Sponsor as a non-clinically relevant protocol deviation.|Participants|Count of Participants|3|3.0||||||
4138979|NCT00884286|3963274|B1|Between 18 and 49 years||Age, Customized|A 17 year-old patient was included and it was considered by the Sponsor as a non-clinically relevant protocol deviation.|Participants|Count of Participants|14|14.0||||||
4138980|NCT00884286|3963272|B3|17 years||Age, Customized|A 17 year-old patient was included and it was considered by the Sponsor as a non-clinically relevant protocol deviation.|Participants|Count of Participants|1|1.0||||||
4138981|NCT00884286|3963273|B2|17 years||Age, Customized|A 17 year-old patient was included and it was considered by the Sponsor as a non-clinically relevant protocol deviation.|Participants|Count of Participants|1|1.0||||||
4138982|NCT00884286|3963274|B1|17 years||Age, Customized|A 17 year-old patient was included and it was considered by the Sponsor as a non-clinically relevant protocol deviation.|Participants|Count of Participants|0|0.0||||||
4138983|NCT00884273|3963287|B3|||Benign Prostatic Hyperplasia Impact Index (BPHII)|The Benign Prostatic Hyperplasia Impact Index (BPHII) is a self-administered questionnaire to measure how much urinary problems affect various domains of health. The higher value the worse are the urinary problems. The minimum possible total value is 0 and the maximum possible total value is 16.|scores on a scale|Mean|4.80|4.8|Standard Deviation|3.49|3.49|||
4138984|NCT00884273|3963288|B2|||Benign Prostatic Hyperplasia Impact Index (BPHII)|The Benign Prostatic Hyperplasia Impact Index (BPHII) is a self-administered questionnaire to measure how much urinary problems affect various domains of health. The higher value the worse are the urinary problems. The minimum possible total value is 0 and the maximum possible total value is 16.|scores on a scale|Mean|4.58|4.58|Standard Deviation|3.58|3.58|||
4138985|NCT00884273|3963289|B1|||Benign Prostatic Hyperplasia Impact Index (BPHII)|The Benign Prostatic Hyperplasia Impact Index (BPHII) is a self-administered questionnaire to measure how much urinary problems affect various domains of health. The higher value the worse are the urinary problems. The minimum possible total value is 0 and the maximum possible total value is 16.|scores on a scale|Mean|5.06|5.06|Standard Deviation|3.39|3.39|||
4138986|NCT00884273|3963287|B3|||Quality of Life (QoL) Related to Urinary Symptoms|The IPSS questionnaire included an additional single question to assess the participant's QoL in relation to his urinary symptoms. The question was: 'If you were to spend the rest of your life with your urinary condition the way it is now, how would you feel about that?' The possible answers to this question ranged from 'delighted' (a score of '0') to 'terrible' (a score of '6'). The figures in the tables present the change (ie decrease) in IPSS QoL score, i.e. the bigger the decrease the better QoL.|scores on a scale|Mean|2.79|2.79|Standard Deviation|1.64|1.64|||
4138987|NCT00884273|3963288|B2|||Quality of Life (QoL) Related to Urinary Symptoms|The IPSS questionnaire included an additional single question to assess the participant's QoL in relation to his urinary symptoms. The question was: 'If you were to spend the rest of your life with your urinary condition the way it is now, how would you feel about that?' The possible answers to this question ranged from 'delighted' (a score of '0') to 'terrible' (a score of '6'). The figures in the tables present the change (ie decrease) in IPSS QoL score, i.e. the bigger the decrease the better QoL.|scores on a scale|Mean|2.73|2.73|Standard Deviation|1.66|1.66|||
4138988|NCT00884273|3963289|B1|||Quality of Life (QoL) Related to Urinary Symptoms|The IPSS questionnaire included an additional single question to assess the participant's QoL in relation to his urinary symptoms. The question was: 'If you were to spend the rest of your life with your urinary condition the way it is now, how would you feel about that?' The possible answers to this question ranged from 'delighted' (a score of '0') to 'terrible' (a score of '6'). The figures in the tables present the change (ie decrease) in IPSS QoL score, i.e. the bigger the decrease the better QoL.|scores on a scale|Mean|2.85|2.85|Standard Deviation|1.62|1.62|||
4138989|NCT00884273|3963287|B3|||Total International Prostate Symptom Score (IPSS)|The IPSS is a tool commonly used to assess the severity of lower urinary tract symptoms (LUTS), and to monitor the progress of the disease once treatment has been initiated. The participant completes a questionnaire containing 7 questions regarding incomplete emptying, frequency, intermittency, urgency, weak stream, straining, and nocturia. Each question is assigned a score of 0-5. The total score is then classified according to the following scale: 0 to 7 = mildly symptomatic; 8 to 19 = moderately symptomatic; and 20 to 35 = severely symptomatic.|scores on a scale|Mean|13.8|13.8|Standard Deviation|7.15|7.15|||
4138990|NCT00884273|3963288|B2|||Total International Prostate Symptom Score (IPSS)|The IPSS is a tool commonly used to assess the severity of lower urinary tract symptoms (LUTS), and to monitor the progress of the disease once treatment has been initiated. The participant completes a questionnaire containing 7 questions regarding incomplete emptying, frequency, intermittency, urgency, weak stream, straining, and nocturia. Each question is assigned a score of 0-5. The total score is then classified according to the following scale: 0 to 7 = mildly symptomatic; 8 to 19 = moderately symptomatic; and 20 to 35 = severely symptomatic.|scores on a scale|Mean|13.4|13.4|Standard Deviation|7.36|7.36|||
4138991|NCT00884273|3963289|B1|||Total International Prostate Symptom Score (IPSS)|The IPSS is a tool commonly used to assess the severity of lower urinary tract symptoms (LUTS), and to monitor the progress of the disease once treatment has been initiated. The participant completes a questionnaire containing 7 questions regarding incomplete emptying, frequency, intermittency, urgency, weak stream, straining, and nocturia. Each question is assigned a score of 0-5. The total score is then classified according to the following scale: 0 to 7 = mildly symptomatic; 8 to 19 = moderately symptomatic; and 20 to 35 = severely symptomatic.|scores on a scale|Mean|14.3|14.3|Standard Deviation|6.91|6.91|||
4138992|NCT00884273|3963287|B3|||Prostate Volume|Prostate volume was measured with a Trans Rectal Ultrasound Scan (TRUS).|milliliter|Mean|52.1|52.1|Standard Deviation|21.1|21.1|||
4138993|NCT00884273|3963288|B2|||Prostate Volume|Prostate volume was measured with a Trans Rectal Ultrasound Scan (TRUS).|milliliter|Mean|49.9|49.9|Standard Deviation|15.5|15.5|||
4138994|NCT00884273|3963289|B1|||Prostate Volume|Prostate volume was measured with a Trans Rectal Ultrasound Scan (TRUS).|milliliter|Mean|54.8|54.8|Standard Deviation|26.0|26.0|||
4138995|NCT00884273|3963287|B3|||Serum Protsate-Specific Antigen (PSA) Levels||nanograms per milliliter|Median|20.2|20.2|Full Range|||1.9|6206.0|
4138996|NCT00884273|3963288|B2|||Serum Protsate-Specific Antigen (PSA) Levels||nanograms per milliliter|Median|15.6|15.6|Full Range|||3.0|2829.0|
4138997|NCT00884273|3963289|B1|||Serum Protsate-Specific Antigen (PSA) Levels||nanograms per milliliter|Median|27.8|27.8|Full Range|||1.9|6206.0|
4138998|NCT00884273|3963287|B3|||Serum Testosterone Levels||nanograms per milliliter|Median|4.23|4.23|Full Range|||0.13|10.8|
4138999|NCT00884273|3963288|B2|||Serum Testosterone Levels||nanograms per milliliter|Median|4.33|4.33|Full Range|||0.13|9.6|
4139000|NCT00884273|3963289|B1|||Serum Testosterone Levels||nanograms per milliliter|Median|4.08|4.08|Full Range|||0.32|10.8|
4139001|NCT00884273|3963287|B3|Not Classifiable||Stage of Prostate Cancer|FAS. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. Some participants did not have their prostate cancer classified for the complete TNM scale (17 participants).|participants|Number|17|17.0||||||
4139002|NCT00884273|3963288|B2|Not Classifiable||Stage of Prostate Cancer|FAS. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. Some participants did not have their prostate cancer classified for the complete TNM scale (17 participants).|participants|Number|11|11.0||||||
4139003|NCT00884273|3963289|B1|Not Classifiable||Stage of Prostate Cancer|FAS. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. Some participants did not have their prostate cancer classified for the complete TNM scale (17 participants).|participants|Number|6|6.0||||||
4139004|NCT00884273|3963287|B3|Metastatic||Stage of Prostate Cancer|FAS. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. Some participants did not have their prostate cancer classified for the complete TNM scale (17 participants).|participants|Number|53|53.0||||||
4139005|NCT00884273|3963288|B2|Metastatic||Stage of Prostate Cancer|FAS. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. Some participants did not have their prostate cancer classified for the complete TNM scale (17 participants).|participants|Number|31|31.0||||||
4139006|NCT00884273|3963289|B1|Metastatic||Stage of Prostate Cancer|FAS. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. Some participants did not have their prostate cancer classified for the complete TNM scale (17 participants).|participants|Number|22|22.0||||||
4139007|NCT00884273|3963287|B3|Locally Advanced||Stage of Prostate Cancer|FAS. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. Some participants did not have their prostate cancer classified for the complete TNM scale (17 participants).|participants|Number|53|53.0||||||
4139008|NCT00884273|3963288|B2|Locally Advanced||Stage of Prostate Cancer|FAS. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. Some participants did not have their prostate cancer classified for the complete TNM scale (17 participants).|participants|Number|23|23.0||||||
4139009|NCT00884273|3963289|B1|Locally Advanced||Stage of Prostate Cancer|FAS. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. Some participants did not have their prostate cancer classified for the complete TNM scale (17 participants).|participants|Number|30|30.0||||||
4139010|NCT00884273|3963287|B3|Localized||Stage of Prostate Cancer|FAS. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. Some participants did not have their prostate cancer classified for the complete TNM scale (17 participants).|participants|Number|56|56.0||||||
4139050|NCT00884273|3963288|B2|Portugal||Region of Enrollment|FAS.|participants|Number|7|7.0||||||
4139051|NCT00884273|3963289|B1|Portugal||Region of Enrollment|FAS.|participants|Number|4|4.0||||||
4139052|NCT00884273|3963287|B3||Unknown or Not Reported|Race (NIH/OMB)|FAS|Participants|Count of Participants|0|0.0||||||
4139011|NCT00884273|3963288|B2|Localized||Stage of Prostate Cancer|FAS. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. Some participants did not have their prostate cancer classified for the complete TNM scale (17 participants).|participants|Number|32|32.0||||||
4139012|NCT00884273|3963289|B1|Localized||Stage of Prostate Cancer|FAS. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. Some participants did not have their prostate cancer classified for the complete TNM scale (17 participants).|participants|Number|24|24.0||||||
4139013|NCT00884273|3963287|B3|Gleason Score 7-10||Gleason Score|FAS. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|146|146.0||||||
4139014|NCT00884273|3963288|B2|Gleason Score 7-10||Gleason Score|FAS. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|81|81.0||||||
4139015|NCT00884273|3963289|B1|Gleason Score 7-10||Gleason Score|FAS. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|65|65.0||||||
4139016|NCT00884273|3963287|B3|Gleason Score 5-6||Gleason Score|FAS. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|31|31.0||||||
4139017|NCT00884273|3963288|B2|Gleason Score 5-6||Gleason Score|FAS. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|15|15.0||||||
4139018|NCT00884273|3963289|B1|Gleason Score 5-6||Gleason Score|FAS. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|16|16.0||||||
4139019|NCT00884273|3963287|B3|Gleason Score 2-4||Gleason Score|FAS. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|2|2.0||||||
4139020|NCT00884273|3963288|B2|Gleason Score 2-4||Gleason Score|FAS. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|1|1.0||||||
4139021|NCT00884273|3963289|B1|Gleason Score 2-4||Gleason Score|FAS. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|1|1.0||||||
4139022|NCT00884273|3963287|B3|||Body Mass Index|FAS.|kilogram per square meter|Mean|26.6|26.6|Standard Deviation|3.88|3.88|||
4139023|NCT00884273|3963288|B2|||Body Mass Index|FAS.|kilogram per square meter|Mean|26.5|26.5|Standard Deviation|3.72|3.72|||
4139024|NCT00884273|3963289|B1|||Body Mass Index|FAS.|kilogram per square meter|Mean|26.8|26.8|Standard Deviation|4.07|4.07|||
4139025|NCT00884273|3963287|B3|||Body Weight|FAS.|kilogram|Mean|79.7|79.7|Standard Deviation|12.2|12.2|||
4139026|NCT00884273|3963288|B2|||Body Weight|FAS.|kilogram|Mean|79.7|79.7|Standard Deviation|12.2|12.2|||
4139027|NCT00884273|3963289|B1|||Body Weight|FAS.|kilogram|Mean|79.7|79.7|Standard Deviation|12.4|12.4|||
4139028|NCT00884273|3963287|B3|Sweden||Region of Enrollment|FAS.|participants|Number|23|23.0||||||
4139029|NCT00884273|3963288|B2|Sweden||Region of Enrollment|FAS.|participants|Number|12|12.0||||||
4139030|NCT00884273|3963289|B1|Sweden||Region of Enrollment|FAS.|participants|Number|11|11.0||||||
4139031|NCT00884273|3963287|B3|Italy||Region of Enrollment|FAS.|participants|Number|42|42.0||||||
4139032|NCT00884273|3963288|B2|Italy||Region of Enrollment|FAS.|participants|Number|22|22.0||||||
4139033|NCT00884273|3963289|B1|Italy||Region of Enrollment|FAS.|participants|Number|20|20.0||||||
4139034|NCT00884273|3963287|B3|Norway||Region of Enrollment|FAS.|participants|Number|12|12.0||||||
4139035|NCT00884273|3963288|B2|Norway||Region of Enrollment|FAS.|participants|Number|8|8.0||||||
4139036|NCT00884273|3963289|B1|Norway||Region of Enrollment|FAS.|participants|Number|4|4.0||||||
4139037|NCT00884273|3963287|B3|Denmark||Region of Enrollment|FAS.|participants|Number|28|28.0||||||
4139038|NCT00884273|3963288|B2|Denmark||Region of Enrollment|FAS.|participants|Number|15|15.0||||||
4139039|NCT00884273|3963289|B1|Denmark||Region of Enrollment|FAS.|participants|Number|13|13.0||||||
4139040|NCT00884273|3963287|B3|Turkey||Region of Enrollment|FAS.|participants|Number|28|28.0||||||
4139041|NCT00884273|3963288|B2|Turkey||Region of Enrollment|FAS.|participants|Number|14|14.0||||||
4139042|NCT00884273|3963289|B1|Turkey||Region of Enrollment|FAS.|participants|Number|14|14.0||||||
4139043|NCT00884273|3963287|B3|Belgium||Region of Enrollment|FAS.|participants|Number|4|4.0||||||
4139044|NCT00884273|3963288|B2|Belgium||Region of Enrollment|FAS.|participants|Number|2|2.0||||||
4139045|NCT00884273|3963289|B1|Belgium||Region of Enrollment|FAS.|participants|Number|2|2.0||||||
4139046|NCT00884273|3963287|B3|Finland||Region of Enrollment|FAS.|participants|Number|31|31.0||||||
4139047|NCT00884273|3963288|B2|Finland||Region of Enrollment|FAS.|participants|Number|17|17.0||||||
4139048|NCT00884273|3963289|B1|Finland||Region of Enrollment|FAS.|participants|Number|14|14.0||||||
4139049|NCT00884273|3963287|B3|Portugal||Region of Enrollment|FAS.|participants|Number|11|11.0||||||
4139053|NCT00884273|3963288|B2||Unknown or Not Reported|Race (NIH/OMB)|FAS|Participants|Count of Participants|0|0.0||||||
4139054|NCT00884273|3963289|B1||Unknown or Not Reported|Race (NIH/OMB)|FAS|Participants|Count of Participants|0|0.0||||||
4139055|NCT00884273|3963287|B3||More than one race|Race (NIH/OMB)|FAS|Participants|Count of Participants|0|0.0||||||
4139056|NCT00884273|3963288|B2||More than one race|Race (NIH/OMB)|FAS|Participants|Count of Participants|0|0.0||||||
4139057|NCT00884273|3963289|B1||More than one race|Race (NIH/OMB)|FAS|Participants|Count of Participants|0|0.0||||||
4139058|NCT00884273|3963287|B3||White|Race (NIH/OMB)|FAS|Participants|Count of Participants|179|179.0||||||
4139059|NCT00884273|3963288|B2||White|Race (NIH/OMB)|FAS|Participants|Count of Participants|97|97.0||||||
4139060|NCT00884273|3963289|B1||White|Race (NIH/OMB)|FAS|Participants|Count of Participants|82|82.0||||||
4139061|NCT00884273|3963287|B3||Black or African American|Race (NIH/OMB)|FAS|Participants|Count of Participants|0|0.0||||||
4139062|NCT00884273|3963288|B2||Black or African American|Race (NIH/OMB)|FAS|Participants|Count of Participants|0|0.0||||||
4139063|NCT00884273|3963289|B1||Black or African American|Race (NIH/OMB)|FAS|Participants|Count of Participants|0|0.0||||||
4139064|NCT00884273|3963287|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|FAS|Participants|Count of Participants|0|0.0||||||
4139065|NCT00884273|3963288|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|FAS|Participants|Count of Participants|0|0.0||||||
4139066|NCT00884273|3963289|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|FAS|Participants|Count of Participants|0|0.0||||||
4139067|NCT00884273|3963287|B3||Asian|Race (NIH/OMB)|FAS|Participants|Count of Participants|0|0.0||||||
4139068|NCT00884273|3963288|B2||Asian|Race (NIH/OMB)|FAS|Participants|Count of Participants|0|0.0||||||
4139069|NCT00884273|3963289|B1||Asian|Race (NIH/OMB)|FAS|Participants|Count of Participants|0|0.0||||||
4139070|NCT00884273|3963287|B3||American Indian or Alaska Native|Race (NIH/OMB)|FAS|Participants|Count of Participants|0|0.0||||||
4139071|NCT00884273|3963288|B2||American Indian or Alaska Native|Race (NIH/OMB)|FAS|Participants|Count of Participants|0|0.0||||||
4139072|NCT00884273|3963289|B1||American Indian or Alaska Native|Race (NIH/OMB)|FAS|Participants|Count of Participants|0|0.0||||||
4139073|NCT00884273|3963287|B3||Male|Sex: Female, Male|FAS.|Participants|Count of Participants|179|179.0||||||
4139074|NCT00884273|3963288|B2||Male|Sex: Female, Male|FAS.|Participants|Count of Participants|97|97.0||||||
4139075|NCT00884273|3963289|B1||Male|Sex: Female, Male|FAS.|Participants|Count of Participants|82|82.0||||||
4139076|NCT00884273|3963287|B3||Female|Sex: Female, Male|FAS.|Participants|Count of Participants|0|0.0||||||
4139077|NCT00884273|3963288|B2||Female|Sex: Female, Male|FAS.|Participants|Count of Participants|0|0.0||||||
4139078|NCT00884273|3963289|B1||Female|Sex: Female, Male|FAS.|Participants|Count of Participants|0|0.0||||||
4139079|NCT00884273|3963287|B3|||Age|Full Analysis Set (FAS).|years|Mean|72.5|72.5|Standard Deviation|7.39|7.39|||
4139080|NCT00884273|3963288|B2|||Age|Full Analysis Set (FAS).|years|Mean|73.0|73.0|Standard Deviation|7.10|7.1|||
4139081|NCT00884273|3963289|B1|||Age|Full Analysis Set (FAS).|years|Mean|71.9|71.9|Standard Deviation|7.71|7.71|||
4139082|NCT00884221|3963314|B3|Turkey||Region of Enrollment||participants|Number|53|53.0||||||
4139083|NCT00884221|3963315|B2|Turkey||Region of Enrollment||participants|Number|27|27.0||||||
4139084|NCT00884221|3963316|B1|Turkey||Region of Enrollment||participants|Number|26|26.0||||||
4139085|NCT00884221|3963314|B3|Sweden||Region of Enrollment||participants|Number|33|33.0||||||
4139086|NCT00884221|3963315|B2|Sweden||Region of Enrollment||participants|Number|19|19.0||||||
4139087|NCT00884221|3963316|B1|Sweden||Region of Enrollment||participants|Number|14|14.0||||||
4139088|NCT00884221|3963314|B3|Spain||Region of Enrollment||participants|Number|357|357.0||||||
4139089|NCT00884221|3963315|B2|Spain||Region of Enrollment||participants|Number|178|178.0||||||
4139090|NCT00884221|3963316|B1|Spain||Region of Enrollment||participants|Number|179|179.0||||||
4139091|NCT00884221|3963314|B3|Poland||Region of Enrollment||participants|Number|143|143.0||||||
4139092|NCT00884221|3963315|B2|Poland||Region of Enrollment||participants|Number|71|71.0||||||
4139093|NCT00884221|3963316|B1|Poland||Region of Enrollment||participants|Number|72|72.0||||||
4139094|NCT00884221|3963314|B3|Denmark||Region of Enrollment||participants|Number|66|66.0||||||
4139095|NCT00884221|3963315|B2|Denmark||Region of Enrollment||participants|Number|33|33.0||||||
4139096|NCT00884221|3963316|B1|Denmark||Region of Enrollment||participants|Number|33|33.0||||||
4139097|NCT00884221|3963314|B3|Czech Republic||Region of Enrollment||participants|Number|57|57.0||||||
4139098|NCT00884221|3963315|B2|Czech Republic||Region of Enrollment||participants|Number|27|27.0||||||
4139099|NCT00884221|3963316|B1|Czech Republic||Region of Enrollment||participants|Number|30|30.0||||||
4139100|NCT00884221|3963314|B3|Belgium||Region of Enrollment||participants|Number|40|40.0||||||
4139101|NCT00884221|3963315|B2|Belgium||Region of Enrollment||participants|Number|20|20.0||||||
4139102|NCT00884221|3963316|B1|Belgium||Region of Enrollment||participants|Number|20|20.0||||||
4139103|NCT00884221|3963314|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4139104|NCT00884221|3963315|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4139105|NCT00884221|3963316|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4139106|NCT00884221|3963314|B3||Female|Sex: Female, Male||Participants|Count of Participants|749|749.0||||||
4139107|NCT00884221|3963315|B2||Female|Sex: Female, Male||Participants|Count of Participants|375|375.0||||||
4139108|NCT00884221|3963316|B1||Female|Sex: Female, Male||Participants|Count of Participants|374|374.0||||||
4139109|NCT00884221|3963314|B3|||Age||years|Mean|30.6|30.6|Standard Deviation|2.69|2.69|||
4139110|NCT00884221|3963315|B2|||Age||years|Mean|30.4|30.4|Standard Deviation|2.62|2.62|||
4139111|NCT00884221|3963316|B1|||Age||years|Mean|30.8|30.8|Standard Deviation|2.75|2.75|||
4139112|NCT00884221|3963314|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4139114|NCT00884221|3963316|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4139115|NCT00884221|3963314|B3||Between 18 and 65 years|Age||Participants|Count of Participants|749|749.0||||||
4139116|NCT00884221|3963315|B2||Between 18 and 65 years|Age||Participants|Count of Participants|375|375.0||||||
4139117|NCT00884221|3963316|B1||Between 18 and 65 years|Age||Participants|Count of Participants|374|374.0||||||
4139118|NCT00884221|3963314|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4139119|NCT00884221|3963315|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4139120|NCT00884221|3963316|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4139121|NCT00884117|3963353|B1||Male|Sex: Female, Male||Participants|Count of Participants|2222|2222.0||||||
4139122|NCT00884117|3963353|B1||Female|Sex: Female, Male||Participants|Count of Participants|2331|2331.0||||||
4139123|NCT00884117|3963353|B1|||Age||years|Mean|19.5|19.5|Standard Deviation|19.24|19.24|||
4139124|NCT00884065|3963395|B3|||Months of pain||Months|Mean|16.18|16.18|Standard Deviation|22.44|22.44|||
4139125|NCT00884065|3963396|B2|||Months of pain||Months|Mean|17.88|17.88|Standard Deviation|27.56|27.56|||
4139126|NCT00884065|3963397|B1|||Months of pain||Months|Mean|14.48|14.48|Standard Deviation|16.21|16.21|||
4139127|NCT00884065|3963395|B3|Spain||Region of Enrollment||participants|Number|50.0|50.0||||||
4139128|NCT00884065|3963396|B2|Spain||Region of Enrollment||participants|Number|25|25.0||||||
4139129|NCT00884065|3963397|B1|Spain||Region of Enrollment||participants|Number|25|25.0||||||
4139130|NCT00884065|3963395|B3||Male|Sex: Female, Male||Participants|Count of Participants|21.0|21.0||||||
4139131|NCT00884065|3963396|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4139132|NCT00884065|3963397|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4139133|NCT00884065|3963395|B3||Female|Sex: Female, Male||Participants|Count of Participants|29.0|29.0||||||
4139134|NCT00884065|3963396|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4139135|NCT00884065|3963397|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4139136|NCT00884065|3963395|B3|||Age||years|Mean|58.78|58.78|Standard Deviation|10.33|10.33|||
4139137|NCT00884065|3963396|B2|||Age||years|Mean|60.8|60.8|Standard Deviation|10.12|10.12|||
4139138|NCT00884065|3963397|B1|||Age||years|Mean|56.76|56.76|Standard Deviation|10.33|10.33|||
4139139|NCT00884065|3963395|B3||>=65 years|Age||Participants|Count of Participants|18.0|18.0||||||
4139140|NCT00884065|3963396|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4139141|NCT00884065|3963397|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4139142|NCT00884065|3963395|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32.0|32.0||||||
4139143|NCT00884065|3963396|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4139144|NCT00884065|3963397|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4139145|NCT00884065|3963395|B3||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4139146|NCT00884065|3963396|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4139147|NCT00884065|3963397|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4139148|NCT00884039|3963414|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4139149|NCT00884039|3963415|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4139150|NCT00884039|3963416|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4139151|NCT00884039|3963414|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4139152|NCT00884039|3963415|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4139153|NCT00884039|3963416|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4139154|NCT00884039|3963414|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4139155|NCT00884039|3963415|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4139156|NCT00884039|3963416|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4139157|NCT00884039|3963414|B3|||Age||years|Mean|65|65.0|Standard Deviation|16|16.0|||
4139158|NCT00884039|3963415|B2|||Age||years|Mean|70|70.0|Standard Deviation|2|2.0|||
4139159|NCT00884039|3963416|B1|||Age||years|Mean|64|64.0|Standard Deviation|19|19.0|||
4139160|NCT00884039|3963414|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4139161|NCT00884039|3963415|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4139162|NCT00884039|3963416|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4139163|NCT00884039|3963414|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4139164|NCT00884039|3963415|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4139165|NCT00884039|3963416|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4139166|NCT00884039|3963414|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4139167|NCT00884039|3963415|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4139168|NCT00884039|3963416|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4139169|NCT00883779|3963423|B3||Male|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
4139170|NCT00883779|3963424|B2||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4139171|NCT00883779|3963425|B1||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4139172|NCT00883779|3963423|B3||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4139173|NCT00883779|3963424|B2||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4139174|NCT00883779|3963425|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4139175|NCT00883779|3963423|B3|||Age||years|Mean|56.8|56.8|Standard Deviation|10.41|10.41|||
4139176|NCT00883779|3963424|B2|||Age||years|Mean|57.2|57.2|Standard Deviation|9.71|9.71|||
4139177|NCT00883779|3963425|B1|||Age||years|Mean|56.4|56.4|Standard Deviation|11.08|11.08|||
4139178|NCT00883753|3963462|B1||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4139179|NCT00883753|3963462|B1||Female|Sex: Female, Male||Participants|Count of Participants|753|753.0||||||
4139180|NCT00883753|3963462|B1|||Age||years|Mean|54.3|54.3|Standard Deviation|12.02|12.02|||
4139181|NCT00883740|3963502|B1|Week 7 Sleep Problems Index II Pregablin||MOS-SS Overall Sleep Index II Baseline Measure (Weeks 1 and 7)|Overall Sleep Problem Index II determined by a 9 item index that provided a composite measure of overall sleep. Baseline intervention period 1 collected at week 1 and baseline intervention period 2 collected at week 7. Score ranged from 0 to 100, higher scores indicated greater sleep problems, negative changes indicated improvement.|Scores on a Scale|Mean|48.79|48.79|Standard Deviation|19.89|19.89|||
4139182|NCT00883740|3963502|B1|Week 7 Sleep Problems Index II Placebo||MOS-SS Overall Sleep Index II Baseline Measure (Weeks 1 and 7)|Overall Sleep Problem Index II determined by a 9 item index that provided a composite measure of overall sleep. Baseline intervention period 1 collected at week 1 and baseline intervention period 2 collected at week 7. Score ranged from 0 to 100, higher scores indicated greater sleep problems, negative changes indicated improvement.|Scores on a Scale|Mean|47.22|47.22|Standard Deviation|18.38|18.38|||
4139183|NCT00883740|3963502|B1|Week 1 Sleep Problems Index II Pregabalin||MOS-SS Overall Sleep Index II Baseline Measure (Weeks 1 and 7)|Overall Sleep Problem Index II determined by a 9 item index that provided a composite measure of overall sleep. Baseline intervention period 1 collected at week 1 and baseline intervention period 2 collected at week 7. Score ranged from 0 to 100, higher scores indicated greater sleep problems, negative changes indicated improvement.|Scores on a Scale|Mean|63.21|63.21|Standard Deviation|14.27|14.27|||
4139184|NCT00883740|3963502|B1|Week 1 Sleep Problems Index II Placebo||MOS-SS Overall Sleep Index II Baseline Measure (Weeks 1 and 7)|Overall Sleep Problem Index II determined by a 9 item index that provided a composite measure of overall sleep. Baseline intervention period 1 collected at week 1 and baseline intervention period 2 collected at week 7. Score ranged from 0 to 100, higher scores indicated greater sleep problems, negative changes indicated improvement.|Scores on a Scale|Mean|62.82|62.82|Standard Deviation|12.96|12.96|||
4139185|NCT00883740|3963502|B1|Week 7 Sleep Disturbance Pregabalin||Medical Outcome Study Sleep Scale (MOS-SS) Sleep Disturbance Baseline Measure (Weeks 1 and 7)|Sleep Disturbance subscale as measured by MOS-SS, a participant rated 12 item instrument. Baseline intervention period 1 collected at week 1 and baseline intervention period 2 collected at week 7. Scores were transformed and ranged from 0 to 100, higher scores indicated greater disturbance, negative changes indicated improvement.|Scores on a Scale|Mean|51.51|51.51|Standard Deviation|26.48|26.48|||
4139186|NCT00883740|3963502|B1|Week 7 Sleep Disturbance Placebo||Medical Outcome Study Sleep Scale (MOS-SS) Sleep Disturbance Baseline Measure (Weeks 1 and 7)|Sleep Disturbance subscale as measured by MOS-SS, a participant rated 12 item instrument. Baseline intervention period 1 collected at week 1 and baseline intervention period 2 collected at week 7. Scores were transformed and ranged from 0 to 100, higher scores indicated greater disturbance, negative changes indicated improvement.|Scores on a Scale|Mean|52.75|52.75|Standard Deviation|24.77|24.77|||
4139187|NCT00883740|3963502|B1|Week 1 Sleep Disturbance Pregabalin||Medical Outcome Study Sleep Scale (MOS-SS) Sleep Disturbance Baseline Measure (Weeks 1 and 7)|Sleep Disturbance subscale as measured by MOS-SS, a participant rated 12 item instrument. Baseline intervention period 1 collected at week 1 and baseline intervention period 2 collected at week 7. Scores were transformed and ranged from 0 to 100, higher scores indicated greater disturbance, negative changes indicated improvement.|Scores on a Scale|Mean|69.29|69.29|Standard Deviation|20.44|20.44|||
4139188|NCT00883740|3963502|B1|Week 1 Sleep Disturbance Placebo||Medical Outcome Study Sleep Scale (MOS-SS) Sleep Disturbance Baseline Measure (Weeks 1 and 7)|Sleep Disturbance subscale as measured by MOS-SS, a participant rated 12 item instrument. Baseline intervention period 1 collected at week 1 and baseline intervention period 2 collected at week 7. Scores were transformed and ranged from 0 to 100, higher scores indicated greater disturbance, negative changes indicated improvement.|Scores on a Scale|Mean|69.32|69.32|Standard Deviation|17.48|17.48|||
4139189|NCT00883740|3963502|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4139190|NCT00883740|3963502|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4139191|NCT00883740|3963502|B1|||Age||Years|Mean|48.4|48.4|Standard Deviation|9.9|9.9|||
4139192|NCT00883675|3963543|B1|China||Region of Enrollment||participants|Number|131|131.0||||||
4139193|NCT00883675|3963543|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4139194|NCT00883675|3963543|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4139195|NCT00883675|3963543|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4139196|NCT00883675|3963543|B1|||Age||years|Mean|59.8|59.8|Standard Deviation|9.3|9.3|||
4139197|NCT00883675|3963543|B1||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
4139198|NCT00883675|3963543|B1||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
4139199|NCT00883675|3963543|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4139200|NCT00883558|3963547|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4139201|NCT00883558|3963547|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139202|NCT00883558|3963547|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4139203|NCT00883558|3963547|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4139204|NCT00883558|3963547|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139205|NCT00883558|3963547|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139206|NCT00883558|3963547|B1||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4139207|NCT00883558|3963547|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4139208|NCT00883558|3963547|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139209|NCT00883558|3963547|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139210|NCT00883558|3963547|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139211|NCT00883558|3963547|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4139212|NCT00883558|3963547|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4139213|NCT00883558|3963547|B1|||Age||years|Mean|41.6|41.6|Standard Deviation|13.28|13.28|||
4139214|NCT00883493|3963559|B3|||Body weight|The overall number of subject the measures are reported is 398- the weight of one patient from Quatiapine XR + Lithium Arm has not been recorded at baseline.|Kilograms|Mean|72.5|72.5|Standard Deviation|15.8|15.8|||
4139215|NCT00883493|3963560|B2|||Body weight|The overall number of subject the measures are reported is 398- the weight of one patient from Quatiapine XR + Lithium Arm has not been recorded at baseline.|Kilograms|Mean|72.3|72.3|Standard Deviation|15.4|15.4|||
4139216|NCT00883493|3963561|B1|||Body weight|The overall number of subject the measures are reported is 398- the weight of one patient from Quatiapine XR + Lithium Arm has not been recorded at baseline.|Kilograms|Mean|72.8|72.8|Standard Deviation|16.3|16.3|||
4139217|NCT00883493|3963559|B3||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4139218|NCT00883493|3963560|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4139219|NCT00883493|3963561|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4139220|NCT00883493|3963559|B3||Female|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
4139221|NCT00883493|3963560|B2||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4139222|NCT00883493|3963561|B1||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4139223|NCT00883493|3963559|B3|||Age, Customized||years|Median|40|40.0|Full Range|||18.0|65.0|
4139224|NCT00883493|3963560|B2|||Age, Customized||years|Median|40|40.0|Full Range|||18.0|65.0|
4139225|NCT00883493|3963561|B1|||Age, Customized||years|Median|40|40.0|Full Range|||19.0|64.0|
4139226|NCT00883493|3963559|B3|||Age||Years|Mean|40.3|40.3|Standard Deviation|11.4|11.4|||
4139227|NCT00883493|3963560|B2|||Age||Years|Mean|39.9|39.9|Standard Deviation|12.1|12.1|||
4139228|NCT00883493|3963561|B1|||Age||Years|Mean|40.6|40.6|Standard Deviation|10.8|10.8|||
4139229|NCT00883389|3963586|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4139230|NCT00883389|3963586|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4139231|NCT00883389|3963586|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4139232|NCT00883389|3963586|B1|||Age||years|Mean|65.4|65.4|Standard Deviation|13.8|13.8|||
4139233|NCT00883389|3963586|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4139234|NCT00883389|3963586|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4139235|NCT00883389|3963586|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4139236|NCT00883337|3963590|B4|>3.5||Baseline EDSS score|"EDSS is an ordinal scale in half-point increments that qualifies disability in patients with MS. It consists of 8 ordinal rating scales assessing seven functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation.~EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS)."|participants|Number|40|40.0||||||
4139237|NCT00883337|3963591|B3|>3.5||Baseline EDSS score|"EDSS is an ordinal scale in half-point increments that qualifies disability in patients with MS. It consists of 8 ordinal rating scales assessing seven functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation.~EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS)."|participants|Number|11|11.0||||||
4139238|NCT00883337|3963592|B2|>3.5||Baseline EDSS score|"EDSS is an ordinal scale in half-point increments that qualifies disability in patients with MS. It consists of 8 ordinal rating scales assessing seven functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation.~EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS)."|participants|Number|16|16.0||||||
4139239|NCT00883337|3963593|B1|>3.5||Baseline EDSS score|"EDSS is an ordinal scale in half-point increments that qualifies disability in patients with MS. It consists of 8 ordinal rating scales assessing seven functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation.~EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS)."|participants|Number|13|13.0||||||
4139240|NCT00883337|3963590|B4|≤3.5||Baseline EDSS score|"EDSS is an ordinal scale in half-point increments that qualifies disability in patients with MS. It consists of 8 ordinal rating scales assessing seven functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation.~EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS)."|participants|Number|284|284.0||||||
4139241|NCT00883337|3963591|B3|≤3.5||Baseline EDSS score|"EDSS is an ordinal scale in half-point increments that qualifies disability in patients with MS. It consists of 8 ordinal rating scales assessing seven functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation.~EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS)."|participants|Number|93|93.0||||||
4139242|NCT00883337|3963592|B2|≤3.5||Baseline EDSS score|"EDSS is an ordinal scale in half-point increments that qualifies disability in patients with MS. It consists of 8 ordinal rating scales assessing seven functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation.~EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS)."|participants|Number|95|95.0||||||
4139243|NCT00883337|3963593|B1|≤3.5||Baseline EDSS score|"EDSS is an ordinal scale in half-point increments that qualifies disability in patients with MS. It consists of 8 ordinal rating scales assessing seven functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation.~EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS)."|participants|Number|96|96.0||||||
4139244|NCT00883337|3963590|B4|Progressive Relapsing||MS subtype||participants|Number|2|2.0||||||
4139245|NCT00883337|3963591|B3|Progressive Relapsing||MS subtype||participants|Number|0|0.0||||||
4139246|NCT00883337|3963592|B2|Progressive Relapsing||MS subtype||participants|Number|2|2.0||||||
4139247|NCT00883337|3963593|B1|Progressive Relapsing||MS subtype||participants|Number|0|0.0||||||
4139248|NCT00883337|3963590|B4|Secondary Progressive||MS subtype||participants|Number|1|1.0||||||
4139249|NCT00883337|3963591|B3|Secondary Progressive||MS subtype||participants|Number|0|0.0||||||
4139250|NCT00883337|3963592|B2|Secondary Progressive||MS subtype||participants|Number|1|1.0||||||
4139251|NCT00883337|3963593|B1|Secondary Progressive||MS subtype||participants|Number|0|0.0||||||
4139252|NCT00883337|3963590|B4|Relapsing Remitting||MS subtype||participants|Number|321|321.0||||||
4139253|NCT00883337|3963591|B3|Relapsing Remitting||MS subtype||participants|Number|104|104.0||||||
4139254|NCT00883337|3963592|B2|Relapsing Remitting||MS subtype||participants|Number|108|108.0||||||
4139255|NCT00883337|3963593|B1|Relapsing Remitting||MS subtype||participants|Number|109|109.0||||||
4139256|NCT00883337|3963590|B4|||Time since most recent MS relapse onset|The information was not available for one participant in the Teriflunomide 14 mg group|months|Mean|8.88|8.88|Standard Deviation|11.79|11.79|||
4139257|NCT00883337|3963591|B3|||Time since most recent MS relapse onset|The information was not available for one participant in the Teriflunomide 14 mg group|months|Mean|9.79|9.79|Standard Deviation|10.72|10.72|||
4139258|NCT00883337|3963592|B2|||Time since most recent MS relapse onset|The information was not available for one participant in the Teriflunomide 14 mg group|months|Mean|7.90|7.9|Standard Deviation|10.34|10.34|||
4139259|NCT00883337|3963593|B1|||Time since most recent MS relapse onset|The information was not available for one participant in the Teriflunomide 14 mg group|months|Mean|9.00|9.0|Standard Deviation|13.96|13.96|||
4139260|NCT00883337|3963590|B4|Within the past 2 years||Number of MS relapses||relapses|Median|2|2.0|Full Range|||0.0|6.0|
4139261|NCT00883337|3963591|B3|Within the past 2 years||Number of MS relapses||relapses|Median|2|2.0|Full Range|||0.0|6.0|
4139262|NCT00883337|3963592|B2|Within the past 2 years||Number of MS relapses||relapses|Median|2|2.0|Full Range|||0.0|4.0|
4139263|NCT00883337|3963593|B1|Within the past 2 years||Number of MS relapses||relapses|Median|2|2.0|Full Range|||0.0|4.0|
4139264|NCT00883337|3963590|B4|Within the past year||Number of MS relapses||relapses|Median|1|1.0|Full Range|||0.0|5.0|
4139265|NCT00883337|3963591|B3|Within the past year||Number of MS relapses||relapses|Median|1|1.0|Full Range|||0.0|5.0|
4139266|NCT00883337|3963592|B2|Within the past year||Number of MS relapses||relapses|Median|1|1.0|Full Range|||0.0|4.0|
4139267|NCT00883337|3963593|B1|Within the past year||Number of MS relapses||relapses|Median|1|1.0|Full Range|||0.0|3.0|
4139268|NCT00883337|3963590|B4|||Time since first diagnosis of Multiple Sclerosis [MS]||years|Mean|3.74|3.74|Standard Deviation|5.71|5.71|||
4139269|NCT00883337|3963591|B3|||Time since first diagnosis of Multiple Sclerosis [MS]||years|Mean|3.82|3.82|Standard Deviation|5.69|5.69|||
4139270|NCT00883337|3963592|B2|||Time since first diagnosis of Multiple Sclerosis [MS]||years|Mean|3.68|3.68|Standard Deviation|6.24|6.24|||
4139271|NCT00883337|3963593|B1|||Time since first diagnosis of Multiple Sclerosis [MS]||years|Mean|3.72|3.72|Standard Deviation|5.19|5.19|||
4139272|NCT00883337|3963590|B4|Western Europe*||Region of enrollment|"Due the small sample size in some countries, the countries were pooled as follows:~North America: Canada;~Eastern Europe: Czech Republic, Greece, Hungary and Poland;~Western Europe: Belgium, France, Germany, Italy, Spain, Switzerland and United Kingdon;~'*' the only participant in Tunisia was included in the Western Europe group."|participants|Number|188|188.0||||||
4139273|NCT00883337|3963591|B3|Western Europe*||Region of enrollment|"Due the small sample size in some countries, the countries were pooled as follows:~North America: Canada;~Eastern Europe: Czech Republic, Greece, Hungary and Poland;~Western Europe: Belgium, France, Germany, Italy, Spain, Switzerland and United Kingdon;~'*' the only participant in Tunisia was included in the Western Europe group."|participants|Number|62|62.0||||||
4139274|NCT00883337|3963592|B2|Western Europe*||Region of enrollment|"Due the small sample size in some countries, the countries were pooled as follows:~North America: Canada;~Eastern Europe: Czech Republic, Greece, Hungary and Poland;~Western Europe: Belgium, France, Germany, Italy, Spain, Switzerland and United Kingdon;~'*' the only participant in Tunisia was included in the Western Europe group."|participants|Number|64|64.0||||||
4139275|NCT00883337|3963593|B1|Western Europe*||Region of enrollment|"Due the small sample size in some countries, the countries were pooled as follows:~North America: Canada;~Eastern Europe: Czech Republic, Greece, Hungary and Poland;~Western Europe: Belgium, France, Germany, Italy, Spain, Switzerland and United Kingdon;~'*' the only participant in Tunisia was included in the Western Europe group."|participants|Number|62|62.0||||||
4139276|NCT00883337|3963590|B4|Eastern Europe||Region of enrollment|"Due the small sample size in some countries, the countries were pooled as follows:~North America: Canada;~Eastern Europe: Czech Republic, Greece, Hungary and Poland;~Western Europe: Belgium, France, Germany, Italy, Spain, Switzerland and United Kingdon;~'*' the only participant in Tunisia was included in the Western Europe group."|participants|Number|115|115.0||||||
4139277|NCT00883337|3963591|B3|Eastern Europe||Region of enrollment|"Due the small sample size in some countries, the countries were pooled as follows:~North America: Canada;~Eastern Europe: Czech Republic, Greece, Hungary and Poland;~Western Europe: Belgium, France, Germany, Italy, Spain, Switzerland and United Kingdon;~'*' the only participant in Tunisia was included in the Western Europe group."|participants|Number|35|35.0||||||
4139278|NCT00883337|3963592|B2|Eastern Europe||Region of enrollment|"Due the small sample size in some countries, the countries were pooled as follows:~North America: Canada;~Eastern Europe: Czech Republic, Greece, Hungary and Poland;~Western Europe: Belgium, France, Germany, Italy, Spain, Switzerland and United Kingdon;~'*' the only participant in Tunisia was included in the Western Europe group."|participants|Number|41|41.0||||||
4139279|NCT00883337|3963593|B1|Eastern Europe||Region of enrollment|"Due the small sample size in some countries, the countries were pooled as follows:~North America: Canada;~Eastern Europe: Czech Republic, Greece, Hungary and Poland;~Western Europe: Belgium, France, Germany, Italy, Spain, Switzerland and United Kingdon;~'*' the only participant in Tunisia was included in the Western Europe group."|participants|Number|39|39.0||||||
4139614|NCT00883090|3963946|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4139280|NCT00883337|3963590|B4|North America||Region of enrollment|"Due the small sample size in some countries, the countries were pooled as follows:~North America: Canada;~Eastern Europe: Czech Republic, Greece, Hungary and Poland;~Western Europe: Belgium, France, Germany, Italy, Spain, Switzerland and United Kingdon;~'*' the only participant in Tunisia was included in the Western Europe group."|participants|Number|21|21.0||||||
4139281|NCT00883337|3963591|B3|North America||Region of enrollment|"Due the small sample size in some countries, the countries were pooled as follows:~North America: Canada;~Eastern Europe: Czech Republic, Greece, Hungary and Poland;~Western Europe: Belgium, France, Germany, Italy, Spain, Switzerland and United Kingdon;~'*' the only participant in Tunisia was included in the Western Europe group."|participants|Number|7|7.0||||||
4139282|NCT00883337|3963592|B2|North America||Region of enrollment|"Due the small sample size in some countries, the countries were pooled as follows:~North America: Canada;~Eastern Europe: Czech Republic, Greece, Hungary and Poland;~Western Europe: Belgium, France, Germany, Italy, Spain, Switzerland and United Kingdon;~'*' the only participant in Tunisia was included in the Western Europe group."|participants|Number|6|6.0||||||
4139283|NCT00883337|3963593|B1|North America||Region of enrollment|"Due the small sample size in some countries, the countries were pooled as follows:~North America: Canada;~Eastern Europe: Czech Republic, Greece, Hungary and Poland;~Western Europe: Belgium, France, Germany, Italy, Spain, Switzerland and United Kingdon;~'*' the only participant in Tunisia was included in the Western Europe group."|participants|Number|8|8.0||||||
4139284|NCT00883337|3963590|B4||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4139285|NCT00883337|3963591|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4139286|NCT00883337|3963592|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4139287|NCT00883337|3963593|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4139288|NCT00883337|3963590|B4||Female|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
4139289|NCT00883337|3963591|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4139290|NCT00883337|3963592|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4139291|NCT00883337|3963593|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4139292|NCT00883337|3963590|B4|||Age||years|Mean|36.3|36.3|Standard Deviation|10.0|10.0|||
4139293|NCT00883337|3963591|B3|||Age||years|Mean|37.0|37.0|Standard Deviation|10.6|10.6|||
4139294|NCT00883337|3963592|B2|||Age||years|Mean|36.8|36.8|Standard Deviation|10.3|10.3|||
4139295|NCT00883337|3963593|B1|||Age||years|Mean|32.5|32.5|Standard Deviation|9.2|9.2|||
4139296|NCT00883246|3963627|B1|No Diabetes||Diabetes||participants|Number|381|381.0||||||
4139297|NCT00883246|3963627|B1|Diabetes||Diabetes||participants|Number|418|418.0||||||
4139298|NCT00883246|3963627|B1|United States||Region of Enrollment||participants|Number|692|692.0||||||
4139299|NCT00883246|3963627|B1|Europe||Region of Enrollment||participants|Number|107|107.0||||||
4139300|NCT00883246|3963627|B1||Male|Sex: Female, Male||Participants|Count of Participants|436|436.0||||||
4139301|NCT00883246|3963627|B1||Female|Sex: Female, Male||Participants|Count of Participants|363|363.0||||||
4139302|NCT00883246|3963627|B1|||Age||years|Mean|70.1|70.1|Standard Deviation|10.7|10.7|||
4139303|NCT00883246|3963627|B1||>=65 years|Age||Participants|Count of Participants|540|540.0||||||
4139304|NCT00883246|3963627|B1||Between 18 and 65 years|Age||Participants|Count of Participants|259|259.0||||||
4139305|NCT00883246|3963627|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4139306|NCT00883233|3963645|B5|Canada||Region of Enrollment||participants|Number|123|123.0||||||
4139307|NCT00883233|3963646|B4|Canada||Region of Enrollment||participants|Number|30|30.0||||||
4139308|NCT00883233|3963647|B3|Canada||Region of Enrollment||participants|Number|29|29.0||||||
4139309|NCT00883233|3963648|B2|Canada||Region of Enrollment||participants|Number|32|32.0||||||
4139310|NCT00883233|3963649|B1|Canada||Region of Enrollment||participants|Number|32|32.0||||||
4139311|NCT00883233|3963645|B5||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4139312|NCT00883233|3963646|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4139313|NCT00883233|3963647|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4139314|NCT00883233|3963648|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4139315|NCT00883233|3963649|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4139316|NCT00883233|3963645|B5||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4139317|NCT00883233|3963646|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4139318|NCT00883233|3963647|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4139319|NCT00883233|3963648|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4139320|NCT00883233|3963649|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4139321|NCT00883233|3963645|B5|||Age||years|Mean|20.6|20.6|Standard Deviation|6.43|6.43|||
4139322|NCT00883233|3963646|B4|||Age||years|Mean|20.8|20.8|Standard Deviation|6.31|6.31|||
4139323|NCT00883233|3963647|B3|||Age||years|Mean|20.9|20.9|Standard Deviation|6.83|6.83|||
4139324|NCT00883233|3963648|B2|||Age||years|Mean|20.4|20.4|Standard Deviation|6.39|6.39|||
4139325|NCT00883233|3963649|B1|||Age||years|Mean|20.2|20.2|Standard Deviation|6.5|6.5|||
4139326|NCT00883233|3963645|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4139327|NCT00883233|3963646|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4139328|NCT00883233|3963647|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4139329|NCT00883233|3963648|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4139330|NCT00883233|3963649|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4139331|NCT00883233|3963645|B5||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4139332|NCT00883233|3963646|B4||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4139333|NCT00883233|3963647|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4139334|NCT00883233|3963648|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4139335|NCT00883233|3963649|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4139336|NCT00883233|3963645|B5||<=18 years|Age||Participants|Count of Participants|57|57.0||||||
4139337|NCT00883233|3963646|B4||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4139338|NCT00883233|3963647|B3||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4139339|NCT00883233|3963648|B2||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4139340|NCT00883233|3963649|B1||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4139341|NCT00883181|3963662|B1|Sexual dysfunction||Anemia Symptoms|Anemia symptoms were available for 692 participants at baseline. Participants may have more than one anemia symptom.|participants|Number|54|54.0||||||
4139342|NCT00883181|3963662|B1|Metabolic dysfunction||Anemia Symptoms|Anemia symptoms were available for 692 participants at baseline. Participants may have more than one anemia symptom.|participants|Number|32|32.0||||||
4139343|NCT00883181|3963662|B1|Impaired immune system||Anemia Symptoms|Anemia symptoms were available for 692 participants at baseline. Participants may have more than one anemia symptom.|participants|Number|12|12.0||||||
4139344|NCT00883181|3963662|B1|Impaired cognitive function||Anemia Symptoms|Anemia symptoms were available for 692 participants at baseline. Participants may have more than one anemia symptom.|participants|Number|17|17.0||||||
4139345|NCT00883181|3963662|B1|Anorexia||Anemia Symptoms|Anemia symptoms were available for 692 participants at baseline. Participants may have more than one anemia symptom.|participants|Number|65|65.0||||||
4139346|NCT00883181|3963662|B1|Nausea||Anemia Symptoms|Anemia symptoms were available for 692 participants at baseline. Participants may have more than one anemia symptom.|participants|Number|38|38.0||||||
4139347|NCT00883181|3963662|B1|Depression||Anemia Symptoms|Anemia symptoms were available for 692 participants at baseline. Participants may have more than one anemia symptom.|participants|Number|113|113.0||||||
4139348|NCT00883181|3963662|B1|Irritability||Anemia Symptoms|Anemia symptoms were available for 692 participants at baseline. Participants may have more than one anemia symptom.|participants|Number|66|66.0||||||
4139349|NCT00883181|3963662|B1|Dizziness and/or vertigo||Anemia Symptoms|Anemia symptoms were available for 692 participants at baseline. Participants may have more than one anemia symptom.|participants|Number|49|49.0||||||
4139350|NCT00883181|3963662|B1|Tachycardia and/or palpitations||Anemia Symptoms|Anemia symptoms were available for 692 participants at baseline. Participants may have more than one anemia symptom.|participants|Number|48|48.0||||||
4139351|NCT00883181|3963662|B1|Dyspnea||Anemia Symptoms|Anemia symptoms were available for 692 participants at baseline. Participants may have more than one anemia symptom.|participants|Number|101|101.0||||||
4139352|NCT00883181|3963662|B1|Headache||Anemia Symptoms|Anemia symptoms were available for 692 participants at baseline. Participants may have more than one anemia symptom.|participants|Number|53|53.0||||||
4139353|NCT00883181|3963662|B1|Pallor/Pale skin||Anemia Symptoms|Anemia symptoms were available for 692 participants at baseline. Participants may have more than one anemia symptom.|participants|Number|86|86.0||||||
4139354|NCT00883181|3963662|B1|Fatigue/tiredness||Anemia Symptoms|Anemia symptoms were available for 692 participants at baseline. Participants may have more than one anemia symptom.|participants|Number|197|197.0||||||
4139355|NCT00883181|3963662|B1|Missing||Hemoglobin Level||participants|Number|81|81.0||||||
4139356|NCT00883181|3963662|B1|≥ 11 g/dL||Hemoglobin Level||participants|Number|1091|1091.0||||||
4139357|NCT00883181|3963662|B1|< 11 g/dL||Hemoglobin Level||participants|Number|175|175.0||||||
4139358|NCT00883181|3963662|B1|Missing||Prior Febrile Neutropenia Episodes|Episodes of febrile neutropenia (FN) that occurred during prior cancer treatment; 698 participants had received prior treatment.|participants|Number|450|450.0||||||
4139359|NCT00883181|3963662|B1|No prior FN episodes||Prior Febrile Neutropenia Episodes|Episodes of febrile neutropenia (FN) that occurred during prior cancer treatment; 698 participants had received prior treatment.|participants|Number|213|213.0||||||
4139360|NCT00883181|3963662|B1|Any prior FN episodes||Prior Febrile Neutropenia Episodes|Episodes of febrile neutropenia (FN) that occurred during prior cancer treatment; 698 participants had received prior treatment.|participants|Number|35|35.0||||||
4139361|NCT00883181|3963662|B1|Missing||Prior Treatment||participants|Number|2|2.0||||||
4139362|NCT00883181|3963662|B1|Other||Prior Treatment||participants|Number|80|80.0||||||
4139363|NCT00883181|3963662|B1|Surgery||Prior Treatment||participants|Number|449|449.0||||||
4139364|NCT00883181|3963662|B1|Chemotherapy and radiotherapy||Prior Treatment||participants|Number|62|62.0||||||
4139365|NCT00883181|3963662|B1|Radiotherapy only||Prior Treatment||participants|Number|19|19.0||||||
4139366|NCT00883181|3963662|B1|Chemotherapy only||Prior Treatment||participants|Number|88|88.0||||||
4139367|NCT00883181|3963662|B1|None||Prior Treatment||participants|Number|647|647.0||||||
4139368|NCT00883181|3963662|B1|Breast cancer||Tumor Type||participants|Number|829|829.0||||||
4139369|NCT00883181|3963662|B1|Small cell lung cancer (SCLC)||Tumor Type||participants|Number|137|137.0||||||
4139370|NCT00883181|3963662|B1|Non-small cell lung cancer (NSCLC)||Tumor Type||participants|Number|224|224.0||||||
4139371|NCT00883181|3963662|B1|Ovarian cancer||Tumor Type||participants|Number|157|157.0||||||
4139372|NCT00883181|3963662|B1|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|19|19.0||||||
4139413|NCT00883168|3963872|B4||Between 18 and 65 years|Age||Participants|Count of Participants|387|387.0||||||
4139414|NCT00883168|3963873|B3||Between 18 and 65 years|Age||Participants|Count of Participants|390|390.0||||||
4139415|NCT00883168|3963874|B2||Between 18 and 65 years|Age||Participants|Count of Participants|390|390.0||||||
4139373|NCT00883181|3963662|B1|4 – 100% Bedridden||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4139374|NCT00883181|3963662|B1|3 – Confined to Bed ≥ 50% of Time||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|9|9.0||||||
4139375|NCT00883181|3963662|B1|2 – Confined to Bed ≤ 50% of Time||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|99|99.0||||||
4139376|NCT00883181|3963662|B1|1 – Symptoms but Ambulatory||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|346|346.0||||||
4139377|NCT00883181|3963662|B1|0 – Normal Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|874|874.0||||||
4139378|NCT00883181|3963662|B1|Not Applicable||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4139379|NCT00883181|3963662|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4139380|NCT00883181|3963662|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4139381|NCT00883181|3963662|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4139382|NCT00883181|3963662|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4139383|NCT00883181|3963662|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|1324|1324.0||||||
4139384|NCT00883181|3963662|B1||Male|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4139385|NCT00883181|3963662|B1||Female|Sex: Female, Male||Participants|Count of Participants|1072|1072.0||||||
4139386|NCT00883181|3963662|B1|||Age||years|Mean|56.4|56.4|Standard Deviation|11.3|11.3|||
4139387|NCT00883168|3963871|B5|United States||Region of Enrollment||participants|Number|1791|1791.0||||||
4139388|NCT00883168|3963872|B4|United States||Region of Enrollment||participants|Number|448|448.0||||||
4139389|NCT00883168|3963873|B3|United States||Region of Enrollment||participants|Number|450|450.0||||||
4139390|NCT00883168|3963874|B2|United States||Region of Enrollment||participants|Number|445|445.0||||||
4139391|NCT00883168|3963875|B1|United States||Region of Enrollment||participants|Number|448|448.0||||||
4139392|NCT00883168|3963871|B5||Male|Sex: Female, Male||Participants|Count of Participants|694|694.0||||||
4139393|NCT00883168|3963872|B4||Male|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4139394|NCT00883168|3963873|B3||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4139395|NCT00883168|3963874|B2||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4139396|NCT00883168|3963875|B1||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4139397|NCT00883168|3963871|B5||Female|Sex: Female, Male||Participants|Count of Participants|1097|1097.0||||||
4139398|NCT00883168|3963872|B4||Female|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
4139399|NCT00883168|3963873|B3||Female|Sex: Female, Male||Participants|Count of Participants|280|280.0||||||
4139400|NCT00883168|3963874|B2||Female|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
4139401|NCT00883168|3963875|B1||Female|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
4139402|NCT00883168|3963871|B5|||Age||years|Mean|35.2|35.2|Standard Deviation|14.5|14.5|||
4139403|NCT00883168|3963872|B4|||Age||years|Mean|34.7|34.7|Standard Deviation|14.1|14.1|||
4139404|NCT00883168|3963873|B3|||Age||years|Mean|34.2|34.2|Standard Deviation|14.5|14.5|||
4139405|NCT00883168|3963874|B2|||Age||years|Mean|36.4|36.4|Standard Deviation|14.8|14.8|||
4139406|NCT00883168|3963875|B1|||Age||years|Mean|35.6|35.6|Standard Deviation|14.5|14.5|||
4139407|NCT00883168|3963871|B5||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
4139408|NCT00883168|3963872|B4||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4139409|NCT00883168|3963873|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4139410|NCT00883168|3963874|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4139411|NCT00883168|3963875|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4139412|NCT00883168|3963871|B5||Between 18 and 65 years|Age||Participants|Count of Participants|1549|1549.0||||||
4139416|NCT00883168|3963875|B1||Between 18 and 65 years|Age||Participants|Count of Participants|382|382.0||||||
4139417|NCT00883168|3963871|B5||<=18 years|Age||Participants|Count of Participants|197|197.0||||||
4139418|NCT00883168|3963872|B4||<=18 years|Age||Participants|Count of Participants|46|46.0||||||
4139419|NCT00883168|3963873|B3||<=18 years|Age||Participants|Count of Participants|56|56.0||||||
4139420|NCT00883168|3963874|B2||<=18 years|Age||Participants|Count of Participants|38|38.0||||||
4139421|NCT00883168|3963875|B1||<=18 years|Age||Participants|Count of Participants|57|57.0||||||
4139422|NCT00883129|3963896|B3|||Centromere(+)||Participants|Count of Participants|3|3.0||||||
4139423|NCT00883129|3963897|B2|||Centromere(+)||Participants|Count of Participants|2|2.0||||||
4139424|NCT00883129|3963898|B1|||Centromere(+)||Participants|Count of Participants|1|1.0||||||
4139425|NCT00883129|3963896|B3|||RNA Polymerase(+)||Participants|Count of Participants|18|18.0||||||
4139426|NCT00883129|3963897|B2|||RNA Polymerase(+)||Participants|Count of Participants|9|9.0||||||
4139427|NCT00883129|3963898|B1|||RNA Polymerase(+)||Participants|Count of Participants|9|9.0||||||
4139428|NCT00883129|3963896|B3|||Topoisomerase-1(+)||Participants|Count of Participants|61|61.0||||||
4139429|NCT00883129|3963897|B2|||Topoisomerase-1(+)||Participants|Count of Participants|32|32.0||||||
4139430|NCT00883129|3963898|B1|||Topoisomerase-1(+)||Participants|Count of Participants|29|29.0||||||
4139431|NCT00883129|3963896|B3|||ANA(+)||Participants|Count of Participants|127|127.0||||||
4139432|NCT00883129|3963897|B2|||ANA(+)||Participants|Count of Participants|66|66.0||||||
4139433|NCT00883129|3963898|B1|||ANA(+)||Participants|Count of Participants|61|61.0||||||
4139434|NCT00883129|3963896|B3|||Quantitative extent of total insterstitial lung disease on HRCT, for lobe of maximum involvement|Score range 0 to 100, with higher score indicating greater lung involvement|Score|Mean|51.2|51.2|Standard Deviation|20.3|20.3|||
4139435|NCT00883129|3963897|B2|||Quantitative extent of total insterstitial lung disease on HRCT, for lobe of maximum involvement|Score range 0 to 100, with higher score indicating greater lung involvement|Score|Mean|52.3|52.3|Standard Deviation|19.9|19.9|||
4139436|NCT00883129|3963898|B1|||Quantitative extent of total insterstitial lung disease on HRCT, for lobe of maximum involvement|Score range 0 to 100, with higher score indicating greater lung involvement|Score|Mean|50.0|50.0|Standard Deviation|20.9|20.9|||
4139437|NCT00883129|3963896|B3|||Quantitative extent of total insterstitial lung disease on HRCT, for whole lung|Score range 0 to 100, with higher score indicating greater lung involvement|Score|Mean|29.5|29.5|Standard Deviation|14.0|14.0|||
4139438|NCT00883129|3963897|B2|||Quantitative extent of total insterstitial lung disease on HRCT, for whole lung|Score range 0 to 100, with higher score indicating greater lung involvement|Score|Mean|31.6|31.6|Standard Deviation|14.4|14.4|||
4139439|NCT00883129|3963898|B1|||Quantitative extent of total insterstitial lung disease on HRCT, for whole lung|Score range 0 to 100, with higher score indicating greater lung involvement|Score|Mean|27.2|27.2|Standard Deviation|13.2|13.2|||
4139440|NCT00883129|3963896|B3|||Quantitative extent of lung fibrosis on HRCT, for lobe of maximum involvement|Score range 0 to 100, with higher score indicating greater lung involvement|Score|Mean|22.8|22.8|Standard Deviation|19.6|19.6|||
4139441|NCT00883129|3963897|B2|||Quantitative extent of lung fibrosis on HRCT, for lobe of maximum involvement|Score range 0 to 100, with higher score indicating greater lung involvement|Score|Mean|22.6|22.6|Standard Deviation|19.3|19.3|||
4139442|NCT00883129|3963898|B1|||Quantitative extent of lung fibrosis on HRCT, for lobe of maximum involvement|Score range 0 to 100, with higher score indicating greater lung involvement|Score|Mean|23.0|23.0|Standard Deviation|20.2|20.2|||
4139443|NCT00883129|3963896|B3|||Quantitative extent of lung fibrosis on HRCT, for whole lung|Score range 0 to 100, with higher score indicating greater lung involvement|Score|Mean|8.6|8.6|Standard Deviation|6.9|6.9|||
4139444|NCT00883129|3963897|B2|||Quantitative extent of lung fibrosis on HRCT, for whole lung|Score range 0 to 100, with higher score indicating greater lung involvement|Score|Mean|8.9|8.9|Standard Deviation|7.0|7.0|||
4139445|NCT00883129|3963898|B1|||Quantitative extent of lung fibrosis on HRCT, for whole lung|Score range 0 to 100, with higher score indicating greater lung involvement|Score|Mean|8.3|8.3|Standard Deviation|6.9|6.9|||
4139446|NCT00883129|3963896|B3|||HAQ disability index|Score range 0-3, with higher scores indicating greater disability|Score|Mean|0.7|0.7|Standard Deviation|0.7|0.7|||
4139447|NCT00883129|3963897|B2|||HAQ disability index|Score range 0-3, with higher scores indicating greater disability|Score|Mean|0.7|0.7|Standard Deviation|0.7|0.7|||
4139448|NCT00883129|3963898|B1|||HAQ disability index|Score range 0-3, with higher scores indicating greater disability|Score|Mean|0.7|0.7|Standard Deviation|0.6|0.6|||
4139449|NCT00883129|3963896|B3|||SF-36 Mental component|Score range 0-100, with lower scores indicating worse health status|Score|Mean|49.4|49.4|Standard Deviation|9.0|9.0|||
4139450|NCT00883129|3963897|B2|||SF-36 Mental component|Score range 0-100, with lower scores indicating worse health status|Score|Mean|49.8|49.8|Standard Deviation|10.0|10.0|||
4139451|NCT00883129|3963898|B1|||SF-36 Mental component|Score range 0-100, with lower scores indicating worse health status|Score|Mean|49.1|49.1|Standard Deviation|7.9|7.9|||
4139452|NCT00883129|3963896|B3|||SF-36 Physical component|Score range 0-100, with lower scores indicating worse health status|Score|Mean|35.8|35.8|Standard Deviation|9.9|9.9|||
4139453|NCT00883129|3963897|B2|||SF-36 Physical component|Score range 0-100, with lower scores indicating worse health status|Score|Mean|35.6|35.6|Standard Deviation|9.8|9.8|||
4139454|NCT00883129|3963898|B1|||SF-36 Physical component|Score range 0-100, with lower scores indicating worse health status|Score|Mean|36.0|36.0|Standard Deviation|10.0|10.0|||
4139455|NCT00883129|3963896|B3|||Mahler Dyspnea Index, mean focal score|Scores range 0-12, with lower scores indicating worse dyspnea|Score|Mean|7.2|7.2|Standard Deviation|2.2|2.2|||
4139456|NCT00883129|3963897|B2|||Mahler Dyspnea Index, mean focal score|Scores range 0-12, with lower scores indicating worse dyspnea|Score|Mean|7.1|7.1|Standard Deviation|2.3|2.3|||
4139457|NCT00883129|3963898|B1|||Mahler Dyspnea Index, mean focal score|Scores range 0-12, with lower scores indicating worse dyspnea|Score|Mean|7.3|7.3|Standard Deviation|2.1|2.1|||
4139458|NCT00883129|3963896|B3|||Single-Breath Diffusing Capacity||Percent of predicted normal value|Mean|60.9|60.9|Standard Deviation|12.8|12.8|||
4139459|NCT00883129|3963897|B2|||Single-Breath Diffusing Capacity||Percent of predicted normal value|Mean|61.0|61.0|Standard Deviation|13.7|13.7|||
4139460|NCT00883129|3963898|B1|||Single-Breath Diffusing Capacity||Percent of predicted normal value|Mean|60.9|60.9|Standard Deviation|11.8|11.8|||
4139461|NCT00883129|3963896|B3|||Total Lung Capacity||Percent of predicted normal value|Mean|65.8|65.8|Standard Deviation|11.1|11.1|||
4139462|NCT00883129|3963897|B2|||Total Lung Capacity||Percent of predicted normal value|Mean|65.5|65.5|Standard Deviation|12.0|12.0|||
4139463|NCT00883129|3963898|B1|||Total Lung Capacity||Percent of predicted normal value|Mean|66.3|66.3|Standard Deviation|10.0|10.0|||
4139464|NCT00883129|3963896|B3|||FEV1/FVC %-predicted||Percent of predicted normal value|Mean|82.6|82.6|Standard Deviation|5.6|5.6|||
4139465|NCT00883129|3963897|B2|||FEV1/FVC %-predicted||Percent of predicted normal value|Mean|83.3|83.3|Standard Deviation|5.6|5.6|||
4139466|NCT00883129|3963898|B1|||FEV1/FVC %-predicted||Percent of predicted normal value|Mean|81.0|81.0|Standard Deviation|5.5|5.5|||
4139467|NCT00883129|3963896|B3|||FVC %-predicted||Percent of predicted normal value|Mean|66.5|66.5|Standard Deviation|9.9|9.9|||
4139468|NCT00883129|3963897|B2|||FVC %-predicted||Percent of predicted normal value|Mean|66.5|66.5|Standard Deviation|8.3|8.3|||
4139469|NCT00883129|3963898|B1|||FVC %-predicted||Percent of predicted normal value|Mean|66.5|66.5|Standard Deviation|9.1|9.1|||
4139470|NCT00883129|3963896|B3|||modified-Rodnan Skin Score|Skin score may range 0-51, with higher scores indicating more severe thickening|Score|Mean|14.7|14.7|Standard Deviation|10.5|10.5|||
4139471|NCT00883129|3963897|B2|||modified-Rodnan Skin Score|Skin score may range 0-51, with higher scores indicating more severe thickening|Score|Mean|14.0|14.0|Standard Deviation|10.6|10.6|||
4139472|NCT00883129|3963898|B1|||modified-Rodnan Skin Score|Skin score may range 0-51, with higher scores indicating more severe thickening|Score|Mean|15.3|15.3|Standard Deviation|10.4|10.4|||
4139473|NCT00883129|3963896|B3|||Diffuse cutaneous scleroderma||Participants|Count of Participants|83|83.0||||||
4139474|NCT00883129|3963897|B2|||Diffuse cutaneous scleroderma||Participants|Count of Participants|40|40.0||||||
4139475|NCT00883129|3963898|B1|||Diffuse cutaneous scleroderma||Participants|Count of Participants|43|43.0||||||
4139476|NCT00883129|3963896|B3|||Limited cutaneous scleroderma||Participants|Count of Participants|59|59.0||||||
4139477|NCT00883129|3963897|B2|||Limited cutaneous scleroderma||Participants|Count of Participants|33|33.0||||||
4139478|NCT00883129|3963898|B1|||Limited cutaneous scleroderma||Participants|Count of Participants|26|26.0||||||
4139479|NCT00883129|3963896|B3|||Duration of scleroderma||years|Mean|2.6|2.6|Standard Deviation|1.8|1.8|||
4139480|NCT00883129|3963897|B2|||Duration of scleroderma||years|Mean|2.5|2.5|Standard Deviation|1.8|1.8|||
4139481|NCT00883129|3963898|B1|||Duration of scleroderma||years|Mean|2.6|2.6|Standard Deviation|1.7|1.7|||
4139482|NCT00883129|3963896|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4139483|NCT00883129|3963897|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4139484|NCT00883129|3963898|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4139485|NCT00883129|3963896|B3||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4139486|NCT00883129|3963897|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4139487|NCT00883129|3963898|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4139488|NCT00883129|3963896|B3|||Age||years|Mean|52.3|52.3|Standard Deviation|9.7|9.7|||
4139489|NCT00883129|3963897|B2|||Age||years|Mean|52.0|52.0|Standard Deviation|9.8|9.8|||
4139490|NCT00883129|3963898|B1|||Age||years|Mean|52.6|52.6|Standard Deviation|9.7|9.7|||
4139491|NCT00883116|3963921|B3|Not reported||Karnofsky Performance Scale Index Status|This scale classifies patients by functional impairment. The lower the Karnofsky score, the more impaired the patient is. 100=No complaints; 90=Normal activity; 80=Normal activity with effort; 70=Cares for self but unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most of his personal needs; 50=Requires considerable assistance; 40=Disabled; requires special care; 30=Severely disabled hospitalization indicated; 20=Very sick; hospital admission necessary; 10=Fatal processes progressing rapidly; 0=Death.|Participants|Number|1|1.0||||||
4139492|NCT00883116|3963922|B2|Not reported||Karnofsky Performance Scale Index Status|This scale classifies patients by functional impairment. The lower the Karnofsky score, the more impaired the patient is. 100=No complaints; 90=Normal activity; 80=Normal activity with effort; 70=Cares for self but unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most of his personal needs; 50=Requires considerable assistance; 40=Disabled; requires special care; 30=Severely disabled hospitalization indicated; 20=Very sick; hospital admission necessary; 10=Fatal processes progressing rapidly; 0=Death.|Participants|Number|1|1.0||||||
4139493|NCT00883116|3963923|B1|Not reported||Karnofsky Performance Scale Index Status|This scale classifies patients by functional impairment. The lower the Karnofsky score, the more impaired the patient is. 100=No complaints; 90=Normal activity; 80=Normal activity with effort; 70=Cares for self but unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most of his personal needs; 50=Requires considerable assistance; 40=Disabled; requires special care; 30=Severely disabled hospitalization indicated; 20=Very sick; hospital admission necessary; 10=Fatal processes progressing rapidly; 0=Death.|Participants|Number|0|0.0||||||
4139494|NCT00883116|3963921|B3|<70||Karnofsky Performance Scale Index Status|This scale classifies patients by functional impairment. The lower the Karnofsky score, the more impaired the patient is. 100=No complaints; 90=Normal activity; 80=Normal activity with effort; 70=Cares for self but unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most of his personal needs; 50=Requires considerable assistance; 40=Disabled; requires special care; 30=Severely disabled hospitalization indicated; 20=Very sick; hospital admission necessary; 10=Fatal processes progressing rapidly; 0=Death.|Participants|Number|2|2.0||||||
4139615|NCT00883090|3963946|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4139495|NCT00883116|3963922|B2|<70||Karnofsky Performance Scale Index Status|This scale classifies patients by functional impairment. The lower the Karnofsky score, the more impaired the patient is. 100=No complaints; 90=Normal activity; 80=Normal activity with effort; 70=Cares for self but unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most of his personal needs; 50=Requires considerable assistance; 40=Disabled; requires special care; 30=Severely disabled hospitalization indicated; 20=Very sick; hospital admission necessary; 10=Fatal processes progressing rapidly; 0=Death.|Participants|Number|2|2.0||||||
4139496|NCT00883116|3963923|B1|<70||Karnofsky Performance Scale Index Status|This scale classifies patients by functional impairment. The lower the Karnofsky score, the more impaired the patient is. 100=No complaints; 90=Normal activity; 80=Normal activity with effort; 70=Cares for self but unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most of his personal needs; 50=Requires considerable assistance; 40=Disabled; requires special care; 30=Severely disabled hospitalization indicated; 20=Very sick; hospital admission necessary; 10=Fatal processes progressing rapidly; 0=Death.|Participants|Number|0|0.0||||||
4139497|NCT00883116|3963921|B3|70||Karnofsky Performance Scale Index Status|This scale classifies patients by functional impairment. The lower the Karnofsky score, the more impaired the patient is. 100=No complaints; 90=Normal activity; 80=Normal activity with effort; 70=Cares for self but unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most of his personal needs; 50=Requires considerable assistance; 40=Disabled; requires special care; 30=Severely disabled hospitalization indicated; 20=Very sick; hospital admission necessary; 10=Fatal processes progressing rapidly; 0=Death.|Participants|Number|35|35.0||||||
4139498|NCT00883116|3963922|B2|70||Karnofsky Performance Scale Index Status|This scale classifies patients by functional impairment. The lower the Karnofsky score, the more impaired the patient is. 100=No complaints; 90=Normal activity; 80=Normal activity with effort; 70=Cares for self but unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most of his personal needs; 50=Requires considerable assistance; 40=Disabled; requires special care; 30=Severely disabled hospitalization indicated; 20=Very sick; hospital admission necessary; 10=Fatal processes progressing rapidly; 0=Death.|Participants|Number|16|16.0||||||
4139499|NCT00883116|3963923|B1|70||Karnofsky Performance Scale Index Status|This scale classifies patients by functional impairment. The lower the Karnofsky score, the more impaired the patient is. 100=No complaints; 90=Normal activity; 80=Normal activity with effort; 70=Cares for self but unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most of his personal needs; 50=Requires considerable assistance; 40=Disabled; requires special care; 30=Severely disabled hospitalization indicated; 20=Very sick; hospital admission necessary; 10=Fatal processes progressing rapidly; 0=Death.|Participants|Number|19|19.0||||||
4139500|NCT00883116|3963921|B3|80||Karnofsky Performance Scale Index Status|This scale classifies patients by functional impairment. The lower the Karnofsky score, the more impaired the patient is. 100=No complaints; 90=Normal activity; 80=Normal activity with effort; 70=Cares for self but unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most of his personal needs; 50=Requires considerable assistance; 40=Disabled; requires special care; 30=Severely disabled hospitalization indicated; 20=Very sick; hospital admission necessary; 10=Fatal processes progressing rapidly; 0=Death.|Participants|Number|112|112.0||||||
4139501|NCT00883116|3963922|B2|80||Karnofsky Performance Scale Index Status|This scale classifies patients by functional impairment. The lower the Karnofsky score, the more impaired the patient is. 100=No complaints; 90=Normal activity; 80=Normal activity with effort; 70=Cares for self but unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most of his personal needs; 50=Requires considerable assistance; 40=Disabled; requires special care; 30=Severely disabled hospitalization indicated; 20=Very sick; hospital admission necessary; 10=Fatal processes progressing rapidly; 0=Death.|Participants|Number|64|64.0||||||
4139502|NCT00883116|3963923|B1|80||Karnofsky Performance Scale Index Status|This scale classifies patients by functional impairment. The lower the Karnofsky score, the more impaired the patient is. 100=No complaints; 90=Normal activity; 80=Normal activity with effort; 70=Cares for self but unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most of his personal needs; 50=Requires considerable assistance; 40=Disabled; requires special care; 30=Severely disabled hospitalization indicated; 20=Very sick; hospital admission necessary; 10=Fatal processes progressing rapidly; 0=Death.|Participants|Number|48|48.0||||||
4139503|NCT00883116|3963921|B3|90||Karnofsky Performance Scale Index Status|This scale classifies patients by functional impairment. The lower the Karnofsky score, the more impaired the patient is. 100=No complaints; 90=Normal activity; 80=Normal activity with effort; 70=Cares for self but unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most of his personal needs; 50=Requires considerable assistance; 40=Disabled; requires special care; 30=Severely disabled hospitalization indicated; 20=Very sick; hospital admission necessary; 10=Fatal processes progressing rapidly; 0=Death.|Participants|Number|174|174.0||||||
4139504|NCT00883116|3963922|B2|90||Karnofsky Performance Scale Index Status|This scale classifies patients by functional impairment. The lower the Karnofsky score, the more impaired the patient is. 100=No complaints; 90=Normal activity; 80=Normal activity with effort; 70=Cares for self but unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most of his personal needs; 50=Requires considerable assistance; 40=Disabled; requires special care; 30=Severely disabled hospitalization indicated; 20=Very sick; hospital admission necessary; 10=Fatal processes progressing rapidly; 0=Death.|Participants|Number|79|79.0||||||
4139505|NCT00883116|3963923|B1|90||Karnofsky Performance Scale Index Status|This scale classifies patients by functional impairment. The lower the Karnofsky score, the more impaired the patient is. 100=No complaints; 90=Normal activity; 80=Normal activity with effort; 70=Cares for self but unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most of his personal needs; 50=Requires considerable assistance; 40=Disabled; requires special care; 30=Severely disabled hospitalization indicated; 20=Very sick; hospital admission necessary; 10=Fatal processes progressing rapidly; 0=Death.|Participants|Number|95|95.0||||||
4139554|NCT00883103|3963937|B3|Urinary Incontinence||Indication for the Visit||participants|Number|67|67.0||||||
4139555|NCT00883103|3963938|B2|Urinary Incontinence||Indication for the Visit||participants|Number|32|32.0||||||
4139506|NCT00883116|3963921|B3|100||Karnofsky Performance Scale Index Status|This scale classifies patients by functional impairment. The lower the Karnofsky score, the more impaired the patient is. 100=No complaints; 90=Normal activity; 80=Normal activity with effort; 70=Cares for self but unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most of his personal needs; 50=Requires considerable assistance; 40=Disabled; requires special care; 30=Severely disabled hospitalization indicated; 20=Very sick; hospital admission necessary; 10=Fatal processes progressing rapidly; 0=Death.|Participants|Number|172|172.0||||||
4139507|NCT00883116|3963922|B2|100||Karnofsky Performance Scale Index Status|This scale classifies patients by functional impairment. The lower the Karnofsky score, the more impaired the patient is. 100=No complaints; 90=Normal activity; 80=Normal activity with effort; 70=Cares for self but unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most of his personal needs; 50=Requires considerable assistance; 40=Disabled; requires special care; 30=Severely disabled hospitalization indicated; 20=Very sick; hospital admission necessary; 10=Fatal processes progressing rapidly; 0=Death.|Participants|Number|86|86.0||||||
4139508|NCT00883116|3963923|B1|100||Karnofsky Performance Scale Index Status|This scale classifies patients by functional impairment. The lower the Karnofsky score, the more impaired the patient is. 100=No complaints; 90=Normal activity; 80=Normal activity with effort; 70=Cares for self but unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most of his personal needs; 50=Requires considerable assistance; 40=Disabled; requires special care; 30=Severely disabled hospitalization indicated; 20=Very sick; hospital admission necessary; 10=Fatal processes progressing rapidly; 0=Death.|Participants|Number|86|86.0||||||
4139509|NCT00883116|3963921|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4139510|NCT00883116|3963922|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4139511|NCT00883116|3963923|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4139512|NCT00883116|3963921|B3|Other||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
4139513|NCT00883116|3963922|B2|Other||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4139514|NCT00883116|3963923|B1|Other||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4139515|NCT00883116|3963921|B3|Asian||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4139516|NCT00883116|3963922|B2|Asian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4139517|NCT00883116|3963923|B1|Asian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4139518|NCT00883116|3963921|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
4139519|NCT00883116|3963922|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4139520|NCT00883116|3963923|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4139521|NCT00883116|3963921|B3|White||Race/Ethnicity, Customized||Participants|Number|428|428.0||||||
4139522|NCT00883116|3963922|B2|White||Race/Ethnicity, Customized||Participants|Number|213|213.0||||||
4139523|NCT00883116|3963923|B1|White||Race/Ethnicity, Customized||Participants|Number|215|215.0||||||
4139524|NCT00883116|3963921|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4139525|NCT00883116|3963922|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4139526|NCT00883116|3963923|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4139527|NCT00883116|3963921|B3||Female|Sex: Female, Male||Participants|Count of Participants|496|496.0||||||
4139528|NCT00883116|3963922|B2||Female|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
4139529|NCT00883116|3963923|B1||Female|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
4139530|NCT00883116|3963921|B3|50 years and older||Age, Customized||Participants|Number|464|464.0||||||
4139531|NCT00883116|3963922|B2|50 years and older||Age, Customized||Participants|Number|230|230.0||||||
4139532|NCT00883116|3963923|B1|50 years and older||Age, Customized||Participants|Number|234|234.0||||||
4139533|NCT00883116|3963921|B3|Younger than 50 years||Age, Customized||Participants|Number|32|32.0||||||
4139534|NCT00883116|3963922|B2|Younger than 50 years||Age, Customized||Participants|Number|18|18.0||||||
4139535|NCT00883116|3963923|B1|Younger than 50 years||Age, Customized||Participants|Number|14|14.0||||||
4139536|NCT00883116|3963921|B3|65 years and older||Age, Customized||Participants|Number|231|231.0||||||
4139537|NCT00883116|3963922|B2|65 years and older||Age, Customized||Participants|Number|109|109.0||||||
4139538|NCT00883116|3963923|B1|65 years and older||Age, Customized||Participants|Number|122|122.0||||||
4139539|NCT00883116|3963921|B3|Younger than 65 years||Age, Customized||Participants|Number|265|265.0||||||
4139540|NCT00883116|3963922|B2|Younger than 65 years||Age, Customized||Participants|Number|139|139.0||||||
4139541|NCT00883116|3963923|B1|Younger than 65 years||Age, Customized||Participants|Number|126|126.0||||||
4139542|NCT00883116|3963921|B3|||Age||Years|Median|64.0|64.0|Full Range|||33.0|88.0|
4139543|NCT00883116|3963922|B2|||Age||Years|Median|64.0|64.0|Full Range|||33.0|88.0|
4139544|NCT00883116|3963923|B1|||Age||Years|Median|64.0|64.0|Full Range|||39.0|86.0|
4139545|NCT00883103|3963937|B3|Missing||Indication for the Visit||participants|Number|1|1.0||||||
4139546|NCT00883103|3963938|B2|Missing||Indication for the Visit||participants|Number|1|1.0||||||
4139547|NCT00883103|3963939|B1|Missing||Indication for the Visit||participants|Number|0|0.0||||||
4139548|NCT00883103|3963937|B3|Both||Indication for the Visit||participants|Number|29|29.0||||||
4139549|NCT00883103|3963938|B2|Both||Indication for the Visit||participants|Number|13|13.0||||||
4139550|NCT00883103|3963939|B1|Both||Indication for the Visit||participants|Number|16|16.0||||||
4139551|NCT00883103|3963937|B3|Pelvic Organ Prolapse||Indication for the Visit||participants|Number|40|40.0||||||
4139552|NCT00883103|3963938|B2|Pelvic Organ Prolapse||Indication for the Visit||participants|Number|22|22.0||||||
4139553|NCT00883103|3963939|B1|Pelvic Organ Prolapse||Indication for the Visit||participants|Number|18|18.0||||||
4139556|NCT00883103|3963939|B1|Urinary Incontinence||Indication for the Visit||participants|Number|35|35.0||||||
4139557|NCT00883103|3963937|B3|No||Examination Anxiety|Self reported as yes/no by participant, recorded before exam.|Participants|Number|41|41.0||||||
4139558|NCT00883103|3963938|B2|No||Examination Anxiety|Self reported as yes/no by participant, recorded before exam.|Participants|Number|20|20.0||||||
4139559|NCT00883103|3963939|B1|No||Examination Anxiety|Self reported as yes/no by participant, recorded before exam.|Participants|Number|21|21.0||||||
4139560|NCT00883103|3963937|B3|Yes||Examination Anxiety|Self reported as yes/no by participant, recorded before exam.|Participants|Number|96|96.0||||||
4139561|NCT00883103|3963938|B2|Yes||Examination Anxiety|Self reported as yes/no by participant, recorded before exam.|Participants|Number|48|48.0||||||
4139562|NCT00883103|3963939|B1|Yes||Examination Anxiety|Self reported as yes/no by participant, recorded before exam.|Participants|Number|48|48.0||||||
4139563|NCT00883103|3963937|B3|No||Current Estrogen Use||participants|Number|123|123.0||||||
4139564|NCT00883103|3963938|B2|No||Current Estrogen Use||participants|Number|62|62.0||||||
4139565|NCT00883103|3963939|B1|No||Current Estrogen Use||participants|Number|61|61.0||||||
4139566|NCT00883103|3963937|B3|Yes||Current Estrogen Use||participants|Number|14|14.0||||||
4139567|NCT00883103|3963938|B2|Yes||Current Estrogen Use||participants|Number|6|6.0||||||
4139568|NCT00883103|3963939|B1|Yes||Current Estrogen Use||participants|Number|8|8.0||||||
4139569|NCT00883103|3963937|B3|No||Neurological Impairment|History of stroke, or degenerative vertebral disease without loss of sensation.|Participants|Number|126|126.0||||||
4139570|NCT00883103|3963938|B2|No||Neurological Impairment|History of stroke, or degenerative vertebral disease without loss of sensation.|Participants|Number|62|62.0||||||
4139571|NCT00883103|3963939|B1|No||Neurological Impairment|History of stroke, or degenerative vertebral disease without loss of sensation.|Participants|Number|64|64.0||||||
4139572|NCT00883103|3963937|B3|Yes||Neurological Impairment|History of stroke, or degenerative vertebral disease without loss of sensation.|Participants|Number|11|11.0||||||
4139573|NCT00883103|3963938|B2|Yes||Neurological Impairment|History of stroke, or degenerative vertebral disease without loss of sensation.|Participants|Number|6|6.0||||||
4139574|NCT00883103|3963939|B1|Yes||Neurological Impairment|History of stroke, or degenerative vertebral disease without loss of sensation.|Participants|Number|5|5.0||||||
4139575|NCT00883103|3963937|B3|No||Vaginal Atrophy||Participants|Number|74|74.0||||||
4139576|NCT00883103|3963938|B2|No||Vaginal Atrophy||Participants|Number|37|37.0||||||
4139577|NCT00883103|3963939|B1|No||Vaginal Atrophy||Participants|Number|37|37.0||||||
4139578|NCT00883103|3963937|B3|Yes||Vaginal Atrophy||Participants|Number|63|63.0||||||
4139579|NCT00883103|3963938|B2|Yes||Vaginal Atrophy||Participants|Number|31|31.0||||||
4139580|NCT00883103|3963939|B1|Yes||Vaginal Atrophy||Participants|Number|32|32.0||||||
4139581|NCT00883103|3963937|B3|No||Diabetes||Participants|Number|119|119.0||||||
4139582|NCT00883103|3963938|B2|No||Diabetes||Participants|Number|56|56.0||||||
4139583|NCT00883103|3963939|B1|No||Diabetes||Participants|Number|63|63.0||||||
4139584|NCT00883103|3963937|B3|Yes||Diabetes||Participants|Number|18|18.0||||||
4139585|NCT00883103|3963938|B2|Yes||Diabetes||Participants|Number|12|12.0||||||
4139586|NCT00883103|3963939|B1|Yes||Diabetes||Participants|Number|6|6.0||||||
4139587|NCT00883103|3963937|B3|||Body Mass Index (BMI)||kg/m^2|Mean|29.2|29.2|Standard Deviation|8.2|8.2|||
4139588|NCT00883103|3963938|B2|||Body Mass Index (BMI)||kg/m^2|Mean|29.1|29.1|Standard Deviation|7.8|7.8|||
4139589|NCT00883103|3963939|B1|||Body Mass Index (BMI)||kg/m^2|Mean|29.3|29.3|Standard Deviation|8.6|8.6|||
4139590|NCT00883103|3963937|B3|||Previous Vaginal Births||Previous Vaginal Births|Mean|2.4|2.4|Standard Deviation|1.5|1.5|||
4139591|NCT00883103|3963938|B2|||Previous Vaginal Births||Previous Vaginal Births|Mean|2.4|2.4|Standard Deviation|1.5|1.5|||
4139592|NCT00883103|3963939|B1|||Previous Vaginal Births||Previous Vaginal Births|Mean|2.4|2.4|Standard Deviation|1.6|1.6|||
4139593|NCT00883103|3963937|B3|||Parity||Previous Live Births|Mean|2.7|2.7|Standard Deviation|1.5|1.5|||
4139594|NCT00883103|3963938|B2|||Parity||Previous Live Births|Mean|2.6|2.6|Standard Deviation|1.5|1.5|||
4139595|NCT00883103|3963939|B1|||Parity||Previous Live Births|Mean|2.7|2.7|Standard Deviation|1.5|1.5|||
4139596|NCT00883103|3963937|B3|United States||Region of Enrollment||participants|Number|137|137.0||||||
4139597|NCT00883103|3963938|B2|United States||Region of Enrollment||participants|Number|68|68.0||||||
4139598|NCT00883103|3963939|B1|United States||Region of Enrollment||participants|Number|69|69.0||||||
4139599|NCT00883103|3963937|B3|Other||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4139600|NCT00883103|3963938|B2|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4139601|NCT00883103|3963939|B1|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4139602|NCT00883103|3963937|B3|White||Race/Ethnicity, Customized||participants|Number|123|123.0||||||
4139603|NCT00883103|3963938|B2|White||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
4139604|NCT00883103|3963939|B1|White||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
4139605|NCT00883103|3963937|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4139606|NCT00883103|3963938|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4139607|NCT00883103|3963939|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4139608|NCT00883103|3963937|B3||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4139609|NCT00883103|3963938|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4139610|NCT00883103|3963939|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4139611|NCT00883103|3963937|B3|||Age||years|Mean|58.5|58.5|Standard Deviation|12.7|12.7|||
4139612|NCT00883103|3963938|B2|||Age||years|Mean|57.1|57.1|Standard Deviation|12.9|12.9|||
4139613|NCT00883103|3963939|B1|||Age||years|Mean|59.9|59.9|Standard Deviation|12.5|12.5|||
4139616|NCT00883090|3963946|B1|||Age||years|Mean|24.0|24.0|Standard Deviation|12.55|12.55|||
4139617|NCT00882999|3963961|B8|||Volume of T2-Weighted Lesions|Lesions were measured through T2-weighted proton density MRI scans.|milliliters (mL)|Mean|8.0|8.0|Standard Deviation|10.10|10.1|||
4139618|NCT00882999|3963962|B7|||Volume of T2-Weighted Lesions|Lesions were measured through T2-weighted proton density MRI scans.|milliliters (mL)|Mean|7.0|7.0|Standard Deviation|8.07|8.07|||
4139619|NCT00882999|3963963|B6|||Volume of T2-Weighted Lesions|Lesions were measured through T2-weighted proton density MRI scans.|milliliters (mL)|Mean|7.1|7.1|Standard Deviation|7.66|7.66|||
4139620|NCT00882999|3963964|B5|||Volume of T2-Weighted Lesions|Lesions were measured through T2-weighted proton density MRI scans.|milliliters (mL)|Mean|10.1|10.1|Standard Deviation|13.90|13.9|||
4139621|NCT00882999|3963965|B4|||Volume of T2-Weighted Lesions|Lesions were measured through T2-weighted proton density MRI scans.|milliliters (mL)|Mean|9.0|9.0|Standard Deviation|11.90|11.9|||
4139622|NCT00882999|3963966|B3|||Volume of T2-Weighted Lesions|Lesions were measured through T2-weighted proton density MRI scans.|milliliters (mL)|Mean|6.6|6.6|Standard Deviation|7.92|7.92|||
4139623|NCT00882999|3963967|B2|||Volume of T2-Weighted Lesions|Lesions were measured through T2-weighted proton density MRI scans.|milliliters (mL)|Mean|7.8|7.8|Standard Deviation|9.21|9.21|||
4139624|NCT00882999|3963968|B1|||Volume of T2-Weighted Lesions|Lesions were measured through T2-weighted proton density MRI scans.|milliliters (mL)|Mean|8.5|8.5|Standard Deviation|10.53|10.53|||
4139625|NCT00882999|3963961|B8|||Number of Gadolinium (Gd)-Enhancing T1-Weighted Lesions|Lesions were measured through Gd-enhancing T1-weighted magnetic resonance imaging (MRI) scans.|lesions|Mean|1.1|1.1|Standard Deviation|2.16|2.16|||
4139626|NCT00882999|3963962|B7|||Number of Gadolinium (Gd)-Enhancing T1-Weighted Lesions|Lesions were measured through Gd-enhancing T1-weighted magnetic resonance imaging (MRI) scans.|lesions|Mean|1.2|1.2|Standard Deviation|2.08|2.08|||
4139627|NCT00882999|3963963|B6|||Number of Gadolinium (Gd)-Enhancing T1-Weighted Lesions|Lesions were measured through Gd-enhancing T1-weighted magnetic resonance imaging (MRI) scans.|lesions|Mean|1.2|1.2|Standard Deviation|2.11|2.11|||
4139628|NCT00882999|3963964|B5|||Number of Gadolinium (Gd)-Enhancing T1-Weighted Lesions|Lesions were measured through Gd-enhancing T1-weighted magnetic resonance imaging (MRI) scans.|lesions|Mean|1.3|1.3|Standard Deviation|2.41|2.41|||
4139629|NCT00882999|3963965|B4|||Number of Gadolinium (Gd)-Enhancing T1-Weighted Lesions|Lesions were measured through Gd-enhancing T1-weighted magnetic resonance imaging (MRI) scans.|lesions|Mean|1.4|1.4|Standard Deviation|2.60|2.6|||
4139630|NCT00882999|3963966|B3|||Number of Gadolinium (Gd)-Enhancing T1-Weighted Lesions|Lesions were measured through Gd-enhancing T1-weighted magnetic resonance imaging (MRI) scans.|lesions|Mean|1.1|1.1|Standard Deviation|1.91|1.91|||
4139631|NCT00882999|3963967|B2|||Number of Gadolinium (Gd)-Enhancing T1-Weighted Lesions|Lesions were measured through Gd-enhancing T1-weighted magnetic resonance imaging (MRI) scans.|lesions|Mean|0.5|0.5|Standard Deviation|0.93|0.93|||
4139632|NCT00882999|3963968|B1|||Number of Gadolinium (Gd)-Enhancing T1-Weighted Lesions|Lesions were measured through Gd-enhancing T1-weighted magnetic resonance imaging (MRI) scans.|lesions|Mean|1.1|1.1|Standard Deviation|2.64|2.64|||
4139633|NCT00882999|3963961|B8|||Number Of Relapses In Past Year||relapses|Mean|1.4|1.4|Standard Deviation|0.97|0.97|||
4139634|NCT00882999|3963962|B7|||Number Of Relapses In Past Year||relapses|Mean|1.5|1.5|Standard Deviation|1.38|1.38|||
4139635|NCT00882999|3963963|B6|||Number Of Relapses In Past Year||relapses|Mean|1.5|1.5|Standard Deviation|0.89|0.89|||
4139636|NCT00882999|3963964|B5|||Number Of Relapses In Past Year||relapses|Mean|1.4|1.4|Standard Deviation|1.11|1.11|||
4139637|NCT00882999|3963965|B4|||Number Of Relapses In Past Year||relapses|Mean|1.2|1.2|Standard Deviation|0.56|0.56|||
4139638|NCT00882999|3963966|B3|||Number Of Relapses In Past Year||relapses|Mean|1.4|1.4|Standard Deviation|0.73|0.73|||
4139639|NCT00882999|3963967|B2|||Number Of Relapses In Past Year||relapses|Mean|1.3|1.3|Standard Deviation|0.51|0.51|||
4139640|NCT00882999|3963968|B1|||Number Of Relapses In Past Year||relapses|Mean|1.4|1.4|Standard Deviation|1.26|1.26|||
4139641|NCT00882999|3963961|B8|||Time Since First Diagnosis||years|Mean|5.3|5.3|Standard Deviation|6.21|6.21|||
4139642|NCT00882999|3963962|B7|||Time Since First Diagnosis||years|Mean|3.8|3.8|Standard Deviation|4.88|4.88|||
4139643|NCT00882999|3963963|B6|||Time Since First Diagnosis||years|Mean|6.0|6.0|Standard Deviation|5.73|5.73|||
4139644|NCT00882999|3963964|B5|||Time Since First Diagnosis||years|Mean|5.0|5.0|Standard Deviation|5.03|5.03|||
4139645|NCT00882999|3963965|B4|||Time Since First Diagnosis||years|Mean|5.0|5.0|Standard Deviation|7.50|7.5|||
4139646|NCT00882999|3963966|B3|||Time Since First Diagnosis||years|Mean|5.4|5.4|Standard Deviation|6.67|6.67|||
4139647|NCT00882999|3963967|B2|||Time Since First Diagnosis||years|Mean|6.3|6.3|Standard Deviation|6.19|6.19|||
4139648|NCT00882999|3963968|B1|||Time Since First Diagnosis||years|Mean|5.9|5.9|Standard Deviation|7.19|7.19|||
4139649|NCT00882999|3963961|B8|||Time Since Onset Of First Symptoms||years|Mean|8.6|8.6|Standard Deviation|7.58|7.58|||
4139650|NCT00882999|3963962|B7|||Time Since Onset Of First Symptoms||years|Mean|7.4|7.4|Standard Deviation|6.70|6.7|||
4139651|NCT00882999|3963963|B6|||Time Since Onset Of First Symptoms||years|Mean|9.2|9.2|Standard Deviation|8.48|8.48|||
4139652|NCT00882999|3963964|B5|||Time Since Onset Of First Symptoms||years|Mean|7.8|7.8|Standard Deviation|5.93|5.93|||
4139653|NCT00882999|3963965|B4|||Time Since Onset Of First Symptoms||years|Mean|8.9|8.9|Standard Deviation|9.52|9.52|||
4139654|NCT00882999|3963966|B3|||Time Since Onset Of First Symptoms||years|Mean|9.2|9.2|Standard Deviation|7.49|7.49|||
4139655|NCT00882999|3963967|B2|||Time Since Onset Of First Symptoms||years|Mean|9.4|9.4|Standard Deviation|6.96|6.96|||
4139656|NCT00882999|3963968|B1|||Time Since Onset Of First Symptoms||years|Mean|8.5|8.5|Standard Deviation|7.81|7.81|||
4139657|NCT00882999|3963961|B8|Canada||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4139658|NCT00882999|3963962|B7|Canada||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4139659|NCT00882999|3963963|B6|Canada||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4139660|NCT00882999|3963964|B5|Canada||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4139661|NCT00882999|3963965|B4|Canada||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4139662|NCT00882999|3963966|B3|Canada||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4139663|NCT00882999|3963967|B2|Canada||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4139664|NCT00882999|3963968|B1|Canada||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4139665|NCT00882999|3963961|B8|Germany||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4139666|NCT00882999|3963962|B7|Germany||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4139667|NCT00882999|3963963|B6|Germany||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4139668|NCT00882999|3963964|B5|Germany||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4139669|NCT00882999|3963965|B4|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4139670|NCT00882999|3963966|B3|Germany||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4139671|NCT00882999|3963967|B2|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4139672|NCT00882999|3963968|B1|Germany||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4139673|NCT00882999|3963961|B8|Finland||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4139674|NCT00882999|3963962|B7|Finland||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4139675|NCT00882999|3963963|B6|Finland||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4139676|NCT00882999|3963964|B5|Finland||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4139677|NCT00882999|3963965|B4|Finland||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4139678|NCT00882999|3963966|B3|Finland||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4139679|NCT00882999|3963967|B2|Finland||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4139680|NCT00882999|3963968|B1|Finland||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4139681|NCT00882999|3963961|B8|Bulgaria||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4139682|NCT00882999|3963962|B7|Bulgaria||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4139683|NCT00882999|3963963|B6|Bulgaria||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4139684|NCT00882999|3963964|B5|Bulgaria||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4139685|NCT00882999|3963965|B4|Bulgaria||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4139686|NCT00882999|3963966|B3|Bulgaria||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4139687|NCT00882999|3963967|B2|Bulgaria||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4139688|NCT00882999|3963968|B1|Bulgaria||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4139689|NCT00882999|3963961|B8|Romania||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4139690|NCT00882999|3963962|B7|Romania||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4139691|NCT00882999|3963963|B6|Romania||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4139692|NCT00882999|3963964|B5|Romania||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4139693|NCT00882999|3963965|B4|Romania||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4139694|NCT00882999|3963966|B3|Romania||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4139695|NCT00882999|3963967|B2|Romania||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4139696|NCT00882999|3963968|B1|Romania||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4139697|NCT00882999|3963961|B8|Poland||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4139698|NCT00882999|3963962|B7|Poland||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4139699|NCT00882999|3963963|B6|Poland||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4139700|NCT00882999|3963964|B5|Poland||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4139701|NCT00882999|3963965|B4|Poland||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4139702|NCT00882999|3963966|B3|Poland||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4139703|NCT00882999|3963967|B2|Poland||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4139704|NCT00882999|3963968|B1|Poland||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4139705|NCT00882999|3963961|B8|Hungary||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4139706|NCT00882999|3963962|B7|Hungary||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4139707|NCT00882999|3963963|B6|Hungary||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4139708|NCT00882999|3963964|B5|Hungary||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4139709|NCT00882999|3963965|B4|Hungary||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4139710|NCT00882999|3963966|B3|Hungary||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4139711|NCT00882999|3963967|B2|Hungary||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4139712|NCT00882999|3963968|B1|Hungary||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4139713|NCT00882999|3963961|B8|Czechia||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4139714|NCT00882999|3963962|B7|Czechia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4139715|NCT00882999|3963963|B6|Czechia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4139716|NCT00882999|3963964|B5|Czechia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4139717|NCT00882999|3963965|B4|Czechia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4139718|NCT00882999|3963966|B3|Czechia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4139719|NCT00882999|3963967|B2|Czechia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4139720|NCT00882999|3963968|B1|Czechia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4139721|NCT00882999|3963961|B8|France||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4139722|NCT00882999|3963962|B7|France||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4139723|NCT00882999|3963963|B6|France||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4139724|NCT00882999|3963964|B5|France||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4139725|NCT00882999|3963965|B4|France||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4139726|NCT00882999|3963966|B3|France||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4139727|NCT00882999|3963967|B2|France||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4139728|NCT00882999|3963968|B1|France||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4139729|NCT00882999|3963961|B8|Russia||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4139730|NCT00882999|3963962|B7|Russia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4139731|NCT00882999|3963963|B6|Russia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4139732|NCT00882999|3963964|B5|Russia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4139733|NCT00882999|3963965|B4|Russia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4139734|NCT00882999|3963966|B3|Russia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4139735|NCT00882999|3963967|B2|Russia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4139736|NCT00882999|3963968|B1|Russia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4139737|NCT00882999|3963961|B8|Israel||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4139738|NCT00882999|3963962|B7|Israel||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4139739|NCT00882999|3963963|B6|Israel||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4139740|NCT00882999|3963964|B5|Israel||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4139741|NCT00882999|3963965|B4|Israel||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4139742|NCT00882999|3963966|B3|Israel||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4139743|NCT00882999|3963967|B2|Israel||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4139744|NCT00882999|3963968|B1|Israel||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4139745|NCT00882999|3963961|B8|Ukraine||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4139746|NCT00882999|3963962|B7|Ukraine||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4139747|NCT00882999|3963963|B6|Ukraine||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4139748|NCT00882999|3963964|B5|Ukraine||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4139749|NCT00882999|3963965|B4|Ukraine||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4139750|NCT00882999|3963966|B3|Ukraine||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4139751|NCT00882999|3963967|B2|Ukraine||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4139752|NCT00882999|3963968|B1|Ukraine||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4139753|NCT00882999|3963961|B8|Slovakia||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
4139754|NCT00882999|3963962|B7|Slovakia||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4139755|NCT00882999|3963963|B6|Slovakia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4139756|NCT00882999|3963964|B5|Slovakia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4139757|NCT00882999|3963965|B4|Slovakia||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4139758|NCT00882999|3963966|B3|Slovakia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4139759|NCT00882999|3963967|B2|Slovakia||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4139760|NCT00882999|3963968|B1|Slovakia||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4139761|NCT00882999|3963961|B8|United States||Region of Enrollment||Participants|Count of Participants|108|108.0||||||
4139762|NCT00882999|3963962|B7|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4139763|NCT00882999|3963963|B6|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4139764|NCT00882999|3963964|B5|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4139765|NCT00882999|3963965|B4|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4139766|NCT00882999|3963966|B3|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4139767|NCT00882999|3963967|B2|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4139768|NCT00882999|3963968|B1|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4139769|NCT00882999|3963961|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139770|NCT00882999|3963962|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139771|NCT00882999|3963963|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139772|NCT00882999|3963964|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139773|NCT00882999|3963965|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139774|NCT00882999|3963966|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139775|NCT00882999|3963967|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139776|NCT00882999|3963968|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139777|NCT00882999|3963961|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139778|NCT00882999|3963962|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139779|NCT00882999|3963963|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139780|NCT00882999|3963964|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139781|NCT00882999|3963965|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139782|NCT00882999|3963966|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139783|NCT00882999|3963967|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139784|NCT00882999|3963968|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139785|NCT00882999|3963961|B8||White|Race (NIH/OMB)||Participants|Count of Participants|228|228.0||||||
4139786|NCT00882999|3963962|B7||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4139787|NCT00882999|3963963|B6||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4139788|NCT00882999|3963964|B5||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4139789|NCT00882999|3963965|B4||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4139790|NCT00882999|3963966|B3||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4139791|NCT00882999|3963967|B2||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4139792|NCT00882999|3963968|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4139793|NCT00882999|3963961|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4139794|NCT00882999|3963962|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4139795|NCT00882999|3963963|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4139796|NCT00882999|3963964|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4139797|NCT00882999|3963965|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4139798|NCT00882999|3963966|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139799|NCT00882999|3963967|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139800|NCT00882999|3963968|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4139801|NCT00882999|3963961|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139802|NCT00882999|3963962|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139803|NCT00882999|3963963|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139804|NCT00882999|3963964|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139805|NCT00882999|3963965|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139806|NCT00882999|3963966|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139807|NCT00882999|3963967|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139808|NCT00882999|3963968|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139809|NCT00882999|3963961|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139810|NCT00882999|3963962|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139811|NCT00882999|3963963|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139812|NCT00882999|3963964|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139813|NCT00882999|3963965|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139814|NCT00882999|3963966|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139815|NCT00882999|3963967|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139816|NCT00882999|3963968|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139817|NCT00882999|3963961|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139818|NCT00882999|3963962|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139819|NCT00882999|3963963|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139820|NCT00882999|3963964|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139821|NCT00882999|3963965|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139822|NCT00882999|3963966|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139823|NCT00882999|3963967|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139824|NCT00882999|3963968|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139825|NCT00882999|3963961|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139826|NCT00882999|3963962|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139827|NCT00882999|3963963|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139828|NCT00882999|3963964|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139829|NCT00882999|3963965|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139830|NCT00882999|3963966|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139831|NCT00882999|3963967|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139832|NCT00882999|3963968|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139833|NCT00882999|3963961|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|241|241.0||||||
4139834|NCT00882999|3963962|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4139835|NCT00882999|3963963|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4139836|NCT00882999|3963964|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4139837|NCT00882999|3963965|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4139838|NCT00882999|3963966|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4139839|NCT00882999|3963967|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4139840|NCT00882999|3963968|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4139841|NCT00882999|3963961|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4139842|NCT00882999|3963962|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4139843|NCT00882999|3963963|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139844|NCT00882999|3963964|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4139845|NCT00882999|3963965|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4139846|NCT00882999|3963966|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139847|NCT00882999|3963967|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139848|NCT00882999|3963968|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139849|NCT00882999|3963961|B8||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4139850|NCT00882999|3963962|B7||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4139851|NCT00882999|3963963|B6||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4139852|NCT00882999|3963964|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4139853|NCT00882999|3963965|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4139854|NCT00882999|3963966|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4139855|NCT00882999|3963967|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4139856|NCT00882999|3963968|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4139857|NCT00882999|3963961|B8||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4139858|NCT00882999|3963962|B7||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4139859|NCT00882999|3963963|B6||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4139860|NCT00882999|3963964|B5||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4139861|NCT00882999|3963965|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4139862|NCT00882999|3963966|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4139863|NCT00882999|3963967|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4139864|NCT00882999|3963968|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4139865|NCT00882999|3963961|B8|||Age||years|Mean|41.3|41.3|Standard Deviation|10.69|10.69|||
4139866|NCT00882999|3963962|B7|||Age||years|Mean|40.3|40.3|Standard Deviation|12.02|12.02|||
4139867|NCT00882999|3963963|B6|||Age||years|Mean|39.0|39.0|Standard Deviation|10.16|10.16|||
4139868|NCT00882999|3963964|B5|||Age||years|Mean|43.1|43.1|Standard Deviation|10.62|10.62|||
4139869|NCT00882999|3963965|B4|||Age||years|Mean|40.8|40.8|Standard Deviation|11.10|11.1|||
4139870|NCT00882999|3963966|B3|||Age||years|Mean|40.8|40.8|Standard Deviation|10.78|10.78|||
4139871|NCT00882999|3963967|B2|||Age||years|Mean|43.1|43.1|Standard Deviation|10.06|10.06|||
4139872|NCT00882999|3963968|B1|||Age||years|Mean|41.7|41.7|Standard Deviation|10.23|10.23|||
4139873|NCT00882921|3964101|B1|UNITED STATES||Region of Enrollment||Participants|Number|6|6.0||||||
4139874|NCT00882921|3964101|B1|UNITED KINGDOM||Region of Enrollment||Participants|Number|14|14.0||||||
4139875|NCT00882921|3964101|B1|BRAZIL||Region of Enrollment||Participants|Number|6|6.0||||||
4139876|NCT00882921|3964101|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4139877|NCT00882921|3964101|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4139878|NCT00882921|3964101|B1|≥12 Years||Age, Customized||Participants|Number|9|9.0||||||
4139879|NCT00882921|3964101|B1|<12 years||Age, Customized||Participants|Number|17|17.0||||||
4139880|NCT00882921|3964101|B1|||Age||Years|Mean|12.82|12.82|Standard Deviation|8.012|8.012|||
4139881|NCT00882908|3964106|B6|North-America||Region of Enrollment||participants|Number|82|82.0||||||
4139882|NCT00882908|3964107|B5|North-America||Region of Enrollment||participants|Number|15|15.0||||||
4139883|NCT00882908|3964108|B4|North-America||Region of Enrollment||participants|Number|22|22.0||||||
4139884|NCT00882908|3964109|B3|North-America||Region of Enrollment||participants|Number|14|14.0||||||
4139885|NCT00882908|3964110|B2|North-America||Region of Enrollment||participants|Number|14|14.0||||||
4139886|NCT00882908|3964111|B1|North-America||Region of Enrollment||participants|Number|17|17.0||||||
4139887|NCT00882908|3964106|B6|Europe||Region of Enrollment||participants|Number|262|262.0||||||
4139888|NCT00882908|3964107|B5|Europe||Region of Enrollment||participants|Number|58|58.0||||||
4139889|NCT00882908|3964108|B4|Europe||Region of Enrollment||participants|Number|44|44.0||||||
4139890|NCT00882908|3964109|B3|Europe||Region of Enrollment||participants|Number|56|56.0||||||
4139891|NCT00882908|3964110|B2|Europe||Region of Enrollment||participants|Number|52|52.0||||||
4139892|NCT00882908|3964111|B1|Europe||Region of Enrollment||participants|Number|52|52.0||||||
4139893|NCT00882908|3964106|B6|Asia Pacific||Region of Enrollment||participants|Number|42|42.0||||||
4139894|NCT00882908|3964107|B5|Asia Pacific||Region of Enrollment||participants|Number|4|4.0||||||
4139895|NCT00882908|3964108|B4|Asia Pacific||Region of Enrollment||participants|Number|13|13.0||||||
4139896|NCT00882908|3964109|B3|Asia Pacific||Region of Enrollment||participants|Number|7|7.0||||||
4139897|NCT00882908|3964110|B2|Asia Pacific||Region of Enrollment||participants|Number|9|9.0||||||
4139898|NCT00882908|3964111|B1|Asia Pacific||Region of Enrollment||participants|Number|9|9.0||||||
4139899|NCT00882908|3964106|B6||Male|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
4139900|NCT00882908|3964107|B5||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4139901|NCT00882908|3964108|B4||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4139902|NCT00882908|3964109|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4139903|NCT00882908|3964110|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4139904|NCT00882908|3964111|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4139905|NCT00882908|3964106|B6||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4139906|NCT00882908|3964107|B5||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4139907|NCT00882908|3964108|B4||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4139908|NCT00882908|3964109|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4139909|NCT00882908|3964110|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4139910|NCT00882908|3964111|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4139911|NCT00882908|3964106|B6|||Age||years|Median|46.5|46.5|Full Range|||18.0|69.0|
4139912|NCT00882908|3964107|B5|||Age||years|Median|45|45.0|Full Range|||21.0|67.0|
4139913|NCT00882908|3964108|B4|||Age||years|Median|47|47.0|Full Range|||18.0|69.0|
4139914|NCT00882908|3964109|B3|||Age||years|Median|47|47.0|Full Range|||18.0|69.0|
4139915|NCT00882908|3964110|B2|||Age||years|Median|46|46.0|Full Range|||18.0|67.0|
4139916|NCT00882908|3964111|B1|||Age||years|Median|47|47.0|Full Range|||19.0|66.0|
4139917|NCT00882778|3964190|B1|Missing, n=4||Dose frequency|Average number of doses per week during prophylaxis period. All = participants from bleeding population and frequent bleeding population (FBP). The FBP is a subset of the bleeding population with at least one bleed per month in the pre-prophylactic period of approximately 6 months.|doses per week|Median|NA||Full Range|||0.0|0.0|No data available
4139918|NCT00882778|3964190|B1|Frequent bleeding population, n=36||Dose frequency|Average number of doses per week during prophylaxis period. All = participants from bleeding population and frequent bleeding population (FBP). The FBP is a subset of the bleeding population with at least one bleed per month in the pre-prophylactic period of approximately 6 months.|doses per week|Median|5.2|5.2|Full Range|||1.0|22.2|
4139919|NCT00882778|3964190|B1|Bleeding population, n=73||Dose frequency|Average number of doses per week during prophylaxis period. All = participants from bleeding population and frequent bleeding population (FBP). The FBP is a subset of the bleeding population with at least one bleed per month in the pre-prophylactic period of approximately 6 months.|doses per week|Median|5.8|5.8|Full Range|||1.0|24.3|
4139920|NCT00882778|3964190|B1|All, n=82||Dose frequency|Average number of doses per week during prophylaxis period. All = participants from bleeding population and frequent bleeding population (FBP). The FBP is a subset of the bleeding population with at least one bleed per month in the pre-prophylactic period of approximately 6 months.|doses per week|Median|5.2|5.2|Full Range|||1.0|24.3|
4139921|NCT00882778|3964190|B1|Missing, n=4||Weekly dose|All = participants from bleeding population and frequent bleeding population (FBP). The FBP is a subset of the bleeding population with at least one bleed per month in the pre-prophylactic period of approximately 6 months.|mcg/kg|Median|NA||Full Range|||0.0|0.0|No data available
4139922|NCT00882778|3964190|B1|Frequent bleeding population, n=36||Weekly dose|All = participants from bleeding population and frequent bleeding population (FBP). The FBP is a subset of the bleeding population with at least one bleed per month in the pre-prophylactic period of approximately 6 months.|mcg/kg|Median|656.2|656.2|Full Range|||94.2|2768.0|
4139923|NCT00882778|3964190|B1|Bleeding population, n=73||Weekly dose|All = participants from bleeding population and frequent bleeding population (FBP). The FBP is a subset of the bleeding population with at least one bleed per month in the pre-prophylactic period of approximately 6 months.|mcg/kg|Median|742.5|742.5|Full Range|||94.2|3100.0|
4139924|NCT00882778|3964190|B1|All, n=82||Weekly dose|All = participants from bleeding population and frequent bleeding population (FBP). The FBP is a subset of the bleeding population with at least one bleed per month in the pre-prophylactic period of approximately 6 months.|mcg/kg|Median|710|710.0|Full Range|||94.2|3100.0|
4139925|NCT00882778|3964190|B1|Frequent bleeding population, n=36||Duration of prophylaxis|All = participants from bleeding population and frequent bleeding population (FBP). The FBP is a subset of the bleeding population with at least one bleed per month in the pre-prophylactic period of approximately 6 months.|days|Median|293|293.0|Full Range|||46.0|1580.0|
4139926|NCT00882778|3964190|B1|Bleeding population, n=74||Duration of prophylaxis|All = participants from bleeding population and frequent bleeding population (FBP). The FBP is a subset of the bleeding population with at least one bleed per month in the pre-prophylactic period of approximately 6 months.|days|Median|293|293.0|Full Range|||35.0|1580.0|
4139927|NCT00882778|3964190|B1|All, n=86||Duration of prophylaxis|All = participants from bleeding population and frequent bleeding population (FBP). The FBP is a subset of the bleeding population with at least one bleed per month in the pre-prophylactic period of approximately 6 months.|days|Median|288|288.0|Full Range|||22.0|3651.0|
4139928|NCT00882778|3964190|B1|Not reported||Relationship to timing of Immune Tolerance Induction (ITI)|Timing (pre-, during, or post- Immune Tolerance Induction (ITI)) of prophylaxis determined within a subset of patients who had “prevention of recurrent bleeding” as the reason for prophylaxis|participants|Number|7|7.0||||||
4139969|NCT00882778|3964190|B1|18 years or above||Age, Customized||participants|Number|18|18.0||||||
4139929|NCT00882778|3964190|B1|Not candidate for ITI||Relationship to timing of Immune Tolerance Induction (ITI)|Timing (pre-, during, or post- Immune Tolerance Induction (ITI)) of prophylaxis determined within a subset of patients who had “prevention of recurrent bleeding” as the reason for prophylaxis|participants|Number|27|27.0||||||
4139930|NCT00882778|3964190|B1|ITI dates unknown||Relationship to timing of Immune Tolerance Induction (ITI)|Timing (pre-, during, or post- Immune Tolerance Induction (ITI)) of prophylaxis determined within a subset of patients who had “prevention of recurrent bleeding” as the reason for prophylaxis|participants|Number|0|0.0||||||
4139931|NCT00882778|3964190|B1|Post-ITI||Relationship to timing of Immune Tolerance Induction (ITI)|Timing (pre-, during, or post- Immune Tolerance Induction (ITI)) of prophylaxis determined within a subset of patients who had “prevention of recurrent bleeding” as the reason for prophylaxis|participants|Number|25|25.0||||||
4139932|NCT00882778|3964190|B1|During ITI||Relationship to timing of Immune Tolerance Induction (ITI)|Timing (pre-, during, or post- Immune Tolerance Induction (ITI)) of prophylaxis determined within a subset of patients who had “prevention of recurrent bleeding” as the reason for prophylaxis|participants|Number|8|8.0||||||
4139933|NCT00882778|3964190|B1|Pre-ITI||Relationship to timing of Immune Tolerance Induction (ITI)|Timing (pre-, during, or post- Immune Tolerance Induction (ITI)) of prophylaxis determined within a subset of patients who had “prevention of recurrent bleeding” as the reason for prophylaxis|participants|Number|19|19.0||||||
4139934|NCT00882778|3964190|B1|Missing||Reason for prophylaxis|Reason patients were given prophylactic activated recombinant human factor VII|participants|Number|3|3.0||||||
4139935|NCT00882778|3964190|B1|Other||Reason for prophylaxis|Reason patients were given prophylactic activated recombinant human factor VII|participants|Number|2|2.0||||||
4139936|NCT00882778|3964190|B1|Prep. for rehab./planned phys. activity||Reason for prophylaxis|Reason patients were given prophylactic activated recombinant human factor VII|participants|Number|2|2.0||||||
4139937|NCT00882778|3964190|B1|In preparation for surgery||Reason for prophylaxis|Reason patients were given prophylactic activated recombinant human factor VII|participants|Number|0|0.0||||||
4139938|NCT00882778|3964190|B1|Prevention of recurrent bleeding||Reason for prophylaxis|Reason patients were given prophylactic activated recombinant human factor VII|participants|Number|79|79.0||||||
4139939|NCT00882778|3964190|B1|Missing, n=5||Peak historical inhibitor titre recorded|All = participants from bleeding population and frequent bleeding population (FBP). The FBP is a subset of the bleeding population with at least one bleed per month in the pre-prophylactic period of approximately 6 months.|Bethesda Units (BU)/mL|Mean|NA||Standard Deviation|NA||||No data available
4139940|NCT00882778|3964190|B1|Frequent bleeding population, n=35||Peak historical inhibitor titre recorded|All = participants from bleeding population and frequent bleeding population (FBP). The FBP is a subset of the bleeding population with at least one bleed per month in the pre-prophylactic period of approximately 6 months.|Bethesda Units (BU)/mL|Mean|737.9|737.9|Standard Deviation|1457|1457.0|||
4139941|NCT00882778|3964190|B1|Bleeding population, n=72||Peak historical inhibitor titre recorded|All = participants from bleeding population and frequent bleeding population (FBP). The FBP is a subset of the bleeding population with at least one bleed per month in the pre-prophylactic period of approximately 6 months.|Bethesda Units (BU)/mL|Mean|571|571.0|Standard Deviation|1224.88|1224.88|||
4139942|NCT00882778|3964190|B1|All, n=81||Peak historical inhibitor titre recorded|All = participants from bleeding population and frequent bleeding population (FBP). The FBP is a subset of the bleeding population with at least one bleed per month in the pre-prophylactic period of approximately 6 months.|Bethesda Units (BU)/mL|Mean|517.7|517.7|Standard Deviation|1164.41|1164.41|||
4139943|NCT00882778|3964190|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4139944|NCT00882778|3964190|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4139945|NCT00882778|3964190|B1|Switzerland||Region of Enrollment||participants|Number|2|2.0||||||
4139946|NCT00882778|3964190|B1|Sweden||Region of Enrollment||participants|Number|4|4.0||||||
4139947|NCT00882778|3964190|B1|Spain||Region of Enrollment||participants|Number|10|10.0||||||
4139948|NCT00882778|3964190|B1|Slovakia||Region of Enrollment||participants|Number|1|1.0||||||
4139949|NCT00882778|3964190|B1|Italy||Region of Enrollment||participants|Number|7|7.0||||||
4139950|NCT00882778|3964190|B1|Ireland||Region of Enrollment||participants|Number|5|5.0||||||
4139951|NCT00882778|3964190|B1|Germany||Region of Enrollment||participants|Number|3|3.0||||||
4139952|NCT00882778|3964190|B1|France||Region of Enrollment||participants|Number|17|17.0||||||
4139953|NCT00882778|3964190|B1|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
4139954|NCT00882778|3964190|B1|Croatia||Region of Enrollment||participants|Number|2|2.0||||||
4139955|NCT00882778|3964190|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4139956|NCT00882778|3964190|B1|Argentina||Region of Enrollment||participants|Number|4|4.0||||||
4139957|NCT00882778|3964190|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4139958|NCT00882778|3964190|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4139959|NCT00882778|3964190|B1||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4139960|NCT00882778|3964190|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4139961|NCT00882778|3964190|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4139962|NCT00882778|3964190|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4139963|NCT00882778|3964190|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4139964|NCT00882778|3964190|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4139965|NCT00882778|3964190|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4139966|NCT00882778|3964190|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4139967|NCT00882778|3964190|B1||Male|Gender||Participants|Count of Participants|86|86.0||||||
4139968|NCT00882778|3964190|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
4139970|NCT00882778|3964190|B1|Between 12 and 17 years||Age, Customized||participants|Number|7|7.0||||||
4139971|NCT00882778|3964190|B1|Below 12 years||Age, Customized||participants|Number|61|61.0||||||
4139972|NCT00882778|3964190|B1|Frequent bleeding population, n=36||Age|All = participants from bleeding population and frequent bleeding population (FBP). The FBP is a subset of the bleeding population with at least one bleed per month in the pre-prophylactic period of approximately 6 months.|years|Mean|12.1|12.1|Standard Deviation|12.67|12.67|||
4139973|NCT00882778|3964190|B1|Bleeding population, n=74||Age|All = participants from bleeding population and frequent bleeding population (FBP). The FBP is a subset of the bleeding population with at least one bleed per month in the pre-prophylactic period of approximately 6 months.|years|Mean|10.9|10.9|Standard Deviation|12.45|12.45|||
4139974|NCT00882778|3964190|B1|All, n=86||Age|All = participants from bleeding population and frequent bleeding population (FBP). The FBP is a subset of the bleeding population with at least one bleed per month in the pre-prophylactic period of approximately 6 months.|years|Mean|11.6|11.6|Standard Deviation|13.03|13.03|||
4139975|NCT00882713|3964221|B1||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4139976|NCT00882713|3964221|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4139977|NCT00882713|3964221|B1|||Age||years|Median|51.5|51.5|Full Range|||18.0|89.0|
4139978|NCT00882687|3964243|B5||Male|Gender||Participants|Count of Participants|31|31.0||||||
4139979|NCT00882687|3964244|B4||Male|Gender||Participants|Count of Participants|9|9.0||||||
4139980|NCT00882687|3964245|B3||Male|Gender||Participants|Count of Participants|6|6.0||||||
4139981|NCT00882687|3964246|B2||Male|Gender||Participants|Count of Participants|10|10.0||||||
4139982|NCT00882687|3964247|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
4139983|NCT00882687|3964243|B5||Female|Gender||Participants|Count of Participants|29|29.0||||||
4139984|NCT00882687|3964244|B4||Female|Gender||Participants|Count of Participants|6|6.0||||||
4139985|NCT00882687|3964245|B3||Female|Gender||Participants|Count of Participants|9|9.0||||||
4139986|NCT00882687|3964246|B2||Female|Gender||Participants|Count of Participants|5|5.0||||||
4139987|NCT00882687|3964247|B1||Female|Gender||Participants|Count of Participants|9|9.0||||||
4139988|NCT00882687|3964243|B5|||Age||years|Mean|40.95|40.95|Standard Deviation|14.019|14.019|||
4139989|NCT00882687|3964244|B4|||Age||years|Mean|39.13|39.13|Standard Deviation|12.212|12.212|||
4139990|NCT00882687|3964245|B3|||Age||years|Mean|45.33|45.33|Standard Deviation|15.891|15.891|||
4139991|NCT00882687|3964246|B2|||Age||years|Mean|37.67|37.67|Standard Deviation|12.613|12.613|||
4139992|NCT00882687|3964247|B1|||Age||years|Mean|41.67|41.67|Standard Deviation|15.207|15.207|||
4139993|NCT00882661|3964280|B4|United States||Region of Enrollment||participants|Number|291|291.0||||||
4139994|NCT00882661|3964281|B3|United States||Region of Enrollment||participants|Number|89|89.0||||||
4139995|NCT00882661|3964282|B2|United States||Region of Enrollment||participants|Number|140|140.0||||||
4139996|NCT00882661|3964283|B1|United States||Region of Enrollment||participants|Number|151|151.0||||||
4139997|NCT00882661|3964280|B4||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4139998|NCT00882661|3964281|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4139999|NCT00882661|3964282|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4140000|NCT00882661|3964283|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4140001|NCT00882661|3964280|B4||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4140002|NCT00882661|3964281|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4140003|NCT00882661|3964282|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4140004|NCT00882661|3964283|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4140005|NCT00882661|3964280|B4|||Age||years|Mean|43.9|43.9|Standard Deviation|7.7|7.7|||
4140006|NCT00882661|3964281|B3|||Age||years|Mean|41.6|41.6|Standard Deviation|8.13|8.13|||
4140007|NCT00882661|3964282|B2|||Age||years|Mean|44.4|44.4|Standard Deviation|7.9|7.9|||
4140008|NCT00882661|3964283|B1|||Age||years|Mean|43.4|43.4|Standard Deviation|7.5|7.5|||
4140009|NCT00882583|3964312|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4140010|NCT00882583|3964313|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4140011|NCT00882583|3964314|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4140012|NCT00882583|3964312|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140013|NCT00882583|3964313|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140014|NCT00882583|3964314|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140015|NCT00882583|3964312|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140016|NCT00882583|3964313|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140017|NCT00882583|3964314|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140018|NCT00882583|3964312|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4140019|NCT00882583|3964313|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4140020|NCT00882583|3964314|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4140021|NCT00882583|3964312|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4140022|NCT00882583|3964313|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4140023|NCT00882583|3964314|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4140024|NCT00882583|3964312|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140025|NCT00882583|3964313|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140026|NCT00882583|3964314|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140027|NCT00882583|3964312|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140028|NCT00882583|3964313|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140029|NCT00882583|3964314|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140030|NCT00882583|3964312|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140031|NCT00882583|3964313|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140032|NCT00882583|3964314|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140033|NCT00882583|3964312|B3||Male|Gender||Participants|Count of Participants|13|13.0||||||
4140034|NCT00882583|3964313|B2||Male|Gender||Participants|Count of Participants|9|9.0||||||
4140035|NCT00882583|3964314|B1||Male|Gender||Participants|Count of Participants|4|4.0||||||
4140036|NCT00882583|3964312|B3||Female|Gender||Participants|Count of Participants|6|6.0||||||
4140037|NCT00882583|3964313|B2||Female|Gender||Participants|Count of Participants|3|3.0||||||
4140038|NCT00882583|3964314|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
4140039|NCT00882583|3964312|B3|||Age|Age in years collected at screening|years|Median|59|59.0|Full Range|||48.0|70.0|
4140040|NCT00882583|3964313|B2|||Age|Age in years collected at screening|years|Median|58|58.0|Full Range|||48.0|68.0|
4140041|NCT00882583|3964314|B1|||Age|Age in years collected at screening|years|Median|65|65.0|Full Range|||60.0|70.0|
4140042|NCT00882557|3964321|B3||Male|Sex: Female, Male|"Safety population (1 patient included in the overall number of baseline participants in the Sequence AB arm was randomized but not treated)"|Participants|Count of Participants|11|11.0||||||
4140043|NCT00882557|3964322|B2||Male|Sex: Female, Male|"Safety population (1 patient included in the overall number of baseline participants in the Sequence AB arm was randomized but not treated)"|Participants|Count of Participants|6|6.0||||||
4140044|NCT00882557|3964323|B1||Male|Sex: Female, Male|"Safety population (1 patient included in the overall number of baseline participants in the Sequence AB arm was randomized but not treated)"|Participants|Count of Participants|5|5.0||||||
4140045|NCT00882557|3964321|B3||Female|Sex: Female, Male|"Safety population (1 patient included in the overall number of baseline participants in the Sequence AB arm was randomized but not treated)"|Participants|Count of Participants|4|4.0||||||
4140046|NCT00882557|3964322|B2||Female|Sex: Female, Male|"Safety population (1 patient included in the overall number of baseline participants in the Sequence AB arm was randomized but not treated)"|Participants|Count of Participants|1|1.0||||||
4140047|NCT00882557|3964323|B1||Female|Sex: Female, Male|"Safety population (1 patient included in the overall number of baseline participants in the Sequence AB arm was randomized but not treated)"|Participants|Count of Participants|3|3.0||||||
4140048|NCT00882557|3964321|B3|||Age|"Safety population (1 patient included in the overall number of baseline participants in the Sequence AB arm was randomized but not treated)"|years|Mean|53.3|53.3|Standard Deviation|10.31|10.31|||
4140049|NCT00882557|3964322|B2|||Age|"Safety population (1 patient included in the overall number of baseline participants in the Sequence AB arm was randomized but not treated)"|years|Mean|55.3|55.3|Standard Deviation|6.05|6.05|||
4140050|NCT00882557|3964323|B1|||Age|"Safety population (1 patient included in the overall number of baseline participants in the Sequence AB arm was randomized but not treated)"|years|Mean|51.6|51.6|Standard Deviation|13.19|13.19|||
4140051|NCT00882518|3964342|B3||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4140052|NCT00882518|3964343|B2||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4140053|NCT00882518|3964344|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4140054|NCT00882518|3964342|B3||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4140055|NCT00882518|3964343|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4140056|NCT00882518|3964344|B1||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4140057|NCT00882518|3964342|B3|age||Age||years|Mean|32.5|32.5|Standard Deviation|10.52|10.52|||
4140058|NCT00882518|3964343|B2|age||Age||years|Mean|32.0|32.0|Standard Deviation|10.33|10.33|||
4140059|NCT00882518|3964344|B1|age||Age||years|Mean|32.9|32.9|Standard Deviation|10.70|10.7|||
4140060|NCT00882440|3964367|B8|||SuDBP|Supine Diastolic Blood Pressure (SuDBP)|mmHg|Mean|103.7|103.7|Standard Deviation|3.8|3.8|||
4140061|NCT00882440|3964368|B7|||SuDBP|Supine Diastolic Blood Pressure (SuDBP)|mmHg|Mean|103.1|103.1|Standard Deviation|3.7|3.7|||
4140062|NCT00882440|3964369|B6|||SuDBP|Supine Diastolic Blood Pressure (SuDBP)|mmHg|Mean|103.4|103.4|Standard Deviation|3.4|3.4|||
4140063|NCT00882440|3964370|B5|||SuDBP|Supine Diastolic Blood Pressure (SuDBP)|mmHg|Mean|104.1|104.1|Standard Deviation|4.2|4.2|||
4140064|NCT00882440|3964371|B4|||SuDBP|Supine Diastolic Blood Pressure (SuDBP)|mmHg|Mean|104.0|104.0|Standard Deviation|3.7|3.7|||
4140065|NCT00882440|3964372|B3|||SuDBP|Supine Diastolic Blood Pressure (SuDBP)|mmHg|Mean|103.3|103.3|Standard Deviation|3.7|3.7|||
4140066|NCT00882440|3964373|B2|||SuDBP|Supine Diastolic Blood Pressure (SuDBP)|mmHg|Mean|104.3|104.3|Standard Deviation|3.9|3.9|||
4140067|NCT00882440|3964374|B1|||SuDBP|Supine Diastolic Blood Pressure (SuDBP)|mmHg|Mean|103.3|103.3|Standard Deviation|3.8|3.8|||
4140068|NCT00882440|3964367|B8|Other||Race/Ethnicity||participants|Number|4|4.0||||||
4140069|NCT00882440|3964368|B7|Other||Race/Ethnicity||participants|Number|2|2.0||||||
4140070|NCT00882440|3964369|B6|Other||Race/Ethnicity||participants|Number|1|1.0||||||
4140071|NCT00882440|3964370|B5|Other||Race/Ethnicity||participants|Number|0|0.0||||||
4140072|NCT00882440|3964371|B4|Other||Race/Ethnicity||participants|Number|0|0.0||||||
4140073|NCT00882440|3964372|B3|Other||Race/Ethnicity||participants|Number|0|0.0||||||
4140074|NCT00882440|3964373|B2|Other||Race/Ethnicity||participants|Number|1|1.0||||||
4140075|NCT00882440|3964374|B1|Other||Race/Ethnicity||participants|Number|0|0.0||||||
4140076|NCT00882440|3964367|B8|Hispanic||Race/Ethnicity||participants|Number|59|59.0||||||
4140077|NCT00882440|3964368|B7|Hispanic||Race/Ethnicity||participants|Number|10|10.0||||||
4140078|NCT00882440|3964369|B6|Hispanic||Race/Ethnicity||participants|Number|8|8.0||||||
4140079|NCT00882440|3964370|B5|Hispanic||Race/Ethnicity||participants|Number|7|7.0||||||
4140080|NCT00882440|3964371|B4|Hispanic||Race/Ethnicity||participants|Number|11|11.0||||||
4140081|NCT00882440|3964372|B3|Hispanic||Race/Ethnicity||participants|Number|5|5.0||||||
4140082|NCT00882440|3964373|B2|Hispanic||Race/Ethnicity||participants|Number|9|9.0||||||
4140083|NCT00882440|3964374|B1|Hispanic||Race/Ethnicity||participants|Number|9|9.0||||||
4140084|NCT00882440|3964367|B8|Black||Race/Ethnicity||participants|Number|75|75.0||||||
4140085|NCT00882440|3964368|B7|Black||Race/Ethnicity||participants|Number|7|7.0||||||
4140086|NCT00882440|3964369|B6|Black||Race/Ethnicity||participants|Number|11|11.0||||||
4140087|NCT00882440|3964370|B5|Black||Race/Ethnicity||participants|Number|17|17.0||||||
4140088|NCT00882440|3964371|B4|Black||Race/Ethnicity||participants|Number|11|11.0||||||
4140089|NCT00882440|3964372|B3|Black||Race/Ethnicity||participants|Number|14|14.0||||||
4140090|NCT00882440|3964373|B2|Black||Race/Ethnicity||participants|Number|10|10.0||||||
4140091|NCT00882440|3964374|B1|Black||Race/Ethnicity||participants|Number|5|5.0||||||
4140092|NCT00882440|3964367|B8|Caucasian||Race/Ethnicity||participants|Number|438|438.0||||||
4140093|NCT00882440|3964368|B7|Caucasian||Race/Ethnicity||participants|Number|64|64.0||||||
4140094|NCT00882440|3964369|B6|Caucasian||Race/Ethnicity||participants|Number|64|64.0||||||
4140095|NCT00882440|3964370|B5|Caucasian||Race/Ethnicity||participants|Number|66|66.0||||||
4140096|NCT00882440|3964371|B4|Caucasian||Race/Ethnicity||participants|Number|57|57.0||||||
4140097|NCT00882440|3964372|B3|Caucasian||Race/Ethnicity||participants|Number|63|63.0||||||
4140098|NCT00882440|3964373|B2|Caucasian||Race/Ethnicity||participants|Number|60|60.0||||||
4140099|NCT00882440|3964374|B1|Caucasian||Race/Ethnicity||participants|Number|64|64.0||||||
4140100|NCT00882440|3964367|B8||Male|Sex: Female, Male||Participants|Count of Participants|383|383.0||||||
4140101|NCT00882440|3964368|B7||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4140102|NCT00882440|3964369|B6||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4140103|NCT00882440|3964370|B5||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4140104|NCT00882440|3964371|B4||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4140105|NCT00882440|3964372|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4140106|NCT00882440|3964373|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4140107|NCT00882440|3964374|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4140108|NCT00882440|3964367|B8||Female|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4140109|NCT00882440|3964368|B7||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4140110|NCT00882440|3964369|B6||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4140111|NCT00882440|3964370|B5||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4140112|NCT00882440|3964371|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4140113|NCT00882440|3964372|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4140114|NCT00882440|3964373|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4140115|NCT00882440|3964374|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4140116|NCT00882440|3964367|B8|||Age||years|Mean|53.1|53.1|Standard Deviation|11.2|11.2|||
4140117|NCT00882440|3964368|B7|||Age||years|Mean|51.9|51.9|Standard Deviation|11.1|11.1|||
4140118|NCT00882440|3964369|B6|||Age||years|Mean|53.9|53.9|Standard Deviation|10.8|10.8|||
4140119|NCT00882440|3964370|B5|||Age||years|Mean|54.0|54.0|Standard Deviation|10.2|10.2|||
4140120|NCT00882440|3964371|B4|||Age||years|Mean|52.8|52.8|Standard Deviation|10.3|10.3|||
4140121|NCT00882440|3964372|B3|||Age||years|Mean|52.8|52.8|Standard Deviation|12.2|12.2|||
4140122|NCT00882440|3964373|B2|||Age||years|Mean|53.9|53.9|Standard Deviation|12.3|12.3|||
4140123|NCT00882440|3964374|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|11.6|11.6|||
4140124|NCT00882362|3964403|B3|Japan||Region of Enrollment||participants|Number|155|155.0||||||
4140125|NCT00882362|3964404|B2|Japan||Region of Enrollment||participants|Number|33|33.0||||||
4140126|NCT00882362|3964405|B1|Japan||Region of Enrollment||participants|Number|122|122.0||||||
4140127|NCT00882362|3964403|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4140128|NCT00882362|3964404|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4140129|NCT00882362|3964405|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4140130|NCT00882362|3964403|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4140131|NCT00882362|3964404|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4140132|NCT00882362|3964405|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4140133|NCT00882362|3964403|B3||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
4140134|NCT00882362|3964404|B2||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
4140135|NCT00882362|3964405|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4140136|NCT00882362|3964403|B3||Between 18 and 65 years|Age||Participants|Count of Participants|122|122.0||||||
4140137|NCT00882362|3964404|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4140138|NCT00882362|3964405|B1||Between 18 and 65 years|Age||Participants|Count of Participants|122|122.0||||||
4140139|NCT00882362|3964403|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4140140|NCT00882362|3964404|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4140141|NCT00882362|3964405|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4140142|NCT00882362|3964403|B3|||Age||years|Mean|46.3|46.3|Standard Deviation|16.1|16.1|||
4140143|NCT00882362|3964404|B2|||Age||years|Mean|73.1|73.1|Standard Deviation|5.6|5.6|||
4140144|NCT00882362|3964405|B1|||Age||years|Mean|39.1|39.1|Standard Deviation|8.6|8.6|||
4140145|NCT00882310|3964412|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4140146|NCT00882310|3964412|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4140147|NCT00882310|3964412|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4140148|NCT00882310|3964412|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4140149|NCT00882310|3964412|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140150|NCT00882310|3964412|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140151|NCT00882310|3964412|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140152|NCT00882310|3964412|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4140153|NCT00882310|3964412|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4140154|NCT00882310|3964412|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4140155|NCT00882310|3964412|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4140156|NCT00882310|3964412|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4140157|NCT00882310|3964412|B1|70-79||Age, Customized||participants|Number|7|7.0||||||
4140158|NCT00882310|3964412|B1|60-69||Age, Customized||participants|Number|17|17.0||||||
4140159|NCT00882310|3964412|B1|50-59||Age, Customized||participants|Number|8|8.0||||||
4140160|NCT00882310|3964412|B1|40-49||Age, Customized||participants|Number|5|5.0||||||
4140161|NCT00882206|3964418|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4140162|NCT00882206|3964418|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4140163|NCT00882206|3964418|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4140164|NCT00882206|3964418|B1|||Age||years|Median|16|16.0|Full Range|||3.0|54.0|
4140165|NCT00882115|3964425|B1|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
4140166|NCT00882115|3964425|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4140167|NCT00882115|3964425|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4140168|NCT00882115|3964425|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4140169|NCT00882115|3964425|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4140170|NCT00882115|3964425|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4140171|NCT00882102|3964429|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4140172|NCT00882102|3964429|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4140173|NCT00882102|3964429|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4140174|NCT00882102|3964429|B1|||Age||years|Median|74|74.0|Full Range|||42.0|87.0|
4140175|NCT00881959|3964433|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
4140176|NCT00881959|3964434|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
4140177|NCT00881959|3964435|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4140178|NCT00881959|3964433|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4140179|NCT00881959|3964434|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4140180|NCT00881959|3964435|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4140181|NCT00881959|3964433|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4140182|NCT00881959|3964434|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4140183|NCT00881959|3964435|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4140184|NCT00881959|3964433|B3|||Age||years|Mean|46.4|46.4|Standard Deviation|14.4|14.4|||
4140185|NCT00881959|3964434|B2|||Age||years|Mean|47.4|47.4|Standard Deviation|14|14.0|||
4140186|NCT00881959|3964435|B1|||Age||years|Mean|43.1|43.1|Standard Deviation|13.7|13.7|||
4140187|NCT00881959|3964433|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4140188|NCT00881959|3964434|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4140189|NCT00881959|3964435|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4140190|NCT00881959|3964433|B3||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4140191|NCT00881959|3964434|B2||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4140192|NCT00881959|3964435|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4140193|NCT00881959|3964433|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4140194|NCT00881959|3964434|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4140195|NCT00881959|3964435|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4140196|NCT00881894|3964442|B3|||Weight||kg|Mean|79.45|79.45|Standard Deviation|7.57|7.57|||
4140197|NCT00881894|3964443|B2|||Weight||kg|Mean|79.98|79.98|Standard Deviation|8.20|8.2|||
4140198|NCT00881894|3964444|B1|||Weight||kg|Mean|78.98|78.98|Standard Deviation|7.08|7.08|||
4140199|NCT00881894|3964442|B3|Germany||Region of Enrollment||participants|Number|44|44.0||||||
4140200|NCT00881894|3964443|B2|Germany||Region of Enrollment||participants|Number|21|21.0||||||
4140201|NCT00881894|3964444|B1|Germany||Region of Enrollment||participants|Number|23|23.0||||||
4140202|NCT00881894|3964442|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4140203|NCT00881894|3964443|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4140204|NCT00881894|3964444|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4140205|NCT00881894|3964442|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4140206|NCT00881894|3964443|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4140207|NCT00881894|3964444|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4140208|NCT00881894|3964442|B3|||Age||years|Mean|39.0|39.0|Standard Deviation|9.3|9.3|||
4140209|NCT00881894|3964443|B2|||Age||years|Mean|39.3|39.3|Standard Deviation|9.1|9.1|||
4140210|NCT00881894|3964444|B1|||Age||years|Mean|38.7|38.7|Standard Deviation|9.8|9.8|||
4140211|NCT00881894|3964442|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4140212|NCT00881894|3964443|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4140213|NCT00881894|3964444|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4140214|NCT00881894|3964442|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4140215|NCT00881894|3964443|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4140216|NCT00881894|3964444|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4140217|NCT00881894|3964442|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4140218|NCT00881894|3964443|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4140219|NCT00881894|3964444|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4140220|NCT00881868|3964475|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4140221|NCT00881868|3964476|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4140222|NCT00881868|3964477|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4140223|NCT00881868|3964475|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4140224|NCT00881868|3964476|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4140225|NCT00881868|3964477|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4140226|NCT00881868|3964475|B3|||Age||years|Mean|43.7|43.7|Standard Deviation|14.69|14.69|||
4140227|NCT00881868|3964476|B2|||Age||years|Mean|41.3|41.3|Standard Deviation|13.72|13.72|||
4140228|NCT00881868|3964477|B1|||Age||years|Mean|46.0|46.0|Standard Deviation|15.41|15.41|||
4140229|NCT00881751|3964490|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4140230|NCT00881751|3964491|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4140231|NCT00881751|3964492|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4140232|NCT00881751|3964490|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140233|NCT00881751|3964491|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140234|NCT00881751|3964492|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140235|NCT00881751|3964490|B3||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4140236|NCT00881751|3964491|B2||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4140237|NCT00881751|3964492|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4140238|NCT00881751|3964490|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4140239|NCT00881751|3964491|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4140240|NCT00881751|3964492|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4140241|NCT00881751|3964490|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140242|NCT00881751|3964491|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140243|NCT00881751|3964492|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140244|NCT00881751|3964490|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4140245|NCT00881751|3964491|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4140246|NCT00881751|3964492|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4140247|NCT00881751|3964490|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4140248|NCT00881751|3964491|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4140249|NCT00881751|3964492|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140250|NCT00881751|3964490|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140251|NCT00881751|3964491|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140252|NCT00881751|3964492|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140253|NCT00881751|3964490|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
4140254|NCT00881751|3964491|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4140255|NCT00881751|3964492|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4140256|NCT00881751|3964490|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4140257|NCT00881751|3964491|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4140258|NCT00881751|3964492|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4140259|NCT00881751|3964490|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4140260|NCT00881751|3964491|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4140261|NCT00881751|3964492|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4140262|NCT00881751|3964490|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4140263|NCT00881751|3964491|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4140264|NCT00881751|3964492|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4140265|NCT00881751|3964490|B3||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4140266|NCT00881751|3964491|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4140267|NCT00881751|3964492|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4140268|NCT00881751|3964490|B3||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4140269|NCT00881751|3964491|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4140270|NCT00881751|3964492|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4140271|NCT00881751|3964490|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4140272|NCT00881751|3964491|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4140273|NCT00881751|3964492|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4140274|NCT00881712|3964505|B4|United States||Region of Enrollment||participants|Number|13|13.0||||||
4140275|NCT00881712|3964508|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4140276|NCT00881712|3964505|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4140277|NCT00881712|3964508|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4140278|NCT00881712|3964505|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4140279|NCT00881712|3964508|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4140280|NCT00881712|3964505|B4|||Age||Years|Median|62|62.0|Full Range|||49.0|82.0|
4140281|NCT00881712|3964508|B1|||Age||Years|Median|62|62.0|Full Range|||49.0|82.0|
4140282|NCT00881712|3964505|B4||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4140283|NCT00881712|3964508|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4140284|NCT00881712|3964505|B4||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4140285|NCT00881712|3964508|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4140286|NCT00881712|3964505|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4140287|NCT00881712|3964508|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4140288|NCT00881647|3964530|B3|Not using psychotropic medication||Using psychotropic medication||participants|Number|27|27.0||||||
4140289|NCT00881647|3964531|B2|Not using psychotropic medication||Using psychotropic medication||participants|Number|9|9.0||||||
4140290|NCT00881647|3964532|B1|Not using psychotropic medication||Using psychotropic medication||participants|Number|18|18.0||||||
4140291|NCT00881647|3964530|B3|Using psychotropic medication||Using psychotropic medication||participants|Number|18|18.0||||||
4140292|NCT00881647|3964531|B2|Using psychotropic medication||Using psychotropic medication||participants|Number|7|7.0||||||
4140293|NCT00881647|3964532|B1|Using psychotropic medication||Using psychotropic medication||participants|Number|11|11.0||||||
4140294|NCT00881647|3964530|B3|Not depressed||Current Depression|Depression symptoms were assessed using the Beck Depression Inventory|participants|Number|36|36.0||||||
4140295|NCT00881647|3964531|B2|Not depressed||Current Depression|Depression symptoms were assessed using the Beck Depression Inventory|participants|Number|12|12.0||||||
4140296|NCT00881647|3964532|B1|Not depressed||Current Depression|Depression symptoms were assessed using the Beck Depression Inventory|participants|Number|24|24.0||||||
4140297|NCT00881647|3964530|B3|Depressed||Current Depression|Depression symptoms were assessed using the Beck Depression Inventory|participants|Number|9|9.0||||||
4140298|NCT00881647|3964531|B2|Depressed||Current Depression|Depression symptoms were assessed using the Beck Depression Inventory|participants|Number|4|4.0||||||
4140299|NCT00881647|3964532|B1|Depressed||Current Depression|Depression symptoms were assessed using the Beck Depression Inventory|participants|Number|5|5.0||||||
4140300|NCT00881647|3964530|B3|||PTSD Duration||years|Mean|18.5|18.5|Standard Deviation|2.1|2.1|||
4140301|NCT00881647|3964531|B2|||PTSD Duration||years|Mean|15.0|15.0|Standard Deviation|13.8|13.8|||
4140302|NCT00881647|3964532|B1|||PTSD Duration||years|Mean|20.4|20.4|Standard Deviation|13.6|13.6|||
4140303|NCT00881647|3964530|B3|Not veteran||Veteran Status||participants|Number|36|36.0||||||
4140304|NCT00881647|3964531|B2|Not veteran||Veteran Status||participants|Number|10|10.0||||||
4140305|NCT00881647|3964532|B1|Not veteran||Veteran Status||participants|Number|26|26.0||||||
4140306|NCT00881647|3964530|B3|Veteran||Veteran Status||participants|Number|9|9.0||||||
4140307|NCT00881647|3964531|B2|Veteran||Veteran Status||participants|Number|6|6.0||||||
4140308|NCT00881647|3964532|B1|Veteran||Veteran Status||participants|Number|3|3.0||||||
4140309|NCT00881647|3964530|B3|Separated||Marital Status||participants|Number|1|1.0||||||
4140310|NCT00881647|3964531|B2|Separated||Marital Status||participants|Number|1|1.0||||||
4140311|NCT00881647|3964532|B1|Separated||Marital Status||participants|Number|0|0.0||||||
4140312|NCT00881647|3964530|B3|Divorced||Marital Status||participants|Number|6|6.0||||||
4140313|NCT00881647|3964531|B2|Divorced||Marital Status||participants|Number|3|3.0||||||
4140314|NCT00881647|3964532|B1|Divorced||Marital Status||participants|Number|3|3.0||||||
4140315|NCT00881647|3964530|B3|Married/Partnered||Marital Status||participants|Number|8|8.0||||||
4140316|NCT00881647|3964531|B2|Married/Partnered||Marital Status||participants|Number|2|2.0||||||
4140317|NCT00881647|3964532|B1|Married/Partnered||Marital Status||participants|Number|6|6.0||||||
4140318|NCT00881647|3964530|B3|Single||Marital Status||participants|Number|30|30.0||||||
4140319|NCT00881647|3964531|B2|Single||Marital Status||participants|Number|10|10.0||||||
4140320|NCT00881647|3964532|B1|Single||Marital Status||participants|Number|20|20.0||||||
4140321|NCT00881647|3964530|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
4140322|NCT00881647|3964531|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4140323|NCT00881647|3964532|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4140324|NCT00881647|3964530|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4140325|NCT00881647|3964531|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4140326|NCT00881647|3964532|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4140327|NCT00881647|3964530|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140328|NCT00881647|3964531|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140329|NCT00881647|3964532|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140330|NCT00881647|3964530|B3||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4140331|NCT00881647|3964531|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4140332|NCT00881647|3964532|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4140333|NCT00881647|3964530|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4140334|NCT00881647|3964531|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4140335|NCT00881647|3964532|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4140336|NCT00881647|3964530|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140337|NCT00881647|3964531|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140338|NCT00881647|3964532|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140339|NCT00881647|3964530|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4140340|NCT00881647|3964531|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4140341|NCT00881647|3964532|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4140342|NCT00881647|3964530|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140343|NCT00881647|3964531|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140344|NCT00881647|3964532|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140345|NCT00881647|3964530|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4140346|NCT00881647|3964531|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4140347|NCT00881647|3964532|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4140348|NCT00881647|3964530|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4140349|NCT00881647|3964531|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4140350|NCT00881647|3964532|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4140351|NCT00881647|3964530|B3|||Age||years|Mean|37.2|37.2|Standard Deviation|10.5|10.5|||
4140352|NCT00881647|3964531|B2|||Age||years|Mean|37.3|37.3|Standard Deviation|11.0|11.0|||
4140353|NCT00881647|3964532|B1|||Age||years|Mean|37.1|37.1|Standard Deviation|10.4|10.4|||
4140354|NCT00881621|3964543|B1|ECOG PS2||ECOG|"ECOG PERFORMANCE STATUS* Grade 0: Fully active, able to carry on all pre-disease performance without restriction~1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work 2: Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours 3: Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours 4: Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair 5: Dead"|participants|Number|2|2.0||||||
4140355|NCT00881621|3964543|B1|ECOG PS 1||ECOG|"ECOG PERFORMANCE STATUS* Grade 0: Fully active, able to carry on all pre-disease performance without restriction~1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work 2: Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours 3: Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours 4: Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair 5: Dead"|participants|Number|12|12.0||||||
4140356|NCT00881621|3964543|B1|ECOG PS 0||ECOG|"ECOG PERFORMANCE STATUS* Grade 0: Fully active, able to carry on all pre-disease performance without restriction~1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work 2: Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours 3: Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours 4: Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair 5: Dead"|participants|Number|3|3.0||||||
4140357|NCT00881621|3964543|B1||Male|Gender||Participants|Count of Participants|13|13.0||||||
4140358|NCT00881621|3964543|B1||Female|Gender||Participants|Count of Participants|4|4.0||||||
4140359|NCT00881621|3964543|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4140360|NCT00881621|3964543|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4140361|NCT00881621|3964543|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4140362|NCT00881530|3964572|B7||Male|Sex: Female, Male||Participants|Count of Participants|334|334.0||||||
4140363|NCT00881530|3964573|B6||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4140364|NCT00881530|3964574|B5||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4140365|NCT00881530|3964575|B4||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4140366|NCT00881530|3964576|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4140367|NCT00881530|3964577|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4140368|NCT00881530|3964578|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4140369|NCT00881530|3964572|B7||Female|Sex: Female, Male||Participants|Count of Participants|325|325.0||||||
4140370|NCT00881530|3964573|B6||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4140371|NCT00881530|3964574|B5||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4140372|NCT00881530|3964575|B4||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4140373|NCT00881530|3964576|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4140374|NCT00881530|3964577|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4140375|NCT00881530|3964578|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4140376|NCT00881530|3964572|B7|||Age||years|Mean|58.6|58.6|Standard Deviation|8.8|8.8|||
4140377|NCT00881530|3964573|B6|||Age||years|Mean|58.3|58.3|Standard Deviation|10.5|10.5|||
4140378|NCT00881530|3964574|B5|||Age||years|Mean|59.9|59.9|Standard Deviation|7.8|7.8|||
4140379|NCT00881530|3964575|B4|||Age||years|Mean|58.4|58.4|Standard Deviation|8.3|8.3|||
4140380|NCT00881530|3964576|B3|||Age||years|Mean|56.8|56.8|Standard Deviation|8.9|8.9|||
4140381|NCT00881530|3964577|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|10.0|10.0|||
4140382|NCT00881530|3964578|B1|||Age||years|Mean|58.3|58.3|Standard Deviation|8.5|8.5|||
4140383|NCT00881504|3964639|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4140384|NCT00881504|3964639|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4140385|NCT00881504|3964639|B1|||Age||years|Mean|68.1|68.1|Standard Deviation|11.7|11.7|||
4140386|NCT00881465|3964644|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4140387|NCT00881465|3964645|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4140388|NCT00881465|3964646|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4140389|NCT00881465|3964644|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4140390|NCT00881465|3964645|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4140391|NCT00881465|3964646|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4140392|NCT00881465|3964644|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4140393|NCT00881465|3964645|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4140394|NCT00881465|3964646|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4140395|NCT00881465|3964644|B3|||Age||years|Mean|11.1|11.1|Standard Deviation|2.59|2.59|||
4140396|NCT00881465|3964645|B2|||Age||years|Mean|11.2|11.2|Standard Deviation|2.81|2.81|||
4140397|NCT00881465|3964646|B1|||Age||years|Mean|11|11.0|Standard Deviation|2.5|2.5|||
4140398|NCT00881465|3964644|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4140399|NCT00881465|3964645|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4140400|NCT00881465|3964646|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4140401|NCT00881465|3964644|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4140402|NCT00881465|3964645|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4140403|NCT00881465|3964646|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4140404|NCT00881465|3964644|B3||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
4140405|NCT00881465|3964645|B2||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4140406|NCT00881465|3964646|B1||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4140407|NCT00881361|3964657|B3|United States||Region of Enrollment||Participants|Count of Participants|701|701.0||||||
4140408|NCT00881361|3964658|B2|United States||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
4140409|NCT00881361|3964659|B1|United States||Region of Enrollment||Participants|Count of Participants|663|663.0||||||
4140410|NCT00881361|3964657|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4140411|NCT00881361|3964658|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4140412|NCT00881361|3964659|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4140413|NCT00881361|3964657|B3||Female|Sex: Female, Male||Participants|Count of Participants|701|701.0||||||
4140414|NCT00881361|3964658|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4140415|NCT00881361|3964659|B1||Female|Sex: Female, Male||Participants|Count of Participants|663|663.0||||||
4140416|NCT00881361|3964657|B3|greater than 70 years old||Age, Customized||participants|Number|25|25.0||||||
4140417|NCT00881361|3964658|B2|greater than 70 years old||Age, Customized||participants|Number|4|4.0||||||
4140418|NCT00881361|3964659|B1|greater than 70 years old||Age, Customized||participants|Number|21|21.0||||||
4140419|NCT00881361|3964657|B3|60-69 years old||Age, Customized||participants|Number|117|117.0||||||
4140420|NCT00881361|3964658|B2|60-69 years old||Age, Customized||participants|Number|5|5.0||||||
4140421|NCT00881361|3964659|B1|60-69 years old||Age, Customized||participants|Number|112|112.0||||||
4140422|NCT00881361|3964657|B3|50-59 years old||Age, Customized||participants|Number|207|207.0||||||
4140423|NCT00881361|3964658|B2|50-59 years old||Age, Customized||participants|Number|10|10.0||||||
4140424|NCT00881361|3964659|B1|50-59 years old||Age, Customized||participants|Number|197|197.0||||||
4140425|NCT00881361|3964657|B3|40-49 years old||Age, Customized||participants|Number|228|228.0||||||
4140426|NCT00881361|3964658|B2|40-49 years old||Age, Customized||participants|Number|15|15.0||||||
4140427|NCT00881361|3964659|B1|40-49 years old||Age, Customized||participants|Number|213|213.0||||||
4140428|NCT00881361|3964657|B3|18-39 years old||Age, Customized||participants|Number|124|124.0||||||
4140429|NCT00881361|3964658|B2|18-39 years old||Age, Customized||participants|Number|4|4.0||||||
4140430|NCT00881361|3964659|B1|18-39 years old||Age, Customized||participants|Number|120|120.0||||||
4140431|NCT00881335|3964674|B3|China||Region of Enrollment||participants|Number|60|60.0||||||
4140432|NCT00881335|3964675|B2|China||Region of Enrollment||participants|Number|30|30.0||||||
4140433|NCT00881335|3964676|B1|China||Region of Enrollment||participants|Number|30|30.0||||||
4140434|NCT00881335|3964674|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4140435|NCT00881335|3964675|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4140436|NCT00881335|3964676|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4140437|NCT00881335|3964674|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4140438|NCT00881335|3964675|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4140439|NCT00881335|3964676|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4140440|NCT00881335|3964674|B3|||Age||years|Mean|87.20|87.2|Standard Deviation|2.56|2.56|||
4140441|NCT00881335|3964675|B2|||Age||years|Mean|87.57|87.57|Standard Deviation|2.95|2.95|||
4140442|NCT00881335|3964676|B1|||Age||years|Mean|86.81|86.81|Standard Deviation|2.06|2.06|||
4140443|NCT00881335|3964674|B3||>=65 years|Age||Participants|Count of Participants|60|60.0||||||
4140444|NCT00881335|3964675|B2||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4140445|NCT00881335|3964676|B1||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4140446|NCT00881335|3964674|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4140447|NCT00881335|3964675|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4140448|NCT00881335|3964676|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4140449|NCT00881335|3964674|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4140450|NCT00881335|3964675|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4140451|NCT00881335|3964676|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4140452|NCT00881205|3964695|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4140453|NCT00881205|3964696|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4140454|NCT00881205|3964697|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4140455|NCT00881205|3964695|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4140456|NCT00881205|3964696|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4140457|NCT00881205|3964697|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4140458|NCT00881205|3964695|B3|||Age||years|Mean|44.3|44.3|Standard Deviation|8.5|8.5|||
4140459|NCT00881205|3964696|B2|||Age||years|Mean|44.0|44.0|Standard Deviation|7.3|7.3|||
4140460|NCT00881205|3964697|B1|||Age||years|Mean|44.6|44.6|Standard Deviation|9.4|9.4|||
4140461|NCT00880919|3964705|B4|United States||Region of Enrollment||participants|Number|95|95.0||||||
4140462|NCT00880919|3964706|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
4140463|NCT00880919|3964707|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4140464|NCT00880919|3964708|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4140465|NCT00880919|3964705|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4140466|NCT00880919|3964706|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4140467|NCT00880919|3964707|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4140468|NCT00880919|3964708|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4140469|NCT00880919|3964705|B4||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4140470|NCT00880919|3964706|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4140471|NCT00880919|3964707|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4140472|NCT00880919|3964708|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4140473|NCT00880919|3964705|B4|||Age||years|Mean|29.5|29.5|Standard Deviation|8.3|8.3|||
4140474|NCT00880919|3964706|B3|||Age||years|Mean|20.1|20.1|Standard Deviation|8.8|8.8|||
4140475|NCT00880919|3964707|B2|||Age||years|Mean|30.2|30.2|Standard Deviation|8.1|8.1|||
4140476|NCT00880919|3964708|B1|||Age||years|Mean|28.2|28.2|Standard Deviation|8.0|8.0|||
4140477|NCT00880919|3964705|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4140478|NCT00880919|3964706|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4140479|NCT00880919|3964707|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4140480|NCT00880919|3964708|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4140481|NCT00880919|3964705|B4||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
4140482|NCT00880919|3964706|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4140483|NCT00880919|3964707|B2||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4140484|NCT00880919|3964708|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4140485|NCT00880919|3964705|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4140486|NCT00880919|3964706|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4140487|NCT00880919|3964707|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4140488|NCT00880919|3964708|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4140489|NCT00880906|3964742|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4140490|NCT00880906|3964743|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4140491|NCT00880906|3964744|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4140492|NCT00880906|3964742|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4140493|NCT00880906|3964743|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4140494|NCT00880906|3964744|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4140495|NCT00880906|3964742|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4140496|NCT00880906|3964743|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4140497|NCT00880906|3964744|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4140498|NCT00880906|3964742|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4140499|NCT00880906|3964743|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4140500|NCT00880906|3964744|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4140501|NCT00880906|3964742|B3||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4140502|NCT00880906|3964743|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4140503|NCT00880906|3964744|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4140504|NCT00880906|3964742|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4140505|NCT00880906|3964743|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4140506|NCT00880906|3964744|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4140507|NCT00880906|3964742|B3|||Age||Years|Median|33|33.0|Full Range|||19.0|69.0|
4140508|NCT00880906|3964743|B2|||Age||Years|Median|32|32.0|Full Range|||20.0|69.0|
4140509|NCT00880906|3964744|B1|||Age||Years|Median|35|35.0|Full Range|||19.0|61.0|
4140510|NCT00880763|3964753|B5|Genotype 1b||Genotype||Participants|Number|87|87.0||||||
4140511|NCT00880763|3964754|B4|Genotype 1b||Genotype||Participants|Number|21|21.0||||||
4140512|NCT00880763|3964755|B3|Genotype 1b||Genotype||Participants|Number|23|23.0||||||
4140513|NCT00880763|3964756|B2|Genotype 1b||Genotype||Participants|Number|21|21.0||||||
4140514|NCT00880763|3964757|B1|Genotype 1b||Genotype||Participants|Number|22|22.0||||||
4140515|NCT00880763|3964753|B5|Genotype 1a||Genotype||Participants|Number|3|3.0||||||
4140516|NCT00880763|3964754|B4|Genotype 1a||Genotype||Participants|Number|1|1.0||||||
4140517|NCT00880763|3964755|B3|Genotype 1a||Genotype||Participants|Number|0|0.0||||||
4140518|NCT00880763|3964756|B2|Genotype 1a||Genotype||Participants|Number|1|1.0||||||
4140519|NCT00880763|3964757|B1|Genotype 1a||Genotype||Participants|Number|1|1.0||||||
4140520|NCT00880763|3964753|B5|Japan||Region of Enrollment||Participants|Number|90|90.0||||||
4140521|NCT00880763|3964754|B4|Japan||Region of Enrollment||Participants|Number|22|22.0||||||
4140522|NCT00880763|3964755|B3|Japan||Region of Enrollment||Participants|Number|23|23.0||||||
4140523|NCT00880763|3964756|B2|Japan||Region of Enrollment||Participants|Number|22|22.0||||||
4140524|NCT00880763|3964757|B1|Japan||Region of Enrollment||Participants|Number|23|23.0||||||
4140525|NCT00880763|3964753|B5||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4140526|NCT00880763|3964754|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4140527|NCT00880763|3964755|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4140528|NCT00880763|3964756|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4140529|NCT00880763|3964757|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4140530|NCT00880763|3964753|B5||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4140531|NCT00880763|3964754|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4140532|NCT00880763|3964755|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4140533|NCT00880763|3964756|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4140534|NCT00880763|3964757|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4140535|NCT00880763|3964753|B5|||Age||Years|Mean|55.1|55.1|Standard Deviation|7.1|7.1|||
4140536|NCT00880763|3964754|B4|||Age||Years|Mean|54.7|54.7|Standard Deviation|6.9|6.9|||
4140537|NCT00880763|3964755|B3|||Age||Years|Mean|56.3|56.3|Standard Deviation|7.8|7.8|||
4140538|NCT00880763|3964756|B2|||Age||Years|Mean|54.3|54.3|Standard Deviation|7.6|7.6|||
4140539|NCT00880763|3964757|B1|||Age||Years|Mean|55.0|55.0|Standard Deviation|6.5|6.5|||
4140540|NCT00880750|3964790|B3|United States||Region of Enrollment||participants|Number|72|72.0||||||
4140541|NCT00880750|3964791|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4140542|NCT00880750|3964792|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4140543|NCT00880750|3964790|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4140544|NCT00880750|3964791|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4140545|NCT00880750|3964792|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4140546|NCT00880750|3964790|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4140547|NCT00880750|3964791|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4140548|NCT00880750|3964792|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4140549|NCT00880750|3964790|B3|||Age||years|Mean|31.4|31.4|Standard Deviation|8.26|8.26|||
4140550|NCT00880750|3964791|B2|||Age||years|Mean|31.3|31.3|Standard Deviation|7.83|7.83|||
4140551|NCT00880750|3964792|B1|||Age||years|Mean|31.5|31.5|Standard Deviation|8.70|8.7|||
4140552|NCT00880750|3964790|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4140553|NCT00880750|3964791|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4140554|NCT00880750|3964792|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4140555|NCT00880750|3964790|B3||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
4140556|NCT00880750|3964791|B2||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4140557|NCT00880750|3964792|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4140558|NCT00880750|3964790|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4140559|NCT00880750|3964791|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4140560|NCT00880750|3964792|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4140561|NCT00880698|3964807|B5|||HIV-1 RNA (copies/ml)|HIV-1 RNA not collected in HIV-1 uninfected stratum. HIV-1 infected RotaTeq (n=35), Placebo (n=37). Upper limit of detection of HIV-1 RNA assay is 750,000 copies/ml.|copies/ml|Median|NA||Inter-Quartile Range|||0.0|0.0|Not collected in HIV-1 uninfected cohort
4140562|NCT00880698|3964808|B4|||HIV-1 RNA (copies/ml)|HIV-1 RNA not collected in HIV-1 uninfected stratum. HIV-1 infected RotaTeq (n=35), Placebo (n=37). Upper limit of detection of HIV-1 RNA assay is 750,000 copies/ml.|copies/ml|Median|83628|83628.0|Inter-Quartile Range|||9660.0|750000.0|
4140563|NCT00880698|3964809|B3|||HIV-1 RNA (copies/ml)|HIV-1 RNA not collected in HIV-1 uninfected stratum. HIV-1 infected RotaTeq (n=35), Placebo (n=37). Upper limit of detection of HIV-1 RNA assay is 750,000 copies/ml.|copies/ml|Median|39827|39827.0|Inter-Quartile Range|||1380.0|569000.0|
4140564|NCT00880698|3964810|B2|||HIV-1 RNA (copies/ml)|HIV-1 RNA not collected in HIV-1 uninfected stratum. HIV-1 infected RotaTeq (n=35), Placebo (n=37). Upper limit of detection of HIV-1 RNA assay is 750,000 copies/ml.|copies/ml|Median|NA||Inter-Quartile Range|||0.0|0.0|Not collected in HIV-1 uninfected cohort
4140565|NCT00880698|3964811|B1|||HIV-1 RNA (copies/ml)|HIV-1 RNA not collected in HIV-1 uninfected stratum. HIV-1 infected RotaTeq (n=35), Placebo (n=37). Upper limit of detection of HIV-1 RNA assay is 750,000 copies/ml.|copies/ml|Median|NA||Inter-Quartile Range|||0.0|0.0|Not collected in HIV-1 uninfected cohort
4140566|NCT00880698|3964807|B5|||Screening CD4 percent (%)||percent|Median|35|35.0|Inter-Quartile Range|||28.0|43.0|
4140567|NCT00880698|3964808|B4|||Screening CD4 percent (%)||percent|Median|29|29.0|Inter-Quartile Range|||23.0|34.0|
4140568|NCT00880698|3964809|B3|||Screening CD4 percent (%)||percent|Median|31|31.0|Inter-Quartile Range|||24.0|38.0|
4140569|NCT00880698|3964810|B2|||Screening CD4 percent (%)||percent|Median|38|38.0|Inter-Quartile Range|||31.0|45.0|
4140570|NCT00880698|3964811|B1|||Screening CD4 percent (%)||percent|Median|37|37.0|Inter-Quartile Range|||33.0|45.0|
4140571|NCT00880698|3964807|B5|No||Ever breast fed||participants|Number|75|75.0||||||
4140572|NCT00880698|3964808|B4|No||Ever breast fed||participants|Number|13|13.0||||||
4140573|NCT00880698|3964809|B3|No||Ever breast fed||participants|Number|15|15.0||||||
4140574|NCT00880698|3964810|B2|No||Ever breast fed||participants|Number|21|21.0||||||
4140575|NCT00880698|3964811|B1|No||Ever breast fed||participants|Number|26|26.0||||||
4140576|NCT00880698|3964807|B5|Yes||Ever breast fed||participants|Number|127|127.0||||||
4140577|NCT00880698|3964808|B4|Yes||Ever breast fed||participants|Number|26|26.0||||||
4140578|NCT00880698|3964809|B3|Yes||Ever breast fed||participants|Number|22|22.0||||||
4140579|NCT00880698|3964810|B2|Yes||Ever breast fed||participants|Number|43|43.0||||||
4140580|NCT00880698|3964811|B1|Yes||Ever breast fed||participants|Number|36|36.0||||||
4140581|NCT00880698|3964807|B5|Zambia||Region of Enrollment||participants|Number|14|14.0||||||
4140582|NCT00880698|3964808|B4|Zambia||Region of Enrollment||participants|Number|4|4.0||||||
4140583|NCT00880698|3964809|B3|Zambia||Region of Enrollment||participants|Number|2|2.0||||||
4140584|NCT00880698|3964810|B2|Zambia||Region of Enrollment||participants|Number|4|4.0||||||
4140585|NCT00880698|3964811|B1|Zambia||Region of Enrollment||participants|Number|4|4.0||||||
4140586|NCT00880698|3964807|B5|Zimbabwe||Region of Enrollment||participants|Number|105|105.0||||||
4140587|NCT00880698|3964808|B4|Zimbabwe||Region of Enrollment||participants|Number|15|15.0||||||
4140588|NCT00880698|3964809|B3|Zimbabwe||Region of Enrollment||participants|Number|16|16.0||||||
4140589|NCT00880698|3964810|B2|Zimbabwe||Region of Enrollment||participants|Number|38|38.0||||||
4140590|NCT00880698|3964811|B1|Zimbabwe||Region of Enrollment||participants|Number|36|36.0||||||
4140591|NCT00880698|3964807|B5|Tanzania||Region of Enrollment||participants|Number|13|13.0||||||
4140592|NCT00880698|3964808|B4|Tanzania||Region of Enrollment||participants|Number|4|4.0||||||
4140593|NCT00880698|3964809|B3|Tanzania||Region of Enrollment||participants|Number|2|2.0||||||
4140594|NCT00880698|3964810|B2|Tanzania||Region of Enrollment||participants|Number|4|4.0||||||
4140595|NCT00880698|3964811|B1|Tanzania||Region of Enrollment||participants|Number|3|3.0||||||
4140596|NCT00880698|3964807|B5|Botswana||Region of Enrollment||participants|Number|70|70.0||||||
4140597|NCT00880698|3964808|B4|Botswana||Region of Enrollment||participants|Number|16|16.0||||||
4140598|NCT00880698|3964809|B3|Botswana||Region of Enrollment||participants|Number|17|17.0||||||
4140599|NCT00880698|3964810|B2|Botswana||Region of Enrollment||participants|Number|18|18.0||||||
4140600|NCT00880698|3964811|B1|Botswana||Region of Enrollment||participants|Number|19|19.0||||||
4140601|NCT00880698|3964807|B5||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4140602|NCT00880698|3964808|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4140603|NCT00880698|3964809|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4140604|NCT00880698|3964810|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4140605|NCT00880698|3964811|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4140606|NCT00880698|3964807|B5||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4140607|NCT00880698|3964808|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4140608|NCT00880698|3964809|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4140609|NCT00880698|3964810|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4140610|NCT00880698|3964811|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4140611|NCT00880698|3964807|B5|85-105 days||Age, Customized||Participants|Number|106|106.0||||||
4140612|NCT00880698|3964808|B4|85-105 days||Age, Customized||Participants|Number|29|29.0||||||
4140613|NCT00880698|3964809|B3|85-105 days||Age, Customized||Participants|Number|26|26.0||||||
4140614|NCT00880698|3964810|B2|85-105 days||Age, Customized||Participants|Number|23|23.0||||||
4140615|NCT00880698|3964811|B1|85-105 days||Age, Customized||Participants|Number|28|28.0||||||
4140616|NCT00880698|3964807|B5|43-84 days||Age, Customized||Participants|Number|88|88.0||||||
4140617|NCT00880698|3964808|B4|43-84 days||Age, Customized||Participants|Number|10|10.0||||||
4140618|NCT00880698|3964809|B3|43-84 days||Age, Customized||Participants|Number|10|10.0||||||
4140619|NCT00880698|3964810|B2|43-84 days||Age, Customized||Participants|Number|39|39.0||||||
4140620|NCT00880698|3964811|B1|43-84 days||Age, Customized||Participants|Number|29|29.0||||||
4140621|NCT00880698|3964807|B5|27-42 days||Age, Customized||Participants|Number|8|8.0||||||
4140622|NCT00880698|3964808|B4|27-42 days||Age, Customized||Participants|Number|0|0.0||||||
4140623|NCT00880698|3964809|B3|27-42 days||Age, Customized||Participants|Number|1|1.0||||||
4140624|NCT00880698|3964810|B2|27-42 days||Age, Customized||Participants|Number|2|2.0||||||
4140625|NCT00880698|3964811|B1|27-42 days||Age, Customized||Participants|Number|5|5.0||||||
4140626|NCT00880698|3964807|B5|||Age||days|Median|87|87.0|Inter-Quartile Range|||75.0|94.0|
4140627|NCT00880698|3964808|B4|||Age||days|Median|93|93.0|Inter-Quartile Range|||83.0|99.0|
4140628|NCT00880698|3964809|B3|||Age||days|Median|92|92.0|Inter-Quartile Range|||82.0|94.0|
4140629|NCT00880698|3964810|B2|||Age||days|Median|79|79.0|Inter-Quartile Range|||71.0|92.0|
4140630|NCT00880698|3964811|B1|||Age||days|Median|82|82.0|Inter-Quartile Range|||71.0|92.0|
4140631|NCT00880685|3964840|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4140632|NCT00880685|3964840|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4140633|NCT00880685|3964840|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4140634|NCT00880685|3964840|B1|||Age||years|Mean|46.6|46.6|Standard Deviation|11.6|11.6|||
4140635|NCT00880685|3964840|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4140636|NCT00880685|3964840|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4140637|NCT00880685|3964840|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4140638|NCT00880620|3964848|B5|||MMSE|The Mini–Mental State Examination (MMSE) is a 30-point questionnaire that is used extensively to measure cognitive impairment. Any score greater than or equal to 24 points (out of 30) indicates a normal cognition. Below this, scores can indicate severe (≤9 points), moderate (10–18 points) or mild (19–23 points) cognitive impairment.|units on a scale|Mean|28.9|28.9|Standard Deviation|1.21|1.21|||
4140639|NCT00880620|3964849|B4|||MMSE|The Mini–Mental State Examination (MMSE) is a 30-point questionnaire that is used extensively to measure cognitive impairment. Any score greater than or equal to 24 points (out of 30) indicates a normal cognition. Below this, scores can indicate severe (≤9 points), moderate (10–18 points) or mild (19–23 points) cognitive impairment.|units on a scale|Mean|28.9|28.9|Standard Deviation|1.18|1.18|||
4140640|NCT00880620|3964850|B3|||MMSE|The Mini–Mental State Examination (MMSE) is a 30-point questionnaire that is used extensively to measure cognitive impairment. Any score greater than or equal to 24 points (out of 30) indicates a normal cognition. Below this, scores can indicate severe (≤9 points), moderate (10–18 points) or mild (19–23 points) cognitive impairment.|units on a scale|Mean|28.7|28.7|Standard Deviation|1.21|1.21|||
4140641|NCT00880620|3964851|B2|||MMSE|The Mini–Mental State Examination (MMSE) is a 30-point questionnaire that is used extensively to measure cognitive impairment. Any score greater than or equal to 24 points (out of 30) indicates a normal cognition. Below this, scores can indicate severe (≤9 points), moderate (10–18 points) or mild (19–23 points) cognitive impairment.|units on a scale|Mean|29.0|29.0|Standard Deviation|1.27|1.27|||
4140642|NCT00880620|3964852|B1|||MMSE|The Mini–Mental State Examination (MMSE) is a 30-point questionnaire that is used extensively to measure cognitive impairment. Any score greater than or equal to 24 points (out of 30) indicates a normal cognition. Below this, scores can indicate severe (≤9 points), moderate (10–18 points) or mild (19–23 points) cognitive impairment.|units on a scale|Mean|28.9|28.9|Standard Deviation|1.18|1.18|||
4140643|NCT00880620|3964848|B5|Remaining||Hoehn and Yahr Stage|"Hoehn and Yahr Staging of Parkinson’s Disease: Stages move from 1 – 5 with the worse outcome stage being Stage 5.~Stage 1 = Symptoms on one side of the body only. Stage 2 = Symptoms on both sides of the body, No impairment of balance. Stage 3 = Balance impairment. Mild to moderate disease. Physically independent. Stage 4 = Severe disability but still able to walk or stand unassisted. Stage 5 = Wheelchair bound or bedridden unless assisted."|units on a scale|Number|83|83.0||||||
4140644|NCT00880620|3964849|B4|Remaining||Hoehn and Yahr Stage|"Hoehn and Yahr Staging of Parkinson’s Disease: Stages move from 1 – 5 with the worse outcome stage being Stage 5.~Stage 1 = Symptoms on one side of the body only. Stage 2 = Symptoms on both sides of the body, No impairment of balance. Stage 3 = Balance impairment. Mild to moderate disease. Physically independent. Stage 4 = Severe disability but still able to walk or stand unassisted. Stage 5 = Wheelchair bound or bedridden unless assisted."|units on a scale|Number|22|22.0||||||
4140645|NCT00880620|3964850|B3|Remaining||Hoehn and Yahr Stage|"Hoehn and Yahr Staging of Parkinson’s Disease: Stages move from 1 – 5 with the worse outcome stage being Stage 5.~Stage 1 = Symptoms on one side of the body only. Stage 2 = Symptoms on both sides of the body, No impairment of balance. Stage 3 = Balance impairment. Mild to moderate disease. Physically independent. Stage 4 = Severe disability but still able to walk or stand unassisted. Stage 5 = Wheelchair bound or bedridden unless assisted."|units on a scale|Number|26|26.0||||||
4140646|NCT00880620|3964851|B2|Remaining||Hoehn and Yahr Stage|"Hoehn and Yahr Staging of Parkinson’s Disease: Stages move from 1 – 5 with the worse outcome stage being Stage 5.~Stage 1 = Symptoms on one side of the body only. Stage 2 = Symptoms on both sides of the body, No impairment of balance. Stage 3 = Balance impairment. Mild to moderate disease. Physically independent. Stage 4 = Severe disability but still able to walk or stand unassisted. Stage 5 = Wheelchair bound or bedridden unless assisted."|units on a scale|Number|19|19.0||||||
4140710|NCT00880620|3964850|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4140711|NCT00880620|3964851|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4140712|NCT00880620|3964852|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4140647|NCT00880620|3964852|B1|Remaining||Hoehn and Yahr Stage|"Hoehn and Yahr Staging of Parkinson’s Disease: Stages move from 1 – 5 with the worse outcome stage being Stage 5.~Stage 1 = Symptoms on one side of the body only. Stage 2 = Symptoms on both sides of the body, No impairment of balance. Stage 3 = Balance impairment. Mild to moderate disease. Physically independent. Stage 4 = Severe disability but still able to walk or stand unassisted. Stage 5 = Wheelchair bound or bedridden unless assisted."|units on a scale|Number|16|16.0||||||
4140648|NCT00880620|3964848|B5|Stage II||Hoehn and Yahr Stage|"Hoehn and Yahr Staging of Parkinson’s Disease: Stages move from 1 – 5 with the worse outcome stage being Stage 5.~Stage 1 = Symptoms on one side of the body only. Stage 2 = Symptoms on both sides of the body, No impairment of balance. Stage 3 = Balance impairment. Mild to moderate disease. Physically independent. Stage 4 = Severe disability but still able to walk or stand unassisted. Stage 5 = Wheelchair bound or bedridden unless assisted."|units on a scale|Number|258|258.0||||||
4140649|NCT00880620|3964849|B4|Stage II||Hoehn and Yahr Stage|"Hoehn and Yahr Staging of Parkinson’s Disease: Stages move from 1 – 5 with the worse outcome stage being Stage 5.~Stage 1 = Symptoms on one side of the body only. Stage 2 = Symptoms on both sides of the body, No impairment of balance. Stage 3 = Balance impairment. Mild to moderate disease. Physically independent. Stage 4 = Severe disability but still able to walk or stand unassisted. Stage 5 = Wheelchair bound or bedridden unless assisted."|units on a scale|Number|62|62.0||||||
4140650|NCT00880620|3964850|B3|Stage II||Hoehn and Yahr Stage|"Hoehn and Yahr Staging of Parkinson’s Disease: Stages move from 1 – 5 with the worse outcome stage being Stage 5.~Stage 1 = Symptoms on one side of the body only. Stage 2 = Symptoms on both sides of the body, No impairment of balance. Stage 3 = Balance impairment. Mild to moderate disease. Physically independent. Stage 4 = Severe disability but still able to walk or stand unassisted. Stage 5 = Wheelchair bound or bedridden unless assisted."|units on a scale|Number|65|65.0||||||
4140651|NCT00880620|3964851|B2|Stage II||Hoehn and Yahr Stage|"Hoehn and Yahr Staging of Parkinson’s Disease: Stages move from 1 – 5 with the worse outcome stage being Stage 5.~Stage 1 = Symptoms on one side of the body only. Stage 2 = Symptoms on both sides of the body, No impairment of balance. Stage 3 = Balance impairment. Mild to moderate disease. Physically independent. Stage 4 = Severe disability but still able to walk or stand unassisted. Stage 5 = Wheelchair bound or bedridden unless assisted."|units on a scale|Number|62|62.0||||||
4140652|NCT00880620|3964852|B1|Stage II||Hoehn and Yahr Stage|"Hoehn and Yahr Staging of Parkinson’s Disease: Stages move from 1 – 5 with the worse outcome stage being Stage 5.~Stage 1 = Symptoms on one side of the body only. Stage 2 = Symptoms on both sides of the body, No impairment of balance. Stage 3 = Balance impairment. Mild to moderate disease. Physically independent. Stage 4 = Severe disability but still able to walk or stand unassisted. Stage 5 = Wheelchair bound or bedridden unless assisted."|units on a scale|Number|69|69.0||||||
4140653|NCT00880620|3964848|B5|Stage I||Hoehn and Yahr Stage|"Hoehn and Yahr Staging of Parkinson’s Disease: Stages move from 1 – 5 with the worse outcome stage being Stage 5.~Stage 1 = Symptoms on one side of the body only. Stage 2 = Symptoms on both sides of the body, No impairment of balance. Stage 3 = Balance impairment. Mild to moderate disease. Physically independent. Stage 4 = Severe disability but still able to walk or stand unassisted. Stage 5 = Wheelchair bound or bedridden unless assisted."|units on a scale|Number|40|40.0||||||
4140654|NCT00880620|3964849|B4|Stage I||Hoehn and Yahr Stage|"Hoehn and Yahr Staging of Parkinson’s Disease: Stages move from 1 – 5 with the worse outcome stage being Stage 5.~Stage 1 = Symptoms on one side of the body only. Stage 2 = Symptoms on both sides of the body, No impairment of balance. Stage 3 = Balance impairment. Mild to moderate disease. Physically independent. Stage 4 = Severe disability but still able to walk or stand unassisted. Stage 5 = Wheelchair bound or bedridden unless assisted."|units on a scale|Number|14|14.0||||||
4140655|NCT00880620|3964850|B3|Stage I||Hoehn and Yahr Stage|"Hoehn and Yahr Staging of Parkinson’s Disease: Stages move from 1 – 5 with the worse outcome stage being Stage 5.~Stage 1 = Symptoms on one side of the body only. Stage 2 = Symptoms on both sides of the body, No impairment of balance. Stage 3 = Balance impairment. Mild to moderate disease. Physically independent. Stage 4 = Severe disability but still able to walk or stand unassisted. Stage 5 = Wheelchair bound or bedridden unless assisted."|units on a scale|Number|13|13.0||||||
4140656|NCT00880620|3964851|B2|Stage I||Hoehn and Yahr Stage|"Hoehn and Yahr Staging of Parkinson’s Disease: Stages move from 1 – 5 with the worse outcome stage being Stage 5.~Stage 1 = Symptoms on one side of the body only. Stage 2 = Symptoms on both sides of the body, No impairment of balance. Stage 3 = Balance impairment. Mild to moderate disease. Physically independent. Stage 4 = Severe disability but still able to walk or stand unassisted. Stage 5 = Wheelchair bound or bedridden unless assisted."|units on a scale|Number|6|6.0||||||
4140657|NCT00880620|3964852|B1|Stage I||Hoehn and Yahr Stage|"Hoehn and Yahr Staging of Parkinson’s Disease: Stages move from 1 – 5 with the worse outcome stage being Stage 5.~Stage 1 = Symptoms on one side of the body only. Stage 2 = Symptoms on both sides of the body, No impairment of balance. Stage 3 = Balance impairment. Mild to moderate disease. Physically independent. Stage 4 = Severe disability but still able to walk or stand unassisted. Stage 5 = Wheelchair bound or bedridden unless assisted."|units on a scale|Number|7|7.0||||||
4140658|NCT00880620|3964848|B5|||UPDRS Parts II and III Score|"Unified Parkinson’s Disease Rating Scale (UPDRS) – Four Parts Higher score values represent a worse outcome.~Subscales II and III were summed:~Part I: Mentation, Behavior and Mood – 4 questions 1-4 Score range: 1-16 Part II: Activities of Daily Living – 13 questions 5-17 Score range: 0-52 Part III: Motor Examination – 19 questions 18-31 and 25 total assessments Score range: 0-100 Part IV: Complications of Therapy (In the past week) – 11 questions Score range: 0-25"|units on a scale|Mean|36.7|36.7|Standard Deviation|13.63|13.63|||
4140659|NCT00880620|3964849|B4|||UPDRS Parts II and III Score|"Unified Parkinson’s Disease Rating Scale (UPDRS) – Four Parts Higher score values represent a worse outcome.~Subscales II and III were summed:~Part I: Mentation, Behavior and Mood – 4 questions 1-4 Score range: 1-16 Part II: Activities of Daily Living – 13 questions 5-17 Score range: 0-52 Part III: Motor Examination – 19 questions 18-31 and 25 total assessments Score range: 0-100 Part IV: Complications of Therapy (In the past week) – 11 questions Score range: 0-25"|units on a scale|Mean|36.3|36.3|Standard Deviation|13.04|13.04|||
4140713|NCT00880620|3964848|B5|White||Race/Ethnicity, Customized||participants|Number|375|375.0||||||
4140714|NCT00880620|3964849|B4|White||Race/Ethnicity, Customized||participants|Number|96|96.0||||||
4140715|NCT00880620|3964850|B3|White||Race/Ethnicity, Customized||participants|Number|102|102.0||||||
4140660|NCT00880620|3964850|B3|||UPDRS Parts II and III Score|"Unified Parkinson’s Disease Rating Scale (UPDRS) – Four Parts Higher score values represent a worse outcome.~Subscales II and III were summed:~Part I: Mentation, Behavior and Mood – 4 questions 1-4 Score range: 1-16 Part II: Activities of Daily Living – 13 questions 5-17 Score range: 0-52 Part III: Motor Examination – 19 questions 18-31 and 25 total assessments Score range: 0-100 Part IV: Complications of Therapy (In the past week) – 11 questions Score range: 0-25"|units on a scale|Mean|38.1|38.1|Standard Deviation|15.63|15.63|||
4140661|NCT00880620|3964851|B2|||UPDRS Parts II and III Score|"Unified Parkinson’s Disease Rating Scale (UPDRS) – Four Parts Higher score values represent a worse outcome.~Subscales II and III were summed:~Part I: Mentation, Behavior and Mood – 4 questions 1-4 Score range: 1-16 Part II: Activities of Daily Living – 13 questions 5-17 Score range: 0-52 Part III: Motor Examination – 19 questions 18-31 and 25 total assessments Score range: 0-100 Part IV: Complications of Therapy (In the past week) – 11 questions Score range: 0-25"|units on a scale|Mean|36.1|36.1|Standard Deviation|13.56|13.56|||
4140662|NCT00880620|3964852|B1|||UPDRS Parts II and III Score|"Unified Parkinson’s Disease Rating Scale (UPDRS) – Four Parts Higher score values represent a worse outcome.~Subscales II and III were summed:~Part I: Mentation, Behavior and Mood – 4 questions 1-4 Score range: 1-16 Part II: Activities of Daily Living – 13 questions 5-17 Score range: 0-52 Part III: Motor Examination – 19 questions 18-31 and 25 total assessments Score range: 0-100 Part IV: Complications of Therapy (In the past week) – 11 questions Score range: 0-25"|units on a scale|Mean|36.3|36.3|Standard Deviation|11.89|11.89|||
4140663|NCT00880620|3964848|B5|||Duration of Parkinson's disease||years|Mean|2.0|2.0|Standard Deviation|2.34|2.34|||
4140664|NCT00880620|3964849|B4|||Duration of Parkinson's disease||years|Mean|2.0|2.0|Standard Deviation|2.33|2.33|||
4140665|NCT00880620|3964850|B3|||Duration of Parkinson's disease||years|Mean|1.8|1.8|Standard Deviation|1.85|1.85|||
4140666|NCT00880620|3964851|B2|||Duration of Parkinson's disease||years|Mean|2.3|2.3|Standard Deviation|3.08|3.08|||
4140667|NCT00880620|3964852|B1|||Duration of Parkinson's disease||years|Mean|1.8|1.8|Standard Deviation|2.01|2.01|||
4140668|NCT00880620|3964848|B5|||Age at Parkinson's disease onset||years|Mean|63.0|63.0|Standard Deviation|10.00|10.0|||
4140669|NCT00880620|3964849|B4|||Age at Parkinson's disease onset||years|Mean|63.0|63.0|Standard Deviation|9.38|9.38|||
4140670|NCT00880620|3964850|B3|||Age at Parkinson's disease onset||years|Mean|63.6|63.6|Standard Deviation|10.43|10.43|||
4140671|NCT00880620|3964851|B2|||Age at Parkinson's disease onset||years|Mean|61.7|61.7|Standard Deviation|10.71|10.71|||
4140672|NCT00880620|3964852|B1|||Age at Parkinson's disease onset||years|Mean|63.7|63.7|Standard Deviation|9.48|9.48|||
4140673|NCT00880620|3964848|B5|Estonia||Region of Enrollment||participants|Number|11|11.0||||||
4140674|NCT00880620|3964849|B4|Estonia||Region of Enrollment||participants|Number|3|3.0||||||
4140675|NCT00880620|3964850|B3|Estonia||Region of Enrollment||participants|Number|3|3.0||||||
4140676|NCT00880620|3964851|B2|Estonia||Region of Enrollment||participants|Number|2|2.0||||||
4140677|NCT00880620|3964852|B1|Estonia||Region of Enrollment||participants|Number|3|3.0||||||
4140678|NCT00880620|3964848|B5|Lithuania||Region of Enrollment||participants|Number|27|27.0||||||
4140679|NCT00880620|3964849|B4|Lithuania||Region of Enrollment||participants|Number|8|8.0||||||
4140680|NCT00880620|3964850|B3|Lithuania||Region of Enrollment||participants|Number|8|8.0||||||
4140681|NCT00880620|3964851|B2|Lithuania||Region of Enrollment||participants|Number|4|4.0||||||
4140682|NCT00880620|3964852|B1|Lithuania||Region of Enrollment||participants|Number|7|7.0||||||
4140683|NCT00880620|3964848|B5|Ukraine||Region of Enrollment||participants|Number|115|115.0||||||
4140684|NCT00880620|3964849|B4|Ukraine||Region of Enrollment||participants|Number|26|26.0||||||
4140685|NCT00880620|3964850|B3|Ukraine||Region of Enrollment||participants|Number|32|32.0||||||
4140686|NCT00880620|3964851|B2|Ukraine||Region of Enrollment||participants|Number|29|29.0||||||
4140687|NCT00880620|3964852|B1|Ukraine||Region of Enrollment||participants|Number|28|28.0||||||
4140688|NCT00880620|3964848|B5|United States||Region of Enrollment||participants|Number|134|134.0||||||
4140689|NCT00880620|3964849|B4|United States||Region of Enrollment||participants|Number|38|38.0||||||
4140690|NCT00880620|3964850|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
4140691|NCT00880620|3964851|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4140692|NCT00880620|3964852|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4140693|NCT00880620|3964848|B5|Romania||Region of Enrollment||participants|Number|55|55.0||||||
4140694|NCT00880620|3964849|B4|Romania||Region of Enrollment||participants|Number|14|14.0||||||
4140695|NCT00880620|3964850|B3|Romania||Region of Enrollment||participants|Number|15|15.0||||||
4140696|NCT00880620|3964851|B2|Romania||Region of Enrollment||participants|Number|13|13.0||||||
4140697|NCT00880620|3964852|B1|Romania||Region of Enrollment||participants|Number|13|13.0||||||
4140698|NCT00880620|3964848|B5|Latvia||Region of Enrollment||participants|Number|2|2.0||||||
4140699|NCT00880620|3964849|B4|Latvia||Region of Enrollment||participants|Number|0|0.0||||||
4140700|NCT00880620|3964850|B3|Latvia||Region of Enrollment||participants|Number|0|0.0||||||
4140701|NCT00880620|3964851|B2|Latvia||Region of Enrollment||participants|Number|1|1.0||||||
4140702|NCT00880620|3964852|B1|Latvia||Region of Enrollment||participants|Number|1|1.0||||||
4140703|NCT00880620|3964848|B5|Canada||Region of Enrollment||participants|Number|37|37.0||||||
4140704|NCT00880620|3964849|B4|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4140705|NCT00880620|3964850|B3|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4140706|NCT00880620|3964851|B2|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4140707|NCT00880620|3964852|B1|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4140708|NCT00880620|3964848|B5|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4140709|NCT00880620|3964849|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4140716|NCT00880620|3964851|B2|White||Race/Ethnicity, Customized||participants|Number|87|87.0||||||
4140717|NCT00880620|3964852|B1|White||Race/Ethnicity, Customized||participants|Number|90|90.0||||||
4140718|NCT00880620|3964848|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4140719|NCT00880620|3964849|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4140720|NCT00880620|3964850|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4140721|NCT00880620|3964851|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4140722|NCT00880620|3964852|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4140723|NCT00880620|3964848|B5|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4140724|NCT00880620|3964849|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4140725|NCT00880620|3964850|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4140726|NCT00880620|3964851|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4140727|NCT00880620|3964852|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4140728|NCT00880620|3964848|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4140729|NCT00880620|3964849|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4140730|NCT00880620|3964850|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4140731|NCT00880620|3964851|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4140732|NCT00880620|3964852|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4140733|NCT00880620|3964848|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|345|345.0||||||
4140734|NCT00880620|3964849|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
4140735|NCT00880620|3964850|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
4140736|NCT00880620|3964851|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
4140737|NCT00880620|3964852|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
4140738|NCT00880620|3964848|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4140739|NCT00880620|3964849|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4140740|NCT00880620|3964850|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4140741|NCT00880620|3964851|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4140742|NCT00880620|3964852|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4140743|NCT00880620|3964848|B5||Male|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4140744|NCT00880620|3964849|B4||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4140745|NCT00880620|3964850|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4140746|NCT00880620|3964851|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4140747|NCT00880620|3964852|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4140748|NCT00880620|3964848|B5||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4140749|NCT00880620|3964849|B4||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4140750|NCT00880620|3964850|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4140751|NCT00880620|3964851|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4140752|NCT00880620|3964852|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4140753|NCT00880620|3964848|B5|||Age||years|Mean|64.8|64.8|Standard Deviation|9.55|9.55|||
4140754|NCT00880620|3964849|B4|||Age||years|Mean|64.8|64.8|Standard Deviation|9.32|9.32|||
4140755|NCT00880620|3964850|B3|||Age||years|Mean|65.2|65.2|Standard Deviation|9.73|9.73|||
4140756|NCT00880620|3964851|B2|||Age||years|Mean|63.8|63.8|Standard Deviation|9.81|9.81|||
4140757|NCT00880620|3964852|B1|||Age||years|Mean|65.4|65.4|Standard Deviation|9.43|9.43|||
4140758|NCT00880581|3964869|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4140759|NCT00880581|3964869|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140760|NCT00880581|3964869|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4140761|NCT00880581|3964869|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4140762|NCT00880581|3964869|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140763|NCT00880581|3964869|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140764|NCT00880581|3964869|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140765|NCT00880581|3964869|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140766|NCT00880581|3964869|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4140767|NCT00880581|3964869|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4140768|NCT00880581|3964869|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4140769|NCT00880581|3964869|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4140770|NCT00880581|3964869|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4140771|NCT00880581|3964869|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4140772|NCT00880581|3964869|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4140773|NCT00880568|3964874|B10||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4140774|NCT00880568|3964875|B9||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4140775|NCT00880568|3964876|B8||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4140776|NCT00880568|3964877|B7||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4140777|NCT00880568|3964878|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4140778|NCT00880568|3964879|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4140779|NCT00880568|3964880|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4140780|NCT00880568|3964881|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4140781|NCT00880568|3964882|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4140782|NCT00880568|3964883|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4140783|NCT00880568|3964874|B10||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4140784|NCT00880568|3964875|B9||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4140785|NCT00880568|3964876|B8||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4140786|NCT00880568|3964877|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4140787|NCT00880568|3964878|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4140788|NCT00880568|3964879|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4140789|NCT00880568|3964880|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4140790|NCT00880568|3964881|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4140791|NCT00880568|3964882|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4140792|NCT00880568|3964883|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4140793|NCT00880568|3964874|B10|||Age||Years|Median|61.0|61.0|Full Range|||42.0|75.0|
4140794|NCT00880568|3964875|B9|||Age||Years|Median|68.0|68.0|Full Range|||59.0|68.0|
4140795|NCT00880568|3964876|B8|||Age||Years|Median|57.5|57.5|Full Range|||42.0|73.0|
4140796|NCT00880568|3964877|B7|||Age||Years|Median|62.5|62.5|Full Range|||56.0|71.0|
4140797|NCT00880568|3964878|B6|||Age||Years|Median|51.0|51.0|Full Range|||43.0|58.0|
4140798|NCT00880568|3964879|B5|||Age||Years|Median|52.0|52.0|Full Range|||48.0|63.0|
4140799|NCT00880568|3964880|B4|||Age||Years|Median|56.0|56.0|Full Range|||56.0|56.0|
4140800|NCT00880568|3964881|B3|||Age||Years|Median|61.0|61.0|Full Range|||53.0|75.0|
4140801|NCT00880568|3964882|B2|||Age||Years|Median|57.0|57.0|Full Range|||54.0|71.0|
4140802|NCT00880568|3964883|B1|||Age||Years|Median|65.0|65.0|Full Range|||64.0|69.0|
4140803|NCT00880555|3964934|B4|||Financial Capacity Instrument - total|The Financial Capacity Instrument is a test of financial knowledge and skills. We used items from five of the domains that have been previously reported: financial concepts (range 0-34), cash transactions (range 0-32), checkbook management (range 0-30), bank statement management (range 0-49), and bill payment (range 0-46). The number of points awarded for correct items depends on the estimated difficulty of the item. We report the sum of all points awarded across the five domains at the baseline evaluation (range 0-191), with higher scores representing greater financial capacity.|points awarded for correct items|Mean|152.4|152.4|Standard Deviation|19.0|19.0|||
4140804|NCT00880555|3964935|B3|||Financial Capacity Instrument - total|The Financial Capacity Instrument is a test of financial knowledge and skills. We used items from five of the domains that have been previously reported: financial concepts (range 0-34), cash transactions (range 0-32), checkbook management (range 0-30), bank statement management (range 0-49), and bill payment (range 0-46). The number of points awarded for correct items depends on the estimated difficulty of the item. We report the sum of all points awarded across the five domains at the baseline evaluation (range 0-191), with higher scores representing greater financial capacity.|points awarded for correct items|Mean|127.1|127.1|Standard Deviation|27.9|27.9|||
4140805|NCT00880555|3964936|B2|||Financial Capacity Instrument - total|The Financial Capacity Instrument is a test of financial knowledge and skills. We used items from five of the domains that have been previously reported: financial concepts (range 0-34), cash transactions (range 0-32), checkbook management (range 0-30), bank statement management (range 0-49), and bill payment (range 0-46). The number of points awarded for correct items depends on the estimated difficulty of the item. We report the sum of all points awarded across the five domains at the baseline evaluation (range 0-191), with higher scores representing greater financial capacity.|points awarded for correct items|Mean|160.2|160.2|Standard Deviation|8.3|8.3|||
4140806|NCT00880555|3964937|B1|||Financial Capacity Instrument - total|The Financial Capacity Instrument is a test of financial knowledge and skills. We used items from five of the domains that have been previously reported: financial concepts (range 0-34), cash transactions (range 0-32), checkbook management (range 0-30), bank statement management (range 0-49), and bill payment (range 0-46). The number of points awarded for correct items depends on the estimated difficulty of the item. We report the sum of all points awarded across the five domains at the baseline evaluation (range 0-191), with higher scores representing greater financial capacity.|points awarded for correct items|Mean|151.8|151.8|Standard Deviation|17.3|17.3|||
4140807|NCT00880555|3964934|B4|||Extended Mini-Mental State Exam|The extended mini-mental state exam (xMMSE) is a 50-item test consisting of the 30 items from the standard MMSE, plus items that a give total of 20 additional possible points. The additional items are 5 points for an executive/working memory task, 2 points for naming, 6 points for delayed recall (with and without cues), 3 additional points for the visual construction, and 4 additional points for recalling the visual construction after a delay.|points awarded for correct items|Mean|44.7|44.7|Standard Deviation|5.2|5.2|||
4140808|NCT00880555|3964935|B3|||Extended Mini-Mental State Exam|The extended mini-mental state exam (xMMSE) is a 50-item test consisting of the 30 items from the standard MMSE, plus items that a give total of 20 additional possible points. The additional items are 5 points for an executive/working memory task, 2 points for naming, 6 points for delayed recall (with and without cues), 3 additional points for the visual construction, and 4 additional points for recalling the visual construction after a delay.|points awarded for correct items|Mean|36.5|36.5|Standard Deviation|4.4|4.4|||
4141037|NCT00880191|3965095|B3||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4140809|NCT00880555|3964936|B2|||Extended Mini-Mental State Exam|The extended mini-mental state exam (xMMSE) is a 50-item test consisting of the 30 items from the standard MMSE, plus items that a give total of 20 additional possible points. The additional items are 5 points for an executive/working memory task, 2 points for naming, 6 points for delayed recall (with and without cues), 3 additional points for the visual construction, and 4 additional points for recalling the visual construction after a delay.|points awarded for correct items|Mean|47.6|47.6|Standard Deviation|2.5|2.5|||
4140810|NCT00880555|3964937|B1|||Extended Mini-Mental State Exam|The extended mini-mental state exam (xMMSE) is a 50-item test consisting of the 30 items from the standard MMSE, plus items that a give total of 20 additional possible points. The additional items are 5 points for an executive/working memory task, 2 points for naming, 6 points for delayed recall (with and without cues), 3 additional points for the visual construction, and 4 additional points for recalling the visual construction after a delay.|points awarded for correct items|Mean|44.2|44.2|Standard Deviation|4.9|4.9|||
4140811|NCT00880555|3964934|B4|||Pyramids and Palm Trees - words|"Participants were cued with a word (e.g., pyramid) and asked to decide which one of two other words was most related to the cue. For the prototypical test item, the target and foil were, respectively, palm tree and pine tree. We report the number of correct items out of 52."|correct matches|Mean|49.9|49.9|Standard Deviation|2.5|2.5|||
4140812|NCT00880555|3964935|B3|||Pyramids and Palm Trees - words|"Participants were cued with a word (e.g., pyramid) and asked to decide which one of two other words was most related to the cue. For the prototypical test item, the target and foil were, respectively, palm tree and pine tree. We report the number of correct items out of 52."|correct matches|Mean|48.4|48.4|Standard Deviation|4.9|4.9|||
4140813|NCT00880555|3964936|B2|||Pyramids and Palm Trees - words|"Participants were cued with a word (e.g., pyramid) and asked to decide which one of two other words was most related to the cue. For the prototypical test item, the target and foil were, respectively, palm tree and pine tree. We report the number of correct items out of 52."|correct matches|Mean|50.4|50.4|Standard Deviation|1.2|1.2|||
4140814|NCT00880555|3964937|B1|||Pyramids and Palm Trees - words|"Participants were cued with a word (e.g., pyramid) and asked to decide which one of two other words was most related to the cue. For the prototypical test item, the target and foil were, respectively, palm tree and pine tree. We report the number of correct items out of 52."|correct matches|Mean|50.0|50.0|Standard Deviation|1.8|1.8|||
4140815|NCT00880555|3964934|B4|||Pyramids and Palm Trees - pictures|Participants were cued with a line drawing (e.g., a pyramid) and asked to decide which one of two other line drawings was most related to the cue. For the prototypical test item, the target and foil were, respectively, a palm tree and a pine tree. We report the number of correct items out of 51.|correct matches|Mean|48.9|48.9|Standard Deviation|2.6|2.6|||
4140816|NCT00880555|3964935|B3|||Pyramids and Palm Trees - pictures|Participants were cued with a line drawing (e.g., a pyramid) and asked to decide which one of two other line drawings was most related to the cue. For the prototypical test item, the target and foil were, respectively, a palm tree and a pine tree. We report the number of correct items out of 51.|correct matches|Mean|46.4|46.4|Standard Deviation|5.1|5.1|||
4140817|NCT00880555|3964936|B2|||Pyramids and Palm Trees - pictures|Participants were cued with a line drawing (e.g., a pyramid) and asked to decide which one of two other line drawings was most related to the cue. For the prototypical test item, the target and foil were, respectively, a palm tree and a pine tree. We report the number of correct items out of 51.|correct matches|Mean|49.6|49.6|Standard Deviation|1.4|1.4|||
4140818|NCT00880555|3964937|B1|||Pyramids and Palm Trees - pictures|Participants were cued with a line drawing (e.g., a pyramid) and asked to decide which one of two other line drawings was most related to the cue. For the prototypical test item, the target and foil were, respectively, a palm tree and a pine tree. We report the number of correct items out of 51.|correct matches|Mean|49.4|49.4|Standard Deviation|1.5|1.5|||
4140819|NCT00880555|3964934|B4|||Boston Naming Test - 30 item|Participants were shown line drawings of objects and asked to name them. The test starts with highly familiar, high frequency words, such as 'bed,' and 'pencil,' and progresses to more difficult items, such as 'abacus' and 'octopus.' We report the number of correctly named items out of stimuli.|pictures named|Mean|25.8|25.8|Standard Deviation|4.0|4.0|||
4140820|NCT00880555|3964935|B3|||Boston Naming Test - 30 item|Participants were shown line drawings of objects and asked to name them. The test starts with highly familiar, high frequency words, such as 'bed,' and 'pencil,' and progresses to more difficult items, such as 'abacus' and 'octopus.' We report the number of correctly named items out of stimuli.|pictures named|Mean|21.6|21.6|Standard Deviation|5.7|5.7|||
4140821|NCT00880555|3964936|B2|||Boston Naming Test - 30 item|Participants were shown line drawings of objects and asked to name them. The test starts with highly familiar, high frequency words, such as 'bed,' and 'pencil,' and progresses to more difficult items, such as 'abacus' and 'octopus.' We report the number of correctly named items out of stimuli.|pictures named|Mean|27.2|27.2|Standard Deviation|2.2|2.2|||
4140822|NCT00880555|3964937|B1|||Boston Naming Test - 30 item|Participants were shown line drawings of objects and asked to name them. The test starts with highly familiar, high frequency words, such as 'bed,' and 'pencil,' and progresses to more difficult items, such as 'abacus' and 'octopus.' We report the number of correctly named items out of stimuli.|pictures named|Mean|25.6|25.6|Standard Deviation|4.1|4.1|||
4140823|NCT00880555|3964934|B4|||Trail Making Test - B|Participants were asked to draw a trial connecting circles in order according to the labels. The labels consisted of the numbers 1-13 and the letters A-M. Participants were told to alternate between numbers and letters (i.e., 1 - A - 2 - B - 3 - C, etc.) and were given a short practice form. We report the time taken to complete the task.|seconds|Mean|110.8|110.8|Standard Deviation|63.6|63.6|||
4140824|NCT00880555|3964935|B3|||Trail Making Test - B|Participants were asked to draw a trial connecting circles in order according to the labels. The labels consisted of the numbers 1-13 and the letters A-M. Participants were told to alternate between numbers and letters (i.e., 1 - A - 2 - B - 3 - C, etc.) and were given a short practice form. We report the time taken to complete the task.|seconds|Mean|178.7|178.7|Standard Deviation|79.2|79.2|||
4140843|NCT00880555|3964934|B4|||10/36 spatial recall - total|Participants were given three chances to memorize the positions of 10 black circles on a 6 x 6 grid. This score is the total number of correct responses over the three learning trials.|positions recalled|Mean|17.9|17.9|Standard Deviation|5.3|5.3|||
4141038|NCT00880191|3965096|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4140825|NCT00880555|3964936|B2|||Trail Making Test - B|Participants were asked to draw a trial connecting circles in order according to the labels. The labels consisted of the numbers 1-13 and the letters A-M. Participants were told to alternate between numbers and letters (i.e., 1 - A - 2 - B - 3 - C, etc.) and were given a short practice form. We report the time taken to complete the task.|seconds|Mean|78.8|78.8|Standard Deviation|25.5|25.5|||
4140826|NCT00880555|3964937|B1|||Trail Making Test - B|Participants were asked to draw a trial connecting circles in order according to the labels. The labels consisted of the numbers 1-13 and the letters A-M. Participants were told to alternate between numbers and letters (i.e., 1 - A - 2 - B - 3 - C, etc.) and were given a short practice form. We report the time taken to complete the task.|seconds|Mean|132.2|132.2|Standard Deviation|64.4|64.4|||
4140827|NCT00880555|3964934|B4|||Trail Making Test - A|Participants were asked to draw a trial connecting labeled in circles in order. The labels consisted of the numbers from 1 to 25 and participants were told to start at 1 and finish at 25. We report the time in seconds for participants to complete the task.|seconds|Mean|44.0|44.0|Standard Deviation|30.1|30.1|||
4140828|NCT00880555|3964935|B3|||Trail Making Test - A|Participants were asked to draw a trial connecting labeled in circles in order. The labels consisted of the numbers from 1 to 25 and participants were told to start at 1 and finish at 25. We report the time in seconds for participants to complete the task.|seconds|Mean|77.0|77.0|Standard Deviation|67.7|67.7|||
4140829|NCT00880555|3964936|B2|||Trail Making Test - A|Participants were asked to draw a trial connecting labeled in circles in order. The labels consisted of the numbers from 1 to 25 and participants were told to start at 1 and finish at 25. We report the time in seconds for participants to complete the task.|seconds|Mean|34.7|34.7|Standard Deviation|11.4|11.4|||
4140830|NCT00880555|3964937|B1|||Trail Making Test - A|Participants were asked to draw a trial connecting labeled in circles in order. The labels consisted of the numbers from 1 to 25 and participants were told to start at 1 and finish at 25. We report the time in seconds for participants to complete the task.|seconds|Mean|45.4|45.4|Standard Deviation|13.8|13.8|||
4140831|NCT00880555|3964934|B4|||Semantic fluency (7 categories)|Participants were given one minute to generate words fitting into 7 different semantic categories. We report the sum of valid responses over the 7 tasks. The categories were: animals, water creatures, tools, vehicles, fruits and vegetables, boats, and verbs.|words generated|Mean|86.2|86.2|Standard Deviation|28.5|28.5|||
4140832|NCT00880555|3964935|B3|||Semantic fluency (7 categories)|Participants were given one minute to generate words fitting into 7 different semantic categories. We report the sum of valid responses over the 7 tasks. The categories were: animals, water creatures, tools, vehicles, fruits and vegetables, boats, and verbs.|words generated|Mean|61.5|61.5|Standard Deviation|25.9|25.9|||
4140833|NCT00880555|3964936|B2|||Semantic fluency (7 categories)|Participants were given one minute to generate words fitting into 7 different semantic categories. We report the sum of valid responses over the 7 tasks. The categories were: animals, water creatures, tools, vehicles, fruits and vegetables, boats, and verbs.|words generated|Mean|101.1|101.1|Standard Deviation|23.3|23.3|||
4140834|NCT00880555|3964937|B1|||Semantic fluency (7 categories)|Participants were given one minute to generate words fitting into 7 different semantic categories. We report the sum of valid responses over the 7 tasks. The categories were: animals, water creatures, tools, vehicles, fruits and vegetables, boats, and verbs.|words generated|Mean|74.6|74.6|Standard Deviation|25.7|25.7|||
4140835|NCT00880555|3964934|B4|||F-, A-, and S-words|Participants were given one minute each to generate as many words as possible that started with the letter F, the letter A, and the letter S. They were instructed not to use capitalized words, such as France, Friday, or Francheska. We report the sum of valid responses over the three tasks.|words generated|Mean|32.5|32.5|Standard Deviation|13.2|13.2|||
4140836|NCT00880555|3964935|B3|||F-, A-, and S-words|Participants were given one minute each to generate as many words as possible that started with the letter F, the letter A, and the letter S. They were instructed not to use capitalized words, such as France, Friday, or Francheska. We report the sum of valid responses over the three tasks.|words generated|Mean|27.5|27.5|Standard Deviation|14.0|14.0|||
4140837|NCT00880555|3964936|B2|||F-, A-, and S-words|Participants were given one minute each to generate as many words as possible that started with the letter F, the letter A, and the letter S. They were instructed not to use capitalized words, such as France, Friday, or Francheska. We report the sum of valid responses over the three tasks.|words generated|Mean|36.4|36.4|Standard Deviation|11.4|11.4|||
4140838|NCT00880555|3964937|B1|||F-, A-, and S-words|Participants were given one minute each to generate as many words as possible that started with the letter F, the letter A, and the letter S. They were instructed not to use capitalized words, such as France, Friday, or Francheska. We report the sum of valid responses over the three tasks.|words generated|Mean|29.1|29.1|Standard Deviation|14.5|14.5|||
4140839|NCT00880555|3964934|B4|||10/36 spatial recall - delayed recall|After three exposures to a 6 x 6 grid with 10 black circles on it, participants were given a different task for 7 minutes and then asked to reproduce the pattern of circles by placing checkers on a blank grid. This score is the total number of correctly placed checkers.|positions recalled|Mean|6.4|6.4|Standard Deviation|2.4|2.4|||
4140840|NCT00880555|3964935|B3|||10/36 spatial recall - delayed recall|After three exposures to a 6 x 6 grid with 10 black circles on it, participants were given a different task for 7 minutes and then asked to reproduce the pattern of circles by placing checkers on a blank grid. This score is the total number of correctly placed checkers.|positions recalled|Mean|5.4|5.4|Standard Deviation|1.7|1.7|||
4140841|NCT00880555|3964936|B2|||10/36 spatial recall - delayed recall|After three exposures to a 6 x 6 grid with 10 black circles on it, participants were given a different task for 7 minutes and then asked to reproduce the pattern of circles by placing checkers on a blank grid. This score is the total number of correctly placed checkers.|positions recalled|Mean|7.2|7.2|Standard Deviation|2.4|2.4|||
4140842|NCT00880555|3964937|B1|||10/36 spatial recall - delayed recall|After three exposures to a 6 x 6 grid with 10 black circles on it, participants were given a different task for 7 minutes and then asked to reproduce the pattern of circles by placing checkers on a blank grid. This score is the total number of correctly placed checkers.|positions recalled|Mean|5.2|5.2|Standard Deviation|2.2|2.2|||
4140916|NCT00880542|3964953|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140917|NCT00880542|3964953|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4140844|NCT00880555|3964935|B3|||10/36 spatial recall - total|Participants were given three chances to memorize the positions of 10 black circles on a 6 x 6 grid. This score is the total number of correct responses over the three learning trials.|positions recalled|Mean|13.8|13.8|Standard Deviation|3.0|3.0|||
4140845|NCT00880555|3964936|B2|||10/36 spatial recall - total|Participants were given three chances to memorize the positions of 10 black circles on a 6 x 6 grid. This score is the total number of correct responses over the three learning trials.|positions recalled|Mean|20.2|20.2|Standard Deviation|5.0|5.0|||
4140846|NCT00880555|3964937|B1|||10/36 spatial recall - total|Participants were given three chances to memorize the positions of 10 black circles on a 6 x 6 grid. This score is the total number of correct responses over the three learning trials.|positions recalled|Mean|15.9|15.9|Standard Deviation|5.0|5.0|||
4140847|NCT00880555|3964934|B4|||10/36 spatial recall - 1st trial|Participants were shown a 6 x 6 grid with black circles on 10 of the squares. After inspecting it for 10 seconds, they were given a blank grid and asked to place black checkers where the circles had been. This score is the number of checkers that were placed in actual locations of the circles.|positions recalled|Mean|5.0|5.0|Standard Deviation|2.0|2.0|||
4140848|NCT00880555|3964935|B3|||10/36 spatial recall - 1st trial|Participants were shown a 6 x 6 grid with black circles on 10 of the squares. After inspecting it for 10 seconds, they were given a blank grid and asked to place black checkers where the circles had been. This score is the number of checkers that were placed in actual locations of the circles.|positions recalled|Mean|4.0|4.0|Standard Deviation|1.6|1.6|||
4140849|NCT00880555|3964936|B2|||10/36 spatial recall - 1st trial|Participants were shown a 6 x 6 grid with black circles on 10 of the squares. After inspecting it for 10 seconds, they were given a blank grid and asked to place black checkers where the circles had been. This score is the number of checkers that were placed in actual locations of the circles.|positions recalled|Mean|5.6|5.6|Standard Deviation|2.0|2.0|||
4140850|NCT00880555|3964937|B1|||10/36 spatial recall - 1st trial|Participants were shown a 6 x 6 grid with black circles on 10 of the squares. After inspecting it for 10 seconds, they were given a blank grid and asked to place black checkers where the circles had been. This score is the number of checkers that were placed in actual locations of the circles.|positions recalled|Mean|4.3|4.3|Standard Deviation|2.0|2.0|||
4140851|NCT00880555|3964934|B4|||Verbal learning - long delay cued recall|After attempting to spontaneously recall words from list A (following a 30 minute delay), participants were asked to recall all words they could recall within certain categories: animals, vegetables, articles of furniture, and ways of traveling (4 words in each category).|words recalled|Mean|8.7|8.7|Standard Deviation|4.3|4.3|||
4140852|NCT00880555|3964935|B3|||Verbal learning - long delay cued recall|After attempting to spontaneously recall words from list A (following a 30 minute delay), participants were asked to recall all words they could recall within certain categories: animals, vegetables, articles of furniture, and ways of traveling (4 words in each category).|words recalled|Mean|3.3|3.3|Standard Deviation|2.4|2.4|||
4140853|NCT00880555|3964936|B2|||Verbal learning - long delay cued recall|After attempting to spontaneously recall words from list A (following a 30 minute delay), participants were asked to recall all words they could recall within certain categories: animals, vegetables, articles of furniture, and ways of traveling (4 words in each category).|words recalled|Mean|11.2|11.2|Standard Deviation|3.2|3.2|||
4140854|NCT00880555|3964937|B1|||Verbal learning - long delay cued recall|After attempting to spontaneously recall words from list A (following a 30 minute delay), participants were asked to recall all words they could recall within certain categories: animals, vegetables, articles of furniture, and ways of traveling (4 words in each category).|words recalled|Mean|7.3|7.3|Standard Deviation|3.7|3.7|||
4140855|NCT00880555|3964934|B4|||Verbal learning - long delay free recall|After 30 minutes, participants were asked to recall words from list A (not from list B) that were presented during five previous exposure trials.|words recalled|Mean|7.5|7.5|Standard Deviation|4.6|4.6|||
4140856|NCT00880555|3964935|B3|||Verbal learning - long delay free recall|After 30 minutes, participants were asked to recall words from list A (not from list B) that were presented during five previous exposure trials.|words recalled|Mean|1.6|1.6|Standard Deviation|2.0|2.0|||
4140857|NCT00880555|3964936|B2|||Verbal learning - long delay free recall|After 30 minutes, participants were asked to recall words from list A (not from list B) that were presented during five previous exposure trials.|words recalled|Mean|10.3|10.3|Standard Deviation|3.5|3.5|||
4140858|NCT00880555|3964937|B1|||Verbal learning - long delay free recall|After 30 minutes, participants were asked to recall words from list A (not from list B) that were presented during five previous exposure trials.|words recalled|Mean|5.8|5.8|Standard Deviation|3.9|3.9|||
4140859|NCT00880555|3964934|B4|||Verbal learning - total trials 1-5|Participants were read a list of 16 words five times in a row, each time being asked immediately to recite back as many words as they could recall. The sum of words recalled on the five attempts is reported here.|words recalled|Mean|40.5|40.5|Standard Deviation|13.2|13.2|||
4140860|NCT00880555|3964935|B3|||Verbal learning - total trials 1-5|Participants were read a list of 16 words five times in a row, each time being asked immediately to recite back as many words as they could recall. The sum of words recalled on the five attempts is reported here.|words recalled|Mean|23.0|23.0|Standard Deviation|8.2|8.2|||
4140861|NCT00880555|3964936|B2|||Verbal learning - total trials 1-5|Participants were read a list of 16 words five times in a row, each time being asked immediately to recite back as many words as they could recall. The sum of words recalled on the five attempts is reported here.|words recalled|Mean|48.7|48.7|Standard Deviation|10.0|10.0|||
4140862|NCT00880555|3964937|B1|||Verbal learning - total trials 1-5|Participants were read a list of 16 words five times in a row, each time being asked immediately to recite back as many words as they could recall. The sum of words recalled on the five attempts is reported here.|words recalled|Mean|35.9|35.9|Standard Deviation|9.6|9.6|||
4140863|NCT00880555|3964934|B4|||Verbal learning - list B immediate recall|After all 5 learning trials with list A, participants were read a second list of 16 words and asked immediately to recite back as many words as they could recall.|words recalled|Mean|4.7|4.7|Standard Deviation|2.0|2.0|||
4140864|NCT00880555|3964935|B3|||Verbal learning - list B immediate recall|After all 5 learning trials with list A, participants were read a second list of 16 words and asked immediately to recite back as many words as they could recall.|words recalled|Mean|2.7|2.7|Standard Deviation|1.3|1.3|||
4140865|NCT00880555|3964936|B2|||Verbal learning - list B immediate recall|After all 5 learning trials with list A, participants were read a second list of 16 words and asked immediately to recite back as many words as they could recall.|words recalled|Mean|5.5|5.5|Standard Deviation|2.2|2.2|||
4140866|NCT00880555|3964937|B1|||Verbal learning - list B immediate recall|After all 5 learning trials with list A, participants were read a second list of 16 words and asked immediately to recite back as many words as they could recall.|words recalled|Mean|4.5|4.5|Standard Deviation|1.4|1.4|||
4140867|NCT00880555|3964934|B4|||Verbal learning - 1st immediate list A|Participants were read a list of 16 words and asked immediately to recite back as many words as they could remember.|words recalled|Mean|5.4|5.4|Standard Deviation|2.2|2.2|||
4140868|NCT00880555|3964935|B3|||Verbal learning - 1st immediate list A|Participants were read a list of 16 words and asked immediately to recite back as many words as they could remember.|words recalled|Mean|3.3|3.3|Standard Deviation|1.4|1.4|||
4140869|NCT00880555|3964936|B2|||Verbal learning - 1st immediate list A|Participants were read a list of 16 words and asked immediately to recite back as many words as they could remember.|words recalled|Mean|6.4|6.4|Standard Deviation|2.2|2.2|||
4140870|NCT00880555|3964937|B1|||Verbal learning - 1st immediate list A|Participants were read a list of 16 words and asked immediately to recite back as many words as they could remember.|words recalled|Mean|5.0|5.0|Standard Deviation|1.7|1.7|||
4140871|NCT00880555|3964934|B4|||Educational level||years|Mean|15.4|15.4|Standard Deviation|2.6|2.6|||
4140872|NCT00880555|3964935|B3|||Educational level||years|Mean|14.8|14.8|Standard Deviation|2.36|2.36|||
4140873|NCT00880555|3964936|B2|||Educational level||years|Mean|16.0|16.0|Standard Deviation|2.39|2.39|||
4140874|NCT00880555|3964937|B1|||Educational level||years|Mean|14.9|14.9|Standard Deviation|2.94|2.94|||
4140875|NCT00880555|3964934|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140876|NCT00880555|3964935|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140877|NCT00880555|3964936|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140878|NCT00880555|3964937|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140879|NCT00880555|3964934|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140880|NCT00880555|3964935|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140881|NCT00880555|3964936|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140882|NCT00880555|3964937|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140883|NCT00880555|3964934|B4||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4140884|NCT00880555|3964935|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4140885|NCT00880555|3964936|B2||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4140886|NCT00880555|3964937|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4140887|NCT00880555|3964934|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4140888|NCT00880555|3964935|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4140889|NCT00880555|3964936|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4140890|NCT00880555|3964937|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4140891|NCT00880555|3964934|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140892|NCT00880555|3964935|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140893|NCT00880555|3964936|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140894|NCT00880555|3964937|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140895|NCT00880555|3964934|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140896|NCT00880555|3964935|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140897|NCT00880555|3964936|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140898|NCT00880555|3964937|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140899|NCT00880555|3964934|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140900|NCT00880555|3964935|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140901|NCT00880555|3964936|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140902|NCT00880555|3964937|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140903|NCT00880555|3964934|B4||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4140904|NCT00880555|3964935|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4140905|NCT00880555|3964936|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4140906|NCT00880555|3964937|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4140907|NCT00880555|3964934|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4140908|NCT00880555|3964935|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4140909|NCT00880555|3964936|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4140910|NCT00880555|3964937|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4140911|NCT00880555|3964934|B4|||Age||years|Mean|68.55|68.55|Standard Deviation|9.26|9.26|||
4140912|NCT00880555|3964935|B3|||Age||years|Mean|74.18|74.18|Standard Deviation|6.29|6.29|||
4140913|NCT00880555|3964936|B2|||Age||years|Mean|65.08|65.08|Standard Deviation|9.46|9.46|||
4140914|NCT00880555|3964937|B1|||Age||years|Mean|71.91|71.91|Standard Deviation|7.63|7.63|||
4140915|NCT00880542|3964953|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140918|NCT00880542|3964953|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140919|NCT00880542|3964953|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140920|NCT00880542|3964953|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140921|NCT00880542|3964953|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140922|NCT00880542|3964953|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4140923|NCT00880542|3964953|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4140924|NCT00880542|3964953|B1|||Age||years|Median|56|56.0|Full Range|||33.0|67.0|
4140925|NCT00880425|3964958|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4140926|NCT00880425|3964958|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4140927|NCT00880425|3964958|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4140928|NCT00880425|3964958|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4140929|NCT00880425|3964958|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4140930|NCT00880399|3964967|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4140931|NCT00880399|3964968|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4140932|NCT00880399|3964969|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4140933|NCT00880399|3964970|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4140934|NCT00880399|3964967|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140935|NCT00880399|3964968|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140936|NCT00880399|3964969|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140937|NCT00880399|3964970|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140938|NCT00880399|3964967|B4||White|Race (NIH/OMB)||Participants|Count of Participants|257|257.0||||||
4140939|NCT00880399|3964968|B3||White|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
4140940|NCT00880399|3964969|B2||White|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
4140941|NCT00880399|3964970|B1||White|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4140942|NCT00880399|3964967|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4140943|NCT00880399|3964968|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4140944|NCT00880399|3964969|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4140945|NCT00880399|3964970|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4140946|NCT00880399|3964967|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140947|NCT00880399|3964968|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140948|NCT00880399|3964969|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140949|NCT00880399|3964970|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140950|NCT00880399|3964967|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4140951|NCT00880399|3964968|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4140952|NCT00880399|3964969|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4140953|NCT00880399|3964970|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4140954|NCT00880399|3964967|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4140955|NCT00880399|3964968|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4140956|NCT00880399|3964969|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4140957|NCT00880399|3964970|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4140958|NCT00880399|3964967|B4||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4140959|NCT00880399|3964968|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4140960|NCT00880399|3964969|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4140961|NCT00880399|3964970|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4140962|NCT00880399|3964967|B4||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4140963|NCT00880399|3964968|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4140964|NCT00880399|3964969|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4140965|NCT00880399|3964970|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4140966|NCT00880399|3964967|B4|||Age||Years|Mean|39.7|39.7|Standard Deviation|11.45|11.45|||
4140967|NCT00880399|3964968|B3|||Age||Years|Mean|38.2|38.2|Standard Deviation|11.15|11.15|||
4140968|NCT00880399|3964969|B2|||Age||Years|Mean|41.0|41.0|Standard Deviation|11.45|11.45|||
4140969|NCT00880399|3964970|B1|||Age||Years|Mean|39.7|39.7|Standard Deviation|11.67|11.67|||
4140970|NCT00880360|3965028|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4140971|NCT00880360|3965028|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4140972|NCT00880360|3965028|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4140973|NCT00880360|3965028|B1|||Age||years|Mean|63|63.0|Standard Deviation|1|1.0|||
4140974|NCT00880360|3965028|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4140975|NCT00880360|3965028|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4140976|NCT00880360|3965028|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4140977|NCT00880334|3965033|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4140978|NCT00880334|3965034|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4140979|NCT00880334|3965035|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4140980|NCT00880334|3965033|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4140981|NCT00880334|3965034|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140982|NCT00880334|3965035|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4140983|NCT00880334|3965033|B3||White|Race (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
4140984|NCT00880334|3965034|B2||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4140985|NCT00880334|3965035|B1||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4140986|NCT00880334|3965033|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4140987|NCT00880334|3965034|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140988|NCT00880334|3965035|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4140989|NCT00880334|3965033|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140990|NCT00880334|3965034|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140991|NCT00880334|3965035|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140992|NCT00880334|3965033|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4140993|NCT00880334|3965034|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4140994|NCT00880334|3965035|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4140995|NCT00880334|3965033|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140996|NCT00880334|3965034|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140997|NCT00880334|3965035|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4140998|NCT00880334|3965033|B3||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4140999|NCT00880334|3965034|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4141000|NCT00880334|3965035|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4141001|NCT00880334|3965033|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4141002|NCT00880334|3965034|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4141003|NCT00880334|3965035|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4141004|NCT00880334|3965033|B3||>=65 years|Age||Participants|Count of Participants|71|71.0||||||
4141005|NCT00880334|3965034|B2||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
4141006|NCT00880334|3965035|B1||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4141007|NCT00880334|3965033|B3||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4141008|NCT00880334|3965034|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4141009|NCT00880334|3965035|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4141010|NCT00880334|3965033|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141011|NCT00880334|3965034|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141012|NCT00880334|3965035|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141013|NCT00880269|3965051|B3||Male|Gender||Participants|Count of Participants|31|31.0||||||
4141014|NCT00880269|3965052|B2||Male|Gender||Participants|Count of Participants|19|19.0||||||
4141015|NCT00880269|3965053|B1||Male|Gender||Participants|Count of Participants|12|12.0||||||
4141016|NCT00880269|3965051|B3||Female|Gender||Participants|Count of Participants|28|28.0||||||
4141017|NCT00880269|3965052|B2||Female|Gender||Participants|Count of Participants|8|8.0||||||
4141018|NCT00880269|3965053|B1||Female|Gender||Participants|Count of Participants|20|20.0||||||
4141019|NCT00880269|3965051|B3|||Age||years|Mean|65.5|65.5|Standard Deviation|10.65|10.65|||
4141020|NCT00880269|3965052|B2|||Age||years|Mean|68.5|68.5|Standard Deviation|7.75|7.75|||
4141021|NCT00880269|3965053|B1|||Age||years|Mean|63|63.0|Standard Deviation|12.13|12.13|||
4141022|NCT00880256|3965070|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4141023|NCT00880256|3965070|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4141024|NCT00880256|3965070|B1|||Age||years|Mean|51|51.0|Standard Deviation|10.6|10.6|||
4141025|NCT00880230|3965075|B1|Switzerland||Region of Enrollment||participants|Number|12|12.0||||||
4141026|NCT00880230|3965075|B1|Germany||Region of Enrollment||participants|Number|70|70.0||||||
4141027|NCT00880230|3965075|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
4141028|NCT00880230|3965075|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4141029|NCT00880230|3965075|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4141030|NCT00880230|3965075|B1|||Age||years|Mean|63.90|63.9|Standard Deviation|9.55|9.55|||
4141031|NCT00880230|3965075|B1||>=65 years|Age||Participants|Count of Participants|56|56.0||||||
4141032|NCT00880230|3965075|B1||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
4141033|NCT00880230|3965075|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141034|NCT00880191|3965095|B3|United States||Region of Enrollment||participants|Number|413|413.0||||||
4141035|NCT00880191|3965096|B2|United States||Region of Enrollment||participants|Number|206|206.0||||||
4141036|NCT00880191|3965097|B1|United States||Region of Enrollment||participants|Number|207|207.0||||||
4141039|NCT00880191|3965097|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4141040|NCT00880191|3965095|B3||Female|Sex: Female, Male||Participants|Count of Participants|290|290.0||||||
4141041|NCT00880191|3965096|B2||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4141042|NCT00880191|3965097|B1||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4141043|NCT00880191|3965095|B3|>=50 Years||Age, Customized||participants|Number|298|298.0||||||
4141044|NCT00880191|3965096|B2|>=50 Years||Age, Customized||participants|Number|148|148.0||||||
4141045|NCT00880191|3965097|B1|>=50 Years||Age, Customized||participants|Number|150|150.0||||||
4141046|NCT00880191|3965095|B3|<50 Years||Age, Customized||participants|Number|115|115.0||||||
4141047|NCT00880191|3965096|B2|<50 Years||Age, Customized||participants|Number|58|58.0||||||
4141048|NCT00880191|3965097|B1|<50 Years||Age, Customized||participants|Number|57|57.0||||||
4141049|NCT00880165|3965116|B3|||Functional Outcome of Sleep Questionnaire|Self-administered validated questionnaire assessing functional outcomes in patients with obstructive sleep apnea. The FOSQ total score range is from 1 to 20 with higher scores indicating better functional outcome. The FOSQ has 5 subscale scores: activity level, vigilance, intimacy and sexual relationships, general productivity, social outcome, The range of subscale scores is from 1 to 4 with higher scores indicating better function. The total score is calculated as the mean of the subscales multiplied by 5.|units on a scale|Mean|14.9|14.9|Standard Deviation|3.0|3.0|||
4141050|NCT00880165|3965117|B2|||Functional Outcome of Sleep Questionnaire|Self-administered validated questionnaire assessing functional outcomes in patients with obstructive sleep apnea. The FOSQ total score range is from 1 to 20 with higher scores indicating better functional outcome. The FOSQ has 5 subscale scores: activity level, vigilance, intimacy and sexual relationships, general productivity, social outcome, The range of subscale scores is from 1 to 4 with higher scores indicating better function. The total score is calculated as the mean of the subscales multiplied by 5.|units on a scale|Mean|15.0|15.0|Standard Deviation|3.2|3.2|||
4141051|NCT00880165|3965118|B1|||Functional Outcome of Sleep Questionnaire|Self-administered validated questionnaire assessing functional outcomes in patients with obstructive sleep apnea. The FOSQ total score range is from 1 to 20 with higher scores indicating better functional outcome. The FOSQ has 5 subscale scores: activity level, vigilance, intimacy and sexual relationships, general productivity, social outcome, The range of subscale scores is from 1 to 4 with higher scores indicating better function. The total score is calculated as the mean of the subscales multiplied by 5.|units on a scale|Mean|14.7|14.7|Standard Deviation|2.9|2.9|||
4141052|NCT00880165|3965116|B3|United States||Region of Enrollment||participants|Number|296|296.0||||||
4141053|NCT00880165|3965117|B2|United States||Region of Enrollment||participants|Number|148|148.0||||||
4141054|NCT00880165|3965118|B1|United States||Region of Enrollment||participants|Number|148|148.0||||||
4141055|NCT00880165|3965116|B3||Male|Sex: Female, Male||Participants|Count of Participants|273|273.0||||||
4141056|NCT00880165|3965117|B2||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4141057|NCT00880165|3965118|B1||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4141058|NCT00880165|3965116|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4141059|NCT00880165|3965117|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4141060|NCT00880165|3965118|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4141061|NCT00880165|3965116|B3||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4141062|NCT00880165|3965117|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4141063|NCT00880165|3965118|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4141064|NCT00880165|3965116|B3||Between 18 and 65 years|Age||Participants|Count of Participants|272|272.0||||||
4141065|NCT00880165|3965117|B2||Between 18 and 65 years|Age||Participants|Count of Participants|135|135.0||||||
4141066|NCT00880165|3965118|B1||Between 18 and 65 years|Age||Participants|Count of Participants|137|137.0||||||
4141067|NCT00880165|3965116|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141068|NCT00880165|3965117|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141069|NCT00880165|3965118|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141070|NCT00880165|3965116|B3|||Age||years|Mean|53.2|53.2|Standard Deviation|10.4|10.4|||
4141071|NCT00880165|3965117|B2|||Age||years|Mean|55.1|55.1|Standard Deviation|10.3|10.3|||
4141072|NCT00880165|3965118|B1|||Age||years|Mean|51.8|51.8|Standard Deviation|10.4|10.4|||
4141073|NCT00880100|3965129|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4141074|NCT00880100|3965129|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4141075|NCT00880100|3965129|B1|||Age||years|Mean|3.8|3.8|Standard Deviation|1.42|1.42|||
4141076|NCT00880100|3965129|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4141077|NCT00880100|3965129|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4141078|NCT00880100|3965129|B1||<=18 years|Age||Participants|Count of Participants|48|48.0||||||
4141079|NCT00880087|3965140|B3||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4141080|NCT00880087|3965141|B2||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4141081|NCT00880087|3965142|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4141082|NCT00880087|3965140|B3||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4141083|NCT00880087|3965141|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4141084|NCT00880087|3965142|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4141085|NCT00880087|3965140|B3|Age Category|12 - 17 yr|Age, Customized||Participants|Count of Participants|45|45.0||||||
4141086|NCT00880087|3965141|B2|Age Category|12 - 17 yr|Age, Customized||Participants|Count of Participants|24|24.0||||||
4141087|NCT00880087|3965142|B1|Age Category|12 - 17 yr|Age, Customized||Participants|Count of Participants|21|21.0||||||
4141088|NCT00880087|3965140|B3|Age Category|2 - <12 yr|Age, Customized||Participants|Count of Participants|83|83.0||||||
4141089|NCT00880087|3965141|B2|Age Category|2 - <12 yr|Age, Customized||Participants|Count of Participants|35|35.0||||||
4141090|NCT00880087|3965142|B1|Age Category|2 - <12 yr|Age, Customized||Participants|Count of Participants|48|48.0||||||
4141091|NCT00880087|3965140|B3|Age Category|< 2 yr|Age, Customized||Participants|Count of Participants|201|201.0||||||
4141092|NCT00880087|3965141|B2|Age Category|< 2 yr|Age, Customized||Participants|Count of Participants|104|104.0||||||
4141093|NCT00880087|3965142|B1|Age Category|< 2 yr|Age, Customized||Participants|Count of Participants|97|97.0||||||
4141094|NCT00880087|3965140|B3|||Age||years|Median|1.0|1.0|Inter-Quartile Range|||0.2|5.8|
4141095|NCT00880087|3965141|B2|||Age||years|Median|0.6|0.6|Inter-Quartile Range|||0.2|6.3|
4141096|NCT00880087|3965142|B1|||Age||years|Median|1.4|1.4|Inter-Quartile Range|||0.3|5.7|
4141097|NCT00880048|3965155|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4141098|NCT00880048|3965156|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141099|NCT00880048|3965157|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4141100|NCT00880048|3965158|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4141101|NCT00880048|3965155|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4141102|NCT00880048|3965156|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4141103|NCT00880048|3965157|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4141104|NCT00880048|3965158|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4141105|NCT00880048|3965155|B4||White|Race (NIH/OMB)||Participants|Count of Participants|237|237.0||||||
4141106|NCT00880048|3965156|B3||White|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
4141107|NCT00880048|3965157|B2||White|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
4141108|NCT00880048|3965158|B1||White|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
4141109|NCT00880048|3965155|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
4141110|NCT00880048|3965156|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4141111|NCT00880048|3965157|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4141112|NCT00880048|3965158|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4141113|NCT00880048|3965155|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4141114|NCT00880048|3965156|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141115|NCT00880048|3965157|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4141116|NCT00880048|3965158|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141117|NCT00880048|3965155|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4141118|NCT00880048|3965156|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4141119|NCT00880048|3965157|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4141120|NCT00880048|3965158|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4141121|NCT00880048|3965155|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4141122|NCT00880048|3965156|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141123|NCT00880048|3965157|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4141124|NCT00880048|3965158|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141125|NCT00880048|3965155|B4||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4141126|NCT00880048|3965156|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4141127|NCT00880048|3965157|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4141128|NCT00880048|3965158|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4141129|NCT00880048|3965155|B4||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4141130|NCT00880048|3965156|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4141131|NCT00880048|3965157|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4141132|NCT00880048|3965158|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4141133|NCT00880048|3965155|B4|||Age||Years|Mean|41.7|41.7|Standard Deviation|10.90|10.9|||
4141134|NCT00880048|3965156|B3|||Age||Years|Mean|43.1|43.1|Standard Deviation|10.66|10.66|||
4141135|NCT00880048|3965157|B2|||Age||Years|Mean|40.4|40.4|Standard Deviation|11.35|11.35|||
4141136|NCT00880048|3965158|B1|||Age||Years|Mean|41.7|41.7|Standard Deviation|10.61|10.61|||
4141137|NCT00880022|3965216|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
4141138|NCT00880022|3965217|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4141139|NCT00880022|3965218|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4141140|NCT00880022|3965216|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4141141|NCT00880022|3965217|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4141142|NCT00880022|3965218|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4141143|NCT00880022|3965216|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4141144|NCT00880022|3965217|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4141145|NCT00880022|3965218|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4141146|NCT00880022|3965216|B3|||Age||years|Mean|55.0|55.0|Standard Deviation|9.4|9.4|||
4141147|NCT00880022|3965217|B2|||Age||years|Mean|52.2|52.2|Standard Deviation|8.6|8.6|||
4141148|NCT00880022|3965218|B1|||Age||years|Mean|58.0|58.0|Standard Deviation|9.3|9.3|||
4141149|NCT00880022|3965216|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4141150|NCT00880022|3965217|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4141151|NCT00880022|3965218|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4141152|NCT00880022|3965216|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4141153|NCT00880022|3965217|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4141154|NCT00880022|3965218|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4141155|NCT00880022|3965216|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141156|NCT00880022|3965217|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141157|NCT00880022|3965218|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141158|NCT00880009|3965227|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4141159|NCT00880009|3965227|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4141160|NCT00880009|3965227|B1|||Age||years|Mean|59.6|59.6|Standard Deviation|9.78|9.78|||
4141161|NCT00879996|3965249|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
4141162|NCT00879996|3965250|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4141163|NCT00879996|3965251|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4141164|NCT00879996|3965249|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4141165|NCT00879996|3965250|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4141166|NCT00879996|3965251|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4141167|NCT00879996|3965249|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4141168|NCT00879996|3965250|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4141169|NCT00879996|3965251|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4141170|NCT00879996|3965249|B3|||Age||years|Mean|38.3|38.3|Standard Deviation|9.7|9.7|||
4141171|NCT00879996|3965250|B2|||Age||years|Mean|39.0|39.0|Standard Deviation|10.9|10.9|||
4141172|NCT00879996|3965251|B1|||Age||years|Mean|37.7|37.7|Standard Deviation|8.6|8.6|||
4141173|NCT00879996|3965249|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4141174|NCT00879996|3965250|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4141175|NCT00879996|3965251|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4141176|NCT00879996|3965249|B3||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4141177|NCT00879996|3965250|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4141178|NCT00879996|3965251|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4141179|NCT00879996|3965249|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141180|NCT00879996|3965250|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141181|NCT00879996|3965251|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141182|NCT00879970|3965264|B4|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4141183|NCT00879970|3965265|B3|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4141184|NCT00879970|3965266|B2|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4141185|NCT00879970|3965267|B1|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4141186|NCT00879970|3965264|B4|Sub-Saharan African||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4141187|NCT00879970|3965265|B3|Sub-Saharan African||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4141188|NCT00879970|3965266|B2|Sub-Saharan African||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4141189|NCT00879970|3965267|B1|Sub-Saharan African||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4141190|NCT00879970|3965264|B4|Malays||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4141191|NCT00879970|3965265|B3|Malays||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4141192|NCT00879970|3965266|B2|Malays||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4141193|NCT00879970|3965267|B1|Malays||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4141194|NCT00879970|3965264|B4|Native Hawaiian/ Australian or Other Asian Pacific||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4141195|NCT00879970|3965265|B3|Native Hawaiian/ Australian or Other Asian Pacific||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4141196|NCT00879970|3965266|B2|Native Hawaiian/ Australian or Other Asian Pacific||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4141197|NCT00879970|3965267|B1|Native Hawaiian/ Australian or Other Asian Pacific||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4141198|NCT00879970|3965264|B4|Arab/ Persian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4141199|NCT00879970|3965265|B3|Arab/ Persian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4141200|NCT00879970|3965266|B2|Arab/ Persian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4141201|NCT00879970|3965267|B1|Arab/ Persian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4141202|NCT00879970|3965264|B4|Japanese||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4141203|NCT00879970|3965265|B3|Japanese||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4141204|NCT00879970|3965266|B2|Japanese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4141205|NCT00879970|3965267|B1|Japanese||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4141206|NCT00879970|3965264|B4|Native North American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4141207|NCT00879970|3965265|B3|Native North American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4141208|NCT00879970|3965266|B2|Native North American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4141209|NCT00879970|3965267|B1|Native North American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4141210|NCT00879970|3965264|B4|Other Asian||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4141211|NCT00879970|3965265|B3|Other Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4141212|NCT00879970|3965266|B2|Other Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4141213|NCT00879970|3965267|B1|Other Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4141214|NCT00879970|3965264|B4|Native South American||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
4141215|NCT00879970|3965265|B3|Native South American||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4141216|NCT00879970|3965266|B2|Native South American||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4141217|NCT00879970|3965267|B1|Native South American||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4141218|NCT00879970|3965264|B4|Black African||Race/Ethnicity, Customized||participants|Number|106|106.0||||||
4141219|NCT00879970|3965265|B3|Black African||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4141220|NCT00879970|3965266|B2|Black African||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4141221|NCT00879970|3965267|B1|Black African||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4141222|NCT00879970|3965264|B4|South Asian||Race/Ethnicity, Customized||participants|Number|157|157.0||||||
4141223|NCT00879970|3965265|B3|South Asian||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
4141224|NCT00879970|3965266|B2|South Asian||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4141225|NCT00879970|3965267|B1|South Asian||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
4141226|NCT00879970|3965264|B4|Unknown||Race/Ethnicity, Customized||participants|Number|122|122.0||||||
4141227|NCT00879970|3965265|B3|Unknown||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4141228|NCT00879970|3965266|B2|Unknown||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4141229|NCT00879970|3965267|B1|Unknown||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
4141230|NCT00879970|3965264|B4|European/ Caucasian/ White||Race/Ethnicity, Customized||participants|Number|826|826.0||||||
4141231|NCT00879970|3965265|B3|European/ Caucasian/ White||Race/Ethnicity, Customized||participants|Number|255|255.0||||||
4141232|NCT00879970|3965266|B2|European/ Caucasian/ White||Race/Ethnicity, Customized||participants|Number|241|241.0||||||
4141233|NCT00879970|3965267|B1|European/ Caucasian/ White||Race/Ethnicity, Customized||participants|Number|330|330.0||||||
4141234|NCT00879970|3965264|B4||Male|Sex: Female, Male||Participants|Count of Participants|784|784.0||||||
4141235|NCT00879970|3965265|B3||Male|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
4141236|NCT00879970|3965266|B2||Male|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
4141237|NCT00879970|3965267|B1||Male|Sex: Female, Male||Participants|Count of Participants|321|321.0||||||
4141238|NCT00879970|3965264|B4||Female|Sex: Female, Male||Participants|Count of Participants|548|548.0||||||
4141239|NCT00879970|3965265|B3||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4141240|NCT00879970|3965266|B2||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4141241|NCT00879970|3965267|B1||Female|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
4141242|NCT00879970|3965264|B4|||Age||Years|Mean|66.4|66.4|Standard Deviation|6.6|6.6|||
4141243|NCT00879970|3965265|B3|||Age||Years|Mean|66.5|66.5|Standard Deviation|6.4|6.4|||
4141244|NCT00879970|3965266|B2|||Age||Years|Mean|66.3|66.3|Standard Deviation|6.6|6.6|||
4141245|NCT00879970|3965267|B1|||Age||Years|Mean|66.4|66.4|Standard Deviation|6.8|6.8|||
4141246|NCT00879879|3965353|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4141247|NCT00879879|3965353|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4141248|NCT00879879|3965353|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4141249|NCT00879879|3965353|B1|||Age||years|Mean|68|68.0|Standard Deviation|6.24|6.24|||
4141250|NCT00879879|3965353|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4141251|NCT00879879|3965353|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4141252|NCT00879879|3965353|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141253|NCT00879814|3965357|B5||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4141254|NCT00879814|3965358|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4141255|NCT00879814|3965359|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4141256|NCT00879814|3965360|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4141257|NCT00879814|3965361|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4141258|NCT00879814|3965357|B5||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4141259|NCT00879814|3965358|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4141260|NCT00879814|3965359|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4141261|NCT00879814|3965360|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4141262|NCT00879814|3965361|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4141263|NCT00879814|3965357|B5|||Age||years|Mean|28.8|28.8|Standard Deviation|6.72|6.72|||
4141264|NCT00879814|3965358|B4|||Age||years|Mean|27.2|27.2|Standard Deviation|5.77|5.77|||
4141265|NCT00879814|3965359|B3|||Age||years|Mean|27.8|27.8|Standard Deviation|6.05|6.05|||
4141266|NCT00879814|3965360|B2|||Age||years|Mean|31.0|31.0|Standard Deviation|7.65|7.65|||
4141267|NCT00879814|3965361|B1|||Age||years|Mean|29.3|29.3|Standard Deviation|7.40|7.4|||
4141268|NCT00879775|3965470|B3|Life enjoyment||Impact of symptom burden to daily life (by MD Anderson Symptom Inventory-Korean)|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a higher level of impact of symptom burden to daily life.|scores|Mean|7.20|7.2|Standard Deviation|1.82|1.82|||
4141269|NCT00879775|3965471|B2|Life enjoyment||Impact of symptom burden to daily life (by MD Anderson Symptom Inventory-Korean)|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a higher level of impact of symptom burden to daily life.|scores|Mean|7.66|7.66|Standard Deviation|1.55|1.55|||
4141270|NCT00879775|3965472|B1|Life enjoyment||Impact of symptom burden to daily life (by MD Anderson Symptom Inventory-Korean)|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a higher level of impact of symptom burden to daily life.|scores|Mean|6.70|6.7|Standard Deviation|1.97|1.97|||
4141271|NCT00879775|3965470|B3|Gait ability||Impact of symptom burden to daily life (by MD Anderson Symptom Inventory-Korean)|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a higher level of impact of symptom burden to daily life.|scores|Mean|5.05|5.05|Standard Deviation|2.28|2.28|||
4141272|NCT00879775|3965471|B2|Gait ability||Impact of symptom burden to daily life (by MD Anderson Symptom Inventory-Korean)|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a higher level of impact of symptom burden to daily life.|scores|Mean|5.61|5.61|Standard Deviation|1.93|1.93|||
4141273|NCT00879775|3965472|B1|Gait ability||Impact of symptom burden to daily life (by MD Anderson Symptom Inventory-Korean)|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a higher level of impact of symptom burden to daily life.|scores|Mean|4.45|4.45|Standard Deviation|2.50|2.5|||
4141274|NCT00879775|3965470|B3|Interpersonal relationship||Impact of symptom burden to daily life (by MD Anderson Symptom Inventory-Korean)|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a higher level of impact of symptom burden to daily life.|scores|Mean|4.95|4.95|Standard Deviation|1.77|1.77|||
4141275|NCT00879775|3965471|B2|Interpersonal relationship||Impact of symptom burden to daily life (by MD Anderson Symptom Inventory-Korean)|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a higher level of impact of symptom burden to daily life.|scores|Mean|5.09|5.09|Standard Deviation|1.54|1.54|||
4141276|NCT00879775|3965472|B1|Interpersonal relationship||Impact of symptom burden to daily life (by MD Anderson Symptom Inventory-Korean)|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a higher level of impact of symptom burden to daily life.|scores|Mean|4.80|4.8|Standard Deviation|2.01|2.01|||
4141277|NCT00879775|3965470|B3|Work||Impact of symptom burden to daily life (by MD Anderson Symptom Inventory-Korean)|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a higher level of impact of symptom burden to daily life.|scores|Mean|6.59|6.59|Standard Deviation|1.91|1.91|||
4141278|NCT00879775|3965471|B2|Work||Impact of symptom burden to daily life (by MD Anderson Symptom Inventory-Korean)|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a higher level of impact of symptom burden to daily life.|scores|Mean|6.90|6.9|Standard Deviation|1.64|1.64|||
4141279|NCT00879775|3965472|B1|Work||Impact of symptom burden to daily life (by MD Anderson Symptom Inventory-Korean)|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a higher level of impact of symptom burden to daily life.|scores|Mean|6.25|6.25|Standard Deviation|2.14|2.14|||
4141280|NCT00879775|3965470|B3|Mode||Impact of symptom burden to daily life (by MD Anderson Symptom Inventory-Korean)|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a higher level of impact of symptom burden to daily life.|scores|Mean|6.00|6.0|Standard Deviation|1.41|1.41|||
4141281|NCT00879775|3965471|B2|Mode||Impact of symptom burden to daily life (by MD Anderson Symptom Inventory-Korean)|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a higher level of impact of symptom burden to daily life.|scores|Mean|6.09|6.09|Standard Deviation|1.33|1.33|||
4141282|NCT00879775|3965472|B1|Mode||Impact of symptom burden to daily life (by MD Anderson Symptom Inventory-Korean)|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a higher level of impact of symptom burden to daily life.|scores|Mean|5.90|5.9|Standard Deviation|1.51|1.51|||
4141283|NCT00879775|3965470|B3|Daily living||Impact of symptom burden to daily life (by MD Anderson Symptom Inventory-Korean)|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a higher level of impact of symptom burden to daily life.|scores|Mean|5.46|5.46|Standard Deviation|2.03|2.03|||
4141284|NCT00879775|3965471|B2|Daily living||Impact of symptom burden to daily life (by MD Anderson Symptom Inventory-Korean)|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a higher level of impact of symptom burden to daily life.|scores|Mean|5.90|5.9|Standard Deviation|1.86|1.86|||
4141285|NCT00879775|3965472|B1|Daily living||Impact of symptom burden to daily life (by MD Anderson Symptom Inventory-Korean)|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a higher level of impact of symptom burden to daily life.|scores|Mean|5.00|5.0|Standard Deviation|2.12|2.12|||
4141286|NCT00879775|3965470|B3|||Health-related quality of life|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a better health-related quality of life.|scores|Mean|4.24|4.24|Standard Deviation|1.22|1.22|||
4141287|NCT00879775|3965471|B2|||Health-related quality of life|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a better health-related quality of life.|scores|Mean|4.19|4.19|Standard Deviation|1.12|1.12|||
4141288|NCT00879775|3965472|B1|||Health-related quality of life|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a better health-related quality of life.|scores|Mean|4.30|4.3|Standard Deviation|1.34|1.34|||
4141289|NCT00879775|3965470|B3|Confusion||Symptom score|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a higher level of symptoms.|scores|Mean|2.24|2.24|Standard Deviation|1.55|1.55|||
4141290|NCT00879775|3965471|B2|Confusion||Symptom score|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a higher level of symptoms.|scores|Mean|2.52|2.52|Standard Deviation|1.50|1.5|||
4141291|NCT00879775|3965472|B1|Confusion||Symptom score|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a higher level of symptoms.|scores|Mean|1.95|1.95|Standard Deviation|1.57|1.57|||
4141292|NCT00879775|3965470|B3|Fatigue||Symptom score|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a higher level of symptoms.|scores|Mean|4.49|4.49|Standard Deviation|1.57|1.57|||
4141293|NCT00879775|3965471|B2|Fatigue||Symptom score|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a higher level of symptoms.|scores|Mean|4.47|4.47|Standard Deviation|1.56|1.56|||
4141294|NCT00879775|3965472|B1|Fatigue||Symptom score|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a higher level of symptoms.|scores|Mean|4.50|4.5|Standard Deviation|1.60|1.6|||
4141295|NCT00879775|3965470|B3|Sadness||Symptom score|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a higher level of symptoms.|scores|Mean|4.39|4.39|Standard Deviation|1.45|1.45|||
4141296|NCT00879775|3965471|B2|Sadness||Symptom score|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a higher level of symptoms.|scores|Mean|4.23|4.23|Standard Deviation|1.51|1.51|||
4141297|NCT00879775|3965472|B1|Sadness||Symptom score|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a higher level of symptoms.|scores|Mean|4.55|4.55|Standard Deviation|1.39|1.39|||
4141298|NCT00879775|3965470|B3|Sleep||Symptom score|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a higher level of symptoms.|scores|Mean|4.05|4.05|Standard Deviation|1.90|1.9|||
4141299|NCT00879775|3965471|B2|Sleep||Symptom score|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a higher level of symptoms.|scores|Mean|3.90|3.9|Standard Deviation|1.86|1.86|||
4141300|NCT00879775|3965472|B1|Sleep||Symptom score|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a higher level of symptoms.|scores|Mean|4.20|4.2|Standard Deviation|1.96|1.96|||
4141301|NCT00879775|3965470|B3|Nausea||Symptom score|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a higher level of symptoms.|scores|Mean|2.27|2.27|Standard Deviation|1.21|1.21|||
4141302|NCT00879775|3965471|B2|Nausea||Symptom score|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a higher level of symptoms.|scores|Mean|2.33|2.33|Standard Deviation|1.23|1.23|||
4141303|NCT00879775|3965472|B1|Nausea||Symptom score|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a higher level of symptoms.|scores|Mean|2.20|2.2|Standard Deviation|1.19|1.19|||
4141304|NCT00879775|3965470|B3|Drowsiness||Symptom score|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a higher level of symptoms.|scores|Mean|4.15|4.15|Standard Deviation|1.54|1.54|||
4141305|NCT00879775|3965471|B2|Drowsiness||Symptom score|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a higher level of symptoms.|scores|Mean|4.24|4.24|Standard Deviation|1.54|1.54|||
4141306|NCT00879775|3965472|B1|Drowsiness||Symptom score|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a higher level of symptoms.|scores|Mean|4.05|4.05|Standard Deviation|1.57|1.57|||
4141307|NCT00879775|3965470|B3|Pain||Symptom score|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a higher level of symptoms.|scores|Mean|3.39|3.39|Standard Deviation|1.09|1.09|||
4141308|NCT00879775|3965471|B2|Pain||Symptom score|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a higher level of symptoms.|scores|Mean|3.52|3.52|Standard Deviation|1.12|1.12|||
4141309|NCT00879775|3965472|B1|Pain||Symptom score|Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a higher level of symptoms.|scores|Mean|3.25|3.25|Standard Deviation|1.06|1.06|||
4141310|NCT00879775|3965470|B3|Korea, Republic of||Region of Enrollment||participants|Number|41|41.0||||||
4141311|NCT00879775|3965471|B2|Korea, Republic of||Region of Enrollment||participants|Number|21|21.0||||||
4141312|NCT00879775|3965472|B1|Korea, Republic of||Region of Enrollment||participants|Number|20|20.0||||||
4141313|NCT00879775|3965470|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4141314|NCT00879775|3965471|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4141315|NCT00879775|3965472|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4141316|NCT00879775|3965470|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4141317|NCT00879775|3965471|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4141318|NCT00879775|3965472|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4141319|NCT00879775|3965470|B3|||Age||years|Mean|65.67|65.67|Standard Deviation|10.88|10.88|||
4141320|NCT00879775|3965471|B2|||Age||years|Mean|67.83|67.83|Standard Deviation|9.76|9.76|||
4141321|NCT00879775|3965472|B1|||Age||years|Mean|63.40|63.4|Standard Deviation|11.76|11.76|||
4141322|NCT00879710|3965487|B3|United States||Region of Enrollment||participants|Number|57|57.0||||||
4141323|NCT00879710|3965488|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
4141324|NCT00879710|3965489|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4141325|NCT00879710|3965487|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4141326|NCT00879710|3965488|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4141327|NCT00879710|3965489|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4141328|NCT00879710|3965487|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4141329|NCT00879710|3965488|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4141330|NCT00879710|3965489|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4141331|NCT00879710|3965487|B3|||Age||years|Mean|57|57.0|Standard Deviation|12|12.0|||
4141332|NCT00879710|3965488|B2|||Age||years|Mean|65|65.0|Standard Deviation|10|10.0|||
4141333|NCT00879710|3965489|B1|||Age||years|Mean|49|49.0|Standard Deviation|13|13.0|||
4141334|NCT00879710|3965487|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4141335|NCT00879710|3965488|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4141336|NCT00879710|3965489|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4141337|NCT00879710|3965487|B3||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4141338|NCT00879710|3965488|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4141339|NCT00879710|3965489|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4141340|NCT00879710|3965487|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141341|NCT00879710|3965488|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141342|NCT00879710|3965489|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141343|NCT00879697|3965500|B3|||Total walking distance|The maximal walking capacity of patients|meter|Mean|595|595.0|Standard Deviation|244|244.0|||
4141344|NCT00879697|3965501|B2|||Total walking distance|The maximal walking capacity of patients|meter|Mean|572|572.0|Standard Deviation|231|231.0|||
4141345|NCT00879697|3965502|B1|||Total walking distance|The maximal walking capacity of patients|meter|Mean|618|618.0|Standard Deviation|282|282.0|||
4141346|NCT00879697|3965500|B3|Brazil||Region of Enrollment||participants|Number|34|34.0||||||
4141347|NCT00879697|3965501|B2|Brazil||Region of Enrollment||participants|Number|17|17.0||||||
4141348|NCT00879697|3965502|B1|Brazil||Region of Enrollment||participants|Number|17|17.0||||||
4141349|NCT00879697|3965500|B3||Male|Gender||Participants|Count of Participants|22|22.0||||||
4141350|NCT00879697|3965501|B2||Male|Gender||Participants|Count of Participants|10|10.0||||||
4141351|NCT00879697|3965502|B1||Male|Gender||Participants|Count of Participants|12|12.0||||||
4141352|NCT00879697|3965500|B3||Female|Gender||Participants|Count of Participants|12|12.0||||||
4141353|NCT00879697|3965501|B2||Female|Gender||Participants|Count of Participants|7|7.0||||||
4141354|NCT00879697|3965502|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
4141355|NCT00879697|3965500|B3|||Age||years|Mean|65.1|65.1|Standard Deviation|9.3|9.3|||
4141356|NCT00879697|3965501|B2|||Age||years|Mean|64.6|64.6|Standard Deviation|8.8|8.8|||
4141357|NCT00879697|3965502|B1|||Age||years|Mean|65.7|65.7|Standard Deviation|9.5|9.5|||
4141358|NCT00879697|3965500|B3||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4141359|NCT00879697|3965501|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4141360|NCT00879697|3965502|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4141361|NCT00879697|3965500|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4141362|NCT00879697|3965501|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4141363|NCT00879697|3965502|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4141364|NCT00879697|3965500|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141365|NCT00879697|3965501|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141366|NCT00879697|3965502|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141367|NCT00879684|3965509|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4141368|NCT00879684|3965509|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4141369|NCT00879684|3965509|B1|||Age||years|Mean|59.8|59.8|Standard Deviation|14.62|14.62|||
4141370|NCT00879645|3965577|B5|United States||Region of Enrollment||participants|Number|28|28.0||||||
4141371|NCT00879645|3965578|B4|United States||Region of Enrollment||participants|Number|7|7.0||||||
4141372|NCT00879645|3965579|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4141373|NCT00879645|3965580|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4141374|NCT00879645|3965581|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4141375|NCT00879645|3965577|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4141376|NCT00879645|3965578|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4141377|NCT00879645|3965579|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4141378|NCT00879645|3965580|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4141379|NCT00879645|3965581|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4141380|NCT00879645|3965577|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4141381|NCT00879645|3965578|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4141382|NCT00879645|3965579|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4141383|NCT00879645|3965580|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4141384|NCT00879645|3965581|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4141385|NCT00879645|3965577|B5|||Age||years|Mean|55.3|55.3|Standard Deviation|10.82|10.82|||
4141386|NCT00879645|3965578|B4|||Age||years|Mean|48.9|48.9|Standard Deviation|11.96|11.96|||
4141387|NCT00879645|3965579|B3|||Age||years|Mean|60.6|60.6|Standard Deviation|7.91|7.91|||
4141388|NCT00879645|3965580|B2|||Age||years|Mean|56.1|56.1|Standard Deviation|14.69|14.69|||
4141389|NCT00879645|3965581|B1|||Age||years|Mean|56.3|56.3|Standard Deviation|7.41|7.41|||
4141390|NCT00879645|3965577|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4141391|NCT00879645|3965578|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4141392|NCT00879645|3965579|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4141393|NCT00879645|3965580|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4141394|NCT00879645|3965581|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4141395|NCT00879645|3965577|B5||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4141396|NCT00879645|3965578|B4||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4141397|NCT00879645|3965579|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4141398|NCT00879645|3965580|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4141399|NCT00879645|3965581|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4141400|NCT00879645|3965577|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141401|NCT00879645|3965578|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141402|NCT00879645|3965579|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141403|NCT00879645|3965580|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141404|NCT00879645|3965581|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141405|NCT00879619|3965602|B1||Male|Gender||Participants|Count of Participants|4|4.0||||||
4141406|NCT00879619|3965602|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
4141407|NCT00879619|3965602|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4141408|NCT00879619|3965602|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4141409|NCT00879619|3965602|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141410|NCT00879411|3965611|B1|||Baseline Systolic Blood Pressure (SBP) values (ABPM)||mm Hg|Mean|136|136.0|Standard Deviation|13.2|13.2|||
4141411|NCT00879411|3965611|B1|||Baseline Diastolic Blood Pressure (DBP) values (ABPM)||mm Hg|Mean|82|82.0|Standard Deviation|9.6|9.6|||
4141412|NCT00879411|3965611|B1|Male||Gender|20 subjects did not indicate any specific gender|participants|Number|357|357.0||||||
4141413|NCT00879411|3965611|B1|Female||Gender|20 subjects did not indicate any specific gender|participants|Number|324|324.0||||||
4141414|NCT00879411|3965611|B1|||Age||Year|Mean|60.5|60.5|Standard Deviation|12.8|12.8|||
4141415|NCT00879398|3965617|B1||Male|Sex: Female, Male||Participants|Count of Participants|1587|1587.0||||||
4141416|NCT00879398|3965617|B1||Female|Sex: Female, Male||Participants|Count of Participants|1520|1520.0||||||
4141417|NCT00879398|3965617|B1|||Age||Years|Mean|60.22|60.22|Standard Deviation|13.98|13.98|||
4141418|NCT00879359|3965627|B1||Clear cell|Tumor histology and grade||Participants|Count of Participants|1|1.0||||||
4141419|NCT00879359|3965627|B1||Endometrioid grade 3|Tumor histology and grade||Participants|Count of Participants|3|3.0||||||
4141420|NCT00879359|3965627|B1||Endometrioid grade 2|Tumor histology and grade||Participants|Count of Participants|5|5.0||||||
4141421|NCT00879359|3965627|B1||Serous papillary|Tumor histology and grade||Participants|Count of Participants|6|6.0||||||
4141422|NCT00879359|3965627|B1||IVB|Stage (FIGO 2009)||Participants|Count of Participants|7|7.0||||||
4141423|NCT00879359|3965627|B1||IIIC2|Stage (FIGO 2009)||Participants|Count of Participants|1|1.0||||||
4141424|NCT00879359|3965627|B1||IIIC1|Stage (FIGO 2009)||Participants|Count of Participants|1|1.0||||||
4141425|NCT00879359|3965627|B1||IIB|Stage (FIGO 2009)||Participants|Count of Participants|1|1.0||||||
4141426|NCT00879359|3965627|B1||IB|Stage (FIGO 2009)||Participants|Count of Participants|1|1.0||||||
4141427|NCT00879359|3965627|B1||IA|Stage (FIGO 2009)||Participants|Count of Participants|4|4.0||||||
4141428|NCT00879359|3965627|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4141429|NCT00879359|3965627|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4141430|NCT00879359|3965627|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4141431|NCT00879359|3965627|B1|||Age||years|Median|63|63.0|Full Range|||32.0|88.0|
4141432|NCT00879333|3965633|B3|Other||Race/Ethnicity, Customized||Participants|Number|33|33.0||||||
4141433|NCT00879333|3965634|B2|Other||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4141434|NCT00879333|3965635|B1|Other||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4141435|NCT00879333|3965633|B3|Native American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4141436|NCT00879333|3965634|B2|Native American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4141437|NCT00879333|3965635|B1|Native American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4141438|NCT00879333|3965633|B3|Asian||Race/Ethnicity, Customized||Participants|Number|377|377.0||||||
4141439|NCT00879333|3965634|B2|Asian||Race/Ethnicity, Customized||Participants|Number|126|126.0||||||
4141440|NCT00879333|3965635|B1|Asian||Race/Ethnicity, Customized||Participants|Number|251|251.0||||||
4141441|NCT00879333|3965633|B3|Black||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4141442|NCT00879333|3965634|B2|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4141443|NCT00879333|3965635|B1|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4141444|NCT00879333|3965633|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|241|241.0||||||
4141445|NCT00879333|3965634|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|75|75.0||||||
4141446|NCT00879333|3965635|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|166|166.0||||||
4141447|NCT00879333|3965633|B3||Male|Sex: Female, Male||Participants|Count of Participants|483|483.0||||||
4141448|NCT00879333|3965634|B2||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4141449|NCT00879333|3965635|B1||Male|Sex: Female, Male||Participants|Count of Participants|322|322.0||||||
4141450|NCT00879333|3965633|B3||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4141451|NCT00879333|3965634|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4141452|NCT00879333|3965635|B1||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4141453|NCT00879333|3965633|B3|>=65 years||Age, Customized||Participants|Number|267|267.0||||||
4141454|NCT00879333|3965634|B2|>=65 years||Age, Customized||Participants|Number|88|88.0||||||
4141455|NCT00879333|3965635|B1|>=65 years||Age, Customized||Participants|Number|179|179.0||||||
4141456|NCT00879333|3965633|B3|< 65 years||Age, Customized||Participants|Number|389|389.0||||||
4141457|NCT00879333|3965634|B2|< 65 years||Age, Customized||Participants|Number|129|129.0||||||
4141458|NCT00879333|3965635|B1|< 65 years||Age, Customized||Participants|Number|260|260.0||||||
4141459|NCT00879333|3965633|B3|||Age||years|Mean|60.4|60.4|Standard Deviation|11.59|11.59|||
4141460|NCT00879333|3965634|B2|||Age||years|Mean|60.8|60.8|Standard Deviation|11.61|11.61|||
4141461|NCT00879333|3965635|B1|||Age||years|Mean|60.3|60.3|Standard Deviation|11.59|11.59|||
4141462|NCT00879255|3965654|B3|United States||Region of Enrollment||participants|Number|125|125.0||||||
4141463|NCT00879255|3965655|B2|United States||Region of Enrollment||participants|Number|64|64.0||||||
4141464|NCT00879255|3965656|B1|United States||Region of Enrollment||participants|Number|61|61.0||||||
4141465|NCT00879255|3965654|B3||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4141466|NCT00879255|3965655|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4141467|NCT00879255|3965656|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4141468|NCT00879255|3965654|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4141469|NCT00879255|3965655|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4141470|NCT00879255|3965656|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4141471|NCT00879255|3965654|B3|||Age||years|Mean|55.3|55.3|Standard Deviation|12.5|12.5|||
4141472|NCT00879255|3965655|B2|||Age||years|Mean|54.6|54.6|Standard Deviation|13.2|13.2|||
4141473|NCT00879255|3965656|B1|||Age||years|Mean|56.1|56.1|Standard Deviation|11.8|11.8|||
4141474|NCT00879229|3965667|B3|||Baseline Dyspnea Index (BDI)|BDI range is 0 to 12 (worst to best).|units on a scale|Mean|4.8|4.8|Standard Deviation|2.13|2.13|||
4141475|NCT00879229|3965668|B2|||Baseline Dyspnea Index (BDI)|BDI range is 0 to 12 (worst to best).|units on a scale|Mean|4.4|4.4|Standard Deviation|2.10|2.1|||
4141476|NCT00879229|3965669|B1|||Baseline Dyspnea Index (BDI)|BDI range is 0 to 12 (worst to best).|units on a scale|Mean|5.0|5.0|Standard Deviation|2.15|2.15|||
4141477|NCT00879229|3965667|B3|Germany||Region of Enrollment||participants|Number|3|3.0||||||
4141478|NCT00879229|3965668|B2|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4141479|NCT00879229|3965669|B1|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4141480|NCT00879229|3965667|B3|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4141481|NCT00879229|3965668|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4141482|NCT00879229|3965669|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4141483|NCT00879229|3965667|B3|Italy||Region of Enrollment||participants|Number|5|5.0||||||
4141484|NCT00879229|3965668|B2|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4141485|NCT00879229|3965669|B1|Italy||Region of Enrollment||participants|Number|4|4.0||||||
4141486|NCT00879229|3965667|B3|Australia||Region of Enrollment||participants|Number|5|5.0||||||
4141487|NCT00879229|3965668|B2|Australia||Region of Enrollment||participants|Number|2|2.0||||||
4141488|NCT00879229|3965669|B1|Australia||Region of Enrollment||participants|Number|3|3.0||||||
4141489|NCT00879229|3965667|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4141490|NCT00879229|3965668|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4141491|NCT00879229|3965669|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4141492|NCT00879229|3965667|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4141493|NCT00879229|3965668|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4141494|NCT00879229|3965669|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4141495|NCT00879229|3965667|B3|White||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4141496|NCT00879229|3965668|B2|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4141497|NCT00879229|3965669|B1|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4141498|NCT00879229|3965667|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4141499|NCT00879229|3965668|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4141500|NCT00879229|3965669|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4141501|NCT00879229|3965667|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4141502|NCT00879229|3965668|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4141503|NCT00879229|3965669|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4141504|NCT00879229|3965667|B3|||Age||years|Mean|68|68.0|Standard Deviation|6.8|6.8|||
4141505|NCT00879229|3965668|B2|||Age||years|Mean|68|68.0|Standard Deviation|5.2|5.2|||
4141506|NCT00879229|3965669|B1|||Age||years|Mean|68|68.0|Standard Deviation|7.7|7.7|||
4141507|NCT00879190|3965694|B3|||Maternal pre-existing comorbidity||participants|Number|39|39.0||||||
4141508|NCT00879190|3965695|B2|||Maternal pre-existing comorbidity||participants|Number|20|20.0||||||
4141509|NCT00879190|3965696|B1|||Maternal pre-existing comorbidity||participants|Number|19|19.0||||||
4141510|NCT00879190|3965694|B3|||Nulliparous||participants|Number|69|69.0||||||
4141511|NCT00879190|3965695|B2|||Nulliparous||participants|Number|39|39.0||||||
4141512|NCT00879190|3965696|B1|||Nulliparous||participants|Number|30|30.0||||||
4141513|NCT00879190|3965694|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4141514|NCT00879190|3965695|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4141515|NCT00879190|3965696|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4141516|NCT00879190|3965694|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4141517|NCT00879190|3965695|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4141518|NCT00879190|3965696|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4141519|NCT00879190|3965694|B3|||Age||years|Mean|28.0|28.0|Standard Deviation|6.4|6.4|||
4141520|NCT00879190|3965695|B2|||Age||years|Mean|28.3|28.3|Standard Deviation|5.6|5.6|||
4141521|NCT00879190|3965696|B1|||Age||years|Mean|27.6|27.6|Standard Deviation|7.1|7.1|||
4141522|NCT00879034|3965707|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4141523|NCT00879034|3965707|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4141524|NCT00879034|3965707|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4141525|NCT00879034|3965707|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4141526|NCT00879034|3965707|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4141527|NCT00879034|3965707|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4141528|NCT00878995|3965716|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4141529|NCT00878995|3965717|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4141530|NCT00878995|3965718|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4141531|NCT00878995|3965716|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141532|NCT00878995|3965717|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141533|NCT00878995|3965718|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141534|NCT00878995|3965716|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141535|NCT00878995|3965717|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141536|NCT00878995|3965718|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141537|NCT00878995|3965716|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4141538|NCT00878995|3965717|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4141539|NCT00878995|3965718|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4141540|NCT00878995|3965716|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4141541|NCT00878995|3965717|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4141542|NCT00878995|3965718|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4141543|NCT00878995|3965716|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141544|NCT00878995|3965717|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141545|NCT00878995|3965718|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141546|NCT00878995|3965716|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141547|NCT00878995|3965717|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141548|NCT00878995|3965718|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141549|NCT00878995|3965716|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141550|NCT00878995|3965717|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141551|NCT00878995|3965718|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141552|NCT00878995|3965716|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141553|NCT00878995|3965717|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141554|NCT00878995|3965718|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141555|NCT00878995|3965716|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4141556|NCT00878995|3965717|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4141557|NCT00878995|3965718|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4141558|NCT00878995|3965716|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4141559|NCT00878995|3965717|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4141560|NCT00878995|3965718|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4141561|NCT00878995|3965716|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4141562|NCT00878995|3965717|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4141563|NCT00878995|3965718|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4141564|NCT00878995|3965716|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4141565|NCT00878995|3965717|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4141566|NCT00878995|3965718|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4141567|NCT00878995|3965716|B3|||Age||years|Mean|51.44|51.44|Standard Deviation|10.30|10.3|||
4141568|NCT00878995|3965717|B2|||Age||years|Mean|48.66|48.66|Standard Deviation|12.26|12.26|||
4141569|NCT00878995|3965718|B1|||Age||years|Mean|54|54.0|Standard Deviation|7.97|7.97|||
4141570|NCT00878969|3965817|B4|United States||Region of Enrollment||participants|Number|78|78.0||||||
4141571|NCT00878969|3965818|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4141572|NCT00878969|3965819|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4141573|NCT00878969|3965820|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4141574|NCT00878969|3965817|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4141575|NCT00878969|3965818|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4141576|NCT00878969|3965819|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4141577|NCT00878969|3965820|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4141578|NCT00878969|3965817|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141579|NCT00878969|3965818|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141580|NCT00878969|3965819|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141581|NCT00878969|3965820|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141582|NCT00878969|3965817|B4||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4141583|NCT00878969|3965818|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4141584|NCT00878969|3965819|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4141585|NCT00878969|3965820|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4141586|NCT00878969|3965817|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4141587|NCT00878969|3965818|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4141588|NCT00878969|3965819|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4141589|NCT00878969|3965820|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4141590|NCT00878969|3965817|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141591|NCT00878969|3965818|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141592|NCT00878969|3965819|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141593|NCT00878969|3965820|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141594|NCT00878969|3965817|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141595|NCT00878969|3965818|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141596|NCT00878969|3965819|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141597|NCT00878969|3965820|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141598|NCT00878969|3965817|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141599|NCT00878969|3965818|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141600|NCT00878969|3965819|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141601|NCT00878969|3965820|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141602|NCT00878969|3965817|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141603|NCT00878969|3965818|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141604|NCT00878969|3965819|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141605|NCT00878969|3965820|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141606|NCT00878969|3965817|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4141607|NCT00878969|3965818|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4141608|NCT00878969|3965819|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4141609|NCT00878969|3965820|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4141610|NCT00878969|3965817|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4141611|NCT00878969|3965818|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4141612|NCT00878969|3965819|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4141613|NCT00878969|3965820|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4141614|NCT00878969|3965817|B4||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4141615|NCT00878969|3965818|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4141616|NCT00878969|3965819|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4141617|NCT00878969|3965820|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4141618|NCT00878969|3965817|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4141619|NCT00878969|3965818|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4141620|NCT00878969|3965819|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4141621|NCT00878969|3965820|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4141622|NCT00878969|3965817|B4|||Age||years|Mean|52|52.0|Standard Deviation|12|12.0|||
4141623|NCT00878969|3965818|B3|||Age||years|Mean|49|49.0|Standard Deviation|9|9.0|||
4141624|NCT00878969|3965819|B2|||Age||years|Mean|53|53.0|Standard Deviation|13|13.0|||
4141625|NCT00878969|3965820|B1|||Age||years|Mean|53|53.0|Standard Deviation|13|13.0|||
4141626|NCT00878878|3965830|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4141627|NCT00878878|3965831|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4141628|NCT00878878|3965832|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4141629|NCT00878878|3965830|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4141630|NCT00878878|3965831|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4141631|NCT00878878|3965832|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4141632|NCT00878878|3965830|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4141633|NCT00878878|3965831|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4141634|NCT00878878|3965832|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4141635|NCT00878878|3965830|B3|||Age||years|Mean|57|57.0|Standard Deviation|16.5|16.5|||
4141636|NCT00878878|3965831|B2|||Age||years|Mean|60|60.0|Standard Deviation|16.7|16.7|||
4141637|NCT00878878|3965832|B1|||Age||years|Mean|53|53.0|Standard Deviation|16.1|16.1|||
4141638|NCT00878878|3965830|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4141639|NCT00878878|3965831|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4141640|NCT00878878|3965832|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4141641|NCT00878878|3965830|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4141642|NCT00878878|3965831|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4141643|NCT00878878|3965832|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4141644|NCT00878878|3965830|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141645|NCT00878878|3965831|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141646|NCT00878878|3965832|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141647|NCT00878826|3965843|B4|Private||Insurance Status||participants|Number|9|9.0||||||
4141648|NCT00878826|3965844|B3|Private||Insurance Status||participants|Number|2|2.0||||||
4141649|NCT00878826|3965845|B2|Private||Insurance Status||participants|Number|4|4.0||||||
4141650|NCT00878826|3965846|B1|Private||Insurance Status||participants|Number|3|3.0||||||
4141651|NCT00878826|3965843|B4|Public||Insurance Status||participants|Number|2|2.0||||||
4141652|NCT00878826|3965844|B3|Public||Insurance Status||participants|Number|0|0.0||||||
4141653|NCT00878826|3965845|B2|Public||Insurance Status||participants|Number|2|2.0||||||
4141654|NCT00878826|3965846|B1|Public||Insurance Status||participants|Number|0|0.0||||||
4141655|NCT00878826|3965843|B4|||BMI at Enrollment||kg/m2|Mean|24.7|24.7|Full Range|||18.4|34.6|
4141656|NCT00878826|3965844|B3|||BMI at Enrollment||kg/m2|Mean|22.6|22.6|Full Range|||21.4|23.9|
4141657|NCT00878826|3965845|B2|||BMI at Enrollment||kg/m2|Mean|26.3|26.3|Full Range|||18.4|34.6|
4141658|NCT00878826|3965846|B1|||BMI at Enrollment||kg/m2|Mean|22.8|22.8|Full Range|||20.9|23.7|
4141659|NCT00878826|3965843|B4|||Weight at Enrollment||kg|Mean|63.4|63.4|Full Range|||54.0|83.0|
4141660|NCT00878826|3965844|B3|||Weight at Enrollment||kg|Mean|59.5|59.5|Full Range|||59.0|60.0|
4141661|NCT00878826|3965845|B2|||Weight at Enrollment||kg|Mean|65.5|65.5|Full Range|||54.0|83.0|
4141662|NCT00878826|3965846|B1|||Weight at Enrollment||kg|Mean|61.7|61.7|Full Range|||57.0|69.0|
4141663|NCT00878826|3965843|B4|||Gestational Age at Enrollment||weeks|Mean|11.73|11.73|Full Range|||7.71|15.29|
4141664|NCT00878826|3965844|B3|||Gestational Age at Enrollment||weeks|Mean|11.64|11.64|Full Range|||9.86|13.43|
4141665|NCT00878826|3965845|B2|||Gestational Age at Enrollment||weeks|Mean|12.19|12.19|Full Range|||10.0|15.29|
4141666|NCT00878826|3965846|B1|||Gestational Age at Enrollment||weeks|Mean|10.86|10.86|Full Range|||7.71|12.71|
4141667|NCT00878826|3965843|B4|United States||Region of Enrollment||participants|Number|11|11.0||||||
4141668|NCT00878826|3965844|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4141669|NCT00878826|3965845|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4141670|NCT00878826|3965846|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4141671|NCT00878826|3965843|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4141672|NCT00878826|3965844|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141673|NCT00878826|3965845|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4141674|NCT00878826|3965846|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141675|NCT00878826|3965843|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141676|NCT00878826|3965844|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141677|NCT00878826|3965845|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141678|NCT00878826|3965846|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141679|NCT00878826|3965843|B4||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4141680|NCT00878826|3965844|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141681|NCT00878826|3965845|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4141682|NCT00878826|3965846|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4141683|NCT00878826|3965843|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141684|NCT00878826|3965844|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141685|NCT00878826|3965845|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141686|NCT00878826|3965846|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141687|NCT00878826|3965843|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141688|NCT00878826|3965844|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141689|NCT00878826|3965845|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141690|NCT00878826|3965846|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141691|NCT00878826|3965843|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4141692|NCT00878826|3965844|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4141693|NCT00878826|3965845|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4141694|NCT00878826|3965846|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4141695|NCT00878826|3965843|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141696|NCT00878826|3965844|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141697|NCT00878826|3965845|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141698|NCT00878826|3965846|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141699|NCT00878826|3965843|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141700|NCT00878826|3965844|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141701|NCT00878826|3965845|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141702|NCT00878826|3965846|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141703|NCT00878826|3965843|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4141704|NCT00878826|3965844|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4141705|NCT00878826|3965845|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4141706|NCT00878826|3965846|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4141707|NCT00878826|3965843|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4141708|NCT00878826|3965844|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141709|NCT00878826|3965845|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4141710|NCT00878826|3965846|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141711|NCT00878826|3965843|B4||Male|Gender||Participants|Count of Participants|0|0.0||||||
4141712|NCT00878826|3965844|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
4141713|NCT00878826|3965845|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
4141714|NCT00878826|3965846|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4141715|NCT00878826|3965843|B4||Female|Gender||Participants|Count of Participants|11|11.0||||||
4141716|NCT00878826|3965844|B3||Female|Gender||Participants|Count of Participants|2|2.0||||||
4141717|NCT00878826|3965845|B2||Female|Gender||Participants|Count of Participants|6|6.0||||||
4141718|NCT00878826|3965846|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
4141719|NCT00878826|3965843|B4|||Age||years|Mean|34.2|34.2|Standard Deviation|1.04|1.04|||
4141720|NCT00878826|3965844|B3|||Age||years|Mean|34.5|34.5|Standard Deviation|6.4|6.4|||
4141721|NCT00878826|3965845|B2|||Age||years|Mean|32.8|32.8|Standard Deviation|6.2|6.2|||
4141722|NCT00878826|3965846|B1|||Age||years|Mean|39.3|39.3|Standard Deviation|2.1|2.1|||
4141723|NCT00878826|3965843|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4141724|NCT00878826|3965844|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4141725|NCT00878826|3965845|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4141726|NCT00878826|3965846|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4141727|NCT00878826|3965843|B4||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4141728|NCT00878826|3965844|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4141729|NCT00878826|3965845|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4141730|NCT00878826|3965846|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4141731|NCT00878826|3965843|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141732|NCT00878826|3965844|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141733|NCT00878826|3965845|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141734|NCT00878826|3965846|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141735|NCT00878800|3965865|B6||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4141736|NCT00878800|3965866|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4141737|NCT00878800|3965867|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4141738|NCT00878800|3965868|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4141739|NCT00878800|3965869|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4141740|NCT00878800|3965870|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4141741|NCT00878800|3965865|B6||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4141742|NCT00878800|3965866|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4141743|NCT00878800|3965867|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4141744|NCT00878800|3965868|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4141745|NCT00878800|3965869|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4141746|NCT00878800|3965870|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4141747|NCT00878800|3965865|B6||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4141748|NCT00878800|3965866|B5||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4141749|NCT00878800|3965867|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4141750|NCT00878800|3965868|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4141751|NCT00878800|3965869|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4141752|NCT00878800|3965870|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4141753|NCT00878800|3965865|B6||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4141754|NCT00878800|3965866|B5||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4141755|NCT00878800|3965867|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4141756|NCT00878800|3965868|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4141757|NCT00878800|3965869|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4141758|NCT00878800|3965870|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4141759|NCT00878800|3965865|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141760|NCT00878800|3965866|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141761|NCT00878800|3965867|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141762|NCT00878800|3965868|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141763|NCT00878800|3965869|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141764|NCT00878800|3965870|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141765|NCT00878722|3965901|B9||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4141766|NCT00878722|3965902|B8||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4141767|NCT00878722|3965903|B7||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4141768|NCT00878722|3965904|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4141769|NCT00878722|3965905|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4141770|NCT00878722|3965906|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4141771|NCT00878722|3965907|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4141772|NCT00878722|3965908|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4141773|NCT00878722|3965909|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4141774|NCT00878722|3965901|B9||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4141775|NCT00878722|3965902|B8||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4141776|NCT00878722|3965903|B7||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4141777|NCT00878722|3965904|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4141778|NCT00878722|3965905|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4141779|NCT00878722|3965906|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4141780|NCT00878722|3965907|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4141781|NCT00878722|3965908|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4141782|NCT00878722|3965909|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4141783|NCT00878722|3965901|B9||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4141784|NCT00878722|3965902|B8||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4141785|NCT00878722|3965903|B7||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4141786|NCT00878722|3965904|B6||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4141787|NCT00878722|3965905|B5||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4141788|NCT00878722|3965906|B4||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4141789|NCT00878722|3965907|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4141790|NCT00878722|3965908|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4141791|NCT00878722|3965909|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4141792|NCT00878722|3965901|B9||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4141793|NCT00878722|3965902|B8||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4141794|NCT00878722|3965903|B7||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4141795|NCT00878722|3965904|B6||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4141796|NCT00878722|3965905|B5||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4141797|NCT00878722|3965906|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4141798|NCT00878722|3965907|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4141799|NCT00878722|3965908|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4141800|NCT00878722|3965909|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4141801|NCT00878722|3965901|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141802|NCT00878722|3965902|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141803|NCT00878722|3965903|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141804|NCT00878722|3965904|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141805|NCT00878722|3965905|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141806|NCT00878722|3965906|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141807|NCT00878722|3965907|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141808|NCT00878722|3965908|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141809|NCT00878722|3965909|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141810|NCT00878709|3965999|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|81|81.0||||||
4141811|NCT00878709|3966000|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
4141812|NCT00878709|3966001|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
4141813|NCT00878709|3965999|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|2300|2300.0||||||
4141814|NCT00878709|3966000|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|1135|1135.0||||||
4141815|NCT00878709|3966001|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|1165|1165.0||||||
4141932|NCT00878553|3966061|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4141816|NCT00878709|3965999|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|74|74.0||||||
4141817|NCT00878709|3966000|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
4141818|NCT00878709|3966001|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
4141819|NCT00878709|3965999|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|385|385.0||||||
4141820|NCT00878709|3966000|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|197|197.0||||||
4141821|NCT00878709|3966001|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|188|188.0||||||
4141822|NCT00878709|3965999|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4141823|NCT00878709|3966000|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4141824|NCT00878709|3966001|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4141825|NCT00878709|3965999|B3||Female|Sex: Female, Male||Participants|Count of Participants|2840|2840.0||||||
4141826|NCT00878709|3966000|B2||Female|Sex: Female, Male||Participants|Count of Participants|1420|1420.0||||||
4141827|NCT00878709|3966001|B1||Female|Sex: Female, Male||Participants|Count of Participants|1420|1420.0||||||
4141828|NCT00878709|3965999|B3|||Age||years|Mean|52.3|52.3|Standard Deviation|10.18|10.18|||
4141829|NCT00878709|3966000|B2|||Age||years|Mean|52.3|52.3|Standard Deviation|10.28|10.28|||
4141830|NCT00878709|3966001|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|10.08|10.08|||
4141831|NCT00878644|3966026|B3||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4141832|NCT00878644|3966027|B2||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4141833|NCT00878644|3966028|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4141834|NCT00878644|3966026|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4141835|NCT00878644|3966027|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4141836|NCT00878644|3966028|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4141837|NCT00878644|3966026|B3|Age Category|12 - 17 yr|Age, Customized||Participants|Count of Participants|53|53.0||||||
4141838|NCT00878644|3966027|B2|Age Category|12 - 17 yr|Age, Customized||Participants|Count of Participants|22|22.0||||||
4141839|NCT00878644|3966028|B1|Age Category|12 - 17 yr|Age, Customized||Participants|Count of Participants|31|31.0||||||
4141840|NCT00878644|3966026|B3|Age Category|2 - <12 yr|Age, Customized||Participants|Count of Participants|93|93.0||||||
4141841|NCT00878644|3966027|B2|Age Category|2 - <12 yr|Age, Customized||Participants|Count of Participants|45|45.0||||||
4141842|NCT00878644|3966028|B1|Age Category|2 - <12 yr|Age, Customized||Participants|Count of Participants|48|48.0||||||
4141843|NCT00878644|3966026|B3|Age Category|< 2 yr|Age, Customized||Participants|Count of Participants|149|149.0||||||
4141844|NCT00878644|3966027|B2|Age Category|< 2 yr|Age, Customized||Participants|Count of Participants|73|73.0||||||
4141845|NCT00878644|3966028|B1|Age Category|< 2 yr|Age, Customized||Participants|Count of Participants|76|76.0||||||
4141846|NCT00878644|3966026|B3|||Age||years|Median|2.0|2.0|Inter-Quartile Range|||0.5|8.7|
4141847|NCT00878644|3966027|B2|||Age||years|Median|1.6|1.6|Inter-Quartile Range|||0.4|7.0|
4141848|NCT00878644|3966028|B1|||Age||years|Median|2.1|2.1|Inter-Quartile Range|||0.6|10.1|
4141849|NCT00878605|3966041|B5|||Baseline Demographics||participants|Number|38|38.0||||||
4141850|NCT00878605|3966042|B4|||Baseline Demographics||participants|Number|9|9.0||||||
4141851|NCT00878605|3966043|B3|||Baseline Demographics||participants|Number|9|9.0||||||
4141852|NCT00878605|3966044|B2|||Baseline Demographics||participants|Number|10|10.0||||||
4141853|NCT00878605|3966045|B1|||Baseline Demographics||participants|Number|10|10.0||||||
4141854|NCT00878605|3966041|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141855|NCT00878605|3966042|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141856|NCT00878605|3966043|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141857|NCT00878605|3966044|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141858|NCT00878605|3966045|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141859|NCT00878605|3966041|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141860|NCT00878605|3966042|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141861|NCT00878605|3966043|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141862|NCT00878605|3966044|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141863|NCT00878605|3966045|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141864|NCT00878605|3966041|B5||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4141865|NCT00878605|3966042|B4||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4141866|NCT00878605|3966043|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4141867|NCT00878605|3966044|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4141868|NCT00878605|3966045|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4141869|NCT00878605|3966041|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4141870|NCT00878605|3966042|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4141871|NCT00878605|3966043|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4141872|NCT00878605|3966044|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4141873|NCT00878605|3966045|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4141933|NCT00878553|3966062|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4141874|NCT00878605|3966041|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141875|NCT00878605|3966042|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141876|NCT00878605|3966043|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141877|NCT00878605|3966044|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141878|NCT00878605|3966045|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141879|NCT00878605|3966041|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4141880|NCT00878605|3966042|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141881|NCT00878605|3966043|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141882|NCT00878605|3966044|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4141883|NCT00878605|3966045|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141884|NCT00878605|3966041|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141885|NCT00878605|3966042|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141886|NCT00878605|3966043|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141887|NCT00878605|3966044|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141888|NCT00878605|3966045|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141889|NCT00878605|3966041|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141890|NCT00878605|3966042|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141891|NCT00878605|3966043|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141892|NCT00878605|3966044|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141893|NCT00878605|3966045|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141894|NCT00878605|3966041|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4141895|NCT00878605|3966042|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4141896|NCT00878605|3966043|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4141897|NCT00878605|3966044|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4141898|NCT00878605|3966045|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4141899|NCT00878605|3966041|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141900|NCT00878605|3966042|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141901|NCT00878605|3966043|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141902|NCT00878605|3966044|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141903|NCT00878605|3966045|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141904|NCT00878605|3966041|B5||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4141905|NCT00878605|3966042|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4141906|NCT00878605|3966043|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4141907|NCT00878605|3966044|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4141908|NCT00878605|3966045|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4141909|NCT00878605|3966041|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4141910|NCT00878605|3966042|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4141911|NCT00878605|3966043|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4141912|NCT00878605|3966044|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4141913|NCT00878605|3966045|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4141914|NCT00878605|3966041|B5|||Age||years|Mean|60.8|60.8|Full Range|||18.0|80.0|
4141915|NCT00878605|3966042|B4|||Age||years|Mean|59.5|59.5|Full Range|||18.0|80.0|
4141916|NCT00878605|3966043|B3|||Age||years|Mean|63.4|63.4|Full Range|||18.0|80.0|
4141917|NCT00878605|3966044|B2|||Age||years|Mean|61.9|61.9|Full Range|||18.0|80.0|
4141918|NCT00878605|3966045|B1|||Age||years|Mean|58.7|58.7|Full Range|||18.0|80.0|
4141919|NCT00878553|3966058|B5|United States||Region of Enrollment||participants|Number|67|67.0||||||
4141920|NCT00878553|3966059|B4|United States||Region of Enrollment||participants|Number|17|17.0||||||
4141921|NCT00878553|3966060|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4141922|NCT00878553|3966061|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4141923|NCT00878553|3966062|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4141924|NCT00878553|3966058|B5||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4141925|NCT00878553|3966059|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4141926|NCT00878553|3966060|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4141927|NCT00878553|3966061|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4141928|NCT00878553|3966062|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4141929|NCT00878553|3966058|B5||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4141930|NCT00878553|3966059|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4141931|NCT00878553|3966060|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4141934|NCT00878553|3966058|B5|||Age||years|Mean|46.1|46.1|Standard Deviation|10.2|10.2|||
4141935|NCT00878553|3966059|B4|||Age||years|Mean|47.5|47.5|Standard Deviation|9.47|9.47|||
4141936|NCT00878553|3966060|B3|||Age||years|Mean|42.5|42.5|Standard Deviation|11.95|11.95|||
4141937|NCT00878553|3966061|B2|||Age||years|Mean|47.1|47.1|Standard Deviation|9.23|9.23|||
4141938|NCT00878553|3966062|B1|||Age||years|Mean|47.3|47.3|Standard Deviation|9.94|9.94|||
4141939|NCT00878553|3966058|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4141940|NCT00878553|3966059|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4141941|NCT00878553|3966060|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4141942|NCT00878553|3966061|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4141943|NCT00878553|3966062|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4141944|NCT00878553|3966058|B5||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
4141945|NCT00878553|3966059|B4||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4141946|NCT00878553|3966060|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4141947|NCT00878553|3966061|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4141948|NCT00878553|3966062|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4141949|NCT00878553|3966058|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141950|NCT00878553|3966059|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141951|NCT00878553|3966060|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141952|NCT00878553|3966061|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141953|NCT00878553|3966062|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4141954|NCT00878501|3966122|B4||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4141955|NCT00878501|3966123|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4141956|NCT00878501|3966124|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4141957|NCT00878501|3966125|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4141958|NCT00878501|3966122|B4||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4141959|NCT00878501|3966123|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4141960|NCT00878501|3966124|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4141961|NCT00878501|3966125|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4141962|NCT00878501|3966122|B4|median and range||Age||Years|Median|62|62.0|Full Range|||40.0|79.0|
4141963|NCT00878501|3966123|B3|median and range||Age||Years|Median|61|61.0|Full Range|||40.0|79.0|
4141964|NCT00878501|3966124|B2|median and range||Age||Years|Median|61|61.0|Full Range|||40.0|79.0|
4141965|NCT00878501|3966125|B1|median and range||Age||Years|Median|62|62.0|Full Range|||40.0|79.0|
4141966|NCT00878436|3966144|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141967|NCT00878436|3966145|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141968|NCT00878436|3966146|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141969|NCT00878436|3966144|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141970|NCT00878436|3966145|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141971|NCT00878436|3966146|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141972|NCT00878436|3966144|B3||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4141973|NCT00878436|3966145|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4141974|NCT00878436|3966146|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4141975|NCT00878436|3966144|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4141976|NCT00878436|3966145|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4141977|NCT00878436|3966146|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4141978|NCT00878436|3966144|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141979|NCT00878436|3966145|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141980|NCT00878436|3966146|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141981|NCT00878436|3966144|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4141982|NCT00878436|3966145|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4141983|NCT00878436|3966146|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141984|NCT00878436|3966144|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141985|NCT00878436|3966145|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141986|NCT00878436|3966146|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4141987|NCT00878436|3966144|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4141988|NCT00878436|3966145|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4141989|NCT00878436|3966146|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4141990|NCT00878436|3966144|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4141991|NCT00878436|3966145|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4141992|NCT00878436|3966146|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4141993|NCT00878436|3966144|B3|||Age||years|Median|69|69.0|Full Range|||48.0|84.0|
4141994|NCT00878436|3966145|B2|||Age||years|Median|69|69.0|Full Range|||50.0|83.0|
4141995|NCT00878436|3966146|B1|||Age||years|Median|69|69.0|Full Range|||48.0|84.0|
4141996|NCT00878228|3966159|B3||Male|Sex: Female, Male|98 patients were enrolled in the study, but 22 were excluded for various reasons. The remaining 76 patients were analyzed for the study.|Participants|Count of Participants|39|39.0||||||
4141997|NCT00878228|3966160|B2||Male|Sex: Female, Male|98 patients were enrolled in the study, but 22 were excluded for various reasons. The remaining 76 patients were analyzed for the study.|Participants|Count of Participants|18|18.0||||||
4141998|NCT00878228|3966161|B1||Male|Sex: Female, Male|98 patients were enrolled in the study, but 22 were excluded for various reasons. The remaining 76 patients were analyzed for the study.|Participants|Count of Participants|21|21.0||||||
4141999|NCT00878228|3966159|B3||Female|Sex: Female, Male|98 patients were enrolled in the study, but 22 were excluded for various reasons. The remaining 76 patients were analyzed for the study.|Participants|Count of Participants|37|37.0||||||
4142000|NCT00878228|3966160|B2||Female|Sex: Female, Male|98 patients were enrolled in the study, but 22 were excluded for various reasons. The remaining 76 patients were analyzed for the study.|Participants|Count of Participants|19|19.0||||||
4142001|NCT00878228|3966161|B1||Female|Sex: Female, Male|98 patients were enrolled in the study, but 22 were excluded for various reasons. The remaining 76 patients were analyzed for the study.|Participants|Count of Participants|18|18.0||||||
4142002|NCT00878228|3966159|B3|||Age|98 patients were enrolled in the study, but 22 were excluded for various reasons. The remaining 76 patients were analyzed for the study.|years|Mean|39|39.0|Standard Deviation|13|13.0|||
4142003|NCT00878228|3966160|B2|||Age|98 patients were enrolled in the study, but 22 were excluded for various reasons. The remaining 76 patients were analyzed for the study.|years|Mean|37|37.0|Standard Deviation|11|11.0|||
4142004|NCT00878228|3966161|B1|||Age|98 patients were enrolled in the study, but 22 were excluded for various reasons. The remaining 76 patients were analyzed for the study.|years|Mean|42|42.0|Standard Deviation|14|14.0|||
4142005|NCT00878215|3966172|B5|United States||Region of Enrollment||participants|Number|40|40.0||||||
4142006|NCT00878215|3966175|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4142007|NCT00878215|3966176|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4142008|NCT00878215|3966172|B5||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4142009|NCT00878215|3966175|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4142010|NCT00878215|3966176|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4142011|NCT00878215|3966172|B5||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4142012|NCT00878215|3966175|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4142013|NCT00878215|3966176|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4142014|NCT00878215|3966172|B5|||Age||years|Median|59|59.0|Full Range|||25.0|81.0|
4142015|NCT00878215|3966175|B2|||Age||years|Median|58|58.0|Full Range|||25.0|78.0|
4142016|NCT00878215|3966176|B1|||Age||years|Median|60|60.0|Full Range|||36.0|81.0|
4142017|NCT00877929|3966189|B3|Drinks - no interference||Alcohol history||participants|Number|261|261.0||||||
4142018|NCT00877929|3966190|B2|Drinks - no interference||Alcohol history||participants|Number|136|136.0||||||
4142019|NCT00877929|3966191|B1|Drinks - no interference||Alcohol history||participants|Number|125|125.0||||||
4142020|NCT00877929|3966189|B3|Non drinker||Alcohol history||participants|Number|445|445.0||||||
4142021|NCT00877929|3966190|B2|Non drinker||Alcohol history||participants|Number|218|218.0||||||
4142022|NCT00877929|3966191|B1|Non drinker||Alcohol history||participants|Number|227|227.0||||||
4142023|NCT00877929|3966189|B3|Currently smokes||Smoking history||participants|Number|83|83.0||||||
4142024|NCT00877929|3966190|B2|Currently smokes||Smoking history||participants|Number|43|43.0||||||
4142025|NCT00877929|3966191|B1|Currently smokes||Smoking history||participants|Number|40|40.0||||||
4142026|NCT00877929|3966189|B3|Ex-smoker||Smoking history||participants|Number|180|180.0||||||
4142027|NCT00877929|3966190|B2|Ex-smoker||Smoking history||participants|Number|89|89.0||||||
4142028|NCT00877929|3966191|B1|Ex-smoker||Smoking history||participants|Number|91|91.0||||||
4142029|NCT00877929|3966189|B3|Never smoked||Smoking history||participants|Number|443|443.0||||||
4142030|NCT00877929|3966190|B2|Never smoked||Smoking history||participants|Number|222|222.0||||||
4142031|NCT00877929|3966191|B1|Never smoked||Smoking history||participants|Number|221|221.0||||||
4142032|NCT00877929|3966189|B3|>= 30 kg/square meter||Body Mass Index Class||participants|Number|406|406.0||||||
4142033|NCT00877929|3966190|B2|>= 30 kg/square meter||Body Mass Index Class||participants|Number|200|200.0||||||
4142034|NCT00877929|3966191|B1|>= 30 kg/square meter||Body Mass Index Class||participants|Number|206|206.0||||||
4142035|NCT00877929|3966189|B3|25 to <30 kg/square meter||Body Mass Index Class||participants|Number|237|237.0||||||
4142036|NCT00877929|3966190|B2|25 to <30 kg/square meter||Body Mass Index Class||participants|Number|123|123.0||||||
4142037|NCT00877929|3966191|B1|25 to <30 kg/square meter||Body Mass Index Class||participants|Number|114|114.0||||||
4142038|NCT00877929|3966189|B3|< 25 kg/square meter||Body Mass Index Class||participants|Number|63|63.0||||||
4142039|NCT00877929|3966190|B2|< 25 kg/square meter||Body Mass Index Class||participants|Number|31|31.0||||||
4142040|NCT00877929|3966191|B1|< 25 kg/square meter||Body Mass Index Class||participants|Number|32|32.0||||||
4142041|NCT00877929|3966189|B3|||Body Mass Index||kilogram / square meter|Mean|32.0|32.0|Standard Deviation|6.1|6.1|||
4142042|NCT00877929|3966190|B2|||Body Mass Index||kilogram / square meter|Mean|31.8|31.8|Standard Deviation|6.1|6.1|||
4142043|NCT00877929|3966191|B1|||Body Mass Index||kilogram / square meter|Mean|32.1|32.1|Standard Deviation|6.0|6.0|||
4142044|NCT00877929|3966189|B3|||Weight||kilogram|Mean|89.9|89.9|Standard Deviation|20.2|20.2|||
4142045|NCT00877929|3966190|B2|||Weight||kilogram|Mean|89.5|89.5|Standard Deviation|19.4|19.4|||
4142046|NCT00877929|3966191|B1|||Weight||kilogram|Mean|90.2|90.2|Standard Deviation|20.9|20.9|||
4142047|NCT00877929|3966189|B3|||Height||centimeter|Mean|167.4|167.4|Standard Deviation|10.6|10.6|||
4142048|NCT00877929|3966190|B2|||Height||centimeter|Mean|167.6|167.6|Standard Deviation|10.9|10.9|||
4142049|NCT00877929|3966191|B1|||Height||centimeter|Mean|167.1|167.1|Standard Deviation|10.3|10.3|||
4142050|NCT00877929|3966189|B3|Black||Race class||participants|Number|84|84.0||||||
4142051|NCT00877929|3966190|B2|Black||Race class||participants|Number|41|41.0||||||
4142052|NCT00877929|3966191|B1|Black||Race class||participants|Number|43|43.0||||||
4142053|NCT00877929|3966189|B3|Non-black||Race class||participants|Number|622|622.0||||||
4142054|NCT00877929|3966190|B2|Non-black||Race class||participants|Number|313|313.0||||||
4142055|NCT00877929|3966191|B1|Non-black||Race class||participants|Number|309|309.0||||||
4142056|NCT00877929|3966189|B3|South Africa||Region of Enrollment||participants|Number|105|105.0||||||
4142057|NCT00877929|3966190|B2|South Africa||Region of Enrollment||participants|Number|52|52.0||||||
4142058|NCT00877929|3966191|B1|South Africa||Region of Enrollment||participants|Number|53|53.0||||||
4142059|NCT00877929|3966189|B3|United States||Region of Enrollment||participants|Number|241|241.0||||||
4142060|NCT00877929|3966190|B2|United States||Region of Enrollment||participants|Number|121|121.0||||||
4142061|NCT00877929|3966191|B1|United States||Region of Enrollment||participants|Number|120|120.0||||||
4142062|NCT00877929|3966189|B3|Slovakia||Region of Enrollment||participants|Number|76|76.0||||||
4142063|NCT00877929|3966190|B2|Slovakia||Region of Enrollment||participants|Number|40|40.0||||||
4142064|NCT00877929|3966191|B1|Slovakia||Region of Enrollment||participants|Number|36|36.0||||||
4142065|NCT00877929|3966189|B3|Sweden||Region of Enrollment||participants|Number|21|21.0||||||
4142066|NCT00877929|3966190|B2|Sweden||Region of Enrollment||participants|Number|10|10.0||||||
4142067|NCT00877929|3966191|B1|Sweden||Region of Enrollment||participants|Number|11|11.0||||||
4142068|NCT00877929|3966189|B3|Republic of Korea||Region of Enrollment||participants|Number|20|20.0||||||
4142069|NCT00877929|3966190|B2|Republic of Korea||Region of Enrollment||participants|Number|11|11.0||||||
4142070|NCT00877929|3966191|B1|Republic of Korea||Region of Enrollment||participants|Number|9|9.0||||||
4142071|NCT00877929|3966189|B3|Argentina||Region of Enrollment||participants|Number|64|64.0||||||
4142072|NCT00877929|3966190|B2|Argentina||Region of Enrollment||participants|Number|31|31.0||||||
4142073|NCT00877929|3966191|B1|Argentina||Region of Enrollment||participants|Number|33|33.0||||||
4142074|NCT00877929|3966189|B3|Netherlands||Region of Enrollment||participants|Number|86|86.0||||||
4142075|NCT00877929|3966190|B2|Netherlands||Region of Enrollment||participants|Number|42|42.0||||||
4142076|NCT00877929|3966191|B1|Netherlands||Region of Enrollment||participants|Number|44|44.0||||||
4142077|NCT00877929|3966189|B3|Mexico||Region of Enrollment||participants|Number|56|56.0||||||
4142078|NCT00877929|3966190|B2|Mexico||Region of Enrollment||participants|Number|29|29.0||||||
4142079|NCT00877929|3966191|B1|Mexico||Region of Enrollment||participants|Number|27|27.0||||||
4142080|NCT00877929|3966189|B3|Spain||Region of Enrollment||participants|Number|37|37.0||||||
4142081|NCT00877929|3966190|B2|Spain||Region of Enrollment||participants|Number|18|18.0||||||
4142082|NCT00877929|3966191|B1|Spain||Region of Enrollment||participants|Number|19|19.0||||||
4142083|NCT00877929|3966189|B3|White||Race/Ethnicity, Customized||participants|Number|538|538.0||||||
4142084|NCT00877929|3966190|B2|White||Race/Ethnicity, Customized||participants|Number|268|268.0||||||
4142085|NCT00877929|3966191|B1|White||Race/Ethnicity, Customized||participants|Number|270|270.0||||||
4142086|NCT00877929|3966189|B3|Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4142087|NCT00877929|3966190|B2|Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4142088|NCT00877929|3966191|B1|Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4142089|NCT00877929|3966189|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|84|84.0||||||
4142090|NCT00877929|3966190|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4142091|NCT00877929|3966191|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4142092|NCT00877929|3966189|B3|Asian||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
4142093|NCT00877929|3966190|B2|Asian||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4142094|NCT00877929|3966191|B1|Asian||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4142095|NCT00877929|3966189|B3|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4142096|NCT00877929|3966190|B2|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4142097|NCT00877929|3966191|B1|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4142098|NCT00877929|3966189|B3||Male|Sex: Female, Male||Participants|Count of Participants|365|365.0||||||
4142099|NCT00877929|3966190|B2||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4142100|NCT00877929|3966191|B1||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4142101|NCT00877929|3966189|B3||Female|Sex: Female, Male||Participants|Count of Participants|341|341.0||||||
4142102|NCT00877929|3966190|B2||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4142103|NCT00877929|3966191|B1||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4142104|NCT00877929|3966189|B3|>= 65 years||Age, Customized||participants|Number|257|257.0||||||
4142105|NCT00877929|3966190|B2|>= 65 years||Age, Customized||participants|Number|119|119.0||||||
4142106|NCT00877929|3966191|B1|>= 65 years||Age, Customized||participants|Number|138|138.0||||||
4142107|NCT00877929|3966189|B3|< 65 years||Age, Customized||participants|Number|449|449.0||||||
4142108|NCT00877929|3966190|B2|< 65 years||Age, Customized||participants|Number|235|235.0||||||
4142109|NCT00877929|3966191|B1|< 65 years||Age, Customized||participants|Number|214|214.0||||||
4142110|NCT00877929|3966189|B3|||Age||years|Mean|60.5|60.5|Standard Deviation|10.1|10.1|||
4142111|NCT00877929|3966190|B2|||Age||years|Mean|60.5|60.5|Standard Deviation|9.7|9.7|||
4142112|NCT00877929|3966191|B1|||Age||years|Mean|60.5|60.5|Standard Deviation|10.4|10.4|||
4142113|NCT00877890|3966278|B3|SU+MET+TZD||Background Oral Antidiabetic Agent||participants|Number|6|6.0||||||
4142114|NCT00877890|3966279|B2|SU+MET+TZD||Background Oral Antidiabetic Agent||participants|Number|1|1.0||||||
4142115|NCT00877890|3966280|B1|SU+MET+TZD||Background Oral Antidiabetic Agent||participants|Number|5|5.0||||||
4142116|NCT00877890|3966278|B3|MET+TZD||Background Oral Antidiabetic Agent||participants|Number|22|22.0||||||
4142117|NCT00877890|3966279|B2|MET+TZD||Background Oral Antidiabetic Agent||participants|Number|9|9.0||||||
4142118|NCT00877890|3966280|B1|MET+TZD||Background Oral Antidiabetic Agent||participants|Number|13|13.0||||||
4142119|NCT00877890|3966278|B3|MET+SU||Background Oral Antidiabetic Agent||participants|Number|59|59.0||||||
4142120|NCT00877890|3966279|B2|MET+SU||Background Oral Antidiabetic Agent||participants|Number|25|25.0||||||
4142121|NCT00877890|3966280|B1|MET+SU||Background Oral Antidiabetic Agent||participants|Number|34|34.0||||||
4142122|NCT00877890|3966278|B3|Thiazolidinediones (TZD)||Background Oral Antidiabetic Agent||participants|Number|6|6.0||||||
4142123|NCT00877890|3966279|B2|Thiazolidinediones (TZD)||Background Oral Antidiabetic Agent||participants|Number|2|2.0||||||
4142124|NCT00877890|3966280|B1|Thiazolidinediones (TZD)||Background Oral Antidiabetic Agent||participants|Number|4|4.0||||||
4142125|NCT00877890|3966278|B3|Sulfonylurea (SU)||Background Oral Antidiabetic Agent||participants|Number|9|9.0||||||
4142126|NCT00877890|3966279|B2|Sulfonylurea (SU)||Background Oral Antidiabetic Agent||participants|Number|8|8.0||||||
4142127|NCT00877890|3966280|B1|Sulfonylurea (SU)||Background Oral Antidiabetic Agent||participants|Number|1|1.0||||||
4142128|NCT00877890|3966278|B3|Metformin (MET)||Background Oral Antidiabetic Agent||participants|Number|103|103.0||||||
4142129|NCT00877890|3966279|B2|Metformin (MET)||Background Oral Antidiabetic Agent||participants|Number|52|52.0||||||
4142130|NCT00877890|3966280|B1|Metformin (MET)||Background Oral Antidiabetic Agent||participants|Number|51|51.0||||||
4142131|NCT00877890|3966278|B3|Diet and Exercise||Background Oral Antidiabetic Agent||participants|Number|47|47.0||||||
4142132|NCT00877890|3966279|B2|Diet and Exercise||Background Oral Antidiabetic Agent||participants|Number|26|26.0||||||
4142133|NCT00877890|3966280|B1|Diet and Exercise||Background Oral Antidiabetic Agent||participants|Number|21|21.0||||||
4142134|NCT00877890|3966278|B3|||Weight||kg|Mean|95.7|95.7|Standard Deviation|19.85|19.85|||
4142135|NCT00877890|3966279|B2|||Weight||kg|Mean|94.3|94.3|Standard Deviation|18.94|18.94|||
4142136|NCT00877890|3966280|B1|||Weight||kg|Mean|97.0|97.0|Standard Deviation|20.66|20.66|||
4142137|NCT00877890|3966278|B3|||Glycosylated hemoglobin (HbA1c)||percentage of total hemoglobin|Mean|8.4|8.4|Standard Deviation|1.16|1.16|||
4142138|NCT00877890|3966279|B2|||Glycosylated hemoglobin (HbA1c)||percentage of total hemoglobin|Mean|8.4|8.4|Standard Deviation|1.23|1.23|||
4142139|NCT00877890|3966280|B1|||Glycosylated hemoglobin (HbA1c)||percentage of total hemoglobin|Mean|8.5|8.5|Standard Deviation|1.10|1.1|||
4142140|NCT00877890|3966278|B3||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4142141|NCT00877890|3966279|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4142142|NCT00877890|3966280|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4142143|NCT00877890|3966278|B3||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4142144|NCT00877890|3966279|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4142145|NCT00877890|3966280|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4142146|NCT00877890|3966278|B3|||Age||years|Mean|55.7|55.7|Standard Deviation|10.71|10.71|||
4142147|NCT00877890|3966279|B2|||Age||years|Mean|55.2|55.2|Standard Deviation|10.27|10.27|||
4142148|NCT00877890|3966280|B1|||Age||years|Mean|56.1|56.1|Standard Deviation|11.14|11.14|||
4142149|NCT00877890|3966278|B3||>=65 years|Age||Participants|Count of Participants|47|47.0||||||
4142150|NCT00877890|3966279|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4142151|NCT00877890|3966280|B1||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4142152|NCT00877890|3966278|B3||Between 18 and 65 years|Age||Participants|Count of Participants|205|205.0||||||
4142153|NCT00877890|3966279|B2||Between 18 and 65 years|Age||Participants|Count of Participants|102|102.0||||||
4142154|NCT00877890|3966280|B1||Between 18 and 65 years|Age||Participants|Count of Participants|103|103.0||||||
4142155|NCT00877890|3966278|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142156|NCT00877890|3966279|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142157|NCT00877890|3966280|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142158|NCT00877877|3966315|B1|Male||Gender|Year 10 cohort|Participants|Number|0|0.0||||||
4142159|NCT00877877|3966315|B1|Female||Gender|Year 10 cohort|Participants|Number|495|495.0||||||
4142160|NCT00877877|3966315|B1|Male||Gender|Year 9 cohort|Participants|Number|0|0.0||||||
4142161|NCT00877877|3966315|B1|Female||Gender|Year 9 cohort|Participants|Number|507|507.0||||||
4142162|NCT00877877|3966315|B1|Male||Gender|Year 8 cohort|Participants|Number|0|0.0||||||
4142163|NCT00877877|3966315|B1|Female||Gender|Year 8 cohort|Participants|Number|522|522.0||||||
4142164|NCT00877877|3966315|B1|Male||Gender|Year 7 cohort|Participants|Number|0|0.0||||||
4142165|NCT00877877|3966315|B1|Female||Gender|Year 7 cohort|Participants|Number|523|523.0||||||
4142166|NCT00877877|3966315|B1||Male|Sex: Female, Male|Year 6 cohort|Participants|Count of Participants|0|0.0||||||
4142167|NCT00877877|3966315|B1||Female|Sex: Female, Male|Year 6 cohort|Participants|Count of Participants|529|529.0||||||
4142168|NCT00877877|3966315|B1|Male||Gender|Year 5 cohort|Participants|Number|0|0.0||||||
4142169|NCT00877877|3966315|B1|Female||Gender|Year 5 cohort|Participants|Number|397|397.0||||||
4142170|NCT00877877|3966315|B1|Year 10||Age||Years|Mean|22.0|22.0|Standard Deviation|1.40|1.4|||
4142171|NCT00877877|3966315|B1|Year 9||Age||Years|Mean|21.1|21.1|Standard Deviation|1.42|1.42|||
4142172|NCT00877877|3966315|B1|Year 8||Age||Years|Mean|20.0|20.0|Standard Deviation|1.40|1.4|||
4142173|NCT00877877|3966315|B1|Year 7||Age||Years|Mean|19.0|19.0|Standard Deviation|1.39|1.39|||
4142174|NCT00877877|3966315|B1|Year 6||Age||Years|Mean|18.0|18.0|Standard Deviation|1.40|1.4|||
4142175|NCT00877877|3966315|B1|Year 5||Age||Years|Mean|17.1|17.1|Standard Deviation|1.40|1.4|||
4142176|NCT00877799|3966341|B6|United States||Region of Enrollment||participants|Number|114|114.0||||||
4142177|NCT00877799|3966342|B5|United States||Region of Enrollment||participants|Number|20|20.0||||||
4142178|NCT00877799|3966343|B4|United States||Region of Enrollment||participants|Number|26|26.0||||||
4142179|NCT00877799|3966344|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4142180|NCT00877799|3966345|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4142181|NCT00877799|3966346|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4142182|NCT00877799|3966341|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4142183|NCT00877799|3966342|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4142184|NCT00877799|3966343|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4142185|NCT00877799|3966344|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4142186|NCT00877799|3966345|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4142187|NCT00877799|3966346|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4142188|NCT00877799|3966341|B6||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4142189|NCT00877799|3966342|B5||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4142190|NCT00877799|3966343|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4142191|NCT00877799|3966344|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4142192|NCT00877799|3966345|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4142193|NCT00877799|3966346|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4142194|NCT00877799|3966341|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4142195|NCT00877799|3966342|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4142196|NCT00877799|3966343|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4142197|NCT00877799|3966344|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4142198|NCT00877799|3966345|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4142199|NCT00877799|3966346|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4142200|NCT00877799|3966341|B6||Between 18 and 65 years|Age||Participants|Count of Participants|114|114.0||||||
4142201|NCT00877799|3966342|B5||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4142202|NCT00877799|3966343|B4||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4142203|NCT00877799|3966344|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4142204|NCT00877799|3966345|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4142205|NCT00877799|3966346|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4142206|NCT00877799|3966341|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142207|NCT00877799|3966342|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142208|NCT00877799|3966343|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142209|NCT00877799|3966344|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142210|NCT00877799|3966345|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142211|NCT00877799|3966346|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142212|NCT00877773|3966365|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4142213|NCT00877773|3966365|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4142214|NCT00877773|3966365|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4142215|NCT00877773|3966365|B1|||Age||years|Median|57|57.0|Full Range|||16.0|73.0|
4142216|NCT00877604|3966369|B3|Italy||Region of Enrollment||participants|Number|34|34.0||||||
4142217|NCT00877604|3966370|B2|Italy||Region of Enrollment||participants|Number|17|17.0||||||
4142218|NCT00877604|3966371|B1|Italy||Region of Enrollment||participants|Number|17|17.0||||||
4142219|NCT00877604|3966369|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4142220|NCT00877604|3966370|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4142221|NCT00877604|3966371|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4142222|NCT00877604|3966369|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4142223|NCT00877604|3966370|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4142224|NCT00877604|3966371|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4142225|NCT00877604|3966369|B3|||Age||years|Mean|56.1|56.1|Standard Deviation|12.3|12.3|||
4142226|NCT00877604|3966370|B2|||Age||years|Mean|58.2|58.2|Standard Deviation|12.9|12.9|||
4142227|NCT00877604|3966371|B1|||Age||years|Mean|54.0|54.0|Standard Deviation|12.2|12.2|||
4142228|NCT00877487|3966378|B1|United States||Region of Enrollment||participants|Number|122|122.0||||||
4142229|NCT00877487|3966378|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4142230|NCT00877487|3966378|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4142231|NCT00877487|3966378|B1|Between 18 and 55 years||Age, Customized|The demographics are based on the safety population defined as all subjects who entered the open-label treatment phase and took at least 1 dose of investigational product (SPD489). 123 subjects enrolled into the study, but 1 subject withdrew prior to receiving a dose of investigational product in the open-label treatment phase. Therefore, 122 subjects are in the safety population.|participants|Number|122|122.0||||||
4142232|NCT00877487|3966378|B1|||Age||years|Mean|35.4|35.4|Standard Deviation|11.16|11.16|||
4142233|NCT00877448|3966389|B8|Israel||Region of Enrollment||participants|Number|63|63.0||||||
4142234|NCT00877448|3966390|B7|Israel||Region of Enrollment||participants|Number|3|3.0||||||
4142235|NCT00877448|3966391|B6|Israel||Region of Enrollment||participants|Number|10|10.0||||||
4142236|NCT00877448|3966392|B5|Israel||Region of Enrollment||participants|Number|10|10.0||||||
4142237|NCT00877448|3966393|B4|Israel||Region of Enrollment||participants|Number|10|10.0||||||
4142238|NCT00877448|3966394|B3|Israel||Region of Enrollment||participants|Number|10|10.0||||||
4142239|NCT00877448|3966395|B2|Israel||Region of Enrollment||participants|Number|10|10.0||||||
4142240|NCT00877448|3966396|B1|Israel||Region of Enrollment||participants|Number|10|10.0||||||
4142241|NCT00877448|3966389|B8||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4142242|NCT00877448|3966390|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4142243|NCT00877448|3966391|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4142244|NCT00877448|3966392|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4142245|NCT00877448|3966393|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4142246|NCT00877448|3966394|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4142247|NCT00877448|3966395|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4142248|NCT00877448|3966396|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4142249|NCT00877448|3966389|B8||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4142250|NCT00877448|3966390|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4142251|NCT00877448|3966391|B6||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4142252|NCT00877448|3966392|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4142253|NCT00877448|3966393|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4142254|NCT00877448|3966394|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4142255|NCT00877448|3966395|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4142256|NCT00877448|3966396|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4142257|NCT00877448|3966389|B8|||Age||years|Mean|25.9|25.9|Standard Deviation|6.4|6.4|||
4142258|NCT00877448|3966390|B7|||Age||years|Mean|25.7|25.7|Standard Deviation|3.3|3.3|||
4142259|NCT00877448|3966391|B6|||Age||years|Mean|25.2|25.2|Standard Deviation|4.5|4.5|||
4142260|NCT00877448|3966392|B5|||Age||years|Mean|29.0|29.0|Standard Deviation|7.4|7.4|||
4142261|NCT00877448|3966393|B4|||Age||years|Mean|26.0|26.0|Standard Deviation|8.4|8.4|||
4142262|NCT00877448|3966394|B3|||Age||years|Mean|25.2|25.2|Standard Deviation|5.3|5.3|||
4142263|NCT00877448|3966395|B2|||Age||years|Mean|25.8|25.8|Standard Deviation|8.8|8.8|||
4142264|NCT00877448|3966396|B1|||Age||years|Mean|24.3|24.3|Standard Deviation|4.0|4.0|||
4142265|NCT00877448|3966389|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4142266|NCT00877448|3966390|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4142267|NCT00877448|3966391|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4142268|NCT00877448|3966392|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4142269|NCT00877448|3966393|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4142270|NCT00877448|3966394|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4142271|NCT00877448|3966395|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4142272|NCT00877448|3966396|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4142273|NCT00877448|3966389|B8||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4142274|NCT00877448|3966390|B7||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4142275|NCT00877448|3966391|B6||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4142276|NCT00877448|3966392|B5||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4142277|NCT00877448|3966393|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4142278|NCT00877448|3966394|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4142279|NCT00877448|3966395|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4142280|NCT00877448|3966396|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4142281|NCT00877448|3966389|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142282|NCT00877448|3966390|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142283|NCT00877448|3966391|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142284|NCT00877448|3966392|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142285|NCT00877448|3966393|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142286|NCT00877448|3966394|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142287|NCT00877448|3966395|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142288|NCT00877448|3966396|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142289|NCT00877383|3966425|B3||Male|Sex: Female, Male||Participants|Count of Participants|747|747.0||||||
4142290|NCT00877383|3966426|B2||Male|Sex: Female, Male||Participants|Count of Participants|387|387.0||||||
4142291|NCT00877383|3966427|B1||Male|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
4142292|NCT00877383|3966425|B3||Female|Sex: Female, Male||Participants|Count of Participants|395|395.0||||||
4142293|NCT00877383|3966426|B2||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4142294|NCT00877383|3966427|B1||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4142295|NCT00877383|3966425|B3|||Age||years|Mean|62.9|62.9|Standard Deviation|8.90|8.9|||
4142296|NCT00877383|3966426|B2|||Age||years|Mean|62.8|62.8|Standard Deviation|8.98|8.98|||
4142297|NCT00877383|3966427|B1|||Age||years|Mean|63.1|63.1|Standard Deviation|8.83|8.83|||
4142298|NCT00877370|3966444|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4142299|NCT00877370|3966444|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4142300|NCT00877370|3966444|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4142301|NCT00877370|3966444|B1|||Age||years|Mean|62|62.0|Standard Deviation|16|16.0|||
4142302|NCT00877370|3966444|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4142303|NCT00877370|3966444|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4142304|NCT00877370|3966444|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142305|NCT00877071|3966448|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4142306|NCT00877071|3966448|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4142307|NCT00877071|3966448|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4142308|NCT00877071|3966448|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4142309|NCT00877071|3966448|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4142310|NCT00877071|3966448|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142311|NCT00877058|3966455|B4|Sweden||Region of Enrollment||participants|Number|459|459.0||||||
4142312|NCT00877058|3966456|B3|Sweden||Region of Enrollment||participants|Number|114|114.0||||||
4142313|NCT00877058|3966457|B2|Sweden||Region of Enrollment||participants|Number|171|171.0||||||
4142314|NCT00877058|3966458|B1|Sweden||Region of Enrollment||participants|Number|174|174.0||||||
4142315|NCT00877058|3966455|B4||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4142316|NCT00877058|3966456|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4142317|NCT00877058|3966457|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4142318|NCT00877058|3966458|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4142319|NCT00877058|3966455|B4||Female|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
4142320|NCT00877058|3966456|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4142321|NCT00877058|3966457|B2||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4142322|NCT00877058|3966458|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4142323|NCT00877058|3966455|B4|≥80 years||Age||years|Median|86|86.0|Inter-Quartile Range|||80.0|97.0|
4142324|NCT00877058|3966456|B3|≥80 years||Age||years|Median|86|86.0|Inter-Quartile Range|||80.0|97.0|
4142325|NCT00877058|3966457|B2|≥80 years||Age||years|Median|85|85.0|Inter-Quartile Range|||80.0|94.0|
4142326|NCT00877058|3966458|B1|≥80 years||Age||years|Median|86|86.0|Inter-Quartile Range|||80.0|97.0|
4142327|NCT00877058|3966455|B4||>=65 years|Age||Participants|Count of Participants|459|459.0||||||
4142328|NCT00877058|3966456|B3||>=65 years|Age||Participants|Count of Participants|114|114.0||||||
4142329|NCT00877058|3966457|B2||>=65 years|Age||Participants|Count of Participants|171|171.0||||||
4142330|NCT00877058|3966458|B1||>=65 years|Age||Participants|Count of Participants|174|174.0||||||
4142331|NCT00877058|3966455|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4142332|NCT00877058|3966456|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4142333|NCT00877058|3966457|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4142334|NCT00877058|3966458|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4142335|NCT00877058|3966455|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142336|NCT00877058|3966456|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142337|NCT00877058|3966457|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142338|NCT00877058|3966458|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142339|NCT00877032|3966474|B8||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4142340|NCT00877032|3966475|B7||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4142341|NCT00877032|3966476|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4142342|NCT00877032|3966477|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4142343|NCT00877032|3966478|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4142344|NCT00877032|3966479|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4142345|NCT00877032|3966480|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4142346|NCT00877032|3966481|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4142347|NCT00877032|3966474|B8||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4142348|NCT00877032|3966475|B7||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4142349|NCT00877032|3966476|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4142350|NCT00877032|3966477|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4142351|NCT00877032|3966478|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4142352|NCT00877032|3966479|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4142353|NCT00877032|3966480|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4142354|NCT00877032|3966481|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4142355|NCT00877032|3966474|B8|||Age||years|Mean|67.6|67.6|Standard Deviation|8.1|8.1|||
4142356|NCT00877032|3966475|B7|||Age||years|Mean|67.4|67.4|Standard Deviation|8.2|8.2|||
4142357|NCT00877032|3966476|B6|||Age||years|Mean|65.0|65.0|Standard Deviation|6.5|6.5|||
4142358|NCT00877032|3966477|B5|||Age||years|Mean|67.8|67.8|Standard Deviation|7.5|7.5|||
4142359|NCT00877032|3966478|B4|||Age||years|Mean|69.2|69.2|Standard Deviation|3.7|3.7|||
4142360|NCT00877032|3966479|B3|||Age||years|Mean|65.5|65.5|Standard Deviation|10.4|10.4|||
4142361|NCT00877032|3966480|B2|||Age||years|Mean|70.2|70.2|Standard Deviation|9.9|9.9|||
4142362|NCT00877032|3966481|B1|||Age||years|Mean|68.2|68.2|Standard Deviation|11.1|11.1|||
4142363|NCT00877006|3966586|B3|||Weight|one participant in the R-CHOP/R-CVP group did not a a weight measurement at baseline|kg|Mean|82.1|82.1|Standard Deviation|18.19|18.19|||
4142364|NCT00877006|3966587|B2|||Weight|one participant in the R-CHOP/R-CVP group did not a a weight measurement at baseline|kg|Mean|82.4|82.4|Standard Deviation|17.93|17.93|||
4142365|NCT00877006|3966588|B1|||Weight|one participant in the R-CHOP/R-CVP group did not a a weight measurement at baseline|kg|Mean|81.9|81.9|Standard Deviation|18.48|18.48|||
4142366|NCT00877006|3966586|B3|4||European Cooperative Oncology Group Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead. 1 participant in the R-CHOP/R-CVP treatment group did not have an assessment at baseline.|participants|Number|0|0.0||||||
4142367|NCT00877006|3966587|B2|4||European Cooperative Oncology Group Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead. 1 participant in the R-CHOP/R-CVP treatment group did not have an assessment at baseline.|participants|Number|0|0.0||||||
4142368|NCT00877006|3966588|B1|4||European Cooperative Oncology Group Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead. 1 participant in the R-CHOP/R-CVP treatment group did not have an assessment at baseline.|participants|Number|0|0.0||||||
4142369|NCT00877006|3966586|B3|3||European Cooperative Oncology Group Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead. 1 participant in the R-CHOP/R-CVP treatment group did not have an assessment at baseline.|participants|Number|1|1.0||||||
4142370|NCT00877006|3966587|B2|3||European Cooperative Oncology Group Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead. 1 participant in the R-CHOP/R-CVP treatment group did not have an assessment at baseline.|participants|Number|0|0.0||||||
4142371|NCT00877006|3966588|B1|3||European Cooperative Oncology Group Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead. 1 participant in the R-CHOP/R-CVP treatment group did not have an assessment at baseline.|participants|Number|1|1.0||||||
4142372|NCT00877006|3966586|B3|2||European Cooperative Oncology Group Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead. 1 participant in the R-CHOP/R-CVP treatment group did not have an assessment at baseline.|participants|Number|19|19.0||||||
4142373|NCT00877006|3966587|B2|2||European Cooperative Oncology Group Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead. 1 participant in the R-CHOP/R-CVP treatment group did not have an assessment at baseline.|participants|Number|10|10.0||||||
4142374|NCT00877006|3966588|B1|2||European Cooperative Oncology Group Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead. 1 participant in the R-CHOP/R-CVP treatment group did not have an assessment at baseline.|participants|Number|9|9.0||||||
4142375|NCT00877006|3966586|B3|1||European Cooperative Oncology Group Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead. 1 participant in the R-CHOP/R-CVP treatment group did not have an assessment at baseline.|participants|Number|139|139.0||||||
4142376|NCT00877006|3966587|B2|1||European Cooperative Oncology Group Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead. 1 participant in the R-CHOP/R-CVP treatment group did not have an assessment at baseline.|participants|Number|69|69.0||||||
4142426|NCT00876915|3966641|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142427|NCT00876915|3966638|B4||White|Race (NIH/OMB)||Participants|Count of Participants|166|166.0||||||
4142377|NCT00877006|3966588|B1|1||European Cooperative Oncology Group Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead. 1 participant in the R-CHOP/R-CVP treatment group did not have an assessment at baseline.|participants|Number|70|70.0||||||
4142378|NCT00877006|3966586|B3|0||European Cooperative Oncology Group Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead. 1 participant in the R-CHOP/R-CVP treatment group did not have an assessment at baseline.|participants|Number|287|287.0||||||
4142379|NCT00877006|3966587|B2|0||European Cooperative Oncology Group Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead. 1 participant in the R-CHOP/R-CVP treatment group did not have an assessment at baseline.|participants|Number|143|143.0||||||
4142380|NCT00877006|3966588|B1|0||European Cooperative Oncology Group Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead. 1 participant in the R-CHOP/R-CVP treatment group did not have an assessment at baseline.|participants|Number|144|144.0||||||
4142381|NCT00877006|3966586|B3||Male|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
4142382|NCT00877006|3966587|B2||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4142383|NCT00877006|3966588|B1||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4142384|NCT00877006|3966586|B3||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4142385|NCT00877006|3966587|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4142386|NCT00877006|3966588|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4142387|NCT00877006|3966586|B3|||Age||years|Mean|59.1|59.1|Standard Deviation|11.77|11.77|||
4142388|NCT00877006|3966587|B2|||Age||years|Mean|58.2|58.2|Standard Deviation|12.11|12.11|||
4142389|NCT00877006|3966588|B1|||Age||years|Mean|60.0|60.0|Standard Deviation|11.37|11.37|||
4142390|NCT00876928|3966627|B3|United States||Region of Enrollment||participants|Number|117|117.0||||||
4142391|NCT00876928|3966628|B2|United States||Region of Enrollment||participants|Number|61|61.0||||||
4142392|NCT00876928|3966629|B1|United States||Region of Enrollment||participants|Number|56|56.0||||||
4142393|NCT00876928|3966627|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4142394|NCT00876928|3966628|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4142395|NCT00876928|3966629|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4142396|NCT00876928|3966627|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4142397|NCT00876928|3966628|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4142398|NCT00876928|3966629|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4142399|NCT00876928|3966627|B3|||Age||Years|Mean|52.4|52.4|Standard Deviation|7.5|7.5|||
4142400|NCT00876928|3966628|B2|||Age||Years|Mean|52.3|52.3|Standard Deviation|8.0|8.0|||
4142401|NCT00876928|3966629|B1|||Age||Years|Mean|52.5|52.5|Standard Deviation|7.0|7.0|||
4142402|NCT00876928|3966627|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4142403|NCT00876928|3966628|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4142404|NCT00876928|3966629|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4142405|NCT00876928|3966627|B3||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
4142406|NCT00876928|3966628|B2||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4142407|NCT00876928|3966629|B1||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4142408|NCT00876928|3966627|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142409|NCT00876928|3966628|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142410|NCT00876928|3966629|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142411|NCT00876915|3966638|B4|United States||Region of Enrollment||participants|Number|192|192.0||||||
4142412|NCT00876915|3966639|B3|United States||Region of Enrollment||participants|Number|101|101.0||||||
4142413|NCT00876915|3966640|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
4142414|NCT00876915|3966641|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4142415|NCT00876915|3966638|B4|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4142416|NCT00876915|3966639|B3|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4142417|NCT00876915|3966640|B2|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4142418|NCT00876915|3966641|B1|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4142419|NCT00876915|3966638|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142420|NCT00876915|3966639|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142421|NCT00876915|3966640|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142422|NCT00876915|3966641|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142423|NCT00876915|3966638|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142424|NCT00876915|3966639|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142425|NCT00876915|3966640|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142428|NCT00876915|3966639|B3||White|Race (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
4142429|NCT00876915|3966640|B2||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4142430|NCT00876915|3966641|B1||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4142431|NCT00876915|3966638|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4142432|NCT00876915|3966639|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4142433|NCT00876915|3966640|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4142434|NCT00876915|3966641|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4142435|NCT00876915|3966638|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4142436|NCT00876915|3966639|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142437|NCT00876915|3966640|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4142438|NCT00876915|3966641|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4142439|NCT00876915|3966638|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4142440|NCT00876915|3966639|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4142441|NCT00876915|3966640|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142442|NCT00876915|3966641|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4142443|NCT00876915|3966638|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4142444|NCT00876915|3966639|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142445|NCT00876915|3966640|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4142446|NCT00876915|3966641|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4142447|NCT00876915|3966638|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4142448|NCT00876915|3966639|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4142449|NCT00876915|3966640|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142450|NCT00876915|3966641|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142451|NCT00876915|3966638|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|189|189.0||||||
4142452|NCT00876915|3966639|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4142453|NCT00876915|3966640|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4142454|NCT00876915|3966641|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4142455|NCT00876915|3966638|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4142456|NCT00876915|3966639|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4142457|NCT00876915|3966640|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4142458|NCT00876915|3966641|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4142459|NCT00876915|3966638|B4||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4142460|NCT00876915|3966639|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4142461|NCT00876915|3966640|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4142462|NCT00876915|3966641|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4142463|NCT00876915|3966638|B4||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4142464|NCT00876915|3966639|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4142465|NCT00876915|3966640|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4142466|NCT00876915|3966641|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4142467|NCT00876915|3966638|B4|||Age||years|Mean|58|58.0|Standard Deviation|12|12.0|||
4142468|NCT00876915|3966639|B3|||Age||years|Mean|58|58.0|Standard Deviation|13|13.0|||
4142469|NCT00876915|3966640|B2|||Age||years|Mean|58|58.0|Standard Deviation|12|12.0|||
4142470|NCT00876915|3966641|B1|||Age||years|Mean|60|60.0|Standard Deviation|10|10.0|||
4142471|NCT00876915|3966638|B4||>=65 years|Age||Participants|Count of Participants|56|56.0||||||
4142472|NCT00876915|3966639|B3||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4142473|NCT00876915|3966640|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4142474|NCT00876915|3966641|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4142475|NCT00876915|3966638|B4||Between 18 and 65 years|Age||Participants|Count of Participants|143|143.0||||||
4142476|NCT00876915|3966639|B3||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
4142477|NCT00876915|3966640|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4142478|NCT00876915|3966641|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4142479|NCT00876915|3966638|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142480|NCT00876915|3966639|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142481|NCT00876915|3966640|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142482|NCT00876915|3966641|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142483|NCT00876733|3966663|B5||Male|Sex: Female, Male||Participants|Count of Participants|538|538.0||||||
4142484|NCT00876733|3966664|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4142485|NCT00876733|3966665|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4142486|NCT00876733|3966666|B2||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4142487|NCT00876733|3966667|B1||Male|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
4142488|NCT00876733|3966663|B5||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4142489|NCT00876733|3966664|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4142490|NCT00876733|3966665|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4142491|NCT00876733|3966666|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4142492|NCT00876733|3966667|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4142493|NCT00876733|3966663|B5|||Age||years|Mean|41.6|41.6|Standard Deviation|9.8|9.8|||
4142494|NCT00876733|3966664|B4|||Age||years|Mean|43.6|43.6|Standard Deviation|7.8|7.8|||
4142495|NCT00876733|3966665|B3|||Age||years|Mean|40.9|40.9|Standard Deviation|9.4|9.4|||
4142496|NCT00876733|3966666|B2|||Age||years|Mean|43.8|43.8|Standard Deviation|9.6|9.6|||
4142497|NCT00876733|3966667|B1|||Age||years|Mean|40.2|40.2|Standard Deviation|9.9|9.9|||
4142498|NCT00876694|3966776|B3||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4142499|NCT00876694|3966777|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4142500|NCT00876694|3966778|B1||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4142501|NCT00876694|3966776|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4142502|NCT00876694|3966777|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4142503|NCT00876694|3966778|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4142504|NCT00876694|3966776|B3|||Age||years|Mean|69.1|69.1|Standard Deviation|7.97|7.97|||
4142505|NCT00876694|3966777|B2|||Age||years|Mean|67.3|67.3|Standard Deviation|8.05|8.05|||
4142506|NCT00876694|3966778|B1|||Age||years|Mean|70|70.0|Standard Deviation|7.81|7.81|||
4142507|NCT00876460|3966797|B9||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4142508|NCT00876460|3966798|B8||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4142509|NCT00876460|3966799|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4142510|NCT00876460|3966800|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4142511|NCT00876460|3966801|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4142512|NCT00876460|3966802|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4142513|NCT00876460|3966803|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4142514|NCT00876460|3966804|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4142515|NCT00876460|3966805|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4142516|NCT00876460|3966797|B9||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4142517|NCT00876460|3966798|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4142518|NCT00876460|3966799|B7||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4142519|NCT00876460|3966800|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4142520|NCT00876460|3966801|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4142521|NCT00876460|3966802|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4142522|NCT00876460|3966803|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4142523|NCT00876460|3966804|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4142524|NCT00876460|3966805|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4142525|NCT00876460|3966797|B9|||Age||years|Median|63.5|63.5|Full Range|||45.0|73.0|
4142526|NCT00876460|3966798|B8|||Age||years|Median|61.5|61.5|Full Range|||51.0|72.0|
4142527|NCT00876460|3966799|B7|||Age||years|Median|64.0|64.0|Full Range|||47.0|72.0|
4142528|NCT00876460|3966800|B6|||Age||years|Median|62.0|62.0|Full Range|||58.0|72.0|
4142529|NCT00876460|3966801|B5|||Age||years|Median|63.0|63.0|Full Range|||60.0|73.0|
4142530|NCT00876460|3966802|B4|||Age||years|Median|65.0|65.0|Full Range|||45.0|70.0|
4142531|NCT00876460|3966803|B3|||Age||years|Median|64.0|64.0|Full Range|||60.0|69.0|
4142532|NCT00876460|3966804|B2|||Age||years|Median|68.0|68.0|Full Range|||59.0|71.0|
4142533|NCT00876460|3966805|B1|||Age||years|Median|58.0|58.0|Full Range|||49.0|58.0|
4142534|NCT00876447|3966882|B3||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4142535|NCT00876447|3966883|B2||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4142536|NCT00876447|3966884|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4142537|NCT00876447|3966882|B3||Female|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
4142538|NCT00876447|3966883|B2||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4142539|NCT00876447|3966884|B1||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4142540|NCT00876447|3966882|B3|≥75 years||Age, Customized||Participants|Number|1|1.0||||||
4142541|NCT00876447|3966883|B2|≥75 years||Age, Customized||Participants|Number|1|1.0||||||
4142542|NCT00876447|3966884|B1|≥75 years||Age, Customized||Participants|Number|0|0.0||||||
4142543|NCT00876447|3966882|B3|≥65 to 74 years||Age, Customized||Participants|Number|24|24.0||||||
4142544|NCT00876447|3966883|B2|≥65 to 74 years||Age, Customized||Participants|Number|10|10.0||||||
4142545|NCT00876447|3966884|B1|≥65 to 74 years||Age, Customized||Participants|Number|14|14.0||||||
4142546|NCT00876447|3966882|B3|≥40 to 64 years||Age, Customized||Participants|Number|251|251.0||||||
4142547|NCT00876447|3966883|B2|≥40 to 64 years||Age, Customized||Participants|Number|135|135.0||||||
4142548|NCT00876447|3966884|B1|≥40 to 64 years||Age, Customized||Participants|Number|116|116.0||||||
4142549|NCT00876447|3966882|B3|<40 years||Age, Customized||Participants|Number|112|112.0||||||
4142550|NCT00876447|3966883|B2|<40 years||Age, Customized||Participants|Number|57|57.0||||||
4142551|NCT00876447|3966884|B1|<40 years||Age, Customized||Participants|Number|55|55.0||||||
4142552|NCT00876395|3966943|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|64|64.0||||||
4142553|NCT00876395|3966944|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
4142554|NCT00876395|3966945|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
4142555|NCT00876395|3966943|B3|Native American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4142556|NCT00876395|3966944|B2|Native American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4142557|NCT00876395|3966945|B1|Native American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4142558|NCT00876395|3966943|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|303|303.0||||||
4142559|NCT00876395|3966944|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|105|105.0||||||
4142560|NCT00876395|3966945|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|198|198.0||||||
4142561|NCT00876395|3966943|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
4142562|NCT00876395|3966944|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4142563|NCT00876395|3966945|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
4142564|NCT00876395|3966943|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|311|311.0||||||
4142565|NCT00876395|3966944|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|97|97.0||||||
4142566|NCT00876395|3966945|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|214|214.0||||||
4142567|NCT00876395|3966943|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4142568|NCT00876395|3966944|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4142569|NCT00876395|3966945|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4142570|NCT00876395|3966943|B3||Female|Sex: Female, Male||Participants|Count of Participants|719|719.0||||||
4142571|NCT00876395|3966944|B2||Female|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
4142572|NCT00876395|3966945|B1||Female|Sex: Female, Male||Participants|Count of Participants|480|480.0||||||
4142573|NCT00876395|3966943|B3|||Age||Years|Mean|53.0|53.0|Standard Deviation|11.53|11.53|||
4142574|NCT00876395|3966944|B2|||Age||Years|Mean|52.1|52.1|Standard Deviation|11.63|11.63|||
4142575|NCT00876395|3966945|B1|||Age||Years|Mean|53.4|53.4|Standard Deviation|11.46|11.46|||
4142576|NCT00876343|3966984|B4|Japan||Region of Enrollment||participants|Number|586|586.0||||||
4142577|NCT00876343|3966985|B3|Japan||Region of Enrollment||participants|Number|195|195.0||||||
4142578|NCT00876343|3966986|B2|Japan||Region of Enrollment||participants|Number|197|197.0||||||
4142579|NCT00876343|3966987|B1|Japan||Region of Enrollment||participants|Number|194|194.0||||||
4142580|NCT00876343|3966984|B4||Male|Sex: Female, Male||Participants|Count of Participants|340|340.0||||||
4142581|NCT00876343|3966985|B3||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4142582|NCT00876343|3966986|B2||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4142583|NCT00876343|3966987|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4142584|NCT00876343|3966984|B4||Female|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
4142585|NCT00876343|3966985|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4142586|NCT00876343|3966986|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4142587|NCT00876343|3966987|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4142588|NCT00876343|3966984|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4142589|NCT00876343|3966985|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4142590|NCT00876343|3966986|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4142591|NCT00876343|3966987|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4142592|NCT00876343|3966984|B4||Between 18 and 65 years|Age||Participants|Count of Participants|586|586.0||||||
4142593|NCT00876343|3966985|B3||Between 18 and 65 years|Age||Participants|Count of Participants|195|195.0||||||
4142594|NCT00876343|3966986|B2||Between 18 and 65 years|Age||Participants|Count of Participants|197|197.0||||||
4142595|NCT00876343|3966987|B1||Between 18 and 65 years|Age||Participants|Count of Participants|194|194.0||||||
4142596|NCT00876343|3966984|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142597|NCT00876343|3966985|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142598|NCT00876343|3966986|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142599|NCT00876343|3966987|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142600|NCT00876343|3966984|B4|||Age||years|Mean|38.7|38.7|Standard Deviation|9.3|9.3|||
4142601|NCT00876343|3966985|B3|||Age||years|Mean|38.7|38.7|Standard Deviation|9.2|9.2|||
4142602|NCT00876343|3966986|B2|||Age||years|Mean|39.2|39.2|Standard Deviation|9.1|9.1|||
4142603|NCT00876343|3966987|B1|||Age||years|Mean|38.1|38.1|Standard Deviation|9.6|9.6|||
4142604|NCT00876265|3967003|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4142605|NCT00876265|3967003|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4142606|NCT00876265|3967003|B1|||Age||years|Mean|52.4|52.4|Standard Deviation|9.5|9.5|||
4142607|NCT00876265|3967003|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4142608|NCT00876265|3967003|B1||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
4142609|NCT00876265|3967003|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142610|NCT00876018|3967009|B4||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4142611|NCT00876018|3967010|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4142612|NCT00876018|3967011|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4142613|NCT00876018|3967012|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4142614|NCT00876018|3967009|B4||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4142615|NCT00876018|3967010|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4142616|NCT00876018|3967011|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4142617|NCT00876018|3967012|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4142618|NCT00876018|3967009|B4|||Age||Years|Mean|8.24|8.24|Standard Deviation|1.02|1.02|||
4142619|NCT00876018|3967010|B3|||Age||Years|Mean|8.29|8.29|Standard Deviation|1.04|1.04|||
4142620|NCT00876018|3967011|B2|||Age||Years|Mean|8.18|8.18|Standard Deviation|1.01|1.01|||
4142621|NCT00876018|3967012|B1|||Age||Years|Mean|8.26|8.26|Standard Deviation|1.02|1.02|||
4142622|NCT00875979|3967067|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4142623|NCT00875979|3967068|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4142624|NCT00875979|3967069|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4142625|NCT00875979|3967067|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4142626|NCT00875979|3967068|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4142627|NCT00875979|3967069|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4142628|NCT00875979|3967067|B3|||Age||years|Mean|52.7|52.7|Standard Deviation|10.5|10.5|||
4142629|NCT00875979|3967068|B2|||Age||years|Mean|52.7|52.7|Standard Deviation|10.8|10.8|||
4142630|NCT00875979|3967069|B1|||Age||years|Mean|53.3|53.3|Standard Deviation|1.5|1.5|||
4142631|NCT00875836|3967080|B3|United States||Region of Enrollment||participants|Number|175|175.0||||||
4142632|NCT00875836|3967081|B2|United States||Region of Enrollment||participants|Number|87|87.0||||||
4142633|NCT00875836|3967082|B1|United States||Region of Enrollment||participants|Number|88|88.0||||||
4142634|NCT00875836|3967080|B3||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4142635|NCT00875836|3967081|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4142636|NCT00875836|3967082|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4142637|NCT00875836|3967080|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4142638|NCT00875836|3967081|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4142639|NCT00875836|3967082|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4142640|NCT00875836|3967080|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4142641|NCT00875836|3967081|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4142642|NCT00875836|3967082|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4142643|NCT00875836|3967080|B3||Between 18 and 65 years|Age||Participants|Count of Participants|175|175.0||||||
4142644|NCT00875836|3967081|B2||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
4142645|NCT00875836|3967082|B1||Between 18 and 65 years|Age||Participants|Count of Participants|88|88.0||||||
4142646|NCT00875836|3967080|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142647|NCT00875836|3967081|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142648|NCT00875836|3967082|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142649|NCT00875810|3967093|B1|Kuwait||Region of Enrollment||participants|Number|1|1.0||||||
4142650|NCT00875810|3967093|B1|Poland||Region of Enrollment||participants|Number|83|83.0||||||
4142651|NCT00875810|3967093|B1|Slovakia||Region of Enrollment||participants|Number|28|28.0||||||
4142652|NCT00875810|3967093|B1|Czech Republic||Region of Enrollment||participants|Number|44|44.0||||||
4142653|NCT00875810|3967093|B1|Hungary||Region of Enrollment||participants|Number|13|13.0||||||
4142654|NCT00875810|3967093|B1|Saudi Arabia||Region of Enrollment||participants|Number|11|11.0||||||
4142655|NCT00875810|3967093|B1|Serbia||Region of Enrollment||participants|Number|10|10.0||||||
4142656|NCT00875810|3967093|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4142657|NCT00875810|3967093|B1||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4142658|NCT00875810|3967093|B1|||Age||years|Mean|43.9|43.9|Standard Deviation|8.6|8.6|||
4142659|NCT00875797|3967100|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4142660|NCT00875797|3967101|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4142661|NCT00875797|3967102|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4142662|NCT00875797|3967100|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4142663|NCT00875797|3967101|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4142664|NCT00875797|3967102|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4142665|NCT00875797|3967100|B3|||Age||years|Mean|53.60|53.6|Standard Deviation|17.13|17.13|||
4142666|NCT00875797|3967101|B2|||Age||years|Mean|51.40|51.4|Standard Deviation|20.19|20.19|||
4142667|NCT00875797|3967102|B1|||Age||years|Mean|55.97|55.97|Standard Deviation|12.90|12.9|||
4142668|NCT00875797|3967100|B3||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4142669|NCT00875797|3967101|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4142670|NCT00875797|3967102|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4142671|NCT00875797|3967100|B3||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4142672|NCT00875797|3967101|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4142673|NCT00875797|3967102|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4142674|NCT00875797|3967100|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4142675|NCT00875797|3967101|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4142676|NCT00875797|3967102|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142677|NCT00875706|3967113|B4|Unknown||Race/Ethnicity, Customized||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4142678|NCT00875706|3967114|B3|Unknown||Race/Ethnicity, Customized||participants|Number|NA|||||||Race/Ethnicity was not collected for this Arm as it was not pertinent to the study.
4142679|NCT00875706|3967115|B2|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4142680|NCT00875706|3967116|B1|Unknown||Race/Ethnicity, Customized||participants|Number|NA|||||||Race/Ethnicity was not collected for this Arm as it was not pertinent to the study.
4142681|NCT00875706|3967113|B4|White||Race/Ethnicity, Customized||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4142682|NCT00875706|3967114|B3|White||Race/Ethnicity, Customized||participants|Number|NA|||||||Race/Ethnicity was not collected for this Arm as it was not pertinent to the study.
4142683|NCT00875706|3967115|B2|White||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4142684|NCT00875706|3967116|B1|White||Race/Ethnicity, Customized||participants|Number|NA|||||||Race/Ethnicity was not collected for this Arm as it was not pertinent to the study.
4142685|NCT00875706|3967113|B4|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4142686|NCT00875706|3967114|B3|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|NA|||||||Race/Ethnicity was not collected for this Arm as it was not pertinent to the study.
4142687|NCT00875706|3967115|B2|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4142688|NCT00875706|3967116|B1|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|NA|||||||Race/Ethnicity was not collected for this Arm as it was not pertinent to the study.
4142689|NCT00875706|3967113|B4|Black||Race/Ethnicity, Customized||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4142690|NCT00875706|3967114|B3|Black||Race/Ethnicity, Customized||participants|Number|NA|||||||Race/Ethnicity was not collected for this Arm as it was not pertinent to the study.
4142691|NCT00875706|3967115|B2|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4142692|NCT00875706|3967116|B1|Black||Race/Ethnicity, Customized||participants|Number|NA|||||||Race/Ethnicity was not collected for this Arm as it was not pertinent to the study.
4142693|NCT00875706|3967113|B4|Asian||Race/Ethnicity, Customized||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4142694|NCT00875706|3967114|B3|Asian||Race/Ethnicity, Customized||participants|Number|NA|||||||Race/Ethnicity was not collected for this Arm as it was not pertinent to the study.
4142695|NCT00875706|3967115|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4142696|NCT00875706|3967116|B1|Asian||Race/Ethnicity, Customized||participants|Number|NA|||||||Race/Ethnicity was not collected for this Arm as it was not pertinent to the study.
4142697|NCT00875706|3967113|B4|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4142698|NCT00875706|3967114|B3|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|NA|||||||Race/Ethnicity was not collected for this Arm as it was not pertinent to the study.
4142699|NCT00875706|3967115|B2|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4142700|NCT00875706|3967116|B1|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|NA|||||||Race/Ethnicity was not collected for this Arm as it was not pertinent to the study.
4142701|NCT00875706|3967113|B4|Unknown||Sex/Gender, Customized||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4142702|NCT00875706|3967114|B3|Unknown||Sex/Gender, Customized||participants|Number|NA|||||||Gender was not collected for this portion of the study as it was not pertinent to the study.
4142703|NCT00875706|3967115|B2|Unknown||Sex/Gender, Customized||participants|Number|1|1.0||||||
4142704|NCT00875706|3967116|B1|Unknown||Sex/Gender, Customized||participants|Number|NA|||||||Gender was not collected for this portion of the study as it was not pertinent to the study.
4142705|NCT00875706|3967113|B4|Female||Sex/Gender, Customized||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4142706|NCT00875706|3967114|B3|Female||Sex/Gender, Customized||participants|Number|NA|||||||Gender was not collected for this portion of the study as it was not pertinent to the study.
4142707|NCT00875706|3967115|B2|Female||Sex/Gender, Customized||participants|Number|19|19.0||||||
4142708|NCT00875706|3967116|B1|Female||Sex/Gender, Customized||participants|Number|NA|||||||Gender was not collected for this portion of the study as it was not pertinent to the study.
4142709|NCT00875706|3967113|B4|Male||Sex/Gender, Customized||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4142710|NCT00875706|3967114|B3|Male||Sex/Gender, Customized||participants|Number|NA|||||||Gender was not collected for this portion of the study as it was not pertinent to the study.
4142711|NCT00875706|3967115|B2|Male||Sex/Gender, Customized||participants|Number|4|4.0||||||
4142712|NCT00875706|3967116|B1|Male||Sex/Gender, Customized||participants|Number|NA|||||||Gender was not collected for this portion of the study as it was not pertinent to the study.
4142713|NCT00875706|3967113|B4||>=65 years|Age||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4142714|NCT00875706|3967114|B3||>=65 years|Age||Participants|Count of Participants|NA|||||||Age was not collected as it was not pertinent to the study.
4142715|NCT00875706|3967115|B2||>=65 years|Age||Participants|Count of Participants|NA|||||||Age was not collected as it was not pertinent to the study.
4142716|NCT00875706|3967116|B1||>=65 years|Age||Participants|Count of Participants|NA|||||||Age was not collected as it was not pertinent to the study.
4142717|NCT00875706|3967113|B4||Between 18 and 65 years|Age||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4142718|NCT00875706|3967114|B3||Between 18 and 65 years|Age||Participants|Count of Participants|NA|||||||Age was not collected as it was not pertinent to the study.
4142719|NCT00875706|3967115|B2||Between 18 and 65 years|Age||Participants|Count of Participants|NA|||||||Age was not collected as it was not pertinent to the study.
4142720|NCT00875706|3967116|B1||Between 18 and 65 years|Age||Participants|Count of Participants|NA|||||||Age was not collected as it was not pertinent to the study.
4142721|NCT00875706|3967113|B4||<=18 years|Age||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4142722|NCT00875706|3967114|B3||<=18 years|Age||Participants|Count of Participants|NA|||||||Age was not collected as it was not pertinent to the study.
4142723|NCT00875706|3967115|B2||<=18 years|Age||Participants|Count of Participants|NA|||||||Age was not collected as it was not pertinent to the study.
4142724|NCT00875706|3967116|B1||<=18 years|Age||Participants|Count of Participants|NA|||||||Age was not collected as it was not pertinent to the study.
4142725|NCT00875615|3967135|B1|Child-Pugh B||Child-Pugh Score|"Child-Pugh score is used to assess the prognosis of chronic liver disease, mainly cirrhosis. Although it was originally used to predict mortality during surgery, it is now used to determine the prognosis, as well as the required strength of treatment and the necessity of liver transplantation.~Chronic liver disease is classified into Child-Pugh class A to C:~Child-Pugh A: Points (5-6); 1 year survival (100%); 2 year survival (85%) Child-Pugh B: Points (7-9); 1 year survival (81%); 2 year survival (57%) Child-Pugh C: Points (10-15); 1 year survival (45%); 2 year survival (35%)"|participants|Number|1|1.0||||||
4142726|NCT00875615|3967135|B1|Child-Pugh A||Child-Pugh Score|"Child-Pugh score is used to assess the prognosis of chronic liver disease, mainly cirrhosis. Although it was originally used to predict mortality during surgery, it is now used to determine the prognosis, as well as the required strength of treatment and the necessity of liver transplantation.~Chronic liver disease is classified into Child-Pugh class A to C:~Child-Pugh A: Points (5-6); 1 year survival (100%); 2 year survival (85%) Child-Pugh B: Points (7-9); 1 year survival (81%); 2 year survival (57%) Child-Pugh C: Points (10-15); 1 year survival (45%); 2 year survival (35%)"|participants|Number|10|10.0||||||
4142727|NCT00875615|3967135|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4142728|NCT00875615|3967135|B1||Male|Gender||Participants|Count of Participants|9|9.0||||||
4142729|NCT00875615|3967135|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
4142730|NCT00875615|3967135|B1|||Age||years|Mean|65|65.0|Full Range|||48.0|84.0|
4142731|NCT00875615|3967135|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4142732|NCT00875615|3967135|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4142733|NCT00875615|3967135|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142734|NCT00875589|3967140|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4142735|NCT00875589|3967141|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4142736|NCT00875589|3967142|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4142737|NCT00875589|3967140|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4142738|NCT00875589|3967141|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4142739|NCT00875589|3967142|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4142740|NCT00875589|3967140|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4142741|NCT00875589|3967141|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4142742|NCT00875589|3967142|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4142743|NCT00875589|3967140|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4142744|NCT00875589|3967141|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4142745|NCT00875589|3967142|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4142746|NCT00875589|3967140|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142747|NCT00875589|3967141|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142748|NCT00875589|3967142|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142749|NCT00875563|3967149|B1||Male|Gender||Participants|Count of Participants|33|33.0||||||
4142750|NCT00875563|3967149|B1||Female|Gender||Participants|Count of Participants|9|9.0||||||
4142751|NCT00875563|3967149|B1|||Age||years|Mean|75.3|75.3|Standard Deviation|7.4|7.4|||
4142752|NCT00875550|3967153|B3|P6 - A declared brain-dead patient||American Society of Anaesthesiologists (ASA) classification||participants|Number|0|0.0||||||
4142753|NCT00875550|3967154|B2|P6 - A declared brain-dead patient||American Society of Anaesthesiologists (ASA) classification||participants|Number|0|0.0||||||
4142754|NCT00875550|3967155|B1|P6 - A declared brain-dead patient||American Society of Anaesthesiologists (ASA) classification||participants|Number|0|0.0||||||
4142755|NCT00875550|3967153|B3|P5 - Moribund patient||American Society of Anaesthesiologists (ASA) classification||participants|Number|0|0.0||||||
4142756|NCT00875550|3967154|B2|P5 - Moribund patient||American Society of Anaesthesiologists (ASA) classification||participants|Number|0|0.0||||||
4142757|NCT00875550|3967155|B1|P5 - Moribund patient||American Society of Anaesthesiologists (ASA) classification||participants|Number|0|0.0||||||
4142758|NCT00875550|3967153|B3|P4 - PT w/ constant threat to life)||American Society of Anaesthesiologists (ASA) classification||participants|Number|20|20.0||||||
4142759|NCT00875550|3967154|B2|P4 - PT w/ constant threat to life)||American Society of Anaesthesiologists (ASA) classification||participants|Number|12|12.0||||||
4142760|NCT00875550|3967155|B1|P4 - PT w/ constant threat to life)||American Society of Anaesthesiologists (ASA) classification||participants|Number|8|8.0||||||
4142761|NCT00875550|3967153|B3|P3 - PT w/ severe systemic disease)||American Society of Anaesthesiologists (ASA) classification||participants|Number|103|103.0||||||
4142762|NCT00875550|3967154|B2|P3 - PT w/ severe systemic disease)||American Society of Anaesthesiologists (ASA) classification||participants|Number|53|53.0||||||
4142763|NCT00875550|3967155|B1|P3 - PT w/ severe systemic disease)||American Society of Anaesthesiologists (ASA) classification||participants|Number|50|50.0||||||
4142764|NCT00875550|3967153|B3|P2 - PT w/ mild systemic disease||American Society of Anaesthesiologists (ASA) classification||participants|Number|44|44.0||||||
4142765|NCT00875550|3967154|B2|P2 - PT w/ mild systemic disease||American Society of Anaesthesiologists (ASA) classification||participants|Number|16|16.0||||||
4142766|NCT00875550|3967155|B1|P2 - PT w/ mild systemic disease||American Society of Anaesthesiologists (ASA) classification||participants|Number|28|28.0||||||
4142767|NCT00875550|3967153|B3|P1 - Normal healthy patient (PT)||American Society of Anaesthesiologists (ASA) classification||participants|Number|8|8.0||||||
4142768|NCT00875550|3967154|B2|P1 - Normal healthy patient (PT)||American Society of Anaesthesiologists (ASA) classification||participants|Number|5|5.0||||||
4142769|NCT00875550|3967155|B1|P1 - Normal healthy patient (PT)||American Society of Anaesthesiologists (ASA) classification||participants|Number|3|3.0||||||
4142770|NCT00875550|3967153|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4142771|NCT00875550|3967154|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4142772|NCT00875550|3967155|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4142773|NCT00875550|3967153|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4142774|NCT00875550|3967154|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4142775|NCT00875550|3967155|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4142776|NCT00875550|3967153|B3||White|Race (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
4142777|NCT00875550|3967154|B2||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4142778|NCT00875550|3967155|B1||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4142779|NCT00875550|3967153|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4142780|NCT00875550|3967154|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4142781|NCT00875550|3967155|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4142782|NCT00875550|3967153|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4142783|NCT00875550|3967154|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4142784|NCT00875550|3967155|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142785|NCT00875550|3967153|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4142786|NCT00875550|3967154|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4142787|NCT00875550|3967155|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142788|NCT00875550|3967153|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4142789|NCT00875550|3967154|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4142790|NCT00875550|3967155|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4142791|NCT00875550|3967153|B3||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4142792|NCT00875550|3967154|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4142793|NCT00875550|3967155|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4142794|NCT00875550|3967153|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4142795|NCT00875550|3967154|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4142796|NCT00875550|3967155|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4142797|NCT00875550|3967153|B3|>=24 months to < 17 years old||Age, Customized||participants|Number|52|52.0||||||
4142798|NCT00875550|3967154|B2|>=24 months to < 17 years old||Age, Customized||participants|Number|26|26.0||||||
4142799|NCT00875550|3967155|B1|>=24 months to < 17 years old||Age, Customized||participants|Number|26|26.0||||||
4142800|NCT00875550|3967153|B3|>= 1 month to < 24 months||Age, Customized||participants|Number|123|123.0||||||
4142801|NCT00875550|3967154|B2|>= 1 month to < 24 months||Age, Customized||participants|Number|60|60.0||||||
4142802|NCT00875550|3967155|B1|>= 1 month to < 24 months||Age, Customized||participants|Number|63|63.0||||||
4142803|NCT00875550|3967153|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4142804|NCT00875550|3967154|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4142805|NCT00875550|3967155|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4142806|NCT00875550|3967153|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4142807|NCT00875550|3967154|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4142808|NCT00875550|3967155|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4142809|NCT00875550|3967153|B3||<=18 years|Age||Participants|Count of Participants|175|175.0||||||
4142810|NCT00875550|3967154|B2||<=18 years|Age||Participants|Count of Participants|86|86.0||||||
4142811|NCT00875550|3967155|B1||<=18 years|Age||Participants|Count of Participants|89|89.0||||||
4142812|NCT00875550|3967153|B3|||Age||years|Mean|2.60|2.6|Standard Deviation|3.814|3.814|||
4142813|NCT00875550|3967154|B2|||Age||years|Mean|2.85|2.85|Standard Deviation|4.172|4.172|||
4142814|NCT00875550|3967155|B1|||Age||years|Mean|2.35|2.35|Standard Deviation|3.437|3.437|||
4142815|NCT00875485|3967172|B3||Male|Sex: Female, Male|The baseline measure data here corresponds to the challenge dose epoch|Participants|Count of Participants|8|8.0||||||
4142816|NCT00875485|3967173|B2||Male|Sex: Female, Male|The baseline measure data here corresponds to the challenge dose epoch|Participants|Count of Participants|4|4.0||||||
4142817|NCT00875485|3967174|B1||Male|Sex: Female, Male|The baseline measure data here corresponds to the challenge dose epoch|Participants|Count of Participants|4|4.0||||||
4142818|NCT00875485|3967172|B3||Female|Sex: Female, Male|The baseline measure data here corresponds to the challenge dose epoch|Participants|Count of Participants|11|11.0||||||
4142819|NCT00875485|3967173|B2||Female|Sex: Female, Male|The baseline measure data here corresponds to the challenge dose epoch|Participants|Count of Participants|7|7.0||||||
4142820|NCT00875485|3967174|B1||Female|Sex: Female, Male|The baseline measure data here corresponds to the challenge dose epoch|Participants|Count of Participants|4|4.0||||||
4142821|NCT00875485|3967172|B3||Male|Sex: Female, Male|The baseline measure data here corresponds to Year 15|Participants|Count of Participants|110|110.0||||||
4142822|NCT00875485|3967173|B2||Male|Sex: Female, Male|The baseline measure data here corresponds to Year 15|Participants|Count of Participants|59|59.0||||||
4142823|NCT00875485|3967174|B1||Male|Sex: Female, Male|The baseline measure data here corresponds to Year 15|Participants|Count of Participants|51|51.0||||||
4142824|NCT00875485|3967172|B3||Female|Sex: Female, Male|The baseline measure data here corresponds to Year 15|Participants|Count of Participants|99|99.0||||||
4142825|NCT00875485|3967173|B2||Female|Sex: Female, Male|The baseline measure data here corresponds to Year 15|Participants|Count of Participants|52|52.0||||||
4142826|NCT00875485|3967174|B1||Female|Sex: Female, Male|The baseline measure data here corresponds to Year 15|Participants|Count of Participants|47|47.0||||||
4142827|NCT00875485|3967172|B3||Male|Sex: Female, Male|The baseline measure data here corresponds to Year 14|Participants|Count of Participants|111|111.0||||||
4142828|NCT00875485|3967173|B2||Male|Sex: Female, Male|The baseline measure data here corresponds to Year 14|Participants|Count of Participants|60|60.0||||||
4142829|NCT00875485|3967174|B1||Male|Sex: Female, Male|The baseline measure data here corresponds to Year 14|Participants|Count of Participants|51|51.0||||||
4142830|NCT00875485|3967172|B3||Female|Sex: Female, Male|The baseline measure data here corresponds to Year 14|Participants|Count of Participants|102|102.0||||||
4142831|NCT00875485|3967173|B2||Female|Sex: Female, Male|The baseline measure data here corresponds to Year 14|Participants|Count of Participants|53|53.0||||||
4142832|NCT00875485|3967174|B1||Female|Sex: Female, Male|The baseline measure data here corresponds to Year 14|Participants|Count of Participants|49|49.0||||||
4142833|NCT00875485|3967172|B3||Male|Sex: Female, Male|The baseline measure data here corresponds to Year 13|Participants|Count of Participants|112|112.0||||||
4142834|NCT00875485|3967173|B2||Male|Sex: Female, Male|The baseline measure data here corresponds to Year 13|Participants|Count of Participants|60|60.0||||||
4142835|NCT00875485|3967174|B1||Male|Sex: Female, Male|The baseline measure data here corresponds to Year 13|Participants|Count of Participants|52|52.0||||||
4142836|NCT00875485|3967172|B3||Female|Sex: Female, Male|The baseline measure data here corresponds to Year 13|Participants|Count of Participants|103|103.0||||||
4142837|NCT00875485|3967173|B2||Female|Sex: Female, Male|The baseline measure data here corresponds to Year 13|Participants|Count of Participants|53|53.0||||||
4142838|NCT00875485|3967174|B1||Female|Sex: Female, Male|The baseline measure data here corresponds to Year 13|Participants|Count of Participants|50|50.0||||||
4142839|NCT00875485|3967172|B3||Male|Sex: Female, Male|The baseline measure data here corresponds to Year 12|Participants|Count of Participants|110|110.0||||||
4142840|NCT00875485|3967173|B2||Male|Sex: Female, Male|The baseline measure data here corresponds to Year 12|Participants|Count of Participants|59|59.0||||||
4142841|NCT00875485|3967174|B1||Male|Sex: Female, Male|The baseline measure data here corresponds to Year 12|Participants|Count of Participants|51|51.0||||||
4142842|NCT00875485|3967172|B3||Female|Sex: Female, Male|The baseline measure data here corresponds to Year 12|Participants|Count of Participants|100|100.0||||||
4142843|NCT00875485|3967173|B2||Female|Sex: Female, Male|The baseline measure data here corresponds to Year 12|Participants|Count of Participants|50|50.0||||||
4142844|NCT00875485|3967174|B1||Female|Sex: Female, Male|The baseline measure data here corresponds to Year 12|Participants|Count of Participants|50|50.0||||||
4142845|NCT00875485|3967172|B3||Male|Sex: Female, Male|The baseline measure data here corresponds to Year 11.|Participants|Count of Participants|109|109.0||||||
4142846|NCT00875485|3967173|B2||Male|Sex: Female, Male|The baseline measure data here corresponds to Year 11.|Participants|Count of Participants|59|59.0||||||
4142847|NCT00875485|3967174|B1||Male|Sex: Female, Male|The baseline measure data here corresponds to Year 11.|Participants|Count of Participants|50|50.0||||||
4142848|NCT00875485|3967172|B3||Female|Sex: Female, Male|The baseline measure data here corresponds to Year 11.|Participants|Count of Participants|101|101.0||||||
4142849|NCT00875485|3967173|B2||Female|Sex: Female, Male|The baseline measure data here corresponds to Year 11.|Participants|Count of Participants|52|52.0||||||
4142850|NCT00875485|3967174|B1||Female|Sex: Female, Male|The baseline measure data here corresponds to Year 11.|Participants|Count of Participants|49|49.0||||||
4142851|NCT00875485|3967172|B3|||Age|The baseline measure data here corresponds to the challenge dose epoch|Years|Mean|29.4|29.4|Standard Deviation|1.22|1.22|||
4142852|NCT00875485|3967173|B2|||Age|The baseline measure data here corresponds to the challenge dose epoch|Years|Mean|29.4|29.4|Standard Deviation|1.3|1.3|||
4142853|NCT00875485|3967174|B1|||Age|The baseline measure data here corresponds to the challenge dose epoch|Years|Mean|29.4|29.4|Standard Deviation|1.2|1.2|||
4142854|NCT00875485|3967172|B3|||Age|The baseline measure data here corresponds to Year 15|Years|Mean|28.3|28.3|Standard Deviation|1.12|1.12|||
4142855|NCT00875485|3967173|B2|||Age|The baseline measure data here corresponds to Year 15|Years|Mean|28.3|28.3|Standard Deviation|1.09|1.09|||
4142856|NCT00875485|3967174|B1|||Age|The baseline measure data here corresponds to Year 15|Years|Mean|28.4|28.4|Standard Deviation|1.15|1.15|||
4142857|NCT00875485|3967172|B3|||Age|The baseline measure data here corresponds to Year 14|Years|Mean|27.40|27.4|Standard Deviation|1.08|1.08|||
4142858|NCT00875485|3967173|B2|||Age|The baseline measure data here corresponds to Year 14|Years|Mean|27.40|27.4|Standard Deviation|1.05|1.05|||
4142859|NCT00875485|3967174|B1|||Age|The baseline measure data here corresponds to Year 14|Years|Mean|27.40|27.4|Standard Deviation|1.11|1.11|||
4142860|NCT00875485|3967172|B3|||Age|The baseline measure data here corresponds to Year 13|Years|Mean|26.40|26.4|Standard Deviation|1.06|1.06|||
4142861|NCT00875485|3967173|B2|||Age|The baseline measure data here corresponds to Year 13|Years|Mean|26.4|26.4|Standard Deviation|1.06|1.06|||
4142862|NCT00875485|3967174|B1|||Age|The baseline measure data here corresponds to Year 13|Years|Mean|26.40|26.4|Standard Deviation|1.07|1.07|||
4142863|NCT00875485|3967172|B3|||Age|The baseline measure data here corresponds to Year 12|Years|Mean|25.40|25.4|Standard Deviation|1.05|1.05|||
4142864|NCT00875485|3967173|B2|||Age|The baseline measure data here corresponds to Year 12|Years|Mean|25.4|25.4|Standard Deviation|1.04|1.04|||
4142865|NCT00875485|3967174|B1|||Age|The baseline measure data here corresponds to Year 12|Years|Mean|25.4|25.4|Standard Deviation|1.06|1.06|||
4142866|NCT00875485|3967172|B3|||Age|The baseline measure data here corresponds to Year 11.|years|Mean|24.5|24.5|Standard Deviation|1.05|1.05|||
4142867|NCT00875485|3967173|B2|||Age|The baseline measure data here corresponds to Year 11.|years|Mean|24.5|24.5|Standard Deviation|1.05|1.05|||
4142868|NCT00875485|3967174|B1|||Age|The baseline measure data here corresponds to Year 11.|years|Mean|24.5|24.5|Standard Deviation|1.06|1.06|||
4142869|NCT00875433|3967215|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4142870|NCT00875433|3967215|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4142871|NCT00875433|3967215|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|11.9|11.9|||
4142872|NCT00875420|3967240|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142873|NCT00875420|3967241|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142874|NCT00875420|3967242|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142875|NCT00875420|3967243|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142876|NCT00875420|3967244|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142877|NCT00875420|3967245|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142878|NCT00875420|3967240|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142879|NCT00875420|3967241|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142880|NCT00875420|3967242|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142881|NCT00875420|3967243|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142882|NCT00875420|3967244|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142883|NCT00875420|3967245|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142884|NCT00875420|3967240|B6||White|Race (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
4142885|NCT00875420|3967241|B5||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4142886|NCT00875420|3967242|B4||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4142887|NCT00875420|3967243|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4142888|NCT00875420|3967244|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4142889|NCT00875420|3967245|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4142890|NCT00875420|3967240|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142891|NCT00875420|3967241|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142892|NCT00875420|3967242|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142893|NCT00875420|3967243|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142894|NCT00875420|3967244|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142895|NCT00875420|3967245|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142896|NCT00875420|3967240|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142897|NCT00875420|3967241|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142898|NCT00875420|3967242|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142899|NCT00875420|3967243|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142900|NCT00875420|3967244|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142901|NCT00875420|3967245|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142902|NCT00875420|3967240|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142903|NCT00875420|3967241|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142904|NCT00875420|3967242|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142905|NCT00875420|3967243|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142906|NCT00875420|3967244|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142907|NCT00875420|3967245|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142908|NCT00875420|3967240|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142909|NCT00875420|3967241|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142910|NCT00875420|3967242|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142911|NCT00875420|3967243|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142912|NCT00875420|3967244|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142913|NCT00875420|3967245|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4142914|NCT00875420|3967240|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4142915|NCT00875420|3967241|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4142916|NCT00875420|3967242|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4142917|NCT00875420|3967243|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4142918|NCT00875420|3967244|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4142919|NCT00875420|3967245|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4142920|NCT00875420|3967240|B6||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4142921|NCT00875420|3967241|B5||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4142922|NCT00875420|3967242|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4142923|NCT00875420|3967243|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4142924|NCT00875420|3967244|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4142925|NCT00875420|3967245|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4142926|NCT00875420|3967240|B6|||Age||years|Mean|54.3|54.3|Standard Deviation|6.24|6.24|||
4142927|NCT00875420|3967241|B5|||Age||years|Mean|53.8|53.8|Standard Deviation|5.74|5.74|||
4142928|NCT00875420|3967242|B4|||Age||years|Mean|55.7|55.7|Standard Deviation|6.45|6.45|||
4142929|NCT00875420|3967243|B3|||Age||years|Mean|53.7|53.7|Standard Deviation|5.68|5.68|||
4142930|NCT00875420|3967244|B2|||Age||years|Mean|55.2|55.2|Standard Deviation|7.74|7.74|||
4142931|NCT00875420|3967245|B1|||Age||years|Mean|53.5|53.5|Standard Deviation|5.74|5.74|||
4142932|NCT00875394|3967276|B4|||Time since diagnosis of diabetes||Years|Mean|8.43|8.43|Standard Deviation|7.68|7.68|||
4142933|NCT00875394|3967277|B3|||Time since diagnosis of diabetes||Years|Mean|10.9|10.9|Standard Deviation|7.7|7.7|||
4142934|NCT00875394|3967278|B2|||Time since diagnosis of diabetes||Years|Mean|6.8|6.8|Standard Deviation|8.5|8.5|||
4142935|NCT00875394|3967279|B1|||Time since diagnosis of diabetes||Years|Mean|8.9|8.9|Standard Deviation|7.1|7.1|||
4142936|NCT00875394|3967276|B4|||Glycosylated Hemoglobin A1C (A1C)||Percent|Mean|8.47|8.47|Standard Deviation|1.61|1.61|||
4142937|NCT00875394|3967277|B3|||Glycosylated Hemoglobin A1C (A1C)||Percent|Mean|8.2|8.2|Standard Deviation|1.1|1.1|||
4142938|NCT00875394|3967278|B2|||Glycosylated Hemoglobin A1C (A1C)||Percent|Mean|8.0|8.0|Standard Deviation|1.8|1.8|||
4142939|NCT00875394|3967279|B1|||Glycosylated Hemoglobin A1C (A1C)||Percent|Mean|8.8|8.8|Standard Deviation|1.5|1.5|||
4142940|NCT00875394|3967276|B4|||Body Mass Index (BMI)||kg/m2|Mean|28.84|28.84|Standard Deviation|4.74|4.74|||
4142941|NCT00875394|3967277|B3|||Body Mass Index (BMI)||kg/m2|Mean|28.3|28.3|Standard Deviation|5.2|5.2|||
4142942|NCT00875394|3967278|B2|||Body Mass Index (BMI)||kg/m2|Mean|28.8|28.8|Standard Deviation|5.1|5.1|||
4142943|NCT00875394|3967279|B1|||Body Mass Index (BMI)||kg/m2|Mean|29.0|29.0|Standard Deviation|4.5|4.5|||
4142944|NCT00875394|3967276|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4142945|NCT00875394|3967277|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4142946|NCT00875394|3967278|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4142947|NCT00875394|3967279|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4142948|NCT00875394|3967276|B4||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4142949|NCT00875394|3967277|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4142950|NCT00875394|3967278|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4142951|NCT00875394|3967279|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4142952|NCT00875394|3967276|B4|||Age||years|Mean|54.69|54.69|Standard Deviation|9.55|9.55|||
4142953|NCT00875394|3967277|B3|||Age||years|Mean|53.3|53.3|Standard Deviation|11.7|11.7|||
4142954|NCT00875394|3967278|B2|||Age||years|Mean|56.0|56.0|Standard Deviation|8.5|8.5|||
4142955|NCT00875394|3967279|B1|||Age||years|Mean|54.2|54.2|Standard Deviation|9.8|9.8|||
4142956|NCT00875329|3967289|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4142957|NCT00875329|3967289|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4142958|NCT00875329|3967289|B1|||Age||years|Mean|41.6|41.6|Standard Deviation|11.14|11.14|||
4142959|NCT00875212|3967293|B1|Brazil||Region of Enrollment||participants|Number|12|12.0||||||
4142960|NCT00875212|3967293|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4142961|NCT00875212|3967293|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4142962|NCT00875212|3967293|B1|||Age||years|Mean|26|26.0|Standard Deviation|3|3.0|||
4142963|NCT00875212|3967293|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4142964|NCT00875212|3967293|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4142965|NCT00875212|3967293|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4142966|NCT00875017|3967304|B7|United States||Region of Enrollment|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|participants|Number|28|28.0||||||
4142967|NCT00875017|3967305|B6|United States||Region of Enrollment|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|participants|Number|5|5.0||||||
4142968|NCT00875017|3967306|B5|United States||Region of Enrollment|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|participants|Number|5|5.0||||||
4143097|NCT00874770|3967387|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4143098|NCT00874770|3967383|B5|||Age||years|Mean|51.3|51.3|Standard Deviation|8.80|8.8|||
4142969|NCT00875017|3967307|B4|United States||Region of Enrollment|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|participants|Number|5|5.0||||||
4142970|NCT00875017|3967308|B3|United States||Region of Enrollment|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|participants|Number|5|5.0||||||
4142971|NCT00875017|3967309|B2|United States||Region of Enrollment|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|participants|Number|5|5.0||||||
4142972|NCT00875017|3967310|B1|United States||Region of Enrollment|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|participants|Number|3|3.0||||||
4142973|NCT00875017|3967304|B7||Male|Sex: Female, Male|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|Participants|Count of Participants|20|20.0||||||
4142974|NCT00875017|3967305|B6||Male|Sex: Female, Male|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|Participants|Count of Participants|3|3.0||||||
4142975|NCT00875017|3967306|B5||Male|Sex: Female, Male|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|Participants|Count of Participants|3|3.0||||||
4142976|NCT00875017|3967307|B4||Male|Sex: Female, Male|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|Participants|Count of Participants|3|3.0||||||
4142977|NCT00875017|3967308|B3||Male|Sex: Female, Male|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|Participants|Count of Participants|4|4.0||||||
4142978|NCT00875017|3967309|B2||Male|Sex: Female, Male|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|Participants|Count of Participants|5|5.0||||||
4142979|NCT00875017|3967310|B1||Male|Sex: Female, Male|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|Participants|Count of Participants|2|2.0||||||
4142980|NCT00875017|3967304|B7||Female|Sex: Female, Male|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|Participants|Count of Participants|8|8.0||||||
4142981|NCT00875017|3967305|B6||Female|Sex: Female, Male|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|Participants|Count of Participants|2|2.0||||||
4142982|NCT00875017|3967306|B5||Female|Sex: Female, Male|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|Participants|Count of Participants|2|2.0||||||
4142983|NCT00875017|3967307|B4||Female|Sex: Female, Male|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|Participants|Count of Participants|2|2.0||||||
4142984|NCT00875017|3967308|B3||Female|Sex: Female, Male|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|Participants|Count of Participants|1|1.0||||||
4142985|NCT00875017|3967309|B2||Female|Sex: Female, Male|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|Participants|Count of Participants|0|0.0||||||
4142986|NCT00875017|3967310|B1||Female|Sex: Female, Male|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|Participants|Count of Participants|1|1.0||||||
4142987|NCT00875017|3967304|B7|||Age|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|years|Mean|25.9|25.9|Standard Deviation|6.06|6.06|||
4142988|NCT00875017|3967305|B6|||Age|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|years|Mean|28.2|28.2|Standard Deviation|6.38|6.38|||
4143099|NCT00874770|3967384|B4|||Age||years|Mean|48|48.0|Standard Deviation|10.20|10.2|||
4143100|NCT00874770|3967385|B3|||Age||years|Mean|52|52.0|Standard Deviation|7.34|7.34|||
4142989|NCT00875017|3967306|B5|||Age|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|years|Mean|25.8|25.8|Standard Deviation|5.45|5.45|||
4142990|NCT00875017|3967307|B4|||Age|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|years|Mean|27.4|27.4|Standard Deviation|9.71|9.71|||
4142991|NCT00875017|3967308|B3|||Age|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|years|Mean|24.4|24.4|Standard Deviation|3.85|3.85|||
4142992|NCT00875017|3967309|B2|||Age|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|years|Mean|23.6|23.6|Standard Deviation|2.07|2.07|||
4142993|NCT00875017|3967310|B1|||Age|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|years|Mean|26.0|26.0|Standard Deviation|9.54|9.54|||
4142994|NCT00875017|3967304|B7||>=65 years|Age|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|Participants|Count of Participants|0|0.0||||||
4142995|NCT00875017|3967305|B6||>=65 years|Age|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|Participants|Count of Participants|0|0.0||||||
4142996|NCT00875017|3967306|B5||>=65 years|Age|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|Participants|Count of Participants|0|0.0||||||
4142997|NCT00875017|3967307|B4||>=65 years|Age|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|Participants|Count of Participants|0|0.0||||||
4142998|NCT00875017|3967308|B3||>=65 years|Age|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|Participants|Count of Participants|0|0.0||||||
4142999|NCT00875017|3967309|B2||>=65 years|Age|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|Participants|Count of Participants|0|0.0||||||
4143000|NCT00875017|3967310|B1||>=65 years|Age|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|Participants|Count of Participants|0|0.0||||||
4143001|NCT00875017|3967304|B7||Between 18 and 65 years|Age|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|Participants|Count of Participants|28|28.0||||||
4143002|NCT00875017|3967305|B6||Between 18 and 65 years|Age|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|Participants|Count of Participants|5|5.0||||||
4143003|NCT00875017|3967306|B5||Between 18 and 65 years|Age|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|Participants|Count of Participants|5|5.0||||||
4143004|NCT00875017|3967307|B4||Between 18 and 65 years|Age|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|Participants|Count of Participants|5|5.0||||||
4143005|NCT00875017|3967308|B3||Between 18 and 65 years|Age|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|Participants|Count of Participants|5|5.0||||||
4143006|NCT00875017|3967309|B2||Between 18 and 65 years|Age|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|Participants|Count of Participants|5|5.0||||||
4143007|NCT00875017|3967310|B1||Between 18 and 65 years|Age|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|Participants|Count of Participants|3|3.0||||||
4143008|NCT00875017|3967304|B7||<=18 years|Age|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|Participants|Count of Participants|0|0.0||||||
4143009|NCT00875017|3967305|B6||<=18 years|Age|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|Participants|Count of Participants|0|0.0||||||
4143010|NCT00875017|3967306|B5||<=18 years|Age|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|Participants|Count of Participants|0|0.0||||||
4143011|NCT00875017|3967307|B4||<=18 years|Age|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|Participants|Count of Participants|0|0.0||||||
4143012|NCT00875017|3967308|B3||<=18 years|Age|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|Participants|Count of Participants|0|0.0||||||
4143013|NCT00875017|3967309|B2||<=18 years|Age|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|Participants|Count of Participants|0|0.0||||||
4143014|NCT00875017|3967310|B1||<=18 years|Age|Although 31 subjects were randomized in the study, the demographics are presented from the Safety Set (n = 28). Safety Set consisted of subjects who had at least one dose of investigational medicinal product and had at least one post-dose safety assessment.|Participants|Count of Participants|0|0.0||||||
4143015|NCT00874939|3967329|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4143016|NCT00874939|3967329|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4143017|NCT00874939|3967329|B1|||Age||Years|Mean|67|67.0|Standard Deviation|2.2|2.2|||
4143018|NCT00874887|3967343|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4143019|NCT00874887|3967344|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4143020|NCT00874887|3967345|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4143021|NCT00874887|3967343|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4143022|NCT00874887|3967344|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4143023|NCT00874887|3967345|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4143024|NCT00874887|3967343|B3|||Age||years|Mean|61.625|61.625|Standard Deviation|8.1085|8.1085|||
4143025|NCT00874887|3967344|B2|||Age||years|Mean|62.5000|62.5|Standard Deviation|8.3892|8.3892|||
4143026|NCT00874887|3967345|B1|||Age||years|Mean|60.3750|60.375|Standard Deviation|7.8278|7.8278|||
4143027|NCT00874848|3967360|B3|Chemotherapy||Prior Cancer Treatment||participants|Number|2|2.0||||||
4143028|NCT00874848|3967361|B2|Chemotherapy||Prior Cancer Treatment||participants|Number|1|1.0||||||
4143029|NCT00874848|3967362|B1|Chemotherapy||Prior Cancer Treatment||participants|Number|1|1.0||||||
4143030|NCT00874848|3967360|B3|Surgery||Prior Cancer Treatment||participants|Number|36|36.0||||||
4143031|NCT00874848|3967361|B2|Surgery||Prior Cancer Treatment||participants|Number|13|13.0||||||
4143032|NCT00874848|3967362|B1|Surgery||Prior Cancer Treatment||participants|Number|23|23.0||||||
4143033|NCT00874848|3967360|B3|Radiotherapy||Prior Cancer Treatment||participants|Number|3|3.0||||||
4143034|NCT00874848|3967361|B2|Radiotherapy||Prior Cancer Treatment||participants|Number|3|3.0||||||
4143035|NCT00874848|3967362|B1|Radiotherapy||Prior Cancer Treatment||participants|Number|0|0.0||||||
4143036|NCT00874848|3967360|B3|||Time from Initial Tumor Diagnosis||months|Mean|0.9|0.9|Standard Deviation|1.21|1.21|||
4143037|NCT00874848|3967361|B2|||Time from Initial Tumor Diagnosis||months|Mean|0.9|0.9|Standard Deviation|1.53|1.53|||
4143038|NCT00874848|3967362|B1|||Time from Initial Tumor Diagnosis||months|Mean|0.9|0.9|Standard Deviation|1.04|1.04|||
4143039|NCT00874848|3967360|B3|||Baseline Body Mass Index||kg/m^2|Mean|25.6|25.6|Standard Deviation|4.40|4.4|||
4143040|NCT00874848|3967361|B2|||Baseline Body Mass Index||kg/m^2|Mean|25.1|25.1|Standard Deviation|3.00|3.0|||
4143041|NCT00874848|3967362|B1|||Baseline Body Mass Index||kg/m^2|Mean|25.9|25.9|Standard Deviation|4.95|4.95|||
4143042|NCT00874848|3967360|B3|||Baseline Weight||kg|Mean|75.0|75.0|Standard Deviation|15.24|15.24|||
4143043|NCT00874848|3967361|B2|||Baseline Weight||kg|Mean|72.8|72.8|Standard Deviation|12.19|12.19|||
4143044|NCT00874848|3967362|B1|||Baseline Weight||kg|Mean|76.2|76.2|Standard Deviation|16.52|16.52|||
4143045|NCT00874848|3967360|B3|||Baseline Height||cm|Mean|170.8|170.8|Standard Deviation|7.96|7.96|||
4143046|NCT00874848|3967361|B2|||Baseline Height||cm|Mean|170.0|170.0|Standard Deviation|8.90|8.9|||
4143047|NCT00874848|3967362|B1|||Baseline Height||cm|Mean|171.1|171.1|Standard Deviation|7.51|7.51|||
4143048|NCT00874848|3967360|B3|Missing||ECOG|"ECOG Score: runs from 0 to 5, with 0 denoting perfect health and 5 death.~0 – Asymptomatic (Fully active, able to carry on all predisease activities without restriction)~1 – Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. For example, light housework, office work)"|participants|Number|2|2.0||||||
4143049|NCT00874848|3967361|B2|Missing||ECOG|"ECOG Score: runs from 0 to 5, with 0 denoting perfect health and 5 death.~0 – Asymptomatic (Fully active, able to carry on all predisease activities without restriction)~1 – Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. For example, light housework, office work)"|participants|Number|1|1.0||||||
4143050|NCT00874848|3967362|B1|Missing||ECOG|"ECOG Score: runs from 0 to 5, with 0 denoting perfect health and 5 death.~0 – Asymptomatic (Fully active, able to carry on all predisease activities without restriction)~1 – Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. For example, light housework, office work)"|participants|Number|1|1.0||||||
4143101|NCT00874770|3967386|B2|||Age||years|Mean|53.2|53.2|Standard Deviation|9.11|9.11|||
4143102|NCT00874770|3967387|B1|||Age||years|Mean|52|52.0|Standard Deviation|8.56|8.56|||
4143051|NCT00874848|3967360|B3|Score = 1||ECOG|"ECOG Score: runs from 0 to 5, with 0 denoting perfect health and 5 death.~0 – Asymptomatic (Fully active, able to carry on all predisease activities without restriction)~1 – Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. For example, light housework, office work)"|participants|Number|56|56.0||||||
4143052|NCT00874848|3967361|B2|Score = 1||ECOG|"ECOG Score: runs from 0 to 5, with 0 denoting perfect health and 5 death.~0 – Asymptomatic (Fully active, able to carry on all predisease activities without restriction)~1 – Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. For example, light housework, office work)"|participants|Number|18|18.0||||||
4143053|NCT00874848|3967362|B1|Score = 1||ECOG|"ECOG Score: runs from 0 to 5, with 0 denoting perfect health and 5 death.~0 – Asymptomatic (Fully active, able to carry on all predisease activities without restriction)~1 – Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. For example, light housework, office work)"|participants|Number|38|38.0||||||
4143054|NCT00874848|3967360|B3|Score = 0||ECOG|"ECOG Score: runs from 0 to 5, with 0 denoting perfect health and 5 death.~0 – Asymptomatic (Fully active, able to carry on all predisease activities without restriction)~1 – Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. For example, light housework, office work)"|participants|Number|30|30.0||||||
4143055|NCT00874848|3967361|B2|Score = 0||ECOG|"ECOG Score: runs from 0 to 5, with 0 denoting perfect health and 5 death.~0 – Asymptomatic (Fully active, able to carry on all predisease activities without restriction)~1 – Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. For example, light housework, office work)"|participants|Number|10|10.0||||||
4143056|NCT00874848|3967362|B1|Score = 0||ECOG|"ECOG Score: runs from 0 to 5, with 0 denoting perfect health and 5 death.~0 – Asymptomatic (Fully active, able to carry on all predisease activities without restriction)~1 – Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. For example, light housework, office work)"|participants|Number|20|20.0||||||
4143057|NCT00874848|3967360|B3|Germany||Region of Enrollment||participants|Number|82|82.0||||||
4143058|NCT00874848|3967361|B2|Germany||Region of Enrollment||participants|Number|27|27.0||||||
4143059|NCT00874848|3967362|B1|Germany||Region of Enrollment||participants|Number|55|55.0||||||
4143060|NCT00874848|3967360|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4143061|NCT00874848|3967361|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4143062|NCT00874848|3967362|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4143063|NCT00874848|3967360|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4143064|NCT00874848|3967361|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4143065|NCT00874848|3967362|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4143066|NCT00874848|3967360|B3|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4143067|NCT00874848|3967361|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4143068|NCT00874848|3967362|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4143069|NCT00874848|3967360|B3|White||Race/Ethnicity, Customized||participants|Number|85|85.0||||||
4143070|NCT00874848|3967361|B2|White||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4143071|NCT00874848|3967362|B1|White||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
4143072|NCT00874848|3967360|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4143073|NCT00874848|3967361|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4143074|NCT00874848|3967362|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4143075|NCT00874848|3967360|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4143076|NCT00874848|3967361|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4143077|NCT00874848|3967362|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4143078|NCT00874848|3967360|B3|||Age||Years|Mean|60.45|60.45|Standard Deviation|8.81|8.81|||
4143079|NCT00874848|3967361|B2|||Age||Years|Mean|62.4|62.4|Standard Deviation|7.04|7.04|||
4143080|NCT00874848|3967362|B1|||Age||Years|Mean|59.3|59.3|Standard Deviation|9.45|9.45|||
4143081|NCT00874822|3967379|B1|United States||Region of Enrollment||participants|Number|216|216.0||||||
4143082|NCT00874822|3967379|B1||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4143083|NCT00874822|3967379|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4143084|NCT00874822|3967379|B1|||Age||years|Mean|62.88|62.88|Standard Deviation|0.86|0.86|||
4143085|NCT00874822|3967379|B1||>=65 years|Age||Participants|Count of Participants|117|117.0||||||
4143086|NCT00874822|3967379|B1||Between 18 and 65 years|Age||Participants|Count of Participants|99|99.0||||||
4143087|NCT00874822|3967379|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4143088|NCT00874770|3967383|B5||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4143089|NCT00874770|3967384|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4143090|NCT00874770|3967385|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4143091|NCT00874770|3967386|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4143092|NCT00874770|3967387|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4143093|NCT00874770|3967383|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4143094|NCT00874770|3967384|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4143095|NCT00874770|3967385|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4143096|NCT00874770|3967386|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4143103|NCT00874614|3967424|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143104|NCT00874614|3967424|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143105|NCT00874614|3967424|B1||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4143106|NCT00874614|3967424|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4143107|NCT00874614|3967424|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143108|NCT00874614|3967424|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4143109|NCT00874614|3967424|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143110|NCT00874614|3967424|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4143111|NCT00874614|3967424|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4143112|NCT00874614|3967424|B1|||Age||years|Median|55|55.0|Full Range|||16.0|72.0|
4143113|NCT00874549|3967432|B5|United States||Region of Enrollment||participants|Number|216|216.0||||||
4143114|NCT00874549|3967433|B4|United States||Region of Enrollment||participants|Number|58|58.0||||||
4143115|NCT00874549|3967434|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
4143116|NCT00874549|3967435|B2|United States||Region of Enrollment||participants|Number|56|56.0||||||
4143117|NCT00874549|3967436|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4143118|NCT00874549|3967432|B5||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4143119|NCT00874549|3967433|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4143120|NCT00874549|3967434|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4143121|NCT00874549|3967435|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4143122|NCT00874549|3967436|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4143123|NCT00874549|3967432|B5||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4143124|NCT00874549|3967433|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4143125|NCT00874549|3967434|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4143126|NCT00874549|3967435|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4143127|NCT00874549|3967436|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4143128|NCT00874549|3967432|B5|||Age||Years|Mean|68.8|68.8|Standard Deviation|7.1|7.1|||
4143129|NCT00874549|3967433|B4|||Age||Years|Mean|69.1|69.1|Standard Deviation|7.3|7.3|||
4143130|NCT00874549|3967434|B3|||Age||Years|Mean|68.5|68.5|Standard Deviation|7.2|7.2|||
4143131|NCT00874549|3967435|B2|||Age||Years|Mean|68.6|68.6|Standard Deviation|7.0|7.0|||
4143132|NCT00874549|3967436|B1|||Age||Years|Mean|69.0|69.0|Standard Deviation|7.2|7.2|||
4143133|NCT00874549|3967432|B5||>=65 years|Age||Participants|Count of Participants|141|141.0||||||
4143134|NCT00874549|3967433|B4||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
4143135|NCT00874549|3967434|B3||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4143136|NCT00874549|3967435|B2||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
4143137|NCT00874549|3967436|B1||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4143138|NCT00874549|3967432|B5||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4143139|NCT00874549|3967433|B4||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4143140|NCT00874549|3967434|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4143141|NCT00874549|3967435|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4143142|NCT00874549|3967436|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4143143|NCT00874549|3967432|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4143144|NCT00874549|3967433|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4143145|NCT00874549|3967434|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4143146|NCT00874549|3967435|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4143147|NCT00874549|3967436|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4143148|NCT00874510|3967505|B3|United States||Region of Enrollment||participants|Number|352|352.0||||||
4143149|NCT00874510|3967506|B2|United States||Region of Enrollment||participants|Number|172|172.0||||||
4143150|NCT00874510|3967507|B1|United States||Region of Enrollment||participants|Number|180|180.0||||||
4143151|NCT00874510|3967505|B3||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4143152|NCT00874510|3967506|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4143153|NCT00874510|3967507|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4143154|NCT00874510|3967505|B3||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4143155|NCT00874510|3967506|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4143156|NCT00874510|3967507|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4143157|NCT00874510|3967505|B3|Year 2 HUP||Age, Customized||years|Mean|28.2|28.2|Standard Deviation|3.0|3.0|||
4143158|NCT00874510|3967506|B2|Year 2 HUP||Age, Customized||years|Mean|28.3|28.3|Standard Deviation|3.0|3.0|||
4143159|NCT00874510|3967507|B1|Year 2 HUP||Age, Customized||years|Mean|28.1|28.1|Standard Deviation|2.9|2.9|||
4143160|NCT00874510|3967505|B3|Year 2 PVAMC||Age, Customized||years|Mean|27.9|27.9|Standard Deviation|2.9|2.9|||
4143161|NCT00874510|3967506|B2|Year 2 PVAMC||Age, Customized||years|Mean|27.9|27.9|Standard Deviation|3.5|3.5|||
4143162|NCT00874510|3967507|B1|Year 2 PVAMC||Age, Customized||years|Mean|27.9|27.9|Standard Deviation|2.4|2.4|||
4143163|NCT00874510|3967505|B3|Year 1 HUP||Age, Customized||years|Mean|27.9|27.9|Standard Deviation|2.1|2.1|||
4143164|NCT00874510|3967506|B2|Year 1 HUP||Age, Customized||years|Mean|27.7|27.7|Standard Deviation|2.0|2.0|||
4143165|NCT00874510|3967507|B1|Year 1 HUP||Age, Customized||years|Mean|28.1|28.1|Standard Deviation|2.2|2.2|||
4143166|NCT00874510|3967505|B3|Year 1 PVAMC||Age, Customized||years|Mean|27.4|27.4|Standard Deviation|2.3|2.3|||
4143167|NCT00874510|3967506|B2|Year 1 PVAMC||Age, Customized||years|Mean|27.3|27.3|Standard Deviation|2.3|2.3|||
4143168|NCT00874510|3967507|B1|Year 1 PVAMC||Age, Customized||years|Mean|27.5|27.5|Standard Deviation|2.3|2.3|||
4143169|NCT00874497|3967514|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4143170|NCT00874497|3967515|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4143171|NCT00874497|3967516|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4143172|NCT00874497|3967514|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4143173|NCT00874497|3967515|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4143174|NCT00874497|3967516|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4143175|NCT00874497|3967514|B3|||Age||years|Mean|58.2|58.2|Standard Deviation|6.70|6.7|||
4143176|NCT00874497|3967515|B2|||Age||years|Mean|58.4|58.4|Standard Deviation|7.71|7.71|||
4143177|NCT00874497|3967516|B1|||Age||years|Mean|58.0|58.0|Standard Deviation|6.04|6.04|||
4143178|NCT00874276|3967555|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4143179|NCT00874276|3967556|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4143180|NCT00874276|3967557|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4143181|NCT00874276|3967555|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4143182|NCT00874276|3967556|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4143183|NCT00874276|3967557|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4143184|NCT00874276|3967555|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4143185|NCT00874276|3967556|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4143186|NCT00874276|3967557|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4143187|NCT00874276|3967555|B3|||Age||years|Mean|26.9|26.9|Standard Deviation|7.3|7.3|||
4143188|NCT00874276|3967556|B2|||Age||years|Mean|28.2|28.2|Standard Deviation|10.4|10.4|||
4143189|NCT00874276|3967557|B1|||Age||years|Mean|26.0|26.0|Standard Deviation|4.6|4.6|||
4143190|NCT00874276|3967555|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4143191|NCT00874276|3967556|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4143192|NCT00874276|3967557|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4143193|NCT00874276|3967555|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4143194|NCT00874276|3967556|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4143195|NCT00874276|3967557|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4143196|NCT00874276|3967555|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4143197|NCT00874276|3967556|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4143198|NCT00874276|3967557|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4143199|NCT00874250|3967566|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4143200|NCT00874250|3967566|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4143201|NCT00874250|3967566|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4143202|NCT00874250|3967566|B1|||Age||years|Mean|71.9|71.9|Standard Deviation|9.8|9.8|||
4143203|NCT00874120|3967578|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4143204|NCT00874120|3967579|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4143205|NCT00874120|3967580|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4143206|NCT00874120|3967578|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4143207|NCT00874120|3967579|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4143208|NCT00874120|3967580|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4143209|NCT00874120|3967578|B3|||Age||years|Mean|29.2|29.2|Standard Deviation|10.53|10.53|||
4143210|NCT00874120|3967579|B2|||Age||years|Mean|29.0|29.0|Standard Deviation|10.99|10.99|||
4143211|NCT00874120|3967580|B1|||Age||years|Mean|29.4|29.4|Standard Deviation|10.14|10.14|||
4143212|NCT00874094|3967587|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4143213|NCT00874094|3967587|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4143214|NCT00874094|3967587|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4143215|NCT00874094|3967587|B1|||Age||years|Mean|54.27|54.27|Standard Deviation|12.11|12.11|||
4143216|NCT00874094|3967587|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4143217|NCT00874094|3967587|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4143218|NCT00874094|3967587|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4143219|NCT00874029|3967594|B1|Guatemala||Region of Enrollment||participants|Number|23|23.0||||||
4143220|NCT00874029|3967594|B1|Mexico||Region of Enrollment||participants|Number|28|28.0||||||
4143221|NCT00874029|3967594|B1|United States||Region of Enrollment||participants|Number|86|86.0||||||
4143222|NCT00874029|3967594|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4143223|NCT00874029|3967594|B1||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4143224|NCT00874029|3967594|B1|Age Latin America (n=51)||Age||years|Median|40.7|40.7|Full Range|4.9|4.9|31.0|50.0|
4143225|NCT00874029|3967594|B1|Age US Sites (n=86)||Age||years|Median|43.4|43.4|Full Range|4.0|4.0|34.0|55.0|
4143226|NCT00874029|3967594|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4143227|NCT00874029|3967594|B1||Between 18 and 65 years|Age||Participants|Count of Participants|137|137.0||||||
4143228|NCT00874029|3967594|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4143229|NCT00873912|3967608|B3|United States||Region of Enrollment||participants|Number|300|300.0||||||
4143230|NCT00873912|3967609|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
4143231|NCT00873912|3967610|B1|United States||Region of Enrollment||participants|Number|240|240.0||||||
4143232|NCT00873912|3967608|B3|Other||Race (NIH/OMB)||participants|Number|3|3.0||||||
4143233|NCT00873912|3967609|B2|Other||Race (NIH/OMB)||participants|Number|0|0.0||||||
4143234|NCT00873912|3967610|B1|Other||Race (NIH/OMB)||participants|Number|3|3.0||||||
4143235|NCT00873912|3967608|B3|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4143236|NCT00873912|3967609|B2|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4143237|NCT00873912|3967610|B1|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4143238|NCT00873912|3967608|B3|More than one race||Race (NIH/OMB)||participants|Number|5|5.0||||||
4143239|NCT00873912|3967609|B2|More than one race||Race (NIH/OMB)||participants|Number|1|1.0||||||
4143240|NCT00873912|3967610|B1|More than one race||Race (NIH/OMB)||participants|Number|4|4.0||||||
4143241|NCT00873912|3967608|B3|White||Race (NIH/OMB)||participants|Number|256|256.0||||||
4143242|NCT00873912|3967609|B2|White||Race (NIH/OMB)||participants|Number|50|50.0||||||
4143243|NCT00873912|3967610|B1|White||Race (NIH/OMB)||participants|Number|206|206.0||||||
4143244|NCT00873912|3967608|B3|Black or African American||Race (NIH/OMB)||participants|Number|23|23.0||||||
4143245|NCT00873912|3967609|B2|Black or African American||Race (NIH/OMB)||participants|Number|5|5.0||||||
4143246|NCT00873912|3967610|B1|Black or African American||Race (NIH/OMB)||participants|Number|18|18.0||||||
4143247|NCT00873912|3967608|B3|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4143248|NCT00873912|3967609|B2|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4143249|NCT00873912|3967610|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4143250|NCT00873912|3967608|B3|Asian||Race (NIH/OMB)||participants|Number|4|4.0||||||
4143251|NCT00873912|3967609|B2|Asian||Race (NIH/OMB)||participants|Number|2|2.0||||||
4143252|NCT00873912|3967610|B1|Asian||Race (NIH/OMB)||participants|Number|2|2.0||||||
4143253|NCT00873912|3967608|B3|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|9|9.0||||||
4143254|NCT00873912|3967609|B2|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|2|2.0||||||
4143255|NCT00873912|3967610|B1|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|7|7.0||||||
4143256|NCT00873912|3967608|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143257|NCT00873912|3967609|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143258|NCT00873912|3967610|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143259|NCT00873912|3967608|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|254|254.0||||||
4143260|NCT00873912|3967609|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4143261|NCT00873912|3967610|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|204|204.0||||||
4143262|NCT00873912|3967608|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4143263|NCT00873912|3967609|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4143264|NCT00873912|3967610|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4143265|NCT00873912|3967608|B3||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4143266|NCT00873912|3967609|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4143267|NCT00873912|3967610|B1||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4143268|NCT00873912|3967608|B3||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4143269|NCT00873912|3967609|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4143270|NCT00873912|3967610|B1||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4143271|NCT00873912|3967608|B3|||Age||years|Mean|31.9|31.9|Standard Deviation|8.2|8.2|||
4143272|NCT00873912|3967609|B2|||Age||years|Mean|30.9|30.9|Standard Deviation|8.6|8.6|||
4143273|NCT00873912|3967610|B1|||Age||years|Mean|32.2|32.2|Standard Deviation|8.1|8.1|||
4143274|NCT00873873|3967625|B5|United States||Region of Enrollment||participants|Number|55|55.0||||||
4143275|NCT00873873|3967626|B4|United States||Region of Enrollment||participants|Number|18|18.0||||||
4143276|NCT00873873|3967627|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4143277|NCT00873873|3967628|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4143278|NCT00873873|3967629|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4143279|NCT00873873|3967625|B5||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4143280|NCT00873873|3967626|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4143281|NCT00873873|3967627|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4143282|NCT00873873|3967628|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4143283|NCT00873873|3967629|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4143284|NCT00873873|3967625|B5||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4143285|NCT00873873|3967626|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4143286|NCT00873873|3967627|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4143287|NCT00873873|3967628|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4143288|NCT00873873|3967629|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4143289|NCT00873873|3967625|B5|||Age||years|Mean|20.0|20.0|Standard Deviation|2.1|2.1|||
4143290|NCT00873873|3967626|B4|||Age||years|Mean|19.9|19.9|Standard Deviation|2.0|2.0|||
4143291|NCT00873873|3967627|B3|||Age||years|Mean|20.8|20.8|Standard Deviation|2.4|2.4|||
4143292|NCT00873873|3967628|B2|||Age||years|Mean|18.9|18.9|Standard Deviation|2.0|2.0|||
4143293|NCT00873873|3967629|B1|||Age||years|Mean|20.0|20.0|Standard Deviation|2.1|2.1|||
4143294|NCT00873873|3967625|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4143295|NCT00873873|3967626|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4143296|NCT00873873|3967627|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4143297|NCT00873873|3967628|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4143298|NCT00873873|3967629|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4143299|NCT00873873|3967625|B5||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4143300|NCT00873873|3967626|B4||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4143301|NCT00873873|3967627|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4143302|NCT00873873|3967628|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4143303|NCT00873873|3967629|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4143304|NCT00873873|3967625|B5||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4143305|NCT00873873|3967626|B4||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4143306|NCT00873873|3967627|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4143307|NCT00873873|3967628|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4143308|NCT00873873|3967629|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4143309|NCT00873860|3967646|B5||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4143310|NCT00873860|3967647|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4143311|NCT00873860|3967648|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4143312|NCT00873860|3967649|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4143313|NCT00873860|3967650|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4143314|NCT00873860|3967646|B5||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4143315|NCT00873860|3967647|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4143316|NCT00873860|3967648|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4143317|NCT00873860|3967649|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4143318|NCT00873860|3967650|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4143319|NCT00873860|3967646|B5|||Age||years|Mean|47.3|47.3|Standard Deviation|10.8|10.8|||
4143320|NCT00873860|3967647|B4|||Age||years|Mean|49.8|49.8|Standard Deviation|10.4|10.4|||
4143321|NCT00873860|3967648|B3|||Age||years|Mean|48.7|48.7|Standard Deviation|11.0|11.0|||
4143322|NCT00873860|3967649|B2|||Age||years|Mean|43.4|43.4|Standard Deviation|11.1|11.1|||
4143323|NCT00873860|3967650|B1|||Age||years|Mean|47.2|47.2|Standard Deviation|9.8|9.8|||
4143324|NCT00873821|3967722|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4143325|NCT00873821|3967723|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4143326|NCT00873821|3967724|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4143327|NCT00873821|3967722|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4143328|NCT00873821|3967723|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4143329|NCT00873821|3967724|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4143330|NCT00873821|3967722|B3|37 to 70 years||Age, Customized||participants|Number|44|44.0||||||
4143331|NCT00873821|3967723|B2|37 to 70 years||Age, Customized||participants|Number|22|22.0||||||
4143332|NCT00873821|3967724|B1|37 to 70 years||Age, Customized||participants|Number|22|22.0||||||
4143333|NCT00873782|3967735|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4143334|NCT00873782|3967735|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4143335|NCT00873782|3967735|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4143336|NCT00873782|3967735|B1|||Age||years|Mean|31|31.0|Standard Deviation|8|8.0|||
4143337|NCT00873782|3967735|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4143338|NCT00873782|3967735|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4143339|NCT00873782|3967735|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4143340|NCT00873730|3967739|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4143341|NCT00873730|3967740|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4143342|NCT00873730|3967741|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4143343|NCT00873730|3967739|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4143344|NCT00873730|3967740|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4143345|NCT00873730|3967741|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4143346|NCT00873730|3967739|B3|||Age||years|Mean|41.43|41.43|Standard Deviation|10.53|10.53|||
4143347|NCT00873730|3967740|B2|||Age||years|Mean|42.63|42.63|Standard Deviation|10.66|10.66|||
4143348|NCT00873730|3967741|B1|||Age||years|Mean|40.22|40.22|Standard Deviation|10.36|10.36|||
4143349|NCT00873457|3967778|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4143350|NCT00873457|3967778|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4143351|NCT00873457|3967778|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4143352|NCT00873457|3967778|B1|>=65 years||Age, Customized||participants|Number|13|13.0||||||
4143353|NCT00873457|3967778|B1|Between 18 and 65 years||Age, Customized||participants|Number|3|3.0||||||
4143354|NCT00873457|3967778|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4143355|NCT00873457|3967778|B1|||Age||years|Median|69.5|69.5|Full Range|||62.0|87.0|
4143356|NCT00873366|3967785|B1||Invasive Breast Cancer in Metastatic|Disease Status||Participants|Count of Participants|1|1.0||||||
4143357|NCT00873366|3967785|B1||Invasive Breast Cancer in Adjuvant|Disease Status||Participants|Count of Participants|72|72.0||||||
4143358|NCT00873366|3967785|B1||Noninvasive Breast Cancer (DCIS)|Disease Status||Participants|Count of Participants|4|4.0||||||
4143359|NCT00873366|3967785|B1|||Body Mass Index (BMI)||kg/m^2|Median|26.8|26.8|Full Range|||18.9|47.8|
4143360|NCT00873366|3967785|B1||1=Symptomatic and fully ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|4|4.0||||||
4143361|NCT00873366|3967785|B1||0=Asymptomatic and fully active|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|73|73.0||||||
4143362|NCT00873366|3967785|B1|United States||Region of Enrollment||Participants|Count of Participants|77|77.0||||||
4143363|NCT00873366|3967785|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143364|NCT00873366|3967785|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143365|NCT00873366|3967785|B1||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4143366|NCT00873366|3967785|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4143367|NCT00873366|3967785|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143368|NCT00873366|3967785|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143369|NCT00873366|3967785|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4143370|NCT00873366|3967785|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143371|NCT00873366|3967785|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4143372|NCT00873366|3967785|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4143373|NCT00873366|3967785|B1|Female||Sex/Gender, Customized||Participants|Count of Participants|77|77.0||||||
4143374|NCT00873366|3967785|B1|||Age||years|Median|52|52.0|Full Range|||28.0|86.0|
4143375|NCT00873327|3967804|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4143376|NCT00873327|3967804|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4143377|NCT00873327|3967804|B1|||Age||years|Mean|0.1|0.1|Standard Deviation|0|0.0|||
4143378|NCT00873327|3967804|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4143379|NCT00873327|3967804|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4143380|NCT00873327|3967804|B1||<=18 years|Age||Participants|Count of Participants|32|32.0||||||
4143381|NCT00873119|3967808|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4143382|NCT00873119|3967809|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4143383|NCT00873119|3967810|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4143384|NCT00873119|3967808|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4143385|NCT00873119|3967809|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4143386|NCT00873119|3967810|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4143387|NCT00873119|3967808|B3||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4143388|NCT00873119|3967809|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4143389|NCT00873119|3967810|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4143390|NCT00873119|3967808|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4143391|NCT00873119|3967809|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4143392|NCT00873119|3967810|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4143393|NCT00873119|3967808|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4143394|NCT00873119|3967809|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4143395|NCT00873119|3967810|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4143396|NCT00873093|3967827|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4143397|NCT00873093|3967828|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143398|NCT00873093|3967829|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4143399|NCT00873093|3967830|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4143400|NCT00873093|3967831|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4143401|NCT00873093|3967832|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4143402|NCT00873093|3967827|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143403|NCT00873093|3967828|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143404|NCT00873093|3967829|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143405|NCT00873093|3967830|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143406|NCT00873093|3967831|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143407|NCT00873093|3967832|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143408|NCT00873093|3967827|B6||White|Race (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
4143409|NCT00873093|3967828|B5||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4143410|NCT00873093|3967829|B4||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4143411|NCT00873093|3967830|B3||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4143412|NCT00873093|3967831|B2||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4143413|NCT00873093|3967832|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4143414|NCT00873093|3967827|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4143415|NCT00873093|3967828|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4143416|NCT00873093|3967829|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4143417|NCT00873093|3967830|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4143418|NCT00873093|3967831|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4143419|NCT00873093|3967832|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143420|NCT00873093|3967827|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4143421|NCT00873093|3967828|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4143422|NCT00873093|3967829|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143423|NCT00873093|3967830|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143424|NCT00873093|3967831|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143425|NCT00873093|3967832|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4143426|NCT00873093|3967827|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4143427|NCT00873093|3967828|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143428|NCT00873093|3967829|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4143429|NCT00873093|3967830|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4143430|NCT00873093|3967831|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4143431|NCT00873093|3967832|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143432|NCT00873093|3967827|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4143433|NCT00873093|3967828|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143434|NCT00873093|3967829|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4143435|NCT00873093|3967830|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4143436|NCT00873093|3967831|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4143437|NCT00873093|3967832|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143438|NCT00873093|3967827|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4143439|NCT00873093|3967828|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143440|NCT00873093|3967829|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143441|NCT00873093|3967830|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143442|NCT00873093|3967831|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4143443|NCT00873093|3967832|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143444|NCT00873093|3967827|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
4143445|NCT00873093|3967828|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4143446|NCT00873093|3967829|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4143447|NCT00873093|3967830|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4143448|NCT00873093|3967831|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4143449|NCT00873093|3967832|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4143450|NCT00873093|3967827|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4143451|NCT00873093|3967828|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143452|NCT00873093|3967829|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4143453|NCT00873093|3967830|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4143454|NCT00873093|3967831|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4143455|NCT00873093|3967832|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4143456|NCT00873093|3967827|B6||Male|Gender||Participants|Count of Participants|85|85.0||||||
4143457|NCT00873093|3967828|B5||Male|Gender||Participants|Count of Participants|5|5.0||||||
4143458|NCT00873093|3967829|B4||Male|Gender||Participants|Count of Participants|17|17.0||||||
4143459|NCT00873093|3967830|B3||Male|Gender||Participants|Count of Participants|28|28.0||||||
4143460|NCT00873093|3967831|B2||Male|Gender||Participants|Count of Participants|33|33.0||||||
4143461|NCT00873093|3967832|B1||Male|Gender||Participants|Count of Participants|2|2.0||||||
4143462|NCT00873093|3967827|B6||Female|Gender||Participants|Count of Participants|63|63.0||||||
4143463|NCT00873093|3967828|B5||Female|Gender||Participants|Count of Participants|5|5.0||||||
4143464|NCT00873093|3967829|B4||Female|Gender||Participants|Count of Participants|6|6.0||||||
4143465|NCT00873093|3967830|B3||Female|Gender||Participants|Count of Participants|21|21.0||||||
4143466|NCT00873093|3967831|B2||Female|Gender||Participants|Count of Participants|29|29.0||||||
4143467|NCT00873093|3967832|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
4143468|NCT00873093|3967827|B6|||Age||years|Mean|10.91|10.91|Standard Deviation|6.23|6.23|||
4143469|NCT00873093|3967828|B5|||Age||years|Mean|13.79|13.79|Standard Deviation|6.27|6.27|||
4143470|NCT00873093|3967829|B4|||Age||years|Mean|13.00|13.0|Standard Deviation|5.28|5.28|||
4143471|NCT00873093|3967830|B3|||Age||years|Mean|9.27|9.27|Standard Deviation|6.06|6.06|||
4143472|NCT00873093|3967831|B2|||Age||years|Mean|10.16|10.16|Standard Deviation|5.77|5.77|||
4143473|NCT00873093|3967832|B1|||Age||years|Mean|23.14|23.14|Standard Deviation|0.57|0.57|||
4143474|NCT00873093|3967827|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4143475|NCT00873093|3967828|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4143476|NCT00873093|3967829|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4143477|NCT00873093|3967830|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4143478|NCT00873093|3967831|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4143479|NCT00873093|3967832|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4143480|NCT00873093|3967827|B6||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4143481|NCT00873093|3967828|B5||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4143482|NCT00873093|3967829|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4143483|NCT00873093|3967830|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4143484|NCT00873093|3967831|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4143485|NCT00873093|3967832|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4143486|NCT00873093|3967827|B6||<=18 years|Age||Participants|Count of Participants|126|126.0||||||
4143487|NCT00873093|3967828|B5||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4143488|NCT00873093|3967829|B4||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
4143489|NCT00873093|3967830|B3||<=18 years|Age||Participants|Count of Participants|45|45.0||||||
4143490|NCT00873093|3967831|B2||<=18 years|Age||Participants|Count of Participants|53|53.0||||||
4143491|NCT00873093|3967832|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4143492|NCT00873041|3967890|B4||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4143493|NCT00873041|3967891|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4143494|NCT00873041|3967892|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4143495|NCT00873041|3967893|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4143496|NCT00873041|3967890|B4||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4143497|NCT00873041|3967891|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4143498|NCT00873041|3967892|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4143499|NCT00873041|3967893|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4143500|NCT00873041|3967890|B4|>=65 years||Age, Customized||Participants|Number|1|1.0||||||
4143501|NCT00873041|3967891|B3|>=65 years||Age, Customized||Participants|Number|0|0.0||||||
4143502|NCT00873041|3967892|B2|>=65 years||Age, Customized||Participants|Number|1|1.0||||||
4143503|NCT00873041|3967893|B1|>=65 years||Age, Customized||Participants|Number|0|0.0||||||
4143504|NCT00873041|3967890|B4|Between 18 and 65 years||Age, Customized||Participants|Number|144|144.0||||||
4143505|NCT00873041|3967891|B3|Between 18 and 65 years||Age, Customized||Participants|Number|48|48.0||||||
4143506|NCT00873041|3967892|B2|Between 18 and 65 years||Age, Customized||Participants|Number|47|47.0||||||
4143507|NCT00873041|3967893|B1|Between 18 and 65 years||Age, Customized||Participants|Number|49|49.0||||||
4143508|NCT00873041|3967890|B4|<18 years||Age, Customized||Participants|Number|21|21.0||||||
4143509|NCT00873041|3967891|B3|<18 years||Age, Customized||Participants|Number|8|8.0||||||
4143510|NCT00873041|3967892|B2|<18 years||Age, Customized||Participants|Number|7|7.0||||||
4143511|NCT00873041|3967893|B1|<18 years||Age, Customized||Participants|Number|6|6.0||||||
4143512|NCT00873015|3967949|B5|United States||Region of Enrollment||participants|Number|19|19.0||||||
4143513|NCT00873015|3967950|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
4143514|NCT00873015|3967951|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4143515|NCT00873015|3967952|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4143516|NCT00873015|3967953|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4143517|NCT00873015|3967949|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4143518|NCT00873015|3967950|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4143519|NCT00873015|3967951|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4143520|NCT00873015|3967952|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4143521|NCT00873015|3967953|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4143522|NCT00873015|3967949|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4143523|NCT00873015|3967950|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4143524|NCT00873015|3967951|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4143525|NCT00873015|3967952|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4143526|NCT00873015|3967953|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4143527|NCT00873015|3967949|B5|||Age||years|Mean|51|51.0|Standard Deviation|9.9|9.9|||
4143528|NCT00873015|3967950|B4|||Age||years|Mean|58|58.0|Standard Deviation|7|7.0|||
4143529|NCT00873015|3967951|B3|||Age||years|Mean|50|50.0|Standard Deviation|5|5.0|||
4143530|NCT00873015|3967952|B2|||Age||years|Mean|52|52.0|Standard Deviation|18.3|18.3|||
4143531|NCT00873015|3967953|B1|||Age||years|Mean|50|50.0|Standard Deviation|10|10.0|||
4143532|NCT00873015|3967949|B5||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4143533|NCT00873015|3967950|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4143534|NCT00873015|3967951|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4143535|NCT00873015|3967952|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4143536|NCT00873015|3967953|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4143537|NCT00873015|3967949|B5||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4143538|NCT00873015|3967950|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4143539|NCT00873015|3967951|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4143540|NCT00873015|3967952|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4143541|NCT00873015|3967953|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4143542|NCT00873015|3967949|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4143543|NCT00873015|3967950|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4143544|NCT00873015|3967951|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4143545|NCT00873015|3967952|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4143546|NCT00873015|3967953|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4143547|NCT00872989|3967963|B3|||Prior treatment with platinum for recurrent disease||participants|Number|62|62.0||||||
4143548|NCT00872989|3967964|B2|||Prior treatment with platinum for recurrent disease||participants|Number|28|28.0||||||
4143549|NCT00872989|3967965|B1|||Prior treatment with platinum for recurrent disease||participants|Number|34|34.0||||||
4143550|NCT00872989|3967963|B3|> 35 units/mL||Baseline serum level of cancer-antigen 125 (CA-125)|The cutoff point for CA-125 is 35 units/mL. Anything above 35 units/mL is abnormal.|participants|Number|102|102.0||||||
4143551|NCT00872989|3967964|B2|> 35 units/mL||Baseline serum level of cancer-antigen 125 (CA-125)|The cutoff point for CA-125 is 35 units/mL. Anything above 35 units/mL is abnormal.|participants|Number|53|53.0||||||
4143552|NCT00872989|3967965|B1|> 35 units/mL||Baseline serum level of cancer-antigen 125 (CA-125)|The cutoff point for CA-125 is 35 units/mL. Anything above 35 units/mL is abnormal.|participants|Number|49|49.0||||||
4143553|NCT00872989|3967963|B3|≤ 35 units/mL||Baseline serum level of cancer-antigen 125 (CA-125)|The cutoff point for CA-125 is 35 units/mL. Anything above 35 units/mL is abnormal.|participants|Number|27|27.0||||||
4143554|NCT00872989|3967964|B2|≤ 35 units/mL||Baseline serum level of cancer-antigen 125 (CA-125)|The cutoff point for CA-125 is 35 units/mL. Anything above 35 units/mL is abnormal.|participants|Number|10|10.0||||||
4143555|NCT00872989|3967965|B1|≤ 35 units/mL||Baseline serum level of cancer-antigen 125 (CA-125)|The cutoff point for CA-125 is 35 units/mL. Anything above 35 units/mL is abnormal.|participants|Number|17|17.0||||||
4143556|NCT00872989|3967963|B3|2||Performance Status|"Patients performance status (PS) are graded into five grades. In this trial, only patients with PS 0-2 are included. The criteria for each grade are the followings:~0: Fully active, able to carry on all pre-disease performance without restriction;~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work;~Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours."|participants|Number|6|6.0||||||
4143557|NCT00872989|3967964|B2|2||Performance Status|"Patients performance status (PS) are graded into five grades. In this trial, only patients with PS 0-2 are included. The criteria for each grade are the followings:~0: Fully active, able to carry on all pre-disease performance without restriction;~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work;~Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours."|participants|Number|4|4.0||||||
4143558|NCT00872989|3967965|B1|2||Performance Status|"Patients performance status (PS) are graded into five grades. In this trial, only patients with PS 0-2 are included. The criteria for each grade are the followings:~0: Fully active, able to carry on all pre-disease performance without restriction;~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work;~Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours."|participants|Number|2|2.0||||||
4143559|NCT00872989|3967963|B3|1||Performance Status|"Patients performance status (PS) are graded into five grades. In this trial, only patients with PS 0-2 are included. The criteria for each grade are the followings:~0: Fully active, able to carry on all pre-disease performance without restriction;~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work;~Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours."|participants|Number|53|53.0||||||
4143560|NCT00872989|3967964|B2|1||Performance Status|"Patients performance status (PS) are graded into five grades. In this trial, only patients with PS 0-2 are included. The criteria for each grade are the followings:~0: Fully active, able to carry on all pre-disease performance without restriction;~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work;~Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours."|participants|Number|26|26.0||||||
4143611|NCT00872898|3967983|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4143612|NCT00872898|3967984|B2|United States||Region of Enrollment||participants|Number|61|61.0||||||
4143613|NCT00872898|3967985|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4143561|NCT00872989|3967965|B1|1||Performance Status|"Patients performance status (PS) are graded into five grades. In this trial, only patients with PS 0-2 are included. The criteria for each grade are the followings:~0: Fully active, able to carry on all pre-disease performance without restriction;~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work;~Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours."|participants|Number|27|27.0||||||
4143562|NCT00872989|3967963|B3|0||Performance Status|"Patients performance status (PS) are graded into five grades. In this trial, only patients with PS 0-2 are included. The criteria for each grade are the followings:~0: Fully active, able to carry on all pre-disease performance without restriction;~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work;~Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours."|participants|Number|70|70.0||||||
4143563|NCT00872989|3967964|B2|0||Performance Status|"Patients performance status (PS) are graded into five grades. In this trial, only patients with PS 0-2 are included. The criteria for each grade are the followings:~0: Fully active, able to carry on all pre-disease performance without restriction;~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work;~Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours."|participants|Number|33|33.0||||||
4143564|NCT00872989|3967965|B1|0||Performance Status|"Patients performance status (PS) are graded into five grades. In this trial, only patients with PS 0-2 are included. The criteria for each grade are the followings:~0: Fully active, able to carry on all pre-disease performance without restriction;~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work;~Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours."|participants|Number|37|37.0||||||
4143565|NCT00872989|3967963|B3|Peritoneal||Primary Site||participants|Number|13|13.0||||||
4143566|NCT00872989|3967964|B2|Peritoneal||Primary Site||participants|Number|6|6.0||||||
4143567|NCT00872989|3967965|B1|Peritoneal||Primary Site||participants|Number|7|7.0||||||
4143568|NCT00872989|3967963|B3|Ovary||Primary Site||participants|Number|109|109.0||||||
4143569|NCT00872989|3967964|B2|Ovary||Primary Site||participants|Number|53|53.0||||||
4143570|NCT00872989|3967965|B1|Ovary||Primary Site||participants|Number|56|56.0||||||
4143571|NCT00872989|3967963|B3|Fallopian Tube||Primary Site||participants|Number|7|7.0||||||
4143572|NCT00872989|3967964|B2|Fallopian Tube||Primary Site||participants|Number|4|4.0||||||
4143573|NCT00872989|3967965|B1|Fallopian Tube||Primary Site||participants|Number|3|3.0||||||
4143574|NCT00872989|3967963|B3|No||Prior Antiangiogenic Therapy||participants|Number|108|108.0||||||
4143575|NCT00872989|3967964|B2|No||Prior Antiangiogenic Therapy||participants|Number|54|54.0||||||
4143576|NCT00872989|3967965|B1|No||Prior Antiangiogenic Therapy||participants|Number|54|54.0||||||
4143577|NCT00872989|3967963|B3|Yes||Prior Antiangiogenic Therapy||participants|Number|21|21.0||||||
4143578|NCT00872989|3967964|B2|Yes||Prior Antiangiogenic Therapy||participants|Number|9|9.0||||||
4143579|NCT00872989|3967965|B1|Yes||Prior Antiangiogenic Therapy||participants|Number|12|12.0||||||
4143580|NCT00872989|3967963|B3|Unknown||Hispanic||participants|Number|1|1.0||||||
4143581|NCT00872989|3967964|B2|Unknown||Hispanic||participants|Number|1|1.0||||||
4143582|NCT00872989|3967965|B1|Unknown||Hispanic||participants|Number|0|0.0||||||
4143583|NCT00872989|3967963|B3|No||Hispanic||participants|Number|122|122.0||||||
4143584|NCT00872989|3967964|B2|No||Hispanic||participants|Number|58|58.0||||||
4143585|NCT00872989|3967965|B1|No||Hispanic||participants|Number|64|64.0||||||
4143586|NCT00872989|3967963|B3|Yes||Hispanic||participants|Number|6|6.0||||||
4143587|NCT00872989|3967964|B2|Yes||Hispanic||participants|Number|4|4.0||||||
4143588|NCT00872989|3967965|B1|Yes||Hispanic||participants|Number|2|2.0||||||
4143589|NCT00872989|3967963|B3|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4143590|NCT00872989|3967964|B2|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4143591|NCT00872989|3967965|B1|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4143592|NCT00872989|3967963|B3|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4143593|NCT00872989|3967964|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4143594|NCT00872989|3967965|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4143595|NCT00872989|3967963|B3|Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4143596|NCT00872989|3967964|B2|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4143597|NCT00872989|3967965|B1|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4143598|NCT00872989|3967963|B3|White||Race/Ethnicity, Customized||participants|Number|114|114.0||||||
4143599|NCT00872989|3967964|B2|White||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
4143600|NCT00872989|3967965|B1|White||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
4143601|NCT00872989|3967963|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
4143602|NCT00872989|3967964|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
4143603|NCT00872989|3967965|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4143604|NCT00872989|3967963|B3||Female|Gender||Participants|Count of Participants|129|129.0||||||
4143605|NCT00872989|3967964|B2||Female|Gender||Participants|Count of Participants|63|63.0||||||
4143606|NCT00872989|3967965|B1||Female|Gender||Participants|Count of Participants|66|66.0||||||
4143607|NCT00872989|3967963|B3|||Age||years|Median|61.9|61.9|Full Range|||32.6|82.5|
4143608|NCT00872989|3967964|B2|||Age||years|Median|61.9|61.9|Full Range|||34.3|82.5|
4143609|NCT00872989|3967965|B1|||Age||years|Median|61.7|61.7|Full Range|||32.6|80.0|
4143610|NCT00872898|3967982|B4|United States||Region of Enrollment||participants|Number|124|124.0||||||
4143614|NCT00872898|3967982|B4||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4143615|NCT00872898|3967983|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4143616|NCT00872898|3967984|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4143617|NCT00872898|3967985|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4143618|NCT00872898|3967982|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4143619|NCT00872898|3967983|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4143620|NCT00872898|3967984|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4143621|NCT00872898|3967985|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4143622|NCT00872898|3967982|B4|13 years to 18 years||Age, Customized||participants|Number|2|2.0||||||
4143623|NCT00872898|3967983|B3|13 years to 18 years||Age, Customized||participants|Number|1|1.0||||||
4143624|NCT00872898|3967984|B2|13 years to 18 years||Age, Customized||participants|Number|1|1.0||||||
4143625|NCT00872898|3967985|B1|13 years to 18 years||Age, Customized||participants|Number|0|0.0||||||
4143626|NCT00872898|3967982|B4|6 years to 12 years||Age, Customized||participants|Number|122|122.0||||||
4143627|NCT00872898|3967983|B3|6 years to 12 years||Age, Customized||participants|Number|59|59.0||||||
4143628|NCT00872898|3967984|B2|6 years to 12 years||Age, Customized||participants|Number|60|60.0||||||
4143629|NCT00872898|3967985|B1|6 years to 12 years||Age, Customized||participants|Number|3|3.0||||||
4143630|NCT00872898|3967982|B4|6 years to 18 years||Age||years|Mean|9.0|9.0|Standard Deviation|0.1|0.1|||
4143631|NCT00872898|3967983|B3|6 years to 18 years||Age||years|Mean|9.0|9.0|Standard Deviation|2.2|2.2|||
4143632|NCT00872898|3967984|B2|6 years to 18 years||Age||years|Mean|8.9|8.9|Standard Deviation|2.2|2.2|||
4143633|NCT00872898|3967985|B1|6 years to 18 years||Age||years|Mean|9.0|9.0|Standard Deviation|2.6|2.6|||
4143634|NCT00872833|3968020|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4143635|NCT00872833|3968020|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4143636|NCT00872833|3968020|B1|||Age||years|Mean|31.8|31.8|Standard Deviation|10.5|10.5|||
4143637|NCT00872729|3968030|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4143638|NCT00872729|3968030|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4143639|NCT00872729|3968030|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4143640|NCT00872729|3968030|B1|||Age||years|Mean|12.8|12.8|Standard Deviation|4.76|4.76|||
4143641|NCT00872729|3968030|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4143642|NCT00872729|3968030|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4143643|NCT00872729|3968030|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4143644|NCT00872599|3968060|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4143645|NCT00872599|3968060|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4143646|NCT00872599|3968060|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4143647|NCT00872599|3968060|B1|||Age||years|Mean|43.4|43.4|Standard Deviation|11.6|11.6|||
4143648|NCT00872599|3968060|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4143649|NCT00872599|3968060|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4143650|NCT00872599|3968060|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4143651|NCT00872534|3968069|B3||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4143652|NCT00872534|3968070|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4143653|NCT00872534|3968071|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4143654|NCT00872534|3968069|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4143655|NCT00872534|3968070|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4143656|NCT00872534|3968071|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4143657|NCT00872534|3968069|B3|||Age||years|Mean|57.3|57.3|Standard Deviation|6.20|6.2|||
4143658|NCT00872534|3968070|B2|||Age||years|Mean|56.6|56.6|Standard Deviation|6.00|6.0|||
4143659|NCT00872534|3968071|B1|||Age||years|Mean|58.1|58.1|Standard Deviation|6.35|6.35|||
4143660|NCT00872521|3968078|B4|Missing race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4143661|NCT00872521|3968079|B3|Missing race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4143662|NCT00872521|3968080|B2|Missing race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4143663|NCT00872521|3968081|B1|Missing race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4143664|NCT00872521|3968078|B4|Appears White||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4143665|NCT00872521|3968079|B3|Appears White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4143666|NCT00872521|3968080|B2|Appears White||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4143667|NCT00872521|3968081|B1|Appears White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4143668|NCT00872521|3968078|B4|South American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4143669|NCT00872521|3968079|B3|South American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4143670|NCT00872521|3968080|B2|South American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4143671|NCT00872521|3968081|B1|South American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4143672|NCT00872521|3968078|B4|Middle Eastern||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4143673|NCT00872521|3968079|B3|Middle Eastern||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4143674|NCT00872521|3968080|B2|Middle Eastern||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4143675|NCT00872521|3968081|B1|Middle Eastern||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4143676|NCT00872521|3968078|B4|Indian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4143677|NCT00872521|3968079|B3|Indian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4143678|NCT00872521|3968080|B2|Indian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4143679|NCT00872521|3968081|B1|Indian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4143680|NCT00872521|3968078|B4|Mauritian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4143681|NCT00872521|3968079|B3|Mauritian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4143682|NCT00872521|3968080|B2|Mauritian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4143683|NCT00872521|3968081|B1|Mauritian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4143684|NCT00872521|3968078|B4|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4143685|NCT00872521|3968079|B3|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4143686|NCT00872521|3968080|B2|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4143687|NCT00872521|3968081|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4143688|NCT00872521|3968078|B4|White||Race/Ethnicity, Customized||Participants|Number|94|94.0||||||
4143689|NCT00872521|3968079|B3|White||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4143690|NCT00872521|3968080|B2|White||Race/Ethnicity, Customized||Participants|Number|63|63.0||||||
4143691|NCT00872521|3968081|B1|White||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
4143692|NCT00872521|3968078|B4||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4143693|NCT00872521|3968079|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4143694|NCT00872521|3968080|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4143695|NCT00872521|3968081|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4143696|NCT00872521|3968078|B4||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4143697|NCT00872521|3968079|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4143698|NCT00872521|3968080|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4143699|NCT00872521|3968081|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4143700|NCT00872521|3968078|B4|||Age||Years|Mean|57.9|57.9|Standard Deviation|9.3|9.3|||
4143701|NCT00872521|3968079|B3|||Age||Years|Mean|55.6|55.6|Standard Deviation|8.1|8.1|||
4143702|NCT00872521|3968080|B2|||Age||Years|Mean|58.1|58.1|Standard Deviation|10.1|10.1|||
4143703|NCT00872521|3968081|B1|||Age||Years|Mean|58.0|58.0|Standard Deviation|7.6|7.6|||
4143704|NCT00872430|3968129|B3|Brazil||Region of Enrollment||participants|Number|20|20.0||||||
4143705|NCT00872430|3968130|B2|Brazil||Region of Enrollment||participants|Number|10|10.0||||||
4143706|NCT00872430|3968131|B1|Brazil||Region of Enrollment||participants|Number|10|10.0||||||
4143707|NCT00872430|3968129|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4143708|NCT00872430|3968130|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4143709|NCT00872430|3968131|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4143710|NCT00872430|3968129|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4143711|NCT00872430|3968130|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4143712|NCT00872430|3968131|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4143713|NCT00872430|3968129|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4143714|NCT00872430|3968130|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4143715|NCT00872430|3968131|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4143716|NCT00872430|3968129|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4143717|NCT00872430|3968130|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4143718|NCT00872430|3968131|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4143719|NCT00872430|3968129|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4143720|NCT00872430|3968130|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4143721|NCT00872430|3968131|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4143722|NCT00872339|3968138|B4||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4143723|NCT00872339|3968139|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4143724|NCT00872339|3968140|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4143725|NCT00872339|3968141|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4143726|NCT00872339|3968138|B4||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4143727|NCT00872339|3968139|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4143728|NCT00872339|3968140|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4143729|NCT00872339|3968141|B1||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4143730|NCT00872339|3968138|B4|||Age||years|Mean|28.8|28.8|Standard Deviation|11.8|11.8|||
4143731|NCT00872339|3968139|B3|||Age||years|Mean|29.5|29.5|Standard Deviation|16.2|16.2|||
4143732|NCT00872339|3968140|B2|||Age||years|Mean|35.8|35.8|Standard Deviation|14.4|14.4|||
4143733|NCT00872339|3968141|B1|||Age||years|Mean|28.2|28.2|Standard Deviation|10.4|10.4|||
4143734|NCT00872170|3968152|B3|Lebanon||Region of Enrollment||participants|Number|2|2.0||||||
4143735|NCT00872170|3968153|B2|Lebanon||Region of Enrollment||participants|Number|0|0.0||||||
4143736|NCT00872170|3968154|B1|Lebanon||Region of Enrollment||participants|Number|2|2.0||||||
4143737|NCT00872170|3968152|B3|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
4143738|NCT00872170|3968153|B2|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4143739|NCT00872170|3968154|B1|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4143740|NCT00872170|3968152|B3|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4143741|NCT00872170|3968153|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4143742|NCT00872170|3968154|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4143743|NCT00872170|3968152|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4143744|NCT00872170|3968153|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4143745|NCT00872170|3968154|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4143746|NCT00872170|3968152|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4143747|NCT00872170|3968153|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4143748|NCT00872170|3968154|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4143749|NCT00872170|3968152|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4143750|NCT00872170|3968153|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4143751|NCT00872170|3968154|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4143752|NCT00872170|3968152|B3|||Age||years|Mean|34.7|34.7|Standard Deviation|11.7|11.7|||
4143753|NCT00872170|3968153|B2|||Age||years|Mean|33.7|33.7|Standard Deviation|12.6|12.6|||
4143754|NCT00872170|3968154|B1|||Age||years|Mean|35.6|35.6|Standard Deviation|11.3|11.3|||
4143755|NCT00872079|3968170|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143756|NCT00872079|3968170|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143757|NCT00872079|3968170|B1||White|Race (NIH/OMB)||Participants|Count of Participants|157|157.0||||||
4143758|NCT00872079|3968170|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4143759|NCT00872079|3968170|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4143760|NCT00872079|3968170|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143761|NCT00872079|3968170|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143762|NCT00872079|3968170|B1||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4143763|NCT00872079|3968170|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4143764|NCT00872079|3968170|B1||>=65 years|Age||Participants|Count of Participants|125|125.0||||||
4143765|NCT00872079|3968170|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4143766|NCT00872079|3968170|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4143767|NCT00872027|3968174|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4143768|NCT00872027|3968175|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4143769|NCT00872027|3968176|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4143770|NCT00872027|3968174|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4143771|NCT00872027|3968175|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4143772|NCT00872027|3968176|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4143773|NCT00872027|3968174|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4143774|NCT00872027|3968175|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4143775|NCT00872027|3968176|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4143776|NCT00872027|3968174|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4143777|NCT00872027|3968175|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4143778|NCT00872027|3968176|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4143779|NCT00872027|3968174|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4143780|NCT00872027|3968175|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4143781|NCT00872027|3968176|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4143782|NCT00872027|3968174|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4143783|NCT00872027|3968175|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4143784|NCT00872027|3968176|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4143785|NCT00872001|3968183|B3||Male|Sex: Female, Male||Participants|Count of Participants|2038|2038.0||||||
4143786|NCT00872001|3968184|B2||Male|Sex: Female, Male||Participants|Count of Participants|1021|1021.0||||||
4143787|NCT00872001|3968185|B1||Male|Sex: Female, Male||Participants|Count of Participants|1017|1017.0||||||
4143788|NCT00872001|3968183|B3||Female|Sex: Female, Male||Participants|Count of Participants|1042|1042.0||||||
4143789|NCT00872001|3968184|B2||Female|Sex: Female, Male||Participants|Count of Participants|523|523.0||||||
4143790|NCT00872001|3968185|B1||Female|Sex: Female, Male||Participants|Count of Participants|519|519.0||||||
4143791|NCT00872001|3968183|B3|||Age||years|Mean|66.5|66.5|Standard Deviation|8.6|8.6|||
4143792|NCT00872001|3968184|B2|||Age||years|Mean|66.7|66.7|Standard Deviation|8.7|8.7|||
4143793|NCT00872001|3968185|B1|||Age||years|Mean|66.2|66.2|Standard Deviation|8.5|8.5|||
4143794|NCT00871975|3968194|B1|United Kingdom||Region of Enrollment||participants|Number|100|100.0||||||
4143795|NCT00871975|3968194|B1|Canada||Region of Enrollment||participants|Number|37|37.0||||||
4143796|NCT00871975|3968194|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4143797|NCT00871975|3968194|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4143798|NCT00871975|3968194|B1||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4143799|NCT00871975|3968194|B1|Greater than or equal to 18 years||Age, Customized||participants|Number|155|155.0||||||
4143800|NCT00871871|3968198|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4143801|NCT00871871|3968199|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4143802|NCT00871871|3968200|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4143803|NCT00871871|3968198|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4143804|NCT00871871|3968199|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4143805|NCT00871871|3968200|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4143806|NCT00871871|3968198|B3|||Age||years|Mean|55|55.0|Full Range|||35.0|73.0|
4143807|NCT00871871|3968199|B2|||Age||years|Mean|54|54.0|Full Range|||37.0|73.0|
4143808|NCT00871871|3968200|B1|||Age||years|Mean|57|57.0|Full Range|||35.0|72.0|
4143809|NCT00871845|3968223|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4143810|NCT00871845|3968224|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4143811|NCT00871845|3968225|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4143812|NCT00871845|3968223|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4143813|NCT00871845|3968224|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4143814|NCT00871845|3968225|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4143815|NCT00871845|3968223|B3||Age ≤ 50 years|Age, Customized||Participants|Count of Participants|12|12.0||||||
4143816|NCT00871845|3968224|B2||Age ≤ 50 years|Age, Customized||Participants|Count of Participants|5|5.0||||||
4143817|NCT00871845|3968225|B1||Age ≤ 50 years|Age, Customized||Participants|Count of Participants|7|7.0||||||
4143818|NCT00871845|3968223|B3||Age > 50 years|Age, Customized||Participants|Count of Participants|24|24.0||||||
4143819|NCT00871845|3968224|B2||Age > 50 years|Age, Customized||Participants|Count of Participants|20|20.0||||||
4143820|NCT00871845|3968225|B1||Age > 50 years|Age, Customized||Participants|Count of Participants|4|4.0||||||
4143821|NCT00871819|3968236|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4143822|NCT00871819|3968236|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4143823|NCT00871819|3968236|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4143824|NCT00871819|3968236|B1|||Age||years|Mean|60|60.0|Standard Deviation|14|14.0|||
4143825|NCT00871819|3968236|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4143826|NCT00871819|3968236|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4143827|NCT00871819|3968236|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4143828|NCT00871780|3968240|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4143829|NCT00871780|3968240|B1||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4143830|NCT00871780|3968240|B1|||Age||years|Mean|35.1|35.1|Standard Deviation|9.56|9.56|||
4143831|NCT00871741|3968258|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143832|NCT00871741|3968259|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143833|NCT00871741|3968260|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143834|NCT00871741|3968258|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143835|NCT00871741|3968259|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143836|NCT00871741|3968260|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143837|NCT00871741|3968258|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4143838|NCT00871741|3968259|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4143839|NCT00871741|3968260|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4143840|NCT00871741|3968258|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143841|NCT00871741|3968259|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143842|NCT00871741|3968260|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143843|NCT00871741|3968258|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143844|NCT00871741|3968259|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143845|NCT00871741|3968260|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143846|NCT00871741|3968258|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143847|NCT00871741|3968259|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143848|NCT00871741|3968260|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143849|NCT00871741|3968258|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143850|NCT00871741|3968259|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143851|NCT00871741|3968260|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4143852|NCT00871741|3968258|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4143853|NCT00871741|3968259|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4143854|NCT00871741|3968260|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4143855|NCT00871741|3968258|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4143856|NCT00871741|3968259|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4143857|NCT00871741|3968260|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4143858|NCT00871741|3968258|B3|||Age||Weeks|Mean|13.28|13.28|Standard Deviation|2.02|2.02|||
4143859|NCT00871741|3968259|B2|||Age||Weeks|Mean|13.9|13.9|Standard Deviation|1.57|1.57|||
4143860|NCT00871741|3968260|B1|||Age||Weeks|Mean|12.8|12.8|Standard Deviation|2.28|2.28|||
4143861|NCT00871728|3968275|B1||Male|Sex: Female, Male|Data presented only for 117 participants as they were part of FAS population.|Participants|Count of Participants|70|70.0||||||
4143862|NCT00871728|3968275|B1||Female|Sex: Female, Male|Data presented only for 117 participants as they were part of FAS population.|Participants|Count of Participants|47|47.0||||||
4143863|NCT00871728|3968275|B1|||Age|Data presented only for 117 participants as they were part of Full Analysis Set (FAS) population.|years|Mean|44.6|44.6|Standard Deviation|10.42|10.42|||
4143864|NCT00871715|3968285|B4|||Amount of pre-randomization outpatient occupational therapy||hours|Mean|3.8|3.8|Standard Deviation|3.0|3.0|||
4143865|NCT00871715|3968286|B3|||Amount of pre-randomization outpatient occupational therapy||hours|Mean|3.7|3.7|Standard Deviation|3.4|3.4|||
4143866|NCT00871715|3968287|B2|||Amount of pre-randomization outpatient occupational therapy||hours|Mean|3.3|3.3|Standard Deviation|2.3|2.3|||
4143867|NCT00871715|3968288|B1|||Amount of pre-randomization outpatient occupational therapy||hours|Mean|4.4|4.4|Standard Deviation|3.1|3.1|||
4143868|NCT00871715|3968285|B4|||Pre-randomization outpatient occupational therapy||participants|Number|105|105.0||||||
4143869|NCT00871715|3968286|B3|||Pre-randomization outpatient occupational therapy||participants|Number|42|42.0||||||
4143870|NCT00871715|3968287|B2|||Pre-randomization outpatient occupational therapy||participants|Number|29|29.0||||||
4143871|NCT00871715|3968288|B1|||Pre-randomization outpatient occupational therapy||participants|Number|34|34.0||||||
4143872|NCT00871715|3968285|B4|Discordant||Concordance|Concordant: the paretic limb is the dominant limb. Discordant: the paretic limb is the non-dominant limb.|participants|Number|185|185.0||||||
4143873|NCT00871715|3968286|B3|Discordant||Concordance|Concordant: the paretic limb is the dominant limb. Discordant: the paretic limb is the non-dominant limb.|participants|Number|65|65.0||||||
4143874|NCT00871715|3968287|B2|Discordant||Concordance|Concordant: the paretic limb is the dominant limb. Discordant: the paretic limb is the non-dominant limb.|participants|Number|56|56.0||||||
4143875|NCT00871715|3968288|B1|Discordant||Concordance|Concordant: the paretic limb is the dominant limb. Discordant: the paretic limb is the non-dominant limb.|participants|Number|64|64.0||||||
4143876|NCT00871715|3968285|B4|Concordant||Concordance|Concordant: the paretic limb is the dominant limb. Discordant: the paretic limb is the non-dominant limb.|participants|Number|176|176.0||||||
4143877|NCT00871715|3968286|B3|Concordant||Concordance|Concordant: the paretic limb is the dominant limb. Discordant: the paretic limb is the non-dominant limb.|participants|Number|57|57.0||||||
4143878|NCT00871715|3968287|B2|Concordant||Concordance|Concordant: the paretic limb is the dominant limb. Discordant: the paretic limb is the non-dominant limb.|participants|Number|64|64.0||||||
4143879|NCT00871715|3968288|B1|Concordant||Concordance|Concordant: the paretic limb is the dominant limb. Discordant: the paretic limb is the non-dominant limb.|participants|Number|55|55.0||||||
4143880|NCT00871715|3968285|B4|High severity, late onset||Strata|"Severity: Upper extremity motor Fugl-Meyer score eligible range: 19-58 (low severity is greater than 35; high severity is less than 36).~Stroke onset, time to randomization: eligible range: 14-106 days (early onset is less than 60 days; late onset is greater than 59 days)."|participants|Number|36|36.0||||||
4143881|NCT00871715|3968286|B3|High severity, late onset||Strata|"Severity: Upper extremity motor Fugl-Meyer score eligible range: 19-58 (low severity is greater than 35; high severity is less than 36).~Stroke onset, time to randomization: eligible range: 14-106 days (early onset is less than 60 days; late onset is greater than 59 days)."|participants|Number|12|12.0||||||
4143882|NCT00871715|3968287|B2|High severity, late onset||Strata|"Severity: Upper extremity motor Fugl-Meyer score eligible range: 19-58 (low severity is greater than 35; high severity is less than 36).~Stroke onset, time to randomization: eligible range: 14-106 days (early onset is less than 60 days; late onset is greater than 59 days)."|participants|Number|12|12.0||||||
4143883|NCT00871715|3968288|B1|High severity, late onset||Strata|"Severity: Upper extremity motor Fugl-Meyer score eligible range: 19-58 (low severity is greater than 35; high severity is less than 36).~Stroke onset, time to randomization: eligible range: 14-106 days (early onset is less than 60 days; late onset is greater than 59 days)."|participants|Number|12|12.0||||||
4143884|NCT00871715|3968285|B4|High severity, early onset||Strata|"Severity: Upper extremity motor Fugl-Meyer score eligible range: 19-58 (low severity is greater than 35; high severity is less than 36).~Stroke onset, time to randomization: eligible range: 14-106 days (early onset is less than 60 days; late onset is greater than 59 days)."|participants|Number|70|70.0||||||
4143885|NCT00871715|3968286|B3|High severity, early onset||Strata|"Severity: Upper extremity motor Fugl-Meyer score eligible range: 19-58 (low severity is greater than 35; high severity is less than 36).~Stroke onset, time to randomization: eligible range: 14-106 days (early onset is less than 60 days; late onset is greater than 59 days)."|participants|Number|25|25.0||||||
4143886|NCT00871715|3968287|B2|High severity, early onset||Strata|"Severity: Upper extremity motor Fugl-Meyer score eligible range: 19-58 (low severity is greater than 35; high severity is less than 36).~Stroke onset, time to randomization: eligible range: 14-106 days (early onset is less than 60 days; late onset is greater than 59 days)."|participants|Number|22|22.0||||||
4143887|NCT00871715|3968288|B1|High severity, early onset||Strata|"Severity: Upper extremity motor Fugl-Meyer score eligible range: 19-58 (low severity is greater than 35; high severity is less than 36).~Stroke onset, time to randomization: eligible range: 14-106 days (early onset is less than 60 days; late onset is greater than 59 days)."|participants|Number|23|23.0||||||
4143888|NCT00871715|3968285|B4|Low severity, late onset||Strata|"Severity: Upper extremity motor Fugl-Meyer score eligible range: 19-58 (low severity is greater than 35; high severity is less than 36).~Stroke onset, time to randomization: eligible range: 14-106 days (early onset is less than 60 days; late onset is greater than 59 days)."|participants|Number|50|50.0||||||
4143889|NCT00871715|3968286|B3|Low severity, late onset||Strata|"Severity: Upper extremity motor Fugl-Meyer score eligible range: 19-58 (low severity is greater than 35; high severity is less than 36).~Stroke onset, time to randomization: eligible range: 14-106 days (early onset is less than 60 days; late onset is greater than 59 days)."|participants|Number|18|18.0||||||
4143890|NCT00871715|3968287|B2|Low severity, late onset||Strata|"Severity: Upper extremity motor Fugl-Meyer score eligible range: 19-58 (low severity is greater than 35; high severity is less than 36).~Stroke onset, time to randomization: eligible range: 14-106 days (early onset is less than 60 days; late onset is greater than 59 days)."|participants|Number|16|16.0||||||
4143891|NCT00871715|3968288|B1|Low severity, late onset||Strata|"Severity: Upper extremity motor Fugl-Meyer score eligible range: 19-58 (low severity is greater than 35; high severity is less than 36).~Stroke onset, time to randomization: eligible range: 14-106 days (early onset is less than 60 days; late onset is greater than 59 days)."|participants|Number|16|16.0||||||
4143892|NCT00871715|3968285|B4|Low severity, early onset||Strata|"Severity: Upper extremity motor Fugl-Meyer score eligible range: 19-58 (low severity is greater than 35; high severity is less than 36).~Stroke onset, time to randomization: eligible range: 14-106 days (early onset is less than 60 days; late onset is greater than 59 days)."|participants|Number|205|205.0||||||
4143893|NCT00871715|3968286|B3|Low severity, early onset||Strata|"Severity: Upper extremity motor Fugl-Meyer score eligible range: 19-58 (low severity is greater than 35; high severity is less than 36).~Stroke onset, time to randomization: eligible range: 14-106 days (early onset is less than 60 days; late onset is greater than 59 days)."|participants|Number|67|67.0||||||
4143894|NCT00871715|3968287|B2|Low severity, early onset||Strata|"Severity: Upper extremity motor Fugl-Meyer score eligible range: 19-58 (low severity is greater than 35; high severity is less than 36).~Stroke onset, time to randomization: eligible range: 14-106 days (early onset is less than 60 days; late onset is greater than 59 days)."|participants|Number|70|70.0||||||
4143895|NCT00871715|3968288|B1|Low severity, early onset||Strata|"Severity: Upper extremity motor Fugl-Meyer score eligible range: 19-58 (low severity is greater than 35; high severity is less than 36).~Stroke onset, time to randomization: eligible range: 14-106 days (early onset is less than 60 days; late onset is greater than 59 days)."|participants|Number|68|68.0||||||
4143896|NCT00871715|3968285|B4|National Institutes of Health Stroke Scale score||Stroke severity|"Upper Extremity Motor Fugl Meyer total score range 0-66; eligible range: 19-58. A lower score indicates greater impairment. For stratification purposes: low severity is greater than or equal to 36; high severity is less than 36.~National Institutes of Health Stroke Scale total score range 0-42; higher values represent greater severity."|units on a scale|Mean|3.6|3.6|Standard Deviation|1.8|1.8|||
4143897|NCT00871715|3968286|B3|National Institutes of Health Stroke Scale score||Stroke severity|"Upper Extremity Motor Fugl Meyer total score range 0-66; eligible range: 19-58. A lower score indicates greater impairment. For stratification purposes: low severity is greater than or equal to 36; high severity is less than 36.~National Institutes of Health Stroke Scale total score range 0-42; higher values represent greater severity."|units on a scale|Mean|3.7|3.7|Standard Deviation|1.7|1.7|||
4143898|NCT00871715|3968287|B2|National Institutes of Health Stroke Scale score||Stroke severity|"Upper Extremity Motor Fugl Meyer total score range 0-66; eligible range: 19-58. A lower score indicates greater impairment. For stratification purposes: low severity is greater than or equal to 36; high severity is less than 36.~National Institutes of Health Stroke Scale total score range 0-42; higher values represent greater severity."|units on a scale|Mean|3.4|3.4|Standard Deviation|1.7|1.7|||
4143899|NCT00871715|3968288|B1|National Institutes of Health Stroke Scale score||Stroke severity|"Upper Extremity Motor Fugl Meyer total score range 0-66; eligible range: 19-58. A lower score indicates greater impairment. For stratification purposes: low severity is greater than or equal to 36; high severity is less than 36.~National Institutes of Health Stroke Scale total score range 0-42; higher values represent greater severity."|units on a scale|Mean|3.6|3.6|Standard Deviation|2.0|2.0|||
4143900|NCT00871715|3968285|B4|Upper Extremity Motor Fugl-Meyer score||Stroke severity|"Upper Extremity Motor Fugl Meyer total score range 0-66; eligible range: 19-58. A lower score indicates greater impairment. For stratification purposes: low severity is greater than or equal to 36; high severity is less than 36.~National Institutes of Health Stroke Scale total score range 0-42; higher values represent greater severity."|units on a scale|Mean|41.6|41.6|Standard Deviation|9.4|9.4|||
4143901|NCT00871715|3968286|B3|Upper Extremity Motor Fugl-Meyer score||Stroke severity|"Upper Extremity Motor Fugl Meyer total score range 0-66; eligible range: 19-58. A lower score indicates greater impairment. For stratification purposes: low severity is greater than or equal to 36; high severity is less than 36.~National Institutes of Health Stroke Scale total score range 0-42; higher values represent greater severity."|units on a scale|Mean|41.6|41.6|Standard Deviation|9.5|9.5|||
4143902|NCT00871715|3968287|B2|Upper Extremity Motor Fugl-Meyer score||Stroke severity|"Upper Extremity Motor Fugl Meyer total score range 0-66; eligible range: 19-58. A lower score indicates greater impairment. For stratification purposes: low severity is greater than or equal to 36; high severity is less than 36.~National Institutes of Health Stroke Scale total score range 0-42; higher values represent greater severity."|units on a scale|Mean|41.5|41.5|Standard Deviation|9.2|9.2|||
4143903|NCT00871715|3968288|B1|Upper Extremity Motor Fugl-Meyer score||Stroke severity|"Upper Extremity Motor Fugl Meyer total score range 0-66; eligible range: 19-58. A lower score indicates greater impairment. For stratification purposes: low severity is greater than or equal to 36; high severity is less than 36.~National Institutes of Health Stroke Scale total score range 0-42; higher values represent greater severity."|units on a scale|Mean|41.7|41.7|Standard Deviation|9.5|9.5|||
4143904|NCT00871715|3968285|B4|Left||Side of hemiparesis||participants|Number|193|193.0||||||
4143905|NCT00871715|3968286|B3|Left||Side of hemiparesis||participants|Number|65|65.0||||||
4143906|NCT00871715|3968287|B2|Left||Side of hemiparesis||participants|Number|60|60.0||||||
4143907|NCT00871715|3968288|B1|Left||Side of hemiparesis||participants|Number|68|68.0||||||
4143908|NCT00871715|3968285|B4|Right||Side of hemiparesis||participants|Number|168|168.0||||||
4143909|NCT00871715|3968286|B3|Right||Side of hemiparesis||participants|Number|57|57.0||||||
4143910|NCT00871715|3968287|B2|Right||Side of hemiparesis||participants|Number|60|60.0||||||
4143911|NCT00871715|3968288|B1|Right||Side of hemiparesis||participants|Number|51|51.0||||||
4143912|NCT00871715|3968285|B4|Other||Stroke location||participants|Number|8|8.0||||||
4143913|NCT00871715|3968286|B3|Other||Stroke location||participants|Number|3|3.0||||||
4143914|NCT00871715|3968287|B2|Other||Stroke location||participants|Number|3|3.0||||||
4143915|NCT00871715|3968288|B1|Other||Stroke location||participants|Number|2|2.0||||||
4143916|NCT00871715|3968285|B4|Brain stem||Stroke location||participants|Number|25|25.0||||||
4143917|NCT00871715|3968286|B3|Brain stem||Stroke location||participants|Number|9|9.0||||||
4143918|NCT00871715|3968287|B2|Brain stem||Stroke location||participants|Number|5|5.0||||||
4143919|NCT00871715|3968288|B1|Brain stem||Stroke location||participants|Number|11|11.0||||||
4143920|NCT00871715|3968285|B4|Cerebellum||Stroke location||participants|Number|1|1.0||||||
4143921|NCT00871715|3968286|B3|Cerebellum||Stroke location||participants|Number|0|0.0||||||
4143922|NCT00871715|3968287|B2|Cerebellum||Stroke location||participants|Number|1|1.0||||||
4143923|NCT00871715|3968288|B1|Cerebellum||Stroke location||participants|Number|0|0.0||||||
4143924|NCT00871715|3968285|B4|Left hemisphere||Stroke location||participants|Number|154|154.0||||||
4143925|NCT00871715|3968286|B3|Left hemisphere||Stroke location||participants|Number|50|50.0||||||
4143926|NCT00871715|3968287|B2|Left hemisphere||Stroke location||participants|Number|55|55.0||||||
4143927|NCT00871715|3968288|B1|Left hemisphere||Stroke location||participants|Number|49|49.0||||||
4143928|NCT00871715|3968285|B4|Right hemisphere||Stroke location||participants|Number|173|173.0||||||
4143929|NCT00871715|3968286|B3|Right hemisphere||Stroke location||participants|Number|60|60.0||||||
4143930|NCT00871715|3968287|B2|Right hemisphere||Stroke location||participants|Number|56|56.0||||||
4143931|NCT00871715|3968288|B1|Right hemisphere||Stroke location||participants|Number|57|57.0||||||
4143932|NCT00871715|3968285|B4|Unknown or Not Reported||Stroke type||participants|Number|2|2.0||||||
4143933|NCT00871715|3968286|B3|Unknown or Not Reported||Stroke type||participants|Number|1|1.0||||||
4143934|NCT00871715|3968287|B2|Unknown or Not Reported||Stroke type||participants|Number|1|1.0||||||
4143935|NCT00871715|3968288|B1|Unknown or Not Reported||Stroke type||participants|Number|0|0.0||||||
4143936|NCT00871715|3968285|B4|Other||Stroke type||participants|Number|6|6.0||||||
4143937|NCT00871715|3968286|B3|Other||Stroke type||participants|Number|1|1.0||||||
4143938|NCT00871715|3968287|B2|Other||Stroke type||participants|Number|5|5.0||||||
4143939|NCT00871715|3968288|B1|Other||Stroke type||participants|Number|0|0.0||||||
4143940|NCT00871715|3968285|B4|Intraparenchymal hemorrhagic||Stroke type||participants|Number|43|43.0||||||
4143941|NCT00871715|3968286|B3|Intraparenchymal hemorrhagic||Stroke type||participants|Number|15|15.0||||||
4143942|NCT00871715|3968287|B2|Intraparenchymal hemorrhagic||Stroke type||participants|Number|12|12.0||||||
4143943|NCT00871715|3968288|B1|Intraparenchymal hemorrhagic||Stroke type||participants|Number|16|16.0||||||
4143944|NCT00871715|3968285|B4|Ischemic with hemorrhagic conversion||Stroke type||participants|Number|11|11.0||||||
4143945|NCT00871715|3968286|B3|Ischemic with hemorrhagic conversion||Stroke type||participants|Number|4|4.0||||||
4143946|NCT00871715|3968287|B2|Ischemic with hemorrhagic conversion||Stroke type||participants|Number|4|4.0||||||
4143947|NCT00871715|3968288|B1|Ischemic with hemorrhagic conversion||Stroke type||participants|Number|3|3.0||||||
4143948|NCT00871715|3968285|B4|Ischemic without hemorrhagic conversion||Stroke type||participants|Number|299|299.0||||||
4143949|NCT00871715|3968286|B3|Ischemic without hemorrhagic conversion||Stroke type||participants|Number|101|101.0||||||
4143950|NCT00871715|3968287|B2|Ischemic without hemorrhagic conversion||Stroke type||participants|Number|98|98.0||||||
4143951|NCT00871715|3968288|B1|Ischemic without hemorrhagic conversion||Stroke type||participants|Number|100|100.0||||||
4143952|NCT00871715|3968285|B4|||Time from stroke to randomization||days|Mean|45.8|45.8|Standard Deviation|22.4|22.4|||
4143953|NCT00871715|3968286|B3|||Time from stroke to randomization||days|Mean|47.0|47.0|Standard Deviation|23.9|23.9|||
4143954|NCT00871715|3968287|B2|||Time from stroke to randomization||days|Mean|45.0|45.0|Standard Deviation|22.8|22.8|||
4143955|NCT00871715|3968288|B1|||Time from stroke to randomization||days|Mean|45.2|45.2|Standard Deviation|20.3|20.3|||
4143956|NCT00871715|3968285|B4|Spanish||Language||participants|Number|4|4.0||||||
4143957|NCT00871715|3968286|B3|Spanish||Language||participants|Number|1|1.0||||||
4143958|NCT00871715|3968287|B2|Spanish||Language||participants|Number|1|1.0||||||
4143959|NCT00871715|3968288|B1|Spanish||Language||participants|Number|2|2.0||||||
4143960|NCT00871715|3968285|B4|English||Language||participants|Number|357|357.0||||||
4143961|NCT00871715|3968286|B3|English||Language||participants|Number|121|121.0||||||
4143962|NCT00871715|3968287|B2|English||Language||participants|Number|119|119.0||||||
4143963|NCT00871715|3968288|B1|English||Language||participants|Number|117|117.0||||||
4143964|NCT00871715|3968285|B4|Other||Referral source|Setting in which participant was first prospectively identified.|participants|Number|1|1.0||||||
4143965|NCT00871715|3968286|B3|Other||Referral source|Setting in which participant was first prospectively identified.|participants|Number|0|0.0||||||
4143966|NCT00871715|3968287|B2|Other||Referral source|Setting in which participant was first prospectively identified.|participants|Number|1|1.0||||||
4143967|NCT00871715|3968288|B1|Other||Referral source|Setting in which participant was first prospectively identified.|participants|Number|0|0.0||||||
4143968|NCT00871715|3968285|B4|Open referral||Referral source|Setting in which participant was first prospectively identified.|participants|Number|24|24.0||||||
4143969|NCT00871715|3968286|B3|Open referral||Referral source|Setting in which participant was first prospectively identified.|participants|Number|8|8.0||||||
4143970|NCT00871715|3968287|B2|Open referral||Referral source|Setting in which participant was first prospectively identified.|participants|Number|7|7.0||||||
4143971|NCT00871715|3968288|B1|Open referral||Referral source|Setting in which participant was first prospectively identified.|participants|Number|9|9.0||||||
4143972|NCT00871715|3968285|B4|Transitional day program||Referral source|Setting in which participant was first prospectively identified.|participants|Number|7|7.0||||||
4143973|NCT00871715|3968286|B3|Transitional day program||Referral source|Setting in which participant was first prospectively identified.|participants|Number|2|2.0||||||
4143974|NCT00871715|3968287|B2|Transitional day program||Referral source|Setting in which participant was first prospectively identified.|participants|Number|2|2.0||||||
4143975|NCT00871715|3968288|B1|Transitional day program||Referral source|Setting in which participant was first prospectively identified.|participants|Number|3|3.0||||||
4144021|NCT00871715|3968286|B3|United States||Region of Enrollment||participants|Number|122|122.0||||||
4143976|NCT00871715|3968285|B4|Acute care||Referral source|Setting in which participant was first prospectively identified.|participants|Number|66|66.0||||||
4143977|NCT00871715|3968286|B3|Acute care||Referral source|Setting in which participant was first prospectively identified.|participants|Number|19|19.0||||||
4143978|NCT00871715|3968287|B2|Acute care||Referral source|Setting in which participant was first prospectively identified.|participants|Number|26|26.0||||||
4143979|NCT00871715|3968288|B1|Acute care||Referral source|Setting in which participant was first prospectively identified.|participants|Number|21|21.0||||||
4143980|NCT00871715|3968285|B4|Outpatient||Referral source|Setting in which participant was first prospectively identified.|participants|Number|16|16.0||||||
4143981|NCT00871715|3968286|B3|Outpatient||Referral source|Setting in which participant was first prospectively identified.|participants|Number|5|5.0||||||
4143982|NCT00871715|3968287|B2|Outpatient||Referral source|Setting in which participant was first prospectively identified.|participants|Number|5|5.0||||||
4143983|NCT00871715|3968288|B1|Outpatient||Referral source|Setting in which participant was first prospectively identified.|participants|Number|6|6.0||||||
4143984|NCT00871715|3968285|B4|Inpatient rehabilitation||Referral source|Setting in which participant was first prospectively identified.|participants|Number|247|247.0||||||
4143985|NCT00871715|3968286|B3|Inpatient rehabilitation||Referral source|Setting in which participant was first prospectively identified.|participants|Number|88|88.0||||||
4143986|NCT00871715|3968287|B2|Inpatient rehabilitation||Referral source|Setting in which participant was first prospectively identified.|participants|Number|79|79.0||||||
4143987|NCT00871715|3968288|B1|Inpatient rehabilitation||Referral source|Setting in which participant was first prospectively identified.|participants|Number|80|80.0||||||
4143988|NCT00871715|3968285|B4|Unknown or Not Reported||Education|Highest level of education completed (self-reported)|participants|Number|1|1.0||||||
4143989|NCT00871715|3968286|B3|Unknown or Not Reported||Education|Highest level of education completed (self-reported)|participants|Number|1|1.0||||||
4143990|NCT00871715|3968287|B2|Unknown or Not Reported||Education|Highest level of education completed (self-reported)|participants|Number|0|0.0||||||
4143991|NCT00871715|3968288|B1|Unknown or Not Reported||Education|Highest level of education completed (self-reported)|participants|Number|0|0.0||||||
4143992|NCT00871715|3968285|B4|Completed doctoral degree||Education|Highest level of education completed (self-reported)|participants|Number|20|20.0||||||
4143993|NCT00871715|3968286|B3|Completed doctoral degree||Education|Highest level of education completed (self-reported)|participants|Number|8|8.0||||||
4143994|NCT00871715|3968287|B2|Completed doctoral degree||Education|Highest level of education completed (self-reported)|participants|Number|6|6.0||||||
4143995|NCT00871715|3968288|B1|Completed doctoral degree||Education|Highest level of education completed (self-reported)|participants|Number|6|6.0||||||
4143996|NCT00871715|3968285|B4|Completed master's degree||Education|Highest level of education completed (self-reported)|participants|Number|33|33.0||||||
4143997|NCT00871715|3968286|B3|Completed master's degree||Education|Highest level of education completed (self-reported)|participants|Number|7|7.0||||||
4143998|NCT00871715|3968287|B2|Completed master's degree||Education|Highest level of education completed (self-reported)|participants|Number|11|11.0||||||
4143999|NCT00871715|3968288|B1|Completed master's degree||Education|Highest level of education completed (self-reported)|participants|Number|15|15.0||||||
4144000|NCT00871715|3968285|B4|Completed bachelor's degree||Education|Highest level of education completed (self-reported)|participants|Number|71|71.0||||||
4144001|NCT00871715|3968286|B3|Completed bachelor's degree||Education|Highest level of education completed (self-reported)|participants|Number|23|23.0||||||
4144002|NCT00871715|3968287|B2|Completed bachelor's degree||Education|Highest level of education completed (self-reported)|participants|Number|26|26.0||||||
4144003|NCT00871715|3968288|B1|Completed bachelor's degree||Education|Highest level of education completed (self-reported)|participants|Number|22|22.0||||||
4144004|NCT00871715|3968285|B4|Some college||Education|Highest level of education completed (self-reported)|participants|Number|130|130.0||||||
4144005|NCT00871715|3968286|B3|Some college||Education|Highest level of education completed (self-reported)|participants|Number|46|46.0||||||
4144006|NCT00871715|3968287|B2|Some college||Education|Highest level of education completed (self-reported)|participants|Number|42|42.0||||||
4144007|NCT00871715|3968288|B1|Some college||Education|Highest level of education completed (self-reported)|participants|Number|42|42.0||||||
4144008|NCT00871715|3968285|B4|Completed high school||Education|Highest level of education completed (self-reported)|participants|Number|72|72.0||||||
4144009|NCT00871715|3968286|B3|Completed high school||Education|Highest level of education completed (self-reported)|participants|Number|27|27.0||||||
4144010|NCT00871715|3968287|B2|Completed high school||Education|Highest level of education completed (self-reported)|participants|Number|21|21.0||||||
4144011|NCT00871715|3968288|B1|Completed high school||Education|Highest level of education completed (self-reported)|participants|Number|24|24.0||||||
4144012|NCT00871715|3968285|B4|Some high school||Education|Highest level of education completed (self-reported)|participants|Number|26|26.0||||||
4144013|NCT00871715|3968286|B3|Some high school||Education|Highest level of education completed (self-reported)|participants|Number|8|8.0||||||
4144014|NCT00871715|3968287|B2|Some high school||Education|Highest level of education completed (self-reported)|participants|Number|12|12.0||||||
4144015|NCT00871715|3968288|B1|Some high school||Education|Highest level of education completed (self-reported)|participants|Number|6|6.0||||||
4144016|NCT00871715|3968285|B4|Less than high school||Education|Highest level of education completed (self-reported)|participants|Number|8|8.0||||||
4144017|NCT00871715|3968286|B3|Less than high school||Education|Highest level of education completed (self-reported)|participants|Number|2|2.0||||||
4144018|NCT00871715|3968287|B2|Less than high school||Education|Highest level of education completed (self-reported)|participants|Number|2|2.0||||||
4144019|NCT00871715|3968288|B1|Less than high school||Education|Highest level of education completed (self-reported)|participants|Number|4|4.0||||||
4144020|NCT00871715|3968285|B4|United States||Region of Enrollment||participants|Number|361|361.0||||||
4144022|NCT00871715|3968287|B2|United States||Region of Enrollment||participants|Number|120|120.0||||||
4144023|NCT00871715|3968288|B1|United States||Region of Enrollment||participants|Number|119|119.0||||||
4144024|NCT00871715|3968285|B4||Unknown or Not Reported|Race (NIH/OMB)|"Self-selected from categories determined in 1997 by the U.S. Office of Management and Budget in accordance with sponsor mandate. For this self-selected measure, 35 participants (9 ASAP, 12 DEUCC, 14 UCC) specified other categories to identify their race. Since an Other field is not available, these 35 are included in the count under Unknown or Not reported"|Participants|Count of Participants|48|48.0||||||
4144025|NCT00871715|3968286|B3||Unknown or Not Reported|Race (NIH/OMB)|"Self-selected from categories determined in 1997 by the U.S. Office of Management and Budget in accordance with sponsor mandate. For this self-selected measure, 35 participants (9 ASAP, 12 DEUCC, 14 UCC) specified other categories to identify their race. Since an Other field is not available, these 35 are included in the count under Unknown or Not reported"|Participants|Count of Participants|18|18.0||||||
4144026|NCT00871715|3968287|B2||Unknown or Not Reported|Race (NIH/OMB)|"Self-selected from categories determined in 1997 by the U.S. Office of Management and Budget in accordance with sponsor mandate. For this self-selected measure, 35 participants (9 ASAP, 12 DEUCC, 14 UCC) specified other categories to identify their race. Since an Other field is not available, these 35 are included in the count under Unknown or Not reported"|Participants|Count of Participants|15|15.0||||||
4144027|NCT00871715|3968288|B1||Unknown or Not Reported|Race (NIH/OMB)|"Self-selected from categories determined in 1997 by the U.S. Office of Management and Budget in accordance with sponsor mandate. For this self-selected measure, 35 participants (9 ASAP, 12 DEUCC, 14 UCC) specified other categories to identify their race. Since an Other field is not available, these 35 are included in the count under Unknown or Not reported"|Participants|Count of Participants|15|15.0||||||
4144028|NCT00871715|3968285|B4||More than one race|Race (NIH/OMB)|"Self-selected from categories determined in 1997 by the U.S. Office of Management and Budget in accordance with sponsor mandate. For this self-selected measure, 35 participants (9 ASAP, 12 DEUCC, 14 UCC) specified other categories to identify their race. Since an Other field is not available, these 35 are included in the count under Unknown or Not reported"|Participants|Count of Participants|7|7.0||||||
4144029|NCT00871715|3968286|B3||More than one race|Race (NIH/OMB)|"Self-selected from categories determined in 1997 by the U.S. Office of Management and Budget in accordance with sponsor mandate. For this self-selected measure, 35 participants (9 ASAP, 12 DEUCC, 14 UCC) specified other categories to identify their race. Since an Other field is not available, these 35 are included in the count under Unknown or Not reported"|Participants|Count of Participants|1|1.0||||||
4144030|NCT00871715|3968287|B2||More than one race|Race (NIH/OMB)|"Self-selected from categories determined in 1997 by the U.S. Office of Management and Budget in accordance with sponsor mandate. For this self-selected measure, 35 participants (9 ASAP, 12 DEUCC, 14 UCC) specified other categories to identify their race. Since an Other field is not available, these 35 are included in the count under Unknown or Not reported"|Participants|Count of Participants|3|3.0||||||
4144031|NCT00871715|3968288|B1||More than one race|Race (NIH/OMB)|"Self-selected from categories determined in 1997 by the U.S. Office of Management and Budget in accordance with sponsor mandate. For this self-selected measure, 35 participants (9 ASAP, 12 DEUCC, 14 UCC) specified other categories to identify their race. Since an Other field is not available, these 35 are included in the count under Unknown or Not reported"|Participants|Count of Participants|3|3.0||||||
4144032|NCT00871715|3968285|B4||White|Race (NIH/OMB)|"Self-selected from categories determined in 1997 by the U.S. Office of Management and Budget in accordance with sponsor mandate. For this self-selected measure, 35 participants (9 ASAP, 12 DEUCC, 14 UCC) specified other categories to identify their race. Since an Other field is not available, these 35 are included in the count under Unknown or Not reported"|Participants|Count of Participants|124|124.0||||||
4144033|NCT00871715|3968286|B3||White|Race (NIH/OMB)|"Self-selected from categories determined in 1997 by the U.S. Office of Management and Budget in accordance with sponsor mandate. For this self-selected measure, 35 participants (9 ASAP, 12 DEUCC, 14 UCC) specified other categories to identify their race. Since an Other field is not available, these 35 are included in the count under Unknown or Not reported"|Participants|Count of Participants|43|43.0||||||
4144034|NCT00871715|3968287|B2||White|Race (NIH/OMB)|"Self-selected from categories determined in 1997 by the U.S. Office of Management and Budget in accordance with sponsor mandate. For this self-selected measure, 35 participants (9 ASAP, 12 DEUCC, 14 UCC) specified other categories to identify their race. Since an Other field is not available, these 35 are included in the count under Unknown or Not reported"|Participants|Count of Participants|43|43.0||||||
4144035|NCT00871715|3968288|B1||White|Race (NIH/OMB)|"Self-selected from categories determined in 1997 by the U.S. Office of Management and Budget in accordance with sponsor mandate. For this self-selected measure, 35 participants (9 ASAP, 12 DEUCC, 14 UCC) specified other categories to identify their race. Since an Other field is not available, these 35 are included in the count under Unknown or Not reported"|Participants|Count of Participants|38|38.0||||||
4144036|NCT00871715|3968285|B4||Black or African American|Race (NIH/OMB)|"Self-selected from categories determined in 1997 by the U.S. Office of Management and Budget in accordance with sponsor mandate. For this self-selected measure, 35 participants (9 ASAP, 12 DEUCC, 14 UCC) specified other categories to identify their race. Since an Other field is not available, these 35 are included in the count under Unknown or Not reported"|Participants|Count of Participants|151|151.0||||||
4144037|NCT00871715|3968286|B3||Black or African American|Race (NIH/OMB)|"Self-selected from categories determined in 1997 by the U.S. Office of Management and Budget in accordance with sponsor mandate. For this self-selected measure, 35 participants (9 ASAP, 12 DEUCC, 14 UCC) specified other categories to identify their race. Since an Other field is not available, these 35 are included in the count under Unknown or Not reported"|Participants|Count of Participants|54|54.0||||||
4144038|NCT00871715|3968287|B2||Black or African American|Race (NIH/OMB)|"Self-selected from categories determined in 1997 by the U.S. Office of Management and Budget in accordance with sponsor mandate. For this self-selected measure, 35 participants (9 ASAP, 12 DEUCC, 14 UCC) specified other categories to identify their race. Since an Other field is not available, these 35 are included in the count under Unknown or Not reported"|Participants|Count of Participants|50|50.0||||||
4144110|NCT00871572|3968330|B5||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4144039|NCT00871715|3968288|B1||Black or African American|Race (NIH/OMB)|"Self-selected from categories determined in 1997 by the U.S. Office of Management and Budget in accordance with sponsor mandate. For this self-selected measure, 35 participants (9 ASAP, 12 DEUCC, 14 UCC) specified other categories to identify their race. Since an Other field is not available, these 35 are included in the count under Unknown or Not reported"|Participants|Count of Participants|47|47.0||||||
4144040|NCT00871715|3968285|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|"Self-selected from categories determined in 1997 by the U.S. Office of Management and Budget in accordance with sponsor mandate. For this self-selected measure, 35 participants (9 ASAP, 12 DEUCC, 14 UCC) specified other categories to identify their race. Since an Other field is not available, these 35 are included in the count under Unknown or Not reported"|Participants|Count of Participants|7|7.0||||||
4144041|NCT00871715|3968286|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|"Self-selected from categories determined in 1997 by the U.S. Office of Management and Budget in accordance with sponsor mandate. For this self-selected measure, 35 participants (9 ASAP, 12 DEUCC, 14 UCC) specified other categories to identify their race. Since an Other field is not available, these 35 are included in the count under Unknown or Not reported"|Participants|Count of Participants|3|3.0||||||
4144042|NCT00871715|3968287|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|"Self-selected from categories determined in 1997 by the U.S. Office of Management and Budget in accordance with sponsor mandate. For this self-selected measure, 35 participants (9 ASAP, 12 DEUCC, 14 UCC) specified other categories to identify their race. Since an Other field is not available, these 35 are included in the count under Unknown or Not reported"|Participants|Count of Participants|1|1.0||||||
4144043|NCT00871715|3968288|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|"Self-selected from categories determined in 1997 by the U.S. Office of Management and Budget in accordance with sponsor mandate. For this self-selected measure, 35 participants (9 ASAP, 12 DEUCC, 14 UCC) specified other categories to identify their race. Since an Other field is not available, these 35 are included in the count under Unknown or Not reported"|Participants|Count of Participants|3|3.0||||||
4144044|NCT00871715|3968285|B4||Asian|Race (NIH/OMB)|"Self-selected from categories determined in 1997 by the U.S. Office of Management and Budget in accordance with sponsor mandate. For this self-selected measure, 35 participants (9 ASAP, 12 DEUCC, 14 UCC) specified other categories to identify their race. Since an Other field is not available, these 35 are included in the count under Unknown or Not reported"|Participants|Count of Participants|19|19.0||||||
4144045|NCT00871715|3968286|B3||Asian|Race (NIH/OMB)|"Self-selected from categories determined in 1997 by the U.S. Office of Management and Budget in accordance with sponsor mandate. For this self-selected measure, 35 participants (9 ASAP, 12 DEUCC, 14 UCC) specified other categories to identify their race. Since an Other field is not available, these 35 are included in the count under Unknown or Not reported"|Participants|Count of Participants|3|3.0||||||
4144046|NCT00871715|3968287|B2||Asian|Race (NIH/OMB)|"Self-selected from categories determined in 1997 by the U.S. Office of Management and Budget in accordance with sponsor mandate. For this self-selected measure, 35 participants (9 ASAP, 12 DEUCC, 14 UCC) specified other categories to identify their race. Since an Other field is not available, these 35 are included in the count under Unknown or Not reported"|Participants|Count of Participants|7|7.0||||||
4144047|NCT00871715|3968288|B1||Asian|Race (NIH/OMB)|"Self-selected from categories determined in 1997 by the U.S. Office of Management and Budget in accordance with sponsor mandate. For this self-selected measure, 35 participants (9 ASAP, 12 DEUCC, 14 UCC) specified other categories to identify their race. Since an Other field is not available, these 35 are included in the count under Unknown or Not reported"|Participants|Count of Participants|9|9.0||||||
4144048|NCT00871715|3968285|B4||American Indian or Alaska Native|Race (NIH/OMB)|"Self-selected from categories determined in 1997 by the U.S. Office of Management and Budget in accordance with sponsor mandate. For this self-selected measure, 35 participants (9 ASAP, 12 DEUCC, 14 UCC) specified other categories to identify their race. Since an Other field is not available, these 35 are included in the count under Unknown or Not reported"|Participants|Count of Participants|5|5.0||||||
4144049|NCT00871715|3968286|B3||American Indian or Alaska Native|Race (NIH/OMB)|"Self-selected from categories determined in 1997 by the U.S. Office of Management and Budget in accordance with sponsor mandate. For this self-selected measure, 35 participants (9 ASAP, 12 DEUCC, 14 UCC) specified other categories to identify their race. Since an Other field is not available, these 35 are included in the count under Unknown or Not reported"|Participants|Count of Participants|0|0.0||||||
4144050|NCT00871715|3968287|B2||American Indian or Alaska Native|Race (NIH/OMB)|"Self-selected from categories determined in 1997 by the U.S. Office of Management and Budget in accordance with sponsor mandate. For this self-selected measure, 35 participants (9 ASAP, 12 DEUCC, 14 UCC) specified other categories to identify their race. Since an Other field is not available, these 35 are included in the count under Unknown or Not reported"|Participants|Count of Participants|1|1.0||||||
4144051|NCT00871715|3968288|B1||American Indian or Alaska Native|Race (NIH/OMB)|"Self-selected from categories determined in 1997 by the U.S. Office of Management and Budget in accordance with sponsor mandate. For this self-selected measure, 35 participants (9 ASAP, 12 DEUCC, 14 UCC) specified other categories to identify their race. Since an Other field is not available, these 35 are included in the count under Unknown or Not reported"|Participants|Count of Participants|4|4.0||||||
4144052|NCT00871715|3968285|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)|Self-selected from categories determined in 1997 by the U.S. Office of Management and Budget in accordance with sponsor mandate.|Participants|Count of Participants|5|5.0||||||
4144053|NCT00871715|3968286|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)|Self-selected from categories determined in 1997 by the U.S. Office of Management and Budget in accordance with sponsor mandate.|Participants|Count of Participants|2|2.0||||||
4144054|NCT00871715|3968287|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)|Self-selected from categories determined in 1997 by the U.S. Office of Management and Budget in accordance with sponsor mandate.|Participants|Count of Participants|0|0.0||||||
4144055|NCT00871715|3968288|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|Self-selected from categories determined in 1997 by the U.S. Office of Management and Budget in accordance with sponsor mandate.|Participants|Count of Participants|3|3.0||||||
4144056|NCT00871715|3968285|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Self-selected from categories determined in 1997 by the U.S. Office of Management and Budget in accordance with sponsor mandate.|Participants|Count of Participants|320|320.0||||||
4144057|NCT00871715|3968286|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Self-selected from categories determined in 1997 by the U.S. Office of Management and Budget in accordance with sponsor mandate.|Participants|Count of Participants|107|107.0||||||
4144058|NCT00871715|3968287|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Self-selected from categories determined in 1997 by the U.S. Office of Management and Budget in accordance with sponsor mandate.|Participants|Count of Participants|106|106.0||||||
4144059|NCT00871715|3968288|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Self-selected from categories determined in 1997 by the U.S. Office of Management and Budget in accordance with sponsor mandate.|Participants|Count of Participants|107|107.0||||||
4144060|NCT00871715|3968285|B4||Hispanic or Latino|Ethnicity (NIH/OMB)|Self-selected from categories determined in 1997 by the U.S. Office of Management and Budget in accordance with sponsor mandate.|Participants|Count of Participants|36|36.0||||||
4144061|NCT00871715|3968286|B3||Hispanic or Latino|Ethnicity (NIH/OMB)|Self-selected from categories determined in 1997 by the U.S. Office of Management and Budget in accordance with sponsor mandate.|Participants|Count of Participants|13|13.0||||||
4144062|NCT00871715|3968287|B2||Hispanic or Latino|Ethnicity (NIH/OMB)|Self-selected from categories determined in 1997 by the U.S. Office of Management and Budget in accordance with sponsor mandate.|Participants|Count of Participants|14|14.0||||||
4144063|NCT00871715|3968288|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|Self-selected from categories determined in 1997 by the U.S. Office of Management and Budget in accordance with sponsor mandate.|Participants|Count of Participants|9|9.0||||||
4144064|NCT00871715|3968285|B4||Male|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4144065|NCT00871715|3968286|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4144066|NCT00871715|3968287|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4144067|NCT00871715|3968288|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4144068|NCT00871715|3968285|B4||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4144069|NCT00871715|3968286|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4144070|NCT00871715|3968287|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4144071|NCT00871715|3968288|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4144072|NCT00871715|3968285|B4|||Age||years|Mean|60.7|60.7|Standard Deviation|12.5|12.5|||
4144073|NCT00871715|3968286|B3|||Age||years|Mean|61.1|61.1|Standard Deviation|13.1|13.1|||
4144074|NCT00871715|3968287|B2|||Age||years|Mean|59.9|59.9|Standard Deviation|10.5|10.5|||
4144075|NCT00871715|3968288|B1|||Age||years|Mean|60.9|60.9|Standard Deviation|13.7|13.7|||
4144076|NCT00871689|3968308|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4144077|NCT00871689|3968308|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4144078|NCT00871689|3968308|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4144079|NCT00871689|3968308|B1|||Age||years|Mean|10.5|10.5|Standard Deviation|2.1|2.1|||
4144080|NCT00871689|3968308|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4144081|NCT00871689|3968308|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4144082|NCT00871689|3968308|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4144083|NCT00871624|3968319|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4144084|NCT00871624|3968320|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4144085|NCT00871624|3968321|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4144086|NCT00871624|3968319|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4144087|NCT00871624|3968320|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4144088|NCT00871624|3968321|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4144089|NCT00871624|3968319|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4144090|NCT00871624|3968320|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4144091|NCT00871624|3968321|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4144092|NCT00871624|3968319|B3|||Age||years|Mean|65|65.0|Standard Deviation|12|12.0|||
4144093|NCT00871624|3968320|B2|||Age||years|Mean|62|62.0|Standard Deviation|17|17.0|||
4144094|NCT00871624|3968321|B1|||Age||years|Mean|68|68.0|Standard Deviation|6|6.0|||
4144095|NCT00871572|3968330|B5|United States||Region of Enrollment||Participants|Count of Participants|87|87.0||||||
4144096|NCT00871572|3968331|B4|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
4144097|NCT00871572|3968332|B3|United States||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
4144098|NCT00871572|3968333|B2|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
4144099|NCT00871572|3968334|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4144100|NCT00871572|3968330|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4144101|NCT00871572|3968331|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144102|NCT00871572|3968332|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4144103|NCT00871572|3968333|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144104|NCT00871572|3968334|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144105|NCT00871572|3968330|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4144106|NCT00871572|3968331|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144107|NCT00871572|3968332|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144108|NCT00871572|3968333|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4144109|NCT00871572|3968334|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144111|NCT00871572|3968331|B4||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4144112|NCT00871572|3968332|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4144113|NCT00871572|3968333|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4144114|NCT00871572|3968334|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4144115|NCT00871572|3968330|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4144116|NCT00871572|3968331|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4144117|NCT00871572|3968332|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4144118|NCT00871572|3968333|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4144119|NCT00871572|3968334|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4144120|NCT00871572|3968330|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144121|NCT00871572|3968331|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144122|NCT00871572|3968332|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144123|NCT00871572|3968333|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144124|NCT00871572|3968334|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144125|NCT00871572|3968330|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4144126|NCT00871572|3968331|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4144127|NCT00871572|3968332|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4144128|NCT00871572|3968333|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4144129|NCT00871572|3968334|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144130|NCT00871572|3968330|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4144131|NCT00871572|3968331|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4144132|NCT00871572|3968332|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4144133|NCT00871572|3968333|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4144134|NCT00871572|3968334|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4144135|NCT00871572|3968330|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144136|NCT00871572|3968331|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144137|NCT00871572|3968332|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144138|NCT00871572|3968333|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144139|NCT00871572|3968334|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144140|NCT00871572|3968330|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4144141|NCT00871572|3968331|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4144142|NCT00871572|3968332|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4144143|NCT00871572|3968333|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4144144|NCT00871572|3968334|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4144145|NCT00871572|3968330|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4144146|NCT00871572|3968331|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4144147|NCT00871572|3968332|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4144148|NCT00871572|3968333|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4144149|NCT00871572|3968334|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4144150|NCT00871572|3968330|B5||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4144151|NCT00871572|3968331|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4144152|NCT00871572|3968332|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4144153|NCT00871572|3968333|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4144154|NCT00871572|3968334|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4144155|NCT00871572|3968330|B5||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4144156|NCT00871572|3968331|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4144157|NCT00871572|3968332|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4144158|NCT00871572|3968333|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4144159|NCT00871572|3968334|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4144160|NCT00871572|3968330|B5|||Age||years|Mean|52.3|52.3|Standard Deviation|8.93|8.93|||
4144161|NCT00871572|3968331|B4|||Age||years|Mean|52.5|52.5|Standard Deviation|6.41|6.41|||
4144162|NCT00871572|3968332|B3|||Age||years|Mean|52.0|52.0|Standard Deviation|10.88|10.88|||
4144163|NCT00871572|3968333|B2|||Age||years|Mean|53.3|53.3|Standard Deviation|10.20|10.2|||
4144164|NCT00871572|3968334|B1|||Age||years|Mean|50.8|50.8|Standard Deviation|4.92|4.92|||
4144165|NCT00871494|3968407|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4144166|NCT00871494|3968407|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4144167|NCT00871494|3968407|B1|||Age||years|Mean|32.2|32.2|Standard Deviation|10.7|10.7|||
4144168|NCT00871429|3968414|B1|United States||Region of Enrollment||participants|Number|99|99.0||||||
4144169|NCT00871429|3968414|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4144170|NCT00871429|3968414|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4144171|NCT00871429|3968414|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4144172|NCT00871429|3968414|B1||Between 18 and 65 years|Age||Participants|Count of Participants|99|99.0||||||
4144173|NCT00871429|3968414|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4144174|NCT00871403|3968422|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|100|100.0||||||
4144175|NCT00871403|3968423|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4144176|NCT00871403|3968424|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
4144177|NCT00871403|3968425|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4144178|NCT00871403|3968422|B4|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4144179|NCT00871403|3968423|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4144180|NCT00871403|3968424|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4144181|NCT00871403|3968425|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4144182|NCT00871403|3968422|B4|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4144183|NCT00871403|3968423|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4144184|NCT00871403|3968424|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4144185|NCT00871403|3968425|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4144186|NCT00871403|3968422|B4|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4144187|NCT00871403|3968423|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4144188|NCT00871403|3968424|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4144189|NCT00871403|3968425|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4144190|NCT00871403|3968422|B4||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4144191|NCT00871403|3968423|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4144192|NCT00871403|3968424|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4144193|NCT00871403|3968425|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4144194|NCT00871403|3968422|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4144195|NCT00871403|3968423|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4144196|NCT00871403|3968424|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4144197|NCT00871403|3968425|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4144198|NCT00871403|3968422|B4|||Age||Years|Mean|61.1|61.1|Standard Deviation|9.16|9.16|||
4144199|NCT00871403|3968423|B3|||Age||Years|Mean|61.8|61.8|Standard Deviation|9.35|9.35|||
4144200|NCT00871403|3968424|B2|||Age||Years|Mean|60.8|60.8|Standard Deviation|8.27|8.27|||
4144201|NCT00871403|3968425|B1|||Age||Years|Mean|60.4|60.4|Standard Deviation|14.32|14.32|||
4144202|NCT00871377|3968440|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4144203|NCT00871377|3968440|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4144204|NCT00871377|3968440|B1|||Age||years|Mean|33.04|33.04|Standard Deviation|10.33|10.33|||
4144205|NCT00871351|3968453|B4|Japan||Region of Enrollment||participants|Number|125|125.0||||||
4144206|NCT00871351|3968454|B3|Japan||Region of Enrollment||participants|Number|32|32.0||||||
4144207|NCT00871351|3968455|B2|Japan||Region of Enrollment||participants|Number|46|46.0||||||
4144208|NCT00871351|3968456|B1|Japan||Region of Enrollment||participants|Number|47|47.0||||||
4144209|NCT00871351|3968453|B4||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4144210|NCT00871351|3968454|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4144211|NCT00871351|3968455|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4144212|NCT00871351|3968456|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4144213|NCT00871351|3968453|B4||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4144214|NCT00871351|3968454|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4144215|NCT00871351|3968455|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4144216|NCT00871351|3968456|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4144217|NCT00871351|3968453|B4|||Age||years|Mean|61.0|61.0|Standard Deviation|11.7|11.7|||
4144218|NCT00871351|3968454|B3|||Age||years|Mean|61.1|61.1|Standard Deviation|12.0|12.0|||
4144219|NCT00871351|3968455|B2|||Age||years|Mean|59.3|59.3|Standard Deviation|11.8|11.8|||
4144220|NCT00871351|3968456|B1|||Age||years|Mean|62.7|62.7|Standard Deviation|11.4|11.4|||
4144221|NCT00871338|3968478|B3|Other||Race/Ethnicity, Customized|Booster vaccination epoch|Participants|Count of Participants|17|17.0||||||
4144222|NCT00871338|3968479|B2|Other||Race/Ethnicity, Customized|Booster vaccination epoch|Participants|Count of Participants|4|4.0||||||
4144223|NCT00871338|3968480|B1|Other||Race/Ethnicity, Customized|Booster vaccination epoch|Participants|Count of Participants|13|13.0||||||
4144224|NCT00871338|3968478|B3|White - Caucasian/European Heritage||Race/Ethnicity, Customized|Booster vaccination epoch|Participants|Count of Participants|243|243.0||||||
4144367|NCT00871143|3968579|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4144225|NCT00871338|3968479|B2|White - Caucasian/European Heritage||Race/Ethnicity, Customized|Booster vaccination epoch|Participants|Count of Participants|124|124.0||||||
4144226|NCT00871338|3968480|B1|White - Caucasian/European Heritage||Race/Ethnicity, Customized|Booster vaccination epoch|Participants|Count of Participants|119|119.0||||||
4144227|NCT00871338|3968478|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized|Booster vaccination epoch|Participants|Count of Participants|0|0.0||||||
4144228|NCT00871338|3968479|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized|Booster vaccination epoch|Participants|Count of Participants|0|0.0||||||
4144229|NCT00871338|3968480|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized|Booster vaccination epoch|Participants|Count of Participants|0|0.0||||||
4144230|NCT00871338|3968478|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Booster vaccination epoch|Participants|Count of Participants|0|0.0||||||
4144231|NCT00871338|3968479|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Booster vaccination epoch|Participants|Count of Participants|0|0.0||||||
4144232|NCT00871338|3968480|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Booster vaccination epoch|Participants|Count of Participants|0|0.0||||||
4144233|NCT00871338|3968478|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Booster vaccination epoch|Participants|Count of Participants|2|2.0||||||
4144234|NCT00871338|3968479|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Booster vaccination epoch|Participants|Count of Participants|1|1.0||||||
4144235|NCT00871338|3968480|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Booster vaccination epoch|Participants|Count of Participants|1|1.0||||||
4144236|NCT00871338|3968478|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized|Booster vaccination epoch|Participants|Count of Participants|0|0.0||||||
4144237|NCT00871338|3968479|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized|Booster vaccination epoch|Participants|Count of Participants|0|0.0||||||
4144238|NCT00871338|3968480|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized|Booster vaccination epoch|Participants|Count of Participants|0|0.0||||||
4144239|NCT00871338|3968478|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized|Booster vaccination epoch|Participants|Count of Participants|2|2.0||||||
4144240|NCT00871338|3968479|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized|Booster vaccination epoch|Participants|Count of Participants|1|1.0||||||
4144241|NCT00871338|3968480|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized|Booster vaccination epoch|Participants|Count of Participants|1|1.0||||||
4144242|NCT00871338|3968478|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Booster vaccination epoch|Participants|Count of Participants|6|6.0||||||
4144243|NCT00871338|3968479|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Booster vaccination epoch|Participants|Count of Participants|3|3.0||||||
4144244|NCT00871338|3968480|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Booster vaccination epoch|Participants|Count of Participants|3|3.0||||||
4144245|NCT00871338|3968478|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized|Booster vaccination epoch|Participants|Count of Participants|0|0.0||||||
4144246|NCT00871338|3968479|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized|Booster vaccination epoch|Participants|Count of Participants|0|0.0||||||
4144247|NCT00871338|3968480|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized|Booster vaccination epoch|Participants|Count of Participants|0|0.0||||||
4144248|NCT00871338|3968478|B3|African Heritage/African American||Race/Ethnicity, Customized|Booster vaccination epoch|Participants|Count of Participants|4|4.0||||||
4144249|NCT00871338|3968479|B2|African Heritage/African American||Race/Ethnicity, Customized|Booster vaccination epoch|Participants|Count of Participants|2|2.0||||||
4144250|NCT00871338|3968480|B1|African Heritage/African American||Race/Ethnicity, Customized|Booster vaccination epoch|Participants|Count of Participants|2|2.0||||||
4144251|NCT00871338|3968478|B3|Other||Race/Ethnicity, Customized|Primary vaccination epoch|Participants|Count of Participants|17|17.0||||||
4144252|NCT00871338|3968479|B2|Other||Race/Ethnicity, Customized|Primary vaccination epoch|Participants|Count of Participants|4|4.0||||||
4144253|NCT00871338|3968480|B1|Other||Race/Ethnicity, Customized|Primary vaccination epoch|Participants|Count of Participants|13|13.0||||||
4144254|NCT00871338|3968478|B3|White - Caucasian/European Heritage||Race/Ethnicity, Customized|Primary vaccination epoch|Participants|Count of Participants|251|251.0||||||
4144255|NCT00871338|3968479|B2|White - Caucasian/European Heritage||Race/Ethnicity, Customized|Primary vaccination epoch|Participants|Count of Participants|130|130.0||||||
4144256|NCT00871338|3968480|B1|White - Caucasian/European Heritage||Race/Ethnicity, Customized|Primary vaccination epoch|Participants|Count of Participants|121|121.0||||||
4144257|NCT00871338|3968478|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Primary vaccination epoch|Participants|Count of Participants|2|2.0||||||
4144258|NCT00871338|3968479|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Primary vaccination epoch|Participants|Count of Participants|1|1.0||||||
4144259|NCT00871338|3968480|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Primary vaccination epoch|Participants|Count of Participants|1|1.0||||||
4144260|NCT00871338|3968478|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized|Primary vaccination epoch|Participants|Count of Participants|3|3.0||||||
4144261|NCT00871338|3968479|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized|Primary vaccination epoch|Participants|Count of Participants|1|1.0||||||
4144262|NCT00871338|3968480|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized|Primary vaccination epoch|Participants|Count of Participants|2|2.0||||||
4144263|NCT00871338|3968478|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Primary vaccination epoch|Participants|Count of Participants|6|6.0||||||
4144264|NCT00871338|3968479|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Primary vaccination epoch|Participants|Count of Participants|3|3.0||||||
4144265|NCT00871338|3968480|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Primary vaccination epoch|Participants|Count of Participants|3|3.0||||||
4144266|NCT00871338|3968478|B3|African Heritage/African American||Race/Ethnicity, Customized|Primary vaccination epoch|Participants|Count of Participants|5|5.0||||||
4144267|NCT00871338|3968479|B2|African Heritage/African American||Race/Ethnicity, Customized|Primary vaccination epoch|Participants|Count of Participants|3|3.0||||||
4144268|NCT00871338|3968480|B1|African Heritage/African American||Race/Ethnicity, Customized|Primary vaccination epoch|Participants|Count of Participants|2|2.0||||||
4144269|NCT00871338|3968478|B3||Male|Sex: Female, Male|Booster vaccination epoch|Participants|Count of Participants|140|140.0||||||
4144270|NCT00871338|3968479|B2||Male|Sex: Female, Male|Booster vaccination epoch|Participants|Count of Participants|60|60.0||||||
4144271|NCT00871338|3968480|B1||Male|Sex: Female, Male|Booster vaccination epoch|Participants|Count of Participants|80|80.0||||||
4144272|NCT00871338|3968478|B3||Female|Sex: Female, Male|Booster vaccination epoch|Participants|Count of Participants|134|134.0||||||
4144273|NCT00871338|3968479|B2||Female|Sex: Female, Male|Booster vaccination epoch|Participants|Count of Participants|75|75.0||||||
4144274|NCT00871338|3968480|B1||Female|Sex: Female, Male|Booster vaccination epoch|Participants|Count of Participants|59|59.0||||||
4144275|NCT00871338|3968478|B3||Male|Sex: Female, Male|Primary vaccination epoch|Participants|Count of Participants|147|147.0||||||
4144276|NCT00871338|3968479|B2||Male|Sex: Female, Male|Primary vaccination epoch|Participants|Count of Participants|64|64.0||||||
4144277|NCT00871338|3968480|B1||Male|Sex: Female, Male|Primary vaccination epoch|Participants|Count of Participants|83|83.0||||||
4144278|NCT00871338|3968478|B3||Female|Sex: Female, Male|Primary vaccination epoch|Participants|Count of Participants|137|137.0||||||
4144279|NCT00871338|3968479|B2||Female|Sex: Female, Male|Primary vaccination epoch|Participants|Count of Participants|78|78.0||||||
4144280|NCT00871338|3968480|B1||Female|Sex: Female, Male|Primary vaccination epoch|Participants|Count of Participants|59|59.0||||||
4144281|NCT00871338|3968478|B3|||Age|Booster vaccination epoch|weeks|Mean|11.85|11.85|Standard Deviation|0.38|0.38|||
4144282|NCT00871338|3968479|B2|||Age|Booster vaccination epoch|weeks|Mean|11.9|11.9|Standard Deviation|0.36|0.36|||
4144283|NCT00871338|3968480|B1|||Age|Booster vaccination epoch|weeks|Mean|11.8|11.8|Standard Deviation|0.39|0.39|||
4144284|NCT00871338|3968478|B3|||Age|Primary vaccination epoch|weeks|Mean|8.15|8.15|Standard Deviation|0.49|0.49|||
4144285|NCT00871338|3968479|B2|||Age|Primary vaccination epoch|weeks|Mean|8.1|8.1|Standard Deviation|0.74|0.74|||
4144286|NCT00871338|3968480|B1|||Age|Primary vaccination epoch|weeks|Mean|8.2|8.2|Standard Deviation|0.69|0.69|||
4144287|NCT00871286|3968559|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4144288|NCT00871286|3968560|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4144289|NCT00871286|3968561|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4144290|NCT00871286|3968559|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4144291|NCT00871286|3968560|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4144292|NCT00871286|3968561|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4144293|NCT00871286|3968559|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4144294|NCT00871286|3968560|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4144295|NCT00871286|3968561|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4144296|NCT00871286|3968559|B3|||Age||years|Mean|39|39.0|Standard Deviation|12.4|12.4|||
4144297|NCT00871286|3968560|B2|||Age||years|Mean|38.9|38.9|Standard Deviation|11.6|11.6|||
4144298|NCT00871286|3968561|B1|||Age||years|Mean|39|39.0|Standard Deviation|13.5|13.5|||
4144299|NCT00871286|3968559|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4144300|NCT00871286|3968560|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4144301|NCT00871286|3968561|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4144302|NCT00871286|3968559|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4144303|NCT00871286|3968560|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4144304|NCT00871286|3968561|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4144305|NCT00871286|3968559|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4144306|NCT00871286|3968560|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4144307|NCT00871286|3968561|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4144308|NCT00871234|3968570|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4144309|NCT00871234|3968570|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4144310|NCT00871234|3968570|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4144311|NCT00871234|3968570|B1|||Age||years|Median|40|40.0|Inter-Quartile Range|||28.0|47.0|
4144312|NCT00871234|3968570|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4144313|NCT00871234|3968570|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4144314|NCT00871234|3968570|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4144315|NCT00871169|3968574|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
4144316|NCT00871169|3968574|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4144317|NCT00871169|3968574|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4144318|NCT00871169|3968574|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4144319|NCT00871169|3968574|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4144320|NCT00871169|3968574|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4144321|NCT00871169|3968574|B1|||Age||years|Median|62|62.0|Full Range|||39.0|75.0|
4144368|NCT00871143|3968580|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4144369|NCT00871143|3968581|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4144370|NCT00871143|3968579|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4144322|NCT00871143|3968579|B3|||Body Image Quality of Life Inventory (BIQLI)|The BIQLI is a 19-item self-report scale that measures the impact of body image concerns on a broad range of life domains (e.g. sense of self, social functioning, sexuality, emotional well-being, exercise and grooming); the BIQLI is scored as the average numeric score of all the items from –3 (‘very negative effect’) to +3 (‘very positive effect’); Cronbach’s α for the scale is 0.95.|units on a scale|Mean|-1.83|-1.83|Standard Deviation|0.80|0.8|||
4144323|NCT00871143|3968580|B2|||Body Image Quality of Life Inventory (BIQLI)|The BIQLI is a 19-item self-report scale that measures the impact of body image concerns on a broad range of life domains (e.g. sense of self, social functioning, sexuality, emotional well-being, exercise and grooming); the BIQLI is scored as the average numeric score of all the items from –3 (‘very negative effect’) to +3 (‘very positive effect’); Cronbach’s α for the scale is 0.95.|units on a scale|Mean|-1.68|-1.68|Standard Deviation|1.04|1.04|||
4144324|NCT00871143|3968581|B1|||Body Image Quality of Life Inventory (BIQLI)|The BIQLI is a 19-item self-report scale that measures the impact of body image concerns on a broad range of life domains (e.g. sense of self, social functioning, sexuality, emotional well-being, exercise and grooming); the BIQLI is scored as the average numeric score of all the items from –3 (‘very negative effect’) to +3 (‘very positive effect’); Cronbach’s α for the scale is 0.95.|units on a scale|Mean|-1.97|-1.97|Standard Deviation|0.56|0.56|||
4144325|NCT00871143|3968579|B3|||Generalised Anxiety Disorder (GAD)-7|The GAD-7 is a 7-item self-report measure for symptoms of generalised anxiety; each item is scored from 0 to 3, and the summed total score ranges from 0 to 21, with higher scores reflecting a greater symptomatology; Cronbach’s α for the measure is 0.92.|units on a scale|Mean|12.21|12.21|Standard Deviation|5.78|5.78|||
4144326|NCT00871143|3968580|B2|||Generalised Anxiety Disorder (GAD)-7|The GAD-7 is a 7-item self-report measure for symptoms of generalised anxiety; each item is scored from 0 to 3, and the summed total score ranges from 0 to 21, with higher scores reflecting a greater symptomatology; Cronbach’s α for the measure is 0.92.|units on a scale|Mean|13.09|13.09|Standard Deviation|5.24|5.24|||
4144327|NCT00871143|3968581|B1|||Generalised Anxiety Disorder (GAD)-7|The GAD-7 is a 7-item self-report measure for symptoms of generalised anxiety; each item is scored from 0 to 3, and the summed total score ranges from 0 to 21, with higher scores reflecting a greater symptomatology; Cronbach’s α for the measure is 0.92.|units on a scale|Mean|11.33|11.33|Standard Deviation|6.32|6.32|||
4144328|NCT00871143|3968579|B3|||Patient Health Questionnaire (PHQ)-9|The PHQ is a 9-item self-report measure of depression; each item is scored from 0 (‘not at all’) to 3 (‘nearly every day’),and the summed total score ranges from 0 to 27, with higher scores reflecting a greater symptomatology of depression; Cronbach’s α for the scale is 0.89.|units on a scale|Mean|13.35|13.35|Standard Deviation|5.97|5.97|||
4144329|NCT00871143|3968580|B2|||Patient Health Questionnaire (PHQ)-9|The PHQ is a 9-item self-report measure of depression; each item is scored from 0 (‘not at all’) to 3 (‘nearly every day’),and the summed total score ranges from 0 to 27, with higher scores reflecting a greater symptomatology of depression; Cronbach’s α for the scale is 0.89.|units on a scale|Mean|13.60|13.6|Standard Deviation|5.44|5.44|||
4144330|NCT00871143|3968581|B1|||Patient Health Questionnaire (PHQ)-9|The PHQ is a 9-item self-report measure of depression; each item is scored from 0 (‘not at all’) to 3 (‘nearly every day’),and the summed total score ranges from 0 to 27, with higher scores reflecting a greater symptomatology of depression; Cronbach’s α for the scale is 0.89.|units on a scale|Mean|13.10|13.1|Standard Deviation|6.50|6.5|||
4144331|NCT00871143|3968579|B3|||Appearance Anxiety Inventory (AAI)|The AAI is a 10- item self-report questionnaire for measuring the frequency of avoidance behaviour and threat-monitoring (e.g. checking, self-focussed attention) that are characteristic of a response to a distorted body image; each item is scored from 0 (‘not at all’) to 4 (‘all the time’), and the range of the total scores is 0–40, with higher scores reflecting a greater frequency of the responses; the AAI has a Cronbach’s α of 0.86.|units on a scale|Mean|27.335|27.335|Standard Deviation|6.83|6.83|||
4144332|NCT00871143|3968580|B2|||Appearance Anxiety Inventory (AAI)|The AAI is a 10- item self-report questionnaire for measuring the frequency of avoidance behaviour and threat-monitoring (e.g. checking, self-focussed attention) that are characteristic of a response to a distorted body image; each item is scored from 0 (‘not at all’) to 4 (‘all the time’), and the range of the total scores is 0–40, with higher scores reflecting a greater frequency of the responses; the AAI has a Cronbach’s α of 0.86.|units on a scale|Mean|27.78|27.78|Standard Deviation|7.03|7.03|||
4144333|NCT00871143|3968581|B1|||Appearance Anxiety Inventory (AAI)|The AAI is a 10- item self-report questionnaire for measuring the frequency of avoidance behaviour and threat-monitoring (e.g. checking, self-focussed attention) that are characteristic of a response to a distorted body image; each item is scored from 0 (‘not at all’) to 4 (‘all the time’), and the range of the total scores is 0–40, with higher scores reflecting a greater frequency of the responses; the AAI has a Cronbach’s α of 0.86.|units on a scale|Mean|26.89|26.89|Standard Deviation|6.62|6.62|||
4144334|NCT00871143|3968579|B3|||Montgomery-Åsberg Depression Rating Scale (MADRS)|MADRS is a 10-item clinician scale rated by a blinded assessor to measure symptoms of depression; each item is rated on a 7-point Likert scale from 0 (indicating ‘normal’ or ‘no difficulties’) to 6, and the range is 0–60; higher scores reflect a greater symptomatology; a MADRS total score of ≥ 25 is regarded as moderate, and of >31 as severe.|units on a scale|Mean|29.31|29.31|Standard Deviation|10.16|10.16|||
4144335|NCT00871143|3968580|B2|||Montgomery-Åsberg Depression Rating Scale (MADRS)|MADRS is a 10-item clinician scale rated by a blinded assessor to measure symptoms of depression; each item is rated on a 7-point Likert scale from 0 (indicating ‘normal’ or ‘no difficulties’) to 6, and the range is 0–60; higher scores reflect a greater symptomatology; a MADRS total score of ≥ 25 is regarded as moderate, and of >31 as severe.|units on a scale|Mean|30.04|30.04|Standard Deviation|9.62|9.62|||
4144336|NCT00871143|3968581|B1|||Montgomery-Åsberg Depression Rating Scale (MADRS)|MADRS is a 10-item clinician scale rated by a blinded assessor to measure symptoms of depression; each item is rated on a 7-point Likert scale from 0 (indicating ‘normal’ or ‘no difficulties’) to 6, and the range is 0–60; higher scores reflect a greater symptomatology; a MADRS total score of ≥ 25 is regarded as moderate, and of >31 as severe.|units on a scale|Mean|28.57|28.57|Standard Deviation|10.69|10.69|||
4144371|NCT00871143|3968580|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4144372|NCT00871143|3968581|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4144337|NCT00871143|3968579|B3|||Brown Assessment of Beliefs Scale (BABS)|BABS is a 7-item clinician scale rated by a blinded assessor to measure the strength of conviction in a belief (e.g. ‘I am as ugly as the Elephant man’); each item is rated from 0 (‘non-delusional belief, or least pathological’) to 4 (‘delusional belief, or most pathological’) and the total scores range from 0 to 24; higher scores represent an increasing delusionality of beliefs; respondents are classified as having delusional BDD beliefs if their total score is 18 or more, and if they score 4 on the first item, indicating they are completely convinced that their belief is accurate.|units on a scale|Mean|18.60|18.6|Standard Deviation|4.41|4.41|||
4144338|NCT00871143|3968580|B2|||Brown Assessment of Beliefs Scale (BABS)|BABS is a 7-item clinician scale rated by a blinded assessor to measure the strength of conviction in a belief (e.g. ‘I am as ugly as the Elephant man’); each item is rated from 0 (‘non-delusional belief, or least pathological’) to 4 (‘delusional belief, or most pathological’) and the total scores range from 0 to 24; higher scores represent an increasing delusionality of beliefs; respondents are classified as having delusional BDD beliefs if their total score is 18 or more, and if they score 4 on the first item, indicating they are completely convinced that their belief is accurate.|units on a scale|Mean|18.96|18.96|Standard Deviation|4.14|4.14|||
4144339|NCT00871143|3968581|B1|||Brown Assessment of Beliefs Scale (BABS)|BABS is a 7-item clinician scale rated by a blinded assessor to measure the strength of conviction in a belief (e.g. ‘I am as ugly as the Elephant man’); each item is rated from 0 (‘non-delusional belief, or least pathological’) to 4 (‘delusional belief, or most pathological’) and the total scores range from 0 to 24; higher scores represent an increasing delusionality of beliefs; respondents are classified as having delusional BDD beliefs if their total score is 18 or more, and if they score 4 on the first item, indicating they are completely convinced that their belief is accurate.|units on a scale|Mean|18.24|18.24|Standard Deviation|4.68|4.68|||
4144340|NCT00871143|3968579|B3|||Yale-Brown Obsessive Compulsive Scale modified for BDD (BDD-YBOCS)|This is a clinician-rated scale administered by a trained blinded assessor. The range is 0–48. Cronbach’s α for the scale is 0.80. Response to treatment is defined as a 30% or greater decrease in the total BDD-YBOCS score, which best corresponded to ‘much improved’ on the Clinical Global Impression (CGI) scale. In the original validation study, this cutoff score produced 1 false negative (96% sensitivity), that is, 1 participant who was rated as much or very much improved on the CGI was not classified as a responder on the BDD-YBOCS using the 30% threshold.|units on a scale|Mean|36.58|36.58|Standard Deviation|5.69|5.69|||
4144341|NCT00871143|3968580|B2|||Yale-Brown Obsessive Compulsive Scale modified for BDD (BDD-YBOCS)|This is a clinician-rated scale administered by a trained blinded assessor. The range is 0–48. Cronbach’s α for the scale is 0.80. Response to treatment is defined as a 30% or greater decrease in the total BDD-YBOCS score, which best corresponded to ‘much improved’ on the Clinical Global Impression (CGI) scale. In the original validation study, this cutoff score produced 1 false negative (96% sensitivity), that is, 1 participant who was rated as much or very much improved on the CGI was not classified as a responder on the BDD-YBOCS using the 30% threshold.|units on a scale|Mean|37.68|37.68|Standard Deviation|4.77|4.77|||
4144342|NCT00871143|3968581|B1|||Yale-Brown Obsessive Compulsive Scale modified for BDD (BDD-YBOCS)|This is a clinician-rated scale administered by a trained blinded assessor. The range is 0–48. Cronbach’s α for the scale is 0.80. Response to treatment is defined as a 30% or greater decrease in the total BDD-YBOCS score, which best corresponded to ‘much improved’ on the Clinical Global Impression (CGI) scale. In the original validation study, this cutoff score produced 1 false negative (96% sensitivity), that is, 1 participant who was rated as much or very much improved on the CGI was not classified as a responder on the BDD-YBOCS using the 30% threshold.|units on a scale|Mean|35.48|35.48|Standard Deviation|6.61|6.61|||
4144343|NCT00871143|3968579|B3|United Kingdom||Region of Enrollment||participants|Number|46|46.0||||||
4144344|NCT00871143|3968580|B2|United Kingdom||Region of Enrollment||participants|Number|25|25.0||||||
4144345|NCT00871143|3968581|B1|United Kingdom||Region of Enrollment||participants|Number|21|21.0||||||
4144346|NCT00871143|3968579|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144347|NCT00871143|3968580|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144348|NCT00871143|3968581|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144349|NCT00871143|3968579|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4144350|NCT00871143|3968580|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4144351|NCT00871143|3968581|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4144352|NCT00871143|3968579|B3||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4144353|NCT00871143|3968580|B2||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4144354|NCT00871143|3968581|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4144355|NCT00871143|3968579|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4144356|NCT00871143|3968580|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4144357|NCT00871143|3968581|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4144358|NCT00871143|3968579|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144359|NCT00871143|3968580|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144360|NCT00871143|3968581|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144361|NCT00871143|3968579|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4144362|NCT00871143|3968580|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144363|NCT00871143|3968581|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4144364|NCT00871143|3968579|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144365|NCT00871143|3968580|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144366|NCT00871143|3968581|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144373|NCT00871143|3968579|B3|||Age||years|Mean|30.0|30.0|Inter-Quartile Range|||25.0|36.5|
4144374|NCT00871143|3968580|B2|||Age||years|Mean|29.0|29.0|Inter-Quartile Range|||25.5|37.0|
4144375|NCT00871143|3968581|B1|||Age||years|Mean|30.0|30.0|Inter-Quartile Range|||24.5|37.5|
4144376|NCT00871143|3968579|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4144377|NCT00871143|3968580|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4144378|NCT00871143|3968581|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4144379|NCT00871143|3968579|B3||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4144380|NCT00871143|3968580|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4144381|NCT00871143|3968581|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4144382|NCT00871143|3968579|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4144383|NCT00871143|3968580|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4144384|NCT00871143|3968581|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4144385|NCT00871117|3968600|B3|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|74|74.0||||||
4144386|NCT00871117|3968601|B2|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
4144387|NCT00871117|3968602|B1|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
4144388|NCT00871117|3968600|B3|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|216|216.0||||||
4144389|NCT00871117|3968601|B2|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|107|107.0||||||
4144390|NCT00871117|3968602|B1|White - Caucasian / European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|109|109.0||||||
4144391|NCT00871117|3968600|B3|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4144392|NCT00871117|3968601|B2|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4144393|NCT00871117|3968602|B1|White - Arabic / North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4144394|NCT00871117|3968600|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4144395|NCT00871117|3968601|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4144396|NCT00871117|3968602|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4144397|NCT00871117|3968600|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
4144398|NCT00871117|3968601|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4144399|NCT00871117|3968602|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4144400|NCT00871117|3968600|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4144401|NCT00871117|3968601|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4144402|NCT00871117|3968602|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4144403|NCT00871117|3968600|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
4144404|NCT00871117|3968601|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4144405|NCT00871117|3968602|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4144406|NCT00871117|3968600|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|68|68.0||||||
4144407|NCT00871117|3968601|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
4144408|NCT00871117|3968602|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
4144409|NCT00871117|3968600|B3|African Heritage / African American||Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
4144410|NCT00871117|3968601|B2|African Heritage / African American||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
4144411|NCT00871117|3968602|B1|African Heritage / African American||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
4144412|NCT00871117|3968600|B3||Male|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
4144413|NCT00871117|3968601|B2||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4144414|NCT00871117|3968602|B1||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4144415|NCT00871117|3968600|B3||Female|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
4144416|NCT00871117|3968601|B2||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4144417|NCT00871117|3968602|B1||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4144418|NCT00871117|3968600|B3|||Age||Years|Mean|4.2|4.2|Standard Deviation|0.39|0.39|||
4144419|NCT00871117|3968601|B2|||Age||Years|Mean|4.2|4.2|Standard Deviation|0.37|0.37|||
4144420|NCT00871117|3968602|B1|||Age||Years|Mean|4.2|4.2|Standard Deviation|0.41|0.41|||
4144421|NCT00871000|3968635|B3|Not specified||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4144422|NCT00871000|3968636|B2|Not specified||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4144423|NCT00871000|3968637|B1|Not specified||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4144424|NCT00871000|3968635|B3|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|294|294.0||||||
4144425|NCT00871000|3968636|B2|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|147|147.0||||||
4144426|NCT00871000|3968637|B1|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|147|147.0||||||
4144427|NCT00871000|3968635|B3|White-Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4144428|NCT00871000|3968636|B2|White-Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4144429|NCT00871000|3968637|B1|White-Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4144430|NCT00871000|3968635|B3|Asian-Central/South Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4144431|NCT00871000|3968636|B2|Asian-Central/South Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4144432|NCT00871000|3968637|B1|Asian-Central/South Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4144433|NCT00871000|3968635|B3|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4144434|NCT00871000|3968636|B2|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4144435|NCT00871000|3968637|B1|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4144436|NCT00871000|3968635|B3||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4144437|NCT00871000|3968636|B2||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4144438|NCT00871000|3968637|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4144439|NCT00871000|3968635|B3||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4144440|NCT00871000|3968636|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4144441|NCT00871000|3968637|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4144442|NCT00871000|3968635|B3|||Age||Years|Mean|5|5.0|Standard Deviation|0.14|0.14|||
4144443|NCT00871000|3968636|B2|||Age||Years|Mean|5|5.0|Standard Deviation|0.14|0.14|||
4144444|NCT00871000|3968637|B1|||Age||Years|Mean|5|5.0|Standard Deviation|0.14|0.14|||
4144445|NCT00870896|3968680|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4144446|NCT00870896|3968680|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4144447|NCT00870896|3968680|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4144448|NCT00870896|3968680|B1|||Age||years|Mean|56|56.0|Standard Deviation|4.52|4.52|||
4144449|NCT00870896|3968680|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4144450|NCT00870896|3968680|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4144451|NCT00870896|3968680|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4144452|NCT00870870|3968686|B5||Nonsquamous|Randomization Stratum||Participants|Count of Participants|34|34.0||||||
4144453|NCT00870870|3968687|B4||Nonsquamous|Randomization Stratum||Participants|Count of Participants|14|14.0||||||
4144454|NCT00870870|3968688|B3||Nonsquamous|Randomization Stratum||Participants|Count of Participants|15|15.0||||||
4144455|NCT00870870|3968689|B2||Nonsquamous|Randomization Stratum||Participants|Count of Participants|3|3.0||||||
4144456|NCT00870870|3968690|B1||Nonsquamous|Randomization Stratum||Participants|Count of Participants|2|2.0||||||
4144457|NCT00870870|3968686|B5||Squamous|Randomization Stratum||Participants|Count of Participants|30|30.0||||||
4144458|NCT00870870|3968687|B4||Squamous|Randomization Stratum||Participants|Count of Participants|11|11.0||||||
4144459|NCT00870870|3968688|B3||Squamous|Randomization Stratum||Participants|Count of Participants|14|14.0||||||
4144460|NCT00870870|3968689|B2||Squamous|Randomization Stratum||Participants|Count of Participants|3|3.0||||||
4144461|NCT00870870|3968690|B1||Squamous|Randomization Stratum||Participants|Count of Participants|2|2.0||||||
4144462|NCT00870870|3968686|B5||1 = Ambulatory, Restricted Work Activity|Eastern Cooperative Oncology Status Performance Status (ECOG PS) Score|ECOG performance status was used to classify participants according to their functional impairment. Score 0 = fully active, able to carry on all pre-disease performance without restriction. Score 1 = restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, for example, light house work, office work.|Participants|Count of Participants|46|46.0||||||
4144463|NCT00870870|3968687|B4||1 = Ambulatory, Restricted Work Activity|Eastern Cooperative Oncology Status Performance Status (ECOG PS) Score|ECOG performance status was used to classify participants according to their functional impairment. Score 0 = fully active, able to carry on all pre-disease performance without restriction. Score 1 = restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, for example, light house work, office work.|Participants|Count of Participants|16|16.0||||||
4144464|NCT00870870|3968688|B3||1 = Ambulatory, Restricted Work Activity|Eastern Cooperative Oncology Status Performance Status (ECOG PS) Score|ECOG performance status was used to classify participants according to their functional impairment. Score 0 = fully active, able to carry on all pre-disease performance without restriction. Score 1 = restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, for example, light house work, office work.|Participants|Count of Participants|24|24.0||||||
4144465|NCT00870870|3968689|B2||1 = Ambulatory, Restricted Work Activity|Eastern Cooperative Oncology Status Performance Status (ECOG PS) Score|ECOG performance status was used to classify participants according to their functional impairment. Score 0 = fully active, able to carry on all pre-disease performance without restriction. Score 1 = restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, for example, light house work, office work.|Participants|Count of Participants|2|2.0||||||
4144466|NCT00870870|3968690|B1||1 = Ambulatory, Restricted Work Activity|Eastern Cooperative Oncology Status Performance Status (ECOG PS) Score|ECOG performance status was used to classify participants according to their functional impairment. Score 0 = fully active, able to carry on all pre-disease performance without restriction. Score 1 = restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, for example, light house work, office work.|Participants|Count of Participants|4|4.0||||||
4144467|NCT00870870|3968686|B5||0 = Fully Active|Eastern Cooperative Oncology Status Performance Status (ECOG PS) Score|ECOG performance status was used to classify participants according to their functional impairment. Score 0 = fully active, able to carry on all pre-disease performance without restriction. Score 1 = restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, for example, light house work, office work.|Participants|Count of Participants|18|18.0||||||
4144468|NCT00870870|3968687|B4||0 = Fully Active|Eastern Cooperative Oncology Status Performance Status (ECOG PS) Score|ECOG performance status was used to classify participants according to their functional impairment. Score 0 = fully active, able to carry on all pre-disease performance without restriction. Score 1 = restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, for example, light house work, office work.|Participants|Count of Participants|9|9.0||||||
4144469|NCT00870870|3968688|B3||0 = Fully Active|Eastern Cooperative Oncology Status Performance Status (ECOG PS) Score|ECOG performance status was used to classify participants according to their functional impairment. Score 0 = fully active, able to carry on all pre-disease performance without restriction. Score 1 = restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, for example, light house work, office work.|Participants|Count of Participants|5|5.0||||||
4144470|NCT00870870|3968689|B2||0 = Fully Active|Eastern Cooperative Oncology Status Performance Status (ECOG PS) Score|ECOG performance status was used to classify participants according to their functional impairment. Score 0 = fully active, able to carry on all pre-disease performance without restriction. Score 1 = restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, for example, light house work, office work.|Participants|Count of Participants|4|4.0||||||
4144471|NCT00870870|3968690|B1||0 = Fully Active|Eastern Cooperative Oncology Status Performance Status (ECOG PS) Score|ECOG performance status was used to classify participants according to their functional impairment. Score 0 = fully active, able to carry on all pre-disease performance without restriction. Score 1 = restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, for example, light house work, office work.|Participants|Count of Participants|0|0.0||||||
4144472|NCT00870870|3968686|B5|||Body Surface Area (BSA)|BSA is the measured or calculated surface area of a human body based on body weight and height.|square meters (m^2)|Mean|1.88|1.88|Standard Deviation|0.225|0.225|||
4144473|NCT00870870|3968687|B4|||Body Surface Area (BSA)|BSA is the measured or calculated surface area of a human body based on body weight and height.|square meters (m^2)|Mean|1.84|1.84|Standard Deviation|0.246|0.246|||
4144474|NCT00870870|3968688|B3|||Body Surface Area (BSA)|BSA is the measured or calculated surface area of a human body based on body weight and height.|square meters (m^2)|Mean|1.89|1.89|Standard Deviation|0.214|0.214|||
4144475|NCT00870870|3968689|B2|||Body Surface Area (BSA)|BSA is the measured or calculated surface area of a human body based on body weight and height.|square meters (m^2)|Mean|1.98|1.98|Standard Deviation|0.223|0.223|||
4144476|NCT00870870|3968690|B1|||Body Surface Area (BSA)|BSA is the measured or calculated surface area of a human body based on body weight and height.|square meters (m^2)|Mean|1.89|1.89|Standard Deviation|0.186|0.186|||
4144477|NCT00870870|3968686|B5|||Weight||kilograms (kg)|Mean|75.27|75.27|Standard Deviation|14.815|14.815|||
4144478|NCT00870870|3968687|B4|||Weight||kilograms (kg)|Mean|72.90|72.9|Standard Deviation|15.957|15.957|||
4144479|NCT00870870|3968688|B3|||Weight||kilograms (kg)|Mean|76.30|76.3|Standard Deviation|13.908|13.908|||
4144480|NCT00870870|3968689|B2|||Weight||kilograms (kg)|Mean|80.43|80.43|Standard Deviation|16.720|16.72|||
4144481|NCT00870870|3968690|B1|||Weight||kilograms (kg)|Mean|74.93|74.93|Standard Deviation|13.814|13.814|||
4144482|NCT00870870|3968686|B5|||Height||centimeters (cm)|Mean|169.99|169.99|Standard Deviation|9.758|9.758|||
4144483|NCT00870870|3968687|B4|||Height||centimeters (cm)|Mean|167.79|167.79|Standard Deviation|10.537|10.537|||
4144484|NCT00870870|3968688|B3|||Height||centimeters (cm)|Mean|170.04|170.04|Standard Deviation|9.356|9.356|||
4144485|NCT00870870|3968689|B2|||Height||centimeters (cm)|Mean|176.78|176.78|Standard Deviation|8.935|8.935|||
4144486|NCT00870870|3968690|B1|||Height||centimeters (cm)|Mean|173.10|173.1|Standard Deviation|3.982|3.982|||
4144487|NCT00870870|3968686|B5|United States||Region of Enrollment||Participants|Count of Participants|64|64.0||||||
4144488|NCT00870870|3968687|B4|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4144489|NCT00870870|3968688|B3|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
4144490|NCT00870870|3968689|B2|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4144491|NCT00870870|3968690|B1|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4144492|NCT00870870|3968686|B5||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4144493|NCT00870870|3968687|B4||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4144494|NCT00870870|3968688|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4144495|NCT00870870|3968689|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4144496|NCT00870870|3968690|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4144497|NCT00870870|3968686|B5||White|Race/Ethnicity, Customized||Participants|Count of Participants|58|58.0||||||
4144498|NCT00870870|3968687|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
4144499|NCT00870870|3968688|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
4144500|NCT00870870|3968689|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4144501|NCT00870870|3968690|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4144502|NCT00870870|3968686|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144503|NCT00870870|3968687|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144504|NCT00870870|3968688|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144505|NCT00870870|3968689|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144506|NCT00870870|3968690|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144507|NCT00870870|3968686|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4144508|NCT00870870|3968687|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4144509|NCT00870870|3968688|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4144510|NCT00870870|3968689|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4144511|NCT00870870|3968690|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4144512|NCT00870870|3968686|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4144513|NCT00870870|3968687|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4144514|NCT00870870|3968688|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144515|NCT00870870|3968689|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144516|NCT00870870|3968690|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144517|NCT00870870|3968686|B5||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4144518|NCT00870870|3968687|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4144519|NCT00870870|3968688|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4144520|NCT00870870|3968689|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4144521|NCT00870870|3968690|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4144522|NCT00870870|3968686|B5||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4144523|NCT00870870|3968687|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4144524|NCT00870870|3968688|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4144525|NCT00870870|3968689|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4144526|NCT00870870|3968690|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4144527|NCT00870870|3968686|B5|||Age||years|Median|62.00|62.0|Full Range|||41.0|77.0|
4144528|NCT00870870|3968687|B4|||Age||years|Median|60.00|60.0|Full Range|||41.0|77.0|
4144529|NCT00870870|3968688|B3|||Age||years|Median|64.00|64.0|Full Range|||45.0|77.0|
4144530|NCT00870870|3968689|B2|||Age||years|Median|54.50|54.5|Full Range|||49.0|69.0|
4144531|NCT00870870|3968690|B1|||Age||years|Median|68.50|68.5|Full Range|||65.0|74.0|
4144532|NCT00870740|3968731|B7||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4144533|NCT00870740|3968732|B6||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4144534|NCT00870740|3968733|B5||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4144535|NCT00870740|3968734|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4144536|NCT00870740|3968735|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4144537|NCT00870740|3968736|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4144538|NCT00870740|3968737|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4144539|NCT00870740|3968731|B7||Female|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
4144540|NCT00870740|3968732|B6||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4144541|NCT00870740|3968733|B5||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4144542|NCT00870740|3968734|B4||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4144543|NCT00870740|3968735|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4144544|NCT00870740|3968736|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4144545|NCT00870740|3968737|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4144546|NCT00870740|3968731|B7|> 55 years||Age, Customized||participants|Number|3|3.0||||||
4144547|NCT00870740|3968732|B6|> 55 years||Age, Customized||participants|Number|1|1.0||||||
4144548|NCT00870740|3968733|B5|> 55 years||Age, Customized||participants|Number|1|1.0||||||
4144549|NCT00870740|3968734|B4|> 55 years||Age, Customized||participants|Number|0|0.0||||||
4144550|NCT00870740|3968735|B3|> 55 years||Age, Customized||participants|Number|0|0.0||||||
4144551|NCT00870740|3968736|B2|> 55 years||Age, Customized||participants|Number|0|0.0||||||
4144552|NCT00870740|3968737|B1|> 55 years||Age, Customized||participants|Number|1|1.0||||||
4144553|NCT00870740|3968731|B7|50 to 55 years||Age, Customized||participants|Number|38|38.0||||||
4144554|NCT00870740|3968732|B6|50 to 55 years||Age, Customized||participants|Number|3|3.0||||||
4144555|NCT00870740|3968733|B5|50 to 55 years||Age, Customized||participants|Number|7|7.0||||||
4144556|NCT00870740|3968734|B4|50 to 55 years||Age, Customized||participants|Number|6|6.0||||||
4144557|NCT00870740|3968735|B3|50 to 55 years||Age, Customized||participants|Number|5|5.0||||||
4144558|NCT00870740|3968736|B2|50 to 55 years||Age, Customized||participants|Number|6|6.0||||||
4144559|NCT00870740|3968737|B1|50 to 55 years||Age, Customized||participants|Number|11|11.0||||||
4144560|NCT00870740|3968731|B7|40 to 49 years||Age, Customized||participants|Number|166|166.0||||||
4144561|NCT00870740|3968732|B6|40 to 49 years||Age, Customized||participants|Number|25|25.0||||||
4144562|NCT00870740|3968733|B5|40 to 49 years||Age, Customized||participants|Number|24|24.0||||||
4144563|NCT00870740|3968734|B4|40 to 49 years||Age, Customized||participants|Number|27|27.0||||||
4144564|NCT00870740|3968735|B3|40 to 49 years||Age, Customized||participants|Number|33|33.0||||||
4144565|NCT00870740|3968736|B2|40 to 49 years||Age, Customized||participants|Number|28|28.0||||||
4144566|NCT00870740|3968737|B1|40 to 49 years||Age, Customized||participants|Number|29|29.0||||||
4144567|NCT00870740|3968731|B7|30 to 39 years||Age, Customized||participants|Number|196|196.0||||||
4144568|NCT00870740|3968732|B6|30 to 39 years||Age, Customized||participants|Number|41|41.0||||||
4144569|NCT00870740|3968733|B5|30 to 39 years||Age, Customized||participants|Number|35|35.0||||||
4144570|NCT00870740|3968734|B4|30 to 39 years||Age, Customized||participants|Number|28|28.0||||||
4144571|NCT00870740|3968735|B3|30 to 39 years||Age, Customized||participants|Number|29|29.0||||||
4144572|NCT00870740|3968736|B2|30 to 39 years||Age, Customized||participants|Number|37|37.0||||||
4144573|NCT00870740|3968737|B1|30 to 39 years||Age, Customized||participants|Number|26|26.0||||||
4144574|NCT00870740|3968731|B7|20 to 29 years||Age, Customized||participants|Number|112|112.0||||||
4144575|NCT00870740|3968732|B6|20 to 29 years||Age, Customized||participants|Number|16|16.0||||||
4144576|NCT00870740|3968733|B5|20 to 29 years||Age, Customized||participants|Number|20|20.0||||||
4144577|NCT00870740|3968734|B4|20 to 29 years||Age, Customized||participants|Number|25|25.0||||||
4144578|NCT00870740|3968735|B3|20 to 29 years||Age, Customized||participants|Number|19|19.0||||||
4144579|NCT00870740|3968736|B2|20 to 29 years||Age, Customized||participants|Number|13|13.0||||||
4144580|NCT00870740|3968737|B1|20 to 29 years||Age, Customized||participants|Number|19|19.0||||||
4144581|NCT00870740|3968731|B7|18 to 19 years||Age, Customized||participants|Number|2|2.0||||||
4144582|NCT00870740|3968732|B6|18 to 19 years||Age, Customized||participants|Number|1|1.0||||||
4144583|NCT00870740|3968733|B5|18 to 19 years||Age, Customized||participants|Number|1|1.0||||||
4144584|NCT00870740|3968734|B4|18 to 19 years||Age, Customized||participants|Number|0|0.0||||||
4144585|NCT00870740|3968735|B3|18 to 19 years||Age, Customized||participants|Number|0|0.0||||||
4144586|NCT00870740|3968736|B2|18 to 19 years||Age, Customized||participants|Number|0|0.0||||||
4144587|NCT00870740|3968737|B1|18 to 19 years||Age, Customized||participants|Number|0|0.0||||||
4144588|NCT00870740|3968731|B7|||Age||years|Mean|36.9|36.9|Standard Deviation|8.77|8.77|||
4144589|NCT00870740|3968732|B6|||Age||years|Mean|36.0|36.0|Standard Deviation|7.60|7.6|||
4144590|NCT00870740|3968733|B5|||Age||years|Mean|36.2|36.2|Standard Deviation|9.03|9.03|||
4144591|NCT00870740|3968734|B4|||Age||years|Mean|36.2|36.2|Standard Deviation|9.30|9.3|||
4144592|NCT00870740|3968735|B3|||Age||years|Mean|36.8|36.8|Standard Deviation|8.76|8.76|||
4144593|NCT00870740|3968736|B2|||Age||years|Mean|37.8|37.8|Standard Deviation|7.98|7.98|||
4144594|NCT00870740|3968737|B1|||Age||years|Mean|38.2|38.2|Standard Deviation|9.78|9.78|||
4144595|NCT00870727|3968816|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
4144596|NCT00870727|3968817|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4144597|NCT00870727|3968818|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4144598|NCT00870727|3968816|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144599|NCT00870727|3968817|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144600|NCT00870727|3968818|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144601|NCT00870727|3968816|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4144602|NCT00870727|3968817|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4144603|NCT00870727|3968818|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4144604|NCT00870727|3968816|B3||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4144605|NCT00870727|3968817|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4144606|NCT00870727|3968818|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4144607|NCT00870727|3968816|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4144608|NCT00870727|3968817|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4144609|NCT00870727|3968818|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4144610|NCT00870727|3968816|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144611|NCT00870727|3968817|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144612|NCT00870727|3968818|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144613|NCT00870727|3968816|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144614|NCT00870727|3968817|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144615|NCT00870727|3968818|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144616|NCT00870727|3968816|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144617|NCT00870727|3968817|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144618|NCT00870727|3968818|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144619|NCT00870727|3968816|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4144620|NCT00870727|3968817|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144621|NCT00870727|3968818|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4144622|NCT00870727|3968816|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4144623|NCT00870727|3968817|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4144624|NCT00870727|3968818|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4144625|NCT00870727|3968816|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144626|NCT00870727|3968817|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144627|NCT00870727|3968818|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144628|NCT00870727|3968816|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4144629|NCT00870727|3968817|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4144630|NCT00870727|3968818|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4144631|NCT00870727|3968816|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4144632|NCT00870727|3968817|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4144633|NCT00870727|3968818|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4144634|NCT00870727|3968816|B3|||Age||years|Mean|9.6|9.6|Standard Deviation|2.7|2.7|||
4144635|NCT00870727|3968817|B2|||Age||years|Mean|9.5|9.5|Standard Deviation|2.3|2.3|||
4144636|NCT00870727|3968818|B1|||Age||years|Mean|9.8|9.8|Standard Deviation|3.0|3.0|||
4144637|NCT00870688|3968835|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4144638|NCT00870688|3968835|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4144639|NCT00870688|3968835|B1|||Age||years|Mean|45.9|45.9|Standard Deviation|23|23.0|||
4144640|NCT00870688|3968835|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4144641|NCT00870688|3968835|B1||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4144642|NCT00870688|3968835|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4144643|NCT00870584|3968838|B3||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4144644|NCT00870584|3968839|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4144645|NCT00870584|3968840|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4144646|NCT00870584|3968838|B3||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4144647|NCT00870584|3968839|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4144648|NCT00870584|3968840|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4144649|NCT00870584|3968838|B3|||Age||years|Mean|41.3|41.3|Standard Deviation|14.71|14.71|||
4144650|NCT00870584|3968839|B2|||Age||years|Mean|40.7|40.7|Standard Deviation|14.85|14.85|||
4144651|NCT00870584|3968840|B1|||Age||years|Mean|41.9|41.9|Standard Deviation|14.60|14.6|||
4144652|NCT00870545|3968849|B1|United States||Region of Enrollment||participants|Number|86|86.0||||||
4144653|NCT00870545|3968849|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4144654|NCT00870545|3968849|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4144655|NCT00870545|3968849|B1|||Age||years|Mean|37.4|37.4|Standard Deviation|9.0|9.0|||
4144656|NCT00870467|3968858|B3|Japan||Region of Enrollment||participants|Number|334|334.0||||||
4144657|NCT00870467|3968859|B2|Japan||Region of Enrollment||participants|Number|163|163.0||||||
4144658|NCT00870467|3968860|B1|Japan||Region of Enrollment||participants|Number|171|171.0||||||
4144659|NCT00870467|3968858|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4144660|NCT00870467|3968859|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4144661|NCT00870467|3968860|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4144662|NCT00870467|3968858|B3||Female|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
4144663|NCT00870467|3968859|B2||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4144664|NCT00870467|3968860|B1||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4144665|NCT00870467|3968858|B3|||Age||years|Mean|54.0|54.0|Standard Deviation|13.15|13.15|||
4144666|NCT00870467|3968859|B2|||Age||years|Mean|54.0|54.0|Standard Deviation|13.20|13.2|||
4144667|NCT00870467|3968860|B1|||Age||years|Mean|54.0|54.0|Standard Deviation|13.13|13.13|||
4144668|NCT00870363|3968909|B5|||CD4 T-Cell count||CELLS/MM^3|Median|436|436.0|Inter-Quartile Range|||283.0|572.0|
4144669|NCT00870363|3968910|B4|||CD4 T-Cell count||CELLS/MM^3|Median|NA||Inter-Quartile Range|||0.0|0.0|not measured in the negative control cohort
4144670|NCT00870363|3968911|B3|||CD4 T-Cell count||CELLS/MM^3|Median|322|322.0|Inter-Quartile Range|||233.0|536.0|
4144671|NCT00870363|3968912|B2|||CD4 T-Cell count||CELLS/MM^3|Median|453|453.0|Inter-Quartile Range|||334.0|713.0|
4144672|NCT00870363|3968913|B1|||CD4 T-Cell count||CELLS/MM^3|Median|441|441.0|Inter-Quartile Range|||369.0|511.0|
4144673|NCT00870363|3968909|B5|United States||Region of Enrollment||participants|Number|38|38.0||||||
4144674|NCT00870363|3968910|B4|United States||Region of Enrollment||participants|Number|12|12.0||||||
4144675|NCT00870363|3968911|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4144676|NCT00870363|3968912|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4144677|NCT00870363|3968913|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4144678|NCT00870363|3968909|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144679|NCT00870363|3968910|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144680|NCT00870363|3968911|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144681|NCT00870363|3968912|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144682|NCT00870363|3968913|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144683|NCT00870363|3968909|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144684|NCT00870363|3968910|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144685|NCT00870363|3968911|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144686|NCT00870363|3968912|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144687|NCT00870363|3968913|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144688|NCT00870363|3968909|B5||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4144689|NCT00870363|3968910|B4||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4144690|NCT00870363|3968911|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4144691|NCT00870363|3968912|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4144692|NCT00870363|3968913|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4144693|NCT00870363|3968909|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4144694|NCT00870363|3968910|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4144695|NCT00870363|3968911|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4144696|NCT00870363|3968912|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4144697|NCT00870363|3968913|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4144698|NCT00870363|3968909|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4144699|NCT00870363|3968910|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4144700|NCT00870363|3968911|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4144701|NCT00870363|3968912|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144702|NCT00870363|3968913|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144703|NCT00870363|3968909|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4144704|NCT00870363|3968910|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4144705|NCT00870363|3968911|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4144706|NCT00870363|3968912|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4144707|NCT00870363|3968913|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144708|NCT00870363|3968909|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144709|NCT00870363|3968910|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144710|NCT00870363|3968911|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144711|NCT00870363|3968912|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144712|NCT00870363|3968913|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144713|NCT00870363|3968909|B5||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4144714|NCT00870363|3968910|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4144715|NCT00870363|3968911|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4144716|NCT00870363|3968912|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4144717|NCT00870363|3968913|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4144718|NCT00870363|3968909|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4144719|NCT00870363|3968910|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4144720|NCT00870363|3968911|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4144721|NCT00870363|3968912|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4144722|NCT00870363|3968913|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4144723|NCT00870363|3968909|B5|||Age||years|Median|37|37.0|Inter-Quartile Range|||25.0|42.0|
4144724|NCT00870363|3968910|B4|||Age||years|Median|35|35.0|Inter-Quartile Range|||29.0|42.0|
4144725|NCT00870363|3968911|B3|||Age||years|Median|37|37.0|Inter-Quartile Range|||25.0|46.0|
4144726|NCT00870363|3968912|B2|||Age||years|Median|35|35.0|Inter-Quartile Range|||27.0|40.0|
4144727|NCT00870363|3968913|B1|||Age||years|Median|38|38.0|Inter-Quartile Range|||25.0|43.0|
4144728|NCT00870233|3968950|B1|United States||Region of Enrollment||Participants|Count of Participants|120|120.0||||||
4144729|NCT00870233|3968950|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4144730|NCT00870233|3968950|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144731|NCT00870233|3968950|B1||White|Race (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
4144732|NCT00870233|3968950|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4144733|NCT00870233|3968950|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144734|NCT00870233|3968950|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4144735|NCT00870233|3968950|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144736|NCT00870233|3968950|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4144737|NCT00870233|3968950|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
4144738|NCT00870233|3968950|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4144739|NCT00870233|3968950|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4144740|NCT00870233|3968950|B1||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4144741|NCT00870233|3968950|B1|||Age||years|Median|55|55.0|Full Range|||18.0|74.0|
4144742|NCT00870194|3968957|B3||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4144743|NCT00870194|3968958|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4144744|NCT00870194|3968959|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4144745|NCT00870194|3968957|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4144746|NCT00870194|3968958|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4144747|NCT00870194|3968959|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4144748|NCT00870194|3968957|B3|||Age||years|Mean|54.7|54.7|Standard Deviation|10.27|10.27|||
4144749|NCT00870194|3968958|B2|||Age||years|Mean|54.6|54.6|Standard Deviation|9.66|9.66|||
4144750|NCT00870194|3968959|B1|||Age||years|Mean|54.8|54.8|Standard Deviation|10.97|10.97|||
4144751|NCT00870194|3968957|B3||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4144752|NCT00870194|3968958|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4144753|NCT00870194|3968959|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4144754|NCT00870194|3968957|B3||Between 18 and 65 years|Age||Participants|Count of Participants|178|178.0||||||
4144755|NCT00870194|3968958|B2||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
4144756|NCT00870194|3968959|B1||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
4144757|NCT00870194|3968957|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4144758|NCT00870194|3968958|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4144759|NCT00870194|3968959|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4144760|NCT00870103|3968998|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4144761|NCT00870103|3968998|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4144762|NCT00870103|3968998|B1||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
4144763|NCT00870103|3968998|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4144764|NCT00870103|3968998|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4144765|NCT00869999|3969003|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4144766|NCT00869999|3969003|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4144767|NCT00869999|3969003|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4144768|NCT00869999|3969003|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4144769|NCT00869999|3969003|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4144770|NCT00869999|3969003|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4144771|NCT00869960|3969009|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4144772|NCT00869960|3969009|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4144773|NCT00869960|3969009|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4144774|NCT00869960|3969009|B1|||Age||years|Mean|27|27.0|Standard Deviation|5.0|5.0|||
4144775|NCT00869960|3969009|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4144776|NCT00869960|3969009|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4144777|NCT00869960|3969009|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4144778|NCT00869947|3969020|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4144779|NCT00869947|3969021|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4144780|NCT00869947|3969022|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4144781|NCT00869947|3969020|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4144782|NCT00869947|3969021|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4144783|NCT00869947|3969022|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4144784|NCT00869947|3969020|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4144785|NCT00869947|3969021|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4144786|NCT00869947|3969022|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4144787|NCT00869947|3969020|B3|18 - 65 years||Age||years|Mean|47.5|47.5|Standard Deviation|8.5|8.5|||
4144788|NCT00869947|3969021|B2|18 - 65 years||Age||years|Mean|49|49.0|Standard Deviation|9|9.0|||
4144789|NCT00869947|3969022|B1|18 - 65 years||Age||years|Mean|46|46.0|Standard Deviation|8|8.0|||
4144790|NCT00869791|3969036|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4144791|NCT00869791|3969036|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144792|NCT00869791|3969036|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144793|NCT00869791|3969036|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4144794|NCT00869791|3969036|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144795|NCT00869791|3969036|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144796|NCT00869791|3969036|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4144797|NCT00869791|3969036|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144798|NCT00869791|3969036|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4144799|NCT00869791|3969036|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4144800|NCT00869791|3969036|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4144801|NCT00869791|3969036|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4144802|NCT00869791|3969036|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4144803|NCT00869791|3969036|B1|||Age||years|Mean|62.7|62.7|Standard Deviation|8.6|8.6|||
4144804|NCT00869778|3969055|B4|||Body Mass Index (BMI)||kg/m^2|Mean|21.74|21.74|Standard Deviation|2.998|2.998|||
4144805|NCT00869778|3969056|B3|||Body Mass Index (BMI)||kg/m^2|Mean|21.99|21.99|Standard Deviation|2.643|2.643|||
4144806|NCT00869778|3969057|B2|||Body Mass Index (BMI)||kg/m^2|Mean|21.55|21.55|Standard Deviation|3.004|3.004|||
4144807|NCT00869778|3969058|B1|||Body Mass Index (BMI)||kg/m^2|Mean|21.92|21.92|Standard Deviation|2.992|2.992|||
4144808|NCT00869778|3969055|B4||Male|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
4144809|NCT00869778|3969056|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4144810|NCT00869778|3969057|B2||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4144811|NCT00869778|3969058|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4144812|NCT00869778|3969055|B4||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4144813|NCT00869778|3969056|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4144814|NCT00869778|3969057|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4144815|NCT00869778|3969058|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4144816|NCT00869778|3969055|B4|||Age||years|Mean|26.8|26.8|Standard Deviation|7.93|7.93|||
4144817|NCT00869778|3969056|B3|||Age||years|Mean|27.4|27.4|Standard Deviation|7.30|7.3|||
4144818|NCT00869778|3969057|B2|||Age||years|Mean|26.9|26.9|Standard Deviation|8.56|8.56|||
4144819|NCT00869778|3969058|B1|||Age||years|Mean|26.7|26.7|Standard Deviation|7.28|7.28|||
4144820|NCT00869622|3969095|B3|No veterbral fractures||Previous Vertebral Fractures||participants|Number|56|56.0||||||
4144821|NCT00869622|3969096|B2|No veterbral fractures||Previous Vertebral Fractures||participants|Number|31|31.0||||||
4144822|NCT00869622|3969097|B1|No veterbral fractures||Previous Vertebral Fractures||participants|Number|25|25.0||||||
4144823|NCT00869622|3969095|B3|Previous vertebral fractures||Previous Vertebral Fractures||participants|Number|24|24.0||||||
4144824|NCT00869622|3969096|B2|Previous vertebral fractures||Previous Vertebral Fractures||participants|Number|9|9.0||||||
4144825|NCT00869622|3969097|B1|Previous vertebral fractures||Previous Vertebral Fractures||participants|Number|15|15.0||||||
4144826|NCT00869622|3969095|B3|||Baseline Vitamin D Level||ng/ml|Mean|29.2|29.2|Standard Deviation|17.5|17.5|||
4144827|NCT00869622|3969096|B2|||Baseline Vitamin D Level||ng/ml|Mean|29.3|29.3|Standard Deviation|16|16.0|||
4144828|NCT00869622|3969097|B1|||Baseline Vitamin D Level||ng/ml|Mean|29.1|29.1|Standard Deviation|19|19.0|||
4144829|NCT00869622|3969095|B3|Non Smokers||Current Smokers||participants|Number|23|23.0||||||
4144830|NCT00869622|3969096|B2|Non Smokers||Current Smokers||participants|Number|12|12.0||||||
4144831|NCT00869622|3969097|B1|Non Smokers||Current Smokers||participants|Number|11|11.0||||||
4144832|NCT00869622|3969095|B3|Smokers||Current Smokers||participants|Number|57|57.0||||||
4144833|NCT00869622|3969096|B2|Smokers||Current Smokers||participants|Number|28|28.0||||||
4144834|NCT00869622|3969097|B1|Smokers||Current Smokers||participants|Number|29|29.0||||||
4144835|NCT00869622|3969095|B3|Other types of seizures||Type of seizures||participants|Number|39|39.0||||||
4144836|NCT00869622|3969096|B2|Other types of seizures||Type of seizures||participants|Number|18|18.0||||||
4144837|NCT00869622|3969097|B1|Other types of seizures||Type of seizures||participants|Number|21|21.0||||||
4144838|NCT00869622|3969095|B3|Grand Mal Seizures||Type of seizures||participants|Number|41|41.0||||||
4144839|NCT00869622|3969096|B2|Grand Mal Seizures||Type of seizures||participants|Number|22|22.0||||||
4144840|NCT00869622|3969097|B1|Grand Mal Seizures||Type of seizures||participants|Number|19|19.0||||||
4144841|NCT00869622|3969095|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
4144842|NCT00869622|3969096|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4144843|NCT00869622|3969097|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4144844|NCT00869622|3969095|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4144845|NCT00869622|3969096|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4144846|NCT00869622|3969097|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4144847|NCT00869622|3969095|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4144848|NCT00869622|3969096|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4144849|NCT00869622|3969097|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4144850|NCT00869622|3969095|B3|||Age||years|Mean|61|61.0|Standard Deviation|13|13.0|||
4144851|NCT00869622|3969096|B2|||Age||years|Mean|58|58.0|Standard Deviation|13|13.0|||
4144852|NCT00869622|3969097|B1|||Age||years|Mean|63|63.0|Standard Deviation|13|13.0|||
4144853|NCT00869622|3969095|B3||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4144854|NCT00869622|3969096|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4144855|NCT00869622|3969097|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4144856|NCT00869622|3969095|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4144857|NCT00869622|3969096|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4144858|NCT00869622|3969097|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4144859|NCT00869622|3969095|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4144860|NCT00869622|3969096|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4144861|NCT00869622|3969097|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4144862|NCT00869609|3969106|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4144863|NCT00869609|3969107|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4144864|NCT00869609|3969108|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4144865|NCT00869609|3969106|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4144866|NCT00869609|3969107|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4144867|NCT00869609|3969108|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4144868|NCT00869609|3969106|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4144869|NCT00869609|3969107|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4144870|NCT00869609|3969108|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4144871|NCT00869609|3969106|B3|||Age||years|Mean|54.7|54.7|Standard Deviation|10.5|10.5|||
4144872|NCT00869609|3969107|B2|||Age||years|Mean|53.4|53.4|Standard Deviation|11.6|11.6|||
4144873|NCT00869609|3969108|B1|||Age||years|Mean|55.9|55.9|Standard Deviation|9.4|9.4|||
4144874|NCT00869557|3969133|B3|> 500||Cluster Determinant 4 (CD4) Cell Count (/µL)||participants|Number|20|20.0||||||
4144875|NCT00869557|3969134|B2|> 500||Cluster Determinant 4 (CD4) Cell Count (/µL)||participants|Number|10|10.0||||||
4144876|NCT00869557|3969135|B1|> 500||Cluster Determinant 4 (CD4) Cell Count (/µL)||participants|Number|10|10.0||||||
4144877|NCT00869557|3969133|B3|351 to ≤ 500||Cluster Determinant 4 (CD4) Cell Count (/µL)||participants|Number|19|19.0||||||
4144878|NCT00869557|3969134|B2|351 to ≤ 500||Cluster Determinant 4 (CD4) Cell Count (/µL)||participants|Number|5|5.0||||||
4144879|NCT00869557|3969135|B1|351 to ≤ 500||Cluster Determinant 4 (CD4) Cell Count (/µL)||participants|Number|14|14.0||||||
4144880|NCT00869557|3969133|B3|201 to ≤ 350||Cluster Determinant 4 (CD4) Cell Count (/µL)||participants|Number|25|25.0||||||
4144881|NCT00869557|3969134|B2|201 to ≤ 350||Cluster Determinant 4 (CD4) Cell Count (/µL)||participants|Number|8|8.0||||||
4144882|NCT00869557|3969135|B1|201 to ≤ 350||Cluster Determinant 4 (CD4) Cell Count (/µL)||participants|Number|17|17.0||||||
4144883|NCT00869557|3969133|B3|51 to ≤ 200||Cluster Determinant 4 (CD4) Cell Count (/µL)||participants|Number|7|7.0||||||
4144884|NCT00869557|3969134|B2|51 to ≤ 200||Cluster Determinant 4 (CD4) Cell Count (/µL)||participants|Number|0|0.0||||||
4144885|NCT00869557|3969135|B1|51 to ≤ 200||Cluster Determinant 4 (CD4) Cell Count (/µL)||participants|Number|7|7.0||||||
4144886|NCT00869557|3969133|B3|≤ 50||Cluster Determinant 4 (CD4) Cell Count (/µL)||participants|Number|0|0.0||||||
4144887|NCT00869557|3969134|B2|≤ 50||Cluster Determinant 4 (CD4) Cell Count (/µL)||participants|Number|0|0.0||||||
4144888|NCT00869557|3969135|B1|≤ 50||Cluster Determinant 4 (CD4) Cell Count (/µL)||participants|Number|0|0.0||||||
4144889|NCT00869557|3969133|B3|> 100,000||HIV-1 RNA Category (copies/mL)||participants|Number|16|16.0||||||
4144890|NCT00869557|3969134|B2|> 100,000||HIV-1 RNA Category (copies/mL)||participants|Number|5|5.0||||||
4144891|NCT00869557|3969135|B1|> 100,000||HIV-1 RNA Category (copies/mL)||participants|Number|11|11.0||||||
4144892|NCT00869557|3969133|B3|≤ 100,000||HIV-1 RNA Category (copies/mL)||participants|Number|55|55.0||||||
4144893|NCT00869557|3969134|B2|≤ 100,000||HIV-1 RNA Category (copies/mL)||participants|Number|18|18.0||||||
4144894|NCT00869557|3969135|B1|≤ 100,000||HIV-1 RNA Category (copies/mL)||participants|Number|37|37.0||||||
4144895|NCT00869557|3969133|B3|Positive||Hepatitis C Virus (HCV) Infection Status||participants|Number|0|0.0||||||
4144896|NCT00869557|3969134|B2|Positive||Hepatitis C Virus (HCV) Infection Status||participants|Number|0|0.0||||||
4144897|NCT00869557|3969135|B1|Positive||Hepatitis C Virus (HCV) Infection Status||participants|Number|0|0.0||||||
4144898|NCT00869557|3969133|B3|Negative||Hepatitis C Virus (HCV) Infection Status||participants|Number|71|71.0||||||
4144899|NCT00869557|3969134|B2|Negative||Hepatitis C Virus (HCV) Infection Status||participants|Number|23|23.0||||||
4144900|NCT00869557|3969135|B1|Negative||Hepatitis C Virus (HCV) Infection Status||participants|Number|48|48.0||||||
4144901|NCT00869557|3969133|B3|Positive||Hepatitis B Virus (HBV) Infection Status||participants|Number|0|0.0||||||
4144902|NCT00869557|3969134|B2|Positive||Hepatitis B Virus (HBV) Infection Status||participants|Number|0|0.0||||||
4144903|NCT00869557|3969135|B1|Positive||Hepatitis B Virus (HBV) Infection Status||participants|Number|0|0.0||||||
4144904|NCT00869557|3969133|B3|Negative||Hepatitis B Virus (HBV) Infection Status||participants|Number|71|71.0||||||
4144905|NCT00869557|3969134|B2|Negative||Hepatitis B Virus (HBV) Infection Status||participants|Number|23|23.0||||||
4144906|NCT00869557|3969135|B1|Negative||Hepatitis B Virus (HBV) Infection Status||participants|Number|48|48.0||||||
4144907|NCT00869557|3969133|B3|AIDS||HIV Disease Status||participants|Number|4|4.0||||||
4144908|NCT00869557|3969134|B2|AIDS||HIV Disease Status||participants|Number|1|1.0||||||
4144909|NCT00869557|3969135|B1|AIDS||HIV Disease Status||participants|Number|3|3.0||||||
4144910|NCT00869557|3969133|B3|Symptomatic HIV Infections||HIV Disease Status||participants|Number|5|5.0||||||
4144911|NCT00869557|3969134|B2|Symptomatic HIV Infections||HIV Disease Status||participants|Number|0|0.0||||||
4144912|NCT00869557|3969135|B1|Symptomatic HIV Infections||HIV Disease Status||participants|Number|5|5.0||||||
4144913|NCT00869557|3969133|B3|Asymptomatic||HIV Disease Status||participants|Number|62|62.0||||||
4144914|NCT00869557|3969134|B2|Asymptomatic||HIV Disease Status||participants|Number|22|22.0||||||
4144915|NCT00869557|3969135|B1|Asymptomatic||HIV Disease Status||participants|Number|40|40.0||||||
4144916|NCT00869557|3969133|B3|United States||Region of Enrollment||participants|Number|71|71.0||||||
4144917|NCT00869557|3969134|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4144918|NCT00869557|3969135|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4144919|NCT00869557|3969133|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4144920|NCT00869557|3969134|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4144921|NCT00869557|3969135|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4144922|NCT00869557|3969133|B3|White||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4144923|NCT00869557|3969134|B2|White||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4144924|NCT00869557|3969135|B1|White||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4144925|NCT00869557|3969133|B3|Black||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4144926|NCT00869557|3969134|B2|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4144927|NCT00869557|3969135|B1|Black||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4144928|NCT00869557|3969133|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4144929|NCT00869557|3969134|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4144930|NCT00869557|3969135|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4144931|NCT00869557|3969133|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4144932|NCT00869557|3969134|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4144933|NCT00869557|3969135|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4144934|NCT00869557|3969133|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4144935|NCT00869557|3969134|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4144936|NCT00869557|3969135|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4144937|NCT00869557|3969133|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4144938|NCT00869557|3969134|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4144939|NCT00869557|3969135|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4144940|NCT00869557|3969133|B3|||Age||years|Mean|36|36.0|Standard Deviation|9.1|9.1|||
4144941|NCT00869557|3969134|B2|||Age||years|Mean|35|35.0|Standard Deviation|9.6|9.6|||
4144942|NCT00869557|3969135|B1|||Age||years|Mean|36|36.0|Standard Deviation|8.9|8.9|||
4144943|NCT00869557|3969133|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4144944|NCT00869557|3969134|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4144945|NCT00869557|3969135|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4144946|NCT00869557|3969133|B3||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4144947|NCT00869557|3969134|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4144948|NCT00869557|3969135|B1||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4144949|NCT00869557|3969133|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4144950|NCT00869557|3969134|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4144951|NCT00869557|3969135|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4144952|NCT00869518|3969153|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4144953|NCT00869518|3969154|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4144954|NCT00869518|3969155|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4144955|NCT00869518|3969153|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4144956|NCT00869518|3969154|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4144957|NCT00869518|3969155|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4144958|NCT00869518|3969153|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4144959|NCT00869518|3969154|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4144960|NCT00869518|3969155|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4144961|NCT00869518|3969153|B3|||Age||years|Mean|42.9|42.9|Full Range|||25.0|63.0|
4144962|NCT00869518|3969154|B2|||Age||years|Mean|43.5|43.5|Full Range|||25.0|63.0|
4144963|NCT00869518|3969155|B1|||Age||years|Mean|42.3|42.3|Full Range|||25.0|49.0|
4144964|NCT00869414|3969168|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4144965|NCT00869414|3969168|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4144966|NCT00869414|3969168|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4144967|NCT00869414|3969168|B1|Age, > 18 years old||Age, Customized||Participants|Count of Participants|16|16.0||||||
4144968|NCT00869401|3969181|B4|United States||Region of Enrollment||participants|Number|209|209.0||||||
4144969|NCT00869401|3969182|B3|United States||Region of Enrollment||participants|Number|63|63.0||||||
4144970|NCT00869401|3969183|B2|United States||Region of Enrollment||participants|Number|133|133.0||||||
4144971|NCT00869401|3969184|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4144972|NCT00869401|3969181|B4||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4144973|NCT00869401|3969182|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4144974|NCT00869401|3969183|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4144975|NCT00869401|3969184|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4144976|NCT00869401|3969181|B4||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4144977|NCT00869401|3969182|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4144978|NCT00869401|3969183|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4144979|NCT00869401|3969184|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4144980|NCT00869401|3969181|B4|||Age||Years|Mean|58|58.0|Standard Deviation|11.4|11.4|||
4144981|NCT00869401|3969182|B3|||Age||Years|Mean|58.2|58.2|Standard Deviation|11.3|11.3|||
4144982|NCT00869401|3969183|B2|||Age||Years|Mean|56.8|56.8|Standard Deviation|11|11.0|||
4144983|NCT00869401|3969184|B1|||Age||Years|Mean|55.3|55.3|Standard Deviation|12.9|12.9|||
4144984|NCT00869375|3969204|B3|||Current smokers||participants|Number|4|4.0||||||
4144985|NCT00869375|3969205|B2|||Current smokers||participants|Number|1|1.0||||||
4144986|NCT00869375|3969206|B1|||Current smokers||participants|Number|3|3.0||||||
4144987|NCT00869375|3969204|B3|||Dyslipidemia||participants|Number|3|3.0||||||
4144988|NCT00869375|3969205|B2|||Dyslipidemia||participants|Number|1|1.0||||||
4144989|NCT00869375|3969206|B1|||Dyslipidemia||participants|Number|2|2.0||||||
4144990|NCT00869375|3969204|B3|||Hypertension||participants|Number|4|4.0||||||
4144991|NCT00869375|3969205|B2|||Hypertension||participants|Number|2|2.0||||||
4144992|NCT00869375|3969206|B1|||Hypertension||participants|Number|2|2.0||||||
4144993|NCT00869375|3969204|B3|||Diabetes||participants|Number|3|3.0||||||
4144994|NCT00869375|3969205|B2|||Diabetes||participants|Number|1|1.0||||||
4144995|NCT00869375|3969206|B1|||Diabetes||participants|Number|2|2.0||||||
4144996|NCT00869375|3969204|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4144997|NCT00869375|3969205|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4144998|NCT00869375|3969206|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4144999|NCT00869375|3969204|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4145000|NCT00869375|3969205|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4145001|NCT00869375|3969206|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4145002|NCT00869375|3969204|B3|||Age||years|Mean|54|54.0|Full Range|||42.0|74.0|
4145003|NCT00869375|3969205|B2|||Age||years|Mean|63|63.0|Full Range|||57.0|74.0|
4145004|NCT00869375|3969206|B1|||Age||years|Mean|45|45.0|Full Range|||42.0|49.0|
4145005|NCT00869362|3969215|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4145006|NCT00869362|3969216|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4145007|NCT00869362|3969217|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4145008|NCT00869362|3969215|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4145009|NCT00869362|3969216|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4145010|NCT00869362|3969217|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4145011|NCT00869362|3969215|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4145012|NCT00869362|3969216|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4145013|NCT00869362|3969217|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4145014|NCT00869362|3969215|B3|||Age||years|Mean|55|55.0|Standard Deviation|12|12.0|||
4145015|NCT00869362|3969216|B2|||Age||years|Mean|52.9|52.9|Standard Deviation|13.7|13.7|||
4145016|NCT00869362|3969217|B1|||Age||years|Mean|57.2|57.2|Standard Deviation|11.3|11.3|||
4145017|NCT00869362|3969215|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4145018|NCT00869362|3969216|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4145019|NCT00869362|3969217|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4145020|NCT00869362|3969215|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4145021|NCT00869362|3969216|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4145022|NCT00869362|3969217|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4145023|NCT00869362|3969215|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145024|NCT00869362|3969216|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145025|NCT00869362|3969217|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145026|NCT00869349|3969226|B3|United States||Region of Enrollment||participants|Number|79|79.0||||||
4145027|NCT00869349|3969227|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4145028|NCT00869349|3969228|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4145029|NCT00869349|3969226|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4145030|NCT00869349|3969227|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4145031|NCT00869349|3969228|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4145032|NCT00869349|3969226|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145033|NCT00869349|3969227|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145034|NCT00869349|3969228|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145035|NCT00869349|3969226|B3||White|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
4145036|NCT00869349|3969227|B2||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4145037|NCT00869349|3969228|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4145038|NCT00869349|3969226|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145039|NCT00869349|3969227|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145040|NCT00869349|3969228|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145041|NCT00869349|3969226|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145042|NCT00869349|3969227|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145043|NCT00869349|3969228|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145044|NCT00869349|3969226|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145045|NCT00869349|3969227|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145046|NCT00869349|3969228|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145047|NCT00869349|3969226|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145048|NCT00869349|3969227|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145049|NCT00869349|3969228|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145050|NCT00869349|3969226|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4145051|NCT00869349|3969227|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4145052|NCT00869349|3969228|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4145053|NCT00869349|3969226|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4145054|NCT00869349|3969227|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4145055|NCT00869349|3969228|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4145056|NCT00869349|3969226|B3|||Age||years|Mean|58.1|58.1|Standard Deviation|12.8|12.8|||
4145057|NCT00869349|3969227|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|12|12.0|||
4145058|NCT00869349|3969228|B1|||Age||years|Mean|57.8|57.8|Standard Deviation|13.8|13.8|||
4145059|NCT00869323|3969239|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4145060|NCT00869323|3969239|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4145061|NCT00869323|3969239|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4145062|NCT00869323|3969239|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4145063|NCT00869323|3969239|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145064|NCT00869258|3969247|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4145065|NCT00869258|3969247|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4145066|NCT00869258|3969247|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4145067|NCT00869258|3969247|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4145068|NCT00869258|3969247|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145069|NCT00869258|3969247|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145070|NCT00869258|3969247|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145071|NCT00869258|3969247|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4145072|NCT00869258|3969247|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4145073|NCT00869258|3969247|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4145074|NCT00869258|3969247|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4145075|NCT00869258|3969247|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145076|NCT00869206|3969251|B3|United States||Region of Enrollment||participants|Number|1822|1822.0||||||
4145077|NCT00869206|3969252|B2|United States||Region of Enrollment||participants|Number|911|911.0||||||
4145078|NCT00869206|3969253|B1|United States||Region of Enrollment||participants|Number|911|911.0||||||
4145079|NCT00869206|3969251|B3||Male|Sex: Female, Male||Participants|Count of Participants|980|980.0||||||
4145080|NCT00869206|3969252|B2||Male|Sex: Female, Male||Participants|Count of Participants|483|483.0||||||
4145081|NCT00869206|3969253|B1||Male|Sex: Female, Male||Participants|Count of Participants|497|497.0||||||
4145082|NCT00869206|3969251|B3||Female|Sex: Female, Male||Participants|Count of Participants|842|842.0||||||
4145083|NCT00869206|3969252|B2||Female|Sex: Female, Male||Participants|Count of Participants|428|428.0||||||
4145084|NCT00869206|3969253|B1||Female|Sex: Female, Male||Participants|Count of Participants|414|414.0||||||
4145085|NCT00869206|3969251|B3|||Age||years|Mean|65.3|65.3|Standard Deviation|11.9|11.9|||
4145086|NCT00869206|3969252|B2|||Age||years|Mean|65.3|65.3|Standard Deviation|11.7|11.7|||
4145087|NCT00869206|3969253|B1|||Age||years|Mean|65.3|65.3|Standard Deviation|12.1|12.1|||
4145088|NCT00869167|3969282|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4145089|NCT00869167|3969283|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4145090|NCT00869167|3969284|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4145091|NCT00869167|3969282|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4145092|NCT00869167|3969283|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4145093|NCT00869167|3969284|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4145094|NCT00869167|3969282|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4145095|NCT00869167|3969283|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4145096|NCT00869167|3969284|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4145097|NCT00869167|3969282|B3|||Age||years|Mean|35.6|35.6|Standard Deviation|6.8|6.8|||
4145098|NCT00869167|3969283|B2|||Age||years|Mean|38|38.0|Standard Deviation|||||
4145099|NCT00869167|3969284|B1|||Age||years|Mean|34.5|34.5|Standard Deviation|9.2|9.2|||
4145100|NCT00869167|3969282|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4145101|NCT00869167|3969283|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4145102|NCT00869167|3969284|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4145103|NCT00869167|3969282|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4145104|NCT00869167|3969283|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4145105|NCT00869167|3969284|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4145106|NCT00869167|3969282|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145107|NCT00869167|3969283|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145108|NCT00869167|3969284|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145109|NCT00869141|3969299|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145110|NCT00869141|3969300|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145111|NCT00869141|3969301|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145112|NCT00869141|3969299|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145113|NCT00869141|3969300|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145114|NCT00869141|3969301|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145115|NCT00869141|3969299|B3||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4145116|NCT00869141|3969300|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4145117|NCT00869141|3969301|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4145118|NCT00869141|3969299|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4145119|NCT00869141|3969300|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145120|NCT00869141|3969301|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4145121|NCT00869141|3969299|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145122|NCT00869141|3969300|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145123|NCT00869141|3969301|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145124|NCT00869141|3969299|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4145125|NCT00869141|3969300|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4145126|NCT00869141|3969301|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4145127|NCT00869141|3969299|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145128|NCT00869141|3969300|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145129|NCT00869141|3969301|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145130|NCT00869141|3969299|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145131|NCT00869141|3969300|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145132|NCT00869141|3969301|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145133|NCT00869141|3969299|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4145134|NCT00869141|3969300|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4145135|NCT00869141|3969301|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4145136|NCT00869141|3969299|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4145137|NCT00869141|3969300|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4145138|NCT00869141|3969301|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4145139|NCT00869141|3969299|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4145140|NCT00869141|3969300|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4145141|NCT00869141|3969301|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4145142|NCT00869141|3969299|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4145143|NCT00869141|3969300|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4145144|NCT00869141|3969301|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4145145|NCT00869141|3969299|B3|||Age||years|Mean|64.3|64.3|Standard Deviation|13.8|13.8|||
4145146|NCT00869141|3969300|B2|||Age||years|Mean|61.6|61.6|Standard Deviation|15.3|15.3|||
4145147|NCT00869141|3969301|B1|||Age||years|Mean|67.5|67.5|Standard Deviation|11.6|11.6|||
4145148|NCT00869128|3969312|B1|Israel||Region of Enrollment||participants|Number|36|36.0||||||
4145149|NCT00869128|3969312|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4145150|NCT00869128|3969312|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4145151|NCT00869128|3969312|B1|||Age||years|Mean|63|63.0|Standard Deviation|8|8.0|||
4145152|NCT00869128|3969312|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4145153|NCT00869128|3969312|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4145154|NCT00869128|3969312|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145155|NCT00869089|3969317|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4145156|NCT00869089|3969317|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4145157|NCT00869089|3969317|B1|Age > or = 18||Age, Customized||participants|Number|5|5.0||||||
4145158|NCT00869089|3969317|B1|Age < 18||Age, Customized||participants|Number|0|0.0||||||
4145159|NCT00869050|3969321|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4145160|NCT00869050|3969321|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4145161|NCT00869050|3969321|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4145162|NCT00869050|3969321|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4145163|NCT00869050|3969321|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4145164|NCT00869050|3969321|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145165|NCT00869050|3969321|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4145166|NCT00869050|3969321|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145167|NCT00869050|3969321|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4145168|NCT00869050|3969321|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4145169|NCT00869050|3969321|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4145170|NCT00869050|3969321|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4145171|NCT00869050|3969321|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4145172|NCT00869050|3969321|B1|Between 80 and 89 years||Age, Customized||participants|Number|1|1.0||||||
4145173|NCT00869050|3969321|B1|Between 70 and 79 years||Age, Customized||participants|Number|1|1.0||||||
4145174|NCT00869050|3969321|B1|Between 60 and 69 years||Age, Customized||participants|Number|9|9.0||||||
4145175|NCT00869050|3969321|B1|Between 50 and 59 years||Age, Customized||participants|Number|22|22.0||||||
4145176|NCT00869050|3969321|B1|Between 40 and 49 years||Age, Customized||participants|Number|6|6.0||||||
4145177|NCT00869050|3969321|B1|Between 30 and 39 years||Age, Customized||participants|Number|2|2.0||||||
4145178|NCT00868998|3969326|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145179|NCT00868998|3969326|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4145180|NCT00868998|3969326|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4145181|NCT00868998|3969326|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145182|NCT00868998|3969326|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145183|NCT00868998|3969326|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4145184|NCT00868998|3969326|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145185|NCT00868998|3969326|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145186|NCT00868998|3969326|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4145187|NCT00868998|3969326|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4145188|NCT00868998|3969326|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4145189|NCT00868998|3969326|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4145190|NCT00868998|3969326|B1|70-79||Age, Customized||participants|Number|1|1.0||||||
4145191|NCT00868998|3969326|B1|60-69||Age, Customized||participants|Number|3|3.0||||||
4145192|NCT00868998|3969326|B1|50-59||Age, Customized||participants|Number|1|1.0||||||
4145193|NCT00868959|3969331|B1|Germany||Region of Enrollment||participants|Number|3|3.0||||||
4145194|NCT00868959|3969331|B1|Japan||Region of Enrollment||participants|Number|6|6.0||||||
4145195|NCT00868959|3969331|B1|South Africa||Region of Enrollment||participants|Number|56|56.0||||||
4145196|NCT00868959|3969331|B1|Peru||Region of Enrollment||participants|Number|12|12.0||||||
4145197|NCT00868959|3969331|B1|Romania||Region of Enrollment||participants|Number|9|9.0||||||
4145198|NCT00868959|3969331|B1|Poland||Region of Enrollment||participants|Number|12|12.0||||||
4145199|NCT00868959|3969331|B1|Canada||Region of Enrollment||participants|Number|14|14.0||||||
4145200|NCT00868959|3969331|B1|Czech Republic||Region of Enrollment||participants|Number|108|108.0||||||
4145201|NCT00868959|3969331|B1|France||Region of Enrollment||participants|Number|23|23.0||||||
4145202|NCT00868959|3969331|B1|India||Region of Enrollment||participants|Number|128|128.0||||||
4145203|NCT00868959|3969331|B1|Colombia||Region of Enrollment||participants|Number|15|15.0||||||
4145204|NCT00868959|3969331|B1|Russian Federation||Region of Enrollment||participants|Number|31|31.0||||||
4145205|NCT00868959|3969331|B1|Lithuania||Region of Enrollment||participants|Number|16|16.0||||||
4145206|NCT00868959|3969331|B1|Ukraine||Region of Enrollment||participants|Number|78|78.0||||||
4145207|NCT00868959|3969331|B1|Slovakia||Region of Enrollment||participants|Number|19|19.0||||||
4145208|NCT00868959|3969331|B1|United States||Region of Enrollment||participants|Number|283|283.0||||||
4145209|NCT00868959|3969331|B1||Male|Sex: Female, Male||Participants|Count of Participants|386|386.0||||||
4145210|NCT00868959|3969331|B1||Female|Sex: Female, Male||Participants|Count of Participants|427|427.0||||||
4145211|NCT00868959|3969331|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4145212|NCT00868959|3969331|B1||Between 18 and 65 years|Age||Participants|Count of Participants|790|790.0||||||
4145213|NCT00868959|3969331|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4145214|NCT00868959|3969331|B1|||Age||years|Mean|42.7|42.7|Standard Deviation|12.03|12.03|||
4145215|NCT00868790|3969337|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4145216|NCT00868790|3969337|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4145217|NCT00868790|3969337|B1|||Age||years|Mean|54.0|54.0|Standard Deviation|9.6|9.6|||
4145218|NCT00868751|3969387|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4145219|NCT00868751|3969387|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4145220|NCT00868751|3969387|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4145221|NCT00868751|3969387|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4145222|NCT00868751|3969387|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4145223|NCT00868751|3969387|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145224|NCT00868712|3969395|B4|United States||Region of Enrollment||participants|Number|70|70.0||||||
4145225|NCT00868712|3969396|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
4145226|NCT00868712|3969397|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4145227|NCT00868712|3969398|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4145228|NCT00868712|3969395|B4||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4145229|NCT00868712|3969396|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4145230|NCT00868712|3969397|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4145231|NCT00868712|3969398|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4145232|NCT00868712|3969395|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4145233|NCT00868712|3969396|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4145234|NCT00868712|3969397|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4145235|NCT00868712|3969398|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4145236|NCT00868712|3969395|B4|||Age||years|Mean|68|68.0|Standard Deviation|13|13.0|||
4145237|NCT00868712|3969396|B3|||Age||years|Mean|73|73.0|Standard Deviation|12|12.0|||
4145238|NCT00868712|3969397|B2|||Age||years|Mean|68|68.0|Standard Deviation|11|11.0|||
4145239|NCT00868712|3969398|B1|||Age||years|Mean|64|64.0|Standard Deviation|13|13.0|||
4145240|NCT00868712|3969395|B4||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4145241|NCT00868712|3969396|B3||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4145242|NCT00868712|3969397|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4145243|NCT00868712|3969398|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4145244|NCT00868712|3969395|B4||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4145245|NCT00868712|3969396|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4145246|NCT00868712|3969397|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4145247|NCT00868712|3969398|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4145248|NCT00868712|3969395|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145249|NCT00868712|3969396|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145250|NCT00868712|3969397|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145251|NCT00868712|3969398|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145252|NCT00868699|3969411|B4|India||Region of Enrollment||participants|Number|73|73.0||||||
4145253|NCT00868699|3969412|B3|India||Region of Enrollment||participants|Number|23|23.0||||||
4145254|NCT00868699|3969413|B2|India||Region of Enrollment||participants|Number|23|23.0||||||
4145255|NCT00868699|3969414|B1|India||Region of Enrollment||participants|Number|27|27.0||||||
4145256|NCT00868699|3969411|B4|Russian Federation||Region of Enrollment||participants|Number|31|31.0||||||
4145257|NCT00868699|3969412|B3|Russian Federation||Region of Enrollment||participants|Number|11|11.0||||||
4145258|NCT00868699|3969413|B2|Russian Federation||Region of Enrollment||participants|Number|10|10.0||||||
4145259|NCT00868699|3969414|B1|Russian Federation||Region of Enrollment||participants|Number|10|10.0||||||
4145260|NCT00868699|3969411|B4|South Africa||Region of Enrollment||participants|Number|54|54.0||||||
4145261|NCT00868699|3969412|B3|South Africa||Region of Enrollment||participants|Number|19|19.0||||||
4145262|NCT00868699|3969413|B2|South Africa||Region of Enrollment||participants|Number|17|17.0||||||
4145263|NCT00868699|3969414|B1|South Africa||Region of Enrollment||participants|Number|18|18.0||||||
4145264|NCT00868699|3969411|B4|Romania||Region of Enrollment||participants|Number|15|15.0||||||
4145265|NCT00868699|3969412|B3|Romania||Region of Enrollment||participants|Number|4|4.0||||||
4145266|NCT00868699|3969413|B2|Romania||Region of Enrollment||participants|Number|2|2.0||||||
4145267|NCT00868699|3969414|B1|Romania||Region of Enrollment||participants|Number|9|9.0||||||
4145268|NCT00868699|3969411|B4|Ukraine||Region of Enrollment||participants|Number|49|49.0||||||
4145269|NCT00868699|3969412|B3|Ukraine||Region of Enrollment||participants|Number|16|16.0||||||
4145270|NCT00868699|3969413|B2|Ukraine||Region of Enrollment||participants|Number|17|17.0||||||
4145271|NCT00868699|3969414|B1|Ukraine||Region of Enrollment||participants|Number|16|16.0||||||
4145272|NCT00868699|3969411|B4|Czech Republic||Region of Enrollment||participants|Number|55|55.0||||||
4145273|NCT00868699|3969412|B3|Czech Republic||Region of Enrollment||participants|Number|17|17.0||||||
4145274|NCT00868699|3969413|B2|Czech Republic||Region of Enrollment||participants|Number|19|19.0||||||
4145275|NCT00868699|3969414|B1|Czech Republic||Region of Enrollment||participants|Number|19|19.0||||||
4145276|NCT00868699|3969411|B4|United States||Region of Enrollment||participants|Number|195|195.0||||||
4145277|NCT00868699|3969412|B3|United States||Region of Enrollment||participants|Number|67|67.0||||||
4145278|NCT00868699|3969413|B2|United States||Region of Enrollment||participants|Number|70|70.0||||||
4145279|NCT00868699|3969414|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
4145280|NCT00868699|3969411|B4|France||Region of Enrollment||participants|Number|13|13.0||||||
4145281|NCT00868699|3969412|B3|France||Region of Enrollment||participants|Number|4|4.0||||||
4145282|NCT00868699|3969413|B2|France||Region of Enrollment||participants|Number|4|4.0||||||
4145283|NCT00868699|3969414|B1|France||Region of Enrollment||participants|Number|5|5.0||||||
4145284|NCT00868699|3969411|B4||Male|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4145285|NCT00868699|3969412|B3||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4145286|NCT00868699|3969413|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4145287|NCT00868699|3969414|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4145288|NCT00868699|3969411|B4||Female|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
4145289|NCT00868699|3969412|B3||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4145290|NCT00868699|3969413|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4145291|NCT00868699|3969414|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4145292|NCT00868699|3969411|B4|||Age||years|Mean|41.5|41.5|Standard Deviation|12.35|12.35|||
4145293|NCT00868699|3969412|B3|||Age||years|Mean|41.3|41.3|Standard Deviation|12.31|12.31|||
4145294|NCT00868699|3969413|B2|||Age||years|Mean|42.0|42.0|Standard Deviation|12.35|12.35|||
4145295|NCT00868699|3969414|B1|||Age||years|Mean|41.2|41.2|Standard Deviation|12.45|12.45|||
4145296|NCT00868699|3969411|B4||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4145297|NCT00868699|3969412|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4145298|NCT00868699|3969413|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4145299|NCT00868699|3969414|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4145300|NCT00868699|3969411|B4||Between 18 and 65 years|Age||Participants|Count of Participants|473|473.0||||||
4145301|NCT00868699|3969412|B3||Between 18 and 65 years|Age||Participants|Count of Participants|155|155.0||||||
4145302|NCT00868699|3969413|B2||Between 18 and 65 years|Age||Participants|Count of Participants|159|159.0||||||
4145303|NCT00868699|3969414|B1||Between 18 and 65 years|Age||Participants|Count of Participants|159|159.0||||||
4145304|NCT00868699|3969411|B4||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4145305|NCT00868699|3969412|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4145306|NCT00868699|3969413|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145307|NCT00868699|3969414|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145308|NCT00868608|3969430|B4||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4145309|NCT00868608|3969431|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4145310|NCT00868608|3969432|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4145311|NCT00868608|3969433|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4145312|NCT00868608|3969430|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4145313|NCT00868608|3969431|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4145314|NCT00868608|3969432|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4145315|NCT00868608|3969433|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4145316|NCT00868608|3969430|B4|||Age||Years|Mean|61.3|61.3|Standard Deviation|10.5|10.5|||
4145317|NCT00868608|3969431|B3|||Age||Years|Mean|65.2|65.2|Standard Deviation|10.0|10.0|||
4145318|NCT00868608|3969432|B2|||Age||Years|Mean|70.8|70.8|Standard Deviation|13.5|13.5|||
4145319|NCT00868608|3969433|B1|||Age||Years|Mean|60.5|60.5|Standard Deviation|10.2|10.2|||
4145320|NCT00868530|3969459|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4145321|NCT00868530|3969459|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4145322|NCT00868530|3969459|B1|||Age||Years|Mean|23.2|23.2|Standard Deviation|10.0|10.0|||
4145323|NCT00868517|3969471|B4|||PTSD-related insomnia duration||years|Mean|5.6|5.6|Standard Deviation|3.9|3.9|||
4145324|NCT00868517|3969472|B3|||PTSD-related insomnia duration||years|Mean|5.7|5.7|Standard Deviation|3.4|3.4|||
4145325|NCT00868517|3969473|B2|||PTSD-related insomnia duration||years|Mean|6.2|6.2|Standard Deviation|5.6|5.6|||
4145326|NCT00868517|3969474|B1|||PTSD-related insomnia duration||years|Mean|4.9|4.9|Standard Deviation|3|3.0|||
4145327|NCT00868517|3969471|B4|||PTSD symptom duration||years|Mean|5.9|5.9|Standard Deviation|3.9|3.9|||
4145328|NCT00868517|3969472|B3|||PTSD symptom duration||years|Mean|6.2|6.2|Standard Deviation|3.2|3.2|||
4145329|NCT00868517|3969473|B2|||PTSD symptom duration||years|Mean|6.3|6.3|Standard Deviation|5.4|5.4|||
4145330|NCT00868517|3969474|B1|||PTSD symptom duration||years|Mean|5.2|5.2|Standard Deviation|3|3.0|||
4145331|NCT00868517|3969471|B4|||Post-Traumatic Stress Disorder Checklist-military version (PCL-M)|The Post-Traumatic Stress Disorder Checklist-military version (PCL-M) is a widely used, 17-item self-report measure of the 17 DSM-IV symptoms of PTSD. Items are rated on a 5-point Likert scale, and the total score (range 17-85) is obtained by summing the scores from each of the 17 items. Total scores of the PCL-M were reported, and higher scores indicate higher degrees of PTSD symptoms.|units on a scale|Mean|57.9|57.9|Standard Deviation|12.0|12.0|||
4145332|NCT00868517|3969472|B3|||Post-Traumatic Stress Disorder Checklist-military version (PCL-M)|The Post-Traumatic Stress Disorder Checklist-military version (PCL-M) is a widely used, 17-item self-report measure of the 17 DSM-IV symptoms of PTSD. Items are rated on a 5-point Likert scale, and the total score (range 17-85) is obtained by summing the scores from each of the 17 items. Total scores of the PCL-M were reported, and higher scores indicate higher degrees of PTSD symptoms.|units on a scale|Mean|60.5|60.5|Standard Deviation|14.4|14.4|||
4145333|NCT00868517|3969473|B2|||Post-Traumatic Stress Disorder Checklist-military version (PCL-M)|The Post-Traumatic Stress Disorder Checklist-military version (PCL-M) is a widely used, 17-item self-report measure of the 17 DSM-IV symptoms of PTSD. Items are rated on a 5-point Likert scale, and the total score (range 17-85) is obtained by summing the scores from each of the 17 items. Total scores of the PCL-M were reported, and higher scores indicate higher degrees of PTSD symptoms.|units on a scale|Mean|57.8|57.8|Standard Deviation|10.3|10.3|||
4145334|NCT00868517|3969474|B1|||Post-Traumatic Stress Disorder Checklist-military version (PCL-M)|The Post-Traumatic Stress Disorder Checklist-military version (PCL-M) is a widely used, 17-item self-report measure of the 17 DSM-IV symptoms of PTSD. Items are rated on a 5-point Likert scale, and the total score (range 17-85) is obtained by summing the scores from each of the 17 items. Total scores of the PCL-M were reported, and higher scores indicate higher degrees of PTSD symptoms.|units on a scale|Mean|55.1|55.1|Standard Deviation|11.4|11.4|||
4145335|NCT00868517|3969471|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4145336|NCT00868517|3969472|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4145337|NCT00868517|3969473|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4145338|NCT00868517|3969474|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4145339|NCT00868517|3969471|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145340|NCT00868517|3969472|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145341|NCT00868517|3969473|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145342|NCT00868517|3969474|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145343|NCT00868517|3969471|B4||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4145344|NCT00868517|3969472|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4145345|NCT00868517|3969473|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4145346|NCT00868517|3969474|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4145347|NCT00868517|3969471|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4145348|NCT00868517|3969472|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4145349|NCT00868517|3969473|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4145350|NCT00868517|3969474|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4145351|NCT00868517|3969471|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145352|NCT00868517|3969472|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145353|NCT00868517|3969473|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145354|NCT00868517|3969474|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145355|NCT00868517|3969471|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145356|NCT00868517|3969472|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145357|NCT00868517|3969473|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145358|NCT00868517|3969474|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145359|NCT00868517|3969471|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145360|NCT00868517|3969472|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145361|NCT00868517|3969473|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145362|NCT00868517|3969474|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145363|NCT00868517|3969471|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4145364|NCT00868517|3969472|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4145365|NCT00868517|3969473|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4145366|NCT00868517|3969474|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4145367|NCT00868517|3969471|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4145368|NCT00868517|3969472|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4145369|NCT00868517|3969473|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4145370|NCT00868517|3969474|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4145371|NCT00868517|3969471|B4|||Age||years|Mean|37.8|37.8|Standard Deviation|9.9|9.9|||
4145372|NCT00868517|3969472|B3|||Age||years|Mean|37.6|37.6|Standard Deviation|8.0|8.0|||
4145373|NCT00868517|3969473|B2|||Age||years|Mean|37.9|37.9|Standard Deviation|10.3|10.3|||
4145374|NCT00868517|3969474|B1|||Age||years|Mean|37.8|37.8|Standard Deviation|11.4|11.4|||
4145375|NCT00868452|3969499|B3|India||Region of Enrollment||participants|Number|80|80.0||||||
4145376|NCT00868452|3969500|B2|India||Region of Enrollment||participants|Number|37|37.0||||||
4145377|NCT00868452|3969501|B1|India||Region of Enrollment||participants|Number|43|43.0||||||
4145378|NCT00868452|3969499|B3|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4145379|NCT00868452|3969500|B2|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4145380|NCT00868452|3969501|B1|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4145381|NCT00868452|3969499|B3|Russian Federation||Region of Enrollment||participants|Number|19|19.0||||||
4145382|NCT00868452|3969500|B2|Russian Federation||Region of Enrollment||participants|Number|10|10.0||||||
4145383|NCT00868452|3969501|B1|Russian Federation||Region of Enrollment||participants|Number|9|9.0||||||
4145384|NCT00868452|3969499|B3|South Africa||Region of Enrollment||participants|Number|18|18.0||||||
4145385|NCT00868452|3969500|B2|South Africa||Region of Enrollment||participants|Number|8|8.0||||||
4145386|NCT00868452|3969501|B1|South Africa||Region of Enrollment||participants|Number|10|10.0||||||
4145387|NCT00868452|3969499|B3|Romania||Region of Enrollment||participants|Number|5|5.0||||||
4145388|NCT00868452|3969500|B2|Romania||Region of Enrollment||participants|Number|3|3.0||||||
4145389|NCT00868452|3969501|B1|Romania||Region of Enrollment||participants|Number|2|2.0||||||
4145390|NCT00868452|3969499|B3|Ukraine||Region of Enrollment||participants|Number|23|23.0||||||
4145391|NCT00868452|3969500|B2|Ukraine||Region of Enrollment||participants|Number|12|12.0||||||
4145392|NCT00868452|3969501|B1|Ukraine||Region of Enrollment||participants|Number|11|11.0||||||
4145393|NCT00868452|3969499|B3|Poland||Region of Enrollment||participants|Number|15|15.0||||||
4145394|NCT00868452|3969500|B2|Poland||Region of Enrollment||participants|Number|6|6.0||||||
4145395|NCT00868452|3969501|B1|Poland||Region of Enrollment||participants|Number|9|9.0||||||
4145396|NCT00868452|3969499|B3|Czech Republic||Region of Enrollment||participants|Number|48|48.0||||||
4145397|NCT00868452|3969500|B2|Czech Republic||Region of Enrollment||participants|Number|21|21.0||||||
4145398|NCT00868452|3969501|B1|Czech Republic||Region of Enrollment||participants|Number|27|27.0||||||
4145399|NCT00868452|3969499|B3|United States||Region of Enrollment||participants|Number|110|110.0||||||
4145400|NCT00868452|3969500|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
4145401|NCT00868452|3969501|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
4145402|NCT00868452|3969499|B3|France||Region of Enrollment||participants|Number|16|16.0||||||
4145403|NCT00868452|3969500|B2|France||Region of Enrollment||participants|Number|8|8.0||||||
4145404|NCT00868452|3969501|B1|France||Region of Enrollment||participants|Number|8|8.0||||||
4145405|NCT00868452|3969499|B3||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4145406|NCT00868452|3969500|B2||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4145407|NCT00868452|3969501|B1||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4145408|NCT00868452|3969499|B3||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4145409|NCT00868452|3969500|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4145410|NCT00868452|3969501|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4145411|NCT00868452|3969499|B3|||Age|Data for full analysis set is provided.|years|Mean|41.7|41.7|Standard Deviation|11.65|11.65|||
4145412|NCT00868452|3969500|B2|||Age|Data for full analysis set is provided.|years|Mean|42.6|42.6|Standard Deviation|11.75|11.75|||
4145413|NCT00868452|3969501|B1|||Age|Data for full analysis set is provided.|years|Mean|41.0|41.0|Standard Deviation|11.53|11.53|||
4145414|NCT00868452|3969499|B3||>=65 years|Age|Data for full analysis set is provided.|Participants|Count of Participants|6|6.0||||||
4145415|NCT00868452|3969500|B2||>=65 years|Age|Data for full analysis set is provided.|Participants|Count of Participants|5|5.0||||||
4145416|NCT00868452|3969501|B1||>=65 years|Age|Data for full analysis set is provided.|Participants|Count of Participants|1|1.0||||||
4145417|NCT00868452|3969499|B3||Between 18 and 65 years|Age|Data for full analysis set is provided.|Participants|Count of Participants|333|333.0||||||
4145418|NCT00868452|3969500|B2||Between 18 and 65 years|Age|Data for full analysis set is provided.|Participants|Count of Participants|155|155.0||||||
4145419|NCT00868452|3969501|B1||Between 18 and 65 years|Age|Data for full analysis set is provided.|Participants|Count of Participants|178|178.0||||||
4145420|NCT00868452|3969499|B3||<=18 years|Age|Data for full analysis set is provided.|Participants|Count of Participants|1|1.0||||||
4145421|NCT00868452|3969500|B2||<=18 years|Age|Data for full analysis set is provided.|Participants|Count of Participants|1|1.0||||||
4145422|NCT00868452|3969501|B1||<=18 years|Age|Data for full analysis set is provided.|Participants|Count of Participants|0|0.0||||||
4145423|NCT00868439|3969512|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4145424|NCT00868439|3969513|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4145425|NCT00868439|3969514|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4145426|NCT00868439|3969512|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4145427|NCT00868439|3969513|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4145428|NCT00868439|3969514|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4145429|NCT00868439|3969512|B3|||Age||years|Mean|68.3|68.3|Standard Deviation|9.50|9.5|||
4145430|NCT00868439|3969513|B2|||Age||years|Mean|68.2|68.2|Standard Deviation|10.46|10.46|||
4145431|NCT00868439|3969514|B1|||Age||years|Mean|68.3|68.3|Standard Deviation|8.66|8.66|||
4145432|NCT00868439|3969512|B3||>=65 years|Age||Participants|Count of Participants|74|74.0||||||
4145433|NCT00868439|3969513|B2||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
4145434|NCT00868439|3969514|B1||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4145435|NCT00868439|3969512|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4145436|NCT00868439|3969513|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4145437|NCT00868439|3969514|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4145438|NCT00868439|3969512|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145439|NCT00868439|3969513|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145440|NCT00868439|3969514|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145441|NCT00868374|3969531|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145442|NCT00868374|3969532|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145443|NCT00868374|3969533|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145444|NCT00868374|3969531|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145445|NCT00868374|3969532|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145446|NCT00868374|3969533|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145447|NCT00868374|3969531|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4145448|NCT00868374|3969532|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4145449|NCT00868374|3969533|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4145450|NCT00868374|3969531|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4145451|NCT00868374|3969532|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4145452|NCT00868374|3969533|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4145453|NCT00868374|3969531|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145454|NCT00868374|3969532|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145455|NCT00868374|3969533|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145456|NCT00868374|3969531|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145457|NCT00868374|3969532|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145458|NCT00868374|3969533|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145459|NCT00868374|3969531|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145460|NCT00868374|3969532|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145627|NCT00868140|3969667|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145461|NCT00868374|3969533|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145462|NCT00868374|3969531|B3||Male|Gender||Participants|Count of Participants|5|5.0||||||
4145463|NCT00868374|3969532|B2||Male|Gender||Participants|Count of Participants|2|2.0||||||
4145464|NCT00868374|3969533|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
4145465|NCT00868374|3969531|B3||Female|Gender||Participants|Count of Participants|18|18.0||||||
4145466|NCT00868374|3969532|B2||Female|Gender||Participants|Count of Participants|9|9.0||||||
4145467|NCT00868374|3969533|B1||Female|Gender||Participants|Count of Participants|9|9.0||||||
4145468|NCT00868374|3969531|B3|Age||Age||years|Mean|45.1|45.1|Standard Deviation|7.1|7.1|||
4145469|NCT00868374|3969532|B2|Age||Age||years|Mean|41.2|41.2|Standard Deviation|6.1|6.1|||
4145470|NCT00868374|3969533|B1|Age||Age||years|Mean|48.3|48.3|Standard Deviation|11.3|11.3|||
4145471|NCT00868348|3969540|B3|Denmark||Region of Enrollment||participants|Number|60|60.0||||||
4145472|NCT00868348|3969541|B2|Denmark||Region of Enrollment||participants|Number|30|30.0||||||
4145473|NCT00868348|3969542|B1|Denmark||Region of Enrollment||participants|Number|30|30.0||||||
4145474|NCT00868348|3969540|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4145475|NCT00868348|3969541|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4145476|NCT00868348|3969542|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4145477|NCT00868348|3969540|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4145478|NCT00868348|3969541|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4145479|NCT00868348|3969542|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4145480|NCT00868348|3969540|B3|||Age||years|Median|71|71.0|Inter-Quartile Range|||63.0|75.0|
4145481|NCT00868348|3969541|B2|||Age||years|Median|70|70.0|Inter-Quartile Range|||65.0|75.0|
4145482|NCT00868348|3969542|B1|||Age||years|Median|71|71.0|Inter-Quartile Range|||61.0|75.0|
4145483|NCT00868348|3969540|B3||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
4145484|NCT00868348|3969541|B2||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4145485|NCT00868348|3969542|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4145486|NCT00868348|3969540|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4145487|NCT00868348|3969541|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4145488|NCT00868348|3969542|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4145489|NCT00868348|3969540|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145490|NCT00868348|3969541|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145491|NCT00868348|3969542|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145492|NCT00868309|3969559|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4145493|NCT00868309|3969560|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4145494|NCT00868309|3969561|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4145495|NCT00868309|3969559|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4145496|NCT00868309|3969560|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4145497|NCT00868309|3969561|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4145498|NCT00868309|3969559|B3|||Age||years|Mean|45.3|45.3|Standard Deviation|12.6|12.6|||
4145499|NCT00868309|3969560|B2|||Age||years|Mean|40.7|40.7|Standard Deviation|16.5|16.5|||
4145500|NCT00868309|3969561|B1|||Age||years|Mean|50.2|50.2|Standard Deviation|4.8|4.8|||
4145501|NCT00868309|3969559|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4145502|NCT00868309|3969560|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4145503|NCT00868309|3969561|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4145504|NCT00868309|3969559|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4145505|NCT00868309|3969560|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4145506|NCT00868309|3969561|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4145507|NCT00868309|3969559|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145508|NCT00868309|3969560|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145509|NCT00868309|3969561|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145510|NCT00868296|3969570|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4145511|NCT00868296|3969571|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4145512|NCT00868296|3969572|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4145513|NCT00868296|3969570|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4145514|NCT00868296|3969571|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4145515|NCT00868296|3969572|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4145516|NCT00868296|3969570|B3|||Age||months|Mean|5.92|5.92|Standard Deviation|3.42|3.42|||
4145517|NCT00868296|3969571|B2|||Age||months|Mean|5.55|5.55|Standard Deviation|3.44|3.44|||
4145518|NCT00868296|3969572|B1|||Age||months|Mean|7.34|7.34|Standard Deviation|3.06|3.06|||
4145519|NCT00868231|3969581|B1|Germany||Region of Enrollment||participants|Number|30|30.0||||||
4145520|NCT00868231|3969581|B1||Male|Gender||Participants|Count of Participants|19|19.0||||||
4145521|NCT00868231|3969581|B1||Female|Gender||Participants|Count of Participants|11|11.0||||||
4145522|NCT00868231|3969581|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|7.9|7.9|||
4145523|NCT00868231|3969581|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4145524|NCT00868231|3969581|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4145525|NCT00868231|3969581|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145526|NCT00868218|3969627|B5|Norway||Region of Enrollment||participants|Number|60|60.0||||||
4145527|NCT00868218|3969628|B4|Norway||Region of Enrollment||participants|Number|15|15.0||||||
4145528|NCT00868218|3969629|B3|Norway||Region of Enrollment||participants|Number|15|15.0||||||
4145529|NCT00868218|3969630|B2|Norway||Region of Enrollment||participants|Number|15|15.0||||||
4145530|NCT00868218|3969631|B1|Norway||Region of Enrollment||participants|Number|15|15.0||||||
4145531|NCT00868218|3969627|B5||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4145532|NCT00868218|3969628|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4145533|NCT00868218|3969629|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4145534|NCT00868218|3969630|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4145535|NCT00868218|3969631|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4145536|NCT00868218|3969627|B5||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4145537|NCT00868218|3969628|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4145538|NCT00868218|3969629|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4145539|NCT00868218|3969630|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4145540|NCT00868218|3969631|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4145541|NCT00868218|3969627|B5|||Age||years|Mean|31|31.0|Full Range|||21.0|49.0|
4145542|NCT00868218|3969628|B4|||Age||years|Mean|31|31.0|Full Range|||21.0|49.0|
4145543|NCT00868218|3969629|B3|||Age||years|Mean|31|31.0|Full Range|||22.0|42.0|
4145544|NCT00868218|3969630|B2|||Age||years|Mean|29|29.0|Full Range|||21.0|44.0|
4145545|NCT00868218|3969631|B1|||Age||years|Mean|32|32.0|Full Range|||21.0|41.0|
4145546|NCT00868218|3969627|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4145547|NCT00868218|3969628|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4145548|NCT00868218|3969629|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4145549|NCT00868218|3969630|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4145550|NCT00868218|3969631|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4145551|NCT00868218|3969627|B5||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4145552|NCT00868218|3969628|B4||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4145553|NCT00868218|3969629|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4145554|NCT00868218|3969630|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4145555|NCT00868218|3969631|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4145556|NCT00868218|3969627|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145557|NCT00868218|3969628|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145558|NCT00868218|3969629|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145559|NCT00868218|3969630|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145560|NCT00868218|3969631|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145561|NCT00868192|3969652|B1|>12 months||Platinum-free interval||participants|Number|11|11.0||||||
4145562|NCT00868192|3969652|B1|6-12 months||Platinum-free interval||participants|Number|11|11.0||||||
4145563|NCT00868192|3969652|B1|<6 months||Platinum-free interval||participants|Number|12|12.0||||||
4145564|NCT00868192|3969652|B1|2||Prior number of chemotherapy regimens||participants|Number|14|14.0||||||
4145565|NCT00868192|3969652|B1|1||Prior number of chemotherapy regimens||participants|Number|20|20.0||||||
4145566|NCT00868192|3969652|B1|1||Gynecologic Oncology Group (GOG) Performance Status|"GOG Performance Status~0 = Fully active, unrestricted activities of daily living~1 = Ambulatory, but restricted in strenuous activity"|participants|Number|12|12.0||||||
4145567|NCT00868192|3969652|B1|0||Gynecologic Oncology Group (GOG) Performance Status|"GOG Performance Status~0 = Fully active, unrestricted activities of daily living~1 = Ambulatory, but restricted in strenuous activity"|participants|Number|22|22.0||||||
4145568|NCT00868192|3969652|B1|Primary peritoneal||Pathologic diagnosis||participants|Number|6|6.0||||||
4145569|NCT00868192|3969652|B1|Fallopian tube||Pathologic diagnosis||participants|Number|1|1.0||||||
4145570|NCT00868192|3969652|B1|Ovarian||Pathologic diagnosis||participants|Number|27|27.0||||||
4145571|NCT00868192|3969652|B1|Grade 3||Tumor grade|"G1: The tissue is well-differentiated (contains many healthy-looking cells).~G2: The tissue is moderately differentiated (more cells appear abnormal than healthy).~G3:The tissue is poorly differentiated or undifferentiated (all or most cells appear abnormal)."|participants|Number|30|30.0||||||
4145572|NCT00868192|3969652|B1|Grade 2||Tumor grade|"G1: The tissue is well-differentiated (contains many healthy-looking cells).~G2: The tissue is moderately differentiated (more cells appear abnormal than healthy).~G3:The tissue is poorly differentiated or undifferentiated (all or most cells appear abnormal)."|participants|Number|1|1.0||||||
4145573|NCT00868192|3969652|B1|Grade 1||Tumor grade|"G1: The tissue is well-differentiated (contains many healthy-looking cells).~G2: The tissue is moderately differentiated (more cells appear abnormal than healthy).~G3:The tissue is poorly differentiated or undifferentiated (all or most cells appear abnormal)."|participants|Number|3|3.0||||||
4145574|NCT00868192|3969652|B1|Other||Histology||participants|Number|5|5.0||||||
4145575|NCT00868192|3969652|B1|Mixed||Histology||participants|Number|3|3.0||||||
4145576|NCT00868192|3969652|B1|Endometriod||Histology||participants|Number|2|2.0||||||
4145577|NCT00868192|3969652|B1|Serous||Histology||participants|Number|24|24.0||||||
4145628|NCT00868140|3969668|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145629|NCT00868140|3969669|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145578|NCT00868192|3969652|B1|Stage IV||Stage|"Staging~I:The cancer is only within the ovary(ies) or fallopian tube(s)~II:Cancer involves 1 or both ovaries or fallopian tube(s) with pelvic extension~III: Cancer involves 1 or both ovaries or fallopian tubes(s) with microscopically confirmed peritoneal metastases outside the pelvis and/or regional lymph node metastasis (also can be primary peritoneal cancer)~IV:Distant spreading (also can be primary peritoneal cancer)"|participants|Number|6|6.0||||||
4145579|NCT00868192|3969652|B1|Stage III||Stage|"Staging~I:The cancer is only within the ovary(ies) or fallopian tube(s)~II:Cancer involves 1 or both ovaries or fallopian tube(s) with pelvic extension~III: Cancer involves 1 or both ovaries or fallopian tubes(s) with microscopically confirmed peritoneal metastases outside the pelvis and/or regional lymph node metastasis (also can be primary peritoneal cancer)~IV:Distant spreading (also can be primary peritoneal cancer)"|participants|Number|27|27.0||||||
4145580|NCT00868192|3969652|B1|Stage I/II||Stage|"Staging~I:The cancer is only within the ovary(ies) or fallopian tube(s)~II:Cancer involves 1 or both ovaries or fallopian tube(s) with pelvic extension~III: Cancer involves 1 or both ovaries or fallopian tubes(s) with microscopically confirmed peritoneal metastases outside the pelvis and/or regional lymph node metastasis (also can be primary peritoneal cancer)~IV:Distant spreading (also can be primary peritoneal cancer)"|participants|Number|1|1.0||||||
4145581|NCT00868192|3969652|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4145582|NCT00868192|3969652|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4145583|NCT00868192|3969652|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4145584|NCT00868192|3969652|B1|||Age||years|Mean|61.5|61.5|Full Range|||31.0|86.0|
4145585|NCT00868140|3969667|B3|Venezuela||Region of Enrollment||participants|Number|32|32.0||||||
4145586|NCT00868140|3969668|B2|Venezuela||Region of Enrollment||participants|Number|16|16.0||||||
4145587|NCT00868140|3969669|B1|Venezuela||Region of Enrollment||participants|Number|16|16.0||||||
4145588|NCT00868140|3969667|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145589|NCT00868140|3969668|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145590|NCT00868140|3969669|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145591|NCT00868140|3969667|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145592|NCT00868140|3969668|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145593|NCT00868140|3969669|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145594|NCT00868140|3969667|B3||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4145595|NCT00868140|3969668|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4145596|NCT00868140|3969669|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4145597|NCT00868140|3969667|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4145598|NCT00868140|3969668|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4145599|NCT00868140|3969669|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4145600|NCT00868140|3969667|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145601|NCT00868140|3969668|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145602|NCT00868140|3969669|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145603|NCT00868140|3969667|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4145604|NCT00868140|3969668|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4145605|NCT00868140|3969669|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4145606|NCT00868140|3969667|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145607|NCT00868140|3969668|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145608|NCT00868140|3969669|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145609|NCT00868140|3969667|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145610|NCT00868140|3969668|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145611|NCT00868140|3969669|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145612|NCT00868140|3969667|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4145613|NCT00868140|3969668|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4145614|NCT00868140|3969669|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4145615|NCT00868140|3969667|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4145616|NCT00868140|3969668|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4145617|NCT00868140|3969669|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4145618|NCT00868140|3969667|B3|Females||Sex/Gender, Customized||participants|Number|32|32.0||||||
4145619|NCT00868140|3969668|B2|Females||Sex/Gender, Customized||participants|Number|16|16.0||||||
4145620|NCT00868140|3969669|B1|Females||Sex/Gender, Customized||participants|Number|16|16.0||||||
4145621|NCT00868140|3969667|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4145622|NCT00868140|3969668|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4145623|NCT00868140|3969669|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4145624|NCT00868140|3969667|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4145625|NCT00868140|3969668|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4145626|NCT00868140|3969669|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4145630|NCT00868101|3969686|B3|Brazil||Region of Enrollment||participants|Number|22|22.0||||||
4145631|NCT00868101|3969687|B2|Brazil||Region of Enrollment||participants|Number|10|10.0||||||
4145632|NCT00868101|3969688|B1|Brazil||Region of Enrollment||participants|Number|12|12.0||||||
4145633|NCT00868101|3969686|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4145634|NCT00868101|3969687|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4145635|NCT00868101|3969688|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4145636|NCT00868101|3969686|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4145637|NCT00868101|3969687|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4145638|NCT00868101|3969688|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4145639|NCT00868101|3969686|B3|||Age||years|Mean|7.3|7.3|Standard Deviation|5.7|5.7|||
4145640|NCT00868101|3969687|B2|||Age||years|Mean|6.6|6.6|Standard Deviation|4.6|4.6|||
4145641|NCT00868101|3969688|B1|||Age||years|Mean|7.9|7.9|Standard Deviation|6.6|6.6|||
4145642|NCT00868101|3969686|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4145643|NCT00868101|3969687|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4145644|NCT00868101|3969688|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4145645|NCT00868101|3969686|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4145646|NCT00868101|3969687|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4145647|NCT00868101|3969688|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4145648|NCT00868101|3969686|B3||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
4145649|NCT00868101|3969687|B2||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4145650|NCT00868101|3969688|B1||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4145651|NCT00867932|3969701|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4145652|NCT00867932|3969701|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4145653|NCT00867932|3969701|B1|Adolescents (12 to 17 years)||Age, Customized||Participants|Count of Participants|6|6.0||||||
4145654|NCT00867932|3969701|B1|Children (2 to 11 years)||Age, Customized||Participants|Count of Participants|1|1.0||||||
4145655|NCT00867932|3969701|B1|||Age||years|Mean|15.01|15.01|Standard Deviation|2.28|2.28|||
4145656|NCT00867659|3969709|B1|||incidence of ovarian hyperstimulation|Incidence of OHSS will be assessed in 20 oocyte donors|particpants|Number|20|20.0||||||
4145657|NCT00867659|3969709|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4145658|NCT00867659|3969709|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4145659|NCT00867659|3969709|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4145660|NCT00867659|3969709|B1|||Age||years|Mean|25|25.0|Standard Deviation|2|2.0|||
4145661|NCT00867659|3969709|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4145662|NCT00867659|3969709|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4145663|NCT00867659|3969709|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145664|NCT00867568|3969714|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4145665|NCT00867568|3969714|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145666|NCT00867568|3969714|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4145667|NCT00867568|3969714|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145668|NCT00867568|3969714|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145669|NCT00867568|3969714|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145670|NCT00867568|3969714|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145671|NCT00867568|3969714|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4145672|NCT00867568|3969714|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4145673|NCT00867568|3969714|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4145674|NCT00867568|3969714|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4145675|NCT00867568|3969714|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4145676|NCT00867568|3969714|B1|||Age|One subject, age 25, was allowed to enroll on study, but was censored from endpoints due to age.|years|Median|7.5|7.5|Full Range|||4.0|25.0|
4145677|NCT00867529|3969723|B1|United States||Region of Enrollment||participants|Number|63|63.0||||||
4145678|NCT00867529|3969723|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4145679|NCT00867529|3969723|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145680|NCT00867529|3969723|B1||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4145681|NCT00867529|3969723|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145682|NCT00867529|3969723|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145683|NCT00867529|3969723|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4145684|NCT00867529|3969723|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4145685|NCT00867529|3969723|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145686|NCT00867529|3969723|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4145687|NCT00867529|3969723|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4145688|NCT00867529|3969723|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4145689|NCT00867529|3969723|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4145690|NCT00867529|3969723|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4145691|NCT00867529|3969723|B1||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4145692|NCT00867529|3969723|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145693|NCT00867503|3969731|B1|Clear Cell||Cell Type||Participants|Number|1|1.0||||||
4145694|NCT00867503|3969731|B1|Endometrioid||Cell Type||Participants|Number|3|3.0||||||
4145695|NCT00867503|3969731|B1|Serous||Cell Type||Participants|Number|6|6.0||||||
4145696|NCT00867503|3969731|B1|3||Tumor Grade|"Criteria met for determination of Grade:~Grade 1: the least malignant, with well-differentiated cells Grade 2: intermediate, with moderately differentiated cells Grade 3: the most malignant, with poorly differentiated cells"|Participants|Number|8|8.0||||||
4145697|NCT00867503|3969731|B1|2||Tumor Grade|"Criteria met for determination of Grade:~Grade 1: the least malignant, with well-differentiated cells Grade 2: intermediate, with moderately differentiated cells Grade 3: the most malignant, with poorly differentiated cells"|Participants|Number|2|2.0||||||
4145698|NCT00867503|3969731|B1|1||Eastern Cooperative Oncology Group performance status|Eastern Cooperative Oncology Group (ECOG) performance status is a scale 0-5. A score of 0 indicates fully active, able to carry on all pre-disease performance without restriction; 1 indicates restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; For more information on the ECOG performance scale refer to Oken, M.M., Creech, R.H., Tormey, D.C., Horton, J., Davis, T.E., McFadden, E.T., Carbone, P.P.: Toxicity And Response Criteria Of The Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649-655, 1982.|Participants|Number|1|1.0||||||
4145699|NCT00867503|3969731|B1|0||Eastern Cooperative Oncology Group performance status|Eastern Cooperative Oncology Group (ECOG) performance status is a scale 0-5. A score of 0 indicates fully active, able to carry on all pre-disease performance without restriction; 1 indicates restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; For more information on the ECOG performance scale refer to Oken, M.M., Creech, R.H., Tormey, D.C., Horton, J., Davis, T.E., McFadden, E.T., Carbone, P.P.: Toxicity And Response Criteria Of The Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649-655, 1982.|Participants|Number|9|9.0||||||
4145700|NCT00867503|3969731|B1|||Median number of prior regimens||Regimens|Median|5|5.0|Full Range|||3.0|10.0|
4145701|NCT00867503|3969731|B1|Peritoneal||Primary Site||participants|Number|1|1.0||||||
4145702|NCT00867503|3969731|B1|Ovarian||Primary Site||participants|Number|9|9.0||||||
4145703|NCT00867503|3969731|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4145704|NCT00867503|3969731|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145705|NCT00867503|3969731|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145706|NCT00867503|3969731|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4145707|NCT00867503|3969731|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145708|NCT00867503|3969731|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145709|NCT00867503|3969731|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145710|NCT00867503|3969731|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145711|NCT00867503|3969731|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145712|NCT00867503|3969731|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4145713|NCT00867503|3969731|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4145714|NCT00867503|3969731|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4145715|NCT00867503|3969731|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4145716|NCT00867503|3969731|B1|||Age||years|Median|58|58.0|Full Range|||34.0|82.0|
4145717|NCT00867490|3969737|B1|Phase III - Aliskiren+HCTZ+amlodipine||Sex/Gender, Customized|Male|Participants|Number|37|37.0||||||
4145718|NCT00867490|3969737|B1|Phase II - Aliskiren+HCTZ||Sex/Gender, Customized|Male|Participants|Number|75|75.0||||||
4145719|NCT00867490|3969737|B1|Phase I - Candesartan+HCTZ||Sex/Gender, Customized|Male|Participants|Number|108|108.0||||||
4145720|NCT00867490|3969737|B1|Phase III - Aliskiren+HCTZ+amlodipine||Sex/Gender, Customized|Female|Participants|Number|24|24.0||||||
4145721|NCT00867490|3969737|B1|Phase II - Aliskiren+HCTZ||Sex/Gender, Customized|Female|Participants|Number|48|48.0||||||
4145722|NCT00867490|3969737|B1|Phase I - Candesartan+HCTZ||Sex/Gender, Customized|Female|Participants|Number|78|78.0||||||
4145723|NCT00867490|3969737|B1|Phase III - Aliskiren+HCTZ+amlodipine||Age||years|Mean|58.9|58.9|Standard Deviation|10.31|10.31|||
4145724|NCT00867490|3969737|B1|Phase II - Aliskiren+HCTZ||Age||years|Mean|57.4|57.4|Standard Deviation|10.87|10.87|||
4145725|NCT00867490|3969737|B1|Phase I - Candesartan+HCTZ||Age||years|Mean|56.2|56.2|Standard Deviation|10.62|10.62|||
4145726|NCT00867451|3969754|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4145727|NCT00867451|3969755|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4145728|NCT00867451|3969756|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4145729|NCT00867451|3969754|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4145730|NCT00867451|3969755|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4145731|NCT00867451|3969756|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4145732|NCT00867451|3969754|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4145733|NCT00867451|3969755|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4145734|NCT00867451|3969756|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4145735|NCT00867451|3969754|B3|||Age||years|Mean|9.0|9.0|Standard Deviation|1.6|1.6|||
4145736|NCT00867451|3969755|B2|||Age||years|Mean|9.5|9.5|Standard Deviation|1.9|1.9|||
4145737|NCT00867451|3969756|B1|||Age||years|Mean|8.5|8.5|Standard Deviation|1.3|1.3|||
4145738|NCT00867451|3969754|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4145739|NCT00867451|3969755|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4145740|NCT00867451|3969756|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4145741|NCT00867451|3969754|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4145742|NCT00867451|3969755|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4145743|NCT00867451|3969756|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4145744|NCT00867451|3969754|B3||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4145745|NCT00867451|3969755|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4145746|NCT00867451|3969756|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4145747|NCT00867360|3969777|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4145748|NCT00867360|3969778|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4145749|NCT00867360|3969779|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4145750|NCT00867360|3969777|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4145751|NCT00867360|3969778|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4145752|NCT00867360|3969779|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4145753|NCT00867360|3969777|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4145754|NCT00867360|3969778|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4145755|NCT00867360|3969779|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4145756|NCT00867360|3969777|B3|||Age||years|Mean|39.88|39.88|Standard Deviation|10.3|10.3|||
4145757|NCT00867360|3969778|B2|||Age||years|Mean|40.00|40.0|Standard Deviation|9.98|9.98|||
4145758|NCT00867360|3969779|B1|||Age||years|Mean|39.67|39.67|Standard Deviation|13.1|13.1|||
4145759|NCT00867321|3969790|B4|United States||Region of Enrollment||participants|Number|24|24.0||||||
4145760|NCT00867321|3969791|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4145761|NCT00867321|3969792|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4145762|NCT00867321|3969793|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4145763|NCT00867321|3969790|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4145764|NCT00867321|3969791|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4145765|NCT00867321|3969792|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4145766|NCT00867321|3969793|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4145767|NCT00867321|3969790|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4145768|NCT00867321|3969791|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4145769|NCT00867321|3969792|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4145770|NCT00867321|3969793|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4145771|NCT00867321|3969790|B4|||Age||years|Median|60.5|60.5|Full Range|||18.0|80.0|
4145772|NCT00867321|3969791|B3|||Age||years|Median|66|66.0|Full Range|||18.0|79.0|
4145773|NCT00867321|3969792|B2|||Age||years|Median|55|55.0|Full Range|||52.0|61.0|
4145774|NCT00867321|3969793|B1|||Age||years|Median|58.5|58.5|Full Range|||54.0|80.0|
4145775|NCT00867308|3969816|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4145776|NCT00867308|3969816|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4145777|NCT00867308|3969817|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4145778|NCT00867308|3969818|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4145779|NCT00867308|3969816|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4145780|NCT00867308|3969817|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4145781|NCT00867308|3969818|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4145782|NCT00867308|3969816|B3|||Age||years|Median|72|72.0|Full Range|||47.0|88.0|
4145783|NCT00867308|3969817|B2|||Age||years|Median|70|70.0|Full Range|||53.0|79.0|
4145784|NCT00867308|3969818|B1|||Age||years|Median|77|77.0|Full Range|||47.0|88.0|
4145785|NCT00867308|3969816|B3||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4145786|NCT00867308|3969817|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4145787|NCT00867308|3969818|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4145788|NCT00867308|3969816|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4145789|NCT00867308|3969817|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4145790|NCT00867308|3969818|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4145791|NCT00867308|3969816|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145792|NCT00867308|3969817|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145793|NCT00867308|3969818|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145794|NCT00867217|3969827|B3|United States||Region of Enrollment||participants|Number|160|160.0||||||
4145795|NCT00867217|3969828|B2|United States||Region of Enrollment||participants|Number|80|80.0||||||
4145796|NCT00867217|3969829|B1|United States||Region of Enrollment||participants|Number|80|80.0||||||
4145797|NCT00867217|3969827|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145798|NCT00867217|3969828|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145799|NCT00867217|3969829|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145800|NCT00867217|3969827|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145801|NCT00867217|3969828|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145802|NCT00867217|3969829|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145803|NCT00867217|3969827|B3||White|Race (NIH/OMB)||Participants|Count of Participants|152|152.0||||||
4145804|NCT00867217|3969828|B2||White|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
4145805|NCT00867217|3969829|B1||White|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4145806|NCT00867217|3969827|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4145807|NCT00867217|3969828|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4145808|NCT00867217|3969829|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4145809|NCT00867217|3969827|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145810|NCT00867217|3969828|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145811|NCT00867217|3969829|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145812|NCT00867217|3969827|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4145813|NCT00867217|3969828|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145814|NCT00867217|3969829|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4145815|NCT00867217|3969827|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145816|NCT00867217|3969828|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145817|NCT00867217|3969829|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145818|NCT00867217|3969827|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4145819|NCT00867217|3969828|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4145820|NCT00867217|3969829|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4145821|NCT00867217|3969827|B3||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4145822|NCT00867217|3969828|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4145823|NCT00867217|3969829|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4145824|NCT00867217|3969827|B3|||Age, Customized||years|Median|62|62.0|Full Range|||34.0|87.0|
4145825|NCT00867217|3969828|B2|||Age, Customized||years|Median|60.5|60.5|Full Range|||42.0|85.0|
4145826|NCT00867217|3969829|B1|||Age, Customized||years|Median|62|62.0|Full Range|||34.0|87.0|
4145827|NCT00867165|3969836|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4145828|NCT00867165|3969837|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4145829|NCT00867165|3969838|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4145830|NCT00867165|3969836|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4145831|NCT00867165|3969837|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4145832|NCT00867165|3969838|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4145833|NCT00867165|3969836|B3|||Age||years|Mean|8.3|8.3|Standard Deviation|1.6|1.6|||
4145834|NCT00867165|3969837|B2|||Age||years|Mean|8.5|8.5|Standard Deviation|1.6|1.6|||
4145835|NCT00867165|3969838|B1|||Age||years|Mean|8.2|8.2|Standard Deviation|1.7|1.7|||
4145836|NCT00867139|3969941|B4|United States||Region of Enrollment||participants|Number|7|7.0||||||
4145837|NCT00867139|3969942|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4145838|NCT00867139|3969943|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4145839|NCT00867139|3969944|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4145840|NCT00867139|3969941|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4145841|NCT00867139|3969942|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4145842|NCT00867139|3969943|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4145843|NCT00867139|3969944|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4145844|NCT00867139|3969941|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4145845|NCT00867139|3969942|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4145846|NCT00867139|3969943|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4145847|NCT00867139|3969944|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4145848|NCT00867139|3969941|B4|||Age||years|Mean|36.3|36.3|Standard Deviation|25.7|25.7|||
4145849|NCT00867139|3969942|B3|||Age||years|Mean|29.5|29.5|Standard Deviation|26.0|26.0|||
4145850|NCT00867139|3969943|B2|||Age||years|Mean|17|17.0|Standard Deviation|0|0.0|||
4145851|NCT00867139|3969944|B1|||Age||years|Mean|59.5|59.5|Standard Deviation|17.7|17.7|||
4145852|NCT00867139|3969941|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4145853|NCT00867139|3969942|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4145854|NCT00867139|3969943|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4145855|NCT00867139|3969944|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4145856|NCT00867139|3969941|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4145857|NCT00867139|3969942|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4145858|NCT00867139|3969943|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4145859|NCT00867139|3969944|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4145860|NCT00867139|3969941|B4||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4145861|NCT00867139|3969942|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4145862|NCT00867139|3969943|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4145863|NCT00867139|3969944|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145864|NCT00867113|3969987|B1|Small Bowel||Primary lesion location|Primary lesion|participant|Number|6|6.0||||||
4145865|NCT00867113|3969987|B1|Sigmoid Colon||Primary lesion location|Primary lesion|participant|Number|1|1.0||||||
4145866|NCT00867113|3969987|B1|Retroperitoneal Mass||Primary lesion location|Primary lesion|participant|Number|1|1.0||||||
4145867|NCT00867113|3969987|B1|Recto Vaginal||Primary lesion location|Primary lesion|participant|Number|1|1.0||||||
4145868|NCT00867113|3969987|B1|Pelvis - Organ Of Origin Unknown||Primary lesion location|Primary lesion|participant|Number|1|1.0||||||
4145869|NCT00867113|3969987|B1|Ileum And Cecum||Primary lesion location|Primary lesion|participant|Number|1|1.0||||||
4145870|NCT00867113|3969987|B1|Gastric Serosa-Min Invasion Outer Musc Prop||Primary lesion location|Primary lesion|participant|Number|1|1.0||||||
4145871|NCT00867113|3969987|B1|Exact Location In Small Bowel Not Identified||Primary lesion location|Primary lesion|participant|Number|1|1.0||||||
4145872|NCT00867113|3969987|B1|Abdominal; Proximal Jejunal||Primary lesion location|Primary lesion|participant|Number|1|1.0||||||
4145873|NCT00867113|3969987|B1|Abdomen||Primary lesion location|Primary lesion|participant|Number|1|1.0||||||
4145874|NCT00867113|3969987|B1|Other||Primary lesion location|Primary lesion|participant|Number|15|15.0||||||
4145875|NCT00867113|3969987|B1|Rectum||Primary lesion location|Primary lesion|participant|Number|1|1.0||||||
4145876|NCT00867113|3969987|B1|Jejunum ileum||Primary lesion location|Primary lesion|participant|Number|21|21.0||||||
4145877|NCT00867113|3969987|B1|Duodenum||Primary lesion location|Primary lesion|participant|Number|4|4.0||||||
4145878|NCT00867113|3969987|B1|Gastric||Primary lesion location|Primary lesion|participant|Number|50|50.0||||||
4145879|NCT00867113|3969987|B1||ECOG = 1|ECOG Status|ECOG 0 = Fully active, able to carry on all pre-disease performance without restriction; ECOG 1 =Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work; ECOG 2 = Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours; ECOG 3 = Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours; ECOG 4 = Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair; ECOG 5 = Dead.|Participants|Count of Participants|32|32.0||||||
4145880|NCT00867113|3969987|B1||ECOG = 0|ECOG Status|ECOG 0 = Fully active, able to carry on all pre-disease performance without restriction; ECOG 1 =Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work; ECOG 2 = Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours; ECOG 3 = Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours; ECOG 4 = Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair; ECOG 5 = Dead.|Participants|Count of Participants|59|59.0||||||
4145881|NCT00867113|3969987|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4145882|NCT00867113|3969987|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4145883|NCT00867113|3969987|B1|||Age||years|Mean|58.9|58.9|Standard Deviation|12.64|12.64|||
4145884|NCT00867087|3969994|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4145885|NCT00867087|3969994|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4145886|NCT00867087|3969994|B1|||Age||Years|Mean|57.7|57.7|Standard Deviation|12.92|12.92|||
4145887|NCT00867035|3970008|B3|||Rosenberg score of 2 or more|The Rosenberg scale is validated and is scored 0-5 with 0= no bad breath, 5=worst bad breath. A score of 2 is the threshold at which bad breath is determined|participants|Number|22|22.0||||||
4145888|NCT00867035|3970009|B2|||Rosenberg score of 2 or more|The Rosenberg scale is validated and is scored 0-5 with 0= no bad breath, 5=worst bad breath. A score of 2 is the threshold at which bad breath is determined|participants|Number|9|9.0||||||
4145889|NCT00867035|3970010|B1|||Rosenberg score of 2 or more|The Rosenberg scale is validated and is scored 0-5 with 0= no bad breath, 5=worst bad breath. A score of 2 is the threshold at which bad breath is determined|participants|Number|13|13.0||||||
4145890|NCT00867035|3970008|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4145891|NCT00867035|3970009|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4145892|NCT00867035|3970010|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4145893|NCT00867035|3970008|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4145894|NCT00867035|3970009|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4145895|NCT00867035|3970010|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4145896|NCT00867035|3970008|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4145897|NCT00867035|3970009|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4145898|NCT00867035|3970010|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4145899|NCT00867035|3970008|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4145900|NCT00867035|3970009|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4145901|NCT00867035|3970010|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4145902|NCT00867035|3970008|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4145903|NCT00867035|3970009|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4145904|NCT00867035|3970010|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4145905|NCT00867035|3970008|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145906|NCT00867035|3970009|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145907|NCT00867035|3970010|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4145908|NCT00867009|3970037|B1|Missing||Pathological Diagnosis||participants|Number|1|1.0||||||
4145909|NCT00867009|3970037|B1|Poorly Differentiated Non-Small Cell||Pathological Diagnosis||participants|Number|8|8.0||||||
4145910|NCT00867009|3970037|B1|Non-Small Cell Lung (NSCL) Cancer||Pathological Diagnosis||participants|Number|9|9.0||||||
4145911|NCT00867009|3970037|B1|Malignant Neoplasm, Adeno Lung||Pathological Diagnosis||participants|Number|88|88.0||||||
4145912|NCT00867009|3970037|B1|Large Cells Lung Carcinoma||Pathological Diagnosis||participants|Number|5|5.0||||||
4145913|NCT00867009|3970037|B1|Carcinoma, Adenosquamous,Lung, Predominantly Adeno||Pathological Diagnosis||participants|Number|1|1.0||||||
4145914|NCT00867009|3970037|B1|Adenocarcinoma (Adeno), Breast||Pathological Diagnosis||participants|Number|1|1.0||||||
4145915|NCT00867009|3970037|B1|Stage IV||Disease Stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIB - the cancer has spread to nearby tissue or spread to far away lymph nodes. Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver|participants|Number|104|104.0||||||
4145916|NCT00867009|3970037|B1|Stage IIIB||Disease Stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIB - the cancer has spread to nearby tissue or spread to far away lymph nodes. Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver|participants|Number|9|9.0||||||
4145917|NCT00867009|3970037|B1|1 - Ambulatory, Restricted Strenuous Activity||Eastern Co-operative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. ECOG Performance Score: 0 - Fully Active; 1 - Ambulatory, Restricted Strenuous Activity; 2 - Ambulatory, No Work Activities; 3 - Partially Confined to Bed, Limited Self Care; 4 - Completely Disabled; 5 - Death|participants|Number|57|57.0||||||
4145918|NCT00867009|3970037|B1|0 - Fully Active||Eastern Co-operative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. ECOG Performance Score: 0 - Fully Active; 1 - Ambulatory, Restricted Strenuous Activity; 2 - Ambulatory, No Work Activities; 3 - Partially Confined to Bed, Limited Self Care; 4 - Completely Disabled; 5 - Death|participants|Number|56|56.0||||||
4145919|NCT00867009|3970037|B1|Italy||Region of Enrollment||participants|Number|26|26.0||||||
4145920|NCT00867009|3970037|B1|Netherlands||Region of Enrollment||participants|Number|16|16.0||||||
4145921|NCT00867009|3970037|B1|Germany||Region of Enrollment||participants|Number|28|28.0||||||
4145922|NCT00867009|3970037|B1|Austria||Region of Enrollment||participants|Number|6|6.0||||||
4145923|NCT00867009|3970037|B1|Spain||Region of Enrollment||participants|Number|25|25.0||||||
4145924|NCT00867009|3970037|B1|Greece||Region of Enrollment||participants|Number|12|12.0||||||
4145925|NCT00867009|3970037|B1|White||Race/Ethnicity, Customized||participants|Number|113|113.0||||||
4145926|NCT00867009|3970037|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4145927|NCT00867009|3970037|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4145928|NCT00867009|3970037|B1|||Age||years|Mean|59.15|59.15|Standard Deviation|8.83|8.83|||
4145929|NCT00866918|3970044|B3|United States||Region of Enrollment||participants|Number|104|104.0||||||
4145930|NCT00866918|3970045|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4145931|NCT00866918|3970046|B1|United States||Region of Enrollment||participants|Number|67|67.0||||||
4145932|NCT00866918|3970044|B3|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4145933|NCT00866918|3970045|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4145934|NCT00866918|3970046|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4145935|NCT00866918|3970044|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4145936|NCT00866918|3970045|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4145937|NCT00866918|3970046|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4145938|NCT00866918|3970044|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145939|NCT00866918|3970045|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145940|NCT00866918|3970046|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145941|NCT00866918|3970044|B3||White|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
4145942|NCT00866918|3970045|B2||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4145943|NCT00866918|3970046|B1||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4145944|NCT00866918|3970044|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4145945|NCT00866918|3970045|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4145946|NCT00866918|3970046|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4145947|NCT00866918|3970044|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145948|NCT00866918|3970045|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145949|NCT00866918|3970046|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145950|NCT00866918|3970044|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4145951|NCT00866918|3970045|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4145952|NCT00866918|3970046|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145953|NCT00866918|3970044|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4145954|NCT00866918|3970045|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4145955|NCT00866918|3970046|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4145956|NCT00866918|3970044|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4145957|NCT00866918|3970045|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4145958|NCT00866918|3970046|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4145959|NCT00866918|3970044|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
4145960|NCT00866918|3970045|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4145961|NCT00866918|3970046|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4145962|NCT00866918|3970044|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4145963|NCT00866918|3970045|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4145964|NCT00866918|3970046|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4145965|NCT00866918|3970044|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4145966|NCT00866918|3970045|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4145967|NCT00866918|3970046|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4145968|NCT00866918|3970044|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4145969|NCT00866918|3970045|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4145970|NCT00866918|3970046|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4145971|NCT00866918|3970044|B3|||Age||Days|Mean|4917.44|4917.44|Standard Deviation|1663.37|1663.37|||
4145972|NCT00866918|3970045|B2|||Age||Days|Mean|4921.33|4921.33|Standard Deviation|1747.04|1747.04|||
4145973|NCT00866918|3970046|B1|||Age||Days|Mean|4915.25|4915.25|Standard Deviation|1627.27|1627.27|||
4145974|NCT00866918|3970044|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4145975|NCT00866918|3970045|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4145976|NCT00866918|3970046|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4145977|NCT00866918|3970044|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4145978|NCT00866918|3970045|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4145979|NCT00866918|3970046|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4145980|NCT00866918|3970044|B3||<=18 years|Age||Participants|Count of Participants|106|106.0||||||
4145981|NCT00866918|3970045|B2||<=18 years|Age||Participants|Count of Participants|38|38.0||||||
4145982|NCT00866918|3970046|B1||<=18 years|Age||Participants|Count of Participants|68|68.0||||||
4145983|NCT00866905|3970059|B1|United States||Region of Enrollment||participants|Number|168|168.0||||||
4145984|NCT00866905|3970059|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4145985|NCT00866905|3970059|B1||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4145986|NCT00866905|3970059|B1|||Age||Years|Median|53|53.0|Full Range|||30.0|79.0|
4145987|NCT00866814|3970064|B1|||Body Mass Index||kg/m^2|Mean|33.5|33.5|Standard Deviation|7.1|7.1|||
4145988|NCT00866814|3970064|B1|United States||Region of Enrollment||participants|Number|119|119.0||||||
4145989|NCT00866814|3970064|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4145990|NCT00866814|3970064|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4145991|NCT00866814|3970064|B1|||Age||years|Mean|55.8|55.8|Standard Deviation|13.6|13.6|||
4145992|NCT00866788|3970073|B5||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4145993|NCT00866788|3970074|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4145994|NCT00866788|3970075|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4145995|NCT00866788|3970076|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4145996|NCT00866788|3970077|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4145997|NCT00866788|3970073|B5||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4145998|NCT00866788|3970074|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4145999|NCT00866788|3970075|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4146000|NCT00866788|3970076|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4146001|NCT00866788|3970077|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4146002|NCT00866788|3970073|B5|>=40 years||Age, Customized||participants|Number|45|45.0||||||
4146003|NCT00866788|3970074|B4|>=40 years||Age, Customized||participants|Number|10|10.0||||||
4146004|NCT00866788|3970075|B3|>=40 years||Age, Customized||participants|Number|12|12.0||||||
4146005|NCT00866788|3970076|B2|>=40 years||Age, Customized||participants|Number|11|11.0||||||
4146006|NCT00866788|3970077|B1|>=40 years||Age, Customized||participants|Number|12|12.0||||||
4146007|NCT00866788|3970073|B5|18-<40 years||Age, Customized||participants|Number|40|40.0||||||
4146008|NCT00866788|3970074|B4|18-<40 years||Age, Customized||participants|Number|11|11.0||||||
4146009|NCT00866788|3970075|B3|18-<40 years||Age, Customized||participants|Number|12|12.0||||||
4146010|NCT00866788|3970076|B2|18-<40 years||Age, Customized||participants|Number|10|10.0||||||
4146011|NCT00866788|3970077|B1|18-<40 years||Age, Customized||participants|Number|7|7.0||||||
4146012|NCT00866788|3970073|B5|12-<18 years||Age, Customized||participants|Number|5|5.0||||||
4146013|NCT00866788|3970074|B4|12-<18 years||Age, Customized||participants|Number|0|0.0||||||
4146014|NCT00866788|3970075|B3|12-<18 years||Age, Customized||participants|Number|1|1.0||||||
4146015|NCT00866788|3970076|B2|12-<18 years||Age, Customized||participants|Number|2|2.0||||||
4146016|NCT00866788|3970077|B1|12-<18 years||Age, Customized||participants|Number|2|2.0||||||
4146017|NCT00866775|3970126|B3|United States||Region of Enrollment||participants|Number|187|187.0||||||
4146018|NCT00866775|3970127|B2|United States||Region of Enrollment||participants|Number|123|123.0||||||
4146019|NCT00866775|3970128|B1|United States||Region of Enrollment||participants|Number|64|64.0||||||
4146020|NCT00866775|3970126|B3|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4146021|NCT00866775|3970127|B2|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4146022|NCT00866775|3970128|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4146023|NCT00866775|3970126|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4146024|NCT00866775|3970127|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4146025|NCT00866775|3970128|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4146026|NCT00866775|3970126|B3|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4146027|NCT00866775|3970127|B2|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4146028|NCT00866775|3970128|B1|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4146029|NCT00866775|3970126|B3|White||Race/Ethnicity, Customized||participants|Number|147|147.0||||||
4146030|NCT00866775|3970127|B2|White||Race/Ethnicity, Customized||participants|Number|94|94.0||||||
4146031|NCT00866775|3970128|B1|White||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
4146032|NCT00866775|3970126|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4146033|NCT00866775|3970127|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4146034|NCT00866775|3970128|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4146035|NCT00866775|3970126|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4146036|NCT00866775|3970127|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4146037|NCT00866775|3970128|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4146038|NCT00866775|3970126|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4146039|NCT00866775|3970127|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4146040|NCT00866775|3970128|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4146041|NCT00866775|3970126|B3|American Indian or Alsaka Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4146042|NCT00866775|3970127|B2|American Indian or Alsaka Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4146043|NCT00866775|3970128|B1|American Indian or Alsaka Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4146044|NCT00866775|3970126|B3||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4146045|NCT00866775|3970127|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4146046|NCT00866775|3970128|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4146047|NCT00866775|3970126|B3||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4146048|NCT00866775|3970127|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4146049|NCT00866775|3970128|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4146050|NCT00866775|3970126|B3|greater than 65 years||Age, Customized||participants|Number|5|5.0||||||
4146051|NCT00866775|3970127|B2|greater than 65 years||Age, Customized||participants|Number|4|4.0||||||
4146052|NCT00866775|3970128|B1|greater than 65 years||Age, Customized||participants|Number|1|1.0||||||
4146053|NCT00866775|3970126|B3|40-65 years||Age, Customized||participants|Number|90|90.0||||||
4146054|NCT00866775|3970127|B2|40-65 years||Age, Customized||participants|Number|61|61.0||||||
4146055|NCT00866775|3970128|B1|40-65 years||Age, Customized||participants|Number|29|29.0||||||
4146056|NCT00866775|3970126|B3|18-39 years||Age, Customized||participants|Number|92|92.0||||||
4146057|NCT00866775|3970127|B2|18-39 years||Age, Customized||participants|Number|61|61.0||||||
4146058|NCT00866775|3970128|B1|18-39 years||Age, Customized||participants|Number|31|31.0||||||
4146059|NCT00866775|3970126|B3|less than 18 years||Age, Customized||participants|Number|6|6.0||||||
4146060|NCT00866775|3970127|B2|less than 18 years||Age, Customized||participants|Number|2|2.0||||||
4146061|NCT00866775|3970128|B1|less than 18 years||Age, Customized||participants|Number|4|4.0||||||
4146062|NCT00866723|3970165|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4146063|NCT00866723|3970165|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4146064|NCT00866723|3970165|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4146065|NCT00866723|3970165|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4146066|NCT00866723|3970165|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4146067|NCT00866723|3970165|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4146068|NCT00866723|3970165|B1|||Age||years|Mean|55|55.0|Full Range|||38.0|68.0|
4146069|NCT00866697|3970170|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|726|726.0||||||
4146070|NCT00866697|3970171|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|363|363.0||||||
4146071|NCT00866697|3970172|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|363|363.0||||||
4146072|NCT00866697|3970170|B3||Japanese/East Asian Her/South East Asian Her|Race/Ethnicity, Customized||Participants|Count of Participants|208|208.0||||||
4146073|NCT00866697|3970171|B2||Japanese/East Asian Her/South East Asian Her|Race/Ethnicity, Customized||Participants|Count of Participants|106|106.0||||||
4146074|NCT00866697|3970172|B1||Japanese/East Asian Her/South East Asian Her|Race/Ethnicity, Customized||Participants|Count of Participants|102|102.0||||||
4146075|NCT00866697|3970170|B3||Central/South Asian Heritage (Her)|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4146076|NCT00866697|3970171|B2||Central/South Asian Heritage (Her)|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4146077|NCT00866697|3970172|B1||Central/South Asian Heritage (Her)|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4146078|NCT00866697|3970170|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4146079|NCT00866697|3970171|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4146080|NCT00866697|3970172|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4146081|NCT00866697|3970170|B3||African American/African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4146082|NCT00866697|3970171|B2||African American/African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4146083|NCT00866697|3970172|B1||African American/African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4146084|NCT00866697|3970170|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4146085|NCT00866697|3970171|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4146086|NCT00866697|3970172|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4146087|NCT00866697|3970170|B3||Female|Sex: Female, Male||Participants|Count of Participants|940|940.0||||||
4146088|NCT00866697|3970171|B2||Female|Sex: Female, Male||Participants|Count of Participants|472|472.0||||||
4146089|NCT00866697|3970172|B1||Female|Sex: Female, Male||Participants|Count of Participants|468|468.0||||||
4146090|NCT00866697|3970170|B3|||Age||Years|Mean|56.3|56.3|Standard Deviation|10.69|10.69|||
4146091|NCT00866697|3970171|B2|||Age||Years|Mean|55.8|55.8|Standard Deviation|10.54|10.54|||
4146092|NCT00866697|3970172|B1|||Age||Years|Mean|56.8|56.8|Standard Deviation|10.83|10.83|||
4146093|NCT00866658|3970213|B3|||Body Mass Index (BMI)|Body mass index was calculated by dividing body weight (kilogram) by the height (meters) squared.|kilogram per square meter (kg/m^2)|Mean|25.26|25.26|Standard Deviation|3.82|3.82|||
4146094|NCT00866658|3970214|B2|||Body Mass Index (BMI)|Body mass index was calculated by dividing body weight (kilogram) by the height (meters) squared.|kilogram per square meter (kg/m^2)|Mean|25.36|25.36|Standard Deviation|3.69|3.69|||
4146095|NCT00866658|3970215|B1|||Body Mass Index (BMI)|Body mass index was calculated by dividing body weight (kilogram) by the height (meters) squared.|kilogram per square meter (kg/m^2)|Mean|25.15|25.15|Standard Deviation|3.94|3.94|||
4146096|NCT00866658|3970213|B3|No||Number of Patients With Sulfonylurea Use|Number of patients with sulfonylurea urea is reported at screening.|participants|Number|92|92.0||||||
4146097|NCT00866658|3970214|B2|No||Number of Patients With Sulfonylurea Use|Number of patients with sulfonylurea urea is reported at screening.|participants|Number|46|46.0||||||
4146098|NCT00866658|3970215|B1|No||Number of Patients With Sulfonylurea Use|Number of patients with sulfonylurea urea is reported at screening.|participants|Number|46|46.0||||||
4146099|NCT00866658|3970213|B3|Yes||Number of Patients With Sulfonylurea Use|Number of patients with sulfonylurea urea is reported at screening.|participants|Number|219|219.0||||||
4146100|NCT00866658|3970214|B2|Yes||Number of Patients With Sulfonylurea Use|Number of patients with sulfonylurea urea is reported at screening.|participants|Number|108|108.0||||||
4146101|NCT00866658|3970215|B1|Yes||Number of Patients With Sulfonylurea Use|Number of patients with sulfonylurea urea is reported at screening.|participants|Number|111|111.0||||||
4146102|NCT00866658|3970213|B3|||Sulfonylurea Treatment Duration|Sulfonylurea treatment duration is reported at screening. Number of patients analyzed = 101 and 100 for Placebo and Lixisenatide treatment arms, respectively.|years|Mean|6.07|6.07|Standard Deviation|5.08|5.08|||
4146103|NCT00866658|3970214|B2|||Sulfonylurea Treatment Duration|Sulfonylurea treatment duration is reported at screening. Number of patients analyzed = 101 and 100 for Placebo and Lixisenatide treatment arms, respectively.|years|Mean|5.33|5.33|Standard Deviation|4.83|4.83|||
4146104|NCT00866658|3970215|B1|||Sulfonylurea Treatment Duration|Sulfonylurea treatment duration is reported at screening. Number of patients analyzed = 101 and 100 for Placebo and Lixisenatide treatment arms, respectively.|years|Mean|6.80|6.8|Standard Deviation|5.24|5.24|||
4146105|NCT00866658|3970213|B3|||Duration of Diabetes|Duration of diabetes is reported at screening.|years|Mean|13.92|13.92|Standard Deviation|7.71|7.71|||
4146106|NCT00866658|3970214|B2|||Duration of Diabetes|Duration of diabetes is reported at screening.|years|Mean|13.71|13.71|Standard Deviation|7.73|7.73|||
4146107|NCT00866658|3970215|B1|||Duration of Diabetes|Duration of diabetes is reported at screening.|years|Mean|14.13|14.13|Standard Deviation|7.72|7.72|||
4146108|NCT00866658|3970213|B3|Premix (Mixed Insulin)||Number of Patients With Insulin Therapy at Screening|NPH included isophane insulin and insulin human injection, isophane. Premix insulin included Novomix.|participants|Number|2|2.0||||||
4146109|NCT00866658|3970214|B2|Premix (Mixed Insulin)||Number of Patients With Insulin Therapy at Screening|NPH included isophane insulin and insulin human injection, isophane. Premix insulin included Novomix.|participants|Number|0|0.0||||||
4146110|NCT00866658|3970215|B1|Premix (Mixed Insulin)||Number of Patients With Insulin Therapy at Screening|NPH included isophane insulin and insulin human injection, isophane. Premix insulin included Novomix.|participants|Number|2|2.0||||||
4146111|NCT00866658|3970213|B3|Neutral Protamine Hagedorn (NPH)||Number of Patients With Insulin Therapy at Screening|NPH included isophane insulin and insulin human injection, isophane. Premix insulin included Novomix.|participants|Number|39|39.0||||||
4146112|NCT00866658|3970214|B2|Neutral Protamine Hagedorn (NPH)||Number of Patients With Insulin Therapy at Screening|NPH included isophane insulin and insulin human injection, isophane. Premix insulin included Novomix.|participants|Number|18|18.0||||||
4146113|NCT00866658|3970215|B1|Neutral Protamine Hagedorn (NPH)||Number of Patients With Insulin Therapy at Screening|NPH included isophane insulin and insulin human injection, isophane. Premix insulin included Novomix.|participants|Number|21|21.0||||||
4146114|NCT00866658|3970213|B3|Detemir||Number of Patients With Insulin Therapy at Screening|NPH included isophane insulin and insulin human injection, isophane. Premix insulin included Novomix.|participants|Number|83|83.0||||||
4146198|NCT00866307|3970321|B1||<=18 years|Age||Participants|Count of Participants|96|96.0||||||
4146115|NCT00866658|3970214|B2|Detemir||Number of Patients With Insulin Therapy at Screening|NPH included isophane insulin and insulin human injection, isophane. Premix insulin included Novomix.|participants|Number|41|41.0||||||
4146116|NCT00866658|3970215|B1|Detemir||Number of Patients With Insulin Therapy at Screening|NPH included isophane insulin and insulin human injection, isophane. Premix insulin included Novomix.|participants|Number|42|42.0||||||
4146117|NCT00866658|3970213|B3|Glargine||Number of Patients With Insulin Therapy at Screening|NPH included isophane insulin and insulin human injection, isophane. Premix insulin included Novomix.|participants|Number|187|187.0||||||
4146118|NCT00866658|3970214|B2|Glargine||Number of Patients With Insulin Therapy at Screening|NPH included isophane insulin and insulin human injection, isophane. Premix insulin included Novomix.|participants|Number|95|95.0||||||
4146119|NCT00866658|3970215|B1|Glargine||Number of Patients With Insulin Therapy at Screening|NPH included isophane insulin and insulin human injection, isophane. Premix insulin included Novomix.|participants|Number|92|92.0||||||
4146120|NCT00866658|3970213|B3|||Total Insulin Dose|Total insulin dose is reported at screening.|units per day|Mean|24.48|24.48|Standard Deviation|14.05|14.05|||
4146121|NCT00866658|3970214|B2|||Total Insulin Dose|Total insulin dose is reported at screening.|units per day|Mean|24.85|24.85|Standard Deviation|13.96|13.96|||
4146122|NCT00866658|3970215|B1|||Total Insulin Dose|Total insulin dose is reported at screening.|units per day|Mean|24.11|24.11|Standard Deviation|14.18|14.18|||
4146123|NCT00866658|3970213|B3|||Basal Insulin Treatment Duration|Basal insulin treatment duration is reported at screening. Number of patients analyzed = 155 and 154 for Placebo and Lixisenatide treatment arms, respectively.|years|Mean|2.97|2.97|Standard Deviation|3.97|3.97|||
4146124|NCT00866658|3970214|B2|||Basal Insulin Treatment Duration|Basal insulin treatment duration is reported at screening. Number of patients analyzed = 155 and 154 for Placebo and Lixisenatide treatment arms, respectively.|years|Mean|2.94|2.94|Standard Deviation|3.67|3.67|||
4146125|NCT00866658|3970215|B1|||Basal Insulin Treatment Duration|Basal insulin treatment duration is reported at screening. Number of patients analyzed = 155 and 154 for Placebo and Lixisenatide treatment arms, respectively.|years|Mean|3.01|3.01|Standard Deviation|4.27|4.27|||
4146126|NCT00866658|3970213|B3|||Glucose Excursion|Glucose excursion = 2-hour PPG minus plasma glucose 30 minutes prior to the meal test, before study drug administration. Number of patients analyzed = 156 and 152 for Placebo and Lixisenatide treatment arms, respectively.|mmol/L|Mean|9.71|9.71|Standard Deviation|3.75|3.75|||
4146127|NCT00866658|3970214|B2|||Glucose Excursion|Glucose excursion = 2-hour PPG minus plasma glucose 30 minutes prior to the meal test, before study drug administration. Number of patients analyzed = 156 and 152 for Placebo and Lixisenatide treatment arms, respectively.|mmol/L|Mean|9.72|9.72|Standard Deviation|3.27|3.27|||
4146128|NCT00866658|3970215|B1|||Glucose Excursion|Glucose excursion = 2-hour PPG minus plasma glucose 30 minutes prior to the meal test, before study drug administration. Number of patients analyzed = 156 and 152 for Placebo and Lixisenatide treatment arms, respectively.|mmol/L|Mean|9.70|9.7|Standard Deviation|4.19|4.19|||
4146129|NCT00866658|3970213|B3|||Average 7-point Self-Monitored Plasma Glucose (SMPG)|Here, number of patients analyzed = 139 and 147 for Placebo and Lixisenatide treatment arms, respectively.|mmol/L|Mean|11.51|11.51|Standard Deviation|2.48|2.48|||
4146130|NCT00866658|3970214|B2|||Average 7-point Self-Monitored Plasma Glucose (SMPG)|Here, number of patients analyzed = 139 and 147 for Placebo and Lixisenatide treatment arms, respectively.|mmol/L|Mean|11.58|11.58|Standard Deviation|2.51|2.51|||
4146131|NCT00866658|3970215|B1|||Average 7-point Self-Monitored Plasma Glucose (SMPG)|Here, number of patients analyzed = 139 and 147 for Placebo and Lixisenatide treatment arms, respectively.|mmol/L|Mean|11.42|11.42|Standard Deviation|2.46|2.46|||
4146132|NCT00866658|3970213|B3|||Fasting Plasma Glucose (FPG)||mmol/L|Mean|7.71|7.71|Standard Deviation|2.28|2.28|||
4146133|NCT00866658|3970214|B2|||Fasting Plasma Glucose (FPG)||mmol/L|Mean|7.67|7.67|Standard Deviation|2.32|2.32|||
4146134|NCT00866658|3970215|B1|||Fasting Plasma Glucose (FPG)||mmol/L|Mean|7.75|7.75|Standard Deviation|2.25|2.25|||
4146135|NCT00866658|3970213|B3|||Number of Patients With Screening HbA1c Greater Than or Equal to 8%||participants|Number|240|240.0||||||
4146136|NCT00866658|3970214|B2|||Number of Patients With Screening HbA1c Greater Than or Equal to 8%||participants|Number|119|119.0||||||
4146137|NCT00866658|3970215|B1|||Number of Patients With Screening HbA1c Greater Than or Equal to 8%||participants|Number|121|121.0||||||
4146138|NCT00866658|3970213|B3|||Number of Patients With Screening HbA1c Less Than 8%||participants|Number|71|71.0||||||
4146139|NCT00866658|3970214|B2|||Number of Patients With Screening HbA1c Less Than 8%||participants|Number|35|35.0||||||
4146140|NCT00866658|3970215|B1|||Number of Patients With Screening HbA1c Less Than 8%||participants|Number|36|36.0||||||
4146141|NCT00866658|3970213|B3|||2-Hour Postprandial Plasma Glucose (PPG)|The 2-hour PPG test measured blood glucose 2 hours after eating a standardized meal. Number of patients analyzed = 156 and 152 for Placebo and Lixisenatide treatment arms, respectively.|millimole per liter (mmol/L)|Mean|17.78|17.78|Standard Deviation|3.66|3.66|||
4146142|NCT00866658|3970214|B2|||2-Hour Postprandial Plasma Glucose (PPG)|The 2-hour PPG test measured blood glucose 2 hours after eating a standardized meal. Number of patients analyzed = 156 and 152 for Placebo and Lixisenatide treatment arms, respectively.|millimole per liter (mmol/L)|Mean|17.81|17.81|Standard Deviation|3.36|3.36|||
4146143|NCT00866658|3970215|B1|||2-Hour Postprandial Plasma Glucose (PPG)|The 2-hour PPG test measured blood glucose 2 hours after eating a standardized meal. Number of patients analyzed = 156 and 152 for Placebo and Lixisenatide treatment arms, respectively.|millimole per liter (mmol/L)|Mean|17.75|17.75|Standard Deviation|3.94|3.94|||
4146144|NCT00866658|3970213|B3|||Body Weight||kilogram (kg)|Mean|65.77|65.77|Standard Deviation|12.72|12.72|||
4146145|NCT00866658|3970214|B2|||Body Weight||kilogram (kg)|Mean|65.93|65.93|Standard Deviation|13.00|13.0|||
4146146|NCT00866658|3970215|B1|||Body Weight||kilogram (kg)|Mean|65.60|65.6|Standard Deviation|12.47|12.47|||
4146147|NCT00866658|3970213|B3|||Glycosylated Hemoglobin (HbA1c)||percentage of hemoglobin|Mean|8.53|8.53|Standard Deviation|0.76|0.76|||
4146148|NCT00866658|3970214|B2|||Glycosylated Hemoglobin (HbA1c)||percentage of hemoglobin|Mean|8.54|8.54|Standard Deviation|0.73|0.73|||
4146149|NCT00866658|3970215|B1|||Glycosylated Hemoglobin (HbA1c)||percentage of hemoglobin|Mean|8.52|8.52|Standard Deviation|0.78|0.78|||
4146150|NCT00866658|3970213|B3|Ethnicity: Non Hispanic||Race/Ethnicity, Customized||participants|Number|311|311.0||||||
4146151|NCT00866658|3970214|B2|Ethnicity: Non Hispanic||Race/Ethnicity, Customized||participants|Number|154|154.0||||||
4146152|NCT00866658|3970215|B1|Ethnicity: Non Hispanic||Race/Ethnicity, Customized||participants|Number|157|157.0||||||
4146153|NCT00866658|3970213|B3|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|311|311.0||||||
4146154|NCT00866658|3970214|B2|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|154|154.0||||||
4146155|NCT00866658|3970215|B1|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|157|157.0||||||
4146156|NCT00866658|3970213|B3||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4146157|NCT00866658|3970214|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4146158|NCT00866658|3970215|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4146159|NCT00866658|3970213|B3||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4146160|NCT00866658|3970214|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4146161|NCT00866658|3970215|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4146162|NCT00866658|3970213|B3|||Age||years|Mean|58.4|58.4|Standard Deviation|10.2|10.2|||
4146163|NCT00866658|3970214|B2|||Age||years|Mean|58.7|58.7|Standard Deviation|10.2|10.2|||
4146164|NCT00866658|3970215|B1|||Age||years|Mean|58.0|58.0|Standard Deviation|10.1|10.1|||
4146165|NCT00866606|3970244|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4146166|NCT00866606|3970244|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4146167|NCT00866606|3970244|B1|||Age||Years|Mean|25.7|25.7|Standard Deviation|13.6|13.6|||
4146168|NCT00866359|3970256|B3|||Duration of Behçet’s disease|At the time of diagnosis, participants must meet the 1990 International Study Group criteria for Behçet’s Disease. In the absence of other clinical explanations, participants must have: recurrent oral ulceration (apthous or herpetiform) recurring at least 3 times in a 12-month period, plus at least two of the following criteria: 1. Recurrent Genital Ulceration, 2. Eye Lesions, 3. Skin Lesions, 4. Positive Result on Pathergy Testing.|years|Mean|5.33|5.33|Standard Deviation|5.143|5.143|||
4146169|NCT00866359|3970257|B2|||Duration of Behçet’s disease|At the time of diagnosis, participants must meet the 1990 International Study Group criteria for Behçet’s Disease. In the absence of other clinical explanations, participants must have: recurrent oral ulceration (apthous or herpetiform) recurring at least 3 times in a 12-month period, plus at least two of the following criteria: 1. Recurrent Genital Ulceration, 2. Eye Lesions, 3. Skin Lesions, 4. Positive Result on Pathergy Testing.|years|Mean|4.92|4.92|Standard Deviation|3.982|3.982|||
4146170|NCT00866359|3970258|B1|||Duration of Behçet’s disease|At the time of diagnosis, participants must meet the 1990 International Study Group criteria for Behçet’s Disease. In the absence of other clinical explanations, participants must have: recurrent oral ulceration (apthous or herpetiform) recurring at least 3 times in a 12-month period, plus at least two of the following criteria: 1. Recurrent Genital Ulceration, 2. Eye Lesions, 3. Skin Lesions, 4. Positive Result on Pathergy Testing.|years|Mean|5.72|5.72|Standard Deviation|6.084|6.084|||
4146171|NCT00866359|3970256|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4146172|NCT00866359|3970257|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4146173|NCT00866359|3970258|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4146174|NCT00866359|3970256|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4146175|NCT00866359|3970257|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4146176|NCT00866359|3970258|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4146177|NCT00866359|3970256|B3|||Age||years|Mean|34.5|34.5|Standard Deviation|10.05|10.05|||
4146178|NCT00866359|3970257|B2|||Age||years|Mean|34.3|34.3|Standard Deviation|9.11|9.11|||
4146179|NCT00866359|3970258|B1|||Age||years|Mean|34.7|34.7|Standard Deviation|10.97|10.97|||
4146180|NCT00866320|3970314|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
4146181|NCT00866320|3970314|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4146182|NCT00866320|3970314|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4146183|NCT00866320|3970314|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|8.1|8.1|||
4146184|NCT00866307|3970321|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4146185|NCT00866307|3970321|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146186|NCT00866307|3970321|B1||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4146187|NCT00866307|3970321|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4146188|NCT00866307|3970321|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4146189|NCT00866307|3970321|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4146190|NCT00866307|3970321|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146191|NCT00866307|3970321|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4146192|NCT00866307|3970321|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4146193|NCT00866307|3970321|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4146194|NCT00866307|3970321|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4146195|NCT00866307|3970321|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4146196|NCT00866307|3970321|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4146197|NCT00866307|3970321|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4146199|NCT00866294|3970330|B4|Asian - Japanese Heritage||Race/Ethnicity, Customized|The number of participants is based on the Full Analysis Set (FAS), consisting of all participants who entered the treatment phase, excluding those who had taken no dose of the investigational product for the treatment phase and those who had no data on the Hamilton Depression Rating Scale (HAM-D) total score after the start of the treatment phase.|participants|Number|365|365.0||||||
4146200|NCT00866294|3970331|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized|The number of participants is based on the Full Analysis Set (FAS), consisting of all participants who entered the treatment phase, excluding those who had taken no dose of the investigational product for the treatment phase and those who had no data on the Hamilton Depression Rating Scale (HAM-D) total score after the start of the treatment phase.|participants|Number|73|73.0||||||
4146201|NCT00866294|3970332|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized|The number of participants is based on the Full Analysis Set (FAS), consisting of all participants who entered the treatment phase, excluding those who had taken no dose of the investigational product for the treatment phase and those who had no data on the Hamilton Depression Rating Scale (HAM-D) total score after the start of the treatment phase.|participants|Number|138|138.0||||||
4146202|NCT00866294|3970333|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized|The number of participants is based on the Full Analysis Set (FAS), consisting of all participants who entered the treatment phase, excluding those who had taken no dose of the investigational product for the treatment phase and those who had no data on the Hamilton Depression Rating Scale (HAM-D) total score after the start of the treatment phase.|participants|Number|154|154.0||||||
4146203|NCT00866294|3970330|B4|Asian - East Asian Heritage||Race/Ethnicity, Customized|The number of participants is based on the Full Analysis Set (FAS), consisting of all participants who entered the treatment phase, excluding those who had taken no dose of the investigational product for the treatment phase and those who had no data on the Hamilton Depression Rating Scale (HAM-D) total score after the start of the treatment phase.|participants|Number|47|47.0||||||
4146204|NCT00866294|3970331|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized|The number of participants is based on the Full Analysis Set (FAS), consisting of all participants who entered the treatment phase, excluding those who had taken no dose of the investigational product for the treatment phase and those who had no data on the Hamilton Depression Rating Scale (HAM-D) total score after the start of the treatment phase.|participants|Number|10|10.0||||||
4146205|NCT00866294|3970332|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized|The number of participants is based on the Full Analysis Set (FAS), consisting of all participants who entered the treatment phase, excluding those who had taken no dose of the investigational product for the treatment phase and those who had no data on the Hamilton Depression Rating Scale (HAM-D) total score after the start of the treatment phase.|participants|Number|20|20.0||||||
4146206|NCT00866294|3970333|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized|The number of participants is based on the Full Analysis Set (FAS), consisting of all participants who entered the treatment phase, excluding those who had taken no dose of the investigational product for the treatment phase and those who had no data on the Hamilton Depression Rating Scale (HAM-D) total score after the start of the treatment phase.|participants|Number|17|17.0||||||
4146207|NCT00866294|3970330|B4||Male|Gender||Participants|Count of Participants|188|188.0||||||
4146208|NCT00866294|3970331|B3||Male|Gender||Participants|Count of Participants|35|35.0||||||
4146209|NCT00866294|3970332|B2||Male|Gender||Participants|Count of Participants|75|75.0||||||
4146210|NCT00866294|3970333|B1||Male|Gender||Participants|Count of Participants|78|78.0||||||
4146211|NCT00866294|3970330|B4||Female|Gender||Participants|Count of Participants|228|228.0||||||
4146212|NCT00866294|3970331|B3||Female|Gender||Participants|Count of Participants|48|48.0||||||
4146213|NCT00866294|3970332|B2||Female|Gender||Participants|Count of Participants|86|86.0||||||
4146214|NCT00866294|3970333|B1||Female|Gender||Participants|Count of Participants|94|94.0||||||
4146215|NCT00866294|3970330|B4|||Age||Years|Mean|36.4|36.4|Standard Deviation|10.62|10.62|||
4146216|NCT00866294|3970331|B3|||Age||Years|Mean|35.5|35.5|Standard Deviation|10.38|10.38|||
4146217|NCT00866294|3970332|B2|||Age||Years|Mean|36.4|36.4|Standard Deviation|11.36|11.36|||
4146218|NCT00866294|3970333|B1|||Age||Years|Mean|36.8|36.8|Standard Deviation|10.04|10.04|||
4146219|NCT00866281|3970362|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4146220|NCT00866281|3970363|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4146221|NCT00866281|3970364|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4146222|NCT00866281|3970362|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4146223|NCT00866281|3970363|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4146224|NCT00866281|3970364|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4146225|NCT00866281|3970362|B3|Adolescents (12-­17 years)||Age, Customized||participants|Number|9|9.0||||||
4146226|NCT00866281|3970363|B2|Adolescents (12-­17 years)||Age, Customized||participants|Number|5|5.0||||||
4146227|NCT00866281|3970364|B1|Adolescents (12-­17 years)||Age, Customized||participants|Number|4|4.0||||||
4146228|NCT00866281|3970362|B3|Children (2-­11 years)||Age, Customized||participants|Number|2|2.0||||||
4146229|NCT00866281|3970363|B2|Children (2-­11 years)||Age, Customized||participants|Number|1|1.0||||||
4146230|NCT00866281|3970364|B1|Children (2-­11 years)||Age, Customized||participants|Number|1|1.0||||||
4146231|NCT00866281|3970362|B3|Infants and toddlers (28 days-23 months)||Age, Customized||participants|Number|11|11.0||||||
4146232|NCT00866281|3970363|B2|Infants and toddlers (28 days-23 months)||Age, Customized||participants|Number|9|9.0||||||
4146233|NCT00866281|3970364|B1|Infants and toddlers (28 days-23 months)||Age, Customized||participants|Number|2|2.0||||||
4146234|NCT00866281|3970362|B3|||Age||years|Mean|7.50|7.5|Standard Deviation|7.070|7.07|||
4146235|NCT00866281|3970363|B2|||Age||years|Mean|6.50|6.5|Standard Deviation|6.903|6.903|||
4146236|NCT00866281|3970364|B1|||Age||years|Mean|9.65|9.65|Standard Deviation|7.479|7.479|||
4146237|NCT00866177|3970381|B1|United States||Region of Enrollment||participants|Number|167|167.0||||||
4146238|NCT00866177|3970381|B1||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4146239|NCT00866177|3970381|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4146240|NCT00866177|3970381|B1||>=65 years|Age||Participants|Count of Participants|60|60.0||||||
4146241|NCT00866177|3970381|B1||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
4146242|NCT00866177|3970381|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4146243|NCT00866047|3970385|B1|Negative||ALK Status|Immunophenotype status with respect to anaplastic lymphoma kinase (ALK) protein|participants|Number|42|42.0||||||
4146244|NCT00866047|3970385|B1|Positive||ALK Status|Immunophenotype status with respect to anaplastic lymphoma kinase (ALK) protein|participants|Number|16|16.0||||||
4146245|NCT00866047|3970385|B1|3-5||Eastern Cooperative Oncology Group Performance Status|"0 = Normal activity~= Symptoms but ambulatory~= In bed <50% of the time~= In bed >50% of the time~= 100% bedridden~= Dead"|participants|Number|0|0.0||||||
4146246|NCT00866047|3970385|B1|2||Eastern Cooperative Oncology Group Performance Status|"0 = Normal activity~= Symptoms but ambulatory~= In bed <50% of the time~= In bed >50% of the time~= 100% bedridden~= Dead"|participants|Number|1|1.0||||||
4146247|NCT00866047|3970385|B1|1||Eastern Cooperative Oncology Group Performance Status|"0 = Normal activity~= Symptoms but ambulatory~= In bed <50% of the time~= In bed >50% of the time~= 100% bedridden~= Dead"|participants|Number|38|38.0||||||
4146248|NCT00866047|3970385|B1|0||Eastern Cooperative Oncology Group Performance Status|"0 = Normal activity~= Symptoms but ambulatory~= In bed <50% of the time~= In bed >50% of the time~= 100% bedridden~= Dead"|participants|Number|19|19.0||||||
4146249|NCT00866047|3970385|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4146250|NCT00866047|3970385|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146251|NCT00866047|3970385|B1||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4146252|NCT00866047|3970385|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4146253|NCT00866047|3970385|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146254|NCT00866047|3970385|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4146255|NCT00866047|3970385|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146256|NCT00866047|3970385|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4146257|NCT00866047|3970385|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4146258|NCT00866047|3970385|B1|||Age, Customized||years|Median|52.0|52.0|Full Range|||14.0|76.0|
4146259|NCT00866034|3970401|B3|Netherlands||Region of Enrollment||participants|Number|617|617.0||||||
4146260|NCT00866034|3970402|B2|Netherlands||Region of Enrollment||participants|Number|309|309.0||||||
4146261|NCT00866034|3970403|B1|Netherlands||Region of Enrollment||participants|Number|308|308.0||||||
4146262|NCT00866034|3970401|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4146263|NCT00866034|3970402|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4146264|NCT00866034|3970403|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4146265|NCT00866034|3970401|B3||Female|Sex: Female, Male||Participants|Count of Participants|617|617.0||||||
4146266|NCT00866034|3970402|B2||Female|Sex: Female, Male||Participants|Count of Participants|309|309.0||||||
4146267|NCT00866034|3970403|B1||Female|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
4146268|NCT00866034|3970401|B3|||Age||years|Mean|32.2|32.2|Standard Deviation|4.0|4.0|||
4146269|NCT00866034|3970402|B2|||Age||years|Mean|32.2|32.2|Standard Deviation|4.2|4.2|||
4146270|NCT00866034|3970403|B1|||Age||years|Mean|32.1|32.1|Standard Deviation|3.9|3.9|||
4146271|NCT00866034|3970401|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4146272|NCT00866034|3970402|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4146273|NCT00866034|3970403|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4146274|NCT00866034|3970401|B3||Between 18 and 65 years|Age||Participants|Count of Participants|617|617.0||||||
4146275|NCT00866034|3970402|B2||Between 18 and 65 years|Age||Participants|Count of Participants|309|309.0||||||
4146276|NCT00866034|3970403|B1||Between 18 and 65 years|Age||Participants|Count of Participants|308|308.0||||||
4146277|NCT00866034|3970401|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4146278|NCT00866034|3970402|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4146279|NCT00866034|3970403|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4146280|NCT00865904|3970412|B6||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4146281|NCT00865904|3970413|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4146282|NCT00865904|3970414|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4146283|NCT00865904|3970415|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4146284|NCT00865904|3970416|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4146285|NCT00865904|3970417|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4146286|NCT00865904|3970412|B6||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4146287|NCT00865904|3970413|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4146288|NCT00865904|3970414|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4146289|NCT00865904|3970415|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4146290|NCT00865904|3970416|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4146291|NCT00865904|3970417|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4146292|NCT00865904|3970412|B6|||Age||years|Mean|28.6|28.6|Standard Deviation|9.1|9.1|||
4146293|NCT00865904|3970413|B5|||Age||years|Mean|26.7|26.7|Standard Deviation|6.82|6.82|||
4146294|NCT00865904|3970414|B4|||Age||years|Mean|30.1|30.1|Standard Deviation|11.55|11.55|||
4146295|NCT00865904|3970415|B3|||Age||years|Mean|27.1|27.1|Standard Deviation|8.20|8.2|||
4146296|NCT00865904|3970416|B2|||Age||years|Mean|27.7|27.7|Standard Deviation|8.98|8.98|||
4146297|NCT00865904|3970417|B1|||Age||years|Mean|31.5|31.5|Standard Deviation|9.35|9.35|||
4146298|NCT00865709|3970476|B3|Missing||KRAS|Kirsten rat sarcoma viral oncogene homolog (KRAS)|Participants|Number|39|39.0||||||
4146299|NCT00865709|3970477|B2|Missing||KRAS|Kirsten rat sarcoma viral oncogene homolog (KRAS)|Participants|Number|17|17.0||||||
4146300|NCT00865709|3970478|B1|Missing||KRAS|Kirsten rat sarcoma viral oncogene homolog (KRAS)|Participants|Number|22|22.0||||||
4146301|NCT00865709|3970476|B3|Wild-Type||KRAS|Kirsten rat sarcoma viral oncogene homolog (KRAS)|Participants|Number|83|83.0||||||
4146302|NCT00865709|3970477|B2|Wild-Type||KRAS|Kirsten rat sarcoma viral oncogene homolog (KRAS)|Participants|Number|41|41.0||||||
4146303|NCT00865709|3970478|B1|Wild-Type||KRAS|Kirsten rat sarcoma viral oncogene homolog (KRAS)|Participants|Number|42|42.0||||||
4146304|NCT00865709|3970476|B3|Mutant||KRAS|Kirsten rat sarcoma viral oncogene homolog (KRAS)|Participants|Number|76|76.0||||||
4146305|NCT00865709|3970477|B2|Mutant||KRAS|Kirsten rat sarcoma viral oncogene homolog (KRAS)|Participants|Number|43|43.0||||||
4146306|NCT00865709|3970478|B1|Mutant||KRAS|Kirsten rat sarcoma viral oncogene homolog (KRAS)|Participants|Number|33|33.0||||||
4146307|NCT00865709|3970476|B3|>=3||Number of metastatic sites by Principal Investigator|Number of metastatic sites by Principal Investigator|Participants|Number|56|56.0||||||
4146308|NCT00865709|3970477|B2|>=3||Number of metastatic sites by Principal Investigator|Number of metastatic sites by Principal Investigator|Participants|Number|30|30.0||||||
4146309|NCT00865709|3970478|B1|>=3||Number of metastatic sites by Principal Investigator|Number of metastatic sites by Principal Investigator|Participants|Number|26|26.0||||||
4146310|NCT00865709|3970476|B3|<3||Number of metastatic sites by Principal Investigator|Number of metastatic sites by Principal Investigator|Participants|Number|142|142.0||||||
4146311|NCT00865709|3970477|B2|<3||Number of metastatic sites by Principal Investigator|Number of metastatic sites by Principal Investigator|Participants|Number|71|71.0||||||
4146312|NCT00865709|3970478|B1|<3||Number of metastatic sites by Principal Investigator|Number of metastatic sites by Principal Investigator|Participants|Number|71|71.0||||||
4146313|NCT00865709|3970476|B3|No||Liver metastases by Principal Investigator|Liver metastases by Principal Investigator|Participants|Number|38|38.0||||||
4146314|NCT00865709|3970477|B2|No||Liver metastases by Principal Investigator|Liver metastases by Principal Investigator|Participants|Number|20|20.0||||||
4146315|NCT00865709|3970478|B1|No||Liver metastases by Principal Investigator|Liver metastases by Principal Investigator|Participants|Number|18|18.0||||||
4146316|NCT00865709|3970476|B3|Yes||Liver metastases by Principal Investigator|Liver metastases by Principal Investigator|Participants|Number|160|160.0||||||
4146317|NCT00865709|3970477|B2|Yes||Liver metastases by Principal Investigator|Liver metastases by Principal Investigator|Participants|Number|81|81.0||||||
4146318|NCT00865709|3970478|B1|Yes||Liver metastases by Principal Investigator|Liver metastases by Principal Investigator|Participants|Number|79|79.0||||||
4146319|NCT00865709|3970476|B3|||Time since initial diagnosis|Time since initial diagnosis was the mean time from initial diagnosis to randomization into the study.|Months|Mean|9.5|9.5|Standard Deviation|16.6|16.6|||
4146320|NCT00865709|3970477|B2|||Time since initial diagnosis|Time since initial diagnosis was the mean time from initial diagnosis to randomization into the study.|Months|Mean|9.2|9.2|Standard Deviation|16.9|16.9|||
4146321|NCT00865709|3970478|B1|||Time since initial diagnosis|Time since initial diagnosis was the mean time from initial diagnosis to randomization into the study.|Months|Mean|9.8|9.8|Standard Deviation|16.2|16.2|||
4146322|NCT00865709|3970476|B3|||Stage of Disease at study entry (TNM Classification, Stage IV)|The TNM (Tumor, Nodes, Metastasis) classification is a three-dimensional solid tumor classification system. The “T” dimension categorizes the size and degree of tumor spreading on an ordinal scale from T0 (best) to T4 (worst). The “N” dimension categorizes the degree of spreading of the tumor into lymph nodes on an ordinal scale from N0 (best) to N3 (worst). The “M” dimension categorizes whether or not the cancer has metastases beyond the lymph nodes on an ordinal scale from M0 (no metastases) to M1 (metastases). All of the 198 randomized patients were at Stage IV of disease.|Participants|Number|198|198.0||||||
4146323|NCT00865709|3970477|B2|||Stage of Disease at study entry (TNM Classification, Stage IV)|The TNM (Tumor, Nodes, Metastasis) classification is a three-dimensional solid tumor classification system. The “T” dimension categorizes the size and degree of tumor spreading on an ordinal scale from T0 (best) to T4 (worst). The “N” dimension categorizes the degree of spreading of the tumor into lymph nodes on an ordinal scale from N0 (best) to N3 (worst). The “M” dimension categorizes whether or not the cancer has metastases beyond the lymph nodes on an ordinal scale from M0 (no metastases) to M1 (metastases). All of the 198 randomized patients were at Stage IV of disease.|Participants|Number|101|101.0||||||
4146324|NCT00865709|3970478|B1|||Stage of Disease at study entry (TNM Classification, Stage IV)|The TNM (Tumor, Nodes, Metastasis) classification is a three-dimensional solid tumor classification system. The “T” dimension categorizes the size and degree of tumor spreading on an ordinal scale from T0 (best) to T4 (worst). The “N” dimension categorizes the degree of spreading of the tumor into lymph nodes on an ordinal scale from N0 (best) to N3 (worst). The “M” dimension categorizes whether or not the cancer has metastases beyond the lymph nodes on an ordinal scale from M0 (no metastases) to M1 (metastases). All of the 198 randomized patients were at Stage IV of disease.|Participants|Number|97|97.0||||||
4146325|NCT00865709|3970476|B3|5= Dead||ECOG (Eastern Cooperative Oncology Group) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|0|0.0||||||
4146326|NCT00865709|3970477|B2|5= Dead||ECOG (Eastern Cooperative Oncology Group) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|0|0.0||||||
4146359|NCT00865709|3970477|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4146327|NCT00865709|3970478|B1|5= Dead||ECOG (Eastern Cooperative Oncology Group) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|0|0.0||||||
4146328|NCT00865709|3970476|B3|4= Completely disabled||ECOG (Eastern Cooperative Oncology Group) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|0|0.0||||||
4146329|NCT00865709|3970477|B2|4= Completely disabled||ECOG (Eastern Cooperative Oncology Group) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|0|0.0||||||
4146330|NCT00865709|3970478|B1|4= Completely disabled||ECOG (Eastern Cooperative Oncology Group) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|0|0.0||||||
4146331|NCT00865709|3970476|B3|3= Capable of limited selfcare||ECOG (Eastern Cooperative Oncology Group) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|0|0.0||||||
4146332|NCT00865709|3970477|B2|3= Capable of limited selfcare||ECOG (Eastern Cooperative Oncology Group) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|0|0.0||||||
4146333|NCT00865709|3970478|B1|3= Capable of limited selfcare||ECOG (Eastern Cooperative Oncology Group) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|0|0.0||||||
4146334|NCT00865709|3970476|B3|2= Ambulatory, capable of all selfcare||ECOG (Eastern Cooperative Oncology Group) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|0|0.0||||||
4146335|NCT00865709|3970477|B2|2= Ambulatory, capable of all selfcare||ECOG (Eastern Cooperative Oncology Group) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|0|0.0||||||
4146336|NCT00865709|3970478|B1|2= Ambulatory, capable of all selfcare||ECOG (Eastern Cooperative Oncology Group) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|0|0.0||||||
4146337|NCT00865709|3970476|B3|1= Restricted in physically strenuous activity||ECOG (Eastern Cooperative Oncology Group) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|128|128.0||||||
4146338|NCT00865709|3970477|B2|1= Restricted in physically strenuous activity||ECOG (Eastern Cooperative Oncology Group) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|65|65.0||||||
4146339|NCT00865709|3970478|B1|1= Restricted in physically strenuous activity||ECOG (Eastern Cooperative Oncology Group) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|63|63.0||||||
4146340|NCT00865709|3970476|B3|0=Fully active without restriction||ECOG (Eastern Cooperative Oncology Group) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|70|70.0||||||
4146341|NCT00865709|3970477|B2|0=Fully active without restriction||ECOG (Eastern Cooperative Oncology Group) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|36|36.0||||||
4146342|NCT00865709|3970478|B1|0=Fully active without restriction||ECOG (Eastern Cooperative Oncology Group) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|34|34.0||||||
4146343|NCT00865709|3970476|B3|United Kingdom||Region of Enrollment||participants|Number|26|26.0||||||
4146344|NCT00865709|3970477|B2|United Kingdom||Region of Enrollment||participants|Number|14|14.0||||||
4146345|NCT00865709|3970478|B1|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
4146346|NCT00865709|3970476|B3|Russian Federation||Region of Enrollment||participants|Number|106|106.0||||||
4146347|NCT00865709|3970477|B2|Russian Federation||Region of Enrollment||participants|Number|52|52.0||||||
4146348|NCT00865709|3970478|B1|Russian Federation||Region of Enrollment||participants|Number|54|54.0||||||
4146349|NCT00865709|3970476|B3|Romania||Region of Enrollment||participants|Number|11|11.0||||||
4146350|NCT00865709|3970477|B2|Romania||Region of Enrollment||participants|Number|8|8.0||||||
4146351|NCT00865709|3970478|B1|Romania||Region of Enrollment||participants|Number|3|3.0||||||
4146352|NCT00865709|3970476|B3|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4146353|NCT00865709|3970477|B2|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
4146354|NCT00865709|3970478|B1|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4146355|NCT00865709|3970476|B3|Spain||Region of Enrollment||participants|Number|50|50.0||||||
4146356|NCT00865709|3970477|B2|Spain||Region of Enrollment||participants|Number|25|25.0||||||
4146357|NCT00865709|3970478|B1|Spain||Region of Enrollment||participants|Number|25|25.0||||||
4146358|NCT00865709|3970476|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4146360|NCT00865709|3970478|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4146361|NCT00865709|3970476|B3||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4146362|NCT00865709|3970477|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4146363|NCT00865709|3970478|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4146364|NCT00865709|3970476|B3||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4146365|NCT00865709|3970477|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4146366|NCT00865709|3970478|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4146367|NCT00865709|3970476|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|9.3|9.3|||
4146368|NCT00865709|3970477|B2|||Age||years|Mean|60.3|60.3|Standard Deviation|8.3|8.3|||
4146369|NCT00865709|3970478|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|10.3|10.3|||
4146370|NCT00865514|3970495|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4146371|NCT00865514|3970495|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4146372|NCT00865514|3970495|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4146373|NCT00865514|3970495|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4146374|NCT00865514|3970495|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4146375|NCT00865514|3970495|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4146376|NCT00865345|3970500|B1|United States||Region of Enrollment||participants|Number|63|63.0||||||
4146377|NCT00865345|3970500|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4146378|NCT00865345|3970500|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4146379|NCT00865345|3970500|B1|||Age||years|Mean|38.7|38.7|Standard Deviation|13.71|13.71|||
4146380|NCT00865345|3970500|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4146381|NCT00865345|3970500|B1||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4146382|NCT00865345|3970500|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4146383|NCT00865306|3970505|B3|United States||Region of Enrollment||participants|Number|64|64.0||||||
4146384|NCT00865306|3970506|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4146385|NCT00865306|3970507|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4146386|NCT00865306|3970505|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4146387|NCT00865306|3970506|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4146388|NCT00865306|3970507|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4146389|NCT00865306|3970505|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4146390|NCT00865306|3970506|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4146391|NCT00865306|3970507|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4146392|NCT00865306|3970505|B3|||Age|The mean age of the children was 5.4 years (SD 1.0). This value did not differ between groups.|years|Mean|5.4|5.4|Standard Deviation|1.0|1.0|||
4146393|NCT00865306|3970506|B2|||Age|The mean age of the children was 5.4 years (SD 1.0). This value did not differ between groups.|years|Mean|5.4|5.4|Standard Deviation|1.0|1.0|||
4146394|NCT00865306|3970507|B1|||Age|The mean age of the children was 5.4 years (SD 1.0). This value did not differ between groups.|years|Mean|5.4|5.4|Standard Deviation|1.0|1.0|||
4146395|NCT00865306|3970505|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4146396|NCT00865306|3970506|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4146397|NCT00865306|3970507|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4146398|NCT00865306|3970505|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4146399|NCT00865306|3970506|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4146400|NCT00865306|3970507|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4146401|NCT00865306|3970505|B3||<=18 years|Age||Participants|Count of Participants|64|64.0||||||
4146402|NCT00865306|3970506|B2||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4146403|NCT00865306|3970507|B1||<=18 years|Age||Participants|Count of Participants|34|34.0||||||
4146404|NCT00865202|3970518|B3|United States||Region of Enrollment||participants|Number|301|301.0||||||
4146405|NCT00865202|3970519|B2|United States||Region of Enrollment||participants|Number|149|149.0||||||
4146406|NCT00865202|3970520|B1|United States||Region of Enrollment||participants|Number|152|152.0||||||
4146407|NCT00865202|3970518|B3||Male|Sex: Female, Male||Participants|Count of Participants|295|295.0||||||
4146408|NCT00865202|3970519|B2||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4146409|NCT00865202|3970520|B1||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4146410|NCT00865202|3970518|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4146411|NCT00865202|3970519|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4146412|NCT00865202|3970520|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4146413|NCT00865202|3970518|B3|Overall Study||Age||years|Mean|69|69.0|Standard Deviation|7|7.0|||
4146414|NCT00865202|3970519|B2|Overall Study||Age||years|Mean|69|69.0|Standard Deviation|8|8.0|||
4146415|NCT00865202|3970520|B1|Overall Study||Age||years|Mean|69|69.0|Standard Deviation|7|7.0|||
4146416|NCT00865189|3970535|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4146417|NCT00865189|3970536|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4146418|NCT00865189|3970537|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4146419|NCT00865189|3970535|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4146420|NCT00865189|3970536|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4146421|NCT00865189|3970537|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4146422|NCT00865189|3970535|B3||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4146423|NCT00865189|3970536|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4146424|NCT00865189|3970537|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4146425|NCT00865189|3970535|B3||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4146426|NCT00865189|3970536|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4146427|NCT00865189|3970537|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4146428|NCT00865189|3970535|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4146429|NCT00865189|3970536|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4146430|NCT00865189|3970537|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4146431|NCT00865124|3970563|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4146432|NCT00865124|3970564|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4146433|NCT00865124|3970565|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4146434|NCT00865124|3970566|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4146435|NCT00865124|3970563|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4146436|NCT00865124|3970564|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4146437|NCT00865124|3970565|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4146438|NCT00865124|3970566|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4146439|NCT00865124|3970563|B4|||Age||years|Mean|54.72|54.72|Standard Deviation|7.66|7.66|||
4146440|NCT00865124|3970564|B3|||Age||years|Mean|55|55.0|Standard Deviation|10|10.0|||
4146441|NCT00865124|3970565|B2|||Age||years|Mean|53|53.0|Standard Deviation|7|7.0|||
4146442|NCT00865124|3970566|B1|||Age||years|Mean|56|56.0|Standard Deviation|6|6.0|||
4146443|NCT00865098|3970585|B1|Japan||Region of Enrollment||participants|Number|22|22.0||||||
4146444|NCT00865098|3970585|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4146445|NCT00865098|3970585|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4146446|NCT00865098|3970585|B1|||Age||years|Mean|67.6|67.6|Standard Deviation|6.59|6.59|||
4146447|NCT00865098|3970585|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4146448|NCT00865098|3970585|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4146449|NCT00865098|3970585|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4146450|NCT00865046|3970594|B4|||Arthritis Self-Efficacy score, other symptoms|This is the other symptoms subscale of The Arthritis Self-Efficacy Scale (ASES). The ASES consists of 20 questions divided into three subscales: physical function (9 questions), other symptoms (6 questions) and pain (5 questions). Participants are asked about their level of certainty that they can perform each task. Each question is scored from 10 = very uncertain to 100 = very certain. Each subscale is scored separately by taking the mean score of the items. Higher scores indicate higher self-efficacy. The range for the other symptoms subscale is 10 to 100.|units on a scale|Mean|68.3|68.3|Standard Deviation|20.8|20.8|||
4146451|NCT00865046|3970595|B3|||Arthritis Self-Efficacy score, other symptoms|This is the other symptoms subscale of The Arthritis Self-Efficacy Scale (ASES). The ASES consists of 20 questions divided into three subscales: physical function (9 questions), other symptoms (6 questions) and pain (5 questions). Participants are asked about their level of certainty that they can perform each task. Each question is scored from 10 = very uncertain to 100 = very certain. Each subscale is scored separately by taking the mean score of the items. Higher scores indicate higher self-efficacy. The range for the other symptoms subscale is 10 to 100.|units on a scale|Mean|68.6|68.6|Standard Deviation|20.9|20.9|||
4146452|NCT00865046|3970596|B2|||Arthritis Self-Efficacy score, other symptoms|This is the other symptoms subscale of The Arthritis Self-Efficacy Scale (ASES). The ASES consists of 20 questions divided into three subscales: physical function (9 questions), other symptoms (6 questions) and pain (5 questions). Participants are asked about their level of certainty that they can perform each task. Each question is scored from 10 = very uncertain to 100 = very certain. Each subscale is scored separately by taking the mean score of the items. Higher scores indicate higher self-efficacy. The range for the other symptoms subscale is 10 to 100.|units on a scale|Mean|65.9|65.9|Standard Deviation|20.3|20.3|||
4146453|NCT00865046|3970597|B1|||Arthritis Self-Efficacy score, other symptoms|This is the other symptoms subscale of The Arthritis Self-Efficacy Scale (ASES). The ASES consists of 20 questions divided into three subscales: physical function (9 questions), other symptoms (6 questions) and pain (5 questions). Participants are asked about their level of certainty that they can perform each task. Each question is scored from 10 = very uncertain to 100 = very certain. Each subscale is scored separately by taking the mean score of the items. Higher scores indicate higher self-efficacy. The range for the other symptoms subscale is 10 to 100.|units on a scale|Mean|70.5|70.5|Standard Deviation|21.1|21.1|||
4146454|NCT00865046|3970594|B4|||Arthritis Self-Efficacy score, function|This is the physical function subscale of The Arthritis Self-Efficacy Scale (ASES). The ASES consists of 20 questions divided into three subscales: physical function (9 questions), other symptoms (6 questions) and pain (5 questions). Participants are asked about their level of certainty that they can perform each task. Each question is scored from 10 = very uncertain to 100 = very certain. Each subscale is scored separately by taking the mean score of the items. Higher scores indicate higher self-efficacy. The range for the physical function subscale is 10 to 100.|units on a scale|Mean|76.6|76.6|Standard Deviation|16.8|16.8|||
4146479|NCT00865046|3970595|B3|||Cognitive Strategies Questionnaire, catastrophizing scale|The catastrophizing scale of the Cognitive Strategies Questionnaire consists of 6 items, each scored from 0 (never state that) to 6 (always state that). The scoring range on the instrument is 0 (best pain coping) to 36 (worst pain coping).|units on a scale|Mean|8.8|8.8|Standard Deviation|9.2|9.2|||
4146546|NCT00865046|3970594|B4||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4146455|NCT00865046|3970595|B3|||Arthritis Self-Efficacy score, function|This is the physical function subscale of The Arthritis Self-Efficacy Scale (ASES). The ASES consists of 20 questions divided into three subscales: physical function (9 questions), other symptoms (6 questions) and pain (5 questions). Participants are asked about their level of certainty that they can perform each task. Each question is scored from 10 = very uncertain to 100 = very certain. Each subscale is scored separately by taking the mean score of the items. Higher scores indicate higher self-efficacy. The range for the physical function subscale is 10 to 100.|units on a scale|Mean|76.1|76.1|Standard Deviation|16.4|16.4|||
4146456|NCT00865046|3970596|B2|||Arthritis Self-Efficacy score, function|This is the physical function subscale of The Arthritis Self-Efficacy Scale (ASES). The ASES consists of 20 questions divided into three subscales: physical function (9 questions), other symptoms (6 questions) and pain (5 questions). Participants are asked about their level of certainty that they can perform each task. Each question is scored from 10 = very uncertain to 100 = very certain. Each subscale is scored separately by taking the mean score of the items. Higher scores indicate higher self-efficacy. The range for the physical function subscale is 10 to 100.|units on a scale|Mean|76.3|76.3|Standard Deviation|16.9|16.9|||
4146457|NCT00865046|3970597|B1|||Arthritis Self-Efficacy score, function|This is the physical function subscale of The Arthritis Self-Efficacy Scale (ASES). The ASES consists of 20 questions divided into three subscales: physical function (9 questions), other symptoms (6 questions) and pain (5 questions). Participants are asked about their level of certainty that they can perform each task. Each question is scored from 10 = very uncertain to 100 = very certain. Each subscale is scored separately by taking the mean score of the items. Higher scores indicate higher self-efficacy. The range for the physical function subscale is 10 to 100.|units on a scale|Mean|77.5|77.5|Standard Deviation|17.0|17.0|||
4146458|NCT00865046|3970594|B4|||Arthritis Self-Efficacy score, pain|This is the pain subscale of The Arthritis Self-Efficacy Scale (ASES). The ASES consists of 20 questions divided into three subscales: physical function (9 questions), other symptoms (6 questions) and pain (5 questions). Participants are asked about their level of certainty that they can perform each task. Each question is scored from 10 = very uncertain to 100 = very certain. Each subscale is scored separately by taking the mean score of the items. Higher scores indicate higher self-efficacy. The range for the pain subscale is 10 to 100.|units on a scale|Mean|62.6|62.6|Standard Deviation|22|22.0|||
4146459|NCT00865046|3970595|B3|||Arthritis Self-Efficacy score, pain|This is the pain subscale of The Arthritis Self-Efficacy Scale (ASES). The ASES consists of 20 questions divided into three subscales: physical function (9 questions), other symptoms (6 questions) and pain (5 questions). Participants are asked about their level of certainty that they can perform each task. Each question is scored from 10 = very uncertain to 100 = very certain. Each subscale is scored separately by taking the mean score of the items. Higher scores indicate higher self-efficacy. The range for the pain subscale is 10 to 100.|units on a scale|Mean|63.9|63.9|Standard Deviation|21.7|21.7|||
4146460|NCT00865046|3970596|B2|||Arthritis Self-Efficacy score, pain|This is the pain subscale of The Arthritis Self-Efficacy Scale (ASES). The ASES consists of 20 questions divided into three subscales: physical function (9 questions), other symptoms (6 questions) and pain (5 questions). Participants are asked about their level of certainty that they can perform each task. Each question is scored from 10 = very uncertain to 100 = very certain. Each subscale is scored separately by taking the mean score of the items. Higher scores indicate higher self-efficacy. The range for the pain subscale is 10 to 100.|units on a scale|Mean|59.5|59.5|Standard Deviation|22.6|22.6|||
4146461|NCT00865046|3970597|B1|||Arthritis Self-Efficacy score, pain|This is the pain subscale of The Arthritis Self-Efficacy Scale (ASES). The ASES consists of 20 questions divided into three subscales: physical function (9 questions), other symptoms (6 questions) and pain (5 questions). Participants are asked about their level of certainty that they can perform each task. Each question is scored from 10 = very uncertain to 100 = very certain. Each subscale is scored separately by taking the mean score of the items. Higher scores indicate higher self-efficacy. The range for the pain subscale is 10 to 100.|units on a scale|Mean|64.3|64.3|Standard Deviation|21.6|21.6|||
4146462|NCT00865046|3970594|B4|||Duration of knee pain||years|Mean|6.4|6.4|Standard Deviation|7.2|7.2|||
4146463|NCT00865046|3970595|B3|||Duration of knee pain||years|Mean|7.2|7.2|Standard Deviation|8.3|8.3|||
4146464|NCT00865046|3970596|B2|||Duration of knee pain||years|Mean|6.2|6.2|Standard Deviation|6.8|6.8|||
4146465|NCT00865046|3970597|B1|||Duration of knee pain||years|Mean|5.7|5.7|Standard Deviation|6.4|6.4|||
4146466|NCT00865046|3970594|B4|||Mean number of opioids|Mean number of opioids per day|opioids|Mean|0.2|0.2|Standard Deviation|0.4|0.4|||
4146467|NCT00865046|3970595|B3|||Mean number of opioids|Mean number of opioids per day|opioids|Mean|0.2|0.2|Standard Deviation|0.4|0.4|||
4146468|NCT00865046|3970596|B2|||Mean number of opioids|Mean number of opioids per day|opioids|Mean|0.3|0.3|Standard Deviation|0.6|0.6|||
4146469|NCT00865046|3970597|B1|||Mean number of opioids|Mean number of opioids per day|opioids|Mean|0.1|0.1|Standard Deviation|0.3|0.3|||
4146470|NCT00865046|3970594|B4|||Mean number of pain medications|Mean number of pain medications per day|medication|Mean|1.1|1.1|Standard Deviation|0.9|0.9|||
4146471|NCT00865046|3970595|B3|||Mean number of pain medications|Mean number of pain medications per day|medication|Mean|1.0|1.0|Standard Deviation|0.9|0.9|||
4146472|NCT00865046|3970596|B2|||Mean number of pain medications|Mean number of pain medications per day|medication|Mean|1.2|1.2|Standard Deviation|0.9|0.9|||
4146473|NCT00865046|3970597|B1|||Mean number of pain medications|Mean number of pain medications per day|medication|Mean|1.1|1.1|Standard Deviation|1.0|1.0|||
4146474|NCT00865046|3970594|B4|||BMI||kg/m2|Mean|32.4|32.4|Standard Deviation|6.5|6.5|||
4146475|NCT00865046|3970595|B3|||BMI||kg/m2|Mean|32.5|32.5|Standard Deviation|6.9|6.9|||
4146476|NCT00865046|3970596|B2|||BMI||kg/m2|Mean|33.1|33.1|Standard Deviation|6.2|6.2|||
4146477|NCT00865046|3970597|B1|||BMI||kg/m2|Mean|31.6|31.6|Standard Deviation|6.5|6.5|||
4146478|NCT00865046|3970594|B4|||Cognitive Strategies Questionnaire, catastrophizing scale|The catastrophizing scale of the Cognitive Strategies Questionnaire consists of 6 items, each scored from 0 (never state that) to 6 (always state that). The scoring range on the instrument is 0 (best pain coping) to 36 (worst pain coping).|units on a scale|Mean|9.6|9.6|Standard Deviation|8.9|8.9|||
4146480|NCT00865046|3970596|B2|||Cognitive Strategies Questionnaire, catastrophizing scale|The catastrophizing scale of the Cognitive Strategies Questionnaire consists of 6 items, each scored from 0 (never state that) to 6 (always state that). The scoring range on the instrument is 0 (best pain coping) to 36 (worst pain coping).|units on a scale|Mean|12.1|12.1|Standard Deviation|9.7|9.7|||
4146481|NCT00865046|3970597|B1|||Cognitive Strategies Questionnaire, catastrophizing scale|The catastrophizing scale of the Cognitive Strategies Questionnaire consists of 6 items, each scored from 0 (never state that) to 6 (always state that). The scoring range on the instrument is 0 (best pain coping) to 36 (worst pain coping).|units on a scale|Mean|7.9|7.9|Standard Deviation|7.8|7.8|||
4146482|NCT00865046|3970594|B4|||CES-D|The Center for Epidemiological Studies-Depression (CES-D) scale is a measure of depressive symptoms. It is a 20 item. Each item is scored from 0 (rarely or none of the time) to 3 (most or all of the time). Scores range from 0 to 60, with high scores indicating greater depressive symptoms.|units on a scale|Mean|12.9|12.9|Standard Deviation|10.4|10.4|||
4146483|NCT00865046|3970595|B3|||CES-D|The Center for Epidemiological Studies-Depression (CES-D) scale is a measure of depressive symptoms. It is a 20 item. Each item is scored from 0 (rarely or none of the time) to 3 (most or all of the time). Scores range from 0 to 60, with high scores indicating greater depressive symptoms.|units on a scale|Mean|12.3|12.3|Standard Deviation|9.6|9.6|||
4146484|NCT00865046|3970596|B2|||CES-D|The Center for Epidemiological Studies-Depression (CES-D) scale is a measure of depressive symptoms. It is a 20 item. Each item is scored from 0 (rarely or none of the time) to 3 (most or all of the time). Scores range from 0 to 60, with high scores indicating greater depressive symptoms.|units on a scale|Mean|14.7|14.7|Standard Deviation|11.2|11.2|||
4146485|NCT00865046|3970597|B1|||CES-D|The Center for Epidemiological Studies-Depression (CES-D) scale is a measure of depressive symptoms. It is a 20 item. Each item is scored from 0 (rarely or none of the time) to 3 (most or all of the time). Scores range from 0 to 60, with high scores indicating greater depressive symptoms.|units on a scale|Mean|11.7|11.7|Standard Deviation|10.3|10.3|||
4146486|NCT00865046|3970594|B4|||Timed Up and Go|The Timed Up and Go (TUG) measures mobility and falls risk. The participant sits in a chair and is timed as (s)he stands up from the chair, walks 3 meters, turns around, walks back to the chair and sits down. The result is expressed in seconds. An older adult who takes at least 12 seconds to complete the TUG is at high risk for falling.|seconds|Mean|13.1|13.1|Standard Deviation|4.7|4.7|||
4146487|NCT00865046|3970595|B3|||Timed Up and Go|The Timed Up and Go (TUG) measures mobility and falls risk. The participant sits in a chair and is timed as (s)he stands up from the chair, walks 3 meters, turns around, walks back to the chair and sits down. The result is expressed in seconds. An older adult who takes at least 12 seconds to complete the TUG is at high risk for falling.|seconds|Mean|13.9|13.9|Standard Deviation|6.9|6.9|||
4146488|NCT00865046|3970596|B2|||Timed Up and Go|The Timed Up and Go (TUG) measures mobility and falls risk. The participant sits in a chair and is timed as (s)he stands up from the chair, walks 3 meters, turns around, walks back to the chair and sits down. The result is expressed in seconds. An older adult who takes at least 12 seconds to complete the TUG is at high risk for falling.|seconds|Mean|13.1|13.1|Standard Deviation|3.8|3.8|||
4146489|NCT00865046|3970597|B1|||Timed Up and Go|The Timed Up and Go (TUG) measures mobility and falls risk. The participant sits in a chair and is timed as (s)he stands up from the chair, walks 3 meters, turns around, walks back to the chair and sits down. The result is expressed in seconds. An older adult who takes at least 12 seconds to complete the TUG is at high risk for falling.|seconds|Mean|12.3|12.3|Standard Deviation|3.4|3.4|||
4146490|NCT00865046|3970594|B4|||Timed stair climb|Participants were timed as they ascended and descended 5 steps.|seconds|Mean|13.6|13.6|Standard Deviation|6.6|6.6|||
4146491|NCT00865046|3970595|B3|||Timed stair climb|Participants were timed as they ascended and descended 5 steps.|seconds|Mean|13.9|13.9|Standard Deviation|7.3|7.3|||
4146492|NCT00865046|3970596|B2|||Timed stair climb|Participants were timed as they ascended and descended 5 steps.|seconds|Mean|14.5|14.5|Standard Deviation|7.8|7.8|||
4146493|NCT00865046|3970597|B1|||Timed stair climb|Participants were timed as they ascended and descended 5 steps.|seconds|Mean|12.5|12.5|Standard Deviation|4.7|4.7|||
4146494|NCT00865046|3970594|B4|||Short Physical Performance Battery|"The SPPB measures performance on 3 items:~Repeated chair stands (number of stands and time to complete as well as a 0-4 ordinal scale))~Balance testing - semitandem stand, side-by-side stand, and tandem stand; each scored as 2 (held for 10 sec), 1 (held for less than 10 sec), 0 (not attempted) as well as a 0-4 ordinal scale for overall balance performance~8 foot walk - 0-4 scale according to velocity Summary ordinal score: 0 (worst performance) to 12 (best performance)"|units on a scale|Mean|6.1|6.1|Standard Deviation|1.7|1.7|||
4146495|NCT00865046|3970595|B3|||Short Physical Performance Battery|"The SPPB measures performance on 3 items:~Repeated chair stands (number of stands and time to complete as well as a 0-4 ordinal scale))~Balance testing - semitandem stand, side-by-side stand, and tandem stand; each scored as 2 (held for 10 sec), 1 (held for less than 10 sec), 0 (not attempted) as well as a 0-4 ordinal scale for overall balance performance~8 foot walk - 0-4 scale according to velocity Summary ordinal score: 0 (worst performance) to 12 (best performance)"|units on a scale|Mean|6.2|6.2|Standard Deviation|1.5|1.5|||
4146496|NCT00865046|3970596|B2|||Short Physical Performance Battery|"The SPPB measures performance on 3 items:~Repeated chair stands (number of stands and time to complete as well as a 0-4 ordinal scale))~Balance testing - semitandem stand, side-by-side stand, and tandem stand; each scored as 2 (held for 10 sec), 1 (held for less than 10 sec), 0 (not attempted) as well as a 0-4 ordinal scale for overall balance performance~8 foot walk - 0-4 scale according to velocity Summary ordinal score: 0 (worst performance) to 12 (best performance)"|units on a scale|Mean|6.1|6.1|Standard Deviation|1.9|1.9|||
4146497|NCT00865046|3970597|B1|||Short Physical Performance Battery|"The SPPB measures performance on 3 items:~Repeated chair stands (number of stands and time to complete as well as a 0-4 ordinal scale))~Balance testing - semitandem stand, side-by-side stand, and tandem stand; each scored as 2 (held for 10 sec), 1 (held for less than 10 sec), 0 (not attempted) as well as a 0-4 ordinal scale for overall balance performance~8 foot walk - 0-4 scale according to velocity Summary ordinal score: 0 (worst performance) to 12 (best performance)"|units on a scale|Mean|6.1|6.1|Standard Deviation|1.8|1.8|||
4146545|NCT00865046|3970597|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4146498|NCT00865046|3970594|B4|||WOMAC|"The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) consists of 24 items divided into 3 subscales:~Pain (5 items), score range 0-20 Stiffness (2 items): score range 0-8 Physical Function (17 items): score range 0-68 Total score ranges from 0 (best possible outcome) to 96 (worst possible outcome)"|units on a scale|Mean|9.8|9.8|Standard Deviation|3.6|3.6|||
4146499|NCT00865046|3970595|B3|||WOMAC|"The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) consists of 24 items divided into 3 subscales:~Pain (5 items), score range 0-20 Stiffness (2 items): score range 0-8 Physical Function (17 items): score range 0-68 Total score ranges from 0 (best possible outcome) to 96 (worst possible outcome)"|units on a scale|Mean|10.6|10.6|Standard Deviation|3.6|3.6|||
4146500|NCT00865046|3970596|B2|||WOMAC|"The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) consists of 24 items divided into 3 subscales:~Pain (5 items), score range 0-20 Stiffness (2 items): score range 0-8 Physical Function (17 items): score range 0-68 Total score ranges from 0 (best possible outcome) to 96 (worst possible outcome)"|units on a scale|Mean|9.9|9.9|Standard Deviation|4.0|4.0|||
4146501|NCT00865046|3970597|B1|||WOMAC|"The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) consists of 24 items divided into 3 subscales:~Pain (5 items), score range 0-20 Stiffness (2 items): score range 0-8 Physical Function (17 items): score range 0-68 Total score ranges from 0 (best possible outcome) to 96 (worst possible outcome)"|units on a scale|Mean|9.0|9.0|Standard Deviation|3.2|3.2|||
4146502|NCT00865046|3970594|B4|United States||Region of Enrollment||participants|Number|190|190.0||||||
4146503|NCT00865046|3970595|B3|United States||Region of Enrollment||participants|Number|63|63.0||||||
4146504|NCT00865046|3970596|B2|United States||Region of Enrollment||participants|Number|64|64.0||||||
4146505|NCT00865046|3970597|B1|United States||Region of Enrollment||participants|Number|63|63.0||||||
4146506|NCT00865046|3970594|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146507|NCT00865046|3970595|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146508|NCT00865046|3970596|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146509|NCT00865046|3970597|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146510|NCT00865046|3970594|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146511|NCT00865046|3970595|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146512|NCT00865046|3970596|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146513|NCT00865046|3970597|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146514|NCT00865046|3970594|B4||White|Race (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
4146515|NCT00865046|3970595|B3||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4146516|NCT00865046|3970596|B2||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4146517|NCT00865046|3970597|B1||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4146518|NCT00865046|3970594|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4146519|NCT00865046|3970595|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4146520|NCT00865046|3970596|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4146521|NCT00865046|3970597|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4146522|NCT00865046|3970594|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146523|NCT00865046|3970595|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146524|NCT00865046|3970596|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146525|NCT00865046|3970597|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146526|NCT00865046|3970594|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146527|NCT00865046|3970595|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146528|NCT00865046|3970596|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146529|NCT00865046|3970597|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146530|NCT00865046|3970594|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146531|NCT00865046|3970595|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146532|NCT00865046|3970596|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146533|NCT00865046|3970597|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146534|NCT00865046|3970594|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146535|NCT00865046|3970595|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146536|NCT00865046|3970596|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146537|NCT00865046|3970597|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146538|NCT00865046|3970594|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|188|188.0||||||
4146539|NCT00865046|3970595|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4146540|NCT00865046|3970596|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4146541|NCT00865046|3970597|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4146542|NCT00865046|3970594|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4146543|NCT00865046|3970595|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146544|NCT00865046|3970596|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146547|NCT00865046|3970595|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4146548|NCT00865046|3970596|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4146549|NCT00865046|3970597|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4146550|NCT00865046|3970594|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4146551|NCT00865046|3970595|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4146552|NCT00865046|3970596|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4146553|NCT00865046|3970597|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4146554|NCT00865046|3970594|B4|||Age||years|Mean|66.5|66.5|Standard Deviation|9.3|9.3|||
4146555|NCT00865046|3970595|B3|||Age||years|Mean|66.8|66.8|Standard Deviation|10.4|10.4|||
4146556|NCT00865046|3970596|B2|||Age||years|Mean|65.8|65.8|Standard Deviation|8.7|8.7|||
4146557|NCT00865046|3970597|B1|||Age||years|Mean|67.1|67.1|Standard Deviation|8.9|8.9|||
4146558|NCT00865020|3970607|B3||Male|Sex: Female, Male||Participants|Count of Participants|438|438.0||||||
4146559|NCT00865020|3970608|B2||Male|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4146560|NCT00865020|3970609|B1||Male|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4146561|NCT00865020|3970607|B3||Female|Sex: Female, Male||Participants|Count of Participants|384|384.0||||||
4146562|NCT00865020|3970608|B2||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4146563|NCT00865020|3970609|B1||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
4146564|NCT00865020|3970607|B3|||Age||years|Mean|55.9|55.9|Standard Deviation|11.68|11.68|||
4146565|NCT00865020|3970608|B2|||Age||years|Mean|56.0|56.0|Standard Deviation|11.91|11.91|||
4146566|NCT00865020|3970609|B1|||Age||years|Mean|55.8|55.8|Standard Deviation|11.46|11.46|||
4146567|NCT00864916|3970624|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4146568|NCT00864916|3970625|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4146569|NCT00864916|3970626|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4146570|NCT00864916|3970624|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4146571|NCT00864916|3970625|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4146572|NCT00864916|3970626|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4146573|NCT00864916|3970624|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4146574|NCT00864916|3970625|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4146575|NCT00864916|3970626|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4146576|NCT00864916|3970624|B3|||Age||years|Mean|36.0|36.0|Standard Deviation|10.6|10.6|||
4146577|NCT00864916|3970625|B2|||Age||years|Mean|34.0|34.0|Standard Deviation|8.8|8.8|||
4146578|NCT00864916|3970626|B1|||Age||years|Mean|37.8|37.8|Standard Deviation|12.1|12.1|||
4146579|NCT00864851|3970633|B4|||Baseline Urinary Albumin/Creatinine (A/Cr) Ratio||mg/g|Mean|303.0|303.0|Standard Deviation|532.27|532.27|||
4146580|NCT00864851|3970634|B3|||Baseline Urinary Albumin/Creatinine (A/Cr) Ratio||mg/g|Mean|298.2|298.2|Standard Deviation|175.85|175.85|||
4146581|NCT00864851|3970635|B2|||Baseline Urinary Albumin/Creatinine (A/Cr) Ratio||mg/g|Mean|293.4|293.4|Standard Deviation|521.23|521.23|||
4146582|NCT00864851|3970636|B1|||Baseline Urinary Albumin/Creatinine (A/Cr) Ratio||mg/g|Mean|313.4|313.4|Standard Deviation|614.07|614.07|||
4146583|NCT00864851|3970633|B4|||Baseline Estimated Glomerular Filtration Rate (eGFR)||mL/min/1.73 m^2|Mean|79.2|79.2|Standard Deviation|33.1|33.1|||
4146584|NCT00864851|3970634|B3|||Baseline Estimated Glomerular Filtration Rate (eGFR)||mL/min/1.73 m^2|Mean|72.1|72.1|Standard Deviation|31.2|31.2|||
4146585|NCT00864851|3970635|B2|||Baseline Estimated Glomerular Filtration Rate (eGFR)||mL/min/1.73 m^2|Mean|78.1|78.1|Standard Deviation|33.8|33.8|||
4146586|NCT00864851|3970636|B1|||Baseline Estimated Glomerular Filtration Rate (eGFR)||mL/min/1.73 m^2|Mean|82.0|82.0|Standard Deviation|34.1|34.1|||
4146587|NCT00864851|3970633|B4|||Baseline Plasma Globotriaosylceramide (GB3)||nmol/ml|Mean|5.800|5.8|Standard Deviation|4.104|4.104|||
4146588|NCT00864851|3970634|B3|||Baseline Plasma Globotriaosylceramide (GB3)||nmol/ml|Mean|5.292|5.292|Standard Deviation|1.865|1.865|||
4146589|NCT00864851|3970635|B2|||Baseline Plasma Globotriaosylceramide (GB3)||nmol/ml|Mean|5.652|5.652|Standard Deviation|5.212|5.212|||
4146590|NCT00864851|3970636|B1|||Baseline Plasma Globotriaosylceramide (GB3)||nmol/ml|Mean|6.067|6.067|Standard Deviation|3.388|3.388|||
4146591|NCT00864851|3970633|B4|Class IV||Baseline New York Heart Association (NYHA) Functional Class|"Class I: Cardiac disease without limitation of physical activity. Ordinary physical activity does not cause undue symptoms.~Class II: Cardiac disease with slight limitation of physical activity. Comfortable at rest, but ordinary physical activity causes symptoms.~Class III: Cardiac disease with marked limitation of physical activity. Comfortable at rest, but less than ordinary activity causes symptoms.~Class IV: Cardiac disease and unable to carry out any physical activity without discomfort. Symptoms of cardiac insufficiency at rest.~Note: Symptoms include fatigue, palpitation or dyspnea"|participants|Number|0|0.0||||||
4146592|NCT00864851|3970634|B3|Class IV||Baseline New York Heart Association (NYHA) Functional Class|"Class I: Cardiac disease without limitation of physical activity. Ordinary physical activity does not cause undue symptoms.~Class II: Cardiac disease with slight limitation of physical activity. Comfortable at rest, but ordinary physical activity causes symptoms.~Class III: Cardiac disease with marked limitation of physical activity. Comfortable at rest, but less than ordinary activity causes symptoms.~Class IV: Cardiac disease and unable to carry out any physical activity without discomfort. Symptoms of cardiac insufficiency at rest.~Note: Symptoms include fatigue, palpitation or dyspnea"|participants|Number|0|0.0||||||
4146624|NCT00864851|3970634|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146625|NCT00864851|3970635|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146593|NCT00864851|3970635|B2|Class IV||Baseline New York Heart Association (NYHA) Functional Class|"Class I: Cardiac disease without limitation of physical activity. Ordinary physical activity does not cause undue symptoms.~Class II: Cardiac disease with slight limitation of physical activity. Comfortable at rest, but ordinary physical activity causes symptoms.~Class III: Cardiac disease with marked limitation of physical activity. Comfortable at rest, but less than ordinary activity causes symptoms.~Class IV: Cardiac disease and unable to carry out any physical activity without discomfort. Symptoms of cardiac insufficiency at rest.~Note: Symptoms include fatigue, palpitation or dyspnea"|participants|Number|0|0.0||||||
4146594|NCT00864851|3970636|B1|Class IV||Baseline New York Heart Association (NYHA) Functional Class|"Class I: Cardiac disease without limitation of physical activity. Ordinary physical activity does not cause undue symptoms.~Class II: Cardiac disease with slight limitation of physical activity. Comfortable at rest, but ordinary physical activity causes symptoms.~Class III: Cardiac disease with marked limitation of physical activity. Comfortable at rest, but less than ordinary activity causes symptoms.~Class IV: Cardiac disease and unable to carry out any physical activity without discomfort. Symptoms of cardiac insufficiency at rest.~Note: Symptoms include fatigue, palpitation or dyspnea"|participants|Number|0|0.0||||||
4146595|NCT00864851|3970633|B4|Class III||Baseline New York Heart Association (NYHA) Functional Class|"Class I: Cardiac disease without limitation of physical activity. Ordinary physical activity does not cause undue symptoms.~Class II: Cardiac disease with slight limitation of physical activity. Comfortable at rest, but ordinary physical activity causes symptoms.~Class III: Cardiac disease with marked limitation of physical activity. Comfortable at rest, but less than ordinary activity causes symptoms.~Class IV: Cardiac disease and unable to carry out any physical activity without discomfort. Symptoms of cardiac insufficiency at rest.~Note: Symptoms include fatigue, palpitation or dyspnea"|participants|Number|4|4.0||||||
4146596|NCT00864851|3970634|B3|Class III||Baseline New York Heart Association (NYHA) Functional Class|"Class I: Cardiac disease without limitation of physical activity. Ordinary physical activity does not cause undue symptoms.~Class II: Cardiac disease with slight limitation of physical activity. Comfortable at rest, but ordinary physical activity causes symptoms.~Class III: Cardiac disease with marked limitation of physical activity. Comfortable at rest, but less than ordinary activity causes symptoms.~Class IV: Cardiac disease and unable to carry out any physical activity without discomfort. Symptoms of cardiac insufficiency at rest.~Note: Symptoms include fatigue, palpitation or dyspnea"|participants|Number|1|1.0||||||
4146597|NCT00864851|3970635|B2|Class III||Baseline New York Heart Association (NYHA) Functional Class|"Class I: Cardiac disease without limitation of physical activity. Ordinary physical activity does not cause undue symptoms.~Class II: Cardiac disease with slight limitation of physical activity. Comfortable at rest, but ordinary physical activity causes symptoms.~Class III: Cardiac disease with marked limitation of physical activity. Comfortable at rest, but less than ordinary activity causes symptoms.~Class IV: Cardiac disease and unable to carry out any physical activity without discomfort. Symptoms of cardiac insufficiency at rest.~Note: Symptoms include fatigue, palpitation or dyspnea"|participants|Number|0|0.0||||||
4146598|NCT00864851|3970636|B1|Class III||Baseline New York Heart Association (NYHA) Functional Class|"Class I: Cardiac disease without limitation of physical activity. Ordinary physical activity does not cause undue symptoms.~Class II: Cardiac disease with slight limitation of physical activity. Comfortable at rest, but ordinary physical activity causes symptoms.~Class III: Cardiac disease with marked limitation of physical activity. Comfortable at rest, but less than ordinary activity causes symptoms.~Class IV: Cardiac disease and unable to carry out any physical activity without discomfort. Symptoms of cardiac insufficiency at rest.~Note: Symptoms include fatigue, palpitation or dyspnea"|participants|Number|3|3.0||||||
4146599|NCT00864851|3970633|B4|Class II||Baseline New York Heart Association (NYHA) Functional Class|"Class I: Cardiac disease without limitation of physical activity. Ordinary physical activity does not cause undue symptoms.~Class II: Cardiac disease with slight limitation of physical activity. Comfortable at rest, but ordinary physical activity causes symptoms.~Class III: Cardiac disease with marked limitation of physical activity. Comfortable at rest, but less than ordinary activity causes symptoms.~Class IV: Cardiac disease and unable to carry out any physical activity without discomfort. Symptoms of cardiac insufficiency at rest.~Note: Symptoms include fatigue, palpitation or dyspnea"|participants|Number|22|22.0||||||
4146600|NCT00864851|3970634|B3|Class II||Baseline New York Heart Association (NYHA) Functional Class|"Class I: Cardiac disease without limitation of physical activity. Ordinary physical activity does not cause undue symptoms.~Class II: Cardiac disease with slight limitation of physical activity. Comfortable at rest, but ordinary physical activity causes symptoms.~Class III: Cardiac disease with marked limitation of physical activity. Comfortable at rest, but less than ordinary activity causes symptoms.~Class IV: Cardiac disease and unable to carry out any physical activity without discomfort. Symptoms of cardiac insufficiency at rest.~Note: Symptoms include fatigue, palpitation or dyspnea"|participants|Number|2|2.0||||||
4146601|NCT00864851|3970635|B2|Class II||Baseline New York Heart Association (NYHA) Functional Class|"Class I: Cardiac disease without limitation of physical activity. Ordinary physical activity does not cause undue symptoms.~Class II: Cardiac disease with slight limitation of physical activity. Comfortable at rest, but ordinary physical activity causes symptoms.~Class III: Cardiac disease with marked limitation of physical activity. Comfortable at rest, but less than ordinary activity causes symptoms.~Class IV: Cardiac disease and unable to carry out any physical activity without discomfort. Symptoms of cardiac insufficiency at rest.~Note: Symptoms include fatigue, palpitation or dyspnea"|participants|Number|9|9.0||||||
4146602|NCT00864851|3970636|B1|Class II||Baseline New York Heart Association (NYHA) Functional Class|"Class I: Cardiac disease without limitation of physical activity. Ordinary physical activity does not cause undue symptoms.~Class II: Cardiac disease with slight limitation of physical activity. Comfortable at rest, but ordinary physical activity causes symptoms.~Class III: Cardiac disease with marked limitation of physical activity. Comfortable at rest, but less than ordinary activity causes symptoms.~Class IV: Cardiac disease and unable to carry out any physical activity without discomfort. Symptoms of cardiac insufficiency at rest.~Note: Symptoms include fatigue, palpitation or dyspnea"|participants|Number|11|11.0||||||
4146626|NCT00864851|3970636|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146627|NCT00864851|3970633|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146628|NCT00864851|3970634|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146603|NCT00864851|3970633|B4|Class I||Baseline New York Heart Association (NYHA) Functional Class|"Class I: Cardiac disease without limitation of physical activity. Ordinary physical activity does not cause undue symptoms.~Class II: Cardiac disease with slight limitation of physical activity. Comfortable at rest, but ordinary physical activity causes symptoms.~Class III: Cardiac disease with marked limitation of physical activity. Comfortable at rest, but less than ordinary activity causes symptoms.~Class IV: Cardiac disease and unable to carry out any physical activity without discomfort. Symptoms of cardiac insufficiency at rest.~Note: Symptoms include fatigue, palpitation or dyspnea"|participants|Number|18|18.0||||||
4146604|NCT00864851|3970634|B3|Class I||Baseline New York Heart Association (NYHA) Functional Class|"Class I: Cardiac disease without limitation of physical activity. Ordinary physical activity does not cause undue symptoms.~Class II: Cardiac disease with slight limitation of physical activity. Comfortable at rest, but ordinary physical activity causes symptoms.~Class III: Cardiac disease with marked limitation of physical activity. Comfortable at rest, but less than ordinary activity causes symptoms.~Class IV: Cardiac disease and unable to carry out any physical activity without discomfort. Symptoms of cardiac insufficiency at rest.~Note: Symptoms include fatigue, palpitation or dyspnea"|participants|Number|2|2.0||||||
4146605|NCT00864851|3970635|B2|Class I||Baseline New York Heart Association (NYHA) Functional Class|"Class I: Cardiac disease without limitation of physical activity. Ordinary physical activity does not cause undue symptoms.~Class II: Cardiac disease with slight limitation of physical activity. Comfortable at rest, but ordinary physical activity causes symptoms.~Class III: Cardiac disease with marked limitation of physical activity. Comfortable at rest, but less than ordinary activity causes symptoms.~Class IV: Cardiac disease and unable to carry out any physical activity without discomfort. Symptoms of cardiac insufficiency at rest.~Note: Symptoms include fatigue, palpitation or dyspnea"|participants|Number|10|10.0||||||
4146606|NCT00864851|3970636|B1|Class I||Baseline New York Heart Association (NYHA) Functional Class|"Class I: Cardiac disease without limitation of physical activity. Ordinary physical activity does not cause undue symptoms.~Class II: Cardiac disease with slight limitation of physical activity. Comfortable at rest, but ordinary physical activity causes symptoms.~Class III: Cardiac disease with marked limitation of physical activity. Comfortable at rest, but less than ordinary activity causes symptoms.~Class IV: Cardiac disease and unable to carry out any physical activity without discomfort. Symptoms of cardiac insufficiency at rest.~Note: Symptoms include fatigue, palpitation or dyspnea"|participants|Number|6|6.0||||||
4146607|NCT00864851|3970633|B4|||Baseline Minnesota Living with Heart Failure Questionnaire (MLHF-Q) Summary Score|Quality of life (QoL) was evaluated using the MLHF-Q, version 2. The questionnaire is designed to assess the degree to which heart failure symptoms affect a patient's daily life. The summary score ranges from 0 to 105, with a score of 105 representing the highest adverse impact on a patient's QoL.|scores on a scale|Mean|28.1|28.1|Standard Deviation|23.8|23.8|||
4146608|NCT00864851|3970634|B3|||Baseline Minnesota Living with Heart Failure Questionnaire (MLHF-Q) Summary Score|Quality of life (QoL) was evaluated using the MLHF-Q, version 2. The questionnaire is designed to assess the degree to which heart failure symptoms affect a patient's daily life. The summary score ranges from 0 to 105, with a score of 105 representing the highest adverse impact on a patient's QoL.|scores on a scale|Mean|19.6|19.6|Standard Deviation|26.5|26.5|||
4146609|NCT00864851|3970635|B2|||Baseline Minnesota Living with Heart Failure Questionnaire (MLHF-Q) Summary Score|Quality of life (QoL) was evaluated using the MLHF-Q, version 2. The questionnaire is designed to assess the degree to which heart failure symptoms affect a patient's daily life. The summary score ranges from 0 to 105, with a score of 105 representing the highest adverse impact on a patient's QoL.|scores on a scale|Mean|21.1|21.1|Standard Deviation|21.0|21.0|||
4146610|NCT00864851|3970636|B1|||Baseline Minnesota Living with Heart Failure Questionnaire (MLHF-Q) Summary Score|Quality of life (QoL) was evaluated using the MLHF-Q, version 2. The questionnaire is designed to assess the degree to which heart failure symptoms affect a patient's daily life. The summary score ranges from 0 to 105, with a score of 105 representing the highest adverse impact on a patient's QoL.|scores on a scale|Mean|37.0|37.0|Standard Deviation|23.8|23.8|||
4146611|NCT00864851|3970633|B4|||Baseline Distance Walked in 6-Minute Walk Test (6MWT)|0.2 mg/kg Every Other Week: n=18 0.2 mg/kg Weekly: n=19 0.4 mg/kg Weekly: n=5 Total: n=42|m|Mean|492.8|492.8|Standard Deviation|97.0|97.0|||
4146612|NCT00864851|3970634|B3|||Baseline Distance Walked in 6-Minute Walk Test (6MWT)|0.2 mg/kg Every Other Week: n=18 0.2 mg/kg Weekly: n=19 0.4 mg/kg Weekly: n=5 Total: n=42|m|Mean|530.7|530.7|Standard Deviation|90.2|90.2|||
4146613|NCT00864851|3970635|B2|||Baseline Distance Walked in 6-Minute Walk Test (6MWT)|0.2 mg/kg Every Other Week: n=18 0.2 mg/kg Weekly: n=19 0.4 mg/kg Weekly: n=5 Total: n=42|m|Mean|514.3|514.3|Standard Deviation|87.3|87.3|||
4146614|NCT00864851|3970636|B1|||Baseline Distance Walked in 6-Minute Walk Test (6MWT)|0.2 mg/kg Every Other Week: n=18 0.2 mg/kg Weekly: n=19 0.4 mg/kg Weekly: n=5 Total: n=42|m|Mean|459.6|459.6|Standard Deviation|103.0|103.0|||
4146615|NCT00864851|3970633|B4|||Baseline Maximal Oxygen Consumption (VO2 max) at Peak Exercise|0.2 mg/kg Every Other Week: n=19 0.2 mg/kg Weekly: n=16 0.4 mg/kg Weekly: n=4 Total: n=39|mL/min/kg|Mean|21.6|21.6|Standard Deviation|7.05|7.05|||
4146616|NCT00864851|3970634|B3|||Baseline Maximal Oxygen Consumption (VO2 max) at Peak Exercise|0.2 mg/kg Every Other Week: n=19 0.2 mg/kg Weekly: n=16 0.4 mg/kg Weekly: n=4 Total: n=39|mL/min/kg|Mean|24.0|24.0|Standard Deviation|11.69|11.69|||
4146617|NCT00864851|3970635|B2|||Baseline Maximal Oxygen Consumption (VO2 max) at Peak Exercise|0.2 mg/kg Every Other Week: n=19 0.2 mg/kg Weekly: n=16 0.4 mg/kg Weekly: n=4 Total: n=39|mL/min/kg|Mean|22.6|22.6|Standard Deviation|6.89|6.89|||
4146618|NCT00864851|3970636|B1|||Baseline Maximal Oxygen Consumption (VO2 max) at Peak Exercise|0.2 mg/kg Every Other Week: n=19 0.2 mg/kg Weekly: n=16 0.4 mg/kg Weekly: n=4 Total: n=39|mL/min/kg|Mean|20.2|20.2|Standard Deviation|6.20|6.2|||
4146619|NCT00864851|3970633|B4|||Baseline Left Ventricular Mass Indexed to Height (LVMI)||g/m^2.7|Mean|81.5|81.5|Standard Deviation|28.5|28.5|||
4146620|NCT00864851|3970634|B3|||Baseline Left Ventricular Mass Indexed to Height (LVMI)||g/m^2.7|Mean|99.3|99.3|Standard Deviation|46.2|46.2|||
4146621|NCT00864851|3970635|B2|||Baseline Left Ventricular Mass Indexed to Height (LVMI)||g/m^2.7|Mean|82.6|82.6|Standard Deviation|28.3|28.3|||
4146622|NCT00864851|3970636|B1|||Baseline Left Ventricular Mass Indexed to Height (LVMI)||g/m^2.7|Mean|76.1|76.1|Standard Deviation|22.8|22.8|||
4146623|NCT00864851|3970633|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146629|NCT00864851|3970635|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146630|NCT00864851|3970636|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146631|NCT00864851|3970633|B4||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4146632|NCT00864851|3970634|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4146633|NCT00864851|3970635|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4146634|NCT00864851|3970636|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4146635|NCT00864851|3970633|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146636|NCT00864851|3970634|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146637|NCT00864851|3970635|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146638|NCT00864851|3970636|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146639|NCT00864851|3970633|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146640|NCT00864851|3970634|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146641|NCT00864851|3970635|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146642|NCT00864851|3970636|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146643|NCT00864851|3970633|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146644|NCT00864851|3970634|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146645|NCT00864851|3970635|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146646|NCT00864851|3970636|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146647|NCT00864851|3970633|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146648|NCT00864851|3970634|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146649|NCT00864851|3970635|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146650|NCT00864851|3970636|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146651|NCT00864851|3970633|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146652|NCT00864851|3970634|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146653|NCT00864851|3970635|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146654|NCT00864851|3970636|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146655|NCT00864851|3970633|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4146656|NCT00864851|3970634|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4146657|NCT00864851|3970635|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4146658|NCT00864851|3970636|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4146659|NCT00864851|3970633|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4146660|NCT00864851|3970634|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146661|NCT00864851|3970635|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4146662|NCT00864851|3970636|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4146663|NCT00864851|3970633|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4146664|NCT00864851|3970634|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4146665|NCT00864851|3970635|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4146666|NCT00864851|3970636|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4146667|NCT00864851|3970633|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4146668|NCT00864851|3970634|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4146669|NCT00864851|3970635|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4146670|NCT00864851|3970636|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4146671|NCT00864851|3970633|B4|>=45 years||Age, Customized||participants|Number|32|32.0||||||
4146672|NCT00864851|3970634|B3|>=45 years||Age, Customized||participants|Number|4|4.0||||||
4146673|NCT00864851|3970635|B2|>=45 years||Age, Customized||participants|Number|13|13.0||||||
4146674|NCT00864851|3970636|B1|>=45 years||Age, Customized||participants|Number|15|15.0||||||
4146675|NCT00864851|3970633|B4|18 to <45 years||Age, Customized||participants|Number|12|12.0||||||
4146676|NCT00864851|3970634|B3|18 to <45 years||Age, Customized||participants|Number|1|1.0||||||
4146677|NCT00864851|3970635|B2|18 to <45 years||Age, Customized||participants|Number|6|6.0||||||
4146678|NCT00864851|3970636|B1|18 to <45 years||Age, Customized||participants|Number|5|5.0||||||
4146679|NCT00864851|3970633|B4|||Age||years|Mean|50.8|50.8|Standard Deviation|9.34|9.34|||
4146680|NCT00864851|3970634|B3|||Age||years|Mean|49.4|49.4|Standard Deviation|9.75|9.75|||
4146681|NCT00864851|3970635|B2|||Age||years|Mean|51.8|51.8|Standard Deviation|11.42|11.42|||
4146682|NCT00864851|3970636|B1|||Age||years|Mean|50.3|50.3|Standard Deviation|7.23|7.23|||
4146683|NCT00864721|3970672|B1|United States||Region of Enrollment||participants|Number|63|63.0||||||
4146684|NCT00864721|3970672|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4146685|NCT00864721|3970672|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4146686|NCT00864721|3970672|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4146687|NCT00864721|3970672|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
4146688|NCT00864721|3970672|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4146689|NCT00864721|3970672|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4146690|NCT00864721|3970672|B1|||Age||years|Mean|78.7|78.7|Standard Deviation|5.08|5.08|||
4146691|NCT00864708|3970680|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4146692|NCT00864708|3970680|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4146693|NCT00864708|3970680|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4146694|NCT00864708|3970680|B1|||Age||years|Mean|37|37.0|Standard Deviation|0|0.0|||
4146695|NCT00864708|3970680|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4146696|NCT00864708|3970680|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4146697|NCT00864708|3970680|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4146698|NCT00864682|3970689|B4|United States||Region of Enrollment||participants|Number|156.0|156.0||||||
4146699|NCT00864682|3970690|B3|United States||Region of Enrollment||participants|Number|53|53.0||||||
4146700|NCT00864682|3970691|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
4146701|NCT00864682|3970692|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
4146702|NCT00864682|3970689|B4||Male|Sex: Female, Male||Participants|Count of Participants|77.0|77.0||||||
4146703|NCT00864682|3970690|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4146704|NCT00864682|3970691|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4146705|NCT00864682|3970692|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4146706|NCT00864682|3970689|B4||Female|Sex: Female, Male||Participants|Count of Participants|79.0|79.0||||||
4146707|NCT00864682|3970690|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4146708|NCT00864682|3970691|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4146709|NCT00864682|3970692|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4146710|NCT00864682|3970689|B4|||Age||years|Mean|53|53.0|Standard Deviation|15|15.0|||
4146711|NCT00864682|3970690|B3|||Age||years|Mean|52|52.0|Standard Deviation|17|17.0|||
4146712|NCT00864682|3970691|B2|||Age||years|Mean|54|54.0|Standard Deviation|14|14.0|||
4146713|NCT00864682|3970692|B1|||Age||years|Mean|53|53.0|Standard Deviation|14|14.0|||
4146714|NCT00864682|3970689|B4||>=65 years|Age||Participants|Count of Participants|35.0|35.0||||||
4146715|NCT00864682|3970690|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4146716|NCT00864682|3970691|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4146717|NCT00864682|3970692|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4146718|NCT00864682|3970689|B4||Between 18 and 65 years|Age||Participants|Count of Participants|121.0|121.0||||||
4146719|NCT00864682|3970690|B3||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4146720|NCT00864682|3970691|B2||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4146721|NCT00864682|3970692|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4146722|NCT00864682|3970689|B4||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4146723|NCT00864682|3970690|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4146724|NCT00864682|3970691|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4146725|NCT00864682|3970692|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4146726|NCT00864539|3970708|B7|||Serum levels of 25(OH)D|Anthropometric and laboratory assessments were carried out at the beginning and at the end of the intervention. In order to perform blood analyses, 3mL of venous blood was taken from all the participants. Laboratory tests included hemoglobin, hematocrit, serum levels of 25(OH)D, iPTH, osteocalcin, bone-specific alkaline phosphatase (BAP), calcium, phosphorous, magnesium, total protein and albumin.|nmol/L|Mean|23.0|23.0|Standard Deviation|20.9|20.9|||
4146727|NCT00864539|3970709|B6|||Serum levels of 25(OH)D|Anthropometric and laboratory assessments were carried out at the beginning and at the end of the intervention. In order to perform blood analyses, 3mL of venous blood was taken from all the participants. Laboratory tests included hemoglobin, hematocrit, serum levels of 25(OH)D, iPTH, osteocalcin, bone-specific alkaline phosphatase (BAP), calcium, phosphorous, magnesium, total protein and albumin.|nmol/L|Mean|19.6|19.6|Standard Deviation|23.7|23.7|||
4146728|NCT00864539|3970710|B5|||Serum levels of 25(OH)D|Anthropometric and laboratory assessments were carried out at the beginning and at the end of the intervention. In order to perform blood analyses, 3mL of venous blood was taken from all the participants. Laboratory tests included hemoglobin, hematocrit, serum levels of 25(OH)D, iPTH, osteocalcin, bone-specific alkaline phosphatase (BAP), calcium, phosphorous, magnesium, total protein and albumin.|nmol/L|Mean|16.6|16.6|Standard Deviation|17.8|17.8|||
4146729|NCT00864539|3970711|B4|||Serum levels of 25(OH)D|Anthropometric and laboratory assessments were carried out at the beginning and at the end of the intervention. In order to perform blood analyses, 3mL of venous blood was taken from all the participants. Laboratory tests included hemoglobin, hematocrit, serum levels of 25(OH)D, iPTH, osteocalcin, bone-specific alkaline phosphatase (BAP), calcium, phosphorous, magnesium, total protein and albumin.|nmol/L|Mean|26.6|26.6|Standard Deviation|22.0|22.0|||
4146730|NCT00864539|3970712|B3|||Serum levels of 25(OH)D|Anthropometric and laboratory assessments were carried out at the beginning and at the end of the intervention. In order to perform blood analyses, 3mL of venous blood was taken from all the participants. Laboratory tests included hemoglobin, hematocrit, serum levels of 25(OH)D, iPTH, osteocalcin, bone-specific alkaline phosphatase (BAP), calcium, phosphorous, magnesium, total protein and albumin.|nmol/L|Mean|18.0|18.0|Standard Deviation|14.4|14.4|||
4146787|NCT00864513|3970733|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4146788|NCT00864513|3970733|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4146789|NCT00864383|3970740|B4|Not available||Time to positivity on MGIT sputum culture|Mycobacteria Growth Indicator Tube (MGIT) was used for the detection of mycobacteria.|participants|Number|39|39.0||||||
4146731|NCT00864539|3970713|B2|||Serum levels of 25(OH)D|Anthropometric and laboratory assessments were carried out at the beginning and at the end of the intervention. In order to perform blood analyses, 3mL of venous blood was taken from all the participants. Laboratory tests included hemoglobin, hematocrit, serum levels of 25(OH)D, iPTH, osteocalcin, bone-specific alkaline phosphatase (BAP), calcium, phosphorous, magnesium, total protein and albumin.|nmol/L|Mean|25.0|25.0|Standard Deviation|17.2|17.2|||
4146732|NCT00864539|3970714|B1|||Serum levels of 25(OH)D|Anthropometric and laboratory assessments were carried out at the beginning and at the end of the intervention. In order to perform blood analyses, 3mL of venous blood was taken from all the participants. Laboratory tests included hemoglobin, hematocrit, serum levels of 25(OH)D, iPTH, osteocalcin, bone-specific alkaline phosphatase (BAP), calcium, phosphorous, magnesium, total protein and albumin.|nmol/L|Mean|30.5|30.5|Standard Deviation|24.7|24.7|||
4146733|NCT00864539|3970708|B7|Iran, Islamic Republic of||Region of Enrollment||participants|Number|585|585.0||||||
4146734|NCT00864539|3970709|B6|Iran, Islamic Republic of||Region of Enrollment||participants|Number|85|85.0||||||
4146735|NCT00864539|3970710|B5|Iran, Islamic Republic of||Region of Enrollment||participants|Number|103|103.0||||||
4146736|NCT00864539|3970711|B4|Iran, Islamic Republic of||Region of Enrollment||participants|Number|96|96.0||||||
4146737|NCT00864539|3970712|B3|Iran, Islamic Republic of||Region of Enrollment||participants|Number|102|102.0||||||
4146738|NCT00864539|3970713|B2|Iran, Islamic Republic of||Region of Enrollment||participants|Number|95|95.0||||||
4146739|NCT00864539|3970714|B1|Iran, Islamic Republic of||Region of Enrollment||participants|Number|104|104.0||||||
4146740|NCT00864539|3970708|B7||Male|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
4146741|NCT00864539|3970709|B6||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4146742|NCT00864539|3970710|B5||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4146743|NCT00864539|3970711|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4146744|NCT00864539|3970712|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4146745|NCT00864539|3970713|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4146746|NCT00864539|3970714|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4146747|NCT00864539|3970708|B7||Female|Sex: Female, Male||Participants|Count of Participants|352|352.0||||||
4146748|NCT00864539|3970709|B6||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4146749|NCT00864539|3970710|B5||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4146750|NCT00864539|3970711|B4||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4146751|NCT00864539|3970712|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4146752|NCT00864539|3970713|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4146753|NCT00864539|3970714|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4146754|NCT00864539|3970708|B7|||Age||years|Mean|10.1|10.1|Standard Deviation|0.8|0.8|||
4146755|NCT00864539|3970709|B6|||Age||years|Mean|9.8|9.8|Standard Deviation|0.8|0.8|||
4146756|NCT00864539|3970710|B5|||Age||years|Mean|10.4|10.4|Standard Deviation|0.6|0.6|||
4146757|NCT00864539|3970711|B4|||Age||years|Mean|9.9|9.9|Standard Deviation|0.8|0.8|||
4146758|NCT00864539|3970712|B3|||Age||years|Mean|10.1|10.1|Standard Deviation|0.6|0.6|||
4146759|NCT00864539|3970713|B2|||Age||years|Mean|10.1|10.1|Standard Deviation|0.8|0.8|||
4146760|NCT00864539|3970714|B1|||Age||years|Mean|10.3|10.3|Standard Deviation|0.7|0.7|||
4146761|NCT00864539|3970708|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4146762|NCT00864539|3970709|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4146763|NCT00864539|3970710|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4146764|NCT00864539|3970711|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4146765|NCT00864539|3970712|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4146766|NCT00864539|3970713|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4146767|NCT00864539|3970714|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4146768|NCT00864539|3970708|B7||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4146769|NCT00864539|3970709|B6||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4146770|NCT00864539|3970710|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4146771|NCT00864539|3970711|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4146772|NCT00864539|3970712|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4146773|NCT00864539|3970713|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4146774|NCT00864539|3970714|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4146775|NCT00864539|3970708|B7||<=18 years|Age||Participants|Count of Participants|585|585.0||||||
4146776|NCT00864539|3970709|B6||<=18 years|Age||Participants|Count of Participants|85|85.0||||||
4146777|NCT00864539|3970710|B5||<=18 years|Age||Participants|Count of Participants|103|103.0||||||
4146778|NCT00864539|3970711|B4||<=18 years|Age||Participants|Count of Participants|96|96.0||||||
4146779|NCT00864539|3970712|B3||<=18 years|Age||Participants|Count of Participants|102|102.0||||||
4146780|NCT00864539|3970713|B2||<=18 years|Age||Participants|Count of Participants|95|95.0||||||
4146781|NCT00864539|3970714|B1||<=18 years|Age||Participants|Count of Participants|104|104.0||||||
4146782|NCT00864513|3970733|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4146783|NCT00864513|3970733|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4146784|NCT00864513|3970733|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4146785|NCT00864513|3970733|B1|||Age||years|Mean|55|55.0|Standard Deviation|30|30.0|||
4146786|NCT00864513|3970733|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4146790|NCT00864383|3970741|B3|Not available||Time to positivity on MGIT sputum culture|Mycobacteria Growth Indicator Tube (MGIT) was used for the detection of mycobacteria.|participants|Number|12|12.0||||||
4146791|NCT00864383|3970742|B2|Not available||Time to positivity on MGIT sputum culture|Mycobacteria Growth Indicator Tube (MGIT) was used for the detection of mycobacteria.|participants|Number|12|12.0||||||
4146792|NCT00864383|3970743|B1|Not available||Time to positivity on MGIT sputum culture|Mycobacteria Growth Indicator Tube (MGIT) was used for the detection of mycobacteria.|participants|Number|15|15.0||||||
4146793|NCT00864383|3970740|B4|< 5 days||Time to positivity on MGIT sputum culture|Mycobacteria Growth Indicator Tube (MGIT) was used for the detection of mycobacteria.|participants|Number|722|722.0||||||
4146794|NCT00864383|3970741|B3|< 5 days||Time to positivity on MGIT sputum culture|Mycobacteria Growth Indicator Tube (MGIT) was used for the detection of mycobacteria.|participants|Number|254|254.0||||||
4146795|NCT00864383|3970742|B2|< 5 days||Time to positivity on MGIT sputum culture|Mycobacteria Growth Indicator Tube (MGIT) was used for the detection of mycobacteria.|participants|Number|239|239.0||||||
4146796|NCT00864383|3970743|B1|< 5 days||Time to positivity on MGIT sputum culture|Mycobacteria Growth Indicator Tube (MGIT) was used for the detection of mycobacteria.|participants|Number|229|229.0||||||
4146797|NCT00864383|3970740|B4|≥ 5 days||Time to positivity on MGIT sputum culture|Mycobacteria Growth Indicator Tube (MGIT) was used for the detection of mycobacteria.|participants|Number|787|787.0||||||
4146798|NCT00864383|3970741|B3|≥ 5 days||Time to positivity on MGIT sputum culture|Mycobacteria Growth Indicator Tube (MGIT) was used for the detection of mycobacteria.|participants|Number|258|258.0||||||
4146799|NCT00864383|3970742|B2|≥ 5 days||Time to positivity on MGIT sputum culture|Mycobacteria Growth Indicator Tube (MGIT) was used for the detection of mycobacteria.|participants|Number|263|263.0||||||
4146800|NCT00864383|3970743|B1|≥ 5 days||Time to positivity on MGIT sputum culture|Mycobacteria Growth Indicator Tube (MGIT) was used for the detection of mycobacteria.|participants|Number|266|266.0||||||
4146801|NCT00864383|3970740|B4|||Cavitation|Chest cavitation based on blinded assessment of the chest radiograph.|participants|Number|1092|1092.0||||||
4146802|NCT00864383|3970741|B3|||Cavitation|Chest cavitation based on blinded assessment of the chest radiograph.|participants|Number|367|367.0||||||
4146803|NCT00864383|3970742|B2|||Cavitation|Chest cavitation based on blinded assessment of the chest radiograph.|participants|Number|357|357.0||||||
4146804|NCT00864383|3970743|B1|||Cavitation|Chest cavitation based on blinded assessment of the chest radiograph.|participants|Number|368|368.0||||||
4146805|NCT00864383|3970740|B4|Pyrazinamide||Drug resistance||participants|Number|27|27.0||||||
4146806|NCT00864383|3970741|B3|Pyrazinamide||Drug resistance||participants|Number|6|6.0||||||
4146807|NCT00864383|3970742|B2|Pyrazinamide||Drug resistance||participants|Number|7|7.0||||||
4146808|NCT00864383|3970743|B1|Pyrazinamide||Drug resistance||participants|Number|14|14.0||||||
4146809|NCT00864383|3970740|B4|Isoniazid||Drug resistance||participants|Number|102|102.0||||||
4146810|NCT00864383|3970741|B3|Isoniazid||Drug resistance||participants|Number|39|39.0||||||
4146811|NCT00864383|3970742|B2|Isoniazid||Drug resistance||participants|Number|34|34.0||||||
4146812|NCT00864383|3970743|B1|Isoniazid||Drug resistance||participants|Number|29|29.0||||||
4146813|NCT00864383|3970740|B4|||HIV positivity||participants|Number|110|110.0||||||
4146814|NCT00864383|3970741|B3|||HIV positivity||participants|Number|35|35.0||||||
4146815|NCT00864383|3970742|B2|||HIV positivity||participants|Number|37|37.0||||||
4146816|NCT00864383|3970743|B1|||HIV positivity||participants|Number|38|38.0||||||
4146817|NCT00864383|3970740|B4|Current||Smoking status||participants|Number|477|477.0||||||
4146818|NCT00864383|3970741|B3|Current||Smoking status||participants|Number|160|160.0||||||
4146819|NCT00864383|3970742|B2|Current||Smoking status||participants|Number|172|172.0||||||
4146820|NCT00864383|3970743|B1|Current||Smoking status||participants|Number|145|145.0||||||
4146821|NCT00864383|3970740|B4|Past||Smoking status||participants|Number|364|364.0||||||
4146822|NCT00864383|3970741|B3|Past||Smoking status||participants|Number|134|134.0||||||
4146823|NCT00864383|3970742|B2|Past||Smoking status||participants|Number|111|111.0||||||
4146824|NCT00864383|3970743|B1|Past||Smoking status||participants|Number|119|119.0||||||
4146825|NCT00864383|3970740|B4|Never||Smoking status||participants|Number|707|707.0||||||
4146826|NCT00864383|3970741|B3|Never||Smoking status||participants|Number|230|230.0||||||
4146827|NCT00864383|3970742|B2|Never||Smoking status||participants|Number|231|231.0||||||
4146828|NCT00864383|3970743|B1|Never||Smoking status||participants|Number|246|246.0||||||
4146829|NCT00864383|3970740|B4|> 75 kg||Weight group||participants|Number|31|31.0||||||
4146830|NCT00864383|3970741|B3|> 75 kg||Weight group||participants|Number|6|6.0||||||
4146831|NCT00864383|3970742|B2|> 75 kg||Weight group||participants|Number|12|12.0||||||
4146832|NCT00864383|3970743|B1|> 75 kg||Weight group||participants|Number|13|13.0||||||
4146833|NCT00864383|3970740|B4|> 55-75 kg||Weight group||participants|Number|493|493.0||||||
4146834|NCT00864383|3970741|B3|> 55-75 kg||Weight group||participants|Number|174|174.0||||||
4146835|NCT00864383|3970742|B2|> 55-75 kg||Weight group||participants|Number|158|158.0||||||
4146836|NCT00864383|3970743|B1|> 55-75 kg||Weight group||participants|Number|161|161.0||||||
4146837|NCT00864383|3970740|B4|> 45-55 kg||Weight group||participants|Number|620|620.0||||||
4146838|NCT00864383|3970741|B3|> 45-55 kg||Weight group||participants|Number|204|204.0||||||
4146839|NCT00864383|3970742|B2|> 45-55 kg||Weight group||participants|Number|210|210.0||||||
4146840|NCT00864383|3970743|B1|> 45-55 kg||Weight group||participants|Number|206|206.0||||||
4146841|NCT00864383|3970740|B4|40-45 kg||Weight group||participants|Number|252|252.0||||||
4146842|NCT00864383|3970741|B3|40-45 kg||Weight group||participants|Number|82|82.0||||||
4146843|NCT00864383|3970742|B2|40-45 kg||Weight group||participants|Number|90|90.0||||||
4146844|NCT00864383|3970743|B1|40-45 kg||Weight group||participants|Number|80|80.0||||||
4146845|NCT00864383|3970740|B4|< 40 kg||Weight group||participants|Number|152|152.0||||||
4146846|NCT00864383|3970741|B3|< 40 kg||Weight group||participants|Number|58|58.0||||||
4146847|NCT00864383|3970742|B2|< 40 kg||Weight group||participants|Number|44|44.0||||||
4146848|NCT00864383|3970743|B1|< 40 kg||Weight group||participants|Number|50|50.0||||||
4146849|NCT00864383|3970740|B4|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4146850|NCT00864383|3970741|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4146851|NCT00864383|3970742|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4146852|NCT00864383|3970743|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4146853|NCT00864383|3970740|B4|Mixed race||Race/Ethnicity, Customized||participants|Number|385|385.0||||||
4146854|NCT00864383|3970741|B3|Mixed race||Race/Ethnicity, Customized||participants|Number|126|126.0||||||
4146855|NCT00864383|3970742|B2|Mixed race||Race/Ethnicity, Customized||participants|Number|148|148.0||||||
4146856|NCT00864383|3970743|B1|Mixed race||Race/Ethnicity, Customized||participants|Number|111|111.0||||||
4146857|NCT00864383|3970740|B4|Asian||Race/Ethnicity, Customized||participants|Number|475|475.0||||||
4146858|NCT00864383|3970741|B3|Asian||Race/Ethnicity, Customized||participants|Number|161|161.0||||||
4146859|NCT00864383|3970742|B2|Asian||Race/Ethnicity, Customized||participants|Number|154|154.0||||||
4146860|NCT00864383|3970743|B1|Asian||Race/Ethnicity, Customized||participants|Number|160|160.0||||||
4146861|NCT00864383|3970740|B4|Black||Race/Ethnicity, Customized||participants|Number|685|685.0||||||
4146862|NCT00864383|3970741|B3|Black||Race/Ethnicity, Customized||participants|Number|237|237.0||||||
4146863|NCT00864383|3970742|B2|Black||Race/Ethnicity, Customized||participants|Number|210|210.0||||||
4146864|NCT00864383|3970743|B1|Black||Race/Ethnicity, Customized||participants|Number|238|238.0||||||
4146865|NCT00864383|3970740|B4||Male|Sex: Female, Male||Participants|Count of Participants|1076|1076.0||||||
4146866|NCT00864383|3970741|B3||Male|Sex: Female, Male||Participants|Count of Participants|369|369.0||||||
4146867|NCT00864383|3970742|B2||Male|Sex: Female, Male||Participants|Count of Participants|351|351.0||||||
4146868|NCT00864383|3970743|B1||Male|Sex: Female, Male||Participants|Count of Participants|356|356.0||||||
4146869|NCT00864383|3970740|B4||Female|Sex: Female, Male||Participants|Count of Participants|472|472.0||||||
4146870|NCT00864383|3970741|B3||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4146871|NCT00864383|3970742|B2||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4146872|NCT00864383|3970743|B1||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4146873|NCT00864383|3970740|B4|> 35 years||Age, Customized||participants|Number|598|598.0||||||
4146874|NCT00864383|3970741|B3|> 35 years||Age, Customized||participants|Number|203|203.0||||||
4146875|NCT00864383|3970742|B2|> 35 years||Age, Customized||participants|Number|190|190.0||||||
4146876|NCT00864383|3970743|B1|> 35 years||Age, Customized||participants|Number|205|205.0||||||
4146877|NCT00864383|3970740|B4|25-35 years||Age, Customized||participants|Number|482|482.0||||||
4146878|NCT00864383|3970741|B3|25-35 years||Age, Customized||participants|Number|175|175.0||||||
4146879|NCT00864383|3970742|B2|25-35 years||Age, Customized||participants|Number|162|162.0||||||
4146880|NCT00864383|3970743|B1|25-35 years||Age, Customized||participants|Number|145|145.0||||||
4146881|NCT00864383|3970740|B4|< 25 years||Age, Customized||participants|Number|468|468.0||||||
4146882|NCT00864383|3970741|B3|< 25 years||Age, Customized||participants|Number|146|146.0||||||
4146883|NCT00864383|3970742|B2|< 25 years||Age, Customized||participants|Number|162|162.0||||||
4146884|NCT00864383|3970743|B1|< 25 years||Age, Customized||participants|Number|160|160.0||||||
4146885|NCT00864253|3970777|B3|unknown||BRAF Status|BRAF is a mutation biomarker for melanoma, a human gene that makes the protein B-Raf. The gene is referred to as a protoco-oncogene B Raf and vRaf murine sarcoma viral oncogene homolog B1, while the protein is known as serine/threonine-protein kinase B-Raf. The protein is involved in sending signals inside cells and in directing cell growth. These BRAF mutations were associated with features of high risk melanoma, including truncal primary, earlier age of onset, lack of chronic skin damage and shortened survival. The BRAF statuses included: Wild type and V600E mutation.|participants|Number|173|173.0||||||
4146886|NCT00864253|3970778|B2|unknown||BRAF Status|BRAF is a mutation biomarker for melanoma, a human gene that makes the protein B-Raf. The gene is referred to as a protoco-oncogene B Raf and vRaf murine sarcoma viral oncogene homolog B1, while the protein is known as serine/threonine-protein kinase B-Raf. The protein is involved in sending signals inside cells and in directing cell growth. These BRAF mutations were associated with features of high risk melanoma, including truncal primary, earlier age of onset, lack of chronic skin damage and shortened survival. The BRAF statuses included: Wild type and V600E mutation.|participants|Number|90|90.0||||||
4146887|NCT00864253|3970779|B1|unknown||BRAF Status|BRAF is a mutation biomarker for melanoma, a human gene that makes the protein B-Raf. The gene is referred to as a protoco-oncogene B Raf and vRaf murine sarcoma viral oncogene homolog B1, while the protein is known as serine/threonine-protein kinase B-Raf. The protein is involved in sending signals inside cells and in directing cell growth. These BRAF mutations were associated with features of high risk melanoma, including truncal primary, earlier age of onset, lack of chronic skin damage and shortened survival. The BRAF statuses included: Wild type and V600E mutation.|participants|Number|83|83.0||||||
4146888|NCT00864253|3970777|B3|Wild Type (mutation negative)||BRAF Status|BRAF is a mutation biomarker for melanoma, a human gene that makes the protein B-Raf. The gene is referred to as a protoco-oncogene B Raf and vRaf murine sarcoma viral oncogene homolog B1, while the protein is known as serine/threonine-protein kinase B-Raf. The protein is involved in sending signals inside cells and in directing cell growth. These BRAF mutations were associated with features of high risk melanoma, including truncal primary, earlier age of onset, lack of chronic skin damage and shortened survival. The BRAF statuses included: Wild type and V600E mutation.|participants|Number|224|224.0||||||
4146953|NCT00864227|3970810|B1|Biphenotypic/Undifferentiated Leukemia||Primary Disease||participants|Number|1|1.0||||||
4146954|NCT00864227|3970810|B1|Acute Myelogeneous Leukemia||Primary Disease||participants|Number|29|29.0||||||
4146889|NCT00864253|3970778|B2|Wild Type (mutation negative)||BRAF Status|BRAF is a mutation biomarker for melanoma, a human gene that makes the protein B-Raf. The gene is referred to as a protoco-oncogene B Raf and vRaf murine sarcoma viral oncogene homolog B1, while the protein is known as serine/threonine-protein kinase B-Raf. The protein is involved in sending signals inside cells and in directing cell growth. These BRAF mutations were associated with features of high risk melanoma, including truncal primary, earlier age of onset, lack of chronic skin damage and shortened survival. The BRAF statuses included: Wild type and V600E mutation.|participants|Number|108|108.0||||||
4146890|NCT00864253|3970779|B1|Wild Type (mutation negative)||BRAF Status|BRAF is a mutation biomarker for melanoma, a human gene that makes the protein B-Raf. The gene is referred to as a protoco-oncogene B Raf and vRaf murine sarcoma viral oncogene homolog B1, while the protein is known as serine/threonine-protein kinase B-Raf. The protein is involved in sending signals inside cells and in directing cell growth. These BRAF mutations were associated with features of high risk melanoma, including truncal primary, earlier age of onset, lack of chronic skin damage and shortened survival. The BRAF statuses included: Wild type and V600E mutation.|participants|Number|116|116.0||||||
4146891|NCT00864253|3970777|B3|V 600 E||BRAF Status|BRAF is a mutation biomarker for melanoma, a human gene that makes the protein B-Raf. The gene is referred to as a protoco-oncogene B Raf and vRaf murine sarcoma viral oncogene homolog B1, while the protein is known as serine/threonine-protein kinase B-Raf. The protein is involved in sending signals inside cells and in directing cell growth. These BRAF mutations were associated with features of high risk melanoma, including truncal primary, earlier age of onset, lack of chronic skin damage and shortened survival. The BRAF statuses included: Wild type and V600E mutation.|participants|Number|132|132.0||||||
4146892|NCT00864253|3970778|B2|V 600 E||BRAF Status|BRAF is a mutation biomarker for melanoma, a human gene that makes the protein B-Raf. The gene is referred to as a protoco-oncogene B Raf and vRaf murine sarcoma viral oncogene homolog B1, while the protein is known as serine/threonine-protein kinase B-Raf. The protein is involved in sending signals inside cells and in directing cell growth. These BRAF mutations were associated with features of high risk melanoma, including truncal primary, earlier age of onset, lack of chronic skin damage and shortened survival. The BRAF statuses included: Wild type and V600E mutation.|participants|Number|67|67.0||||||
4146893|NCT00864253|3970779|B1|V 600 E||BRAF Status|BRAF is a mutation biomarker for melanoma, a human gene that makes the protein B-Raf. The gene is referred to as a protoco-oncogene B Raf and vRaf murine sarcoma viral oncogene homolog B1, while the protein is known as serine/threonine-protein kinase B-Raf. The protein is involved in sending signals inside cells and in directing cell growth. These BRAF mutations were associated with features of high risk melanoma, including truncal primary, earlier age of onset, lack of chronic skin damage and shortened survival. The BRAF statuses included: Wild type and V600E mutation.|participants|Number|65|65.0||||||
4146894|NCT00864253|3970777|B3|M1c||Metastatic Stage|Distant Metastatic (M) Stages: MX: Distant metastasis cannot be assessed; M0: No distant metastasis; M1= Distant metastasis; M1a: Metastasis to skin, subcutaneous tissues or distant lymph nodes; M1b: metastasis to lung; M1c: metastasis to all other visceral sites or distant metastasis at any site associated with an elevated serum lactic dehyrogenase|participants|Number|346|346.0||||||
4146895|NCT00864253|3970778|B2|M1c||Metastatic Stage|Distant Metastatic (M) Stages: MX: Distant metastasis cannot be assessed; M0: No distant metastasis; M1= Distant metastasis; M1a: Metastasis to skin, subcutaneous tissues or distant lymph nodes; M1b: metastasis to lung; M1c: metastasis to all other visceral sites or distant metastasis at any site associated with an elevated serum lactic dehyrogenase|participants|Number|175|175.0||||||
4146896|NCT00864253|3970779|B1|M1c||Metastatic Stage|Distant Metastatic (M) Stages: MX: Distant metastasis cannot be assessed; M0: No distant metastasis; M1= Distant metastasis; M1a: Metastasis to skin, subcutaneous tissues or distant lymph nodes; M1b: metastasis to lung; M1c: metastasis to all other visceral sites or distant metastasis at any site associated with an elevated serum lactic dehyrogenase|participants|Number|171|171.0||||||
4146897|NCT00864253|3970777|B3|M1b||Metastatic Stage|Distant Metastatic (M) Stages: MX: Distant metastasis cannot be assessed; M0: No distant metastasis; M1= Distant metastasis; M1a: Metastasis to skin, subcutaneous tissues or distant lymph nodes; M1b: metastasis to lung; M1c: metastasis to all other visceral sites or distant metastasis at any site associated with an elevated serum lactic dehyrogenase|participants|Number|135|135.0||||||
4146898|NCT00864253|3970778|B2|M1b||Metastatic Stage|Distant Metastatic (M) Stages: MX: Distant metastasis cannot be assessed; M0: No distant metastasis; M1= Distant metastasis; M1a: Metastasis to skin, subcutaneous tissues or distant lymph nodes; M1b: metastasis to lung; M1c: metastasis to all other visceral sites or distant metastasis at any site associated with an elevated serum lactic dehyrogenase|participants|Number|69|69.0||||||
4146899|NCT00864253|3970779|B1|M1b||Metastatic Stage|Distant Metastatic (M) Stages: MX: Distant metastasis cannot be assessed; M0: No distant metastasis; M1= Distant metastasis; M1a: Metastasis to skin, subcutaneous tissues or distant lymph nodes; M1b: metastasis to lung; M1c: metastasis to all other visceral sites or distant metastasis at any site associated with an elevated serum lactic dehyrogenase|participants|Number|66|66.0||||||
4146900|NCT00864253|3970777|B3|M1a||Metastatic Stage|Distant Metastatic (M) Stages: MX: Distant metastasis cannot be assessed; M0: No distant metastasis; M1= Distant metastasis; M1a: Metastasis to skin, subcutaneous tissues or distant lymph nodes; M1b: metastasis to lung; M1c: metastasis to all other visceral sites or distant metastasis at any site associated with an elevated serum lactic dehyrogenase|participants|Number|48|48.0||||||
4146901|NCT00864253|3970778|B2|M1a||Metastatic Stage|Distant Metastatic (M) Stages: MX: Distant metastasis cannot be assessed; M0: No distant metastasis; M1= Distant metastasis; M1a: Metastasis to skin, subcutaneous tissues or distant lymph nodes; M1b: metastasis to lung; M1c: metastasis to all other visceral sites or distant metastasis at any site associated with an elevated serum lactic dehyrogenase|participants|Number|21|21.0||||||
4146902|NCT00864253|3970779|B1|M1a||Metastatic Stage|Distant Metastatic (M) Stages: MX: Distant metastasis cannot be assessed; M0: No distant metastasis; M1= Distant metastasis; M1a: Metastasis to skin, subcutaneous tissues or distant lymph nodes; M1b: metastasis to lung; M1c: metastasis to all other visceral sites or distant metastasis at any site associated with an elevated serum lactic dehyrogenase|participants|Number|27|27.0||||||
4146955|NCT00864227|3970810|B1|Acute Lymphoblastic Leukemia||Primary Disease||participants|Number|6|6.0||||||
4147122|NCT00863746|3970924|B3|< 65 years||Age, Customized||Participants|Number|461|461.0||||||
4146903|NCT00864253|3970777|B3|>2 * ULN||Baseline Lactate Dehydrogenase value|The serum level of Lactate Dehydrogenase (LDH) is considered a risk factor for overall survival in participants with metastatic melanoma. LDH is a blood test used as a general indicator of the existence and severity of acute or chronic tissue damage and used to monitor cancers such as metastatic melanoma. The baseline LDH value was considered to be the last central laboratory LDH value before randomization. If the central laboratory data was not available, the last non-missing local laboratory value before randomization was used.|participants|Number|4|4.0||||||
4146904|NCT00864253|3970778|B2|>2 * ULN||Baseline Lactate Dehydrogenase value|The serum level of Lactate Dehydrogenase (LDH) is considered a risk factor for overall survival in participants with metastatic melanoma. LDH is a blood test used as a general indicator of the existence and severity of acute or chronic tissue damage and used to monitor cancers such as metastatic melanoma. The baseline LDH value was considered to be the last central laboratory LDH value before randomization. If the central laboratory data was not available, the last non-missing local laboratory value before randomization was used.|participants|Number|1|1.0||||||
4146905|NCT00864253|3970779|B1|>2 * ULN||Baseline Lactate Dehydrogenase value|The serum level of Lactate Dehydrogenase (LDH) is considered a risk factor for overall survival in participants with metastatic melanoma. LDH is a blood test used as a general indicator of the existence and severity of acute or chronic tissue damage and used to monitor cancers such as metastatic melanoma. The baseline LDH value was considered to be the last central laboratory LDH value before randomization. If the central laboratory data was not available, the last non-missing local laboratory value before randomization was used.|participants|Number|3|3.0||||||
4146906|NCT00864253|3970777|B3|>1.1-2 * ULN||Baseline Lactate Dehydrogenase value|The serum level of Lactate Dehydrogenase (LDH) is considered a risk factor for overall survival in participants with metastatic melanoma. LDH is a blood test used as a general indicator of the existence and severity of acute or chronic tissue damage and used to monitor cancers such as metastatic melanoma. The baseline LDH value was considered to be the last central laboratory LDH value before randomization. If the central laboratory data was not available, the last non-missing local laboratory value before randomization was used.|participants|Number|107|107.0||||||
4146907|NCT00864253|3970778|B2|>1.1-2 * ULN||Baseline Lactate Dehydrogenase value|The serum level of Lactate Dehydrogenase (LDH) is considered a risk factor for overall survival in participants with metastatic melanoma. LDH is a blood test used as a general indicator of the existence and severity of acute or chronic tissue damage and used to monitor cancers such as metastatic melanoma. The baseline LDH value was considered to be the last central laboratory LDH value before randomization. If the central laboratory data was not available, the last non-missing local laboratory value before randomization was used.|participants|Number|56|56.0||||||
4146908|NCT00864253|3970779|B1|>1.1-2 * ULN||Baseline Lactate Dehydrogenase value|The serum level of Lactate Dehydrogenase (LDH) is considered a risk factor for overall survival in participants with metastatic melanoma. LDH is a blood test used as a general indicator of the existence and severity of acute or chronic tissue damage and used to monitor cancers such as metastatic melanoma. The baseline LDH value was considered to be the last central laboratory LDH value before randomization. If the central laboratory data was not available, the last non-missing local laboratory value before randomization was used.|participants|Number|51|51.0||||||
4146909|NCT00864253|3970777|B3|0.8-1.1 * ULN||Baseline Lactate Dehydrogenase value|The serum level of Lactate Dehydrogenase (LDH) is considered a risk factor for overall survival in participants with metastatic melanoma. LDH is a blood test used as a general indicator of the existence and severity of acute or chronic tissue damage and used to monitor cancers such as metastatic melanoma. The baseline LDH value was considered to be the last central laboratory LDH value before randomization. If the central laboratory data was not available, the last non-missing local laboratory value before randomization was used.|participants|Number|141|141.0||||||
4146910|NCT00864253|3970778|B2|0.8-1.1 * ULN||Baseline Lactate Dehydrogenase value|The serum level of Lactate Dehydrogenase (LDH) is considered a risk factor for overall survival in participants with metastatic melanoma. LDH is a blood test used as a general indicator of the existence and severity of acute or chronic tissue damage and used to monitor cancers such as metastatic melanoma. The baseline LDH value was considered to be the last central laboratory LDH value before randomization. If the central laboratory data was not available, the last non-missing local laboratory value before randomization was used.|participants|Number|69|69.0||||||
4146911|NCT00864253|3970779|B1|0.8-1.1 * ULN||Baseline Lactate Dehydrogenase value|The serum level of Lactate Dehydrogenase (LDH) is considered a risk factor for overall survival in participants with metastatic melanoma. LDH is a blood test used as a general indicator of the existence and severity of acute or chronic tissue damage and used to monitor cancers such as metastatic melanoma. The baseline LDH value was considered to be the last central laboratory LDH value before randomization. If the central laboratory data was not available, the last non-missing local laboratory value before randomization was used.|participants|Number|72|72.0||||||
4146912|NCT00864253|3970777|B3|<0.8 * Upper Limit of Normal (ULN)||Baseline Lactate Dehydrogenase value|The serum level of Lactate Dehydrogenase (LDH) is considered a risk factor for overall survival in participants with metastatic melanoma. LDH is a blood test used as a general indicator of the existence and severity of acute or chronic tissue damage and used to monitor cancers such as metastatic melanoma. The baseline LDH value was considered to be the last central laboratory LDH value before randomization. If the central laboratory data was not available, the last non-missing local laboratory value before randomization was used.|participants|Number|277|277.0||||||
4146913|NCT00864253|3970778|B2|<0.8 * Upper Limit of Normal (ULN)||Baseline Lactate Dehydrogenase value|The serum level of Lactate Dehydrogenase (LDH) is considered a risk factor for overall survival in participants with metastatic melanoma. LDH is a blood test used as a general indicator of the existence and severity of acute or chronic tissue damage and used to monitor cancers such as metastatic melanoma. The baseline LDH value was considered to be the last central laboratory LDH value before randomization. If the central laboratory data was not available, the last non-missing local laboratory value before randomization was used.|participants|Number|139|139.0||||||
4146956|NCT00864227|3970810|B1|60%||Karnofsky Performance-status Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|1|1.0||||||
4146957|NCT00864227|3970810|B1|70%||Karnofsky Performance-status Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|2|2.0||||||
4146914|NCT00864253|3970779|B1|<0.8 * Upper Limit of Normal (ULN)||Baseline Lactate Dehydrogenase value|The serum level of Lactate Dehydrogenase (LDH) is considered a risk factor for overall survival in participants with metastatic melanoma. LDH is a blood test used as a general indicator of the existence and severity of acute or chronic tissue damage and used to monitor cancers such as metastatic melanoma. The baseline LDH value was considered to be the last central laboratory LDH value before randomization. If the central laboratory data was not available, the last non-missing local laboratory value before randomization was used.|participants|Number|138|138.0||||||
4146915|NCT00864253|3970777|B3|4 = Completely Disabled||Eastern Cooperative Oncology Group Performance Status|ECOG-Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|0|0.0||||||
4146916|NCT00864253|3970778|B2|4 = Completely Disabled||Eastern Cooperative Oncology Group Performance Status|ECOG-Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|0|0.0||||||
4146917|NCT00864253|3970779|B1|4 = Completely Disabled||Eastern Cooperative Oncology Group Performance Status|ECOG-Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|0|0.0||||||
4146918|NCT00864253|3970777|B3|3 = Limited Self-Care||Eastern Cooperative Oncology Group Performance Status|ECOG-Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|0|0.0||||||
4146919|NCT00864253|3970778|B2|3 = Limited Self-Care||Eastern Cooperative Oncology Group Performance Status|ECOG-Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|0|0.0||||||
4146920|NCT00864253|3970779|B1|3 = Limited Self-Care||Eastern Cooperative Oncology Group Performance Status|ECOG-Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|0|0.0||||||
4146921|NCT00864253|3970777|B3|2 = Ambulatory but Unable to Work||Eastern Cooperative Oncology Group Performance Status|ECOG-Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|3|3.0||||||
4146922|NCT00864253|3970778|B2|2 = Ambulatory but Unable to Work||Eastern Cooperative Oncology Group Performance Status|ECOG-Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|2|2.0||||||
4146923|NCT00864253|3970779|B1|2 = Ambulatory but Unable to Work||Eastern Cooperative Oncology Group Performance Status|ECOG-Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|1|1.0||||||
4146924|NCT00864253|3970777|B3|1= Restrictive but Ambulatory||Eastern Cooperative Oncology Group Performance Status|ECOG-Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|150|150.0||||||
4146958|NCT00864227|3970810|B1|80%||Karnofsky Performance-status Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|7|7.0||||||
4146959|NCT00864227|3970810|B1|90%||Karnofsky Performance-status Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|30|30.0||||||
4146925|NCT00864253|3970778|B2|1= Restrictive but Ambulatory||Eastern Cooperative Oncology Group Performance Status|ECOG-Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|82|82.0||||||
4146926|NCT00864253|3970779|B1|1= Restrictive but Ambulatory||Eastern Cooperative Oncology Group Performance Status|ECOG-Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|68|68.0||||||
4146927|NCT00864253|3970777|B3|0 = Fully Active||Eastern Cooperative Oncology Group Performance Status|ECOG-Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|376|376.0||||||
4146928|NCT00864253|3970778|B2|0 = Fully Active||Eastern Cooperative Oncology Group Performance Status|ECOG-Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|181|181.0||||||
4146929|NCT00864253|3970779|B1|0 = Fully Active||Eastern Cooperative Oncology Group Performance Status|ECOG-Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|195|195.0||||||
4146930|NCT00864253|3970777|B3||Male|Sex: Female, Male||Participants|Count of Participants|347|347.0||||||
4146931|NCT00864253|3970778|B2||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4146932|NCT00864253|3970779|B1||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4146933|NCT00864253|3970777|B3||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4146934|NCT00864253|3970778|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4146935|NCT00864253|3970779|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4146936|NCT00864253|3970777|B3|||Age||years|Median|63.0|63.0|Full Range|12.85|12.85|21.0|87.0|
4146937|NCT00864253|3970778|B2|||Age||years|Median|64.0|64.0|Full Range|12.06|12.06|28.0|87.0|
4146938|NCT00864253|3970779|B1|||Age||years|Median|62.0|62.0|Full Range|13.44|13.44|21.0|85.0|
4146939|NCT00864227|3970810|B1|6/6||HLA Typing Match Score - 1st Cord to 2nd Cord|Units must be HLA-matched at 4 of 6 HLA-A and B (intermediate resolution molecular typing) and DRB1 (high resolution molecular typing) with each other and 4 of 6 with the recipient.|participants|Number|4|4.0||||||
4146940|NCT00864227|3970810|B1|5/6||HLA Typing Match Score - 1st Cord to 2nd Cord|Units must be HLA-matched at 4 of 6 HLA-A and B (intermediate resolution molecular typing) and DRB1 (high resolution molecular typing) with each other and 4 of 6 with the recipient.|participants|Number|11|11.0||||||
4146941|NCT00864227|3970810|B1|4/6||HLA Typing Match Score - 1st Cord to 2nd Cord|Units must be HLA-matched at 4 of 6 HLA-A and B (intermediate resolution molecular typing) and DRB1 (high resolution molecular typing) with each other and 4 of 6 with the recipient.|participants|Number|35|35.0||||||
4146942|NCT00864227|3970810|B1|6/6||HLA Typing Match Score - 2nd Cord|Units must be HLA-matched at 4 of 6 HLA-A and B (intermediate resolution molecular typing) and DRB1 (high resolution molecular typing) with each other and 4 of 6 with the recipient.|participants|Number|3|3.0||||||
4146943|NCT00864227|3970810|B1|5/6||HLA Typing Match Score - 2nd Cord|Units must be HLA-matched at 4 of 6 HLA-A and B (intermediate resolution molecular typing) and DRB1 (high resolution molecular typing) with each other and 4 of 6 with the recipient.|participants|Number|17|17.0||||||
4146944|NCT00864227|3970810|B1|4/6||HLA Typing Match Score - 2nd Cord|Units must be HLA-matched at 4 of 6 HLA-A and B (intermediate resolution molecular typing) and DRB1 (high resolution molecular typing) with each other and 4 of 6 with the recipient.|participants|Number|30|30.0||||||
4146945|NCT00864227|3970810|B1|6/6||HLA Typing Match Score - 1st Cord|Units must be HLA-matched at 4 of 6 HLA-A and B (intermediate resolution molecular typing) and DRB1 (high resolution molecular typing) with each other and 4 of 6 with the recipient.|participants|Number|5|5.0||||||
4146946|NCT00864227|3970810|B1|5/6||HLA Typing Match Score - 1st Cord|Units must be HLA-matched at 4 of 6 HLA-A and B (intermediate resolution molecular typing) and DRB1 (high resolution molecular typing) with each other and 4 of 6 with the recipient.|participants|Number|21|21.0||||||
4146947|NCT00864227|3970810|B1|4/6||HLA Typing Match Score - 1st Cord|Units must be HLA-matched at 4 of 6 HLA-A and B (intermediate resolution molecular typing) and DRB1 (high resolution molecular typing) with each other and 4 of 6 with the recipient.|participants|Number|24|24.0||||||
4146948|NCT00864227|3970810|B1|Follicular Non-Hodgkins Lymphoma||Primary Disease||participants|Number|4|4.0||||||
4146949|NCT00864227|3970810|B1|Marginal Zone B-cell Lymphoma||Primary Disease||participants|Number|1|1.0||||||
4146950|NCT00864227|3970810|B1|Large Cell Lymphoma||Primary Disease||participants|Number|3|3.0||||||
4146951|NCT00864227|3970810|B1|Hodgkins Lymphoma||Primary Disease||participants|Number|5|5.0||||||
4146952|NCT00864227|3970810|B1|Burkitt's Lymphoma||Primary Disease||participants|Number|1|1.0||||||
4146960|NCT00864227|3970810|B1|100%||Karnofsky Performance-status Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|10|10.0||||||
4146961|NCT00864227|3970810|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146962|NCT00864227|3970810|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146963|NCT00864227|3970810|B1||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4146964|NCT00864227|3970810|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4146965|NCT00864227|3970810|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146966|NCT00864227|3970810|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4146967|NCT00864227|3970810|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4146968|NCT00864227|3970810|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4146969|NCT00864227|3970810|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4146970|NCT00864227|3970810|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4146971|NCT00864227|3970810|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4146972|NCT00864227|3970810|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4146973|NCT00864227|3970810|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|13.6|13.6|||
4146974|NCT00864123|3970825|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4146975|NCT00864123|3970826|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4146976|NCT00864123|3970827|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4146977|NCT00864123|3970825|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4146978|NCT00864123|3970826|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4146979|NCT00864123|3970827|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4146980|NCT00864123|3970825|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4146981|NCT00864123|3970826|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4146982|NCT00864123|3970827|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4146983|NCT00864123|3970825|B3|||Age||years|Mean|12.2|12.2|Standard Deviation|2.8|2.8|||
4146984|NCT00864123|3970826|B2|||Age||years|Mean|11.9|11.9|Standard Deviation|1.9|1.9|||
4146985|NCT00864123|3970827|B1|||Age||years|Mean|12.5|12.5|Standard Deviation|3.5|3.5|||
4146986|NCT00864123|3970825|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4146987|NCT00864123|3970826|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4146988|NCT00864123|3970827|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4146989|NCT00864123|3970825|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4146990|NCT00864123|3970826|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4146991|NCT00864123|3970827|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4146992|NCT00864123|3970825|B3||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4146993|NCT00864123|3970826|B2||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4146994|NCT00864123|3970827|B1||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4146995|NCT00864084|3970838|B1|Canada||Region of Enrollment||participants|Number|14|14.0||||||
4146996|NCT00864084|3970838|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4146997|NCT00864084|3970838|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4146998|NCT00864084|3970838|B1|||Age||years|Mean|69.6|69.6|Standard Deviation|8.3|8.3|||
4146999|NCT00864084|3970838|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4147000|NCT00864084|3970838|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4147001|NCT00864084|3970838|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4147002|NCT00864032|3970861|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4147003|NCT00864032|3970861|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4147004|NCT00864032|3970861|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4147005|NCT00864032|3970861|B1|||Age||years|Mean|44|44.0|Standard Deviation|12|12.0|||
4147006|NCT00864032|3970861|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4147007|NCT00864032|3970861|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4147008|NCT00864032|3970861|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4147009|NCT00863798|3970869|B4|Suicidal ideation||Participants with Columbia Suicide-Severity Rating Scale (C-SSRS) total score|C-SSRS was mapped into Columbia Classification Algorithm of Suicide Assessment (C-CASA)(1-4) to prospectively assess whether participants experienced: completed suicide(1),suicide attempt(2),preparatory acts toward imminent suicidal behavior(3),suicidal ideation,any suicidal behavior and ideation(4).Participants with “yes” response were reported.|Participants|Number|97|97.0||||||
4147010|NCT00863798|3970870|B3|Suicidal ideation||Participants with Columbia Suicide-Severity Rating Scale (C-SSRS) total score|C-SSRS was mapped into Columbia Classification Algorithm of Suicide Assessment (C-CASA)(1-4) to prospectively assess whether participants experienced: completed suicide(1),suicide attempt(2),preparatory acts toward imminent suicidal behavior(3),suicidal ideation,any suicidal behavior and ideation(4).Participants with “yes” response were reported.|Participants|Number|29|29.0||||||
4147070|NCT00863746|3970926|B1|1||ECOG (Eastern Cooperative Oncology Group) performance status|A scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|233|233.0||||||
4147011|NCT00863798|3970871|B2|Suicidal ideation||Participants with Columbia Suicide-Severity Rating Scale (C-SSRS) total score|C-SSRS was mapped into Columbia Classification Algorithm of Suicide Assessment (C-CASA)(1-4) to prospectively assess whether participants experienced: completed suicide(1),suicide attempt(2),preparatory acts toward imminent suicidal behavior(3),suicidal ideation,any suicidal behavior and ideation(4).Participants with “yes” response were reported.|Participants|Number|31|31.0||||||
4147012|NCT00863798|3970872|B1|Suicidal ideation||Participants with Columbia Suicide-Severity Rating Scale (C-SSRS) total score|C-SSRS was mapped into Columbia Classification Algorithm of Suicide Assessment (C-CASA)(1-4) to prospectively assess whether participants experienced: completed suicide(1),suicide attempt(2),preparatory acts toward imminent suicidal behavior(3),suicidal ideation,any suicidal behavior and ideation(4).Participants with “yes” response were reported.|Participants|Number|37|37.0||||||
4147013|NCT00863798|3970869|B4|Preparatory acts toward imminent suicidal behavior||Participants with Columbia Suicide-Severity Rating Scale (C-SSRS) total score|C-SSRS was mapped into Columbia Classification Algorithm of Suicide Assessment (C-CASA)(1-4) to prospectively assess whether participants experienced: completed suicide(1),suicide attempt(2),preparatory acts toward imminent suicidal behavior(3),suicidal ideation,any suicidal behavior and ideation(4).Participants with “yes” response were reported.|Participants|Number|0|0.0||||||
4147014|NCT00863798|3970870|B3|Preparatory acts toward imminent suicidal behavior||Participants with Columbia Suicide-Severity Rating Scale (C-SSRS) total score|C-SSRS was mapped into Columbia Classification Algorithm of Suicide Assessment (C-CASA)(1-4) to prospectively assess whether participants experienced: completed suicide(1),suicide attempt(2),preparatory acts toward imminent suicidal behavior(3),suicidal ideation,any suicidal behavior and ideation(4).Participants with “yes” response were reported.|Participants|Number|0|0.0||||||
4147015|NCT00863798|3970871|B2|Preparatory acts toward imminent suicidal behavior||Participants with Columbia Suicide-Severity Rating Scale (C-SSRS) total score|C-SSRS was mapped into Columbia Classification Algorithm of Suicide Assessment (C-CASA)(1-4) to prospectively assess whether participants experienced: completed suicide(1),suicide attempt(2),preparatory acts toward imminent suicidal behavior(3),suicidal ideation,any suicidal behavior and ideation(4).Participants with “yes” response were reported.|Participants|Number|0|0.0||||||
4147016|NCT00863798|3970872|B1|Preparatory acts toward imminent suicidal behavior||Participants with Columbia Suicide-Severity Rating Scale (C-SSRS) total score|C-SSRS was mapped into Columbia Classification Algorithm of Suicide Assessment (C-CASA)(1-4) to prospectively assess whether participants experienced: completed suicide(1),suicide attempt(2),preparatory acts toward imminent suicidal behavior(3),suicidal ideation,any suicidal behavior and ideation(4).Participants with “yes” response were reported.|Participants|Number|0|0.0||||||
4147017|NCT00863798|3970869|B4|Suicide Attempt||Participants with Columbia Suicide-Severity Rating Scale (C-SSRS) total score|C-SSRS was mapped into Columbia Classification Algorithm of Suicide Assessment (C-CASA)(1-4) to prospectively assess whether participants experienced: completed suicide(1),suicide attempt(2),preparatory acts toward imminent suicidal behavior(3),suicidal ideation,any suicidal behavior and ideation(4).Participants with “yes” response were reported.|Participants|Number|0|0.0||||||
4147018|NCT00863798|3970870|B3|Suicide Attempt||Participants with Columbia Suicide-Severity Rating Scale (C-SSRS) total score|C-SSRS was mapped into Columbia Classification Algorithm of Suicide Assessment (C-CASA)(1-4) to prospectively assess whether participants experienced: completed suicide(1),suicide attempt(2),preparatory acts toward imminent suicidal behavior(3),suicidal ideation,any suicidal behavior and ideation(4).Participants with “yes” response were reported.|Participants|Number|0|0.0||||||
4147019|NCT00863798|3970871|B2|Suicide Attempt||Participants with Columbia Suicide-Severity Rating Scale (C-SSRS) total score|C-SSRS was mapped into Columbia Classification Algorithm of Suicide Assessment (C-CASA)(1-4) to prospectively assess whether participants experienced: completed suicide(1),suicide attempt(2),preparatory acts toward imminent suicidal behavior(3),suicidal ideation,any suicidal behavior and ideation(4).Participants with “yes” response were reported.|Participants|Number|0|0.0||||||
4147020|NCT00863798|3970872|B1|Suicide Attempt||Participants with Columbia Suicide-Severity Rating Scale (C-SSRS) total score|C-SSRS was mapped into Columbia Classification Algorithm of Suicide Assessment (C-CASA)(1-4) to prospectively assess whether participants experienced: completed suicide(1),suicide attempt(2),preparatory acts toward imminent suicidal behavior(3),suicidal ideation,any suicidal behavior and ideation(4).Participants with “yes” response were reported.|Participants|Number|0|0.0||||||
4147021|NCT00863798|3970869|B4|Completed Suicide||Participants with Columbia Suicide-Severity Rating Scale (C-SSRS) total score|C-SSRS was mapped into Columbia Classification Algorithm of Suicide Assessment (C-CASA)(1-4) to prospectively assess whether participants experienced: completed suicide(1),suicide attempt(2),preparatory acts toward imminent suicidal behavior(3),suicidal ideation,any suicidal behavior and ideation(4).Participants with “yes” response were reported.|Participants|Number|0|0.0||||||
4147022|NCT00863798|3970870|B3|Completed Suicide||Participants with Columbia Suicide-Severity Rating Scale (C-SSRS) total score|C-SSRS was mapped into Columbia Classification Algorithm of Suicide Assessment (C-CASA)(1-4) to prospectively assess whether participants experienced: completed suicide(1),suicide attempt(2),preparatory acts toward imminent suicidal behavior(3),suicidal ideation,any suicidal behavior and ideation(4).Participants with “yes” response were reported.|Participants|Number|0|0.0||||||
4147023|NCT00863798|3970871|B2|Completed Suicide||Participants with Columbia Suicide-Severity Rating Scale (C-SSRS) total score|C-SSRS was mapped into Columbia Classification Algorithm of Suicide Assessment (C-CASA)(1-4) to prospectively assess whether participants experienced: completed suicide(1),suicide attempt(2),preparatory acts toward imminent suicidal behavior(3),suicidal ideation,any suicidal behavior and ideation(4).Participants with “yes” response were reported.|Participants|Number|0|0.0||||||
4147024|NCT00863798|3970872|B1|Completed Suicide||Participants with Columbia Suicide-Severity Rating Scale (C-SSRS) total score|C-SSRS was mapped into Columbia Classification Algorithm of Suicide Assessment (C-CASA)(1-4) to prospectively assess whether participants experienced: completed suicide(1),suicide attempt(2),preparatory acts toward imminent suicidal behavior(3),suicidal ideation,any suicidal behavior and ideation(4).Participants with “yes” response were reported.|Participants|Number|0|0.0||||||
4147071|NCT00863746|3970924|B3|0||ECOG (Eastern Cooperative Oncology Group) performance status|A scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|220|220.0||||||
4147123|NCT00863746|3970925|B2|< 65 years||Age, Customized||Participants|Number|222|222.0||||||
4147025|NCT00863798|3970869|B4|||Participants with Sexual dysfunction|Arizona Sexual Experiences Scale (ASEX) includes 5 questions that evaluate sexual function exclusively during week prior to completion in the following areas: libido, excitability and ability to reach orgasm. Sexual dysfunction=ASEX total score of 19 or greater, or a score of 5 or greater on any item, or a score of 4 or greater on any 3 items.|Percentage of Participants|Number|185.9|185.9||||||
4147026|NCT00863798|3970870|B3|||Participants with Sexual dysfunction|Arizona Sexual Experiences Scale (ASEX) includes 5 questions that evaluate sexual function exclusively during week prior to completion in the following areas: libido, excitability and ability to reach orgasm. Sexual dysfunction=ASEX total score of 19 or greater, or a score of 5 or greater on any item, or a score of 4 or greater on any 3 items.|Percentage of Participants|Number|65.8|65.8||||||
4147027|NCT00863798|3970871|B2|||Participants with Sexual dysfunction|Arizona Sexual Experiences Scale (ASEX) includes 5 questions that evaluate sexual function exclusively during week prior to completion in the following areas: libido, excitability and ability to reach orgasm. Sexual dysfunction=ASEX total score of 19 or greater, or a score of 5 or greater on any item, or a score of 4 or greater on any 3 items.|Percentage of Participants|Number|61.3|61.3||||||
4147028|NCT00863798|3970872|B1|||Participants with Sexual dysfunction|Arizona Sexual Experiences Scale (ASEX) includes 5 questions that evaluate sexual function exclusively during week prior to completion in the following areas: libido, excitability and ability to reach orgasm. Sexual dysfunction=ASEX total score of 19 or greater, or a score of 5 or greater on any item, or a score of 4 or greater on any 3 items.|Percentage of Participants|Number|58.8|58.8||||||
4147029|NCT00863798|3970869|B4|||World Health Organization 5-Item Well-Being Index (WHO-5)|WHO-5 evaluates positive psychological well-being. WHO-5 consists of 5 questions and each is rated on a 6-point scale. The total score ranges from 0 to 25 ( 0= worst possible quality of life; 25=best possible quality of life).|Units on a scale|Mean|7.31|7.31|Standard Deviation|4.65|4.65|||
4147030|NCT00863798|3970870|B3|||World Health Organization 5-Item Well-Being Index (WHO-5)|WHO-5 evaluates positive psychological well-being. WHO-5 consists of 5 questions and each is rated on a 6-point scale. The total score ranges from 0 to 25 ( 0= worst possible quality of life; 25=best possible quality of life).|Units on a scale|Mean|7.06|7.06|Standard Deviation|4.26|4.26|||
4147031|NCT00863798|3970871|B2|||World Health Organization 5-Item Well-Being Index (WHO-5)|WHO-5 evaluates positive psychological well-being. WHO-5 consists of 5 questions and each is rated on a 6-point scale. The total score ranges from 0 to 25 ( 0= worst possible quality of life; 25=best possible quality of life).|Units on a scale|Mean|7.47|7.47|Standard Deviation|4.86|4.86|||
4147032|NCT00863798|3970872|B1|||World Health Organization 5-Item Well-Being Index (WHO-5)|WHO-5 evaluates positive psychological well-being. WHO-5 consists of 5 questions and each is rated on a 6-point scale. The total score ranges from 0 to 25 ( 0= worst possible quality of life; 25=best possible quality of life).|Units on a scale|Mean|7.39|7.39|Standard Deviation|4.80|4.8|||
4147033|NCT00863798|3970869|B4|||Sheehan Disability Scale (SDS) Total Score|SDS: a self-administered tool that measures functional impairment in 3 domains: Work/School, Social Life, and Family Life/Home Responsibilities.Participant rates extent to which each of these domains are impaired by his/her symptoms using 10 point visual analog scale:(0=not at all impaired,10=extremely impaired) for total maximum score of 30.|Units on a scale|Mean|16.78|16.78|Standard Deviation|8.12|8.12|||
4147034|NCT00863798|3970870|B3|||Sheehan Disability Scale (SDS) Total Score|SDS: a self-administered tool that measures functional impairment in 3 domains: Work/School, Social Life, and Family Life/Home Responsibilities.Participant rates extent to which each of these domains are impaired by his/her symptoms using 10 point visual analog scale:(0=not at all impaired,10=extremely impaired) for total maximum score of 30.|Units on a scale|Mean|17.06|17.06|Standard Deviation|7.73|7.73|||
4147035|NCT00863798|3970871|B2|||Sheehan Disability Scale (SDS) Total Score|SDS: a self-administered tool that measures functional impairment in 3 domains: Work/School, Social Life, and Family Life/Home Responsibilities.Participant rates extent to which each of these domains are impaired by his/her symptoms using 10 point visual analog scale:(0=not at all impaired,10=extremely impaired) for total maximum score of 30.|Units on a scale|Mean|16.42|16.42|Standard Deviation|8.37|8.37|||
4147036|NCT00863798|3970872|B1|||Sheehan Disability Scale (SDS) Total Score|SDS: a self-administered tool that measures functional impairment in 3 domains: Work/School, Social Life, and Family Life/Home Responsibilities.Participant rates extent to which each of these domains are impaired by his/her symptoms using 10 point visual analog scale:(0=not at all impaired,10=extremely impaired) for total maximum score of 30.|Units on a scale|Mean|16.88|16.88|Standard Deviation|8.25|8.25|||
4147037|NCT00863798|3970869|B4|||HAM-D6 total score|HAM-D6: a standardized, clinician-administered rating scale that assesses 6 items associated with major depression and is a subset of the HAM-D17. HAM-D6 score ranges from 0-22. The scale uses HAM-D17 items: 1, 2, 7, 8, 10 and 13. Item 13 is scored 0-2 and all others are scored 0-4.|Units on a scale|Mean|12.71|12.71|Standard Deviation|1.47|1.47|||
4147038|NCT00863798|3970870|B3|||HAM-D6 total score|HAM-D6: a standardized, clinician-administered rating scale that assesses 6 items associated with major depression and is a subset of the HAM-D17. HAM-D6 score ranges from 0-22. The scale uses HAM-D17 items: 1, 2, 7, 8, 10 and 13. Item 13 is scored 0-2 and all others are scored 0-4.|Units on a scale|Mean|12.63|12.63|Standard Deviation|1.49|1.49|||
4147039|NCT00863798|3970871|B2|||HAM-D6 total score|HAM-D6: a standardized, clinician-administered rating scale that assesses 6 items associated with major depression and is a subset of the HAM-D17. HAM-D6 score ranges from 0-22. The scale uses HAM-D17 items: 1, 2, 7, 8, 10 and 13. Item 13 is scored 0-2 and all others are scored 0-4.|Units on a scale|Mean|12.77|12.77|Standard Deviation|1.41|1.41|||
4147040|NCT00863798|3970872|B1|||HAM-D6 total score|HAM-D6: a standardized, clinician-administered rating scale that assesses 6 items associated with major depression and is a subset of the HAM-D17. HAM-D6 score ranges from 0-22. The scale uses HAM-D17 items: 1, 2, 7, 8, 10 and 13. Item 13 is scored 0-2 and all others are scored 0-4.|Units on a scale|Mean|12.72|12.72|Standard Deviation|1.51|1.51|||
4147041|NCT00863798|3970869|B4|||Montgomery-Asberg Depression Rating Scale (MADRS) total score|MADRS measures the overall severity of depressive symptoms. The MADRS has a 10-item checklist. Items are rated on a scale of 0-6, for a total score range of 0 (low severity of depressive symptoms) to 60 (high severity of depressive symptoms).|Units on a scale|Mean|28.12|28.12|Standard Deviation|4.69|4.69|||
4147120|NCT00863746|3970925|B2|>= 65 and < 75 years||Age, Customized||Participants|Number|102|102.0||||||
4147042|NCT00863798|3970870|B3|||Montgomery-Asberg Depression Rating Scale (MADRS) total score|MADRS measures the overall severity of depressive symptoms. The MADRS has a 10-item checklist. Items are rated on a scale of 0-6, for a total score range of 0 (low severity of depressive symptoms) to 60 (high severity of depressive symptoms).|Units on a scale|Mean|28.44|28.44|Standard Deviation|4.83|4.83|||
4147043|NCT00863798|3970871|B2|||Montgomery-Asberg Depression Rating Scale (MADRS) total score|MADRS measures the overall severity of depressive symptoms. The MADRS has a 10-item checklist. Items are rated on a scale of 0-6, for a total score range of 0 (low severity of depressive symptoms) to 60 (high severity of depressive symptoms).|Units on a scale|Mean|27.59|27.59|Standard Deviation|4.49|4.49|||
4147044|NCT00863798|3970872|B1|||Montgomery-Asberg Depression Rating Scale (MADRS) total score|MADRS measures the overall severity of depressive symptoms. The MADRS has a 10-item checklist. Items are rated on a scale of 0-6, for a total score range of 0 (low severity of depressive symptoms) to 60 (high severity of depressive symptoms).|Units on a scale|Mean|28.33|28.33|Standard Deviation|4.71|4.71|||
4147045|NCT00863798|3970869|B4|||Clinical Global Impressions Scale-Severity of Illness (CGI-S) Score|CGI-S: 7-point clinician rated scale to assess severity of participant's current illness state; range: 1 (normal - not ill at all) to 7 (among the most extremely ill patients). Higher score = more affected.|Units on a scale|Mean|4.14|4.14|Standard Deviation|0.36|0.36|||
4147046|NCT00863798|3970870|B3|||Clinical Global Impressions Scale-Severity of Illness (CGI-S) Score|CGI-S: 7-point clinician rated scale to assess severity of participant's current illness state; range: 1 (normal - not ill at all) to 7 (among the most extremely ill patients). Higher score = more affected.|Units on a scale|Mean|4.16|4.16|Standard Deviation|0.39|0.39|||
4147047|NCT00863798|3970871|B2|||Clinical Global Impressions Scale-Severity of Illness (CGI-S) Score|CGI-S: 7-point clinician rated scale to assess severity of participant's current illness state; range: 1 (normal - not ill at all) to 7 (among the most extremely ill patients). Higher score = more affected.|Units on a scale|Mean|4.14|4.14|Standard Deviation|0.34|0.34|||
4147048|NCT00863798|3970872|B1|||Clinical Global Impressions Scale-Severity of Illness (CGI-S) Score|CGI-S: 7-point clinician rated scale to assess severity of participant's current illness state; range: 1 (normal - not ill at all) to 7 (among the most extremely ill patients). Higher score = more affected.|Units on a scale|Mean|4.14|4.14|Standard Deviation|0.35|0.35|||
4147049|NCT00863798|3970869|B4|||Hamilton Psychiatric Scale for Depression-17 item HAM-D17) total score|HAM-D17 : a standardized, clinician-administered rating scale that assesses 17 items characteristically associated with major depression. Items are scored on either a 3 point (0 to 2) or a 5 point scale (0 to 4), with 0=none/absent and 4=most severe, for a maximum total score of 50.|Units on a scale|Mean|23.06|23.06|Standard Deviation|2.51|2.51|||
4147050|NCT00863798|3970870|B3|||Hamilton Psychiatric Scale for Depression-17 item HAM-D17) total score|HAM-D17 : a standardized, clinician-administered rating scale that assesses 17 items characteristically associated with major depression. Items are scored on either a 3 point (0 to 2) or a 5 point scale (0 to 4), with 0=none/absent and 4=most severe, for a maximum total score of 50.|Units on a scale|Mean|23.12|23.12|Standard Deviation|2.62|2.62|||
4147051|NCT00863798|3970871|B2|||Hamilton Psychiatric Scale for Depression-17 item HAM-D17) total score|HAM-D17 : a standardized, clinician-administered rating scale that assesses 17 items characteristically associated with major depression. Items are scored on either a 3 point (0 to 2) or a 5 point scale (0 to 4), with 0=none/absent and 4=most severe, for a maximum total score of 50.|Units on a scale|Mean|22.83|22.83|Standard Deviation|2.26|2.26|||
4147052|NCT00863798|3970872|B1|||Hamilton Psychiatric Scale for Depression-17 item HAM-D17) total score|HAM-D17 : a standardized, clinician-administered rating scale that assesses 17 items characteristically associated with major depression. Items are scored on either a 3 point (0 to 2) or a 5 point scale (0 to 4), with 0=none/absent and 4=most severe, for a maximum total score of 50.|Units on a scale|Mean|23.23|23.23|Standard Deviation|2.63|2.63|||
4147053|NCT00863798|3970869|B4||Male|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
4147054|NCT00863798|3970870|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4147055|NCT00863798|3970871|B2||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4147056|NCT00863798|3970872|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4147057|NCT00863798|3970869|B4||Female|Sex: Female, Male||Participants|Count of Participants|409|409.0||||||
4147058|NCT00863798|3970870|B3||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4147059|NCT00863798|3970871|B2||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4147060|NCT00863798|3970872|B1||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4147061|NCT00863798|3970869|B4|||Age||Years|Mean|41.74|41.74|Standard Deviation|13.36|13.36|||
4147062|NCT00863798|3970870|B3|||Age||Years|Mean|42.47|42.47|Standard Deviation|13.47|13.47|||
4147063|NCT00863798|3970871|B2|||Age||Years|Mean|41.01|41.01|Standard Deviation|13.75|13.75|||
4147064|NCT00863798|3970872|B1|||Age||Years|Mean|41.75|41.75|Standard Deviation|12.85|12.85|||
4147065|NCT00863746|3970924|B3|2||ECOG (Eastern Cooperative Oncology Group) performance status|A scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|1|1.0||||||
4147066|NCT00863746|3970925|B2|2||ECOG (Eastern Cooperative Oncology Group) performance status|A scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|0|0.0||||||
4147067|NCT00863746|3970926|B1|2||ECOG (Eastern Cooperative Oncology Group) performance status|A scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|1|1.0||||||
4147068|NCT00863746|3970924|B3|1||ECOG (Eastern Cooperative Oncology Group) performance status|A scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|475|475.0||||||
4147069|NCT00863746|3970925|B2|1||ECOG (Eastern Cooperative Oncology Group) performance status|A scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|242|242.0||||||
4147121|NCT00863746|3970926|B1|>= 65 and < 75 years||Age, Customized||Participants|Number|91|91.0||||||
4147072|NCT00863746|3970925|B2|0||ECOG (Eastern Cooperative Oncology Group) performance status|A scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|110|110.0||||||
4147073|NCT00863746|3970926|B1|0||ECOG (Eastern Cooperative Oncology Group) performance status|A scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|110|110.0||||||
4147074|NCT00863746|3970924|B3|Missing||ECOG (Eastern Cooperative Oncology Group) performance status|A scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|7|7.0||||||
4147075|NCT00863746|3970925|B2|Missing||ECOG (Eastern Cooperative Oncology Group) performance status|A scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|1|1.0||||||
4147076|NCT00863746|3970926|B1|Missing||ECOG (Eastern Cooperative Oncology Group) performance status|A scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|6|6.0||||||
4147077|NCT00863746|3970924|B3|Yes||Prior EGFR (Epidermal Growth Factor Receptor) inhibitor treatment||Participants|Number|416|416.0||||||
4147078|NCT00863746|3970925|B2|Yes||Prior EGFR (Epidermal Growth Factor Receptor) inhibitor treatment||Participants|Number|207|207.0||||||
4147079|NCT00863746|3970926|B1|Yes||Prior EGFR (Epidermal Growth Factor Receptor) inhibitor treatment||Participants|Number|209|209.0||||||
4147080|NCT00863746|3970924|B3|No||Prior EGFR (Epidermal Growth Factor Receptor) inhibitor treatment||Participants|Number|287|287.0||||||
4147081|NCT00863746|3970925|B2|No||Prior EGFR (Epidermal Growth Factor Receptor) inhibitor treatment||Participants|Number|146|146.0||||||
4147082|NCT00863746|3970926|B1|No||Prior EGFR (Epidermal Growth Factor Receptor) inhibitor treatment||Participants|Number|141|141.0||||||
4147083|NCT00863746|3970924|B3|Missing||Brain metastasis||Participants|Number|1|1.0||||||
4147084|NCT00863746|3970925|B2|Missing||Brain metastasis||Participants|Number|0|0.0||||||
4147085|NCT00863746|3970926|B1|Missing||Brain metastasis||Participants|Number|1|1.0||||||
4147086|NCT00863746|3970924|B3|Yes||Brain metastasis||Participants|Number|110|110.0||||||
4147087|NCT00863746|3970925|B2|Yes||Brain metastasis||Participants|Number|54|54.0||||||
4147088|NCT00863746|3970926|B1|Yes||Brain metastasis||Participants|Number|56|56.0||||||
4147089|NCT00863746|3970924|B3|No||Brain metastasis||Participants|Number|592|592.0||||||
4147090|NCT00863746|3970925|B2|No||Brain metastasis||Participants|Number|299|299.0||||||
4147091|NCT00863746|3970926|B1|No||Brain metastasis||Participants|Number|293|293.0||||||
4147092|NCT00863746|3970924|B3|5 regimens||Number of participants with prior anti-cancer therapy and diagnostic procedures||Participants|Number|1|1.0||||||
4147093|NCT00863746|3970925|B2|5 regimens||Number of participants with prior anti-cancer therapy and diagnostic procedures||Participants|Number|0|0.0||||||
4147094|NCT00863746|3970926|B1|5 regimens||Number of participants with prior anti-cancer therapy and diagnostic procedures||Participants|Number|1|1.0||||||
4147095|NCT00863746|3970924|B3|4 regimens||Number of participants with prior anti-cancer therapy and diagnostic procedures||Participants|Number|6|6.0||||||
4147096|NCT00863746|3970925|B2|4 regimens||Number of participants with prior anti-cancer therapy and diagnostic procedures||Participants|Number|3|3.0||||||
4147097|NCT00863746|3970926|B1|4 regimens||Number of participants with prior anti-cancer therapy and diagnostic procedures||Participants|Number|3|3.0||||||
4147098|NCT00863746|3970924|B3|3 regimens||Number of participants with prior anti-cancer therapy and diagnostic procedures||Participants|Number|311|311.0||||||
4147099|NCT00863746|3970925|B2|3 regimens||Number of participants with prior anti-cancer therapy and diagnostic procedures||Participants|Number|153|153.0||||||
4147100|NCT00863746|3970926|B1|3 regimens||Number of participants with prior anti-cancer therapy and diagnostic procedures||Participants|Number|158|158.0||||||
4147101|NCT00863746|3970924|B3|2 regimens||Number of participants with prior anti-cancer therapy and diagnostic procedures||Participants|Number|385|385.0||||||
4147102|NCT00863746|3970925|B2|2 regimens||Number of participants with prior anti-cancer therapy and diagnostic procedures||Participants|Number|197|197.0||||||
4147103|NCT00863746|3970926|B1|2 regimens||Number of participants with prior anti-cancer therapy and diagnostic procedures||Participants|Number|188|188.0||||||
4147104|NCT00863746|3970924|B3|Group 2 (S. America, Eastern Europe, Asia-Pacific)||Region (CRF [case report form])||Participants|Number|462|462.0||||||
4147105|NCT00863746|3970925|B2|Group 2 (S. America, Eastern Europe, Asia-Pacific)||Region (CRF [case report form])||Participants|Number|234|234.0||||||
4147106|NCT00863746|3970926|B1|Group 2 (S. America, Eastern Europe, Asia-Pacific)||Region (CRF [case report form])||Participants|Number|228|228.0||||||
4147107|NCT00863746|3970924|B3|Group 1 (North America, Northern/Western Europe)||Region (CRF [case report form])||Participants|Number|241|241.0||||||
4147108|NCT00863746|3970925|B2|Group 1 (North America, Northern/Western Europe)||Region (CRF [case report form])||Participants|Number|119|119.0||||||
4147109|NCT00863746|3970926|B1|Group 1 (North America, Northern/Western Europe)||Region (CRF [case report form])||Participants|Number|122|122.0||||||
4147110|NCT00863746|3970924|B3||Male|Sex: Female, Male||Participants|Count of Participants|395|395.0||||||
4147111|NCT00863746|3970925|B2||Male|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4147112|NCT00863746|3970926|B1||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4147113|NCT00863746|3970924|B3||Female|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
4147114|NCT00863746|3970925|B2||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4147115|NCT00863746|3970926|B1||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4147116|NCT00863746|3970924|B3|>= 75 years||Age, Customized||Participants|Number|49|49.0||||||
4147117|NCT00863746|3970925|B2|>= 75 years||Age, Customized||Participants|Number|29|29.0||||||
4147118|NCT00863746|3970926|B1|>= 75 years||Age, Customized||Participants|Number|20|20.0||||||
4147119|NCT00863746|3970924|B3|>= 65 and < 75 years||Age, Customized||Participants|Number|193|193.0||||||
4147124|NCT00863746|3970926|B1|< 65 years||Age, Customized||Participants|Number|239|239.0||||||
4147125|NCT00863746|3970924|B3|||Age||Years|Mean|59.9|59.9|Standard Deviation|10.3|10.3|||
4147126|NCT00863746|3970925|B2|||Age||Years|Mean|60.9|60.9|Standard Deviation|9.8|9.8|||
4147127|NCT00863746|3970926|B1|||Age||Years|Mean|58.9|58.9|Standard Deviation|10.7|10.7|||
4147128|NCT00863707|3970951|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4147129|NCT00863707|3970952|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4147130|NCT00863707|3970953|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4147131|NCT00863707|3970951|B3|Native Hawaiian - Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4147132|NCT00863707|3970952|B2|Native Hawaiian - Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4147133|NCT00863707|3970953|B1|Native Hawaiian - Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4147134|NCT00863707|3970951|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4147135|NCT00863707|3970952|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4147136|NCT00863707|3970953|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4147137|NCT00863707|3970951|B3|Asian||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4147138|NCT00863707|3970952|B2|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4147139|NCT00863707|3970953|B1|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4147140|NCT00863707|3970951|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|115|115.0||||||
4147141|NCT00863707|3970952|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
4147142|NCT00863707|3970953|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4147143|NCT00863707|3970951|B3|White||Race/Ethnicity, Customized||participants|Number|369|369.0||||||
4147144|NCT00863707|3970952|B2|White||Race/Ethnicity, Customized||participants|Number|254|254.0||||||
4147145|NCT00863707|3970953|B1|White||Race/Ethnicity, Customized||participants|Number|115|115.0||||||
4147146|NCT00863707|3970951|B3||Male|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
4147147|NCT00863707|3970952|B2||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4147148|NCT00863707|3970953|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4147149|NCT00863707|3970951|B3||Female|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
4147150|NCT00863707|3970952|B2||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4147151|NCT00863707|3970953|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4147152|NCT00863707|3970951|B3|||Age||years|Mean|66.3|66.3|Standard Deviation|11.12|11.12|||
4147153|NCT00863707|3970952|B2|||Age||years|Mean|66.4|66.4|Standard Deviation|11.25|11.25|||
4147154|NCT00863707|3970953|B1|||Age||years|Mean|66.1|66.1|Standard Deviation|10.91|10.91|||
4147155|NCT00863655|3970960|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4147156|NCT00863655|3970961|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4147157|NCT00863655|3970962|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4147158|NCT00863655|3970960|B3||Female|Sex: Female, Male||Participants|Count of Participants|724|724.0||||||
4147159|NCT00863655|3970961|B2||Female|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
4147160|NCT00863655|3970962|B1||Female|Sex: Female, Male||Participants|Count of Participants|485|485.0||||||
4147161|NCT00863655|3970960|B3|>= 65 years||Age, Customized||Participants|Number|275|275.0||||||
4147162|NCT00863655|3970961|B2|>= 65 years||Age, Customized||Participants|Number|80|80.0||||||
4147163|NCT00863655|3970962|B1|>= 65 years||Age, Customized||Participants|Number|195|195.0||||||
4147164|NCT00863655|3970960|B3|< 65 years||Age, Customized||Participants|Number|449|449.0||||||
4147165|NCT00863655|3970961|B2|< 65 years||Age, Customized||Participants|Number|159|159.0||||||
4147166|NCT00863655|3970962|B1|< 65 years||Age, Customized||Participants|Number|290|290.0||||||
4147167|NCT00863655|3970960|B3|||Age||years|Mean|62.1|62.1|Standard Deviation|10.14|10.14|||
4147168|NCT00863655|3970961|B2|||Age||years|Mean|61.2|61.2|Standard Deviation|9.75|9.75|||
4147169|NCT00863655|3970962|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|10.31|10.31|||
4147170|NCT00863551|3970990|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4147171|NCT00863551|3970990|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4147172|NCT00863551|3970990|B1|||Age||years|Median|68|68.0|Full Range|||65.0|74.0|
4147173|NCT00863512|3970998|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
4147174|NCT00863512|3970999|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4147175|NCT00863512|3971000|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4147176|NCT00863512|3970998|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147177|NCT00863512|3970999|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147178|NCT00863512|3971000|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147179|NCT00863512|3970998|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147180|NCT00863512|3970999|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147181|NCT00863512|3971000|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147182|NCT00863512|3970998|B3||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4147183|NCT00863512|3970999|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4147184|NCT00863512|3971000|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4147185|NCT00863512|3970998|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4147186|NCT00863512|3970999|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4147187|NCT00863512|3971000|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4147188|NCT00863512|3970998|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4147189|NCT00863512|3970999|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4147190|NCT00863512|3971000|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147191|NCT00863512|3970998|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147192|NCT00863512|3970999|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147193|NCT00863512|3971000|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147194|NCT00863512|3970998|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147195|NCT00863512|3970999|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147196|NCT00863512|3971000|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147197|NCT00863512|3970998|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4147198|NCT00863512|3970999|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4147199|NCT00863512|3971000|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4147200|NCT00863512|3970998|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4147201|NCT00863512|3970999|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4147202|NCT00863512|3971000|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4147203|NCT00863512|3970998|B3|||Age||years|Median|67|67.0|Full Range|||43.0|78.0|
4147204|NCT00863512|3970999|B2|||Age||years|Median|63|63.0|Full Range|||49.0|77.0|
4147205|NCT00863512|3971000|B1|||Age||years|Median|67|67.0|Full Range|||43.0|78.0|
4147206|NCT00863434|3971007|B1|||Minimal Residual Disease (blast %) as Assessed by Bone Marrow Flow Cytometry|Percent of white blood cells that are blasts (by flow cytometry).|percent of white blood cells|Median|4.35|4.35|Full Range|||4.3|4.4|
4147207|NCT00863434|3971007|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4147208|NCT00863434|3971007|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4147209|NCT00863434|3971007|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4147210|NCT00863434|3971007|B1|||Age||years|Median|41.5|41.5|Full Range|||34.0|49.0|
4147211|NCT00863434|3971007|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4147212|NCT00863434|3971007|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4147213|NCT00863434|3971007|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4147214|NCT00863356|3971013|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4147215|NCT00863356|3971013|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4147216|NCT00863356|3971013|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4147217|NCT00863356|3971013|B1|||Age||years|Mean|67|67.0|Standard Deviation|19|19.0|||
4147218|NCT00863356|3971013|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4147219|NCT00863356|3971013|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4147220|NCT00863356|3971013|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4147221|NCT00863343|3971017|B3|Result Totals||Sex/Gender, Customized|NA. Analysis of gender distribution is not relevant to the study. The disease state is not specific to gender.|participants|Number|391|391.0||||||
4147222|NCT00863343|3971018|B2|Result Totals||Sex/Gender, Customized|NA. Analysis of gender distribution is not relevant to the study. The disease state is not specific to gender.|participants|Number|374|374.0||||||
4147223|NCT00863343|3971019|B1|Result Totals||Sex/Gender, Customized|NA. Analysis of gender distribution is not relevant to the study. The disease state is not specific to gender.|participants|Number|17|17.0||||||
4147224|NCT00863343|3971018|B2|Male||Sex/Gender, Customized|NA. Analysis of gender distribution is not relevant to the study. The disease state is not specific to gender.|participants|Number|NA|||||||Analysis of gender distribution is not relevant to the study. The disease state is not specific to gender.
4147225|NCT00863343|3971019|B1|Male||Sex/Gender, Customized|NA. Analysis of gender distribution is not relevant to the study. The disease state is not specific to gender.|participants|Number|NA|||||||Analysis of gender distribution is not relevant to the study. The disease state is not specific to gender.
4147226|NCT00863343|3971018|B2|Female||Sex/Gender, Customized|NA. Analysis of gender distribution is not relevant to the study. The disease state is not specific to gender.|participants|Number|NA|||||||Analysis of gender distribution is not relevant to the study. The disease state is not specific to gender.
4147227|NCT00863343|3971019|B1|Female||Sex/Gender, Customized|NA. Analysis of gender distribution is not relevant to the study. The disease state is not specific to gender.|participants|Number|NA|||||||Analysis of gender distribution is not relevant to the study. The disease state is not specific to gender.
4147228|NCT00863343|3971017|B3|Between 0 and 100 years||Age, Customized||participants|Number|391|391.0||||||
4147229|NCT00863343|3971018|B2|Between 0 and 100 years||Age, Customized||participants|Number|374|374.0||||||
4147230|NCT00863343|3971019|B1|Between 0 and 100 years||Age, Customized||participants|Number|17|17.0||||||
4147231|NCT00863330|3971032|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4147232|NCT00863330|3971032|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4147233|NCT00863330|3971032|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4147234|NCT00863330|3971032|B1|18 or over||Age, Customized||participants|Number|6|6.0||||||
4147235|NCT00863317|3971036|B3|United States||Region of Enrollment||participants|Number|124|124.0||||||
4147236|NCT00863317|3971037|B2|United States||Region of Enrollment||participants|Number|64|64.0||||||
4147237|NCT00863317|3971038|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4147238|NCT00863317|3971036|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4147239|NCT00863317|3971037|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4147240|NCT00863317|3971038|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4147241|NCT00863317|3971036|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4147242|NCT00863317|3971037|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4147243|NCT00863317|3971038|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4147244|NCT00863317|3971036|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4147245|NCT00863317|3971037|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4147246|NCT00863317|3971038|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4147247|NCT00863317|3971036|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4147248|NCT00863317|3971037|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4147249|NCT00863317|3971038|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4147250|NCT00863317|3971036|B3||<=18 years|Age||Participants|Count of Participants|124|124.0||||||
4147251|NCT00863317|3971037|B2||<=18 years|Age||Participants|Count of Participants|64|64.0||||||
4147252|NCT00863317|3971038|B1||<=18 years|Age||Participants|Count of Participants|60|60.0||||||
4147253|NCT00863265|3971045|B1|race|hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4147254|NCT00863265|3971045|B1|race|asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4147255|NCT00863265|3971045|B1|race|white|Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
4147256|NCT00863265|3971045|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4147257|NCT00863265|3971045|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4147258|NCT00863265|3971045|B1|||Age||years|Mean|47|47.0|Standard Deviation|15|15.0|||
4147259|NCT00863122|3971064|B3|||Patients with a diagnosis of NF2||participants|Number|9|9.0||||||
4147260|NCT00863122|3971065|B2|||Patients with a diagnosis of NF2||participants|Number|0|0.0||||||
4147261|NCT00863122|3971066|B1|||Patients with a diagnosis of NF2||participants|Number|9|9.0||||||
4147262|NCT00863122|3971064|B3|||Karnofsky Performance Status (KPS)|"KPS is a physician-reported outcome measuring an individual's functional impairment. Scores range from 0% (death) to 100% (normal no complaints; no evidence of disease).~Specific to these results, 70% represents an ability to care for self; unable to carry on normal activity or to do active work, and 90% represents an ability to carry on normal activity; minor signs or symptoms of disease."|units on a scale (percent)|Median|90|90.0|Full Range|||70.0|100.0|
4147263|NCT00863122|3971066|B1|||Karnofsky Performance Status (KPS)|"KPS is a physician-reported outcome measuring an individual's functional impairment. Scores range from 0% (death) to 100% (normal no complaints; no evidence of disease).~Specific to these results, 70% represents an ability to care for self; unable to carry on normal activity or to do active work, and 90% represents an ability to carry on normal activity; minor signs or symptoms of disease."|units on a scale (percent)|Median|90|90.0|Full Range|||70.0|100.0|
4147264|NCT00863122|3971064|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4147265|NCT00863122|3971065|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4147266|NCT00863122|3971066|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4147267|NCT00863122|3971064|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4147268|NCT00863122|3971065|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4147269|NCT00863122|3971066|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4147270|NCT00863122|3971064|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4147271|NCT00863122|3971065|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4147272|NCT00863122|3971066|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4147273|NCT00863122|3971064|B3|||Age||years|Median|43.5|43.5|Full Range|||20.0|61.0|
4147274|NCT00863122|3971065|B2|||Age||years|Median|40|40.0|Full Range|||30.0|61.0|
4147275|NCT00863122|3971066|B1|||Age||years|Median|44|44.0|Full Range|||20.0|60.0|
4147276|NCT00863122|3971064|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4147277|NCT00863122|3971065|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4147278|NCT00863122|3971066|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4147279|NCT00863122|3971064|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4147280|NCT00863122|3971065|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4147281|NCT00863122|3971066|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4147282|NCT00863122|3971064|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4147283|NCT00863122|3971065|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4147284|NCT00863122|3971066|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4147285|NCT00863109|3971077|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4147286|NCT00863109|3971077|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4147287|NCT00863109|3971077|B1|||Age||years|Mean|47.4|47.4|Standard Deviation|10.7|10.7|||
4147335|NCT00863057|3971092|B3|<= 1.70||Baseline Log10(HIV RNA Viral Load) in copies/mL||participants|Number|3|3.0||||||
4147336|NCT00863057|3971093|B2|<= 1.70||Baseline Log10(HIV RNA Viral Load) in copies/mL||participants|Number|3|3.0||||||
4147337|NCT00863057|3971094|B1|<= 1.70||Baseline Log10(HIV RNA Viral Load) in copies/mL||participants|Number|2|2.0||||||
4147530|NCT00862745|3971255|B3|United States||Region of Enrollment||participants|Number|645|645.0||||||
4147288|NCT00863057|3971090|B5|||Baseline Center for Epidemiologic Studies Depression (CES-D) Scores|"The CES-D is a 20-item self-report rating inventory measuring characteristic attitudes and symptoms of depression. Participants were asked to score each item:(0)Rarely,(1)Occasionally,(2)Sometimes,(3)Most of time.Some items are multiplied by -1 to change direction.~The overall CES-D score is simply the sum of 20 items. The highest possible total CES-D score is 48, and the lowest possible score is -12. The total CES-D score is considered missing if more than 4 items are not answered."|Scores on a scale|Mean|12|12.0|Standard Deviation|13|13.0|||
4147289|NCT00863057|3971091|B4|||Baseline Center for Epidemiologic Studies Depression (CES-D) Scores|"The CES-D is a 20-item self-report rating inventory measuring characteristic attitudes and symptoms of depression. Participants were asked to score each item:(0)Rarely,(1)Occasionally,(2)Sometimes,(3)Most of time.Some items are multiplied by -1 to change direction.~The overall CES-D score is simply the sum of 20 items. The highest possible total CES-D score is 48, and the lowest possible score is -12. The total CES-D score is considered missing if more than 4 items are not answered."|Scores on a scale|Mean|16|16.0|Standard Deviation|22|22.0|||
4147290|NCT00863057|3971092|B3|||Baseline Center for Epidemiologic Studies Depression (CES-D) Scores|"The CES-D is a 20-item self-report rating inventory measuring characteristic attitudes and symptoms of depression. Participants were asked to score each item:(0)Rarely,(1)Occasionally,(2)Sometimes,(3)Most of time.Some items are multiplied by -1 to change direction.~The overall CES-D score is simply the sum of 20 items. The highest possible total CES-D score is 48, and the lowest possible score is -12. The total CES-D score is considered missing if more than 4 items are not answered."|Scores on a scale|Mean|9|9.0|Standard Deviation|9|9.0|||
4147291|NCT00863057|3971093|B2|||Baseline Center for Epidemiologic Studies Depression (CES-D) Scores|"The CES-D is a 20-item self-report rating inventory measuring characteristic attitudes and symptoms of depression. Participants were asked to score each item:(0)Rarely,(1)Occasionally,(2)Sometimes,(3)Most of time.Some items are multiplied by -1 to change direction.~The overall CES-D score is simply the sum of 20 items. The highest possible total CES-D score is 48, and the lowest possible score is -12. The total CES-D score is considered missing if more than 4 items are not answered."|Scores on a scale|Mean|11|11.0|Standard Deviation|8|8.0|||
4147292|NCT00863057|3971094|B1|||Baseline Center for Epidemiologic Studies Depression (CES-D) Scores|"The CES-D is a 20-item self-report rating inventory measuring characteristic attitudes and symptoms of depression. Participants were asked to score each item:(0)Rarely,(1)Occasionally,(2)Sometimes,(3)Most of time.Some items are multiplied by -1 to change direction.~The overall CES-D score is simply the sum of 20 items. The highest possible total CES-D score is 48, and the lowest possible score is -12. The total CES-D score is considered missing if more than 4 items are not answered."|Scores on a scale|Mean|13|13.0|Standard Deviation|10|10.0|||
4147293|NCT00863057|3971090|B5|||Baseline Brief Pain Inventory (BPI) Interference Scores|"The BPI interference scale measured level of interference with the following seven items:~General activity~Mood~Walking ability~Normal work~Relations with other people~Sleep~Enjoyment of life~Interference scales range from 0=’Does not interfere’ to 10=’Completely interferes’. The overall BPI score is the mean of seven items."|Scores on a scale|Mean|5.1|5.1|Standard Deviation|2.3|2.3|||
4147294|NCT00863057|3971091|B4|||Baseline Brief Pain Inventory (BPI) Interference Scores|"The BPI interference scale measured level of interference with the following seven items:~General activity~Mood~Walking ability~Normal work~Relations with other people~Sleep~Enjoyment of life~Interference scales range from 0=’Does not interfere’ to 10=’Completely interferes’. The overall BPI score is the mean of seven items."|Scores on a scale|Mean|6.1|6.1|Standard Deviation|3.7|3.7|||
4147295|NCT00863057|3971092|B3|||Baseline Brief Pain Inventory (BPI) Interference Scores|"The BPI interference scale measured level of interference with the following seven items:~General activity~Mood~Walking ability~Normal work~Relations with other people~Sleep~Enjoyment of life~Interference scales range from 0=’Does not interfere’ to 10=’Completely interferes’. The overall BPI score is the mean of seven items."|Scores on a scale|Mean|4.5|4.5|Standard Deviation|2.8|2.8|||
4147296|NCT00863057|3971093|B2|||Baseline Brief Pain Inventory (BPI) Interference Scores|"The BPI interference scale measured level of interference with the following seven items:~General activity~Mood~Walking ability~Normal work~Relations with other people~Sleep~Enjoyment of life~Interference scales range from 0=’Does not interfere’ to 10=’Completely interferes’. The overall BPI score is the mean of seven items."|Scores on a scale|Mean|4.1|4.1|Standard Deviation|0.5|0.5|||
4147297|NCT00863057|3971094|B1|||Baseline Brief Pain Inventory (BPI) Interference Scores|"The BPI interference scale measured level of interference with the following seven items:~General activity~Mood~Walking ability~Normal work~Relations with other people~Sleep~Enjoyment of life~Interference scales range from 0=’Does not interfere’ to 10=’Completely interferes’. The overall BPI score is the mean of seven items."|Scores on a scale|Mean|5.6|5.6|Standard Deviation|1.1|1.1|||
4147298|NCT00863057|3971090|B5|||Baseline Night Time Mean Pain Intensity (MPI) Scores|Pain was measured on an 11-point Likert numerical rating scale, ranging from 0=“No pain” to 10=“Pain as bad as you can imagine”.Participants were given diary at weeks 0, 5, 10, and 15. They started diary 7 days prior to their clinic visits at 0,4,9,14,19. Each day, recorded a number from 0 to 10. These numbers were averaged by the number of days so the total range of scores is still from 0 to 10.|Scores on a scale|Mean|7.3|7.3|Standard Deviation|1.1|1.1|||
4147299|NCT00863057|3971091|B4|||Baseline Night Time Mean Pain Intensity (MPI) Scores|Pain was measured on an 11-point Likert numerical rating scale, ranging from 0=“No pain” to 10=“Pain as bad as you can imagine”.Participants were given diary at weeks 0, 5, 10, and 15. They started diary 7 days prior to their clinic visits at 0,4,9,14,19. Each day, recorded a number from 0 to 10. These numbers were averaged by the number of days so the total range of scores is still from 0 to 10.|Scores on a scale|Mean|8|8.0|Standard Deviation|1.4|1.4|||
4147300|NCT00863057|3971092|B3|||Baseline Night Time Mean Pain Intensity (MPI) Scores|Pain was measured on an 11-point Likert numerical rating scale, ranging from 0=“No pain” to 10=“Pain as bad as you can imagine”.Participants were given diary at weeks 0, 5, 10, and 15. They started diary 7 days prior to their clinic visits at 0,4,9,14,19. Each day, recorded a number from 0 to 10. These numbers were averaged by the number of days so the total range of scores is still from 0 to 10.|Scores on a scale|Mean|7.3|7.3|Standard Deviation|1.2|1.2|||
4147338|NCT00863057|3971090|B5|||Baseline CD8 Counts||cells/µL|Mean|809.73|809.73|Standard Deviation|618|618.0|353.0|1333.0|
4147339|NCT00863057|3971091|B4|||Baseline CD8 Counts||cells/µL|Mean|794.75|794.75|Standard Deviation|534|534.0|399.0|1190.5|
4147301|NCT00863057|3971093|B2|||Baseline Night Time Mean Pain Intensity (MPI) Scores|Pain was measured on an 11-point Likert numerical rating scale, ranging from 0=“No pain” to 10=“Pain as bad as you can imagine”.Participants were given diary at weeks 0, 5, 10, and 15. They started diary 7 days prior to their clinic visits at 0,4,9,14,19. Each day, recorded a number from 0 to 10. These numbers were averaged by the number of days so the total range of scores is still from 0 to 10.|Scores on a scale|Mean|6.8|6.8|Standard Deviation|1.0|1.0|||
4147302|NCT00863057|3971094|B1|||Baseline Night Time Mean Pain Intensity (MPI) Scores|Pain was measured on an 11-point Likert numerical rating scale, ranging from 0=“No pain” to 10=“Pain as bad as you can imagine”.Participants were given diary at weeks 0, 5, 10, and 15. They started diary 7 days prior to their clinic visits at 0,4,9,14,19. Each day, recorded a number from 0 to 10. These numbers were averaged by the number of days so the total range of scores is still from 0 to 10.|Scores on a scale|Mean|7.3|7.3|Standard Deviation|1.0|1.0|||
4147303|NCT00863057|3971090|B5|||Baseline Daily Mean Pain Intensity (MPI) Scores|Pain was measured on an 11-point Likert numerical rating scale, ranging from 0=“No pain” to 10=“Pain as bad as you can imagine”.Participants were given diary at weeks 0, 5, 10, and 15. They started diary 7 days prior to their clinic visits at 0,4,9,14,19. Each day, recorded a number from 0 to 10. These numbers were averaged by the number of days so the total range of scores is still from 0 to 10.|Scores on a scale|Mean|6.9|6.9|Standard Deviation|1.4|1.4|||
4147304|NCT00863057|3971091|B4|||Baseline Daily Mean Pain Intensity (MPI) Scores|Pain was measured on an 11-point Likert numerical rating scale, ranging from 0=“No pain” to 10=“Pain as bad as you can imagine”.Participants were given diary at weeks 0, 5, 10, and 15. They started diary 7 days prior to their clinic visits at 0,4,9,14,19. Each day, recorded a number from 0 to 10. These numbers were averaged by the number of days so the total range of scores is still from 0 to 10.|Scores on a scale|Mean|7.3|7.3|Standard Deviation|2.2|2.2|||
4147305|NCT00863057|3971092|B3|||Baseline Daily Mean Pain Intensity (MPI) Scores|Pain was measured on an 11-point Likert numerical rating scale, ranging from 0=“No pain” to 10=“Pain as bad as you can imagine”.Participants were given diary at weeks 0, 5, 10, and 15. They started diary 7 days prior to their clinic visits at 0,4,9,14,19. Each day, recorded a number from 0 to 10. These numbers were averaged by the number of days so the total range of scores is still from 0 to 10.|Scores on a scale|Mean|6|6.0|Standard Deviation|1|1.0|||
4147306|NCT00863057|3971093|B2|||Baseline Daily Mean Pain Intensity (MPI) Scores|Pain was measured on an 11-point Likert numerical rating scale, ranging from 0=“No pain” to 10=“Pain as bad as you can imagine”.Participants were given diary at weeks 0, 5, 10, and 15. They started diary 7 days prior to their clinic visits at 0,4,9,14,19. Each day, recorded a number from 0 to 10. These numbers were averaged by the number of days so the total range of scores is still from 0 to 10.|Scores on a scale|Mean|6.5|6.5|Standard Deviation|1.3|1.3|||
4147307|NCT00863057|3971094|B1|||Baseline Daily Mean Pain Intensity (MPI) Scores|Pain was measured on an 11-point Likert numerical rating scale, ranging from 0=“No pain” to 10=“Pain as bad as you can imagine”.Participants were given diary at weeks 0, 5, 10, and 15. They started diary 7 days prior to their clinic visits at 0,4,9,14,19. Each day, recorded a number from 0 to 10. These numbers were averaged by the number of days so the total range of scores is still from 0 to 10.|Scores on a scale|Mean|7.8|7.8|Standard Deviation|0.5|0.5|||
4147308|NCT00863057|3971090|B5|=5.90||Baseline Log10(HIV RNA Viral Load) in copies/mL||participants|Number|1|1.0||||||
4147309|NCT00863057|3971091|B4|=5.90||Baseline Log10(HIV RNA Viral Load) in copies/mL||participants|Number|1|1.0||||||
4147310|NCT00863057|3971092|B3|=5.90||Baseline Log10(HIV RNA Viral Load) in copies/mL||participants|Number|0|0.0||||||
4147311|NCT00863057|3971093|B2|=5.90||Baseline Log10(HIV RNA Viral Load) in copies/mL||participants|Number|0|0.0||||||
4147312|NCT00863057|3971094|B1|=5.90||Baseline Log10(HIV RNA Viral Load) in copies/mL||participants|Number|0|0.0||||||
4147313|NCT00863057|3971090|B5|=4.61||Baseline Log10(HIV RNA Viral Load) in copies/mL||participants|Number|1|1.0||||||
4147314|NCT00863057|3971091|B4|=4.61||Baseline Log10(HIV RNA Viral Load) in copies/mL||participants|Number|0|0.0||||||
4147315|NCT00863057|3971092|B3|=4.61||Baseline Log10(HIV RNA Viral Load) in copies/mL||participants|Number|0|0.0||||||
4147316|NCT00863057|3971093|B2|=4.61||Baseline Log10(HIV RNA Viral Load) in copies/mL||participants|Number|1|1.0||||||
4147317|NCT00863057|3971094|B1|=4.61||Baseline Log10(HIV RNA Viral Load) in copies/mL||participants|Number|0|0.0||||||
4147318|NCT00863057|3971090|B5|=2.34||Baseline Log10(HIV RNA Viral Load) in copies/mL||participants|Number|1|1.0||||||
4147319|NCT00863057|3971091|B4|=2.34||Baseline Log10(HIV RNA Viral Load) in copies/mL||participants|Number|0|0.0||||||
4147320|NCT00863057|3971092|B3|=2.34||Baseline Log10(HIV RNA Viral Load) in copies/mL||participants|Number|0|0.0||||||
4147321|NCT00863057|3971093|B2|=2.34||Baseline Log10(HIV RNA Viral Load) in copies/mL||participants|Number|0|0.0||||||
4147322|NCT00863057|3971094|B1|=2.34||Baseline Log10(HIV RNA Viral Load) in copies/mL||participants|Number|1|1.0||||||
4147323|NCT00863057|3971090|B5|=2.19||Baseline Log10(HIV RNA Viral Load) in copies/mL||participants|Number|1|1.0||||||
4147324|NCT00863057|3971091|B4|=2.19||Baseline Log10(HIV RNA Viral Load) in copies/mL||participants|Number|0|0.0||||||
4147325|NCT00863057|3971092|B3|=2.19||Baseline Log10(HIV RNA Viral Load) in copies/mL||participants|Number|0|0.0||||||
4147326|NCT00863057|3971093|B2|=2.19||Baseline Log10(HIV RNA Viral Load) in copies/mL||participants|Number|0|0.0||||||
4147327|NCT00863057|3971094|B1|=2.19||Baseline Log10(HIV RNA Viral Load) in copies/mL||participants|Number|1|1.0||||||
4147328|NCT00863057|3971090|B5|=1.71||Baseline Log10(HIV RNA Viral Load) in copies/mL||participants|Number|1|1.0||||||
4147329|NCT00863057|3971091|B4|=1.71||Baseline Log10(HIV RNA Viral Load) in copies/mL||participants|Number|1|1.0||||||
4147330|NCT00863057|3971092|B3|=1.71||Baseline Log10(HIV RNA Viral Load) in copies/mL||participants|Number|0|0.0||||||
4147331|NCT00863057|3971093|B2|=1.71||Baseline Log10(HIV RNA Viral Load) in copies/mL||participants|Number|0|0.0||||||
4147332|NCT00863057|3971094|B1|=1.71||Baseline Log10(HIV RNA Viral Load) in copies/mL||participants|Number|0|0.0||||||
4147333|NCT00863057|3971090|B5|<= 1.70||Baseline Log10(HIV RNA Viral Load) in copies/mL||participants|Number|10|10.0||||||
4147334|NCT00863057|3971091|B4|<= 1.70||Baseline Log10(HIV RNA Viral Load) in copies/mL||participants|Number|2|2.0||||||
4147340|NCT00863057|3971092|B3|||Baseline CD8 Counts||cells/µL|Mean|1042.33|1042.33|Standard Deviation|1110|1110.0|366.0|2324.0|
4147341|NCT00863057|3971093|B2|||Baseline CD8 Counts||cells/µL|Mean|490|490.0|Standard Deviation|205|205.0|347.0|633.0|
4147342|NCT00863057|3971094|B1|||Baseline CD8 Counts||cells/µL|Mean|970|970.0|Standard Deviation|639|639.0|441.5|1498.5|
4147343|NCT00863057|3971090|B5|||Baseline CD4 Counts||cells/µL|Mean|486|486.0|Standard Deviation|315|315.0|||
4147344|NCT00863057|3971091|B4|||Baseline CD4 Counts||cells/µL|Mean|249|249.0|Standard Deviation|173|173.0|||
4147345|NCT00863057|3971092|B3|||Baseline CD4 Counts||cells/µL|Mean|867|867.0|Standard Deviation|162|162.0|||
4147346|NCT00863057|3971093|B2|||Baseline CD4 Counts||cells/µL|Mean|522|522.0|Standard Deviation|328|328.0|||
4147347|NCT00863057|3971094|B1|||Baseline CD4 Counts||cells/µL|Mean|400|400.0|Standard Deviation|278|278.0|||
4147348|NCT00863057|3971090|B5|United States||Region of Enrollment||participants|Number|15|15.0||||||
4147349|NCT00863057|3971091|B4|United States||Region of Enrollment||participants|Number|4|4.0||||||
4147350|NCT00863057|3971092|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4147351|NCT00863057|3971093|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4147352|NCT00863057|3971094|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4147353|NCT00863057|3971090|B5|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4147354|NCT00863057|3971091|B4|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4147355|NCT00863057|3971092|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4147356|NCT00863057|3971093|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4147357|NCT00863057|3971094|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4147358|NCT00863057|3971090|B5|Black/African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4147359|NCT00863057|3971091|B4|Black/African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4147360|NCT00863057|3971092|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4147361|NCT00863057|3971093|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4147362|NCT00863057|3971094|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4147363|NCT00863057|3971090|B5|White/Caucasian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4147364|NCT00863057|3971091|B4|White/Caucasian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4147365|NCT00863057|3971092|B3|White/Caucasian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4147366|NCT00863057|3971093|B2|White/Caucasian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4147367|NCT00863057|3971094|B1|White/Caucasian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4147368|NCT00863057|3971090|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4147369|NCT00863057|3971091|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4147370|NCT00863057|3971092|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4147371|NCT00863057|3971093|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4147372|NCT00863057|3971094|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4147373|NCT00863057|3971090|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4147374|NCT00863057|3971091|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4147375|NCT00863057|3971092|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4147376|NCT00863057|3971093|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4147377|NCT00863057|3971094|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4147378|NCT00863057|3971090|B5|>= 60||Age, Customized||participants|Number|3|3.0||||||
4147379|NCT00863057|3971091|B4|>= 60||Age, Customized||participants|Number|0|0.0||||||
4147380|NCT00863057|3971092|B3|>= 60||Age, Customized||participants|Number|1|1.0||||||
4147381|NCT00863057|3971093|B2|>= 60||Age, Customized||participants|Number|1|1.0||||||
4147382|NCT00863057|3971094|B1|>= 60||Age, Customized||participants|Number|1|1.0||||||
4147383|NCT00863057|3971090|B5|50-59||Age, Customized||participants|Number|8|8.0||||||
4147384|NCT00863057|3971091|B4|50-59||Age, Customized||participants|Number|2|2.0||||||
4147385|NCT00863057|3971092|B3|50-59||Age, Customized||participants|Number|1|1.0||||||
4147386|NCT00863057|3971093|B2|50-59||Age, Customized||participants|Number|2|2.0||||||
4147387|NCT00863057|3971094|B1|50-59||Age, Customized||participants|Number|3|3.0||||||
4147388|NCT00863057|3971090|B5|40-49||Age, Customized||participants|Number|2|2.0||||||
4147389|NCT00863057|3971091|B4|40-49||Age, Customized||participants|Number|1|1.0||||||
4147390|NCT00863057|3971092|B3|40-49||Age, Customized||participants|Number|1|1.0||||||
4147391|NCT00863057|3971093|B2|40-49||Age, Customized||participants|Number|0|0.0||||||
4147392|NCT00863057|3971094|B1|40-49||Age, Customized||participants|Number|0|0.0||||||
4147393|NCT00863057|3971090|B5|30-39||Age, Customized||participants|Number|1|1.0||||||
4147394|NCT00863057|3971091|B4|30-39||Age, Customized||participants|Number|0|0.0||||||
4147395|NCT00863057|3971092|B3|30-39||Age, Customized||participants|Number|0|0.0||||||
4147396|NCT00863057|3971093|B2|30-39||Age, Customized||participants|Number|1|1.0||||||
4147397|NCT00863057|3971094|B1|30-39||Age, Customized||participants|Number|0|0.0||||||
4147398|NCT00863057|3971090|B5|20-29||Age, Customized||participants|Number|1|1.0||||||
4147399|NCT00863057|3971091|B4|20-29||Age, Customized||participants|Number|1|1.0||||||
4147400|NCT00863057|3971092|B3|20-29||Age, Customized||participants|Number|0|0.0||||||
4147401|NCT00863057|3971093|B2|20-29||Age, Customized||participants|Number|0|0.0||||||
4147402|NCT00863057|3971094|B1|20-29||Age, Customized||participants|Number|0|0.0||||||
4147403|NCT00862979|3971145|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147404|NCT00862979|3971146|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147405|NCT00862979|3971147|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147406|NCT00862979|3971145|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147407|NCT00862979|3971146|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147408|NCT00862979|3971147|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147409|NCT00862979|3971145|B3||White|Race (NIH/OMB)||Participants|Count of Participants|145|145.0||||||
4147410|NCT00862979|3971146|B2||White|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
4147411|NCT00862979|3971147|B1||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4147412|NCT00862979|3971145|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147413|NCT00862979|3971146|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147414|NCT00862979|3971147|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147415|NCT00862979|3971145|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147416|NCT00862979|3971146|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147417|NCT00862979|3971147|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147418|NCT00862979|3971145|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147419|NCT00862979|3971146|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147420|NCT00862979|3971147|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147421|NCT00862979|3971145|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147422|NCT00862979|3971146|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147423|NCT00862979|3971147|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147424|NCT00862979|3971145|B3||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4147425|NCT00862979|3971146|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4147426|NCT00862979|3971147|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4147427|NCT00862979|3971145|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4147428|NCT00862979|3971146|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4147429|NCT00862979|3971147|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4147430|NCT00862979|3971145|B3|||Age||years|Mean|51.5|51.5|Standard Deviation|9.8|9.8|||
4147431|NCT00862979|3971146|B2|||Age||years|Mean|50.3|50.3|Standard Deviation|9.8|9.8|||
4147432|NCT00862979|3971147|B1|||Age||years|Mean|52.7|52.7|Standard Deviation|9.7|9.7|||
4147433|NCT00862940|3971164|B3|Hippocampal Volume (HCV)||Magnetic Resonance Imaging (MRI) Descriptives||mL; mm^3|Mean|5086.1|5086.1|Standard Deviation|924.9|924.9|||
4147434|NCT00862940|3971165|B2|Hippocampal Volume (HCV)||Magnetic Resonance Imaging (MRI) Descriptives||mL; mm^3|Mean|5107.6|5107.6|Standard Deviation|836.7|836.7|||
4147435|NCT00862940|3971166|B1|Hippocampal Volume (HCV)||Magnetic Resonance Imaging (MRI) Descriptives||mL; mm^3|Mean|5063.0|5063.0|Standard Deviation|1014.3|1014.3|||
4147436|NCT00862940|3971164|B3|Total Brain Volume (TBV)||Magnetic Resonance Imaging (MRI) Descriptives||mL; mm^3|Mean|963.6|963.6|Standard Deviation|105.8|105.8|||
4147437|NCT00862940|3971165|B2|Total Brain Volume (TBV)||Magnetic Resonance Imaging (MRI) Descriptives||mL; mm^3|Mean|968.9|968.9|Standard Deviation|108.3|108.3|||
4147438|NCT00862940|3971166|B1|Total Brain Volume (TBV)||Magnetic Resonance Imaging (MRI) Descriptives||mL; mm^3|Mean|957.9|957.9|Standard Deviation|103.3|103.3|||
4147439|NCT00862940|3971164|B3|||Neuropsychiatric Inventory (NPI): Baseline Efficacy Scores|NPI: A scale specifically developed to assess behavioural disturbances in patients with dementia. It is based on responses from the caregiver. The range is 0 to 120, with higher score reflecting higher frequency and severity of the disturbances.|Points|Mean|13.0|13.0|Standard Deviation|12.6|12.6|||
4147440|NCT00862940|3971165|B2|||Neuropsychiatric Inventory (NPI): Baseline Efficacy Scores|NPI: A scale specifically developed to assess behavioural disturbances in patients with dementia. It is based on responses from the caregiver. The range is 0 to 120, with higher score reflecting higher frequency and severity of the disturbances.|Points|Mean|12.8|12.8|Standard Deviation|12.4|12.4|||
4147441|NCT00862940|3971166|B1|||Neuropsychiatric Inventory (NPI): Baseline Efficacy Scores|NPI: A scale specifically developed to assess behavioural disturbances in patients with dementia. It is based on responses from the caregiver. The range is 0 to 120, with higher score reflecting higher frequency and severity of the disturbances.|Points|Mean|13.1|13.1|Standard Deviation|12.8|12.8|||
4147442|NCT00862940|3971164|B3|||Mini Mental State Examination (MMSE): Baseline Efficacy Scores|MMSE: Brief, structured examination of mental status that assesses orientation, memory, attention, naming, comprehension, and praxis. The range is 0 to 30, with a lower score indicating a worse mental state.|Points|Mean|16.9|16.9|Standard Deviation|2.4|2.4|||
4147443|NCT00862940|3971165|B2|||Mini Mental State Examination (MMSE): Baseline Efficacy Scores|MMSE: Brief, structured examination of mental status that assesses orientation, memory, attention, naming, comprehension, and praxis. The range is 0 to 30, with a lower score indicating a worse mental state.|Points|Mean|17.0|17.0|Standard Deviation|2.4|2.4|||
4147444|NCT00862940|3971166|B1|||Mini Mental State Examination (MMSE): Baseline Efficacy Scores|MMSE: Brief, structured examination of mental status that assesses orientation, memory, attention, naming, comprehension, and praxis. The range is 0 to 30, with a lower score indicating a worse mental state.|Points|Mean|16.9|16.9|Standard Deviation|2.4|2.4|||
4147468|NCT00862940|3971166|B1|||Age||years|Mean|73.7|73.7|Standard Deviation|8.8|8.8|||
4147469|NCT00862849|3971179|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4147445|NCT00862940|3971164|B3|||Stroop Interference Test - Congruent (SIT-C): Baseline Efficacy Scores|SIT-C: A test to demonstrate the reaction time. Names of colours are printed in the same ink as the colours named. The time taken to complete the test was recorded, as was the number of errors. The more time spent and the higher number of errors indicates lower reaction time.|Seconds|Mean|69.6|69.6|Standard Deviation|45.4|45.4|||
4147446|NCT00862940|3971165|B2|||Stroop Interference Test - Congruent (SIT-C): Baseline Efficacy Scores|SIT-C: A test to demonstrate the reaction time. Names of colours are printed in the same ink as the colours named. The time taken to complete the test was recorded, as was the number of errors. The more time spent and the higher number of errors indicates lower reaction time.|Seconds|Mean|68.8|68.8|Standard Deviation|41.7|41.7|||
4147447|NCT00862940|3971166|B1|||Stroop Interference Test - Congruent (SIT-C): Baseline Efficacy Scores|SIT-C: A test to demonstrate the reaction time. Names of colours are printed in the same ink as the colours named. The time taken to complete the test was recorded, as was the number of errors. The more time spent and the higher number of errors indicates lower reaction time.|Seconds|Mean|70.5|70.5|Standard Deviation|49.1|49.1|||
4147448|NCT00862940|3971164|B3|||Stroop Interference Test - Incongruent (SIT-I): Baseline Efficacy Scores|SIT-I: A test to demonstrate the reaction time. Names of colours are printed in a different ink than the colour named. The time taken to complete the test was recorded, as was the number of errors. The more time spent and the higher number of errors indicates lower reaction time.|Seconds|Mean|173.4|173.4|Standard Deviation|58.5|58.5|||
4147449|NCT00862940|3971165|B2|||Stroop Interference Test - Incongruent (SIT-I): Baseline Efficacy Scores|SIT-I: A test to demonstrate the reaction time. Names of colours are printed in a different ink than the colour named. The time taken to complete the test was recorded, as was the number of errors. The more time spent and the higher number of errors indicates lower reaction time.|Seconds|Mean|176.4|176.4|Standard Deviation|56.7|56.7|||
4147450|NCT00862940|3971166|B1|||Stroop Interference Test - Incongruent (SIT-I): Baseline Efficacy Scores|SIT-I: A test to demonstrate the reaction time. Names of colours are printed in a different ink than the colour named. The time taken to complete the test was recorded, as was the number of errors. The more time spent and the higher number of errors indicates lower reaction time.|Seconds|Mean|170.3|170.3|Standard Deviation|60.4|60.4|||
4147451|NCT00862940|3971164|B3|||ADAS-cog-Orientation Test (ADAS-cog-OT): Baseline Efficacy Scores|ADAS-cog-OT: A subscale of the ADAS-cog test with 8 questions and designed to determine how well oriented the patient is with regard to time and place. The total score was calculated as 8 minus the total number of correct answers, with higher scores indicating greater cognitive impairment.|Points|Mean|4.1|4.1|Standard Deviation|1.7|1.7|||
4147452|NCT00862940|3971165|B2|||ADAS-cog-Orientation Test (ADAS-cog-OT): Baseline Efficacy Scores|ADAS-cog-OT: A subscale of the ADAS-cog test with 8 questions and designed to determine how well oriented the patient is with regard to time and place. The total score was calculated as 8 minus the total number of correct answers, with higher scores indicating greater cognitive impairment.|Points|Mean|4.0|4.0|Standard Deviation|1.7|1.7|||
4147453|NCT00862940|3971166|B1|||ADAS-cog-Orientation Test (ADAS-cog-OT): Baseline Efficacy Scores|ADAS-cog-OT: A subscale of the ADAS-cog test with 8 questions and designed to determine how well oriented the patient is with regard to time and place. The total score was calculated as 8 minus the total number of correct answers, with higher scores indicating greater cognitive impairment.|Points|Mean|4.2|4.2|Standard Deviation|1.6|1.6|||
4147454|NCT00862940|3971164|B3|||Category Fluency Test (CFT): Baseline Efficacy Scores|CFT: The patient was asked to, during 1 minute, say aloud as many different words as possible from the categories animals and fruits. The total score was calculated as the number of appropriate words generated, with higher scores indicating lower cognitive impairment.|Number of words|Mean|13.4|13.4|Standard Deviation|5.9|5.9|||
4147455|NCT00862940|3971165|B2|||Category Fluency Test (CFT): Baseline Efficacy Scores|CFT: The patient was asked to, during 1 minute, say aloud as many different words as possible from the categories animals and fruits. The total score was calculated as the number of appropriate words generated, with higher scores indicating lower cognitive impairment.|Number of words|Mean|13.3|13.3|Standard Deviation|5.9|5.9|||
4147456|NCT00862940|3971166|B1|||Category Fluency Test (CFT): Baseline Efficacy Scores|CFT: The patient was asked to, during 1 minute, say aloud as many different words as possible from the categories animals and fruits. The total score was calculated as the number of appropriate words generated, with higher scores indicating lower cognitive impairment.|Number of words|Mean|13.5|13.5|Standard Deviation|5.8|5.8|||
4147457|NCT00862940|3971164|B3|||Controlled Oral Word Association Test (COWAT): Baseline Efficacy Scores|COWAT: Verbal fluency test. The patient was asked to, during 1 minute, generate as many words as possible beginning with three pre-specified letters. The total score was calculated as the sum of acceptable words generated, with higher scores indicating lower cognitive impairment.|Number of words|Mean|19.4|19.4|Standard Deviation|9.6|9.6|||
4147458|NCT00862940|3971165|B2|||Controlled Oral Word Association Test (COWAT): Baseline Efficacy Scores|COWAT: Verbal fluency test. The patient was asked to, during 1 minute, generate as many words as possible beginning with three pre-specified letters. The total score was calculated as the sum of acceptable words generated, with higher scores indicating lower cognitive impairment.|Number of words|Mean|19.2|19.2|Standard Deviation|8.8|8.8|||
4147459|NCT00862940|3971166|B1|||Controlled Oral Word Association Test (COWAT): Baseline Efficacy Scores|COWAT: Verbal fluency test. The patient was asked to, during 1 minute, generate as many words as possible beginning with three pre-specified letters. The total score was calculated as the sum of acceptable words generated, with higher scores indicating lower cognitive impairment.|Number of words|Mean|19.7|19.7|Standard Deviation|10.3|10.3|||
4147460|NCT00862940|3971164|B3||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4147461|NCT00862940|3971165|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4147462|NCT00862940|3971166|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4147463|NCT00862940|3971164|B3||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4147464|NCT00862940|3971165|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4147465|NCT00862940|3971166|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4147466|NCT00862940|3971164|B3|||Age||years|Mean|74.1|74.1|Standard Deviation|8.3|8.3|||
4147467|NCT00862940|3971165|B2|||Age||years|Mean|74.4|74.4|Standard Deviation|7.7|7.7|||
4147470|NCT00862849|3971179|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147471|NCT00862849|3971179|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4147472|NCT00862849|3971179|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4147473|NCT00862849|3971179|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147474|NCT00862849|3971179|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147475|NCT00862849|3971179|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4147476|NCT00862849|3971179|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4147477|NCT00862849|3971179|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147478|NCT00862849|3971179|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4147479|NCT00862849|3971179|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147480|NCT00862849|3971179|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4147481|NCT00862849|3971179|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4147482|NCT00862849|3971179|B1|||Age||years|Mean|35.9|35.9|Standard Deviation|9.24|9.24|||
4147483|NCT00862836|3971207|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4147484|NCT00862836|3971207|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4147485|NCT00862836|3971207|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4147486|NCT00862836|3971207|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4147487|NCT00862836|3971207|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4147488|NCT00862823|3971218|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4147489|NCT00862823|3971218|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4147490|NCT00862823|3971218|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4147491|NCT00862823|3971218|B1|||Age||years|Mean|33.3|33.3|Standard Deviation|10.9|10.9|||
4147492|NCT00862823|3971218|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4147493|NCT00862823|3971218|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4147494|NCT00862823|3971218|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4147495|NCT00862810|3971226|B3|United States||Region of Enrollment||participants|Number|72|72.0||||||
4147496|NCT00862810|3971227|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
4147497|NCT00862810|3971228|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4147498|NCT00862810|3971226|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4147499|NCT00862810|3971227|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4147500|NCT00862810|3971228|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4147501|NCT00862810|3971226|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4147502|NCT00862810|3971227|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4147503|NCT00862810|3971228|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4147504|NCT00862810|3971226|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4147505|NCT00862810|3971227|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4147506|NCT00862810|3971228|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4147507|NCT00862810|3971226|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4147508|NCT00862810|3971227|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4147509|NCT00862810|3971228|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4147510|NCT00862810|3971226|B3||<=18 years|Age||Participants|Count of Participants|72|72.0||||||
4147511|NCT00862810|3971227|B2||<=18 years|Age||Participants|Count of Participants|39|39.0||||||
4147512|NCT00862810|3971228|B1||<=18 years|Age||Participants|Count of Participants|33|33.0||||||
4147513|NCT00862784|3971235|B1|Spain||Region of Enrollment||participants|Number|43|43.0||||||
4147514|NCT00862784|3971235|B1|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4147515|NCT00862784|3971235|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147516|NCT00862784|3971235|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147517|NCT00862784|3971235|B1||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4147518|NCT00862784|3971235|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147519|NCT00862784|3971235|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147520|NCT00862784|3971235|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147521|NCT00862784|3971235|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147522|NCT00862784|3971235|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147523|NCT00862784|3971235|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4147524|NCT00862784|3971235|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4147525|NCT00862784|3971235|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4147526|NCT00862784|3971235|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4147527|NCT00862784|3971235|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4147528|NCT00862784|3971235|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4147529|NCT00862784|3971235|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4147531|NCT00862745|3971256|B2|United States||Region of Enrollment||participants|Number|323|323.0||||||
4147532|NCT00862745|3971257|B1|United States||Region of Enrollment||participants|Number|322|322.0||||||
4147533|NCT00862745|3971255|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4147534|NCT00862745|3971256|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4147535|NCT00862745|3971257|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4147536|NCT00862745|3971255|B3||Female|Sex: Female, Male||Participants|Count of Participants|645|645.0||||||
4147537|NCT00862745|3971256|B2||Female|Sex: Female, Male||Participants|Count of Participants|323|323.0||||||
4147538|NCT00862745|3971257|B1||Female|Sex: Female, Male||Participants|Count of Participants|322|322.0||||||
4147539|NCT00862745|3971255|B3|||Age||years|Mean|56.0|56.0|Standard Deviation|14.5|14.5|||
4147540|NCT00862745|3971256|B2|||Age||years|Mean|55.9|55.9|Standard Deviation|14.2|14.2|||
4147541|NCT00862745|3971257|B1|||Age||years|Mean|56.2|56.2|Standard Deviation|14.7|14.7|||
4147542|NCT00862745|3971255|B3||>=65 years|Age||Participants|Count of Participants|181|181.0||||||
4147543|NCT00862745|3971256|B2||>=65 years|Age||Participants|Count of Participants|89|89.0||||||
4147544|NCT00862745|3971257|B1||>=65 years|Age||Participants|Count of Participants|92|92.0||||||
4147545|NCT00862745|3971255|B3||Between 18 and 65 years|Age||Participants|Count of Participants|464|464.0||||||
4147546|NCT00862745|3971256|B2||Between 18 and 65 years|Age||Participants|Count of Participants|234|234.0||||||
4147547|NCT00862745|3971257|B1||Between 18 and 65 years|Age||Participants|Count of Participants|230|230.0||||||
4147548|NCT00862745|3971255|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4147549|NCT00862745|3971256|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4147550|NCT00862745|3971257|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4147551|NCT00862719|3971264|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147552|NCT00862719|3971265|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147553|NCT00862719|3971266|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147554|NCT00862719|3971267|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147555|NCT00862719|3971268|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147556|NCT00862719|3971264|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147557|NCT00862719|3971265|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147558|NCT00862719|3971266|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147559|NCT00862719|3971267|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147560|NCT00862719|3971268|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147561|NCT00862719|3971264|B5||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4147562|NCT00862719|3971265|B4||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4147563|NCT00862719|3971266|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4147564|NCT00862719|3971267|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4147565|NCT00862719|3971268|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4147566|NCT00862719|3971264|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4147567|NCT00862719|3971265|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147568|NCT00862719|3971266|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147569|NCT00862719|3971267|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4147570|NCT00862719|3971268|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4147571|NCT00862719|3971264|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147572|NCT00862719|3971265|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147573|NCT00862719|3971266|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147574|NCT00862719|3971267|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147575|NCT00862719|3971268|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147576|NCT00862719|3971264|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147577|NCT00862719|3971265|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147578|NCT00862719|3971266|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147579|NCT00862719|3971267|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147580|NCT00862719|3971268|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147581|NCT00862719|3971264|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147582|NCT00862719|3971265|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147583|NCT00862719|3971266|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147584|NCT00862719|3971267|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147585|NCT00862719|3971268|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147586|NCT00862719|3971264|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147587|NCT00862719|3971265|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147588|NCT00862719|3971266|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147589|NCT00862719|3971267|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147590|NCT00862719|3971268|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147591|NCT00862719|3971264|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4147592|NCT00862719|3971265|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4147593|NCT00862719|3971266|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4147594|NCT00862719|3971267|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4147595|NCT00862719|3971268|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4147596|NCT00862719|3971264|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147597|NCT00862719|3971265|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147598|NCT00862719|3971266|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147599|NCT00862719|3971267|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147600|NCT00862719|3971268|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4147601|NCT00862719|3971264|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4147602|NCT00862719|3971265|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4147603|NCT00862719|3971266|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4147604|NCT00862719|3971267|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4147605|NCT00862719|3971268|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4147606|NCT00862719|3971264|B5||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4147607|NCT00862719|3971265|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4147608|NCT00862719|3971266|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4147609|NCT00862719|3971267|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4147610|NCT00862719|3971268|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4147611|NCT00862719|3971264|B5|||Age||years|Mean|40.6|40.6|Standard Deviation|10.62|10.62|||
4147612|NCT00862719|3971265|B4|||Age||years|Mean|54.9|54.9|Standard Deviation|0|0.0|||
4147613|NCT00862719|3971266|B3|||Age||years|Mean|46.9|46.9|Standard Deviation|7.94|7.94|||
4147614|NCT00862719|3971267|B2|||Age||years|Mean|34.8|34.8|Standard Deviation|8.95|8.95|||
4147615|NCT00862719|3971268|B1|||Age||years|Mean|40.6|40.6|Standard Deviation|10.86|10.86|||
4147616|NCT00862719|3971264|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4147617|NCT00862719|3971265|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4147618|NCT00862719|3971266|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4147619|NCT00862719|3971267|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4147620|NCT00862719|3971268|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4147621|NCT00862719|3971264|B5||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4147622|NCT00862719|3971265|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4147623|NCT00862719|3971266|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4147624|NCT00862719|3971267|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4147625|NCT00862719|3971268|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4147626|NCT00862719|3971264|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4147627|NCT00862719|3971265|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4147628|NCT00862719|3971266|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4147629|NCT00862719|3971267|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4147630|NCT00862719|3971268|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4147631|NCT00862654|3971290|B5|Korea, Republic of||Region of Enrollment||participants|Number|36|36.0||||||
4147632|NCT00862654|3971291|B4|Korea, Republic of||Region of Enrollment||participants|Number|9|9.0||||||
4147633|NCT00862654|3971292|B3|Korea, Republic of||Region of Enrollment||participants|Number|9|9.0||||||
4147634|NCT00862654|3971293|B2|Korea, Republic of||Region of Enrollment||participants|Number|9|9.0||||||
4147635|NCT00862654|3971294|B1|Korea, Republic of||Region of Enrollment||participants|Number|9|9.0||||||
4147636|NCT00862654|3971290|B5|Germany||Region of Enrollment||participants|Number|140|140.0||||||
4147637|NCT00862654|3971291|B4|Germany||Region of Enrollment||participants|Number|34|34.0||||||
4147638|NCT00862654|3971292|B3|Germany||Region of Enrollment||participants|Number|34|34.0||||||
4147639|NCT00862654|3971293|B2|Germany||Region of Enrollment||participants|Number|37|37.0||||||
4147640|NCT00862654|3971294|B1|Germany||Region of Enrollment||participants|Number|35|35.0||||||
4147641|NCT00862654|3971290|B5|Belgium||Region of Enrollment||participants|Number|33|33.0||||||
4147642|NCT00862654|3971291|B4|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
4147643|NCT00862654|3971292|B3|Belgium||Region of Enrollment||participants|Number|9|9.0||||||
4147644|NCT00862654|3971293|B2|Belgium||Region of Enrollment||participants|Number|7|7.0||||||
4147645|NCT00862654|3971294|B1|Belgium||Region of Enrollment||participants|Number|9|9.0||||||
4147646|NCT00862654|3971290|B5|Mexico||Region of Enrollment||participants|Number|70|70.0||||||
4147647|NCT00862654|3971291|B4|Mexico||Region of Enrollment||participants|Number|17|17.0||||||
4147648|NCT00862654|3971292|B3|Mexico||Region of Enrollment||participants|Number|18|18.0||||||
4147649|NCT00862654|3971293|B2|Mexico||Region of Enrollment||participants|Number|18|18.0||||||
4147650|NCT00862654|3971294|B1|Mexico||Region of Enrollment||participants|Number|17|17.0||||||
4147651|NCT00862654|3971290|B5|France||Region of Enrollment||participants|Number|47|47.0||||||
4147652|NCT00862654|3971291|B4|France||Region of Enrollment||participants|Number|12|12.0||||||
4147653|NCT00862654|3971292|B3|France||Region of Enrollment||participants|Number|12|12.0||||||
4147654|NCT00862654|3971293|B2|France||Region of Enrollment||participants|Number|11|11.0||||||
4147655|NCT00862654|3971294|B1|France||Region of Enrollment||participants|Number|12|12.0||||||
4147656|NCT00862654|3971290|B5||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4147657|NCT00862654|3971291|B4||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4147658|NCT00862654|3971292|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4147659|NCT00862654|3971293|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4147660|NCT00862654|3971294|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4147661|NCT00862654|3971290|B5||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4147662|NCT00862654|3971291|B4||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4147663|NCT00862654|3971292|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4147664|NCT00862654|3971293|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4147665|NCT00862654|3971294|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4147666|NCT00862654|3971290|B5|||Age||years|Mean|45.1|45.1|Standard Deviation|16.0|16.0|||
4147667|NCT00862654|3971291|B4|||Age||years|Mean|44.7|44.7|Standard Deviation|15.5|15.5|||
4147668|NCT00862654|3971292|B3|||Age||years|Mean|44.9|44.9|Standard Deviation|15.3|15.3|||
4147669|NCT00862654|3971293|B2|||Age||years|Mean|43.8|43.8|Standard Deviation|17.2|17.2|||
4147670|NCT00862654|3971294|B1|||Age||years|Mean|46.9|46.9|Standard Deviation|16.0|16.0|||
4147671|NCT00862654|3971290|B5||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4147672|NCT00862654|3971291|B4||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4147673|NCT00862654|3971292|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4147674|NCT00862654|3971293|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4147675|NCT00862654|3971294|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4147676|NCT00862654|3971290|B5||Between 18 and 65 years|Age||Participants|Count of Participants|271|271.0||||||
4147677|NCT00862654|3971291|B4||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4147678|NCT00862654|3971292|B3||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4147679|NCT00862654|3971293|B2||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
4147680|NCT00862654|3971294|B1||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4147681|NCT00862654|3971290|B5||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4147682|NCT00862654|3971291|B4||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4147683|NCT00862654|3971292|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4147684|NCT00862654|3971293|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4147685|NCT00862654|3971294|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4147686|NCT00862641|3971307|B5|Other||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4147687|NCT00862641|3971308|B4|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4147688|NCT00862641|3971309|B3|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4147689|NCT00862641|3971310|B2|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4147690|NCT00862641|3971311|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4147691|NCT00862641|3971307|B5|Native Hawaiian - Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4147692|NCT00862641|3971308|B4|Native Hawaiian - Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4147693|NCT00862641|3971309|B3|Native Hawaiian - Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4147694|NCT00862641|3971310|B2|Native Hawaiian - Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4147695|NCT00862641|3971311|B1|Native Hawaiian - Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4147696|NCT00862641|3971307|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4147697|NCT00862641|3971308|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4147698|NCT00862641|3971309|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4147699|NCT00862641|3971310|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4147700|NCT00862641|3971311|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4147701|NCT00862641|3971307|B5|Asian||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4147702|NCT00862641|3971308|B4|Asian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4147703|NCT00862641|3971309|B3|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4147704|NCT00862641|3971310|B2|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4147705|NCT00862641|3971311|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4147706|NCT00862641|3971307|B5|Black or African American||Race/Ethnicity, Customized||Participants|Number|141|141.0||||||
4147707|NCT00862641|3971308|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4147708|NCT00862641|3971309|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4147709|NCT00862641|3971310|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|61|61.0||||||
4147802|NCT00862459|3971408|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4147710|NCT00862641|3971311|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|45|45.0||||||
4147711|NCT00862641|3971307|B5|White||Race/Ethnicity, Customized||Participants|Number|831|831.0||||||
4147712|NCT00862641|3971308|B4|White||Race/Ethnicity, Customized||Participants|Number|284|284.0||||||
4147713|NCT00862641|3971309|B3|White||Race/Ethnicity, Customized||Participants|Number|136|136.0||||||
4147714|NCT00862641|3971310|B2|White||Race/Ethnicity, Customized||Participants|Number|283|283.0||||||
4147715|NCT00862641|3971311|B1|White||Race/Ethnicity, Customized||Participants|Number|128|128.0||||||
4147716|NCT00862641|3971307|B5||Male|Sex: Female, Male||Participants|Count of Participants|440|440.0||||||
4147717|NCT00862641|3971308|B4||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4147718|NCT00862641|3971309|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4147719|NCT00862641|3971310|B2||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4147720|NCT00862641|3971311|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4147721|NCT00862641|3971307|B5||Female|Sex: Female, Male||Participants|Count of Participants|559|559.0||||||
4147722|NCT00862641|3971308|B4||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4147723|NCT00862641|3971309|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4147724|NCT00862641|3971310|B2||Female|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4147725|NCT00862641|3971311|B1||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4147726|NCT00862641|3971307|B5|>=65 years||Age, Customized||participants|Number|263|263.0||||||
4147727|NCT00862641|3971308|B4|>=65 years||Age, Customized||participants|Number|127|127.0||||||
4147728|NCT00862641|3971309|B3|>=65 years||Age, Customized||participants|Number|56|56.0||||||
4147729|NCT00862641|3971310|B2|>=65 years||Age, Customized||participants|Number|52|52.0||||||
4147730|NCT00862641|3971311|B1|>=65 years||Age, Customized||participants|Number|28|28.0||||||
4147731|NCT00862641|3971307|B5|Between 18 and 64 years||Age, Customized||participants|Number|736|736.0||||||
4147732|NCT00862641|3971308|B4|Between 18 and 64 years||Age, Customized||participants|Number|189|189.0||||||
4147733|NCT00862641|3971309|B3|Between 18 and 64 years||Age, Customized||participants|Number|95|95.0||||||
4147734|NCT00862641|3971310|B2|Between 18 and 64 years||Age, Customized||participants|Number|304|304.0||||||
4147735|NCT00862641|3971311|B1|Between 18 and 64 years||Age, Customized||participants|Number|148|148.0||||||
4147736|NCT00862563|3971356|B5|||Wechsler Abbreviated Scale of Intelligence (WAIS)|The WASI assesses general cognitive functioning. The Vocabulary and Matrix Reasoning subtests were administered to subjects in this study. The Vocabulary subtest is used to evaluate verbal knowledge, verbal expressiveness, and fund of information. The Matrix Reasoning subtest measures nonverbal reasoning and general intellectual ability. Scores range between 55 to 157, with the higher scores indicating greater intelligence. The mean score for this test is set to be 100.|scale scores|Mean|113.1|113.1|Standard Deviation|12.0|12.0|||
4147737|NCT00862563|3971357|B4|||Wechsler Abbreviated Scale of Intelligence (WAIS)|The WASI assesses general cognitive functioning. The Vocabulary and Matrix Reasoning subtests were administered to subjects in this study. The Vocabulary subtest is used to evaluate verbal knowledge, verbal expressiveness, and fund of information. The Matrix Reasoning subtest measures nonverbal reasoning and general intellectual ability. Scores range between 55 to 157, with the higher scores indicating greater intelligence. The mean score for this test is set to be 100.|scale scores|Mean|110.7|110.7|Standard Deviation|14.0|14.0|||
4147738|NCT00862563|3971358|B3|||Wechsler Abbreviated Scale of Intelligence (WAIS)|The WASI assesses general cognitive functioning. The Vocabulary and Matrix Reasoning subtests were administered to subjects in this study. The Vocabulary subtest is used to evaluate verbal knowledge, verbal expressiveness, and fund of information. The Matrix Reasoning subtest measures nonverbal reasoning and general intellectual ability. Scores range between 55 to 157, with the higher scores indicating greater intelligence. The mean score for this test is set to be 100.|scale scores|Mean|113.6|113.6|Standard Deviation|12.6|12.6|||
4147739|NCT00862563|3971359|B2|||Wechsler Abbreviated Scale of Intelligence (WAIS)|The WASI assesses general cognitive functioning. The Vocabulary and Matrix Reasoning subtests were administered to subjects in this study. The Vocabulary subtest is used to evaluate verbal knowledge, verbal expressiveness, and fund of information. The Matrix Reasoning subtest measures nonverbal reasoning and general intellectual ability. Scores range between 55 to 157, with the higher scores indicating greater intelligence. The mean score for this test is set to be 100.|scale scores|Mean|113.3|113.3|Standard Deviation|11.6|11.6|||
4147740|NCT00862563|3971360|B1|||Wechsler Abbreviated Scale of Intelligence (WAIS)|The WASI assesses general cognitive functioning. The Vocabulary and Matrix Reasoning subtests were administered to subjects in this study. The Vocabulary subtest is used to evaluate verbal knowledge, verbal expressiveness, and fund of information. The Matrix Reasoning subtest measures nonverbal reasoning and general intellectual ability. Scores range between 55 to 157, with the higher scores indicating greater intelligence. The mean score for this test is set to be 100.|scale scores|Mean|115.3|115.3|Standard Deviation|8.9|8.9|||
4147741|NCT00862563|3971356|B5|||Alcohol Use Identification Test (AUDIT)|The AUDIT assesses the extent to which an individual exhibits patterns of harmful or hazardous alcohol use. Scale scores for this test can range from 0 to 40, with higher scores indicating greater levels of harmful or hazardous alcohol use.|units on a scale|Mean|23.4|23.4|Standard Deviation|5.4|5.4|||
4147742|NCT00862563|3971357|B4|||Alcohol Use Identification Test (AUDIT)|The AUDIT assesses the extent to which an individual exhibits patterns of harmful or hazardous alcohol use. Scale scores for this test can range from 0 to 40, with higher scores indicating greater levels of harmful or hazardous alcohol use.|units on a scale|Mean|23.7|23.7|Standard Deviation|4.7|4.7|||
4147743|NCT00862563|3971358|B3|||Alcohol Use Identification Test (AUDIT)|The AUDIT assesses the extent to which an individual exhibits patterns of harmful or hazardous alcohol use. Scale scores for this test can range from 0 to 40, with higher scores indicating greater levels of harmful or hazardous alcohol use.|units on a scale|Mean|24.6|24.6|Standard Deviation|5.7|5.7|||
4147803|NCT00862459|3971405|B4|Black||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4147744|NCT00862563|3971359|B2|||Alcohol Use Identification Test (AUDIT)|The AUDIT assesses the extent to which an individual exhibits patterns of harmful or hazardous alcohol use. Scale scores for this test can range from 0 to 40, with higher scores indicating greater levels of harmful or hazardous alcohol use.|units on a scale|Mean|23.1|23.1|Standard Deviation|5.2|5.2|||
4147745|NCT00862563|3971360|B1|||Alcohol Use Identification Test (AUDIT)|The AUDIT assesses the extent to which an individual exhibits patterns of harmful or hazardous alcohol use. Scale scores for this test can range from 0 to 40, with higher scores indicating greater levels of harmful or hazardous alcohol use.|units on a scale|Mean|22.1|22.1|Standard Deviation|5.9|5.9|||
4147746|NCT00862563|3971356|B5|||Education||years|Mean|15.4|15.4|Standard Deviation|2.4|2.4|||
4147747|NCT00862563|3971357|B4|||Education||years|Mean|15.3|15.3|Standard Deviation|2.7|2.7|||
4147748|NCT00862563|3971358|B3|||Education||years|Mean|15.4|15.4|Standard Deviation|1.9|1.9|||
4147749|NCT00862563|3971359|B2|||Education||years|Mean|15.2|15.2|Standard Deviation|2.4|2.4|||
4147750|NCT00862563|3971360|B1|||Education||years|Mean|15.6|15.6|Standard Deviation|2.5|2.5|||
4147751|NCT00862563|3971356|B5|United States||Region of Enrollment||participants|Number|85|85.0||||||
4147752|NCT00862563|3971357|B4|United States||Region of Enrollment||participants|Number|24|24.0||||||
4147753|NCT00862563|3971358|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4147754|NCT00862563|3971359|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4147755|NCT00862563|3971360|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4147756|NCT00862563|3971356|B5||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4147757|NCT00862563|3971357|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4147758|NCT00862563|3971358|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4147759|NCT00862563|3971359|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4147760|NCT00862563|3971360|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4147761|NCT00862563|3971356|B5||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4147762|NCT00862563|3971357|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4147763|NCT00862563|3971358|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4147764|NCT00862563|3971359|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4147765|NCT00862563|3971360|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4147766|NCT00862563|3971356|B5|||Age||Years|Mean|47.0|47.0|Standard Deviation|9.4|9.4|||
4147767|NCT00862563|3971357|B4|||Age||Years|Mean|46.8|46.8|Standard Deviation|7.3|7.3|||
4147768|NCT00862563|3971358|B3|||Age||Years|Mean|46.8|46.8|Standard Deviation|10.5|10.5|||
4147769|NCT00862563|3971359|B2|||Age||Years|Mean|47.5|47.5|Standard Deviation|10.5|10.5|||
4147770|NCT00862563|3971360|B1|||Age||Years|Mean|47.0|47.0|Standard Deviation|10.0|10.0|||
4147771|NCT00862563|3971356|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4147772|NCT00862563|3971357|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4147773|NCT00862563|3971358|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4147774|NCT00862563|3971359|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4147775|NCT00862563|3971360|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4147776|NCT00862563|3971356|B5||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
4147777|NCT00862563|3971357|B4||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4147778|NCT00862563|3971358|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4147779|NCT00862563|3971359|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4147780|NCT00862563|3971360|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4147781|NCT00862563|3971356|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4147782|NCT00862563|3971357|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4147783|NCT00862563|3971358|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4147784|NCT00862563|3971359|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4147785|NCT00862563|3971360|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4147786|NCT00862537|3971401|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4147787|NCT00862537|3971401|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4147788|NCT00862537|3971401|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4147789|NCT00862537|3971401|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4147790|NCT00862537|3971401|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4147791|NCT00862459|3971405|B4|Other||Race/Ethnicity, Customized||Participants|Number|93|93.0||||||
4147792|NCT00862459|3971406|B3|Other||Race/Ethnicity, Customized||Participants|Number|34|34.0||||||
4147793|NCT00862459|3971407|B2|Other||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
4147794|NCT00862459|3971408|B1|Other||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
4147795|NCT00862459|3971405|B4|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4147796|NCT00862459|3971406|B3|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4147797|NCT00862459|3971407|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4147798|NCT00862459|3971408|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4147799|NCT00862459|3971405|B4|Hispanic||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4147800|NCT00862459|3971406|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4147801|NCT00862459|3971407|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4147804|NCT00862459|3971406|B3|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4147805|NCT00862459|3971407|B2|Black||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4147806|NCT00862459|3971408|B1|Black||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4147807|NCT00862459|3971405|B4|Caucasian||Race/Ethnicity, Customized||Participants|Number|104|104.0||||||
4147808|NCT00862459|3971406|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
4147809|NCT00862459|3971407|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|45|45.0||||||
4147810|NCT00862459|3971408|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
4147811|NCT00862459|3971405|B4||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4147812|NCT00862459|3971406|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4147813|NCT00862459|3971407|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4147814|NCT00862459|3971408|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4147815|NCT00862459|3971405|B4||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4147816|NCT00862459|3971406|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4147817|NCT00862459|3971407|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4147818|NCT00862459|3971408|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4147819|NCT00862459|3971405|B4|>=65 years||Age, Customized||Years|Number|31|31.0||||||
4147820|NCT00862459|3971406|B3|>=65 years||Age, Customized||Years|Number|12|12.0||||||
4147821|NCT00862459|3971407|B2|>=65 years||Age, Customized||Years|Number|9|9.0||||||
4147822|NCT00862459|3971408|B1|>=65 years||Age, Customized||Years|Number|10|10.0||||||
4147823|NCT00862459|3971405|B4|45-64 years||Age, Customized||Years|Number|91|91.0||||||
4147824|NCT00862459|3971406|B3|45-64 years||Age, Customized||Years|Number|28|28.0||||||
4147825|NCT00862459|3971407|B2|45-64 years||Age, Customized||Years|Number|39|39.0||||||
4147826|NCT00862459|3971408|B1|45-64 years||Age, Customized||Years|Number|24|24.0||||||
4147827|NCT00862459|3971405|B4|<45 years||Age, Customized||Years|Number|107|107.0||||||
4147828|NCT00862459|3971406|B3|<45 years||Age, Customized||Years|Number|29|29.0||||||
4147829|NCT00862459|3971407|B2|<45 years||Age, Customized||Years|Number|42|42.0||||||
4147830|NCT00862459|3971408|B1|<45 years||Age, Customized||Years|Number|36|36.0||||||
4147831|NCT00862277|3971554|B4|United States||Region of Enrollment||participants|Number|762|762.0||||||
4147832|NCT00862277|3971555|B3|United States||Region of Enrollment||participants|Number|105|105.0||||||
4147833|NCT00862277|3971556|B2|United States||Region of Enrollment||participants|Number|96|96.0||||||
4147834|NCT00862277|3971557|B1|United States||Region of Enrollment||participants|Number|561|561.0||||||
4147835|NCT00862277|3971554|B4||Male|Sex: Female, Male||Participants|Count of Participants|385|385.0||||||
4147836|NCT00862277|3971555|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4147837|NCT00862277|3971556|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4147838|NCT00862277|3971557|B1||Male|Sex: Female, Male||Participants|Count of Participants|297|297.0||||||
4147839|NCT00862277|3971554|B4||Female|Sex: Female, Male||Participants|Count of Participants|377|377.0||||||
4147840|NCT00862277|3971555|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4147841|NCT00862277|3971556|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4147842|NCT00862277|3971557|B1||Female|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
4147843|NCT00862277|3971554|B4|||Age||Years|Mean|19.7|19.7|Standard Deviation|3.27|3.27|||
4147844|NCT00862277|3971555|B3|||Age||Years|Mean|19.3|19.3|Standard Deviation|3.98|3.98|||
4147845|NCT00862277|3971556|B2|||Age||Years|Mean|23.3|23.3|Standard Deviation|2.17|2.17|||
4147846|NCT00862277|3971557|B1|||Age||Years|Mean|19.1|19.1|Standard Deviation|2.87|2.87|||
4147847|NCT00862277|3971554|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4147848|NCT00862277|3971555|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4147849|NCT00862277|3971556|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4147850|NCT00862277|3971557|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4147851|NCT00862277|3971554|B4||Between 18 and 65 years|Age||Participants|Count of Participants|500|500.0||||||
4147852|NCT00862277|3971555|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4147853|NCT00862277|3971556|B2||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
4147854|NCT00862277|3971557|B1||Between 18 and 65 years|Age||Participants|Count of Participants|356|356.0||||||
4147855|NCT00862277|3971554|B4||<=18 years|Age||Participants|Count of Participants|262|262.0||||||
4147856|NCT00862277|3971555|B3||<=18 years|Age||Participants|Count of Participants|57|57.0||||||
4147857|NCT00862277|3971556|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4147858|NCT00862277|3971557|B1||<=18 years|Age||Participants|Count of Participants|205|205.0||||||
4147859|NCT00862251|3971570|B4||Male|Sex: Female, Male||Participants|Count of Participants|422|422.0||||||
4147860|NCT00862251|3971571|B3||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4147861|NCT00862251|3971572|B2||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4147862|NCT00862251|3971573|B1||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4147863|NCT00862251|3971570|B4||Female|Sex: Female, Male||Participants|Count of Participants|386|386.0||||||
4147864|NCT00862251|3971571|B3||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4147865|NCT00862251|3971572|B2||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4147866|NCT00862251|3971573|B1||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4147867|NCT00862251|3971570|B4|||Age||years|Mean|64.0|64.0|Standard Deviation|8.5|8.5|||
4147868|NCT00862251|3971571|B3|||Age||years|Mean|63.6|63.6|Standard Deviation|8.4|8.4|||
4147869|NCT00862251|3971572|B2|||Age||years|Mean|64.7|64.7|Standard Deviation|8.3|8.3|||
4147870|NCT00862251|3971573|B1|||Age||years|Mean|64.1|64.1|Standard Deviation|8.8|8.8|||
4147871|NCT00862186|3971628|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4147872|NCT00862186|3971628|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4147873|NCT00862186|3971628|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4147874|NCT00862186|3971628|B1|||Age||years|Mean|13.33|13.33|Standard Deviation|3.18|3.18|||
4147875|NCT00862186|3971628|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4147876|NCT00862186|3971628|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4147877|NCT00862186|3971628|B1||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4147878|NCT00862134|3971633|B3|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4147879|NCT00862134|3971634|B2|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4147880|NCT00862134|3971635|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4147881|NCT00862134|3971633|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
4147882|NCT00862134|3971634|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4147883|NCT00862134|3971635|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4147884|NCT00862134|3971633|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4147885|NCT00862134|3971634|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4147886|NCT00862134|3971635|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4147887|NCT00862134|3971633|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4147888|NCT00862134|3971634|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4147889|NCT00862134|3971635|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4147890|NCT00862134|3971633|B3|||Age||years|Mean|63|63.0|Standard Deviation|7.70|7.7|||
4147891|NCT00862134|3971634|B2|||Age||years|Mean|64|64.0|Standard Deviation|7.58|7.58|||
4147892|NCT00862134|3971635|B1|||Age||years|Mean|61|61.0|Standard Deviation|7.78|7.78|||
4147893|NCT00862134|3971633|B3||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4147894|NCT00862134|3971634|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4147895|NCT00862134|3971635|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4147896|NCT00862134|3971633|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4147897|NCT00862134|3971634|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4147898|NCT00862134|3971635|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4147899|NCT00862134|3971633|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4147900|NCT00862134|3971634|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4147901|NCT00862134|3971635|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4147902|NCT00862121|3971646|B3|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
4147903|NCT00862121|3971647|B2|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
4147904|NCT00862121|3971648|B1|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
4147905|NCT00862121|3971646|B3|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4147906|NCT00862121|3971647|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4147907|NCT00862121|3971648|B1|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4147908|NCT00862121|3971646|B3|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4147909|NCT00862121|3971647|B2|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4147910|NCT00862121|3971648|B1|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4147911|NCT00862121|3971646|B3|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
4147912|NCT00862121|3971647|B2|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
4147913|NCT00862121|3971648|B1|Denmark||Region of Enrollment||participants|Number|0|0.0||||||
4147914|NCT00862121|3971646|B3|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4147915|NCT00862121|3971647|B2|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4147916|NCT00862121|3971648|B1|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
4147917|NCT00862121|3971646|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4147918|NCT00862121|3971647|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4147919|NCT00862121|3971648|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4147920|NCT00862121|3971646|B3|France||Region of Enrollment||participants|Number|1|1.0||||||
4147921|NCT00862121|3971647|B2|France||Region of Enrollment||participants|Number|1|1.0||||||
4147922|NCT00862121|3971648|B1|France||Region of Enrollment||participants|Number|0|0.0||||||
4147923|NCT00862121|3971646|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4147924|NCT00862121|3971647|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4147925|NCT00862121|3971648|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4147926|NCT00862121|3971646|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4147927|NCT00862121|3971647|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4147928|NCT00862121|3971648|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4147929|NCT00862121|3971646|B3|||Age||years|Mean|37.5|37.5|Standard Deviation|12.4|12.4|||
4147930|NCT00862121|3971647|B2|||Age||years|Mean|37.5|37.5|Standard Deviation|12.6|12.6|||
4147931|NCT00862121|3971648|B1|||Age||years|Mean|37.6|37.6|Standard Deviation|13.2|13.2|||
4147932|NCT00862121|3971646|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4147933|NCT00862121|3971647|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4147934|NCT00862121|3971648|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4147935|NCT00862121|3971646|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4147936|NCT00862121|3971647|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4147937|NCT00862121|3971648|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4147938|NCT00862121|3971646|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4147939|NCT00862121|3971647|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4147940|NCT00862121|3971648|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4147941|NCT00862082|3971665|B3|Hong Kong||Region of Enrollment||participants|Number|4|4.0||||||
4147942|NCT00862082|3971666|B2|Hong Kong||Region of Enrollment||participants|Number|3|3.0||||||
4147943|NCT00862082|3971667|B1|Hong Kong||Region of Enrollment||participants|Number|1|1.0||||||
4147944|NCT00862082|3971665|B3|Taiwan||Region of Enrollment||participants|Number|7|7.0||||||
4147945|NCT00862082|3971666|B2|Taiwan||Region of Enrollment||participants|Number|2|2.0||||||
4147946|NCT00862082|3971667|B1|Taiwan||Region of Enrollment||participants|Number|5|5.0||||||
4147947|NCT00862082|3971665|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4147948|NCT00862082|3971666|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4147949|NCT00862082|3971667|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4147950|NCT00862082|3971665|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4147951|NCT00862082|3971666|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4147952|NCT00862082|3971667|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4147953|NCT00862082|3971665|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4147954|NCT00862082|3971666|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4147955|NCT00862082|3971667|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4147956|NCT00862082|3971665|B3|||Age||years|Mean|58|58.0|Standard Deviation|13|13.0|||
4147957|NCT00862082|3971666|B2|||Age||years|Mean|59|59.0|Standard Deviation|13|13.0|||
4147958|NCT00862082|3971667|B1|||Age||years|Mean|57|57.0|Standard Deviation|13|13.0|||
4147959|NCT00862082|3971665|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4147960|NCT00862082|3971666|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4147961|NCT00862082|3971667|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4147962|NCT00862082|3971665|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4147963|NCT00862082|3971666|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4147964|NCT00862082|3971667|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4147965|NCT00862082|3971665|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4147966|NCT00862082|3971666|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4147967|NCT00862082|3971667|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4147968|NCT00861913|3971711|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4147969|NCT00861913|3971711|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4147970|NCT00861913|3971711|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4147971|NCT00861913|3971711|B1|||Age||years|Median|64|64.0|Full Range|||24.0|86.0|
4147972|NCT00861757|3971719|B5|||Prostate Volume|Prostate volume is defined as the volume of prostate estimated by transabdominal or transrectal ultrasound.|mL|Mean|34.8|34.8|Standard Deviation|13.8|13.8|||
4147973|NCT00861757|3971720|B4|||Prostate Volume|Prostate volume is defined as the volume of prostate estimated by transabdominal or transrectal ultrasound.|mL|Mean|33.9|33.9|Standard Deviation|11.1|11.1|||
4147974|NCT00861757|3971721|B3|||Prostate Volume|Prostate volume is defined as the volume of prostate estimated by transabdominal or transrectal ultrasound.|mL|Mean|34.8|34.8|Standard Deviation|13.7|13.7|||
4147975|NCT00861757|3971722|B2|||Prostate Volume|Prostate volume is defined as the volume of prostate estimated by transabdominal or transrectal ultrasound.|mL|Mean|35.3|35.3|Standard Deviation|16.1|16.1|||
4147976|NCT00861757|3971723|B1|||Prostate Volume|Prostate volume is defined as the volume of prostate estimated by transabdominal or transrectal ultrasound.|mL|Mean|35.1|35.1|Standard Deviation|14.0|14.0|||
4147977|NCT00861757|3971719|B5|||Postvoid Residual Volume (PVR)|Postvoid residual volume (PVR) is defined as the volume of urine remaining in the bladder after voiding, estimated by ultrasound.|milliliters (mL)|Mean|37.7|37.7|Standard Deviation|44.5|44.5|||
4147978|NCT00861757|3971720|B4|||Postvoid Residual Volume (PVR)|Postvoid residual volume (PVR) is defined as the volume of urine remaining in the bladder after voiding, estimated by ultrasound.|milliliters (mL)|Mean|32.7|32.7|Standard Deviation|37.1|37.1|||
4147979|NCT00861757|3971721|B3|||Postvoid Residual Volume (PVR)|Postvoid residual volume (PVR) is defined as the volume of urine remaining in the bladder after voiding, estimated by ultrasound.|milliliters (mL)|Mean|38.4|38.4|Standard Deviation|51.2|51.2|||
4147980|NCT00861757|3971722|B2|||Postvoid Residual Volume (PVR)|Postvoid residual volume (PVR) is defined as the volume of urine remaining in the bladder after voiding, estimated by ultrasound.|milliliters (mL)|Mean|37.7|37.7|Standard Deviation|40.3|40.3|||
4147981|NCT00861757|3971723|B1|||Postvoid Residual Volume (PVR)|Postvoid residual volume (PVR) is defined as the volume of urine remaining in the bladder after voiding, estimated by ultrasound.|milliliters (mL)|Mean|41.9|41.9|Standard Deviation|47.7|47.7|||
4147982|NCT00861757|3971719|B5|No||Previous BPH Therapy||participants|Number|493|493.0||||||
4147983|NCT00861757|3971720|B4|No||Previous BPH Therapy||participants|Number|125|125.0||||||
4147984|NCT00861757|3971721|B3|No||Previous BPH Therapy||participants|Number|119|119.0||||||
4147985|NCT00861757|3971722|B2|No||Previous BPH Therapy||participants|Number|123|123.0||||||
4147986|NCT00861757|3971723|B1|No||Previous BPH Therapy||participants|Number|126|126.0||||||
4147987|NCT00861757|3971719|B5|Yes||Previous BPH Therapy||participants|Number|119|119.0||||||
4147988|NCT00861757|3971720|B4|Yes||Previous BPH Therapy||participants|Number|27|27.0||||||
4147989|NCT00861757|3971721|B3|Yes||Previous BPH Therapy||participants|Number|36|36.0||||||
4147990|NCT00861757|3971722|B2|Yes||Previous BPH Therapy||participants|Number|28|28.0||||||
4147991|NCT00861757|3971723|B1|Yes||Previous BPH Therapy||participants|Number|28|28.0||||||
4147992|NCT00861757|3971719|B5|No||Previous Alpha-Blocker Therapy||participants|Number|277|277.0||||||
4147993|NCT00861757|3971720|B4|No||Previous Alpha-Blocker Therapy||participants|Number|65|65.0||||||
4147994|NCT00861757|3971721|B3|No||Previous Alpha-Blocker Therapy||participants|Number|73|73.0||||||
4147995|NCT00861757|3971722|B2|No||Previous Alpha-Blocker Therapy||participants|Number|68|68.0||||||
4147996|NCT00861757|3971723|B1|No||Previous Alpha-Blocker Therapy||participants|Number|71|71.0||||||
4147997|NCT00861757|3971719|B5|Yes||Previous Alpha-Blocker Therapy||participants|Number|335|335.0||||||
4147998|NCT00861757|3971720|B4|Yes||Previous Alpha-Blocker Therapy||participants|Number|87|87.0||||||
4147999|NCT00861757|3971721|B3|Yes||Previous Alpha-Blocker Therapy||participants|Number|82|82.0||||||
4148000|NCT00861757|3971722|B2|Yes||Previous Alpha-Blocker Therapy||participants|Number|83|83.0||||||
4148001|NCT00861757|3971723|B1|Yes||Previous Alpha-Blocker Therapy||participants|Number|83|83.0||||||
4148002|NCT00861757|3971719|B5|Severe||Clinical Global Impressions of Severity Scale (CGI-S)|The Clinical Global Impressions of Severity Scale (CGI-S) measures clinician's perception of severity of illness prior to assessments during study visits. Scores range from 1 (Normal) to 4 (Severe) where 1=Normal, 2=Mild, 3=Moderate, and 4=Severe.|participants|Number|94|94.0||||||
4148003|NCT00861757|3971720|B4|Severe||Clinical Global Impressions of Severity Scale (CGI-S)|The Clinical Global Impressions of Severity Scale (CGI-S) measures clinician's perception of severity of illness prior to assessments during study visits. Scores range from 1 (Normal) to 4 (Severe) where 1=Normal, 2=Mild, 3=Moderate, and 4=Severe.|participants|Number|25|25.0||||||
4148004|NCT00861757|3971721|B3|Severe||Clinical Global Impressions of Severity Scale (CGI-S)|The Clinical Global Impressions of Severity Scale (CGI-S) measures clinician's perception of severity of illness prior to assessments during study visits. Scores range from 1 (Normal) to 4 (Severe) where 1=Normal, 2=Mild, 3=Moderate, and 4=Severe.|participants|Number|27|27.0||||||
4148005|NCT00861757|3971722|B2|Severe||Clinical Global Impressions of Severity Scale (CGI-S)|The Clinical Global Impressions of Severity Scale (CGI-S) measures clinician's perception of severity of illness prior to assessments during study visits. Scores range from 1 (Normal) to 4 (Severe) where 1=Normal, 2=Mild, 3=Moderate, and 4=Severe.|participants|Number|28|28.0||||||
4148006|NCT00861757|3971723|B1|Severe||Clinical Global Impressions of Severity Scale (CGI-S)|The Clinical Global Impressions of Severity Scale (CGI-S) measures clinician's perception of severity of illness prior to assessments during study visits. Scores range from 1 (Normal) to 4 (Severe) where 1=Normal, 2=Mild, 3=Moderate, and 4=Severe.|participants|Number|14|14.0||||||
4148007|NCT00861757|3971719|B5|Moderate||Clinical Global Impressions of Severity Scale (CGI-S)|The Clinical Global Impressions of Severity Scale (CGI-S) measures clinician's perception of severity of illness prior to assessments during study visits. Scores range from 1 (Normal) to 4 (Severe) where 1=Normal, 2=Mild, 3=Moderate, and 4=Severe.|participants|Number|371|371.0||||||
4148008|NCT00861757|3971720|B4|Moderate||Clinical Global Impressions of Severity Scale (CGI-S)|The Clinical Global Impressions of Severity Scale (CGI-S) measures clinician's perception of severity of illness prior to assessments during study visits. Scores range from 1 (Normal) to 4 (Severe) where 1=Normal, 2=Mild, 3=Moderate, and 4=Severe.|participants|Number|92|92.0||||||
4148009|NCT00861757|3971721|B3|Moderate||Clinical Global Impressions of Severity Scale (CGI-S)|The Clinical Global Impressions of Severity Scale (CGI-S) measures clinician's perception of severity of illness prior to assessments during study visits. Scores range from 1 (Normal) to 4 (Severe) where 1=Normal, 2=Mild, 3=Moderate, and 4=Severe.|participants|Number|95|95.0||||||
4148010|NCT00861757|3971722|B2|Moderate||Clinical Global Impressions of Severity Scale (CGI-S)|The Clinical Global Impressions of Severity Scale (CGI-S) measures clinician's perception of severity of illness prior to assessments during study visits. Scores range from 1 (Normal) to 4 (Severe) where 1=Normal, 2=Mild, 3=Moderate, and 4=Severe.|participants|Number|87|87.0||||||
4148011|NCT00861757|3971723|B1|Moderate||Clinical Global Impressions of Severity Scale (CGI-S)|The Clinical Global Impressions of Severity Scale (CGI-S) measures clinician's perception of severity of illness prior to assessments during study visits. Scores range from 1 (Normal) to 4 (Severe) where 1=Normal, 2=Mild, 3=Moderate, and 4=Severe.|participants|Number|97|97.0||||||
4148012|NCT00861757|3971719|B5|Mild||Clinical Global Impressions of Severity Scale (CGI-S)|The Clinical Global Impressions of Severity Scale (CGI-S) measures clinician's perception of severity of illness prior to assessments during study visits. Scores range from 1 (Normal) to 4 (Severe) where 1=Normal, 2=Mild, 3=Moderate, and 4=Severe.|participants|Number|146|146.0||||||
4148013|NCT00861757|3971720|B4|Mild||Clinical Global Impressions of Severity Scale (CGI-S)|The Clinical Global Impressions of Severity Scale (CGI-S) measures clinician's perception of severity of illness prior to assessments during study visits. Scores range from 1 (Normal) to 4 (Severe) where 1=Normal, 2=Mild, 3=Moderate, and 4=Severe.|participants|Number|35|35.0||||||
4148014|NCT00861757|3971721|B3|Mild||Clinical Global Impressions of Severity Scale (CGI-S)|The Clinical Global Impressions of Severity Scale (CGI-S) measures clinician's perception of severity of illness prior to assessments during study visits. Scores range from 1 (Normal) to 4 (Severe) where 1=Normal, 2=Mild, 3=Moderate, and 4=Severe.|participants|Number|33|33.0||||||
4148015|NCT00861757|3971722|B2|Mild||Clinical Global Impressions of Severity Scale (CGI-S)|The Clinical Global Impressions of Severity Scale (CGI-S) measures clinician's perception of severity of illness prior to assessments during study visits. Scores range from 1 (Normal) to 4 (Severe) where 1=Normal, 2=Mild, 3=Moderate, and 4=Severe.|participants|Number|36|36.0||||||
4148113|NCT00861757|3971720|B4|||Age||years|Mean|62.6|62.6|Standard Deviation|7.9|7.9|||
4148114|NCT00861757|3971721|B3|||Age||years|Mean|62.3|62.3|Standard Deviation|8.0|8.0|||
4148016|NCT00861757|3971723|B1|Mild||Clinical Global Impressions of Severity Scale (CGI-S)|The Clinical Global Impressions of Severity Scale (CGI-S) measures clinician's perception of severity of illness prior to assessments during study visits. Scores range from 1 (Normal) to 4 (Severe) where 1=Normal, 2=Mild, 3=Moderate, and 4=Severe.|participants|Number|42|42.0||||||
4148017|NCT00861757|3971719|B5|Normal||Clinical Global Impressions of Severity Scale (CGI-S)|The Clinical Global Impressions of Severity Scale (CGI-S) measures clinician's perception of severity of illness prior to assessments during study visits. Scores range from 1 (Normal) to 4 (Severe) where 1=Normal, 2=Mild, 3=Moderate, and 4=Severe.|participants|Number|1|1.0||||||
4148018|NCT00861757|3971720|B4|Normal||Clinical Global Impressions of Severity Scale (CGI-S)|The Clinical Global Impressions of Severity Scale (CGI-S) measures clinician's perception of severity of illness prior to assessments during study visits. Scores range from 1 (Normal) to 4 (Severe) where 1=Normal, 2=Mild, 3=Moderate, and 4=Severe.|participants|Number|0|0.0||||||
4148019|NCT00861757|3971721|B3|Normal||Clinical Global Impressions of Severity Scale (CGI-S)|The Clinical Global Impressions of Severity Scale (CGI-S) measures clinician's perception of severity of illness prior to assessments during study visits. Scores range from 1 (Normal) to 4 (Severe) where 1=Normal, 2=Mild, 3=Moderate, and 4=Severe.|participants|Number|0|0.0||||||
4148020|NCT00861757|3971722|B2|Normal||Clinical Global Impressions of Severity Scale (CGI-S)|The Clinical Global Impressions of Severity Scale (CGI-S) measures clinician's perception of severity of illness prior to assessments during study visits. Scores range from 1 (Normal) to 4 (Severe) where 1=Normal, 2=Mild, 3=Moderate, and 4=Severe.|participants|Number|0|0.0||||||
4148021|NCT00861757|3971723|B1|Normal||Clinical Global Impressions of Severity Scale (CGI-S)|The Clinical Global Impressions of Severity Scale (CGI-S) measures clinician's perception of severity of illness prior to assessments during study visits. Scores range from 1 (Normal) to 4 (Severe) where 1=Normal, 2=Mild, 3=Moderate, and 4=Severe.|participants|Number|1|1.0||||||
4148022|NCT00861757|3971719|B5|Severe||Patient Global Impressions of Severity Scale (PGI-S)|The Patient Global Impressions of Severity Scale (PGI-S) measures patient's perception of severity of illness prior to clinical assessments during study visits. Scores range from 1 (Normal) to 4 (Severe) where 1=Normal, 2=Mild, 3=Moderate, and 4=Severe.|participants|Number|65|65.0||||||
4148023|NCT00861757|3971720|B4|Severe||Patient Global Impressions of Severity Scale (PGI-S)|The Patient Global Impressions of Severity Scale (PGI-S) measures patient's perception of severity of illness prior to clinical assessments during study visits. Scores range from 1 (Normal) to 4 (Severe) where 1=Normal, 2=Mild, 3=Moderate, and 4=Severe.|participants|Number|20|20.0||||||
4148024|NCT00861757|3971721|B3|Severe||Patient Global Impressions of Severity Scale (PGI-S)|The Patient Global Impressions of Severity Scale (PGI-S) measures patient's perception of severity of illness prior to clinical assessments during study visits. Scores range from 1 (Normal) to 4 (Severe) where 1=Normal, 2=Mild, 3=Moderate, and 4=Severe.|participants|Number|12|12.0||||||
4148025|NCT00861757|3971722|B2|Severe||Patient Global Impressions of Severity Scale (PGI-S)|The Patient Global Impressions of Severity Scale (PGI-S) measures patient's perception of severity of illness prior to clinical assessments during study visits. Scores range from 1 (Normal) to 4 (Severe) where 1=Normal, 2=Mild, 3=Moderate, and 4=Severe.|participants|Number|18|18.0||||||
4148026|NCT00861757|3971723|B1|Severe||Patient Global Impressions of Severity Scale (PGI-S)|The Patient Global Impressions of Severity Scale (PGI-S) measures patient's perception of severity of illness prior to clinical assessments during study visits. Scores range from 1 (Normal) to 4 (Severe) where 1=Normal, 2=Mild, 3=Moderate, and 4=Severe.|participants|Number|15|15.0||||||
4148027|NCT00861757|3971719|B5|Moderate||Patient Global Impressions of Severity Scale (PGI-S)|The Patient Global Impressions of Severity Scale (PGI-S) measures patient's perception of severity of illness prior to clinical assessments during study visits. Scores range from 1 (Normal) to 4 (Severe) where 1=Normal, 2=Mild, 3=Moderate, and 4=Severe.|participants|Number|377|377.0||||||
4148028|NCT00861757|3971720|B4|Moderate||Patient Global Impressions of Severity Scale (PGI-S)|The Patient Global Impressions of Severity Scale (PGI-S) measures patient's perception of severity of illness prior to clinical assessments during study visits. Scores range from 1 (Normal) to 4 (Severe) where 1=Normal, 2=Mild, 3=Moderate, and 4=Severe.|participants|Number|93|93.0||||||
4148029|NCT00861757|3971721|B3|Moderate||Patient Global Impressions of Severity Scale (PGI-S)|The Patient Global Impressions of Severity Scale (PGI-S) measures patient's perception of severity of illness prior to clinical assessments during study visits. Scores range from 1 (Normal) to 4 (Severe) where 1=Normal, 2=Mild, 3=Moderate, and 4=Severe.|participants|Number|100|100.0||||||
4148030|NCT00861757|3971722|B2|Moderate||Patient Global Impressions of Severity Scale (PGI-S)|The Patient Global Impressions of Severity Scale (PGI-S) measures patient's perception of severity of illness prior to clinical assessments during study visits. Scores range from 1 (Normal) to 4 (Severe) where 1=Normal, 2=Mild, 3=Moderate, and 4=Severe.|participants|Number|92|92.0||||||
4148031|NCT00861757|3971723|B1|Moderate||Patient Global Impressions of Severity Scale (PGI-S)|The Patient Global Impressions of Severity Scale (PGI-S) measures patient's perception of severity of illness prior to clinical assessments during study visits. Scores range from 1 (Normal) to 4 (Severe) where 1=Normal, 2=Mild, 3=Moderate, and 4=Severe.|participants|Number|92|92.0||||||
4148032|NCT00861757|3971719|B5|Mild||Patient Global Impressions of Severity Scale (PGI-S)|The Patient Global Impressions of Severity Scale (PGI-S) measures patient's perception of severity of illness prior to clinical assessments during study visits. Scores range from 1 (Normal) to 4 (Severe) where 1=Normal, 2=Mild, 3=Moderate, and 4=Severe.|participants|Number|168|168.0||||||
4148033|NCT00861757|3971720|B4|Mild||Patient Global Impressions of Severity Scale (PGI-S)|The Patient Global Impressions of Severity Scale (PGI-S) measures patient's perception of severity of illness prior to clinical assessments during study visits. Scores range from 1 (Normal) to 4 (Severe) where 1=Normal, 2=Mild, 3=Moderate, and 4=Severe.|participants|Number|39|39.0||||||
4148034|NCT00861757|3971721|B3|Mild||Patient Global Impressions of Severity Scale (PGI-S)|The Patient Global Impressions of Severity Scale (PGI-S) measures patient's perception of severity of illness prior to clinical assessments during study visits. Scores range from 1 (Normal) to 4 (Severe) where 1=Normal, 2=Mild, 3=Moderate, and 4=Severe.|participants|Number|43|43.0||||||
4148115|NCT00861757|3971722|B2|||Age||years|Mean|63.7|63.7|Standard Deviation|7.2|7.2|||
4148116|NCT00861757|3971723|B1|||Age||years|Mean|63.7|63.7|Standard Deviation|8.1|8.1|||
4148117|NCT00861744|3971780|B5||Male|Sex: Female, Male||Participants|Count of Participants|624|624.0||||||
4148035|NCT00861757|3971722|B2|Mild||Patient Global Impressions of Severity Scale (PGI-S)|The Patient Global Impressions of Severity Scale (PGI-S) measures patient's perception of severity of illness prior to clinical assessments during study visits. Scores range from 1 (Normal) to 4 (Severe) where 1=Normal, 2=Mild, 3=Moderate, and 4=Severe.|participants|Number|41|41.0||||||
4148036|NCT00861757|3971723|B1|Mild||Patient Global Impressions of Severity Scale (PGI-S)|The Patient Global Impressions of Severity Scale (PGI-S) measures patient's perception of severity of illness prior to clinical assessments during study visits. Scores range from 1 (Normal) to 4 (Severe) where 1=Normal, 2=Mild, 3=Moderate, and 4=Severe.|participants|Number|45|45.0||||||
4148037|NCT00861757|3971719|B5|Normal||Patient Global Impressions of Severity Scale (PGI-S)|The Patient Global Impressions of Severity Scale (PGI-S) measures patient's perception of severity of illness prior to clinical assessments during study visits. Scores range from 1 (Normal) to 4 (Severe) where 1=Normal, 2=Mild, 3=Moderate, and 4=Severe.|participants|Number|2|2.0||||||
4148038|NCT00861757|3971720|B4|Normal||Patient Global Impressions of Severity Scale (PGI-S)|The Patient Global Impressions of Severity Scale (PGI-S) measures patient's perception of severity of illness prior to clinical assessments during study visits. Scores range from 1 (Normal) to 4 (Severe) where 1=Normal, 2=Mild, 3=Moderate, and 4=Severe.|participants|Number|0|0.0||||||
4148039|NCT00861757|3971721|B3|Normal||Patient Global Impressions of Severity Scale (PGI-S)|The Patient Global Impressions of Severity Scale (PGI-S) measures patient's perception of severity of illness prior to clinical assessments during study visits. Scores range from 1 (Normal) to 4 (Severe) where 1=Normal, 2=Mild, 3=Moderate, and 4=Severe.|participants|Number|0|0.0||||||
4148040|NCT00861757|3971722|B2|Normal||Patient Global Impressions of Severity Scale (PGI-S)|The Patient Global Impressions of Severity Scale (PGI-S) measures patient's perception of severity of illness prior to clinical assessments during study visits. Scores range from 1 (Normal) to 4 (Severe) where 1=Normal, 2=Mild, 3=Moderate, and 4=Severe.|participants|Number|0|0.0||||||
4148041|NCT00861757|3971723|B1|Normal||Patient Global Impressions of Severity Scale (PGI-S)|The Patient Global Impressions of Severity Scale (PGI-S) measures patient's perception of severity of illness prior to clinical assessments during study visits. Scores range from 1 (Normal) to 4 (Severe) where 1=Normal, 2=Mild, 3=Moderate, and 4=Severe.|participants|Number|2|2.0||||||
4148042|NCT00861757|3971719|B5|||Duration of BPH||Years|Mean|3.7|3.7|Standard Deviation|3.2|3.2|||
4148043|NCT00861757|3971720|B4|||Duration of BPH||Years|Mean|3.7|3.7|Standard Deviation|3.2|3.2|||
4148044|NCT00861757|3971721|B3|||Duration of BPH||Years|Mean|3.5|3.5|Standard Deviation|2.9|2.9|||
4148045|NCT00861757|3971722|B2|||Duration of BPH||Years|Mean|3.7|3.7|Standard Deviation|3.3|3.3|||
4148046|NCT00861757|3971723|B1|||Duration of BPH||Years|Mean|3.7|3.7|Standard Deviation|3.4|3.4|||
4148047|NCT00861757|3971719|B5|Severe (IPSS>=20)||Benign Prostatic Hyperplasia (BPH) Severity|The International Prostate Symptom Score (IPSS) Total Score is obtained by combining the scores of the responses to 1 through 7 component questions. Each question is scored from 0-5 for an IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|204|204.0||||||
4148048|NCT00861757|3971720|B4|Severe (IPSS>=20)||Benign Prostatic Hyperplasia (BPH) Severity|The International Prostate Symptom Score (IPSS) Total Score is obtained by combining the scores of the responses to 1 through 7 component questions. Each question is scored from 0-5 for an IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|50|50.0||||||
4148049|NCT00861757|3971721|B3|Severe (IPSS>=20)||Benign Prostatic Hyperplasia (BPH) Severity|The International Prostate Symptom Score (IPSS) Total Score is obtained by combining the scores of the responses to 1 through 7 component questions. Each question is scored from 0-5 for an IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|53|53.0||||||
4148050|NCT00861757|3971722|B2|Severe (IPSS>=20)||Benign Prostatic Hyperplasia (BPH) Severity|The International Prostate Symptom Score (IPSS) Total Score is obtained by combining the scores of the responses to 1 through 7 component questions. Each question is scored from 0-5 for an IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|49|49.0||||||
4148051|NCT00861757|3971723|B1|Severe (IPSS>=20)||Benign Prostatic Hyperplasia (BPH) Severity|The International Prostate Symptom Score (IPSS) Total Score is obtained by combining the scores of the responses to 1 through 7 component questions. Each question is scored from 0-5 for an IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|52|52.0||||||
4148052|NCT00861757|3971719|B5|Moderate (IPSS<20)||Benign Prostatic Hyperplasia (BPH) Severity|The International Prostate Symptom Score (IPSS) Total Score is obtained by combining the scores of the responses to 1 through 7 component questions. Each question is scored from 0-5 for an IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|408|408.0||||||
4148053|NCT00861757|3971720|B4|Moderate (IPSS<20)||Benign Prostatic Hyperplasia (BPH) Severity|The International Prostate Symptom Score (IPSS) Total Score is obtained by combining the scores of the responses to 1 through 7 component questions. Each question is scored from 0-5 for an IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|102|102.0||||||
4148054|NCT00861757|3971721|B3|Moderate (IPSS<20)||Benign Prostatic Hyperplasia (BPH) Severity|The International Prostate Symptom Score (IPSS) Total Score is obtained by combining the scores of the responses to 1 through 7 component questions. Each question is scored from 0-5 for an IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|102|102.0||||||
4148055|NCT00861757|3971722|B2|Moderate (IPSS<20)||Benign Prostatic Hyperplasia (BPH) Severity|The International Prostate Symptom Score (IPSS) Total Score is obtained by combining the scores of the responses to 1 through 7 component questions. Each question is scored from 0-5 for an IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|102|102.0||||||
4148118|NCT00861744|3971781|B4||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4148119|NCT00861744|3971782|B3||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4148120|NCT00861744|3971783|B2||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4148056|NCT00861757|3971723|B1|Moderate (IPSS<20)||Benign Prostatic Hyperplasia (BPH) Severity|The International Prostate Symptom Score (IPSS) Total Score is obtained by combining the scores of the responses to 1 through 7 component questions. Each question is scored from 0-5 for an IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|102|102.0||||||
4148057|NCT00861757|3971719|B5|No||Current Alcohol Use||participants|Number|286|286.0||||||
4148058|NCT00861757|3971720|B4|No||Current Alcohol Use||participants|Number|69|69.0||||||
4148059|NCT00861757|3971721|B3|No||Current Alcohol Use||participants|Number|71|71.0||||||
4148060|NCT00861757|3971722|B2|No||Current Alcohol Use||participants|Number|70|70.0||||||
4148061|NCT00861757|3971723|B1|No||Current Alcohol Use||participants|Number|76|76.0||||||
4148062|NCT00861757|3971719|B5|Yes||Current Alcohol Use||participants|Number|326|326.0||||||
4148063|NCT00861757|3971720|B4|Yes||Current Alcohol Use||participants|Number|83|83.0||||||
4148064|NCT00861757|3971721|B3|Yes||Current Alcohol Use||participants|Number|84|84.0||||||
4148065|NCT00861757|3971722|B2|Yes||Current Alcohol Use||participants|Number|81|81.0||||||
4148066|NCT00861757|3971723|B1|Yes||Current Alcohol Use||participants|Number|78|78.0||||||
4148067|NCT00861757|3971719|B5|No||Current Tobacco Use||participants|Number|496|496.0||||||
4148068|NCT00861757|3971720|B4|No||Current Tobacco Use||participants|Number|129|129.0||||||
4148069|NCT00861757|3971721|B3|No||Current Tobacco Use||participants|Number|119|119.0||||||
4148070|NCT00861757|3971722|B2|No||Current Tobacco Use||participants|Number|121|121.0||||||
4148071|NCT00861757|3971723|B1|No||Current Tobacco Use||participants|Number|127|127.0||||||
4148072|NCT00861757|3971719|B5|Yes||Current Tobacco Use||participants|Number|116|116.0||||||
4148073|NCT00861757|3971720|B4|Yes||Current Tobacco Use||participants|Number|23|23.0||||||
4148074|NCT00861757|3971721|B3|Yes||Current Tobacco Use||participants|Number|36|36.0||||||
4148075|NCT00861757|3971722|B2|Yes||Current Tobacco Use||participants|Number|30|30.0||||||
4148076|NCT00861757|3971723|B1|Yes||Current Tobacco Use||participants|Number|27|27.0||||||
4148077|NCT00861757|3971719|B5|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters (kg/m^2)|Mean|24.2|24.2|Standard Deviation|2.8|2.8|||
4148078|NCT00861757|3971720|B4|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters (kg/m^2)|Mean|24.4|24.4|Standard Deviation|2.9|2.9|||
4148079|NCT00861757|3971721|B3|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters (kg/m^2)|Mean|24.2|24.2|Standard Deviation|2.8|2.8|||
4148080|NCT00861757|3971722|B2|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters (kg/m^2)|Mean|23.9|23.9|Standard Deviation|2.8|2.8|||
4148081|NCT00861757|3971723|B1|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters (kg/m^2)|Mean|24.3|24.3|Standard Deviation|2.9|2.9|||
4148082|NCT00861757|3971719|B5|Korea, Republic of||Region of Enrollment||participants|Number|180|180.0||||||
4148083|NCT00861757|3971720|B4|Korea, Republic of||Region of Enrollment||participants|Number|45|45.0||||||
4148084|NCT00861757|3971721|B3|Korea, Republic of||Region of Enrollment||participants|Number|47|47.0||||||
4148085|NCT00861757|3971722|B2|Korea, Republic of||Region of Enrollment||participants|Number|44|44.0||||||
4148086|NCT00861757|3971723|B1|Korea, Republic of||Region of Enrollment||participants|Number|44|44.0||||||
4148087|NCT00861757|3971719|B5|Japan||Region of Enrollment||participants|Number|342|342.0||||||
4148088|NCT00861757|3971720|B4|Japan||Region of Enrollment||participants|Number|85|85.0||||||
4148089|NCT00861757|3971721|B3|Japan||Region of Enrollment||participants|Number|87|87.0||||||
4148090|NCT00861757|3971722|B2|Japan||Region of Enrollment||participants|Number|84|84.0||||||
4148091|NCT00861757|3971723|B1|Japan||Region of Enrollment||participants|Number|86|86.0||||||
4148092|NCT00861757|3971719|B5|Taiwan||Region of Enrollment||participants|Number|90|90.0||||||
4148093|NCT00861757|3971720|B4|Taiwan||Region of Enrollment||participants|Number|22|22.0||||||
4148094|NCT00861757|3971721|B3|Taiwan||Region of Enrollment||participants|Number|21|21.0||||||
4148095|NCT00861757|3971722|B2|Taiwan||Region of Enrollment||participants|Number|23|23.0||||||
4148096|NCT00861757|3971723|B1|Taiwan||Region of Enrollment||participants|Number|24|24.0||||||
4148097|NCT00861757|3971719|B5|Asian||Race/Ethnicity, Customized||participants|Number|612|612.0||||||
4148098|NCT00861757|3971720|B4|Asian||Race/Ethnicity, Customized||participants|Number|152|152.0||||||
4148099|NCT00861757|3971721|B3|Asian||Race/Ethnicity, Customized||participants|Number|155|155.0||||||
4148100|NCT00861757|3971722|B2|Asian||Race/Ethnicity, Customized||participants|Number|151|151.0||||||
4148101|NCT00861757|3971723|B1|Asian||Race/Ethnicity, Customized||participants|Number|154|154.0||||||
4148102|NCT00861757|3971719|B5||Male|Sex: Female, Male||Participants|Count of Participants|612|612.0||||||
4148103|NCT00861757|3971720|B4||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4148104|NCT00861757|3971721|B3||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4148105|NCT00861757|3971722|B2||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4148106|NCT00861757|3971723|B1||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4148107|NCT00861757|3971719|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4148108|NCT00861757|3971720|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4148109|NCT00861757|3971721|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4148110|NCT00861757|3971722|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4148111|NCT00861757|3971723|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4148112|NCT00861757|3971719|B5|||Age||years|Mean|63.1|63.1|Standard Deviation|7.8|7.8|||
4148121|NCT00861744|3971784|B1||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4148122|NCT00861744|3971780|B5||Female|Sex: Female, Male||Participants|Count of Participants|596|596.0||||||
4148123|NCT00861744|3971781|B4||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4148124|NCT00861744|3971782|B3||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4148125|NCT00861744|3971783|B2||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4148126|NCT00861744|3971784|B1||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4148127|NCT00861744|3971780|B5|||Age||Months|Mean|12.4|12.4|Standard Deviation|0.70|0.7|||
4148128|NCT00861744|3971781|B4|||Age||Months|Mean|12.4|12.4|Standard Deviation|0.75|0.75|||
4148129|NCT00861744|3971782|B3|||Age||Months|Mean|12.2|12.2|Standard Deviation|0.56|0.56|||
4148130|NCT00861744|3971783|B2|||Age||Months|Mean|12.4|12.4|Standard Deviation|0.73|0.73|||
4148131|NCT00861744|3971784|B1|||Age||Months|Mean|12.4|12.4|Standard Deviation|0.75|0.75|||
4148132|NCT00861705|3971965|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4148133|NCT00861705|3971966|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4148134|NCT00861705|3971967|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4148135|NCT00861705|3971968|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4148136|NCT00861705|3971969|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4148137|NCT00861705|3971965|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4148138|NCT00861705|3971966|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4148139|NCT00861705|3971967|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4148140|NCT00861705|3971968|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4148141|NCT00861705|3971969|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4148142|NCT00861705|3971965|B5||White|Race (NIH/OMB)||Participants|Count of Participants|331|331.0||||||
4148143|NCT00861705|3971966|B4||White|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
4148144|NCT00861705|3971967|B3||White|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
4148145|NCT00861705|3971968|B2||White|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
4148146|NCT00861705|3971969|B1||White|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4148147|NCT00861705|3971965|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
4148148|NCT00861705|3971966|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4148149|NCT00861705|3971967|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4148150|NCT00861705|3971968|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4148151|NCT00861705|3971969|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4148152|NCT00861705|3971965|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4148153|NCT00861705|3971966|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148154|NCT00861705|3971967|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148155|NCT00861705|3971968|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148156|NCT00861705|3971969|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4148157|NCT00861705|3971965|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4148158|NCT00861705|3971966|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4148159|NCT00861705|3971967|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4148160|NCT00861705|3971968|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4148161|NCT00861705|3971969|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4148162|NCT00861705|3971965|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4148163|NCT00861705|3971966|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4148164|NCT00861705|3971967|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148165|NCT00861705|3971968|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148166|NCT00861705|3971969|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4148167|NCT00861705|3971965|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4148168|NCT00861705|3971966|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4148169|NCT00861705|3971967|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4148170|NCT00861705|3971968|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4148171|NCT00861705|3971969|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4148172|NCT00861705|3971965|B5||Female|Sex: Female, Male||Participants|Count of Participants|454|454.0||||||
4148173|NCT00861705|3971966|B4||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4148174|NCT00861705|3971967|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4148175|NCT00861705|3971968|B2||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4148176|NCT00861705|3971969|B1||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4148177|NCT00861705|3971965|B5|||Age||years|Mean|49.1|49.1|Standard Deviation|10.7|10.7|||
4148178|NCT00861705|3971966|B4|||Age||years|Mean|47.1|47.1|Standard Deviation|9.8|9.8|||
4148179|NCT00861705|3971967|B3|||Age||years|Mean|50.9|50.9|Standard Deviation|10.8|10.8|||
4148180|NCT00861705|3971968|B2|||Age||years|Mean|48.3|48.3|Standard Deviation|10.8|10.8|||
4148181|NCT00861705|3971969|B1|||Age||years|Mean|50.2|50.2|Standard Deviation|11.1|11.1|||
4148182|NCT00861692|3971988|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4148183|NCT00861692|3971988|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4148184|NCT00861692|3971988|B1|||Age||years|Mean|71.7|71.7|Standard Deviation|10.4|10.4|||
4148185|NCT00861614|3971998|B3||Male|Sex: Female, Male||Participants|Count of Participants|799|799.0||||||
4148186|NCT00861614|3971999|B2||Male|Sex: Female, Male||Participants|Count of Participants|400|400.0||||||
4148187|NCT00861614|3972000|B1||Male|Sex: Female, Male||Participants|Count of Participants|399|399.0||||||
4148188|NCT00861614|3971998|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4148189|NCT00861614|3971999|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4148190|NCT00861614|3972000|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4148191|NCT00861614|3971998|B3|||Age||years|Mean|67.6|67.6|Standard Deviation|7.56|7.56|||
4148192|NCT00861614|3971999|B2|||Age||years|Mean|67.1|67.1|Standard Deviation|7.56|7.56|||
4148193|NCT00861614|3972000|B1|||Age||years|Mean|68.2|68.2|Standard Deviation|7.53|7.53|||
4148194|NCT00861601|3972031|B4|Class C||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15, with 5 being mild and 15 being severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess the severity of liver disease. A CP score of 5 or 6 is classified as Class A (mild), a score of 7-9 is classified as Class B (moderate), and a score >=10 is classified as Class C (severe). Participants with a CP score <10 were enrolled in the study|participants|Number|0|0.0||||||
4148195|NCT00861601|3972032|B3|Class C||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15, with 5 being mild and 15 being severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess the severity of liver disease. A CP score of 5 or 6 is classified as Class A (mild), a score of 7-9 is classified as Class B (moderate), and a score >=10 is classified as Class C (severe). Participants with a CP score <10 were enrolled in the study|participants|Number|0|0.0||||||
4148196|NCT00861601|3972033|B2|Class C||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15, with 5 being mild and 15 being severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess the severity of liver disease. A CP score of 5 or 6 is classified as Class A (mild), a score of 7-9 is classified as Class B (moderate), and a score >=10 is classified as Class C (severe). Participants with a CP score <10 were enrolled in the study|participants|Number|0|0.0||||||
4148197|NCT00861601|3972034|B1|Class C||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15, with 5 being mild and 15 being severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess the severity of liver disease. A CP score of 5 or 6 is classified as Class A (mild), a score of 7-9 is classified as Class B (moderate), and a score >=10 is classified as Class C (severe). Participants with a CP score <10 were enrolled in the study|participants|Number|0|0.0||||||
4148198|NCT00861601|3972031|B4|Class B||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15, with 5 being mild and 15 being severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess the severity of liver disease. A CP score of 5 or 6 is classified as Class A (mild), a score of 7-9 is classified as Class B (moderate), and a score >=10 is classified as Class C (severe). Participants with a CP score <10 were enrolled in the study|participants|Number|15|15.0||||||
4148199|NCT00861601|3972032|B3|Class B||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15, with 5 being mild and 15 being severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess the severity of liver disease. A CP score of 5 or 6 is classified as Class A (mild), a score of 7-9 is classified as Class B (moderate), and a score >=10 is classified as Class C (severe). Participants with a CP score <10 were enrolled in the study|participants|Number|5|5.0||||||
4148200|NCT00861601|3972033|B2|Class B||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15, with 5 being mild and 15 being severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess the severity of liver disease. A CP score of 5 or 6 is classified as Class A (mild), a score of 7-9 is classified as Class B (moderate), and a score >=10 is classified as Class C (severe). Participants with a CP score <10 were enrolled in the study|participants|Number|6|6.0||||||
4148201|NCT00861601|3972034|B1|Class B||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15, with 5 being mild and 15 being severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess the severity of liver disease. A CP score of 5 or 6 is classified as Class A (mild), a score of 7-9 is classified as Class B (moderate), and a score >=10 is classified as Class C (severe). Participants with a CP score <10 were enrolled in the study|participants|Number|4|4.0||||||
4148202|NCT00861601|3972031|B4|Class A||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15, with 5 being mild and 15 being severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess the severity of liver disease. A CP score of 5 or 6 is classified as Class A (mild), a score of 7-9 is classified as Class B (moderate), and a score >=10 is classified as Class C (severe). Participants with a CP score <10 were enrolled in the study|participants|Number|23|23.0||||||
4148307|NCT00860847|3972126|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4148308|NCT00860847|3972127|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4148309|NCT00860847|3972128|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4148203|NCT00861601|3972032|B3|Class A||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15, with 5 being mild and 15 being severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess the severity of liver disease. A CP score of 5 or 6 is classified as Class A (mild), a score of 7-9 is classified as Class B (moderate), and a score >=10 is classified as Class C (severe). Participants with a CP score <10 were enrolled in the study|participants|Number|7|7.0||||||
4148204|NCT00861601|3972033|B2|Class A||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15, with 5 being mild and 15 being severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess the severity of liver disease. A CP score of 5 or 6 is classified as Class A (mild), a score of 7-9 is classified as Class B (moderate), and a score >=10 is classified as Class C (severe). Participants with a CP score <10 were enrolled in the study|participants|Number|8|8.0||||||
4148205|NCT00861601|3972034|B1|Class A||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15, with 5 being mild and 15 being severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess the severity of liver disease. A CP score of 5 or 6 is classified as Class A (mild), a score of 7-9 is classified as Class B (moderate), and a score >=10 is classified as Class C (severe). Participants with a CP score <10 were enrolled in the study|participants|Number|8|8.0||||||
4148206|NCT00861601|3972031|B4|Asian-Japanese Heritage||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4148207|NCT00861601|3972032|B3|Asian-Japanese Heritage||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4148208|NCT00861601|3972033|B2|Asian-Japanese Heritage||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4148209|NCT00861601|3972034|B1|Asian-Japanese Heritage||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4148210|NCT00861601|3972031|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4148211|NCT00861601|3972032|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4148212|NCT00861601|3972033|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4148213|NCT00861601|3972034|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4148214|NCT00861601|3972031|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4148215|NCT00861601|3972032|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4148216|NCT00861601|3972033|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4148217|NCT00861601|3972034|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4148218|NCT00861601|3972031|B4|||Age||years|Mean|61.8|61.8|Standard Deviation|9.78|9.78|||
4148219|NCT00861601|3972032|B3|||Age||years|Mean|66.3|66.3|Standard Deviation|8.84|8.84|||
4148220|NCT00861601|3972033|B2|||Age||years|Mean|57.7|57.7|Standard Deviation|8.69|8.69|||
4148221|NCT00861601|3972034|B1|||Age||years|Mean|62.2|62.2|Standard Deviation|10.51|10.51|||
4148222|NCT00861471|3972086|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4148223|NCT00861471|3972086|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4148224|NCT00861471|3972086|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4148225|NCT00861471|3972086|B1|||Age||years|Mean|67.2|67.2|Standard Deviation|9.9|9.9|||
4148226|NCT00861471|3972086|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4148227|NCT00861471|3972086|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4148228|NCT00861471|3972086|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4148229|NCT00861341|3972094|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4148230|NCT00861341|3972094|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4148231|NCT00861341|3972094|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4148232|NCT00861341|3972094|B1|||Age||years|Mean|49|49.0|Standard Deviation|32|32.0|||
4148233|NCT00861341|3972094|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4148234|NCT00861341|3972094|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4148235|NCT00861341|3972094|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4148236|NCT00861263|3972099|B1|United States||Region of Enrollment||participants|Number|193|193.0||||||
4148237|NCT00861263|3972099|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4148238|NCT00861263|3972099|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4148239|NCT00861263|3972099|B1|||Age||years|Mean|62|62.0|Standard Deviation|10|10.0|||
4148240|NCT00861263|3972099|B1||>=65 years|Age||Participants|Count of Participants|99|99.0||||||
4148241|NCT00861263|3972099|B1||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
4148242|NCT00861263|3972099|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4148243|NCT00861198|3972103|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
4148244|NCT00861198|3972103|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4148245|NCT00861198|3972103|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4148246|NCT00861198|3972103|B1|||Age||years|Mean|66|66.0|Full Range|||22.0|96.0|
4148247|NCT00861146|3972107|B3|||Proportion days heavy drinking|Heavy drinking days were defined as days with > 6 standard drinks per day for men and > 4 standard drinks per day for women. The baseline measure examined the proportion of heavy drinking days in the 90 days prior to the last day of reported drinking prior to study enrollment.|proportion|Mean|.56|0.56|Standard Deviation|.35|0.35|||
4148248|NCT00861146|3972108|B2|||Proportion days heavy drinking|Heavy drinking days were defined as days with > 6 standard drinks per day for men and > 4 standard drinks per day for women. The baseline measure examined the proportion of heavy drinking days in the 90 days prior to the last day of reported drinking prior to study enrollment.|proportion|Mean|.52|0.52|Standard Deviation|.38|0.38|||
4148249|NCT00861146|3972109|B1|||Proportion days heavy drinking|Heavy drinking days were defined as days with > 6 standard drinks per day for men and > 4 standard drinks per day for women. The baseline measure examined the proportion of heavy drinking days in the 90 days prior to the last day of reported drinking prior to study enrollment.|proportion|Mean|.58|0.58|Standard Deviation|.33|0.33|||
4148250|NCT00861146|3972107|B3|||Cigarettes smoked/day||cigarettes|Mean|16.2|16.2|Standard Deviation|8.7|8.7|||
4148251|NCT00861146|3972108|B2|||Cigarettes smoked/day||cigarettes|Mean|16.8|16.8|Standard Deviation|10.0|10.0|||
4148252|NCT00861146|3972109|B1|||Cigarettes smoked/day||cigarettes|Mean|16.0|16.0|Standard Deviation|8.0|8.0|||
4148253|NCT00861146|3972107|B3|United States||Region of Enrollment||participants|Number|151|151.0||||||
4148254|NCT00861146|3972108|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
4148255|NCT00861146|3972109|B1|United States||Region of Enrollment||participants|Number|105|105.0||||||
4148256|NCT00861146|3972107|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4148257|NCT00861146|3972108|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4148258|NCT00861146|3972109|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4148259|NCT00861146|3972107|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148260|NCT00861146|3972108|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148261|NCT00861146|3972109|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148262|NCT00861146|3972107|B3||White|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
4148263|NCT00861146|3972108|B2||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4148264|NCT00861146|3972109|B1||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4148265|NCT00861146|3972107|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4148266|NCT00861146|3972108|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4148267|NCT00861146|3972109|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4148268|NCT00861146|3972107|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148269|NCT00861146|3972108|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148270|NCT00861146|3972109|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148271|NCT00861146|3972107|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148272|NCT00861146|3972108|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148273|NCT00861146|3972109|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148274|NCT00861146|3972107|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148275|NCT00861146|3972108|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148276|NCT00861146|3972109|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148277|NCT00861146|3972107|B3||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4148278|NCT00861146|3972108|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4148279|NCT00861146|3972109|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4148280|NCT00861146|3972107|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4148281|NCT00861146|3972108|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4148282|NCT00861146|3972109|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4148283|NCT00861146|3972107|B3|||Age||years|Mean|49.1|49.1|Standard Deviation|8.95|8.95|||
4148284|NCT00861146|3972108|B2|||Age||years|Mean|48.1|48.1|Standard Deviation|8.68|8.68|||
4148285|NCT00861146|3972109|B1|||Age||years|Mean|49.5|49.5|Standard Deviation|9.07|9.07|||
4148286|NCT00860951|3972120|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4148287|NCT00860951|3972120|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4148288|NCT00860951|3972120|B1|||Age||years|Mean|43|43.0|Full Range|||18.0|79.0|
4148289|NCT00860847|3972126|B3|United States||Region of Enrollment||participants|Number|65|65.0||||||
4148290|NCT00860847|3972127|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4148291|NCT00860847|3972128|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4148292|NCT00860847|3972126|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4148293|NCT00860847|3972127|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4148294|NCT00860847|3972128|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4148295|NCT00860847|3972126|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4148296|NCT00860847|3972127|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4148297|NCT00860847|3972128|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4148298|NCT00860847|3972126|B3|||Age||years|Mean|55|55.0|Standard Deviation|6|6.0|||
4148299|NCT00860847|3972127|B2|||Age||years|Mean|55|55.0|Standard Deviation|6|6.0|||
4148300|NCT00860847|3972128|B1|||Age||years|Mean|55|55.0|Standard Deviation|6|6.0|||
4148301|NCT00860847|3972126|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4148302|NCT00860847|3972127|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4148303|NCT00860847|3972128|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4148304|NCT00860847|3972126|B3||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4148305|NCT00860847|3972127|B2||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4148306|NCT00860847|3972128|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4148310|NCT00860795|3972135|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4148311|NCT00860795|3972136|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4148312|NCT00860795|3972137|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4148313|NCT00860795|3972135|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4148314|NCT00860795|3972136|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4148315|NCT00860795|3972137|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4148316|NCT00860795|3972135|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4148317|NCT00860795|3972136|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4148318|NCT00860795|3972137|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4148319|NCT00860795|3972135|B3|||Age||years|Mean|36.5|36.5|Standard Deviation|13.2|13.2|||
4148320|NCT00860795|3972136|B2|||Age||years|Mean|37.4|37.4|Standard Deviation|14.3|14.3|||
4148321|NCT00860795|3972137|B1|||Age||years|Mean|35.5|35.5|Standard Deviation|12.6|12.6|||
4148322|NCT00860795|3972135|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4148323|NCT00860795|3972136|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4148324|NCT00860795|3972137|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4148325|NCT00860795|3972135|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4148326|NCT00860795|3972136|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4148327|NCT00860795|3972137|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4148328|NCT00860795|3972135|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4148329|NCT00860795|3972136|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4148330|NCT00860795|3972137|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4148331|NCT00860743|3972156|B7|United States||Region of Enrollment||participants|Number|63|63.0||||||
4148332|NCT00860743|3972157|B6|United States||Region of Enrollment||participants|Number|10|10.0||||||
4148333|NCT00860743|3972158|B5|United States||Region of Enrollment||participants|Number|13|13.0||||||
4148334|NCT00860743|3972159|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
4148335|NCT00860743|3972160|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4148336|NCT00860743|3972161|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4148337|NCT00860743|3972162|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4148338|NCT00860743|3972156|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148339|NCT00860743|3972157|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148340|NCT00860743|3972158|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148341|NCT00860743|3972159|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148342|NCT00860743|3972160|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148343|NCT00860743|3972161|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148344|NCT00860743|3972162|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148345|NCT00860743|3972156|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148346|NCT00860743|3972157|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148347|NCT00860743|3972158|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148348|NCT00860743|3972159|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148349|NCT00860743|3972160|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148350|NCT00860743|3972161|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148351|NCT00860743|3972162|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148352|NCT00860743|3972156|B7||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4148353|NCT00860743|3972157|B6||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4148354|NCT00860743|3972158|B5||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4148355|NCT00860743|3972159|B4||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4148356|NCT00860743|3972160|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4148357|NCT00860743|3972161|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4148358|NCT00860743|3972162|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4148359|NCT00860743|3972156|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4148360|NCT00860743|3972157|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4148361|NCT00860743|3972158|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4148362|NCT00860743|3972159|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4148363|NCT00860743|3972160|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4148364|NCT00860743|3972161|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4148365|NCT00860743|3972162|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4148366|NCT00860743|3972156|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148367|NCT00860743|3972157|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148368|NCT00860743|3972158|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148369|NCT00860743|3972159|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148370|NCT00860743|3972160|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148371|NCT00860743|3972161|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148372|NCT00860743|3972162|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148373|NCT00860743|3972156|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148374|NCT00860743|3972157|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148375|NCT00860743|3972158|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148376|NCT00860743|3972159|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148377|NCT00860743|3972160|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148378|NCT00860743|3972161|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148379|NCT00860743|3972162|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148380|NCT00860743|3972156|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148381|NCT00860743|3972157|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148382|NCT00860743|3972158|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148383|NCT00860743|3972159|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148384|NCT00860743|3972160|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148385|NCT00860743|3972161|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148386|NCT00860743|3972162|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148387|NCT00860743|3972156|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148388|NCT00860743|3972157|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148389|NCT00860743|3972158|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148390|NCT00860743|3972159|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148391|NCT00860743|3972160|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148392|NCT00860743|3972161|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148393|NCT00860743|3972162|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148394|NCT00860743|3972156|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4148395|NCT00860743|3972157|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4148396|NCT00860743|3972158|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4148397|NCT00860743|3972159|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4148398|NCT00860743|3972160|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4148399|NCT00860743|3972161|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4148400|NCT00860743|3972162|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4148401|NCT00860743|3972156|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4148402|NCT00860743|3972157|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4148403|NCT00860743|3972158|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148404|NCT00860743|3972159|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148405|NCT00860743|3972160|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148406|NCT00860743|3972161|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148407|NCT00860743|3972162|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148408|NCT00860743|3972156|B7||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4148409|NCT00860743|3972157|B6||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4148410|NCT00860743|3972158|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4148411|NCT00860743|3972159|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4148412|NCT00860743|3972160|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4148413|NCT00860743|3972161|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4148414|NCT00860743|3972162|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4148415|NCT00860743|3972156|B7||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4148416|NCT00860743|3972157|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4148417|NCT00860743|3972158|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4148418|NCT00860743|3972159|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4148419|NCT00860743|3972160|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4148420|NCT00860743|3972161|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4148421|NCT00860743|3972162|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4148422|NCT00860743|3972156|B7|||Age, Customized||years|Mean|26.6|26.6|Standard Deviation|5.4|5.4|||
4148423|NCT00860743|3972157|B6|||Age, Customized||years|Mean|29.1|29.1|Standard Deviation|5.1|5.1|||
4148424|NCT00860743|3972158|B5|||Age, Customized||years|Mean|31.2|31.2|Standard Deviation|6.2|6.2|||
4148425|NCT00860743|3972159|B4|||Age, Customized||years|Mean|24.8|24.8|Standard Deviation|4.1|4.1|||
4148426|NCT00860743|3972160|B3|||Age, Customized||years|Mean|25.2|25.2|Standard Deviation|4.0|4.0|||
4148427|NCT00860743|3972161|B2|||Age, Customized||years|Mean|26.6|26.6|Standard Deviation|5.9|5.9|||
4148428|NCT00860743|3972162|B1|||Age, Customized||years|Mean|24.8|24.8|Standard Deviation|3.1|3.1|||
4148429|NCT00860535|3972169|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4148430|NCT00860535|3972169|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4148431|NCT00860535|3972169|B1|||Age||years|Mean|48.0|48.0|Standard Deviation|15.3|15.3|||
4148432|NCT00860470|3972174|B3|||Previous Pregnancy Loss||participants|Number|10080|10080.0||||||
4148433|NCT00860470|3972175|B2|||Previous Pregnancy Loss||participants|Number|5,106|5.0||||||
4148434|NCT00860470|3972176|B1|||Previous Pregnancy Loss||participants|Number|4,974|4.0||||||
4148435|NCT00860470|3972174|B3|>=4||Parity||participants|Number|4380|4380.0||||||
4148436|NCT00860470|3972175|B2|>=4||Parity||participants|Number|2,194|2.0||||||
4148437|NCT00860470|3972176|B1|>=4||Parity||participants|Number|2,186|2.0||||||
4148438|NCT00860470|3972174|B3|1-3||Parity||participants|Number|26775|26775.0||||||
4148439|NCT00860470|3972175|B2|1-3||Parity||participants|Number|13,520|13.0||||||
4148440|NCT00860470|3972176|B1|1-3||Parity||participants|Number|13,255|13.0||||||
4148441|NCT00860470|3972174|B3|0||Parity||participants|Number|13318|13318.0||||||
4148442|NCT00860470|3972175|B2|0||Parity||participants|Number|6,647|6.0||||||
4148443|NCT00860470|3972176|B1|0||Parity||participants|Number|6,671|6.0||||||
4148444|NCT00860470|3972174|B3|Illiterate||Literacy||participants|Number|18766|18766.0||||||
4148445|NCT00860470|3972175|B2|Illiterate||Literacy||participants|Number|9,420|9.0||||||
4148446|NCT00860470|3972176|B1|Illiterate||Literacy||participants|Number|9,346|9.0||||||
4148447|NCT00860470|3972174|B3|Literate||Literacy||participants|Number|25801|25801.0||||||
4148448|NCT00860470|3972175|B2|Literate||Literacy||participants|Number|12,985|12.0||||||
4148449|NCT00860470|3972176|B1|Literate||Literacy||participants|Number|12,816|12.0||||||
4148450|NCT00860470|3972174|B3|||Gestational Age in weeks||weeks|Mean|10.30|10.3|Standard Deviation|4.7|4.7|||
4148451|NCT00860470|3972175|B2|||Gestational Age in weeks||weeks|Mean|10.28|10.28|Standard Deviation|4.7|4.7|||
4148452|NCT00860470|3972176|B1|||Gestational Age in weeks||weeks|Mean|10.34|10.34|Standard Deviation|4.7|4.7|||
4148453|NCT00860470|3972174|B3|Bangladesh||Region of Enrollment||participants|Number|44567|44567.0||||||
4148454|NCT00860470|3972175|B2|Bangladesh||Region of Enrollment||participants|Number|22,405|22.0||||||
4148455|NCT00860470|3972176|B1|Bangladesh||Region of Enrollment||participants|Number|22,162|22.0||||||
4148456|NCT00860470|3972174|B3|Asian, Bangladeshi||Race/Ethnicity, Customized||participants|Number|44567|44567.0||||||
4148457|NCT00860470|3972175|B2|Asian, Bangladeshi||Race/Ethnicity, Customized||participants|Number|22,405|22.0||||||
4148458|NCT00860470|3972176|B1|Asian, Bangladeshi||Race/Ethnicity, Customized||participants|Number|22,162|22.0||||||
4148459|NCT00860470|3972174|B3|Male||Gender||participants|Number|0|0.0||||||
4148460|NCT00860470|3972175|B2|Male||Gender||participants|Number|0|0.0||||||
4148461|NCT00860470|3972176|B1|Male||Gender||participants|Number|0|0.0||||||
4148462|NCT00860470|3972174|B3|Female||Gender||participants|Number|44567|44567.0||||||
4148463|NCT00860470|3972175|B2|Female||Gender||participants|Number|22,405|22.0||||||
4148464|NCT00860470|3972176|B1|Female||Gender||participants|Number|22,162|22.0||||||
4148465|NCT00860470|3972174|B3|||Age||years|Mean|24.3|24.3|Standard Deviation|6.43|6.43|||
4148466|NCT00860470|3972175|B2|||Age||years|Mean|24.4|24.4|Standard Deviation|6.44|6.44|||
4148467|NCT00860470|3972176|B1|||Age||years|Mean|24.3|24.3|Standard Deviation|6.43|6.43|||
4148468|NCT00860457|3972201|B1|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4148469|NCT00860457|3972201|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4148470|NCT00860457|3972201|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4148471|NCT00860457|3972201|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4148472|NCT00860457|3972201|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4148473|NCT00860457|3972201|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4148474|NCT00860457|3972201|B1|||Age||years|Median|60.5|60.5|Full Range|||41.0|78.0|
4148475|NCT00860405|3972205|B3|||Height||cm|Mean|104.0|104.0|Standard Deviation|15.1|15.1|||
4148476|NCT00860405|3972206|B2|||Height||cm|Mean|101.3|101.3|Standard Deviation|12.8|12.8|||
4148477|NCT00860405|3972207|B1|||Height||cm|Mean|106.6|106.6|Standard Deviation|16.8|16.8|||
4148478|NCT00860405|3972205|B3|||Weight||kg|Mean|16.9|16.9|Standard Deviation|7.2|7.2|||
4148479|NCT00860405|3972206|B2|||Weight||kg|Mean|15.4|15.4|Standard Deviation|4.4|4.4|||
4148480|NCT00860405|3972207|B1|||Weight||kg|Mean|18.2|18.2|Standard Deviation|8.9|8.9|||
4148481|NCT00860405|3972205|B3|Austria||Region of Enrollment||participants|Number|21|21.0||||||
4148482|NCT00860405|3972206|B2|Austria||Region of Enrollment||participants|Number|10|10.0||||||
4148483|NCT00860405|3972207|B1|Austria||Region of Enrollment||participants|Number|11|11.0||||||
4148484|NCT00860405|3972205|B3|Belgium||Region of Enrollment||participants|Number|40|40.0||||||
4148485|NCT00860405|3972206|B2|Belgium||Region of Enrollment||participants|Number|20|20.0||||||
4148486|NCT00860405|3972207|B1|Belgium||Region of Enrollment||participants|Number|20|20.0||||||
4148487|NCT00860405|3972205|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4148488|NCT00860405|3972206|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4148489|NCT00860405|3972207|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4148490|NCT00860405|3972205|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4148491|NCT00860405|3972206|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4148492|NCT00860405|3972207|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4148493|NCT00860405|3972205|B3|||Age||years|Mean|4.6|4.6|Standard Deviation|2.6|2.6|||
4148494|NCT00860405|3972206|B2|||Age||years|Mean|4.0|4.0|Standard Deviation|2.0|2.0|||
4148495|NCT00860405|3972207|B1|||Age||years|Mean|5.2|5.2|Standard Deviation|2.9|2.9|||
4148496|NCT00860314|3972230|B3|Germany||Region of Enrollment||participants|Number|96|96.0||||||
4148497|NCT00860314|3972231|B2|Germany||Region of Enrollment||participants|Number|48|48.0||||||
4148498|NCT00860314|3972232|B1|Germany||Region of Enrollment||participants|Number|48|48.0||||||
4148499|NCT00860314|3972230|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4148500|NCT00860314|3972231|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4148501|NCT00860314|3972232|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4148502|NCT00860314|3972230|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4148503|NCT00860314|3972231|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4148504|NCT00860314|3972232|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4148505|NCT00860314|3972230|B3|||Age||years|Mean|62|62.0|Standard Deviation|12.29|12.29|||
4148506|NCT00860314|3972231|B2|||Age||years|Mean|62|62.0|Standard Deviation|12.53|12.53|||
4148507|NCT00860314|3972232|B1|||Age||years|Mean|62|62.0|Standard Deviation|12.18|12.18|||
4148508|NCT00860314|3972230|B3||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4148509|NCT00860314|3972231|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4148510|NCT00860314|3972232|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4148511|NCT00860314|3972230|B3||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4148512|NCT00860314|3972231|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4148513|NCT00860314|3972232|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4148514|NCT00860314|3972230|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4148515|NCT00860314|3972231|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4148516|NCT00860314|3972232|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4148517|NCT00860262|3972245|B4|>= 3||Number of previous antihypertensive treatments||participants|Number|202|202.0||||||
4148518|NCT00860262|3972246|B3|>= 3||Number of previous antihypertensive treatments||participants|Number|45|45.0||||||
4148519|NCT00860262|3972247|B2|>= 3||Number of previous antihypertensive treatments||participants|Number|54|54.0||||||
4148520|NCT00860262|3972248|B1|>= 3||Number of previous antihypertensive treatments||participants|Number|103|103.0||||||
4148521|NCT00860262|3972245|B4|2||Number of previous antihypertensive treatments||participants|Number|266|266.0||||||
4148522|NCT00860262|3972246|B3|2||Number of previous antihypertensive treatments||participants|Number|71|71.0||||||
4148523|NCT00860262|3972247|B2|2||Number of previous antihypertensive treatments||participants|Number|59|59.0||||||
4148524|NCT00860262|3972248|B1|2||Number of previous antihypertensive treatments||participants|Number|136|136.0||||||
4148525|NCT00860262|3972245|B4|1||Number of previous antihypertensive treatments||participants|Number|278|278.0||||||
4148526|NCT00860262|3972246|B3|1||Number of previous antihypertensive treatments||participants|Number|78|78.0||||||
4148527|NCT00860262|3972247|B2|1||Number of previous antihypertensive treatments||participants|Number|67|67.0||||||
4148528|NCT00860262|3972248|B1|1||Number of previous antihypertensive treatments||participants|Number|133|133.0||||||
4148529|NCT00860262|3972245|B4|0||Number of previous antihypertensive treatments||participants|Number|112|112.0||||||
4148530|NCT00860262|3972246|B3|0||Number of previous antihypertensive treatments||participants|Number|26|26.0||||||
4148531|NCT00860262|3972247|B2|0||Number of previous antihypertensive treatments||participants|Number|37|37.0||||||
4148532|NCT00860262|3972248|B1|0||Number of previous antihypertensive treatments||participants|Number|49|49.0||||||
4148533|NCT00860262|3972245|B4|> 10 years||Duration of Hypertension Class||participants|Number|297|297.0||||||
4148534|NCT00860262|3972246|B3|> 10 years||Duration of Hypertension Class||participants|Number|74|74.0||||||
4148535|NCT00860262|3972247|B2|> 10 years||Duration of Hypertension Class||participants|Number|67|67.0||||||
4148536|NCT00860262|3972248|B1|> 10 years||Duration of Hypertension Class||participants|Number|156|156.0||||||
4148537|NCT00860262|3972245|B4|6 - 10 years||Duration of Hypertension Class||participants|Number|218|218.0||||||
4148538|NCT00860262|3972246|B3|6 - 10 years||Duration of Hypertension Class||participants|Number|54|54.0||||||
4148539|NCT00860262|3972247|B2|6 - 10 years||Duration of Hypertension Class||participants|Number|61|61.0||||||
4148540|NCT00860262|3972248|B1|6 - 10 years||Duration of Hypertension Class||participants|Number|103|103.0||||||
4148541|NCT00860262|3972245|B4|1 - 5 years||Duration of Hypertension Class||participants|Number|260|260.0||||||
4148542|NCT00860262|3972246|B3|1 - 5 years||Duration of Hypertension Class||participants|Number|72|72.0||||||
4148543|NCT00860262|3972247|B2|1 - 5 years||Duration of Hypertension Class||participants|Number|64|64.0||||||
4148544|NCT00860262|3972248|B1|1 - 5 years||Duration of Hypertension Class||participants|Number|124|124.0||||||
4148545|NCT00860262|3972245|B4|< 1 year||Duration of Hypertension Class||participants|Number|83|83.0||||||
4148546|NCT00860262|3972246|B3|< 1 year||Duration of Hypertension Class||participants|Number|20|20.0||||||
4148547|NCT00860262|3972247|B2|< 1 year||Duration of Hypertension Class||participants|Number|25|25.0||||||
4148548|NCT00860262|3972248|B1|< 1 year||Duration of Hypertension Class||participants|Number|38|38.0||||||
4148549|NCT00860262|3972245|B4|||Duration of Hypertension||years|Mean|10.1|10.1|Standard Deviation|9.6|9.6|||
4148550|NCT00860262|3972246|B3|||Duration of Hypertension||years|Mean|10.3|10.3|Standard Deviation|10.1|10.1|||
4148551|NCT00860262|3972247|B2|||Duration of Hypertension||years|Mean|9.4|9.4|Standard Deviation|9.2|9.2|||
4148552|NCT00860262|3972248|B1|||Duration of Hypertension||years|Mean|10.3|10.3|Standard Deviation|9.6|9.6|||
4148553|NCT00860262|3972245|B4|Yes||Type II Diabetes||participants|Number|129|129.0||||||
4148554|NCT00860262|3972246|B3|Yes||Type II Diabetes||participants|Number|23|23.0||||||
4148555|NCT00860262|3972247|B2|Yes||Type II Diabetes||participants|Number|34|34.0||||||
4148556|NCT00860262|3972248|B1|Yes||Type II Diabetes||participants|Number|72|72.0||||||
4148557|NCT00860262|3972245|B4|No||Type II Diabetes||participants|Number|729|729.0||||||
4148558|NCT00860262|3972246|B3|No||Type II Diabetes||participants|Number|197|197.0||||||
4148559|NCT00860262|3972247|B2|No||Type II Diabetes||participants|Number|183|183.0||||||
4148560|NCT00860262|3972248|B1|No||Type II Diabetes||participants|Number|349|349.0||||||
4148561|NCT00860262|3972245|B4|Black||Race Class||participants|Number|64|64.0||||||
4148562|NCT00860262|3972246|B3|Black||Race Class||participants|Number|15|15.0||||||
4148563|NCT00860262|3972247|B2|Black||Race Class||participants|Number|15|15.0||||||
4148564|NCT00860262|3972248|B1|Black||Race Class||participants|Number|34|34.0||||||
4148565|NCT00860262|3972245|B4|Non-Black||Race Class||participants|Number|794|794.0||||||
4148566|NCT00860262|3972246|B3|Non-Black||Race Class||participants|Number|205|205.0||||||
4148567|NCT00860262|3972247|B2|Non-Black||Race Class||participants|Number|202|202.0||||||
4148568|NCT00860262|3972248|B1|Non-Black||Race Class||participants|Number|387|387.0||||||
4148569|NCT00860262|3972245|B4|BMI >= 30||Body Mass Index Class||participants|Number|408|408.0||||||
4148570|NCT00860262|3972246|B3|BMI >= 30||Body Mass Index Class||participants|Number|103|103.0||||||
4148571|NCT00860262|3972247|B2|BMI >= 30||Body Mass Index Class||participants|Number|107|107.0||||||
4148572|NCT00860262|3972248|B1|BMI >= 30||Body Mass Index Class||participants|Number|198|198.0||||||
4148573|NCT00860262|3972245|B4|25 <= BMI < 30||Body Mass Index Class||participants|Number|321|321.0||||||
4148574|NCT00860262|3972246|B3|25 <= BMI < 30||Body Mass Index Class||participants|Number|82|82.0||||||
4148575|NCT00860262|3972247|B2|25 <= BMI < 30||Body Mass Index Class||participants|Number|79|79.0||||||
4148576|NCT00860262|3972248|B1|25 <= BMI < 30||Body Mass Index Class||participants|Number|160|160.0||||||
4148577|NCT00860262|3972245|B4|BMI < 25||Body Mass Index Class||participants|Number|129|129.0||||||
4148578|NCT00860262|3972246|B3|BMI < 25||Body Mass Index Class||participants|Number|35|35.0||||||
4148579|NCT00860262|3972247|B2|BMI < 25||Body Mass Index Class||participants|Number|31|31.0||||||
4148580|NCT00860262|3972248|B1|BMI < 25||Body Mass Index Class||participants|Number|63|63.0||||||
4148581|NCT00860262|3972245|B4|||Body Mass Index (BMI)||kilograms/square meter|Mean|30.6|30.6|Standard Deviation|5.8|5.8|||
4148582|NCT00860262|3972246|B3|||Body Mass Index (BMI)||kilograms/square meter|Mean|30.7|30.7|Standard Deviation|6.3|6.3|||
4148583|NCT00860262|3972247|B2|||Body Mass Index (BMI)||kilograms/square meter|Mean|30.2|30.2|Standard Deviation|5.2|5.2|||
4148584|NCT00860262|3972248|B1|||Body Mass Index (BMI)||kilograms/square meter|Mean|30.6|30.6|Standard Deviation|5.9|5.9|||
4148585|NCT00860262|3972245|B4|Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4148586|NCT00860262|3972246|B3|Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4148587|NCT00860262|3972247|B2|Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4148588|NCT00860262|3972248|B1|Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4148589|NCT00860262|3972245|B4|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4148590|NCT00860262|3972246|B3|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4148591|NCT00860262|3972247|B2|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4148592|NCT00860262|3972248|B1|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4148593|NCT00860262|3972245|B4|Asian||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
4148594|NCT00860262|3972246|B3|Asian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4148595|NCT00860262|3972247|B2|Asian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4148596|NCT00860262|3972248|B1|Asian||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4148597|NCT00860262|3972245|B4|Black/African American||Race/Ethnicity, Customized||participants|Number|64|64.0||||||
4148598|NCT00860262|3972246|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4148599|NCT00860262|3972247|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4148600|NCT00860262|3972248|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4148601|NCT00860262|3972245|B4|White||Race/Ethnicity, Customized||participants|Number|738|738.0||||||
4148602|NCT00860262|3972246|B3|White||Race/Ethnicity, Customized||participants|Number|190|190.0||||||
4148603|NCT00860262|3972247|B2|White||Race/Ethnicity, Customized||participants|Number|186|186.0||||||
4148604|NCT00860262|3972248|B1|White||Race/Ethnicity, Customized||participants|Number|362|362.0||||||
4148605|NCT00860262|3972245|B4||Male|Sex: Female, Male||Participants|Count of Participants|445|445.0||||||
4148606|NCT00860262|3972246|B3||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4148607|NCT00860262|3972247|B2||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4148608|NCT00860262|3972248|B1||Male|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
4148609|NCT00860262|3972245|B4||Female|Sex: Female, Male||Participants|Count of Participants|413|413.0||||||
4148610|NCT00860262|3972246|B3||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4148611|NCT00860262|3972247|B2||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4148612|NCT00860262|3972248|B1||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4148613|NCT00860262|3972245|B4|>= 65 years||Age, Customized||Participants|Number|235|235.0||||||
4148614|NCT00860262|3972246|B3|>= 65 years||Age, Customized||Participants|Number|64|64.0||||||
4148615|NCT00860262|3972247|B2|>= 65 years||Age, Customized||Participants|Number|59|59.0||||||
4148616|NCT00860262|3972248|B1|>= 65 years||Age, Customized||Participants|Number|112|112.0||||||
4148617|NCT00860262|3972245|B4|< 65 years||Age, Customized||Participants|Number|623|623.0||||||
4148618|NCT00860262|3972246|B3|< 65 years||Age, Customized||Participants|Number|156|156.0||||||
4148619|NCT00860262|3972247|B2|< 65 years||Age, Customized||Participants|Number|158|158.0||||||
4148620|NCT00860262|3972248|B1|< 65 years||Age, Customized||Participants|Number|309|309.0||||||
4148621|NCT00860262|3972245|B4|||Age||years|Mean|58.2|58.2|Standard Deviation|10.3|10.3|||
4148622|NCT00860262|3972246|B3|||Age||years|Mean|58.6|58.6|Standard Deviation|10.5|10.5|||
4148623|NCT00860262|3972247|B2|||Age||years|Mean|58.1|58.1|Standard Deviation|10.2|10.2|||
4148624|NCT00860262|3972248|B1|||Age||years|Mean|58.0|58.0|Standard Deviation|10.4|10.4|||
4148625|NCT00860249|3972360|B4|United States||Region of Enrollment||participants|Number|60|60.0||||||
4148626|NCT00860249|3972361|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4148627|NCT00860249|3972362|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4148628|NCT00860249|3972363|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4148629|NCT00860249|3972360|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4148630|NCT00860249|3972361|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4148631|NCT00860249|3972362|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4148632|NCT00860249|3972363|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4148633|NCT00860249|3972360|B4||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4148634|NCT00860249|3972361|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4148635|NCT00860249|3972362|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4148636|NCT00860249|3972363|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4148637|NCT00860249|3972360|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4148638|NCT00860249|3972361|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4148639|NCT00860249|3972362|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4148640|NCT00860249|3972363|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4148641|NCT00860249|3972360|B4||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4148642|NCT00860249|3972361|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4148643|NCT00860249|3972362|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4148644|NCT00860249|3972363|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4148645|NCT00860249|3972360|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4148646|NCT00860249|3972361|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4148647|NCT00860249|3972362|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4148648|NCT00860249|3972363|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4148649|NCT00860171|3972376|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4148650|NCT00860171|3972376|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148651|NCT00860171|3972376|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148652|NCT00860171|3972376|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4148653|NCT00860171|3972376|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148654|NCT00860171|3972376|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148655|NCT00860171|3972376|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148656|NCT00860171|3972376|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148657|NCT00860171|3972376|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4148658|NCT00860171|3972376|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4148659|NCT00860171|3972376|B1|||Age||years|Mean|56.81|56.81|Standard Deviation|15.63|15.63|||
4148660|NCT00860158|3972383|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4148661|NCT00860158|3972383|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4148662|NCT00860158|3972383|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4148663|NCT00860158|3972383|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4148664|NCT00860158|3972383|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4148665|NCT00860158|3972383|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4148666|NCT00860067|3972392|B4|United States||Region of Enrollment||participants|Number|1800|1800.0||||||
4148667|NCT00860067|3972393|B3|United States||Region of Enrollment||participants|Number|301|301.0||||||
4148668|NCT00860067|3972394|B2|United States||Region of Enrollment||participants|Number|299|299.0||||||
4148669|NCT00860067|3972395|B1|United States||Region of Enrollment||participants|Number|1200|1200.0||||||
4148670|NCT00860067|3972392|B4|Multiracial||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4148671|NCT00860067|3972393|B3|Multiracial||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4148672|NCT00860067|3972394|B2|Multiracial||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4148673|NCT00860067|3972395|B1|Multiracial||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4148674|NCT00860067|3972392|B4|Other||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4148675|NCT00860067|3972393|B3|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4148676|NCT00860067|3972394|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4148677|NCT00860067|3972395|B1|Other||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4148678|NCT00860067|3972392|B4|White||Race/Ethnicity, Customized||Participants|Number|1374|1374.0||||||
4148679|NCT00860067|3972393|B3|White||Race/Ethnicity, Customized||Participants|Number|230|230.0||||||
4148680|NCT00860067|3972394|B2|White||Race/Ethnicity, Customized||Participants|Number|228|228.0||||||
4148681|NCT00860067|3972395|B1|White||Race/Ethnicity, Customized||Participants|Number|916|916.0||||||
4148682|NCT00860067|3972392|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4148683|NCT00860067|3972393|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4148684|NCT00860067|3972394|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4148685|NCT00860067|3972395|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4148686|NCT00860067|3972392|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|376|376.0||||||
4148687|NCT00860067|3972393|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|61|61.0||||||
4148688|NCT00860067|3972394|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|66|66.0||||||
4148689|NCT00860067|3972395|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|249|249.0||||||
4148690|NCT00860067|3972392|B4|Asian||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4148691|NCT00860067|3972393|B3|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4148692|NCT00860067|3972394|B2|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4148693|NCT00860067|3972395|B1|Asian||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4148694|NCT00860067|3972392|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4148695|NCT00860067|3972393|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4148696|NCT00860067|3972394|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4148697|NCT00860067|3972395|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4148698|NCT00860067|3972392|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148699|NCT00860067|3972393|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148700|NCT00860067|3972394|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148701|NCT00860067|3972395|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148702|NCT00860067|3972392|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1391|1391.0||||||
4148703|NCT00860067|3972393|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|223|223.0||||||
4148704|NCT00860067|3972394|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|232|232.0||||||
4148705|NCT00860067|3972395|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|936|936.0||||||
4148706|NCT00860067|3972392|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|409|409.0||||||
4148707|NCT00860067|3972393|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
4148708|NCT00860067|3972394|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4148709|NCT00860067|3972395|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|264|264.0||||||
4148710|NCT00860067|3972392|B4||Male|Sex: Female, Male||Participants|Count of Participants|806|806.0||||||
4148711|NCT00860067|3972393|B3||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4148712|NCT00860067|3972394|B2||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4148713|NCT00860067|3972395|B1||Male|Sex: Female, Male||Participants|Count of Participants|542|542.0||||||
4148714|NCT00860067|3972392|B4||Female|Sex: Female, Male||Participants|Count of Participants|994|994.0||||||
4148715|NCT00860067|3972393|B3||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4148716|NCT00860067|3972394|B2||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4148717|NCT00860067|3972395|B1||Female|Sex: Female, Male||Participants|Count of Participants|658|658.0||||||
4148718|NCT00860067|3972392|B4|Participants||Age||years|Mean|32.7|32.7|Standard Deviation|9.2|9.2|||
4148719|NCT00860067|3972393|B3|Participants||Age||years|Mean|32.8|32.8|Standard Deviation|9.2|9.2|||
4148720|NCT00860067|3972394|B2|Participants||Age||years|Mean|32.8|32.8|Standard Deviation|9.2|9.2|||
4148721|NCT00860067|3972395|B1|Participants||Age||years|Mean|32.6|32.6|Standard Deviation|9.2|9.2|||
4148722|NCT00860028|3972455|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4148723|NCT00860028|3972456|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4148724|NCT00860028|3972457|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4148725|NCT00860028|3972455|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4148726|NCT00860028|3972456|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4148727|NCT00860028|3972457|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4148728|NCT00860028|3972455|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4148729|NCT00860028|3972456|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4148730|NCT00860028|3972457|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4148731|NCT00860028|3972455|B3|||Age||years|Mean|43.17|43.17|Standard Deviation|8.12|8.12|||
4148732|NCT00860028|3972456|B2|||Age||years|Mean|43.47|43.47|Standard Deviation|7.99|7.99|||
4148733|NCT00860028|3972457|B1|||Age||years|Mean|42.87|42.87|Standard Deviation|8.52|8.52|||
4148734|NCT00860028|3972455|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4148735|NCT00860028|3972456|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4148736|NCT00860028|3972457|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4148737|NCT00860028|3972455|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4148738|NCT00860028|3972456|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4148739|NCT00860028|3972457|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4148740|NCT00860028|3972455|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4148741|NCT00860028|3972456|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4148742|NCT00860028|3972457|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4148743|NCT00859950|3972468|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4148744|NCT00859950|3972469|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4148745|NCT00859950|3972470|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4148746|NCT00859950|3972468|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4148747|NCT00859950|3972469|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4148748|NCT00859950|3972470|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4148749|NCT00859950|3972468|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4148750|NCT00859950|3972469|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4148751|NCT00859950|3972470|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4148752|NCT00859950|3972468|B3||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
4148753|NCT00859950|3972469|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4148754|NCT00859950|3972470|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4148755|NCT00859950|3972468|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4148756|NCT00859950|3972469|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4148757|NCT00859950|3972470|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4148758|NCT00859937|3972477|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4148759|NCT00859937|3972478|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4148760|NCT00859937|3972479|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4148761|NCT00859937|3972477|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4148762|NCT00859937|3972478|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4148763|NCT00859937|3972479|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4148764|NCT00859937|3972477|B3|||Age||years|Median|56|56.0|Full Range|||20.0|82.0|
4148765|NCT00859937|3972478|B2|||Age||years|Median|56|56.0|Full Range|||20.0|71.0|
4148766|NCT00859937|3972479|B1|||Age||years|Median|56|56.0|Full Range|||30.0|82.0|
4148767|NCT00859898|3972492|B4|||Total Body Weight|Participants were weighed and weight recorded in kilograms (kg).|kg|Mean|88.08|88.08|Standard Deviation|19.452|19.452|||
4148768|NCT00859898|3972493|B3|||Total Body Weight|Participants were weighed and weight recorded in kilograms (kg).|kg|Mean|87.24|87.24|Standard Deviation|19.423|19.423|||
4148769|NCT00859898|3972494|B2|||Total Body Weight|Participants were weighed and weight recorded in kilograms (kg).|kg|Mean|88.53|88.53|Standard Deviation|19.334|19.334|||
4148770|NCT00859898|3972495|B1|||Total Body Weight|Participants were weighed and weight recorded in kilograms (kg).|kg|Mean|88.43|88.43|Standard Deviation|19.668|19.668|||
4148771|NCT00859898|3972492|B4|||Hemoglobin A1c|Hemoglobin A1c (HbA1c) was reported as percent of hemoglobin.|percent of hemoglobin|Mean|9.06|9.06|Standard Deviation|1.280|1.28|||
4148772|NCT00859898|3972493|B3|||Hemoglobin A1c|Hemoglobin A1c (HbA1c) was reported as percent of hemoglobin.|percent of hemoglobin|Mean|9.05|9.05|Standard Deviation|1.308|1.308|||
4148773|NCT00859898|3972494|B2|||Hemoglobin A1c|Hemoglobin A1c (HbA1c) was reported as percent of hemoglobin.|percent of hemoglobin|Mean|9.05|9.05|Standard Deviation|1.279|1.279|||
4148774|NCT00859898|3972495|B1|||Hemoglobin A1c|Hemoglobin A1c (HbA1c) was reported as percent of hemoglobin.|percent of hemoglobin|Mean|9.09|9.09|Standard Deviation|1.258|1.258|||
4148775|NCT00859898|3972492|B4|||Waist Circumference|The participants waist was measured in centimeters (cm).|cm|Mean|103.75|103.75|Standard Deviation|13.225|13.225|||
4148776|NCT00859898|3972493|B3|||Waist Circumference|The participants waist was measured in centimeters (cm).|cm|Mean|103.03|103.03|Standard Deviation|13.224|13.224|||
4148777|NCT00859898|3972494|B2|||Waist Circumference|The participants waist was measured in centimeters (cm).|cm|Mean|103.86|103.86|Standard Deviation|12.805|12.805|||
4148778|NCT00859898|3972495|B1|||Waist Circumference|The participants waist was measured in centimeters (cm).|cm|Mean|104.33|104.33|Standard Deviation|13.678|13.678|||
4148779|NCT00859898|3972492|B4|>= 30 kg/m^2||Body Mass Index|Body Mass Index (BMI) was kilograms (kg) body weight divided by height in meters (m) squared (kg/m^2). Less than (<); Greater than, equal to (>=).|participants|Number|372|372.0||||||
4148780|NCT00859898|3972493|B3|>= 30 kg/m^2||Body Mass Index|Body Mass Index (BMI) was kilograms (kg) body weight divided by height in meters (m) squared (kg/m^2). Less than (<); Greater than, equal to (>=).|participants|Number|118|118.0||||||
4148781|NCT00859898|3972494|B2|>= 30 kg/m^2||Body Mass Index|Body Mass Index (BMI) was kilograms (kg) body weight divided by height in meters (m) squared (kg/m^2). Less than (<); Greater than, equal to (>=).|participants|Number|131|131.0||||||
4148782|NCT00859898|3972495|B1|>= 30 kg/m^2||Body Mass Index|Body Mass Index (BMI) was kilograms (kg) body weight divided by height in meters (m) squared (kg/m^2). Less than (<); Greater than, equal to (>=).|participants|Number|123|123.0||||||
4148827|NCT00859898|3972492|B4||Female|Sex: Female, Male||Participants|Count of Participants|330|330.0||||||
4148783|NCT00859898|3972492|B4|>= 27 kg/m^2 - <30 kg/m^2||Body Mass Index|Body Mass Index (BMI) was kilograms (kg) body weight divided by height in meters (m) squared (kg/m^2). Less than (<); Greater than, equal to (>=).|participants|Number|133|133.0||||||
4148784|NCT00859898|3972493|B3|>= 27 kg/m^2 - <30 kg/m^2||Body Mass Index|Body Mass Index (BMI) was kilograms (kg) body weight divided by height in meters (m) squared (kg/m^2). Less than (<); Greater than, equal to (>=).|participants|Number|49|49.0||||||
4148785|NCT00859898|3972494|B2|>= 27 kg/m^2 - <30 kg/m^2||Body Mass Index|Body Mass Index (BMI) was kilograms (kg) body weight divided by height in meters (m) squared (kg/m^2). Less than (<); Greater than, equal to (>=).|participants|Number|39|39.0||||||
4148786|NCT00859898|3972495|B1|>= 27 kg/m^2 - <30 kg/m^2||Body Mass Index|Body Mass Index (BMI) was kilograms (kg) body weight divided by height in meters (m) squared (kg/m^2). Less than (<); Greater than, equal to (>=).|participants|Number|45|45.0||||||
4148787|NCT00859898|3972492|B4|>= 25 kg/m^2 - <27 kg/m^2||Body Mass Index|Body Mass Index (BMI) was kilograms (kg) body weight divided by height in meters (m) squared (kg/m^2). Less than (<); Greater than, equal to (>=).|participants|Number|67|67.0||||||
4148788|NCT00859898|3972493|B3|>= 25 kg/m^2 - <27 kg/m^2||Body Mass Index|Body Mass Index (BMI) was kilograms (kg) body weight divided by height in meters (m) squared (kg/m^2). Less than (<); Greater than, equal to (>=).|participants|Number|20|20.0||||||
4148789|NCT00859898|3972494|B2|>= 25 kg/m^2 - <27 kg/m^2||Body Mass Index|Body Mass Index (BMI) was kilograms (kg) body weight divided by height in meters (m) squared (kg/m^2). Less than (<); Greater than, equal to (>=).|participants|Number|24|24.0||||||
4148790|NCT00859898|3972495|B1|>= 25 kg/m^2 - <27 kg/m^2||Body Mass Index|Body Mass Index (BMI) was kilograms (kg) body weight divided by height in meters (m) squared (kg/m^2). Less than (<); Greater than, equal to (>=).|participants|Number|23|23.0||||||
4148791|NCT00859898|3972492|B4|< 25 kg/m^2||Body Mass Index|Body Mass Index (BMI) was kilograms (kg) body weight divided by height in meters (m) squared (kg/m^2). Less than (<); Greater than, equal to (>=).|participants|Number|66|66.0||||||
4148792|NCT00859898|3972493|B3|< 25 kg/m^2||Body Mass Index|Body Mass Index (BMI) was kilograms (kg) body weight divided by height in meters (m) squared (kg/m^2). Less than (<); Greater than, equal to (>=).|participants|Number|21|21.0||||||
4148793|NCT00859898|3972494|B2|< 25 kg/m^2||Body Mass Index|Body Mass Index (BMI) was kilograms (kg) body weight divided by height in meters (m) squared (kg/m^2). Less than (<); Greater than, equal to (>=).|participants|Number|25|25.0||||||
4148794|NCT00859898|3972495|B1|< 25 kg/m^2||Body Mass Index|Body Mass Index (BMI) was kilograms (kg) body weight divided by height in meters (m) squared (kg/m^2). Less than (<); Greater than, equal to (>=).|participants|Number|20|20.0||||||
4148795|NCT00859898|3972492|B4|Other Race||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4148796|NCT00859898|3972493|B3|Other Race||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4148797|NCT00859898|3972494|B2|Other Race||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4148798|NCT00859898|3972495|B1|Other Race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4148799|NCT00859898|3972492|B4|Asian||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
4148800|NCT00859898|3972493|B3|Asian||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4148801|NCT00859898|3972494|B2|Asian||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4148802|NCT00859898|3972495|B1|Asian||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4148803|NCT00859898|3972492|B4|Black/African American||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4148804|NCT00859898|3972493|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4148805|NCT00859898|3972494|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4148806|NCT00859898|3972495|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4148807|NCT00859898|3972492|B4|White||Race/Ethnicity, Customized||participants|Number|516|516.0||||||
4148808|NCT00859898|3972493|B3|White||Race/Ethnicity, Customized||participants|Number|166|166.0||||||
4148809|NCT00859898|3972494|B2|White||Race/Ethnicity, Customized||participants|Number|176|176.0||||||
4148810|NCT00859898|3972495|B1|White||Race/Ethnicity, Customized||participants|Number|174|174.0||||||
4148811|NCT00859898|3972492|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)|Ethnicity of participants|Participants|Count of Participants|364|364.0||||||
4148812|NCT00859898|3972493|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)|Ethnicity of participants|Participants|Count of Participants|119|119.0||||||
4148813|NCT00859898|3972494|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)|Ethnicity of participants|Participants|Count of Participants|122|122.0||||||
4148814|NCT00859898|3972495|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|Ethnicity of participants|Participants|Count of Participants|123|123.0||||||
4148815|NCT00859898|3972492|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity of participants|Participants|Count of Participants|171|171.0||||||
4148816|NCT00859898|3972493|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity of participants|Participants|Count of Participants|54|54.0||||||
4148817|NCT00859898|3972494|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity of participants|Participants|Count of Participants|63|63.0||||||
4148818|NCT00859898|3972495|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity of participants|Participants|Count of Participants|54|54.0||||||
4148819|NCT00859898|3972492|B4||Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity of participants|Participants|Count of Participants|103|103.0||||||
4148820|NCT00859898|3972493|B3||Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity of participants|Participants|Count of Participants|35|35.0||||||
4148821|NCT00859898|3972494|B2||Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity of participants|Participants|Count of Participants|34|34.0||||||
4148822|NCT00859898|3972495|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity of participants|Participants|Count of Participants|34|34.0||||||
4148823|NCT00859898|3972492|B4||Male|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
4148824|NCT00859898|3972493|B3||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4148825|NCT00859898|3972494|B2||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4148826|NCT00859898|3972495|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4148828|NCT00859898|3972493|B3||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4148829|NCT00859898|3972494|B2||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4148830|NCT00859898|3972495|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4148831|NCT00859898|3972492|B4|Female > 50 years||Age, Customized|Female age categorization less than equal to (<=) 50 years or greater than (>) 50 years.|participants|Number|199|199.0||||||
4148832|NCT00859898|3972493|B3|Female > 50 years||Age, Customized|Female age categorization less than equal to (<=) 50 years or greater than (>) 50 years.|participants|Number|67|67.0||||||
4148833|NCT00859898|3972494|B2|Female > 50 years||Age, Customized|Female age categorization less than equal to (<=) 50 years or greater than (>) 50 years.|participants|Number|70|70.0||||||
4148834|NCT00859898|3972495|B1|Female > 50 years||Age, Customized|Female age categorization less than equal to (<=) 50 years or greater than (>) 50 years.|participants|Number|62|62.0||||||
4148835|NCT00859898|3972492|B4|Female <= 50 years||Age, Customized|Female age categorization less than equal to (<=) 50 years or greater than (>) 50 years.|participants|Number|131|131.0||||||
4148836|NCT00859898|3972493|B3|Female <= 50 years||Age, Customized|Female age categorization less than equal to (<=) 50 years or greater than (>) 50 years.|participants|Number|44|44.0||||||
4148837|NCT00859898|3972494|B2|Female <= 50 years||Age, Customized|Female age categorization less than equal to (<=) 50 years or greater than (>) 50 years.|participants|Number|44|44.0||||||
4148838|NCT00859898|3972495|B1|Female <= 50 years||Age, Customized|Female age categorization less than equal to (<=) 50 years or greater than (>) 50 years.|participants|Number|43|43.0||||||
4148839|NCT00859898|3972492|B4|Not Reported||Age, Customized||participants|Number|0|0.0||||||
4148840|NCT00859898|3972493|B3|Not Reported||Age, Customized||participants|Number|0|0.0||||||
4148841|NCT00859898|3972494|B2|Not Reported||Age, Customized||participants|Number|0|0.0||||||
4148842|NCT00859898|3972495|B1|Not Reported||Age, Customized||participants|Number|0|0.0||||||
4148843|NCT00859898|3972492|B4|>= 75 years||Age, Customized||participants|Number|5|5.0||||||
4148844|NCT00859898|3972493|B3|>= 75 years||Age, Customized||participants|Number|2|2.0||||||
4148845|NCT00859898|3972494|B2|>= 75 years||Age, Customized||participants|Number|3|3.0||||||
4148846|NCT00859898|3972495|B1|>= 75 years||Age, Customized||participants|Number|0|0.0||||||
4148847|NCT00859898|3972492|B4|Greater than, equal to (>=) 65 and < 75 years||Age, Customized||participants|Number|70|70.0||||||
4148848|NCT00859898|3972493|B3|Greater than, equal to (>=) 65 and < 75 years||Age, Customized||participants|Number|25|25.0||||||
4148849|NCT00859898|3972494|B2|Greater than, equal to (>=) 65 and < 75 years||Age, Customized||participants|Number|24|24.0||||||
4148850|NCT00859898|3972495|B1|Greater than, equal to (>=) 65 and < 75 years||Age, Customized||participants|Number|21|21.0||||||
4148851|NCT00859898|3972492|B4|Less than (<) 65 years||Age, Customized||participants|Number|563|563.0||||||
4148852|NCT00859898|3972493|B3|Less than (<) 65 years||Age, Customized||participants|Number|181|181.0||||||
4148853|NCT00859898|3972494|B2|Less than (<) 65 years||Age, Customized||participants|Number|192|192.0||||||
4148854|NCT00859898|3972495|B1|Less than (<) 65 years||Age, Customized||participants|Number|190|190.0||||||
4148855|NCT00859898|3972492|B4|||Age||years|Mean|51.6|51.6|Standard Deviation|10.72|10.72|||
4148856|NCT00859898|3972493|B3|||Age||years|Mean|52.7|52.7|Standard Deviation|10.38|10.38|||
4148857|NCT00859898|3972494|B2|||Age||years|Mean|51.1|51.1|Standard Deviation|11.53|11.53|||
4148858|NCT00859898|3972495|B1|||Age||years|Mean|51.0|51.0|Standard Deviation|10.13|10.13|||
4148859|NCT00859833|3972538|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4148860|NCT00859833|3972538|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4148861|NCT00859833|3972538|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4148862|NCT00859833|3972538|B1|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4148863|NCT00859833|3972538|B1|Between 18 and 65 years||Age, Customized||participants|Number|30|30.0||||||
4148864|NCT00859833|3972538|B1|||Age||years|Mean|49.5|49.5|Standard Deviation|11.5|11.5|||
4148865|NCT00859651|3972543|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4148866|NCT00859651|3972544|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4148867|NCT00859651|3972545|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4148868|NCT00859651|3972543|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4148869|NCT00859651|3972544|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4148870|NCT00859651|3972545|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4148871|NCT00859651|3972543|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4148872|NCT00859651|3972544|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4148873|NCT00859651|3972545|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4148874|NCT00859651|3972543|B3|||Age||years|Median|50|50.0|Full Range|||37.0|73.0|
4148875|NCT00859651|3972544|B2|||Age||years|Median|50.5|50.5|Full Range|||37.0|69.0|
4148876|NCT00859651|3972545|B1|||Age||years|Median|50.0|50.0|Full Range|||45.0|73.0|
4148877|NCT00859638|3972554|B3|Canada||Region of Enrollment||participants|Number|124|124.0||||||
4148878|NCT00859638|3972555|B2|Canada||Region of Enrollment||participants|Number|59|59.0||||||
4148879|NCT00859638|3972556|B1|Canada||Region of Enrollment||participants|Number|65|65.0||||||
4148880|NCT00859638|3972554|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4148881|NCT00859638|3972555|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4148882|NCT00859638|3972556|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4148883|NCT00859638|3972554|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4148884|NCT00859638|3972555|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4148885|NCT00859638|3972556|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4148886|NCT00859638|3972554|B3|||Age||years|Mean|63.08|63.08|Standard Deviation|11.05|11.05|||
4148887|NCT00859638|3972555|B2|||Age||years|Mean|62.62|62.62|Standard Deviation|10.48|10.48|||
4148888|NCT00859638|3972556|B1|||Age||years|Mean|63.57|63.57|Standard Deviation|11.81|11.81|||
4148889|NCT00859638|3972554|B3||>=65 years|Age||Participants|Count of Participants|47|47.0||||||
4148890|NCT00859638|3972555|B2||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4148891|NCT00859638|3972556|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4148892|NCT00859638|3972554|B3||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
4148893|NCT00859638|3972555|B2||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4148894|NCT00859638|3972556|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4148895|NCT00859638|3972554|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4148896|NCT00859638|3972555|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4148897|NCT00859638|3972556|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4148898|NCT00859586|3972563|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4148899|NCT00859586|3972563|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4148900|NCT00859586|3972563|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4148901|NCT00859586|3972563|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4148902|NCT00859586|3972563|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4148903|NCT00859586|3972563|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4148904|NCT00859586|3972563|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4148905|NCT00859586|3972563|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4148906|NCT00859586|3972563|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4148907|NCT00859573|3972567|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4148908|NCT00859573|3972568|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4148909|NCT00859573|3972569|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4148910|NCT00859573|3972567|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4148911|NCT00859573|3972568|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4148912|NCT00859573|3972569|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4148913|NCT00859573|3972567|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4148914|NCT00859573|3972568|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4148915|NCT00859573|3972569|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4148916|NCT00859573|3972567|B3|||Age||years|Mean|32.56|32.56|Standard Deviation|9.19|9.19|||
4148917|NCT00859573|3972568|B2|||Age||years|Mean|35.88|35.88|Standard Deviation|12.15|12.15|||
4148918|NCT00859573|3972569|B1|||Age||years|Mean|29.25|29.25|Standard Deviation|2.87|2.87|||
4148919|NCT00859573|3972567|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4148920|NCT00859573|3972568|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4148921|NCT00859573|3972569|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4148922|NCT00859573|3972567|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4148923|NCT00859573|3972568|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4148924|NCT00859573|3972569|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4148925|NCT00859573|3972567|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4148926|NCT00859573|3972568|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4148927|NCT00859573|3972569|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4148928|NCT00859547|3972576|B1|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4148929|NCT00859547|3972576|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4148930|NCT00859547|3972576|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4148931|NCT00859547|3972576|B1|American Indian/Alaskan native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4148932|NCT00859547|3972576|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4148933|NCT00859547|3972576|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4148934|NCT00859547|3972576|B1|12-17 years||Age, Customized||participants|Number|8|8.0||||||
4148935|NCT00859547|3972576|B1|7-11 years||Age, Customized||participants|Number|3|3.0||||||
4148936|NCT00859547|3972576|B1|3-6 years||Age, Customized||participants|Number|8|8.0||||||
4148937|NCT00859547|3972576|B1|0-2 years||Age, Customized||participants|Number|11|11.0||||||
4148938|NCT00859521|3972587|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4148939|NCT00859521|3972588|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4148940|NCT00859521|3972589|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4148941|NCT00859521|3972587|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4148942|NCT00859521|3972588|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4148943|NCT00859521|3972589|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4148944|NCT00859521|3972587|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4148945|NCT00859521|3972588|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4148946|NCT00859521|3972589|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4148947|NCT00859521|3972587|B3|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4148948|NCT00859521|3972588|B2|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4148949|NCT00859521|3972589|B1|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4148950|NCT00859521|3972587|B3|White||Race/Ethnicity, Customized||Participants|Number|26|26.0||||||
4148951|NCT00859521|3972588|B2|White||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4148952|NCT00859521|3972589|B1|White||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4148953|NCT00859521|3972587|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4148954|NCT00859521|3972588|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4148955|NCT00859521|3972589|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4148956|NCT00859521|3972587|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4148957|NCT00859521|3972588|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4148958|NCT00859521|3972589|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4148959|NCT00859521|3972587|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4148960|NCT00859521|3972588|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4148961|NCT00859521|3972589|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4148962|NCT00859521|3972587|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4148963|NCT00859521|3972588|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4148964|NCT00859521|3972589|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4148965|NCT00859521|3972587|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4148966|NCT00859521|3972588|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4148967|NCT00859521|3972589|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4148968|NCT00859508|3972598|B3|United States||Region of Enrollment||participants|Number|105|105.0||||||
4148969|NCT00859508|3972599|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4148970|NCT00859508|3972600|B1|United States||Region of Enrollment||participants|Number|68|68.0||||||
4148971|NCT00859508|3972598|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4148972|NCT00859508|3972599|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4148973|NCT00859508|3972600|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4148974|NCT00859508|3972598|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4148975|NCT00859508|3972599|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4148976|NCT00859508|3972600|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4148977|NCT00859508|3972598|B3|||Age||years|Mean|47.2|47.2|Standard Deviation|13.25|13.25|||
4148978|NCT00859508|3972599|B2|||Age||years|Mean|48.6|48.6|Standard Deviation|14.03|14.03|||
4148979|NCT00859508|3972600|B1|||Age||years|Mean|46.5|46.5|Standard Deviation|12.85|12.85|||
4148980|NCT00859508|3972598|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4148981|NCT00859508|3972599|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4148982|NCT00859508|3972600|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4148983|NCT00859508|3972598|B3||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
4148984|NCT00859508|3972599|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4148985|NCT00859508|3972600|B1||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4148986|NCT00859508|3972598|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4148987|NCT00859508|3972599|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4148988|NCT00859508|3972600|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4148989|NCT00859469|3972607|B1|1 or more||Prior chemotherapy regimens||participants|Number|18|18.0||||||
4148990|NCT00859469|3972607|B1|0||Prior chemotherapy regimens||participants|Number|11|11.0||||||
4148991|NCT00859469|3972607|B1|Biphasic||Pathologic Subtype|Epithelioid vs. Sarcomatoid vs. Biphasic|participants|Number|7|7.0||||||
4148992|NCT00859469|3972607|B1|Sarcomatoid||Pathologic Subtype|Epithelioid vs. Sarcomatoid vs. Biphasic|participants|Number|3|3.0||||||
4148993|NCT00859469|3972607|B1|Epithelioid||Pathologic Subtype|Epithelioid vs. Sarcomatoid vs. Biphasic|participants|Number|19|19.0||||||
4148994|NCT00859469|3972607|B1|Peritoneal||Primary Site|Pleural vs. Peritoneal|participants|Number|13|13.0||||||
4148995|NCT00859469|3972607|B1|Pleural||Primary Site|Pleural vs. Peritoneal|participants|Number|16|16.0||||||
4148996|NCT00859469|3972607|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4148997|NCT00859469|3972607|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4148998|NCT00859469|3972607|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4148999|NCT00859469|3972607|B1|||Age||years|Mean|63.0|63.0|Standard Deviation|11.5|11.5|||
4149000|NCT00859469|3972607|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4149001|NCT00859469|3972607|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4149002|NCT00859469|3972607|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4149003|NCT00859430|3972613|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4149004|NCT00859430|3972614|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4149005|NCT00859430|3972615|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4149006|NCT00859430|3972613|B3|Multi-Racial||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4149007|NCT00859430|3972614|B2|Multi-Racial||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4149008|NCT00859430|3972615|B1|Multi-Racial||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4149009|NCT00859430|3972613|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4149010|NCT00859430|3972614|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4149011|NCT00859430|3972615|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4149012|NCT00859430|3972613|B3|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4149013|NCT00859430|3972614|B2|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4149014|NCT00859430|3972615|B1|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4149015|NCT00859430|3972613|B3|White||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4149016|NCT00859430|3972614|B2|White||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4149017|NCT00859430|3972615|B1|White||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4149018|NCT00859430|3972613|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4149019|NCT00859430|3972614|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4149020|NCT00859430|3972615|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4149021|NCT00859430|3972613|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4149022|NCT00859430|3972614|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4149023|NCT00859430|3972615|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4149024|NCT00859430|3972613|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4149025|NCT00859430|3972614|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4149026|NCT00859430|3972615|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4149027|NCT00859430|3972613|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4149028|NCT00859430|3972614|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4149029|NCT00859430|3972615|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4149030|NCT00859430|3972613|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4149031|NCT00859430|3972614|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4149032|NCT00859430|3972615|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4149033|NCT00859339|3972624|B1|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4149034|NCT00859339|3972624|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4149035|NCT00859339|3972624|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4149036|NCT00859339|3972624|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4149037|NCT00859339|3972624|B1|||Age||years|Median|70|70.0|Full Range|||48.0|74.0|
4149038|NCT00859313|3972632|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4149039|NCT00859313|3972632|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4149040|NCT00859313|3972632|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4149041|NCT00859313|3972632|B1|||Age||years|Mean|65.7|65.7|Standard Deviation|7.4|7.4|||
4149042|NCT00859313|3972632|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4149043|NCT00859313|3972632|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4149044|NCT00859313|3972632|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4149045|NCT00859222|3972636|B4|anaplastic oligoastrocytoma (AOA)||Histology||participants|Number|3|3.0||||||
4149046|NCT00859222|3972637|B3|anaplastic oligoastrocytoma (AOA)||Histology||participants|Number|2|2.0||||||
4149047|NCT00859222|3972638|B2|anaplastic oligoastrocytoma (AOA)||Histology||participants|Number|0|0.0||||||
4149048|NCT00859222|3972639|B1|anaplastic oligoastrocytoma (AOA)||Histology||participants|Number|1|1.0||||||
4149049|NCT00859222|3972636|B4|anaplastic oligodendroglioma (AO)||Histology||participants|Number|5|5.0||||||
4149050|NCT00859222|3972637|B3|anaplastic oligodendroglioma (AO)||Histology||participants|Number|5|5.0||||||
4149051|NCT00859222|3972638|B2|anaplastic oligodendroglioma (AO)||Histology||participants|Number|0|0.0||||||
4149052|NCT00859222|3972639|B1|anaplastic oligodendroglioma (AO)||Histology||participants|Number|0|0.0||||||
4149053|NCT00859222|3972636|B4|anaplastic astrocytoma (AA)||Histology||participants|Number|9|9.0||||||
4149054|NCT00859222|3972637|B3|anaplastic astrocytoma (AA)||Histology||participants|Number|8|8.0||||||
4149055|NCT00859222|3972638|B2|anaplastic astrocytoma (AA)||Histology||participants|Number|0|0.0||||||
4149056|NCT00859222|3972639|B1|anaplastic astrocytoma (AA)||Histology||participants|Number|1|1.0||||||
4149057|NCT00859222|3972636|B4|glioblastoma (GBM)||Histology||participants|Number|34|34.0||||||
4149058|NCT00859222|3972637|B3|glioblastoma (GBM)||Histology||participants|Number|0|0.0||||||
4149059|NCT00859222|3972638|B2|glioblastoma (GBM)||Histology||participants|Number|24|24.0||||||
4149060|NCT00859222|3972639|B1|glioblastoma (GBM)||Histology||participants|Number|10|10.0||||||
4149061|NCT00859222|3972636|B4|4||Number of Prior Relapses||participants|Number|1|1.0||||||
4149062|NCT00859222|3972637|B3|4||Number of Prior Relapses||participants|Number|1|1.0||||||
4149063|NCT00859222|3972638|B2|4||Number of Prior Relapses||participants|Number|0|0.0||||||
4149064|NCT00859222|3972639|B1|4||Number of Prior Relapses||participants|Number|0|0.0||||||
4149065|NCT00859222|3972636|B4|3||Number of Prior Relapses||participants|Number|3|3.0||||||
4149066|NCT00859222|3972637|B3|3||Number of Prior Relapses||participants|Number|3|3.0||||||
4149067|NCT00859222|3972638|B2|3||Number of Prior Relapses||participants|Number|0|0.0||||||
4149068|NCT00859222|3972639|B1|3||Number of Prior Relapses||participants|Number|0|0.0||||||
4149069|NCT00859222|3972636|B4|2||Number of Prior Relapses||participants|Number|13|13.0||||||
4149070|NCT00859222|3972637|B3|2||Number of Prior Relapses||participants|Number|4|4.0||||||
4149071|NCT00859222|3972638|B2|2||Number of Prior Relapses||participants|Number|9|9.0||||||
4149072|NCT00859222|3972639|B1|2||Number of Prior Relapses||participants|Number|0|0.0||||||
4149073|NCT00859222|3972636|B4|1||Number of Prior Relapses||participants|Number|34|34.0||||||
4149074|NCT00859222|3972637|B3|1||Number of Prior Relapses||participants|Number|7|7.0||||||
4149075|NCT00859222|3972638|B2|1||Number of Prior Relapses||participants|Number|15|15.0||||||
4149076|NCT00859222|3972639|B1|1||Number of Prior Relapses||participants|Number|12|12.0||||||
4149077|NCT00859222|3972636|B4|Non-White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4149078|NCT00859222|3972637|B3|Non-White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4149079|NCT00859222|3972638|B2|Non-White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4149080|NCT00859222|3972639|B1|Non-White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4149081|NCT00859222|3972636|B4|White||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4149082|NCT00859222|3972637|B3|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4149083|NCT00859222|3972638|B2|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4149084|NCT00859222|3972639|B1|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4149085|NCT00859222|3972636|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4149086|NCT00859222|3972637|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4149087|NCT00859222|3972638|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4149088|NCT00859222|3972639|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4149089|NCT00859222|3972636|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4149090|NCT00859222|3972637|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4149091|NCT00859222|3972638|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4149092|NCT00859222|3972639|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4149093|NCT00859222|3972636|B4|||Age||years|Median|50|50.0|Full Range|||22.0|71.0|
4149094|NCT00859222|3972637|B3|||Age||years|Median|48|48.0|Full Range|||31.0|69.0|
4149095|NCT00859222|3972638|B2|||Age||years|Median|53|53.0|Full Range|||22.0|66.0|
4149096|NCT00859222|3972639|B1|||Age||years|Median|50|50.0|Full Range|||30.0|71.0|
4149097|NCT00859131|3972668|B3||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4149098|NCT00859131|3972669|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4149099|NCT00859131|3972670|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4149100|NCT00859131|3972668|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4149101|NCT00859131|3972669|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4149102|NCT00859131|3972670|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4149103|NCT00859131|3972668|B3|||Age||years|Mean|50.2|50.2|Standard Deviation|13.5|13.5|||
4149104|NCT00859131|3972669|B2|||Age||years|Mean|49|49.0|Standard Deviation|14|14.0|||
4149105|NCT00859131|3972670|B1|||Age||years|Mean|52|52.0|Standard Deviation|13|13.0|||
4149106|NCT00859053|3972689|B5||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4149107|NCT00859053|3972690|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4149108|NCT00859053|3972691|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4149109|NCT00859053|3972692|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4149110|NCT00859053|3972693|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4149111|NCT00859053|3972689|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4149112|NCT00859053|3972690|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4149113|NCT00859053|3972691|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4149114|NCT00859053|3972692|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4149115|NCT00859053|3972693|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4149116|NCT00859053|3972689|B5|>= 65 years||Age, Customized||participants|Number|2|2.0||||||
4149117|NCT00859053|3972690|B4|>= 65 years||Age, Customized||participants|Number|0|0.0||||||
4149118|NCT00859053|3972691|B3|>= 65 years||Age, Customized||participants|Number|1|1.0||||||
4149119|NCT00859053|3972692|B2|>= 65 years||Age, Customized||participants|Number|1|1.0||||||
4149120|NCT00859053|3972693|B1|>= 65 years||Age, Customized||participants|Number|0|0.0||||||
4149121|NCT00859053|3972689|B5|< 65 years||Age, Customized||participants|Number|28|28.0||||||
4149122|NCT00859053|3972690|B4|< 65 years||Age, Customized||participants|Number|12|12.0||||||
4149123|NCT00859053|3972691|B3|< 65 years||Age, Customized||participants|Number|5|5.0||||||
4149124|NCT00859053|3972692|B2|< 65 years||Age, Customized||participants|Number|5|5.0||||||
4149125|NCT00859053|3972693|B1|< 65 years||Age, Customized||participants|Number|6|6.0||||||
4149126|NCT00859040|3972738|B3|||KPS scores|100% = Normal; 90% = Normal activity, minor signs/symptoms; 80% = Normal activity w/ effort, some signs/symptoms; 70% = Cares for self, unable to do normal activity/active work; 60% = Requires occasional assistance, but cares for most personal needs; 50% = Requires considerable assistance/frequent medical care; 40% = Disabled, requires special care & assistance; 30% = Severely disabled, hospital admission is indicated but death not imminent; 20% = Very sick, hospitalization necessary, active supportive treatment necessary; 10% = Moribund, fatal processes progressing rapidly; 0% = Dead.|percent|Median|85|85.0|Full Range|||60.0|100.0|
4149179|NCT00859027|3972756|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4149180|NCT00859014|3972765|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4149181|NCT00859014|3972765|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4149127|NCT00859040|3972739|B2|||KPS scores|100% = Normal; 90% = Normal activity, minor signs/symptoms; 80% = Normal activity w/ effort, some signs/symptoms; 70% = Cares for self, unable to do normal activity/active work; 60% = Requires occasional assistance, but cares for most personal needs; 50% = Requires considerable assistance/frequent medical care; 40% = Disabled, requires special care & assistance; 30% = Severely disabled, hospital admission is indicated but death not imminent; 20% = Very sick, hospitalization necessary, active supportive treatment necessary; 10% = Moribund, fatal processes progressing rapidly; 0% = Dead.|percent|Median|90|90.0|Full Range|||70.0|100.0|
4149128|NCT00859040|3972740|B1|||KPS scores|100% = Normal; 90% = Normal activity, minor signs/symptoms; 80% = Normal activity w/ effort, some signs/symptoms; 70% = Cares for self, unable to do normal activity/active work; 60% = Requires occasional assistance, but cares for most personal needs; 50% = Requires considerable assistance/frequent medical care; 40% = Disabled, requires special care & assistance; 30% = Severely disabled, hospital admission is indicated but death not imminent; 20% = Very sick, hospitalization necessary, active supportive treatment necessary; 10% = Moribund, fatal processes progressing rapidly; 0% = Dead.|percent|Median|80|80.0|Full Range|||60.0|100.0|
4149129|NCT00859040|3972738|B3|White (Unknown Ethnicity)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4149130|NCT00859040|3972739|B2|White (Unknown Ethnicity)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4149131|NCT00859040|3972740|B1|White (Unknown Ethnicity)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4149132|NCT00859040|3972738|B3|Hispanic or Latino (Unknown Race)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4149133|NCT00859040|3972739|B2|Hispanic or Latino (Unknown Race)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4149134|NCT00859040|3972740|B1|Hispanic or Latino (Unknown Race)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4149135|NCT00859040|3972738|B3|Black or African American, Non-Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4149136|NCT00859040|3972739|B2|Black or African American, Non-Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4149137|NCT00859040|3972740|B1|Black or African American, Non-Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4149138|NCT00859040|3972738|B3|White, Non-Hispanic||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4149139|NCT00859040|3972739|B2|White, Non-Hispanic||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4149140|NCT00859040|3972740|B1|White, Non-Hispanic||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4149141|NCT00859040|3972738|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4149142|NCT00859040|3972739|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4149143|NCT00859040|3972740|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4149144|NCT00859040|3972738|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4149145|NCT00859040|3972739|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4149146|NCT00859040|3972740|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4149147|NCT00859040|3972738|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4149148|NCT00859040|3972739|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4149149|NCT00859040|3972740|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4149150|NCT00859040|3972738|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4149151|NCT00859040|3972739|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4149152|NCT00859040|3972740|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4149153|NCT00859040|3972738|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4149154|NCT00859040|3972739|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4149155|NCT00859040|3972740|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4149156|NCT00859040|3972738|B3|||Age||years|Median|54|54.0|Full Range|||36.0|81.0|
4149157|NCT00859040|3972739|B2|||Age||years|Median|52|52.0|Full Range|||36.0|81.0|
4149158|NCT00859040|3972740|B1|||Age||years|Median|59|59.0|Full Range|||39.0|74.0|
4149159|NCT00859027|3972754|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4149160|NCT00859027|3972755|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4149161|NCT00859027|3972756|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4149162|NCT00859027|3972754|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4149163|NCT00859027|3972755|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4149164|NCT00859027|3972756|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4149165|NCT00859027|3972754|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4149166|NCT00859027|3972755|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4149167|NCT00859027|3972756|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4149168|NCT00859027|3972754|B3|||Age||years|Mean|71|71.0|Standard Deviation|8|8.0|||
4149169|NCT00859027|3972755|B2|||Age||years|Mean|72|72.0|Standard Deviation|7|7.0|||
4149170|NCT00859027|3972756|B1|||Age||years|Mean|70|70.0|Standard Deviation|9|9.0|||
4149171|NCT00859027|3972754|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4149172|NCT00859027|3972755|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4149173|NCT00859027|3972756|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4149174|NCT00859027|3972754|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4149175|NCT00859027|3972755|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4149176|NCT00859027|3972756|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4149177|NCT00859027|3972754|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4149178|NCT00859027|3972755|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4149182|NCT00859014|3972765|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4149183|NCT00859014|3972765|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4149184|NCT00859014|3972765|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4149185|NCT00859014|3972765|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4149186|NCT00859014|3972765|B1|||Age||years|Mean|60.7|60.7|Standard Deviation|13.3|13.3|||
4149187|NCT00858962|3972770|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4149188|NCT00858962|3972770|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4149189|NCT00858962|3972770|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4149190|NCT00858962|3972770|B1|||Age||years|Mean|44|44.0|Full Range|||30.0|57.0|
4149191|NCT00858858|3972774|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4149192|NCT00858858|3972774|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4149193|NCT00858858|3972774|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4149194|NCT00858858|3972774|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4149195|NCT00858858|3972774|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4149196|NCT00858858|3972774|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4149197|NCT00858845|3972778|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4149198|NCT00858845|3972779|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4149199|NCT00858845|3972780|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4149200|NCT00858845|3972778|B3|Male||Sex/Gender, Customized||participants|Number|7|7.0||||||
4149201|NCT00858845|3972779|B2|Male||Sex/Gender, Customized||participants|Number|NA|||||||Data were not retained with detail needed to report by treatment arm
4149202|NCT00858845|3972780|B1|Male||Sex/Gender, Customized||participants|Number|NA|||||||Data were not retained with detail needed to report by treatment arm
4149203|NCT00858845|3972778|B3|Female||Sex/Gender, Customized||participants|Number|4|4.0||||||
4149204|NCT00858845|3972779|B2|Female||Sex/Gender, Customized||participants|Number|NA|||||||Data were not retained with detail needed to report by treatment arm
4149205|NCT00858845|3972780|B1|Female||Sex/Gender, Customized||participants|Number|NA|||||||Data were not retained with detail needed to report by treatment arm.
4149206|NCT00858845|3972778|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4149207|NCT00858845|3972779|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4149208|NCT00858845|3972780|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4149209|NCT00858845|3972778|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4149210|NCT00858845|3972779|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4149211|NCT00858845|3972780|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4149212|NCT00858845|3972778|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4149213|NCT00858845|3972779|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4149214|NCT00858845|3972780|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4149215|NCT00858832|3972791|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4149216|NCT00858832|3972792|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4149217|NCT00858832|3972793|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4149218|NCT00858832|3972791|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4149219|NCT00858832|3972792|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4149220|NCT00858832|3972793|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4149221|NCT00858832|3972791|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4149222|NCT00858832|3972792|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4149223|NCT00858832|3972793|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4149224|NCT00858832|3972791|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4149225|NCT00858832|3972792|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4149226|NCT00858832|3972793|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4149227|NCT00858832|3972791|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4149228|NCT00858832|3972792|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4149229|NCT00858832|3972793|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4149230|NCT00858780|3972800|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4149231|NCT00858780|3972800|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4149232|NCT00858780|3972800|B1|||Age||years|Mean|56.14|56.14|Standard Deviation|11.60|11.6|||
4149233|NCT00858702|3972877|B3|Japan||Region of Enrollment||participants|Number|105|105.0||||||
4149234|NCT00858702|3972878|B2|Japan||Region of Enrollment||participants|Number|52|52.0||||||
4149235|NCT00858702|3972879|B1|Japan||Region of Enrollment||participants|Number|53|53.0||||||
4149236|NCT00858702|3972877|B3|Japanese||Race/Ethnicity, Customized||Participants|Number|105|105.0||||||
4149237|NCT00858702|3972878|B2|Japanese||Race/Ethnicity, Customized||Participants|Number|52|52.0||||||
4149238|NCT00858702|3972879|B1|Japanese||Race/Ethnicity, Customized||Participants|Number|53|53.0||||||
4149239|NCT00858702|3972877|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4149240|NCT00858702|3972878|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4149241|NCT00858702|3972879|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4149242|NCT00858702|3972877|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4149243|NCT00858702|3972878|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4149244|NCT00858702|3972879|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4149245|NCT00858702|3972877|B3|||Age||years|Mean|56.8|56.8|Standard Deviation|10.3|10.3|||
4149246|NCT00858702|3972878|B2|||Age||years|Mean|57.4|57.4|Standard Deviation|9.4|9.4|||
4149247|NCT00858702|3972879|B1|||Age||years|Mean|56.2|56.2|Standard Deviation|11.2|11.2|||
4149248|NCT00858689|3972888|B1|Canada||Region of Enrollment||participants|Number|20|20.0||||||
4149249|NCT00858689|3972888|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4149250|NCT00858689|3972888|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4149251|NCT00858689|3972888|B1|||Age||years|Mean|18|18.0|Standard Deviation|5|5.0|||
4149252|NCT00858689|3972888|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4149253|NCT00858689|3972888|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4149254|NCT00858689|3972888|B1||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4149255|NCT00858637|3972893|B3||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4149256|NCT00858637|3972894|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4149257|NCT00858637|3972895|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4149258|NCT00858637|3972893|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4149259|NCT00858637|3972894|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4149260|NCT00858637|3972895|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4149261|NCT00858637|3972893|B3|||Age||years|Mean|53.8|53.8|Standard Deviation|13.8|13.8|||
4149262|NCT00858637|3972894|B2|||Age||years|Mean|54.2|54.2|Standard Deviation|13.6|13.6|||
4149263|NCT00858637|3972895|B1|||Age||years|Mean|53.3|53.3|Standard Deviation|14.1|14.1|||
4149264|NCT00858507|3972910|B3|United States||Region of Enrollment||participants|Number|184|184.0||||||
4149265|NCT00858507|3972911|B2|United States||Region of Enrollment||participants|Number|101|101.0||||||
4149266|NCT00858507|3972912|B1|United States||Region of Enrollment||participants|Number|83|83.0||||||
4149267|NCT00858507|3972910|B3||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4149268|NCT00858507|3972911|B2||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4149269|NCT00858507|3972912|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4149270|NCT00858507|3972910|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4149271|NCT00858507|3972911|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4149272|NCT00858507|3972912|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4149273|NCT00858507|3972910|B3|||Age||years|Mean|48.6|48.6|Standard Deviation|10.8|10.8|||
4149274|NCT00858507|3972911|B2|||Age||years|Mean|48.5|48.5|Standard Deviation|10.2|10.2|||
4149275|NCT00858507|3972912|B1|||Age||years|Mean|48.8|48.8|Standard Deviation|11.6|11.6|||
4149276|NCT00858507|3972910|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4149277|NCT00858507|3972911|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4149278|NCT00858507|3972912|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4149279|NCT00858507|3972910|B3||Between 18 and 65 years|Age||Participants|Count of Participants|176|176.0||||||
4149280|NCT00858507|3972911|B2||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
4149281|NCT00858507|3972912|B1||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
4149282|NCT00858507|3972910|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4149283|NCT00858507|3972911|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4149284|NCT00858507|3972912|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4149285|NCT00858494|3972919|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
4149286|NCT00858494|3972919|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4149287|NCT00858494|3972919|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4149288|NCT00858494|3972919|B1|||Age||years|Mean|3.5|3.5|Standard Deviation|1.2|1.2|||
4149289|NCT00858494|3972919|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4149290|NCT00858494|3972919|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4149291|NCT00858494|3972919|B1||<=18 years|Age||Participants|Count of Participants|49|49.0||||||
4149292|NCT00858468|3972924|B3|United States||Region of Enrollment||participants|Number|393|393.0||||||
4149293|NCT00858468|3972925|B2|United States||Region of Enrollment||participants|Number|192|192.0||||||
4149294|NCT00858468|3972926|B1|United States||Region of Enrollment||participants|Number|201|201.0||||||
4149295|NCT00858468|3972924|B3||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4149296|NCT00858468|3972925|B2||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4149297|NCT00858468|3972926|B1||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4149298|NCT00858468|3972924|B3||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4149299|NCT00858468|3972925|B2||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4149300|NCT00858468|3972926|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4149301|NCT00858468|3972924|B3|||Age||Weeks|Mean|18.0|18.0|Standard Deviation|8.9|8.9|||
4149302|NCT00858468|3972925|B2|||Age||Weeks|Mean|27.0|27.0|Standard Deviation|1.31|1.31|||
4149303|NCT00858468|3972926|B1|||Age||Weeks|Mean|9.4|9.4|Standard Deviation|0.98|0.98|||
4149304|NCT00858468|3972924|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4149305|NCT00858468|3972925|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4149306|NCT00858468|3972926|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4149307|NCT00858468|3972924|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4149308|NCT00858468|3972925|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4149309|NCT00858468|3972926|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4149310|NCT00858468|3972924|B3||<=18 years|Age||Participants|Count of Participants|393|393.0||||||
4149311|NCT00858468|3972925|B2||<=18 years|Age||Participants|Count of Participants|192|192.0||||||
4149312|NCT00858468|3972926|B1||<=18 years|Age||Participants|Count of Participants|201|201.0||||||
4149313|NCT00858442|3972939|B3|Chile||Region of Enrollment||participants|Number|44|44.0||||||
4149314|NCT00858442|3972940|B2|Chile||Region of Enrollment||participants|Number|23|23.0||||||
4149315|NCT00858442|3972941|B1|Chile||Region of Enrollment||participants|Number|21|21.0||||||
4149316|NCT00858442|3972939|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4149317|NCT00858442|3972940|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4149318|NCT00858442|3972941|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4149319|NCT00858442|3972939|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4149320|NCT00858442|3972940|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4149321|NCT00858442|3972941|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4149322|NCT00858442|3972939|B3|||Age||years|Mean|14.2|14.2|Standard Deviation|3.3|3.3|||
4149323|NCT00858442|3972940|B2|||Age||years|Mean|14.1|14.1|Standard Deviation|3.5|3.5|||
4149324|NCT00858442|3972941|B1|||Age||years|Mean|14.5|14.5|Standard Deviation|3.1|3.1|||
4149325|NCT00858403|3972952|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4149326|NCT00858403|3972952|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4149327|NCT00858403|3972952|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4149328|NCT00858403|3972952|B1|Between 70 and 79 years||Age, Customized||participants|Number|2|2.0||||||
4149329|NCT00858403|3972952|B1|Between 60 and 69 years||Age, Customized||participants|Number|4|4.0||||||
4149330|NCT00858403|3972952|B1|Between 40 and 49 years||Age, Customized||participants|Number|1|1.0||||||
4149331|NCT00858390|3972962|B3|||Resting energy expenditure||kcal/d|Mean|1866|1866.0|Standard Deviation|729.5|729.5|||
4149332|NCT00858390|3972963|B2|||Resting energy expenditure||kcal/d|Mean|1773|1773.0|Standard Deviation|778.8|778.8|||
4149333|NCT00858390|3972964|B1|||Resting energy expenditure||kcal/d|Mean|1954|1954.0|Standard Deviation|691.9|691.9|||
4149334|NCT00858390|3972962|B3|||Positive Breath Test Results|An exhaled gas concentration of 9% cumulative percent dose recovery was defined as assimilating the 13C-uracil and therefore a positive breath test.|participants|Number|10|10.0||||||
4149335|NCT00858390|3972963|B2|||Positive Breath Test Results|An exhaled gas concentration of 9% cumulative percent dose recovery was defined as assimilating the 13C-uracil and therefore a positive breath test.|participants|Number|6|6.0||||||
4149336|NCT00858390|3972964|B1|||Positive Breath Test Results|An exhaled gas concentration of 9% cumulative percent dose recovery was defined as assimilating the 13C-uracil and therefore a positive breath test.|participants|Number|4|4.0||||||
4149337|NCT00858390|3972962|B3|||Organs Transplanted||Solid organs transplanted|Mean|3.8|3.8|Standard Deviation|2|2.0|||
4149338|NCT00858390|3972963|B2|||Organs Transplanted||Solid organs transplanted|Mean|4.1|4.1|Standard Deviation|2.1|2.1|||
4149339|NCT00858390|3972964|B1|||Organs Transplanted||Solid organs transplanted|Mean|3.5|3.5|Standard Deviation|1.8|1.8|||
4149340|NCT00858390|3972962|B3|||Organs procured||Solid organs procured|Mean|4.53|4.53|Standard Deviation|1.7|1.7|||
4149341|NCT00858390|3972963|B2|||Organs procured||Solid organs procured|Mean|4.4|4.4|Standard Deviation|4.0|4.0|||
4149342|NCT00858390|3972964|B1|||Organs procured||Solid organs procured|Mean|4.6|4.6|Standard Deviation|1.5|1.5|||
4149343|NCT00858390|3972962|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4149344|NCT00858390|3972963|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4149345|NCT00858390|3972964|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4149346|NCT00858390|3972962|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149347|NCT00858390|3972963|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149348|NCT00858390|3972964|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149349|NCT00858390|3972962|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4149350|NCT00858390|3972963|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4149351|NCT00858390|3972964|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4149352|NCT00858390|3972962|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4149353|NCT00858390|3972963|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4149354|NCT00858390|3972964|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4149355|NCT00858390|3972962|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149356|NCT00858390|3972963|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149357|NCT00858390|3972964|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149358|NCT00858390|3972962|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149359|NCT00858390|3972963|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149360|NCT00858390|3972964|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149361|NCT00858390|3972962|B3||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4149362|NCT00858390|3972963|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4149363|NCT00858390|3972964|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4149364|NCT00858390|3972962|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4149365|NCT00858390|3972963|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4149366|NCT00858390|3972964|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149367|NCT00858390|3972962|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149368|NCT00858390|3972963|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149369|NCT00858390|3972964|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149370|NCT00858390|3972962|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4149371|NCT00858390|3972963|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149372|NCT00858390|3972964|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4149373|NCT00858390|3972962|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149374|NCT00858390|3972963|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149375|NCT00858390|3972964|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149376|NCT00858390|3972962|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4149377|NCT00858390|3972963|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4149378|NCT00858390|3972964|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4149379|NCT00858390|3972962|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4149380|NCT00858390|3972963|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4149381|NCT00858390|3972964|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4149382|NCT00858390|3972962|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4149383|NCT00858390|3972963|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4149384|NCT00858390|3972964|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4149385|NCT00858390|3972962|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4149386|NCT00858390|3972963|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4149387|NCT00858390|3972964|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4149388|NCT00858390|3972962|B3||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4149389|NCT00858390|3972963|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4149390|NCT00858390|3972964|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4149391|NCT00858390|3972962|B3|||Age||years|Mean|41.9|41.9|Standard Deviation|14.7|14.7|||
4149392|NCT00858390|3972963|B2|||Age||years|Mean|38.9|38.9|Standard Deviation|14.5|14.5|||
4149393|NCT00858390|3972964|B1|||Age||years|Mean|44.5|44.5|Standard Deviation|14.7|14.7|||
4149394|NCT00858364|3972971|B3||≥ 10 g/dL|Screening Hemoglobin|Stratification factor at the time of randomization.|Participants|Count of Participants|1213|1213.0||||||
4149395|NCT00858364|3972972|B2||≥ 10 g/dL|Screening Hemoglobin|Stratification factor at the time of randomization.|Participants|Count of Participants|810|810.0||||||
4149396|NCT00858364|3972973|B1||≥ 10 g/dL|Screening Hemoglobin|Stratification factor at the time of randomization.|Participants|Count of Participants|403|403.0||||||
4149397|NCT00858364|3972971|B3||< 10 g/dL|Screening Hemoglobin|Stratification factor at the time of randomization.|Participants|Count of Participants|1303|1303.0||||||
4149398|NCT00858364|3972972|B2||< 10 g/dL|Screening Hemoglobin|Stratification factor at the time of randomization.|Participants|Count of Participants|870|870.0||||||
4149399|NCT00858364|3972973|B1||< 10 g/dL|Screening Hemoglobin|Stratification factor at the time of randomization.|Participants|Count of Participants|433|433.0||||||
4149400|NCT00858364|3972971|B3||Non-squamous|Histology|Stratification factor at the time of randomization|Participants|Count of Participants|1638|1638.0||||||
4149401|NCT00858364|3972972|B2||Non-squamous|Histology|Stratification factor at the time of randomization|Participants|Count of Participants|1091|1091.0||||||
4149402|NCT00858364|3972973|B1||Non-squamous|Histology|Stratification factor at the time of randomization|Participants|Count of Participants|547|547.0||||||
4149403|NCT00858364|3972971|B3||Squamous|Histology|Stratification factor at the time of randomization|Participants|Count of Participants|878|878.0||||||
4149404|NCT00858364|3972972|B2||Squamous|Histology|Stratification factor at the time of randomization|Participants|Count of Participants|589|589.0||||||
4149405|NCT00858364|3972973|B1||Squamous|Histology|Stratification factor at the time of randomization|Participants|Count of Participants|289|289.0||||||
4149406|NCT00858364|3972971|B3||Japan|Geographic Region|Stratification factor at the time of randomization.|Participants|Count of Participants|16|16.0||||||
4149407|NCT00858364|3972972|B2||Japan|Geographic Region|Stratification factor at the time of randomization.|Participants|Count of Participants|10|10.0||||||
4149408|NCT00858364|3972973|B1||Japan|Geographic Region|Stratification factor at the time of randomization.|Participants|Count of Participants|6|6.0||||||
4149409|NCT00858364|3972971|B3||China|Geographic Region|Stratification factor at the time of randomization.|Participants|Count of Participants|366|366.0||||||
4149410|NCT00858364|3972972|B2||China|Geographic Region|Stratification factor at the time of randomization.|Participants|Count of Participants|243|243.0||||||
4149411|NCT00858364|3972973|B1||China|Geographic Region|Stratification factor at the time of randomization.|Participants|Count of Participants|123|123.0||||||
4149412|NCT00858364|3972971|B3||North America|Geographic Region|Stratification factor at the time of randomization.|Participants|Count of Participants|291|291.0||||||
4149413|NCT00858364|3972972|B2||North America|Geographic Region|Stratification factor at the time of randomization.|Participants|Count of Participants|192|192.0||||||
4149414|NCT00858364|3972973|B1||North America|Geographic Region|Stratification factor at the time of randomization.|Participants|Count of Participants|99|99.0||||||
4149415|NCT00858364|3972971|B3||India|Geographic Region|Stratification factor at the time of randomization.|Participants|Count of Participants|507|507.0||||||
4149416|NCT00858364|3972972|B2||India|Geographic Region|Stratification factor at the time of randomization.|Participants|Count of Participants|339|339.0||||||
4149417|NCT00858364|3972973|B1||India|Geographic Region|Stratification factor at the time of randomization.|Participants|Count of Participants|168|168.0||||||
4149418|NCT00858364|3972971|B3||Latin America and Asia|Geographic Region|Stratification factor at the time of randomization.|Participants|Count of Participants|503|503.0||||||
4149419|NCT00858364|3972972|B2||Latin America and Asia|Geographic Region|Stratification factor at the time of randomization.|Participants|Count of Participants|337|337.0||||||
4149420|NCT00858364|3972973|B1||Latin America and Asia|Geographic Region|Stratification factor at the time of randomization.|Participants|Count of Participants|166|166.0||||||
4149421|NCT00858364|3972971|B3||Central and Eastern Europe|Geographic Region|Stratification factor at the time of randomization.|Participants|Count of Participants|671|671.0||||||
4149422|NCT00858364|3972972|B2||Central and Eastern Europe|Geographic Region|Stratification factor at the time of randomization.|Participants|Count of Participants|451|451.0||||||
4149423|NCT00858364|3972973|B1||Central and Eastern Europe|Geographic Region|Stratification factor at the time of randomization.|Participants|Count of Participants|220|220.0||||||
4149424|NCT00858364|3972971|B3||Western Europe, Israel and South Africa|Geographic Region|Stratification factor at the time of randomization.|Participants|Count of Participants|162|162.0||||||
4149425|NCT00858364|3972972|B2||Western Europe, Israel and South Africa|Geographic Region|Stratification factor at the time of randomization.|Participants|Count of Participants|108|108.0||||||
4149426|NCT00858364|3972973|B1||Western Europe, Israel and South Africa|Geographic Region|Stratification factor at the time of randomization.|Participants|Count of Participants|54|54.0||||||
4149427|NCT00858364|3972971|B3||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|126|126.0||||||
4149428|NCT00858364|3972972|B2||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|81|81.0||||||
4149429|NCT00858364|3972973|B1||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|45|45.0||||||
4149430|NCT00858364|3972971|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
4149431|NCT00858364|3972972|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4149432|NCT00858364|3972973|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4149433|NCT00858364|3972971|B3||Aborigine|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4149434|NCT00858364|3972972|B2||Aborigine|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4149435|NCT00858364|3972973|B1||Aborigine|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4149436|NCT00858364|3972971|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4149437|NCT00858364|3972972|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4149438|NCT00858364|3972973|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4149439|NCT00858364|3972971|B3||Japanese|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
4149440|NCT00858364|3972972|B2||Japanese|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4149441|NCT00858364|3972973|B1||Japanese|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4149442|NCT00858364|3972971|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1098|1098.0||||||
4149443|NCT00858364|3972972|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|741|741.0||||||
4149444|NCT00858364|3972973|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|357|357.0||||||
4149445|NCT00858364|3972971|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|73|73.0||||||
4149446|NCT00858364|3972972|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
4149447|NCT00858364|3972973|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
4149448|NCT00858364|3972971|B3||White or Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|1212|1212.0||||||
4149449|NCT00858364|3972972|B2||White or Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|808|808.0||||||
4149450|NCT00858364|3972973|B1||White or Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|404|404.0||||||
4149451|NCT00858364|3972971|B3||Male|Sex: Female, Male||Participants|Count of Participants|1683|1683.0||||||
4149452|NCT00858364|3972972|B2||Male|Sex: Female, Male||Participants|Count of Participants|1118|1118.0||||||
4149453|NCT00858364|3972973|B1||Male|Sex: Female, Male||Participants|Count of Participants|565|565.0||||||
4149454|NCT00858364|3972971|B3||Female|Sex: Female, Male||Participants|Count of Participants|866|866.0||||||
4149455|NCT00858364|3972972|B2||Female|Sex: Female, Male||Participants|Count of Participants|585|585.0||||||
4149456|NCT00858364|3972973|B1||Female|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
4149457|NCT00858364|3972971|B3||≥ 85 years|Age, Customized||Participants|Count of Participants|14|14.0||||||
4149458|NCT00858364|3972972|B2||≥ 85 years|Age, Customized||Participants|Count of Participants|8|8.0||||||
4149459|NCT00858364|3972973|B1||≥ 85 years|Age, Customized||Participants|Count of Participants|6|6.0||||||
4149460|NCT00858364|3972971|B3||75 - 84 years|Age, Customized||Participants|Count of Participants|205|205.0||||||
4149461|NCT00858364|3972972|B2||75 - 84 years|Age, Customized||Participants|Count of Participants|134|134.0||||||
4149462|NCT00858364|3972973|B1||75 - 84 years|Age, Customized||Participants|Count of Participants|71|71.0||||||
4149463|NCT00858364|3972971|B3||65 - 74 years|Age, Customized||Participants|Count of Participants|834|834.0||||||
4149464|NCT00858364|3972972|B2||65 - 74 years|Age, Customized||Participants|Count of Participants|547|547.0||||||
4149465|NCT00858364|3972973|B1||65 - 74 years|Age, Customized||Participants|Count of Participants|287|287.0||||||
4149466|NCT00858364|3972971|B3||18 - 64 years|Age, Customized||Participants|Count of Participants|1496|1496.0||||||
4149467|NCT00858364|3972972|B2||18 - 64 years|Age, Customized||Participants|Count of Participants|1014|1014.0||||||
4149468|NCT00858364|3972973|B1||18 - 64 years|Age, Customized||Participants|Count of Participants|482|482.0||||||
4149469|NCT00858364|3972971|B3|||Age||years|Mean|61.8|61.8|Standard Deviation|9.8|9.8|||
4149470|NCT00858364|3972972|B2|||Age||years|Mean|61.6|61.6|Standard Deviation|9.8|9.8|||
4149471|NCT00858364|3972973|B1|||Age||years|Mean|62.2|62.2|Standard Deviation|9.9|9.9|||
4149472|NCT00858247|3972994|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
4149473|NCT00858247|3972995|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4149474|NCT00858247|3972996|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4149475|NCT00858247|3972994|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4149476|NCT00858247|3972995|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4149477|NCT00858247|3972996|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4149478|NCT00858247|3972994|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4149479|NCT00858247|3972995|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4149480|NCT00858247|3972996|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4149481|NCT00858247|3972994|B3|||Age||years|Median|14.5|14.5|Inter-Quartile Range|||13.5|16.4|
4149482|NCT00858247|3972995|B2|||Age||years|Median|14.7|14.7|Inter-Quartile Range|||13.5|16.0|
4149483|NCT00858247|3972996|B1|||Age||years|Median|14.5|14.5|Inter-Quartile Range|||13.5|16.6|
4149484|NCT00858208|3973013|B1|optical coherence tomography||Procedures used for age-related macular degeneration (AMD) diagnosis|Procedures used in the diagnosis of age-related macular degeneration (AMD) included fluorescein angiography, indocyanine green angiography, and optical coherence tomography.|participants|Number|18|18.0||||||
4149485|NCT00858208|3973013|B1|indocyanine green angiography||Procedures used for age-related macular degeneration (AMD) diagnosis|Procedures used in the diagnosis of age-related macular degeneration (AMD) included fluorescein angiography, indocyanine green angiography, and optical coherence tomography.|participants|Number|0|0.0||||||
4149486|NCT00858208|3973013|B1|fluorescein angiography||Procedures used for age-related macular degeneration (AMD) diagnosis|Procedures used in the diagnosis of age-related macular degeneration (AMD) included fluorescein angiography, indocyanine green angiography, and optical coherence tomography.|participants|Number|66|66.0||||||
4149487|NCT00858208|3973013|B1|Peripheral Vision (n=85)||National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) sub-scale scores at baseline|Participant-reported 25 item questionnaire. Responses to each question converted to 0-100 score. Questions grouped into 11 vision-targeted categories and 1 general heath category. Sub-scale score=mean score in a category. Range of sub-scale scores=0 to 100 where higher scores represent better functioning. n=participants with evaluable data.|scores on a scale|Mean|67.65|67.65|Standard Deviation|29.586|29.586|||
4149488|NCT00858208|3973013|B1|Color Vision (n=83)||National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) sub-scale scores at baseline|Participant-reported 25 item questionnaire. Responses to each question converted to 0-100 score. Questions grouped into 11 vision-targeted categories and 1 general heath category. Sub-scale score=mean score in a category. Range of sub-scale scores=0 to 100 where higher scores represent better functioning. n=participants with evaluable data.|scores on a scale|Mean|79.82|79.82|Standard Deviation|23.896|23.896|||
4149489|NCT00858208|3973013|B1|Driving (n=30)||National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) sub-scale scores at baseline|Participant-reported 25 item questionnaire. Responses to each question converted to 0-100 score. Questions grouped into 11 vision-targeted categories and 1 general heath category. Sub-scale score=mean score in a category. Range of sub-scale scores=0 to 100 where higher scores represent better functioning. n=participants with evaluable data.|scores on a scale|Mean|49.72|49.72|Standard Deviation|35.523|35.523|||
4149490|NCT00858208|3973013|B1|Dependency (n=85)||National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) sub-scale scores at baseline|Participant-reported 25 item questionnaire. Responses to each question converted to 0-100 score. Questions grouped into 11 vision-targeted categories and 1 general heath category. Sub-scale score=mean score in a category. Range of sub-scale scores=0 to 100 where higher scores represent better functioning. n=participants with evaluable data.|scores on a scale|Mean|61.27|61.27|Standard Deviation|28.542|28.542|||
4149491|NCT00858208|3973013|B1|Role Difficulties (n=85)||National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) sub-scale scores at baseline|Participant-reported 25 item questionnaire. Responses to each question converted to 0-100 score. Questions grouped into 11 vision-targeted categories and 1 general heath category. Sub-scale score=mean score in a category. Range of sub-scale scores=0 to 100 where higher scores represent better functioning. n=participants with evaluable data.|scores on a scale|Mean|57.06|57.06|Standard Deviation|31.425|31.425|||
4149492|NCT00858208|3973013|B1|Mental Health (n=85)||National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) sub-scale scores at baseline|Participant-reported 25 item questionnaire. Responses to each question converted to 0-100 score. Questions grouped into 11 vision-targeted categories and 1 general heath category. Sub-scale score=mean score in a category. Range of sub-scale scores=0 to 100 where higher scores represent better functioning. n=participants with evaluable data.|scores on a scale|Mean|50.51|50.51|Standard Deviation|24.056|24.056|||
4149493|NCT00858208|3973013|B1|Social Functioning (n=85)||National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) sub-scale scores at baseline|Participant-reported 25 item questionnaire. Responses to each question converted to 0-100 score. Questions grouped into 11 vision-targeted categories and 1 general heath category. Sub-scale score=mean score in a category. Range of sub-scale scores=0 to 100 where higher scores represent better functioning. n=participants with evaluable data.|scores on a scale|Mean|72.35|72.35|Standard Deviation|28.809|28.809|||
4149524|NCT00857961|3973104|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149494|NCT00858208|3973013|B1|Distance Activities (n=85)||National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) sub-scale scores at baseline|Participant-reported 25 item questionnaire. Responses to each question converted to 0-100 score. Questions grouped into 11 vision-targeted categories and 1 general heath category. Sub-scale score=mean score in a category. Range of sub-scale scores=0 to 100 where higher scores represent better functioning. n=participants with evaluable data.|scores on a scale|Mean|58.73|58.73|Standard Deviation|28.264|28.264|||
4149495|NCT00858208|3973013|B1|Near Activities (n=85)||National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) sub-scale scores at baseline|Participant-reported 25 item questionnaire. Responses to each question converted to 0-100 score. Questions grouped into 11 vision-targeted categories and 1 general heath category. Sub-scale score=mean score in a category. Range of sub-scale scores=0 to 100 where higher scores represent better functioning. n=participants with evaluable data.|scores on a scale|Mean|53.09|53.09|Standard Deviation|28.976|28.976|||
4149496|NCT00858208|3973013|B1|Ocular Pain (n=85)||National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) sub-scale scores at baseline|Participant-reported 25 item questionnaire. Responses to each question converted to 0-100 score. Questions grouped into 11 vision-targeted categories and 1 general heath category. Sub-scale score=mean score in a category. Range of sub-scale scores=0 to 100 where higher scores represent better functioning. n=participants with evaluable data.|scores on a scale|Mean|80.74|80.74|Standard Deviation|20.912|20.912|||
4149497|NCT00858208|3973013|B1|General Vision (n=85)||National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) sub-scale scores at baseline|Participant-reported 25 item questionnaire. Responses to each question converted to 0-100 score. Questions grouped into 11 vision-targeted categories and 1 general heath category. Sub-scale score=mean score in a category. Range of sub-scale scores=0 to 100 where higher scores represent better functioning. n=participants with evaluable data.|scores on a scale|Mean|55.53|55.53|Standard Deviation|16.439|16.439|||
4149498|NCT00858208|3973013|B1|General Health (n=85)||National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) sub-scale scores at baseline|Participant-reported 25 item questionnaire. Responses to each question converted to 0-100 score. Questions grouped into 11 vision-targeted categories and 1 general heath category. Sub-scale score=mean score in a category. Range of sub-scale scores=0 to 100 where higher scores represent better functioning. n=participants with evaluable data.|scores on a scale|Mean|45.00|45.0|Standard Deviation|23.081|23.081|||
4149499|NCT00858208|3973013|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4149500|NCT00858208|3973013|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4149501|NCT00858208|3973013|B1|||Age||years|Mean|74.0|74.0|Standard Deviation|6.8|6.8|||
4149502|NCT00858143|3973030|B1||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4149503|NCT00858143|3973030|B1||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4149504|NCT00858143|3973030|B1|||Age||years|Mean|50.3|50.3|Standard Deviation|13.8|13.8|||
4149505|NCT00858130|3973079|B1|||VEINES-Sym|The VEINES-QOL/Sym Questionnaire is a patient-based questionnaire designed for self-completion and measures the impact of deep venous thrombosis (DVT) on symptoms and quality of life from the patient's perspective. It contains 26 items covering symptoms, limitations in daily activities, and psychological impact of patients with a DVT. Summary scores are generated for disease specific quality of life (VEINES-QOL) and venous symptoms (VEINES-Sym) each ranging from 0 to 100. For the VEINES-Sym, higher scores indicate better outcomes.|units on a scale|Median|46.93|46.93|Full Range|||36.67|58.41|
4149506|NCT00858130|3973079|B1|||VEINES-Quality of Life (QOL)|The VEINES-QOL/Sym Questionnaire is a patient-based questionnaire designed for self-completion and measures the impact of deep venous thrombosis (DVT) on symptoms and quality of life from the patient's perspective. It contains 26 items covering symptoms, limitations in daily activities, and psychological impact of patients with a DVT. Summary scores are generated for disease specific quality of life (VEINES-QOL) and venous symptoms (VEINES-Sym) each ranging from 0 to 100. For the VEINES-QOL, higher scores indicate a better quality of life.|units on a scale|Median|48.30|48.3|Full Range|||31.11|57.46|
4149507|NCT00858130|3973079|B1|||Villalta Scale|The Villalta PTS scale is based on patient symptoms including cramps, pain, and redness. The severity of PTS was categorized using the Villalta scale. Points are given for 11 descriptors according to severity ranging from 0 (not present) to 3 (severe) with overall scores from 0 to 33. Higher scores represent more severe disease. A score of ≥ 5 indicated mild PTS, 10-14 moderate PTS, and a score of ≥ 15, or the presence of a venous ulcer, indicated severe PTS.|units on a scale|Median|13|13.0|Full Range|||6.0|22.0|
4149508|NCT00858130|3973079|B1|||Leg Calf Circumference|Leg measurements around the largest part of both calves were taken.|centimeters (cm)|Median|41|41.0|Full Range|||33.0|51.0|
4149509|NCT00858130|3973079|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4149510|NCT00858130|3973079|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4149511|NCT00858130|3973079|B1|||Age||years|Median|54|54.0|Full Range|||21.0|64.0|
4149512|NCT00858013|3973087|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4149513|NCT00858013|3973088|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4149514|NCT00858013|3973089|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4149515|NCT00858013|3973087|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4149516|NCT00858013|3973088|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4149517|NCT00858013|3973089|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4149518|NCT00858013|3973087|B3|||Age||years|Mean|55|55.0|Standard Deviation|11|11.0|||
4149519|NCT00858013|3973088|B2|||Age||years|Mean|55.1|55.1|Standard Deviation|12.3|12.3|||
4149520|NCT00858013|3973089|B1|||Age||years|Mean|55.0|55.0|Standard Deviation|10.5|10.5|||
4149521|NCT00857961|3973104|B1|||Average Baseline Testosterone||nanograms per deciliter (ng/dL)|Mean|193.2|193.2|Standard Deviation|73.9|73.9|||
4149522|NCT00857961|3973104|B1|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meter (kg/m^2)|Mean|30.1|30.1|Standard Deviation|3.2|3.2|||
4149523|NCT00857961|3973104|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4149525|NCT00857961|3973104|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149526|NCT00857961|3973104|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4149527|NCT00857961|3973104|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4149528|NCT00857961|3973104|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149529|NCT00857961|3973104|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149530|NCT00857961|3973104|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149531|NCT00857961|3973104|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149532|NCT00857961|3973104|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4149533|NCT00857961|3973104|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4149534|NCT00857961|3973104|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4149535|NCT00857961|3973104|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4149536|NCT00857961|3973104|B1|||Age||years|Mean|47.3|47.3|Standard Deviation|12.3|12.3|||
4149537|NCT00857948|3973138|B5|United States||Region of Enrollment||Participants|Number|78|78.0||||||
4149538|NCT00857948|3973139|B4|United States||Region of Enrollment||Participants|Number|23|23.0||||||
4149539|NCT00857948|3973140|B3|United States||Region of Enrollment||Participants|Number|19|19.0||||||
4149540|NCT00857948|3973141|B2|United States||Region of Enrollment||Participants|Number|18|18.0||||||
4149541|NCT00857948|3973142|B1|United States||Region of Enrollment||Participants|Number|18|18.0||||||
4149542|NCT00857948|3973138|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4149543|NCT00857948|3973139|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4149544|NCT00857948|3973140|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4149545|NCT00857948|3973141|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4149546|NCT00857948|3973142|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4149547|NCT00857948|3973138|B5||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4149548|NCT00857948|3973139|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4149549|NCT00857948|3973140|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4149550|NCT00857948|3973141|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4149551|NCT00857948|3973142|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4149552|NCT00857948|3973138|B5|Age Continuous||Age||Years|Mean|12.83|12.83|Standard Deviation|10.79|10.79|||
4149553|NCT00857948|3973139|B4|Age Continuous||Age||Years|Mean|11.13|11.13|Standard Deviation|8.73|8.73|||
4149554|NCT00857948|3973140|B3|Age Continuous||Age||Years|Mean|14.21|14.21|Standard Deviation|12.87|12.87|||
4149555|NCT00857948|3973141|B2|Age Continuous||Age||Years|Mean|14.11|14.11|Standard Deviation|8.71|8.71|||
4149556|NCT00857948|3973142|B1|Age Continuous||Age||Years|Mean|12.28|12.28|Standard Deviation|13.00|13.0|||
4149557|NCT00857948|3973138|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4149558|NCT00857948|3973139|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4149559|NCT00857948|3973140|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4149560|NCT00857948|3973141|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4149561|NCT00857948|3973142|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4149562|NCT00857948|3973138|B5||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4149563|NCT00857948|3973139|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4149564|NCT00857948|3973140|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4149565|NCT00857948|3973141|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4149566|NCT00857948|3973142|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4149567|NCT00857948|3973138|B5||<=18 years|Age||Participants|Count of Participants|64|64.0||||||
4149568|NCT00857948|3973139|B4||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
4149569|NCT00857948|3973140|B3||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4149570|NCT00857948|3973141|B2||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4149571|NCT00857948|3973142|B1||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4149572|NCT00857896|3973167|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4149573|NCT00857896|3973167|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4149574|NCT00857896|3973167|B1|||Age||years|Mean|13.1|13.1|Standard Deviation|2.7|2.7|||
4149575|NCT00857857|3973179|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149576|NCT00857857|3973179|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149577|NCT00857857|3973179|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4149578|NCT00857857|3973179|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149579|NCT00857857|3973179|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149580|NCT00857857|3973179|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149581|NCT00857857|3973179|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149582|NCT00857857|3973179|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4149583|NCT00857857|3973179|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4149584|NCT00857857|3973179|B1|||Age||Years|Mean|39.4|39.4|Standard Deviation|11.25|11.25|||
4149585|NCT00857818|3973321|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149586|NCT00857818|3973322|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149587|NCT00857818|3973323|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149588|NCT00857818|3973321|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149589|NCT00857818|3973322|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149590|NCT00857818|3973323|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149591|NCT00857818|3973321|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4149592|NCT00857818|3973322|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4149593|NCT00857818|3973323|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4149594|NCT00857818|3973321|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4149595|NCT00857818|3973322|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149596|NCT00857818|3973323|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4149597|NCT00857818|3973321|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149598|NCT00857818|3973322|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149599|NCT00857818|3973323|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149600|NCT00857818|3973321|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4149601|NCT00857818|3973322|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4149602|NCT00857818|3973323|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4149603|NCT00857818|3973321|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4149604|NCT00857818|3973322|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4149605|NCT00857818|3973323|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149606|NCT00857818|3973321|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4149607|NCT00857818|3973322|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4149608|NCT00857818|3973323|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4149609|NCT00857818|3973321|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4149610|NCT00857818|3973322|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4149611|NCT00857818|3973323|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4149612|NCT00857818|3973321|B3|||Age||years|Mean|35.9|35.9|Standard Deviation|10.06|10.06|||
4149613|NCT00857818|3973322|B2|||Age||years|Mean|32.9|32.9|Standard Deviation|9.10|9.1|||
4149614|NCT00857818|3973323|B1|||Age||years|Mean|39.0|39.0|Standard Deviation|10.36|10.36|||
4149615|NCT00857792|3973352|B1|United States||Region of Enrollment||participants|Number|120|120.0||||||
4149616|NCT00857792|3973352|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4149617|NCT00857792|3973352|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4149618|NCT00857792|3973352|B1|||Age||years|Mean|54|54.0|Standard Deviation|11|11.0|||
4149619|NCT00857766|3973356|B3|White||Race/Ethnicity, Customized||participants|Number|228|228.0||||||
4149620|NCT00857766|3973357|B2|White||Race/Ethnicity, Customized||participants|Number|114|114.0||||||
4149621|NCT00857766|3973358|B1|White||Race/Ethnicity, Customized||participants|Number|114|114.0||||||
4149622|NCT00857766|3973356|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4149623|NCT00857766|3973357|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4149624|NCT00857766|3973358|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4149625|NCT00857766|3973356|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4149626|NCT00857766|3973357|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4149627|NCT00857766|3973358|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4149628|NCT00857766|3973356|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4149629|NCT00857766|3973357|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4149630|NCT00857766|3973358|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4149631|NCT00857766|3973356|B3||Male|Gender||Participants|Count of Participants|142|142.0||||||
4149632|NCT00857766|3973357|B2||Male|Gender||Participants|Count of Participants|74|74.0||||||
4149633|NCT00857766|3973358|B1||Male|Gender||Participants|Count of Participants|68|68.0||||||
4149634|NCT00857766|3973356|B3||Female|Gender||Participants|Count of Participants|107|107.0||||||
4149635|NCT00857766|3973357|B2||Female|Gender||Participants|Count of Participants|52|52.0||||||
4149636|NCT00857766|3973358|B1||Female|Gender||Participants|Count of Participants|55|55.0||||||
4149637|NCT00857766|3973356|B3|||Age||Years|Mean|63.5|63.5|Standard Deviation|8.40|8.4|||
4149638|NCT00857766|3973357|B2|||Age||Years|Mean|63.5|63.5|Standard Deviation|7.88|7.88|||
4149639|NCT00857766|3973358|B1|||Age||Years|Mean|63.6|63.6|Standard Deviation|8.92|8.92|||
4149640|NCT00857727|3973369|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4149641|NCT00857727|3973370|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4149642|NCT00857727|3973371|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4149643|NCT00857727|3973369|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4149644|NCT00857727|3973370|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4149645|NCT00857727|3973371|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4149646|NCT00857727|3973369|B3|||Age||years|Mean|4.7|4.7|Standard Deviation|2.8|2.8|||
4149647|NCT00857727|3973370|B2|||Age||years|Mean|4.2|4.2|Standard Deviation|2.7|2.7|||
4149648|NCT00857727|3973371|B1|||Age||years|Mean|5.2|5.2|Standard Deviation|2.6|2.6|||
4149649|NCT00857714|3973394|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149650|NCT00857714|3973394|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149651|NCT00857714|3973394|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4149652|NCT00857714|3973394|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149653|NCT00857714|3973394|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149654|NCT00857714|3973394|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149655|NCT00857714|3973394|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149656|NCT00857714|3973394|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4149657|NCT00857714|3973394|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4149658|NCT00857714|3973394|B1|||Age||years|Mean|63|63.0|Standard Deviation|NA||||Only one patient available; standard deviation cannot be calculated.
4149659|NCT00857714|3973394|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4149660|NCT00857714|3973394|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4149661|NCT00857714|3973394|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4149662|NCT00857649|3973399|B3|||CMAI - Long Form: Baseline Total Score|"The Cohen-Mansfield Agitation Inventory (CMAI) - Long Form looks specifically at agitated behaviour in patients with cognitive impairment. It is a seven-point rating scale assessing the frequency of up to 29 agitated behaviours, ranging from 1 = Never to 7 = Several times an hour. Rating is based on responses obtained from interviews with the caregiver. The total score ranges from 29 to 203, with a higher score reflecting more frequent behavioural disturbances."|Scores on a scale|Mean|46.9|46.9|Standard Deviation|10.9|10.9|||
4149663|NCT00857649|3973400|B2|||CMAI - Long Form: Baseline Total Score|"The Cohen-Mansfield Agitation Inventory (CMAI) - Long Form looks specifically at agitated behaviour in patients with cognitive impairment. It is a seven-point rating scale assessing the frequency of up to 29 agitated behaviours, ranging from 1 = Never to 7 = Several times an hour. Rating is based on responses obtained from interviews with the caregiver. The total score ranges from 29 to 203, with a higher score reflecting more frequent behavioural disturbances."|Scores on a scale|Mean|47.0|47.0|Standard Deviation|10.9|10.9|||
4149664|NCT00857649|3973401|B1|||CMAI - Long Form: Baseline Total Score|"The Cohen-Mansfield Agitation Inventory (CMAI) - Long Form looks specifically at agitated behaviour in patients with cognitive impairment. It is a seven-point rating scale assessing the frequency of up to 29 agitated behaviours, ranging from 1 = Never to 7 = Several times an hour. Rating is based on responses obtained from interviews with the caregiver. The total score ranges from 29 to 203, with a higher score reflecting more frequent behavioural disturbances."|Scores on a scale|Mean|46.8|46.8|Standard Deviation|10.9|10.9|||
4149665|NCT00857649|3973399|B3|||ADCS-ADL - 19 items: Baseline Total Score|Alzheimer's Disease Cooperative Study - Activities of Daily Living Inventory (ADCS-ADL) - 19 items total score version for moderate to severe AD will measure patient's functioning. This battery of ADL questions is used here to measure the functional capabilities of patients with dementia. The inventory is done by interviewing a person in close contact with the patient and covers the most usual and consistent performance of the patient over the preceding 4 weeks. Total score is from 0 to 54. The higher score, the lower impairment.|Scores on a scale|Mean|35.8|35.8|Standard Deviation|9.3|9.3|||
4149666|NCT00857649|3973400|B2|||ADCS-ADL - 19 items: Baseline Total Score|Alzheimer's Disease Cooperative Study - Activities of Daily Living Inventory (ADCS-ADL) - 19 items total score version for moderate to severe AD will measure patient's functioning. This battery of ADL questions is used here to measure the functional capabilities of patients with dementia. The inventory is done by interviewing a person in close contact with the patient and covers the most usual and consistent performance of the patient over the preceding 4 weeks. Total score is from 0 to 54. The higher score, the lower impairment.|Scores on a scale|Mean|36.4|36.4|Standard Deviation|8.6|8.6|||
4149667|NCT00857649|3973401|B1|||ADCS-ADL - 19 items: Baseline Total Score|Alzheimer's Disease Cooperative Study - Activities of Daily Living Inventory (ADCS-ADL) - 19 items total score version for moderate to severe AD will measure patient's functioning. This battery of ADL questions is used here to measure the functional capabilities of patients with dementia. The inventory is done by interviewing a person in close contact with the patient and covers the most usual and consistent performance of the patient over the preceding 4 weeks. Total score is from 0 to 54. The higher score, the lower impairment.|Scores on a scale|Mean|35.3|35.3|Standard Deviation|9.9|9.9|||
4149668|NCT00857649|3973399|B3|||CIBIC-plus: Baseline Severity Score|"The Clinician's Interview-Based Impression of Change-Plus Version (CIBIC-plus) is a global rating that is derived through an independent, comprehensive interview with the patient and caregiver by a rater who is barred from knowledge of all other psychometric test scores conducted as part of this protocol as well as from reported safety data. The rating is made on a 7-point scale ranging from 1 = marked improvement to 7 = marked worsening. A score of 4 indicates no change."|Scores on a scale|Mean|4.4|4.4|Standard Deviation|0.9|0.9|||
4149669|NCT00857649|3973400|B2|||CIBIC-plus: Baseline Severity Score|"The Clinician's Interview-Based Impression of Change-Plus Version (CIBIC-plus) is a global rating that is derived through an independent, comprehensive interview with the patient and caregiver by a rater who is barred from knowledge of all other psychometric test scores conducted as part of this protocol as well as from reported safety data. The rating is made on a 7-point scale ranging from 1 = marked improvement to 7 = marked worsening. A score of 4 indicates no change."|Scores on a scale|Mean|4.4|4.4|Standard Deviation|0.9|0.9|||
4149745|NCT00857545|3973486|B1|||Recurring and/or Persistent Disease|Recurrent/persistent patients|Participants|Count of Participants|86|86.0||||||
4149746|NCT00857545|3973484|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4149670|NCT00857649|3973401|B1|||CIBIC-plus: Baseline Severity Score|"The Clinician's Interview-Based Impression of Change-Plus Version (CIBIC-plus) is a global rating that is derived through an independent, comprehensive interview with the patient and caregiver by a rater who is barred from knowledge of all other psychometric test scores conducted as part of this protocol as well as from reported safety data. The rating is made on a 7-point scale ranging from 1 = marked improvement to 7 = marked worsening. A score of 4 indicates no change."|Scores on a scale|Mean|4.4|4.4|Standard Deviation|0.9|0.9|||
4149671|NCT00857649|3973399|B3|||SIB: Baseline Total Score|The Severe Impairment Battery (SIB) is a validated scale used to assess cognitive function in patients with moderate to severe dementia. Items are single words or one-step commands combined with gestures. Nine domains are assessed, and the total score is between 0 and 100. A lower total score reflects the loss of cognitive function.|Scores on a scale|Mean|82.1|82.1|Standard Deviation|13.7|13.7|||
4149672|NCT00857649|3973400|B2|||SIB: Baseline Total Score|The Severe Impairment Battery (SIB) is a validated scale used to assess cognitive function in patients with moderate to severe dementia. Items are single words or one-step commands combined with gestures. Nine domains are assessed, and the total score is between 0 and 100. A lower total score reflects the loss of cognitive function.|Scores on a scale|Mean|82.0|82.0|Standard Deviation|12.9|12.9|||
4149673|NCT00857649|3973401|B1|||SIB: Baseline Total Score|The Severe Impairment Battery (SIB) is a validated scale used to assess cognitive function in patients with moderate to severe dementia. Items are single words or one-step commands combined with gestures. Nine domains are assessed, and the total score is between 0 and 100. A lower total score reflects the loss of cognitive function.|Scores on a scale|Mean|82.3|82.3|Standard Deviation|14.6|14.6|||
4149674|NCT00857649|3973399|B3|||NPI: Baseline Total Score|The Neuropsychiatric Inventory (NPI) is a validated scale that assesses behavioural disturbances in patients with dementia. The 12 item version consists of 10 behavioural and 2 neurovegetative areas. It provides both a total score as well as scores for a number of sub-scales. The frequency, severity and caregiver distress for each domain are measured. The NPI is based upon responses obtained from the caregiver. The total score is from 0 to 144. A higher score reflects more frequency and severity of the disturbances.|Scores on a scale|Mean|30.1|30.1|Standard Deviation|14.0|14.0|||
4149675|NCT00857649|3973400|B2|||NPI: Baseline Total Score|The Neuropsychiatric Inventory (NPI) is a validated scale that assesses behavioural disturbances in patients with dementia. The 12 item version consists of 10 behavioural and 2 neurovegetative areas. It provides both a total score as well as scores for a number of sub-scales. The frequency, severity and caregiver distress for each domain are measured. The NPI is based upon responses obtained from the caregiver. The total score is from 0 to 144. A higher score reflects more frequency and severity of the disturbances.|Scores on a scale|Mean|29.2|29.2|Standard Deviation|13.3|13.3|||
4149676|NCT00857649|3973401|B1|||NPI: Baseline Total Score|The Neuropsychiatric Inventory (NPI) is a validated scale that assesses behavioural disturbances in patients with dementia. The 12 item version consists of 10 behavioural and 2 neurovegetative areas. It provides both a total score as well as scores for a number of sub-scales. The frequency, severity and caregiver distress for each domain are measured. The NPI is based upon responses obtained from the caregiver. The total score is from 0 to 144. A higher score reflects more frequency and severity of the disturbances.|Scores on a scale|Mean|30.9|30.9|Standard Deviation|14.8|14.8|||
4149677|NCT00857649|3973399|B3||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4149678|NCT00857649|3973400|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4149679|NCT00857649|3973401|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4149680|NCT00857649|3973399|B3||Female|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
4149681|NCT00857649|3973400|B2||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4149682|NCT00857649|3973401|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4149683|NCT00857649|3973399|B3|||Age||years|Mean|74.9|74.9|Standard Deviation|7.4|7.4|||
4149684|NCT00857649|3973400|B2|||Age||years|Mean|75.1|75.1|Standard Deviation|6.9|6.9|||
4149685|NCT00857649|3973401|B1|||Age||years|Mean|74.7|74.7|Standard Deviation|7.9|7.9|||
4149686|NCT00857623|3973416|B3||Male|Sex: Female, Male|All randomized patients.|Participants|Count of Participants|70|70.0||||||
4149687|NCT00857623|3973417|B2||Male|Sex: Female, Male|All randomized patients.|Participants|Count of Participants|34|34.0||||||
4149688|NCT00857623|3973418|B1||Male|Sex: Female, Male|All randomized patients.|Participants|Count of Participants|36|36.0||||||
4149689|NCT00857623|3973416|B3||Female|Sex: Female, Male|All randomized patients.|Participants|Count of Participants|57|57.0||||||
4149690|NCT00857623|3973417|B2||Female|Sex: Female, Male|All randomized patients.|Participants|Count of Participants|31|31.0||||||
4149691|NCT00857623|3973418|B1||Female|Sex: Female, Male|All randomized patients.|Participants|Count of Participants|26|26.0||||||
4149692|NCT00857623|3973416|B3|||Age|All randomized patients.|years|Mean|58.1|58.1|Standard Deviation|8.95|8.95|||
4149693|NCT00857623|3973417|B2|||Age|All randomized patients.|years|Mean|57.0|57.0|Standard Deviation|8.7|8.7|||
4149694|NCT00857623|3973418|B1|||Age|All randomized patients.|years|Mean|59.2|59.2|Standard Deviation|9.2|9.2|||
4149695|NCT00857584|3973441|B3|||Hamilton Anxiety Rating Scale (HARS) total score, Continuous|HARS assesses severity of anxiety symptoms. It ranges from a minimum of 0 to a maximum of 56 (higher scores indicating a greater severity of anxiety symptoms)|score on a scale|Mean|20.04|20.04|Standard Deviation|7.38|7.38|13.02|26.4|
4149696|NCT00857584|3973442|B2|||Hamilton Anxiety Rating Scale (HARS) total score, Continuous|HARS assesses severity of anxiety symptoms. It ranges from a minimum of 0 to a maximum of 56 (higher scores indicating a greater severity of anxiety symptoms)|score on a scale|Mean|17.6|17.6|Standard Deviation|4.46|4.46|13.02|22.2|
4149697|NCT00857584|3973443|B1|||Hamilton Anxiety Rating Scale (HARS) total score, Continuous|HARS assesses severity of anxiety symptoms. It ranges from a minimum of 0 to a maximum of 56 (higher scores indicating a greater severity of anxiety symptoms)|score on a scale|Mean|22.4|22.4|Standard Deviation|4.03|4.03|18.5|26.4|
4149747|NCT00857545|3973485|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4149748|NCT00857545|3973486|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4149698|NCT00857584|3973441|B3|||Clinical Impression Global Scale - Bipolar total score (CGI-BP-M), Continuous|CGI-BP-M assesses severity of clinical status. It ranges from a minimum of 1 to a maximum of 7 (higher scores indicating a greater clinical severity)|score on a scale|Mean|5.2|5.2|Standard Deviation|0.8|0.8|4.7|5.9|
4149699|NCT00857584|3973442|B2|||Clinical Impression Global Scale - Bipolar total score (CGI-BP-M), Continuous|CGI-BP-M assesses severity of clinical status. It ranges from a minimum of 1 to a maximum of 7 (higher scores indicating a greater clinical severity)|score on a scale|Mean|5.3|5.3|Standard Deviation|0.8|0.8|4.8|5.9|
4149700|NCT00857584|3973443|B1|||Clinical Impression Global Scale - Bipolar total score (CGI-BP-M), Continuous|CGI-BP-M assesses severity of clinical status. It ranges from a minimum of 1 to a maximum of 7 (higher scores indicating a greater clinical severity)|score on a scale|Mean|5.1|5.1|Standard Deviation|0.7|0.7|4.7|5.6|
4149701|NCT00857584|3973441|B3|||Montgomery Asberg Depression Rating Scale (MADRS) total score, Continuous|MADRS assesses severity of depressive symptoms. It ranges from a minimum of 0 to a maximum of 60 (higher scores indicating a greater severity of depressive symptoms)|score on a scale|Mean|28.9|28.9|Standard Deviation|5.3|5.3|||
4149702|NCT00857584|3973442|B2|||Montgomery Asberg Depression Rating Scale (MADRS) total score, Continuous|MADRS assesses severity of depressive symptoms. It ranges from a minimum of 0 to a maximum of 60 (higher scores indicating a greater severity of depressive symptoms)|score on a scale|Mean|28.2|28.2|Standard Deviation|5.8|5.8|26.7|31.7|
4149703|NCT00857584|3973443|B1|||Montgomery Asberg Depression Rating Scale (MADRS) total score, Continuous|MADRS assesses severity of depressive symptoms. It ranges from a minimum of 0 to a maximum of 60 (higher scores indicating a greater severity of depressive symptoms)|score on a scale|Mean|29.5|29.5|Standard Deviation|5.0|5.0|26.6|32.4|
4149704|NCT00857584|3973441|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4149705|NCT00857584|3973442|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4149706|NCT00857584|3973443|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4149707|NCT00857584|3973441|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4149708|NCT00857584|3973442|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4149709|NCT00857584|3973443|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4149710|NCT00857584|3973441|B3|||Age||years|Mean|46.07|46.07|Standard Deviation|12.6|12.6|||
4149711|NCT00857584|3973442|B2|||Age||years|Mean|43.3|43.3|Standard Deviation|12.6|12.6|||
4149712|NCT00857584|3973443|B1|||Age||years|Mean|48.5|48.5|Standard Deviation|12.5|12.5|||
4149713|NCT00857545|3973484|B3||Undifferentiated Carcinoma|Cell Type||Participants|Count of Participants|2|2.0||||||
4149714|NCT00857545|3973485|B2||Undifferentiated Carcinoma|Cell Type||Participants|Count of Participants|1|1.0||||||
4149715|NCT00857545|3973486|B1||Undifferentiated Carcinoma|Cell Type||Participants|Count of Participants|1|1.0||||||
4149716|NCT00857545|3973484|B3||Transitional Cell Carcinoma|Cell Type||Participants|Count of Participants|2|2.0||||||
4149717|NCT00857545|3973485|B2||Transitional Cell Carcinoma|Cell Type||Participants|Count of Participants|2|2.0||||||
4149718|NCT00857545|3973486|B1||Transitional Cell Carcinoma|Cell Type||Participants|Count of Participants|0|0.0||||||
4149719|NCT00857545|3973484|B3||Serous Adenocarcinoma|Cell Type||Participants|Count of Participants|145|145.0||||||
4149720|NCT00857545|3973485|B2||Serous Adenocarcinoma|Cell Type||Participants|Count of Participants|76|76.0||||||
4149721|NCT00857545|3973486|B1||Serous Adenocarcinoma|Cell Type||Participants|Count of Participants|69|69.0||||||
4149722|NCT00857545|3973484|B3||Other Carcinoma|Cell Type||Participants|Count of Participants|2|2.0||||||
4149723|NCT00857545|3973485|B2||Other Carcinoma|Cell Type||Participants|Count of Participants|0|0.0||||||
4149724|NCT00857545|3973486|B1||Other Carcinoma|Cell Type||Participants|Count of Participants|2|2.0||||||
4149725|NCT00857545|3973484|B3||Mixed Epithelial Carcinoma|Cell Type||Participants|Count of Participants|4|4.0||||||
4149726|NCT00857545|3973485|B2||Mixed Epithelial Carcinoma|Cell Type||Participants|Count of Participants|2|2.0||||||
4149727|NCT00857545|3973486|B1||Mixed Epithelial Carcinoma|Cell Type||Participants|Count of Participants|2|2.0||||||
4149728|NCT00857545|3973484|B3||Endometrioid Adenocarcinoma|Cell Type||Participants|Count of Participants|7|7.0||||||
4149729|NCT00857545|3973485|B2||Endometrioid Adenocarcinoma|Cell Type||Participants|Count of Participants|1|1.0||||||
4149730|NCT00857545|3973486|B1||Endometrioid Adenocarcinoma|Cell Type||Participants|Count of Participants|6|6.0||||||
4149731|NCT00857545|3973484|B3||Clear Cell Carcinoma|Cell Type||Participants|Count of Participants|2|2.0||||||
4149732|NCT00857545|3973485|B2||Clear Cell Carcinoma|Cell Type||Participants|Count of Participants|1|1.0||||||
4149733|NCT00857545|3973486|B1||Clear Cell Carcinoma|Cell Type||Participants|Count of Participants|1|1.0||||||
4149734|NCT00857545|3973484|B3||Adenosquamous|Cell Type||Participants|Count of Participants|2|2.0||||||
4149735|NCT00857545|3973485|B2||Adenosquamous|Cell Type||Participants|Count of Participants|0|0.0||||||
4149736|NCT00857545|3973486|B1||Adenosquamous|Cell Type||Participants|Count of Participants|2|2.0||||||
4149737|NCT00857545|3973484|B3||Adenocarcinoma, Unsp.|Cell Type||Participants|Count of Participants|4|4.0||||||
4149738|NCT00857545|3973485|B2||Adenocarcinoma, Unsp.|Cell Type||Participants|Count of Participants|1|1.0||||||
4149739|NCT00857545|3973486|B1||Adenocarcinoma, Unsp.|Cell Type||Participants|Count of Participants|3|3.0||||||
4149740|NCT00857545|3973484|B3||Adenocarcinoma with Squam. Diff ' n|Cell Type||Participants|Count of Participants|1|1.0||||||
4149741|NCT00857545|3973485|B2||Adenocarcinoma with Squam. Diff ' n|Cell Type||Participants|Count of Participants|1|1.0||||||
4149742|NCT00857545|3973486|B1||Adenocarcinoma with Squam. Diff ' n|Cell Type||Participants|Count of Participants|0|0.0||||||
4149743|NCT00857545|3973484|B3|||Recurring and/or Persistent Disease|Recurrent/persistent patients|Participants|Count of Participants|171|171.0||||||
4149744|NCT00857545|3973485|B2|||Recurring and/or Persistent Disease|Recurrent/persistent patients|Participants|Count of Participants|85|85.0||||||
4149749|NCT00857545|3973484|B3||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4149750|NCT00857545|3973485|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4149751|NCT00857545|3973486|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4149752|NCT00857545|3973484|B3|80-89||Age, Customized||Participants|Count of Participants|2|2.0||||||
4149753|NCT00857545|3973485|B2|80-89||Age, Customized||Participants|Count of Participants|0|0.0||||||
4149754|NCT00857545|3973486|B1|80-89||Age, Customized||Participants|Count of Participants|2|2.0||||||
4149755|NCT00857545|3973484|B3|70-79||Age, Customized||Participants|Count of Participants|24|24.0||||||
4149756|NCT00857545|3973485|B2|70-79||Age, Customized||Participants|Count of Participants|14|14.0||||||
4149757|NCT00857545|3973486|B1|70-79||Age, Customized||Participants|Count of Participants|10|10.0||||||
4149758|NCT00857545|3973484|B3|60-69||Age, Customized||Participants|Count of Participants|63|63.0||||||
4149759|NCT00857545|3973485|B2|60-69||Age, Customized||Participants|Count of Participants|26|26.0||||||
4149760|NCT00857545|3973486|B1|60-69||Age, Customized||Participants|Count of Participants|37|37.0||||||
4149761|NCT00857545|3973484|B3|50-59||Age, Customized||Participants|Count of Participants|60|60.0||||||
4149762|NCT00857545|3973485|B2|50-59||Age, Customized||Participants|Count of Participants|31|31.0||||||
4149763|NCT00857545|3973486|B1|50-59||Age, Customized||Participants|Count of Participants|29|29.0||||||
4149764|NCT00857545|3973484|B3|40-49||Age, Customized||Participants|Count of Participants|22|22.0||||||
4149765|NCT00857545|3973485|B2|40-49||Age, Customized||Participants|Count of Participants|14|14.0||||||
4149766|NCT00857545|3973486|B1|40-49||Age, Customized||Participants|Count of Participants|8|8.0||||||
4149767|NCT00857545|3973484|B3|||Age||years|Mean|60.2|60.2|Standard Deviation|8.9|8.9|||
4149768|NCT00857545|3973485|B2|||Age||years|Mean|59.1|59.1|Standard Deviation|9.1|9.1|||
4149769|NCT00857545|3973486|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|8.6|8.6|||
4149770|NCT00857532|3973497|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4149771|NCT00857532|3973497|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4149772|NCT00857532|3973497|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4149773|NCT00857532|3973497|B1|||Age||years|Mean|71.3|71.3|Standard Deviation|6.72|6.72|||
4149774|NCT00857506|3973505|B4|United States||Region of Enrollment||participants|Number|152|152.0||||||
4149775|NCT00857506|3973506|B3|United States||Region of Enrollment||participants|Number|69|69.0||||||
4149776|NCT00857506|3973507|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
4149777|NCT00857506|3973508|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4149778|NCT00857506|3973505|B4||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4149779|NCT00857506|3973506|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4149780|NCT00857506|3973507|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4149781|NCT00857506|3973508|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4149782|NCT00857506|3973505|B4||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4149783|NCT00857506|3973506|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4149784|NCT00857506|3973507|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4149785|NCT00857506|3973508|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4149786|NCT00857506|3973505|B4|||Age||years|Mean|71.8|71.8|Standard Deviation|10.73|10.73|||
4149787|NCT00857506|3973506|B3|||Age||years|Mean|69.8|69.8|Standard Deviation|11.26|11.26|||
4149788|NCT00857506|3973507|B2|||Age||years|Mean|71.5|71.5|Standard Deviation|10.09|10.09|||
4149789|NCT00857506|3973508|B1|||Age||years|Mean|76.7|76.7|Standard Deviation|9.23|9.23|||
4149790|NCT00857454|3973536|B1|||Baseline Total Testosterone Level||nanograms per deciliter (ng/dL)|Mean|217.93|217.93|Standard Deviation|84.70|84.7|||
4149791|NCT00857454|3973536|B1|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square metter (kg/m^2)|Mean|29.78|29.78|Standard Deviation|3.61|3.61|||
4149792|NCT00857454|3973536|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
4149793|NCT00857454|3973536|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4149794|NCT00857454|3973536|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4149795|NCT00857454|3973536|B1|African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4149796|NCT00857454|3973536|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
4149797|NCT00857454|3973536|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4149798|NCT00857454|3973536|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4149799|NCT00857454|3973536|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|12.13|12.13|||
4149800|NCT00857415|3973547|B3|United States||Region of Enrollment||participants|Number|226|226.0||||||
4149801|NCT00857415|3973548|B2|United States||Region of Enrollment||participants|Number|74|74.0||||||
4149802|NCT00857415|3973549|B1|United States||Region of Enrollment||participants|Number|152|152.0||||||
4149803|NCT00857415|3973547|B3||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4149804|NCT00857415|3973548|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4149805|NCT00857415|3973549|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4149806|NCT00857415|3973547|B3||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4149807|NCT00857415|3973548|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4149808|NCT00857415|3973549|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4149809|NCT00857415|3973547|B3|||Age||years|Mean|61.3|61.3|Standard Deviation|26.84|26.84|||
4149810|NCT00857415|3973548|B2|||Age||years|Mean|26.6|26.6|Standard Deviation|6.50|6.5|||
4149811|NCT00857415|3973549|B1|||Age||years|Mean|78.1|78.1|Standard Deviation|13.35|13.35|||
4149812|NCT00857311|3973557|B5|United States||Region of Enrollment||participants|Number|17|17.0||||||
4149813|NCT00857311|3973559|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4149814|NCT00857311|3973561|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4149815|NCT00857311|3973557|B5|Male||Gender||participants|Number|8|8.0||||||
4149816|NCT00857311|3973559|B3|Male||Gender||participants|Number|4|4.0||||||
4149817|NCT00857311|3973561|B1|Male||Gender||participants|Number|4|4.0||||||
4149818|NCT00857311|3973557|B5|Female||Gender||participants|Number|9|9.0||||||
4149819|NCT00857311|3973559|B3|Female||Gender||participants|Number|4|4.0||||||
4149820|NCT00857311|3973561|B1|Female||Gender||participants|Number|5|5.0||||||
4149821|NCT00857311|3973557|B5|||Age, Customized||years|Mean|40.4|40.4|Full Range|||22.0|54.0|
4149822|NCT00857311|3973559|B3|||Age, Customized||years|Mean|39.3|39.3|Full Range|||22.0|49.0|
4149823|NCT00857311|3973561|B1|||Age, Customized||years|Mean|41.4|41.4|Full Range|||33.0|54.0|
4149824|NCT00857285|3973574|B3|Taiwan||Region of Enrollment||participants|Number|130|130.0||||||
4149825|NCT00857285|3973575|B2|Taiwan||Region of Enrollment||participants|Number|65|65.0||||||
4149826|NCT00857285|3973576|B1|Taiwan||Region of Enrollment||participants|Number|65|65.0||||||
4149827|NCT00857285|3973574|B3|Taiwanese||Race/Ethnicity, Customized||participants|Number|130|130.0||||||
4149828|NCT00857285|3973575|B2|Taiwanese||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
4149829|NCT00857285|3973576|B1|Taiwanese||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
4149830|NCT00857285|3973574|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4149831|NCT00857285|3973575|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4149832|NCT00857285|3973576|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4149833|NCT00857285|3973574|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4149834|NCT00857285|3973575|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4149835|NCT00857285|3973576|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4149836|NCT00857285|3973574|B3|||Age||years|Mean|48.98|48.98|Standard Deviation|9.94|9.94|||
4149837|NCT00857285|3973575|B2|||Age||years|Mean|48.34|48.34|Standard Deviation|9.17|9.17|||
4149838|NCT00857285|3973576|B1|||Age||years|Mean|49.63|49.63|Standard Deviation|10.69|10.69|||
4149839|NCT00857272|3973581|B3|United States||Region of Enrollment||participants|Number|308|308.0||||||
4149840|NCT00857272|3973582|B2|United States||Region of Enrollment||participants|Number|154|154.0||||||
4149841|NCT00857272|3973583|B1|United States||Region of Enrollment||participants|Number|154|154.0||||||
4149842|NCT00857272|3973581|B3||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4149843|NCT00857272|3973582|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4149844|NCT00857272|3973583|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4149845|NCT00857272|3973581|B3||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4149846|NCT00857272|3973582|B2||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4149847|NCT00857272|3973583|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4149848|NCT00857272|3973581|B3|||Age||years|Mean|55.9|55.9|Standard Deviation|12.6|12.6|||
4149849|NCT00857272|3973582|B2|||Age||years|Mean|55.0|55.0|Standard Deviation|13.0|13.0|||
4149850|NCT00857272|3973583|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|12.1|12.1|||
4149851|NCT00857272|3973581|B3||>=65 years|Age||Participants|Count of Participants|82|82.0||||||
4149852|NCT00857272|3973582|B2||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4149853|NCT00857272|3973583|B1||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
4149854|NCT00857272|3973581|B3||Between 18 and 65 years|Age||Participants|Count of Participants|226|226.0||||||
4149855|NCT00857272|3973582|B2||Between 18 and 65 years|Age||Participants|Count of Participants|116|116.0||||||
4149856|NCT00857272|3973583|B1||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
4149857|NCT00857272|3973581|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4149858|NCT00857272|3973582|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4149859|NCT00857272|3973583|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4149860|NCT00857259|3973590|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4149861|NCT00857259|3973591|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4149862|NCT00857259|3973592|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4149863|NCT00857259|3973593|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4149864|NCT00857259|3973590|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4149865|NCT00857259|3973591|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4149866|NCT00857259|3973592|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4149867|NCT00857259|3973593|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4149868|NCT00857259|3973590|B4|||Age||years|Mean|76.6|76.6|Standard Deviation|9.49|9.49|||
4149869|NCT00857259|3973591|B3|||Age||years|Mean|78.1|78.1|Standard Deviation|14.23|14.23|||
4149870|NCT00857259|3973592|B2|||Age||years|Mean|71.00|71.0|Standard Deviation|||||
4149871|NCT00857259|3973593|B1|||Age||years|Mean|75.9|75.9|Standard Deviation|3.44|3.44|||
4149872|NCT00857246|3973605|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4149873|NCT00857246|3973605|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4149874|NCT00857246|3973605|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149875|NCT00857246|3973605|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4149876|NCT00857246|3973605|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4149877|NCT00857246|3973605|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149878|NCT00857246|3973605|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4149879|NCT00857246|3973605|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149880|NCT00857246|3973605|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4149881|NCT00857246|3973605|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4149882|NCT00857246|3973605|B1|74-83 years||Age, Customized||participants|Number|5|5.0||||||
4149883|NCT00857246|3973605|B1|64-73 years||Age, Customized||participants|Number|3|3.0||||||
4149884|NCT00857246|3973605|B1|54-63 years||Age, Customized||participants|Number|12|12.0||||||
4149885|NCT00857246|3973605|B1|45-53 years||Age, Customized||participants|Number|8|8.0||||||
4149886|NCT00857246|3973605|B1|35-44 years||Age, Customized||participants|Number|1|1.0||||||
4149887|NCT00857246|3973605|B1|25-34 years||Age, Customized||participants|Number|1|1.0||||||
4149888|NCT00857233|3973615|B1|||ADCS-ADL - 19 items: Baseline Total Score|The Alzheimer's Disease Cooperative Study - Activities of Daily Living Inventory (ADCS-ADL) 19-item version total score for moderate to severe AD will measure patient's functioning. This battery of ADL questions is used here to measure the functional capabilities of patients with dementia. The inventory is done by interviewing a person in close contact with the patient and covers the most usual and consistent performance of the patient over the preceding 4 weeks. Total score is from 0 to 54. The higher score, the lower impairment.|Scores on a scale|Mean|33.43|33.43|Standard Deviation|10.06|10.06|||
4149889|NCT00857233|3973615|B1|||CIBIC-plus: Baseline Severity Score|"Clinician's Interview-Based Impression of Change-Plus Version (CIBIC-plus) is a global rating that is derived through an independent, comprehensive interview with the patient and caregiver by a rater who is barred from knowledge of all other psychometric test scores conducted as part of this protocol as well as from reported safety data. The rating is made on a 7-point scale ranging from 1 = marked improvement to 7 = marked worsening. A score of 4 indicates no change."|Scores on a scale|Mean|4.52|4.52|Standard Deviation|0.85|0.85|||
4149890|NCT00857233|3973615|B1|||SIB: Baseline Total Score|The Severe Impairment Battery (SIB) is a validated scale used to assess cognitive function in patients with moderate to severe dementia. Items are single words or one-step commands combined with gestures. Nine domains are assessed, and the total score is between 0 and 100. A lower total score reflects the loss of cognitive function.|Scores on a Scale|Mean|79.99|79.99|Standard Deviation|16.36|16.36|||
4149891|NCT00857233|3973615|B1|||NPI: Baseline Total Score|The Neuropsychiatric Inventory (NPI) is a validated scale that assesses behavioural disturbances in patients with dementia. The 12 item version consists of 10 behavioural and 2 neurovegetative areas. It provides both a total score as well as scores for a number of sub-scales. The frequency, severity and caregiver distress for each domain are measured. The NPI is based upon responses obtained from the caregiver. The total score is from 0 to 144. A higher score reflects more frequency and severity of the disturbances.|Scores on a scale|Mean|22.32|22.32|Standard Deviation|15.41|15.41|||
4149892|NCT00857233|3973615|B1||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4149893|NCT00857233|3973615|B1||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4149894|NCT00857233|3973615|B1|||Age||years|Mean|75|75.0|Standard Deviation|7.3|7.3|||
4149895|NCT00857220|3973624|B1|United States||Region of Enrollment||participants|Number|303|303.0||||||
4149896|NCT00857220|3973624|B1||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4149897|NCT00857220|3973624|B1||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4149898|NCT00857220|3973624|B1|||Age||years|Mean|11.2|11.2|Standard Deviation|3.2|3.2|||
4149899|NCT00857220|3973624|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4149900|NCT00857220|3973624|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4149901|NCT00857220|3973624|B1||<=18 years|Age||Participants|Count of Participants|303|303.0||||||
4149902|NCT00856986|3973641|B6|||Fasting plasma glucose (FPG)|At Week -12|mmol/L|Mean|9.6|9.6|Standard Deviation|2.1|2.1|||
4149903|NCT00856986|3973642|B5|||Fasting plasma glucose (FPG)|At Week -12|mmol/L|Mean|10.4|10.4|Standard Deviation|2.3|2.3|||
4149904|NCT00856986|3973643|B4|||Fasting plasma glucose (FPG)|At Week -12|mmol/L|Mean|9.5|9.5|Standard Deviation|3|3.0|||
4149905|NCT00856986|3973644|B3|||Fasting plasma glucose (FPG)|At Week -12|mmol/L|Mean|9.2|9.2|Standard Deviation|1.8|1.8|||
4149906|NCT00856986|3973645|B2|||Fasting plasma glucose (FPG)|At Week -12|mmol/L|Mean|10.2|10.2|Standard Deviation|2.4|2.4|||
4149907|NCT00856986|3973646|B1|||Fasting plasma glucose (FPG)|At Week -12|mmol/L|Mean|10.3|10.3|Standard Deviation|2.5|2.5|||
4149908|NCT00856986|3973641|B6|||Glycosylated haemoglobin (HbA1c)|At Week -12|Percentage point of total HbA1c|Mean|7.9|7.9|Standard Deviation|0.8|0.8|||
4149909|NCT00856986|3973642|B5|||Glycosylated haemoglobin (HbA1c)|At Week -12|Percentage point of total HbA1c|Mean|8.4|8.4|Standard Deviation|0.7|0.7|||
4149910|NCT00856986|3973643|B4|||Glycosylated haemoglobin (HbA1c)|At Week -12|Percentage point of total HbA1c|Mean|8|8.0|Standard Deviation|0.8|0.8|||
4149911|NCT00856986|3973644|B3|||Glycosylated haemoglobin (HbA1c)|At Week -12|Percentage point of total HbA1c|Mean|7.7|7.7|Standard Deviation|0.7|0.7|||
4149912|NCT00856986|3973645|B2|||Glycosylated haemoglobin (HbA1c)|At Week -12|Percentage point of total HbA1c|Mean|8.2|8.2|Standard Deviation|0.7|0.7|||
4149913|NCT00856986|3973646|B1|||Glycosylated haemoglobin (HbA1c)|At Week -12|Percentage point of total HbA1c|Mean|8.3|8.3|Standard Deviation|0.8|0.8|||
4149914|NCT00856986|3973641|B6|||Diabetes History||years|Mean|7.4|7.4|Standard Deviation|5.8|5.8|||
4149915|NCT00856986|3973642|B5|||Diabetes History||years|Mean|6.8|6.8|Standard Deviation|5.4|5.4|||
4149916|NCT00856986|3973643|B4|||Diabetes History||years|Mean|8.4|8.4|Standard Deviation|6.4|6.4|||
4149917|NCT00856986|3973644|B3|||Diabetes History||years|Mean|6.6|6.6|Standard Deviation|5.7|5.7|||
4149918|NCT00856986|3973645|B2|||Diabetes History||years|Mean|8.6|8.6|Standard Deviation|5.8|5.8|||
4149919|NCT00856986|3973646|B1|||Diabetes History||years|Mean|8.5|8.5|Standard Deviation|6|6.0|||
4149920|NCT00856986|3973641|B6|||Body Mass Index (BMI)|At Week -12|kg/m^2|Mean|34.4|34.4|Standard Deviation|6.5|6.5|||
4149921|NCT00856986|3973642|B5|||Body Mass Index (BMI)|At Week -12|kg/m^2|Mean|36.5|36.5|Standard Deviation|7.7|7.7|||
4149922|NCT00856986|3973643|B4|||Body Mass Index (BMI)|At Week -12|kg/m^2|Mean|31.8|31.8|Standard Deviation|6|6.0|||
4149923|NCT00856986|3973644|B3|||Body Mass Index (BMI)|At Week -12|kg/m^2|Mean|34.4|34.4|Standard Deviation|6.7|6.7|||
4149924|NCT00856986|3973645|B2|||Body Mass Index (BMI)|At Week -12|kg/m^2|Mean|34.9|34.9|Standard Deviation|6.3|6.3|||
4149925|NCT00856986|3973646|B1|||Body Mass Index (BMI)|At Week -12|kg/m^2|Mean|33.9|33.9|Standard Deviation|6|6.0|||
4149926|NCT00856986|3973641|B6|||Body weight|At Week -12|kg|Mean|99|99.0|Standard Deviation|21|21.0|||
4149927|NCT00856986|3973642|B5|||Body weight|At Week -12|kg|Mean|109|109.0|Standard Deviation|25.7|25.7|||
4149928|NCT00856986|3973643|B4|||Body weight|At Week -12|kg|Mean|90.2|90.2|Standard Deviation|18.5|18.5|||
4149929|NCT00856986|3973644|B3|||Body weight|At Week -12|kg|Mean|99|99.0|Standard Deviation|20.8|20.8|||
4149930|NCT00856986|3973645|B2|||Body weight|At Week -12|kg|Mean|99.5|99.5|Standard Deviation|21.2|21.2|||
4149931|NCT00856986|3973646|B1|||Body weight|At Week -12|kg|Mean|98.6|98.6|Standard Deviation|21.3|21.3|||
4149932|NCT00856986|3973641|B6|||Height||meter|Mean|1.69|1.69|Standard Deviation|0.1|0.1|||
4149933|NCT00856986|3973642|B5|||Height||meter|Mean|1.72|1.72|Standard Deviation|0.09|0.09|||
4149934|NCT00856986|3973643|B4|||Height||meter|Mean|1.68|1.68|Standard Deviation|0.1|0.1|||
4149935|NCT00856986|3973644|B3|||Height||meter|Mean|1.7|1.7|Standard Deviation|0.1|0.1|||
4149936|NCT00856986|3973645|B2|||Height||meter|Mean|1.69|1.69|Standard Deviation|0.11|0.11|||
4149937|NCT00856986|3973646|B1|||Height||meter|Mean|1.7|1.7|Standard Deviation|0.1|0.1|||
4149938|NCT00856986|3973641|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4149939|NCT00856986|3973642|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4149940|NCT00856986|3973643|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4149941|NCT00856986|3973644|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4149942|NCT00856986|3973645|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4149943|NCT00856986|3973646|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4149944|NCT00856986|3973641|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149945|NCT00856986|3973642|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149946|NCT00856986|3973643|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149947|NCT00856986|3973644|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149948|NCT00856986|3973645|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149949|NCT00856986|3973646|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149950|NCT00856986|3973641|B6||White|Race (NIH/OMB)||Participants|Count of Participants|923|923.0||||||
4149951|NCT00856986|3973642|B5||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4149952|NCT00856986|3973643|B4||White|Race (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
4149953|NCT00856986|3973644|B3||White|Race (NIH/OMB)||Participants|Count of Participants|470|470.0||||||
4149954|NCT00856986|3973645|B2||White|Race (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
4149955|NCT00856986|3973646|B1||White|Race (NIH/OMB)||Participants|Count of Participants|141|141.0||||||
4149956|NCT00856986|3973641|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4149957|NCT00856986|3973642|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4149958|NCT00856986|3973643|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4149959|NCT00856986|3973644|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4149960|NCT00856986|3973645|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4149961|NCT00856986|3973646|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4149962|NCT00856986|3973641|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4149963|NCT00856986|3973642|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149964|NCT00856986|3973643|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149965|NCT00856986|3973644|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149966|NCT00856986|3973645|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4149967|NCT00856986|3973646|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149968|NCT00856986|3973641|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4149969|NCT00856986|3973642|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149970|NCT00856986|3973643|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4149971|NCT00856986|3973644|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4149972|NCT00856986|3973645|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4149973|NCT00856986|3973646|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4149974|NCT00856986|3973641|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4149975|NCT00856986|3973642|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149976|NCT00856986|3973643|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149977|NCT00856986|3973644|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149978|NCT00856986|3973645|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4149979|NCT00856986|3973646|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149980|NCT00856986|3973641|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149981|NCT00856986|3973642|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149982|NCT00856986|3973643|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149983|NCT00856986|3973644|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149984|NCT00856986|3973645|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149985|NCT00856986|3973646|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4149986|NCT00856986|3973641|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|883|883.0||||||
4149987|NCT00856986|3973642|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4149988|NCT00856986|3973643|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
4149989|NCT00856986|3973644|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|450|450.0||||||
4149990|NCT00856986|3973645|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
4149991|NCT00856986|3973646|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|136|136.0||||||
4149992|NCT00856986|3973641|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
4149993|NCT00856986|3973642|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4149994|NCT00856986|3973643|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4149995|NCT00856986|3973644|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4149996|NCT00856986|3973645|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4149997|NCT00856986|3973646|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4149998|NCT00856986|3973641|B6||Male|Sex: Female, Male||Participants|Count of Participants|563|563.0||||||
4149999|NCT00856986|3973642|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4150000|NCT00856986|3973643|B4||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4150001|NCT00856986|3973644|B3||Male|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
4150002|NCT00856986|3973645|B2||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4150003|NCT00856986|3973646|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4150004|NCT00856986|3973641|B6||Female|Sex: Female, Male||Participants|Count of Participants|448|448.0||||||
4150005|NCT00856986|3973642|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4150006|NCT00856986|3973643|B4||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4150007|NCT00856986|3973644|B3||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4150008|NCT00856986|3973645|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4150009|NCT00856986|3973646|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4150010|NCT00856986|3973641|B6|||Age||years|Mean|56.9|56.9|Standard Deviation|9.7|9.7|||
4150011|NCT00856986|3973642|B5|||Age||years|Mean|54.3|54.3|Standard Deviation|10.3|10.3|||
4150012|NCT00856986|3973643|B4|||Age||years|Mean|58.7|58.7|Standard Deviation|10.8|10.8|||
4150013|NCT00856986|3973644|B3|||Age||years|Mean|56.7|56.7|Standard Deviation|9.7|9.7|||
4150014|NCT00856986|3973645|B2|||Age||years|Mean|57|57.0|Standard Deviation|9.5|9.5|||
4150015|NCT00856986|3973646|B1|||Age||years|Mean|57.5|57.5|Standard Deviation|9.8|9.8|||
4150016|NCT00856973|3973817|B4|United States||Region of Enrollment||participants|Number|483|483.0||||||
4150017|NCT00856973|3973818|B3|United States||Region of Enrollment||participants|Number|160|160.0||||||
4150018|NCT00856973|3973819|B2|United States||Region of Enrollment||participants|Number|163|163.0||||||
4150019|NCT00856973|3973820|B1|United States||Region of Enrollment||participants|Number|160|160.0||||||
4150020|NCT00856973|3973817|B4||Male|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
4150021|NCT00856973|3973818|B3||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4150022|NCT00856973|3973819|B2||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4150023|NCT00856973|3973820|B1||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4150024|NCT00856973|3973817|B4||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4150025|NCT00856973|3973818|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4150026|NCT00856973|3973819|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4150027|NCT00856973|3973820|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4150028|NCT00856973|3973817|B4|||Age||years|Mean|11.5|11.5|Standard Deviation|3.0|3.0|||
4150029|NCT00856973|3973818|B3|||Age||years|Mean|11.6|11.6|Standard Deviation|3.0|3.0|||
4150030|NCT00856973|3973819|B2|||Age||years|Mean|11.4|11.4|Standard Deviation|3.0|3.0|||
4150031|NCT00856973|3973820|B1|||Age||years|Mean|11.3|11.3|Standard Deviation|3.0|3.0|||
4150032|NCT00856973|3973817|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4150033|NCT00856973|3973818|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4150034|NCT00856973|3973819|B2||>=65 years|Age||Participants|Count of Participants|00|0.0||||||
4150035|NCT00856973|3973820|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4150036|NCT00856973|3973817|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4150037|NCT00856973|3973818|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4150038|NCT00856973|3973819|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4150039|NCT00856973|3973820|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4150040|NCT00856973|3973817|B4||<=18 years|Age||Participants|Count of Participants|483|483.0||||||
4150041|NCT00856973|3973818|B3||<=18 years|Age||Participants|Count of Participants|160|160.0||||||
4150042|NCT00856973|3973819|B2||<=18 years|Age||Participants|Count of Participants|163|163.0||||||
4150043|NCT00856973|3973820|B1||<=18 years|Age||Participants|Count of Participants|160|160.0||||||
4150044|NCT00856934|3973887|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4150045|NCT00856934|3973888|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4150046|NCT00856934|3973889|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4150047|NCT00856934|3973890|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4150048|NCT00856934|3973887|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4150049|NCT00856934|3973888|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4150050|NCT00856934|3973889|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4150051|NCT00856934|3973890|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4150052|NCT00856934|3973887|B4|||Age||years|Mean|44.7|44.7|Standard Deviation|16.2|16.2|||
4150053|NCT00856934|3973888|B3|||Age||years|Mean|46.9|46.9|Standard Deviation|20.5|20.5|||
4150054|NCT00856934|3973889|B2|||Age||years|Mean|45.5|45.5|Standard Deviation|15.3|15.3|||
4150055|NCT00856934|3973890|B1|||Age||years|Mean|42.5|42.5|Standard Deviation|11.9|11.9|||
4150056|NCT00856934|3973887|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4150057|NCT00856934|3973888|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4150058|NCT00856934|3973889|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4150059|NCT00856934|3973890|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4150060|NCT00856934|3973887|B4||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4150061|NCT00856934|3973888|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4150062|NCT00856934|3973889|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4150063|NCT00856934|3973890|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4150064|NCT00856934|3973887|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4150065|NCT00856934|3973888|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4150066|NCT00856934|3973889|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4150067|NCT00856934|3973890|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4150068|NCT00856908|3973900|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4150069|NCT00856908|3973901|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4150070|NCT00856908|3973902|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4150071|NCT00856908|3973900|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4150072|NCT00856908|3973901|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4150073|NCT00856908|3973902|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4150074|NCT00856908|3973900|B3|||Age||years|Mean|53.8|53.8|Full Range|||40.0|69.0|
4150075|NCT00856908|3973901|B2|||Age||years|Mean|57.2|57.2|Full Range|||41.0|69.0|
4150076|NCT00856908|3973902|B1|||Age||years|Mean|52.6|52.6|Full Range|||40.0|65.0|
4150077|NCT00856843|3973928|B3|United States||Region of Enrollment||participants|Number|136|136.0||||||
4150078|NCT00856843|3973929|B2|United States||Region of Enrollment||participants|Number|68|68.0||||||
4150079|NCT00856843|3973930|B1|United States||Region of Enrollment||participants|Number|68|68.0||||||
4150080|NCT00856843|3973928|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4150081|NCT00856843|3973929|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4150082|NCT00856843|3973930|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4150083|NCT00856843|3973928|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4150084|NCT00856843|3973929|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4150085|NCT00856843|3973930|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4150086|NCT00856843|3973928|B3|||Age||years|Mean|57.2|57.2|Standard Deviation|10.8|10.8|||
4150087|NCT00856843|3973929|B2|||Age||years|Mean|57.7|57.7|Standard Deviation|10.8|10.8|||
4150088|NCT00856843|3973930|B1|||Age||years|Mean|56.7|56.7|Standard Deviation|11.0|11.0|||
4150089|NCT00856843|3973928|B3||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
4150090|NCT00856843|3973929|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4150091|NCT00856843|3973930|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4150092|NCT00856843|3973928|B3||Between 18 and 65 years|Age||Participants|Count of Participants|103|103.0||||||
4150093|NCT00856843|3973929|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4150094|NCT00856843|3973930|B1||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4150095|NCT00856843|3973928|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4150096|NCT00856843|3973929|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4150097|NCT00856843|3973930|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4150098|NCT00856830|3973963|B5|United States||Region of Enrollment||participants|Number|30|30.0||||||
4150099|NCT00856830|3973964|B4|United States||Region of Enrollment||participants|Number|15|15.0||||||
4150100|NCT00856830|3973965|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4150101|NCT00856830|3973966|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4150102|NCT00856830|3973967|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4150103|NCT00856830|3973963|B5||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4150104|NCT00856830|3973964|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4150105|NCT00856830|3973965|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4150106|NCT00856830|3973966|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4150107|NCT00856830|3973967|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4150108|NCT00856830|3973963|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4150109|NCT00856830|3973964|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4150110|NCT00856830|3973965|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4150111|NCT00856830|3973966|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4150112|NCT00856830|3973967|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4150113|NCT00856830|3973963|B5||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4150114|NCT00856830|3973964|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4150115|NCT00856830|3973965|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4150116|NCT00856830|3973966|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4150117|NCT00856830|3973967|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4150118|NCT00856830|3973963|B5||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4150119|NCT00856830|3973964|B4||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4150120|NCT00856830|3973965|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4150121|NCT00856830|3973966|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4150122|NCT00856830|3973967|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4150123|NCT00856830|3973963|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4150124|NCT00856830|3973964|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4150125|NCT00856830|3973965|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4150126|NCT00856830|3973966|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4150127|NCT00856830|3973967|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4150128|NCT00856791|3973976|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4150129|NCT00856791|3973976|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4150130|NCT00856791|3973976|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4150131|NCT00856791|3973976|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4150132|NCT00856791|3973976|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4150133|NCT00856791|3973976|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4150134|NCT00856778|3973981|B1|Canada||Region of Enrollment||participants|Number|36|36.0||||||
4150135|NCT00856778|3973981|B1|United States||Region of Enrollment||participants|Number|62|62.0||||||
4150136|NCT00856778|3973981|B1||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4150137|NCT00856778|3973981|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4150138|NCT00856778|3973981|B1|||Age||years|Mean|67.0|67.0|Standard Deviation|8.5|8.5|||
4150139|NCT00856778|3973981|B1||>=65 years|Age||Participants|Count of Participants|54|54.0||||||
4150140|NCT00856778|3973981|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4150141|NCT00856778|3973981|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4150142|NCT00856739|3973997|B4||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4150143|NCT00856739|3973998|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4150144|NCT00856739|3973999|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4150145|NCT00856739|3974000|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4150146|NCT00856739|3973997|B4||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4150147|NCT00856739|3973998|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4150148|NCT00856739|3973999|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4150149|NCT00856739|3974000|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4150150|NCT00856739|3973997|B4|||Age||years|Mean|39.89|39.89|Standard Deviation|12.06|12.06|||
4150151|NCT00856739|3973998|B3|||Age||years|Mean|39.8|39.8|Standard Deviation|11.27|11.27|||
4150152|NCT00856739|3973999|B2|||Age||years|Mean|40.91|40.91|Standard Deviation|13.08|13.08|||
4150153|NCT00856739|3974000|B1|||Age||years|Mean|39.2|39.2|Standard Deviation|11.99|11.99|||
4150154|NCT00856726|3974013|B1|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
4150155|NCT00856726|3974013|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150156|NCT00856726|3974013|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150157|NCT00856726|3974013|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4150158|NCT00856726|3974013|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4150159|NCT00856726|3974013|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150160|NCT00856726|3974013|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150161|NCT00856726|3974013|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150162|NCT00856726|3974013|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150163|NCT00856726|3974013|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4150164|NCT00856726|3974013|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4150165|NCT00856726|3974013|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4150166|NCT00856726|3974013|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4150167|NCT00856726|3974013|B1|||Age||years|Mean|36|36.0|Standard Deviation|11|11.0|||
4150168|NCT00856726|3974013|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4150169|NCT00856726|3974013|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4150170|NCT00856726|3974013|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4150171|NCT00856661|3974022|B3|Other||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4150172|NCT00856661|3974023|B2|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4150173|NCT00856661|3974024|B1|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4150174|NCT00856661|3974022|B3|Asian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4150175|NCT00856661|3974023|B2|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4150176|NCT00856661|3974024|B1|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4150177|NCT00856661|3974022|B3|Black or african americal||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4150178|NCT00856661|3974023|B2|Black or african americal||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4150179|NCT00856661|3974024|B1|Black or african americal||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4150180|NCT00856661|3974022|B3|White||Race/Ethnicity, Customized||participants|Number|226|226.0||||||
4150181|NCT00856661|3974023|B2|White||Race/Ethnicity, Customized||participants|Number|115|115.0||||||
4150182|NCT00856661|3974024|B1|White||Race/Ethnicity, Customized||participants|Number|111|111.0||||||
4150183|NCT00856661|3974022|B3||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4150184|NCT00856661|3974023|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4150185|NCT00856661|3974024|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4150186|NCT00856661|3974022|B3||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4150187|NCT00856661|3974023|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4150188|NCT00856661|3974024|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4150189|NCT00856661|3974022|B3|||Age||years|Mean|68.6|68.6|Standard Deviation|11.8|11.8|||
4150190|NCT00856661|3974023|B2|||Age||years|Mean|68.2|68.2|Standard Deviation|12.5|12.5|||
4150191|NCT00856661|3974024|B1|||Age||years|Mean|69.1|69.1|Standard Deviation|11.1|11.1|||
4150192|NCT00856635|3974037|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4150193|NCT00856635|3974038|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4150194|NCT00856635|3974039|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4150195|NCT00856635|3974037|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4150196|NCT00856635|3974038|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4150197|NCT00856635|3974039|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4150198|NCT00856635|3974037|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4150199|NCT00856635|3974038|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4150200|NCT00856635|3974039|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4150201|NCT00856635|3974037|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4150202|NCT00856635|3974038|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4150203|NCT00856635|3974039|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4150204|NCT00856635|3974037|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4150205|NCT00856635|3974038|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4150206|NCT00856635|3974039|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4150207|NCT00856635|3974037|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4150208|NCT00856635|3974038|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4150209|NCT00856635|3974039|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4150210|NCT00856635|3974037|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4150211|NCT00856635|3974038|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4150212|NCT00856635|3974039|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4150213|NCT00856635|3974037|B3|||Age||years|Mean|33.0|33.0|Standard Deviation|6.9|6.9|||
4150214|NCT00856635|3974038|B2|||Age||years|Mean|34.4|34.4|Standard Deviation|6.5|6.5|||
4150215|NCT00856635|3974039|B1|||Age||years|Mean|31.7|31.7|Standard Deviation|7.1|7.1|||
4150216|NCT00856609|3974048|B3|||Spontaneous physical activity||kcal/day|Mean|80.0|80.0|Standard Deviation|45.1|45.1|||
4150217|NCT00856609|3974049|B2|||Spontaneous physical activity||kcal/day|Mean|79.4|79.4|Standard Deviation|43.4|43.4|||
4150218|NCT00856609|3974050|B1|||Spontaneous physical activity||kcal/day|Mean|80.4|80.4|Standard Deviation|47.1|47.1|||
4150219|NCT00856609|3974048|B3|||Awake fed thermogenesis||kcal/day|Mean|648.7|648.7|Standard Deviation|203.2|203.2|||
4150220|NCT00856609|3974049|B2|||Awake fed thermogenesis||kcal/day|Mean|671.0|671.0|Standard Deviation|232.0|232.0|||
4150221|NCT00856609|3974050|B1|||Awake fed thermogenesis||kcal/day|Mean|629.9|629.9|Standard Deviation|176.3|176.3|||
4150222|NCT00856609|3974048|B3|||Sleeping metabolic rate||kcal/day|Mean|1810.1|1810.1|Standard Deviation|279.7|279.7|||
4150223|NCT00856609|3974049|B2|||Sleeping metabolic rate||kcal/day|Mean|1800.6|1800.6|Standard Deviation|286.5|286.5|||
4150224|NCT00856609|3974050|B1|||Sleeping metabolic rate||kcal/day|Mean|1818.1|1818.1|Standard Deviation|277.5|277.5|||
4150225|NCT00856609|3974048|B3|||Lipid Oxidation||kcal/day|Mean|823.3|823.3|Standard Deviation|353.1|353.1|||
4150226|NCT00856609|3974049|B2|||Lipid Oxidation||kcal/day|Mean|873.5|873.5|Standard Deviation|377.6|377.6|||
4150227|NCT00856609|3974050|B1|||Lipid Oxidation||kcal/day|Mean|781.0|781.0|Standard Deviation|330.2|330.2|||
4150228|NCT00856609|3974048|B3|||Carbohydrate oxidation||kcal/day|Mean|1097.0|1097.0|Standard Deviation|338.3|338.3|||
4150229|NCT00856609|3974049|B2|||Carbohydrate oxidation||kcal/day|Mean|1068.4|1068.4|Standard Deviation|322.5|322.5|||
4150230|NCT00856609|3974050|B1|||Carbohydrate oxidation||kcal/day|Mean|1121.1|1121.1|Standard Deviation|353.5|353.5|||
4150231|NCT00856609|3974048|B3|||Respiratory quotient||ratio|Mean|0.86|0.86|Standard Deviation|0.03|0.03|||
4150232|NCT00856609|3974049|B2|||Respiratory quotient||ratio|Mean|0.85|0.85|Standard Deviation|0.03|0.03|||
4150233|NCT00856609|3974050|B1|||Respiratory quotient||ratio|Mean|0.86|0.86|Standard Deviation|0.03|0.03|||
4150234|NCT00856609|3974048|B3|||24 hour energy expenditure||kcal/day|Mean|2325.9|2325.9|Standard Deviation|385.3|385.3|||
4150235|NCT00856609|3974049|B2|||24 hour energy expenditure||kcal/day|Mean|2333.8|2333.8|Standard Deviation|422.0|422.0|||
4150236|NCT00856609|3974050|B1|||24 hour energy expenditure||kcal/day|Mean|2319.3|2319.3|Standard Deviation|377.0|377.0|||
4150237|NCT00856609|3974048|B3|||Soda intake||kcal/day|Mean|195.0|195.0|Standard Deviation|159.5|159.5|||
4150238|NCT00856609|3974049|B2|||Soda intake||kcal/day|Mean|183.3|183.3|Standard Deviation|169.1|169.1|||
4150239|NCT00856609|3974050|B1|||Soda intake||kcal/day|Mean|206.5|206.5|Standard Deviation|191.3|191.3|||
4150240|NCT00856609|3974048|B3|||Protein intake||kcal/day|Mean|415.6|415.6|Standard Deviation|150.1|150.1|||
4150241|NCT00856609|3974049|B2|||Protein intake||kcal/day|Mean|396.9|396.9|Standard Deviation|139.6|139.6|||
4150242|NCT00856609|3974050|B1|||Protein intake||kcal/day|Mean|434.2|434.2|Standard Deviation|159.5|159.5|||
4150243|NCT00856609|3974048|B3|||Fat intake||kcal/day|Mean|1218.1|1218.1|Standard Deviation|491.2|491.2|||
4150244|NCT00856609|3974049|B2|||Fat intake||kcal/day|Mean|1130.9|1130.9|Standard Deviation|484.6|484.6|||
4150245|NCT00856609|3974050|B1|||Fat intake||kcal/day|Mean|1305.3|1305.3|Standard Deviation|488.4|488.4|||
4150246|NCT00856609|3974048|B3|||Carbohydrates intake||kcal/day|Mean|1689.7|1689.7|Standard Deviation|544.0|544.0|||
4150247|NCT00856609|3974049|B2|||Carbohydrates intake||kcal/day|Mean|1593.8|1593.8|Standard Deviation|476.1|476.1|||
4150248|NCT00856609|3974050|B1|||Carbohydrates intake||kcal/day|Mean|1785.5|1785.5|Standard Deviation|595.5|595.5|||
4150249|NCT00856609|3974048|B3|||Percentage of calories needed for weight maintenance participants consumed||Percentage of Carlories|Mean|112.3|112.3|Standard Deviation|36.9|36.9|||
4150250|NCT00856609|3974049|B2|||Percentage of calories needed for weight maintenance participants consumed||Percentage of Carlories|Mean|105.4|105.4|Standard Deviation|29.6|29.6|||
4150251|NCT00856609|3974050|B1|||Percentage of calories needed for weight maintenance participants consumed||Percentage of Carlories|Mean|119.3|119.3|Standard Deviation|42.1|42.1|||
4150252|NCT00856609|3974048|B3|||Mean energy intake||kcal/day|Mean|3294.5|3294.5|Standard Deviation|1096.3|1096.3|||
4150253|NCT00856609|3974049|B2|||Mean energy intake||kcal/day|Mean|3093.5|3093.5|Standard Deviation|992.3|992.3|||
4150254|NCT00856609|3974050|B1|||Mean energy intake||kcal/day|Mean|3495.5|3495.5|Standard Deviation|1169.6|1169.6|||
4150255|NCT00856609|3974048|B3|||Two-hour glucose||mg/dl|Mean|137.2|137.2|Standard Deviation|25.6|25.6|||
4150256|NCT00856609|3974049|B2|||Two-hour glucose||mg/dl|Mean|135.1|135.1|Standard Deviation|25.6|25.6|||
4150257|NCT00856609|3974050|B1|||Two-hour glucose||mg/dl|Mean|139.4|139.4|Standard Deviation|25.7|25.7|||
4150258|NCT00856609|3974048|B3|||Fasting glucose||mg/dl|Mean|97.8|97.8|Standard Deviation|8.6|8.6|||
4150259|NCT00856609|3974049|B2|||Fasting glucose||mg/dl|Mean|98.8|98.8|Standard Deviation|8.8|8.8|||
4150260|NCT00856609|3974050|B1|||Fasting glucose||mg/dl|Mean|96.9|96.9|Standard Deviation|8.5|8.5|||
4150261|NCT00856609|3974048|B3|||Body fat||percent|Mean|44.2|44.2|Standard Deviation|7.8|7.8|||
4150262|NCT00856609|3974049|B2|||Body fat||percent|Mean|44.4|44.4|Standard Deviation|8.7|8.7|||
4150263|NCT00856609|3974050|B1|||Body fat||percent|Mean|44.0|44.0|Standard Deviation|6.9|6.9|||
4150264|NCT00856609|3974048|B3|||Fat mass||Kg|Mean|29.4|29.4|Standard Deviation|8.8|8.8|||
4150265|NCT00856609|3974049|B2|||Fat mass||Kg|Mean|30.8|30.8|Standard Deviation|8.7|8.7|||
4150266|NCT00856609|3974050|B1|||Fat mass||Kg|Mean|27.9|27.9|Standard Deviation|8.8|8.8|||
4150267|NCT00856609|3974048|B3|||Fat free mass||Kg|Mean|36.3|36.3|Standard Deviation|12.8|12.8|||
4150268|NCT00856609|3974049|B2|||Fat free mass||Kg|Mean|37.9|37.9|Standard Deviation|8.7|8.7|||
4150269|NCT00856609|3974050|B1|||Fat free mass||Kg|Mean|34.6|34.6|Standard Deviation|11.5|11.5|||
4150270|NCT00856609|3974048|B3|||Body Mass Index||kg/m^2|Mean|38.1|38.1|Standard Deviation|6.7|6.7|||
4150271|NCT00856609|3974049|B2|||Body Mass Index||kg/m^2|Mean|38.2|38.2|Standard Deviation|6.8|6.8|||
4150272|NCT00856609|3974050|B1|||Body Mass Index||kg/m^2|Mean|38.0|38.0|Standard Deviation|6.6|6.6|||
4150273|NCT00856609|3974048|B3|||Body weight||kg|Mean|107.1|107.1|Standard Deviation|19.9|19.9|||
4150274|NCT00856609|3974049|B2|||Body weight||kg|Mean|108.8|108.8|Standard Deviation|20.7|20.7|||
4150275|NCT00856609|3974050|B1|||Body weight||kg|Mean|105.5|105.5|Standard Deviation|19.2|19.2|||
4150276|NCT00856609|3974048|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4150277|NCT00856609|3974049|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4150278|NCT00856609|3974050|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4150279|NCT00856609|3974048|B3|Native American||Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
4150280|NCT00856609|3974049|B2|Native American||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4150281|NCT00856609|3974050|B1|Native American||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
4150282|NCT00856609|3974048|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4150283|NCT00856609|3974049|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4150284|NCT00856609|3974050|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4150285|NCT00856609|3974048|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
4150286|NCT00856609|3974049|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4150287|NCT00856609|3974050|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4150288|NCT00856609|3974048|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4150289|NCT00856609|3974049|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4150290|NCT00856609|3974050|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4150291|NCT00856609|3974048|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4150292|NCT00856609|3974049|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4150293|NCT00856609|3974050|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4150294|NCT00856609|3974048|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4150295|NCT00856609|3974049|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4150296|NCT00856609|3974050|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4150297|NCT00856609|3974048|B3|||Age||years|Mean|34.4|34.4|Standard Deviation|8.7|8.7|||
4150298|NCT00856609|3974049|B2|||Age||years|Mean|33.7|33.7|Standard Deviation|9.0|9.0|||
4150299|NCT00856609|3974050|B1|||Age||years|Mean|35.1|35.1|Standard Deviation|8.4|8.4|||
4150300|NCT00856583|3974061|B3|> 5 years||Time since last suicide attempt||participants|Number|527|527.0||||||
4150301|NCT00856583|3974062|B2|> 5 years||Time since last suicide attempt||participants|Number|268|268.0||||||
4150302|NCT00856583|3974063|B1|> 5 years||Time since last suicide attempt||participants|Number|259|259.0||||||
4150303|NCT00856583|3974061|B3|1 to 5 years||Time since last suicide attempt||participants|Number|444|444.0||||||
4150304|NCT00856583|3974062|B2|1 to 5 years||Time since last suicide attempt||participants|Number|218|218.0||||||
4150305|NCT00856583|3974063|B1|1 to 5 years||Time since last suicide attempt||participants|Number|226|226.0||||||
4150306|NCT00856583|3974061|B3|< 1 year||Time since last suicide attempt||participants|Number|239|239.0||||||
4150307|NCT00856583|3974062|B2|< 1 year||Time since last suicide attempt||participants|Number|117|117.0||||||
4150308|NCT00856583|3974063|B1|< 1 year||Time since last suicide attempt||participants|Number|122|122.0||||||
4150309|NCT00856583|3974061|B3|No previous suicide attempt or unknown||Time since last suicide attempt||participants|Number|8599|8599.0||||||
4150310|NCT00856583|3974062|B2|No previous suicide attempt or unknown||Time since last suicide attempt||participants|Number|4301|4301.0||||||
4150311|NCT00856583|3974063|B1|No previous suicide attempt or unknown||Time since last suicide attempt||participants|Number|4298|4298.0||||||
4150312|NCT00856583|3974061|B3|>= 5 previous suicide attempts||Number of previous suicide attempts||participants|Number|70|70.0||||||
4150313|NCT00856583|3974062|B2|>= 5 previous suicide attempts||Number of previous suicide attempts||participants|Number|36|36.0||||||
4150314|NCT00856583|3974063|B1|>= 5 previous suicide attempts||Number of previous suicide attempts||participants|Number|34|34.0||||||
4150315|NCT00856583|3974061|B3|4 previous suicide attempts||Number of previous suicide attempts||participants|Number|31|31.0||||||
4150316|NCT00856583|3974062|B2|4 previous suicide attempts||Number of previous suicide attempts||participants|Number|13|13.0||||||
4150317|NCT00856583|3974063|B1|4 previous suicide attempts||Number of previous suicide attempts||participants|Number|18|18.0||||||
4150318|NCT00856583|3974061|B3|3 previous suicide attempts||Number of previous suicide attempts||participants|Number|105|105.0||||||
4150319|NCT00856583|3974062|B2|3 previous suicide attempts||Number of previous suicide attempts||participants|Number|53|53.0||||||
4150320|NCT00856583|3974063|B1|3 previous suicide attempts||Number of previous suicide attempts||participants|Number|52|52.0||||||
4150321|NCT00856583|3974061|B3|2 previous suicide attempts||Number of previous suicide attempts||participants|Number|251|251.0||||||
4150322|NCT00856583|3974062|B2|2 previous suicide attempts||Number of previous suicide attempts||participants|Number|126|126.0||||||
4150323|NCT00856583|3974063|B1|2 previous suicide attempts||Number of previous suicide attempts||participants|Number|125|125.0||||||
4150324|NCT00856583|3974061|B3|1 previous suicide attempt||Number of previous suicide attempts||participants|Number|755|755.0||||||
4150325|NCT00856583|3974062|B2|1 previous suicide attempt||Number of previous suicide attempts||participants|Number|377|377.0||||||
4150326|NCT00856583|3974063|B1|1 previous suicide attempt||Number of previous suicide attempts||participants|Number|378|378.0||||||
4150327|NCT00856583|3974061|B3|0 previous suicide attempts||Number of previous suicide attempts||participants|Number|8569|8569.0||||||
4150328|NCT00856583|3974062|B2|0 previous suicide attempts||Number of previous suicide attempts||participants|Number|4288|4288.0||||||
4150329|NCT00856583|3974063|B1|0 previous suicide attempts||Number of previous suicide attempts||participants|Number|4281|4281.0||||||
4150330|NCT00856583|3974061|B3|Unknown||Number of previous suicide attempts||participants|Number|28|28.0||||||
4150331|NCT00856583|3974062|B2|Unknown||Number of previous suicide attempts||participants|Number|11|11.0||||||
4150332|NCT00856583|3974063|B1|Unknown||Number of previous suicide attempts||participants|Number|17|17.0||||||
4150333|NCT00856583|3974061|B3|Other||Reasons for prescription of study drug||participants|Number|193|193.0||||||
4150334|NCT00856583|3974062|B2|Other||Reasons for prescription of study drug||participants|Number|104|104.0||||||
4150335|NCT00856583|3974063|B1|Other||Reasons for prescription of study drug||participants|Number|89|89.0||||||
4150336|NCT00856583|3974061|B3|Patient's choice||Reasons for prescription of study drug||participants|Number|1971|1971.0||||||
4150337|NCT00856583|3974062|B2|Patient's choice||Reasons for prescription of study drug||participants|Number|979|979.0||||||
4150338|NCT00856583|3974063|B1|Patient's choice||Reasons for prescription of study drug||participants|Number|992|992.0||||||
4150339|NCT00856583|3974061|B3|None or poor compliance||Reasons for prescription of study drug||participants|Number|330|330.0||||||
4150340|NCT00856583|3974062|B2|None or poor compliance||Reasons for prescription of study drug||participants|Number|169|169.0||||||
4150341|NCT00856583|3974063|B1|None or poor compliance||Reasons for prescription of study drug||participants|Number|161|161.0||||||
4150342|NCT00856583|3974061|B3|Lack of efficacy||Reasons for prescription of study drug||participants|Number|5122|5122.0||||||
4150343|NCT00856583|3974062|B2|Lack of efficacy||Reasons for prescription of study drug||participants|Number|2580|2580.0||||||
4150344|NCT00856583|3974063|B1|Lack of efficacy||Reasons for prescription of study drug||participants|Number|2542|2542.0||||||
4150345|NCT00856583|3974061|B3|Adverse drug reaction||Reasons for prescription of study drug||participants|Number|2193|2193.0||||||
4150346|NCT00856583|3974062|B2|Adverse drug reaction||Reasons for prescription of study drug||participants|Number|1072|1072.0||||||
4150347|NCT00856583|3974063|B1|Adverse drug reaction||Reasons for prescription of study drug||participants|Number|1121|1121.0||||||
4150348|NCT00856583|3974061|B3|> 10 years||Duration of schizophrenia||participants|Number|4147|4147.0||||||
4150349|NCT00856583|3974062|B2|> 10 years||Duration of schizophrenia||participants|Number|2071|2071.0||||||
4150350|NCT00856583|3974063|B1|> 10 years||Duration of schizophrenia||participants|Number|2076|2076.0||||||
4150351|NCT00856583|3974061|B3|5 to 10 years||Duration of schizophrenia||participants|Number|2532|2532.0||||||
4150352|NCT00856583|3974062|B2|5 to 10 years||Duration of schizophrenia||participants|Number|1278|1278.0||||||
4150353|NCT00856583|3974063|B1|5 to 10 years||Duration of schizophrenia||participants|Number|1254|1254.0||||||
4150354|NCT00856583|3974061|B3|< 5 years||Duration of schizophrenia||participants|Number|2918|2918.0||||||
4150355|NCT00856583|3974062|B2|< 5 years||Duration of schizophrenia||participants|Number|1468|1468.0||||||
4150356|NCT00856583|3974063|B1|< 5 years||Duration of schizophrenia||participants|Number|1450|1450.0||||||
4150357|NCT00856583|3974061|B3|Unknown||Duration of schizophrenia||participants|Number|212|212.0||||||
4150358|NCT00856583|3974062|B2|Unknown||Duration of schizophrenia||participants|Number|87|87.0||||||
4150359|NCT00856583|3974063|B1|Unknown||Duration of schizophrenia||participants|Number|125|125.0||||||
4150360|NCT00856583|3974061|B3||Male|Sex: Female, Male||Participants|Count of Participants|5426|5426.0||||||
4150361|NCT00856583|3974062|B2||Male|Sex: Female, Male||Participants|Count of Participants|2716|2716.0||||||
4150362|NCT00856583|3974063|B1||Male|Sex: Female, Male||Participants|Count of Participants|2710|2710.0||||||
4150363|NCT00856583|3974061|B3||Female|Sex: Female, Male||Participants|Count of Participants|4383|4383.0||||||
4150364|NCT00856583|3974062|B2||Female|Sex: Female, Male||Participants|Count of Participants|2188|2188.0||||||
4150365|NCT00856583|3974063|B1||Female|Sex: Female, Male||Participants|Count of Participants|2195|2195.0||||||
4150366|NCT00856583|3974061|B3|> 65 years||Age, Customized||participants|Number|183|183.0||||||
4150367|NCT00856583|3974062|B2|> 65 years||Age, Customized||participants|Number|84|84.0||||||
4150368|NCT00856583|3974063|B1|> 65 years||Age, Customized||participants|Number|99|99.0||||||
4150369|NCT00856583|3974061|B3|18 to 65 years||Age, Customized||participants|Number|9626|9626.0||||||
4150370|NCT00856583|3974062|B2|18 to 65 years||Age, Customized||participants|Number|4820|4820.0||||||
4150371|NCT00856583|3974063|B1|18 to 65 years||Age, Customized||participants|Number|4806|4806.0||||||
4150372|NCT00856583|3974061|B3|||Age||years|Mean|38.3|38.3|Standard Deviation|11.8|11.8|||
4150373|NCT00856583|3974062|B2|||Age||years|Mean|38.3|38.3|Standard Deviation|11.7|11.7|||
4150374|NCT00856583|3974063|B1|||Age||years|Mean|38.4|38.4|Standard Deviation|11.8|11.8|||
4150375|NCT00856557|3974092|B3|PGY3||Year in residency||participants|Number|43|43.0||||||
4150376|NCT00856557|3974093|B2|PGY3||Year in residency||participants|Number|19|19.0||||||
4150377|NCT00856557|3974094|B1|PGY3||Year in residency||participants|Number|24|24.0||||||
4150378|NCT00856557|3974092|B3|PGY2||Year in residency||participants|Number|76|76.0||||||
4150379|NCT00856557|3974093|B2|PGY2||Year in residency||participants|Number|45|45.0||||||
4150380|NCT00856557|3974094|B1|PGY2||Year in residency||participants|Number|31|31.0||||||
4150381|NCT00856557|3974092|B3|Post Grad Yr (PGY) 1||Year in residency||participants|Number|19|19.0||||||
4150382|NCT00856557|3974093|B2|Post Grad Yr (PGY) 1||Year in residency||participants|Number|12|12.0||||||
4150383|NCT00856557|3974094|B1|Post Grad Yr (PGY) 1||Year in residency||participants|Number|7|7.0||||||
4150384|NCT00856557|3974092|B3|United States||Region of Enrollment||participants|Number|138|138.0||||||
4150385|NCT00856557|3974093|B2|United States||Region of Enrollment||participants|Number|76|76.0||||||
4150386|NCT00856557|3974094|B1|United States||Region of Enrollment||participants|Number|62|62.0||||||
4150387|NCT00856557|3974092|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4150388|NCT00856557|3974093|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4150389|NCT00856557|3974094|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4150390|NCT00856557|3974092|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4150391|NCT00856557|3974093|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4150392|NCT00856557|3974094|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4150393|NCT00856557|3974092|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4150394|NCT00856557|3974093|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4150395|NCT00856557|3974094|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4150396|NCT00856557|3974092|B3||Between 18 and 65 years|Age||Participants|Count of Participants|138|138.0||||||
4150397|NCT00856557|3974093|B2||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
4150398|NCT00856557|3974094|B1||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4150399|NCT00856557|3974092|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4150400|NCT00856557|3974093|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4150401|NCT00856557|3974094|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4150402|NCT00856544|3974105|B5||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4150403|NCT00856544|3974106|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4150404|NCT00856544|3974107|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4150405|NCT00856544|3974108|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4150406|NCT00856544|3974109|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4150407|NCT00856544|3974105|B5||Female|Sex: Female, Male||Participants|Count of Participants|645|645.0||||||
4150408|NCT00856544|3974106|B4||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4150409|NCT00856544|3974107|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4150410|NCT00856544|3974108|B2||Female|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
4150411|NCT00856544|3974109|B1||Female|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
4150412|NCT00856544|3974105|B5|||Age||Years|Mean|52.3|52.3|Standard Deviation|11.6|11.6|||
4150413|NCT00856544|3974106|B4|||Age||Years|Mean|53.3|53.3|Standard Deviation|10.8|10.8|||
4150414|NCT00856544|3974107|B3|||Age||Years|Mean|50.8|50.8|Standard Deviation|11.2|11.2|||
4150415|NCT00856544|3974108|B2|||Age||Years|Mean|51.9|51.9|Standard Deviation|11.8|11.8|||
4150416|NCT00856544|3974109|B1|||Age||Years|Mean|52.7|52.7|Standard Deviation|11.7|11.7|||
4150417|NCT00856518|3974289|B3||Male|Gender||Participants|Count of Participants|11|11.0||||||
4150418|NCT00856518|3974290|B2||Male|Gender||Participants|Count of Participants|5|5.0||||||
4150419|NCT00856518|3974291|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
4150420|NCT00856518|3974289|B3||Female|Gender||Participants|Count of Participants|31|31.0||||||
4150421|NCT00856518|3974290|B2||Female|Gender||Participants|Count of Participants|13|13.0||||||
4150422|NCT00856518|3974291|B1||Female|Gender||Participants|Count of Participants|18|18.0||||||
4150423|NCT00856518|3974289|B3|||Age||years|Mean|55|55.0|Standard Deviation|9|9.0|||
4150424|NCT00856518|3974290|B2|||Age||years|Mean|58|58.0|Standard Deviation|8|8.0|||
4150425|NCT00856518|3974291|B1|||Age||years|Mean|53|53.0|Standard Deviation|9|9.0|||
4150426|NCT00856492|3974302|B4||IIIC|Breast cancer stage|"Measure Description: As per AJCC 6th ed, 2002:~https://cancerstaging.org/references-tools/deskreferences/Documents/AJCC6thEdCancerStagingManualPart2.pdf"|Participants|Count of Participants|8|8.0||||||
4150427|NCT00856492|3974303|B3||IIIC|Breast cancer stage|"Measure Description: As per AJCC 6th ed, 2002:~https://cancerstaging.org/references-tools/deskreferences/Documents/AJCC6thEdCancerStagingManualPart2.pdf"|Participants|Count of Participants|2|2.0||||||
4150428|NCT00856492|3974304|B2||IIIC|Breast cancer stage|"Measure Description: As per AJCC 6th ed, 2002:~https://cancerstaging.org/references-tools/deskreferences/Documents/AJCC6thEdCancerStagingManualPart2.pdf"|Participants|Count of Participants|4|4.0||||||
4150429|NCT00856492|3974305|B1||IIIC|Breast cancer stage|"Measure Description: As per AJCC 6th ed, 2002:~https://cancerstaging.org/references-tools/deskreferences/Documents/AJCC6thEdCancerStagingManualPart2.pdf"|Participants|Count of Participants|2|2.0||||||
4150430|NCT00856492|3974302|B4||IIIB|Breast cancer stage|"Measure Description: As per AJCC 6th ed, 2002:~https://cancerstaging.org/references-tools/deskreferences/Documents/AJCC6thEdCancerStagingManualPart2.pdf"|Participants|Count of Participants|53|53.0||||||
4150431|NCT00856492|3974303|B3||IIIB|Breast cancer stage|"Measure Description: As per AJCC 6th ed, 2002:~https://cancerstaging.org/references-tools/deskreferences/Documents/AJCC6thEdCancerStagingManualPart2.pdf"|Participants|Count of Participants|12|12.0||||||
4150432|NCT00856492|3974304|B2||IIIB|Breast cancer stage|"Measure Description: As per AJCC 6th ed, 2002:~https://cancerstaging.org/references-tools/deskreferences/Documents/AJCC6thEdCancerStagingManualPart2.pdf"|Participants|Count of Participants|12|12.0||||||
4150433|NCT00856492|3974305|B1||IIIB|Breast cancer stage|"Measure Description: As per AJCC 6th ed, 2002:~https://cancerstaging.org/references-tools/deskreferences/Documents/AJCC6thEdCancerStagingManualPart2.pdf"|Participants|Count of Participants|29|29.0||||||
4150434|NCT00856492|3974302|B4||IIIA|Breast cancer stage|"Measure Description: As per AJCC 6th ed, 2002:~https://cancerstaging.org/references-tools/deskreferences/Documents/AJCC6thEdCancerStagingManualPart2.pdf"|Participants|Count of Participants|62|62.0||||||
4150435|NCT00856492|3974303|B3||IIIA|Breast cancer stage|"Measure Description: As per AJCC 6th ed, 2002:~https://cancerstaging.org/references-tools/deskreferences/Documents/AJCC6thEdCancerStagingManualPart2.pdf"|Participants|Count of Participants|14|14.0||||||
4150436|NCT00856492|3974304|B2||IIIA|Breast cancer stage|"Measure Description: As per AJCC 6th ed, 2002:~https://cancerstaging.org/references-tools/deskreferences/Documents/AJCC6thEdCancerStagingManualPart2.pdf"|Participants|Count of Participants|16|16.0||||||
4150483|NCT00856492|3974303|B3|||Age||years|Median|51.6|51.6|Full Range|||31.0|66.0|
4150484|NCT00856492|3974304|B2|||Age||years|Median|49.7|49.7|Full Range|||33.0|75.0|
4150437|NCT00856492|3974305|B1||IIIA|Breast cancer stage|"Measure Description: As per AJCC 6th ed, 2002:~https://cancerstaging.org/references-tools/deskreferences/Documents/AJCC6thEdCancerStagingManualPart2.pdf"|Participants|Count of Participants|32|32.0||||||
4150438|NCT00856492|3974302|B4||IIB|Breast cancer stage|"Measure Description: As per AJCC 6th ed, 2002:~https://cancerstaging.org/references-tools/deskreferences/Documents/AJCC6thEdCancerStagingManualPart2.pdf"|Participants|Count of Participants|87|87.0||||||
4150439|NCT00856492|3974303|B3||IIB|Breast cancer stage|"Measure Description: As per AJCC 6th ed, 2002:~https://cancerstaging.org/references-tools/deskreferences/Documents/AJCC6thEdCancerStagingManualPart2.pdf"|Participants|Count of Participants|22|22.0||||||
4150440|NCT00856492|3974304|B2||IIB|Breast cancer stage|"Measure Description: As per AJCC 6th ed, 2002:~https://cancerstaging.org/references-tools/deskreferences/Documents/AJCC6thEdCancerStagingManualPart2.pdf"|Participants|Count of Participants|30|30.0||||||
4150441|NCT00856492|3974305|B1||IIB|Breast cancer stage|"Measure Description: As per AJCC 6th ed, 2002:~https://cancerstaging.org/references-tools/deskreferences/Documents/AJCC6thEdCancerStagingManualPart2.pdf"|Participants|Count of Participants|35|35.0||||||
4150442|NCT00856492|3974302|B4||Negative: ER- and PR- (TNBC)|Hormone receptor status||Participants|Count of Participants|67|67.0||||||
4150443|NCT00856492|3974303|B3||Negative: ER- and PR- (TNBC)|Hormone receptor status||Participants|Count of Participants|16|16.0||||||
4150444|NCT00856492|3974304|B2||Negative: ER- and PR- (TNBC)|Hormone receptor status||Participants|Count of Participants|19|19.0||||||
4150445|NCT00856492|3974305|B1||Negative: ER- and PR- (TNBC)|Hormone receptor status||Participants|Count of Participants|32|32.0||||||
4150446|NCT00856492|3974302|B4||Positive: ER+ or PgR+|Hormone receptor status||Participants|Count of Participants|144|144.0||||||
4150447|NCT00856492|3974303|B3||Positive: ER+ or PgR+|Hormone receptor status||Participants|Count of Participants|35|35.0||||||
4150448|NCT00856492|3974304|B2||Positive: ER+ or PgR+|Hormone receptor status||Participants|Count of Participants|43|43.0||||||
4150449|NCT00856492|3974305|B1||Positive: ER+ or PgR+|Hormone receptor status||Participants|Count of Participants|66|66.0||||||
4150450|NCT00856492|3974302|B4||Non-IBC LABC|Inflammatory Breast Cancer (IBC) or Non-IBC Locally Advanced Breast Cancer (LABC)||Participants|Count of Participants|187|187.0||||||
4150451|NCT00856492|3974303|B3||Non-IBC LABC|Inflammatory Breast Cancer (IBC) or Non-IBC Locally Advanced Breast Cancer (LABC)||Participants|Count of Participants|44|44.0||||||
4150452|NCT00856492|3974304|B2||Non-IBC LABC|Inflammatory Breast Cancer (IBC) or Non-IBC Locally Advanced Breast Cancer (LABC)||Participants|Count of Participants|55|55.0||||||
4150453|NCT00856492|3974305|B1||Non-IBC LABC|Inflammatory Breast Cancer (IBC) or Non-IBC Locally Advanced Breast Cancer (LABC)||Participants|Count of Participants|88|88.0||||||
4150454|NCT00856492|3974302|B4||IBC|Inflammatory Breast Cancer (IBC) or Non-IBC Locally Advanced Breast Cancer (LABC)||Participants|Count of Participants|24|24.0||||||
4150455|NCT00856492|3974303|B3||IBC|Inflammatory Breast Cancer (IBC) or Non-IBC Locally Advanced Breast Cancer (LABC)||Participants|Count of Participants|7|7.0||||||
4150456|NCT00856492|3974304|B2||IBC|Inflammatory Breast Cancer (IBC) or Non-IBC Locally Advanced Breast Cancer (LABC)||Participants|Count of Participants|7|7.0||||||
4150457|NCT00856492|3974305|B1||IBC|Inflammatory Breast Cancer (IBC) or Non-IBC Locally Advanced Breast Cancer (LABC)||Participants|Count of Participants|10|10.0||||||
4150458|NCT00856492|3974302|B4|Race/Ethnicity|Other/unknown|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4150459|NCT00856492|3974303|B3|Race/Ethnicity|Other/unknown|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4150460|NCT00856492|3974304|B2|Race/Ethnicity|Other/unknown|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4150461|NCT00856492|3974305|B1|Race/Ethnicity|Other/unknown|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4150462|NCT00856492|3974302|B4|Race/Ethnicity|Asian/Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4150463|NCT00856492|3974303|B3|Race/Ethnicity|Asian/Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4150464|NCT00856492|3974304|B2|Race/Ethnicity|Asian/Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4150465|NCT00856492|3974305|B1|Race/Ethnicity|Asian/Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4150466|NCT00856492|3974302|B4|Race/Ethnicity|Black|Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
4150467|NCT00856492|3974303|B3|Race/Ethnicity|Black|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4150468|NCT00856492|3974304|B2|Race/Ethnicity|Black|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4150469|NCT00856492|3974305|B1|Race/Ethnicity|Black|Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
4150470|NCT00856492|3974302|B4|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|154|154.0||||||
4150471|NCT00856492|3974303|B3|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
4150472|NCT00856492|3974304|B2|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
4150473|NCT00856492|3974305|B1|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|70|70.0||||||
4150474|NCT00856492|3974302|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4150475|NCT00856492|3974303|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4150476|NCT00856492|3974304|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4150477|NCT00856492|3974305|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4150478|NCT00856492|3974302|B4||Female|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4150479|NCT00856492|3974303|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4150480|NCT00856492|3974304|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4150481|NCT00856492|3974305|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4150482|NCT00856492|3974302|B4|||Age||years|Median|51.5|51.5|Full Range|||22.0|75.0|
4150485|NCT00856492|3974305|B1|||Age||years|Median|51.7|51.7|Full Range|||22.0|71.0|
4150486|NCT00856414|3974321|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4150487|NCT00856414|3974321|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4150488|NCT00856414|3974321|B1|||Age||years|Median|43.5|43.5|Full Range|||35.1|56.6|
4150489|NCT00856388|3974329|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4150490|NCT00856388|3974329|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4150491|NCT00856388|3974329|B1|||Age||years|Mean|54.6|54.6|Standard Deviation|14.3|14.3|||
4150492|NCT00856388|3974329|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4150493|NCT00856388|3974329|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4150494|NCT00856388|3974329|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4150495|NCT00856349|3974340|B1|Thailand||Region of Enrollment||participants|Number|18|18.0||||||
4150496|NCT00856349|3974340|B1|India||Region of Enrollment||participants|Number|118|118.0||||||
4150497|NCT00856349|3974340|B1|Korea, Republic of||Region of Enrollment||participants|Number|24|24.0||||||
4150498|NCT00856349|3974340|B1|China||Region of Enrollment||participants|Number|28|28.0||||||
4150499|NCT00856349|3974340|B1|New Zealand||Region of Enrollment||participants|Number|26|26.0||||||
4150500|NCT00856349|3974340|B1|Australia||Region of Enrollment||participants|Number|69|69.0||||||
4150501|NCT00856349|3974340|B1|Singapore||Region of Enrollment||participants|Number|39|39.0||||||
4150502|NCT00856349|3974340|B1|Argentina||Region of Enrollment||participants|Number|19|19.0||||||
4150503|NCT00856349|3974340|B1|Canada||Region of Enrollment||participants|Number|434|434.0||||||
4150504|NCT00856349|3974340|B1|Mexico||Region of Enrollment||participants|Number|8|8.0||||||
4150505|NCT00856349|3974340|B1|Hong Kong||Region of Enrollment||participants|Number|15|15.0||||||
4150506|NCT00856349|3974340|B1|Taiwan||Region of Enrollment||participants|Number|27|27.0||||||
4150507|NCT00856349|3974340|B1|United States||Region of Enrollment||participants|Number|3307|3307.0||||||
4150508|NCT00856349|3974340|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|298|298.0||||||
4150509|NCT00856349|3974340|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4150510|NCT00856349|3974340|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3151|3151.0||||||
4150511|NCT00856349|3974340|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|360|360.0||||||
4150512|NCT00856349|3974340|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4150513|NCT00856349|3974340|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|295|295.0||||||
4150514|NCT00856349|3974340|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4150515|NCT00856349|3974340|B1||Male|Sex: Female, Male||Participants|Count of Participants|3161|3161.0||||||
4150516|NCT00856349|3974340|B1||Female|Sex: Female, Male||Participants|Count of Participants|971|971.0||||||
4150517|NCT00856349|3974340|B1|||Age||years|Mean|66|66.0|Standard Deviation|13|13.0|||
4150518|NCT00856323|3974349|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
4150519|NCT00856323|3974349|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4150520|NCT00856323|3974349|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4150521|NCT00856323|3974349|B1|||Age||years|Mean|36.1|36.1|Standard Deviation|7.9|7.9|||
4150522|NCT00856323|3974349|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4150523|NCT00856323|3974349|B1||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4150524|NCT00856323|3974349|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4150525|NCT00856297|3974356|B6||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4150526|NCT00856297|3974357|B5||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4150527|NCT00856297|3974358|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4150528|NCT00856297|3974359|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4150529|NCT00856297|3974360|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4150530|NCT00856297|3974361|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4150531|NCT00856297|3974356|B6||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4150532|NCT00856297|3974357|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4150533|NCT00856297|3974358|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4150534|NCT00856297|3974359|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4150535|NCT00856297|3974360|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4150536|NCT00856297|3974361|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4150537|NCT00856297|3974356|B6|||Age||years|Mean|19.2|19.2|Standard Deviation|2.3|2.3|||
4150538|NCT00856297|3974357|B5|||Age||years|Mean|19.7|19.7|Standard Deviation|2.3|2.3|||
4150539|NCT00856297|3974358|B4|||Age||years|Mean|19.0|19.0|Standard Deviation|1.9|1.9|||
4150540|NCT00856297|3974359|B3|||Age||years|Mean|19.3|19.3|Standard Deviation|2.4|2.4|||
4150541|NCT00856297|3974360|B2|||Age||years|Mean|18.8|18.8|Standard Deviation|2.4|2.4|||
4150542|NCT00856297|3974361|B1|||Age||years|Mean|19.4|19.4|Standard Deviation|2.4|2.4|||
4150543|NCT00856284|3974395|B4|Ex-smoker||Smoking history||participants|Number|564|564.0||||||
4150544|NCT00856284|3974396|B3|Ex-smoker||Smoking history||participants|Number|185|185.0||||||
4150545|NCT00856284|3974397|B2|Ex-smoker||Smoking history||participants|Number|177|177.0||||||
4150546|NCT00856284|3974398|B1|Ex-smoker||Smoking history||participants|Number|202|202.0||||||
4150547|NCT00856284|3974395|B4|Current smoker||Smoking history||participants|Number|368|368.0||||||
4150548|NCT00856284|3974396|B3|Current smoker||Smoking history||participants|Number|111|111.0||||||
4150549|NCT00856284|3974397|B2|Current smoker||Smoking history||participants|Number|122|122.0||||||
4150550|NCT00856284|3974398|B1|Current smoker||Smoking history||participants|Number|135|135.0||||||
4150551|NCT00856284|3974395|B4|Never smoked||Smoking history||participants|Number|1707|1707.0||||||
4150552|NCT00856284|3974396|B3|Never smoked||Smoking history||participants|Number|578|578.0||||||
4150553|NCT00856284|3974397|B2|Never smoked||Smoking history||participants|Number|586|586.0||||||
4150554|NCT00856284|3974398|B1|Never smoked||Smoking history||participants|Number|543|543.0||||||
4150555|NCT00856284|3974395|B4|Cockcroft-Gault||Glomerular filtration rate|Glomerular filtration rate (GFR) was calculated using the modification of diet in renal disease (MDRD) formula and the Cockcroft-Gault formula. Data include 877, 883 and 870 participants in each treatment arm, respectively.|mL/min/1.73m^2|Mean|108.9|108.9|Standard Deviation|32.96|32.96|||
4150556|NCT00856284|3974396|B3|Cockcroft-Gault||Glomerular filtration rate|Glomerular filtration rate (GFR) was calculated using the modification of diet in renal disease (MDRD) formula and the Cockcroft-Gault formula. Data include 877, 883 and 870 participants in each treatment arm, respectively.|mL/min/1.73m^2|Mean|108.0|108.0|Standard Deviation|32.64|32.64|||
4150557|NCT00856284|3974397|B2|Cockcroft-Gault||Glomerular filtration rate|Glomerular filtration rate (GFR) was calculated using the modification of diet in renal disease (MDRD) formula and the Cockcroft-Gault formula. Data include 877, 883 and 870 participants in each treatment arm, respectively.|mL/min/1.73m^2|Mean|109.3|109.3|Standard Deviation|32.85|32.85|||
4150558|NCT00856284|3974398|B1|Cockcroft-Gault||Glomerular filtration rate|Glomerular filtration rate (GFR) was calculated using the modification of diet in renal disease (MDRD) formula and the Cockcroft-Gault formula. Data include 877, 883 and 870 participants in each treatment arm, respectively.|mL/min/1.73m^2|Mean|109.3|109.3|Standard Deviation|33.40|33.4|||
4150559|NCT00856284|3974395|B4|MDRD||Glomerular filtration rate|Glomerular filtration rate (GFR) was calculated using the modification of diet in renal disease (MDRD) formula and the Cockcroft-Gault formula. Data include 877, 883 and 870 participants in each treatment arm, respectively.|mL/min/1.73m^2|Mean|82.56|82.56|Standard Deviation|16.591|16.591|||
4150560|NCT00856284|3974396|B3|MDRD||Glomerular filtration rate|Glomerular filtration rate (GFR) was calculated using the modification of diet in renal disease (MDRD) formula and the Cockcroft-Gault formula. Data include 877, 883 and 870 participants in each treatment arm, respectively.|mL/min/1.73m^2|Mean|82.28|82.28|Standard Deviation|16.994|16.994|||
4150561|NCT00856284|3974397|B2|MDRD||Glomerular filtration rate|Glomerular filtration rate (GFR) was calculated using the modification of diet in renal disease (MDRD) formula and the Cockcroft-Gault formula. Data include 877, 883 and 870 participants in each treatment arm, respectively.|mL/min/1.73m^2|Mean|82.35|82.35|Standard Deviation|16.199|16.199|||
4150562|NCT00856284|3974398|B1|MDRD||Glomerular filtration rate|Glomerular filtration rate (GFR) was calculated using the modification of diet in renal disease (MDRD) formula and the Cockcroft-Gault formula. Data include 877, 883 and 870 participants in each treatment arm, respectively.|mL/min/1.73m^2|Mean|83.04|83.04|Standard Deviation|16.586|16.586|||
4150563|NCT00856284|3974395|B4|||Metformin dose||mg|Mean|1828.6|1828.6|Standard Deviation|389.85|389.85|||
4150564|NCT00856284|3974396|B3|||Metformin dose||mg|Mean|1823.4|1823.4|Standard Deviation|390.63|390.63|||
4150565|NCT00856284|3974397|B2|||Metformin dose||mg|Mean|1837.2|1837.2|Standard Deviation|373.06|373.06|||
4150566|NCT00856284|3974398|B1|||Metformin dose||mg|Mean|1825.2|1825.2|Standard Deviation|405.59|405.59|||
4150567|NCT00856284|3974395|B4|||Diabetes duration|Diabetes duration data available for 880, 884 and 874 participants in each treatment arm, respectively.|years|Mean|5.52|5.52|Standard Deviation|4.985|4.985|||
4150568|NCT00856284|3974396|B3|||Diabetes duration|Diabetes duration data available for 880, 884 and 874 participants in each treatment arm, respectively.|years|Mean|5.48|5.48|Standard Deviation|4.884|4.884|||
4150569|NCT00856284|3974397|B2|||Diabetes duration|Diabetes duration data available for 880, 884 and 874 participants in each treatment arm, respectively.|years|Mean|5.42|5.42|Standard Deviation|4.730|4.73|||
4150570|NCT00856284|3974398|B1|||Diabetes duration|Diabetes duration data available for 880, 884 and 874 participants in each treatment arm, respectively.|years|Mean|5.65|5.65|Standard Deviation|5.324|5.324|||
4150571|NCT00856284|3974395|B4|≥8.0%||Baseline HbA1c Category||participants|Number|791|791.0||||||
4150572|NCT00856284|3974396|B3|≥8.0%||Baseline HbA1c Category||participants|Number|261|261.0||||||
4150573|NCT00856284|3974397|B2|≥8.0%||Baseline HbA1c Category||participants|Number|265|265.0||||||
4150574|NCT00856284|3974398|B1|≥8.0%||Baseline HbA1c Category||participants|Number|265|265.0||||||
4150575|NCT00856284|3974395|B4|<8.0%||Baseline HbA1c Category||participants|Number|1848|1848.0||||||
4150576|NCT00856284|3974396|B3|<8.0%||Baseline HbA1c Category||participants|Number|613|613.0||||||
4150577|NCT00856284|3974397|B2|<8.0%||Baseline HbA1c Category||participants|Number|620|620.0||||||
4150578|NCT00856284|3974398|B1|<8.0%||Baseline HbA1c Category||participants|Number|615|615.0||||||
4150579|NCT00856284|3974395|B4|||Glycosylated hemoglobin (HbA1c)|Mean HbA1c data includes 877, 883 and 870 participants in each treatment arm, respectively.|percentage|Mean|7.60|7.6|Standard Deviation|0.607|0.607|||
4150580|NCT00856284|3974396|B3|||Glycosylated hemoglobin (HbA1c)|Mean HbA1c data includes 877, 883 and 870 participants in each treatment arm, respectively.|percentage|Mean|7.60|7.6|Standard Deviation|0.617|0.617|||
4150581|NCT00856284|3974397|B2|||Glycosylated hemoglobin (HbA1c)|Mean HbA1c data includes 877, 883 and 870 participants in each treatment arm, respectively.|percentage|Mean|7.61|7.61|Standard Deviation|0.606|0.606|||
4150582|NCT00856284|3974398|B1|||Glycosylated hemoglobin (HbA1c)|Mean HbA1c data includes 877, 883 and 870 participants in each treatment arm, respectively.|percentage|Mean|7.59|7.59|Standard Deviation|0.599|0.599|||
4150583|NCT00856284|3974395|B4|||Body Mass Index (BMI)|BMI data available for 879, 885 and 872 participants in each treatment arm, respectively.|kg/m^2|Mean|31.22|31.22|Standard Deviation|5.358|5.358|||
4150584|NCT00856284|3974396|B3|||Body Mass Index (BMI)|BMI data available for 879, 885 and 872 participants in each treatment arm, respectively.|kg/m^2|Mean|31.11|31.11|Standard Deviation|5.320|5.32|||
4150687|NCT00856206|3974447|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4150585|NCT00856284|3974397|B2|||Body Mass Index (BMI)|BMI data available for 879, 885 and 872 participants in each treatment arm, respectively.|kg/m^2|Mean|31.27|31.27|Standard Deviation|5.341|5.341|||
4150586|NCT00856284|3974398|B1|||Body Mass Index (BMI)|BMI data available for 879, 885 and 872 participants in each treatment arm, respectively.|kg/m^2|Mean|31.27|31.27|Standard Deviation|5.417|5.417|||
4150587|NCT00856284|3974395|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2051|2051.0||||||
4150588|NCT00856284|3974396|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|682|682.0||||||
4150589|NCT00856284|3974397|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|681|681.0||||||
4150590|NCT00856284|3974398|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|688|688.0||||||
4150591|NCT00856284|3974395|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|588|588.0||||||
4150592|NCT00856284|3974396|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|192|192.0||||||
4150593|NCT00856284|3974397|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|204|204.0||||||
4150594|NCT00856284|3974398|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|192|192.0||||||
4150595|NCT00856284|3974395|B4|Multiracial||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4150596|NCT00856284|3974396|B3|Multiracial||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4150597|NCT00856284|3974397|B2|Multiracial||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4150598|NCT00856284|3974398|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4150599|NCT00856284|3974395|B4|White||Race/Ethnicity, Customized||participants|Number|1645|1645.0||||||
4150600|NCT00856284|3974396|B3|White||Race/Ethnicity, Customized||participants|Number|533|533.0||||||
4150601|NCT00856284|3974397|B2|White||Race/Ethnicity, Customized||participants|Number|555|555.0||||||
4150602|NCT00856284|3974398|B1|White||Race/Ethnicity, Customized||participants|Number|557|557.0||||||
4150603|NCT00856284|3974395|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4150604|NCT00856284|3974396|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4150605|NCT00856284|3974397|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4150606|NCT00856284|3974398|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4150607|NCT00856284|3974395|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|221|221.0||||||
4150608|NCT00856284|3974396|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
4150609|NCT00856284|3974397|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
4150610|NCT00856284|3974398|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
4150611|NCT00856284|3974395|B4|Asian||Race/Ethnicity, Customized||participants|Number|601|601.0||||||
4150612|NCT00856284|3974396|B3|Asian||Race/Ethnicity, Customized||participants|Number|203|203.0||||||
4150613|NCT00856284|3974397|B2|Asian||Race/Ethnicity, Customized||participants|Number|207|207.0||||||
4150614|NCT00856284|3974398|B1|Asian||Race/Ethnicity, Customized||participants|Number|191|191.0||||||
4150615|NCT00856284|3974395|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|118|118.0||||||
4150616|NCT00856284|3974396|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4150617|NCT00856284|3974397|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4150618|NCT00856284|3974398|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4150619|NCT00856284|3974395|B4||Male|Sex: Female, Male||Participants|Count of Participants|1312|1312.0||||||
4150620|NCT00856284|3974396|B3||Male|Sex: Female, Male||Participants|Count of Participants|441|441.0||||||
4150621|NCT00856284|3974397|B2||Male|Sex: Female, Male||Participants|Count of Participants|452|452.0||||||
4150622|NCT00856284|3974398|B1||Male|Sex: Female, Male||Participants|Count of Participants|419|419.0||||||
4150623|NCT00856284|3974395|B4||Female|Sex: Female, Male||Participants|Count of Participants|1327|1327.0||||||
4150624|NCT00856284|3974396|B3||Female|Sex: Female, Male||Participants|Count of Participants|433|433.0||||||
4150625|NCT00856284|3974397|B2||Female|Sex: Female, Male||Participants|Count of Participants|433|433.0||||||
4150626|NCT00856284|3974398|B1||Female|Sex: Female, Male||Participants|Count of Participants|461|461.0||||||
4150627|NCT00856284|3974395|B4|≥75 years||Age, Customized|Categories ≥65 years and ≥75 years are not mutually exclusive. Participants ≥75 years are counted in both categories.|participants|Number|45|45.0||||||
4150628|NCT00856284|3974396|B3|≥75 years||Age, Customized|Categories ≥65 years and ≥75 years are not mutually exclusive. Participants ≥75 years are counted in both categories.|participants|Number|15|15.0||||||
4150629|NCT00856284|3974397|B2|≥75 years||Age, Customized|Categories ≥65 years and ≥75 years are not mutually exclusive. Participants ≥75 years are counted in both categories.|participants|Number|17|17.0||||||
4150630|NCT00856284|3974398|B1|≥75 years||Age, Customized|Categories ≥65 years and ≥75 years are not mutually exclusive. Participants ≥75 years are counted in both categories.|participants|Number|13|13.0||||||
4150631|NCT00856284|3974395|B4|≥65 years||Age, Customized|Categories ≥65 years and ≥75 years are not mutually exclusive. Participants ≥75 years are counted in both categories.|participants|Number|472|472.0||||||
4150632|NCT00856284|3974396|B3|≥65 years||Age, Customized|Categories ≥65 years and ≥75 years are not mutually exclusive. Participants ≥75 years are counted in both categories.|participants|Number|151|151.0||||||
4150633|NCT00856284|3974397|B2|≥65 years||Age, Customized|Categories ≥65 years and ≥75 years are not mutually exclusive. Participants ≥75 years are counted in both categories.|participants|Number|175|175.0||||||
4150634|NCT00856284|3974398|B1|≥65 years||Age, Customized|Categories ≥65 years and ≥75 years are not mutually exclusive. Participants ≥75 years are counted in both categories.|participants|Number|146|146.0||||||
4150635|NCT00856284|3974395|B4|<65 years||Age, Customized|Categories ≥65 years and ≥75 years are not mutually exclusive. Participants ≥75 years are counted in both categories.|participants|Number|2167|2167.0||||||
4150636|NCT00856284|3974396|B3|<65 years||Age, Customized|Categories ≥65 years and ≥75 years are not mutually exclusive. Participants ≥75 years are counted in both categories.|participants|Number|723|723.0||||||
4150637|NCT00856284|3974397|B2|<65 years||Age, Customized|Categories ≥65 years and ≥75 years are not mutually exclusive. Participants ≥75 years are counted in both categories.|participants|Number|710|710.0||||||
4150638|NCT00856284|3974398|B1|<65 years||Age, Customized|Categories ≥65 years and ≥75 years are not mutually exclusive. Participants ≥75 years are counted in both categories.|participants|Number|734|734.0||||||
4150639|NCT00856284|3974395|B4|||Age||years|Mean|55.4|55.4|Standard Deviation|9.67|9.67|||
4150640|NCT00856284|3974396|B3|||Age||years|Mean|55.4|55.4|Standard Deviation|9.60|9.6|||
4150641|NCT00856284|3974397|B2|||Age||years|Mean|55.5|55.5|Standard Deviation|9.81|9.81|||
4150642|NCT00856284|3974398|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|9.60|9.6|||
4150643|NCT00856245|3974426|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150644|NCT00856245|3974426|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4150645|NCT00856245|3974426|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150646|NCT00856245|3974426|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4150647|NCT00856245|3974426|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4150648|NCT00856245|3974426|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4150649|NCT00856245|3974426|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4150650|NCT00856245|3974426|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4150651|NCT00856232|3974431|B4|United States||Region of Enrollment||participants|Number|91|91.0||||||
4150652|NCT00856232|3974432|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4150653|NCT00856232|3974433|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4150654|NCT00856232|3974434|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4150655|NCT00856232|3974431|B4||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4150656|NCT00856232|3974432|B3||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||gender data not collected as part of IRB protocol
4150657|NCT00856232|3974433|B2||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||gender data not collected as part of IRB protocol
4150658|NCT00856232|3974434|B1||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||gender data not collected as part of IRB protocol
4150659|NCT00856232|3974431|B4||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4150660|NCT00856232|3974432|B3||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||gender data not collected as part of IRB protocol
4150661|NCT00856232|3974433|B2||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||gender data not collected as part of IRB protocol
4150662|NCT00856232|3974434|B1||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||gender data not collected as part of IRB protocol
4150663|NCT00856232|3974431|B4|>=65 years||Age||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4150664|NCT00856232|3974432|B3|>=65 years||Age||participants|Number|NA|||||||Age data not collected as part of IRB protocol
4150665|NCT00856232|3974433|B2|>=65 years||Age||participants|Number|NA|||||||Age data not collected as part of IRB protocol
4150666|NCT00856232|3974434|B1|>=65 years||Age||participants|Number|NA|||||||Age data not collected as part of IRB protocol
4150667|NCT00856232|3974431|B4|Between 18 and 65 years||Age||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4150668|NCT00856232|3974432|B3|Between 18 and 65 years||Age||participants|Number|NA|||||||Age data not collected as part of IRB protocol
4150669|NCT00856232|3974433|B2|Between 18 and 65 years||Age||participants|Number|NA|||||||Age data not collected as part of IRB protocol
4150670|NCT00856232|3974434|B1|Between 18 and 65 years||Age||participants|Number|NA|||||||Age data not collected as part of IRB protocol
4150671|NCT00856232|3974431|B4|<=18 years||Age||participants|Number|0|0.0||||||
4150672|NCT00856232|3974432|B3|<=18 years||Age||participants|Number|0|0.0||||||
4150673|NCT00856232|3974433|B2|<=18 years||Age||participants|Number|0|0.0||||||
4150674|NCT00856232|3974434|B1|<=18 years||Age||participants|Number|0|0.0||||||
4150675|NCT00856206|3974447|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150676|NCT00856206|3974448|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150677|NCT00856206|3974449|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150678|NCT00856206|3974447|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150679|NCT00856206|3974448|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150680|NCT00856206|3974449|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150681|NCT00856206|3974447|B3||White|Race (NIH/OMB)||Participants|Count of Participants|868|868.0||||||
4150682|NCT00856206|3974448|B2||White|Race (NIH/OMB)||Participants|Count of Participants|658|658.0||||||
4150683|NCT00856206|3974449|B1||White|Race (NIH/OMB)||Participants|Count of Participants|210|210.0||||||
4150684|NCT00856206|3974447|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|272|272.0||||||
4150685|NCT00856206|3974448|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|202|202.0||||||
4150686|NCT00856206|3974449|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4150688|NCT00856206|3974448|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4150689|NCT00856206|3974449|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4150690|NCT00856206|3974447|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|162|162.0||||||
4150691|NCT00856206|3974448|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
4150692|NCT00856206|3974449|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4150693|NCT00856206|3974447|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4150694|NCT00856206|3974448|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4150695|NCT00856206|3974449|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4150696|NCT00856206|3974447|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150697|NCT00856206|3974448|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150698|NCT00856206|3974449|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150699|NCT00856206|3974447|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1266|1266.0||||||
4150700|NCT00856206|3974448|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|947|947.0||||||
4150701|NCT00856206|3974449|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|319|319.0||||||
4150702|NCT00856206|3974447|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4150703|NCT00856206|3974448|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4150704|NCT00856206|3974449|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4150705|NCT00856206|3974447|B3||Male|Sex: Female, Male||Participants|Count of Participants|1154|1154.0||||||
4150706|NCT00856206|3974448|B2||Male|Sex: Female, Male||Participants|Count of Participants|857|857.0||||||
4150707|NCT00856206|3974449|B1||Male|Sex: Female, Male||Participants|Count of Participants|297|297.0||||||
4150708|NCT00856206|3974447|B3||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4150709|NCT00856206|3974448|B2||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4150710|NCT00856206|3974449|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4150711|NCT00856206|3974447|B3|||Age||years|Mean|52.7|52.7|Standard Deviation|11.25|11.25|||
4150712|NCT00856206|3974448|B2|||Age||years|Mean|52.8|52.8|Standard Deviation|11.48|11.48|||
4150713|NCT00856206|3974449|B1|||Age||years|Mean|52.4|52.4|Standard Deviation|10.55|10.55|||
4150714|NCT00856193|3974464|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4150715|NCT00856193|3974464|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4150716|NCT00856193|3974464|B1|||Age||years|Mean|60.5|60.5|Standard Deviation|9.13|9.13|||
4150717|NCT00856180|3974477|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4150718|NCT00856180|3974477|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4150719|NCT00856180|3974477|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4150720|NCT00856180|3974477|B1|||Age||years|Median|64|64.0|Full Range|||44.0|82.0|
4150721|NCT00856050|3974486|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4150722|NCT00856050|3974486|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4150723|NCT00856050|3974486|B1|||Age||years|Mean|56|56.0|Full Range|||44.0|74.0|
4150724|NCT00856024|3974490|B1|Brazil||Region of Enrollment||participants|Number|902|902.0||||||
4150725|NCT00856024|3974490|B1||Male|Sex: Female, Male||Participants|Count of Participants|535|535.0||||||
4150726|NCT00856024|3974490|B1||Female|Sex: Female, Male||Participants|Count of Participants|367|367.0||||||
4150727|NCT00856024|3974490|B1|||Age|Age data were only available for 900 participants|years|Mean|49.9|49.9|Standard Deviation|9.8|9.8|||
4150728|NCT00855959|3974502|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4150729|NCT00855959|3974502|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4150730|NCT00855959|3974502|B1|||Age||Years|Mean|43.9|43.9|Standard Deviation|13.4|13.4|||
4150731|NCT00855933|3974517|B3|||Whole Mouth Average Lobene Modified Gingival Index||Units on a scale|Mean|2.40|2.4|Standard Deviation|0.27|0.27|||
4150732|NCT00855933|3974518|B2|||Whole Mouth Average Lobene Modified Gingival Index||Units on a scale|Mean|2.38|2.38|Standard Deviation|0.27|0.27|||
4150733|NCT00855933|3974519|B1|||Whole Mouth Average Lobene Modified Gingival Index||Units on a scale|Mean|2.41|2.41|Standard Deviation|0.28|0.28|||
4150734|NCT00855933|3974517|B3|Guatemala||Region of Enrollment||participants|Number|60|60.0||||||
4150735|NCT00855933|3974518|B2|Guatemala||Region of Enrollment||participants|Number|30|30.0||||||
4150736|NCT00855933|3974519|B1|Guatemala||Region of Enrollment||participants|Number|30|30.0||||||
4150737|NCT00855933|3974517|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4150738|NCT00855933|3974518|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4150739|NCT00855933|3974519|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4150740|NCT00855933|3974517|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4150741|NCT00855933|3974518|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4150742|NCT00855933|3974519|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4150743|NCT00855933|3974517|B3|||Age||years|Mean|28.7|28.7|Standard Deviation|9.71|9.71|||
4150744|NCT00855933|3974518|B2|||Age||years|Mean|27.8|27.8|Standard Deviation|9.41|9.41|||
4150745|NCT00855933|3974519|B1|||Age||years|Mean|29.5|29.5|Standard Deviation|10.08|10.08|||
4150746|NCT00855933|3974517|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4150747|NCT00855933|3974518|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4150748|NCT00855933|3974519|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4150749|NCT00855933|3974517|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4150750|NCT00855933|3974518|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4150751|NCT00855933|3974519|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4150752|NCT00855933|3974517|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4150753|NCT00855933|3974518|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4150754|NCT00855933|3974519|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4150755|NCT00855920|3974526|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150756|NCT00855920|3974527|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150757|NCT00855920|3974528|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150758|NCT00855920|3974529|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150759|NCT00855920|3974526|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150760|NCT00855920|3974527|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150761|NCT00855920|3974528|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150762|NCT00855920|3974529|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150763|NCT00855920|3974526|B4||White|Race (NIH/OMB)||Participants|Count of Participants|168|168.0||||||
4150764|NCT00855920|3974527|B3||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4150765|NCT00855920|3974528|B2||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4150766|NCT00855920|3974529|B1||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4150767|NCT00855920|3974526|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4150768|NCT00855920|3974527|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4150769|NCT00855920|3974528|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4150770|NCT00855920|3974529|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4150771|NCT00855920|3974526|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4150772|NCT00855920|3974527|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150773|NCT00855920|3974528|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4150774|NCT00855920|3974529|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150775|NCT00855920|3974526|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4150776|NCT00855920|3974527|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4150777|NCT00855920|3974528|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4150778|NCT00855920|3974529|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4150779|NCT00855920|3974526|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4150780|NCT00855920|3974527|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150781|NCT00855920|3974528|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4150782|NCT00855920|3974529|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4150783|NCT00855920|3974526|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150784|NCT00855920|3974527|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150785|NCT00855920|3974528|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150786|NCT00855920|3974529|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150787|NCT00855920|3974526|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|210|210.0||||||
4150788|NCT00855920|3974527|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4150789|NCT00855920|3974528|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4150790|NCT00855920|3974529|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4150791|NCT00855920|3974526|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4150792|NCT00855920|3974527|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4150793|NCT00855920|3974528|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4150794|NCT00855920|3974529|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4150795|NCT00855920|3974526|B4||Male|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4150796|NCT00855920|3974527|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4150797|NCT00855920|3974528|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4150798|NCT00855920|3974529|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4150799|NCT00855920|3974526|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4150800|NCT00855920|3974527|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4150801|NCT00855920|3974528|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4150802|NCT00855920|3974529|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4150803|NCT00855920|3974526|B4|||Age||years|Mean|50.3|50.3|Standard Deviation|10.59|10.59|||
4150804|NCT00855920|3974527|B3|||Age||years|Mean|51.0|51.0|Standard Deviation|10.83|10.83|||
4150805|NCT00855920|3974528|B2|||Age||years|Mean|48.6|48.6|Standard Deviation|9.95|9.95|||
4150806|NCT00855920|3974529|B1|||Age||years|Mean|51.3|51.3|Standard Deviation|10.90|10.9|||
4150807|NCT00855894|3974548|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4150808|NCT00855894|3974548|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4150809|NCT00855894|3974548|B1|||Age||years|Mean|60.7|60.7|Standard Deviation|8.3|8.3|||
4150810|NCT00855868|3974556|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
4150811|NCT00855868|3974557|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4150812|NCT00855868|3974558|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4150813|NCT00855868|3974556|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4150814|NCT00855868|3974557|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4150815|NCT00855868|3974558|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4150816|NCT00855868|3974556|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4150817|NCT00855868|3974557|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4150818|NCT00855868|3974558|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4150819|NCT00855868|3974556|B3|||Age||years|Mean|70.7|70.7|Standard Deviation|9.39|9.39|||
4150820|NCT00855868|3974557|B2|||Age||years|Mean|71.5|71.5|Standard Deviation|9.23|9.23|||
4150821|NCT00855868|3974558|B1|||Age||years|Mean|69.8|69.8|Standard Deviation|9.88|9.88|||
4150822|NCT00855842|3974565|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4150823|NCT00855842|3974565|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4150824|NCT00855842|3974565|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4150825|NCT00855842|3974565|B1|||Age||years|Mean|27|27.0|Standard Deviation|5|5.0|||
4150826|NCT00855842|3974565|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4150827|NCT00855842|3974565|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4150828|NCT00855842|3974565|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4150829|NCT00855816|3974569|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
4150830|NCT00855816|3974570|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4150831|NCT00855816|3974571|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
4150832|NCT00855816|3974569|B3||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4150833|NCT00855816|3974570|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4150834|NCT00855816|3974571|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4150835|NCT00855816|3974569|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4150836|NCT00855816|3974570|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4150837|NCT00855816|3974571|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4150838|NCT00855816|3974569|B3|||Age||years|Mean|53.14|53.14|Standard Deviation|10.8|10.8|||
4150839|NCT00855816|3974570|B2|||Age||years|Mean|53.21|53.21|Standard Deviation|10.62|10.62|||
4150840|NCT00855816|3974571|B1|||Age||years|Mean|53.09|53.09|Standard Deviation|11.04|11.04|||
4150841|NCT00855738|3974578|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4150842|NCT00855738|3974578|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4150843|NCT00855738|3974578|B1|||Age||years|Mean|45.3|45.3|Standard Deviation|16.1|16.1|||
4150844|NCT00855595|3974604|B3|||Previous duration of rosacea||Months|Mean|132.8|132.8|Standard Deviation|117.0|117.0|||
4150845|NCT00855595|3974605|B2|||Previous duration of rosacea||Months|Mean|134.9|134.9|Standard Deviation|107.2|107.2|||
4150846|NCT00855595|3974606|B1|||Previous duration of rosacea||Months|Mean|130.8|130.8|Standard Deviation|126.1|126.1|||
4150847|NCT00855595|3974604|B3|||Number of lesions at Baseline||Lesions|Mean|21.3|21.3|Standard Deviation|10.76|10.76|||
4150848|NCT00855595|3974605|B2|||Number of lesions at Baseline||Lesions|Mean|21.9|21.9|Standard Deviation|10.50|10.5|||
4150849|NCT00855595|3974606|B1|||Number of lesions at Baseline||Lesions|Mean|20.6|20.6|Standard Deviation|11.01|11.01|||
4150850|NCT00855595|3974604|B3|IGA Score 6- Severe||Investigator’s Global Assessment (IGA) score at Baseline|IGA categories: 0 - Clear; 1 - Minimal; 2 - Mild; 3 - Mild to moderate; 4 - Moderate; 5 - Moderate to severe; 6 - Severe (refer to Detailed Description field in Protocol section for more information).|Participants|Number|4|4.0||||||
4150851|NCT00855595|3974605|B2|IGA Score 6- Severe||Investigator’s Global Assessment (IGA) score at Baseline|IGA categories: 0 - Clear; 1 - Minimal; 2 - Mild; 3 - Mild to moderate; 4 - Moderate; 5 - Moderate to severe; 6 - Severe (refer to Detailed Description field in Protocol section for more information).|Participants|Number|3|3.0||||||
4150852|NCT00855595|3974606|B1|IGA Score 6- Severe||Investigator’s Global Assessment (IGA) score at Baseline|IGA categories: 0 - Clear; 1 - Minimal; 2 - Mild; 3 - Mild to moderate; 4 - Moderate; 5 - Moderate to severe; 6 - Severe (refer to Detailed Description field in Protocol section for more information).|Participants|Number|1|1.0||||||
4150853|NCT00855595|3974604|B3|IGA Score 5 - Moderate to Severe||Investigator’s Global Assessment (IGA) score at Baseline|IGA categories: 0 - Clear; 1 - Minimal; 2 - Mild; 3 - Mild to moderate; 4 - Moderate; 5 - Moderate to severe; 6 - Severe (refer to Detailed Description field in Protocol section for more information).|Participants|Number|48|48.0||||||
4150854|NCT00855595|3974605|B2|IGA Score 5 - Moderate to Severe||Investigator’s Global Assessment (IGA) score at Baseline|IGA categories: 0 - Clear; 1 - Minimal; 2 - Mild; 3 - Mild to moderate; 4 - Moderate; 5 - Moderate to severe; 6 - Severe (refer to Detailed Description field in Protocol section for more information).|Participants|Number|22|22.0||||||
4150973|NCT00855582|3974644|B3|France||Region of Enrollment||participants|Number|21|21.0||||||
4150855|NCT00855595|3974606|B1|IGA Score 5 - Moderate to Severe||Investigator’s Global Assessment (IGA) score at Baseline|IGA categories: 0 - Clear; 1 - Minimal; 2 - Mild; 3 - Mild to moderate; 4 - Moderate; 5 - Moderate to severe; 6 - Severe (refer to Detailed Description field in Protocol section for more information).|Participants|Number|26|26.0||||||
4150856|NCT00855595|3974604|B3|IGA Score 4 - Moderate||Investigator’s Global Assessment (IGA) score at Baseline|IGA categories: 0 - Clear; 1 - Minimal; 2 - Mild; 3 - Mild to moderate; 4 - Moderate; 5 - Moderate to severe; 6 - Severe (refer to Detailed Description field in Protocol section for more information).|Participants|Number|155|155.0||||||
4150857|NCT00855595|3974605|B2|IGA Score 4 - Moderate||Investigator’s Global Assessment (IGA) score at Baseline|IGA categories: 0 - Clear; 1 - Minimal; 2 - Mild; 3 - Mild to moderate; 4 - Moderate; 5 - Moderate to severe; 6 - Severe (refer to Detailed Description field in Protocol section for more information).|Participants|Number|76|76.0||||||
4150858|NCT00855595|3974606|B1|IGA Score 4 - Moderate||Investigator’s Global Assessment (IGA) score at Baseline|IGA categories: 0 - Clear; 1 - Minimal; 2 - Mild; 3 - Mild to moderate; 4 - Moderate; 5 - Moderate to severe; 6 - Severe (refer to Detailed Description field in Protocol section for more information).|Participants|Number|79|79.0||||||
4150859|NCT00855595|3974604|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4150860|NCT00855595|3974605|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4150861|NCT00855595|3974606|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4150862|NCT00855595|3974604|B3||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4150863|NCT00855595|3974605|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4150864|NCT00855595|3974606|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4150865|NCT00855595|3974604|B3|||Age||Years|Mean|49.4|49.4|Standard Deviation|12.2|12.2|||
4150866|NCT00855595|3974605|B2|||Age||Years|Mean|48.4|48.4|Standard Deviation|11.5|11.5|||
4150867|NCT00855595|3974606|B1|||Age||Years|Mean|50.4|50.4|Standard Deviation|12.7|12.7|||
4150868|NCT00855582|3974643|B4|≥1 year||ED - Duration||participants|Number|555|555.0||||||
4150869|NCT00855582|3974644|B3|≥1 year||ED - Duration||participants|Number|181|181.0||||||
4150870|NCT00855582|3974645|B2|≥1 year||ED - Duration||participants|Number|188|188.0||||||
4150871|NCT00855582|3974646|B1|≥1 year||ED - Duration||participants|Number|186|186.0||||||
4150872|NCT00855582|3974643|B4|<1 year||ED - Duration||participants|Number|51|51.0||||||
4150873|NCT00855582|3974644|B3|<1 year||ED - Duration||participants|Number|19|19.0||||||
4150874|NCT00855582|3974645|B2|<1 year||ED - Duration||participants|Number|20|20.0||||||
4150875|NCT00855582|3974646|B1|<1 year||ED - Duration||participants|Number|12|12.0||||||
4150876|NCT00855582|3974643|B4|Severe (IIEF EF Domain 1-10)||ED - Severity|Self-reported erectile function over the past 4 weeks. Scores range from 0 (low or no erectile function) to 5 (high erectile function) on 6 questions (1-5, 15 of the IIEF). Total Erectile Function Domain scores range from 0 to 30; lower numerical scores represent greater severity of erectile dysfunction.|participants|Number|161|161.0||||||
4150877|NCT00855582|3974644|B3|Severe (IIEF EF Domain 1-10)||ED - Severity|Self-reported erectile function over the past 4 weeks. Scores range from 0 (low or no erectile function) to 5 (high erectile function) on 6 questions (1-5, 15 of the IIEF). Total Erectile Function Domain scores range from 0 to 30; lower numerical scores represent greater severity of erectile dysfunction.|participants|Number|58|58.0||||||
4150878|NCT00855582|3974645|B2|Severe (IIEF EF Domain 1-10)||ED - Severity|Self-reported erectile function over the past 4 weeks. Scores range from 0 (low or no erectile function) to 5 (high erectile function) on 6 questions (1-5, 15 of the IIEF). Total Erectile Function Domain scores range from 0 to 30; lower numerical scores represent greater severity of erectile dysfunction.|participants|Number|55|55.0||||||
4150879|NCT00855582|3974646|B1|Severe (IIEF EF Domain 1-10)||ED - Severity|Self-reported erectile function over the past 4 weeks. Scores range from 0 (low or no erectile function) to 5 (high erectile function) on 6 questions (1-5, 15 of the IIEF). Total Erectile Function Domain scores range from 0 to 30; lower numerical scores represent greater severity of erectile dysfunction.|participants|Number|48|48.0||||||
4150880|NCT00855582|3974643|B4|Moderate (IIEF EF Domain 11-16)||ED - Severity|Self-reported erectile function over the past 4 weeks. Scores range from 0 (low or no erectile function) to 5 (high erectile function) on 6 questions (1-5, 15 of the IIEF). Total Erectile Function Domain scores range from 0 to 30; lower numerical scores represent greater severity of erectile dysfunction.|participants|Number|149|149.0||||||
4150881|NCT00855582|3974644|B3|Moderate (IIEF EF Domain 11-16)||ED - Severity|Self-reported erectile function over the past 4 weeks. Scores range from 0 (low or no erectile function) to 5 (high erectile function) on 6 questions (1-5, 15 of the IIEF). Total Erectile Function Domain scores range from 0 to 30; lower numerical scores represent greater severity of erectile dysfunction.|participants|Number|49|49.0||||||
4150882|NCT00855582|3974645|B2|Moderate (IIEF EF Domain 11-16)||ED - Severity|Self-reported erectile function over the past 4 weeks. Scores range from 0 (low or no erectile function) to 5 (high erectile function) on 6 questions (1-5, 15 of the IIEF). Total Erectile Function Domain scores range from 0 to 30; lower numerical scores represent greater severity of erectile dysfunction.|participants|Number|54|54.0||||||
4150883|NCT00855582|3974646|B1|Moderate (IIEF EF Domain 11-16)||ED - Severity|Self-reported erectile function over the past 4 weeks. Scores range from 0 (low or no erectile function) to 5 (high erectile function) on 6 questions (1-5, 15 of the IIEF). Total Erectile Function Domain scores range from 0 to 30; lower numerical scores represent greater severity of erectile dysfunction.|participants|Number|46|46.0||||||
4150884|NCT00855582|3974643|B4|Mild (IIEF EF Domain 17-30)||ED - Severity|Self-reported erectile function over the past 4 weeks. Scores range from 0 (low or no erectile function) to 5 (high erectile function) on 6 questions (1-5, 15 of the IIEF). Total Erectile Function Domain scores range from 0 to 30; lower numerical scores represent greater severity of erectile dysfunction.|participants|Number|296|296.0||||||
4150885|NCT00855582|3974644|B3|Mild (IIEF EF Domain 17-30)||ED - Severity|Self-reported erectile function over the past 4 weeks. Scores range from 0 (low or no erectile function) to 5 (high erectile function) on 6 questions (1-5, 15 of the IIEF). Total Erectile Function Domain scores range from 0 to 30; lower numerical scores represent greater severity of erectile dysfunction.|participants|Number|93|93.0||||||
4150886|NCT00855582|3974645|B2|Mild (IIEF EF Domain 17-30)||ED - Severity|Self-reported erectile function over the past 4 weeks. Scores range from 0 (low or no erectile function) to 5 (high erectile function) on 6 questions (1-5, 15 of the IIEF). Total Erectile Function Domain scores range from 0 to 30; lower numerical scores represent greater severity of erectile dysfunction.|participants|Number|99|99.0||||||
4150887|NCT00855582|3974646|B1|Mild (IIEF EF Domain 17-30)||ED - Severity|Self-reported erectile function over the past 4 weeks. Scores range from 0 (low or no erectile function) to 5 (high erectile function) on 6 questions (1-5, 15 of the IIEF). Total Erectile Function Domain scores range from 0 to 30; lower numerical scores represent greater severity of erectile dysfunction.|participants|Number|104|104.0||||||
4150888|NCT00855582|3974643|B4|Unknown||Erectile Dysfunction (ED) - Etiology||participants|Number|124|124.0||||||
4150889|NCT00855582|3974644|B3|Unknown||Erectile Dysfunction (ED) - Etiology||participants|Number|40|40.0||||||
4150890|NCT00855582|3974645|B2|Unknown||Erectile Dysfunction (ED) - Etiology||participants|Number|40|40.0||||||
4150891|NCT00855582|3974646|B1|Unknown||Erectile Dysfunction (ED) - Etiology||participants|Number|44|44.0||||||
4150892|NCT00855582|3974643|B4|Mixed||Erectile Dysfunction (ED) - Etiology||participants|Number|222|222.0||||||
4150893|NCT00855582|3974644|B3|Mixed||Erectile Dysfunction (ED) - Etiology||participants|Number|63|63.0||||||
4150894|NCT00855582|3974645|B2|Mixed||Erectile Dysfunction (ED) - Etiology||participants|Number|83|83.0||||||
4150895|NCT00855582|3974646|B1|Mixed||Erectile Dysfunction (ED) - Etiology||participants|Number|76|76.0||||||
4150896|NCT00855582|3974643|B4|Organic||Erectile Dysfunction (ED) - Etiology||participants|Number|220|220.0||||||
4150897|NCT00855582|3974644|B3|Organic||Erectile Dysfunction (ED) - Etiology||participants|Number|85|85.0||||||
4150898|NCT00855582|3974645|B2|Organic||Erectile Dysfunction (ED) - Etiology||participants|Number|70|70.0||||||
4150899|NCT00855582|3974646|B1|Organic||Erectile Dysfunction (ED) - Etiology||participants|Number|65|65.0||||||
4150900|NCT00855582|3974643|B4|Psychogenic||Erectile Dysfunction (ED) - Etiology||participants|Number|40|40.0||||||
4150901|NCT00855582|3974644|B3|Psychogenic||Erectile Dysfunction (ED) - Etiology||participants|Number|12|12.0||||||
4150902|NCT00855582|3974645|B2|Psychogenic||Erectile Dysfunction (ED) - Etiology||participants|Number|15|15.0||||||
4150903|NCT00855582|3974646|B1|Psychogenic||Erectile Dysfunction (ED) - Etiology||participants|Number|13|13.0||||||
4150904|NCT00855582|3974643|B4|||Postvoid Residual Volume (PRV)||mL|Mean|53.2|53.2|Standard Deviation|57.72|57.72|||
4150905|NCT00855582|3974644|B3|||Postvoid Residual Volume (PRV)||mL|Mean|55.5|55.5|Standard Deviation|60.46|60.46|||
4150906|NCT00855582|3974645|B2|||Postvoid Residual Volume (PRV)||mL|Mean|51.1|51.1|Standard Deviation|60.91|60.91|||
4150907|NCT00855582|3974646|B1|||Postvoid Residual Volume (PRV)||mL|Mean|53.0|53.0|Standard Deviation|51.24|51.24|||
4150908|NCT00855582|3974643|B4|Unknown||Peak Urine Flow Rate (Qmax)||participants|Number|49|49.0||||||
4150909|NCT00855582|3974644|B3|Unknown||Peak Urine Flow Rate (Qmax)||participants|Number|19|19.0||||||
4150910|NCT00855582|3974645|B2|Unknown||Peak Urine Flow Rate (Qmax)||participants|Number|22|22.0||||||
4150911|NCT00855582|3974646|B1|Unknown||Peak Urine Flow Rate (Qmax)||participants|Number|8|8.0||||||
4150912|NCT00855582|3974643|B4|>15mL/sec||Peak Urine Flow Rate (Qmax)||participants|Number|53|53.0||||||
4150913|NCT00855582|3974644|B3|>15mL/sec||Peak Urine Flow Rate (Qmax)||participants|Number|16|16.0||||||
4150914|NCT00855582|3974645|B2|>15mL/sec||Peak Urine Flow Rate (Qmax)||participants|Number|16|16.0||||||
4150915|NCT00855582|3974646|B1|>15mL/sec||Peak Urine Flow Rate (Qmax)||participants|Number|21|21.0||||||
4150916|NCT00855582|3974643|B4|10-15 mL/sec||Peak Urine Flow Rate (Qmax)||participants|Number|222|222.0||||||
4150917|NCT00855582|3974644|B3|10-15 mL/sec||Peak Urine Flow Rate (Qmax)||participants|Number|66|66.0||||||
4150918|NCT00855582|3974645|B2|10-15 mL/sec||Peak Urine Flow Rate (Qmax)||participants|Number|83|83.0||||||
4150919|NCT00855582|3974646|B1|10-15 mL/sec||Peak Urine Flow Rate (Qmax)||participants|Number|73|73.0||||||
4150920|NCT00855582|3974643|B4|<10 mL/sec||Peak Urine Flow Rate (Qmax)||participants|Number|282|282.0||||||
4150921|NCT00855582|3974644|B3|<10 mL/sec||Peak Urine Flow Rate (Qmax)||participants|Number|99|99.0||||||
4150922|NCT00855582|3974645|B2|<10 mL/sec||Peak Urine Flow Rate (Qmax)||participants|Number|87|87.0||||||
4150923|NCT00855582|3974646|B1|<10 mL/sec||Peak Urine Flow Rate (Qmax)||participants|Number|96|96.0||||||
4150924|NCT00855582|3974643|B4|Unknown||Lower Urinary Tract Symptoms (LUTS) Severity|The total IPSS is obtained by combining the scores of the responses to component questions 1 through 7. Each question is scored from 0-5 for a total IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|1|1.0||||||
4150925|NCT00855582|3974644|B3|Unknown||Lower Urinary Tract Symptoms (LUTS) Severity|The total IPSS is obtained by combining the scores of the responses to component questions 1 through 7. Each question is scored from 0-5 for a total IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|0|0.0||||||
4150926|NCT00855582|3974645|B2|Unknown||Lower Urinary Tract Symptoms (LUTS) Severity|The total IPSS is obtained by combining the scores of the responses to component questions 1 through 7. Each question is scored from 0-5 for a total IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|0|0.0||||||
4150927|NCT00855582|3974646|B1|Unknown||Lower Urinary Tract Symptoms (LUTS) Severity|The total IPSS is obtained by combining the scores of the responses to component questions 1 through 7. Each question is scored from 0-5 for a total IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|1|1.0||||||
4150928|NCT00855582|3974643|B4|Severe (IPSS ≥20)||Lower Urinary Tract Symptoms (LUTS) Severity|The total IPSS is obtained by combining the scores of the responses to component questions 1 through 7. Each question is scored from 0-5 for a total IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|236|236.0||||||
4150974|NCT00855582|3974645|B2|France||Region of Enrollment||participants|Number|24|24.0||||||
4150929|NCT00855582|3974644|B3|Severe (IPSS ≥20)||Lower Urinary Tract Symptoms (LUTS) Severity|The total IPSS is obtained by combining the scores of the responses to component questions 1 through 7. Each question is scored from 0-5 for a total IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|78|78.0||||||
4150930|NCT00855582|3974645|B2|Severe (IPSS ≥20)||Lower Urinary Tract Symptoms (LUTS) Severity|The total IPSS is obtained by combining the scores of the responses to component questions 1 through 7. Each question is scored from 0-5 for a total IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|84|84.0||||||
4150931|NCT00855582|3974646|B1|Severe (IPSS ≥20)||Lower Urinary Tract Symptoms (LUTS) Severity|The total IPSS is obtained by combining the scores of the responses to component questions 1 through 7. Each question is scored from 0-5 for a total IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|74|74.0||||||
4150932|NCT00855582|3974643|B4|Moderate (IPSS <20)||Lower Urinary Tract Symptoms (LUTS) Severity|The total IPSS is obtained by combining the scores of the responses to component questions 1 through 7. Each question is scored from 0-5 for a total IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|369|369.0||||||
4150933|NCT00855582|3974644|B3|Moderate (IPSS <20)||Lower Urinary Tract Symptoms (LUTS) Severity|The total IPSS is obtained by combining the scores of the responses to component questions 1 through 7. Each question is scored from 0-5 for a total IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|122|122.0||||||
4150934|NCT00855582|3974645|B2|Moderate (IPSS <20)||Lower Urinary Tract Symptoms (LUTS) Severity|The total IPSS is obtained by combining the scores of the responses to component questions 1 through 7. Each question is scored from 0-5 for a total IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|124|124.0||||||
4150935|NCT00855582|3974646|B1|Moderate (IPSS <20)||Lower Urinary Tract Symptoms (LUTS) Severity|The total IPSS is obtained by combining the scores of the responses to component questions 1 through 7. Each question is scored from 0-5 for a total IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|123|123.0||||||
4150936|NCT00855582|3974643|B4|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kg/m²|Mean|28.1|28.1|Standard Deviation|4.3|4.3|||
4150937|NCT00855582|3974644|B3|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kg/m²|Mean|28.6|28.6|Standard Deviation|4.8|4.8|||
4150938|NCT00855582|3974645|B2|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kg/m²|Mean|28.0|28.0|Standard Deviation|4.18|4.18|||
4150939|NCT00855582|3974646|B1|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kg/m²|Mean|27.7|27.7|Standard Deviation|3.86|3.86|||
4150940|NCT00855582|3974643|B4|Italy||Region of Enrollment||participants|Number|39|39.0||||||
4150941|NCT00855582|3974644|B3|Italy||Region of Enrollment||participants|Number|14|14.0||||||
4150942|NCT00855582|3974645|B2|Italy||Region of Enrollment||participants|Number|10|10.0||||||
4150943|NCT00855582|3974646|B1|Italy||Region of Enrollment||participants|Number|15|15.0||||||
4150944|NCT00855582|3974643|B4|Germany||Region of Enrollment||participants|Number|31|31.0||||||
4150945|NCT00855582|3974644|B3|Germany||Region of Enrollment||participants|Number|9|9.0||||||
4150946|NCT00855582|3974645|B2|Germany||Region of Enrollment||participants|Number|12|12.0||||||
4150947|NCT00855582|3974646|B1|Germany||Region of Enrollment||participants|Number|10|10.0||||||
4150948|NCT00855582|3974643|B4|Russian Federation||Region of Enrollment||participants|Number|75|75.0||||||
4150949|NCT00855582|3974644|B3|Russian Federation||Region of Enrollment||participants|Number|25|25.0||||||
4150950|NCT00855582|3974645|B2|Russian Federation||Region of Enrollment||participants|Number|29|29.0||||||
4150951|NCT00855582|3974646|B1|Russian Federation||Region of Enrollment||participants|Number|21|21.0||||||
4150952|NCT00855582|3974643|B4|Greece||Region of Enrollment||participants|Number|25|25.0||||||
4150953|NCT00855582|3974644|B3|Greece||Region of Enrollment||participants|Number|9|9.0||||||
4150954|NCT00855582|3974645|B2|Greece||Region of Enrollment||participants|Number|9|9.0||||||
4150955|NCT00855582|3974646|B1|Greece||Region of Enrollment||participants|Number|7|7.0||||||
4150956|NCT00855582|3974643|B4|Canada||Region of Enrollment||participants|Number|71|71.0||||||
4150957|NCT00855582|3974644|B3|Canada||Region of Enrollment||participants|Number|26|26.0||||||
4150958|NCT00855582|3974645|B2|Canada||Region of Enrollment||participants|Number|23|23.0||||||
4150959|NCT00855582|3974646|B1|Canada||Region of Enrollment||participants|Number|22|22.0||||||
4150960|NCT00855582|3974643|B4|Mexico||Region of Enrollment||participants|Number|76|76.0||||||
4150961|NCT00855582|3974644|B3|Mexico||Region of Enrollment||participants|Number|22|22.0||||||
4150962|NCT00855582|3974645|B2|Mexico||Region of Enrollment||participants|Number|27|27.0||||||
4150963|NCT00855582|3974646|B1|Mexico||Region of Enrollment||participants|Number|27|27.0||||||
4150964|NCT00855582|3974643|B4|United States||Region of Enrollment||participants|Number|210|210.0||||||
4150965|NCT00855582|3974644|B3|United States||Region of Enrollment||participants|Number|68|68.0||||||
4150966|NCT00855582|3974645|B2|United States||Region of Enrollment||participants|Number|71|71.0||||||
4150967|NCT00855582|3974646|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
4150968|NCT00855582|3974643|B4|Portugal||Region of Enrollment||participants|Number|17|17.0||||||
4150969|NCT00855582|3974644|B3|Portugal||Region of Enrollment||participants|Number|6|6.0||||||
4150970|NCT00855582|3974645|B2|Portugal||Region of Enrollment||participants|Number|3|3.0||||||
4150971|NCT00855582|3974646|B1|Portugal||Region of Enrollment||participants|Number|8|8.0||||||
4150972|NCT00855582|3974643|B4|France||Region of Enrollment||participants|Number|62|62.0||||||
4150975|NCT00855582|3974646|B1|France||Region of Enrollment||participants|Number|17|17.0||||||
4150976|NCT00855582|3974643|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150977|NCT00855582|3974644|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150978|NCT00855582|3974645|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150979|NCT00855582|3974646|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150980|NCT00855582|3974643|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4150981|NCT00855582|3974644|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150982|NCT00855582|3974645|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4150983|NCT00855582|3974646|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4150984|NCT00855582|3974643|B4||White|Race (NIH/OMB)||Participants|Count of Participants|565|565.0||||||
4150985|NCT00855582|3974644|B3||White|Race (NIH/OMB)||Participants|Count of Participants|190|190.0||||||
4150986|NCT00855582|3974645|B2||White|Race (NIH/OMB)||Participants|Count of Participants|194|194.0||||||
4150987|NCT00855582|3974646|B1||White|Race (NIH/OMB)||Participants|Count of Participants|181|181.0||||||
4150988|NCT00855582|3974643|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4150989|NCT00855582|3974644|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4150990|NCT00855582|3974645|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4150991|NCT00855582|3974646|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4150992|NCT00855582|3974643|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150993|NCT00855582|3974644|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150994|NCT00855582|3974645|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150995|NCT00855582|3974646|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4150996|NCT00855582|3974643|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4150997|NCT00855582|3974644|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4150998|NCT00855582|3974645|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4150999|NCT00855582|3974646|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4151000|NCT00855582|3974643|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4151001|NCT00855582|3974644|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151002|NCT00855582|3974645|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151003|NCT00855582|3974646|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4151004|NCT00855582|3974643|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151005|NCT00855582|3974644|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151006|NCT00855582|3974645|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151007|NCT00855582|3974646|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151008|NCT00855582|3974643|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|512|512.0||||||
4151009|NCT00855582|3974644|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|170|170.0||||||
4151010|NCT00855582|3974645|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|177|177.0||||||
4151011|NCT00855582|3974646|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|165|165.0||||||
4151012|NCT00855582|3974643|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
4151013|NCT00855582|3974644|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4151014|NCT00855582|3974645|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4151015|NCT00855582|3974646|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4151016|NCT00855582|3974643|B4||Male|Sex: Female, Male||Participants|Count of Participants|606|606.0||||||
4151017|NCT00855582|3974644|B3||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4151018|NCT00855582|3974645|B2||Male|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4151019|NCT00855582|3974646|B1||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4151020|NCT00855582|3974643|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4151021|NCT00855582|3974644|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4151022|NCT00855582|3974645|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4151023|NCT00855582|3974646|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4151024|NCT00855582|3974643|B4|||Age||years|Mean|62.6|62.6|Standard Deviation|8.08|8.08|||
4151025|NCT00855582|3974644|B3|||Age||years|Mean|62.9|62.9|Standard Deviation|8.23|8.23|||
4151026|NCT00855582|3974645|B2|||Age||years|Mean|62.5|62.5|Standard Deviation|8.43|8.43|||
4151027|NCT00855582|3974646|B1|||Age||years|Mean|62.2|62.2|Standard Deviation|7.56|7.56|||
4151028|NCT00855465|3974735|B3|||Pulmonary vascular resistance|The pulmonary vascular resistance (PVR) is a calculated hemodynamic parameter. PVR is derived from the directly measured parameters mean pulmonary arterial pressure (PAPmean) and pulmonary capillary wedge pressure (PCWP), divided by the cardiac output (CO). PVR and PAPmean are acquired during a right heart catheterization. CO is a calculated hemodynamic parameter, too. Formula: PVR = 80*(PAPmean - PCWP)/CO|dyn*s*cm^-5|Mean|786.68|786.68|Standard Deviation|420.21|420.21|||
4151029|NCT00855465|3974736|B2|||Pulmonary vascular resistance|The pulmonary vascular resistance (PVR) is a calculated hemodynamic parameter. PVR is derived from the directly measured parameters mean pulmonary arterial pressure (PAPmean) and pulmonary capillary wedge pressure (PCWP), divided by the cardiac output (CO). PVR and PAPmean are acquired during a right heart catheterization. CO is a calculated hemodynamic parameter, too. Formula: PVR = 80*(PAPmean - PCWP)/CO|dyn*s*cm^-5|Mean|779.32|779.32|Standard Deviation|400.94|400.94|||
4151030|NCT00855465|3974737|B1|||Pulmonary vascular resistance|The pulmonary vascular resistance (PVR) is a calculated hemodynamic parameter. PVR is derived from the directly measured parameters mean pulmonary arterial pressure (PAPmean) and pulmonary capillary wedge pressure (PCWP), divided by the cardiac output (CO). PVR and PAPmean are acquired during a right heart catheterization. CO is a calculated hemodynamic parameter, too. Formula: PVR = 80*(PAPmean - PCWP)/CO|dyn*s*cm^-5|Mean|790.68|790.68|Standard Deviation|431.57|431.57|||
4151031|NCT00855465|3974735|B3|IV||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (Patients with PH but without resulting limitation of physical activity) to class IV (Patients with PH with inability to carry out any physical activity without symptoms. These patients manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement; changes to a higher functional class resemble deterioration of pulmonary arterial hypertension (PAH).|Participants|Number|10|10.0||||||
4151032|NCT00855465|3974736|B2|IV||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (Patients with PH but without resulting limitation of physical activity) to class IV (Patients with PH with inability to carry out any physical activity without symptoms. These patients manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement; changes to a higher functional class resemble deterioration of pulmonary arterial hypertension (PAH).|Participants|Number|2|2.0||||||
4151033|NCT00855465|3974737|B1|IV||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (Patients with PH but without resulting limitation of physical activity) to class IV (Patients with PH with inability to carry out any physical activity without symptoms. These patients manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement; changes to a higher functional class resemble deterioration of pulmonary arterial hypertension (PAH).|Participants|Number|8|8.0||||||
4151034|NCT00855465|3974735|B3|III||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (Patients with PH but without resulting limitation of physical activity) to class IV (Patients with PH with inability to carry out any physical activity without symptoms. These patients manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement; changes to a higher functional class resemble deterioration of pulmonary arterial hypertension (PAH).|Participants|Number|167|167.0||||||
4151035|NCT00855465|3974736|B2|III||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (Patients with PH but without resulting limitation of physical activity) to class IV (Patients with PH with inability to carry out any physical activity without symptoms. These patients manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement; changes to a higher functional class resemble deterioration of pulmonary arterial hypertension (PAH).|Participants|Number|60|60.0||||||
4151036|NCT00855465|3974737|B1|III||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (Patients with PH but without resulting limitation of physical activity) to class IV (Patients with PH with inability to carry out any physical activity without symptoms. These patients manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement; changes to a higher functional class resemble deterioration of pulmonary arterial hypertension (PAH).|Participants|Number|107|107.0||||||
4151037|NCT00855465|3974735|B3|II||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (Patients with PH but without resulting limitation of physical activity) to class IV (Patients with PH with inability to carry out any physical activity without symptoms. These patients manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement; changes to a higher functional class resemble deterioration of pulmonary arterial hypertension (PAH).|Participants|Number|80|80.0||||||
4151038|NCT00855465|3974736|B2|II||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (Patients with PH but without resulting limitation of physical activity) to class IV (Patients with PH with inability to carry out any physical activity without symptoms. These patients manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement; changes to a higher functional class resemble deterioration of pulmonary arterial hypertension (PAH).|Participants|Number|25|25.0||||||
4151039|NCT00855465|3974737|B1|II||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (Patients with PH but without resulting limitation of physical activity) to class IV (Patients with PH with inability to carry out any physical activity without symptoms. These patients manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement; changes to a higher functional class resemble deterioration of pulmonary arterial hypertension (PAH).|Participants|Number|55|55.0||||||
4151040|NCT00855465|3974735|B3|I||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (Patients with PH but without resulting limitation of physical activity) to class IV (Patients with PH with inability to carry out any physical activity without symptoms. These patients manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement; changes to a higher functional class resemble deterioration of pulmonary arterial hypertension (PAH).|Participants|Number|3|3.0||||||
4151041|NCT00855465|3974736|B2|I||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (Patients with PH but without resulting limitation of physical activity) to class IV (Patients with PH with inability to carry out any physical activity without symptoms. These patients manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement; changes to a higher functional class resemble deterioration of pulmonary arterial hypertension (PAH).|Participants|Number|0|0.0||||||
4151042|NCT00855465|3974737|B1|I||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (Patients with PH but without resulting limitation of physical activity) to class IV (Patients with PH with inability to carry out any physical activity without symptoms. These patients manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement; changes to a higher functional class resemble deterioration of pulmonary arterial hypertension (PAH).|Participants|Number|3|3.0||||||
4151043|NCT00855465|3974735|B3|missing||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (Patients with PH but without resulting limitation of physical activity) to class IV (Patients with PH with inability to carry out any physical activity without symptoms. These patients manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement; changes to a higher functional class resemble deterioration of pulmonary arterial hypertension (PAH).|Participants|Number|1|1.0||||||
4151044|NCT00855465|3974736|B2|missing||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (Patients with PH but without resulting limitation of physical activity) to class IV (Patients with PH with inability to carry out any physical activity without symptoms. These patients manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement; changes to a higher functional class resemble deterioration of pulmonary arterial hypertension (PAH).|Participants|Number|1|1.0||||||
4151045|NCT00855465|3974737|B1|missing||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (Patients with PH but without resulting limitation of physical activity) to class IV (Patients with PH with inability to carry out any physical activity without symptoms. These patients manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement; changes to a higher functional class resemble deterioration of pulmonary arterial hypertension (PAH).|Participants|Number|0|0.0||||||
4151046|NCT00855465|3974735|B3|||6-minute walking distance|6-minute walking distance (6MWD) is a measure for the objective evaluation of a participant's functional exercise capacity.|Meters|Mean|346.9|346.9|Standard Deviation|79.7|79.7|||
4151047|NCT00855465|3974736|B2|||6-minute walking distance|6-minute walking distance (6MWD) is a measure for the objective evaluation of a participant's functional exercise capacity.|Meters|Mean|356.0|356.0|Standard Deviation|74.7|74.7|||
4151048|NCT00855465|3974737|B1|||6-minute walking distance|6-minute walking distance (6MWD) is a measure for the objective evaluation of a participant's functional exercise capacity.|Meters|Mean|342.3|342.3|Standard Deviation|81.9|81.9|||
4151049|NCT00855465|3974735|B3|||Body Mass Index||kg/m^2|Mean|27.33|27.33|Standard Deviation|5.60|5.6|||
4151050|NCT00855465|3974736|B2|||Body Mass Index||kg/m^2|Mean|27.73|27.73|Standard Deviation|5.30|5.3|||
4151051|NCT00855465|3974737|B1|||Body Mass Index||kg/m^2|Mean|27.13|27.13|Standard Deviation|5.75|5.75|||
4151052|NCT00855465|3974735|B3|Postoperative CTEPH||Operability|CTEPH defined as inoperable or as persisting/recurrent PH after pulmonary endarterectomy (PEA).|Participants|Number|72|72.0||||||
4151053|NCT00855465|3974736|B2|Postoperative CTEPH||Operability|CTEPH defined as inoperable or as persisting/recurrent PH after pulmonary endarterectomy (PEA).|Participants|Number|20|20.0||||||
4151054|NCT00855465|3974737|B1|Postoperative CTEPH||Operability|CTEPH defined as inoperable or as persisting/recurrent PH after pulmonary endarterectomy (PEA).|Participants|Number|52|52.0||||||
4151055|NCT00855465|3974735|B3|Inoperable CTEPH||Operability|CTEPH defined as inoperable or as persisting/recurrent PH after pulmonary endarterectomy (PEA).|Participants|Number|189|189.0||||||
4151056|NCT00855465|3974736|B2|Inoperable CTEPH||Operability|CTEPH defined as inoperable or as persisting/recurrent PH after pulmonary endarterectomy (PEA).|Participants|Number|68|68.0||||||
4151057|NCT00855465|3974737|B1|Inoperable CTEPH||Operability|CTEPH defined as inoperable or as persisting/recurrent PH after pulmonary endarterectomy (PEA).|Participants|Number|121|121.0||||||
4151058|NCT00855465|3974735|B3|Not reported||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4151059|NCT00855465|3974736|B2|Not reported||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4151060|NCT00855465|3974737|B1|Not reported||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4151061|NCT00855465|3974735|B3|Mixed||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4151062|NCT00855465|3974736|B2|Mixed||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151063|NCT00855465|3974737|B1|Mixed||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4151064|NCT00855465|3974735|B3|Asian||Race/Ethnicity, Customized||Participants|Number|57|57.0||||||
4151065|NCT00855465|3974736|B2|Asian||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
4151066|NCT00855465|3974737|B1|Asian||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
4151067|NCT00855465|3974735|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4151068|NCT00855465|3974736|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4151069|NCT00855465|3974737|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4151070|NCT00855465|3974735|B3|White||Race/Ethnicity, Customized||Participants|Number|185|185.0||||||
4151071|NCT00855465|3974736|B2|White||Race/Ethnicity, Customized||Participants|Number|65|65.0||||||
4151072|NCT00855465|3974737|B1|White||Race/Ethnicity, Customized||Participants|Number|120|120.0||||||
4151073|NCT00855465|3974735|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4151074|NCT00855465|3974736|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4151075|NCT00855465|3974737|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4151076|NCT00855465|3974735|B3||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4151077|NCT00855465|3974736|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4151078|NCT00855465|3974737|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4151079|NCT00855465|3974735|B3|||Age||Years|Mean|59.3|59.3|Standard Deviation|13.5|13.5|||
4151080|NCT00855465|3974736|B2|||Age||Years|Mean|59.2|59.2|Standard Deviation|12.7|12.7|||
4151081|NCT00855465|3974737|B1|||Age||Years|Mean|59.3|59.3|Standard Deviation|13.9|13.9|||
4151082|NCT00855439|3974826|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
4151083|NCT00855439|3974827|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4151084|NCT00855439|3974828|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4151085|NCT00855439|3974826|B3||Male|Gender||Participants|Count of Participants|26|26.0||||||
4151086|NCT00855439|3974827|B2||Male|Gender||Participants|Count of Participants|13|13.0||||||
4151087|NCT00855439|3974828|B1||Male|Gender||Participants|Count of Participants|13|13.0||||||
4151088|NCT00855439|3974826|B3||Female|Gender||Participants|Count of Participants|20|20.0||||||
4151089|NCT00855439|3974827|B2||Female|Gender||Participants|Count of Participants|11|11.0||||||
4151090|NCT00855439|3974828|B1||Female|Gender||Participants|Count of Participants|9|9.0||||||
4151091|NCT00855439|3974826|B3|||Age||years|Mean|53|53.0|Standard Deviation|10|10.0|||
4151092|NCT00855439|3974827|B2|||Age||years|Mean|54|54.0|Standard Deviation|9|9.0|||
4151093|NCT00855439|3974828|B1|||Age||years|Mean|51|51.0|Standard Deviation|13|13.0|||
4151094|NCT00855439|3974826|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4151095|NCT00855439|3974827|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4151096|NCT00855439|3974828|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4151097|NCT00855439|3974826|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4151098|NCT00855439|3974827|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4151099|NCT00855439|3974828|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4151100|NCT00855439|3974826|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4151101|NCT00855439|3974827|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4151102|NCT00855439|3974828|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4151103|NCT00855413|3974841|B1|United States||Region of Enrollment|Region of enrollment for all participants|participants|Number|15|15.0||||||
4151104|NCT00855413|3974841|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151105|NCT00855413|3974841|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151106|NCT00855413|3974841|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4151107|NCT00855413|3974841|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4151108|NCT00855413|3974841|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151109|NCT00855413|3974841|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151110|NCT00855413|3974841|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151111|NCT00855413|3974841|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151112|NCT00855413|3974841|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4151113|NCT00855413|3974841|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4151114|NCT00855413|3974841|B1||Male|Sex: Female, Male|Gender of participants enrolled onto the study|Participants|Count of Participants|13|13.0||||||
4151115|NCT00855413|3974841|B1||Female|Sex: Female, Male|Gender of participants enrolled onto the study|Participants|Count of Participants|2|2.0||||||
4151116|NCT00855413|3974841|B1|Age||Age|Median age and range of all participants enrolled in study|years|Median|23|23.0|Full Range|||19.0|51.0|
4151117|NCT00855335|3974882|B6|United States||Region of Enrollment||Participants|Count of Participants|77|77.0||||||
4151118|NCT00855335|3974883|B5|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4151119|NCT00855335|3974884|B4|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4151120|NCT00855335|3974885|B3|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4151121|NCT00855335|3974886|B2|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4151122|NCT00855335|3974887|B1|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4151123|NCT00855335|3974882|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4151124|NCT00855335|3974883|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4151125|NCT00855335|3974884|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4151126|NCT00855335|3974885|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4151127|NCT00855335|3974886|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4151128|NCT00855335|3974887|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4151129|NCT00855335|3974882|B6||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4151130|NCT00855335|3974883|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4151131|NCT00855335|3974884|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4151132|NCT00855335|3974885|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4151133|NCT00855335|3974886|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4151134|NCT00855335|3974887|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4151135|NCT00855335|3974882|B6|||Age||years|Mean|26.1|26.1|Standard Deviation|4.75|4.75|||
4151136|NCT00855335|3974883|B5|||Age||years|Mean|28.86|28.86|Standard Deviation|4.71|4.71|||
4151137|NCT00855335|3974884|B4|||Age||years|Mean|27.2|27.2|Standard Deviation|4.51|4.51|||
4151138|NCT00855335|3974885|B3|||Age||years|Mean|26.3|26.3|Standard Deviation|4.91|4.91|||
4151139|NCT00855335|3974886|B2|||Age||years|Mean|24.2|24.2|Standard Deviation|3.45|3.45|||
4151140|NCT00855335|3974887|B1|||Age||years|Mean|25.7|25.7|Standard Deviation|5.6|5.6|||
4151141|NCT00855309|3974976|B3|United States||Region of Enrollment||participants|Number|112|112.0||||||
4151142|NCT00855309|3974977|B2|United States||Region of Enrollment||participants|Number|55|55.0||||||
4151143|NCT00855309|3974978|B1|United States||Region of Enrollment||participants|Number|57|57.0||||||
4151144|NCT00855309|3974976|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4151145|NCT00855309|3974977|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4151146|NCT00855309|3974978|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4151147|NCT00855309|3974976|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4151148|NCT00855309|3974977|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4151149|NCT00855309|3974978|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4151150|NCT00855309|3974976|B3|||Age||years|Mean|54.4|54.4|Standard Deviation|14.0|14.0|||
4151151|NCT00855309|3974977|B2|||Age||years|Mean|53.3|53.3|Standard Deviation|14.4|14.4|||
4151152|NCT00855309|3974978|B1|||Age||years|Mean|55.3|55.3|Standard Deviation|13.5|13.5|||
4151153|NCT00855309|3974976|B3||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4151154|NCT00855309|3974977|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4151155|NCT00855309|3974978|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4151156|NCT00855309|3974976|B3||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
4151157|NCT00855309|3974977|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4151158|NCT00855309|3974978|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4151159|NCT00855309|3974976|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4151160|NCT00855309|3974977|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4151161|NCT00855309|3974978|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4151162|NCT00855218|3974985|B3|||Time of first study medication since most recent progression||Months|Median|1.09|1.09|Full Range|||0.2|8.1|
4151163|NCT00855218|3974986|B2|||Time of first study medication since most recent progression||Months|Median|1.25|1.25|Full Range|||0.2|8.1|
4151164|NCT00855218|3974987|B1|||Time of first study medication since most recent progression||Months|Median|1.02|1.02|Full Range|||0.2|6.8|
4151165|NCT00855218|3974985|B3|||Time of first study medication since first progression|This variable shows the time from the first treatment with study drug until radiological confirmed disease progression.|Months|Median|1.91|1.91|Full Range|||0.2|28.9|
4151166|NCT00855218|3974986|B2|||Time of first study medication since first progression|This variable shows the time from the first treatment with study drug until radiological confirmed disease progression.|Months|Median|2.56|2.56|Full Range|||0.2|28.9|
4151167|NCT00855218|3974987|B1|||Time of first study medication since first progression|This variable shows the time from the first treatment with study drug until radiological confirmed disease progression.|Months|Median|1.45|1.45|Full Range|||0.2|22.0|
4151168|NCT00855218|3974985|B3|||Time of first study medication since initial diagnosis|This variable shows time from the first diagnosis of HCC until the first treatment with study drug.|Months|Median|1.71|1.71|Full Range|||0.1|96.4|
4151169|NCT00855218|3974986|B2|||Time of first study medication since initial diagnosis|This variable shows time from the first diagnosis of HCC until the first treatment with study drug.|Months|Median|1.91|1.91|Full Range|||0.1|96.4|
4151170|NCT00855218|3974987|B1|||Time of first study medication since initial diagnosis|This variable shows time from the first diagnosis of HCC until the first treatment with study drug.|Months|Median|1.60|1.6|Full Range|||0.1|47.6|
4151171|NCT00855218|3974985|B3|Class B||Child pugh classification|Used to assess the severity of a participant’s liver disease, the prognosis, and the appropriate treatment. A Child-Pugh class A (well-compensated disease); class B (significant functional compromise); and class C (decompensated disease).|Participants|Number|1|1.0||||||
4151172|NCT00855218|3974986|B2|Class B||Child pugh classification|Used to assess the severity of a participant’s liver disease, the prognosis, and the appropriate treatment. A Child-Pugh class A (well-compensated disease); class B (significant functional compromise); and class C (decompensated disease).|Participants|Number|0|0.0||||||
4151173|NCT00855218|3974987|B1|Class B||Child pugh classification|Used to assess the severity of a participant’s liver disease, the prognosis, and the appropriate treatment. A Child-Pugh class A (well-compensated disease); class B (significant functional compromise); and class C (decompensated disease).|Participants|Number|1|1.0||||||
4151174|NCT00855218|3974985|B3|Class A||Child pugh classification|Used to assess the severity of a participant’s liver disease, the prognosis, and the appropriate treatment. A Child-Pugh class A (well-compensated disease); class B (significant functional compromise); and class C (decompensated disease).|Participants|Number|305|305.0||||||
4151175|NCT00855218|3974986|B2|Class A||Child pugh classification|Used to assess the severity of a participant’s liver disease, the prognosis, and the appropriate treatment. A Child-Pugh class A (well-compensated disease); class B (significant functional compromise); and class C (decompensated disease).|Participants|Number|152|152.0||||||
4151176|NCT00855218|3974987|B1|Class A||Child pugh classification|Used to assess the severity of a participant’s liver disease, the prognosis, and the appropriate treatment. A Child-Pugh class A (well-compensated disease); class B (significant functional compromise); and class C (decompensated disease).|Participants|Number|153|153.0||||||
4151177|NCT00855218|3974985|B3|Missing||Child pugh classification|Used to assess the severity of a participant’s liver disease, the prognosis, and the appropriate treatment. A Child-Pugh class A (well-compensated disease); class B (significant functional compromise); and class C (decompensated disease).|Participants|Number|1|1.0||||||
4151178|NCT00855218|3974986|B2|Missing||Child pugh classification|Used to assess the severity of a participant’s liver disease, the prognosis, and the appropriate treatment. A Child-Pugh class A (well-compensated disease); class B (significant functional compromise); and class C (decompensated disease).|Participants|Number|1|1.0||||||
4151381|NCT00855010|3975052|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4151179|NCT00855218|3974987|B1|Missing||Child pugh classification|Used to assess the severity of a participant’s liver disease, the prognosis, and the appropriate treatment. A Child-Pugh class A (well-compensated disease); class B (significant functional compromise); and class C (decompensated disease).|Participants|Number|0|0.0||||||
4151180|NCT00855218|3974985|B3|>/=400 ng/mL||Alfa-fetoprotein||Participants|Number|82|82.0||||||
4151181|NCT00855218|3974986|B2|>/=400 ng/mL||Alfa-fetoprotein||Participants|Number|41|41.0||||||
4151182|NCT00855218|3974987|B1|>/=400 ng/mL||Alfa-fetoprotein||Participants|Number|41|41.0||||||
4151183|NCT00855218|3974985|B3|<400 ng/mL||Alfa-fetoprotein||Participants|Number|225|225.0||||||
4151184|NCT00855218|3974986|B2|<400 ng/mL||Alfa-fetoprotein||Participants|Number|112|112.0||||||
4151185|NCT00855218|3974987|B1|<400 ng/mL||Alfa-fetoprotein||Participants|Number|113|113.0||||||
4151186|NCT00855218|3974985|B3|14||Number of non-target lesions||Participants|Number|1|1.0||||||
4151187|NCT00855218|3974986|B2|14||Number of non-target lesions||Participants|Number|0|0.0||||||
4151188|NCT00855218|3974987|B1|14||Number of non-target lesions||Participants|Number|1|1.0||||||
4151189|NCT00855218|3974985|B3|10||Number of non-target lesions||Participants|Number|2|2.0||||||
4151190|NCT00855218|3974986|B2|10||Number of non-target lesions||Participants|Number|1|1.0||||||
4151191|NCT00855218|3974987|B1|10||Number of non-target lesions||Participants|Number|1|1.0||||||
4151192|NCT00855218|3974985|B3|8||Number of non-target lesions||Participants|Number|2|2.0||||||
4151193|NCT00855218|3974986|B2|8||Number of non-target lesions||Participants|Number|1|1.0||||||
4151194|NCT00855218|3974987|B1|8||Number of non-target lesions||Participants|Number|1|1.0||||||
4151195|NCT00855218|3974985|B3|7||Number of non-target lesions||Participants|Number|3|3.0||||||
4151196|NCT00855218|3974986|B2|7||Number of non-target lesions||Participants|Number|2|2.0||||||
4151197|NCT00855218|3974987|B1|7||Number of non-target lesions||Participants|Number|1|1.0||||||
4151198|NCT00855218|3974985|B3|6||Number of non-target lesions||Participants|Number|1|1.0||||||
4151199|NCT00855218|3974986|B2|6||Number of non-target lesions||Participants|Number|1|1.0||||||
4151200|NCT00855218|3974987|B1|6||Number of non-target lesions||Participants|Number|0|0.0||||||
4151201|NCT00855218|3974985|B3|5||Number of non-target lesions||Participants|Number|6|6.0||||||
4151202|NCT00855218|3974986|B2|5||Number of non-target lesions||Participants|Number|2|2.0||||||
4151203|NCT00855218|3974987|B1|5||Number of non-target lesions||Participants|Number|4|4.0||||||
4151204|NCT00855218|3974985|B3|4||Number of non-target lesions||Participants|Number|9|9.0||||||
4151205|NCT00855218|3974986|B2|4||Number of non-target lesions||Participants|Number|6|6.0||||||
4151206|NCT00855218|3974987|B1|4||Number of non-target lesions||Participants|Number|3|3.0||||||
4151207|NCT00855218|3974985|B3|3||Number of non-target lesions||Participants|Number|17|17.0||||||
4151208|NCT00855218|3974986|B2|3||Number of non-target lesions||Participants|Number|10|10.0||||||
4151209|NCT00855218|3974987|B1|3||Number of non-target lesions||Participants|Number|7|7.0||||||
4151210|NCT00855218|3974985|B3|2||Number of non-target lesions||Participants|Number|42|42.0||||||
4151211|NCT00855218|3974986|B2|2||Number of non-target lesions||Participants|Number|18|18.0||||||
4151212|NCT00855218|3974987|B1|2||Number of non-target lesions||Participants|Number|24|24.0||||||
4151213|NCT00855218|3974985|B3|1||Number of non-target lesions||Participants|Number|79|79.0||||||
4151214|NCT00855218|3974986|B2|1||Number of non-target lesions||Participants|Number|39|39.0||||||
4151215|NCT00855218|3974987|B1|1||Number of non-target lesions||Participants|Number|40|40.0||||||
4151216|NCT00855218|3974985|B3|0||Number of non-target lesions||Participants|Number|145|145.0||||||
4151217|NCT00855218|3974986|B2|0||Number of non-target lesions||Participants|Number|73|73.0||||||
4151218|NCT00855218|3974987|B1|0||Number of non-target lesions||Participants|Number|72|72.0||||||
4151219|NCT00855218|3974985|B3|5||Number of target lesions||Participants|Number|43|43.0||||||
4151220|NCT00855218|3974986|B2|5||Number of target lesions||Participants|Number|22|22.0||||||
4151221|NCT00855218|3974987|B1|5||Number of target lesions||Participants|Number|21|21.0||||||
4151222|NCT00855218|3974985|B3|4||Number of target lesions||Participants|Number|30|30.0||||||
4151223|NCT00855218|3974986|B2|4||Number of target lesions||Participants|Number|18|18.0||||||
4151224|NCT00855218|3974987|B1|4||Number of target lesions||Participants|Number|12|12.0||||||
4151225|NCT00855218|3974985|B3|3||Number of target lesions||Participants|Number|66|66.0||||||
4151226|NCT00855218|3974986|B2|3||Number of target lesions||Participants|Number|33|33.0||||||
4151227|NCT00855218|3974987|B1|3||Number of target lesions||Participants|Number|33|33.0||||||
4151228|NCT00855218|3974985|B3|2||Number of target lesions||Participants|Number|107|107.0||||||
4151229|NCT00855218|3974986|B2|2||Number of target lesions||Participants|Number|49|49.0||||||
4151230|NCT00855218|3974987|B1|2||Number of target lesions||Participants|Number|58|58.0||||||
4151231|NCT00855218|3974985|B3|1||Number of target lesions||Participants|Number|61|61.0||||||
4151232|NCT00855218|3974986|B2|1||Number of target lesions||Participants|Number|31|31.0||||||
4151233|NCT00855218|3974987|B1|1||Number of target lesions||Participants|Number|30|30.0||||||
4151234|NCT00855218|3974985|B3|Grade 0||Eastern Cooperative Oncology Group (ECOG) performance status at enrollment|Measures on a scale from grade 0 (best) to grade 5 (worst) cancer's affect on patient's life. 0=Fully active without restriction; 1= Restricted in physically strenuous activity; 2= Ambulatory, capable of all selfcare; 3= Capable of limited selfcare; 4= Completely disabled; 5= Dead|Scores on a scale|Number|306|306.0||||||
4151235|NCT00855218|3974986|B2|Grade 0||Eastern Cooperative Oncology Group (ECOG) performance status at enrollment|Measures on a scale from grade 0 (best) to grade 5 (worst) cancer's affect on patient's life. 0=Fully active without restriction; 1= Restricted in physically strenuous activity; 2= Ambulatory, capable of all selfcare; 3= Capable of limited selfcare; 4= Completely disabled; 5= Dead|Scores on a scale|Number|152|152.0||||||
4151382|NCT00855010|3975053|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4151236|NCT00855218|3974987|B1|Grade 0||Eastern Cooperative Oncology Group (ECOG) performance status at enrollment|Measures on a scale from grade 0 (best) to grade 5 (worst) cancer's affect on patient's life. 0=Fully active without restriction; 1= Restricted in physically strenuous activity; 2= Ambulatory, capable of all selfcare; 3= Capable of limited selfcare; 4= Completely disabled; 5= Dead|Scores on a scale|Number|154|154.0||||||
4151237|NCT00855218|3974985|B3|Missing||Eastern Cooperative Oncology Group (ECOG) performance status at enrollment|Measures on a scale from grade 0 (best) to grade 5 (worst) cancer's affect on patient's life. 0=Fully active without restriction; 1= Restricted in physically strenuous activity; 2= Ambulatory, capable of all selfcare; 3= Capable of limited selfcare; 4= Completely disabled; 5= Dead|Scores on a scale|Number|1|1.0||||||
4151238|NCT00855218|3974986|B2|Missing||Eastern Cooperative Oncology Group (ECOG) performance status at enrollment|Measures on a scale from grade 0 (best) to grade 5 (worst) cancer's affect on patient's life. 0=Fully active without restriction; 1= Restricted in physically strenuous activity; 2= Ambulatory, capable of all selfcare; 3= Capable of limited selfcare; 4= Completely disabled; 5= Dead|Scores on a scale|Number|1|1.0||||||
4151239|NCT00855218|3974987|B1|Missing||Eastern Cooperative Oncology Group (ECOG) performance status at enrollment|Measures on a scale from grade 0 (best) to grade 5 (worst) cancer's affect on patient's life. 0=Fully active without restriction; 1= Restricted in physically strenuous activity; 2= Ambulatory, capable of all selfcare; 3= Capable of limited selfcare; 4= Completely disabled; 5= Dead|Scores on a scale|Number|0|0.0||||||
4151240|NCT00855218|3974985|B3||Male|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
4151241|NCT00855218|3974986|B2||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4151242|NCT00855218|3974987|B1||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4151243|NCT00855218|3974985|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4151244|NCT00855218|3974986|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4151245|NCT00855218|3974987|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4151246|NCT00855218|3974985|B3|>=75 years||Age, Customized||Participants|Number|48|48.0||||||
4151247|NCT00855218|3974986|B2|>=75 years||Age, Customized||Participants|Number|23|23.0||||||
4151248|NCT00855218|3974987|B1|>=75 years||Age, Customized||Participants|Number|25|25.0||||||
4151249|NCT00855218|3974985|B3|65 - 74 years||Age, Customized||Participants|Number|100|100.0||||||
4151250|NCT00855218|3974986|B2|65 - 74 years||Age, Customized||Participants|Number|48|48.0||||||
4151251|NCT00855218|3974987|B1|65 - 74 years||Age, Customized||Participants|Number|52|52.0||||||
4151252|NCT00855218|3974985|B3|<65 years||Age, Customized||Participants|Number|159|159.0||||||
4151253|NCT00855218|3974986|B2|<65 years||Age, Customized||Participants|Number|82|82.0||||||
4151254|NCT00855218|3974987|B1|<65 years||Age, Customized||Participants|Number|77|77.0||||||
4151255|NCT00855218|3974985|B3|||Age||Years|Mean|62.6|62.6|Standard Deviation|11.9|11.9|||
4151256|NCT00855218|3974986|B2|||Age||Years|Mean|62.7|62.7|Standard Deviation|11.9|11.9|||
4151257|NCT00855218|3974987|B1|||Age||Years|Mean|62.5|62.5|Standard Deviation|11.9|11.9|||
4151258|NCT00855166|3975004|B3|||Fasting Plasma Glucose||Milligram per deciliter|Mean|148.82|148.82|Standard Deviation|24.815|24.815|||
4151259|NCT00855166|3975005|B2|||Fasting Plasma Glucose||Milligram per deciliter|Mean|148.01|148.01|Standard Deviation|24.650|24.65|||
4151260|NCT00855166|3975006|B1|||Fasting Plasma Glucose||Milligram per deciliter|Mean|149.60|149.6|Standard Deviation|25.086|25.086|||
4151261|NCT00855166|3975004|B3|||Glycosylated hemoglobin A1c (HbA1c)||Percent|Mean|7.17|7.17|Standard Deviation|0.489|0.489|||
4151262|NCT00855166|3975005|B2|||Glycosylated hemoglobin A1c (HbA1c)||Percent|Mean|7.19|7.19|Standard Deviation|0.443|0.443|||
4151263|NCT00855166|3975006|B1|||Glycosylated hemoglobin A1c (HbA1c)||Percent|Mean|7.16|7.16|Standard Deviation|0.531|0.531|||
4151264|NCT00855166|3975004|B3|||Body Mass Index||kg/m2|Mean|31.87|31.87|Standard Deviation|3.882|3.882|||
4151265|NCT00855166|3975005|B2|||Body Mass Index||kg/m2|Mean|32.06|32.06|Standard Deviation|3.887|3.887|||
4151266|NCT00855166|3975006|B1|||Body Mass Index||kg/m2|Mean|31.68|31.68|Standard Deviation|3.890|3.89|||
4151267|NCT00855166|3975004|B3|||Body Weight||Kilogram|Mean|91.48|91.48|Standard Deviation|13.894|13.894|||
4151268|NCT00855166|3975005|B2|||Body Weight||Kilogram|Mean|92.06|92.06|Standard Deviation|14.128|14.128|||
4151269|NCT00855166|3975006|B1|||Body Weight||Kilogram|Mean|90.91|90.91|Standard Deviation|13.716|13.716|||
4151270|NCT00855166|3975004|B3|White||Race/Ethnicity, Customized||Participants|Number|180|180.0||||||
4151271|NCT00855166|3975005|B2|White||Race/Ethnicity, Customized||Participants|Number|89|89.0||||||
4151272|NCT00855166|3975006|B1|White||Race/Ethnicity, Customized||Participants|Number|91|91.0||||||
4151273|NCT00855166|3975004|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4151274|NCT00855166|3975005|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4151275|NCT00855166|3975006|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4151276|NCT00855166|3975004|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4151277|NCT00855166|3975005|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4151278|NCT00855166|3975006|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4151279|NCT00855166|3975004|B3|||Age||Years|Mean|60.7|60.7|Standard Deviation|7.49|7.49|||
4151280|NCT00855166|3975005|B2|||Age||Years|Mean|60.6|60.6|Standard Deviation|8.16|8.16|||
4151281|NCT00855166|3975006|B1|||Age||Years|Mean|60.8|60.8|Standard Deviation|6.82|6.82|||
4151282|NCT00855062|3975025|B3|||Digit Span Forward|"Digit span assesses attention, concentration, and mental control(e.g., Repeat the numbers 1-2-3 in reverse sequence).~Since the score depends on age and education levels, the raw score was standardized as follows:~Zx =(x − μx)/σx where Zx is the age and education adjusted z-score, x is the raw score, and μx and σx are the age and education stratified norms."|z-scores|Mean|0.11|0.11|Standard Deviation|0.90|0.9|||
4151383|NCT00855010|3975054|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4151283|NCT00855062|3975026|B2|||Digit Span Forward|"Digit span assesses attention, concentration, and mental control(e.g., Repeat the numbers 1-2-3 in reverse sequence).~Since the score depends on age and education levels, the raw score was standardized as follows:~Zx =(x − μx)/σx where Zx is the age and education adjusted z-score, x is the raw score, and μx and σx are the age and education stratified norms."|z-scores|Mean|0.19|0.19|Standard Deviation|0.99|0.99|||
4151284|NCT00855062|3975027|B1|||Digit Span Forward|"Digit span assesses attention, concentration, and mental control(e.g., Repeat the numbers 1-2-3 in reverse sequence).~Since the score depends on age and education levels, the raw score was standardized as follows:~Zx =(x − μx)/σx where Zx is the age and education adjusted z-score, x is the raw score, and μx and σx are the age and education stratified norms."|z-scores|Mean|0.02|0.02|Standard Deviation|0.79|0.79|||
4151285|NCT00855062|3975025|B3|||Digit Span Backward|"Digit span assesses attention, concentration, and mental control(e.g., Repeat the numbers 1-2-3 in reverse sequence).~Since the score depends on age and education levels, the raw score was standardized as follows:~Zx =(x − μx)/σx where Zx is the age and education adjusted z-score, x is the raw score, and μx and σx are the age and education stratified norms."|z-scores|Mean|-0.81|-0.81|Standard Deviation|0.93|0.93|||
4151286|NCT00855062|3975026|B2|||Digit Span Backward|"Digit span assesses attention, concentration, and mental control(e.g., Repeat the numbers 1-2-3 in reverse sequence).~Since the score depends on age and education levels, the raw score was standardized as follows:~Zx =(x − μx)/σx where Zx is the age and education adjusted z-score, x is the raw score, and μx and σx are the age and education stratified norms."|z-scores|Mean|-0.94|-0.94|Standard Deviation|1.06|1.06|||
4151287|NCT00855062|3975027|B1|||Digit Span Backward|"Digit span assesses attention, concentration, and mental control(e.g., Repeat the numbers 1-2-3 in reverse sequence).~Since the score depends on age and education levels, the raw score was standardized as follows:~Zx =(x − μx)/σx where Zx is the age and education adjusted z-score, x is the raw score, and μx and σx are the age and education stratified norms."|z-scores|Mean|-0.68|-0.68|Standard Deviation|0.75|0.75|||
4151288|NCT00855062|3975025|B3|||Symbol Digit|"This test assesses the participant's ability to maintain rapid visual-motor sequencing in a timed test. The score is the total number of correctly transcribed numbers in the time limit (90 seconds). Participants receive 1 point for each item filled in correctly. Maximum score is 110 points.~Since the score depends on age and education levels, the raw score was standardized as follows:~Zx =(x − μx)/σx where Zx is the age and education adjusted z-score, x is the raw score, and μx and σx are the age and education stratified norms."|z-scores|Mean|-0.86|-0.86|Standard Deviation|0.88|0.88|||
4151289|NCT00855062|3975026|B2|||Symbol Digit|"This test assesses the participant's ability to maintain rapid visual-motor sequencing in a timed test. The score is the total number of correctly transcribed numbers in the time limit (90 seconds). Participants receive 1 point for each item filled in correctly. Maximum score is 110 points.~Since the score depends on age and education levels, the raw score was standardized as follows:~Zx =(x − μx)/σx where Zx is the age and education adjusted z-score, x is the raw score, and μx and σx are the age and education stratified norms."|z-scores|Mean|-0.86|-0.86|Standard Deviation|0.80|0.8|||
4151290|NCT00855062|3975027|B1|||Symbol Digit|"This test assesses the participant's ability to maintain rapid visual-motor sequencing in a timed test. The score is the total number of correctly transcribed numbers in the time limit (90 seconds). Participants receive 1 point for each item filled in correctly. Maximum score is 110 points.~Since the score depends on age and education levels, the raw score was standardized as follows:~Zx =(x − μx)/σx where Zx is the age and education adjusted z-score, x is the raw score, and μx and σx are the age and education stratified norms."|z-scores|Mean|-0.87|-0.87|Standard Deviation|0.96|0.96|||
4151291|NCT00855062|3975025|B3|||Grooved Pegboard Non-dominant|"The grooved pegboard is a manipulative dexterity test requiring rapid visual-motor coordination. The test is completed using the dominant hand (GPD) and then using the non-dominant hand (GPN). The score for each hand is the time in seconds that the participant takes to complete the entire board.~Since the score depends on age and education levels, the raw score was standardized as follows:~Zx =(x − μx)/σx where Zx is the age and education adjusted z-score, x is the raw score, and μx and σx are the age and education stratified norms."|z-scores|Mean|-0.52|-0.52|Standard Deviation|1.61|1.61|||
4151292|NCT00855062|3975026|B2|||Grooved Pegboard Non-dominant|"The grooved pegboard is a manipulative dexterity test requiring rapid visual-motor coordination. The test is completed using the dominant hand (GPD) and then using the non-dominant hand (GPN). The score for each hand is the time in seconds that the participant takes to complete the entire board.~Since the score depends on age and education levels, the raw score was standardized as follows:~Zx =(x − μx)/σx where Zx is the age and education adjusted z-score, x is the raw score, and μx and σx are the age and education stratified norms."|z-scores|Mean|-0.48|-0.48|Standard Deviation|1.42|1.42|||
4151293|NCT00855062|3975027|B1|||Grooved Pegboard Non-dominant|"The grooved pegboard is a manipulative dexterity test requiring rapid visual-motor coordination. The test is completed using the dominant hand (GPD) and then using the non-dominant hand (GPN). The score for each hand is the time in seconds that the participant takes to complete the entire board.~Since the score depends on age and education levels, the raw score was standardized as follows:~Zx =(x − μx)/σx where Zx is the age and education adjusted z-score, x is the raw score, and μx and σx are the age and education stratified norms."|z-scores|Mean|-0.56|-0.56|Standard Deviation|1.82|1.82|||
4151294|NCT00855062|3975025|B3|||Grooved Pegboard Dominant|"The grooved pegboard is a manipulative dexterity test requiring rapid visual-motor coordination. The test is completed using the dominant hand (GPD) and then using the non-dominant hand (GPN). The score for each hand is the time in seconds that the participant takes to complete the entire board.~Since the score depends on age and education levels, the raw score was standardized as follows:~Zx =(x − μx)/σx where Zx is the age and education adjusted z-score, x is the raw score, and μx and σx are the age and education stratified norms."|z-scores|Mean|-0.18|-0.18|Standard Deviation|1.37|1.37|||
4151295|NCT00855062|3975026|B2|||Grooved Pegboard Dominant|"The grooved pegboard is a manipulative dexterity test requiring rapid visual-motor coordination. The test is completed using the dominant hand (GPD) and then using the non-dominant hand (GPN). The score for each hand is the time in seconds that the participant takes to complete the entire board.~Since the score depends on age and education levels, the raw score was standardized as follows:~Zx =(x − μx)/σx where Zx is the age and education adjusted z-score, x is the raw score, and μx and σx are the age and education stratified norms."|z-scores|Mean|-0.03|-0.03|Standard Deviation|1.14|1.14|||
4151296|NCT00855062|3975027|B1|||Grooved Pegboard Dominant|"The grooved pegboard is a manipulative dexterity test requiring rapid visual-motor coordination. The test is completed using the dominant hand (GPD) and then using the non-dominant hand (GPN). The score for each hand is the time in seconds that the participant takes to complete the entire board.~Since the score depends on age and education levels, the raw score was standardized as follows:~Zx =(x − μx)/σx where Zx is the age and education adjusted z-score, x is the raw score, and μx and σx are the age and education stratified norms."|z-scores|Mean|-0.34|-0.34|Standard Deviation|1.58|1.58|||
4151297|NCT00855062|3975025|B3|||Color Trails 2|"The Color Trails tests measure speed of attention, sequencing, mental flexibility, visual search, and motor function.~Since the score depends on age and education levels, the raw score was standardized as follows:~Zx =(x − μx)/σx where Zx is the age and education adjusted z-score, x is the raw score, and μx and σx are the age and education stratified norms."|z-scores|Mean|-2.44|-2.44|Standard Deviation|2.05|2.05|||
4151298|NCT00855062|3975026|B2|||Color Trails 2|"The Color Trails tests measure speed of attention, sequencing, mental flexibility, visual search, and motor function.~Since the score depends on age and education levels, the raw score was standardized as follows:~Zx =(x − μx)/σx where Zx is the age and education adjusted z-score, x is the raw score, and μx and σx are the age and education stratified norms."|z-scores|Mean|-2.33|-2.33|Standard Deviation|2.05|2.05|||
4151299|NCT00855062|3975027|B1|||Color Trails 2|"The Color Trails tests measure speed of attention, sequencing, mental flexibility, visual search, and motor function.~Since the score depends on age and education levels, the raw score was standardized as follows:~Zx =(x − μx)/σx where Zx is the age and education adjusted z-score, x is the raw score, and μx and σx are the age and education stratified norms."|z-scores|Mean|-2.55|-2.55|Standard Deviation|2.07|2.07|||
4151300|NCT00855062|3975025|B3|||Color Trails 1|"The Color Trails tests measure speed of attention, sequencing, mental flexibility, visual search, and motor function.~Since the score depends on age and education levels, the raw score was standardized as follows:~Zx =(x − μx)/σx where Zx is the age and education adjusted z-score, x is the raw score, and μx and σx are the age and education stratified norms."|z-scores|Mean|-1.51|-1.51|Standard Deviation|2.60|2.6|||
4151301|NCT00855062|3975026|B2|||Color Trails 1|"The Color Trails tests measure speed of attention, sequencing, mental flexibility, visual search, and motor function.~Since the score depends on age and education levels, the raw score was standardized as follows:~Zx =(x − μx)/σx where Zx is the age and education adjusted z-score, x is the raw score, and μx and σx are the age and education stratified norms."|z-scores|Mean|-1.65|-1.65|Standard Deviation|3.03|3.03|||
4151302|NCT00855062|3975027|B1|||Color Trails 1|"The Color Trails tests measure speed of attention, sequencing, mental flexibility, visual search, and motor function.~Since the score depends on age and education levels, the raw score was standardized as follows:~Zx =(x − μx)/σx where Zx is the age and education adjusted z-score, x is the raw score, and μx and σx are the age and education stratified norms."|z-scores|Mean|-1.35|-1.35|Standard Deviation|2.03|2.03|||
4151303|NCT00855062|3975025|B3|||WHO-UCLA Auditory Verbal Learning Test (AVLT): Delayed|"World Health Organization-University of California Los Angeles (WHO-UCLA) Auditory Verbal Learning Test (AVLT) is a memory assessment.~Since the score depends on age and education levels, the raw score was standardized as follows:~Zx =(x − μx)/σx where Zx is the age and education adjusted z-score, x is the raw score, and μx and σx are the age and education stratified norms."|z-scores|Mean|-1.16|-1.16|Standard Deviation|1.00|1.0|||
4151304|NCT00855062|3975026|B2|||WHO-UCLA Auditory Verbal Learning Test (AVLT): Delayed|"World Health Organization-University of California Los Angeles (WHO-UCLA) Auditory Verbal Learning Test (AVLT) is a memory assessment.~Since the score depends on age and education levels, the raw score was standardized as follows:~Zx =(x − μx)/σx where Zx is the age and education adjusted z-score, x is the raw score, and μx and σx are the age and education stratified norms."|z-scores|Mean|-1.15|-1.15|Standard Deviation|1.18|1.18|||
4151305|NCT00855062|3975027|B1|||WHO-UCLA Auditory Verbal Learning Test (AVLT): Delayed|"World Health Organization-University of California Los Angeles (WHO-UCLA) Auditory Verbal Learning Test (AVLT) is a memory assessment.~Since the score depends on age and education levels, the raw score was standardized as follows:~Zx =(x − μx)/σx where Zx is the age and education adjusted z-score, x is the raw score, and μx and σx are the age and education stratified norms."|z-scores|Mean|-1.17|-1.17|Standard Deviation|0.79|0.79|||
4151306|NCT00855062|3975025|B3|||WHO-UCLA Auditory Verbal Learning Test (AVLT): Trials Total|"World Health Organization-University of California Los Angeles (WHO-UCLA) Auditory Verbal Learning Test (AVLT) is a full-scale memory assessment.~Since the score depends on age and education levels, the raw score was standardized as follows:~Zx =(x − μx)/σx where Zx is the age and education adjusted z-score, x is the raw score, and μx and σx are the age and education stratified norms."|z-scores|Mean|-1.38|-1.38|Standard Deviation|1.02|1.02|||
4151307|NCT00855062|3975026|B2|||WHO-UCLA Auditory Verbal Learning Test (AVLT): Trials Total|"World Health Organization-University of California Los Angeles (WHO-UCLA) Auditory Verbal Learning Test (AVLT) is a full-scale memory assessment.~Since the score depends on age and education levels, the raw score was standardized as follows:~Zx =(x − μx)/σx where Zx is the age and education adjusted z-score, x is the raw score, and μx and σx are the age and education stratified norms."|z-scores|Mean|-1.48|-1.48|Standard Deviation|1.14|1.14|||
4151308|NCT00855062|3975027|B1|||WHO-UCLA Auditory Verbal Learning Test (AVLT): Trials Total|"World Health Organization-University of California Los Angeles (WHO-UCLA) Auditory Verbal Learning Test (AVLT) is a full-scale memory assessment.~Since the score depends on age and education levels, the raw score was standardized as follows:~Zx =(x − μx)/σx where Zx is the age and education adjusted z-score, x is the raw score, and μx and σx are the age and education stratified norms."|z-scores|Mean|-1.28|-1.28|Standard Deviation|0.88|0.88|||
4151309|NCT00855062|3975025|B3|||Baseline Uganda Neuropsychological Test Battery Summary measure (U NP Sum)|Uganda Neuropsychological Test Battery Summary measure (U NP Sum)is the average z-scores of the 9 neurupsychological tests:Grooved Pegboard Dominant Hand,Grooved Pegboard Non-dominant Hand,Color Trail1,Color Trail2,Symbol Digit,WHO/UCLA Verbal Learning Test Trial 5,WHO/UCLA Verbal Learning Test Delayed Recall,Digit Span-Forward,Digit Span-Backward Since the score depends on age and education levels, the raw score was standardized as follows: Zx =(x − μx)/σx where Zx is the age and education adjusted z-score, x is the raw score, and μx and σx are the age and education stratified norms.|z-scores|Mean|-0.97|-0.97|Standard Deviation|0.82|0.82|-1.18|-0.55|
4151384|NCT00855010|3975052|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4151310|NCT00855062|3975026|B2|||Baseline Uganda Neuropsychological Test Battery Summary measure (U NP Sum)|Uganda Neuropsychological Test Battery Summary measure (U NP Sum)is the average z-scores of the 9 neurupsychological tests:Grooved Pegboard Dominant Hand,Grooved Pegboard Non-dominant Hand,Color Trail1,Color Trail2,Symbol Digit,WHO/UCLA Verbal Learning Test Trial 5,WHO/UCLA Verbal Learning Test Delayed Recall,Digit Span-Forward,Digit Span-Backward Since the score depends on age and education levels, the raw score was standardized as follows: Zx =(x − μx)/σx where Zx is the age and education adjusted z-score, x is the raw score, and μx and σx are the age and education stratified norms.|z-scores|Mean|-0.97|-0.97|Standard Deviation|0.86|0.86|-1.18|-0.58|
4151311|NCT00855062|3975027|B1|||Baseline Uganda Neuropsychological Test Battery Summary measure (U NP Sum)|Uganda Neuropsychological Test Battery Summary measure (U NP Sum)is the average z-scores of the 9 neurupsychological tests:Grooved Pegboard Dominant Hand,Grooved Pegboard Non-dominant Hand,Color Trail1,Color Trail2,Symbol Digit,WHO/UCLA Verbal Learning Test Trial 5,WHO/UCLA Verbal Learning Test Delayed Recall,Digit Span-Forward,Digit Span-Backward Since the score depends on age and education levels, the raw score was standardized as follows: Zx =(x − μx)/σx where Zx is the age and education adjusted z-score, x is the raw score, and μx and σx are the age and education stratified norms.|z-scores|Mean|-0.97|-0.97|Standard Deviation|0.78|0.78|-1.16|-0.55|
4151312|NCT00855062|3975025|B3|Can not assess||Baseline Overall Neurological Assessment||Participants|Number|1|1.0||||||
4151313|NCT00855062|3975026|B2|Can not assess||Baseline Overall Neurological Assessment||Participants|Number|0|0.0||||||
4151314|NCT00855062|3975027|B1|Can not assess||Baseline Overall Neurological Assessment||Participants|Number|1|1.0||||||
4151315|NCT00855062|3975025|B3|CNS and PNS abnormality||Baseline Overall Neurological Assessment||Participants|Number|2|2.0||||||
4151316|NCT00855062|3975026|B2|CNS and PNS abnormality||Baseline Overall Neurological Assessment||Participants|Number|1|1.0||||||
4151317|NCT00855062|3975027|B1|CNS and PNS abnormality||Baseline Overall Neurological Assessment||Participants|Number|1|1.0||||||
4151318|NCT00855062|3975025|B3|Peripheral Nervous System (PNS) abnormality only||Baseline Overall Neurological Assessment||Participants|Number|5|5.0||||||
4151319|NCT00855062|3975026|B2|Peripheral Nervous System (PNS) abnormality only||Baseline Overall Neurological Assessment||Participants|Number|1|1.0||||||
4151320|NCT00855062|3975027|B1|Peripheral Nervous System (PNS) abnormality only||Baseline Overall Neurological Assessment||Participants|Number|4|4.0||||||
4151321|NCT00855062|3975025|B3|Central Nervous System (CNS) abnormality only||Baseline Overall Neurological Assessment||Participants|Number|9|9.0||||||
4151322|NCT00855062|3975026|B2|Central Nervous System (CNS) abnormality only||Baseline Overall Neurological Assessment||Participants|Number|5|5.0||||||
4151323|NCT00855062|3975027|B1|Central Nervous System (CNS) abnormality only||Baseline Overall Neurological Assessment||Participants|Number|4|4.0||||||
4151324|NCT00855062|3975025|B3|Normal neurological assessment||Baseline Overall Neurological Assessment||Participants|Number|56|56.0||||||
4151325|NCT00855062|3975026|B2|Normal neurological assessment||Baseline Overall Neurological Assessment||Participants|Number|30|30.0||||||
4151326|NCT00855062|3975027|B1|Normal neurological assessment||Baseline Overall Neurological Assessment||Participants|Number|26|26.0||||||
4151327|NCT00855062|3975025|B3|Not having any difficulties on the tasks||Baseline Instrumental Activities of Daily Living (IADL)|"16 tasks: Housekeeping,Managing Finances,Buying Groceries,Cooking,Planning Social Activities,Understanding Reading Materials/TV,Transportation,Using the Telephone,Home Repairs,Bathing,Dressing,Shopping,Laundry,Taking/Keeping Track of Medication,Child Care,Work.~For the baseline IADL measure, participants were given four choices to choose for having difficulty on the 16 tasks:Primarily Cognitive problems,Primarily physical problems,equally cognitive and physical problems,not having any difficulties on previous tasks."|Participants|Number|64|64.0||||||
4151328|NCT00855062|3975026|B2|Not having any difficulties on the tasks||Baseline Instrumental Activities of Daily Living (IADL)|"16 tasks: Housekeeping,Managing Finances,Buying Groceries,Cooking,Planning Social Activities,Understanding Reading Materials/TV,Transportation,Using the Telephone,Home Repairs,Bathing,Dressing,Shopping,Laundry,Taking/Keeping Track of Medication,Child Care,Work.~For the baseline IADL measure, participants were given four choices to choose for having difficulty on the 16 tasks:Primarily Cognitive problems,Primarily physical problems,equally cognitive and physical problems,not having any difficulties on previous tasks."|Participants|Number|35|35.0||||||
4151329|NCT00855062|3975027|B1|Not having any difficulties on the tasks||Baseline Instrumental Activities of Daily Living (IADL)|"16 tasks: Housekeeping,Managing Finances,Buying Groceries,Cooking,Planning Social Activities,Understanding Reading Materials/TV,Transportation,Using the Telephone,Home Repairs,Bathing,Dressing,Shopping,Laundry,Taking/Keeping Track of Medication,Child Care,Work.~For the baseline IADL measure, participants were given four choices to choose for having difficulty on the 16 tasks:Primarily Cognitive problems,Primarily physical problems,equally cognitive and physical problems,not having any difficulties on previous tasks."|Participants|Number|29|29.0||||||
4151330|NCT00855062|3975025|B3|Primarily physical problems||Baseline Instrumental Activities of Daily Living (IADL)|"16 tasks: Housekeeping,Managing Finances,Buying Groceries,Cooking,Planning Social Activities,Understanding Reading Materials/TV,Transportation,Using the Telephone,Home Repairs,Bathing,Dressing,Shopping,Laundry,Taking/Keeping Track of Medication,Child Care,Work.~For the baseline IADL measure, participants were given four choices to choose for having difficulty on the 16 tasks:Primarily Cognitive problems,Primarily physical problems,equally cognitive and physical problems,not having any difficulties on previous tasks."|Participants|Number|8|8.0||||||
4151331|NCT00855062|3975026|B2|Primarily physical problems||Baseline Instrumental Activities of Daily Living (IADL)|"16 tasks: Housekeeping,Managing Finances,Buying Groceries,Cooking,Planning Social Activities,Understanding Reading Materials/TV,Transportation,Using the Telephone,Home Repairs,Bathing,Dressing,Shopping,Laundry,Taking/Keeping Track of Medication,Child Care,Work.~For the baseline IADL measure, participants were given four choices to choose for having difficulty on the 16 tasks:Primarily Cognitive problems,Primarily physical problems,equally cognitive and physical problems,not having any difficulties on previous tasks."|Participants|Number|2|2.0||||||
4151385|NCT00855010|3975053|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4151386|NCT00855010|3975054|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4151387|NCT00855010|3975052|B3|||Age||years|Mean|52.4|52.4|Standard Deviation|10.3|10.3|||
4151388|NCT00855010|3975053|B2|||Age||years|Mean|52.2|52.2|Standard Deviation|10.6|10.6|||
4151332|NCT00855062|3975027|B1|Primarily physical problems||Baseline Instrumental Activities of Daily Living (IADL)|"16 tasks: Housekeeping,Managing Finances,Buying Groceries,Cooking,Planning Social Activities,Understanding Reading Materials/TV,Transportation,Using the Telephone,Home Repairs,Bathing,Dressing,Shopping,Laundry,Taking/Keeping Track of Medication,Child Care,Work.~For the baseline IADL measure, participants were given four choices to choose for having difficulty on the 16 tasks:Primarily Cognitive problems,Primarily physical problems,equally cognitive and physical problems,not having any difficulties on previous tasks."|Participants|Number|6|6.0||||||
4151333|NCT00855062|3975025|B3|Primarily cognitive problems||Baseline Instrumental Activities of Daily Living (IADL)|"16 tasks: Housekeeping,Managing Finances,Buying Groceries,Cooking,Planning Social Activities,Understanding Reading Materials/TV,Transportation,Using the Telephone,Home Repairs,Bathing,Dressing,Shopping,Laundry,Taking/Keeping Track of Medication,Child Care,Work.~For the baseline IADL measure, participants were given four choices to choose for having difficulty on the 16 tasks:Primarily Cognitive problems,Primarily physical problems,equally cognitive and physical problems,not having any difficulties on previous tasks."|Participants|Number|1|1.0||||||
4151334|NCT00855062|3975026|B2|Primarily cognitive problems||Baseline Instrumental Activities of Daily Living (IADL)|"16 tasks: Housekeeping,Managing Finances,Buying Groceries,Cooking,Planning Social Activities,Understanding Reading Materials/TV,Transportation,Using the Telephone,Home Repairs,Bathing,Dressing,Shopping,Laundry,Taking/Keeping Track of Medication,Child Care,Work.~For the baseline IADL measure, participants were given four choices to choose for having difficulty on the 16 tasks:Primarily Cognitive problems,Primarily physical problems,equally cognitive and physical problems,not having any difficulties on previous tasks."|Participants|Number|0|0.0||||||
4151335|NCT00855062|3975027|B1|Primarily cognitive problems||Baseline Instrumental Activities of Daily Living (IADL)|"16 tasks: Housekeeping,Managing Finances,Buying Groceries,Cooking,Planning Social Activities,Understanding Reading Materials/TV,Transportation,Using the Telephone,Home Repairs,Bathing,Dressing,Shopping,Laundry,Taking/Keeping Track of Medication,Child Care,Work.~For the baseline IADL measure, participants were given four choices to choose for having difficulty on the 16 tasks:Primarily Cognitive problems,Primarily physical problems,equally cognitive and physical problems,not having any difficulties on previous tasks."|Participants|Number|1|1.0||||||
4151336|NCT00855062|3975025|B3|100 (Karnofsky Score)||Baseline Karnofsky's Performance Score|100:Normal,90:normal;Minor Signs or Symptoms of Disease,80:Normal Activity with Effort;Some Signs or Symptoms of Disease,70:Cares for Self,Unable to Carry on Normal Activity or to Do Active Work,60:Requires Occasional Assistance but is Able to Care for Most of Needs,50:Requires Considerable Assistance and Frequent Medical Care,40:Disabled,Requires Special Care and Assistance,30:Severely Disabled; Hospitalization Indicated Although Death is Not Imminent,20:Very Sick; Hospitalization Necessary;Active Supportive Treatment is Necessary,10:Moribund, Fatal Processes Progressing Rapidly,0:Death|Participants|Number|1|1.0||||||
4151337|NCT00855062|3975026|B2|100 (Karnofsky Score)||Baseline Karnofsky's Performance Score|100:Normal,90:normal;Minor Signs or Symptoms of Disease,80:Normal Activity with Effort;Some Signs or Symptoms of Disease,70:Cares for Self,Unable to Carry on Normal Activity or to Do Active Work,60:Requires Occasional Assistance but is Able to Care for Most of Needs,50:Requires Considerable Assistance and Frequent Medical Care,40:Disabled,Requires Special Care and Assistance,30:Severely Disabled; Hospitalization Indicated Although Death is Not Imminent,20:Very Sick; Hospitalization Necessary;Active Supportive Treatment is Necessary,10:Moribund, Fatal Processes Progressing Rapidly,0:Death|Participants|Number|1|1.0||||||
4151338|NCT00855062|3975027|B1|100 (Karnofsky Score)||Baseline Karnofsky's Performance Score|100:Normal,90:normal;Minor Signs or Symptoms of Disease,80:Normal Activity with Effort;Some Signs or Symptoms of Disease,70:Cares for Self,Unable to Carry on Normal Activity or to Do Active Work,60:Requires Occasional Assistance but is Able to Care for Most of Needs,50:Requires Considerable Assistance and Frequent Medical Care,40:Disabled,Requires Special Care and Assistance,30:Severely Disabled; Hospitalization Indicated Although Death is Not Imminent,20:Very Sick; Hospitalization Necessary;Active Supportive Treatment is Necessary,10:Moribund, Fatal Processes Progressing Rapidly,0:Death|Participants|Number|0|0.0||||||
4151339|NCT00855062|3975025|B3|90 (Karnofsky Score)||Baseline Karnofsky's Performance Score|100:Normal,90:normal;Minor Signs or Symptoms of Disease,80:Normal Activity with Effort;Some Signs or Symptoms of Disease,70:Cares for Self,Unable to Carry on Normal Activity or to Do Active Work,60:Requires Occasional Assistance but is Able to Care for Most of Needs,50:Requires Considerable Assistance and Frequent Medical Care,40:Disabled,Requires Special Care and Assistance,30:Severely Disabled; Hospitalization Indicated Although Death is Not Imminent,20:Very Sick; Hospitalization Necessary;Active Supportive Treatment is Necessary,10:Moribund, Fatal Processes Progressing Rapidly,0:Death|Participants|Number|69|69.0||||||
4151340|NCT00855062|3975026|B2|90 (Karnofsky Score)||Baseline Karnofsky's Performance Score|100:Normal,90:normal;Minor Signs or Symptoms of Disease,80:Normal Activity with Effort;Some Signs or Symptoms of Disease,70:Cares for Self,Unable to Carry on Normal Activity or to Do Active Work,60:Requires Occasional Assistance but is Able to Care for Most of Needs,50:Requires Considerable Assistance and Frequent Medical Care,40:Disabled,Requires Special Care and Assistance,30:Severely Disabled; Hospitalization Indicated Although Death is Not Imminent,20:Very Sick; Hospitalization Necessary;Active Supportive Treatment is Necessary,10:Moribund, Fatal Processes Progressing Rapidly,0:Death|Participants|Number|34|34.0||||||
4151341|NCT00855062|3975027|B1|90 (Karnofsky Score)||Baseline Karnofsky's Performance Score|100:Normal,90:normal;Minor Signs or Symptoms of Disease,80:Normal Activity with Effort;Some Signs or Symptoms of Disease,70:Cares for Self,Unable to Carry on Normal Activity or to Do Active Work,60:Requires Occasional Assistance but is Able to Care for Most of Needs,50:Requires Considerable Assistance and Frequent Medical Care,40:Disabled,Requires Special Care and Assistance,30:Severely Disabled; Hospitalization Indicated Although Death is Not Imminent,20:Very Sick; Hospitalization Necessary;Active Supportive Treatment is Necessary,10:Moribund, Fatal Processes Progressing Rapidly,0:Death|Participants|Number|35|35.0||||||
4151342|NCT00855062|3975025|B3|80 (Karnofsky Score)||Baseline Karnofsky's Performance Score|100:Normal,90:normal;Minor Signs or Symptoms of Disease,80:Normal Activity with Effort;Some Signs or Symptoms of Disease,70:Cares for Self,Unable to Carry on Normal Activity or to Do Active Work,60:Requires Occasional Assistance but is Able to Care for Most of Needs,50:Requires Considerable Assistance and Frequent Medical Care,40:Disabled,Requires Special Care and Assistance,30:Severely Disabled; Hospitalization Indicated Although Death is Not Imminent,20:Very Sick; Hospitalization Necessary;Active Supportive Treatment is Necessary,10:Moribund, Fatal Processes Progressing Rapidly,0:Death|Participants|Number|3|3.0||||||
4151343|NCT00855062|3975026|B2|80 (Karnofsky Score)||Baseline Karnofsky's Performance Score|100:Normal,90:normal;Minor Signs or Symptoms of Disease,80:Normal Activity with Effort;Some Signs or Symptoms of Disease,70:Cares for Self,Unable to Carry on Normal Activity or to Do Active Work,60:Requires Occasional Assistance but is Able to Care for Most of Needs,50:Requires Considerable Assistance and Frequent Medical Care,40:Disabled,Requires Special Care and Assistance,30:Severely Disabled; Hospitalization Indicated Although Death is Not Imminent,20:Very Sick; Hospitalization Necessary;Active Supportive Treatment is Necessary,10:Moribund, Fatal Processes Progressing Rapidly,0:Death|Participants|Number|2|2.0||||||
4151344|NCT00855062|3975027|B1|80 (Karnofsky Score)||Baseline Karnofsky's Performance Score|100:Normal,90:normal;Minor Signs or Symptoms of Disease,80:Normal Activity with Effort;Some Signs or Symptoms of Disease,70:Cares for Self,Unable to Carry on Normal Activity or to Do Active Work,60:Requires Occasional Assistance but is Able to Care for Most of Needs,50:Requires Considerable Assistance and Frequent Medical Care,40:Disabled,Requires Special Care and Assistance,30:Severely Disabled; Hospitalization Indicated Although Death is Not Imminent,20:Very Sick; Hospitalization Necessary;Active Supportive Treatment is Necessary,10:Moribund, Fatal Processes Progressing Rapidly,0:Death|Participants|Number|1|1.0||||||
4151345|NCT00855062|3975025|B3|||Baseline Log10(Human immunodeficiency virus (HIV) Ribonucleic Acid (RNA) Viral Load (VL))||copies/mL|Log Mean|4.50|4.5|Inter-Quartile Range|||4.1|5.1|
4151346|NCT00855062|3975026|B2|||Baseline Log10(Human immunodeficiency virus (HIV) Ribonucleic Acid (RNA) Viral Load (VL))||copies/mL|Log Mean|4.59|4.59|Inter-Quartile Range|||4.12|5.25|
4151347|NCT00855062|3975027|B1|||Baseline Log10(Human immunodeficiency virus (HIV) Ribonucleic Acid (RNA) Viral Load (VL))||copies/mL|Log Mean|4.41|4.41|Inter-Quartile Range|||4.09|4.94|
4151348|NCT00855062|3975025|B3|||Baseline Cluster of Differentiation Four (CD4) Count||cells/mm^3|Median|313|313.0|Full Range|||251.0|500.0|
4151349|NCT00855062|3975026|B2|||Baseline Cluster of Differentiation Four (CD4) Count||cells/mm^3|Median|305|305.0|Full Range|||252.0|500.0|
4151350|NCT00855062|3975027|B1|||Baseline Cluster of Differentiation Four (CD4) Count||cells/mm^3|Median|319|319.0|Full Range|||251.0|469.0|
4151351|NCT00855062|3975025|B3|Mild||Baseline Memorial Sloan Kettering (MSK) Acquired Immune Deficiency Syndrome (AIDS) Dementia Scale|"The Memorial Sloan Kettering (MSK) clinical scale was defined below:~Stage 0: normal~Stage 0.5: equivocal/subclinical~Stage 1: mild~Stage 2: moderate~Stage 3: severe~Stage 4: end stage"|Participants|Number|1|1.0||||||
4151352|NCT00855062|3975026|B2|Mild||Baseline Memorial Sloan Kettering (MSK) Acquired Immune Deficiency Syndrome (AIDS) Dementia Scale|"The Memorial Sloan Kettering (MSK) clinical scale was defined below:~Stage 0: normal~Stage 0.5: equivocal/subclinical~Stage 1: mild~Stage 2: moderate~Stage 3: severe~Stage 4: end stage"|Participants|Number|0|0.0||||||
4151353|NCT00855062|3975027|B1|Mild||Baseline Memorial Sloan Kettering (MSK) Acquired Immune Deficiency Syndrome (AIDS) Dementia Scale|"The Memorial Sloan Kettering (MSK) clinical scale was defined below:~Stage 0: normal~Stage 0.5: equivocal/subclinical~Stage 1: mild~Stage 2: moderate~Stage 3: severe~Stage 4: end stage"|Participants|Number|1|1.0||||||
4151354|NCT00855062|3975025|B3|Equivocal/subclinical||Baseline Memorial Sloan Kettering (MSK) Acquired Immune Deficiency Syndrome (AIDS) Dementia Scale|"The Memorial Sloan Kettering (MSK) clinical scale was defined below:~Stage 0: normal~Stage 0.5: equivocal/subclinical~Stage 1: mild~Stage 2: moderate~Stage 3: severe~Stage 4: end stage"|Participants|Number|72|72.0||||||
4151355|NCT00855062|3975026|B2|Equivocal/subclinical||Baseline Memorial Sloan Kettering (MSK) Acquired Immune Deficiency Syndrome (AIDS) Dementia Scale|"The Memorial Sloan Kettering (MSK) clinical scale was defined below:~Stage 0: normal~Stage 0.5: equivocal/subclinical~Stage 1: mild~Stage 2: moderate~Stage 3: severe~Stage 4: end stage"|Participants|Number|37|37.0||||||
4151356|NCT00855062|3975027|B1|Equivocal/subclinical||Baseline Memorial Sloan Kettering (MSK) Acquired Immune Deficiency Syndrome (AIDS) Dementia Scale|"The Memorial Sloan Kettering (MSK) clinical scale was defined below:~Stage 0: normal~Stage 0.5: equivocal/subclinical~Stage 1: mild~Stage 2: moderate~Stage 3: severe~Stage 4: end stage"|Participants|Number|35|35.0||||||
4151357|NCT00855062|3975025|B3|Uganda||Region of Enrollment||participants|Number|73|73.0||||||
4151358|NCT00855062|3975026|B2|Uganda||Region of Enrollment||participants|Number|37|37.0||||||
4151359|NCT00855062|3975027|B1|Uganda||Region of Enrollment||participants|Number|36|36.0||||||
4151360|NCT00855062|3975025|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4151361|NCT00855062|3975026|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4151362|NCT00855062|3975027|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4151363|NCT00855062|3975025|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4151364|NCT00855062|3975026|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4151365|NCT00855062|3975027|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4151366|NCT00855062|3975025|B3|||Age||years|Mean|37.0|37.0|Standard Deviation|7.66|7.66|||
4151367|NCT00855062|3975026|B2|||Age||years|Mean|36.7|36.7|Standard Deviation|7.17|7.17|||
4151368|NCT00855062|3975027|B1|||Age||years|Mean|37.3|37.3|Standard Deviation|8.21|8.21|||
4151369|NCT00855062|3975025|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4151370|NCT00855062|3975026|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4151371|NCT00855062|3975027|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4151372|NCT00855062|3975025|B3||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4151373|NCT00855062|3975026|B2||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4151374|NCT00855062|3975027|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4151375|NCT00855062|3975025|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4151376|NCT00855062|3975026|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4151377|NCT00855062|3975027|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4151378|NCT00855010|3975052|B3|United States||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
4151379|NCT00855010|3975053|B2|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4151380|NCT00855010|3975054|B1|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4151389|NCT00855010|3975054|B1|||Age||years|Mean|52.6|52.6|Standard Deviation|9.9|9.9|||
4151390|NCT00855010|3975052|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4151391|NCT00855010|3975053|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4151392|NCT00855010|3975054|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4151393|NCT00855010|3975052|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4151394|NCT00855010|3975053|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4151395|NCT00855010|3975054|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4151396|NCT00855010|3975052|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4151397|NCT00855010|3975053|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4151398|NCT00855010|3975054|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4151399|NCT00854906|3975077|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4151400|NCT00854906|3975077|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4151401|NCT00854906|3975077|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4151402|NCT00854906|3975077|B1|||Age||years|Mean|39.6|39.6|Standard Deviation|15.5|15.5|||
4151403|NCT00854906|3975077|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4151404|NCT00854906|3975077|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4151405|NCT00854906|3975077|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4151406|NCT00854724|3975084|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4151407|NCT00854724|3975085|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4151408|NCT00854724|3975086|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4151409|NCT00854724|3975084|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4151410|NCT00854724|3975085|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4151411|NCT00854724|3975086|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4151412|NCT00854724|3975084|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4151413|NCT00854724|3975085|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4151414|NCT00854724|3975086|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4151415|NCT00854724|3975084|B3|||Age||years|Mean|24.4|24.4|Standard Deviation|3.2|3.2|||
4151416|NCT00854724|3975085|B2|||Age||years|Mean|24.5|24.5|Standard Deviation|3.7|3.7|||
4151417|NCT00854724|3975086|B1|||Age||years|Mean|24.3|24.3|Standard Deviation|2.9|2.9|||
4151418|NCT00854724|3975084|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4151419|NCT00854724|3975085|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4151420|NCT00854724|3975086|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4151421|NCT00854724|3975084|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4151422|NCT00854724|3975085|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4151423|NCT00854724|3975086|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4151424|NCT00854724|3975084|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4151425|NCT00854724|3975085|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4151426|NCT00854724|3975086|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4151427|NCT00854620|3975093|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4151428|NCT00854620|3975093|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4151429|NCT00854620|3975093|B1|||Age||years|Median|60|60.0|Full Range|||47.0|77.0|
4151430|NCT00854607|3975097|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4151431|NCT00854607|3975097|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4151432|NCT00854607|3975097|B1|||Age||years|Mean|56.9|56.9|Standard Deviation|13.3|13.3|||
4151433|NCT00854594|3975130|B3|Unknown||Sex/Gender, Customized||participants|Number|3|3.0||||||
4151434|NCT00854594|3975131|B2|Unknown||Sex/Gender, Customized||participants|Number|3|3.0||||||
4151435|NCT00854594|3975132|B1|Unknown||Sex/Gender, Customized||participants|Number|0|0.0||||||
4151436|NCT00854594|3975130|B3|Female||Sex/Gender, Customized||participants|Number|89|89.0||||||
4151437|NCT00854594|3975131|B2|Female||Sex/Gender, Customized||participants|Number|53|53.0||||||
4151438|NCT00854594|3975132|B1|Female||Sex/Gender, Customized||participants|Number|36|36.0||||||
4151439|NCT00854594|3975130|B3|Male||Sex/Gender, Customized||participants|Number|25|25.0||||||
4151440|NCT00854594|3975131|B2|Male||Sex/Gender, Customized||participants|Number|13|13.0||||||
4151441|NCT00854594|3975132|B1|Male||Sex/Gender, Customized||participants|Number|12|12.0||||||
4151442|NCT00854594|3975130|B3|60 years or greater||Age, Customized|Age categories indicated in provider questionnaire.|participants|Number|5|5.0||||||
4151443|NCT00854594|3975131|B2|60 years or greater||Age, Customized|Age categories indicated in provider questionnaire.|participants|Number|5|5.0||||||
4151444|NCT00854594|3975132|B1|60 years or greater||Age, Customized|Age categories indicated in provider questionnaire.|participants|Number|0|0.0||||||
4151445|NCT00854594|3975130|B3|40 to 59 years||Age, Customized|Age categories indicated in provider questionnaire.|participants|Number|89|89.0||||||
4151446|NCT00854594|3975131|B2|40 to 59 years||Age, Customized|Age categories indicated in provider questionnaire.|participants|Number|48|48.0||||||
4151447|NCT00854594|3975132|B1|40 to 59 years||Age, Customized|Age categories indicated in provider questionnaire.|participants|Number|41|41.0||||||
4151448|NCT00854594|3975130|B3|39 years or less||Age, Customized|Age categories indicated in provider questionnaire.|participants|Number|19|19.0||||||
4151449|NCT00854594|3975131|B2|39 years or less||Age, Customized|Age categories indicated in provider questionnaire.|participants|Number|12|12.0||||||
4151450|NCT00854594|3975132|B1|39 years or less||Age, Customized|Age categories indicated in provider questionnaire.|participants|Number|7|7.0||||||
4151451|NCT00854594|3975130|B3|Missing||Age, Customized|Age categories indicated in provider questionnaire.|participants|Number|4|4.0||||||
4151452|NCT00854594|3975131|B2|Missing||Age, Customized|Age categories indicated in provider questionnaire.|participants|Number|4|4.0||||||
4151453|NCT00854594|3975132|B1|Missing||Age, Customized|Age categories indicated in provider questionnaire.|participants|Number|0|0.0||||||
4151454|NCT00854581|3975145|B1|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4151455|NCT00854581|3975145|B1|Trinidad||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4151456|NCT00854581|3975145|B1|St. Croix||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4151457|NCT00854581|3975145|B1|Jamaica||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4151458|NCT00854581|3975145|B1|Haiti||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4151459|NCT00854581|3975145|B1|Dominican Republic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4151460|NCT00854581|3975145|B1|Brazil||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4151461|NCT00854581|3975145|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151462|NCT00854581|3975145|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4151463|NCT00854581|3975145|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151464|NCT00854581|3975145|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4151465|NCT00854581|3975145|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151466|NCT00854581|3975145|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151467|NCT00854581|3975145|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151468|NCT00854581|3975145|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4151469|NCT00854581|3975145|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4151470|NCT00854581|3975145|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4151471|NCT00854581|3975145|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4151472|NCT00854581|3975145|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4151473|NCT00854373|3975158|B3|United States||Region of Enrollment||participants|Number|188|188.0||||||
4151474|NCT00854373|3975159|B2|United States||Region of Enrollment||participants|Number|93|93.0||||||
4151475|NCT00854373|3975160|B1|United States||Region of Enrollment||participants|Number|95|95.0||||||
4151476|NCT00854373|3975158|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4151477|NCT00854373|3975159|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4151478|NCT00854373|3975160|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4151479|NCT00854373|3975158|B3||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4151480|NCT00854373|3975159|B2||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4151481|NCT00854373|3975160|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4151482|NCT00854373|3975158|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4151483|NCT00854373|3975159|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4151484|NCT00854373|3975160|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4151485|NCT00854373|3975158|B3||Between 18 and 65 years|Age||Participants|Count of Participants|188|188.0||||||
4151486|NCT00854373|3975159|B2||Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
4151487|NCT00854373|3975160|B1||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
4151488|NCT00854373|3975158|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4151489|NCT00854373|3975159|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4151490|NCT00854373|3975160|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4151491|NCT00854360|3975171|B5|United States||Region of Enrollment||participants|Number|486|486.0||||||
4151492|NCT00854360|3975172|B4|United States||Region of Enrollment||participants|Number|123|123.0||||||
4151493|NCT00854360|3975173|B3|United States||Region of Enrollment||participants|Number|122|122.0||||||
4151494|NCT00854360|3975174|B2|United States||Region of Enrollment||participants|Number|123|123.0||||||
4151495|NCT00854360|3975175|B1|United States||Region of Enrollment||participants|Number|118|118.0||||||
4151496|NCT00854360|3975171|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|430|430.0||||||
4151497|NCT00854360|3975172|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|108|108.0||||||
4151498|NCT00854360|3975173|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|105|105.0||||||
4151499|NCT00854360|3975174|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|113|113.0||||||
4151500|NCT00854360|3975175|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|104|104.0||||||
4151501|NCT00854360|3975171|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
4151502|NCT00854360|3975172|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4151503|NCT00854360|3975173|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4151504|NCT00854360|3975174|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4151505|NCT00854360|3975175|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4151506|NCT00854360|3975171|B5|Other||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4151507|NCT00854360|3975172|B4|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4151508|NCT00854360|3975173|B3|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4151509|NCT00854360|3975174|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4151510|NCT00854360|3975175|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4151511|NCT00854360|3975171|B5|Asian||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4151512|NCT00854360|3975172|B4|Asian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4151513|NCT00854360|3975173|B3|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151514|NCT00854360|3975174|B2|Asian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4151515|NCT00854360|3975175|B1|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4151516|NCT00854360|3975171|B5|Black||Race/Ethnicity, Customized||Participants|Number|82|82.0||||||
4151517|NCT00854360|3975172|B4|Black||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4151518|NCT00854360|3975173|B3|Black||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4151519|NCT00854360|3975174|B2|Black||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4151520|NCT00854360|3975175|B1|Black||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
4151521|NCT00854360|3975171|B5|White||Race/Ethnicity, Customized||Participants|Number|386|386.0||||||
4151522|NCT00854360|3975172|B4|White||Race/Ethnicity, Customized||Participants|Number|97|97.0||||||
4151523|NCT00854360|3975173|B3|White||Race/Ethnicity, Customized||Participants|Number|98|98.0||||||
4151524|NCT00854360|3975174|B2|White||Race/Ethnicity, Customized||Participants|Number|99|99.0||||||
4151525|NCT00854360|3975175|B1|White||Race/Ethnicity, Customized||Participants|Number|92|92.0||||||
4151526|NCT00854360|3975171|B5||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4151527|NCT00854360|3975172|B4||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4151528|NCT00854360|3975173|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4151529|NCT00854360|3975174|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4151530|NCT00854360|3975175|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4151531|NCT00854360|3975171|B5||Female|Sex: Female, Male||Participants|Count of Participants|316|316.0||||||
4151532|NCT00854360|3975172|B4||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4151533|NCT00854360|3975173|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4151534|NCT00854360|3975174|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4151535|NCT00854360|3975175|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4151536|NCT00854360|3975171|B5|||Age|Demographic data are provided for the Intent to Treat population.|years|Mean|38.5|38.5|Standard Deviation|14.45|14.45|||
4151537|NCT00854360|3975172|B4|||Age|Demographic data are provided for the Intent to Treat population.|years|Mean|38.2|38.2|Standard Deviation|13.95|13.95|||
4151538|NCT00854360|3975173|B3|||Age|Demographic data are provided for the Intent to Treat population.|years|Mean|38.5|38.5|Standard Deviation|14.74|14.74|||
4151539|NCT00854360|3975174|B2|||Age|Demographic data are provided for the Intent to Treat population.|years|Mean|39.8|39.8|Standard Deviation|15.26|15.26|||
4151540|NCT00854360|3975175|B1|||Age|Demographic data are provided for the Intent to Treat population.|years|Mean|37.6|37.6|Standard Deviation|13.86|13.86|||
4151541|NCT00854308|3975208|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4151542|NCT00854308|3975209|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4151543|NCT00854308|3975210|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4151544|NCT00854308|3975208|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4151545|NCT00854308|3975209|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4151546|NCT00854308|3975210|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4151547|NCT00854308|3975208|B3|||Age||years|Mean|63.1|63.1|Standard Deviation|10.0|10.0|||
4151548|NCT00854308|3975209|B2|||Age||years|Mean|62.7|62.7|Standard Deviation|10.6|10.6|||
4151549|NCT00854308|3975210|B1|||Age||years|Mean|63.6|63.6|Standard Deviation|9.4|9.4|||
4151550|NCT00854113|3975225|B12|Others||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4151551|NCT00854113|3975226|B11|Others||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151552|NCT00854113|3975227|B10|Others||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4151553|NCT00854113|3975228|B9|Others||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4151554|NCT00854113|3975229|B8|Others||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151555|NCT00854113|3975230|B7|Others||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4151556|NCT00854113|3975231|B6|Others||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151557|NCT00854113|3975232|B5|Others||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151558|NCT00854113|3975233|B4|Others||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151559|NCT00854113|3975234|B3|Others||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4151560|NCT00854113|3975235|B2|Others||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151561|NCT00854113|3975236|B1|Others||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151562|NCT00854113|3975225|B12|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151563|NCT00854113|3975226|B11|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151564|NCT00854113|3975227|B10|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151565|NCT00854113|3975228|B9|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151566|NCT00854113|3975229|B8|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151567|NCT00854113|3975230|B7|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151568|NCT00854113|3975231|B6|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151569|NCT00854113|3975232|B5|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151570|NCT00854113|3975233|B4|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151571|NCT00854113|3975234|B3|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151572|NCT00854113|3975235|B2|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151573|NCT00854113|3975236|B1|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151574|NCT00854113|3975225|B12|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151575|NCT00854113|3975226|B11|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151576|NCT00854113|3975227|B10|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151577|NCT00854113|3975228|B9|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151578|NCT00854113|3975229|B8|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151579|NCT00854113|3975230|B7|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151580|NCT00854113|3975231|B6|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151581|NCT00854113|3975232|B5|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151582|NCT00854113|3975233|B4|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151583|NCT00854113|3975234|B3|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151584|NCT00854113|3975235|B2|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151585|NCT00854113|3975236|B1|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151586|NCT00854113|3975225|B12|White||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4151587|NCT00854113|3975226|B11|White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4151588|NCT00854113|3975227|B10|White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151589|NCT00854113|3975228|B9|White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4151590|NCT00854113|3975229|B8|White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4151591|NCT00854113|3975230|B7|White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151592|NCT00854113|3975231|B6|White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151593|NCT00854113|3975232|B5|White||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4151594|NCT00854113|3975233|B4|White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151595|NCT00854113|3975234|B3|White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4151596|NCT00854113|3975235|B2|White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4151597|NCT00854113|3975236|B1|White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151598|NCT00854113|3975225|B12|Black or African American||Race/Ethnicity, Customized||Participants|Number|64|64.0||||||
4151599|NCT00854113|3975226|B11|Black or African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4151600|NCT00854113|3975227|B10|Black or African American||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4151601|NCT00854113|3975228|B9|Black or African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4151602|NCT00854113|3975229|B8|Black or African American||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4151603|NCT00854113|3975230|B7|Black or African American||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4151604|NCT00854113|3975231|B6|Black or African American||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4151605|NCT00854113|3975232|B5|Black or African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4151606|NCT00854113|3975233|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4151607|NCT00854113|3975234|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4151608|NCT00854113|3975235|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4151609|NCT00854113|3975236|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4151610|NCT00854113|3975225|B12|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151611|NCT00854113|3975226|B11|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151612|NCT00854113|3975227|B10|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151613|NCT00854113|3975228|B9|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151614|NCT00854113|3975229|B8|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151615|NCT00854113|3975230|B7|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151616|NCT00854113|3975231|B6|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151617|NCT00854113|3975232|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151618|NCT00854113|3975233|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151619|NCT00854113|3975234|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151620|NCT00854113|3975235|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151621|NCT00854113|3975236|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151622|NCT00854113|3975225|B12|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151623|NCT00854113|3975226|B11|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151624|NCT00854113|3975227|B10|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151625|NCT00854113|3975228|B9|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151626|NCT00854113|3975229|B8|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151627|NCT00854113|3975230|B7|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151628|NCT00854113|3975231|B6|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151629|NCT00854113|3975232|B5|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151630|NCT00854113|3975233|B4|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151631|NCT00854113|3975234|B3|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151632|NCT00854113|3975235|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151633|NCT00854113|3975236|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151634|NCT00854113|3975225|B12|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151635|NCT00854113|3975226|B11|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151636|NCT00854113|3975227|B10|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151637|NCT00854113|3975228|B9|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151638|NCT00854113|3975229|B8|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151639|NCT00854113|3975230|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151640|NCT00854113|3975231|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151641|NCT00854113|3975232|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151642|NCT00854113|3975233|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151643|NCT00854113|3975234|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151644|NCT00854113|3975235|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151645|NCT00854113|3975236|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4151646|NCT00854113|3975225|B12||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151647|NCT00854113|3975226|B11||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151648|NCT00854113|3975227|B10||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151649|NCT00854113|3975228|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151650|NCT00854113|3975229|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151651|NCT00854113|3975230|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151652|NCT00854113|3975231|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151653|NCT00854113|3975232|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151654|NCT00854113|3975233|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151655|NCT00854113|3975234|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151656|NCT00854113|3975235|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151657|NCT00854113|3975236|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151658|NCT00854113|3975225|B12||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4151659|NCT00854113|3975226|B11||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4151660|NCT00854113|3975227|B10||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4151661|NCT00854113|3975228|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4151662|NCT00854113|3975229|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4151663|NCT00854113|3975230|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4151664|NCT00854113|3975231|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4151665|NCT00854113|3975232|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4151666|NCT00854113|3975233|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4151667|NCT00854113|3975234|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4151668|NCT00854113|3975235|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4151669|NCT00854113|3975236|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4151670|NCT00854113|3975225|B12||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4151671|NCT00854113|3975226|B11||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151672|NCT00854113|3975227|B10||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4151673|NCT00854113|3975228|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4151674|NCT00854113|3975229|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4151675|NCT00854113|3975230|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4151676|NCT00854113|3975231|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151677|NCT00854113|3975232|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151678|NCT00854113|3975233|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4151679|NCT00854113|3975234|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4151680|NCT00854113|3975235|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4151681|NCT00854113|3975236|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4151682|NCT00854113|3975225|B12||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4151683|NCT00854113|3975226|B11||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4151684|NCT00854113|3975227|B10||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4151685|NCT00854113|3975228|B9||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4151686|NCT00854113|3975229|B8||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4151687|NCT00854113|3975230|B7||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4151688|NCT00854113|3975231|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4151689|NCT00854113|3975232|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4151690|NCT00854113|3975233|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4151691|NCT00854113|3975234|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4151692|NCT00854113|3975235|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4151693|NCT00854113|3975236|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4151694|NCT00854113|3975225|B12||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4151695|NCT00854113|3975226|B11||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4151696|NCT00854113|3975227|B10||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4151697|NCT00854113|3975228|B9||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4151698|NCT00854113|3975229|B8||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4151699|NCT00854113|3975230|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4151700|NCT00854113|3975231|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4151701|NCT00854113|3975232|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4151702|NCT00854113|3975233|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4151703|NCT00854113|3975234|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4151704|NCT00854113|3975235|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4151705|NCT00854113|3975236|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4151706|NCT00854113|3975225|B12|||Age||years|Mean|32|32.0|Full Range|||18.0|55.0|
4151707|NCT00854113|3975226|B11|||Age||years|Mean|26|26.0|Full Range|||22.0|32.0|
4151708|NCT00854113|3975227|B10|||Age||years|Mean|22|22.0|Full Range|||18.0|28.0|
4151709|NCT00854113|3975228|B9|||Age||years|Mean|35|35.0|Full Range|||21.0|49.0|
4151710|NCT00854113|3975229|B8|||Age||years|Mean|30|30.0|Full Range|||20.0|44.0|
4151711|NCT00854113|3975230|B7|||Age||years|Mean|33|33.0|Full Range|||19.0|53.0|
4151712|NCT00854113|3975231|B6|||Age||years|Mean|35|35.0|Full Range|||23.0|55.0|
4151713|NCT00854113|3975232|B5|||Age||years|Mean|29|29.0|Full Range|||23.0|35.0|
4151714|NCT00854113|3975233|B4|||Age||years|Mean|32|32.0|Full Range|||18.0|55.0|
4151715|NCT00854113|3975234|B3|||Age||years|Mean|25|25.0|Full Range|||19.0|40.0|
4151716|NCT00854113|3975235|B2|||Age||years|Mean|26|26.0|Full Range|||18.0|31.0|
4151717|NCT00854113|3975236|B1|||Age||years|Mean|43|43.0|Full Range|||29.0|55.0|
4151718|NCT00854087|3975347|B3|Other||HCV Genotypes||participants|Number|1|1.0||||||
4151719|NCT00854087|3975348|B2|Other||HCV Genotypes||participants|Number|1|1.0||||||
4151720|NCT00854087|3975349|B1|Other||HCV Genotypes||participants|Number|0|0.0||||||
4151721|NCT00854087|3975347|B3|4||HCV Genotypes||participants|Number|1|1.0||||||
4151722|NCT00854087|3975348|B2|4||HCV Genotypes||participants|Number|0|0.0||||||
4151723|NCT00854087|3975349|B1|4||HCV Genotypes||participants|Number|1|1.0||||||
4151724|NCT00854087|3975347|B3|3||HCV Genotypes||participants|Number|11|11.0||||||
4151725|NCT00854087|3975348|B2|3||HCV Genotypes||participants|Number|5|5.0||||||
4151726|NCT00854087|3975349|B1|3||HCV Genotypes||participants|Number|6|6.0||||||
4151727|NCT00854087|3975347|B3|2||HCV Genotypes||participants|Number|5|5.0||||||
4151728|NCT00854087|3975348|B2|2||HCV Genotypes||participants|Number|1|1.0||||||
4151729|NCT00854087|3975349|B1|2||HCV Genotypes||participants|Number|4|4.0||||||
4151730|NCT00854087|3975347|B3|1||HCV Genotypes||participants|Number|100|100.0||||||
4151731|NCT00854087|3975348|B2|1||HCV Genotypes||participants|Number|52|52.0||||||
4151732|NCT00854087|3975349|B1|1||HCV Genotypes||participants|Number|48|48.0||||||
4151733|NCT00854087|3975347|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151734|NCT00854087|3975348|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151735|NCT00854087|3975349|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151736|NCT00854087|3975347|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
4151737|NCT00854087|3975348|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4151738|NCT00854087|3975349|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4151739|NCT00854087|3975347|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4151740|NCT00854087|3975348|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4151741|NCT00854087|3975349|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4151742|NCT00854087|3975347|B3||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4151743|NCT00854087|3975348|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4151744|NCT00854087|3975349|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4151745|NCT00854087|3975347|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4151746|NCT00854087|3975348|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4151747|NCT00854087|3975349|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4151748|NCT00854087|3975347|B3|||Age||years|Mean|55.3|55.3|Standard Deviation|7.67|7.67|||
4151749|NCT00854087|3975348|B2|||Age||years|Mean|55.1|55.1|Standard Deviation|8.61|8.61|||
4151750|NCT00854087|3975349|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|6.72|6.72|||
4151751|NCT00853996|3975356|B1|||Age First Live Birth||years|Mean|28|28.0|Standard Deviation|4|4.0|||
4151752|NCT00853996|3975356|B1|||5-Year Gail Risk|Projected risk of a women developing breast cancer within the next 5 years, as calculated using the Gail Risk Model.|Percent risk of developing breast cancer|Mean|3.6|3.6|Standard Deviation|4.4|4.4|||
4151753|NCT00853996|3975356|B1|||BMI||kg/m^2|Mean|25.8|25.8|Standard Deviation|4.8|4.8|||
4151754|NCT00853996|3975356|B1|||Weight||pounds|Mean|155|155.0|Standard Deviation|29|29.0|||
4151755|NCT00853996|3975356|B1|||Height||inches|Mean|65|65.0|Standard Deviation|2|2.0|||
4151756|NCT00853996|3975356|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4151757|NCT00853996|3975356|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4151758|NCT00853996|3975356|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4151759|NCT00853996|3975356|B1|||Age||years|Mean|42.8|42.8|Standard Deviation|5.2|5.2|||
4151760|NCT00853970|3975366|B3||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4151761|NCT00853970|3975367|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4151762|NCT00853970|3975368|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4151763|NCT00853970|3975366|B3||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4151764|NCT00853970|3975367|B2||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4151765|NCT00853970|3975368|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4151766|NCT00853970|3975366|B3|||Age||years|Mean|69.8|69.8|Full Range|||34.0|90.0|
4151767|NCT00853970|3975367|B2|||Age||years|Mean|69.1|69.1|Full Range|||40.0|90.0|
4151768|NCT00853970|3975368|B1|||Age||years|Mean|70.4|70.4|Full Range|||34.0|87.0|
4151769|NCT00853957|3975377|B3||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4151770|NCT00853957|3975378|B2||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4151771|NCT00853957|3975379|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4151772|NCT00853957|3975377|B3||Female|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
4151773|NCT00853957|3975378|B2||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4151774|NCT00853957|3975379|B1||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4151775|NCT00853957|3975377|B3|≥55 years||Age, Customized||participants|Number|193|193.0||||||
4151776|NCT00853957|3975378|B2|≥55 years||Age, Customized||participants|Number|96|96.0||||||
4151777|NCT00853957|3975379|B1|≥55 years||Age, Customized||participants|Number|97|97.0||||||
4151778|NCT00853957|3975377|B3|<55 years||Age, Customized||participants|Number|250|250.0||||||
4151779|NCT00853957|3975378|B2|<55 years||Age, Customized||participants|Number|127|127.0||||||
4151780|NCT00853957|3975379|B1|<55 years||Age, Customized||participants|Number|123|123.0||||||
4151781|NCT00853957|3975377|B3|||Age||years|Mean|52.8|52.8|Standard Deviation|9.97|9.97|||
4151782|NCT00853957|3975378|B2|||Age||years|Mean|52.4|52.4|Standard Deviation|10.57|10.57|||
4151783|NCT00853957|3975379|B1|||Age||years|Mean|53.2|53.2|Standard Deviation|9.33|9.33|||
4151784|NCT00853905|3975396|B3|||Interocular Pressure (mmHg)||mmHg|Median|24.0|24.0|Full Range|||8.5|56.0|
4151785|NCT00853905|3975397|B2|||Interocular Pressure (mmHg)||mmHg|Median|23.8|23.8|Full Range|||8.5|56.0|
4151786|NCT00853905|3975398|B1|||Interocular Pressure (mmHg)||mmHg|Median|24.5|24.5|Full Range|||13.0|40.0|
4151787|NCT00853905|3975396|B3|United States||Region of Enrollment||participants|Number|77|77.0||||||
4151788|NCT00853905|3975397|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4151789|NCT00853905|3975398|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4151790|NCT00853905|3975396|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4151791|NCT00853905|3975397|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4151792|NCT00853905|3975398|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4151793|NCT00853905|3975396|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151794|NCT00853905|3975397|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151795|NCT00853905|3975398|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151796|NCT00853905|3975396|B3||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4151797|NCT00853905|3975397|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4151798|NCT00853905|3975398|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4151799|NCT00853905|3975396|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4151800|NCT00853905|3975397|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4151801|NCT00853905|3975398|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4151802|NCT00853905|3975396|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151803|NCT00853905|3975397|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151804|NCT00853905|3975398|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151805|NCT00853905|3975396|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4151806|NCT00853905|3975397|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4151807|NCT00853905|3975398|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151808|NCT00853905|3975396|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151809|NCT00853905|3975397|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151810|NCT00853905|3975398|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151811|NCT00853905|3975396|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4151812|NCT00853905|3975397|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4151813|NCT00853905|3975398|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4151814|NCT00853905|3975396|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4151815|NCT00853905|3975397|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4151816|NCT00853905|3975398|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4151817|NCT00853905|3975396|B3|||Age||years|Median|68.5|68.5|Full Range|||42.0|88.0|
4151818|NCT00853905|3975397|B2|||Age||years|Median|69|69.0|Full Range|||42.0|88.0|
4151819|NCT00853905|3975398|B1|||Age||years|Median|68|68.0|Full Range|||47.0|88.0|
4151820|NCT00853840|3975413|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4151821|NCT00853840|3975413|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4151822|NCT00853840|3975413|B1|||Age||years|Mean|34.6|34.6|Standard Deviation|9.1|9.1|||
4151823|NCT00853827|3975429|B3||Male|Sex: Female, Male||Participants|Count of Participants|467|467.0||||||
4151824|NCT00853827|3975430|B2||Male|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
4151825|NCT00853827|3975431|B1||Male|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
4151826|NCT00853827|3975429|B3||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4151827|NCT00853827|3975430|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4151828|NCT00853827|3975431|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4151829|NCT00853827|3975429|B3|||Age||years|Mean|59.7|59.7|Standard Deviation|8.86|8.86|||
4151830|NCT00853827|3975430|B2|||Age||years|Mean|59.2|59.2|Standard Deviation|8.32|8.32|||
4151831|NCT00853827|3975431|B1|||Age||years|Mean|60.2|60.2|Standard Deviation|9.35|9.35|||
4151832|NCT00853762|3975444|B5||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4151833|NCT00853762|3975445|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4151834|NCT00853762|3975446|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4151835|NCT00853762|3975447|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4151836|NCT00853762|3975448|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4151837|NCT00853762|3975444|B5||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4151838|NCT00853762|3975445|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4151839|NCT00853762|3975446|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4151840|NCT00853762|3975447|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4151841|NCT00853762|3975448|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4151842|NCT00853762|3975444|B5|||Age||years|Mean|36.8|36.8|Standard Deviation|9.3|9.3|||
4151843|NCT00853762|3975445|B4|||Age||years|Mean|34.4|34.4|Standard Deviation|8.6|8.6|||
4151844|NCT00853762|3975446|B3|||Age||years|Mean|37.4|37.4|Standard Deviation|11.2|11.2|||
4151845|NCT00853762|3975447|B2|||Age||years|Mean|36.8|36.8|Standard Deviation|9.1|9.1|||
4151846|NCT00853762|3975448|B1|||Age||years|Mean|39.4|39.4|Standard Deviation|8.4|8.4|||
4151847|NCT00853749|3975517|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4151848|NCT00853749|3975518|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4151849|NCT00853749|3975519|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4151850|NCT00853749|3975517|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4151851|NCT00853749|3975518|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4151852|NCT00853749|3975519|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4151853|NCT00853749|3975517|B3|||Age||years|Mean|7.6|7.6|Standard Deviation|0.2|0.2|||
4151854|NCT00853749|3975518|B2|||Age||years|Mean|7.6|7.6|Standard Deviation|0.2|0.2|||
4151855|NCT00853749|3975519|B1|||Age||years|Mean|7.6|7.6|Standard Deviation|0.2|0.2|||
4151856|NCT00853723|3975538|B4|United States||Region of Enrollment||participants|Number|105|105.0||||||
4151857|NCT00853723|3975539|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
4151858|NCT00853723|3975540|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
4151859|NCT00853723|3975541|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4151860|NCT00853723|3975538|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4151861|NCT00853723|3975539|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4151862|NCT00853723|3975540|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4151863|NCT00853723|3975541|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4151864|NCT00853723|3975538|B4||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4151865|NCT00853723|3975539|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4151866|NCT00853723|3975540|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4151867|NCT00853723|3975541|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4151868|NCT00853723|3975538|B4|||Age||years|Mean|61.4|61.4|Standard Deviation|5.20|5.2|||
4151869|NCT00853723|3975539|B3|||Age||years|Mean|62.4|62.4|Standard Deviation|5.26|5.26|||
4151870|NCT00853723|3975540|B2|||Age||years|Mean|61.2|61.2|Standard Deviation|5.10|5.1|||
4151871|NCT00853723|3975541|B1|||Age||years|Mean|60.6|60.6|Standard Deviation|5.22|5.22|||
4151872|NCT00853723|3975538|B4||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4151873|NCT00853723|3975539|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4151874|NCT00853723|3975540|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4151875|NCT00853723|3975541|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4151876|NCT00853723|3975538|B4||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
4151877|NCT00853723|3975539|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4151878|NCT00853723|3975540|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4151879|NCT00853723|3975541|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4151880|NCT00853723|3975538|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4151881|NCT00853723|3975539|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4151882|NCT00853723|3975540|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4151883|NCT00853723|3975541|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4151884|NCT00853671|3975587|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4151885|NCT00853671|3975587|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4151886|NCT00853671|3975587|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4151887|NCT00853671|3975587|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|10.4|10.4|||
4151888|NCT00853671|3975587|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4151889|NCT00853671|3975587|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4151890|NCT00853671|3975587|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4151891|NCT00853658|3975594|B4||Male|Sex: Female, Male||Participants|Count of Participants|5491|5491.0||||||
4151892|NCT00853658|3975595|B3||Male|Sex: Female, Male||Participants|Count of Participants|1837|1837.0||||||
4151893|NCT00853658|3975596|B2||Male|Sex: Female, Male||Participants|Count of Participants|1808|1808.0||||||
4151894|NCT00853658|3975597|B1||Male|Sex: Female, Male||Participants|Count of Participants|1846|1846.0||||||
4151895|NCT00853658|3975594|B4||Female|Sex: Female, Male||Participants|Count of Participants|1525|1525.0||||||
4151896|NCT00853658|3975595|B3||Female|Sex: Female, Male||Participants|Count of Participants|499|499.0||||||
4151897|NCT00853658|3975596|B2||Female|Sex: Female, Male||Participants|Count of Participants|532|532.0||||||
4151898|NCT00853658|3975597|B1||Female|Sex: Female, Male||Participants|Count of Participants|494|494.0||||||
4151899|NCT00853658|3975594|B4|||Age||years|Mean|63.2|63.2|Standard Deviation|11.81|11.81|||
4151900|NCT00853658|3975595|B3|||Age||years|Mean|63.3|63.3|Standard Deviation|11.71|11.71|||
4151901|NCT00853658|3975596|B2|||Age||years|Mean|63.3|63.3|Standard Deviation|12.06|12.06|||
4151902|NCT00853658|3975597|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|11.65|11.65|||
4151903|NCT00853606|3975613|B1|United States||Region of Enrollment||participants|Number|712|712.0||||||
4151904|NCT00853606|3975613|B1||Male|Sex: Female, Male||Participants|Count of Participants|712|712.0||||||
4151905|NCT00853606|3975613|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4151906|NCT00853606|3975613|B1|||Age||years|Mean|56.4|56.4|Standard Deviation|10.19|10.19|||
4151907|NCT00853593|3975619|B1|||Left Ventricular Ejection Fraction (LVEF)|All subjects who underwent an implant attempt (193) were included in the study population analysis. Note, one subject did not have a LVEF within 365 days of baseline and a study deviation was reported for not meeting inclusion/exclusion criteria.|Percent|Mean|25.7|25.7|Standard Deviation|6.5|6.5|||
4151908|NCT00853593|3975619|B1|||Intrinsic QRS Width|All subjects who underwent an implant attempt (193) were included in the study population analysis.|Milliseconds|Mean|154.1|154.1|Standard Deviation|24.9|24.9|||
4151909|NCT00853593|3975619|B1|Other||Race/Ethnicity|All subjects who underwent an implant attempt (193) were included in the study population.|participants|Number|1|1.0||||||
4151910|NCT00853593|3975619|B1|Subject chose not to provide information||Race/Ethnicity|All subjects who underwent an implant attempt (193) were included in the study population.|participants|Number|6|6.0||||||
4151911|NCT00853593|3975619|B1|White/Caucasian||Race/Ethnicity|All subjects who underwent an implant attempt (193) were included in the study population.|participants|Number|168|168.0||||||
4151912|NCT00853593|3975619|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity|All subjects who underwent an implant attempt (193) were included in the study population.|participants|Number|1|1.0||||||
4151913|NCT00853593|3975619|B1|Hispanic or Latino||Race/Ethnicity|All subjects who underwent an implant attempt (193) were included in the study population.|participants|Number|6|6.0||||||
4151914|NCT00853593|3975619|B1|Black or African American||Race/Ethnicity|All subjects who underwent an implant attempt (193) were included in the study population.|participants|Number|9|9.0||||||
4151915|NCT00853593|3975619|B1|Asian||Race/Ethnicity|All subjects who underwent an implant attempt (193) were included in the study population.|participants|Number|2|2.0||||||
4151916|NCT00853593|3975619|B1|Class IV||New York Heart Association|All subjects who underwent an implant attempt (193) were included in the study population analysis|participants|Number|1|1.0||||||
4151917|NCT00853593|3975619|B1|Class III||New York Heart Association|All subjects who underwent an implant attempt (193) were included in the study population analysis|participants|Number|192|192.0||||||
4151918|NCT00853593|3975619|B1|Italy||Region of Enrollment|All subjects who underwent an implant attempt (193) were included in the study population analysis.|participants|Number|0|0.0||||||
4151919|NCT00853593|3975619|B1|Austria||Region of Enrollment|All subjects who underwent an implant attempt (193) were included in the study population analysis.|participants|Number|6|6.0||||||
4151920|NCT00853593|3975619|B1|Denmark||Region of Enrollment|All subjects who underwent an implant attempt (193) were included in the study population analysis.|participants|Number|3|3.0||||||
4151921|NCT00853593|3975619|B1|Australia||Region of Enrollment|All subjects who underwent an implant attempt (193) were included in the study population analysis.|participants|Number|2|2.0||||||
4151922|NCT00853593|3975619|B1|Canada||Region of Enrollment|All subjects who underwent an implant attempt (193) were included in the study population analysis.|participants|Number|47|47.0||||||
4151923|NCT00853593|3975619|B1|Saudi Arabia||Region of Enrollment|All subjects who underwent an implant attempt (193) were included in the study population analysis.|participants|Number|0|0.0||||||
4151924|NCT00853593|3975619|B1|United States||Region of Enrollment|All subjects who underwent an implant attempt (193) were included in the study population analysis.|participants|Number|125|125.0||||||
4151925|NCT00853593|3975619|B1|France||Region of Enrollment|All subjects who underwent an implant attempt (193) were included in the study population analysis.|participants|Number|10|10.0||||||
4151926|NCT00853593|3975619|B1||Male|Sex: Female, Male|All subjects who underwent an implant attempt (193) were included in the study population analysis.|Participants|Count of Participants|140|140.0||||||
4151927|NCT00853593|3975619|B1||Female|Sex: Female, Male|All subjects who underwent an implant attempt (193) were included in the study population analysis.|Participants|Count of Participants|53|53.0||||||
4151928|NCT00853593|3975619|B1|||Age|All subjects who underwent an implant attempt (193) were included in the study population analysis.|years|Mean|69.6|69.6|Standard Deviation|10.8|10.8|||
4151929|NCT00853593|3975619|B1||>=65 years|Age|All subjects who underwent an implant attempt (193) were included in the study population analysis.|Participants|Count of Participants|131|131.0||||||
4151930|NCT00853593|3975619|B1||Between 18 and 65 years|Age|All subjects who underwent an implant attempt (193) were included in the study population analysis.|Participants|Count of Participants|62|62.0||||||
4151931|NCT00853593|3975619|B1||<=18 years|Age|All subjects who underwent an implant attempt (193) were included in the study population analysis.|Participants|Count of Participants|0|0.0||||||
4151932|NCT00853580|3975644|B3|Australia||Region of Enrollment||participants|Number|34|34.0||||||
4151933|NCT00853580|3975645|B2|Australia||Region of Enrollment||participants|Number|17|17.0||||||
4151934|NCT00853580|3975646|B1|Australia||Region of Enrollment||participants|Number|17|17.0||||||
4151935|NCT00853580|3975644|B3|United States||Region of Enrollment||participants|Number|112|112.0||||||
4151936|NCT00853580|3975645|B2|United States||Region of Enrollment||participants|Number|55|55.0||||||
4151937|NCT00853580|3975646|B1|United States||Region of Enrollment||participants|Number|57|57.0||||||
4151938|NCT00853580|3975644|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151939|NCT00853580|3975645|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151940|NCT00853580|3975646|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151941|NCT00853580|3975644|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4151942|NCT00853580|3975645|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4151943|NCT00853580|3975646|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4151944|NCT00853580|3975644|B3||White|Race (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
4151945|NCT00853580|3975645|B2||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4151946|NCT00853580|3975646|B1||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4151947|NCT00853580|3975644|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4151948|NCT00853580|3975645|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4151949|NCT00853580|3975646|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4151950|NCT00853580|3975644|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151951|NCT00853580|3975645|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151952|NCT00853580|3975646|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151953|NCT00853580|3975644|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151954|NCT00853580|3975645|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151955|NCT00853580|3975646|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151956|NCT00853580|3975644|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151957|NCT00853580|3975645|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151958|NCT00853580|3975646|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151959|NCT00853580|3975644|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4151960|NCT00853580|3975645|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4151961|NCT00853580|3975646|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4151962|NCT00853580|3975644|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4151963|NCT00853580|3975645|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4151964|NCT00853580|3975646|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4151965|NCT00853580|3975644|B3|||Age||Years|Mean|11.6|11.6|Standard Deviation|2.10|2.1|||
4151966|NCT00853580|3975645|B2|||Age||Years|Mean|11.7|11.7|Standard Deviation|1.95|1.95|||
4151967|NCT00853580|3975646|B1|||Age||Years|Mean|11.5|11.5|Standard Deviation|2.25|2.25|||
4151968|NCT00853580|3975644|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4151969|NCT00853580|3975645|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4151970|NCT00853580|3975646|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4151971|NCT00853580|3975644|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4151972|NCT00853580|3975645|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4151973|NCT00853580|3975646|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4151974|NCT00853580|3975644|B3||<=18 years|Age||Participants|Count of Participants|144|144.0||||||
4151975|NCT00853580|3975645|B2||<=18 years|Age||Participants|Count of Participants|70|70.0||||||
4151976|NCT00853580|3975646|B1||<=18 years|Age||Participants|Count of Participants|74|74.0||||||
4151977|NCT00853489|3975702|B3|||Count of participants||Participants|Count of Participants|30|30.0||||||
4151978|NCT00853489|3975703|B2|||Count of participants||Participants|Count of Participants|14|14.0||||||
4151979|NCT00853489|3975704|B1|||Count of participants||Participants|Count of Participants|16|16.0||||||
4151980|NCT00853489|3975702|B3|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4151981|NCT00853489|3975703|B2|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4151982|NCT00853489|3975704|B1|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4151983|NCT00853489|3975702|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151984|NCT00853489|3975703|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151985|NCT00853489|3975704|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151986|NCT00853489|3975702|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151987|NCT00853489|3975703|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151988|NCT00853489|3975704|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151989|NCT00853489|3975702|B3||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4151990|NCT00853489|3975703|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4151991|NCT00853489|3975704|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4151992|NCT00853489|3975702|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4151993|NCT00853489|3975703|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4151994|NCT00853489|3975704|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4151995|NCT00853489|3975702|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151996|NCT00853489|3975703|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151997|NCT00853489|3975704|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151998|NCT00853489|3975702|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4151999|NCT00853489|3975703|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152000|NCT00853489|3975704|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152001|NCT00853489|3975702|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152002|NCT00853489|3975703|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152003|NCT00853489|3975704|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152004|NCT00853489|3975702|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152005|NCT00853489|3975703|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152006|NCT00853489|3975704|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152007|NCT00853489|3975702|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4152008|NCT00853489|3975703|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4152009|NCT00853489|3975704|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4152010|NCT00853489|3975702|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4152011|NCT00853489|3975703|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4152012|NCT00853489|3975704|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4152013|NCT00853489|3975702|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4152014|NCT00853489|3975703|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4152015|NCT00853489|3975704|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4152016|NCT00853489|3975702|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4152017|NCT00853489|3975703|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4152018|NCT00853489|3975704|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4152019|NCT00853489|3975702|B3|||Age||years|Mean|36|36.0|Standard Deviation|12|12.0|||
4152020|NCT00853489|3975703|B2|||Age||years|Mean|35|35.0|Standard Deviation|12|12.0|||
4152021|NCT00853489|3975704|B1|||Age||years|Mean|37|37.0|Standard Deviation|12|12.0|||
4152022|NCT00853489|3975702|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4152023|NCT00853489|3975703|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4152024|NCT00853489|3975704|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4152025|NCT00853489|3975702|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4152026|NCT00853489|3975703|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4152027|NCT00853489|3975704|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4152028|NCT00853489|3975702|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4152029|NCT00853489|3975703|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4152030|NCT00853489|3975704|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4152031|NCT00853385|3975715|B6||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4152032|NCT00853385|3975716|B5||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4152033|NCT00853385|3975717|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4152034|NCT00853385|3975718|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4152035|NCT00853385|3975719|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4152036|NCT00853385|3975720|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4152037|NCT00853385|3975715|B6||Female|Sex: Female, Male||Participants|Count of Participants|586|586.0||||||
4152038|NCT00853385|3975716|B5||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4152039|NCT00853385|3975717|B4||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4152040|NCT00853385|3975718|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4152041|NCT00853385|3975719|B2||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4152042|NCT00853385|3975720|B1||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4152043|NCT00853385|3975715|B6|||Age||years|Mean|52.9|52.9|Standard Deviation|12.1|12.1|||
4152044|NCT00853385|3975716|B5|||Age||years|Mean|52.5|52.5|Standard Deviation|11.7|11.7|||
4152045|NCT00853385|3975717|B4|||Age||years|Mean|51.9|51.9|Standard Deviation|13.7|13.7|||
4152046|NCT00853385|3975718|B3|||Age||years|Mean|55.5|55.5|Standard Deviation|13.7|13.7|||
4152047|NCT00853385|3975719|B2|||Age||years|Mean|52.9|52.9|Standard Deviation|11.8|11.8|||
4152048|NCT00853385|3975720|B1|||Age||years|Mean|53.0|53.0|Standard Deviation|11.9|11.9|||
4152049|NCT00853333|3975937|B4|United States||Region of Enrollment||participants|Number|86|86.0||||||
4152050|NCT00853333|3975938|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4152051|NCT00853333|3975939|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4152052|NCT00853333|3975940|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4152053|NCT00853333|3975937|B4||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4152054|NCT00853333|3975938|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4152055|NCT00853333|3975939|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4152056|NCT00853333|3975940|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4152057|NCT00853333|3975937|B4||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4152058|NCT00853333|3975938|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4152059|NCT00853333|3975939|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4152060|NCT00853333|3975940|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4152061|NCT00853333|3975937|B4|||Age||years|Mean|25.01|25.01|Standard Deviation|4.84|4.84|||
4152062|NCT00853333|3975938|B3|||Age||years|Mean|25.83|25.83|Standard Deviation|5.41|5.41|||
4152063|NCT00853333|3975939|B2|||Age||years|Mean|24.46|24.46|Standard Deviation|4.64|4.64|||
4152064|NCT00853333|3975940|B1|||Age||years|Mean|24.74|24.74|Standard Deviation|4.47|4.47|||
4152065|NCT00853307|3975950|B3|||Body Surface Area (BSA)|Body Surface Area = square root [height (cm)*weight (kg) / 3600 ].|meter (m)^2|Mean|1.72|1.72|Standard Deviation|0.212|0.212|||
4152066|NCT00853307|3975951|B2|||Body Surface Area (BSA)|Body Surface Area = square root [height (cm)*weight (kg) / 3600 ].|meter (m)^2|Mean|1.72|1.72|Standard Deviation|0.223|0.223|||
4152067|NCT00853307|3975952|B1|||Body Surface Area (BSA)|Body Surface Area = square root [height (cm)*weight (kg) / 3600 ].|meter (m)^2|Mean|1.72|1.72|Standard Deviation|0.167|0.167|||
4152068|NCT00853307|3975950|B3|||Weight||kilogram (kg)|Mean|67.63|67.63|Standard Deviation|15.951|15.951|||
4152069|NCT00853307|3975951|B2|||Weight||kilogram (kg)|Mean|68.22|68.22|Standard Deviation|17.227|17.227|||
4152070|NCT00853307|3975952|B1|||Weight||kilogram (kg)|Mean|65.16|65.16|Standard Deviation|9.638|9.638|||
4152071|NCT00853307|3975950|B3|||Height||centimeter (cm)|Mean|161.0|161.0|Standard Deviation|7.34|7.34|||
4152072|NCT00853307|3975951|B2|||Height||centimeter (cm)|Mean|160.9|160.9|Standard Deviation|7.76|7.76|||
4152073|NCT00853307|3975952|B1|||Height||centimeter (cm)|Mean|162.0|162.0|Standard Deviation|4.83|4.83|||
4152074|NCT00853307|3975950|B3|ECOG Performance Status = 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance is defined as: 0=Normal activity (fully active, able to carry on all predisease performance without restriction); 1=Symptoms but ambulatory (restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature); 2=In bed <50% of the time (ambulatory and capable of all self-care, but unable to carry out any work activities); 3=In bed >50% of the time (capable of only limited self-care); 4=100% bedridden (completely disabled, cannot carry on any selfcare, totally confined to bed or chair).|participants|Number|11|11.0||||||
4152075|NCT00853307|3975951|B2|ECOG Performance Status = 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance is defined as: 0=Normal activity (fully active, able to carry on all predisease performance without restriction); 1=Symptoms but ambulatory (restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature); 2=In bed <50% of the time (ambulatory and capable of all self-care, but unable to carry out any work activities); 3=In bed >50% of the time (capable of only limited self-care); 4=100% bedridden (completely disabled, cannot carry on any selfcare, totally confined to bed or chair).|participants|Number|7|7.0||||||
4152118|NCT00853242|3975975|B6|Greater Than or Equal to (>=) 7.0 mg/dL||Serum Phosphorus Level||participants|Number|31|31.0||||||
4152119|NCT00853242|3975976|B5|Greater Than or Equal to (>=) 7.0 mg/dL||Serum Phosphorus Level||participants|Number|28|28.0||||||
4152120|NCT00853242|3975977|B4|Greater Than or Equal to (>=) 7.0 mg/dL||Serum Phosphorus Level||participants|Number|29|29.0||||||
4152076|NCT00853307|3975952|B1|ECOG Performance Status = 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance is defined as: 0=Normal activity (fully active, able to carry on all predisease performance without restriction); 1=Symptoms but ambulatory (restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature); 2=In bed <50% of the time (ambulatory and capable of all self-care, but unable to carry out any work activities); 3=In bed >50% of the time (capable of only limited self-care); 4=100% bedridden (completely disabled, cannot carry on any selfcare, totally confined to bed or chair).|participants|Number|4|4.0||||||
4152077|NCT00853307|3975950|B3|ECOG Performance Status = 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance is defined as: 0=Normal activity (fully active, able to carry on all predisease performance without restriction); 1=Symptoms but ambulatory (restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature); 2=In bed <50% of the time (ambulatory and capable of all self-care, but unable to carry out any work activities); 3=In bed >50% of the time (capable of only limited self-care); 4=100% bedridden (completely disabled, cannot carry on any selfcare, totally confined to bed or chair).|participants|Number|20|20.0||||||
4152078|NCT00853307|3975951|B2|ECOG Performance Status = 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance is defined as: 0=Normal activity (fully active, able to carry on all predisease performance without restriction); 1=Symptoms but ambulatory (restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature); 2=In bed <50% of the time (ambulatory and capable of all self-care, but unable to carry out any work activities); 3=In bed >50% of the time (capable of only limited self-care); 4=100% bedridden (completely disabled, cannot carry on any selfcare, totally confined to bed or chair).|participants|Number|18|18.0||||||
4152079|NCT00853307|3975952|B1|ECOG Performance Status = 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance is defined as: 0=Normal activity (fully active, able to carry on all predisease performance without restriction); 1=Symptoms but ambulatory (restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature); 2=In bed <50% of the time (ambulatory and capable of all self-care, but unable to carry out any work activities); 3=In bed >50% of the time (capable of only limited self-care); 4=100% bedridden (completely disabled, cannot carry on any selfcare, totally confined to bed or chair).|participants|Number|2|2.0||||||
4152080|NCT00853307|3975950|B3|||Years Since Initial Diagnosis||years|Mean|2.13|2.13|Standard Deviation|1.356|1.356|||
4152081|NCT00853307|3975951|B2|||Years Since Initial Diagnosis||years|Mean|2.26|2.26|Standard Deviation|1.448|1.448|||
4152082|NCT00853307|3975952|B1|||Years Since Initial Diagnosis||years|Mean|1.59|1.59|Standard Deviation|0.736|0.736|||
4152083|NCT00853307|3975950|B3|Primary Peritoneal Carcinoma||Primary diagnosis||participants|Number|5|5.0||||||
4152084|NCT00853307|3975951|B2|Primary Peritoneal Carcinoma||Primary diagnosis||participants|Number|4|4.0||||||
4152085|NCT00853307|3975952|B1|Primary Peritoneal Carcinoma||Primary diagnosis||participants|Number|1|1.0||||||
4152086|NCT00853307|3975950|B3|Fallopian Tube||Primary diagnosis||participants|Number|1|1.0||||||
4152087|NCT00853307|3975951|B2|Fallopian Tube||Primary diagnosis||participants|Number|1|1.0||||||
4152088|NCT00853307|3975952|B1|Fallopian Tube||Primary diagnosis||participants|Number|0|0.0||||||
4152089|NCT00853307|3975950|B3|Epithelial Ovarian||Primary diagnosis||participants|Number|25|25.0||||||
4152090|NCT00853307|3975951|B2|Epithelial Ovarian||Primary diagnosis||participants|Number|20|20.0||||||
4152091|NCT00853307|3975952|B1|Epithelial Ovarian||Primary diagnosis||participants|Number|5|5.0||||||
4152092|NCT00853307|3975950|B3|Not Reported||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4152093|NCT00853307|3975951|B2|Not Reported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4152094|NCT00853307|3975952|B1|Not Reported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4152095|NCT00853307|3975950|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4152096|NCT00853307|3975951|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4152097|NCT00853307|3975952|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4152098|NCT00853307|3975950|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4152099|NCT00853307|3975951|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4152100|NCT00853307|3975952|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4152101|NCT00853307|3975950|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4152102|NCT00853307|3975951|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4152103|NCT00853307|3975952|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4152104|NCT00853307|3975950|B3|White||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4152105|NCT00853307|3975951|B2|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4152106|NCT00853307|3975952|B1|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4152107|NCT00853307|3975950|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4152108|NCT00853307|3975951|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4152109|NCT00853307|3975952|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4152110|NCT00853307|3975950|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4152111|NCT00853307|3975951|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4152112|NCT00853307|3975952|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4152113|NCT00853307|3975950|B3|||Age||years|Mean|57.0|57.0|Standard Deviation|14.18|14.18|||
4152114|NCT00853307|3975951|B2|||Age||years|Mean|56.6|56.6|Standard Deviation|14.19|14.19|||
4152115|NCT00853307|3975952|B1|||Age||years|Mean|58.3|58.3|Standard Deviation|15.38|15.38|||
4152116|NCT00853242|3975973|B8|Greater Than or Equal to (>=) 7.0 mg/dL||Serum Phosphorus Level||participants|Number|201|201.0||||||
4152117|NCT00853242|3975974|B7|Greater Than or Equal to (>=) 7.0 mg/dL||Serum Phosphorus Level||participants|Number|31|31.0||||||
4152121|NCT00853242|3975978|B3|Greater Than or Equal to (>=) 7.0 mg/dL||Serum Phosphorus Level||participants|Number|27|27.0||||||
4152122|NCT00853242|3975979|B2|Greater Than or Equal to (>=) 7.0 mg/dL||Serum Phosphorus Level||participants|Number|27|27.0||||||
4152123|NCT00853242|3975980|B1|Greater Than or Equal to (>=) 7.0 mg/dL||Serum Phosphorus Level||participants|Number|28|28.0||||||
4152124|NCT00853242|3975973|B8|less than (<) 7.0 milligram per deciliter (mg/dL)||Serum Phosphorus Level||participants|Number|145|145.0||||||
4152125|NCT00853242|3975974|B7|less than (<) 7.0 milligram per deciliter (mg/dL)||Serum Phosphorus Level||participants|Number|17|17.0||||||
4152126|NCT00853242|3975975|B6|less than (<) 7.0 milligram per deciliter (mg/dL)||Serum Phosphorus Level||participants|Number|20|20.0||||||
4152127|NCT00853242|3975976|B5|less than (<) 7.0 milligram per deciliter (mg/dL)||Serum Phosphorus Level||participants|Number|22|22.0||||||
4152128|NCT00853242|3975977|B4|less than (<) 7.0 milligram per deciliter (mg/dL)||Serum Phosphorus Level||participants|Number|21|21.0||||||
4152129|NCT00853242|3975978|B3|less than (<) 7.0 milligram per deciliter (mg/dL)||Serum Phosphorus Level||participants|Number|21|21.0||||||
4152130|NCT00853242|3975979|B2|less than (<) 7.0 milligram per deciliter (mg/dL)||Serum Phosphorus Level||participants|Number|22|22.0||||||
4152131|NCT00853242|3975980|B1|less than (<) 7.0 milligram per deciliter (mg/dL)||Serum Phosphorus Level||participants|Number|22|22.0||||||
4152132|NCT00853242|3975973|B8|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4152133|NCT00853242|3975974|B7|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4152134|NCT00853242|3975975|B6|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4152135|NCT00853242|3975976|B5|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4152136|NCT00853242|3975977|B4|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4152137|NCT00853242|3975978|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4152138|NCT00853242|3975979|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4152139|NCT00853242|3975980|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4152140|NCT00853242|3975973|B8|White||Race/Ethnicity, Customized||participants|Number|173|173.0||||||
4152141|NCT00853242|3975974|B7|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4152142|NCT00853242|3975975|B6|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4152143|NCT00853242|3975976|B5|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4152144|NCT00853242|3975977|B4|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4152145|NCT00853242|3975978|B3|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4152146|NCT00853242|3975979|B2|White||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4152147|NCT00853242|3975980|B1|White||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4152148|NCT00853242|3975973|B8|Black or African American||Race/Ethnicity, Customized||participants|Number|161|161.0||||||
4152149|NCT00853242|3975974|B7|Black or African American||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4152150|NCT00853242|3975975|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4152151|NCT00853242|3975976|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4152152|NCT00853242|3975977|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4152153|NCT00853242|3975978|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4152154|NCT00853242|3975979|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4152155|NCT00853242|3975980|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4152156|NCT00853242|3975973|B8|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4152157|NCT00853242|3975974|B7|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4152158|NCT00853242|3975975|B6|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4152159|NCT00853242|3975976|B5|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4152160|NCT00853242|3975977|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4152161|NCT00853242|3975978|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4152162|NCT00853242|3975979|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4152163|NCT00853242|3975980|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4152164|NCT00853242|3975973|B8||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4152165|NCT00853242|3975974|B7||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4152166|NCT00853242|3975975|B6||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4152167|NCT00853242|3975976|B5||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4152168|NCT00853242|3975977|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4152169|NCT00853242|3975978|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4152170|NCT00853242|3975979|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4152171|NCT00853242|3975980|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4152172|NCT00853242|3975973|B8||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4152173|NCT00853242|3975974|B7||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4152174|NCT00853242|3975975|B6||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4152175|NCT00853242|3975976|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4152176|NCT00853242|3975977|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4152177|NCT00853242|3975978|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4152178|NCT00853242|3975979|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4152179|NCT00853242|3975980|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4152180|NCT00853242|3975973|B8|||Age||years|Mean|56.2|56.2|Standard Deviation|12.7|12.7|||
4152181|NCT00853242|3975974|B7|||Age||years|Mean|53.6|53.6|Standard Deviation|13.1|13.1|||
4152182|NCT00853242|3975975|B6|||Age||years|Mean|56.6|56.6|Standard Deviation|11.9|11.9|||
4152183|NCT00853242|3975976|B5|||Age||years|Mean|54.6|54.6|Standard Deviation|13.4|13.4|||
4152184|NCT00853242|3975977|B4|||Age||years|Mean|56.7|56.7|Standard Deviation|13.3|13.3|||
4152185|NCT00853242|3975978|B3|||Age||years|Mean|54.7|54.7|Standard Deviation|11.3|11.3|||
4152186|NCT00853242|3975979|B2|||Age||years|Mean|58.3|58.3|Standard Deviation|12.0|12.0|||
4152187|NCT00853242|3975980|B1|||Age||years|Mean|59.1|59.1|Standard Deviation|13.6|13.6|||
4152188|NCT00853229|3976026|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4152189|NCT00853229|3976027|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4152190|NCT00853229|3976028|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4152191|NCT00853229|3976026|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4152192|NCT00853229|3976027|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4152193|NCT00853229|3976028|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4152194|NCT00853229|3976026|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4152195|NCT00853229|3976027|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4152196|NCT00853229|3976028|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4152197|NCT00853229|3976026|B3|||Age||years|Mean|35.6|35.6|Standard Deviation|11.0|11.0|||
4152198|NCT00853229|3976027|B2|||Age||years|Mean|36.3|36.3|Standard Deviation|13.1|13.1|||
4152199|NCT00853229|3976028|B1|||Age||years|Mean|35.0|35.0|Standard Deviation|8.9|8.9|||
4152200|NCT00853151|3976035|B5|Puerto Rico||Region of Enrollment||participants|Number|10|10.0||||||
4152201|NCT00853151|3976036|B4|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
4152202|NCT00853151|3976037|B3|Puerto Rico||Region of Enrollment||participants|Number|5|5.0||||||
4152203|NCT00853151|3976038|B2|Puerto Rico||Region of Enrollment||participants|Number|3|3.0||||||
4152204|NCT00853151|3976039|B1|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
4152205|NCT00853151|3976035|B5|United States||Region of Enrollment||participants|Number|121|121.0||||||
4152206|NCT00853151|3976036|B4|United States||Region of Enrollment||participants|Number|17|17.0||||||
4152207|NCT00853151|3976037|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
4152208|NCT00853151|3976038|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
4152209|NCT00853151|3976039|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4152210|NCT00853151|3976035|B5|Not Assessed||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4152211|NCT00853151|3976036|B4|Not Assessed||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4152212|NCT00853151|3976037|B3|Not Assessed||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4152213|NCT00853151|3976038|B2|Not Assessed||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4152214|NCT00853151|3976039|B1|Not Assessed||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4152215|NCT00853151|3976035|B5|White||Race/Ethnicity, Customized||participants|Number|108|108.0||||||
4152216|NCT00853151|3976036|B4|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4152217|NCT00853151|3976037|B3|White||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4152218|NCT00853151|3976038|B2|White||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4152219|NCT00853151|3976039|B1|White||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4152220|NCT00853151|3976035|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4152221|NCT00853151|3976036|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4152222|NCT00853151|3976037|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4152223|NCT00853151|3976038|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4152224|NCT00853151|3976039|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4152225|NCT00853151|3976035|B5|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4152226|NCT00853151|3976036|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4152227|NCT00853151|3976037|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4152228|NCT00853151|3976038|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4152229|NCT00853151|3976039|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4152230|NCT00853151|3976035|B5|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4152231|NCT00853151|3976036|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4152232|NCT00853151|3976037|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4152233|NCT00853151|3976038|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4152234|NCT00853151|3976039|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4152235|NCT00853151|3976035|B5||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4152236|NCT00853151|3976036|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4152237|NCT00853151|3976037|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4152238|NCT00853151|3976038|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4152239|NCT00853151|3976039|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4152240|NCT00853151|3976035|B5||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4152241|NCT00853151|3976036|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4152242|NCT00853151|3976037|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4152243|NCT00853151|3976038|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4152244|NCT00853151|3976039|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4152245|NCT00853151|3976035|B5|||Age||years|Mean|53.3|53.3|Standard Deviation|9.33|9.33|||
4152246|NCT00853151|3976036|B4|||Age||years|Mean|55.4|55.4|Standard Deviation|7.90|7.9|||
4152247|NCT00853151|3976037|B3|||Age||years|Mean|52.9|52.9|Standard Deviation|8.99|8.99|||
4152248|NCT00853151|3976038|B2|||Age||years|Mean|52.4|52.4|Standard Deviation|10.12|10.12|||
4152249|NCT00853151|3976039|B1|||Age||years|Mean|53.7|53.7|Standard Deviation|9.69|9.69|||
4152250|NCT00853112|3976184|B8||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4152251|NCT00853112|3976185|B7||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4152252|NCT00853112|3976186|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4152253|NCT00853112|3976187|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4152254|NCT00853112|3976188|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4152255|NCT00853112|3976189|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4152256|NCT00853112|3976190|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4152257|NCT00853112|3976191|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4152258|NCT00853112|3976184|B8||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4152259|NCT00853112|3976185|B7||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4152260|NCT00853112|3976186|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4152261|NCT00853112|3976187|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4152262|NCT00853112|3976188|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4152263|NCT00853112|3976189|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4152264|NCT00853112|3976190|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4152265|NCT00853112|3976191|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4152266|NCT00853112|3976184|B8|Greater than or equal to (>=) 65 Years||Age, Customized||participants|Number|10|10.0||||||
4152267|NCT00853112|3976185|B7|Greater than or equal to (>=) 65 Years||Age, Customized||participants|Number|1|1.0||||||
4152268|NCT00853112|3976186|B6|Greater than or equal to (>=) 65 Years||Age, Customized||participants|Number|2|2.0||||||
4152269|NCT00853112|3976187|B5|Greater than or equal to (>=) 65 Years||Age, Customized||participants|Number|2|2.0||||||
4152270|NCT00853112|3976188|B4|Greater than or equal to (>=) 65 Years||Age, Customized||participants|Number|1|1.0||||||
4152271|NCT00853112|3976189|B3|Greater than or equal to (>=) 65 Years||Age, Customized||participants|Number|0|0.0||||||
4152272|NCT00853112|3976190|B2|Greater than or equal to (>=) 65 Years||Age, Customized||participants|Number|3|3.0||||||
4152273|NCT00853112|3976191|B1|Greater than or equal to (>=) 65 Years||Age, Customized||participants|Number|1|1.0||||||
4152274|NCT00853112|3976184|B8|Between 45 and 64 Years||Age, Customized||participants|Number|13|13.0||||||
4152275|NCT00853112|3976185|B7|Between 45 and 64 Years||Age, Customized||participants|Number|2|2.0||||||
4152276|NCT00853112|3976186|B6|Between 45 and 64 Years||Age, Customized||participants|Number|3|3.0||||||
4152277|NCT00853112|3976187|B5|Between 45 and 64 Years||Age, Customized||participants|Number|2|2.0||||||
4152278|NCT00853112|3976188|B4|Between 45 and 64 Years||Age, Customized||participants|Number|0|0.0||||||
4152279|NCT00853112|3976189|B3|Between 45 and 64 Years||Age, Customized||participants|Number|3|3.0||||||
4152280|NCT00853112|3976190|B2|Between 45 and 64 Years||Age, Customized||participants|Number|1|1.0||||||
4152281|NCT00853112|3976191|B1|Between 45 and 64 Years||Age, Customized||participants|Number|2|2.0||||||
4152282|NCT00853112|3976184|B8|Between 18 and 44 Years||Age, Customized||participants|Number|21|21.0||||||
4152283|NCT00853112|3976185|B7|Between 18 and 44 Years||Age, Customized||participants|Number|3|3.0||||||
4152284|NCT00853112|3976186|B6|Between 18 and 44 Years||Age, Customized||participants|Number|2|2.0||||||
4152285|NCT00853112|3976187|B5|Between 18 and 44 Years||Age, Customized||participants|Number|2|2.0||||||
4152286|NCT00853112|3976188|B4|Between 18 and 44 Years||Age, Customized||participants|Number|5|5.0||||||
4152287|NCT00853112|3976189|B3|Between 18 and 44 Years||Age, Customized||participants|Number|4|4.0||||||
4152288|NCT00853112|3976190|B2|Between 18 and 44 Years||Age, Customized||participants|Number|2|2.0||||||
4152289|NCT00853112|3976191|B1|Between 18 and 44 Years||Age, Customized||participants|Number|3|3.0||||||
4152290|NCT00853099|3976304|B4|||Mayo score|"A composite score of ulcerative colitis disease activity calculated as the sum of 4 subscores:~Stool frequency, based on the participant's diary, scored from 0 (normal number of stools) to 3 (≥5 stools than normal);~Rectal bleeding, based on the participant's diary, scored from 0 (no blood) to 3 (blood only passed);~Endoscopy, scored from 0 (normal or inactive disease) to 3 (severe disease, spontaneous bleeding, ulceration);~Physician's Global Assessment, scored from 0 (normal) to 3 (severe disease). The total Mayo score ranges from 0 to 12; higher scores indicate more severe disease."|scores on a scale|Mean|8.5|8.5|Standard Deviation|1.47|1.47|||
4152291|NCT00853099|3976305|B3|||Mayo score|"A composite score of ulcerative colitis disease activity calculated as the sum of 4 subscores:~Stool frequency, based on the participant's diary, scored from 0 (normal number of stools) to 3 (≥5 stools than normal);~Rectal bleeding, based on the participant's diary, scored from 0 (no blood) to 3 (blood only passed);~Endoscopy, scored from 0 (normal or inactive disease) to 3 (severe disease, spontaneous bleeding, ulceration);~Physician's Global Assessment, scored from 0 (normal) to 3 (severe disease). The total Mayo score ranges from 0 to 12; higher scores indicate more severe disease."|scores on a scale|Mean|8.6|8.6|Standard Deviation|1.44|1.44|||
4152337|NCT00853073|3976350|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4152292|NCT00853099|3976306|B2|||Mayo score|"A composite score of ulcerative colitis disease activity calculated as the sum of 4 subscores:~Stool frequency, based on the participant's diary, scored from 0 (normal number of stools) to 3 (≥5 stools than normal);~Rectal bleeding, based on the participant's diary, scored from 0 (no blood) to 3 (blood only passed);~Endoscopy, scored from 0 (normal or inactive disease) to 3 (severe disease, spontaneous bleeding, ulceration);~Physician's Global Assessment, scored from 0 (normal) to 3 (severe disease). The total Mayo score ranges from 0 to 12; higher scores indicate more severe disease."|scores on a scale|Mean|8.5|8.5|Standard Deviation|1.42|1.42|||
4152293|NCT00853099|3976307|B1|||Mayo score|"A composite score of ulcerative colitis disease activity calculated as the sum of 4 subscores:~Stool frequency, based on the participant's diary, scored from 0 (normal number of stools) to 3 (≥5 stools than normal);~Rectal bleeding, based on the participant's diary, scored from 0 (no blood) to 3 (blood only passed);~Endoscopy, scored from 0 (normal or inactive disease) to 3 (severe disease, spontaneous bleeding, ulceration);~Physician's Global Assessment, scored from 0 (normal) to 3 (severe disease). The total Mayo score ranges from 0 to 12; higher scores indicate more severe disease."|scores on a scale|Mean|8.5|8.5|Standard Deviation|1.56|1.56|||
4152294|NCT00853099|3976304|B4|Japan||Region of Enrollment||participants|Number|273|273.0||||||
4152295|NCT00853099|3976305|B3|Japan||Region of Enrollment||participants|Number|90|90.0||||||
4152296|NCT00853099|3976306|B2|Japan||Region of Enrollment||participants|Number|87|87.0||||||
4152297|NCT00853099|3976307|B1|Japan||Region of Enrollment||participants|Number|96|96.0||||||
4152298|NCT00853099|3976304|B4||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4152299|NCT00853099|3976305|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4152300|NCT00853099|3976306|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4152301|NCT00853099|3976307|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4152302|NCT00853099|3976304|B4||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4152303|NCT00853099|3976305|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4152304|NCT00853099|3976306|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4152305|NCT00853099|3976307|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4152306|NCT00853099|3976304|B4|||Age|Demographic data are provided for the Full Analysis Set (participants who received at least one dose of study drug in the double-blind portion of the study).|years|Mean|42.7|42.7|Standard Deviation|14.38|14.38|||
4152307|NCT00853099|3976305|B3|||Age|Demographic data are provided for the Full Analysis Set (participants who received at least one dose of study drug in the double-blind portion of the study).|years|Mean|42.5|42.5|Standard Deviation|14.56|14.56|||
4152308|NCT00853099|3976306|B2|||Age|Demographic data are provided for the Full Analysis Set (participants who received at least one dose of study drug in the double-blind portion of the study).|years|Mean|44.4|44.4|Standard Deviation|15.04|15.04|||
4152309|NCT00853099|3976307|B1|||Age|Demographic data are provided for the Full Analysis Set (participants who received at least one dose of study drug in the double-blind portion of the study).|years|Mean|41.3|41.3|Standard Deviation|13.56|13.56|||
4152310|NCT00853073|3976350|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
4152311|NCT00853073|3976351|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4152312|NCT00853073|3976352|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4152313|NCT00853073|3976350|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152314|NCT00853073|3976351|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152315|NCT00853073|3976352|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152316|NCT00853073|3976350|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152317|NCT00853073|3976351|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152318|NCT00853073|3976352|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152319|NCT00853073|3976350|B3||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4152320|NCT00853073|3976351|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4152321|NCT00853073|3976352|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4152322|NCT00853073|3976350|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4152323|NCT00853073|3976351|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4152324|NCT00853073|3976352|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4152325|NCT00853073|3976350|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152326|NCT00853073|3976351|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152327|NCT00853073|3976352|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152328|NCT00853073|3976350|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4152329|NCT00853073|3976351|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152330|NCT00853073|3976352|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4152331|NCT00853073|3976350|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152332|NCT00853073|3976351|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152333|NCT00853073|3976352|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152334|NCT00853073|3976350|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4152335|NCT00853073|3976351|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4152336|NCT00853073|3976352|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4152338|NCT00853073|3976351|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4152339|NCT00853073|3976352|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4152340|NCT00853073|3976350|B3|||Age||years|Mean|67.9|67.9|Full Range|||37.0|91.0|
4152341|NCT00853073|3976351|B2|||Age||years|Mean|71.2|71.2|Full Range|||45.0|89.0|
4152342|NCT00853073|3976352|B1|||Age||years|Mean|64.6|64.6|Full Range|||37.0|91.0|
4152343|NCT00853047|3976361|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152344|NCT00853047|3976362|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152345|NCT00853047|3976363|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152346|NCT00853047|3976364|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152347|NCT00853047|3976365|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152348|NCT00853047|3976366|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152349|NCT00853047|3976361|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152350|NCT00853047|3976362|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152351|NCT00853047|3976363|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152352|NCT00853047|3976364|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152353|NCT00853047|3976365|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152354|NCT00853047|3976366|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152355|NCT00853047|3976361|B6||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4152356|NCT00853047|3976362|B5||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4152357|NCT00853047|3976363|B4||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4152358|NCT00853047|3976364|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4152359|NCT00853047|3976365|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4152360|NCT00853047|3976366|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4152361|NCT00853047|3976361|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4152362|NCT00853047|3976362|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152363|NCT00853047|3976363|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152364|NCT00853047|3976364|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152365|NCT00853047|3976365|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4152366|NCT00853047|3976366|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152367|NCT00853047|3976361|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152368|NCT00853047|3976362|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152369|NCT00853047|3976363|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152370|NCT00853047|3976364|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152371|NCT00853047|3976365|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152372|NCT00853047|3976366|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152373|NCT00853047|3976361|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152374|NCT00853047|3976362|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152375|NCT00853047|3976363|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152376|NCT00853047|3976364|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152377|NCT00853047|3976365|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152378|NCT00853047|3976366|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152379|NCT00853047|3976361|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152380|NCT00853047|3976362|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152381|NCT00853047|3976363|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152382|NCT00853047|3976364|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152383|NCT00853047|3976365|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152384|NCT00853047|3976366|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152385|NCT00853047|3976361|B6||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4152386|NCT00853047|3976362|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4152387|NCT00853047|3976363|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4152388|NCT00853047|3976364|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4152389|NCT00853047|3976365|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4152390|NCT00853047|3976366|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4152391|NCT00853047|3976361|B6||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4152392|NCT00853047|3976362|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4152393|NCT00853047|3976363|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4152394|NCT00853047|3976364|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4152395|NCT00853047|3976365|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4152396|NCT00853047|3976366|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4152397|NCT00853047|3976361|B6|||Age||years|Mean|60.8|60.8|Standard Deviation|11.39|11.39|||
4152398|NCT00853047|3976362|B5|||Age||years|Mean|65.7|65.7|Standard Deviation|9.94|9.94|||
4152399|NCT00853047|3976363|B4|||Age||years|Mean|52.7|52.7|Standard Deviation|9.81|9.81|||
4152400|NCT00853047|3976364|B3|||Age||years|Mean|61.0|61.0|Standard Deviation|16.09|16.09|||
4152401|NCT00853047|3976365|B2|||Age||years|Mean|51.7|51.7|Standard Deviation|8.08|8.08|||
4152402|NCT00853047|3976366|B1|||Age||years|Mean|62.4|62.4|Standard Deviation|11.72|11.72|||
4152403|NCT00853021|3976437|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4152404|NCT00853021|3976437|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4152405|NCT00853021|3976437|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152406|NCT00853021|3976437|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4152407|NCT00853021|3976437|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152408|NCT00853021|3976437|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152409|NCT00853021|3976437|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152410|NCT00853021|3976437|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152411|NCT00853021|3976437|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4152412|NCT00853021|3976437|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4152413|NCT00853021|3976437|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152414|NCT00853021|3976437|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4152415|NCT00853021|3976437|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4152416|NCT00853021|3976437|B1|||Age||years|Mean|59.4|59.4|Standard Deviation|6.7|6.7|||
4152417|NCT00852995|3976444|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4152418|NCT00852995|3976445|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4152419|NCT00852995|3976446|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4152420|NCT00852995|3976447|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4152421|NCT00852995|3976448|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4152422|NCT00852995|3976449|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4152423|NCT00852995|3976444|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152424|NCT00852995|3976445|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152425|NCT00852995|3976446|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152426|NCT00852995|3976447|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152427|NCT00852995|3976448|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152428|NCT00852995|3976449|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152429|NCT00852995|3976444|B6||White|Race (NIH/OMB)||Participants|Count of Participants|164|164.0||||||
4152430|NCT00852995|3976445|B5||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4152431|NCT00852995|3976446|B4||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4152432|NCT00852995|3976447|B3||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4152433|NCT00852995|3976448|B2||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4152434|NCT00852995|3976449|B1||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4152435|NCT00852995|3976444|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4152436|NCT00852995|3976445|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4152437|NCT00852995|3976446|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4152438|NCT00852995|3976447|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4152439|NCT00852995|3976448|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4152440|NCT00852995|3976449|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4152441|NCT00852995|3976444|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152442|NCT00852995|3976445|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152443|NCT00852995|3976446|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152444|NCT00852995|3976447|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152445|NCT00852995|3976448|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152446|NCT00852995|3976449|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152447|NCT00852995|3976444|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4152448|NCT00852995|3976445|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4152449|NCT00852995|3976446|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152450|NCT00852995|3976447|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152451|NCT00852995|3976448|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152452|NCT00852995|3976449|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152511|NCT00852969|3976496|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4152453|NCT00852995|3976444|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4152454|NCT00852995|3976445|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152455|NCT00852995|3976446|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152456|NCT00852995|3976447|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152457|NCT00852995|3976448|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152458|NCT00852995|3976449|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4152459|NCT00852995|3976444|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152460|NCT00852995|3976445|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152461|NCT00852995|3976446|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152462|NCT00852995|3976447|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152463|NCT00852995|3976448|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152464|NCT00852995|3976449|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152465|NCT00852995|3976444|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|173|173.0||||||
4152466|NCT00852995|3976445|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4152467|NCT00852995|3976446|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4152468|NCT00852995|3976447|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4152469|NCT00852995|3976448|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4152470|NCT00852995|3976449|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4152471|NCT00852995|3976444|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4152472|NCT00852995|3976445|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4152473|NCT00852995|3976446|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4152474|NCT00852995|3976447|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4152475|NCT00852995|3976448|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4152476|NCT00852995|3976449|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4152477|NCT00852995|3976444|B6||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4152478|NCT00852995|3976445|B5||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4152479|NCT00852995|3976446|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4152480|NCT00852995|3976447|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4152481|NCT00852995|3976448|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4152482|NCT00852995|3976449|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4152483|NCT00852995|3976444|B6||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4152484|NCT00852995|3976445|B5||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4152485|NCT00852995|3976446|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4152486|NCT00852995|3976447|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4152487|NCT00852995|3976448|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4152488|NCT00852995|3976449|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4152489|NCT00852995|3976444|B6|Male Age||Age, Customized||years|Mean|59.0|59.0|Full Range|||22.0|93.0|
4152490|NCT00852995|3976445|B5|Male Age||Age, Customized||years|Mean|58.2|58.2|Full Range|||24.0|80.0|
4152491|NCT00852995|3976446|B4|Male Age||Age, Customized||years|Mean|56.0|56.0|Full Range|||22.0|75.0|
4152492|NCT00852995|3976447|B3|Male Age||Age, Customized||years|Mean|60.1|60.1|Full Range|||28.0|93.0|
4152493|NCT00852995|3976448|B2|Male Age||Age, Customized||years|Mean|61.6|61.6|Full Range|||24.0|88.0|
4152494|NCT00852995|3976449|B1|Male Age||Age, Customized||years|Mean|58.4|58.4|Full Range|||33.0|91.0|
4152495|NCT00852995|3976444|B6|Female Age||Age, Customized||years|Mean|66.5|66.5|Full Range|||24.0|94.0|
4152496|NCT00852995|3976445|B5|Female Age||Age, Customized||years|Mean|69.7|69.7|Full Range|||39.0|94.0|
4152497|NCT00852995|3976446|B4|Female Age||Age, Customized||years|Mean|65.1|65.1|Full Range|||27.0|89.0|
4152498|NCT00852995|3976447|B3|Female Age||Age, Customized||years|Mean|67.7|67.7|Full Range|||33.0|89.0|
4152499|NCT00852995|3976448|B2|Female Age||Age, Customized||years|Mean|61.8|61.8|Full Range|||24.0|87.0|
4152500|NCT00852995|3976449|B1|Female Age||Age, Customized||years|Mean|69.1|69.1|Full Range|||49.0|90.0|
4152501|NCT00852995|3976444|B6|||Age||years|Mean|61.6|61.6|Standard Deviation|15.2|15.2|||
4152502|NCT00852995|3976445|B5|||Age||years|Mean|61.8|61.8|Standard Deviation|16.1|16.1|||
4152503|NCT00852995|3976446|B4|||Age||years|Mean|59.8|59.8|Standard Deviation|15.0|15.0|||
4152504|NCT00852995|3976447|B3|||Age||years|Mean|62.6|62.6|Standard Deviation|15.4|15.4|||
4152505|NCT00852995|3976448|B2|||Age||years|Mean|61.7|61.7|Standard Deviation|15.7|15.7|||
4152506|NCT00852995|3976449|B1|||Age||years|Mean|62.1|62.1|Standard Deviation|14.1|14.1|||
4152507|NCT00852969|3976495|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4152508|NCT00852969|3976496|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4152509|NCT00852969|3976497|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4152510|NCT00852969|3976495|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4152512|NCT00852969|3976497|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4152513|NCT00852969|3976495|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4152514|NCT00852969|3976496|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4152515|NCT00852969|3976497|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4152516|NCT00852969|3976495|B3|||Age||years|Mean|54.2|54.2|Standard Deviation|11.9|11.9|||
4152517|NCT00852969|3976496|B2|||Age||years|Mean|50.4|50.4|Standard Deviation|11.9|11.9|||
4152518|NCT00852969|3976497|B1|||Age||years|Mean|58.1|58.1|Standard Deviation|10.9|10.9|||
4152519|NCT00852969|3976495|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4152520|NCT00852969|3976496|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4152521|NCT00852969|3976497|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4152522|NCT00852969|3976495|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4152523|NCT00852969|3976496|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4152524|NCT00852969|3976497|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4152525|NCT00852969|3976495|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4152526|NCT00852969|3976496|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4152527|NCT00852969|3976497|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4152528|NCT00852930|3976506|B4|||Duration of lymphedema prior to study enrollment||months|Median|25.4|25.4|Inter-Quartile Range|||6.0|86.0|
4152529|NCT00852930|3976507|B3|||Duration of lymphedema prior to study enrollment||months|Median|25.2|25.2|Inter-Quartile Range|||6.0|142.0|
4152530|NCT00852930|3976508|B2|||Duration of lymphedema prior to study enrollment||months|Median|18.9|18.9|Inter-Quartile Range|||5.0|73.0|
4152531|NCT00852930|3976509|B1|||Duration of lymphedema prior to study enrollment||months|Median|27.0|27.0|Inter-Quartile Range|||6.0|58.0|
4152532|NCT00852930|3976506|B4|||Time from surgery to lymphedema diagnosis||months|Median|11.1|11.1|Inter-Quartile Range|||3.0|73.0|
4152533|NCT00852930|3976507|B3|||Time from surgery to lymphedema diagnosis||months|Median|30.0|30.0|Inter-Quartile Range|||2.0|84.0|
4152534|NCT00852930|3976508|B2|||Time from surgery to lymphedema diagnosis||months|Median|14.8|14.8|Inter-Quartile Range|||5.0|108.0|
4152535|NCT00852930|3976509|B1|||Time from surgery to lymphedema diagnosis||months|Median|7.2|7.2|Inter-Quartile Range|||4.0|27.0|
4152536|NCT00852930|3976506|B4|United States||Region of Enrollment||participants|Number|46|46.0||||||
4152537|NCT00852930|3976507|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4152538|NCT00852930|3976508|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4152539|NCT00852930|3976509|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4152540|NCT00852930|3976506|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152541|NCT00852930|3976507|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152542|NCT00852930|3976508|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152543|NCT00852930|3976509|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152544|NCT00852930|3976506|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152545|NCT00852930|3976507|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152546|NCT00852930|3976508|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152547|NCT00852930|3976509|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152548|NCT00852930|3976506|B4||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4152549|NCT00852930|3976507|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4152550|NCT00852930|3976508|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4152551|NCT00852930|3976509|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4152552|NCT00852930|3976506|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4152553|NCT00852930|3976507|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152554|NCT00852930|3976508|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4152555|NCT00852930|3976509|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4152556|NCT00852930|3976506|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152557|NCT00852930|3976507|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152558|NCT00852930|3976508|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152559|NCT00852930|3976509|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152560|NCT00852930|3976506|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152561|NCT00852930|3976507|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152562|NCT00852930|3976508|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152563|NCT00852930|3976509|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152564|NCT00852930|3976506|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152565|NCT00852930|3976507|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152566|NCT00852930|3976508|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152567|NCT00852930|3976509|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152568|NCT00852930|3976506|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4152569|NCT00852930|3976507|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152570|NCT00852930|3976508|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4152571|NCT00852930|3976509|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152572|NCT00852930|3976506|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4152573|NCT00852930|3976507|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4152574|NCT00852930|3976508|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4152575|NCT00852930|3976509|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4152576|NCT00852930|3976506|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152577|NCT00852930|3976507|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152578|NCT00852930|3976508|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152579|NCT00852930|3976509|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152580|NCT00852930|3976506|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4152581|NCT00852930|3976507|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4152582|NCT00852930|3976508|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4152583|NCT00852930|3976509|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4152584|NCT00852930|3976506|B4||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4152585|NCT00852930|3976507|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4152586|NCT00852930|3976508|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4152587|NCT00852930|3976509|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4152588|NCT00852930|3976506|B4|||Age||years|Mean|66.6|66.6|Standard Deviation|10.2|10.2|||
4152589|NCT00852930|3976507|B3|||Age||years|Mean|66.0|66.0|Standard Deviation|10.2|10.2|||
4152590|NCT00852930|3976508|B2|||Age||years|Mean|67.5|67.5|Standard Deviation|10.3|10.3|||
4152591|NCT00852930|3976509|B1|||Age||years|Mean|66.4|66.4|Standard Deviation|11.3|11.3|||
4152592|NCT00852917|3976528|B5||Male|Sex: Female, Male||Participants|Count of Participants|208.0|208.0||||||
4152593|NCT00852917|3976529|B4||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4152594|NCT00852917|3976530|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4152595|NCT00852917|3976531|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4152596|NCT00852917|3976532|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4152597|NCT00852917|3976528|B5||Female|Sex: Female, Male||Participants|Count of Participants|344.0|344.0||||||
4152598|NCT00852917|3976529|B4||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4152599|NCT00852917|3976530|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4152600|NCT00852917|3976531|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4152601|NCT00852917|3976532|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4152602|NCT00852917|3976528|B5|||Age||years|Mean|61.3|61.3|Standard Deviation|9.3|9.3|||
4152603|NCT00852917|3976529|B4|||Age||years|Mean|61.1|61.1|Standard Deviation|9.7|9.7|||
4152604|NCT00852917|3976530|B3|||Age||years|Mean|60.3|60.3|Standard Deviation|9.4|9.4|||
4152605|NCT00852917|3976531|B2|||Age||years|Mean|61.1|61.1|Standard Deviation|9.1|9.1|||
4152606|NCT00852917|3976532|B1|||Age||years|Mean|62.9|62.9|Standard Deviation|8.3|8.3|||
4152607|NCT00852917|3976528|B5||>=65 years|Age||Participants|Count of Participants|225.0|225.0||||||
4152608|NCT00852917|3976529|B4||>=65 years|Age||Participants|Count of Participants|91|91.0||||||
4152609|NCT00852917|3976530|B3||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4152610|NCT00852917|3976531|B2||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
4152611|NCT00852917|3976532|B1||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4152612|NCT00852917|3976528|B5||Between 18 and 65 years|Age||Participants|Count of Participants|327.0|327.0||||||
4152613|NCT00852917|3976529|B4||Between 18 and 65 years|Age||Participants|Count of Participants|136|136.0||||||
4152614|NCT00852917|3976530|B3||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
4152615|NCT00852917|3976531|B2||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4152616|NCT00852917|3976532|B1||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4152617|NCT00852917|3976528|B5||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4152618|NCT00852917|3976529|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4152619|NCT00852917|3976530|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4152620|NCT00852917|3976531|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4152621|NCT00852917|3976532|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4152622|NCT00852761|3976573|B3|||Body Mass Index|Body mass index (BMI) is a measure of body fat based on height and weight that applies to adult men and women and is measured in kg/m^2.|kg/m^2|Mean|30.6|30.6|Standard Deviation|7.6|7.6|||
4152623|NCT00852761|3976574|B2|||Body Mass Index|Body mass index (BMI) is a measure of body fat based on height and weight that applies to adult men and women and is measured in kg/m^2.|kg/m^2|Mean|30.0|30.0|Standard Deviation|8.8|8.8|||
4152624|NCT00852761|3976575|B1|||Body Mass Index|Body mass index (BMI) is a measure of body fat based on height and weight that applies to adult men and women and is measured in kg/m^2.|kg/m^2|Mean|31.2|31.2|Standard Deviation|6.4|6.4|||
4152625|NCT00852761|3976573|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
4152626|NCT00852761|3976574|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4152627|NCT00852761|3976575|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4152628|NCT00852761|3976573|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152629|NCT00852761|3976574|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152630|NCT00852761|3976575|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152631|NCT00852761|3976573|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152632|NCT00852761|3976574|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152633|NCT00852761|3976575|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152634|NCT00852761|3976573|B3||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4152635|NCT00852761|3976574|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4152636|NCT00852761|3976575|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4152637|NCT00852761|3976573|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4152638|NCT00852761|3976574|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4152639|NCT00852761|3976575|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4152640|NCT00852761|3976573|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152641|NCT00852761|3976574|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152642|NCT00852761|3976575|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152643|NCT00852761|3976573|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152644|NCT00852761|3976574|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152645|NCT00852761|3976575|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152646|NCT00852761|3976573|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152647|NCT00852761|3976574|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152648|NCT00852761|3976575|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152649|NCT00852761|3976573|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4152650|NCT00852761|3976574|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4152651|NCT00852761|3976575|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4152652|NCT00852761|3976573|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4152653|NCT00852761|3976574|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4152654|NCT00852761|3976575|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4152655|NCT00852761|3976573|B3|||Age, Customized||years|Mean|48.4|48.4|Standard Deviation|12.2|12.2|||
4152656|NCT00852761|3976574|B2|||Age, Customized||years|Mean|48.6|48.6|Standard Deviation|13|13.0|||
4152657|NCT00852761|3976575|B1|||Age, Customized||years|Mean|48.2|48.2|Standard Deviation|11.7|11.7|||
4152658|NCT00852644|3976618|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152659|NCT00852644|3976618|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152660|NCT00852644|3976618|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4152661|NCT00852644|3976618|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4152662|NCT00852644|3976618|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152663|NCT00852644|3976618|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152664|NCT00852644|3976618|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152665|NCT00852644|3976618|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4152666|NCT00852644|3976618|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4152667|NCT00852644|3976618|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4152668|NCT00852644|3976618|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4152669|NCT00852644|3976618|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4152670|NCT00852631|3976644|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4152671|NCT00852631|3976644|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4152672|NCT00852631|3976644|B1|||Age||Years|Median|43|43.0|Standard Deviation|39.5|39.5|||
4152673|NCT00852592|3976650|B3|||Global Assessment of Functioning (GAF)|The Global Assessment of Function (GAF) was used to assess psychosocial functioning. Scores range from 0-100 with higher values representing higher functioning and better outcome.|units on a scale|Mean|55.4|55.4|Standard Deviation|5.76|5.76|||
4152674|NCT00852592|3976651|B2|||Global Assessment of Functioning (GAF)|The Global Assessment of Function (GAF) was used to assess psychosocial functioning. Scores range from 0-100 with higher values representing higher functioning and better outcome.|units on a scale|Mean|53.5|53.5|Standard Deviation|5.32|5.32|||
4152675|NCT00852592|3976652|B1|||Global Assessment of Functioning (GAF)|The Global Assessment of Function (GAF) was used to assess psychosocial functioning. Scores range from 0-100 with higher values representing higher functioning and better outcome.|units on a scale|Mean|57.4|57.4|Standard Deviation|5.61|5.61|||
4152676|NCT00852592|3976650|B3|||SIGH-ADS depression score|The Structured Interview Guide for the Hamilton Depression Rating Scale-HRS-D with Atypical Depression Supplement (SIGH-ADS) provides a benchmark for depression severity; SIGH-ADS scores range from 0-79; higher values represent increased depression severity and worse outcome.|units on a scale|Mean|28.1|28.1|Standard Deviation|5.9|5.9|||
4152677|NCT00852592|3976651|B2|||SIGH-ADS depression score|The Structured Interview Guide for the Hamilton Depression Rating Scale-HRS-D with Atypical Depression Supplement (SIGH-ADS) provides a benchmark for depression severity; SIGH-ADS scores range from 0-79; higher values represent increased depression severity and worse outcome.|units on a scale|Mean|30.1|30.1|Standard Deviation|6.1|6.1|||
4152678|NCT00852592|3976652|B1|||SIGH-ADS depression score|The Structured Interview Guide for the Hamilton Depression Rating Scale-HRS-D with Atypical Depression Supplement (SIGH-ADS) provides a benchmark for depression severity; SIGH-ADS scores range from 0-79; higher values represent increased depression severity and worse outcome.|units on a scale|Mean|26.1|26.1|Standard Deviation|5.2|5.2|||
4152679|NCT00852592|3976650|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
4152680|NCT00852592|3976651|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4152681|NCT00852592|3976652|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4152682|NCT00852592|3976650|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4152683|NCT00852592|3976651|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4152684|NCT00852592|3976652|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4152685|NCT00852592|3976650|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4152686|NCT00852592|3976651|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4152687|NCT00852592|3976652|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4152688|NCT00852592|3976650|B3|||Age||years|Mean|44|44.0|Standard Deviation|13|13.0|||
4152689|NCT00852592|3976651|B2|||Age||years|Mean|45|45.0|Standard Deviation|15|15.0|||
4152690|NCT00852592|3976652|B1|||Age||years|Mean|43|43.0|Standard Deviation|12|12.0|||
4152691|NCT00852592|3976650|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4152692|NCT00852592|3976651|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4152693|NCT00852592|3976652|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4152694|NCT00852592|3976650|B3||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4152695|NCT00852592|3976651|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4152696|NCT00852592|3976652|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4152697|NCT00852592|3976650|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4152698|NCT00852592|3976651|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4152699|NCT00852592|3976652|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4152700|NCT00852540|3976661|B3|White - Mixed Race||Race/Ethnicity, Customized|Baseline characterisitcs were collected in all participants in the Intent-to-Treat Clinical (ITTC) Popluation, comprised of all randomized participants who took at least one dose of study medication. Three participants in both treatment groups were randomized but did not receive study medication.|participants|Number|11|11.0||||||
4152701|NCT00852540|3976662|B2|White - Mixed Race||Race/Ethnicity, Customized|Baseline characterisitcs were collected in all participants in the Intent-to-Treat Clinical (ITTC) Popluation, comprised of all randomized participants who took at least one dose of study medication. Three participants in both treatment groups were randomized but did not receive study medication.|participants|Number|1|1.0||||||
4152702|NCT00852540|3976663|B1|White - Mixed Race||Race/Ethnicity, Customized|Baseline characterisitcs were collected in all participants in the Intent-to-Treat Clinical (ITTC) Popluation, comprised of all randomized participants who took at least one dose of study medication. Three participants in both treatment groups were randomized but did not receive study medication.|participants|Number|10|10.0||||||
4152703|NCT00852540|3976661|B3|White/Caucasian/European||Race/Ethnicity, Customized|Baseline characterisitcs were collected in all participants in the Intent-to-Treat Clinical (ITTC) Popluation, comprised of all randomized participants who took at least one dose of study medication. Three participants in both treatment groups were randomized but did not receive study medication.|participants|Number|340|340.0||||||
4152704|NCT00852540|3976662|B2|White/Caucasian/European||Race/Ethnicity, Customized|Baseline characterisitcs were collected in all participants in the Intent-to-Treat Clinical (ITTC) Popluation, comprised of all randomized participants who took at least one dose of study medication. Three participants in both treatment groups were randomized but did not receive study medication.|participants|Number|118|118.0||||||
4152705|NCT00852540|3976663|B1|White/Caucasian/European||Race/Ethnicity, Customized|Baseline characterisitcs were collected in all participants in the Intent-to-Treat Clinical (ITTC) Popluation, comprised of all randomized participants who took at least one dose of study medication. Three participants in both treatment groups were randomized but did not receive study medication.|participants|Number|222|222.0||||||
4152706|NCT00852540|3976661|B3|Arabic/North African Heritage||Race/Ethnicity, Customized|Baseline characterisitcs were collected in all participants in the Intent-to-Treat Clinical (ITTC) Popluation, comprised of all randomized participants who took at least one dose of study medication. Three participants in both treatment groups were randomized but did not receive study medication.|participants|Number|3|3.0||||||
4152707|NCT00852540|3976662|B2|Arabic/North African Heritage||Race/Ethnicity, Customized|Baseline characterisitcs were collected in all participants in the Intent-to-Treat Clinical (ITTC) Popluation, comprised of all randomized participants who took at least one dose of study medication. Three participants in both treatment groups were randomized but did not receive study medication.|participants|Number|3|3.0||||||
4152708|NCT00852540|3976663|B1|Arabic/North African Heritage||Race/Ethnicity, Customized|Baseline characterisitcs were collected in all participants in the Intent-to-Treat Clinical (ITTC) Popluation, comprised of all randomized participants who took at least one dose of study medication. Three participants in both treatment groups were randomized but did not receive study medication.|participants|Number|0|0.0||||||
4152709|NCT00852540|3976661|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|Baseline characterisitcs were collected in all participants in the Intent-to-Treat Clinical (ITTC) Popluation, comprised of all randomized participants who took at least one dose of study medication. Three participants in both treatment groups were randomized but did not receive study medication.|participants|Number|6|6.0||||||
4152710|NCT00852540|3976662|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|Baseline characterisitcs were collected in all participants in the Intent-to-Treat Clinical (ITTC) Popluation, comprised of all randomized participants who took at least one dose of study medication. Three participants in both treatment groups were randomized but did not receive study medication.|participants|Number|1|1.0||||||
4152711|NCT00852540|3976663|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|Baseline characterisitcs were collected in all participants in the Intent-to-Treat Clinical (ITTC) Popluation, comprised of all randomized participants who took at least one dose of study medication. Three participants in both treatment groups were randomized but did not receive study medication.|participants|Number|5|5.0||||||
4152712|NCT00852540|3976661|B3|South East Asian Heritage||Race/Ethnicity, Customized|Baseline characterisitcs were collected in all participants in the Intent-to-Treat Clinical (ITTC) Popluation, comprised of all randomized participants who took at least one dose of study medication. Three participants in both treatment groups were randomized but did not receive study medication.|participants|Number|3|3.0||||||
4152713|NCT00852540|3976662|B2|South East Asian Heritage||Race/Ethnicity, Customized|Baseline characterisitcs were collected in all participants in the Intent-to-Treat Clinical (ITTC) Popluation, comprised of all randomized participants who took at least one dose of study medication. Three participants in both treatment groups were randomized but did not receive study medication.|participants|Number|0|0.0||||||
4152714|NCT00852540|3976663|B1|South East Asian Heritage||Race/Ethnicity, Customized|Baseline characterisitcs were collected in all participants in the Intent-to-Treat Clinical (ITTC) Popluation, comprised of all randomized participants who took at least one dose of study medication. Three participants in both treatment groups were randomized but did not receive study medication.|participants|Number|3|3.0||||||
4152715|NCT00852540|3976661|B3|Japanese Heritage||Race/Ethnicity, Customized|Baseline characterisitcs were collected in all participants in the Intent-to-Treat Clinical (ITTC) Popluation, comprised of all randomized participants who took at least one dose of study medication. Three participants in both treatment groups were randomized but did not receive study medication.|participants|Number|7|7.0||||||
4152716|NCT00852540|3976662|B2|Japanese Heritage||Race/Ethnicity, Customized|Baseline characterisitcs were collected in all participants in the Intent-to-Treat Clinical (ITTC) Popluation, comprised of all randomized participants who took at least one dose of study medication. Three participants in both treatment groups were randomized but did not receive study medication.|participants|Number|2|2.0||||||
4152717|NCT00852540|3976663|B1|Japanese Heritage||Race/Ethnicity, Customized|Baseline characterisitcs were collected in all participants in the Intent-to-Treat Clinical (ITTC) Popluation, comprised of all randomized participants who took at least one dose of study medication. Three participants in both treatment groups were randomized but did not receive study medication.|participants|Number|5|5.0||||||
4152718|NCT00852540|3976661|B3|East Asian Heritage||Race/Ethnicity, Customized|Baseline characterisitcs were collected in all participants in the Intent-to-Treat Clinical (ITTC) Popluation, comprised of all randomized participants who took at least one dose of study medication. Three participants in both treatment groups were randomized but did not receive study medication.|participants|Number|1|1.0||||||
4152719|NCT00852540|3976662|B2|East Asian Heritage||Race/Ethnicity, Customized|Baseline characterisitcs were collected in all participants in the Intent-to-Treat Clinical (ITTC) Popluation, comprised of all randomized participants who took at least one dose of study medication. Three participants in both treatment groups were randomized but did not receive study medication.|participants|Number|1|1.0||||||
4152720|NCT00852540|3976663|B1|East Asian Heritage||Race/Ethnicity, Customized|Baseline characterisitcs were collected in all participants in the Intent-to-Treat Clinical (ITTC) Popluation, comprised of all randomized participants who took at least one dose of study medication. Three participants in both treatment groups were randomized but did not receive study medication.|participants|Number|0|0.0||||||
4152721|NCT00852540|3976661|B3|Central/South Asian Heritage||Race/Ethnicity, Customized|Baseline characterisitcs were collected in all participants in the Intent-to-Treat Clinical (ITTC) Popluation, comprised of all randomized participants who took at least one dose of study medication. Three participants in both treatment groups were randomized but did not receive study medication.|participants|Number|2|2.0||||||
4152722|NCT00852540|3976662|B2|Central/South Asian Heritage||Race/Ethnicity, Customized|Baseline characterisitcs were collected in all participants in the Intent-to-Treat Clinical (ITTC) Popluation, comprised of all randomized participants who took at least one dose of study medication. Three participants in both treatment groups were randomized but did not receive study medication.|participants|Number|1|1.0||||||
4152723|NCT00852540|3976663|B1|Central/South Asian Heritage||Race/Ethnicity, Customized|Baseline characterisitcs were collected in all participants in the Intent-to-Treat Clinical (ITTC) Popluation, comprised of all randomized participants who took at least one dose of study medication. Three participants in both treatment groups were randomized but did not receive study medication.|participants|Number|1|1.0||||||
4152724|NCT00852540|3976661|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|Baseline characterisitcs were collected in all participants in the Intent-to-Treat Clinical (ITTC) Popluation, comprised of all randomized participants who took at least one dose of study medication. Three participants in both treatment groups were randomized but did not receive study medication.|participants|Number|5|5.0||||||
4152725|NCT00852540|3976662|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|Baseline characterisitcs were collected in all participants in the Intent-to-Treat Clinical (ITTC) Popluation, comprised of all randomized participants who took at least one dose of study medication. Three participants in both treatment groups were randomized but did not receive study medication.|participants|Number|0|0.0||||||
4152726|NCT00852540|3976663|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Baseline characterisitcs were collected in all participants in the Intent-to-Treat Clinical (ITTC) Popluation, comprised of all randomized participants who took at least one dose of study medication. Three participants in both treatment groups were randomized but did not receive study medication.|participants|Number|5|5.0||||||
4152727|NCT00852540|3976661|B3|African American/African Heritage||Race/Ethnicity, Customized|Baseline characterisitcs were collected in all participants in the Intent-to-Treat Clinical (ITTC) Popluation, comprised of all randomized participants who took at least one dose of study medication. Three participants in both treatment groups were randomized but did not receive study medication.|participants|Number|26|26.0||||||
4152728|NCT00852540|3976662|B2|African American/African Heritage||Race/Ethnicity, Customized|Baseline characterisitcs were collected in all participants in the Intent-to-Treat Clinical (ITTC) Popluation, comprised of all randomized participants who took at least one dose of study medication. Three participants in both treatment groups were randomized but did not receive study medication.|participants|Number|10|10.0||||||
4152729|NCT00852540|3976663|B1|African American/African Heritage||Race/Ethnicity, Customized|Baseline characterisitcs were collected in all participants in the Intent-to-Treat Clinical (ITTC) Popluation, comprised of all randomized participants who took at least one dose of study medication. Three participants in both treatment groups were randomized but did not receive study medication.|participants|Number|16|16.0||||||
4152730|NCT00852540|3976661|B3||Male|Sex: Female, Male|Baseline characterisitcs were collected in all participants in the Intent-to-Treat Clinical (ITTC) Popluation, comprised of all randomized participants who took at least one dose of study medication. Three participants in both treatment groups were randomized but did not receive study medication.|Participants|Count of Participants|247|247.0||||||
4152731|NCT00852540|3976662|B2||Male|Sex: Female, Male|Baseline characterisitcs were collected in all participants in the Intent-to-Treat Clinical (ITTC) Popluation, comprised of all randomized participants who took at least one dose of study medication. Three participants in both treatment groups were randomized but did not receive study medication.|Participants|Count of Participants|88|88.0||||||
4152732|NCT00852540|3976663|B1||Male|Sex: Female, Male|Baseline characterisitcs were collected in all participants in the Intent-to-Treat Clinical (ITTC) Popluation, comprised of all randomized participants who took at least one dose of study medication. Three participants in both treatment groups were randomized but did not receive study medication.|Participants|Count of Participants|159|159.0||||||
4152733|NCT00852540|3976661|B3||Female|Sex: Female, Male|Baseline characterisitcs were collected in all participants in the Intent-to-Treat Clinical (ITTC) Popluation, comprised of all randomized participants who took at least one dose of study medication. Three participants in both treatment groups were randomized but did not receive study medication.|Participants|Count of Participants|157|157.0||||||
4152734|NCT00852540|3976662|B2||Female|Sex: Female, Male|Baseline characterisitcs were collected in all participants in the Intent-to-Treat Clinical (ITTC) Popluation, comprised of all randomized participants who took at least one dose of study medication. Three participants in both treatment groups were randomized but did not receive study medication.|Participants|Count of Participants|49|49.0||||||
4152735|NCT00852540|3976663|B1||Female|Sex: Female, Male|Baseline characterisitcs were collected in all participants in the Intent-to-Treat Clinical (ITTC) Popluation, comprised of all randomized participants who took at least one dose of study medication. Three participants in both treatment groups were randomized but did not receive study medication.|Participants|Count of Participants|108|108.0||||||
4152736|NCT00852540|3976661|B3|||Age|Baseline characterisitcs were collected in all participants in the Intent-to-Treat Clinical (ITTC) Popluation, comprised of all randomized participants who took at least one dose of study medication. Three participants in both treatment groups were randomized but did not receive study medication.|Years|Mean|34.3|34.3|Standard Deviation|21.69|21.69|||
4152737|NCT00852540|3976662|B2|||Age|Baseline characterisitcs were collected in all participants in the Intent-to-Treat Clinical (ITTC) Popluation, comprised of all randomized participants who took at least one dose of study medication. Three participants in both treatment groups were randomized but did not receive study medication.|Years|Mean|33.8|33.8|Standard Deviation|22.38|22.38|||
4152738|NCT00852540|3976663|B1|||Age|Baseline characterisitcs were collected in all participants in the Intent-to-Treat Clinical (ITTC) Popluation, comprised of all randomized participants who took at least one dose of study medication. Three participants in both treatment groups were randomized but did not receive study medication.|Years|Mean|34.6|34.6|Standard Deviation|21.37|21.37|||
4152739|NCT00852527|3976690|B1|United States||Region of Enrollment|A sample of 438 OEF/OIF Veterans enrolled across the three sites (n Tucson = 131; n Hines = 134; n Lexington = 173).|participants|Number|438|438.0||||||
4152740|NCT00852527|3976690|B1|Unknown||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4152741|NCT00852527|3976690|B1|Multi-Racial||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4152742|NCT00852527|3976690|B1|Other||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4152743|NCT00852527|3976690|B1|White||Race/Ethnicity, Customized||participants|Number|330|330.0||||||
4152744|NCT00852527|3976690|B1|African-American||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4152745|NCT00852527|3976690|B1||Male|Sex: Female, Male||Participants|Count of Participants|392|392.0||||||
4152746|NCT00852527|3976690|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4152747|NCT00852527|3976690|B1|Age||Age||years|Mean|33|33.0|Standard Deviation|8|8.0|||
4152748|NCT00852475|3976696|B3|United States||Region of Enrollment||participants|Number|86|86.0||||||
4152749|NCT00852475|3976697|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4152750|NCT00852475|3976698|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4152751|NCT00852475|3976696|B3||Male|Gender||Participants|Count of Participants|18|18.0||||||
4152752|NCT00852475|3976697|B2||Male|Gender||Participants|Count of Participants|8|8.0||||||
4152753|NCT00852475|3976698|B1||Male|Gender||Participants|Count of Participants|10|10.0||||||
4152754|NCT00852475|3976696|B3||Female|Gender||Participants|Count of Participants|28|28.0||||||
4152755|NCT00852475|3976697|B2||Female|Gender||Participants|Count of Participants|12|12.0||||||
4152756|NCT00852475|3976698|B1||Female|Gender||Participants|Count of Participants|16|16.0||||||
4152757|NCT00852475|3976696|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4152758|NCT00852475|3976697|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4152759|NCT00852475|3976698|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4152760|NCT00852475|3976696|B3||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4152761|NCT00852475|3976697|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4152762|NCT00852475|3976698|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4152763|NCT00852475|3976696|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4152764|NCT00852475|3976697|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4152765|NCT00852475|3976698|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4152766|NCT00852397|3976707|B4||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4152767|NCT00852397|3976708|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4152768|NCT00852397|3976709|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4152769|NCT00852397|3976710|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4152770|NCT00852397|3976707|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4152771|NCT00852397|3976708|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4152772|NCT00852397|3976709|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4152773|NCT00852397|3976710|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4152774|NCT00852397|3976707|B4|||Age||years|Mean|64.6|64.6|Standard Deviation|9.5|9.5|||
4152775|NCT00852397|3976708|B3|||Age||years|Mean|64.0|64.0|Standard Deviation|9.2|9.2|||
4152776|NCT00852397|3976709|B2|||Age||years|Mean|66.0|66.0|Standard Deviation|9.0|9.0|||
4152777|NCT00852397|3976710|B1|||Age||years|Mean|63.9|63.9|Standard Deviation|10.1|10.1|||
4152778|NCT00852241|3976741|B1|female||Sex/Gender, Customized|female only. PI left institution, no data is available.|Participants|Count of Participants|0|0.0||||||
4152779|NCT00852241|3976741|B1|18-70 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4152780|NCT00852202|3976745|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4152781|NCT00852202|3976746|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4152782|NCT00852202|3976747|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4152783|NCT00852202|3976748|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4152784|NCT00852202|3976745|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4152785|NCT00852202|3976746|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4152786|NCT00852202|3976747|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4152787|NCT00852202|3976748|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4152788|NCT00852202|3976745|B4|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4152789|NCT00852202|3976746|B3|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4152790|NCT00852202|3976747|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4152791|NCT00852202|3976748|B1|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4152792|NCT00852202|3976745|B4|Asian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4152793|NCT00852202|3976746|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4152794|NCT00852202|3976747|B2|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4152795|NCT00852202|3976748|B1|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4152796|NCT00852202|3976745|B4|Black||Race/Ethnicity, Customized||Participants|Number|46|46.0||||||
4152797|NCT00852202|3976746|B3|Black||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4152798|NCT00852202|3976747|B2|Black||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4152799|NCT00852202|3976748|B1|Black||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4152800|NCT00852202|3976745|B4|Non-Caucasian||Race/Ethnicity, Customized||Participants|Number|55|55.0||||||
4152801|NCT00852202|3976746|B3|Non-Caucasian||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4152802|NCT00852202|3976747|B2|Non-Caucasian||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4152803|NCT00852202|3976748|B1|Non-Caucasian||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
4152804|NCT00852202|3976745|B4|Caucasian||Race/Ethnicity, Customized||Participants|Number|172|172.0||||||
4152805|NCT00852202|3976746|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|62|62.0||||||
4152806|NCT00852202|3976747|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|56|56.0||||||
4152807|NCT00852202|3976748|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|54|54.0||||||
4152808|NCT00852202|3976745|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152809|NCT00852202|3976746|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152810|NCT00852202|3976747|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152811|NCT00852202|3976748|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152812|NCT00852202|3976745|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|214|214.0||||||
4152813|NCT00852202|3976746|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
4152814|NCT00852202|3976747|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
4152815|NCT00852202|3976748|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4152816|NCT00852202|3976745|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4152817|NCT00852202|3976746|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4152818|NCT00852202|3976747|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4152819|NCT00852202|3976748|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4152820|NCT00852202|3976745|B4|Male||Sex/Gender, Customized||participant|Number|82|82.0||||||
4152821|NCT00852202|3976746|B3|Male||Sex/Gender, Customized||participant|Number|24|24.0||||||
4152822|NCT00852202|3976747|B2|Male||Sex/Gender, Customized||participant|Number|27|27.0||||||
4152823|NCT00852202|3976748|B1|Male||Sex/Gender, Customized||participant|Number|31|31.0||||||
4152824|NCT00852202|3976745|B4|Female||Sex/Gender, Customized||participant|Number|145|145.0||||||
4152825|NCT00852202|3976746|B3|Female||Sex/Gender, Customized||participant|Number|51|51.0||||||
4152826|NCT00852202|3976747|B2|Female||Sex/Gender, Customized||participant|Number|48|48.0||||||
4152827|NCT00852202|3976748|B1|Female||Sex/Gender, Customized||participant|Number|46|46.0||||||
4152828|NCT00852202|3976745|B4|≥ 60||Age, Customized||Participants|Number|3|3.0||||||
4152829|NCT00852202|3976746|B3|≥ 60||Age, Customized||Participants|Number|2|2.0||||||
4152830|NCT00852202|3976747|B2|≥ 60||Age, Customized||Participants|Number|0|0.0||||||
4152831|NCT00852202|3976748|B1|≥ 60||Age, Customized||Participants|Number|1|1.0||||||
4152832|NCT00852202|3976745|B4|50, 60||Age, Customized||Participants|Number|40|40.0||||||
4152833|NCT00852202|3976746|B3|50, 60||Age, Customized||Participants|Number|13|13.0||||||
4152834|NCT00852202|3976747|B2|50, 60||Age, Customized||Participants|Number|10|10.0||||||
4152835|NCT00852202|3976748|B1|50, 60||Age, Customized||Participants|Number|17|17.0||||||
4152836|NCT00852202|3976745|B4|40, 50||Age, Customized||Participants|Number|66|66.0||||||
4152837|NCT00852202|3976746|B3|40, 50||Age, Customized||Participants|Number|20|20.0||||||
4152838|NCT00852202|3976747|B2|40, 50||Age, Customized||Participants|Number|23|23.0||||||
4152839|NCT00852202|3976748|B1|40, 50||Age, Customized||Participants|Number|23|23.0||||||
4152840|NCT00852202|3976745|B4|30, 40||Age, Customized||Participants|Number|64|64.0||||||
4152841|NCT00852202|3976746|B3|30, 40||Age, Customized||Participants|Number|20|20.0||||||
4152842|NCT00852202|3976747|B2|30, 40||Age, Customized||Participants|Number|20|20.0||||||
4152843|NCT00852202|3976748|B1|30, 40||Age, Customized||Participants|Number|24|24.0||||||
4152844|NCT00852202|3976745|B4|20, 30||Age, Customized||Participants|Number|50|50.0||||||
4152845|NCT00852202|3976746|B3|20, 30||Age, Customized||Participants|Number|18|18.0||||||
4152846|NCT00852202|3976747|B2|20, 30||Age, Customized||Participants|Number|21|21.0||||||
4152847|NCT00852202|3976748|B1|20, 30||Age, Customized||Participants|Number|11|11.0||||||
4152848|NCT00852202|3976745|B4|< 20||Age, Customized||Participants|Number|4|4.0||||||
4152849|NCT00852202|3976746|B3|< 20||Age, Customized||Participants|Number|2|2.0||||||
4152850|NCT00852202|3976747|B2|< 20||Age, Customized||Participants|Number|1|1.0||||||
4152851|NCT00852202|3976748|B1|< 20||Age, Customized||Participants|Number|1|1.0||||||
4152852|NCT00852202|3976745|B4|||Age||Years|Mean|38.9|38.9|Standard Deviation|11.2|11.2|||
4152853|NCT00852202|3976746|B3|||Age||Years|Mean|38.8|38.8|Standard Deviation|12.1|12.1|||
4152854|NCT00852202|3976747|B2|||Age||Years|Mean|37.4|37.4|Standard Deviation|10.7|10.7|||
4152855|NCT00852202|3976748|B1|||Age||Years|Mean|40.6|40.6|Standard Deviation|10.7|10.7|||
4152856|NCT00852137|3976761|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4152857|NCT00852137|3976762|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4152858|NCT00852137|3976763|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4152859|NCT00852137|3976761|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4152860|NCT00852137|3976762|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4152861|NCT00852137|3976763|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4152862|NCT00852137|3976761|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4152863|NCT00852137|3976762|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4152864|NCT00852137|3976763|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4152865|NCT00852137|3976761|B3|||Age||years|Mean|63.3|63.3|Standard Deviation|9.7|9.7|||
4152866|NCT00852137|3976762|B2|||Age||years|Mean|64.7|64.7|Standard Deviation|12|12.0|||
4152867|NCT00852137|3976763|B1|||Age||years|Mean|63|63.0|Standard Deviation|9.7|9.7|||
4152868|NCT00852137|3976761|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4152869|NCT00852137|3976762|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4152870|NCT00852137|3976763|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4152871|NCT00852137|3976761|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4152872|NCT00852137|3976762|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4152873|NCT00852137|3976763|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4152874|NCT00852137|3976761|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4152875|NCT00852137|3976762|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4152876|NCT00852137|3976763|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4152877|NCT00852124|3976784|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4152878|NCT00852124|3976786|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4152879|NCT00852124|3976784|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152880|NCT00852124|3976786|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152881|NCT00852124|3976784|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152882|NCT00852124|3976786|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152883|NCT00852124|3976784|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4152884|NCT00852124|3976786|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4152885|NCT00852124|3976784|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152886|NCT00852124|3976786|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153092|NCT00851747|3976982|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4152887|NCT00852124|3976784|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152888|NCT00852124|3976786|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152889|NCT00852124|3976784|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152890|NCT00852124|3976786|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152891|NCT00852124|3976784|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152892|NCT00852124|3976786|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4152893|NCT00852124|3976784|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4152894|NCT00852124|3976786|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4152895|NCT00852124|3976784|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4152896|NCT00852124|3976786|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4152897|NCT00852124|3976784|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4152898|NCT00852124|3976786|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4152899|NCT00852124|3976784|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4152900|NCT00852124|3976786|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4152901|NCT00852124|3976784|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4152902|NCT00852124|3976786|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4152903|NCT00851903|3976792|B1|||Self-Monitored Fasting Plasma Glucose|mITT population but due to missing values N=104|mg/dL|Mean|144.4|144.4|Standard Deviation|38.2|38.2|||
4152904|NCT00851903|3976792|B1|||Fasting Plasma Glucose|mITT population but due to missing values N=110|mg/dL|Mean|151.5|151.5|Standard Deviation|46.9|46.9|||
4152905|NCT00851903|3976792|B1|||Glycosylated Hemoglobin A1c (HbA1c)|mITT population|percent|Mean|8.0|8.0|Standard Deviation|1.0|1.0|||
4152906|NCT00851903|3976792|B1|No||At least one diabetic late complication|"mITT population~Diabetic late complications: myocardial infarction, angina pectoris, coronary artery disease, heart failure, stroke, transient ischemic attack, peripheral vascular disease, diabetic neuropathy, diabetic nephropathy, diabetic retinopathy~Information collected at EASIE study entry (24 weeks before baseline)"|participants|Number|88|88.0||||||
4152907|NCT00851903|3976792|B1|Yes||At least one diabetic late complication|"mITT population~Diabetic late complications: myocardial infarction, angina pectoris, coronary artery disease, heart failure, stroke, transient ischemic attack, peripheral vascular disease, diabetic neuropathy, diabetic nephropathy, diabetic retinopathy~Information collected at EASIE study entry (24 weeks before baseline)"|participants|Number|23|23.0||||||
4152908|NCT00851903|3976792|B1|||Duration of diabetes|"mITT population~Duration of diabetes collected at EASIE study entry (24 weeks before baseline)"|years|Median|4.1|4.1|Inter-Quartile Range|5.1|5.1|2.0|8.3|
4152909|NCT00851903|3976792|B1|||Heart Rate|mITT population|beats/min|Mean|76.9|76.9|Standard Deviation|9.1|9.1|||
4152910|NCT00851903|3976792|B1|||Diastolic Blood Pressure|mITT population|mmHg|Mean|80.1|80.1|Standard Deviation|7.3|7.3|||
4152911|NCT00851903|3976792|B1|||Systolic Blood Pressure|mITT population|mmHg|Mean|129.9|129.9|Standard Deviation|15.5|15.5|||
4152912|NCT00851903|3976792|B1|||Body Mass Index|mITT population|kg/m²|Mean|31.3|31.3|Standard Deviation|5.2|5.2|||
4152913|NCT00851903|3976792|B1|||Body Weight|mITT population|kg|Mean|84.6|84.6|Standard Deviation|21.0|21.0|||
4152914|NCT00851903|3976792|B1||Male|Sex: Female, Male|mITT population|Participants|Count of Participants|55|55.0||||||
4152915|NCT00851903|3976792|B1||Female|Sex: Female, Male|mITT population|Participants|Count of Participants|56|56.0||||||
4152916|NCT00851903|3976792|B1|||Age|"mITT population~Age collected at EASIE study entry (24 weeks before baseline)"|years|Mean|52.4|52.4|Standard Deviation|9.3|9.3|||
4152917|NCT00851890|3976802|B5||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4152918|NCT00851890|3976803|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4152919|NCT00851890|3976804|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4152920|NCT00851890|3976805|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4152921|NCT00851890|3976806|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4152922|NCT00851890|3976802|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4152923|NCT00851890|3976803|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4152924|NCT00851890|3976804|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4152925|NCT00851890|3976805|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4152926|NCT00851890|3976806|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4152927|NCT00851890|3976802|B5|||Age||years|Mean|46.5|46.5|Standard Deviation|9.80|9.8|||
4152928|NCT00851890|3976803|B4|||Age||years|Mean|48.2|48.2|Standard Deviation|7.31|7.31|||
4152929|NCT00851890|3976804|B3|||Age||years|Mean|47.8|47.8|Standard Deviation|9.50|9.5|||
4152930|NCT00851890|3976805|B2|||Age||years|Mean|44.6|44.6|Standard Deviation|12.96|12.96|||
4152931|NCT00851890|3976806|B1|||Age||years|Mean|45.8|45.8|Standard Deviation|9.62|9.62|||
4152932|NCT00851877|3976866|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4152933|NCT00851877|3976866|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4152934|NCT00851877|3976866|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4152935|NCT00851877|3976866|B1|||Age||years|Median|55.5|55.5|Full Range|||45.0|76.0|
4152936|NCT00851799|3976875|B4|||CD4+ T-cell count|CD4+ T-cell counts were calculated as the mean of the two most recent values available on or before study entry.|cells/mm^3]|Median|349|349.0|Inter-Quartile Range|||203.0|455.0|
4152937|NCT00851799|3976876|B3|||CD4+ T-cell count|CD4+ T-cell counts were calculated as the mean of the two most recent values available on or before study entry.|cells/mm^3]|Median|355|355.0|Inter-Quartile Range|||207.0|461.0|
4152938|NCT00851799|3976877|B2|||CD4+ T-cell count|CD4+ T-cell counts were calculated as the mean of the two most recent values available on or before study entry.|cells/mm^3]|Median|343|343.0|Inter-Quartile Range|||185.0|445.0|
4152939|NCT00851799|3976878|B1|||CD4+ T-cell count|CD4+ T-cell counts were calculated as the mean of the two most recent values available on or before study entry.|cells/mm^3]|Median|350|350.0|Inter-Quartile Range|||211.0|461.0|
4152940|NCT00851799|3976875|B4|||HIV-1 RNA|HIV-1 RNA was calculated as the geometric mean of the two most recent HIV-1 RNA (log 10 copies/mL) obtained on or before study entry. In the event that these two values differed by more than 1 log10 copy/mL, the outlying value (based on review of all HIV-1 RNA levels available prior to study entry by the study virologist) was excluded with the baseline level determined by the remaining sample. Note that screening HIV-1 RNA values were not used in the calculation of baseline HIV-1 RNA levels.|log10 copies/mL|Median|4.5|4.5|Inter-Quartile Range|||4.0|5.1|
4152941|NCT00851799|3976876|B3|||HIV-1 RNA|HIV-1 RNA was calculated as the geometric mean of the two most recent HIV-1 RNA (log 10 copies/mL) obtained on or before study entry. In the event that these two values differed by more than 1 log10 copy/mL, the outlying value (based on review of all HIV-1 RNA levels available prior to study entry by the study virologist) was excluded with the baseline level determined by the remaining sample. Note that screening HIV-1 RNA values were not used in the calculation of baseline HIV-1 RNA levels.|log10 copies/mL|Median|4.5|4.5|Inter-Quartile Range|||4.0|4.9|
4152942|NCT00851799|3976877|B2|||HIV-1 RNA|HIV-1 RNA was calculated as the geometric mean of the two most recent HIV-1 RNA (log 10 copies/mL) obtained on or before study entry. In the event that these two values differed by more than 1 log10 copy/mL, the outlying value (based on review of all HIV-1 RNA levels available prior to study entry by the study virologist) was excluded with the baseline level determined by the remaining sample. Note that screening HIV-1 RNA values were not used in the calculation of baseline HIV-1 RNA levels.|log10 copies/mL|Median|4.5|4.5|Inter-Quartile Range|||4.1|5.1|
4152943|NCT00851799|3976878|B1|||HIV-1 RNA|HIV-1 RNA was calculated as the geometric mean of the two most recent HIV-1 RNA (log 10 copies/mL) obtained on or before study entry. In the event that these two values differed by more than 1 log10 copy/mL, the outlying value (based on review of all HIV-1 RNA levels available prior to study entry by the study virologist) was excluded with the baseline level determined by the remaining sample. Note that screening HIV-1 RNA values were not used in the calculation of baseline HIV-1 RNA levels.|log10 copies/mL|Median|4.6|4.6|Inter-Quartile Range|||4.0|5.1|
4152944|NCT00851799|3976875|B4|Unknown/missing||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry.|participants|Number|1|1.0||||||
4152945|NCT00851799|3976876|B3|Unknown/missing||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry.|participants|Number|0|0.0||||||
4152946|NCT00851799|3976877|B2|Unknown/missing||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry.|participants|Number|1|1.0||||||
4152947|NCT00851799|3976878|B1|Unknown/missing||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry.|participants|Number|0|0.0||||||
4152948|NCT00851799|3976875|B4|More than one race||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry.|participants|Number|2|2.0||||||
4152949|NCT00851799|3976876|B3|More than one race||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry.|participants|Number|1|1.0||||||
4152950|NCT00851799|3976877|B2|More than one race||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry.|participants|Number|1|1.0||||||
4152951|NCT00851799|3976878|B1|More than one race||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry.|participants|Number|0|0.0||||||
4152952|NCT00851799|3976875|B4|American Indian, Alaskan Native||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry.|participants|Number|3|3.0||||||
4152953|NCT00851799|3976876|B3|American Indian, Alaskan Native||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry.|participants|Number|1|1.0||||||
4152954|NCT00851799|3976877|B2|American Indian, Alaskan Native||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry.|participants|Number|2|2.0||||||
4152955|NCT00851799|3976878|B1|American Indian, Alaskan Native||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry.|participants|Number|0|0.0||||||
4152956|NCT00851799|3976875|B4|Asian, Pacific Islander||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry.|participants|Number|8|8.0||||||
4152957|NCT00851799|3976876|B3|Asian, Pacific Islander||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry.|participants|Number|1|1.0||||||
4152958|NCT00851799|3976877|B2|Asian, Pacific Islander||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry.|participants|Number|5|5.0||||||
4152959|NCT00851799|3976878|B1|Asian, Pacific Islander||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry.|participants|Number|2|2.0||||||
4152960|NCT00851799|3976875|B4|Hispanic (Regardless of Race)||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry.|participants|Number|65|65.0||||||
4152961|NCT00851799|3976876|B3|Hispanic (Regardless of Race)||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry.|participants|Number|25|25.0||||||
4152962|NCT00851799|3976877|B2|Hispanic (Regardless of Race)||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry.|participants|Number|20|20.0||||||
4152963|NCT00851799|3976878|B1|Hispanic (Regardless of Race)||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry.|participants|Number|20|20.0||||||
4152964|NCT00851799|3976875|B4|Black Non-Hispanic||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry.|participants|Number|105|105.0||||||
4152965|NCT00851799|3976876|B3|Black Non-Hispanic||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry.|participants|Number|37|37.0||||||
4152966|NCT00851799|3976877|B2|Black Non-Hispanic||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry.|participants|Number|34|34.0||||||
4152967|NCT00851799|3976878|B1|Black Non-Hispanic||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry.|participants|Number|34|34.0||||||
4152968|NCT00851799|3976875|B4|White Non-Hispanic||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry.|participants|Number|144|144.0||||||
4152969|NCT00851799|3976876|B3|White Non-Hispanic||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry.|participants|Number|48|48.0||||||
4152970|NCT00851799|3976877|B2|White Non-Hispanic||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry.|participants|Number|43|43.0||||||
4152971|NCT00851799|3976878|B1|White Non-Hispanic||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry.|participants|Number|53|53.0||||||
4152972|NCT00851799|3976875|B4||Male|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
4152973|NCT00851799|3976876|B3||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4152974|NCT00851799|3976877|B2||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4152975|NCT00851799|3976878|B1||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4152976|NCT00851799|3976875|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4152977|NCT00851799|3976876|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4152978|NCT00851799|3976877|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4152979|NCT00851799|3976878|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4152980|NCT00851799|3976875|B4|||Age||years|Median|36|36.0|Inter-Quartile Range|||28.0|45.0|
4152981|NCT00851799|3976876|B3|||Age||years|Median|35|35.0|Inter-Quartile Range|||27.0|46.0|
4152982|NCT00851799|3976877|B2|||Age||years|Median|36|36.0|Inter-Quartile Range|||27.0|44.0|
4152983|NCT00851799|3976878|B1|||Age||years|Median|37|37.0|Inter-Quartile Range|||31.0|45.0|
4152984|NCT00851799|3976875|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4152985|NCT00851799|3976876|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4152986|NCT00851799|3976877|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4152987|NCT00851799|3976878|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4152988|NCT00851799|3976875|B4||Between 18 and 65 years|Age||Participants|Count of Participants|325|325.0||||||
4152989|NCT00851799|3976876|B3||Between 18 and 65 years|Age||Participants|Count of Participants|113|113.0||||||
4152990|NCT00851799|3976877|B2||Between 18 and 65 years|Age||Participants|Count of Participants|105|105.0||||||
4152991|NCT00851799|3976878|B1||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
4152992|NCT00851799|3976875|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4152993|NCT00851799|3976876|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4152994|NCT00851799|3976877|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4152995|NCT00851799|3976878|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4152996|NCT00851786|3976966|B3|None||Duration from Historary Retinal Necrosis||participants|Number|393|393.0||||||
4152997|NCT00851786|3976967|B2|None||Duration from Historary Retinal Necrosis||participants|Number|99|99.0||||||
4152998|NCT00851786|3976968|B1|None||Duration from Historary Retinal Necrosis||participants|Number|294|294.0||||||
4152999|NCT00851786|3976966|B3|>5 years||Duration from Historary Retinal Necrosis||participants|Number|2|2.0||||||
4153000|NCT00851786|3976967|B2|>5 years||Duration from Historary Retinal Necrosis||participants|Number|0|0.0||||||
4153001|NCT00851786|3976968|B1|>5 years||Duration from Historary Retinal Necrosis||participants|Number|2|2.0||||||
4153002|NCT00851786|3976966|B3|None||History of most recent Zoster||participants|Number|261|261.0||||||
4153003|NCT00851786|3976967|B2|None||History of most recent Zoster||participants|Number|68|68.0||||||
4153004|NCT00851786|3976968|B1|None||History of most recent Zoster||participants|Number|193|193.0||||||
4153005|NCT00851786|3976966|B3|>5 years||History of most recent Zoster||participants|Number|87|87.0||||||
4153006|NCT00851786|3976967|B2|>5 years||History of most recent Zoster||participants|Number|22|22.0||||||
4153007|NCT00851786|3976968|B1|>5 years||History of most recent Zoster||participants|Number|65|65.0||||||
4153008|NCT00851786|3976966|B3|>2-5 years||History of most recent Zoster||participants|Number|30|30.0||||||
4153009|NCT00851786|3976967|B2|>2-5 years||History of most recent Zoster||participants|Number|7|7.0||||||
4153010|NCT00851786|3976968|B1|>2-5 years||History of most recent Zoster||participants|Number|23|23.0||||||
4153011|NCT00851786|3976966|B3|>1-2 years||History of most recent Zoster||participants|Number|14|14.0||||||
4153012|NCT00851786|3976967|B2|>1-2 years||History of most recent Zoster||participants|Number|1|1.0||||||
4153013|NCT00851786|3976968|B1|>1-2 years||History of most recent Zoster||participants|Number|13|13.0||||||
4153014|NCT00851786|3976966|B3|0-1 year||History of most recent Zoster||participants|Number|3|3.0||||||
4153015|NCT00851786|3976967|B2|0-1 year||History of most recent Zoster||participants|Number|1|1.0||||||
4153016|NCT00851786|3976968|B1|0-1 year||History of most recent Zoster||participants|Number|2|2.0||||||
4153017|NCT00851786|3976966|B3|None||History of Chickenpox||participants|Number|75|75.0||||||
4153018|NCT00851786|3976967|B2|None||History of Chickenpox||participants|Number|15|15.0||||||
4153019|NCT00851786|3976968|B1|None||History of Chickenpox||participants|Number|60|60.0||||||
4153020|NCT00851786|3976966|B3|Zoster/no Chickpox||History of Chickenpox||participants|Number|24|24.0||||||
4153021|NCT00851786|3976967|B2|Zoster/no Chickpox||History of Chickenpox||participants|Number|7|7.0||||||
4153022|NCT00851786|3976968|B1|Zoster/no Chickpox||History of Chickenpox||participants|Number|17|17.0||||||
4153023|NCT00851786|3976966|B3|>5 years||History of Chickenpox||participants|Number|296|296.0||||||
4153024|NCT00851786|3976967|B2|>5 years||History of Chickenpox||participants|Number|77|77.0||||||
4153025|NCT00851786|3976968|B1|>5 years||History of Chickenpox||participants|Number|219|219.0||||||
4153026|NCT00851786|3976966|B3|No||Prior History of AIDS||participants|Number|10|10.0||||||
4153027|NCT00851786|3976967|B2|No||Prior History of AIDS||participants|Number|2|2.0||||||
4153028|NCT00851786|3976968|B1|No||Prior History of AIDS||participants|Number|8|8.0||||||
4153029|NCT00851786|3976966|B3|Yes||Prior History of AIDS||participants|Number|385|385.0||||||
4153030|NCT00851786|3976967|B2|Yes||Prior History of AIDS||participants|Number|97|97.0||||||
4153031|NCT00851786|3976968|B1|Yes||Prior History of AIDS||participants|Number|288|288.0||||||
4153032|NCT00851786|3976966|B3|||HIV-1 RNA||log10 copies/mL|Median|1.68|1.68|Inter-Quartile Range|||1.68|1.7|
4153033|NCT00851786|3976967|B2|||HIV-1 RNA||log10 copies/mL|Median|1.68|1.68|Inter-Quartile Range|||1.68|1.7|
4153034|NCT00851786|3976968|B1|||HIV-1 RNA||log10 copies/mL|Median|1.68|1.68|Inter-Quartile Range|||1.68|1.7|
4153035|NCT00851786|3976966|B3|||Entry CD4||cells/µL|Median|394|394.0|Inter-Quartile Range|||281.0|605.0|
4153036|NCT00851786|3976967|B2|||Entry CD4||cells/µL|Median|362|362.0|Inter-Quartile Range|||276.0|579.0|
4153037|NCT00851786|3976968|B1|||Entry CD4||cells/µL|Median|399|399.0|Inter-Quartile Range|||282.0|607.0|
4153038|NCT00851786|3976966|B3|||Screen CD4||cells/µL|Median|372|372.0|Inter-Quartile Range|||286.0|606.0|
4153039|NCT00851786|3976967|B2|||Screen CD4||cells/µL|Median|353|353.0|Inter-Quartile Range|||278.0|561.0|
4153040|NCT00851786|3976968|B1|||Screen CD4||cells/µL|Median|373|373.0|Inter-Quartile Range|||286.0|634.5|
4153041|NCT00851786|3976966|B3|||Nadir CD4||cells/µL|Median|188|188.0|Inter-Quartile Range|||108.0|287.0|
4153042|NCT00851786|3976967|B2|||Nadir CD4||cells/µL|Median|178|178.0|Inter-Quartile Range|||104.5|285.0|
4153043|NCT00851786|3976968|B1|||Nadir CD4||cells/µL|Median|197|197.0|Inter-Quartile Range|||109.0|287.0|
4153044|NCT00851786|3976966|B3|Previously||IV drug history||participants|Number|65|65.0||||||
4153045|NCT00851786|3976967|B2|Previously||IV drug history||participants|Number|13|13.0||||||
4153046|NCT00851786|3976968|B1|Previously||IV drug history||participants|Number|52|52.0||||||
4153047|NCT00851786|3976966|B3|Never||IV drug history||participants|Number|330|330.0||||||
4153048|NCT00851786|3976967|B2|Never||IV drug history||participants|Number|86|86.0||||||
4153049|NCT00851786|3976968|B1|Never||IV drug history||participants|Number|244|244.0||||||
4153050|NCT00851786|3976966|B3|Unknown/missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4153051|NCT00851786|3976967|B2|Unknown/missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4153052|NCT00851786|3976968|B1|Unknown/missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4153053|NCT00851786|3976966|B3|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4153054|NCT00851786|3976967|B2|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4153055|NCT00851786|3976968|B1|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4153056|NCT00851786|3976966|B3|American Indian, Alaskan Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4153057|NCT00851786|3976967|B2|American Indian, Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4153058|NCT00851786|3976968|B1|American Indian, Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4153059|NCT00851786|3976966|B3|Asian, Pacific islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4153060|NCT00851786|3976967|B2|Asian, Pacific islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4153061|NCT00851786|3976968|B1|Asian, Pacific islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4153062|NCT00851786|3976966|B3|Hispanic (regardless of race)||Race/Ethnicity, Customized||participants|Number|87|87.0||||||
4153063|NCT00851786|3976967|B2|Hispanic (regardless of race)||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4153064|NCT00851786|3976968|B1|Hispanic (regardless of race)||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
4153065|NCT00851786|3976966|B3|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|116|116.0||||||
4153066|NCT00851786|3976967|B2|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4153067|NCT00851786|3976968|B1|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|90|90.0||||||
4153068|NCT00851786|3976966|B3|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|185|185.0||||||
4153069|NCT00851786|3976967|B2|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4153070|NCT00851786|3976968|B1|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|141|141.0||||||
4153071|NCT00851786|3976966|B3||Male|Sex: Female, Male||Participants|Count of Participants|333|333.0||||||
4153072|NCT00851786|3976967|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4153073|NCT00851786|3976968|B1||Male|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
4153074|NCT00851786|3976966|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4153075|NCT00851786|3976967|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4153076|NCT00851786|3976968|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4153077|NCT00851786|3976966|B3|||Age||years|Median|49|49.0|Inter-Quartile Range|||44.0|56.0|
4153078|NCT00851786|3976967|B2|||Age||years|Median|49|49.0|Inter-Quartile Range|||44.0|55.0|
4153079|NCT00851786|3976968|B1|||Age||years|Median|49|49.0|Inter-Quartile Range|||44.0|56.0|
4153080|NCT00851786|3976966|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4153081|NCT00851786|3976967|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4153082|NCT00851786|3976968|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4153083|NCT00851786|3976966|B3||Between 18 and 65 years|Age||Participants|Count of Participants|379|379.0||||||
4153084|NCT00851786|3976967|B2||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
4153085|NCT00851786|3976968|B1||Between 18 and 65 years|Age||Participants|Count of Participants|285|285.0||||||
4153086|NCT00851786|3976966|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4153087|NCT00851786|3976967|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4153088|NCT00851786|3976968|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4153089|NCT00851747|3976979|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4153090|NCT00851747|3976980|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4153091|NCT00851747|3976981|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4153093|NCT00851747|3976979|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4153094|NCT00851747|3976980|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4153095|NCT00851747|3976981|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4153096|NCT00851747|3976982|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4153097|NCT00851747|3976979|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153098|NCT00851747|3976979|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4153099|NCT00851747|3976979|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4153100|NCT00851721|3976991|B3|New Zealand||Region of Enrollment||participants|Number|2|2.0||||||
4153101|NCT00851721|3976992|B2|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
4153102|NCT00851721|3976993|B1|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
4153103|NCT00851721|3976991|B3|Japan||Region of Enrollment||participants|Number|2|2.0||||||
4153104|NCT00851721|3976992|B2|Japan||Region of Enrollment||participants|Number|1|1.0||||||
4153105|NCT00851721|3976993|B1|Japan||Region of Enrollment||participants|Number|1|1.0||||||
4153106|NCT00851721|3976991|B3|Bulgaria||Region of Enrollment||participants|Number|2|2.0||||||
4153107|NCT00851721|3976992|B2|Bulgaria||Region of Enrollment||participants|Number|2|2.0||||||
4153108|NCT00851721|3976993|B1|Bulgaria||Region of Enrollment||participants|Number|0|0.0||||||
4153109|NCT00851721|3976991|B3|Russian Federation||Region of Enrollment||participants|Number|11|11.0||||||
4153110|NCT00851721|3976992|B2|Russian Federation||Region of Enrollment||participants|Number|3|3.0||||||
4153111|NCT00851721|3976993|B1|Russian Federation||Region of Enrollment||participants|Number|8|8.0||||||
4153112|NCT00851721|3976991|B3|Croatia||Region of Enrollment||participants|Number|1|1.0||||||
4153113|NCT00851721|3976992|B2|Croatia||Region of Enrollment||participants|Number|1|1.0||||||
4153114|NCT00851721|3976993|B1|Croatia||Region of Enrollment||participants|Number|0|0.0||||||
4153115|NCT00851721|3976991|B3|Romania||Region of Enrollment||participants|Number|1|1.0||||||
4153116|NCT00851721|3976992|B2|Romania||Region of Enrollment||participants|Number|1|1.0||||||
4153117|NCT00851721|3976993|B1|Romania||Region of Enrollment||participants|Number|0|0.0||||||
4153118|NCT00851721|3976991|B3|Ukraine||Region of Enrollment||participants|Number|8|8.0||||||
4153119|NCT00851721|3976992|B2|Ukraine||Region of Enrollment||participants|Number|4|4.0||||||
4153120|NCT00851721|3976993|B1|Ukraine||Region of Enrollment||participants|Number|4|4.0||||||
4153121|NCT00851721|3976991|B3|Brazil||Region of Enrollment||participants|Number|5|5.0||||||
4153122|NCT00851721|3976992|B2|Brazil||Region of Enrollment||participants|Number|2|2.0||||||
4153123|NCT00851721|3976993|B1|Brazil||Region of Enrollment||participants|Number|3|3.0||||||
4153124|NCT00851721|3976991|B3|Poland||Region of Enrollment||participants|Number|2|2.0||||||
4153125|NCT00851721|3976992|B2|Poland||Region of Enrollment||participants|Number|1|1.0||||||
4153126|NCT00851721|3976993|B1|Poland||Region of Enrollment||participants|Number|1|1.0||||||
4153127|NCT00851721|3976991|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4153128|NCT00851721|3976992|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4153129|NCT00851721|3976993|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4153130|NCT00851721|3976991|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4153131|NCT00851721|3976992|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4153132|NCT00851721|3976993|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4153133|NCT00851721|3976991|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4153134|NCT00851721|3976992|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4153135|NCT00851721|3976993|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4153136|NCT00851721|3976991|B3|||Age||years|Mean|27.4|27.4|Standard Deviation|15.2|15.2|||
4153137|NCT00851721|3976992|B2|||Age||years|Mean|25.6|25.6|Standard Deviation|15.4|15.4|||
4153138|NCT00851721|3976993|B1|||Age||years|Mean|29.1|29.1|Standard Deviation|15.2|15.2|||
4153139|NCT00851682|3977082|B3|United States||Region of Enrollment||participants|Number|65|65.0||||||
4153140|NCT00851682|3977083|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4153141|NCT00851682|3977084|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4153142|NCT00851682|3977082|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4153143|NCT00851682|3977083|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4153144|NCT00851682|3977084|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4153145|NCT00851682|3977082|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4153146|NCT00851682|3977083|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4153147|NCT00851682|3977084|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4153148|NCT00851682|3977082|B3|||Age||years|Mean|61|61.0|Full Range|||39.0|76.0|
4153149|NCT00851682|3977083|B2|||Age||years|Mean|66|66.0|Full Range|||58.0|73.0|
4153150|NCT00851682|3977084|B1|||Age||years|Mean|60|60.0|Full Range|||39.0|76.0|
4153151|NCT00851682|3977082|B3||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4153152|NCT00851682|3977083|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4153153|NCT00851682|3977084|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4153154|NCT00851682|3977082|B3||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4153155|NCT00851682|3977083|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4153156|NCT00851682|3977084|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4153157|NCT00851682|3977082|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4153158|NCT00851682|3977083|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4153159|NCT00851682|3977084|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4153160|NCT00851643|3977093|B7|Australia||Region of Enrollment||participants|Number|150|150.0||||||
4153161|NCT00851643|3977094|B6|Australia||Region of Enrollment||participants|Number|30|30.0||||||
4153162|NCT00851643|3977095|B5|Australia||Region of Enrollment||participants|Number|30|30.0||||||
4153163|NCT00851643|3977096|B4|Australia||Region of Enrollment||participants|Number|15|15.0||||||
4153164|NCT00851643|3977097|B3|Australia||Region of Enrollment||participants|Number|30|30.0||||||
4153165|NCT00851643|3977098|B2|Australia||Region of Enrollment||participants|Number|30|30.0||||||
4153166|NCT00851643|3977099|B1|Australia||Region of Enrollment||participants|Number|15|15.0||||||
4153167|NCT00851643|3977093|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4153168|NCT00851643|3977094|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4153169|NCT00851643|3977095|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4153170|NCT00851643|3977096|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4153171|NCT00851643|3977097|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4153172|NCT00851643|3977098|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4153173|NCT00851643|3977099|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4153174|NCT00851643|3977093|B7||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4153175|NCT00851643|3977094|B6||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4153176|NCT00851643|3977095|B5||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4153177|NCT00851643|3977096|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4153178|NCT00851643|3977097|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4153179|NCT00851643|3977098|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4153180|NCT00851643|3977099|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4153181|NCT00851643|3977093|B7|||Age||years|Mean|20.5|20.5|Standard Deviation|1.7|1.7|||
4153182|NCT00851643|3977094|B6|||Age||years|Mean|20.8|20.8|Standard Deviation|2.0|2.0|||
4153183|NCT00851643|3977095|B5|||Age||years|Mean|20.5|20.5|Standard Deviation|1.8|1.8|||
4153184|NCT00851643|3977096|B4|||Age||years|Mean|19.9|19.9|Standard Deviation|1.6|1.6|||
4153185|NCT00851643|3977097|B3|||Age||years|Mean|20.2|20.2|Standard Deviation|1.5|1.5|||
4153186|NCT00851643|3977098|B2|||Age||years|Mean|20.8|20.8|Standard Deviation|1.8|1.8|||
4153187|NCT00851643|3977099|B1|||Age||years|Mean|20.3|20.3|Standard Deviation|1.6|1.6|||
4153188|NCT00851630|3977123|B3|Tanzania||Region of Enrollment||participants|Number|70.0|70.0||||||
4153189|NCT00851630|3977124|B2|Tanzania||Region of Enrollment||participants|Number|35|35.0||||||
4153190|NCT00851630|3977125|B1|Tanzania||Region of Enrollment||participants|Number|35|35.0||||||
4153191|NCT00851630|3977123|B3||Male|Sex: Female, Male||Participants|Count of Participants|41.0|41.0||||||
4153192|NCT00851630|3977124|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4153193|NCT00851630|3977125|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4153194|NCT00851630|3977123|B3||Female|Sex: Female, Male||Participants|Count of Participants|29.0|29.0||||||
4153195|NCT00851630|3977124|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4153196|NCT00851630|3977125|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4153197|NCT00851630|3977123|B3|||Age||years|Median|36.2|36.2|Inter-Quartile Range|||32.4|43.6|
4153198|NCT00851630|3977124|B2|||Age||years|Median|36.7|36.7|Inter-Quartile Range|||32.4|44.3|
4153199|NCT00851630|3977125|B1|||Age||years|Median|36.0|36.0|Inter-Quartile Range|||32.4|43.6|
4153200|NCT00851630|3977123|B3||>=65 years|Age||Participants|Count of Participants|0.0|0.0||||||
4153201|NCT00851630|3977124|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153202|NCT00851630|3977125|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153203|NCT00851630|3977123|B3||Between 18 and 65 years|Age||Participants|Count of Participants|69.0|69.0||||||
4153204|NCT00851630|3977124|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4153205|NCT00851630|3977125|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4153206|NCT00851630|3977123|B3||<=18 years|Age||Participants|Count of Participants|1.0|1.0||||||
4153207|NCT00851630|3977124|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4153208|NCT00851630|3977125|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4153209|NCT00851591|3977138|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4153210|NCT00851591|3977139|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4153211|NCT00851591|3977140|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4153212|NCT00851591|3977138|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4153213|NCT00851591|3977139|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4153214|NCT00851591|3977140|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4153215|NCT00851591|3977138|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153216|NCT00851591|3977139|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153217|NCT00851591|3977140|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153218|NCT00851591|3977138|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4153219|NCT00851591|3977139|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4153220|NCT00851591|3977140|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4153221|NCT00851591|3977138|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4153222|NCT00851591|3977139|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4153223|NCT00851591|3977140|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4153224|NCT00851552|3977147|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4153225|NCT00851552|3977147|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4153226|NCT00851552|3977147|B1|||Age||years|Mean|61.78|61.78|Standard Deviation|18.82|18.82|||
4153227|NCT00851409|3977152|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4153228|NCT00851409|3977152|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4153229|NCT00851409|3977152|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153230|NCT00851409|3977152|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4153231|NCT00851409|3977152|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4153232|NCT00851318|3977157|B5|||Body Weight||kg|Mean|55.56|55.56|Standard Deviation|10.83|10.83|||
4153233|NCT00851318|3977158|B4|||Body Weight||kg|Mean|54.92|54.92|Standard Deviation|9.47|9.47|||
4153234|NCT00851318|3977159|B3|||Body Weight||kg|Mean|55.81|55.81|Standard Deviation|11.34|11.34|||
4153235|NCT00851318|3977160|B2|||Body Weight||kg|Mean|54.27|54.27|Standard Deviation|9.57|9.57|||
4153236|NCT00851318|3977161|B1|||Body Weight||kg|Mean|56.30|56.3|Standard Deviation|12.00|12.0|||
4153237|NCT00851318|3977157|B5|Japan||Region of Enrollment||participants|Number|285|285.0||||||
4153238|NCT00851318|3977158|B4|Japan||Region of Enrollment||participants|Number|92|92.0||||||
4153239|NCT00851318|3977159|B3|Japan||Region of Enrollment||participants|Number|93|93.0||||||
4153240|NCT00851318|3977160|B2|Japan||Region of Enrollment||participants|Number|19|19.0||||||
4153241|NCT00851318|3977161|B1|Japan||Region of Enrollment||participants|Number|81|81.0||||||
4153242|NCT00851318|3977157|B5||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4153243|NCT00851318|3977158|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4153244|NCT00851318|3977159|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4153245|NCT00851318|3977160|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4153246|NCT00851318|3977161|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4153247|NCT00851318|3977157|B5||Female|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
4153248|NCT00851318|3977158|B4||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4153249|NCT00851318|3977159|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4153250|NCT00851318|3977160|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4153251|NCT00851318|3977161|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4153252|NCT00851318|3977157|B5|≧ 65 years||Age, Customized||participants|Number|40|40.0||||||
4153253|NCT00851318|3977158|B4|≧ 65 years||Age, Customized||participants|Number|16|16.0||||||
4153254|NCT00851318|3977159|B3|≧ 65 years||Age, Customized||participants|Number|12|12.0||||||
4153255|NCT00851318|3977160|B2|≧ 65 years||Age, Customized||participants|Number|3|3.0||||||
4153256|NCT00851318|3977161|B1|≧ 65 years||Age, Customized||participants|Number|9|9.0||||||
4153257|NCT00851318|3977157|B5|< 65 years||Age, Customized||participants|Number|245|245.0||||||
4153258|NCT00851318|3977158|B4|< 65 years||Age, Customized||participants|Number|76|76.0||||||
4153259|NCT00851318|3977159|B3|< 65 years||Age, Customized||participants|Number|81|81.0||||||
4153260|NCT00851318|3977160|B2|< 65 years||Age, Customized||participants|Number|16|16.0||||||
4153261|NCT00851318|3977161|B1|< 65 years||Age, Customized||participants|Number|72|72.0||||||
4153262|NCT00851318|3977157|B5|||Age||years|Mean|52.8|52.8|Standard Deviation|11.1|11.1|||
4153263|NCT00851318|3977158|B4|||Age||years|Mean|54.1|54.1|Standard Deviation|11.0|11.0|||
4153264|NCT00851318|3977159|B3|||Age||years|Mean|52.9|52.9|Standard Deviation|11.0|11.0|||
4153265|NCT00851318|3977160|B2|||Age||years|Mean|51.3|51.3|Standard Deviation|13.7|13.7|||
4153266|NCT00851318|3977161|B1|||Age||years|Mean|51.8|51.8|Standard Deviation|10.7|10.7|||
4153267|NCT00851279|3977194|B1|||ICD implanted prior to the ablation procedure||participants|Number|38|38.0||||||
4153268|NCT00851279|3977194|B1|||Pre-procedural arrhythmia treatment with amiodarone||participants|Number|34|34.0||||||
4153269|NCT00851279|3977194|B1|||Pre-procedural arrhythmia treatment with beta-blockers||participants|Number|47|47.0||||||
4153270|NCT00851279|3977194|B1|||History of diabetes||participants|Number|16|16.0||||||
4153271|NCT00851279|3977194|B1|||History of transient ischemic attack (TIA)||participants|Number|3|3.0||||||
4153272|NCT00851279|3977194|B1|||History of cerebro-vascular accident (CVA)||participants|Number|9|9.0||||||
4153273|NCT00851279|3977194|B1|||Left Ventricular Ejection Fraction||percent|Mean|31.5|31.5|Inter-Quartile Range|||25.0|40.0|
4153274|NCT00851279|3977194|B1|Germany||Region of Enrollment||participants|Number|9|9.0||||||
4153275|NCT00851279|3977194|B1|Czech Republic||Region of Enrollment||participants|Number|32|32.0||||||
4153276|NCT00851279|3977194|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4153277|NCT00851279|3977194|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4153278|NCT00851279|3977194|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4153279|NCT00851279|3977194|B1|||Age||years|Median|67|67.0|Standard Deviation|7|7.0|||
4153280|NCT00851279|3977194|B1||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
4153281|NCT00851279|3977194|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4153282|NCT00851279|3977194|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4153283|NCT00851253|3977198|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4153284|NCT00851253|3977199|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4153285|NCT00851253|3977200|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153286|NCT00851253|3977198|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153287|NCT00851253|3977199|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153288|NCT00851253|3977200|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153289|NCT00851253|3977198|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4153290|NCT00851253|3977199|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4153291|NCT00851253|3977200|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153292|NCT00851253|3977198|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4153293|NCT00851253|3977199|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4153294|NCT00851253|3977200|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4153295|NCT00851253|3977198|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153296|NCT00851253|3977199|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153297|NCT00851253|3977200|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153298|NCT00851253|3977198|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4153299|NCT00851253|3977199|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4153300|NCT00851253|3977200|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153301|NCT00851253|3977198|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153302|NCT00851253|3977199|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153303|NCT00851253|3977200|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153304|NCT00851253|3977198|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4153305|NCT00851253|3977199|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4153306|NCT00851253|3977200|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4153307|NCT00851253|3977198|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4153308|NCT00851253|3977199|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4153309|NCT00851253|3977200|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4153310|NCT00851253|3977198|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4153311|NCT00851253|3977199|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4153312|NCT00851253|3977200|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4153313|NCT00851253|3977198|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4153314|NCT00851253|3977199|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4153315|NCT00851253|3977200|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4153316|NCT00851253|3977198|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4153317|NCT00851253|3977199|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4153318|NCT00851253|3977200|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4153319|NCT00851084|3977209|B3|||Body Surface Are (BSA)||m^2|Mean|1.8|1.8|Standard Deviation|0.2|0.2|||
4153320|NCT00851084|3977210|B2|||Body Surface Are (BSA)||m^2|Mean|1.8|1.8|Standard Deviation|0.2|0.2|||
4153321|NCT00851084|3977211|B1|||Body Surface Are (BSA)||m^2|Mean|1.8|1.8|Standard Deviation|0.2|0.2|||
4153322|NCT00851084|3977209|B3|Australia||Region of Enrollment||participants|Number|11|11.0||||||
4153323|NCT00851084|3977210|B2|Australia||Region of Enrollment||participants|Number|9|9.0||||||
4153324|NCT00851084|3977211|B1|Australia||Region of Enrollment||participants|Number|2|2.0||||||
4153325|NCT00851084|3977209|B3|Italy||Region of Enrollment||participants|Number|15|15.0||||||
4153326|NCT00851084|3977210|B2|Italy||Region of Enrollment||participants|Number|5|5.0||||||
4153327|NCT00851084|3977211|B1|Italy||Region of Enrollment||participants|Number|10|10.0||||||
4153328|NCT00851084|3977209|B3|Russian Federation||Region of Enrollment||participants|Number|30|30.0||||||
4153329|NCT00851084|3977210|B2|Russian Federation||Region of Enrollment||participants|Number|15|15.0||||||
4153330|NCT00851084|3977211|B1|Russian Federation||Region of Enrollment||participants|Number|15|15.0||||||
4153331|NCT00851084|3977209|B3|Spain||Region of Enrollment||participants|Number|42|42.0||||||
4153332|NCT00851084|3977210|B2|Spain||Region of Enrollment||participants|Number|18|18.0||||||
4153333|NCT00851084|3977211|B1|Spain||Region of Enrollment||participants|Number|24|24.0||||||
4153334|NCT00851084|3977209|B3|Germany||Region of Enrollment||participants|Number|42|42.0||||||
4153335|NCT00851084|3977210|B2|Germany||Region of Enrollment||participants|Number|24|24.0||||||
4153336|NCT00851084|3977211|B1|Germany||Region of Enrollment||participants|Number|18|18.0||||||
4153337|NCT00851084|3977209|B3|Korea, Republic of||Region of Enrollment||participants|Number|46|46.0||||||
4153338|NCT00851084|3977210|B2|Korea, Republic of||Region of Enrollment||participants|Number|20|20.0||||||
4153339|NCT00851084|3977211|B1|Korea, Republic of||Region of Enrollment||participants|Number|26|26.0||||||
4153340|NCT00851084|3977209|B3|United Kingdom||Region of Enrollment||participants|Number|50|50.0||||||
4153341|NCT00851084|3977210|B2|United Kingdom||Region of Enrollment||participants|Number|28|28.0||||||
4153342|NCT00851084|3977211|B1|United Kingdom||Region of Enrollment||participants|Number|22|22.0||||||
4153343|NCT00851084|3977209|B3|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4153344|NCT00851084|3977210|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4153345|NCT00851084|3977211|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4153346|NCT00851084|3977209|B3|Asian/Oriental||Race/Ethnicity, Customized||Participants|Number|47|47.0||||||
4153347|NCT00851084|3977210|B2|Asian/Oriental||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
4153348|NCT00851084|3977211|B1|Asian/Oriental||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
4153349|NCT00851084|3977209|B3|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4153350|NCT00851084|3977210|B2|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4153351|NCT00851084|3977211|B1|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4153352|NCT00851084|3977209|B3|Caucasian/White||Race/Ethnicity, Customized||Participants|Number|187|187.0||||||
4153353|NCT00851084|3977210|B2|Caucasian/White||Race/Ethnicity, Customized||Participants|Number|97|97.0||||||
4153354|NCT00851084|3977211|B1|Caucasian/White||Race/Ethnicity, Customized||Participants|Number|90|90.0||||||
4153355|NCT00851084|3977209|B3||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4153356|NCT00851084|3977210|B2||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4153357|NCT00851084|3977211|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4153358|NCT00851084|3977209|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4153359|NCT00851084|3977210|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4153360|NCT00851084|3977211|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4153361|NCT00851084|3977209|B3|>=75||Age, Customized||Participants|Number|13|13.0||||||
4153362|NCT00851084|3977210|B2|>=75||Age, Customized||Participants|Number|4|4.0||||||
4153363|NCT00851084|3977211|B1|>=75||Age, Customized||Participants|Number|9|9.0||||||
4153364|NCT00851084|3977209|B3|>=65 but <75||Age, Customized||Participants|Number|88|88.0||||||
4153365|NCT00851084|3977210|B2|>=65 but <75||Age, Customized||Participants|Number|45|45.0||||||
4153366|NCT00851084|3977211|B1|>=65 but <75||Age, Customized||Participants|Number|43|43.0||||||
4153367|NCT00851084|3977209|B3|<65||Age, Customized||Participants|Number|135|135.0||||||
4153368|NCT00851084|3977210|B2|<65||Age, Customized||Participants|Number|70|70.0||||||
4153369|NCT00851084|3977211|B1|<65||Age, Customized||Participants|Number|65|65.0||||||
4153370|NCT00851084|3977209|B3|||Age||Years|Mean|62.1|62.1|Standard Deviation|9.4|9.4|||
4153371|NCT00851084|3977210|B2|||Age||Years|Mean|61.8|61.8|Standard Deviation|9.0|9.0|||
4153372|NCT00851084|3977211|B1|||Age||Years|Mean|62.4|62.4|Standard Deviation|9.7|9.7|||
4153373|NCT00851006|3977228|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4153374|NCT00851006|3977228|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153375|NCT00851006|3977228|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153376|NCT00851006|3977228|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4153377|NCT00851006|3977228|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153378|NCT00851006|3977228|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153379|NCT00851006|3977228|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153380|NCT00851006|3977228|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153381|NCT00851006|3977228|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4153382|NCT00851006|3977228|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4153383|NCT00851006|3977228|B1|Age||Age||years|Mean|15.6|15.6|Full Range|||14.0|18.0|
4153384|NCT00850993|3977236|B5||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4153385|NCT00850993|3977237|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4153386|NCT00850993|3977238|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4153387|NCT00850993|3977239|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4153388|NCT00850993|3977240|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4153389|NCT00850993|3977236|B5||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4153390|NCT00850993|3977237|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4153391|NCT00850993|3977238|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4153392|NCT00850993|3977239|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4153393|NCT00850993|3977240|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4153394|NCT00850993|3977236|B5|||Age||hours|Mean|20|20.0|Standard Deviation|10.9|10.9|||
4153395|NCT00850993|3977237|B4|||Age||hours|Mean|21.8|21.8|Standard Deviation|19.8|19.8|||
4153396|NCT00850993|3977238|B3|||Age||hours|Mean|23.3|23.3|Standard Deviation|10.9|10.9|||
4153397|NCT00850993|3977239|B2|||Age||hours|Mean|16.5|16.5|Standard Deviation|7.8|7.8|||
4153398|NCT00850993|3977240|B1|||Age||hours|Mean|19.1|19.1|Standard Deviation|6.8|6.8|||
4153399|NCT00850993|3977236|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153400|NCT00850993|3977237|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153401|NCT00850993|3977238|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153402|NCT00850993|3977239|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153403|NCT00850993|3977240|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153404|NCT00850993|3977236|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4153405|NCT00850993|3977237|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4153406|NCT00850993|3977238|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4153407|NCT00850993|3977239|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4153408|NCT00850993|3977240|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4153409|NCT00850993|3977236|B5||<=18 years|Age||Participants|Count of Participants|58|58.0||||||
4153410|NCT00850993|3977237|B4||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4153411|NCT00850993|3977238|B3||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
4153412|NCT00850993|3977239|B2||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
4153413|NCT00850993|3977240|B1||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4153414|NCT00850889|3977257|B1|Canada||Region of Enrollment||participants|Number|32|32.0||||||
4153415|NCT00850889|3977257|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4153416|NCT00850889|3977257|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4153417|NCT00850889|3977257|B1|||Age||years|Mean|51.8|51.8|Standard Deviation|7.82|7.82|||
4153418|NCT00850889|3977257|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4153419|NCT00850889|3977257|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4153420|NCT00850889|3977257|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4153421|NCT00850759|3977268|B5|United States||Region of Enrollment||participants|Number|231|231.0||||||
4153422|NCT00850759|3977269|B4|United States||Region of Enrollment||participants|Number|58|58.0||||||
4153423|NCT00850759|3977270|B3|United States||Region of Enrollment||participants|Number|57|57.0||||||
4153424|NCT00850759|3977271|B2|United States||Region of Enrollment||participants|Number|57|57.0||||||
4153425|NCT00850759|3977272|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
4153426|NCT00850759|3977268|B5||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4153427|NCT00850759|3977269|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4153428|NCT00850759|3977270|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4153429|NCT00850759|3977271|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4153430|NCT00850759|3977272|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4153431|NCT00850759|3977268|B5||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4153432|NCT00850759|3977269|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4153433|NCT00850759|3977270|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4153434|NCT00850759|3977271|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4153435|NCT00850759|3977272|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4153436|NCT00850759|3977268|B5|||Age||years|Mean|8.0|8.0|Standard Deviation|0.65|0.65|||
4153437|NCT00850759|3977269|B4|||Age||years|Mean|8.1|8.1|Standard Deviation|0.63|0.63|||
4153438|NCT00850759|3977270|B3|||Age||years|Mean|7.9|7.9|Standard Deviation|0.68|0.68|||
4153439|NCT00850759|3977271|B2|||Age||years|Mean|8.1|8.1|Standard Deviation|0.63|0.63|||
4153440|NCT00850759|3977272|B1|||Age||years|Mean|7.9|7.9|Standard Deviation|0.67|0.67|||
4153441|NCT00850759|3977268|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153442|NCT00850759|3977269|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153443|NCT00850759|3977270|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153444|NCT00850759|3977271|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153445|NCT00850759|3977272|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153446|NCT00850759|3977268|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4153447|NCT00850759|3977269|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4153448|NCT00850759|3977270|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4153449|NCT00850759|3977271|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4153450|NCT00850759|3977272|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4153451|NCT00850759|3977268|B5||<=18 years|Age||Participants|Count of Participants|231|231.0||||||
4153452|NCT00850759|3977269|B4||<=18 years|Age||Participants|Count of Participants|58|58.0||||||
4153453|NCT00850759|3977270|B3||<=18 years|Age||Participants|Count of Participants|57|57.0||||||
4153454|NCT00850759|3977271|B2||<=18 years|Age||Participants|Count of Participants|57|57.0||||||
4153455|NCT00850759|3977272|B1||<=18 years|Age||Participants|Count of Participants|59|59.0||||||
4153456|NCT00850642|3977289|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153457|NCT00850642|3977290|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153458|NCT00850642|3977291|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153459|NCT00850642|3977289|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153460|NCT00850642|3977290|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153461|NCT00850642|3977291|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153462|NCT00850642|3977289|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4153463|NCT00850642|3977290|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4153464|NCT00850642|3977291|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4153465|NCT00850642|3977289|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153466|NCT00850642|3977290|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153467|NCT00850642|3977291|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153468|NCT00850642|3977289|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153469|NCT00850642|3977290|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153470|NCT00850642|3977291|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153471|NCT00850642|3977289|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153472|NCT00850642|3977290|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153473|NCT00850642|3977291|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153474|NCT00850642|3977289|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153475|NCT00850642|3977290|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153476|NCT00850642|3977291|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153477|NCT00850642|3977289|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4153478|NCT00850642|3977290|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4153479|NCT00850642|3977291|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4153480|NCT00850642|3977289|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4153481|NCT00850642|3977290|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4153482|NCT00850642|3977291|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4153483|NCT00850642|3977289|B3|||Age||Years|Mean|55.3|55.3|Standard Deviation|8.98|8.98|||
4153484|NCT00850642|3977290|B2|||Age||Years|Mean|57.8|57.8|Standard Deviation|6.65|6.65|||
4153485|NCT00850642|3977291|B1|||Age||Years|Mean|52.0|52.0|Standard Deviation|12.12|12.12|||
4153486|NCT00850603|3977325|B6|United States||Region of Enrollment||participants|Number|170|170.0||||||
4153487|NCT00850603|3977326|B5|United States||Region of Enrollment||participants|Number|34|34.0||||||
4153488|NCT00850603|3977327|B4|United States||Region of Enrollment||participants|Number|34|34.0||||||
4153489|NCT00850603|3977328|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
4153490|NCT00850603|3977329|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
4153491|NCT00850603|3977330|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4153492|NCT00850603|3977325|B6||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4153493|NCT00850603|3977326|B5||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4153494|NCT00850603|3977327|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4153495|NCT00850603|3977328|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4153496|NCT00850603|3977329|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4153497|NCT00850603|3977330|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4153498|NCT00850603|3977325|B6||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4153499|NCT00850603|3977326|B5||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4153500|NCT00850603|3977327|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4153501|NCT00850603|3977328|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4153502|NCT00850603|3977329|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4153503|NCT00850603|3977330|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4153504|NCT00850603|3977325|B6|||Age||years|Mean|25.6|25.6|Standard Deviation|9.42|9.42|||
4153505|NCT00850603|3977326|B5|||Age||years|Mean|28.9|28.9|Standard Deviation|12.85|12.85|||
4153506|NCT00850603|3977327|B4|||Age||years|Mean|24.5|24.5|Standard Deviation|8.46|8.46|||
4153507|NCT00850603|3977328|B3|||Age||years|Mean|24.4|24.4|Standard Deviation|7.64|7.64|||
4153508|NCT00850603|3977329|B2|||Age||years|Mean|24.3|24.3|Standard Deviation|7.10|7.1|||
4153509|NCT00850603|3977330|B1|||Age||years|Mean|25.8|25.8|Standard Deviation|9.68|9.68|||
4153510|NCT00850603|3977325|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153511|NCT00850603|3977326|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153512|NCT00850603|3977327|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153513|NCT00850603|3977328|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153514|NCT00850603|3977329|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153515|NCT00850603|3977330|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153516|NCT00850603|3977325|B6||Between 18 and 65 years|Age||Participants|Count of Participants|159|159.0||||||
4153517|NCT00850603|3977326|B5||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4153518|NCT00850603|3977327|B4||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4153519|NCT00850603|3977328|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4153520|NCT00850603|3977329|B2||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4153521|NCT00850603|3977330|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4153522|NCT00850603|3977325|B6||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4153523|NCT00850603|3977326|B5||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4153524|NCT00850603|3977327|B4||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4153525|NCT00850603|3977328|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4153526|NCT00850603|3977329|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4153527|NCT00850603|3977330|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4153528|NCT00850564|3977356|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4153529|NCT00850564|3977356|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4153530|NCT00850564|3977356|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4153531|NCT00850564|3977356|B1|||Age||years|Mean|44|44.0|Standard Deviation|13|13.0|||
4153532|NCT00850564|3977356|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153533|NCT00850564|3977356|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4153534|NCT00850564|3977356|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4153535|NCT00850538|3977361|B1|United States||Region of Enrollment||participants|Number|101|101.0||||||
4153536|NCT00850538|3977361|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4153537|NCT00850538|3977361|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4153538|NCT00850538|3977361|B1|||Age||years|Mean|63.89|63.89|Standard Deviation|8.59|8.59|||
4153539|NCT00850538|3977361|B1||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
4153540|NCT00850538|3977361|B1||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4153541|NCT00850538|3977361|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4153542|NCT00850499|3977365|B3|Italy||Region of Enrollment||participants|Number|4|4.0||||||
4153543|NCT00850499|3977366|B2|Italy||Region of Enrollment||participants|Number|3|3.0||||||
4153544|NCT00850499|3977367|B1|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4153545|NCT00850499|3977365|B3|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4153546|NCT00850499|3977366|B2|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
4153547|NCT00850499|3977367|B1|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4153548|NCT00850499|3977365|B3|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4153549|NCT00850499|3977366|B2|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4153550|NCT00850499|3977367|B1|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4153551|NCT00850499|3977365|B3|Israel||Region of Enrollment||participants|Number|1|1.0||||||
4153552|NCT00850499|3977366|B2|Israel||Region of Enrollment||participants|Number|0|0.0||||||
4153553|NCT00850499|3977367|B1|Israel||Region of Enrollment||participants|Number|1|1.0||||||
4153554|NCT00850499|3977365|B3|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4153555|NCT00850499|3977366|B2|Spain||Region of Enrollment||participants|Number|0|0.0||||||
4153556|NCT00850499|3977367|B1|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4153557|NCT00850499|3977365|B3|Greece||Region of Enrollment||participants|Number|1|1.0||||||
4153558|NCT00850499|3977366|B2|Greece||Region of Enrollment||participants|Number|1|1.0||||||
4153559|NCT00850499|3977367|B1|Greece||Region of Enrollment||participants|Number|0|0.0||||||
4153560|NCT00850499|3977365|B3|France||Region of Enrollment||participants|Number|3|3.0||||||
4153561|NCT00850499|3977366|B2|France||Region of Enrollment||participants|Number|3|3.0||||||
4153562|NCT00850499|3977367|B1|France||Region of Enrollment||participants|Number|0|0.0||||||
4153563|NCT00850499|3977365|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4153564|NCT00850499|3977366|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4153565|NCT00850499|3977367|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4153566|NCT00850499|3977365|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4153567|NCT00850499|3977366|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4153568|NCT00850499|3977367|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4153569|NCT00850499|3977365|B3|||Age||years|Mean|60.4|60.4|Standard Deviation|10.47|10.47|||
4153570|NCT00850499|3977366|B2|||Age||years|Mean|60.0|60.0|Standard Deviation|10.06|10.06|||
4153571|NCT00850499|3977367|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|12.84|12.84|||
4153572|NCT00850499|3977365|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4153573|NCT00850499|3977366|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4153574|NCT00850499|3977367|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4153575|NCT00850499|3977365|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4153576|NCT00850499|3977366|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4153577|NCT00850499|3977367|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4153578|NCT00850499|3977365|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4153579|NCT00850499|3977366|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4153580|NCT00850499|3977367|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4153581|NCT00850473|3977376|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4153582|NCT00850473|3977376|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4153583|NCT00850473|3977376|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4153584|NCT00850473|3977376|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153585|NCT00850473|3977376|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4153586|NCT00850473|3977376|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4153587|NCT00850460|3977380|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4153588|NCT00850460|3977381|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4153589|NCT00850460|3977382|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4153590|NCT00850460|3977380|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4153591|NCT00850460|3977381|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4153592|NCT00850460|3977382|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4153593|NCT00850460|3977380|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153594|NCT00850460|3977381|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153595|NCT00850460|3977382|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153596|NCT00850460|3977380|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4153597|NCT00850460|3977381|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4153598|NCT00850460|3977382|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4153599|NCT00850460|3977380|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4153600|NCT00850460|3977381|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153601|NCT00850460|3977382|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4153602|NCT00850460|3977380|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153603|NCT00850460|3977381|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153604|NCT00850460|3977382|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153605|NCT00850460|3977380|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153606|NCT00850460|3977381|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153607|NCT00850460|3977382|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153608|NCT00850460|3977380|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153609|NCT00850460|3977381|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153610|NCT00850460|3977382|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153611|NCT00850460|3977380|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4153612|NCT00850460|3977381|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4153613|NCT00850460|3977382|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4153614|NCT00850460|3977380|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4153615|NCT00850460|3977381|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4153616|NCT00850460|3977382|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4153617|NCT00850460|3977380|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153618|NCT00850460|3977381|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153619|NCT00850460|3977382|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153620|NCT00850460|3977380|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4153621|NCT00850460|3977381|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4153622|NCT00850460|3977382|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4153623|NCT00850460|3977380|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4153624|NCT00850460|3977381|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4153625|NCT00850460|3977382|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4153626|NCT00850421|3977391|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4153627|NCT00850421|3977391|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4153628|NCT00850421|3977391|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153629|NCT00850421|3977391|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4153630|NCT00850421|3977391|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4153631|NCT00850395|3977397|B1|||Acquired Immune Deficiency Syndrome Clinical Trials Group Symptom Distress Module(SDM) Overall Score|SDM: 20 items questionnaire, each item rated from 0 to 4, 0=complete absence of symptom and 4=very bothersome symptom. Overall score: sum of scores for each of 20 items of questionnaire, with 0=best health and 80=worst health. A positive change from baseline indicates decline in participant’s quality of life. Number of participants evaluable=55.|units on a scale|Mean|17.37|17.37|Standard Deviation|14.026|14.026|||
4153632|NCT00850395|3977397|B1|Category C||Number of Participants With Centers for Disease Control and Prevention (CDC) Classification|Participants were classified based on the severity as mild (Category A), moderate (Category B), and severe (Category C).|participants|Number|27|27.0||||||
4153633|NCT00850395|3977397|B1|Category B||Number of Participants With Centers for Disease Control and Prevention (CDC) Classification|Participants were classified based on the severity as mild (Category A), moderate (Category B), and severe (Category C).|participants|Number|21|21.0||||||
4153634|NCT00850395|3977397|B1|Category A||Number of Participants With Centers for Disease Control and Prevention (CDC) Classification|Participants were classified based on the severity as mild (Category A), moderate (Category B), and severe (Category C).|participants|Number|31|31.0||||||
4153635|NCT00850395|3977397|B1|||Cluster of Differentiation 4 (CD4+) Cell Counts||cells/microliter (cells/mcL)|Mean|458.8|458.8|Standard Deviation|250.14|250.14|||
4153636|NCT00850395|3977397|B1|||Log 10 Transformed Human Immunodeficiency Virus-1 Ribonucleic Acid (HIV-1 RNA)|Number of participants evaluable for this measure=78.|copies/milliliter (copies/mL)|Mean|3.01|3.01|Standard Deviation|1.599|1.599|||
4153637|NCT00850395|3977397|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4153638|NCT00850395|3977397|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4153639|NCT00850395|3977397|B1|||Age||years|Mean|44.1|44.1|Standard Deviation|11.2|11.2|||
4153640|NCT00850343|3977413|B5|||Body Weight||kg|Mean|57.30|57.3|Standard Deviation|11.06|11.06|||
4153641|NCT00850343|3977414|B4|||Body Weight||kg|Mean|58.65|58.65|Standard Deviation|11.83|11.83|||
4153642|NCT00850343|3977415|B3|||Body Weight||kg|Mean|59.36|59.36|Standard Deviation|11.11|11.11|||
4153643|NCT00850343|3977416|B2|||Body Weight||kg|Mean|55.92|55.92|Standard Deviation|9.55|9.55|||
4153644|NCT00850343|3977417|B1|||Body Weight||kg|Mean|56.12|56.12|Standard Deviation|10.84|10.84|||
4153645|NCT00850343|3977413|B5|Japan||Region of Enrollment||participants|Number|208|208.0||||||
4153646|NCT00850343|3977414|B4|Japan||Region of Enrollment||participants|Number|43|43.0||||||
4153647|NCT00850343|3977415|B3|Japan||Region of Enrollment||participants|Number|43|43.0||||||
4153648|NCT00850343|3977416|B2|Japan||Region of Enrollment||participants|Number|12|12.0||||||
4153649|NCT00850343|3977417|B1|Japan||Region of Enrollment||participants|Number|110|110.0||||||
4153650|NCT00850343|3977413|B5||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4153651|NCT00850343|3977414|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4153652|NCT00850343|3977415|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4153653|NCT00850343|3977416|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4153654|NCT00850343|3977417|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4153655|NCT00850343|3977413|B5||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4153656|NCT00850343|3977414|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4153657|NCT00850343|3977415|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4153658|NCT00850343|3977416|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4153659|NCT00850343|3977417|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4153660|NCT00850343|3977413|B5|≧ 65 years||Age, Customized||participants|Number|41|41.0||||||
4153661|NCT00850343|3977414|B4|≧ 65 years||Age, Customized||participants|Number|11|11.0||||||
4153662|NCT00850343|3977415|B3|≧ 65 years||Age, Customized||participants|Number|8|8.0||||||
4153663|NCT00850343|3977416|B2|≧ 65 years||Age, Customized||participants|Number|2|2.0||||||
4153664|NCT00850343|3977417|B1|≧ 65 years||Age, Customized||participants|Number|20|20.0||||||
4153665|NCT00850343|3977413|B5|< 65 years||Age, Customized||participants|Number|167|167.0||||||
4153666|NCT00850343|3977414|B4|< 65 years||Age, Customized||participants|Number|32|32.0||||||
4153667|NCT00850343|3977415|B3|< 65 years||Age, Customized||participants|Number|35|35.0||||||
4153668|NCT00850343|3977416|B2|< 65 years||Age, Customized||participants|Number|10|10.0||||||
4153669|NCT00850343|3977417|B1|< 65 years||Age, Customized||participants|Number|90|90.0||||||
4153670|NCT00850343|3977413|B5|||Age||years|Mean|55.5|55.5|Standard Deviation|10.0|10.0|||
4153671|NCT00850343|3977414|B4|||Age||years|Mean|55.9|55.9|Standard Deviation|10.7|10.7|||
4153672|NCT00850343|3977415|B3|||Age||years|Mean|54.6|54.6|Standard Deviation|9.7|9.7|||
4153673|NCT00850343|3977416|B2|||Age||years|Mean|59.3|59.3|Standard Deviation|6.5|6.5|||
4153674|NCT00850343|3977417|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|10.2|10.2|||
4153675|NCT00850200|3977450|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4153676|NCT00850200|3977450|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4153677|NCT00850200|3977450|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4153678|NCT00850200|3977450|B1|||Age||years|Median|24.5|24.5|Full Range|13.5|13.5|7.7|57.6|
4153679|NCT00850200|3977450|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153680|NCT00850200|3977450|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4153681|NCT00850200|3977450|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4153682|NCT00850174|3977456|B3|Canada||Region of Enrollment||participants|Number|60|60.0||||||
4153683|NCT00850174|3977457|B2|Canada||Region of Enrollment||participants|Number|30|30.0||||||
4153684|NCT00850174|3977458|B1|Canada||Region of Enrollment||participants|Number|30|30.0||||||
4153685|NCT00850174|3977456|B3|Asian||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4153686|NCT00850174|3977457|B2|Asian||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4153687|NCT00850174|3977458|B1|Asian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4153688|NCT00850174|3977456|B3|Black||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4153689|NCT00850174|3977457|B2|Black||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4153690|NCT00850174|3977458|B1|Black||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4153691|NCT00850174|3977456|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|34|34.0||||||
4153692|NCT00850174|3977457|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4153693|NCT00850174|3977458|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4153694|NCT00850174|3977456|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4153695|NCT00850174|3977457|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4153696|NCT00850174|3977458|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4153697|NCT00850174|3977456|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4153698|NCT00850174|3977457|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4153699|NCT00850174|3977458|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4153700|NCT00850174|3977456|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153701|NCT00850174|3977457|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153702|NCT00850174|3977458|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153703|NCT00850174|3977456|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4153704|NCT00850174|3977457|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4153705|NCT00850174|3977458|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4153706|NCT00850174|3977456|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4153707|NCT00850174|3977457|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4153708|NCT00850174|3977458|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4153709|NCT00850135|3977473|B1|Private||Insurance status||participants|Number|24|24.0||||||
4153710|NCT00850135|3977473|B1|Public||Insurance status||participants|Number|29|29.0||||||
4153711|NCT00850135|3977473|B1|||BMI at enrollment||kg/m2|Mean|32.5|32.5|Standard Deviation|8.5|8.5|||
4153712|NCT00850135|3977473|B1|||Pre-pregnancy BMI||kg/m2|Mean|29.1|29.1|Standard Deviation|8.4|8.4|||
4153713|NCT00850135|3977473|B1|Multiparous||Parity||participants|Number|30|30.0||||||
4153714|NCT00850135|3977473|B1|Nulliparous||Parity||participants|Number|23|23.0||||||
4153715|NCT00850135|3977473|B1|||Gestational Age at Enrollment||weeks|Mean|25.9|25.9|Standard Deviation|1.2|1.2|||
4153716|NCT00850135|3977473|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
4153717|NCT00850135|3977473|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4153718|NCT00850135|3977473|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4153719|NCT00850135|3977473|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4153720|NCT00850135|3977473|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153721|NCT00850135|3977473|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4153722|NCT00850135|3977473|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4153723|NCT00850135|3977473|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153724|NCT00850135|3977473|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153725|NCT00850135|3977473|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4153726|NCT00850135|3977473|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4153727|NCT00850135|3977473|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4153728|NCT00850135|3977473|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4153729|NCT00850135|3977473|B1|||Age||years|Mean|30|30.0|Standard Deviation|5|5.0|||
4153730|NCT00850135|3977473|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153731|NCT00850135|3977473|B1||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4153732|NCT00850135|3977473|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4153733|NCT00850096|3977479|B3|United States||Region of Enrollment||participants|Number|94|94.0||||||
4153734|NCT00850096|3977480|B2|United States||Region of Enrollment||participants|Number|47|47.0||||||
4153735|NCT00850096|3977481|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
4153736|NCT00850096|3977479|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4153737|NCT00850096|3977480|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4153738|NCT00850096|3977481|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4153739|NCT00850096|3977479|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4153740|NCT00850096|3977480|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4153741|NCT00850096|3977481|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4153742|NCT00850096|3977479|B3|||Age||years|Mean|56.3|56.3|Standard Deviation|9.50|9.5|||
4153743|NCT00850096|3977480|B2|||Age||years|Mean|57.4|57.4|Standard Deviation|8.85|8.85|||
4153744|NCT00850096|3977481|B1|||Age||years|Mean|55.3|55.3|Standard Deviation|10.2|10.2|||
4153745|NCT00850070|3977490|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
4153746|NCT00850070|3977491|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4153747|NCT00850070|3977492|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4153748|NCT00850070|3977490|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4153749|NCT00850070|3977491|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4153750|NCT00850070|3977492|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4153751|NCT00850070|3977490|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4153752|NCT00850070|3977491|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4153753|NCT00850070|3977492|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4153754|NCT00850070|3977490|B3|||Age||years|Mean|5|5.0|Standard Deviation|1|1.0|||
4153755|NCT00850070|3977491|B2|||Age||years|Mean|5|5.0|Standard Deviation|1|1.0|||
4153756|NCT00850070|3977492|B1|||Age||years|Mean|5|5.0|Standard Deviation|1|1.0|||
4153757|NCT00850070|3977490|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153758|NCT00850070|3977491|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153759|NCT00850070|3977492|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153760|NCT00850070|3977490|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4153761|NCT00850070|3977491|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4153762|NCT00850070|3977492|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4153763|NCT00850070|3977490|B3||<=18 years|Age||Participants|Count of Participants|46|46.0||||||
4153764|NCT00850070|3977491|B2||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
4153765|NCT00850070|3977492|B1||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
4153766|NCT00850031|3977517|B1|Philippines||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4153767|NCT00850031|3977517|B1|Germany||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4153768|NCT00850031|3977517|B1|Australia||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
4153769|NCT00850031|3977517|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4153770|NCT00850031|3977517|B1|Singapore||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4153771|NCT00850031|3977517|B1|Austria||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
4153772|NCT00850031|3977517|B1|New Zealand||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4153773|NCT00850031|3977517|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4153774|NCT00850031|3977517|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4153775|NCT00850031|3977517|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153776|NCT00850031|3977517|B1||Between 18 and 65 years|Age||Participants|Count of Participants|118|118.0||||||
4153777|NCT00850031|3977517|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4153778|NCT00849940|3977522|B1|United States||Region of Enrollment||participants|Number|72|72.0||||||
4153779|NCT00849940|3977522|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4153780|NCT00849940|3977522|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4153781|NCT00849940|3977522|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4153782|NCT00849940|3977522|B1||Male|Gender||Participants|Count of Participants|38|38.0||||||
4153783|NCT00849940|3977522|B1||Female|Gender||Participants|Count of Participants|34|34.0||||||
4153784|NCT00849940|3977522|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153785|NCT00849940|3977522|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4153786|NCT00849940|3977522|B1||<=18 years|Age||Participants|Count of Participants|72|72.0||||||
4153787|NCT00849901|3977530|B4|||Clinical Global Impressions of Severity (CGI-Severity) score|CGI-Severity score evaluates the severity of illness at the time of assessment. The score ranges from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|4.5|4.5|Standard Deviation|0.62|0.62|||
4153788|NCT00849901|3977531|B3|||Clinical Global Impressions of Severity (CGI-Severity) score|CGI-Severity score evaluates the severity of illness at the time of assessment. The score ranges from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|4.6|4.6|Standard Deviation|0.65|0.65|||
4153789|NCT00849901|3977532|B2|||Clinical Global Impressions of Severity (CGI-Severity) score|CGI-Severity score evaluates the severity of illness at the time of assessment. The score ranges from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|4.5|4.5|Standard Deviation|0.58|0.58|||
4153790|NCT00849901|3977533|B1|||Clinical Global Impressions of Severity (CGI-Severity) score|CGI-Severity score evaluates the severity of illness at the time of assessment. The score ranges from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|4.5|4.5|Standard Deviation|0.62|0.62|||
4153791|NCT00849901|3977530|B4|Behavior||CDRS-R Subscale Scores|CDRS-R Subscale score include Mood (Sum of items 8, 11, 14, 15), Somatic (Sum of items 4-7, 16, 17), Subjective (Sum of items 9, 10, 12, 13) and Behavior (Sum of items 1-3). Mood and Subjective subscale scores range from 4 to 28; Somatic subscale scores range from 6 to 36; Behavior subscale scores range from 3 to 21.|units on a scale|Mean|13.1|13.1|Standard Deviation|2.89|2.89|||
4153792|NCT00849901|3977531|B3|Behavior||CDRS-R Subscale Scores|CDRS-R Subscale score include Mood (Sum of items 8, 11, 14, 15), Somatic (Sum of items 4-7, 16, 17), Subjective (Sum of items 9, 10, 12, 13) and Behavior (Sum of items 1-3). Mood and Subjective subscale scores range from 4 to 28; Somatic subscale scores range from 6 to 36; Behavior subscale scores range from 3 to 21.|units on a scale|Mean|13.5|13.5|Standard Deviation|3.00|3.0|||
4153793|NCT00849901|3977532|B2|Behavior||CDRS-R Subscale Scores|CDRS-R Subscale score include Mood (Sum of items 8, 11, 14, 15), Somatic (Sum of items 4-7, 16, 17), Subjective (Sum of items 9, 10, 12, 13) and Behavior (Sum of items 1-3). Mood and Subjective subscale scores range from 4 to 28; Somatic subscale scores range from 6 to 36; Behavior subscale scores range from 3 to 21.|units on a scale|Mean|12.8|12.8|Standard Deviation|2.87|2.87|||
4153794|NCT00849901|3977533|B1|Behavior||CDRS-R Subscale Scores|CDRS-R Subscale score include Mood (Sum of items 8, 11, 14, 15), Somatic (Sum of items 4-7, 16, 17), Subjective (Sum of items 9, 10, 12, 13) and Behavior (Sum of items 1-3). Mood and Subjective subscale scores range from 4 to 28; Somatic subscale scores range from 6 to 36; Behavior subscale scores range from 3 to 21.|units on a scale|Mean|13.0|13.0|Standard Deviation|2.79|2.79|||
4153795|NCT00849901|3977530|B4|Subjective||CDRS-R Subscale Scores|CDRS-R Subscale score include Mood (Sum of items 8, 11, 14, 15), Somatic (Sum of items 4-7, 16, 17), Subjective (Sum of items 9, 10, 12, 13) and Behavior (Sum of items 1-3). Mood and Subjective subscale scores range from 4 to 28; Somatic subscale scores range from 6 to 36; Behavior subscale scores range from 3 to 21.|units on a scale|Mean|10.3|10.3|Standard Deviation|3.25|3.25|||
4153796|NCT00849901|3977531|B3|Subjective||CDRS-R Subscale Scores|CDRS-R Subscale score include Mood (Sum of items 8, 11, 14, 15), Somatic (Sum of items 4-7, 16, 17), Subjective (Sum of items 9, 10, 12, 13) and Behavior (Sum of items 1-3). Mood and Subjective subscale scores range from 4 to 28; Somatic subscale scores range from 6 to 36; Behavior subscale scores range from 3 to 21.|units on a scale|Mean|10.4|10.4|Standard Deviation|3.46|3.46|||
4153797|NCT00849901|3977532|B2|Subjective||CDRS-R Subscale Scores|CDRS-R Subscale score include Mood (Sum of items 8, 11, 14, 15), Somatic (Sum of items 4-7, 16, 17), Subjective (Sum of items 9, 10, 12, 13) and Behavior (Sum of items 1-3). Mood and Subjective subscale scores range from 4 to 28; Somatic subscale scores range from 6 to 36; Behavior subscale scores range from 3 to 21.|units on a scale|Mean|10.4|10.4|Standard Deviation|3.24|3.24|||
4153798|NCT00849901|3977533|B1|Subjective||CDRS-R Subscale Scores|CDRS-R Subscale score include Mood (Sum of items 8, 11, 14, 15), Somatic (Sum of items 4-7, 16, 17), Subjective (Sum of items 9, 10, 12, 13) and Behavior (Sum of items 1-3). Mood and Subjective subscale scores range from 4 to 28; Somatic subscale scores range from 6 to 36; Behavior subscale scores range from 3 to 21.|units on a scale|Mean|10.1|10.1|Standard Deviation|3.08|3.08|||
4153825|NCT00849901|3977532|B2|Ukraine||Region of Enrollment||participants|Number|23|23.0||||||
4153799|NCT00849901|3977530|B4|Somatic||CDRS-R Subscale Scores|CDRS-R Subscale score include Mood (Sum of items 8, 11, 14, 15), Somatic (Sum of items 4-7, 16, 17), Subjective (Sum of items 9, 10, 12, 13) and Behavior (Sum of items 1-3). Mood and Subjective subscale scores range from 4 to 28; Somatic subscale scores range from 6 to 36; Behavior subscale scores range from 3 to 21.|units on a scale|Mean|19.8|19.8|Standard Deviation|4.48|4.48|||
4153800|NCT00849901|3977531|B3|Somatic||CDRS-R Subscale Scores|CDRS-R Subscale score include Mood (Sum of items 8, 11, 14, 15), Somatic (Sum of items 4-7, 16, 17), Subjective (Sum of items 9, 10, 12, 13) and Behavior (Sum of items 1-3). Mood and Subjective subscale scores range from 4 to 28; Somatic subscale scores range from 6 to 36; Behavior subscale scores range from 3 to 21.|units on a scale|Mean|20.0|20.0|Standard Deviation|4.75|4.75|||
4153801|NCT00849901|3977532|B2|Somatic||CDRS-R Subscale Scores|CDRS-R Subscale score include Mood (Sum of items 8, 11, 14, 15), Somatic (Sum of items 4-7, 16, 17), Subjective (Sum of items 9, 10, 12, 13) and Behavior (Sum of items 1-3). Mood and Subjective subscale scores range from 4 to 28; Somatic subscale scores range from 6 to 36; Behavior subscale scores range from 3 to 21.|units on a scale|Mean|19.7|19.7|Standard Deviation|4.21|4.21|||
4153802|NCT00849901|3977533|B1|Somatic||CDRS-R Subscale Scores|CDRS-R Subscale score include Mood (Sum of items 8, 11, 14, 15), Somatic (Sum of items 4-7, 16, 17), Subjective (Sum of items 9, 10, 12, 13) and Behavior (Sum of items 1-3). Mood and Subjective subscale scores range from 4 to 28; Somatic subscale scores range from 6 to 36; Behavior subscale scores range from 3 to 21.|units on a scale|Mean|19.8|19.8|Standard Deviation|4.54|4.54|||
4153803|NCT00849901|3977530|B4|Mood||CDRS-R Subscale Scores|CDRS-R Subscale score include Mood (Sum of items 8, 11, 14, 15), Somatic (Sum of items 4-7, 16, 17), Subjective (Sum of items 9, 10, 12, 13) and Behavior (Sum of items 1-3). Mood and Subjective subscale scores range from 4 to 28; Somatic subscale scores range from 6 to 36; Behavior subscale scores range from 3 to 21.|units on a scale|Mean|16.1|16.1|Standard Deviation|3.66|3.66|||
4153804|NCT00849901|3977531|B3|Mood||CDRS-R Subscale Scores|CDRS-R Subscale score include Mood (Sum of items 8, 11, 14, 15), Somatic (Sum of items 4-7, 16, 17), Subjective (Sum of items 9, 10, 12, 13) and Behavior (Sum of items 1-3). Mood and Subjective subscale scores range from 4 to 28; Somatic subscale scores range from 6 to 36; Behavior subscale scores range from 3 to 21.|units on a scale|Mean|16.1|16.1|Standard Deviation|3.59|3.59|||
4153805|NCT00849901|3977532|B2|Mood||CDRS-R Subscale Scores|CDRS-R Subscale score include Mood (Sum of items 8, 11, 14, 15), Somatic (Sum of items 4-7, 16, 17), Subjective (Sum of items 9, 10, 12, 13) and Behavior (Sum of items 1-3). Mood and Subjective subscale scores range from 4 to 28; Somatic subscale scores range from 6 to 36; Behavior subscale scores range from 3 to 21.|units on a scale|Mean|15.9|15.9|Standard Deviation|3.85|3.85|||
4153806|NCT00849901|3977533|B1|Mood||CDRS-R Subscale Scores|CDRS-R Subscale score include Mood (Sum of items 8, 11, 14, 15), Somatic (Sum of items 4-7, 16, 17), Subjective (Sum of items 9, 10, 12, 13) and Behavior (Sum of items 1-3). Mood and Subjective subscale scores range from 4 to 28; Somatic subscale scores range from 6 to 36; Behavior subscale scores range from 3 to 21.|units on a scale|Mean|16.3|16.3|Standard Deviation|3.54|3.54|||
4153807|NCT00849901|3977530|B4|||Children's Depression Rating Scale-Revised (CDRS-R) Total Score|CDRS-R Total score measure the presence and severity of depression in children. The scale consists of 17 items scored on a 1-to-5- or 1-to-7-point scale. A rating of 1 indicates normal functioning. Total scores range from 17 to 113. In general, scores below 20 indicate an absence of depression, scores of 20 to 30 indicate borderline depression, and scores of 40 to 60 indicate moderate depression.|units on a scale|Mean|59.4|59.4|Standard Deviation|10.85|10.85|||
4153808|NCT00849901|3977531|B3|||Children's Depression Rating Scale-Revised (CDRS-R) Total Score|CDRS-R Total score measure the presence and severity of depression in children. The scale consists of 17 items scored on a 1-to-5- or 1-to-7-point scale. A rating of 1 indicates normal functioning. Total scores range from 17 to 113. In general, scores below 20 indicate an absence of depression, scores of 20 to 30 indicate borderline depression, and scores of 40 to 60 indicate moderate depression.|units on a scale|Mean|60.2|60.2|Standard Deviation|11.67|11.67|||
4153809|NCT00849901|3977532|B2|||Children's Depression Rating Scale-Revised (CDRS-R) Total Score|CDRS-R Total score measure the presence and severity of depression in children. The scale consists of 17 items scored on a 1-to-5- or 1-to-7-point scale. A rating of 1 indicates normal functioning. Total scores range from 17 to 113. In general, scores below 20 indicate an absence of depression, scores of 20 to 30 indicate borderline depression, and scores of 40 to 60 indicate moderate depression.|units on a scale|Mean|58.8|58.8|Standard Deviation|10.56|10.56|||
4153810|NCT00849901|3977533|B1|||Children's Depression Rating Scale-Revised (CDRS-R) Total Score|CDRS-R Total score measure the presence and severity of depression in children. The scale consists of 17 items scored on a 1-to-5- or 1-to-7-point scale. A rating of 1 indicates normal functioning. Total scores range from 17 to 113. In general, scores below 20 indicate an absence of depression, scores of 20 to 30 indicate borderline depression, and scores of 40 to 60 indicate moderate depression.|units on a scale|Mean|59.2|59.2|Standard Deviation|10.45|10.45|||
4153811|NCT00849901|3977530|B4|South Africa||Region of Enrollment||participants|Number|67|67.0||||||
4153812|NCT00849901|3977531|B3|South Africa||Region of Enrollment||participants|Number|22|22.0||||||
4153813|NCT00849901|3977532|B2|South Africa||Region of Enrollment||participants|Number|24|24.0||||||
4153814|NCT00849901|3977533|B1|South Africa||Region of Enrollment||participants|Number|21|21.0||||||
4153815|NCT00849901|3977530|B4|Estonia||Region of Enrollment||participants|Number|1|1.0||||||
4153816|NCT00849901|3977531|B3|Estonia||Region of Enrollment||participants|Number|0|0.0||||||
4153817|NCT00849901|3977532|B2|Estonia||Region of Enrollment||participants|Number|0|0.0||||||
4153818|NCT00849901|3977533|B1|Estonia||Region of Enrollment||participants|Number|1|1.0||||||
4153819|NCT00849901|3977530|B4|Russian Federation||Region of Enrollment||participants|Number|40|40.0||||||
4153820|NCT00849901|3977531|B3|Russian Federation||Region of Enrollment||participants|Number|12|12.0||||||
4153821|NCT00849901|3977532|B2|Russian Federation||Region of Enrollment||participants|Number|15|15.0||||||
4153822|NCT00849901|3977533|B1|Russian Federation||Region of Enrollment||participants|Number|13|13.0||||||
4153823|NCT00849901|3977530|B4|Ukraine||Region of Enrollment||participants|Number|66|66.0||||||
4153824|NCT00849901|3977531|B3|Ukraine||Region of Enrollment||participants|Number|18|18.0||||||
4153826|NCT00849901|3977533|B1|Ukraine||Region of Enrollment||participants|Number|25|25.0||||||
4153827|NCT00849901|3977530|B4|Slovakia||Region of Enrollment||participants|Number|6|6.0||||||
4153828|NCT00849901|3977531|B3|Slovakia||Region of Enrollment||participants|Number|1|1.0||||||
4153829|NCT00849901|3977532|B2|Slovakia||Region of Enrollment||participants|Number|3|3.0||||||
4153830|NCT00849901|3977533|B1|Slovakia||Region of Enrollment||participants|Number|2|2.0||||||
4153831|NCT00849901|3977530|B4|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4153832|NCT00849901|3977531|B3|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4153833|NCT00849901|3977532|B2|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4153834|NCT00849901|3977533|B1|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4153835|NCT00849901|3977530|B4|France||Region of Enrollment||participants|Number|8|8.0||||||
4153836|NCT00849901|3977531|B3|France||Region of Enrollment||participants|Number|3|3.0||||||
4153837|NCT00849901|3977532|B2|France||Region of Enrollment||participants|Number|2|2.0||||||
4153838|NCT00849901|3977533|B1|France||Region of Enrollment||participants|Number|3|3.0||||||
4153839|NCT00849901|3977530|B4|Finland||Region of Enrollment||participants|Number|5|5.0||||||
4153840|NCT00849901|3977531|B3|Finland||Region of Enrollment||participants|Number|0|0.0||||||
4153841|NCT00849901|3977532|B2|Finland||Region of Enrollment||participants|Number|4|4.0||||||
4153842|NCT00849901|3977533|B1|Finland||Region of Enrollment||participants|Number|1|1.0||||||
4153843|NCT00849901|3977530|B4|United States||Region of Enrollment||participants|Number|140|140.0||||||
4153844|NCT00849901|3977531|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
4153845|NCT00849901|3977532|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
4153846|NCT00849901|3977533|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4153847|NCT00849901|3977530|B4|Not Provided||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4153848|NCT00849901|3977531|B3|Not Provided||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4153849|NCT00849901|3977532|B2|Not Provided||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4153850|NCT00849901|3977533|B1|Not Provided||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4153851|NCT00849901|3977530|B4|Multiracial||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4153852|NCT00849901|3977531|B3|Multiracial||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4153853|NCT00849901|3977532|B2|Multiracial||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4153854|NCT00849901|3977533|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4153855|NCT00849901|3977530|B4|White||Race/Ethnicity, Customized||participants|Number|262|262.0||||||
4153856|NCT00849901|3977531|B3|White||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
4153857|NCT00849901|3977532|B2|White||Race/Ethnicity, Customized||participants|Number|93|93.0||||||
4153858|NCT00849901|3977533|B1|White||Race/Ethnicity, Customized||participants|Number|90|90.0||||||
4153859|NCT00849901|3977530|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4153860|NCT00849901|3977531|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4153861|NCT00849901|3977532|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4153862|NCT00849901|3977533|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4153863|NCT00849901|3977530|B4|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4153864|NCT00849901|3977531|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4153865|NCT00849901|3977532|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4153866|NCT00849901|3977533|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4153867|NCT00849901|3977530|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4153868|NCT00849901|3977531|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4153869|NCT00849901|3977532|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4153870|NCT00849901|3977533|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4153871|NCT00849901|3977530|B4||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4153872|NCT00849901|3977531|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4153873|NCT00849901|3977532|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4153874|NCT00849901|3977533|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4153875|NCT00849901|3977530|B4||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4153876|NCT00849901|3977531|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4153877|NCT00849901|3977532|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4153878|NCT00849901|3977533|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4153879|NCT00849901|3977530|B4|||Age||years|Mean|13.16|13.16|Standard Deviation|3.120|3.12|||
4153880|NCT00849901|3977531|B3|||Age||years|Mean|13.28|13.28|Standard Deviation|3.055|3.055|||
4153881|NCT00849901|3977532|B2|||Age||years|Mean|13.08|13.08|Standard Deviation|3.272|3.272|||
4153882|NCT00849901|3977533|B1|||Age||years|Mean|13.14|13.14|Standard Deviation|3.043|3.043|||
4153883|NCT00849875|3977579|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4153884|NCT00849875|3977580|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4153885|NCT00849875|3977581|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4153886|NCT00849875|3977582|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4153887|NCT00849875|3977579|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4153888|NCT00849875|3977580|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4153889|NCT00849875|3977581|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4153890|NCT00849875|3977582|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4153891|NCT00849875|3977579|B4|||Age||Years|Mean|55.44|55.44|Standard Deviation|15.99|15.99|||
4153892|NCT00849875|3977580|B3|||Age||Years|Mean|66|66.0|Standard Deviation|0|0.0|||
4153893|NCT00849875|3977581|B2|||Age||Years|Mean|56.1|56.1|Standard Deviation|18|18.0|||
4153894|NCT00849875|3977582|B1|||Age||Years|Mean|54.8|54.8|Standard Deviation|15.4|15.4|||
4153895|NCT00849862|3977662|B3|Canada||Region of Enrollment||participants|Number|22|22.0||||||
4153896|NCT00849862|3977663|B2|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4153897|NCT00849862|3977664|B1|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4153898|NCT00849862|3977662|B3|American Hispanic||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4153899|NCT00849862|3977663|B2|American Hispanic||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4153900|NCT00849862|3977664|B1|American Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4153901|NCT00849862|3977662|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
4153902|NCT00849862|3977663|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4153903|NCT00849862|3977664|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4153904|NCT00849862|3977662|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4153905|NCT00849862|3977663|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4153906|NCT00849862|3977664|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4153907|NCT00849862|3977662|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4153908|NCT00849862|3977663|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4153909|NCT00849862|3977664|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4153910|NCT00849862|3977662|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153911|NCT00849862|3977663|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153912|NCT00849862|3977664|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153913|NCT00849862|3977662|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4153914|NCT00849862|3977663|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4153915|NCT00849862|3977664|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4153916|NCT00849862|3977662|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4153917|NCT00849862|3977663|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4153918|NCT00849862|3977664|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4153919|NCT00849810|3977673|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4153920|NCT00849810|3977673|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4153921|NCT00849810|3977673|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4153922|NCT00849810|3977673|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4153923|NCT00849810|3977673|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4153924|NCT00849810|3977673|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4153925|NCT00849797|3977677|B3|Canada||Region of Enrollment||participants|Number|120|120.0||||||
4153926|NCT00849797|3977678|B2|Canada||Region of Enrollment||participants|Number|60|60.0||||||
4153927|NCT00849797|3977679|B1|Canada||Region of Enrollment||participants|Number|60|60.0||||||
4153928|NCT00849797|3977677|B3|Black||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4153929|NCT00849797|3977678|B2|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4153930|NCT00849797|3977679|B1|Black||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4153931|NCT00849797|3977677|B3|American Hispanic||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4153932|NCT00849797|3977678|B2|American Hispanic||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4153933|NCT00849797|3977679|B1|American Hispanic||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4153934|NCT00849797|3977677|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|99|99.0||||||
4153935|NCT00849797|3977678|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|51|51.0||||||
4153936|NCT00849797|3977679|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|48|48.0||||||
4153937|NCT00849797|3977677|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4153938|NCT00849797|3977678|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4153939|NCT00849797|3977679|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4153940|NCT00849797|3977677|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4153941|NCT00849797|3977678|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4153942|NCT00849797|3977679|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4153943|NCT00849797|3977677|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4153944|NCT00849797|3977678|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4153945|NCT00849797|3977679|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4153946|NCT00849797|3977677|B3||Between 18 and 65 years|Age||Participants|Count of Participants|114|114.0||||||
4153947|NCT00849797|3977678|B2||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4153948|NCT00849797|3977679|B1||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4153949|NCT00849797|3977677|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4153950|NCT00849797|3977678|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4153951|NCT00849797|3977679|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4153952|NCT00849693|3977694|B5|||Clinical Global Impressions of Severity (CGI-Severity) score|CGI-Severity score evaluates the severity of illness at the time of assessment. The score ranges from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|4.6|4.6|Standard Deviation|0.63|0.63|||
4153953|NCT00849693|3977695|B4|||Clinical Global Impressions of Severity (CGI-Severity) score|CGI-Severity score evaluates the severity of illness at the time of assessment. The score ranges from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|4.5|4.5|Standard Deviation|0.63|0.63|||
4153954|NCT00849693|3977696|B3|||Clinical Global Impressions of Severity (CGI-Severity) score|CGI-Severity score evaluates the severity of illness at the time of assessment. The score ranges from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|4.6|4.6|Standard Deviation|0.59|0.59|||
4153955|NCT00849693|3977697|B2|||Clinical Global Impressions of Severity (CGI-Severity) score|CGI-Severity score evaluates the severity of illness at the time of assessment. The score ranges from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|4.6|4.6|Standard Deviation|0.65|0.65|||
4153956|NCT00849693|3977698|B1|||Clinical Global Impressions of Severity (CGI-Severity) score|CGI-Severity score evaluates the severity of illness at the time of assessment. The score ranges from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|4.6|4.6|Standard Deviation|0.65|0.65|||
4153957|NCT00849693|3977694|B5|Behavior||CDRS-R Subscale Scores|CDRS-R Subscale score include Mood (Sum of items 8, 11, 14, 15), Somatic (Sum of items 4-7, 16, 17), Subjective (Sum of items 9, 10, 12, 13) and Behavior (Sum of items 1-3). Mood and Subjective subscale scores range from 4 to 28; Somatic subscale scores range from 6 to 36; Behavior subscale scores range from 3 to 21.|units on a scale|Mean|12.8|12.8|Standard Deviation|3.12|3.12|||
4153958|NCT00849693|3977695|B4|Behavior||CDRS-R Subscale Scores|CDRS-R Subscale score include Mood (Sum of items 8, 11, 14, 15), Somatic (Sum of items 4-7, 16, 17), Subjective (Sum of items 9, 10, 12, 13) and Behavior (Sum of items 1-3). Mood and Subjective subscale scores range from 4 to 28; Somatic subscale scores range from 6 to 36; Behavior subscale scores range from 3 to 21.|units on a scale|Mean|12.6|12.6|Standard Deviation|3.14|3.14|||
4153959|NCT00849693|3977696|B3|Behavior||CDRS-R Subscale Scores|CDRS-R Subscale score include Mood (Sum of items 8, 11, 14, 15), Somatic (Sum of items 4-7, 16, 17), Subjective (Sum of items 9, 10, 12, 13) and Behavior (Sum of items 1-3). Mood and Subjective subscale scores range from 4 to 28; Somatic subscale scores range from 6 to 36; Behavior subscale scores range from 3 to 21.|units on a scale|Mean|12.7|12.7|Standard Deviation|3.12|3.12|||
4153960|NCT00849693|3977697|B2|Behavior||CDRS-R Subscale Scores|CDRS-R Subscale score include Mood (Sum of items 8, 11, 14, 15), Somatic (Sum of items 4-7, 16, 17), Subjective (Sum of items 9, 10, 12, 13) and Behavior (Sum of items 1-3). Mood and Subjective subscale scores range from 4 to 28; Somatic subscale scores range from 6 to 36; Behavior subscale scores range from 3 to 21.|units on a scale|Mean|13.1|13.1|Standard Deviation|3.19|3.19|||
4153961|NCT00849693|3977698|B1|Behavior||CDRS-R Subscale Scores|CDRS-R Subscale score include Mood (Sum of items 8, 11, 14, 15), Somatic (Sum of items 4-7, 16, 17), Subjective (Sum of items 9, 10, 12, 13) and Behavior (Sum of items 1-3). Mood and Subjective subscale scores range from 4 to 28; Somatic subscale scores range from 6 to 36; Behavior subscale scores range from 3 to 21.|units on a scale|Mean|13.0|13.0|Standard Deviation|3.04|3.04|||
4153962|NCT00849693|3977694|B5|Subjective||CDRS-R Subscale Scores|CDRS-R Subscale score include Mood (Sum of items 8, 11, 14, 15), Somatic (Sum of items 4-7, 16, 17), Subjective (Sum of items 9, 10, 12, 13) and Behavior (Sum of items 1-3). Mood and Subjective subscale scores range from 4 to 28; Somatic subscale scores range from 6 to 36; Behavior subscale scores range from 3 to 21.|units on a scale|Mean|10.2|10.2|Standard Deviation|3.32|3.32|||
4153963|NCT00849693|3977695|B4|Subjective||CDRS-R Subscale Scores|CDRS-R Subscale score include Mood (Sum of items 8, 11, 14, 15), Somatic (Sum of items 4-7, 16, 17), Subjective (Sum of items 9, 10, 12, 13) and Behavior (Sum of items 1-3). Mood and Subjective subscale scores range from 4 to 28; Somatic subscale scores range from 6 to 36; Behavior subscale scores range from 3 to 21.|units on a scale|Mean|10.0|10.0|Standard Deviation|2.79|2.79|||
4153964|NCT00849693|3977696|B3|Subjective||CDRS-R Subscale Scores|CDRS-R Subscale score include Mood (Sum of items 8, 11, 14, 15), Somatic (Sum of items 4-7, 16, 17), Subjective (Sum of items 9, 10, 12, 13) and Behavior (Sum of items 1-3). Mood and Subjective subscale scores range from 4 to 28; Somatic subscale scores range from 6 to 36; Behavior subscale scores range from 3 to 21.|units on a scale|Mean|10.0|10.0|Standard Deviation|3.35|3.35|||
4153965|NCT00849693|3977697|B2|Subjective||CDRS-R Subscale Scores|CDRS-R Subscale score include Mood (Sum of items 8, 11, 14, 15), Somatic (Sum of items 4-7, 16, 17), Subjective (Sum of items 9, 10, 12, 13) and Behavior (Sum of items 1-3). Mood and Subjective subscale scores range from 4 to 28; Somatic subscale scores range from 6 to 36; Behavior subscale scores range from 3 to 21.|units on a scale|Mean|10.6|10.6|Standard Deviation|3.60|3.6|||
4153966|NCT00849693|3977698|B1|Subjective||CDRS-R Subscale Scores|CDRS-R Subscale score include Mood (Sum of items 8, 11, 14, 15), Somatic (Sum of items 4-7, 16, 17), Subjective (Sum of items 9, 10, 12, 13) and Behavior (Sum of items 1-3). Mood and Subjective subscale scores range from 4 to 28; Somatic subscale scores range from 6 to 36; Behavior subscale scores range from 3 to 21.|units on a scale|Mean|10.1|10.1|Standard Deviation|3.51|3.51|||
4153967|NCT00849693|3977694|B5|Somatic||CDRS-R Subscale Scores|CDRS-R Subscale score include Mood (Sum of items 8, 11, 14, 15), Somatic (Sum of items 4-7, 16, 17), Subjective (Sum of items 9, 10, 12, 13) and Behavior (Sum of items 1-3). Mood and Subjective subscale scores range from 4 to 28; Somatic subscale scores range from 6 to 36; Behavior subscale scores range from 3 to 21.|units on a scale|Mean|19.5|19.5|Standard Deviation|4.57|4.57|||
4153968|NCT00849693|3977695|B4|Somatic||CDRS-R Subscale Scores|CDRS-R Subscale score include Mood (Sum of items 8, 11, 14, 15), Somatic (Sum of items 4-7, 16, 17), Subjective (Sum of items 9, 10, 12, 13) and Behavior (Sum of items 1-3). Mood and Subjective subscale scores range from 4 to 28; Somatic subscale scores range from 6 to 36; Behavior subscale scores range from 3 to 21.|units on a scale|Mean|19.5|19.5|Standard Deviation|4.28|4.28|||
4153992|NCT00849693|3977694|B5|Mexico||Region of Enrollment||participants|Number|74|74.0||||||
4153993|NCT00849693|3977695|B4|Mexico||Region of Enrollment||participants|Number|17|17.0||||||
4153969|NCT00849693|3977696|B3|Somatic||CDRS-R Subscale Scores|CDRS-R Subscale score include Mood (Sum of items 8, 11, 14, 15), Somatic (Sum of items 4-7, 16, 17), Subjective (Sum of items 9, 10, 12, 13) and Behavior (Sum of items 1-3). Mood and Subjective subscale scores range from 4 to 28; Somatic subscale scores range from 6 to 36; Behavior subscale scores range from 3 to 21.|units on a scale|Mean|19.3|19.3|Standard Deviation|4.60|4.6|||
4153970|NCT00849693|3977697|B2|Somatic||CDRS-R Subscale Scores|CDRS-R Subscale score include Mood (Sum of items 8, 11, 14, 15), Somatic (Sum of items 4-7, 16, 17), Subjective (Sum of items 9, 10, 12, 13) and Behavior (Sum of items 1-3). Mood and Subjective subscale scores range from 4 to 28; Somatic subscale scores range from 6 to 36; Behavior subscale scores range from 3 to 21.|units on a scale|Mean|19.7|19.7|Standard Deviation|4.87|4.87|||
4153971|NCT00849693|3977698|B1|Somatic||CDRS-R Subscale Scores|CDRS-R Subscale score include Mood (Sum of items 8, 11, 14, 15), Somatic (Sum of items 4-7, 16, 17), Subjective (Sum of items 9, 10, 12, 13) and Behavior (Sum of items 1-3). Mood and Subjective subscale scores range from 4 to 28; Somatic subscale scores range from 6 to 36; Behavior subscale scores range from 3 to 21.|units on a scale|Mean|19.6|19.6|Standard Deviation|4.58|4.58|||
4153972|NCT00849693|3977694|B5|Mood||CDRS-R Subscale Scores|CDRS-R Subscale score include Mood (Sum of items 8, 11, 14, 15), Somatic (Sum of items 4-7, 16, 17), Subjective (Sum of items 9, 10, 12, 13) and Behavior (Sum of items 1-3). Mood and Subjective subscale scores range from 4 to 28; Somatic subscale scores range from 6 to 36; Behavior subscale scores range from 3 to 21.|units on a scale|Mean|16.2|16.2|Standard Deviation|3.55|3.55|||
4153973|NCT00849693|3977695|B4|Mood||CDRS-R Subscale Scores|CDRS-R Subscale score include Mood (Sum of items 8, 11, 14, 15), Somatic (Sum of items 4-7, 16, 17), Subjective (Sum of items 9, 10, 12, 13) and Behavior (Sum of items 1-3). Mood and Subjective subscale scores range from 4 to 28; Somatic subscale scores range from 6 to 36; Behavior subscale scores range from 3 to 21.|units on a scale|Mean|16.0|16.0|Standard Deviation|3.38|3.38|||
4153974|NCT00849693|3977696|B3|Mood||CDRS-R Subscale Scores|CDRS-R Subscale score include Mood (Sum of items 8, 11, 14, 15), Somatic (Sum of items 4-7, 16, 17), Subjective (Sum of items 9, 10, 12, 13) and Behavior (Sum of items 1-3). Mood and Subjective subscale scores range from 4 to 28; Somatic subscale scores range from 6 to 36; Behavior subscale scores range from 3 to 21.|units on a scale|Mean|16.0|16.0|Standard Deviation|3.52|3.52|||
4153975|NCT00849693|3977697|B2|Mood||CDRS-R Subscale Scores|CDRS-R Subscale score include Mood (Sum of items 8, 11, 14, 15), Somatic (Sum of items 4-7, 16, 17), Subjective (Sum of items 9, 10, 12, 13) and Behavior (Sum of items 1-3). Mood and Subjective subscale scores range from 4 to 28; Somatic subscale scores range from 6 to 36; Behavior subscale scores range from 3 to 21.|units on a scale|Mean|16.4|16.4|Standard Deviation|3.64|3.64|||
4153976|NCT00849693|3977698|B1|Mood||CDRS-R Subscale Scores|CDRS-R Subscale score include Mood (Sum of items 8, 11, 14, 15), Somatic (Sum of items 4-7, 16, 17), Subjective (Sum of items 9, 10, 12, 13) and Behavior (Sum of items 1-3). Mood and Subjective subscale scores range from 4 to 28; Somatic subscale scores range from 6 to 36; Behavior subscale scores range from 3 to 21.|units on a scale|Mean|16.6|16.6|Standard Deviation|3.69|3.69|||
4153977|NCT00849693|3977694|B5|||Children's Depression Rating Scale-Revised (CDRS-R) Total Score|CDRS-R Total score measure the presence and severity of depression in children. The scale consists of 17 items scored on a 1-to-5- or 1-to-7-point scale. A rating of 1 indicates normal functioning. Total scores range from 17 to 113. In general, scores below 20 indicate an absence of depression, scores of 20 to 30 indicate borderline depression, and scores of 40 to 60 indicate moderate depression.|units on a scale|Mean|58.8|58.8|Standard Deviation|10.33|10.33|||
4153978|NCT00849693|3977695|B4|||Children's Depression Rating Scale-Revised (CDRS-R) Total Score|CDRS-R Total score measure the presence and severity of depression in children. The scale consists of 17 items scored on a 1-to-5- or 1-to-7-point scale. A rating of 1 indicates normal functioning. Total scores range from 17 to 113. In general, scores below 20 indicate an absence of depression, scores of 20 to 30 indicate borderline depression, and scores of 40 to 60 indicate moderate depression.|units on a scale|Mean|58.2|58.2|Standard Deviation|9.35|9.35|||
4153979|NCT00849693|3977696|B3|||Children's Depression Rating Scale-Revised (CDRS-R) Total Score|CDRS-R Total score measure the presence and severity of depression in children. The scale consists of 17 items scored on a 1-to-5- or 1-to-7-point scale. A rating of 1 indicates normal functioning. Total scores range from 17 to 113. In general, scores below 20 indicate an absence of depression, scores of 20 to 30 indicate borderline depression, and scores of 40 to 60 indicate moderate depression.|units on a scale|Mean|57.9|57.9|Standard Deviation|10.11|10.11|||
4153980|NCT00849693|3977697|B2|||Children's Depression Rating Scale-Revised (CDRS-R) Total Score|CDRS-R Total score measure the presence and severity of depression in children. The scale consists of 17 items scored on a 1-to-5- or 1-to-7-point scale. A rating of 1 indicates normal functioning. Total scores range from 17 to 113. In general, scores below 20 indicate an absence of depression, scores of 20 to 30 indicate borderline depression, and scores of 40 to 60 indicate moderate depression.|units on a scale|Mean|59.8|59.8|Standard Deviation|11.00|11.0|||
4153981|NCT00849693|3977698|B1|||Children's Depression Rating Scale-Revised (CDRS-R) Total Score|CDRS-R Total score measure the presence and severity of depression in children. The scale consists of 17 items scored on a 1-to-5- or 1-to-7-point scale. A rating of 1 indicates normal functioning. Total scores range from 17 to 113. In general, scores below 20 indicate an absence of depression, scores of 20 to 30 indicate borderline depression, and scores of 40 to 60 indicate moderate depression.|units on a scale|Mean|59.3|59.3|Standard Deviation|10.87|10.87|||
4153982|NCT00849693|3977694|B5|Argentina||Region of Enrollment||participants|Number|1|1.0||||||
4153983|NCT00849693|3977695|B4|Argentina||Region of Enrollment||participants|Number|0|0.0||||||
4153984|NCT00849693|3977696|B3|Argentina||Region of Enrollment||participants|Number|1|1.0||||||
4153985|NCT00849693|3977697|B2|Argentina||Region of Enrollment||participants|Number|0|0.0||||||
4153986|NCT00849693|3977698|B1|Argentina||Region of Enrollment||participants|Number|0|0.0||||||
4153987|NCT00849693|3977694|B5|Canada||Region of Enrollment||participants|Number|24|24.0||||||
4153988|NCT00849693|3977695|B4|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4153989|NCT00849693|3977696|B3|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4153990|NCT00849693|3977697|B2|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4153991|NCT00849693|3977698|B1|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4153994|NCT00849693|3977696|B3|Mexico||Region of Enrollment||participants|Number|16|16.0||||||
4153995|NCT00849693|3977697|B2|Mexico||Region of Enrollment||participants|Number|25|25.0||||||
4153996|NCT00849693|3977698|B1|Mexico||Region of Enrollment||participants|Number|16|16.0||||||
4153997|NCT00849693|3977694|B5|United States||Region of Enrollment||participants|Number|364|364.0||||||
4153998|NCT00849693|3977695|B4|United States||Region of Enrollment||participants|Number|98|98.0||||||
4153999|NCT00849693|3977696|B3|United States||Region of Enrollment||participants|Number|93|93.0||||||
4154000|NCT00849693|3977697|B2|United States||Region of Enrollment||participants|Number|86|86.0||||||
4154001|NCT00849693|3977698|B1|United States||Region of Enrollment||participants|Number|87|87.0||||||
4154002|NCT00849693|3977694|B5|Not Provided||Race/Ethnicity, Customized||Participant|Number|15|15.0||||||
4154003|NCT00849693|3977695|B4|Not Provided||Race/Ethnicity, Customized||Participant|Number|3|3.0||||||
4154004|NCT00849693|3977696|B3|Not Provided||Race/Ethnicity, Customized||Participant|Number|3|3.0||||||
4154005|NCT00849693|3977697|B2|Not Provided||Race/Ethnicity, Customized||Participant|Number|3|3.0||||||
4154006|NCT00849693|3977698|B1|Not Provided||Race/Ethnicity, Customized||Participant|Number|6|6.0||||||
4154007|NCT00849693|3977694|B5|Multiracial||Race/Ethnicity, Customized||Participant|Number|34|34.0||||||
4154008|NCT00849693|3977695|B4|Multiracial||Race/Ethnicity, Customized||Participant|Number|13|13.0||||||
4154009|NCT00849693|3977696|B3|Multiracial||Race/Ethnicity, Customized||Participant|Number|9|9.0||||||
4154010|NCT00849693|3977697|B2|Multiracial||Race/Ethnicity, Customized||Participant|Number|6|6.0||||||
4154011|NCT00849693|3977698|B1|Multiracial||Race/Ethnicity, Customized||Participant|Number|6|6.0||||||
4154012|NCT00849693|3977694|B5|White||Race/Ethnicity, Customized||Participant|Number|244|244.0||||||
4154013|NCT00849693|3977695|B4|White||Race/Ethnicity, Customized||Participant|Number|62|62.0||||||
4154014|NCT00849693|3977696|B3|White||Race/Ethnicity, Customized||Participant|Number|67|67.0||||||
4154015|NCT00849693|3977697|B2|White||Race/Ethnicity, Customized||Participant|Number|61|61.0||||||
4154016|NCT00849693|3977698|B1|White||Race/Ethnicity, Customized||Participant|Number|54|54.0||||||
4154017|NCT00849693|3977694|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participant|Number|1|1.0||||||
4154018|NCT00849693|3977695|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participant|Number|0|0.0||||||
4154019|NCT00849693|3977696|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participant|Number|0|0.0||||||
4154020|NCT00849693|3977697|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participant|Number|1|1.0||||||
4154021|NCT00849693|3977698|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participant|Number|0|0.0||||||
4154022|NCT00849693|3977694|B5|Black or African American||Race/Ethnicity, Customized||Participant|Number|93|93.0||||||
4154023|NCT00849693|3977695|B4|Black or African American||Race/Ethnicity, Customized||Participant|Number|24|24.0||||||
4154024|NCT00849693|3977696|B3|Black or African American||Race/Ethnicity, Customized||Participant|Number|21|21.0||||||
4154025|NCT00849693|3977697|B2|Black or African American||Race/Ethnicity, Customized||Participant|Number|21|21.0||||||
4154026|NCT00849693|3977698|B1|Black or African American||Race/Ethnicity, Customized||Participant|Number|27|27.0||||||
4154027|NCT00849693|3977694|B5|Asian||Race/Ethnicity, Customized||Participant|Number|3|3.0||||||
4154028|NCT00849693|3977695|B4|Asian||Race/Ethnicity, Customized||Participant|Number|1|1.0||||||
4154029|NCT00849693|3977696|B3|Asian||Race/Ethnicity, Customized||Participant|Number|1|1.0||||||
4154030|NCT00849693|3977697|B2|Asian||Race/Ethnicity, Customized||Participant|Number|1|1.0||||||
4154031|NCT00849693|3977698|B1|Asian||Race/Ethnicity, Customized||Participant|Number|0|0.0||||||
4154032|NCT00849693|3977694|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participant|Number|73|73.0||||||
4154033|NCT00849693|3977695|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participant|Number|19|19.0||||||
4154034|NCT00849693|3977696|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participant|Number|16|16.0||||||
4154035|NCT00849693|3977697|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participant|Number|23|23.0||||||
4154036|NCT00849693|3977698|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participant|Number|15|15.0||||||
4154037|NCT00849693|3977694|B5||Male|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
4154038|NCT00849693|3977695|B4||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4154039|NCT00849693|3977696|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4154040|NCT00849693|3977697|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4154041|NCT00849693|3977698|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4154042|NCT00849693|3977694|B5||Female|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
4154043|NCT00849693|3977695|B4||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4154044|NCT00849693|3977696|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4154045|NCT00849693|3977697|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4154046|NCT00849693|3977698|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4154047|NCT00849693|3977694|B5|||Age||years|Mean|12.98|12.98|Standard Deviation|2.977|2.977|||
4154048|NCT00849693|3977695|B4|||Age||years|Mean|13.09|13.09|Standard Deviation|2.895|2.895|||
4154049|NCT00849693|3977696|B3|||Age||years|Mean|13.04|13.04|Standard Deviation|3.205|3.205|||
4154050|NCT00849693|3977697|B2|||Age||years|Mean|12.86|12.86|Standard Deviation|2.904|2.904|||
4154051|NCT00849693|3977698|B1|||Age||years|Mean|12.92|12.92|Standard Deviation|2.925|2.925|||
4154052|NCT00849680|3977760|B9|United States||Region of Enrollment||participants|Number|317|317.0||||||
4154053|NCT00849680|3977761|B8|United States||Region of Enrollment||participants|Number|31|31.0||||||
4154054|NCT00849680|3977762|B7|United States||Region of Enrollment||participants|Number|78|78.0||||||
4154055|NCT00849680|3977763|B6|United States||Region of Enrollment||participants|Number|42|42.0||||||
4154056|NCT00849680|3977764|B5|United States||Region of Enrollment||participants|Number|42|42.0||||||
4154057|NCT00849680|3977765|B4|United States||Region of Enrollment||participants|Number|42|42.0||||||
4154058|NCT00849680|3977766|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4154059|NCT00849680|3977767|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4154060|NCT00849680|3977768|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4154061|NCT00849680|3977760|B9||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4154062|NCT00849680|3977761|B8||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4154063|NCT00849680|3977762|B7||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4154064|NCT00849680|3977763|B6||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4154065|NCT00849680|3977764|B5||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4154066|NCT00849680|3977765|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4154067|NCT00849680|3977766|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4154068|NCT00849680|3977767|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4154069|NCT00849680|3977768|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4154070|NCT00849680|3977760|B9||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4154071|NCT00849680|3977761|B8||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4154072|NCT00849680|3977762|B7||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4154073|NCT00849680|3977763|B6||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4154074|NCT00849680|3977764|B5||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4154075|NCT00849680|3977765|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4154076|NCT00849680|3977766|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4154077|NCT00849680|3977767|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4154078|NCT00849680|3977768|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4154079|NCT00849680|3977760|B9|||Age, Customized||Years|Mean|34.0|34.0|Full Range|||18.0|50.0|
4154080|NCT00849680|3977761|B8|||Age, Customized||Years|Mean|34.8|34.8|Full Range|||19.0|50.0|
4154081|NCT00849680|3977762|B7|||Age, Customized||Years|Mean|35.7|35.7|Full Range|||19.0|50.0|
4154082|NCT00849680|3977763|B6|||Age, Customized||Years|Mean|34.0|34.0|Full Range|||18.0|50.0|
4154083|NCT00849680|3977764|B5|||Age, Customized||Years|Mean|33.3|33.3|Full Range|||18.0|50.0|
4154084|NCT00849680|3977765|B4|||Age, Customized||Years|Mean|32.6|32.6|Full Range|||19.0|50.0|
4154085|NCT00849680|3977766|B3|||Age, Customized||Years|Mean|33.2|33.2|Full Range|||19.0|50.0|
4154086|NCT00849680|3977767|B2|||Age, Customized||Years|Mean|34.3|34.3|Full Range|||18.0|46.0|
4154087|NCT00849680|3977768|B1|||Age, Customized||Years|Mean|32.4|32.4|Full Range|||19.0|50.0|
4154088|NCT00849524|3977817|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4154089|NCT00849524|3977817|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4154090|NCT00849524|3977817|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4154091|NCT00849524|3977817|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4154092|NCT00849524|3977817|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4154093|NCT00849524|3977817|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154094|NCT00849485|3977823|B3|Canada||Region of Enrollment||participants|Number|22|22.0||||||
4154095|NCT00849485|3977824|B2|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4154096|NCT00849485|3977825|B1|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4154097|NCT00849485|3977823|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4154098|NCT00849485|3977824|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4154099|NCT00849485|3977825|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4154100|NCT00849485|3977823|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4154101|NCT00849485|3977824|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4154102|NCT00849485|3977825|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4154103|NCT00849485|3977823|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4154104|NCT00849485|3977824|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4154105|NCT00849485|3977825|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4154106|NCT00849485|3977823|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4154107|NCT00849485|3977824|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4154108|NCT00849485|3977825|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4154109|NCT00849485|3977823|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4154110|NCT00849485|3977824|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4154111|NCT00849485|3977825|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4154112|NCT00849485|3977823|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154113|NCT00849485|3977824|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154114|NCT00849485|3977825|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154227|NCT00849108|3977909|B1|North America||Region of Enrollment||participants|Number|33|33.0||||||
4154115|NCT00849472|3977834|B1|Negative||Number of participants with the indicted hormonal status (ER+ and PR+ / ER- and PR-)|BC data are reported for members of the Treated Population. Estrogen causes certain breast cancers (called ER+ cancers) to grow; these cancer cells have ERs on their surfaces. ER+ and PR+ indicate ER and PR positivity; a minus sign indicates that cells are negative for receptors. A participant's hormone status determines treatment modalities.|participants|Number|27|27.0||||||
4154116|NCT00849472|3977834|B1|Positive||Number of participants with the indicted hormonal status (ER+ and PR+ / ER- and PR-)|BC data are reported for members of the Treated Population. Estrogen causes certain breast cancers (called ER+ cancers) to grow; these cancer cells have ERs on their surfaces. ER+ and PR+ indicate ER and PR positivity; a minus sign indicates that cells are negative for receptors. A participant's hormone status determines treatment modalities.|participants|Number|74|74.0||||||
4154117|NCT00849472|3977834|B1|HER-2/NEU status equivocal (uncertain)||Number of participants with a positive or negative status for the indicated hormone receptors|Baseline Characteristic (BC) data are reported for members of the Treated Population. Receptor status is used to determine a course of treatment. Participants with hormone-receptor positive tumors could have been treated with hormonal therapy. Human epidermal growth factor receptor-2 (HER-2) is also known as NEU. Each participant was to be assessed for each tumor hormone receptor.|participants|Number|1|1.0||||||
4154118|NCT00849472|3977834|B1|HER-2/NEU status negative||Number of participants with a positive or negative status for the indicated hormone receptors|Baseline Characteristic (BC) data are reported for members of the Treated Population. Receptor status is used to determine a course of treatment. Participants with hormone-receptor positive tumors could have been treated with hormonal therapy. Human epidermal growth factor receptor-2 (HER-2) is also known as NEU. Each participant was to be assessed for each tumor hormone receptor.|participants|Number|99|99.0||||||
4154119|NCT00849472|3977834|B1|HER-2/NEU status positive||Number of participants with a positive or negative status for the indicated hormone receptors|Baseline Characteristic (BC) data are reported for members of the Treated Population. Receptor status is used to determine a course of treatment. Participants with hormone-receptor positive tumors could have been treated with hormonal therapy. Human epidermal growth factor receptor-2 (HER-2) is also known as NEU. Each participant was to be assessed for each tumor hormone receptor.|participants|Number|1|1.0||||||
4154120|NCT00849472|3977834|B1|PgR status negative||Number of participants with a positive or negative status for the indicated hormone receptors|Baseline Characteristic (BC) data are reported for members of the Treated Population. Receptor status is used to determine a course of treatment. Participants with hormone-receptor positive tumors could have been treated with hormonal therapy. Human epidermal growth factor receptor-2 (HER-2) is also known as NEU. Each participant was to be assessed for each tumor hormone receptor.|participants|Number|39|39.0||||||
4154121|NCT00849472|3977834|B1|Progesterone receptor (PgR) status positive||Number of participants with a positive or negative status for the indicated hormone receptors|Baseline Characteristic (BC) data are reported for members of the Treated Population. Receptor status is used to determine a course of treatment. Participants with hormone-receptor positive tumors could have been treated with hormonal therapy. Human epidermal growth factor receptor-2 (HER-2) is also known as NEU. Each participant was to be assessed for each tumor hormone receptor.|participants|Number|62|62.0||||||
4154122|NCT00849472|3977834|B1|ER status negative||Number of participants with a positive or negative status for the indicated hormone receptors|Baseline Characteristic (BC) data are reported for members of the Treated Population. Receptor status is used to determine a course of treatment. Participants with hormone-receptor positive tumors could have been treated with hormonal therapy. Human epidermal growth factor receptor-2 (HER-2) is also known as NEU. Each participant was to be assessed for each tumor hormone receptor.|participants|Number|28|28.0||||||
4154123|NCT00849472|3977834|B1|Estrogen receptor (ER) status positive||Number of participants with a positive or negative status for the indicated hormone receptors|Baseline Characteristic (BC) data are reported for members of the Treated Population. Receptor status is used to determine a course of treatment. Participants with hormone-receptor positive tumors could have been treated with hormonal therapy. Human epidermal growth factor receptor-2 (HER-2) is also known as NEU. Each participant was to be assessed for each tumor hormone receptor.|participants|Number|73|73.0||||||
4154124|NCT00849472|3977834|B1|AI or AN + White - W/C/EH||Race/Ethnicity, Customized|Baseline Characteristic data are reported for members of the Treated Population, comprised of all participants who entered the study and received at least one dose of any study medication.|participants|Number|1|1.0||||||
4154125|NCT00849472|3977834|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized|Baseline Characteristic data are reported for members of the Treated Population, comprised of all participants who entered the study and received at least one dose of any study medication.|participants|Number|1|1.0||||||
4154126|NCT00849472|3977834|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Baseline Characteristic data are reported for members of the Treated Population, comprised of all participants who entered the study and received at least one dose of any study medication.|participants|Number|1|1.0||||||
4154127|NCT00849472|3977834|B1|American Indian (AI) or Alaskan Native (AN)||Race/Ethnicity, Customized|Baseline Characteristic data are reported for members of the Treated Population, comprised of all participants who entered the study and received at least one dose of any study medication.|participants|Number|1|1.0||||||
4154128|NCT00849472|3977834|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Baseline Characteristic data are reported for members of the Treated Population, comprised of all participants who entered the study and received at least one dose of any study medication.|participants|Number|3|3.0||||||
4154129|NCT00849472|3977834|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized|Baseline Characteristic data are reported for members of the Treated Population, comprised of all participants who entered the study and received at least one dose of any study medication.|participants|Number|3|3.0||||||
4154130|NCT00849472|3977834|B1|African American/African Heritage||Race/Ethnicity, Customized|Baseline Characteristic data are reported for members of the Treated Population, comprised of all participants who entered the study and received at least one dose of any study medication.|participants|Number|10|10.0||||||
4154131|NCT00849472|3977834|B1|White - White/Caucasian/European Heritage (W/C/EH)||Race/Ethnicity, Customized|Baseline Characteristic data are reported for members of the Treated Population, comprised of all participants who entered the study and received at least one dose of any study medication.|participants|Number|81|81.0||||||
4154132|NCT00849472|3977834|B1||Male|Sex: Female, Male|Baseline Characteristic data are reported for members of the Treated Population, comprised of all participants who entered the study and received at least one dose of any study medication.|Participants|Count of Participants|0|0.0||||||
4154133|NCT00849472|3977834|B1||Female|Sex: Female, Male|Baseline Characteristic data are reported for members of the Treated Population, comprised of all participants who entered the study and received at least one dose of any study medication.|Participants|Count of Participants|101|101.0||||||
4154134|NCT00849472|3977834|B1|||Age|Baseline Characteristic data are reported for members of the Treated Population, comprised of all participants who entered the study and received at least one dose of any study medication.|Years|Mean|50.9|50.9|Standard Deviation|9.72|9.72|||
4154135|NCT00849381|3977848|B1|Male||Gender|Non-compliant center population|Participants|Number|0|0.0||||||
4154136|NCT00849381|3977848|B1|Female||Gender|Non-compliant center population|Participants|Number|243|243.0||||||
4154137|NCT00849381|3977848|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4154138|NCT00849381|3977848|B1||Female|Sex: Female, Male||Participants|Count of Participants|1237|1237.0||||||
4154139|NCT00849381|3977848|B1|||Age|Non-compliant center population|Years|Mean|28.7|28.7|Standard Deviation|1.59|1.59|||
4154140|NCT00849381|3977848|B1|||Age||Years|Mean|28.2|28.2|Standard Deviation|1.47|1.47|||
4154141|NCT00849290|3977854|B1||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4154142|NCT00849290|3977854|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4154143|NCT00849290|3977854|B1|||Age||years|Mean|70.0|70.0|Full Range|||40.0|87.0|
4154144|NCT00849251|3977858|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154145|NCT00849251|3977858|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154146|NCT00849251|3977858|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4154147|NCT00849251|3977858|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4154148|NCT00849251|3977858|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154149|NCT00849251|3977858|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4154150|NCT00849251|3977858|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154151|NCT00849251|3977858|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4154152|NCT00849251|3977858|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4154153|NCT00849251|3977858|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4154154|NCT00849251|3977858|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4154155|NCT00849251|3977858|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4154156|NCT00849251|3977858|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4154157|NCT00849251|3977858|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4154158|NCT00849251|3977858|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154159|NCT00849212|3977865|B1||Male|Sex: Female, Male|Safety analysis set: The population after excluding the following patients: a) Patients who do not meet the inclusion criteria regarding “indication,” b) Patients untreated c) Patients with no evaluable data on safety|Participants|Count of Participants|16|16.0||||||
4154160|NCT00849212|3977865|B1||Female|Sex: Female, Male|Safety analysis set: The population after excluding the following patients: a) Patients who do not meet the inclusion criteria regarding “indication,” b) Patients untreated c) Patients with no evaluable data on safety|Participants|Count of Participants|14|14.0||||||
4154161|NCT00849212|3977865|B1|||Age|Safety analysis set|Years|Mean|35.4|35.4|Standard Deviation|10.6|10.6|||
4154162|NCT00849186|3977870|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4154163|NCT00849186|3977870|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4154164|NCT00849186|3977870|B1|||Age||years|Mean|60.24|60.24|Standard Deviation|9.57|9.57|||
4154165|NCT00849147|3977876|B1|||Weight||kilograms|Median|78|78.0|Full Range|||21.0|184.0|
4154166|NCT00849147|3977876|B1|10/10||HLA Typing Match Score - Host vs Graft (HVG) direction|HLA typing will be performed at high resolution (allele level) for the HLA-A, -B, Cw, DRB1, and –DQB1 loci. A minimum match of 5/10 is required.|participants|Number|1|1.0||||||
4154167|NCT00849147|3977876|B1|9/10||HLA Typing Match Score - Host vs Graft (HVG) direction|HLA typing will be performed at high resolution (allele level) for the HLA-A, -B, Cw, DRB1, and –DQB1 loci. A minimum match of 5/10 is required.|participants|Number|1|1.0||||||
4154168|NCT00849147|3977876|B1|8/10||HLA Typing Match Score - Host vs Graft (HVG) direction|HLA typing will be performed at high resolution (allele level) for the HLA-A, -B, Cw, DRB1, and –DQB1 loci. A minimum match of 5/10 is required.|participants|Number|1|1.0||||||
4154169|NCT00849147|3977876|B1|7/10||HLA Typing Match Score - Host vs Graft (HVG) direction|HLA typing will be performed at high resolution (allele level) for the HLA-A, -B, Cw, DRB1, and –DQB1 loci. A minimum match of 5/10 is required.|participants|Number|3|3.0||||||
4154170|NCT00849147|3977876|B1|6/10||HLA Typing Match Score - Host vs Graft (HVG) direction|HLA typing will be performed at high resolution (allele level) for the HLA-A, -B, Cw, DRB1, and –DQB1 loci. A minimum match of 5/10 is required.|participants|Number|22|22.0||||||
4154171|NCT00849147|3977876|B1|5/10||HLA Typing Match Score - Host vs Graft (HVG) direction|HLA typing will be performed at high resolution (allele level) for the HLA-A, -B, Cw, DRB1, and –DQB1 loci. A minimum match of 5/10 is required.|participants|Number|22|22.0||||||
4154172|NCT00849147|3977876|B1|8/10||Human leucocyte antigen (HLA) Typing Match Score - GVH direction|HLA typing will be performed at high resolution (allele level) for the HLA-A, -B, Cw, DRB1, and –DQB1 loci. A minimum match of 5/10 is required.|participants|Number|1|1.0||||||
4154173|NCT00849147|3977876|B1|7/10||Human leucocyte antigen (HLA) Typing Match Score - GVH direction|HLA typing will be performed at high resolution (allele level) for the HLA-A, -B, Cw, DRB1, and –DQB1 loci. A minimum match of 5/10 is required.|participants|Number|9|9.0||||||
4154174|NCT00849147|3977876|B1|6/10||Human leucocyte antigen (HLA) Typing Match Score - GVH direction|HLA typing will be performed at high resolution (allele level) for the HLA-A, -B, Cw, DRB1, and –DQB1 loci. A minimum match of 5/10 is required.|participants|Number|12|12.0||||||
4154175|NCT00849147|3977876|B1|5/10||Human leucocyte antigen (HLA) Typing Match Score - GVH direction|HLA typing will be performed at high resolution (allele level) for the HLA-A, -B, Cw, DRB1, and –DQB1 loci. A minimum match of 5/10 is required.|participants|Number|28|28.0||||||
4154176|NCT00849147|3977876|B1|Mantle Cell Lymphoma||Primary Disease||participants|Number|3|3.0||||||
4154177|NCT00849147|3977876|B1|Marginal Zone B-cell Lymphoma||Primary Disease||participants|Number|1|1.0||||||
4154178|NCT00849147|3977876|B1|Large Cell Lymphoma||Primary Disease||participants|Number|8|8.0||||||
4154179|NCT00849147|3977876|B1|Hodgkins Lymphoma||Primary Disease||participants|Number|7|7.0||||||
4154180|NCT00849147|3977876|B1|Biphenotypic/Undifferentiated Leukemia||Primary Disease||participants|Number|3|3.0||||||
4154181|NCT00849147|3977876|B1|Acute Myelogeneous Leukemia||Primary Disease||participants|Number|22|22.0||||||
4154182|NCT00849147|3977876|B1|Acute Lymphoblastic Leukemia||Primary Disease||participants|Number|6|6.0||||||
4154183|NCT00849147|3977876|B1|70%||Karnofsky Performance-status score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|3|3.0||||||
4154184|NCT00849147|3977876|B1|80%||Karnofsky Performance-status score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|9|9.0||||||
4154185|NCT00849147|3977876|B1|90%||Karnofsky Performance-status score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|19|19.0||||||
4154186|NCT00849147|3977876|B1|100%||Karnofsky Performance-status score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|19|19.0||||||
4154187|NCT00849147|3977876|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4154188|NCT00849147|3977876|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154189|NCT00849147|3977876|B1||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4154190|NCT00849147|3977876|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4154191|NCT00849147|3977876|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4154192|NCT00849147|3977876|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4154193|NCT00849147|3977876|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154194|NCT00849147|3977876|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4154195|NCT00849147|3977876|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4154196|NCT00849147|3977876|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4154197|NCT00849147|3977876|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4154198|NCT00849147|3977876|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4154199|NCT00849147|3977876|B1|||Age||years|Mean|45.4|45.4|Standard Deviation|18.1|18.1|||
4154200|NCT00849121|3977891|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4154201|NCT00849121|3977892|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4154202|NCT00849121|3977893|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4154203|NCT00849121|3977891|B3|White||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4154204|NCT00849121|3977892|B2|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4154205|NCT00849121|3977893|B1|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4154206|NCT00849121|3977891|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4154207|NCT00849121|3977892|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4154208|NCT00849121|3977893|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4154209|NCT00849121|3977891|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4154210|NCT00849121|3977892|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4154211|NCT00849121|3977893|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4154212|NCT00849121|3977891|B3|80-89 years||Age, Customized||participants|Number|5|5.0||||||
4154213|NCT00849121|3977892|B2|80-89 years||Age, Customized||participants|Number|0|0.0||||||
4154214|NCT00849121|3977893|B1|80-89 years||Age, Customized||participants|Number|5|5.0||||||
4154215|NCT00849121|3977891|B3|70-79 years||Age, Customized||participants|Number|4|4.0||||||
4154216|NCT00849121|3977892|B2|70-79 years||Age, Customized||participants|Number|3|3.0||||||
4154217|NCT00849121|3977893|B1|70-79 years||Age, Customized||participants|Number|1|1.0||||||
4154218|NCT00849121|3977891|B3|60-69 years||Age, Customized||participants|Number|7|7.0||||||
4154219|NCT00849121|3977892|B2|60-69 years||Age, Customized||participants|Number|6|6.0||||||
4154220|NCT00849121|3977893|B1|60-69 years||Age, Customized||participants|Number|1|1.0||||||
4154221|NCT00849121|3977891|B3|40-49 years||Age, Customized||participants|Number|1|1.0||||||
4154222|NCT00849121|3977892|B2|40-49 years||Age, Customized||participants|Number|0|0.0||||||
4154223|NCT00849121|3977893|B1|40-49 years||Age, Customized||participants|Number|1|1.0||||||
4154224|NCT00849108|3977906|B4|North America||Region of Enrollment||participants|Number|176|176.0||||||
4154225|NCT00849108|3977907|B3|North America||Region of Enrollment||participants|Number|76|76.0||||||
4154226|NCT00849108|3977908|B2|North America||Region of Enrollment||participants|Number|67|67.0||||||
4154228|NCT00849108|3977906|B4||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4154229|NCT00849108|3977907|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4154230|NCT00849108|3977908|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4154231|NCT00849108|3977909|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4154232|NCT00849108|3977906|B4||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4154233|NCT00849108|3977907|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4154234|NCT00849108|3977908|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4154235|NCT00849108|3977909|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4154236|NCT00849108|3977906|B4||>=65 years|Age||Participants|Count of Participants|91|91.0||||||
4154237|NCT00849108|3977907|B3||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4154238|NCT00849108|3977908|B2||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
4154239|NCT00849108|3977909|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4154240|NCT00849108|3977906|B4||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
4154241|NCT00849108|3977907|B3||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4154242|NCT00849108|3977908|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4154243|NCT00849108|3977909|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4154244|NCT00849108|3977906|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154245|NCT00849108|3977907|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154246|NCT00849108|3977908|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154247|NCT00849108|3977909|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154248|NCT00849056|3977918|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|210|210.0||||||
4154249|NCT00849056|3977919|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|104|104.0||||||
4154250|NCT00849056|3977920|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|106|106.0||||||
4154251|NCT00849056|3977918|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4154252|NCT00849056|3977919|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4154253|NCT00849056|3977920|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4154254|NCT00849056|3977918|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4154255|NCT00849056|3977919|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4154256|NCT00849056|3977920|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4154257|NCT00849056|3977918|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4154258|NCT00849056|3977919|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4154259|NCT00849056|3977920|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4154260|NCT00849056|3977918|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4154261|NCT00849056|3977919|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4154262|NCT00849056|3977920|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4154263|NCT00849056|3977918|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4154264|NCT00849056|3977919|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4154265|NCT00849056|3977920|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4154266|NCT00849056|3977918|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4154267|NCT00849056|3977919|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4154268|NCT00849056|3977920|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4154269|NCT00849056|3977918|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|33|33.0||||||
4154270|NCT00849056|3977919|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4154271|NCT00849056|3977920|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4154272|NCT00849056|3977918|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|39|39.0||||||
4154273|NCT00849056|3977919|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4154274|NCT00849056|3977920|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
4154275|NCT00849056|3977918|B3||Male|Gender||Participants|Count of Participants|180|180.0||||||
4154276|NCT00849056|3977919|B2||Male|Gender||Participants|Count of Participants|92|92.0||||||
4154277|NCT00849056|3977920|B1||Male|Gender||Participants|Count of Participants|88|88.0||||||
4154278|NCT00849056|3977918|B3||Female|Gender||Participants|Count of Participants|121|121.0||||||
4154279|NCT00849056|3977919|B2||Female|Gender||Participants|Count of Participants|58|58.0||||||
4154280|NCT00849056|3977920|B1||Female|Gender||Participants|Count of Participants|63|63.0||||||
4154281|NCT00849056|3977918|B3|||Age||Years|Mean|55.0|55.0|Standard Deviation|9.67|9.67|||
4154282|NCT00849056|3977919|B2|||Age||Years|Mean|55.2|55.2|Standard Deviation|9.98|9.98|||
4154283|NCT00849056|3977920|B1|||Age||Years|Mean|54.9|54.9|Standard Deviation|9.40|9.4|||
4154284|NCT00849017|3977943|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|240|240.0||||||
4154285|NCT00849017|3977944|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|78|78.0||||||
4154286|NCT00849017|3977945|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|85|85.0||||||
4154287|NCT00849017|3977946|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|77|77.0||||||
4154288|NCT00849017|3977943|B4|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4154289|NCT00849017|3977944|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4154290|NCT00849017|3977945|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4154291|NCT00849017|3977946|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4154292|NCT00849017|3977943|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4154293|NCT00849017|3977944|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4154294|NCT00849017|3977945|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4154295|NCT00849017|3977946|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4154296|NCT00849017|3977943|B4|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4154297|NCT00849017|3977944|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4154298|NCT00849017|3977945|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4154299|NCT00849017|3977946|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4154300|NCT00849017|3977943|B4|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4154301|NCT00849017|3977944|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4154302|NCT00849017|3977945|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4154303|NCT00849017|3977946|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4154304|NCT00849017|3977943|B4|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4154305|NCT00849017|3977944|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4154306|NCT00849017|3977945|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4154307|NCT00849017|3977946|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4154308|NCT00849017|3977943|B4|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4154309|NCT00849017|3977944|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4154310|NCT00849017|3977945|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4154311|NCT00849017|3977946|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4154312|NCT00849017|3977943|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4154313|NCT00849017|3977944|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4154314|NCT00849017|3977945|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4154315|NCT00849017|3977946|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4154316|NCT00849017|3977943|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|38|38.0||||||
4154317|NCT00849017|3977944|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4154318|NCT00849017|3977945|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4154319|NCT00849017|3977946|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4154320|NCT00849017|3977943|B4||Male|Gender||Participants|Count of Participants|166|166.0||||||
4154321|NCT00849017|3977944|B3||Male|Gender||Participants|Count of Participants|50|50.0||||||
4154322|NCT00849017|3977945|B2||Male|Gender||Participants|Count of Participants|58|58.0||||||
4154323|NCT00849017|3977946|B1||Male|Gender||Participants|Count of Participants|58|58.0||||||
4154324|NCT00849017|3977943|B4||Female|Gender||Participants|Count of Participants|135|135.0||||||
4154325|NCT00849017|3977944|B3||Female|Gender||Participants|Count of Participants|49|49.0||||||
4154326|NCT00849017|3977945|B2||Female|Gender||Participants|Count of Participants|43|43.0||||||
4154327|NCT00849017|3977946|B1||Female|Gender||Participants|Count of Participants|43|43.0||||||
4154328|NCT00849017|3977943|B4|||Age||Years|Mean|52.9|52.9|Standard Deviation|11.43|11.43|||
4154329|NCT00849017|3977944|B3|||Age||Years|Mean|52.0|52.0|Standard Deviation|11.75|11.75|||
4154330|NCT00849017|3977945|B2|||Age||Years|Mean|53.6|53.6|Standard Deviation|10.89|10.89|||
4154331|NCT00849017|3977946|B1|||Age||Years|Mean|53.1|53.1|Standard Deviation|11.68|11.68|||
4154332|NCT00848965|3977991|B1|White||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
4154333|NCT00848965|3977991|B1|Japanese/East Asian Heritage (EAH)/South EAH||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4154334|NCT00848965|3977991|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4154335|NCT00848965|3977991|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4154336|NCT00848965|3977991|B1|||Age||Years|Mean|27.2|27.2|Standard Deviation|5.30|5.3|||
4154337|NCT00848926|3978033|B1|2-5||Eastern Cooperative Oncology Group Performance Status|"0 = Normal activity~= Symptoms but ambulatory~= In bed <50% of the time~= In bed >50% of the time~= 100% bedridden~= Dead"|participants|Number|0|0.0||||||
4154338|NCT00848926|3978033|B1|1||Eastern Cooperative Oncology Group Performance Status|"0 = Normal activity~= Symptoms but ambulatory~= In bed <50% of the time~= In bed >50% of the time~= 100% bedridden~= Dead"|participants|Number|60|60.0||||||
4154339|NCT00848926|3978033|B1|0||Eastern Cooperative Oncology Group Performance Status|"0 = Normal activity~= Symptoms but ambulatory~= In bed <50% of the time~= In bed >50% of the time~= 100% bedridden~= Dead"|participants|Number|42|42.0||||||
4154340|NCT00848926|3978033|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4154341|NCT00848926|3978033|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154342|NCT00848926|3978033|B1||White|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
4154343|NCT00848926|3978033|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4154344|NCT00848926|3978033|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154345|NCT00848926|3978033|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4154346|NCT00848926|3978033|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154347|NCT00848926|3978033|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4154348|NCT00848926|3978033|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4154349|NCT00848926|3978033|B1|||Age, Customized||years|Median|31.0|31.0|Full Range|||15.0|77.0|
4154350|NCT00848783|3978049|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
4154351|NCT00848783|3978050|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4154352|NCT00848783|3978051|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4154353|NCT00848783|3978052|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4154354|NCT00848783|3978049|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4154355|NCT00848783|3978050|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4154356|NCT00848783|3978051|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4154357|NCT00848783|3978052|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4154358|NCT00848783|3978049|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4154359|NCT00848783|3978050|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4154360|NCT00848783|3978051|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4154361|NCT00848783|3978052|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4154362|NCT00848783|3978049|B4|||Age||years|Mean|54.8|54.8|Standard Deviation|8.8|8.8|||
4154363|NCT00848783|3978050|B3|||Age||years|Mean|60|60.0|Standard Deviation|0|0.0|||
4154364|NCT00848783|3978051|B2|||Age||years|Mean|54.3|54.3|Standard Deviation|3.2|3.2|||
4154365|NCT00848783|3978052|B1|||Age||years|Mean|53.8|53.8|Standard Deviation|12.8|12.8|||
4154366|NCT00848783|3978049|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4154367|NCT00848783|3978050|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4154368|NCT00848783|3978051|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4154369|NCT00848783|3978052|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4154370|NCT00848783|3978049|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4154371|NCT00848783|3978050|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4154372|NCT00848783|3978051|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4154373|NCT00848783|3978052|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4154374|NCT00848783|3978049|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154375|NCT00848783|3978050|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154376|NCT00848783|3978051|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154377|NCT00848783|3978052|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154378|NCT00848744|3978063|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4154379|NCT00848744|3978063|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4154380|NCT00848744|3978063|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4154381|NCT00848744|3978063|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4154382|NCT00848744|3978063|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4154383|NCT00848744|3978063|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4154384|NCT00848549|3978070|B3|Male (Extension Study 314, NCT00848549)||Sex/Gender, Customized||participants|Number|179|179.0||||||
4154385|NCT00848549|3978071|B2|Male (Extension Study 314, NCT00848549)||Sex/Gender, Customized||participants|Number|99|99.0||||||
4154386|NCT00848549|3978072|B1|Male (Extension Study 314, NCT00848549)||Sex/Gender, Customized||participants|Number|80|80.0||||||
4154387|NCT00848549|3978070|B3|Female (Extension Study 314, NCT00848549)||Sex/Gender, Customized||participants|Number|116|116.0||||||
4154388|NCT00848549|3978071|B2|Female (Extension Study 314, NCT00848549)||Sex/Gender, Customized||participants|Number|59|59.0||||||
4154389|NCT00848549|3978072|B1|Female (Extension Study 314, NCT00848549)||Sex/Gender, Customized||participants|Number|57|57.0||||||
4154390|NCT00848549|3978070|B3|Male (Base Study 310, NCT00477295)||Sex/Gender, Customized||participants|Number|346|346.0||||||
4154391|NCT00848549|3978071|B2|Male (Base Study 310, NCT00477295)||Sex/Gender, Customized||participants|Number|172|172.0||||||
4154392|NCT00848549|3978072|B1|Male (Base Study 310, NCT00477295)||Sex/Gender, Customized||participants|Number|174|174.0||||||
4154393|NCT00848549|3978070|B3|Female (Base Study 310, NCT00477295)||Sex/Gender, Customized||participants|Number|235|235.0||||||
4154394|NCT00848549|3978071|B2|Female (Base Study 310, NCT00477295)||Sex/Gender, Customized||participants|Number|128|128.0||||||
4154395|NCT00848549|3978072|B1|Female (Base Study 310, NCT00477295)||Sex/Gender, Customized||participants|Number|107|107.0||||||
4154396|NCT00848549|3978070|B3|Extension Study 314 (NCT00848549, n=295)||Age||years|Mean|36.1|36.1|Standard Deviation|15.53|15.53|||
4154397|NCT00848549|3978071|B2|Extension Study 314 (NCT00848549, n=295)||Age||years|Mean|34.4|34.4|Standard Deviation|14.93|14.93|||
4154398|NCT00848549|3978072|B1|Extension Study 314 (NCT00848549, n=295)||Age||years|Mean|37.8|37.8|Standard Deviation|16.13|16.13|||
4154399|NCT00848549|3978070|B3|Base Study 310 (NCT00477295, n=583)||Age||years|Mean|36.35|36.35|Standard Deviation|15.92|15.92|||
4154400|NCT00848549|3978071|B2|Base Study 310 (NCT00477295, n=583)||Age||years|Mean|35.6|35.6|Standard Deviation|15.50|15.5|||
4154401|NCT00848549|3978072|B1|Base Study 310 (NCT00477295, n=583)||Age||years|Mean|37.1|37.1|Standard Deviation|16.33|16.33|||
4154402|NCT00848536|3978089|B3||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4154403|NCT00848536|3978090|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4154404|NCT00848536|3978091|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4154405|NCT00848536|3978089|B3||Female|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
4154406|NCT00848536|3978090|B2||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4154407|NCT00848536|3978091|B1||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4154408|NCT00848536|3978089|B3||>=65 years|Age||Participants|Count of Participants|168|168.0||||||
4154409|NCT00848536|3978090|B2||>=65 years|Age||Participants|Count of Participants|77|77.0||||||
4154410|NCT00848536|3978091|B1||>=65 years|Age||Participants|Count of Participants|91|91.0||||||
4154411|NCT00848536|3978089|B3||Between 18 and 65 years|Age||Participants|Count of Participants|203|203.0||||||
4154412|NCT00848536|3978090|B2||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
4154413|NCT00848536|3978091|B1||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
4154414|NCT00848536|3978089|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154415|NCT00848536|3978090|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154416|NCT00848536|3978091|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154417|NCT00848510|3978102|B5||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4154418|NCT00848510|3978103|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4154419|NCT00848510|3978104|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4154420|NCT00848510|3978105|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4154421|NCT00848510|3978106|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4154422|NCT00848510|3978102|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4154423|NCT00848510|3978103|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4154424|NCT00848510|3978104|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4154425|NCT00848510|3978105|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4154426|NCT00848510|3978106|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4154427|NCT00848510|3978102|B5|||Age||Years|Mean|61.2|61.2|Standard Deviation|12.48|12.48|||
4154428|NCT00848510|3978103|B4|||Age||Years|Mean|57.8|57.8|Standard Deviation|16.58|16.58|||
4154429|NCT00848510|3978104|B3|||Age||Years|Mean|68.9|68.9|Standard Deviation|10.68|10.68|||
4154430|NCT00848510|3978105|B2|||Age||Years|Mean|58.9|58.9|Standard Deviation|9.94|9.94|||
4154431|NCT00848510|3978106|B1|||Age||Years|Mean|61.6|61.6|Standard Deviation|11.13|11.13|||
4154432|NCT00848497|3978155|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4154433|NCT00848497|3978156|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4154434|NCT00848497|3978157|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4154435|NCT00848497|3978155|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4154436|NCT00848497|3978156|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4154437|NCT00848497|3978157|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4154438|NCT00848497|3978155|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4154439|NCT00848497|3978156|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4154440|NCT00848497|3978157|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4154441|NCT00848497|3978155|B3|||Age||years|Mean|56|56.0|Standard Deviation|4|4.0|||
4154442|NCT00848497|3978156|B2|||Age||years|Mean|59|59.0|Standard Deviation|0|0.0|||
4154443|NCT00848497|3978157|B1|||Age||years|Mean|54|54.0|Standard Deviation|4|4.0|||
4154444|NCT00848497|3978155|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4154445|NCT00848497|3978156|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4154446|NCT00848497|3978157|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4154447|NCT00848497|3978155|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4154448|NCT00848497|3978156|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4154449|NCT00848497|3978157|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4154450|NCT00848497|3978155|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154451|NCT00848497|3978156|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154452|NCT00848497|3978157|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154453|NCT00848484|3978170|B3|Russia||Study Region||participants|Number|39|39.0||||||
4154454|NCT00848484|3978171|B2|Russia||Study Region||participants|Number|20|20.0||||||
4154455|NCT00848484|3978172|B1|Russia||Study Region||participants|Number|19|19.0||||||
4154456|NCT00848484|3978170|B3|United States||Study Region||participants|Number|15|15.0||||||
4154457|NCT00848484|3978171|B2|United States||Study Region||participants|Number|7|7.0||||||
4154458|NCT00848484|3978172|B1|United States||Study Region||participants|Number|8|8.0||||||
4154459|NCT00848484|3978170|B3|White||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4154460|NCT00848484|3978171|B2|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4154461|NCT00848484|3978172|B1|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4154462|NCT00848484|3978170|B3|Multi-Racial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4154463|NCT00848484|3978171|B2|Multi-Racial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4154464|NCT00848484|3978172|B1|Multi-Racial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4154465|NCT00848484|3978170|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4154466|NCT00848484|3978171|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4154467|NCT00848484|3978172|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4154468|NCT00848484|3978170|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154469|NCT00848484|3978171|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154470|NCT00848484|3978172|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154471|NCT00848484|3978170|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4154472|NCT00848484|3978171|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4154473|NCT00848484|3978172|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4154474|NCT00848484|3978170|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4154475|NCT00848484|3978171|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154476|NCT00848484|3978172|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4154477|NCT00848484|3978170|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4154478|NCT00848484|3978171|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4154479|NCT00848484|3978172|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4154480|NCT00848484|3978170|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4154481|NCT00848484|3978171|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4154482|NCT00848484|3978172|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4154483|NCT00848484|3978170|B3|||Age||years|Mean|35.0|35.0|Standard Deviation|8.8|8.8|||
4154484|NCT00848484|3978171|B2|||Age||years|Mean|36.1|36.1|Standard Deviation|9.1|9.1|||
4154485|NCT00848484|3978172|B1|||Age||years|Mean|33.8|33.8|Standard Deviation|8.5|8.5|||
4154486|NCT00848393|3978189|B4|United States||Region of Enrollment||participants|Number|48|48.0||||||
4154487|NCT00848393|3978190|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4154488|NCT00848393|3978191|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4154489|NCT00848393|3978192|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4154490|NCT00848393|3978189|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4154491|NCT00848393|3978190|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4154492|NCT00848393|3978191|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4154493|NCT00848393|3978192|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4154494|NCT00848393|3978189|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4154495|NCT00848393|3978190|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4154496|NCT00848393|3978191|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4154497|NCT00848393|3978192|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4154498|NCT00848393|3978189|B4|||Age||months|Median|4|4.0|Full Range|||1.0|35.0|
4154499|NCT00848393|3978190|B3|||Age||months|Median|5|5.0|Full Range|||2.0|21.0|
4154500|NCT00848393|3978191|B2|||Age||months|Median|4|4.0|Full Range|||3.0|7.0|
4154501|NCT00848393|3978192|B1|||Age||months|Median|4|4.0|Full Range|||1.0|35.0|
4154502|NCT00848393|3978189|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4154503|NCT00848393|3978190|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4154504|NCT00848393|3978191|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4154505|NCT00848393|3978192|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4154506|NCT00848393|3978189|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4154507|NCT00848393|3978190|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4154508|NCT00848393|3978191|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4154509|NCT00848393|3978192|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4154510|NCT00848393|3978189|B4||<=18 years|Age||Participants|Count of Participants|48|48.0||||||
4154511|NCT00848393|3978190|B3||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4154512|NCT00848393|3978191|B2||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4154513|NCT00848393|3978192|B1||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
4154514|NCT00848367|3978220|B3|Canada||Region of Enrollment||participants|Number|102|102.0||||||
4154515|NCT00848367|3978221|B2|Canada||Region of Enrollment||participants|Number|52|52.0||||||
4154516|NCT00848367|3978222|B1|Canada||Region of Enrollment||participants|Number|50|50.0||||||
4154517|NCT00848367|3978220|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4154518|NCT00848367|3978221|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4154519|NCT00848367|3978222|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4154520|NCT00848367|3978220|B3||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4154521|NCT00848367|3978221|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4154522|NCT00848367|3978222|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4154523|NCT00848367|3978220|B3|||Age||years|Mean|44.32|44.32|Standard Deviation|11.79|11.79|||
4154524|NCT00848367|3978221|B2|||Age||years|Mean|46.23|46.23|Standard Deviation|12.67|12.67|||
4154525|NCT00848367|3978222|B1|||Age||years|Mean|42.29|42.29|Standard Deviation|10.54|10.54|||
4154526|NCT00848367|3978220|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4154527|NCT00848367|3978221|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4154528|NCT00848367|3978222|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4154529|NCT00848367|3978220|B3||Between 18 and 65 years|Age||Participants|Count of Participants|99|99.0||||||
4154530|NCT00848367|3978221|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4154531|NCT00848367|3978222|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4154532|NCT00848367|3978220|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154533|NCT00848367|3978221|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154534|NCT00848367|3978222|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154535|NCT00848354|3978231|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4154536|NCT00848354|3978232|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4154537|NCT00848354|3978233|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4154538|NCT00848354|3978231|B3||Female|Sex: Female, Male||Participants|Count of Participants|377|377.0||||||
4154539|NCT00848354|3978232|B2||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4154540|NCT00848354|3978233|B1||Female|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
4154541|NCT00848354|3978231|B3|||Age||years|Mean|48.5|48.5|Standard Deviation|11.78|11.78|||
4154542|NCT00848354|3978232|B2|||Age||years|Mean|48.7|48.7|Standard Deviation|11.40|11.4|||
4154543|NCT00848354|3978233|B1|||Age||years|Mean|48.4|48.4|Standard Deviation|11.99|11.99|||
4154544|NCT00848250|3978384|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4154545|NCT00848250|3978385|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4154546|NCT00848250|3978386|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4154547|NCT00848250|3978384|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154548|NCT00848250|3978385|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154549|NCT00848250|3978386|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154550|NCT00848250|3978384|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154551|NCT00848250|3978385|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154552|NCT00848250|3978386|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154553|NCT00848250|3978384|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4154554|NCT00848250|3978385|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4154555|NCT00848250|3978386|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4154556|NCT00848250|3978384|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4154557|NCT00848250|3978385|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4154558|NCT00848250|3978386|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4154559|NCT00848250|3978384|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154560|NCT00848250|3978385|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154561|NCT00848250|3978386|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154562|NCT00848250|3978384|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154563|NCT00848250|3978385|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154564|NCT00848250|3978386|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154565|NCT00848250|3978384|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154566|NCT00848250|3978385|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154567|NCT00848250|3978386|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154568|NCT00848250|3978384|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4154569|NCT00848250|3978385|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4154570|NCT00848250|3978386|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4154571|NCT00848250|3978384|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4154572|NCT00848250|3978385|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4154573|NCT00848250|3978386|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4154574|NCT00848250|3978384|B3|||Age||months|Mean|17.2|17.2|Standard Deviation|5.02|5.02|||
4154575|NCT00848250|3978385|B2|||Age||months|Mean|20.8|20.8|Standard Deviation|6.5|6.5|||
4154576|NCT00848250|3978386|B1|||Age||months|Mean|13.7|13.7|Standard Deviation|3.5|3.5|||
4154577|NCT00848237|3978405|B1|United States||Region of Enrollment||participants|Number|5521|5521.0||||||
4154578|NCT00848237|3978405|B1||Male|Sex: Female, Male||Participants|Count of Participants|4052|4052.0||||||
4154579|NCT00848237|3978405|B1||Female|Sex: Female, Male||Participants|Count of Participants|1469|1469.0||||||
4154580|NCT00848237|3978405|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|11.4|11.4|||
4154581|NCT00848237|3978405|B1|>=65 years||Age|Note: 6 subjects: Age unknown|participants|Number|2279|2279.0||||||
4154582|NCT00848237|3978405|B1|Between 18 and 65 years||Age|Note: 6 subjects: Age unknown|participants|Number|3235|3235.0||||||
4154583|NCT00848237|3978405|B1|<=18 years||Age|Note: 6 subjects: Age unknown|participants|Number|1|1.0||||||
4154584|NCT00848211|3978414|B5|United States||Region of Enrollment||participants|Number|24|24.0||||||
4154585|NCT00848211|3978415|B4|United States||Region of Enrollment||participants|Number|5|5.0||||||
4154586|NCT00848211|3978416|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4154587|NCT00848211|3978417|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4154588|NCT00848211|3978418|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4154589|NCT00848211|3978414|B5||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4154590|NCT00848211|3978415|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4154591|NCT00848211|3978416|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4154592|NCT00848211|3978417|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4154593|NCT00848211|3978418|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4154594|NCT00848211|3978414|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4154595|NCT00848211|3978415|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4154596|NCT00848211|3978416|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4154597|NCT00848211|3978417|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4154598|NCT00848211|3978418|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4154599|NCT00848211|3978414|B5|||Age||years|Mean|45.9|45.9|Standard Deviation|8.67|8.67|||
4154600|NCT00848211|3978415|B4|||Age||years|Mean|51|51.0|Standard Deviation|5|5.0|||
4154601|NCT00848211|3978416|B3|||Age||years|Mean|41|41.0|Standard Deviation|8|8.0|||
4154602|NCT00848211|3978417|B2|||Age||years|Mean|48|48.0|Standard Deviation|9|9.0|||
4154603|NCT00848211|3978418|B1|||Age||years|Mean|44|44.0|Standard Deviation|10|10.0|||
4154604|NCT00848211|3978414|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4154605|NCT00848211|3978415|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4154606|NCT00848211|3978416|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4154607|NCT00848211|3978417|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4154608|NCT00848211|3978418|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4154609|NCT00848211|3978414|B5||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4154610|NCT00848211|3978415|B4||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4154611|NCT00848211|3978416|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4154612|NCT00848211|3978417|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4154613|NCT00848211|3978418|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4154614|NCT00848211|3978414|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154615|NCT00848211|3978415|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154616|NCT00848211|3978416|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154617|NCT00848211|3978417|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154618|NCT00848211|3978418|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154619|NCT00848198|3978439|B1|United Kingdom||Region of Enrollment||participants|Number|25|25.0||||||
4154620|NCT00848198|3978439|B1|Germany||Region of Enrollment||participants|Number|50|50.0||||||
4154621|NCT00848198|3978439|B1|Spain||Region of Enrollment||participants|Number|50|50.0||||||
4154622|NCT00848198|3978439|B1|United States||Region of Enrollment||participants|Number|139|139.0||||||
4154623|NCT00848198|3978439|B1|France||Region of Enrollment||participants|Number|50|50.0||||||
4154624|NCT00848198|3978439|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4154625|NCT00848198|3978439|B1||Female|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
4154626|NCT00848198|3978439|B1|||Age||years|Mean|46.3|46.3|Standard Deviation|16.9|16.9|||
4154627|NCT00848198|3978439|B1||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
4154628|NCT00848198|3978439|B1||Between 18 and 65 years|Age||Participants|Count of Participants|269|269.0||||||
4154629|NCT00848198|3978439|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154630|NCT00848185|3978477|B4|Spain||Region of Enrollment|The donors were recruit for the clinic|participants|Number|96|96.0||||||
4154631|NCT00848185|3978478|B3|Spain||Region of Enrollment|The donors were recruit for the clinic|participants|Number|32|32.0||||||
4154632|NCT00848185|3978479|B2|Spain||Region of Enrollment|The donors were recruit for the clinic|participants|Number|32|32.0||||||
4154633|NCT00848185|3978480|B1|Spain||Region of Enrollment|The donors were recruit for the clinic|participants|Number|32|32.0||||||
4154634|NCT00848185|3978477|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4154635|NCT00848185|3978478|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4154636|NCT00848185|3978479|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4154637|NCT00848185|3978480|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4154638|NCT00848185|3978477|B4||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4154639|NCT00848185|3978478|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4154640|NCT00848185|3978479|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4154641|NCT00848185|3978480|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4154642|NCT00848185|3978477|B4|||Age||years|Mean|25.1|25.1|Standard Deviation|3.7|3.7|||
4154643|NCT00848185|3978478|B3|||Age||years|Mean|24.5|24.5|Standard Deviation|3.7|3.7|||
4154644|NCT00848185|3978479|B2|||Age||years|Mean|23.7|23.7|Standard Deviation|3.9|3.9|||
4154645|NCT00848185|3978480|B1|||Age||years|Mean|27.2|27.2|Standard Deviation|3.5|3.5|||
4154646|NCT00848185|3978477|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4154647|NCT00848185|3978478|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4154648|NCT00848185|3978479|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4154649|NCT00848185|3978480|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4154650|NCT00848185|3978477|B4||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
4154651|NCT00848185|3978478|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4154652|NCT00848185|3978479|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4154653|NCT00848185|3978480|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4154654|NCT00848185|3978477|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154655|NCT00848185|3978478|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154656|NCT00848185|3978479|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154657|NCT00848185|3978480|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154658|NCT00848172|3978490|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4154659|NCT00848172|3978491|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4154660|NCT00848172|3978492|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4154661|NCT00848172|3978490|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4154662|NCT00848172|3978491|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4154663|NCT00848172|3978492|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4154664|NCT00848172|3978490|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4154665|NCT00848172|3978491|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4154666|NCT00848172|3978492|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4154667|NCT00848172|3978490|B3|||Age||years|Mean|61.95|61.95|Standard Deviation|9.90|9.9|||
4154668|NCT00848172|3978491|B2|||Age||years|Mean|64.22|64.22|Standard Deviation|8.60|8.6|||
4154669|NCT00848172|3978492|B1|||Age||years|Mean|59.90|59.9|Standard Deviation|10.97|10.97|||
4154670|NCT00848172|3978490|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4154671|NCT00848172|3978491|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4154672|NCT00848172|3978492|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4154673|NCT00848172|3978490|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4154674|NCT00848172|3978491|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4154675|NCT00848172|3978492|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4154676|NCT00848172|3978490|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154677|NCT00848172|3978491|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154678|NCT00848172|3978492|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154679|NCT00848120|3978504|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4154680|NCT00848120|3978504|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4154681|NCT00848120|3978504|B1|||Age||years|Mean|47|47.0|Standard Deviation|14.1|14.1|||
4154682|NCT00848107|3978516|B1|Diffuse||Scleroderma Classification|Systemic sclerosis (SSc) is commonly categorized into diffuse and limited forms but can also include the overlap syndrome (associated with other connective tissue diseases). The main distinguishing feature of the diffuse form is skin involvement proximal to the elbows and ankles and a higher risk of internal organ involvement. In limited SSc, skin involvement is confined to face, hands, feet, or forearms; however, a significant proportion of patients develop pulmonary hypertension.|participants|Number|33|33.0||||||
4154683|NCT00848107|3978516|B1|Limited||Scleroderma Classification|Systemic sclerosis (SSc) is commonly categorized into diffuse and limited forms but can also include the overlap syndrome (associated with other connective tissue diseases). The main distinguishing feature of the diffuse form is skin involvement proximal to the elbows and ankles and a higher risk of internal organ involvement. In limited SSc, skin involvement is confined to face, hands, feet, or forearms; however, a significant proportion of patients develop pulmonary hypertension.|participants|Number|82|82.0||||||
4154684|NCT00848107|3978516|B1|||Years since scleroderma diagnosis||years|Mean|10.9|10.9|Full Range|||0.0|35.0|
4154685|NCT00848107|3978516|B1|Not provided||Race/Ethnicity, Customized|*Note a subject can be included in more than one race category|participants|Number|1|1.0||||||
4154686|NCT00848107|3978516|B1|Native American||Race/Ethnicity, Customized|*Note a subject can be included in more than one race category|participants|Number|1|1.0||||||
4154687|NCT00848107|3978516|B1|African-American||Race/Ethnicity, Customized|*Note a subject can be included in more than one race category|participants|Number|13|13.0||||||
4154688|NCT00848107|3978516|B1|Caucasian||Race/Ethnicity, Customized|*Note a subject can be included in more than one race category|participants|Number|97|97.0||||||
4154689|NCT00848107|3978516|B1|Asian||Race/Ethnicity, Customized|*Note a subject can be included in more than one race category|participants|Number|4|4.0||||||
4154690|NCT00848107|3978516|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4154691|NCT00848107|3978516|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4154692|NCT00848107|3978516|B1|||Age||years|Mean|50|50.0|Full Range|||21.0|82.0|
4154693|NCT00848081|3978524|B3|Puerto Rico||Region of Enrollment||participants|Number|13|13.0||||||
4154694|NCT00848081|3978525|B2|Puerto Rico||Region of Enrollment||participants|Number|10|10.0||||||
4154695|NCT00848081|3978526|B1|Puerto Rico||Region of Enrollment||participants|Number|3|3.0||||||
4154696|NCT00848081|3978524|B3|United States||Region of Enrollment||participants|Number|305|305.0||||||
4154697|NCT00848081|3978525|B2|United States||Region of Enrollment||participants|Number|148|148.0||||||
4154698|NCT00848081|3978526|B1|United States||Region of Enrollment||participants|Number|157|157.0||||||
4154699|NCT00848081|3978524|B3||Unknown or Not Reported|Race (NIH/OMB)|If a subject reported multiple race categories, he was counted as “more than one race” but not in any single category.|Participants|Count of Participants|0|0.0||||||
4154700|NCT00848081|3978525|B2||Unknown or Not Reported|Race (NIH/OMB)|If a subject reported multiple race categories, he was counted as “more than one race” but not in any single category.|Participants|Count of Participants|0|0.0||||||
4154701|NCT00848081|3978526|B1||Unknown or Not Reported|Race (NIH/OMB)|If a subject reported multiple race categories, he was counted as “more than one race” but not in any single category.|Participants|Count of Participants|0|0.0||||||
4154702|NCT00848081|3978524|B3||More than one race|Race (NIH/OMB)|If a subject reported multiple race categories, he was counted as “more than one race” but not in any single category.|Participants|Count of Participants|2|2.0||||||
4154703|NCT00848081|3978525|B2||More than one race|Race (NIH/OMB)|If a subject reported multiple race categories, he was counted as “more than one race” but not in any single category.|Participants|Count of Participants|2|2.0||||||
4154704|NCT00848081|3978526|B1||More than one race|Race (NIH/OMB)|If a subject reported multiple race categories, he was counted as “more than one race” but not in any single category.|Participants|Count of Participants|0|0.0||||||
4154705|NCT00848081|3978524|B3||White|Race (NIH/OMB)|If a subject reported multiple race categories, he was counted as “more than one race” but not in any single category.|Participants|Count of Participants|281|281.0||||||
4154706|NCT00848081|3978525|B2||White|Race (NIH/OMB)|If a subject reported multiple race categories, he was counted as “more than one race” but not in any single category.|Participants|Count of Participants|137|137.0||||||
4154707|NCT00848081|3978526|B1||White|Race (NIH/OMB)|If a subject reported multiple race categories, he was counted as “more than one race” but not in any single category.|Participants|Count of Participants|144|144.0||||||
4154708|NCT00848081|3978524|B3||Black or African American|Race (NIH/OMB)|If a subject reported multiple race categories, he was counted as “more than one race” but not in any single category.|Participants|Count of Participants|31|31.0||||||
4154709|NCT00848081|3978525|B2||Black or African American|Race (NIH/OMB)|If a subject reported multiple race categories, he was counted as “more than one race” but not in any single category.|Participants|Count of Participants|17|17.0||||||
4154710|NCT00848081|3978526|B1||Black or African American|Race (NIH/OMB)|If a subject reported multiple race categories, he was counted as “more than one race” but not in any single category.|Participants|Count of Participants|14|14.0||||||
4154711|NCT00848081|3978524|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|If a subject reported multiple race categories, he was counted as “more than one race” but not in any single category.|Participants|Count of Participants|1|1.0||||||
4154712|NCT00848081|3978525|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|If a subject reported multiple race categories, he was counted as “more than one race” but not in any single category.|Participants|Count of Participants|1|1.0||||||
4154713|NCT00848081|3978526|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|If a subject reported multiple race categories, he was counted as “more than one race” but not in any single category.|Participants|Count of Participants|0|0.0||||||
4154714|NCT00848081|3978524|B3||Asian|Race (NIH/OMB)|If a subject reported multiple race categories, he was counted as “more than one race” but not in any single category.|Participants|Count of Participants|2|2.0||||||
4154715|NCT00848081|3978525|B2||Asian|Race (NIH/OMB)|If a subject reported multiple race categories, he was counted as “more than one race” but not in any single category.|Participants|Count of Participants|1|1.0||||||
4154716|NCT00848081|3978526|B1||Asian|Race (NIH/OMB)|If a subject reported multiple race categories, he was counted as “more than one race” but not in any single category.|Participants|Count of Participants|1|1.0||||||
4154717|NCT00848081|3978524|B3||American Indian or Alaska Native|Race (NIH/OMB)|If a subject reported multiple race categories, he was counted as “more than one race” but not in any single category.|Participants|Count of Participants|1|1.0||||||
4154718|NCT00848081|3978525|B2||American Indian or Alaska Native|Race (NIH/OMB)|If a subject reported multiple race categories, he was counted as “more than one race” but not in any single category.|Participants|Count of Participants|0|0.0||||||
4154719|NCT00848081|3978526|B1||American Indian or Alaska Native|Race (NIH/OMB)|If a subject reported multiple race categories, he was counted as “more than one race” but not in any single category.|Participants|Count of Participants|1|1.0||||||
4154720|NCT00848081|3978524|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154721|NCT00848081|3978525|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154722|NCT00848081|3978526|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154723|NCT00848081|3978524|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|280|280.0||||||
4154724|NCT00848081|3978525|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
4154725|NCT00848081|3978526|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|142|142.0||||||
4154726|NCT00848081|3978524|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4154727|NCT00848081|3978525|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4154728|NCT00848081|3978526|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4154729|NCT00848081|3978524|B3||Male|Sex: Female, Male||Participants|Count of Participants|318|318.0||||||
4154730|NCT00848081|3978525|B2||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4154731|NCT00848081|3978526|B1||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4154732|NCT00848081|3978524|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4154733|NCT00848081|3978525|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4154734|NCT00848081|3978526|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4154735|NCT00848081|3978524|B3|||Age||years|Mean|67.38|67.38|Standard Deviation|9.10|9.1|||
4154736|NCT00848081|3978525|B2|||Age||years|Mean|67.41|67.41|Standard Deviation|9.11|9.11|||
4154737|NCT00848081|3978526|B1|||Age||years|Mean|67.35|67.35|Standard Deviation|9.13|9.13|||
4154738|NCT00848042|3978541|B4|United States||Region of Enrollment||participants|Number|11|11.0||||||
4154739|NCT00848042|3978542|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4154740|NCT00848042|3978543|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4154741|NCT00848042|3978544|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4154742|NCT00848042|3978541|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154743|NCT00848042|3978542|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154744|NCT00848042|3978543|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154745|NCT00848042|3978544|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154746|NCT00848042|3978541|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154747|NCT00848042|3978542|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154748|NCT00848042|3978543|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154749|NCT00848042|3978544|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154750|NCT00848042|3978541|B4||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4154751|NCT00848042|3978542|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154752|NCT00848042|3978543|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4154753|NCT00848042|3978544|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4154754|NCT00848042|3978541|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4154755|NCT00848042|3978542|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4154756|NCT00848042|3978543|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4154757|NCT00848042|3978544|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154758|NCT00848042|3978541|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154759|NCT00848042|3978542|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154760|NCT00848042|3978543|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154761|NCT00848042|3978544|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154762|NCT00848042|3978541|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154763|NCT00848042|3978542|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154764|NCT00848042|3978543|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154765|NCT00848042|3978544|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154766|NCT00848042|3978541|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154767|NCT00848042|3978542|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154768|NCT00848042|3978543|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154769|NCT00848042|3978544|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154770|NCT00848042|3978541|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154771|NCT00848042|3978542|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154772|NCT00848042|3978543|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154773|NCT00848042|3978544|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154774|NCT00848042|3978541|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4154775|NCT00848042|3978542|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4154776|NCT00848042|3978543|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4154777|NCT00848042|3978544|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4154778|NCT00848042|3978541|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4154779|NCT00848042|3978542|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154780|NCT00848042|3978543|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154781|NCT00848042|3978544|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4154782|NCT00848042|3978541|B4||Male|Gender||Participants|Count of Participants|8|8.0||||||
4154783|NCT00848042|3978542|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
4154784|NCT00848042|3978543|B2||Male|Gender||Participants|Count of Participants|4|4.0||||||
4154785|NCT00848042|3978544|B1||Male|Gender||Participants|Count of Participants|4|4.0||||||
4154786|NCT00848042|3978541|B4||Female|Gender||Participants|Count of Participants|3|3.0||||||
4154787|NCT00848042|3978542|B3||Female|Gender||Participants|Count of Participants|1|1.0||||||
4154788|NCT00848042|3978543|B2||Female|Gender||Participants|Count of Participants|1|1.0||||||
4154789|NCT00848042|3978544|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
4154790|NCT00848042|3978541|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4154791|NCT00848042|3978542|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4154792|NCT00848042|3978543|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4154793|NCT00848042|3978544|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4154794|NCT00848042|3978541|B4||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4154795|NCT00848042|3978542|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4154796|NCT00848042|3978543|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4154797|NCT00848042|3978544|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4154798|NCT00848042|3978541|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154799|NCT00848042|3978542|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154800|NCT00848042|3978543|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154801|NCT00848042|3978544|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154802|NCT00848016|3978557|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4154803|NCT00848016|3978557|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4154804|NCT00848016|3978557|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4154805|NCT00848016|3978557|B1|||Age||years|Median|50|50.0|Full Range|||28.0|76.0|
4154806|NCT00847912|3978563|B3|United States||Region of Enrollment||participants|Number|932|932.0||||||
4154807|NCT00847912|3978564|B2|United States||Region of Enrollment||participants|Number|464|464.0||||||
4154808|NCT00847912|3978565|B1|United States||Region of Enrollment||participants|Number|468|468.0||||||
4154809|NCT00847912|3978563|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4154810|NCT00847912|3978564|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4154811|NCT00847912|3978565|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4154812|NCT00847912|3978563|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4154813|NCT00847912|3978564|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4154814|NCT00847912|3978565|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4154815|NCT00847912|3978563|B3||White|Race (NIH/OMB)||Participants|Count of Participants|912|912.0||||||
4154816|NCT00847912|3978564|B2||White|Race (NIH/OMB)||Participants|Count of Participants|457|457.0||||||
4154817|NCT00847912|3978565|B1||White|Race (NIH/OMB)||Participants|Count of Participants|455|455.0||||||
4154818|NCT00847912|3978563|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154819|NCT00847912|3978564|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154820|NCT00847912|3978565|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154821|NCT00847912|3978563|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4154822|NCT00847912|3978564|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4154823|NCT00847912|3978565|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154824|NCT00847912|3978563|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154825|NCT00847912|3978564|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154826|NCT00847912|3978565|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154827|NCT00847912|3978563|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4154828|NCT00847912|3978564|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154829|NCT00847912|3978565|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4154830|NCT00847912|3978563|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154831|NCT00847912|3978564|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154832|NCT00847912|3978565|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4154833|NCT00847912|3978563|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|923|923.0||||||
4154834|NCT00847912|3978564|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|459|459.0||||||
4154835|NCT00847912|3978565|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|464|464.0||||||
4154836|NCT00847912|3978563|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4154837|NCT00847912|3978564|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4154838|NCT00847912|3978565|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4154839|NCT00847912|3978563|B3||Male|Sex: Female, Male||Participants|Count of Participants|916|916.0||||||
4154840|NCT00847912|3978564|B2||Male|Sex: Female, Male||Participants|Count of Participants|459|459.0||||||
4154841|NCT00847912|3978565|B1||Male|Sex: Female, Male||Participants|Count of Participants|457|457.0||||||
4154842|NCT00847912|3978563|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4154843|NCT00847912|3978564|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4154844|NCT00847912|3978565|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4154845|NCT00847912|3978563|B3|||Age||years|Mean|71.1|71.1|Standard Deviation|9.3|9.3|||
4154846|NCT00847912|3978564|B2|||Age||years|Mean|71.5|71.5|Standard Deviation|9.4|9.4|||
4154847|NCT00847912|3978565|B1|||Age||years|Mean|70.7|70.7|Standard Deviation|9.2|9.2|||
4154848|NCT00847886|3978574|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4154849|NCT00847886|3978575|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4154850|NCT00847886|3978576|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4154851|NCT00847886|3978574|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4154852|NCT00847886|3978575|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4154853|NCT00847886|3978576|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4154854|NCT00847886|3978574|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4154855|NCT00847886|3978575|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4154856|NCT00847886|3978576|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4154857|NCT00847886|3978574|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|10.67|10.67|||
4154858|NCT00847886|3978575|B2|||Age||years|Mean|58.7|58.7|Standard Deviation|14.74|14.74|||
4154859|NCT00847886|3978576|B1|||Age||years|Mean|59.8|59.8|Standard Deviation|10.25|10.25|||
4154860|NCT00847808|3978603|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4154861|NCT00847808|3978603|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4154862|NCT00847808|3978603|B1|≥65 years||Age, Customized||participants|Number|28|28.0||||||
4154863|NCT00847808|3978603|B1|45 to <65 years||Age, Customized||participants|Number|94|94.0||||||
4154864|NCT00847808|3978603|B1|<45 years||Age, Customized||participants|Number|56|56.0||||||
4154865|NCT00847704|3978620|B1|||Time since stroke||Months|Mean|113.5|113.5|Standard Deviation|85.5|85.5|||
4154866|NCT00847704|3978620|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4154867|NCT00847704|3978620|B1||Male|Gender||Participants|Count of Participants|1|1.0||||||
4154868|NCT00847704|3978620|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
4154869|NCT00847704|3978620|B1|||Age||years|Mean|67|67.0|Standard Deviation|2.0|2.0|||
4154870|NCT00847665|3978629|B3|Spain||Region of Enrollment||participants|Number|330|330.0||||||
4154871|NCT00847665|3978630|B2|Spain||Region of Enrollment||participants|Number|165|165.0||||||
4154872|NCT00847665|3978631|B1|Spain||Region of Enrollment||participants|Number|165|165.0||||||
4154873|NCT00847665|3978629|B3||Male|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
4154874|NCT00847665|3978630|B2||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4154875|NCT00847665|3978631|B1||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4154876|NCT00847665|3978629|B3||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4154877|NCT00847665|3978630|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4154878|NCT00847665|3978631|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4154879|NCT00847665|3978629|B3|||Age||years|Mean|61|61.0|Standard Deviation|15|15.0|||
4154880|NCT00847665|3978630|B2|||Age||years|Mean|62|62.0|Standard Deviation|14|14.0|||
4154881|NCT00847665|3978631|B1|||Age||years|Mean|61|61.0|Standard Deviation|15|15.0|||
4154882|NCT00847665|3978629|B3||>=65 years|Age||Participants|Count of Participants|160|160.0||||||
4154883|NCT00847665|3978630|B2||>=65 years|Age||Participants|Count of Participants|84|84.0||||||
4154884|NCT00847665|3978631|B1||>=65 years|Age||Participants|Count of Participants|76|76.0||||||
4154885|NCT00847665|3978629|B3||Between 18 and 65 years|Age||Participants|Count of Participants|170|170.0||||||
4154886|NCT00847665|3978630|B2||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
4154887|NCT00847665|3978631|B1||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
4154888|NCT00847665|3978629|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154889|NCT00847665|3978630|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154890|NCT00847665|3978631|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4154891|NCT00847626|3978644|B12|Missing||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|1|1.0||||||
4154892|NCT00847626|3978645|B11|Missing||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|0|0.0||||||
4154893|NCT00847626|3978646|B10|Missing||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|0|0.0||||||
4154894|NCT00847626|3978647|B9|Missing||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|1|1.0||||||
4154895|NCT00847626|3978648|B8|Missing||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|0|0.0||||||
4154896|NCT00847626|3978649|B7|Missing||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|0|0.0||||||
4154952|NCT00847626|3978645|B11|Ex-smoker||Smoking Status||participants|Number|39|39.0||||||
4154953|NCT00847626|3978646|B10|Ex-smoker||Smoking Status||participants|Number|32|32.0||||||
4154954|NCT00847626|3978647|B9|Ex-smoker||Smoking Status||participants|Number|38|38.0||||||
4154897|NCT00847626|3978650|B6|Missing||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|0|0.0||||||
4154898|NCT00847626|3978651|B5|Missing||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|0|0.0||||||
4154899|NCT00847626|3978652|B4|Missing||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|0|0.0||||||
4154900|NCT00847626|3978653|B3|Missing||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|0|0.0||||||
4154901|NCT00847626|3978654|B2|Missing||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|0|0.0||||||
4154902|NCT00847626|3978655|B1|Missing||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|0|0.0||||||
4154903|NCT00847626|3978644|B12|≥90||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|521|521.0||||||
4154904|NCT00847626|3978645|B11|≥90||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|55|55.0||||||
4154905|NCT00847626|3978646|B10|≥90||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|46|46.0||||||
4154906|NCT00847626|3978647|B9|≥90||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|49|49.0||||||
4154907|NCT00847626|3978648|B8|≥90||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|50|50.0||||||
4154908|NCT00847626|3978649|B7|≥90||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|44|44.0||||||
4154909|NCT00847626|3978650|B6|≥90||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|42|42.0||||||
4154910|NCT00847626|3978651|B5|≥90||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|38|38.0||||||
4154911|NCT00847626|3978652|B4|≥90||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|51|51.0||||||
4154912|NCT00847626|3978653|B3|≥90||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|48|48.0||||||
4154913|NCT00847626|3978654|B2|≥90||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|50|50.0||||||
4154914|NCT00847626|3978655|B1|≥90||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|48|48.0||||||
4154955|NCT00847626|3978648|B8|Ex-smoker||Smoking Status||participants|Number|39|39.0||||||
4154915|NCT00847626|3978644|B12|≥60 and <90||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|1083|1083.0||||||
4154916|NCT00847626|3978645|B11|≥60 and <90||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|99|99.0||||||
4154917|NCT00847626|3978646|B10|≥60 and <90||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|95|95.0||||||
4154918|NCT00847626|3978647|B9|≥60 and <90||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|94|94.0||||||
4154919|NCT00847626|3978648|B8|≥60 and <90||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|100|100.0||||||
4154920|NCT00847626|3978649|B7|≥60 and <90||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|101|101.0||||||
4154921|NCT00847626|3978650|B6|≥60 and <90||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|110|110.0||||||
4154922|NCT00847626|3978651|B5|≥60 and <90||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|109|109.0||||||
4154923|NCT00847626|3978652|B4|≥60 and <90||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|97|97.0||||||
4154924|NCT00847626|3978653|B3|≥60 and <90||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|93|93.0||||||
4154925|NCT00847626|3978654|B2|≥60 and <90||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|90|90.0||||||
4154926|NCT00847626|3978655|B1|≥60 and <90||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|95|95.0||||||
4154927|NCT00847626|3978644|B12|≥30 and <60||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|108|108.0||||||
4154928|NCT00847626|3978645|B11|≥30 and <60||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|8|8.0||||||
4154929|NCT00847626|3978646|B10|≥30 and <60||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|11|11.0||||||
4154930|NCT00847626|3978647|B9|≥30 and <60||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|11|11.0||||||
4154931|NCT00847626|3978648|B8|≥30 and <60||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|9|9.0||||||
4154932|NCT00847626|3978649|B7|≥30 and <60||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|12|12.0||||||
4154933|NCT00847626|3978650|B6|≥30 and <60||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|10|10.0||||||
4154934|NCT00847626|3978651|B5|≥30 and <60||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|6|6.0||||||
4154935|NCT00847626|3978652|B4|≥30 and <60||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|8|8.0||||||
4154936|NCT00847626|3978653|B3|≥30 and <60||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|6|6.0||||||
4154937|NCT00847626|3978654|B2|≥30 and <60||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|14|14.0||||||
4154938|NCT00847626|3978655|B1|≥30 and <60||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|13|13.0||||||
4154939|NCT00847626|3978644|B12|≥0 and <30||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|1|1.0||||||
4154940|NCT00847626|3978645|B11|≥0 and <30||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|0|0.0||||||
4154941|NCT00847626|3978646|B10|≥0 and <30||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|1|1.0||||||
4154942|NCT00847626|3978647|B9|≥0 and <30||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|0|0.0||||||
4154943|NCT00847626|3978648|B8|≥0 and <30||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|0|0.0||||||
4154944|NCT00847626|3978649|B7|≥0 and <30||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|0|0.0||||||
4154945|NCT00847626|3978650|B6|≥0 and <30||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|0|0.0||||||
4154946|NCT00847626|3978651|B5|≥0 and <30||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|0|0.0||||||
4154947|NCT00847626|3978652|B4|≥0 and <30||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|0|0.0||||||
4154948|NCT00847626|3978653|B3|≥0 and <30||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|0|0.0||||||
4154949|NCT00847626|3978654|B2|≥0 and <30||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|0|0.0||||||
4154950|NCT00847626|3978655|B1|≥0 and <30||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2) Mild renal impairment(60 to <90 mL/min/1.73 m2) Moderate renal impairment (30 to <60 mL/min/1.73 m2) Severe renal impairment (0 to <30 mL/min/1.73 m2)~Includes all randomized participants"|participants|Number|0|0.0||||||
4154951|NCT00847626|3978644|B12|Ex-smoker||Smoking Status||participants|Number|428|428.0||||||
4154956|NCT00847626|3978649|B7|Ex-smoker||Smoking Status||participants|Number|39|39.0||||||
4154957|NCT00847626|3978650|B6|Ex-smoker||Smoking Status||participants|Number|40|40.0||||||
4154958|NCT00847626|3978651|B5|Ex-smoker||Smoking Status||participants|Number|36|36.0||||||
4154959|NCT00847626|3978652|B4|Ex-smoker||Smoking Status||participants|Number|42|42.0||||||
4154960|NCT00847626|3978653|B3|Ex-smoker||Smoking Status||participants|Number|41|41.0||||||
4154961|NCT00847626|3978654|B2|Ex-smoker||Smoking Status||participants|Number|42|42.0||||||
4154962|NCT00847626|3978655|B1|Ex-smoker||Smoking Status||participants|Number|40|40.0||||||
4154963|NCT00847626|3978644|B12|Current smoker||Smoking Status||participants|Number|303|303.0||||||
4154964|NCT00847626|3978645|B11|Current smoker||Smoking Status||participants|Number|29|29.0||||||
4154965|NCT00847626|3978646|B10|Current smoker||Smoking Status||participants|Number|31|31.0||||||
4154966|NCT00847626|3978647|B9|Current smoker||Smoking Status||participants|Number|25|25.0||||||
4154967|NCT00847626|3978648|B8|Current smoker||Smoking Status||participants|Number|29|29.0||||||
4154968|NCT00847626|3978649|B7|Current smoker||Smoking Status||participants|Number|25|25.0||||||
4154969|NCT00847626|3978650|B6|Current smoker||Smoking Status||participants|Number|28|28.0||||||
4154970|NCT00847626|3978651|B5|Current smoker||Smoking Status||participants|Number|26|26.0||||||
4154971|NCT00847626|3978652|B4|Current smoker||Smoking Status||participants|Number|35|35.0||||||
4154972|NCT00847626|3978653|B3|Current smoker||Smoking Status||participants|Number|25|25.0||||||
4154973|NCT00847626|3978654|B2|Current smoker||Smoking Status||participants|Number|28|28.0||||||
4154974|NCT00847626|3978655|B1|Current smoker||Smoking Status||participants|Number|22|22.0||||||
4154975|NCT00847626|3978644|B12|Never smoked||Smoking Status||participants|Number|983|983.0||||||
4154976|NCT00847626|3978645|B11|Never smoked||Smoking Status||participants|Number|94|94.0||||||
4154977|NCT00847626|3978646|B10|Never smoked||Smoking Status||participants|Number|90|90.0||||||
4154978|NCT00847626|3978647|B9|Never smoked||Smoking Status||participants|Number|92|92.0||||||
4154979|NCT00847626|3978648|B8|Never smoked||Smoking Status||participants|Number|91|91.0||||||
4154980|NCT00847626|3978649|B7|Never smoked||Smoking Status||participants|Number|93|93.0||||||
4154981|NCT00847626|3978650|B6|Never smoked||Smoking Status||participants|Number|94|94.0||||||
4154982|NCT00847626|3978651|B5|Never smoked||Smoking Status||participants|Number|91|91.0||||||
4154983|NCT00847626|3978652|B4|Never smoked||Smoking Status||participants|Number|79|79.0||||||
4154984|NCT00847626|3978653|B3|Never smoked||Smoking Status||participants|Number|81|81.0||||||
4154985|NCT00847626|3978654|B2|Never smoked||Smoking Status||participants|Number|84|84.0||||||
4154986|NCT00847626|3978655|B1|Never smoked||Smoking Status||participants|Number|94|94.0||||||
4154987|NCT00847626|3978644|B12|||Body Mass Index (BMI)||kg/m^2|Mean|31.4|31.4|Standard Deviation|5.92|5.92|||
4154988|NCT00847626|3978645|B11|||Body Mass Index (BMI)||kg/m^2|Mean|30.8|30.8|Standard Deviation|6.28|6.28|||
4154989|NCT00847626|3978646|B10|||Body Mass Index (BMI)||kg/m^2|Mean|31.0|31.0|Standard Deviation|5.85|5.85|||
4154990|NCT00847626|3978647|B9|||Body Mass Index (BMI)||kg/m^2|Mean|31.3|31.3|Standard Deviation|5.23|5.23|||
4154991|NCT00847626|3978648|B8|||Body Mass Index (BMI)||kg/m^2|Mean|31.2|31.2|Standard Deviation|5.78|5.78|||
4154992|NCT00847626|3978649|B7|||Body Mass Index (BMI)||kg/m^2|Mean|31.2|31.2|Standard Deviation|5.85|5.85|||
4154993|NCT00847626|3978650|B6|||Body Mass Index (BMI)||kg/m^2|Mean|31.5|31.5|Standard Deviation|6.28|6.28|||
4154994|NCT00847626|3978651|B5|||Body Mass Index (BMI)||kg/m^2|Mean|31.4|31.4|Standard Deviation|5.84|5.84|||
4154995|NCT00847626|3978652|B4|||Body Mass Index (BMI)||kg/m^2|Mean|32.2|32.2|Standard Deviation|6.01|6.01|||
4154996|NCT00847626|3978653|B3|||Body Mass Index (BMI)||kg/m^2|Mean|31.8|31.8|Standard Deviation|6.57|6.57|||
4154997|NCT00847626|3978654|B2|||Body Mass Index (BMI)||kg/m^2|Mean|31.0|31.0|Standard Deviation|5.65|5.65|||
4154998|NCT00847626|3978655|B1|||Body Mass Index (BMI)||kg/m^2|Mean|32.2|32.2|Standard Deviation|5.73|5.73|||
4154999|NCT00847626|3978644|B12|||Weight||kg|Mean|87.80|87.8|Standard Deviation|20.289|20.289|||
4155000|NCT00847626|3978645|B11|||Weight||kg|Mean|86.27|86.27|Standard Deviation|20.354|20.354|||
4155001|NCT00847626|3978646|B10|||Weight||kg|Mean|87.54|87.54|Standard Deviation|19.019|19.019|||
4155002|NCT00847626|3978647|B9|||Weight||kg|Mean|87.27|87.27|Standard Deviation|18.934|18.934|||
4155003|NCT00847626|3978648|B8|||Weight||kg|Mean|86.70|86.7|Standard Deviation|20.270|20.27|||
4155004|NCT00847626|3978649|B7|||Weight||kg|Mean|89.12|89.12|Standard Deviation|21.049|21.049|||
4155005|NCT00847626|3978650|B6|||Weight||kg|Mean|86.44|86.44|Standard Deviation|20.412|20.412|||
4155006|NCT00847626|3978651|B5|||Weight||kg|Mean|87.31|87.31|Standard Deviation|19.209|19.209|||
4155007|NCT00847626|3978652|B4|||Weight||kg|Mean|90.16|90.16|Standard Deviation|21.949|21.949|||
4155008|NCT00847626|3978653|B3|||Weight||kg|Mean|89.28|89.28|Standard Deviation|21.484|21.484|||
4155009|NCT00847626|3978654|B2|||Weight||kg|Mean|86.06|86.06|Standard Deviation|18.056|18.056|||
4155010|NCT00847626|3978655|B1|||Weight||kg|Mean|89.85|89.85|Standard Deviation|22.076|22.076|||
4155011|NCT00847626|3978644|B12|||Height||cm|Mean|166.8|166.8|Standard Deviation|11.32|11.32|||
4155012|NCT00847626|3978645|B11|||Height||cm|Mean|167.1|167.1|Standard Deviation|11.85|11.85|||
4155013|NCT00847626|3978646|B10|||Height||cm|Mean|167.7|167.7|Standard Deviation|12.27|12.27|||
4155014|NCT00847626|3978647|B9|||Height||cm|Mean|166.4|166.4|Standard Deviation|10.65|10.65|||
4155015|NCT00847626|3978648|B8|||Height||cm|Mean|166.1|166.1|Standard Deviation|11.36|11.36|||
4155016|NCT00847626|3978649|B7|||Height||cm|Mean|168.3|168.3|Standard Deviation|11.07|11.07|||
4155017|NCT00847626|3978650|B6|||Height||cm|Mean|165.4|165.4|Standard Deviation|10.79|10.79|||
4155018|NCT00847626|3978651|B5|||Height||cm|Mean|166.6|166.6|Standard Deviation|10.81|10.81|||
4155019|NCT00847626|3978652|B4|||Height||cm|Mean|166.8|166.8|Standard Deviation|11.64|11.64|||
4155020|NCT00847626|3978653|B3|||Height||cm|Mean|167.1|167.1|Standard Deviation|11.44|11.44|||
4155021|NCT00847626|3978654|B2|||Height||cm|Mean|166.6|166.6|Standard Deviation|10.85|10.85|||
4155022|NCT00847626|3978655|B1|||Height||cm|Mean|166.3|166.3|Standard Deviation|11.71|11.71|||
4155023|NCT00847626|3978644|B12|United States||Region of Enrollment||participants|Number|1074|1074.0||||||
4155024|NCT00847626|3978645|B11|United States||Region of Enrollment||participants|Number|101|101.0||||||
4155025|NCT00847626|3978646|B10|United States||Region of Enrollment||participants|Number|97|97.0||||||
4155026|NCT00847626|3978647|B9|United States||Region of Enrollment||participants|Number|97|97.0||||||
4155027|NCT00847626|3978648|B8|United States||Region of Enrollment||participants|Number|105|105.0||||||
4155028|NCT00847626|3978649|B7|United States||Region of Enrollment||participants|Number|101|101.0||||||
4155029|NCT00847626|3978650|B6|United States||Region of Enrollment||participants|Number|102|102.0||||||
4155030|NCT00847626|3978651|B5|United States||Region of Enrollment||participants|Number|90|90.0||||||
4155031|NCT00847626|3978652|B4|United States||Region of Enrollment||participants|Number|100|100.0||||||
4155032|NCT00847626|3978653|B3|United States||Region of Enrollment||participants|Number|87|87.0||||||
4155033|NCT00847626|3978654|B2|United States||Region of Enrollment||participants|Number|94|94.0||||||
4155034|NCT00847626|3978655|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
4155035|NCT00847626|3978644|B12|Russian Federation||Region of Enrollment||participants|Number|58|58.0||||||
4155036|NCT00847626|3978645|B11|Russian Federation||Region of Enrollment||participants|Number|6|6.0||||||
4155037|NCT00847626|3978646|B10|Russian Federation||Region of Enrollment||participants|Number|4|4.0||||||
4155038|NCT00847626|3978647|B9|Russian Federation||Region of Enrollment||participants|Number|5|5.0||||||
4155039|NCT00847626|3978648|B8|Russian Federation||Region of Enrollment||participants|Number|6|6.0||||||
4155040|NCT00847626|3978649|B7|Russian Federation||Region of Enrollment||participants|Number|6|6.0||||||
4155041|NCT00847626|3978650|B6|Russian Federation||Region of Enrollment||participants|Number|6|6.0||||||
4155042|NCT00847626|3978651|B5|Russian Federation||Region of Enrollment||participants|Number|5|5.0||||||
4155043|NCT00847626|3978652|B4|Russian Federation||Region of Enrollment||participants|Number|5|5.0||||||
4155044|NCT00847626|3978653|B3|Russian Federation||Region of Enrollment||participants|Number|5|5.0||||||
4155045|NCT00847626|3978654|B2|Russian Federation||Region of Enrollment||participants|Number|5|5.0||||||
4155046|NCT00847626|3978655|B1|Russian Federation||Region of Enrollment||participants|Number|5|5.0||||||
4155047|NCT00847626|3978644|B12|Poland||Region of Enrollment||participants|Number|85|85.0||||||
4155048|NCT00847626|3978645|B11|Poland||Region of Enrollment||participants|Number|8|8.0||||||
4155049|NCT00847626|3978646|B10|Poland||Region of Enrollment||participants|Number|7|7.0||||||
4155050|NCT00847626|3978647|B9|Poland||Region of Enrollment||participants|Number|8|8.0||||||
4155051|NCT00847626|3978648|B8|Poland||Region of Enrollment||participants|Number|8|8.0||||||
4155052|NCT00847626|3978649|B7|Poland||Region of Enrollment||participants|Number|7|7.0||||||
4155053|NCT00847626|3978650|B6|Poland||Region of Enrollment||participants|Number|8|8.0||||||
4155054|NCT00847626|3978651|B5|Poland||Region of Enrollment||participants|Number|8|8.0||||||
4155055|NCT00847626|3978652|B4|Poland||Region of Enrollment||participants|Number|8|8.0||||||
4155056|NCT00847626|3978653|B3|Poland||Region of Enrollment||participants|Number|7|7.0||||||
4155057|NCT00847626|3978654|B2|Poland||Region of Enrollment||participants|Number|8|8.0||||||
4155058|NCT00847626|3978655|B1|Poland||Region of Enrollment||participants|Number|8|8.0||||||
4155059|NCT00847626|3978644|B12|Peru||Region of Enrollment||participants|Number|134|134.0||||||
4155060|NCT00847626|3978645|B11|Peru||Region of Enrollment||participants|Number|12|12.0||||||
4155061|NCT00847626|3978646|B10|Peru||Region of Enrollment||participants|Number|12|12.0||||||
4155062|NCT00847626|3978647|B9|Peru||Region of Enrollment||participants|Number|13|13.0||||||
4155063|NCT00847626|3978648|B8|Peru||Region of Enrollment||participants|Number|11|11.0||||||
4155064|NCT00847626|3978649|B7|Peru||Region of Enrollment||participants|Number|12|12.0||||||
4155065|NCT00847626|3978650|B6|Peru||Region of Enrollment||participants|Number|14|14.0||||||
4155066|NCT00847626|3978651|B5|Peru||Region of Enrollment||participants|Number|12|12.0||||||
4155067|NCT00847626|3978652|B4|Peru||Region of Enrollment||participants|Number|12|12.0||||||
4155068|NCT00847626|3978653|B3|Peru||Region of Enrollment||participants|Number|13|13.0||||||
4155069|NCT00847626|3978654|B2|Peru||Region of Enrollment||participants|Number|12|12.0||||||
4155070|NCT00847626|3978655|B1|Peru||Region of Enrollment||participants|Number|11|11.0||||||
4155071|NCT00847626|3978644|B12|Netherlands||Region of Enrollment||participants|Number|67|67.0||||||
4155072|NCT00847626|3978645|B11|Netherlands||Region of Enrollment||participants|Number|7|7.0||||||
4155073|NCT00847626|3978646|B10|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
4155074|NCT00847626|3978647|B9|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
4155075|NCT00847626|3978648|B8|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
4155076|NCT00847626|3978649|B7|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
4155077|NCT00847626|3978650|B6|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
4155078|NCT00847626|3978651|B5|Netherlands||Region of Enrollment||participants|Number|7|7.0||||||
4155079|NCT00847626|3978652|B4|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
4155080|NCT00847626|3978653|B3|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
4155081|NCT00847626|3978654|B2|Netherlands||Region of Enrollment||participants|Number|7|7.0||||||
4155082|NCT00847626|3978655|B1|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
4155083|NCT00847626|3978644|B12|Mexico||Region of Enrollment||participants|Number|119|119.0||||||
4155084|NCT00847626|3978645|B11|Mexico||Region of Enrollment||participants|Number|12|12.0||||||
4155085|NCT00847626|3978646|B10|Mexico||Region of Enrollment||participants|Number|11|11.0||||||
4155086|NCT00847626|3978647|B9|Mexico||Region of Enrollment||participants|Number|13|13.0||||||
4155087|NCT00847626|3978648|B8|Mexico||Region of Enrollment||participants|Number|8|8.0||||||
4155088|NCT00847626|3978649|B7|Mexico||Region of Enrollment||participants|Number|11|11.0||||||
4155089|NCT00847626|3978650|B6|Mexico||Region of Enrollment||participants|Number|11|11.0||||||
4155090|NCT00847626|3978651|B5|Mexico||Region of Enrollment||participants|Number|12|12.0||||||
4155091|NCT00847626|3978652|B4|Mexico||Region of Enrollment||participants|Number|9|9.0||||||
4155092|NCT00847626|3978653|B3|Mexico||Region of Enrollment||participants|Number|11|11.0||||||
4155093|NCT00847626|3978654|B2|Mexico||Region of Enrollment||participants|Number|11|11.0||||||
4155094|NCT00847626|3978655|B1|Mexico||Region of Enrollment||participants|Number|10|10.0||||||
4155095|NCT00847626|3978644|B12|Guatemala||Region of Enrollment||participants|Number|96|96.0||||||
4155096|NCT00847626|3978645|B11|Guatemala||Region of Enrollment||participants|Number|9|9.0||||||
4155097|NCT00847626|3978646|B10|Guatemala||Region of Enrollment||participants|Number|9|9.0||||||
4155098|NCT00847626|3978647|B9|Guatemala||Region of Enrollment||participants|Number|8|8.0||||||
4155099|NCT00847626|3978648|B8|Guatemala||Region of Enrollment||participants|Number|9|9.0||||||
4155100|NCT00847626|3978649|B7|Guatemala||Region of Enrollment||participants|Number|8|8.0||||||
4155101|NCT00847626|3978650|B6|Guatemala||Region of Enrollment||participants|Number|8|8.0||||||
4155102|NCT00847626|3978651|B5|Guatemala||Region of Enrollment||participants|Number|10|10.0||||||
4155103|NCT00847626|3978652|B4|Guatemala||Region of Enrollment||participants|Number|10|10.0||||||
4155104|NCT00847626|3978653|B3|Guatemala||Region of Enrollment||participants|Number|9|9.0||||||
4155105|NCT00847626|3978654|B2|Guatemala||Region of Enrollment||participants|Number|8|8.0||||||
4155106|NCT00847626|3978655|B1|Guatemala||Region of Enrollment||participants|Number|8|8.0||||||
4155107|NCT00847626|3978644|B12|Germany||Region of Enrollment||participants|Number|53|53.0||||||
4155108|NCT00847626|3978645|B11|Germany||Region of Enrollment||participants|Number|5|5.0||||||
4155109|NCT00847626|3978646|B10|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4155110|NCT00847626|3978647|B9|Germany||Region of Enrollment||participants|Number|3|3.0||||||
4155111|NCT00847626|3978648|B8|Germany||Region of Enrollment||participants|Number|5|5.0||||||
4155112|NCT00847626|3978649|B7|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4155113|NCT00847626|3978650|B6|Germany||Region of Enrollment||participants|Number|5|5.0||||||
4155114|NCT00847626|3978651|B5|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4155115|NCT00847626|3978652|B4|Germany||Region of Enrollment||participants|Number|5|5.0||||||
4155116|NCT00847626|3978653|B3|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4155117|NCT00847626|3978654|B2|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4155118|NCT00847626|3978655|B1|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4155119|NCT00847626|3978644|B12|Chile||Region of Enrollment||participants|Number|26|26.0||||||
4155120|NCT00847626|3978645|B11|Chile||Region of Enrollment||participants|Number|2|2.0||||||
4155121|NCT00847626|3978646|B10|Chile||Region of Enrollment||participants|Number|3|3.0||||||
4155122|NCT00847626|3978647|B9|Chile||Region of Enrollment||participants|Number|2|2.0||||||
4155123|NCT00847626|3978648|B8|Chile||Region of Enrollment||participants|Number|1|1.0||||||
4155124|NCT00847626|3978649|B7|Chile||Region of Enrollment||participants|Number|2|2.0||||||
4155125|NCT00847626|3978650|B6|Chile||Region of Enrollment||participants|Number|3|3.0||||||
4155126|NCT00847626|3978651|B5|Chile||Region of Enrollment||participants|Number|2|2.0||||||
4155127|NCT00847626|3978652|B4|Chile||Region of Enrollment||participants|Number|2|2.0||||||
4155128|NCT00847626|3978653|B3|Chile||Region of Enrollment||participants|Number|3|3.0||||||
4155129|NCT00847626|3978654|B2|Chile||Region of Enrollment||participants|Number|3|3.0||||||
4155130|NCT00847626|3978655|B1|Chile||Region of Enrollment||participants|Number|3|3.0||||||
4155131|NCT00847626|3978644|B12|Austria||Region of Enrollment||participants|Number|2|2.0||||||
4155132|NCT00847626|3978645|B11|Austria||Region of Enrollment||participants|Number|0|0.0||||||
4155133|NCT00847626|3978646|B10|Austria||Region of Enrollment||participants|Number|0|0.0||||||
4155134|NCT00847626|3978647|B9|Austria||Region of Enrollment||participants|Number|0|0.0||||||
4155135|NCT00847626|3978648|B8|Austria||Region of Enrollment||participants|Number|0|0.0||||||
4155136|NCT00847626|3978649|B7|Austria||Region of Enrollment||participants|Number|0|0.0||||||
4155137|NCT00847626|3978650|B6|Austria||Region of Enrollment||participants|Number|0|0.0||||||
4155138|NCT00847626|3978651|B5|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4155139|NCT00847626|3978652|B4|Austria||Region of Enrollment||participants|Number|0|0.0||||||
4155140|NCT00847626|3978653|B3|Austria||Region of Enrollment||participants|Number|0|0.0||||||
4155141|NCT00847626|3978654|B2|Austria||Region of Enrollment||participants|Number|0|0.0||||||
4155142|NCT00847626|3978655|B1|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4155143|NCT00847626|3978644|B12|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4155144|NCT00847626|3978645|B11|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4155145|NCT00847626|3978646|B10|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4155146|NCT00847626|3978647|B9|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4155147|NCT00847626|3978648|B8|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4155148|NCT00847626|3978649|B7|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4155149|NCT00847626|3978650|B6|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4155150|NCT00847626|3978651|B5|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4155151|NCT00847626|3978652|B4|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4155152|NCT00847626|3978653|B3|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4155153|NCT00847626|3978654|B2|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4155154|NCT00847626|3978655|B1|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4155155|NCT00847626|3978644|B12|More than one race||Race (NIH/OMB)||participants|Number|15|15.0||||||
4155156|NCT00847626|3978645|B11|More than one race||Race (NIH/OMB)||participants|Number|2|2.0||||||
4155157|NCT00847626|3978646|B10|More than one race||Race (NIH/OMB)||participants|Number|1|1.0||||||
4155158|NCT00847626|3978647|B9|More than one race||Race (NIH/OMB)||participants|Number|1|1.0||||||
4155159|NCT00847626|3978648|B8|More than one race||Race (NIH/OMB)||participants|Number|2|2.0||||||
4155160|NCT00847626|3978649|B7|More than one race||Race (NIH/OMB)||participants|Number|1|1.0||||||
4155161|NCT00847626|3978650|B6|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4155162|NCT00847626|3978651|B5|More than one race||Race (NIH/OMB)||participants|Number|1|1.0||||||
4155163|NCT00847626|3978652|B4|More than one race||Race (NIH/OMB)||participants|Number|2|2.0||||||
4155164|NCT00847626|3978653|B3|More than one race||Race (NIH/OMB)||participants|Number|1|1.0||||||
4155165|NCT00847626|3978654|B2|More than one race||Race (NIH/OMB)||participants|Number|2|2.0||||||
4155166|NCT00847626|3978655|B1|More than one race||Race (NIH/OMB)||participants|Number|2|2.0||||||
4155167|NCT00847626|3978644|B12|White||Race (NIH/OMB)||participants|Number|1210|1210.0||||||
4155168|NCT00847626|3978645|B11|White||Race (NIH/OMB)||participants|Number|111|111.0||||||
4155169|NCT00847626|3978646|B10|White||Race (NIH/OMB)||participants|Number|105|105.0||||||
4155170|NCT00847626|3978647|B9|White||Race (NIH/OMB)||participants|Number|113|113.0||||||
4155171|NCT00847626|3978648|B8|White||Race (NIH/OMB)||participants|Number|111|111.0||||||
4155172|NCT00847626|3978649|B7|White||Race (NIH/OMB)||participants|Number|111|111.0||||||
4155173|NCT00847626|3978650|B6|White||Race (NIH/OMB)||participants|Number|109|109.0||||||
4155174|NCT00847626|3978651|B5|White||Race (NIH/OMB)||participants|Number|114|114.0||||||
4155175|NCT00847626|3978652|B4|White||Race (NIH/OMB)||participants|Number|111|111.0||||||
4155176|NCT00847626|3978653|B3|White||Race (NIH/OMB)||participants|Number|102|102.0||||||
4155177|NCT00847626|3978654|B2|White||Race (NIH/OMB)||participants|Number|112|112.0||||||
4155178|NCT00847626|3978655|B1|White||Race (NIH/OMB)||participants|Number|111|111.0||||||
4155179|NCT00847626|3978644|B12|Black or African American||Race (NIH/OMB)||participants|Number|342|342.0||||||
4155180|NCT00847626|3978645|B11|Black or African American||Race (NIH/OMB)||participants|Number|35|35.0||||||
4155181|NCT00847626|3978646|B10|Black or African American||Race (NIH/OMB)||participants|Number|35|35.0||||||
4155182|NCT00847626|3978647|B9|Black or African American||Race (NIH/OMB)||participants|Number|31|31.0||||||
4155183|NCT00847626|3978648|B8|Black or African American||Race (NIH/OMB)||participants|Number|29|29.0||||||
4155184|NCT00847626|3978649|B7|Black or African American||Race (NIH/OMB)||participants|Number|31|31.0||||||
4155185|NCT00847626|3978650|B6|Black or African American||Race (NIH/OMB)||participants|Number|34|34.0||||||
4155186|NCT00847626|3978651|B5|Black or African American||Race (NIH/OMB)||participants|Number|26|26.0||||||
4155187|NCT00847626|3978652|B4|Black or African American||Race (NIH/OMB)||participants|Number|30|30.0||||||
4155188|NCT00847626|3978653|B3|Black or African American||Race (NIH/OMB)||participants|Number|29|29.0||||||
4155189|NCT00847626|3978654|B2|Black or African American||Race (NIH/OMB)||participants|Number|28|28.0||||||
4155190|NCT00847626|3978655|B1|Black or African American||Race (NIH/OMB)||participants|Number|34|34.0||||||
4155191|NCT00847626|3978644|B12|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|2|2.0||||||
4155192|NCT00847626|3978645|B11|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4155193|NCT00847626|3978646|B10|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4155194|NCT00847626|3978647|B9|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4155195|NCT00847626|3978648|B8|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4155196|NCT00847626|3978649|B7|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|1|1.0||||||
4155197|NCT00847626|3978650|B6|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4155198|NCT00847626|3978651|B5|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4155199|NCT00847626|3978652|B4|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4155200|NCT00847626|3978653|B3|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4155201|NCT00847626|3978654|B2|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|1|1.0||||||
4155202|NCT00847626|3978655|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4155203|NCT00847626|3978644|B12|Asian||Race (NIH/OMB)||participants|Number|34|34.0||||||
4155204|NCT00847626|3978645|B11|Asian||Race (NIH/OMB)||participants|Number|4|4.0||||||
4155205|NCT00847626|3978646|B10|Asian||Race (NIH/OMB)||participants|Number|1|1.0||||||
4155206|NCT00847626|3978647|B9|Asian||Race (NIH/OMB)||participants|Number|1|1.0||||||
4155207|NCT00847626|3978648|B8|Asian||Race (NIH/OMB)||participants|Number|7|7.0||||||
4155208|NCT00847626|3978649|B7|Asian||Race (NIH/OMB)||participants|Number|1|1.0||||||
4155209|NCT00847626|3978650|B6|Asian||Race (NIH/OMB)||participants|Number|3|3.0||||||
4155210|NCT00847626|3978651|B5|Asian||Race (NIH/OMB)||participants|Number|2|2.0||||||
4155211|NCT00847626|3978652|B4|Asian||Race (NIH/OMB)||participants|Number|4|4.0||||||
4155212|NCT00847626|3978653|B3|Asian||Race (NIH/OMB)||participants|Number|4|4.0||||||
4155213|NCT00847626|3978654|B2|Asian||Race (NIH/OMB)||participants|Number|3|3.0||||||
4155214|NCT00847626|3978655|B1|Asian||Race (NIH/OMB)||participants|Number|4|4.0||||||
4155215|NCT00847626|3978644|B12|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|142|142.0||||||
4155216|NCT00847626|3978645|B11|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|14|14.0||||||
4155217|NCT00847626|3978646|B10|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|13|13.0||||||
4155218|NCT00847626|3978647|B9|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|11|11.0||||||
4155219|NCT00847626|3978648|B8|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|14|14.0||||||
4155220|NCT00847626|3978649|B7|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|14|14.0||||||
4155221|NCT00847626|3978650|B6|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|16|16.0||||||
4155222|NCT00847626|3978651|B5|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|12|12.0||||||
4155223|NCT00847626|3978652|B4|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|13|13.0||||||
4155224|NCT00847626|3978653|B3|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|13|13.0||||||
4155225|NCT00847626|3978654|B2|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|13|13.0||||||
4155226|NCT00847626|3978655|B1|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|9|9.0||||||
4155227|NCT00847626|3978644|B12||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|640|640.0||||||
4155228|NCT00847626|3978645|B11||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4155229|NCT00847626|3978646|B10||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4155230|NCT00847626|3978647|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4155231|NCT00847626|3978648|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4155232|NCT00847626|3978649|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4155233|NCT00847626|3978650|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4155234|NCT00847626|3978651|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4155235|NCT00847626|3978652|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4155236|NCT00847626|3978653|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4155237|NCT00847626|3978654|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4155238|NCT00847626|3978655|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4155239|NCT00847626|3978644|B12||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|897|897.0||||||
4155240|NCT00847626|3978645|B11||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4155241|NCT00847626|3978646|B10||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
4155242|NCT00847626|3978647|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
4155243|NCT00847626|3978648|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4155244|NCT00847626|3978649|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
4155245|NCT00847626|3978650|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
4155246|NCT00847626|3978651|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
4155247|NCT00847626|3978652|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
4155248|NCT00847626|3978653|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
4155249|NCT00847626|3978654|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4155250|NCT00847626|3978655|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4155251|NCT00847626|3978644|B12||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|177|177.0||||||
4155252|NCT00847626|3978645|B11||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4155253|NCT00847626|3978646|B10||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4155254|NCT00847626|3978647|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4155255|NCT00847626|3978648|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4155256|NCT00847626|3978649|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4155257|NCT00847626|3978650|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4155258|NCT00847626|3978651|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4155259|NCT00847626|3978652|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4155260|NCT00847626|3978653|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4155261|NCT00847626|3978654|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4155262|NCT00847626|3978655|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4155263|NCT00847626|3978644|B12||Male|Sex: Female, Male||Participants|Count of Participants|805|805.0||||||
4155264|NCT00847626|3978645|B11||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4155265|NCT00847626|3978646|B10||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4155266|NCT00847626|3978647|B9||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4155267|NCT00847626|3978648|B8||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4155268|NCT00847626|3978649|B7||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4155269|NCT00847626|3978650|B6||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4155270|NCT00847626|3978651|B5||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4155271|NCT00847626|3978652|B4||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4155272|NCT00847626|3978653|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4155273|NCT00847626|3978654|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4155274|NCT00847626|3978655|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4155275|NCT00847626|3978644|B12||Female|Sex: Female, Male||Participants|Count of Participants|909|909.0||||||
4155276|NCT00847626|3978645|B11||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4155277|NCT00847626|3978646|B10||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4155278|NCT00847626|3978647|B9||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4155279|NCT00847626|3978648|B8||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4155280|NCT00847626|3978649|B7||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4155281|NCT00847626|3978650|B6||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4155282|NCT00847626|3978651|B5||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4155283|NCT00847626|3978652|B4||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4155284|NCT00847626|3978653|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4155285|NCT00847626|3978654|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4155286|NCT00847626|3978655|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4155287|NCT00847626|3978644|B12|≥65 years||Age, Customized||participants|Number|422|422.0||||||
4155288|NCT00847626|3978645|B11|≥65 years||Age, Customized||participants|Number|39|39.0||||||
4155289|NCT00847626|3978646|B10|≥65 years||Age, Customized||participants|Number|38|38.0||||||
4155290|NCT00847626|3978647|B9|≥65 years||Age, Customized||participants|Number|40|40.0||||||
4155291|NCT00847626|3978648|B8|≥65 years||Age, Customized||participants|Number|33|33.0||||||
4155292|NCT00847626|3978649|B7|≥65 years||Age, Customized||participants|Number|39|39.0||||||
4155293|NCT00847626|3978650|B6|≥65 years||Age, Customized||participants|Number|39|39.0||||||
4155294|NCT00847626|3978651|B5|≥65 years||Age, Customized||participants|Number|38|38.0||||||
4155295|NCT00847626|3978652|B4|≥65 years||Age, Customized||participants|Number|42|42.0||||||
4155296|NCT00847626|3978653|B3|≥65 years||Age, Customized||participants|Number|30|30.0||||||
4155297|NCT00847626|3978654|B2|≥65 years||Age, Customized||participants|Number|41|41.0||||||
4155298|NCT00847626|3978655|B1|≥65 years||Age, Customized||participants|Number|43|43.0||||||
4155299|NCT00847626|3978644|B12|Between 45 to 64 years||Age, Customized||participants|Number|1089|1089.0||||||
4155300|NCT00847626|3978645|B11|Between 45 to 64 years||Age, Customized||participants|Number|107|107.0||||||
4155301|NCT00847626|3978646|B10|Between 45 to 64 years||Age, Customized||participants|Number|98|98.0||||||
4155302|NCT00847626|3978647|B9|Between 45 to 64 years||Age, Customized||participants|Number|97|97.0||||||
4155303|NCT00847626|3978648|B8|Between 45 to 64 years||Age, Customized||participants|Number|108|108.0||||||
4155304|NCT00847626|3978649|B7|Between 45 to 64 years||Age, Customized||participants|Number|97|97.0||||||
4155305|NCT00847626|3978650|B6|Between 45 to 64 years||Age, Customized||participants|Number|104|104.0||||||
4155306|NCT00847626|3978651|B5|Between 45 to 64 years||Age, Customized||participants|Number|90|90.0||||||
4155307|NCT00847626|3978652|B4|Between 45 to 64 years||Age, Customized||participants|Number|93|93.0||||||
4155308|NCT00847626|3978653|B3|Between 45 to 64 years||Age, Customized||participants|Number|100|100.0||||||
4155309|NCT00847626|3978654|B2|Between 45 to 64 years||Age, Customized||participants|Number|97|97.0||||||
4155310|NCT00847626|3978655|B1|Between 45 to 64 years||Age, Customized||participants|Number|98|98.0||||||
4155311|NCT00847626|3978644|B12|<45 years||Age, Customized||participants|Number|203|203.0||||||
4155312|NCT00847626|3978645|B11|<45 years||Age, Customized||participants|Number|16|16.0||||||
4155313|NCT00847626|3978646|B10|<45 years||Age, Customized||participants|Number|17|17.0||||||
4155314|NCT00847626|3978647|B9|<45 years||Age, Customized||participants|Number|18|18.0||||||
4155315|NCT00847626|3978648|B8|<45 years||Age, Customized||participants|Number|18|18.0||||||
4155316|NCT00847626|3978649|B7|<45 years||Age, Customized||participants|Number|21|21.0||||||
4155317|NCT00847626|3978650|B6|<45 years||Age, Customized||participants|Number|19|19.0||||||
4155318|NCT00847626|3978651|B5|<45 years||Age, Customized||participants|Number|25|25.0||||||
4155319|NCT00847626|3978652|B4|<45 years||Age, Customized||participants|Number|21|21.0||||||
4155320|NCT00847626|3978653|B3|<45 years||Age, Customized||participants|Number|17|17.0||||||
4155321|NCT00847626|3978654|B2|<45 years||Age, Customized||participants|Number|16|16.0||||||
4155322|NCT00847626|3978655|B1|<45 years||Age, Customized||participants|Number|15|15.0||||||
4155323|NCT00847626|3978644|B12|||Age||years|Mean|57.2|57.2|Standard Deviation|10.82|10.82|||
4155324|NCT00847626|3978645|B11|||Age||years|Mean|57.3|57.3|Standard Deviation|10.87|10.87|||
4155325|NCT00847626|3978646|B10|||Age||years|Mean|57.8|57.8|Standard Deviation|10.28|10.28|||
4155326|NCT00847626|3978647|B9|||Age||years|Mean|57.3|57.3|Standard Deviation|11.04|11.04|||
4155327|NCT00847626|3978648|B8|||Age||years|Mean|56.2|56.2|Standard Deviation|10.04|10.04|||
4155328|NCT00847626|3978649|B7|||Age||years|Mean|57.3|57.3|Standard Deviation|11.30|11.3|||
4155329|NCT00847626|3978650|B6|||Age||years|Mean|57.6|57.6|Standard Deviation|11.04|11.04|||
4155330|NCT00847626|3978651|B5|||Age||years|Mean|55.8|55.8|Standard Deviation|11.22|11.22|||
4155331|NCT00847626|3978652|B4|||Age||years|Mean|57.4|57.4|Standard Deviation|11.07|11.07|||
4155332|NCT00847626|3978653|B3|||Age||years|Mean|56.2|56.2|Standard Deviation|10.50|10.5|||
4155333|NCT00847626|3978654|B2|||Age||years|Mean|57.4|57.4|Standard Deviation|11.13|11.13|||
4155334|NCT00847626|3978655|B1|||Age||years|Mean|58.2|58.2|Standard Deviation|10.57|10.57|||
4155335|NCT00847613|3978860|B5||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4155336|NCT00847613|3978861|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4155337|NCT00847613|3978862|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4155338|NCT00847613|3978863|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4155339|NCT00847613|3978864|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4155340|NCT00847613|3978860|B5||Female|Sex: Female, Male||Participants|Count of Participants|679|679.0||||||
4155341|NCT00847613|3978861|B4||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4155342|NCT00847613|3978862|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4155343|NCT00847613|3978863|B2||Female|Sex: Female, Male||Participants|Count of Participants|273|273.0||||||
4155344|NCT00847613|3978864|B1||Female|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
4155345|NCT00847613|3978860|B5|||Age||years|Mean|52.8|52.8|Standard Deviation|11.5|11.5|||
4155346|NCT00847613|3978861|B4|||Age||years|Mean|52.1|52.1|Standard Deviation|11.8|11.8|||
4155347|NCT00847613|3978862|B3|||Age||years|Mean|53.2|53.2|Standard Deviation|11.5|11.5|||
4155348|NCT00847613|3978863|B2|||Age||years|Mean|52.0|52.0|Standard Deviation|11.4|11.4|||
4155349|NCT00847613|3978864|B1|||Age||years|Mean|53.7|53.7|Standard Deviation|11.6|11.6|||
4155350|NCT00847587|3979105|B3|United States||Region of Enrollment||participants|Number|69|69.0||||||
4155351|NCT00847587|3979106|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
4155352|NCT00847587|3979107|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4155353|NCT00847587|3979105|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4155354|NCT00847587|3979106|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4155355|NCT00847587|3979107|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4155356|NCT00847587|3979105|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4155357|NCT00847587|3979106|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4155358|NCT00847587|3979107|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4155359|NCT00847587|3979105|B3|||Age||years|Mean|26|26.0|Standard Deviation|6|6.0|||
4155360|NCT00847587|3979106|B2|||Age||years|Mean|25|25.0|Standard Deviation|6|6.0|||
4155361|NCT00847587|3979107|B1|||Age||years|Mean|27|27.0|Standard Deviation|6|6.0|||
4155362|NCT00847561|3979116|B3|United States||Region of Enrollment||participants|Number|136|136.0||||||
4155363|NCT00847561|3979117|B2|United States||Region of Enrollment||participants|Number|66|66.0||||||
4155364|NCT00847561|3979118|B1|United States||Region of Enrollment||participants|Number|70|70.0||||||
4155365|NCT00847561|3979116|B3|other ethnicity/race||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4155366|NCT00847561|3979117|B2|other ethnicity/race||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4155367|NCT00847561|3979118|B1|other ethnicity/race||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4155368|NCT00847561|3979116|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|115|115.0||||||
4155369|NCT00847561|3979117|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
4155370|NCT00847561|3979118|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
4155371|NCT00847561|3979116|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4155372|NCT00847561|3979117|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4155373|NCT00847561|3979118|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4155374|NCT00847561|3979116|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4155375|NCT00847561|3979117|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4155376|NCT00847561|3979118|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4155377|NCT00847561|3979116|B3|||Age||years|Mean|8.69|8.69|Standard Deviation|1.80|1.8|||
4155378|NCT00847561|3979117|B2|||Age||years|Mean|8.86|8.86|Standard Deviation|1.85|1.85|||
4155379|NCT00847561|3979118|B1|||Age||years|Mean|8.53|8.53|Standard Deviation|7.76|7.76|||
4155380|NCT00847535|3979125|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4155381|NCT00847535|3979125|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4155382|NCT00847535|3979125|B1|||Age||years|Mean|54|54.0|Standard Deviation|1|1.0|||
4155383|NCT00847522|3979135|B1|United States||Region of Enrollment||Participants|Count of Participants|90|90.0||||||
4155384|NCT00847522|3979135|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4155385|NCT00847522|3979135|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4155386|NCT00847522|3979135|B1|||Age||years|Median|50.5|50.5|Full Range|||24.0|88.0|
4155387|NCT00847509|3979140|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
4155388|NCT00847509|3979140|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4155389|NCT00847509|3979140|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4155390|NCT00847509|3979140|B1|||Age||years|Mean|64.67|64.67|Standard Deviation|10.38|10.38|||
4155391|NCT00847509|3979140|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4155392|NCT00847509|3979140|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4155393|NCT00847509|3979140|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4155394|NCT00847405|3979144|B3|Canada||Region of Enrollment||participants|Number|28|28.0||||||
4155395|NCT00847405|3979145|B2|Canada||Region of Enrollment||participants|Number|14|14.0||||||
4155396|NCT00847405|3979146|B1|Canada||Region of Enrollment||participants|Number|14|14.0||||||
4155397|NCT00847405|3979144|B3|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4155398|NCT00847405|3979145|B2|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4155399|NCT00847405|3979146|B1|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4155400|NCT00847405|3979144|B3|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4155401|NCT00847405|3979145|B2|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4155402|NCT00847405|3979146|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4155403|NCT00847405|3979144|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4155404|NCT00847405|3979145|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4155405|NCT00847405|3979146|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4155406|NCT00847405|3979144|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4155407|NCT00847405|3979145|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4155408|NCT00847405|3979146|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4155409|NCT00847405|3979144|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4155410|NCT00847405|3979145|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4155411|NCT00847405|3979146|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4155412|NCT00847405|3979144|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4155413|NCT00847405|3979145|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4155414|NCT00847405|3979146|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4155415|NCT00847405|3979144|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4155416|NCT00847405|3979145|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4155417|NCT00847405|3979146|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4155418|NCT00847405|3979144|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4155419|NCT00847405|3979145|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4155420|NCT00847405|3979146|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4155421|NCT00847301|3979155|B1||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4155422|NCT00847301|3979155|B1||Female|Sex: Female, Male||Participants|Count of Participants|324|324.0||||||
4155423|NCT00847301|3979155|B1|||Age||years|Mean|78.6|78.6|Standard Deviation|7.4|7.4|||
4155424|NCT00847288|3979163|B3|||Diastolic blood pressure||mmHg|Mean|70.8|70.8|Standard Deviation|10.5|10.5|||
4155425|NCT00847288|3979164|B2|||Diastolic blood pressure||mmHg|Mean|72.4|72.4|Standard Deviation|10.7|10.7|||
4155426|NCT00847288|3979165|B1|||Diastolic blood pressure||mmHg|Mean|69.2|69.2|Standard Deviation|10.1|10.1|||
4155427|NCT00847288|3979163|B3|||Systolic blood pressure||mmHg|Mean|120.6|120.6|Standard Deviation|17.2|17.2|||
4155428|NCT00847288|3979164|B2|||Systolic blood pressure||mmHg|Mean|122.7|122.7|Standard Deviation|17.1|17.1|||
4155429|NCT00847288|3979165|B1|||Systolic blood pressure||mmHg|Mean|118.6|118.6|Standard Deviation|17.0|17.0|||
4155430|NCT00847288|3979163|B3|||Weight||lbs|Mean|196.3|196.3|Standard Deviation|47.4|47.4|||
4155431|NCT00847288|3979164|B2|||Weight||lbs|Mean|196.1|196.1|Standard Deviation|48.8|48.8|||
4155432|NCT00847288|3979165|B1|||Weight||lbs|Mean|196.5|196.5|Standard Deviation|45.9|45.9|||
4155433|NCT00847288|3979163|B3|||Height||inches|Mean|68.1|68.1|Standard Deviation|4.1|4.1|||
4155434|NCT00847288|3979164|B2|||Height||inches|Mean|68.1|68.1|Standard Deviation|4.2|4.2|||
4155435|NCT00847288|3979165|B1|||Height||inches|Mean|68.2|68.2|Standard Deviation|4.0|4.0|||
4155436|NCT00847288|3979163|B3|Not Available||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4155437|NCT00847288|3979164|B2|Not Available||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4155438|NCT00847288|3979165|B1|Not Available||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4155439|NCT00847288|3979163|B3|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4155440|NCT00847288|3979164|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4155441|NCT00847288|3979165|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4155442|NCT00847288|3979163|B3|Multiple||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4155443|NCT00847288|3979164|B2|Multiple||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4155444|NCT00847288|3979165|B1|Multiple||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4155445|NCT00847288|3979163|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|89|89.0||||||
4155446|NCT00847288|3979164|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
4155447|NCT00847288|3979165|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4155448|NCT00847288|3979163|B3|Hawaiian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4155449|NCT00847288|3979164|B2|Hawaiian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4155450|NCT00847288|3979165|B1|Hawaiian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4155451|NCT00847288|3979163|B3|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4155452|NCT00847288|3979164|B2|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4155453|NCT00847288|3979165|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4155454|NCT00847288|3979163|B3|American Indian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4155455|NCT00847288|3979164|B2|American Indian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4155456|NCT00847288|3979165|B1|American Indian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4155457|NCT00847288|3979163|B3|Black||Race/Ethnicity, Customized||participants|Number|151|151.0||||||
4155458|NCT00847288|3979164|B2|Black||Race/Ethnicity, Customized||participants|Number|98|98.0||||||
4155459|NCT00847288|3979165|B1|Black||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
4155460|NCT00847288|3979163|B3|White||Race/Ethnicity, Customized||participants|Number|1370|1370.0||||||
4155461|NCT00847288|3979164|B2|White||Race/Ethnicity, Customized||participants|Number|621|621.0||||||
4155462|NCT00847288|3979165|B1|White||Race/Ethnicity, Customized||participants|Number|749|749.0||||||
4155463|NCT00847288|3979163|B3||Male|Sex: Female, Male||Participants|Count of Participants|1206|1206.0||||||
4155464|NCT00847288|3979164|B2||Male|Sex: Female, Male||Participants|Count of Participants|603|603.0||||||
4155465|NCT00847288|3979165|B1||Male|Sex: Female, Male||Participants|Count of Participants|603|603.0||||||
4155466|NCT00847288|3979163|B3||Female|Sex: Female, Male||Participants|Count of Participants|462|462.0||||||
4155467|NCT00847288|3979164|B2||Female|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
4155468|NCT00847288|3979165|B1||Female|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
4155469|NCT00847288|3979163|B3|||Age||years|Mean|68.0|68.0|Standard Deviation|11.7|11.7|||
4155470|NCT00847288|3979164|B2|||Age||years|Mean|67.6|67.6|Standard Deviation|11.6|11.6|||
4155471|NCT00847288|3979165|B1|||Age||years|Mean|68.3|68.3|Standard Deviation|11.8|11.8|||
4155472|NCT00847210|3979178|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4155473|NCT00847210|3979179|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4155474|NCT00847210|3979180|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4155475|NCT00847210|3979178|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4155476|NCT00847210|3979179|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4155477|NCT00847210|3979180|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4155478|NCT00847210|3979178|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4155479|NCT00847210|3979179|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4155480|NCT00847210|3979180|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4155481|NCT00847210|3979178|B3|||Age||years|Mean|14.6|14.6|Standard Deviation|1.75|1.75|||
4155482|NCT00847210|3979179|B2|||Age||years|Mean|14.6|14.6|Standard Deviation|1.89|1.89|||
4155483|NCT00847210|3979180|B1|||Age||years|Mean|14.6|14.6|Standard Deviation|1.65|1.65|||
4155484|NCT00847197|3979201|B3|||Pulse||beats/minute|Mean|68.1|68.1|Standard Deviation|8.8|8.8|||
4155485|NCT00847197|3979202|B2|||Pulse||beats/minute|Mean|68.5|68.5|Standard Deviation|8.9|8.9|||
4155486|NCT00847197|3979203|B1|||Pulse||beats/minute|Mean|67.8|67.8|Standard Deviation|8.8|8.8|||
4155487|NCT00847197|3979201|B3|||Diastolic Blood Pressure||mm Hg|Mean|77.6|77.6|Standard Deviation|8.9|8.9|||
4155488|NCT00847197|3979202|B2|||Diastolic Blood Pressure||mm Hg|Mean|77.1|77.1|Standard Deviation|9.0|9.0|||
4155489|NCT00847197|3979203|B1|||Diastolic Blood Pressure||mm Hg|Mean|77.9|77.9|Standard Deviation|8.9|8.9|||
4155490|NCT00847197|3979201|B3|||Systolic Blood Pressure||mm Hg|Mean|122.7|122.7|Standard Deviation|13.5|13.5|||
4155491|NCT00847197|3979202|B2|||Systolic Blood Pressure||mm Hg|Mean|122.3|122.3|Standard Deviation|13.5|13.5|||
4155492|NCT00847197|3979203|B1|||Systolic Blood Pressure||mm Hg|Mean|122.9|122.9|Standard Deviation|13.6|13.6|||
4155493|NCT00847197|3979201|B3|||Body Mass Index||kg/m^2|Mean|28.7|28.7|Standard Deviation|4.8|4.8|||
4155494|NCT00847197|3979202|B2|||Body Mass Index||kg/m^2|Mean|28.7|28.7|Standard Deviation|4.5|4.5|||
4155495|NCT00847197|3979203|B1|||Body Mass Index||kg/m^2|Mean|28.7|28.7|Standard Deviation|5.0|5.0|||
4155496|NCT00847197|3979201|B3|||Height||Centimeter|Mean|168.2|168.2|Standard Deviation|10.3|10.3|||
4155497|NCT00847197|3979202|B2|||Height||Centimeter|Mean|167.9|167.9|Standard Deviation|10.2|10.2|||
4155498|NCT00847197|3979203|B1|||Height||Centimeter|Mean|168.3|168.3|Standard Deviation|10.5|10.5|||
4155499|NCT00847197|3979201|B3|||Weight||Kilogram|Mean|81.7|81.7|Standard Deviation|17.7|17.7|||
4155500|NCT00847197|3979202|B2|||Weight||Kilogram|Mean|81.6|81.6|Standard Deviation|17.5|17.5|||
4155501|NCT00847197|3979203|B1|||Weight||Kilogram|Mean|81.9|81.9|Standard Deviation|17.9|17.9|||
4155502|NCT00847197|3979201|B3|Others (> 125 mg/dL)||Glycemic Status||Participants|Number|2|2.0||||||
4155503|NCT00847197|3979202|B2|Others (> 125 mg/dL)||Glycemic Status||Participants|Number|1|1.0||||||
4155504|NCT00847197|3979203|B1|Others (> 125 mg/dL)||Glycemic Status||Participants|Number|1|1.0||||||
4155505|NCT00847197|3979201|B3|Impaired Fasting Glucose ( ≥ 100 & ≤ 125 mg/dL)||Glycemic Status||Participants|Number|57|57.0||||||
4155506|NCT00847197|3979202|B2|Impaired Fasting Glucose ( ≥ 100 & ≤ 125 mg/dL)||Glycemic Status||Participants|Number|21|21.0||||||
4155507|NCT00847197|3979203|B1|Impaired Fasting Glucose ( ≥ 100 & ≤ 125 mg/dL)||Glycemic Status||Participants|Number|36|36.0||||||
4155508|NCT00847197|3979201|B3|Normal (< 100 mg/dL)||Glycemic Status||Participants|Number|132|132.0||||||
4155509|NCT00847197|3979202|B2|Normal (< 100 mg/dL)||Glycemic Status||Participants|Number|53|53.0||||||
4155510|NCT00847197|3979203|B1|Normal (< 100 mg/dL)||Glycemic Status||Participants|Number|79|79.0||||||
4155511|NCT00847197|3979201|B3|No||Prior Niacin History||Participants|Number|170|170.0||||||
4155512|NCT00847197|3979202|B2|No||Prior Niacin History||Participants|Number|64|64.0||||||
4155513|NCT00847197|3979203|B1|No||Prior Niacin History||Participants|Number|106|106.0||||||
4155514|NCT00847197|3979201|B3|Yes||Prior Niacin History||Participants|Number|21|21.0||||||
4155515|NCT00847197|3979202|B2|Yes||Prior Niacin History||Participants|Number|11|11.0||||||
4155516|NCT00847197|3979203|B1|Yes||Prior Niacin History||Participants|Number|10|10.0||||||
4155517|NCT00847197|3979201|B3|Multiple Risk||Coronary Heart Disease (CHD) Risk Category||Participants|Number|42|42.0||||||
4155518|NCT00847197|3979202|B2|Multiple Risk||Coronary Heart Disease (CHD) Risk Category||Participants|Number|16|16.0||||||
4155519|NCT00847197|3979203|B1|Multiple Risk||Coronary Heart Disease (CHD) Risk Category||Participants|Number|26|26.0||||||
4155520|NCT00847197|3979201|B3|Low Risk||Coronary Heart Disease (CHD) Risk Category||Participants|Number|149|149.0||||||
4155521|NCT00847197|3979202|B2|Low Risk||Coronary Heart Disease (CHD) Risk Category||Participants|Number|59|59.0||||||
4155522|NCT00847197|3979203|B1|Low Risk||Coronary Heart Disease (CHD) Risk Category||Participants|Number|90|90.0||||||
4155523|NCT00847197|3979201|B3|=> 40||Body Mass Index (BMI) Category||participants|Number|5|5.0||||||
4155524|NCT00847197|3979202|B2|=> 40||Body Mass Index (BMI) Category||participants|Number|2|2.0||||||
4155525|NCT00847197|3979203|B1|=> 40||Body Mass Index (BMI) Category||participants|Number|3|3.0||||||
4155526|NCT00847197|3979201|B3|31 - 39||Body Mass Index (BMI) Category||participants|Number|45|45.0||||||
4155527|NCT00847197|3979202|B2|31 - 39||Body Mass Index (BMI) Category||participants|Number|17|17.0||||||
4155528|NCT00847197|3979203|B1|31 - 39||Body Mass Index (BMI) Category||participants|Number|28|28.0||||||
4155529|NCT00847197|3979201|B3|25 - 30||Body Mass Index (BMI) Category||participants|Number|107|107.0||||||
4155530|NCT00847197|3979202|B2|25 - 30||Body Mass Index (BMI) Category||participants|Number|42|42.0||||||
4155531|NCT00847197|3979203|B1|25 - 30||Body Mass Index (BMI) Category||participants|Number|65|65.0||||||
4155532|NCT00847197|3979201|B3|< 25||Body Mass Index (BMI) Category||participants|Number|34|34.0||||||
4155533|NCT00847197|3979202|B2|< 25||Body Mass Index (BMI) Category||participants|Number|14|14.0||||||
4155534|NCT00847197|3979203|B1|< 25||Body Mass Index (BMI) Category||participants|Number|20|20.0||||||
4155535|NCT00847197|3979201|B3|Ex-United States||Region|Ex-United States: Malaysia, Canada, Peru, Philipines, Colombia, Sweden, Finland|participants|Number|97|97.0||||||
4155536|NCT00847197|3979202|B2|Ex-United States||Region|Ex-United States: Malaysia, Canada, Peru, Philipines, Colombia, Sweden, Finland|participants|Number|37|37.0||||||
4155537|NCT00847197|3979203|B1|Ex-United States||Region|Ex-United States: Malaysia, Canada, Peru, Philipines, Colombia, Sweden, Finland|participants|Number|60|60.0||||||
4155538|NCT00847197|3979201|B3|United States||Region|Ex-United States: Malaysia, Canada, Peru, Philipines, Colombia, Sweden, Finland|participants|Number|94|94.0||||||
4155539|NCT00847197|3979202|B2|United States||Region|Ex-United States: Malaysia, Canada, Peru, Philipines, Colombia, Sweden, Finland|participants|Number|38|38.0||||||
4155540|NCT00847197|3979203|B1|United States||Region|Ex-United States: Malaysia, Canada, Peru, Philipines, Colombia, Sweden, Finland|participants|Number|56|56.0||||||
4155541|NCT00847197|3979201|B3||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4155542|NCT00847197|3979202|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4155543|NCT00847197|3979203|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4155544|NCT00847197|3979201|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4155545|NCT00847197|3979202|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4155546|NCT00847197|3979203|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4155547|NCT00847197|3979201|B3|||Age||years|Mean|51.9|51.9|Standard Deviation|10.7|10.7|||
4155548|NCT00847197|3979202|B2|||Age||years|Mean|50.9|50.9|Standard Deviation|11.1|11.1|||
4155549|NCT00847197|3979203|B1|||Age||years|Mean|52.6|52.6|Standard Deviation|10.4|10.4|||
4155550|NCT00847171|3979214|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4155551|NCT00847171|3979214|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4155552|NCT00847171|3979214|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4155553|NCT00847171|3979214|B1|||Age||years|Mean|47|47.0|Full Range|||34.0|66.0|
4155554|NCT00847145|3979220|B9||Male|Sex: Female, Male||Participants|Count of Participants|1152|1152.0||||||
4155555|NCT00847145|3979221|B8||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4155556|NCT00847145|3979222|B7||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4155557|NCT00847145|3979223|B6||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4155558|NCT00847145|3979224|B5||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4155559|NCT00847145|3979225|B4||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4155560|NCT00847145|3979226|B3||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4155561|NCT00847145|3979227|B2||Male|Sex: Female, Male||Participants|Count of Participants|303|303.0||||||
4155562|NCT00847145|3979228|B1||Male|Sex: Female, Male||Participants|Count of Participants|339|339.0||||||
4155563|NCT00847145|3979220|B9||Female|Sex: Female, Male||Participants|Count of Participants|1097|1097.0||||||
4155564|NCT00847145|3979221|B8||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4155565|NCT00847145|3979222|B7||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4155566|NCT00847145|3979223|B6||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4155567|NCT00847145|3979224|B5||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4155568|NCT00847145|3979225|B4||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4155569|NCT00847145|3979226|B3||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4155570|NCT00847145|3979227|B2||Female|Sex: Female, Male||Participants|Count of Participants|330|330.0||||||
4155571|NCT00847145|3979228|B1||Female|Sex: Female, Male||Participants|Count of Participants|290|290.0||||||
4155572|NCT00847145|3979220|B9|||Age||years|Mean|12.3|12.3|Standard Deviation|0.5|0.5|||
4155573|NCT00847145|3979221|B8|||Age||years|Mean|12.2|12.2|Standard Deviation|0.4|0.4|||
4155574|NCT00847145|3979222|B7|||Age||years|Mean|12.2|12.2|Standard Deviation|0.5|0.5|||
4155575|NCT00847145|3979223|B6|||Age||years|Mean|12.2|12.2|Standard Deviation|0.4|0.4|||
4155576|NCT00847145|3979224|B5|||Age||years|Mean|12.2|12.2|Standard Deviation|0.5|0.5|||
4155577|NCT00847145|3979225|B4|||Age||years|Mean|12.3|12.3|Standard Deviation|0.5|0.5|||
4155578|NCT00847145|3979226|B3|||Age||years|Mean|12.3|12.3|Standard Deviation|0.5|0.5|||
4155579|NCT00847145|3979227|B2|||Age||years|Mean|12.3|12.3|Standard Deviation|0.5|0.5|||
4155580|NCT00847145|3979228|B1|||Age||years|Mean|12.3|12.3|Standard Deviation|0.5|0.5|||
4155581|NCT00847132|3979283|B3|||Women and Ischemia Syndrome Evaluation-Number (WISE)|"The WISE is a 10-item scale that assesses the number and severity of cardiac symptoms. Each question offers 4 responses: 0 = None (no symptom), 1 = Mild, 2 = Moderate, 3 = Severe.~The Severity score represents the severity of cardiac illness. It's derived by adding all scores together. The Severity score can range from 0-30. A lower score means less severity of symptoms.~The Number score represents the number of symptoms of cardiac illness. It's derived by counting the number of symptoms that scored 1 or more. The Number score can range from 0-10. A lower score means fewer symptoms."|units on a scale|Mean|6.0|6.0|Standard Deviation|2.1|2.1|||
4155582|NCT00847132|3979284|B2|||Women and Ischemia Syndrome Evaluation-Number (WISE)|"The WISE is a 10-item scale that assesses the number and severity of cardiac symptoms. Each question offers 4 responses: 0 = None (no symptom), 1 = Mild, 2 = Moderate, 3 = Severe.~The Severity score represents the severity of cardiac illness. It's derived by adding all scores together. The Severity score can range from 0-30. A lower score means less severity of symptoms.~The Number score represents the number of symptoms of cardiac illness. It's derived by counting the number of symptoms that scored 1 or more. The Number score can range from 0-10. A lower score means fewer symptoms."|units on a scale|Mean|6.1|6.1|Standard Deviation|2.0|2.0|||
4155583|NCT00847132|3979285|B1|||Women and Ischemia Syndrome Evaluation-Number (WISE)|"The WISE is a 10-item scale that assesses the number and severity of cardiac symptoms. Each question offers 4 responses: 0 = None (no symptom), 1 = Mild, 2 = Moderate, 3 = Severe.~The Severity score represents the severity of cardiac illness. It's derived by adding all scores together. The Severity score can range from 0-30. A lower score means less severity of symptoms.~The Number score represents the number of symptoms of cardiac illness. It's derived by counting the number of symptoms that scored 1 or more. The Number score can range from 0-10. A lower score means fewer symptoms."|units on a scale|Mean|6.0|6.0|Standard Deviation|2.2|2.2|||
4155584|NCT00847132|3979283|B3|||Medical Outcomes Study Short Form-12 Physical Component Score (SF-12 PCS)|The SF-12 Physical Component Score is a 6-item scale that assesses physical health-related quality of life. Each question provides the option of 2-6 answers. Some questions are Yes/No (2 options), while others ask how often something occurs (6 options, etc.). Scores are calculated using a formula and can range from 0 to 100. A score of 50 indicates average physical health-related quality of life. Higher scores represent higher than average physical health-related quality of life, and lower scores represent lower physical health-related quality of life.|units on a scale|Mean|31.8|31.8|Standard Deviation|9.9|9.9|||
4155585|NCT00847132|3979284|B2|||Medical Outcomes Study Short Form-12 Physical Component Score (SF-12 PCS)|The SF-12 Physical Component Score is a 6-item scale that assesses physical health-related quality of life. Each question provides the option of 2-6 answers. Some questions are Yes/No (2 options), while others ask how often something occurs (6 options, etc.). Scores are calculated using a formula and can range from 0 to 100. A score of 50 indicates average physical health-related quality of life. Higher scores represent higher than average physical health-related quality of life, and lower scores represent lower physical health-related quality of life.|units on a scale|Mean|31.3|31.3|Standard Deviation|9.4|9.4|||
4155586|NCT00847132|3979285|B1|||Medical Outcomes Study Short Form-12 Physical Component Score (SF-12 PCS)|The SF-12 Physical Component Score is a 6-item scale that assesses physical health-related quality of life. Each question provides the option of 2-6 answers. Some questions are Yes/No (2 options), while others ask how often something occurs (6 options, etc.). Scores are calculated using a formula and can range from 0 to 100. A score of 50 indicates average physical health-related quality of life. Higher scores represent higher than average physical health-related quality of life, and lower scores represent lower physical health-related quality of life.|units on a scale|Mean|32.2|32.2|Standard Deviation|10.4|10.4|||
4155587|NCT00847132|3979283|B3|||Women and Ischemia Syndrome Evaluation-Severity (WISE)|"The WISE is a 10-item scale that assesses the number and severity of cardiac symptoms. Each question offers 4 responses: 0 = None (no symptom), 1 = Mild, 2 = Moderate, 3 = Severe.~The Severity score represents the severity of cardiac illness. It's derived by adding all scores together. The Severity score can range from 0-30. A lower score means less severity of symptoms.~The Number score represents the number of symptoms of cardiac illness. It's derived by counting the number of symptoms that scored 1 or more. The Number score can range from 0-10. A lower score means fewer symptoms."|units on a scale|Mean|11.9|11.9|Standard Deviation|5.1|5.1|||
4155588|NCT00847132|3979284|B2|||Women and Ischemia Syndrome Evaluation-Severity (WISE)|"The WISE is a 10-item scale that assesses the number and severity of cardiac symptoms. Each question offers 4 responses: 0 = None (no symptom), 1 = Mild, 2 = Moderate, 3 = Severe.~The Severity score represents the severity of cardiac illness. It's derived by adding all scores together. The Severity score can range from 0-30. A lower score means less severity of symptoms.~The Number score represents the number of symptoms of cardiac illness. It's derived by counting the number of symptoms that scored 1 or more. The Number score can range from 0-10. A lower score means fewer symptoms."|units on a scale|Mean|11.7|11.7|Standard Deviation|4.6|4.6|||
4155589|NCT00847132|3979285|B1|||Women and Ischemia Syndrome Evaluation-Severity (WISE)|"The WISE is a 10-item scale that assesses the number and severity of cardiac symptoms. Each question offers 4 responses: 0 = None (no symptom), 1 = Mild, 2 = Moderate, 3 = Severe.~The Severity score represents the severity of cardiac illness. It's derived by adding all scores together. The Severity score can range from 0-30. A lower score means less severity of symptoms.~The Number score represents the number of symptoms of cardiac illness. It's derived by counting the number of symptoms that scored 1 or more. The Number score can range from 0-10. A lower score means fewer symptoms."|units on a scale|Mean|12.1|12.1|Standard Deviation|5.5|5.5|||
4155659|NCT00846885|3979311|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4155660|NCT00846885|3979312|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4155590|NCT00847132|3979283|B3|||Massachusetts General Hospital Cognitive and Physical Functioning Questionnaire (CPFQ)|The MGH CPFQ is a 7-item scale that assesses cognitive and executive function in mood and anxiety disorders. The MGH CPFQ asks about patients' abilities in different areas of cognition and executive function. Each question includes the following response options: 1 = greater than normal ability, 2 = normal ability, 3 = minimally diminished ability, 4 = moderately diminished ability, 5 = markedly diminished ability, 6 = totally absent ability. Scores are added and range from 7 to 42. Higher scores mean lower functioning abilities.|units on a scale|Mean|25.7|25.7|Standard Deviation|4.8|4.8|||
4155591|NCT00847132|3979284|B2|||Massachusetts General Hospital Cognitive and Physical Functioning Questionnaire (CPFQ)|The MGH CPFQ is a 7-item scale that assesses cognitive and executive function in mood and anxiety disorders. The MGH CPFQ asks about patients' abilities in different areas of cognition and executive function. Each question includes the following response options: 1 = greater than normal ability, 2 = normal ability, 3 = minimally diminished ability, 4 = moderately diminished ability, 5 = markedly diminished ability, 6 = totally absent ability. Scores are added and range from 7 to 42. Higher scores mean lower functioning abilities.|units on a scale|Mean|25.4|25.4|Standard Deviation|4.4|4.4|||
4155592|NCT00847132|3979285|B1|||Massachusetts General Hospital Cognitive and Physical Functioning Questionnaire (CPFQ)|The MGH CPFQ is a 7-item scale that assesses cognitive and executive function in mood and anxiety disorders. The MGH CPFQ asks about patients' abilities in different areas of cognition and executive function. Each question includes the following response options: 1 = greater than normal ability, 2 = normal ability, 3 = minimally diminished ability, 4 = moderately diminished ability, 5 = markedly diminished ability, 6 = totally absent ability. Scores are added and range from 7 to 42. Higher scores mean lower functioning abilities.|units on a scale|Mean|26.1|26.1|Standard Deviation|5.2|5.2|||
4155593|NCT00847132|3979283|B3|||Hospital Anxiety and Depression Scale—Anxiety Subscale (HADS-A)|The HADS-A is a 7-item scale used to measure anxiety severity. Each question asks about a specific symptom of anxiety and offers four answers: 0 = Never / Not at all, 1 = A little / Time to time, 2 = Quite often / Usually, 3 = Most of the time / Very often. Scores are totaled and range from 0-21. A higher score means more anxiety.|units on a scale|Mean|10.3|10.3|Standard Deviation|4.3|4.3|||
4155594|NCT00847132|3979284|B2|||Hospital Anxiety and Depression Scale—Anxiety Subscale (HADS-A)|The HADS-A is a 7-item scale used to measure anxiety severity. Each question asks about a specific symptom of anxiety and offers four answers: 0 = Never / Not at all, 1 = A little / Time to time, 2 = Quite often / Usually, 3 = Most of the time / Very often. Scores are totaled and range from 0-21. A higher score means more anxiety.|units on a scale|Mean|9.7|9.7|Standard Deviation|4|4.0|||
4155595|NCT00847132|3979285|B1|||Hospital Anxiety and Depression Scale—Anxiety Subscale (HADS-A)|The HADS-A is a 7-item scale used to measure anxiety severity. Each question asks about a specific symptom of anxiety and offers four answers: 0 = Never / Not at all, 1 = A little / Time to time, 2 = Quite often / Usually, 3 = Most of the time / Very often. Scores are totaled and range from 0-21. A higher score means more anxiety.|units on a scale|Mean|10.8|10.8|Standard Deviation|4.5|4.5|||
4155596|NCT00847132|3979283|B3|||Medical Outcomes Study Short Form-12 Mental Component Score (SF-12 MCS)|The SF-12 Mental Component Score is a 6-item scale that assesses mental health-related quality of life. Each question provides the option of 2-6 answers. Some questions are Yes/No (2 options), while others ask how often something occurs (6 options, etc.). Scores are calculated using a formula and can range from 0 to 100. A score of 50 indicates average mental health-related quality of life. Higher scores represent higher than average mental health-related quality of life, and lower scores represent lower mental health-related quality of life.|units on a scale|Mean|31.7|31.7|Standard Deviation|7.9|7.9|||
4155597|NCT00847132|3979284|B2|||Medical Outcomes Study Short Form-12 Mental Component Score (SF-12 MCS)|The SF-12 Mental Component Score is a 6-item scale that assesses mental health-related quality of life. Each question provides the option of 2-6 answers. Some questions are Yes/No (2 options), while others ask how often something occurs (6 options, etc.). Scores are calculated using a formula and can range from 0 to 100. A score of 50 indicates average mental health-related quality of life. Higher scores represent higher than average mental health-related quality of life, and lower scores represent lower mental health-related quality of life.|units on a scale|Mean|32.5|32.5|Standard Deviation|7.8|7.8|||
4155598|NCT00847132|3979285|B1|||Medical Outcomes Study Short Form-12 Mental Component Score (SF-12 MCS)|The SF-12 Mental Component Score is a 6-item scale that assesses mental health-related quality of life. Each question provides the option of 2-6 answers. Some questions are Yes/No (2 options), while others ask how often something occurs (6 options, etc.). Scores are calculated using a formula and can range from 0 to 100. A score of 50 indicates average mental health-related quality of life. Higher scores represent higher than average mental health-related quality of life, and lower scores represent lower mental health-related quality of life.|units on a scale|Mean|30.9|30.9|Standard Deviation|8|8.0|||
4155599|NCT00847132|3979283|B3|||Patient Health Questionnaire-9 (PHQ-9)|The PHQ-9 is a 9-item scale that measures depression severity. Each question asks how often the subject experiences symptoms of depression and offers four answers: 0 = Not at all, 1 = Several days, 2 = More than half the days, 3 = Nearly every day. Scores are totaled and range from 0-27. To be considered depressed, subjects had to (a) have a total score of 10 or more, (b) answer five questions with a score of 2 or 3, and (c) one of the five questions had to be question 1 or question 2 (or both). Anyone who did not meet these criteria were not considered depressed.|units on a scale|Mean|17.6|17.6|Standard Deviation|3.5|3.5|||
4155600|NCT00847132|3979284|B2|||Patient Health Questionnaire-9 (PHQ-9)|The PHQ-9 is a 9-item scale that measures depression severity. Each question asks how often the subject experiences symptoms of depression and offers four answers: 0 = Not at all, 1 = Several days, 2 = More than half the days, 3 = Nearly every day. Scores are totaled and range from 0-27. To be considered depressed, subjects had to (a) have a total score of 10 or more, (b) answer five questions with a score of 2 or 3, and (c) one of the five questions had to be question 1 or question 2 (or both). Anyone who did not meet these criteria were not considered depressed.|units on a scale|Mean|17.3|17.3|Standard Deviation|3.1|3.1|||
4155661|NCT00846885|3979313|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4155662|NCT00846885|3979311|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4155663|NCT00846885|3979312|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4155664|NCT00846885|3979313|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4155601|NCT00847132|3979285|B1|||Patient Health Questionnaire-9 (PHQ-9)|The PHQ-9 is a 9-item scale that measures depression severity. Each question asks how often the subject experiences symptoms of depression and offers four answers: 0 = Not at all, 1 = Several days, 2 = More than half the days, 3 = Nearly every day. Scores are totaled and range from 0-27. To be considered depressed, subjects had to (a) have a total score of 10 or more, (b) answer five questions with a score of 2 or 3, and (c) one of the five questions had to be question 1 or question 2 (or both). Anyone who did not meet these criteria were not considered depressed.|units on a scale|Mean|17.9|17.9|Standard Deviation|3.8|3.8|||
4155602|NCT00847132|3979283|B3|United States||Region of Enrollment||participants|Number|175|175.0||||||
4155603|NCT00847132|3979284|B2|United States||Region of Enrollment||participants|Number|85|85.0||||||
4155604|NCT00847132|3979285|B1|United States||Region of Enrollment||participants|Number|90|90.0||||||
4155605|NCT00847132|3979283|B3|Not White||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4155606|NCT00847132|3979284|B2|Not White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4155607|NCT00847132|3979285|B1|Not White||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4155608|NCT00847132|3979283|B3|White||Race/Ethnicity, Customized||participants|Number|160|160.0||||||
4155609|NCT00847132|3979284|B2|White||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
4155610|NCT00847132|3979285|B1|White||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
4155611|NCT00847132|3979283|B3||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4155612|NCT00847132|3979284|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4155613|NCT00847132|3979285|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4155614|NCT00847132|3979283|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4155615|NCT00847132|3979284|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4155616|NCT00847132|3979285|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4155617|NCT00847132|3979283|B3|||Age||years|Mean|62.35|62.35|Standard Deviation|12.5|12.5|||
4155618|NCT00847132|3979284|B2|||Age||years|Mean|62.6|62.6|Standard Deviation|12.2|12.2|||
4155619|NCT00847132|3979285|B1|||Age||years|Mean|62.1|62.1|Standard Deviation|12.8|12.8|||
4155620|NCT00847015|3979294|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4155621|NCT00847015|3979294|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4155622|NCT00847015|3979294|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4155623|NCT00847015|3979294|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4155624|NCT00847015|3979294|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4155625|NCT00847015|3979294|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4155626|NCT00847002|3979300|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4155627|NCT00847002|3979301|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4155628|NCT00847002|3979302|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4155629|NCT00847002|3979300|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4155630|NCT00847002|3979301|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4155631|NCT00847002|3979302|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4155632|NCT00847002|3979300|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4155633|NCT00847002|3979301|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4155634|NCT00847002|3979302|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4155635|NCT00847002|3979300|B3|||Age||years|Mean|56.5|56.5|Standard Deviation|14.3|14.3|||
4155636|NCT00847002|3979301|B2|||Age||years|Mean|54|54.0|Standard Deviation|18.9|18.9|||
4155637|NCT00847002|3979302|B1|||Age||years|Mean|59|59.0|Standard Deviation|9.8|9.8|||
4155638|NCT00847002|3979300|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4155639|NCT00847002|3979301|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4155640|NCT00847002|3979302|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4155641|NCT00847002|3979300|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4155642|NCT00847002|3979301|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4155643|NCT00847002|3979302|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4155644|NCT00847002|3979300|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4155645|NCT00847002|3979301|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4155646|NCT00847002|3979302|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4155647|NCT00846885|3979311|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
4155648|NCT00846885|3979312|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4155649|NCT00846885|3979313|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4155650|NCT00846885|3979311|B3|White||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4155651|NCT00846885|3979312|B2|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4155652|NCT00846885|3979313|B1|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4155653|NCT00846885|3979311|B3|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4155654|NCT00846885|3979312|B2|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4155655|NCT00846885|3979313|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4155656|NCT00846885|3979311|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4155657|NCT00846885|3979312|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4155658|NCT00846885|3979313|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4155665|NCT00846885|3979311|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4155666|NCT00846885|3979312|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4155667|NCT00846885|3979313|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4155668|NCT00846885|3979311|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4155669|NCT00846885|3979312|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4155670|NCT00846885|3979313|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4155671|NCT00846885|3979311|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4155672|NCT00846885|3979312|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4155673|NCT00846885|3979313|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4155674|NCT00846846|3979322|B1|United States||Region of Enrollment||participants|Number|1018|1018.0||||||
4155675|NCT00846846|3979322|B1||Male|Sex: Female, Male||Participants|Count of Participants|744|744.0||||||
4155676|NCT00846846|3979322|B1||Female|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
4155677|NCT00846846|3979322|B1|||Age||Years|Mean|63.16|63.16|Full Range|||31.0|90.0|
4155678|NCT00846807|3979327|B1||Male|Sex: Female, Male||Participants|Count of Participants|2231|2231.0||||||
4155679|NCT00846807|3979327|B1||Female|Sex: Female, Male||Participants|Count of Participants|3061|3061.0||||||
4155680|NCT00846807|3979327|B1|||Age||Years|Mean|62.6|62.6|Standard Deviation|9.2|9.2|||
4155681|NCT00846768|3979335|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4155682|NCT00846768|3979335|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4155683|NCT00846768|3979335|B1|||Age||years|Mean|65.57|65.57|Standard Deviation|7.96|7.96|||
4155684|NCT00846651|3979408|B3|United States||Region of Enrollment||participants|Number|82|82.0||||||
4155685|NCT00846651|3979409|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
4155686|NCT00846651|3979410|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4155687|NCT00846651|3979408|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4155688|NCT00846651|3979409|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4155689|NCT00846651|3979410|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4155690|NCT00846651|3979408|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4155691|NCT00846651|3979409|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4155692|NCT00846651|3979410|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4155693|NCT00846651|3979408|B3|||Age||years|Mean|26.6|26.6|Standard Deviation|5.3|5.3|||
4155694|NCT00846651|3979409|B2|||Age||years|Mean|28.3|28.3|Standard Deviation|5.9|5.9|||
4155695|NCT00846651|3979410|B1|||Age||years|Mean|25.9|25.9|Standard Deviation|5.1|5.1|||
4155696|NCT00846651|3979408|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4155697|NCT00846651|3979409|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4155698|NCT00846651|3979410|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4155699|NCT00846651|3979408|B3||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
4155700|NCT00846651|3979409|B2||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4155701|NCT00846651|3979410|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4155702|NCT00846651|3979408|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4155703|NCT00846651|3979409|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4155704|NCT00846651|3979410|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4155705|NCT00846586|3979427|B3||Male|Sex: Female, Male||Participants|Count of Participants|777|777.0||||||
4155706|NCT00846586|3979428|B2||Male|Sex: Female, Male||Participants|Count of Participants|378|378.0||||||
4155707|NCT00846586|3979429|B1||Male|Sex: Female, Male||Participants|Count of Participants|399|399.0||||||
4155708|NCT00846586|3979427|B3||Female|Sex: Female, Male||Participants|Count of Participants|354|354.0||||||
4155709|NCT00846586|3979428|B2||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4155710|NCT00846586|3979429|B1||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4155711|NCT00846586|3979427|B3|||Age|Demographics are reported for the safety set which includes all patients who received at least 1 dose of study drug.|years|Mean|63.7|63.7|Standard Deviation|9.14|9.14|||
4155712|NCT00846586|3979428|B2|||Age|Demographics are reported for the safety set which includes all patients who received at least 1 dose of study drug.|years|Mean|63.4|63.4|Standard Deviation|9.22|9.22|||
4155713|NCT00846586|3979429|B1|||Age|Demographics are reported for the safety set which includes all patients who received at least 1 dose of study drug.|years|Mean|64.0|64.0|Standard Deviation|9.07|9.07|||
4155714|NCT00846573|3979446|B4|United States||Region of Enrollment||participants|Number|14|14.0||||||
4155715|NCT00846573|3979447|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4155716|NCT00846573|3979448|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4155717|NCT00846573|3979449|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4155718|NCT00846573|3979446|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4155719|NCT00846573|3979447|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4155720|NCT00846573|3979448|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4155721|NCT00846573|3979449|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4155722|NCT00846573|3979446|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4155723|NCT00846573|3979447|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4155724|NCT00846573|3979448|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4155725|NCT00846573|3979449|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4155726|NCT00846573|3979446|B4|||Age||years|Mean|27.14|27.14|Standard Deviation|9.42|9.42|||
4155727|NCT00846573|3979447|B3|||Age||years|Mean|27|27.0|Standard Deviation|8.25|8.25|||
4155728|NCT00846573|3979448|B2|||Age||years|Mean|34.5|34.5|Standard Deviation|14.85|14.85|||
4155729|NCT00846573|3979449|B1|||Age||years|Mean|24.4|24.4|Standard Deviation|9.74|9.74|||
4155730|NCT00846573|3979446|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4155731|NCT00846573|3979447|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4155732|NCT00846573|3979448|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4155733|NCT00846573|3979449|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4155734|NCT00846573|3979446|B4||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4155735|NCT00846573|3979447|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4155736|NCT00846573|3979448|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4155737|NCT00846573|3979449|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4155738|NCT00846573|3979446|B4||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4155739|NCT00846573|3979447|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4155740|NCT00846573|3979448|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4155741|NCT00846573|3979449|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4155742|NCT00846547|3979460|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4155743|NCT00846547|3979460|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4155744|NCT00846547|3979460|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4155745|NCT00846547|3979460|B1|||Age||years|Mean|11.8|11.8|Standard Deviation|3.13|3.13|||
4155746|NCT00846547|3979460|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4155747|NCT00846547|3979460|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4155748|NCT00846547|3979460|B1||<=18 years|Age||Participants|Count of Participants|32|32.0||||||
4155749|NCT00846521|3979464|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4155750|NCT00846521|3979464|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4155751|NCT00846521|3979464|B1|||Age||years|Mean|15.2|15.2|Standard Deviation|1.1|1.1|||
4155752|NCT00846495|3979469|B3|United States||Region of Enrollment||participants|Number|55|55.0||||||
4155753|NCT00846495|3979470|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4155754|NCT00846495|3979471|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4155755|NCT00846495|3979469|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4155756|NCT00846495|3979470|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4155757|NCT00846495|3979471|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4155758|NCT00846495|3979469|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4155759|NCT00846495|3979470|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4155760|NCT00846495|3979471|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4155761|NCT00846495|3979469|B3|||Age||years|Mean|37.47|37.47|Standard Deviation|9.82|9.82|||
4155762|NCT00846495|3979470|B2|||Age||years|Mean|37.33|37.33|Standard Deviation|9.46|9.46|||
4155763|NCT00846495|3979471|B1|||Age||years|Mean|37.61|37.61|Standard Deviation|10.3|10.3|||
4155764|NCT00846495|3979469|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4155765|NCT00846495|3979470|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4155766|NCT00846495|3979471|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4155767|NCT00846495|3979469|B3||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4155768|NCT00846495|3979470|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4155769|NCT00846495|3979471|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4155770|NCT00846495|3979469|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4155771|NCT00846495|3979470|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4155772|NCT00846495|3979471|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4155773|NCT00846391|3979492|B4|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4155774|NCT00846391|3979493|B3|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4155775|NCT00846391|3979494|B2|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4155776|NCT00846391|3979495|B1|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4155777|NCT00846391|3979492|B4|Multi-Racial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4155778|NCT00846391|3979493|B3|Multi-Racial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4155779|NCT00846391|3979494|B2|Multi-Racial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4155780|NCT00846391|3979495|B1|Multi-Racial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4155781|NCT00846391|3979492|B4|Black OR African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4155782|NCT00846391|3979493|B3|Black OR African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4155783|NCT00846391|3979494|B2|Black OR African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4155784|NCT00846391|3979495|B1|Black OR African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4155785|NCT00846391|3979492|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4155786|NCT00846391|3979493|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4155787|NCT00846391|3979494|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4155788|NCT00846391|3979495|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4155789|NCT00846391|3979492|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4155790|NCT00846391|3979493|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4155791|NCT00846391|3979494|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4155792|NCT00846391|3979495|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4155793|NCT00846391|3979492|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4155794|NCT00846391|3979493|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4155795|NCT00846391|3979494|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4155796|NCT00846391|3979495|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4155797|NCT00846391|3979492|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4155798|NCT00846391|3979493|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4155799|NCT00846391|3979494|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4155800|NCT00846391|3979495|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4155801|NCT00846391|3979492|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4155802|NCT00846391|3979493|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4155803|NCT00846391|3979494|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4155804|NCT00846391|3979495|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4155805|NCT00846391|3979492|B4|||Age||years|Mean|53.0|53.0|Standard Deviation|9.0|9.0|||
4155806|NCT00846391|3979493|B3|||Age||years|Mean|53.5|53.5|Standard Deviation|7.5|7.5|||
4155807|NCT00846391|3979494|B2|||Age||years|Mean|55.5|55.5|Standard Deviation|7.7|7.7|||
4155808|NCT00846391|3979495|B1|||Age||years|Mean|49.8|49.8|Standard Deviation|13.4|13.4|||
4155809|NCT00846365|3979505|B4|No||Diabetes Status||participants|Number|897|897.0||||||
4155810|NCT00846365|3979506|B3|No||Diabetes Status||participants|Number|285|285.0||||||
4155811|NCT00846365|3979507|B2|No||Diabetes Status||participants|Number|298|298.0||||||
4155812|NCT00846365|3979508|B1|No||Diabetes Status||participants|Number|314|314.0||||||
4155813|NCT00846365|3979505|B4|Yes||Diabetes Status||participants|Number|188|188.0||||||
4155814|NCT00846365|3979506|B3|Yes||Diabetes Status||participants|Number|71|71.0||||||
4155815|NCT00846365|3979507|B2|Yes||Diabetes Status||participants|Number|59|59.0||||||
4155816|NCT00846365|3979508|B1|Yes||Diabetes Status||participants|Number|58|58.0||||||
4155817|NCT00846365|3979505|B4|Missing||Chronic Kidney Disease (CKD) Status|Participant was considered to have CKD if their eGFR was <60 ml/min/1.73 m^2 or urinary albumin:creatinine ratio was >200 mg albumin/g creatinine at Screening.|participants|Number|1|1.0||||||
4155818|NCT00846365|3979506|B3|Missing||Chronic Kidney Disease (CKD) Status|Participant was considered to have CKD if their eGFR was <60 ml/min/1.73 m^2 or urinary albumin:creatinine ratio was >200 mg albumin/g creatinine at Screening.|participants|Number|0|0.0||||||
4155819|NCT00846365|3979507|B2|Missing||Chronic Kidney Disease (CKD) Status|Participant was considered to have CKD if their eGFR was <60 ml/min/1.73 m^2 or urinary albumin:creatinine ratio was >200 mg albumin/g creatinine at Screening.|participants|Number|1|1.0||||||
4155820|NCT00846365|3979508|B1|Missing||Chronic Kidney Disease (CKD) Status|Participant was considered to have CKD if their eGFR was <60 ml/min/1.73 m^2 or urinary albumin:creatinine ratio was >200 mg albumin/g creatinine at Screening.|participants|Number|0|0.0||||||
4155821|NCT00846365|3979505|B4|No||Chronic Kidney Disease (CKD) Status|Participant was considered to have CKD if their eGFR was <60 ml/min/1.73 m^2 or urinary albumin:creatinine ratio was >200 mg albumin/g creatinine at Screening.|participants|Number|990|990.0||||||
4155822|NCT00846365|3979506|B3|No||Chronic Kidney Disease (CKD) Status|Participant was considered to have CKD if their eGFR was <60 ml/min/1.73 m^2 or urinary albumin:creatinine ratio was >200 mg albumin/g creatinine at Screening.|participants|Number|328|328.0||||||
4155823|NCT00846365|3979507|B2|No||Chronic Kidney Disease (CKD) Status|Participant was considered to have CKD if their eGFR was <60 ml/min/1.73 m^2 or urinary albumin:creatinine ratio was >200 mg albumin/g creatinine at Screening.|participants|Number|315|315.0||||||
4155824|NCT00846365|3979508|B1|No||Chronic Kidney Disease (CKD) Status|Participant was considered to have CKD if their eGFR was <60 ml/min/1.73 m^2 or urinary albumin:creatinine ratio was >200 mg albumin/g creatinine at Screening.|participants|Number|347|347.0||||||
4155825|NCT00846365|3979505|B4|Yes||Chronic Kidney Disease (CKD) Status|Participant was considered to have CKD if their eGFR was <60 ml/min/1.73 m^2 or urinary albumin:creatinine ratio was >200 mg albumin/g creatinine at Screening.|participants|Number|94|94.0||||||
4155826|NCT00846365|3979506|B3|Yes||Chronic Kidney Disease (CKD) Status|Participant was considered to have CKD if their eGFR was <60 ml/min/1.73 m^2 or urinary albumin:creatinine ratio was >200 mg albumin/g creatinine at Screening.|participants|Number|28|28.0||||||
4155827|NCT00846365|3979507|B2|Yes||Chronic Kidney Disease (CKD) Status|Participant was considered to have CKD if their eGFR was <60 ml/min/1.73 m^2 or urinary albumin:creatinine ratio was >200 mg albumin/g creatinine at Screening.|participants|Number|41|41.0||||||
4155828|NCT00846365|3979508|B1|Yes||Chronic Kidney Disease (CKD) Status|Participant was considered to have CKD if their eGFR was <60 ml/min/1.73 m^2 or urinary albumin:creatinine ratio was >200 mg albumin/g creatinine at Screening.|participants|Number|25|25.0||||||
4155829|NCT00846365|3979505|B4|Normal||Estimated Glomerular Filtration Rate (eGFR) Category|"eGFR = creatinine clearance, estimated using the Modification of Diet in Renal Disease equation with the following parameters:~Moderate impairment: ≥30 to <60 mL/min/1.73 m^2~Mild impairment: ≥60 to <90 mL/min/1.73 m^2~Normal: ≥90 mL/min/1.73 m^2"|participants|Number|377|377.0||||||
4155866|NCT00846365|3979506|B3|United States||Region of Enrollment||participants|Number|295|295.0||||||
4155830|NCT00846365|3979506|B3|Normal||Estimated Glomerular Filtration Rate (eGFR) Category|"eGFR = creatinine clearance, estimated using the Modification of Diet in Renal Disease equation with the following parameters:~Moderate impairment: ≥30 to <60 mL/min/1.73 m^2~Mild impairment: ≥60 to <90 mL/min/1.73 m^2~Normal: ≥90 mL/min/1.73 m^2"|participants|Number|126|126.0||||||
4155831|NCT00846365|3979507|B2|Normal||Estimated Glomerular Filtration Rate (eGFR) Category|"eGFR = creatinine clearance, estimated using the Modification of Diet in Renal Disease equation with the following parameters:~Moderate impairment: ≥30 to <60 mL/min/1.73 m^2~Mild impairment: ≥60 to <90 mL/min/1.73 m^2~Normal: ≥90 mL/min/1.73 m^2"|participants|Number|125|125.0||||||
4155832|NCT00846365|3979508|B1|Normal||Estimated Glomerular Filtration Rate (eGFR) Category|"eGFR = creatinine clearance, estimated using the Modification of Diet in Renal Disease equation with the following parameters:~Moderate impairment: ≥30 to <60 mL/min/1.73 m^2~Mild impairment: ≥60 to <90 mL/min/1.73 m^2~Normal: ≥90 mL/min/1.73 m^2"|participants|Number|126|126.0||||||
4155833|NCT00846365|3979505|B4|Mild impairment||Estimated Glomerular Filtration Rate (eGFR) Category|"eGFR = creatinine clearance, estimated using the Modification of Diet in Renal Disease equation with the following parameters:~Moderate impairment: ≥30 to <60 mL/min/1.73 m^2~Mild impairment: ≥60 to <90 mL/min/1.73 m^2~Normal: ≥90 mL/min/1.73 m^2"|participants|Number|632|632.0||||||
4155834|NCT00846365|3979506|B3|Mild impairment||Estimated Glomerular Filtration Rate (eGFR) Category|"eGFR = creatinine clearance, estimated using the Modification of Diet in Renal Disease equation with the following parameters:~Moderate impairment: ≥30 to <60 mL/min/1.73 m^2~Mild impairment: ≥60 to <90 mL/min/1.73 m^2~Normal: ≥90 mL/min/1.73 m^2"|participants|Number|205|205.0||||||
4155835|NCT00846365|3979507|B2|Mild impairment||Estimated Glomerular Filtration Rate (eGFR) Category|"eGFR = creatinine clearance, estimated using the Modification of Diet in Renal Disease equation with the following parameters:~Moderate impairment: ≥30 to <60 mL/min/1.73 m^2~Mild impairment: ≥60 to <90 mL/min/1.73 m^2~Normal: ≥90 mL/min/1.73 m^2"|participants|Number|207|207.0||||||
4155836|NCT00846365|3979508|B1|Mild impairment||Estimated Glomerular Filtration Rate (eGFR) Category|"eGFR = creatinine clearance, estimated using the Modification of Diet in Renal Disease equation with the following parameters:~Moderate impairment: ≥30 to <60 mL/min/1.73 m^2~Mild impairment: ≥60 to <90 mL/min/1.73 m^2~Normal: ≥90 mL/min/1.73 m^2"|participants|Number|220|220.0||||||
4155837|NCT00846365|3979505|B4|Moderate impairment||Estimated Glomerular Filtration Rate (eGFR) Category|"eGFR = creatinine clearance, estimated using the Modification of Diet in Renal Disease equation with the following parameters:~Moderate impairment: ≥30 to <60 mL/min/1.73 m^2~Mild impairment: ≥60 to <90 mL/min/1.73 m^2~Normal: ≥90 mL/min/1.73 m^2"|participants|Number|76|76.0||||||
4155838|NCT00846365|3979506|B3|Moderate impairment||Estimated Glomerular Filtration Rate (eGFR) Category|"eGFR = creatinine clearance, estimated using the Modification of Diet in Renal Disease equation with the following parameters:~Moderate impairment: ≥30 to <60 mL/min/1.73 m^2~Mild impairment: ≥60 to <90 mL/min/1.73 m^2~Normal: ≥90 mL/min/1.73 m^2"|participants|Number|25|25.0||||||
4155839|NCT00846365|3979507|B2|Moderate impairment||Estimated Glomerular Filtration Rate (eGFR) Category|"eGFR = creatinine clearance, estimated using the Modification of Diet in Renal Disease equation with the following parameters:~Moderate impairment: ≥30 to <60 mL/min/1.73 m^2~Mild impairment: ≥60 to <90 mL/min/1.73 m^2~Normal: ≥90 mL/min/1.73 m^2"|participants|Number|25|25.0||||||
4155840|NCT00846365|3979508|B1|Moderate impairment||Estimated Glomerular Filtration Rate (eGFR) Category|"eGFR = creatinine clearance, estimated using the Modification of Diet in Renal Disease equation with the following parameters:~Moderate impairment: ≥30 to <60 mL/min/1.73 m^2~Mild impairment: ≥60 to <90 mL/min/1.73 m^2~Normal: ≥90 mL/min/1.73 m^2"|participants|Number|26|26.0||||||
4155841|NCT00846365|3979505|B4|||Body Mass Index (BMI)|BMI was calculated using height at Screening and weight at Baseline.|kg/m^2|Mean|31.8|31.8|Standard Deviation|6.14|6.14|||
4155842|NCT00846365|3979506|B3|||Body Mass Index (BMI)|BMI was calculated using height at Screening and weight at Baseline.|kg/m^2|Mean|31.9|31.9|Standard Deviation|6.08|6.08|||
4155843|NCT00846365|3979507|B2|||Body Mass Index (BMI)|BMI was calculated using height at Screening and weight at Baseline.|kg/m^2|Mean|31.8|31.8|Standard Deviation|6.40|6.4|||
4155844|NCT00846365|3979508|B1|||Body Mass Index (BMI)|BMI was calculated using height at Screening and weight at Baseline.|kg/m^2|Mean|31.7|31.7|Standard Deviation|5.94|5.94|||
4155845|NCT00846365|3979505|B4|||Height||cm|Mean|167.8|167.8|Standard Deviation|10.87|10.87|||
4155846|NCT00846365|3979506|B3|||Height||cm|Mean|168.2|168.2|Standard Deviation|10.30|10.3|||
4155847|NCT00846365|3979507|B2|||Height||cm|Mean|167.8|167.8|Standard Deviation|11.06|11.06|||
4155848|NCT00846365|3979508|B1|||Height||cm|Mean|167.5|167.5|Standard Deviation|11.22|11.22|||
4155849|NCT00846365|3979505|B4|||Weight||kg|Mean|89.95|89.95|Standard Deviation|20.981|20.981|||
4155850|NCT00846365|3979506|B3|||Weight||kg|Mean|90.66|90.66|Standard Deviation|20.700|20.7|||
4155851|NCT00846365|3979507|B2|||Weight||kg|Mean|89.87|89.87|Standard Deviation|21.281|21.281|||
4155852|NCT00846365|3979508|B1|||Weight||kg|Mean|89.35|89.35|Standard Deviation|20.995|20.995|||
4155853|NCT00846365|3979505|B4|Argentina||Region of Enrollment||participants|Number|31|31.0||||||
4155854|NCT00846365|3979506|B3|Argentina||Region of Enrollment||participants|Number|9|9.0||||||
4155855|NCT00846365|3979507|B2|Argentina||Region of Enrollment||participants|Number|9|9.0||||||
4155856|NCT00846365|3979508|B1|Argentina||Region of Enrollment||participants|Number|13|13.0||||||
4155857|NCT00846365|3979505|B4|Chile||Region of Enrollment||participants|Number|31|31.0||||||
4155858|NCT00846365|3979506|B3|Chile||Region of Enrollment||participants|Number|9|9.0||||||
4155859|NCT00846365|3979507|B2|Chile||Region of Enrollment||participants|Number|10|10.0||||||
4155860|NCT00846365|3979508|B1|Chile||Region of Enrollment||participants|Number|12|12.0||||||
4155861|NCT00846365|3979505|B4|Mexico||Region of Enrollment||participants|Number|132|132.0||||||
4155862|NCT00846365|3979506|B3|Mexico||Region of Enrollment||participants|Number|43|43.0||||||
4155863|NCT00846365|3979507|B2|Mexico||Region of Enrollment||participants|Number|44|44.0||||||
4155864|NCT00846365|3979508|B1|Mexico||Region of Enrollment||participants|Number|45|45.0||||||
4155865|NCT00846365|3979505|B4|United States||Region of Enrollment||participants|Number|891|891.0||||||
4155867|NCT00846365|3979507|B2|United States||Region of Enrollment||participants|Number|294|294.0||||||
4155868|NCT00846365|3979508|B1|United States||Region of Enrollment||participants|Number|302|302.0||||||
4155869|NCT00846365|3979505|B4|Unknown or Not Reported||Race (NIH/OMB)|Participants could choose more than one category for race. Participants who chose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|0|0.0||||||
4155870|NCT00846365|3979506|B3|Unknown or Not Reported||Race (NIH/OMB)|Participants could choose more than one category for race. Participants who chose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|0|0.0||||||
4155871|NCT00846365|3979507|B2|Unknown or Not Reported||Race (NIH/OMB)|Participants could choose more than one category for race. Participants who chose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|0|0.0||||||
4155872|NCT00846365|3979508|B1|Unknown or Not Reported||Race (NIH/OMB)|Participants could choose more than one category for race. Participants who chose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|0|0.0||||||
4155873|NCT00846365|3979505|B4|More than one race||Race (NIH/OMB)|Participants could choose more than one category for race. Participants who chose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|11|11.0||||||
4155874|NCT00846365|3979506|B3|More than one race||Race (NIH/OMB)|Participants could choose more than one category for race. Participants who chose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|4|4.0||||||
4155875|NCT00846365|3979507|B2|More than one race||Race (NIH/OMB)|Participants could choose more than one category for race. Participants who chose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|2|2.0||||||
4155876|NCT00846365|3979508|B1|More than one race||Race (NIH/OMB)|Participants could choose more than one category for race. Participants who chose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|5|5.0||||||
4155877|NCT00846365|3979505|B4|White||Race (NIH/OMB)|Participants could choose more than one category for race. Participants who chose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|680|680.0||||||
4155878|NCT00846365|3979506|B3|White||Race (NIH/OMB)|Participants could choose more than one category for race. Participants who chose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|220|220.0||||||
4155879|NCT00846365|3979507|B2|White||Race (NIH/OMB)|Participants could choose more than one category for race. Participants who chose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|225|225.0||||||
4155880|NCT00846365|3979508|B1|White||Race (NIH/OMB)|Participants could choose more than one category for race. Participants who chose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|235|235.0||||||
4155881|NCT00846365|3979505|B4|Black or African American||Race (NIH/OMB)|Participants could choose more than one category for race. Participants who chose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|290|290.0||||||
4155882|NCT00846365|3979506|B3|Black or African American||Race (NIH/OMB)|Participants could choose more than one category for race. Participants who chose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|100|100.0||||||
4155883|NCT00846365|3979507|B2|Black or African American||Race (NIH/OMB)|Participants could choose more than one category for race. Participants who chose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|95|95.0||||||
4155884|NCT00846365|3979508|B1|Black or African American||Race (NIH/OMB)|Participants could choose more than one category for race. Participants who chose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|95|95.0||||||
4155885|NCT00846365|3979505|B4|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|Participants could choose more than one category for race. Participants who chose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|3|3.0||||||
4155886|NCT00846365|3979506|B3|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|Participants could choose more than one category for race. Participants who chose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|0|0.0||||||
4155887|NCT00846365|3979507|B2|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|Participants could choose more than one category for race. Participants who chose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|0|0.0||||||
4155888|NCT00846365|3979508|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|Participants could choose more than one category for race. Participants who chose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|3|3.0||||||
4155889|NCT00846365|3979505|B4|Asian||Race (NIH/OMB)|Participants could choose more than one category for race. Participants who chose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|17|17.0||||||
4155890|NCT00846365|3979506|B3|Asian||Race (NIH/OMB)|Participants could choose more than one category for race. Participants who chose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|5|5.0||||||
4155891|NCT00846365|3979507|B2|Asian||Race (NIH/OMB)|Participants could choose more than one category for race. Participants who chose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|5|5.0||||||
4155940|NCT00846287|3979564|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4155892|NCT00846365|3979508|B1|Asian||Race (NIH/OMB)|Participants could choose more than one category for race. Participants who chose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|7|7.0||||||
4155893|NCT00846365|3979505|B4|American Indian or Alaska Native||Race (NIH/OMB)|Participants could choose more than one category for race. Participants who chose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|106|106.0||||||
4155894|NCT00846365|3979506|B3|American Indian or Alaska Native||Race (NIH/OMB)|Participants could choose more than one category for race. Participants who chose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|35|35.0||||||
4155895|NCT00846365|3979507|B2|American Indian or Alaska Native||Race (NIH/OMB)|Participants could choose more than one category for race. Participants who chose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|34|34.0||||||
4155896|NCT00846365|3979508|B1|American Indian or Alaska Native||Race (NIH/OMB)|Participants could choose more than one category for race. Participants who chose more than 1 race category are included in each category indicated and are also included in the multiracial category.|participants|Number|37|37.0||||||
4155897|NCT00846365|3979505|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)|Ethnicity was not collected from Latin American sites.|Participants|Count of Participants|194|194.0||||||
4155898|NCT00846365|3979506|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)|Ethnicity was not collected from Latin American sites.|Participants|Count of Participants|61|61.0||||||
4155899|NCT00846365|3979507|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)|Ethnicity was not collected from Latin American sites.|Participants|Count of Participants|63|63.0||||||
4155900|NCT00846365|3979508|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|Ethnicity was not collected from Latin American sites.|Participants|Count of Participants|70|70.0||||||
4155901|NCT00846365|3979505|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity was not collected from Latin American sites.|Participants|Count of Participants|769|769.0||||||
4155902|NCT00846365|3979506|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity was not collected from Latin American sites.|Participants|Count of Participants|251|251.0||||||
4155903|NCT00846365|3979507|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity was not collected from Latin American sites.|Participants|Count of Participants|253|253.0||||||
4155904|NCT00846365|3979508|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity was not collected from Latin American sites.|Participants|Count of Participants|265|265.0||||||
4155905|NCT00846365|3979505|B4||Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity was not collected from Latin American sites.|Participants|Count of Participants|122|122.0||||||
4155906|NCT00846365|3979506|B3||Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity was not collected from Latin American sites.|Participants|Count of Participants|44|44.0||||||
4155907|NCT00846365|3979507|B2||Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity was not collected from Latin American sites.|Participants|Count of Participants|41|41.0||||||
4155908|NCT00846365|3979508|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity was not collected from Latin American sites.|Participants|Count of Participants|37|37.0||||||
4155909|NCT00846365|3979505|B4||Male|Sex: Female, Male||Participants|Count of Participants|563|563.0||||||
4155910|NCT00846365|3979506|B3||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4155911|NCT00846365|3979507|B2||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4155912|NCT00846365|3979508|B1||Male|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4155913|NCT00846365|3979505|B4||Female|Sex: Female, Male||Participants|Count of Participants|522|522.0||||||
4155914|NCT00846365|3979506|B3||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4155915|NCT00846365|3979507|B2||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4155916|NCT00846365|3979508|B1||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4155917|NCT00846365|3979505|B4|≥65 years||Age, Customized||participants|Number|214|214.0||||||
4155918|NCT00846365|3979506|B3|≥65 years||Age, Customized||participants|Number|66|66.0||||||
4155919|NCT00846365|3979507|B2|≥65 years||Age, Customized||participants|Number|75|75.0||||||
4155920|NCT00846365|3979508|B1|≥65 years||Age, Customized||participants|Number|73|73.0||||||
4155921|NCT00846365|3979505|B4|45 to 64 years||Age, Customized||participants|Number|745|745.0||||||
4155922|NCT00846365|3979506|B3|45 to 64 years||Age, Customized||participants|Number|249|249.0||||||
4155923|NCT00846365|3979507|B2|45 to 64 years||Age, Customized||participants|Number|244|244.0||||||
4155924|NCT00846365|3979508|B1|45 to 64 years||Age, Customized||participants|Number|252|252.0||||||
4155925|NCT00846365|3979505|B4|<45 years||Age, Customized||participants|Number|126|126.0||||||
4155926|NCT00846365|3979506|B3|<45 years||Age, Customized||participants|Number|41|41.0||||||
4155927|NCT00846365|3979507|B2|<45 years||Age, Customized||participants|Number|38|38.0||||||
4155928|NCT00846365|3979508|B1|<45 years||Age, Customized||participants|Number|47|47.0||||||
4155929|NCT00846365|3979505|B4|||Age||years|Mean|56.0|56.0|Standard Deviation|10.38|10.38|||
4155930|NCT00846365|3979506|B3|||Age||years|Mean|55.7|55.7|Standard Deviation|9.78|9.78|||
4155931|NCT00846365|3979507|B2|||Age||years|Mean|56.7|56.7|Standard Deviation|10.83|10.83|||
4155932|NCT00846365|3979508|B1|||Age||years|Mean|55.5|55.5|Standard Deviation|10.49|10.49|||
4155933|NCT00846287|3979563|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4155934|NCT00846287|3979564|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4155935|NCT00846287|3979565|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4155936|NCT00846287|3979563|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4155937|NCT00846287|3979564|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4155938|NCT00846287|3979565|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4155939|NCT00846287|3979563|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4155941|NCT00846287|3979565|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4155942|NCT00846287|3979563|B3|||Age||years|Mean|66|66.0|Standard Deviation|10|10.0|||
4155943|NCT00846287|3979564|B2|||Age||years|Mean|68|68.0|Standard Deviation|11|11.0|||
4155944|NCT00846287|3979565|B1|||Age||years|Mean|63|63.0|Standard Deviation|7|7.0|||
4155945|NCT00846287|3979563|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4155946|NCT00846287|3979564|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4155947|NCT00846287|3979565|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4155948|NCT00846287|3979563|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4155949|NCT00846287|3979564|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4155950|NCT00846287|3979565|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4155951|NCT00846287|3979563|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4155952|NCT00846287|3979564|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4155953|NCT00846287|3979565|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4155954|NCT00846066|3979574|B3|Second and Third year Residents||Level of Training|The level of training during residency,|participants|Number|33|33.0||||||
4155955|NCT00846066|3979575|B2|Second and Third year Residents||Level of Training|The level of training during residency,|participants|Number|18|18.0||||||
4155956|NCT00846066|3979576|B1|Second and Third year Residents||Level of Training|The level of training during residency,|participants|Number|15|15.0||||||
4155957|NCT00846066|3979574|B3|First year Residents||Level of Training|The level of training during residency,|participants|Number|23|23.0||||||
4155958|NCT00846066|3979575|B2|First year Residents||Level of Training|The level of training during residency,|participants|Number|11|11.0||||||
4155959|NCT00846066|3979576|B1|First year Residents||Level of Training|The level of training during residency,|participants|Number|12|12.0||||||
4155960|NCT00846066|3979574|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4155961|NCT00846066|3979575|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4155962|NCT00846066|3979576|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4155963|NCT00846066|3979574|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4155964|NCT00846066|3979575|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4155965|NCT00846066|3979576|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4155966|NCT00846066|3979574|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4155967|NCT00846066|3979575|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4155968|NCT00846066|3979576|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4155969|NCT00846066|3979574|B3||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4155970|NCT00846066|3979575|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4155971|NCT00846066|3979576|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4155972|NCT00846066|3979574|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4155973|NCT00846066|3979575|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4155974|NCT00846066|3979576|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4155975|NCT00846053|3979589|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4155976|NCT00846053|3979590|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4155977|NCT00846053|3979591|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4155978|NCT00846053|3979589|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4155979|NCT00846053|3979590|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4155980|NCT00846053|3979591|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4155981|NCT00846053|3979589|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4155982|NCT00846053|3979590|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4155983|NCT00846053|3979591|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4155984|NCT00846053|3979589|B3|||Age||years|Mean|15.5|15.5|Standard Deviation|2.6|2.6|||
4155985|NCT00846053|3979590|B2|||Age||years|Mean|16.6|16.6|Standard Deviation|2.9|2.9|||
4155986|NCT00846053|3979591|B1|||Age||years|Mean|15|15.0|Standard Deviation|1.9|1.9|||
4155987|NCT00846053|3979589|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4155988|NCT00846053|3979590|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4155989|NCT00846053|3979591|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4155990|NCT00846053|3979589|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4155991|NCT00846053|3979590|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4155992|NCT00846053|3979591|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4155993|NCT00846053|3979589|B3||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4155994|NCT00846053|3979590|B2||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4155995|NCT00846053|3979591|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4155996|NCT00846027|3979600|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4155997|NCT00846027|3979600|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4155998|NCT00846027|3979600|B1|||Age||years|Mean|52.20|52.2|Standard Deviation|12.48|12.48|||
4155999|NCT00845975|3979607|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4156000|NCT00845975|3979608|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4156001|NCT00845975|3979609|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4156002|NCT00845975|3979607|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4156003|NCT00845975|3979608|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4156004|NCT00845975|3979609|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4156005|NCT00845975|3979607|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4156006|NCT00845975|3979608|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4156007|NCT00845975|3979609|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4156008|NCT00845975|3979607|B3|||Age||years|Mean|63.58|63.58|Standard Deviation|9.55|9.55|||
4156009|NCT00845975|3979608|B2|||Age||years|Mean|66.18|66.18|Standard Deviation|9.10|9.1|||
4156010|NCT00845975|3979609|B1|||Age||years|Mean|60|60.0|Standard Deviation|9.53|9.53|||
4156011|NCT00845975|3979607|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4156012|NCT00845975|3979608|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4156013|NCT00845975|3979609|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4156014|NCT00845975|3979607|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4156015|NCT00845975|3979608|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4156016|NCT00845975|3979609|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4156017|NCT00845975|3979607|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4156018|NCT00845975|3979608|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4156019|NCT00845975|3979609|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4156020|NCT00845897|3979620|B4|United States||Region of Enrollment||participants|Number|17|17.0||||||
4156021|NCT00845897|3979621|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4156022|NCT00845897|3979622|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4156023|NCT00845897|3979623|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4156024|NCT00845897|3979620|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4156025|NCT00845897|3979621|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4156026|NCT00845897|3979622|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4156027|NCT00845897|3979623|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4156028|NCT00845897|3979620|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4156029|NCT00845897|3979621|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4156030|NCT00845897|3979622|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4156031|NCT00845897|3979623|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4156032|NCT00845897|3979620|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4156033|NCT00845897|3979621|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4156034|NCT00845897|3979622|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4156035|NCT00845897|3979623|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4156036|NCT00845897|3979620|B4||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4156037|NCT00845897|3979621|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4156038|NCT00845897|3979622|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4156039|NCT00845897|3979623|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4156040|NCT00845897|3979620|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4156041|NCT00845897|3979621|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4156042|NCT00845897|3979622|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4156043|NCT00845897|3979623|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4156044|NCT00845858|3979636|B4|United States||Region of Enrollment||participants|Number|287|287.0||||||
4156045|NCT00845858|3979637|B3|United States||Region of Enrollment||participants|Number|95|95.0||||||
4156046|NCT00845858|3979638|B2|United States||Region of Enrollment||participants|Number|96|96.0||||||
4156047|NCT00845858|3979639|B1|United States||Region of Enrollment||participants|Number|96|96.0||||||
4156048|NCT00845858|3979636|B4||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4156049|NCT00845858|3979637|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4156050|NCT00845858|3979638|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4156051|NCT00845858|3979639|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4156052|NCT00845858|3979636|B4||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4156053|NCT00845858|3979637|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4156054|NCT00845858|3979638|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4156055|NCT00845858|3979639|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4156056|NCT00845858|3979636|B4||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4156057|NCT00845858|3979637|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4156058|NCT00845858|3979638|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4156059|NCT00845858|3979639|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4156060|NCT00845858|3979636|B4||Between 18 and 65 years|Age||Participants|Count of Participants|249|249.0||||||
4156061|NCT00845858|3979637|B3||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
4156062|NCT00845858|3979638|B2||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
4156063|NCT00845858|3979639|B1||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
4156064|NCT00845858|3979636|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4156065|NCT00845858|3979637|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4156066|NCT00845858|3979638|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4156067|NCT00845858|3979639|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4156068|NCT00845858|3979636|B4|||Age||years|Mean|51.4|51.4|Standard Deviation|11.56|11.56|||
4156069|NCT00845858|3979637|B3|||Age||years|Mean|52.4|52.4|Standard Deviation|10.03|10.03|||
4156070|NCT00845858|3979638|B2|||Age||years|Mean|50.3|50.3|Standard Deviation|12.40|12.4|||
4156071|NCT00845858|3979639|B1|||Age||years|Mean|51.6|51.6|Standard Deviation|12.13|12.13|||
4156072|NCT00845845|3979652|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4156073|NCT00845845|3979653|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4156074|NCT00845845|3979654|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4156075|NCT00845845|3979652|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156076|NCT00845845|3979653|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156077|NCT00845845|3979654|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156078|NCT00845845|3979652|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4156079|NCT00845845|3979653|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4156080|NCT00845845|3979654|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4156081|NCT00845845|3979652|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4156082|NCT00845845|3979653|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4156083|NCT00845845|3979654|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4156084|NCT00845845|3979652|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4156085|NCT00845845|3979653|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4156086|NCT00845845|3979654|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4156087|NCT00845845|3979652|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4156088|NCT00845845|3979653|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4156089|NCT00845845|3979654|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4156090|NCT00845845|3979652|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4156091|NCT00845845|3979653|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4156092|NCT00845845|3979654|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4156093|NCT00845845|3979652|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4156094|NCT00845845|3979653|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4156095|NCT00845845|3979654|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4156096|NCT00845845|3979652|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4156097|NCT00845845|3979653|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4156098|NCT00845845|3979654|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4156099|NCT00845832|3979663|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4156100|NCT00845832|3979664|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4156101|NCT00845832|3979665|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4156102|NCT00845832|3979666|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4156103|NCT00845832|3979663|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4156104|NCT00845832|3979664|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4156105|NCT00845832|3979665|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4156106|NCT00845832|3979666|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4156107|NCT00845832|3979663|B4|||Age||years|Mean|48.3|48.3|Standard Deviation|8.94|8.94|||
4156108|NCT00845832|3979664|B3|||Age||years|Mean|50.0|50.0|Standard Deviation|6.97|6.97|||
4156109|NCT00845832|3979665|B2|||Age||years|Mean|48.2|48.2|Standard Deviation|10.50|10.5|||
4156110|NCT00845832|3979666|B1|||Age||years|Mean|41.3|41.3|Standard Deviation|11.02|11.02|||
4156111|NCT00845728|3979712|B3||Male|Sex: Female, Male||Participants|Count of Participants|2657|2657.0||||||
4156112|NCT00845728|3979713|B2||Male|Sex: Female, Male||Participants|Count of Participants|1313|1313.0||||||
4156113|NCT00845728|3979714|B1||Male|Sex: Female, Male||Participants|Count of Participants|1344|1344.0||||||
4156114|NCT00845728|3979712|B3||Female|Sex: Female, Male||Participants|Count of Participants|782|782.0||||||
4156115|NCT00845728|3979713|B2||Female|Sex: Female, Male||Participants|Count of Participants|405|405.0||||||
4156116|NCT00845728|3979714|B1||Female|Sex: Female, Male||Participants|Count of Participants|377|377.0||||||
4156117|NCT00845728|3979712|B3|≥ 65 years||Age, Customized||Participants|Number|1601|1601.0||||||
4156118|NCT00845728|3979713|B2|≥ 65 years||Age, Customized||Participants|Number|809|809.0||||||
4156119|NCT00845728|3979714|B1|≥ 65 years||Age, Customized||Participants|Number|792|792.0||||||
4156120|NCT00845728|3979712|B3|<65 years||Age, Customized||Participants|Number|1838|1838.0||||||
4156121|NCT00845728|3979713|B2|<65 years||Age, Customized||Participants|Number|909|909.0||||||
4156122|NCT00845728|3979714|B1|<65 years||Age, Customized||Participants|Number|929|929.0||||||
4156123|NCT00845702|3979723|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4156124|NCT00845702|3979723|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4156125|NCT00845702|3979723|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4156126|NCT00845702|3979723|B1|||Age||years|Mean|62|62.0|Standard Deviation|15|15.0|||
4156127|NCT00845702|3979723|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4156128|NCT00845702|3979723|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4156129|NCT00845702|3979723|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4156130|NCT00845676|3979729|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4156131|NCT00845676|3979729|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4156132|NCT00845676|3979729|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4156133|NCT00845676|3979729|B1|||Age||years|Mean|42|42.0|Full Range|||26.0|59.0|
4156134|NCT00845663|3979733|B3|||Body Weight||kilogram|Mean|66.59|66.59|Standard Deviation|10.12|10.12|||
4156135|NCT00845663|3979734|B2|||Body Weight||kilogram|Mean|66.58|66.58|Standard Deviation|10.23|10.23|||
4156136|NCT00845663|3979735|B1|||Body Weight||kilogram|Mean|66.59|66.59|Standard Deviation|10.11|10.11|||
4156137|NCT00845663|3979733|B3|||Body Surface Area||Square meter|Mean|1.765|1.765|Standard Deviation|0.171|0.171|||
4156138|NCT00845663|3979734|B2|||Body Surface Area||Square meter|Mean|1.770|1.77|Standard Deviation|0.172|0.172|||
4156139|NCT00845663|3979735|B1|||Body Surface Area||Square meter|Mean|1.759|1.759|Standard Deviation|0.171|0.171|||
4156140|NCT00845663|3979733|B3|||Body Mass Index||kilogram/square meter|Mean|23.15|23.15|Standard Deviation|2.48|2.48|||
4156141|NCT00845663|3979734|B2|||Body Mass Index||kilogram/square meter|Mean|22.93|22.93|Standard Deviation|2.43|2.43|||
4156142|NCT00845663|3979735|B1|||Body Mass Index||kilogram/square meter|Mean|23.36|23.36|Standard Deviation|2.53|2.53|||
4156143|NCT00845663|3979733|B3|||Body Height||cm|Mean|169.38|169.38|Standard Deviation|9.24|9.24|||
4156144|NCT00845663|3979734|B2|||Body Height||cm|Mean|170.12|170.12|Standard Deviation|9.04|9.04|||
4156145|NCT00845663|3979735|B1|||Body Height||cm|Mean|168.64|168.64|Standard Deviation|9.47|9.47|||
4156146|NCT00845663|3979733|B3|France||Region of Enrollment||participants|Number|98|98.0||||||
4156147|NCT00845663|3979734|B2|France||Region of Enrollment||participants|Number|49|49.0||||||
4156148|NCT00845663|3979735|B1|France||Region of Enrollment||participants|Number|49|49.0||||||
4156149|NCT00845663|3979733|B3||Unknown or Not Reported|Race (NIH/OMB)|Race|Participants|Count of Participants|0|0.0||||||
4156150|NCT00845663|3979734|B2||Unknown or Not Reported|Race (NIH/OMB)|Race|Participants|Count of Participants|0|0.0||||||
4156151|NCT00845663|3979735|B1||Unknown or Not Reported|Race (NIH/OMB)|Race|Participants|Count of Participants|0|0.0||||||
4156152|NCT00845663|3979733|B3||More than one race|Race (NIH/OMB)|Race|Participants|Count of Participants|0|0.0||||||
4156153|NCT00845663|3979734|B2||More than one race|Race (NIH/OMB)|Race|Participants|Count of Participants|0|0.0||||||
4156154|NCT00845663|3979735|B1||More than one race|Race (NIH/OMB)|Race|Participants|Count of Participants|0|0.0||||||
4156155|NCT00845663|3979733|B3||White|Race (NIH/OMB)|Race|Participants|Count of Participants|97|97.0||||||
4156156|NCT00845663|3979734|B2||White|Race (NIH/OMB)|Race|Participants|Count of Participants|49|49.0||||||
4156157|NCT00845663|3979735|B1||White|Race (NIH/OMB)|Race|Participants|Count of Participants|48|48.0||||||
4156158|NCT00845663|3979733|B3||Black or African American|Race (NIH/OMB)|Race|Participants|Count of Participants|1|1.0||||||
4156159|NCT00845663|3979734|B2||Black or African American|Race (NIH/OMB)|Race|Participants|Count of Participants|0|0.0||||||
4156160|NCT00845663|3979735|B1||Black or African American|Race (NIH/OMB)|Race|Participants|Count of Participants|1|1.0||||||
4156161|NCT00845663|3979733|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race|Participants|Count of Participants|0|0.0||||||
4156162|NCT00845663|3979734|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race|Participants|Count of Participants|0|0.0||||||
4156163|NCT00845663|3979735|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race|Participants|Count of Participants|0|0.0||||||
4156164|NCT00845663|3979733|B3||Asian|Race (NIH/OMB)|Race|Participants|Count of Participants|0|0.0||||||
4156165|NCT00845663|3979734|B2||Asian|Race (NIH/OMB)|Race|Participants|Count of Participants|0|0.0||||||
4156166|NCT00845663|3979735|B1||Asian|Race (NIH/OMB)|Race|Participants|Count of Participants|0|0.0||||||
4156167|NCT00845663|3979733|B3||American Indian or Alaska Native|Race (NIH/OMB)|Race|Participants|Count of Participants|0|0.0||||||
4156168|NCT00845663|3979734|B2||American Indian or Alaska Native|Race (NIH/OMB)|Race|Participants|Count of Participants|0|0.0||||||
4156169|NCT00845663|3979735|B1||American Indian or Alaska Native|Race (NIH/OMB)|Race|Participants|Count of Participants|0|0.0||||||
4156170|NCT00845663|3979733|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4156171|NCT00845663|3979734|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4156172|NCT00845663|3979735|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4156173|NCT00845663|3979733|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4156174|NCT00845663|3979734|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4156175|NCT00845663|3979735|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4156176|NCT00845663|3979733|B3|||Age||years|Mean|35.98|35.98|Standard Deviation|10.14|10.14|||
4156177|NCT00845663|3979734|B2|||Age||years|Mean|33.18|33.18|Standard Deviation|9.63|9.63|||
4156178|NCT00845663|3979735|B1|||Age||years|Mean|38.78|38.78|Standard Deviation|9.95|9.95|||
4156179|NCT00845663|3979733|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4156180|NCT00845663|3979734|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4156181|NCT00845663|3979735|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4156182|NCT00845663|3979733|B3||Between 18 and 65 years|Age||Participants|Count of Participants|98|98.0||||||
4156183|NCT00845663|3979734|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4156184|NCT00845663|3979735|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4156185|NCT00845663|3979733|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4156186|NCT00845663|3979734|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4156187|NCT00845663|3979735|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4156188|NCT00845650|3979784|B7|≥ 25 kg/m^2||Body Mass Index||Participants|Count of Participants|88|88.0||||||
4156189|NCT00845650|3979785|B6|≥ 25 kg/m^2||Body Mass Index||Participants|Count of Participants|10|10.0||||||
4156190|NCT00845650|3979786|B5|≥ 25 kg/m^2||Body Mass Index||Participants|Count of Participants|22|22.0||||||
4156191|NCT00845650|3979787|B4|≥ 25 kg/m^2||Body Mass Index||Participants|Count of Participants|11|11.0||||||
4156192|NCT00845650|3979788|B3|≥ 25 kg/m^2||Body Mass Index||Participants|Count of Participants|20|20.0||||||
4156193|NCT00845650|3979789|B2|≥ 25 kg/m^2||Body Mass Index||Participants|Count of Participants|4|4.0||||||
4156194|NCT00845650|3979790|B1|≥ 25 kg/m^2||Body Mass Index||Participants|Count of Participants|21|21.0||||||
4156195|NCT00845650|3979784|B7|< 25 kg/m^2||Body Mass Index||Participants|Count of Participants|41|41.0||||||
4156196|NCT00845650|3979785|B6|< 25 kg/m^2||Body Mass Index||Participants|Count of Participants|7|7.0||||||
4156197|NCT00845650|3979786|B5|< 25 kg/m^2||Body Mass Index||Participants|Count of Participants|9|9.0||||||
4156198|NCT00845650|3979787|B4|< 25 kg/m^2||Body Mass Index||Participants|Count of Participants|3|3.0||||||
4156199|NCT00845650|3979788|B3|< 25 kg/m^2||Body Mass Index||Participants|Count of Participants|11|11.0||||||
4156200|NCT00845650|3979789|B2|< 25 kg/m^2||Body Mass Index||Participants|Count of Participants|1|1.0||||||
4156201|NCT00845650|3979790|B1|< 25 kg/m^2||Body Mass Index||Participants|Count of Participants|10|10.0||||||
4156202|NCT00845650|3979784|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4156203|NCT00845650|3979785|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4156204|NCT00845650|3979786|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4156205|NCT00845650|3979787|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4156206|NCT00845650|3979788|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156207|NCT00845650|3979789|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156208|NCT00845650|3979790|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156209|NCT00845650|3979784|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4156210|NCT00845650|3979785|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156211|NCT00845650|3979786|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4156212|NCT00845650|3979787|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156213|NCT00845650|3979788|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156214|NCT00845650|3979789|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156215|NCT00845650|3979790|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156216|NCT00845650|3979784|B7||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4156217|NCT00845650|3979785|B6||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4156218|NCT00845650|3979786|B5||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4156219|NCT00845650|3979787|B4||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4156220|NCT00845650|3979788|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4156221|NCT00845650|3979789|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4156222|NCT00845650|3979790|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4156223|NCT00845650|3979784|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
4156224|NCT00845650|3979785|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4156225|NCT00845650|3979786|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4156226|NCT00845650|3979787|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4156227|NCT00845650|3979788|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4156228|NCT00845650|3979789|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4156229|NCT00845650|3979790|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4156230|NCT00845650|3979784|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156231|NCT00845650|3979785|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156232|NCT00845650|3979786|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156233|NCT00845650|3979787|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156234|NCT00845650|3979788|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156235|NCT00845650|3979789|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156236|NCT00845650|3979790|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156237|NCT00845650|3979784|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4156238|NCT00845650|3979785|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156239|NCT00845650|3979786|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4156240|NCT00845650|3979787|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156241|NCT00845650|3979788|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4156242|NCT00845650|3979789|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156243|NCT00845650|3979790|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156244|NCT00845650|3979784|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156245|NCT00845650|3979785|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156246|NCT00845650|3979786|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156247|NCT00845650|3979787|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156248|NCT00845650|3979788|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156249|NCT00845650|3979789|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156250|NCT00845650|3979790|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156251|NCT00845650|3979784|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156252|NCT00845650|3979785|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156253|NCT00845650|3979786|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156254|NCT00845650|3979787|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156255|NCT00845650|3979788|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156256|NCT00845650|3979789|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156257|NCT00845650|3979790|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156258|NCT00845650|3979784|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|121|121.0||||||
4156259|NCT00845650|3979785|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4156260|NCT00845650|3979786|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4156261|NCT00845650|3979787|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4156262|NCT00845650|3979788|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4156263|NCT00845650|3979789|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4156264|NCT00845650|3979790|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4156265|NCT00845650|3979784|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4156266|NCT00845650|3979785|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4156267|NCT00845650|3979786|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4156268|NCT00845650|3979787|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4156269|NCT00845650|3979788|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156270|NCT00845650|3979789|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156271|NCT00845650|3979790|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4156272|NCT00845650|3979784|B7||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4156273|NCT00845650|3979785|B6||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4156274|NCT00845650|3979786|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4156275|NCT00845650|3979787|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4156276|NCT00845650|3979788|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4156277|NCT00845650|3979789|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4156278|NCT00845650|3979790|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4156279|NCT00845650|3979784|B7||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4156280|NCT00845650|3979785|B6||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4156281|NCT00845650|3979786|B5||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4156282|NCT00845650|3979787|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4156283|NCT00845650|3979788|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4156284|NCT00845650|3979789|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4156285|NCT00845650|3979790|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4156286|NCT00845650|3979784|B7|≥ 50 years||Age, Customized||Participants|Count of Participants|10|10.0||||||
4156287|NCT00845650|3979785|B6|≥ 50 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
4156288|NCT00845650|3979786|B5|≥ 50 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4156289|NCT00845650|3979787|B4|≥ 50 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
4156290|NCT00845650|3979788|B3|≥ 50 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
4156291|NCT00845650|3979789|B2|≥ 50 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
4156292|NCT00845650|3979790|B1|≥ 50 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
4156293|NCT00845650|3979784|B7|40 to < 50 years||Age, Customized||Participants|Count of Participants|33|33.0||||||
4156294|NCT00845650|3979785|B6|40 to < 50 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
4156295|NCT00845650|3979786|B5|40 to < 50 years||Age, Customized||Participants|Count of Participants|11|11.0||||||
4156296|NCT00845650|3979787|B4|40 to < 50 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
4156297|NCT00845650|3979788|B3|40 to < 50 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
4156298|NCT00845650|3979789|B2|40 to < 50 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
4156299|NCT00845650|3979790|B1|40 to < 50 years||Age, Customized||Participants|Count of Participants|9|9.0||||||
4156300|NCT00845650|3979784|B7|30 to < 40 years||Age, Customized||Participants|Count of Participants|36|36.0||||||
4156301|NCT00845650|3979785|B6|30 to < 40 years||Age, Customized||Participants|Count of Participants|8|8.0||||||
4156302|NCT00845650|3979786|B5|30 to < 40 years||Age, Customized||Participants|Count of Participants|7|7.0||||||
4156303|NCT00845650|3979787|B4|30 to < 40 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
4156304|NCT00845650|3979788|B3|30 to < 40 years||Age, Customized||Participants|Count of Participants|7|7.0||||||
4156305|NCT00845650|3979789|B2|30 to < 40 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
4156306|NCT00845650|3979790|B1|30 to < 40 years||Age, Customized||Participants|Count of Participants|7|7.0||||||
4156307|NCT00845650|3979784|B7|18 to < 30 years||Age, Customized||Participants|Count of Participants|50|50.0||||||
4156308|NCT00845650|3979785|B6|18 to < 30 years||Age, Customized||Participants|Count of Participants|4|4.0||||||
4156309|NCT00845650|3979786|B5|18 to < 30 years||Age, Customized||Participants|Count of Participants|13|13.0||||||
4156310|NCT00845650|3979787|B4|18 to < 30 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
4156311|NCT00845650|3979788|B3|18 to < 30 years||Age, Customized||Participants|Count of Participants|16|16.0||||||
4156312|NCT00845650|3979789|B2|18 to < 30 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
4156313|NCT00845650|3979790|B1|18 to < 30 years||Age, Customized||Participants|Count of Participants|12|12.0||||||
4156314|NCT00845650|3979784|B7|||Age||years|Mean|34.3|34.3|Standard Deviation|10.0|10.0|||
4156315|NCT00845650|3979785|B6|||Age||years|Mean|36.6|36.6|Standard Deviation|9.8|9.8|||
4156316|NCT00845650|3979786|B5|||Age||years|Mean|33.3|33.3|Standard Deviation|9.1|9.1|||
4156317|NCT00845650|3979787|B4|||Age||years|Mean|37.1|37.1|Standard Deviation|9.4|9.4|||
4156318|NCT00845650|3979788|B3|||Age||years|Mean|32.1|32.1|Standard Deviation|10.6|10.6|||
4156319|NCT00845650|3979789|B2|||Age||years|Mean|35.2|35.2|Standard Deviation|13.8|13.8|||
4156320|NCT00845650|3979790|B1|||Age||years|Mean|35.1|35.1|Standard Deviation|10.3|10.3|||
4156321|NCT00845520|3979830|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4156322|NCT00845520|3979831|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4156323|NCT00845520|3979832|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4156324|NCT00845520|3979833|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4156325|NCT00845520|3979830|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156326|NCT00845520|3979831|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156327|NCT00845520|3979832|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156328|NCT00845520|3979833|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156329|NCT00845520|3979830|B4||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4156330|NCT00845520|3979831|B3||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4156331|NCT00845520|3979832|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4156332|NCT00845520|3979833|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4156333|NCT00845520|3979830|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4156334|NCT00845520|3979831|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156335|NCT00845520|3979832|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156336|NCT00845520|3979833|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4156337|NCT00845520|3979830|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156338|NCT00845520|3979831|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156339|NCT00845520|3979832|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156340|NCT00845520|3979833|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156341|NCT00845520|3979830|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4156342|NCT00845520|3979831|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156343|NCT00845520|3979832|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4156344|NCT00845520|3979833|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156345|NCT00845520|3979830|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156346|NCT00845520|3979831|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156347|NCT00845520|3979832|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156348|NCT00845520|3979833|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156349|NCT00845520|3979830|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4156350|NCT00845520|3979831|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4156351|NCT00845520|3979832|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4156352|NCT00845520|3979833|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4156353|NCT00845520|3979830|B4||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4156354|NCT00845520|3979831|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4156355|NCT00845520|3979832|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4156356|NCT00845520|3979833|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4156357|NCT00845520|3979830|B4|||Age||years|Mean|66.1|66.1|Standard Deviation|8.6|8.6|||
4156358|NCT00845520|3979831|B3|||Age||years|Mean|65.9|65.9|Standard Deviation|9.2|9.2|||
4156359|NCT00845520|3979832|B2|||Age||years|Mean|65.6|65.6|Standard Deviation|7.3|7.3|||
4156360|NCT00845520|3979833|B1|||Age||years|Mean|66.3|66.3|Standard Deviation|9.3|9.3|||
4156361|NCT00845507|3979849|B3|||Weight||Pounds|Mean|204|204.0|Standard Deviation|44|44.0|||
4156362|NCT00845507|3979850|B2|||Weight||Pounds|Mean|209|209.0|Standard Deviation|51|51.0|||
4156363|NCT00845507|3979851|B1|||Weight||Pounds|Mean|197|197.0|Standard Deviation|32|32.0|||
4156364|NCT00845507|3979849|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
4156365|NCT00845507|3979850|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4156366|NCT00845507|3979851|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4156367|NCT00845507|3979849|B3|Race|Non-White|Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
4156368|NCT00845507|3979850|B2|Race|Non-White|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4156369|NCT00845507|3979851|B1|Race|Non-White|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4156370|NCT00845507|3979849|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
4156371|NCT00845507|3979850|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
4156372|NCT00845507|3979851|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4156373|NCT00845507|3979849|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4156374|NCT00845507|3979850|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4156375|NCT00845507|3979851|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4156376|NCT00845507|3979849|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4156377|NCT00845507|3979850|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4156378|NCT00845507|3979851|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4156379|NCT00845507|3979849|B3|||Age||years|Mean|41.4|41.4|Standard Deviation|10.9|10.9|||
4156380|NCT00845507|3979850|B2|||Age||years|Mean|39.3|39.3|Standard Deviation|11.7|11.7|||
4156381|NCT00845507|3979851|B1|||Age||years|Mean|44.2|44.2|Standard Deviation|9.3|9.3|||
4156382|NCT00845481|3979860|B1|France||Region of Enrollment||participants|Number|24|24.0||||||
4156383|NCT00845481|3979860|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4156384|NCT00845481|3979860|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4156385|NCT00845481|3979860|B1|>=68 years||Age, Customized||participants|Number|1|1.0||||||
4156386|NCT00845481|3979860|B1|Between 18 and 67 years||Age, Customized||participants|Number|23|23.0||||||
4156387|NCT00845481|3979860|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4156388|NCT00845481|3979860|B1|||Age||years|Mean|50.5|50.5|Standard Deviation|9.6|9.6|||
4156389|NCT00845429|3979869|B4|United States||Region of Enrollment||participants|Number|729|729.0||||||
4156390|NCT00845429|3979870|B3|United States||Region of Enrollment||participants|Number|244|244.0||||||
4156391|NCT00845429|3979871|B2|United States||Region of Enrollment||participants|Number|241|241.0||||||
4156392|NCT00845429|3979872|B1|United States||Region of Enrollment||participants|Number|244|244.0||||||
4156393|NCT00845429|3979869|B4||Male|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
4156394|NCT00845429|3979870|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4156395|NCT00845429|3979871|B2||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4156396|NCT00845429|3979872|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4156397|NCT00845429|3979869|B4||Female|Sex: Female, Male||Participants|Count of Participants|471|471.0||||||
4156398|NCT00845429|3979870|B3||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4156399|NCT00845429|3979871|B2||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4156400|NCT00845429|3979872|B1||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4156401|NCT00845429|3979869|B4|||Age||Years|Mean|34.3|34.3|Standard Deviation|9.32|9.32|||
4156402|NCT00845429|3979870|B3|||Age||Years|Mean|34.1|34.1|Standard Deviation|9.42|9.42|||
4156403|NCT00845429|3979871|B2|||Age||Years|Mean|34.5|34.5|Standard Deviation|9.18|9.18|||
4156404|NCT00845429|3979872|B1|||Age||Years|Mean|34.4|34.4|Standard Deviation|9.41|9.41|||
4156405|NCT00845429|3979869|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4156406|NCT00845429|3979870|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4156407|NCT00845429|3979871|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4156408|NCT00845429|3979872|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4156409|NCT00845429|3979869|B4||Between 18 and 65 years|Age||Participants|Count of Participants|729|729.0||||||
4156410|NCT00845429|3979870|B3||Between 18 and 65 years|Age||Participants|Count of Participants|244|244.0||||||
4156411|NCT00845429|3979871|B2||Between 18 and 65 years|Age||Participants|Count of Participants|241|241.0||||||
4156412|NCT00845429|3979872|B1||Between 18 and 65 years|Age||Participants|Count of Participants|244|244.0||||||
4156413|NCT00845429|3979869|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4156414|NCT00845429|3979870|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4156415|NCT00845429|3979871|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4156416|NCT00845429|3979872|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4156417|NCT00845195|3979891|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4156418|NCT00845195|3979892|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4156419|NCT00845195|3979893|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4156420|NCT00845195|3979891|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4156421|NCT00845195|3979892|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4156422|NCT00845195|3979893|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4156423|NCT00845195|3979891|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4156424|NCT00845195|3979892|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4156425|NCT00845195|3979893|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4156426|NCT00845195|3979891|B3||Between 18 and 65 years|Age||Participants|Count of Participants|139|139.0||||||
4156427|NCT00845195|3979892|B2||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4156428|NCT00845195|3979893|B1||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
4156429|NCT00845195|3979891|B3||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4156430|NCT00845195|3979892|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4156431|NCT00845195|3979893|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4156432|NCT00845182|3979906|B4|United States||Region of Enrollment||participants|Number|43|43.0||||||
4156433|NCT00845182|3979907|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4156434|NCT00845182|3979908|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4156435|NCT00845182|3979909|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4156436|NCT00845182|3979906|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4156437|NCT00845182|3979907|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4156438|NCT00845182|3979908|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4156439|NCT00845182|3979909|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4156440|NCT00845182|3979906|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4156441|NCT00845182|3979907|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4156442|NCT00845182|3979908|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4156443|NCT00845182|3979909|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4156444|NCT00845182|3979906|B4|||Age||years|Mean|54.2|54.2|Standard Deviation|8.02|8.02|||
4156445|NCT00845182|3979907|B3|||Age||years|Mean|53.8|53.8|Standard Deviation|9.8|9.8|||
4156446|NCT00845182|3979908|B2|||Age||years|Mean|54.3|54.3|Standard Deviation|8.5|8.5|||
4156447|NCT00845182|3979909|B1|||Age||years|Mean|54.6|54.6|Standard Deviation|5.7|5.7|||
4156448|NCT00845182|3979906|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4156449|NCT00845182|3979907|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4156450|NCT00845182|3979908|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4156451|NCT00845182|3979909|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4156452|NCT00845182|3979906|B4||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4156453|NCT00845182|3979907|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4156454|NCT00845182|3979908|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4156455|NCT00845182|3979909|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4156456|NCT00845182|3979906|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4156457|NCT00845182|3979907|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4156458|NCT00845182|3979908|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4156459|NCT00845182|3979909|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4156460|NCT00845130|3979923|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
4156461|NCT00845130|3979924|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4156462|NCT00845130|3979925|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4156463|NCT00845130|3979923|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4156464|NCT00845130|3979924|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4156465|NCT00845130|3979925|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4156466|NCT00845130|3979923|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4156467|NCT00845130|3979924|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4156468|NCT00845130|3979925|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4156469|NCT00845130|3979923|B3|||Age||years|Mean|47|47.0|Standard Deviation|6|6.0|||
4156470|NCT00845130|3979924|B2|||Age||years|Mean|45|45.0|Standard Deviation|7|7.0|||
4156471|NCT00845130|3979925|B1|||Age||years|Mean|48|48.0|Standard Deviation|5|5.0|||
4156472|NCT00845130|3979923|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4156473|NCT00845130|3979924|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4156474|NCT00845130|3979925|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4156475|NCT00845130|3979923|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4156476|NCT00845130|3979924|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4156477|NCT00845130|3979925|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4156478|NCT00845130|3979923|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4156479|NCT00845130|3979924|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4156480|NCT00845130|3979925|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4156481|NCT00845065|3979934|B3||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4156482|NCT00845065|3979935|B2||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4156483|NCT00845065|3979936|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4156484|NCT00845065|3979934|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4156485|NCT00845065|3979935|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4156486|NCT00845065|3979936|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4156487|NCT00845065|3979934|B3|||Age||years|Mean|52.5|52.5|Standard Deviation|7.1|7.1|||
4156488|NCT00845065|3979935|B2|||Age||years|Mean|52.0|52.0|Standard Deviation|7.2|7.2|||
4156489|NCT00845065|3979936|B1|||Age||years|Mean|53.5|53.5|Standard Deviation|6.8|6.8|||
4156490|NCT00845039|3979951|B3|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4156491|NCT00845039|3979952|B2|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4156492|NCT00845039|3979953|B1|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4156493|NCT00845039|3979951|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156494|NCT00845039|3979952|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156495|NCT00845039|3979953|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156496|NCT00845039|3979951|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156497|NCT00845039|3979952|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156498|NCT00845039|3979953|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156499|NCT00845039|3979951|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4156500|NCT00845039|3979952|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156501|NCT00845039|3979953|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4156502|NCT00845039|3979951|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4156503|NCT00845039|3979952|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4156504|NCT00845039|3979953|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156505|NCT00845039|3979951|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156506|NCT00845039|3979952|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156507|NCT00845039|3979953|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156508|NCT00845039|3979951|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156509|NCT00845039|3979952|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156510|NCT00845039|3979953|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156511|NCT00845039|3979951|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156512|NCT00845039|3979952|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156513|NCT00845039|3979953|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156514|NCT00845039|3979951|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156515|NCT00845039|3979952|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156516|NCT00845039|3979953|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156517|NCT00845039|3979951|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4156518|NCT00845039|3979952|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4156519|NCT00845039|3979953|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4156520|NCT00845039|3979951|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156521|NCT00845039|3979952|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156522|NCT00845039|3979953|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156523|NCT00845039|3979951|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4156524|NCT00845039|3979952|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4156525|NCT00845039|3979953|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4156526|NCT00845039|3979951|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4156527|NCT00845039|3979952|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4156528|NCT00845039|3979953|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4156529|NCT00845039|3979951|B3|||Age||years|Mean|55.8|55.8|Full Range|||48.0|63.0|
4156530|NCT00845039|3979952|B2|||Age||years|Mean|59.5|59.5|Full Range|||56.0|63.0|
4156531|NCT00845039|3979953|B1|||Age||years|Mean|52.0|52.0|Full Range|||48.0|56.0|
4156532|NCT00845000|3979975|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4156533|NCT00845000|3979976|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4156534|NCT00845000|3979977|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4156535|NCT00845000|3979978|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4156536|NCT00845000|3979979|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4156537|NCT00845000|3979980|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4156538|NCT00845000|3979981|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4156539|NCT00845000|3979975|B7||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4156540|NCT00845000|3979976|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4156541|NCT00845000|3979977|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4156542|NCT00845000|3979978|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4156543|NCT00845000|3979979|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4156544|NCT00845000|3979980|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4156545|NCT00845000|3979981|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4156546|NCT00845000|3979975|B7|||Age||Years|Mean|61.9|61.9|Standard Deviation|6.7|6.7|||
4156547|NCT00845000|3979976|B6|||Age||Years|Mean|57.5|57.5|Standard Deviation|3.5|3.5|||
4156548|NCT00845000|3979977|B5|||Age||Years|Mean|68.5|68.5|Standard Deviation|13.4|13.4|||
4156549|NCT00845000|3979978|B4|||Age||Years|Mean|63.5|63.5|Standard Deviation|6.4|6.4|||
4156550|NCT00845000|3979979|B3|||Age||Years|Mean|65.0|65.0|Standard Deviation|4.2|4.2|||
4156551|NCT00845000|3979980|B2|||Age||Years|Mean|59.5|59.5|Standard Deviation|3.5|3.5|||
4156552|NCT00845000|3979981|B1|||Age||Years|Mean|57.5|57.5|Standard Deviation|4.9|4.9|||
4156553|NCT00844896|3980003|B3|United States||Region of Enrollment||participants|Number|57|57.0||||||
4156554|NCT00844896|3980004|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4156555|NCT00844896|3980005|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4156556|NCT00844896|3980003|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4156557|NCT00844896|3980004|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4156558|NCT00844896|3980005|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4156559|NCT00844896|3980003|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4156560|NCT00844896|3980004|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4156561|NCT00844896|3980005|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4156562|NCT00844896|3980003|B3|||Age||years|Mean|2.1|2.1|Standard Deviation|1.5|1.5|||
4156563|NCT00844896|3980004|B2|||Age||years|Mean|2.3|2.3|Standard Deviation|1.6|1.6|||
4156564|NCT00844896|3980005|B1|||Age||years|Mean|1.9|1.9|Standard Deviation|1.4|1.4|||
4156565|NCT00844896|3980003|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4156566|NCT00844896|3980004|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4156567|NCT00844896|3980005|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4156568|NCT00844896|3980003|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4156569|NCT00844896|3980004|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4156570|NCT00844896|3980005|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4156571|NCT00844896|3980003|B3||<=18 years|Age||Participants|Count of Participants|57|57.0||||||
4156572|NCT00844896|3980004|B2||<=18 years|Age||Participants|Count of Participants|28|28.0||||||
4156573|NCT00844896|3980005|B1||<=18 years|Age||Participants|Count of Participants|29|29.0||||||
4156574|NCT00844883|3980028|B1|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
4156575|NCT00844883|3980028|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4156576|NCT00844883|3980028|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4156577|NCT00844883|3980028|B1|||Age||years|Median|60|60.0|Inter-Quartile Range|||35.0|67.0|
4156578|NCT00844857|3980038|B3|||Number of Previous Mixed Episodes in Past 12 Months|A Mixed Episode is characterized by a period of time in which the criteria are met both for a Manic Episode and for a Major Depressive Episode nearly every day.|episodes|Mean|0.58|0.58|Standard Deviation|3.29|3.29|||
4156579|NCT00844857|3980039|B2|||Number of Previous Mixed Episodes in Past 12 Months|A Mixed Episode is characterized by a period of time in which the criteria are met both for a Manic Episode and for a Major Depressive Episode nearly every day.|episodes|Mean|0.39|0.39|Standard Deviation|1.05|1.05|||
4156580|NCT00844857|3980040|B1|||Number of Previous Mixed Episodes in Past 12 Months|A Mixed Episode is characterized by a period of time in which the criteria are met both for a Manic Episode and for a Major Depressive Episode nearly every day.|episodes|Mean|0.68|0.68|Standard Deviation|3.97|3.97|||
4156581|NCT00844857|3980038|B3|||Number of Previous Episodes of Depression in Past 12 Months||episodes|Mean|1.82|1.82|Standard Deviation|3.64|3.64|||
4156582|NCT00844857|3980039|B2|||Number of Previous Episodes of Depression in Past 12 Months||episodes|Mean|1.71|1.71|Standard Deviation|2.31|2.31|||
4156583|NCT00844857|3980040|B1|||Number of Previous Episodes of Depression in Past 12 Months||episodes|Mean|1.88|1.88|Standard Deviation|4.16|4.16|||
4156584|NCT00844857|3980038|B3|||Number of Previous Episodes of Mania in Past 12 Months||episodes|Mean|1.27|1.27|Standard Deviation|3.37|3.37|||
4156585|NCT00844857|3980039|B2|||Number of Previous Episodes of Mania in Past 12 Months||episodes|Mean|1.27|1.27|Standard Deviation|1.89|1.89|||
4156586|NCT00844857|3980040|B1|||Number of Previous Episodes of Mania in Past 12 Months||episodes|Mean|1.26|1.26|Standard Deviation|3.91|3.91|||
4156587|NCT00844857|3980038|B3|||Number of Previous Mixed Episodes During Participants Life|A Mixed Episode is characterized by a period of time in which the criteria are met both for a Manic Episode and for a Major Depressive Episode nearly every day.|episodes|Mean|1.70|1.7|Standard Deviation|6.68|6.68|||
4156588|NCT00844857|3980039|B2|||Number of Previous Mixed Episodes During Participants Life|A Mixed Episode is characterized by a period of time in which the criteria are met both for a Manic Episode and for a Major Depressive Episode nearly every day.|episodes|Mean|1.53|1.53|Standard Deviation|3.96|3.96|||
4156589|NCT00844857|3980040|B1|||Number of Previous Mixed Episodes During Participants Life|A Mixed Episode is characterized by a period of time in which the criteria are met both for a Manic Episode and for a Major Depressive Episode nearly every day.|episodes|Mean|1.79|1.79|Standard Deviation|7.69|7.69|||
4156590|NCT00844857|3980038|B3|||Number of Previous Episodes of Depression During Participants Life||episodes|Mean|4.45|4.45|Standard Deviation|8.36|8.36|||
4156591|NCT00844857|3980039|B2|||Number of Previous Episodes of Depression During Participants Life||episodes|Mean|4.11|4.11|Standard Deviation|6.58|6.58|||
4156592|NCT00844857|3980040|B1|||Number of Previous Episodes of Depression During Participants Life||episodes|Mean|4.63|4.63|Standard Deviation|9.13|9.13|||
4156593|NCT00844857|3980038|B3|||Number of Previous Episodes of Mania During Participants Life||episodes|Mean|3.85|3.85|Standard Deviation|9.12|9.12|||
4156594|NCT00844857|3980039|B2|||Number of Previous Episodes of Mania During Participants Life||episodes|Mean|3.75|3.75|Standard Deviation|5.69|5.69|||
4156595|NCT00844857|3980040|B1|||Number of Previous Episodes of Mania During Participants Life||episodes|Mean|3.91|3.91|Standard Deviation|10.43|10.43|||
4156596|NCT00844857|3980038|B3|Missing, participant did not reply||Race||participants|Number|4|4.0||||||
4156597|NCT00844857|3980039|B2|Missing, participant did not reply||Race||participants|Number|1|1.0||||||
4156598|NCT00844857|3980040|B1|Missing, participant did not reply||Race||participants|Number|3|3.0||||||
4156599|NCT00844857|3980038|B3|Multiple||Race||participants|Number|22|22.0||||||
4156600|NCT00844857|3980039|B2|Multiple||Race||participants|Number|7|7.0||||||
4156601|NCT00844857|3980040|B1|Multiple||Race||participants|Number|15|15.0||||||
4156602|NCT00844857|3980038|B3|White||Race||participants|Number|180|180.0||||||
4156603|NCT00844857|3980039|B2|White||Race||participants|Number|61|61.0||||||
4156604|NCT00844857|3980040|B1|White||Race||participants|Number|119|119.0||||||
4156605|NCT00844857|3980038|B3|Native Hawaiian or Other Pacific Islander||Race||participants|Number|1|1.0||||||
4156606|NCT00844857|3980039|B2|Native Hawaiian or Other Pacific Islander||Race||participants|Number|0|0.0||||||
4156607|NCT00844857|3980040|B1|Native Hawaiian or Other Pacific Islander||Race||participants|Number|1|1.0||||||
4156608|NCT00844857|3980038|B3|Black or African American||Race||participants|Number|34|34.0||||||
4156609|NCT00844857|3980039|B2|Black or African American||Race||participants|Number|11|11.0||||||
4156610|NCT00844857|3980040|B1|Black or African American||Race||participants|Number|23|23.0||||||
4156611|NCT00844857|3980038|B3|Asian||Race||participants|Number|0|0.0||||||
4156612|NCT00844857|3980039|B2|Asian||Race||participants|Number|0|0.0||||||
4156613|NCT00844857|3980040|B1|Asian||Race||participants|Number|0|0.0||||||
4156614|NCT00844857|3980038|B3|American Indian or Alaska Native||Race||participants|Number|14|14.0||||||
4156615|NCT00844857|3980039|B2|American Indian or Alaska Native||Race||participants|Number|5|5.0||||||
4156616|NCT00844857|3980040|B1|American Indian or Alaska Native||Race||participants|Number|9|9.0||||||
4156617|NCT00844857|3980038|B3|Missing, participant did not reply||Ethnicity||participants|Number|1|1.0||||||
4156618|NCT00844857|3980039|B2|Missing, participant did not reply||Ethnicity||participants|Number|1|1.0||||||
4156619|NCT00844857|3980040|B1|Missing, participant did not reply||Ethnicity||participants|Number|0|0.0||||||
4156620|NCT00844857|3980038|B3|Not Hispanic or Latino||Ethnicity||participants|Number|193|193.0||||||
4156621|NCT00844857|3980039|B2|Not Hispanic or Latino||Ethnicity||participants|Number|61|61.0||||||
4156622|NCT00844857|3980040|B1|Not Hispanic or Latino||Ethnicity||participants|Number|132|132.0||||||
4156623|NCT00844857|3980038|B3|Hispanic or Latino||Ethnicity||participants|Number|61|61.0||||||
4156624|NCT00844857|3980039|B2|Hispanic or Latino||Ethnicity||participants|Number|23|23.0||||||
4156625|NCT00844857|3980040|B1|Hispanic or Latino||Ethnicity||participants|Number|38|38.0||||||
4156626|NCT00844857|3980038|B3|Mexico||Region of Enrollment||participants|Number|23|23.0||||||
4156627|NCT00844857|3980039|B2|Mexico||Region of Enrollment||participants|Number|7|7.0||||||
4156628|NCT00844857|3980040|B1|Mexico||Region of Enrollment||participants|Number|16|16.0||||||
4156629|NCT00844857|3980038|B3|Russian Federation||Region of Enrollment||participants|Number|44|44.0||||||
4156630|NCT00844857|3980039|B2|Russian Federation||Region of Enrollment||participants|Number|13|13.0||||||
4156631|NCT00844857|3980040|B1|Russian Federation||Region of Enrollment||participants|Number|31|31.0||||||
4156632|NCT00844857|3980038|B3|United States||Region of Enrollment||participants|Number|188|188.0||||||
4156633|NCT00844857|3980039|B2|United States||Region of Enrollment||participants|Number|65|65.0||||||
4156634|NCT00844857|3980040|B1|United States||Region of Enrollment||participants|Number|123|123.0||||||
4156635|NCT00844857|3980038|B3||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4156636|NCT00844857|3980039|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4156637|NCT00844857|3980040|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4156638|NCT00844857|3980038|B3||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4156639|NCT00844857|3980039|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4156640|NCT00844857|3980040|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4156641|NCT00844857|3980038|B3|||Age||years|Mean|14.74|14.74|Standard Deviation|2.25|2.25|||
4156642|NCT00844857|3980039|B2|||Age||years|Mean|15.03|15.03|Standard Deviation|2.13|2.13|||
4156643|NCT00844857|3980040|B1|||Age||years|Mean|14.59|14.59|Standard Deviation|2.30|2.3|||
4156644|NCT00844844|3980085|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156645|NCT00844844|3980085|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156646|NCT00844844|3980085|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4156647|NCT00844844|3980085|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4156648|NCT00844844|3980085|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156649|NCT00844844|3980085|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4156650|NCT00844844|3980085|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156651|NCT00844844|3980085|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4156652|NCT00844844|3980085|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4156653|NCT00844844|3980085|B1|||Age||Years|Mean|31.8|31.8|Standard Deviation|13.32|13.32|||
4156654|NCT00844831|3980099|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4156655|NCT00844831|3980099|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4156656|NCT00844831|3980099|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4156657|NCT00844831|3980099|B1|||Age||years|Mean|52|52.0|Standard Deviation|5|5.0|||
4156658|NCT00844831|3980099|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4156659|NCT00844831|3980099|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4156660|NCT00844831|3980099|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4156661|NCT00844805|3980107|B3||Male|Sex: Female, Male|Gender is based on the Intent-to-Treat (ITT) population which consisted of participants treated with Infliximab + Naproxen (n=105) and participants treated with Placebo + Naproxen (n=51).|Participants|Count of Participants|112|112.0||||||
4156662|NCT00844805|3980108|B2||Male|Sex: Female, Male|Gender is based on the Intent-to-Treat (ITT) population which consisted of participants treated with Infliximab + Naproxen (n=105) and participants treated with Placebo + Naproxen (n=51).|Participants|Count of Participants|40|40.0||||||
4156663|NCT00844805|3980109|B1||Male|Sex: Female, Male|Gender is based on the Intent-to-Treat (ITT) population which consisted of participants treated with Infliximab + Naproxen (n=105) and participants treated with Placebo + Naproxen (n=51).|Participants|Count of Participants|72|72.0||||||
4156664|NCT00844805|3980107|B3||Female|Sex: Female, Male|Gender is based on the Intent-to-Treat (ITT) population which consisted of participants treated with Infliximab + Naproxen (n=105) and participants treated with Placebo + Naproxen (n=51).|Participants|Count of Participants|44|44.0||||||
4156665|NCT00844805|3980108|B2||Female|Sex: Female, Male|Gender is based on the Intent-to-Treat (ITT) population which consisted of participants treated with Infliximab + Naproxen (n=105) and participants treated with Placebo + Naproxen (n=51).|Participants|Count of Participants|11|11.0||||||
4156666|NCT00844805|3980109|B1||Female|Sex: Female, Male|Gender is based on the Intent-to-Treat (ITT) population which consisted of participants treated with Infliximab + Naproxen (n=105) and participants treated with Placebo + Naproxen (n=51).|Participants|Count of Participants|33|33.0||||||
4156667|NCT00844805|3980107|B3|||Age|Mean age presented is based on the Intent-to-Treat (ITT) population which consisted of participants treated with Infliximab + Naproxen (n=105) and participants treated with Placebo + Naproxen (n=51).|years|Mean|31.4|31.4|Standard Deviation|8.12|8.12|||
4156668|NCT00844805|3980108|B2|||Age|Mean age presented is based on the Intent-to-Treat (ITT) population which consisted of participants treated with Infliximab + Naproxen (n=105) and participants treated with Placebo + Naproxen (n=51).|years|Mean|30.7|30.7|Standard Deviation|7.34|7.34|||
4156669|NCT00844805|3980109|B1|||Age|Mean age presented is based on the Intent-to-Treat (ITT) population which consisted of participants treated with Infliximab + Naproxen (n=105) and participants treated with Placebo + Naproxen (n=51).|years|Mean|31.7|31.7|Standard Deviation|8.51|8.51|||
4156670|NCT00844753|3980152|B5|United States||Region of Enrollment||participants|Number|128|128.0||||||
4156671|NCT00844753|3980153|B4|United States||Region of Enrollment||participants|Number|32|32.0||||||
4156672|NCT00844753|3980154|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4156673|NCT00844753|3980155|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
4156674|NCT00844753|3980156|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4156675|NCT00844753|3980152|B5||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4156676|NCT00844753|3980153|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4156677|NCT00844753|3980154|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4156678|NCT00844753|3980155|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4156679|NCT00844753|3980156|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4156680|NCT00844753|3980152|B5||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4156681|NCT00844753|3980153|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4156682|NCT00844753|3980154|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4156683|NCT00844753|3980155|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4156684|NCT00844753|3980156|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4156685|NCT00844753|3980152|B5|||Age||years|Mean|8.1|8.1|Standard Deviation|2.1|2.1|||
4156686|NCT00844753|3980153|B4|||Age||years|Mean|8.2|8.2|Standard Deviation|2.4|2.4|||
4156687|NCT00844753|3980154|B3|||Age||years|Mean|7.7|7.7|Standard Deviation|1.5|1.5|||
4156688|NCT00844753|3980155|B2|||Age||years|Mean|8.6|8.6|Standard Deviation|2.3|2.3|||
4156689|NCT00844753|3980156|B1|||Age||years|Mean|8.0|8.0|Standard Deviation|1.9|1.9|||
4156690|NCT00844714|3980171|B1|||Flow-mediated vasodilation (FMD)|endothelial function as assessed by flow-mediated vasodilation of the brachial artery|mm|Median|3.9|3.9|Inter-Quartile Range|||3.4|5.8|
4156691|NCT00844714|3980171|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4156692|NCT00844714|3980171|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4156693|NCT00844714|3980171|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4156694|NCT00844714|3980171|B1|||Age||years|Median|54|54.0|Inter-Quartile Range|||46.0|61.0|
4156695|NCT00844649|3980175|B3|>5||Number of Baseline Lesions (Target + Non-Target)|Target lesions are those measurable at baseline and are generally the largest lesions, most reliably measured and most representative of the participants sites of disease. Non target lesions are all of the sites of disease present at baseline not classified as target lesions. They include bone and cystic lesions and pleural/pericardial effusion/ascites. The Independent Radiology Reviewers (IRR) only evaluated scans for those with baseline and follow-up scans.|participants|Number|538|538.0||||||
4156696|NCT00844649|3980176|B2|>5||Number of Baseline Lesions (Target + Non-Target)|Target lesions are those measurable at baseline and are generally the largest lesions, most reliably measured and most representative of the participants sites of disease. Non target lesions are all of the sites of disease present at baseline not classified as target lesions. They include bone and cystic lesions and pleural/pericardial effusion/ascites. The Independent Radiology Reviewers (IRR) only evaluated scans for those with baseline and follow-up scans.|participants|Number|262|262.0||||||
4156697|NCT00844649|3980177|B1|>5||Number of Baseline Lesions (Target + Non-Target)|Target lesions are those measurable at baseline and are generally the largest lesions, most reliably measured and most representative of the participants sites of disease. Non target lesions are all of the sites of disease present at baseline not classified as target lesions. They include bone and cystic lesions and pleural/pericardial effusion/ascites. The Independent Radiology Reviewers (IRR) only evaluated scans for those with baseline and follow-up scans.|participants|Number|276|276.0||||||
4156698|NCT00844649|3980175|B3|5||Number of Baseline Lesions (Target + Non-Target)|Target lesions are those measurable at baseline and are generally the largest lesions, most reliably measured and most representative of the participants sites of disease. Non target lesions are all of the sites of disease present at baseline not classified as target lesions. They include bone and cystic lesions and pleural/pericardial effusion/ascites. The Independent Radiology Reviewers (IRR) only evaluated scans for those with baseline and follow-up scans.|participants|Number|16|16.0||||||
4156699|NCT00844649|3980176|B2|5||Number of Baseline Lesions (Target + Non-Target)|Target lesions are those measurable at baseline and are generally the largest lesions, most reliably measured and most representative of the participants sites of disease. Non target lesions are all of the sites of disease present at baseline not classified as target lesions. They include bone and cystic lesions and pleural/pericardial effusion/ascites. The Independent Radiology Reviewers (IRR) only evaluated scans for those with baseline and follow-up scans.|participants|Number|8|8.0||||||
4156700|NCT00844649|3980177|B1|5||Number of Baseline Lesions (Target + Non-Target)|Target lesions are those measurable at baseline and are generally the largest lesions, most reliably measured and most representative of the participants sites of disease. Non target lesions are all of the sites of disease present at baseline not classified as target lesions. They include bone and cystic lesions and pleural/pericardial effusion/ascites. The Independent Radiology Reviewers (IRR) only evaluated scans for those with baseline and follow-up scans.|participants|Number|8|8.0||||||
4156701|NCT00844649|3980175|B3|4||Number of Baseline Lesions (Target + Non-Target)|Target lesions are those measurable at baseline and are generally the largest lesions, most reliably measured and most representative of the participants sites of disease. Non target lesions are all of the sites of disease present at baseline not classified as target lesions. They include bone and cystic lesions and pleural/pericardial effusion/ascites. The Independent Radiology Reviewers (IRR) only evaluated scans for those with baseline and follow-up scans.|participants|Number|80|80.0||||||
4156702|NCT00844649|3980176|B2|4||Number of Baseline Lesions (Target + Non-Target)|Target lesions are those measurable at baseline and are generally the largest lesions, most reliably measured and most representative of the participants sites of disease. Non target lesions are all of the sites of disease present at baseline not classified as target lesions. They include bone and cystic lesions and pleural/pericardial effusion/ascites. The Independent Radiology Reviewers (IRR) only evaluated scans for those with baseline and follow-up scans.|participants|Number|43|43.0||||||
4156703|NCT00844649|3980177|B1|4||Number of Baseline Lesions (Target + Non-Target)|Target lesions are those measurable at baseline and are generally the largest lesions, most reliably measured and most representative of the participants sites of disease. Non target lesions are all of the sites of disease present at baseline not classified as target lesions. They include bone and cystic lesions and pleural/pericardial effusion/ascites. The Independent Radiology Reviewers (IRR) only evaluated scans for those with baseline and follow-up scans.|participants|Number|37|37.0||||||
4156704|NCT00844649|3980175|B3|3||Number of Baseline Lesions (Target + Non-Target)|Target lesions are those measurable at baseline and are generally the largest lesions, most reliably measured and most representative of the participants sites of disease. Non target lesions are all of the sites of disease present at baseline not classified as target lesions. They include bone and cystic lesions and pleural/pericardial effusion/ascites. The Independent Radiology Reviewers (IRR) only evaluated scans for those with baseline and follow-up scans.|participants|Number|14|14.0||||||
4156705|NCT00844649|3980176|B2|3||Number of Baseline Lesions (Target + Non-Target)|Target lesions are those measurable at baseline and are generally the largest lesions, most reliably measured and most representative of the participants sites of disease. Non target lesions are all of the sites of disease present at baseline not classified as target lesions. They include bone and cystic lesions and pleural/pericardial effusion/ascites. The Independent Radiology Reviewers (IRR) only evaluated scans for those with baseline and follow-up scans.|participants|Number|7|7.0||||||
4156706|NCT00844649|3980177|B1|3||Number of Baseline Lesions (Target + Non-Target)|Target lesions are those measurable at baseline and are generally the largest lesions, most reliably measured and most representative of the participants sites of disease. Non target lesions are all of the sites of disease present at baseline not classified as target lesions. They include bone and cystic lesions and pleural/pericardial effusion/ascites. The Independent Radiology Reviewers (IRR) only evaluated scans for those with baseline and follow-up scans.|participants|Number|7|7.0||||||
4156707|NCT00844649|3980175|B3|2||Number of Baseline Lesions (Target + Non-Target)|Target lesions are those measurable at baseline and are generally the largest lesions, most reliably measured and most representative of the participants sites of disease. Non target lesions are all of the sites of disease present at baseline not classified as target lesions. They include bone and cystic lesions and pleural/pericardial effusion/ascites. The Independent Radiology Reviewers (IRR) only evaluated scans for those with baseline and follow-up scans.|participants|Number|57|57.0||||||
4156708|NCT00844649|3980176|B2|2||Number of Baseline Lesions (Target + Non-Target)|Target lesions are those measurable at baseline and are generally the largest lesions, most reliably measured and most representative of the participants sites of disease. Non target lesions are all of the sites of disease present at baseline not classified as target lesions. They include bone and cystic lesions and pleural/pericardial effusion/ascites. The Independent Radiology Reviewers (IRR) only evaluated scans for those with baseline and follow-up scans.|participants|Number|25|25.0||||||
4156760|NCT00844649|3980177|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4156709|NCT00844649|3980177|B1|2||Number of Baseline Lesions (Target + Non-Target)|Target lesions are those measurable at baseline and are generally the largest lesions, most reliably measured and most representative of the participants sites of disease. Non target lesions are all of the sites of disease present at baseline not classified as target lesions. They include bone and cystic lesions and pleural/pericardial effusion/ascites. The Independent Radiology Reviewers (IRR) only evaluated scans for those with baseline and follow-up scans.|participants|Number|32|32.0||||||
4156710|NCT00844649|3980175|B3|1||Number of Baseline Lesions (Target + Non-Target)|Target lesions are those measurable at baseline and are generally the largest lesions, most reliably measured and most representative of the participants sites of disease. Non target lesions are all of the sites of disease present at baseline not classified as target lesions. They include bone and cystic lesions and pleural/pericardial effusion/ascites. The Independent Radiology Reviewers (IRR) only evaluated scans for those with baseline and follow-up scans.|participants|Number|1|1.0||||||
4156711|NCT00844649|3980176|B2|1||Number of Baseline Lesions (Target + Non-Target)|Target lesions are those measurable at baseline and are generally the largest lesions, most reliably measured and most representative of the participants sites of disease. Non target lesions are all of the sites of disease present at baseline not classified as target lesions. They include bone and cystic lesions and pleural/pericardial effusion/ascites. The Independent Radiology Reviewers (IRR) only evaluated scans for those with baseline and follow-up scans.|participants|Number|0|0.0||||||
4156712|NCT00844649|3980177|B1|1||Number of Baseline Lesions (Target + Non-Target)|Target lesions are those measurable at baseline and are generally the largest lesions, most reliably measured and most representative of the participants sites of disease. Non target lesions are all of the sites of disease present at baseline not classified as target lesions. They include bone and cystic lesions and pleural/pericardial effusion/ascites. The Independent Radiology Reviewers (IRR) only evaluated scans for those with baseline and follow-up scans.|participants|Number|1|1.0||||||
4156713|NCT00844649|3980175|B3|Unknown = not specified||Pancreatic Primary Tumor Location|Main location or area of the pancreas where the disease is detected at diagnosis. Unknown location refers to disease area not being specified.|participants|Number|7|7.0||||||
4156714|NCT00844649|3980176|B2|Unknown = not specified||Pancreatic Primary Tumor Location|Main location or area of the pancreas where the disease is detected at diagnosis. Unknown location refers to disease area not being specified.|participants|Number|4|4.0||||||
4156715|NCT00844649|3980177|B1|Unknown = not specified||Pancreatic Primary Tumor Location|Main location or area of the pancreas where the disease is detected at diagnosis. Unknown location refers to disease area not being specified.|participants|Number|3|3.0||||||
4156716|NCT00844649|3980175|B3|Tail||Pancreatic Primary Tumor Location|Main location or area of the pancreas where the disease is detected at diagnosis. Unknown location refers to disease area not being specified.|participants|Number|215|215.0||||||
4156717|NCT00844649|3980176|B2|Tail||Pancreatic Primary Tumor Location|Main location or area of the pancreas where the disease is detected at diagnosis. Unknown location refers to disease area not being specified.|participants|Number|110|110.0||||||
4156718|NCT00844649|3980177|B1|Tail||Pancreatic Primary Tumor Location|Main location or area of the pancreas where the disease is detected at diagnosis. Unknown location refers to disease area not being specified.|participants|Number|105|105.0||||||
4156719|NCT00844649|3980175|B3|Body||Pancreatic Primary Tumor Location|Main location or area of the pancreas where the disease is detected at diagnosis. Unknown location refers to disease area not being specified.|participants|Number|268|268.0||||||
4156720|NCT00844649|3980176|B2|Body||Pancreatic Primary Tumor Location|Main location or area of the pancreas where the disease is detected at diagnosis. Unknown location refers to disease area not being specified.|participants|Number|136|136.0||||||
4156721|NCT00844649|3980177|B1|Body||Pancreatic Primary Tumor Location|Main location or area of the pancreas where the disease is detected at diagnosis. Unknown location refers to disease area not being specified.|participants|Number|132|132.0||||||
4156722|NCT00844649|3980175|B3|Head||Pancreatic Primary Tumor Location|Main location or area of the pancreas where the disease is detected at diagnosis. Unknown location refers to disease area not being specified.|participants|Number|371|371.0||||||
4156723|NCT00844649|3980176|B2|Head||Pancreatic Primary Tumor Location|Main location or area of the pancreas where the disease is detected at diagnosis. Unknown location refers to disease area not being specified.|participants|Number|180|180.0||||||
4156724|NCT00844649|3980177|B1|Head||Pancreatic Primary Tumor Location|Main location or area of the pancreas where the disease is detected at diagnosis. Unknown location refers to disease area not being specified.|participants|Number|191|191.0||||||
4156725|NCT00844649|3980175|B3|0% = Dead||Karnofsky Performance Status (KPS)|"The Karnofsky Performance Status Scale (KPS) was designed to measure the level of participant activity and medical care requirements. A general measure of participant independence and has been widely used as a general assessment of participants with cancer. The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a participant's ability to survive chemotherapy for cancer. Two participants from the Albumin bound paclitaxel arm and one from the Gemcitabine arm did not have KPS performed."|participants|Number|0|0.0||||||
4156726|NCT00844649|3980176|B2|0% = Dead||Karnofsky Performance Status (KPS)|"The Karnofsky Performance Status Scale (KPS) was designed to measure the level of participant activity and medical care requirements. A general measure of participant independence and has been widely used as a general assessment of participants with cancer. The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a participant's ability to survive chemotherapy for cancer. Two participants from the Albumin bound paclitaxel arm and one from the Gemcitabine arm did not have KPS performed."|participants|Number|0|0.0||||||
4156727|NCT00844649|3980177|B1|0% = Dead||Karnofsky Performance Status (KPS)|"The Karnofsky Performance Status Scale (KPS) was designed to measure the level of participant activity and medical care requirements. A general measure of participant independence and has been widely used as a general assessment of participants with cancer. The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a participant's ability to survive chemotherapy for cancer. Two participants from the Albumin bound paclitaxel arm and one from the Gemcitabine arm did not have KPS performed."|participants|Number|0|0.0||||||
4156728|NCT00844649|3980175|B3|10% = Moribund, fatal processes progressing fast||Karnofsky Performance Status (KPS)|"The Karnofsky Performance Status Scale (KPS) was designed to measure the level of participant activity and medical care requirements. A general measure of participant independence and has been widely used as a general assessment of participants with cancer. The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a participant's ability to survive chemotherapy for cancer. Two participants from the Albumin bound paclitaxel arm and one from the Gemcitabine arm did not have KPS performed."|participants|Number|0|0.0||||||
4156729|NCT00844649|3980176|B2|10% = Moribund, fatal processes progressing fast||Karnofsky Performance Status (KPS)|"The Karnofsky Performance Status Scale (KPS) was designed to measure the level of participant activity and medical care requirements. A general measure of participant independence and has been widely used as a general assessment of participants with cancer. The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a participant's ability to survive chemotherapy for cancer. Two participants from the Albumin bound paclitaxel arm and one from the Gemcitabine arm did not have KPS performed."|participants|Number|0|0.0||||||
4156730|NCT00844649|3980177|B1|10% = Moribund, fatal processes progressing fast||Karnofsky Performance Status (KPS)|"The Karnofsky Performance Status Scale (KPS) was designed to measure the level of participant activity and medical care requirements. A general measure of participant independence and has been widely used as a general assessment of participants with cancer. The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a participant's ability to survive chemotherapy for cancer. Two participants from the Albumin bound paclitaxel arm and one from the Gemcitabine arm did not have KPS performed."|participants|Number|0|0.0||||||
4156731|NCT00844649|3980175|B3|20% = hospitalized; requires supportive treatment||Karnofsky Performance Status (KPS)|"The Karnofsky Performance Status Scale (KPS) was designed to measure the level of participant activity and medical care requirements. A general measure of participant independence and has been widely used as a general assessment of participants with cancer. The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a participant's ability to survive chemotherapy for cancer. Two participants from the Albumin bound paclitaxel arm and one from the Gemcitabine arm did not have KPS performed."|participants|Number|0|0.0||||||
4156732|NCT00844649|3980176|B2|20% = hospitalized; requires supportive treatment||Karnofsky Performance Status (KPS)|"The Karnofsky Performance Status Scale (KPS) was designed to measure the level of participant activity and medical care requirements. A general measure of participant independence and has been widely used as a general assessment of participants with cancer. The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a participant's ability to survive chemotherapy for cancer. Two participants from the Albumin bound paclitaxel arm and one from the Gemcitabine arm did not have KPS performed."|participants|Number|0|0.0||||||
4156733|NCT00844649|3980177|B1|20% = hospitalized; requires supportive treatment||Karnofsky Performance Status (KPS)|"The Karnofsky Performance Status Scale (KPS) was designed to measure the level of participant activity and medical care requirements. A general measure of participant independence and has been widely used as a general assessment of participants with cancer. The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a participant's ability to survive chemotherapy for cancer. Two participants from the Albumin bound paclitaxel arm and one from the Gemcitabine arm did not have KPS performed."|participants|Number|0|0.0||||||
4156734|NCT00844649|3980175|B3|30% = severely disabled; death is imminent||Karnofsky Performance Status (KPS)|"The Karnofsky Performance Status Scale (KPS) was designed to measure the level of participant activity and medical care requirements. A general measure of participant independence and has been widely used as a general assessment of participants with cancer. The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a participant's ability to survive chemotherapy for cancer. Two participants from the Albumin bound paclitaxel arm and one from the Gemcitabine arm did not have KPS performed."|participants|Number|0|0.0||||||
4156735|NCT00844649|3980176|B2|30% = severely disabled; death is imminent||Karnofsky Performance Status (KPS)|"The Karnofsky Performance Status Scale (KPS) was designed to measure the level of participant activity and medical care requirements. A general measure of participant independence and has been widely used as a general assessment of participants with cancer. The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a participant's ability to survive chemotherapy for cancer. Two participants from the Albumin bound paclitaxel arm and one from the Gemcitabine arm did not have KPS performed."|participants|Number|0|0.0||||||
4156736|NCT00844649|3980177|B1|30% = severely disabled; death is imminent||Karnofsky Performance Status (KPS)|"The Karnofsky Performance Status Scale (KPS) was designed to measure the level of participant activity and medical care requirements. A general measure of participant independence and has been widely used as a general assessment of participants with cancer. The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a participant's ability to survive chemotherapy for cancer. Two participants from the Albumin bound paclitaxel arm and one from the Gemcitabine arm did not have KPS performed."|participants|Number|0|0.0||||||
4156737|NCT00844649|3980175|B3|40% = disabled; requires special care & assistance||Karnofsky Performance Status (KPS)|"The Karnofsky Performance Status Scale (KPS) was designed to measure the level of participant activity and medical care requirements. A general measure of participant independence and has been widely used as a general assessment of participants with cancer. The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a participant's ability to survive chemotherapy for cancer. Two participants from the Albumin bound paclitaxel arm and one from the Gemcitabine arm did not have KPS performed."|participants|Number|0|0.0||||||
4156761|NCT00844649|3980175|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4156762|NCT00844649|3980176|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4156766|NCT00844649|3980177|B1||White|Race (NIH/OMB)||Participants|Count of Participants|378|378.0||||||
4156738|NCT00844649|3980176|B2|40% = disabled; requires special care & assistance||Karnofsky Performance Status (KPS)|"The Karnofsky Performance Status Scale (KPS) was designed to measure the level of participant activity and medical care requirements. A general measure of participant independence and has been widely used as a general assessment of participants with cancer. The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a participant's ability to survive chemotherapy for cancer. Two participants from the Albumin bound paclitaxel arm and one from the Gemcitabine arm did not have KPS performed."|participants|Number|0|0.0||||||
4156739|NCT00844649|3980177|B1|40% = disabled; requires special care & assistance||Karnofsky Performance Status (KPS)|"The Karnofsky Performance Status Scale (KPS) was designed to measure the level of participant activity and medical care requirements. A general measure of participant independence and has been widely used as a general assessment of participants with cancer. The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a participant's ability to survive chemotherapy for cancer. Two participants from the Albumin bound paclitaxel arm and one from the Gemcitabine arm did not have KPS performed."|participants|Number|0|0.0||||||
4156740|NCT00844649|3980175|B3|50% = needs help often and medical care||Karnofsky Performance Status (KPS)|"The Karnofsky Performance Status Scale (KPS) was designed to measure the level of participant activity and medical care requirements. A general measure of participant independence and has been widely used as a general assessment of participants with cancer. The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a participant's ability to survive chemotherapy for cancer. Two participants from the Albumin bound paclitaxel arm and one from the Gemcitabine arm did not have KPS performed."|participants|Number|0|0.0||||||
4156741|NCT00844649|3980176|B2|50% = needs help often and medical care||Karnofsky Performance Status (KPS)|"The Karnofsky Performance Status Scale (KPS) was designed to measure the level of participant activity and medical care requirements. A general measure of participant independence and has been widely used as a general assessment of participants with cancer. The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a participant's ability to survive chemotherapy for cancer. Two participants from the Albumin bound paclitaxel arm and one from the Gemcitabine arm did not have KPS performed."|participants|Number|0|0.0||||||
4156742|NCT00844649|3980177|B1|50% = needs help often and medical care||Karnofsky Performance Status (KPS)|"The Karnofsky Performance Status Scale (KPS) was designed to measure the level of participant activity and medical care requirements. A general measure of participant independence and has been widely used as a general assessment of participants with cancer. The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a participant's ability to survive chemotherapy for cancer. Two participants from the Albumin bound paclitaxel arm and one from the Gemcitabine arm did not have KPS performed."|participants|Number|0|0.0||||||
4156743|NCT00844649|3980175|B3|60% = needs help, can manage most tasks||Karnofsky Performance Status (KPS)|"The Karnofsky Performance Status Scale (KPS) was designed to measure the level of participant activity and medical care requirements. A general measure of participant independence and has been widely used as a general assessment of participants with cancer. The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a participant's ability to survive chemotherapy for cancer. Two participants from the Albumin bound paclitaxel arm and one from the Gemcitabine arm did not have KPS performed."|participants|Number|2|2.0||||||
4156744|NCT00844649|3980176|B2|60% = needs help, can manage most tasks||Karnofsky Performance Status (KPS)|"The Karnofsky Performance Status Scale (KPS) was designed to measure the level of participant activity and medical care requirements. A general measure of participant independence and has been widely used as a general assessment of participants with cancer. The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a participant's ability to survive chemotherapy for cancer. Two participants from the Albumin bound paclitaxel arm and one from the Gemcitabine arm did not have KPS performed."|participants|Number|0|0.0||||||
4156745|NCT00844649|3980177|B1|60% = needs help, can manage most tasks||Karnofsky Performance Status (KPS)|"The Karnofsky Performance Status Scale (KPS) was designed to measure the level of participant activity and medical care requirements. A general measure of participant independence and has been widely used as a general assessment of participants with cancer. The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a participant's ability to survive chemotherapy for cancer. Two participants from the Albumin bound paclitaxel arm and one from the Gemcitabine arm did not have KPS performed."|participants|Number|2|2.0||||||
4156746|NCT00844649|3980175|B3|70% = caring for self, unable to work||Karnofsky Performance Status (KPS)|"The Karnofsky Performance Status Scale (KPS) was designed to measure the level of participant activity and medical care requirements. A general measure of participant independence and has been widely used as a general assessment of participants with cancer. The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a participant's ability to survive chemotherapy for cancer. Two participants from the Albumin bound paclitaxel arm and one from the Gemcitabine arm did not have KPS performed."|participants|Number|63|63.0||||||
4156747|NCT00844649|3980176|B2|70% = caring for self, unable to work||Karnofsky Performance Status (KPS)|"The Karnofsky Performance Status Scale (KPS) was designed to measure the level of participant activity and medical care requirements. A general measure of participant independence and has been widely used as a general assessment of participants with cancer. The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a participant's ability to survive chemotherapy for cancer. Two participants from the Albumin bound paclitaxel arm and one from the Gemcitabine arm did not have KPS performed."|participants|Number|33|33.0||||||
4156763|NCT00844649|3980177|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4156764|NCT00844649|3980175|B3||White|Race (NIH/OMB)||Participants|Count of Participants|753|753.0||||||
4156765|NCT00844649|3980176|B2||White|Race (NIH/OMB)||Participants|Count of Participants|375|375.0||||||
4156748|NCT00844649|3980177|B1|70% = caring for self, unable to work||Karnofsky Performance Status (KPS)|"The Karnofsky Performance Status Scale (KPS) was designed to measure the level of participant activity and medical care requirements. A general measure of participant independence and has been widely used as a general assessment of participants with cancer. The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a participant's ability to survive chemotherapy for cancer. Two participants from the Albumin bound paclitaxel arm and one from the Gemcitabine arm did not have KPS performed."|participants|Number|30|30.0||||||
4156749|NCT00844649|3980175|B3|80% = normal activity, some symptoms of disease||Karnofsky Performance Status (KPS)|"The Karnofsky Performance Status Scale (KPS) was designed to measure the level of participant activity and medical care requirements. A general measure of participant independence and has been widely used as a general assessment of participants with cancer. The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a participant's ability to survive chemotherapy for cancer. Two participants from the Albumin bound paclitaxel arm and one from the Gemcitabine arm did not have KPS performed."|participants|Number|277|277.0||||||
4156750|NCT00844649|3980176|B2|80% = normal activity, some symptoms of disease||Karnofsky Performance Status (KPS)|"The Karnofsky Performance Status Scale (KPS) was designed to measure the level of participant activity and medical care requirements. A general measure of participant independence and has been widely used as a general assessment of participants with cancer. The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a participant's ability to survive chemotherapy for cancer. Two participants from the Albumin bound paclitaxel arm and one from the Gemcitabine arm did not have KPS performed."|participants|Number|128|128.0||||||
4156751|NCT00844649|3980177|B1|80% = normal activity, some symptoms of disease||Karnofsky Performance Status (KPS)|"The Karnofsky Performance Status Scale (KPS) was designed to measure the level of participant activity and medical care requirements. A general measure of participant independence and has been widely used as a general assessment of participants with cancer. The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a participant's ability to survive chemotherapy for cancer. Two participants from the Albumin bound paclitaxel arm and one from the Gemcitabine arm did not have KPS performed."|participants|Number|149|149.0||||||
4156752|NCT00844649|3980175|B3|90% = normal activity, few symptoms of disease||Karnofsky Performance Status (KPS)|"The Karnofsky Performance Status Scale (KPS) was designed to measure the level of participant activity and medical care requirements. A general measure of participant independence and has been widely used as a general assessment of participants with cancer. The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a participant's ability to survive chemotherapy for cancer. Two participants from the Albumin bound paclitaxel arm and one from the Gemcitabine arm did not have KPS performed."|participants|Number|378|378.0||||||
4156753|NCT00844649|3980176|B2|90% = normal activity, few symptoms of disease||Karnofsky Performance Status (KPS)|"The Karnofsky Performance Status Scale (KPS) was designed to measure the level of participant activity and medical care requirements. A general measure of participant independence and has been widely used as a general assessment of participants with cancer. The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a participant's ability to survive chemotherapy for cancer. Two participants from the Albumin bound paclitaxel arm and one from the Gemcitabine arm did not have KPS performed."|participants|Number|199|199.0||||||
4156754|NCT00844649|3980177|B1|90% = normal activity, few symptoms of disease||Karnofsky Performance Status (KPS)|"The Karnofsky Performance Status Scale (KPS) was designed to measure the level of participant activity and medical care requirements. A general measure of participant independence and has been widely used as a general assessment of participants with cancer. The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a participant's ability to survive chemotherapy for cancer. Two participants from the Albumin bound paclitaxel arm and one from the Gemcitabine arm did not have KPS performed."|participants|Number|179|179.0||||||
4156755|NCT00844649|3980175|B3|100% = normal, no complaints, no signs of disease||Karnofsky Performance Status (KPS)|"The Karnofsky Performance Status Scale (KPS) was designed to measure the level of participant activity and medical care requirements. A general measure of participant independence and has been widely used as a general assessment of participants with cancer. The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a participant's ability to survive chemotherapy for cancer. Two participants from the Albumin bound paclitaxel arm and one from the Gemcitabine arm did not have KPS performed."|participants|Number|138|138.0||||||
4156756|NCT00844649|3980176|B2|100% = normal, no complaints, no signs of disease||Karnofsky Performance Status (KPS)|"The Karnofsky Performance Status Scale (KPS) was designed to measure the level of participant activity and medical care requirements. A general measure of participant independence and has been widely used as a general assessment of participants with cancer. The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a participant's ability to survive chemotherapy for cancer. Two participants from the Albumin bound paclitaxel arm and one from the Gemcitabine arm did not have KPS performed."|participants|Number|69|69.0||||||
4156757|NCT00844649|3980177|B1|100% = normal, no complaints, no signs of disease||Karnofsky Performance Status (KPS)|"The Karnofsky Performance Status Scale (KPS) was designed to measure the level of participant activity and medical care requirements. A general measure of participant independence and has been widely used as a general assessment of participants with cancer. The Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a participant's ability to survive chemotherapy for cancer. Two participants from the Albumin bound paclitaxel arm and one from the Gemcitabine arm did not have KPS performed."|participants|Number|69|69.0||||||
4156758|NCT00844649|3980175|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4156759|NCT00844649|3980176|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4156767|NCT00844649|3980175|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4156768|NCT00844649|3980176|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4156769|NCT00844649|3980177|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4156770|NCT00844649|3980175|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4156771|NCT00844649|3980176|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156772|NCT00844649|3980177|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4156773|NCT00844649|3980175|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4156774|NCT00844649|3980176|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4156775|NCT00844649|3980177|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4156776|NCT00844649|3980175|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156777|NCT00844649|3980176|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156778|NCT00844649|3980177|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156779|NCT00844649|3980175|B3||Male|Gender||Participants|Count of Participants|502|502.0||||||
4156780|NCT00844649|3980176|B2||Male|Gender||Participants|Count of Participants|257|257.0||||||
4156781|NCT00844649|3980177|B1||Male|Gender||Participants|Count of Participants|245|245.0||||||
4156782|NCT00844649|3980175|B3||Female|Gender||Participants|Count of Participants|359|359.0||||||
4156783|NCT00844649|3980176|B2||Female|Gender||Participants|Count of Participants|173|173.0||||||
4156784|NCT00844649|3980177|B1||Female|Gender||Participants|Count of Participants|186|186.0||||||
4156785|NCT00844649|3980175|B3|||Age||years|Mean|62.2|62.2|Standard Deviation|10.04|10.04|||
4156786|NCT00844649|3980176|B2|||Age||years|Mean|63.0|63.0|Standard Deviation|9.27|9.27|||
4156787|NCT00844649|3980177|B1|||Age||years|Mean|61.4|61.4|Standard Deviation|10.70|10.7|||
4156788|NCT00844597|3980196|B7|||Height||centimeters|Mean|124.5|124.5|Standard Deviation|8.99|8.99|||
4156789|NCT00844597|3980197|B6|||Height||centimeters|Mean|126.5|126.5|Standard Deviation|7.18|7.18|||
4156790|NCT00844597|3980198|B5|||Height||centimeters|Mean|123.7|123.7|Standard Deviation|10.04|10.04|||
4156791|NCT00844597|3980199|B4|||Height||centimeters|Mean|126.9|126.9|Standard Deviation|14.40|14.4|||
4156792|NCT00844597|3980200|B3|||Height||centimeters|Mean|126.9|126.9|Standard Deviation|5.09|5.09|||
4156793|NCT00844597|3980201|B2|||Height||centimeters|Mean|110.7|110.7|Standard Deviation|4.45|4.45|||
4156794|NCT00844597|3980202|B1|||Height||centimeters|Mean|127.3|127.3|Standard Deviation|5.05|5.05|||
4156795|NCT00844597|3980196|B7|||Body Weight||kilograms|Mean|34.5|34.5|Standard Deviation|10.84|10.84|||
4156796|NCT00844597|3980197|B6|||Body Weight||kilograms|Mean|33.0|33.0|Standard Deviation|8.71|8.71|||
4156797|NCT00844597|3980198|B5|||Body Weight||kilograms|Mean|34.6|34.6|Standard Deviation|14.01|14.01|||
4156798|NCT00844597|3980199|B4|||Body Weight||kilograms|Mean|40.1|40.1|Standard Deviation|19.00|19.0|||
4156799|NCT00844597|3980200|B3|||Body Weight||kilograms|Mean|42.6|42.6|Standard Deviation|6.36|6.36|||
4156800|NCT00844597|3980201|B2|||Body Weight||kilograms|Mean|23.7|23.7|Standard Deviation|3.46|3.46|||
4156801|NCT00844597|3980202|B1|||Body Weight||kilograms|Mean|33|33.0|Standard Deviation|4.09|4.09|||
4156802|NCT00844597|3980196|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156803|NCT00844597|3980197|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156804|NCT00844597|3980198|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156805|NCT00844597|3980199|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156806|NCT00844597|3980200|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156807|NCT00844597|3980201|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156808|NCT00844597|3980202|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156809|NCT00844597|3980196|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156810|NCT00844597|3980197|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156811|NCT00844597|3980198|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156812|NCT00844597|3980199|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156813|NCT00844597|3980200|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156814|NCT00844597|3980201|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156815|NCT00844597|3980202|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156816|NCT00844597|3980196|B7||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4156817|NCT00844597|3980197|B6||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4156818|NCT00844597|3980198|B5||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4156819|NCT00844597|3980199|B4||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4156820|NCT00844597|3980200|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4156821|NCT00844597|3980201|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4156822|NCT00844597|3980202|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4156823|NCT00844597|3980196|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156824|NCT00844597|3980197|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156881|NCT00844597|3980198|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4156825|NCT00844597|3980198|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156826|NCT00844597|3980199|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156827|NCT00844597|3980200|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156828|NCT00844597|3980201|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156829|NCT00844597|3980202|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156830|NCT00844597|3980196|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156831|NCT00844597|3980197|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156832|NCT00844597|3980198|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156833|NCT00844597|3980199|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156834|NCT00844597|3980200|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156835|NCT00844597|3980201|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156836|NCT00844597|3980202|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156837|NCT00844597|3980196|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4156838|NCT00844597|3980197|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156839|NCT00844597|3980198|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156840|NCT00844597|3980199|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156841|NCT00844597|3980200|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156842|NCT00844597|3980201|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4156843|NCT00844597|3980202|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156844|NCT00844597|3980196|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156845|NCT00844597|3980197|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156846|NCT00844597|3980198|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156847|NCT00844597|3980199|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156848|NCT00844597|3980200|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156849|NCT00844597|3980201|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156850|NCT00844597|3980202|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156851|NCT00844597|3980196|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156852|NCT00844597|3980197|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156853|NCT00844597|3980198|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156854|NCT00844597|3980199|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156855|NCT00844597|3980200|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156856|NCT00844597|3980201|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156857|NCT00844597|3980202|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156858|NCT00844597|3980196|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4156859|NCT00844597|3980197|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4156860|NCT00844597|3980198|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4156861|NCT00844597|3980199|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4156862|NCT00844597|3980200|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4156863|NCT00844597|3980201|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4156864|NCT00844597|3980202|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4156865|NCT00844597|3980196|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156866|NCT00844597|3980197|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156867|NCT00844597|3980198|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156868|NCT00844597|3980199|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156869|NCT00844597|3980200|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156870|NCT00844597|3980201|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156871|NCT00844597|3980202|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156872|NCT00844597|3980196|B7||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4156873|NCT00844597|3980197|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4156874|NCT00844597|3980198|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4156875|NCT00844597|3980199|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4156876|NCT00844597|3980200|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4156877|NCT00844597|3980201|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4156878|NCT00844597|3980202|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4156879|NCT00844597|3980196|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4156880|NCT00844597|3980197|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4156882|NCT00844597|3980199|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4156883|NCT00844597|3980200|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4156884|NCT00844597|3980201|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4156885|NCT00844597|3980202|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4156886|NCT00844597|3980196|B7|||Age||years|Mean|8.7|8.7|Standard Deviation|1.91|1.91|||
4156887|NCT00844597|3980197|B6|||Age||years|Mean|8.8|8.8|Standard Deviation|1.26|1.26|||
4156888|NCT00844597|3980198|B5|||Age||years|Mean|8.8|8.8|Standard Deviation|2.75|2.75|||
4156889|NCT00844597|3980199|B4|||Age||years|Mean|9.7|9.7|Standard Deviation|0.58|0.58|||
4156890|NCT00844597|3980200|B3|||Age||years|Mean|11.0|11.0|Standard Deviation|2.83|2.83|||
4156891|NCT00844597|3980201|B2|||Age||years|Mean|6.0|6.0|Standard Deviation|0.0|0.0|||
4156892|NCT00844597|3980202|B1|||Age||years|Mean|8.3|8.3|Standard Deviation|0.50|0.5|||
4156893|NCT00844558|3980225|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
4156894|NCT00844558|3980226|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4156895|NCT00844558|3980227|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4156896|NCT00844558|3980225|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4156897|NCT00844558|3980226|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4156898|NCT00844558|3980227|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4156899|NCT00844558|3980225|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4156900|NCT00844558|3980226|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4156901|NCT00844558|3980227|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4156902|NCT00844558|3980225|B3|||Age||years|Mean|69.3|69.3|Standard Deviation|7.35|7.35|||
4156903|NCT00844558|3980226|B2|||Age||years|Mean|69.6|69.6|Standard Deviation|6.4|6.4|||
4156904|NCT00844558|3980227|B1|||Age||years|Mean|69.1|69.1|Standard Deviation|7.3|7.3|||
4156905|NCT00844545|3980244|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156906|NCT00844545|3980244|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156907|NCT00844545|3980244|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4156908|NCT00844545|3980244|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4156909|NCT00844545|3980244|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156910|NCT00844545|3980244|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4156911|NCT00844545|3980244|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156912|NCT00844545|3980244|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4156913|NCT00844545|3980244|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4156914|NCT00844545|3980244|B1|||Age||Years|Mean|31.8|31.8|Standard Deviation|13.32|13.32|||
4156915|NCT00844532|3980258|B1|United States||Region of Enrollment||participants|Number|151|151.0||||||
4156916|NCT00844532|3980258|B1||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4156917|NCT00844532|3980258|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4156918|NCT00844532|3980258|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|9.3|9.3|||
4156919|NCT00844532|3980258|B1||>=65 years|Age||Participants|Count of Participants|66|66.0||||||
4156920|NCT00844532|3980258|B1||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
4156921|NCT00844532|3980258|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4156922|NCT00844519|3980342|B3|United States||Region of Enrollment||participants|Number|52|52.0||||||
4156923|NCT00844519|3980343|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4156924|NCT00844519|3980344|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4156925|NCT00844519|3980342|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4156926|NCT00844519|3980343|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4156927|NCT00844519|3980344|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4156928|NCT00844519|3980342|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4156929|NCT00844519|3980343|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4156930|NCT00844519|3980344|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4156931|NCT00844519|3980342|B3|||Age||years|Median|52|52.0|Inter-Quartile Range|||45.0|59.0|
4156932|NCT00844519|3980343|B2|||Age||years|Median|52|52.0|Inter-Quartile Range|||47.0|57.0|
4156933|NCT00844519|3980344|B1|||Age||years|Median|52|52.0|Inter-Quartile Range|||45.0|60.0|
4156934|NCT00844480|3980351|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156935|NCT00844480|3980352|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156936|NCT00844480|3980353|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156937|NCT00844480|3980351|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4156938|NCT00844480|3980352|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4156939|NCT00844480|3980353|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4156940|NCT00844480|3980351|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4156941|NCT00844480|3980352|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4156942|NCT00844480|3980353|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4156943|NCT00844480|3980351|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4156944|NCT00844480|3980352|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4156945|NCT00844480|3980353|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4156946|NCT00844480|3980351|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4156947|NCT00844480|3980352|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4156948|NCT00844480|3980353|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4156949|NCT00844480|3980351|B3|||Age||years|Mean|38.9|38.9|Standard Deviation|16.0|16.0|||
4156950|NCT00844480|3980352|B2|||Age||years|Mean|34.1|34.1|Standard Deviation|15.5|15.5|||
4156951|NCT00844480|3980353|B1|||Age||years|Mean|44.3|44.3|Standard Deviation|16.3|16.3|||
4156952|NCT00844428|3980362|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156953|NCT00844428|3980362|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156954|NCT00844428|3980362|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4156955|NCT00844428|3980362|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4156956|NCT00844428|3980362|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156957|NCT00844428|3980362|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156958|NCT00844428|3980362|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4156959|NCT00844428|3980362|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4156960|NCT00844428|3980362|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4156961|NCT00844428|3980362|B1|||Age||Years|Mean|32.3|32.3|Standard Deviation|14.92|14.92|||
4156962|NCT00844415|3980378|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4156963|NCT00844415|3980378|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4156964|NCT00844415|3980378|B1|||Age||years|Mean|15.7|15.7|Standard Deviation|1.3|1.3|||
4156965|NCT00844376|3980392|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4156966|NCT00844376|3980392|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4156967|NCT00844376|3980392|B1|||Age||years|Mean|34.8|34.8|Standard Deviation|7.7|7.7|||
4156968|NCT00844298|3980411|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4156969|NCT00844298|3980411|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4156970|NCT00844298|3980411|B1|||Age||years|Median|47.0|47.0|Full Range|||17.0|71.0|
4156971|NCT00844194|3980415|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4156972|NCT00844194|3980416|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4156973|NCT00844194|3980417|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4156974|NCT00844194|3980415|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4156975|NCT00844194|3980416|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4156976|NCT00844194|3980417|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4156977|NCT00844194|3980415|B3|||Age||Years|Mean|67.3|67.3|Standard Deviation|10.1|10.1|||
4156978|NCT00844194|3980416|B2|||Age||Years|Mean|66.6|66.6|Standard Deviation|9.8|9.8|||
4156979|NCT00844194|3980417|B1|||Age||Years|Mean|67.5|67.5|Standard Deviation|10.2|10.2|||
4156980|NCT00844090|3980622|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4156981|NCT00844090|3980623|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4156982|NCT00844090|3980624|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4156983|NCT00844090|3980622|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4156984|NCT00844090|3980623|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4156985|NCT00844090|3980624|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4156986|NCT00844090|3980622|B3|||Age||years|Mean|55.3|55.3|Standard Deviation|9.1|9.1|||
4156987|NCT00844090|3980623|B2|||Age||years|Mean|56.0|56.0|Standard Deviation|8.4|8.4|||
4156988|NCT00844090|3980624|B1|||Age||years|Mean|54.7|54.7|Standard Deviation|9.9|9.9|||
4156989|NCT00844090|3980622|B3||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
4156990|NCT00844090|3980623|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4156991|NCT00844090|3980624|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4156992|NCT00844090|3980622|B3||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4156993|NCT00844090|3980623|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4156994|NCT00844090|3980624|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4156995|NCT00844090|3980622|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4156996|NCT00844090|3980623|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4156997|NCT00844090|3980624|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4156998|NCT00844051|3980631|B3|United States||Region of Enrollment||participants|Number|4455|4455.0||||||
4156999|NCT00844051|3980632|B2|United States||Region of Enrollment||participants|Number|2368|2368.0||||||
4157000|NCT00844051|3980633|B1|United States||Region of Enrollment||participants|Number|2087|2087.0||||||
4157001|NCT00844051|3980631|B3||Male|Sex: Female, Male||Participants|Count of Participants|2322|2322.0||||||
4157002|NCT00844051|3980632|B2||Male|Sex: Female, Male||Participants|Count of Participants|1222|1222.0||||||
4157003|NCT00844051|3980633|B1||Male|Sex: Female, Male||Participants|Count of Participants|1100|1100.0||||||
4157004|NCT00844051|3980631|B3||Female|Sex: Female, Male||Participants|Count of Participants|2133|2133.0||||||
4157005|NCT00844051|3980632|B2||Female|Sex: Female, Male||Participants|Count of Participants|1146|1146.0||||||
4157006|NCT00844051|3980633|B1||Female|Sex: Female, Male||Participants|Count of Participants|987|987.0||||||
4157007|NCT00844051|3980631|B3|||Age||years|Mean|8.3|8.3|Full Range|||5.0|13.0|
4157008|NCT00844051|3980632|B2|||Age||years|Mean|8.3|8.3|Full Range|||5.0|13.0|
4157009|NCT00844051|3980633|B1|||Age||years|Mean|8.2|8.2|Full Range|||5.0|13.0|
4157010|NCT00844051|3980631|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4157011|NCT00844051|3980632|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4157012|NCT00844051|3980633|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4157013|NCT00844051|3980631|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4157014|NCT00844051|3980632|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4157015|NCT00844051|3980633|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4157016|NCT00844051|3980631|B3||<=18 years|Age||Participants|Count of Participants|4455|4455.0||||||
4157017|NCT00844051|3980632|B2||<=18 years|Age||Participants|Count of Participants|2368|2368.0||||||
4157018|NCT00844051|3980633|B1||<=18 years|Age||Participants|Count of Participants|2087|2087.0||||||
4157019|NCT00843986|3980642|B3|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4157020|NCT00843986|3980643|B2|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4157021|NCT00843986|3980644|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4157022|NCT00843986|3980642|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4157023|NCT00843986|3980643|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4157024|NCT00843986|3980644|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4157025|NCT00843986|3980642|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4157026|NCT00843986|3980643|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4157027|NCT00843986|3980644|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4157028|NCT00843986|3980642|B3|||Age||years|Mean|62.8|62.8|Standard Deviation|10.07|10.07|||
4157029|NCT00843986|3980643|B2|||Age||years|Mean|65.8|65.8|Standard Deviation|7.78|7.78|||
4157030|NCT00843986|3980644|B1|||Age||years|Mean|56.7|56.7|Standard Deviation|13.05|13.05|||
4157031|NCT00843843|3980671|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4157032|NCT00843843|3980672|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4157033|NCT00843843|3980673|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4157034|NCT00843843|3980671|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4157035|NCT00843843|3980672|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4157036|NCT00843843|3980673|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157037|NCT00843843|3980671|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157038|NCT00843843|3980672|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157039|NCT00843843|3980673|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157040|NCT00843843|3980671|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4157041|NCT00843843|3980672|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4157042|NCT00843843|3980673|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4157043|NCT00843843|3980671|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4157044|NCT00843843|3980672|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4157045|NCT00843843|3980673|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4157046|NCT00843843|3980671|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157047|NCT00843843|3980672|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157048|NCT00843843|3980673|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157049|NCT00843843|3980671|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4157050|NCT00843843|3980672|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4157051|NCT00843843|3980673|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157052|NCT00843843|3980671|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157053|NCT00843843|3980672|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157054|NCT00843843|3980673|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157055|NCT00843843|3980671|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157056|NCT00843843|3980672|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157057|NCT00843843|3980673|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157058|NCT00843843|3980671|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4157059|NCT00843843|3980672|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4157060|NCT00843843|3980673|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4157061|NCT00843843|3980671|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4157062|NCT00843843|3980672|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4157063|NCT00843843|3980673|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157064|NCT00843843|3980671|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4157065|NCT00843843|3980672|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4157066|NCT00843843|3980673|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4157067|NCT00843843|3980671|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4157068|NCT00843843|3980672|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4157069|NCT00843843|3980673|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4157070|NCT00843843|3980671|B3|||Age||years|Mean|28.5|28.5|Standard Deviation|7.5|7.5|||
4157071|NCT00843843|3980672|B2|||Age||years|Mean|26.5|26.5|Standard Deviation|5.8|5.8|||
4157072|NCT00843843|3980673|B1|||Age||years|Mean|30.5|30.5|Standard Deviation|9.0|9.0|||
4157073|NCT00843830|3980682|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4157074|NCT00843830|3980682|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4157075|NCT00843830|3980682|B1|||Age||years|Mean|61|61.0|Full Range|||56.0|65.0|
4157076|NCT00843778|3980687|B1|Poland||Region of Enrollment||participants|Number|77|77.0||||||
4157077|NCT00843778|3980687|B1|Italy||Region of Enrollment||participants|Number|7|7.0||||||
4157078|NCT00843778|3980687|B1|Germany||Region of Enrollment||participants|Number|28|28.0||||||
4157079|NCT00843778|3980687|B1|France||Region of Enrollment||participants|Number|3|3.0||||||
4157080|NCT00843778|3980687|B1|Austria||Region of Enrollment||participants|Number|15|15.0||||||
4157081|NCT00843778|3980687|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4157082|NCT00843778|3980687|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4157083|NCT00843778|3980687|B1|||Age||years|Mean|52.8|52.8|Standard Deviation|12.3|12.3|||
4157084|NCT00843778|3980687|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4157085|NCT00843778|3980687|B1||Between 18 and 65 years|Age||Participants|Count of Participants|113|113.0||||||
4157086|NCT00843778|3980687|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4157087|NCT00843713|3980720|B3|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4157088|NCT00843713|3980721|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4157089|NCT00843713|3980722|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4157090|NCT00843713|3980720|B3|Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4157091|NCT00843713|3980721|B2|Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4157092|NCT00843713|3980722|B1|Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4157093|NCT00843713|3980720|B3|African-American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4157094|NCT00843713|3980721|B2|African-American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4157095|NCT00843713|3980722|B1|African-American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4157096|NCT00843713|3980720|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4157097|NCT00843713|3980721|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4157098|NCT00843713|3980722|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4157099|NCT00843713|3980720|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4157100|NCT00843713|3980721|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4157101|NCT00843713|3980722|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4157102|NCT00843713|3980720|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4157103|NCT00843713|3980721|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4157104|NCT00843713|3980722|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4157105|NCT00843713|3980720|B3|||Age||Years|Mean|53|53.0|Inter-Quartile Range|||47.0|59.0|
4157106|NCT00843713|3980721|B2|||Age||Years|Mean|54|54.0|Inter-Quartile Range|||47.0|59.0|
4157107|NCT00843713|3980722|B1|||Age||Years|Mean|53|53.0|Inter-Quartile Range|||47.0|59.0|
4157108|NCT00843635|3980729|B4|Radiation only||Pre-Operative Treatment, Details||participants|Number|5|5.0||||||
4157109|NCT00843635|3980730|B3|Radiation only||Pre-Operative Treatment, Details||participants|Number|0|0.0||||||
4157110|NCT00843635|3980731|B2|Radiation only||Pre-Operative Treatment, Details||participants|Number|1|1.0||||||
4157111|NCT00843635|3980732|B1|Radiation only||Pre-Operative Treatment, Details||participants|Number|4|4.0||||||
4157112|NCT00843635|3980729|B4|Chemo + Radiation||Pre-Operative Treatment, Details||participants|Number|4|4.0||||||
4157113|NCT00843635|3980730|B3|Chemo + Radiation||Pre-Operative Treatment, Details||participants|Number|2|2.0||||||
4157114|NCT00843635|3980731|B2|Chemo + Radiation||Pre-Operative Treatment, Details||participants|Number|1|1.0||||||
4157115|NCT00843635|3980732|B1|Chemo + Radiation||Pre-Operative Treatment, Details||participants|Number|1|1.0||||||
4157116|NCT00843635|3980729|B4|No||Pre-Operative Treatment, Details||participants|Number|26|26.0||||||
4157117|NCT00843635|3980730|B3|No||Pre-Operative Treatment, Details||participants|Number|3|3.0||||||
4157118|NCT00843635|3980731|B2|No||Pre-Operative Treatment, Details||participants|Number|13|13.0||||||
4157119|NCT00843635|3980732|B1|No||Pre-Operative Treatment, Details||participants|Number|10|10.0||||||
4157120|NCT00843635|3980729|B4|Yes||Pre-Operative Treatment||participants|Number|9|9.0||||||
4157121|NCT00843635|3980730|B3|Yes||Pre-Operative Treatment||participants|Number|2|2.0||||||
4157122|NCT00843635|3980731|B2|Yes||Pre-Operative Treatment||participants|Number|2|2.0||||||
4157123|NCT00843635|3980732|B1|Yes||Pre-Operative Treatment||participants|Number|5|5.0||||||
4157124|NCT00843635|3980729|B4|No||Pre-Operative Treatment||participants|Number|26|26.0||||||
4157125|NCT00843635|3980730|B3|No||Pre-Operative Treatment||participants|Number|3|3.0||||||
4157126|NCT00843635|3980731|B2|No||Pre-Operative Treatment||participants|Number|13|13.0||||||
4157127|NCT00843635|3980732|B1|No||Pre-Operative Treatment||participants|Number|10|10.0||||||
4157128|NCT00843635|3980729|B4|No||Positive for Human Papillomavirus (HPV+)||participants|Number|31|31.0||||||
4157129|NCT00843635|3980730|B3|No||Positive for Human Papillomavirus (HPV+)||participants|Number|5|5.0||||||
4157130|NCT00843635|3980731|B2|No||Positive for Human Papillomavirus (HPV+)||participants|Number|14|14.0||||||
4157131|NCT00843635|3980732|B1|No||Positive for Human Papillomavirus (HPV+)||participants|Number|12|12.0||||||
4157132|NCT00843635|3980729|B4|Yes||Positive for Human Papillomavirus (HPV+)||participants|Number|4|4.0||||||
4157133|NCT00843635|3980730|B3|Yes||Positive for Human Papillomavirus (HPV+)||participants|Number|0|0.0||||||
4157134|NCT00843635|3980731|B2|Yes||Positive for Human Papillomavirus (HPV+)||participants|Number|1|1.0||||||
4157135|NCT00843635|3980732|B1|Yes||Positive for Human Papillomavirus (HPV+)||participants|Number|3|3.0||||||
4157136|NCT00843635|3980729|B4|N3||N Stage - Regional Lymph Nodes|"Number of participants on each arm grouped by whether or not the cancer has reached nearby lymph nodes at Baseline:~N0 - No regional lymph node involvement (no cancer found in the lymph nodes)~N1 - N3 - Involvement of regional lymph nodes (number and/or extent of spread)"|participants|Number|1|1.0||||||
4157137|NCT00843635|3980730|B3|N3||N Stage - Regional Lymph Nodes|"Number of participants on each arm grouped by whether or not the cancer has reached nearby lymph nodes at Baseline:~N0 - No regional lymph node involvement (no cancer found in the lymph nodes)~N1 - N3 - Involvement of regional lymph nodes (number and/or extent of spread)"|participants|Number|0|0.0||||||
4157138|NCT00843635|3980731|B2|N3||N Stage - Regional Lymph Nodes|"Number of participants on each arm grouped by whether or not the cancer has reached nearby lymph nodes at Baseline:~N0 - No regional lymph node involvement (no cancer found in the lymph nodes)~N1 - N3 - Involvement of regional lymph nodes (number and/or extent of spread)"|participants|Number|0|0.0||||||
4157139|NCT00843635|3980732|B1|N3||N Stage - Regional Lymph Nodes|"Number of participants on each arm grouped by whether or not the cancer has reached nearby lymph nodes at Baseline:~N0 - No regional lymph node involvement (no cancer found in the lymph nodes)~N1 - N3 - Involvement of regional lymph nodes (number and/or extent of spread)"|participants|Number|1|1.0||||||
4157140|NCT00843635|3980729|B4|N2c||N Stage - Regional Lymph Nodes|"Number of participants on each arm grouped by whether or not the cancer has reached nearby lymph nodes at Baseline:~N0 - No regional lymph node involvement (no cancer found in the lymph nodes)~N1 - N3 - Involvement of regional lymph nodes (number and/or extent of spread)"|participants|Number|3|3.0||||||
4157141|NCT00843635|3980730|B3|N2c||N Stage - Regional Lymph Nodes|"Number of participants on each arm grouped by whether or not the cancer has reached nearby lymph nodes at Baseline:~N0 - No regional lymph node involvement (no cancer found in the lymph nodes)~N1 - N3 - Involvement of regional lymph nodes (number and/or extent of spread)"|participants|Number|0|0.0||||||
4157142|NCT00843635|3980731|B2|N2c||N Stage - Regional Lymph Nodes|"Number of participants on each arm grouped by whether or not the cancer has reached nearby lymph nodes at Baseline:~N0 - No regional lymph node involvement (no cancer found in the lymph nodes)~N1 - N3 - Involvement of regional lymph nodes (number and/or extent of spread)"|participants|Number|2|2.0||||||
4157143|NCT00843635|3980732|B1|N2c||N Stage - Regional Lymph Nodes|"Number of participants on each arm grouped by whether or not the cancer has reached nearby lymph nodes at Baseline:~N0 - No regional lymph node involvement (no cancer found in the lymph nodes)~N1 - N3 - Involvement of regional lymph nodes (number and/or extent of spread)"|participants|Number|1|1.0||||||
4157144|NCT00843635|3980729|B4|N2b||N Stage - Regional Lymph Nodes|"Number of participants on each arm grouped by whether or not the cancer has reached nearby lymph nodes at Baseline:~N0 - No regional lymph node involvement (no cancer found in the lymph nodes)~N1 - N3 - Involvement of regional lymph nodes (number and/or extent of spread)"|participants|Number|7|7.0||||||
4157145|NCT00843635|3980730|B3|N2b||N Stage - Regional Lymph Nodes|"Number of participants on each arm grouped by whether or not the cancer has reached nearby lymph nodes at Baseline:~N0 - No regional lymph node involvement (no cancer found in the lymph nodes)~N1 - N3 - Involvement of regional lymph nodes (number and/or extent of spread)"|participants|Number|0|0.0||||||
4157146|NCT00843635|3980731|B2|N2b||N Stage - Regional Lymph Nodes|"Number of participants on each arm grouped by whether or not the cancer has reached nearby lymph nodes at Baseline:~N0 - No regional lymph node involvement (no cancer found in the lymph nodes)~N1 - N3 - Involvement of regional lymph nodes (number and/or extent of spread)"|participants|Number|3|3.0||||||
4157147|NCT00843635|3980732|B1|N2b||N Stage - Regional Lymph Nodes|"Number of participants on each arm grouped by whether or not the cancer has reached nearby lymph nodes at Baseline:~N0 - No regional lymph node involvement (no cancer found in the lymph nodes)~N1 - N3 - Involvement of regional lymph nodes (number and/or extent of spread)"|participants|Number|4|4.0||||||
4157148|NCT00843635|3980729|B4|N1||N Stage - Regional Lymph Nodes|"Number of participants on each arm grouped by whether or not the cancer has reached nearby lymph nodes at Baseline:~N0 - No regional lymph node involvement (no cancer found in the lymph nodes)~N1 - N3 - Involvement of regional lymph nodes (number and/or extent of spread)"|participants|Number|4|4.0||||||
4157149|NCT00843635|3980730|B3|N1||N Stage - Regional Lymph Nodes|"Number of participants on each arm grouped by whether or not the cancer has reached nearby lymph nodes at Baseline:~N0 - No regional lymph node involvement (no cancer found in the lymph nodes)~N1 - N3 - Involvement of regional lymph nodes (number and/or extent of spread)"|participants|Number|1|1.0||||||
4157150|NCT00843635|3980731|B2|N1||N Stage - Regional Lymph Nodes|"Number of participants on each arm grouped by whether or not the cancer has reached nearby lymph nodes at Baseline:~N0 - No regional lymph node involvement (no cancer found in the lymph nodes)~N1 - N3 - Involvement of regional lymph nodes (number and/or extent of spread)"|participants|Number|1|1.0||||||
4157151|NCT00843635|3980732|B1|N1||N Stage - Regional Lymph Nodes|"Number of participants on each arm grouped by whether or not the cancer has reached nearby lymph nodes at Baseline:~N0 - No regional lymph node involvement (no cancer found in the lymph nodes)~N1 - N3 - Involvement of regional lymph nodes (number and/or extent of spread)"|participants|Number|2|2.0||||||
4157232|NCT00843635|3980729|B4|United States||Region of Enrollment||participants|Number|35|35.0||||||
4157233|NCT00843635|3980730|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4157152|NCT00843635|3980729|B4|N0||N Stage - Regional Lymph Nodes|"Number of participants on each arm grouped by whether or not the cancer has reached nearby lymph nodes at Baseline:~N0 - No regional lymph node involvement (no cancer found in the lymph nodes)~N1 - N3 - Involvement of regional lymph nodes (number and/or extent of spread)"|participants|Number|20|20.0||||||
4157153|NCT00843635|3980730|B3|N0||N Stage - Regional Lymph Nodes|"Number of participants on each arm grouped by whether or not the cancer has reached nearby lymph nodes at Baseline:~N0 - No regional lymph node involvement (no cancer found in the lymph nodes)~N1 - N3 - Involvement of regional lymph nodes (number and/or extent of spread)"|participants|Number|4|4.0||||||
4157154|NCT00843635|3980731|B2|N0||N Stage - Regional Lymph Nodes|"Number of participants on each arm grouped by whether or not the cancer has reached nearby lymph nodes at Baseline:~N0 - No regional lymph node involvement (no cancer found in the lymph nodes)~N1 - N3 - Involvement of regional lymph nodes (number and/or extent of spread)"|participants|Number|9|9.0||||||
4157155|NCT00843635|3980732|B1|N0||N Stage - Regional Lymph Nodes|"Number of participants on each arm grouped by whether or not the cancer has reached nearby lymph nodes at Baseline:~N0 - No regional lymph node involvement (no cancer found in the lymph nodes)~N1 - N3 - Involvement of regional lymph nodes (number and/or extent of spread)"|participants|Number|7|7.0||||||
4157156|NCT00843635|3980729|B4|T4||T-Stage|"Number of participants on each arm grouped by the size and/or extent (reach) of the primary tumor (T) at Baseline: T1, T2, T3 and T4.~Numbers after the T (such as T1, T2, T3, and T4) might describe the tumor size and/or amount of spread into nearby structures. The higher the T number, the larger the tumor and/or the more it has grown into nearby tissues."|participants|Number|9|9.0||||||
4157157|NCT00843635|3980730|B3|T4||T-Stage|"Number of participants on each arm grouped by the size and/or extent (reach) of the primary tumor (T) at Baseline: T1, T2, T3 and T4.~Numbers after the T (such as T1, T2, T3, and T4) might describe the tumor size and/or amount of spread into nearby structures. The higher the T number, the larger the tumor and/or the more it has grown into nearby tissues."|participants|Number|1|1.0||||||
4157158|NCT00843635|3980731|B2|T4||T-Stage|"Number of participants on each arm grouped by the size and/or extent (reach) of the primary tumor (T) at Baseline: T1, T2, T3 and T4.~Numbers after the T (such as T1, T2, T3, and T4) might describe the tumor size and/or amount of spread into nearby structures. The higher the T number, the larger the tumor and/or the more it has grown into nearby tissues."|participants|Number|4|4.0||||||
4157159|NCT00843635|3980732|B1|T4||T-Stage|"Number of participants on each arm grouped by the size and/or extent (reach) of the primary tumor (T) at Baseline: T1, T2, T3 and T4.~Numbers after the T (such as T1, T2, T3, and T4) might describe the tumor size and/or amount of spread into nearby structures. The higher the T number, the larger the tumor and/or the more it has grown into nearby tissues."|participants|Number|4|4.0||||||
4157160|NCT00843635|3980729|B4|T3||T-Stage|"Number of participants on each arm grouped by the size and/or extent (reach) of the primary tumor (T) at Baseline: T1, T2, T3 and T4.~Numbers after the T (such as T1, T2, T3, and T4) might describe the tumor size and/or amount of spread into nearby structures. The higher the T number, the larger the tumor and/or the more it has grown into nearby tissues."|participants|Number|2|2.0||||||
4157161|NCT00843635|3980730|B3|T3||T-Stage|"Number of participants on each arm grouped by the size and/or extent (reach) of the primary tumor (T) at Baseline: T1, T2, T3 and T4.~Numbers after the T (such as T1, T2, T3, and T4) might describe the tumor size and/or amount of spread into nearby structures. The higher the T number, the larger the tumor and/or the more it has grown into nearby tissues."|participants|Number|1|1.0||||||
4157162|NCT00843635|3980731|B2|T3||T-Stage|"Number of participants on each arm grouped by the size and/or extent (reach) of the primary tumor (T) at Baseline: T1, T2, T3 and T4.~Numbers after the T (such as T1, T2, T3, and T4) might describe the tumor size and/or amount of spread into nearby structures. The higher the T number, the larger the tumor and/or the more it has grown into nearby tissues."|participants|Number|0|0.0||||||
4157163|NCT00843635|3980732|B1|T3||T-Stage|"Number of participants on each arm grouped by the size and/or extent (reach) of the primary tumor (T) at Baseline: T1, T2, T3 and T4.~Numbers after the T (such as T1, T2, T3, and T4) might describe the tumor size and/or amount of spread into nearby structures. The higher the T number, the larger the tumor and/or the more it has grown into nearby tissues."|participants|Number|1|1.0||||||
4157164|NCT00843635|3980729|B4|T2||T-Stage|"Number of participants on each arm grouped by the size and/or extent (reach) of the primary tumor (T) at Baseline: T1, T2, T3 and T4.~Numbers after the T (such as T1, T2, T3, and T4) might describe the tumor size and/or amount of spread into nearby structures. The higher the T number, the larger the tumor and/or the more it has grown into nearby tissues."|participants|Number|15|15.0||||||
4157165|NCT00843635|3980730|B3|T2||T-Stage|"Number of participants on each arm grouped by the size and/or extent (reach) of the primary tumor (T) at Baseline: T1, T2, T3 and T4.~Numbers after the T (such as T1, T2, T3, and T4) might describe the tumor size and/or amount of spread into nearby structures. The higher the T number, the larger the tumor and/or the more it has grown into nearby tissues."|participants|Number|2|2.0||||||
4157166|NCT00843635|3980731|B2|T2||T-Stage|"Number of participants on each arm grouped by the size and/or extent (reach) of the primary tumor (T) at Baseline: T1, T2, T3 and T4.~Numbers after the T (such as T1, T2, T3, and T4) might describe the tumor size and/or amount of spread into nearby structures. The higher the T number, the larger the tumor and/or the more it has grown into nearby tissues."|participants|Number|4|4.0||||||
4157167|NCT00843635|3980732|B1|T2||T-Stage|"Number of participants on each arm grouped by the size and/or extent (reach) of the primary tumor (T) at Baseline: T1, T2, T3 and T4.~Numbers after the T (such as T1, T2, T3, and T4) might describe the tumor size and/or amount of spread into nearby structures. The higher the T number, the larger the tumor and/or the more it has grown into nearby tissues."|participants|Number|9|9.0||||||
4157168|NCT00843635|3980729|B4|T1||T-Stage|"Number of participants on each arm grouped by the size and/or extent (reach) of the primary tumor (T) at Baseline: T1, T2, T3 and T4.~Numbers after the T (such as T1, T2, T3, and T4) might describe the tumor size and/or amount of spread into nearby structures. The higher the T number, the larger the tumor and/or the more it has grown into nearby tissues."|participants|Number|9|9.0||||||
4157169|NCT00843635|3980730|B3|T1||T-Stage|"Number of participants on each arm grouped by the size and/or extent (reach) of the primary tumor (T) at Baseline: T1, T2, T3 and T4.~Numbers after the T (such as T1, T2, T3, and T4) might describe the tumor size and/or amount of spread into nearby structures. The higher the T number, the larger the tumor and/or the more it has grown into nearby tissues."|participants|Number|1|1.0||||||
4157170|NCT00843635|3980731|B2|T1||T-Stage|"Number of participants on each arm grouped by the size and/or extent (reach) of the primary tumor (T) at Baseline: T1, T2, T3 and T4.~Numbers after the T (such as T1, T2, T3, and T4) might describe the tumor size and/or amount of spread into nearby structures. The higher the T number, the larger the tumor and/or the more it has grown into nearby tissues."|participants|Number|7|7.0||||||
4157171|NCT00843635|3980732|B1|T1||T-Stage|"Number of participants on each arm grouped by the size and/or extent (reach) of the primary tumor (T) at Baseline: T1, T2, T3 and T4.~Numbers after the T (such as T1, T2, T3, and T4) might describe the tumor size and/or amount of spread into nearby structures. The higher the T number, the larger the tumor and/or the more it has grown into nearby tissues."|participants|Number|1|1.0||||||
4157172|NCT00843635|3980729|B4|||Tumor Size (cm) Median||cm|Median|3|3.0|Inter-Quartile Range|||0.5|8.5|
4157173|NCT00843635|3980730|B3|||Tumor Size (cm) Median||cm|Median|4|4.0|Inter-Quartile Range|||0.6|5.5|
4157174|NCT00843635|3980731|B2|||Tumor Size (cm) Median||cm|Median|2.1|2.1|Inter-Quartile Range|||0.5|5.5|
4157175|NCT00843635|3980732|B1|||Tumor Size (cm) Median||cm|Median|3|3.0|Inter-Quartile Range|||2.0|8.5|
4157176|NCT00843635|3980729|B4|||Tumor size (cm) Mean||cm|Mean|3.1|3.1|Standard Deviation|1.7|1.7|||
4157177|NCT00843635|3980730|B3|||Tumor size (cm) Mean||cm|Mean|3.5|3.5|Standard Deviation|1.9|1.9|||
4157178|NCT00843635|3980731|B2|||Tumor size (cm) Mean||cm|Mean|2.4|2.4|Standard Deviation|1.3|1.3|||
4157179|NCT00843635|3980732|B1|||Tumor size (cm) Mean||cm|Mean|3.7|3.7|Standard Deviation|1.8|1.8|||
4157180|NCT00843635|3980729|B4|Oro Pharynx||Site||participants|Number|4|4.0||||||
4157181|NCT00843635|3980730|B3|Oro Pharynx||Site||participants|Number|1|1.0||||||
4157182|NCT00843635|3980731|B2|Oro Pharynx||Site||participants|Number|1|1.0||||||
4157183|NCT00843635|3980732|B1|Oro Pharynx||Site||participants|Number|2|2.0||||||
4157184|NCT00843635|3980729|B4|Oral Cavity||Site||participants|Number|31|31.0||||||
4157185|NCT00843635|3980730|B3|Oral Cavity||Site||participants|Number|4|4.0||||||
4157186|NCT00843635|3980731|B2|Oral Cavity||Site||participants|Number|14|14.0||||||
4157187|NCT00843635|3980732|B1|Oral Cavity||Site||participants|Number|13|13.0||||||
4157188|NCT00843635|3980729|B4|Snuff/Chew/Smokeless||Type of Tobacco Use||participants|Number|1|1.0||||||
4157189|NCT00843635|3980730|B3|Snuff/Chew/Smokeless||Type of Tobacco Use||participants|Number|0|0.0||||||
4157190|NCT00843635|3980731|B2|Snuff/Chew/Smokeless||Type of Tobacco Use||participants|Number|1|1.0||||||
4157191|NCT00843635|3980732|B1|Snuff/Chew/Smokeless||Type of Tobacco Use||participants|Number|0|0.0||||||
4157192|NCT00843635|3980729|B4|Cigar/Pipe||Type of Tobacco Use||participants|Number|1|1.0||||||
4157193|NCT00843635|3980730|B3|Cigar/Pipe||Type of Tobacco Use||participants|Number|0|0.0||||||
4157194|NCT00843635|3980731|B2|Cigar/Pipe||Type of Tobacco Use||participants|Number|1|1.0||||||
4157195|NCT00843635|3980732|B1|Cigar/Pipe||Type of Tobacco Use||participants|Number|0|0.0||||||
4157196|NCT00843635|3980729|B4|Cigarettes||Type of Tobacco Use||participants|Number|27|27.0||||||
4157197|NCT00843635|3980730|B3|Cigarettes||Type of Tobacco Use||participants|Number|4|4.0||||||
4157198|NCT00843635|3980731|B2|Cigarettes||Type of Tobacco Use||participants|Number|11|11.0||||||
4157199|NCT00843635|3980732|B1|Cigarettes||Type of Tobacco Use||participants|Number|12|12.0||||||
4157200|NCT00843635|3980729|B4|Never||Type of Tobacco Use||participants|Number|6|6.0||||||
4157201|NCT00843635|3980730|B3|Never||Type of Tobacco Use||participants|Number|1|1.0||||||
4157202|NCT00843635|3980731|B2|Never||Type of Tobacco Use||participants|Number|2|2.0||||||
4157203|NCT00843635|3980732|B1|Never||Type of Tobacco Use||participants|Number|3|3.0||||||
4157204|NCT00843635|3980729|B4|Never||Tobacco Use||participants|Number|6|6.0||||||
4157205|NCT00843635|3980730|B3|Never||Tobacco Use||participants|Number|1|1.0||||||
4157206|NCT00843635|3980731|B2|Never||Tobacco Use||participants|Number|2|2.0||||||
4157207|NCT00843635|3980732|B1|Never||Tobacco Use||participants|Number|3|3.0||||||
4157208|NCT00843635|3980729|B4|Quit > 20 years ago||Tobacco Use||participants|Number|3|3.0||||||
4157209|NCT00843635|3980730|B3|Quit > 20 years ago||Tobacco Use||participants|Number|0|0.0||||||
4157210|NCT00843635|3980731|B2|Quit > 20 years ago||Tobacco Use||participants|Number|3|3.0||||||
4157211|NCT00843635|3980732|B1|Quit > 20 years ago||Tobacco Use||participants|Number|0|0.0||||||
4157212|NCT00843635|3980729|B4|Quit < 20 years ago||Tobacco Use||participants|Number|8|8.0||||||
4157213|NCT00843635|3980730|B3|Quit < 20 years ago||Tobacco Use||participants|Number|4|4.0||||||
4157214|NCT00843635|3980731|B2|Quit < 20 years ago||Tobacco Use||participants|Number|1|1.0||||||
4157215|NCT00843635|3980732|B1|Quit < 20 years ago||Tobacco Use||participants|Number|3|3.0||||||
4157216|NCT00843635|3980729|B4|Current||Tobacco Use||participants|Number|18|18.0||||||
4157217|NCT00843635|3980730|B3|Current||Tobacco Use||participants|Number|0|0.0||||||
4157218|NCT00843635|3980731|B2|Current||Tobacco Use||participants|Number|9|9.0||||||
4157219|NCT00843635|3980732|B1|Current||Tobacco Use||participants|Number|9|9.0||||||
4157220|NCT00843635|3980729|B4|Past Use||Alcohol Use||participants|Number|7|7.0||||||
4157221|NCT00843635|3980730|B3|Past Use||Alcohol Use||participants|Number|0|0.0||||||
4157222|NCT00843635|3980731|B2|Past Use||Alcohol Use||participants|Number|5|5.0||||||
4157223|NCT00843635|3980732|B1|Past Use||Alcohol Use||participants|Number|2|2.0||||||
4157224|NCT00843635|3980729|B4|Current Use||Alcohol Use||participants|Number|23|23.0||||||
4157225|NCT00843635|3980730|B3|Current Use||Alcohol Use||participants|Number|4|4.0||||||
4157226|NCT00843635|3980731|B2|Current Use||Alcohol Use||participants|Number|8|8.0||||||
4157227|NCT00843635|3980732|B1|Current Use||Alcohol Use||participants|Number|11|11.0||||||
4157228|NCT00843635|3980729|B4|Never||Alcohol Use||participants|Number|5|5.0||||||
4157229|NCT00843635|3980730|B3|Never||Alcohol Use||participants|Number|1|1.0||||||
4157230|NCT00843635|3980731|B2|Never||Alcohol Use||participants|Number|2|2.0||||||
4157231|NCT00843635|3980732|B1|Never||Alcohol Use||participants|Number|2|2.0||||||
4157234|NCT00843635|3980731|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4157235|NCT00843635|3980732|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4157236|NCT00843635|3980729|B4|Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4157237|NCT00843635|3980730|B3|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4157238|NCT00843635|3980731|B2|Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4157239|NCT00843635|3980732|B1|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4157240|NCT00843635|3980729|B4|South Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4157241|NCT00843635|3980730|B3|South Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4157242|NCT00843635|3980731|B2|South Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4157243|NCT00843635|3980732|B1|South Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4157244|NCT00843635|3980729|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4157245|NCT00843635|3980730|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4157246|NCT00843635|3980731|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4157247|NCT00843635|3980732|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4157248|NCT00843635|3980729|B4|White, Non-Hispanic||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4157249|NCT00843635|3980730|B3|White, Non-Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4157250|NCT00843635|3980731|B2|White, Non-Hispanic||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4157251|NCT00843635|3980732|B1|White, Non-Hispanic||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4157252|NCT00843635|3980729|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4157253|NCT00843635|3980730|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4157254|NCT00843635|3980731|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4157255|NCT00843635|3980732|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4157256|NCT00843635|3980729|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4157257|NCT00843635|3980730|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4157258|NCT00843635|3980731|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4157259|NCT00843635|3980732|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4157260|NCT00843635|3980729|B4|70+ years of age||Age, Customized||participants|Number|8|8.0||||||
4157261|NCT00843635|3980730|B3|70+ years of age||Age, Customized||participants|Number|1|1.0||||||
4157262|NCT00843635|3980731|B2|70+ years of age||Age, Customized||participants|Number|4|4.0||||||
4157263|NCT00843635|3980732|B1|70+ years of age||Age, Customized||participants|Number|3|3.0||||||
4157264|NCT00843635|3980729|B4|60 to 69 years of age||Age, Customized||participants|Number|12|12.0||||||
4157265|NCT00843635|3980730|B3|60 to 69 years of age||Age, Customized||participants|Number|4|4.0||||||
4157266|NCT00843635|3980731|B2|60 to 69 years of age||Age, Customized||participants|Number|3|3.0||||||
4157267|NCT00843635|3980732|B1|60 to 69 years of age||Age, Customized||participants|Number|5|5.0||||||
4157268|NCT00843635|3980729|B4|50 to 59 years of age||Age, Customized||participants|Number|7|7.0||||||
4157269|NCT00843635|3980730|B3|50 to 59 years of age||Age, Customized||participants|Number|0|0.0||||||
4157270|NCT00843635|3980731|B2|50 to 59 years of age||Age, Customized||participants|Number|2|2.0||||||
4157271|NCT00843635|3980732|B1|50 to 59 years of age||Age, Customized||participants|Number|5|5.0||||||
4157272|NCT00843635|3980729|B4|< 50 years of age||Age, Customized||participants|Number|8|8.0||||||
4157273|NCT00843635|3980730|B3|< 50 years of age||Age, Customized||participants|Number|0|0.0||||||
4157274|NCT00843635|3980731|B2|< 50 years of age||Age, Customized||participants|Number|6|6.0||||||
4157275|NCT00843635|3980732|B1|< 50 years of age||Age, Customized||participants|Number|2|2.0||||||
4157276|NCT00843635|3980729|B4|||Age||years|Median|63|63.0|Inter-Quartile Range|||39.0|81.0|
4157277|NCT00843635|3980730|B3|||Age||years|Median|67|67.0|Inter-Quartile Range|||60.0|72.0|
4157278|NCT00843635|3980731|B2|||Age||years|Median|54|54.0|Inter-Quartile Range|||39.0|81.0|
4157279|NCT00843635|3980732|B1|||Age||years|Median|61|61.0|Inter-Quartile Range|||39.0|76.0|
4157280|NCT00843635|3980729|B4|||Age||years|Mean|60.3|60.3|Standard Deviation|11.6|11.6|||
4157281|NCT00843635|3980730|B3|||Age||years|Mean|66.8|66.8|Standard Deviation|4.3|4.3|||
4157282|NCT00843635|3980731|B2|||Age||years|Mean|59|59.0|Standard Deviation|13.9|13.9|||
4157283|NCT00843635|3980732|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|10.5|10.5|||
4157284|NCT00843622|3980752|B3|United States||Region of Enrollment||participants|Number|250|250.0||||||
4157285|NCT00843622|3980753|B2|United States||Region of Enrollment||participants|Number|125|125.0||||||
4157286|NCT00843622|3980754|B1|United States||Region of Enrollment||participants|Number|125|125.0||||||
4157287|NCT00843622|3980752|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4157288|NCT00843622|3980753|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4157289|NCT00843622|3980754|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4157290|NCT00843622|3980752|B3||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4157291|NCT00843622|3980753|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4157292|NCT00843622|3980754|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4157293|NCT00843622|3980752|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4157294|NCT00843622|3980753|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4157295|NCT00843622|3980754|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4157296|NCT00843622|3980752|B3||Between 18 and 65 years|Age||Participants|Count of Participants|250|250.0||||||
4157297|NCT00843622|3980753|B2||Between 18 and 65 years|Age||Participants|Count of Participants|125|125.0||||||
4157298|NCT00843622|3980754|B1||Between 18 and 65 years|Age||Participants|Count of Participants|125|125.0||||||
4157299|NCT00843622|3980752|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4157300|NCT00843622|3980753|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4157301|NCT00843622|3980754|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4157302|NCT00843518|3980761|B3|||14-Item Alzheimer's Disease Assessment Scale, Cognitive Subscale (ADAS-Cog14)|ADAS-Cog14, a 14-item rating scale, measured the severity of cognitive dysfunction in persons with Alzheimer's disease (AD). Scores ranged from 0 to 90, with a higher score indicating worse cognitive functioning.|units on a scale|Mean|41.6|41.6|Standard Deviation|19.22|19.22|||
4157303|NCT00843518|3980762|B2|||14-Item Alzheimer's Disease Assessment Scale, Cognitive Subscale (ADAS-Cog14)|ADAS-Cog14, a 14-item rating scale, measured the severity of cognitive dysfunction in persons with Alzheimer's disease (AD). Scores ranged from 0 to 90, with a higher score indicating worse cognitive functioning.|units on a scale|Mean|40.0|40.0|Standard Deviation|18.07|18.07|||
4157304|NCT00843518|3980763|B1|||14-Item Alzheimer's Disease Assessment Scale, Cognitive Subscale (ADAS-Cog14)|ADAS-Cog14, a 14-item rating scale, measured the severity of cognitive dysfunction in persons with Alzheimer's disease (AD). Scores ranged from 0 to 90, with a higher score indicating worse cognitive functioning.|units on a scale|Mean|43.3|43.3|Standard Deviation|20.42|20.42|||
4157305|NCT00843518|3980761|B3|||Clinical Global Impression-Severity-Global Functioning (CGI-S-GF)|CGI-S-GF was a 7-point, single-item rating scale for overall functioning based on the investigator's general clinical experience with a similar participant population. This Likert scale ranged from 0 (normal) to 7 (most severely ill).|units on a scale|Mean|4.1|4.1|Standard Deviation|0.82|0.82|||
4157306|NCT00843518|3980762|B2|||Clinical Global Impression-Severity-Global Functioning (CGI-S-GF)|CGI-S-GF was a 7-point, single-item rating scale for overall functioning based on the investigator's general clinical experience with a similar participant population. This Likert scale ranged from 0 (normal) to 7 (most severely ill).|units on a scale|Mean|4.0|4.0|Standard Deviation|0.78|0.78|||
4157307|NCT00843518|3980763|B1|||Clinical Global Impression-Severity-Global Functioning (CGI-S-GF)|CGI-S-GF was a 7-point, single-item rating scale for overall functioning based on the investigator's general clinical experience with a similar participant population. This Likert scale ranged from 0 (normal) to 7 (most severely ill).|units on a scale|Mean|4.1|4.1|Standard Deviation|0.88|0.88|||
4157308|NCT00843518|3980761|B3|||Clinical Global Impression-Severity-Agitation/Aggressive (CGI-S-A/A)|CGI-S-A/A was a 7-point, single-item rating scale for overall severity of symptoms based on the investigator's general clinical experience with a similar participant population. This Likert scale ranged from 0 (normal) to 7 (most severely ill).|units on a scale|Mean|4.1|4.1|Standard Deviation|0.68|0.68|||
4157309|NCT00843518|3980762|B2|||Clinical Global Impression-Severity-Agitation/Aggressive (CGI-S-A/A)|CGI-S-A/A was a 7-point, single-item rating scale for overall severity of symptoms based on the investigator's general clinical experience with a similar participant population. This Likert scale ranged from 0 (normal) to 7 (most severely ill).|units on a scale|Mean|4.1|4.1|Standard Deviation|0.69|0.69|||
4157310|NCT00843518|3980763|B1|||Clinical Global Impression-Severity-Agitation/Aggressive (CGI-S-A/A)|CGI-S-A/A was a 7-point, single-item rating scale for overall severity of symptoms based on the investigator's general clinical experience with a similar participant population. This Likert scale ranged from 0 (normal) to 7 (most severely ill).|units on a scale|Mean|4.1|4.1|Standard Deviation|0.68|0.68|||
4157311|NCT00843518|3980761|B3|||Total T-Score in the Frontal System Behaviors (FrSBe) Scale|FrSBe was a 46-item, caregiver-rated scale that assessed behaviors associated with damage to the frontal lobes and frontal systems of the brain, including executive function, disinhibition, and apathy. Raw scores were normalized to T-scores based on gender, education, and age. Higher T scores represent a worse outcome. A score of 50 reflects a normative sample, and T scores at or above 65 are considered clinically significant.|units on a scale|Mean|90.7|90.7|Standard Deviation|22.11|22.11|||
4157312|NCT00843518|3980762|B2|||Total T-Score in the Frontal System Behaviors (FrSBe) Scale|FrSBe was a 46-item, caregiver-rated scale that assessed behaviors associated with damage to the frontal lobes and frontal systems of the brain, including executive function, disinhibition, and apathy. Raw scores were normalized to T-scores based on gender, education, and age. Higher T scores represent a worse outcome. A score of 50 reflects a normative sample, and T scores at or above 65 are considered clinically significant.|units on a scale|Mean|89.1|89.1|Standard Deviation|18.50|18.5|||
4157313|NCT00843518|3980763|B1|||Total T-Score in the Frontal System Behaviors (FrSBe) Scale|FrSBe was a 46-item, caregiver-rated scale that assessed behaviors associated with damage to the frontal lobes and frontal systems of the brain, including executive function, disinhibition, and apathy. Raw scores were normalized to T-scores based on gender, education, and age. Higher T scores represent a worse outcome. A score of 50 reflects a normative sample, and T scores at or above 65 are considered clinically significant.|units on a scale|Mean|92.4|92.4|Standard Deviation|22.50|22.5|||
4157314|NCT00843518|3980761|B3|||Cornell Scale for Depression in Dementia (CSDD)|CSDD was a 19-item, clinician-rated scale designed to measure the presence and severity of depressive symptoms in dementia participants. Symptoms were rated as absent, mild/intermittent, or severe. Scores ranged from 0 to 38; scores of 8 or more suggested clinical depression.|units on a scale|Mean|8.2|8.2|Standard Deviation|4.99|4.99|||
4157315|NCT00843518|3980762|B2|||Cornell Scale for Depression in Dementia (CSDD)|CSDD was a 19-item, clinician-rated scale designed to measure the presence and severity of depressive symptoms in dementia participants. Symptoms were rated as absent, mild/intermittent, or severe. Scores ranged from 0 to 38; scores of 8 or more suggested clinical depression.|units on a scale|Mean|8.0|8.0|Standard Deviation|4.63|4.63|||
4157316|NCT00843518|3980763|B1|||Cornell Scale for Depression in Dementia (CSDD)|CSDD was a 19-item, clinician-rated scale designed to measure the presence and severity of depressive symptoms in dementia participants. Symptoms were rated as absent, mild/intermittent, or severe. Scores ranged from 0 to 38; scores of 8 or more suggested clinical depression.|units on a scale|Mean|8.4|8.4|Standard Deviation|5.40|5.4|||
4157374|NCT00843518|3980761|B3|||Age||years|Mean|77.44|77.44|Standard Deviation|7.874|7.874|||
4157317|NCT00843518|3980761|B3|||Cohen-Mansfield Agitation Inventory-Community (CMAI-C) Version|CMAI-C is the Cohen-Mansfield Agitation Inventory – Community Version, and it contained 36 questions. The first 35 items were rated from 1 (never) to 7 (several times per hour) and the last item asked if there was any other inappropriate behavior, with a free text field to specify the behavior. The total score ranged from 7 to 245 (7 x 35), with higher scores reflecting more severe agitation.|units on a scale|Mean|68.9|68.9|Standard Deviation|20.52|20.52|||
4157318|NCT00843518|3980762|B2|||Cohen-Mansfield Agitation Inventory-Community (CMAI-C) Version|CMAI-C is the Cohen-Mansfield Agitation Inventory – Community Version, and it contained 36 questions. The first 35 items were rated from 1 (never) to 7 (several times per hour) and the last item asked if there was any other inappropriate behavior, with a free text field to specify the behavior. The total score ranged from 7 to 245 (7 x 35), with higher scores reflecting more severe agitation.|units on a scale|Mean|64.7|64.7|Standard Deviation|17.58|17.58|||
4157319|NCT00843518|3980763|B1|||Cohen-Mansfield Agitation Inventory-Community (CMAI-C) Version|CMAI-C is the Cohen-Mansfield Agitation Inventory – Community Version, and it contained 36 questions. The first 35 items were rated from 1 (never) to 7 (several times per hour) and the last item asked if there was any other inappropriate behavior, with a free text field to specify the behavior. The total score ranged from 7 to 245 (7 x 35), with higher scores reflecting more severe agitation.|units on a scale|Mean|73.6|73.6|Standard Deviation|22.55|22.55|||
4157320|NCT00843518|3980761|B3|||Neuropsychiatric Inventory (NPI) Psychosis Subscale|The NPI Psychosis subscale score was the sum of the delusions and hallucinations items of the standard 12-item NPI that measured psychosis symptoms in participants with Alzheimer's dementia. Scores for each subscale (frequency x severity) were calculated for each item score and ranged from 0 to 24 with higher scores indicating more frequent and/or severe neuropsychiatric symptoms.|units on a scale|Mean|2.8|2.8|Standard Deviation|4.60|4.6|||
4157321|NCT00843518|3980762|B2|||Neuropsychiatric Inventory (NPI) Psychosis Subscale|The NPI Psychosis subscale score was the sum of the delusions and hallucinations items of the standard 12-item NPI that measured psychosis symptoms in participants with Alzheimer's dementia. Scores for each subscale (frequency x severity) were calculated for each item score and ranged from 0 to 24 with higher scores indicating more frequent and/or severe neuropsychiatric symptoms.|units on a scale|Mean|2.4|2.4|Standard Deviation|3.92|3.92|||
4157322|NCT00843518|3980763|B1|||Neuropsychiatric Inventory (NPI) Psychosis Subscale|The NPI Psychosis subscale score was the sum of the delusions and hallucinations items of the standard 12-item NPI that measured psychosis symptoms in participants with Alzheimer's dementia. Scores for each subscale (frequency x severity) were calculated for each item score and ranged from 0 to 24 with higher scores indicating more frequent and/or severe neuropsychiatric symptoms.|units on a scale|Mean|3.2|3.2|Standard Deviation|5.24|5.24|||
4157323|NCT00843518|3980761|B3|||Neuropsychiatric Inventory (NPI) Depression Domain|NPI Depression domain was an item of the standard 12-item NPI that measured depression in participants with Alzheimer's dementia. Scores for each subscale (frequency x severity) were calculated to obtain the item score, which ranged from 0 to 12, with higher scores indicating more frequent and/or severe neuropsychiatric symptoms.|units on a scale|Mean|2.0|2.0|Standard Deviation|2.73|2.73|||
4157324|NCT00843518|3980762|B2|||Neuropsychiatric Inventory (NPI) Depression Domain|NPI Depression domain was an item of the standard 12-item NPI that measured depression in participants with Alzheimer's dementia. Scores for each subscale (frequency x severity) were calculated to obtain the item score, which ranged from 0 to 12, with higher scores indicating more frequent and/or severe neuropsychiatric symptoms.|units on a scale|Mean|1.8|1.8|Standard Deviation|2.33|2.33|||
4157325|NCT00843518|3980763|B1|||Neuropsychiatric Inventory (NPI) Depression Domain|NPI Depression domain was an item of the standard 12-item NPI that measured depression in participants with Alzheimer's dementia. Scores for each subscale (frequency x severity) were calculated to obtain the item score, which ranged from 0 to 12, with higher scores indicating more frequent and/or severe neuropsychiatric symptoms.|units on a scale|Mean|2.2|2.2|Standard Deviation|3.10|3.1|||
4157326|NCT00843518|3980761|B3|||10-Item version of Neuropsychiatric Inventory (NPI-10)|NPI assessed noncognitive psychopathology in participants with Alzheimer’s dementia. A 10-item scale of the standard 12-item NPI measured neuropsychiatric symptoms minus appetite and sleep disturbance. Scores for each subscale (frequency × severity) were calculated to obtain the item score. The total subscale score ranged from 0 to 120, with higher scores indicating more frequent and/or severe A/A symptoms. If a symptom was not present at all, the site would not enter anything for frequency or severity, and a zero would be imputed for that item.|units on a scale|Mean|30.7|30.7|Standard Deviation|14.95|14.95|||
4157327|NCT00843518|3980762|B2|||10-Item version of Neuropsychiatric Inventory (NPI-10)|NPI assessed noncognitive psychopathology in participants with Alzheimer’s dementia. A 10-item scale of the standard 12-item NPI measured neuropsychiatric symptoms minus appetite and sleep disturbance. Scores for each subscale (frequency × severity) were calculated to obtain the item score. The total subscale score ranged from 0 to 120, with higher scores indicating more frequent and/or severe A/A symptoms. If a symptom was not present at all, the site would not enter anything for frequency or severity, and a zero would be imputed for that item.|units on a scale|Mean|29.7|29.7|Standard Deviation|13.22|13.22|||
4157328|NCT00843518|3980763|B1|||10-Item version of Neuropsychiatric Inventory (NPI-10)|NPI assessed noncognitive psychopathology in participants with Alzheimer’s dementia. A 10-item scale of the standard 12-item NPI measured neuropsychiatric symptoms minus appetite and sleep disturbance. Scores for each subscale (frequency × severity) were calculated to obtain the item score. The total subscale score ranged from 0 to 120, with higher scores indicating more frequent and/or severe A/A symptoms. If a symptom was not present at all, the site would not enter anything for frequency or severity, and a zero would be imputed for that item.|units on a scale|Mean|31.9|31.9|Standard Deviation|16.67|16.67|||
4157329|NCT00843518|3980761|B3|||4-Item version of Neuropsychiatric Inventory (NPI-4) of Agitation and Aggression (A/A)|NPI assessed noncognitive psychopathology in participants with Alzheimer's dementia. A 4-item subscale of the standard 12-item NPI measured the neuropsychiatric symptoms of A/A, with items consisting of agitation/aggression, aberrant motor behavior, irritability/emotional lability, and disinhibition. Scores for each subscale (frequency x severity) were calculated to obtain each item score. The total subscale score ranged from 0 to 48, with higher scores indicating more frequent and/or severe A/A symptoms. If a symptom was not present at all then a zero would be imputed for that item.|units on a scale|Mean|18.4|18.4|Standard Deviation|8.42|8.42|||
4157330|NCT00843518|3980762|B2|||4-Item version of Neuropsychiatric Inventory (NPI-4) of Agitation and Aggression (A/A)|NPI assessed noncognitive psychopathology in participants with Alzheimer's dementia. A 4-item subscale of the standard 12-item NPI measured the neuropsychiatric symptoms of A/A, with items consisting of agitation/aggression, aberrant motor behavior, irritability/emotional lability, and disinhibition. Scores for each subscale (frequency x severity) were calculated to obtain each item score. The total subscale score ranged from 0 to 48, with higher scores indicating more frequent and/or severe A/A symptoms. If a symptom was not present at all then a zero would be imputed for that item.|units on a scale|Mean|18.1|18.1|Standard Deviation|8.19|8.19|||
4157331|NCT00843518|3980763|B1|||4-Item version of Neuropsychiatric Inventory (NPI-4) of Agitation and Aggression (A/A)|NPI assessed noncognitive psychopathology in participants with Alzheimer's dementia. A 4-item subscale of the standard 12-item NPI measured the neuropsychiatric symptoms of A/A, with items consisting of agitation/aggression, aberrant motor behavior, irritability/emotional lability, and disinhibition. Scores for each subscale (frequency x severity) were calculated to obtain each item score. The total subscale score ranged from 0 to 48, with higher scores indicating more frequent and/or severe A/A symptoms. If a symptom was not present at all then a zero would be imputed for that item.|units on a scale|Mean|18.8|18.8|Standard Deviation|8.72|8.72|||
4157332|NCT00843518|3980761|B3|||Mini Mental State Examination (MMSE)|MMSE assessed cognitive function in elderly participants. The scale ranged from 0 to 30, with higher scores indicating higher cognitive function.|units on a scale|Mean|17.0|17.0|Standard Deviation|5.72|5.72|||
4157333|NCT00843518|3980762|B2|||Mini Mental State Examination (MMSE)|MMSE assessed cognitive function in elderly participants. The scale ranged from 0 to 30, with higher scores indicating higher cognitive function.|units on a scale|Mean|18.0|18.0|Standard Deviation|5.26|5.26|||
4157334|NCT00843518|3980763|B1|||Mini Mental State Examination (MMSE)|MMSE assessed cognitive function in elderly participants. The scale ranged from 0 to 30, with higher scores indicating higher cognitive function.|units on a scale|Mean|16.0|16.0|Standard Deviation|6.06|6.06|||
4157335|NCT00843518|3980761|B3|United States||Region of Enrollment||participants|Number|132|132.0||||||
4157336|NCT00843518|3980762|B2|United States||Region of Enrollment||participants|Number|69|69.0||||||
4157337|NCT00843518|3980763|B1|United States||Region of Enrollment||participants|Number|63|63.0||||||
4157338|NCT00843518|3980761|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4157339|NCT00843518|3980762|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157340|NCT00843518|3980763|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4157341|NCT00843518|3980761|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157342|NCT00843518|3980762|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157343|NCT00843518|3980763|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157344|NCT00843518|3980761|B3||White|Race (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
4157345|NCT00843518|3980762|B2||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4157346|NCT00843518|3980763|B1||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4157347|NCT00843518|3980761|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4157348|NCT00843518|3980762|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4157349|NCT00843518|3980763|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4157350|NCT00843518|3980761|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157351|NCT00843518|3980762|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157352|NCT00843518|3980763|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157353|NCT00843518|3980761|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157354|NCT00843518|3980762|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157355|NCT00843518|3980763|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157356|NCT00843518|3980761|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4157357|NCT00843518|3980762|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4157358|NCT00843518|3980763|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157359|NCT00843518|3980761|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157360|NCT00843518|3980762|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157361|NCT00843518|3980763|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157362|NCT00843518|3980761|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
4157363|NCT00843518|3980762|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
4157364|NCT00843518|3980763|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4157365|NCT00843518|3980761|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4157366|NCT00843518|3980762|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157367|NCT00843518|3980763|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4157368|NCT00843518|3980761|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4157369|NCT00843518|3980762|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4157370|NCT00843518|3980763|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4157371|NCT00843518|3980761|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4157372|NCT00843518|3980762|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4157373|NCT00843518|3980763|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4157375|NCT00843518|3980762|B2|||Age||years|Mean|77.66|77.66|Standard Deviation|7.574|7.574|||
4157376|NCT00843518|3980763|B1|||Age||years|Mean|77.21|77.21|Standard Deviation|8.246|8.246|||
4157377|NCT00843492|3980792|B3||Male|Sex: Female, Male|Baseline characteristic data was collected in members of the Intent-to-Treat (ITT) Population, comprised of all randomized patients (recorded in the Interactive Voice Response System [IVRS] database) with a venous thromboembolism (VTE) status or experiencing death.|Participants|Count of Participants|579|579.0||||||
4157378|NCT00843492|3980793|B2||Male|Sex: Female, Male|Baseline characteristic data was collected in members of the Intent-to-Treat (ITT) Population, comprised of all randomized patients (recorded in the Interactive Voice Response System [IVRS] database) with a venous thromboembolism (VTE) status or experiencing death.|Participants|Count of Participants|293|293.0||||||
4157379|NCT00843492|3980794|B1||Male|Sex: Female, Male|Baseline characteristic data was collected in members of the Intent-to-Treat (ITT) Population, comprised of all randomized patients (recorded in the Interactive Voice Response System [IVRS] database) with a venous thromboembolism (VTE) status or experiencing death.|Participants|Count of Participants|286|286.0||||||
4157380|NCT00843492|3980792|B3||Female|Sex: Female, Male|Baseline characteristic data was collected in members of the Intent-to-Treat (ITT) Population, comprised of all randomized patients (recorded in the Interactive Voice Response System [IVRS] database) with a venous thromboembolism (VTE) status or experiencing death.|Participants|Count of Participants|664|664.0||||||
4157381|NCT00843492|3980793|B2||Female|Sex: Female, Male|Baseline characteristic data was collected in members of the Intent-to-Treat (ITT) Population, comprised of all randomized patients (recorded in the Interactive Voice Response System [IVRS] database) with a venous thromboembolism (VTE) status or experiencing death.|Participants|Count of Participants|328|328.0||||||
4157382|NCT00843492|3980794|B1||Female|Sex: Female, Male|Baseline characteristic data was collected in members of the Intent-to-Treat (ITT) Population, comprised of all randomized patients (recorded in the Interactive Voice Response System [IVRS] database) with a venous thromboembolism (VTE) status or experiencing death.|Participants|Count of Participants|336|336.0||||||
4157383|NCT00843492|3980792|B3|Years||Age|Baseline characteristic data was collected in members of the Intent-to-Treat (ITT) Population, comprised of all randomized patients (recorded in the Interactive Voice Response System [IVRS] database) with a venous thromboembolism (VTE) status or experiencing death.|Years|Mean|46.3|46.3|Standard Deviation|15.8|15.8|||
4157384|NCT00843492|3980793|B2|Years||Age|Baseline characteristic data was collected in members of the Intent-to-Treat (ITT) Population, comprised of all randomized patients (recorded in the Interactive Voice Response System [IVRS] database) with a venous thromboembolism (VTE) status or experiencing death.|Years|Mean|46.1|46.1|Standard Deviation|16.0|16.0|||
4157385|NCT00843492|3980794|B1|Years||Age|Baseline characteristic data was collected in members of the Intent-to-Treat (ITT) Population, comprised of all randomized patients (recorded in the Interactive Voice Response System [IVRS] database) with a venous thromboembolism (VTE) status or experiencing death.|Years|Mean|46.5|46.5|Standard Deviation|15.7|15.7|||
4157386|NCT00843479|3980813|B3|Brazil||Region of Enrollment||participants|Number|24|24.0||||||
4157387|NCT00843479|3980814|B2|Brazil||Region of Enrollment||participants|Number|12|12.0||||||
4157388|NCT00843479|3980815|B1|Brazil||Region of Enrollment||participants|Number|12|12.0||||||
4157389|NCT00843479|3980813|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4157390|NCT00843479|3980814|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4157391|NCT00843479|3980815|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4157392|NCT00843479|3980813|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4157393|NCT00843479|3980814|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4157394|NCT00843479|3980815|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4157395|NCT00843479|3980813|B3|||Age||years|Mean|54|54.0|Standard Deviation|3|3.0|||
4157396|NCT00843479|3980814|B2|||Age||years|Mean|44|44.0|Standard Deviation|4|4.0|||
4157397|NCT00843479|3980815|B1|||Age||years|Mean|64|64.0|Standard Deviation|2|2.0|||
4157398|NCT00843479|3980813|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||0|0.0|||
4157399|NCT00843479|3980814|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||0|0.0|||
4157400|NCT00843479|3980815|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||0|0.0|||
4157401|NCT00843479|3980813|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||0|0.0|||
4157402|NCT00843479|3980814|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||0|0.0|||
4157403|NCT00843479|3980815|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||0|0.0|||
4157404|NCT00843479|3980813|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||0|0.0|||
4157405|NCT00843479|3980814|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||0|0.0|||
4157406|NCT00843479|3980815|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||0|0.0|||
4157407|NCT00843466|3980832|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4157408|NCT00843466|3980833|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4157409|NCT00843466|3980834|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4157410|NCT00843466|3980832|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4157411|NCT00843466|3980833|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4157412|NCT00843466|3980834|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4157413|NCT00843466|3980832|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4157414|NCT00843466|3980833|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4157415|NCT00843466|3980834|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4157416|NCT00843466|3980832|B3|||Age||years|Median|41|41.0|Full Range|||18.0|78.0|
4157417|NCT00843466|3980833|B2|||Age||years|Median|40|40.0|Full Range|||20.0|65.0|
4157418|NCT00843466|3980834|B1|||Age||years|Median|45|45.0|Full Range|||18.0|78.0|
4157419|NCT00843466|3980832|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4157420|NCT00843466|3980833|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4157421|NCT00843466|3980834|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4157422|NCT00843466|3980832|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4157423|NCT00843466|3980833|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4157424|NCT00843466|3980834|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4157425|NCT00843466|3980832|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4157426|NCT00843466|3980833|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4157427|NCT00843466|3980834|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4157428|NCT00843349|3980841|B5|United States||Region of Enrollment||participants|Number|43|43.0||||||
4157429|NCT00843349|3980842|B4|United States||Region of Enrollment||participants|Number|11|11.0||||||
4157430|NCT00843349|3980843|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4157431|NCT00843349|3980844|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4157432|NCT00843349|3980845|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4157433|NCT00843349|3980841|B5||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4157434|NCT00843349|3980842|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4157435|NCT00843349|3980843|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4157436|NCT00843349|3980844|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4157437|NCT00843349|3980845|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4157438|NCT00843349|3980841|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4157439|NCT00843349|3980842|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4157440|NCT00843349|3980843|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4157441|NCT00843349|3980844|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4157442|NCT00843349|3980845|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4157443|NCT00843349|3980841|B5|||Age||years|Mean|55.4|55.4|Standard Deviation|10.3|10.3|||
4157444|NCT00843349|3980842|B4|||Age||years|Mean|55.1|55.1|Standard Deviation|12.6|12.6|||
4157445|NCT00843349|3980843|B3|||Age||years|Mean|56.2|56.2|Standard Deviation|10.1|10.1|||
4157446|NCT00843349|3980844|B2|||Age||years|Mean|55.1|55.1|Standard Deviation|12.6|12.6|||
4157447|NCT00843349|3980845|B1|||Age||years|Mean|56.1|56.1|Standard Deviation|10.0|10.0|||
4157448|NCT00843349|3980841|B5||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4157449|NCT00843349|3980842|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4157450|NCT00843349|3980843|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4157451|NCT00843349|3980844|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4157452|NCT00843349|3980845|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4157453|NCT00843349|3980841|B5||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4157454|NCT00843349|3980842|B4||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4157455|NCT00843349|3980843|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4157456|NCT00843349|3980844|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4157457|NCT00843349|3980845|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4157458|NCT00843349|3980841|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4157459|NCT00843349|3980842|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4157460|NCT00843349|3980843|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4157461|NCT00843349|3980844|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4157462|NCT00843349|3980845|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4157463|NCT00843310|3980862|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4157464|NCT00843310|3980862|B1|Unknown or Not Reported||Race/Ethnicity, Customized||paticipants|Number|0|0.0||||||
4157465|NCT00843310|3980862|B1|More than one race||Race/Ethnicity, Customized||paticipants|Number|0|0.0||||||
4157466|NCT00843310|3980862|B1|White||Race/Ethnicity, Customized||paticipants|Number|7|7.0||||||
4157467|NCT00843310|3980862|B1|Black or African American||Race/Ethnicity, Customized||paticipants|Number|0|0.0||||||
4157468|NCT00843310|3980862|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||paticipants|Number|0|0.0||||||
4157469|NCT00843310|3980862|B1|Asian||Race/Ethnicity, Customized||paticipants|Number|0|0.0||||||
4157470|NCT00843310|3980862|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||paticipants|Number|1|1.0||||||
4157471|NCT00843310|3980862|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4157472|NCT00843310|3980862|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4157473|NCT00843310|3980862|B1|||Age||years|Median|69|69.0|Full Range|||67.0|81.0|
4157474|NCT00843310|3980862|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4157475|NCT00843310|3980862|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4157476|NCT00843310|3980862|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4157477|NCT00843284|3980866|B1|Unspecified||Sex/Gender, Customized||participants|Number|3|3.0||||||
4157478|NCT00843284|3980866|B1|Male||Sex/Gender, Customized||participants|Number|254|254.0||||||
4157479|NCT00843284|3980866|B1|Female||Sex/Gender, Customized||participants|Number|434|434.0||||||
4157480|NCT00843284|3980866|B1|||Age||years|Mean|62.9|62.9|Standard Deviation|13.7|13.7|||
4157481|NCT00843193|3980874|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|191|191.0||||||
4157482|NCT00843193|3980875|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|96|96.0||||||
4157483|NCT00843193|3980876|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|95|95.0||||||
4157484|NCT00843193|3980874|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4157485|NCT00843193|3980875|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4157486|NCT00843193|3980876|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4157487|NCT00843193|3980874|B3|Japanese/East Asian/South East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4157488|NCT00843193|3980875|B2|Japanese/East Asian/South East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4157489|NCT00843193|3980876|B1|Japanese/East Asian/South East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4157490|NCT00843193|3980874|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4157491|NCT00843193|3980875|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4157492|NCT00843193|3980876|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4157493|NCT00843193|3980874|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4157494|NCT00843193|3980875|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4157495|NCT00843193|3980876|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4157496|NCT00843193|3980874|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4157497|NCT00843193|3980875|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4157498|NCT00843193|3980876|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4157499|NCT00843193|3980874|B3|||Age||Years|Mean|51.2|51.2|Standard Deviation|11.43|11.43|||
4157500|NCT00843193|3980875|B2|||Age||Years|Mean|51.2|51.2|Standard Deviation|11.13|11.13|||
4157501|NCT00843193|3980876|B1|||Age||Years|Mean|51.2|51.2|Standard Deviation|11.78|11.78|||
4157502|NCT00843180|3980911|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4157503|NCT00843180|3980912|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4157504|NCT00843180|3980913|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4157505|NCT00843180|3980911|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4157506|NCT00843180|3980912|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4157507|NCT00843180|3980913|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4157508|NCT00843180|3980911|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4157509|NCT00843180|3980912|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4157510|NCT00843180|3980913|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4157511|NCT00843180|3980911|B3|||Age||years|Mean|11.7|11.7|Standard Deviation|4.0|4.0|||
4157512|NCT00843180|3980912|B2|||Age||years|Mean|13.7|13.7|Standard Deviation|4.3|4.3|||
4157513|NCT00843180|3980913|B1|||Age||years|Mean|10.9|10.9|Standard Deviation|3.7|3.7|||
4157514|NCT00843180|3980911|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4157515|NCT00843180|3980912|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4157516|NCT00843180|3980913|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4157517|NCT00843180|3980911|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4157518|NCT00843180|3980912|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4157519|NCT00843180|3980913|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4157520|NCT00843180|3980911|B3||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
4157521|NCT00843180|3980912|B2||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4157522|NCT00843180|3980913|B1||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4157523|NCT00843167|3980926|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
4157524|NCT00843167|3980927|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4157525|NCT00843167|3980928|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4157526|NCT00843167|3980926|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157527|NCT00843167|3980927|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157528|NCT00843167|3980928|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157529|NCT00843167|3980926|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157530|NCT00843167|3980927|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157531|NCT00843167|3980928|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157532|NCT00843167|3980926|B3||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4157533|NCT00843167|3980927|B2||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4157534|NCT00843167|3980928|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4157535|NCT00843167|3980926|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4157536|NCT00843167|3980927|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4157537|NCT00843167|3980928|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157538|NCT00843167|3980926|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157539|NCT00843167|3980927|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157540|NCT00843167|3980928|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157541|NCT00843167|3980926|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4157542|NCT00843167|3980927|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4157543|NCT00843167|3980928|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4157544|NCT00843167|3980926|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4157545|NCT00843167|3980927|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4157546|NCT00843167|3980928|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4157547|NCT00843167|3980926|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4157548|NCT00843167|3980927|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4157549|NCT00843167|3980928|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4157550|NCT00843167|3980926|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4157551|NCT00843167|3980927|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4157552|NCT00843167|3980928|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4157553|NCT00843167|3980926|B3|||Age||years|Mean|54.4|54.4|Standard Deviation|12.1|12.1|||
4157554|NCT00843167|3980927|B2|||Age||years|Mean|55.3|55.3|Standard Deviation|14.3|14.3|||
4157555|NCT00843167|3980928|B1|||Age||years|Mean|53.5|53.5|Standard Deviation|9.5|9.5|||
4157556|NCT00843167|3980926|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4157557|NCT00843167|3980927|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4157558|NCT00843167|3980928|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4157559|NCT00843167|3980926|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4157560|NCT00843167|3980927|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4157561|NCT00843167|3980928|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4157562|NCT00843167|3980926|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4157563|NCT00843167|3980927|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4157564|NCT00843167|3980928|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4157565|NCT00843115|3980942|B1||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4157566|NCT00843115|3980942|B1||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4157567|NCT00843115|3980942|B1|||Age||years|Mean|80.1|80.1|Standard Deviation|7.5|7.5|||
4157568|NCT00843050|3980988|B1|India||Region of Enrollment||participants|Number|5|5.0||||||
4157569|NCT00843050|3980988|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4157570|NCT00843050|3980988|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4157571|NCT00843050|3980988|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4157572|NCT00843050|3980988|B1|||Age||years|Mean|65.8|65.8|Standard Deviation|9.99|9.99|||
4157573|NCT00843050|3980988|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4157574|NCT00843050|3980988|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4157575|NCT00843050|3980988|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4157576|NCT00843024|3980994|B5|||Body Mass Index|Body Mass Index is calculated as: weight (kg)/height (m^2)|Kilograms per meters squared (kg/m^2)|Mean|23.7|23.7|Standard Deviation|5.36|5.36|||
4157577|NCT00843024|3980995|B4|||Body Mass Index|Body Mass Index is calculated as: weight (kg)/height (m^2)|Kilograms per meters squared (kg/m^2)|Mean|24.6|24.6|Standard Deviation|5.68|5.68|||
4157578|NCT00843024|3980996|B3|||Body Mass Index|Body Mass Index is calculated as: weight (kg)/height (m^2)|Kilograms per meters squared (kg/m^2)|Mean|22.9|22.9|Standard Deviation|4.53|4.53|||
4157579|NCT00843024|3980997|B2|||Body Mass Index|Body Mass Index is calculated as: weight (kg)/height (m^2)|Kilograms per meters squared (kg/m^2)|Mean|23.3|23.3|Standard Deviation|5.62|5.62|||
4157580|NCT00843024|3980998|B1|||Body Mass Index|Body Mass Index is calculated as: weight (kg)/height (m^2)|Kilograms per meters squared (kg/m^2)|Mean|23.5|23.5|Standard Deviation|5.28|5.28|||
4157581|NCT00843024|3980994|B5|||Weight||Kilograms (kg)|Mean|64.6|64.6|Standard Deviation|17.63|17.63|||
4157582|NCT00843024|3980995|B4|||Weight||Kilograms (kg)|Mean|66.8|66.8|Standard Deviation|19.13|19.13|||
4157583|NCT00843024|3980996|B3|||Weight||Kilograms (kg)|Mean|62.8|62.8|Standard Deviation|14.49|14.49|||
4157584|NCT00843024|3980997|B2|||Weight||Kilograms (kg)|Mean|64.2|64.2|Standard Deviation|19.29|19.29|||
4157585|NCT00843024|3980998|B1|||Weight||Kilograms (kg)|Mean|63.8|63.8|Standard Deviation|16.67|16.67|||
4157586|NCT00843024|3980994|B5|Missing||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4157587|NCT00843024|3980995|B4|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4157588|NCT00843024|3980996|B3|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4157589|NCT00843024|3980997|B2|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4157590|NCT00843024|3980998|B1|Missing||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4157591|NCT00843024|3980994|B5|Native Hawaiian/ other Pacific Islander and White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4157592|NCT00843024|3980995|B4|Native Hawaiian/ other Pacific Islander and White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4157593|NCT00843024|3980996|B3|Native Hawaiian/ other Pacific Islander and White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4157594|NCT00843024|3980997|B2|Native Hawaiian/ other Pacific Islander and White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4157595|NCT00843024|3980998|B1|Native Hawaiian/ other Pacific Islander and White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4157596|NCT00843024|3980994|B5|Asian and White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4157597|NCT00843024|3980995|B4|Asian and White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4157598|NCT00843024|3980996|B3|Asian and White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4157599|NCT00843024|3980997|B2|Asian and White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4157600|NCT00843024|3980998|B1|Asian and White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4157601|NCT00843024|3980994|B5|Asian and Native Hawaiian/other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4157602|NCT00843024|3980995|B4|Asian and Native Hawaiian/other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4157603|NCT00843024|3980996|B3|Asian and Native Hawaiian/other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4157604|NCT00843024|3980997|B2|Asian and Native Hawaiian/other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4157605|NCT00843024|3980998|B1|Asian and Native Hawaiian/other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4157606|NCT00843024|3980994|B5|American Indian or Alaska Native and White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4157607|NCT00843024|3980995|B4|American Indian or Alaska Native and White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4157608|NCT00843024|3980996|B3|American Indian or Alaska Native and White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4157609|NCT00843024|3980997|B2|American Indian or Alaska Native and White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4157610|NCT00843024|3980998|B1|American Indian or Alaska Native and White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4157611|NCT00843024|3980994|B5|African American/African Heritage and White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4157612|NCT00843024|3980995|B4|African American/African Heritage and White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4157613|NCT00843024|3980996|B3|African American/African Heritage and White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4157614|NCT00843024|3980997|B2|African American/African Heritage and White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4157615|NCT00843024|3980998|B1|African American/African Heritage and White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4157616|NCT00843024|3980994|B5|White||Race/Ethnicity, Customized||participants|Number|397|397.0||||||
4157617|NCT00843024|3980995|B4|White||Race/Ethnicity, Customized||participants|Number|130|130.0||||||
4157618|NCT00843024|3980996|B3|White||Race/Ethnicity, Customized||participants|Number|84|84.0||||||
4157619|NCT00843024|3980997|B2|White||Race/Ethnicity, Customized||participants|Number|75|75.0||||||
4157620|NCT00843024|3980998|B1|White||Race/Ethnicity, Customized||participants|Number|108|108.0||||||
4157621|NCT00843024|3980994|B5|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4157622|NCT00843024|3980995|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4157623|NCT00843024|3980996|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4157624|NCT00843024|3980997|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4157625|NCT00843024|3980998|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4157626|NCT00843024|3980994|B5|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4157627|NCT00843024|3980995|B4|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4157628|NCT00843024|3980996|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4157629|NCT00843024|3980997|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4157630|NCT00843024|3980998|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4157631|NCT00843024|3980994|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4157632|NCT00843024|3980995|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4157633|NCT00843024|3980996|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4157634|NCT00843024|3980997|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4157635|NCT00843024|3980998|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4157636|NCT00843024|3980994|B5|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
4157637|NCT00843024|3980995|B4|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4157638|NCT00843024|3980996|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4157639|NCT00843024|3980997|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4157640|NCT00843024|3980998|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4157641|NCT00843024|3980994|B5||Male|Gender||Participants|Count of Participants|203|203.0||||||
4157642|NCT00843024|3980995|B4||Male|Gender||Participants|Count of Participants|58|58.0||||||
4157643|NCT00843024|3980996|B3||Male|Gender||Participants|Count of Participants|41|41.0||||||
4157644|NCT00843024|3980997|B2||Male|Gender||Participants|Count of Participants|44|44.0||||||
4157645|NCT00843024|3980998|B1||Male|Gender||Participants|Count of Participants|60|60.0||||||
4157646|NCT00843024|3980994|B5||Female|Gender||Participants|Count of Participants|287|287.0||||||
4157647|NCT00843024|3980995|B4||Female|Gender||Participants|Count of Participants|94|94.0||||||
4157648|NCT00843024|3980996|B3||Female|Gender||Participants|Count of Participants|56|56.0||||||
4157649|NCT00843024|3980997|B2||Female|Gender||Participants|Count of Participants|52|52.0||||||
4157650|NCT00843024|3980998|B1||Female|Gender||Participants|Count of Participants|85|85.0||||||
4157651|NCT00843024|3980994|B5|||Age|Baseline characteristics are provided for participants in the Intent-to-Treat (ITT) Population, comprised of all participants who provided any post-treatment efficacy assessment.|Years|Mean|14.7|14.7|Standard Deviation|1.72|1.72|||
4157652|NCT00843024|3980995|B4|||Age|Baseline characteristics are provided for participants in the Intent-to-Treat (ITT) Population, comprised of all participants who provided any post-treatment efficacy assessment.|Years|Mean|14.8|14.8|Standard Deviation|1.69|1.69|||
4157653|NCT00843024|3980996|B3|||Age|Baseline characteristics are provided for participants in the Intent-to-Treat (ITT) Population, comprised of all participants who provided any post-treatment efficacy assessment.|Years|Mean|14.7|14.7|Standard Deviation|1.65|1.65|||
4157654|NCT00843024|3980997|B2|||Age|Baseline characteristics are provided for participants in the Intent-to-Treat (ITT) Population, comprised of all participants who provided any post-treatment efficacy assessment.|Years|Mean|14.8|14.8|Standard Deviation|1.81|1.81|||
4157655|NCT00843024|3980998|B1|||Age|Baseline characteristics are provided for participants in the Intent-to-Treat (ITT) Population, comprised of all participants who provided any post-treatment efficacy assessment.|Years|Mean|14.7|14.7|Standard Deviation|1.76|1.76|||
4157656|NCT00842985|3981068|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
4157657|NCT00842985|3981068|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4157658|NCT00842985|3981068|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4157659|NCT00842985|3981068|B1|||Age||years|Mean|33.7|33.7|Standard Deviation|7.7|7.7|||
4157660|NCT00842985|3981068|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4157661|NCT00842985|3981068|B1||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4157662|NCT00842985|3981068|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4157663|NCT00842946|3981075|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
4157664|NCT00842946|3981076|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4157665|NCT00842946|3981077|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4157666|NCT00842946|3981075|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4157667|NCT00842946|3981076|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4157668|NCT00842946|3981077|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4157669|NCT00842946|3981075|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4157670|NCT00842946|3981076|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4157671|NCT00842946|3981077|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4157672|NCT00842946|3981075|B3|||Age||years|Mean|31.93|31.93|Standard Deviation|10.55|10.55|||
4157673|NCT00842946|3981076|B2|||Age||years|Mean|29.96|29.96|Standard Deviation|8.41|8.41|||
4157674|NCT00842946|3981077|B1|||Age||years|Mean|34.20|34.2|Standard Deviation|12.40|12.4|||
4157675|NCT00842946|3981075|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4157676|NCT00842946|3981076|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4157677|NCT00842946|3981077|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4157678|NCT00842946|3981075|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4157679|NCT00842946|3981076|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4157680|NCT00842946|3981077|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4157681|NCT00842946|3981075|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4157682|NCT00842946|3981076|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4157683|NCT00842946|3981077|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4157684|NCT00842829|3981084|B3|Other (not specified)||Cancer Site||participants|Number|81|81.0||||||
4157685|NCT00842829|3981085|B2|Other (not specified)||Cancer Site||participants|Number|42|42.0||||||
4157686|NCT00842829|3981086|B1|Other (not specified)||Cancer Site||participants|Number|39|39.0||||||
4157687|NCT00842829|3981084|B3|Lung||Cancer Site||participants|Number|47|47.0||||||
4157688|NCT00842829|3981085|B2|Lung||Cancer Site||participants|Number|21|21.0||||||
4157689|NCT00842829|3981086|B1|Lung||Cancer Site||participants|Number|26|26.0||||||
4157690|NCT00842829|3981084|B3|Prostate||Cancer Site||participants|Number|25|25.0||||||
4157691|NCT00842829|3981085|B2|Prostate||Cancer Site||participants|Number|17|17.0||||||
4157692|NCT00842829|3981086|B1|Prostate||Cancer Site||participants|Number|8|8.0||||||
4157693|NCT00842829|3981084|B3|Pancreas/stomach||Cancer Site||participants|Number|24|24.0||||||
4157694|NCT00842829|3981085|B2|Pancreas/stomach||Cancer Site||participants|Number|11|11.0||||||
4157695|NCT00842829|3981086|B1|Pancreas/stomach||Cancer Site||participants|Number|13|13.0||||||
4157696|NCT00842829|3981084|B3|Oesophageal||Cancer Site||participants|Number|6|6.0||||||
4157697|NCT00842829|3981085|B2|Oesophageal||Cancer Site||participants|Number|2|2.0||||||
4157698|NCT00842829|3981086|B1|Oesophageal||Cancer Site||participants|Number|4|4.0||||||
4157699|NCT00842829|3981084|B3|Myeloma||Cancer Site||participants|Number|9|9.0||||||
4157700|NCT00842829|3981085|B2|Myeloma||Cancer Site||participants|Number|4|4.0||||||
4157701|NCT00842829|3981086|B1|Myeloma||Cancer Site||participants|Number|5|5.0||||||
4157702|NCT00842829|3981084|B3|Leukemia/lymphoma||Cancer Site||participants|Number|6|6.0||||||
4157703|NCT00842829|3981085|B2|Leukemia/lymphoma||Cancer Site||participants|Number|4|4.0||||||
4157704|NCT00842829|3981086|B1|Leukemia/lymphoma||Cancer Site||participants|Number|2|2.0||||||
4157705|NCT00842829|3981084|B3|Head/neck||Cancer Site||participants|Number|24|24.0||||||
4157706|NCT00842829|3981085|B2|Head/neck||Cancer Site||participants|Number|12|12.0||||||
4157707|NCT00842829|3981086|B1|Head/neck||Cancer Site||participants|Number|12|12.0||||||
4157708|NCT00842829|3981084|B3|Colon/rectum + Pancreas/stomach + other||Cancer Site||participants|Number|1|1.0||||||
4157709|NCT00842829|3981085|B2|Colon/rectum + Pancreas/stomach + other||Cancer Site||participants|Number|0|0.0||||||
4157710|NCT00842829|3981086|B1|Colon/rectum + Pancreas/stomach + other||Cancer Site||participants|Number|1|1.0||||||
4157711|NCT00842829|3981084|B3|Colon/rectum||Cancer Site||participants|Number|40|40.0||||||
4157712|NCT00842829|3981085|B2|Colon/rectum||Cancer Site||participants|Number|25|25.0||||||
4157713|NCT00842829|3981086|B1|Colon/rectum||Cancer Site||participants|Number|15|15.0||||||
4157714|NCT00842829|3981084|B3|Breast||Cancer Site||participants|Number|67|67.0||||||
4157715|NCT00842829|3981085|B2|Breast||Cancer Site||participants|Number|36|36.0||||||
4157716|NCT00842829|3981086|B1|Breast||Cancer Site||participants|Number|31|31.0||||||
4157717|NCT00842829|3981084|B3|Italy||Region of Enrollment||participants|Number|72|72.0||||||
4157718|NCT00842829|3981085|B2|Italy||Region of Enrollment||participants|Number|37|37.0||||||
4157719|NCT00842829|3981086|B1|Italy||Region of Enrollment||participants|Number|35|35.0||||||
4157720|NCT00842829|3981084|B3|United Kingdom||Region of Enrollment||participants|Number|15|15.0||||||
4157721|NCT00842829|3981085|B2|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
4157722|NCT00842829|3981086|B1|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
4157723|NCT00842829|3981084|B3|Germany||Region of Enrollment||participants|Number|70|70.0||||||
4157724|NCT00842829|3981085|B2|Germany||Region of Enrollment||participants|Number|38|38.0||||||
4157725|NCT00842829|3981086|B1|Germany||Region of Enrollment||participants|Number|32|32.0||||||
4157726|NCT00842829|3981084|B3|Ireland||Region of Enrollment||participants|Number|1|1.0||||||
4157727|NCT00842829|3981085|B2|Ireland||Region of Enrollment||participants|Number|0|0.0||||||
4157728|NCT00842829|3981086|B1|Ireland||Region of Enrollment||participants|Number|1|1.0||||||
4157729|NCT00842829|3981084|B3|Poland||Region of Enrollment||participants|Number|79|79.0||||||
4157730|NCT00842829|3981085|B2|Poland||Region of Enrollment||participants|Number|41|41.0||||||
4157731|NCT00842829|3981086|B1|Poland||Region of Enrollment||participants|Number|38|38.0||||||
4157732|NCT00842829|3981084|B3|Spain||Region of Enrollment||participants|Number|52|52.0||||||
4157733|NCT00842829|3981085|B2|Spain||Region of Enrollment||participants|Number|26|26.0||||||
4157734|NCT00842829|3981086|B1|Spain||Region of Enrollment||participants|Number|26|26.0||||||
4157735|NCT00842829|3981084|B3|France||Region of Enrollment||participants|Number|41|41.0||||||
4157736|NCT00842829|3981085|B2|France||Region of Enrollment||participants|Number|25|25.0||||||
4157737|NCT00842829|3981086|B1|France||Region of Enrollment||participants|Number|16|16.0||||||
4157738|NCT00842829|3981084|B3||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4157739|NCT00842829|3981085|B2||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4157740|NCT00842829|3981086|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4157741|NCT00842829|3981084|B3||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4157742|NCT00842829|3981085|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4157743|NCT00842829|3981086|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4157744|NCT00842829|3981084|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|11.32|11.32|||
4157745|NCT00842829|3981085|B2|||Age||years|Mean|60.1|60.1|Standard Deviation|10.97|10.97|||
4157746|NCT00842829|3981086|B1|||Age||years|Mean|59.5|59.5|Standard Deviation|11.72|11.72|||
4157747|NCT00842751|3981122|B1|||Serum oestradiol concentration||pg/mL|Median|15|15.0|Standard Deviation|5|5.0|||
4157748|NCT00842751|3981122|B1|||Serum dihydrotestosterone concentration||ng/dL|Mean|32|32.0|Standard Deviation|12|12.0|||
4157749|NCT00842751|3981122|B1|||Serum testosterone concentration||ng/dL|Mean|405|405.0|Standard Deviation|14|14.0|||
4157750|NCT00842751|3981122|B1|||Body Mass Index (BMI)||kg/m2|Mean|24|24.0|Standard Deviation|3|3.0|||
4157751|NCT00842751|3981122|B1|||Height||cm|Mean|181|181.0|Standard Deviation|7|7.0|||
4157752|NCT00842751|3981122|B1|||Weight||kg|Mean|80|80.0|Standard Deviation|13|13.0|||
4157753|NCT00842751|3981122|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4157754|NCT00842751|3981122|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4157755|NCT00842751|3981122|B1|||Age||years|Mean|32|32.0|Standard Deviation|9|9.0|||
4157756|NCT00842712|3981136|B8||Male|Gender||Participants|Count of Participants|147|147.0||||||
4157757|NCT00842712|3981137|B7||Male|Gender||Participants|Count of Participants|57|57.0||||||
4157758|NCT00842712|3981138|B6||Male|Gender||Participants|Count of Participants|32|32.0||||||
4157759|NCT00842712|3981139|B5||Male|Gender||Participants|Count of Participants|51|51.0||||||
4157760|NCT00842712|3981140|B4||Male|Gender||Participants|Count of Participants|1|1.0||||||
4157761|NCT00842712|3981141|B3||Male|Gender||Participants|Count of Participants|1|1.0||||||
4157762|NCT00842712|3981142|B2||Male|Gender||Participants|Count of Participants|3|3.0||||||
4157763|NCT00842712|3981143|B1||Male|Gender||Participants|Count of Participants|2|2.0||||||
4157764|NCT00842712|3981136|B8||Female|Gender||Participants|Count of Participants|85|85.0||||||
4157765|NCT00842712|3981137|B7||Female|Gender||Participants|Count of Participants|27|27.0||||||
4157766|NCT00842712|3981138|B6||Female|Gender||Participants|Count of Participants|19|19.0||||||
4157767|NCT00842712|3981139|B5||Female|Gender||Participants|Count of Participants|34|34.0||||||
4157768|NCT00842712|3981140|B4||Female|Gender||Participants|Count of Participants|2|2.0||||||
4157769|NCT00842712|3981141|B3||Female|Gender||Participants|Count of Participants|2|2.0||||||
4157770|NCT00842712|3981142|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
4157771|NCT00842712|3981143|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
4157772|NCT00842712|3981136|B8|Greater than or equal to 65 years||Age, Customized||participants|Number|50|50.0||||||
4157773|NCT00842712|3981137|B7|Greater than or equal to 65 years||Age, Customized||participants|Number|18|18.0||||||
4157774|NCT00842712|3981138|B6|Greater than or equal to 65 years||Age, Customized||participants|Number|14|14.0||||||
4157775|NCT00842712|3981139|B5|Greater than or equal to 65 years||Age, Customized||participants|Number|17|17.0||||||
4157776|NCT00842712|3981140|B4|Greater than or equal to 65 years||Age, Customized||participants|Number|0|0.0||||||
4157777|NCT00842712|3981141|B3|Greater than or equal to 65 years||Age, Customized||participants|Number|0|0.0||||||
4157778|NCT00842712|3981142|B2|Greater than or equal to 65 years||Age, Customized||participants|Number|1|1.0||||||
4157779|NCT00842712|3981143|B1|Greater than or equal to 65 years||Age, Customized||participants|Number|0|0.0||||||
4157780|NCT00842712|3981136|B8|Less than 65 years||Age, Customized||participants|Number|182|182.0||||||
4157781|NCT00842712|3981137|B7|Less than 65 years||Age, Customized||participants|Number|66|66.0||||||
4157782|NCT00842712|3981138|B6|Less than 65 years||Age, Customized||participants|Number|37|37.0||||||
4157783|NCT00842712|3981139|B5|Less than 65 years||Age, Customized||participants|Number|68|68.0||||||
4157784|NCT00842712|3981140|B4|Less than 65 years||Age, Customized||participants|Number|3|3.0||||||
4157785|NCT00842712|3981141|B3|Less than 65 years||Age, Customized||participants|Number|3|3.0||||||
4157786|NCT00842712|3981142|B2|Less than 65 years||Age, Customized||participants|Number|2|2.0||||||
4157787|NCT00842712|3981143|B1|Less than 65 years||Age, Customized||participants|Number|3|3.0||||||
4157788|NCT00842608|3981177|B5|United States||Region of Enrollment||participants|Number|551|551.0||||||
4157789|NCT00842608|3981178|B4|United States||Region of Enrollment||participants|Number|101|101.0||||||
4157790|NCT00842608|3981179|B3|United States||Region of Enrollment||participants|Number|99|99.0||||||
4157791|NCT00842608|3981180|B2|United States||Region of Enrollment||participants|Number|177|177.0||||||
4157792|NCT00842608|3981181|B1|United States||Region of Enrollment||participants|Number|174|174.0||||||
4157793|NCT00842608|3981177|B5||Male|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
4157794|NCT00842608|3981178|B4||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4157795|NCT00842608|3981179|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4157796|NCT00842608|3981180|B2||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4157797|NCT00842608|3981181|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4157798|NCT00842608|3981177|B5||Female|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
4157799|NCT00842608|3981178|B4||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4157800|NCT00842608|3981179|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4157801|NCT00842608|3981180|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4157802|NCT00842608|3981181|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4157803|NCT00842608|3981177|B5||>=65 years|Age||Participants|Count of Participants|209|209.0||||||
4157804|NCT00842608|3981178|B4||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
4157805|NCT00842608|3981179|B3||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
4157806|NCT00842608|3981180|B2||>=65 years|Age||Participants|Count of Participants|63|63.0||||||
4157807|NCT00842608|3981181|B1||>=65 years|Age||Participants|Count of Participants|62|62.0||||||
4157808|NCT00842608|3981177|B5||Between 18 and 65 years|Age||Participants|Count of Participants|342|342.0||||||
4157809|NCT00842608|3981178|B4||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4157810|NCT00842608|3981179|B3||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4157811|NCT00842608|3981180|B2||Between 18 and 65 years|Age||Participants|Count of Participants|114|114.0||||||
4157812|NCT00842608|3981181|B1||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
4157813|NCT00842608|3981177|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4157814|NCT00842608|3981178|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4157815|NCT00842608|3981179|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4157816|NCT00842608|3981180|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4157817|NCT00842608|3981181|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4157818|NCT00842543|3981202|B5|United States||Region of Enrollment||participants|Number|39|39.0||||||
4157819|NCT00842543|3981203|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
4157820|NCT00842543|3981204|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4157821|NCT00842543|3981205|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4157822|NCT00842543|3981206|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4157823|NCT00842543|3981202|B5||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4157824|NCT00842543|3981203|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4157825|NCT00842543|3981204|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4157826|NCT00842543|3981205|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4157827|NCT00842543|3981206|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4157828|NCT00842543|3981202|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4157829|NCT00842543|3981203|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4157830|NCT00842543|3981204|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4157831|NCT00842543|3981205|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4157832|NCT00842543|3981206|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4157833|NCT00842543|3981202|B5|||Age||years|Mean|9.145|9.145|Standard Deviation|1.39|1.39|||
4157834|NCT00842543|3981203|B4|||Age||years|Mean|9.28|9.28|Standard Deviation|1.48|1.48|||
4157835|NCT00842543|3981204|B3|||Age||years|Mean|9.35|9.35|Standard Deviation|1.41|1.41|||
4157836|NCT00842543|3981205|B2|||Age||years|Mean|9.48|9.48|Standard Deviation|1.17|1.17|||
4157837|NCT00842543|3981206|B1|||Age||years|Mean|8.73|8.73|Standard Deviation|1.44|1.44|||
4157838|NCT00842543|3981202|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4157839|NCT00842543|3981203|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4157840|NCT00842543|3981204|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4157841|NCT00842543|3981205|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4157842|NCT00842543|3981206|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4157843|NCT00842543|3981202|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4157844|NCT00842543|3981203|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4157845|NCT00842543|3981204|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4157846|NCT00842543|3981205|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4157847|NCT00842543|3981206|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4157848|NCT00842543|3981202|B5||<=18 years|Age||Participants|Count of Participants|39|39.0||||||
4157849|NCT00842543|3981203|B4||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4157850|NCT00842543|3981204|B3||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4157851|NCT00842543|3981205|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4157852|NCT00842543|3981206|B1||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4157853|NCT00842361|3981221|B3|||Body weight||kg|Mean|59.30|59.3|Standard Deviation|9.12|9.12|||
4157854|NCT00842361|3981222|B2|||Body weight||kg|Mean|57.32|57.32|Standard Deviation|7.94|7.94|||
4157855|NCT00842361|3981223|B1|||Body weight||kg|Mean|61.22|61.22|Standard Deviation|9.88|9.88|||
4157856|NCT00842361|3981221|B3|||Fasting plasma glucose (FPG)||mg/L|Mean|142.7|142.7|Standard Deviation|37.3|37.3|||
4157857|NCT00842361|3981222|B2|||Fasting plasma glucose (FPG)||mg/L|Mean|140.8|140.8|Standard Deviation|38.6|38.6|||
4157858|NCT00842361|3981223|B1|||Fasting plasma glucose (FPG)||mg/L|Mean|144.6|144.6|Standard Deviation|36.4|36.4|||
4157859|NCT00842361|3981221|B3|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|7.40|7.4|Standard Deviation|0.84|0.84|||
4157860|NCT00842361|3981222|B2|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|7.44|7.44|Standard Deviation|0.84|0.84|||
4157861|NCT00842361|3981223|B1|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|7.36|7.36|Standard Deviation|0.86|0.86|||
4157862|NCT00842361|3981221|B3||Male|Gender||Participants|Count of Participants|42|42.0||||||
4157863|NCT00842361|3981222|B2||Male|Gender||Participants|Count of Participants|18|18.0||||||
4157864|NCT00842361|3981223|B1||Male|Gender||Participants|Count of Participants|24|24.0||||||
4157865|NCT00842361|3981221|B3||Female|Gender||Participants|Count of Participants|23|23.0||||||
4157866|NCT00842361|3981222|B2||Female|Gender||Participants|Count of Participants|14|14.0||||||
4157867|NCT00842361|3981223|B1||Female|Gender||Participants|Count of Participants|9|9.0||||||
4157868|NCT00842361|3981221|B3|||Age||years|Mean|64.5|64.5|Standard Deviation|9.8|9.8|||
4157869|NCT00842361|3981222|B2|||Age||years|Mean|64.7|64.7|Standard Deviation|11.2|11.2|||
4157870|NCT00842361|3981223|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|8.4|8.4|||
4157871|NCT00842348|3981242|B3|Caucasian/White||Race/Ethnicity, Customized||participants|Number|85|85.0||||||
4157872|NCT00842348|3981243|B2|Caucasian/White||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4157873|NCT00842348|3981244|B1|Caucasian/White||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4157874|NCT00842348|3981242|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4157875|NCT00842348|3981243|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4157876|NCT00842348|3981244|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4157877|NCT00842348|3981242|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4157878|NCT00842348|3981243|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4157879|NCT00842348|3981244|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4157880|NCT00842348|3981242|B3||Male|Gender||Participants|Count of Participants|44|44.0||||||
4157881|NCT00842348|3981243|B2||Male|Gender||Participants|Count of Participants|25|25.0||||||
4157882|NCT00842348|3981244|B1||Male|Gender||Participants|Count of Participants|19|19.0||||||
4157883|NCT00842348|3981242|B3||Female|Gender||Participants|Count of Participants|45|45.0||||||
4157884|NCT00842348|3981243|B2||Female|Gender||Participants|Count of Participants|22|22.0||||||
4157885|NCT00842348|3981244|B1||Female|Gender||Participants|Count of Participants|23|23.0||||||
4157886|NCT00842348|3981242|B3|||Age||years|Mean|62.9|62.9|Standard Deviation|10.6|10.6|||
4157887|NCT00842348|3981243|B2|||Age||years|Mean|61.3|61.3|Standard Deviation|10.2|10.2|||
4157888|NCT00842348|3981244|B1|||Age||years|Mean|64.8|64.8|Standard Deviation|10.8|10.8|||
4157889|NCT00842335|3981255|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4157890|NCT00842335|3981255|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4157891|NCT00842335|3981255|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4157892|NCT00842335|3981255|B1|||Age||years|Mean|59.8|59.8|Standard Deviation|9.11|9.11|||
4157893|NCT00842335|3981255|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4157987|NCT00842023|3981374|B1|||Age||years|Mean|68.6|68.6|Standard Deviation|14.1|14.1|||
4157894|NCT00842335|3981255|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4157895|NCT00842335|3981255|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4157896|NCT00842296|3981262|B1|C6||CEAP|"CEAP (Clinical/Etiology/Anatomy/Pathophysiology) Clinical Score:~C0: No visible/palpable sign C1: Reticular spider veins C2: Simple varicose veins C3: Ankle edema C4: Skin pigmentation C5: Healed venous ulcer C6: Open venous ulcer~395 out of 396 limbs reported a Baseline CEAP score."|limbs|Number|2|2.0||||||
4157897|NCT00842296|3981262|B1|C5||CEAP|"CEAP (Clinical/Etiology/Anatomy/Pathophysiology) Clinical Score:~C0: No visible/palpable sign C1: Reticular spider veins C2: Simple varicose veins C3: Ankle edema C4: Skin pigmentation C5: Healed venous ulcer C6: Open venous ulcer~395 out of 396 limbs reported a Baseline CEAP score."|limbs|Number|4|4.0||||||
4157898|NCT00842296|3981262|B1|C4||CEAP|"CEAP (Clinical/Etiology/Anatomy/Pathophysiology) Clinical Score:~C0: No visible/palpable sign C1: Reticular spider veins C2: Simple varicose veins C3: Ankle edema C4: Skin pigmentation C5: Healed venous ulcer C6: Open venous ulcer~395 out of 396 limbs reported a Baseline CEAP score."|limbs|Number|60|60.0||||||
4157899|NCT00842296|3981262|B1|C3||CEAP|"CEAP (Clinical/Etiology/Anatomy/Pathophysiology) Clinical Score:~C0: No visible/palpable sign C1: Reticular spider veins C2: Simple varicose veins C3: Ankle edema C4: Skin pigmentation C5: Healed venous ulcer C6: Open venous ulcer~395 out of 396 limbs reported a Baseline CEAP score."|limbs|Number|110|110.0||||||
4157900|NCT00842296|3981262|B1|C2||CEAP|"CEAP (Clinical/Etiology/Anatomy/Pathophysiology) Clinical Score:~C0: No visible/palpable sign C1: Reticular spider veins C2: Simple varicose veins C3: Ankle edema C4: Skin pigmentation C5: Healed venous ulcer C6: Open venous ulcer~395 out of 396 limbs reported a Baseline CEAP score."|limbs|Number|213|213.0||||||
4157901|NCT00842296|3981262|B1|C1||CEAP|"CEAP (Clinical/Etiology/Anatomy/Pathophysiology) Clinical Score:~C0: No visible/palpable sign C1: Reticular spider veins C2: Simple varicose veins C3: Ankle edema C4: Skin pigmentation C5: Healed venous ulcer C6: Open venous ulcer~395 out of 396 limbs reported a Baseline CEAP score."|limbs|Number|5|5.0||||||
4157902|NCT00842296|3981262|B1|C0||CEAP|"CEAP (Clinical/Etiology/Anatomy/Pathophysiology) Clinical Score:~C0: No visible/palpable sign C1: Reticular spider veins C2: Simple varicose veins C3: Ankle edema C4: Skin pigmentation C5: Healed venous ulcer C6: Open venous ulcer~395 out of 396 limbs reported a Baseline CEAP score."|limbs|Number|1|1.0||||||
4157903|NCT00842296|3981262|B1|Europe||Region of Enrollment||participants|Number|225|225.0||||||
4157904|NCT00842296|3981262|B1|United States||Region of Enrollment||participants|Number|101|101.0||||||
4157905|NCT00842296|3981262|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4157906|NCT00842296|3981262|B1||Female|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
4157907|NCT00842296|3981262|B1|||Age||years|Mean|50.8|50.8|Standard Deviation|13.3|13.3|||
4157908|NCT00842257|3981288|B1|Bevacizumab||Prior therapy||participants|Number|17|17.0||||||
4157909|NCT00842257|3981288|B1|Irinotecan||Prior therapy||participants|Number|18|18.0||||||
4157910|NCT00842257|3981288|B1|Oxaliplatin||Prior therapy||participants|Number|19|19.0||||||
4157911|NCT00842257|3981288|B1|Flouropyrimidine||Prior therapy||participants|Number|20|20.0||||||
4157912|NCT00842257|3981288|B1|Cetuximab||Prior therapy||participants|Number|20|20.0||||||
4157913|NCT00842257|3981288|B1|Lymph Nodes||Metastatic sites||participants|Number|9|9.0||||||
4157914|NCT00842257|3981288|B1|Lung||Metastatic sites||participants|Number|11|11.0||||||
4157915|NCT00842257|3981288|B1|Liver||Metastatic sites||participants|Number|15|15.0||||||
4157916|NCT00842257|3981288|B1|Rectal||Primary tumor||Participants|Count of Participants|3|3.0||||||
4157917|NCT00842257|3981288|B1|Colon||Primary tumor||Participants|Count of Participants|17|17.0||||||
4157918|NCT00842257|3981288|B1|2||ECOG PS|"Eastern Cooperative Oncology Group Performance Status. 0 Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|Participants|Count of Participants|2|2.0||||||
4157919|NCT00842257|3981288|B1|1||ECOG PS|"Eastern Cooperative Oncology Group Performance Status. 0 Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|Participants|Count of Participants|14|14.0||||||
4157920|NCT00842257|3981288|B1|0||ECOG PS|"Eastern Cooperative Oncology Group Performance Status. 0 Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|Participants|Count of Participants|4|4.0||||||
4157921|NCT00842257|3981288|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4157922|NCT00842257|3981288|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4157923|NCT00842257|3981288|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4157924|NCT00842257|3981288|B1|||Age||years|Median|54.5|54.5|Full Range|||39.0|77.0|
4157925|NCT00842244|3981295|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4157926|NCT00842244|3981295|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4157927|NCT00842244|3981295|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|11.5|11.5|||
4157928|NCT00842231|3981314|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4157929|NCT00842231|3981314|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4157988|NCT00842023|3981372|B3||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
4157930|NCT00842231|3981314|B1|||Age, Customized|All patients were within the study inclusion/exclusion criteria and were within the ages of 50 and 75. No other specific age data is available.|Participants|Number|40|40.0||||||
4157931|NCT00842153|3981320|B3|Other (not included above; including mixed race)||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4157932|NCT00842153|3981321|B2|Other (not included above; including mixed race)||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4157933|NCT00842153|3981322|B1|Other (not included above; including mixed race)||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4157934|NCT00842153|3981320|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4157935|NCT00842153|3981321|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4157936|NCT00842153|3981322|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4157937|NCT00842153|3981320|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4157938|NCT00842153|3981321|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4157939|NCT00842153|3981322|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4157940|NCT00842153|3981320|B3|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4157941|NCT00842153|3981321|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4157942|NCT00842153|3981322|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4157943|NCT00842153|3981320|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4157944|NCT00842153|3981321|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4157945|NCT00842153|3981322|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4157946|NCT00842153|3981320|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4157947|NCT00842153|3981321|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4157948|NCT00842153|3981322|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4157949|NCT00842153|3981320|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4157950|NCT00842153|3981321|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4157951|NCT00842153|3981322|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4157952|NCT00842153|3981320|B3|||Age||Years|Mean|50.6|50.6|Standard Deviation|17.1|17.1|||
4157953|NCT00842153|3981321|B2|||Age||Years|Mean|47.2|47.2|Standard Deviation|13.4|13.4|||
4157954|NCT00842153|3981322|B1|||Age||Years|Mean|54.2|54.2|Standard Deviation|20.0|20.0|||
4157955|NCT00842075|3981361|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4157956|NCT00842075|3981362|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4157957|NCT00842075|3981363|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4157958|NCT00842075|3981361|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4157959|NCT00842075|3981362|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4157960|NCT00842075|3981363|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4157961|NCT00842075|3981361|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4157962|NCT00842075|3981362|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4157963|NCT00842075|3981363|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4157964|NCT00842075|3981361|B3|||Age||years|Mean|15|15.0|Standard Deviation|2|2.0|||
4157965|NCT00842075|3981362|B2|||Age||years|Mean|NA||Standard Deviation|NA||||study results do not report this
4157966|NCT00842075|3981363|B1|||Age||years|Mean|NA||Standard Deviation|NA||||study results do not report this
4157967|NCT00842075|3981361|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4157968|NCT00842075|3981362|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4157969|NCT00842075|3981363|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4157970|NCT00842075|3981361|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4157971|NCT00842075|3981362|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4157972|NCT00842075|3981363|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4157973|NCT00842075|3981361|B3||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4157974|NCT00842075|3981362|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4157975|NCT00842075|3981363|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4157976|NCT00842023|3981372|B3|United States||Region of Enrollment|Sample size was estimated at 90 patients total; however, 1 patient was enrolled twice. Therefore, only 89 patients were enrolled in the primary study.|participants|Number|89|89.0||||||
4157977|NCT00842023|3981373|B2|United States||Region of Enrollment|Sample size was estimated at 90 patients total; however, 1 patient was enrolled twice. Therefore, only 89 patients were enrolled in the primary study.|participants|Number|44|44.0||||||
4157978|NCT00842023|3981374|B1|United States||Region of Enrollment|Sample size was estimated at 90 patients total; however, 1 patient was enrolled twice. Therefore, only 89 patients were enrolled in the primary study.|participants|Number|45|45.0||||||
4157979|NCT00842023|3981372|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4157980|NCT00842023|3981373|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4157981|NCT00842023|3981374|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4157982|NCT00842023|3981372|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4157983|NCT00842023|3981373|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4157984|NCT00842023|3981374|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4157985|NCT00842023|3981372|B3|||Age||years|Mean|67.7|67.7|Standard Deviation|16.7|16.7|||
4157986|NCT00842023|3981373|B2|||Age||years|Mean|66.8|66.8|Standard Deviation|17.2|17.2|||
4157989|NCT00842023|3981373|B2||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4157990|NCT00842023|3981374|B1||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4157991|NCT00842023|3981372|B3||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4157992|NCT00842023|3981373|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4157993|NCT00842023|3981374|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4157994|NCT00842023|3981372|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4157995|NCT00842023|3981373|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4157996|NCT00842023|3981374|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4157997|NCT00841971|3981385|B3|United States||Region of Enrollment||participants|Number|200|200.0||||||
4157998|NCT00841971|3981386|B2|United States||Region of Enrollment||participants|Number|100|100.0||||||
4157999|NCT00841971|3981387|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
4158000|NCT00841971|3981385|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158001|NCT00841971|3981386|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158002|NCT00841971|3981387|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158003|NCT00841971|3981385|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|135|135.0||||||
4158004|NCT00841971|3981386|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4158005|NCT00841971|3981387|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
4158006|NCT00841971|3981385|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4158007|NCT00841971|3981386|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4158008|NCT00841971|3981387|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4158009|NCT00841971|3981385|B3||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4158010|NCT00841971|3981386|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4158011|NCT00841971|3981387|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4158012|NCT00841971|3981385|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4158013|NCT00841971|3981386|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4158014|NCT00841971|3981387|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4158015|NCT00841971|3981385|B3|||Age||years|Median|58|58.0|Inter-Quartile Range|||52.0|62.0|
4158016|NCT00841971|3981386|B2|||Age||years|Median|58|58.0|Inter-Quartile Range|||51.0|62.0|
4158017|NCT00841971|3981387|B1|||Age||years|Median|58|58.0|Inter-Quartile Range|||52.0|62.0|
4158018|NCT00841971|3981385|B3||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4158019|NCT00841971|3981386|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4158020|NCT00841971|3981387|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4158021|NCT00841971|3981385|B3||Between 18 and 65 years|Age||Participants|Count of Participants|178|178.0||||||
4158022|NCT00841971|3981386|B2||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
4158023|NCT00841971|3981387|B1||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
4158024|NCT00841971|3981385|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158025|NCT00841971|3981386|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158026|NCT00841971|3981387|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158027|NCT00841906|3981396|B3|Non-Smokers||Smoking Status||participants|Number|23|23.0||||||
4158028|NCT00841906|3981397|B2|Non-Smokers||Smoking Status||participants|Number|9|9.0||||||
4158029|NCT00841906|3981398|B1|Non-Smokers||Smoking Status||participants|Number|16|16.0||||||
4158030|NCT00841906|3981396|B3|Smokers||Smoking Status||participants|Number|7|7.0||||||
4158031|NCT00841906|3981397|B2|Smokers||Smoking Status||participants|Number|5|5.0||||||
4158032|NCT00841906|3981398|B1|Smokers||Smoking Status||participants|Number|2|2.0||||||
4158033|NCT00841906|3981396|B3|||Body Mass Index||kg/m^2|Mean|34.2|34.2|Standard Deviation|7.9|7.9|||
4158034|NCT00841906|3981397|B2|||Body Mass Index||kg/m^2|Mean|32.6|32.6|Standard Deviation|6.6|6.6|||
4158035|NCT00841906|3981398|B1|||Body Mass Index||kg/m^2|Mean|35.4|35.4|Standard Deviation|8.8|8.8|||
4158036|NCT00841906|3981396|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4158037|NCT00841906|3981397|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4158038|NCT00841906|3981398|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4158039|NCT00841906|3981396|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158040|NCT00841906|3981397|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158041|NCT00841906|3981398|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158042|NCT00841906|3981396|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158043|NCT00841906|3981397|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158044|NCT00841906|3981398|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158045|NCT00841906|3981396|B3||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4158046|NCT00841906|3981397|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4158047|NCT00841906|3981398|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4158048|NCT00841906|3981396|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4158049|NCT00841906|3981397|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158050|NCT00841906|3981398|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4158051|NCT00841906|3981396|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158052|NCT00841906|3981397|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158053|NCT00841906|3981398|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158054|NCT00841906|3981396|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158055|NCT00841906|3981397|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158056|NCT00841906|3981398|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158057|NCT00841906|3981396|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158058|NCT00841906|3981397|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158059|NCT00841906|3981398|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158060|NCT00841906|3981396|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4158061|NCT00841906|3981397|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4158062|NCT00841906|3981398|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4158063|NCT00841906|3981396|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4158064|NCT00841906|3981397|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4158065|NCT00841906|3981398|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4158066|NCT00841906|3981396|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4158067|NCT00841906|3981397|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158068|NCT00841906|3981398|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4158069|NCT00841906|3981396|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4158070|NCT00841906|3981397|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4158071|NCT00841906|3981398|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4158072|NCT00841906|3981396|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158073|NCT00841906|3981397|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158074|NCT00841906|3981398|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158075|NCT00841828|3981411|B3|N2=metastases in 4-9 axillary lymph nodes||Nodal Status||participants|Number|3|3.0||||||
4158076|NCT00841828|3981412|B2|N2=metastases in 4-9 axillary lymph nodes||Nodal Status||participants|Number|2|2.0||||||
4158077|NCT00841828|3981413|B1|N2=metastases in 4-9 axillary lymph nodes||Nodal Status||participants|Number|1|1.0||||||
4158078|NCT00841828|3981411|B3|N1=metastases 1-3 axillary lymph node/s||Nodal Status||participants|Number|67|67.0||||||
4158079|NCT00841828|3981412|B2|N1=metastases 1-3 axillary lymph node/s||Nodal Status||participants|Number|35|35.0||||||
4158080|NCT00841828|3981413|B1|N1=metastases 1-3 axillary lymph node/s||Nodal Status||participants|Number|32|32.0||||||
4158081|NCT00841828|3981411|B3|N0=no regional lymph node metastases||Nodal Status||participants|Number|32|32.0||||||
4158082|NCT00841828|3981412|B2|N0=no regional lymph node metastases||Nodal Status||participants|Number|13|13.0||||||
4158083|NCT00841828|3981413|B1|N0=no regional lymph node metastases||Nodal Status||participants|Number|19|19.0||||||
4158084|NCT00841828|3981411|B3|||Tumor Size||centemetres|Median|3.3|3.3|Full Range|||1.0|15.8|
4158085|NCT00841828|3981412|B2|||Tumor Size||centemetres|Median|3.3|3.3|Full Range|||1.0|10.0|
4158086|NCT00841828|3981413|B1|||Tumor Size||centemetres|Median|3.5|3.5|Full Range|||1.0|15.8|
4158087|NCT00841828|3981411|B3|Negative||Estrogen Receptor||participants|Number|43|43.0||||||
4158088|NCT00841828|3981412|B2|Negative||Estrogen Receptor||participants|Number|20|20.0||||||
4158089|NCT00841828|3981413|B1|Negative||Estrogen Receptor||participants|Number|23|23.0||||||
4158090|NCT00841828|3981411|B3|Positive||Estrogen Receptor||participants|Number|59|59.0||||||
4158091|NCT00841828|3981412|B2|Positive||Estrogen Receptor||participants|Number|30|30.0||||||
4158092|NCT00841828|3981413|B1|Positive||Estrogen Receptor||participants|Number|29|29.0||||||
4158093|NCT00841828|3981411|B3|Postmenopausal||Menopausal Status||participants|Number|45|45.0||||||
4158094|NCT00841828|3981412|B2|Postmenopausal||Menopausal Status||participants|Number|21|21.0||||||
4158095|NCT00841828|3981413|B1|Postmenopausal||Menopausal Status||participants|Number|24|24.0||||||
4158096|NCT00841828|3981411|B3|Premenopausal||Menopausal Status||participants|Number|57|57.0||||||
4158097|NCT00841828|3981412|B2|Premenopausal||Menopausal Status||participants|Number|29|29.0||||||
4158098|NCT00841828|3981413|B1|Premenopausal||Menopausal Status||participants|Number|28|28.0||||||
4158099|NCT00841828|3981411|B3|Spain||Region of Enrollment||participants|Number|102|102.0||||||
4158100|NCT00841828|3981412|B2|Spain||Region of Enrollment||participants|Number|50|50.0||||||
4158101|NCT00841828|3981413|B1|Spain||Region of Enrollment||participants|Number|52|52.0||||||
4158102|NCT00841828|3981411|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4158103|NCT00841828|3981412|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4158104|NCT00841828|3981413|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4158105|NCT00841828|3981411|B3||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4158106|NCT00841828|3981412|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4158107|NCT00841828|3981413|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4158108|NCT00841828|3981411|B3|||Age||years|Median|48|48.0|Full Range|||30.0|79.0|
4158109|NCT00841828|3981412|B2|||Age||years|Median|48.5|48.5|Full Range|||32.0|74.0|
4158110|NCT00841828|3981413|B1|||Age||years|Median|48|48.0|Full Range|||30.0|79.0|
4158111|NCT00841815|3981422|B3|Canada||Region of Enrollment||participants|Number|28|28.0||||||
4158112|NCT00841815|3981423|B2|Canada||Region of Enrollment||participants|Number|14|14.0||||||
4158113|NCT00841815|3981424|B1|Canada||Region of Enrollment||participants|Number|14|14.0||||||
4158114|NCT00841815|3981422|B3|Black||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4158115|NCT00841815|3981423|B2|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4158116|NCT00841815|3981424|B1|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4158117|NCT00841815|3981422|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4158118|NCT00841815|3981423|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4158119|NCT00841815|3981424|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4158120|NCT00841815|3981422|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
4158121|NCT00841815|3981423|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4158122|NCT00841815|3981424|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4158123|NCT00841815|3981422|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4158124|NCT00841815|3981423|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4158125|NCT00841815|3981424|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4158126|NCT00841815|3981422|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4158127|NCT00841815|3981423|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4158128|NCT00841815|3981424|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4158129|NCT00841815|3981422|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158130|NCT00841815|3981423|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158131|NCT00841815|3981424|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158132|NCT00841815|3981422|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4158133|NCT00841815|3981423|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4158134|NCT00841815|3981424|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4158135|NCT00841815|3981422|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158136|NCT00841815|3981423|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158137|NCT00841815|3981424|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158138|NCT00841776|3981433|B3|||Propionibacterium acne counts|Mean colony forming unit P. acne counts|P. acne counts|Mean|4.69|4.69|Standard Deviation|0.88|0.88|||
4158139|NCT00841776|3981434|B2|||Propionibacterium acne counts|Mean colony forming unit P. acne counts|P. acne counts|Mean|4.74|4.74|Standard Deviation|0.58|0.58|||
4158140|NCT00841776|3981435|B1|||Propionibacterium acne counts|Mean colony forming unit P. acne counts|P. acne counts|Mean|4.63|4.63|Standard Deviation|1.12|1.12|||
4158141|NCT00841776|3981433|B3|||Erythromycin-resistant lesion count|Erythromycin-resistant Colony forming Unit lesion count|Erythromycin-resistant lesion count|Mean|2.10|2.1|Standard Deviation|1.25|1.25|||
4158142|NCT00841776|3981434|B2|||Erythromycin-resistant lesion count|Erythromycin-resistant Colony forming Unit lesion count|Erythromycin-resistant lesion count|Mean|1.92|1.92|Standard Deviation|1.11|1.11|||
4158143|NCT00841776|3981435|B1|||Erythromycin-resistant lesion count|Erythromycin-resistant Colony forming Unit lesion count|Erythromycin-resistant lesion count|Mean|2.29|2.29|Standard Deviation|1.37|1.37|||
4158144|NCT00841776|3981433|B3|||Clinidamycin-resistant propionibacterium acne (P.acne) counts|Clinidamycin-resistant Colony Forming Unit Propionibacterium acne counts|Clinidamycin-resistant p. acne counts|Mean|2.16|2.16|Standard Deviation|1.27|1.27|||
4158145|NCT00841776|3981434|B2|||Clinidamycin-resistant propionibacterium acne (P.acne) counts|Clinidamycin-resistant Colony Forming Unit Propionibacterium acne counts|Clinidamycin-resistant p. acne counts|Mean|2.02|2.02|Standard Deviation|1.21|1.21|||
4158146|NCT00841776|3981435|B1|||Clinidamycin-resistant propionibacterium acne (P.acne) counts|Clinidamycin-resistant Colony Forming Unit Propionibacterium acne counts|Clinidamycin-resistant p. acne counts|Mean|2.29|2.29|Standard Deviation|1.34|1.34|||
4158147|NCT00841776|3981433|B3|Total Lesion Counts||Acne Lesion Counts|P. acne Lesion Counts|Acne Lesion Counts|Mean|58.46|58.46|Standard Deviation|21.72|21.72|||
4158148|NCT00841776|3981434|B2|Total Lesion Counts||Acne Lesion Counts|P. acne Lesion Counts|Acne Lesion Counts|Mean|57.89|57.89|Standard Deviation|19.99|19.99|||
4158149|NCT00841776|3981435|B1|Total Lesion Counts||Acne Lesion Counts|P. acne Lesion Counts|Acne Lesion Counts|Mean|59.04|59.04|Standard Deviation|23.68|23.68|||
4158150|NCT00841776|3981433|B3|Noninflammatory Lesion Counts||Acne Lesion Counts|P. acne Lesion Counts|Acne Lesion Counts|Mean|34.70|34.7|Standard Deviation|17.90|17.9|||
4158151|NCT00841776|3981434|B2|Noninflammatory Lesion Counts||Acne Lesion Counts|P. acne Lesion Counts|Acne Lesion Counts|Mean|35.11|35.11|Standard Deviation|15.40|15.4|||
4158152|NCT00841776|3981435|B1|Noninflammatory Lesion Counts||Acne Lesion Counts|P. acne Lesion Counts|Acne Lesion Counts|Mean|34.30|34.3|Standard Deviation|20.38|20.38|||
4158153|NCT00841776|3981433|B3|Inflammatory Lesion Counts||Acne Lesion Counts|P. acne Lesion Counts|Acne Lesion Counts|Mean|23.76|23.76|Standard Deviation|8.98|8.98|||
4158154|NCT00841776|3981434|B2|Inflammatory Lesion Counts||Acne Lesion Counts|P. acne Lesion Counts|Acne Lesion Counts|Mean|22.78|22.78|Standard Deviation|7.07|7.07|||
4158155|NCT00841776|3981435|B1|Inflammatory Lesion Counts||Acne Lesion Counts|P. acne Lesion Counts|Acne Lesion Counts|Mean|24.74|24.74|Standard Deviation|10.61|10.61|||
4158156|NCT00841776|3981433|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
4158157|NCT00841776|3981434|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4158158|NCT00841776|3981435|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4158159|NCT00841776|3981433|B3|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4158160|NCT00841776|3981434|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4158161|NCT00841776|3981435|B1|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4158162|NCT00841776|3981433|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4158163|NCT00841776|3981434|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4158164|NCT00841776|3981435|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4158165|NCT00841776|3981433|B3|Black||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4158166|NCT00841776|3981434|B2|Black||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4158167|NCT00841776|3981435|B1|Black||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4158168|NCT00841776|3981433|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|43|43.0||||||
4158169|NCT00841776|3981434|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4158170|NCT00841776|3981435|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
4158171|NCT00841776|3981433|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4158172|NCT00841776|3981434|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4158173|NCT00841776|3981435|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4158174|NCT00841776|3981433|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4158175|NCT00841776|3981434|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4158176|NCT00841776|3981435|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4158177|NCT00841776|3981433|B3|||Age||years|Mean|16.9|16.9|Standard Deviation|6.0|6.0|||
4158178|NCT00841776|3981434|B2|||Age||years|Mean|16.2|16.2|Standard Deviation|4.9|4.9|||
4158179|NCT00841776|3981435|B1|||Age||years|Mean|17.6|17.6|Standard Deviation|6.9|6.9|||
4158180|NCT00841763|3981452|B3|Male(>60 yrs; N= 110, 28)||Sex/Gender, Customized||Subjects|Number|138|138.0||||||
4158181|NCT00841763|3981453|B2|Male(>60 yrs; N= 110, 28)||Sex/Gender, Customized||Subjects|Number|28|28.0||||||
4158182|NCT00841763|3981454|B1|Male(>60 yrs; N= 110, 28)||Sex/Gender, Customized||Subjects|Number|110|110.0||||||
4158183|NCT00841763|3981452|B3|Female (>60 yrs; N= 109; 28)||Sex/Gender, Customized||Subjects|Number|137|137.0||||||
4158184|NCT00841763|3981453|B2|Female (>60 yrs; N= 109; 28)||Sex/Gender, Customized||Subjects|Number|28|28.0||||||
4158185|NCT00841763|3981454|B1|Female (>60 yrs; N= 109; 28)||Sex/Gender, Customized||Subjects|Number|109|109.0||||||
4158186|NCT00841763|3981452|B3|Male(<=60 yrs)||Sex/Gender, Customized||Subjects|Number|1481|1481.0||||||
4158187|NCT00841763|3981453|B2|Male(<=60 yrs)||Sex/Gender, Customized||Subjects|Number|291|291.0||||||
4158188|NCT00841763|3981454|B1|Male(<=60 yrs)||Sex/Gender, Customized||Subjects|Number|1190|1190.0||||||
4158189|NCT00841763|3981452|B3|Female (<=60 yrs)||Sex/Gender, Customized||Subjects|Number|1890|1890.0||||||
4158190|NCT00841763|3981453|B2|Female (<=60 yrs)||Sex/Gender, Customized||Subjects|Number|388|388.0||||||
4158191|NCT00841763|3981454|B1|Female (<=60 yrs)||Sex/Gender, Customized||Subjects|Number|1502|1502.0||||||
4158192|NCT00841763|3981452|B3|>60 years (N=196, 50)||Age, Customized|The number of subjects analyzed is not consistent with the Participant Flow module due to randomization errors. The enrolled set as randomized is reported in the Participant Flow Module but in the Baseline Measure module, the enrolled set as treated is reported (2 randomization errors so 2 subjects were changed from the TIV+aH5N1 group to the PL+aTIV group). Moreover, a subset to the enrolled population as treated excluded the one subject who was not vaccinated.|years|Mean|61.9|61.9|Standard Deviation|1.5|1.5|||
4158193|NCT00841763|3981453|B2|>60 years (N=196, 50)||Age, Customized|The number of subjects analyzed is not consistent with the Participant Flow module due to randomization errors. The enrolled set as randomized is reported in the Participant Flow Module but in the Baseline Measure module, the enrolled set as treated is reported (2 randomization errors so 2 subjects were changed from the TIV+aH5N1 group to the PL+aTIV group). Moreover, a subset to the enrolled population as treated excluded the one subject who was not vaccinated.|years|Mean|62.1|62.1|Standard Deviation|1.8|1.8|||
4158194|NCT00841763|3981454|B1|>60 years (N=196, 50)||Age, Customized|The number of subjects analyzed is not consistent with the Participant Flow module due to randomization errors. The enrolled set as randomized is reported in the Participant Flow Module but in the Baseline Measure module, the enrolled set as treated is reported (2 randomization errors so 2 subjects were changed from the TIV+aH5N1 group to the PL+aTIV group). Moreover, a subset to the enrolled population as treated excluded the one subject who was not vaccinated.|years|Mean|61.9|61.9|Standard Deviation|1.4|1.4|||
4158195|NCT00841763|3981452|B3|<= 60 years||Age, Customized|The number of subjects analyzed is not consistent with the Participant Flow module due to randomization errors. The enrolled set as randomized is reported in the Participant Flow Module but in the Baseline Measure module, the enrolled set as treated is reported (2 randomization errors so 2 subjects were changed from the TIV+aH5N1 group to the PL+aTIV group). Moreover, a subset to the enrolled population as treated excluded the one subject who was not vaccinated.|years|Mean|40.7|40.7|Standard Deviation|11.7|11.7|||
4158196|NCT00841763|3981453|B2|<= 60 years||Age, Customized|The number of subjects analyzed is not consistent with the Participant Flow module due to randomization errors. The enrolled set as randomized is reported in the Participant Flow Module but in the Baseline Measure module, the enrolled set as treated is reported (2 randomization errors so 2 subjects were changed from the TIV+aH5N1 group to the PL+aTIV group). Moreover, a subset to the enrolled population as treated excluded the one subject who was not vaccinated.|years|Mean|40.5|40.5|Standard Deviation|12.0|12.0|||
4158197|NCT00841763|3981454|B1|<= 60 years||Age, Customized|The number of subjects analyzed is not consistent with the Participant Flow module due to randomization errors. The enrolled set as randomized is reported in the Participant Flow Module but in the Baseline Measure module, the enrolled set as treated is reported (2 randomization errors so 2 subjects were changed from the TIV+aH5N1 group to the PL+aTIV group). Moreover, a subset to the enrolled population as treated excluded the one subject who was not vaccinated.|years|Mean|40.7|40.7|Standard Deviation|11.6|11.6|||
4158198|NCT00841698|3981517|B3|Canada||Region of Enrollment||participants|Number|50|50.0||||||
4158199|NCT00841698|3981518|B2|Canada||Region of Enrollment||participants|Number|25|25.0||||||
4158200|NCT00841698|3981519|B1|Canada||Region of Enrollment||participants|Number|25|25.0||||||
4158201|NCT00841698|3981517|B3|American Hispanic||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4158202|NCT00841698|3981518|B2|American Hispanic||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4158203|NCT00841698|3981519|B1|American Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4158204|NCT00841698|3981517|B3|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4158205|NCT00841698|3981518|B2|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4158206|NCT00841698|3981519|B1|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4158207|NCT00841698|3981517|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|46|46.0||||||
4158208|NCT00841698|3981518|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4158209|NCT00841698|3981519|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
4158210|NCT00841698|3981517|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4158211|NCT00841698|3981518|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4158212|NCT00841698|3981519|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4158213|NCT00841698|3981517|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4158214|NCT00841698|3981518|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4158215|NCT00841698|3981519|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4158216|NCT00841698|3981517|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158217|NCT00841698|3981518|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158218|NCT00841698|3981519|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158219|NCT00841698|3981517|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4158220|NCT00841698|3981518|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4158221|NCT00841698|3981519|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4158222|NCT00841698|3981517|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158223|NCT00841698|3981518|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158224|NCT00841698|3981519|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158225|NCT00841672|3981528|B3||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4158226|NCT00841672|3981529|B2||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4158227|NCT00841672|3981530|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4158228|NCT00841672|3981528|B3||Female|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4158229|NCT00841672|3981529|B2||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4158230|NCT00841672|3981530|B1||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4158231|NCT00841672|3981528|B3|||Age||years|Mean|59|59.0|Standard Deviation|10.60|10.6|||
4158232|NCT00841672|3981529|B2|||Age||years|Mean|59|59.0|Standard Deviation|10.82|10.82|||
4158233|NCT00841672|3981530|B1|||Age||years|Mean|59|59.0|Standard Deviation|10.38|10.38|||
4158234|NCT00841659|3981545|B3|Canada||Region of Enrollment||participants|Number|24|24.0||||||
4158235|NCT00841659|3981546|B2|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4158236|NCT00841659|3981547|B1|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4158237|NCT00841659|3981545|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4158238|NCT00841659|3981546|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4158239|NCT00841659|3981547|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4158240|NCT00841659|3981545|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
4158241|NCT00841659|3981546|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4158242|NCT00841659|3981547|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4158243|NCT00841659|3981545|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4158244|NCT00841659|3981546|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4158245|NCT00841659|3981547|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4158246|NCT00841659|3981545|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4158247|NCT00841659|3981546|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4158248|NCT00841659|3981547|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4158249|NCT00841659|3981545|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158250|NCT00841659|3981546|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158251|NCT00841659|3981547|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158252|NCT00841659|3981545|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4158253|NCT00841659|3981546|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4158254|NCT00841659|3981547|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4158255|NCT00841659|3981545|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158256|NCT00841659|3981546|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158257|NCT00841659|3981547|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158258|NCT00841568|3981556|B1|Japan||Region of Enrollment||participants|Number|17|17.0||||||
4158259|NCT00841568|3981556|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4158260|NCT00841568|3981556|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4158261|NCT00841568|3981556|B1|||Age||years|Mean|41.8|41.8|Standard Deviation|8.6|8.6|||
4158262|NCT00841568|3981556|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158263|NCT00841568|3981556|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4158264|NCT00841568|3981556|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158265|NCT00841555|3981569|B4|United States||Region of Enrollment||patients|Number|9|9.0||||||
4158266|NCT00841555|3981570|B3|United States||Region of Enrollment||patients|Number|3|3.0||||||
4158267|NCT00841555|3981571|B2|United States||Region of Enrollment||patients|Number|3|3.0||||||
4158268|NCT00841555|3981572|B1|United States||Region of Enrollment||patients|Number|3|3.0||||||
4158269|NCT00841555|3981569|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158270|NCT00841555|3981570|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158271|NCT00841555|3981571|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158272|NCT00841555|3981572|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158273|NCT00841555|3981569|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158274|NCT00841555|3981570|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158275|NCT00841555|3981571|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158276|NCT00841555|3981572|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158277|NCT00841555|3981569|B4||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4158278|NCT00841555|3981570|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4158279|NCT00841555|3981571|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4158280|NCT00841555|3981572|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4158281|NCT00841555|3981569|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158282|NCT00841555|3981570|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158283|NCT00841555|3981571|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158284|NCT00841555|3981572|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158285|NCT00841555|3981569|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158286|NCT00841555|3981570|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158287|NCT00841555|3981571|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158288|NCT00841555|3981572|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158289|NCT00841555|3981569|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158290|NCT00841555|3981570|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158291|NCT00841555|3981571|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158292|NCT00841555|3981572|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158293|NCT00841555|3981569|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158294|NCT00841555|3981570|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158295|NCT00841555|3981571|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158296|NCT00841555|3981572|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158297|NCT00841555|3981569|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158298|NCT00841555|3981570|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158299|NCT00841555|3981571|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158300|NCT00841555|3981572|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158301|NCT00841555|3981569|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4158302|NCT00841555|3981570|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4158303|NCT00841555|3981571|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4158304|NCT00841555|3981572|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4158305|NCT00841555|3981569|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158306|NCT00841555|3981570|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158307|NCT00841555|3981571|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158308|NCT00841555|3981572|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158309|NCT00841555|3981569|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4158310|NCT00841555|3981570|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4158311|NCT00841555|3981571|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4158312|NCT00841555|3981572|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4158313|NCT00841555|3981569|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4158314|NCT00841555|3981570|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4158315|NCT00841555|3981571|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4158316|NCT00841555|3981572|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4158317|NCT00841555|3981569|B4||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4158318|NCT00841555|3981570|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4158319|NCT00841555|3981571|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4158320|NCT00841555|3981572|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4158321|NCT00841555|3981569|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4158322|NCT00841555|3981570|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4158323|NCT00841555|3981571|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4158324|NCT00841555|3981572|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4158325|NCT00841555|3981569|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158326|NCT00841555|3981570|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158327|NCT00841555|3981571|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158328|NCT00841555|3981572|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158329|NCT00841542|3981582|B3|Canada||Region of Enrollment||participants|Number|28|28.0||||||
4158330|NCT00841542|3981583|B2|Canada||Region of Enrollment||participants|Number|14|14.0||||||
4158331|NCT00841542|3981584|B1|Canada||Region of Enrollment||participants|Number|14|14.0||||||
4158332|NCT00841542|3981582|B3|Mulatto||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4158333|NCT00841542|3981583|B2|Mulatto||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4158334|NCT00841542|3981584|B1|Mulatto||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4158335|NCT00841542|3981582|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4158336|NCT00841542|3981583|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4158337|NCT00841542|3981584|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4158338|NCT00841542|3981582|B3|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4158339|NCT00841542|3981583|B2|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4158340|NCT00841542|3981584|B1|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4158341|NCT00841542|3981582|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
4158342|NCT00841542|3981583|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4158343|NCT00841542|3981584|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4158344|NCT00841542|3981582|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4158345|NCT00841542|3981583|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4158346|NCT00841542|3981584|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4158347|NCT00841542|3981582|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4158348|NCT00841542|3981583|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4158349|NCT00841542|3981584|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4158350|NCT00841542|3981582|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158351|NCT00841542|3981583|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158352|NCT00841542|3981584|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158353|NCT00841542|3981582|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4158354|NCT00841542|3981583|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4158355|NCT00841542|3981584|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4158356|NCT00841542|3981582|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158357|NCT00841542|3981583|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158358|NCT00841542|3981584|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158359|NCT00841412|3981593|B1|United States||Region of Enrollment||participants|Number|200|200.0||||||
4158360|NCT00841412|3981593|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158361|NCT00841412|3981593|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158362|NCT00841412|3981593|B1||White|Race (NIH/OMB)||Participants|Count of Participants|171|171.0||||||
4158363|NCT00841412|3981593|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4158364|NCT00841412|3981593|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158365|NCT00841412|3981593|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158366|NCT00841412|3981593|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158367|NCT00841412|3981593|B1||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4158368|NCT00841412|3981593|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4158369|NCT00841412|3981593|B1|||Age||years|Mean|76.00|76.0|Standard Deviation|11.97|11.97|||
4158370|NCT00841321|3981598|B3|Secondary Progressive MS||Type of Multiple Sclerosis||Participants|Number|33|33.0||||||
4158371|NCT00841321|3981599|B2|Secondary Progressive MS||Type of Multiple Sclerosis||Participants|Number|14|14.0||||||
4158372|NCT00841321|3981600|B1|Secondary Progressive MS||Type of Multiple Sclerosis||Participants|Number|19|19.0||||||
4158373|NCT00841321|3981598|B3|Relapsing Remitting MS||Type of Multiple Sclerosis||Participants|Number|77|77.0||||||
4158374|NCT00841321|3981599|B2|Relapsing Remitting MS||Type of Multiple Sclerosis||Participants|Number|42|42.0||||||
4158375|NCT00841321|3981600|B1|Relapsing Remitting MS||Type of Multiple Sclerosis||Participants|Number|35|35.0||||||
4158376|NCT00841321|3981598|B3|Progressive Remitting MS||Type of Multiple Sclerosis||Participants|Number|1|1.0||||||
4158377|NCT00841321|3981599|B2|Progressive Remitting MS||Type of Multiple Sclerosis||Participants|Number|0|0.0||||||
4158378|NCT00841321|3981600|B1|Progressive Remitting MS||Type of Multiple Sclerosis||Participants|Number|1|1.0||||||
4158379|NCT00841321|3981598|B3|Primary Progressive MS||Type of Multiple Sclerosis||Participants|Number|9|9.0||||||
4158380|NCT00841321|3981599|B2|Primary Progressive MS||Type of Multiple Sclerosis||Participants|Number|5|5.0||||||
4158381|NCT00841321|3981600|B1|Primary Progressive MS||Type of Multiple Sclerosis||Participants|Number|4|4.0||||||
4158382|NCT00841321|3981598|B3|||Expanded Disability Status Scale|"0:Normal~No disability(dis) 1.5:(min)signs~Min dis~Moderate(mod) dis~Amb no aid>=500 m 4.5:>=300 m~>=200 m 5.5:>=100 m~Amb unilateral aid>=100 m 6.5:Amb bilateral aid>=20 m~Amb < 5 m 7.5:Unable to take few steps~Bedbound, uses of arms 8.5:Bedbound some use of arms & some self care~Helpless in bed 9.5:Unable to communicate/eat/swallow~Dead"|units on a scale|Mean|4|4.0|Standard Deviation|2|2.0|||
4158383|NCT00841321|3981599|B2|||Expanded Disability Status Scale|"0:Normal~No disability(dis) 1.5:(min)signs~Min dis~Moderate(mod) dis~Amb no aid>=500 m 4.5:>=300 m~>=200 m 5.5:>=100 m~Amb unilateral aid>=100 m 6.5:Amb bilateral aid>=20 m~Amb < 5 m 7.5:Unable to take few steps~Bedbound, uses of arms 8.5:Bedbound some use of arms & some self care~Helpless in bed 9.5:Unable to communicate/eat/swallow~Dead"|units on a scale|Mean|4|4.0|Standard Deviation|2|2.0|||
4158384|NCT00841321|3981600|B1|||Expanded Disability Status Scale|"0:Normal~No disability(dis) 1.5:(min)signs~Min dis~Moderate(mod) dis~Amb no aid>=500 m 4.5:>=300 m~>=200 m 5.5:>=100 m~Amb unilateral aid>=100 m 6.5:Amb bilateral aid>=20 m~Amb < 5 m 7.5:Unable to take few steps~Bedbound, uses of arms 8.5:Bedbound some use of arms & some self care~Helpless in bed 9.5:Unable to communicate/eat/swallow~Dead"|units on a scale|Mean|4|4.0|Standard Deviation|2|2.0|||
4158385|NCT00841321|3981598|B3|||Disease duration, average number of years|For each group the average number of years that participants had Multiple Sclerosis|years|Mean|20.1|20.1|Standard Deviation|11.8|11.8|||
4158386|NCT00841321|3981599|B2|||Disease duration, average number of years|For each group the average number of years that participants had Multiple Sclerosis|years|Mean|20.9|20.9|Standard Deviation|11.8|11.8|||
4158387|NCT00841321|3981600|B1|||Disease duration, average number of years|For each group the average number of years that participants had Multiple Sclerosis|years|Mean|19.3|19.3|Standard Deviation|11.8|11.8|||
4158388|NCT00841321|3981598|B3|Non-white||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4158389|NCT00841321|3981599|B2|Non-white||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4158390|NCT00841321|3981600|B1|Non-white||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4158391|NCT00841321|3981598|B3|White||Race/Ethnicity, Customized||participants|Number|114|114.0||||||
4158392|NCT00841321|3981599|B2|White||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
4158393|NCT00841321|3981600|B1|White||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
4158394|NCT00841321|3981598|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4158395|NCT00841321|3981599|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4158396|NCT00841321|3981600|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4158397|NCT00841321|3981598|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4158398|NCT00841321|3981599|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4158399|NCT00841321|3981600|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4158400|NCT00841321|3981598|B3|||Age||years|Mean|52.1|52.1|Standard Deviation|9.1|9.1|||
4158401|NCT00841321|3981599|B2|||Age||years|Mean|51.3|51.3|Standard Deviation|8.6|8.6|||
4158402|NCT00841321|3981600|B1|||Age||years|Mean|53.0|53.0|Standard Deviation|9.5|9.5|||
4158403|NCT00841321|3981598|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158404|NCT00841321|3981599|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158405|NCT00841321|3981600|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158406|NCT00841321|3981598|B3||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
4158407|NCT00841321|3981599|B2||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4158408|NCT00841321|3981600|B1||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4158409|NCT00841321|3981598|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158410|NCT00841321|3981599|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158411|NCT00841321|3981600|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158412|NCT00841269|3981613|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4158413|NCT00841269|3981614|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4158414|NCT00841269|3981615|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4158415|NCT00841269|3981613|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158416|NCT00841269|3981614|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158417|NCT00841269|3981615|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158418|NCT00841269|3981613|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158419|NCT00841269|3981614|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158420|NCT00841269|3981615|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158421|NCT00841269|3981613|B3||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4158422|NCT00841269|3981614|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4158423|NCT00841269|3981615|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4158424|NCT00841269|3981613|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158425|NCT00841269|3981614|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158426|NCT00841269|3981615|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158427|NCT00841269|3981613|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158428|NCT00841269|3981614|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158429|NCT00841269|3981615|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158430|NCT00841269|3981613|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4158431|NCT00841269|3981614|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4158432|NCT00841269|3981615|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158433|NCT00841269|3981613|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158434|NCT00841269|3981614|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158435|NCT00841269|3981615|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158436|NCT00841269|3981613|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4158437|NCT00841269|3981614|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4158438|NCT00841269|3981615|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4158439|NCT00841269|3981613|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4158440|NCT00841269|3981614|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4158441|NCT00841269|3981615|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4158442|NCT00841269|3981613|B3|||Age||years|Mean|15.83|15.83|Standard Deviation|1.68|1.68|||
4158443|NCT00841269|3981614|B2|||Age||years|Mean|15.67|15.67|Standard Deviation|1.84|1.84|||
4158444|NCT00841269|3981615|B1|||Age||years|Mean|16.05|16.05|Standard Deviation|1.50|1.5|||
4158445|NCT00841269|3981613|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158446|NCT00841269|3981614|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158447|NCT00841269|3981615|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158448|NCT00841269|3981613|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4158449|NCT00841269|3981614|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4158450|NCT00841269|3981615|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4158451|NCT00841269|3981613|B3||<=18 years|Age||Participants|Count of Participants|38|38.0||||||
4158452|NCT00841269|3981614|B2||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
4158453|NCT00841269|3981615|B1||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
4158454|NCT00841204|3981625|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4158455|NCT00841204|3981626|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4158456|NCT00841204|3981627|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4158457|NCT00841204|3981625|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4158458|NCT00841204|3981626|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4158459|NCT00841204|3981627|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4158460|NCT00841204|3981625|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4158461|NCT00841204|3981626|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4158462|NCT00841204|3981627|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4158463|NCT00841204|3981625|B3|||Age||years|Mean|46.0|46.0|Standard Deviation|9.24|9.24|||
4158464|NCT00841204|3981626|B2|||Age||years|Mean|45.9|45.9|Standard Deviation|8.59|8.59|||
4158465|NCT00841204|3981627|B1|||Age||years|Mean|46.2|46.2|Standard Deviation|10.0|10.0|||
4158466|NCT00841204|3981625|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158467|NCT00841204|3981626|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158468|NCT00841204|3981627|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158469|NCT00841204|3981625|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4158470|NCT00841204|3981626|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4158471|NCT00841204|3981627|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4158472|NCT00841204|3981625|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158473|NCT00841204|3981626|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158474|NCT00841204|3981627|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158475|NCT00841087|3981648|B3|||Body weight||kg|Mean|63.23|63.23|Standard Deviation|9.61|9.61|||
4158476|NCT00841087|3981649|B2|||Body weight||kg|Mean|62.28|62.28|Standard Deviation|7.85|7.85|||
4158477|NCT00841087|3981650|B1|||Body weight||kg|Mean|64.15|64.15|Standard Deviation|11.11|11.11|||
4158478|NCT00841087|3981648|B3|||Fasting plasma glucose (FPG)||mg/dL|Mean|162.1|162.1|Standard Deviation|63.4|63.4|||
4158479|NCT00841087|3981649|B2|||Fasting plasma glucose (FPG)||mg/dL|Mean|141.8|141.8|Standard Deviation|54.3|54.3|||
4158480|NCT00841087|3981650|B1|||Fasting plasma glucose (FPG)||mg/dL|Mean|181.8|181.8|Standard Deviation|66.2|66.2|||
4158481|NCT00841087|3981648|B3|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|7.35|7.35|Standard Deviation|0.86|0.86|||
4158482|NCT00841087|3981649|B2|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|7.32|7.32|Standard Deviation|0.86|0.86|||
4158483|NCT00841087|3981650|B1|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|7.39|7.39|Standard Deviation|0.86|0.86|||
4158484|NCT00841087|3981648|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4158485|NCT00841087|3981649|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4158486|NCT00841087|3981650|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4158487|NCT00841087|3981648|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4158488|NCT00841087|3981649|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4158489|NCT00841087|3981650|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4158490|NCT00841087|3981648|B3|||Age||years|Mean|44.4|44.4|Standard Deviation|15.1|15.1|||
4158491|NCT00841087|3981649|B2|||Age||years|Mean|43.2|43.2|Standard Deviation|15.4|15.4|||
4158492|NCT00841087|3981650|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|15.0|15.0|||
4158493|NCT00841035|3981669|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4158494|NCT00841035|3981669|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4158495|NCT00841035|3981669|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4158496|NCT00841035|3981669|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4158497|NCT00841035|3981669|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4158498|NCT00841035|3981669|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158499|NCT00840996|3981674|B3||Male|Gender||Participants|Count of Participants|70|70.0||||||
4158500|NCT00840996|3981675|B2||Male|Gender||Participants|Count of Participants|35|35.0||||||
4158501|NCT00840996|3981676|B1||Male|Gender||Participants|Count of Participants|35|35.0||||||
4158502|NCT00840996|3981674|B3||Female|Gender||Participants|Count of Participants|45|45.0||||||
4158503|NCT00840996|3981675|B2||Female|Gender||Participants|Count of Participants|23|23.0||||||
4158504|NCT00840996|3981676|B1||Female|Gender||Participants|Count of Participants|22|22.0||||||
4158505|NCT00840996|3981674|B3|||Age||years|Mean|56|56.0|Standard Deviation|11|11.0|||
4158506|NCT00840996|3981675|B2|||Age||years|Mean|54|54.0|Standard Deviation|11|11.0|||
4158507|NCT00840996|3981676|B1|||Age||years|Mean|58|58.0|Standard Deviation|11|11.0|||
4158508|NCT00840879|3981695|B3|Canada||Region of Enrollment||participants|Number|28|28.0||||||
4158509|NCT00840879|3981696|B2|Canada||Region of Enrollment||participants|Number|14|14.0||||||
4158510|NCT00840879|3981697|B1|Canada||Region of Enrollment||participants|Number|14|14.0||||||
4158511|NCT00840879|3981695|B3|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4158512|NCT00840879|3981696|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4158513|NCT00840879|3981697|B1|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4158514|NCT00840879|3981695|B3|Black||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4158515|NCT00840879|3981696|B2|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4158516|NCT00840879|3981697|B1|Black||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4158517|NCT00840879|3981695|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
4158518|NCT00840879|3981696|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4158519|NCT00840879|3981697|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4158520|NCT00840879|3981695|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4158521|NCT00840879|3981696|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4158522|NCT00840879|3981697|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4158523|NCT00840879|3981695|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4158524|NCT00840879|3981696|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4158525|NCT00840879|3981697|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4158526|NCT00840879|3981695|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158527|NCT00840879|3981696|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158528|NCT00840879|3981697|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158529|NCT00840879|3981695|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4158530|NCT00840879|3981696|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4158531|NCT00840879|3981697|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4158532|NCT00840879|3981695|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158533|NCT00840879|3981696|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158534|NCT00840879|3981697|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158535|NCT00840866|3981706|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
4158536|NCT00840866|3981707|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4158537|NCT00840866|3981708|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4158538|NCT00840866|3981706|B3|White||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4158539|NCT00840866|3981707|B2|White||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4158540|NCT00840866|3981708|B1|White||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4158541|NCT00840866|3981706|B3|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4158542|NCT00840866|3981707|B2|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4158543|NCT00840866|3981708|B1|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4158544|NCT00840866|3981706|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4158545|NCT00840866|3981707|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4158546|NCT00840866|3981708|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4158547|NCT00840866|3981706|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4158548|NCT00840866|3981707|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4158549|NCT00840866|3981708|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4158550|NCT00840866|3981706|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158551|NCT00840866|3981707|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158552|NCT00840866|3981708|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158553|NCT00840866|3981706|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4158554|NCT00840866|3981707|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4158555|NCT00840866|3981708|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4158556|NCT00840866|3981706|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158557|NCT00840866|3981707|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158558|NCT00840866|3981708|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158559|NCT00840840|3981717|B3|Canada||Region of Enrollment||participants|Number|48|48.0||||||
4158560|NCT00840840|3981718|B2|Canada||Region of Enrollment||participants|Number|24|24.0||||||
4158561|NCT00840840|3981719|B1|Canada||Region of Enrollment||participants|Number|24|24.0||||||
4158562|NCT00840840|3981717|B3|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4158563|NCT00840840|3981718|B2|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4158564|NCT00840840|3981719|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4158565|NCT00840840|3981717|B3|Black||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4158566|NCT00840840|3981718|B2|Black||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4158567|NCT00840840|3981719|B1|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4158568|NCT00840840|3981717|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|38|38.0||||||
4158569|NCT00840840|3981718|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4158570|NCT00840840|3981719|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
4158571|NCT00840840|3981717|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4158572|NCT00840840|3981718|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4158573|NCT00840840|3981719|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4158574|NCT00840840|3981717|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4158575|NCT00840840|3981718|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4158576|NCT00840840|3981719|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4158577|NCT00840840|3981717|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158578|NCT00840840|3981718|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158579|NCT00840840|3981719|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158580|NCT00840840|3981717|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4158581|NCT00840840|3981718|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4158582|NCT00840840|3981719|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4158583|NCT00840840|3981717|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158584|NCT00840840|3981718|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158585|NCT00840840|3981719|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158586|NCT00840658|3981734|B5|Mexico||Region of Enrollment||participants|Number|584|584.0||||||
4158587|NCT00840658|3981735|B4|Mexico||Region of Enrollment||participants|Number|146|146.0||||||
4158588|NCT00840658|3981736|B3|Mexico||Region of Enrollment||participants|Number|148|148.0||||||
4158589|NCT00840658|3981737|B2|Mexico||Region of Enrollment||participants|Number|146|146.0||||||
4158590|NCT00840658|3981738|B1|Mexico||Region of Enrollment||participants|Number|144|144.0||||||
4158591|NCT00840658|3981734|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4158592|NCT00840658|3981735|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4158593|NCT00840658|3981736|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4158594|NCT00840658|3981737|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4158595|NCT00840658|3981738|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4158596|NCT00840658|3981734|B5||Female|Sex: Female, Male||Participants|Count of Participants|584|584.0||||||
4158597|NCT00840658|3981735|B4||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4158598|NCT00840658|3981736|B3||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4158599|NCT00840658|3981737|B2||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4158600|NCT00840658|3981738|B1||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4158601|NCT00840658|3981734|B5|||Age||years|Median|33|33.0|Inter-Quartile Range|2740|2740.0|27.0|40.0|
4158602|NCT00840658|3981735|B4|||Age||years|Median|34|34.0|Inter-Quartile Range|2940|2940.0|28.0|40.0|
4158603|NCT00840658|3981736|B3|||Age||years|Median|34|34.0|Inter-Quartile Range|2740|2740.0|29.0|40.0|
4158604|NCT00840658|3981737|B2|||Age||years|Median|32|32.0|Inter-Quartile Range|2740|2740.0|27.0|40.0|
4158605|NCT00840658|3981738|B1|||Age||years|Median|33|33.0|Inter-Quartile Range|2742|2742.0|27.0|42.0|
4158606|NCT00840632|3981751|B3|Canada||Region of Enrollment||participants|Number|40|40.0||||||
4158607|NCT00840632|3981752|B2|Canada||Region of Enrollment||participants|Number|20|20.0||||||
4158608|NCT00840632|3981753|B1|Canada||Region of Enrollment||participants|Number|20|20.0||||||
4158609|NCT00840632|3981751|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4158610|NCT00840632|3981752|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4158611|NCT00840632|3981753|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4158612|NCT00840632|3981751|B3|Asian||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4158613|NCT00840632|3981752|B2|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4158614|NCT00840632|3981753|B1|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4158615|NCT00840632|3981751|B3|Black||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4158616|NCT00840632|3981752|B2|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4158617|NCT00840632|3981753|B1|Black||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4158618|NCT00840632|3981751|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
4158619|NCT00840632|3981752|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4158620|NCT00840632|3981753|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4158621|NCT00840632|3981751|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4158622|NCT00840632|3981752|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4158623|NCT00840632|3981753|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4158624|NCT00840632|3981751|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4158625|NCT00840632|3981752|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4158626|NCT00840632|3981753|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4158627|NCT00840632|3981751|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158628|NCT00840632|3981752|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158629|NCT00840632|3981753|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158630|NCT00840632|3981751|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4158631|NCT00840632|3981752|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4158632|NCT00840632|3981753|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4158633|NCT00840632|3981751|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158634|NCT00840632|3981752|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158635|NCT00840632|3981753|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158636|NCT00840476|3981768|B3|Canada||Region of Enrollment||participants|Number|28|28.0||||||
4158637|NCT00840476|3981769|B2|Canada||Region of Enrollment||participants|Number|14|14.0||||||
4158638|NCT00840476|3981770|B1|Canada||Region of Enrollment||participants|Number|14|14.0||||||
4158639|NCT00840476|3981768|B3|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4158640|NCT00840476|3981769|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4158641|NCT00840476|3981770|B1|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4158642|NCT00840476|3981768|B3|Black||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4158643|NCT00840476|3981769|B2|Black||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4158644|NCT00840476|3981770|B1|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4158645|NCT00840476|3981768|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4158646|NCT00840476|3981769|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4158647|NCT00840476|3981770|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4158648|NCT00840476|3981768|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4158649|NCT00840476|3981769|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4158650|NCT00840476|3981770|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4158651|NCT00840476|3981768|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4158652|NCT00840476|3981769|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4158653|NCT00840476|3981770|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4158654|NCT00840476|3981768|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4158655|NCT00840476|3981769|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158656|NCT00840476|3981770|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4158657|NCT00840476|3981768|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4158658|NCT00840476|3981769|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4158659|NCT00840476|3981770|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4158660|NCT00840476|3981768|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158661|NCT00840476|3981769|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158662|NCT00840476|3981770|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158663|NCT00840450|3981779|B1|Sensitive||Platinum Sensitivity||Participants|Number|2|2.0||||||
4158664|NCT00840450|3981779|B1|Resistant||Platinum Sensitivity||Participants|Number|10|10.0||||||
4158665|NCT00840450|3981779|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4158666|NCT00840450|3981779|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4158667|NCT00840450|3981779|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4158668|NCT00840450|3981779|B1|||Age||years|Mean|61|61.0|Standard Deviation|8|8.0|||
4158669|NCT00840450|3981779|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4158670|NCT00840450|3981779|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4158671|NCT00840450|3981779|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158672|NCT00840411|3981785|B3|United States||Region of Enrollment||participants|Number|66|66.0||||||
4158673|NCT00840411|3981786|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4158674|NCT00840411|3981787|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4158675|NCT00840411|3981785|B3|Black||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4158676|NCT00840411|3981786|B2|Black||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4158677|NCT00840411|3981787|B1|Black||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4158678|NCT00840411|3981785|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|53|53.0||||||
4158679|NCT00840411|3981786|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
4158680|NCT00840411|3981787|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
4158681|NCT00840411|3981785|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4158682|NCT00840411|3981786|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4158683|NCT00840411|3981787|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4158684|NCT00840411|3981785|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4158685|NCT00840411|3981786|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4158686|NCT00840411|3981787|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4158687|NCT00840411|3981785|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4158688|NCT00840411|3981786|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4158689|NCT00840411|3981787|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4158690|NCT00840411|3981785|B3||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4158691|NCT00840411|3981786|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4158692|NCT00840411|3981787|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4158693|NCT00840411|3981785|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158694|NCT00840411|3981786|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158695|NCT00840411|3981787|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158696|NCT00840307|3981796|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4158697|NCT00840307|3981796|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4158698|NCT00840307|3981796|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4158699|NCT00840307|3981796|B1|||Age||years|Mean|49.1|49.1|Standard Deviation|11.0|11.0|||
4158700|NCT00840307|3981796|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158701|NCT00840307|3981796|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4158702|NCT00840307|3981796|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158703|NCT00840294|3981800|B3|||PSA level||ng/mL|Mean|7.0|7.0|Full Range|||2.4|45.7|
4158704|NCT00840294|3981801|B2|||PSA level||ng/mL|Mean|7.6|7.6|Full Range|||3.1|45.7|
4158705|NCT00840294|3981802|B1|||PSA level||ng/mL|Mean|6.5|6.5|Full Range|||2.4|17.4|
4158706|NCT00840294|3981800|B3|United States||Region of Enrollment||participants|Number|77|77.0||||||
4158707|NCT00840294|3981801|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
4158708|NCT00840294|3981802|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4158709|NCT00840294|3981800|B3|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4158710|NCT00840294|3981801|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4158711|NCT00840294|3981802|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4158712|NCT00840294|3981800|B3|African-American||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4158713|NCT00840294|3981801|B2|African-American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4158714|NCT00840294|3981802|B1|African-American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4158715|NCT00840294|3981800|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4158716|NCT00840294|3981801|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4158717|NCT00840294|3981802|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4158718|NCT00840294|3981800|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4158719|NCT00840294|3981801|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4158720|NCT00840294|3981802|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4158721|NCT00840294|3981800|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4158722|NCT00840294|3981801|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4158723|NCT00840294|3981802|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4158724|NCT00840294|3981800|B3|||Age||years|Mean|60.6|60.6|Inter-Quartile Range|||53.1|66.7|
4158725|NCT00840294|3981801|B2|||Age||years|Mean|60.4|60.4|Inter-Quartile Range|||53.1|66.6|
4158726|NCT00840294|3981802|B1|||Age||years|Mean|61.7|61.7|Inter-Quartile Range|||55.5|66.7|
4158727|NCT00840281|3981811|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
4158728|NCT00840281|3981812|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4158729|NCT00840281|3981813|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4158730|NCT00840281|3981811|B3|White||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4158731|NCT00840281|3981812|B2|White||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4158732|NCT00840281|3981813|B1|White||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4158733|NCT00840281|3981811|B3|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4158734|NCT00840281|3981812|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4158735|NCT00840281|3981813|B1|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4158736|NCT00840281|3981811|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4158737|NCT00840281|3981812|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4158738|NCT00840281|3981813|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4158739|NCT00840281|3981811|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4158740|NCT00840281|3981812|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4158741|NCT00840281|3981813|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4158742|NCT00840281|3981811|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4158743|NCT00840281|3981812|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4158744|NCT00840281|3981813|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4158745|NCT00840281|3981811|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158746|NCT00840281|3981812|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158747|NCT00840281|3981813|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158748|NCT00840281|3981811|B3||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4158749|NCT00840281|3981812|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4158750|NCT00840281|3981813|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4158751|NCT00840281|3981811|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158752|NCT00840281|3981812|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158753|NCT00840281|3981813|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158754|NCT00840216|3981822|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4158755|NCT00840216|3981823|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4158756|NCT00840216|3981824|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4158757|NCT00840216|3981822|B3|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4158758|NCT00840216|3981823|B2|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4158759|NCT00840216|3981824|B1|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4158760|NCT00840216|3981822|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4158761|NCT00840216|3981823|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4158762|NCT00840216|3981824|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4158763|NCT00840216|3981822|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4158764|NCT00840216|3981823|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4158765|NCT00840216|3981824|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4158766|NCT00840216|3981822|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4158767|NCT00840216|3981823|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4158768|NCT00840216|3981824|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4158769|NCT00840216|3981822|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4158770|NCT00840216|3981823|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4158771|NCT00840216|3981824|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4158772|NCT00840216|3981822|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4158773|NCT00840216|3981823|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4158774|NCT00840216|3981824|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4158775|NCT00840216|3981822|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158776|NCT00840216|3981823|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158777|NCT00840216|3981824|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158778|NCT00840203|3981833|B3|United States||Region of Enrollment||participants|Number|72|72.0||||||
4158779|NCT00840203|3981834|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
4158780|NCT00840203|3981835|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4158781|NCT00840203|3981833|B3|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4158782|NCT00840203|3981834|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4158783|NCT00840203|3981835|B1|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4158784|NCT00840203|3981833|B3|Biracial||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4158785|NCT00840203|3981834|B2|Biracial||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4158786|NCT00840203|3981835|B1|Biracial||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4158787|NCT00840203|3981833|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4158788|NCT00840203|3981834|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4158789|NCT00840203|3981835|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4158790|NCT00840203|3981833|B3|Black||Race/Ethnicity, Customized||Participants|Number|33|33.0||||||
4158791|NCT00840203|3981834|B2|Black||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4158792|NCT00840203|3981835|B1|Black||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4158793|NCT00840203|3981833|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
4158794|NCT00840203|3981834|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4158795|NCT00840203|3981835|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4158796|NCT00840203|3981833|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4158797|NCT00840203|3981834|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4158798|NCT00840203|3981835|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4158799|NCT00840203|3981833|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4158800|NCT00840203|3981834|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4158801|NCT00840203|3981835|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4158802|NCT00840203|3981833|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158803|NCT00840203|3981834|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158804|NCT00840203|3981835|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158805|NCT00840203|3981833|B3||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
4158806|NCT00840203|3981834|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4158807|NCT00840203|3981835|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4158808|NCT00840203|3981833|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158809|NCT00840203|3981834|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158810|NCT00840203|3981835|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158811|NCT00840099|3981850|B3|Canada||Region of Enrollment||participants|Number|48|48.0||||||
4158812|NCT00840099|3981851|B2|Canada||Region of Enrollment||participants|Number|24|24.0||||||
4158813|NCT00840099|3981852|B1|Canada||Region of Enrollment||participants|Number|24|24.0||||||
4158814|NCT00840099|3981850|B3|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4158815|NCT00840099|3981851|B2|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4158816|NCT00840099|3981852|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4158817|NCT00840099|3981850|B3|Black||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4158818|NCT00840099|3981851|B2|Black||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4158819|NCT00840099|3981852|B1|Black||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4158820|NCT00840099|3981850|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
4158821|NCT00840099|3981851|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4158822|NCT00840099|3981852|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4158823|NCT00840099|3981850|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4158824|NCT00840099|3981851|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4158825|NCT00840099|3981852|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4158826|NCT00840099|3981850|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4158827|NCT00840099|3981851|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4158828|NCT00840099|3981852|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4158829|NCT00840099|3981850|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158830|NCT00840099|3981851|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158831|NCT00840099|3981852|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158832|NCT00840099|3981850|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4158833|NCT00840099|3981851|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4158834|NCT00840099|3981852|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4158835|NCT00840099|3981850|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158836|NCT00840099|3981851|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158837|NCT00840099|3981852|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158838|NCT00840086|3981867|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4158839|NCT00840086|3981867|B1|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4158840|NCT00840086|3981867|B1|Turkey||Region of Enrollment||participants|Number|11|11.0||||||
4158841|NCT00840086|3981867|B1|Taiwan||Region of Enrollment||participants|Number|4|4.0||||||
4158842|NCT00840086|3981867|B1|Switzerland||Region of Enrollment||participants|Number|5|5.0||||||
4158843|NCT00840086|3981867|B1|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4158844|NCT00840086|3981867|B1|Serbia||Region of Enrollment||participants|Number|19|19.0||||||
4158845|NCT00840086|3981867|B1|Russia||Region of Enrollment||participants|Number|5|5.0||||||
4158846|NCT00840086|3981867|B1|Malaysia||Region of Enrollment||participants|Number|5|5.0||||||
4158847|NCT00840086|3981867|B1|Japan||Region of Enrollment||participants|Number|9|9.0||||||
4158848|NCT00840086|3981867|B1|Italy||Region of Enrollment||participants|Number|7|7.0||||||
4158849|NCT00840086|3981867|B1|Israel||Region of Enrollment||participants|Number|12|12.0||||||
4158850|NCT00840086|3981867|B1|Germany||Region of Enrollment||participants|Number|10|10.0||||||
4158851|NCT00840086|3981867|B1|Croatia||Region of Enrollment||participants|Number|11|11.0||||||
4158852|NCT00840086|3981867|B1|Brazil||Region of Enrollment||participants|Number|16|16.0||||||
4158853|NCT00840086|3981867|B1|Not Hispanic Or Latino||Race/Ethnicity, Customized||participants|Number|125|125.0||||||
4158854|NCT00840086|3981867|B1|Hispanic Or Latino||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4158855|NCT00840086|3981867|B1||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4158856|NCT00840086|3981867|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4158857|NCT00840086|3981867|B1|||Age||years|Mean|28|28.0|Standard Deviation|11.79|11.79|||
4158858|NCT00840073|3981874|B3|Canada||Region of Enrollment||participants|Number|50|50.0||||||
4158859|NCT00840073|3981875|B2|Canada||Region of Enrollment||participants|Number|25|25.0||||||
4158860|NCT00840073|3981876|B1|Canada||Region of Enrollment||participants|Number|25|25.0||||||
4158861|NCT00840073|3981874|B3|Asian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4158862|NCT00840073|3981875|B2|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4158863|NCT00840073|3981876|B1|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4158864|NCT00840073|3981874|B3|Black||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4158865|NCT00840073|3981875|B2|Black||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4158866|NCT00840073|3981876|B1|Black||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4158867|NCT00840073|3981874|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
4158868|NCT00840073|3981875|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4158869|NCT00840073|3981876|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4158870|NCT00840073|3981874|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4158871|NCT00840073|3981875|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4158872|NCT00840073|3981876|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4158873|NCT00840073|3981874|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4158874|NCT00840073|3981875|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4158875|NCT00840073|3981876|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4158876|NCT00840073|3981874|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158877|NCT00840073|3981875|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158878|NCT00840073|3981876|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158879|NCT00840073|3981874|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4158880|NCT00840073|3981875|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4158881|NCT00840073|3981876|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4158882|NCT00840073|3981874|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158883|NCT00840073|3981875|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158884|NCT00840073|3981876|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158885|NCT00840060|3981889|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4158886|NCT00840060|3981890|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4158887|NCT00840060|3981891|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4158888|NCT00840060|3981889|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4158889|NCT00840060|3981890|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4158890|NCT00840060|3981891|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4158891|NCT00840060|3981889|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4158892|NCT00840060|3981890|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4158893|NCT00840060|3981891|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4158894|NCT00840060|3981889|B3|||Age||years|Mean|4.74|4.74|Standard Deviation|.53|0.53|||
4158895|NCT00840060|3981890|B2|||Age||years|Mean|4.90|4.9|Standard Deviation|.51|0.51|||
4158896|NCT00840060|3981891|B1|||Age||years|Mean|4.56|4.56|Standard Deviation|.50|0.5|||
4158897|NCT00840060|3981889|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158898|NCT00840060|3981890|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158899|NCT00840060|3981891|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158900|NCT00840060|3981889|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4158901|NCT00840060|3981890|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4158902|NCT00840060|3981891|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4158903|NCT00840060|3981889|B3||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
4158904|NCT00840060|3981890|B2||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
4158905|NCT00840060|3981891|B1||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
4158906|NCT00840034|3981900|B3|United States||Region of Enrollment||Participants|Count of Participants|227|227.0||||||
4158907|NCT00840034|3981901|B2|United States||Region of Enrollment||Participants|Count of Participants|116|116.0||||||
4158908|NCT00840034|3981902|B1|United States||Region of Enrollment||Participants|Count of Participants|111|111.0||||||
4158909|NCT00840034|3981900|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4158910|NCT00840034|3981901|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4158911|NCT00840034|3981902|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4158912|NCT00840034|3981900|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4158913|NCT00840034|3981901|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4158914|NCT00840034|3981902|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4158915|NCT00840034|3981900|B3||White|Race (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
4158916|NCT00840034|3981901|B2||White|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
4158917|NCT00840034|3981902|B1||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4158918|NCT00840034|3981900|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4158919|NCT00840034|3981901|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4158920|NCT00840034|3981902|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4158921|NCT00840034|3981900|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158922|NCT00840034|3981901|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158923|NCT00840034|3981902|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158924|NCT00840034|3981900|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4158925|NCT00840034|3981901|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4158926|NCT00840034|3981902|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4158927|NCT00840034|3981900|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4158928|NCT00840034|3981901|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4158929|NCT00840034|3981902|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4158930|NCT00840034|3981900|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158931|NCT00840034|3981901|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158932|NCT00840034|3981902|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158933|NCT00840034|3981900|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|185|185.0||||||
4158934|NCT00840034|3981901|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
4158935|NCT00840034|3981902|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
4158936|NCT00840034|3981900|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4158937|NCT00840034|3981901|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4158938|NCT00840034|3981902|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4158939|NCT00840034|3981900|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4158940|NCT00840034|3981901|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4158941|NCT00840034|3981902|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4158942|NCT00840034|3981900|B3||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4158943|NCT00840034|3981901|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4158944|NCT00840034|3981902|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4158945|NCT00840034|3981900|B3|||Age||years|Mean|45.0|45.0|Standard Deviation|10.83|10.83|||
4158946|NCT00840034|3981901|B2|||Age||years|Mean|44.1|44.1|Standard Deviation|10.90|10.9|||
4158947|NCT00840034|3981902|B1|||Age||years|Mean|46.1|46.1|Standard Deviation|10.71|10.71|||
4158948|NCT00839982|3981939|B1|United States||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
4158949|NCT00839982|3981939|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4158950|NCT00839982|3981939|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4158951|NCT00839982|3981939|B1|||Age||years|Median|72|72.0|Full Range|||62.0|83.0|
4158952|NCT00839982|3981939|B1||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4158953|NCT00839982|3981939|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4158954|NCT00839982|3981939|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158955|NCT00839956|3981956|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4158956|NCT00839956|3981956|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158957|NCT00839956|3981956|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158958|NCT00839956|3981956|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4158959|NCT00839956|3981956|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4158960|NCT00839956|3981956|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158961|NCT00839956|3981956|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4158962|NCT00839956|3981956|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158963|NCT00839956|3981956|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158964|NCT00839956|3981956|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4158965|NCT00839956|3981956|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4158966|NCT00839956|3981956|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4158967|NCT00839956|3981956|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4158968|NCT00839956|3981956|B1|||Age||years|Median|60|60.0|Full Range|||40.0|73.0|
4158969|NCT00839956|3981956|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4158970|NCT00839956|3981956|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4158971|NCT00839956|3981956|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158972|NCT00839930|3981963|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4158973|NCT00839930|3981964|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4158974|NCT00839930|3981965|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4158975|NCT00839930|3981963|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4158976|NCT00839930|3981964|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4158977|NCT00839930|3981965|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4158978|NCT00839930|3981963|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
4158979|NCT00839930|3981964|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4158980|NCT00839930|3981965|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4158981|NCT00839930|3981963|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4158982|NCT00839930|3981964|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4158983|NCT00839930|3981965|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4158984|NCT00839930|3981963|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4158985|NCT00839930|3981964|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4158986|NCT00839930|3981965|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4158987|NCT00839930|3981963|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158988|NCT00839930|3981964|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158989|NCT00839930|3981965|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4158990|NCT00839930|3981963|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4158991|NCT00839930|3981964|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4158992|NCT00839930|3981965|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4158993|NCT00839930|3981963|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158994|NCT00839930|3981964|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158995|NCT00839930|3981965|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4158996|NCT00839917|3981974|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4158997|NCT00839917|3981975|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4158998|NCT00839917|3981976|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4158999|NCT00839917|3981974|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4159000|NCT00839917|3981975|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4159001|NCT00839917|3981976|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4159002|NCT00839917|3981974|B3|12 to 15 months||Age, Customized||participants|Number|30|30.0||||||
4159003|NCT00839917|3981975|B2|12 to 15 months||Age, Customized||participants|Number|17|17.0||||||
4159004|NCT00839917|3981976|B1|12 to 15 months||Age, Customized||participants|Number|13|13.0||||||
4159005|NCT00839800|3982013|B3||Male|Sex: Female, Male||Participants|Count of Participants|677|677.0||||||
4159006|NCT00839800|3982014|B2||Male|Sex: Female, Male||Participants|Count of Participants|350|350.0||||||
4159007|NCT00839800|3982015|B1||Male|Sex: Female, Male||Participants|Count of Participants|327|327.0||||||
4159008|NCT00839800|3982013|B3||Female|Sex: Female, Male||Participants|Count of Participants|1414|1414.0||||||
4159009|NCT00839800|3982014|B2||Female|Sex: Female, Male||Participants|Count of Participants|692|692.0||||||
4159010|NCT00839800|3982015|B1||Female|Sex: Female, Male||Participants|Count of Participants|722|722.0||||||
4159011|NCT00839800|3982013|B3|||Age||years|Mean|45.7|45.7|Full Range|||16.0|85.0|
4159012|NCT00839800|3982014|B2|||Age||years|Mean|45.6|45.6|Full Range|||16.0|85.0|
4159013|NCT00839800|3982015|B1|||Age||years|Mean|45.7|45.7|Full Range|||16.0|84.0|
4159014|NCT00839540|3982046|B4|United States||Region of Enrollment||participants|Number|21|21.0||||||
4159015|NCT00839540|3982047|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4159016|NCT00839540|3982048|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4159017|NCT00839540|3982049|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4159018|NCT00839540|3982046|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4159019|NCT00839540|3982047|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4159020|NCT00839540|3982048|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4159021|NCT00839540|3982049|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4159022|NCT00839540|3982046|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4159023|NCT00839540|3982047|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4159024|NCT00839540|3982048|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4159025|NCT00839540|3982049|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4159026|NCT00839540|3982046|B4|||Age||years|Mean|57.6|57.6|Standard Deviation|18.65374|18.65374|||
4159027|NCT00839540|3982047|B3|||Age||years|Mean|44.0|44.0|Standard Deviation|20.43282|20.43282|||
4159028|NCT00839540|3982048|B2|||Age||years|Mean|57.81|57.81|Standard Deviation|17.38585|17.38585|||
4159029|NCT00839540|3982049|B1|||Age||years|Mean|64.62|64.62|Standard Deviation|16.13282|16.13282|||
4159030|NCT00839540|3982046|B4||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4159031|NCT00839540|3982047|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4159032|NCT00839540|3982048|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4159033|NCT00839540|3982049|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4159034|NCT00839540|3982046|B4||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4159035|NCT00839540|3982047|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4159036|NCT00839540|3982048|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4159037|NCT00839540|3982049|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4159038|NCT00839540|3982046|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159039|NCT00839540|3982047|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159040|NCT00839540|3982048|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159041|NCT00839540|3982049|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159042|NCT00839527|3982059|B4|Mexican American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4159043|NCT00839527|3982060|B3|Mexican American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4159044|NCT00839527|3982061|B2|Mexican American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4159045|NCT00839527|3982062|B1|Mexican American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4159046|NCT00839527|3982059|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|456|456.0||||||
4159047|NCT00839527|3982060|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|176|176.0||||||
4159048|NCT00839527|3982061|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|201|201.0||||||
4159049|NCT00839527|3982062|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|79|79.0||||||
4159050|NCT00839527|3982059|B4|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4159051|NCT00839527|3982060|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4159052|NCT00839527|3982061|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4159053|NCT00839527|3982062|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4159054|NCT00839527|3982059|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4159055|NCT00839527|3982060|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4159056|NCT00839527|3982061|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4159057|NCT00839527|3982062|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4159058|NCT00839527|3982059|B4|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|45|45.0||||||
4159059|NCT00839527|3982060|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4159060|NCT00839527|3982061|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
4159061|NCT00839527|3982062|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4159062|NCT00839527|3982059|B4|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4159063|NCT00839527|3982060|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4159064|NCT00839527|3982061|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4159065|NCT00839527|3982062|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4159066|NCT00839527|3982059|B4|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4159067|NCT00839527|3982060|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4159068|NCT00839527|3982061|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4159069|NCT00839527|3982062|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4159070|NCT00839527|3982059|B4|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
4159071|NCT00839527|3982060|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4159072|NCT00839527|3982061|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4159073|NCT00839527|3982062|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4159074|NCT00839527|3982059|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|41|41.0||||||
4159075|NCT00839527|3982060|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4159076|NCT00839527|3982061|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4159077|NCT00839527|3982062|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4159078|NCT00839527|3982059|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|68|68.0||||||
4159079|NCT00839527|3982060|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|34|34.0||||||
4159080|NCT00839527|3982061|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
4159081|NCT00839527|3982062|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4159082|NCT00839527|3982059|B4||Male|Gender||Participants|Count of Participants|353|353.0||||||
4159083|NCT00839527|3982060|B3||Male|Gender||Participants|Count of Participants|135|135.0||||||
4159084|NCT00839527|3982061|B2||Male|Gender||Participants|Count of Participants|148|148.0||||||
4159085|NCT00839527|3982062|B1||Male|Gender||Participants|Count of Participants|70|70.0||||||
4159086|NCT00839527|3982059|B4||Female|Gender||Participants|Count of Participants|310|310.0||||||
4159087|NCT00839527|3982060|B3||Female|Gender||Participants|Count of Participants|136|136.0||||||
4159088|NCT00839527|3982061|B2||Female|Gender||Participants|Count of Participants|129|129.0||||||
4159089|NCT00839527|3982062|B1||Female|Gender||Participants|Count of Participants|45|45.0||||||
4159090|NCT00839527|3982059|B4|||Age||Years|Mean|55.2|55.2|Standard Deviation|9.46|9.46|||
4159091|NCT00839527|3982060|B3|||Age||Years|Mean|54.5|54.5|Standard Deviation|9.47|9.47|||
4159092|NCT00839527|3982061|B2|||Age||Years|Mean|55.7|55.7|Standard Deviation|9.39|9.39|||
4159093|NCT00839527|3982062|B1|||Age||Years|Mean|55.7|55.7|Standard Deviation|9.59|9.59|||
4159094|NCT00839436|3982096|B4|||CD4 T cell count||cells/microliter|Median|18|18.0|Inter-Quartile Range|||14.0|116.0|
4159095|NCT00839436|3982097|B3|||CD4 T cell count||cells/microliter|Median|15|15.0|Inter-Quartile Range|||15.0|15.0|
4159096|NCT00839436|3982098|B2|||CD4 T cell count||cells/microliter|Median|52|52.0|Inter-Quartile Range|||20.0|183.5|
4159097|NCT00839436|3982099|B1|||CD4 T cell count||cells/microliter|Median|13|13.0|Inter-Quartile Range|||10.0|18.0|
4159098|NCT00839436|3982096|B4|United States||Region of Enrollment||participants|Number|9|9.0||||||
4159099|NCT00839436|3982097|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4159100|NCT00839436|3982098|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4159101|NCT00839436|3982099|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4159102|NCT00839436|3982096|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4159103|NCT00839436|3982097|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4159104|NCT00839436|3982098|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4159105|NCT00839436|3982099|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4159106|NCT00839436|3982096|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4159107|NCT00839436|3982097|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4159108|NCT00839436|3982098|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4159109|NCT00839436|3982099|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4159110|NCT00839436|3982096|B4|||Age||years|Median|51|51.0|Inter-Quartile Range|||33.5|56.5|
4159111|NCT00839436|3982097|B3|||Age||years|Median|33|33.0|Inter-Quartile Range|||33.0|33.0|
4159112|NCT00839436|3982098|B2|||Age||years|Median|56|56.0|Inter-Quartile Range|||44.5|63.5|
4159113|NCT00839436|3982099|B1|||Age||years|Median|49|49.0|Inter-Quartile Range|||23.0|51.0|
4159114|NCT00839436|3982096|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4159115|NCT00839436|3982097|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4159116|NCT00839436|3982098|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4159117|NCT00839436|3982099|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4159118|NCT00839436|3982096|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4159119|NCT00839436|3982097|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4159120|NCT00839436|3982098|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4159121|NCT00839436|3982099|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4159122|NCT00839436|3982096|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159123|NCT00839436|3982097|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159124|NCT00839436|3982098|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159125|NCT00839436|3982099|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159126|NCT00839423|3982109|B5|||CGI-S: Baseline Severity Score|The Clinical Global Impression – Severity of Illness (CGI-S) is a 7-point scale rated from 1 (normal, not at all ill) to 7 (among the most extremely ill patients). The investigator should use his/her total clinical experience with this patient population to judge how mentally ill the patient is at the time of rating.|units on a scale|Mean|5.2|5.2|Standard Deviation|0.7|0.7|||
4159127|NCT00839423|3982110|B4|||CGI-S: Baseline Severity Score|The Clinical Global Impression – Severity of Illness (CGI-S) is a 7-point scale rated from 1 (normal, not at all ill) to 7 (among the most extremely ill patients). The investigator should use his/her total clinical experience with this patient population to judge how mentally ill the patient is at the time of rating.|units on a scale|Mean|5.2|5.2|Standard Deviation|0.7|0.7|||
4159128|NCT00839423|3982111|B3|||CGI-S: Baseline Severity Score|The Clinical Global Impression – Severity of Illness (CGI-S) is a 7-point scale rated from 1 (normal, not at all ill) to 7 (among the most extremely ill patients). The investigator should use his/her total clinical experience with this patient population to judge how mentally ill the patient is at the time of rating.|units on a scale|Mean|5.1|5.1|Standard Deviation|0.7|0.7|||
4159129|NCT00839423|3982112|B2|||CGI-S: Baseline Severity Score|The Clinical Global Impression – Severity of Illness (CGI-S) is a 7-point scale rated from 1 (normal, not at all ill) to 7 (among the most extremely ill patients). The investigator should use his/her total clinical experience with this patient population to judge how mentally ill the patient is at the time of rating.|units on a scale|Mean|5.2|5.2|Standard Deviation|0.7|0.7|||
4159130|NCT00839423|3982113|B1|||CGI-S: Baseline Severity Score|The Clinical Global Impression – Severity of Illness (CGI-S) is a 7-point scale rated from 1 (normal, not at all ill) to 7 (among the most extremely ill patients). The investigator should use his/her total clinical experience with this patient population to judge how mentally ill the patient is at the time of rating.|units on a scale|Mean|5.1|5.1|Standard Deviation|0.7|0.7|||
4159131|NCT00839423|3982109|B5|||HAM-A: Baseline Total Score|The Hamilton Anxiety Rating Scale (HAM-A) consists of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behaviour at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic, and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total score from 0 to 56. The higher the score, the more severe.|units on a scale|Mean|22.2|22.2|Standard Deviation|5.8|5.8|||
4159132|NCT00839423|3982110|B4|||HAM-A: Baseline Total Score|The Hamilton Anxiety Rating Scale (HAM-A) consists of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behaviour at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic, and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total score from 0 to 56. The higher the score, the more severe.|units on a scale|Mean|22.0|22.0|Standard Deviation|5.5|5.5|||
4159133|NCT00839423|3982111|B3|||HAM-A: Baseline Total Score|The Hamilton Anxiety Rating Scale (HAM-A) consists of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behaviour at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic, and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total score from 0 to 56. The higher the score, the more severe.|units on a scale|Mean|22.3|22.3|Standard Deviation|5.6|5.6|||
4159134|NCT00839423|3982112|B2|||HAM-A: Baseline Total Score|The Hamilton Anxiety Rating Scale (HAM-A) consists of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behaviour at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic, and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total score from 0 to 56. The higher the score, the more severe.|units on a scale|Mean|21.7|21.7|Standard Deviation|6.2|6.2|||
4159155|NCT00839423|3982113|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4159156|NCT00839423|3982109|B5|||Age||years|Mean|43.3|43.3|Standard Deviation|11.5|11.5|||
4159157|NCT00839423|3982110|B4|||Age||years|Mean|45.0|45.0|Standard Deviation|10.3|10.3|||
4159135|NCT00839423|3982113|B1|||HAM-A: Baseline Total Score|The Hamilton Anxiety Rating Scale (HAM-A) consists of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behaviour at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic, and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total score from 0 to 56. The higher the score, the more severe.|units on a scale|Mean|22.9|22.9|Standard Deviation|5.9|5.9|||
4159136|NCT00839423|3982109|B5|||Baseline 24-item HAM-D Total Score|The 24-item Hamilton Depression Rating Scale (HAM-D) is based on the 21-item HAM-D plus an additional 3 items (helplessness, hopelessness, and worthlessness). The observer makes his/her assessment on the basis of a specific statement, content, tone, facial expression, and gestures of the patient during the interview, and scores each item from 0 to 2 or 0 to 4. Total score from 0 to 76. The higher the score, the more severe.|units on a scale|Mean|29.6|29.6|Standard Deviation|5.2|5.2|||
4159137|NCT00839423|3982110|B4|||Baseline 24-item HAM-D Total Score|The 24-item Hamilton Depression Rating Scale (HAM-D) is based on the 21-item HAM-D plus an additional 3 items (helplessness, hopelessness, and worthlessness). The observer makes his/her assessment on the basis of a specific statement, content, tone, facial expression, and gestures of the patient during the interview, and scores each item from 0 to 2 or 0 to 4. Total score from 0 to 76. The higher the score, the more severe.|units on a scale|Mean|29.4|29.4|Standard Deviation|5.0|5.0|||
4159138|NCT00839423|3982111|B3|||Baseline 24-item HAM-D Total Score|The 24-item Hamilton Depression Rating Scale (HAM-D) is based on the 21-item HAM-D plus an additional 3 items (helplessness, hopelessness, and worthlessness). The observer makes his/her assessment on the basis of a specific statement, content, tone, facial expression, and gestures of the patient during the interview, and scores each item from 0 to 2 or 0 to 4. Total score from 0 to 76. The higher the score, the more severe.|units on a scale|Mean|29.3|29.3|Standard Deviation|5.6|5.6|||
4159139|NCT00839423|3982112|B2|||Baseline 24-item HAM-D Total Score|The 24-item Hamilton Depression Rating Scale (HAM-D) is based on the 21-item HAM-D plus an additional 3 items (helplessness, hopelessness, and worthlessness). The observer makes his/her assessment on the basis of a specific statement, content, tone, facial expression, and gestures of the patient during the interview, and scores each item from 0 to 2 or 0 to 4. Total score from 0 to 76. The higher the score, the more severe.|units on a scale|Mean|29.9|29.9|Standard Deviation|5.4|5.4|||
4159140|NCT00839423|3982113|B1|||Baseline 24-item HAM-D Total Score|The 24-item Hamilton Depression Rating Scale (HAM-D) is based on the 21-item HAM-D plus an additional 3 items (helplessness, hopelessness, and worthlessness). The observer makes his/her assessment on the basis of a specific statement, content, tone, facial expression, and gestures of the patient during the interview, and scores each item from 0 to 2 or 0 to 4. Total score from 0 to 76. The higher the score, the more severe.|units on a scale|Mean|29.7|29.7|Standard Deviation|5.0|5.0|||
4159141|NCT00839423|3982109|B5|||MADRS: Baseline Total Score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 (no symptom) to 6 (severe symptom). The 10 items represent the core symptoms of depressive illness. The rating should be based on a clinical interview with the patient, moving from broadly phrased questions about symptoms to more detailed ones, which allow a precise rating of severity, covering the last 7 days. Total score from 0 to 60. The higher the score, the more severe.|units on a scale|Mean|34.0|34.0|Standard Deviation|2.8|2.8|||
4159142|NCT00839423|3982110|B4|||MADRS: Baseline Total Score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 (no symptom) to 6 (severe symptom). The 10 items represent the core symptoms of depressive illness. The rating should be based on a clinical interview with the patient, moving from broadly phrased questions about symptoms to more detailed ones, which allow a precise rating of severity, covering the last 7 days. Total score from 0 to 60. The higher the score, the more severe.|units on a scale|Mean|34.2|34.2|Standard Deviation|3.1|3.1|||
4159143|NCT00839423|3982111|B3|||MADRS: Baseline Total Score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 (no symptom) to 6 (severe symptom). The 10 items represent the core symptoms of depressive illness. The rating should be based on a clinical interview with the patient, moving from broadly phrased questions about symptoms to more detailed ones, which allow a precise rating of severity, covering the last 7 days. Total score from 0 to 60. The higher the score, the more severe.|units on a scale|Mean|34.0|34.0|Standard Deviation|2.8|2.8|||
4159144|NCT00839423|3982112|B2|||MADRS: Baseline Total Score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 (no symptom) to 6 (severe symptom). The 10 items represent the core symptoms of depressive illness. The rating should be based on a clinical interview with the patient, moving from broadly phrased questions about symptoms to more detailed ones, which allow a precise rating of severity, covering the last 7 days. Total score from 0 to 60. The higher the score, the more severe.|units on a scale|Mean|34.1|34.1|Standard Deviation|2.6|2.6|||
4159145|NCT00839423|3982113|B1|||MADRS: Baseline Total Score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 (no symptom) to 6 (severe symptom). The 10 items represent the core symptoms of depressive illness. The rating should be based on a clinical interview with the patient, moving from broadly phrased questions about symptoms to more detailed ones, which allow a precise rating of severity, covering the last 7 days. Total score from 0 to 60. The higher the score, the more severe.|units on a scale|Mean|33.9|33.9|Standard Deviation|2.7|2.7|||
4159146|NCT00839423|3982109|B5||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4159147|NCT00839423|3982110|B4||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4159148|NCT00839423|3982111|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4159149|NCT00839423|3982112|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4159150|NCT00839423|3982113|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4159151|NCT00839423|3982109|B5||Female|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
4159152|NCT00839423|3982110|B4||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4159153|NCT00839423|3982111|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4159154|NCT00839423|3982112|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4159158|NCT00839423|3982111|B3|||Age||years|Mean|42.3|42.3|Standard Deviation|13.1|13.1|||
4159159|NCT00839423|3982112|B2|||Age||years|Mean|43.8|43.8|Standard Deviation|11.6|11.6|||
4159160|NCT00839423|3982113|B1|||Age||years|Mean|42.0|42.0|Standard Deviation|10.9|10.9|||
4159161|NCT00839332|3982154|B4|ECOG Status 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death) as follows: 0 - Fully Active; 1 - Ambulatory, Restricted Strenuous Activity; 2 - Ambulatory, No Work Activities; 3 - Partially Confined to Bed, Limited Self Care; 4 - Completely Disabled; and 5 - Dead.|Participants|Count of Participants|9|9.0||||||
4159162|NCT00839332|3982155|B3|ECOG Status 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death) as follows: 0 - Fully Active; 1 - Ambulatory, Restricted Strenuous Activity; 2 - Ambulatory, No Work Activities; 3 - Partially Confined to Bed, Limited Self Care; 4 - Completely Disabled; and 5 - Dead.|Participants|Count of Participants|3|3.0||||||
4159163|NCT00839332|3982156|B2|ECOG Status 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death) as follows: 0 - Fully Active; 1 - Ambulatory, Restricted Strenuous Activity; 2 - Ambulatory, No Work Activities; 3 - Partially Confined to Bed, Limited Self Care; 4 - Completely Disabled; and 5 - Dead.|Participants|Count of Participants|6|6.0||||||
4159164|NCT00839332|3982157|B1|ECOG Status 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death) as follows: 0 - Fully Active; 1 - Ambulatory, Restricted Strenuous Activity; 2 - Ambulatory, No Work Activities; 3 - Partially Confined to Bed, Limited Self Care; 4 - Completely Disabled; and 5 - Dead.|Participants|Count of Participants|0|0.0||||||
4159165|NCT00839332|3982154|B4|ECOG Status 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death) as follows: 0 - Fully Active; 1 - Ambulatory, Restricted Strenuous Activity; 2 - Ambulatory, No Work Activities; 3 - Partially Confined to Bed, Limited Self Care; 4 - Completely Disabled; and 5 - Dead.|Participants|Count of Participants|79|79.0||||||
4159166|NCT00839332|3982155|B3|ECOG Status 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death) as follows: 0 - Fully Active; 1 - Ambulatory, Restricted Strenuous Activity; 2 - Ambulatory, No Work Activities; 3 - Partially Confined to Bed, Limited Self Care; 4 - Completely Disabled; and 5 - Dead.|Participants|Count of Participants|17|17.0||||||
4159167|NCT00839332|3982156|B2|ECOG Status 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death) as follows: 0 - Fully Active; 1 - Ambulatory, Restricted Strenuous Activity; 2 - Ambulatory, No Work Activities; 3 - Partially Confined to Bed, Limited Self Care; 4 - Completely Disabled; and 5 - Dead.|Participants|Count of Participants|31|31.0||||||
4159168|NCT00839332|3982157|B1|ECOG Status 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death) as follows: 0 - Fully Active; 1 - Ambulatory, Restricted Strenuous Activity; 2 - Ambulatory, No Work Activities; 3 - Partially Confined to Bed, Limited Self Care; 4 - Completely Disabled; and 5 - Dead.|Participants|Count of Participants|31|31.0||||||
4159169|NCT00839332|3982154|B4|ECOG Status 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death) as follows: 0 - Fully Active; 1 - Ambulatory, Restricted Strenuous Activity; 2 - Ambulatory, No Work Activities; 3 - Partially Confined to Bed, Limited Self Care; 4 - Completely Disabled; and 5 - Dead.|Participants|Count of Participants|61|61.0||||||
4159170|NCT00839332|3982155|B3|ECOG Status 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death) as follows: 0 - Fully Active; 1 - Ambulatory, Restricted Strenuous Activity; 2 - Ambulatory, No Work Activities; 3 - Partially Confined to Bed, Limited Self Care; 4 - Completely Disabled; and 5 - Dead.|Participants|Count of Participants|14|14.0||||||
4159171|NCT00839332|3982156|B2|ECOG Status 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death) as follows: 0 - Fully Active; 1 - Ambulatory, Restricted Strenuous Activity; 2 - Ambulatory, No Work Activities; 3 - Partially Confined to Bed, Limited Self Care; 4 - Completely Disabled; and 5 - Dead.|Participants|Count of Participants|28|28.0||||||
4159172|NCT00839332|3982157|B1|ECOG Status 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death) as follows: 0 - Fully Active; 1 - Ambulatory, Restricted Strenuous Activity; 2 - Ambulatory, No Work Activities; 3 - Partially Confined to Bed, Limited Self Care; 4 - Completely Disabled; and 5 - Dead.|Participants|Count of Participants|19|19.0||||||
4159173|NCT00839332|3982154|B4|Tumor||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4159174|NCT00839332|3982155|B3|Tumor||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159175|NCT00839332|3982156|B2|Tumor||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159176|NCT00839332|3982157|B1|Tumor||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4159177|NCT00839332|3982154|B4|Squamous Cell Carcinoma, Cervix||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4159178|NCT00839332|3982155|B3|Squamous Cell Carcinoma, Cervix||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159179|NCT00839332|3982156|B2|Squamous Cell Carcinoma, Cervix||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159180|NCT00839332|3982157|B1|Squamous Cell Carcinoma, Cervix||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4159181|NCT00839332|3982154|B4|Ovarian Adenocarcinoma||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4159182|NCT00839332|3982155|B3|Ovarian Adenocarcinoma||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159183|NCT00839332|3982156|B2|Ovarian Adenocarcinoma||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159184|NCT00839332|3982157|B1|Ovarian Adenocarcinoma||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4159185|NCT00839332|3982154|B4|Mesothelioma, Pleural, Malignant||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4159186|NCT00839332|3982155|B3|Mesothelioma, Pleural, Malignant||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159187|NCT00839332|3982156|B2|Mesothelioma, Pleural, Malignant||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159188|NCT00839332|3982157|B1|Mesothelioma, Pleural, Malignant||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4159189|NCT00839332|3982154|B4|Lymphoma, Non-Hodgkin's Lymphoma||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4159190|NCT00839332|3982155|B3|Lymphoma, Non-Hodgkin's Lymphoma||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159191|NCT00839332|3982156|B2|Lymphoma, Non-Hodgkin's Lymphoma||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159192|NCT00839332|3982157|B1|Lymphoma, Non-Hodgkin's Lymphoma||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4159193|NCT00839332|3982154|B4|Ewing's Sarcoma||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4159194|NCT00839332|3982155|B3|Ewing's Sarcoma||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159195|NCT00839332|3982156|B2|Ewing's Sarcoma||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159196|NCT00839332|3982157|B1|Ewing's Sarcoma||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4159197|NCT00839332|3982154|B4|Carcinoma, Transitional Cell, Urothelium||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4159198|NCT00839332|3982155|B3|Carcinoma, Transitional Cell, Urothelium||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159199|NCT00839332|3982156|B2|Carcinoma, Transitional Cell, Urothelium||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159200|NCT00839332|3982157|B1|Carcinoma, Transitional Cell, Urothelium||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4159201|NCT00839332|3982154|B4|Carcinoma, Small Cell, Lung||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4159202|NCT00839332|3982155|B3|Carcinoma, Small Cell, Lung||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159203|NCT00839332|3982156|B2|Carcinoma, Small Cell, Lung||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159204|NCT00839332|3982157|B1|Carcinoma, Small Cell, Lung||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4159205|NCT00839332|3982154|B4|Carcinoma, Peritoneal||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4159206|NCT00839332|3982155|B3|Carcinoma, Peritoneal||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159207|NCT00839332|3982156|B2|Carcinoma, Peritoneal||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159208|NCT00839332|3982157|B1|Carcinoma, Peritoneal||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4159209|NCT00839332|3982154|B4|Carcinoma, Ovarian||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4159210|NCT00839332|3982155|B3|Carcinoma, Ovarian||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159211|NCT00839332|3982156|B2|Carcinoma, Ovarian||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159212|NCT00839332|3982157|B1|Carcinoma, Ovarian||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4159213|NCT00839332|3982154|B4|Carcinoma, Head and Neck||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4159214|NCT00839332|3982155|B3|Carcinoma, Head and Neck||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159215|NCT00839332|3982156|B2|Carcinoma, Head and Neck||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159216|NCT00839332|3982157|B1|Carcinoma, Head and Neck||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4159217|NCT00839332|3982154|B4|Ampulla of Pancreas||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4159218|NCT00839332|3982155|B3|Ampulla of Pancreas||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159219|NCT00839332|3982156|B2|Ampulla of Pancreas||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159220|NCT00839332|3982157|B1|Ampulla of Pancreas||Initial Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4159221|NCT00839332|3982154|B4|Squamous Cell Carcinoma, Head and Neck||Initial Pathological Diagnosis||Participants|Count of Participants|2|2.0||||||
4159222|NCT00839332|3982155|B3|Squamous Cell Carcinoma, Head and Neck||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159223|NCT00839332|3982156|B2|Squamous Cell Carcinoma, Head and Neck||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159224|NCT00839332|3982157|B1|Squamous Cell Carcinoma, Head and Neck||Initial Pathological Diagnosis||Participants|Count of Participants|2|2.0||||||
4159225|NCT00839332|3982154|B4|Sarcoma, Leiomyosarcoma, Abdomen (Non-Gist)||Initial Pathological Diagnosis||Participants|Count of Participants|2|2.0||||||
4159226|NCT00839332|3982155|B3|Sarcoma, Leiomyosarcoma, Abdomen (Non-Gist)||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159278|NCT00839332|3982155|B3|Germany||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4159227|NCT00839332|3982156|B2|Sarcoma, Leiomyosarcoma, Abdomen (Non-Gist)||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159228|NCT00839332|3982157|B1|Sarcoma, Leiomyosarcoma, Abdomen (Non-Gist)||Initial Pathological Diagnosis||Participants|Count of Participants|2|2.0||||||
4159229|NCT00839332|3982154|B4|Carcinoma, Renal Cell||Initial Pathological Diagnosis||Participants|Count of Participants|2|2.0||||||
4159230|NCT00839332|3982155|B3|Carcinoma, Renal Cell||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159231|NCT00839332|3982156|B2|Carcinoma, Renal Cell||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159232|NCT00839332|3982157|B1|Carcinoma, Renal Cell||Initial Pathological Diagnosis||Participants|Count of Participants|2|2.0||||||
4159233|NCT00839332|3982154|B4|Carcinoma, Infiltrating Ductal, Breast||Initial Pathological Diagnosis||Participants|Count of Participants|2|2.0||||||
4159234|NCT00839332|3982155|B3|Carcinoma, Infiltrating Ductal, Breast||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159235|NCT00839332|3982156|B2|Carcinoma, Infiltrating Ductal, Breast||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159236|NCT00839332|3982157|B1|Carcinoma, Infiltrating Ductal, Breast||Initial Pathological Diagnosis||Participants|Count of Participants|2|2.0||||||
4159237|NCT00839332|3982154|B4|Carcinoma, Endometrium||Initial Pathological Diagnosis||Participants|Count of Participants|2|2.0||||||
4159238|NCT00839332|3982155|B3|Carcinoma, Endometrium||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159239|NCT00839332|3982156|B2|Carcinoma, Endometrium||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159240|NCT00839332|3982157|B1|Carcinoma, Endometrium||Initial Pathological Diagnosis||Participants|Count of Participants|2|2.0||||||
4159241|NCT00839332|3982154|B4|Adenocarcinoma, Rectum||Initial Pathological Diagnosis||Participants|Count of Participants|2|2.0||||||
4159242|NCT00839332|3982155|B3|Adenocarcinoma, Rectum||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159243|NCT00839332|3982156|B2|Adenocarcinoma, Rectum||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159244|NCT00839332|3982157|B1|Adenocarcinoma, Rectum||Initial Pathological Diagnosis||Participants|Count of Participants|2|2.0||||||
4159245|NCT00839332|3982154|B4|Adenocarcinoma, Cervix||Initial Pathological Diagnosis||Participants|Count of Participants|2|2.0||||||
4159246|NCT00839332|3982155|B3|Adenocarcinoma, Cervix||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159247|NCT00839332|3982156|B2|Adenocarcinoma, Cervix||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159248|NCT00839332|3982157|B1|Adenocarcinoma, Cervix||Initial Pathological Diagnosis||Participants|Count of Participants|2|2.0||||||
4159249|NCT00839332|3982154|B4|Carcinoma, Non-Small Cell, Lung NOS||Initial Pathological Diagnosis||Participants|Count of Participants|3|3.0||||||
4159250|NCT00839332|3982155|B3|Carcinoma, Non-Small Cell, Lung NOS||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159251|NCT00839332|3982156|B2|Carcinoma, Non-Small Cell, Lung NOS||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159252|NCT00839332|3982157|B1|Carcinoma, Non-Small Cell, Lung NOS||Initial Pathological Diagnosis||Participants|Count of Participants|3|3.0||||||
4159253|NCT00839332|3982154|B4|Carcinoma, Breast||Initial Pathological Diagnosis||Participants|Count of Participants|4|4.0||||||
4159254|NCT00839332|3982155|B3|Carcinoma, Breast||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159255|NCT00839332|3982156|B2|Carcinoma, Breast||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159256|NCT00839332|3982157|B1|Carcinoma, Breast||Initial Pathological Diagnosis||Participants|Count of Participants|4|4.0||||||
4159257|NCT00839332|3982154|B4|Adenocarcinoma, Colon||Initial Pathological Diagnosis||Participants|Count of Participants|7|7.0||||||
4159258|NCT00839332|3982155|B3|Adenocarcinoma, Colon||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159259|NCT00839332|3982156|B2|Adenocarcinoma, Colon||Initial Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4159260|NCT00839332|3982157|B1|Adenocarcinoma, Colon||Initial Pathological Diagnosis||Participants|Count of Participants|7|7.0||||||
4159261|NCT00839332|3982154|B4|Adenocarcinoma, Pancreas||Initial Pathological Diagnosis||Participants|Count of Participants|109|109.0||||||
4159262|NCT00839332|3982155|B3|Adenocarcinoma, Pancreas||Initial Pathological Diagnosis||Participants|Count of Participants|34|34.0||||||
4159263|NCT00839332|3982156|B2|Adenocarcinoma, Pancreas||Initial Pathological Diagnosis||Participants|Count of Participants|65|65.0||||||
4159264|NCT00839332|3982157|B1|Adenocarcinoma, Pancreas||Initial Pathological Diagnosis||Participants|Count of Participants|10|10.0||||||
4159265|NCT00839332|3982154|B4|Poland||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4159266|NCT00839332|3982155|B3|Poland||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4159267|NCT00839332|3982156|B2|Poland||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4159268|NCT00839332|3982157|B1|Poland||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4159269|NCT00839332|3982154|B4|Italy||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4159270|NCT00839332|3982155|B3|Italy||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4159271|NCT00839332|3982156|B2|Italy||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4159272|NCT00839332|3982157|B1|Italy||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4159273|NCT00839332|3982154|B4|Netherlands||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4159274|NCT00839332|3982155|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4159275|NCT00839332|3982156|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4159276|NCT00839332|3982157|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4159277|NCT00839332|3982154|B4|Germany||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
4159279|NCT00839332|3982156|B2|Germany||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
4159280|NCT00839332|3982157|B1|Germany||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4159281|NCT00839332|3982154|B4|Romania||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4159282|NCT00839332|3982155|B3|Romania||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4159283|NCT00839332|3982156|B2|Romania||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4159284|NCT00839332|3982157|B1|Romania||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4159285|NCT00839332|3982154|B4|Spain||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
4159286|NCT00839332|3982155|B3|Spain||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4159287|NCT00839332|3982156|B2|Spain||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4159288|NCT00839332|3982157|B1|Spain||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4159289|NCT00839332|3982154|B4|United States||Region of Enrollment||Participants|Count of Participants|73|73.0||||||
4159290|NCT00839332|3982155|B3|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4159291|NCT00839332|3982156|B2|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
4159292|NCT00839332|3982157|B1|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
4159293|NCT00839332|3982154|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4159294|NCT00839332|3982155|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4159295|NCT00839332|3982156|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4159296|NCT00839332|3982157|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4159297|NCT00839332|3982154|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4159298|NCT00839332|3982155|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4159299|NCT00839332|3982156|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4159300|NCT00839332|3982157|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4159301|NCT00839332|3982154|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4159302|NCT00839332|3982155|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4159303|NCT00839332|3982156|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4159304|NCT00839332|3982157|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4159305|NCT00839332|3982154|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|140|140.0||||||
4159306|NCT00839332|3982155|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
4159307|NCT00839332|3982156|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|62|62.0||||||
4159308|NCT00839332|3982157|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
4159309|NCT00839332|3982154|B4||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4159310|NCT00839332|3982155|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4159311|NCT00839332|3982156|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4159312|NCT00839332|3982157|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4159313|NCT00839332|3982154|B4||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4159314|NCT00839332|3982155|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4159315|NCT00839332|3982156|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4159316|NCT00839332|3982157|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4159317|NCT00839332|3982154|B4|||Age||years|Mean|62.54|62.54|Standard Deviation|11.8|11.8|||
4159318|NCT00839332|3982155|B3|||Age||years|Mean|64.4|64.4|Standard Deviation|10.1|10.1|||
4159319|NCT00839332|3982156|B2|||Age||years|Mean|64.3|64.3|Standard Deviation|8.3|8.3|||
4159320|NCT00839332|3982157|B1|||Age||years|Mean|59.0|59.0|Standard Deviation|12.2|12.2|||
4159321|NCT00839319|3982182|B6|||Intratesticular Dihydrotestosterone (ITT-DHT)||nmol/L|Median|11.9|11.9|Inter-Quartile Range|||7.3|21.3|
4159322|NCT00839319|3982183|B5|||Intratesticular Dihydrotestosterone (ITT-DHT)||nmol/L|Median|12.9|12.9|Inter-Quartile Range|||7.9|15.5|
4159323|NCT00839319|3982184|B4|||Intratesticular Dihydrotestosterone (ITT-DHT)||nmol/L|Median|18.8|18.8|Inter-Quartile Range|||11.1|22.2|
4159324|NCT00839319|3982185|B3|||Intratesticular Dihydrotestosterone (ITT-DHT)||nmol/L|Median|7.6|7.6|Inter-Quartile Range|||7.1|21.3|
4159325|NCT00839319|3982186|B2|||Intratesticular Dihydrotestosterone (ITT-DHT)||nmol/L|Median|5.0|5.0|Inter-Quartile Range|||4.5|11.0|
4159326|NCT00839319|3982187|B1|||Intratesticular Dihydrotestosterone (ITT-DHT)||nmol/L|Median|18.0|18.0|Inter-Quartile Range|||11.9|24.5|
4159327|NCT00839319|3982182|B6|||Intratesticular Testosterone (ITT-T)||nmol/L|Median|2508|2508.0|Inter-Quartile Range|||1753.0|3502.0|
4159328|NCT00839319|3982183|B5|||Intratesticular Testosterone (ITT-T)||nmol/L|Median|2933|2933.0|Inter-Quartile Range|||1527.0|3390.0|
4159329|NCT00839319|3982184|B4|||Intratesticular Testosterone (ITT-T)||nmol/L|Median|3502|3502.0|Inter-Quartile Range|||2305.0|3959.0|
4159330|NCT00839319|3982185|B3|||Intratesticular Testosterone (ITT-T)||nmol/L|Median|1821|1821.0|Inter-Quartile Range|||1753.0|2412.0|
4159331|NCT00839319|3982186|B2|||Intratesticular Testosterone (ITT-T)||nmol/L|Median|2425|2425.0|Inter-Quartile Range|||1700.0|3380.0|
4159332|NCT00839319|3982187|B1|||Intratesticular Testosterone (ITT-T)||nmol/L|Median|3467|3467.0|Inter-Quartile Range|||2508.0|3839.0|
4159333|NCT00839319|3982182|B6|||Serum 17-Hydroxyprogesterone||nmol/L|Median|4.9|4.9|Inter-Quartile Range|||3.9|6.5|
4159334|NCT00839319|3982183|B5|||Serum 17-Hydroxyprogesterone||nmol/L|Median|4.6|4.6|Inter-Quartile Range|||3.7|5.4|
4159335|NCT00839319|3982184|B4|||Serum 17-Hydroxyprogesterone||nmol/L|Median|4.3|4.3|Inter-Quartile Range|||4.0|4.5|
4159336|NCT00839319|3982185|B3|||Serum 17-Hydroxyprogesterone||nmol/L|Median|5.9|5.9|Inter-Quartile Range|||5.1|7.6|
4159337|NCT00839319|3982186|B2|||Serum 17-Hydroxyprogesterone||nmol/L|Median|4.9|4.9|Inter-Quartile Range|||4.2|6.5|
4159338|NCT00839319|3982187|B1|||Serum 17-Hydroxyprogesterone||nmol/L|Median|4.7|4.7|Inter-Quartile Range|||3.8|7.8|
4159339|NCT00839319|3982182|B6|||Serum Estradiol||pmol/L|Median|77|77.0|Inter-Quartile Range|||46.0|104.0|
4159340|NCT00839319|3982183|B5|||Serum Estradiol||pmol/L|Median|86|86.0|Inter-Quartile Range|||54.0|95.0|
4159341|NCT00839319|3982184|B4|||Serum Estradiol||pmol/L|Median|77|77.0|Inter-Quartile Range|||44.0|95.0|
4159342|NCT00839319|3982185|B3|||Serum Estradiol||pmol/L|Median|62|62.0|Inter-Quartile Range|||48.0|78.0|
4159343|NCT00839319|3982186|B2|||Serum Estradiol||pmol/L|Median|65|65.0|Inter-Quartile Range|||34.0|125.0|
4159344|NCT00839319|3982187|B1|||Serum Estradiol||pmol/L|Median|89|89.0|Inter-Quartile Range|||47.0|150.0|
4159345|NCT00839319|3982182|B6|||Serum Dihydrotestosterone (DHT)||nmol/L|Median|1.1|1.1|Inter-Quartile Range|||0.9|1.4|
4159346|NCT00839319|3982183|B5|||Serum Dihydrotestosterone (DHT)||nmol/L|Median|1.1|1.1|Inter-Quartile Range|||1.1|1.2|
4159347|NCT00839319|3982184|B4|||Serum Dihydrotestosterone (DHT)||nmol/L|Median|0.9|0.9|Inter-Quartile Range|||0.7|1.5|
4159348|NCT00839319|3982185|B3|||Serum Dihydrotestosterone (DHT)||nmol/L|Median|1.2|1.2|Inter-Quartile Range|||1.0|1.3|
4159349|NCT00839319|3982186|B2|||Serum Dihydrotestosterone (DHT)||nmol/L|Median|1.3|1.3|Inter-Quartile Range|||0.9|1.7|
4159350|NCT00839319|3982187|B1|||Serum Dihydrotestosterone (DHT)||nmol/L|Median|1.0|1.0|Inter-Quartile Range|||0.7|1.5|
4159351|NCT00839319|3982182|B6|||Serum Testosterone (T)||nmol/L|Median|14.6|14.6|Inter-Quartile Range|||12.0|17.3|
4159352|NCT00839319|3982183|B5|||Serum Testosterone (T)||nmol/L|Median|15.0|15.0|Inter-Quartile Range|||13.7|18.3|
4159353|NCT00839319|3982184|B4|||Serum Testosterone (T)||nmol/L|Median|16.8|16.8|Inter-Quartile Range|||14.4|18.6|
4159354|NCT00839319|3982185|B3|||Serum Testosterone (T)||nmol/L|Median|14.2|14.2|Inter-Quartile Range|||12.7|14.9|
4159355|NCT00839319|3982186|B2|||Serum Testosterone (T)||nmol/L|Median|15.0|15.0|Inter-Quartile Range|||11.4|20.9|
4159356|NCT00839319|3982187|B1|||Serum Testosterone (T)||nmol/L|Median|13.0|13.0|Inter-Quartile Range|||11.3|16.9|
4159357|NCT00839319|3982182|B6|||Serum Follicle Simulating Hormone (FSH)||IU/L|Median|2.4|2.4|Inter-Quartile Range|||1.5|3.0|
4159358|NCT00839319|3982183|B5|||Serum Follicle Simulating Hormone (FSH)||IU/L|Median|1.9|1.9|Inter-Quartile Range|||1.3|2.8|
4159359|NCT00839319|3982184|B4|||Serum Follicle Simulating Hormone (FSH)||IU/L|Median|2.2|2.2|Inter-Quartile Range|||1.9|2.5|
4159360|NCT00839319|3982185|B3|||Serum Follicle Simulating Hormone (FSH)||IU/L|Median|2.6|2.6|Inter-Quartile Range|||2.2|3.2|
4159361|NCT00839319|3982186|B2|||Serum Follicle Simulating Hormone (FSH)||IU/L|Median|2.4|2.4|Inter-Quartile Range|||2.0|2.8|
4159362|NCT00839319|3982187|B1|||Serum Follicle Simulating Hormone (FSH)||IU/L|Median|2.7|2.7|Inter-Quartile Range|||1.2|3.4|
4159363|NCT00839319|3982182|B6|||Serum Luteinizing Hormone (LH)||IU/L|Median|3.4|3.4|Inter-Quartile Range|||2.6|4.9|
4159364|NCT00839319|3982183|B5|||Serum Luteinizing Hormone (LH)||IU/L|Median|3.8|3.8|Inter-Quartile Range|||2.6|4.6|
4159365|NCT00839319|3982184|B4|||Serum Luteinizing Hormone (LH)||IU/L|Median|2.9|2.9|Inter-Quartile Range|||2.3|3.7|
4159366|NCT00839319|3982185|B3|||Serum Luteinizing Hormone (LH)||IU/L|Median|3.4|3.4|Inter-Quartile Range|||3.4|4.9|
4159367|NCT00839319|3982186|B2|||Serum Luteinizing Hormone (LH)||IU/L|Median|3.0|3.0|Inter-Quartile Range|||2.6|4.9|
4159368|NCT00839319|3982187|B1|||Serum Luteinizing Hormone (LH)||IU/L|Median|3.5|3.5|Inter-Quartile Range|||3.1|4.8|
4159369|NCT00839319|3982182|B6|||Body Mass Index (BMI)||kg/m^2|Median|24.1|24.1|Inter-Quartile Range|||22.9|26.3|
4159370|NCT00839319|3982183|B5|||Body Mass Index (BMI)||kg/m^2|Median|23.7|23.7|Inter-Quartile Range|||21.1|25.4|
4159371|NCT00839319|3982184|B4|||Body Mass Index (BMI)||kg/m^2|Median|25.8|25.8|Inter-Quartile Range|||22.9|26.0|
4159372|NCT00839319|3982185|B3|||Body Mass Index (BMI)||kg/m^2|Median|24.9|24.9|Inter-Quartile Range|||21.2|26.3|
4159373|NCT00839319|3982186|B2|||Body Mass Index (BMI)||kg/m^2|Median|24.1|24.1|Inter-Quartile Range|||23.2|26.7|
4159374|NCT00839319|3982187|B1|||Body Mass Index (BMI)||kg/m^2|Median|24.8|24.8|Inter-Quartile Range|||23.6|26.3|
4159375|NCT00839319|3982182|B6||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4159376|NCT00839319|3982183|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4159377|NCT00839319|3982184|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4159378|NCT00839319|3982185|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4159379|NCT00839319|3982186|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4159380|NCT00839319|3982187|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4159381|NCT00839319|3982182|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4159382|NCT00839319|3982183|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4159383|NCT00839319|3982184|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4159384|NCT00839319|3982185|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4159385|NCT00839319|3982186|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4159386|NCT00839319|3982187|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4159387|NCT00839319|3982182|B6|||Age, Customized||years|Median|22|22.0|Inter-Quartile Range|||20.0|26.0|
4159388|NCT00839319|3982183|B5|||Age, Customized||years|Median|22|22.0|Inter-Quartile Range|||20.0|24.0|
4159389|NCT00839319|3982184|B4|||Age, Customized||years|Median|22|22.0|Inter-Quartile Range|||21.0|26.0|
4159390|NCT00839319|3982185|B3|||Age, Customized||years|Median|22|22.0|Inter-Quartile Range|||20.0|24.0|
4159391|NCT00839319|3982186|B2|||Age, Customized||years|Median|25|25.0|Inter-Quartile Range|||20.0|29.0|
4159392|NCT00839319|3982187|B1|||Age, Customized||years|Median|21|21.0|Inter-Quartile Range|||20.0|26.0|
4159393|NCT00839306|3982218|B3||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4159394|NCT00839306|3982219|B2||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4159395|NCT00839306|3982220|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4159396|NCT00839306|3982218|B3||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4159397|NCT00839306|3982219|B2||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4159398|NCT00839306|3982220|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4159399|NCT00839306|3982218|B3|||Age, Customized||Years|Mean|47.5|47.5|Standard Deviation|12.43|12.43|||
4159400|NCT00839306|3982219|B2|||Age, Customized||Years|Mean|47.5|47.5|Standard Deviation|12.06|12.06|||
4159401|NCT00839306|3982220|B1|||Age, Customized||Years|Mean|47.5|47.5|Standard Deviation|13.55|13.55|||
4159402|NCT00839241|3982229|B3|Poland||Region of Enrollment||participants|Number|45|45.0||||||
4159403|NCT00839241|3982230|B2|Poland||Region of Enrollment||participants|Number|25|25.0||||||
4159404|NCT00839241|3982231|B1|Poland||Region of Enrollment||participants|Number|20|20.0||||||
4159405|NCT00839241|3982229|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4159406|NCT00839241|3982230|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4159407|NCT00839241|3982231|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4159408|NCT00839241|3982229|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4159409|NCT00839241|3982230|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4159410|NCT00839241|3982231|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4159411|NCT00839241|3982229|B3|||Age||years|Mean|66.8|66.8|Standard Deviation|9.1|9.1|||
4159412|NCT00839241|3982230|B2|||Age||years|Mean|66.6|66.6|Standard Deviation|8.3|8.3|||
4159413|NCT00839241|3982231|B1|||Age||years|Mean|67.1|67.1|Standard Deviation|10.3|10.3|||
4159414|NCT00839241|3982229|B3||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4159415|NCT00839241|3982230|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4159416|NCT00839241|3982231|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4159417|NCT00839241|3982229|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4159418|NCT00839241|3982230|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4159419|NCT00839241|3982231|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4159420|NCT00839241|3982229|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159421|NCT00839241|3982230|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159422|NCT00839241|3982231|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159423|NCT00839098|3982316|B4|United States||Region of Enrollment||participants|Number|28|28.0||||||
4159424|NCT00839098|3982317|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4159425|NCT00839098|3982318|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4159426|NCT00839098|3982319|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4159427|NCT00839098|3982316|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4159428|NCT00839098|3982317|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4159429|NCT00839098|3982318|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4159430|NCT00839098|3982319|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4159431|NCT00839098|3982316|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4159432|NCT00839098|3982317|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4159433|NCT00839098|3982318|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4159434|NCT00839098|3982319|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4159435|NCT00839098|3982316|B4|||Age||Years of age|Mean|53.2|53.2|Standard Deviation|14.0|14.0|||
4159436|NCT00839098|3982317|B3|||Age||Years of age|Mean|54.5|54.5|Standard Deviation|17.0|17.0|||
4159437|NCT00839098|3982318|B2|||Age||Years of age|Mean|53.4|53.4|Standard Deviation|9.1|9.1|||
4159438|NCT00839098|3982319|B1|||Age||Years of age|Mean|47.0|47.0|Standard Deviation|19.9|19.9|||
4159439|NCT00839098|3982316|B4||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4159440|NCT00839098|3982317|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4159441|NCT00839098|3982318|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4159442|NCT00839098|3982319|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4159443|NCT00839098|3982316|B4||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4159444|NCT00839098|3982317|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4159445|NCT00839098|3982318|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4159446|NCT00839098|3982319|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4159447|NCT00839098|3982316|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159448|NCT00839098|3982317|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159449|NCT00839098|3982318|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159450|NCT00839098|3982319|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159451|NCT00839072|3982347|B1|Canada||Region of Enrollment||participants|Number|24|24.0||||||
4159452|NCT00839072|3982347|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4159453|NCT00839072|3982347|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4159454|NCT00839072|3982347|B1|||Age||years|Mean|35|35.0|Standard Deviation|6|6.0|||
4159455|NCT00839072|3982347|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4159456|NCT00839072|3982347|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4159457|NCT00839072|3982347|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159458|NCT00838981|3982364|B5|United States||Region of Enrollment||participants|Number|91|91.0||||||
4159459|NCT00838981|3982365|B4|United States||Region of Enrollment||participants|Number|27|27.0||||||
4159460|NCT00838981|3982366|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4159461|NCT00838981|3982367|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4159462|NCT00838981|3982368|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4159463|NCT00838981|3982364|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4159464|NCT00838981|3982365|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4159465|NCT00838981|3982366|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4159466|NCT00838981|3982367|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4159467|NCT00838981|3982368|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4159468|NCT00838981|3982364|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4159469|NCT00838981|3982365|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4159470|NCT00838981|3982366|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4159471|NCT00838981|3982367|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4159472|NCT00838981|3982368|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4159473|NCT00838981|3982364|B5||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4159474|NCT00838981|3982365|B4||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4159475|NCT00838981|3982366|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4159476|NCT00838981|3982367|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4159477|NCT00838981|3982368|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4159478|NCT00838981|3982364|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4159479|NCT00838981|3982365|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4159480|NCT00838981|3982366|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4159481|NCT00838981|3982367|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4159482|NCT00838981|3982368|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4159483|NCT00838981|3982364|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4159484|NCT00838981|3982365|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4159485|NCT00838981|3982366|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4159486|NCT00838981|3982367|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4159487|NCT00838981|3982368|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4159488|NCT00838981|3982364|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4159489|NCT00838981|3982365|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4159490|NCT00838981|3982366|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4159491|NCT00838981|3982367|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4159492|NCT00838981|3982368|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4159493|NCT00838981|3982364|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4159494|NCT00838981|3982365|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4159495|NCT00838981|3982366|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4159496|NCT00838981|3982367|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4159497|NCT00838981|3982368|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4159498|NCT00838981|3982364|B5||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4159499|NCT00838981|3982365|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4159500|NCT00838981|3982366|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4159501|NCT00838981|3982367|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4159502|NCT00838981|3982368|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4159503|NCT00838981|3982364|B5||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4159504|NCT00838981|3982365|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4159505|NCT00838981|3982366|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4159506|NCT00838981|3982367|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4159507|NCT00838981|3982368|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4159508|NCT00838981|3982364|B5|||Age||participants|Mean|38.3|38.3|Standard Deviation|10.7|10.7|||
4159509|NCT00838981|3982365|B4|||Age||participants|Mean|38.2|38.2|Standard Deviation|11.4|11.4|||
4159510|NCT00838981|3982366|B3|||Age||participants|Mean|34.5|34.5|Standard Deviation|10.2|10.2|||
4159511|NCT00838981|3982367|B2|||Age||participants|Mean|41.5|41.5|Standard Deviation|9.7|9.7|||
4159512|NCT00838981|3982368|B1|||Age||participants|Mean|38.9|38.9|Standard Deviation|10.8|10.8|||
4159513|NCT00838981|3982364|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4159514|NCT00838981|3982365|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4159515|NCT00838981|3982366|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4159516|NCT00838981|3982367|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4159517|NCT00838981|3982368|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4159518|NCT00838981|3982364|B5||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
4159519|NCT00838981|3982365|B4||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4159520|NCT00838981|3982366|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4159521|NCT00838981|3982367|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4159522|NCT00838981|3982368|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4159523|NCT00838981|3982364|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159524|NCT00838981|3982365|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159525|NCT00838981|3982366|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159526|NCT00838981|3982367|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159527|NCT00838981|3982368|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159528|NCT00838929|3982389|B4|United States||Region of Enrollment||participants|Number|17|17.0||||||
4159529|NCT00838929|3982390|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4159530|NCT00838929|3982391|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4159531|NCT00838929|3982392|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4159532|NCT00838929|3982389|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4159533|NCT00838929|3982390|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4159534|NCT00838929|3982391|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4159535|NCT00838929|3982392|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4159536|NCT00838929|3982389|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4159537|NCT00838929|3982390|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4159538|NCT00838929|3982391|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4159539|NCT00838929|3982392|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4159540|NCT00838929|3982389|B4||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4159541|NCT00838929|3982390|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4159542|NCT00838929|3982391|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4159543|NCT00838929|3982392|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4159544|NCT00838929|3982389|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4159545|NCT00838929|3982390|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4159546|NCT00838929|3982391|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4159547|NCT00838929|3982392|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4159548|NCT00838929|3982389|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159549|NCT00838929|3982390|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159550|NCT00838929|3982391|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159551|NCT00838929|3982392|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159552|NCT00838916|3982400|B3|Other - Mexican||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4159553|NCT00838916|3982401|B2|Other - Mexican||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4159554|NCT00838916|3982402|B1|Other - Mexican||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4159555|NCT00838916|3982400|B3|Other - Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4159556|NCT00838916|3982401|B2|Other - Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4159557|NCT00838916|3982402|B1|Other - Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4159558|NCT00838916|3982400|B3|Other - Central American Indian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4159559|NCT00838916|3982401|B2|Other - Central American Indian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4159560|NCT00838916|3982402|B1|Other - Central American Indian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4159561|NCT00838916|3982400|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|500|500.0||||||
4159562|NCT00838916|3982401|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|158|158.0||||||
4159563|NCT00838916|3982402|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|342|342.0||||||
4159564|NCT00838916|3982400|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4159565|NCT00838916|3982401|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4159566|NCT00838916|3982402|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4159567|NCT00838916|3982400|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4159568|NCT00838916|3982401|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4159569|NCT00838916|3982402|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4159570|NCT00838916|3982400|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
4159571|NCT00838916|3982401|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4159572|NCT00838916|3982402|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4159573|NCT00838916|3982400|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4159574|NCT00838916|3982401|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4159575|NCT00838916|3982402|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4159576|NCT00838916|3982400|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4159577|NCT00838916|3982401|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4159578|NCT00838916|3982402|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4159579|NCT00838916|3982400|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4159580|NCT00838916|3982401|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4159581|NCT00838916|3982402|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4159582|NCT00838916|3982400|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4159583|NCT00838916|3982401|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4159584|NCT00838916|3982402|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4159585|NCT00838916|3982400|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|194|194.0||||||
4159586|NCT00838916|3982401|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|64|64.0||||||
4159587|NCT00838916|3982402|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|130|130.0||||||
4159588|NCT00838916|3982400|B3||Male|Gender||Participants|Count of Participants|418|418.0||||||
4159589|NCT00838916|3982401|B2||Male|Gender||Participants|Count of Participants|132|132.0||||||
4159590|NCT00838916|3982402|B1||Male|Gender||Participants|Count of Participants|286|286.0||||||
4159591|NCT00838916|3982400|B3||Female|Gender||Participants|Count of Participants|327|327.0||||||
4159592|NCT00838916|3982401|B2||Female|Gender||Participants|Count of Participants|109|109.0||||||
4159593|NCT00838916|3982402|B1||Female|Gender||Participants|Count of Participants|218|218.0||||||
4159594|NCT00838916|3982400|B3|||Age||Years|Mean|55.5|55.5|Standard Deviation|9.48|9.48|||
4159595|NCT00838916|3982401|B2|||Age||Years|Mean|54.7|54.7|Standard Deviation|9.75|9.75|||
4159596|NCT00838916|3982402|B1|||Age||Years|Mean|55.8|55.8|Standard Deviation|9.33|9.33|||
4159597|NCT00838903|3982428|B5|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|723|723.0||||||
4159598|NCT00838903|3982429|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|214|214.0||||||
4159599|NCT00838903|3982430|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|220|220.0||||||
4159600|NCT00838903|3982431|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|225|225.0||||||
4159601|NCT00838903|3982432|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|64|64.0||||||
4159602|NCT00838903|3982428|B5|White - Arabic/North African Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|13|13.0||||||
4159603|NCT00838903|3982429|B4|White - Arabic/North African Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|3|3.0||||||
4159604|NCT00838903|3982430|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|9|9.0||||||
4159605|NCT00838903|3982431|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|1|1.0||||||
4159606|NCT00838903|3982432|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|0|0.0||||||
4159607|NCT00838903|3982428|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|2|2.0||||||
4159608|NCT00838903|3982429|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|1|1.0||||||
4159609|NCT00838903|3982430|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|0|0.0||||||
4159610|NCT00838903|3982431|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|0|0.0||||||
4159611|NCT00838903|3982432|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|1|1.0||||||
4159612|NCT00838903|3982428|B5|Asian - South East Asian Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|34|34.0||||||
4159613|NCT00838903|3982429|B4|Asian - South East Asian Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|11|11.0||||||
4159614|NCT00838903|3982430|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|9|9.0||||||
4159615|NCT00838903|3982431|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|11|11.0||||||
4159616|NCT00838903|3982432|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|3|3.0||||||
4159617|NCT00838903|3982428|B5|Asian - Japanese Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|2|2.0||||||
4159618|NCT00838903|3982429|B4|Asian - Japanese Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|0|0.0||||||
4159619|NCT00838903|3982430|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|1|1.0||||||
4159620|NCT00838903|3982431|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|0|0.0||||||
4159621|NCT00838903|3982432|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|1|1.0||||||
4159622|NCT00838903|3982428|B5|Asian - East Asian Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|10|10.0||||||
4159623|NCT00838903|3982429|B4|Asian - East Asian Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|5|5.0||||||
4159624|NCT00838903|3982430|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|3|3.0||||||
4159625|NCT00838903|3982431|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|2|2.0||||||
4159626|NCT00838903|3982432|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|0|0.0||||||
4159627|NCT00838903|3982428|B5|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|13|13.0||||||
4159628|NCT00838903|3982429|B4|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|2|2.0||||||
4159629|NCT00838903|3982430|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|3|3.0||||||
4159630|NCT00838903|3982431|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|7|7.0||||||
4159631|NCT00838903|3982432|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|1|1.0||||||
4159632|NCT00838903|3982428|B5|American Indian or Alaskan Native||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|73|73.0||||||
4159633|NCT00838903|3982429|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|17|17.0||||||
4159634|NCT00838903|3982430|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|25|25.0||||||
4159635|NCT00838903|3982431|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|22|22.0||||||
4159636|NCT00838903|3982432|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|9|9.0||||||
4159637|NCT00838903|3982428|B5|African American/African Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|150|150.0||||||
4159638|NCT00838903|3982429|B4|African American/African Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|53|53.0||||||
4159639|NCT00838903|3982430|B3|African American/African Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|39|39.0||||||
4159640|NCT00838903|3982431|B2|African American/African Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|35|35.0||||||
4159641|NCT00838903|3982432|B1|African American/African Heritage||Race/Ethnicity, Customized|A participant may have been counted in more than one category.|Participants|Number|23|23.0||||||
4159642|NCT00838903|3982428|B5||Male|Gender||Participants|Count of Participants|482|482.0||||||
4159643|NCT00838903|3982429|B4||Male|Gender||Participants|Count of Participants|135|135.0||||||
4159644|NCT00838903|3982430|B3||Male|Gender||Participants|Count of Participants|158|158.0||||||
4159645|NCT00838903|3982431|B2||Male|Gender||Participants|Count of Participants|139|139.0||||||
4159646|NCT00838903|3982432|B1||Male|Gender||Participants|Count of Participants|50|50.0||||||
4159647|NCT00838903|3982428|B5||Female|Gender||Participants|Count of Participants|530|530.0||||||
4159648|NCT00838903|3982429|B4||Female|Gender||Participants|Count of Participants|167|167.0||||||
4159649|NCT00838903|3982430|B3||Female|Gender||Participants|Count of Participants|149|149.0||||||
4159650|NCT00838903|3982431|B2||Female|Gender||Participants|Count of Participants|163|163.0||||||
4159651|NCT00838903|3982432|B1||Female|Gender||Participants|Count of Participants|51|51.0||||||
4159652|NCT00838903|3982428|B5|||Age||Years|Mean|54.5|54.5|Standard Deviation|9.97|9.97|||
4159653|NCT00838903|3982429|B4|||Age||Years|Mean|54.3|54.3|Standard Deviation|10.12|10.12|||
4159654|NCT00838903|3982430|B3|||Age||Years|Mean|54.4|54.4|Standard Deviation|9.97|9.97|||
4159655|NCT00838903|3982431|B2|||Age||Years|Mean|54.3|54.3|Standard Deviation|9.81|9.81|||
4159656|NCT00838903|3982432|B1|||Age||Years|Mean|56.1|56.1|Standard Deviation|10.01|10.01|||
4159657|NCT00838695|3982477|B3|||plasma epinephrine||pg/ml|Mean|19.4|19.4|Standard Deviation|13.7|13.7|||
4159658|NCT00838695|3982478|B2|||plasma epinephrine||pg/ml|Mean|18.5|18.5|Standard Deviation|12.5|12.5|||
4159659|NCT00838695|3982479|B1|||plasma epinephrine||pg/ml|Mean|21.0|21.0|Standard Deviation|15.6|15.6|||
4159660|NCT00838695|3982477|B3|||plasma norepinephrine||pg/ml|Mean|168.9|168.9|Standard Deviation|63.2|63.2|||
4159661|NCT00838695|3982478|B2|||plasma norepinephrine||pg/ml|Mean|162.3|162.3|Standard Deviation|58|58.0|||
4159662|NCT00838695|3982479|B1|||plasma norepinephrine||pg/ml|Mean|179.5|179.5|Standard Deviation|70.8|70.8|||
4159663|NCT00838695|3982477|B3|United States||Region of Enrollment||Participants|Count of Participants|106|106.0||||||
4159664|NCT00838695|3982478|B2|United States||Region of Enrollment||Participants|Count of Participants|64|64.0||||||
4159665|NCT00838695|3982479|B1|United States||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
4159666|NCT00838695|3982477|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4159667|NCT00838695|3982478|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4159668|NCT00838695|3982479|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4159669|NCT00838695|3982477|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4159670|NCT00838695|3982478|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4159671|NCT00838695|3982479|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4159672|NCT00838695|3982477|B3|||Age||years|Mean|27|27.0|Standard Deviation|7|7.0|||
4159673|NCT00838695|3982478|B2|||Age||years|Mean|26.9|26.9|Standard Deviation|6.8|6.8|||
4159674|NCT00838695|3982479|B1|||Age||years|Mean|28.1|28.1|Standard Deviation|8|8.0|||
4159675|NCT00838682|3982488|B3|Korea, Republic of||Region of Enrollment||participants|Number|106|106.0||||||
4159676|NCT00838682|3982489|B2|Korea, Republic of||Region of Enrollment||participants|Number|52|52.0||||||
4159677|NCT00838682|3982490|B1|Korea, Republic of||Region of Enrollment||participants|Number|54|54.0||||||
4159678|NCT00838682|3982488|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4159679|NCT00838682|3982489|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4159680|NCT00838682|3982490|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4159681|NCT00838682|3982488|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4159682|NCT00838682|3982489|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4159683|NCT00838682|3982490|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4159684|NCT00838682|3982488|B3|||Age||years|Mean|56.6|56.6|Standard Deviation|16.0|16.0|||
4159685|NCT00838682|3982489|B2|||Age||years|Mean|57.1|57.1|Standard Deviation|15.8|15.8|||
4159686|NCT00838682|3982490|B1|||Age||years|Mean|56.1|56.1|Standard Deviation|16.2|16.2|||
4159687|NCT00838630|3982507|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4159688|NCT00838630|3982508|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4159689|NCT00838630|3982509|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4159690|NCT00838630|3982507|B3|Black||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4159691|NCT00838630|3982508|B2|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4159692|NCT00838630|3982509|B1|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4159693|NCT00838630|3982507|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
4159694|NCT00838630|3982508|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4159695|NCT00838630|3982509|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4159696|NCT00838630|3982507|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4159697|NCT00838630|3982508|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4159698|NCT00838630|3982509|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4159699|NCT00838630|3982507|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4159700|NCT00838630|3982508|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4159701|NCT00838630|3982509|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4159702|NCT00838630|3982507|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4159703|NCT00838630|3982508|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4159704|NCT00838630|3982509|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4159705|NCT00838630|3982507|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4159706|NCT00838630|3982508|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4159707|NCT00838630|3982509|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4159708|NCT00838630|3982507|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159709|NCT00838630|3982508|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159710|NCT00838630|3982509|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159711|NCT00838578|3982518|B1|United States||Region of Enrollment||participants|Number|63|63.0||||||
4159712|NCT00838578|3982518|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4159713|NCT00838578|3982518|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4159714|NCT00838578|3982518|B1|||Age||years|Mean|59.83|59.83|Standard Deviation|10.185|10.185|||
4159715|NCT00838578|3982518|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4159716|NCT00838578|3982518|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4159717|NCT00838578|3982518|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159718|NCT00838565|3982526|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4159719|NCT00838565|3982527|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4159720|NCT00838565|3982528|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4159721|NCT00838565|3982529|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4159722|NCT00838565|3982530|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4159723|NCT00838565|3982531|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4159724|NCT00838565|3982532|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4159725|NCT00838565|3982526|B7||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4159726|NCT00838565|3982527|B6||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4159727|NCT00838565|3982528|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4159728|NCT00838565|3982529|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4159729|NCT00838565|3982530|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4159730|NCT00838565|3982531|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4159731|NCT00838565|3982532|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4159732|NCT00838565|3982526|B7|||Age||years|Mean|55.2|55.2|Standard Deviation|10.1|10.1|||
4159733|NCT00838565|3982527|B6|||Age||years|Mean|55.4|55.4|Standard Deviation|9.8|9.8|||
4159734|NCT00838565|3982528|B5|||Age||years|Mean|56.7|56.7|Standard Deviation|8.9|8.9|||
4159735|NCT00838565|3982529|B4|||Age||years|Mean|46.0|46.0|Standard Deviation|4.1|4.1|||
4159736|NCT00838565|3982530|B3|||Age||years|Mean|49.8|49.8|Standard Deviation|13.5|13.5|||
4159737|NCT00838565|3982531|B2|||Age||years|Mean|61.7|61.7|Standard Deviation|7.9|7.9|||
4159738|NCT00838565|3982532|B1|||Age||years|Mean|59.6|59.6|Standard Deviation|8.5|8.5|||
4159739|NCT00838539|3982630|B13||Unknown or Not Reported|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|31|31.0||||||
4159740|NCT00838539|3982631|B12||Unknown or Not Reported|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|2|2.0||||||
4159741|NCT00838539|3982632|B11||Unknown or Not Reported|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|1|1.0||||||
4159742|NCT00838539|3982633|B10||Unknown or Not Reported|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|5|5.0||||||
4159743|NCT00838539|3982634|B9||Unknown or Not Reported|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|3|3.0||||||
4159744|NCT00838539|3982635|B8||Unknown or Not Reported|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|3|3.0||||||
4159745|NCT00838539|3982636|B7||Unknown or Not Reported|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|3|3.0||||||
4159746|NCT00838539|3982637|B6||Unknown or Not Reported|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|1|1.0||||||
4159747|NCT00838539|3982638|B5||Unknown or Not Reported|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|3|3.0||||||
4159748|NCT00838539|3982639|B4||Unknown or Not Reported|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|3|3.0||||||
4159749|NCT00838539|3982640|B3||Unknown or Not Reported|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|3|3.0||||||
4159750|NCT00838539|3982641|B2||Unknown or Not Reported|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|2|2.0||||||
4159751|NCT00838539|3982642|B1||Unknown or Not Reported|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|2|2.0||||||
4159752|NCT00838539|3982630|B13||More than one race|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159753|NCT00838539|3982631|B12||More than one race|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159754|NCT00838539|3982632|B11||More than one race|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159755|NCT00838539|3982633|B10||More than one race|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159756|NCT00838539|3982634|B9||More than one race|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159757|NCT00838539|3982635|B8||More than one race|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159758|NCT00838539|3982636|B7||More than one race|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159759|NCT00838539|3982637|B6||More than one race|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159760|NCT00838539|3982638|B5||More than one race|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159761|NCT00838539|3982639|B4||More than one race|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159762|NCT00838539|3982640|B3||More than one race|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159763|NCT00838539|3982641|B2||More than one race|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159764|NCT00838539|3982642|B1||More than one race|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159765|NCT00838539|3982630|B13||White|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|26|26.0||||||
4159766|NCT00838539|3982631|B12||White|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|1|1.0||||||
4159767|NCT00838539|3982632|B11||White|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|3|3.0||||||
4159768|NCT00838539|3982633|B10||White|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|2|2.0||||||
4159769|NCT00838539|3982634|B9||White|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|2|2.0||||||
4159770|NCT00838539|3982635|B8||White|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|3|3.0||||||
4159771|NCT00838539|3982636|B7||White|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|4|4.0||||||
4159772|NCT00838539|3982637|B6||White|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|3|3.0||||||
4159773|NCT00838539|3982638|B5||White|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|1|1.0||||||
4159774|NCT00838539|3982639|B4||White|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|1|1.0||||||
4159775|NCT00838539|3982640|B3||White|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|2|2.0||||||
4159776|NCT00838539|3982641|B2||White|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|3|3.0||||||
4159777|NCT00838539|3982642|B1||White|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|1|1.0||||||
4159778|NCT00838539|3982630|B13||Black or African American|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|1|1.0||||||
4159779|NCT00838539|3982631|B12||Black or African American|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159780|NCT00838539|3982632|B11||Black or African American|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159781|NCT00838539|3982633|B10||Black or African American|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|1|1.0||||||
4159782|NCT00838539|3982634|B9||Black or African American|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159783|NCT00838539|3982635|B8||Black or African American|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159784|NCT00838539|3982636|B7||Black or African American|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159785|NCT00838539|3982637|B6||Black or African American|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159786|NCT00838539|3982638|B5||Black or African American|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159787|NCT00838539|3982639|B4||Black or African American|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159788|NCT00838539|3982640|B3||Black or African American|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159789|NCT00838539|3982641|B2||Black or African American|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159790|NCT00838539|3982642|B1||Black or African American|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159791|NCT00838539|3982630|B13||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159792|NCT00838539|3982631|B12||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159793|NCT00838539|3982632|B11||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159794|NCT00838539|3982633|B10||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159795|NCT00838539|3982634|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159796|NCT00838539|3982635|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159797|NCT00838539|3982636|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159798|NCT00838539|3982637|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159799|NCT00838539|3982638|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159800|NCT00838539|3982639|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159801|NCT00838539|3982640|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159802|NCT00838539|3982641|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159803|NCT00838539|3982642|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159804|NCT00838539|3982630|B13||Asian|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|2|2.0||||||
4159805|NCT00838539|3982631|B12||Asian|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|1|1.0||||||
4159806|NCT00838539|3982632|B11||Asian|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|1|1.0||||||
4159807|NCT00838539|3982633|B10||Asian|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159808|NCT00838539|3982634|B9||Asian|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159809|NCT00838539|3982635|B8||Asian|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159810|NCT00838539|3982636|B7||Asian|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159811|NCT00838539|3982637|B6||Asian|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159812|NCT00838539|3982638|B5||Asian|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159813|NCT00838539|3982639|B4||Asian|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159814|NCT00838539|3982640|B3||Asian|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159815|NCT00838539|3982641|B2||Asian|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159816|NCT00838539|3982642|B1||Asian|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159817|NCT00838539|3982630|B13||American Indian or Alaska Native|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159818|NCT00838539|3982631|B12||American Indian or Alaska Native|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159819|NCT00838539|3982632|B11||American Indian or Alaska Native|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159820|NCT00838539|3982633|B10||American Indian or Alaska Native|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159821|NCT00838539|3982634|B9||American Indian or Alaska Native|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159822|NCT00838539|3982635|B8||American Indian or Alaska Native|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159823|NCT00838539|3982636|B7||American Indian or Alaska Native|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159824|NCT00838539|3982637|B6||American Indian or Alaska Native|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159825|NCT00838539|3982638|B5||American Indian or Alaska Native|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159826|NCT00838539|3982639|B4||American Indian or Alaska Native|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159827|NCT00838539|3982640|B3||American Indian or Alaska Native|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159828|NCT00838539|3982641|B2||American Indian or Alaska Native|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159829|NCT00838539|3982642|B1||American Indian or Alaska Native|Race (NIH/OMB)|Race was not reported for 31 subjects in site in France.|Participants|Count of Participants|0|0.0||||||
4159830|NCT00838539|3982630|B13||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4159831|NCT00838539|3982631|B12||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4159832|NCT00838539|3982632|B11||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4159833|NCT00838539|3982633|B10||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4159834|NCT00838539|3982634|B9||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4159835|NCT00838539|3982635|B8||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4159836|NCT00838539|3982636|B7||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4159837|NCT00838539|3982637|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4159838|NCT00838539|3982638|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4159839|NCT00838539|3982639|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4159840|NCT00838539|3982640|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4159841|NCT00838539|3982641|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4159842|NCT00838539|3982642|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4159843|NCT00838539|3982630|B13||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4159844|NCT00838539|3982631|B12||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4159845|NCT00838539|3982632|B11||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4159846|NCT00838539|3982633|B10||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4159847|NCT00838539|3982634|B9||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4159848|NCT00838539|3982635|B8||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4159849|NCT00838539|3982636|B7||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4159850|NCT00838539|3982637|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4159851|NCT00838539|3982638|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4159852|NCT00838539|3982639|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4159853|NCT00838539|3982640|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4159854|NCT00838539|3982641|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4159855|NCT00838539|3982642|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4159856|NCT00838539|3982630|B13|||Age||years|Mean|50.82|50.82|Standard Deviation|12.70|12.7|||
4159857|NCT00838539|3982631|B12|||Age||years|Mean|56.75|56.75|Standard Deviation|5.74|5.74|||
4159858|NCT00838539|3982632|B11|||Age||years|Mean|50.00|50.0|Standard Deviation|7.00|7.0|||
4159859|NCT00838539|3982633|B10|||Age||years|Mean|44.50|44.5|Standard Deviation|18.72|18.72|||
4159860|NCT00838539|3982634|B9|||Age||years|Mean|59.60|59.6|Standard Deviation|10.62|10.62|||
4159861|NCT00838539|3982635|B8|||Age||years|Mean|53.17|53.17|Standard Deviation|11.62|11.62|||
4159862|NCT00838539|3982636|B7|||Age||years|Mean|49.29|49.29|Standard Deviation|12.20|12.2|||
4159863|NCT00838539|3982637|B6|||Age||years|Mean|49.75|49.75|Standard Deviation|5.68|5.68|||
4159864|NCT00838539|3982638|B5|||Age||years|Mean|49.75|49.75|Standard Deviation|4.79|4.79|||
4159865|NCT00838539|3982639|B4|||Age||years|Mean|49.50|49.5|Standard Deviation|7.94|7.94|||
4159866|NCT00838539|3982640|B3|||Age||years|Mean|43.00|43.0|Standard Deviation|16.40|16.4|||
4159867|NCT00838539|3982641|B2|||Age||years|Mean|58.60|58.6|Standard Deviation|10.26|10.26|||
4159868|NCT00838539|3982642|B1|||Age||years|Mean|50.00|50.0|Standard Deviation|26.15|26.15|||
4159869|NCT00838539|3982630|B13||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4159870|NCT00838539|3982631|B12||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4159871|NCT00838539|3982632|B11||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4159872|NCT00838539|3982633|B10||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4159873|NCT00838539|3982634|B9||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4159874|NCT00838539|3982635|B8||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4159875|NCT00838539|3982636|B7||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4159876|NCT00838539|3982637|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4159877|NCT00838539|3982638|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4159878|NCT00838539|3982639|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4159879|NCT00838539|3982640|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4159880|NCT00838539|3982641|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4159881|NCT00838539|3982642|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4159882|NCT00838539|3982630|B13||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4159883|NCT00838539|3982631|B12||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4159884|NCT00838539|3982632|B11||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4159885|NCT00838539|3982633|B10||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4159886|NCT00838539|3982634|B9||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4159887|NCT00838539|3982635|B8||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4159888|NCT00838539|3982636|B7||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4159889|NCT00838539|3982637|B6||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4159890|NCT00838539|3982638|B5||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4159891|NCT00838539|3982639|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4159892|NCT00838539|3982640|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4159893|NCT00838539|3982641|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4159894|NCT00838539|3982642|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4159895|NCT00838539|3982630|B13||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159896|NCT00838539|3982631|B12||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159897|NCT00838539|3982632|B11||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159898|NCT00838539|3982633|B10||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159899|NCT00838539|3982634|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159900|NCT00838539|3982635|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159901|NCT00838539|3982636|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159902|NCT00838539|3982637|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159903|NCT00838539|3982638|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159904|NCT00838539|3982639|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159905|NCT00838539|3982640|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159906|NCT00838539|3982641|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159907|NCT00838539|3982642|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159908|NCT00838526|3982701|B3||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4159909|NCT00838526|3982702|B2||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4159910|NCT00838526|3982703|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4159911|NCT00838526|3982701|B3||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4159912|NCT00838526|3982702|B2||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4159913|NCT00838526|3982703|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4159914|NCT00838526|3982701|B3|||Age, Customized||Years|Mean|46.5|46.5|Standard Deviation|12.64|12.64|||
4159915|NCT00838526|3982702|B2|||Age, Customized||Years|Mean|46.4|46.4|Standard Deviation|12.83|12.83|||
4159916|NCT00838526|3982703|B1|||Age, Customized||Years|Mean|46.7|46.7|Standard Deviation|12.15|12.15|||
4159917|NCT00838513|3982712|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4159918|NCT00838513|3982712|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4159919|NCT00838513|3982712|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4159920|NCT00838513|3982712|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4159921|NCT00838513|3982712|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4159922|NCT00838513|3982712|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4159923|NCT00838513|3982712|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4159924|NCT00838513|3982712|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4159925|NCT00838513|3982712|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4159926|NCT00838513|3982712|B1|||Age||Years|Mean|32.3|32.3|Standard Deviation|14.92|14.92|||
4159927|NCT00838331|3982728|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4159928|NCT00838331|3982728|B1|"Other"||Race/Ethnicity, Customized|"The volunteer population was composed of 4 Caucasians, 1 African-American, 2 Asian-Americans, and 1 participant whose race was categorized as other."|participants|Number|1|1.0||||||
4159929|NCT00838331|3982728|B1|Asian-American||Race/Ethnicity, Customized|"The volunteer population was composed of 4 Caucasians, 1 African-American, 2 Asian-Americans, and 1 participant whose race was categorized as other."|participants|Number|2|2.0||||||
4159930|NCT00838331|3982728|B1|African-American||Race/Ethnicity, Customized|"The volunteer population was composed of 4 Caucasians, 1 African-American, 2 Asian-Americans, and 1 participant whose race was categorized as other."|participants|Number|1|1.0||||||
4159931|NCT00838331|3982728|B1|Caucasian||Race/Ethnicity, Customized|"The volunteer population was composed of 4 Caucasians, 1 African-American, 2 Asian-Americans, and 1 participant whose race was categorized as other."|participants|Number|4|4.0||||||
4159932|NCT00838331|3982728|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4159933|NCT00838331|3982728|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4159934|NCT00838331|3982728|B1|||Age||years|Mean|26.6|26.6|Standard Deviation|3.4|3.4|||
4159935|NCT00838331|3982728|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4159936|NCT00838331|3982728|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4159937|NCT00838331|3982728|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159938|NCT00838279|3982732|B3|Canada||Region of Enrollment||participants|Number|32|32.0||||||
4159939|NCT00838279|3982733|B2|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4159940|NCT00838279|3982734|B1|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4159941|NCT00838279|3982732|B3|American Hispanic||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4159942|NCT00838279|3982733|B2|American Hispanic||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4159943|NCT00838279|3982734|B1|American Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4159944|NCT00838279|3982732|B3|Black||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4159945|NCT00838279|3982733|B2|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4159946|NCT00838279|3982734|B1|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4159947|NCT00838279|3982732|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
4159948|NCT00838279|3982733|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4159949|NCT00838279|3982734|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4159950|NCT00838279|3982732|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4159951|NCT00838279|3982733|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4159952|NCT00838279|3982734|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4159953|NCT00838279|3982732|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4159954|NCT00838279|3982733|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4159955|NCT00838279|3982734|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4159956|NCT00838279|3982732|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4159957|NCT00838279|3982733|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4159958|NCT00838279|3982734|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4159959|NCT00838279|3982732|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4159960|NCT00838279|3982733|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4159961|NCT00838279|3982734|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4159962|NCT00838279|3982732|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159963|NCT00838279|3982733|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159964|NCT00838279|3982734|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4159965|NCT00838201|3982743|B3|Japanese||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4159966|NCT00838201|3982744|B2|Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4159967|NCT00838201|3982745|B1|Japanese||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4159968|NCT00838201|3982743|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|43|43.0||||||
4159969|NCT00838201|3982744|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4159970|NCT00838201|3982745|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|26|26.0||||||
4159971|NCT00838201|3982743|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4159972|NCT00838201|3982744|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4159973|NCT00838201|3982745|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4159974|NCT00838201|3982743|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|326|326.0||||||
4159975|NCT00838201|3982744|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|173|173.0||||||
4159976|NCT00838201|3982745|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|153|153.0||||||
4159977|NCT00838201|3982743|B3||Male|Sex: Female, Male||Participants|Count of Participants|384|384.0||||||
4159978|NCT00838201|3982744|B2||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4159979|NCT00838201|3982745|B1||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4159980|NCT00838201|3982743|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4159981|NCT00838201|3982744|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4159982|NCT00838201|3982745|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4159983|NCT00838201|3982743|B3|||Age||Years|Mean|73.6|73.6|Standard Deviation|6.9|6.9|||
4159984|NCT00838201|3982744|B2|||Age||Years|Mean|74.1|74.1|Standard Deviation|6.6|6.6|||
4159985|NCT00838201|3982745|B1|||Age||Years|Mean|73|73.0|Standard Deviation|7.1|7.1|||
4159986|NCT00838162|3982752|B5|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4159987|NCT00838162|3982753|B4|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4159988|NCT00838162|3982754|B3|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4159989|NCT00838162|3982755|B2|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4159990|NCT00838162|3982756|B1|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4159991|NCT00838162|3982752|B5|White||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
4159992|NCT00838162|3982753|B4|White||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4159993|NCT00838162|3982754|B3|White||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4159994|NCT00838162|3982755|B2|White||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4159995|NCT00838162|3982756|B1|White||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4159996|NCT00838162|3982752|B5||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4159997|NCT00838162|3982753|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4159998|NCT00838162|3982754|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4159999|NCT00838162|3982755|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4160000|NCT00838162|3982756|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4160001|NCT00838162|3982752|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4160002|NCT00838162|3982753|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4160003|NCT00838162|3982754|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4160004|NCT00838162|3982755|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4160005|NCT00838162|3982756|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4160006|NCT00838162|3982752|B5|||Age||years|Mean|35.1|35.1|Standard Deviation|8.65|8.65|||
4160007|NCT00838162|3982753|B4|||Age||years|Mean|37.8|37.8|Standard Deviation|10.19|10.19|||
4160008|NCT00838162|3982754|B3|||Age||years|Mean|35.5|35.5|Standard Deviation|6.87|6.87|||
4160009|NCT00838162|3982755|B2|||Age||years|Mean|38.1|38.1|Standard Deviation|8.66|8.66|||
4160010|NCT00838162|3982756|B1|||Age||years|Mean|29.7|29.7|Standard Deviation|7.23|7.23|||
4160011|NCT00838136|3982801|B3|Canada||Region of Enrollment||participants|Number|32|32.0||||||
4160012|NCT00838136|3982802|B2|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4160013|NCT00838136|3982803|B1|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4160014|NCT00838136|3982801|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4160015|NCT00838136|3982802|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4160016|NCT00838136|3982803|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4160017|NCT00838136|3982801|B3|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4160018|NCT00838136|3982802|B2|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4160019|NCT00838136|3982803|B1|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4160020|NCT00838136|3982801|B3|American Hispanic||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4160021|NCT00838136|3982802|B2|American Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4160022|NCT00838136|3982803|B1|American Hispanic||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4160023|NCT00838136|3982801|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
4160024|NCT00838136|3982802|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4160025|NCT00838136|3982803|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4160026|NCT00838136|3982801|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4160027|NCT00838136|3982802|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4160028|NCT00838136|3982803|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4160029|NCT00838136|3982801|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4160030|NCT00838136|3982802|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4160031|NCT00838136|3982803|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4160032|NCT00838136|3982801|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4160033|NCT00838136|3982802|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4160034|NCT00838136|3982803|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4160035|NCT00838136|3982801|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4160036|NCT00838136|3982802|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4160037|NCT00838136|3982803|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4160038|NCT00838136|3982801|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4160039|NCT00838136|3982802|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4160040|NCT00838136|3982803|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4160041|NCT00838110|3982812|B3||Male|Sex: Female, Male||Participants|Count of Participants|351|351.0||||||
4160042|NCT00838110|3982813|B2||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4160043|NCT00838110|3982814|B1||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4160044|NCT00838110|3982812|B3||Female|Sex: Female, Male||Participants|Count of Participants|390|390.0||||||
4160045|NCT00838110|3982813|B2||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4160046|NCT00838110|3982814|B1||Female|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4160047|NCT00838110|3982812|B3|Greater than 85 years||Age, Customized||Participants|Number|70|70.0||||||
4160048|NCT00838110|3982813|B2|Greater than 85 years||Age, Customized||Participants|Number|38|38.0||||||
4160049|NCT00838110|3982814|B1|Greater than 85 years||Age, Customized||Participants|Number|32|32.0||||||
4160050|NCT00838110|3982812|B3|80 to 85 years||Age, Customized||Participants|Number|212|212.0||||||
4160051|NCT00838110|3982813|B2|80 to 85 years||Age, Customized||Participants|Number|103|103.0||||||
4160052|NCT00838110|3982814|B1|80 to 85 years||Age, Customized||Participants|Number|109|109.0||||||
4160053|NCT00838110|3982812|B3|70 to 79 years||Age, Customized||Participants|Number|309|309.0||||||
4160054|NCT00838110|3982813|B2|70 to 79 years||Age, Customized||Participants|Number|154|154.0||||||
4160055|NCT00838110|3982814|B1|70 to 79 years||Age, Customized||Participants|Number|155|155.0||||||
4160056|NCT00838110|3982812|B3|60 to 69 years||Age, Customized||Participants|Number|113|113.0||||||
4160057|NCT00838110|3982813|B2|60 to 69 years||Age, Customized||Participants|Number|63|63.0||||||
4160058|NCT00838110|3982814|B1|60 to 69 years||Age, Customized||Participants|Number|50|50.0||||||
4160059|NCT00838110|3982812|B3|50 to 59 years||Age, Customized||Participants|Number|37|37.0||||||
4160060|NCT00838110|3982813|B2|50 to 59 years||Age, Customized||Participants|Number|13|13.0||||||
4160061|NCT00838110|3982814|B1|50 to 59 years||Age, Customized||Participants|Number|24|24.0||||||
4160062|NCT00838097|3982837|B1|Not recorded||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4160063|NCT00838097|3982837|B1|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4160064|NCT00838097|3982837|B1|Japanese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4160065|NCT00838097|3982837|B1|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4160066|NCT00838097|3982837|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4160067|NCT00838097|3982837|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|274|274.0||||||
4160068|NCT00838097|3982837|B1||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4160069|NCT00838097|3982837|B1||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4160070|NCT00838097|3982837|B1|≥ 12 years||Age, Customized||participants|Number|133|133.0||||||
4160071|NCT00838097|3982837|B1|6 to < 12 years||Age, Customized||participants|Number|90|90.0||||||
4160072|NCT00838097|3982837|B1|1 to < 6 years||Age, Customized||participants|Number|83|83.0||||||
4160073|NCT00838097|3982837|B1|< 1 year||Age, Customized||participants|Number|13|13.0||||||
4160074|NCT00838097|3982837|B1|||Age||years|Mean|9.1|9.1|Standard Deviation|5.0|5.0|||
4160075|NCT00837967|3982845|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4160076|NCT00837967|3982845|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4160077|NCT00837967|3982845|B1|||Age||years|Mean|44.3|44.3|Standard Deviation|14.8|14.8|||
4160078|NCT00837902|3982862|B3|LEU/LEU||GRK5 Genotype||Participants|Count of Participants|5|5.0||||||
4160079|NCT00837902|3982863|B2|LEU/LEU||GRK5 Genotype||Participants|Count of Participants|5|5.0||||||
4160080|NCT00837902|3982864|B1|LEU/LEU||GRK5 Genotype||Participants|Count of Participants|0|0.0||||||
4160081|NCT00837902|3982862|B3|GLN/LEU||GRK5 Genotype||Participants|Count of Participants|35|35.0||||||
4160082|NCT00837902|3982863|B2|GLN/LEU||GRK5 Genotype||Participants|Count of Participants|35|35.0||||||
4160083|NCT00837902|3982864|B1|GLN/LEU||GRK5 Genotype||Participants|Count of Participants|0|0.0||||||
4160084|NCT00837902|3982862|B3|GLN/GLN||GRK5 Genotype||Participants|Count of Participants|114|114.0||||||
4160085|NCT00837902|3982863|B2|GLN/GLN||GRK5 Genotype||Participants|Count of Participants|29|29.0||||||
4160086|NCT00837902|3982864|B1|GLN/GLN||GRK5 Genotype||Participants|Count of Participants|85|85.0||||||
4160087|NCT00837902|3982862|B3|||diastolic blood pressure||mmHg|Mean|65.0|65.0|Standard Deviation|7.1|7.1|||
4160088|NCT00837902|3982863|B2|||diastolic blood pressure||mmHg|Mean|66.2|66.2|Standard Deviation|7.5|7.5|||
4160089|NCT00837902|3982864|B1|||diastolic blood pressure||mmHg|Mean|64.0|64.0|Standard Deviation|6.8|6.8|||
4160090|NCT00837902|3982862|B3|||systolic blood pressure||mmHg|Mean|111.1|111.1|Standard Deviation|11.8|11.8|||
4160091|NCT00837902|3982863|B2|||systolic blood pressure||mmHg|Mean|112.5|112.5|Standard Deviation|12.1|12.1|||
4160092|NCT00837902|3982864|B1|||systolic blood pressure||mmHg|Mean|109.9|109.9|Standard Deviation|11.4|11.4|||
4160093|NCT00837902|3982862|B3|United States||Region of Enrollment||participants|Number|154|154.0||||||
4160094|NCT00837902|3982863|B2|United States||Region of Enrollment||participants|Number|69|69.0||||||
4160095|NCT00837902|3982864|B1|United States||Region of Enrollment||participants|Number|85|85.0||||||
4160096|NCT00837902|3982862|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4160097|NCT00837902|3982863|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4160098|NCT00837902|3982864|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4160099|NCT00837902|3982862|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4160100|NCT00837902|3982863|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4160101|NCT00837902|3982864|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4160102|NCT00837902|3982862|B3|||Age||years|Mean|26.5|26.5|Standard Deviation|6.2|6.2|||
4160103|NCT00837902|3982863|B2|||Age||years|Mean|25.9|25.9|Standard Deviation|6|6.0|||
4160104|NCT00837902|3982864|B1|||Age||years|Mean|27.0|27.0|Standard Deviation|6.4|6.4|||
4160105|NCT00837876|3982872|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4160106|NCT00837876|3982872|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4160107|NCT00837876|3982872|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4160108|NCT00837876|3982872|B1|||Age||years|Mean|62|62.0|Standard Deviation|1|1.0|||
4160109|NCT00837876|3982872|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4160110|NCT00837876|3982872|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4160111|NCT00837876|3982872|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4160112|NCT00837824|3982879|B3|Hispanic||Race/Ethnicity, Customized||Number of Participants|Number|1|1.0||||||
4160113|NCT00837824|3982880|B2|Hispanic||Race/Ethnicity, Customized||Number of Participants|Number|0|0.0||||||
4160114|NCT00837824|3982881|B1|Hispanic||Race/Ethnicity, Customized||Number of Participants|Number|1|1.0||||||
4160115|NCT00837824|3982879|B3|Black||Race/Ethnicity, Customized||Number of Participants|Number|5|5.0||||||
4160116|NCT00837824|3982880|B2|Black||Race/Ethnicity, Customized||Number of Participants|Number|2|2.0||||||
4160117|NCT00837824|3982881|B1|Black||Race/Ethnicity, Customized||Number of Participants|Number|3|3.0||||||
4160118|NCT00837824|3982879|B3|Caucasian||Race/Ethnicity, Customized||Number of Participants|Number|14|14.0||||||
4160119|NCT00837824|3982880|B2|Caucasian||Race/Ethnicity, Customized||Number of Participants|Number|7|7.0||||||
4160120|NCT00837824|3982881|B1|Caucasian||Race/Ethnicity, Customized||Number of Participants|Number|7|7.0||||||
4160121|NCT00837824|3982879|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4160122|NCT00837824|3982880|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4160123|NCT00837824|3982881|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4160124|NCT00837824|3982879|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4160125|NCT00837824|3982880|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4160126|NCT00837824|3982881|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4160127|NCT00837824|3982879|B3|||Age||years|Mean|49.2|49.2|Standard Deviation|7.04|7.04|||
4160128|NCT00837824|3982880|B2|||Age||years|Mean|48.9|48.9|Standard Deviation|7.55|7.55|||
4160129|NCT00837824|3982881|B1|||Age||years|Mean|49.4|49.4|Standard Deviation|6.96|6.96|||
4160130|NCT00837824|3982879|B3|≥ 40 Years||Age, Customized||Years|Number|18|18.0||||||
4160131|NCT00837824|3982880|B2|≥ 40 Years||Age, Customized||Years|Number|8|8.0||||||
4160132|NCT00837824|3982881|B1|≥ 40 Years||Age, Customized||Years|Number|10|10.0||||||
4160133|NCT00837824|3982879|B3|< 40 Years||Age, Customized||Years|Number|2|2.0||||||
4160134|NCT00837824|3982880|B2|< 40 Years||Age, Customized||Years|Number|1|1.0||||||
4160135|NCT00837824|3982881|B1|< 40 Years||Age, Customized||Years|Number|1|1.0||||||
4160136|NCT00837811|3982891|B4|United States||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
4160137|NCT00837811|3982892|B3|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4160138|NCT00837811|3982893|B2|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
4160139|NCT00837811|3982894|B1|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4160140|NCT00837811|3982891|B4|Romania||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4160141|NCT00837811|3982892|B3|Romania||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4160142|NCT00837811|3982893|B2|Romania||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4160143|NCT00837811|3982894|B1|Romania||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4160144|NCT00837811|3982891|B4|Puerto Rico||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4160145|NCT00837811|3982892|B3|Puerto Rico||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4160146|NCT00837811|3982893|B2|Puerto Rico||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4160147|NCT00837811|3982894|B1|Puerto Rico||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4160148|NCT00837811|3982891|B4|Poland||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
4160149|NCT00837811|3982892|B3|Poland||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4160150|NCT00837811|3982893|B2|Poland||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4160151|NCT00837811|3982894|B1|Poland||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4160152|NCT00837811|3982891|B4|Mexico||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
4160153|NCT00837811|3982892|B3|Mexico||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4160154|NCT00837811|3982893|B2|Mexico||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4160155|NCT00837811|3982894|B1|Mexico||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4160156|NCT00837811|3982891|B4|India||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4160157|NCT00837811|3982892|B3|India||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4160158|NCT00837811|3982893|B2|India||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4160159|NCT00837811|3982894|B1|India||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4160160|NCT00837811|3982891|B4|Hungary||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4160161|NCT00837811|3982892|B3|Hungary||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4160162|NCT00837811|3982893|B2|Hungary||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4160163|NCT00837811|3982894|B1|Hungary||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4160164|NCT00837811|3982891|B4|Germany||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4160165|NCT00837811|3982892|B3|Germany||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4160166|NCT00837811|3982893|B2|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4160167|NCT00837811|3982894|B1|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4160168|NCT00837811|3982891|B4|Chile||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4160169|NCT00837811|3982892|B3|Chile||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4160170|NCT00837811|3982893|B2|Chile||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4160171|NCT00837811|3982894|B1|Chile||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4160172|NCT00837811|3982891|B4|Canada||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4160173|NCT00837811|3982892|B3|Canada||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4160174|NCT00837811|3982893|B2|Canada||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4160175|NCT00837811|3982894|B1|Canada||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4160176|NCT00837811|3982891|B4|Brazil||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4160177|NCT00837811|3982892|B3|Brazil||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4160178|NCT00837811|3982893|B2|Brazil||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4160179|NCT00837811|3982894|B1|Brazil||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4160180|NCT00837811|3982891|B4|Belgium||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4160181|NCT00837811|3982892|B3|Belgium||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4160182|NCT00837811|3982893|B2|Belgium||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4160183|NCT00837811|3982894|B1|Belgium||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4160184|NCT00837811|3982891|B4|Australia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4160185|NCT00837811|3982892|B3|Australia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4160186|NCT00837811|3982893|B2|Australia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4160187|NCT00837811|3982894|B1|Australia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4160188|NCT00837811|3982891|B4|Austria||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4160189|NCT00837811|3982892|B3|Austria||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4160190|NCT00837811|3982893|B2|Austria||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4160191|NCT00837811|3982894|B1|Austria||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4160192|NCT00837811|3982891|B4|West Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4160193|NCT00837811|3982892|B3|West Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4160194|NCT00837811|3982893|B2|West Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4160195|NCT00837811|3982894|B1|West Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4160196|NCT00837811|3982891|B4|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4160197|NCT00837811|3982892|B3|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4160198|NCT00837811|3982893|B2|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4160199|NCT00837811|3982894|B1|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4160200|NCT00837811|3982891|B4|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
4160201|NCT00837811|3982892|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4160202|NCT00837811|3982893|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
4160203|NCT00837811|3982894|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
4160204|NCT00837811|3982891|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4160205|NCT00837811|3982892|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4160206|NCT00837811|3982893|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4160207|NCT00837811|3982894|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4160208|NCT00837811|3982891|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|115|115.0||||||
4160209|NCT00837811|3982892|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4160210|NCT00837811|3982893|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|80|80.0||||||
4160211|NCT00837811|3982894|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
4160212|NCT00837811|3982891|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4160213|NCT00837811|3982892|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4160214|NCT00837811|3982893|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4160215|NCT00837811|3982894|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4160216|NCT00837811|3982891|B4||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4160217|NCT00837811|3982892|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4160218|NCT00837811|3982893|B2||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4160219|NCT00837811|3982894|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4160220|NCT00837811|3982891|B4|||Age||years|Mean|52.2|52.2|Standard Deviation|12.08|12.08|||
4160281|NCT00837577|3983018|B2|||Age||years|Mean|58.60|58.6|Standard Deviation|9.73|9.73|||
4160221|NCT00837811|3982892|B3|||Age||years|Mean|61.5|61.5|Standard Deviation|NA||||Only 1 participant in the analysis, therefore standard deviation is not calculable.
4160222|NCT00837811|3982893|B2|||Age||years|Mean|51.5|51.5|Standard Deviation|12.20|12.2|||
4160223|NCT00837811|3982894|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|11.86|11.86|||
4160224|NCT00837759|3982981|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4160225|NCT00837759|3982981|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160226|NCT00837759|3982981|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160227|NCT00837759|3982981|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4160228|NCT00837759|3982981|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160229|NCT00837759|3982981|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160230|NCT00837759|3982981|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160231|NCT00837759|3982981|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160232|NCT00837759|3982981|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4160233|NCT00837759|3982981|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4160234|NCT00837759|3982981|B1|||Age||years|Mean|21.9|21.9|Standard Deviation|3.2|3.2|||
4160235|NCT00837759|3982981|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4160236|NCT00837759|3982981|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4160237|NCT00837759|3982981|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4160238|NCT00837616|3982990|B3|Chile||Region of Enrollment||participants|Number|16|16.0||||||
4160239|NCT00837616|3982991|B2|Chile||Region of Enrollment||participants|Number|7|7.0||||||
4160240|NCT00837616|3982992|B1|Chile||Region of Enrollment||participants|Number|9|9.0||||||
4160241|NCT00837616|3982990|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4160242|NCT00837616|3982991|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4160243|NCT00837616|3982992|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4160244|NCT00837616|3982990|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4160245|NCT00837616|3982991|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4160246|NCT00837616|3982992|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4160247|NCT00837616|3982990|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4160248|NCT00837616|3982991|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4160249|NCT00837616|3982992|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4160250|NCT00837616|3982990|B3|||Age||years|Mean|16.7|16.7|Standard Deviation|1.7|1.7|||
4160251|NCT00837616|3982991|B2|||Age||years|Mean|16.7|16.7|Standard Deviation|1.8|1.8|||
4160252|NCT00837616|3982992|B1|||Age||years|Mean|16.7|16.7|Standard Deviation|1.7|1.7|||
4160253|NCT00837616|3982990|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4160254|NCT00837616|3982991|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4160255|NCT00837616|3982992|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4160256|NCT00837616|3982990|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4160257|NCT00837616|3982991|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4160258|NCT00837616|3982992|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4160259|NCT00837616|3982990|B3||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
4160260|NCT00837616|3982991|B2||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4160261|NCT00837616|3982992|B1||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4160262|NCT00837577|3983017|B3|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|152.14|152.14|Standard Deviation|34.02|34.02|||
4160263|NCT00837577|3983018|B2|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|151.54|151.54|Standard Deviation|30.57|30.57|||
4160264|NCT00837577|3983019|B1|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|152.69|152.69|Standard Deviation|37.06|37.06|||
4160265|NCT00837577|3983017|B3|||2-hour Postprandial Glucose||mg/dL|Mean|213.92|213.92|Standard Deviation|52.82|52.82|||
4160266|NCT00837577|3983018|B2|||2-hour Postprandial Glucose||mg/dL|Mean|209.40|209.4|Standard Deviation|52.42|52.42|||
4160267|NCT00837577|3983019|B1|||2-hour Postprandial Glucose||mg/dL|Mean|217.99|217.99|Standard Deviation|53.22|53.22|||
4160268|NCT00837577|3983017|B3|||Hemoglobin A1c (HbA1c)||Percent|Mean|7.51|7.51|Standard Deviation|0.79|0.79|||
4160269|NCT00837577|3983018|B2|||Hemoglobin A1c (HbA1c)||Percent|Mean|7.50|7.5|Standard Deviation|0.84|0.84|||
4160270|NCT00837577|3983019|B1|||Hemoglobin A1c (HbA1c)||Percent|Mean|7.52|7.52|Standard Deviation|0.75|0.75|||
4160271|NCT00837577|3983017|B3|Japan||Region of Enrollment||participants|Number|133|133.0||||||
4160272|NCT00837577|3983018|B2|Japan||Region of Enrollment||participants|Number|63|63.0||||||
4160273|NCT00837577|3983019|B1|Japan||Region of Enrollment||participants|Number|70|70.0||||||
4160274|NCT00837577|3983017|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4160275|NCT00837577|3983018|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4160276|NCT00837577|3983019|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4160277|NCT00837577|3983017|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4160278|NCT00837577|3983018|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4160279|NCT00837577|3983019|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4160280|NCT00837577|3983017|B3|||Age||years|Mean|60.57|60.57|Standard Deviation|10.15|10.15|||
4160282|NCT00837577|3983019|B1|||Age||years|Mean|62.34|62.34|Standard Deviation|10.25|10.25|||
4160283|NCT00837512|3983031|B1|Male||Subcutaneous insulin catheter|Subcutaneous insulin catheter used to deliver insulin at a depth of 9 mm (9000 micrometers)|participants|Number|9|9.0||||||
4160284|NCT00837512|3983031|B1|Female||Subcutaneous insulin catheter|Subcutaneous insulin catheter used to deliver insulin at a depth of 9 mm (9000 micrometers)|participants|Number|7|7.0||||||
4160285|NCT00837512|3983031|B1|Male||Microneedle|Subcutaneous insulin catheter used to deliver insulin at a depth of 9 mm (9000 micrometers)|Participants|Number|9|9.0||||||
4160286|NCT00837512|3983031|B1|Female||Microneedle|Subcutaneous insulin catheter used to deliver insulin at a depth of 9 mm (9000 micrometers)|Participants|Number|7|7.0||||||
4160287|NCT00837512|3983031|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4160288|NCT00837512|3983031|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4160289|NCT00837512|3983031|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4160290|NCT00837512|3983031|B1|||Age||years|Mean|14.61|14.61|Standard Deviation|2.19|2.19|||
4160291|NCT00837512|3983031|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4160292|NCT00837512|3983031|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4160293|NCT00837512|3983031|B1||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4160294|NCT00837486|3983038|B3|||Baseline depression score|Montgomery-Åsberg Depression Rating Scale (MADRS); total score can range from 0 (no symptoms) to 60 (severe depression)|units on a scale|Mean|36.7|36.7|Standard Deviation|4.3|4.3|||
4160295|NCT00837486|3983039|B2|||Baseline depression score|Montgomery-Åsberg Depression Rating Scale (MADRS); total score can range from 0 (no symptoms) to 60 (severe depression)|units on a scale|Mean|36.4|36.4|Standard Deviation|3.3|3.3|||
4160296|NCT00837486|3983040|B1|||Baseline depression score|Montgomery-Åsberg Depression Rating Scale (MADRS); total score can range from 0 (no symptoms) to 60 (severe depression)|units on a scale|Mean|37.0|37.0|Standard Deviation|5.1|5.1|||
4160297|NCT00837486|3983038|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4160298|NCT00837486|3983039|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4160299|NCT00837486|3983040|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4160300|NCT00837486|3983038|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4160301|NCT00837486|3983039|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4160302|NCT00837486|3983040|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4160303|NCT00837486|3983038|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4160304|NCT00837486|3983039|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4160305|NCT00837486|3983040|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4160306|NCT00837486|3983038|B3|||Age||years|Mean|47.7|47.7|Standard Deviation|12.0|12.0|||
4160307|NCT00837486|3983039|B2|||Age||years|Mean|48.9|48.9|Standard Deviation|8.9|8.9|||
4160308|NCT00837486|3983040|B1|||Age||years|Mean|46.6|46.6|Standard Deviation|14.4|14.4|||
4160309|NCT00837473|3983053|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4160310|NCT00837473|3983053|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4160311|NCT00837473|3983053|B1|||Age||years|Mean|56.13|56.13|Standard Deviation|9.45|9.45|||
4160312|NCT00837447|3983066|B1|Korea, Republic of||Region of Enrollment||participants|Number|54|54.0||||||
4160313|NCT00837447|3983066|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4160314|NCT00837447|3983066|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4160315|NCT00837447|3983066|B1|||Age||years|Mean|69.7|69.7|Standard Deviation|6.43|6.43|||
4160316|NCT00837447|3983066|B1||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
4160317|NCT00837447|3983066|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4160318|NCT00837447|3983066|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4160319|NCT00837434|3983071|B3|||Disease Activity Score Using C-reactive Protein (DAS28-CRP)|The DAS28 is: a score on a scale (0 to 10) indicating current activity of rheumatoid arthritis (>5.1=high disease activity; <=3.2=low disease activity; <2.6=remission); a continuous variable which is a composite of 4 variables(the number of tender joints out of 28, the number of swollen joints out of 28 joints, serum C-reactive protein (CRP) in mg/L and subject assessment of disease activity measure on a visual analogue scale (VAS) of 100 mm).|scores on a scale|Mean|5.3|5.3|Standard Deviation|0.9|0.9|||
4160320|NCT00837434|3983072|B2|||Disease Activity Score Using C-reactive Protein (DAS28-CRP)|The DAS28 is: a score on a scale (0 to 10) indicating current activity of rheumatoid arthritis (>5.1=high disease activity; <=3.2=low disease activity; <2.6=remission); a continuous variable which is a composite of 4 variables(the number of tender joints out of 28, the number of swollen joints out of 28 joints, serum C-reactive protein (CRP) in mg/L and subject assessment of disease activity measure on a visual analogue scale (VAS) of 100 mm).|scores on a scale|Mean|5.4|5.4|Standard Deviation|0.7|0.7|||
4160321|NCT00837434|3983073|B1|||Disease Activity Score Using C-reactive Protein (DAS28-CRP)|The DAS28 is: a score on a scale (0 to 10) indicating current activity of rheumatoid arthritis (>5.1=high disease activity; <=3.2=low disease activity; <2.6=remission); a continuous variable which is a composite of 4 variables(the number of tender joints out of 28, the number of swollen joints out of 28 joints, serum C-reactive protein (CRP) in mg/L and subject assessment of disease activity measure on a visual analogue scale (VAS) of 100 mm).|scores on a scale|Mean|5.2|5.2|Standard Deviation|1.0|1.0|||
4160322|NCT00837434|3983071|B3|||Patient’s Global Assessment of Disease Activity- Visual Analog Scale (PtGADA-VAS)|"A self-reported measure of perceived disease activity obtained by responding to the question considering all the ways that your arthritis affects you, rate how you are doing on the following scale by placing a vertical mark. A vertical mark on a 10 cm line rated 0 (very well) to 10 (very bad) determines the score. The range: 0 to 10, with 10 being severe symptoms)."|cm|Mean|6.4|6.4|Standard Deviation|2.5|2.5|||
4160323|NCT00837434|3983072|B2|||Patient’s Global Assessment of Disease Activity- Visual Analog Scale (PtGADA-VAS)|"A self-reported measure of perceived disease activity obtained by responding to the question considering all the ways that your arthritis affects you, rate how you are doing on the following scale by placing a vertical mark. A vertical mark on a 10 cm line rated 0 (very well) to 10 (very bad) determines the score. The range: 0 to 10, with 10 being severe symptoms)."|cm|Mean|7.3|7.3|Standard Deviation|2.0|2.0|||
4160324|NCT00837434|3983073|B1|||Patient’s Global Assessment of Disease Activity- Visual Analog Scale (PtGADA-VAS)|"A self-reported measure of perceived disease activity obtained by responding to the question considering all the ways that your arthritis affects you, rate how you are doing on the following scale by placing a vertical mark. A vertical mark on a 10 cm line rated 0 (very well) to 10 (very bad) determines the score. The range: 0 to 10, with 10 being severe symptoms)."|cm|Mean|5.9|5.9|Standard Deviation|2.6|2.6|||
4160325|NCT00837434|3983071|B3|||Swollen Joint Count at Baseline|Swollen Joint Count (SJC) is calculated based on swelling response of 28 joints examined. SJC possible values range from 0 to 28. A lower SJC indicates less joint swelling.|Joints|Mean|9.7|9.7|Standard Deviation|6.0|6.0|||
4160326|NCT00837434|3983072|B2|||Swollen Joint Count at Baseline|Swollen Joint Count (SJC) is calculated based on swelling response of 28 joints examined. SJC possible values range from 0 to 28. A lower SJC indicates less joint swelling.|Joints|Mean|9.4|9.4|Standard Deviation|5.9|5.9|||
4160327|NCT00837434|3983073|B1|||Swollen Joint Count at Baseline|Swollen Joint Count (SJC) is calculated based on swelling response of 28 joints examined. SJC possible values range from 0 to 28. A lower SJC indicates less joint swelling.|Joints|Mean|9.9|9.9|Standard Deviation|6.2|6.2|||
4160328|NCT00837434|3983071|B3|||Tender Joint Count|Tender Joint Count (TJC) is calculated based on tenderness response of 28 joints examined. TJC possible values range from 0 to 28. A lower TJC indicates less joint tenderness.|Joints|Mean|12.3|12.3|Standard Deviation|6.7|6.7|||
4160329|NCT00837434|3983072|B2|||Tender Joint Count|Tender Joint Count (TJC) is calculated based on tenderness response of 28 joints examined. TJC possible values range from 0 to 28. A lower TJC indicates less joint tenderness.|Joints|Mean|12.6|12.6|Standard Deviation|7.2|7.2|||
4160330|NCT00837434|3983073|B1|||Tender Joint Count|Tender Joint Count (TJC) is calculated based on tenderness response of 28 joints examined. TJC possible values range from 0 to 28. A lower TJC indicates less joint tenderness.|Joints|Mean|12.2|12.2|Standard Deviation|6.6|6.6|||
4160331|NCT00837434|3983071|B3|||C-reactive Protein (CRP) Level|CRP is an acute phase reactant that is used to identify the presence of nonspecific inflammation. The CRP normal reference range depends on the laboratory. In this study the upper limit of normal ranged from 4 to 10.9 mg/L. An increased CRP level indicated the presence of inflammation. A low CRP may mean an absence of inflammation.|mg/L|Mean|13.8|13.8|Standard Deviation|24.9|24.9|||
4160332|NCT00837434|3983072|B2|||C-reactive Protein (CRP) Level|CRP is an acute phase reactant that is used to identify the presence of nonspecific inflammation. The CRP normal reference range depends on the laboratory. In this study the upper limit of normal ranged from 4 to 10.9 mg/L. An increased CRP level indicated the presence of inflammation. A low CRP may mean an absence of inflammation.|mg/L|Mean|13.3|13.3|Standard Deviation|24.3|24.3|||
4160333|NCT00837434|3983073|B1|||C-reactive Protein (CRP) Level|CRP is an acute phase reactant that is used to identify the presence of nonspecific inflammation. The CRP normal reference range depends on the laboratory. In this study the upper limit of normal ranged from 4 to 10.9 mg/L. An increased CRP level indicated the presence of inflammation. A low CRP may mean an absence of inflammation.|mg/L|Mean|14.1|14.1|Standard Deviation|25.5|25.5|||
4160334|NCT00837434|3983071|B3|||Health Assessment Questionnaire-Disability Index (HAQ-DI) Score|HAQ-DI is derived based on the mean of individual scores in 8 categories of daily living activities (using 20 questions). Each question is scored 0-3 (0=no difficulty, 1=some difficulty, 2=much difficulty, and 3=unable to do). In addition, category scores are modified if an aid or device is used, for example, a walker, or help is received from another person in the daily living activities. Scores from each of the 8 categories are totaled and can range from 0 to 24.|scores on a scale|Mean|1.4|1.4|Standard Deviation|0.7|0.7|||
4160335|NCT00837434|3983072|B2|||Health Assessment Questionnaire-Disability Index (HAQ-DI) Score|HAQ-DI is derived based on the mean of individual scores in 8 categories of daily living activities (using 20 questions). Each question is scored 0-3 (0=no difficulty, 1=some difficulty, 2=much difficulty, and 3=unable to do). In addition, category scores are modified if an aid or device is used, for example, a walker, or help is received from another person in the daily living activities. Scores from each of the 8 categories are totaled and can range from 0 to 24.|scores on a scale|Mean|1.3|1.3|Standard Deviation|0.6|0.6|||
4160336|NCT00837434|3983073|B1|||Health Assessment Questionnaire-Disability Index (HAQ-DI) Score|HAQ-DI is derived based on the mean of individual scores in 8 categories of daily living activities (using 20 questions). Each question is scored 0-3 (0=no difficulty, 1=some difficulty, 2=much difficulty, and 3=unable to do). In addition, category scores are modified if an aid or device is used, for example, a walker, or help is received from another person in the daily living activities. Scores from each of the 8 categories are totaled and can range from 0 to 24.|scores on a scale|Mean|1.4|1.4|Standard Deviation|0.7|0.7|||
4160337|NCT00837434|3983071|B3|||Years with Rheumatoid Arthritis|Years since diagnosis of rheumatoid arthritis by a physician. Participants were required to be diagnosed with Rheumatoid Arthritis at least 3 months before enrolling in the study.|years|Mean|5.3|5.3|Standard Deviation|7.0|7.0|||
4160338|NCT00837434|3983072|B2|||Years with Rheumatoid Arthritis|Years since diagnosis of rheumatoid arthritis by a physician. Participants were required to be diagnosed with Rheumatoid Arthritis at least 3 months before enrolling in the study.|years|Mean|4.3|4.3|Standard Deviation|5.2|5.2|||
4160339|NCT00837434|3983073|B1|||Years with Rheumatoid Arthritis|Years since diagnosis of rheumatoid arthritis by a physician. Participants were required to be diagnosed with Rheumatoid Arthritis at least 3 months before enrolling in the study.|years|Mean|5.8|5.8|Standard Deviation|7.7|7.7|||
4160340|NCT00837434|3983071|B3|||Methotrexate Dosage|Participants were required to be on a stable dose of methotrexate to be enrolled in the study. Stable dose definition: between 7.5 mg and 25 mg by mouth or subcutaneously weekly for at least 8 weeks prior to randomization.|mg|Mean|17.9|17.9|Standard Deviation|3.9|3.9|||
4160402|NCT00837434|3983073|B1|||Age||years|Mean|51.7|51.7|Standard Deviation|9.4|9.4|||
4160403|NCT00837330|3983092|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4160341|NCT00837434|3983072|B2|||Methotrexate Dosage|Participants were required to be on a stable dose of methotrexate to be enrolled in the study. Stable dose definition: between 7.5 mg and 25 mg by mouth or subcutaneously weekly for at least 8 weeks prior to randomization.|mg|Mean|18.8|18.8|Standard Deviation|3.8|3.8|||
4160342|NCT00837434|3983073|B1|||Methotrexate Dosage|Participants were required to be on a stable dose of methotrexate to be enrolled in the study. Stable dose definition: between 7.5 mg and 25 mg by mouth or subcutaneously weekly for at least 8 weeks prior to randomization.|mg|Mean|17.4|17.4|Standard Deviation|4.0|4.0|||
4160343|NCT00837434|3983071|B3|Negative||Detection of Antibodies to Cyclic Citrullinated Antibody Peptide|Anti-CCP is often present in the blood of individuals with RA. Positive value for anti-CCP: >/=8 IU/mL. Negative value for anti-CCP: <8 IU/mL. High anti-CCP indicates an aggressive RA and a higher risk of joint damage.|participants|Number|22|22.0||||||
4160344|NCT00837434|3983072|B2|Negative||Detection of Antibodies to Cyclic Citrullinated Antibody Peptide|Anti-CCP is often present in the blood of individuals with RA. Positive value for anti-CCP: >/=8 IU/mL. Negative value for anti-CCP: <8 IU/mL. High anti-CCP indicates an aggressive RA and a higher risk of joint damage.|participants|Number|8|8.0||||||
4160345|NCT00837434|3983073|B1|Negative||Detection of Antibodies to Cyclic Citrullinated Antibody Peptide|Anti-CCP is often present in the blood of individuals with RA. Positive value for anti-CCP: >/=8 IU/mL. Negative value for anti-CCP: <8 IU/mL. High anti-CCP indicates an aggressive RA and a higher risk of joint damage.|participants|Number|14|14.0||||||
4160346|NCT00837434|3983071|B3|Positive||Detection of Antibodies to Cyclic Citrullinated Antibody Peptide|Anti-CCP is often present in the blood of individuals with RA. Positive value for anti-CCP: >/=8 IU/mL. Negative value for anti-CCP: <8 IU/mL. High anti-CCP indicates an aggressive RA and a higher risk of joint damage.|participants|Number|36|36.0||||||
4160347|NCT00837434|3983072|B2|Positive||Detection of Antibodies to Cyclic Citrullinated Antibody Peptide|Anti-CCP is often present in the blood of individuals with RA. Positive value for anti-CCP: >/=8 IU/mL. Negative value for anti-CCP: <8 IU/mL. High anti-CCP indicates an aggressive RA and a higher risk of joint damage.|participants|Number|11|11.0||||||
4160348|NCT00837434|3983073|B1|Positive||Detection of Antibodies to Cyclic Citrullinated Antibody Peptide|Anti-CCP is often present in the blood of individuals with RA. Positive value for anti-CCP: >/=8 IU/mL. Negative value for anti-CCP: <8 IU/mL. High anti-CCP indicates an aggressive RA and a higher risk of joint damage.|participants|Number|25|25.0||||||
4160349|NCT00837434|3983071|B3|Negative||Detection of IgM-Rheumatoid Factor (IgM RF)|Serum IgM RF is an antibody often present in the blood of a person with rheumatoid arthritis. Positive value for RF: >/=0.5 IU/mL. Negative value for RF: <0.5 IU/mL. Presence of IgM RF indicates aggressive rheumatoid arthritis (RA) and higher risk of joint damage.|participants|Number|25|25.0||||||
4160350|NCT00837434|3983072|B2|Negative||Detection of IgM-Rheumatoid Factor (IgM RF)|Serum IgM RF is an antibody often present in the blood of a person with rheumatoid arthritis. Positive value for RF: >/=0.5 IU/mL. Negative value for RF: <0.5 IU/mL. Presence of IgM RF indicates aggressive rheumatoid arthritis (RA) and higher risk of joint damage.|participants|Number|10|10.0||||||
4160351|NCT00837434|3983073|B1|Negative||Detection of IgM-Rheumatoid Factor (IgM RF)|Serum IgM RF is an antibody often present in the blood of a person with rheumatoid arthritis. Positive value for RF: >/=0.5 IU/mL. Negative value for RF: <0.5 IU/mL. Presence of IgM RF indicates aggressive rheumatoid arthritis (RA) and higher risk of joint damage.|participants|Number|15|15.0||||||
4160352|NCT00837434|3983071|B3|Positive||Detection of IgM-Rheumatoid Factor (IgM RF)|Serum IgM RF is an antibody often present in the blood of a person with rheumatoid arthritis. Positive value for RF: >/=0.5 IU/mL. Negative value for RF: <0.5 IU/mL. Presence of IgM RF indicates aggressive rheumatoid arthritis (RA) and higher risk of joint damage.|participants|Number|33|33.0||||||
4160353|NCT00837434|3983072|B2|Positive||Detection of IgM-Rheumatoid Factor (IgM RF)|Serum IgM RF is an antibody often present in the blood of a person with rheumatoid arthritis. Positive value for RF: >/=0.5 IU/mL. Negative value for RF: <0.5 IU/mL. Presence of IgM RF indicates aggressive rheumatoid arthritis (RA) and higher risk of joint damage.|participants|Number|9|9.0||||||
4160354|NCT00837434|3983073|B1|Positive||Detection of IgM-Rheumatoid Factor (IgM RF)|Serum IgM RF is an antibody often present in the blood of a person with rheumatoid arthritis. Positive value for RF: >/=0.5 IU/mL. Negative value for RF: <0.5 IU/mL. Presence of IgM RF indicates aggressive rheumatoid arthritis (RA) and higher risk of joint damage.|participants|Number|24|24.0||||||
4160355|NCT00837434|3983071|B3|Negative||Detection of Either IgM-Rheumatoid Factor or Antibodies to Cyclic Citrullinated Peptide|Serum IgM-Rheumatoid Factor (IgM RF) is an antibody often present in the blood of a person with rheumatoid arthritis. Positive value for RF: >/=0.5 IU/mL. Negative value for RF: <0.5 IU/mL. Presence of IgM RF indicates aggressive rheumatoid arthritis (RA) and higher risk of joint damage. Antibodies to Cyclic Citrullinated Peptide (anti-CCP) is often detected in in the blood of individuals with RA. Positive value for anti-CCP: >/=8 IU/mL. Negative value for anti-CCP: <8 IU/mL. High anti-CCP indicates an aggressive RA and a higher risk of joint damage.|participants|Number|14|14.0||||||
4160356|NCT00837434|3983072|B2|Negative||Detection of Either IgM-Rheumatoid Factor or Antibodies to Cyclic Citrullinated Peptide|Serum IgM-Rheumatoid Factor (IgM RF) is an antibody often present in the blood of a person with rheumatoid arthritis. Positive value for RF: >/=0.5 IU/mL. Negative value for RF: <0.5 IU/mL. Presence of IgM RF indicates aggressive rheumatoid arthritis (RA) and higher risk of joint damage. Antibodies to Cyclic Citrullinated Peptide (anti-CCP) is often detected in in the blood of individuals with RA. Positive value for anti-CCP: >/=8 IU/mL. Negative value for anti-CCP: <8 IU/mL. High anti-CCP indicates an aggressive RA and a higher risk of joint damage.|participants|Number|5|5.0||||||
4160357|NCT00837434|3983073|B1|Negative||Detection of Either IgM-Rheumatoid Factor or Antibodies to Cyclic Citrullinated Peptide|Serum IgM-Rheumatoid Factor (IgM RF) is an antibody often present in the blood of a person with rheumatoid arthritis. Positive value for RF: >/=0.5 IU/mL. Negative value for RF: <0.5 IU/mL. Presence of IgM RF indicates aggressive rheumatoid arthritis (RA) and higher risk of joint damage. Antibodies to Cyclic Citrullinated Peptide (anti-CCP) is often detected in in the blood of individuals with RA. Positive value for anti-CCP: >/=8 IU/mL. Negative value for anti-CCP: <8 IU/mL. High anti-CCP indicates an aggressive RA and a higher risk of joint damage.|participants|Number|9|9.0||||||
4160404|NCT00837330|3983093|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4160405|NCT00837330|3983094|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4160358|NCT00837434|3983071|B3|Positive||Detection of Either IgM-Rheumatoid Factor or Antibodies to Cyclic Citrullinated Peptide|Serum IgM-Rheumatoid Factor (IgM RF) is an antibody often present in the blood of a person with rheumatoid arthritis. Positive value for RF: >/=0.5 IU/mL. Negative value for RF: <0.5 IU/mL. Presence of IgM RF indicates aggressive rheumatoid arthritis (RA) and higher risk of joint damage. Antibodies to Cyclic Citrullinated Peptide (anti-CCP) is often detected in in the blood of individuals with RA. Positive value for anti-CCP: >/=8 IU/mL. Negative value for anti-CCP: <8 IU/mL. High anti-CCP indicates an aggressive RA and a higher risk of joint damage.|participants|Number|44|44.0||||||
4160359|NCT00837434|3983072|B2|Positive||Detection of Either IgM-Rheumatoid Factor or Antibodies to Cyclic Citrullinated Peptide|Serum IgM-Rheumatoid Factor (IgM RF) is an antibody often present in the blood of a person with rheumatoid arthritis. Positive value for RF: >/=0.5 IU/mL. Negative value for RF: <0.5 IU/mL. Presence of IgM RF indicates aggressive rheumatoid arthritis (RA) and higher risk of joint damage. Antibodies to Cyclic Citrullinated Peptide (anti-CCP) is often detected in in the blood of individuals with RA. Positive value for anti-CCP: >/=8 IU/mL. Negative value for anti-CCP: <8 IU/mL. High anti-CCP indicates an aggressive RA and a higher risk of joint damage.|participants|Number|14|14.0||||||
4160360|NCT00837434|3983073|B1|Positive||Detection of Either IgM-Rheumatoid Factor or Antibodies to Cyclic Citrullinated Peptide|Serum IgM-Rheumatoid Factor (IgM RF) is an antibody often present in the blood of a person with rheumatoid arthritis. Positive value for RF: >/=0.5 IU/mL. Negative value for RF: <0.5 IU/mL. Presence of IgM RF indicates aggressive rheumatoid arthritis (RA) and higher risk of joint damage. Antibodies to Cyclic Citrullinated Peptide (anti-CCP) is often detected in in the blood of individuals with RA. Positive value for anti-CCP: >/=8 IU/mL. Negative value for anti-CCP: <8 IU/mL. High anti-CCP indicates an aggressive RA and a higher risk of joint damage.|participants|Number|30|30.0||||||
4160361|NCT00837434|3983071|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
4160362|NCT00837434|3983072|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4160363|NCT00837434|3983073|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4160364|NCT00837434|3983071|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4160365|NCT00837434|3983072|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160366|NCT00837434|3983073|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4160367|NCT00837434|3983071|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160368|NCT00837434|3983072|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160369|NCT00837434|3983073|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160370|NCT00837434|3983071|B3||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4160371|NCT00837434|3983072|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4160372|NCT00837434|3983073|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4160373|NCT00837434|3983071|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4160374|NCT00837434|3983072|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4160375|NCT00837434|3983073|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4160376|NCT00837434|3983071|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160377|NCT00837434|3983072|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160378|NCT00837434|3983073|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160379|NCT00837434|3983071|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160380|NCT00837434|3983072|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160381|NCT00837434|3983073|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160382|NCT00837434|3983071|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160383|NCT00837434|3983072|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160384|NCT00837434|3983073|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160385|NCT00837434|3983071|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160386|NCT00837434|3983072|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160387|NCT00837434|3983073|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160388|NCT00837434|3983071|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4160389|NCT00837434|3983072|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4160390|NCT00837434|3983073|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4160391|NCT00837434|3983071|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4160392|NCT00837434|3983072|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4160393|NCT00837434|3983073|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4160394|NCT00837434|3983071|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4160395|NCT00837434|3983072|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4160396|NCT00837434|3983073|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4160397|NCT00837434|3983071|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4160398|NCT00837434|3983072|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4160399|NCT00837434|3983073|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4160400|NCT00837434|3983071|B3|||Age||years|Mean|52.0|52.0|Standard Deviation|11.0|11.0|||
4160401|NCT00837434|3983072|B2|||Age||years|Mean|52.7|52.7|Standard Deviation|14.0|14.0|||
4160406|NCT00837330|3983092|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4160407|NCT00837330|3983093|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4160408|NCT00837330|3983094|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4160409|NCT00837330|3983092|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4160410|NCT00837330|3983093|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4160411|NCT00837330|3983094|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4160412|NCT00837330|3983092|B3|||Age||years|Mean|64|64.0|Standard Deviation|11|11.0|||
4160413|NCT00837330|3983093|B2|||Age||years|Mean|65|65.0|Standard Deviation|8|8.0|||
4160414|NCT00837330|3983094|B1|||Age||years|Mean|64|64.0|Standard Deviation|14|14.0|||
4160415|NCT00837330|3983092|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4160416|NCT00837330|3983093|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4160417|NCT00837330|3983094|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4160418|NCT00837330|3983092|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4160419|NCT00837330|3983093|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4160420|NCT00837330|3983094|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4160421|NCT00837330|3983092|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4160422|NCT00837330|3983093|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4160423|NCT00837330|3983094|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4160424|NCT00837252|3983101|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4160425|NCT00837252|3983101|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4160426|NCT00837252|3983101|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4160427|NCT00837252|3983101|B1|||Age||years|Mean|50|50.0|Standard Deviation|10.4|10.4|||
4160428|NCT00837252|3983101|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4160429|NCT00837252|3983101|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4160430|NCT00837252|3983101|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4160431|NCT00837213|3983116|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4160432|NCT00837213|3983117|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4160433|NCT00837213|3983118|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4160434|NCT00837213|3983116|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4160435|NCT00837213|3983117|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4160436|NCT00837213|3983118|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4160437|NCT00837213|3983116|B3|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4160438|NCT00837213|3983117|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4160439|NCT00837213|3983118|B1|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4160440|NCT00837213|3983116|B3|White||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4160441|NCT00837213|3983117|B2|White||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4160442|NCT00837213|3983118|B1|White||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4160443|NCT00837213|3983116|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4160444|NCT00837213|3983117|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4160445|NCT00837213|3983118|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4160446|NCT00837213|3983116|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4160447|NCT00837213|3983117|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4160448|NCT00837213|3983118|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4160449|NCT00837213|3983116|B3|||Age||years|Mean|22.9|22.9|Standard Deviation|7.7|7.7|||
4160450|NCT00837213|3983117|B2|||Age||years|Mean|21.9|21.9|Standard Deviation|6.9|6.9|||
4160451|NCT00837213|3983118|B1|||Age||years|Mean|23.9|23.9|Standard Deviation|8.5|8.5|||
4160452|NCT00837200|3983139|B1|Not treated with Prior Regimens||Prior Regimens||participants|Number|10|10.0||||||
4160453|NCT00837200|3983139|B1|Pre-Treated with 3 Median prior Regimens||Prior Regimens||participants|Number|3|3.0||||||
4160454|NCT00837200|3983139|B1|Diffuse Large B-cell Lymphoma||Participants Diagnosis||participants|Number|6|6.0||||||
4160455|NCT00837200|3983139|B1|Multiple Myeloma||Participants Diagnosis||participants|Number|7|7.0||||||
4160456|NCT00837200|3983139|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4160457|NCT00837200|3983139|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4160458|NCT00837200|3983139|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4160459|NCT00837200|3983139|B1|Partipants under 70 years old||Age, Customized||participants|Number|7|7.0||||||
4160460|NCT00837200|3983139|B1|Participants over 70 years old||Age, Customized||participants|Number|6|6.0||||||
4160461|NCT00837200|3983139|B1|||Age||years|Mean|64.9|64.9|Full Range|||46.0|80.0|
4160462|NCT00837200|3983139|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4160463|NCT00837200|3983139|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4160464|NCT00837200|3983139|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4160465|NCT00837161|3983145|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4160466|NCT00837161|3983145|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4160467|NCT00837161|3983145|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4160468|NCT00837161|3983145|B1|||Age||years|Mean|46.7|46.7|Standard Deviation|5.7|5.7|||
4160469|NCT00837161|3983145|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4160470|NCT00837161|3983145|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4160471|NCT00837161|3983145|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4160472|NCT00837148|3983153|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4160473|NCT00837148|3983153|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4160474|NCT00837148|3983153|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4160475|NCT00837148|3983153|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4160476|NCT00837148|3983153|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4160477|NCT00837096|3983157|B3|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
4160478|NCT00837096|3983158|B2|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4160479|NCT00837096|3983159|B1|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4160480|NCT00837096|3983157|B3|Germany||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4160481|NCT00837096|3983158|B2|Germany||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4160482|NCT00837096|3983159|B1|Germany||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4160483|NCT00837096|3983157|B3|Other: Arabic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4160484|NCT00837096|3983158|B2|Other: Arabic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4160485|NCT00837096|3983159|B1|Other: Arabic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4160486|NCT00837096|3983157|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4160487|NCT00837096|3983158|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4160488|NCT00837096|3983159|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4160489|NCT00837096|3983157|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4160490|NCT00837096|3983158|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4160491|NCT00837096|3983159|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4160492|NCT00837096|3983157|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4160493|NCT00837096|3983158|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4160494|NCT00837096|3983159|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4160495|NCT00837096|3983157|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4160496|NCT00837096|3983158|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4160497|NCT00837096|3983159|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4160498|NCT00837096|3983157|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4160499|NCT00837096|3983158|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4160500|NCT00837096|3983159|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4160501|NCT00837096|3983157|B3|||Age||years|Mean|55.2|55.2|Standard Deviation|12.33|12.33|||
4160502|NCT00837096|3983158|B2|||Age||years|Mean|55.9|55.9|Standard Deviation|14.56|14.56|||
4160503|NCT00837096|3983159|B1|||Age||years|Mean|52.9|52.9|Standard Deviation|13.15|13.15|||
4160504|NCT00837031|3983166|B1|United States||Region of Enrollment||participants|Number|72|72.0||||||
4160505|NCT00837031|3983166|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4160506|NCT00837031|3983166|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4160507|NCT00837031|3983166|B1|||Age||years|Median|64|64.0|Full Range|||39.0|88.0|
4160508|NCT00836953|3983172|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4160509|NCT00836953|3983172|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4160510|NCT00836953|3983172|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4160511|NCT00836953|3983172|B1|Age Continuous||Age||Months|Mean|19.08|19.08|Standard Deviation|9.69|9.69|||
4160512|NCT00836953|3983172|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4160513|NCT00836953|3983172|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4160514|NCT00836953|3983172|B1||<=18 years|Age||Participants|Count of Participants|33|33.0||||||
4160515|NCT00836927|3983178|B6|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4160516|NCT00836927|3983179|B5|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4160517|NCT00836927|3983180|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4160518|NCT00836927|3983181|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4160519|NCT00836927|3983182|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4160520|NCT00836927|3983183|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4160521|NCT00836927|3983178|B6|White||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4160522|NCT00836927|3983179|B5|White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4160523|NCT00836927|3983180|B4|White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4160524|NCT00836927|3983181|B3|White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4160525|NCT00836927|3983182|B2|White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4160526|NCT00836927|3983183|B1|White||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4160527|NCT00836927|3983178|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4160528|NCT00836927|3983179|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4160529|NCT00836927|3983180|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4160530|NCT00836927|3983181|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4160531|NCT00836927|3983182|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4160532|NCT00836927|3983183|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4160533|NCT00836927|3983178|B6||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4160534|NCT00836927|3983179|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4160535|NCT00836927|3983180|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4160536|NCT00836927|3983181|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4160537|NCT00836927|3983182|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4160538|NCT00836927|3983183|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4160539|NCT00836927|3983178|B6|||Age||Years|Mean|46.1|46.1|Standard Deviation|18.4|18.4|||
4160540|NCT00836927|3983179|B5|||Age||Years|Mean|13.0|13.0|Standard Deviation|||||
4160541|NCT00836927|3983180|B4|||Age||Years|Mean|53.0|53.0|Standard Deviation|||||
4160542|NCT00836927|3983181|B3|||Age||Years|Mean|67.0|67.0|Standard Deviation|||||
4160543|NCT00836927|3983182|B2|||Age||Years|Mean|47.0|47.0|Standard Deviation|||||
4160544|NCT00836927|3983183|B1|||Age||Years|Mean|47.7|47.7|Standard Deviation|15.0|15.0|||
4160545|NCT00836901|3983219|B3|Canada||Region of Enrollment||participants|Number|52|52.0||||||
4160546|NCT00836901|3983220|B2|Canada||Region of Enrollment||participants|Number|28|28.0||||||
4160547|NCT00836901|3983221|B1|Canada||Region of Enrollment||participants|Number|24|24.0||||||
4160548|NCT00836901|3983219|B3|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4160549|NCT00836901|3983220|B2|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4160550|NCT00836901|3983221|B1|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4160551|NCT00836901|3983219|B3|American Hispanic||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4160552|NCT00836901|3983220|B2|American Hispanic||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4160553|NCT00836901|3983221|B1|American Hispanic||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4160554|NCT00836901|3983219|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|41|41.0||||||
4160555|NCT00836901|3983220|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
4160556|NCT00836901|3983221|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
4160557|NCT00836901|3983219|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4160558|NCT00836901|3983220|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4160559|NCT00836901|3983221|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4160560|NCT00836901|3983219|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4160561|NCT00836901|3983220|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4160562|NCT00836901|3983221|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4160563|NCT00836901|3983219|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4160564|NCT00836901|3983220|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4160565|NCT00836901|3983221|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4160566|NCT00836901|3983219|B3||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4160567|NCT00836901|3983220|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4160568|NCT00836901|3983221|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4160569|NCT00836901|3983219|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4160570|NCT00836901|3983220|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4160571|NCT00836901|3983221|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4160572|NCT00836875|3983236|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4160573|NCT00836875|3983237|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4160574|NCT00836875|3983238|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4160575|NCT00836875|3983236|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4160576|NCT00836875|3983237|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4160577|NCT00836875|3983238|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4160578|NCT00836875|3983236|B3|||Age||years|Mean|11.9|11.9|Standard Deviation|3.5|3.5|||
4160579|NCT00836875|3983237|B2|||Age||years|Mean|14.1|14.1|Standard Deviation|1.7|1.7|||
4160580|NCT00836875|3983238|B1|||Age||years|Mean|7.9|7.9|Standard Deviation|2.3|2.3|||
4160581|NCT00836810|3983253|B3|||Polymyalgia Rheumatica Disease Activity Score|"PMR Disease Activity Score (PMR-AS). Formula:~PMR-AS = C-reactive protein (mg/L) + visual analogue scale, patient (0[better]-10[worse] cm) + visual analogue scale, physician (0[better]-10[worse] cm) + morning stiffness (min) x 0.1 + elevation of the upper limbs (3 = none; 2 = below shoulder girdle; 1 = up to shoulder girdle; 0 = above shoulder girdle)~A score below 7 implies low disease activity, a score range of 7 – 17 reflects medium activity and a score of more than 17 indicates an active disease."|units on a scale|Mean|39.9|39.9|Standard Deviation|19.6|19.6|||
4160630|NCT00836719|3983279|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160631|NCT00836719|3983279|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160632|NCT00836719|3983279|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160633|NCT00836719|3983279|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4160582|NCT00836810|3983254|B2|||Polymyalgia Rheumatica Disease Activity Score|"PMR Disease Activity Score (PMR-AS). Formula:~PMR-AS = C-reactive protein (mg/L) + visual analogue scale, patient (0[better]-10[worse] cm) + visual analogue scale, physician (0[better]-10[worse] cm) + morning stiffness (min) x 0.1 + elevation of the upper limbs (3 = none; 2 = below shoulder girdle; 1 = up to shoulder girdle; 0 = above shoulder girdle)~A score below 7 implies low disease activity, a score range of 7 – 17 reflects medium activity and a score of more than 17 indicates an active disease."|units on a scale|Mean|47.1|47.1|Standard Deviation|22.2|22.2|||
4160583|NCT00836810|3983255|B1|||Polymyalgia Rheumatica Disease Activity Score|"PMR Disease Activity Score (PMR-AS). Formula:~PMR-AS = C-reactive protein (mg/L) + visual analogue scale, patient (0[better]-10[worse] cm) + visual analogue scale, physician (0[better]-10[worse] cm) + morning stiffness (min) x 0.1 + elevation of the upper limbs (3 = none; 2 = below shoulder girdle; 1 = up to shoulder girdle; 0 = above shoulder girdle)~A score below 7 implies low disease activity, a score range of 7 – 17 reflects medium activity and a score of more than 17 indicates an active disease."|units on a scale|Mean|29.1|29.1|Standard Deviation|8.7|8.7|||
4160584|NCT00836810|3983253|B3|||Clinician's opinion of disease activity||VAS 0mm (better) - 100mm (worse)|Mean|59.1|59.1|Standard Deviation|18.0|18.0|||
4160585|NCT00836810|3983254|B2|||Clinician's opinion of disease activity||VAS 0mm (better) - 100mm (worse)|Mean|62.0|62.0|Standard Deviation|15.0|15.0|||
4160586|NCT00836810|3983255|B1|||Clinician's opinion of disease activity||VAS 0mm (better) - 100mm (worse)|Mean|54.8|54.8|Standard Deviation|23.6|23.6|||
4160587|NCT00836810|3983253|B3|||Patient's opinion of condition||VAS 0mm (better) - 100mm (worse)|Mean|60.4|60.4|Standard Deviation|21.4|21.4|||
4160588|NCT00836810|3983254|B2|||Patient's opinion of condition||VAS 0mm (better) - 100mm (worse)|Mean|64.2|64.2|Standard Deviation|16.3|16.3|||
4160589|NCT00836810|3983255|B1|||Patient's opinion of condition||VAS 0mm (better) - 100mm (worse)|Mean|54.8|54.8|Standard Deviation|29.3|29.3|||
4160590|NCT00836810|3983253|B3|||Pain|VAS 0mm (better) -100mm (worse)|mm|Mean|59.2|59.2|Standard Deviation|25.1|25.1|||
4160591|NCT00836810|3983254|B2|||Pain|VAS 0mm (better) -100mm (worse)|mm|Mean|62.2|62.2|Standard Deviation|15.0|15.0|||
4160592|NCT00836810|3983255|B1|||Pain|VAS 0mm (better) -100mm (worse)|mm|Mean|54.8|54.8|Standard Deviation|23.6|23.6|||
4160593|NCT00836810|3983253|B3|||Morning stiffness||minutes|Mean|96.7|96.7|Standard Deviation|48.3|48.3|||
4160594|NCT00836810|3983254|B2|||Morning stiffness||minutes|Mean|115|115.0|Standard Deviation|55|55.0|||
4160595|NCT00836810|3983255|B1|||Morning stiffness||minutes|Mean|75|75.0|Standard Deviation|38.7|38.7|||
4160596|NCT00836810|3983253|B3|||plasma viscosity (mPa.s)||mPa.s|Median|1.8|1.8|Full Range|||1.73|2.13|
4160597|NCT00836810|3983254|B2|||plasma viscosity (mPa.s)||mPa.s|Median|1.875|1.875|Full Range|||1.75|2.13|
4160598|NCT00836810|3983255|B1|||plasma viscosity (mPa.s)||mPa.s|Median|1.77|1.77|Full Range|||1.73|1.9|
4160599|NCT00836810|3983253|B3|||plasma IL-6 AUC||pg*hr/ml|Mean|218|218.0|Standard Deviation|228|228.0|||
4160600|NCT00836810|3983254|B2|||plasma IL-6 AUC||pg*hr/ml|Mean|236|236.0|Standard Deviation|246|246.0|||
4160601|NCT00836810|3983255|B1|||plasma IL-6 AUC||pg*hr/ml|Mean|191|191.0|Standard Deviation|232|232.0|||
4160602|NCT00836810|3983253|B3|||plasma IL-6 peak values (pg/ml)||pg/ml|Mean|45.5|45.5|Standard Deviation|32.4|32.4|||
4160603|NCT00836810|3983254|B2|||plasma IL-6 peak values (pg/ml)||pg/ml|Mean|40.1|40.1|Standard Deviation|22.3|22.3|||
4160604|NCT00836810|3983255|B1|||plasma IL-6 peak values (pg/ml)||pg/ml|Mean|53.5|53.5|Standard Deviation|46.7|46.7|||
4160605|NCT00836810|3983253|B3|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
4160606|NCT00836810|3983254|B2|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4160607|NCT00836810|3983255|B1|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4160608|NCT00836810|3983253|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4160609|NCT00836810|3983254|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4160610|NCT00836810|3983255|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4160611|NCT00836810|3983253|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4160612|NCT00836810|3983254|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4160613|NCT00836810|3983255|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4160614|NCT00836810|3983253|B3|||Age||years|Median|76|76.0|Full Range|||67.0|79.0|
4160615|NCT00836810|3983254|B2|||Age||years|Median|72.5|72.5|Full Range|||67.0|79.0|
4160616|NCT00836810|3983255|B1|||Age||years|Median|77.5|77.5|Full Range|||67.0|79.0|
4160617|NCT00836745|3983272|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4160618|NCT00836745|3983272|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4160619|NCT00836745|3983272|B1|||Age||years|Mean|57.8|57.8|Standard Deviation|9.5|9.5|||
4160620|NCT00836719|3983279|B1|||Disease duration||years|Median|14|14.0|Full Range|||3.0|34.0|
4160621|NCT00836719|3983279|B1|||Expanded Disability Status Scale|Expanded Disability Status Scale. Scored according to Neurostatus guidelines.Vakues range from 0-10. Higher values are worse.|points|Median|4|4.0|Full Range|||1.0|6.5|
4160622|NCT00836719|3983279|B1|Secondary Progressive||Type of MS||participants|Number|1|1.0||||||
4160623|NCT00836719|3983279|B1|Relapsing Remitting||Type of MS||participants|Number|9|9.0||||||
4160624|NCT00836719|3983279|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4160625|NCT00836719|3983279|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160626|NCT00836719|3983279|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4160627|NCT00836719|3983279|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4160628|NCT00836719|3983279|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4160629|NCT00836719|3983279|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160634|NCT00836719|3983279|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4160635|NCT00836719|3983279|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4160636|NCT00836719|3983279|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4160637|NCT00836719|3983279|B1|||Age||years|Median|45|45.0|Full Range|||39.0|56.0|
4160638|NCT00836706|3983284|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4160639|NCT00836706|3983285|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4160640|NCT00836706|3983286|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4160641|NCT00836706|3983284|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4160642|NCT00836706|3983285|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4160643|NCT00836706|3983286|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4160644|NCT00836706|3983284|B3|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4160645|NCT00836706|3983285|B2|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4160646|NCT00836706|3983286|B1|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4160647|NCT00836706|3983284|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
4160648|NCT00836706|3983285|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4160649|NCT00836706|3983286|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4160650|NCT00836706|3983284|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4160651|NCT00836706|3983285|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4160652|NCT00836706|3983286|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4160653|NCT00836706|3983284|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4160654|NCT00836706|3983285|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4160655|NCT00836706|3983286|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4160656|NCT00836706|3983284|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4160657|NCT00836706|3983285|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4160658|NCT00836706|3983286|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4160659|NCT00836706|3983284|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4160660|NCT00836706|3983285|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4160661|NCT00836706|3983286|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4160662|NCT00836706|3983284|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4160663|NCT00836706|3983285|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4160664|NCT00836706|3983286|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4160665|NCT00836693|3983295|B3|||Body Mass Index (BMI)||kilograms per square meter (kg/m²)|Mean|27.86|27.86|Standard Deviation|4.313|4.313|||
4160666|NCT00836693|3983296|B2|||Body Mass Index (BMI)||kilograms per square meter (kg/m²)|Mean|27.74|27.74|Standard Deviation|3.423|3.423|||
4160667|NCT00836693|3983297|B1|||Body Mass Index (BMI)||kilograms per square meter (kg/m²)|Mean|27.92|27.92|Standard Deviation|4.685|4.685|||
4160668|NCT00836693|3983295|B3|Spain||Region of Enrollment||participants|Number|46|46.0||||||
4160669|NCT00836693|3983296|B2|Spain||Region of Enrollment||participants|Number|15|15.0||||||
4160670|NCT00836693|3983297|B1|Spain||Region of Enrollment||participants|Number|31|31.0||||||
4160671|NCT00836693|3983295|B3|Poland||Region of Enrollment||participants|Number|45|45.0||||||
4160672|NCT00836693|3983296|B2|Poland||Region of Enrollment||participants|Number|14|14.0||||||
4160673|NCT00836693|3983297|B1|Poland||Region of Enrollment||participants|Number|31|31.0||||||
4160674|NCT00836693|3983295|B3|Italy||Region of Enrollment||participants|Number|40|40.0||||||
4160675|NCT00836693|3983296|B2|Italy||Region of Enrollment||participants|Number|13|13.0||||||
4160676|NCT00836693|3983297|B1|Italy||Region of Enrollment||participants|Number|27|27.0||||||
4160677|NCT00836693|3983295|B3|Greece||Region of Enrollment||participants|Number|28|28.0||||||
4160678|NCT00836693|3983296|B2|Greece||Region of Enrollment||participants|Number|9|9.0||||||
4160679|NCT00836693|3983297|B1|Greece||Region of Enrollment||participants|Number|19|19.0||||||
4160680|NCT00836693|3983295|B3|Germany||Region of Enrollment||participants|Number|58|58.0||||||
4160681|NCT00836693|3983296|B2|Germany||Region of Enrollment||participants|Number|19|19.0||||||
4160682|NCT00836693|3983297|B1|Germany||Region of Enrollment||participants|Number|39|39.0||||||
4160683|NCT00836693|3983295|B3|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4160684|NCT00836693|3983296|B2|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4160685|NCT00836693|3983297|B1|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4160686|NCT00836693|3983295|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4160687|NCT00836693|3983296|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4160688|NCT00836693|3983297|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4160689|NCT00836693|3983295|B3|White||Race/Ethnicity, Customized||participants|Number|213|213.0||||||
4160690|NCT00836693|3983296|B2|White||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
4160691|NCT00836693|3983297|B1|White||Race/Ethnicity, Customized||participants|Number|144|144.0||||||
4160692|NCT00836693|3983295|B3||Male|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
4160693|NCT00836693|3983296|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4160694|NCT00836693|3983297|B1||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4160695|NCT00836693|3983295|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4160696|NCT00836693|3983296|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4160697|NCT00836693|3983297|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4160698|NCT00836693|3983295|B3|||Age||years|Mean|52.1|52.1|Standard Deviation|10.71|10.71|||
4160699|NCT00836693|3983296|B2|||Age||years|Mean|51.9|51.9|Standard Deviation|10.35|10.35|||
4160700|NCT00836693|3983297|B1|||Age||years|Mean|52.2|52.2|Standard Deviation|10.90|10.9|||
4160701|NCT00836641|3983338|B3|Germany||Region of Enrollment||participants|Number|70|70.0||||||
4160702|NCT00836641|3983339|B2|Germany||Region of Enrollment||participants|Number|34|34.0||||||
4160703|NCT00836641|3983340|B1|Germany||Region of Enrollment||participants|Number|36|36.0||||||
4160704|NCT00836641|3983338|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4160705|NCT00836641|3983339|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4160706|NCT00836641|3983340|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4160707|NCT00836641|3983338|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4160708|NCT00836641|3983339|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4160709|NCT00836641|3983340|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4160710|NCT00836641|3983338|B3|||Age||years|Mean|3|3.0|Standard Deviation|0.6|0.6|||
4160711|NCT00836641|3983339|B2|||Age||years|Mean|3|3.0|Standard Deviation|0.7|0.7|||
4160712|NCT00836641|3983340|B1|||Age||years|Mean|3|3.0|Standard Deviation|0.5|0.5|||
4160713|NCT00836641|3983338|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4160714|NCT00836641|3983339|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4160715|NCT00836641|3983340|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4160716|NCT00836641|3983338|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4160717|NCT00836641|3983339|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4160718|NCT00836641|3983340|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4160719|NCT00836641|3983338|B3||<=18 years|Age||Participants|Count of Participants|70|70.0||||||
4160720|NCT00836641|3983339|B2||<=18 years|Age||Participants|Count of Participants|34|34.0||||||
4160721|NCT00836641|3983340|B1||<=18 years|Age||Participants|Count of Participants|36|36.0||||||
4160722|NCT00836498|3983348|B3|United States||Region of Enrollment||participants|Number|66|66.0||||||
4160723|NCT00836498|3983349|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4160724|NCT00836498|3983350|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4160725|NCT00836498|3983348|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4160726|NCT00836498|3983349|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4160727|NCT00836498|3983350|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4160728|NCT00836498|3983348|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4160729|NCT00836498|3983349|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4160730|NCT00836498|3983350|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4160731|NCT00836498|3983348|B3|||Age, Customized|Between 65 and 80 years.|participants|Number|66|66.0||||||
4160732|NCT00836498|3983349|B2|||Age, Customized|Between 65 and 80 years.|participants|Number|22|22.0||||||
4160733|NCT00836498|3983350|B1|||Age, Customized|Between 65 and 80 years.|participants|Number|44|44.0||||||
4160734|NCT00836472|3983381|B3|Canada||Region of Enrollment||participants|Number|60|60.0||||||
4160735|NCT00836472|3983382|B2|Canada||Region of Enrollment||participants|Number|30|30.0||||||
4160736|NCT00836472|3983383|B1|Canada||Region of Enrollment||participants|Number|30|30.0||||||
4160737|NCT00836472|3983381|B3|American Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4160738|NCT00836472|3983382|B2|American Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4160739|NCT00836472|3983383|B1|American Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4160740|NCT00836472|3983381|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4160741|NCT00836472|3983382|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4160742|NCT00836472|3983383|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4160743|NCT00836472|3983381|B3|Black||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4160744|NCT00836472|3983382|B2|Black||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4160745|NCT00836472|3983383|B1|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4160746|NCT00836472|3983381|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|51|51.0||||||
4160747|NCT00836472|3983382|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
4160748|NCT00836472|3983383|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|28|28.0||||||
4160749|NCT00836472|3983381|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4160750|NCT00836472|3983382|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4160751|NCT00836472|3983383|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4160752|NCT00836472|3983381|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4160753|NCT00836472|3983382|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4160754|NCT00836472|3983383|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4160755|NCT00836472|3983381|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4160756|NCT00836472|3983382|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4160757|NCT00836472|3983383|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4160758|NCT00836472|3983381|B3||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4160759|NCT00836472|3983382|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4160760|NCT00836472|3983383|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4160761|NCT00836472|3983381|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4160762|NCT00836472|3983382|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4160763|NCT00836472|3983383|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4160764|NCT00836433|3983398|B3|United States||Region of Enrollment||participants|Number|689|689.0||||||
4160765|NCT00836433|3983399|B2|United States||Region of Enrollment||participants|Number|328|328.0||||||
4160766|NCT00836433|3983400|B1|United States||Region of Enrollment||participants|Number|361|361.0||||||
4160767|NCT00836433|3983398|B3||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4160768|NCT00836433|3983399|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4160769|NCT00836433|3983400|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4160770|NCT00836433|3983398|B3||Female|Sex: Female, Male||Participants|Count of Participants|592|592.0||||||
4160771|NCT00836433|3983399|B2||Female|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
4160772|NCT00836433|3983400|B1||Female|Sex: Female, Male||Participants|Count of Participants|307|307.0||||||
4160773|NCT00836433|3983398|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4160774|NCT00836433|3983399|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4160775|NCT00836433|3983400|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4160776|NCT00836433|3983398|B3||Between 18 and 65 years|Age||Participants|Count of Participants|689|689.0||||||
4160777|NCT00836433|3983399|B2||Between 18 and 65 years|Age||Participants|Count of Participants|328|328.0||||||
4160778|NCT00836433|3983400|B1||Between 18 and 65 years|Age||Participants|Count of Participants|361|361.0||||||
4160779|NCT00836433|3983398|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4160780|NCT00836433|3983399|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4160781|NCT00836433|3983400|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4160782|NCT00836433|3983398|B3|||Age||years|Mean|44|44.0|Standard Deviation|5|5.0|||
4160783|NCT00836433|3983399|B2|||Age||years|Mean|42|42.0|Standard Deviation|5|5.0|||
4160784|NCT00836433|3983400|B1|||Age||years|Mean|45|45.0|Standard Deviation|6|6.0|||
4160785|NCT00836407|3983409|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4160786|NCT00836407|3983410|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4160787|NCT00836407|3983411|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4160788|NCT00836407|3983409|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4160789|NCT00836407|3983410|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4160790|NCT00836407|3983411|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4160791|NCT00836407|3983409|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4160792|NCT00836407|3983410|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4160793|NCT00836407|3983411|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4160794|NCT00836407|3983409|B3|||Age||years|Mean|62.1|62.1|Standard Deviation|8.2|8.2|||
4160795|NCT00836407|3983410|B2|||Age||years|Mean|61.9|61.9|Standard Deviation|8.9|8.9|||
4160796|NCT00836407|3983411|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|7.8|7.8|||
4160797|NCT00836407|3983409|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4160798|NCT00836407|3983410|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4160799|NCT00836407|3983411|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4160800|NCT00836407|3983409|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4160801|NCT00836407|3983410|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4160802|NCT00836407|3983411|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4160803|NCT00836407|3983409|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4160804|NCT00836407|3983410|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4160805|NCT00836407|3983411|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4160806|NCT00836355|3983420|B5|Male||Gender||participants|Number|4|4.0||||||
4160807|NCT00836355|3983421|B4|Male||Gender||participants|Number|1|1.0||||||
4160808|NCT00836355|3983423|B2|Male||Gender||participants|Number|3|3.0||||||
4160809|NCT00836355|3983420|B5|Female||Gender||participants|Number|2|2.0||||||
4160810|NCT00836355|3983421|B4|Female||Gender||participants|Number|1|1.0||||||
4160811|NCT00836355|3983423|B2|Female||Gender||participants|Number|1|1.0||||||
4160812|NCT00836355|3983420|B5|>=65 years||Age||participants|Number|1|1.0||||||
4160813|NCT00836355|3983421|B4|>=65 years||Age||participants|Number|1|1.0||||||
4160814|NCT00836355|3983423|B2|>=65 years||Age||participants|Number|0|0.0||||||
4160815|NCT00836355|3983420|B5|Between 18 and 65 years||Age||participants|Number|5|5.0||||||
4160816|NCT00836355|3983421|B4|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
4160817|NCT00836355|3983423|B2|Between 18 and 65 years||Age||participants|Number|4|4.0||||||
4160818|NCT00836355|3983420|B5|<=18 years||Age||participants|Number|0|0.0||||||
4160819|NCT00836355|3983421|B4|<=18 years||Age||participants|Number|0|0.0||||||
4160820|NCT00836355|3983423|B2|<=18 years||Age||participants|Number|0|0.0||||||
4160821|NCT00836342|3983445|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160822|NCT00836342|3983446|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160823|NCT00836342|3983447|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160824|NCT00836342|3983448|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160825|NCT00836342|3983445|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4160826|NCT00836342|3983446|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4160827|NCT00836342|3983447|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160828|NCT00836342|3983448|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160829|NCT00836342|3983445|B4||White|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
4160830|NCT00836342|3983446|B3||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4160831|NCT00836342|3983447|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4160832|NCT00836342|3983448|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4160833|NCT00836342|3983445|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4160834|NCT00836342|3983446|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4160835|NCT00836342|3983447|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160836|NCT00836342|3983448|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160837|NCT00836342|3983445|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160838|NCT00836342|3983446|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160839|NCT00836342|3983447|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160840|NCT00836342|3983448|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160841|NCT00836342|3983445|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4160842|NCT00836342|3983446|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4160843|NCT00836342|3983447|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160844|NCT00836342|3983448|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160845|NCT00836342|3983445|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160846|NCT00836342|3983446|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160847|NCT00836342|3983447|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160848|NCT00836342|3983448|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160849|NCT00836342|3983445|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4160850|NCT00836342|3983446|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4160851|NCT00836342|3983447|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4160852|NCT00836342|3983448|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4160853|NCT00836342|3983445|B4||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4160854|NCT00836342|3983446|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4160855|NCT00836342|3983447|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4160856|NCT00836342|3983448|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4160857|NCT00836342|3983445|B4|Mean age||Age||years|Mean|60.2|60.2|Full Range|||50.0|75.0|
4160858|NCT00836342|3983446|B3|Mean age||Age||years|Mean|57.4|57.4|Full Range|||50.0|75.0|
4160859|NCT00836342|3983447|B2|Mean age||Age||years|Mean|60.9|60.9|Full Range|||50.0|75.0|
4160860|NCT00836342|3983448|B1|Mean age||Age||years|Mean|63.9|63.9|Full Range|||50.0|75.0|
4160861|NCT00836277|3983461|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160862|NCT00836277|3983461|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160863|NCT00836277|3983461|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4160864|NCT00836277|3983461|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160865|NCT00836277|3983461|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160866|NCT00836277|3983461|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160867|NCT00836277|3983461|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4160868|NCT00836277|3983461|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4160869|NCT00836277|3983461|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4160870|NCT00836277|3983461|B1|||Age||years|Median|62.5|62.5|Full Range|||33.0|79.0|
4160871|NCT00836095|3983469|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4160872|NCT00836095|3983470|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4160873|NCT00836095|3983471|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4160874|NCT00836095|3983469|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4160875|NCT00836095|3983470|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4160876|NCT00836095|3983471|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4160877|NCT00836095|3983469|B3|||Age||years|Mean|45|45.0|Standard Deviation|14|14.0|||
4160878|NCT00836095|3983470|B2|||Age||years|Mean|41|41.0|Standard Deviation|14|14.0|||
4160879|NCT00836095|3983471|B1|||Age||years|Mean|49|49.0|Standard Deviation|14|14.0|||
4160880|NCT00836056|3983480|B3|Canada||Region of Enrollment||participants|Number|24|24.0||||||
4160881|NCT00836056|3983481|B2|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4160882|NCT00836056|3983482|B1|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4160883|NCT00836056|3983480|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
4160884|NCT00836056|3983481|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4160885|NCT00836056|3983482|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4160886|NCT00836056|3983480|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4160887|NCT00836056|3983481|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4160888|NCT00836056|3983482|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4160889|NCT00836056|3983480|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4160890|NCT00836056|3983481|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4160891|NCT00836056|3983482|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4160892|NCT00836056|3983480|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4160893|NCT00836056|3983481|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4160894|NCT00836056|3983482|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4160895|NCT00836056|3983480|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4160896|NCT00836056|3983481|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4160897|NCT00836056|3983482|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4160898|NCT00836056|3983480|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4160899|NCT00836056|3983481|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4160900|NCT00836056|3983482|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4160901|NCT00836017|3983491|B1||Male|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
4160902|NCT00836017|3983491|B1||Female|Sex: Female, Male||Participants|Count of Participants|774|774.0||||||
4160903|NCT00836017|3983491|B1|||Age||Years|Mean|58.0|58.0|Standard Deviation|14.7|14.7|||
4160904|NCT00836004|3983499|B3|Canada||Region of Enrollment||participants|Number|24|24.0||||||
4160905|NCT00836004|3983500|B2|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4160906|NCT00836004|3983501|B1|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4160907|NCT00836004|3983499|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
4160908|NCT00836004|3983500|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4160909|NCT00836004|3983501|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4160910|NCT00836004|3983499|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4160911|NCT00836004|3983500|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4160912|NCT00836004|3983501|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4160913|NCT00836004|3983499|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4160914|NCT00836004|3983500|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4160915|NCT00836004|3983501|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4160916|NCT00836004|3983499|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4160917|NCT00836004|3983500|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4160918|NCT00836004|3983501|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4160919|NCT00836004|3983499|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4160920|NCT00836004|3983500|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4160921|NCT00836004|3983501|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4160922|NCT00836004|3983499|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4160923|NCT00836004|3983500|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4160924|NCT00836004|3983501|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4160925|NCT00835991|3983510|B3|Canada||Region of Enrollment||participants|Number|60|60.0||||||
4160926|NCT00835991|3983511|B2|Canada||Region of Enrollment||participants|Number|30|30.0||||||
4160927|NCT00835991|3983512|B1|Canada||Region of Enrollment||participants|Number|30|30.0||||||
4160928|NCT00835991|3983510|B3|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4160929|NCT00835991|3983511|B2|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4160930|NCT00835991|3983512|B1|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4160931|NCT00835991|3983510|B3|American Hispanic||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4160932|NCT00835991|3983511|B2|American Hispanic||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4160933|NCT00835991|3983512|B1|American Hispanic||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4160934|NCT00835991|3983510|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|51|51.0||||||
4160935|NCT00835991|3983511|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
4160936|NCT00835991|3983512|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
4160937|NCT00835991|3983510|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4160938|NCT00835991|3983511|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4160939|NCT00835991|3983512|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4160940|NCT00835991|3983510|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4160941|NCT00835991|3983511|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4160942|NCT00835991|3983512|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4160943|NCT00835991|3983510|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4160944|NCT00835991|3983511|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4160945|NCT00835991|3983512|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4160946|NCT00835991|3983510|B3||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4160947|NCT00835991|3983511|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4160948|NCT00835991|3983512|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4160949|NCT00835991|3983510|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4160950|NCT00835991|3983511|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4160951|NCT00835991|3983512|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4160952|NCT00835978|3983527|B5||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4160953|NCT00835978|3983528|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4160954|NCT00835978|3983529|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4160955|NCT00835978|3983530|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4160956|NCT00835978|3983531|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4160957|NCT00835978|3983527|B5||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4160958|NCT00835978|3983528|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4160959|NCT00835978|3983529|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4160960|NCT00835978|3983530|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4160961|NCT00835978|3983531|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4160962|NCT00835978|3983527|B5|>= 65 Years||Age, Customized||Participants|Number|77|77.0||||||
4160963|NCT00835978|3983528|B4|>= 65 Years||Age, Customized||Participants|Number|4|4.0||||||
4160964|NCT00835978|3983529|B3|>= 65 Years||Age, Customized||Participants|Number|37|37.0||||||
4160965|NCT00835978|3983530|B2|>= 65 Years||Age, Customized||Participants|Number|18|18.0||||||
4160966|NCT00835978|3983531|B1|>= 65 Years||Age, Customized||Participants|Number|18|18.0||||||
4160967|NCT00835978|3983527|B5|< 65 Years||Age, Customized||Participants|Number|136|136.0||||||
4160968|NCT00835978|3983528|B4|< 65 Years||Age, Customized||Participants|Number|6|6.0||||||
4160969|NCT00835978|3983529|B3|< 65 Years||Age, Customized||Participants|Number|54|54.0||||||
4160970|NCT00835978|3983530|B2|< 65 Years||Age, Customized||Participants|Number|38|38.0||||||
4160971|NCT00835978|3983531|B1|< 65 Years||Age, Customized||Participants|Number|38|38.0||||||
4160972|NCT00835978|3983527|B5|||Age||Years|Mean|61.2|61.2|Standard Deviation|9.7|9.7|||
4160973|NCT00835978|3983528|B4|||Age||Years|Mean|62.9|62.9|Standard Deviation|7.5|7.5|||
4160974|NCT00835978|3983529|B3|||Age||Years|Mean|62.9|62.9|Standard Deviation|8.9|8.9|||
4160975|NCT00835978|3983530|B2|||Age||Years|Mean|59.6|59.6|Standard Deviation|10.5|10.5|||
4160976|NCT00835978|3983531|B1|||Age||Years|Mean|59.7|59.7|Standard Deviation|10.2|10.2|||
4160977|NCT00835926|3983592|B3|United States||Region of Enrollment||participants|Number|121|121.0||||||
4160978|NCT00835926|3983593|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
4160979|NCT00835926|3983594|B1|United States||Region of Enrollment||participants|Number|61|61.0||||||
4160980|NCT00835926|3983592|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4160981|NCT00835926|3983593|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4160982|NCT00835926|3983594|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4160983|NCT00835926|3983592|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4160984|NCT00835926|3983593|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4160985|NCT00835926|3983594|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4160986|NCT00835926|3983592|B3|Age Continuous||Age||Years|Mean|57.1|57.1|Standard Deviation|18.65|18.65|||
4160987|NCT00835926|3983593|B2|Age Continuous||Age||Years|Mean|73.7|73.7|Standard Deviation|6.16|6.16|||
4160988|NCT00835926|3983594|B1|Age Continuous||Age||Years|Mean|40.7|40.7|Standard Deviation|10.43|10.43|||
4160989|NCT00835926|3983592|B3||>=65 years|Age||Participants|Count of Participants|55|55.0||||||
4160990|NCT00835926|3983593|B2||>=65 years|Age||Participants|Count of Participants|55|55.0||||||
4160991|NCT00835926|3983594|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4160992|NCT00835926|3983592|B3||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4160993|NCT00835926|3983593|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4160994|NCT00835926|3983594|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4160995|NCT00835926|3983592|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4160996|NCT00835926|3983593|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4160997|NCT00835926|3983594|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4160998|NCT00835900|3983607|B3|||Baseline CPD||Cigarettes Per Day|Mean|21|21.0|Standard Deviation|5|5.0|||
4160999|NCT00835900|3983608|B2|||Baseline CPD||Cigarettes Per Day|Mean|21|21.0|Standard Deviation|5|5.0|||
4161000|NCT00835900|3983609|B1|||Baseline CPD||Cigarettes Per Day|Mean|21|21.0|Standard Deviation|5|5.0|||
4161001|NCT00835900|3983607|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|52|52.0||||||
4161002|NCT00835900|3983608|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
4161003|NCT00835900|3983609|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
4161004|NCT00835900|3983607|B3|Nonwhite||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4161005|NCT00835900|3983608|B2|Nonwhite||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4161006|NCT00835900|3983609|B1|Nonwhite||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4161007|NCT00835900|3983607|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4161008|NCT00835900|3983608|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4161009|NCT00835900|3983609|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4161010|NCT00835900|3983607|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4161011|NCT00835900|3983608|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4161012|NCT00835900|3983609|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4161013|NCT00835900|3983607|B3|||Age||years|Mean|48|48.0|Standard Deviation|9|9.0|||
4161014|NCT00835900|3983608|B2|||Age||years|Mean|49|49.0|Standard Deviation|10|10.0|||
4161015|NCT00835900|3983609|B1|||Age||years|Mean|48|48.0|Standard Deviation|10|10.0|||
4161016|NCT00835861|3983618|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
4161017|NCT00835861|3983619|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4161018|NCT00835861|3983620|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4161019|NCT00835861|3983618|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4161020|NCT00835861|3983619|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4161021|NCT00835861|3983620|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4161022|NCT00835861|3983618|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4161023|NCT00835861|3983619|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4161024|NCT00835861|3983620|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4161025|NCT00835861|3983618|B3|||Age||years|Mean|32.7|32.7|Standard Deviation|4.6|4.6|||
4161026|NCT00835861|3983619|B2|||Age||years|Mean|29.7|29.7|Standard Deviation|4.1|4.1|||
4161027|NCT00835861|3983620|B1|||Age||years|Mean|35.7|35.7|Standard Deviation|2.6|2.6|||
4161028|NCT00835861|3983618|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161029|NCT00835861|3983619|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161030|NCT00835861|3983620|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161031|NCT00835861|3983618|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4161032|NCT00835861|3983619|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4161033|NCT00835861|3983620|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4161034|NCT00835861|3983618|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161035|NCT00835861|3983619|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161036|NCT00835861|3983620|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161037|NCT00835796|3983643|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4161038|NCT00835796|3983644|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4161039|NCT00835796|3983645|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4161040|NCT00835796|3983643|B3|Black||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4161041|NCT00835796|3983644|B2|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4161042|NCT00835796|3983645|B1|Black||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4161043|NCT00835796|3983643|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4161044|NCT00835796|3983644|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4161045|NCT00835796|3983645|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4161046|NCT00835796|3983643|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4161047|NCT00835796|3983644|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4161048|NCT00835796|3983645|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4161049|NCT00835796|3983643|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4161050|NCT00835796|3983644|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4161051|NCT00835796|3983645|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4161052|NCT00835796|3983643|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4161053|NCT00835796|3983644|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4161054|NCT00835796|3983645|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4161055|NCT00835796|3983643|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161056|NCT00835796|3983644|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161057|NCT00835796|3983645|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161058|NCT00835796|3983643|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4161059|NCT00835796|3983644|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4161060|NCT00835796|3983645|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4161061|NCT00835796|3983643|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161062|NCT00835796|3983644|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161063|NCT00835796|3983645|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161064|NCT00835731|3983654|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4161065|NCT00835731|3983655|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4161066|NCT00835731|3983656|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4161067|NCT00835731|3983654|B3||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4161068|NCT00835731|3983655|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4161069|NCT00835731|3983656|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4161070|NCT00835731|3983654|B3|||Age||years|Mean|24.0|24.0|Standard Deviation|5.2|5.2|||
4161071|NCT00835731|3983655|B2|||Age||years|Mean|24.0|24.0|Standard Deviation|5.0|5.0|||
4161072|NCT00835731|3983656|B1|||Age||years|Mean|24.1|24.1|Standard Deviation|5.5|5.5|||
4161073|NCT00835731|3983654|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161074|NCT00835731|3983655|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161075|NCT00835731|3983656|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161076|NCT00835731|3983654|B3||Between 18 and 65 years|Age||Participants|Count of Participants|125|125.0||||||
4161077|NCT00835731|3983655|B2||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4161078|NCT00835731|3983656|B1||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4161079|NCT00835731|3983654|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161080|NCT00835731|3983655|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161081|NCT00835731|3983656|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161082|NCT00835705|3983675|B3|Canada||Region of Enrollment||participants|Number|52|52.0||||||
4161083|NCT00835705|3983676|B2|Canada||Region of Enrollment||participants|Number|28|28.0||||||
4161084|NCT00835705|3983677|B1|Canada||Region of Enrollment||participants|Number|24|24.0||||||
4161085|NCT00835705|3983675|B3|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4161086|NCT00835705|3983676|B2|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4161087|NCT00835705|3983677|B1|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4161088|NCT00835705|3983675|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|51|51.0||||||
4161089|NCT00835705|3983676|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|28|28.0||||||
4161090|NCT00835705|3983677|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
4161091|NCT00835705|3983675|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4161092|NCT00835705|3983676|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4161093|NCT00835705|3983677|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4161094|NCT00835705|3983675|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4161095|NCT00835705|3983676|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4161096|NCT00835705|3983677|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4161097|NCT00835705|3983675|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161098|NCT00835705|3983676|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161099|NCT00835705|3983677|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161100|NCT00835705|3983675|B3||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4161101|NCT00835705|3983676|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4161102|NCT00835705|3983677|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4161103|NCT00835705|3983675|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161104|NCT00835705|3983676|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161105|NCT00835705|3983677|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161106|NCT00835692|3983692|B3|United States||Region of Enrollment||participants|Number|56|56.0||||||
4161107|NCT00835692|3983693|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4161108|NCT00835692|3983694|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4161109|NCT00835692|3983692|B3|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4161110|NCT00835692|3983693|B2|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4161111|NCT00835692|3983694|B1|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4161112|NCT00835692|3983692|B3|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4161113|NCT00835692|3983693|B2|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4161114|NCT00835692|3983694|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4161115|NCT00835692|3983692|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4161116|NCT00835692|3983693|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4161117|NCT00835692|3983694|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4161118|NCT00835692|3983692|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|50|50.0||||||
4161119|NCT00835692|3983693|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
4161120|NCT00835692|3983694|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
4161121|NCT00835692|3983692|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4161122|NCT00835692|3983693|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4161123|NCT00835692|3983694|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4161124|NCT00835692|3983692|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4161125|NCT00835692|3983693|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4161126|NCT00835692|3983694|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4161127|NCT00835692|3983692|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161128|NCT00835692|3983693|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161129|NCT00835692|3983694|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161130|NCT00835692|3983692|B3||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4161131|NCT00835692|3983693|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4161132|NCT00835692|3983694|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4161133|NCT00835692|3983692|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161134|NCT00835692|3983693|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161135|NCT00835692|3983694|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161136|NCT00835679|3983703|B5|United States||Region of Enrollment||participants|Number|9|9.0||||||
4161137|NCT00835679|3983707|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4161138|NCT00835679|3983703|B5|Male||Gender||participants|Number|4|4.0||||||
4161139|NCT00835679|3983707|B1|Male||Gender||participants|Number|4|4.0||||||
4161140|NCT00835679|3983703|B5|Female||Gender||participants|Number|5|5.0||||||
4161141|NCT00835679|3983707|B1|Female||Gender||participants|Number|5|5.0||||||
4161142|NCT00835679|3983703|B5|||Age||years|Mean|58|58.0|Standard Deviation|1|1.0|||
4161143|NCT00835679|3983707|B1|||Age||years|Mean|58|58.0|Standard Deviation|1|1.0|||
4161144|NCT00835679|3983703|B5|>=65 years||Age||participants|Number|2|2.0||||||
4161145|NCT00835679|3983707|B1|>=65 years||Age||participants|Number|2|2.0||||||
4161146|NCT00835679|3983703|B5|Between 18 and 65 years||Age||participants|Number|7|7.0||||||
4161147|NCT00835679|3983707|B1|Between 18 and 65 years||Age||participants|Number|7|7.0||||||
4161148|NCT00835679|3983703|B5|<=18 years||Age||participants|Number|0|0.0||||||
4161149|NCT00835679|3983707|B1|<=18 years||Age||participants|Number|0|0.0||||||
4161150|NCT00835666|3983732|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4161151|NCT00835666|3983733|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4161152|NCT00835666|3983734|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4161153|NCT00835666|3983732|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4161154|NCT00835666|3983733|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4161155|NCT00835666|3983734|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4161156|NCT00835666|3983732|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4161157|NCT00835666|3983733|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4161158|NCT00835666|3983734|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4161159|NCT00835666|3983732|B3|Black||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
4161160|NCT00835666|3983733|B2|Black||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4161161|NCT00835666|3983734|B1|Black||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4161162|NCT00835666|3983732|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4161163|NCT00835666|3983733|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4161164|NCT00835666|3983734|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4161165|NCT00835666|3983732|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4161166|NCT00835666|3983733|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4161167|NCT00835666|3983734|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4161168|NCT00835666|3983732|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4161169|NCT00835666|3983733|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4161170|NCT00835666|3983734|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4161171|NCT00835666|3983732|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161172|NCT00835666|3983733|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161173|NCT00835666|3983734|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161174|NCT00835666|3983732|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4161175|NCT00835666|3983733|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4161176|NCT00835666|3983734|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4161177|NCT00835666|3983732|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161178|NCT00835666|3983733|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161179|NCT00835666|3983734|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161180|NCT00835640|3983743|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4161181|NCT00835640|3983744|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4161182|NCT00835640|3983745|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4161183|NCT00835640|3983743|B3|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4161184|NCT00835640|3983744|B2|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4161185|NCT00835640|3983745|B1|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4161186|NCT00835640|3983743|B3|American Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4161187|NCT00835640|3983744|B2|American Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4161188|NCT00835640|3983745|B1|American Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4161189|NCT00835640|3983743|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4161190|NCT00835640|3983744|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4161191|NCT00835640|3983745|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4161192|NCT00835640|3983743|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4161193|NCT00835640|3983744|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4161194|NCT00835640|3983745|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4161195|NCT00835640|3983743|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161196|NCT00835640|3983744|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161197|NCT00835640|3983745|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161198|NCT00835640|3983743|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4161199|NCT00835640|3983744|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4161200|NCT00835640|3983745|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4161201|NCT00835640|3983743|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161202|NCT00835640|3983744|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161203|NCT00835640|3983745|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161204|NCT00835614|3983754|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4161205|NCT00835614|3983755|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4161206|NCT00835614|3983756|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4161207|NCT00835614|3983754|B3|White||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4161208|NCT00835614|3983755|B2|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4161209|NCT00835614|3983756|B1|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4161210|NCT00835614|3983754|B3|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4161211|NCT00835614|3983755|B2|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4161212|NCT00835614|3983756|B1|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4161213|NCT00835614|3983754|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4161214|NCT00835614|3983755|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4161215|NCT00835614|3983756|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4161216|NCT00835614|3983754|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4161217|NCT00835614|3983755|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4161218|NCT00835614|3983756|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4161219|NCT00835614|3983754|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161220|NCT00835614|3983755|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161221|NCT00835614|3983756|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161222|NCT00835614|3983754|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4161223|NCT00835614|3983755|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4161224|NCT00835614|3983756|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4161225|NCT00835614|3983754|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161226|NCT00835614|3983755|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161227|NCT00835614|3983756|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161228|NCT00835588|3983765|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
4161229|NCT00835588|3983766|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
4161230|NCT00835588|3983767|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4161231|NCT00835588|3983765|B3|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4161232|NCT00835588|3983766|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4161233|NCT00835588|3983767|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4161234|NCT00835588|3983765|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4161235|NCT00835588|3983766|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4161236|NCT00835588|3983767|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4161237|NCT00835588|3983765|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4161238|NCT00835588|3983766|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4161239|NCT00835588|3983767|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4161240|NCT00835588|3983765|B3|American Indian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4161241|NCT00835588|3983766|B2|American Indian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4161242|NCT00835588|3983767|B1|American Indian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4161243|NCT00835588|3983765|B3|Black||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4161244|NCT00835588|3983766|B2|Black||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4161245|NCT00835588|3983767|B1|Black||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4161246|NCT00835588|3983765|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|83|83.0||||||
4161247|NCT00835588|3983766|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|42|42.0||||||
4161248|NCT00835588|3983767|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|41|41.0||||||
4161249|NCT00835588|3983765|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4161250|NCT00835588|3983766|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4161251|NCT00835588|3983767|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4161252|NCT00835588|3983765|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4161253|NCT00835588|3983766|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4161254|NCT00835588|3983767|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4161255|NCT00835588|3983765|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161256|NCT00835588|3983766|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161257|NCT00835588|3983767|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161258|NCT00835588|3983765|B3||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4161259|NCT00835588|3983766|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4161260|NCT00835588|3983767|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4161261|NCT00835588|3983765|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161262|NCT00835588|3983766|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161263|NCT00835588|3983767|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161264|NCT00835575|3983776|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4161265|NCT00835575|3983777|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4161266|NCT00835575|3983778|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4161267|NCT00835575|3983776|B3|White||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4161268|NCT00835575|3983777|B2|White||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4161269|NCT00835575|3983778|B1|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4161270|NCT00835575|3983776|B3|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4161271|NCT00835575|3983777|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4161272|NCT00835575|3983778|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4161273|NCT00835575|3983776|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4161274|NCT00835575|3983777|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4161275|NCT00835575|3983778|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4161276|NCT00835575|3983776|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4161277|NCT00835575|3983777|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4161278|NCT00835575|3983778|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4161279|NCT00835575|3983776|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161280|NCT00835575|3983777|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161281|NCT00835575|3983778|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161282|NCT00835575|3983776|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4161283|NCT00835575|3983777|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4161284|NCT00835575|3983778|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4161285|NCT00835575|3983776|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161286|NCT00835575|3983777|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161287|NCT00835575|3983778|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161288|NCT00835549|3983787|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4161289|NCT00835549|3983788|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4161290|NCT00835549|3983789|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4161291|NCT00835549|3983787|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161292|NCT00835549|3983788|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161293|NCT00835549|3983789|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161294|NCT00835549|3983787|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4161295|NCT00835549|3983788|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4161296|NCT00835549|3983789|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4161297|NCT00835549|3983787|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4161298|NCT00835549|3983788|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4161299|NCT00835549|3983789|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4161300|NCT00835549|3983787|B3|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4161301|NCT00835549|3983788|B2|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4161302|NCT00835549|3983789|B1|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4161303|NCT00835549|3983787|B3|Black||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4161304|NCT00835549|3983788|B2|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4161305|NCT00835549|3983789|B1|Black||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4161306|NCT00835549|3983787|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4161307|NCT00835549|3983788|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4161308|NCT00835549|3983789|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4161309|NCT00835549|3983787|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4161310|NCT00835549|3983788|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4161311|NCT00835549|3983789|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4161312|NCT00835549|3983787|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161313|NCT00835549|3983788|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161314|NCT00835549|3983789|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161315|NCT00835549|3983787|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4161316|NCT00835549|3983788|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4161317|NCT00835549|3983789|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4161318|NCT00835549|3983787|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161319|NCT00835549|3983788|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161320|NCT00835549|3983789|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161321|NCT00835536|3983798|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
4161322|NCT00835536|3983799|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4161323|NCT00835536|3983800|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4161324|NCT00835536|3983798|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4161325|NCT00835536|3983799|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4161326|NCT00835536|3983800|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4161327|NCT00835536|3983798|B3|White||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4161328|NCT00835536|3983799|B2|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4161329|NCT00835536|3983800|B1|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4161330|NCT00835536|3983798|B3|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4161331|NCT00835536|3983799|B2|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4161332|NCT00835536|3983800|B1|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4161333|NCT00835536|3983798|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4161334|NCT00835536|3983799|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4161335|NCT00835536|3983800|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4161336|NCT00835536|3983798|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4161337|NCT00835536|3983799|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4161338|NCT00835536|3983800|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4161339|NCT00835536|3983798|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4161340|NCT00835536|3983799|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4161341|NCT00835536|3983800|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4161342|NCT00835536|3983798|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4161343|NCT00835536|3983799|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4161344|NCT00835536|3983800|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4161345|NCT00835536|3983798|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4161346|NCT00835536|3983799|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4161347|NCT00835536|3983800|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4161348|NCT00835536|3983798|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161349|NCT00835536|3983799|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161350|NCT00835536|3983800|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161351|NCT00835510|3983807|B4|Belize||Region of Enrollment||participants|Number|55|55.0||||||
4161352|NCT00835510|3983808|B3|Belize||Region of Enrollment||participants|Number|9|9.0||||||
4161353|NCT00835510|3983809|B2|Belize||Region of Enrollment||participants|Number|20|20.0||||||
4161354|NCT00835510|3983810|B1|Belize||Region of Enrollment||participants|Number|26|26.0||||||
4161355|NCT00835510|3983807|B4|United States||Region of Enrollment||participants|Number|320|320.0||||||
4161356|NCT00835510|3983808|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
4161357|NCT00835510|3983809|B2|United States||Region of Enrollment||participants|Number|135|135.0||||||
4161358|NCT00835510|3983810|B1|United States||Region of Enrollment||participants|Number|123|123.0||||||
4161359|NCT00835510|3983807|B4||Male|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
4161360|NCT00835510|3983808|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4161361|NCT00835510|3983809|B2||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4161362|NCT00835510|3983810|B1||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4161363|NCT00835510|3983807|B4||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4161364|NCT00835510|3983808|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4161365|NCT00835510|3983809|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4161366|NCT00835510|3983810|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4161367|NCT00835510|3983807|B4||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4161368|NCT00835510|3983808|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4161369|NCT00835510|3983809|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4161370|NCT00835510|3983810|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4161371|NCT00835510|3983807|B4||Between 18 and 65 years|Age||Participants|Count of Participants|343|343.0||||||
4161372|NCT00835510|3983808|B3||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4161373|NCT00835510|3983809|B2||Between 18 and 65 years|Age||Participants|Count of Participants|142|142.0||||||
4161374|NCT00835510|3983810|B1||Between 18 and 65 years|Age||Participants|Count of Participants|135|135.0||||||
4161375|NCT00835510|3983807|B4||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4161376|NCT00835510|3983808|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4161377|NCT00835510|3983809|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4161378|NCT00835510|3983810|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4161379|NCT00835497|3983832|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4161380|NCT00835497|3983833|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4161381|NCT00835497|3983834|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4161382|NCT00835497|3983832|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4161383|NCT00835497|3983833|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4161384|NCT00835497|3983834|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4161385|NCT00835497|3983832|B3|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4161386|NCT00835497|3983833|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4161387|NCT00835497|3983834|B1|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4161388|NCT00835497|3983832|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|36|36.0||||||
4161389|NCT00835497|3983833|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
4161390|NCT00835497|3983834|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4161391|NCT00835497|3983832|B3|Native American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4161392|NCT00835497|3983833|B2|Native American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4161393|NCT00835497|3983834|B1|Native American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4161394|NCT00835497|3983832|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4161395|NCT00835497|3983833|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4161396|NCT00835497|3983834|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4161397|NCT00835497|3983832|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4161398|NCT00835497|3983833|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4161399|NCT00835497|3983834|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4161400|NCT00835497|3983832|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161401|NCT00835497|3983833|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161402|NCT00835497|3983834|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161403|NCT00835497|3983832|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4161404|NCT00835497|3983833|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4161405|NCT00835497|3983834|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4161406|NCT00835497|3983832|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161407|NCT00835497|3983833|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161408|NCT00835497|3983834|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161409|NCT00835484|3983849|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4161410|NCT00835484|3983850|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4161411|NCT00835484|3983851|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4161412|NCT00835484|3983849|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161413|NCT00835484|3983850|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161414|NCT00835484|3983851|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161415|NCT00835484|3983849|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4161416|NCT00835484|3983850|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4161417|NCT00835484|3983851|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4161418|NCT00835484|3983849|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4161419|NCT00835484|3983850|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161420|NCT00835484|3983851|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4161421|NCT00835484|3983849|B3|White||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4161422|NCT00835484|3983850|B2|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4161423|NCT00835484|3983851|B1|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4161424|NCT00835484|3983849|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4161425|NCT00835484|3983850|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4161426|NCT00835484|3983851|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4161427|NCT00835484|3983849|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4161428|NCT00835484|3983850|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4161429|NCT00835484|3983851|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4161430|NCT00835484|3983849|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4161431|NCT00835484|3983850|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161432|NCT00835484|3983851|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4161433|NCT00835484|3983849|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4161434|NCT00835484|3983850|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4161435|NCT00835484|3983851|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4161436|NCT00835484|3983849|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161437|NCT00835484|3983850|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161438|NCT00835484|3983851|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161439|NCT00835406|3983860|B3|Canada||Region of Enrollment||participants|Number|140|140.0||||||
4161440|NCT00835406|3983861|B2|Canada||Region of Enrollment||participants|Number|70|70.0||||||
4161441|NCT00835406|3983862|B1|Canada||Region of Enrollment||participants|Number|70|70.0||||||
4161442|NCT00835406|3983860|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161443|NCT00835406|3983861|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161444|NCT00835406|3983862|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161445|NCT00835406|3983860|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161446|NCT00835406|3983861|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161447|NCT00835406|3983862|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161448|NCT00835406|3983860|B3||White|Race (NIH/OMB)||Participants|Count of Participants|139|139.0||||||
4161449|NCT00835406|3983861|B2||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
4161450|NCT00835406|3983862|B1||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4161451|NCT00835406|3983860|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4161452|NCT00835406|3983861|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4161453|NCT00835406|3983862|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161454|NCT00835406|3983860|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161455|NCT00835406|3983861|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161456|NCT00835406|3983862|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161457|NCT00835406|3983860|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161458|NCT00835406|3983861|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161459|NCT00835406|3983862|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161460|NCT00835406|3983860|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161461|NCT00835406|3983861|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161462|NCT00835406|3983862|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161463|NCT00835406|3983860|B3||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4161464|NCT00835406|3983861|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4161465|NCT00835406|3983862|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4161466|NCT00835406|3983860|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4161467|NCT00835406|3983861|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4161468|NCT00835406|3983862|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4161469|NCT00835406|3983860|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161470|NCT00835406|3983861|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161471|NCT00835406|3983862|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161472|NCT00835406|3983860|B3||Between 18 and 65 years|Age||Participants|Count of Participants|140|140.0||||||
4161473|NCT00835406|3983861|B2||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4161474|NCT00835406|3983862|B1||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4161475|NCT00835406|3983860|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161476|NCT00835406|3983861|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161477|NCT00835406|3983862|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161478|NCT00835380|3983869|B1|||Pulse||Beats per minute (BPM)|Mean|80.05|80.05|Standard Deviation|5.04|5.04|||
4161479|NCT00835380|3983869|B1|||Body Temperature||Degrees Celsius|Mean|35.56|35.56|Standard Deviation|0.31|0.31|||
4161480|NCT00835380|3983869|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4161481|NCT00835380|3983869|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4161482|NCT00835380|3983869|B1|||Age||Months|Mean|14.7|14.7|Standard Deviation|1.6|1.6|||
4161483|NCT00835367|3983874|B3|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4161484|NCT00835367|3983875|B2|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4161485|NCT00835367|3983876|B1|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4161486|NCT00835367|3983874|B3|American Hispanic||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4161487|NCT00835367|3983875|B2|American Hispanic||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4161488|NCT00835367|3983876|B1|American Hispanic||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4161489|NCT00835367|3983874|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|55|55.0||||||
4161490|NCT00835367|3983875|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
4161491|NCT00835367|3983876|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|28|28.0||||||
4161492|NCT00835367|3983874|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4161493|NCT00835367|3983875|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4161494|NCT00835367|3983876|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4161495|NCT00835367|3983874|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4161496|NCT00835367|3983875|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4161497|NCT00835367|3983876|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4161498|NCT00835367|3983874|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4161499|NCT00835367|3983875|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4161500|NCT00835367|3983876|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4161501|NCT00835367|3983874|B3||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4161502|NCT00835367|3983875|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4161503|NCT00835367|3983876|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4161504|NCT00835367|3983874|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161505|NCT00835367|3983875|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161506|NCT00835367|3983876|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161507|NCT00835354|3983897|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4161508|NCT00835354|3983898|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4161509|NCT00835354|3983899|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4161510|NCT00835354|3983897|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161511|NCT00835354|3983898|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161512|NCT00835354|3983899|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161513|NCT00835354|3983897|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4161514|NCT00835354|3983898|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4161515|NCT00835354|3983899|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4161516|NCT00835354|3983897|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4161517|NCT00835354|3983898|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4161518|NCT00835354|3983899|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161519|NCT00835354|3983897|B3|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4161520|NCT00835354|3983898|B2|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4161521|NCT00835354|3983899|B1|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4161522|NCT00835354|3983897|B3|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4161523|NCT00835354|3983898|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4161524|NCT00835354|3983899|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4161525|NCT00835354|3983897|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4161526|NCT00835354|3983898|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4161527|NCT00835354|3983899|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4161528|NCT00835354|3983897|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4161529|NCT00835354|3983898|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4161530|NCT00835354|3983899|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4161531|NCT00835354|3983897|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161532|NCT00835354|3983898|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161533|NCT00835354|3983899|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161534|NCT00835354|3983897|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4161535|NCT00835354|3983898|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4161536|NCT00835354|3983899|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4161537|NCT00835354|3983897|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161538|NCT00835354|3983898|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161539|NCT00835354|3983899|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161540|NCT00835341|3983908|B3|China||Region of Enrollment||participants|Number|93|93.0||||||
4161541|NCT00835341|3983909|B2|China||Region of Enrollment||participants|Number|58|58.0||||||
4161542|NCT00835341|3983910|B1|China||Region of Enrollment||participants|Number|35|35.0||||||
4161543|NCT00835341|3983908|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4161544|NCT00835341|3983909|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4161545|NCT00835341|3983910|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4161546|NCT00835341|3983908|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4161547|NCT00835341|3983909|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4161548|NCT00835341|3983910|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4161549|NCT00835341|3983908|B3|||Age||years|Mean|57.7|57.7|Standard Deviation|11.3|11.3|||
4161550|NCT00835341|3983909|B2|||Age||years|Mean|57.9|57.9|Standard Deviation|11.0|11.0|||
4161551|NCT00835341|3983910|B1|||Age||years|Mean|57.5|57.5|Standard Deviation|12.0|12.0|||
4161552|NCT00835341|3983908|B3||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4161553|NCT00835341|3983909|B2||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4161554|NCT00835341|3983910|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4161555|NCT00835341|3983908|B3||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4161556|NCT00835341|3983909|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4161557|NCT00835341|3983910|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4161558|NCT00835341|3983908|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161559|NCT00835341|3983909|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161560|NCT00835341|3983910|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161561|NCT00835276|3983917|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
4161562|NCT00835276|3983918|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4161563|NCT00835276|3983919|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4161564|NCT00835276|3983917|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4161565|NCT00835276|3983918|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4161566|NCT00835276|3983919|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4161567|NCT00835276|3983917|B3|White||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4161568|NCT00835276|3983918|B2|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4161569|NCT00835276|3983919|B1|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4161570|NCT00835276|3983917|B3|American Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4161571|NCT00835276|3983918|B2|American Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4161572|NCT00835276|3983919|B1|American Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4161573|NCT00835276|3983917|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4161574|NCT00835276|3983918|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4161575|NCT00835276|3983919|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4161576|NCT00835276|3983917|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4161577|NCT00835276|3983918|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4161578|NCT00835276|3983919|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4161579|NCT00835276|3983917|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161580|NCT00835276|3983918|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161581|NCT00835276|3983919|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161582|NCT00835276|3983917|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4161583|NCT00835276|3983918|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4161584|NCT00835276|3983919|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4161585|NCT00835276|3983917|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161586|NCT00835276|3983918|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161587|NCT00835276|3983919|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161588|NCT00835263|3983928|B3|Canada||Region of Enrollment||participants|Number|32|32.0||||||
4161589|NCT00835263|3983929|B2|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4161590|NCT00835263|3983930|B1|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4161591|NCT00835263|3983928|B3|American Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4161592|NCT00835263|3983929|B2|American Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4161593|NCT00835263|3983930|B1|American Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4161594|NCT00835263|3983928|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|31|31.0||||||
4161595|NCT00835263|3983929|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4161596|NCT00835263|3983930|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4161597|NCT00835263|3983928|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4161598|NCT00835263|3983929|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4161599|NCT00835263|3983930|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4161600|NCT00835263|3983928|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4161601|NCT00835263|3983929|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4161602|NCT00835263|3983930|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4161603|NCT00835263|3983928|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161604|NCT00835263|3983929|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161605|NCT00835263|3983930|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161606|NCT00835263|3983928|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4161607|NCT00835263|3983929|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4161608|NCT00835263|3983930|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4161609|NCT00835263|3983928|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161610|NCT00835263|3983929|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161611|NCT00835263|3983930|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161612|NCT00835237|3983939|B3||Male|Sex: Female, Male||Participants|Count of Participants|617|617.0||||||
4161613|NCT00835237|3983940|B2||Male|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4161614|NCT00835237|3983941|B1||Male|Sex: Female, Male||Participants|Count of Participants|409|409.0||||||
4161615|NCT00835237|3983939|B3||Female|Sex: Female, Male||Participants|Count of Participants|715|715.0||||||
4161616|NCT00835237|3983940|B2||Female|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
4161617|NCT00835237|3983941|B1||Female|Sex: Female, Male||Participants|Count of Participants|478|478.0||||||
4161618|NCT00835237|3983939|B3|||Age||years|Mean|71.7|71.7|Standard Deviation|5.44|5.44|||
4161619|NCT00835237|3983940|B2|||Age||years|Mean|71.9|71.9|Standard Deviation|5.62|5.62|||
4161620|NCT00835237|3983941|B1|||Age||years|Mean|71.6|71.6|Standard Deviation|5.35|5.35|||
4161621|NCT00835224|3983966|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4161622|NCT00835224|3983966|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4161623|NCT00835224|3983966|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4161624|NCT00835224|3983966|B1|||Age||years|Mean|40|40.0|Standard Deviation|12|12.0|||
4161625|NCT00835224|3983966|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161626|NCT00835224|3983966|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4161627|NCT00835224|3983966|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161628|NCT00835211|3983980|B3|Canada||Region of Enrollment||participants|Number|48|48.0||||||
4161629|NCT00835211|3983981|B2|Canada||Region of Enrollment||participants|Number|24|24.0||||||
4161630|NCT00835211|3983982|B1|Canada||Region of Enrollment||participants|Number|24|24.0||||||
4161631|NCT00835211|3983980|B3|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4161632|NCT00835211|3983981|B2|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4161633|NCT00835211|3983982|B1|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4161634|NCT00835211|3983980|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4161635|NCT00835211|3983981|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4161636|NCT00835211|3983982|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4161637|NCT00835211|3983980|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|42|42.0||||||
4161638|NCT00835211|3983981|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
4161639|NCT00835211|3983982|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4161640|NCT00835211|3983980|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4161641|NCT00835211|3983981|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4161642|NCT00835211|3983982|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4161643|NCT00835211|3983980|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4161644|NCT00835211|3983981|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4161645|NCT00835211|3983982|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4161646|NCT00835211|3983980|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161647|NCT00835211|3983981|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161648|NCT00835211|3983982|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161649|NCT00835211|3983980|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4161650|NCT00835211|3983981|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4161651|NCT00835211|3983982|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4161652|NCT00835211|3983980|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161653|NCT00835211|3983981|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161654|NCT00835211|3983982|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161655|NCT00835198|3983991|B3||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4161656|NCT00835198|3983992|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4161657|NCT00835198|3983993|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4161658|NCT00835198|3983991|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4161659|NCT00835198|3983992|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4161660|NCT00835198|3983993|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4161661|NCT00835198|3983991|B3|||Age||years|Median|20.0|20.0|Full Range|||12.1|52.2|
4161662|NCT00835198|3983992|B2|||Age||years|Median|19.7|19.7|Full Range|||12.5|52.2|
4161663|NCT00835198|3983993|B1|||Age||years|Median|20.2|20.2|Full Range|||12.1|46.1|
4161664|NCT00835185|3984006|B1|Spain||Region of Enrollment||participants|Number|31|31.0||||||
4161665|NCT00835185|3984006|B1|Belgium||Region of Enrollment||participants|Number|13|13.0||||||
4161666|NCT00835185|3984006|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161667|NCT00835185|3984006|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161668|NCT00835185|3984006|B1||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4161669|NCT00835185|3984006|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4161670|NCT00835185|3984006|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161671|NCT00835185|3984006|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161672|NCT00835185|3984006|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161673|NCT00835185|3984006|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161674|NCT00835185|3984006|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4161675|NCT00835185|3984006|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4161676|NCT00835185|3984006|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4161677|NCT00835185|3984006|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4161678|NCT00835185|3984006|B1|||Age||years|Mean|63.3|63.3|Standard Deviation|11.75|11.75|||
4161679|NCT00835172|3984027|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4161680|NCT00835172|3984028|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4161681|NCT00835172|3984029|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4161682|NCT00835172|3984027|B3|Biracial||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4161683|NCT00835172|3984028|B2|Biracial||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4161684|NCT00835172|3984029|B1|Biracial||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4161685|NCT00835172|3984027|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4161686|NCT00835172|3984028|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4161687|NCT00835172|3984029|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4161688|NCT00835172|3984027|B3|Black||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4161689|NCT00835172|3984028|B2|Black||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4161690|NCT00835172|3984029|B1|Black||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4161691|NCT00835172|3984027|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4161692|NCT00835172|3984028|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4161693|NCT00835172|3984029|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4161694|NCT00835172|3984027|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4161695|NCT00835172|3984028|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4161696|NCT00835172|3984029|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4161697|NCT00835172|3984027|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4161698|NCT00835172|3984028|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4161699|NCT00835172|3984029|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4161700|NCT00835172|3984027|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161701|NCT00835172|3984028|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161702|NCT00835172|3984029|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161703|NCT00835172|3984027|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4161704|NCT00835172|3984028|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4161705|NCT00835172|3984029|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4161706|NCT00835172|3984027|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161707|NCT00835172|3984028|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161708|NCT00835172|3984029|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161709|NCT00835159|3984038|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
4161710|NCT00835159|3984039|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4161711|NCT00835159|3984040|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4161712|NCT00835159|3984038|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4161713|NCT00835159|3984039|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4161714|NCT00835159|3984040|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4161715|NCT00835159|3984038|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4161716|NCT00835159|3984039|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4161717|NCT00835159|3984040|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4161718|NCT00835159|3984038|B3|||Age||years|Mean|72.4286|72.4286|Standard Deviation|6.06403|6.06403|||
4161719|NCT00835159|3984039|B2|||Age||years|Mean|72.6471|72.6471|Standard Deviation|6.52822|6.52822|||
4161720|NCT00835159|3984040|B1|||Age||years|Mean|72.0909|72.0909|Standard Deviation|5.55796|5.55796|||
4161721|NCT00835159|3984038|B3||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4161722|NCT00835159|3984039|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4161723|NCT00835159|3984040|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4161724|NCT00835159|3984038|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4161725|NCT00835159|3984039|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4161726|NCT00835159|3984040|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4161727|NCT00835159|3984038|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161728|NCT00835159|3984039|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161729|NCT00835159|3984040|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161730|NCT00835146|3984047|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
4161731|NCT00835146|3984048|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4161732|NCT00835146|3984049|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4161733|NCT00835146|3984047|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4161734|NCT00835146|3984048|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4161735|NCT00835146|3984049|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4161736|NCT00835146|3984047|B3|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4161737|NCT00835146|3984048|B2|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4161738|NCT00835146|3984049|B1|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4161739|NCT00835146|3984047|B3|Black||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4161740|NCT00835146|3984048|B2|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4161741|NCT00835146|3984049|B1|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4161742|NCT00835146|3984047|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4161743|NCT00835146|3984048|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4161744|NCT00835146|3984049|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4161745|NCT00835146|3984047|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4161746|NCT00835146|3984048|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4161747|NCT00835146|3984049|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4161748|NCT00835146|3984047|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161749|NCT00835146|3984048|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161750|NCT00835146|3984049|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161751|NCT00835146|3984047|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4161752|NCT00835146|3984048|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4161753|NCT00835146|3984049|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4161754|NCT00835146|3984047|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161755|NCT00835146|3984048|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161756|NCT00835146|3984049|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161757|NCT00835120|3984056|B1|No||Insulin resistance||participants|Number|4|4.0||||||
4161758|NCT00835120|3984056|B1|Yes||Insulin resistance||participants|Number|30|30.0||||||
4161759|NCT00835120|3984056|B1|No||Metabolic syndrome||participants|Number|2|2.0||||||
4161760|NCT00835120|3984056|B1|Yes||Metabolic syndrome||participants|Number|32|32.0||||||
4161761|NCT00835120|3984056|B1|No||History of sexual abuse||participants|Number|25|25.0||||||
4161762|NCT00835120|3984056|B1|Yes||History of sexual abuse||participants|Number|9|9.0||||||
4161763|NCT00835120|3984056|B1|No||History of verbal abuse||participants|Number|20|20.0||||||
4161764|NCT00835120|3984056|B1|Yes||History of verbal abuse||participants|Number|14|14.0||||||
4161765|NCT00835120|3984056|B1|No||History of physical abuse||participants|Number|24|24.0||||||
4161766|NCT00835120|3984056|B1|Yes||History of physical abuse||participants|Number|10|10.0||||||
4161767|NCT00835120|3984056|B1|Alcohol use disorder, lifetime||Comorbid diagnoses||participants|Number|19|19.0||||||
4161768|NCT00835120|3984056|B1|Obsessive-compulsive disorder||Comorbid diagnoses||participants|Number|5|5.0||||||
4161769|NCT00835120|3984056|B1|Post-traumatic stress disorder||Comorbid diagnoses||participants|Number|12|12.0||||||
4161770|NCT00835120|3984056|B1|Panic disorder||Comorbid diagnoses||participants|Number|11|11.0||||||
4161771|NCT00835120|3984056|B1|Generalized anxiety disorder||Comorbid diagnoses||participants|Number|25|25.0||||||
4161772|NCT00835120|3984056|B1|>=4 mood stabilizers or antidepressant||Medication treatment failures during current episode||participants|Number|15|15.0||||||
4161773|NCT00835120|3984056|B1|>=2 mood stabilizers (MS) or a MS + antidepressant||Medication treatment failures during current episode||participants|Number|26|26.0||||||
4161774|NCT00835120|3984056|B1|No||Employed||participants|Number|22|22.0||||||
4161775|NCT00835120|3984056|B1|Yes||Employed||participants|Number|12|12.0||||||
4161776|NCT00835120|3984056|B1|||Number of prior suicide attempts||suicide attempts|Mean|1.2|1.2|Standard Deviation|2.0|2.0|||
4161777|NCT00835120|3984056|B1|||Number of prior hospitalizations||hospitalizations|Mean|2|2.0|Standard Deviation|4.0|4.0|||
4161778|NCT00835120|3984056|B1|||Duration of mood state||days|Mean|315.5|315.5|Standard Deviation|331.6|331.6|||
4161779|NCT00835120|3984056|B1|||Age first treated for mania/hypomania||years|Mean|40.8|40.8|Standard Deviation|12.0|12.0|||
4161780|NCT00835120|3984056|B1|||Age first treated for depression||years|Mean|34.7|34.7|Standard Deviation|11.3|11.3|||
4161781|NCT00835120|3984056|B1|||Age of mania/hypomania onset||years|Mean|23.5|23.5|Standard Deviation|19.2|19.2|||
4161782|NCT00835120|3984056|B1|||Age of depression onset||years|Mean|17.8|17.8|Standard Deviation|10.9|10.9|||
4161783|NCT00835120|3984056|B1|Bipolar not otherwise specified||Bipolar Subtype||participants|Number|2|2.0||||||
4161784|NCT00835120|3984056|B1|Bipolar 2||Bipolar Subtype||participants|Number|5|5.0||||||
4161785|NCT00835120|3984056|B1|Bipolar 1||Bipolar Subtype||participants|Number|27|27.0||||||
4161786|NCT00835120|3984056|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161787|NCT00835120|3984056|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161788|NCT00835120|3984056|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4161789|NCT00835120|3984056|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4161790|NCT00835120|3984056|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161791|NCT00835120|3984056|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4161792|NCT00835120|3984056|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161793|NCT00835120|3984056|B1||Male|Gender||Participants|Count of Participants|15|15.0||||||
4161794|NCT00835120|3984056|B1||Female|Gender||Participants|Count of Participants|19|19.0||||||
4161795|NCT00835120|3984056|B1|||Age||years|Mean|47.8|47.8|Standard Deviation|10.9|10.9|||
4161796|NCT00835081|3984064|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4161797|NCT00835081|3984065|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4161798|NCT00835081|3984066|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4161799|NCT00835081|3984064|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161800|NCT00835081|3984065|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161801|NCT00835081|3984066|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161802|NCT00835081|3984064|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4161803|NCT00835081|3984065|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4161804|NCT00835081|3984066|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4161805|NCT00835081|3984064|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4161806|NCT00835081|3984065|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4161807|NCT00835081|3984066|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4161808|NCT00835081|3984064|B3|White||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4161809|NCT00835081|3984065|B2|White||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4161810|NCT00835081|3984066|B1|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4161811|NCT00835081|3984064|B3|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4161812|NCT00835081|3984065|B2|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4161813|NCT00835081|3984066|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4161814|NCT00835081|3984064|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4161815|NCT00835081|3984065|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4161816|NCT00835081|3984066|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4161817|NCT00835081|3984064|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4161818|NCT00835081|3984065|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4161819|NCT00835081|3984066|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4161820|NCT00835081|3984064|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4161821|NCT00835081|3984065|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4161822|NCT00835081|3984066|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4161823|NCT00835081|3984064|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161824|NCT00835081|3984065|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161825|NCT00835081|3984066|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161826|NCT00835081|3984064|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4161827|NCT00835081|3984065|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4161828|NCT00835081|3984066|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4161829|NCT00835081|3984064|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161830|NCT00835081|3984065|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161831|NCT00835081|3984066|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161832|NCT00835068|3984075|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4161833|NCT00835068|3984076|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4161834|NCT00835068|3984077|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4161835|NCT00835068|3984075|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4161836|NCT00835068|3984076|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4161837|NCT00835068|3984077|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4161838|NCT00835068|3984075|B3|||Age||years|Mean|22.98|22.98|Standard Deviation|16.353|16.353|||
4161839|NCT00835068|3984076|B2|||Age||years|Mean|1.30|1.3|Standard Deviation|||||
4161840|NCT00835068|3984077|B1|||Age||years|Mean|23.36|23.36|Standard Deviation|16.237|16.237|||
4161841|NCT00835042|3984096|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
4161842|NCT00835042|3984097|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4161843|NCT00835042|3984098|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4161844|NCT00835042|3984096|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4161845|NCT00835042|3984097|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4161846|NCT00835042|3984098|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4161847|NCT00835042|3984096|B3|White||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
4161848|NCT00835042|3984097|B2|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4161849|NCT00835042|3984098|B1|White||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4161850|NCT00835042|3984096|B3|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4161851|NCT00835042|3984097|B2|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4161852|NCT00835042|3984098|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4161853|NCT00835042|3984096|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4161854|NCT00835042|3984097|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4161855|NCT00835042|3984098|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4161856|NCT00835042|3984096|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4161857|NCT00835042|3984097|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4161858|NCT00835042|3984098|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4161859|NCT00835042|3984096|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161860|NCT00835042|3984097|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161861|NCT00835042|3984098|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161862|NCT00835042|3984096|B3||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4161863|NCT00835042|3984097|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4161864|NCT00835042|3984098|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4161865|NCT00835042|3984096|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161866|NCT00835042|3984097|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161867|NCT00835042|3984098|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161868|NCT00835003|3984119|B3|Denmark||Region of Enrollment||participants|Number|1274|1274.0||||||
4161869|NCT00835003|3984120|B2|Denmark||Region of Enrollment||participants|Number|638|638.0||||||
4161870|NCT00835003|3984121|B1|Denmark||Region of Enrollment||participants|Number|636|636.0||||||
4161871|NCT00835003|3984119|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4161872|NCT00835003|3984120|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4161873|NCT00835003|3984121|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4161874|NCT00835003|3984119|B3||Female|Sex: Female, Male||Participants|Count of Participants|1274|1274.0||||||
4161875|NCT00835003|3984120|B2||Female|Sex: Female, Male||Participants|Count of Participants|638|638.0||||||
4161876|NCT00835003|3984121|B1||Female|Sex: Female, Male||Participants|Count of Participants|636|636.0||||||
4161877|NCT00835003|3984119|B3|||Age||years|Mean|31.8|31.8|Standard Deviation|4.0|4.0|||
4161878|NCT00835003|3984120|B2|||Age||years|Mean|31.6|31.6|Standard Deviation|4.6|4.6|||
4161879|NCT00835003|3984121|B1|||Age||years|Mean|32.1|32.1|Standard Deviation|4.4|4.4|||
4161880|NCT00834990|3984128|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4161881|NCT00834990|3984129|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4161882|NCT00834990|3984130|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4161883|NCT00834990|3984128|B3|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4161884|NCT00834990|3984129|B2|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4161885|NCT00834990|3984130|B1|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4161886|NCT00834990|3984128|B3|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4161887|NCT00834990|3984129|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4161888|NCT00834990|3984130|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4161889|NCT00834990|3984128|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4161890|NCT00834990|3984129|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4161891|NCT00834990|3984130|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4161892|NCT00834990|3984128|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4161893|NCT00834990|3984129|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4161894|NCT00834990|3984130|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4161895|NCT00834990|3984128|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161896|NCT00834990|3984129|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161897|NCT00834990|3984130|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161898|NCT00834990|3984128|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4161899|NCT00834990|3984129|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4161900|NCT00834990|3984130|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4161901|NCT00834990|3984128|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161902|NCT00834990|3984129|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161903|NCT00834990|3984130|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161904|NCT00834977|3984139|B3|Canada||Region of Enrollment||participants|Number|48|48.0||||||
4161905|NCT00834977|3984140|B2|Canada||Region of Enrollment||participants|Number|24|24.0||||||
4161906|NCT00834977|3984141|B1|Canada||Region of Enrollment||participants|Number|24|24.0||||||
4161907|NCT00834977|3984139|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4161908|NCT00834977|3984140|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4161909|NCT00834977|3984141|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4161910|NCT00834977|3984139|B3|White||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4161911|NCT00834977|3984140|B2|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4161912|NCT00834977|3984141|B1|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4161913|NCT00834977|3984139|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4161914|NCT00834977|3984140|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4161915|NCT00834977|3984141|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4161916|NCT00834977|3984139|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4161917|NCT00834977|3984140|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4161918|NCT00834977|3984141|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4161919|NCT00834977|3984139|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4161920|NCT00834977|3984140|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4161921|NCT00834977|3984141|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4161922|NCT00834977|3984139|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4161923|NCT00834977|3984140|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4161924|NCT00834977|3984141|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4161925|NCT00834977|3984139|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4161926|NCT00834977|3984140|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4161927|NCT00834977|3984141|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4161928|NCT00834977|3984139|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161929|NCT00834977|3984140|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161930|NCT00834977|3984141|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161931|NCT00834964|3984162|B3|Canada||Region of Enrollment||participants|Number|30|30.0||||||
4161932|NCT00834964|3984163|B2|Canada||Region of Enrollment||participants|Number|15|15.0||||||
4161933|NCT00834964|3984164|B1|Canada||Region of Enrollment||participants|Number|15|15.0||||||
4161934|NCT00834964|3984162|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
4161935|NCT00834964|3984163|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4161936|NCT00834964|3984164|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4161937|NCT00834964|3984162|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4161938|NCT00834964|3984163|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4161939|NCT00834964|3984164|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4161940|NCT00834964|3984162|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4161941|NCT00834964|3984163|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4161942|NCT00834964|3984164|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4161943|NCT00834964|3984162|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161944|NCT00834964|3984163|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161945|NCT00834964|3984164|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161946|NCT00834964|3984162|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4161947|NCT00834964|3984163|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4161948|NCT00834964|3984164|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4161949|NCT00834964|3984162|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161950|NCT00834964|3984163|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161951|NCT00834964|3984164|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161952|NCT00834912|3984179|B7||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4161953|NCT00834912|3984180|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4161954|NCT00834912|3984181|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4161955|NCT00834912|3984182|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4161956|NCT00834912|3984183|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4161957|NCT00834912|3984184|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4161958|NCT00834912|3984185|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4161959|NCT00834912|3984179|B7||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4161960|NCT00834912|3984180|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4161961|NCT00834912|3984181|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4161962|NCT00834912|3984182|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4161963|NCT00834912|3984183|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4161964|NCT00834912|3984184|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4161965|NCT00834912|3984185|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4161966|NCT00834912|3984179|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161967|NCT00834912|3984180|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161968|NCT00834912|3984181|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161969|NCT00834912|3984182|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161970|NCT00834912|3984183|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161971|NCT00834912|3984184|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161972|NCT00834912|3984185|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4161973|NCT00834912|3984179|B7||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4161974|NCT00834912|3984180|B6||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4161975|NCT00834912|3984181|B5||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4161976|NCT00834912|3984182|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4161977|NCT00834912|3984183|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4161978|NCT00834912|3984184|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4161979|NCT00834912|3984185|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4161980|NCT00834912|3984179|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161981|NCT00834912|3984180|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161982|NCT00834912|3984181|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161983|NCT00834912|3984182|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161984|NCT00834912|3984183|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161985|NCT00834912|3984184|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161986|NCT00834912|3984185|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4161987|NCT00834899|3984210|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4161988|NCT00834899|3984211|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4161989|NCT00834899|3984212|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4161990|NCT00834899|3984210|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161991|NCT00834899|3984211|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161992|NCT00834899|3984212|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161993|NCT00834899|3984210|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161994|NCT00834899|3984211|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161995|NCT00834899|3984212|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161996|NCT00834899|3984210|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161997|NCT00834899|3984211|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161998|NCT00834899|3984212|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4161999|NCT00834899|3984210|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4162000|NCT00834899|3984211|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4162001|NCT00834899|3984212|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4162002|NCT00834899|3984210|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162003|NCT00834899|3984211|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162004|NCT00834899|3984212|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162005|NCT00834899|3984210|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162006|NCT00834899|3984211|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162007|NCT00834899|3984212|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162008|NCT00834899|3984210|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162009|NCT00834899|3984211|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162010|NCT00834899|3984212|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162011|NCT00834899|3984210|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162012|NCT00834899|3984211|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162013|NCT00834899|3984212|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162014|NCT00834899|3984210|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4162015|NCT00834899|3984211|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4162016|NCT00834899|3984212|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4162017|NCT00834899|3984210|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162018|NCT00834899|3984211|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162019|NCT00834899|3984212|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162020|NCT00834899|3984210|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4162021|NCT00834899|3984211|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4162022|NCT00834899|3984212|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4162023|NCT00834899|3984210|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4162024|NCT00834899|3984211|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4162025|NCT00834899|3984212|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4162026|NCT00834899|3984210|B3|||Age||years|Mean|31.6|31.6|Standard Deviation|9.55|9.55|||
4162027|NCT00834899|3984211|B2|||Age||years|Mean|34.0|34.0|Standard Deviation|12.19|12.19|||
4162028|NCT00834899|3984212|B1|||Age||years|Mean|30.6|30.6|Standard Deviation|8.78|8.78|||
4162029|NCT00834899|3984210|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162030|NCT00834899|3984211|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162031|NCT00834899|3984212|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162032|NCT00834899|3984210|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4162033|NCT00834899|3984211|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4162034|NCT00834899|3984212|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4162035|NCT00834899|3984210|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162036|NCT00834899|3984211|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162037|NCT00834899|3984212|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162038|NCT00834886|3984225|B5|Norway||Region of Enrollment||participants|Number|40|40.0||||||
4162039|NCT00834886|3984226|B4|Norway||Region of Enrollment||participants|Number|10|10.0||||||
4162040|NCT00834886|3984227|B3|Norway||Region of Enrollment||participants|Number|10|10.0||||||
4162041|NCT00834886|3984228|B2|Norway||Region of Enrollment||participants|Number|10|10.0||||||
4162042|NCT00834886|3984229|B1|Norway||Region of Enrollment||participants|Number|10|10.0||||||
4162043|NCT00834886|3984225|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4162044|NCT00834886|3984226|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4162045|NCT00834886|3984227|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4162046|NCT00834886|3984228|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4162047|NCT00834886|3984229|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4162048|NCT00834886|3984225|B5||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4162049|NCT00834886|3984226|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4162050|NCT00834886|3984227|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4162051|NCT00834886|3984228|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4162052|NCT00834886|3984229|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4162053|NCT00834886|3984225|B5|Age||Age, Customized||years|Mean|20.7|20.7|Standard Deviation|3.1|3.1|||
4162054|NCT00834886|3984226|B4|Age||Age, Customized||years|Mean|20.8|20.8|Standard Deviation|3.4|3.4|||
4162055|NCT00834886|3984227|B3|Age||Age, Customized||years|Mean|20.7|20.7|Standard Deviation|3.4|3.4|||
4162056|NCT00834886|3984228|B2|Age||Age, Customized||years|Mean|21.2|21.2|Standard Deviation|2.7|2.7|||
4162057|NCT00834886|3984229|B1|Age||Age, Customized||years|Mean|20.3|20.3|Standard Deviation|3.3|3.3|||
4162058|NCT00834873|3984250|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4162059|NCT00834873|3984251|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4162060|NCT00834873|3984252|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4162061|NCT00834873|3984250|B3|Black||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4162062|NCT00834873|3984251|B2|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4162063|NCT00834873|3984252|B1|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4162064|NCT00834873|3984250|B3|Caucasion||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
4162065|NCT00834873|3984251|B2|Caucasion||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4162066|NCT00834873|3984252|B1|Caucasion||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4162067|NCT00834873|3984250|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4162068|NCT00834873|3984251|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4162069|NCT00834873|3984252|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4162070|NCT00834873|3984250|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4162071|NCT00834873|3984251|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4162072|NCT00834873|3984252|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4162073|NCT00834873|3984250|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162074|NCT00834873|3984251|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162075|NCT00834873|3984252|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162076|NCT00834873|3984250|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4162077|NCT00834873|3984251|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4162078|NCT00834873|3984252|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4162079|NCT00834873|3984250|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162080|NCT00834873|3984251|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162081|NCT00834873|3984252|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162082|NCT00834834|3984261|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162083|NCT00834834|3984262|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162084|NCT00834834|3984263|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162085|NCT00834834|3984261|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4162086|NCT00834834|3984262|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4162087|NCT00834834|3984263|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4162088|NCT00834834|3984261|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4162089|NCT00834834|3984262|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4162090|NCT00834834|3984263|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4162091|NCT00834834|3984261|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4162092|NCT00834834|3984262|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4162093|NCT00834834|3984263|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4162094|NCT00834834|3984261|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4162095|NCT00834834|3984262|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4162096|NCT00834834|3984263|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4162097|NCT00834834|3984261|B3|||Age||years|Mean|29.3|29.3|Standard Deviation|9.4|9.4|||
4162098|NCT00834834|3984262|B2|||Age||years|Mean|30.6|30.6|Standard Deviation|10.8|10.8|||
4162099|NCT00834834|3984263|B1|||Age||years|Mean|27.9|27.9|Standard Deviation|7.8|7.8|||
4162100|NCT00834808|3984272|B4||Male|Sex: Female, Male||Participants|Count of Participants|27.0|27.0||||||
4162101|NCT00834808|3984273|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4162102|NCT00834808|3984274|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4162103|NCT00834808|3984275|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4162104|NCT00834808|3984272|B4||Female|Sex: Female, Male||Participants|Count of Participants|0.0|0.0||||||
4162105|NCT00834808|3984273|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4162106|NCT00834808|3984274|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4162107|NCT00834808|3984275|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4162108|NCT00834808|3984272|B4||>=65 years|Age||Participants|Count of Participants|0.0|0.0||||||
4162109|NCT00834808|3984273|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162110|NCT00834808|3984274|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162111|NCT00834808|3984275|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162112|NCT00834808|3984272|B4||Between 18 and 65 years|Age||Participants|Count of Participants|27.0|27.0||||||
4162113|NCT00834808|3984273|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4162114|NCT00834808|3984274|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4162115|NCT00834808|3984275|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4162116|NCT00834808|3984272|B4||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4162117|NCT00834808|3984273|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162118|NCT00834808|3984274|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162119|NCT00834808|3984275|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162120|NCT00834795|3984297|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4162121|NCT00834795|3984298|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4162122|NCT00834795|3984299|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4162123|NCT00834795|3984297|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4162124|NCT00834795|3984298|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4162125|NCT00834795|3984299|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4162126|NCT00834795|3984297|B3|Black||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4162127|NCT00834795|3984298|B2|Black||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4162128|NCT00834795|3984299|B1|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4162129|NCT00834795|3984297|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
4162130|NCT00834795|3984298|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4162131|NCT00834795|3984299|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4162132|NCT00834795|3984297|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4162133|NCT00834795|3984298|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4162134|NCT00834795|3984299|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4162135|NCT00834795|3984297|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4162136|NCT00834795|3984298|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4162137|NCT00834795|3984299|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4162138|NCT00834795|3984297|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162139|NCT00834795|3984298|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162140|NCT00834795|3984299|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162141|NCT00834795|3984297|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4162142|NCT00834795|3984298|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4162143|NCT00834795|3984299|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4162144|NCT00834795|3984297|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162145|NCT00834795|3984298|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162146|NCT00834795|3984299|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162147|NCT00834756|3984308|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4162148|NCT00834756|3984309|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4162149|NCT00834756|3984310|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4162150|NCT00834756|3984308|B3|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4162151|NCT00834756|3984309|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4162152|NCT00834756|3984310|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4162153|NCT00834756|3984308|B3|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4162154|NCT00834756|3984309|B2|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4162155|NCT00834756|3984310|B1|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4162156|NCT00834756|3984308|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|31|31.0||||||
4162157|NCT00834756|3984309|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4162158|NCT00834756|3984310|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4162159|NCT00834756|3984308|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4162160|NCT00834756|3984309|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4162161|NCT00834756|3984310|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4162162|NCT00834756|3984308|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4162163|NCT00834756|3984309|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4162164|NCT00834756|3984310|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4162165|NCT00834756|3984308|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162166|NCT00834756|3984309|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162167|NCT00834756|3984310|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162168|NCT00834756|3984308|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4162169|NCT00834756|3984309|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4162170|NCT00834756|3984310|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4162171|NCT00834756|3984308|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162172|NCT00834756|3984309|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162173|NCT00834756|3984310|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162174|NCT00834743|3984319|B3|Canada||Region of Enrollment||participants|Number|32|32.0||||||
4162175|NCT00834743|3984320|B2|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4162176|NCT00834743|3984321|B1|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4162177|NCT00834743|3984319|B3|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4162178|NCT00834743|3984320|B2|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4162179|NCT00834743|3984321|B1|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4162180|NCT00834743|3984319|B3|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4162181|NCT00834743|3984320|B2|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4162182|NCT00834743|3984321|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4162183|NCT00834743|3984319|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4162184|NCT00834743|3984320|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4162185|NCT00834743|3984321|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4162186|NCT00834743|3984319|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4162187|NCT00834743|3984320|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4162188|NCT00834743|3984321|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4162189|NCT00834743|3984319|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4162190|NCT00834743|3984320|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4162191|NCT00834743|3984321|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4162192|NCT00834743|3984319|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162193|NCT00834743|3984320|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162194|NCT00834743|3984321|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162195|NCT00834743|3984319|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4162196|NCT00834743|3984320|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4162197|NCT00834743|3984321|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4162198|NCT00834743|3984319|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162199|NCT00834743|3984320|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162200|NCT00834743|3984321|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162201|NCT00834717|3984330|B3|Canada||Region of Enrollment||participants|Number|40|40.0||||||
4162202|NCT00834717|3984331|B2|Canada||Region of Enrollment||participants|Number|20|20.0||||||
4162203|NCT00834717|3984332|B1|Canada||Region of Enrollment||participants|Number|20|20.0||||||
4162204|NCT00834717|3984330|B3|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4162205|NCT00834717|3984331|B2|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4162206|NCT00834717|3984332|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4162207|NCT00834717|3984330|B3|Black||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4162208|NCT00834717|3984331|B2|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4162209|NCT00834717|3984332|B1|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4162210|NCT00834717|3984330|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
4162211|NCT00834717|3984331|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4162212|NCT00834717|3984332|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4162213|NCT00834717|3984330|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4162214|NCT00834717|3984331|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4162215|NCT00834717|3984332|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4162216|NCT00834717|3984330|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4162217|NCT00834717|3984331|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4162218|NCT00834717|3984332|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4162219|NCT00834717|3984330|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162220|NCT00834717|3984331|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162221|NCT00834717|3984332|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162222|NCT00834717|3984330|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4162223|NCT00834717|3984331|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4162224|NCT00834717|3984332|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4162225|NCT00834717|3984330|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162226|NCT00834717|3984331|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162227|NCT00834717|3984332|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162228|NCT00834678|3984341|B1|2 prior regimens||Total number of prior treatment regimens||participants|Number|7|7.0||||||
4162229|NCT00834678|3984341|B1|1 prior regimen||Total number of prior treatment regimens||participants|Number|4|4.0||||||
4162230|NCT00834678|3984341|B1|Both||Prior chemotherapy||participants|Number|6|6.0||||||
4162231|NCT00834678|3984341|B1|Metastasis/local recurrence only||Prior chemotherapy||participants|Number|1|1.0||||||
4162232|NCT00834678|3984341|B1|Adjuvant only||Prior chemotherapy||participants|Number|4|4.0||||||
4162233|NCT00834678|3984341|B1|Brain||Site of metastasis|A patient can be represented among multiple sites|participants|Number|1|1.0||||||
4162234|NCT00834678|3984341|B1|Chest wall/skin||Site of metastasis|A patient can be represented among multiple sites|participants|Number|3|3.0||||||
4162235|NCT00834678|3984341|B1|Liver||Site of metastasis|A patient can be represented among multiple sites|participants|Number|3|3.0||||||
4162236|NCT00834678|3984341|B1|Bone||Site of metastasis|A patient can be represented among multiple sites|participants|Number|4|4.0||||||
4162237|NCT00834678|3984341|B1|Lung/pleura||Site of metastasis|A patient can be represented among multiple sites|participants|Number|6|6.0||||||
4162238|NCT00834678|3984341|B1|Lymph nodes||Site of metastasis|A patient can be represented among multiple sites|participants|Number|9|9.0||||||
4162239|NCT00834678|3984341|B1|2 (Ambulatory and capable selfcare)||ECOG (Eastern Cooperative Oncology Group) performance status||participants|Number|1|1.0||||||
4162240|NCT00834678|3984341|B1|1 (Restricted)||ECOG (Eastern Cooperative Oncology Group) performance status||participants|Number|6|6.0||||||
4162241|NCT00834678|3984341|B1|0 (Fully active)||ECOG (Eastern Cooperative Oncology Group) performance status||participants|Number|4|4.0||||||
4162242|NCT00834678|3984341|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4162243|NCT00834678|3984341|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162244|NCT00834678|3984341|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162245|NCT00834678|3984341|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4162246|NCT00834678|3984341|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4162247|NCT00834678|3984341|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162248|NCT00834678|3984341|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162249|NCT00834678|3984341|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162250|NCT00834678|3984341|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4162251|NCT00834678|3984341|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4162252|NCT00834678|3984341|B1|||Age||years|Median|53|53.0|Full Range|||38.0|66.0|
4162253|NCT00834652|3984353|B3|||Baseline Body Mass Index (BMI)||kg/m^2|Mean|38.30|38.3|Full Range|||27.44|59.23|
4162254|NCT00834652|3984354|B2|||Baseline Body Mass Index (BMI)||kg/m^2|Mean|38.07|38.07|Full Range|||27.8|58.42|
4162255|NCT00834652|3984355|B1|||Baseline Body Mass Index (BMI)||kg/m^2|Mean|38.53|38.53|Full Range|||27.44|59.23|
4162256|NCT00834652|3984353|B3|||Education||years|Mean|14.62|14.62|Full Range|||8.0|20.0|
4162257|NCT00834652|3984354|B2|||Education||years|Mean|14.60|14.6|Full Range|||8.0|20.0|
4162258|NCT00834652|3984355|B1|||Education||years|Mean|14.64|14.64|Full Range|||10.0|18.0|
4162259|NCT00834652|3984353|B3|||Marital Status (married)||participants|Number|93|93.0||||||
4162260|NCT00834652|3984354|B2|||Marital Status (married)||participants|Number|45|45.0||||||
4162261|NCT00834652|3984355|B1|||Marital Status (married)||participants|Number|48|48.0||||||
4162262|NCT00834652|3984353|B3|United States||Region of Enrollment||participants|Number|206|206.0||||||
4162263|NCT00834652|3984354|B2|United States||Region of Enrollment||participants|Number|102|102.0||||||
4162264|NCT00834652|3984355|B1|United States||Region of Enrollment||participants|Number|104|104.0||||||
4162265|NCT00834652|3984353|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4162266|NCT00834652|3984354|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4162267|NCT00834652|3984355|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4162268|NCT00834652|3984353|B3||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4162269|NCT00834652|3984354|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4162270|NCT00834652|3984355|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4162271|NCT00834652|3984353|B3|||Age||years|Mean|42.91|42.91|Full Range|||20.0|60.0|
4162272|NCT00834652|3984354|B2|||Age||years|Mean|42.15|42.15|Full Range|||22.0|58.0|
4162273|NCT00834652|3984355|B1|||Age||years|Mean|43.67|43.67|Full Range|||20.0|60.0|
4162274|NCT00834639|3984362|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4162275|NCT00834639|3984363|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4162276|NCT00834639|3984364|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4162277|NCT00834639|3984362|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4162278|NCT00834639|3984363|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4162279|NCT00834639|3984364|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4162280|NCT00834639|3984362|B3|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4162281|NCT00834639|3984363|B2|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4162282|NCT00834639|3984364|B1|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4162283|NCT00834639|3984362|B3|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4162284|NCT00834639|3984363|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4162285|NCT00834639|3984364|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4162286|NCT00834639|3984362|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4162287|NCT00834639|3984363|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4162288|NCT00834639|3984364|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4162289|NCT00834639|3984362|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4162290|NCT00834639|3984363|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4162291|NCT00834639|3984364|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4162292|NCT00834639|3984362|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162293|NCT00834639|3984363|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162294|NCT00834639|3984364|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162295|NCT00834639|3984362|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4162296|NCT00834639|3984363|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4162297|NCT00834639|3984364|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4162298|NCT00834639|3984362|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162299|NCT00834639|3984363|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162300|NCT00834639|3984364|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162301|NCT00834626|3984373|B1|India||Region of Enrollment||participants|Number|30|30.0||||||
4162302|NCT00834626|3984373|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4162303|NCT00834626|3984373|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4162304|NCT00834626|3984373|B1|||Age||years|Mean|47.233|47.233|Standard Deviation|9.605|9.605|||
4162305|NCT00834626|3984373|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162306|NCT00834626|3984373|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4162307|NCT00834626|3984373|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162308|NCT00834613|3984380|B3|Canada||Region of Enrollment||participants|Number|32|32.0||||||
4162309|NCT00834613|3984381|B2|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4162310|NCT00834613|3984382|B1|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4162311|NCT00834613|3984380|B3|White||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4162312|NCT00834613|3984381|B2|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4162313|NCT00834613|3984382|B1|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4162314|NCT00834613|3984380|B3|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4162315|NCT00834613|3984381|B2|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4162316|NCT00834613|3984382|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4162317|NCT00834613|3984380|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4162318|NCT00834613|3984381|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4162319|NCT00834613|3984382|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4162320|NCT00834613|3984380|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4162321|NCT00834613|3984381|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4162322|NCT00834613|3984382|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4162323|NCT00834613|3984380|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4162324|NCT00834613|3984381|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4162325|NCT00834613|3984382|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4162326|NCT00834613|3984380|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162327|NCT00834613|3984381|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162328|NCT00834613|3984382|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162329|NCT00834613|3984380|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4162330|NCT00834613|3984381|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4162331|NCT00834613|3984382|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4162332|NCT00834613|3984380|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162333|NCT00834613|3984381|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162334|NCT00834613|3984382|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162335|NCT00834587|3984391|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4162336|NCT00834587|3984392|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4162337|NCT00834587|3984393|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4162338|NCT00834587|3984391|B3|Native Anerican||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4162339|NCT00834587|3984392|B2|Native Anerican||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4162340|NCT00834587|3984393|B1|Native Anerican||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4162341|NCT00834587|3984391|B3|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4162342|NCT00834587|3984392|B2|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4162343|NCT00834587|3984393|B1|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4162344|NCT00834587|3984391|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4162345|NCT00834587|3984392|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4162346|NCT00834587|3984393|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4162347|NCT00834587|3984391|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
4162348|NCT00834587|3984392|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4162349|NCT00834587|3984393|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4162350|NCT00834587|3984391|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4162351|NCT00834587|3984392|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4162352|NCT00834587|3984393|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4162353|NCT00834587|3984391|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4162354|NCT00834587|3984392|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4162355|NCT00834587|3984393|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4162356|NCT00834587|3984391|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162357|NCT00834587|3984392|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162358|NCT00834587|3984393|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162359|NCT00834587|3984391|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4162360|NCT00834587|3984392|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4162361|NCT00834587|3984393|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4162362|NCT00834587|3984391|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162363|NCT00834587|3984392|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162364|NCT00834587|3984393|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162365|NCT00834574|3984408|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4162366|NCT00834574|3984409|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4162367|NCT00834574|3984410|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4162368|NCT00834574|3984408|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162369|NCT00834574|3984409|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162370|NCT00834574|3984410|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162371|NCT00834574|3984408|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4162372|NCT00834574|3984409|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4162373|NCT00834574|3984410|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4162374|NCT00834574|3984408|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4162375|NCT00834574|3984409|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4162376|NCT00834574|3984410|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4162377|NCT00834574|3984408|B3|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4162378|NCT00834574|3984409|B2|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4162379|NCT00834574|3984410|B1|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4162380|NCT00834574|3984408|B3|Black||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4162381|NCT00834574|3984409|B2|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4162382|NCT00834574|3984410|B1|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4162383|NCT00834574|3984408|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4162384|NCT00834574|3984409|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4162385|NCT00834574|3984410|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4162386|NCT00834574|3984408|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4162387|NCT00834574|3984409|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4162388|NCT00834574|3984410|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4162389|NCT00834574|3984408|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162390|NCT00834574|3984409|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162391|NCT00834574|3984410|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162392|NCT00834574|3984408|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4162393|NCT00834574|3984409|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4162394|NCT00834574|3984410|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4162395|NCT00834574|3984408|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162396|NCT00834574|3984409|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162397|NCT00834574|3984410|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162398|NCT00834561|3984419|B3|Canada||Region of Enrollment||participants|Number|32|32.0||||||
4162399|NCT00834561|3984420|B2|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4162400|NCT00834561|3984421|B1|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4162401|NCT00834561|3984419|B3|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4162402|NCT00834561|3984420|B2|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4162403|NCT00834561|3984421|B1|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4162404|NCT00834561|3984419|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
4162405|NCT00834561|3984420|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4162406|NCT00834561|3984421|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4162407|NCT00834561|3984419|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4162408|NCT00834561|3984420|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4162409|NCT00834561|3984421|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4162410|NCT00834561|3984419|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4162411|NCT00834561|3984420|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4162412|NCT00834561|3984421|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4162413|NCT00834561|3984419|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162414|NCT00834561|3984420|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162415|NCT00834561|3984421|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162416|NCT00834561|3984419|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4162417|NCT00834561|3984420|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4162418|NCT00834561|3984421|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4162419|NCT00834561|3984419|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162420|NCT00834561|3984420|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162421|NCT00834561|3984421|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162422|NCT00834535|3984430|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4162423|NCT00834535|3984431|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4162424|NCT00834535|3984432|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4162425|NCT00834535|3984430|B3|White||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4162426|NCT00834535|3984431|B2|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4162427|NCT00834535|3984432|B1|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4162428|NCT00834535|3984430|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4162429|NCT00834535|3984431|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4162430|NCT00834535|3984432|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4162431|NCT00834535|3984430|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4162432|NCT00834535|3984431|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4162433|NCT00834535|3984432|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4162434|NCT00834535|3984430|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162435|NCT00834535|3984431|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162436|NCT00834535|3984432|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162437|NCT00834535|3984430|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4162438|NCT00834535|3984431|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4162439|NCT00834535|3984432|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4162440|NCT00834535|3984430|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162441|NCT00834535|3984431|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162442|NCT00834535|3984432|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162443|NCT00834522|3984441|B3|Canada||Region of Enrollment||participants|Number|80|80.0||||||
4162444|NCT00834522|3984442|B2|Canada||Region of Enrollment||participants|Number|40|40.0||||||
4162445|NCT00834522|3984443|B1|Canada||Region of Enrollment||participants|Number|40|40.0||||||
4162446|NCT00834522|3984441|B3|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4162447|NCT00834522|3984442|B2|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4162448|NCT00834522|3984443|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4162449|NCT00834522|3984441|B3|Black||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4162450|NCT00834522|3984442|B2|Black||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4162451|NCT00834522|3984443|B1|Black||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4162452|NCT00834522|3984441|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|62|62.0||||||
4162453|NCT00834522|3984442|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|28|28.0||||||
4162454|NCT00834522|3984443|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|34|34.0||||||
4162455|NCT00834522|3984441|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4162456|NCT00834522|3984442|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4162457|NCT00834522|3984443|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4162458|NCT00834522|3984441|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4162459|NCT00834522|3984442|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4162460|NCT00834522|3984443|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4162461|NCT00834522|3984441|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162462|NCT00834522|3984442|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162463|NCT00834522|3984443|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162464|NCT00834522|3984441|B3||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4162465|NCT00834522|3984442|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4162466|NCT00834522|3984443|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4162467|NCT00834522|3984441|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162468|NCT00834522|3984442|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162469|NCT00834522|3984443|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162470|NCT00834483|3984452|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4162471|NCT00834483|3984453|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4162472|NCT00834483|3984454|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4162473|NCT00834483|3984452|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4162474|NCT00834483|3984453|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4162475|NCT00834483|3984454|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4162476|NCT00834483|3984452|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4162477|NCT00834483|3984453|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4162478|NCT00834483|3984454|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4162479|NCT00834483|3984452|B3|||Age||years|Mean|63.95|63.95|Standard Deviation|10.8|10.8|||
4162480|NCT00834483|3984453|B2|||Age||years|Mean|63.5|63.5|Standard Deviation|10.8|10.8|||
4162481|NCT00834483|3984454|B1|||Age||years|Mean|64.4|64.4|Standard Deviation|10.86|10.86|||
4162482|NCT00834483|3984452|B3||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4162483|NCT00834483|3984453|B2||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4162484|NCT00834483|3984454|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4162485|NCT00834483|3984452|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4162486|NCT00834483|3984453|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4162487|NCT00834483|3984454|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4162488|NCT00834483|3984452|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162489|NCT00834483|3984453|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162490|NCT00834483|3984454|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162491|NCT00834444|3984465|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4162492|NCT00834444|3984466|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4162493|NCT00834444|3984467|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4162494|NCT00834444|3984465|B3|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4162495|NCT00834444|3984466|B2|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4162496|NCT00834444|3984467|B1|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4162497|NCT00834444|3984465|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4162498|NCT00834444|3984466|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4162499|NCT00834444|3984467|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4162500|NCT00834444|3984465|B3|White||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4162501|NCT00834444|3984466|B2|White||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4162502|NCT00834444|3984467|B1|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4162503|NCT00834444|3984465|B3|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4162504|NCT00834444|3984466|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4162505|NCT00834444|3984467|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4162506|NCT00834444|3984465|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4162507|NCT00834444|3984466|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4162508|NCT00834444|3984467|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4162509|NCT00834444|3984465|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4162510|NCT00834444|3984466|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4162511|NCT00834444|3984467|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4162512|NCT00834444|3984465|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162513|NCT00834444|3984466|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162514|NCT00834444|3984467|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162515|NCT00834444|3984465|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4162516|NCT00834444|3984466|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4162517|NCT00834444|3984467|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4162518|NCT00834444|3984465|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162519|NCT00834444|3984466|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162520|NCT00834444|3984467|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162521|NCT00834431|3984476|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4162522|NCT00834431|3984477|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4162523|NCT00834431|3984478|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4162524|NCT00834431|3984476|B3|White||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4162525|NCT00834431|3984477|B2|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4162526|NCT00834431|3984478|B1|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4162527|NCT00834431|3984476|B3|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4162528|NCT00834431|3984477|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4162529|NCT00834431|3984478|B1|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4162530|NCT00834431|3984476|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4162531|NCT00834431|3984477|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4162532|NCT00834431|3984478|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4162533|NCT00834431|3984476|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4162534|NCT00834431|3984477|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4162535|NCT00834431|3984478|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4162536|NCT00834431|3984476|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4162537|NCT00834431|3984477|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4162538|NCT00834431|3984478|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4162539|NCT00834431|3984476|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162540|NCT00834431|3984477|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162541|NCT00834431|3984478|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162542|NCT00834431|3984476|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4162543|NCT00834431|3984477|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4162544|NCT00834431|3984478|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4162545|NCT00834431|3984476|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162546|NCT00834431|3984477|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162547|NCT00834431|3984478|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162548|NCT00834418|3984487|B3|United States||Region of Enrollment||participants|Number|84|84.0||||||
4162549|NCT00834418|3984488|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
4162550|NCT00834418|3984489|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4162551|NCT00834418|3984487|B3|American Indian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4162552|NCT00834418|3984488|B2|American Indian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4162553|NCT00834418|3984489|B1|American Indian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4162554|NCT00834418|3984487|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4162555|NCT00834418|3984488|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4162556|NCT00834418|3984489|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4162557|NCT00834418|3984487|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|80|80.0||||||
4162558|NCT00834418|3984488|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
4162559|NCT00834418|3984489|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
4162560|NCT00834418|3984487|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4162561|NCT00834418|3984488|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4162562|NCT00834418|3984489|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4162563|NCT00834418|3984487|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4162564|NCT00834418|3984488|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4162565|NCT00834418|3984489|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4162566|NCT00834418|3984487|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4162567|NCT00834418|3984488|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4162568|NCT00834418|3984489|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4162569|NCT00834418|3984487|B3||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
4162570|NCT00834418|3984488|B2||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4162571|NCT00834418|3984489|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4162572|NCT00834418|3984487|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162573|NCT00834418|3984488|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162574|NCT00834418|3984489|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162575|NCT00834405|3984496|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
4162576|NCT00834405|3984497|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4162577|NCT00834405|3984498|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4162578|NCT00834405|3984496|B3|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4162579|NCT00834405|3984497|B2|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4162580|NCT00834405|3984498|B1|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4162581|NCT00834405|3984496|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|36|36.0||||||
4162582|NCT00834405|3984497|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4162583|NCT00834405|3984498|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4162584|NCT00834405|3984496|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4162585|NCT00834405|3984497|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4162586|NCT00834405|3984498|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4162587|NCT00834405|3984496|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4162588|NCT00834405|3984497|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4162589|NCT00834405|3984498|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4162590|NCT00834405|3984496|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4162591|NCT00834405|3984497|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4162592|NCT00834405|3984498|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4162593|NCT00834405|3984496|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4162594|NCT00834405|3984497|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4162595|NCT00834405|3984498|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4162596|NCT00834405|3984496|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162597|NCT00834405|3984497|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162598|NCT00834405|3984498|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162599|NCT00834366|3984505|B3||Male|Sex: Female, Male||Participants|Count of Participants|15.0|15.0||||||
4162600|NCT00834366|3984506|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4162601|NCT00834366|3984507|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4162602|NCT00834366|3984505|B3||Female|Sex: Female, Male||Participants|Count of Participants|11.0|11.0||||||
4162603|NCT00834366|3984506|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4162604|NCT00834366|3984507|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4162605|NCT00834366|3984505|B3||>=65 years|Age||Participants|Count of Participants|0.0|0.0||||||
4162606|NCT00834366|3984506|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162607|NCT00834366|3984507|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162608|NCT00834366|3984505|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26.0|26.0||||||
4162609|NCT00834366|3984506|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4162610|NCT00834366|3984507|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4162611|NCT00834366|3984505|B3||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4162612|NCT00834366|3984506|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162613|NCT00834366|3984507|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162614|NCT00834340|3984522|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4162615|NCT00834340|3984523|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4162616|NCT00834340|3984524|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4162617|NCT00834340|3984522|B3|Biracial||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4162618|NCT00834340|3984523|B2|Biracial||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4162619|NCT00834340|3984524|B1|Biracial||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4162620|NCT00834340|3984522|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4162621|NCT00834340|3984523|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4162622|NCT00834340|3984524|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4162623|NCT00834340|3984522|B3|Black||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4162624|NCT00834340|3984523|B2|Black||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4162625|NCT00834340|3984524|B1|Black||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4162626|NCT00834340|3984522|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4162627|NCT00834340|3984523|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4162628|NCT00834340|3984524|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4162629|NCT00834340|3984522|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4162630|NCT00834340|3984523|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4162631|NCT00834340|3984524|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4162632|NCT00834340|3984522|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4162633|NCT00834340|3984523|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4162634|NCT00834340|3984524|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4162635|NCT00834340|3984522|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162636|NCT00834340|3984523|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162637|NCT00834340|3984524|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162638|NCT00834340|3984522|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4162639|NCT00834340|3984523|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4162640|NCT00834340|3984524|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4162641|NCT00834340|3984522|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162642|NCT00834340|3984523|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162643|NCT00834340|3984524|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162644|NCT00834288|3984533|B3||Male|Sex: Female, Male||Participants|Count of Participants|22.0|22.0||||||
4162645|NCT00834288|3984534|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4162646|NCT00834288|3984535|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4162647|NCT00834288|3984533|B3||Female|Sex: Female, Male||Participants|Count of Participants|4.0|4.0||||||
4162648|NCT00834288|3984534|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4162649|NCT00834288|3984535|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4162650|NCT00834288|3984533|B3||>=65 years|Age||Participants|Count of Participants|0.0|0.0||||||
4162651|NCT00834288|3984534|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162652|NCT00834288|3984535|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162653|NCT00834288|3984533|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26.0|26.0||||||
4162654|NCT00834288|3984534|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4162655|NCT00834288|3984535|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4162656|NCT00834288|3984533|B3||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4162657|NCT00834288|3984534|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162658|NCT00834288|3984535|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162659|NCT00834275|3984556|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4162660|NCT00834275|3984557|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4162661|NCT00834275|3984558|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4162662|NCT00834275|3984556|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162663|NCT00834275|3984557|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162664|NCT00834275|3984558|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162665|NCT00834275|3984556|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4162666|NCT00834275|3984557|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4162667|NCT00834275|3984558|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4162668|NCT00834275|3984556|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4162669|NCT00834275|3984557|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4162670|NCT00834275|3984558|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4162671|NCT00834275|3984556|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162672|NCT00834275|3984557|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162733|NCT00834236|3984586|B1|Taiwan||Region of Enrollment||participants|Number|29|29.0||||||
4162673|NCT00834275|3984558|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162674|NCT00834275|3984556|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4162675|NCT00834275|3984557|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162676|NCT00834275|3984558|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4162677|NCT00834275|3984556|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4162678|NCT00834275|3984557|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4162679|NCT00834275|3984558|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4162680|NCT00834275|3984556|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4162681|NCT00834275|3984557|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4162682|NCT00834275|3984558|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4162683|NCT00834275|3984556|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162684|NCT00834275|3984557|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162685|NCT00834275|3984558|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162686|NCT00834275|3984556|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4162687|NCT00834275|3984557|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4162688|NCT00834275|3984558|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4162689|NCT00834275|3984556|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162690|NCT00834275|3984557|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162691|NCT00834275|3984558|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162692|NCT00834275|3984556|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4162693|NCT00834275|3984557|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4162694|NCT00834275|3984558|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4162695|NCT00834275|3984556|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4162696|NCT00834275|3984557|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4162697|NCT00834275|3984558|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4162698|NCT00834275|3984556|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4162699|NCT00834275|3984557|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4162700|NCT00834275|3984558|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162701|NCT00834275|3984556|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4162702|NCT00834275|3984557|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4162703|NCT00834275|3984558|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4162704|NCT00834275|3984556|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162705|NCT00834275|3984557|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162706|NCT00834275|3984558|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162707|NCT00834249|3984567|B3|Canada||Region of Enrollment||participants|Number|18|18.0||||||
4162708|NCT00834249|3984568|B2|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4162709|NCT00834249|3984569|B1|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4162710|NCT00834249|3984567|B3|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4162711|NCT00834249|3984568|B2|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4162712|NCT00834249|3984569|B1|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4162713|NCT00834249|3984567|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4162714|NCT00834249|3984568|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4162715|NCT00834249|3984569|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4162716|NCT00834249|3984567|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4162717|NCT00834249|3984568|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4162718|NCT00834249|3984569|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4162719|NCT00834249|3984567|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4162720|NCT00834249|3984568|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4162721|NCT00834249|3984569|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4162722|NCT00834249|3984567|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162723|NCT00834249|3984568|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162724|NCT00834249|3984569|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162725|NCT00834249|3984567|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4162726|NCT00834249|3984568|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4162727|NCT00834249|3984569|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4162728|NCT00834249|3984567|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162729|NCT00834249|3984568|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162730|NCT00834249|3984569|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162731|NCT00834236|3984584|B3|Taiwan||Region of Enrollment||participants|Number|76|76.0||||||
4162732|NCT00834236|3984585|B2|Taiwan||Region of Enrollment||participants|Number|47|47.0||||||
4162734|NCT00834236|3984584|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4162735|NCT00834236|3984585|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4162736|NCT00834236|3984586|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4162737|NCT00834236|3984584|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4162738|NCT00834236|3984585|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4162739|NCT00834236|3984586|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4162740|NCT00834236|3984584|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|14.6|14.6|||
4162741|NCT00834236|3984585|B2|||Age||years|Mean|51.4|51.4|Standard Deviation|14.9|14.9|||
4162742|NCT00834236|3984586|B1|||Age||years|Mean|67.5|67.5|Standard Deviation|14.3|14.3|||
4162743|NCT00834236|3984584|B3||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4162744|NCT00834236|3984585|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4162745|NCT00834236|3984586|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4162746|NCT00834236|3984584|B3||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4162747|NCT00834236|3984585|B2||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4162748|NCT00834236|3984586|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4162749|NCT00834236|3984584|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162750|NCT00834236|3984585|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162751|NCT00834236|3984586|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162752|NCT00834210|3984593|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4162753|NCT00834210|3984594|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4162754|NCT00834210|3984595|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4162755|NCT00834210|3984593|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4162756|NCT00834210|3984594|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4162757|NCT00834210|3984595|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4162758|NCT00834210|3984593|B3|||Age||years|Median|17.2|17.2|Full Range|||12.1|45.7|
4162759|NCT00834210|3984594|B2|||Age||years|Median|16.7|16.7|Full Range|||12.1|42.9|
4162760|NCT00834210|3984595|B1|||Age||years|Median|17.8|17.8|Full Range|||12.2|45.7|
4162761|NCT00834197|3984608|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4162762|NCT00834197|3984609|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4162763|NCT00834197|3984610|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4162764|NCT00834197|3984608|B3|White||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4162765|NCT00834197|3984609|B2|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4162766|NCT00834197|3984610|B1|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4162767|NCT00834197|3984608|B3|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4162768|NCT00834197|3984609|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4162769|NCT00834197|3984610|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4162770|NCT00834197|3984608|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4162771|NCT00834197|3984609|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4162772|NCT00834197|3984610|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4162773|NCT00834197|3984608|B3|American Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4162774|NCT00834197|3984609|B2|American Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4162775|NCT00834197|3984610|B1|American Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4162776|NCT00834197|3984608|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4162777|NCT00834197|3984609|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4162778|NCT00834197|3984610|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4162779|NCT00834197|3984608|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4162780|NCT00834197|3984609|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4162781|NCT00834197|3984610|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4162782|NCT00834197|3984608|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162783|NCT00834197|3984609|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162784|NCT00834197|3984610|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162785|NCT00834197|3984608|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4162786|NCT00834197|3984609|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4162787|NCT00834197|3984610|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4162788|NCT00834197|3984608|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162789|NCT00834197|3984609|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162790|NCT00834197|3984610|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162791|NCT00834171|3984620|B2||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||There were 17 males enrolled in the entire study. Baseline characteristics for gender only analyzed for total study not for individual arms.
4162792|NCT00834171|3984621|B1||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||There were 17 males enrolled in the entire study. Baseline characteristics for gender only analyzed for total study not for individual arms.
4162852|NCT00834067|3984672|B1|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4162853|NCT00834067|3984670|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4162793|NCT00834171|3984620|B2||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||There were 33 females enrolled in the entire study. Baseline characteristics for gender only analyzed for total study not for individual arms.
4162794|NCT00834171|3984621|B1||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||There were 33 females enrolled in the entire study. Baseline characteristics for gender only analyzed for total study not for individual arms.
4162795|NCT00834171|3984619|B3|||Age||years|Mean|58.8|58.8|Full Range|||17.0|85.0|
4162796|NCT00834171|3984620|B2|||Age||years|Mean|NA||Full Range|||0.0|0.0|Baseline characteristics for age only analyzed for total study not for individual arms.
4162797|NCT00834171|3984621|B1|||Age||years|Mean|NA||Full Range|||0.0|0.0|Baseline characteristics for age only analyzed for total study not for individual arms.
4162798|NCT00834132|3984628|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4162799|NCT00834132|3984629|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4162800|NCT00834132|3984630|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4162801|NCT00834132|3984628|B3|Black||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4162802|NCT00834132|3984629|B2|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4162803|NCT00834132|3984630|B1|Black||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4162804|NCT00834132|3984628|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4162805|NCT00834132|3984629|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4162806|NCT00834132|3984630|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4162807|NCT00834132|3984628|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4162808|NCT00834132|3984629|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4162809|NCT00834132|3984630|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4162810|NCT00834132|3984628|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4162811|NCT00834132|3984629|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4162812|NCT00834132|3984630|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4162813|NCT00834132|3984628|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162814|NCT00834132|3984629|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162815|NCT00834132|3984630|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162816|NCT00834132|3984628|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4162817|NCT00834132|3984629|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4162818|NCT00834132|3984630|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4162819|NCT00834132|3984628|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162820|NCT00834132|3984629|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162821|NCT00834132|3984630|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162822|NCT00834106|3984639|B3|Asian||Race/Ethnicity, Customized||Participants|Number|3006|3006.0||||||
4162823|NCT00834106|3984640|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1503|1503.0||||||
4162824|NCT00834106|3984641|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1503|1503.0||||||
4162825|NCT00834106|3984639|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4162826|NCT00834106|3984640|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4162827|NCT00834106|3984641|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4162828|NCT00834106|3984639|B3||Female|Sex: Female, Male||Participants|Count of Participants|3006|3006.0||||||
4162829|NCT00834106|3984640|B2||Female|Sex: Female, Male||Participants|Count of Participants|1503|1503.0||||||
4162830|NCT00834106|3984641|B1||Female|Sex: Female, Male||Participants|Count of Participants|1503|1503.0||||||
4162831|NCT00834106|3984639|B3|27 to 45 years of age||Age, Customized||Participants|Number|1166|1166.0||||||
4162832|NCT00834106|3984640|B2|27 to 45 years of age||Age, Customized||Participants|Number|586|586.0||||||
4162833|NCT00834106|3984641|B1|27 to 45 years of age||Age, Customized||Participants|Number|580|580.0||||||
4162834|NCT00834106|3984639|B3|20 to 26 years of age||Age, Customized||Participants|Number|1840|1840.0||||||
4162835|NCT00834106|3984640|B2|20 to 26 years of age||Age, Customized||Participants|Number|917|917.0||||||
4162836|NCT00834106|3984641|B1|20 to 26 years of age||Age, Customized||Participants|Number|923|923.0||||||
4162837|NCT00834106|3984639|B3|||Age||Years|Mean|28.7|28.7|Standard Deviation|6.4|6.4|||
4162838|NCT00834106|3984640|B2|||Age||Years|Mean|28.7|28.7|Standard Deviation|6.4|6.4|||
4162839|NCT00834106|3984641|B1|||Age||Years|Mean|28.7|28.7|Standard Deviation|6.4|6.4|||
4162840|NCT00834080|3984666|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4162841|NCT00834080|3984666|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4162842|NCT00834080|3984666|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4162843|NCT00834080|3984666|B1|||Age||years|Mean|42.4|42.4|Standard Deviation|10.39|10.39|||
4162844|NCT00834080|3984666|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162845|NCT00834080|3984666|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4162846|NCT00834080|3984666|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162847|NCT00834067|3984670|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4162848|NCT00834067|3984671|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4162849|NCT00834067|3984672|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4162850|NCT00834067|3984670|B3|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4162851|NCT00834067|3984671|B2|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4162854|NCT00834067|3984671|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4162855|NCT00834067|3984672|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4162856|NCT00834067|3984670|B3|White||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4162857|NCT00834067|3984671|B2|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4162858|NCT00834067|3984672|B1|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4162859|NCT00834067|3984670|B3|Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4162860|NCT00834067|3984671|B2|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4162861|NCT00834067|3984672|B1|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4162862|NCT00834067|3984670|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4162863|NCT00834067|3984671|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4162864|NCT00834067|3984672|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4162865|NCT00834067|3984670|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4162866|NCT00834067|3984671|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4162867|NCT00834067|3984672|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4162868|NCT00834067|3984670|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4162869|NCT00834067|3984671|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4162870|NCT00834067|3984672|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4162871|NCT00834067|3984670|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162872|NCT00834067|3984671|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162873|NCT00834067|3984672|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162874|NCT00834067|3984670|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4162875|NCT00834067|3984671|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4162876|NCT00834067|3984672|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4162877|NCT00834067|3984670|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162878|NCT00834067|3984671|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162879|NCT00834067|3984672|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162880|NCT00834041|3984693|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4162881|NCT00834041|3984694|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4162882|NCT00834041|3984695|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4162883|NCT00834041|3984693|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4162884|NCT00834041|3984694|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4162885|NCT00834041|3984695|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4162886|NCT00834041|3984693|B3|12-17 years old||Age, Customized||participants|Number|19|19.0||||||
4162887|NCT00834041|3984694|B2|12-17 years old||Age, Customized||participants|Number|10|10.0||||||
4162888|NCT00834041|3984695|B1|12-17 years old||Age, Customized||participants|Number|9|9.0||||||
4162889|NCT00834041|3984693|B3|6-11 years old||Age, Customized||participants|Number|20|20.0||||||
4162890|NCT00834041|3984694|B2|6-11 years old||Age, Customized||participants|Number|10|10.0||||||
4162891|NCT00834041|3984695|B1|6-11 years old||Age, Customized||participants|Number|10|10.0||||||
4162892|NCT00834041|3984693|B3|||Age||years|Mean|12.0|12.0|Standard Deviation|3.44|3.44|||
4162893|NCT00834041|3984694|B2|||Age||years|Mean|11.8|11.8|Standard Deviation|3.78|3.78|||
4162894|NCT00834041|3984695|B1|||Age||years|Mean|12.2|12.2|Standard Deviation|3.12|3.12|||
4162895|NCT00833989|3984710|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162896|NCT00833989|3984711|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162897|NCT00833989|3984712|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162898|NCT00833989|3984713|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|00|0.0||||||
4162899|NCT00833989|3984714|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162900|NCT00833989|3984710|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162901|NCT00833989|3984711|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162902|NCT00833989|3984712|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162903|NCT00833989|3984713|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162904|NCT00833989|3984714|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162905|NCT00833989|3984710|B5||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4162906|NCT00833989|3984711|B4||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4162907|NCT00833989|3984712|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4162908|NCT00833989|3984713|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4162909|NCT00833989|3984714|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4162910|NCT00833989|3984710|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162911|NCT00833989|3984711|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162912|NCT00833989|3984712|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162913|NCT00833989|3984713|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162914|NCT00833989|3984714|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162915|NCT00833989|3984710|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162916|NCT00833989|3984711|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162917|NCT00833989|3984712|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162918|NCT00833989|3984713|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162919|NCT00833989|3984714|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162920|NCT00833989|3984710|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4162921|NCT00833989|3984711|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4162922|NCT00833989|3984712|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162923|NCT00833989|3984713|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4162924|NCT00833989|3984714|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162925|NCT00833989|3984710|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162926|NCT00833989|3984711|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162927|NCT00833989|3984712|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162928|NCT00833989|3984713|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162929|NCT00833989|3984714|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4162930|NCT00833989|3984710|B5||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4162931|NCT00833989|3984711|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4162932|NCT00833989|3984712|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4162933|NCT00833989|3984713|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4162934|NCT00833989|3984714|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4162935|NCT00833989|3984710|B5||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4162936|NCT00833989|3984711|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4162937|NCT00833989|3984712|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4162938|NCT00833989|3984713|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4162939|NCT00833989|3984714|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4162940|NCT00833989|3984710|B5|||Age||Year|Mean|64.2|64.2|Standard Deviation|12.27|12.27|||
4162941|NCT00833989|3984711|B4|||Age||Year|Mean|59.3|59.3|Standard Deviation|12.99|12.99|||
4162942|NCT00833989|3984712|B3|||Age||Year|Mean|63.9|63.9|Standard Deviation|13.76|13.76|||
4162943|NCT00833989|3984713|B2|||Age||Year|Mean|62.1|62.1|Standard Deviation|13.01|13.01|||
4162944|NCT00833989|3984714|B1|||Age||Year|Mean|67.6|67.6|Standard Deviation|10.79|10.79|||
4162945|NCT00833976|3984821|B1|United States||Region of Enrollment||participants|Number|65|65.0||||||
4162946|NCT00833976|3984821|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4162947|NCT00833976|3984821|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4162948|NCT00833976|3984821|B1|||Age||years|Median|48|48.0|Standard Deviation|13|13.0|||
4162949|NCT00833937|3984827|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4162950|NCT00833937|3984828|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4162951|NCT00833937|3984829|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4162952|NCT00833937|3984827|B3|Hispanic||Race, Customized||Participants|Number|2|2.0||||||
4162953|NCT00833937|3984828|B2|Hispanic||Race, Customized||Participants|Number|1|1.0||||||
4162954|NCT00833937|3984829|B1|Hispanic||Race, Customized||Participants|Number|1|1.0||||||
4162955|NCT00833937|3984827|B3|Black||Race, Customized||Participants|Number|6|6.0||||||
4162956|NCT00833937|3984828|B2|Black||Race, Customized||Participants|Number|4|4.0||||||
4162957|NCT00833937|3984829|B1|Black||Race, Customized||Participants|Number|2|2.0||||||
4162958|NCT00833937|3984827|B3|Caucasian||Race, Customized||Participants|Number|16|16.0||||||
4162959|NCT00833937|3984828|B2|Caucasian||Race, Customized||Participants|Number|7|7.0||||||
4162960|NCT00833937|3984829|B1|Caucasian||Race, Customized||Participants|Number|9|9.0||||||
4162961|NCT00833937|3984827|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4162962|NCT00833937|3984828|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4162963|NCT00833937|3984829|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4162964|NCT00833937|3984827|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4162965|NCT00833937|3984828|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4162966|NCT00833937|3984829|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4162967|NCT00833937|3984827|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162968|NCT00833937|3984828|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162969|NCT00833937|3984829|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4162970|NCT00833937|3984827|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4162971|NCT00833937|3984828|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4162972|NCT00833937|3984829|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4162973|NCT00833937|3984827|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162974|NCT00833937|3984828|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162975|NCT00833937|3984829|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162976|NCT00833924|3984838|B1||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4162977|NCT00833924|3984838|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4162978|NCT00833924|3984838|B1|||Age||years|Mean|71.8|71.8|Standard Deviation|8.7|8.7|||
4162979|NCT00833911|3984843|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4162980|NCT00833911|3984843|B1||Female|Sex: Female, Male||Participants|Count of Participants|333|333.0||||||
4162981|NCT00833911|3984843|B1|||Age||years|Mean|61.4|61.4|Standard Deviation|8.5|8.5|||
4162982|NCT00833911|3984843|B1||>=65 years|Age||Participants|Count of Participants|163|163.0||||||
4162983|NCT00833911|3984843|B1||Between 18 and 65 years|Age||Participants|Count of Participants|229|229.0||||||
4162984|NCT00833911|3984843|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4162985|NCT00833898|3984851|B3|Unknown or Not Reported||Employment Status (During Caregiving)||participants|Number|8|8.0||||||
4162986|NCT00833898|3984852|B2|Unknown or Not Reported||Employment Status (During Caregiving)||participants|Number|3|3.0||||||
4162987|NCT00833898|3984853|B1|Unknown or Not Reported||Employment Status (During Caregiving)||participants|Number|5|5.0||||||
4162988|NCT00833898|3984851|B3|Retired||Employment Status (During Caregiving)||participants|Number|30|30.0||||||
4162989|NCT00833898|3984852|B2|Retired||Employment Status (During Caregiving)||participants|Number|15|15.0||||||
4162990|NCT00833898|3984853|B1|Retired||Employment Status (During Caregiving)||participants|Number|15|15.0||||||
4162991|NCT00833898|3984851|B3|On leave||Employment Status (During Caregiving)||participants|Number|36|36.0||||||
4162992|NCT00833898|3984852|B2|On leave||Employment Status (During Caregiving)||participants|Number|19|19.0||||||
4162993|NCT00833898|3984853|B1|On leave||Employment Status (During Caregiving)||participants|Number|17|17.0||||||
4162994|NCT00833898|3984851|B3|Unemployed||Employment Status (During Caregiving)||participants|Number|22|22.0||||||
4162995|NCT00833898|3984852|B2|Unemployed||Employment Status (During Caregiving)||participants|Number|8|8.0||||||
4162996|NCT00833898|3984853|B1|Unemployed||Employment Status (During Caregiving)||participants|Number|14|14.0||||||
4162997|NCT00833898|3984851|B3|Part-time||Employment Status (During Caregiving)||participants|Number|17|17.0||||||
4162998|NCT00833898|3984852|B2|Part-time||Employment Status (During Caregiving)||participants|Number|10|10.0||||||
4162999|NCT00833898|3984853|B1|Part-time||Employment Status (During Caregiving)||participants|Number|7|7.0||||||
4163000|NCT00833898|3984851|B3|Full-time||Employment Status (During Caregiving)||participants|Number|35|35.0||||||
4163001|NCT00833898|3984852|B2|Full-time||Employment Status (During Caregiving)||participants|Number|19|19.0||||||
4163002|NCT00833898|3984853|B1|Full-time||Employment Status (During Caregiving)||participants|Number|16|16.0||||||
4163003|NCT00833898|3984851|B3|Unknown or Not Reported||Employment Status (Before Caregiving)||participants|Number|6|6.0||||||
4163004|NCT00833898|3984852|B2|Unknown or Not Reported||Employment Status (Before Caregiving)||participants|Number|3|3.0||||||
4163005|NCT00833898|3984853|B1|Unknown or Not Reported||Employment Status (Before Caregiving)||participants|Number|3|3.0||||||
4163006|NCT00833898|3984851|B3|Retired||Employment Status (Before Caregiving)||participants|Number|29|29.0||||||
4163007|NCT00833898|3984852|B2|Retired||Employment Status (Before Caregiving)||participants|Number|13|13.0||||||
4163008|NCT00833898|3984853|B1|Retired||Employment Status (Before Caregiving)||participants|Number|16|16.0||||||
4163009|NCT00833898|3984851|B3|On leave||Employment Status (Before Caregiving)||participants|Number|3|3.0||||||
4163010|NCT00833898|3984852|B2|On leave||Employment Status (Before Caregiving)||participants|Number|2|2.0||||||
4163011|NCT00833898|3984853|B1|On leave||Employment Status (Before Caregiving)||participants|Number|1|1.0||||||
4163012|NCT00833898|3984851|B3|Unemployed||Employment Status (Before Caregiving)||participants|Number|15|15.0||||||
4163013|NCT00833898|3984852|B2|Unemployed||Employment Status (Before Caregiving)||participants|Number|7|7.0||||||
4163014|NCT00833898|3984853|B1|Unemployed||Employment Status (Before Caregiving)||participants|Number|8|8.0||||||
4163015|NCT00833898|3984851|B3|Part-time||Employment Status (Before Caregiving)||participants|Number|24|24.0||||||
4163016|NCT00833898|3984852|B2|Part-time||Employment Status (Before Caregiving)||participants|Number|13|13.0||||||
4163017|NCT00833898|3984853|B1|Part-time||Employment Status (Before Caregiving)||participants|Number|11|11.0||||||
4163018|NCT00833898|3984851|B3|Full-time||Employment Status (Before Caregiving)||participants|Number|71|71.0||||||
4163019|NCT00833898|3984852|B2|Full-time||Employment Status (Before Caregiving)||participants|Number|36|36.0||||||
4163020|NCT00833898|3984853|B1|Full-time||Employment Status (Before Caregiving)||participants|Number|35|35.0||||||
4163021|NCT00833898|3984851|B3|Unknown or Not Reported||Relationship to patient||participants|Number|2|2.0||||||
4163022|NCT00833898|3984852|B2|Unknown or Not Reported||Relationship to patient||participants|Number|1|1.0||||||
4163023|NCT00833898|3984853|B1|Unknown or Not Reported||Relationship to patient||participants|Number|1|1.0||||||
4163024|NCT00833898|3984851|B3|Other||Relationship to patient||participants|Number|16|16.0||||||
4163025|NCT00833898|3984852|B2|Other||Relationship to patient||participants|Number|8|8.0||||||
4163026|NCT00833898|3984853|B1|Other||Relationship to patient||participants|Number|8|8.0||||||
4163027|NCT00833898|3984851|B3|Parent||Relationship to patient||participants|Number|27|27.0||||||
4163028|NCT00833898|3984852|B2|Parent||Relationship to patient||participants|Number|8|8.0||||||
4163029|NCT00833898|3984853|B1|Parent||Relationship to patient||participants|Number|19|19.0||||||
4163030|NCT00833898|3984851|B3|Spouse/partner||Relationship to patient||participants|Number|103|103.0||||||
4163031|NCT00833898|3984852|B2|Spouse/partner||Relationship to patient||participants|Number|57|57.0||||||
4163032|NCT00833898|3984853|B1|Spouse/partner||Relationship to patient||participants|Number|46|46.0||||||
4163033|NCT00833898|3984851|B3|Unknown or Not Reported||Annual income|Income in dollars|participants|Number|9|9.0||||||
4163034|NCT00833898|3984852|B2|Unknown or Not Reported||Annual income|Income in dollars|participants|Number|5|5.0||||||
4163035|NCT00833898|3984853|B1|Unknown or Not Reported||Annual income|Income in dollars|participants|Number|4|4.0||||||
4163036|NCT00833898|3984851|B3|> 65,000||Annual income|Income in dollars|participants|Number|60|60.0||||||
4163037|NCT00833898|3984852|B2|> 65,000||Annual income|Income in dollars|participants|Number|29|29.0||||||
4163038|NCT00833898|3984853|B1|> 65,000||Annual income|Income in dollars|participants|Number|31|31.0||||||
4163039|NCT00833898|3984851|B3|45,000-64,999||Annual income|Income in dollars|participants|Number|26|26.0||||||
4163040|NCT00833898|3984852|B2|45,000-64,999||Annual income|Income in dollars|participants|Number|15|15.0||||||
4163041|NCT00833898|3984853|B1|45,000-64,999||Annual income|Income in dollars|participants|Number|11|11.0||||||
4163042|NCT00833898|3984851|B3|25,000-44,999||Annual income|Income in dollars|participants|Number|29|29.0||||||
4163043|NCT00833898|3984852|B2|25,000-44,999||Annual income|Income in dollars|participants|Number|14|14.0||||||
4163044|NCT00833898|3984853|B1|25,000-44,999||Annual income|Income in dollars|participants|Number|15|15.0||||||
4163045|NCT00833898|3984851|B3|< 25,000||Annual income|Income in dollars|participants|Number|24|24.0||||||
4163046|NCT00833898|3984852|B2|< 25,000||Annual income|Income in dollars|participants|Number|11|11.0||||||
4163047|NCT00833898|3984853|B1|< 25,000||Annual income|Income in dollars|participants|Number|13|13.0||||||
4163048|NCT00833898|3984851|B3|United States||Region of Enrollment||participants|Number|148|148.0||||||
4163049|NCT00833898|3984852|B2|United States||Region of Enrollment||participants|Number|74|74.0||||||
4163050|NCT00833898|3984853|B1|United States||Region of Enrollment||participants|Number|74|74.0||||||
4163051|NCT00833898|3984851|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4163052|NCT00833898|3984852|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4163053|NCT00833898|3984853|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4163054|NCT00833898|3984851|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4163055|NCT00833898|3984852|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4163056|NCT00833898|3984853|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4163057|NCT00833898|3984851|B3|Latino/Hispanic/Mexian-American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4163058|NCT00833898|3984852|B2|Latino/Hispanic/Mexian-American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4163059|NCT00833898|3984853|B1|Latino/Hispanic/Mexian-American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4163060|NCT00833898|3984851|B3|Asian/Oriental/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4163061|NCT00833898|3984852|B2|Asian/Oriental/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4163062|NCT00833898|3984853|B1|Asian/Oriental/Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4163063|NCT00833898|3984851|B3|Black/African-American (not Latino/Hispanic)||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4163064|NCT00833898|3984852|B2|Black/African-American (not Latino/Hispanic)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4163065|NCT00833898|3984853|B1|Black/African-American (not Latino/Hispanic)||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4163066|NCT00833898|3984851|B3|Caucasian (not Latino/Hispanic)||Race/Ethnicity, Customized||participants|Number|133|133.0||||||
4163067|NCT00833898|3984852|B2|Caucasian (not Latino/Hispanic)||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
4163068|NCT00833898|3984853|B1|Caucasian (not Latino/Hispanic)||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
4163069|NCT00833898|3984851|B3|Male||Gender|For Caregiver Control gender information, participant did not reported their gender (n = 1).|participants|Number|35|35.0||||||
4163070|NCT00833898|3984852|B2|Male||Gender|For Caregiver Control gender information, participant did not reported their gender (n = 1).|participants|Number|18|18.0||||||
4163071|NCT00833898|3984853|B1|Male||Gender|For Caregiver Control gender information, participant did not reported their gender (n = 1).|participants|Number|17|17.0||||||
4163072|NCT00833898|3984851|B3|Female||Gender|For Caregiver Control gender information, participant did not reported their gender (n = 1).|participants|Number|112|112.0||||||
4163073|NCT00833898|3984852|B2|Female||Gender|For Caregiver Control gender information, participant did not reported their gender (n = 1).|participants|Number|56|56.0||||||
4163074|NCT00833898|3984853|B1|Female||Gender|For Caregiver Control gender information, participant did not reported their gender (n = 1).|participants|Number|56|56.0||||||
4163075|NCT00833898|3984851|B3|||Age||years|Mean|53.5|53.5|Standard Deviation|12.285|12.285|||
4163076|NCT00833898|3984852|B2|||Age||years|Mean|52.2|52.2|Standard Deviation|12.169|12.169|||
4163077|NCT00833898|3984853|B1|||Age||years|Mean|54.8|54.8|Standard Deviation|12.355|12.355|||
4163078|NCT00833859|3984900|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4163079|NCT00833859|3984900|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4163080|NCT00833859|3984900|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4163081|NCT00833859|3984900|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4163082|NCT00833859|3984900|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4163083|NCT00833859|3984900|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4163084|NCT00833833|3984907|B7|No||Prior Stem Cell Transplant||participants|Number|68|68.0||||||
4163085|NCT00833833|3984908|B6|No||Prior Stem Cell Transplant||participants|Number|26|26.0||||||
4163086|NCT00833833|3984909|B5|No||Prior Stem Cell Transplant||participants|Number|29|29.0||||||
4163087|NCT00833833|3984910|B4|No||Prior Stem Cell Transplant||participants|Number|4|4.0||||||
4163088|NCT00833833|3984911|B3|No||Prior Stem Cell Transplant||participants|Number|3|3.0||||||
4163089|NCT00833833|3984912|B2|No||Prior Stem Cell Transplant||participants|Number|4|4.0||||||
4163090|NCT00833833|3984913|B1|No||Prior Stem Cell Transplant||participants|Number|2|2.0||||||
4163091|NCT00833833|3984907|B7|Yes||Prior Stem Cell Transplant||participants|Number|191|191.0||||||
4163092|NCT00833833|3984908|B6|Yes||Prior Stem Cell Transplant||participants|Number|82|82.0||||||
4163093|NCT00833833|3984909|B5|Yes||Prior Stem Cell Transplant||participants|Number|84|84.0||||||
4163094|NCT00833833|3984910|B4|Yes||Prior Stem Cell Transplant||participants|Number|6|6.0||||||
4163095|NCT00833833|3984911|B3|Yes||Prior Stem Cell Transplant||participants|Number|11|11.0||||||
4163096|NCT00833833|3984912|B2|Yes||Prior Stem Cell Transplant||participants|Number|4|4.0||||||
4163097|NCT00833833|3984913|B1|Yes||Prior Stem Cell Transplant||participants|Number|4|4.0||||||
4163098|NCT00833833|3984907|B7|No||Prior Thalidomide Exposure||participants|Number|81|81.0||||||
4163099|NCT00833833|3984908|B6|No||Prior Thalidomide Exposure||participants|Number|36|36.0||||||
4163100|NCT00833833|3984909|B5|No||Prior Thalidomide Exposure||participants|Number|37|37.0||||||
4163101|NCT00833833|3984910|B4|No||Prior Thalidomide Exposure||participants|Number|1|1.0||||||
4163102|NCT00833833|3984911|B3|No||Prior Thalidomide Exposure||participants|Number|3|3.0||||||
4163103|NCT00833833|3984912|B2|No||Prior Thalidomide Exposure||participants|Number|2|2.0||||||
4163104|NCT00833833|3984913|B1|No||Prior Thalidomide Exposure||participants|Number|2|2.0||||||
4163105|NCT00833833|3984907|B7|Yes||Prior Thalidomide Exposure||participants|Number|178|178.0||||||
4163106|NCT00833833|3984908|B6|Yes||Prior Thalidomide Exposure||participants|Number|72|72.0||||||
4163107|NCT00833833|3984909|B5|Yes||Prior Thalidomide Exposure||participants|Number|76|76.0||||||
4163108|NCT00833833|3984910|B4|Yes||Prior Thalidomide Exposure||participants|Number|9|9.0||||||
4163109|NCT00833833|3984911|B3|Yes||Prior Thalidomide Exposure||participants|Number|11|11.0||||||
4163110|NCT00833833|3984912|B2|Yes||Prior Thalidomide Exposure||participants|Number|6|6.0||||||
4163111|NCT00833833|3984913|B1|Yes||Prior Thalidomide Exposure||participants|Number|4|4.0||||||
4163112|NCT00833833|3984907|B7|No||Prior Anti-Myeloma Therapies||participants|Number|0|0.0||||||
4163113|NCT00833833|3984908|B6|No||Prior Anti-Myeloma Therapies||participants|Number|0|0.0||||||
4163114|NCT00833833|3984909|B5|No||Prior Anti-Myeloma Therapies||participants|Number|0|0.0||||||
4163115|NCT00833833|3984910|B4|No||Prior Anti-Myeloma Therapies||participants|Number|0|0.0||||||
4163116|NCT00833833|3984911|B3|No||Prior Anti-Myeloma Therapies||participants|Number|0|0.0||||||
4163117|NCT00833833|3984912|B2|No||Prior Anti-Myeloma Therapies||participants|Number|0|0.0||||||
4163118|NCT00833833|3984913|B1|No||Prior Anti-Myeloma Therapies||participants|Number|0|0.0||||||
4163119|NCT00833833|3984907|B7|Yes||Prior Anti-Myeloma Therapies||participants|Number|259|259.0||||||
4163120|NCT00833833|3984908|B6|Yes||Prior Anti-Myeloma Therapies||participants|Number|108|108.0||||||
4163121|NCT00833833|3984909|B5|Yes||Prior Anti-Myeloma Therapies||participants|Number|113|113.0||||||
4163122|NCT00833833|3984910|B4|Yes||Prior Anti-Myeloma Therapies||participants|Number|10|10.0||||||
4163123|NCT00833833|3984911|B3|Yes||Prior Anti-Myeloma Therapies||participants|Number|14|14.0||||||
4163124|NCT00833833|3984912|B2|Yes||Prior Anti-Myeloma Therapies||participants|Number|8|8.0||||||
4163125|NCT00833833|3984913|B1|Yes||Prior Anti-Myeloma Therapies||participants|Number|6|6.0||||||
4163126|NCT00833833|3984907|B7|Stage III||Baseline Multiple Myeloma Stage|Multiple myeloma has three stages, which are known as stage I, stage II and stage III. Staging in myeloma is done on the basis of the value of serum albumin and beta-2 microglobulin level. Stage I has the best prognosis and stage III the worst prognosis.|participants|Number|172|172.0||||||
4163127|NCT00833833|3984908|B6|Stage III||Baseline Multiple Myeloma Stage|Multiple myeloma has three stages, which are known as stage I, stage II and stage III. Staging in myeloma is done on the basis of the value of serum albumin and beta-2 microglobulin level. Stage I has the best prognosis and stage III the worst prognosis.|participants|Number|71|71.0||||||
4163128|NCT00833833|3984909|B5|Stage III||Baseline Multiple Myeloma Stage|Multiple myeloma has three stages, which are known as stage I, stage II and stage III. Staging in myeloma is done on the basis of the value of serum albumin and beta-2 microglobulin level. Stage I has the best prognosis and stage III the worst prognosis.|participants|Number|76|76.0||||||
4163129|NCT00833833|3984910|B4|Stage III||Baseline Multiple Myeloma Stage|Multiple myeloma has three stages, which are known as stage I, stage II and stage III. Staging in myeloma is done on the basis of the value of serum albumin and beta-2 microglobulin level. Stage I has the best prognosis and stage III the worst prognosis.|participants|Number|7|7.0||||||
4163130|NCT00833833|3984911|B3|Stage III||Baseline Multiple Myeloma Stage|Multiple myeloma has three stages, which are known as stage I, stage II and stage III. Staging in myeloma is done on the basis of the value of serum albumin and beta-2 microglobulin level. Stage I has the best prognosis and stage III the worst prognosis.|participants|Number|7|7.0||||||
4163131|NCT00833833|3984912|B2|Stage III||Baseline Multiple Myeloma Stage|Multiple myeloma has three stages, which are known as stage I, stage II and stage III. Staging in myeloma is done on the basis of the value of serum albumin and beta-2 microglobulin level. Stage I has the best prognosis and stage III the worst prognosis.|participants|Number|6|6.0||||||
4163132|NCT00833833|3984913|B1|Stage III||Baseline Multiple Myeloma Stage|Multiple myeloma has three stages, which are known as stage I, stage II and stage III. Staging in myeloma is done on the basis of the value of serum albumin and beta-2 microglobulin level. Stage I has the best prognosis and stage III the worst prognosis.|participants|Number|5|5.0||||||
4163133|NCT00833833|3984907|B7|Stage II||Baseline Multiple Myeloma Stage|Multiple myeloma has three stages, which are known as stage I, stage II and stage III. Staging in myeloma is done on the basis of the value of serum albumin and beta-2 microglobulin level. Stage I has the best prognosis and stage III the worst prognosis.|participants|Number|64|64.0||||||
4163134|NCT00833833|3984908|B6|Stage II||Baseline Multiple Myeloma Stage|Multiple myeloma has three stages, which are known as stage I, stage II and stage III. Staging in myeloma is done on the basis of the value of serum albumin and beta-2 microglobulin level. Stage I has the best prognosis and stage III the worst prognosis.|participants|Number|29|29.0||||||
4163180|NCT00833833|3984912|B2|Missing||Baseline Electrocardiogram Findings||participants|Number|0|0.0||||||
4163135|NCT00833833|3984909|B5|Stage II||Baseline Multiple Myeloma Stage|Multiple myeloma has three stages, which are known as stage I, stage II and stage III. Staging in myeloma is done on the basis of the value of serum albumin and beta-2 microglobulin level. Stage I has the best prognosis and stage III the worst prognosis.|participants|Number|29|29.0||||||
4163136|NCT00833833|3984910|B4|Stage II||Baseline Multiple Myeloma Stage|Multiple myeloma has three stages, which are known as stage I, stage II and stage III. Staging in myeloma is done on the basis of the value of serum albumin and beta-2 microglobulin level. Stage I has the best prognosis and stage III the worst prognosis.|participants|Number|1|1.0||||||
4163137|NCT00833833|3984911|B3|Stage II||Baseline Multiple Myeloma Stage|Multiple myeloma has three stages, which are known as stage I, stage II and stage III. Staging in myeloma is done on the basis of the value of serum albumin and beta-2 microglobulin level. Stage I has the best prognosis and stage III the worst prognosis.|participants|Number|4|4.0||||||
4163138|NCT00833833|3984912|B2|Stage II||Baseline Multiple Myeloma Stage|Multiple myeloma has three stages, which are known as stage I, stage II and stage III. Staging in myeloma is done on the basis of the value of serum albumin and beta-2 microglobulin level. Stage I has the best prognosis and stage III the worst prognosis.|participants|Number|1|1.0||||||
4163139|NCT00833833|3984913|B1|Stage II||Baseline Multiple Myeloma Stage|Multiple myeloma has three stages, which are known as stage I, stage II and stage III. Staging in myeloma is done on the basis of the value of serum albumin and beta-2 microglobulin level. Stage I has the best prognosis and stage III the worst prognosis.|participants|Number|0|0.0||||||
4163140|NCT00833833|3984907|B7|Stage I||Baseline Multiple Myeloma Stage|Multiple myeloma has three stages, which are known as stage I, stage II and stage III. Staging in myeloma is done on the basis of the value of serum albumin and beta-2 microglobulin level. Stage I has the best prognosis and stage III the worst prognosis.|participants|Number|23|23.0||||||
4163141|NCT00833833|3984908|B6|Stage I||Baseline Multiple Myeloma Stage|Multiple myeloma has three stages, which are known as stage I, stage II and stage III. Staging in myeloma is done on the basis of the value of serum albumin and beta-2 microglobulin level. Stage I has the best prognosis and stage III the worst prognosis.|participants|Number|8|8.0||||||
4163142|NCT00833833|3984909|B5|Stage I||Baseline Multiple Myeloma Stage|Multiple myeloma has three stages, which are known as stage I, stage II and stage III. Staging in myeloma is done on the basis of the value of serum albumin and beta-2 microglobulin level. Stage I has the best prognosis and stage III the worst prognosis.|participants|Number|8|8.0||||||
4163143|NCT00833833|3984910|B4|Stage I||Baseline Multiple Myeloma Stage|Multiple myeloma has three stages, which are known as stage I, stage II and stage III. Staging in myeloma is done on the basis of the value of serum albumin and beta-2 microglobulin level. Stage I has the best prognosis and stage III the worst prognosis.|participants|Number|2|2.0||||||
4163144|NCT00833833|3984911|B3|Stage I||Baseline Multiple Myeloma Stage|Multiple myeloma has three stages, which are known as stage I, stage II and stage III. Staging in myeloma is done on the basis of the value of serum albumin and beta-2 microglobulin level. Stage I has the best prognosis and stage III the worst prognosis.|participants|Number|3|3.0||||||
4163145|NCT00833833|3984912|B2|Stage I||Baseline Multiple Myeloma Stage|Multiple myeloma has three stages, which are known as stage I, stage II and stage III. Staging in myeloma is done on the basis of the value of serum albumin and beta-2 microglobulin level. Stage I has the best prognosis and stage III the worst prognosis.|participants|Number|1|1.0||||||
4163146|NCT00833833|3984913|B1|Stage I||Baseline Multiple Myeloma Stage|Multiple myeloma has three stages, which are known as stage I, stage II and stage III. Staging in myeloma is done on the basis of the value of serum albumin and beta-2 microglobulin level. Stage I has the best prognosis and stage III the worst prognosis.|participants|Number|1|1.0||||||
4163147|NCT00833833|3984907|B7|3||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|2|2.0||||||
4163148|NCT00833833|3984908|B6|3||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|2|2.0||||||
4163149|NCT00833833|3984909|B5|3||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|0|0.0||||||
4163150|NCT00833833|3984910|B4|3||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|0|0.0||||||
4163151|NCT00833833|3984911|B3|3||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|0|0.0||||||
4163152|NCT00833833|3984912|B2|3||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|0|0.0||||||
4163153|NCT00833833|3984913|B1|3||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|0|0.0||||||
4163154|NCT00833833|3984907|B7|2||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|32|32.0||||||
4163155|NCT00833833|3984908|B6|2||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|11|11.0||||||
4163156|NCT00833833|3984909|B5|2||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|13|13.0||||||
4163157|NCT00833833|3984910|B4|2||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|3|3.0||||||
4163158|NCT00833833|3984911|B3|2||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|1|1.0||||||
4163159|NCT00833833|3984912|B2|2||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|0|0.0||||||
4163160|NCT00833833|3984913|B1|2||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|4|4.0||||||
4163161|NCT00833833|3984907|B7|1||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|163|163.0||||||
4163162|NCT00833833|3984908|B6|1||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|71|71.0||||||
4163163|NCT00833833|3984909|B5|1||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|68|68.0||||||
4163164|NCT00833833|3984910|B4|1||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|5|5.0||||||
4163165|NCT00833833|3984911|B3|1||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|10|10.0||||||
4163166|NCT00833833|3984912|B2|1||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|8|8.0||||||
4163167|NCT00833833|3984913|B1|1||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|1|1.0||||||
4163168|NCT00833833|3984907|B7|0||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|62|62.0||||||
4163169|NCT00833833|3984908|B6|0||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|24|24.0||||||
4163170|NCT00833833|3984909|B5|0||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|32|32.0||||||
4163171|NCT00833833|3984910|B4|0||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|2|2.0||||||
4163172|NCT00833833|3984911|B3|0||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|3|3.0||||||
4163173|NCT00833833|3984912|B2|0||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|0|0.0||||||
4163174|NCT00833833|3984913|B1|0||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|1|1.0||||||
4163175|NCT00833833|3984907|B7|Missing||Baseline Electrocardiogram Findings||participants|Number|8|8.0||||||
4163176|NCT00833833|3984908|B6|Missing||Baseline Electrocardiogram Findings||participants|Number|4|4.0||||||
4163177|NCT00833833|3984909|B5|Missing||Baseline Electrocardiogram Findings||participants|Number|4|4.0||||||
4163178|NCT00833833|3984910|B4|Missing||Baseline Electrocardiogram Findings||participants|Number|0|0.0||||||
4163179|NCT00833833|3984911|B3|Missing||Baseline Electrocardiogram Findings||participants|Number|0|0.0||||||
4163181|NCT00833833|3984913|B1|Missing||Baseline Electrocardiogram Findings||participants|Number|0|0.0||||||
4163182|NCT00833833|3984907|B7|Abnormal, clinically significant||Baseline Electrocardiogram Findings||participants|Number|1|1.0||||||
4163183|NCT00833833|3984908|B6|Abnormal, clinically significant||Baseline Electrocardiogram Findings||participants|Number|1|1.0||||||
4163184|NCT00833833|3984909|B5|Abnormal, clinically significant||Baseline Electrocardiogram Findings||participants|Number|0|0.0||||||
4163185|NCT00833833|3984910|B4|Abnormal, clinically significant||Baseline Electrocardiogram Findings||participants|Number|0|0.0||||||
4163186|NCT00833833|3984911|B3|Abnormal, clinically significant||Baseline Electrocardiogram Findings||participants|Number|0|0.0||||||
4163187|NCT00833833|3984912|B2|Abnormal, clinically significant||Baseline Electrocardiogram Findings||participants|Number|0|0.0||||||
4163188|NCT00833833|3984913|B1|Abnormal, clinically significant||Baseline Electrocardiogram Findings||participants|Number|0|0.0||||||
4163189|NCT00833833|3984907|B7|Abnormal, not clinically significant||Baseline Electrocardiogram Findings||participants|Number|140|140.0||||||
4163190|NCT00833833|3984908|B6|Abnormal, not clinically significant||Baseline Electrocardiogram Findings||participants|Number|59|59.0||||||
4163191|NCT00833833|3984909|B5|Abnormal, not clinically significant||Baseline Electrocardiogram Findings||participants|Number|56|56.0||||||
4163192|NCT00833833|3984910|B4|Abnormal, not clinically significant||Baseline Electrocardiogram Findings||participants|Number|6|6.0||||||
4163193|NCT00833833|3984911|B3|Abnormal, not clinically significant||Baseline Electrocardiogram Findings||participants|Number|11|11.0||||||
4163194|NCT00833833|3984912|B2|Abnormal, not clinically significant||Baseline Electrocardiogram Findings||participants|Number|5|5.0||||||
4163195|NCT00833833|3984913|B1|Abnormal, not clinically significant||Baseline Electrocardiogram Findings||participants|Number|3|3.0||||||
4163196|NCT00833833|3984907|B7|Normal||Baseline Electrocardiogram Findings||participants|Number|110|110.0||||||
4163197|NCT00833833|3984908|B6|Normal||Baseline Electrocardiogram Findings||participants|Number|44|44.0||||||
4163198|NCT00833833|3984909|B5|Normal||Baseline Electrocardiogram Findings||participants|Number|53|53.0||||||
4163199|NCT00833833|3984910|B4|Normal||Baseline Electrocardiogram Findings||participants|Number|4|4.0||||||
4163200|NCT00833833|3984911|B3|Normal||Baseline Electrocardiogram Findings||participants|Number|3|3.0||||||
4163201|NCT00833833|3984912|B2|Normal||Baseline Electrocardiogram Findings||participants|Number|3|3.0||||||
4163202|NCT00833833|3984913|B1|Normal||Baseline Electrocardiogram Findings||participants|Number|3|3.0||||||
4163203|NCT00833833|3984907|B7|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4163204|NCT00833833|3984908|B6|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4163205|NCT00833833|3984909|B5|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4163206|NCT00833833|3984910|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4163207|NCT00833833|3984911|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4163208|NCT00833833|3984912|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4163209|NCT00833833|3984913|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4163210|NCT00833833|3984907|B7|White||Race/Ethnicity, Customized||participants|Number|213|213.0||||||
4163211|NCT00833833|3984908|B6|White||Race/Ethnicity, Customized||participants|Number|86|86.0||||||
4163212|NCT00833833|3984909|B5|White||Race/Ethnicity, Customized||participants|Number|92|92.0||||||
4163213|NCT00833833|3984910|B4|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4163214|NCT00833833|3984911|B3|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4163215|NCT00833833|3984912|B2|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4163216|NCT00833833|3984913|B1|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4163217|NCT00833833|3984907|B7|Black or African American||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4163218|NCT00833833|3984908|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4163219|NCT00833833|3984909|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4163220|NCT00833833|3984910|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4163221|NCT00833833|3984911|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4163222|NCT00833833|3984912|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4163223|NCT00833833|3984913|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4163224|NCT00833833|3984907|B7|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4163225|NCT00833833|3984908|B6|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4163226|NCT00833833|3984909|B5|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4163227|NCT00833833|3984910|B4|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4163228|NCT00833833|3984911|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4163229|NCT00833833|3984912|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4163230|NCT00833833|3984913|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4163231|NCT00833833|3984907|B7||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4163232|NCT00833833|3984908|B6||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4163233|NCT00833833|3984909|B5||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4163234|NCT00833833|3984910|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4163235|NCT00833833|3984911|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4163236|NCT00833833|3984912|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4163237|NCT00833833|3984913|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4163238|NCT00833833|3984907|B7||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4163239|NCT00833833|3984908|B6||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4163240|NCT00833833|3984909|B5||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4163241|NCT00833833|3984910|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4163242|NCT00833833|3984911|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4163243|NCT00833833|3984912|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4163244|NCT00833833|3984913|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4163245|NCT00833833|3984907|B7|>75 years||Age, Customized||participants|Number|33|33.0||||||
4163246|NCT00833833|3984908|B6|>75 years||Age, Customized||participants|Number|13|13.0||||||
4163247|NCT00833833|3984909|B5|>75 years||Age, Customized||participants|Number|14|14.0||||||
4163248|NCT00833833|3984910|B4|>75 years||Age, Customized||participants|Number|1|1.0||||||
4163249|NCT00833833|3984911|B3|>75 years||Age, Customized||participants|Number|3|3.0||||||
4163250|NCT00833833|3984912|B2|>75 years||Age, Customized||participants|Number|2|2.0||||||
4163251|NCT00833833|3984913|B1|>75 years||Age, Customized||participants|Number|0|0.0||||||
4163252|NCT00833833|3984907|B7|<=75 years||Age, Customized||participants|Number|226|226.0||||||
4163253|NCT00833833|3984908|B6|<=75 years||Age, Customized||participants|Number|95|95.0||||||
4163254|NCT00833833|3984909|B5|<=75 years||Age, Customized||participants|Number|99|99.0||||||
4163255|NCT00833833|3984910|B4|<=75 years||Age, Customized||participants|Number|9|9.0||||||
4163256|NCT00833833|3984911|B3|<=75 years||Age, Customized||participants|Number|11|11.0||||||
4163257|NCT00833833|3984912|B2|<=75 years||Age, Customized||participants|Number|6|6.0||||||
4163258|NCT00833833|3984913|B1|<=75 years||Age, Customized||participants|Number|6|6.0||||||
4163259|NCT00833833|3984907|B7|||Age||years|Mean|64.1|64.1|Standard Deviation|9.86|9.86|||
4163260|NCT00833833|3984908|B6|||Age||years|Mean|62.9|62.9|Standard Deviation|10.35|10.35|||
4163261|NCT00833833|3984909|B5|||Age||years|Mean|64.4|64.4|Standard Deviation|9.24|9.24|||
4163262|NCT00833833|3984910|B4|||Age||years|Mean|61.3|61.3|Standard Deviation|14.06|14.06|||
4163263|NCT00833833|3984911|B3|||Age||years|Mean|67.5|67.5|Standard Deviation|8.98|8.98|||
4163264|NCT00833833|3984912|B2|||Age||years|Mean|70.4|70.4|Standard Deviation|6.63|6.63|||
4163265|NCT00833833|3984913|B1|||Age||years|Mean|64.7|64.7|Standard Deviation|6.83|6.83|||
4163266|NCT00833794|3984956|B3||Male|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
4163267|NCT00833794|3984957|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4163268|NCT00833794|3984958|B1||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4163269|NCT00833794|3984956|B3||Female|Sex: Female, Male||Participants|Count of Participants|408|408.0||||||
4163270|NCT00833794|3984957|B2||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4163271|NCT00833794|3984958|B1||Female|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4163272|NCT00833794|3984956|B3|||Age||years|Mean|62.0|62.0|Standard Deviation|9.0|9.0|||
4163273|NCT00833794|3984957|B2|||Age||years|Mean|62.3|62.3|Standard Deviation|8.9|8.9|||
4163274|NCT00833794|3984958|B1|||Age||years|Mean|61.8|61.8|Standard Deviation|9.0|9.0|||
4163275|NCT00833794|3984956|B3||>=65 years|Age||Participants|Count of Participants|278|278.0||||||
4163276|NCT00833794|3984957|B2||>=65 years|Age||Participants|Count of Participants|98|98.0||||||
4163277|NCT00833794|3984958|B1||>=65 years|Age||Participants|Count of Participants|180|180.0||||||
4163278|NCT00833794|3984956|B3||Between 18 and 65 years|Age||Participants|Count of Participants|368|368.0||||||
4163279|NCT00833794|3984957|B2||Between 18 and 65 years|Age||Participants|Count of Participants|116|116.0||||||
4163280|NCT00833794|3984958|B1||Between 18 and 65 years|Age||Participants|Count of Participants|252|252.0||||||
4163281|NCT00833794|3984956|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4163282|NCT00833794|3984957|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4163283|NCT00833794|3984958|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4163284|NCT00833781|3984985|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4163285|NCT00833781|3984986|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4163286|NCT00833781|3984987|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4163287|NCT00833781|3984985|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4163288|NCT00833781|3984986|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4163289|NCT00833781|3984987|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4163290|NCT00833781|3984985|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4163291|NCT00833781|3984986|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4163292|NCT00833781|3984987|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4163293|NCT00833781|3984985|B3|||Age||years|Median|46.7|46.7|Full Range|||33.0|55.0|
4163294|NCT00833781|3984986|B2|||Age||years|Median|49|49.0|Full Range|||42.0|52.0|
4163295|NCT00833781|3984987|B1|||Age||years|Median|44|44.0|Full Range|||33.0|55.0|
4163296|NCT00833755|3984999|B5||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4163297|NCT00833755|3985000|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4163298|NCT00833755|3985001|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4163299|NCT00833755|3985002|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4163300|NCT00833755|3985003|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4163301|NCT00833755|3984999|B5||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4163302|NCT00833755|3985000|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4163303|NCT00833755|3985001|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4163304|NCT00833755|3985002|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4163305|NCT00833755|3985003|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4163306|NCT00833755|3984999|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4163307|NCT00833755|3985000|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4163308|NCT00833755|3985001|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4163309|NCT00833755|3985002|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4163310|NCT00833755|3985003|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4163311|NCT00833755|3984999|B5||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
4163312|NCT00833755|3985000|B4||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4163313|NCT00833755|3985001|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4163314|NCT00833755|3985002|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4163315|NCT00833755|3985003|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4163316|NCT00833755|3984999|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4163317|NCT00833755|3985000|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4163318|NCT00833755|3985001|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4163319|NCT00833755|3985002|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4163320|NCT00833755|3985003|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4163321|NCT00833703|3985024|B3|||Age at shunt palliation||days|Mean|19.4|19.4|Standard Deviation|22.3|22.3|||
4163322|NCT00833703|3985025|B2|||Age at shunt palliation||days|Mean|13.7|13.7|Standard Deviation|12.7|12.7|||
4163323|NCT00833703|3985026|B1|||Age at shunt palliation||days|Mean|25.7|25.7|Standard Deviation|28.7|28.7|||
4163324|NCT00833703|3985024|B3|No||Shunt on cardiopulmonary bypass||participants|Number|42|42.0||||||
4163325|NCT00833703|3985025|B2|No||Shunt on cardiopulmonary bypass||participants|Number|21|21.0||||||
4163326|NCT00833703|3985026|B1|No||Shunt on cardiopulmonary bypass||participants|Number|21|21.0||||||
4163327|NCT00833703|3985024|B3|Yes||Shunt on cardiopulmonary bypass||participants|Number|7|7.0||||||
4163328|NCT00833703|3985025|B2|Yes||Shunt on cardiopulmonary bypass||participants|Number|5|5.0||||||
4163329|NCT00833703|3985026|B1|Yes||Shunt on cardiopulmonary bypass||participants|Number|2|2.0||||||
4163330|NCT00833703|3985024|B3|Stent of ductus arteriosus||Type of initial shunt palliation||participants|Number|4|4.0||||||
4163331|NCT00833703|3985025|B2|Stent of ductus arteriosus||Type of initial shunt palliation||participants|Number|1|1.0||||||
4163332|NCT00833703|3985026|B1|Stent of ductus arteriosus||Type of initial shunt palliation||participants|Number|3|3.0||||||
4163333|NCT00833703|3985024|B3|Central shunt||Type of initial shunt palliation||participants|Number|4|4.0||||||
4163334|NCT00833703|3985025|B2|Central shunt||Type of initial shunt palliation||participants|Number|3|3.0||||||
4163335|NCT00833703|3985026|B1|Central shunt||Type of initial shunt palliation||participants|Number|1|1.0||||||
4163336|NCT00833703|3985024|B3|Sano procedure without Norwood||Type of initial shunt palliation||participants|Number|2|2.0||||||
4163337|NCT00833703|3985025|B2|Sano procedure without Norwood||Type of initial shunt palliation||participants|Number|1|1.0||||||
4163338|NCT00833703|3985026|B1|Sano procedure without Norwood||Type of initial shunt palliation||participants|Number|1|1.0||||||
4163339|NCT00833703|3985024|B3|Sano procedure with Norwood||Type of initial shunt palliation||participants|Number|0|0.0||||||
4163340|NCT00833703|3985025|B2|Sano procedure with Norwood||Type of initial shunt palliation||participants|Number|0|0.0||||||
4163341|NCT00833703|3985026|B1|Sano procedure with Norwood||Type of initial shunt palliation||participants|Number|0|0.0||||||
4163342|NCT00833703|3985024|B3|Modified Blalock Taussig Shunt without Norwood||Type of initial shunt palliation||participants|Number|38|38.0||||||
4163343|NCT00833703|3985025|B2|Modified Blalock Taussig Shunt without Norwood||Type of initial shunt palliation||participants|Number|20|20.0||||||
4163344|NCT00833703|3985026|B1|Modified Blalock Taussig Shunt without Norwood||Type of initial shunt palliation||participants|Number|18|18.0||||||
4163345|NCT00833703|3985024|B3|Modified Blalock Taussig Shunt with Norwood||Type of initial shunt palliation||participants|Number|1|1.0||||||
4163346|NCT00833703|3985025|B2|Modified Blalock Taussig Shunt with Norwood||Type of initial shunt palliation||participants|Number|1|1.0||||||
4163347|NCT00833703|3985026|B1|Modified Blalock Taussig Shunt with Norwood||Type of initial shunt palliation||participants|Number|0|0.0||||||
4163348|NCT00833703|3985024|B3|||Height at inclusion||centimeters (cm)|Mean|70.8|70.8|Standard Deviation|7.8|7.8|||
4163349|NCT00833703|3985025|B2|||Height at inclusion||centimeters (cm)|Mean|70.0|70.0|Standard Deviation|10.4|10.4|||
4163350|NCT00833703|3985026|B1|||Height at inclusion||centimeters (cm)|Mean|71.8|71.8|Standard Deviation|2.8|2.8|||
4163351|NCT00833703|3985024|B3|||Weight at inclusion||kilograms (kg)|Mean|8.0|8.0|Standard Deviation|1.2|1.2|||
4163352|NCT00833703|3985025|B2|||Weight at inclusion||kilograms (kg)|Mean|8.1|8.1|Standard Deviation|1.2|1.2|||
4163353|NCT00833703|3985026|B1|||Weight at inclusion||kilograms (kg)|Mean|7.9|7.9|Standard Deviation|1.1|1.1|||
4163354|NCT00833703|3985024|B3|Germany||Region of Enrollment||participants|Number|3|3.0||||||
4163355|NCT00833703|3985025|B2|Germany||Region of Enrollment||participants|Number|3|3.0||||||
4163356|NCT00833703|3985026|B1|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4163357|NCT00833703|3985024|B3|Poland||Region of Enrollment||participants|Number|2|2.0||||||
4163358|NCT00833703|3985025|B2|Poland||Region of Enrollment||participants|Number|1|1.0||||||
4163359|NCT00833703|3985026|B1|Poland||Region of Enrollment||participants|Number|1|1.0||||||
4163360|NCT00833703|3985024|B3|Malaysia||Region of Enrollment||participants|Number|2|2.0||||||
4163361|NCT00833703|3985025|B2|Malaysia||Region of Enrollment||participants|Number|1|1.0||||||
4163362|NCT00833703|3985026|B1|Malaysia||Region of Enrollment||participants|Number|1|1.0||||||
4163363|NCT00833703|3985024|B3|Brazil||Region of Enrollment||participants|Number|6|6.0||||||
4163364|NCT00833703|3985025|B2|Brazil||Region of Enrollment||participants|Number|2|2.0||||||
4163365|NCT00833703|3985026|B1|Brazil||Region of Enrollment||participants|Number|4|4.0||||||
4163366|NCT00833703|3985024|B3|Mexico||Region of Enrollment||participants|Number|10|10.0||||||
4163367|NCT00833703|3985025|B2|Mexico||Region of Enrollment||participants|Number|4|4.0||||||
4163368|NCT00833703|3985026|B1|Mexico||Region of Enrollment||participants|Number|6|6.0||||||
4163369|NCT00833703|3985024|B3|Hungary||Region of Enrollment||participants|Number|3|3.0||||||
4163370|NCT00833703|3985025|B2|Hungary||Region of Enrollment||participants|Number|1|1.0||||||
4163371|NCT00833703|3985026|B1|Hungary||Region of Enrollment||participants|Number|2|2.0||||||
4163372|NCT00833703|3985024|B3|France||Region of Enrollment||participants|Number|1|1.0||||||
4163373|NCT00833703|3985025|B2|France||Region of Enrollment||participants|Number|1|1.0||||||
4163374|NCT00833703|3985026|B1|France||Region of Enrollment||participants|Number|0|0.0||||||
4163375|NCT00833703|3985024|B3|India||Region of Enrollment||participants|Number|1|1.0||||||
4163376|NCT00833703|3985025|B2|India||Region of Enrollment||participants|Number|1|1.0||||||
4163377|NCT00833703|3985026|B1|India||Region of Enrollment||participants|Number|0|0.0||||||
4163378|NCT00833703|3985024|B3|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4163379|NCT00833703|3985025|B2|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4163380|NCT00833703|3985026|B1|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4163381|NCT00833703|3985024|B3|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4163382|NCT00833703|3985025|B2|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4163383|NCT00833703|3985026|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4163384|NCT00833703|3985024|B3|Russian Federation||Region of Enrollment||participants|Number|1|1.0||||||
4163385|NCT00833703|3985025|B2|Russian Federation||Region of Enrollment||participants|Number|0|0.0||||||
4163386|NCT00833703|3985026|B1|Russian Federation||Region of Enrollment||participants|Number|1|1.0||||||
4163387|NCT00833703|3985024|B3|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4163388|NCT00833703|3985025|B2|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4163389|NCT00833703|3985026|B1|Spain||Region of Enrollment||participants|Number|0|0.0||||||
4163390|NCT00833703|3985024|B3|Taiwan||Region of Enrollment||participants|Number|9|9.0||||||
4163391|NCT00833703|3985025|B2|Taiwan||Region of Enrollment||participants|Number|5|5.0||||||
4163392|NCT00833703|3985026|B1|Taiwan||Region of Enrollment||participants|Number|4|4.0||||||
4163393|NCT00833703|3985024|B3|Portugal||Region of Enrollment||participants|Number|4|4.0||||||
4163394|NCT00833703|3985025|B2|Portugal||Region of Enrollment||participants|Number|1|1.0||||||
4163395|NCT00833703|3985026|B1|Portugal||Region of Enrollment||participants|Number|3|3.0||||||
4163396|NCT00833703|3985024|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4163397|NCT00833703|3985025|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4163398|NCT00833703|3985026|B1|United States||Region of Enrollment||participants|Number|0|0.0||||||
4163399|NCT00833703|3985024|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4163400|NCT00833703|3985025|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4163401|NCT00833703|3985026|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4163402|NCT00833703|3985024|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4163403|NCT00833703|3985025|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4163404|NCT00833703|3985026|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4163405|NCT00833703|3985024|B3|at inclusion||Age||days|Mean|368.0|368.0|Standard Deviation|3.5|3.5|||
4163406|NCT00833703|3985025|B2|at inclusion||Age||days|Mean|368.0|368.0|Standard Deviation|2.7|2.7|||
4163407|NCT00833703|3985026|B1|at inclusion||Age||days|Mean|368.1|368.1|Standard Deviation|4.2|4.2|||
4163408|NCT00833703|3985024|B3|at randomization in CLARINET study||Age||days|Mean|38.8|38.8|Standard Deviation|23.8|23.8|||
4163409|NCT00833703|3985025|B2|at randomization in CLARINET study||Age||days|Mean|33.1|33.1|Standard Deviation|20.5|20.5|||
4163410|NCT00833703|3985026|B1|at randomization in CLARINET study||Age||days|Mean|45.2|45.2|Standard Deviation|26.1|26.1|||
4163411|NCT00833690|3985037|B4|||Geriatric Depression Scale-short form (GDS-S)|GDS-S is a short 15 'yes/no' question instrument for assessing depression in older adults. Questions are answered by the research participant (i.e., self-rater). Scores range range from 0 to 15 and higher scores represent greater depression. Scores of 5-9 and >9 have been correlated with mild and moderate-severe depression, respectively.|Score|Mean|1.5|1.5|Standard Deviation|2.1|2.1|||
4163412|NCT00833690|3985038|B3|||Geriatric Depression Scale-short form (GDS-S)|GDS-S is a short 15 'yes/no' question instrument for assessing depression in older adults. Questions are answered by the research participant (i.e., self-rater). Scores range range from 0 to 15 and higher scores represent greater depression. Scores of 5-9 and >9 have been correlated with mild and moderate-severe depression, respectively.|Score|Mean|1.8|1.8|Standard Deviation|2.6|2.6|||
4163413|NCT00833690|3985039|B2|||Geriatric Depression Scale-short form (GDS-S)|GDS-S is a short 15 'yes/no' question instrument for assessing depression in older adults. Questions are answered by the research participant (i.e., self-rater). Scores range range from 0 to 15 and higher scores represent greater depression. Scores of 5-9 and >9 have been correlated with mild and moderate-severe depression, respectively.|Score|Mean|1.4|1.4|Standard Deviation|1.7|1.7|||
4163448|NCT00833690|3985038|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4163414|NCT00833690|3985040|B1|||Geriatric Depression Scale-short form (GDS-S)|GDS-S is a short 15 'yes/no' question instrument for assessing depression in older adults. Questions are answered by the research participant (i.e., self-rater). Scores range range from 0 to 15 and higher scores represent greater depression. Scores of 5-9 and >9 have been correlated with mild and moderate-severe depression, respectively.|Score|Mean|1.5|1.5|Standard Deviation|1.9|1.9|||
4163415|NCT00833690|3985037|B4|||Montreal Cognitive Assessment (MoCA)|The MoCA assesses short term and working memory, visual-spatial abilities, executive function, attention, concentration, language and orientation. The total score ranges from 0 to 30 (highest function).|Score|Mean|28|28.0|Standard Deviation|1.9|1.9|||
4163416|NCT00833690|3985038|B3|||Montreal Cognitive Assessment (MoCA)|The MoCA assesses short term and working memory, visual-spatial abilities, executive function, attention, concentration, language and orientation. The total score ranges from 0 to 30 (highest function).|Score|Mean|28|28.0|Standard Deviation|2.0|2.0|||
4163417|NCT00833690|3985039|B2|||Montreal Cognitive Assessment (MoCA)|The MoCA assesses short term and working memory, visual-spatial abilities, executive function, attention, concentration, language and orientation. The total score ranges from 0 to 30 (highest function).|Score|Mean|28|28.0|Standard Deviation|1.8|1.8|||
4163418|NCT00833690|3985040|B1|||Montreal Cognitive Assessment (MoCA)|The MoCA assesses short term and working memory, visual-spatial abilities, executive function, attention, concentration, language and orientation. The total score ranges from 0 to 30 (highest function).|Score|Mean|28|28.0|Standard Deviation|1.9|1.9|||
4163419|NCT00833690|3985037|B4|||United Parkinson's Disease Rating Scale (UPDRS) score total|"The UPDRS is designed to monitor disability and impairment due to Parkinson's disease. It comprises several parts. Part I evaluates Mentation, Behavior, and Mood (with a maximum of 16 points; more points are worse); Part II evaluates Activities of Daily Living (with a maximum of 52 points); Part III entails a Motor Examination (with a maximum of 108 points). Total score of Parts I-III sums the points from all parts and thus can range from a minimum of 0 (best) to a maximum of 176 (worst)."|points|Mean|22|22.0|Standard Deviation|10|10.0|||
4163420|NCT00833690|3985038|B3|||United Parkinson's Disease Rating Scale (UPDRS) score total|"The UPDRS is designed to monitor disability and impairment due to Parkinson's disease. It comprises several parts. Part I evaluates Mentation, Behavior, and Mood (with a maximum of 16 points; more points are worse); Part II evaluates Activities of Daily Living (with a maximum of 52 points); Part III entails a Motor Examination (with a maximum of 108 points). Total score of Parts I-III sums the points from all parts and thus can range from a minimum of 0 (best) to a maximum of 176 (worst)."|points|Mean|21|21.0|Standard Deviation|10|10.0|||
4163421|NCT00833690|3985039|B2|||United Parkinson's Disease Rating Scale (UPDRS) score total|"The UPDRS is designed to monitor disability and impairment due to Parkinson's disease. It comprises several parts. Part I evaluates Mentation, Behavior, and Mood (with a maximum of 16 points; more points are worse); Part II evaluates Activities of Daily Living (with a maximum of 52 points); Part III entails a Motor Examination (with a maximum of 108 points). Total score of Parts I-III sums the points from all parts and thus can range from a minimum of 0 (best) to a maximum of 176 (worst)."|points|Mean|20|20.0|Standard Deviation|9|9.0|||
4163422|NCT00833690|3985040|B1|||United Parkinson's Disease Rating Scale (UPDRS) score total|"The UPDRS is designed to monitor disability and impairment due to Parkinson's disease. It comprises several parts. Part I evaluates Mentation, Behavior, and Mood (with a maximum of 16 points; more points are worse); Part II evaluates Activities of Daily Living (with a maximum of 52 points); Part III entails a Motor Examination (with a maximum of 108 points). Total score of Parts I-III sums the points from all parts and thus can range from a minimum of 0 (best) to a maximum of 176 (worst)."|points|Mean|23|23.0|Standard Deviation|10|10.0|||
4163423|NCT00833690|3985037|B4|||Serum urate in men||mg/dL|Mean|4.8|4.8|Standard Deviation|0.7|0.7|||
4163424|NCT00833690|3985038|B3|||Serum urate in men||mg/dL|Mean|4.9|4.9|Standard Deviation|0.9|0.9|||
4163425|NCT00833690|3985039|B2|||Serum urate in men||mg/dL|Mean|5.0|5.0|Standard Deviation|0.8|0.8|||
4163426|NCT00833690|3985040|B1|||Serum urate in men||mg/dL|Mean|4.7|4.7|Standard Deviation|0.5|0.5|||
4163427|NCT00833690|3985037|B4|||Serum urate in women||mg/dL|Mean|4.2|4.2|Standard Deviation|1.0|1.0|||
4163428|NCT00833690|3985038|B3|||Serum urate in women||mg/dL|Mean|4.4|4.4|Standard Deviation|0.8|0.8|||
4163429|NCT00833690|3985039|B2|||Serum urate in women||mg/dL|Mean|3.9|3.9|Standard Deviation|1.3|1.3|||
4163430|NCT00833690|3985040|B1|||Serum urate in women||mg/dL|Mean|4.4|4.4|Standard Deviation|0.8|0.8|||
4163431|NCT00833690|3985037|B4|||Serum Urate||mg/dL|Mean|4.5|4.5|Standard Deviation|0.9|0.9|||
4163432|NCT00833690|3985038|B3|||Serum Urate||mg/dL|Mean|4.6|4.6|Standard Deviation|0.9|0.9|||
4163433|NCT00833690|3985039|B2|||Serum Urate||mg/dL|Mean|4.3|4.3|Standard Deviation|1.2|1.2|||
4163434|NCT00833690|3985040|B1|||Serum Urate||mg/dL|Mean|4.5|4.5|Standard Deviation|0.7|0.7|||
4163435|NCT00833690|3985037|B4|||Years since diagnosis||Years|Mean|1.0|1.0|Standard Deviation|1.1|1.1|||
4163436|NCT00833690|3985038|B3|||Years since diagnosis||Years|Mean|0.6|0.6|Standard Deviation|0.7|0.7|||
4163437|NCT00833690|3985039|B2|||Years since diagnosis||Years|Mean|1.3|1.3|Standard Deviation|1.0|1.0|||
4163438|NCT00833690|3985040|B1|||Years since diagnosis||Years|Mean|1.1|1.1|Standard Deviation|1.3|1.3|||
4163439|NCT00833690|3985037|B4|||Years since symptom onset||Years|Mean|2.4|2.4|Standard Deviation|1.8|1.8|||
4163440|NCT00833690|3985038|B3|||Years since symptom onset||Years|Mean|2.2|2.2|Standard Deviation|2.0|2.0|||
4163441|NCT00833690|3985039|B2|||Years since symptom onset||Years|Mean|2.8|2.8|Standard Deviation|1.9|1.9|||
4163442|NCT00833690|3985040|B1|||Years since symptom onset||Years|Mean|2.4|2.4|Standard Deviation|1.3|1.3|||
4163443|NCT00833690|3985037|B4|United States||Region of Enrollment||participants|Number|75|75.0||||||
4163444|NCT00833690|3985038|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4163445|NCT00833690|3985039|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4163446|NCT00833690|3985040|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4163447|NCT00833690|3985037|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4163449|NCT00833690|3985039|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4163450|NCT00833690|3985040|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4163451|NCT00833690|3985037|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163452|NCT00833690|3985038|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163453|NCT00833690|3985039|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163454|NCT00833690|3985040|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163455|NCT00833690|3985037|B4||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4163456|NCT00833690|3985038|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4163457|NCT00833690|3985039|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4163458|NCT00833690|3985040|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4163459|NCT00833690|3985037|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163460|NCT00833690|3985038|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163461|NCT00833690|3985039|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163462|NCT00833690|3985040|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163463|NCT00833690|3985037|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4163464|NCT00833690|3985038|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4163465|NCT00833690|3985039|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163466|NCT00833690|3985040|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163467|NCT00833690|3985037|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163468|NCT00833690|3985038|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163469|NCT00833690|3985039|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163470|NCT00833690|3985040|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163471|NCT00833690|3985037|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163472|NCT00833690|3985038|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163473|NCT00833690|3985039|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163474|NCT00833690|3985040|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163475|NCT00833690|3985037|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163476|NCT00833690|3985038|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163477|NCT00833690|3985039|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163478|NCT00833690|3985040|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163479|NCT00833690|3985037|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
4163480|NCT00833690|3985038|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4163481|NCT00833690|3985039|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4163482|NCT00833690|3985040|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4163483|NCT00833690|3985037|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4163484|NCT00833690|3985038|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163485|NCT00833690|3985039|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4163486|NCT00833690|3985040|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163487|NCT00833690|3985037|B4||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4163488|NCT00833690|3985038|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4163489|NCT00833690|3985039|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4163490|NCT00833690|3985040|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4163491|NCT00833690|3985037|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4163492|NCT00833690|3985038|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4163493|NCT00833690|3985039|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4163494|NCT00833690|3985040|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4163495|NCT00833690|3985037|B4|||Age||years|Mean|62|62.0|Standard Deviation|10|10.0|||
4163496|NCT00833690|3985038|B3|||Age||years|Mean|62|62.0|Standard Deviation|11|11.0|||
4163497|NCT00833690|3985039|B2|||Age||years|Mean|62|62.0|Standard Deviation|10|10.0|||
4163498|NCT00833690|3985040|B1|||Age||years|Mean|61|61.0|Standard Deviation|11|11.0|||
4163499|NCT00833664|3985164|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4163500|NCT00833664|3985165|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4163501|NCT00833664|3985166|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4163502|NCT00833664|3985164|B3|Biracial||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4163503|NCT00833664|3985165|B2|Biracial||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4163504|NCT00833664|3985166|B1|Biracial||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4163505|NCT00833664|3985164|B3|Black||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4163506|NCT00833664|3985165|B2|Black||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4163507|NCT00833664|3985166|B1|Black||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4163508|NCT00833664|3985164|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4163509|NCT00833664|3985165|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4163510|NCT00833664|3985166|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4163511|NCT00833664|3985164|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4163512|NCT00833664|3985165|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4163513|NCT00833664|3985166|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4163514|NCT00833664|3985164|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4163515|NCT00833664|3985165|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4163516|NCT00833664|3985166|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4163517|NCT00833664|3985164|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4163518|NCT00833664|3985165|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4163519|NCT00833664|3985166|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4163520|NCT00833664|3985164|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4163521|NCT00833664|3985165|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4163522|NCT00833664|3985166|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4163523|NCT00833664|3985164|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4163524|NCT00833664|3985165|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4163525|NCT00833664|3985166|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4163526|NCT00833638|3985175|B4|||Sexual Encounter Profile Diary question number 5|"Sexual Encounter Profile Diary question number 5: Were you satisfied overall with this sexual experience? Data are presented as the mean percentage of participants who answered yes."|percentage of participants|Mean|6.77|6.77|Standard Deviation|16.27|16.27|||
4163527|NCT00833638|3985176|B3|||Sexual Encounter Profile Diary question number 5|"Sexual Encounter Profile Diary question number 5: Were you satisfied overall with this sexual experience? Data are presented as the mean percentage of participants who answered yes."|percentage of participants|Mean|8.08|8.08|Standard Deviation|16.88|16.88|||
4163528|NCT00833638|3985177|B2|||Sexual Encounter Profile Diary question number 5|"Sexual Encounter Profile Diary question number 5: Were you satisfied overall with this sexual experience? Data are presented as the mean percentage of participants who answered yes."|percentage of participants|Mean|4.39|4.39|Standard Deviation|12.31|12.31|||
4163529|NCT00833638|3985178|B1|||Sexual Encounter Profile Diary question number 5|"Sexual Encounter Profile Diary question number 5: Were you satisfied overall with this sexual experience? Data are presented as the mean percentage of participants who answered yes."|percentage of participants|Mean|7.67|7.67|Standard Deviation|18.73|18.73|||
4163530|NCT00833638|3985175|B4|||Sexual Encounter Profile Diary question number 4|"Sexual Encounter Profile Diary question number 4: Were you satisfied with the hardness of your erection? Data are presented as the mean percentage of participants who answered yes."|percentage of participants|Mean|7.26|7.26|Standard Deviation|16.64|16.64|||
4163531|NCT00833638|3985176|B3|||Sexual Encounter Profile Diary question number 4|"Sexual Encounter Profile Diary question number 4: Were you satisfied with the hardness of your erection? Data are presented as the mean percentage of participants who answered yes."|percentage of participants|Mean|8.36|8.36|Standard Deviation|16.88|16.88|||
4163532|NCT00833638|3985177|B2|||Sexual Encounter Profile Diary question number 4|"Sexual Encounter Profile Diary question number 4: Were you satisfied with the hardness of your erection? Data are presented as the mean percentage of participants who answered yes."|percentage of participants|Mean|4.96|4.96|Standard Deviation|13.19|13.19|||
4163533|NCT00833638|3985178|B1|||Sexual Encounter Profile Diary question number 4|"Sexual Encounter Profile Diary question number 4: Were you satisfied with the hardness of your erection? Data are presented as the mean percentage of participants who answered yes."|percentage of participants|Mean|8.33|8.33|Standard Deviation|19.18|19.18|||
4163534|NCT00833638|3985175|B4|||Sexual Encounter Profile Diary question number 3|"Sexual Encounter Profile Diary question number 3: Did your erection last long enough for you to have successful intercourse? Data are presented as the mean percentage of participants who answered yes."|percentage of participants|Mean|28.80|28.8|Standard Deviation|34.85|34.85|||
4163535|NCT00833638|3985176|B3|||Sexual Encounter Profile Diary question number 3|"Sexual Encounter Profile Diary question number 3: Did your erection last long enough for you to have successful intercourse? Data are presented as the mean percentage of participants who answered yes."|percentage of participants|Mean|29.95|29.95|Standard Deviation|34.85|34.85|||
4163536|NCT00833638|3985177|B2|||Sexual Encounter Profile Diary question number 3|"Sexual Encounter Profile Diary question number 3: Did your erection last long enough for you to have successful intercourse? Data are presented as the mean percentage of participants who answered yes."|percentage of participants|Mean|25.42|25.42|Standard Deviation|32.62|32.62|||
4163537|NCT00833638|3985178|B1|||Sexual Encounter Profile Diary question number 3|"Sexual Encounter Profile Diary question number 3: Did your erection last long enough for you to have successful intercourse? Data are presented as the mean percentage of participants who answered yes."|percentage of participants|Mean|30.90|30.9|Standard Deviation|36.99|36.99|||
4163538|NCT00833638|3985175|B4|||Sexual Encounter Profile Diary question number 2|"Sexual Encounter Profile Diary question number 2: Were you able insert your penis into your partner's vagina? Data are presented as the mean percentage of participants who answered yes."|percentage of participants|Mean|54.41|54.41|Standard Deviation|38.94|38.94|||
4163539|NCT00833638|3985176|B3|||Sexual Encounter Profile Diary question number 2|"Sexual Encounter Profile Diary question number 2: Were you able insert your penis into your partner's vagina? Data are presented as the mean percentage of participants who answered yes."|percentage of participants|Mean|56.16|56.16|Standard Deviation|37.14|37.14|||
4163582|NCT00833638|3985175|B4|||Age||years|Mean|58.87|58.87|Standard Deviation|10.58|10.58|||
4163583|NCT00833638|3985176|B3|||Age||years|Mean|59.23|59.23|Standard Deviation|10.63|10.63|||
4163540|NCT00833638|3985177|B2|||Sexual Encounter Profile Diary question number 2|"Sexual Encounter Profile Diary question number 2: Were you able insert your penis into your partner's vagina? Data are presented as the mean percentage of participants who answered yes."|percentage of participants|Mean|54.20|54.2|Standard Deviation|39.47|39.47|||
4163541|NCT00833638|3985178|B1|||Sexual Encounter Profile Diary question number 2|"Sexual Encounter Profile Diary question number 2: Were you able insert your penis into your partner's vagina? Data are presented as the mean percentage of participants who answered yes."|percentage of participants|Mean|52.70|52.7|Standard Deviation|40.58|40.58|||
4163542|NCT00833638|3985175|B4|||Sexual Encounter Profile Diary question number 1|"Sexual Encounter Profile Diary question number 1: Were you able to achieve at least some erection (some enlargement of the penis)? Data are presented as the mean percentage of participants who answered yes."|percentage of participants|Mean|77.34|77.34|Standard Deviation|33.55|33.55|||
4163543|NCT00833638|3985176|B3|||Sexual Encounter Profile Diary question number 1|"Sexual Encounter Profile Diary question number 1: Were you able to achieve at least some erection (some enlargement of the penis)? Data are presented as the mean percentage of participants who answered yes."|percentage of participants|Mean|82.26|82.26|Standard Deviation|28.98|28.98|||
4163544|NCT00833638|3985177|B2|||Sexual Encounter Profile Diary question number 1|"Sexual Encounter Profile Diary question number 1: Were you able to achieve at least some erection (some enlargement of the penis)? Data are presented as the mean percentage of participants who answered yes."|percentage of participants|Mean|75.22|75.22|Standard Deviation|35.69|35.69|||
4163545|NCT00833638|3985178|B1|||Sexual Encounter Profile Diary question number 1|"Sexual Encounter Profile Diary question number 1: Were you able to achieve at least some erection (some enlargement of the penis)? Data are presented as the mean percentage of participants who answered yes."|percentage of participants|Mean|74.04|74.04|Standard Deviation|35.64|35.64|||
4163546|NCT00833638|3985175|B4|United States||Region of Enrollment||participants|Number|372|372.0||||||
4163547|NCT00833638|3985176|B3|United States||Region of Enrollment||participants|Number|133|133.0||||||
4163548|NCT00833638|3985177|B2|United States||Region of Enrollment||participants|Number|118|118.0||||||
4163549|NCT00833638|3985178|B1|United States||Region of Enrollment||participants|Number|121|121.0||||||
4163550|NCT00833638|3985175|B4|White||Race/Ethnicity, Customized|American Indian or Alaska Native|participants|Number|283|283.0||||||
4163551|NCT00833638|3985176|B3|White||Race/Ethnicity, Customized|American Indian or Alaska Native|participants|Number|107|107.0||||||
4163552|NCT00833638|3985177|B2|White||Race/Ethnicity, Customized|American Indian or Alaska Native|participants|Number|87|87.0||||||
4163553|NCT00833638|3985178|B1|White||Race/Ethnicity, Customized|American Indian or Alaska Native|participants|Number|89|89.0||||||
4163554|NCT00833638|3985175|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|American Indian or Alaska Native|participants|Number|1|1.0||||||
4163555|NCT00833638|3985176|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|American Indian or Alaska Native|participants|Number|1|1.0||||||
4163556|NCT00833638|3985177|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|American Indian or Alaska Native|participants|Number|0|0.0||||||
4163557|NCT00833638|3985178|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|American Indian or Alaska Native|participants|Number|0|0.0||||||
4163558|NCT00833638|3985175|B4|Multiple||Race/Ethnicity, Customized|American Indian or Alaska Native|participants|Number|9|9.0||||||
4163559|NCT00833638|3985176|B3|Multiple||Race/Ethnicity, Customized|American Indian or Alaska Native|participants|Number|2|2.0||||||
4163560|NCT00833638|3985177|B2|Multiple||Race/Ethnicity, Customized|American Indian or Alaska Native|participants|Number|6|6.0||||||
4163561|NCT00833638|3985178|B1|Multiple||Race/Ethnicity, Customized|American Indian or Alaska Native|participants|Number|1|1.0||||||
4163562|NCT00833638|3985175|B4|Black or African American||Race/Ethnicity, Customized|American Indian or Alaska Native|participants|Number|68|68.0||||||
4163563|NCT00833638|3985176|B3|Black or African American||Race/Ethnicity, Customized|American Indian or Alaska Native|participants|Number|22|22.0||||||
4163564|NCT00833638|3985177|B2|Black or African American||Race/Ethnicity, Customized|American Indian or Alaska Native|participants|Number|21|21.0||||||
4163565|NCT00833638|3985178|B1|Black or African American||Race/Ethnicity, Customized|American Indian or Alaska Native|participants|Number|25|25.0||||||
4163566|NCT00833638|3985175|B4|Asian||Race/Ethnicity, Customized|American Indian or Alaska Native|participants|Number|7|7.0||||||
4163567|NCT00833638|3985176|B3|Asian||Race/Ethnicity, Customized|American Indian or Alaska Native|participants|Number|1|1.0||||||
4163568|NCT00833638|3985177|B2|Asian||Race/Ethnicity, Customized|American Indian or Alaska Native|participants|Number|4|4.0||||||
4163569|NCT00833638|3985178|B1|Asian||Race/Ethnicity, Customized|American Indian or Alaska Native|participants|Number|2|2.0||||||
4163570|NCT00833638|3985175|B4|American Indian or Alaska Native||Race/Ethnicity, Customized|American Indian or Alaska Native|participants|Number|4|4.0||||||
4163571|NCT00833638|3985176|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|American Indian or Alaska Native|participants|Number|0|0.0||||||
4163572|NCT00833638|3985177|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|American Indian or Alaska Native|participants|Number|0|0.0||||||
4163573|NCT00833638|3985178|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|American Indian or Alaska Native|participants|Number|4|4.0||||||
4163574|NCT00833638|3985175|B4||Male|Sex: Female, Male||Participants|Count of Participants|372|372.0||||||
4163575|NCT00833638|3985176|B3||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4163576|NCT00833638|3985177|B2||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4163577|NCT00833638|3985178|B1||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4163578|NCT00833638|3985175|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4163579|NCT00833638|3985176|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4163580|NCT00833638|3985177|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4163581|NCT00833638|3985178|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4163584|NCT00833638|3985177|B2|||Age||years|Mean|57.68|57.68|Standard Deviation|11.07|11.07|||
4163585|NCT00833638|3985178|B1|||Age||years|Mean|59.63|59.63|Standard Deviation|10.02|10.02|||
4163586|NCT00833586|3985220|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
4163587|NCT00833586|3985221|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4163588|NCT00833586|3985222|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4163589|NCT00833586|3985220|B3|Biracial||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4163590|NCT00833586|3985221|B2|Biracial||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4163591|NCT00833586|3985222|B1|Biracial||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4163592|NCT00833586|3985220|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4163593|NCT00833586|3985221|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4163594|NCT00833586|3985222|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4163595|NCT00833586|3985220|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4163596|NCT00833586|3985221|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4163597|NCT00833586|3985222|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4163598|NCT00833586|3985220|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4163599|NCT00833586|3985221|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4163600|NCT00833586|3985222|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4163601|NCT00833586|3985220|B3|Black||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4163602|NCT00833586|3985221|B2|Black||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4163603|NCT00833586|3985222|B1|Black||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4163604|NCT00833586|3985220|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4163605|NCT00833586|3985221|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4163606|NCT00833586|3985222|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4163607|NCT00833586|3985220|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4163608|NCT00833586|3985221|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4163609|NCT00833586|3985222|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4163610|NCT00833586|3985220|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4163611|NCT00833586|3985221|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4163612|NCT00833586|3985222|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4163613|NCT00833586|3985220|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4163614|NCT00833586|3985221|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4163615|NCT00833586|3985222|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4163616|NCT00833586|3985220|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4163617|NCT00833586|3985221|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4163618|NCT00833586|3985222|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4163619|NCT00833560|3985231|B1||Male|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4163620|NCT00833560|3985231|B1||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4163621|NCT00833560|3985231|B1|>65 years||Age, Customized||Participants|Number|16|16.0||||||
4163622|NCT00833560|3985231|B1|Between 50 and 60 years||Age, Customized||Participants|Number|253|253.0||||||
4163623|NCT00833560|3985231|B1|Between 40 and 49 years||Age, Customized||Participants|Number|109|109.0||||||
4163624|NCT00833560|3985231|B1|Between 20 and 39 years||Age, Customized||Participants|Number|17|17.0||||||
4163625|NCT00833560|3985231|B1|||Age||Years|Mean|52.4|52.4|Standard Deviation|6.5|6.5|||
4163626|NCT00833547|3985238|B3|||sleep spindle density|spindles per minute during Stage 2 sleep|spindles per minute|Mean|1.3|1.3|Standard Deviation|.5|0.5|||
4163627|NCT00833547|3985239|B2|||sleep spindle density|spindles per minute during Stage 2 sleep|spindles per minute|Mean|1.08|1.08|Standard Deviation|.43|0.43|||
4163628|NCT00833547|3985240|B1|||sleep spindle density|spindles per minute during Stage 2 sleep|spindles per minute|Mean|1.57|1.57|Standard Deviation|.56|0.56|||
4163629|NCT00833547|3985238|B3|||Overnight change on finger tapping task|"The finger tapping task involves pressing four numerically labeled keys on a standard computer keyboard with the fingers of the left hand, repeating a five element sequence (4-1-3-2-4) as quickly and accurately as possible for 30s. During both training and test sessions, participants alternated tapping and resting for 30s for a total of 12 tapping trials. The measure was the number of correct sequences per trial. Overnight change was the percent change in correct sequences from the last three training trials to the first three test trials the following morning."|percent change|Mean|2|2.0|Standard Deviation|23|23.0|||
4163630|NCT00833547|3985239|B2|||Overnight change on finger tapping task|"The finger tapping task involves pressing four numerically labeled keys on a standard computer keyboard with the fingers of the left hand, repeating a five element sequence (4-1-3-2-4) as quickly and accurately as possible for 30s. During both training and test sessions, participants alternated tapping and resting for 30s for a total of 12 tapping trials. The measure was the number of correct sequences per trial. Overnight change was the percent change in correct sequences from the last three training trials to the first three test trials the following morning."|percent change|Mean|-5|-5.0|Standard Deviation|25|25.0|||
4163678|NCT00833482|3985261|B2|2/17||CYP2C19 Genotype of Participants|Genotypes with functional alleles indicative of extensive metabolizers=17/17, 1/17, 2/17, 3/17, 1/1, 1/2, and 1/3. Genotypes indicative of poor metabolizers=2/2, 2/3, and 3/3.|Participants|Number|0|0.0||||||
4163679|NCT00833482|3985262|B1|2/17||CYP2C19 Genotype of Participants|Genotypes with functional alleles indicative of extensive metabolizers=17/17, 1/17, 2/17, 3/17, 1/1, 1/2, and 1/3. Genotypes indicative of poor metabolizers=2/2, 2/3, and 3/3.|Participants|Number|1|1.0||||||
4163631|NCT00833547|3985240|B1|||Overnight change on finger tapping task|"The finger tapping task involves pressing four numerically labeled keys on a standard computer keyboard with the fingers of the left hand, repeating a five element sequence (4-1-3-2-4) as quickly and accurately as possible for 30s. During both training and test sessions, participants alternated tapping and resting for 30s for a total of 12 tapping trials. The measure was the number of correct sequences per trial. Overnight change was the percent change in correct sequences from the last three training trials to the first three test trials the following morning."|percent change|Mean|8|8.0|Standard Deviation|19|19.0|||
4163632|NCT00833547|3985238|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4163633|NCT00833547|3985239|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4163634|NCT00833547|3985240|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4163635|NCT00833547|3985238|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4163636|NCT00833547|3985239|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4163637|NCT00833547|3985240|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4163638|NCT00833547|3985238|B3|||Age||years|Mean|34|34.0|Standard Deviation|9|9.0|||
4163639|NCT00833547|3985239|B2|||Age||years|Mean|34|34.0|Standard Deviation|9|9.0|||
4163640|NCT00833547|3985240|B1|||Age||years|Mean|35|35.0|Standard Deviation|10|10.0|||
4163641|NCT00833521|3985249|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
4163642|NCT00833521|3985250|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4163643|NCT00833521|3985251|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4163644|NCT00833521|3985249|B3|Black||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4163645|NCT00833521|3985250|B2|Black||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4163646|NCT00833521|3985251|B1|Black||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4163647|NCT00833521|3985249|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4163648|NCT00833521|3985250|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4163649|NCT00833521|3985251|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4163650|NCT00833521|3985249|B3|American Indian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4163651|NCT00833521|3985250|B2|American Indian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4163652|NCT00833521|3985251|B1|American Indian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4163653|NCT00833521|3985249|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
4163654|NCT00833521|3985250|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4163655|NCT00833521|3985251|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4163656|NCT00833521|3985249|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4163657|NCT00833521|3985250|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4163658|NCT00833521|3985251|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4163659|NCT00833521|3985249|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4163660|NCT00833521|3985250|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4163661|NCT00833521|3985251|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4163662|NCT00833521|3985249|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4163663|NCT00833521|3985250|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4163664|NCT00833521|3985251|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4163665|NCT00833521|3985249|B3||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4163666|NCT00833521|3985250|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4163667|NCT00833521|3985251|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4163668|NCT00833521|3985249|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4163669|NCT00833521|3985250|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4163670|NCT00833521|3985251|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4163671|NCT00833482|3985260|B3|3/3||CYP2C19 Genotype of Participants|Genotypes with functional alleles indicative of extensive metabolizers=17/17, 1/17, 2/17, 3/17, 1/1, 1/2, and 1/3. Genotypes indicative of poor metabolizers=2/2, 2/3, and 3/3.|Participants|Number|1|1.0||||||
4163672|NCT00833482|3985261|B2|3/3||CYP2C19 Genotype of Participants|Genotypes with functional alleles indicative of extensive metabolizers=17/17, 1/17, 2/17, 3/17, 1/1, 1/2, and 1/3. Genotypes indicative of poor metabolizers=2/2, 2/3, and 3/3.|Participants|Number|1|1.0||||||
4163673|NCT00833482|3985262|B1|3/3||CYP2C19 Genotype of Participants|Genotypes with functional alleles indicative of extensive metabolizers=17/17, 1/17, 2/17, 3/17, 1/1, 1/2, and 1/3. Genotypes indicative of poor metabolizers=2/2, 2/3, and 3/3.|Participants|Number|0|0.0||||||
4163674|NCT00833482|3985260|B3|17/17||CYP2C19 Genotype of Participants|Genotypes with functional alleles indicative of extensive metabolizers=17/17, 1/17, 2/17, 3/17, 1/1, 1/2, and 1/3. Genotypes indicative of poor metabolizers=2/2, 2/3, and 3/3.|Participants|Number|1|1.0||||||
4163675|NCT00833482|3985261|B2|17/17||CYP2C19 Genotype of Participants|Genotypes with functional alleles indicative of extensive metabolizers=17/17, 1/17, 2/17, 3/17, 1/1, 1/2, and 1/3. Genotypes indicative of poor metabolizers=2/2, 2/3, and 3/3.|Participants|Number|0|0.0||||||
4163676|NCT00833482|3985262|B1|17/17||CYP2C19 Genotype of Participants|Genotypes with functional alleles indicative of extensive metabolizers=17/17, 1/17, 2/17, 3/17, 1/1, 1/2, and 1/3. Genotypes indicative of poor metabolizers=2/2, 2/3, and 3/3.|Participants|Number|1|1.0||||||
4163677|NCT00833482|3985260|B3|2/17||CYP2C19 Genotype of Participants|Genotypes with functional alleles indicative of extensive metabolizers=17/17, 1/17, 2/17, 3/17, 1/1, 1/2, and 1/3. Genotypes indicative of poor metabolizers=2/2, 2/3, and 3/3.|Participants|Number|1|1.0||||||
4163722|NCT00833469|3985323|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4163680|NCT00833482|3985260|B3|2/3||CYP2C19 Genotype of Participants|Genotypes with functional alleles indicative of extensive metabolizers=17/17, 1/17, 2/17, 3/17, 1/1, 1/2, and 1/3. Genotypes indicative of poor metabolizers=2/2, 2/3, and 3/3.|Participants|Number|1|1.0||||||
4163681|NCT00833482|3985261|B2|2/3||CYP2C19 Genotype of Participants|Genotypes with functional alleles indicative of extensive metabolizers=17/17, 1/17, 2/17, 3/17, 1/1, 1/2, and 1/3. Genotypes indicative of poor metabolizers=2/2, 2/3, and 3/3.|Participants|Number|1|1.0||||||
4163682|NCT00833482|3985262|B1|2/3||CYP2C19 Genotype of Participants|Genotypes with functional alleles indicative of extensive metabolizers=17/17, 1/17, 2/17, 3/17, 1/1, 1/2, and 1/3. Genotypes indicative of poor metabolizers=2/2, 2/3, and 3/3.|Participants|Number|0|0.0||||||
4163683|NCT00833482|3985260|B3|2/2||CYP2C19 Genotype of Participants|Genotypes with functional alleles indicative of extensive metabolizers=17/17, 1/17, 2/17, 3/17, 1/1, 1/2, and 1/3. Genotypes indicative of poor metabolizers=2/2, 2/3, and 3/3.|Participants|Number|6|6.0||||||
4163684|NCT00833482|3985261|B2|2/2||CYP2C19 Genotype of Participants|Genotypes with functional alleles indicative of extensive metabolizers=17/17, 1/17, 2/17, 3/17, 1/1, 1/2, and 1/3. Genotypes indicative of poor metabolizers=2/2, 2/3, and 3/3.|Participants|Number|6|6.0||||||
4163685|NCT00833482|3985262|B1|2/2||CYP2C19 Genotype of Participants|Genotypes with functional alleles indicative of extensive metabolizers=17/17, 1/17, 2/17, 3/17, 1/1, 1/2, and 1/3. Genotypes indicative of poor metabolizers=2/2, 2/3, and 3/3.|Participants|Number|0|0.0||||||
4163686|NCT00833482|3985260|B3|1/17||CYP2C19 Genotype of Participants|Genotypes with functional alleles indicative of extensive metabolizers=17/17, 1/17, 2/17, 3/17, 1/1, 1/2, and 1/3. Genotypes indicative of poor metabolizers=2/2, 2/3, and 3/3.|Participants|Number|6|6.0||||||
4163687|NCT00833482|3985261|B2|1/17||CYP2C19 Genotype of Participants|Genotypes with functional alleles indicative of extensive metabolizers=17/17, 1/17, 2/17, 3/17, 1/1, 1/2, and 1/3. Genotypes indicative of poor metabolizers=2/2, 2/3, and 3/3.|Participants|Number|0|0.0||||||
4163688|NCT00833482|3985262|B1|1/17||CYP2C19 Genotype of Participants|Genotypes with functional alleles indicative of extensive metabolizers=17/17, 1/17, 2/17, 3/17, 1/1, 1/2, and 1/3. Genotypes indicative of poor metabolizers=2/2, 2/3, and 3/3.|Participants|Number|6|6.0||||||
4163689|NCT00833482|3985260|B3|1/2||CYP2C19 Genotype of Participants|Genotypes with functional alleles indicative of extensive metabolizers=17/17, 1/17, 2/17, 3/17, 1/1, 1/2, and 1/3. Genotypes indicative of poor metabolizers=2/2, 2/3, and 3/3.|Participants|Number|5|5.0||||||
4163690|NCT00833482|3985261|B2|1/2||CYP2C19 Genotype of Participants|Genotypes with functional alleles indicative of extensive metabolizers=17/17, 1/17, 2/17, 3/17, 1/1, 1/2, and 1/3. Genotypes indicative of poor metabolizers=2/2, 2/3, and 3/3.|Participants|Number|0|0.0||||||
4163691|NCT00833482|3985262|B1|1/2||CYP2C19 Genotype of Participants|Genotypes with functional alleles indicative of extensive metabolizers=17/17, 1/17, 2/17, 3/17, 1/1, 1/2, and 1/3. Genotypes indicative of poor metabolizers=2/2, 2/3, and 3/3.|Participants|Number|5|5.0||||||
4163692|NCT00833482|3985260|B3|1/1||CYP2C19 Genotype of Participants|Genotypes with functional alleles indicative of extensive metabolizers=17/17, 1/17, 2/17, 3/17, 1/1, 1/2, and 1/3. Genotypes indicative of poor metabolizers=2/2, 2/3, and 3/3.|Participants|Number|11|11.0||||||
4163693|NCT00833482|3985261|B2|1/1||CYP2C19 Genotype of Participants|Genotypes with functional alleles indicative of extensive metabolizers=17/17, 1/17, 2/17, 3/17, 1/1, 1/2, and 1/3. Genotypes indicative of poor metabolizers=2/2, 2/3, and 3/3.|Participants|Number|0|0.0||||||
4163694|NCT00833482|3985262|B1|1/1||CYP2C19 Genotype of Participants|Genotypes with functional alleles indicative of extensive metabolizers=17/17, 1/17, 2/17, 3/17, 1/1, 1/2, and 1/3. Genotypes indicative of poor metabolizers=2/2, 2/3, and 3/3.|Participants|Number|11|11.0||||||
4163695|NCT00833482|3985260|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4163696|NCT00833482|3985261|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4163697|NCT00833482|3985262|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4163698|NCT00833482|3985260|B3|Not reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4163699|NCT00833482|3985261|B2|Not reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4163700|NCT00833482|3985262|B1|Not reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4163701|NCT00833482|3985260|B3|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4163702|NCT00833482|3985261|B2|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4163703|NCT00833482|3985262|B1|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4163704|NCT00833482|3985260|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4163705|NCT00833482|3985261|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4163706|NCT00833482|3985262|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4163707|NCT00833482|3985260|B3|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4163708|NCT00833482|3985261|B2|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4163709|NCT00833482|3985262|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4163710|NCT00833482|3985260|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4163711|NCT00833482|3985261|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4163712|NCT00833482|3985262|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4163713|NCT00833482|3985260|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4163714|NCT00833482|3985261|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4163715|NCT00833482|3985262|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4163716|NCT00833482|3985260|B3|||Age||years|Mean|31|31.0|Standard Deviation|9|9.0|||
4163717|NCT00833482|3985261|B2|||Age||years|Mean|30|30.0|Standard Deviation|7|7.0|||
4163718|NCT00833482|3985262|B1|||Age||years|Mean|31|31.0|Standard Deviation|10|10.0|||
4163719|NCT00833469|3985323|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4163720|NCT00833469|3985323|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163721|NCT00833469|3985323|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4163723|NCT00833469|3985323|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4163724|NCT00833469|3985323|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163725|NCT00833469|3985323|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4163726|NCT00833469|3985323|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163727|NCT00833469|3985323|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163728|NCT00833469|3985323|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163729|NCT00833469|3985323|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163730|NCT00833469|3985323|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4163731|NCT00833469|3985323|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4163732|NCT00833469|3985323|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4163733|NCT00833469|3985323|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4163734|NCT00833469|3985323|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4163735|NCT00833443|3985329|B3|United States||Region of Enrollment||participants|Number|84|84.0||||||
4163736|NCT00833443|3985330|B2|United States||Region of Enrollment||participants|Number|43|43.0||||||
4163737|NCT00833443|3985331|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4163738|NCT00833443|3985329|B3|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4163739|NCT00833443|3985330|B2|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4163740|NCT00833443|3985331|B1|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4163741|NCT00833443|3985329|B3|African American||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4163742|NCT00833443|3985330|B2|African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4163743|NCT00833443|3985331|B1|African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4163744|NCT00833443|3985329|B3|White||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4163745|NCT00833443|3985330|B2|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4163746|NCT00833443|3985331|B1|White||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4163747|NCT00833443|3985329|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4163748|NCT00833443|3985330|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4163749|NCT00833443|3985331|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4163750|NCT00833443|3985329|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4163751|NCT00833443|3985330|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4163752|NCT00833443|3985331|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4163753|NCT00833443|3985329|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4163754|NCT00833443|3985330|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4163755|NCT00833443|3985331|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4163756|NCT00833443|3985329|B3|||Age||years|Mean|38.4|38.4|Standard Deviation|10.1|10.1|||
4163757|NCT00833443|3985330|B2|||Age||years|Mean|38.1|38.1|Standard Deviation|10.3|10.3|||
4163758|NCT00833443|3985331|B1|||Age||years|Mean|38.6|38.6|Standard Deviation|10.1|10.1|||
4163759|NCT00833417|3985344|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4163760|NCT00833417|3985345|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4163761|NCT00833417|3985346|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4163762|NCT00833417|3985344|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4163763|NCT00833417|3985345|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4163764|NCT00833417|3985346|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4163765|NCT00833417|3985344|B3|||Age||years|Mean|61.4|61.4|Standard Deviation|15.2|15.2|||
4163766|NCT00833417|3985345|B2|||Age||years|Mean|61.2|61.2|Standard Deviation|16.8|16.8|||
4163767|NCT00833417|3985346|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|11.4|11.4|||
4163768|NCT00833365|3985360|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4163769|NCT00833365|3985361|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4163770|NCT00833365|3985362|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4163771|NCT00833365|3985360|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4163772|NCT00833365|3985361|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4163773|NCT00833365|3985362|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4163774|NCT00833365|3985360|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4163775|NCT00833365|3985361|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4163776|NCT00833365|3985362|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4163777|NCT00833365|3985360|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4163778|NCT00833365|3985361|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4163779|NCT00833365|3985362|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4163780|NCT00833365|3985360|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4163781|NCT00833365|3985361|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4163782|NCT00833365|3985362|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4163783|NCT00833365|3985360|B3||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4163784|NCT00833365|3985361|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4163785|NCT00833365|3985362|B1||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4163786|NCT00833248|3985371|B3|||Quality of Life (QoL) Related to Urinary Symptoms|FAS. The IPSS questionnaire included an additional single question to assess the participant's QoL in relation to his urinary symptoms. The question was: 'If you were to spend the rest of your life with your urinary condition the way it is now, how would you feel about that?' The possible answers to this question ranged from 'delighted' (a score of '0') to 'terrible' (a score of '6').|scores on a scale|Mean|2.19|2.19|Standard Deviation|1.62|1.62|||
4163787|NCT00833248|3985372|B2|||Quality of Life (QoL) Related to Urinary Symptoms|FAS. The IPSS questionnaire included an additional single question to assess the participant's QoL in relation to his urinary symptoms. The question was: 'If you were to spend the rest of your life with your urinary condition the way it is now, how would you feel about that?' The possible answers to this question ranged from 'delighted' (a score of '0') to 'terrible' (a score of '6').|scores on a scale|Mean|1.94|1.94|Standard Deviation|1.56|1.56|||
4163788|NCT00833248|3985373|B1|||Quality of Life (QoL) Related to Urinary Symptoms|FAS. The IPSS questionnaire included an additional single question to assess the participant's QoL in relation to his urinary symptoms. The question was: 'If you were to spend the rest of your life with your urinary condition the way it is now, how would you feel about that?' The possible answers to this question ranged from 'delighted' (a score of '0') to 'terrible' (a score of '6').|scores on a scale|Mean|2.27|2.27|Standard Deviation|1.63|1.63|||
4163789|NCT00833248|3985371|B3|||Total International Prostate Symptom Score (IPSS)|FAS. The IPSS is a tool commonly used to assess the severity of lower urinary tract symptoms (LUTS), and to monitor the progress of the disease once treatment has been initiated. The participant completes a questionnaire containing 7 questions regarding incomplete emptying, frequency, intermittency, urgency, weak stream, straining, and nocturia. Each question is assigned a score of 0-5. The total score is then classified according to the following scale: 0 to 7 = mildly symptomatic; 8 to 19 = moderately symptomatic; and 20 to 35 = severely symptomatic.|scores on a scale|Mean|9.23|9.23|Standard Deviation|6.61|6.61|||
4163790|NCT00833248|3985372|B2|||Total International Prostate Symptom Score (IPSS)|FAS. The IPSS is a tool commonly used to assess the severity of lower urinary tract symptoms (LUTS), and to monitor the progress of the disease once treatment has been initiated. The participant completes a questionnaire containing 7 questions regarding incomplete emptying, frequency, intermittency, urgency, weak stream, straining, and nocturia. Each question is assigned a score of 0-5. The total score is then classified according to the following scale: 0 to 7 = mildly symptomatic; 8 to 19 = moderately symptomatic; and 20 to 35 = severely symptomatic.|scores on a scale|Mean|8.46|8.46|Standard Deviation|6.3|6.3|||
4163791|NCT00833248|3985373|B1|||Total International Prostate Symptom Score (IPSS)|FAS. The IPSS is a tool commonly used to assess the severity of lower urinary tract symptoms (LUTS), and to monitor the progress of the disease once treatment has been initiated. The participant completes a questionnaire containing 7 questions regarding incomplete emptying, frequency, intermittency, urgency, weak stream, straining, and nocturia. Each question is assigned a score of 0-5. The total score is then classified according to the following scale: 0 to 7 = mildly symptomatic; 8 to 19 = moderately symptomatic; and 20 to 35 = severely symptomatic.|scores on a scale|Mean|9.5|9.5|Standard Deviation|6.71|6.71|||
4163792|NCT00833248|3985371|B3|||Prostate Volume|FAS. Prostate volume was measured with a Trans Rectal Ultrasound Scan (TRUS).|milliliter|Mean|51.3|51.3|Standard Deviation|19.9|19.9|||
4163793|NCT00833248|3985372|B2|||Prostate Volume|FAS. Prostate volume was measured with a Trans Rectal Ultrasound Scan (TRUS).|milliliter|Mean|52.5|52.5|Standard Deviation|18.8|18.8|||
4163794|NCT00833248|3985373|B1|||Prostate Volume|FAS. Prostate volume was measured with a Trans Rectal Ultrasound Scan (TRUS).|milliliter|Mean|50.9|50.9|Standard Deviation|20.3|20.3|||
4163795|NCT00833248|3985371|B3|||Serum Oestradiol Levels|FAS.|nanograms per deciliter|Median|1.9|1.9|Full Range|||0.74|4.4|
4163796|NCT00833248|3985372|B2|||Serum Oestradiol Levels|FAS.|nanograms per deciliter|Median|1.9|1.9|Full Range|||1.0|3.6|
4163797|NCT00833248|3985373|B1|||Serum Oestradiol Levels|FAS.|nanograms per deciliter|Median|1.9|1.9|Full Range|||0.74|4.4|
4163798|NCT00833248|3985371|B3|||Serum Prostate-Specific Antigen (PSA) Levels|FAS.|nanograms per millilter|Median|9.95|9.95|Full Range|||2.5|339.0|
4163799|NCT00833248|3985372|B2|||Serum Prostate-Specific Antigen (PSA) Levels|FAS.|nanograms per millilter|Median|9.75|9.75|Full Range|||2.9|80.0|
4163800|NCT00833248|3985373|B1|||Serum Prostate-Specific Antigen (PSA) Levels|FAS.|nanograms per millilter|Median|10|10.0|Full Range|||2.5|339.0|
4163801|NCT00833248|3985371|B3|||Serum Testosterone Levels|FAS.|nanograms per milliliter|Median|4.06|4.06|Full Range|||0.188|11.2|
4163802|NCT00833248|3985372|B2|||Serum Testosterone Levels|FAS.|nanograms per milliliter|Median|4.42|4.42|Full Range|||0.188|8.16|
4163803|NCT00833248|3985373|B1|||Serum Testosterone Levels|FAS.|nanograms per milliliter|Median|3.92|3.92|Full Range|||0.557|11.2|
4163804|NCT00833248|3985371|B3|Not Classifiable||Stage of Prostate Cancer|FAS. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. Some participants did not have their prostate cancer classified for the complete TNM scale (9 participants).|participants|Number|9|9.0||||||
4163805|NCT00833248|3985372|B2|Not Classifiable||Stage of Prostate Cancer|FAS. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. Some participants did not have their prostate cancer classified for the complete TNM scale (9 participants).|participants|Number|3|3.0||||||
4163821|NCT00833248|3985373|B1|Gleason Score 7||Gleason Score|FAS. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|97|97.0||||||
4163875|NCT00833248|3985373|B1||Male|Sex: Female, Male|FAS.|Participants|Count of Participants|180|180.0||||||
4163806|NCT00833248|3985373|B1|Not Classifiable||Stage of Prostate Cancer|FAS. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. Some participants did not have their prostate cancer classified for the complete TNM scale (9 participants).|participants|Number|6|6.0||||||
4163807|NCT00833248|3985371|B3|Metastatic||Stage of Prostate Cancer|FAS. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. Some participants did not have their prostate cancer classified for the complete TNM scale (9 participants).|participants|Number|0|0.0||||||
4163808|NCT00833248|3985372|B2|Metastatic||Stage of Prostate Cancer|FAS. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. Some participants did not have their prostate cancer classified for the complete TNM scale (9 participants).|participants|Number|0|0.0||||||
4163809|NCT00833248|3985373|B1|Metastatic||Stage of Prostate Cancer|FAS. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. Some participants did not have their prostate cancer classified for the complete TNM scale (9 participants).|participants|Number|0|0.0||||||
4163810|NCT00833248|3985371|B3|Locally Advanced||Stage of Prostate Cancer|FAS. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. Some participants did not have their prostate cancer classified for the complete TNM scale (9 participants).|participants|Number|83|83.0||||||
4163811|NCT00833248|3985372|B2|Locally Advanced||Stage of Prostate Cancer|FAS. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. Some participants did not have their prostate cancer classified for the complete TNM scale (9 participants).|participants|Number|20|20.0||||||
4163812|NCT00833248|3985373|B1|Locally Advanced||Stage of Prostate Cancer|FAS. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. Some participants did not have their prostate cancer classified for the complete TNM scale (9 participants).|participants|Number|63|63.0||||||
4163813|NCT00833248|3985371|B3|Localized||Stage of Prostate Cancer|FAS. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. Some participants did not have their prostate cancer classified for the complete TNM scale (9 participants).|participants|Number|152|152.0||||||
4163814|NCT00833248|3985372|B2|Localized||Stage of Prostate Cancer|FAS. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. Some participants did not have their prostate cancer classified for the complete TNM scale (9 participants).|participants|Number|41|41.0||||||
4163815|NCT00833248|3985373|B1|Localized||Stage of Prostate Cancer|FAS. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. Some participants did not have their prostate cancer classified for the complete TNM scale (9 participants).|participants|Number|111|111.0||||||
4163816|NCT00833248|3985371|B3|Gleason Score 8-10||Gleason Score|FAS. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|52|52.0||||||
4163817|NCT00833248|3985372|B2|Gleason Score 8-10||Gleason Score|FAS. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|10|10.0||||||
4163818|NCT00833248|3985373|B1|Gleason Score 8-10||Gleason Score|FAS. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|42|42.0||||||
4163819|NCT00833248|3985371|B3|Gleason Score 7||Gleason Score|FAS. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|139|139.0||||||
4163820|NCT00833248|3985372|B2|Gleason Score 7||Gleason Score|FAS. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|42|42.0||||||
4163822|NCT00833248|3985371|B3|Gleason Score 2-6||Gleason Score|FAS. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|53|53.0||||||
4163823|NCT00833248|3985372|B2|Gleason Score 2-6||Gleason Score|FAS. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|12|12.0||||||
4163824|NCT00833248|3985373|B1|Gleason Score 2-6||Gleason Score|FAS. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|41|41.0||||||
4163825|NCT00833248|3985371|B3|||Body Mass Index|FAS.|kilogram per square meter|Mean|27.5|27.5|Standard Deviation|3.93|3.93|||
4163826|NCT00833248|3985372|B2|||Body Mass Index|FAS.|kilogram per square meter|Mean|26.8|26.8|Standard Deviation|3.69|3.69|||
4163827|NCT00833248|3985373|B1|||Body Mass Index|FAS.|kilogram per square meter|Mean|27.8|27.8|Standard Deviation|3.99|3.99|||
4163828|NCT00833248|3985371|B3|||Body Weight|FAS.|kilogram|Mean|82.9|82.9|Standard Deviation|13.8|13.8|||
4163829|NCT00833248|3985372|B2|||Body Weight|FAS.|kilogram|Mean|80.9|80.9|Standard Deviation|12.4|12.4|||
4163830|NCT00833248|3985373|B1|||Body Weight|FAS.|kilogram|Mean|83.6|83.6|Standard Deviation|14.2|14.2|||
4163831|NCT00833248|3985371|B3|United Kingdom||Region of Enrollment|FAS.|participants|Number|56|56.0||||||
4163832|NCT00833248|3985372|B2|United Kingdom||Region of Enrollment|FAS.|participants|Number|15|15.0||||||
4163833|NCT00833248|3985373|B1|United Kingdom||Region of Enrollment|FAS.|participants|Number|41|41.0||||||
4163834|NCT00833248|3985371|B3|Germany||Region of Enrollment|FAS.|participants|Number|13|13.0||||||
4163835|NCT00833248|3985372|B2|Germany||Region of Enrollment|FAS.|participants|Number|4|4.0||||||
4163836|NCT00833248|3985373|B1|Germany||Region of Enrollment|FAS.|participants|Number|9|9.0||||||
4163837|NCT00833248|3985371|B3|Netherlands||Region of Enrollment|FAS.|participants|Number|13|13.0||||||
4163838|NCT00833248|3985372|B2|Netherlands||Region of Enrollment|FAS.|participants|Number|2|2.0||||||
4163839|NCT00833248|3985373|B1|Netherlands||Region of Enrollment|FAS.|participants|Number|11|11.0||||||
4163840|NCT00833248|3985371|B3|Spain||Region of Enrollment|FAS.|participants|Number|12|12.0||||||
4163841|NCT00833248|3985372|B2|Spain||Region of Enrollment|FAS.|participants|Number|3|3.0||||||
4163842|NCT00833248|3985373|B1|Spain||Region of Enrollment|FAS.|participants|Number|9|9.0||||||
4163843|NCT00833248|3985371|B3|Greece||Region of Enrollment|FAS.|participants|Number|7|7.0||||||
4163844|NCT00833248|3985372|B2|Greece||Region of Enrollment|FAS.|participants|Number|2|2.0||||||
4163845|NCT00833248|3985373|B1|Greece||Region of Enrollment|FAS.|participants|Number|5|5.0||||||
4163846|NCT00833248|3985371|B3|France||Region of Enrollment|FAS.|participants|Number|82|82.0||||||
4163847|NCT00833248|3985372|B2|France||Region of Enrollment|FAS.|participants|Number|22|22.0||||||
4163848|NCT00833248|3985373|B1|France||Region of Enrollment|FAS.|participants|Number|60|60.0||||||
4163849|NCT00833248|3985371|B3|United States||Region of Enrollment|FAS.|participants|Number|61|61.0||||||
4163850|NCT00833248|3985372|B2|United States||Region of Enrollment|FAS.|participants|Number|16|16.0||||||
4163851|NCT00833248|3985373|B1|United States||Region of Enrollment|FAS.|participants|Number|45|45.0||||||
4163852|NCT00833248|3985371|B3||Unknown or Not Reported|Race (NIH/OMB)|FAS.|Participants|Count of Participants|0|0.0||||||
4163853|NCT00833248|3985372|B2||Unknown or Not Reported|Race (NIH/OMB)|FAS.|Participants|Count of Participants|0|0.0||||||
4163854|NCT00833248|3985373|B1||Unknown or Not Reported|Race (NIH/OMB)|FAS.|Participants|Count of Participants|0|0.0||||||
4163855|NCT00833248|3985371|B3||More than one race|Race (NIH/OMB)|FAS.|Participants|Count of Participants|0|0.0||||||
4163856|NCT00833248|3985372|B2||More than one race|Race (NIH/OMB)|FAS.|Participants|Count of Participants|0|0.0||||||
4163857|NCT00833248|3985373|B1||More than one race|Race (NIH/OMB)|FAS.|Participants|Count of Participants|0|0.0||||||
4163858|NCT00833248|3985371|B3||White|Race (NIH/OMB)|FAS.|Participants|Count of Participants|224|224.0||||||
4163859|NCT00833248|3985372|B2||White|Race (NIH/OMB)|FAS.|Participants|Count of Participants|61|61.0||||||
4163860|NCT00833248|3985373|B1||White|Race (NIH/OMB)|FAS.|Participants|Count of Participants|163|163.0||||||
4163861|NCT00833248|3985371|B3||Black or African American|Race (NIH/OMB)|FAS.|Participants|Count of Participants|18|18.0||||||
4163862|NCT00833248|3985372|B2||Black or African American|Race (NIH/OMB)|FAS.|Participants|Count of Participants|3|3.0||||||
4163863|NCT00833248|3985373|B1||Black or African American|Race (NIH/OMB)|FAS.|Participants|Count of Participants|15|15.0||||||
4163864|NCT00833248|3985371|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|FAS.|Participants|Count of Participants|0|0.0||||||
4163865|NCT00833248|3985372|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|FAS.|Participants|Count of Participants|0|0.0||||||
4163866|NCT00833248|3985373|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|FAS.|Participants|Count of Participants|0|0.0||||||
4163867|NCT00833248|3985371|B3||Asian|Race (NIH/OMB)|FAS.|Participants|Count of Participants|1|1.0||||||
4163868|NCT00833248|3985372|B2||Asian|Race (NIH/OMB)|FAS.|Participants|Count of Participants|0|0.0||||||
4163869|NCT00833248|3985373|B1||Asian|Race (NIH/OMB)|FAS.|Participants|Count of Participants|1|1.0||||||
4163870|NCT00833248|3985371|B3||American Indian or Alaska Native|Race (NIH/OMB)|FAS.|Participants|Count of Participants|1|1.0||||||
4163871|NCT00833248|3985372|B2||American Indian or Alaska Native|Race (NIH/OMB)|FAS.|Participants|Count of Participants|0|0.0||||||
4163872|NCT00833248|3985373|B1||American Indian or Alaska Native|Race (NIH/OMB)|FAS.|Participants|Count of Participants|1|1.0||||||
4163873|NCT00833248|3985371|B3||Male|Sex: Female, Male|FAS.|Participants|Count of Participants|244|244.0||||||
4163874|NCT00833248|3985372|B2||Male|Sex: Female, Male|FAS.|Participants|Count of Participants|64|64.0||||||
4163876|NCT00833248|3985371|B3||Female|Sex: Female, Male|FAS.|Participants|Count of Participants|0|0.0||||||
4163877|NCT00833248|3985372|B2||Female|Sex: Female, Male|FAS.|Participants|Count of Participants|0|0.0||||||
4163878|NCT00833248|3985373|B1||Female|Sex: Female, Male|FAS.|Participants|Count of Participants|0|0.0||||||
4163879|NCT00833248|3985371|B3|||Age|Full analysis set (FAS).|years|Mean|70.6|70.6|Standard Deviation|6.25|6.25|||
4163880|NCT00833248|3985372|B2|||Age|Full analysis set (FAS).|years|Mean|70.8|70.8|Standard Deviation|5.96|5.96|||
4163881|NCT00833248|3985373|B1|||Age|Full analysis set (FAS).|years|Mean|70.6|70.6|Standard Deviation|6.37|6.37|||
4163882|NCT00833092|3985396|B3|United States||Region of Enrollment||participants|Number|111|111.0||||||
4163883|NCT00833092|3985397|B2|United States||Region of Enrollment||participants|Number|57|57.0||||||
4163884|NCT00833092|3985398|B1|United States||Region of Enrollment||participants|Number|54|54.0||||||
4163885|NCT00833092|3985396|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4163886|NCT00833092|3985397|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4163887|NCT00833092|3985398|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4163888|NCT00833092|3985396|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4163889|NCT00833092|3985397|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4163890|NCT00833092|3985398|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4163891|NCT00833092|3985396|B3|||Age||years|Mean|59.3|59.3|Standard Deviation|7.5|7.5|||
4163892|NCT00833092|3985397|B2|||Age||years|Mean|58.2|58.2|Standard Deviation|6.2|6.2|||
4163893|NCT00833092|3985398|B1|||Age||years|Mean|60.4|60.4|Standard Deviation|8.7|8.7|||
4163894|NCT00833092|3985396|B3||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4163895|NCT00833092|3985397|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4163896|NCT00833092|3985398|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4163897|NCT00833092|3985396|B3||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
4163898|NCT00833092|3985397|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4163899|NCT00833092|3985398|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4163900|NCT00833092|3985396|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4163901|NCT00833092|3985397|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4163902|NCT00833092|3985398|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4163903|NCT00833053|3985405|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4163904|NCT00833053|3985406|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4163905|NCT00833053|3985407|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4163906|NCT00833053|3985405|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4163907|NCT00833053|3985406|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4163908|NCT00833053|3985407|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4163909|NCT00833053|3985405|B3|||Age||years|Mean|46.8|46.8|Standard Deviation|16.11|16.11|||
4163910|NCT00833053|3985406|B2|||Age||years|Mean|48.2|48.2|Standard Deviation|17.03|17.03|||
4163911|NCT00833053|3985407|B1|||Age||years|Mean|45.3|45.3|Standard Deviation|15.38|15.38|||
4163912|NCT00833040|3985426|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4163913|NCT00833040|3985426|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4163914|NCT00833040|3985426|B1|||Age||years|Mean|53.5|53.5|Standard Deviation|11.5|11.5|||
4163915|NCT00833027|3985436|B1|||Fasting plasma glucose||mmol/L|Mean|9.3|9.3|Standard Deviation|2.87|2.87|||
4163916|NCT00833027|3985436|B1|||Weight||Kilograms|Mean|92.6|92.6|Standard Deviation|24.42|24.42|||
4163917|NCT00833027|3985436|B1|||Hemoglobin A1c (HbA1c)||percent|Mean|7.73|7.73|Standard Deviation|1.11|1.11|||
4163918|NCT00833027|3985436|B1|Other||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4163919|NCT00833027|3985436|B1|Native Indian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4163920|NCT00833027|3985436|B1|Asian||Race/Ethnicity, Customized||participants|Number|73|73.0||||||
4163921|NCT00833027|3985436|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4163922|NCT00833027|3985436|B1|Black||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4163923|NCT00833027|3985436|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|491|491.0||||||
4163924|NCT00833027|3985436|B1||Male|Sex: Female, Male||Participants|Count of Participants|350|350.0||||||
4163925|NCT00833027|3985436|B1||Female|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
4163926|NCT00833027|3985436|B1|||Age||years|Mean|58.0|58.0|Standard Deviation|11.23|11.23|||
4163927|NCT00832975|3985441|B1||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4163928|NCT00832975|3985441|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4163929|NCT00832975|3985441|B1|||Age||years|Mean|61.67|61.67|Standard Deviation|13.39|13.39|||
4163930|NCT00832871|3985446|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4163931|NCT00832871|3985446|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4163932|NCT00832871|3985446|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4163933|NCT00832871|3985446|B1|||Age||years|Median|45|45.0|Full Range|||25.0|64.0|
4163934|NCT00832819|3985452|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4163935|NCT00832819|3985453|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4163936|NCT00832819|3985454|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4163937|NCT00832819|3985455|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4163938|NCT00832819|3985452|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4163939|NCT00832819|3985453|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4163940|NCT00832819|3985454|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4163941|NCT00832819|3985455|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4163942|NCT00832819|3985452|B4|||Age||Years|Mean|56.4|56.4|Standard Deviation|10.4|10.4|||
4163943|NCT00832819|3985453|B3|||Age||Years|Mean|58.4|58.4|Standard Deviation|11.2|11.2|||
4163944|NCT00832819|3985454|B2|||Age||Years|Mean|54.8|54.8|Standard Deviation|9.7|9.7|||
4163945|NCT00832819|3985455|B1|||Age||Years|Mean|52.8|52.8|Standard Deviation|9.3|9.3|||
4163946|NCT00832780|3985463|B1|United States||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
4163947|NCT00832780|3985463|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163948|NCT00832780|3985463|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163949|NCT00832780|3985463|B1||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4163950|NCT00832780|3985463|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4163951|NCT00832780|3985463|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163952|NCT00832780|3985463|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4163953|NCT00832780|3985463|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4163954|NCT00832780|3985463|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163955|NCT00832780|3985463|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4163956|NCT00832780|3985463|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4163957|NCT00832780|3985463|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4163958|NCT00832780|3985463|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4163959|NCT00832780|3985463|B1|||Age||years|Mean|68.42|68.42|Standard Deviation|9.98|9.98|||
4163960|NCT00832780|3985463|B1||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4163961|NCT00832780|3985463|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4163962|NCT00832780|3985463|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4163963|NCT00832767|3985471|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4163964|NCT00832767|3985472|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4163965|NCT00832767|3985473|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4163966|NCT00832767|3985471|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163967|NCT00832767|3985472|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163968|NCT00832767|3985473|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163969|NCT00832767|3985471|B3||White|Race (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
4163970|NCT00832767|3985472|B2||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4163971|NCT00832767|3985473|B1||White|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
4163972|NCT00832767|3985471|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4163973|NCT00832767|3985472|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4163974|NCT00832767|3985473|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4163975|NCT00832767|3985471|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163976|NCT00832767|3985472|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163977|NCT00832767|3985473|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163978|NCT00832767|3985471|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4163979|NCT00832767|3985472|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4163980|NCT00832767|3985473|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4163981|NCT00832767|3985471|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163982|NCT00832767|3985472|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163983|NCT00832767|3985473|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4163984|NCT00832767|3985471|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4163985|NCT00832767|3985472|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4163986|NCT00832767|3985473|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4163987|NCT00832767|3985471|B3||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4163988|NCT00832767|3985472|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4163989|NCT00832767|3985473|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4163990|NCT00832767|3985471|B3|||Age, Customized||years|Mean|44.9|44.9|Full Range|||18.0|77.0|
4163991|NCT00832767|3985472|B2|||Age, Customized||years|Mean|44.0|44.0|Full Range|||19.0|68.0|
4163992|NCT00832767|3985473|B1|||Age, Customized||years|Mean|45.8|45.8|Full Range|||18.0|77.0|
4163993|NCT00832650|3985502|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4163994|NCT00832650|3985503|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4163995|NCT00832650|3985504|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4163996|NCT00832650|3985505|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4163997|NCT00832650|3985502|B4||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4163998|NCT00832650|3985503|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4163999|NCT00832650|3985504|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4164000|NCT00832650|3985505|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4164001|NCT00832650|3985502|B4|greater than 45 years||Age, Customized||participants|Number|12|12.0||||||
4164002|NCT00832650|3985503|B3|greater than 45 years||Age, Customized||participants|Number|3|3.0||||||
4164003|NCT00832650|3985504|B2|greater than 45 years||Age, Customized||participants|Number|3|3.0||||||
4164004|NCT00832650|3985505|B1|greater than 45 years||Age, Customized||participants|Number|6|6.0||||||
4164005|NCT00832650|3985502|B4|36 to 45 years||Age, Customized||participants|Number|17|17.0||||||
4164006|NCT00832650|3985503|B3|36 to 45 years||Age, Customized||participants|Number|8|8.0||||||
4164007|NCT00832650|3985504|B2|36 to 45 years||Age, Customized||participants|Number|2|2.0||||||
4164008|NCT00832650|3985505|B1|36 to 45 years||Age, Customized||participants|Number|7|7.0||||||
4164009|NCT00832650|3985502|B4|26 to 35 years||Age, Customized||participants|Number|15|15.0||||||
4164010|NCT00832650|3985503|B3|26 to 35 years||Age, Customized||participants|Number|6|6.0||||||
4164011|NCT00832650|3985504|B2|26 to 35 years||Age, Customized||participants|Number|2|2.0||||||
4164012|NCT00832650|3985505|B1|26 to 35 years||Age, Customized||participants|Number|7|7.0||||||
4164013|NCT00832650|3985502|B4|18 to 25 years||Age, Customized||participants|Number|16|16.0||||||
4164014|NCT00832650|3985503|B3|18 to 25 years||Age, Customized||participants|Number|6|6.0||||||
4164015|NCT00832650|3985504|B2|18 to 25 years||Age, Customized||participants|Number|5|5.0||||||
4164016|NCT00832650|3985505|B1|18 to 25 years||Age, Customized||participants|Number|5|5.0||||||
4164017|NCT00832650|3985502|B4|less than 18 years||Age, Customized||participants|Number|0|0.0||||||
4164018|NCT00832650|3985503|B3|less than 18 years||Age, Customized||participants|Number|0|0.0||||||
4164019|NCT00832650|3985504|B2|less than 18 years||Age, Customized||participants|Number|0|0.0||||||
4164020|NCT00832650|3985505|B1|less than 18 years||Age, Customized||participants|Number|0|0.0||||||
4164021|NCT00832637|3985539|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4164022|NCT00832637|3985539|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4164023|NCT00832637|3985539|B1|||Age||years|Median|59|59.0|Full Range|||42.0|77.0|
4164024|NCT00832624|3985547|B1|||Weight||Kilograms|Mean|71.59|71.59|Standard Deviation|11.55|11.55|||
4164025|NCT00832624|3985547|B1|Brazil||Region of Enrollment||participants|Number|10|10.0||||||
4164026|NCT00832624|3985547|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4164027|NCT00832624|3985547|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4164028|NCT00832624|3985547|B1|||Age||years|Mean|51.7|51.7|Standard Deviation|14.0|14.0|||
4164029|NCT00832598|3985551|B1|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4164030|NCT00832598|3985551|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4164031|NCT00832598|3985551|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4164032|NCT00832598|3985551|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4164033|NCT00832598|3985551|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4164034|NCT00832598|3985551|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4164035|NCT00832598|3985551|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4164036|NCT00832598|3985551|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4164037|NCT00832598|3985551|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4164038|NCT00832598|3985551|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4164039|NCT00832598|3985551|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4164040|NCT00832598|3985551|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4164041|NCT00832598|3985551|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4164042|NCT00832598|3985551|B1|||Age||years|Median|46|46.0|Full Range|||34.0|70.0|
4164043|NCT00832585|3985557|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4164044|NCT00832585|3985557|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4164045|NCT00832585|3985557|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4164046|NCT00832585|3985557|B1|||Age||years|Mean|32.84|32.84|Standard Deviation|6.34|6.34|||
4164047|NCT00832585|3985557|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4164048|NCT00832585|3985557|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4164049|NCT00832585|3985557|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4164050|NCT00832572|3985562|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4164051|NCT00832572|3985563|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4164052|NCT00832572|3985564|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4164053|NCT00832572|3985562|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4164054|NCT00832572|3985563|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4164055|NCT00832572|3985564|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4164056|NCT00832572|3985562|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4164057|NCT00832572|3985563|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4164058|NCT00832572|3985564|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4164059|NCT00832572|3985562|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4164060|NCT00832572|3985563|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4164061|NCT00832572|3985564|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4164062|NCT00832572|3985562|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4164063|NCT00832572|3985563|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4164064|NCT00832572|3985564|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4164065|NCT00832520|3985577|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4164066|NCT00832520|3985577|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4164067|NCT00832520|3985577|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4164068|NCT00832520|3985577|B1|||Age||years|Mean|59|59.0|Standard Deviation|10|10.0|||
4164069|NCT00832520|3985577|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4164070|NCT00832520|3985577|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4164071|NCT00832520|3985577|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4164072|NCT00832455|3985582|B1|||Asthma Diagnosis Duration||Months|Mean|45.58|45.58|Standard Deviation|34.72|34.72|||
4164073|NCT00832455|3985582|B1|No Use||ICS (Inhaled Corticosteroids) Use||Participants|Number|97|97.0||||||
4164074|NCT00832455|3985582|B1|Use||ICS (Inhaled Corticosteroids) Use||Participants|Number|323|323.0||||||
4164075|NCT00832455|3985582|B1||Male|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
4164076|NCT00832455|3985582|B1||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4164077|NCT00832455|3985582|B1|||Age||years|Mean|7.00|7.0|Standard Deviation|3.33|3.33|||
4164078|NCT00832416|3985602|B5||Male|Sex: Female, Male||Participants|Count of Participants|224.0|224.0||||||
4164079|NCT00832416|3985603|B4||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4164080|NCT00832416|3985604|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4164081|NCT00832416|3985605|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4164082|NCT00832416|3985606|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4164083|NCT00832416|3985602|B5||Female|Sex: Female, Male||Participants|Count of Participants|341.0|341.0||||||
4164084|NCT00832416|3985603|B4||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4164085|NCT00832416|3985604|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4164086|NCT00832416|3985605|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4164087|NCT00832416|3985606|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4164088|NCT00832416|3985602|B5|||Age||years|Mean|60.4|60.4|Standard Deviation|9.3|9.3|||
4164089|NCT00832416|3985603|B4|||Age||years|Mean|60.6|60.6|Standard Deviation|9.6|9.6|||
4164090|NCT00832416|3985604|B3|||Age||years|Mean|61.0|61.0|Standard Deviation|9.6|9.6|||
4164091|NCT00832416|3985605|B2|||Age||years|Mean|59.8|59.8|Standard Deviation|8.4|8.4|||
4164092|NCT00832416|3985606|B1|||Age||years|Mean|59.8|59.8|Standard Deviation|9.0|9.0|||
4164093|NCT00832416|3985602|B5||>=65 years|Age||Participants|Count of Participants|214.0|214.0||||||
4164094|NCT00832416|3985603|B4||>=65 years|Age||Participants|Count of Participants|88|88.0||||||
4164095|NCT00832416|3985604|B3||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
4164096|NCT00832416|3985605|B2||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4164097|NCT00832416|3985606|B1||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
4164098|NCT00832416|3985602|B5||Between 18 and 65 years|Age||Participants|Count of Participants|351.0|351.0||||||
4164099|NCT00832416|3985603|B4||Between 18 and 65 years|Age||Participants|Count of Participants|139|139.0||||||
4164100|NCT00832416|3985604|B3||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4164101|NCT00832416|3985605|B2||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
4164102|NCT00832416|3985606|B1||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
4164103|NCT00832416|3985602|B5||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4164104|NCT00832416|3985603|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4164105|NCT00832416|3985604|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4164106|NCT00832416|3985605|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4164107|NCT00832416|3985606|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4164108|NCT00832390|3985647|B4|||Time Since Diagnosis of Diabetes||Years|Mean|5.82|5.82|Standard Deviation|6.25|6.25|||
4164109|NCT00832390|3985648|B3|||Time Since Diagnosis of Diabetes||Years|Mean|5.2|5.2|Standard Deviation|0.0|0.0|||
4164110|NCT00832390|3985649|B2|||Time Since Diagnosis of Diabetes||Years|Mean|6.2|6.2|Standard Deviation|6.0|6.0|||
4164111|NCT00832390|3985650|B1|||Time Since Diagnosis of Diabetes||Years|Mean|5.3|5.3|Standard Deviation|7.0|7.0|||
4164112|NCT00832390|3985647|B4|||Glycosylated Hemoglobin A1C (A1C)||Percent|Mean|7.96|7.96|Standard Deviation|1.33|1.33|||
4164113|NCT00832390|3985648|B3|||Glycosylated Hemoglobin A1C (A1C)||Percent|Mean|6.9|6.9|Standard Deviation|0.0|0.0|||
4164114|NCT00832390|3985649|B2|||Glycosylated Hemoglobin A1C (A1C)||Percent|Mean|8.6|8.6|Standard Deviation|1.4|1.4|||
4164115|NCT00832390|3985650|B1|||Glycosylated Hemoglobin A1C (A1C)||Percent|Mean|7.1|7.1|Standard Deviation|0.6|0.6|||
4164116|NCT00832390|3985647|B4|||Body Mass Index (BMI)||kg/m2|Mean|28.14|28.14|Standard Deviation|7.41|7.41|||
4164117|NCT00832390|3985648|B3|||Body Mass Index (BMI)||kg/m2|Mean|26.0|26.0|Standard Deviation|0.0|0.0|||
4164118|NCT00832390|3985649|B2|||Body Mass Index (BMI)||kg/m2|Mean|28.9|28.9|Standard Deviation|5.2|5.2|||
4164119|NCT00832390|3985650|B1|||Body Mass Index (BMI)||kg/m2|Mean|27.4|27.4|Standard Deviation|10.0|10.0|||
4164120|NCT00832390|3985647|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4164121|NCT00832390|3985648|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4164122|NCT00832390|3985649|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4164123|NCT00832390|3985650|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4164124|NCT00832390|3985647|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4164125|NCT00832390|3985648|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4164126|NCT00832390|3985649|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4164127|NCT00832390|3985650|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4164128|NCT00832390|3985647|B4|||Age||years|Mean|54.62|54.62|Standard Deviation|11.43|11.43|||
4164129|NCT00832390|3985648|B3|||Age||years|Mean|51.0|51.0|Standard Deviation|0.0|0.0|||
4164130|NCT00832390|3985649|B2|||Age||years|Mean|52.5|52.5|Standard Deviation|9.3|9.3|||
4164131|NCT00832390|3985650|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|14.1|14.1|||
4164132|NCT00832377|3985660|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4164133|NCT00832377|3985660|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4164134|NCT00832377|3985660|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|10.92|10.92|||
4164135|NCT00832338|3985667|B1|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4164136|NCT00832338|3985667|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4164137|NCT00832338|3985667|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4164138|NCT00832338|3985667|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4164139|NCT00832338|3985667|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4164140|NCT00832338|3985667|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4164141|NCT00832338|3985667|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4164142|NCT00832338|3985667|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4164143|NCT00832338|3985667|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4164144|NCT00832338|3985667|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4164145|NCT00832338|3985667|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4164146|NCT00832338|3985667|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4164147|NCT00832338|3985667|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4164148|NCT00832338|3985667|B1|||Age||years|Mean|54.91|54.91|Standard Deviation|9.69|9.69|||
4164149|NCT00832299|3985671|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4164150|NCT00832299|3985671|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4164151|NCT00832299|3985671|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4164152|NCT00832299|3985671|B1|||Age||years|Mean|40|40.0|Standard Deviation|10|10.0|||
4164153|NCT00832299|3985671|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4164154|NCT00832299|3985671|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4164155|NCT00832299|3985671|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4164156|NCT00832260|3985676|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4164157|NCT00832260|3985676|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4164158|NCT00832260|3985676|B1|||Age||years|Mean|73|73.0|Standard Deviation|8.4|8.4|||
4164159|NCT00832130|3985681|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4164160|NCT00832130|3985682|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4164161|NCT00832130|3985683|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4164162|NCT00832130|3985681|B3||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4164163|NCT00832130|3985682|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4164164|NCT00832130|3985683|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4164165|NCT00832130|3985681|B3|||Age||Years|Mean|53.4|53.4|Standard Deviation|15.5|15.5|||
4164166|NCT00832130|3985682|B2|||Age||Years|Mean|54.4|54.4|Standard Deviation|16.4|16.4|||
4164167|NCT00832130|3985683|B1|||Age||Years|Mean|52.4|52.4|Standard Deviation|14.6|14.6|||
4164168|NCT00832117|3985704|B3|100 - Normal no complaints; no evidence of disease||Karnofsky Performance Status|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|15|15.0||||||
4164169|NCT00832117|3985705|B2|100 - Normal no complaints; no evidence of disease||Karnofsky Performance Status|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|2|2.0||||||
4164170|NCT00832117|3985706|B1|100 - Normal no complaints; no evidence of disease||Karnofsky Performance Status|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|13|13.0||||||
4164171|NCT00832117|3985704|B3|90 - Normal activity; minor signs of disease||Karnofsky Performance Status|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|3|3.0||||||
4164228|NCT00832000|3985741|B1|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4164229|NCT00832000|3985741|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4164172|NCT00832117|3985705|B2|90 - Normal activity; minor signs of disease||Karnofsky Performance Status|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|1|1.0||||||
4164173|NCT00832117|3985706|B1|90 - Normal activity; minor signs of disease||Karnofsky Performance Status|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|2|2.0||||||
4164174|NCT00832117|3985704|B3|80 - Activity with effort; some signs of disease||Karnofsky Performance Status|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|11|11.0||||||
4164175|NCT00832117|3985705|B2|80 - Activity with effort; some signs of disease||Karnofsky Performance Status|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|2|2.0||||||
4164176|NCT00832117|3985706|B1|80 - Activity with effort; some signs of disease||Karnofsky Performance Status|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|9|9.0||||||
4164177|NCT00832117|3985704|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4164178|NCT00832117|3985705|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4164179|NCT00832117|3985706|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4164180|NCT00832117|3985704|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4164181|NCT00832117|3985705|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4164182|NCT00832117|3985706|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4164183|NCT00832117|3985704|B3|>= 50 years||Age, Customized||participants|Number|24|24.0||||||
4164184|NCT00832117|3985705|B2|>= 50 years||Age, Customized||participants|Number|3|3.0||||||
4164185|NCT00832117|3985706|B1|>= 50 years||Age, Customized||participants|Number|21|21.0||||||
4164186|NCT00832117|3985704|B3|< 50 years||Age, Customized||participants|Number|5|5.0||||||
4164187|NCT00832117|3985705|B2|< 50 years||Age, Customized||participants|Number|2|2.0||||||
4164188|NCT00832117|3985706|B1|< 50 years||Age, Customized||participants|Number|3|3.0||||||
4164189|NCT00832117|3985704|B3|>= 65 years||Age, Customized||participants|Number|12|12.0||||||
4164190|NCT00832117|3985705|B2|>= 65 years||Age, Customized||participants|Number|0|0.0||||||
4164191|NCT00832117|3985706|B1|>= 65 years||Age, Customized||participants|Number|12|12.0||||||
4164192|NCT00832117|3985704|B3|< 65 years||Age, Customized||participants|Number|17|17.0||||||
4164193|NCT00832117|3985705|B2|< 65 years||Age, Customized||participants|Number|5|5.0||||||
4164194|NCT00832117|3985706|B1|< 65 years||Age, Customized||participants|Number|12|12.0||||||
4164195|NCT00832117|3985704|B3|||Age||years|Median|63|63.0|Full Range|||30.0|77.0|
4164196|NCT00832117|3985705|B2|||Age||years|Median|54|54.0|Full Range|||30.0|61.0|
4164197|NCT00832117|3985706|B1|||Age||years|Median|64|64.0|Full Range|||33.0|77.0|
4164198|NCT00832091|3985723|B3|Italy||Region of Enrollment||participants|Number|28|28.0||||||
4164199|NCT00832091|3985724|B2|Italy||Region of Enrollment||participants|Number|17|17.0||||||
4164200|NCT00832091|3985725|B1|Italy||Region of Enrollment||participants|Number|11|11.0||||||
4164201|NCT00832091|3985723|B3|Poland||Region of Enrollment||participants|Number|44|44.0||||||
4164202|NCT00832091|3985724|B2|Poland||Region of Enrollment||participants|Number|38|38.0||||||
4164203|NCT00832091|3985725|B1|Poland||Region of Enrollment||participants|Number|6|6.0||||||
4164204|NCT00832091|3985723|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4164205|NCT00832091|3985724|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4164206|NCT00832091|3985725|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4164207|NCT00832091|3985723|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4164208|NCT00832091|3985724|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4164209|NCT00832091|3985725|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4164210|NCT00832091|3985723|B3||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4164211|NCT00832091|3985724|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4164212|NCT00832091|3985725|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4164213|NCT00832091|3985723|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4164214|NCT00832091|3985724|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4164215|NCT00832091|3985725|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4164216|NCT00832091|3985723|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4164217|NCT00832091|3985724|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4164218|NCT00832091|3985725|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4164219|NCT00832078|3985734|B1|Denmark||Region of Enrollment||participants|Number|25|25.0||||||
4164220|NCT00832078|3985734|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4164221|NCT00832078|3985734|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4164222|NCT00832078|3985734|B1|||Age||years|Mean|27.3|27.3|Standard Deviation|10.4|10.4|||
4164223|NCT00832078|3985734|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4164224|NCT00832078|3985734|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4164225|NCT00832078|3985734|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4164226|NCT00832000|3985741|B1|Italy||Region of Enrollment||participants|Number|12|12.0||||||
4164227|NCT00832000|3985741|B1|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
4164230|NCT00832000|3985741|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4164231|NCT00832000|3985741|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4164232|NCT00832000|3985741|B1|||Age||years|Mean|42.9|42.9|Standard Deviation|25|25.0|||
4164233|NCT00832000|3985741|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4164234|NCT00832000|3985741|B1||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4164235|NCT00832000|3985741|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4164236|NCT00831987|3985778|B3|United States||Region of Enrollment||participants|Number|120|120.0||||||
4164237|NCT00831987|3985779|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
4164238|NCT00831987|3985780|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4164239|NCT00831987|3985778|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4164240|NCT00831987|3985779|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4164241|NCT00831987|3985780|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4164242|NCT00831987|3985778|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4164243|NCT00831987|3985779|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4164244|NCT00831987|3985780|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4164245|NCT00831987|3985778|B3|||Age||Years|Mean|57.7|57.7|Standard Deviation|18.7|18.7|||
4164246|NCT00831987|3985779|B2|||Age||Years|Mean|74|74.0|Standard Deviation|5.9|5.9|||
4164247|NCT00831987|3985780|B1|||Age||Years|Mean|41.3|41.3|Standard Deviation|11.1|11.1|||
4164248|NCT00831987|3985778|B3||>=65 years|Age||Participants|Count of Participants|56|56.0||||||
4164249|NCT00831987|3985779|B2||>=65 years|Age||Participants|Count of Participants|56|56.0||||||
4164250|NCT00831987|3985780|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4164251|NCT00831987|3985778|B3||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4164252|NCT00831987|3985779|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4164253|NCT00831987|3985780|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4164254|NCT00831987|3985778|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4164255|NCT00831987|3985779|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4164256|NCT00831987|3985780|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4164257|NCT00831844|3985793|B11|Australia||Region of Enrollment||participants|Number|6|6.0||||||
4164258|NCT00831844|3985795|B9|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4164259|NCT00831844|3985796|B8|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4164260|NCT00831844|3985797|B7|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4164261|NCT00831844|3985798|B6|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4164262|NCT00831844|3985799|B5|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4164263|NCT00831844|3985800|B4|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4164264|NCT00831844|3985801|B3|Australia||Region of Enrollment||participants|Number|3|3.0||||||
4164265|NCT00831844|3985802|B2|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4164266|NCT00831844|3985803|B1|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4164267|NCT00831844|3985793|B11|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4164268|NCT00831844|3985795|B9|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4164269|NCT00831844|3985796|B8|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4164270|NCT00831844|3985797|B7|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4164271|NCT00831844|3985798|B6|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4164272|NCT00831844|3985799|B5|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4164273|NCT00831844|3985800|B4|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4164274|NCT00831844|3985801|B3|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4164275|NCT00831844|3985802|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4164276|NCT00831844|3985803|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4164277|NCT00831844|3985793|B11|United States||Region of Enrollment||participants|Number|108|108.0||||||
4164278|NCT00831844|3985795|B9|United States||Region of Enrollment||participants|Number|8|8.0||||||
4164279|NCT00831844|3985796|B8|United States||Region of Enrollment||participants|Number|10|10.0||||||
4164280|NCT00831844|3985797|B7|United States||Region of Enrollment||participants|Number|9|9.0||||||
4164281|NCT00831844|3985798|B6|United States||Region of Enrollment||participants|Number|19|19.0||||||
4164282|NCT00831844|3985799|B5|United States||Region of Enrollment||participants|Number|14|14.0||||||
4164283|NCT00831844|3985800|B4|United States||Region of Enrollment||participants|Number|9|9.0||||||
4164284|NCT00831844|3985801|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4164285|NCT00831844|3985802|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4164286|NCT00831844|3985803|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4164287|NCT00831844|3985793|B11|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|16|16.0||||||
4164288|NCT00831844|3985795|B9|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|1|1.0||||||
4164289|NCT00831844|3985796|B8|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|1|1.0||||||
4164290|NCT00831844|3985797|B7|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|3|3.0||||||
4164291|NCT00831844|3985798|B6|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|1|1.0||||||
4164292|NCT00831844|3985799|B5|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|1|1.0||||||
4164293|NCT00831844|3985800|B4|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|1|1.0||||||
4164294|NCT00831844|3985801|B3|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|3|3.0||||||
4164295|NCT00831844|3985802|B2|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|2|2.0||||||
4164296|NCT00831844|3985803|B1|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|3|3.0||||||
4164297|NCT00831844|3985793|B11|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4164298|NCT00831844|3985795|B9|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4164299|NCT00831844|3985796|B8|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4164300|NCT00831844|3985797|B7|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4164301|NCT00831844|3985798|B6|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4164302|NCT00831844|3985799|B5|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4164303|NCT00831844|3985800|B4|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4164304|NCT00831844|3985801|B3|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4164305|NCT00831844|3985802|B2|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4164306|NCT00831844|3985803|B1|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4164307|NCT00831844|3985793|B11|White||Race (NIH/OMB)||participants|Number|80|80.0||||||
4164308|NCT00831844|3985795|B9|White||Race (NIH/OMB)||participants|Number|6|6.0||||||
4164309|NCT00831844|3985796|B8|White||Race (NIH/OMB)||participants|Number|6|6.0||||||
4164310|NCT00831844|3985797|B7|White||Race (NIH/OMB)||participants|Number|6|6.0||||||
4164311|NCT00831844|3985798|B6|White||Race (NIH/OMB)||participants|Number|16|16.0||||||
4164312|NCT00831844|3985799|B5|White||Race (NIH/OMB)||participants|Number|12|12.0||||||
4164313|NCT00831844|3985800|B4|White||Race (NIH/OMB)||participants|Number|8|8.0||||||
4164314|NCT00831844|3985801|B3|White||Race (NIH/OMB)||participants|Number|13|13.0||||||
4164315|NCT00831844|3985802|B2|White||Race (NIH/OMB)||participants|Number|9|9.0||||||
4164316|NCT00831844|3985803|B1|White||Race (NIH/OMB)||participants|Number|4|4.0||||||
4164317|NCT00831844|3985793|B11|Black or African American||Race (NIH/OMB)||participants|Number|15|15.0||||||
4164318|NCT00831844|3985795|B9|Black or African American||Race (NIH/OMB)||participants|Number|2|2.0||||||
4164319|NCT00831844|3985796|B8|Black or African American||Race (NIH/OMB)||participants|Number|3|3.0||||||
4164320|NCT00831844|3985797|B7|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
4164321|NCT00831844|3985798|B6|Black or African American||Race (NIH/OMB)||participants|Number|3|3.0||||||
4164322|NCT00831844|3985799|B5|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
4164323|NCT00831844|3985800|B4|Black or African American||Race (NIH/OMB)||participants|Number|1|1.0||||||
4164324|NCT00831844|3985801|B3|Black or African American||Race (NIH/OMB)||participants|Number|4|4.0||||||
4164325|NCT00831844|3985802|B2|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
4164326|NCT00831844|3985803|B1|Black or African American||Race (NIH/OMB)||participants|Number|2|2.0||||||
4164327|NCT00831844|3985793|B11|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4164328|NCT00831844|3985795|B9|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4164329|NCT00831844|3985796|B8|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4164330|NCT00831844|3985797|B7|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4164331|NCT00831844|3985798|B6|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4164332|NCT00831844|3985799|B5|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4164333|NCT00831844|3985800|B4|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4164334|NCT00831844|3985801|B3|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4164335|NCT00831844|3985802|B2|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4164336|NCT00831844|3985803|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4164337|NCT00831844|3985793|B11|Asian||Race (NIH/OMB)||participants|Number|5|5.0||||||
4164338|NCT00831844|3985795|B9|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
4164339|NCT00831844|3985796|B8|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
4164340|NCT00831844|3985797|B7|Asian||Race (NIH/OMB)||participants|Number|1|1.0||||||
4164341|NCT00831844|3985798|B6|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
4164342|NCT00831844|3985799|B5|Asian||Race (NIH/OMB)||participants|Number|1|1.0||||||
4164343|NCT00831844|3985800|B4|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
4164344|NCT00831844|3985801|B3|Asian||Race (NIH/OMB)||participants|Number|1|1.0||||||
4164345|NCT00831844|3985802|B2|Asian||Race (NIH/OMB)||participants|Number|1|1.0||||||
4164346|NCT00831844|3985803|B1|Asian||Race (NIH/OMB)||participants|Number|1|1.0||||||
4164347|NCT00831844|3985793|B11|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
4164348|NCT00831844|3985795|B9|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
4164349|NCT00831844|3985796|B8|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
4164350|NCT00831844|3985797|B7|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
4164351|NCT00831844|3985798|B6|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
4164352|NCT00831844|3985799|B5|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
4164353|NCT00831844|3985800|B4|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
4164354|NCT00831844|3985801|B3|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
4164355|NCT00831844|3985802|B2|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
4164356|NCT00831844|3985803|B1|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
4164357|NCT00831844|3985793|B11|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|5|5.0||||||
4164358|NCT00831844|3985795|B9|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|1|1.0||||||
4164359|NCT00831844|3985796|B8|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
4164360|NCT00831844|3985797|B7|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|1|1.0||||||
4164361|NCT00831844|3985798|B6|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
4164362|NCT00831844|3985799|B5|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
4164363|NCT00831844|3985800|B4|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
4164364|NCT00831844|3985801|B3|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|1|1.0||||||
4164365|NCT00831844|3985802|B2|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
4164366|NCT00831844|3985803|B1|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|2|2.0||||||
4164367|NCT00831844|3985793|B11|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|96|96.0||||||
4164368|NCT00831844|3985795|B9|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|7|7.0||||||
4164369|NCT00831844|3985796|B8|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|9|9.0||||||
4164370|NCT00831844|3985797|B7|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|8|8.0||||||
4164371|NCT00831844|3985798|B6|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|18|18.0||||||
4164372|NCT00831844|3985799|B5|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|14|14.0||||||
4164373|NCT00831844|3985800|B4|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|8|8.0||||||
4164374|NCT00831844|3985801|B3|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|17|17.0||||||
4164375|NCT00831844|3985802|B2|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|8|8.0||||||
4164376|NCT00831844|3985803|B1|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|7|7.0||||||
4164377|NCT00831844|3985793|B11|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|15|15.0||||||
4164378|NCT00831844|3985795|B9|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|1|1.0||||||
4164379|NCT00831844|3985796|B8|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|1|1.0||||||
4164380|NCT00831844|3985797|B7|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|1|1.0||||||
4164381|NCT00831844|3985798|B6|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|2|2.0||||||
4164382|NCT00831844|3985799|B5|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
4164383|NCT00831844|3985800|B4|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|2|2.0||||||
4164384|NCT00831844|3985801|B3|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|3|3.0||||||
4164385|NCT00831844|3985802|B2|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|4|4.0||||||
4164386|NCT00831844|3985803|B1|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|1|1.0||||||
4164387|NCT00831844|3985793|B11|Male||Gender||participants|Number|61|61.0||||||
4164388|NCT00831844|3985795|B9|Male||Gender||participants|Number|1|1.0||||||
4164389|NCT00831844|3985796|B8|Male||Gender||participants|Number|7|7.0||||||
4164390|NCT00831844|3985797|B7|Male||Gender||participants|Number|1|1.0||||||
4164391|NCT00831844|3985798|B6|Male||Gender||participants|Number|12|12.0||||||
4164392|NCT00831844|3985799|B5|Male||Gender||participants|Number|8|8.0||||||
4164393|NCT00831844|3985800|B4|Male||Gender||participants|Number|4|4.0||||||
4164394|NCT00831844|3985801|B3|Male||Gender||participants|Number|15|15.0||||||
4164395|NCT00831844|3985802|B2|Male||Gender||participants|Number|6|6.0||||||
4164396|NCT00831844|3985803|B1|Male||Gender||participants|Number|7|7.0||||||
4164397|NCT00831844|3985793|B11|Female||Gender||participants|Number|55|55.0||||||
4164398|NCT00831844|3985795|B9|Female||Gender||participants|Number|8|8.0||||||
4164399|NCT00831844|3985796|B8|Female||Gender||participants|Number|3|3.0||||||
4164400|NCT00831844|3985797|B7|Female||Gender||participants|Number|9|9.0||||||
4164401|NCT00831844|3985798|B6|Female||Gender||participants|Number|8|8.0||||||
4164402|NCT00831844|3985799|B5|Female||Gender||participants|Number|6|6.0||||||
4164403|NCT00831844|3985800|B4|Female||Gender||participants|Number|6|6.0||||||
4164404|NCT00831844|3985801|B3|Female||Gender||participants|Number|6|6.0||||||
4164405|NCT00831844|3985802|B2|Female||Gender||participants|Number|6|6.0||||||
4164406|NCT00831844|3985803|B1|Female||Gender||participants|Number|3|3.0||||||
4164407|NCT00831844|3985793|B11|||Age||years|Median|13|13.0|Full Range|||2.0|30.0|
4164408|NCT00831844|3985795|B9|||Age||years|Median|7|7.0|Full Range|||4.0|14.0|
4164409|NCT00831844|3985796|B8|||Age||years|Median|14.5|14.5|Full Range|||3.0|24.0|
4164410|NCT00831844|3985797|B7|||Age||years|Median|14.5|14.5|Full Range|||4.0|26.0|
4164411|NCT00831844|3985798|B6|||Age||years|Median|10.5|10.5|Full Range|||2.0|30.0|
4164412|NCT00831844|3985799|B5|||Age||years|Median|17|17.0|Full Range|||8.0|28.0|
4164413|NCT00831844|3985800|B4|||Age||years|Median|14|14.0|Full Range|||10.0|29.0|
4164414|NCT00831844|3985801|B3|||Age||years|Median|14|14.0|Full Range|||3.0|22.0|
4164415|NCT00831844|3985802|B2|||Age||years|Median|17.5|17.5|Full Range|||12.0|26.0|
4164416|NCT00831844|3985803|B1|||Age||years|Median|3|3.0|Full Range|||2.0|7.0|
4164417|NCT00831844|3985793|B11|>=65 years||Age||participants|Number|0|0.0||||||
4164418|NCT00831844|3985795|B9|>=65 years||Age||participants|Number|0|0.0||||||
4164419|NCT00831844|3985796|B8|>=65 years||Age||participants|Number|0|0.0||||||
4164420|NCT00831844|3985797|B7|>=65 years||Age||participants|Number|0|0.0||||||
4164421|NCT00831844|3985798|B6|>=65 years||Age||participants|Number|0|0.0||||||
4164422|NCT00831844|3985799|B5|>=65 years||Age||participants|Number|0|0.0||||||
4164423|NCT00831844|3985800|B4|>=65 years||Age||participants|Number|0|0.0||||||
4164424|NCT00831844|3985801|B3|>=65 years||Age||participants|Number|0|0.0||||||
4164425|NCT00831844|3985802|B2|>=65 years||Age||participants|Number|0|0.0||||||
4164426|NCT00831844|3985803|B1|>=65 years||Age||participants|Number|0|0.0||||||
4164427|NCT00831844|3985793|B11|Between 18 and 65 years||Age||participants|Number|23|23.0||||||
4164428|NCT00831844|3985795|B9|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
4164429|NCT00831844|3985796|B8|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
4164430|NCT00831844|3985797|B7|Between 18 and 65 years||Age||participants|Number|3|3.0||||||
4164431|NCT00831844|3985798|B6|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
4164432|NCT00831844|3985799|B5|Between 18 and 65 years||Age||participants|Number|5|5.0||||||
4164433|NCT00831844|3985800|B4|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
4164434|NCT00831844|3985801|B3|Between 18 and 65 years||Age||participants|Number|5|5.0||||||
4164435|NCT00831844|3985802|B2|Between 18 and 65 years||Age||participants|Number|4|4.0||||||
4164436|NCT00831844|3985803|B1|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
4164437|NCT00831844|3985793|B11|<=18 years||Age||participants|Number|93|93.0||||||
4164438|NCT00831844|3985795|B9|<=18 years||Age||participants|Number|9|9.0||||||
4164439|NCT00831844|3985796|B8|<=18 years||Age||participants|Number|8|8.0||||||
4164440|NCT00831844|3985797|B7|<=18 years||Age||participants|Number|7|7.0||||||
4164441|NCT00831844|3985798|B6|<=18 years||Age||participants|Number|18|18.0||||||
4164442|NCT00831844|3985799|B5|<=18 years||Age||participants|Number|9|9.0||||||
4164443|NCT00831844|3985800|B4|<=18 years||Age||participants|Number|8|8.0||||||
4164444|NCT00831844|3985801|B3|<=18 years||Age||participants|Number|16|16.0||||||
4164445|NCT00831844|3985802|B2|<=18 years||Age||participants|Number|8|8.0||||||
4164446|NCT00831844|3985803|B1|<=18 years||Age||participants|Number|10|10.0||||||
4164447|NCT00831779|3985834|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4164448|NCT00831779|3985835|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4164449|NCT00831779|3985836|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4164450|NCT00831779|3985834|B3|Black/African American||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4164451|NCT00831779|3985835|B2|Black/African American||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4164452|NCT00831779|3985836|B1|Black/African American||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4164453|NCT00831779|3985834|B3|White||Race/Ethnicity, Customized||Participants|Number|28|28.0||||||
4164454|NCT00831779|3985835|B2|White||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4164455|NCT00831779|3985836|B1|White||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4164456|NCT00831779|3985834|B3|Female||Sex/Gender, Customized||Participants|Number|15|15.0||||||
4164457|NCT00831779|3985835|B2|Female||Sex/Gender, Customized||Participants|Number|8|8.0||||||
4164458|NCT00831779|3985836|B1|Female||Sex/Gender, Customized||Participants|Number|7|7.0||||||
4164459|NCT00831779|3985834|B3|Male||Sex/Gender, Customized||Participants|Number|29|29.0||||||
4164460|NCT00831779|3985835|B2|Male||Sex/Gender, Customized||Participants|Number|15|15.0||||||
4164461|NCT00831779|3985836|B1|Male||Sex/Gender, Customized||Participants|Number|14|14.0||||||
4164462|NCT00831779|3985834|B3|65-70 years||Age, Customized||Participants|Number|7|7.0||||||
4164463|NCT00831779|3985835|B2|65-70 years||Age, Customized||Participants|Number|4|4.0||||||
4164464|NCT00831779|3985836|B1|65-70 years||Age, Customized||Participants|Number|3|3.0||||||
4164465|NCT00831779|3985834|B3|Younger than 65 years||Age, Customized||Participants|Number|37|37.0||||||
4164466|NCT00831779|3985835|B2|Younger than 65 years||Age, Customized||Participants|Number|19|19.0||||||
4164467|NCT00831779|3985836|B1|Younger than 65 years||Age, Customized||Participants|Number|18|18.0||||||
4164468|NCT00831779|3985834|B3|||Age||Years|Mean|54.8|54.8|Standard Deviation|8.49|8.49|||
4164469|NCT00831779|3985835|B2|||Age||Years|Mean|56.2|56.2|Standard Deviation|8.85|8.85|||
4164470|NCT00831779|3985836|B1|||Age||Years|Mean|53.3|53.3|Standard Deviation|8.02|8.02|||
4164471|NCT00831766|3985845|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
4164472|NCT00831766|3985846|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4164473|NCT00831766|3985847|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4164474|NCT00831766|3985845|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4164475|NCT00831766|3985846|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4164476|NCT00831766|3985847|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4164477|NCT00831766|3985845|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4164478|NCT00831766|3985846|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4164479|NCT00831766|3985847|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4164480|NCT00831766|3985845|B3|||Age||years|Mean|67.7|67.7|Full Range|||35.0|82.0|
4164481|NCT00831766|3985846|B2|||Age||years|Mean|70|70.0|Full Range|||60.0|82.0|
4164482|NCT00831766|3985847|B1|||Age||years|Mean|65|65.0|Full Range|||35.0|79.0|
4164483|NCT00831766|3985845|B3||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4164484|NCT00831766|3985846|B2||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4164485|NCT00831766|3985847|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4164486|NCT00831766|3985845|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4164487|NCT00831766|3985846|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4164488|NCT00831766|3985847|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4164489|NCT00831766|3985845|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4164490|NCT00831766|3985846|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4164491|NCT00831766|3985847|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4164492|NCT00831753|3985857|B3|Peru||Region of Enrollment||Participants|Number|263|263.0||||||
4164493|NCT00831753|3985858|B2|Peru||Region of Enrollment||Participants|Number|131|131.0||||||
4164494|NCT00831753|3985859|B1|Peru||Region of Enrollment||Participants|Number|132|132.0||||||
4164495|NCT00831753|3985857|B3||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4164496|NCT00831753|3985858|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4164497|NCT00831753|3985859|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4164498|NCT00831753|3985857|B3||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4164499|NCT00831753|3985858|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4164500|NCT00831753|3985859|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4164501|NCT00831753|3985857|B3|||Age||Months|Mean|1.74|1.74|Standard Deviation|0.128|0.128|||
4164502|NCT00831753|3985858|B2|||Age||Months|Mean|1.72|1.72|Standard Deviation|0.123|0.123|||
4164503|NCT00831753|3985859|B1|||Age||Months|Mean|1.75|1.75|Standard Deviation|0.132|0.132|||
4164504|NCT00831753|3985857|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4164505|NCT00831753|3985858|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4164506|NCT00831753|3985859|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4164507|NCT00831753|3985857|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4164508|NCT00831753|3985858|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4164509|NCT00831753|3985859|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4164510|NCT00831753|3985857|B3||<=18 years|Age||Participants|Count of Participants|263|263.0||||||
4164511|NCT00831753|3985858|B2||<=18 years|Age||Participants|Count of Participants|131|131.0||||||
4164512|NCT00831753|3985859|B1||<=18 years|Age||Participants|Count of Participants|132|132.0||||||
4164513|NCT00831701|3985872|B3|Switzerland||Region of Enrollment||participants|Number|100|100.0||||||
4164514|NCT00831701|3985873|B2|Switzerland||Region of Enrollment||participants|Number|50|50.0||||||
4164515|NCT00831701|3985874|B1|Switzerland||Region of Enrollment||participants|Number|50|50.0||||||
4164516|NCT00831701|3985872|B3||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4164517|NCT00831701|3985873|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4164518|NCT00831701|3985874|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4164519|NCT00831701|3985872|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4164520|NCT00831701|3985873|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4164521|NCT00831701|3985874|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4164522|NCT00831701|3985872|B3|||Age||years|Mean|40.8|40.8|Standard Deviation|13.5|13.5|||
4164523|NCT00831701|3985873|B2|||Age||years|Mean|43.4|43.4|Standard Deviation|13.9|13.9|||
4164524|NCT00831701|3985874|B1|||Age||years|Mean|38.2|38.2|Standard Deviation|12.7|12.7|||
4164525|NCT00831701|3985872|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4164526|NCT00831701|3985873|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4164527|NCT00831701|3985874|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4164528|NCT00831701|3985872|B3||Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
4164529|NCT00831701|3985873|B2||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4164530|NCT00831701|3985874|B1||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4164531|NCT00831701|3985872|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4164532|NCT00831701|3985873|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4164533|NCT00831701|3985874|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4164534|NCT00831675|3985889|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4164535|NCT00831675|3985890|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4164536|NCT00831675|3985891|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4164537|NCT00831675|3985889|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4164538|NCT00831675|3985890|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4164539|NCT00831675|3985891|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4164540|NCT00831675|3985889|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4164541|NCT00831675|3985890|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4164542|NCT00831675|3985891|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4164543|NCT00831675|3985889|B3|Age Continuous||Age||Months|Mean|15.6|15.6|Standard Deviation|7.3|7.3|||
4164544|NCT00831675|3985890|B2|Age Continuous||Age||Months|Mean|20|20.0|Standard Deviation|6.0|6.0|||
4164545|NCT00831675|3985891|B1|Age Continuous||Age||Months|Mean|8.9|8.9|Standard Deviation|2.1|2.1|||
4164546|NCT00831675|3985889|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4164547|NCT00831675|3985890|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4164548|NCT00831675|3985891|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4164549|NCT00831675|3985889|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4164550|NCT00831675|3985890|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4164551|NCT00831675|3985891|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4164552|NCT00831675|3985889|B3||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4164553|NCT00831675|3985890|B2||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
4164554|NCT00831675|3985891|B1||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4164555|NCT00831493|3985904|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4164556|NCT00831493|3985904|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4164557|NCT00831493|3985904|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4164558|NCT00831493|3985904|B1|||Age||years|Median|55|55.0|Full Range|||40.0|70.0|
4164559|NCT00831480|3985908|B1|||Evidence of Metastatic Disease||participants|Number|9|9.0||||||
4164560|NCT00831480|3985908|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4164561|NCT00831480|3985908|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4164562|NCT00831480|3985908|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4164563|NCT00831480|3985908|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4164564|NCT00831480|3985908|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4164565|NCT00831480|3985908|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4164566|NCT00831480|3985908|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4164567|NCT00831480|3985908|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4164568|NCT00831480|3985908|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4164569|NCT00831480|3985908|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4164570|NCT00831480|3985908|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4164571|NCT00831480|3985908|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4164572|NCT00831480|3985908|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4164573|NCT00831480|3985908|B1||>=65 years|Age|Image and biopsy proven metastatic RCC|Participants|Count of Participants|2|2.0||||||
4164574|NCT00831480|3985908|B1||Between 18 and 65 years|Age|Image and biopsy proven metastatic RCC|Participants|Count of Participants|7|7.0||||||
4164575|NCT00831480|3985908|B1||<=18 years|Age|Image and biopsy proven metastatic RCC|Participants|Count of Participants|0|0.0||||||
4164576|NCT00831480|3985908|B1|||Age||years|Mean|58.9|58.9|Full Range|||46.0|70.0|
4164577|NCT00831441|3985912|B3|Unstable angina||ACS Index Event|Participants were enrolled in the study only after experiencing an acute coronary syndrome (post-ACS) and were categorized as having ST-segment elevation myocardial infarction (STEMI), non-STEMI, or unstable angina.|participants|Number|1391|1391.0||||||
4164578|NCT00831441|3985913|B2|Unstable angina||ACS Index Event|Participants were enrolled in the study only after experiencing an acute coronary syndrome (post-ACS) and were categorized as having ST-segment elevation myocardial infarction (STEMI), non-STEMI, or unstable angina.|participants|Number|698|698.0||||||
4164579|NCT00831441|3985914|B1|Unstable angina||ACS Index Event|Participants were enrolled in the study only after experiencing an acute coronary syndrome (post-ACS) and were categorized as having ST-segment elevation myocardial infarction (STEMI), non-STEMI, or unstable angina.|participants|Number|693|693.0||||||
4164580|NCT00831441|3985912|B3|non-STEMI||ACS Index Event|Participants were enrolled in the study only after experiencing an acute coronary syndrome (post-ACS) and were categorized as having ST-segment elevation myocardial infarction (STEMI), non-STEMI, or unstable angina.|participants|Number|3163|3163.0||||||
4164581|NCT00831441|3985913|B2|non-STEMI||ACS Index Event|Participants were enrolled in the study only after experiencing an acute coronary syndrome (post-ACS) and were categorized as having ST-segment elevation myocardial infarction (STEMI), non-STEMI, or unstable angina.|participants|Number|1581|1581.0||||||
4164582|NCT00831441|3985914|B1|non-STEMI||ACS Index Event|Participants were enrolled in the study only after experiencing an acute coronary syndrome (post-ACS) and were categorized as having ST-segment elevation myocardial infarction (STEMI), non-STEMI, or unstable angina.|participants|Number|1582|1582.0||||||
4164583|NCT00831441|3985912|B3|STEMI||ACS Index Event|Participants were enrolled in the study only after experiencing an acute coronary syndrome (post-ACS) and were categorized as having ST-segment elevation myocardial infarction (STEMI), non-STEMI, or unstable angina.|participants|Number|2838|2838.0||||||
4164584|NCT00831441|3985913|B2|STEMI||ACS Index Event|Participants were enrolled in the study only after experiencing an acute coronary syndrome (post-ACS) and were categorized as having ST-segment elevation myocardial infarction (STEMI), non-STEMI, or unstable angina.|participants|Number|1426|1426.0||||||
4164585|NCT00831441|3985914|B1|STEMI||ACS Index Event|Participants were enrolled in the study only after experiencing an acute coronary syndrome (post-ACS) and were categorized as having ST-segment elevation myocardial infarction (STEMI), non-STEMI, or unstable angina.|participants|Number|1412|1412.0||||||
4164586|NCT00831441|3985912|B3|Single Antiplatelet Therapy||Antiplatelet Therapy||participants|Number|1459|1459.0||||||
4164587|NCT00831441|3985913|B2|Single Antiplatelet Therapy||Antiplatelet Therapy||participants|Number|737|737.0||||||
4164588|NCT00831441|3985914|B1|Single Antiplatelet Therapy||Antiplatelet Therapy||participants|Number|722|722.0||||||
4164589|NCT00831441|3985912|B3|Dual Antiplatelet Therapy||Antiplatelet Therapy||participants|Number|5933|5933.0||||||
4164590|NCT00831441|3985913|B2|Dual Antiplatelet Therapy||Antiplatelet Therapy||participants|Number|2968|2968.0||||||
4164591|NCT00831441|3985914|B1|Dual Antiplatelet Therapy||Antiplatelet Therapy||participants|Number|2965|2965.0||||||
4164592|NCT00831441|3985912|B3|Germany||Region of Enrollment||participants|Number|160|160.0||||||
4164593|NCT00831441|3985913|B2|Germany||Region of Enrollment||participants|Number|80|80.0||||||
4164594|NCT00831441|3985914|B1|Germany||Region of Enrollment||participants|Number|80|80.0||||||
4164595|NCT00831441|3985912|B3|Peru||Region of Enrollment||participants|Number|132|132.0||||||
4164596|NCT00831441|3985913|B2|Peru||Region of Enrollment||participants|Number|66|66.0||||||
4164597|NCT00831441|3985914|B1|Peru||Region of Enrollment||participants|Number|66|66.0||||||
4164598|NCT00831441|3985912|B3|Australia||Region of Enrollment||participants|Number|38|38.0||||||
4164599|NCT00831441|3985913|B2|Australia||Region of Enrollment||participants|Number|23|23.0||||||
4164600|NCT00831441|3985914|B1|Australia||Region of Enrollment||participants|Number|15|15.0||||||
4164601|NCT00831441|3985912|B3|Israel||Region of Enrollment||participants|Number|139|139.0||||||
4164602|NCT00831441|3985913|B2|Israel||Region of Enrollment||participants|Number|66|66.0||||||
4164603|NCT00831441|3985914|B1|Israel||Region of Enrollment||participants|Number|73|73.0||||||
4164604|NCT00831441|3985912|B3|Mexico||Region of Enrollment||participants|Number|322|322.0||||||
4164605|NCT00831441|3985913|B2|Mexico||Region of Enrollment||participants|Number|161|161.0||||||
4164606|NCT00831441|3985914|B1|Mexico||Region of Enrollment||participants|Number|161|161.0||||||
4164607|NCT00831441|3985912|B3|South Africa||Region of Enrollment||participants|Number|133|133.0||||||
4164608|NCT00831441|3985913|B2|South Africa||Region of Enrollment||participants|Number|67|67.0||||||
4164609|NCT00831441|3985914|B1|South Africa||Region of Enrollment||participants|Number|66|66.0||||||
4164610|NCT00831441|3985912|B3|Italy||Region of Enrollment||participants|Number|44|44.0||||||
4164611|NCT00831441|3985913|B2|Italy||Region of Enrollment||participants|Number|21|21.0||||||
4164612|NCT00831441|3985914|B1|Italy||Region of Enrollment||participants|Number|23|23.0||||||
4164613|NCT00831441|3985912|B3|Denmark||Region of Enrollment||participants|Number|71|71.0||||||
4164614|NCT00831441|3985913|B2|Denmark||Region of Enrollment||participants|Number|34|34.0||||||
4164615|NCT00831441|3985914|B1|Denmark||Region of Enrollment||participants|Number|37|37.0||||||
4164616|NCT00831441|3985912|B3|Finland||Region of Enrollment||participants|Number|7|7.0||||||
4164617|NCT00831441|3985913|B2|Finland||Region of Enrollment||participants|Number|3|3.0||||||
4164618|NCT00831441|3985914|B1|Finland||Region of Enrollment||participants|Number|4|4.0||||||
4164619|NCT00831441|3985912|B3|Norway||Region of Enrollment||participants|Number|51|51.0||||||
4164620|NCT00831441|3985913|B2|Norway||Region of Enrollment||participants|Number|25|25.0||||||
4164621|NCT00831441|3985914|B1|Norway||Region of Enrollment||participants|Number|26|26.0||||||
4164622|NCT00831441|3985912|B3|Belgium||Region of Enrollment||participants|Number|97|97.0||||||
4164623|NCT00831441|3985913|B2|Belgium||Region of Enrollment||participants|Number|50|50.0||||||
4164624|NCT00831441|3985914|B1|Belgium||Region of Enrollment||participants|Number|47|47.0||||||
4164625|NCT00831441|3985912|B3|Turkey||Region of Enrollment||participants|Number|20|20.0||||||
4164626|NCT00831441|3985913|B2|Turkey||Region of Enrollment||participants|Number|11|11.0||||||
4164627|NCT00831441|3985914|B1|Turkey||Region of Enrollment||participants|Number|9|9.0||||||
4164628|NCT00831441|3985912|B3|Czech Republic||Region of Enrollment||participants|Number|108|108.0||||||
4164629|NCT00831441|3985913|B2|Czech Republic||Region of Enrollment||participants|Number|54|54.0||||||
4164630|NCT00831441|3985914|B1|Czech Republic||Region of Enrollment||participants|Number|54|54.0||||||
4164631|NCT00831441|3985912|B3|Canada||Region of Enrollment||participants|Number|254|254.0||||||
4164632|NCT00831441|3985913|B2|Canada||Region of Enrollment||participants|Number|128|128.0||||||
4164633|NCT00831441|3985914|B1|Canada||Region of Enrollment||participants|Number|126|126.0||||||
4164634|NCT00831441|3985912|B3|New Zealand||Region of Enrollment||participants|Number|22|22.0||||||
4164635|NCT00831441|3985913|B2|New Zealand||Region of Enrollment||participants|Number|9|9.0||||||
4164636|NCT00831441|3985914|B1|New Zealand||Region of Enrollment||participants|Number|13|13.0||||||
4164637|NCT00831441|3985912|B3|Spain||Region of Enrollment||participants|Number|160|160.0||||||
4164638|NCT00831441|3985913|B2|Spain||Region of Enrollment||participants|Number|79|79.0||||||
4164639|NCT00831441|3985914|B1|Spain||Region of Enrollment||participants|Number|81|81.0||||||
4164640|NCT00831441|3985912|B3|India||Region of Enrollment||participants|Number|794|794.0||||||
4164641|NCT00831441|3985913|B2|India||Region of Enrollment||participants|Number|398|398.0||||||
4164642|NCT00831441|3985914|B1|India||Region of Enrollment||participants|Number|396|396.0||||||
4164643|NCT00831441|3985912|B3|Switzerland||Region of Enrollment||participants|Number|38|38.0||||||
4164644|NCT00831441|3985913|B2|Switzerland||Region of Enrollment||participants|Number|20|20.0||||||
4164645|NCT00831441|3985914|B1|Switzerland||Region of Enrollment||participants|Number|18|18.0||||||
4164646|NCT00831441|3985912|B3|United Kingdom||Region of Enrollment||participants|Number|45|45.0||||||
4164647|NCT00831441|3985913|B2|United Kingdom||Region of Enrollment||participants|Number|21|21.0||||||
4164648|NCT00831441|3985914|B1|United Kingdom||Region of Enrollment||participants|Number|24|24.0||||||
4164649|NCT00831441|3985912|B3|Ukraine||Region of Enrollment||participants|Number|258|258.0||||||
4164650|NCT00831441|3985913|B2|Ukraine||Region of Enrollment||participants|Number|130|130.0||||||
4164651|NCT00831441|3985914|B1|Ukraine||Region of Enrollment||participants|Number|128|128.0||||||
4164652|NCT00831441|3985912|B3|Japan||Region of Enrollment||participants|Number|186|186.0||||||
4164653|NCT00831441|3985913|B2|Japan||Region of Enrollment||participants|Number|95|95.0||||||
4164654|NCT00831441|3985914|B1|Japan||Region of Enrollment||participants|Number|91|91.0||||||
4164655|NCT00831441|3985912|B3|Hungary||Region of Enrollment||participants|Number|241|241.0||||||
4164656|NCT00831441|3985913|B2|Hungary||Region of Enrollment||participants|Number|120|120.0||||||
4164657|NCT00831441|3985914|B1|Hungary||Region of Enrollment||participants|Number|121|121.0||||||
4164658|NCT00831441|3985912|B3|Romania||Region of Enrollment||participants|Number|158|158.0||||||
4164659|NCT00831441|3985913|B2|Romania||Region of Enrollment||participants|Number|80|80.0||||||
4164660|NCT00831441|3985914|B1|Romania||Region of Enrollment||participants|Number|78|78.0||||||
4164661|NCT00831441|3985912|B3|Argentina||Region of Enrollment||participants|Number|256|256.0||||||
4164662|NCT00831441|3985913|B2|Argentina||Region of Enrollment||participants|Number|125|125.0||||||
4164663|NCT00831441|3985914|B1|Argentina||Region of Enrollment||participants|Number|131|131.0||||||
4164664|NCT00831441|3985912|B3|Colombia||Region of Enrollment||participants|Number|88|88.0||||||
4164665|NCT00831441|3985913|B2|Colombia||Region of Enrollment||participants|Number|43|43.0||||||
4164666|NCT00831441|3985914|B1|Colombia||Region of Enrollment||participants|Number|45|45.0||||||
4164667|NCT00831441|3985912|B3|Chile||Region of Enrollment||participants|Number|56|56.0||||||
4164668|NCT00831441|3985913|B2|Chile||Region of Enrollment||participants|Number|26|26.0||||||
4164669|NCT00831441|3985914|B1|Chile||Region of Enrollment||participants|Number|30|30.0||||||
4164670|NCT00831441|3985912|B3|Bulgaria||Region of Enrollment||participants|Number|202|202.0||||||
4164671|NCT00831441|3985913|B2|Bulgaria||Region of Enrollment||participants|Number|102|102.0||||||
4164672|NCT00831441|3985914|B1|Bulgaria||Region of Enrollment||participants|Number|100|100.0||||||
4164673|NCT00831441|3985912|B3|France||Region of Enrollment||participants|Number|40|40.0||||||
4164674|NCT00831441|3985913|B2|France||Region of Enrollment||participants|Number|18|18.0||||||
4164675|NCT00831441|3985914|B1|France||Region of Enrollment||participants|Number|22|22.0||||||
4164676|NCT00831441|3985912|B3|Slovakia||Region of Enrollment||participants|Number|59|59.0||||||
4164677|NCT00831441|3985913|B2|Slovakia||Region of Enrollment||participants|Number|29|29.0||||||
4164678|NCT00831441|3985914|B1|Slovakia||Region of Enrollment||participants|Number|30|30.0||||||
4164679|NCT00831441|3985912|B3|Brazil||Region of Enrollment||participants|Number|250|250.0||||||
4164680|NCT00831441|3985913|B2|Brazil||Region of Enrollment||participants|Number|125|125.0||||||
4164681|NCT00831441|3985914|B1|Brazil||Region of Enrollment||participants|Number|125|125.0||||||
4164682|NCT00831441|3985912|B3|Korea, Republic of||Region of Enrollment||participants|Number|177|177.0||||||
4164683|NCT00831441|3985913|B2|Korea, Republic of||Region of Enrollment||participants|Number|89|89.0||||||
4164684|NCT00831441|3985914|B1|Korea, Republic of||Region of Enrollment||participants|Number|88|88.0||||||
4164685|NCT00831441|3985912|B3|Poland||Region of Enrollment||participants|Number|353|353.0||||||
4164686|NCT00831441|3985913|B2|Poland||Region of Enrollment||participants|Number|177|177.0||||||
4164687|NCT00831441|3985914|B1|Poland||Region of Enrollment||participants|Number|176|176.0||||||
4164688|NCT00831441|3985912|B3|China||Region of Enrollment||participants|Number|75|75.0||||||
4164689|NCT00831441|3985913|B2|China||Region of Enrollment||participants|Number|39|39.0||||||
4164690|NCT00831441|3985914|B1|China||Region of Enrollment||participants|Number|36|36.0||||||
4164691|NCT00831441|3985912|B3|Netherlands||Region of Enrollment||participants|Number|97|97.0||||||
4164692|NCT00831441|3985913|B2|Netherlands||Region of Enrollment||participants|Number|52|52.0||||||
4164693|NCT00831441|3985914|B1|Netherlands||Region of Enrollment||participants|Number|45|45.0||||||
4164694|NCT00831441|3985912|B3|Sweden||Region of Enrollment||participants|Number|105|105.0||||||
4164695|NCT00831441|3985913|B2|Sweden||Region of Enrollment||participants|Number|55|55.0||||||
4164696|NCT00831441|3985914|B1|Sweden||Region of Enrollment||participants|Number|50|50.0||||||
4164697|NCT00831441|3985912|B3|Austria||Region of Enrollment||participants|Number|114|114.0||||||
4164698|NCT00831441|3985913|B2|Austria||Region of Enrollment||participants|Number|56|56.0||||||
4164699|NCT00831441|3985914|B1|Austria||Region of Enrollment||participants|Number|58|58.0||||||
4164700|NCT00831441|3985912|B3|United States||Region of Enrollment||participants|Number|905|905.0||||||
4164701|NCT00831441|3985913|B2|United States||Region of Enrollment||participants|Number|455|455.0||||||
4164702|NCT00831441|3985914|B1|United States||Region of Enrollment||participants|Number|450|450.0||||||
4164703|NCT00831441|3985912|B3|Singapore||Region of Enrollment||participants|Number|25|25.0||||||
4164704|NCT00831441|3985913|B2|Singapore||Region of Enrollment||participants|Number|14|14.0||||||
4164705|NCT00831441|3985914|B1|Singapore||Region of Enrollment||participants|Number|11|11.0||||||
4164706|NCT00831441|3985912|B3|Puerto Rico||Region of Enrollment||participants|Number|30|30.0||||||
4164707|NCT00831441|3985913|B2|Puerto Rico||Region of Enrollment||participants|Number|17|17.0||||||
4164708|NCT00831441|3985914|B1|Puerto Rico||Region of Enrollment||participants|Number|13|13.0||||||
4164709|NCT00831441|3985912|B3|Russian Federation||Region of Enrollment||participants|Number|1082|1082.0||||||
4164710|NCT00831441|3985913|B2|Russian Federation||Region of Enrollment||participants|Number|542|542.0||||||
4164711|NCT00831441|3985914|B1|Russian Federation||Region of Enrollment||participants|Number|540|540.0||||||
4164712|NCT00831441|3985912|B3||Male|Sex: Female, Male||Participants|Count of Participants|5014|5014.0||||||
4164713|NCT00831441|3985913|B2||Male|Sex: Female, Male||Participants|Count of Participants|2496|2496.0||||||
4164714|NCT00831441|3985914|B1||Male|Sex: Female, Male||Participants|Count of Participants|2518|2518.0||||||
4164715|NCT00831441|3985912|B3||Female|Sex: Female, Male||Participants|Count of Participants|2378|2378.0||||||
4164716|NCT00831441|3985913|B2||Female|Sex: Female, Male||Participants|Count of Participants|1209|1209.0||||||
4164717|NCT00831441|3985914|B1||Female|Sex: Female, Male||Participants|Count of Participants|1169|1169.0||||||
4164718|NCT00831441|3985912|B3|≥ 75 years||Age, Customized|Less than (<); Greater than, equal to (≥).|participants|Number|1494|1494.0||||||
4164719|NCT00831441|3985913|B2|≥ 75 years||Age, Customized|Less than (<); Greater than, equal to (≥).|participants|Number|739|739.0||||||
4164720|NCT00831441|3985914|B1|≥ 75 years||Age, Customized|Less than (<); Greater than, equal to (≥).|participants|Number|755|755.0||||||
4164721|NCT00831441|3985912|B3|≥ 65 and < 75 years||Age, Customized|Less than (<); Greater than, equal to (≥).|participants|Number|2860|2860.0||||||
4164722|NCT00831441|3985913|B2|≥ 65 and < 75 years||Age, Customized|Less than (<); Greater than, equal to (≥).|participants|Number|1440|1440.0||||||
4164723|NCT00831441|3985914|B1|≥ 65 and < 75 years||Age, Customized|Less than (<); Greater than, equal to (≥).|participants|Number|1420|1420.0||||||
4164724|NCT00831441|3985912|B3|< 65 years||Age, Customized|Less than (<); Greater than, equal to (≥).|participants|Number|3038|3038.0||||||
4164725|NCT00831441|3985913|B2|< 65 years||Age, Customized|Less than (<); Greater than, equal to (≥).|participants|Number|1526|1526.0||||||
4164726|NCT00831441|3985914|B1|< 65 years||Age, Customized|Less than (<); Greater than, equal to (≥).|participants|Number|1512|1512.0||||||
4164727|NCT00831441|3985912|B3|||Age||years|Mean|65.4|65.4|Standard Deviation|10.97|10.97|||
4164728|NCT00831441|3985913|B2|||Age||years|Mean|65.3|65.3|Standard Deviation|10.89|10.89|||
4164729|NCT00831441|3985914|B1|||Age||years|Mean|65.4|65.4|Standard Deviation|11.05|11.05|||
4164730|NCT00831428|3985943|B1|United Kingdom||Region of Enrollment||participants|Number|97|97.0||||||
4164731|NCT00831428|3985943|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4164732|NCT00831428|3985943|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4164733|NCT00831428|3985943|B1|||Age||years|Mean|15.2|15.2|Standard Deviation|0.25|0.25|||
4164734|NCT00831428|3985943|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4164735|NCT00831428|3985943|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4164736|NCT00831428|3985943|B1||<=18 years|Age||Participants|Count of Participants|97|97.0||||||
4164737|NCT00831415|3985947|B1|||Clinical Global Impression-Severity of Illness [CGI-S] score|CGI-S is a 7-point clinician rated scale to assess severity of current illness state. Range is 1 (normal - not ill at all) to 7 (among the most extremely ill). Higher score = more affected.|scores on a scale|Mean|3.25|3.25|Standard Deviation|1.11|1.11|||
4164738|NCT00831415|3985947|B1|5=Minimally worse||Categorical scores on Clinical Global Impression-Improvement [CGI-I]|CGI-I is a 7-point clinician rated scale ranging from 1 (very much improved) to 7 (very much worse). Improvement is defined as a score of 1 (very much improved), 2 (much improved), or 3 (minimally improved) on the scale. Higher score = more affected. Baseline for CGI-I in this Extension study (NCT00831415 [3151A1-3350 / B2061002]) was measured against CGI-I baseline (Day -1) data in Core study (NCT00798707 [3151A1-3359 / B2061003]).|participants|Number|3|3.0||||||
4164739|NCT00831415|3985947|B1|4=No change||Categorical scores on Clinical Global Impression-Improvement [CGI-I]|CGI-I is a 7-point clinician rated scale ranging from 1 (very much improved) to 7 (very much worse). Improvement is defined as a score of 1 (very much improved), 2 (much improved), or 3 (minimally improved) on the scale. Higher score = more affected. Baseline for CGI-I in this Extension study (NCT00831415 [3151A1-3350 / B2061002]) was measured against CGI-I baseline (Day -1) data in Core study (NCT00798707 [3151A1-3359 / B2061003]).|participants|Number|51|51.0||||||
4164740|NCT00831415|3985947|B1|3=Minimally improved||Categorical scores on Clinical Global Impression-Improvement [CGI-I]|CGI-I is a 7-point clinician rated scale ranging from 1 (very much improved) to 7 (very much worse). Improvement is defined as a score of 1 (very much improved), 2 (much improved), or 3 (minimally improved) on the scale. Higher score = more affected. Baseline for CGI-I in this Extension study (NCT00831415 [3151A1-3350 / B2061002]) was measured against CGI-I baseline (Day -1) data in Core study (NCT00798707 [3151A1-3359 / B2061003]).|participants|Number|94|94.0||||||
4164741|NCT00831415|3985947|B1|2=Much improved||Categorical scores on Clinical Global Impression-Improvement [CGI-I]|CGI-I is a 7-point clinician rated scale ranging from 1 (very much improved) to 7 (very much worse). Improvement is defined as a score of 1 (very much improved), 2 (much improved), or 3 (minimally improved) on the scale. Higher score = more affected. Baseline for CGI-I in this Extension study (NCT00831415 [3151A1-3350 / B2061002]) was measured against CGI-I baseline (Day -1) data in Core study (NCT00798707 [3151A1-3359 / B2061003]).|participants|Number|81|81.0||||||
4164742|NCT00831415|3985947|B1|1=Very much improved||Categorical scores on Clinical Global Impression-Improvement [CGI-I]|CGI-I is a 7-point clinician rated scale ranging from 1 (very much improved) to 7 (very much worse). Improvement is defined as a score of 1 (very much improved), 2 (much improved), or 3 (minimally improved) on the scale. Higher score = more affected. Baseline for CGI-I in this Extension study (NCT00831415 [3151A1-3350 / B2061002]) was measured against CGI-I baseline (Day -1) data in Core study (NCT00798707 [3151A1-3359 / B2061003]).|participants|Number|75|75.0||||||
4164743|NCT00831415|3985947|B1|||Hamilton Psychiatric Scale for Depression-17 Item (HAM-D17) score|HAM-D17 is a standardized, clinician-administered rating scale that assesses 17 items characteristically associated with major depression. Items are scored on either a 3-point (0 to 2) or a 5-point scale (0 to 4) with 0=none/absent and 4=most severe, for a maximum total score of 50. Higher scores indicate greater severity.|scores on a scale|Mean|12.86|12.86|Standard Deviation|6.30|6.3|||
4164744|NCT00831415|3985947|B1||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4164745|NCT00831415|3985947|B1||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4164746|NCT00831415|3985947|B1|||Age||years|Mean|38.45|38.45|Standard Deviation|10.81|10.81|||
4164747|NCT00831389|3985954|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4164748|NCT00831389|3985955|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4164749|NCT00831389|3985956|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4164750|NCT00831389|3985954|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4164751|NCT00831389|3985955|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4164752|NCT00831389|3985956|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4164753|NCT00831389|3985954|B3|||Age||years|Mean|15.9|15.9|Standard Deviation|3.8|3.8|||
4164754|NCT00831389|3985955|B2|||Age||years|Mean|17.7|17.7|Standard Deviation|4.7|4.7|||
4164755|NCT00831389|3985956|B1|||Age||years|Mean|14.4|14.4|Standard Deviation|2.1|2.1|||
4164756|NCT00831389|3985954|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4164757|NCT00831389|3985955|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4164758|NCT00831389|3985956|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4164759|NCT00831389|3985954|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4164760|NCT00831389|3985955|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4164761|NCT00831389|3985956|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4164762|NCT00831389|3985954|B3||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4164763|NCT00831389|3985955|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4164764|NCT00831389|3985956|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4164765|NCT00831311|3985981|B3|Argentina||Region of Enrollment||Participants|Number|624|624.0||||||
4164766|NCT00831311|3985982|B2|Argentina||Region of Enrollment||Participants|Number|312|312.0||||||
4164767|NCT00831311|3985983|B1|Argentina||Region of Enrollment||Participants|Number|312|312.0||||||
4164768|NCT00831311|3985981|B3||Male|Sex: Female, Male||Participants|Count of Participants|329|329.0||||||
4164769|NCT00831311|3985982|B2||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4164770|NCT00831311|3985983|B1||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4164771|NCT00831311|3985981|B3||Female|Sex: Female, Male||Participants|Count of Participants|295|295.0||||||
4164772|NCT00831311|3985982|B2||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4164773|NCT00831311|3985983|B1||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4164774|NCT00831311|3985981|B3|||Age||Months|Mean|1.76|1.76|Standard Deviation|0.11|0.11|||
4164775|NCT00831311|3985982|B2|||Age||Months|Mean|1.77|1.77|Standard Deviation|0.11|0.11|||
4164776|NCT00831311|3985983|B1|||Age||Months|Mean|1.76|1.76|Standard Deviation|0.12|0.12|||
4164777|NCT00831311|3985981|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4164778|NCT00831311|3985982|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4164779|NCT00831311|3985983|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4164780|NCT00831311|3985981|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4164781|NCT00831311|3985982|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4164782|NCT00831311|3985983|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4164783|NCT00831311|3985981|B3||<=18 years|Age||Participants|Count of Participants|624|624.0||||||
4164784|NCT00831311|3985982|B2||<=18 years|Age||Participants|Count of Participants|312|312.0||||||
4164785|NCT00831311|3985983|B1||<=18 years|Age||Participants|Count of Participants|312|312.0||||||
4164786|NCT00831272|3986002|B5|||% Days Drinking||% days of any drinking|Mean|81.9|81.9|Standard Deviation|20.7|20.7|||
4164787|NCT00831272|3986003|B4|||% Days Drinking||% days of any drinking|Mean|82.5|82.5|Standard Deviation|19.8|19.8|||
4164788|NCT00831272|3986004|B3|||% Days Drinking||% days of any drinking|Mean|82.8|82.8|Standard Deviation|20.2|20.2|||
4164789|NCT00831272|3986005|B2|||% Days Drinking||% days of any drinking|Mean|82.7|82.7|Standard Deviation|20.9|20.9|||
4164790|NCT00831272|3986006|B1|||% Days Drinking||% days of any drinking|Mean|78.9|78.9|Standard Deviation|23.1|23.1|||
4164791|NCT00831272|3986002|B5|||% Days Heavy Drinking||% days of heavy drinking|Mean|69.9|69.9|Standard Deviation|27.4|27.4|||
4164792|NCT00831272|3986003|B4|||% Days Heavy Drinking||% days of heavy drinking|Mean|70.9|70.9|Standard Deviation|28|28.0|||
4164793|NCT00831272|3986004|B3|||% Days Heavy Drinking||% days of heavy drinking|Mean|67.5|67.5|Standard Deviation|26.8|26.8|||
4164794|NCT00831272|3986005|B2|||% Days Heavy Drinking||% days of heavy drinking|Mean|72.5|72.5|Standard Deviation|27.8|27.8|||
4164795|NCT00831272|3986006|B1|||% Days Heavy Drinking||% days of heavy drinking|Mean|68|68.0|Standard Deviation|29.8|29.8|||
4164796|NCT00831272|3986002|B5||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4164797|NCT00831272|3986003|B4||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4164798|NCT00831272|3986004|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4164799|NCT00831272|3986005|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4164800|NCT00831272|3986006|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4164801|NCT00831272|3986002|B5||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4164802|NCT00831272|3986003|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4164803|NCT00831272|3986004|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4164804|NCT00831272|3986005|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4164805|NCT00831272|3986006|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4164806|NCT00831272|3986002|B5|||Age||years|Mean|48.2|48.2|Standard Deviation|12.7|12.7|||
4164807|NCT00831272|3986003|B4|||Age||years|Mean|48.2|48.2|Standard Deviation|11.9|11.9|||
4164808|NCT00831272|3986004|B3|||Age||years|Mean|51.2|51.2|Standard Deviation|13.0|13.0|||
4164809|NCT00831272|3986005|B2|||Age||years|Mean|46.9|46.9|Standard Deviation|11.8|11.8|||
4164810|NCT00831272|3986006|B1|||Age||years|Mean|45.8|45.8|Standard Deviation|13.4|13.4|||
4164811|NCT00831233|3986019|B3|Not Classifiable||Stage of Prostate Cancer|FAS. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. The majority of participants did not have their prostate cancer classified for the complete TNM scale (17 participants) or were known for having metastatic prostate cancer (14 participants).|participants|Number|17|17.0||||||
4164812|NCT00831233|3986020|B2|Not Classifiable||Stage of Prostate Cancer|FAS. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. The majority of participants did not have their prostate cancer classified for the complete TNM scale (17 participants) or were known for having metastatic prostate cancer (14 participants).|participants|Number|8|8.0||||||
4164875|NCT00831233|3986020|B2|||Age|Full Analysis Set (FAS).|years|Mean|71.0|71.0|Standard Deviation|8.39|8.39|||
4164929|NCT00830960|3986097|B6|Taiwan||Region of Enrollment||participants|Number|11|11.0||||||
4164813|NCT00831233|3986021|B1|Not Classifiable||Stage of Prostate Cancer|FAS. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. The majority of participants did not have their prostate cancer classified for the complete TNM scale (17 participants) or were known for having metastatic prostate cancer (14 participants).|participants|Number|9|9.0||||||
4164814|NCT00831233|3986019|B3|Metastatic||Stage of Prostate Cancer|FAS. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. The majority of participants did not have their prostate cancer classified for the complete TNM scale (17 participants) or were known for having metastatic prostate cancer (14 participants).|participants|Number|14|14.0||||||
4164815|NCT00831233|3986020|B2|Metastatic||Stage of Prostate Cancer|FAS. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. The majority of participants did not have their prostate cancer classified for the complete TNM scale (17 participants) or were known for having metastatic prostate cancer (14 participants).|participants|Number|4|4.0||||||
4164816|NCT00831233|3986021|B1|Metastatic||Stage of Prostate Cancer|FAS. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. The majority of participants did not have their prostate cancer classified for the complete TNM scale (17 participants) or were known for having metastatic prostate cancer (14 participants).|participants|Number|10|10.0||||||
4164817|NCT00831233|3986019|B3|Locally Advanced||Stage of Prostate Cancer|FAS. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. The majority of participants did not have their prostate cancer classified for the complete TNM scale (17 participants) or were known for having metastatic prostate cancer (14 participants).|participants|Number|5|5.0||||||
4164818|NCT00831233|3986020|B2|Locally Advanced||Stage of Prostate Cancer|FAS. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. The majority of participants did not have their prostate cancer classified for the complete TNM scale (17 participants) or were known for having metastatic prostate cancer (14 participants).|participants|Number|1|1.0||||||
4164819|NCT00831233|3986021|B1|Locally Advanced||Stage of Prostate Cancer|FAS. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. The majority of participants did not have their prostate cancer classified for the complete TNM scale (17 participants) or were known for having metastatic prostate cancer (14 participants).|participants|Number|4|4.0||||||
4164820|NCT00831233|3986019|B3|Localized||Stage of Prostate Cancer|FAS. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. The majority of participants did not have their prostate cancer classified for the complete TNM scale (17 participants) or were known for having metastatic prostate cancer (14 participants).|participants|Number|4|4.0||||||
4164821|NCT00831233|3986020|B2|Localized||Stage of Prostate Cancer|FAS. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. The majority of participants did not have their prostate cancer classified for the complete TNM scale (17 participants) or were known for having metastatic prostate cancer (14 participants).|participants|Number|0|0.0||||||
4164822|NCT00831233|3986021|B1|Localized||Stage of Prostate Cancer|FAS. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor. The majority of participants did not have their prostate cancer classified for the complete TNM scale (17 participants) or were known for having metastatic prostate cancer (14 participants).|participants|Number|4|4.0||||||
4164823|NCT00831233|3986019|B3|7-10||Gleason Score|FAS. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|38|38.0||||||
4164824|NCT00831233|3986020|B2|7-10||Gleason Score|FAS. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|13|13.0||||||
4164825|NCT00831233|3986021|B1|7-10||Gleason Score|FAS. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|25|25.0||||||
4164826|NCT00831233|3986019|B3|5-6||Gleason Score|FAS. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|2|2.0||||||
4164827|NCT00831233|3986020|B2|5-6||Gleason Score|FAS. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|0|0.0||||||
4164828|NCT00831233|3986021|B1|5-6||Gleason Score|FAS. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|2|2.0||||||
4164829|NCT00831233|3986019|B3|2-4||Gleason Score|FAS. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|0|0.0||||||
4164830|NCT00831233|3986020|B2|2-4||Gleason Score|FAS. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|0|0.0||||||
4164831|NCT00831233|3986021|B1|2-4||Gleason Score|FAS. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|0|0.0||||||
4164832|NCT00831233|3986019|B3|||Body mass index|FAS.|kilogram per square meter|Mean|26.7|26.7|Standard Deviation|3.91|3.91|||
4164833|NCT00831233|3986020|B2|||Body mass index|FAS.|kilogram per square meter|Mean|26.8|26.8|Standard Deviation|3.75|3.75|||
4164834|NCT00831233|3986021|B1|||Body mass index|FAS.|kilogram per square meter|Mean|26.7|26.7|Standard Deviation|4.06|4.06|||
4164835|NCT00831233|3986019|B3|||Body weight|FAS.|kilogram|Mean|80.3|80.3|Standard Deviation|12.5|12.5|||
4164836|NCT00831233|3986020|B2|||Body weight|FAS.|kilogram|Mean|78.2|78.2|Standard Deviation|8.5|8.5|||
4164837|NCT00831233|3986021|B1|||Body weight|FAS.|kilogram|Mean|81.4|81.4|Standard Deviation|14.0|14.0|||
4164838|NCT00831233|3986019|B3|United Kingdom||Region of Enrollment|FAS.|participants|Number|12|12.0||||||
4164839|NCT00831233|3986020|B2|United Kingdom||Region of Enrollment|FAS.|participants|Number|2|2.0||||||
4164840|NCT00831233|3986021|B1|United Kingdom||Region of Enrollment|FAS.|participants|Number|10|10.0||||||
4164841|NCT00831233|3986019|B3|Germany||Region of Enrollment|FAS.|participants|Number|20|20.0||||||
4164842|NCT00831233|3986020|B2|Germany||Region of Enrollment|FAS.|participants|Number|7|7.0||||||
4164843|NCT00831233|3986021|B1|Germany||Region of Enrollment|FAS.|participants|Number|13|13.0||||||
4164844|NCT00831233|3986019|B3|Spain||Region of Enrollment|FAS.|participants|Number|8|8.0||||||
4164845|NCT00831233|3986020|B2|Spain||Region of Enrollment|FAS.|participants|Number|4|4.0||||||
4164846|NCT00831233|3986021|B1|Spain||Region of Enrollment|FAS.|participants|Number|4|4.0||||||
4164847|NCT00831233|3986019|B3||Unknown or Not Reported|Race (NIH/OMB)|FAS.|Participants|Count of Participants|0|0.0||||||
4164848|NCT00831233|3986020|B2||Unknown or Not Reported|Race (NIH/OMB)|FAS.|Participants|Count of Participants|0|0.0||||||
4164849|NCT00831233|3986021|B1||Unknown or Not Reported|Race (NIH/OMB)|FAS.|Participants|Count of Participants|0|0.0||||||
4164850|NCT00831233|3986019|B3||More than one race|Race (NIH/OMB)|FAS.|Participants|Count of Participants|0|0.0||||||
4164851|NCT00831233|3986020|B2||More than one race|Race (NIH/OMB)|FAS.|Participants|Count of Participants|0|0.0||||||
4164852|NCT00831233|3986021|B1||More than one race|Race (NIH/OMB)|FAS.|Participants|Count of Participants|0|0.0||||||
4164853|NCT00831233|3986019|B3||White|Race (NIH/OMB)|FAS.|Participants|Count of Participants|39|39.0||||||
4164854|NCT00831233|3986020|B2||White|Race (NIH/OMB)|FAS.|Participants|Count of Participants|12|12.0||||||
4164855|NCT00831233|3986021|B1||White|Race (NIH/OMB)|FAS.|Participants|Count of Participants|27|27.0||||||
4164856|NCT00831233|3986019|B3||Black or African American|Race (NIH/OMB)|FAS.|Participants|Count of Participants|1|1.0||||||
4164857|NCT00831233|3986020|B2||Black or African American|Race (NIH/OMB)|FAS.|Participants|Count of Participants|1|1.0||||||
4164858|NCT00831233|3986021|B1||Black or African American|Race (NIH/OMB)|FAS.|Participants|Count of Participants|0|0.0||||||
4164859|NCT00831233|3986019|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|FAS.|Participants|Count of Participants|0|0.0||||||
4164860|NCT00831233|3986020|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|FAS.|Participants|Count of Participants|0|0.0||||||
4164861|NCT00831233|3986021|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|FAS.|Participants|Count of Participants|0|0.0||||||
4164862|NCT00831233|3986019|B3||Asian|Race (NIH/OMB)|FAS.|Participants|Count of Participants|0|0.0||||||
4164863|NCT00831233|3986020|B2||Asian|Race (NIH/OMB)|FAS.|Participants|Count of Participants|0|0.0||||||
4164864|NCT00831233|3986021|B1||Asian|Race (NIH/OMB)|FAS.|Participants|Count of Participants|0|0.0||||||
4164865|NCT00831233|3986019|B3||American Indian or Alaska Native|Race (NIH/OMB)|FAS.|Participants|Count of Participants|0|0.0||||||
4164866|NCT00831233|3986020|B2||American Indian or Alaska Native|Race (NIH/OMB)|FAS.|Participants|Count of Participants|0|0.0||||||
4164867|NCT00831233|3986021|B1||American Indian or Alaska Native|Race (NIH/OMB)|FAS.|Participants|Count of Participants|0|0.0||||||
4164868|NCT00831233|3986019|B3||Male|Sex: Female, Male|FAS.|Participants|Count of Participants|40|40.0||||||
4164869|NCT00831233|3986020|B2||Male|Sex: Female, Male|FAS.|Participants|Count of Participants|13|13.0||||||
4164870|NCT00831233|3986021|B1||Male|Sex: Female, Male|FAS.|Participants|Count of Participants|27|27.0||||||
4164871|NCT00831233|3986019|B3||Female|Sex: Female, Male|FAS.|Participants|Count of Participants|0|0.0||||||
4164872|NCT00831233|3986020|B2||Female|Sex: Female, Male|FAS.|Participants|Count of Participants|0|0.0||||||
4164873|NCT00831233|3986021|B1||Female|Sex: Female, Male|FAS.|Participants|Count of Participants|0|0.0||||||
4164874|NCT00831233|3986019|B3|||Age|Full Analysis Set (FAS).|years|Mean|70.3|70.3|Standard Deviation|8.49|8.49|||
4164876|NCT00831233|3986021|B1|||Age|Full Analysis Set (FAS).|years|Mean|69.9|69.9|Standard Deviation|8.68|8.68|||
4164877|NCT00831181|3986046|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4164878|NCT00831181|3986046|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4164879|NCT00831181|3986046|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4164880|NCT00831181|3986046|B1|||Age||years|Mean|60.3|60.3|Standard Deviation|10.5|10.5|||
4164881|NCT00831181|3986046|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4164882|NCT00831181|3986046|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4164883|NCT00831181|3986046|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4164884|NCT00831129|3986057|B3||Male|Gender||Participants|Count of Participants|23|23.0||||||
4164885|NCT00831129|3986058|B2||Male|Gender||Participants|Count of Participants|9|9.0||||||
4164886|NCT00831129|3986059|B1||Male|Gender||Participants|Count of Participants|14|14.0||||||
4164887|NCT00831129|3986057|B3||Female|Gender||Participants|Count of Participants|20|20.0||||||
4164888|NCT00831129|3986058|B2||Female|Gender||Participants|Count of Participants|14|14.0||||||
4164889|NCT00831129|3986059|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
4164890|NCT00831129|3986057|B3|||Age||years|Mean|57.03|57.03|Standard Deviation|10.7|10.7|||
4164891|NCT00831129|3986058|B2|||Age||years|Mean|58.7|58.7|Standard Deviation|12.1|12.1|||
4164892|NCT00831129|3986059|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|9.3|9.3|||
4164893|NCT00830960|3986096|B7|ST segment elevation myocardial infarction||Qualifying Diagnosis||participants|Number|395|395.0||||||
4164894|NCT00830960|3986097|B6|ST segment elevation myocardial infarction||Qualifying Diagnosis||participants|Number|53|53.0||||||
4164895|NCT00830960|3986098|B5|ST segment elevation myocardial infarction||Qualifying Diagnosis||participants|Number|55|55.0||||||
4164896|NCT00830960|3986099|B4|ST segment elevation myocardial infarction||Qualifying Diagnosis||participants|Number|77|77.0||||||
4164897|NCT00830960|3986100|B3|ST segment elevation myocardial infarction||Qualifying Diagnosis||participants|Number|74|74.0||||||
4164898|NCT00830960|3986101|B2|ST segment elevation myocardial infarction||Qualifying Diagnosis||participants|Number|64|64.0||||||
4164899|NCT00830960|3986102|B1|ST segment elevation myocardial infarction||Qualifying Diagnosis||participants|Number|72|72.0||||||
4164900|NCT00830960|3986096|B7|Non-ST segment elevation myocardial infarction||Qualifying Diagnosis||participants|Number|87|87.0||||||
4164901|NCT00830960|3986097|B6|Non-ST segment elevation myocardial infarction||Qualifying Diagnosis||participants|Number|10|10.0||||||
4164902|NCT00830960|3986098|B5|Non-ST segment elevation myocardial infarction||Qualifying Diagnosis||participants|Number|10|10.0||||||
4164903|NCT00830960|3986099|B4|Non-ST segment elevation myocardial infarction||Qualifying Diagnosis||participants|Number|17|17.0||||||
4164904|NCT00830960|3986100|B3|Non-ST segment elevation myocardial infarction||Qualifying Diagnosis||participants|Number|21|21.0||||||
4164905|NCT00830960|3986101|B2|Non-ST segment elevation myocardial infarction||Qualifying Diagnosis||participants|Number|16|16.0||||||
4164906|NCT00830960|3986102|B1|Non-ST segment elevation myocardial infarction||Qualifying Diagnosis||participants|Number|13|13.0||||||
4164907|NCT00830960|3986096|B7|Unstable angina (UA)||Qualifying Diagnosis||participants|Number|209|209.0||||||
4164908|NCT00830960|3986097|B6|Unstable angina (UA)||Qualifying Diagnosis||participants|Number|30|30.0||||||
4164909|NCT00830960|3986098|B5|Unstable angina (UA)||Qualifying Diagnosis||participants|Number|26|26.0||||||
4164910|NCT00830960|3986099|B4|Unstable angina (UA)||Qualifying Diagnosis||participants|Number|41|41.0||||||
4164911|NCT00830960|3986100|B3|Unstable angina (UA)||Qualifying Diagnosis||participants|Number|38|38.0||||||
4164912|NCT00830960|3986101|B2|Unstable angina (UA)||Qualifying Diagnosis||participants|Number|42|42.0||||||
4164913|NCT00830960|3986102|B1|Unstable angina (UA)||Qualifying Diagnosis||participants|Number|32|32.0||||||
4164914|NCT00830960|3986096|B7|BMI||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m²)|Mean|24.74|24.74|Standard Deviation|3.510|3.51|||
4164915|NCT00830960|3986097|B6|BMI||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m²)|Mean|22.10|22.1|Standard Deviation|3.166|3.166|||
4164916|NCT00830960|3986098|B5|BMI||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m²)|Mean|22.02|22.02|Standard Deviation|4.106|4.106|||
4164917|NCT00830960|3986099|B4|BMI||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m²)|Mean|26.19|26.19|Standard Deviation|2.999|2.999|||
4164918|NCT00830960|3986100|B3|BMI||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m²)|Mean|26.06|26.06|Standard Deviation|2.637|2.637|||
4164919|NCT00830960|3986101|B2|BMI||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m²)|Mean|25.75|25.75|Standard Deviation|2.990|2.99|||
4164920|NCT00830960|3986102|B1|BMI||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m²)|Mean|25.86|25.86|Standard Deviation|2.907|2.907|||
4164921|NCT00830960|3986096|B7|Thailand||Region of Enrollment||participants|Number|29|29.0||||||
4164922|NCT00830960|3986097|B6|Thailand||Region of Enrollment||participants|Number|6|6.0||||||
4164923|NCT00830960|3986098|B5|Thailand||Region of Enrollment||participants|Number|4|4.0||||||
4164924|NCT00830960|3986099|B4|Thailand||Region of Enrollment||participants|Number|5|5.0||||||
4164925|NCT00830960|3986100|B3|Thailand||Region of Enrollment||participants|Number|5|5.0||||||
4164926|NCT00830960|3986101|B2|Thailand||Region of Enrollment||participants|Number|4|4.0||||||
4164927|NCT00830960|3986102|B1|Thailand||Region of Enrollment||participants|Number|5|5.0||||||
4164928|NCT00830960|3986096|B7|Taiwan||Region of Enrollment||participants|Number|78|78.0||||||
4164930|NCT00830960|3986098|B5|Taiwan||Region of Enrollment||participants|Number|10|10.0||||||
4164931|NCT00830960|3986099|B4|Taiwan||Region of Enrollment||participants|Number|16|16.0||||||
4164932|NCT00830960|3986100|B3|Taiwan||Region of Enrollment||participants|Number|15|15.0||||||
4164933|NCT00830960|3986101|B2|Taiwan||Region of Enrollment||participants|Number|14|14.0||||||
4164934|NCT00830960|3986102|B1|Taiwan||Region of Enrollment||participants|Number|12|12.0||||||
4164935|NCT00830960|3986096|B7|Korea, Republic of||Region of Enrollment||participants|Number|101|101.0||||||
4164936|NCT00830960|3986097|B6|Korea, Republic of||Region of Enrollment||participants|Number|15|15.0||||||
4164937|NCT00830960|3986098|B5|Korea, Republic of||Region of Enrollment||participants|Number|13|13.0||||||
4164938|NCT00830960|3986099|B4|Korea, Republic of||Region of Enrollment||participants|Number|19|19.0||||||
4164939|NCT00830960|3986100|B3|Korea, Republic of||Region of Enrollment||participants|Number|20|20.0||||||
4164940|NCT00830960|3986101|B2|Korea, Republic of||Region of Enrollment||participants|Number|19|19.0||||||
4164941|NCT00830960|3986102|B1|Korea, Republic of||Region of Enrollment||participants|Number|15|15.0||||||
4164942|NCT00830960|3986096|B7|China||Region of Enrollment||participants|Number|483|483.0||||||
4164943|NCT00830960|3986097|B6|China||Region of Enrollment||participants|Number|61|61.0||||||
4164944|NCT00830960|3986098|B5|China||Region of Enrollment||participants|Number|64|64.0||||||
4164945|NCT00830960|3986099|B4|China||Region of Enrollment||participants|Number|95|95.0||||||
4164946|NCT00830960|3986100|B3|China||Region of Enrollment||participants|Number|93|93.0||||||
4164947|NCT00830960|3986101|B2|China||Region of Enrollment||participants|Number|85|85.0||||||
4164948|NCT00830960|3986102|B1|China||Region of Enrollment||participants|Number|85|85.0||||||
4164949|NCT00830960|3986096|B7||Male|Sex: Female, Male||Participants|Count of Participants|517|517.0||||||
4164950|NCT00830960|3986097|B6||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4164951|NCT00830960|3986098|B5||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4164952|NCT00830960|3986099|B4||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4164953|NCT00830960|3986100|B3||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4164954|NCT00830960|3986101|B2||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4164955|NCT00830960|3986102|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4164956|NCT00830960|3986096|B7||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4164957|NCT00830960|3986097|B6||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4164958|NCT00830960|3986098|B5||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4164959|NCT00830960|3986099|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4164960|NCT00830960|3986100|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4164961|NCT00830960|3986101|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4164962|NCT00830960|3986102|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4164963|NCT00830960|3986096|B7|Mean Age Overall||Age|Total mean age is based on all randomized participants who received at least 1 dose of study drug, and for whom information was available (n=689).|years|Mean|60.8|60.8|Standard Deviation|11.13|11.13|||
4164964|NCT00830960|3986097|B6|Mean Age Overall||Age|Total mean age is based on all randomized participants who received at least 1 dose of study drug, and for whom information was available (n=689).|years|Mean|69.1|69.1|Standard Deviation|12.08|12.08|||
4164965|NCT00830960|3986098|B5|Mean Age Overall||Age|Total mean age is based on all randomized participants who received at least 1 dose of study drug, and for whom information was available (n=689).|years|Mean|68.5|68.5|Standard Deviation|9.74|9.74|||
4164966|NCT00830960|3986099|B4|Mean Age Overall||Age|Total mean age is based on all randomized participants who received at least 1 dose of study drug, and for whom information was available (n=689).|years|Mean|58.3|58.3|Standard Deviation|8.95|8.95|||
4164967|NCT00830960|3986100|B3|Mean Age Overall||Age|Total mean age is based on all randomized participants who received at least 1 dose of study drug, and for whom information was available (n=689).|years|Mean|57.2|57.2|Standard Deviation|10.49|10.49|||
4164968|NCT00830960|3986101|B2|Mean Age Overall||Age|Total mean age is based on all randomized participants who received at least 1 dose of study drug, and for whom information was available (n=689).|years|Mean|57.7|57.7|Standard Deviation|9.47|9.47|||
4164969|NCT00830960|3986102|B1|Mean Age Overall||Age|Total mean age is based on all randomized participants who received at least 1 dose of study drug, and for whom information was available (n=689).|years|Mean|58.3|58.3|Standard Deviation|9.83|9.83|||
4164970|NCT00830947|3986221|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4164971|NCT00830947|3986222|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4164972|NCT00830947|3986223|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4164973|NCT00830947|3986221|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4164974|NCT00830947|3986222|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4164975|NCT00830947|3986223|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4164976|NCT00830947|3986221|B3|||Age||years|Mean|21.6|21.6|Standard Deviation|8.2|8.2|||
4164977|NCT00830947|3986222|B2|||Age||years|Mean|21.4|21.4|Standard Deviation|7.8|7.8|||
4164978|NCT00830947|3986223|B1|||Age||years|Mean|21.8|21.8|Standard Deviation|8.7|8.7|||
4164979|NCT00830804|3986230|B1|United States||Region of Enrollment||participants|Number|112|112.0||||||
4164980|NCT00830804|3986230|B1||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4164981|NCT00830804|3986230|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4164982|NCT00830804|3986230|B1|60-69||Age, Customized|Age (in years) of participants at study entry|participants|Number|4|4.0||||||
4165079|NCT00830518|3986342|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4164983|NCT00830804|3986230|B1|50-59||Age, Customized|Age (in years) of participants at study entry|participants|Number|12|12.0||||||
4164984|NCT00830804|3986230|B1|40-49||Age, Customized|Age (in years) of participants at study entry|participants|Number|25|25.0||||||
4164985|NCT00830804|3986230|B1|30-39||Age, Customized|Age (in years) of participants at study entry|participants|Number|38|38.0||||||
4164986|NCT00830804|3986230|B1|18-29||Age, Customized|Age (in years) of participants at study entry|participants|Number|33|33.0||||||
4164987|NCT00830804|3986230|B1|||Age|Age (in years) of participants at study entry|years|Median|36|36.0|Full Range|11|11.0|19.0|66.0|
4164988|NCT00830791|3986250|B7|Male||Gender||participants|Number|10|10.0||||||
4164989|NCT00830791|3986253|B4|Male||Gender||participants|Number|3|3.0||||||
4164990|NCT00830791|3986254|B3|Male||Gender||participants|Number|3|3.0||||||
4164991|NCT00830791|3986255|B2|Male||Gender||participants|Number|2|2.0||||||
4164992|NCT00830791|3986256|B1|Male||Gender||participants|Number|2|2.0||||||
4164993|NCT00830791|3986250|B7|Female||Gender||participants|Number|22|22.0||||||
4164994|NCT00830791|3986253|B4|Female||Gender||participants|Number|5|5.0||||||
4164995|NCT00830791|3986254|B3|Female||Gender||participants|Number|5|5.0||||||
4164996|NCT00830791|3986255|B2|Female||Gender||participants|Number|6|6.0||||||
4164997|NCT00830791|3986256|B1|Female||Gender||participants|Number|6|6.0||||||
4164998|NCT00830791|3986250|B7|>=65 years||Age||participants|Number|6|6.0||||||
4164999|NCT00830791|3986253|B4|>=65 years||Age||participants|Number|1|1.0||||||
4165000|NCT00830791|3986254|B3|>=65 years||Age||participants|Number|1|1.0||||||
4165001|NCT00830791|3986255|B2|>=65 years||Age||participants|Number|2|2.0||||||
4165002|NCT00830791|3986256|B1|>=65 years||Age||participants|Number|2|2.0||||||
4165003|NCT00830791|3986250|B7|Between 18 and 65 years||Age||participants|Number|26|26.0||||||
4165004|NCT00830791|3986253|B4|Between 18 and 65 years||Age||participants|Number|7|7.0||||||
4165005|NCT00830791|3986254|B3|Between 18 and 65 years||Age||participants|Number|7|7.0||||||
4165006|NCT00830791|3986255|B2|Between 18 and 65 years||Age||participants|Number|6|6.0||||||
4165007|NCT00830791|3986256|B1|Between 18 and 65 years||Age||participants|Number|6|6.0||||||
4165008|NCT00830791|3986250|B7|<=18 years||Age||participants|Number|0|0.0||||||
4165009|NCT00830791|3986253|B4|<=18 years||Age||participants|Number|0|0.0||||||
4165010|NCT00830791|3986254|B3|<=18 years||Age||participants|Number|0|0.0||||||
4165011|NCT00830791|3986255|B2|<=18 years||Age||participants|Number|0|0.0||||||
4165012|NCT00830791|3986256|B1|<=18 years||Age||participants|Number|0|0.0||||||
4165013|NCT00830765|3986308|B3|United States||Region of Enrollment||participants|Number|144|144.0||||||
4165014|NCT00830765|3986309|B2|United States||Region of Enrollment||participants|Number|71|71.0||||||
4165015|NCT00830765|3986310|B1|United States||Region of Enrollment||participants|Number|73|73.0||||||
4165016|NCT00830765|3986308|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4165017|NCT00830765|3986309|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4165018|NCT00830765|3986310|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4165019|NCT00830765|3986308|B3||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4165020|NCT00830765|3986309|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4165021|NCT00830765|3986310|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4165022|NCT00830765|3986308|B3|||Age||years|Mean|24.4|24.4|Standard Deviation|5.1|5.1|||
4165023|NCT00830765|3986309|B2|||Age||years|Mean|23.3|23.3|Standard Deviation|5.8|5.8|||
4165024|NCT00830765|3986310|B1|||Age||years|Mean|25.4|25.4|Standard Deviation|5.0|5.0|||
4165025|NCT00830765|3986308|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4165026|NCT00830765|3986309|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4165027|NCT00830765|3986310|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4165028|NCT00830765|3986308|B3||Between 18 and 65 years|Age||Participants|Count of Participants|144|144.0||||||
4165029|NCT00830765|3986309|B2||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4165030|NCT00830765|3986310|B1||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4165031|NCT00830765|3986308|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165032|NCT00830765|3986309|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165033|NCT00830765|3986310|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165034|NCT00830596|3986317|B4||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4165035|NCT00830596|3986318|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4165036|NCT00830596|3986319|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4165037|NCT00830596|3986320|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4165038|NCT00830596|3986317|B4||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4165039|NCT00830596|3986318|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4165040|NCT00830596|3986319|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4165041|NCT00830596|3986320|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4165042|NCT00830596|3986317|B4|||Age||years|Mean|44.3|44.3|Standard Deviation|10.4|10.4|||
4165043|NCT00830596|3986318|B3|||Age||years|Mean|44.4|44.4|Standard Deviation|10.5|10.5|||
4165044|NCT00830596|3986319|B2|||Age||years|Mean|44.5|44.5|Standard Deviation|10.2|10.2|||
4165045|NCT00830596|3986320|B1|||Age||years|Mean|44.1|44.1|Standard Deviation|10.6|10.6|||
4165080|NCT00830518|3986343|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4165081|NCT00830518|3986344|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4165046|NCT00830518|3986342|B3|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance is defined as: 0=Normal activity (fully active, able to carry on all predisease performance without restriction); 1=Symptoms but ambulatory (restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature); 2=In bed <50% of the time (ambulatory and capable of all self-care, but unable to carry out any work activities.|participants|Number|8|8.0||||||
4165047|NCT00830518|3986343|B2|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance is defined as: 0=Normal activity (fully active, able to carry on all predisease performance without restriction); 1=Symptoms but ambulatory (restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature); 2=In bed <50% of the time (ambulatory and capable of all self-care, but unable to carry out any work activities.|participants|Number|0|0.0||||||
4165048|NCT00830518|3986344|B1|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance is defined as: 0=Normal activity (fully active, able to carry on all predisease performance without restriction); 1=Symptoms but ambulatory (restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature); 2=In bed <50% of the time (ambulatory and capable of all self-care, but unable to carry out any work activities.|participants|Number|8|8.0||||||
4165049|NCT00830518|3986342|B3|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance is defined as: 0=Normal activity (fully active, able to carry on all predisease performance without restriction); 1=Symptoms but ambulatory (restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature); 2=In bed <50% of the time (ambulatory and capable of all self-care, but unable to carry out any work activities.|participants|Number|37|37.0||||||
4165050|NCT00830518|3986343|B2|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance is defined as: 0=Normal activity (fully active, able to carry on all predisease performance without restriction); 1=Symptoms but ambulatory (restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature); 2=In bed <50% of the time (ambulatory and capable of all self-care, but unable to carry out any work activities.|participants|Number|8|8.0||||||
4165051|NCT00830518|3986344|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance is defined as: 0=Normal activity (fully active, able to carry on all predisease performance without restriction); 1=Symptoms but ambulatory (restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature); 2=In bed <50% of the time (ambulatory and capable of all self-care, but unable to carry out any work activities.|participants|Number|29|29.0||||||
4165052|NCT00830518|3986342|B3|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance is defined as: 0=Normal activity (fully active, able to carry on all predisease performance without restriction); 1=Symptoms but ambulatory (restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature); 2=In bed <50% of the time (ambulatory and capable of all self-care, but unable to carry out any work activities.|participants|Number|12|12.0||||||
4165053|NCT00830518|3986343|B2|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance is defined as: 0=Normal activity (fully active, able to carry on all predisease performance without restriction); 1=Symptoms but ambulatory (restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature); 2=In bed <50% of the time (ambulatory and capable of all self-care, but unable to carry out any work activities.|participants|Number|3|3.0||||||
4165054|NCT00830518|3986344|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance is defined as: 0=Normal activity (fully active, able to carry on all predisease performance without restriction); 1=Symptoms but ambulatory (restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature); 2=In bed <50% of the time (ambulatory and capable of all self-care, but unable to carry out any work activities.|participants|Number|9|9.0||||||
4165055|NCT00830518|3986342|B3|||Years Since Initial Diagnosis||years|Mean|0.68|0.68|Standard Deviation|0.787|0.787|||
4165056|NCT00830518|3986343|B2|||Years Since Initial Diagnosis||years|Mean|0.82|0.82|Standard Deviation|0.780|0.78|||
4165057|NCT00830518|3986344|B1|||Years Since Initial Diagnosis||years|Mean|0.65|0.65|Standard Deviation|0.793|0.793|||
4165058|NCT00830518|3986342|B3|||Baseline Body Surface Area (BSA)||m^2|Mean|1.86|1.86|Standard Deviation|0.219|0.219|||
4165059|NCT00830518|3986343|B2|||Baseline Body Surface Area (BSA)||m^2|Mean|1.94|1.94|Standard Deviation|0.262|0.262|||
4165060|NCT00830518|3986344|B1|||Baseline Body Surface Area (BSA)||m^2|Mean|1.83|1.83|Standard Deviation|0.203|0.203|||
4165061|NCT00830518|3986342|B3|||Weight||kg|Mean|75.0|75.0|Standard Deviation|14.62|14.62|||
4165062|NCT00830518|3986343|B2|||Weight||kg|Mean|80.4|80.4|Standard Deviation|17.27|17.27|||
4165063|NCT00830518|3986344|B1|||Weight||kg|Mean|73.7|73.7|Standard Deviation|13.80|13.8|||
4165064|NCT00830518|3986342|B3|||Height||cm|Mean|167.0|167.0|Standard Deviation|8.93|8.93|||
4165065|NCT00830518|3986343|B2|||Height||cm|Mean|171.4|171.4|Standard Deviation|9.98|9.98|||
4165066|NCT00830518|3986344|B1|||Height||cm|Mean|165.8|165.8|Standard Deviation|8.35|8.35|||
4165067|NCT00830518|3986342|B3|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4165068|NCT00830518|3986343|B2|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4165069|NCT00830518|3986344|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4165070|NCT00830518|3986342|B3|France||Region of Enrollment||participants|Number|13|13.0||||||
4165071|NCT00830518|3986343|B2|France||Region of Enrollment||participants|Number|2|2.0||||||
4165072|NCT00830518|3986344|B1|France||Region of Enrollment||participants|Number|11|11.0||||||
4165073|NCT00830518|3986342|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4165074|NCT00830518|3986343|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4165075|NCT00830518|3986344|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4165076|NCT00830518|3986342|B3|Not Reported||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4165077|NCT00830518|3986343|B2|Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4165078|NCT00830518|3986344|B1|Not Reported||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4165082|NCT00830518|3986342|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4165083|NCT00830518|3986343|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4165084|NCT00830518|3986344|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4165085|NCT00830518|3986342|B3|White||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4165086|NCT00830518|3986343|B2|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4165087|NCT00830518|3986344|B1|White||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4165088|NCT00830518|3986342|B3|Not Reported||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4165089|NCT00830518|3986343|B2|Not Reported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4165090|NCT00830518|3986344|B1|Not Reported||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4165091|NCT00830518|3986342|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4165092|NCT00830518|3986343|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4165093|NCT00830518|3986344|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4165094|NCT00830518|3986342|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4165095|NCT00830518|3986343|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4165096|NCT00830518|3986344|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4165097|NCT00830518|3986342|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4165098|NCT00830518|3986343|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4165099|NCT00830518|3986344|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4165100|NCT00830518|3986342|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4165101|NCT00830518|3986343|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4165102|NCT00830518|3986344|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4165103|NCT00830518|3986342|B3|≥60 years||Age, Customized||participants|Number|51|51.0||||||
4165104|NCT00830518|3986343|B2|≥60 years||Age, Customized||participants|Number|9|9.0||||||
4165105|NCT00830518|3986344|B1|≥60 years||Age, Customized||participants|Number|42|42.0||||||
4165106|NCT00830518|3986342|B3|<60 years||Age, Customized||participants|Number|6|6.0||||||
4165107|NCT00830518|3986343|B2|<60 years||Age, Customized||participants|Number|2|2.0||||||
4165108|NCT00830518|3986344|B1|<60 years||Age, Customized||participants|Number|4|4.0||||||
4165109|NCT00830518|3986342|B3|||Age||years|Mean|71.4|71.4|Standard Deviation|8.54|8.54|||
4165110|NCT00830518|3986343|B2|||Age||years|Mean|69.5|69.5|Standard Deviation|12.50|12.5|||
4165111|NCT00830518|3986344|B1|||Age||years|Mean|71.9|71.9|Standard Deviation|7.41|7.41|||
4165112|NCT00830440|3986362|B3|Netherlands||Region of Enrollment||participants|Number|37|37.0||||||
4165113|NCT00830440|3986363|B2|Netherlands||Region of Enrollment||participants|Number|11|11.0||||||
4165114|NCT00830440|3986364|B1|Netherlands||Region of Enrollment||participants|Number|26|26.0||||||
4165115|NCT00830440|3986362|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4165116|NCT00830440|3986363|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4165117|NCT00830440|3986364|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4165118|NCT00830440|3986362|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4165119|NCT00830440|3986363|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4165120|NCT00830440|3986364|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4165121|NCT00830440|3986362|B3|||Age||years|Mean|41.0|41.0|Standard Deviation|9.53|9.53|||
4165122|NCT00830440|3986363|B2|||Age||years|Mean|41.2|41.2|Standard Deviation|10.46|10.46|||
4165123|NCT00830440|3986364|B1|||Age||years|Mean|40.9|40.9|Standard Deviation|9.33|9.33|||
4165124|NCT00830388|3986375|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4165125|NCT00830388|3986375|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4165126|NCT00830388|3986375|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4165127|NCT00830388|3986375|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4165128|NCT00830388|3986375|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4165129|NCT00830388|3986375|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165130|NCT00830375|3986380|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4165131|NCT00830375|3986380|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4165132|NCT00830375|3986380|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4165133|NCT00830375|3986380|B1|||Age||years|Mean|32|32.0|Standard Deviation|12.4|12.4|||
4165134|NCT00830375|3986380|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4165135|NCT00830375|3986380|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4165136|NCT00830375|3986380|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165137|NCT00830362|3986384|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4165138|NCT00830362|3986385|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4165139|NCT00830362|3986386|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4165140|NCT00830362|3986384|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4165141|NCT00830362|3986385|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4165142|NCT00830362|3986386|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4165143|NCT00830362|3986384|B3|||Age||years|Mean|39.9|39.9|Standard Deviation|1.3|1.3|||
4165144|NCT00830362|3986385|B2|||Age||years|Mean|40.8|40.8|Standard Deviation|2.0|2.0|||
4165145|NCT00830362|3986386|B1|||Age||years|Mean|39.1|39.1|Standard Deviation|1.6|1.6|||
4165146|NCT00830336|3986393|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
4165147|NCT00830336|3986394|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4165148|NCT00830336|3986395|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4165149|NCT00830336|3986393|B3|Pacific Islander/Hawaiian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4165150|NCT00830336|3986394|B2|Pacific Islander/Hawaiian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4165151|NCT00830336|3986395|B1|Pacific Islander/Hawaiian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4165152|NCT00830336|3986393|B3|Native American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4165153|NCT00830336|3986394|B2|Native American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4165154|NCT00830336|3986395|B1|Native American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4165155|NCT00830336|3986393|B3|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4165156|NCT00830336|3986394|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4165157|NCT00830336|3986395|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4165158|NCT00830336|3986393|B3|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4165159|NCT00830336|3986394|B2|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4165160|NCT00830336|3986395|B1|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4165161|NCT00830336|3986393|B3|White||Race/Ethnicity, Customized||Participants|Number|74|74.0||||||
4165162|NCT00830336|3986394|B2|White||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
4165163|NCT00830336|3986395|B1|White||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
4165164|NCT00830336|3986393|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4165165|NCT00830336|3986394|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4165166|NCT00830336|3986395|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4165167|NCT00830336|3986393|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4165168|NCT00830336|3986394|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4165169|NCT00830336|3986395|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4165170|NCT00830336|3986393|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4165171|NCT00830336|3986394|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4165172|NCT00830336|3986395|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4165173|NCT00830336|3986393|B3||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
4165174|NCT00830336|3986394|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4165175|NCT00830336|3986395|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4165176|NCT00830336|3986393|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165177|NCT00830336|3986394|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165178|NCT00830336|3986395|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165179|NCT00830310|3986404|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4165180|NCT00830310|3986404|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165181|NCT00830310|3986404|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165182|NCT00830310|3986404|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4165183|NCT00830310|3986404|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4165184|NCT00830310|3986404|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165185|NCT00830310|3986404|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165186|NCT00830310|3986404|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165187|NCT00830310|3986404|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4165188|NCT00830310|3986404|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4165189|NCT00830310|3986404|B1|||Age||years|Mean|43.1|43.1|Standard Deviation|11.3|11.3|||
4165190|NCT00830310|3986404|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4165191|NCT00830310|3986404|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4165192|NCT00830310|3986404|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165193|NCT00830284|3986416|B1|||Patients had to meet the ALI criteria||Participants|Count of Participants|10|10.0||||||
4165194|NCT00830284|3986416|B1||Male|Gender||Participants|Count of Participants|2|2.0||||||
4165195|NCT00830284|3986416|B1||Female|Gender||Participants|Count of Participants|8|8.0||||||
4165196|NCT00830284|3986416|B1|||Age||years|Mean|9.35|9.35|Standard Deviation|2.3|2.3|||
4165197|NCT00830284|3986416|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4165198|NCT00830284|3986416|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4165199|NCT00830284|3986416|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4165200|NCT00830258|3986421|B3|Canada||Region of Enrollment||participants|Number|60|60.0||||||
4165201|NCT00830258|3986422|B2|Canada||Region of Enrollment||participants|Number|30|30.0||||||
4165202|NCT00830258|3986423|B1|Canada||Region of Enrollment||participants|Number|30|30.0||||||
4165203|NCT00830258|3986421|B3|Asian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4165204|NCT00830258|3986422|B2|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4165205|NCT00830258|3986423|B1|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4165206|NCT00830258|3986421|B3|Black||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4165207|NCT00830258|3986422|B2|Black||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4165208|NCT00830258|3986423|B1|Black||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4165209|NCT00830258|3986421|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|43|43.0||||||
4165210|NCT00830258|3986422|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4165211|NCT00830258|3986423|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
4165212|NCT00830258|3986421|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4165213|NCT00830258|3986422|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4165214|NCT00830258|3986423|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4165215|NCT00830258|3986421|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4165216|NCT00830258|3986422|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4165217|NCT00830258|3986423|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4165218|NCT00830258|3986421|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4165219|NCT00830258|3986422|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4165220|NCT00830258|3986423|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4165221|NCT00830258|3986421|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4165222|NCT00830258|3986422|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4165223|NCT00830258|3986423|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4165224|NCT00830258|3986421|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165225|NCT00830258|3986422|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165226|NCT00830258|3986423|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165227|NCT00830232|3986432|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4165228|NCT00830232|3986433|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4165229|NCT00830232|3986434|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4165230|NCT00830232|3986432|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4165231|NCT00830232|3986433|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4165232|NCT00830232|3986434|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4165233|NCT00830232|3986432|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4165234|NCT00830232|3986433|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4165235|NCT00830232|3986434|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4165236|NCT00830232|3986432|B3|||Age||years|Mean|66.7|66.7|Standard Deviation|8.2|8.2|||
4165237|NCT00830232|3986433|B2|||Age||years|Mean|67|67.0|Standard Deviation|8.5|8.5|||
4165238|NCT00830232|3986434|B1|||Age||years|Mean|66|66.0|Standard Deviation|8.07|8.07|||
4165239|NCT00830232|3986432|B3||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4165240|NCT00830232|3986433|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4165241|NCT00830232|3986434|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4165242|NCT00830232|3986432|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4165243|NCT00830232|3986433|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4165244|NCT00830232|3986434|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4165245|NCT00830232|3986432|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165246|NCT00830232|3986433|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165247|NCT00830232|3986434|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165248|NCT00830219|3986441|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
4165249|NCT00830219|3986442|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4165250|NCT00830219|3986443|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4165251|NCT00830219|3986441|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4165252|NCT00830219|3986442|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4165253|NCT00830219|3986443|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4165254|NCT00830219|3986441|B3|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4165255|NCT00830219|3986442|B2|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4165256|NCT00830219|3986443|B1|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4165257|NCT00830219|3986441|B3|Black||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4165258|NCT00830219|3986442|B2|Black||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4165259|NCT00830219|3986443|B1|Black||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4165260|NCT00830219|3986441|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4165261|NCT00830219|3986442|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4165262|NCT00830219|3986443|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4165263|NCT00830219|3986441|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4165264|NCT00830219|3986442|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4165265|NCT00830219|3986443|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4165266|NCT00830219|3986441|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4165267|NCT00830219|3986442|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4165268|NCT00830219|3986443|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4165269|NCT00830219|3986441|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4165270|NCT00830219|3986442|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4165271|NCT00830219|3986443|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4165272|NCT00830219|3986441|B3||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4165273|NCT00830219|3986442|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4165274|NCT00830219|3986443|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4165275|NCT00830219|3986441|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165276|NCT00830219|3986442|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165277|NCT00830219|3986443|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165278|NCT00830206|3986452|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
4165279|NCT00830206|3986453|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4165280|NCT00830206|3986454|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4165281|NCT00830206|3986452|B3|Native American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4165282|NCT00830206|3986453|B2|Native American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4165283|NCT00830206|3986454|B1|Native American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4165284|NCT00830206|3986452|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4165285|NCT00830206|3986453|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4165286|NCT00830206|3986454|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4165287|NCT00830206|3986452|B3|Black||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4165288|NCT00830206|3986453|B2|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4165289|NCT00830206|3986454|B1|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4165290|NCT00830206|3986452|B3|White||Race/Ethnicity, Customized||Participants|Number|73|73.0||||||
4165291|NCT00830206|3986453|B2|White||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
4165292|NCT00830206|3986454|B1|White||Race/Ethnicity, Customized||Participants|Number|38|38.0||||||
4165293|NCT00830206|3986452|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4165294|NCT00830206|3986453|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4165295|NCT00830206|3986454|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4165296|NCT00830206|3986452|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4165297|NCT00830206|3986453|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4165298|NCT00830206|3986454|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4165299|NCT00830206|3986452|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4165300|NCT00830206|3986453|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4165301|NCT00830206|3986454|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4165302|NCT00830206|3986452|B3||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
4165303|NCT00830206|3986453|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4165304|NCT00830206|3986454|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4165305|NCT00830206|3986452|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165306|NCT00830206|3986453|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165307|NCT00830206|3986454|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165308|NCT00830167|3986463|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4165309|NCT00830167|3986464|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4165310|NCT00830167|3986465|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4165311|NCT00830167|3986463|B3||Female|Sex: Female, Male||Participants|Count of Participants|443|443.0||||||
4165312|NCT00830167|3986464|B2||Female|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
4165313|NCT00830167|3986465|B1||Female|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
4165314|NCT00830167|3986463|B3|>=65 years||Age, Customized||Participants|Number|45|45.0||||||
4165315|NCT00830167|3986464|B2|>=65 years||Age, Customized||Participants|Number|24|24.0||||||
4165316|NCT00830167|3986465|B1|>=65 years||Age, Customized||Participants|Number|21|21.0||||||
4165317|NCT00830167|3986463|B3|Between 45 years and 64 years||Age, Customized||Participants|Number|248|248.0||||||
4165318|NCT00830167|3986464|B2|Between 45 years and 64 years||Age, Customized||Participants|Number|125|125.0||||||
4165319|NCT00830167|3986465|B1|Between 45 years and 64 years||Age, Customized||Participants|Number|123|123.0||||||
4165320|NCT00830167|3986463|B3|Between 18 years and 44 years||Age, Customized||Participants|Number|205|205.0||||||
4165321|NCT00830167|3986464|B2|Between 18 years and 44 years||Age, Customized||Participants|Number|101|101.0||||||
4165322|NCT00830167|3986465|B1|Between 18 years and 44 years||Age, Customized||Participants|Number|104|104.0||||||
4165323|NCT00830167|3986463|B3|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4165324|NCT00830167|3986464|B2|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4165325|NCT00830167|3986465|B1|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4165326|NCT00830128|3986536|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4165327|NCT00830128|3986536|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4165328|NCT00830128|3986536|B1|>= 65 years||Age, Customized||Participants|Number|10|10.0||||||
4165329|NCT00830128|3986536|B1|Between 45 and 64 years||Age, Customized||Participants|Number|49|49.0||||||
4165330|NCT00830128|3986536|B1|Between 18 and 44 years||Age, Customized||Participants|Number|47|47.0||||||
4165331|NCT00830128|3986536|B1|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4165332|NCT00830115|3986551|B1|Missing data||Nicotine use||participants|Number|18|18.0||||||
4165333|NCT00830115|3986551|B1|Non-smoker||Nicotine use||participants|Number|685|685.0||||||
4165334|NCT00830115|3986551|B1|Smoker||Nicotine use||participants|Number|342|342.0||||||
4165335|NCT00830115|3986551|B1|Missing data||Drug abuse||participants|Number|15|15.0||||||
4165336|NCT00830115|3986551|B1|No drug abuse||Drug abuse||participants|Number|1016|1016.0||||||
4165337|NCT00830115|3986551|B1|Drug abuse||Drug abuse||participants|Number|14|14.0||||||
4165338|NCT00830115|3986551|B1|Missing Data||Diagnosis: reflux disease||participants|Number|3|3.0||||||
4165339|NCT00830115|3986551|B1|eGERD (Erosive Gastro-Esophageal Reflux Disease)||Diagnosis: reflux disease||participants|Number|649|649.0||||||
4165340|NCT00830115|3986551|B1|NERD (Non-Erosive Reflux Disease)||Diagnosis: reflux disease||participants|Number|393|393.0||||||
4165341|NCT00830115|3986551|B1|Missing data||Alcohol use||participants|Number|10|10.0||||||
4165342|NCT00830115|3986551|B1|Not daily||Alcohol use||participants|Number|862|862.0||||||
4165343|NCT00830115|3986551|B1|Daily||Alcohol use||participants|Number|173|173.0||||||
4165344|NCT00830115|3986551|B1|Missing data||Sex/Gender, Customized||participants|Number|2|2.0||||||
4165345|NCT00830115|3986551|B1|Male||Sex/Gender, Customized||participants|Number|563|563.0||||||
4165346|NCT00830115|3986551|B1|Female||Sex/Gender, Customized||participants|Number|480|480.0||||||
4165347|NCT00830115|3986551|B1|||Age|The measured value is related to the number of 1041 subjects (= valid cases). This number differs from the overall number of baseline participants due to missing data for 4 subjects.|years|Mean|52.9|52.9|Standard Deviation|15.39|15.39|||
4165348|NCT00830076|3986567|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4165349|NCT00830076|3986567|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4165350|NCT00830076|3986567|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4165351|NCT00830076|3986567|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4165352|NCT00830076|3986567|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4165353|NCT00830076|3986567|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165354|NCT00830037|3986576|B3|Low proteinuria stratum (<3g/g)||Proteinuria|Proteinuria was estimated using measurements of urinary protein and creatinine before iron administration at baseline|participants|Number|118|118.0||||||
4165355|NCT00830037|3986577|B2|Low proteinuria stratum (<3g/g)||Proteinuria|Proteinuria was estimated using measurements of urinary protein and creatinine before iron administration at baseline|participants|Number|60|60.0||||||
4165356|NCT00830037|3986578|B1|Low proteinuria stratum (<3g/g)||Proteinuria|Proteinuria was estimated using measurements of urinary protein and creatinine before iron administration at baseline|participants|Number|58|58.0||||||
4165357|NCT00830037|3986576|B3|High proteinuria stratum (≥3g/g)||Proteinuria|Proteinuria was estimated using measurements of urinary protein and creatinine before iron administration at baseline|participants|Number|18|18.0||||||
4165358|NCT00830037|3986577|B2|High proteinuria stratum (≥3g/g)||Proteinuria|Proteinuria was estimated using measurements of urinary protein and creatinine before iron administration at baseline|participants|Number|9|9.0||||||
4165359|NCT00830037|3986578|B1|High proteinuria stratum (≥3g/g)||Proteinuria|Proteinuria was estimated using measurements of urinary protein and creatinine before iron administration at baseline|participants|Number|9|9.0||||||
4165360|NCT00830037|3986576|B3|||eGFR|Estimated GFR by the four-component MDRD (Modification of Diet in Renal Disease) formula|ml/min per 1.73m2|Mean|34.5|34.5|Standard Deviation|10.0|10.0|||
4165361|NCT00830037|3986577|B2|||eGFR|Estimated GFR by the four-component MDRD (Modification of Diet in Renal Disease) formula|ml/min per 1.73m2|Mean|34.7|34.7|Standard Deviation|10.0|10.0|||
4165362|NCT00830037|3986578|B1|||eGFR|Estimated GFR by the four-component MDRD (Modification of Diet in Renal Disease) formula|ml/min per 1.73m2|Mean|34.3|34.3|Standard Deviation|10.2|10.2|||
4165363|NCT00830037|3986576|B3|White||Race/Ethnicity, Customized||participants|Number|89|89.0||||||
4165364|NCT00830037|3986577|B2|White||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4165365|NCT00830037|3986578|B1|White||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4165366|NCT00830037|3986576|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4165367|NCT00830037|3986577|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4165368|NCT00830037|3986578|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4165369|NCT00830037|3986576|B3|Black||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4165370|NCT00830037|3986577|B2|Black||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4165371|NCT00830037|3986578|B1|Black||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4165372|NCT00830037|3986576|B3||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4165373|NCT00830037|3986577|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4165374|NCT00830037|3986578|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4165375|NCT00830037|3986576|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4165376|NCT00830037|3986577|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4165377|NCT00830037|3986578|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4165378|NCT00830037|3986576|B3|||Age||years|Mean|65.5|65.5|Standard Deviation|11.3|11.3|||
4165379|NCT00830037|3986577|B2|||Age||years|Mean|67.8|67.8|Standard Deviation|11.5|11.5|||
4165380|NCT00830037|3986578|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|10.7|10.7|||
4165381|NCT00830024|3986587|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4165382|NCT00830024|3986588|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4165383|NCT00830024|3986589|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4165384|NCT00830024|3986587|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4165385|NCT00830024|3986588|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4165386|NCT00830024|3986589|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4165387|NCT00830024|3986587|B3|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4165388|NCT00830024|3986588|B2|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4165389|NCT00830024|3986589|B1|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4165390|NCT00830024|3986587|B3|White||Race/Ethnicity, Customized||Participants|Number|34|34.0||||||
4165391|NCT00830024|3986588|B2|White||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4165392|NCT00830024|3986589|B1|White||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4165393|NCT00830024|3986587|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4165394|NCT00830024|3986588|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4165395|NCT00830024|3986589|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4165396|NCT00830024|3986587|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4165397|NCT00830024|3986588|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4165398|NCT00830024|3986589|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4165399|NCT00830024|3986587|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4165400|NCT00830024|3986588|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4165401|NCT00830024|3986589|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4165402|NCT00830024|3986587|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4165403|NCT00830024|3986588|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4165404|NCT00830024|3986589|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4165405|NCT00830024|3986587|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165406|NCT00830024|3986588|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165407|NCT00830024|3986589|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165408|NCT00829998|3986598|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
4165409|NCT00829998|3986599|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4165410|NCT00829998|3986600|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4165411|NCT00829998|3986598|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4165412|NCT00829998|3986599|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4165413|NCT00829998|3986600|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4165414|NCT00829998|3986598|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4165415|NCT00829998|3986599|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4165416|NCT00829998|3986600|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4165417|NCT00829998|3986598|B3|Black||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
4165418|NCT00829998|3986599|B2|Black||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4165419|NCT00829998|3986600|B1|Black||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4165420|NCT00829998|3986598|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4165421|NCT00829998|3986599|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4165422|NCT00829998|3986600|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4165423|NCT00829998|3986598|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4165424|NCT00829998|3986599|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4165425|NCT00829998|3986600|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4165426|NCT00829998|3986598|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4165427|NCT00829998|3986599|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4165428|NCT00829998|3986600|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4165429|NCT00829998|3986598|B3||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4165430|NCT00829998|3986599|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4165431|NCT00829998|3986600|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4165432|NCT00829998|3986598|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165433|NCT00829998|3986599|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165434|NCT00829998|3986600|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165435|NCT00829985|3986609|B3|||German Cockroach-Specific Serum Immunoglobulin Subclass 4 (IgG4) Levels||mg/mL|Median|0.09|0.09|Full Range|||0.01|3.59|
4165436|NCT00829985|3986610|B2|||German Cockroach-Specific Serum Immunoglobulin Subclass 4 (IgG4) Levels||mg/mL|Median|0.08|0.08|Full Range|||0.02|1.03|
4165437|NCT00829985|3986611|B1|||German Cockroach-Specific Serum Immunoglobulin Subclass 4 (IgG4) Levels||mg/mL|Median|0.19|0.19|Full Range|||0.01|3.59|
4165438|NCT00829985|3986609|B3|||German Cockroach-Specific Serum IgE Levels||kU/L|Median|2.0|2.0|Full Range|||0.4|150.0|
4165439|NCT00829985|3986610|B2|||German Cockroach-Specific Serum IgE Levels||kU/L|Median|2.9|2.9|Full Range|||0.4|113.3|
4165440|NCT00829985|3986611|B1|||German Cockroach-Specific Serum IgE Levels||kU/L|Median|1.9|1.9|Full Range|||0.4|150.0|
4165441|NCT00829985|3986609|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
4165442|NCT00829985|3986610|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4165443|NCT00829985|3986611|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4165444|NCT00829985|3986609|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4165445|NCT00829985|3986610|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4165446|NCT00829985|3986611|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4165447|NCT00829985|3986609|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4165448|NCT00829985|3986610|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4165449|NCT00829985|3986611|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4165450|NCT00829985|3986609|B3|||Age||years|Mean|32|32.0|Standard Deviation|10.6|10.6|||
4165451|NCT00829985|3986610|B2|||Age||years|Mean|33|33.0|Standard Deviation|11.4|11.4|||
4165452|NCT00829985|3986611|B1|||Age||years|Mean|31|31.0|Standard Deviation|9.9|9.9|||
4165453|NCT00829933|3986626|B5|Japan||Region of Enrollment||participants|Number|525|525.0||||||
4165454|NCT00829933|3986627|B4|Japan||Region of Enrollment||participants|Number|129|129.0||||||
4165455|NCT00829933|3986628|B3|Japan||Region of Enrollment||participants|Number|131|131.0||||||
4165456|NCT00829933|3986629|B2|Japan||Region of Enrollment||participants|Number|134|134.0||||||
4165457|NCT00829933|3986630|B1|Japan||Region of Enrollment||participants|Number|131|131.0||||||
4165458|NCT00829933|3986626|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165459|NCT00829933|3986627|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165460|NCT00829933|3986628|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165461|NCT00829933|3986629|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165462|NCT00829933|3986630|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165463|NCT00829933|3986626|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165464|NCT00829933|3986627|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165465|NCT00829933|3986628|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165466|NCT00829933|3986629|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165467|NCT00829933|3986630|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165468|NCT00829933|3986626|B5||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165469|NCT00829933|3986627|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165470|NCT00829933|3986628|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165471|NCT00829933|3986629|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165472|NCT00829933|3986630|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165473|NCT00829933|3986626|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165474|NCT00829933|3986627|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165475|NCT00829933|3986628|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165476|NCT00829933|3986629|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165477|NCT00829933|3986630|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165478|NCT00829933|3986626|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165479|NCT00829933|3986627|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165480|NCT00829933|3986628|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165481|NCT00829933|3986629|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165482|NCT00829933|3986630|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165483|NCT00829933|3986626|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|525|525.0||||||
4165484|NCT00829933|3986627|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
4165485|NCT00829933|3986628|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
4165486|NCT00829933|3986629|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
4165487|NCT00829933|3986630|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
4165488|NCT00829933|3986626|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165489|NCT00829933|3986627|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165490|NCT00829933|3986628|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165491|NCT00829933|3986629|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165492|NCT00829933|3986630|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165493|NCT00829933|3986626|B5||Male|Sex: Female, Male||Participants|Count of Participants|433|433.0||||||
4165494|NCT00829933|3986627|B4||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4165495|NCT00829933|3986628|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4165496|NCT00829933|3986629|B2||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4165497|NCT00829933|3986630|B1||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4165498|NCT00829933|3986626|B5||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4165499|NCT00829933|3986627|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4165500|NCT00829933|3986628|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4165501|NCT00829933|3986629|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4165502|NCT00829933|3986630|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4165503|NCT00829933|3986626|B5|||Age||years|Mean|69.0|69.0|Standard Deviation|8.2|8.2|||
4165504|NCT00829933|3986627|B4|||Age||years|Mean|68.8|68.8|Standard Deviation|8.2|8.2|||
4165505|NCT00829933|3986628|B3|||Age||years|Mean|68.4|68.4|Standard Deviation|8.2|8.2|||
4165506|NCT00829933|3986629|B2|||Age||years|Mean|69.5|69.5|Standard Deviation|8.8|8.8|||
4165507|NCT00829933|3986630|B1|||Age||years|Mean|69.4|69.4|Standard Deviation|7.5|7.5|||
4165508|NCT00829868|3986643|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4165509|NCT00829868|3986644|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4165510|NCT00829868|3986645|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4165511|NCT00829868|3986643|B3|Biracial||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4165512|NCT00829868|3986644|B2|Biracial||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4165513|NCT00829868|3986645|B1|Biracial||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4165514|NCT00829868|3986643|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4165515|NCT00829868|3986644|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4165516|NCT00829868|3986645|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4165517|NCT00829868|3986643|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4165518|NCT00829868|3986644|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4165519|NCT00829868|3986645|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4165520|NCT00829868|3986643|B3|Black||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4165521|NCT00829868|3986644|B2|Black||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4165522|NCT00829868|3986645|B1|Black||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4165523|NCT00829868|3986643|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4165524|NCT00829868|3986644|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4165525|NCT00829868|3986645|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4165526|NCT00829868|3986643|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4165527|NCT00829868|3986644|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4165528|NCT00829868|3986645|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4165529|NCT00829868|3986643|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4165530|NCT00829868|3986644|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4165531|NCT00829868|3986645|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4165532|NCT00829868|3986643|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4165533|NCT00829868|3986644|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4165534|NCT00829868|3986645|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4165535|NCT00829868|3986643|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165536|NCT00829868|3986644|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165537|NCT00829868|3986645|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165538|NCT00829829|3986654|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165539|NCT00829829|3986655|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165540|NCT00829829|3986656|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165541|NCT00829829|3986657|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165542|NCT00829829|3986654|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165543|NCT00829829|3986655|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165544|NCT00829829|3986656|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165545|NCT00829829|3986657|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165546|NCT00829829|3986654|B4||White|Race (NIH/OMB)||Participants|Count of Participants|193|193.0||||||
4165547|NCT00829829|3986655|B3||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
4165548|NCT00829829|3986656|B2||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4165549|NCT00829829|3986657|B1||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4165550|NCT00829829|3986654|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4165551|NCT00829829|3986655|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4165552|NCT00829829|3986656|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4165553|NCT00829829|3986657|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4165554|NCT00829829|3986654|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4165555|NCT00829829|3986655|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4165556|NCT00829829|3986656|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165557|NCT00829829|3986657|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165558|NCT00829829|3986654|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4165559|NCT00829829|3986655|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4165560|NCT00829829|3986656|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4165561|NCT00829829|3986657|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4165562|NCT00829829|3986654|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165563|NCT00829829|3986655|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165564|NCT00829829|3986656|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165565|NCT00829829|3986657|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165566|NCT00829829|3986654|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165567|NCT00829829|3986655|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165568|NCT00829829|3986656|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165569|NCT00829829|3986657|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165570|NCT00829829|3986654|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|234|234.0||||||
4165571|NCT00829829|3986655|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
4165572|NCT00829829|3986656|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
4165573|NCT00829829|3986657|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
4165574|NCT00829829|3986654|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4165575|NCT00829829|3986655|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4165576|NCT00829829|3986656|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4165577|NCT00829829|3986657|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4165578|NCT00829829|3986654|B4||Male|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4165579|NCT00829829|3986655|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4165580|NCT00829829|3986656|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4165581|NCT00829829|3986657|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4165582|NCT00829829|3986654|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4165583|NCT00829829|3986655|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4165584|NCT00829829|3986656|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4165585|NCT00829829|3986657|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4165586|NCT00829829|3986654|B4|||Age||years|Mean|52.3|52.3|Standard Deviation|12.6|12.6|||
4165587|NCT00829829|3986655|B3|||Age||years|Mean|51.9|51.9|Standard Deviation|11.6|11.6|||
4165588|NCT00829829|3986656|B2|||Age||years|Mean|52.9|52.9|Standard Deviation|12.5|12.5|||
4165589|NCT00829829|3986657|B1|||Age||years|Mean|52.2|52.2|Standard Deviation|13.6|13.6|||
4165590|NCT00829790|3986682|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4165591|NCT00829790|3986683|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4165592|NCT00829790|3986684|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4165593|NCT00829790|3986682|B3|More than One||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4165594|NCT00829790|3986683|B2|More than One||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4165595|NCT00829790|3986684|B1|More than One||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4165596|NCT00829790|3986682|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4165597|NCT00829790|3986683|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4165598|NCT00829790|3986684|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4165599|NCT00829790|3986682|B3|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4165600|NCT00829790|3986683|B2|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4165601|NCT00829790|3986684|B1|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4165602|NCT00829790|3986682|B3|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4165603|NCT00829790|3986683|B2|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4165604|NCT00829790|3986684|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4165605|NCT00829790|3986682|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4165606|NCT00829790|3986683|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4165607|NCT00829790|3986684|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4165608|NCT00829790|3986682|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4165609|NCT00829790|3986683|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4165610|NCT00829790|3986684|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4165611|NCT00829790|3986682|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4165612|NCT00829790|3986683|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4165613|NCT00829790|3986684|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4165614|NCT00829790|3986682|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4165615|NCT00829790|3986683|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4165616|NCT00829790|3986684|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4165617|NCT00829790|3986682|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165618|NCT00829790|3986683|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165619|NCT00829790|3986684|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165620|NCT00829764|3986693|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4165621|NCT00829764|3986694|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4165622|NCT00829764|3986695|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4165623|NCT00829764|3986693|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4165624|NCT00829764|3986694|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4165625|NCT00829764|3986695|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4165626|NCT00829764|3986693|B3|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4165627|NCT00829764|3986694|B2|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4165628|NCT00829764|3986695|B1|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4165629|NCT00829764|3986693|B3|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4165630|NCT00829764|3986694|B2|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4165631|NCT00829764|3986695|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4165632|NCT00829764|3986693|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4165633|NCT00829764|3986694|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4165634|NCT00829764|3986695|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4165635|NCT00829764|3986693|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4165636|NCT00829764|3986694|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4165637|NCT00829764|3986695|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4165638|NCT00829764|3986693|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4165639|NCT00829764|3986694|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4165640|NCT00829764|3986695|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4165641|NCT00829764|3986693|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4165642|NCT00829764|3986694|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4165643|NCT00829764|3986695|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4165644|NCT00829764|3986693|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165645|NCT00829764|3986694|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165646|NCT00829764|3986695|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165647|NCT00829738|3986704|B1|Missing data||Indication for prescription of pantoprazole||percentage of participants|Number|3.0|3.0||||||
4165648|NCT00829738|3986704|B1|Acute reflux oesophagitis||Indication for prescription of pantoprazole||percentage of participants|Number|57.2|57.2||||||
4165649|NCT00829738|3986704|B1|Long-term therapy and/or relapse prophylaxis||Indication for prescription of pantoprazole||percentage of participants|Number|39.8|39.8||||||
4165650|NCT00829738|3986704|B1|Missing data||Drug abuse||percentage of participants|Number|0.9|0.9||||||
4165651|NCT00829738|3986704|B1|No drug abuse||Drug abuse||percentage of participants|Number|95.5|95.5||||||
4165652|NCT00829738|3986704|B1|Drug abuse||Drug abuse||percentage of participants|Number|3.6|3.6||||||
4165653|NCT00829738|3986704|B1|Missing data||Alcohol use||percentage of participants|Number|0.6|0.6||||||
4165654|NCT00829738|3986704|B1|Not daily||Alcohol use||percentage of participants|Number|77.4|77.4||||||
4165655|NCT00829738|3986704|B1|Daily||Alcohol use||percentage of participants|Number|21.9|21.9||||||
4165656|NCT00829738|3986704|B1|Missing data||Nicotine use||percentage of participants|Number|0.4|0.4||||||
4165657|NCT00829738|3986704|B1|Non-smoker||Nicotine use||percentage of participants|Number|62.8|62.8||||||
4165658|NCT00829738|3986704|B1|Smoker||Nicotine use||percentage of participants|Number|36.7|36.7||||||
4165659|NCT00829738|3986704|B1|Missing data||Sex/Gender, Customized||percentage of participants|Number|0.4|0.4||||||
4165660|NCT00829738|3986704|B1|Male||Sex/Gender, Customized||percentage of participants|Number|52.0|52.0||||||
4165661|NCT00829738|3986704|B1|Female||Sex/Gender, Customized||percentage of participants|Number|47.6|47.6||||||
4165662|NCT00829738|3986704|B1|||Age|The measured value is related to the number of 4125 subjects (= valid cases). This number differs from the overall number of baseline participants due to missing data for 63 subjects.|years|Mean|55.3|55.3|Standard Deviation|14.82|14.82|||
4165663|NCT00829712|3986720|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4165664|NCT00829712|3986721|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4165665|NCT00829712|3986722|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4165666|NCT00829712|3986720|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4165667|NCT00829712|3986721|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4165668|NCT00829712|3986722|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4165669|NCT00829712|3986720|B3|White||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4165670|NCT00829712|3986721|B2|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4165671|NCT00829712|3986722|B1|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4165672|NCT00829712|3986720|B3|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4165673|NCT00829712|3986721|B2|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4165674|NCT00829712|3986722|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4165675|NCT00829712|3986720|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4165676|NCT00829712|3986721|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4165677|NCT00829712|3986722|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4165678|NCT00829712|3986720|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4165679|NCT00829712|3986721|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4165680|NCT00829712|3986722|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4165681|NCT00829712|3986720|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4165682|NCT00829712|3986721|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4165683|NCT00829712|3986722|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4165684|NCT00829712|3986720|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4165685|NCT00829712|3986721|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4165686|NCT00829712|3986722|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4165687|NCT00829712|3986720|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165688|NCT00829712|3986721|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165689|NCT00829712|3986722|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165690|NCT00829686|3986731|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4165691|NCT00829686|3986732|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4165692|NCT00829686|3986733|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4165693|NCT00829686|3986731|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4165694|NCT00829686|3986732|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4165695|NCT00829686|3986733|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4165696|NCT00829686|3986731|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4165697|NCT00829686|3986732|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4165698|NCT00829686|3986733|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4165699|NCT00829686|3986731|B3|Age 41-65 years||Age, Customized||Participants|Count of Participants|13|13.0||||||
4165700|NCT00829686|3986732|B2|Age 41-65 years||Age, Customized||Participants|Count of Participants|8|8.0||||||
4165701|NCT00829686|3986733|B1|Age 41-65 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
4165702|NCT00829686|3986731|B3|Age 26-40 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
4165703|NCT00829686|3986732|B2|Age 26-40 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
4165704|NCT00829686|3986733|B1|Age 26-40 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
4165705|NCT00829686|3986731|B3|Age 18-25 years||Age, Customized||Participants|Count of Participants|13|13.0||||||
4165706|NCT00829686|3986732|B2|Age 18-25 years||Age, Customized||Participants|Count of Participants|7|7.0||||||
4165707|NCT00829686|3986733|B1|Age 18-25 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
4165708|NCT00829686|3986731|B3|||Age||years|Mean|34.3|34.3|Standard Deviation|2|2.0|||
4165709|NCT00829686|3986732|B2|||Age||years|Mean|34.5|34.5|Standard Deviation|2|2.0|||
4165710|NCT00829686|3986733|B1|||Age||years|Mean|33.4|33.4|Standard Deviation|2|2.0|||
4165711|NCT00829686|3986731|B3||>=65 years|Age|Age (Years)|Participants|Count of Participants|0|0.0||||||
4165712|NCT00829686|3986732|B2||>=65 years|Age|Age (Years)|Participants|Count of Participants|0|0.0||||||
4165713|NCT00829686|3986733|B1||>=65 years|Age|Age (Years)|Participants|Count of Participants|0|0.0||||||
4165714|NCT00829686|3986731|B3||Between 18 and 65 years|Age|Age (Years)|Participants|Count of Participants|31|31.0||||||
4165715|NCT00829686|3986732|B2||Between 18 and 65 years|Age|Age (Years)|Participants|Count of Participants|18|18.0||||||
4165716|NCT00829686|3986733|B1||Between 18 and 65 years|Age|Age (Years)|Participants|Count of Participants|13|13.0||||||
4165717|NCT00829686|3986731|B3||<=18 years|Age|Age (Years)|Participants|Count of Participants|0|0.0||||||
4165718|NCT00829686|3986732|B2||<=18 years|Age|Age (Years)|Participants|Count of Participants|0|0.0||||||
4165719|NCT00829686|3986733|B1||<=18 years|Age|Age (Years)|Participants|Count of Participants|0|0.0||||||
4165720|NCT00829673|3986740|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4165721|NCT00829673|3986741|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4165722|NCT00829673|3986742|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4165723|NCT00829673|3986740|B3|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4165724|NCT00829673|3986741|B2|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4165725|NCT00829673|3986742|B1|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4165726|NCT00829673|3986740|B3|Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4165727|NCT00829673|3986741|B2|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4165728|NCT00829673|3986742|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4165729|NCT00829673|3986740|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4165730|NCT00829673|3986741|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4165731|NCT00829673|3986742|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4165732|NCT00829673|3986740|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4165733|NCT00829673|3986741|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4165734|NCT00829673|3986742|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4165735|NCT00829673|3986740|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4165736|NCT00829673|3986741|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4165737|NCT00829673|3986742|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4165738|NCT00829673|3986740|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4165739|NCT00829673|3986741|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4165740|NCT00829673|3986742|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4165741|NCT00829673|3986740|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165742|NCT00829673|3986741|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165743|NCT00829673|3986742|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165744|NCT00829621|3986751|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4165745|NCT00829621|3986752|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4165746|NCT00829621|3986753|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4165747|NCT00829621|3986751|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4165748|NCT00829621|3986752|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4165749|NCT00829621|3986753|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4165750|NCT00829621|3986751|B3|||Age||years|Mean|43|43.0|Standard Deviation|17|17.0|||
4165751|NCT00829621|3986752|B2|||Age||years|Mean|42.1|42.1|Standard Deviation|16.6|16.6|||
4165752|NCT00829621|3986753|B1|||Age||years|Mean|45|45.0|Standard Deviation|17.5|17.5|||
4165753|NCT00829530|3986760|B3|Canada||Region of Enrollment||participants|Number|40|40.0||||||
4165754|NCT00829530|3986761|B2|Canada||Region of Enrollment||participants|Number|20|20.0||||||
4165755|NCT00829530|3986762|B1|Canada||Region of Enrollment||participants|Number|20|20.0||||||
4165756|NCT00829530|3986760|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4165757|NCT00829530|3986761|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4165758|NCT00829530|3986762|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4165759|NCT00829530|3986760|B3|White||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4165760|NCT00829530|3986761|B2|White||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4165761|NCT00829530|3986762|B1|White||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4165762|NCT00829530|3986760|B3|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4165763|NCT00829530|3986761|B2|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4165764|NCT00829530|3986762|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4165765|NCT00829530|3986760|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4165766|NCT00829530|3986761|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4165767|NCT00829530|3986762|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4165768|NCT00829530|3986760|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4165769|NCT00829530|3986761|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4165770|NCT00829530|3986762|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4165771|NCT00829530|3986760|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4165772|NCT00829530|3986761|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4165773|NCT00829530|3986762|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4165774|NCT00829530|3986760|B3||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4165775|NCT00829530|3986761|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4165776|NCT00829530|3986762|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4165777|NCT00829530|3986760|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165778|NCT00829530|3986761|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165779|NCT00829530|3986762|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165780|NCT00829504|3986775|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
4165781|NCT00829504|3986776|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4165782|NCT00829504|3986777|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4165783|NCT00829504|3986775|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4165784|NCT00829504|3986776|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4165785|NCT00829504|3986777|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4165786|NCT00829504|3986775|B3|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4165787|NCT00829504|3986776|B2|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4165788|NCT00829504|3986777|B1|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4165789|NCT00829504|3986775|B3|Black||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4165790|NCT00829504|3986776|B2|Black||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4165791|NCT00829504|3986777|B1|Black||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4165792|NCT00829504|3986775|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4165793|NCT00829504|3986776|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4165794|NCT00829504|3986777|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4165795|NCT00829504|3986775|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4165796|NCT00829504|3986776|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4165797|NCT00829504|3986777|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4165798|NCT00829504|3986775|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4165799|NCT00829504|3986776|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4165800|NCT00829504|3986777|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4165801|NCT00829504|3986775|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4165802|NCT00829504|3986776|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4165803|NCT00829504|3986777|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4165804|NCT00829504|3986775|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165805|NCT00829504|3986776|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165806|NCT00829504|3986777|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165807|NCT00829452|3986786|B3|Canada||Region of Enrollment||participants|Number|40|40.0||||||
4165808|NCT00829452|3986787|B2|Canada||Region of Enrollment||participants|Number|20|20.0||||||
4165809|NCT00829452|3986788|B1|Canada||Region of Enrollment||participants|Number|20|20.0||||||
4165810|NCT00829452|3986786|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4165811|NCT00829452|3986787|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4165812|NCT00829452|3986788|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4165813|NCT00829452|3986786|B3|White||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4165814|NCT00829452|3986787|B2|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4165815|NCT00829452|3986788|B1|White||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4165816|NCT00829452|3986786|B3|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4165817|NCT00829452|3986787|B2|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4165818|NCT00829452|3986788|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4165819|NCT00829452|3986786|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4165820|NCT00829452|3986787|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4165821|NCT00829452|3986788|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4165822|NCT00829452|3986786|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4165823|NCT00829452|3986787|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4165824|NCT00829452|3986788|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4165825|NCT00829452|3986786|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4165826|NCT00829452|3986787|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4165827|NCT00829452|3986788|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4165828|NCT00829452|3986786|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4165829|NCT00829452|3986787|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4165830|NCT00829452|3986788|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4165831|NCT00829452|3986786|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4165832|NCT00829452|3986787|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4165833|NCT00829452|3986788|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4165834|NCT00829452|3986786|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165835|NCT00829452|3986787|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165836|NCT00829452|3986788|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165837|NCT00829439|3986801|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4165838|NCT00829439|3986801|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4165839|NCT00829439|3986801|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4165840|NCT00829439|3986801|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4165841|NCT00829439|3986801|B1||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4165842|NCT00829426|3986808|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4165843|NCT00829426|3986809|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4165844|NCT00829426|3986810|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4165845|NCT00829426|3986808|B3|Native American or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4165846|NCT00829426|3986809|B2|Native American or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4165847|NCT00829426|3986810|B1|Native American or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4165848|NCT00829426|3986808|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4165849|NCT00829426|3986809|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4165850|NCT00829426|3986810|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4165851|NCT00829426|3986808|B3|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4165852|NCT00829426|3986809|B2|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4165853|NCT00829426|3986810|B1|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4165854|NCT00829426|3986808|B3|White||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
4165855|NCT00829426|3986809|B2|White||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4165856|NCT00829426|3986810|B1|White||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4165857|NCT00829426|3986808|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4165858|NCT00829426|3986809|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4165859|NCT00829426|3986810|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4165860|NCT00829426|3986808|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4165861|NCT00829426|3986809|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4165862|NCT00829426|3986810|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4165863|NCT00829426|3986808|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4165864|NCT00829426|3986809|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4165865|NCT00829426|3986810|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4165866|NCT00829426|3986808|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4165867|NCT00829426|3986809|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4165868|NCT00829426|3986810|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4165869|NCT00829426|3986808|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165870|NCT00829426|3986809|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165871|NCT00829426|3986810|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165872|NCT00829413|3986819|B1|Canada||Region of Enrollment||participants|Number|34|34.0||||||
4165873|NCT00829413|3986819|B1|Europe||Region of Enrollment||participants|Number|93|93.0||||||
4165874|NCT00829413|3986819|B1|United States||Region of Enrollment||participants|Number|132|132.0||||||
4165875|NCT00829413|3986819|B1|Other||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4165876|NCT00829413|3986819|B1|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4165877|NCT00829413|3986819|B1|Black||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4165878|NCT00829413|3986819|B1|White||Race/Ethnicity, Customized||participants|Number|206|206.0||||||
4165879|NCT00829413|3986819|B1||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4165880|NCT00829413|3986819|B1||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4165881|NCT00829413|3986819|B1|||Age||years|Mean|56.9|56.9|Standard Deviation|13.4|13.4|||
4165882|NCT00829413|3986819|B1||>=65 years|Age||Participants|Count of Participants|74|74.0||||||
4165883|NCT00829413|3986819|B1||Between 18 and 65 years|Age||Participants|Count of Participants|185|185.0||||||
4165884|NCT00829413|3986819|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165885|NCT00829387|3986866|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4165886|NCT00829387|3986867|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165887|NCT00829387|3986868|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4165888|NCT00829387|3986866|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165889|NCT00829387|3986867|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165890|NCT00829387|3986868|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165891|NCT00829387|3986866|B3||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4165892|NCT00829387|3986867|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4165893|NCT00829387|3986868|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4165894|NCT00829387|3986866|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4165895|NCT00829387|3986867|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4165896|NCT00829387|3986868|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4165897|NCT00829387|3986866|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165898|NCT00829387|3986867|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165899|NCT00829387|3986868|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165900|NCT00829387|3986866|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165901|NCT00829387|3986867|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165902|NCT00829387|3986868|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165903|NCT00829387|3986866|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4165904|NCT00829387|3986867|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4165905|NCT00829387|3986868|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4165906|NCT00829387|3986866|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4165907|NCT00829387|3986867|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4165908|NCT00829387|3986868|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4165909|NCT00829387|3986866|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4165910|NCT00829387|3986867|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4165911|NCT00829387|3986868|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4165912|NCT00829387|3986866|B3|||Age||years|Mean|62.3|62.3|Standard Deviation|8.4|8.4|||
4165913|NCT00829387|3986867|B2|||Age||years|Mean|60.8|60.8|Standard Deviation|7.58|7.58|||
4165914|NCT00829387|3986868|B1|||Age||years|Mean|63.9|63.9|Standard Deviation|9.12|9.12|||
4165915|NCT00829309|3986885|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4165916|NCT00829309|3986886|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4165917|NCT00829309|3986887|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4165918|NCT00829309|3986885|B3|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4165919|NCT00829309|3986886|B2|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4165920|NCT00829309|3986887|B1|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4165921|NCT00829309|3986885|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4165922|NCT00829309|3986886|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4165923|NCT00829309|3986887|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4165924|NCT00829309|3986885|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4165925|NCT00829309|3986886|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4165926|NCT00829309|3986887|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4165927|NCT00829309|3986885|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4165928|NCT00829309|3986886|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4165929|NCT00829309|3986887|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4165930|NCT00829309|3986885|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4165931|NCT00829309|3986886|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4165932|NCT00829309|3986887|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4165933|NCT00829309|3986885|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4165934|NCT00829309|3986886|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4165935|NCT00829309|3986887|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4165936|NCT00829309|3986885|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4165937|NCT00829309|3986886|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4165938|NCT00829309|3986887|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4165939|NCT00829309|3986885|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165940|NCT00829309|3986886|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165941|NCT00829309|3986887|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4165942|NCT00829296|3986896|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4165943|NCT00829296|3986897|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4165944|NCT00829296|3986898|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4165945|NCT00829296|3986896|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4165946|NCT00829296|3986897|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4165947|NCT00829296|3986898|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4165948|NCT00829296|3986896|B3|||Age||years|Mean|64.5|64.5|Standard Deviation|6.4|6.4|||
4165949|NCT00829296|3986897|B2|||Age||years|Mean|64.1|64.1|Standard Deviation|6.1|6.1|||
4165950|NCT00829296|3986898|B1|||Age||years|Mean|65.0|65.0|Standard Deviation|6.9|6.9|||
4165951|NCT00829283|3986911|B3|||BMI||kg/m^2|Mean|38.9|38.9|Standard Deviation|5.9|5.9|||
4165952|NCT00829283|3986912|B2|||BMI||kg/m^2|Mean|39.4|39.4|Standard Deviation|6.0|6.0|||
4165953|NCT00829283|3986913|B1|||BMI||kg/m^2|Mean|37.5|37.5|Standard Deviation|5.7|5.7|||
4165954|NCT00829283|3986911|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4165955|NCT00829283|3986912|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4165956|NCT00829283|3986913|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4165957|NCT00829283|3986911|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4165958|NCT00829283|3986912|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4165959|NCT00829283|3986913|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4165960|NCT00829283|3986911|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4165961|NCT00829283|3986912|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4165962|NCT00829283|3986913|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4165963|NCT00829283|3986911|B3|Black||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4165964|NCT00829283|3986912|B2|Black||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4165965|NCT00829283|3986913|B1|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4165966|NCT00829283|3986911|B3|White||Race/Ethnicity, Customized||participants|Number|150|150.0||||||
4165967|NCT00829283|3986912|B2|White||Race/Ethnicity, Customized||participants|Number|120|120.0||||||
4165968|NCT00829283|3986913|B1|White||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4165969|NCT00829283|3986911|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4165970|NCT00829283|3986912|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4165971|NCT00829283|3986913|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4165972|NCT00829283|3986911|B3||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4165973|NCT00829283|3986912|B2||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4165974|NCT00829283|3986913|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4165975|NCT00829283|3986911|B3|||Age||years|Mean|48.4|48.4|Standard Deviation|9.5|9.5|||
4165976|NCT00829283|3986912|B2|||Age||years|Mean|48.0|48.0|Standard Deviation|9.6|9.6|||
4165977|NCT00829283|3986913|B1|||Age||years|Mean|50.0|50.0|Standard Deviation|9.2|9.2|||
4165978|NCT00829244|3986922|B3|||Serum Progesterone (P4)|Number of participants analyzed (N) = 86 and 93 for GONAL-f® CONSORT calculator and GONAL-f® standard treatment arm group respectively at screening.|nanomole/liter (nmol/L)|Mean|2.868|2.868|Standard Deviation|2.303|2.303|||
4165979|NCT00829244|3986923|B2|||Serum Progesterone (P4)|Number of participants analyzed (N) = 86 and 93 for GONAL-f® CONSORT calculator and GONAL-f® standard treatment arm group respectively at screening.|nanomole/liter (nmol/L)|Mean|2.803|2.803|Standard Deviation|2.291|2.291|||
4165980|NCT00829244|3986924|B1|||Serum Progesterone (P4)|Number of participants analyzed (N) = 86 and 93 for GONAL-f® CONSORT calculator and GONAL-f® standard treatment arm group respectively at screening.|nanomole/liter (nmol/L)|Mean|2.934|2.934|Standard Deviation|2.328|2.328|||
4165981|NCT00829244|3986922|B3|||Serum Anti-Mullerian Hormone (AMH)|Number of participants analyzed (N) = 86 and 93 for GONAL-f® CONSORT calculator and GONAL-f® standard treatment arm group respectively at screening.|nanogram/milliliter (ng/mL)|Mean|2.551|2.551|Standard Deviation|1.692|1.692|||
4165982|NCT00829244|3986923|B2|||Serum Anti-Mullerian Hormone (AMH)|Number of participants analyzed (N) = 86 and 93 for GONAL-f® CONSORT calculator and GONAL-f® standard treatment arm group respectively at screening.|nanogram/milliliter (ng/mL)|Mean|2.399|2.399|Standard Deviation|1.492|1.492|||
4165983|NCT00829244|3986924|B1|||Serum Anti-Mullerian Hormone (AMH)|Number of participants analyzed (N) = 86 and 93 for GONAL-f® CONSORT calculator and GONAL-f® standard treatment arm group respectively at screening.|nanogram/milliliter (ng/mL)|Mean|2.705|2.705|Standard Deviation|1.870|1.87|||
4165984|NCT00829244|3986922|B3|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
4165985|NCT00829244|3986923|B2|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4165986|NCT00829244|3986924|B1|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4165987|NCT00829244|3986922|B3|Switzerland||Region of Enrollment||participants|Number|25|25.0||||||
4165988|NCT00829244|3986923|B2|Switzerland||Region of Enrollment||participants|Number|14|14.0||||||
4165989|NCT00829244|3986924|B1|Switzerland||Region of Enrollment||participants|Number|11|11.0||||||
4165990|NCT00829244|3986922|B3|Sweden||Region of Enrollment||participants|Number|15|15.0||||||
4165991|NCT00829244|3986923|B2|Sweden||Region of Enrollment||participants|Number|7|7.0||||||
4165992|NCT00829244|3986924|B1|Sweden||Region of Enrollment||participants|Number|8|8.0||||||
4165993|NCT00829244|3986922|B3|Spain||Region of Enrollment||participants|Number|10|10.0||||||
4165994|NCT00829244|3986923|B2|Spain||Region of Enrollment||participants|Number|6|6.0||||||
4165995|NCT00829244|3986924|B1|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4165996|NCT00829244|3986922|B3|Netherlands||Region of Enrollment||participants|Number|11|11.0||||||
4165997|NCT00829244|3986923|B2|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
4165998|NCT00829244|3986924|B1|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
4165999|NCT00829244|3986922|B3|Italy||Region of Enrollment||participants|Number|20|20.0||||||
4166000|NCT00829244|3986923|B2|Italy||Region of Enrollment||participants|Number|10|10.0||||||
4166001|NCT00829244|3986924|B1|Italy||Region of Enrollment||participants|Number|10|10.0||||||
4166002|NCT00829244|3986922|B3|Germany||Region of Enrollment||participants|Number|29|29.0||||||
4166003|NCT00829244|3986923|B2|Germany||Region of Enrollment||participants|Number|16|16.0||||||
4166004|NCT00829244|3986924|B1|Germany||Region of Enrollment||participants|Number|13|13.0||||||
4166005|NCT00829244|3986922|B3|France||Region of Enrollment||participants|Number|11|11.0||||||
4166006|NCT00829244|3986923|B2|France||Region of Enrollment||participants|Number|5|5.0||||||
4166007|NCT00829244|3986924|B1|France||Region of Enrollment||participants|Number|6|6.0||||||
4166008|NCT00829244|3986922|B3|Denmark||Region of Enrollment||participants|Number|52|52.0||||||
4166009|NCT00829244|3986923|B2|Denmark||Region of Enrollment||participants|Number|26|26.0||||||
4166010|NCT00829244|3986924|B1|Denmark||Region of Enrollment||participants|Number|26|26.0||||||
4166011|NCT00829244|3986922|B3|Chile||Region of Enrollment||participants|Number|15|15.0||||||
4166012|NCT00829244|3986923|B2|Chile||Region of Enrollment||participants|Number|8|8.0||||||
4166013|NCT00829244|3986924|B1|Chile||Region of Enrollment||participants|Number|7|7.0||||||
4166014|NCT00829244|3986922|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4166015|NCT00829244|3986923|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4166016|NCT00829244|3986924|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4166017|NCT00829244|3986922|B3||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4166018|NCT00829244|3986923|B2||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4166019|NCT00829244|3986924|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4166020|NCT00829244|3986922|B3|||Age|Number of participants analyzed (N) = 86 and 93 for GONAL-f® CONSORT calculator and GONAL-f® standard treatment arm group respectively at screening.|years|Mean|30.3|30.3|Standard Deviation|2.8|2.8|||
4166021|NCT00829244|3986923|B2|||Age|Number of participants analyzed (N) = 86 and 93 for GONAL-f® CONSORT calculator and GONAL-f® standard treatment arm group respectively at screening.|years|Mean|30.6|30.6|Standard Deviation|2.6|2.6|||
4166022|NCT00829244|3986924|B1|||Age|Number of participants analyzed (N) = 86 and 93 for GONAL-f® CONSORT calculator and GONAL-f® standard treatment arm group respectively at screening.|years|Mean|30.0|30.0|Standard Deviation|2.9|2.9|||
4166023|NCT00829244|3986922|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4166024|NCT00829244|3986923|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4166025|NCT00829244|3986924|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4166026|NCT00829244|3986922|B3||Between 18 and 65 years|Age||Participants|Count of Participants|200|200.0||||||
4166027|NCT00829244|3986923|B2||Between 18 and 65 years|Age||Participants|Count of Participants|104|104.0||||||
4166028|NCT00829244|3986924|B1||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
4166029|NCT00829244|3986922|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166030|NCT00829244|3986923|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166031|NCT00829244|3986924|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166032|NCT00829179|3986955|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4166033|NCT00829179|3986955|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4166034|NCT00829179|3986955|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4166035|NCT00829179|3986955|B1|||Age||years|Mean|31.8|31.8|Standard Deviation|9.1|9.1|||
4166036|NCT00829179|3986955|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4166037|NCT00829179|3986955|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4166038|NCT00829179|3986955|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166039|NCT00829166|3986959|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4166040|NCT00829166|3986960|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4166041|NCT00829166|3986961|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4166042|NCT00829166|3986959|B3||Female|Sex: Female, Male||Participants|Count of Participants|986|986.0||||||
4166043|NCT00829166|3986960|B2||Female|Sex: Female, Male||Participants|Count of Participants|492|492.0||||||
4166044|NCT00829166|3986961|B1||Female|Sex: Female, Male||Participants|Count of Participants|494|494.0||||||
4166045|NCT00829166|3986959|B3|||Age||years|Mean|52.7|52.7|Standard Deviation|10.9|10.9|||
4166046|NCT00829166|3986960|B2|||Age||years|Mean|53.2|53.2|Standard Deviation|10.8|10.8|||
4166047|NCT00829166|3986961|B1|||Age||years|Mean|52.2|52.2|Standard Deviation|11.0|11.0|||
4166048|NCT00829049|3987001|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4166049|NCT00829049|3987002|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4166050|NCT00829049|3987003|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4166051|NCT00829049|3987001|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4166052|NCT00829049|3987002|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4166053|NCT00829049|3987003|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4166054|NCT00829049|3987001|B3|||Age||years|Mean|20.9|20.9|Full Range|7.6|7.6|12.6|51.4|
4166055|NCT00829049|3987002|B2|||Age||years|Mean|20.8|20.8|Full Range|7.6|7.6|12.6|51.4|
4166056|NCT00829049|3987003|B1|||Age||years|Mean|20.9|20.9|Full Range|7.7|7.7|12.6|45.7|
4166057|NCT00829036|3987016|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4166058|NCT00829036|3987016|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166059|NCT00829036|3987016|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4166060|NCT00829036|3987016|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4166061|NCT00829036|3987016|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166062|NCT00829036|3987016|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166063|NCT00829036|3987016|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4166064|NCT00829036|3987016|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4166065|NCT00829036|3987016|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4166066|NCT00829036|3987016|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166067|NCT00829036|3987016|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166068|NCT00829036|3987016|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4166069|NCT00829036|3987016|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4166070|NCT00829036|3987016|B1|||Age||years|Mean|50.9|50.9|Standard Deviation|13.4|13.4|||
4166071|NCT00829010|3987020|B6||Male|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
4166072|NCT00829010|3987021|B5||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4166073|NCT00829010|3987022|B4||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4166074|NCT00829010|3987023|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4166075|NCT00829010|3987024|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4166076|NCT00829010|3987025|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4166077|NCT00829010|3987020|B6||Female|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4166078|NCT00829010|3987021|B5||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4166079|NCT00829010|3987022|B4||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4166080|NCT00829010|3987023|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4166081|NCT00829010|3987024|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4166082|NCT00829010|3987025|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4166083|NCT00829010|3987020|B6|||Age||Weeks|Mean|6.2|6.2|Standard Deviation|0.59|0.59|||
4166084|NCT00829010|3987021|B5|||Age||Weeks|Mean|6.1|6.1|Standard Deviation|0.29|0.29|||
4166085|NCT00829010|3987022|B4|||Age||Weeks|Mean|6.1|6.1|Standard Deviation|0.35|0.35|||
4166086|NCT00829010|3987023|B3|||Age||Weeks|Mean|6.1|6.1|Standard Deviation|0.41|0.41|||
4166087|NCT00829010|3987024|B2|||Age||Weeks|Mean|6.3|6.3|Standard Deviation|0.65|0.65|||
4166088|NCT00829010|3987025|B1|||Age||Weeks|Mean|6.6|6.6|Standard Deviation|0.92|0.92|||
4166089|NCT00828984|3987191|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166090|NCT00828984|3987192|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166091|NCT00828984|3987193|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166092|NCT00828984|3987194|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166093|NCT00828984|3987191|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166094|NCT00828984|3987192|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166095|NCT00828984|3987193|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166096|NCT00828984|3987194|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166097|NCT00828984|3987191|B4||White|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
4166098|NCT00828984|3987192|B3||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4166099|NCT00828984|3987193|B2||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4166100|NCT00828984|3987194|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4166101|NCT00828984|3987191|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4166102|NCT00828984|3987192|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166103|NCT00828984|3987193|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4166104|NCT00828984|3987194|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4166105|NCT00828984|3987191|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166106|NCT00828984|3987192|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166107|NCT00828984|3987193|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166108|NCT00828984|3987194|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166109|NCT00828984|3987191|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4166110|NCT00828984|3987192|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4166111|NCT00828984|3987193|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166112|NCT00828984|3987194|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166113|NCT00828984|3987191|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166114|NCT00828984|3987192|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166115|NCT00828984|3987193|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166116|NCT00828984|3987194|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166117|NCT00828984|3987191|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166118|NCT00828984|3987192|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166119|NCT00828984|3987193|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166120|NCT00828984|3987194|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166121|NCT00828984|3987191|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
4166122|NCT00828984|3987192|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4166123|NCT00828984|3987193|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4166124|NCT00828984|3987194|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4166125|NCT00828984|3987191|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4166126|NCT00828984|3987192|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166127|NCT00828984|3987193|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4166128|NCT00828984|3987194|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4166129|NCT00828984|3987191|B4||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4166130|NCT00828984|3987192|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4166131|NCT00828984|3987193|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4166132|NCT00828984|3987194|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4166133|NCT00828984|3987191|B4||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4166134|NCT00828984|3987192|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4166135|NCT00828984|3987193|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4166136|NCT00828984|3987194|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4166137|NCT00828984|3987191|B4||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4166138|NCT00828984|3987192|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4166139|NCT00828984|3987193|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4166140|NCT00828984|3987194|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4166141|NCT00828984|3987191|B4||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4166142|NCT00828984|3987192|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4166143|NCT00828984|3987193|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4166144|NCT00828984|3987194|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4166145|NCT00828984|3987191|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166146|NCT00828984|3987192|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166147|NCT00828984|3987193|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166148|NCT00828984|3987194|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166149|NCT00828945|3987219|B1|||Low-density lipoprotein (LDL) lower than 2.5 millimole/liter (mmol/L)|LDL levels were self-assessed by participants using CARE diagnostica LDL-cholesterol test. The targeted level of LDL was lower than 2.5 mmol/L.|Percentage of participants|Number|30.7|30.7||||||
4166150|NCT00828945|3987219|B1|||Positive response on self -estimated treatment compliance|Participants with “Yes” response to a question which stated “Have you been taking at least 90 percentage (%) of your medication for hyperlipidemia?”|Percentage of participants|Number|94.2|94.2||||||
4166151|NCT00828945|3987219|B1||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4166152|NCT00828945|3987219|B1||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4166153|NCT00828945|3987219|B1|||Age||Years|Mean|65.4|65.4|Standard Deviation|9.2|9.2|||
4166154|NCT00828841|3987233|B4|United States||Region of Enrollment||participants|Number|601|601.0||||||
4166155|NCT00828841|3987234|B3|United States||Region of Enrollment||participants|Number|130|130.0||||||
4166156|NCT00828841|3987235|B2|United States||Region of Enrollment||participants|Number|236|236.0||||||
4166157|NCT00828841|3987236|B1|United States||Region of Enrollment||participants|Number|235|235.0||||||
4166158|NCT00828841|3987233|B4||Male|Sex: Female, Male||Participants|Count of Participants|350|350.0||||||
4166159|NCT00828841|3987234|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4166160|NCT00828841|3987235|B2||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4166161|NCT00828841|3987236|B1||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4166162|NCT00828841|3987233|B4||Female|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4166163|NCT00828841|3987234|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4166164|NCT00828841|3987235|B2||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4166165|NCT00828841|3987236|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4166166|NCT00828841|3987233|B4|||Age||years|Mean|65.2|65.2|Standard Deviation|9.2|9.2|||
4166167|NCT00828841|3987234|B3|||Age||years|Mean|65.6|65.6|Standard Deviation|9.4|9.4|||
4166168|NCT00828841|3987235|B2|||Age||years|Mean|64.9|64.9|Standard Deviation|9.5|9.5|||
4166169|NCT00828841|3987236|B1|||Age||years|Mean|65.3|65.3|Standard Deviation|8.9|8.9|||
4166170|NCT00828750|3987251|B1|Asian – Japanese Heritage||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4166171|NCT00828750|3987251|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4166172|NCT00828750|3987251|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4166173|NCT00828750|3987251|B1|||Age||Years|Mean|54.7|54.7|Standard Deviation|13.57|13.57|||
4166174|NCT00828711|3987262|B4|United States||Region of Enrollment||participants|Number|373|373.0||||||
4166175|NCT00828711|3987263|B3|United States||Region of Enrollment||participants|Number|131|131.0||||||
4166176|NCT00828711|3987264|B2|United States||Region of Enrollment||participants|Number|125|125.0||||||
4166177|NCT00828711|3987265|B1|United States||Region of Enrollment||participants|Number|117|117.0||||||
4166178|NCT00828711|3987262|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4166179|NCT00828711|3987263|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4166180|NCT00828711|3987264|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4166181|NCT00828711|3987265|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4166182|NCT00828711|3987262|B4||Female|Sex: Female, Male||Participants|Count of Participants|373|373.0||||||
4166183|NCT00828711|3987263|B3||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4166184|NCT00828711|3987264|B2||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4166185|NCT00828711|3987265|B1||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4166186|NCT00828711|3987262|B4|||Age||years|Mean|25.8|25.8|Standard Deviation|6.01|6.01|||
4166187|NCT00828711|3987263|B3|||Age||years|Mean|25.5|25.5|Standard Deviation|5.93|5.93|||
4166188|NCT00828711|3987264|B2|||Age||years|Mean|25.8|25.8|Standard Deviation|5.92|5.92|||
4166189|NCT00828711|3987265|B1|||Age||years|Mean|26.0|26.0|Standard Deviation|6.24|6.24|||
4166190|NCT00828711|3987262|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4166191|NCT00828711|3987263|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4166192|NCT00828711|3987264|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4166193|NCT00828711|3987265|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4166194|NCT00828711|3987262|B4||Between 18 and 65 years|Age||Participants|Count of Participants|373|373.0||||||
4166195|NCT00828711|3987263|B3||Between 18 and 65 years|Age||Participants|Count of Participants|131|131.0||||||
4166196|NCT00828711|3987264|B2||Between 18 and 65 years|Age||Participants|Count of Participants|125|125.0||||||
4166197|NCT00828711|3987265|B1||Between 18 and 65 years|Age||Participants|Count of Participants|117|117.0||||||
4166198|NCT00828711|3987262|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166199|NCT00828711|3987263|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166200|NCT00828711|3987264|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166201|NCT00828711|3987265|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166202|NCT00828568|3987296|B4|United States||Region of Enrollment||participants|Number|422|422.0||||||
4166203|NCT00828568|3987297|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4166204|NCT00828568|3987298|B2|United States||Region of Enrollment||participants|Number|179|179.0||||||
4166205|NCT00828568|3987299|B1|United States||Region of Enrollment||participants|Number|183|183.0||||||
4166206|NCT00828568|3987296|B4||Male|Sex: Female, Male||Participants|Count of Participants|347|347.0||||||
4166207|NCT00828568|3987297|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4166208|NCT00828568|3987298|B2||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4166209|NCT00828568|3987299|B1||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4166210|NCT00828568|3987296|B4||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4166211|NCT00828568|3987297|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4166212|NCT00828568|3987298|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4166213|NCT00828568|3987299|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4166214|NCT00828568|3987296|B4|||Age||years|Mean|67.2|67.2|Standard Deviation|9.8|9.8|||
4166215|NCT00828568|3987297|B3|||Age||years|Mean|64.7|64.7|Standard Deviation|9.7|9.7|||
4166216|NCT00828568|3987298|B2|||Age||years|Mean|67.2|67.2|Standard Deviation|10.1|10.1|||
4166217|NCT00828568|3987299|B1|||Age||years|Mean|68.0|68.0|Standard Deviation|9.5|9.5|||
4166218|NCT00828568|3987296|B4||>=65 years|Age||Participants|Count of Participants|251|251.0||||||
4166219|NCT00828568|3987297|B3||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
4166220|NCT00828568|3987298|B2||>=65 years|Age||Participants|Count of Participants|106|106.0||||||
4166221|NCT00828568|3987299|B1||>=65 years|Age||Participants|Count of Participants|112|112.0||||||
4166337|NCT00828321|3987370|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4166222|NCT00828568|3987296|B4||Between 18 and 65 years|Age||Participants|Count of Participants|171|171.0||||||
4166223|NCT00828568|3987297|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4166224|NCT00828568|3987298|B2||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4166225|NCT00828568|3987299|B1||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4166226|NCT00828568|3987296|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166227|NCT00828568|3987297|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166228|NCT00828568|3987298|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166229|NCT00828568|3987299|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166230|NCT00828542|3987314|B3|Brazil||Region of Enrollment||participants|Number|46|46.0||||||
4166231|NCT00828542|3987315|B2|Brazil||Region of Enrollment||participants|Number|23|23.0||||||
4166232|NCT00828542|3987316|B1|Brazil||Region of Enrollment||participants|Number|23|23.0||||||
4166233|NCT00828542|3987314|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4166234|NCT00828542|3987315|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4166235|NCT00828542|3987316|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4166236|NCT00828542|3987314|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4166237|NCT00828542|3987315|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4166238|NCT00828542|3987316|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4166239|NCT00828542|3987314|B3|||Age||years|Mean|22.6|22.6|Standard Deviation|3.2|3.2|||
4166240|NCT00828542|3987315|B2|||Age||years|Mean|22.9|22.9|Standard Deviation|4.4|4.4|||
4166241|NCT00828542|3987316|B1|||Age||years|Mean|22.5|22.5|Standard Deviation|2.5|2.5|||
4166242|NCT00828542|3987314|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4166243|NCT00828542|3987315|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4166244|NCT00828542|3987316|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4166245|NCT00828542|3987314|B3||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4166246|NCT00828542|3987315|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4166247|NCT00828542|3987316|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4166248|NCT00828542|3987314|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166249|NCT00828542|3987315|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166250|NCT00828542|3987316|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166251|NCT00828516|3987323|B1|United Kingdom||Region of Enrollment||participants|Number|35|35.0||||||
4166252|NCT00828516|3987323|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4166253|NCT00828516|3987323|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4166254|NCT00828516|3987323|B1|||Age||years|Mean|57.5|57.5|Standard Deviation|9.3|9.3|||
4166255|NCT00828516|3987323|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4166256|NCT00828516|3987323|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4166257|NCT00828516|3987323|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166258|NCT00828464|3987328|B1|||Total Hand Eczema Severity Index (HESI)|Total Hand Eczema Severity Index (total HESI) Score 0 to 360 where 0 is the best and 360 is the worst score.|Units on a scale|Mean|32.1|32.1|Standard Deviation|17.0|17.0|||
4166259|NCT00828464|3987328|B1|||Time since Diagnosis of Chronic Hand Dermatitis (years)|Time since Diagnosis of Chronic Hand Dermatitis, Allergic, Irritant or Contact Dermatitis (years)|Years|Mean|18.92|18.92|Standard Deviation|15|15.0|||
4166260|NCT00828464|3987328|B1|Moderate||ISGA-Chronic Hand Dermatitis|Investigators Static Global Assessment (ISGA)- Chronic Hand Dermatitis Score=2 mild Score=3 moderate These are the only scores that are permitted for entry on this study.|Participants|Number|14|14.0||||||
4166261|NCT00828464|3987328|B1|Mild||ISGA-Chronic Hand Dermatitis|Investigators Static Global Assessment (ISGA)- Chronic Hand Dermatitis Score=2 mild Score=3 moderate These are the only scores that are permitted for entry on this study.|Participants|Number|16|16.0||||||
4166262|NCT00828464|3987328|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4166263|NCT00828464|3987328|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4166264|NCT00828464|3987328|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4166265|NCT00828464|3987328|B1|||Age||years|Mean|47.5|47.5|Standard Deviation|14.9|14.9|||
4166266|NCT00828464|3987328|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4166267|NCT00828464|3987328|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4166268|NCT00828464|3987328|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166269|NCT00828451|3987345|B1|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4166270|NCT00828451|3987345|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4166271|NCT00828451|3987345|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4166272|NCT00828451|3987345|B1|||Age||Days|Median|4|4.0|Inter-Quartile Range|||2.0|5.0|
4166273|NCT00828451|3987345|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4166274|NCT00828451|3987345|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4166275|NCT00828451|3987345|B1||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
4166276|NCT00828412|3987351|B3|||Three item severity score|The average of the sum of scores for erythema, edema/papulation, and excoriation for two target lesions. Scoring on a scale of 0 to 3 (none to severe). Maximum score is 9.|units on a scale|Mean|5.5|5.5|Standard Deviation|0.7|0.7|||
4166338|NCT00828321|3987371|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4166277|NCT00828412|3987352|B2|||Three item severity score|The average of the sum of scores for erythema, edema/papulation, and excoriation for two target lesions. Scoring on a scale of 0 to 3 (none to severe). Maximum score is 9.|units on a scale|Mean|5.5|5.5|Standard Deviation|0.7|0.7|||
4166278|NCT00828412|3987353|B1|||Three item severity score|The average of the sum of scores for erythema, edema/papulation, and excoriation for two target lesions. Scoring on a scale of 0 to 3 (none to severe). Maximum score is 9.|units on a scale|Mean|5.4|5.4|Standard Deviation|0.7|0.7|||
4166279|NCT00828412|3987351|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
4166280|NCT00828412|3987352|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
4166281|NCT00828412|3987353|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4166282|NCT00828412|3987351|B3||Male|Gender||Participants|Count of Participants|45|45.0||||||
4166283|NCT00828412|3987352|B2||Male|Gender||Participants|Count of Participants|20|20.0||||||
4166284|NCT00828412|3987353|B1||Male|Gender||Participants|Count of Participants|25|25.0||||||
4166285|NCT00828412|3987351|B3||Female|Gender||Participants|Count of Participants|55|55.0||||||
4166286|NCT00828412|3987352|B2||Female|Gender||Participants|Count of Participants|30|30.0||||||
4166287|NCT00828412|3987353|B1||Female|Gender||Participants|Count of Participants|25|25.0||||||
4166288|NCT00828412|3987351|B3|||Age||years|Mean|5.2|5.2|Standard Deviation|3.4|3.4|||
4166289|NCT00828412|3987352|B2|||Age||years|Mean|4.8|4.8|Standard Deviation|3.3|3.3|||
4166290|NCT00828412|3987353|B1|||Age||years|Mean|5.5|5.5|Standard Deviation|3.5|3.5|||
4166291|NCT00828412|3987351|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4166292|NCT00828412|3987352|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4166293|NCT00828412|3987353|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4166294|NCT00828412|3987351|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4166295|NCT00828412|3987352|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4166296|NCT00828412|3987353|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4166297|NCT00828412|3987351|B3||<=18 years|Age||Participants|Count of Participants|100|100.0||||||
4166298|NCT00828412|3987352|B2||<=18 years|Age||Participants|Count of Participants|50|50.0||||||
4166299|NCT00828412|3987353|B1||<=18 years|Age||Participants|Count of Participants|50|50.0||||||
4166300|NCT00828347|3987360|B3|Japan||Region of Enrollment||participants|Number|23|23.0||||||
4166301|NCT00828347|3987361|B2|Japan||Region of Enrollment||participants|Number|11|11.0||||||
4166302|NCT00828347|3987362|B1|Japan||Region of Enrollment||participants|Number|12|12.0||||||
4166303|NCT00828347|3987360|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4166304|NCT00828347|3987361|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4166305|NCT00828347|3987362|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4166306|NCT00828347|3987360|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4166307|NCT00828347|3987361|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4166308|NCT00828347|3987362|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4166309|NCT00828347|3987360|B3|||Age||years|Mean|67.7|67.7|Standard Deviation|11.8|11.8|||
4166310|NCT00828347|3987361|B2|||Age||years|Mean|69.0|69.0|Standard Deviation|13.7|13.7|||
4166311|NCT00828347|3987362|B1|||Age||years|Mean|66.3|66.3|Standard Deviation|9.9|9.9|||
4166312|NCT00828347|3987360|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4166313|NCT00828347|3987361|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4166314|NCT00828347|3987362|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4166315|NCT00828347|3987360|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4166316|NCT00828347|3987361|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4166317|NCT00828347|3987362|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4166318|NCT00828347|3987360|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166319|NCT00828347|3987361|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166320|NCT00828347|3987362|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166321|NCT00828321|3987369|B3|Canada||Region of Enrollment||participants|Number|40|40.0||||||
4166322|NCT00828321|3987370|B2|Canada||Region of Enrollment||participants|Number|20|20.0||||||
4166323|NCT00828321|3987371|B1|Canada||Region of Enrollment||participants|Number|20|20.0||||||
4166324|NCT00828321|3987369|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4166325|NCT00828321|3987370|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4166326|NCT00828321|3987371|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4166327|NCT00828321|3987369|B3|White||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4166328|NCT00828321|3987370|B2|White||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4166329|NCT00828321|3987371|B1|White||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4166330|NCT00828321|3987369|B3|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4166331|NCT00828321|3987370|B2|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4166332|NCT00828321|3987371|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4166333|NCT00828321|3987369|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4166334|NCT00828321|3987370|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4166335|NCT00828321|3987371|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4166336|NCT00828321|3987369|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4166339|NCT00828321|3987369|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4166340|NCT00828321|3987370|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4166341|NCT00828321|3987371|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4166342|NCT00828321|3987369|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4166343|NCT00828321|3987370|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4166344|NCT00828321|3987371|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4166345|NCT00828321|3987369|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166346|NCT00828321|3987370|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166347|NCT00828321|3987371|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166348|NCT00828308|3987384|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4166349|NCT00828308|3987384|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4166350|NCT00828308|3987384|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4166351|NCT00828308|3987384|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|29|29.0|||
4166352|NCT00828308|3987384|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4166353|NCT00828308|3987384|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4166354|NCT00828308|3987384|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166355|NCT00828295|3987388|B3|Russian Federation||Region of Enrollment||participants|Number|53|53.0||||||
4166356|NCT00828295|3987389|B2|Russian Federation||Region of Enrollment||participants|Number|26|26.0||||||
4166357|NCT00828295|3987390|B1|Russian Federation||Region of Enrollment||participants|Number|27|27.0||||||
4166358|NCT00828295|3987388|B3|Ukraine||Region of Enrollment||participants|Number|97|97.0||||||
4166359|NCT00828295|3987389|B2|Ukraine||Region of Enrollment||participants|Number|49|49.0||||||
4166360|NCT00828295|3987390|B1|Ukraine||Region of Enrollment||participants|Number|48|48.0||||||
4166361|NCT00828295|3987388|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166362|NCT00828295|3987389|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166363|NCT00828295|3987390|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166364|NCT00828295|3987388|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166365|NCT00828295|3987389|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166366|NCT00828295|3987390|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166367|NCT00828295|3987388|B3||White|Race (NIH/OMB)||Participants|Count of Participants|150|150.0||||||
4166368|NCT00828295|3987389|B2||White|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4166369|NCT00828295|3987390|B1||White|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4166370|NCT00828295|3987388|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166371|NCT00828295|3987389|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166372|NCT00828295|3987390|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166373|NCT00828295|3987388|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166374|NCT00828295|3987389|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166375|NCT00828295|3987390|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166376|NCT00828295|3987388|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166377|NCT00828295|3987389|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166378|NCT00828295|3987390|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166379|NCT00828295|3987388|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166380|NCT00828295|3987389|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166381|NCT00828295|3987390|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166382|NCT00828295|3987388|B3||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4166383|NCT00828295|3987389|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4166384|NCT00828295|3987390|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4166385|NCT00828295|3987388|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4166386|NCT00828295|3987389|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4166387|NCT00828295|3987390|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4166388|NCT00828295|3987388|B3|12 to <17 years||Age, Customized||participants|Number|47|47.0||||||
4166389|NCT00828295|3987389|B2|12 to <17 years||Age, Customized||participants|Number|22|22.0||||||
4166390|NCT00828295|3987390|B1|12 to <17 years||Age, Customized||participants|Number|25|25.0||||||
4166391|NCT00828295|3987388|B3|6 to <12 years||Age, Customized||participants|Number|62|62.0||||||
4166392|NCT00828295|3987389|B2|6 to <12 years||Age, Customized||participants|Number|33|33.0||||||
4166393|NCT00828295|3987390|B1|6 to <12 years||Age, Customized||participants|Number|29|29.0||||||
4166394|NCT00828295|3987388|B3|2 to <6 years||Age, Customized||participants|Number|34|34.0||||||
4166395|NCT00828295|3987389|B2|2 to <6 years||Age, Customized||participants|Number|16|16.0||||||
4166396|NCT00828295|3987390|B1|2 to <6 years||Age, Customized||participants|Number|18|18.0||||||
4166397|NCT00828295|3987388|B3|<2 years||Age, Customized||participants|Number|7|7.0||||||
4166398|NCT00828295|3987389|B2|<2 years||Age, Customized||participants|Number|4|4.0||||||
4166399|NCT00828295|3987390|B1|<2 years||Age, Customized||participants|Number|3|3.0||||||
4166400|NCT00828204|3987399|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4166401|NCT00828204|3987400|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4166402|NCT00828204|3987401|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4166403|NCT00828204|3987399|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4166404|NCT00828204|3987400|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4166405|NCT00828204|3987401|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4166406|NCT00828204|3987399|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4166407|NCT00828204|3987400|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4166408|NCT00828204|3987401|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4166409|NCT00828204|3987399|B3||Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
4166410|NCT00828204|3987400|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4166411|NCT00828204|3987401|B1||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
4166412|NCT00828204|3987399|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166413|NCT00828204|3987400|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166414|NCT00828204|3987401|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166415|NCT00828191|3987419|B3|United States||Region of Enrollment||participants|Number|800|800.0||||||
4166416|NCT00828191|3987420|B2|United States||Region of Enrollment||participants|Number|400|400.0||||||
4166417|NCT00828191|3987421|B1|United States||Region of Enrollment||participants|Number|400|400.0||||||
4166418|NCT00828191|3987419|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4166419|NCT00828191|3987420|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4166420|NCT00828191|3987421|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4166421|NCT00828191|3987419|B3||Female|Sex: Female, Male||Participants|Count of Participants|800|800.0||||||
4166422|NCT00828191|3987420|B2||Female|Sex: Female, Male||Participants|Count of Participants|400|400.0||||||
4166423|NCT00828191|3987421|B1||Female|Sex: Female, Male||Participants|Count of Participants|400|400.0||||||
4166424|NCT00828191|3987419|B3|||Age||years|Mean|34.3|34.3|Standard Deviation|4.4|4.4|||
4166425|NCT00828191|3987420|B2|||Age||years|Mean|34.3|34.3|Standard Deviation|4.5|4.5|||
4166426|NCT00828191|3987421|B1|||Age||years|Mean|34.3|34.3|Standard Deviation|4.4|4.4|||
4166427|NCT00828191|3987419|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4166428|NCT00828191|3987420|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4166429|NCT00828191|3987421|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4166430|NCT00828191|3987419|B3||Between 18 and 65 years|Age||Participants|Count of Participants|800|800.0||||||
4166431|NCT00828191|3987420|B2||Between 18 and 65 years|Age||Participants|Count of Participants|400|400.0||||||
4166432|NCT00828191|3987421|B1||Between 18 and 65 years|Age||Participants|Count of Participants|400|400.0||||||
4166433|NCT00828191|3987419|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166434|NCT00828191|3987420|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166435|NCT00828191|3987421|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166436|NCT00828178|3987432|B3|United States||Region of Enrollment||participants|Number|87|87.0||||||
4166437|NCT00828178|3987433|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
4166438|NCT00828178|3987434|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4166439|NCT00828178|3987432|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4166440|NCT00828178|3987433|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4166441|NCT00828178|3987434|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4166442|NCT00828178|3987432|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4166443|NCT00828178|3987433|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4166444|NCT00828178|3987434|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4166445|NCT00828178|3987432|B3|||Age||years|Mean|47.2|47.2|Standard Deviation|10.4|10.4|||
4166446|NCT00828178|3987433|B2|||Age||years|Mean|45.5|45.5|Standard Deviation|10.8|10.8|||
4166447|NCT00828178|3987434|B1|||Age||years|Mean|48.9|48.9|Standard Deviation|10.6|10.6|||
4166448|NCT00828178|3987432|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4166449|NCT00828178|3987433|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4166450|NCT00828178|3987434|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4166451|NCT00828178|3987432|B3||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
4166452|NCT00828178|3987433|B2||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4166453|NCT00828178|3987434|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4166454|NCT00828178|3987432|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166455|NCT00828178|3987433|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166456|NCT00828178|3987434|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166457|NCT00828139|3987445|B5|1||Performance Status|"0 ----- Fully active, able to carry on all pre-disease performance without restriction.~1 ----- Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~The higher grade, the worse outcome."|participants|Number|127|127.0||||||
4166487|NCT00828139|3987445|B5|Multiple lesions, single organ||Metastatic Disease Sites||participants|Number|40|40.0||||||
4166488|NCT00828139|3987446|B4|Multiple lesions, single organ||Metastatic Disease Sites||participants|Number|11|11.0||||||
4166458|NCT00828139|3987446|B4|1||Performance Status|"0 ----- Fully active, able to carry on all pre-disease performance without restriction.~1 ----- Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~The higher grade, the worse outcome."|participants|Number|32|32.0||||||
4166459|NCT00828139|3987447|B3|1||Performance Status|"0 ----- Fully active, able to carry on all pre-disease performance without restriction.~1 ----- Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~The higher grade, the worse outcome."|participants|Number|43|43.0||||||
4166460|NCT00828139|3987448|B2|1||Performance Status|"0 ----- Fully active, able to carry on all pre-disease performance without restriction.~1 ----- Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~The higher grade, the worse outcome."|participants|Number|24|24.0||||||
4166461|NCT00828139|3987449|B1|1||Performance Status|"0 ----- Fully active, able to carry on all pre-disease performance without restriction.~1 ----- Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~The higher grade, the worse outcome."|participants|Number|28|28.0||||||
4166462|NCT00828139|3987445|B5|0||Performance Status|"0 ----- Fully active, able to carry on all pre-disease performance without restriction.~1 ----- Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~The higher grade, the worse outcome."|participants|Number|62|62.0||||||
4166463|NCT00828139|3987446|B4|0||Performance Status|"0 ----- Fully active, able to carry on all pre-disease performance without restriction.~1 ----- Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~The higher grade, the worse outcome."|participants|Number|19|19.0||||||
4166464|NCT00828139|3987447|B3|0||Performance Status|"0 ----- Fully active, able to carry on all pre-disease performance without restriction.~1 ----- Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~The higher grade, the worse outcome."|participants|Number|12|12.0||||||
4166465|NCT00828139|3987448|B2|0||Performance Status|"0 ----- Fully active, able to carry on all pre-disease performance without restriction.~1 ----- Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~The higher grade, the worse outcome."|participants|Number|17|17.0||||||
4166466|NCT00828139|3987449|B1|0||Performance Status|"0 ----- Fully active, able to carry on all pre-disease performance without restriction.~1 ----- Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~The higher grade, the worse outcome."|participants|Number|14|14.0||||||
4166467|NCT00828139|3987445|B5|Limited||Stage|"In limited stage small cell lung cancer, the cancer resides in one lung or in the nearby tissue.~In the extensive stage, cancer has spread to tissue outside of the originally affected lung."|participants|Number|58|58.0||||||
4166468|NCT00828139|3987446|B4|Limited||Stage|"In limited stage small cell lung cancer, the cancer resides in one lung or in the nearby tissue.~In the extensive stage, cancer has spread to tissue outside of the originally affected lung."|participants|Number|9|9.0||||||
4166469|NCT00828139|3987447|B3|Limited||Stage|"In limited stage small cell lung cancer, the cancer resides in one lung or in the nearby tissue.~In the extensive stage, cancer has spread to tissue outside of the originally affected lung."|participants|Number|16|16.0||||||
4166470|NCT00828139|3987448|B2|Limited||Stage|"In limited stage small cell lung cancer, the cancer resides in one lung or in the nearby tissue.~In the extensive stage, cancer has spread to tissue outside of the originally affected lung."|participants|Number|18|18.0||||||
4166471|NCT00828139|3987449|B1|Limited||Stage|"In limited stage small cell lung cancer, the cancer resides in one lung or in the nearby tissue.~In the extensive stage, cancer has spread to tissue outside of the originally affected lung."|participants|Number|15|15.0||||||
4166472|NCT00828139|3987445|B5|Extensive||Stage|"In limited stage small cell lung cancer, the cancer resides in one lung or in the nearby tissue.~In the extensive stage, cancer has spread to tissue outside of the originally affected lung."|participants|Number|131|131.0||||||
4166473|NCT00828139|3987446|B4|Extensive||Stage|"In limited stage small cell lung cancer, the cancer resides in one lung or in the nearby tissue.~In the extensive stage, cancer has spread to tissue outside of the originally affected lung."|participants|Number|42|42.0||||||
4166474|NCT00828139|3987447|B3|Extensive||Stage|"In limited stage small cell lung cancer, the cancer resides in one lung or in the nearby tissue.~In the extensive stage, cancer has spread to tissue outside of the originally affected lung."|participants|Number|39|39.0||||||
4166475|NCT00828139|3987448|B2|Extensive||Stage|"In limited stage small cell lung cancer, the cancer resides in one lung or in the nearby tissue.~In the extensive stage, cancer has spread to tissue outside of the originally affected lung."|participants|Number|23|23.0||||||
4166476|NCT00828139|3987449|B1|Extensive||Stage|"In limited stage small cell lung cancer, the cancer resides in one lung or in the nearby tissue.~In the extensive stage, cancer has spread to tissue outside of the originally affected lung."|participants|Number|27|27.0||||||
4166477|NCT00828139|3987445|B5|None||Metastatic Disease Sites||participants|Number|6|6.0||||||
4166478|NCT00828139|3987446|B4|None||Metastatic Disease Sites||participants|Number|2|2.0||||||
4166479|NCT00828139|3987447|B3|None||Metastatic Disease Sites||participants|Number|1|1.0||||||
4166480|NCT00828139|3987448|B2|None||Metastatic Disease Sites||participants|Number|1|1.0||||||
4166481|NCT00828139|3987449|B1|None||Metastatic Disease Sites||participants|Number|2|2.0||||||
4166482|NCT00828139|3987445|B5|Multiple lesions, multiple organs||Metastatic Disease Sites||participants|Number|122|122.0||||||
4166483|NCT00828139|3987446|B4|Multiple lesions, multiple organs||Metastatic Disease Sites||participants|Number|34|34.0||||||
4166484|NCT00828139|3987447|B3|Multiple lesions, multiple organs||Metastatic Disease Sites||participants|Number|41|41.0||||||
4166485|NCT00828139|3987448|B2|Multiple lesions, multiple organs||Metastatic Disease Sites||participants|Number|22|22.0||||||
4166486|NCT00828139|3987449|B1|Multiple lesions, multiple organs||Metastatic Disease Sites||participants|Number|25|25.0||||||
4166550|NCT00828113|3987472|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4166489|NCT00828139|3987447|B3|Multiple lesions, single organ||Metastatic Disease Sites||participants|Number|9|9.0||||||
4166490|NCT00828139|3987448|B2|Multiple lesions, single organ||Metastatic Disease Sites||participants|Number|9|9.0||||||
4166491|NCT00828139|3987449|B1|Multiple lesions, single organ||Metastatic Disease Sites||participants|Number|11|11.0||||||
4166492|NCT00828139|3987445|B5|Single lesion, single organ||Metastatic Disease Sites||participants|Number|21|21.0||||||
4166493|NCT00828139|3987446|B4|Single lesion, single organ||Metastatic Disease Sites||participants|Number|4|4.0||||||
4166494|NCT00828139|3987447|B3|Single lesion, single organ||Metastatic Disease Sites||participants|Number|4|4.0||||||
4166495|NCT00828139|3987448|B2|Single lesion, single organ||Metastatic Disease Sites||participants|Number|9|9.0||||||
4166496|NCT00828139|3987449|B1|Single lesion, single organ||Metastatic Disease Sites||participants|Number|4|4.0||||||
4166497|NCT00828139|3987445|B5|Unknown/Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4166498|NCT00828139|3987446|B4|Unknown/Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4166499|NCT00828139|3987447|B3|Unknown/Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4166500|NCT00828139|3987448|B2|Unknown/Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4166501|NCT00828139|3987449|B1|Unknown/Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4166502|NCT00828139|3987445|B5|Native American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4166503|NCT00828139|3987446|B4|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4166504|NCT00828139|3987447|B3|Native American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4166505|NCT00828139|3987448|B2|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4166506|NCT00828139|3987449|B1|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4166507|NCT00828139|3987445|B5|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4166508|NCT00828139|3987446|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4166509|NCT00828139|3987447|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4166510|NCT00828139|3987448|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4166511|NCT00828139|3987449|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4166512|NCT00828139|3987445|B5|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4166513|NCT00828139|3987446|B4|Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4166514|NCT00828139|3987447|B3|Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4166515|NCT00828139|3987448|B2|Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4166516|NCT00828139|3987449|B1|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4166517|NCT00828139|3987445|B5|Black||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4166518|NCT00828139|3987446|B4|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4166519|NCT00828139|3987447|B3|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4166520|NCT00828139|3987448|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4166521|NCT00828139|3987449|B1|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4166522|NCT00828139|3987445|B5|White||Race/Ethnicity, Customized||participants|Number|168|168.0||||||
4166523|NCT00828139|3987446|B4|White||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4166524|NCT00828139|3987447|B3|White||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4166525|NCT00828139|3987448|B2|White||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4166526|NCT00828139|3987449|B1|White||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4166527|NCT00828139|3987445|B5||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4166528|NCT00828139|3987446|B4||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4166529|NCT00828139|3987447|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4166530|NCT00828139|3987448|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4166531|NCT00828139|3987449|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4166532|NCT00828139|3987445|B5||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4166533|NCT00828139|3987446|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4166534|NCT00828139|3987447|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4166535|NCT00828139|3987448|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4166536|NCT00828139|3987449|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4166537|NCT00828139|3987445|B5|||Age||years|Median|62.5|62.5|Full Range|||33.2|85.1|
4166538|NCT00828139|3987446|B4|||Age||years|Median|63.6|63.6|Full Range|||45.1|85.1|
4166539|NCT00828139|3987447|B3|||Age||years|Median|60.9|60.9|Full Range|||40.1|82.6|
4166540|NCT00828139|3987448|B2|||Age||years|Median|60.1|60.1|Full Range|||33.2|85.1|
4166541|NCT00828139|3987449|B1|||Age||years|Median|63.4|63.4|Full Range|||43.1|81.8|
4166542|NCT00828113|3987470|B3|United States||Region of Enrollment||participants|Number|101|101.0||||||
4166543|NCT00828113|3987471|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
4166544|NCT00828113|3987472|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4166545|NCT00828113|3987470|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4166546|NCT00828113|3987471|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4166547|NCT00828113|3987472|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4166548|NCT00828113|3987470|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4166549|NCT00828113|3987471|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4166551|NCT00828113|3987470|B3|||Age||years|Mean|42.9|42.9|Standard Deviation|12.0|12.0|||
4166552|NCT00828113|3987471|B2|||Age||years|Mean|43.2|43.2|Standard Deviation|12.4|12.4|||
4166553|NCT00828113|3987472|B1|||Age||years|Mean|42.6|42.6|Standard Deviation|11.6|11.6|||
4166554|NCT00828113|3987470|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4166555|NCT00828113|3987471|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4166556|NCT00828113|3987472|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4166557|NCT00828113|3987470|B3||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
4166558|NCT00828113|3987471|B2||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4166559|NCT00828113|3987472|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4166560|NCT00828113|3987470|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166561|NCT00828113|3987471|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166562|NCT00828113|3987472|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166563|NCT00828074|3987479|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
4166564|NCT00828074|3987480|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4166565|NCT00828074|3987481|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4166566|NCT00828074|3987479|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
4166567|NCT00828074|3987480|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
4166568|NCT00828074|3987481|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4166569|NCT00828074|3987479|B3||Female|Gender||Participants|Count of Participants|46|46.0||||||
4166570|NCT00828074|3987480|B2||Female|Gender||Participants|Count of Participants|5|5.0||||||
4166571|NCT00828074|3987481|B1||Female|Gender||Participants|Count of Participants|41|41.0||||||
4166572|NCT00828074|3987479|B3|||Age||years|Median|55|55.0|Full Range|||31.0|72.0|
4166573|NCT00828074|3987480|B2|||Age||years|Median|59|59.0|Full Range|||46.0|67.0|
4166574|NCT00828074|3987481|B1|||Age||years|Median|54|54.0|Full Range|||31.0|72.0|
4166575|NCT00828061|3987495|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4166576|NCT00828061|3987495|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4166577|NCT00828061|3987495|B1|||Age||years|Mean|40.4|40.4|Full Range|||22.0|55.0|
4166578|NCT00827983|3987511|B3|Italy||Region of Enrollment||participants|Number|319|319.0||||||
4166579|NCT00827983|3987512|B2|Italy||Region of Enrollment||participants|Number|162|162.0||||||
4166580|NCT00827983|3987513|B1|Italy||Region of Enrollment||participants|Number|157|157.0||||||
4166581|NCT00827983|3987511|B3|Switzerland||Region of Enrollment||participants|Number|98|98.0||||||
4166582|NCT00827983|3987512|B2|Switzerland||Region of Enrollment||participants|Number|50|50.0||||||
4166583|NCT00827983|3987513|B1|Switzerland||Region of Enrollment||participants|Number|48|48.0||||||
4166584|NCT00827983|3987511|B3|United Kingdom||Region of Enrollment||participants|Number|91|91.0||||||
4166585|NCT00827983|3987512|B2|United Kingdom||Region of Enrollment||participants|Number|45|45.0||||||
4166586|NCT00827983|3987513|B1|United Kingdom||Region of Enrollment||participants|Number|46|46.0||||||
4166587|NCT00827983|3987511|B3|Germany||Region of Enrollment||participants|Number|47|47.0||||||
4166588|NCT00827983|3987512|B2|Germany||Region of Enrollment||participants|Number|23|23.0||||||
4166589|NCT00827983|3987513|B1|Germany||Region of Enrollment||participants|Number|24|24.0||||||
4166590|NCT00827983|3987511|B3|Hungary||Region of Enrollment||participants|Number|128|128.0||||||
4166591|NCT00827983|3987512|B2|Hungary||Region of Enrollment||participants|Number|64|64.0||||||
4166592|NCT00827983|3987513|B1|Hungary||Region of Enrollment||participants|Number|64|64.0||||||
4166593|NCT00827983|3987511|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4166594|NCT00827983|3987512|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4166595|NCT00827983|3987513|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4166596|NCT00827983|3987511|B3||Female|Sex: Female, Male||Participants|Count of Participants|683|683.0||||||
4166597|NCT00827983|3987512|B2||Female|Sex: Female, Male||Participants|Count of Participants|344|344.0||||||
4166598|NCT00827983|3987513|B1||Female|Sex: Female, Male||Participants|Count of Participants|339|339.0||||||
4166599|NCT00827983|3987511|B3|||Age||years|Mean|33.8|33.8|Standard Deviation|4.3|4.3|||
4166600|NCT00827983|3987512|B2|||Age||years|Mean|33.9|33.9|Standard Deviation|4.3|4.3|||
4166601|NCT00827983|3987513|B1|||Age||years|Mean|33.8|33.8|Standard Deviation|4.3|4.3|||
4166602|NCT00827983|3987511|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4166603|NCT00827983|3987512|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4166604|NCT00827983|3987513|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4166605|NCT00827983|3987511|B3||Between 18 and 65 years|Age||Participants|Count of Participants|683|683.0||||||
4166606|NCT00827983|3987512|B2||Between 18 and 65 years|Age||Participants|Count of Participants|344|344.0||||||
4166607|NCT00827983|3987513|B1||Between 18 and 65 years|Age||Participants|Count of Participants|339|339.0||||||
4166608|NCT00827983|3987511|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166609|NCT00827983|3987512|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166610|NCT00827983|3987513|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166611|NCT00827944|3987524|B3|Sweden||Region of Enrollment||participants|Number|173|173.0||||||
4166612|NCT00827944|3987525|B2|Sweden||Region of Enrollment||participants|Number|86|86.0||||||
4166613|NCT00827944|3987526|B1|Sweden||Region of Enrollment||participants|Number|87|87.0||||||
4166614|NCT00827944|3987524|B3|United Kingdom||Region of Enrollment||participants|Number|181|181.0||||||
4166615|NCT00827944|3987525|B2|United Kingdom||Region of Enrollment||participants|Number|89|89.0||||||
4166616|NCT00827944|3987526|B1|United Kingdom||Region of Enrollment||participants|Number|92|92.0||||||
4166617|NCT00827944|3987524|B3|Netherlands||Region of Enrollment||participants|Number|117|117.0||||||
4166618|NCT00827944|3987525|B2|Netherlands||Region of Enrollment||participants|Number|59|59.0||||||
4166619|NCT00827944|3987526|B1|Netherlands||Region of Enrollment||participants|Number|58|58.0||||||
4166620|NCT00827944|3987524|B3|Germany||Region of Enrollment||participants|Number|107|107.0||||||
4166621|NCT00827944|3987525|B2|Germany||Region of Enrollment||participants|Number|53|53.0||||||
4166622|NCT00827944|3987526|B1|Germany||Region of Enrollment||participants|Number|54|54.0||||||
4166623|NCT00827944|3987524|B3|Belgium||Region of Enrollment||participants|Number|25|25.0||||||
4166624|NCT00827944|3987525|B2|Belgium||Region of Enrollment||participants|Number|12|12.0||||||
4166625|NCT00827944|3987526|B1|Belgium||Region of Enrollment||participants|Number|13|13.0||||||
4166626|NCT00827944|3987524|B3||Male|Gender||Participants|Count of Participants|603|603.0||||||
4166627|NCT00827944|3987525|B2||Male|Gender||Participants|Count of Participants|299|299.0||||||
4166628|NCT00827944|3987526|B1||Male|Gender||Participants|Count of Participants|304|304.0||||||
4166629|NCT00827944|3987524|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
4166630|NCT00827944|3987525|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
4166631|NCT00827944|3987526|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
4166632|NCT00827944|3987524|B3|||Age||years|Mean|57.2|57.2|Standard Deviation|11.5|11.5|||
4166633|NCT00827944|3987525|B2|||Age||years|Mean|57.2|57.2|Standard Deviation|10.9|10.9|||
4166634|NCT00827944|3987526|B1|||Age||years|Mean|57.3|57.3|Standard Deviation|12.1|12.1|||
4166635|NCT00827931|3987545|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4166636|NCT00827931|3987546|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4166637|NCT00827931|3987547|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4166638|NCT00827931|3987545|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4166639|NCT00827931|3987546|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4166640|NCT00827931|3987547|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4166641|NCT00827931|3987545|B3|Greater than or equal to 65 years||Age, Customized||Participants|Number|11|11.0||||||
4166642|NCT00827931|3987546|B2|Greater than or equal to 65 years||Age, Customized||Participants|Number|7|7.0||||||
4166643|NCT00827931|3987547|B1|Greater than or equal to 65 years||Age, Customized||Participants|Number|4|4.0||||||
4166644|NCT00827931|3987545|B3|45 to 64 years||Age, Customized||Participants|Number|43|43.0||||||
4166645|NCT00827931|3987546|B2|45 to 64 years||Age, Customized||Participants|Number|22|22.0||||||
4166646|NCT00827931|3987547|B1|45 to 64 years||Age, Customized||Participants|Number|21|21.0||||||
4166647|NCT00827931|3987545|B3|18 to 44 years||Age, Customized||Participants|Number|40|40.0||||||
4166648|NCT00827931|3987546|B2|18 to 44 years||Age, Customized||Participants|Number|16|16.0||||||
4166649|NCT00827931|3987547|B1|18 to 44 years||Age, Customized||Participants|Number|24|24.0||||||
4166650|NCT00827918|3987566|B4||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4166651|NCT00827918|3987567|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4166652|NCT00827918|3987568|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4166653|NCT00827918|3987569|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4166654|NCT00827918|3987566|B4||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4166655|NCT00827918|3987567|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4166656|NCT00827918|3987568|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4166657|NCT00827918|3987569|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4166658|NCT00827918|3987566|B4|||Age||years|Mean|36.8|36.8|Full Range|||20.0|55.0|
4166659|NCT00827918|3987567|B3|||Age||years|Mean|36.4|36.4|Full Range|||22.0|54.0|
4166660|NCT00827918|3987568|B2|||Age||years|Mean|36.1|36.1|Full Range|||20.0|55.0|
4166661|NCT00827918|3987569|B1|||Age||years|Mean|37.4|37.4|Full Range|||21.0|55.0|
4166662|NCT00827827|3987597|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
4166663|NCT00827827|3987598|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4166664|NCT00827827|3987599|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4166665|NCT00827827|3987597|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4166666|NCT00827827|3987598|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4166667|NCT00827827|3987599|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4166668|NCT00827827|3987597|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4166669|NCT00827827|3987598|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4166670|NCT00827827|3987599|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4166671|NCT00827827|3987597|B3|||Age||years|Mean|56.2|56.2|Standard Deviation|10.3|10.3|||
4166672|NCT00827827|3987598|B2|||Age||years|Mean|55.2|55.2|Standard Deviation|8.7|8.7|||
4166673|NCT00827827|3987599|B1|||Age||years|Mean|56.9|56.9|Standard Deviation|11.5|11.5|||
4166674|NCT00827827|3987597|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4166675|NCT00827827|3987598|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4166676|NCT00827827|3987599|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4166677|NCT00827827|3987597|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4166678|NCT00827827|3987598|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4166679|NCT00827827|3987599|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4166680|NCT00827827|3987597|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166681|NCT00827827|3987598|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166682|NCT00827827|3987599|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166683|NCT00827632|3987642|B3|Nonusers||Oral Contraceptive Pill Compliance||Participants|Number|18|18.0||||||
4166684|NCT00827632|3987643|B2|Nonusers||Oral Contraceptive Pill Compliance||Participants|Number|12|12.0||||||
4166685|NCT00827632|3987644|B1|Nonusers||Oral Contraceptive Pill Compliance||Participants|Number|6|6.0||||||
4166686|NCT00827632|3987642|B3|Inconsistent Users||Oral Contraceptive Pill Compliance||Participants|Number|13|13.0||||||
4166687|NCT00827632|3987643|B2|Inconsistent Users||Oral Contraceptive Pill Compliance||Participants|Number|9|9.0||||||
4166688|NCT00827632|3987644|B1|Inconsistent Users||Oral Contraceptive Pill Compliance||Participants|Number|4|4.0||||||
4166689|NCT00827632|3987642|B3|Consistent Users||Oral Contraceptive Pill Compliance||Participants|Number|150|150.0||||||
4166690|NCT00827632|3987643|B2|Consistent Users||Oral Contraceptive Pill Compliance||Participants|Number|54|54.0||||||
4166691|NCT00827632|3987644|B1|Consistent Users||Oral Contraceptive Pill Compliance||Participants|Number|96|96.0||||||
4166692|NCT00827632|3987642|B3|Non-compliant OCP users (dropped from analysis)||Race/Ethnicity, Customized||Participants|Number|31|31.0||||||
4166693|NCT00827632|3987643|B2|Non-compliant OCP users (dropped from analysis)||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
4166694|NCT00827632|3987644|B1|Non-compliant OCP users (dropped from analysis)||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4166695|NCT00827632|3987642|B3|Non-Hispanic Asian||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4166696|NCT00827632|3987643|B2|Non-Hispanic Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4166697|NCT00827632|3987644|B1|Non-Hispanic Asian||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4166698|NCT00827632|3987642|B3|Non-Hispanic White||Race/Ethnicity, Customized||Participants|Number|44|44.0||||||
4166699|NCT00827632|3987643|B2|Non-Hispanic White||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4166700|NCT00827632|3987644|B1|Non-Hispanic White||Race/Ethnicity, Customized||Participants|Number|33|33.0||||||
4166701|NCT00827632|3987642|B3|Non-Hispanic African American||Race/Ethnicity, Customized||Participants|Number|53|53.0||||||
4166702|NCT00827632|3987643|B2|Non-Hispanic African American||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
4166703|NCT00827632|3987644|B1|Non-Hispanic African American||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
4166704|NCT00827632|3987642|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|38|38.0||||||
4166705|NCT00827632|3987643|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4166706|NCT00827632|3987644|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4166707|NCT00827632|3987642|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4166708|NCT00827632|3987643|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4166709|NCT00827632|3987644|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4166710|NCT00827632|3987642|B3||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4166711|NCT00827632|3987643|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4166712|NCT00827632|3987644|B1||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4166713|NCT00827632|3987642|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4166714|NCT00827632|3987643|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4166715|NCT00827632|3987644|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4166716|NCT00827632|3987642|B3||Between 18 and 65 years|Age||Participants|Count of Participants|181|181.0||||||
4166717|NCT00827632|3987643|B2||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4166718|NCT00827632|3987644|B1||Between 18 and 65 years|Age||Participants|Count of Participants|106|106.0||||||
4166719|NCT00827632|3987642|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166720|NCT00827632|3987643|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166721|NCT00827632|3987644|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166722|NCT00827606|3987651|B3||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4166723|NCT00827606|3987652|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4166724|NCT00827606|3987653|B1||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4166725|NCT00827606|3987651|B3||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4166726|NCT00827606|3987652|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4166727|NCT00827606|3987653|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4166728|NCT00827606|3987651|B3|||Age||years|Mean|10.2|10.2|Standard Deviation|2.48|2.48|||
4166729|NCT00827606|3987652|B2|||Age||years|Mean|12.0|12.0|Standard Deviation|1.68|1.68|||
4166730|NCT00827606|3987653|B1|||Age||years|Mean|8.5|8.5|Standard Deviation|1.86|1.86|||
4166731|NCT00827567|3987715|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4166732|NCT00827567|3987715|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4166733|NCT00827567|3987715|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4166734|NCT00827567|3987715|B1|||Age||years|Mean|58.5|58.5|Standard Deviation|7.65|7.65|||
4166735|NCT00827567|3987715|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4166736|NCT00827567|3987715|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4166737|NCT00827567|3987715|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166738|NCT00827541|3987719|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4166739|NCT00827541|3987720|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4166740|NCT00827541|3987721|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4166741|NCT00827541|3987719|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4166742|NCT00827541|3987720|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4166743|NCT00827541|3987721|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4166744|NCT00827541|3987719|B3|||Age||years|Mean|59.64|59.64|Standard Deviation|15.68|15.68|||
4166745|NCT00827541|3987720|B2|||Age||years|Mean|59.27|59.27|Standard Deviation|16.47|16.47|||
4166746|NCT00827541|3987721|B1|||Age||years|Mean|61.53|61.53|Standard Deviation|11.01|11.01|||
4166747|NCT00827502|3987734|B1|Demographic information not collected||Sex/Gender, Customized||participants|Number|5|5.0||||||
4166748|NCT00827502|3987734|B1|Unspecified||Sex/Gender, Customized||participants|Number|5|5.0||||||
4166749|NCT00827502|3987734|B1|Male||Sex/Gender, Customized||participants|Number|245|245.0||||||
4166750|NCT00827502|3987734|B1|Female||Sex/Gender, Customized||participants|Number|155|155.0||||||
4166751|NCT00827502|3987734|B1|Demographic information not collected||Age, Customized||participants|Number|5|5.0||||||
4166752|NCT00827502|3987734|B1|Unspecified||Age, Customized||participants|Number|2|2.0||||||
4166753|NCT00827502|3987734|B1|>= 65 years||Age, Customized||participants|Number|9|9.0||||||
4166754|NCT00827502|3987734|B1|45-64 years||Age, Customized||participants|Number|73|73.0||||||
4166755|NCT00827502|3987734|B1|18-44 years||Age, Customized||participants|Number|270|270.0||||||
4166756|NCT00827502|3987734|B1|<18 years||Age, Customized||participants|Number|51|51.0||||||
4166757|NCT00827372|3987740|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166758|NCT00827372|3987740|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166759|NCT00827372|3987740|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4166760|NCT00827372|3987740|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4166761|NCT00827372|3987740|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166762|NCT00827372|3987740|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166763|NCT00827372|3987740|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166764|NCT00827372|3987740|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166765|NCT00827372|3987740|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4166766|NCT00827372|3987740|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166767|NCT00827372|3987740|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4166768|NCT00827372|3987740|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4166769|NCT00827372|3987740|B1|||Age||Years|Mean|56.3|56.3|Standard Deviation|11.92|11.92|||
4166770|NCT00827372|3987740|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4166771|NCT00827372|3987740|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4166772|NCT00827372|3987740|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166773|NCT00827255|3987748|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4166774|NCT00827255|3987748|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4166775|NCT00827255|3987748|B1|>=80 years||Age, Customized||participants|Number|2|2.0||||||
4166776|NCT00827255|3987748|B1|Between 70 and 79 years||Age, Customized||participants|Number|11|11.0||||||
4166777|NCT00827255|3987748|B1|Between 60 and 69 years||Age, Customized||participants|Number|5|5.0||||||
4166778|NCT00827255|3987748|B1|Between 50 and 59 years||Age, Customized||participants|Number|8|8.0||||||
4166779|NCT00827255|3987748|B1|Between 40 and 49 years||Age, Customized||participants|Number|2|2.0||||||
4166780|NCT00827255|3987748|B1|<40 years||Age, Customized||participants|Number|7|7.0||||||
4166781|NCT00827242|3987753|B3|Severe||Clinician Global Impression of Severity (CGI-S)|Measures clinician's perception of severity of illness at the time of assessment. The responses were grouped into an ordinal scale with 4 categories: normal; mild; moderate; and severe, and were based on postponing urination, straining to begin urination, a weak urinary stream, stopping and restarting urination several times when urinating, prolonged urination with the end of urine flow slowing to a trickle, bladder not feeling emptied after urinating, having to urinate again less than two hours after the last time urinating, accidental urinary leakage, or having to get up at night to urinate.|participants|Number|52|52.0||||||
4166782|NCT00827242|3987754|B2|Severe||Clinician Global Impression of Severity (CGI-S)|Measures clinician's perception of severity of illness at the time of assessment. The responses were grouped into an ordinal scale with 4 categories: normal; mild; moderate; and severe, and were based on postponing urination, straining to begin urination, a weak urinary stream, stopping and restarting urination several times when urinating, prolonged urination with the end of urine flow slowing to a trickle, bladder not feeling emptied after urinating, having to urinate again less than two hours after the last time urinating, accidental urinary leakage, or having to get up at night to urinate.|participants|Number|31|31.0||||||
4166783|NCT00827242|3987755|B1|Severe||Clinician Global Impression of Severity (CGI-S)|Measures clinician's perception of severity of illness at the time of assessment. The responses were grouped into an ordinal scale with 4 categories: normal; mild; moderate; and severe, and were based on postponing urination, straining to begin urination, a weak urinary stream, stopping and restarting urination several times when urinating, prolonged urination with the end of urine flow slowing to a trickle, bladder not feeling emptied after urinating, having to urinate again less than two hours after the last time urinating, accidental urinary leakage, or having to get up at night to urinate.|participants|Number|21|21.0||||||
4166784|NCT00827242|3987753|B3|Moderate||Clinician Global Impression of Severity (CGI-S)|Measures clinician's perception of severity of illness at the time of assessment. The responses were grouped into an ordinal scale with 4 categories: normal; mild; moderate; and severe, and were based on postponing urination, straining to begin urination, a weak urinary stream, stopping and restarting urination several times when urinating, prolonged urination with the end of urine flow slowing to a trickle, bladder not feeling emptied after urinating, having to urinate again less than two hours after the last time urinating, accidental urinary leakage, or having to get up at night to urinate.|participants|Number|199|199.0||||||
4166785|NCT00827242|3987754|B2|Moderate||Clinician Global Impression of Severity (CGI-S)|Measures clinician's perception of severity of illness at the time of assessment. The responses were grouped into an ordinal scale with 4 categories: normal; mild; moderate; and severe, and were based on postponing urination, straining to begin urination, a weak urinary stream, stopping and restarting urination several times when urinating, prolonged urination with the end of urine flow slowing to a trickle, bladder not feeling emptied after urinating, having to urinate again less than two hours after the last time urinating, accidental urinary leakage, or having to get up at night to urinate.|participants|Number|95|95.0||||||
4166786|NCT00827242|3987755|B1|Moderate||Clinician Global Impression of Severity (CGI-S)|Measures clinician's perception of severity of illness at the time of assessment. The responses were grouped into an ordinal scale with 4 categories: normal; mild; moderate; and severe, and were based on postponing urination, straining to begin urination, a weak urinary stream, stopping and restarting urination several times when urinating, prolonged urination with the end of urine flow slowing to a trickle, bladder not feeling emptied after urinating, having to urinate again less than two hours after the last time urinating, accidental urinary leakage, or having to get up at night to urinate.|participants|Number|104|104.0||||||
4166787|NCT00827242|3987753|B3|Mild||Clinician Global Impression of Severity (CGI-S)|Measures clinician's perception of severity of illness at the time of assessment. The responses were grouped into an ordinal scale with 4 categories: normal; mild; moderate; and severe, and were based on postponing urination, straining to begin urination, a weak urinary stream, stopping and restarting urination several times when urinating, prolonged urination with the end of urine flow slowing to a trickle, bladder not feeling emptied after urinating, having to urinate again less than two hours after the last time urinating, accidental urinary leakage, or having to get up at night to urinate.|participants|Number|73|73.0||||||
4166788|NCT00827242|3987754|B2|Mild||Clinician Global Impression of Severity (CGI-S)|Measures clinician's perception of severity of illness at the time of assessment. The responses were grouped into an ordinal scale with 4 categories: normal; mild; moderate; and severe, and were based on postponing urination, straining to begin urination, a weak urinary stream, stopping and restarting urination several times when urinating, prolonged urination with the end of urine flow slowing to a trickle, bladder not feeling emptied after urinating, having to urinate again less than two hours after the last time urinating, accidental urinary leakage, or having to get up at night to urinate.|participants|Number|37|37.0||||||
4166789|NCT00827242|3987755|B1|Mild||Clinician Global Impression of Severity (CGI-S)|Measures clinician's perception of severity of illness at the time of assessment. The responses were grouped into an ordinal scale with 4 categories: normal; mild; moderate; and severe, and were based on postponing urination, straining to begin urination, a weak urinary stream, stopping and restarting urination several times when urinating, prolonged urination with the end of urine flow slowing to a trickle, bladder not feeling emptied after urinating, having to urinate again less than two hours after the last time urinating, accidental urinary leakage, or having to get up at night to urinate.|participants|Number|36|36.0||||||
4166790|NCT00827242|3987753|B3|Normal||Clinician Global Impression of Severity (CGI-S)|Measures clinician's perception of severity of illness at the time of assessment. The responses were grouped into an ordinal scale with 4 categories: normal; mild; moderate; and severe, and were based on postponing urination, straining to begin urination, a weak urinary stream, stopping and restarting urination several times when urinating, prolonged urination with the end of urine flow slowing to a trickle, bladder not feeling emptied after urinating, having to urinate again less than two hours after the last time urinating, accidental urinary leakage, or having to get up at night to urinate.|participants|Number|1|1.0||||||
4166791|NCT00827242|3987754|B2|Normal||Clinician Global Impression of Severity (CGI-S)|Measures clinician's perception of severity of illness at the time of assessment. The responses were grouped into an ordinal scale with 4 categories: normal; mild; moderate; and severe, and were based on postponing urination, straining to begin urination, a weak urinary stream, stopping and restarting urination several times when urinating, prolonged urination with the end of urine flow slowing to a trickle, bladder not feeling emptied after urinating, having to urinate again less than two hours after the last time urinating, accidental urinary leakage, or having to get up at night to urinate.|participants|Number|1|1.0||||||
4166792|NCT00827242|3987755|B1|Normal||Clinician Global Impression of Severity (CGI-S)|Measures clinician's perception of severity of illness at the time of assessment. The responses were grouped into an ordinal scale with 4 categories: normal; mild; moderate; and severe, and were based on postponing urination, straining to begin urination, a weak urinary stream, stopping and restarting urination several times when urinating, prolonged urination with the end of urine flow slowing to a trickle, bladder not feeling emptied after urinating, having to urinate again less than two hours after the last time urinating, accidental urinary leakage, or having to get up at night to urinate.|participants|Number|0|0.0||||||
4166793|NCT00827242|3987753|B3|Severe||Patient Global Impression of Severity (PGI-S)|Measures patient's perception of severity of illness at the time of assessment. The responses were grouped into an ordinal scale with 4 categories: normal; mild; moderate; and severe, and were based on postponing urination, straining to begin urination, a weak urinary stream, stopping and restarting urination several times when urinating, prolonged urination with the end of urine flow slowing to a trickle, bladder not feeling emptied after urinating, having to urinate again less than two hours after the last time urinating, accidental urinary leakage, or having to get up at night to urinate.|participants|Number|43|43.0||||||
4166831|NCT00827242|3987755|B1|Mild||ED Severity|ED is defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse. Severity is based on investigator's opinion. Participant population includes all randomized subjects with ED.|participants|Number|34|34.0||||||
4166832|NCT00827242|3987753|B3|No||Erectile Dysfunction (ED)|ED is defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse.|participants|Number|101|101.0||||||
4166794|NCT00827242|3987754|B2|Severe||Patient Global Impression of Severity (PGI-S)|Measures patient's perception of severity of illness at the time of assessment. The responses were grouped into an ordinal scale with 4 categories: normal; mild; moderate; and severe, and were based on postponing urination, straining to begin urination, a weak urinary stream, stopping and restarting urination several times when urinating, prolonged urination with the end of urine flow slowing to a trickle, bladder not feeling emptied after urinating, having to urinate again less than two hours after the last time urinating, accidental urinary leakage, or having to get up at night to urinate.|participants|Number|24|24.0||||||
4166795|NCT00827242|3987755|B1|Severe||Patient Global Impression of Severity (PGI-S)|Measures patient's perception of severity of illness at the time of assessment. The responses were grouped into an ordinal scale with 4 categories: normal; mild; moderate; and severe, and were based on postponing urination, straining to begin urination, a weak urinary stream, stopping and restarting urination several times when urinating, prolonged urination with the end of urine flow slowing to a trickle, bladder not feeling emptied after urinating, having to urinate again less than two hours after the last time urinating, accidental urinary leakage, or having to get up at night to urinate.|participants|Number|19|19.0||||||
4166796|NCT00827242|3987753|B3|Moderate||Patient Global Impression of Severity (PGI-S)|Measures patient's perception of severity of illness at the time of assessment. The responses were grouped into an ordinal scale with 4 categories: normal; mild; moderate; and severe, and were based on postponing urination, straining to begin urination, a weak urinary stream, stopping and restarting urination several times when urinating, prolonged urination with the end of urine flow slowing to a trickle, bladder not feeling emptied after urinating, having to urinate again less than two hours after the last time urinating, accidental urinary leakage, or having to get up at night to urinate.|participants|Number|207|207.0||||||
4166797|NCT00827242|3987754|B2|Moderate||Patient Global Impression of Severity (PGI-S)|Measures patient's perception of severity of illness at the time of assessment. The responses were grouped into an ordinal scale with 4 categories: normal; mild; moderate; and severe, and were based on postponing urination, straining to begin urination, a weak urinary stream, stopping and restarting urination several times when urinating, prolonged urination with the end of urine flow slowing to a trickle, bladder not feeling emptied after urinating, having to urinate again less than two hours after the last time urinating, accidental urinary leakage, or having to get up at night to urinate.|participants|Number|105|105.0||||||
4166798|NCT00827242|3987755|B1|Moderate||Patient Global Impression of Severity (PGI-S)|Measures patient's perception of severity of illness at the time of assessment. The responses were grouped into an ordinal scale with 4 categories: normal; mild; moderate; and severe, and were based on postponing urination, straining to begin urination, a weak urinary stream, stopping and restarting urination several times when urinating, prolonged urination with the end of urine flow slowing to a trickle, bladder not feeling emptied after urinating, having to urinate again less than two hours after the last time urinating, accidental urinary leakage, or having to get up at night to urinate.|participants|Number|102|102.0||||||
4166799|NCT00827242|3987753|B3|Mild||Patient Global Impression of Severity (PGI-S)|Measures patient's perception of severity of illness at the time of assessment. The responses were grouped into an ordinal scale with 4 categories: normal; mild; moderate; and severe, and were based on postponing urination, straining to begin urination, a weak urinary stream, stopping and restarting urination several times when urinating, prolonged urination with the end of urine flow slowing to a trickle, bladder not feeling emptied after urinating, having to urinate again less than two hours after the last time urinating, accidental urinary leakage, or having to get up at night to urinate.|participants|Number|62|62.0||||||
4166800|NCT00827242|3987754|B2|Mild||Patient Global Impression of Severity (PGI-S)|Measures patient's perception of severity of illness at the time of assessment. The responses were grouped into an ordinal scale with 4 categories: normal; mild; moderate; and severe, and were based on postponing urination, straining to begin urination, a weak urinary stream, stopping and restarting urination several times when urinating, prolonged urination with the end of urine flow slowing to a trickle, bladder not feeling emptied after urinating, having to urinate again less than two hours after the last time urinating, accidental urinary leakage, or having to get up at night to urinate.|participants|Number|27|27.0||||||
4166801|NCT00827242|3987755|B1|Mild||Patient Global Impression of Severity (PGI-S)|Measures patient's perception of severity of illness at the time of assessment. The responses were grouped into an ordinal scale with 4 categories: normal; mild; moderate; and severe, and were based on postponing urination, straining to begin urination, a weak urinary stream, stopping and restarting urination several times when urinating, prolonged urination with the end of urine flow slowing to a trickle, bladder not feeling emptied after urinating, having to urinate again less than two hours after the last time urinating, accidental urinary leakage, or having to get up at night to urinate.|participants|Number|35|35.0||||||
4166802|NCT00827242|3987753|B3|Normal||Patient Global Impression of Severity (PGI-S)|Measures patient's perception of severity of illness at the time of assessment. The responses were grouped into an ordinal scale with 4 categories: normal; mild; moderate; and severe, and were based on postponing urination, straining to begin urination, a weak urinary stream, stopping and restarting urination several times when urinating, prolonged urination with the end of urine flow slowing to a trickle, bladder not feeling emptied after urinating, having to urinate again less than two hours after the last time urinating, accidental urinary leakage, or having to get up at night to urinate.|participants|Number|13|13.0||||||
4166803|NCT00827242|3987754|B2|Normal||Patient Global Impression of Severity (PGI-S)|Measures patient's perception of severity of illness at the time of assessment. The responses were grouped into an ordinal scale with 4 categories: normal; mild; moderate; and severe, and were based on postponing urination, straining to begin urination, a weak urinary stream, stopping and restarting urination several times when urinating, prolonged urination with the end of urine flow slowing to a trickle, bladder not feeling emptied after urinating, having to urinate again less than two hours after the last time urinating, accidental urinary leakage, or having to get up at night to urinate.|participants|Number|8|8.0||||||
4166833|NCT00827242|3987754|B2|No||Erectile Dysfunction (ED)|ED is defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse.|participants|Number|52|52.0||||||
4166834|NCT00827242|3987755|B1|No||Erectile Dysfunction (ED)|ED is defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse.|participants|Number|49|49.0||||||
4166939|NCT00826943|3987848|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4166804|NCT00827242|3987755|B1|Normal||Patient Global Impression of Severity (PGI-S)|Measures patient's perception of severity of illness at the time of assessment. The responses were grouped into an ordinal scale with 4 categories: normal; mild; moderate; and severe, and were based on postponing urination, straining to begin urination, a weak urinary stream, stopping and restarting urination several times when urinating, prolonged urination with the end of urine flow slowing to a trickle, bladder not feeling emptied after urinating, having to urinate again less than two hours after the last time urinating, accidental urinary leakage, or having to get up at night to urinate.|participants|Number|5|5.0||||||
4166805|NCT00827242|3987753|B3|No||Expect to Remain Sexually Active|Participant population is based on number of randomized subjects who are reported to be sexually active with a female partner.|participants|Number|1|1.0||||||
4166806|NCT00827242|3987754|B2|No||Expect to Remain Sexually Active|Participant population is based on number of randomized subjects who are reported to be sexually active with a female partner.|participants|Number|0|0.0||||||
4166807|NCT00827242|3987755|B1|No||Expect to Remain Sexually Active|Participant population is based on number of randomized subjects who are reported to be sexually active with a female partner.|participants|Number|1|1.0||||||
4166808|NCT00827242|3987753|B3|Yes||Expect to Remain Sexually Active|Participant population is based on number of randomized subjects who are reported to be sexually active with a female partner.|participants|Number|256|256.0||||||
4166809|NCT00827242|3987754|B2|Yes||Expect to Remain Sexually Active|Participant population is based on number of randomized subjects who are reported to be sexually active with a female partner.|participants|Number|129|129.0||||||
4166810|NCT00827242|3987755|B1|Yes||Expect to Remain Sexually Active|Participant population is based on number of randomized subjects who are reported to be sexually active with a female partner.|participants|Number|127|127.0||||||
4166811|NCT00827242|3987753|B3|No||Sexually Active with a Female Partner||participants|Number|68|68.0||||||
4166812|NCT00827242|3987754|B2|No||Sexually Active with a Female Partner||participants|Number|35|35.0||||||
4166813|NCT00827242|3987755|B1|No||Sexually Active with a Female Partner||participants|Number|33|33.0||||||
4166814|NCT00827242|3987753|B3|Yes||Sexually Active with a Female Partner||participants|Number|257|257.0||||||
4166815|NCT00827242|3987754|B2|Yes||Sexually Active with a Female Partner||participants|Number|129|129.0||||||
4166816|NCT00827242|3987755|B1|Yes||Sexually Active with a Female Partner||participants|Number|128|128.0||||||
4166817|NCT00827242|3987753|B3|>=1 year||ED Duration|ED is defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse. Participant population includes all randomized subjects with ED.|participants|Number|193|193.0||||||
4166818|NCT00827242|3987754|B2|>=1 year||ED Duration|ED is defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse. Participant population includes all randomized subjects with ED.|participants|Number|95|95.0||||||
4166819|NCT00827242|3987755|B1|>=1 year||ED Duration|ED is defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse. Participant population includes all randomized subjects with ED.|participants|Number|98|98.0||||||
4166820|NCT00827242|3987753|B3|<1 year||ED Duration|ED is defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse. Participant population includes all randomized subjects with ED.|participants|Number|31|31.0||||||
4166821|NCT00827242|3987754|B2|<1 year||ED Duration|ED is defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse. Participant population includes all randomized subjects with ED.|participants|Number|17|17.0||||||
4166822|NCT00827242|3987755|B1|<1 year||ED Duration|ED is defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse. Participant population includes all randomized subjects with ED.|participants|Number|14|14.0||||||
4166823|NCT00827242|3987753|B3|Severe||ED Severity|ED is defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse. Severity is based on investigator's opinion. Participant population includes all randomized subjects with ED.|participants|Number|30|30.0||||||
4166824|NCT00827242|3987754|B2|Severe||ED Severity|ED is defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse. Severity is based on investigator's opinion. Participant population includes all randomized subjects with ED.|participants|Number|13|13.0||||||
4166825|NCT00827242|3987755|B1|Severe||ED Severity|ED is defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse. Severity is based on investigator's opinion. Participant population includes all randomized subjects with ED.|participants|Number|17|17.0||||||
4166826|NCT00827242|3987753|B3|Moderate||ED Severity|ED is defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse. Severity is based on investigator's opinion. Participant population includes all randomized subjects with ED.|participants|Number|120|120.0||||||
4166827|NCT00827242|3987754|B2|Moderate||ED Severity|ED is defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse. Severity is based on investigator's opinion. Participant population includes all randomized subjects with ED.|participants|Number|59|59.0||||||
4166828|NCT00827242|3987755|B1|Moderate||ED Severity|ED is defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse. Severity is based on investigator's opinion. Participant population includes all randomized subjects with ED.|participants|Number|61|61.0||||||
4166829|NCT00827242|3987753|B3|Mild||ED Severity|ED is defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse. Severity is based on investigator's opinion. Participant population includes all randomized subjects with ED.|participants|Number|74|74.0||||||
4166830|NCT00827242|3987754|B2|Mild||ED Severity|ED is defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse. Severity is based on investigator's opinion. Participant population includes all randomized subjects with ED.|participants|Number|40|40.0||||||
4166835|NCT00827242|3987753|B3|Yes||Erectile Dysfunction (ED)|ED is defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse.|participants|Number|224|224.0||||||
4166836|NCT00827242|3987754|B2|Yes||Erectile Dysfunction (ED)|ED is defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse.|participants|Number|112|112.0||||||
4166837|NCT00827242|3987755|B1|Yes||Erectile Dysfunction (ED)|ED is defined as a consistent change in the quality of erection adversely affecting subject satisfaction with sexual intercourse.|participants|Number|112|112.0||||||
4166838|NCT00827242|3987753|B3|||Prostate-Specific Antigen (PSA)|PSA is a tumor marker associated with prostate cancer. The participant population includes all randomized subjects with non-missing data (n=164 for placebo and n=160 for tadalafil).|ng/mL|Mean|2.1|2.1|Standard Deviation|1.74|1.74|||
4166839|NCT00827242|3987754|B2|||Prostate-Specific Antigen (PSA)|PSA is a tumor marker associated with prostate cancer. The participant population includes all randomized subjects with non-missing data (n=164 for placebo and n=160 for tadalafil).|ng/mL|Mean|2.2|2.2|Standard Deviation|1.72|1.72|||
4166840|NCT00827242|3987755|B1|||Prostate-Specific Antigen (PSA)|PSA is a tumor marker associated with prostate cancer. The participant population includes all randomized subjects with non-missing data (n=164 for placebo and n=160 for tadalafil).|ng/mL|Mean|2.0|2.0|Standard Deviation|1.75|1.75|||
4166841|NCT00827242|3987753|B3|||Post-void Residual Volume (PVR)|The amount of urine remaining in the bladder after void completion.|mL|Mean|54.2|54.2|Standard Deviation|53.70|53.7|||
4166842|NCT00827242|3987754|B2|||Post-void Residual Volume (PVR)|The amount of urine remaining in the bladder after void completion.|mL|Mean|63.3|63.3|Standard Deviation|59.88|59.88|||
4166843|NCT00827242|3987755|B1|||Post-void Residual Volume (PVR)|The amount of urine remaining in the bladder after void completion.|mL|Mean|44.9|44.9|Standard Deviation|44.87|44.87|||
4166844|NCT00827242|3987753|B3|>15 mL/sec||Peak Urine Flow Rate (Qmax) Category|Participants were categorized by Qmax: defined as the peak urine flow rate (measured in mL/second using standard calibrated flowmeter). Based on measurements from 305 randomized participants with a valid uroflowmetry assessment. Uroflowmetry assessments were considered valid and the data were included in statistical analyses only if the prevoid total bladder volume (assessed by ultrasound) was >=150 mL to <=550 mL and the volume of voided urine (Vcomp) was >=125 mL.|participants|Number|44|44.0||||||
4166845|NCT00827242|3987754|B2|>15 mL/sec||Peak Urine Flow Rate (Qmax) Category|Participants were categorized by Qmax: defined as the peak urine flow rate (measured in mL/second using standard calibrated flowmeter). Based on measurements from 305 randomized participants with a valid uroflowmetry assessment. Uroflowmetry assessments were considered valid and the data were included in statistical analyses only if the prevoid total bladder volume (assessed by ultrasound) was >=150 mL to <=550 mL and the volume of voided urine (Vcomp) was >=125 mL.|participants|Number|24|24.0||||||
4166846|NCT00827242|3987755|B1|>15 mL/sec||Peak Urine Flow Rate (Qmax) Category|Participants were categorized by Qmax: defined as the peak urine flow rate (measured in mL/second using standard calibrated flowmeter). Based on measurements from 305 randomized participants with a valid uroflowmetry assessment. Uroflowmetry assessments were considered valid and the data were included in statistical analyses only if the prevoid total bladder volume (assessed by ultrasound) was >=150 mL to <=550 mL and the volume of voided urine (Vcomp) was >=125 mL.|participants|Number|20|20.0||||||
4166847|NCT00827242|3987753|B3|10-15 mL/sec||Peak Urine Flow Rate (Qmax) Category|Participants were categorized by Qmax: defined as the peak urine flow rate (measured in mL/second using standard calibrated flowmeter). Based on measurements from 305 randomized participants with a valid uroflowmetry assessment. Uroflowmetry assessments were considered valid and the data were included in statistical analyses only if the prevoid total bladder volume (assessed by ultrasound) was >=150 mL to <=550 mL and the volume of voided urine (Vcomp) was >=125 mL.|participants|Number|145|145.0||||||
4166848|NCT00827242|3987754|B2|10-15 mL/sec||Peak Urine Flow Rate (Qmax) Category|Participants were categorized by Qmax: defined as the peak urine flow rate (measured in mL/second using standard calibrated flowmeter). Based on measurements from 305 randomized participants with a valid uroflowmetry assessment. Uroflowmetry assessments were considered valid and the data were included in statistical analyses only if the prevoid total bladder volume (assessed by ultrasound) was >=150 mL to <=550 mL and the volume of voided urine (Vcomp) was >=125 mL.|participants|Number|67|67.0||||||
4166849|NCT00827242|3987755|B1|10-15 mL/sec||Peak Urine Flow Rate (Qmax) Category|Participants were categorized by Qmax: defined as the peak urine flow rate (measured in mL/second using standard calibrated flowmeter). Based on measurements from 305 randomized participants with a valid uroflowmetry assessment. Uroflowmetry assessments were considered valid and the data were included in statistical analyses only if the prevoid total bladder volume (assessed by ultrasound) was >=150 mL to <=550 mL and the volume of voided urine (Vcomp) was >=125 mL.|participants|Number|78|78.0||||||
4166850|NCT00827242|3987753|B3|<10 mL/sec||Peak Urine Flow Rate (Qmax) Category|Participants were categorized by Qmax: defined as the peak urine flow rate (measured in mL/second using standard calibrated flowmeter). Based on measurements from 305 randomized participants with a valid uroflowmetry assessment. Uroflowmetry assessments were considered valid and the data were included in statistical analyses only if the prevoid total bladder volume (assessed by ultrasound) was >=150 mL to <=550 mL and the volume of voided urine (Vcomp) was >=125 mL.|participants|Number|116|116.0||||||
4166851|NCT00827242|3987754|B2|<10 mL/sec||Peak Urine Flow Rate (Qmax) Category|Participants were categorized by Qmax: defined as the peak urine flow rate (measured in mL/second using standard calibrated flowmeter). Based on measurements from 305 randomized participants with a valid uroflowmetry assessment. Uroflowmetry assessments were considered valid and the data were included in statistical analyses only if the prevoid total bladder volume (assessed by ultrasound) was >=150 mL to <=550 mL and the volume of voided urine (Vcomp) was >=125 mL.|participants|Number|62|62.0||||||
4166852|NCT00827242|3987755|B1|<10 mL/sec||Peak Urine Flow Rate (Qmax) Category|Participants were categorized by Qmax: defined as the peak urine flow rate (measured in mL/second using standard calibrated flowmeter). Based on measurements from 305 randomized participants with a valid uroflowmetry assessment. Uroflowmetry assessments were considered valid and the data were included in statistical analyses only if the prevoid total bladder volume (assessed by ultrasound) was >=150 mL to <=550 mL and the volume of voided urine (Vcomp) was >=125 mL.|participants|Number|54|54.0||||||
4166881|NCT00827242|3987754|B2||Asian|Race (NIH/OMB)|"If a subject reported multiple race categories, he was counted as more than one race, but not in any single category."|Participants|Count of Participants|0|0.0||||||
4166940|NCT00826943|3987848|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4166853|NCT00827242|3987753|B3|Severe||Baseline Lower Urinary Tract Symptoms (LUTS) Severity|Baseline LUTS severity was assessed using the International Prostate Symptom Score (IPSS). The IPSS Total Score is obtained by combining the scores of the responses to 1 through 7 component questions. Each question is scored from 0-5 for an IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms. Moderate was considered an IPSS score <20. Severe was considered an IPSS>=20.|participants|Number|115|115.0||||||
4166854|NCT00827242|3987754|B2|Severe||Baseline Lower Urinary Tract Symptoms (LUTS) Severity|Baseline LUTS severity was assessed using the International Prostate Symptom Score (IPSS). The IPSS Total Score is obtained by combining the scores of the responses to 1 through 7 component questions. Each question is scored from 0-5 for an IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms. Moderate was considered an IPSS score <20. Severe was considered an IPSS>=20.|participants|Number|54|54.0||||||
4166855|NCT00827242|3987755|B1|Severe||Baseline Lower Urinary Tract Symptoms (LUTS) Severity|Baseline LUTS severity was assessed using the International Prostate Symptom Score (IPSS). The IPSS Total Score is obtained by combining the scores of the responses to 1 through 7 component questions. Each question is scored from 0-5 for an IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms. Moderate was considered an IPSS score <20. Severe was considered an IPSS>=20.|participants|Number|61|61.0||||||
4166856|NCT00827242|3987753|B3|Moderate||Baseline Lower Urinary Tract Symptoms (LUTS) Severity|Baseline LUTS severity was assessed using the International Prostate Symptom Score (IPSS). The IPSS Total Score is obtained by combining the scores of the responses to 1 through 7 component questions. Each question is scored from 0-5 for an IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms. Moderate was considered an IPSS score <20. Severe was considered an IPSS>=20.|participants|Number|210|210.0||||||
4166857|NCT00827242|3987754|B2|Moderate||Baseline Lower Urinary Tract Symptoms (LUTS) Severity|Baseline LUTS severity was assessed using the International Prostate Symptom Score (IPSS). The IPSS Total Score is obtained by combining the scores of the responses to 1 through 7 component questions. Each question is scored from 0-5 for an IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms. Moderate was considered an IPSS score <20. Severe was considered an IPSS>=20.|participants|Number|110|110.0||||||
4166858|NCT00827242|3987755|B1|Moderate||Baseline Lower Urinary Tract Symptoms (LUTS) Severity|Baseline LUTS severity was assessed using the International Prostate Symptom Score (IPSS). The IPSS Total Score is obtained by combining the scores of the responses to 1 through 7 component questions. Each question is scored from 0-5 for an IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms. Moderate was considered an IPSS score <20. Severe was considered an IPSS>=20.|participants|Number|100|100.0||||||
4166859|NCT00827242|3987753|B3|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilogram (kg)/meter (m)^2|Mean|27.7|27.7|Standard Deviation|4.07|4.07|||
4166860|NCT00827242|3987754|B2|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilogram (kg)/meter (m)^2|Mean|28.4|28.4|Standard Deviation|4.21|4.21|||
4166861|NCT00827242|3987755|B1|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilogram (kg)/meter (m)^2|Mean|27.1|27.1|Standard Deviation|3.82|3.82|||
4166862|NCT00827242|3987753|B3|Europe||Region of Enrollment||participants|Number|137|137.0||||||
4166863|NCT00827242|3987754|B2|Europe||Region of Enrollment||participants|Number|69|69.0||||||
4166864|NCT00827242|3987755|B1|Europe||Region of Enrollment||participants|Number|68|68.0||||||
4166865|NCT00827242|3987753|B3|South America||Region of Enrollment||participants|Number|86|86.0||||||
4166866|NCT00827242|3987754|B2|South America||Region of Enrollment||participants|Number|43|43.0||||||
4166867|NCT00827242|3987755|B1|South America||Region of Enrollment||participants|Number|43|43.0||||||
4166868|NCT00827242|3987753|B3|United States||Region of Enrollment||participants|Number|102|102.0||||||
4166869|NCT00827242|3987754|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
4166870|NCT00827242|3987755|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4166871|NCT00827242|3987753|B3||More than one race|Race (NIH/OMB)|"If a subject reported multiple race categories, he was counted as more than one race, but not in any single category."|Participants|Count of Participants|2|2.0||||||
4166872|NCT00827242|3987754|B2||More than one race|Race (NIH/OMB)|"If a subject reported multiple race categories, he was counted as more than one race, but not in any single category."|Participants|Count of Participants|1|1.0||||||
4166873|NCT00827242|3987755|B1||More than one race|Race (NIH/OMB)|"If a subject reported multiple race categories, he was counted as more than one race, but not in any single category."|Participants|Count of Participants|1|1.0||||||
4166874|NCT00827242|3987753|B3||White|Race (NIH/OMB)|"If a subject reported multiple race categories, he was counted as more than one race, but not in any single category."|Participants|Count of Participants|296|296.0||||||
4166875|NCT00827242|3987754|B2||White|Race (NIH/OMB)|"If a subject reported multiple race categories, he was counted as more than one race, but not in any single category."|Participants|Count of Participants|150|150.0||||||
4166876|NCT00827242|3987755|B1||White|Race (NIH/OMB)|"If a subject reported multiple race categories, he was counted as more than one race, but not in any single category."|Participants|Count of Participants|146|146.0||||||
4166877|NCT00827242|3987753|B3||Black or African American|Race (NIH/OMB)|"If a subject reported multiple race categories, he was counted as more than one race, but not in any single category."|Participants|Count of Participants|8|8.0||||||
4166878|NCT00827242|3987754|B2||Black or African American|Race (NIH/OMB)|"If a subject reported multiple race categories, he was counted as more than one race, but not in any single category."|Participants|Count of Participants|5|5.0||||||
4166879|NCT00827242|3987755|B1||Black or African American|Race (NIH/OMB)|"If a subject reported multiple race categories, he was counted as more than one race, but not in any single category."|Participants|Count of Participants|3|3.0||||||
4166880|NCT00827242|3987753|B3||Asian|Race (NIH/OMB)|"If a subject reported multiple race categories, he was counted as more than one race, but not in any single category."|Participants|Count of Participants|2|2.0||||||
4166882|NCT00827242|3987755|B1||Asian|Race (NIH/OMB)|"If a subject reported multiple race categories, he was counted as more than one race, but not in any single category."|Participants|Count of Participants|2|2.0||||||
4166883|NCT00827242|3987753|B3||American Indian or Alaska Native|Race (NIH/OMB)|"If a subject reported multiple race categories, he was counted as more than one race, but not in any single category."|Participants|Count of Participants|17|17.0||||||
4166884|NCT00827242|3987754|B2||American Indian or Alaska Native|Race (NIH/OMB)|"If a subject reported multiple race categories, he was counted as more than one race, but not in any single category."|Participants|Count of Participants|8|8.0||||||
4166885|NCT00827242|3987755|B1||American Indian or Alaska Native|Race (NIH/OMB)|"If a subject reported multiple race categories, he was counted as more than one race, but not in any single category."|Participants|Count of Participants|9|9.0||||||
4166886|NCT00827242|3987753|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|235|235.0||||||
4166887|NCT00827242|3987754|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
4166888|NCT00827242|3987755|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
4166889|NCT00827242|3987753|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4166890|NCT00827242|3987754|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4166891|NCT00827242|3987755|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4166892|NCT00827242|3987753|B3||Male|Sex: Female, Male||Participants|Count of Participants|325|325.0||||||
4166893|NCT00827242|3987754|B2||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4166894|NCT00827242|3987755|B1||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4166895|NCT00827242|3987753|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4166896|NCT00827242|3987754|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4166897|NCT00827242|3987755|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4166898|NCT00827242|3987753|B3|||Age||years|Mean|64.9|64.9|Standard Deviation|9.26|9.26|||
4166899|NCT00827242|3987754|B2|||Age||years|Mean|64.6|64.6|Standard Deviation|10.03|10.03|||
4166900|NCT00827242|3987755|B1|||Age||years|Mean|65.1|65.1|Standard Deviation|8.43|8.43|||
4166901|NCT00827112|3987792|B3||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4166902|NCT00827112|3987793|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4166903|NCT00827112|3987794|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4166904|NCT00827112|3987792|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4166905|NCT00827112|3987793|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4166906|NCT00827112|3987794|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4166907|NCT00827112|3987792|B3|||Age||Years|Mean|36.8|36.8|Standard Deviation|10.4|10.4|||
4166908|NCT00827112|3987793|B2|||Age||Years|Mean|35.3|35.3|Standard Deviation|10.5|10.5|||
4166909|NCT00827112|3987794|B1|||Age||Years|Mean|38.3|38.3|Standard Deviation|10.2|10.2|||
4166910|NCT00827099|3987828|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4166911|NCT00827099|3987828|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4166912|NCT00827099|3987828|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4166913|NCT00827099|3987828|B1|||Age||years|Mean|35.8|35.8|Standard Deviation|9.86|9.86|||
4166914|NCT00827099|3987828|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4166915|NCT00827099|3987828|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4166916|NCT00827099|3987828|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166917|NCT00827073|3987837|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4166918|NCT00827073|3987838|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4166919|NCT00827073|3987839|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4166920|NCT00827073|3987837|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4166921|NCT00827073|3987838|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4166922|NCT00827073|3987839|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4166923|NCT00827073|3987837|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4166924|NCT00827073|3987838|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4166925|NCT00827073|3987839|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4166926|NCT00827073|3987837|B3||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4166927|NCT00827073|3987838|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4166928|NCT00827073|3987839|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4166929|NCT00827073|3987837|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4166930|NCT00827073|3987838|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4166931|NCT00827073|3987839|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4166932|NCT00827073|3987837|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166933|NCT00827073|3987838|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166934|NCT00827073|3987839|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166935|NCT00827073|3987837|B3|||Age||year|Mean|69.2|69.2|Standard Deviation|9.8|9.8|||
4166936|NCT00827073|3987838|B2|||Age||year|Mean|68.4|68.4|Standard Deviation|11.8|11.8|||
4166937|NCT00827073|3987839|B1|||Age||year|Mean|70.0|70.0|Standard Deviation|7.4|7.4|||
4166938|NCT00826943|3987848|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4166941|NCT00826943|3987848|B1|||Age||years|Mean|37.5|37.5|Standard Deviation|10.9|10.9|||
4166942|NCT00826943|3987848|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4166943|NCT00826943|3987848|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4166944|NCT00826943|3987848|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166945|NCT00826800|3987867|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4166946|NCT00826800|3987867|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4166947|NCT00826800|3987867|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4166948|NCT00826800|3987867|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4166949|NCT00826800|3987867|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4166950|NCT00826800|3987867|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166951|NCT00826748|3987871|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4166952|NCT00826748|3987872|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4166953|NCT00826748|3987873|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4166954|NCT00826748|3987874|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4166955|NCT00826748|3987871|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4166956|NCT00826748|3987872|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4166957|NCT00826748|3987873|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4166958|NCT00826748|3987874|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4166959|NCT00826748|3987871|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4166960|NCT00826748|3987872|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4166961|NCT00826748|3987873|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4166962|NCT00826748|3987874|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4166963|NCT00826748|3987871|B4||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4166964|NCT00826748|3987872|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4166965|NCT00826748|3987873|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4166966|NCT00826748|3987874|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4166967|NCT00826748|3987871|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166968|NCT00826748|3987872|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166969|NCT00826748|3987873|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166970|NCT00826748|3987874|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166971|NCT00826618|3987884|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4166972|NCT00826618|3987884|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4166973|NCT00826618|3987884|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4166974|NCT00826618|3987884|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4166975|NCT00826618|3987884|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4166976|NCT00826618|3987884|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4166977|NCT00826618|3987884|B1|||Age||years|Mean|54|54.0|Standard Deviation|19|19.0|||
4166978|NCT00826540|3987888|B1|Mutated||Kirsten rat sarcoma (KRAS)||participants|Number|40|40.0||||||
4166979|NCT00826540|3987888|B1|Wild-type||Kirsten rat sarcoma (KRAS)||participants|Number|39|39.0||||||
4166980|NCT00826540|3987888|B1|1 (Restricted in physically strenuous activity)||Performance Score|The Eastern Cooperative Oncology Group (ECOG) performance score, runs from 0 to 5, with 0 denoting perfect health and 5 death.|participants|Number|35|35.0||||||
4166981|NCT00826540|3987888|B1|0 (Fully active)||Performance Score|The Eastern Cooperative Oncology Group (ECOG) performance score, runs from 0 to 5, with 0 denoting perfect health and 5 death.|participants|Number|44|44.0||||||
4166982|NCT00826540|3987888|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4166983|NCT00826540|3987888|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4166984|NCT00826540|3987888|B1|||Age||years|Median|62|62.0|Full Range|||36.0|88.0|
4166985|NCT00826449|3987892|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
4166986|NCT00826449|3987893|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
4166987|NCT00826449|3987894|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4166988|NCT00826449|3987892|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166989|NCT00826449|3987893|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166990|NCT00826449|3987894|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166991|NCT00826449|3987892|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166992|NCT00826449|3987893|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166993|NCT00826449|3987894|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4166994|NCT00826449|3987892|B3||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4166995|NCT00826449|3987893|B2||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4166996|NCT00826449|3987894|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4166997|NCT00826449|3987892|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4166998|NCT00826449|3987893|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4166999|NCT00826449|3987894|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167000|NCT00826449|3987892|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167001|NCT00826449|3987893|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167002|NCT00826449|3987894|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167003|NCT00826449|3987892|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4167004|NCT00826449|3987893|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4167005|NCT00826449|3987894|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167006|NCT00826449|3987892|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167007|NCT00826449|3987893|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167008|NCT00826449|3987894|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167009|NCT00826449|3987892|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167010|NCT00826449|3987893|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167011|NCT00826449|3987894|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167012|NCT00826449|3987892|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4167013|NCT00826449|3987893|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4167014|NCT00826449|3987894|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4167015|NCT00826449|3987892|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4167016|NCT00826449|3987893|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4167017|NCT00826449|3987894|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167018|NCT00826449|3987892|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4167019|NCT00826449|3987893|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4167020|NCT00826449|3987894|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4167021|NCT00826449|3987892|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4167022|NCT00826449|3987893|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4167023|NCT00826449|3987894|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4167024|NCT00826449|3987892|B3|||Age||years|Median|62|62.0|Full Range|||44.0|89.0|
4167025|NCT00826449|3987893|B2|||Age||years|Median|63|63.0|Full Range|||44.0|89.0|
4167026|NCT00826449|3987894|B1|||Age||years|Median|61|61.0|Full Range|||47.0|74.0|
4167027|NCT00826280|3987900|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4167028|NCT00826280|3987901|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4167029|NCT00826280|3987902|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4167030|NCT00826280|3987903|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4167031|NCT00826280|3987900|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4167032|NCT00826280|3987901|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4167033|NCT00826280|3987902|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4167034|NCT00826280|3987903|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4167035|NCT00826280|3987900|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4167036|NCT00826280|3987901|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4167037|NCT00826280|3987902|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4167038|NCT00826280|3987903|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4167039|NCT00826280|3987900|B4|White||Race/Ethnicity, Customized||participants|Number|192|192.0||||||
4167040|NCT00826280|3987901|B3|White||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
4167041|NCT00826280|3987902|B2|White||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
4167042|NCT00826280|3987903|B1|White||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
4167043|NCT00826280|3987900|B4||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4167044|NCT00826280|3987901|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4167045|NCT00826280|3987902|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4167046|NCT00826280|3987903|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4167047|NCT00826280|3987900|B4||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4167048|NCT00826280|3987901|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4167049|NCT00826280|3987902|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4167050|NCT00826280|3987903|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4167051|NCT00826280|3987900|B4|||Age||years|Mean|67.7|67.7|Standard Deviation|9.91|9.91|||
4167052|NCT00826280|3987901|B3|||Age||years|Mean|69.4|69.4|Standard Deviation|8.23|8.23|||
4167053|NCT00826280|3987902|B2|||Age||years|Mean|65.7|65.7|Standard Deviation|11.11|11.11|||
4167054|NCT00826280|3987903|B1|||Age||years|Mean|68.0|68.0|Standard Deviation|9.99|9.99|||
4167055|NCT00826267|3987931|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4167056|NCT00826267|3987932|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4167057|NCT00826267|3987933|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4167058|NCT00826267|3987934|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4167059|NCT00826267|3987931|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4167060|NCT00826267|3987932|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4167061|NCT00826267|3987933|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4167062|NCT00826267|3987934|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4167063|NCT00826267|3987931|B4|||Age||years|Mean|50.3|50.3|Standard Deviation|12.5|12.5|||
4167064|NCT00826267|3987932|B3|||Age||years|Mean|44.1|44.1|Standard Deviation|12.2|12.2|||
4167065|NCT00826267|3987933|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|13.4|13.4|||
4167066|NCT00826267|3987934|B1|||Age||years|Mean|50.7|50.7|Standard Deviation|8.7|8.7|||
4167067|NCT00826228|3987954|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4167068|NCT00826228|3987954|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4167069|NCT00826228|3987954|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4167070|NCT00826228|3987954|B1|||Age||years|Mean|34.0|34.0|Standard Deviation|7.8|7.8|||
4167071|NCT00826228|3987954|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4167072|NCT00826228|3987954|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4167073|NCT00826228|3987954|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167074|NCT00826202|3987959|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
4167075|NCT00826202|3987960|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4167076|NCT00826202|3987961|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4167077|NCT00826202|3987959|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4167078|NCT00826202|3987960|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4167079|NCT00826202|3987961|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4167080|NCT00826202|3987959|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4167081|NCT00826202|3987960|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4167082|NCT00826202|3987961|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4167083|NCT00826202|3987959|B3|||Age||years|Mean|19.5|19.5|Standard Deviation|4.1|4.1|||
4167084|NCT00826202|3987960|B2|||Age||years|Mean|19|19.0|Standard Deviation|3.5|3.5|||
4167085|NCT00826202|3987961|B1|||Age||years|Mean|20|20.0|Standard Deviation|4.9|4.9|||
4167086|NCT00826202|3987959|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4167087|NCT00826202|3987960|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4167088|NCT00826202|3987961|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4167089|NCT00826202|3987959|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4167090|NCT00826202|3987960|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4167091|NCT00826202|3987961|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4167092|NCT00826202|3987959|B3||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4167093|NCT00826202|3987960|B2||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4167094|NCT00826202|3987961|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4167095|NCT00826176|3987974|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4167096|NCT00826176|3987975|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4167097|NCT00826176|3987976|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4167098|NCT00826176|3987974|B3||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4167099|NCT00826176|3987975|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4167100|NCT00826176|3987976|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4167101|NCT00826176|3987974|B3|||Age||years|Mean|47.7|47.7|Standard Deviation|10.2|10.2|||
4167102|NCT00826176|3987975|B2|||Age||years|Mean|47.2|47.2|Standard Deviation|11.0|11.0|||
4167103|NCT00826176|3987976|B1|||Age||years|Mean|47.9|47.9|Standard Deviation|10.0|10.0|||
4167104|NCT00826111|3987987|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4167105|NCT00826111|3987988|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4167106|NCT00826111|3987989|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4167107|NCT00826111|3987987|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4167108|NCT00826111|3987988|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4167109|NCT00826111|3987989|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4167110|NCT00826111|3987987|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4167111|NCT00826111|3987988|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4167112|NCT00826111|3987989|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4167113|NCT00826111|3987987|B3|||Age||years|Mean|28.6|28.6|Standard Deviation|7.1|7.1|||
4167114|NCT00826111|3987988|B2|||Age||years|Mean|25.4|25.4|Standard Deviation|5.0|5.0|||
4167115|NCT00826111|3987989|B1|||Age||years|Mean|29.8|29.8|Standard Deviation|7.5|7.5|||
4167116|NCT00826111|3987987|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4167117|NCT00826111|3987988|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4167118|NCT00826111|3987989|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4167119|NCT00826111|3987987|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4167120|NCT00826111|3987988|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4167121|NCT00826111|3987989|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4167122|NCT00826111|3987987|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167123|NCT00826111|3987988|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167124|NCT00826111|3987989|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167125|NCT00826007|3988012|B3|No documented beta blocker use||Beta-blocker medication in regimen||participants|Number|332|332.0||||||
4167126|NCT00826007|3988013|B2|No documented beta blocker use||Beta-blocker medication in regimen||participants|Number|172|172.0||||||
4167127|NCT00826007|3988014|B1|No documented beta blocker use||Beta-blocker medication in regimen||participants|Number|160|160.0||||||
4167128|NCT00826007|3988012|B3|Documented Beta blocker use||Beta-blocker medication in regimen||participants|Number|255|255.0||||||
4167129|NCT00826007|3988013|B2|Documented Beta blocker use||Beta-blocker medication in regimen||participants|Number|107|107.0||||||
4167130|NCT00826007|3988014|B1|Documented Beta blocker use||Beta-blocker medication in regimen||participants|Number|148|148.0||||||
4167131|NCT00826007|3988012|B3|No documented insulin use||Insulin regimen prior to preop arrival||participants|Number|81|81.0||||||
4167132|NCT00826007|3988013|B2|No documented insulin use||Insulin regimen prior to preop arrival||participants|Number|39|39.0||||||
4167133|NCT00826007|3988014|B1|No documented insulin use||Insulin regimen prior to preop arrival||participants|Number|42|42.0||||||
4167134|NCT00826007|3988012|B3|Insulin use||Insulin regimen prior to preop arrival||participants|Number|506|506.0||||||
4167135|NCT00826007|3988013|B2|Insulin use||Insulin regimen prior to preop arrival||participants|Number|240|240.0||||||
4167136|NCT00826007|3988014|B1|Insulin use||Insulin regimen prior to preop arrival||participants|Number|266|266.0||||||
4167137|NCT00826007|3988012|B3|Renal disease not documented||Renal disease||participants|Number|448|448.0||||||
4167138|NCT00826007|3988013|B2|Renal disease not documented||Renal disease||participants|Number|225|225.0||||||
4167139|NCT00826007|3988014|B1|Renal disease not documented||Renal disease||participants|Number|223|223.0||||||
4167140|NCT00826007|3988012|B3|Renal disease documented||Renal disease||participants|Number|139|139.0||||||
4167141|NCT00826007|3988013|B2|Renal disease documented||Renal disease||participants|Number|54|54.0||||||
4167142|NCT00826007|3988014|B1|Renal disease documented||Renal disease||participants|Number|85|85.0||||||
4167143|NCT00826007|3988012|B3|type not documented||Diabetes type||participants|Number|111|111.0||||||
4167144|NCT00826007|3988013|B2|type not documented||Diabetes type||participants|Number|57|57.0||||||
4167145|NCT00826007|3988014|B1|type not documented||Diabetes type||participants|Number|54|54.0||||||
4167146|NCT00826007|3988012|B3|Type 2 diabetes||Diabetes type||participants|Number|392|392.0||||||
4167147|NCT00826007|3988013|B2|Type 2 diabetes||Diabetes type||participants|Number|175|175.0||||||
4167148|NCT00826007|3988014|B1|Type 2 diabetes||Diabetes type||participants|Number|217|217.0||||||
4167149|NCT00826007|3988012|B3|Type 1 diabetes||Diabetes type||participants|Number|84|84.0||||||
4167150|NCT00826007|3988013|B2|Type 1 diabetes||Diabetes type||participants|Number|47|47.0||||||
4167151|NCT00826007|3988014|B1|Type 1 diabetes||Diabetes type||participants|Number|37|37.0||||||
4167152|NCT00826007|3988012|B3|United States||Region of Enrollment||participants|Number|587|587.0||||||
4167153|NCT00826007|3988013|B2|United States||Region of Enrollment||participants|Number|279|279.0||||||
4167154|NCT00826007|3988014|B1|United States||Region of Enrollment||participants|Number|308|308.0||||||
4167155|NCT00826007|3988012|B3||Male|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
4167156|NCT00826007|3988013|B2||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4167157|NCT00826007|3988014|B1||Male|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4167158|NCT00826007|3988012|B3||Female|Sex: Female, Male||Participants|Count of Participants|279|279.0||||||
4167159|NCT00826007|3988013|B2||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4167160|NCT00826007|3988014|B1||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4167161|NCT00826007|3988012|B3|||Age||years|Mean|58.96|58.96|Standard Deviation|14.57|14.57|||
4167162|NCT00826007|3988013|B2|||Age||years|Mean|56.34|56.34|Standard Deviation|14.18|14.18|||
4167163|NCT00826007|3988014|B1|||Age||years|Mean|61.34|61.34|Standard Deviation|14.93|14.93|||
4167164|NCT00825994|3988020|B1|No answer||History of previous major depressive episode||participants|Number|1|1.0||||||
4167165|NCT00825994|3988020|B1|No||History of previous major depressive episode||participants|Number|15|15.0||||||
4167166|NCT00825994|3988020|B1|Yes||History of previous major depressive episode||participants|Number|8|8.0||||||
4167167|NCT00825994|3988020|B1|Surgically Postmenopausal||Menopause Status||participants|Number|2|2.0||||||
4167168|NCT00825994|3988020|B1|Naturally Postmenopausal||Menopause Status||participants|Number|13|13.0||||||
4167169|NCT00825994|3988020|B1|Perimenopausal||Menopause Status||participants|Number|9|9.0||||||
4167170|NCT00825994|3988020|B1|Unknown||Education||participants|Number|1|1.0||||||
4167171|NCT00825994|3988020|B1|High school diploma or GED||Education||participants|Number|2|2.0||||||
4167172|NCT00825994|3988020|B1|Attended some college||Education||participants|Number|11|11.0||||||
4167173|NCT00825994|3988020|B1|College graduate||Education||participants|Number|5|5.0||||||
4167174|NCT00825994|3988020|B1|Attended graduate school||Education||participants|Number|5|5.0||||||
4167175|NCT00825994|3988020|B1|Other||Employment Status||participants|Number|1|1.0||||||
4167176|NCT00825994|3988020|B1|Retired||Employment Status||participants|Number|1|1.0||||||
4167177|NCT00825994|3988020|B1|Unemployed||Employment Status||participants|Number|3|3.0||||||
4167178|NCT00825994|3988020|B1|Disabled||Employment Status||participants|Number|1|1.0||||||
4167179|NCT00825994|3988020|B1|Student||Employment Status||participants|Number|1|1.0||||||
4167180|NCT00825994|3988020|B1|Homemaker||Employment Status||participants|Number|2|2.0||||||
4167181|NCT00825994|3988020|B1|Part-time||Employment Status||participants|Number|3|3.0||||||
4167182|NCT00825994|3988020|B1|Full-time||Employment Status||participants|Number|12|12.0||||||
4167183|NCT00825994|3988020|B1|Widowed/divorced||Marital Status||participants|Number|10|10.0||||||
4167184|NCT00825994|3988020|B1|Single (never married)||Marital Status||participants|Number|6|6.0||||||
4167185|NCT00825994|3988020|B1|Married/living with partner||Marital Status||participants|Number|8|8.0||||||
4167186|NCT00825994|3988020|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4167187|NCT00825994|3988020|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4167188|NCT00825994|3988020|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167189|NCT00825994|3988020|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4167190|NCT00825994|3988020|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4167191|NCT00825994|3988020|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167192|NCT00825994|3988020|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4167193|NCT00825994|3988020|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167194|NCT00825994|3988020|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4167195|NCT00825994|3988020|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4167196|NCT00825994|3988020|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4167197|NCT00825994|3988020|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4167198|NCT00825994|3988020|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4167199|NCT00825994|3988020|B1|||Age||years|Mean|52.5|52.5|Standard Deviation|4.9|4.9|||
4167200|NCT00825994|3988020|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4167201|NCT00825994|3988020|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4167202|NCT00825994|3988020|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167203|NCT00825916|3988025|B4|United States||Region of Enrollment||participants|Number|59|59.0||||||
4167204|NCT00825916|3988026|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4167205|NCT00825916|3988027|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4167206|NCT00825916|3988028|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4167207|NCT00825916|3988025|B4||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4167208|NCT00825916|3988026|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4167209|NCT00825916|3988027|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4167210|NCT00825916|3988028|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4167211|NCT00825916|3988025|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4167212|NCT00825916|3988026|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4167213|NCT00825916|3988027|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4167214|NCT00825916|3988028|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4167215|NCT00825916|3988025|B4|||Age||years|Mean|37.9|37.9|Standard Deviation|11.3|11.3|||
4167216|NCT00825916|3988026|B3|||Age||years|Mean|38.2|38.2|Standard Deviation|11.1|11.1|||
4167217|NCT00825916|3988027|B2|||Age||years|Mean|37.5|37.5|Standard Deviation|11.7|11.7|||
4167218|NCT00825916|3988028|B1|||Age||years|Mean|38.2|38.2|Standard Deviation|11.1|11.1|||
4167219|NCT00825916|3988025|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4167220|NCT00825916|3988026|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4167221|NCT00825916|3988027|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4167222|NCT00825916|3988028|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4167223|NCT00825916|3988025|B4||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4167224|NCT00825916|3988026|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4167225|NCT00825916|3988027|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4167226|NCT00825916|3988028|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4167227|NCT00825916|3988025|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167228|NCT00825916|3988026|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167229|NCT00825916|3988027|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167230|NCT00825916|3988028|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167231|NCT00825825|3988071|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4167232|NCT00825825|3988071|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4167233|NCT00825825|3988071|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4167234|NCT00825825|3988071|B1|||Age||years|Mean|30.1|30.1|Standard Deviation|7.9|7.9|||
4167235|NCT00825825|3988071|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4167236|NCT00825825|3988071|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4167237|NCT00825825|3988071|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167238|NCT00825812|3988088|B5||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4167239|NCT00825812|3988089|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4167240|NCT00825812|3988090|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4167241|NCT00825812|3988091|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4167242|NCT00825812|3988092|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4167243|NCT00825812|3988088|B5||Female|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
4167244|NCT00825812|3988089|B4||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4167245|NCT00825812|3988090|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4167246|NCT00825812|3988091|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4167247|NCT00825812|3988092|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4167248|NCT00825812|3988088|B5|||Age||years|Mean|42.2|42.2|Full Range|||18.0|64.0|
4167249|NCT00825812|3988089|B4|||Age||years|Mean|39.4|39.4|Full Range|10.8|10.8|18.0|61.0|
4167250|NCT00825812|3988090|B3|||Age||years|Mean|39.9|39.9|Full Range|10.8|10.8|19.0|63.0|
4167251|NCT00825812|3988091|B2|||Age||years|Mean|51.9|51.9|Full Range|7.3|7.3|34.0|63.0|
4167252|NCT00825812|3988092|B1|||Age||years|Mean|52.0|52.0|Full Range|10.3|10.3|27.0|64.0|
4167253|NCT00825786|3988109|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4167254|NCT00825786|3988110|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4167255|NCT00825786|3988111|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4167256|NCT00825786|3988109|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4167257|NCT00825786|3988110|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4167258|NCT00825786|3988111|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4167259|NCT00825786|3988109|B3|||Age||years|Mean|47|47.0|Standard Deviation|14|14.0|||
4167260|NCT00825786|3988110|B2|||Age||years|Mean|46|46.0|Standard Deviation|14|14.0|||
4167261|NCT00825786|3988111|B1|||Age||years|Mean|49|49.0|Standard Deviation|13|13.0|||
4167262|NCT00825734|3988130|B1|United States||Region of Enrollment||participants|Number|83|83.0||||||
4167263|NCT00825734|3988130|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4167264|NCT00825734|3988130|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4167265|NCT00825734|3988130|B1|||Age||Years|Median|57|57.0|Full Range|||30.0|80.0|
4167266|NCT00825682|3988140|B3|Israel||Region of Enrollment||participants|Number|72|72.0||||||
4167267|NCT00825682|3988141|B2|Israel||Region of Enrollment||participants|Number|25|25.0||||||
4167268|NCT00825682|3988142|B1|Israel||Region of Enrollment||participants|Number|47|47.0||||||
4167269|NCT00825682|3988140|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4167270|NCT00825682|3988141|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4167271|NCT00825682|3988142|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4167272|NCT00825682|3988140|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4167273|NCT00825682|3988141|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4167274|NCT00825682|3988142|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4167275|NCT00825682|3988140|B3|||Age||years|Mean|54.6|54.6|Standard Deviation|10.4|10.4|||
4167276|NCT00825682|3988141|B2|||Age||years|Mean|52.3|52.3|Standard Deviation|11.78|11.78|||
4167277|NCT00825682|3988142|B1|||Age||years|Mean|56|56.0|Standard Deviation|9.47|9.47|||
4167278|NCT00825682|3988140|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4167279|NCT00825682|3988141|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4167280|NCT00825682|3988142|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4167281|NCT00825682|3988140|B3||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4167282|NCT00825682|3988141|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4167283|NCT00825682|3988142|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4167284|NCT00825682|3988140|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167285|NCT00825682|3988141|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167286|NCT00825682|3988142|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167287|NCT00825630|3988153|B5|||H. Pyori Positive|Basline particpants include all those with suspected H.pylori infection that are tested with the FDA cleared BreathID 13C urea breath test and are found to be positive, that is DOB (delta over baseline) >=5|particpants|Number|123|123.0||||||
4167288|NCT00825630|3988154|B4|||H. Pyori Positive|Basline particpants include all those with suspected H.pylori infection that are tested with the FDA cleared BreathID 13C urea breath test and are found to be positive, that is DOB (delta over baseline) >=5|particpants|Number|13|13.0||||||
4167289|NCT00825630|3988155|B3|||H. Pyori Positive|Basline particpants include all those with suspected H.pylori infection that are tested with the FDA cleared BreathID 13C urea breath test and are found to be positive, that is DOB (delta over baseline) >=5|particpants|Number|19|19.0||||||
4167290|NCT00825630|3988156|B2|||H. Pyori Positive|Basline particpants include all those with suspected H.pylori infection that are tested with the FDA cleared BreathID 13C urea breath test and are found to be positive, that is DOB (delta over baseline) >=5|particpants|Number|62|62.0||||||
4167291|NCT00825630|3988157|B1|||H. Pyori Positive|Basline particpants include all those with suspected H.pylori infection that are tested with the FDA cleared BreathID 13C urea breath test and are found to be positive, that is DOB (delta over baseline) >=5|particpants|Number|29|29.0||||||
4167292|NCT00825630|3988153|B5|Israel||Region of Enrollment||participants|Number|123|123.0||||||
4167293|NCT00825630|3988154|B4|Israel||Region of Enrollment||participants|Number|13|13.0||||||
4167294|NCT00825630|3988155|B3|Israel||Region of Enrollment||participants|Number|19|19.0||||||
4167295|NCT00825630|3988156|B2|Israel||Region of Enrollment||participants|Number|62|62.0||||||
4167296|NCT00825630|3988157|B1|Israel||Region of Enrollment||participants|Number|29|29.0||||||
4167297|NCT00825630|3988153|B5||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4167298|NCT00825630|3988154|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4167299|NCT00825630|3988155|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4167300|NCT00825630|3988156|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4167301|NCT00825630|3988157|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4167302|NCT00825630|3988153|B5||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4167303|NCT00825630|3988154|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4167304|NCT00825630|3988155|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4167305|NCT00825630|3988156|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4167306|NCT00825630|3988157|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4167307|NCT00825630|3988153|B5|||Age||years|Mean|52.46|52.46|Standard Deviation|14.01|14.01|||
4167308|NCT00825630|3988154|B4|||Age||years|Mean|55.38|55.38|Standard Deviation|14.84|14.84|||
4167309|NCT00825630|3988155|B3|||Age||years|Mean|51.84|51.84|Standard Deviation|12.78|12.78|||
4167310|NCT00825630|3988156|B2|||Age||years|Mean|52.48|52.48|Standard Deviation|13.35|13.35|||
4167311|NCT00825630|3988157|B1|||Age||years|Mean|52.86|52.86|Standard Deviation|14.67|14.67|||
4167312|NCT00825630|3988153|B5||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4167313|NCT00825630|3988154|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4167314|NCT00825630|3988155|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4167315|NCT00825630|3988156|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4167316|NCT00825630|3988157|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4167317|NCT00825630|3988153|B5||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
4167318|NCT00825630|3988154|B4||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4167319|NCT00825630|3988155|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4167320|NCT00825630|3988156|B2||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4167321|NCT00825630|3988157|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4167322|NCT00825630|3988153|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167323|NCT00825630|3988154|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167324|NCT00825630|3988155|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167325|NCT00825630|3988156|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167326|NCT00825630|3988157|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167327|NCT00825565|3988170|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4167328|NCT00825565|3988170|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4167329|NCT00825565|3988170|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4167330|NCT00825565|3988170|B1|||Age||years|Mean|3.3|3.3|Standard Deviation|2.7|2.7|||
4167331|NCT00825565|3988170|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4167332|NCT00825565|3988170|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4167333|NCT00825565|3988170|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4167334|NCT00825500|3988180|B4|United States||Region of Enrollment||participants|Number|366|366.0||||||
4167335|NCT00825500|3988181|B3|United States||Region of Enrollment||participants|Number|120|120.0||||||
4167336|NCT00825500|3988182|B2|United States||Region of Enrollment||participants|Number|121|121.0||||||
4167337|NCT00825500|3988183|B1|United States||Region of Enrollment||participants|Number|125|125.0||||||
4167338|NCT00825500|3988180|B4||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4167339|NCT00825500|3988181|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4167340|NCT00825500|3988182|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4167341|NCT00825500|3988183|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4167342|NCT00825500|3988180|B4||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4167343|NCT00825500|3988181|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4167344|NCT00825500|3988182|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4167345|NCT00825500|3988183|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4167346|NCT00825500|3988180|B4|||Age||years|Mean|41.5|41.5|Standard Deviation|12.33|12.33|||
4167347|NCT00825500|3988181|B3|||Age||years|Mean|42|42.0|Standard Deviation|12.74|12.74|||
4167348|NCT00825500|3988182|B2|||Age||years|Mean|41.2|41.2|Standard Deviation|12.19|12.19|||
4167349|NCT00825500|3988183|B1|||Age||years|Mean|41.5|41.5|Standard Deviation|12.14|12.14|||
4167350|NCT00825500|3988180|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4167351|NCT00825500|3988181|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4167352|NCT00825500|3988182|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4167353|NCT00825500|3988183|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4167354|NCT00825500|3988180|B4||Between 18 and 65 years|Age||Participants|Count of Participants|366|366.0||||||
4167355|NCT00825500|3988181|B3||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
4167356|NCT00825500|3988182|B2||Between 18 and 65 years|Age||Participants|Count of Participants|121|121.0||||||
4167357|NCT00825500|3988183|B1||Between 18 and 65 years|Age||Participants|Count of Participants|125|125.0||||||
4167358|NCT00825500|3988180|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167359|NCT00825500|3988181|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167360|NCT00825500|3988182|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167361|NCT00825500|3988183|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167362|NCT00825370|3988196|B3|||Vomiting||Participants|Count of Participants|92|92.0||||||
4167363|NCT00825370|3988197|B2|||Vomiting||Participants|Count of Participants|46|46.0||||||
4167364|NCT00825370|3988198|B1|||Vomiting||Participants|Count of Participants|46|46.0||||||
4167365|NCT00825370|3988196|B3|||Nausea||Participants|Count of Participants|106|106.0||||||
4167366|NCT00825370|3988197|B2|||Nausea||Participants|Count of Participants|44|44.0||||||
4167367|NCT00825370|3988198|B1|||Nausea||Participants|Count of Participants|62|62.0||||||
4167368|NCT00825370|3988196|B3|10||Pain Intensity|"Pain intensity is measured on a numerical rating score (NRS) scale of 0 (no pain) to 10 (worst pain imaginable). This pain intensity measure is the pain intensity of the patient before treatment in the Emergency Department."|Participants|Count of Participants|189|189.0||||||
4167369|NCT00825370|3988197|B2|10||Pain Intensity|"Pain intensity is measured on a numerical rating score (NRS) scale of 0 (no pain) to 10 (worst pain imaginable). This pain intensity measure is the pain intensity of the patient before treatment in the Emergency Department."|Participants|Count of Participants|91|91.0||||||
4167370|NCT00825370|3988198|B1|10||Pain Intensity|"Pain intensity is measured on a numerical rating score (NRS) scale of 0 (no pain) to 10 (worst pain imaginable). This pain intensity measure is the pain intensity of the patient before treatment in the Emergency Department."|Participants|Count of Participants|98|98.0||||||
4167371|NCT00825370|3988196|B3|9||Pain Intensity|"Pain intensity is measured on a numerical rating score (NRS) scale of 0 (no pain) to 10 (worst pain imaginable). This pain intensity measure is the pain intensity of the patient before treatment in the Emergency Department."|Participants|Count of Participants|49|49.0||||||
4167372|NCT00825370|3988197|B2|9||Pain Intensity|"Pain intensity is measured on a numerical rating score (NRS) scale of 0 (no pain) to 10 (worst pain imaginable). This pain intensity measure is the pain intensity of the patient before treatment in the Emergency Department."|Participants|Count of Participants|24|24.0||||||
4167373|NCT00825370|3988198|B1|9||Pain Intensity|"Pain intensity is measured on a numerical rating score (NRS) scale of 0 (no pain) to 10 (worst pain imaginable). This pain intensity measure is the pain intensity of the patient before treatment in the Emergency Department."|Participants|Count of Participants|25|25.0||||||
4167374|NCT00825370|3988196|B3|8||Pain Intensity|"Pain intensity is measured on a numerical rating score (NRS) scale of 0 (no pain) to 10 (worst pain imaginable). This pain intensity measure is the pain intensity of the patient before treatment in the Emergency Department."|Participants|Count of Participants|54|54.0||||||
4167375|NCT00825370|3988197|B2|8||Pain Intensity|"Pain intensity is measured on a numerical rating score (NRS) scale of 0 (no pain) to 10 (worst pain imaginable). This pain intensity measure is the pain intensity of the patient before treatment in the Emergency Department."|Participants|Count of Participants|32|32.0||||||
4167376|NCT00825370|3988198|B1|8||Pain Intensity|"Pain intensity is measured on a numerical rating score (NRS) scale of 0 (no pain) to 10 (worst pain imaginable). This pain intensity measure is the pain intensity of the patient before treatment in the Emergency Department."|Participants|Count of Participants|22|22.0||||||
4167377|NCT00825370|3988196|B3|3-7||Pain Intensity|"Pain intensity is measured on a numerical rating score (NRS) scale of 0 (no pain) to 10 (worst pain imaginable). This pain intensity measure is the pain intensity of the patient before treatment in the Emergency Department."|Participants|Count of Participants|46|46.0||||||
4167378|NCT00825370|3988197|B2|3-7||Pain Intensity|"Pain intensity is measured on a numerical rating score (NRS) scale of 0 (no pain) to 10 (worst pain imaginable). This pain intensity measure is the pain intensity of the patient before treatment in the Emergency Department."|Participants|Count of Participants|24|24.0||||||
4167379|NCT00825370|3988198|B1|3-7||Pain Intensity|"Pain intensity is measured on a numerical rating score (NRS) scale of 0 (no pain) to 10 (worst pain imaginable). This pain intensity measure is the pain intensity of the patient before treatment in the Emergency Department."|Participants|Count of Participants|22|22.0||||||
4167380|NCT00825370|3988196|B3||Other|Location of pain||Participants|Count of Participants|130|130.0||||||
4167381|NCT00825370|3988197|B2||Other|Location of pain||Participants|Count of Participants|76|76.0||||||
4167382|NCT00825370|3988198|B1||Other|Location of pain||Participants|Count of Participants|54|54.0||||||
4167383|NCT00825370|3988196|B3||Abdomen|Location of pain||Participants|Count of Participants|208|208.0||||||
4167384|NCT00825370|3988197|B2||Abdomen|Location of pain||Participants|Count of Participants|95|95.0||||||
4167385|NCT00825370|3988198|B1||Abdomen|Location of pain||Participants|Count of Participants|113|113.0||||||
4167386|NCT00825370|3988196|B3|||Weight||pounds|Mean|179|179.0|Standard Deviation|48|48.0|||
4167387|NCT00825370|3988197|B2|||Weight||pounds|Mean|173|173.0|Standard Deviation|44|44.0|||
4167388|NCT00825370|3988198|B1|||Weight||pounds|Mean|185|185.0|Standard Deviation|52|52.0|||
4167389|NCT00825370|3988196|B3|United States||Region of Enrollment||Participants|Count of Participants|338|338.0||||||
4167390|NCT00825370|3988197|B2|United States||Region of Enrollment||Participants|Count of Participants|171|171.0||||||
4167391|NCT00825370|3988198|B1|United States||Region of Enrollment||Participants|Count of Participants|167|167.0||||||
4167392|NCT00825370|3988196|B3|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4167393|NCT00825370|3988197|B2|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4167394|NCT00825370|3988198|B1|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4167395|NCT00825370|3988196|B3|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
4167396|NCT00825370|3988197|B2|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4167397|NCT00825370|3988198|B1|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4167398|NCT00825370|3988196|B3|Race/Ethnicity|Black|Race/Ethnicity, Customized||Participants|Count of Participants|90|90.0||||||
4167399|NCT00825370|3988197|B2|Race/Ethnicity|Black|Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
4167400|NCT00825370|3988198|B1|Race/Ethnicity|Black|Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
4167401|NCT00825370|3988196|B3|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|224|224.0||||||
4167402|NCT00825370|3988197|B2|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|114|114.0||||||
4167403|NCT00825370|3988198|B1|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|110|110.0||||||
4167404|NCT00825370|3988196|B3||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4167405|NCT00825370|3988197|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4167406|NCT00825370|3988198|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4167407|NCT00825370|3988196|B3||Female|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4167408|NCT00825370|3988197|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4167409|NCT00825370|3988198|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4167410|NCT00825370|3988196|B3|||Age||years|Mean|42|42.0|Standard Deviation|12|12.0|||
4167411|NCT00825370|3988197|B2|||Age||years|Mean|42|42.0|Standard Deviation|13|13.0|||
4167412|NCT00825370|3988198|B1|||Age||years|Mean|42|42.0|Standard Deviation|11|11.0|||
4167413|NCT00825344|3988211|B3|United States||Region of Enrollment||participants|Number|77|77.0||||||
4167414|NCT00825344|3988212|B2|United States||Region of Enrollment||participants|Number|43|43.0||||||
4167415|NCT00825344|3988213|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4167416|NCT00825344|3988211|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4167417|NCT00825344|3988212|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4167418|NCT00825344|3988213|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4167419|NCT00825344|3988211|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4167420|NCT00825344|3988212|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4167421|NCT00825344|3988213|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4167422|NCT00825344|3988211|B3|||Age||years|Mean|57.9|57.9|Standard Deviation|2.9|2.9|||
4167423|NCT00825344|3988212|B2|||Age||years|Mean|58.4|58.4|Standard Deviation|2.8|2.8|||
4167424|NCT00825344|3988213|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|3.1|3.1|||
4167425|NCT00825344|3988211|B3||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4167426|NCT00825344|3988212|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4167427|NCT00825344|3988213|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4167428|NCT00825344|3988211|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4167429|NCT00825344|3988212|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4167430|NCT00825344|3988213|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4167431|NCT00825344|3988211|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4167432|NCT00825344|3988212|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167433|NCT00825344|3988213|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4167434|NCT00825318|3988224|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4167435|NCT00825318|3988224|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4167436|NCT00825318|3988224|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4167437|NCT00825318|3988224|B1|||Age||years|Mean|50.6|50.6|Standard Deviation|8.23|8.23|||
4167438|NCT00825318|3988224|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4167439|NCT00825318|3988224|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4167440|NCT00825318|3988224|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167441|NCT00825305|3988232|B3||Male|Sex: Female, Male|Baseline measures are presented for safety population.|Participants|Count of Participants|347|347.0||||||
4167442|NCT00825305|3988233|B2||Male|Sex: Female, Male|Baseline measures are presented for safety population.|Participants|Count of Participants|121|121.0||||||
4167443|NCT00825305|3988234|B1||Male|Sex: Female, Male|Baseline measures are presented for safety population.|Participants|Count of Participants|226|226.0||||||
4167444|NCT00825305|3988232|B3||Female|Sex: Female, Male|Baseline measures are presented for safety population.|Participants|Count of Participants|477|477.0||||||
4167445|NCT00825305|3988233|B2||Female|Sex: Female, Male|Baseline measures are presented for safety population.|Participants|Count of Participants|154|154.0||||||
4167446|NCT00825305|3988234|B1||Female|Sex: Female, Male|Baseline measures are presented for safety population.|Participants|Count of Participants|323|323.0||||||
4167447|NCT00825305|3988232|B3|||Age|Baseline measures are presented for safety population.|years|Mean|38.58|38.58|Standard Deviation|7.09|7.09|||
4167448|NCT00825305|3988233|B2|||Age|Baseline measures are presented for safety population.|years|Mean|39.33|39.33|Standard Deviation|6.93|6.93|||
4167449|NCT00825305|3988234|B1|||Age|Baseline measures are presented for safety population.|years|Mean|38.2|38.2|Standard Deviation|7.14|7.14|||
4167450|NCT00825266|3988247|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4167451|NCT00825266|3988248|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4167452|NCT00825266|3988249|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4167453|NCT00825266|3988247|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4167454|NCT00825266|3988248|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4167455|NCT00825266|3988249|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4167456|NCT00825266|3988247|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4167457|NCT00825266|3988248|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4167458|NCT00825266|3988249|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4167459|NCT00825266|3988247|B3|||Age||years|Mean|56|56.0|Full Range|||51.0|61.0|
4167460|NCT00825266|3988248|B2|||Age||years|Mean|51|51.0|Full Range|||51.0|51.0|
4167461|NCT00825266|3988249|B1|||Age||years|Mean|61|61.0|Full Range|||61.0|61.0|
4167462|NCT00825227|3988260|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4167463|NCT00825227|3988261|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4167464|NCT00825227|3988262|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4167465|NCT00825227|3988260|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4167466|NCT00825227|3988261|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4167467|NCT00825227|3988262|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4167468|NCT00825227|3988260|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4167469|NCT00825227|3988261|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4167470|NCT00825227|3988262|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4167471|NCT00825227|3988260|B3|||Age||years|Mean|58.3|58.3|Standard Deviation|4.62|4.62|||
4167472|NCT00825227|3988261|B2|||Age||years|Mean|56.5|56.5|Standard Deviation|5.80|5.8|||
4167473|NCT00825227|3988262|B1|||Age||years|Mean|59.5|59.5|Standard Deviation|3.73|3.73|||
4167474|NCT00825227|3988260|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4167475|NCT00825227|3988261|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4167476|NCT00825227|3988262|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4167477|NCT00825227|3988260|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4167478|NCT00825227|3988261|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4167479|NCT00825227|3988262|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4167480|NCT00825227|3988260|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167481|NCT00825227|3988261|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167482|NCT00825227|3988262|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167483|NCT00825175|3988273|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4167484|NCT00825175|3988274|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4167485|NCT00825175|3988275|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4167486|NCT00825175|3988273|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4167487|NCT00825175|3988274|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4167488|NCT00825175|3988275|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4167489|NCT00825175|3988273|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4167490|NCT00825175|3988274|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4167491|NCT00825175|3988275|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4167492|NCT00825175|3988273|B3|||Age||years|Mean|12|12.0|Standard Deviation|2|2.0|||
4167493|NCT00825175|3988274|B2|||Age||years|Mean|12|12.0|Standard Deviation|2|2.0|||
4167494|NCT00825175|3988275|B1|||Age||years|Mean|12|12.0|Standard Deviation|2|2.0|||
4167495|NCT00825175|3988273|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4167496|NCT00825175|3988274|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4167497|NCT00825175|3988275|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4167498|NCT00825175|3988273|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4167499|NCT00825175|3988274|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4167500|NCT00825175|3988275|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4167501|NCT00825175|3988273|B3||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
4167502|NCT00825175|3988274|B2||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4167503|NCT00825175|3988275|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4167504|NCT00825162|3988282|B4|Australia||Region of Enrollment||participants|Number|1992|1992.0||||||
4167505|NCT00825162|3988283|B3|Australia||Region of Enrollment||participants|Number|402|402.0||||||
4167506|NCT00825162|3988284|B2|Australia||Region of Enrollment||participants|Number|880|880.0||||||
4167507|NCT00825162|3988285|B1|Australia||Region of Enrollment||participants|Number|710|710.0||||||
4167508|NCT00825162|3988282|B4||Male|Sex: Female, Male||Participants|Count of Participants|1026|1026.0||||||
4167509|NCT00825162|3988283|B3||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4167510|NCT00825162|3988284|B2||Male|Sex: Female, Male||Participants|Count of Participants|441|441.0||||||
4167511|NCT00825162|3988285|B1||Male|Sex: Female, Male||Participants|Count of Participants|385|385.0||||||
4167512|NCT00825162|3988282|B4||Female|Sex: Female, Male||Participants|Count of Participants|966|966.0||||||
4167513|NCT00825162|3988283|B3||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4167514|NCT00825162|3988284|B2||Female|Sex: Female, Male||Participants|Count of Participants|439|439.0||||||
4167515|NCT00825162|3988285|B1||Female|Sex: Female, Male||Participants|Count of Participants|325|325.0||||||
4167516|NCT00825162|3988282|B4|||Age||years|Mean|5.66|5.66|Standard Deviation|4.21|4.21|||
4167517|NCT00825162|3988283|B3|||Age||years|Mean|12.64|12.64|Standard Deviation|2.48|2.48|||
4167518|NCT00825162|3988284|B2|||Age||years|Mean|5.54|5.54|Standard Deviation|1.66|1.66|||
4167519|NCT00825162|3988285|B1|||Age||years|Mean|1.84|1.84|Standard Deviation|0.74|0.74|||
4167520|NCT00825162|3988282|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4167521|NCT00825162|3988283|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4167522|NCT00825162|3988284|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4167523|NCT00825162|3988285|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4167524|NCT00825162|3988282|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4167525|NCT00825162|3988283|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4167526|NCT00825162|3988284|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4167527|NCT00825162|3988285|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4167528|NCT00825162|3988282|B4||<=18 years|Age||Participants|Count of Participants|1992|1992.0||||||
4167529|NCT00825162|3988283|B3||<=18 years|Age||Participants|Count of Participants|402|402.0||||||
4167530|NCT00825162|3988284|B2||<=18 years|Age||Participants|Count of Participants|880|880.0||||||
4167531|NCT00825162|3988285|B1||<=18 years|Age||Participants|Count of Participants|710|710.0||||||
4167532|NCT00824993|3988311|B3|United States||Region of Enrollment||Participants|Count of Participants|78|78.0||||||
4167533|NCT00824993|3988312|B2|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
4167534|NCT00824993|3988313|B1|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
4167535|NCT00824993|3988311|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4167536|NCT00824993|3988312|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167537|NCT00824993|3988313|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4167538|NCT00824993|3988311|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167539|NCT00824993|3988312|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167540|NCT00824993|3988313|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167541|NCT00824993|3988311|B3||White|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4167542|NCT00824993|3988312|B2||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4167543|NCT00824993|3988313|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4167544|NCT00824993|3988311|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4167545|NCT00824993|3988312|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167546|NCT00824993|3988313|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4167547|NCT00824993|3988311|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167548|NCT00824993|3988312|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167549|NCT00824993|3988313|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167550|NCT00824993|3988311|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4167551|NCT00824993|3988312|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167552|NCT00824993|3988313|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4167553|NCT00824993|3988311|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167554|NCT00824993|3988312|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167555|NCT00824993|3988313|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167556|NCT00824993|3988311|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4167557|NCT00824993|3988312|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4167558|NCT00824993|3988313|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4167559|NCT00824993|3988311|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4167560|NCT00824993|3988312|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4167561|NCT00824993|3988313|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4167562|NCT00824993|3988311|B3|||Age||years|Median|54|54.0|Full Range|||20.0|70.0|
4167563|NCT00824993|3988312|B2|||Age||years|Median|53|53.0|Full Range|||20.0|70.0|
4167564|NCT00824993|3988313|B1|||Age||years|Median|55|55.0|Full Range|||20.0|68.0|
4167565|NCT00824993|3988311|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4167566|NCT00824993|3988312|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4167567|NCT00824993|3988313|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4167568|NCT00824993|3988311|B3||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4167569|NCT00824993|3988312|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4167570|NCT00824993|3988313|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4167571|NCT00824993|3988311|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167572|NCT00824993|3988312|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167573|NCT00824993|3988313|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167574|NCT00824850|3988320|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4167575|NCT00824850|3988321|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4167576|NCT00824850|3988322|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4167577|NCT00824850|3988320|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4167578|NCT00824850|3988321|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4167579|NCT00824850|3988322|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4167580|NCT00824850|3988320|B3|||Age||years|Mean|12.8|12.8|Standard Deviation|1.0|1.0|||
4167581|NCT00824850|3988321|B2|||Age||years|Mean|13.1|13.1|Standard Deviation|0.9|0.9|||
4167582|NCT00824850|3988322|B1|||Age||years|Mean|12.6|12.6|Standard Deviation|1.1|1.1|||
4167583|NCT00824824|3988367|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4167584|NCT00824824|3988368|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4167585|NCT00824824|3988369|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4167586|NCT00824824|3988367|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167587|NCT00824824|3988368|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167588|NCT00824824|3988369|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167589|NCT00824824|3988367|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167590|NCT00824824|3988368|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167591|NCT00824824|3988369|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167592|NCT00824824|3988367|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4167593|NCT00824824|3988368|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4167594|NCT00824824|3988369|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4167595|NCT00824824|3988367|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4167596|NCT00824824|3988368|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167597|NCT00824824|3988369|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4167598|NCT00824824|3988367|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167599|NCT00824824|3988368|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167600|NCT00824824|3988369|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167601|NCT00824824|3988367|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167602|NCT00824824|3988368|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167603|NCT00824824|3988369|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167604|NCT00824824|3988367|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167605|NCT00824824|3988368|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167606|NCT00824824|3988369|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167607|NCT00824824|3988367|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4167608|NCT00824824|3988368|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4167609|NCT00824824|3988369|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4167610|NCT00824824|3988367|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4167611|NCT00824824|3988368|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4167612|NCT00824824|3988369|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4167613|NCT00824824|3988367|B3|||Age||years|Mean|63|63.0|Standard Deviation|8.3|8.3|||
4167614|NCT00824824|3988368|B2|||Age||years|Mean|60.0|60.0|Standard Deviation|8.6|8.6|||
4167615|NCT00824824|3988369|B1|||Age||years|Mean|64.5|64.5|Standard Deviation|8.2|8.2|||
4167616|NCT00824772|3988376|B1|Korea, Republic of||Region of Enrollment||participants|Number|204|204.0||||||
4167617|NCT00824772|3988376|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4167618|NCT00824772|3988376|B1||Female|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4167619|NCT00824772|3988376|B1|||Age||years|Mean|45.3|45.3|Standard Deviation|4.9|4.9|||
4167620|NCT00824772|3988376|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4167621|NCT00824772|3988376|B1||Between 18 and 65 years|Age||Participants|Count of Participants|204|204.0||||||
4167622|NCT00824772|3988376|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167623|NCT00824746|3988381|B1|Korea, Republic of||Region of Enrollment||participants|Number|23|23.0||||||
4167624|NCT00824746|3988381|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4167625|NCT00824746|3988381|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4167626|NCT00824746|3988381|B1|||Age||years|Mean|64.9|64.9|Standard Deviation|7.2|7.2|||
4167627|NCT00824746|3988381|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4167628|NCT00824746|3988381|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4167629|NCT00824746|3988381|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167630|NCT00824733|3988387|B1|United States||Region of Enrollment||patients|Number|6|6.0||||||
4167631|NCT00824733|3988387|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167632|NCT00824733|3988387|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167633|NCT00824733|3988387|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4167634|NCT00824733|3988387|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4167635|NCT00824733|3988387|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167636|NCT00824733|3988387|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167637|NCT00824733|3988387|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167638|NCT00824733|3988387|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167639|NCT00824733|3988387|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4167640|NCT00824733|3988387|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4167641|NCT00824733|3988387|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4167642|NCT00824733|3988387|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4167643|NCT00824733|3988387|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4167644|NCT00824733|3988387|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4167645|NCT00824733|3988387|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167646|NCT00824720|3988393|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4167647|NCT00824720|3988394|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4167648|NCT00824720|3988395|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4167649|NCT00824720|3988396|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4167650|NCT00824720|3988393|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4167651|NCT00824720|3988394|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4167652|NCT00824720|3988395|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4167653|NCT00824720|3988396|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4167654|NCT00824720|3988393|B4|||Age|This baseline measure includes all subjects with a plug insertion.|years|Mean|65.2|65.2|Standard Deviation|12.0|12.0|||
4167655|NCT00824720|3988394|B3|||Age|This baseline measure includes all subjects with a plug insertion.|years|Mean|64.5|64.5|Standard Deviation|10.6|10.6|||
4167656|NCT00824720|3988395|B2|||Age|This baseline measure includes all subjects with a plug insertion.|years|Mean|64.6|64.6|Standard Deviation|12.9|12.9|||
4167657|NCT00824720|3988396|B1|||Age|This baseline measure includes all subjects with a plug insertion.|years|Mean|66.7|66.7|Standard Deviation|13.4|13.4|||
4167658|NCT00824655|3988412|B3|Male||Sex/Gender, Customized||participants|Number|124|124.0||||||
4167659|NCT00824655|3988413|B2|Male||Sex/Gender, Customized||participants|Number|56|56.0||||||
4167660|NCT00824655|3988414|B1|Male||Sex/Gender, Customized||participants|Number|68|68.0||||||
4167661|NCT00824655|3988412|B3|Female||Sex/Gender, Customized||participants|Number|110|110.0||||||
4167662|NCT00824655|3988413|B2|Female||Sex/Gender, Customized||participants|Number|60|60.0||||||
4167663|NCT00824655|3988414|B1|Female||Sex/Gender, Customized||participants|Number|50|50.0||||||
4167664|NCT00824655|3988412|B3|||Age||months|Mean|8.5|8.5|Standard Deviation|3.42|3.42|||
4167665|NCT00824655|3988413|B2|||Age||months|Mean|11.9|11.9|Standard Deviation|0.52|0.52|||
4167666|NCT00824655|3988414|B1|||Age||months|Mean|5.1|5.1|Standard Deviation|0.37|0.37|||
4167667|NCT00824616|3988433|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4167668|NCT00824616|3988434|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4167669|NCT00824616|3988435|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4167670|NCT00824616|3988433|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4167671|NCT00824616|3988434|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4167672|NCT00824616|3988435|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4167673|NCT00824616|3988433|B3|||Age||years|Mean|54.8|54.8|Standard Deviation|9.5|9.5|||
4167674|NCT00824616|3988434|B2|||Age||years|Mean|54.1|54.1|Standard Deviation|10.2|10.2|||
4167675|NCT00824616|3988435|B1|||Age||years|Mean|55.5|55.5|Standard Deviation|8.8|8.8|||
4167676|NCT00824564|3988444|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4167677|NCT00824564|3988445|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4167678|NCT00824564|3988446|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4167679|NCT00824564|3988444|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4167680|NCT00824564|3988445|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4167681|NCT00824564|3988446|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4167682|NCT00824564|3988444|B3|||Age||Years|Mean|35.1|35.1|Standard Deviation|14.9|14.9|||
4167683|NCT00824564|3988445|B2|||Age||Years|Mean|36.6|36.6|Standard Deviation|17.0|17.0|||
4167684|NCT00824564|3988446|B1|||Age||Years|Mean|33.7|33.7|Standard Deviation|12.6|12.6|||
4167685|NCT00824538|3988465|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4167686|NCT00824538|3988465|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4167687|NCT00824538|3988465|B1|||Age||years|Mean|52|52.0|Standard Deviation|5|5.0|||
4167688|NCT00824512|3988473|B3|||Number of repeats of Guanine Adenine Adenine (GAA) sequence||GAA sequence repetitions|Median|700|700.0|Full Range|||100.0|1000.0|
4167689|NCT00824512|3988474|B2|||Number of repeats of Guanine Adenine Adenine (GAA) sequence||GAA sequence repetitions|Median|810|810.0|Full Range|||100.0|1000.0|
4167690|NCT00824512|3988475|B1|||Number of repeats of Guanine Adenine Adenine (GAA) sequence||GAA sequence repetitions|Median|700|700.0|Full Range|||500.0|950.0|
4167691|NCT00824512|3988473|B3|||Duration since first symptoms||years|Median|7.8|7.8|Full Range|||3.0|18.0|
4167692|NCT00824512|3988474|B2|||Duration since first symptoms||years|Median|7.7|7.7|Full Range|||4.0|18.0|
4167693|NCT00824512|3988475|B1|||Duration since first symptoms||years|Median|8.1|8.1|Full Range|||3.0|15.0|
4167694|NCT00824512|3988473|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4167695|NCT00824512|3988474|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4167696|NCT00824512|3988475|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4167697|NCT00824512|3988473|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4167698|NCT00824512|3988474|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4167699|NCT00824512|3988475|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4167700|NCT00824512|3988473|B3|16-22 years||Age, Customized||participants|Number|12|12.0||||||
4167701|NCT00824512|3988474|B2|16-22 years||Age, Customized||participants|Number|6|6.0||||||
4167702|NCT00824512|3988475|B1|16-22 years||Age, Customized||participants|Number|6|6.0||||||
4167703|NCT00824512|3988473|B3|12-15 years||Age, Customized||participants|Number|9|9.0||||||
4167704|NCT00824512|3988474|B2|12-15 years||Age, Customized||participants|Number|4|4.0||||||
4167705|NCT00824512|3988475|B1|12-15 years||Age, Customized||participants|Number|5|5.0||||||
4167706|NCT00824473|3988524|B3|United States||Region of Enrollment|Number of participants based on ITT population|participants|Number|505|505.0||||||
4167707|NCT00824473|3988525|B2|United States||Region of Enrollment|Number of participants based on ITT population|participants|Number|251|251.0||||||
4167708|NCT00824473|3988526|B1|United States||Region of Enrollment|Number of participants based on ITT population|participants|Number|254|254.0||||||
4167709|NCT00824473|3988524|B3||Male|Sex: Female, Male|Number of participants based on ITT population|Participants|Count of Participants|198|198.0||||||
4167710|NCT00824473|3988525|B2||Male|Sex: Female, Male|Number of participants based on ITT population|Participants|Count of Participants|94|94.0||||||
4167711|NCT00824473|3988526|B1||Male|Sex: Female, Male|Number of participants based on ITT population|Participants|Count of Participants|104|104.0||||||
4167712|NCT00824473|3988524|B3||Female|Sex: Female, Male|Number of participants based on ITT population|Participants|Count of Participants|307|307.0||||||
4167713|NCT00824473|3988525|B2||Female|Sex: Female, Male|Number of participants based on ITT population|Participants|Count of Participants|157|157.0||||||
4167714|NCT00824473|3988526|B1||Female|Sex: Female, Male|Number of participants based on ITT population|Participants|Count of Participants|150|150.0||||||
4167715|NCT00824473|3988524|B3|||Age|Number of participants based on ITT population|years|Mean|38.2|38.2|Standard Deviation|14.48|14.48|||
4167716|NCT00824473|3988525|B2|||Age|Number of participants based on ITT population|years|Mean|38.0|38.0|Standard Deviation|14.40|14.4|||
4167717|NCT00824473|3988526|B1|||Age|Number of participants based on ITT population|years|Mean|38.5|38.5|Standard Deviation|14.59|14.59|||
4167718|NCT00824473|3988524|B3||>=65 years|Age|Number of participants based on ITT population|Participants|Count of Participants|16|16.0||||||
4167719|NCT00824473|3988525|B2||>=65 years|Age|Number of participants based on ITT population|Participants|Count of Participants|9|9.0||||||
4167720|NCT00824473|3988526|B1||>=65 years|Age|Number of participants based on ITT population|Participants|Count of Participants|7|7.0||||||
4167721|NCT00824473|3988524|B3||Between 18 and 65 years|Age|Number of participants based on ITT population|Participants|Count of Participants|438|438.0||||||
4167722|NCT00824473|3988525|B2||Between 18 and 65 years|Age|Number of participants based on ITT population|Participants|Count of Participants|218|218.0||||||
4167723|NCT00824473|3988526|B1||Between 18 and 65 years|Age|Number of participants based on ITT population|Participants|Count of Participants|220|220.0||||||
4167724|NCT00824473|3988524|B3||<=18 years|Age|Number of participants based on ITT population|Participants|Count of Participants|51|51.0||||||
4167725|NCT00824473|3988525|B2||<=18 years|Age|Number of participants based on ITT population|Participants|Count of Participants|24|24.0||||||
4167726|NCT00824473|3988526|B1||<=18 years|Age|Number of participants based on ITT population|Participants|Count of Participants|27|27.0||||||
4167727|NCT00824460|3988543|B7|Switzerland||Region of Enrollment||participants|Number|5|5.0||||||
4167728|NCT00824460|3988544|B6|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4167729|NCT00824460|3988545|B5|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4167730|NCT00824460|3988546|B4|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4167731|NCT00824460|3988547|B3|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
4167732|NCT00824460|3988548|B2|Switzerland||Region of Enrollment||participants|Number|2|2.0||||||
4167733|NCT00824460|3988549|B1|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
4167734|NCT00824460|3988543|B7|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4167735|NCT00824460|3988544|B6|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4167736|NCT00824460|3988545|B5|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4167737|NCT00824460|3988546|B4|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4167738|NCT00824460|3988547|B3|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4167739|NCT00824460|3988548|B2|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4167740|NCT00824460|3988549|B1|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4167741|NCT00824460|3988543|B7|Bulgaria||Region of Enrollment||participants|Number|23|23.0||||||
4167742|NCT00824460|3988544|B6|Bulgaria||Region of Enrollment||participants|Number|1|1.0||||||
4167743|NCT00824460|3988545|B5|Bulgaria||Region of Enrollment||participants|Number|7|7.0||||||
4167744|NCT00824460|3988546|B4|Bulgaria||Region of Enrollment||participants|Number|4|4.0||||||
4167745|NCT00824460|3988547|B3|Bulgaria||Region of Enrollment||participants|Number|5|5.0||||||
4167746|NCT00824460|3988548|B2|Bulgaria||Region of Enrollment||participants|Number|3|3.0||||||
4167747|NCT00824460|3988549|B1|Bulgaria||Region of Enrollment||participants|Number|3|3.0||||||
4167748|NCT00824460|3988543|B7|Russian Federation||Region of Enrollment||participants|Number|28|28.0||||||
4167749|NCT00824460|3988544|B6|Russian Federation||Region of Enrollment||participants|Number|6|6.0||||||
4167750|NCT00824460|3988545|B5|Russian Federation||Region of Enrollment||participants|Number|2|2.0||||||
4167751|NCT00824460|3988546|B4|Russian Federation||Region of Enrollment||participants|Number|5|5.0||||||
4167752|NCT00824460|3988547|B3|Russian Federation||Region of Enrollment||participants|Number|3|3.0||||||
4167753|NCT00824460|3988548|B2|Russian Federation||Region of Enrollment||participants|Number|5|5.0||||||
4167754|NCT00824460|3988549|B1|Russian Federation||Region of Enrollment||participants|Number|7|7.0||||||
4167755|NCT00824460|3988543|B7|Croatia||Region of Enrollment||participants|Number|40|40.0||||||
4167756|NCT00824460|3988544|B6|Croatia||Region of Enrollment||participants|Number|7|7.0||||||
4167757|NCT00824460|3988545|B5|Croatia||Region of Enrollment||participants|Number|8|8.0||||||
4167758|NCT00824460|3988546|B4|Croatia||Region of Enrollment||participants|Number|8|8.0||||||
4167759|NCT00824460|3988547|B3|Croatia||Region of Enrollment||participants|Number|9|9.0||||||
4167760|NCT00824460|3988548|B2|Croatia||Region of Enrollment||participants|Number|3|3.0||||||
4167761|NCT00824460|3988549|B1|Croatia||Region of Enrollment||participants|Number|5|5.0||||||
4167762|NCT00824460|3988543|B7|Romania||Region of Enrollment||participants|Number|12|12.0||||||
4167763|NCT00824460|3988544|B6|Romania||Region of Enrollment||participants|Number|0|0.0||||||
4167764|NCT00824460|3988545|B5|Romania||Region of Enrollment||participants|Number|1|1.0||||||
4167765|NCT00824460|3988546|B4|Romania||Region of Enrollment||participants|Number|3|3.0||||||
4167766|NCT00824460|3988547|B3|Romania||Region of Enrollment||participants|Number|2|2.0||||||
4167767|NCT00824460|3988548|B2|Romania||Region of Enrollment||participants|Number|4|4.0||||||
4167768|NCT00824460|3988549|B1|Romania||Region of Enrollment||participants|Number|2|2.0||||||
4167769|NCT00824460|3988543|B7|Poland||Region of Enrollment||participants|Number|15|15.0||||||
4167770|NCT00824460|3988544|B6|Poland||Region of Enrollment||participants|Number|4|4.0||||||
4167771|NCT00824460|3988545|B5|Poland||Region of Enrollment||participants|Number|0|0.0||||||
4167772|NCT00824460|3988546|B4|Poland||Region of Enrollment||participants|Number|2|2.0||||||
4167773|NCT00824460|3988547|B3|Poland||Region of Enrollment||participants|Number|3|3.0||||||
4167774|NCT00824460|3988548|B2|Poland||Region of Enrollment||participants|Number|2|2.0||||||
4167775|NCT00824460|3988549|B1|Poland||Region of Enrollment||participants|Number|4|4.0||||||
4167776|NCT00824460|3988543|B7|Czech Republic||Region of Enrollment||participants|Number|8|8.0||||||
4167777|NCT00824460|3988544|B6|Czech Republic||Region of Enrollment||participants|Number|2|2.0||||||
4167778|NCT00824460|3988545|B5|Czech Republic||Region of Enrollment||participants|Number|3|3.0||||||
4167779|NCT00824460|3988546|B4|Czech Republic||Region of Enrollment||participants|Number|0|0.0||||||
4167780|NCT00824460|3988547|B3|Czech Republic||Region of Enrollment||participants|Number|0|0.0||||||
4167781|NCT00824460|3988548|B2|Czech Republic||Region of Enrollment||participants|Number|3|3.0||||||
4167782|NCT00824460|3988549|B1|Czech Republic||Region of Enrollment||participants|Number|0|0.0||||||
4167783|NCT00824460|3988543|B7|United States||Region of Enrollment||participants|Number|21|21.0||||||
4167784|NCT00824460|3988544|B6|United States||Region of Enrollment||participants|Number|4|4.0||||||
4167785|NCT00824460|3988545|B5|United States||Region of Enrollment||participants|Number|2|2.0||||||
4167786|NCT00824460|3988546|B4|United States||Region of Enrollment||participants|Number|4|4.0||||||
4167787|NCT00824460|3988547|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4167788|NCT00824460|3988548|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4167789|NCT00824460|3988549|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4167790|NCT00824460|3988543|B7||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4167791|NCT00824460|3988544|B6||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4167792|NCT00824460|3988545|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4167793|NCT00824460|3988546|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4167794|NCT00824460|3988547|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4167795|NCT00824460|3988548|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4167796|NCT00824460|3988549|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4167797|NCT00824460|3988543|B7||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4167798|NCT00824460|3988544|B6||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4167799|NCT00824460|3988545|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4167800|NCT00824460|3988546|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4167801|NCT00824460|3988547|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4167802|NCT00824460|3988548|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4167803|NCT00824460|3988549|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4167804|NCT00824460|3988543|B7|||Age||years|Mean|60.5|60.5|Standard Deviation|12.50|12.5|||
4167805|NCT00824460|3988544|B6|||Age||years|Mean|61.1|61.1|Standard Deviation|11.00|11.0|||
4167806|NCT00824460|3988545|B5|||Age||years|Mean|59.3|59.3|Standard Deviation|12.32|12.32|||
4167807|NCT00824460|3988546|B4|||Age||years|Mean|60.6|60.6|Standard Deviation|12.74|12.74|||
4167808|NCT00824460|3988547|B3|||Age||years|Mean|61.9|61.9|Standard Deviation|13.71|13.71|||
4167809|NCT00824460|3988548|B2|||Age||years|Mean|59.7|59.7|Standard Deviation|13.80|13.8|||
4167810|NCT00824460|3988549|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|12.29|12.29|||
4167811|NCT00824460|3988543|B7||>=65 years|Age||Participants|Count of Participants|61|61.0||||||
4167812|NCT00824460|3988544|B6||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4167813|NCT00824460|3988545|B5||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4167814|NCT00824460|3988546|B4||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4167815|NCT00824460|3988547|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4167816|NCT00824460|3988548|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4167817|NCT00824460|3988549|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4167818|NCT00824460|3988543|B7||Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
4167819|NCT00824460|3988544|B6||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4167878|NCT00824434|3988586|B1|New Zealand||Region of Enrollment||participants|Number|39|39.0||||||
4167820|NCT00824460|3988545|B5||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4167821|NCT00824460|3988546|B4||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4167822|NCT00824460|3988547|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4167823|NCT00824460|3988548|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4167824|NCT00824460|3988549|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4167825|NCT00824460|3988543|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167826|NCT00824460|3988544|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167827|NCT00824460|3988545|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167828|NCT00824460|3988546|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167829|NCT00824460|3988547|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167830|NCT00824460|3988548|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167831|NCT00824460|3988549|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167832|NCT00824434|3988586|B1|3||Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion TIMI 1 - Penetration with minimal perfusion TIMI 2 - Partial perfusion TIMI 3 - Complete perfusion|Lesion|Number|98|98.0||||||
4167833|NCT00824434|3988586|B1|2||Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion TIMI 1 - Penetration with minimal perfusion TIMI 2 - Partial perfusion TIMI 3 - Complete perfusion|Lesion|Number|1|1.0||||||
4167834|NCT00824434|3988586|B1|1||Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion TIMI 1 - Penetration with minimal perfusion TIMI 2 - Partial perfusion TIMI 3 - Complete perfusion|Lesion|Number|0|0.0||||||
4167835|NCT00824434|3988586|B1|0||Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion TIMI 1 - Penetration with minimal perfusion TIMI 2 - Partial perfusion TIMI 3 - Complete perfusion|Lesion|Number|1|1.0||||||
4167836|NCT00824434|3988586|B1|C||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A lesions: minimally complex, readily accessible, non-angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, and an absence of thrombus.~Type B lesions: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, with presence of thrombus.~Type C lesions: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|Lesions|Number|25|25.0||||||
4167837|NCT00824434|3988586|B1|B2||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A lesions: minimally complex, readily accessible, non-angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, and an absence of thrombus.~Type B lesions: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, with presence of thrombus.~Type C lesions: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|Lesions|Number|42|42.0||||||
4167838|NCT00824434|3988586|B1|B1||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A lesions: minimally complex, readily accessible, non-angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, and an absence of thrombus.~Type B lesions: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, with presence of thrombus.~Type C lesions: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|Lesions|Number|28|28.0||||||
4167839|NCT00824434|3988586|B1|A||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A lesions: minimally complex, readily accessible, non-angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, and an absence of thrombus.~Type B lesions: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, with presence of thrombus.~Type C lesions: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|Lesions|Number|5|5.0||||||
4167840|NCT00824434|3988586|B1|Branch Vessel Disease||Lesion Characteristics|The same lesion may be included in more than one category therefore the number of lesions for this baseline measure does not equal the total number of lesions or participants in the group.|Lesions|Number|6|6.0||||||
4167841|NCT00824434|3988586|B1|Total Occlusion||Lesion Characteristics|The same lesion may be included in more than one category therefore the number of lesions for this baseline measure does not equal the total number of lesions or participants in the group.|Lesions|Number|1|1.0||||||
4167842|NCT00824434|3988586|B1|Calcification, any||Lesion Characteristics|The same lesion may be included in more than one category therefore the number of lesions for this baseline measure does not equal the total number of lesions or participants in the group.|Lesions|Number|18|18.0||||||
4167843|NCT00824434|3988586|B1|Tortuosity||Lesion Characteristics|The same lesion may be included in more than one category therefore the number of lesions for this baseline measure does not equal the total number of lesions or participants in the group.|Lesions|Number|9|9.0||||||
4167844|NCT00824434|3988586|B1|Bend >45%||Lesion Characteristics|The same lesion may be included in more than one category therefore the number of lesions for this baseline measure does not equal the total number of lesions or participants in the group.|Lesions|Number|12|12.0||||||
4167845|NCT00824434|3988586|B1|Eccentric Lesion||Lesion Characteristics|The same lesion may be included in more than one category therefore the number of lesions for this baseline measure does not equal the total number of lesions or participants in the group.|Lesions|Number|53|53.0||||||
4167846|NCT00824434|3988586|B1|||Lesion Characteristic-Diameter Stenosis||Percent Diameter Stenosis|Mean|74.09|74.09|Standard Deviation|10.93|10.93|||
4167847|NCT00824434|3988586|B1|Lesion Length||Lesion Characteristics||millimeters|Mean|15.40|15.4|Standard Deviation|7.03|7.03|||
4167848|NCT00824434|3988586|B1|Minimum Lumen Diameter||Lesion Characteristics||millimeters|Mean|0.71|0.71|Standard Deviation|0.34|0.34|||
4167849|NCT00824434|3988586|B1|Reference Vessel Diameter||Lesion Characteristics||millimeters|Mean|2.72|2.72|Standard Deviation|0.53|0.53|||
4167850|NCT00824434|3988586|B1|Ostial||Lesion Location||Lesions|Number|2|2.0||||||
4167851|NCT00824434|3988586|B1|Distal||Lesion Location||Lesions|Number|7|7.0||||||
4167852|NCT00824434|3988586|B1|Mid||Lesion Location||Lesions|Number|54|54.0||||||
4167853|NCT00824434|3988586|B1|Proximal||Lesion Location||Lesions|Number|37|37.0||||||
4167854|NCT00824434|3988586|B1|Right Coronary Artery||Lesion Characteristic-Target Vessel||Lesion|Number|35|35.0||||||
4167855|NCT00824434|3988586|B1|Left Circumflex Artery||Lesion Characteristic-Target Vessel||Lesion|Number|30|30.0||||||
4167856|NCT00824434|3988586|B1|Left Anterior Descending Artery||Lesion Characteristic-Target Vessel||Lesion|Number|35|35.0||||||
4167857|NCT00824434|3988586|B1|History of Peripheral Vascular Disease||Renal and Peripheral History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|3|3.0||||||
4167858|NCT00824434|3988586|B1|History of Renal Disease||Renal and Peripheral History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|1|1.0||||||
4167859|NCT00824434|3988586|B1|History of Cerebrovascular Accident||Neurologic History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|3|3.0||||||
4167860|NCT00824434|3988586|B1|History of Transient Ischemic Attack||Neurologic History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|2|2.0||||||
4167861|NCT00824434|3988586|B1|||Cardiac History-Left Ventricular Ejection Fraction||Percent ejection fraction|Mean|64.41|64.41|Standard Deviation|13.30|13.3|||
4167862|NCT00824434|3988586|B1|History of Left Main Disease||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|2|2.0||||||
4167863|NCT00824434|3988586|B1|History of Multivessel Disease||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|34|34.0||||||
4167864|NCT00824434|3988586|B1|History of Arrhythmia||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|4|4.0||||||
4167865|NCT00824434|3988586|B1|History of Coronary Artery Bypass Graft||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|5|5.0||||||
4167866|NCT00824434|3988586|B1|History of Percutaneous Coronary Intervention||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|31|31.0||||||
4167867|NCT00824434|3988586|B1|Previous MI||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|39|39.0||||||
4167868|NCT00824434|3988586|B1|Family History of Coronary Artery Disease||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|49|49.0||||||
4167869|NCT00824434|3988586|B1|Silent Ischemia||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|2|2.0||||||
4167870|NCT00824434|3988586|B1|No Angina||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|5|5.0||||||
4167871|NCT00824434|3988586|B1|Unstable Angina||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|38|38.0||||||
4167872|NCT00824434|3988586|B1|Stable Angina||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|57|57.0||||||
4167873|NCT00824434|3988586|B1|History of Bleeding Disorder||General Medical History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|3|3.0||||||
4167874|NCT00824434|3988586|B1|Hypertension Requiring. Medication||General Medical History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|66|66.0||||||
4167875|NCT00824434|3988586|B1|Hyperlipidemia Requiring Medication||General Medical History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|81|81.0||||||
4167876|NCT00824434|3988586|B1|Medically Treated Diabetes||General Medical History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|19|19.0||||||
4167877|NCT00824434|3988586|B1|Smoking, Ever||General Medical History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|64|64.0||||||
4167879|NCT00824434|3988586|B1|Australia||Region of Enrollment||participants|Number|49|49.0||||||
4167880|NCT00824434|3988586|B1|Singapore||Region of Enrollment||participants|Number|3|3.0||||||
4167881|NCT00824434|3988586|B1|Malaysia||Region of Enrollment||participants|Number|9|9.0||||||
4167882|NCT00824434|3988586|B1|Other||Race/Ethnicity, Customized|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|3|3.0||||||
4167883|NCT00824434|3988586|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|2|2.0||||||
4167884|NCT00824434|3988586|B1|Maori||Race/Ethnicity, Customized|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|1|1.0||||||
4167885|NCT00824434|3988586|B1|Caucasian||Race/Ethnicity, Customized|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|78|78.0||||||
4167886|NCT00824434|3988586|B1|Asian||Race/Ethnicity, Customized|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|16|16.0||||||
4167887|NCT00824434|3988586|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4167888|NCT00824434|3988586|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4167889|NCT00824434|3988586|B1|||Age||years|Mean|61.82|61.82|Standard Deviation|9.92|9.92|||
4167890|NCT00824434|3988586|B1||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
4167891|NCT00824434|3988586|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4167892|NCT00824434|3988586|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4167893|NCT00824421|3988605|B4||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4167894|NCT00824421|3988606|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4167895|NCT00824421|3988607|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4167896|NCT00824421|3988608|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4167897|NCT00824421|3988605|B4||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4167898|NCT00824421|3988606|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4167899|NCT00824421|3988607|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4167900|NCT00824421|3988608|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4167901|NCT00824421|3988605|B4|||Age||years|Mean|36.2|36.2|Standard Deviation|8.2|8.2|||
4167902|NCT00824421|3988606|B3|||Age||years|Mean|36.3|36.3|Standard Deviation|8.7|8.7|||
4167903|NCT00824421|3988607|B2|||Age||years|Mean|35.7|35.7|Standard Deviation|8.2|8.2|||
4167904|NCT00824421|3988608|B1|||Age||years|Mean|36.5|36.5|Standard Deviation|8.0|8.0|||
4167905|NCT00824408|3988656|B6||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4167906|NCT00824408|3988657|B5||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4167907|NCT00824408|3988658|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4167908|NCT00824408|3988659|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4167909|NCT00824408|3988660|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4167910|NCT00824408|3988661|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4167911|NCT00824408|3988656|B6||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4167912|NCT00824408|3988657|B5||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4167913|NCT00824408|3988658|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4167914|NCT00824408|3988659|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4167915|NCT00824408|3988660|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4167916|NCT00824408|3988661|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4167917|NCT00824408|3988656|B6|||Age||years|Mean|63.1|63.1|Standard Deviation|9.12|9.12|||
4167918|NCT00824408|3988657|B5|||Age||years|Mean|62.5|62.5|Standard Deviation|8.89|8.89|||
4167919|NCT00824408|3988658|B4|||Age||years|Mean|63.5|63.5|Standard Deviation|10.26|10.26|||
4167920|NCT00824408|3988659|B3|||Age||years|Mean|62.9|62.9|Standard Deviation|8.60|8.6|||
4167921|NCT00824408|3988660|B2|||Age||years|Mean|62.3|62.3|Standard Deviation|6.83|6.83|||
4167922|NCT00824408|3988661|B1|||Age||years|Mean|66.2|66.2|Standard Deviation|8.30|8.3|||
4167923|NCT00824382|3988713|B5|50% to 80%||Percent predicted normal FEV1|based on Japanese equation|Participants|Number|172|172.0||||||
4167924|NCT00824382|3988714|B4|50% to 80%||Percent predicted normal FEV1|based on Japanese equation|Participants|Number|45|45.0||||||
4167925|NCT00824382|3988715|B3|50% to 80%||Percent predicted normal FEV1|based on Japanese equation|Participants|Number|41|41.0||||||
4167926|NCT00824382|3988716|B2|50% to 80%||Percent predicted normal FEV1|based on Japanese equation|Participants|Number|43|43.0||||||
4167927|NCT00824382|3988717|B1|50% to 80%||Percent predicted normal FEV1|based on Japanese equation|Participants|Number|43|43.0||||||
4167928|NCT00824382|3988713|B5|30 to < 50%||Percent predicted normal FEV1|based on Japanese equation|Participants|Number|154|154.0||||||
4167929|NCT00824382|3988714|B4|30 to < 50%||Percent predicted normal FEV1|based on Japanese equation|Participants|Number|41|41.0||||||
4167930|NCT00824382|3988715|B3|30 to < 50%||Percent predicted normal FEV1|based on Japanese equation|Participants|Number|38|38.0||||||
4167931|NCT00824382|3988716|B2|30 to < 50%||Percent predicted normal FEV1|based on Japanese equation|Participants|Number|40|40.0||||||
4167932|NCT00824382|3988717|B1|30 to < 50%||Percent predicted normal FEV1|based on Japanese equation|Participants|Number|35|35.0||||||
4167933|NCT00824382|3988713|B5|< 30%||Percent predicted normal FEV1|based on Japanese equation|Participants|Number|2|2.0||||||
4167934|NCT00824382|3988714|B4|< 30%||Percent predicted normal FEV1|based on Japanese equation|Participants|Number|0|0.0||||||
4167935|NCT00824382|3988715|B3|< 30%||Percent predicted normal FEV1|based on Japanese equation|Participants|Number|0|0.0||||||
4167936|NCT00824382|3988716|B2|< 30%||Percent predicted normal FEV1|based on Japanese equation|Participants|Number|1|1.0||||||
4167937|NCT00824382|3988717|B1|< 30%||Percent predicted normal FEV1|based on Japanese equation|Participants|Number|1|1.0||||||
4167938|NCT00824382|3988713|B5|||Percent predicted normal FEV1|Based on Japanese equation|percent|Mean|51.45|51.45|Standard Deviation|12.76|12.76|||
4167939|NCT00824382|3988714|B4|||Percent predicted normal FEV1|Based on Japanese equation|percent|Mean|51.73|51.73|Standard Deviation|11.81|11.81|||
4167940|NCT00824382|3988715|B3|||Percent predicted normal FEV1|Based on Japanese equation|percent|Mean|52.07|52.07|Standard Deviation|12.82|12.82|||
4167941|NCT00824382|3988716|B2|||Percent predicted normal FEV1|Based on Japanese equation|percent|Mean|51.36|51.36|Standard Deviation|14.15|14.15|||
4167942|NCT00824382|3988717|B1|||Percent predicted normal FEV1|Based on Japanese equation|percent|Mean|50.64|50.64|Standard Deviation|12.32|12.32|||
4167943|NCT00824382|3988713|B5||Male|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
4167944|NCT00824382|3988714|B4||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4167945|NCT00824382|3988715|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4167946|NCT00824382|3988716|B2||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4167947|NCT00824382|3988717|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4167948|NCT00824382|3988713|B5||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4167949|NCT00824382|3988714|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4167950|NCT00824382|3988715|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4167951|NCT00824382|3988716|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4167952|NCT00824382|3988717|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4167953|NCT00824382|3988713|B5|||Age||years|Mean|69.3|69.3|Standard Deviation|7.1|7.1|||
4167954|NCT00824382|3988714|B4|||Age||years|Mean|69.3|69.3|Standard Deviation|7.4|7.4|||
4167955|NCT00824382|3988715|B3|||Age||years|Mean|70.1|70.1|Standard Deviation|6.7|6.7|||
4167956|NCT00824382|3988716|B2|||Age||years|Mean|68.9|68.9|Standard Deviation|7.6|7.6|||
4167957|NCT00824382|3988717|B1|||Age||years|Mean|68.9|68.9|Standard Deviation|6.5|6.5|||
4167958|NCT00824369|3988790|B7||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4167959|NCT00824369|3988791|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4167960|NCT00824369|3988792|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4167961|NCT00824369|3988793|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4167962|NCT00824369|3988794|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4167963|NCT00824369|3988795|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4167964|NCT00824369|3988796|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4167965|NCT00824369|3988790|B7||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4167966|NCT00824369|3988791|B6||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4167967|NCT00824369|3988792|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4167968|NCT00824369|3988793|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4167969|NCT00824369|3988794|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4167970|NCT00824369|3988795|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4167971|NCT00824369|3988796|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4167972|NCT00824369|3988790|B7|Participants from A5271022||Age, Customized||years|Mean|41.2|41.2|Standard Deviation|9.1|9.1|||
4167973|NCT00824369|3988791|B6|Participants from A5271022||Age, Customized||years|Mean|41.6|41.6|Standard Deviation|9.4|9.4|||
4167974|NCT00824369|3988792|B5|Participants from A5271022||Age, Customized||years|Mean|39.1|39.1|Standard Deviation|9.0|9.0|||
4167975|NCT00824369|3988793|B4|Participants from A5271022||Age, Customized||years|Mean|42.7|42.7|Standard Deviation|9.1|9.1|||
4167976|NCT00824369|3988794|B3|Participants from A5271022||Age, Customized||years|Mean|NA||Standard Deviation|NA||||This arm belongs to the study A5271015 and not A5271022.
4167977|NCT00824369|3988795|B2|Participants from A5271022||Age, Customized||years|Mean|NA||Standard Deviation|NA||||This arm belongs to the study A5271015 and not A5271022.
4167978|NCT00824369|3988796|B1|Participants from A5271022||Age, Customized||years|Mean|NA||Standard Deviation|NA||||This arm belongs to the study A5271015 and not A5271022.
4167979|NCT00824369|3988790|B7|Participants from A5271015||Age, Customized||years|Mean|34.2|34.2|Standard Deviation|4.8|4.8|||
4167980|NCT00824369|3988791|B6|Participants from A5271015||Age, Customized||years|Mean|NA||Standard Deviation|NA||||This arm belongs to the study A5271022 and not A5271015.
4167981|NCT00824369|3988792|B5|Participants from A5271015||Age, Customized||years|Mean|NA||Standard Deviation|NA||||This arm belongs to the study A5271022 and not A5271015.
4167982|NCT00824369|3988793|B4|Participants from A5271015||Age, Customized||years|Mean|NA||Standard Deviation|NA||||This arm belongs to the study A5271022 and not A5271015.
4167983|NCT00824369|3988794|B3|Participants from A5271015||Age, Customized||years|Mean|38.3|38.3|Standard Deviation|3.2|3.2|||
4167984|NCT00824369|3988795|B2|Participants from A5271015||Age, Customized||years|Mean|31.5|31.5|Standard Deviation|1.7|1.7|||
4167985|NCT00824369|3988796|B1|Participants from A5271015||Age, Customized||years|Mean|33.8|33.8|Standard Deviation|6.1|6.1|||
4167986|NCT00824291|3988839|B3||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4167987|NCT00824291|3988840|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4167988|NCT00824291|3988841|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4167989|NCT00824291|3988839|B3||Female|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
4167990|NCT00824291|3988840|B2||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4167991|NCT00824291|3988841|B1||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4167992|NCT00824291|3988839|B3|||Age||years|Mean|42.63|42.63|Standard Deviation|12.04|12.04|||
4167993|NCT00824291|3988840|B2|||Age||years|Mean|41.57|41.57|Standard Deviation|12.64|12.64|||
4167994|NCT00824291|3988841|B1|||Age||years|Mean|43.16|43.16|Standard Deviation|11.72|11.72|||
4167995|NCT00824265|3988862|B3||White - White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|311|311.0||||||
4167996|NCT00824265|3988863|B2||White - White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|153|153.0||||||
4167997|NCT00824265|3988864|B1||White - White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|158|158.0||||||
4167998|NCT00824265|3988862|B3||White - Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4167999|NCT00824265|3988863|B2||White - Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4168000|NCT00824265|3988864|B1||White - Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4168001|NCT00824265|3988862|B3||Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4168002|NCT00824265|3988863|B2||Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4168003|NCT00824265|3988864|B1||Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4168004|NCT00824265|3988862|B3||Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4168005|NCT00824265|3988863|B2||Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4168006|NCT00824265|3988864|B1||Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4168007|NCT00824265|3988862|B3||Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
4168008|NCT00824265|3988863|B2||Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
4168009|NCT00824265|3988864|B1||Asian - Central/South Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4168010|NCT00824265|3988862|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4168011|NCT00824265|3988863|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4168012|NCT00824265|3988864|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4168013|NCT00824265|3988862|B3||African American/African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4168014|NCT00824265|3988863|B2||African American/African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4168015|NCT00824265|3988864|B1||African American/African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4168016|NCT00824265|3988862|B3||Male|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
4168017|NCT00824265|3988863|B2||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4168018|NCT00824265|3988864|B1||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4168019|NCT00824265|3988862|B3||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4168020|NCT00824265|3988863|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4168021|NCT00824265|3988864|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4168022|NCT00824265|3988862|B3|||Age||Years|Mean|61.5|61.5|Standard Deviation|9.53|9.53|||
4168023|NCT00824265|3988863|B2|||Age||Years|Mean|61.6|61.6|Standard Deviation|10.21|10.21|||
4168024|NCT00824265|3988864|B1|||Age||Years|Mean|61.4|61.4|Standard Deviation|8.82|8.82|||
4168025|NCT00824161|3988926|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4168026|NCT00824161|3988926|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4168027|NCT00824161|3988926|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4168028|NCT00824161|3988926|B1|||Age||years|Mean|55.8|55.8|Standard Deviation|10.19|10.19|||
4168029|NCT00824161|3988926|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4168030|NCT00824161|3988926|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4168031|NCT00824161|3988926|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168032|NCT00824070|3988932|B4|Non-Caucasian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4168033|NCT00824070|3988933|B3|Non-Caucasian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4168034|NCT00824070|3988934|B2|Non-Caucasian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4168035|NCT00824070|3988935|B1|Non-Caucasian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4168036|NCT00824070|3988932|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|98|98.0||||||
4168037|NCT00824070|3988933|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4168038|NCT00824070|3988934|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4168039|NCT00824070|3988935|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4168040|NCT00824070|3988932|B4||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4168041|NCT00824070|3988933|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4168042|NCT00824070|3988934|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4168043|NCT00824070|3988935|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4168044|NCT00824070|3988932|B4||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4168045|NCT00824070|3988933|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4168046|NCT00824070|3988934|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4168047|NCT00824070|3988935|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4168048|NCT00824070|3988932|B4|>/= 80||Age, Customized||participants|Number|16|16.0||||||
4168049|NCT00824070|3988933|B3|>/= 80||Age, Customized||participants|Number|7|7.0||||||
4168050|NCT00824070|3988934|B2|>/= 80||Age, Customized||participants|Number|5|5.0||||||
4168051|NCT00824070|3988935|B1|>/= 80||Age, Customized||participants|Number|4|4.0||||||
4168052|NCT00824070|3988932|B4|70-79 years||Age, Customized||participants|Number|44|44.0||||||
4168053|NCT00824070|3988933|B3|70-79 years||Age, Customized||participants|Number|14|14.0||||||
4168054|NCT00824070|3988934|B2|70-79 years||Age, Customized||participants|Number|19|19.0||||||
4168055|NCT00824070|3988935|B1|70-79 years||Age, Customized||participants|Number|11|11.0||||||
4168056|NCT00824070|3988932|B4|60-69 years||Age, Customized||participants|Number|32|32.0||||||
4168057|NCT00824070|3988933|B3|60-69 years||Age, Customized||participants|Number|10|10.0||||||
4168058|NCT00824070|3988934|B2|60-69 years||Age, Customized||participants|Number|7|7.0||||||
4168059|NCT00824070|3988935|B1|60-69 years||Age, Customized||participants|Number|15|15.0||||||
4168060|NCT00824070|3988932|B4|<60 years||Age, Customized||participants|Number|13|13.0||||||
4168061|NCT00824070|3988933|B3|<60 years||Age, Customized||participants|Number|5|5.0||9.6|9.6|||
4168062|NCT00824070|3988934|B2|<60 years||Age, Customized||participants|Number|4|4.0||9.9|9.9|||
4168063|NCT00824070|3988935|B1|<60 years||Age, Customized||participants|Number|4|4.0||8.1|8.1|||
4168064|NCT00824044|3988945|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
4168065|NCT00824044|3988946|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4168066|NCT00824044|3988947|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4168067|NCT00824044|3988945|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4168068|NCT00824044|3988946|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4168069|NCT00824044|3988947|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4168070|NCT00824044|3988945|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4168071|NCT00824044|3988946|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4168072|NCT00824044|3988947|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4168073|NCT00824044|3988945|B3|Age unknown||Age, Customized|Age at screen was not available for 2 participants.|participants|Number|2|2.0||||||
4168074|NCT00824044|3988946|B2|Age unknown||Age, Customized|Age at screen was not available for 2 participants.|participants|Number|1|1.0||||||
4168075|NCT00824044|3988947|B1|Age unknown||Age, Customized|Age at screen was not available for 2 participants.|participants|Number|1|1.0||||||
4168076|NCT00824044|3988945|B3|>=65 years||Age, Customized|Age at screen was not available for 2 participants.|participants|Number|4|4.0||||||
4168077|NCT00824044|3988946|B2|>=65 years||Age, Customized|Age at screen was not available for 2 participants.|participants|Number|1|1.0||||||
4168078|NCT00824044|3988947|B1|>=65 years||Age, Customized|Age at screen was not available for 2 participants.|participants|Number|3|3.0||||||
4168079|NCT00824044|3988945|B3|Between 18 and 65 years||Age, Customized|Age at screen was not available for 2 participants.|participants|Number|33|33.0||||||
4168080|NCT00824044|3988946|B2|Between 18 and 65 years||Age, Customized|Age at screen was not available for 2 participants.|participants|Number|14|14.0||||||
4168081|NCT00824044|3988947|B1|Between 18 and 65 years||Age, Customized|Age at screen was not available for 2 participants.|participants|Number|19|19.0||||||
4168082|NCT00824044|3988945|B3|<=18 years||Age, Customized|Age at screen was not available for 2 participants.|participants|Number|0|0.0||||||
4168083|NCT00824044|3988946|B2|<=18 years||Age, Customized|Age at screen was not available for 2 participants.|participants|Number|0|0.0||||||
4168084|NCT00824044|3988947|B1|<=18 years||Age, Customized|Age at screen was not available for 2 participants.|participants|Number|0|0.0||||||
4168085|NCT00824044|3988945|B3|||Age||years|Mean|43.9|43.9|Standard Deviation|14.8|14.8|||
4168086|NCT00824044|3988946|B2|||Age||years|Mean|43.3|43.3|Standard Deviation|15.5|15.5|||
4168087|NCT00824044|3988947|B1|||Age||years|Mean|44.8|44.8|Standard Deviation|14.2|14.2|||
4168088|NCT00824005|3988990|B3|United States||Region of Enrollment||participants|Number|92|92.0||||||
4168089|NCT00824005|3988991|B2|United States||Region of Enrollment||participants|Number|61|61.0||||||
4168090|NCT00824005|3988992|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4168091|NCT00824005|3988990|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4168092|NCT00824005|3988991|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4168093|NCT00824005|3988992|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4168094|NCT00824005|3988990|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4168095|NCT00824005|3988991|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4168096|NCT00824005|3988992|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4168097|NCT00824005|3988990|B3|||Age||years|Mean|63.4|63.4|Standard Deviation|10.1|10.1|||
4168098|NCT00824005|3988991|B2|||Age||years|Mean|63.95|63.95|Standard Deviation|10.90|10.9|||
4168099|NCT00824005|3988992|B1|||Age||years|Mean|62.32|62.32|Standard Deviation|8.25|8.25|||
4168100|NCT00823979|3989025|B4||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4168101|NCT00823979|3989026|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4168102|NCT00823979|3989027|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4168103|NCT00823979|3989028|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4168104|NCT00823979|3989025|B4||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4168105|NCT00823979|3989026|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4168106|NCT00823979|3989027|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4168107|NCT00823979|3989028|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4168108|NCT00823979|3989025|B4|||Age||years|Mean|41.0|41.0|Standard Deviation|8.9|8.9|||
4168109|NCT00823979|3989026|B3|||Age||years|Mean|41.9|41.9|Standard Deviation|9.1|9.1|||
4168110|NCT00823979|3989027|B2|||Age||years|Mean|40.0|40.0|Standard Deviation|8.7|8.7|||
4168111|NCT00823979|3989028|B1|||Age||years|Mean|41.1|41.1|Standard Deviation|8.9|8.9|||
4168112|NCT00823966|3989068|B1|Japan||Region of Enrollment||participants|Number|3|3.0||||||
4168113|NCT00823966|3989068|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4168114|NCT00823966|3989068|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4168115|NCT00823966|3989068|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4168116|NCT00823966|3989068|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4168117|NCT00823966|3989068|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168118|NCT00823901|3989073|B3|United States||Region of Enrollment||participants|Number|83|83.0||||||
4168119|NCT00823901|3989074|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4168120|NCT00823901|3989075|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4168121|NCT00823901|3989073|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4168122|NCT00823901|3989074|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4168123|NCT00823901|3989075|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4168124|NCT00823901|3989073|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4168125|NCT00823901|3989074|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4168126|NCT00823901|3989075|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4168127|NCT00823901|3989073|B3|||Age||years|Mean|52.17|52.17|Standard Deviation|13.74|13.74|||
4168128|NCT00823901|3989074|B2|||Age||years|Mean|51.2|51.2|Standard Deviation|14.0|14.0|||
4168129|NCT00823901|3989075|B1|||Age||years|Mean|53.2|53.2|Standard Deviation|13.6|13.6|||
4168130|NCT00823901|3989073|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4168131|NCT00823901|3989074|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4168132|NCT00823901|3989075|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4168133|NCT00823901|3989073|B3||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
4168134|NCT00823901|3989074|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4168135|NCT00823901|3989075|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4168136|NCT00823901|3989073|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168137|NCT00823901|3989074|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168138|NCT00823901|3989075|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168139|NCT00823836|3989082|B3|||Race/Ethnicity, Customized||participants|Number|302|302.0||||||
4168140|NCT00823836|3989083|B2|||Race/Ethnicity, Customized||participants|Number|146|146.0||||||
4168141|NCT00823836|3989084|B1|||Race/Ethnicity, Customized||participants|Number|156|156.0||||||
4168142|NCT00823836|3989082|B3||Male|Gender||Participants|Count of Participants|128|128.0||||||
4168143|NCT00823836|3989083|B2||Male|Gender||Participants|Count of Participants|65|65.0||||||
4168144|NCT00823836|3989084|B1||Male|Gender||Participants|Count of Participants|63|63.0||||||
4168145|NCT00823836|3989082|B3||Female|Gender||Participants|Count of Participants|174|174.0||||||
4168146|NCT00823836|3989083|B2||Female|Gender||Participants|Count of Participants|81|81.0||||||
4168147|NCT00823836|3989084|B1||Female|Gender||Participants|Count of Participants|93|93.0||||||
4168148|NCT00823836|3989082|B3|||Age||Years|Mean|68.8|68.8|Standard Deviation|8.08|8.08|||
4168149|NCT00823836|3989083|B2|||Age||Years|Mean|68.3|68.3|Standard Deviation|8.22|8.22|||
4168150|NCT00823836|3989084|B1|||Age||Years|Mean|69.3|69.3|Standard Deviation|7.95|7.95|||
4168151|NCT00823823|3989189|B3|United States||Region of Enrollment||participants|Number|202|202.0||||||
4168152|NCT00823823|3989190|B2|United States||Region of Enrollment||participants|Number|101|101.0||||||
4168153|NCT00823823|3989191|B1|United States||Region of Enrollment||participants|Number|101|101.0||||||
4168154|NCT00823823|3989189|B3||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4168155|NCT00823823|3989190|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4168156|NCT00823823|3989191|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4168157|NCT00823823|3989189|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4168158|NCT00823823|3989190|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4168159|NCT00823823|3989191|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4168160|NCT00823823|3989189|B3|||Age||years|Mean|10|10.0|Standard Deviation|3|3.0|||
4168161|NCT00823823|3989190|B2|||Age||years|Mean|10|10.0|Standard Deviation|6|6.0|||
4168162|NCT00823823|3989191|B1|||Age||years|Mean|9|9.0|Standard Deviation|6|6.0|||
4168163|NCT00823823|3989189|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4168164|NCT00823823|3989190|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4168165|NCT00823823|3989191|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4168166|NCT00823823|3989189|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4168167|NCT00823823|3989190|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4168168|NCT00823823|3989191|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4168169|NCT00823823|3989189|B3||<=18 years|Age||Participants|Count of Participants|202|202.0||||||
4168170|NCT00823823|3989190|B2||<=18 years|Age||Participants|Count of Participants|101|101.0||||||
4168171|NCT00823823|3989191|B1||<=18 years|Age||Participants|Count of Participants|101|101.0||||||
4168172|NCT00823797|3989200|B3|United States||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
4168173|NCT00823797|3989201|B2|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4168174|NCT00823797|3989202|B1|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
4168175|NCT00823797|3989200|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4168176|NCT00823797|3989201|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4168177|NCT00823797|3989202|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168178|NCT00823797|3989200|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168179|NCT00823797|3989201|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168180|NCT00823797|3989202|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168181|NCT00823797|3989200|B3||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4168182|NCT00823797|3989201|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4168183|NCT00823797|3989202|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4168184|NCT00823797|3989200|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4168185|NCT00823797|3989201|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168186|NCT00823797|3989202|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4168187|NCT00823797|3989200|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168188|NCT00823797|3989201|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168189|NCT00823797|3989202|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168190|NCT00823797|3989200|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4168191|NCT00823797|3989201|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4168192|NCT00823797|3989202|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4168193|NCT00823797|3989200|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4168194|NCT00823797|3989201|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168195|NCT00823797|3989202|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4168196|NCT00823797|3989200|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168197|NCT00823797|3989201|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168198|NCT00823797|3989202|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168199|NCT00823797|3989200|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4168200|NCT00823797|3989201|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4168201|NCT00823797|3989202|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4168202|NCT00823797|3989200|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4168203|NCT00823797|3989201|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168204|NCT00823797|3989202|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4168205|NCT00823797|3989200|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4168206|NCT00823797|3989201|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4168207|NCT00823797|3989202|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4168208|NCT00823797|3989200|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4168209|NCT00823797|3989201|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4168210|NCT00823797|3989202|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4168211|NCT00823797|3989200|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4168212|NCT00823797|3989201|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4168213|NCT00823797|3989202|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4168214|NCT00823797|3989200|B3||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4168215|NCT00823797|3989201|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4168216|NCT00823797|3989202|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4168217|NCT00823797|3989200|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168218|NCT00823797|3989201|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168219|NCT00823797|3989202|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168236|NCT00823719|3989215|B2|Asian-Japanese/East or South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4168237|NCT00823719|3989216|B1|Asian-Japanese/East or South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4168220|NCT00823719|3989214|B3|Early relapsers/Refractory||Number of participants in the indicated categories per best response to first line treatment|Late relapsers are those participants with a complete response (CR) >12 months after adequate R-CHOP-like first-line treatment. Early relapsers are those participants with a CR <= 12 months and >=28 days prior to study treatment after adequate first-line treatment. Refractory participants are those with a CR <28 days, partial response, stable disease, or progressive disease following first-line treatment.|participants|Number|49|49.0||||||
4168221|NCT00823719|3989215|B2|Early relapsers/Refractory||Number of participants in the indicated categories per best response to first line treatment|Late relapsers are those participants with a complete response (CR) >12 months after adequate R-CHOP-like first-line treatment. Early relapsers are those participants with a CR <= 12 months and >=28 days prior to study treatment after adequate first-line treatment. Refractory participants are those with a CR <28 days, partial response, stable disease, or progressive disease following first-line treatment.|participants|Number|27|27.0||||||
4168222|NCT00823719|3989216|B1|Early relapsers/Refractory||Number of participants in the indicated categories per best response to first line treatment|Late relapsers are those participants with a complete response (CR) >12 months after adequate R-CHOP-like first-line treatment. Early relapsers are those participants with a CR <= 12 months and >=28 days prior to study treatment after adequate first-line treatment. Refractory participants are those with a CR <28 days, partial response, stable disease, or progressive disease following first-line treatment.|participants|Number|22|22.0||||||
4168223|NCT00823719|3989214|B3|Late relapsers||Number of participants in the indicated categories per best response to first line treatment|Late relapsers are those participants with a complete response (CR) >12 months after adequate R-CHOP-like first-line treatment. Early relapsers are those participants with a CR <= 12 months and >=28 days prior to study treatment after adequate first-line treatment. Refractory participants are those with a CR <28 days, partial response, stable disease, or progressive disease following first-line treatment.|participants|Number|12|12.0||||||
4168224|NCT00823719|3989215|B2|Late relapsers||Number of participants in the indicated categories per best response to first line treatment|Late relapsers are those participants with a complete response (CR) >12 months after adequate R-CHOP-like first-line treatment. Early relapsers are those participants with a CR <= 12 months and >=28 days prior to study treatment after adequate first-line treatment. Refractory participants are those with a CR <28 days, partial response, stable disease, or progressive disease following first-line treatment.|participants|Number|8|8.0||||||
4168225|NCT00823719|3989216|B1|Late relapsers||Number of participants in the indicated categories per best response to first line treatment|Late relapsers are those participants with a complete response (CR) >12 months after adequate R-CHOP-like first-line treatment. Early relapsers are those participants with a CR <= 12 months and >=28 days prior to study treatment after adequate first-line treatment. Refractory participants are those with a CR <28 days, partial response, stable disease, or progressive disease following first-line treatment.|participants|Number|4|4.0||||||
4168226|NCT00823719|3989214|B3|2 or 3||Number of participants with the indicated number of risk factors|The secondary age adjusted international prognostic index (SaaIPI) is assessed according to the absence or presence of 3 risk factors (RFs) at the start of Screening: Eastern Cooperative Oncology Group performance status greater than 1, lactate dehydrogenase level greater than the upper level of normal, and Ann Arbor stage II or IV disease. The presence of 0, 1, and 2/ 3 RFs corresponds to an SaaIPI score reflecting low, intermediate, and high risk of disease.|participants|Number|29|29.0||||||
4168227|NCT00823719|3989215|B2|2 or 3||Number of participants with the indicated number of risk factors|The secondary age adjusted international prognostic index (SaaIPI) is assessed according to the absence or presence of 3 risk factors (RFs) at the start of Screening: Eastern Cooperative Oncology Group performance status greater than 1, lactate dehydrogenase level greater than the upper level of normal, and Ann Arbor stage II or IV disease. The presence of 0, 1, and 2/ 3 RFs corresponds to an SaaIPI score reflecting low, intermediate, and high risk of disease.|participants|Number|16|16.0||||||
4168228|NCT00823719|3989216|B1|2 or 3||Number of participants with the indicated number of risk factors|The secondary age adjusted international prognostic index (SaaIPI) is assessed according to the absence or presence of 3 risk factors (RFs) at the start of Screening: Eastern Cooperative Oncology Group performance status greater than 1, lactate dehydrogenase level greater than the upper level of normal, and Ann Arbor stage II or IV disease. The presence of 0, 1, and 2/ 3 RFs corresponds to an SaaIPI score reflecting low, intermediate, and high risk of disease.|participants|Number|13|13.0||||||
4168229|NCT00823719|3989214|B3|0 or 1||Number of participants with the indicated number of risk factors|The secondary age adjusted international prognostic index (SaaIPI) is assessed according to the absence or presence of 3 risk factors (RFs) at the start of Screening: Eastern Cooperative Oncology Group performance status greater than 1, lactate dehydrogenase level greater than the upper level of normal, and Ann Arbor stage II or IV disease. The presence of 0, 1, and 2/ 3 RFs corresponds to an SaaIPI score reflecting low, intermediate, and high risk of disease.|participants|Number|32|32.0||||||
4168230|NCT00823719|3989215|B2|0 or 1||Number of participants with the indicated number of risk factors|The secondary age adjusted international prognostic index (SaaIPI) is assessed according to the absence or presence of 3 risk factors (RFs) at the start of Screening: Eastern Cooperative Oncology Group performance status greater than 1, lactate dehydrogenase level greater than the upper level of normal, and Ann Arbor stage II or IV disease. The presence of 0, 1, and 2/ 3 RFs corresponds to an SaaIPI score reflecting low, intermediate, and high risk of disease.|participants|Number|19|19.0||||||
4168231|NCT00823719|3989216|B1|0 or 1||Number of participants with the indicated number of risk factors|The secondary age adjusted international prognostic index (SaaIPI) is assessed according to the absence or presence of 3 risk factors (RFs) at the start of Screening: Eastern Cooperative Oncology Group performance status greater than 1, lactate dehydrogenase level greater than the upper level of normal, and Ann Arbor stage II or IV disease. The presence of 0, 1, and 2/ 3 RFs corresponds to an SaaIPI score reflecting low, intermediate, and high risk of disease.|participants|Number|13|13.0||||||
4168232|NCT00823719|3989214|B3|White||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
4168233|NCT00823719|3989215|B2|White||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4168234|NCT00823719|3989216|B1|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4168235|NCT00823719|3989214|B3|Asian-Japanese/East or South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4168238|NCT00823719|3989214|B3|Asian-Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4168239|NCT00823719|3989215|B2|Asian-Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4168240|NCT00823719|3989216|B1|Asian-Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4168241|NCT00823719|3989214|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4168242|NCT00823719|3989215|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4168243|NCT00823719|3989216|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4168244|NCT00823719|3989214|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4168245|NCT00823719|3989215|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4168246|NCT00823719|3989216|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4168247|NCT00823719|3989214|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4168248|NCT00823719|3989215|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4168249|NCT00823719|3989216|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4168250|NCT00823719|3989214|B3|||Age||Years|Mean|51.6|51.6|Standard Deviation|13.34|13.34|||
4168251|NCT00823719|3989215|B2|||Age||Years|Mean|53.0|53.0|Standard Deviation|13.02|13.02|||
4168252|NCT00823719|3989216|B1|||Age||Years|Mean|49.7|49.7|Standard Deviation|13.79|13.79|||
4168253|NCT00823615|3989270|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4168254|NCT00823615|3989270|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4168255|NCT00823615|3989270|B1|||Age||years|Mean|47.6|47.6|Standard Deviation|4.7|4.7|||
4168256|NCT00823472|3989279|B3|Netherlands||Region of Enrollment||participants|Number|59|59.0||||||
4168257|NCT00823472|3989280|B2|Netherlands||Region of Enrollment||participants|Number|28|28.0||||||
4168258|NCT00823472|3989281|B1|Netherlands||Region of Enrollment||participants|Number|31|31.0||||||
4168259|NCT00823472|3989279|B3|Belgium||Region of Enrollment||participants|Number|88|88.0||||||
4168260|NCT00823472|3989280|B2|Belgium||Region of Enrollment||participants|Number|39|39.0||||||
4168261|NCT00823472|3989281|B1|Belgium||Region of Enrollment||participants|Number|49|49.0||||||
4168262|NCT00823472|3989279|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4168263|NCT00823472|3989280|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4168264|NCT00823472|3989281|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4168265|NCT00823472|3989279|B3||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4168266|NCT00823472|3989280|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4168267|NCT00823472|3989281|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4168268|NCT00823472|3989279|B3|||Age||years|Mean|31.0|31.0|Standard Deviation|4.0|4.0|||
4168269|NCT00823472|3989280|B2|||Age||years|Mean|31.1|31.1|Standard Deviation|4.4|4.4|||
4168270|NCT00823472|3989281|B1|||Age||years|Mean|31.0|31.0|Standard Deviation|3.5|3.5|||
4168271|NCT00823472|3989279|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4168272|NCT00823472|3989280|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4168273|NCT00823472|3989281|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4168274|NCT00823472|3989279|B3||Between 18 and 65 years|Age||Participants|Count of Participants|147|147.0||||||
4168275|NCT00823472|3989280|B2||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
4168276|NCT00823472|3989281|B1||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4168277|NCT00823472|3989279|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168278|NCT00823472|3989280|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168279|NCT00823472|3989281|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168280|NCT00823303|3989290|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4168281|NCT00823303|3989291|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4168282|NCT00823303|3989292|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4168283|NCT00823303|3989290|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168284|NCT00823303|3989291|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168285|NCT00823303|3989292|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168286|NCT00823303|3989290|B3||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4168287|NCT00823303|3989291|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4168288|NCT00823303|3989292|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4168289|NCT00823303|3989290|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4168290|NCT00823303|3989291|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4168291|NCT00823303|3989292|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4168292|NCT00823303|3989290|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168293|NCT00823303|3989291|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168294|NCT00823303|3989292|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168295|NCT00823303|3989290|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168296|NCT00823303|3989291|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168297|NCT00823303|3989292|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168298|NCT00823303|3989290|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168299|NCT00823303|3989291|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168300|NCT00823303|3989292|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168301|NCT00823303|3989290|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4168302|NCT00823303|3989291|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4168303|NCT00823303|3989292|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4168304|NCT00823303|3989290|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4168305|NCT00823303|3989291|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4168306|NCT00823303|3989292|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4168307|NCT00823303|3989290|B3|||Age||years|Mean|65.6|65.6|Standard Deviation|12.9|12.9|||
4168308|NCT00823303|3989291|B2|||Age||years|Mean|64.7|64.7|Standard Deviation|12.6|12.6|||
4168309|NCT00823303|3989292|B1|||Age||years|Mean|66.6|66.6|Standard Deviation|13.2|13.2|||
4168310|NCT00823264|3989299|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4168311|NCT00823264|3989300|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4168312|NCT00823264|3989301|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4168313|NCT00823264|3989299|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4168314|NCT00823264|3989300|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4168315|NCT00823264|3989301|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4168316|NCT00823264|3989299|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4168317|NCT00823264|3989300|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4168318|NCT00823264|3989301|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4168319|NCT00823264|3989299|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4168320|NCT00823264|3989300|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4168321|NCT00823264|3989301|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4168322|NCT00823264|3989299|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4168323|NCT00823264|3989300|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4168324|NCT00823264|3989301|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4168325|NCT00823264|3989299|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168326|NCT00823264|3989300|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168327|NCT00823264|3989301|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168328|NCT00823212|3989308|B3|TIMI 3||Lesion Characteristic - Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion TIMI 1 - Penetration with minimal perfusion TIMI 2 - Partial perfusion TIMI 3 - Complete perfusion A participant may be treated for >1 lesion, therefore the number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesion|Number|1626|1626.0||||||
4168329|NCT00823212|3989309|B2|TIMI 3||Lesion Characteristic - Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion TIMI 1 - Penetration with minimal perfusion TIMI 2 - Partial perfusion TIMI 3 - Complete perfusion A participant may be treated for >1 lesion, therefore the number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesion|Number|818|818.0||||||
4168330|NCT00823212|3989310|B1|TIMI 3||Lesion Characteristic - Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion TIMI 1 - Penetration with minimal perfusion TIMI 2 - Partial perfusion TIMI 3 - Complete perfusion A participant may be treated for >1 lesion, therefore the number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesion|Number|808|808.0||||||
4168331|NCT00823212|3989308|B3|TIMI 2||Lesion Characteristic - Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion TIMI 1 - Penetration with minimal perfusion TIMI 2 - Partial perfusion TIMI 3 - Complete perfusion A participant may be treated for >1 lesion, therefore the number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesion|Number|56|56.0||||||
4168332|NCT00823212|3989309|B2|TIMI 2||Lesion Characteristic - Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion TIMI 1 - Penetration with minimal perfusion TIMI 2 - Partial perfusion TIMI 3 - Complete perfusion A participant may be treated for >1 lesion, therefore the number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesion|Number|29|29.0||||||
4168333|NCT00823212|3989310|B1|TIMI 2||Lesion Characteristic - Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion TIMI 1 - Penetration with minimal perfusion TIMI 2 - Partial perfusion TIMI 3 - Complete perfusion A participant may be treated for >1 lesion, therefore the number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesion|Number|27|27.0||||||
4168334|NCT00823212|3989308|B3|TIMI 1||Lesion Characteristic - Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion TIMI 1 - Penetration with minimal perfusion TIMI 2 - Partial perfusion TIMI 3 - Complete perfusion A participant may be treated for >1 lesion, therefore the number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesion|Number|11|11.0||||||
4168335|NCT00823212|3989309|B2|TIMI 1||Lesion Characteristic - Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion TIMI 1 - Penetration with minimal perfusion TIMI 2 - Partial perfusion TIMI 3 - Complete perfusion A participant may be treated for >1 lesion, therefore the number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesion|Number|5|5.0||||||
4168365|NCT00823212|3989309|B2|> 90 Degree Bend||Lesion Characteristics|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|13|13.0||||||
4168336|NCT00823212|3989310|B1|TIMI 1||Lesion Characteristic - Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion TIMI 1 - Penetration with minimal perfusion TIMI 2 - Partial perfusion TIMI 3 - Complete perfusion A participant may be treated for >1 lesion, therefore the number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesion|Number|6|6.0||||||
4168337|NCT00823212|3989308|B3|TIMI 0||Lesion Characteristic - Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion TIMI 1 - Penetration with minimal perfusion TIMI 2 - Partial perfusion TIMI 3 - Complete perfusion A participant may be treated for >1 lesion, therefore the number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesion|Number|0|0.0||||||
4168338|NCT00823212|3989309|B2|TIMI 0||Lesion Characteristic - Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion TIMI 1 - Penetration with minimal perfusion TIMI 2 - Partial perfusion TIMI 3 - Complete perfusion A participant may be treated for >1 lesion, therefore the number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesion|Number|0|0.0||||||
4168339|NCT00823212|3989310|B1|TIMI 0||Lesion Characteristic - Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion TIMI 1 - Penetration with minimal perfusion TIMI 2 - Partial perfusion TIMI 3 - Complete perfusion A participant may be treated for >1 lesion, therefore the number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesion|Number|0|0.0||||||
4168340|NCT00823212|3989308|B3|Type C||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A: minimally complex, readily accessible, non-angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, absence of thrombus.~Type B: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial location with presence of thrombus.~Type C: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts,friable lesions"|Lesions|Number|352|352.0||||||
4168341|NCT00823212|3989309|B2|Type C||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A: minimally complex, readily accessible, non-angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, absence of thrombus.~Type B: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial location with presence of thrombus.~Type C: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts,friable lesions"|Lesions|Number|179|179.0||||||
4168342|NCT00823212|3989310|B1|Type C||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A: minimally complex, readily accessible, non-angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, absence of thrombus.~Type B: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial location with presence of thrombus.~Type C: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts,friable lesions"|Lesions|Number|173|173.0||||||
4168343|NCT00823212|3989308|B3|Type B2||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A: minimally complex, readily accessible, non-angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, absence of thrombus.~Type B: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial location with presence of thrombus.~Type C: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts,friable lesions"|Lesions|Number|739|739.0||||||
4168344|NCT00823212|3989309|B2|Type B2||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A: minimally complex, readily accessible, non-angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, absence of thrombus.~Type B: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial location with presence of thrombus.~Type C: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts,friable lesions"|Lesions|Number|378|378.0||||||
4168345|NCT00823212|3989310|B1|Type B2||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A: minimally complex, readily accessible, non-angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, absence of thrombus.~Type B: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial location with presence of thrombus.~Type C: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts,friable lesions"|Lesions|Number|361|361.0||||||
4168346|NCT00823212|3989308|B3|Type B1||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A: minimally complex, readily accessible, non-angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, absence of thrombus.~Type B: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial location with presence of thrombus.~Type C: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts,friable lesions"|Lesions|Number|448|448.0||||||
4168347|NCT00823212|3989309|B2|Type B1||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A: minimally complex, readily accessible, non-angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, absence of thrombus.~Type B: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial location with presence of thrombus.~Type C: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts,friable lesions"|Lesions|Number|223|223.0||||||
4168414|NCT00823212|3989310|B1|History of Cerebrovascular Accident||Comorbidities|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|23|23.0||||||
4168348|NCT00823212|3989310|B1|Type B1||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A: minimally complex, readily accessible, non-angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, absence of thrombus.~Type B: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial location with presence of thrombus.~Type C: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts,friable lesions"|Lesions|Number|225|225.0||||||
4168349|NCT00823212|3989308|B3|Type A||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A: minimally complex, readily accessible, non-angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, absence of thrombus.~Type B: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial location with presence of thrombus.~Type C: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts,friable lesions"|Lesions|Number|154|154.0||||||
4168350|NCT00823212|3989309|B2|Type A||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A: minimally complex, readily accessible, non-angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, absence of thrombus.~Type B: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial location with presence of thrombus.~Type C: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts,friable lesions"|Lesions|Number|72|72.0||||||
4168351|NCT00823212|3989310|B1|Type A||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A: minimally complex, readily accessible, non-angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, absence of thrombus.~Type B: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial location with presence of thrombus.~Type C: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts,friable lesions"|Lesions|Number|82|82.0||||||
4168352|NCT00823212|3989308|B3|Bifurcation||Lesion Characteristics|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|140|140.0||||||
4168353|NCT00823212|3989309|B2|Bifurcation||Lesion Characteristics|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|78|78.0||||||
4168354|NCT00823212|3989310|B1|Bifurcation||Lesion Characteristics|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|62|62.0||||||
4168355|NCT00823212|3989308|B3|Total Occlusion||Lesion Characteristics|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|11|11.0||||||
4168356|NCT00823212|3989309|B2|Total Occlusion||Lesion Characteristics|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|5|5.0||||||
4168357|NCT00823212|3989310|B1|Total Occlusion||Lesion Characteristics|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|6|6.0||||||
4168358|NCT00823212|3989308|B3|Calcification, any||Lesion Characteristics|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|474|474.0||||||
4168359|NCT00823212|3989309|B2|Calcification, any||Lesion Characteristics|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|238|238.0||||||
4168360|NCT00823212|3989310|B1|Calcification, any||Lesion Characteristics|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|236|236.0||||||
4168361|NCT00823212|3989308|B3|Tortuosity, any||Lesion Characteristics|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|134|134.0||||||
4168362|NCT00823212|3989309|B2|Tortuosity, any||Lesion Characteristics|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|72|72.0||||||
4168363|NCT00823212|3989310|B1|Tortuosity, any||Lesion Characteristics|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|62|62.0||||||
4168364|NCT00823212|3989308|B3|> 90 Degree Bend||Lesion Characteristics|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|31|31.0||||||
4168554|NCT00822926|3989460|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4168366|NCT00823212|3989310|B1|> 90 Degree Bend||Lesion Characteristics|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|18|18.0||||||
4168367|NCT00823212|3989308|B3|> 45 Degree Bend||Lesion Characteristics|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|290|290.0||||||
4168368|NCT00823212|3989309|B2|> 45 Degree Bend||Lesion Characteristics|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|148|148.0||||||
4168369|NCT00823212|3989310|B1|> 45 Degree Bend||Lesion Characteristics|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|142|142.0||||||
4168370|NCT00823212|3989308|B3|Eccentric Lesion||Lesion Characteristics|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|931|931.0||||||
4168371|NCT00823212|3989309|B2|Eccentric Lesion||Lesion Characteristics|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|477|477.0||||||
4168372|NCT00823212|3989310|B1|Eccentric Lesion||Lesion Characteristics|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|454|454.0||||||
4168373|NCT00823212|3989308|B3|||Lesion Characteristic-Percent Diameter Stenosis||Percent Diameter Stenosis|Mean|71.86|71.86|Standard Deviation|11.46|11.46|||
4168374|NCT00823212|3989309|B2|||Lesion Characteristic-Percent Diameter Stenosis||Percent Diameter Stenosis|Mean|71.81|71.81|Standard Deviation|11.46|11.46|||
4168375|NCT00823212|3989310|B1|||Lesion Characteristic-Percent Diameter Stenosis||Percent Diameter Stenosis|Mean|71.90|71.9|Standard Deviation|11.47|11.47|||
4168376|NCT00823212|3989308|B3|Lesion Length||Lesion Characteristics||Millimeters|Mean|12.72|12.72|Standard Deviation|5.63|5.63|||
4168377|NCT00823212|3989309|B2|Lesion Length||Lesion Characteristics||Millimeters|Mean|12.95|12.95|Standard Deviation|5.74|5.74|||
4168378|NCT00823212|3989310|B1|Lesion Length||Lesion Characteristics||Millimeters|Mean|12.50|12.5|Standard Deviation|5.51|5.51|||
4168379|NCT00823212|3989308|B3|Minimum Lumen Diameter||Lesion Characteristics||Millimeters|Mean|0.75|0.75|Standard Deviation|0.34|0.34|||
4168380|NCT00823212|3989309|B2|Minimum Lumen Diameter||Lesion Characteristics||Millimeters|Mean|0.75|0.75|Standard Deviation|0.35|0.35|||
4168381|NCT00823212|3989310|B1|Minimum Lumen Diameter||Lesion Characteristics||Millimeters|Mean|0.74|0.74|Standard Deviation|0.34|0.34|||
4168382|NCT00823212|3989308|B3|Reference Vessel Diameter||Lesion Characteristics||Millimeters|Mean|2.65|2.65|Standard Deviation|0.49|0.49|||
4168383|NCT00823212|3989309|B2|Reference Vessel Diameter||Lesion Characteristics||Millimeters|Mean|2.67|2.67|Standard Deviation|0.49|0.49|||
4168384|NCT00823212|3989310|B1|Reference Vessel Diameter||Lesion Characteristics||Millimeters|Mean|2.63|2.63|Standard Deviation|0.49|0.49|||
4168385|NCT00823212|3989308|B3|Distal||Lesion Characteristic: Lesion Location|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|156|156.0||||||
4168386|NCT00823212|3989309|B2|Distal||Lesion Characteristic: Lesion Location|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|84|84.0||||||
4168387|NCT00823212|3989310|B1|Distal||Lesion Characteristic: Lesion Location|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|72|72.0||||||
4168388|NCT00823212|3989308|B3|Mid||Lesion Characteristic: Lesion Location|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|788|788.0||||||
4168389|NCT00823212|3989309|B2|Mid||Lesion Characteristic: Lesion Location|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|387|387.0||||||
4168390|NCT00823212|3989310|B1|Mid||Lesion Characteristic: Lesion Location|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|401|401.0||||||
4168391|NCT00823212|3989308|B3|Proximal||Lesion Characteristic: Lesion Location|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|686|686.0||||||
4168392|NCT00823212|3989309|B2|Proximal||Lesion Characteristic: Lesion Location|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|348|348.0||||||
4168555|NCT00822926|3989461|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4168393|NCT00823212|3989310|B1|Proximal||Lesion Characteristic: Lesion Location|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|338|338.0||||||
4168394|NCT00823212|3989308|B3|Ostial||Lesion Characteristic: Lesion Location|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|63|63.0||||||
4168395|NCT00823212|3989309|B2|Ostial||Lesion Characteristic: Lesion Location|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|33|33.0||||||
4168396|NCT00823212|3989310|B1|Ostial||Lesion Characteristic: Lesion Location|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesions|Number|30|30.0||||||
4168397|NCT00823212|3989308|B3|Right Coronary Artery||Lesion Characteristic: Target Lesion Vessel|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesion|Number|541|541.0||||||
4168398|NCT00823212|3989309|B2|Right Coronary Artery||Lesion Characteristic: Target Lesion Vessel|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesion|Number|273|273.0||||||
4168399|NCT00823212|3989310|B1|Right Coronary Artery||Lesion Characteristic: Target Lesion Vessel|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesion|Number|268|268.0||||||
4168400|NCT00823212|3989308|B3|Left Circumflex Artery||Lesion Characteristic: Target Lesion Vessel|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesion|Number|441|441.0||||||
4168401|NCT00823212|3989309|B2|Left Circumflex Artery||Lesion Characteristic: Target Lesion Vessel|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesion|Number|222|222.0||||||
4168402|NCT00823212|3989310|B1|Left Circumflex Artery||Lesion Characteristic: Target Lesion Vessel|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesion|Number|219|219.0||||||
4168403|NCT00823212|3989308|B3|Left Anterior Descending Artery||Lesion Characteristic: Target Lesion Vessel|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesion|Number|711|711.0||||||
4168404|NCT00823212|3989309|B2|Left Anterior Descending Artery||Lesion Characteristic: Target Lesion Vessel|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesion|Number|357|357.0||||||
4168405|NCT00823212|3989310|B1|Left Anterior Descending Artery||Lesion Characteristic: Target Lesion Vessel|Reported per lesion. The same participant may have been treated for >1 lesion and therefore may be included in more than one category. Thus, the total number of lesions for this baseline measure does not equal the total number of participants in the group.|Lesion|Number|354|354.0||||||
4168406|NCT00823212|3989308|B3|History of Gastrointestinal Bleeding||Comorbidities|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|18|18.0||||||
4168407|NCT00823212|3989309|B2|History of Gastrointestinal Bleeding||Comorbidities|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|10|10.0||||||
4168408|NCT00823212|3989310|B1|History of Gastrointestinal Bleeding||Comorbidities|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|8|8.0||||||
4168409|NCT00823212|3989308|B3|History of Renal Disease||Comorbidities|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|49|49.0||||||
4168410|NCT00823212|3989309|B2|History of Renal Disease||Comorbidities|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|26|26.0||||||
4168411|NCT00823212|3989310|B1|History of Renal Disease||Comorbidities|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|23|23.0||||||
4168412|NCT00823212|3989308|B3|History of Cerebrovascular Accident||Comorbidities|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|50|50.0||||||
4168413|NCT00823212|3989309|B2|History of Cerebrovascular Accident||Comorbidities|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|27|27.0||||||
4168415|NCT00823212|3989308|B3|History of Transient Ischemic Attack||Comorbidities|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|44|44.0||||||
4168416|NCT00823212|3989309|B2|History of Transient Ischemic Attack||Comorbidities|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|31|31.0||||||
4168417|NCT00823212|3989310|B1|History of Transient Ischemic Attack||Comorbidities|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|13|13.0||||||
4168418|NCT00823212|3989308|B3|History of Peripheral Vascular Disease||Comorbidities|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|136|136.0||||||
4168419|NCT00823212|3989309|B2|History of Peripheral Vascular Disease||Comorbidities|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|70|70.0||||||
4168420|NCT00823212|3989310|B1|History of Peripheral Vascular Disease||Comorbidities|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participants|Number|66|66.0||||||
4168421|NCT00823212|3989308|B3|Family History of Coronary Artery Disease||Cardiac Risk Factor|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|793|793.0||||||
4168422|NCT00823212|3989309|B2|Family History of Coronary Artery Disease||Cardiac Risk Factor|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|392|392.0||||||
4168423|NCT00823212|3989310|B1|Family History of Coronary Artery Disease||Cardiac Risk Factor|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|401|401.0||||||
4168424|NCT00823212|3989308|B3|Hypertension Requiring Medication||Cardiac Risk Factor|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|1102|1102.0||||||
4168425|NCT00823212|3989309|B2|Hypertension Requiring Medication||Cardiac Risk Factor|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|544|544.0||||||
4168426|NCT00823212|3989310|B1|Hypertension Requiring Medication||Cardiac Risk Factor|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|558|558.0||||||
4168427|NCT00823212|3989308|B3|Hyperlipidemia Requiring Medication||Cardiac Risk Factor|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|1177|1177.0||||||
4168428|NCT00823212|3989309|B2|Hyperlipidemia Requiring Medication||Cardiac Risk Factor|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|598|598.0||||||
4168429|NCT00823212|3989310|B1|Hyperlipidemia Requiring Medication||Cardiac Risk Factor|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|579|579.0||||||
4168430|NCT00823212|3989308|B3|Medically Treated Diabetes||Cardiac Risk Factor|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|360|360.0||||||
4168431|NCT00823212|3989309|B2|Medically Treated Diabetes||Cardiac Risk Factor|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|169|169.0||||||
4168432|NCT00823212|3989310|B1|Medically Treated Diabetes||Cardiac Risk Factor|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|191|191.0||||||
4168433|NCT00823212|3989308|B3|Smoking, Ever||Cardiac Risk Factor|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|941|941.0||||||
4168434|NCT00823212|3989309|B2|Smoking, Ever||Cardiac Risk Factor|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|493|493.0||||||
4168435|NCT00823212|3989310|B1|Smoking, Ever||Cardiac Risk Factor|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|448|448.0||||||
4168436|NCT00823212|3989308|B3|||Cardiac History-Ejection Fraction||Percent Ejection Fraction|Mean|59.29|59.29|Standard Deviation|9.81|9.81|||
4168437|NCT00823212|3989309|B2|||Cardiac History-Ejection Fraction||Percent Ejection Fraction|Mean|59.53|59.53|Standard Deviation|10.07|10.07|||
4168438|NCT00823212|3989310|B1|||Cardiac History-Ejection Fraction||Percent Ejection Fraction|Mean|59.04|59.04|Standard Deviation|9.54|9.54|||
4168439|NCT00823212|3989308|B3|Silent Ischemia||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|271|271.0||||||
4168556|NCT00822926|3989462|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4168440|NCT00823212|3989309|B2|Silent Ischemia||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|128|128.0||||||
4168441|NCT00823212|3989310|B1|Silent Ischemia||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|143|143.0||||||
4168442|NCT00823212|3989308|B3|Unstable Angina||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|373|373.0||||||
4168443|NCT00823212|3989309|B2|Unstable Angina||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|185|185.0||||||
4168444|NCT00823212|3989310|B1|Unstable Angina||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|188|188.0||||||
4168445|NCT00823212|3989308|B3|Stable Angina||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|937|937.0||||||
4168446|NCT00823212|3989309|B2|Stable Angina||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|474|474.0||||||
4168447|NCT00823212|3989310|B1|Stable Angina||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|463|463.0||||||
4168448|NCT00823212|3989308|B3|Congestive Heart Failure||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|107|107.0||||||
4168449|NCT00823212|3989309|B2|Congestive Heart Failure||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|57|57.0||||||
4168450|NCT00823212|3989310|B1|Congestive Heart Failure||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|50|50.0||||||
4168451|NCT00823212|3989308|B3|Previous Myocardial Infarction (MI)||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|320|320.0||||||
4168452|NCT00823212|3989309|B2|Previous Myocardial Infarction (MI)||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|160|160.0||||||
4168453|NCT00823212|3989310|B1|Previous Myocardial Infarction (MI)||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|160|160.0||||||
4168454|NCT00823212|3989308|B3|Previous Coronary Artery Bypass Graft (CABG)||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|85|85.0||||||
4168455|NCT00823212|3989309|B2|Previous Coronary Artery Bypass Graft (CABG)||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|45|45.0||||||
4168456|NCT00823212|3989310|B1|Previous Coronary Artery Bypass Graft (CABG)||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|40|40.0||||||
4168457|NCT00823212|3989308|B3|Previous Percutaneous Coronary Intervention (PCI)||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|485|485.0||||||
4168458|NCT00823212|3989309|B2|Previous Percutaneous Coronary Intervention (PCI)||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|238|238.0||||||
4168459|NCT00823212|3989310|B1|Previous Percutaneous Coronary Intervention (PCI)||Cardiac History|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|Participant|Number|247|247.0||||||
4168460|NCT00823212|3989308|B3|Pacifica||Region of Enrollment||participants|Number|56|56.0||||||
4168461|NCT00823212|3989309|B2|Pacifica||Region of Enrollment||participants|Number|27|27.0||||||
4168462|NCT00823212|3989310|B1|Pacifica||Region of Enrollment||participants|Number|29|29.0||||||
4168463|NCT00823212|3989308|B3|Europe||Region of Enrollment||participants|Number|562|562.0||||||
4168464|NCT00823212|3989309|B2|Europe||Region of Enrollment||participants|Number|286|286.0||||||
4168465|NCT00823212|3989310|B1|Europe||Region of Enrollment||participants|Number|276|276.0||||||
4168466|NCT00823212|3989308|B3|Japan||Region of Enrollment||participants|Number|124|124.0||||||
4168467|NCT00823212|3989309|B2|Japan||Region of Enrollment||participants|Number|63|63.0||||||
4168468|NCT00823212|3989310|B1|Japan||Region of Enrollment||participants|Number|61|61.0||||||
4168469|NCT00823212|3989308|B3|United States||Region of Enrollment||participants|Number|788|788.0||||||
4168470|NCT00823212|3989309|B2|United States||Region of Enrollment||participants|Number|392|392.0||||||
4168471|NCT00823212|3989310|B1|United States||Region of Enrollment||participants|Number|396|396.0||||||
4168472|NCT00823212|3989308|B3|Not Disclosed||Race/Ethnicity, Customized|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participant|Number|11|11.0||||||
4168473|NCT00823212|3989309|B2|Not Disclosed||Race/Ethnicity, Customized|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participant|Number|5|5.0||||||
4168474|NCT00823212|3989310|B1|Not Disclosed||Race/Ethnicity, Customized|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participant|Number|6|6.0||||||
4168475|NCT00823212|3989308|B3|Maori||Race/Ethnicity, Customized|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participant|Number|1|1.0||||||
4168476|NCT00823212|3989309|B2|Maori||Race/Ethnicity, Customized|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participant|Number|1|1.0||||||
4168477|NCT00823212|3989310|B1|Maori||Race/Ethnicity, Customized|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participant|Number|0|0.0||||||
4168478|NCT00823212|3989308|B3|Other||Race/Ethnicity, Customized|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participant|Number|5|5.0||||||
4168479|NCT00823212|3989309|B2|Other||Race/Ethnicity, Customized|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participant|Number|4|4.0||||||
4168480|NCT00823212|3989310|B1|Other||Race/Ethnicity, Customized|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participant|Number|1|1.0||||||
4168481|NCT00823212|3989308|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participant|Number|7|7.0||||||
4168482|NCT00823212|3989309|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participant|Number|3|3.0||||||
4168483|NCT00823212|3989310|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participant|Number|4|4.0||||||
4168484|NCT00823212|3989308|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participant|Number|7|7.0||||||
4168485|NCT00823212|3989309|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participant|Number|3|3.0||||||
4168486|NCT00823212|3989310|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participant|Number|4|4.0||||||
4168487|NCT00823212|3989308|B3|Black of African heritage||Race/Ethnicity, Customized|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participant|Number|39|39.0||||||
4168488|NCT00823212|3989309|B2|Black of African heritage||Race/Ethnicity, Customized|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participant|Number|18|18.0||||||
4168489|NCT00823212|3989310|B1|Black of African heritage||Race/Ethnicity, Customized|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participant|Number|21|21.0||||||
4168490|NCT00823212|3989308|B3|Asian||Race/Ethnicity, Customized|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participant|Number|143|143.0||||||
4168491|NCT00823212|3989309|B2|Asian||Race/Ethnicity, Customized|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participant|Number|75|75.0||||||
4168492|NCT00823212|3989310|B1|Asian||Race/Ethnicity, Customized|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participant|Number|68|68.0||||||
4168493|NCT00823212|3989308|B3|Hispanic or Latino||Race/Ethnicity, Customized|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participant|Number|28|28.0||||||
4168494|NCT00823212|3989309|B2|Hispanic or Latino||Race/Ethnicity, Customized|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participant|Number|13|13.0||||||
4168495|NCT00823212|3989310|B1|Hispanic or Latino||Race/Ethnicity, Customized|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participant|Number|15|15.0||||||
4168557|NCT00822926|3989460|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4168496|NCT00823212|3989308|B3|Caucasian||Race/Ethnicity, Customized|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participant|Number|1294|1294.0||||||
4168497|NCT00823212|3989309|B2|Caucasian||Race/Ethnicity, Customized|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participant|Number|650|650.0||||||
4168498|NCT00823212|3989310|B1|Caucasian||Race/Ethnicity, Customized|The same participant may be included in more than one category therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participant|Number|644|644.0||||||
4168499|NCT00823212|3989308|B3||Male|Sex: Female, Male||Participants|Count of Participants|1092|1092.0||||||
4168500|NCT00823212|3989309|B2||Male|Sex: Female, Male||Participants|Count of Participants|550|550.0||||||
4168501|NCT00823212|3989310|B1||Male|Sex: Female, Male||Participants|Count of Participants|542|542.0||||||
4168502|NCT00823212|3989308|B3||Female|Sex: Female, Male||Participants|Count of Participants|438|438.0||||||
4168503|NCT00823212|3989309|B2||Female|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4168504|NCT00823212|3989310|B1||Female|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
4168505|NCT00823212|3989308|B3|||Age||years|Mean|63.55|63.55|Standard Deviation|10.28|10.28|||
4168506|NCT00823212|3989309|B2|||Age||years|Mean|63.99|63.99|Standard Deviation|10.27|10.27|||
4168507|NCT00823212|3989310|B1|||Age||years|Mean|63.11|63.11|Standard Deviation|10.28|10.28|||
4168508|NCT00823212|3989308|B3||>=65 years|Age||Participants|Count of Participants|740|740.0||||||
4168509|NCT00823212|3989309|B2||>=65 years|Age||Participants|Count of Participants|391|391.0||||||
4168510|NCT00823212|3989310|B1||>=65 years|Age||Participants|Count of Participants|349|349.0||||||
4168511|NCT00823212|3989308|B3||Between 18 and 65 years|Age||Participants|Count of Participants|790|790.0||||||
4168512|NCT00823212|3989309|B2||Between 18 and 65 years|Age||Participants|Count of Participants|377|377.0||||||
4168513|NCT00823212|3989310|B1||Between 18 and 65 years|Age||Participants|Count of Participants|413|413.0||||||
4168514|NCT00823212|3989308|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168515|NCT00823212|3989309|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168516|NCT00823212|3989310|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168517|NCT00823199|3989393|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4168518|NCT00823199|3989393|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4168519|NCT00823199|3989393|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4168520|NCT00823199|3989393|B1|||Age||years|Mean|38|38.0|Standard Deviation|9.3|9.3|||
4168521|NCT00823199|3989393|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4168522|NCT00823199|3989393|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4168523|NCT00823199|3989393|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168524|NCT00823095|3989399|B1|18 to 65 years||Evidence of a colonized wound on the lower extremity.||participants|Number|3|3.0||||||
4168525|NCT00823095|3989399|B1|>=65 years||Evidence of a colonized wound on the lower extremity.||participants|Number|4|4.0||||||
4168526|NCT00823095|3989399|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4168527|NCT00823095|3989399|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4168528|NCT00823095|3989399|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4168529|NCT00823095|3989399|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4168530|NCT00823095|3989399|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4168531|NCT00823095|3989399|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168532|NCT00823082|3989404|B3|Italy||Region of Enrollment||participants|Number|194|194.0||||||
4168533|NCT00823082|3989405|B2|Italy||Region of Enrollment||participants|Number|94|94.0||||||
4168534|NCT00823082|3989406|B1|Italy||Region of Enrollment||participants|Number|100|100.0||||||
4168535|NCT00823082|3989404|B3||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4168536|NCT00823082|3989405|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4168537|NCT00823082|3989406|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4168538|NCT00823082|3989404|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4168539|NCT00823082|3989405|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4168540|NCT00823082|3989406|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4168541|NCT00823082|3989404|B3|||Age||years|Mean|67.05|67.05|Standard Deviation|10.81|10.81|||
4168542|NCT00823082|3989405|B2|||Age||years|Mean|67.63|67.63|Standard Deviation|11.18|11.18|||
4168543|NCT00823082|3989406|B1|||Age||years|Mean|66.51|66.51|Standard Deviation|10.48|10.48|||
4168544|NCT00823069|3989441|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4168545|NCT00823069|3989441|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4168546|NCT00823069|3989441|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4168547|NCT00823069|3989441|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|8.0|8.0|||
4168548|NCT00823069|3989441|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4168549|NCT00823069|3989441|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4168550|NCT00823069|3989441|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168551|NCT00823043|3989448|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4168552|NCT00823043|3989448|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4168553|NCT00823043|3989448|B1|||Age||years|Mean|70.7|70.7|Standard Deviation|11.4|11.4|||
4168558|NCT00822926|3989461|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4168559|NCT00822926|3989462|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4168560|NCT00822926|3989460|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4168561|NCT00822926|3989461|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4168562|NCT00822926|3989462|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4168563|NCT00822926|3989460|B3|||Age||years|Mean|48.75|48.75|Standard Deviation|5.12|5.12|||
4168564|NCT00822926|3989461|B2|||Age||years|Mean|48.5|48.5|Standard Deviation|7.78|7.78|||
4168565|NCT00822926|3989462|B1|||Age||years|Mean|49|49.0|Standard Deviation|4.24|4.24|||
4168566|NCT00822926|3989460|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4168567|NCT00822926|3989461|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4168568|NCT00822926|3989462|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4168569|NCT00822926|3989460|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4168570|NCT00822926|3989461|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4168571|NCT00822926|3989462|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4168572|NCT00822926|3989460|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168573|NCT00822926|3989461|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168574|NCT00822926|3989462|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168575|NCT00822900|3989475|B3|Severe||Index GCS score at randomization|The index Glasgow Coma Scale (GCS) score is the highest reliable GCS score documented before randomization.The GCS is scored between 3 and 15, 3 being the worst, and 15 the best. A score of 13 or higher correlates with a mild brain injury, 9 to 12 is a moderate injury and 8 or less a severe brain injury.|participants|Number|156|156.0||||||
4168576|NCT00822900|3989476|B2|Severe||Index GCS score at randomization|The index Glasgow Coma Scale (GCS) score is the highest reliable GCS score documented before randomization.The GCS is scored between 3 and 15, 3 being the worst, and 15 the best. A score of 13 or higher correlates with a mild brain injury, 9 to 12 is a moderate injury and 8 or less a severe brain injury.|participants|Number|77|77.0||||||
4168577|NCT00822900|3989477|B1|Severe||Index GCS score at randomization|The index Glasgow Coma Scale (GCS) score is the highest reliable GCS score documented before randomization.The GCS is scored between 3 and 15, 3 being the worst, and 15 the best. A score of 13 or higher correlates with a mild brain injury, 9 to 12 is a moderate injury and 8 or less a severe brain injury.|participants|Number|79|79.0||||||
4168578|NCT00822900|3989475|B3|Moderate to severe||Index GCS score at randomization|The index Glasgow Coma Scale (GCS) score is the highest reliable GCS score documented before randomization.The GCS is scored between 3 and 15, 3 being the worst, and 15 the best. A score of 13 or higher correlates with a mild brain injury, 9 to 12 is a moderate injury and 8 or less a severe brain injury.|participants|Number|472|472.0||||||
4168579|NCT00822900|3989476|B2|Moderate to severe||Index GCS score at randomization|The index Glasgow Coma Scale (GCS) score is the highest reliable GCS score documented before randomization.The GCS is scored between 3 and 15, 3 being the worst, and 15 the best. A score of 13 or higher correlates with a mild brain injury, 9 to 12 is a moderate injury and 8 or less a severe brain injury.|participants|Number|238|238.0||||||
4168580|NCT00822900|3989477|B1|Moderate to severe||Index GCS score at randomization|The index Glasgow Coma Scale (GCS) score is the highest reliable GCS score documented before randomization.The GCS is scored between 3 and 15, 3 being the worst, and 15 the best. A score of 13 or higher correlates with a mild brain injury, 9 to 12 is a moderate injury and 8 or less a severe brain injury.|participants|Number|234|234.0||||||
4168581|NCT00822900|3989475|B3|Moderate||Index GCS score at randomization|The index Glasgow Coma Scale (GCS) score is the highest reliable GCS score documented before randomization.The GCS is scored between 3 and 15, 3 being the worst, and 15 the best. A score of 13 or higher correlates with a mild brain injury, 9 to 12 is a moderate injury and 8 or less a severe brain injury.|participants|Number|254|254.0||||||
4168582|NCT00822900|3989476|B2|Moderate||Index GCS score at randomization|The index Glasgow Coma Scale (GCS) score is the highest reliable GCS score documented before randomization.The GCS is scored between 3 and 15, 3 being the worst, and 15 the best. A score of 13 or higher correlates with a mild brain injury, 9 to 12 is a moderate injury and 8 or less a severe brain injury.|participants|Number|125|125.0||||||
4168583|NCT00822900|3989477|B1|Moderate||Index GCS score at randomization|The index Glasgow Coma Scale (GCS) score is the highest reliable GCS score documented before randomization.The GCS is scored between 3 and 15, 3 being the worst, and 15 the best. A score of 13 or higher correlates with a mild brain injury, 9 to 12 is a moderate injury and 8 or less a severe brain injury.|participants|Number|129|129.0||||||
4168584|NCT00822900|3989475|B3|United States||Region of Enrollment||participants|Number|882|882.0||||||
4168585|NCT00822900|3989476|B2|United States||Region of Enrollment||participants|Number|440|440.0||||||
4168586|NCT00822900|3989477|B1|United States||Region of Enrollment||participants|Number|442|442.0||||||
4168587|NCT00822900|3989475|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4168588|NCT00822900|3989476|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4168589|NCT00822900|3989477|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4168590|NCT00822900|3989475|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4168591|NCT00822900|3989476|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4168592|NCT00822900|3989477|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4168593|NCT00822900|3989475|B3||White|Race (NIH/OMB)||Participants|Count of Participants|661|661.0||||||
4168594|NCT00822900|3989476|B2||White|Race (NIH/OMB)||Participants|Count of Participants|331|331.0||||||
4168595|NCT00822900|3989477|B1||White|Race (NIH/OMB)||Participants|Count of Participants|330|330.0||||||
4168596|NCT00822900|3989475|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
4168597|NCT00822900|3989476|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4168598|NCT00822900|3989477|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4168599|NCT00822900|3989475|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4168600|NCT00822900|3989476|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4168601|NCT00822900|3989477|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4168602|NCT00822900|3989475|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4168603|NCT00822900|3989476|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4168604|NCT00822900|3989477|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4168605|NCT00822900|3989475|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4168606|NCT00822900|3989476|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4168607|NCT00822900|3989477|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4168608|NCT00822900|3989475|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4168609|NCT00822900|3989476|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4168610|NCT00822900|3989477|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4168611|NCT00822900|3989475|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|690|690.0||||||
4168612|NCT00822900|3989476|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|343|343.0||||||
4168613|NCT00822900|3989477|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|347|347.0||||||
4168614|NCT00822900|3989475|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
4168615|NCT00822900|3989476|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4168616|NCT00822900|3989477|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4168617|NCT00822900|3989475|B3||Male|Sex: Female, Male||Participants|Count of Participants|650|650.0||||||
4168618|NCT00822900|3989476|B2||Male|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
4168619|NCT00822900|3989477|B1||Male|Sex: Female, Male||Participants|Count of Participants|324|324.0||||||
4168620|NCT00822900|3989475|B3||Female|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
4168621|NCT00822900|3989476|B2||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4168622|NCT00822900|3989477|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4168623|NCT00822900|3989475|B3|||Age||years|Mean|39|39.0|Standard Deviation|18|18.0|||
4168624|NCT00822900|3989476|B2|||Age||years|Mean|38|38.0|Standard Deviation|17|17.0|||
4168625|NCT00822900|3989477|B1|||Age||years|Mean|39|39.0|Standard Deviation|18|18.0|||
4168626|NCT00822770|3989506|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
4168627|NCT00822770|3989506|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4168628|NCT00822770|3989506|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4168629|NCT00822770|3989506|B1|||Age||years|Median|56|56.0|Full Range|||25.0|65.0|
4168630|NCT00822757|3989510|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4168631|NCT00822757|3989511|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4168632|NCT00822757|3989512|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4168633|NCT00822757|3989510|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4168634|NCT00822757|3989511|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4168635|NCT00822757|3989512|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4168636|NCT00822757|3989510|B3|70 to 80 years of age||Age, Customized||participants|Number|11|11.0||||||
4168637|NCT00822757|3989511|B2|70 to 80 years of age||Age, Customized||participants|Number|0|0.0||||||
4168638|NCT00822757|3989512|B1|70 to 80 years of age||Age, Customized||participants|Number|11|11.0||||||
4168639|NCT00822757|3989510|B3|60 to 69 years of age||Age, Customized||participants|Number|15|15.0||||||
4168640|NCT00822757|3989511|B2|60 to 69 years of age||Age, Customized||participants|Number|5|5.0||||||
4168641|NCT00822757|3989512|B1|60 to 69 years of age||Age, Customized||participants|Number|10|10.0||||||
4168642|NCT00822757|3989510|B3|50 to 59 years of age||Age, Customized||participants|Number|1|1.0||||||
4168643|NCT00822757|3989511|B2|50 to 59 years of age||Age, Customized||participants|Number|0|0.0||||||
4168644|NCT00822757|3989512|B1|50 to 59 years of age||Age, Customized||participants|Number|1|1.0||||||
4168645|NCT00822757|3989510|B3|40 to 49 years of age||Age, Customized||participants|Number|12|12.0||||||
4168646|NCT00822757|3989511|B2|40 to 49 years of age||Age, Customized||participants|Number|4|4.0||||||
4168647|NCT00822757|3989512|B1|40 to 49 years of age||Age, Customized||participants|Number|8|8.0||||||
4168648|NCT00822757|3989510|B3|30 to 39 years of age||Age, Customized||participants|Number|5|5.0||||||
4168649|NCT00822757|3989511|B2|30 to 39 years of age||Age, Customized||participants|Number|0|0.0||||||
4168650|NCT00822757|3989512|B1|30 to 39 years of age||Age, Customized||participants|Number|5|5.0||||||
4168651|NCT00822757|3989510|B3|18 to 29 years of age||Age, Customized||participants|Number|7|7.0||||||
4168652|NCT00822757|3989511|B2|18 to 29 years of age||Age, Customized||participants|Number|1|1.0||||||
4168653|NCT00822757|3989512|B1|18 to 29 years of age||Age, Customized||participants|Number|6|6.0||||||
4168654|NCT00822757|3989510|B3|17 years of age and under||Age, Customized||participants|Number|0|0.0||||||
4168655|NCT00822757|3989511|B2|17 years of age and under||Age, Customized||participants|Number|0|0.0||||||
4168656|NCT00822757|3989512|B1|17 years of age and under||Age, Customized||participants|Number|0|0.0||||||
4168657|NCT00822692|3989523|B3|United States||Region of Enrollment||participants|Number|139|139.0||||||
4168658|NCT00822692|3989524|B2|United States||Region of Enrollment||participants|Number|76|76.0||||||
4168659|NCT00822692|3989525|B1|United States||Region of Enrollment||participants|Number|63|63.0||||||
4168660|NCT00822692|3989523|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4168661|NCT00822692|3989524|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4168662|NCT00822692|3989525|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4168663|NCT00822692|3989523|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4168664|NCT00822692|3989524|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4168665|NCT00822692|3989525|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4168666|NCT00822692|3989523|B3|||Age||years|Mean|31.06|31.06|Standard Deviation|13|13.0|||
4168667|NCT00822692|3989524|B2|||Age||years|Mean|30.6|30.6|Standard Deviation|13|13.0|||
4168668|NCT00822692|3989525|B1|||Age||years|Mean|31.6|31.6|Standard Deviation|13|13.0|||
4168669|NCT00822692|3989523|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4168670|NCT00822692|3989524|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4168671|NCT00822692|3989525|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4168672|NCT00822692|3989523|B3||Between 18 and 65 years|Age||Participants|Count of Participants|139|139.0||||||
4168673|NCT00822692|3989524|B2||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
4168674|NCT00822692|3989525|B1||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4168675|NCT00822692|3989523|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168676|NCT00822692|3989524|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168677|NCT00822692|3989525|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168678|NCT00822588|3989541|B3|Netherlands||Region of Enrollment||participants|Number|168|168.0||||||
4168679|NCT00822588|3989542|B2|Netherlands||Region of Enrollment||participants|Number|86|86.0||||||
4168680|NCT00822588|3989543|B1|Netherlands||Region of Enrollment||participants|Number|82|82.0||||||
4168681|NCT00822588|3989541|B3|Norway||Region of Enrollment||participants|Number|13|13.0||||||
4168682|NCT00822588|3989542|B2|Norway||Region of Enrollment||participants|Number|6|6.0||||||
4168683|NCT00822588|3989543|B1|Norway||Region of Enrollment||participants|Number|7|7.0||||||
4168684|NCT00822588|3989541|B3|Austria||Region of Enrollment||participants|Number|25|25.0||||||
4168685|NCT00822588|3989542|B2|Austria||Region of Enrollment||participants|Number|13|13.0||||||
4168686|NCT00822588|3989543|B1|Austria||Region of Enrollment||participants|Number|12|12.0||||||
4168687|NCT00822588|3989541|B3|Spain||Region of Enrollment||participants|Number|10|10.0||||||
4168688|NCT00822588|3989542|B2|Spain||Region of Enrollment||participants|Number|5|5.0||||||
4168689|NCT00822588|3989543|B1|Spain||Region of Enrollment||participants|Number|5|5.0||||||
4168690|NCT00822588|3989541|B3||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4168691|NCT00822588|3989542|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4168692|NCT00822588|3989543|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4168693|NCT00822588|3989541|B3||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4168694|NCT00822588|3989542|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4168695|NCT00822588|3989543|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4168696|NCT00822588|3989541|B3|||Age||years|Mean|66|66.0|Standard Deviation|11|11.0|||
4168697|NCT00822588|3989542|B2|||Age||years|Mean|65|65.0|Standard Deviation|12|12.0|||
4168698|NCT00822588|3989543|B1|||Age||years|Mean|67|67.0|Standard Deviation|11|11.0|||
4168699|NCT00822588|3989541|B3||>=65 years|Age||Participants|Count of Participants|123|123.0||||||
4168700|NCT00822588|3989542|B2||>=65 years|Age||Participants|Count of Participants|61|61.0||||||
4168701|NCT00822588|3989543|B1||>=65 years|Age||Participants|Count of Participants|62|62.0||||||
4168702|NCT00822588|3989541|B3||Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
4168703|NCT00822588|3989542|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4168704|NCT00822588|3989543|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4168705|NCT00822588|3989541|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168706|NCT00822588|3989542|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168707|NCT00822588|3989543|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168708|NCT00822523|3989550|B4|United States||Region of Enrollment||participants|Number|13|13.0||||||
4168709|NCT00822523|3989551|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4168710|NCT00822523|3989552|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4168711|NCT00822523|3989553|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4168712|NCT00822523|3989550|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4168713|NCT00822523|3989551|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4168714|NCT00822523|3989552|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4168715|NCT00822523|3989553|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4168716|NCT00822523|3989550|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4168717|NCT00822523|3989551|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4168718|NCT00822523|3989552|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4168719|NCT00822523|3989553|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4168720|NCT00822523|3989550|B4|||Age||years|Mean|29.2|29.2|Standard Deviation|2.3|2.3|||
4168721|NCT00822523|3989551|B3|||Age||years|Mean|29.5|29.5|Standard Deviation|2.0|2.0|||
4168722|NCT00822523|3989552|B2|||Age||years|Mean|26.8|26.8|Standard Deviation|2.1|2.1|||
4168723|NCT00822523|3989553|B1|||Age||years|Mean|31|31.0|Standard Deviation|5.9|5.9|||
4168724|NCT00822523|3989550|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4168725|NCT00822523|3989551|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4168726|NCT00822523|3989552|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4168727|NCT00822523|3989553|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4168728|NCT00822523|3989550|B4||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4168729|NCT00822523|3989551|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4168730|NCT00822523|3989552|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4168731|NCT00822523|3989553|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4168732|NCT00822523|3989550|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168733|NCT00822523|3989551|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168734|NCT00822523|3989552|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168735|NCT00822523|3989553|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168736|NCT00822510|3989599|B3|United States||Region of Enrollment||participants|Number|79|79.0||||||
4168737|NCT00822510|3989600|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
4168738|NCT00822510|3989601|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4168739|NCT00822510|3989599|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4168740|NCT00822510|3989600|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4168741|NCT00822510|3989601|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168742|NCT00822510|3989599|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168743|NCT00822510|3989600|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168744|NCT00822510|3989601|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168745|NCT00822510|3989599|B3||White|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
4168746|NCT00822510|3989600|B2||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4168747|NCT00822510|3989601|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4168748|NCT00822510|3989599|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4168749|NCT00822510|3989600|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4168750|NCT00822510|3989601|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4168751|NCT00822510|3989599|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168752|NCT00822510|3989600|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168753|NCT00822510|3989601|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168754|NCT00822510|3989599|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168755|NCT00822510|3989600|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168756|NCT00822510|3989601|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168757|NCT00822510|3989599|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168758|NCT00822510|3989600|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168759|NCT00822510|3989601|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168760|NCT00822510|3989599|B3||Male|Sex: Female, Male|Participants were asked if they were male or female|Participants|Count of Participants|79|79.0||||||
4168761|NCT00822510|3989600|B2||Male|Sex: Female, Male|Participants were asked if they were male or female|Participants|Count of Participants|41|41.0||||||
4168762|NCT00822510|3989601|B1||Male|Sex: Female, Male|Participants were asked if they were male or female|Participants|Count of Participants|38|38.0||||||
4168763|NCT00822510|3989599|B3||Female|Sex: Female, Male|Participants were asked if they were male or female|Participants|Count of Participants|0|0.0||||||
4168764|NCT00822510|3989600|B2||Female|Sex: Female, Male|Participants were asked if they were male or female|Participants|Count of Participants|0|0.0||||||
4168765|NCT00822510|3989601|B1||Female|Sex: Female, Male|Participants were asked if they were male or female|Participants|Count of Participants|0|0.0||||||
4168766|NCT00822510|3989599|B3|||Age||years|Mean|66.9|66.9|Standard Deviation|9.6|9.6|||
4168767|NCT00822510|3989600|B2|||Age||years|Mean|68.3|68.3|Standard Deviation|9.6|9.6|||
4168768|NCT00822510|3989601|B1|||Age||years|Mean|65.7|65.7|Standard Deviation|9.5|9.5|||
4168769|NCT00822354|3989620|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4168770|NCT00822354|3989621|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4168771|NCT00822354|3989622|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4168772|NCT00822354|3989620|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4168773|NCT00822354|3989621|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4168774|NCT00822354|3989622|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4168775|NCT00822354|3989620|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4168776|NCT00822354|3989621|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4168777|NCT00822354|3989622|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4168778|NCT00822354|3989620|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4168779|NCT00822354|3989621|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4168780|NCT00822354|3989622|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4168781|NCT00822354|3989620|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4168782|NCT00822354|3989621|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4168783|NCT00822354|3989622|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4168784|NCT00822354|3989620|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168785|NCT00822354|3989621|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168786|NCT00822354|3989622|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168787|NCT00822328|3989651|B3|Taiwan||Region of Enrollment||participants|Number|24|24.0||||||
4168788|NCT00822328|3989652|B2|Taiwan||Region of Enrollment||participants|Number|12|12.0||||||
4168789|NCT00822328|3989653|B1|Taiwan||Region of Enrollment||participants|Number|12|12.0||||||
4168790|NCT00822328|3989651|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4168791|NCT00822328|3989652|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4168792|NCT00822328|3989653|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4168793|NCT00822328|3989651|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4168794|NCT00822328|3989652|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4168795|NCT00822328|3989653|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4168796|NCT00822328|3989651|B3|||Age||years|Mean|31.21|31.21|Standard Deviation|5.17|5.17|||
4168797|NCT00822328|3989652|B2|||Age||years|Mean|32.42|32.42|Standard Deviation|6.33|6.33|||
4168798|NCT00822328|3989653|B1|||Age||years|Mean|30.00|30.0|Standard Deviation|3.54|3.54|||
4168799|NCT00822328|3989651|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4168800|NCT00822328|3989652|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4168801|NCT00822328|3989653|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4168802|NCT00822328|3989651|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4168803|NCT00822328|3989652|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4168804|NCT00822328|3989653|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4168805|NCT00822328|3989651|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168806|NCT00822328|3989652|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168807|NCT00822328|3989653|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168808|NCT00822237|3989662|B3||Male|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
4168809|NCT00822237|3989663|B2||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4168810|NCT00822237|3989664|B1||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4168811|NCT00822237|3989662|B3||Female|Sex: Female, Male||Participants|Count of Participants|296|296.0||||||
4168812|NCT00822237|3989663|B2||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4168813|NCT00822237|3989664|B1||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4168814|NCT00822237|3989662|B3|||Age||months|Mean|13.0|13.0|Standard Deviation|1.83|1.83|||
4168815|NCT00822237|3989663|B2|||Age||months|Mean|13.0|13.0|Standard Deviation|1.83|1.83|||
4168816|NCT00822237|3989664|B1|||Age||months|Mean|13.0|13.0|Standard Deviation|1.83|1.83|||
4168817|NCT00822185|3989670|B6||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4168818|NCT00822185|3989671|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4168819|NCT00822185|3989672|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4168820|NCT00822185|3989673|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4168821|NCT00822185|3989674|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4168822|NCT00822185|3989675|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4168823|NCT00822185|3989670|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4168824|NCT00822185|3989671|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4168825|NCT00822185|3989672|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4168826|NCT00822185|3989673|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4168827|NCT00822185|3989674|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4168828|NCT00822185|3989675|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4168829|NCT00822185|3989670|B6|||Age||years|Mean|26.3|26.3|Standard Deviation|5.6|5.6|||
4168830|NCT00822185|3989671|B5|||Age||years|Mean|26.5|26.5|Standard Deviation|7.7|7.7|||
4168831|NCT00822185|3989672|B4|||Age||years|Mean|26.3|26.3|Standard Deviation|5.1|5.1|||
4168832|NCT00822185|3989673|B3|||Age||years|Mean|26.5|26.5|Standard Deviation|3.5|3.5|||
4168833|NCT00822185|3989674|B2|||Age||years|Mean|23.3|23.3|Standard Deviation|3.4|3.4|||
4168834|NCT00822185|3989675|B1|||Age||years|Mean|28.8|28.8|Standard Deviation|6.5|6.5|||
4168835|NCT00822172|3989744|B3|United States||Region of Enrollment||participants|Number|163|163.0||||||
4168836|NCT00822172|3989745|B2|United States||Region of Enrollment||participants|Number|83|83.0||||||
4168837|NCT00822172|3989746|B1|United States||Region of Enrollment||participants|Number|80|80.0||||||
4168838|NCT00822172|3989744|B3||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4168839|NCT00822172|3989745|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4168840|NCT00822172|3989746|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4168841|NCT00822172|3989744|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4168842|NCT00822172|3989745|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4168843|NCT00822172|3989746|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4168844|NCT00822172|3989744|B3|||Age||years|Mean|66.5|66.5|Standard Deviation|8.74|8.74|||
4168845|NCT00822172|3989745|B2|||Age||years|Mean|67.3|67.3|Standard Deviation|8.00|8.0|||
4168846|NCT00822172|3989746|B1|||Age||years|Mean|65.8|65.8|Standard Deviation|9.39|9.39|||
4168847|NCT00822172|3989744|B3||>=65 years|Age||Participants|Count of Participants|93|93.0||||||
4168848|NCT00822172|3989745|B2||>=65 years|Age||Participants|Count of Participants|56|56.0||||||
4168849|NCT00822172|3989746|B1||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
4168850|NCT00822172|3989744|B3||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4168851|NCT00822172|3989745|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4168852|NCT00822172|3989746|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4168853|NCT00822172|3989744|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168854|NCT00822172|3989745|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168855|NCT00822172|3989746|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168856|NCT00822120|3989753|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4168857|NCT00822120|3989754|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4168858|NCT00822120|3989755|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4168859|NCT00822120|3989753|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4168860|NCT00822120|3989754|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168861|NCT00822120|3989755|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4168862|NCT00822120|3989753|B3||White|Race (NIH/OMB)||Participants|Count of Participants|279|279.0||||||
4168863|NCT00822120|3989754|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4168864|NCT00822120|3989755|B1||White|Race (NIH/OMB)||Participants|Count of Participants|274|274.0||||||
4168865|NCT00822120|3989753|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4168866|NCT00822120|3989754|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4168867|NCT00822120|3989755|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4168868|NCT00822120|3989753|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4168869|NCT00822120|3989754|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168870|NCT00822120|3989755|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4168871|NCT00822120|3989753|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4168872|NCT00822120|3989754|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168873|NCT00822120|3989755|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4168874|NCT00822120|3989753|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168875|NCT00822120|3989754|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168876|NCT00822120|3989755|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168877|NCT00822120|3989753|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4168878|NCT00822120|3989754|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4168879|NCT00822120|3989755|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4168880|NCT00822120|3989753|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|281|281.0||||||
4168881|NCT00822120|3989754|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4168882|NCT00822120|3989755|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|273|273.0||||||
4168883|NCT00822120|3989753|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4168884|NCT00822120|3989754|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4168885|NCT00822120|3989755|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4168886|NCT00822120|3989753|B3||Male|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4168887|NCT00822120|3989754|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4168888|NCT00822120|3989755|B1||Male|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4168889|NCT00822120|3989753|B3||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4168890|NCT00822120|3989754|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4168891|NCT00822120|3989755|B1||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4168892|NCT00822120|3989753|B3|||Age||years|Median|32.4|32.4|Full Range|||18.0|60.0|
4168893|NCT00822120|3989754|B2|||Age||years|Median|44.6|44.6|Full Range|||25.0|50.0|
4168894|NCT00822120|3989755|B1|||Age||years|Median|32.1|32.1|Full Range|||18.0|60.0|
4168895|NCT00822094|3989783|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4168896|NCT00822094|3989784|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4168897|NCT00822094|3989785|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4168898|NCT00822094|3989783|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4168899|NCT00822094|3989784|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4168900|NCT00822094|3989785|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4168901|NCT00822094|3989783|B3|||Age||years|Mean|50.2|50.2|Standard Deviation|11.57|11.57|||
4168902|NCT00822094|3989784|B2|||Age||years|Mean|51.8|51.8|Standard Deviation|11.54|11.54|||
4168903|NCT00822094|3989785|B1|||Age||years|Mean|49.4|49.4|Standard Deviation|11.57|11.57|||
4168904|NCT00821964|3989802|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4168905|NCT00821964|3989802|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4168906|NCT00821964|3989802|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4168907|NCT00821964|3989802|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4168908|NCT00821964|3989802|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168909|NCT00821964|3989802|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168910|NCT00821964|3989802|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168911|NCT00821964|3989802|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168912|NCT00821964|3989802|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168913|NCT00821964|3989802|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4168914|NCT00821964|3989802|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4168915|NCT00821964|3989802|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4168916|NCT00821964|3989802|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4168917|NCT00821964|3989802|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4168918|NCT00821964|3989802|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4168919|NCT00821964|3989802|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168920|NCT00821951|3989811|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4168921|NCT00821951|3989811|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4168922|NCT00821951|3989811|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4168923|NCT00821951|3989811|B1|||Age||years|Mean|68.5|68.5|Standard Deviation|8.2|8.2|||
4168924|NCT00821951|3989811|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4168925|NCT00821951|3989811|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4168926|NCT00821951|3989811|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168927|NCT00821886|3989815|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
4168928|NCT00821886|3989815|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4168929|NCT00821886|3989815|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4168930|NCT00821886|3989815|B1|||Age||years|Median|53|53.0|Full Range|||25.0|83.0|
4168931|NCT00821873|3989822|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4168932|NCT00821873|3989822|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4168933|NCT00821873|3989822|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4168934|NCT00821873|3989822|B1|||Age||years|Mean|33.1|33.1|Standard Deviation|10.2|10.2|||
4168935|NCT00821873|3989822|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4168936|NCT00821873|3989822|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4168937|NCT00821873|3989822|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168938|NCT00821821|3989826|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4168939|NCT00821821|3989827|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4168940|NCT00821821|3989828|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4168941|NCT00821821|3989829|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4168942|NCT00821821|3989826|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4168943|NCT00821821|3989827|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4168944|NCT00821821|3989828|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4168945|NCT00821821|3989829|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4168946|NCT00821821|3989826|B4||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4168947|NCT00821821|3989827|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4168948|NCT00821821|3989828|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4168949|NCT00821821|3989829|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4168950|NCT00821821|3989826|B4||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4168951|NCT00821821|3989827|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4168952|NCT00821821|3989828|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4168953|NCT00821821|3989829|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4168954|NCT00821821|3989826|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168955|NCT00821821|3989827|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168956|NCT00821821|3989828|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168957|NCT00821821|3989829|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168958|NCT00821678|3989841|B3|Other Race/Ethnicity||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4168959|NCT00821678|3989842|B2|Other Race/Ethnicity||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4168960|NCT00821678|3989843|B1|Other Race/Ethnicity||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4168961|NCT00821678|3989841|B3|African American||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
4168962|NCT00821678|3989842|B2|African American||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4168963|NCT00821678|3989843|B1|African American||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4168964|NCT00821678|3989841|B3|Caucasian Hispanic||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4168965|NCT00821678|3989842|B2|Caucasian Hispanic||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4168966|NCT00821678|3989843|B1|Caucasian Hispanic||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4168967|NCT00821678|3989841|B3|Caucasian Non-Hispanic||Race/Ethnicity, Customized||participants|Number|169|169.0||||||
4168968|NCT00821678|3989842|B2|Caucasian Non-Hispanic||Race/Ethnicity, Customized||participants|Number|92|92.0||||||
4168969|NCT00821678|3989843|B1|Caucasian Non-Hispanic||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
4168970|NCT00821678|3989841|B3||Male|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
4168971|NCT00821678|3989842|B2||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4168972|NCT00821678|3989843|B1||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4168973|NCT00821678|3989841|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4168974|NCT00821678|3989842|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4168975|NCT00821678|3989843|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4168976|NCT00821678|3989841|B3|||Age||years|Mean|52.2|52.2|Standard Deviation|13.8|13.8|||
4168977|NCT00821678|3989842|B2|||Age||years|Mean|52.5|52.5|Standard Deviation|13.6|13.6|||
4168978|NCT00821678|3989843|B1|||Age||years|Mean|51.9|51.9|Standard Deviation|14.0|14.0|||
4168979|NCT00821587|3989864|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
4168980|NCT00821587|3989865|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4168981|NCT00821587|3989866|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4168982|NCT00821587|3989864|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4168983|NCT00821587|3989865|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4168984|NCT00821587|3989866|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4168985|NCT00821587|3989864|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4168986|NCT00821587|3989865|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4168987|NCT00821587|3989866|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4168988|NCT00821587|3989864|B3|||Age||years|Mean|53.3|53.3|Standard Deviation|5.9|5.9|||
4168989|NCT00821587|3989865|B2|||Age||years|Mean|52.2|52.2|Standard Deviation|6.4|6.4|||
4168990|NCT00821587|3989866|B1|||Age||years|Mean|54.4|54.4|Standard Deviation|5.4|5.4|||
4168991|NCT00821587|3989864|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4168992|NCT00821587|3989865|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4168993|NCT00821587|3989866|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4168994|NCT00821587|3989864|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4168995|NCT00821587|3989865|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4168996|NCT00821587|3989866|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4168997|NCT00821587|3989864|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168998|NCT00821587|3989865|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4168999|NCT00821587|3989866|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169000|NCT00821509|3989873|B4|Finland||Region of Enrollment||participants|Number|683|683.0||||||
4169001|NCT00821509|3989874|B3|Finland||Region of Enrollment||participants|Number|224|224.0||||||
4169002|NCT00821509|3989875|B2|Finland||Region of Enrollment||participants|Number|202|202.0||||||
4169003|NCT00821509|3989876|B1|Finland||Region of Enrollment||participants|Number|257|257.0||||||
4169004|NCT00821509|3989873|B4||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4169005|NCT00821509|3989874|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4169006|NCT00821509|3989875|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4169007|NCT00821509|3989876|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4169008|NCT00821509|3989873|B4||Female|Sex: Female, Male||Participants|Count of Participants|501|501.0||||||
4169009|NCT00821509|3989874|B3||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4169010|NCT00821509|3989875|B2||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4169011|NCT00821509|3989876|B1||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4169012|NCT00821509|3989873|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4169013|NCT00821509|3989874|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4169014|NCT00821509|3989875|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4169015|NCT00821509|3989876|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4169016|NCT00821509|3989873|B4||Between 18 and 65 years|Age||Participants|Count of Participants|683|683.0||||||
4169017|NCT00821509|3989874|B3||Between 18 and 65 years|Age||Participants|Count of Participants|224|224.0||||||
4169018|NCT00821509|3989875|B2||Between 18 and 65 years|Age||Participants|Count of Participants|202|202.0||||||
4169019|NCT00821509|3989876|B1||Between 18 and 65 years|Age||Participants|Count of Participants|257|257.0||||||
4169020|NCT00821509|3989873|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169021|NCT00821509|3989874|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169022|NCT00821509|3989875|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169023|NCT00821509|3989876|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169024|NCT00821431|3989889|B3|United Kingdom||Region of Enrollment||participants|Number|53|53.0||||||
4169025|NCT00821431|3989890|B2|United Kingdom||Region of Enrollment||participants|Number|30|30.0||||||
4169026|NCT00821431|3989891|B1|United Kingdom||Region of Enrollment||participants|Number|23|23.0||||||
4169027|NCT00821431|3989889|B3|Germany||Region of Enrollment||participants|Number|21|21.0||||||
4169028|NCT00821431|3989890|B2|Germany||Region of Enrollment||participants|Number|12|12.0||||||
4169029|NCT00821431|3989891|B1|Germany||Region of Enrollment||participants|Number|9|9.0||||||
4169030|NCT00821431|3989889|B3|Ireland||Region of Enrollment||participants|Number|10|10.0||||||
4169031|NCT00821431|3989890|B2|Ireland||Region of Enrollment||participants|Number|5|5.0||||||
4169032|NCT00821431|3989891|B1|Ireland||Region of Enrollment||participants|Number|5|5.0||||||
4169033|NCT00821431|3989889|B3|France||Region of Enrollment||participants|Number|6|6.0||||||
4169034|NCT00821431|3989890|B2|France||Region of Enrollment||participants|Number|5|5.0||||||
4169035|NCT00821431|3989891|B1|France||Region of Enrollment||participants|Number|1|1.0||||||
4169036|NCT00821431|3989889|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4169037|NCT00821431|3989890|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4169038|NCT00821431|3989891|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4169039|NCT00821431|3989889|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4169040|NCT00821431|3989890|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4169041|NCT00821431|3989891|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4169042|NCT00821431|3989889|B3|||Age||years|Mean|61.89|61.89|Standard Deviation|15.90|15.9|||
4169043|NCT00821431|3989890|B2|||Age||years|Mean|62.6|62.6|Standard Deviation|15.41|15.41|||
4169044|NCT00821431|3989891|B1|||Age||years|Mean|60.9|60.9|Standard Deviation|16.72|16.72|||
4169045|NCT00821327|3989900|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4169046|NCT00821327|3989900|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4169047|NCT00821327|3989900|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4169048|NCT00821327|3989900|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4169049|NCT00821327|3989900|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4169050|NCT00821327|3989900|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4169051|NCT00821327|3989900|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4169052|NCT00821327|3989900|B1|||Age||years|Mean|64.0|64.0|Standard Deviation|9.7|9.7|||
4169053|NCT00821236|3989906|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4169054|NCT00821236|3989907|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4169055|NCT00821236|3989908|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4169056|NCT00821236|3989909|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4169057|NCT00821236|3989906|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4169058|NCT00821236|3989907|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4169059|NCT00821236|3989908|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4169060|NCT00821236|3989909|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4169061|NCT00821236|3989906|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4169062|NCT00821236|3989907|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4169063|NCT00821236|3989908|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4169064|NCT00821236|3989909|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4169065|NCT00821236|3989906|B4||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4169066|NCT00821236|3989907|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4169067|NCT00821236|3989908|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4169068|NCT00821236|3989909|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4169069|NCT00821236|3989906|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169070|NCT00821236|3989907|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169071|NCT00821236|3989908|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169072|NCT00821236|3989909|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169073|NCT00821184|3989923|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4169074|NCT00821184|3989924|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4169075|NCT00821184|3989925|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4169076|NCT00821184|3989923|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4169077|NCT00821184|3989924|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4169078|NCT00821184|3989925|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4169079|NCT00821184|3989923|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4169080|NCT00821184|3989924|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4169081|NCT00821184|3989925|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4169082|NCT00821184|3989923|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4169083|NCT00821184|3989924|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4169084|NCT00821184|3989925|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4169085|NCT00821184|3989923|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4169086|NCT00821184|3989924|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4169087|NCT00821184|3989925|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4169088|NCT00821184|3989923|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169089|NCT00821184|3989924|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169090|NCT00821184|3989925|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169091|NCT00821119|3989934|B3|Brazil||Region of Enrollment||participants|Number|200|200.0||||||
4169092|NCT00821119|3989935|B2|Brazil||Region of Enrollment||participants|Number|100|100.0||||||
4169093|NCT00821119|3989936|B1|Brazil||Region of Enrollment||participants|Number|100|100.0||||||
4169094|NCT00821119|3989934|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4169095|NCT00821119|3989935|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4169096|NCT00821119|3989936|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4169097|NCT00821119|3989934|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4169098|NCT00821119|3989935|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4169099|NCT00821119|3989936|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4169100|NCT00821119|3989934|B3|||Age||weeks of gestation|Mean|30|30.0|Standard Deviation|1.2|1.2|||
4169101|NCT00821119|3989935|B2|||Age||weeks of gestation|Mean|29|29.0|Standard Deviation|1.6|1.6|||
4169102|NCT00821119|3989936|B1|||Age||weeks of gestation|Mean|30.1|30.1|Standard Deviation|2.3|2.3|||
4169103|NCT00821119|3989934|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4169104|NCT00821119|3989935|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4169105|NCT00821119|3989936|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4169106|NCT00821119|3989934|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4169107|NCT00821119|3989935|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4169108|NCT00821119|3989936|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4169109|NCT00821119|3989934|B3||<=18 years|Age||Participants|Count of Participants|200|200.0||||||
4169110|NCT00821119|3989935|B2||<=18 years|Age||Participants|Count of Participants|100|100.0||||||
4169111|NCT00821119|3989936|B1||<=18 years|Age||Participants|Count of Participants|100|100.0||||||
4169112|NCT00821093|3989947|B3||Male|Sex: Female, Male||Participants|Count of Participants|785|785.0||||||
4169113|NCT00821093|3989948|B2||Male|Sex: Female, Male||Participants|Count of Participants|415|415.0||||||
4169114|NCT00821093|3989949|B1||Male|Sex: Female, Male||Participants|Count of Participants|370|370.0||||||
4169115|NCT00821093|3989947|B3||Female|Sex: Female, Male||Participants|Count of Participants|336|336.0||||||
4169116|NCT00821093|3989948|B2||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4169117|NCT00821093|3989949|B1||Female|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4169118|NCT00821093|3989947|B3|||Age|Demographic data are based on the safety set of patients.|years|Mean|62.8|62.8|Standard Deviation|8.78|8.78|||
4169119|NCT00821093|3989948|B2|||Age|Demographic data are based on the safety set of patients.|years|Mean|63.2|63.2|Standard Deviation|8.69|8.69|||
4169120|NCT00821093|3989949|B1|||Age|Demographic data are based on the safety set of patients.|years|Mean|62.4|62.4|Standard Deviation|8.86|8.86|||
4169121|NCT00821041|3989958|B3|||Total Sleep Time|Total sleep time is collected from patients self-report weekly sleep diaries. It is the length of time spent in bed minus sleep onset latency and time spent awake in bed.|Hours|Mean|5.58|5.58|Full Range|||1.73|10.8|
4169122|NCT00821041|3989959|B2|||Total Sleep Time|Total sleep time is collected from patients self-report weekly sleep diaries. It is the length of time spent in bed minus sleep onset latency and time spent awake in bed.|Hours|Mean|5.61|5.61|Full Range|||1.73|10.35|
4169123|NCT00821041|3989960|B1|||Total Sleep Time|Total sleep time is collected from patients self-report weekly sleep diaries. It is the length of time spent in bed minus sleep onset latency and time spent awake in bed.|Hours|Mean|5.54|5.54|Full Range|||1.74|10.8|
4169124|NCT00821041|3989958|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4169125|NCT00821041|3989959|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4169126|NCT00821041|3989960|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4169127|NCT00821041|3989958|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4169128|NCT00821041|3989959|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4169129|NCT00821041|3989960|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4169130|NCT00821041|3989958|B3|||Age||Years|Mean|49.54|49.54|Standard Deviation|12.32|12.32|||
4169131|NCT00821041|3989959|B2|||Age||Years|Mean|48.56|48.56|Standard Deviation|11.39|11.39|||
4169132|NCT00821041|3989960|B1|||Age||Years|Mean|50.45|50.45|Standard Deviation|13.26|13.26|||
4169133|NCT00820898|3989969|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169134|NCT00820898|3989969|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169135|NCT00820898|3989969|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4169136|NCT00820898|3989969|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4169137|NCT00820898|3989969|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169138|NCT00820898|3989969|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169139|NCT00820898|3989969|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4169140|NCT00820898|3989969|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4169141|NCT00820898|3989969|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4169142|NCT00820898|3989969|B1||70-79 years|Age, Customized||Participants|Count of Participants|6|6.0||||||
4169143|NCT00820898|3989969|B1||60-69 years|Age, Customized||Participants|Count of Participants|8|8.0||||||
4169144|NCT00820898|3989969|B1||50-59 years|Age, Customized||Participants|Count of Participants|8|8.0||||||
4169145|NCT00820898|3989969|B1||40-49 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
4169146|NCT00820872|3989979|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4169147|NCT00820872|3989979|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169148|NCT00820872|3989979|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4169149|NCT00820872|3989979|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169150|NCT00820872|3989979|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169151|NCT00820872|3989979|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169152|NCT00820872|3989979|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169153|NCT00820872|3989979|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4169154|NCT00820872|3989979|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4169155|NCT00820872|3989979|B1|||Age||Years|Median|54.5|54.5|Full Range|||29.0|70.0|
4169156|NCT00820755|3989983|B1||Male|Sex: Female, Male||Participants|Count of Participants|436|436.0||||||
4169157|NCT00820755|3989983|B1||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4169158|NCT00820755|3989983|B1|||Age||years|Mean|60.4|60.4|Standard Deviation|9.28|9.28|||
4169159|NCT00820664|3990006|B4|||Body Mass Index (BMI)||kg/m^2|Mean|28.05|28.05|Standard Deviation|2.92|2.92|||
4169160|NCT00820664|3990007|B3|||Body Mass Index (BMI)||kg/m^2|Mean|27.43|27.43|Standard Deviation|1.98|1.98|||
4169161|NCT00820664|3990008|B2|||Body Mass Index (BMI)||kg/m^2|Mean|28.69|28.69|Standard Deviation|2.74|2.74|||
4169162|NCT00820664|3990009|B1|||Body Mass Index (BMI)||kg/m^2|Mean|27.87|27.87|Standard Deviation|3.95|3.95|||
4169163|NCT00820664|3990006|B4|White||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4169164|NCT00820664|3990007|B3|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4169165|NCT00820664|3990008|B2|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4169166|NCT00820664|3990009|B1|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4169167|NCT00820664|3990006|B4|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4169168|NCT00820664|3990007|B3|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4169169|NCT00820664|3990008|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4169170|NCT00820664|3990009|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4169171|NCT00820664|3990006|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4169172|NCT00820664|3990007|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4169173|NCT00820664|3990008|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4169174|NCT00820664|3990009|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4169175|NCT00820664|3990006|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4169176|NCT00820664|3990007|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4169177|NCT00820664|3990008|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4169178|NCT00820664|3990009|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4169179|NCT00820664|3990006|B4|||Age||years|Mean|54.41|54.41|Standard Deviation|4.30|4.3|||
4169180|NCT00820664|3990007|B3|||Age||years|Mean|55.33|55.33|Standard Deviation|3.04|3.04|||
4169181|NCT00820664|3990008|B2|||Age||years|Mean|53.91|53.91|Standard Deviation|5.65|5.65|||
4169182|NCT00820664|3990009|B1|||Age||years|Mean|54.11|54.11|Standard Deviation|3.76|3.76|||
4169183|NCT00820612|3990019|B3|United States||Region of Enrollment||participants|Number|602|602.0||||||
4169184|NCT00820612|3990020|B2|United States||Region of Enrollment||participants|Number|295|295.0||||||
4169185|NCT00820612|3990021|B1|United States||Region of Enrollment||participants|Number|307|307.0||||||
4169186|NCT00820612|3990019|B3||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4169187|NCT00820612|3990020|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4169188|NCT00820612|3990021|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4169189|NCT00820612|3990019|B3||Female|Sex: Female, Male||Participants|Count of Participants|476|476.0||||||
4169190|NCT00820612|3990020|B2||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4169191|NCT00820612|3990021|B1||Female|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
4169192|NCT00820612|3990019|B3|||Age||years|Mean|45.3|45.3|Standard Deviation|13.3|13.3|||
4169193|NCT00820612|3990020|B2|||Age||years|Mean|44.5|44.5|Standard Deviation|13.5|13.5|||
4169194|NCT00820612|3990021|B1|||Age||years|Mean|46.0|46.0|Standard Deviation|13.1|13.1|||
4169195|NCT00820612|3990019|B3||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
4169196|NCT00820612|3990020|B2||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4169197|NCT00820612|3990021|B1||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4169198|NCT00820612|3990019|B3||Between 18 and 65 years|Age||Participants|Count of Participants|552|552.0||||||
4169199|NCT00820612|3990020|B2||Between 18 and 65 years|Age||Participants|Count of Participants|272|272.0||||||
4169200|NCT00820612|3990021|B1||Between 18 and 65 years|Age||Participants|Count of Participants|280|280.0||||||
4169201|NCT00820612|3990019|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169202|NCT00820612|3990020|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169203|NCT00820612|3990021|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169204|NCT00820573|3990028|B5|United States||Region of Enrollment||participants|Number|16|16.0||||||
4169205|NCT00820573|3990029|B4|United States||Region of Enrollment||participants|Number|4|4.0||||||
4169206|NCT00820573|3990030|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4169207|NCT00820573|3990031|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4169208|NCT00820573|3990032|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4169209|NCT00820573|3990028|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4169210|NCT00820573|3990029|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4169211|NCT00820573|3990030|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4169212|NCT00820573|3990031|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4169213|NCT00820573|3990032|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4169214|NCT00820573|3990028|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4169215|NCT00820573|3990029|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4169216|NCT00820573|3990030|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4169217|NCT00820573|3990031|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4169218|NCT00820573|3990032|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4169219|NCT00820573|3990028|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4169220|NCT00820573|3990029|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4169221|NCT00820573|3990030|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4169222|NCT00820573|3990031|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4169223|NCT00820573|3990032|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4169224|NCT00820573|3990028|B5||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4169225|NCT00820573|3990029|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4169226|NCT00820573|3990030|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4169227|NCT00820573|3990031|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4169228|NCT00820573|3990032|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4169229|NCT00820573|3990028|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169230|NCT00820573|3990029|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169231|NCT00820573|3990030|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169232|NCT00820573|3990031|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169233|NCT00820573|3990032|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169234|NCT00820534|3990057|B3|United Kingdom||Region of Enrollment||participants|Number|126|126.0||||||
4169235|NCT00820534|3990058|B2|United Kingdom||Region of Enrollment||participants|Number|62|62.0||||||
4169236|NCT00820534|3990059|B1|United Kingdom||Region of Enrollment||participants|Number|64|64.0||||||
4169237|NCT00820534|3990057|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4169238|NCT00820534|3990058|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4169239|NCT00820534|3990059|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4169240|NCT00820534|3990057|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4169241|NCT00820534|3990058|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4169242|NCT00820534|3990059|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4169243|NCT00820534|3990057|B3|||Age||years|Mean|31.6|31.6|Standard Deviation|10.4|10.4|||
4169244|NCT00820534|3990058|B2|||Age||years|Mean|31.8|31.8|Standard Deviation|9.3|9.3|||
4169245|NCT00820534|3990059|B1|||Age||years|Mean|31.4|31.4|Standard Deviation|11.3|11.3|||
4169246|NCT00820534|3990057|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4169247|NCT00820534|3990058|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4169248|NCT00820534|3990059|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4169249|NCT00820534|3990057|B3||Between 18 and 65 years|Age||Participants|Count of Participants|125|125.0||||||
4169250|NCT00820534|3990058|B2||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4169251|NCT00820534|3990059|B1||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4169252|NCT00820534|3990057|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169253|NCT00820534|3990058|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169254|NCT00820534|3990059|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169255|NCT00820443|3990068|B1|Congenital Hip Dysplasia||Diagnosis||participants|Number|5|5.0||||||
4169256|NCT00820443|3990068|B1|Rheumatoid Arthritis||Diagnosis||participants|Number|3|3.0||||||
4169257|NCT00820443|3990068|B1|Avascular necrosis||Diagnosis||participants|Number|25|25.0||||||
4169258|NCT00820443|3990068|B1|Post-traumatic Arthritis||Diagnosis||participants|Number|4|4.0||||||
4169259|NCT00820443|3990068|B1|Osteo/degenerative arthritis||Diagnosis||participants|Number|216|216.0||||||
4169260|NCT00820443|3990068|B1|Male||Weight||lbs|Mean|205.4|205.4|Standard Deviation|37.3|37.3|||
4169261|NCT00820443|3990068|B1|Female||Weight||lbs|Mean|164.7|164.7|Standard Deviation|31.1|31.1|||
4169262|NCT00820443|3990068|B1|Male||Height||Inches|Mean|70.4|70.4|Standard Deviation|3.0|3.0|||
4169263|NCT00820443|3990068|B1|Female||Height||Inches|Mean|64.2|64.2|Standard Deviation|2.4|2.4|||
4169264|NCT00820443|3990068|B1|Male||BMI||kg/m^(2)|Mean|29.1|29.1|Standard Deviation|4.6|4.6|||
4169265|NCT00820443|3990068|B1|Female||BMI||kg/m^(2)|Mean|28.2|28.2|Standard Deviation|5.2|5.2|||
4169266|NCT00820443|3990068|B1||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4169267|NCT00820443|3990068|B1||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4169268|NCT00820443|3990068|B1|Male||Age||years|Mean|60.3|60.3|Standard Deviation|13.4|13.4|||
4169269|NCT00820443|3990068|B1|Female||Age||years|Mean|60.8|60.8|Standard Deviation|12.9|12.9|||
4169270|NCT00820248|3990076|B3||Yes|Smoking||Participants|Count of Participants|229|229.0||||||
4169271|NCT00820248|3990077|B2||Yes|Smoking||Participants|Count of Participants|116|116.0||||||
4169272|NCT00820248|3990078|B1||Yes|Smoking||Participants|Count of Participants|113|113.0||||||
4169273|NCT00820248|3990076|B3||No|Smoking||Participants|Count of Participants|91|91.0||||||
4169274|NCT00820248|3990077|B2||No|Smoking||Participants|Count of Participants|44|44.0||||||
4169275|NCT00820248|3990078|B1||No|Smoking||Participants|Count of Participants|47|47.0||||||
4169276|NCT00820248|3990076|B3||Hypopharynx|Anatomic Location||Participants|Count of Participants|19|19.0||||||
4169277|NCT00820248|3990077|B2||Hypopharynx|Anatomic Location||Participants|Count of Participants|11|11.0||||||
4169278|NCT00820248|3990078|B1||Hypopharynx|Anatomic Location||Participants|Count of Participants|8|8.0||||||
4169279|NCT00820248|3990076|B3||Larynx|Anatomic Location||Participants|Count of Participants|35|35.0||||||
4169280|NCT00820248|3990077|B2||Larynx|Anatomic Location||Participants|Count of Participants|17|17.0||||||
4169281|NCT00820248|3990078|B1||Larynx|Anatomic Location||Participants|Count of Participants|18|18.0||||||
4169282|NCT00820248|3990076|B3||Oropharynx|Anatomic Location||Participants|Count of Participants|259|259.0||||||
4169283|NCT00820248|3990077|B2||Oropharynx|Anatomic Location||Participants|Count of Participants|127|127.0||||||
4169284|NCT00820248|3990078|B1||Oropharynx|Anatomic Location||Participants|Count of Participants|132|132.0||||||
4169285|NCT00820248|3990076|B3||Oral Cavity|Anatomic Location||Participants|Count of Participants|7|7.0||||||
4169286|NCT00820248|3990077|B2||Oral Cavity|Anatomic Location||Participants|Count of Participants|5|5.0||||||
4169287|NCT00820248|3990078|B1||Oral Cavity|Anatomic Location||Participants|Count of Participants|2|2.0||||||
4169288|NCT00820248|3990076|B3||1|ECOG Performance Status|"Performance Status:~0: Fully active, able to carry on all pre-disease performance without restriction~1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work"|Participants|Count of Participants|94|94.0||||||
4169289|NCT00820248|3990077|B2||1|ECOG Performance Status|"Performance Status:~0: Fully active, able to carry on all pre-disease performance without restriction~1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work"|Participants|Count of Participants|45|45.0||||||
4169290|NCT00820248|3990078|B1||1|ECOG Performance Status|"Performance Status:~0: Fully active, able to carry on all pre-disease performance without restriction~1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work"|Participants|Count of Participants|49|49.0||||||
4169291|NCT00820248|3990076|B3||0|ECOG Performance Status|"Performance Status:~0: Fully active, able to carry on all pre-disease performance without restriction~1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work"|Participants|Count of Participants|226|226.0||||||
4169292|NCT00820248|3990077|B2||0|ECOG Performance Status|"Performance Status:~0: Fully active, able to carry on all pre-disease performance without restriction~1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work"|Participants|Count of Participants|115|115.0||||||
4169293|NCT00820248|3990078|B1||0|ECOG Performance Status|"Performance Status:~0: Fully active, able to carry on all pre-disease performance without restriction~1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work"|Participants|Count of Participants|111|111.0||||||
4169294|NCT00820248|3990076|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169295|NCT00820248|3990077|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169296|NCT00820248|3990078|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169297|NCT00820248|3990076|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169298|NCT00820248|3990077|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169299|NCT00820248|3990078|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169300|NCT00820248|3990076|B3||White|Race (NIH/OMB)||Participants|Count of Participants|308|308.0||||||
4169301|NCT00820248|3990077|B2||White|Race (NIH/OMB)||Participants|Count of Participants|150|150.0||||||
4169302|NCT00820248|3990078|B1||White|Race (NIH/OMB)||Participants|Count of Participants|158|158.0||||||
4169303|NCT00820248|3990076|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4169304|NCT00820248|3990077|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4169305|NCT00820248|3990078|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4169306|NCT00820248|3990076|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169307|NCT00820248|3990077|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169308|NCT00820248|3990078|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169309|NCT00820248|3990076|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4169310|NCT00820248|3990077|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4169311|NCT00820248|3990078|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4169369|NCT00819910|3990116|B5|||Age||years|Mean|56|56.0|Standard Deviation|10.1|10.1|||
4169312|NCT00820248|3990076|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4169313|NCT00820248|3990077|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4169314|NCT00820248|3990078|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169315|NCT00820248|3990076|B3||Male|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
4169316|NCT00820248|3990077|B2||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4169317|NCT00820248|3990078|B1||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4169318|NCT00820248|3990076|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4169319|NCT00820248|3990077|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4169320|NCT00820248|3990078|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4169321|NCT00820248|3990076|B3|||Age||years|Mean|56.54|56.54|Standard Deviation|7.46|7.46|||
4169322|NCT00820248|3990077|B2|||Age||years|Mean|56.40|56.4|Standard Deviation|7.43|7.43|||
4169323|NCT00820248|3990078|B1|||Age||years|Mean|56.68|56.68|Standard Deviation|7.50|7.5|||
4169324|NCT00820222|3990087|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4169325|NCT00820222|3990088|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4169326|NCT00820222|3990089|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4169327|NCT00820222|3990087|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4169328|NCT00820222|3990088|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4169329|NCT00820222|3990089|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4169330|NCT00820222|3990087|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4169331|NCT00820222|3990088|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4169332|NCT00820222|3990089|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4169333|NCT00820222|3990087|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4169334|NCT00820222|3990088|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4169335|NCT00820222|3990089|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4169336|NCT00820222|3990087|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4169337|NCT00820222|3990088|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4169338|NCT00820222|3990089|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4169339|NCT00820222|3990087|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4169340|NCT00820222|3990088|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4169341|NCT00820222|3990089|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4169342|NCT00820222|3990087|B3|White - White/Caucasian/European||Race/Ethnicity, Customized||participants|Number|526|526.0||||||
4169343|NCT00820222|3990088|B2|White - White/Caucasian/European||Race/Ethnicity, Customized||participants|Number|260|260.0||||||
4169344|NCT00820222|3990089|B1|White - White/Caucasian/European||Race/Ethnicity, Customized||participants|Number|266|266.0||||||
4169345|NCT00820222|3990087|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4169346|NCT00820222|3990088|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4169347|NCT00820222|3990089|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4169348|NCT00820222|3990087|B3||Female|Sex: Female, Male||Participants|Count of Participants|540|540.0||||||
4169349|NCT00820222|3990088|B2||Female|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
4169350|NCT00820222|3990089|B1||Female|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
4169351|NCT00820222|3990087|B3|||Age||Years|Mean|54.6|54.6|Standard Deviation|10.30|10.3|||
4169352|NCT00820222|3990088|B2|||Age||Years|Mean|55.8|55.8|Standard Deviation|10.26|10.26|||
4169353|NCT00820222|3990089|B1|||Age||Years|Mean|53.4|53.4|Standard Deviation|10.23|10.23|||
4169354|NCT00819910|3990116|B5|United States||Region of Enrollment||participants|Number|34|34.0||||||
4169355|NCT00819910|3990117|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
4169356|NCT00819910|3990118|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4169357|NCT00819910|3990119|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4169358|NCT00819910|3990120|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4169359|NCT00819910|3990116|B5||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4169360|NCT00819910|3990117|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4169361|NCT00819910|3990118|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4169362|NCT00819910|3990119|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4169363|NCT00819910|3990120|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4169364|NCT00819910|3990116|B5||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4169365|NCT00819910|3990117|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4169366|NCT00819910|3990118|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4169367|NCT00819910|3990119|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4169368|NCT00819910|3990120|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4169370|NCT00819910|3990117|B4|||Age||years|Mean|57.4|57.4|Standard Deviation|11.1|11.1|||
4169371|NCT00819910|3990118|B3|||Age||years|Mean|57.3|57.3|Standard Deviation|8.4|8.4|||
4169372|NCT00819910|3990119|B2|||Age||years|Mean|61.2|61.2|Standard Deviation|11.6|11.6|||
4169373|NCT00819910|3990120|B1|||Age||years|Mean|54.7|54.7|Standard Deviation|9.5|9.5|||
4169374|NCT00819910|3990116|B5||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4169375|NCT00819910|3990117|B4||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4169376|NCT00819910|3990118|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4169377|NCT00819910|3990119|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4169378|NCT00819910|3990120|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4169379|NCT00819910|3990116|B5||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4169380|NCT00819910|3990117|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4169381|NCT00819910|3990118|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4169382|NCT00819910|3990119|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4169383|NCT00819910|3990120|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4169384|NCT00819910|3990116|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169385|NCT00819910|3990117|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169386|NCT00819910|3990118|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169387|NCT00819910|3990119|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169388|NCT00819910|3990120|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169389|NCT00819832|3990149|B7|United States||Region of Enrollment||participants|Number|3|3.0||||||
4169390|NCT00819832|3990155|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4169391|NCT00819832|3990149|B7|Male||Gender||participants|Number|0|0.0||||||
4169392|NCT00819832|3990155|B1|Male||Gender||participants|Number|0|0.0||||||
4169393|NCT00819832|3990149|B7|Female||Gender||participants|Number|3|3.0||||||
4169394|NCT00819832|3990155|B1|Female||Gender||participants|Number|3|3.0||||||
4169395|NCT00819832|3990149|B7|||Age||years|Median|63|63.0|Full Range|||49.0|75.0|
4169396|NCT00819832|3990155|B1|||Age||years|Median|63|63.0|Full Range|||49.0|75.0|
4169397|NCT00819780|3990174|B3|Sample acceptance failure||RAS and BRAF Mutation Status|This analysis was performed on tumors from 136 and 137 participants in each treatment group respectively. BRAF = v-raf murine sarcoma viral oncogene homolog B1; RAS = rat sarcoma viral oncogene homolog, and includes Kirsten rat sarcoma-2 viral oncogene (KRAS) exons 2, 3 & 4 and neuroblastoma RAS viral (v-ras) oncogene (NRAS) exons 2, 3, and 4. Participants may appear in more than one category.|participants|Number|15|15.0||||||
4169398|NCT00819780|3990175|B2|Sample acceptance failure||RAS and BRAF Mutation Status|This analysis was performed on tumors from 136 and 137 participants in each treatment group respectively. BRAF = v-raf murine sarcoma viral oncogene homolog B1; RAS = rat sarcoma viral oncogene homolog, and includes Kirsten rat sarcoma-2 viral oncogene (KRAS) exons 2, 3 & 4 and neuroblastoma RAS viral (v-ras) oncogene (NRAS) exons 2, 3, and 4. Participants may appear in more than one category.|participants|Number|7|7.0||||||
4169399|NCT00819780|3990176|B1|Sample acceptance failure||RAS and BRAF Mutation Status|This analysis was performed on tumors from 136 and 137 participants in each treatment group respectively. BRAF = v-raf murine sarcoma viral oncogene homolog B1; RAS = rat sarcoma viral oncogene homolog, and includes Kirsten rat sarcoma-2 viral oncogene (KRAS) exons 2, 3 & 4 and neuroblastoma RAS viral (v-ras) oncogene (NRAS) exons 2, 3, and 4. Participants may appear in more than one category.|participants|Number|8|8.0||||||
4169400|NCT00819780|3990174|B3|Testing not performed||RAS and BRAF Mutation Status|This analysis was performed on tumors from 136 and 137 participants in each treatment group respectively. BRAF = v-raf murine sarcoma viral oncogene homolog B1; RAS = rat sarcoma viral oncogene homolog, and includes Kirsten rat sarcoma-2 viral oncogene (KRAS) exons 2, 3 & 4 and neuroblastoma RAS viral (v-ras) oncogene (NRAS) exons 2, 3, and 4. Participants may appear in more than one category.|participants|Number|31|31.0||||||
4169401|NCT00819780|3990175|B2|Testing not performed||RAS and BRAF Mutation Status|This analysis was performed on tumors from 136 and 137 participants in each treatment group respectively. BRAF = v-raf murine sarcoma viral oncogene homolog B1; RAS = rat sarcoma viral oncogene homolog, and includes Kirsten rat sarcoma-2 viral oncogene (KRAS) exons 2, 3 & 4 and neuroblastoma RAS viral (v-ras) oncogene (NRAS) exons 2, 3, and 4. Participants may appear in more than one category.|participants|Number|18|18.0||||||
4169402|NCT00819780|3990176|B1|Testing not performed||RAS and BRAF Mutation Status|This analysis was performed on tumors from 136 and 137 participants in each treatment group respectively. BRAF = v-raf murine sarcoma viral oncogene homolog B1; RAS = rat sarcoma viral oncogene homolog, and includes Kirsten rat sarcoma-2 viral oncogene (KRAS) exons 2, 3 & 4 and neuroblastoma RAS viral (v-ras) oncogene (NRAS) exons 2, 3, and 4. Participants may appear in more than one category.|participants|Number|13|13.0||||||
4169403|NCT00819780|3990174|B3|RAS/BRAF wild-type||RAS and BRAF Mutation Status|This analysis was performed on tumors from 136 and 137 participants in each treatment group respectively. BRAF = v-raf murine sarcoma viral oncogene homolog B1; RAS = rat sarcoma viral oncogene homolog, and includes Kirsten rat sarcoma-2 viral oncogene (KRAS) exons 2, 3 & 4 and neuroblastoma RAS viral (v-ras) oncogene (NRAS) exons 2, 3, and 4. Participants may appear in more than one category.|participants|Number|156|156.0||||||
4169404|NCT00819780|3990175|B2|RAS/BRAF wild-type||RAS and BRAF Mutation Status|This analysis was performed on tumors from 136 and 137 participants in each treatment group respectively. BRAF = v-raf murine sarcoma viral oncogene homolog B1; RAS = rat sarcoma viral oncogene homolog, and includes Kirsten rat sarcoma-2 viral oncogene (KRAS) exons 2, 3 & 4 and neuroblastoma RAS viral (v-ras) oncogene (NRAS) exons 2, 3, and 4. Participants may appear in more than one category.|participants|Number|79|79.0||||||
4169444|NCT00819767|3990211|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4169445|NCT00819767|3990209|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4169446|NCT00819767|3990210|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4169405|NCT00819780|3990176|B1|RAS/BRAF wild-type||RAS and BRAF Mutation Status|This analysis was performed on tumors from 136 and 137 participants in each treatment group respectively. BRAF = v-raf murine sarcoma viral oncogene homolog B1; RAS = rat sarcoma viral oncogene homolog, and includes Kirsten rat sarcoma-2 viral oncogene (KRAS) exons 2, 3 & 4 and neuroblastoma RAS viral (v-ras) oncogene (NRAS) exons 2, 3, and 4. Participants may appear in more than one category.|participants|Number|77|77.0||||||
4169406|NCT00819780|3990174|B3|RAS Wild-type||RAS and BRAF Mutation Status|This analysis was performed on tumors from 136 and 137 participants in each treatment group respectively. BRAF = v-raf murine sarcoma viral oncogene homolog B1; RAS = rat sarcoma viral oncogene homolog, and includes Kirsten rat sarcoma-2 viral oncogene (KRAS) exons 2, 3 & 4 and neuroblastoma RAS viral (v-ras) oncogene (NRAS) exons 2, 3, and 4. Participants may appear in more than one category.|participants|Number|170|170.0||||||
4169407|NCT00819780|3990175|B2|RAS Wild-type||RAS and BRAF Mutation Status|This analysis was performed on tumors from 136 and 137 participants in each treatment group respectively. BRAF = v-raf murine sarcoma viral oncogene homolog B1; RAS = rat sarcoma viral oncogene homolog, and includes Kirsten rat sarcoma-2 viral oncogene (KRAS) exons 2, 3 & 4 and neuroblastoma RAS viral (v-ras) oncogene (NRAS) exons 2, 3, and 4. Participants may appear in more than one category.|participants|Number|82|82.0||||||
4169408|NCT00819780|3990176|B1|RAS Wild-type||RAS and BRAF Mutation Status|This analysis was performed on tumors from 136 and 137 participants in each treatment group respectively. BRAF = v-raf murine sarcoma viral oncogene homolog B1; RAS = rat sarcoma viral oncogene homolog, and includes Kirsten rat sarcoma-2 viral oncogene (KRAS) exons 2, 3 & 4 and neuroblastoma RAS viral (v-ras) oncogene (NRAS) exons 2, 3, and 4. Participants may appear in more than one category.|participants|Number|88|88.0||||||
4169409|NCT00819780|3990174|B3|BRAF wild-type||RAS and BRAF Mutation Status|This analysis was performed on tumors from 136 and 137 participants in each treatment group respectively. BRAF = v-raf murine sarcoma viral oncogene homolog B1; RAS = rat sarcoma viral oncogene homolog, and includes Kirsten rat sarcoma-2 viral oncogene (KRAS) exons 2, 3 & 4 and neuroblastoma RAS viral (v-ras) oncogene (NRAS) exons 2, 3, and 4. Participants may appear in more than one category.|participants|Number|211|211.0||||||
4169410|NCT00819780|3990175|B2|BRAF wild-type||RAS and BRAF Mutation Status|This analysis was performed on tumors from 136 and 137 participants in each treatment group respectively. BRAF = v-raf murine sarcoma viral oncogene homolog B1; RAS = rat sarcoma viral oncogene homolog, and includes Kirsten rat sarcoma-2 viral oncogene (KRAS) exons 2, 3 & 4 and neuroblastoma RAS viral (v-ras) oncogene (NRAS) exons 2, 3, and 4. Participants may appear in more than one category.|participants|Number|108|108.0||||||
4169411|NCT00819780|3990176|B1|BRAF wild-type||RAS and BRAF Mutation Status|This analysis was performed on tumors from 136 and 137 participants in each treatment group respectively. BRAF = v-raf murine sarcoma viral oncogene homolog B1; RAS = rat sarcoma viral oncogene homolog, and includes Kirsten rat sarcoma-2 viral oncogene (KRAS) exons 2, 3 & 4 and neuroblastoma RAS viral (v-ras) oncogene (NRAS) exons 2, 3, and 4. Participants may appear in more than one category.|participants|Number|103|103.0||||||
4169412|NCT00819780|3990174|B3|No||Prior Adjuvant Oxaliplatin Therapy||participants|Number|257|257.0||||||
4169413|NCT00819780|3990175|B2|No||Prior Adjuvant Oxaliplatin Therapy||participants|Number|129|129.0||||||
4169414|NCT00819780|3990176|B1|No||Prior Adjuvant Oxaliplatin Therapy||participants|Number|128|128.0||||||
4169415|NCT00819780|3990174|B3|Yes||Prior Adjuvant Oxaliplatin Therapy||participants|Number|28|28.0||||||
4169416|NCT00819780|3990175|B2|Yes||Prior Adjuvant Oxaliplatin Therapy||participants|Number|14|14.0||||||
4169417|NCT00819780|3990176|B1|Yes||Prior Adjuvant Oxaliplatin Therapy||participants|Number|14|14.0||||||
4169418|NCT00819780|3990174|B3|Japanese||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4169419|NCT00819780|3990175|B2|Japanese||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4169420|NCT00819780|3990176|B1|Japanese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4169421|NCT00819780|3990174|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4169422|NCT00819780|3990175|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4169423|NCT00819780|3990176|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4169424|NCT00819780|3990174|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4169425|NCT00819780|3990175|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4169426|NCT00819780|3990176|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4169427|NCT00819780|3990174|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4169428|NCT00819780|3990175|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4169429|NCT00819780|3990176|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4169430|NCT00819780|3990174|B3|White or Caucasian||Race/Ethnicity, Customized||participants|Number|258|258.0||||||
4169431|NCT00819780|3990175|B2|White or Caucasian||Race/Ethnicity, Customized||participants|Number|127|127.0||||||
4169432|NCT00819780|3990176|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|131|131.0||||||
4169433|NCT00819780|3990174|B3||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4169434|NCT00819780|3990175|B2||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4169435|NCT00819780|3990176|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4169436|NCT00819780|3990174|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4169437|NCT00819780|3990175|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4169438|NCT00819780|3990176|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4169439|NCT00819780|3990174|B3|||Age||years|Mean|61.0|61.0|Standard Deviation|10.1|10.1|||
4169440|NCT00819780|3990175|B2|||Age||years|Mean|60.5|60.5|Standard Deviation|9.8|9.8|||
4169441|NCT00819780|3990176|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|10.4|10.4|||
4169442|NCT00819767|3990209|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4169443|NCT00819767|3990210|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4169447|NCT00819767|3990211|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4169448|NCT00819767|3990209|B3|||Age||years|Mean|59|59.0|Standard Deviation|7.4|7.4|||
4169449|NCT00819767|3990210|B2|||Age||years|Mean|60|60.0|Standard Deviation|8.3|8.3|||
4169450|NCT00819767|3990211|B1|||Age||years|Mean|58|58.0|Standard Deviation|6.3|6.3|||
4169451|NCT00819741|3990222|B3|||HbA1c|Glycosylated haemoglobin A1c|percentage (%) of total haemoglobin|Mean|10.82|10.82|Standard Deviation|1.48|1.48|||
4169452|NCT00819741|3990223|B2|||HbA1c|Glycosylated haemoglobin A1c|percentage (%) of total haemoglobin|Mean|10.73|10.73|Standard Deviation|1.50|1.5|||
4169453|NCT00819741|3990224|B1|||HbA1c|Glycosylated haemoglobin A1c|percentage (%) of total haemoglobin|Mean|10.91|10.91|Standard Deviation|1.45|1.45|||
4169454|NCT00819741|3990222|B3|||Duration of diabetes|Number of months since dignosis|months|Mean|0.21|0.21|Standard Deviation|1.22|1.22|||
4169455|NCT00819741|3990223|B2|||Duration of diabetes|Number of months since dignosis|months|Mean|0.28|0.28|Standard Deviation|1.57|1.57|||
4169456|NCT00819741|3990224|B1|||Duration of diabetes|Number of months since dignosis|months|Mean|0.14|0.14|Standard Deviation|0.73|0.73|||
4169457|NCT00819741|3990222|B3|||Weight||kg|Mean|68.3|68.3|Standard Deviation|10.9|10.9|||
4169458|NCT00819741|3990223|B2|||Weight||kg|Mean|68.2|68.2|Standard Deviation|11.0|11.0|||
4169459|NCT00819741|3990224|B1|||Weight||kg|Mean|68.3|68.3|Standard Deviation|10.8|10.8|||
4169460|NCT00819741|3990222|B3|||BMI|BMI (Body Mass Index)|kg/m^2|Mean|24.47|24.47|Standard Deviation|3.00|3.0|||
4169461|NCT00819741|3990223|B2|||BMI|BMI (Body Mass Index)|kg/m^2|Mean|24.44|24.44|Standard Deviation|3.05|3.05|||
4169462|NCT00819741|3990224|B1|||BMI|BMI (Body Mass Index)|kg/m^2|Mean|24.50|24.5|Standard Deviation|2.97|2.97|||
4169463|NCT00819741|3990222|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169464|NCT00819741|3990223|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169465|NCT00819741|3990224|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169466|NCT00819741|3990222|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169467|NCT00819741|3990223|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169468|NCT00819741|3990224|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169469|NCT00819741|3990222|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169470|NCT00819741|3990223|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169471|NCT00819741|3990224|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169472|NCT00819741|3990222|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169473|NCT00819741|3990223|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169474|NCT00819741|3990224|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169475|NCT00819741|3990222|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169476|NCT00819741|3990223|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169477|NCT00819741|3990224|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169478|NCT00819741|3990222|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|432|432.0||||||
4169479|NCT00819741|3990223|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|214|214.0||||||
4169480|NCT00819741|3990224|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|218|218.0||||||
4169481|NCT00819741|3990222|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169482|NCT00819741|3990223|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169483|NCT00819741|3990224|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169484|NCT00819741|3990222|B3||Male|Gender||Participants|Count of Participants|313|313.0||||||
4169485|NCT00819741|3990223|B2||Male|Gender||Participants|Count of Participants|155|155.0||||||
4169486|NCT00819741|3990224|B1||Male|Gender||Participants|Count of Participants|158|158.0||||||
4169487|NCT00819741|3990222|B3||Female|Gender||Participants|Count of Participants|119|119.0||||||
4169488|NCT00819741|3990223|B2||Female|Gender||Participants|Count of Participants|59|59.0||||||
4169489|NCT00819741|3990224|B1||Female|Gender||Participants|Count of Participants|60|60.0||||||
4169490|NCT00819741|3990222|B3|||Age||years|Mean|49.9|49.9|Standard Deviation|10.0|10.0|||
4169491|NCT00819741|3990223|B2|||Age||years|Mean|49.4|49.4|Standard Deviation|10.0|10.0|||
4169492|NCT00819741|3990224|B1|||Age||years|Mean|50.4|50.4|Standard Deviation|9.6|9.6|||
4169493|NCT00819637|3990259|B4|Male||Gender|Age group 18-65 years of age|participants|Number|1|1.0||||||
4169494|NCT00819637|3990262|B1|Male||Gender|Age group 18-65 years of age|participants|Number|1|1.0||||||
4169495|NCT00819637|3990259|B4|Female||Gender|Age group 18-65 years of age|participants|Number|1|1.0||||||
4169496|NCT00819637|3990262|B1|Female||Gender|Age group 18-65 years of age|participants|Number|1|1.0||||||
4169497|NCT00819637|3990259|B4|>=65 years||Age||participants|Number|0|0.0||||||
4169498|NCT00819637|3990262|B1|>=65 years||Age||participants|Number|0|0.0||||||
4169499|NCT00819637|3990259|B4|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
4169500|NCT00819637|3990262|B1|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
4169501|NCT00819637|3990259|B4|<=18 years||Age||participants|Number|0|0.0||||||
4169502|NCT00819637|3990262|B1|<=18 years||Age||participants|Number|0|0.0||||||
4169503|NCT00819585|3990272|B8||Male|Sex: Female, Male||Participants|Count of Participants|405|405.0||||||
4169504|NCT00819585|3990273|B7||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4169505|NCT00819585|3990274|B6||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4169506|NCT00819585|3990275|B5||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4169507|NCT00819585|3990276|B4||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4169508|NCT00819585|3990277|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4169509|NCT00819585|3990278|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4169510|NCT00819585|3990279|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4169511|NCT00819585|3990272|B8||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4169512|NCT00819585|3990273|B7||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4169513|NCT00819585|3990274|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4169514|NCT00819585|3990275|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4169515|NCT00819585|3990276|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4169516|NCT00819585|3990277|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4169517|NCT00819585|3990278|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4169518|NCT00819585|3990279|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4169519|NCT00819585|3990272|B8|||Age||Years|Mean|52.4|52.4|Standard Deviation|11.02|11.02|||
4169520|NCT00819585|3990273|B7|||Age||Years|Mean|52.4|52.4|Standard Deviation|10.69|10.69|||
4169521|NCT00819585|3990274|B6|||Age||Years|Mean|52.8|52.8|Standard Deviation|10.38|10.38|||
4169522|NCT00819585|3990275|B5|||Age||Years|Mean|52.4|52.4|Standard Deviation|11.30|11.3|||
4169523|NCT00819585|3990276|B4|||Age||Years|Mean|52.6|52.6|Standard Deviation|10.78|10.78|||
4169524|NCT00819585|3990277|B3|||Age||Years|Mean|51.3|51.3|Standard Deviation|12.41|12.41|||
4169525|NCT00819585|3990278|B2|||Age||Years|Mean|54.4|54.4|Standard Deviation|12.18|12.18|||
4169526|NCT00819585|3990279|B1|||Age||Years|Mean|50.7|50.7|Standard Deviation|9.72|9.72|||
4169527|NCT00819507|3990360|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4169528|NCT00819507|3990360|B1|Mixed race||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4169529|NCT00819507|3990360|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4169530|NCT00819507|3990360|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4169531|NCT00819507|3990360|B1|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4169532|NCT00819507|3990360|B1|Caucasian, Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
4169533|NCT00819507|3990360|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4169534|NCT00819507|3990360|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4169535|NCT00819507|3990360|B1|||Age||years|Mean|39|39.0|Full Range|||17.0|67.0|
4169536|NCT00819403|3990365|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4169537|NCT00819403|3990366|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4169538|NCT00819403|3990367|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4169539|NCT00819403|3990365|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4169540|NCT00819403|3990366|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4169541|NCT00819403|3990367|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4169542|NCT00819403|3990365|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4169543|NCT00819403|3990366|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4169544|NCT00819403|3990367|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4169545|NCT00819403|3990365|B3|||Age||years|Mean|48.5|48.5|Standard Deviation|10.1|10.1|||
4169546|NCT00819403|3990366|B2|||Age||years|Mean|50.5|50.5|Standard Deviation|12.6|12.6|||
4169547|NCT00819403|3990367|B1|||Age||years|Mean|46.3|46.3|Standard Deviation|6.6|6.6|||
4169548|NCT00819403|3990365|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4169549|NCT00819403|3990366|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4169550|NCT00819403|3990367|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4169551|NCT00819403|3990365|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4169552|NCT00819403|3990366|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4169553|NCT00819403|3990367|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4169554|NCT00819403|3990365|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169555|NCT00819403|3990366|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169556|NCT00819403|3990367|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169557|NCT00819390|3990376|B5|United States||Region of Enrollment||participants|Number|70|70.0||||||
4169558|NCT00819390|3990377|B4|United States||Region of Enrollment||participants|Number|19|19.0||||||
4169559|NCT00819390|3990378|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4169560|NCT00819390|3990379|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4169561|NCT00819390|3990380|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4169562|NCT00819390|3990376|B5||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4169563|NCT00819390|3990377|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4169564|NCT00819390|3990378|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4169565|NCT00819390|3990379|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4169566|NCT00819390|3990380|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4169567|NCT00819390|3990376|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4169568|NCT00819390|3990377|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4169569|NCT00819390|3990378|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4169570|NCT00819390|3990379|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4169571|NCT00819390|3990380|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4169572|NCT00819390|3990376|B5|70-79 years||Age, Customized||participants|Number|1|1.0||||||
4169573|NCT00819390|3990377|B4|70-79 years||Age, Customized||participants|Number|0|0.0||||||
4169574|NCT00819390|3990378|B3|70-79 years||Age, Customized||participants|Number|1|1.0||||||
4169575|NCT00819390|3990379|B2|70-79 years||Age, Customized||participants|Number|0|0.0||||||
4169576|NCT00819390|3990380|B1|70-79 years||Age, Customized||participants|Number|0|0.0||||||
4169577|NCT00819390|3990376|B5|60-69 years||Age, Customized||participants|Number|2|2.0||||||
4169578|NCT00819390|3990377|B4|60-69 years||Age, Customized||participants|Number|2|2.0||||||
4169579|NCT00819390|3990378|B3|60-69 years||Age, Customized||participants|Number|0|0.0||||||
4169580|NCT00819390|3990379|B2|60-69 years||Age, Customized||participants|Number|0|0.0||||||
4169581|NCT00819390|3990380|B1|60-69 years||Age, Customized||participants|Number|0|0.0||||||
4169582|NCT00819390|3990376|B5|50-59 years||Age, Customized||participants|Number|18|18.0||||||
4169583|NCT00819390|3990377|B4|50-59 years||Age, Customized||participants|Number|7|7.0||||||
4169584|NCT00819390|3990378|B3|50-59 years||Age, Customized||participants|Number|10|10.0||||||
4169585|NCT00819390|3990379|B2|50-59 years||Age, Customized||participants|Number|0|0.0||||||
4169586|NCT00819390|3990380|B1|50-59 years||Age, Customized||participants|Number|1|1.0||||||
4169587|NCT00819390|3990376|B5|40-49 years||Age, Customized||participants|Number|25|25.0||||||
4169588|NCT00819390|3990377|B4|40-49 years||Age, Customized||participants|Number|7|7.0||||||
4169589|NCT00819390|3990378|B3|40-49 years||Age, Customized||participants|Number|5|5.0||||||
4169590|NCT00819390|3990379|B2|40-49 years||Age, Customized||participants|Number|8|8.0||||||
4169591|NCT00819390|3990380|B1|40-49 years||Age, Customized||participants|Number|5|5.0||||||
4169592|NCT00819390|3990376|B5|30-39 years||Age, Customized||participants|Number|16|16.0||||||
4169593|NCT00819390|3990377|B4|30-39 years||Age, Customized||participants|Number|3|3.0||||||
4169594|NCT00819390|3990378|B3|30-39 years||Age, Customized||participants|Number|1|1.0||||||
4169595|NCT00819390|3990379|B2|30-39 years||Age, Customized||participants|Number|7|7.0||||||
4169596|NCT00819390|3990380|B1|30-39 years||Age, Customized||participants|Number|5|5.0||||||
4169597|NCT00819390|3990376|B5|18-29 years||Age, Customized||participants|Number|8|8.0||||||
4169598|NCT00819390|3990377|B4|18-29 years||Age, Customized||participants|Number|0|0.0||||||
4169599|NCT00819390|3990378|B3|18-29 years||Age, Customized||participants|Number|1|1.0||||||
4169600|NCT00819390|3990379|B2|18-29 years||Age, Customized||participants|Number|2|2.0||||||
4169601|NCT00819390|3990380|B1|18-29 years||Age, Customized||participants|Number|5|5.0||||||
4169602|NCT00819390|3990376|B5|||Age||years|Median|46|46.0|Inter-Quartile Range|||36.0|50.0|
4169603|NCT00819390|3990377|B4|||Age||years|Median|49|49.0|Inter-Quartile Range|||41.0|56.0|
4169604|NCT00819390|3990378|B3|||Age||years|Median|50|50.0|Inter-Quartile Range|||48.0|55.0|
4169605|NCT00819390|3990379|B2|||Age||years|Median|39|39.0|Inter-Quartile Range|||35.0|44.0|
4169606|NCT00819390|3990380|B1|||Age||years|Median|35|35.0|Inter-Quartile Range|||29.0|43.0|
4169607|NCT00819286|3990493|B3||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4169608|NCT00819286|3990494|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4169609|NCT00819286|3990495|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4169610|NCT00819286|3990493|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4169611|NCT00819286|3990494|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4169612|NCT00819286|3990495|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4169613|NCT00819286|3990493|B3|||Age||years|Mean|65.2|65.2|Standard Deviation|9.4|9.4|||
4169614|NCT00819286|3990494|B2|||Age||years|Mean|66.3|66.3|Standard Deviation|9.8|9.8|||
4169615|NCT00819286|3990495|B1|||Age||years|Mean|64.0|64.0|Standard Deviation|8.9|8.9|||
4169616|NCT00819260|3990504|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4169617|NCT00819260|3990504|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4169618|NCT00819260|3990504|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4169619|NCT00819260|3990504|B1|||Age||years|Median|44|44.0|Full Range|0|0.0|20.0|62.0|
4169620|NCT00819260|3990504|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4169621|NCT00819260|3990504|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4169622|NCT00819260|3990504|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169623|NCT00819247|3990516|B4|||Serum Testosterone level|Testosterone is a steroid hormone from the androgen group, and the principal male sex hormone. This test measures the amount of testosterone in the blood. Androgen deprivation is used to manage prostate cancer.|nanogram/milliliter|Median|4.0|4.0|Full Range|||1.21|8.94|
4169624|NCT00819247|3990517|B3|||Serum Testosterone level|Testosterone is a steroid hormone from the androgen group, and the principal male sex hormone. This test measures the amount of testosterone in the blood. Androgen deprivation is used to manage prostate cancer.|nanogram/milliliter|Median|4.8|4.8|Full Range|||1.58|8.94|
4169625|NCT00819247|3990518|B2|||Serum Testosterone level|Testosterone is a steroid hormone from the androgen group, and the principal male sex hormone. This test measures the amount of testosterone in the blood. Androgen deprivation is used to manage prostate cancer.|nanogram/milliliter|Median|4.1|4.1|Full Range|||1.21|7.84|
4169722|NCT00819234|3990547|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4169626|NCT00819247|3990519|B1|||Serum Testosterone level|Testosterone is a steroid hormone from the androgen group, and the principal male sex hormone. This test measures the amount of testosterone in the blood. Androgen deprivation is used to manage prostate cancer.|nanogram/milliliter|Median|3.7|3.7|Full Range|||2.13|7.63|
4169627|NCT00819247|3990516|B4|||Serum Prostate-Specific Antigen level|Prostate-specific antigen (PSA) is a protein produced by the cells of the prostate gland. The PSA test measures the level of PSA in the blood. High PSA levels have a positive correlation to prostate cancer.|nanogram/milliliter|Median|61.1|61.1|Full Range|||18.1|12500.0|
4169628|NCT00819247|3990517|B3|||Serum Prostate-Specific Antigen level|Prostate-specific antigen (PSA) is a protein produced by the cells of the prostate gland. The PSA test measures the level of PSA in the blood. High PSA levels have a positive correlation to prostate cancer.|nanogram/milliliter|Median|82.9|82.9|Full Range|||23.7|12500.0|
4169629|NCT00819247|3990518|B2|||Serum Prostate-Specific Antigen level|Prostate-specific antigen (PSA) is a protein produced by the cells of the prostate gland. The PSA test measures the level of PSA in the blood. High PSA levels have a positive correlation to prostate cancer.|nanogram/milliliter|Median|64.6|64.6|Full Range|||18.1|2380.0|
4169630|NCT00819247|3990519|B1|||Serum Prostate-Specific Antigen level|Prostate-specific antigen (PSA) is a protein produced by the cells of the prostate gland. The PSA test measures the level of PSA in the blood. High PSA levels have a positive correlation to prostate cancer.|nanogram/milliliter|Median|50.3|50.3|Full Range|||23.2|2580.0|
4169631|NCT00819247|3990516|B4|||Days Since Diagnosis of Prostate Cancer|The number of days passed since a diagnosis of prostate cancer was made for each participant.|days|Mean|99.9|99.9|Standard Deviation|377.2|377.2|||
4169632|NCT00819247|3990517|B3|||Days Since Diagnosis of Prostate Cancer|The number of days passed since a diagnosis of prostate cancer was made for each participant.|days|Mean|88.8|88.8|Standard Deviation|370.0|370.0|||
4169633|NCT00819247|3990518|B2|||Days Since Diagnosis of Prostate Cancer|The number of days passed since a diagnosis of prostate cancer was made for each participant.|days|Mean|153.8|153.8|Standard Deviation|518.1|518.1|||
4169634|NCT00819247|3990519|B1|||Days Since Diagnosis of Prostate Cancer|The number of days passed since a diagnosis of prostate cancer was made for each participant.|days|Mean|52.7|52.7|Standard Deviation|116.0|116.0|||
4169635|NCT00819247|3990516|B4|||Body Mass Index|Body mass index is a measure of body fat based on height and weight|kilogram per square meter|Median|26.1|26.1|Full Range|||17.4|40.9|
4169636|NCT00819247|3990517|B3|||Body Mass Index|Body mass index is a measure of body fat based on height and weight|kilogram per square meter|Median|25.2|25.2|Full Range|||19.8|34.1|
4169637|NCT00819247|3990518|B2|||Body Mass Index|Body mass index is a measure of body fat based on height and weight|kilogram per square meter|Median|26.6|26.6|Full Range|||17.4|40.9|
4169638|NCT00819247|3990519|B1|||Body Mass Index|Body mass index is a measure of body fat based on height and weight|kilogram per square meter|Median|26.2|26.2|Full Range|||18.0|36.4|
4169639|NCT00819247|3990516|B4|Not classifiable||Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|5|5.0||||||
4169640|NCT00819247|3990517|B3|Not classifiable||Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|0|0.0||||||
4169641|NCT00819247|3990518|B2|Not classifiable||Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|2|2.0||||||
4169642|NCT00819247|3990519|B1|Not classifiable||Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|3|3.0||||||
4169643|NCT00819247|3990516|B4|Metastatic||Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|42|42.0||||||
4169644|NCT00819247|3990517|B3|Metastatic||Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|17|17.0||||||
4169645|NCT00819247|3990518|B2|Metastatic||Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|14|14.0||||||
4169646|NCT00819247|3990519|B1|Metastatic||Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|11|11.0||||||
4169647|NCT00819247|3990516|B4|Locally advanced||Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|60|60.0||||||
4169723|NCT00819234|3990547|B1||Female|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4169724|NCT00819234|3990547|B1|||Age||years|Mean|47.3|47.3|Standard Deviation|10.27|10.27|||
4169648|NCT00819247|3990517|B3|Locally advanced||Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|18|18.0||||||
4169649|NCT00819247|3990518|B2|Locally advanced||Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|21|21.0||||||
4169650|NCT00819247|3990519|B1|Locally advanced||Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|21|21.0||||||
4169651|NCT00819247|3990516|B4|Localized||Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|22|22.0||||||
4169652|NCT00819247|3990517|B3|Localized||Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|5|5.0||||||
4169653|NCT00819247|3990518|B2|Localized||Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|9|9.0||||||
4169654|NCT00819247|3990519|B1|Localized||Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|8|8.0||||||
4169655|NCT00819247|3990516|B4|7-10||Participant Counts by Gleason Score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|88|88.0||||||
4169656|NCT00819247|3990517|B3|7-10||Participant Counts by Gleason Score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|26|26.0||||||
4169657|NCT00819247|3990518|B2|7-10||Participant Counts by Gleason Score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|34|34.0||||||
4169658|NCT00819247|3990519|B1|7-10||Participant Counts by Gleason Score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|28|28.0||||||
4169659|NCT00819247|3990516|B4|5-6||Participant Counts by Gleason Score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|29|29.0||||||
4169660|NCT00819247|3990517|B3|5-6||Participant Counts by Gleason Score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|11|11.0||||||
4169661|NCT00819247|3990518|B2|5-6||Participant Counts by Gleason Score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|7|7.0||||||
4169662|NCT00819247|3990519|B1|5-6||Participant Counts by Gleason Score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|11|11.0||||||
4169663|NCT00819247|3990516|B4|2-4||Participant Counts by Gleason Score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|9|9.0||||||
4169664|NCT00819247|3990517|B3|2-4||Participant Counts by Gleason Score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|2|2.0||||||
4169665|NCT00819247|3990518|B2|2-4||Participant Counts by Gleason Score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|4|4.0||||||
4169666|NCT00819247|3990519|B1|2-4||Participant Counts by Gleason Score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|3|3.0||||||
4169667|NCT00819247|3990516|B4|unknown||Participant Counts by Gleason Score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|3|3.0||||||
4169744|NCT00819182|3990717|B1|||Hot Flash Bother|Self-reported rating using a scale from 0 (not at all bothersome) to 10 (extremely bothersome). Calculated as 24 hour averages.|Scores on a scale|Mean|4.52|4.52|Standard Deviation|1.72|1.72|||
4169668|NCT00819247|3990517|B3|unknown||Participant Counts by Gleason Score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|1|1.0||||||
4169669|NCT00819247|3990518|B2|unknown||Participant Counts by Gleason Score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|1|1.0||||||
4169670|NCT00819247|3990519|B1|unknown||Participant Counts by Gleason Score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|1|1.0||||||
4169671|NCT00819247|3990516|B4|United Kingdom||Region of Enrollment||participants|Number|129|129.0||||||
4169672|NCT00819247|3990517|B3|United Kingdom||Region of Enrollment||participants|Number|40|40.0||||||
4169673|NCT00819247|3990518|B2|United Kingdom||Region of Enrollment||participants|Number|46|46.0||||||
4169674|NCT00819247|3990519|B1|United Kingdom||Region of Enrollment||participants|Number|43|43.0||||||
4169675|NCT00819247|3990516|B4|Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4169676|NCT00819247|3990517|B3|Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4169677|NCT00819247|3990518|B2|Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4169678|NCT00819247|3990519|B1|Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4169679|NCT00819247|3990516|B4|Afro-carribean||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4169680|NCT00819247|3990517|B3|Afro-carribean||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4169681|NCT00819247|3990518|B2|Afro-carribean||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4169682|NCT00819247|3990519|B1|Afro-carribean||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4169683|NCT00819247|3990516|B4|Oriental / Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4169684|NCT00819247|3990517|B3|Oriental / Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4169685|NCT00819247|3990518|B2|Oriental / Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4169686|NCT00819247|3990519|B1|Oriental / Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4169687|NCT00819247|3990516|B4|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4169688|NCT00819247|3990517|B3|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4169689|NCT00819247|3990518|B2|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4169690|NCT00819247|3990519|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4169691|NCT00819247|3990516|B4|White||Race/Ethnicity, Customized||participants|Number|122|122.0||||||
4169692|NCT00819247|3990517|B3|White||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4169693|NCT00819247|3990518|B2|White||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4169694|NCT00819247|3990519|B1|White||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4169695|NCT00819247|3990516|B4||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4169696|NCT00819247|3990517|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4169697|NCT00819247|3990518|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4169698|NCT00819247|3990519|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4169699|NCT00819247|3990516|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4169700|NCT00819247|3990517|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4169701|NCT00819247|3990518|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4169702|NCT00819247|3990519|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4169703|NCT00819247|3990516|B4|||Age||years|Mean|72.7|72.7|Standard Deviation|7.0|7.0|||
4169704|NCT00819247|3990517|B3|||Age||years|Mean|71.8|71.8|Standard Deviation|7.1|7.1|||
4169705|NCT00819247|3990518|B2|||Age||years|Mean|73.7|73.7|Standard Deviation|7.2|7.2|||
4169706|NCT00819247|3990519|B1|||Age||years|Mean|72.4|72.4|Standard Deviation|6.6|6.6|||
4169707|NCT00819247|3990516|B4||>=65 years|Age||Participants|Count of Participants|111|111.0||||||
4169708|NCT00819247|3990517|B3||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
4169709|NCT00819247|3990518|B2||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
4169710|NCT00819247|3990519|B1||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
4169711|NCT00819247|3990516|B4||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4169712|NCT00819247|3990517|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4169713|NCT00819247|3990518|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4169714|NCT00819247|3990519|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4169715|NCT00819247|3990516|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169716|NCT00819247|3990517|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169717|NCT00819247|3990518|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169718|NCT00819247|3990519|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169719|NCT00819234|3990547|B1|||Body Mass Index (BMI) at Baseline|Baseline refers to Week 28 in original study. If Week 28 was missing or after the first dose in DFA102E, the last available value on or prior to Week 28 was used. Body Mass Index (BMI) was measured as kilogram per meter of height squared (kg/m^2).|kg/m^2|Mean|34.16|34.16|Standard Deviation|4.988|4.988|||
4169720|NCT00819234|3990547|B1|||Body Weight at Baseline|Baseline in the extension study was Week 28 in the original study. If Week 28 value was missing or after the first dose in DFA102E, the last available value on or prior to Week 28 was used.|kilograms|Mean|95.83|95.83|Standard Deviation|17.007|17.007|||
4169721|NCT00819234|3990547|B1|United States||Region of Enrollment||participants|Number|273|273.0||||||
4169725|NCT00819182|3990714|B4|||Sleep Disturbance|Self-report using the Pittsburgh Sleep Quality Index which is composed of 19-items to assess sleep quality and disturbances during the past week. Scores range from 0-21 with higher scores indicating poorer sleep quality and more sleep disturbance.|Global sleep quality score|Mean|7.99|7.99|Standard Deviation|3.50|3.5|||
4169726|NCT00819182|3990715|B3|||Sleep Disturbance|Self-report using the Pittsburgh Sleep Quality Index which is composed of 19-items to assess sleep quality and disturbances during the past week. Scores range from 0-21 with higher scores indicating poorer sleep quality and more sleep disturbance.|Global sleep quality score|Mean|8.14|8.14|Standard Deviation|3.66|3.66|||
4169727|NCT00819182|3990716|B2|||Sleep Disturbance|Self-report using the Pittsburgh Sleep Quality Index which is composed of 19-items to assess sleep quality and disturbances during the past week. Scores range from 0-21 with higher scores indicating poorer sleep quality and more sleep disturbance.|Global sleep quality score|Mean|8.59|8.59|Standard Deviation|3.59|3.59|||
4169728|NCT00819182|3990717|B1|||Sleep Disturbance|Self-report using the Pittsburgh Sleep Quality Index which is composed of 19-items to assess sleep quality and disturbances during the past week. Scores range from 0-21 with higher scores indicating poorer sleep quality and more sleep disturbance.|Global sleep quality score|Mean|7.38|7.38|Standard Deviation|3.23|3.23|||
4169729|NCT00819182|3990714|B4|||Mood Disturbance|Self-report using the well-validated Profile of Mood States-Short Form questionnaire. Six subscales are computed. Total scores are computed using the formula Depression-Dejection + Tension-Anxiety + Anger-Hostility + Fatigue-Inertia + Confusion-Bewilderment + (24 - Vigor-Activity). Total scores range from 0 to 124 with higher scores indicating higher mood disturbance.|Scores on a scale|Mean|43.03|43.03|Standard Deviation|23.86|23.86|||
4169730|NCT00819182|3990715|B3|||Mood Disturbance|Self-report using the well-validated Profile of Mood States-Short Form questionnaire. Six subscales are computed. Total scores are computed using the formula Depression-Dejection + Tension-Anxiety + Anger-Hostility + Fatigue-Inertia + Confusion-Bewilderment + (24 - Vigor-Activity). Total scores range from 0 to 124 with higher scores indicating higher mood disturbance.|Scores on a scale|Mean|39.50|39.5|Standard Deviation|24.47|24.47|||
4169731|NCT00819182|3990716|B2|||Mood Disturbance|Self-report using the well-validated Profile of Mood States-Short Form questionnaire. Six subscales are computed. Total scores are computed using the formula Depression-Dejection + Tension-Anxiety + Anger-Hostility + Fatigue-Inertia + Confusion-Bewilderment + (24 - Vigor-Activity). Total scores range from 0 to 124 with higher scores indicating higher mood disturbance.|Scores on a scale|Mean|47.17|47.17|Standard Deviation|23.03|23.03|||
4169732|NCT00819182|3990717|B1|||Mood Disturbance|Self-report using the well-validated Profile of Mood States-Short Form questionnaire. Six subscales are computed. Total scores are computed using the formula Depression-Dejection + Tension-Anxiety + Anger-Hostility + Fatigue-Inertia + Confusion-Bewilderment + (24 - Vigor-Activity). Total scores range from 0 to 124 with higher scores indicating higher mood disturbance.|Scores on a scale|Mean|40.08|40.08|Standard Deviation|24.77|24.77|||
4169733|NCT00819182|3990714|B4|||Perceived Control Over Hot Flashes|Self-report using well-validated, standardized questionnaire composed of 15 items with response option ratings of 1-4. Scores were summed with potential range of 15-60. Lower scores indicated less control over hot flashes; higher scores indicate higher perceived control over hot flashes.|Scores on a scale|Mean|37.57|37.57|Standard Deviation|4.80|4.8|||
4169734|NCT00819182|3990715|B3|||Perceived Control Over Hot Flashes|Self-report using well-validated, standardized questionnaire composed of 15 items with response option ratings of 1-4. Scores were summed with potential range of 15-60. Lower scores indicated less control over hot flashes; higher scores indicate higher perceived control over hot flashes.|Scores on a scale|Mean|37.95|37.95|Standard Deviation|4.64|4.64|||
4169735|NCT00819182|3990716|B2|||Perceived Control Over Hot Flashes|Self-report using well-validated, standardized questionnaire composed of 15 items with response option ratings of 1-4. Scores were summed with potential range of 15-60. Lower scores indicated less control over hot flashes; higher scores indicate higher perceived control over hot flashes.|Scores on a scale|Mean|37.48|37.48|Standard Deviation|5.10|5.1|||
4169736|NCT00819182|3990717|B1|||Perceived Control Over Hot Flashes|Self-report using well-validated, standardized questionnaire composed of 15 items with response option ratings of 1-4. Scores were summed with potential range of 15-60. Lower scores indicated less control over hot flashes; higher scores indicate higher perceived control over hot flashes.|Scores on a scale|Mean|37.38|37.38|Standard Deviation|4.68|4.68|||
4169737|NCT00819182|3990714|B4|||Hot Flash Related Daily Interference|Self-report using well-validated, standardized questionnaire. Subject rated interference items on scale from 0 to 10. Total score range was 0-100 with higher scores indicating greater interference with daily life.|Scores on a scale|Mean|4.32|4.32|Standard Deviation|2.43|2.43|||
4169738|NCT00819182|3990715|B3|||Hot Flash Related Daily Interference|Self-report using well-validated, standardized questionnaire. Subject rated interference items on scale from 0 to 10. Total score range was 0-100 with higher scores indicating greater interference with daily life.|Scores on a scale|Mean|4.51|4.51|Standard Deviation|2.61|2.61|||
4169739|NCT00819182|3990716|B2|||Hot Flash Related Daily Interference|Self-report using well-validated, standardized questionnaire. Subject rated interference items on scale from 0 to 10. Total score range was 0-100 with higher scores indicating greater interference with daily life.|Scores on a scale|Mean|4.58|4.58|Standard Deviation|2.46|2.46|||
4169740|NCT00819182|3990717|B1|||Hot Flash Related Daily Interference|Self-report using well-validated, standardized questionnaire. Subject rated interference items on scale from 0 to 10. Total score range was 0-100 with higher scores indicating greater interference with daily life.|Scores on a scale|Mean|3.99|3.99|Standard Deviation|2.35|2.35|||
4169741|NCT00819182|3990714|B4|||Hot Flash Bother|Self-reported rating using a scale from 0 (not at all bothersome) to 10 (extremely bothersome). Calculated as 24 hour averages.|Scores on a scale|Mean|4.66|4.66|Standard Deviation|1.64|1.64|||
4169742|NCT00819182|3990715|B3|||Hot Flash Bother|Self-reported rating using a scale from 0 (not at all bothersome) to 10 (extremely bothersome). Calculated as 24 hour averages.|Scores on a scale|Mean|4.69|4.69|Standard Deviation|1.32|1.32|||
4169743|NCT00819182|3990716|B2|||Hot Flash Bother|Self-reported rating using a scale from 0 (not at all bothersome) to 10 (extremely bothersome). Calculated as 24 hour averages.|Scores on a scale|Mean|4.78|4.78|Standard Deviation|1.72|1.72|||
4169781|NCT00819182|3990714|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169745|NCT00819182|3990714|B4|||Hot Flash Severity|Self-reported rating using a scale from 0 (not at all severe) to 10 (extremely severe). Calculated as 24 hour averages.|Scores on a scale|Mean|5.17|5.17|Standard Deviation|1.53|1.53|||
4169746|NCT00819182|3990715|B3|||Hot Flash Severity|Self-reported rating using a scale from 0 (not at all severe) to 10 (extremely severe). Calculated as 24 hour averages.|Scores on a scale|Mean|5.40|5.4|Standard Deviation|1.26|1.26|||
4169747|NCT00819182|3990716|B2|||Hot Flash Severity|Self-reported rating using a scale from 0 (not at all severe) to 10 (extremely severe). Calculated as 24 hour averages.|Scores on a scale|Mean|5.23|5.23|Standard Deviation|1.58|1.58|||
4169748|NCT00819182|3990717|B1|||Hot Flash Severity|Self-reported rating using a scale from 0 (not at all severe) to 10 (extremely severe). Calculated as 24 hour averages.|Scores on a scale|Mean|4.50|4.5|Standard Deviation|1.60|1.6|||
4169749|NCT00819182|3990714|B4|||Hot Flash Frequency|Prospective, real-time electronic diary used by participants for a minimum of 24 hours to a maximum of 7 days. Duration of use was determined by participant choice.|Hot flashes per 24 hr|Mean|6.84|6.84|Standard Deviation|4.12|4.12|||
4169750|NCT00819182|3990715|B3|||Hot Flash Frequency|Prospective, real-time electronic diary used by participants for a minimum of 24 hours to a maximum of 7 days. Duration of use was determined by participant choice.|Hot flashes per 24 hr|Mean|7.31|7.31|Standard Deviation|4.04|4.04|||
4169751|NCT00819182|3990716|B2|||Hot Flash Frequency|Prospective, real-time electronic diary used by participants for a minimum of 24 hours to a maximum of 7 days. Duration of use was determined by participant choice.|Hot flashes per 24 hr|Mean|6.43|6.43|Standard Deviation|3.96|3.96|||
4169752|NCT00819182|3990717|B1|||Hot Flash Frequency|Prospective, real-time electronic diary used by participants for a minimum of 24 hours to a maximum of 7 days. Duration of use was determined by participant choice.|Hot flashes per 24 hr|Mean|7.02|7.02|Standard Deviation|4.32|4.32|||
4169753|NCT00819182|3990714|B4|Menopausal Women with No Cancer History||Breast Cancer History|Breast cancer survivors > 4 weeks post-completion of surgery, radiation, and/or chemotherapy for nonmetastatic breast cancer with no additional cancer history OR menopausal women with no cancer history|Participants|Number|122|122.0||||||
4169754|NCT00819182|3990715|B3|Menopausal Women with No Cancer History||Breast Cancer History|Breast cancer survivors > 4 weeks post-completion of surgery, radiation, and/or chemotherapy for nonmetastatic breast cancer with no additional cancer history OR menopausal women with no cancer history|Participants|Number|24|24.0||||||
4169755|NCT00819182|3990716|B2|Menopausal Women with No Cancer History||Breast Cancer History|Breast cancer survivors > 4 weeks post-completion of surgery, radiation, and/or chemotherapy for nonmetastatic breast cancer with no additional cancer history OR menopausal women with no cancer history|Participants|Number|48|48.0||||||
4169756|NCT00819182|3990717|B1|Menopausal Women with No Cancer History||Breast Cancer History|Breast cancer survivors > 4 weeks post-completion of surgery, radiation, and/or chemotherapy for nonmetastatic breast cancer with no additional cancer history OR menopausal women with no cancer history|Participants|Number|50|50.0||||||
4169757|NCT00819182|3990714|B4|Breast Cancer Survivor||Breast Cancer History|Breast cancer survivors > 4 weeks post-completion of surgery, radiation, and/or chemotherapy for nonmetastatic breast cancer with no additional cancer history OR menopausal women with no cancer history|Participants|Number|96|96.0||||||
4169758|NCT00819182|3990715|B3|Breast Cancer Survivor||Breast Cancer History|Breast cancer survivors > 4 weeks post-completion of surgery, radiation, and/or chemotherapy for nonmetastatic breast cancer with no additional cancer history OR menopausal women with no cancer history|Participants|Number|20|20.0||||||
4169759|NCT00819182|3990716|B2|Breast Cancer Survivor||Breast Cancer History|Breast cancer survivors > 4 weeks post-completion of surgery, radiation, and/or chemotherapy for nonmetastatic breast cancer with no additional cancer history OR menopausal women with no cancer history|Participants|Number|38|38.0||||||
4169760|NCT00819182|3990717|B1|Breast Cancer Survivor||Breast Cancer History|Breast cancer survivors > 4 weeks post-completion of surgery, radiation, and/or chemotherapy for nonmetastatic breast cancer with no additional cancer history OR menopausal women with no cancer history|Participants|Number|38|38.0||||||
4169761|NCT00819182|3990714|B4|United States||Region of Enrollment||participants|Number|218|218.0||||||
4169762|NCT00819182|3990715|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
4169763|NCT00819182|3990716|B2|United States||Region of Enrollment||participants|Number|86|86.0||||||
4169764|NCT00819182|3990717|B1|United States||Region of Enrollment||participants|Number|88|88.0||||||
4169765|NCT00819182|3990714|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169766|NCT00819182|3990715|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169767|NCT00819182|3990716|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169768|NCT00819182|3990717|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169769|NCT00819182|3990714|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4169770|NCT00819182|3990715|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169771|NCT00819182|3990716|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4169772|NCT00819182|3990717|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4169773|NCT00819182|3990714|B4||White|Race (NIH/OMB)||Participants|Count of Participants|155|155.0||||||
4169774|NCT00819182|3990715|B3||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4169775|NCT00819182|3990716|B2||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4169776|NCT00819182|3990717|B1||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4169777|NCT00819182|3990714|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4169778|NCT00819182|3990715|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4169779|NCT00819182|3990716|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4169780|NCT00819182|3990717|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4169917|NCT00819156|3990751|B5||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4169782|NCT00819182|3990715|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169783|NCT00819182|3990716|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169784|NCT00819182|3990717|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169785|NCT00819182|3990714|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4169786|NCT00819182|3990715|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169787|NCT00819182|3990716|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169788|NCT00819182|3990717|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4169789|NCT00819182|3990714|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4169790|NCT00819182|3990715|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169791|NCT00819182|3990716|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169792|NCT00819182|3990717|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4169793|NCT00819182|3990714|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169794|NCT00819182|3990715|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169795|NCT00819182|3990716|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169796|NCT00819182|3990717|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169797|NCT00819182|3990714|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|215|215.0||||||
4169798|NCT00819182|3990715|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4169799|NCT00819182|3990716|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4169800|NCT00819182|3990717|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
4169801|NCT00819182|3990714|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4169802|NCT00819182|3990715|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169803|NCT00819182|3990716|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169804|NCT00819182|3990717|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4169805|NCT00819182|3990714|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4169806|NCT00819182|3990715|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4169807|NCT00819182|3990716|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4169808|NCT00819182|3990717|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4169809|NCT00819182|3990714|B4||Female|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4169810|NCT00819182|3990715|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4169811|NCT00819182|3990716|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4169812|NCT00819182|3990717|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4169813|NCT00819182|3990714|B4|||Age||years|Mean|52.86|52.86|Standard Deviation|6.62|6.62|||
4169814|NCT00819182|3990715|B3|||Age||years|Mean|53.52|53.52|Standard Deviation|5.68|5.68|||
4169815|NCT00819182|3990716|B2|||Age||years|Mean|51.93|51.93|Standard Deviation|6.81|6.81|||
4169816|NCT00819182|3990717|B1|||Age||years|Mean|53.44|53.44|Standard Deviation|6.84|6.84|||
4169817|NCT00819156|3990749|B7|||Serum Prostate-specific Antigen|Prostate-specific antigen (PSA) is a protein produced by the cells of the prostate gland. The PSA test measures the level of PSA in the blood. High PSA levels have a positive correlation to prostate cancer.|nanogram / milliliter|Median|27.6|27.6|Full Range|||2.0|1730.0|
4169818|NCT00819156|3990750|B6|||Serum Prostate-specific Antigen|Prostate-specific antigen (PSA) is a protein produced by the cells of the prostate gland. The PSA test measures the level of PSA in the blood. High PSA levels have a positive correlation to prostate cancer.|nanogram / milliliter|Median|32|32.0|Full Range|||2.0|1297.0|
4169819|NCT00819156|3990751|B5|||Serum Prostate-specific Antigen|Prostate-specific antigen (PSA) is a protein produced by the cells of the prostate gland. The PSA test measures the level of PSA in the blood. High PSA levels have a positive correlation to prostate cancer.|nanogram / milliliter|Median|35.3|35.3|Full Range|||2.4|1110.0|
4169820|NCT00819156|3990752|B4|||Serum Prostate-specific Antigen|Prostate-specific antigen (PSA) is a protein produced by the cells of the prostate gland. The PSA test measures the level of PSA in the blood. High PSA levels have a positive correlation to prostate cancer.|nanogram / milliliter|Median|23.1|23.1|Full Range|||3.6|586.0|
4169821|NCT00819156|3990753|B3|||Serum Prostate-specific Antigen|Prostate-specific antigen (PSA) is a protein produced by the cells of the prostate gland. The PSA test measures the level of PSA in the blood. High PSA levels have a positive correlation to prostate cancer.|nanogram / milliliter|Median|31.5|31.5|Full Range|||2.6|901.0|
4169822|NCT00819156|3990754|B2|||Serum Prostate-specific Antigen|Prostate-specific antigen (PSA) is a protein produced by the cells of the prostate gland. The PSA test measures the level of PSA in the blood. High PSA levels have a positive correlation to prostate cancer.|nanogram / milliliter|Median|31.5|31.5|Full Range|||3.3|1730.0|
4169823|NCT00819156|3990755|B1|||Serum Prostate-specific Antigen|Prostate-specific antigen (PSA) is a protein produced by the cells of the prostate gland. The PSA test measures the level of PSA in the blood. High PSA levels have a positive correlation to prostate cancer.|nanogram / milliliter|Median|15.2|15.2|Full Range|||2.6|332.0|
4169824|NCT00819156|3990749|B7|||Median Serum Testosterone Level|Testosterone is a steroid hormone from the androgen group, and the principal male sex hormone. This test measures the amount of testosterone in the blood. Androgen deprivation is used to manage prostate cancer.|nanogram / milliliter|Median|4.13|4.13|Full Range|||0.816|10.2|
4169918|NCT00819156|3990752|B4||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4169825|NCT00819156|3990750|B6|||Median Serum Testosterone Level|Testosterone is a steroid hormone from the androgen group, and the principal male sex hormone. This test measures the amount of testosterone in the blood. Androgen deprivation is used to manage prostate cancer.|nanogram / milliliter|Median|3.88|3.88|Full Range|||1.69|8.63|
4169826|NCT00819156|3990751|B5|||Median Serum Testosterone Level|Testosterone is a steroid hormone from the androgen group, and the principal male sex hormone. This test measures the amount of testosterone in the blood. Androgen deprivation is used to manage prostate cancer.|nanogram / milliliter|Median|4.07|4.07|Full Range|||2.02|7.7|
4169827|NCT00819156|3990752|B4|||Median Serum Testosterone Level|Testosterone is a steroid hormone from the androgen group, and the principal male sex hormone. This test measures the amount of testosterone in the blood. Androgen deprivation is used to manage prostate cancer.|nanogram / milliliter|Median|4.28|4.28|Full Range|||1.4|10.2|
4169828|NCT00819156|3990753|B3|||Median Serum Testosterone Level|Testosterone is a steroid hormone from the androgen group, and the principal male sex hormone. This test measures the amount of testosterone in the blood. Androgen deprivation is used to manage prostate cancer.|nanogram / milliliter|Median|4.79|4.79|Full Range|||2.8|9.47|
4169829|NCT00819156|3990754|B2|||Median Serum Testosterone Level|Testosterone is a steroid hormone from the androgen group, and the principal male sex hormone. This test measures the amount of testosterone in the blood. Androgen deprivation is used to manage prostate cancer.|nanogram / milliliter|Median|3.93|3.93|Full Range|||1.53|9.29|
4169830|NCT00819156|3990755|B1|||Median Serum Testosterone Level|Testosterone is a steroid hormone from the androgen group, and the principal male sex hormone. This test measures the amount of testosterone in the blood. Androgen deprivation is used to manage prostate cancer.|nanogram / milliliter|Median|4.47|4.47|Full Range|||0.816|7.1|
4169831|NCT00819156|3990749|B7|||Days Since Diagnosis of Prostate Cancer|The mean number of days that have passed since a diagnosis of prostate cancer was made for each patient.|days|Mean|323|323.0|Standard Deviation|756|756.0|||
4169832|NCT00819156|3990750|B6|||Days Since Diagnosis of Prostate Cancer|The mean number of days that have passed since a diagnosis of prostate cancer was made for each patient.|days|Mean|352|352.0|Standard Deviation|743|743.0|||
4169833|NCT00819156|3990751|B5|||Days Since Diagnosis of Prostate Cancer|The mean number of days that have passed since a diagnosis of prostate cancer was made for each patient.|days|Mean|229|229.0|Standard Deviation|508|508.0|||
4169834|NCT00819156|3990752|B4|||Days Since Diagnosis of Prostate Cancer|The mean number of days that have passed since a diagnosis of prostate cancer was made for each patient.|days|Mean|383|383.0|Standard Deviation|817|817.0|||
4169835|NCT00819156|3990753|B3|||Days Since Diagnosis of Prostate Cancer|The mean number of days that have passed since a diagnosis of prostate cancer was made for each patient.|days|Mean|375|375.0|Standard Deviation|1098|1098.0|||
4169836|NCT00819156|3990754|B2|||Days Since Diagnosis of Prostate Cancer|The mean number of days that have passed since a diagnosis of prostate cancer was made for each patient.|days|Mean|122|122.0|Standard Deviation|230|230.0|||
4169837|NCT00819156|3990755|B1|||Days Since Diagnosis of Prostate Cancer|The mean number of days that have passed since a diagnosis of prostate cancer was made for each patient.|days|Mean|493|493.0|Standard Deviation|849|849.0|||
4169838|NCT00819156|3990749|B7|||Body Mass Index|Body mass index is a measure of body fat based on height and weight.|kilograms per square meter|Mean|26.3|26.3|Standard Deviation|3.94|3.94|17.9|41.1|
4169839|NCT00819156|3990750|B6|||Body Mass Index|Body mass index is a measure of body fat based on height and weight.|kilograms per square meter|Mean|25.3|25.3|Standard Deviation|2.73|2.73|20.3|29.8|
4169840|NCT00819156|3990751|B5|||Body Mass Index|Body mass index is a measure of body fat based on height and weight.|kilograms per square meter|Mean|26|26.0|Standard Deviation|3.28|3.28|18.2|32.7|
4169841|NCT00819156|3990752|B4|||Body Mass Index|Body mass index is a measure of body fat based on height and weight.|kilograms per square meter|Mean|27.7|27.7|Standard Deviation|5.3|5.3|18.5|41.1|
4169842|NCT00819156|3990753|B3|||Body Mass Index|Body mass index is a measure of body fat based on height and weight.|kilograms per square meter|Mean|25.9|25.9|Standard Deviation|4.46|4.46|17.9|36.3|
4169843|NCT00819156|3990754|B2|||Body Mass Index|Body mass index is a measure of body fat based on height and weight.|kilograms per square meter|Mean|26.4|26.4|Standard Deviation|3.74|3.74|20.3|36.8|
4169844|NCT00819156|3990755|B1|||Body Mass Index|Body mass index is a measure of body fat based on height and weight.|kilograms per square meter|Mean|26.4|26.4|Standard Deviation|3.5|3.5|18.1|36.0|
4169845|NCT00819156|3990749|B7|7-10||Patient Counts by Gleason Score|The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10 with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|73|73.0||||||
4169846|NCT00819156|3990750|B6|7-10||Patient Counts by Gleason Score|The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10 with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|15|15.0||||||
4169847|NCT00819156|3990751|B5|7-10||Patient Counts by Gleason Score|The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10 with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|12|12.0||||||
4169848|NCT00819156|3990752|B4|7-10||Patient Counts by Gleason Score|The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10 with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|11|11.0||||||
4169849|NCT00819156|3990753|B3|7-10||Patient Counts by Gleason Score|The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10 with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|10|10.0||||||
4169850|NCT00819156|3990754|B2|7-10||Patient Counts by Gleason Score|The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10 with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|12|12.0||||||
4169919|NCT00819156|3990753|B3||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4169920|NCT00819156|3990754|B2||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4169851|NCT00819156|3990755|B1|7-10||Patient Counts by Gleason Score|The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10 with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|13|13.0||||||
4169852|NCT00819156|3990749|B7|5-6||Patient Counts by Gleason Score|The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10 with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|76|76.0||||||
4169853|NCT00819156|3990750|B6|5-6||Patient Counts by Gleason Score|The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10 with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|12|12.0||||||
4169854|NCT00819156|3990751|B5|5-6||Patient Counts by Gleason Score|The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10 with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|17|17.0||||||
4169855|NCT00819156|3990752|B4|5-6||Patient Counts by Gleason Score|The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10 with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|10|10.0||||||
4169856|NCT00819156|3990753|B3|5-6||Patient Counts by Gleason Score|The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10 with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|14|14.0||||||
4169857|NCT00819156|3990754|B2|5-6||Patient Counts by Gleason Score|The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10 with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|10|10.0||||||
4169858|NCT00819156|3990755|B1|5-6||Patient Counts by Gleason Score|The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10 with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|13|13.0||||||
4169859|NCT00819156|3990749|B7|2-4||Patient Counts by Gleason Score|The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10 with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|36|36.0||||||
4169860|NCT00819156|3990750|B6|2-4||Patient Counts by Gleason Score|The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10 with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|3|3.0||||||
4169861|NCT00819156|3990751|B5|2-4||Patient Counts by Gleason Score|The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10 with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|4|4.0||||||
4169862|NCT00819156|3990752|B4|2-4||Patient Counts by Gleason Score|The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10 with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|9|9.0||||||
4169863|NCT00819156|3990753|B3|2-4||Patient Counts by Gleason Score|The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10 with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|6|6.0||||||
4169864|NCT00819156|3990754|B2|2-4||Patient Counts by Gleason Score|The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10 with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|10|10.0||||||
4169865|NCT00819156|3990755|B1|2-4||Patient Counts by Gleason Score|The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10 with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|4|4.0||||||
4169866|NCT00819156|3990749|B7|unknown||Patient Counts by Gleason Score|The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10 with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|2|2.0||||||
4169867|NCT00819156|3990750|B6|unknown||Patient Counts by Gleason Score|The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10 with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|0|0.0||||||
4169868|NCT00819156|3990751|B5|unknown||Patient Counts by Gleason Score|The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10 with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|0|0.0||||||
4169869|NCT00819156|3990752|B4|unknown||Patient Counts by Gleason Score|The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10 with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|0|0.0||||||
4169870|NCT00819156|3990753|B3|unknown||Patient Counts by Gleason Score|The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10 with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|2|2.0||||||
4169871|NCT00819156|3990754|B2|unknown||Patient Counts by Gleason Score|The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10 with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|0|0.0||||||
4169872|NCT00819156|3990755|B1|unknown||Patient Counts by Gleason Score|The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10 with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|0|0.0||||||
4169921|NCT00819156|3990755|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4169922|NCT00819156|3990749|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4169873|NCT00819156|3990749|B7|Not classifiable||Number of Patients at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tummors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|patients|Number|50|50.0||||||
4169874|NCT00819156|3990750|B6|Not classifiable||Number of Patients at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tummors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|patients|Number|8|8.0||||||
4169875|NCT00819156|3990751|B5|Not classifiable||Number of Patients at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tummors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|patients|Number|7|7.0||||||
4169876|NCT00819156|3990752|B4|Not classifiable||Number of Patients at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tummors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|patients|Number|8|8.0||||||
4169877|NCT00819156|3990753|B3|Not classifiable||Number of Patients at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tummors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|patients|Number|10|10.0||||||
4169878|NCT00819156|3990754|B2|Not classifiable||Number of Patients at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tummors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|patients|Number|7|7.0||||||
4169879|NCT00819156|3990755|B1|Not classifiable||Number of Patients at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tummors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|patients|Number|10|10.0||||||
4169880|NCT00819156|3990749|B7|Metastatic||Number of Patients at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tummors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|patients|Number|36|36.0||||||
4169881|NCT00819156|3990750|B6|Metastatic||Number of Patients at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tummors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|patients|Number|7|7.0||||||
4169882|NCT00819156|3990751|B5|Metastatic||Number of Patients at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tummors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|patients|Number|7|7.0||||||
4169883|NCT00819156|3990752|B4|Metastatic||Number of Patients at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tummors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|patients|Number|5|5.0||||||
4169884|NCT00819156|3990753|B3|Metastatic||Number of Patients at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tummors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|patients|Number|5|5.0||||||
4169885|NCT00819156|3990754|B2|Metastatic||Number of Patients at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tummors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|patients|Number|8|8.0||||||
4169886|NCT00819156|3990755|B1|Metastatic||Number of Patients at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tummors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|patients|Number|4|4.0||||||
4169887|NCT00819156|3990749|B7|Locally advanced||Number of Patients at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tummors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|patients|Number|60|60.0||||||
4169888|NCT00819156|3990750|B6|Locally advanced||Number of Patients at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tummors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|patients|Number|10|10.0||||||
4169923|NCT00819156|3990750|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169924|NCT00819156|3990751|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4170044|NCT00819052|3990876|B2|Never smoked||Smoking History||participants|Number|131|131.0||||||
4169889|NCT00819156|3990751|B5|Locally advanced||Number of Patients at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tummors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|patients|Number|8|8.0||||||
4169890|NCT00819156|3990752|B4|Locally advanced||Number of Patients at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tummors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|patients|Number|12|12.0||||||
4169891|NCT00819156|3990753|B3|Locally advanced||Number of Patients at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tummors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|patients|Number|11|11.0||||||
4169892|NCT00819156|3990754|B2|Locally advanced||Number of Patients at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tummors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|patients|Number|11|11.0||||||
4169893|NCT00819156|3990755|B1|Locally advanced||Number of Patients at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tummors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|patients|Number|8|8.0||||||
4169894|NCT00819156|3990749|B7|Localized||Number of Patients at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tummors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|patients|Number|41|41.0||||||
4169895|NCT00819156|3990750|B6|Localized||Number of Patients at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tummors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|patients|Number|5|5.0||||||
4169896|NCT00819156|3990751|B5|Localized||Number of Patients at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tummors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|patients|Number|11|11.0||||||
4169897|NCT00819156|3990752|B4|Localized||Number of Patients at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tummors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|patients|Number|5|5.0||||||
4169898|NCT00819156|3990753|B3|Localized||Number of Patients at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tummors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|patients|Number|6|6.0||||||
4169899|NCT00819156|3990754|B2|Localized||Number of Patients at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tummors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|patients|Number|6|6.0||||||
4169900|NCT00819156|3990755|B1|Localized||Number of Patients at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tummors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|patients|Number|8|8.0||||||
4169901|NCT00819156|3990749|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169902|NCT00819156|3990750|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169903|NCT00819156|3990751|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169904|NCT00819156|3990752|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169905|NCT00819156|3990753|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169906|NCT00819156|3990754|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169907|NCT00819156|3990755|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169908|NCT00819156|3990749|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169909|NCT00819156|3990750|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169910|NCT00819156|3990751|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169911|NCT00819156|3990752|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169912|NCT00819156|3990753|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169913|NCT00819156|3990754|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169914|NCT00819156|3990755|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169915|NCT00819156|3990749|B7||White|Race (NIH/OMB)||Participants|Count of Participants|180|180.0||||||
4169916|NCT00819156|3990750|B6||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4169925|NCT00819156|3990752|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169926|NCT00819156|3990753|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4169927|NCT00819156|3990754|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4169928|NCT00819156|3990755|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4169929|NCT00819156|3990749|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169930|NCT00819156|3990750|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169931|NCT00819156|3990751|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169932|NCT00819156|3990752|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169933|NCT00819156|3990753|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169934|NCT00819156|3990754|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169935|NCT00819156|3990755|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169936|NCT00819156|3990749|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4169937|NCT00819156|3990750|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169938|NCT00819156|3990751|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4169939|NCT00819156|3990752|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169940|NCT00819156|3990753|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169941|NCT00819156|3990754|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169942|NCT00819156|3990755|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169943|NCT00819156|3990749|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169944|NCT00819156|3990750|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169945|NCT00819156|3990751|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169946|NCT00819156|3990752|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169947|NCT00819156|3990753|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169948|NCT00819156|3990754|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169949|NCT00819156|3990755|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4169950|NCT00819156|3990749|B7||Male|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4169951|NCT00819156|3990750|B6||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4169952|NCT00819156|3990751|B5||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4169953|NCT00819156|3990752|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4169954|NCT00819156|3990753|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4169955|NCT00819156|3990754|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4169956|NCT00819156|3990755|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4169957|NCT00819156|3990749|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4169958|NCT00819156|3990750|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4169959|NCT00819156|3990751|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4169960|NCT00819156|3990752|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4169961|NCT00819156|3990753|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4169962|NCT00819156|3990754|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4169963|NCT00819156|3990755|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4169964|NCT00819156|3990749|B7|||Age||years|Mean|70.9|70.9|Standard Deviation|7.75|7.75|||
4169965|NCT00819156|3990750|B6|||Age||years|Mean|70.7|70.7|Standard Deviation|8.59|8.59|||
4169966|NCT00819156|3990751|B5|||Age||years|Mean|70.7|70.7|Standard Deviation|7.56|7.56|||
4169967|NCT00819156|3990752|B4|||Age||years|Mean|70.4|70.4|Standard Deviation|7.07|7.07|||
4169968|NCT00819156|3990753|B3|||Age||years|Mean|73.3|73.3|Standard Deviation|7.39|7.39|||
4169969|NCT00819156|3990754|B2|||Age||years|Mean|70.6|70.6|Standard Deviation|7.72|7.72|||
4169970|NCT00819156|3990755|B1|||Age||years|Mean|69.9|69.9|Standard Deviation|8.27|8.27|||
4169971|NCT00819156|3990749|B7||>=65 years|Age||Participants|Count of Participants|150|150.0||||||
4169972|NCT00819156|3990750|B6||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4169973|NCT00819156|3990751|B5||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4169974|NCT00819156|3990752|B4||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4169975|NCT00819156|3990753|B3||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4169976|NCT00819156|3990754|B2||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4169977|NCT00819156|3990755|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4169978|NCT00819156|3990749|B7||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4169979|NCT00819156|3990750|B6||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4169980|NCT00819156|3990751|B5||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4169981|NCT00819156|3990752|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4169982|NCT00819156|3990753|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4169983|NCT00819156|3990754|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4169984|NCT00819156|3990755|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4169985|NCT00819156|3990749|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169986|NCT00819156|3990750|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169987|NCT00819156|3990751|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169988|NCT00819156|3990752|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169989|NCT00819156|3990753|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169990|NCT00819156|3990754|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169991|NCT00819156|3990755|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4169992|NCT00819091|3990848|B3|||Fasting blood plasma glucose (FPG)||milligram/deciliter (mg/dL)|Mean|179.6|179.6|Standard Deviation|50.9|50.9|||
4169993|NCT00819091|3990849|B2|||Fasting blood plasma glucose (FPG)||milligram/deciliter (mg/dL)|Mean|182.0|182.0|Standard Deviation|51.8|51.8|||
4169994|NCT00819091|3990850|B1|||Fasting blood plasma glucose (FPG)||milligram/deciliter (mg/dL)|Mean|174.9|174.9|Standard Deviation|49.0|49.0|||
4169995|NCT00819091|3990848|B3|||Baseline glycosylated hemoglobin (HbA1c)||percentage|Mean|8.61|8.61|Standard Deviation|0.81|0.81|||
4169996|NCT00819091|3990849|B2|||Baseline glycosylated hemoglobin (HbA1c)||percentage|Mean|8.61|8.61|Standard Deviation|0.85|0.85|||
4169997|NCT00819091|3990850|B1|||Baseline glycosylated hemoglobin (HbA1c)||percentage|Mean|8.6|8.6|Standard Deviation|0.72|0.72|||
4169998|NCT00819091|3990848|B3|||Body Mass Index (BMI)||kilogram/square meter|Mean|28.33|28.33|Standard Deviation|5.04|5.04|||
4169999|NCT00819091|3990849|B2|||Body Mass Index (BMI)||kilogram/square meter|Mean|28.40|28.4|Standard Deviation|5.02|5.02|||
4170000|NCT00819091|3990850|B1|||Body Mass Index (BMI)||kilogram/square meter|Mean|28.21|28.21|Standard Deviation|5.12|5.12|||
4170001|NCT00819091|3990848|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4170002|NCT00819091|3990849|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4170003|NCT00819091|3990850|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4170004|NCT00819091|3990848|B3|Not Hispanic||Race/Ethnicity, Customized||participants|Number|203|203.0||||||
4170005|NCT00819091|3990849|B2|Not Hispanic||Race/Ethnicity, Customized||participants|Number|133|133.0||||||
4170006|NCT00819091|3990850|B1|Not Hispanic||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
4170007|NCT00819091|3990848|B3|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4170008|NCT00819091|3990849|B2|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4170009|NCT00819091|3990850|B1|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4170010|NCT00819091|3990848|B3|Asian||Race/Ethnicity, Customized||participants|Number|119|119.0||||||
4170011|NCT00819091|3990849|B2|Asian||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
4170012|NCT00819091|3990850|B1|Asian||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4170013|NCT00819091|3990848|B3|Black||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4170014|NCT00819091|3990849|B2|Black||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4170015|NCT00819091|3990850|B1|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4170016|NCT00819091|3990848|B3|White||Race/Ethnicity, Customized||participants|Number|107|107.0||||||
4170017|NCT00819091|3990849|B2|White||Race/Ethnicity, Customized||participants|Number|73|73.0||||||
4170018|NCT00819091|3990850|B1|White||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4170019|NCT00819091|3990848|B3||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4170020|NCT00819091|3990849|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4170021|NCT00819091|3990850|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4170022|NCT00819091|3990848|B3||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4170023|NCT00819091|3990849|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4170024|NCT00819091|3990850|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4170025|NCT00819091|3990848|B3|||Age||years|Mean|56.9|56.9|Standard Deviation|9.9|9.9|||
4170026|NCT00819091|3990849|B2|||Age||years|Mean|57.2|57.2|Standard Deviation|9.8|9.8|||
4170027|NCT00819091|3990850|B1|||Age||years|Mean|56.2|56.2|Standard Deviation|10.2|10.2|||
4170028|NCT00819052|3990875|B3|Drinks - could interfere with trial||Alcohol Status||participants|Number|7|7.0||||||
4170029|NCT00819052|3990876|B2|Drinks - could interfere with trial||Alcohol Status||participants|Number|6|6.0||||||
4170030|NCT00819052|3990877|B1|Drinks - could interfere with trial||Alcohol Status||participants|Number|1|1.0||||||
4170031|NCT00819052|3990875|B3|Drinks - no interfere with trial||Alcohol Status||participants|Number|317|317.0||||||
4170032|NCT00819052|3990876|B2|Drinks - no interfere with trial||Alcohol Status||participants|Number|214|214.0||||||
4170033|NCT00819052|3990877|B1|Drinks - no interfere with trial||Alcohol Status||participants|Number|103|103.0||||||
4170034|NCT00819052|3990875|B3|Non drinker||Alcohol Status||participants|Number|119|119.0||||||
4170035|NCT00819052|3990876|B2|Non drinker||Alcohol Status||participants|Number|75|75.0||||||
4170036|NCT00819052|3990877|B1|Non drinker||Alcohol Status||participants|Number|44|44.0||||||
4170037|NCT00819052|3990875|B3|Current smoker||Smoking History||participants|Number|140|140.0||||||
4170038|NCT00819052|3990876|B2|Current smoker||Smoking History||participants|Number|97|97.0||||||
4170039|NCT00819052|3990877|B1|Current smoker||Smoking History||participants|Number|43|43.0||||||
4170040|NCT00819052|3990875|B3|Ex-smoker||Smoking History||participants|Number|104|104.0||||||
4170041|NCT00819052|3990876|B2|Ex-smoker||Smoking History||participants|Number|67|67.0||||||
4170042|NCT00819052|3990877|B1|Ex-smoker||Smoking History||participants|Number|37|37.0||||||
4170043|NCT00819052|3990875|B3|Never smoked||Smoking History||participants|Number|199|199.0||||||
4170045|NCT00819052|3990877|B1|Never smoked||Smoking History||participants|Number|68|68.0||||||
4170046|NCT00819052|3990875|B3|Europe||Region of Enrollment||participants|Number|299|299.0||||||
4170047|NCT00819052|3990876|B2|Europe||Region of Enrollment||participants|Number|197|197.0||||||
4170048|NCT00819052|3990877|B1|Europe||Region of Enrollment||participants|Number|102|102.0||||||
4170049|NCT00819052|3990875|B3|North America||Region of Enrollment||participants|Number|144|144.0||||||
4170050|NCT00819052|3990876|B2|North America||Region of Enrollment||participants|Number|98|98.0||||||
4170051|NCT00819052|3990877|B1|North America||Region of Enrollment||participants|Number|46|46.0||||||
4170052|NCT00819052|3990875|B3|Not Hispanic / Latino||Race/Ethnicity, Customized||Participants|Number|42|42.0||||||
4170053|NCT00819052|3990876|B2|Not Hispanic / Latino||Race/Ethnicity, Customized||Participants|Number|26|26.0||||||
4170054|NCT00819052|3990877|B1|Not Hispanic / Latino||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4170055|NCT00819052|3990875|B3|Hispanic / Latino||Race/Ethnicity, Customized||Participants|Number|401|401.0||||||
4170056|NCT00819052|3990876|B2|Hispanic / Latino||Race/Ethnicity, Customized||Participants|Number|269|269.0||||||
4170057|NCT00819052|3990877|B1|Hispanic / Latino||Race/Ethnicity, Customized||Participants|Number|132|132.0||||||
4170058|NCT00819052|3990875|B3|White||Race/Ethnicity, Customized||participants|Number|404|404.0||||||
4170059|NCT00819052|3990876|B2|White||Race/Ethnicity, Customized||participants|Number|270|270.0||||||
4170060|NCT00819052|3990877|B1|White||Race/Ethnicity, Customized||participants|Number|134|134.0||||||
4170061|NCT00819052|3990875|B3|Black||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4170062|NCT00819052|3990876|B2|Black||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4170063|NCT00819052|3990877|B1|Black||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4170064|NCT00819052|3990875|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4170065|NCT00819052|3990876|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4170066|NCT00819052|3990877|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4170067|NCT00819052|3990875|B3||Male|Sex: Female, Male||Participants|Count of Participants|374|374.0||||||
4170068|NCT00819052|3990876|B2||Male|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
4170069|NCT00819052|3990877|B1||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4170070|NCT00819052|3990875|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4170071|NCT00819052|3990876|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4170072|NCT00819052|3990877|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4170073|NCT00819052|3990875|B3|65 years or more||Age, Customized||participants|Number|28|28.0||||||
4170074|NCT00819052|3990876|B2|65 years or more||Age, Customized||participants|Number|19|19.0||||||
4170075|NCT00819052|3990877|B1|65 years or more||Age, Customized||participants|Number|9|9.0||||||
4170076|NCT00819052|3990875|B3|56 to < 65 years||Age, Customized||participants|Number|62|62.0||||||
4170077|NCT00819052|3990876|B2|56 to < 65 years||Age, Customized||participants|Number|38|38.0||||||
4170078|NCT00819052|3990877|B1|56 to < 65 years||Age, Customized||participants|Number|24|24.0||||||
4170079|NCT00819052|3990875|B3|41 to < 56 years||Age, Customized||participants|Number|247|247.0||||||
4170080|NCT00819052|3990876|B2|41 to < 56 years||Age, Customized||participants|Number|168|168.0||||||
4170081|NCT00819052|3990877|B1|41 to < 56 years||Age, Customized||participants|Number|79|79.0||||||
4170082|NCT00819052|3990875|B3|18 to < 41 years||Age, Customized||participants|Number|106|106.0||||||
4170083|NCT00819052|3990876|B2|18 to < 41 years||Age, Customized||participants|Number|70|70.0||||||
4170084|NCT00819052|3990877|B1|18 to < 41 years||Age, Customized||participants|Number|36|36.0||||||
4170085|NCT00819052|3990875|B3|||Age||years|Mean|47.4|47.4|Standard Deviation|9.7|9.7|||
4170086|NCT00819052|3990876|B2|||Age||years|Mean|47.3|47.3|Standard Deviation|9.6|9.6|||
4170087|NCT00819052|3990877|B1|||Age||years|Mean|47.6|47.6|Standard Deviation|9.8|9.8|||
4170088|NCT00819039|3990990|B4||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4170089|NCT00819039|3990991|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4170090|NCT00819039|3990992|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4170091|NCT00819039|3990993|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4170092|NCT00819039|3990990|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4170093|NCT00819039|3990991|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4170094|NCT00819039|3990992|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4170095|NCT00819039|3990993|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4170096|NCT00819039|3990990|B4|12 to 17 years||Age, Customized||Participants|Number|24|24.0||||||
4170097|NCT00819039|3990991|B3|12 to 17 years||Age, Customized||Participants|Number|7|7.0||||||
4170098|NCT00819039|3990992|B2|12 to 17 years||Age, Customized||Participants|Number|7|7.0||||||
4170099|NCT00819039|3990993|B1|12 to 17 years||Age, Customized||Participants|Number|10|10.0||||||
4170100|NCT00819039|3990990|B4|6 to <12 years||Age, Customized||Participants|Number|22|22.0||||||
4170101|NCT00819039|3990991|B3|6 to <12 years||Age, Customized||Participants|Number|6|6.0||||||
4170102|NCT00819039|3990992|B2|6 to <12 years||Age, Customized||Participants|Number|5|5.0||||||
4170103|NCT00819039|3990993|B1|6 to <12 years||Age, Customized||Participants|Number|11|11.0||||||
4170104|NCT00819039|3990990|B4|2 to <6 years||Age, Customized||Participants|Number|25|25.0||||||
4170105|NCT00819039|3990991|B3|2 to <6 years||Age, Customized||Participants|Number|7|7.0||||||
4170106|NCT00819039|3990992|B2|2 to <6 years||Age, Customized||Participants|Number|7|7.0||||||
4170107|NCT00819039|3990993|B1|2 to <6 years||Age, Customized||Participants|Number|11|11.0||||||
4170108|NCT00819039|3990990|B4|0.5 to <2 years||Age, Customized||Participants|Number|27|27.0||||||
4170109|NCT00819039|3990991|B3|0.5 to <2 years||Age, Customized||Participants|Number|5|5.0||||||
4170110|NCT00819039|3990992|B2|0.5 to <2 years||Age, Customized||Participants|Number|8|8.0||||||
4170111|NCT00819039|3990993|B1|0.5 to <2 years||Age, Customized||Participants|Number|14|14.0||||||
4170112|NCT00819013|3991021|B5|United States||Region of Enrollment||Participants|Number|87|87.0||||||
4170113|NCT00819013|3991022|B4|United States||Region of Enrollment||Participants|Number|21|21.0||||||
4170114|NCT00819013|3991023|B3|United States||Region of Enrollment||Participants|Number|21|21.0||||||
4170115|NCT00819013|3991024|B2|United States||Region of Enrollment||Participants|Number|23|23.0||||||
4170116|NCT00819013|3991025|B1|United States||Region of Enrollment||Participants|Number|22|22.0||||||
4170117|NCT00819013|3991021|B5||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4170118|NCT00819013|3991022|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4170119|NCT00819013|3991023|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4170120|NCT00819013|3991024|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4170121|NCT00819013|3991025|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4170122|NCT00819013|3991021|B5||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4170123|NCT00819013|3991022|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4170124|NCT00819013|3991023|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4170125|NCT00819013|3991024|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4170126|NCT00819013|3991025|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4170127|NCT00819013|3991021|B5|||Age||Years|Mean|28.5|28.5|Standard Deviation|6.1175|6.1175|||
4170128|NCT00819013|3991022|B4|||Age||Years|Mean|29.4|29.4|Standard Deviation|6.84|6.84|||
4170129|NCT00819013|3991023|B3|||Age||Years|Mean|27.9|27.9|Standard Deviation|6.76|6.76|||
4170130|NCT00819013|3991024|B2|||Age||Years|Mean|27.7|27.7|Standard Deviation|4.96|4.96|||
4170131|NCT00819013|3991025|B1|||Age||Years|Mean|29.1|29.1|Standard Deviation|5.91|5.91|||
4170132|NCT00819013|3991021|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4170133|NCT00819013|3991022|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4170134|NCT00819013|3991023|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4170135|NCT00819013|3991024|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4170136|NCT00819013|3991025|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4170137|NCT00819013|3991021|B5||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
4170138|NCT00819013|3991022|B4||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4170139|NCT00819013|3991023|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4170140|NCT00819013|3991024|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4170141|NCT00819013|3991025|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4170142|NCT00819013|3991021|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4170143|NCT00819013|3991022|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4170144|NCT00819013|3991023|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4170145|NCT00819013|3991024|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4170146|NCT00819013|3991025|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4170147|NCT00818961|3991078|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4170148|NCT00818961|3991078|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4170149|NCT00818961|3991078|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4170150|NCT00818961|3991078|B1|||Age||years|Mean|56.44|56.44|Standard Deviation|6.92|6.92|||
4170151|NCT00818961|3991078|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4170152|NCT00818961|3991078|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4170153|NCT00818961|3991078|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4170154|NCT00818883|3991092|B3|||Diabetes status||participants|Number|66|66.0||||||
4170155|NCT00818883|3991093|B2|||Diabetes status||participants|Number|35|35.0||||||
4170156|NCT00818883|3991094|B1|||Diabetes status||participants|Number|31|31.0||||||
4170157|NCT00818883|3991092|B3|||Chronic Kidney Disease (CKD) Status|"Participant was considered to have CKD if their eGFR was <60 ml/min/1.73 m2 or urinary albumin:creatinine ratio was >200 mg albumin/g creatinine at Screening.~Includes all randomized participants."|participants|Number|48|48.0||||||
4170158|NCT00818883|3991093|B2|||Chronic Kidney Disease (CKD) Status|"Participant was considered to have CKD if their eGFR was <60 ml/min/1.73 m2 or urinary albumin:creatinine ratio was >200 mg albumin/g creatinine at Screening.~Includes all randomized participants."|participants|Number|24|24.0||||||
4170159|NCT00818883|3991094|B1|||Chronic Kidney Disease (CKD) Status|"Participant was considered to have CKD if their eGFR was <60 ml/min/1.73 m2 or urinary albumin:creatinine ratio was >200 mg albumin/g creatinine at Screening.~Includes all randomized participants."|participants|Number|24|24.0||||||
4170160|NCT00818883|3991092|B3|||Body Mass Index (BMI)||kg/m2|Median|31.2|31.2|Standard Deviation|6.13|6.13|||
4170161|NCT00818883|3991093|B2|||Body Mass Index (BMI)||kg/m2|Median|31.8|31.8|Standard Deviation|6.10|6.1|||
4170162|NCT00818883|3991094|B1|||Body Mass Index (BMI)||kg/m2|Median|30.7|30.7|Standard Deviation|6.12|6.12|||
4170163|NCT00818883|3991092|B3|||Height||cm|Mean|168.9|168.9|Standard Deviation|9.88|9.88|||
4170164|NCT00818883|3991093|B2|||Height||cm|Mean|168.8|168.8|Standard Deviation|9.69|9.69|||
4170165|NCT00818883|3991094|B1|||Height||cm|Mean|168.9|168.9|Standard Deviation|10.08|10.08|||
4170166|NCT00818883|3991092|B3|||Weight||kg|Mean|89.11|89.11|Standard Deviation|19.260|19.26|||
4170167|NCT00818883|3991093|B2|||Weight||kg|Mean|90.61|90.61|Standard Deviation|19.252|19.252|||
4170168|NCT00818883|3991094|B1|||Weight||kg|Mean|87.60|87.6|Standard Deviation|19.181|19.181|||
4170169|NCT00818883|3991092|B3|Normal||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2); Mild renal impairment(≥60 to <90 mL/min/1.73 m2); Moderate renal impairment (≥30 to <60 mL/min/1.73 m2)"|participants|Number|198|198.0||||||
4170170|NCT00818883|3991093|B2|Normal||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2); Mild renal impairment(≥60 to <90 mL/min/1.73 m2); Moderate renal impairment (≥30 to <60 mL/min/1.73 m2)"|participants|Number|98|98.0||||||
4170171|NCT00818883|3991094|B1|Normal||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2); Mild renal impairment(≥60 to <90 mL/min/1.73 m2); Moderate renal impairment (≥30 to <60 mL/min/1.73 m2)"|participants|Number|100|100.0||||||
4170172|NCT00818883|3991092|B3|Mild impairment||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2); Mild renal impairment(≥60 to <90 mL/min/1.73 m2); Moderate renal impairment (≥30 to <60 mL/min/1.73 m2)"|participants|Number|364|364.0||||||
4170173|NCT00818883|3991093|B2|Mild impairment||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2); Mild renal impairment(≥60 to <90 mL/min/1.73 m2); Moderate renal impairment (≥30 to <60 mL/min/1.73 m2)"|participants|Number|184|184.0||||||
4170174|NCT00818883|3991094|B1|Mild impairment||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2); Mild renal impairment(≥60 to <90 mL/min/1.73 m2); Moderate renal impairment (≥30 to <60 mL/min/1.73 m2)"|participants|Number|180|180.0||||||
4170175|NCT00818883|3991092|B3|Moderate impairment||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2); Mild renal impairment(≥60 to <90 mL/min/1.73 m2); Moderate renal impairment (≥30 to <60 mL/min/1.73 m2)"|participants|Number|47|47.0||||||
4170176|NCT00818883|3991093|B2|Moderate impairment||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2); Mild renal impairment(≥60 to <90 mL/min/1.73 m2); Moderate renal impairment (≥30 to <60 mL/min/1.73 m2)"|participants|Number|24|24.0||||||
4170177|NCT00818883|3991094|B1|Moderate impairment||Estimated glomerular filtration rate (eGFR)|"eGFR based on calculated creatinine clearance.~Categories:~Normal renal function (≥90 mL/min/1.73 m2); Mild renal impairment(≥60 to <90 mL/min/1.73 m2); Moderate renal impairment (≥30 to <60 mL/min/1.73 m2)"|participants|Number|23|23.0||||||
4170178|NCT00818883|3991092|B3|Russian Federation||Region of Enrollment||participants|Number|182|182.0||||||
4170179|NCT00818883|3991093|B2|Russian Federation||Region of Enrollment||participants|Number|92|92.0||||||
4170180|NCT00818883|3991094|B1|Russian Federation||Region of Enrollment||participants|Number|90|90.0||||||
4170181|NCT00818883|3991092|B3|United States||Region of Enrollment||participants|Number|427|427.0||||||
4170182|NCT00818883|3991093|B2|United States||Region of Enrollment||participants|Number|214|214.0||||||
4170183|NCT00818883|3991094|B1|United States||Region of Enrollment||participants|Number|213|213.0||||||
4170184|NCT00818883|3991092|B3|Unknown or Not Reported||Race (NIH/OMB)|Participants could choose more than 1 category for race. Participants who indicated more than 1 race category are included in each category indicated, and they are also included in the multiracial category. Thus, the sum of the number of participants by racial category may be greater than the total number of participants in the treatment group.|participants|Number|0|0.0||||||
4170185|NCT00818883|3991093|B2|Unknown or Not Reported||Race (NIH/OMB)|Participants could choose more than 1 category for race. Participants who indicated more than 1 race category are included in each category indicated, and they are also included in the multiracial category. Thus, the sum of the number of participants by racial category may be greater than the total number of participants in the treatment group.|participants|Number|0|0.0||||||
4170186|NCT00818883|3991094|B1|Unknown or Not Reported||Race (NIH/OMB)|Participants could choose more than 1 category for race. Participants who indicated more than 1 race category are included in each category indicated, and they are also included in the multiracial category. Thus, the sum of the number of participants by racial category may be greater than the total number of participants in the treatment group.|participants|Number|0|0.0||||||
4170187|NCT00818883|3991092|B3|More than one race||Race (NIH/OMB)|Participants could choose more than 1 category for race. Participants who indicated more than 1 race category are included in each category indicated, and they are also included in the multiracial category. Thus, the sum of the number of participants by racial category may be greater than the total number of participants in the treatment group.|participants|Number|5|5.0||||||
4170188|NCT00818883|3991093|B2|More than one race||Race (NIH/OMB)|Participants could choose more than 1 category for race. Participants who indicated more than 1 race category are included in each category indicated, and they are also included in the multiracial category. Thus, the sum of the number of participants by racial category may be greater than the total number of participants in the treatment group.|participants|Number|0|0.0||||||
4170189|NCT00818883|3991094|B1|More than one race||Race (NIH/OMB)|Participants could choose more than 1 category for race. Participants who indicated more than 1 race category are included in each category indicated, and they are also included in the multiracial category. Thus, the sum of the number of participants by racial category may be greater than the total number of participants in the treatment group.|participants|Number|5|5.0||||||
4170190|NCT00818883|3991092|B3|White||Race (NIH/OMB)|Participants could choose more than 1 category for race. Participants who indicated more than 1 race category are included in each category indicated, and they are also included in the multiracial category. Thus, the sum of the number of participants by racial category may be greater than the total number of participants in the treatment group.|participants|Number|517|517.0||||||
4170214|NCT00818883|3991092|B3||Male|Sex: Female, Male||Participants|Count of Participants|296|296.0||||||
4170215|NCT00818883|3991093|B2||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4170191|NCT00818883|3991093|B2|White||Race (NIH/OMB)|Participants could choose more than 1 category for race. Participants who indicated more than 1 race category are included in each category indicated, and they are also included in the multiracial category. Thus, the sum of the number of participants by racial category may be greater than the total number of participants in the treatment group.|participants|Number|265|265.0||||||
4170192|NCT00818883|3991094|B1|White||Race (NIH/OMB)|Participants could choose more than 1 category for race. Participants who indicated more than 1 race category are included in each category indicated, and they are also included in the multiracial category. Thus, the sum of the number of participants by racial category may be greater than the total number of participants in the treatment group.|participants|Number|252|252.0||||||
4170193|NCT00818883|3991092|B3|Black or African American||Race (NIH/OMB)|Participants could choose more than 1 category for race. Participants who indicated more than 1 race category are included in each category indicated, and they are also included in the multiracial category. Thus, the sum of the number of participants by racial category may be greater than the total number of participants in the treatment group.|participants|Number|84|84.0||||||
4170194|NCT00818883|3991093|B2|Black or African American||Race (NIH/OMB)|Participants could choose more than 1 category for race. Participants who indicated more than 1 race category are included in each category indicated, and they are also included in the multiracial category. Thus, the sum of the number of participants by racial category may be greater than the total number of participants in the treatment group.|participants|Number|38|38.0||||||
4170195|NCT00818883|3991094|B1|Black or African American||Race (NIH/OMB)|Participants could choose more than 1 category for race. Participants who indicated more than 1 race category are included in each category indicated, and they are also included in the multiracial category. Thus, the sum of the number of participants by racial category may be greater than the total number of participants in the treatment group.|participants|Number|46|46.0||||||
4170196|NCT00818883|3991092|B3|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|Participants could choose more than 1 category for race. Participants who indicated more than 1 race category are included in each category indicated, and they are also included in the multiracial category. Thus, the sum of the number of participants by racial category may be greater than the total number of participants in the treatment group.|participants|Number|1|1.0||||||
4170197|NCT00818883|3991093|B2|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|Participants could choose more than 1 category for race. Participants who indicated more than 1 race category are included in each category indicated, and they are also included in the multiracial category. Thus, the sum of the number of participants by racial category may be greater than the total number of participants in the treatment group.|participants|Number|0|0.0||||||
4170198|NCT00818883|3991094|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|Participants could choose more than 1 category for race. Participants who indicated more than 1 race category are included in each category indicated, and they are also included in the multiracial category. Thus, the sum of the number of participants by racial category may be greater than the total number of participants in the treatment group.|participants|Number|1|1.0||||||
4170199|NCT00818883|3991092|B3|Asian||Race (NIH/OMB)|Participants could choose more than 1 category for race. Participants who indicated more than 1 race category are included in each category indicated, and they are also included in the multiracial category. Thus, the sum of the number of participants by racial category may be greater than the total number of participants in the treatment group.|participants|Number|5|5.0||||||
4170200|NCT00818883|3991093|B2|Asian||Race (NIH/OMB)|Participants could choose more than 1 category for race. Participants who indicated more than 1 race category are included in each category indicated, and they are also included in the multiracial category. Thus, the sum of the number of participants by racial category may be greater than the total number of participants in the treatment group.|participants|Number|2|2.0||||||
4170201|NCT00818883|3991094|B1|Asian||Race (NIH/OMB)|Participants could choose more than 1 category for race. Participants who indicated more than 1 race category are included in each category indicated, and they are also included in the multiracial category. Thus, the sum of the number of participants by racial category may be greater than the total number of participants in the treatment group.|participants|Number|3|3.0||||||
4170202|NCT00818883|3991092|B3|American Indian or Alaska Native||Race (NIH/OMB)|Participants could choose more than 1 category for race. Participants who indicated more than 1 race category are included in each category indicated, and they are also included in the multiracial category. Thus, the sum of the number of participants by racial category may be greater than the total number of participants in the treatment group.|participants|Number|7|7.0||||||
4170203|NCT00818883|3991093|B2|American Indian or Alaska Native||Race (NIH/OMB)|Participants could choose more than 1 category for race. Participants who indicated more than 1 race category are included in each category indicated, and they are also included in the multiracial category. Thus, the sum of the number of participants by racial category may be greater than the total number of participants in the treatment group.|participants|Number|1|1.0||||||
4170204|NCT00818883|3991094|B1|American Indian or Alaska Native||Race (NIH/OMB)|Participants could choose more than 1 category for race. Participants who indicated more than 1 race category are included in each category indicated, and they are also included in the multiracial category. Thus, the sum of the number of participants by racial category may be greater than the total number of participants in the treatment group.|participants|Number|6|6.0||||||
4170205|NCT00818883|3991092|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|184|184.0||||||
4170206|NCT00818883|3991093|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
4170207|NCT00818883|3991094|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4170208|NCT00818883|3991092|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|357|357.0||||||
4170209|NCT00818883|3991093|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|184|184.0||||||
4170210|NCT00818883|3991094|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|173|173.0||||||
4170211|NCT00818883|3991092|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4170212|NCT00818883|3991093|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4170213|NCT00818883|3991094|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4170216|NCT00818883|3991094|B1||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4170217|NCT00818883|3991092|B3||Female|Sex: Female, Male||Participants|Count of Participants|313|313.0||||||
4170218|NCT00818883|3991093|B2||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4170219|NCT00818883|3991094|B1||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4170220|NCT00818883|3991092|B3|≥65 years||Age, Customized||participants|Number|132|132.0||||||
4170221|NCT00818883|3991093|B2|≥65 years||Age, Customized||participants|Number|61|61.0||||||
4170222|NCT00818883|3991094|B1|≥65 years||Age, Customized||participants|Number|71|71.0||||||
4170223|NCT00818883|3991092|B3|Between 45 and 64 years||Age, Customized||participants|Number|384|384.0||||||
4170224|NCT00818883|3991093|B2|Between 45 and 64 years||Age, Customized||participants|Number|195|195.0||||||
4170225|NCT00818883|3991094|B1|Between 45 and 64 years||Age, Customized||participants|Number|189|189.0||||||
4170226|NCT00818883|3991092|B3|<45 years||Age, Customized||participants|Number|93|93.0||||||
4170227|NCT00818883|3991093|B2|<45 years||Age, Customized||participants|Number|50|50.0||||||
4170228|NCT00818883|3991094|B1|<45 years||Age, Customized||participants|Number|43|43.0||||||
4170229|NCT00818883|3991092|B3|||Age||years|Mean|56.4|56.4|Standard Deviation|10.88|10.88|||
4170230|NCT00818883|3991093|B2|||Age||years|Mean|55.9|55.9|Standard Deviation|10.97|10.97|||
4170231|NCT00818883|3991094|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|10.79|10.79|||
4170232|NCT00818805|3991129|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4170233|NCT00818805|3991129|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4170234|NCT00818805|3991129|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4170235|NCT00818805|3991129|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4170236|NCT00818805|3991129|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4170237|NCT00818779|3991140|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
4170238|NCT00818779|3991141|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4170239|NCT00818779|3991142|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4170240|NCT00818779|3991140|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4170241|NCT00818779|3991141|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4170242|NCT00818779|3991142|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4170243|NCT00818779|3991140|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4170244|NCT00818779|3991141|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4170245|NCT00818779|3991142|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4170246|NCT00818779|3991140|B3|||Age||years|Mean|65|65.0|Standard Deviation|13|13.0|||
4170247|NCT00818779|3991141|B2|||Age||years|Mean|63|63.0|Standard Deviation|16|16.0|||
4170248|NCT00818779|3991142|B1|||Age||years|Mean|68|68.0|Standard Deviation|10|10.0|||
4170249|NCT00818779|3991140|B3||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4170250|NCT00818779|3991141|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4170251|NCT00818779|3991142|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4170252|NCT00818779|3991140|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4170253|NCT00818779|3991141|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4170254|NCT00818779|3991142|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4170255|NCT00818779|3991140|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4170256|NCT00818779|3991141|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4170257|NCT00818779|3991142|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4170258|NCT00818766|3991157|B3||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4170259|NCT00818766|3991158|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4170260|NCT00818766|3991159|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4170261|NCT00818766|3991157|B3||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4170262|NCT00818766|3991158|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4170263|NCT00818766|3991159|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4170264|NCT00818766|3991157|B3|||Age||years|Median|62.5|62.5|Full Range|||24.0|85.0|
4170265|NCT00818766|3991158|B2|||Age||years|Median|62|62.0|Full Range|||26.0|84.0|
4170266|NCT00818766|3991159|B1|||Age||years|Median|63|63.0|Full Range|||24.0|85.0|
4170267|NCT00818753|3991186|B4|||Creatinine clearance|Baseline creatinine clearance was not available for 3 patients in the Dabigatran 110mg treatment group.|mL/min|Mean|97.0|97.0|Standard Deviation|28.6|28.6|||
4170268|NCT00818753|3991187|B3|||Creatinine clearance|Baseline creatinine clearance was not available for 3 patients in the Dabigatran 110mg treatment group.|mL/min|Mean|95.7|95.7|Standard Deviation|26.5|26.5|||
4170269|NCT00818753|3991188|B2|||Creatinine clearance|Baseline creatinine clearance was not available for 3 patients in the Dabigatran 110mg treatment group.|mL/min|Mean|96.3|96.3|Standard Deviation|19.3|19.3|||
4170270|NCT00818753|3991189|B1|||Creatinine clearance|Baseline creatinine clearance was not available for 3 patients in the Dabigatran 110mg treatment group.|mL/min|Mean|98.5|98.5|Standard Deviation|38.2|38.2|||
4170271|NCT00818753|3991186|B4|||Race/Ethnicity, Customized|All participants were white|participants|Number|53|53.0||||||
4170272|NCT00818753|3991187|B3|||Race/Ethnicity, Customized|All participants were white|participants|Number|10|10.0||||||
4170273|NCT00818753|3991188|B2|||Race/Ethnicity, Customized|All participants were white|participants|Number|21|21.0||||||
4170274|NCT00818753|3991189|B1|||Race/Ethnicity, Customized|All participants were white|participants|Number|22|22.0||||||
4170275|NCT00818753|3991186|B4||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4170276|NCT00818753|3991187|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4170277|NCT00818753|3991188|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4170278|NCT00818753|3991189|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4170279|NCT00818753|3991186|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4170280|NCT00818753|3991187|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4170281|NCT00818753|3991188|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4170282|NCT00818753|3991189|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4170283|NCT00818753|3991186|B4|||Age||Years|Mean|64.8|64.8|Standard Deviation|8.5|8.5|||
4170284|NCT00818753|3991187|B3|||Age||Years|Mean|67.0|67.0|Standard Deviation|8.3|8.3|||
4170285|NCT00818753|3991188|B2|||Age||Years|Mean|63.0|63.0|Standard Deviation|8.5|8.5|||
4170286|NCT00818753|3991189|B1|||Age||Years|Mean|65.5|65.5|Standard Deviation|8.7|8.7|||
4170287|NCT00818662|3991211|B5|Canada||Region of Enrollment||participants|Number|25|25.0||||||
4170288|NCT00818662|3991212|B4|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4170289|NCT00818662|3991213|B3|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4170290|NCT00818662|3991214|B2|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4170291|NCT00818662|3991215|B1|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4170292|NCT00818662|3991211|B5|United States||Region of Enrollment||participants|Number|358|358.0||||||
4170293|NCT00818662|3991212|B4|United States||Region of Enrollment||participants|Number|58|58.0||||||
4170294|NCT00818662|3991213|B3|United States||Region of Enrollment||participants|Number|56|56.0||||||
4170295|NCT00818662|3991214|B2|United States||Region of Enrollment||participants|Number|127|127.0||||||
4170296|NCT00818662|3991215|B1|United States||Region of Enrollment||participants|Number|117|117.0||||||
4170297|NCT00818662|3991211|B5||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4170298|NCT00818662|3991212|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4170299|NCT00818662|3991213|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4170300|NCT00818662|3991214|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4170301|NCT00818662|3991215|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4170302|NCT00818662|3991211|B5||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4170303|NCT00818662|3991212|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4170304|NCT00818662|3991213|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4170305|NCT00818662|3991214|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4170306|NCT00818662|3991215|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4170307|NCT00818662|3991211|B5|||Age||years|Mean|70.3|70.3|Standard Deviation|9.3|9.3|||
4170308|NCT00818662|3991212|B4|||Age||years|Mean|70.1|70.1|Standard Deviation|10.3|10.3|||
4170309|NCT00818662|3991213|B3|||Age||years|Mean|70.3|70.3|Standard Deviation|9.7|9.7|||
4170310|NCT00818662|3991214|B2|||Age||years|Mean|70.1|70.1|Standard Deviation|8.3|8.3|||
4170311|NCT00818662|3991215|B1|||Age||years|Mean|70.5|70.5|Standard Deviation|9.6|9.6|||
4170312|NCT00818649|3991304|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4170313|NCT00818649|3991304|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170314|NCT00818649|3991304|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170315|NCT00818649|3991304|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4170316|NCT00818649|3991304|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4170317|NCT00818649|3991304|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170318|NCT00818649|3991304|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170319|NCT00818649|3991304|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170320|NCT00818649|3991304|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4170321|NCT00818649|3991304|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4170322|NCT00818649|3991304|B1|||Age||Years|Median|65.5|65.5|Full Range|||47.0|88.0|
4170323|NCT00818649|3991304|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4170324|NCT00818649|3991304|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4170325|NCT00818649|3991304|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4170326|NCT00818623|3991310|B9|||Weight||kilogram|Mean|78.4|78.4|Standard Deviation|11.6|11.6|||
4170327|NCT00818623|3991311|B8|||Weight||kilogram|Mean|81.7|81.7|Standard Deviation|11.1|11.1|||
4170328|NCT00818623|3991312|B7|||Weight||kilogram|Mean|73.5|73.5|Standard Deviation|9.55|9.55|||
4170329|NCT00818623|3991313|B6|||Weight||kilogram|Mean|81.5|81.5|Standard Deviation|10.7|10.7|||
4170330|NCT00818623|3991314|B5|||Weight||kilogram|Mean|74.2|74.2|Standard Deviation|9.88|9.88|||
4170331|NCT00818623|3991315|B4|||Weight||kilogram|Mean|78.2|78.2|Standard Deviation|13.7|13.7|||
4170332|NCT00818623|3991316|B3|||Weight||kilogram|Mean|80.7|80.7|Standard Deviation|11.8|11.8|||
4170333|NCT00818623|3991317|B2|||Weight||kilogram|Mean|82.2|82.2|Standard Deviation|12.1|12.1|||
4170334|NCT00818623|3991318|B1|||Weight||kilogram|Mean|77.8|77.8|Standard Deviation|12.4|12.4|||
4170335|NCT00818623|3991310|B9|||Time since prostate cancer diagnosis||days|Mean|156|156.0|Standard Deviation|439|439.0|||
4170476|NCT00818623|3991316|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4170336|NCT00818623|3991311|B8|||Time since prostate cancer diagnosis||days|Mean|46.6|46.6|Standard Deviation|54.4|54.4|||
4170337|NCT00818623|3991312|B7|||Time since prostate cancer diagnosis||days|Mean|121|121.0|Standard Deviation|425|425.0|||
4170338|NCT00818623|3991313|B6|||Time since prostate cancer diagnosis||days|Mean|313|313.0|Standard Deviation|837|837.0|||
4170339|NCT00818623|3991314|B5|||Time since prostate cancer diagnosis||days|Mean|252|252.0|Standard Deviation|560|560.0|||
4170340|NCT00818623|3991315|B4|||Time since prostate cancer diagnosis||days|Mean|146|146.0|Standard Deviation|298|298.0|||
4170341|NCT00818623|3991316|B3|||Time since prostate cancer diagnosis||days|Mean|222|222.0|Standard Deviation|328|328.0|||
4170342|NCT00818623|3991317|B2|||Time since prostate cancer diagnosis||days|Mean|65.9|65.9|Standard Deviation|53.5|53.5|||
4170343|NCT00818623|3991318|B1|||Time since prostate cancer diagnosis||days|Mean|83.2|83.2|Standard Deviation|157|157.0|||
4170344|NCT00818623|3991310|B9|||Serum testosterone levels||nanogram per milliliter|Median|4.16|4.16|Full Range|||1.08|12.5|
4170345|NCT00818623|3991311|B8|||Serum testosterone levels||nanogram per milliliter|Median|3.68|3.68|Full Range|||1.45|7.26|
4170346|NCT00818623|3991312|B7|||Serum testosterone levels||nanogram per milliliter|Median|4.46|4.46|Full Range|||1.81|11.2|
4170347|NCT00818623|3991313|B6|||Serum testosterone levels||nanogram per milliliter|Median|4.02|4.02|Full Range|||1.49|12.5|
4170348|NCT00818623|3991314|B5|||Serum testosterone levels||nanogram per milliliter|Median|5.60|5.6|Full Range|||3.01|9.36|
4170349|NCT00818623|3991315|B4|||Serum testosterone levels||nanogram per milliliter|Median|4.64|4.64|Full Range|||1.97|7.93|
4170350|NCT00818623|3991316|B3|||Serum testosterone levels||nanogram per milliliter|Median|3.02|3.02|Full Range|||1.65|5.12|
4170351|NCT00818623|3991317|B2|||Serum testosterone levels||nanogram per milliliter|Median|3.10|3.1|Full Range|||1.08|6.91|
4170352|NCT00818623|3991318|B1|||Serum testosterone levels||nanogram per milliliter|Median|4.30|4.3|Full Range|||2.37|12.5|
4170353|NCT00818623|3991310|B9|||Serum prostate-specific antigen levels||nanogram per milliliter|Median|37.9|37.9|Full Range|||1.7|6450.0|
4170354|NCT00818623|3991311|B8|||Serum prostate-specific antigen levels||nanogram per milliliter|Median|23.8|23.8|Full Range|||1.7|731.0|
4170355|NCT00818623|3991312|B7|||Serum prostate-specific antigen levels||nanogram per milliliter|Median|31.9|31.9|Full Range|||5.2|3490.0|
4170356|NCT00818623|3991313|B6|||Serum prostate-specific antigen levels||nanogram per milliliter|Median|31.0|31.0|Full Range|||4.5|357.0|
4170357|NCT00818623|3991314|B5|||Serum prostate-specific antigen levels||nanogram per milliliter|Median|46.9|46.9|Full Range|||2.3|6450.0|
4170358|NCT00818623|3991315|B4|||Serum prostate-specific antigen levels||nanogram per milliliter|Median|32.3|32.3|Full Range|||3.8|1474.0|
4170359|NCT00818623|3991316|B3|||Serum prostate-specific antigen levels||nanogram per milliliter|Median|109|109.0|Full Range|||4.1|1079.0|
4170360|NCT00818623|3991317|B2|||Serum prostate-specific antigen levels||nanogram per milliliter|Median|58.8|58.8|Full Range|||9.7|5514.0|
4170361|NCT00818623|3991318|B1|||Serum prostate-specific antigen levels||nanogram per milliliter|Median|42.5|42.5|Full Range|||3.0|4509.0|
4170362|NCT00818623|3991310|B9|||Body mass index||kilgram per square meter|Mean|26.0|26.0|Standard Deviation|3.32|3.32|||
4170363|NCT00818623|3991311|B8|||Body mass index||kilgram per square meter|Mean|27.1|27.1|Standard Deviation|3.63|3.63|||
4170364|NCT00818623|3991312|B7|||Body mass index||kilgram per square meter|Mean|24.8|24.8|Standard Deviation|2.72|2.72|||
4170365|NCT00818623|3991313|B6|||Body mass index||kilgram per square meter|Mean|26.9|26.9|Standard Deviation|3.18|3.18|||
4170366|NCT00818623|3991314|B5|||Body mass index||kilgram per square meter|Mean|24.5|24.5|Standard Deviation|2.92|2.92|||
4170367|NCT00818623|3991315|B4|||Body mass index||kilgram per square meter|Mean|25.9|25.9|Standard Deviation|2.99|2.99|||
4170368|NCT00818623|3991316|B3|||Body mass index||kilgram per square meter|Mean|26.3|26.3|Standard Deviation|3.74|3.74|||
4170369|NCT00818623|3991317|B2|||Body mass index||kilgram per square meter|Mean|26.6|26.6|Standard Deviation|4.58|4.58|||
4170370|NCT00818623|3991318|B1|||Body mass index||kilgram per square meter|Mean|26.2|26.2|Standard Deviation|2.97|2.97|||
4170371|NCT00818623|3991310|B9|Not classifiable||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|11|11.0||||||
4170372|NCT00818623|3991311|B8|Not classifiable||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|2|2.0||||||
4170373|NCT00818623|3991312|B7|Not classifiable||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|1|1.0||||||
4170374|NCT00818623|3991313|B6|Not classifiable||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|2|2.0||||||
4170375|NCT00818623|3991314|B5|Not classifiable||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|3|3.0||||||
4170477|NCT00818623|3991317|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4170376|NCT00818623|3991315|B4|Not classifiable||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|1|1.0||||||
4170377|NCT00818623|3991316|B3|Not classifiable||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|0|0.0||||||
4170378|NCT00818623|3991317|B2|Not classifiable||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|2|2.0||||||
4170379|NCT00818623|3991318|B1|Not classifiable||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|0|0.0||||||
4170380|NCT00818623|3991310|B9|Metastatic||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|52|52.0||||||
4170381|NCT00818623|3991311|B8|Metastatic||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|2|2.0||||||
4170382|NCT00818623|3991312|B7|Metastatic||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|10|10.0||||||
4170383|NCT00818623|3991313|B6|Metastatic||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|6|6.0||||||
4170384|NCT00818623|3991314|B5|Metastatic||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|12|12.0||||||
4170385|NCT00818623|3991315|B4|Metastatic||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|6|6.0||||||
4170386|NCT00818623|3991316|B3|Metastatic||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|4|4.0||||||
4170387|NCT00818623|3991317|B2|Metastatic||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|3|3.0||||||
4170388|NCT00818623|3991318|B1|Metastatic||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|9|9.0||||||
4170389|NCT00818623|3991310|B9|Locally advanced||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|63|63.0||||||
4170390|NCT00818623|3991311|B8|Locally advanced||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|9|9.0||||||
4170391|NCT00818623|3991312|B7|Locally advanced||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|5|5.0||||||
4170392|NCT00818623|3991313|B6|Locally advanced||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|10|10.0||||||
4170412|NCT00818623|3991315|B4|7-10||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|17|17.0||||||
4170393|NCT00818623|3991314|B5|Locally advanced||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|8|8.0||||||
4170394|NCT00818623|3991315|B4|Locally advanced||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|14|14.0||||||
4170395|NCT00818623|3991316|B3|Locally advanced||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|5|5.0||||||
4170396|NCT00818623|3991317|B2|Locally advanced||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|6|6.0||||||
4170397|NCT00818623|3991318|B1|Locally advanced||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|6|6.0||||||
4170398|NCT00818623|3991310|B9|Localized||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|46|46.0||||||
4170399|NCT00818623|3991311|B8|Localized||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|14|14.0||||||
4170400|NCT00818623|3991312|B7|Localized||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|8|8.0||||||
4170401|NCT00818623|3991313|B6|Localized||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|6|6.0||||||
4170402|NCT00818623|3991314|B5|Localized||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|1|1.0||||||
4170403|NCT00818623|3991315|B4|Localized||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|3|3.0||||||
4170404|NCT00818623|3991316|B3|Localized||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|3|3.0||||||
4170405|NCT00818623|3991317|B2|Localized||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|1|1.0||||||
4170406|NCT00818623|3991318|B1|Localized||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|10|10.0||||||
4170407|NCT00818623|3991310|B9|7-10||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|98|98.0||||||
4170408|NCT00818623|3991311|B8|7-10||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|9|9.0||||||
4170409|NCT00818623|3991312|B7|7-10||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|13|13.0||||||
4170410|NCT00818623|3991313|B6|7-10||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|16|16.0||||||
4170411|NCT00818623|3991314|B5|7-10||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|16|16.0||||||
4170413|NCT00818623|3991316|B3|7-10||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|5|5.0||||||
4170414|NCT00818623|3991317|B2|7-10||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|5|5.0||||||
4170415|NCT00818623|3991318|B1|7-10||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|17|17.0||||||
4170416|NCT00818623|3991310|B9|5-6||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|43|43.0||||||
4170417|NCT00818623|3991311|B8|5-6||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|6|6.0||||||
4170418|NCT00818623|3991312|B7|5-6||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|6|6.0||||||
4170419|NCT00818623|3991313|B6|5-6||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|6|6.0||||||
4170420|NCT00818623|3991314|B5|5-6||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|3|3.0||||||
4170421|NCT00818623|3991315|B4|5-6||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|6|6.0||||||
4170422|NCT00818623|3991316|B3|5-6||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|5|5.0||||||
4170423|NCT00818623|3991317|B2|5-6||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|7|7.0||||||
4170424|NCT00818623|3991318|B1|5-6||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|4|4.0||||||
4170425|NCT00818623|3991310|B9|2-4||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|31|31.0||||||
4170426|NCT00818623|3991311|B8|2-4||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|12|12.0||||||
4170427|NCT00818623|3991312|B7|2-4||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|5|5.0||||||
4170428|NCT00818623|3991313|B6|2-4||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|2|2.0||||||
4170429|NCT00818623|3991314|B5|2-4||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|5|5.0||||||
4170430|NCT00818623|3991315|B4|2-4||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|1|1.0||||||
4170431|NCT00818623|3991316|B3|2-4||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|2|2.0||||||
4170432|NCT00818623|3991317|B2|2-4||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|0|0.0||||||
4170433|NCT00818623|3991318|B1|2-4||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|4|4.0||||||
4170434|NCT00818623|3991310|B9|0-1||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|0|0.0||||||
4170435|NCT00818623|3991311|B8|0-1||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|0|0.0||||||
4170436|NCT00818623|3991312|B7|0-1||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|0|0.0||||||
4170437|NCT00818623|3991313|B6|0-1||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|0|0.0||||||
4170438|NCT00818623|3991314|B5|0-1||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|0|0.0||||||
4170439|NCT00818623|3991315|B4|0-1||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|0|0.0||||||
4170440|NCT00818623|3991316|B3|0-1||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|0|0.0||||||
4170441|NCT00818623|3991317|B2|0-1||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|0|0.0||||||
4170442|NCT00818623|3991318|B1|0-1||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|0|0.0||||||
4170443|NCT00818623|3991310|B9|No||Curative intent|A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|165|165.0||||||
4170444|NCT00818623|3991311|B8|No||Curative intent|A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|26|26.0||||||
4170445|NCT00818623|3991312|B7|No||Curative intent|A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|24|24.0||||||
4170446|NCT00818623|3991313|B6|No||Curative intent|A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|24|24.0||||||
4170447|NCT00818623|3991314|B5|No||Curative intent|A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|23|23.0||||||
4170448|NCT00818623|3991315|B4|No||Curative intent|A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|21|21.0||||||
4170449|NCT00818623|3991316|B3|No||Curative intent|A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|10|10.0||||||
4170450|NCT00818623|3991317|B2|No||Curative intent|A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|12|12.0||||||
4170451|NCT00818623|3991318|B1|No||Curative intent|A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|25|25.0||||||
4170452|NCT00818623|3991310|B9|Yes||Curative intent|A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|7|7.0||||||
4170453|NCT00818623|3991311|B8|Yes||Curative intent|A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|1|1.0||||||
4170454|NCT00818623|3991312|B7|Yes||Curative intent|A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|0|0.0||||||
4170455|NCT00818623|3991313|B6|Yes||Curative intent|A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|0|0.0||||||
4170456|NCT00818623|3991314|B5|Yes||Curative intent|A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|1|1.0||||||
4170457|NCT00818623|3991315|B4|Yes||Curative intent|A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|3|3.0||||||
4170458|NCT00818623|3991316|B3|Yes||Curative intent|A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|2|2.0||||||
4170459|NCT00818623|3991317|B2|Yes||Curative intent|A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|0|0.0||||||
4170460|NCT00818623|3991318|B1|Yes||Curative intent|A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|0|0.0||||||
4170461|NCT00818623|3991310|B9|Caucasian||Race/Ethnicity, Customized||participants|Number|172|172.0||||||
4170462|NCT00818623|3991311|B8|Caucasian||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4170463|NCT00818623|3991312|B7|Caucasian||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4170464|NCT00818623|3991313|B6|Caucasian||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4170465|NCT00818623|3991314|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4170466|NCT00818623|3991315|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4170467|NCT00818623|3991316|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4170468|NCT00818623|3991317|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4170469|NCT00818623|3991318|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4170470|NCT00818623|3991310|B9||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4170471|NCT00818623|3991311|B8||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4170472|NCT00818623|3991312|B7||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4170473|NCT00818623|3991313|B6||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4170474|NCT00818623|3991314|B5||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4170475|NCT00818623|3991315|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4170478|NCT00818623|3991318|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4170479|NCT00818623|3991310|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4170480|NCT00818623|3991311|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4170481|NCT00818623|3991312|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4170482|NCT00818623|3991313|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4170483|NCT00818623|3991314|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4170484|NCT00818623|3991315|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4170485|NCT00818623|3991316|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4170486|NCT00818623|3991317|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4170487|NCT00818623|3991318|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4170488|NCT00818623|3991310|B9|||Age||years|Mean|71.9|71.9|Standard Deviation|7.83|7.83|||
4170489|NCT00818623|3991311|B8|||Age||years|Mean|71.1|71.1|Standard Deviation|6.87|6.87|||
4170490|NCT00818623|3991312|B7|||Age||years|Mean|71.7|71.7|Standard Deviation|9.54|9.54|||
4170491|NCT00818623|3991313|B6|||Age||years|Mean|73.1|73.1|Standard Deviation|5.96|5.96|||
4170492|NCT00818623|3991314|B5|||Age||years|Mean|71.5|71.5|Standard Deviation|8.27|8.27|||
4170493|NCT00818623|3991315|B4|||Age||years|Mean|74.3|74.3|Standard Deviation|6.48|6.48|||
4170494|NCT00818623|3991316|B3|||Age||years|Mean|70.1|70.1|Standard Deviation|8.08|8.08|||
4170495|NCT00818623|3991317|B2|||Age||years|Mean|73.8|73.8|Standard Deviation|3.97|3.97|||
4170496|NCT00818623|3991318|B1|||Age||years|Mean|70.0|70.0|Standard Deviation|10.3|10.3|||
4170497|NCT00818623|3991310|B9||>=65 years|Age||Participants|Count of Participants|143|143.0||||||
4170498|NCT00818623|3991311|B8||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4170499|NCT00818623|3991312|B7||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4170500|NCT00818623|3991313|B6||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4170501|NCT00818623|3991314|B5||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4170502|NCT00818623|3991315|B4||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4170503|NCT00818623|3991316|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4170504|NCT00818623|3991317|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4170505|NCT00818623|3991318|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4170506|NCT00818623|3991310|B9||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4170507|NCT00818623|3991311|B8||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4170508|NCT00818623|3991312|B7||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4170509|NCT00818623|3991313|B6||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4170510|NCT00818623|3991314|B5||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4170511|NCT00818623|3991315|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4170512|NCT00818623|3991316|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4170513|NCT00818623|3991317|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4170514|NCT00818623|3991318|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4170515|NCT00818623|3991310|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4170516|NCT00818623|3991311|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4170517|NCT00818623|3991312|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4170518|NCT00818623|3991313|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4170519|NCT00818623|3991314|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4170520|NCT00818623|3991315|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4170521|NCT00818623|3991316|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4170522|NCT00818623|3991317|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4170523|NCT00818623|3991318|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4170524|NCT00818519|3991399|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4170525|NCT00818519|3991400|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4170526|NCT00818519|3991401|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4170527|NCT00818519|3991399|B3||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4170528|NCT00818519|3991400|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4170529|NCT00818519|3991401|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4170530|NCT00818519|3991399|B3|||Age|Age of participants was derived from birth date entered onto CRF (Case Report Form)|Years|Mean|23.7|23.7|Standard Deviation|5.6|5.6|||
4170531|NCT00818519|3991400|B2|||Age|Age of participants was derived from birth date entered onto CRF (Case Report Form)|Years|Mean|23.4|23.4|Standard Deviation|5.4|5.4|||
4170532|NCT00818519|3991401|B1|||Age|Age of participants was derived from birth date entered onto CRF (Case Report Form)|Years|Mean|24.0|24.0|Standard Deviation|5.8|5.8|||
4170533|NCT00818454|3991432|B1|||Weight||Kilograms|Mean|89.9|89.9|Standard Deviation|21.0|21.0|||
4170534|NCT00818454|3991432|B1|||Height||Centimeters|Mean|169.9|169.9|Standard Deviation|11.0|11.0|||
4170535|NCT00818454|3991432|B1|Drinks - possible interference||Alcohol history||Participants|Number|0|0.0||||||
4170536|NCT00818454|3991432|B1|Drinks - no interference||Alcohol history||Participants|Number|150|150.0||||||
4170537|NCT00818454|3991432|B1|Non drinker||Alcohol history||Participants|Number|76|76.0||||||
4170538|NCT00818454|3991432|B1|Currently smokes||Smoking history||Participants|Number|0|0.0||||||
4170539|NCT00818454|3991432|B1|Ex-smoker||Smoking history||Participants|Number|63|63.0||||||
4170540|NCT00818454|3991432|B1|Never smoked||Smoking history||Participants|Number|163|163.0||||||
4170541|NCT00818454|3991432|B1|||Body mass index||Kilograms per square meter|Mean|31.1|31.1|Standard Deviation|6.7|6.7|||
4170542|NCT00818454|3991432|B1|White||Race/Ethnicity, Customized||Participants|Number|174|174.0||||||
4170543|NCT00818454|3991432|B1|Hawaiian/Pacif. Isle||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4170544|NCT00818454|3991432|B1|Black/African Amer.||Race/Ethnicity, Customized||Participants|Number|44|44.0||||||
4170545|NCT00818454|3991432|B1|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4170546|NCT00818454|3991432|B1|Amer. Ind./Alaska Nat||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4170547|NCT00818454|3991432|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170548|NCT00818454|3991432|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|215|215.0||||||
4170549|NCT00818454|3991432|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4170550|NCT00818454|3991432|B1||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4170551|NCT00818454|3991432|B1||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4170552|NCT00818454|3991432|B1|||Age||Years|Mean|47.1|47.1|Standard Deviation|13.7|13.7|||
4170553|NCT00818441|3991461|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4170554|NCT00818441|3991462|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4170555|NCT00818441|3991463|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4170556|NCT00818441|3991461|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4170557|NCT00818441|3991462|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4170558|NCT00818441|3991463|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4170559|NCT00818441|3991461|B3|||Age||years|Mean|61.3|61.3|Standard Deviation|11.30|11.3|||
4170560|NCT00818441|3991462|B2|||Age||years|Mean|57.3|57.3|Standard Deviation|10.88|10.88|||
4170561|NCT00818441|3991463|B1|||Age||years|Mean|62.7|62.7|Standard Deviation|11.18|11.18|||
4170562|NCT00818389|3991484|B3|||Vital Capacity|Vital capacity (VC) testing is a measure of lung function that is performed using a standard spirometer and the Slow VC method. Three trials were required (5 maximum); the best of 3 was used.|Percent of predicted normal|Mean|90.18|90.18|Standard Deviation|18.20|18.2|||
4170563|NCT00818389|3991485|B2|||Vital Capacity|Vital capacity (VC) testing is a measure of lung function that is performed using a standard spirometer and the Slow VC method. Three trials were required (5 maximum); the best of 3 was used.|Percent of predicted normal|Mean|86.9|86.9|Standard Deviation|16.9|16.9|||
4170564|NCT00818389|3991486|B1|||Vital Capacity|Vital capacity (VC) testing is a measure of lung function that is performed using a standard spirometer and the Slow VC method. Three trials were required (5 maximum); the best of 3 was used.|Percent of predicted normal|Mean|94.0|94.0|Standard Deviation|18.1|18.1|||
4170565|NCT00818389|3991484|B3|||ALS Functional Rating Scale-Revised (ALSFRS-R)|ALSFRS-R is an ordinal rating scale questionnaire (rating 0-4) used to determine subject's assessment of their capability and independence in 12 functional activities (i.e. this is a patient-reported questionnaire scale of disability). Each question has a rating of 0-4 with 4 being the most functional and 0 being the least functional. The most functional total score is 48.|Scores on a scale|Mean|37.43|37.43|Standard Deviation|5.24|5.24|||
4170566|NCT00818389|3991485|B2|||ALS Functional Rating Scale-Revised (ALSFRS-R)|ALSFRS-R is an ordinal rating scale questionnaire (rating 0-4) used to determine subject's assessment of their capability and independence in 12 functional activities (i.e. this is a patient-reported questionnaire scale of disability). Each question has a rating of 0-4 with 4 being the most functional and 0 being the least functional. The most functional total score is 48.|Scores on a scale|Mean|36.5|36.5|Standard Deviation|5.7|5.7|||
4170567|NCT00818389|3991486|B1|||ALS Functional Rating Scale-Revised (ALSFRS-R)|ALSFRS-R is an ordinal rating scale questionnaire (rating 0-4) used to determine subject's assessment of their capability and independence in 12 functional activities (i.e. this is a patient-reported questionnaire scale of disability). Each question has a rating of 0-4 with 4 being the most functional and 0 being the least functional. The most functional total score is 48.|Scores on a scale|Mean|38.4|38.4|Standard Deviation|4.6|4.6|||
4170568|NCT00818389|3991484|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170569|NCT00818389|3991485|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170570|NCT00818389|3991486|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170571|NCT00818389|3991484|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170572|NCT00818389|3991485|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170573|NCT00818389|3991486|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170574|NCT00818389|3991484|B3||White|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
4170575|NCT00818389|3991485|B2||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4170576|NCT00818389|3991486|B1||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4170577|NCT00818389|3991484|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4170578|NCT00818389|3991485|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4170579|NCT00818389|3991486|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4170580|NCT00818389|3991484|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170581|NCT00818389|3991485|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170582|NCT00818389|3991486|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170583|NCT00818389|3991484|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170584|NCT00818389|3991485|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170585|NCT00818389|3991486|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170586|NCT00818389|3991484|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170587|NCT00818389|3991485|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170588|NCT00818389|3991486|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170589|NCT00818389|3991484|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170590|NCT00818389|3991485|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170591|NCT00818389|3991486|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170592|NCT00818389|3991484|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
4170593|NCT00818389|3991485|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4170594|NCT00818389|3991486|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4170595|NCT00818389|3991484|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4170596|NCT00818389|3991485|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4170597|NCT00818389|3991486|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170598|NCT00818389|3991484|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4170599|NCT00818389|3991485|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4170600|NCT00818389|3991486|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4170601|NCT00818389|3991484|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4170602|NCT00818389|3991485|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4170603|NCT00818389|3991486|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4170604|NCT00818389|3991484|B3|||Age||Years|Mean|56.24|56.24|Standard Deviation|11.16|11.16|||
4170605|NCT00818389|3991485|B2|||Age||Years|Mean|55.5|55.5|Standard Deviation|11.9|11.9|||
4170606|NCT00818389|3991486|B1|||Age||Years|Mean|58.3|58.3|Standard Deviation|10.2|10.2|||
4170607|NCT00818337|3991497|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4170608|NCT00818337|3991497|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4170609|NCT00818337|3991497|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4170610|NCT00818337|3991497|B1|Resistant to 81 mg||Age||years|Mean|56.7|56.7|Standard Deviation|7.1|7.1|||
4170611|NCT00818337|3991497|B1|Non-resistant to 81 mg||Age||years|Mean|52.6|52.6|Standard Deviation|8.3|8.3|||
4170612|NCT00818337|3991497|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4170613|NCT00818337|3991497|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4170614|NCT00818337|3991497|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4170615|NCT00818324|3991502|B1|Japan||Region of Enrollment||participants|Number|154|154.0||||||
4170616|NCT00818324|3991502|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4170617|NCT00818324|3991502|B1||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4170618|NCT00818324|3991502|B1||>=65 years|Age||Participants|Count of Participants|64|64.0||||||
4170619|NCT00818324|3991502|B1||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
4170620|NCT00818324|3991502|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4170621|NCT00818324|3991502|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|14.7|14.7|||
4170622|NCT00818272|3991507|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4170623|NCT00818272|3991507|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4170624|NCT00818272|3991507|B1|||Age|Age data collected for 147 participants|years|Mean|36.01|36.01|Standard Deviation|11.13|11.13|||
4170625|NCT00818259|3991515|B8||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4170626|NCT00818259|3991516|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4170627|NCT00818259|3991517|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4170628|NCT00818259|3991518|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4170629|NCT00818259|3991519|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4170630|NCT00818259|3991520|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4170631|NCT00818259|3991521|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4170632|NCT00818259|3991522|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4170633|NCT00818259|3991515|B8||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4170634|NCT00818259|3991516|B7||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4170635|NCT00818259|3991517|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4170636|NCT00818259|3991518|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4170637|NCT00818259|3991519|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4170638|NCT00818259|3991520|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4170639|NCT00818259|3991521|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4170640|NCT00818259|3991522|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4170641|NCT00818259|3991515|B8|12 years to 17 years||Age, Customized||Participants|Number|23|23.0||||||
4170642|NCT00818259|3991516|B7|12 years to 17 years||Age, Customized||Participants|Number|0|0.0||||||
4170643|NCT00818259|3991517|B6|12 years to 17 years||Age, Customized||Participants|Number|0|0.0||||||
4170644|NCT00818259|3991518|B5|12 years to 17 years||Age, Customized||Participants|Number|0|0.0||||||
4170645|NCT00818259|3991519|B4|12 years to 17 years||Age, Customized||Participants|Number|0|0.0||||||
4170646|NCT00818259|3991520|B3|12 years to 17 years||Age, Customized||Participants|Number|0|0.0||||||
4170647|NCT00818259|3991521|B2|12 years to 17 years||Age, Customized||Participants|Number|11|11.0||||||
4170648|NCT00818259|3991522|B1|12 years to 17 years||Age, Customized||Participants|Number|12|12.0||||||
4170649|NCT00818259|3991515|B8|6 years to <12 years||Age, Customized||Participants|Number|25|25.0||||||
4170650|NCT00818259|3991516|B7|6 years to <12 years||Age, Customized||Participants|Number|2|2.0||||||
4170651|NCT00818259|3991517|B6|6 years to <12 years||Age, Customized||Participants|Number|4|4.0||||||
4170652|NCT00818259|3991518|B5|6 years to <12 years||Age, Customized||Participants|Number|7|7.0||||||
4170653|NCT00818259|3991519|B4|6 years to <12 years||Age, Customized||Participants|Number|6|6.0||||||
4170654|NCT00818259|3991520|B3|6 years to <12 years||Age, Customized||Participants|Number|6|6.0||||||
4170655|NCT00818259|3991521|B2|6 years to <12 years||Age, Customized||Participants|Number|0|0.0||||||
4170656|NCT00818259|3991522|B1|6 years to <12 years||Age, Customized||Participants|Number|0|0.0||||||
4170657|NCT00818259|3991515|B8|2 years to <6 years||Age, Customized||Participants|Number|25|25.0||||||
4170658|NCT00818259|3991516|B7|2 years to <6 years||Age, Customized||Participants|Number|3|3.0||||||
4170659|NCT00818259|3991517|B6|2 years to <6 years||Age, Customized||Participants|Number|0|0.0||||||
4170660|NCT00818259|3991518|B5|2 years to <6 years||Age, Customized||Participants|Number|6|6.0||||||
4170661|NCT00818259|3991519|B4|2 years to <6 years||Age, Customized||Participants|Number|8|8.0||||||
4170662|NCT00818259|3991520|B3|2 years to <6 years||Age, Customized||Participants|Number|8|8.0||||||
4170663|NCT00818259|3991521|B2|2 years to <6 years||Age, Customized||Participants|Number|0|0.0||||||
4170664|NCT00818259|3991522|B1|2 years to <6 years||Age, Customized||Participants|Number|0|0.0||||||
4170665|NCT00818259|3991515|B8|6 months to <2 years||Age, Customized||Participants|Number|19|19.0||||||
4170666|NCT00818259|3991516|B7|6 months to <2 years||Age, Customized||Participants|Number|1|1.0||||||
4170667|NCT00818259|3991517|B6|6 months to <2 years||Age, Customized||Participants|Number|1|1.0||||||
4170668|NCT00818259|3991518|B5|6 months to <2 years||Age, Customized||Participants|Number|6|6.0||||||
4170669|NCT00818259|3991519|B4|6 months to <2 years||Age, Customized||Participants|Number|6|6.0||||||
4170670|NCT00818259|3991520|B3|6 months to <2 years||Age, Customized||Participants|Number|5|5.0||||||
4170671|NCT00818259|3991521|B2|6 months to <2 years||Age, Customized||Participants|Number|0|0.0||||||
4170672|NCT00818259|3991522|B1|6 months to <2 years||Age, Customized||Participants|Number|0|0.0||||||
4170673|NCT00818246|3991602|B1|Canada||Region of Enrollment||participants|Number|40|40.0||||||
4170674|NCT00818246|3991602|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4170675|NCT00818246|3991602|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4170676|NCT00818246|3991602|B1|||Age||years|Mean|45|45.0|Standard Deviation|7|7.0|||
4170677|NCT00818246|3991602|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4170678|NCT00818246|3991602|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4170679|NCT00818246|3991602|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4170680|NCT00818207|3991609|B3||Male|Sex: Female, Male||Participants|Count of Participants|691|691.0||||||
4170681|NCT00818207|3991610|B2||Male|Sex: Female, Male||Participants|Count of Participants|337|337.0||||||
4170682|NCT00818207|3991611|B1||Male|Sex: Female, Male||Participants|Count of Participants|354|354.0||||||
4170683|NCT00818207|3991609|B3||Female|Sex: Female, Male||Participants|Count of Participants|689|689.0||||||
4170684|NCT00818207|3991610|B2||Female|Sex: Female, Male||Participants|Count of Participants|347|347.0||||||
4170685|NCT00818207|3991611|B1||Female|Sex: Female, Male||Participants|Count of Participants|342|342.0||||||
4170686|NCT00818207|3991609|B3|||Age||Years|Mean|46.6|46.6|Standard Deviation|12.3|12.3|||
4170687|NCT00818207|3991610|B2|||Age||Years|Mean|46.7|46.7|Standard Deviation|12.3|12.3|||
4170688|NCT00818207|3991611|B1|||Age||Years|Mean|46.5|46.5|Standard Deviation|12.3|12.3|||
4170689|NCT00818168|3991626|B1|Germany||Region of Enrollment||participants|Number|320|320.0||||||
4170690|NCT00818168|3991626|B1||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4170691|NCT00818168|3991626|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4170692|NCT00818168|3991626|B1|||Age||years|Mean|40.99|40.99|Standard Deviation|12.02|12.02|||
4170693|NCT00818116|3991634|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4170694|NCT00818116|3991634|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4170695|NCT00818116|3991634|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4170696|NCT00818116|3991634|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4170697|NCT00818116|3991634|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4170698|NCT00817999|3991638|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4170699|NCT00817999|3991639|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4170700|NCT00817999|3991640|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4170701|NCT00817999|3991638|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4170702|NCT00817999|3991639|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4170703|NCT00817999|3991640|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4170704|NCT00817999|3991638|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4170705|NCT00817999|3991639|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4170706|NCT00817999|3991640|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4170707|NCT00817999|3991638|B3|||Age||years|Mean|25.47|25.47|Standard Deviation|5.66|5.66|||
4170708|NCT00817999|3991639|B2|||Age||years|Mean|25.47|25.47|Standard Deviation|5.66|5.66|||
4170709|NCT00817999|3991640|B1|||Age||years|Mean|24.4|24.4|Standard Deviation|5.9|5.9|||
4170710|NCT00817999|3991638|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4170711|NCT00817999|3991639|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4170712|NCT00817999|3991640|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4170713|NCT00817999|3991638|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4170714|NCT00817999|3991639|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4170715|NCT00817999|3991640|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4170716|NCT00817999|3991638|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4170717|NCT00817999|3991639|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4170718|NCT00817999|3991640|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4170719|NCT00817843|3991649|B1|Netherlands||Region of Enrollment||participants|Number|84|84.0||||||
4170720|NCT00817843|3991649|B1|Spain||Region of Enrollment||participants|Number|16|16.0||||||
4170721|NCT00817843|3991649|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4170722|NCT00817843|3991649|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4170723|NCT00817843|3991649|B1|||Age||years|Mean|57|57.0|Standard Deviation|9|9.0|||
4170724|NCT00817843|3991649|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4170725|NCT00817843|3991649|B1||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
4170726|NCT00817843|3991649|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4170727|NCT00817804|3991655|B3|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4170728|NCT00817804|3991656|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4170729|NCT00817804|3991657|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4170730|NCT00817804|3991655|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4170731|NCT00817804|3991656|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4170732|NCT00817804|3991657|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4170733|NCT00817804|3991655|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4170734|NCT00817804|3991656|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4170735|NCT00817804|3991657|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4170736|NCT00817804|3991655|B3|||Age||years|Mean|13.0|13.0|Standard Deviation|4.4|4.4|||
4170737|NCT00817804|3991656|B2|||Age||years|Mean|11.5|11.5|Standard Deviation|4.9|4.9|||
4170738|NCT00817804|3991657|B1|||Age||years|Mean|16.0|16.0|Standard Deviation|0|0.0|||
4170739|NCT00817804|3991655|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4170740|NCT00817804|3991656|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4170741|NCT00817804|3991657|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4170742|NCT00817804|3991655|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4170743|NCT00817804|3991656|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4170744|NCT00817804|3991657|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4170745|NCT00817804|3991655|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4170746|NCT00817804|3991656|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4170747|NCT00817804|3991657|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4170748|NCT00817778|3991664|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4170749|NCT00817778|3991665|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4170750|NCT00817778|3991666|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4170751|NCT00817778|3991664|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4170752|NCT00817778|3991665|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4170753|NCT00817778|3991666|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4170754|NCT00817778|3991664|B3|||Age||years|Mean|60.2|60.2|Full Range|||34.0|74.0|
4170755|NCT00817778|3991665|B2|||Age||years|Mean|60.3|60.3|Full Range|||34.0|74.0|
4170756|NCT00817778|3991666|B1|||Age||years|Mean|60.2|60.2|Full Range|||39.0|72.0|
4170757|NCT00817596|3991692|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4170758|NCT00817596|3991692|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4170759|NCT00817596|3991692|B1|||Age||years|Mean|56|56.0|Standard Deviation|13|13.0|||
4170760|NCT00817531|3991696|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4170761|NCT00817531|3991696|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4170762|NCT00817531|3991696|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4170763|NCT00817531|3991696|B1|||Age||years|Mean|48.5|48.5|Standard Deviation|12.7|12.7|||
4170764|NCT00817531|3991696|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4170765|NCT00817531|3991696|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4170766|NCT00817531|3991696|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4170767|NCT00817479|3991700|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4170768|NCT00817479|3991701|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4170769|NCT00817479|3991702|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4170770|NCT00817479|3991700|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4170771|NCT00817479|3991701|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4170772|NCT00817479|3991702|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4170773|NCT00817479|3991700|B3|||Age||years|Median|56|56.0|Full Range|||44.0|80.0|
4170774|NCT00817479|3991701|B2|||Age||years|Median|53.5|53.5|Full Range|||44.0|73.0|
4170775|NCT00817479|3991702|B1|||Age||years|Median|61|61.0|Full Range|||46.0|80.0|
4170776|NCT00817336|3991711|B3|||PANSS total|Positive and Negative Symptom Scale (PANSS) range from 30-210, with higher scores worse|units on a scale|Mean|80.8|80.8|Standard Deviation|8.4|8.4|||
4170777|NCT00817336|3991712|B2|||PANSS total|Positive and Negative Symptom Scale (PANSS) range from 30-210, with higher scores worse|units on a scale|Mean|80.1|80.1|Standard Deviation|10|10.0|||
4170778|NCT00817336|3991713|B1|||PANSS total|Positive and Negative Symptom Scale (PANSS) range from 30-210, with higher scores worse|units on a scale|Mean|83.7|83.7|Standard Deviation|9|9.0|||
4170779|NCT00817336|3991711|B3|||Chlorpromazine equivalents||mg|Mean|965|965.0|Standard Deviation|760|760.0|||
4170780|NCT00817336|3991712|B2|||Chlorpromazine equivalents||mg|Mean|795|795.0|Standard Deviation|496|496.0|||
4170781|NCT00817336|3991713|B1|||Chlorpromazine equivalents||mg|Mean|1135|1135.0|Standard Deviation|967|967.0|||
4170782|NCT00817336|3991711|B3|||In-patient number||Participants|Count of Participants|10|10.0||||||
4170783|NCT00817336|3991712|B2|||In-patient number||Participants|Count of Participants|4|4.0||||||
4170784|NCT00817336|3991713|B1|||In-patient number||Participants|Count of Participants|6|6.0||||||
4170785|NCT00817336|3991711|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4170786|NCT00817336|3991712|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4170787|NCT00817336|3991713|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4170788|NCT00817336|3991711|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4170789|NCT00817336|3991712|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4170790|NCT00817336|3991713|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4170791|NCT00817336|3991711|B3|||Age||years|Mean|40|40.0|Standard Deviation|11|11.0|||
4170792|NCT00817336|3991712|B2|||Age||years|Mean|44.6|44.6|Standard Deviation|11|11.0|||
4170793|NCT00817336|3991713|B1|||Age||years|Mean|36|36.0|Standard Deviation|10|10.0|||
4170794|NCT00817219|3991725|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4170795|NCT00817219|3991725|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4170796|NCT00817219|3991725|B1|||Age||years|Mean|14.6|14.6|Standard Deviation|1.6|1.6|||
4170797|NCT00817206|3991738|B3|Europe||Region of Enrollment||participants|Number|83|83.0||||||
4170798|NCT00817206|3991739|B2|Europe||Region of Enrollment||participants|Number|42|42.0||||||
4170799|NCT00817206|3991740|B1|Europe||Region of Enrollment||participants|Number|41|41.0||||||
4170800|NCT00817206|3991738|B3|United States||Region of Enrollment||participants|Number|243|243.0||||||
4170801|NCT00817206|3991739|B2|United States||Region of Enrollment||participants|Number|121|121.0||||||
4170802|NCT00817206|3991740|B1|United States||Region of Enrollment||participants|Number|122|122.0||||||
4170803|NCT00817206|3991738|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4170804|NCT00817206|3991739|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4170805|NCT00817206|3991740|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4170806|NCT00817206|3991738|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170807|NCT00817206|3991739|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170808|NCT00817206|3991740|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170809|NCT00817206|3991738|B3||White|Race (NIH/OMB)||Participants|Count of Participants|237|237.0||||||
4170810|NCT00817206|3991739|B2||White|Race (NIH/OMB)||Participants|Count of Participants|117|117.0||||||
4170811|NCT00817206|3991740|B1||White|Race (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
4170812|NCT00817206|3991738|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4170813|NCT00817206|3991739|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4170814|NCT00817206|3991740|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4170815|NCT00817206|3991738|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4170816|NCT00817206|3991739|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4170817|NCT00817206|3991740|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170818|NCT00817206|3991738|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4170819|NCT00817206|3991739|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4170820|NCT00817206|3991740|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4170821|NCT00817206|3991738|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4170822|NCT00817206|3991739|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4170823|NCT00817206|3991740|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170824|NCT00817206|3991738|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170825|NCT00817206|3991739|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170826|NCT00817206|3991740|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170827|NCT00817206|3991738|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|271|271.0||||||
4170828|NCT00817206|3991739|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
4170829|NCT00817206|3991740|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|137|137.0||||||
4170830|NCT00817206|3991738|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4170831|NCT00817206|3991739|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4170832|NCT00817206|3991740|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4170833|NCT00817206|3991738|B3||Male|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
4170834|NCT00817206|3991739|B2||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4170835|NCT00817206|3991740|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4170836|NCT00817206|3991738|B3||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4170837|NCT00817206|3991739|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4170838|NCT00817206|3991740|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4170839|NCT00817206|3991738|B3|||Age||years|Mean|50.3|50.3|Standard Deviation|1.61|1.61|||
4170840|NCT00817206|3991739|B2|||Age||years|Mean|50.2|50.2|Standard Deviation|13.49|13.49|||
4170841|NCT00817206|3991740|B1|||Age||years|Mean|50.4|50.4|Standard Deviation|11.71|11.71|||
4170842|NCT00817206|3991738|B3||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
4170843|NCT00817206|3991739|B2||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4170844|NCT00817206|3991740|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4170845|NCT00817206|3991738|B3||Between 18 and 65 years|Age||Participants|Count of Participants|283|283.0||||||
4170846|NCT00817206|3991739|B2||Between 18 and 65 years|Age||Participants|Count of Participants|137|137.0||||||
4170847|NCT00817206|3991740|B1||Between 18 and 65 years|Age||Participants|Count of Participants|146|146.0||||||
4170848|NCT00817206|3991738|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4170849|NCT00817206|3991739|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4170850|NCT00817206|3991740|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4170851|NCT00817063|3991747|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4170852|NCT00817063|3991748|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4170853|NCT00817063|3991749|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4170854|NCT00817063|3991747|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170855|NCT00817063|3991748|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170856|NCT00817063|3991749|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170857|NCT00817063|3991747|B3||White|Race (NIH/OMB)||Participants|Count of Participants|501|501.0||||||
4170858|NCT00817063|3991748|B2||White|Race (NIH/OMB)||Participants|Count of Participants|238|238.0||||||
4170859|NCT00817063|3991749|B1||White|Race (NIH/OMB)||Participants|Count of Participants|263|263.0||||||
4170860|NCT00817063|3991747|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4170861|NCT00817063|3991748|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4170862|NCT00817063|3991749|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4170863|NCT00817063|3991747|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170864|NCT00817063|3991748|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170865|NCT00817063|3991749|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170866|NCT00817063|3991747|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4170867|NCT00817063|3991748|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4170868|NCT00817063|3991749|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4170869|NCT00817063|3991747|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170870|NCT00817063|3991748|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170871|NCT00817063|3991749|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4170872|NCT00817063|3991747|B3||Male|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
4170873|NCT00817063|3991748|B2||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4170874|NCT00817063|3991749|B1||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4170875|NCT00817063|3991747|B3||Female|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
4170876|NCT00817063|3991748|B2||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4170877|NCT00817063|3991749|B1||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4170878|NCT00817063|3991747|B3|||Age||Years|Mean|47.3|47.3|Standard Deviation|12.75|12.75|||
4170879|NCT00817063|3991748|B2|||Age||Years|Mean|47.5|47.5|Standard Deviation|12.96|12.96|||
4170880|NCT00817063|3991749|B1|||Age||Years|Mean|47.1|47.1|Standard Deviation|12.55|12.55|||
4170881|NCT00816907|3991792|B3||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4170882|NCT00816907|3991793|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4170883|NCT00816907|3991794|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4170884|NCT00816907|3991792|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4170885|NCT00816907|3991793|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4170886|NCT00816907|3991794|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4170887|NCT00816907|3991792|B3|||Age||years|Mean|43.2|43.2|Standard Deviation|11.1|11.1|||
4170888|NCT00816907|3991793|B2|||Age||years|Mean|41.4|41.4|Standard Deviation|11.5|11.5|||
4170889|NCT00816907|3991794|B1|||Age||years|Mean|45.0|45.0|Standard Deviation|10.3|10.3|||
4170890|NCT00816829|3991815|B3|France||Region of Enrollment||participants|Number|34|34.0||||||
4170891|NCT00816829|3991816|B2|France||Region of Enrollment||participants|Number|18|18.0||||||
4170892|NCT00816829|3991817|B1|France||Region of Enrollment||participants|Number|16|16.0||||||
4170893|NCT00816829|3991815|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4170894|NCT00816829|3991816|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4170895|NCT00816829|3991817|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4170896|NCT00816829|3991815|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4170897|NCT00816829|3991816|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4170898|NCT00816829|3991817|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4170899|NCT00816829|3991815|B3|||Age||years|Mean|55.6|55.6|Standard Deviation|5.8|5.8|||
4170900|NCT00816829|3991816|B2|||Age||years|Mean|55.9|55.9|Standard Deviation|5.4|5.4|||
4170901|NCT00816829|3991817|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|6.5|6.5|||
4170902|NCT00816777|3991842|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4170903|NCT00816777|3991843|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4170904|NCT00816777|3991844|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4170905|NCT00816777|3991842|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4170906|NCT00816777|3991843|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4170907|NCT00816777|3991844|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4170908|NCT00816777|3991842|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4170909|NCT00816777|3991843|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4170910|NCT00816777|3991844|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4170911|NCT00816777|3991842|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4170912|NCT00816777|3991843|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4170913|NCT00816777|3991844|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4170914|NCT00816777|3991842|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4170915|NCT00816777|3991843|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4170916|NCT00816777|3991844|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4170917|NCT00816777|3991842|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4170918|NCT00816777|3991843|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4170919|NCT00816777|3991844|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4170920|NCT00816777|3991842|B3|||Age||years|Mean|58.25|58.25|Full Range|||55.0|64.0|
4170921|NCT00816777|3991843|B2|||Age||years|Mean|63|63.0|Full Range|||60.0|64.0|
4170922|NCT00816777|3991844|B1|||Age||years|Mean|56|56.0|Full Range|||55.0|57.0|
4170923|NCT00816595|3991865|B3|United States||Region of Enrollment||participants|Number|66|66.0||||||
4170924|NCT00816595|3991866|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4170925|NCT00816595|3991867|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4170926|NCT00816595|3991865|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4170927|NCT00816595|3991866|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4170928|NCT00816595|3991867|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4170929|NCT00816595|3991865|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4170930|NCT00816595|3991866|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4170931|NCT00816595|3991867|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4170932|NCT00816595|3991865|B3|||Age||years|Median|63.5|63.5|Full Range|||43.0|81.0|
4170933|NCT00816595|3991866|B2|||Age||years|Median|63|63.0|Full Range|||50.0|78.0|
4170934|NCT00816595|3991867|B1|||Age||years|Median|65|65.0|Full Range|||43.0|81.0|
4170935|NCT00816556|3991878|B4|United States||Region of Enrollment||participants|Number|56|56.0||||||
4170936|NCT00816556|3991879|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4170937|NCT00816556|3991880|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4170938|NCT00816556|3991881|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4170939|NCT00816556|3991878|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4170940|NCT00816556|3991879|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4170941|NCT00816556|3991880|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4170942|NCT00816556|3991881|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4170943|NCT00816556|3991878|B4||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4170944|NCT00816556|3991879|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4170945|NCT00816556|3991880|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4170946|NCT00816556|3991881|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4170947|NCT00816556|3991878|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4170948|NCT00816556|3991879|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4170949|NCT00816556|3991880|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4170950|NCT00816556|3991881|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4170951|NCT00816556|3991878|B4||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4170952|NCT00816556|3991879|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4170953|NCT00816556|3991880|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4170954|NCT00816556|3991881|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4170955|NCT00816556|3991878|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4170956|NCT00816556|3991879|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4170957|NCT00816556|3991880|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4170958|NCT00816556|3991881|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4170959|NCT00816400|3991897|B10||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4170960|NCT00816400|3991898|B9||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4170961|NCT00816400|3991899|B8||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4170962|NCT00816400|3991900|B7||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4170963|NCT00816400|3991901|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4170964|NCT00816400|3991902|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4170965|NCT00816400|3991903|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4170966|NCT00816400|3991904|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4170967|NCT00816400|3991905|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4170968|NCT00816400|3991906|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4170969|NCT00816400|3991897|B10||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4170970|NCT00816400|3991898|B9||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4170971|NCT00816400|3991899|B8||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4170972|NCT00816400|3991900|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4170973|NCT00816400|3991901|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4170974|NCT00816400|3991902|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4170975|NCT00816400|3991903|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4170976|NCT00816400|3991904|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4170977|NCT00816400|3991905|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4170978|NCT00816400|3991906|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4170979|NCT00816400|3991897|B10|||Age||Years|Mean|63.3|63.3|Standard Deviation|10.3|10.3|||
4170980|NCT00816400|3991898|B9|||Age||Years|Mean|59.3|59.3|Standard Deviation|6.6|6.6|||
4170981|NCT00816400|3991899|B8|||Age||Years|Mean|68.2|68.2|Standard Deviation|15.1|15.1|||
4170982|NCT00816400|3991900|B7|||Age||Years|Mean|68.3|68.3|Standard Deviation|8.4|8.4|||
4170983|NCT00816400|3991901|B6|||Age||Years|Mean|58.0|58.0|Standard Deviation|8.5|8.5|||
4170984|NCT00816400|3991902|B5|||Age||Years|Mean|67.0|67.0|Standard Deviation|10.5|10.5|||
4170985|NCT00816400|3991903|B4|||Age||Years|Mean|66.3|66.3|Standard Deviation|9.1|9.1|||
4170986|NCT00816400|3991904|B3|||Age||Years|Mean|60.2|60.2|Standard Deviation|8.5|8.5|||
4170987|NCT00816400|3991905|B2|||Age||Years|Mean|65.0|65.0|Standard Deviation|8.5|8.5|||
4170988|NCT00816400|3991906|B1|||Age||Years|Mean|58.0|58.0|Standard Deviation|16.5|16.5|||
4170989|NCT00816348|3992098|B1|||bilirubin level||mg/dL|Mean|6.79|6.79|Standard Deviation|4.14|4.14|||
4170990|NCT00816348|3992098|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4170991|NCT00816348|3992098|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4170992|NCT00816348|3992098|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4170993|NCT00816348|3992098|B1|||Age||days|Mean|89.3|89.3|Full Range|||35.0|306.0|
4170994|NCT00816348|3992098|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4170995|NCT00816348|3992098|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4170996|NCT00816348|3992098|B1||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4170997|NCT00816166|3992102|B3|Austria||Region of Enrollment||participants|Number|8|8.0||||||
4170998|NCT00816166|3992103|B2|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4170999|NCT00816166|3992104|B1|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4171000|NCT00816166|3992102|B3|China||Region of Enrollment||participants|Number|14|14.0||||||
4171001|NCT00816166|3992103|B2|China||Region of Enrollment||participants|Number|7|7.0||||||
4171002|NCT00816166|3992104|B1|China||Region of Enrollment||participants|Number|7|7.0||||||
4171003|NCT00816166|3992102|B3|United States||Region of Enrollment||participants|Number|89|89.0||||||
4171004|NCT00816166|3992103|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
4171005|NCT00816166|3992104|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
4171006|NCT00816166|3992102|B3|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4171007|NCT00816166|3992103|B2|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4171008|NCT00816166|3992104|B1|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4171009|NCT00816166|3992102|B3|White||Race/Ethnicity, Customized||Participants|Number|80|80.0||||||
4171010|NCT00816166|3992103|B2|White||Race/Ethnicity, Customized||Participants|Number|38|38.0||||||
4171011|NCT00816166|3992104|B1|White||Race/Ethnicity, Customized||Participants|Number|42|42.0||||||
4171012|NCT00816166|3992102|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4171013|NCT00816166|3992103|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4171014|NCT00816166|3992104|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4171015|NCT00816166|3992102|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4171016|NCT00816166|3992103|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4171017|NCT00816166|3992104|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4171018|NCT00816166|3992102|B3|Asian||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4171019|NCT00816166|3992103|B2|Asian||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4171020|NCT00816166|3992104|B1|Asian||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4171021|NCT00816166|3992102|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171022|NCT00816166|3992103|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171023|NCT00816166|3992104|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171024|NCT00816166|3992102|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
4171025|NCT00816166|3992103|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4171026|NCT00816166|3992104|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4171027|NCT00816166|3992102|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4171028|NCT00816166|3992103|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4171029|NCT00816166|3992104|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4171030|NCT00816166|3992102|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4171031|NCT00816166|3992103|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4171032|NCT00816166|3992104|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4171033|NCT00816166|3992102|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4171034|NCT00816166|3992103|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4171035|NCT00816166|3992104|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4171036|NCT00816166|3992102|B3|||Age||years|Mean|61.8|61.8|Standard Deviation|12.5|12.5|||
4171037|NCT00816166|3992103|B2|||Age||years|Mean|61.8|61.8|Standard Deviation|12.8|12.8|||
4171038|NCT00816166|3992104|B1|||Age||years|Mean|61.8|61.8|Standard Deviation|12.3|12.3|||
4171039|NCT00816101|3992111|B4|United States||Region of Enrollment||participants|Number|26|26.0||||||
4171040|NCT00816101|3992112|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4171041|NCT00816101|3992113|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4171042|NCT00816101|3992114|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4171043|NCT00816101|3992111|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4171044|NCT00816101|3992112|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4171045|NCT00816101|3992113|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4171046|NCT00816101|3992114|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4171047|NCT00816101|3992111|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4171048|NCT00816101|3992112|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4171049|NCT00816101|3992113|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4171050|NCT00816101|3992114|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4171051|NCT00816101|3992111|B4|||Age||years|Mean|74.9|74.9|Standard Deviation|8.6|8.6|||
4171052|NCT00816101|3992112|B3|||Age||years|Mean|76.6|76.6|Standard Deviation|8.4|8.4|||
4171053|NCT00816101|3992113|B2|||Age||years|Mean|74.8|74.8|Standard Deviation|9.9|9.9|||
4171054|NCT00816101|3992114|B1|||Age||years|Mean|76.6|76.6|Standard Deviation|8.4|8.4|||
4171055|NCT00816101|3992111|B4||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4171056|NCT00816101|3992112|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4171057|NCT00816101|3992113|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4171058|NCT00816101|3992114|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4171059|NCT00816101|3992111|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4171060|NCT00816101|3992112|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4171061|NCT00816101|3992113|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4171062|NCT00816101|3992114|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4171063|NCT00816101|3992111|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4171064|NCT00816101|3992112|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4171065|NCT00816101|3992113|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4171066|NCT00816101|3992114|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4171067|NCT00816062|3992130|B1|United States||Region of Enrollment||participants|Number|260|260.0||||||
4171068|NCT00816062|3992130|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171069|NCT00816062|3992130|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4171070|NCT00816062|3992130|B1||White|Race (NIH/OMB)||Participants|Count of Participants|241|241.0||||||
4171071|NCT00816062|3992130|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4171072|NCT00816062|3992130|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171073|NCT00816062|3992130|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4171074|NCT00816062|3992130|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171075|NCT00816062|3992130|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171076|NCT00816062|3992130|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|254|254.0||||||
4171077|NCT00816062|3992130|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4171078|NCT00816062|3992130|B1||Male|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
4171079|NCT00816062|3992130|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4171080|NCT00816062|3992130|B1|||Age||years|Mean|73.7|73.7|Standard Deviation|7.9|7.9|||
4171081|NCT00816036|3992135|B3|United States||Region of Enrollment||participants|Number|898|898.0||||||
4171082|NCT00816036|3992136|B2|United States||Region of Enrollment||participants|Number|395|395.0||||||
4171083|NCT00816036|3992137|B1|United States||Region of Enrollment||participants|Number|503|503.0||||||
4171084|NCT00816036|3992135|B3||Male|Sex: Female, Male||Participants|Count of Participants|862|862.0||||||
4171085|NCT00816036|3992136|B2||Male|Sex: Female, Male||Participants|Count of Participants|382|382.0||||||
4171086|NCT00816036|3992137|B1||Male|Sex: Female, Male||Participants|Count of Participants|480|480.0||||||
4171087|NCT00816036|3992135|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4171088|NCT00816036|3992136|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4171089|NCT00816036|3992137|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4171090|NCT00816036|3992135|B3|||Age||years|Mean|59.1|59.1|Standard Deviation|9.9|9.9|||
4171091|NCT00816036|3992136|B2|||Age||years|Mean|58.8|58.8|Standard Deviation|10.2|10.2|||
4171092|NCT00816036|3992137|B1|||Age||years|Mean|59.4|59.4|Standard Deviation|9.7|9.7|||
4171093|NCT00816023|3992148|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4171094|NCT00816023|3992149|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171095|NCT00816023|3992150|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4171096|NCT00816023|3992151|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4171097|NCT00816023|3992152|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171098|NCT00816023|3992148|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171099|NCT00816023|3992149|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171100|NCT00816023|3992150|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171101|NCT00816023|3992151|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171102|NCT00816023|3992152|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171103|NCT00816023|3992148|B5||White|Race (NIH/OMB)||Participants|Count of Participants|252|252.0||||||
4171104|NCT00816023|3992149|B4||White|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
4171105|NCT00816023|3992150|B3||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4171106|NCT00816023|3992151|B2||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4171107|NCT00816023|3992152|B1||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4171108|NCT00816023|3992148|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4171109|NCT00816023|3992149|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4171110|NCT00816023|3992150|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4171111|NCT00816023|3992151|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4171112|NCT00816023|3992152|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4171113|NCT00816023|3992148|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171114|NCT00816023|3992149|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171115|NCT00816023|3992150|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171116|NCT00816023|3992151|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171117|NCT00816023|3992152|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171118|NCT00816023|3992148|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4171119|NCT00816023|3992149|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171120|NCT00816023|3992150|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4171121|NCT00816023|3992151|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4171122|NCT00816023|3992152|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171123|NCT00816023|3992148|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171124|NCT00816023|3992149|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171125|NCT00816023|3992150|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171126|NCT00816023|3992151|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171127|NCT00816023|3992152|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171128|NCT00816023|3992148|B5||Male|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4171129|NCT00816023|3992149|B4||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4171130|NCT00816023|3992150|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4171131|NCT00816023|3992151|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4171132|NCT00816023|3992152|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4171133|NCT00816023|3992148|B5||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4171134|NCT00816023|3992149|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4171135|NCT00816023|3992150|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4171136|NCT00816023|3992151|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4171137|NCT00816023|3992152|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4171138|NCT00816023|3992148|B5|||Age||years|Mean|63.4|63.4|Standard Deviation|10.15|10.15|||
4171139|NCT00816023|3992149|B4|||Age||years|Mean|63.6|63.6|Standard Deviation|10.90|10.9|||
4171140|NCT00816023|3992150|B3|||Age||years|Mean|63.2|63.2|Standard Deviation|10.73|10.73|||
4171141|NCT00816023|3992151|B2|||Age||years|Mean|63.9|63.9|Standard Deviation|9.40|9.4|||
4171142|NCT00816023|3992152|B1|||Age||years|Mean|63.1|63.1|Standard Deviation|9.96|9.96|||
4171143|NCT00815919|3992169|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4171144|NCT00815919|3992169|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4171145|NCT00815919|3992169|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4171146|NCT00815919|3992169|B1|||Age||years|Median|51|51.0|Full Range|||25.0|69.0|
4171147|NCT00815919|3992169|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4171148|NCT00815919|3992169|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4171149|NCT00815919|3992169|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4171150|NCT00815776|3992177|B4|Mexico||Region of Enrollment||participants|Number|152|152.0||||||
4171151|NCT00815776|3992178|B3|Mexico||Region of Enrollment||participants|Number|28|28.0||||||
4171152|NCT00815776|3992179|B2|Mexico||Region of Enrollment||participants|Number|64|64.0||||||
4171153|NCT00815776|3992180|B1|Mexico||Region of Enrollment||participants|Number|60|60.0||||||
4171154|NCT00815776|3992177|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4171155|NCT00815776|3992178|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4171156|NCT00815776|3992179|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4171157|NCT00815776|3992180|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4171158|NCT00815776|3992177|B4||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4171159|NCT00815776|3992178|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4171160|NCT00815776|3992179|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4171161|NCT00815776|3992180|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4171162|NCT00815776|3992177|B4|||Age||years|Mean|37.41|37.41|Standard Deviation|11.20|11.2|||
4171163|NCT00815776|3992178|B3|||Age||years|Mean|36.27|36.27|Standard Deviation|12.97|12.97|||
4171164|NCT00815776|3992179|B2|||Age||years|Mean|38.02|38.02|Standard Deviation|11.02|11.02|||
4171165|NCT00815776|3992180|B1|||Age||years|Mean|37.29|37.29|Standard Deviation|10.63|10.63|||
4171166|NCT00815776|3992177|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4171167|NCT00815776|3992178|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4171168|NCT00815776|3992179|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4171169|NCT00815776|3992180|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4171170|NCT00815776|3992177|B4||Between 18 and 65 years|Age||Participants|Count of Participants|151|151.0||||||
4171171|NCT00815776|3992178|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4171172|NCT00815776|3992179|B2||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4171173|NCT00815776|3992180|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4171174|NCT00815776|3992177|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4171175|NCT00815776|3992178|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4171176|NCT00815776|3992179|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4171177|NCT00815776|3992180|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4171178|NCT00815698|3992196|B3|Denmark||Region of Enrollment||participants|Number|334|334.0||||||
4171179|NCT00815698|3992197|B2|Denmark||Region of Enrollment||participants|Number|171|171.0||||||
4171180|NCT00815698|3992198|B1|Denmark||Region of Enrollment||participants|Number|163|163.0||||||
4171181|NCT00815698|3992196|B3||Male|Sex: Female, Male||Participants|Count of Participants|334|334.0||||||
4171182|NCT00815698|3992197|B2||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4171183|NCT00815698|3992198|B1||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4171184|NCT00815698|3992196|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4171185|NCT00815698|3992197|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4171186|NCT00815698|3992198|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4171187|NCT00815698|3992196|B3|||Age||years|Median|58.0|58.0|Inter-Quartile Range|||40.2|67.5|
4171188|NCT00815698|3992197|B2|||Age||years|Median|59.9|59.9|Inter-Quartile Range|||45.8|67.5|
4171189|NCT00815698|3992198|B1|||Age||years|Median|56.8|56.8|Inter-Quartile Range|||40.2|65.1|
4171190|NCT00815685|3992207|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4171191|NCT00815685|3992207|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4171192|NCT00815685|3992207|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4171193|NCT00815685|3992207|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4171194|NCT00815685|3992207|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4171195|NCT00815685|3992207|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4171196|NCT00815659|3992212|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4171197|NCT00815659|3992212|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4171198|NCT00815659|3992212|B1|||Age||Years|Mean|50.9|50.9|Standard Deviation|9.5|9.5|||
4171199|NCT00815633|3992255|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4171200|NCT00815633|3992255|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4171201|NCT00815633|3992255|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4171202|NCT00815633|3992255|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4171203|NCT00815633|3992255|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4171204|NCT00815516|3992260|B3|Missing||Presence of End-Organ Dissemination (EOD)|End-organ dissemination was assessed using echocardiogram, abdominal ultrasound, including evaluation of the liver, spleen, and kidneys, head ultrasound, computed tomography (CT) or magnetic resonance imaging (MRI), and retinal exam (if clinically feasible). End-organ dissemination was assessed by the data review panel (DRP). Missing for the DRP assessment means that no evidence for EOD was documented.|participants|Number|20|20.0||||||
4171205|NCT00815516|3992261|B2|Missing||Presence of End-Organ Dissemination (EOD)|End-organ dissemination was assessed using echocardiogram, abdominal ultrasound, including evaluation of the liver, spleen, and kidneys, head ultrasound, computed tomography (CT) or magnetic resonance imaging (MRI), and retinal exam (if clinically feasible). End-organ dissemination was assessed by the data review panel (DRP). Missing for the DRP assessment means that no evidence for EOD was documented.|participants|Number|7|7.0||||||
4171206|NCT00815516|3992262|B1|Missing||Presence of End-Organ Dissemination (EOD)|End-organ dissemination was assessed using echocardiogram, abdominal ultrasound, including evaluation of the liver, spleen, and kidneys, head ultrasound, computed tomography (CT) or magnetic resonance imaging (MRI), and retinal exam (if clinically feasible). End-organ dissemination was assessed by the data review panel (DRP). Missing for the DRP assessment means that no evidence for EOD was documented.|participants|Number|13|13.0||||||
4171207|NCT00815516|3992260|B3|Yes||Presence of End-Organ Dissemination (EOD)|End-organ dissemination was assessed using echocardiogram, abdominal ultrasound, including evaluation of the liver, spleen, and kidneys, head ultrasound, computed tomography (CT) or magnetic resonance imaging (MRI), and retinal exam (if clinically feasible). End-organ dissemination was assessed by the data review panel (DRP). Missing for the DRP assessment means that no evidence for EOD was documented.|participants|Number|10|10.0||||||
4171208|NCT00815516|3992261|B2|Yes||Presence of End-Organ Dissemination (EOD)|End-organ dissemination was assessed using echocardiogram, abdominal ultrasound, including evaluation of the liver, spleen, and kidneys, head ultrasound, computed tomography (CT) or magnetic resonance imaging (MRI), and retinal exam (if clinically feasible). End-organ dissemination was assessed by the data review panel (DRP). Missing for the DRP assessment means that no evidence for EOD was documented.|participants|Number|3|3.0||||||
4171209|NCT00815516|3992262|B1|Yes||Presence of End-Organ Dissemination (EOD)|End-organ dissemination was assessed using echocardiogram, abdominal ultrasound, including evaluation of the liver, spleen, and kidneys, head ultrasound, computed tomography (CT) or magnetic resonance imaging (MRI), and retinal exam (if clinically feasible). End-organ dissemination was assessed by the data review panel (DRP). Missing for the DRP assessment means that no evidence for EOD was documented.|participants|Number|7|7.0||||||
4171210|NCT00815516|3992260|B3|Missing||Fungal Infection Type|Candidemia: diagnosed if Candida isolated from blood only; Invasive candidiasis: diagnosed if Candida isolated from blood in addition to other body fluids such as cerebrospinal fluid (CSF), peritoneal fluid, or urine.|participants|Number|1|1.0||||||
4171211|NCT00815516|3992261|B2|Missing||Fungal Infection Type|Candidemia: diagnosed if Candida isolated from blood only; Invasive candidiasis: diagnosed if Candida isolated from blood in addition to other body fluids such as cerebrospinal fluid (CSF), peritoneal fluid, or urine.|participants|Number|1|1.0||||||
4171212|NCT00815516|3992262|B1|Missing||Fungal Infection Type|Candidemia: diagnosed if Candida isolated from blood only; Invasive candidiasis: diagnosed if Candida isolated from blood in addition to other body fluids such as cerebrospinal fluid (CSF), peritoneal fluid, or urine.|participants|Number|0|0.0||||||
4171213|NCT00815516|3992260|B3|Invasive Candidiasis||Fungal Infection Type|Candidemia: diagnosed if Candida isolated from blood only; Invasive candidiasis: diagnosed if Candida isolated from blood in addition to other body fluids such as cerebrospinal fluid (CSF), peritoneal fluid, or urine.|participants|Number|10|10.0||||||
4171214|NCT00815516|3992261|B2|Invasive Candidiasis||Fungal Infection Type|Candidemia: diagnosed if Candida isolated from blood only; Invasive candidiasis: diagnosed if Candida isolated from blood in addition to other body fluids such as cerebrospinal fluid (CSF), peritoneal fluid, or urine.|participants|Number|2|2.0||||||
4171215|NCT00815516|3992262|B1|Invasive Candidiasis||Fungal Infection Type|Candidemia: diagnosed if Candida isolated from blood only; Invasive candidiasis: diagnosed if Candida isolated from blood in addition to other body fluids such as cerebrospinal fluid (CSF), peritoneal fluid, or urine.|participants|Number|8|8.0||||||
4171216|NCT00815516|3992260|B3|Candidemia||Fungal Infection Type|Candidemia: diagnosed if Candida isolated from blood only; Invasive candidiasis: diagnosed if Candida isolated from blood in addition to other body fluids such as cerebrospinal fluid (CSF), peritoneal fluid, or urine.|participants|Number|19|19.0||||||
4171217|NCT00815516|3992261|B2|Candidemia||Fungal Infection Type|Candidemia: diagnosed if Candida isolated from blood only; Invasive candidiasis: diagnosed if Candida isolated from blood in addition to other body fluids such as cerebrospinal fluid (CSF), peritoneal fluid, or urine.|participants|Number|7|7.0||||||
4171218|NCT00815516|3992262|B1|Candidemia||Fungal Infection Type|Candidemia: diagnosed if Candida isolated from blood only; Invasive candidiasis: diagnosed if Candida isolated from blood in addition to other body fluids such as cerebrospinal fluid (CSF), peritoneal fluid, or urine.|participants|Number|12|12.0||||||
4171219|NCT00815516|3992260|B3|||Birth Weight||grams|Mean|1928.6|1928.6|Standard Deviation|923.34|923.34|||
4171220|NCT00815516|3992261|B2|||Birth Weight||grams|Mean|2171.4|2171.4|Standard Deviation|1008.79|1008.79|||
4171221|NCT00815516|3992262|B1|||Birth Weight||grams|Mean|1807.3|1807.3|Standard Deviation|879.03|879.03|||
4171222|NCT00815516|3992260|B3|Other||Region of Enrollment||participants|Number|1|1.0||||||
4171223|NCT00815516|3992261|B2|Other||Region of Enrollment||participants|Number|0|0.0||||||
4171224|NCT00815516|3992262|B1|Other||Region of Enrollment||participants|Number|1|1.0||||||
4171225|NCT00815516|3992260|B3|Latin America /Mexico||Region of Enrollment||participants|Number|5|5.0||||||
4171226|NCT00815516|3992261|B2|Latin America /Mexico||Region of Enrollment||participants|Number|1|1.0||||||
4171227|NCT00815516|3992262|B1|Latin America /Mexico||Region of Enrollment||participants|Number|4|4.0||||||
4171228|NCT00815516|3992260|B3|North America /Europe||Region of Enrollment||participants|Number|24|24.0||||||
4171229|NCT00815516|3992261|B2|North America /Europe||Region of Enrollment||participants|Number|9|9.0||||||
4171230|NCT00815516|3992262|B1|North America /Europe||Region of Enrollment||participants|Number|15|15.0||||||
4171231|NCT00815516|3992260|B3|≥ 27 Weeks||Gestational Age||participants|Number|25|25.0||||||
4171232|NCT00815516|3992261|B2|≥ 27 Weeks||Gestational Age||participants|Number|8|8.0||||||
4171233|NCT00815516|3992262|B1|≥ 27 Weeks||Gestational Age||participants|Number|17|17.0||||||
4171234|NCT00815516|3992260|B3|< 27 Weeks||Gestational Age||participants|Number|5|5.0||||||
4171235|NCT00815516|3992261|B2|< 27 Weeks||Gestational Age||participants|Number|2|2.0||||||
4171236|NCT00815516|3992262|B1|< 27 Weeks||Gestational Age||participants|Number|3|3.0||||||
4171237|NCT00815516|3992260|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4171238|NCT00815516|3992261|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4171239|NCT00815516|3992262|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4171240|NCT00815516|3992260|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4171241|NCT00815516|3992261|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4171242|NCT00815516|3992262|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4171243|NCT00815516|3992260|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4171244|NCT00815516|3992261|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4171245|NCT00815516|3992262|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4171246|NCT00815516|3992260|B3|White||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4171247|NCT00815516|3992261|B2|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4171248|NCT00815516|3992262|B1|White||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4171249|NCT00815516|3992260|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4171250|NCT00815516|3992261|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4171251|NCT00815516|3992262|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4171252|NCT00815516|3992260|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4171253|NCT00815516|3992261|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4171254|NCT00815516|3992262|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4171255|NCT00815516|3992260|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4171256|NCT00815516|3992261|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4171257|NCT00815516|3992262|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4171258|NCT00815516|3992260|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4171259|NCT00815516|3992261|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4171260|NCT00815516|3992262|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4171261|NCT00815516|3992260|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4171262|NCT00815516|3992261|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4171263|NCT00815516|3992262|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4171264|NCT00815516|3992260|B3|> 4 weeks to 4 months||Age, Customized||participants|Number|5|5.0||||||
4171265|NCT00815516|3992261|B2|> 4 weeks to 4 months||Age, Customized||participants|Number|0|0.0||||||
4171266|NCT00815516|3992262|B1|> 4 weeks to 4 months||Age, Customized||participants|Number|5|5.0||||||
4171267|NCT00815516|3992260|B3|≤ 4 weeks||Age, Customized||participants|Number|25|25.0||||||
4171268|NCT00815516|3992261|B2|≤ 4 weeks||Age, Customized||participants|Number|10|10.0||||||
4171269|NCT00815516|3992262|B1|≤ 4 weeks||Age, Customized||participants|Number|15|15.0||||||
4171270|NCT00815516|3992260|B3|||Age||days|Mean|25.7|25.7|Standard Deviation|23.70|23.7|||
4171271|NCT00815516|3992261|B2|||Age||days|Mean|16.9|16.9|Standard Deviation|5.13|5.13|||
4171272|NCT00815516|3992262|B1|||Age||days|Mean|30.2|30.2|Standard Deviation|27.99|27.99|||
4171273|NCT00815490|3992292|B3|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4171274|NCT00815490|3992293|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4171275|NCT00815490|3992294|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4171276|NCT00815490|3992292|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4171277|NCT00815490|3992293|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4171278|NCT00815490|3992294|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4171279|NCT00815490|3992292|B3|African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4171280|NCT00815490|3992293|B2|African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4171281|NCT00815490|3992294|B1|African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4171282|NCT00815490|3992292|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4171283|NCT00815490|3992293|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4171284|NCT00815490|3992294|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4171285|NCT00815490|3992292|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4171286|NCT00815490|3992293|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4171287|NCT00815490|3992294|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4171288|NCT00815490|3992292|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4171289|NCT00815490|3992293|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4171290|NCT00815490|3992294|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4171291|NCT00815490|3992292|B3|||Age|Age|Years|Mean|25.7|25.7|Full Range|||21.0|34.0|
4171292|NCT00815490|3992293|B2|||Age|Age|Years|Mean|26|26.0|Full Range|||21.0|34.0|
4171293|NCT00815490|3992294|B1|||Age|Age|Years|Mean|25|25.0|Full Range|||21.0|31.0|
4171294|NCT00815360|3992301|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4171295|NCT00815360|3992302|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4171296|NCT00815360|3992303|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4171297|NCT00815360|3992301|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4171298|NCT00815360|3992302|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4171299|NCT00815360|3992303|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4171300|NCT00815360|3992301|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4171301|NCT00815360|3992302|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4171302|NCT00815360|3992303|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4171303|NCT00815360|3992301|B3|||Age||years|Mean|58.0|58.0|Standard Deviation|7.4|7.4|||
4171304|NCT00815360|3992302|B2|||Age||years|Mean|58.3|58.3|Standard Deviation|6.5|6.5|||
4171305|NCT00815360|3992303|B1|||Age||years|Mean|57.7|57.7|Standard Deviation|7.5|7.5|||
4171306|NCT00815360|3992301|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4171307|NCT00815360|3992302|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4171308|NCT00815360|3992303|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4171309|NCT00815360|3992301|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4171310|NCT00815360|3992302|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4171311|NCT00815360|3992303|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4171312|NCT00815360|3992301|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4171313|NCT00815360|3992302|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4171314|NCT00815360|3992303|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4171315|NCT00815347|3992312|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4171316|NCT00815347|3992312|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4171317|NCT00815347|3992312|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4171318|NCT00815347|3992312|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4171319|NCT00815347|3992312|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4171320|NCT00815308|3992328|B1|China||Region of Enrollment||participants|Number|55|55.0||||||
4171321|NCT00815308|3992328|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4171322|NCT00815308|3992328|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4171323|NCT00815308|3992328|B1|||Age||years|Mean|57.68|57.68|Standard Deviation|6.93|6.93|||
4171324|NCT00815308|3992328|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4171325|NCT00815308|3992328|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4171326|NCT00815308|3992328|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4171327|NCT00815295|3992334|B4|United States||Region of Enrollment||participants|Number|28|28.0||||||
4171328|NCT00815295|3992335|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4171329|NCT00815295|3992336|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4171330|NCT00815295|3992337|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4171331|NCT00815295|3992334|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4171332|NCT00815295|3992335|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4171333|NCT00815295|3992336|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4171334|NCT00815295|3992337|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4171335|NCT00815295|3992334|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4171336|NCT00815295|3992335|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4171337|NCT00815295|3992336|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4171338|NCT00815295|3992337|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4171339|NCT00815295|3992334|B4|||Age||years|Mean|61.0|61.0|Standard Deviation|9.7|9.7|||
4171340|NCT00815295|3992335|B3|||Age||years|Mean|62.8|62.8|Standard Deviation|12.3|12.3|||
4171341|NCT00815295|3992336|B2|||Age||years|Mean|61.2|61.2|Standard Deviation|7.2|7.2|||
4171342|NCT00815295|3992337|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|7.8|7.8|||
4171343|NCT00815191|3992349|B3|||Body mass index||kg/m^2|Mean|26.2|26.2|Standard Deviation|6.0|6.0|||
4171344|NCT00815191|3992350|B2|||Body mass index||kg/m^2|Mean|26.3|26.3|Standard Deviation|5.3|5.3|||
4171345|NCT00815191|3992351|B1|||Body mass index||kg/m^2|Mean|26.1|26.1|Standard Deviation|6.6|6.6|||
4171346|NCT00815191|3992349|B3|Unknown||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4171347|NCT00815191|3992350|B2|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4171348|NCT00815191|3992351|B1|Unknown||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4171349|NCT00815191|3992349|B3|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4171350|NCT00815191|3992350|B2|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4171351|NCT00815191|3992351|B1|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4171352|NCT00815191|3992349|B3|White||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
4171353|NCT00815191|3992350|B2|White||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4171354|NCT00815191|3992351|B1|White||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4171355|NCT00815191|3992349|B3|Missing||Sex/Gender, Customized||participants|Number|5|5.0||||||
4171356|NCT00815191|3992350|B2|Missing||Sex/Gender, Customized||participants|Number|2|2.0||||||
4171357|NCT00815191|3992351|B1|Missing||Sex/Gender, Customized||participants|Number|3|3.0||||||
4171358|NCT00815191|3992349|B3|Male||Sex/Gender, Customized||participants|Number|41|41.0||||||
4171359|NCT00815191|3992350|B2|Male||Sex/Gender, Customized||participants|Number|18|18.0||||||
4171360|NCT00815191|3992351|B1|Male||Sex/Gender, Customized||participants|Number|23|23.0||||||
4171361|NCT00815191|3992349|B3|Female||Sex/Gender, Customized||participants|Number|25|25.0||||||
4171362|NCT00815191|3992350|B2|Female||Sex/Gender, Customized||participants|Number|14|14.0||||||
4171363|NCT00815191|3992351|B1|Female||Sex/Gender, Customized||participants|Number|11|11.0||||||
4171364|NCT00815191|3992349|B3|||Age||years|Mean|49|49.0|Standard Deviation|15|15.0|||
4171365|NCT00815191|3992350|B2|||Age||years|Mean|50|50.0|Standard Deviation|15|15.0|||
4171366|NCT00815191|3992351|B1|||Age||years|Mean|48|48.0|Standard Deviation|15|15.0|||
4171367|NCT00815087|3992358|B3|Taiwan||Region of Enrollment||participants|Number|20|20.0||||||
4171368|NCT00815087|3992359|B2|Taiwan||Region of Enrollment||participants|Number|10|10.0||||||
4171369|NCT00815087|3992360|B1|Taiwan||Region of Enrollment||participants|Number|10|10.0||||||
4171370|NCT00815087|3992358|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4171371|NCT00815087|3992359|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4171372|NCT00815087|3992360|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4171373|NCT00815087|3992358|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4171374|NCT00815087|3992359|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4171375|NCT00815087|3992360|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4171376|NCT00815087|3992358|B3|||Age||years|Mean|54.2|54.2|Standard Deviation|10.3|10.3|||
4171377|NCT00815087|3992359|B2|||Age||years|Mean|56.1|56.1|Standard Deviation|11.8|11.8|||
4171378|NCT00815087|3992360|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|7.4|7.4|||
4171379|NCT00815087|3992358|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4171380|NCT00815087|3992359|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4171381|NCT00815087|3992360|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4171382|NCT00815087|3992358|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4171383|NCT00815087|3992359|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4171384|NCT00815087|3992360|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4171385|NCT00815087|3992358|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4171386|NCT00815087|3992359|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4171387|NCT00815087|3992360|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4171388|NCT00815035|3992367|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4171389|NCT00815035|3992368|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4171390|NCT00815035|3992369|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4171391|NCT00815035|3992367|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171392|NCT00815035|3992368|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171393|NCT00815035|3992369|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171394|NCT00815035|3992367|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4171395|NCT00815035|3992368|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4171396|NCT00815035|3992369|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4171397|NCT00815035|3992367|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4171398|NCT00815035|3992368|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4171399|NCT00815035|3992369|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4171400|NCT00815035|3992367|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4171401|NCT00815035|3992368|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171402|NCT00815035|3992369|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4171403|NCT00815035|3992367|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171507|NCT00814788|3992475|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4171404|NCT00815035|3992368|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171405|NCT00815035|3992369|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171406|NCT00815035|3992367|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171407|NCT00815035|3992368|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171408|NCT00815035|3992369|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171409|NCT00815035|3992367|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171410|NCT00815035|3992368|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171411|NCT00815035|3992369|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171412|NCT00815035|3992367|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171413|NCT00815035|3992368|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171414|NCT00815035|3992369|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171415|NCT00815035|3992367|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4171416|NCT00815035|3992368|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4171417|NCT00815035|3992369|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4171418|NCT00815035|3992367|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171419|NCT00815035|3992368|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171420|NCT00815035|3992369|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171421|NCT00815035|3992367|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4171422|NCT00815035|3992368|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4171423|NCT00815035|3992369|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4171424|NCT00815035|3992367|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4171425|NCT00815035|3992368|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4171426|NCT00815035|3992369|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4171427|NCT00815035|3992367|B3|||Age||years|Mean|5.0|5.0|Full Range|||3.6|6.9|
4171428|NCT00815035|3992368|B2|||Age||years|Mean|4.8|4.8|Full Range|||3.6|6.9|
4171429|NCT00815035|3992369|B1|||Age||years|Mean|5.1|5.1|Full Range|||3.8|6.9|
4171430|NCT00815035|3992367|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4171431|NCT00815035|3992368|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4171432|NCT00815035|3992369|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4171433|NCT00815035|3992367|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4171434|NCT00815035|3992368|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4171435|NCT00815035|3992369|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4171436|NCT00815035|3992367|B3||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4171437|NCT00815035|3992368|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4171438|NCT00815035|3992369|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4171439|NCT00814983|3992387|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4171440|NCT00814983|3992389|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4171441|NCT00814983|3992387|B3|Male||Gender||participants|Number|7|7.0||||||
4171442|NCT00814983|3992389|B1|Male||Gender||participants|Number|7|7.0||||||
4171443|NCT00814983|3992387|B3|Female||Gender||participants|Number|8|8.0||||||
4171444|NCT00814983|3992389|B1|Female||Gender||participants|Number|8|8.0||||||
4171445|NCT00814983|3992387|B3|>=65 years||Age||participants|Number|0|0.0||||||
4171446|NCT00814983|3992389|B1|>=65 years||Age||participants|Number|0|0.0||||||
4171447|NCT00814983|3992387|B3|Between 18 and 65 years||Age||participants|Number|15|15.0||||||
4171448|NCT00814983|3992389|B1|Between 18 and 65 years||Age||participants|Number|15|15.0||||||
4171449|NCT00814983|3992387|B3|<=18 years||Age||participants|Number|0|0.0||||||
4171450|NCT00814983|3992389|B1|<=18 years||Age||participants|Number|0|0.0||||||
4171451|NCT00814970|3992400|B1|Belgium||Region of Enrollment||participants|Number|15|15.0||||||
4171452|NCT00814970|3992400|B1|Germany||Region of Enrollment||participants|Number|48|48.0||||||
4171453|NCT00814970|3992400|B1|United States||Region of Enrollment||participants|Number|133|133.0||||||
4171454|NCT00814970|3992400|B1||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4171455|NCT00814970|3992400|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4171456|NCT00814970|3992400|B1|||Age||years|Mean|68.7|68.7|Standard Deviation|10.5|10.5|||
4171457|NCT00814970|3992400|B1||>=65 years|Age||Participants|Count of Participants|122|122.0||||||
4171458|NCT00814970|3992400|B1||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
4171459|NCT00814970|3992400|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4171460|NCT00814879|3992431|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
4171461|NCT00814879|3992432|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4171462|NCT00814879|3992433|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4171463|NCT00814879|3992431|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4171464|NCT00814879|3992432|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4171465|NCT00814879|3992433|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171466|NCT00814879|3992431|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171467|NCT00814879|3992432|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171468|NCT00814879|3992433|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171469|NCT00814879|3992431|B3||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4171470|NCT00814879|3992432|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4171471|NCT00814879|3992433|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4171472|NCT00814879|3992431|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4171473|NCT00814879|3992432|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4171474|NCT00814879|3992433|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4171475|NCT00814879|3992431|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171476|NCT00814879|3992432|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171477|NCT00814879|3992433|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171478|NCT00814879|3992431|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171479|NCT00814879|3992432|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171480|NCT00814879|3992433|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171481|NCT00814879|3992431|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4171482|NCT00814879|3992432|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171483|NCT00814879|3992433|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4171484|NCT00814879|3992431|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4171485|NCT00814879|3992432|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4171486|NCT00814879|3992433|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4171487|NCT00814879|3992431|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4171488|NCT00814879|3992432|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4171489|NCT00814879|3992433|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4171490|NCT00814879|3992431|B3|||Age||years|Mean|48.2|48.2|Standard Deviation|9.6|9.6|||
4171491|NCT00814879|3992432|B2|||Age||years|Mean|48.0|48.0|Standard Deviation|9.7|9.7|||
4171492|NCT00814879|3992433|B1|||Age||years|Mean|48.5|48.5|Standard Deviation|9.8|9.8|||
4171493|NCT00814801|3992450|B4||Male|Sex: Female, Male|Six participants were excluded from the randomized patients as no evaluation on both Alzheimer's disease assessment scale (ADAS) and Clinician's Interview-Based Impression of Change (CIBIC) was made after treatment with study medication.|Participants|Count of Participants|172|172.0||||||
4171494|NCT00814801|3992451|B3||Male|Sex: Female, Male|Six participants were excluded from the randomized patients as no evaluation on both Alzheimer's disease assessment scale (ADAS) and Clinician's Interview-Based Impression of Change (CIBIC) was made after treatment with study medication.|Participants|Count of Participants|47|47.0||||||
4171495|NCT00814801|3992452|B2||Male|Sex: Female, Male|Six participants were excluded from the randomized patients as no evaluation on both Alzheimer's disease assessment scale (ADAS) and Clinician's Interview-Based Impression of Change (CIBIC) was made after treatment with study medication.|Participants|Count of Participants|66|66.0||||||
4171496|NCT00814801|3992453|B1||Male|Sex: Female, Male|Six participants were excluded from the randomized patients as no evaluation on both Alzheimer's disease assessment scale (ADAS) and Clinician's Interview-Based Impression of Change (CIBIC) was made after treatment with study medication.|Participants|Count of Participants|59|59.0||||||
4171497|NCT00814801|3992450|B4||Female|Sex: Female, Male|Six participants were excluded from the randomized patients as no evaluation on both Alzheimer's disease assessment scale (ADAS) and Clinician's Interview-Based Impression of Change (CIBIC) was made after treatment with study medication.|Participants|Count of Participants|402|402.0||||||
4171498|NCT00814801|3992451|B3||Female|Sex: Female, Male|Six participants were excluded from the randomized patients as no evaluation on both Alzheimer's disease assessment scale (ADAS) and Clinician's Interview-Based Impression of Change (CIBIC) was made after treatment with study medication.|Participants|Count of Participants|145|145.0||||||
4171499|NCT00814801|3992452|B2||Female|Sex: Female, Male|Six participants were excluded from the randomized patients as no evaluation on both Alzheimer's disease assessment scale (ADAS) and Clinician's Interview-Based Impression of Change (CIBIC) was made after treatment with study medication.|Participants|Count of Participants|125|125.0||||||
4171500|NCT00814801|3992453|B1||Female|Sex: Female, Male|Six participants were excluded from the randomized patients as no evaluation on both Alzheimer's disease assessment scale (ADAS) and Clinician's Interview-Based Impression of Change (CIBIC) was made after treatment with study medication.|Participants|Count of Participants|132|132.0||||||
4171501|NCT00814801|3992450|B4|||Age|Six participants were excluded from the randomized patients as no evaluation on both ADAS and CIBIC was made after treatment with study medication.|years|Mean|75.2|75.2|Standard Deviation|8.3|8.3|||
4171502|NCT00814801|3992451|B3|||Age|Six participants were excluded from the randomized patients as no evaluation on both ADAS and CIBIC was made after treatment with study medication.|years|Mean|74.6|74.6|Standard Deviation|8.8|8.8|||
4171503|NCT00814801|3992452|B2|||Age|Six participants were excluded from the randomized patients as no evaluation on both ADAS and CIBIC was made after treatment with study medication.|years|Mean|75.6|75.6|Standard Deviation|8.4|8.4|||
4171504|NCT00814801|3992453|B1|||Age|Six participants were excluded from the randomized patients as no evaluation on both ADAS and CIBIC was made after treatment with study medication.|years|Mean|75.5|75.5|Standard Deviation|7.6|7.6|||
4171505|NCT00814788|3992475|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4171506|NCT00814788|3992475|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4171508|NCT00814788|3992475|B1|||Age||years|Mean|71.1|71.1|Full Range|||53.0|87.0|
4171509|NCT00814775|3992481|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4171510|NCT00814775|3992482|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4171511|NCT00814775|3992483|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4171512|NCT00814775|3992481|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4171513|NCT00814775|3992482|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4171514|NCT00814775|3992483|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4171515|NCT00814775|3992481|B3|||Age||years|Mean|59|59.0|Standard Deviation|16|16.0|||
4171516|NCT00814775|3992482|B2|||Age||years|Mean|59|59.0|Standard Deviation|15|15.0|||
4171517|NCT00814775|3992483|B1|||Age||years|Mean|58|58.0|Standard Deviation|16|16.0|||
4171518|NCT00814710|3992492|B3||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4171519|NCT00814710|3992493|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4171520|NCT00814710|3992494|B1||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4171521|NCT00814710|3992492|B3||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4171522|NCT00814710|3992493|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4171523|NCT00814710|3992494|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4171524|NCT00814710|3992492|B3|||Age||Weeks|Mean|6.7|6.7|Standard Deviation|1.07|1.07|||
4171525|NCT00814710|3992493|B2|||Age||Weeks|Mean|6.7|6.7|Standard Deviation|1.05|1.05|||
4171526|NCT00814710|3992494|B1|||Age||Weeks|Mean|6.7|6.7|Standard Deviation|1.08|1.08|||
4171527|NCT00814697|3992533|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4171528|NCT00814697|3992533|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4171529|NCT00814697|3992533|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4171530|NCT00814697|3992533|B1|||Age||years|Mean|73.1|73.1|Standard Deviation|7.9|7.9|||
4171531|NCT00814697|3992533|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4171532|NCT00814697|3992533|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4171533|NCT00814697|3992533|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4171534|NCT00814671|3992537|B4|South Africa||Region of Enrollment||participants|Number|153|153.0||||||
4171535|NCT00814671|3992538|B3|South Africa||Region of Enrollment||participants|Number|51|51.0||||||
4171536|NCT00814671|3992539|B2|South Africa||Region of Enrollment||participants|Number|48|48.0||||||
4171537|NCT00814671|3992540|B1|South Africa||Region of Enrollment||participants|Number|54|54.0||||||
4171538|NCT00814671|3992537|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171539|NCT00814671|3992538|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171540|NCT00814671|3992539|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171541|NCT00814671|3992540|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171542|NCT00814671|3992537|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171543|NCT00814671|3992538|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171544|NCT00814671|3992539|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171545|NCT00814671|3992540|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171546|NCT00814671|3992537|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171547|NCT00814671|3992538|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171548|NCT00814671|3992539|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171549|NCT00814671|3992540|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171550|NCT00814671|3992537|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|153|153.0||||||
4171551|NCT00814671|3992538|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4171552|NCT00814671|3992539|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4171553|NCT00814671|3992540|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4171554|NCT00814671|3992537|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171555|NCT00814671|3992538|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171556|NCT00814671|3992539|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171557|NCT00814671|3992540|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171558|NCT00814671|3992537|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171559|NCT00814671|3992538|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171560|NCT00814671|3992539|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171561|NCT00814671|3992540|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171562|NCT00814671|3992537|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171563|NCT00814671|3992538|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171564|NCT00814671|3992539|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171565|NCT00814671|3992540|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171566|NCT00814671|3992537|B4||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4171567|NCT00814671|3992538|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4171568|NCT00814671|3992539|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4171569|NCT00814671|3992540|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4171570|NCT00814671|3992537|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4171571|NCT00814671|3992538|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4171572|NCT00814671|3992539|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4171573|NCT00814671|3992540|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4171574|NCT00814671|3992537|B4|||Age||years|Median|29|29.0|Inter-Quartile Range|||24.0|38.0|
4171575|NCT00814671|3992538|B3|||Age||years|Median|29|29.0|Inter-Quartile Range|||24.0|38.0|
4171576|NCT00814671|3992539|B2|||Age||years|Median|30|30.0|Inter-Quartile Range|||25.0|36.0|
4171577|NCT00814671|3992540|B1|||Age||years|Median|29|29.0|Inter-Quartile Range|||23.0|39.0|
4171578|NCT00814658|3992561|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4171579|NCT00814658|3992562|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4171580|NCT00814658|3992563|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4171581|NCT00814658|3992561|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4171582|NCT00814658|3992562|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4171583|NCT00814658|3992563|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4171584|NCT00814658|3992561|B3|||Age||years|Mean|76.0|76.0|Standard Deviation|6.2|6.2|||
4171585|NCT00814658|3992562|B2|||Age||years|Mean|74.3|74.3|Standard Deviation|6.5|6.5|||
4171586|NCT00814658|3992563|B1|||Age||years|Mean|78.1|78.1|Standard Deviation|5.3|5.3|||
4171587|NCT00814632|3992630|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4171588|NCT00814632|3992630|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4171589|NCT00814632|3992630|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4171590|NCT00814632|3992630|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4171591|NCT00814632|3992630|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4171592|NCT00814632|3992630|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4171593|NCT00814580|3992634|B3|USA||Region of Enrollment|The summary statistics provided for baseline characteristic was based on safety population that includes 192 subjects in tapentadol group and 186 subjects in oxycodone group. The safety population includes randomized subjects took at least one dose of study drug.|participants|Number|378|378.0||||||
4171594|NCT00814580|3992635|B2|USA||Region of Enrollment|The summary statistics provided for baseline characteristic was based on safety population that includes 192 subjects in tapentadol group and 186 subjects in oxycodone group. The safety population includes randomized subjects took at least one dose of study drug.|participants|Number|186|186.0||||||
4171595|NCT00814580|3992636|B1|USA||Region of Enrollment|The summary statistics provided for baseline characteristic was based on safety population that includes 192 subjects in tapentadol group and 186 subjects in oxycodone group. The safety population includes randomized subjects took at least one dose of study drug.|participants|Number|192|192.0||||||
4171596|NCT00814580|3992634|B3||Male|Sex: Female, Male|The summary statistics provided for baseline characteristic was based on safety population that includes 192 subjects in tapentadol group and 186 subjects in oxycodone group. The safety population includes randomized subjects took at least one dose of study drug.|Participants|Count of Participants|251|251.0||||||
4171597|NCT00814580|3992635|B2||Male|Sex: Female, Male|The summary statistics provided for baseline characteristic was based on safety population that includes 192 subjects in tapentadol group and 186 subjects in oxycodone group. The safety population includes randomized subjects took at least one dose of study drug.|Participants|Count of Participants|128|128.0||||||
4171598|NCT00814580|3992636|B1||Male|Sex: Female, Male|The summary statistics provided for baseline characteristic was based on safety population that includes 192 subjects in tapentadol group and 186 subjects in oxycodone group. The safety population includes randomized subjects took at least one dose of study drug.|Participants|Count of Participants|123|123.0||||||
4171599|NCT00814580|3992634|B3||Female|Sex: Female, Male|The summary statistics provided for baseline characteristic was based on safety population that includes 192 subjects in tapentadol group and 186 subjects in oxycodone group. The safety population includes randomized subjects took at least one dose of study drug.|Participants|Count of Participants|127|127.0||||||
4171600|NCT00814580|3992635|B2||Female|Sex: Female, Male|The summary statistics provided for baseline characteristic was based on safety population that includes 192 subjects in tapentadol group and 186 subjects in oxycodone group. The safety population includes randomized subjects took at least one dose of study drug.|Participants|Count of Participants|58|58.0||||||
4171601|NCT00814580|3992636|B1||Female|Sex: Female, Male|The summary statistics provided for baseline characteristic was based on safety population that includes 192 subjects in tapentadol group and 186 subjects in oxycodone group. The safety population includes randomized subjects took at least one dose of study drug.|Participants|Count of Participants|69|69.0||||||
4171602|NCT00814580|3992634|B3|||Age|The summary statistics provided for baseline characteristic was based on safety population that includes 192 subjects in tapentadol group and 186 subjects in oxycodone group. The safety population includes randomized subjects took at least one dose of study drug.|years|Mean|52.9|52.9|Standard Deviation|14.96|14.96|||
4171603|NCT00814580|3992635|B2|||Age|The summary statistics provided for baseline characteristic was based on safety population that includes 192 subjects in tapentadol group and 186 subjects in oxycodone group. The safety population includes randomized subjects took at least one dose of study drug.|years|Mean|52.7|52.7|Standard Deviation|14.97|14.97|||
4171604|NCT00814580|3992636|B1|||Age|The summary statistics provided for baseline characteristic was based on safety population that includes 192 subjects in tapentadol group and 186 subjects in oxycodone group. The safety population includes randomized subjects took at least one dose of study drug.|years|Mean|53.2|53.2|Standard Deviation|14.98|14.98|||
4171707|NCT00814333|3992888|B1|Female||Gender||participants|Number|0|0.0||||||
4171605|NCT00814580|3992634|B3||>=65 years|Age|The summary statistics provided for baseline characteristic was based on safety population that includes 192 subjects in tapentadol group and 186 subjects in oxycodone group. The safety population includes randomized subjects took at least one dose of study drug.|Participants|Count of Participants|93|93.0||||||
4171606|NCT00814580|3992635|B2||>=65 years|Age|The summary statistics provided for baseline characteristic was based on safety population that includes 192 subjects in tapentadol group and 186 subjects in oxycodone group. The safety population includes randomized subjects took at least one dose of study drug.|Participants|Count of Participants|43|43.0||||||
4171607|NCT00814580|3992636|B1||>=65 years|Age|The summary statistics provided for baseline characteristic was based on safety population that includes 192 subjects in tapentadol group and 186 subjects in oxycodone group. The safety population includes randomized subjects took at least one dose of study drug.|Participants|Count of Participants|50|50.0||||||
4171608|NCT00814580|3992634|B3||Between 18 and 65 years|Age|The summary statistics provided for baseline characteristic was based on safety population that includes 192 subjects in tapentadol group and 186 subjects in oxycodone group. The safety population includes randomized subjects took at least one dose of study drug.|Participants|Count of Participants|275|275.0||||||
4171609|NCT00814580|3992635|B2||Between 18 and 65 years|Age|The summary statistics provided for baseline characteristic was based on safety population that includes 192 subjects in tapentadol group and 186 subjects in oxycodone group. The safety population includes randomized subjects took at least one dose of study drug.|Participants|Count of Participants|137|137.0||||||
4171610|NCT00814580|3992636|B1||Between 18 and 65 years|Age|The summary statistics provided for baseline characteristic was based on safety population that includes 192 subjects in tapentadol group and 186 subjects in oxycodone group. The safety population includes randomized subjects took at least one dose of study drug.|Participants|Count of Participants|138|138.0||||||
4171611|NCT00814580|3992634|B3||<=18 years|Age|The summary statistics provided for baseline characteristic was based on safety population that includes 192 subjects in tapentadol group and 186 subjects in oxycodone group. The safety population includes randomized subjects took at least one dose of study drug.|Participants|Count of Participants|10|10.0||||||
4171612|NCT00814580|3992635|B2||<=18 years|Age|The summary statistics provided for baseline characteristic was based on safety population that includes 192 subjects in tapentadol group and 186 subjects in oxycodone group. The safety population includes randomized subjects took at least one dose of study drug.|Participants|Count of Participants|6|6.0||||||
4171613|NCT00814580|3992636|B1||<=18 years|Age|The summary statistics provided for baseline characteristic was based on safety population that includes 192 subjects in tapentadol group and 186 subjects in oxycodone group. The safety population includes randomized subjects took at least one dose of study drug.|Participants|Count of Participants|4|4.0||||||
4171614|NCT00814502|3992765|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4171615|NCT00814502|3992766|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4171616|NCT00814502|3992767|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4171617|NCT00814502|3992765|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4171618|NCT00814502|3992766|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171619|NCT00814502|3992767|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4171620|NCT00814502|3992765|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171621|NCT00814502|3992766|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171622|NCT00814502|3992767|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171623|NCT00814502|3992765|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4171624|NCT00814502|3992766|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4171625|NCT00814502|3992767|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4171626|NCT00814502|3992765|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4171627|NCT00814502|3992766|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4171628|NCT00814502|3992767|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171629|NCT00814502|3992765|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171630|NCT00814502|3992766|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171631|NCT00814502|3992767|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171632|NCT00814502|3992765|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171633|NCT00814502|3992766|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171634|NCT00814502|3992767|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171635|NCT00814502|3992765|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171636|NCT00814502|3992766|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171637|NCT00814502|3992767|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171638|NCT00814502|3992765|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4171639|NCT00814502|3992766|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4171640|NCT00814502|3992767|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4171641|NCT00814502|3992765|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4171642|NCT00814502|3992766|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4171643|NCT00814502|3992767|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4171644|NCT00814502|3992765|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171708|NCT00814333|3992886|B3|>=65 years||Age||participants|Number|0|0.0||||||
4171645|NCT00814502|3992766|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171646|NCT00814502|3992767|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171647|NCT00814502|3992765|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4171648|NCT00814502|3992766|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4171649|NCT00814502|3992767|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4171650|NCT00814502|3992765|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4171651|NCT00814502|3992766|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4171652|NCT00814502|3992767|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4171653|NCT00814502|3992765|B3|Age < 60||Age, Customized||Participants|Count of Participants|0|0.0||||||
4171654|NCT00814502|3992766|B2|Age < 60||Age, Customized||Participants|Count of Participants|0|0.0||||||
4171655|NCT00814502|3992767|B1|Age < 60||Age, Customized||Participants|Count of Participants|0|0.0||||||
4171656|NCT00814502|3992765|B3|Age > = 60||Age, Customized||Participants|Count of Participants|17|17.0||||||
4171657|NCT00814502|3992766|B2|Age > = 60||Age, Customized||Participants|Count of Participants|9|9.0||||||
4171658|NCT00814502|3992767|B1|Age > = 60||Age, Customized||Participants|Count of Participants|8|8.0||||||
4171659|NCT00814489|3992778|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4171660|NCT00814489|3992779|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4171661|NCT00814489|3992780|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4171662|NCT00814489|3992781|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4171663|NCT00814489|3992778|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4171664|NCT00814489|3992779|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4171665|NCT00814489|3992780|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4171666|NCT00814489|3992781|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4171667|NCT00814489|3992778|B4|||Age||Years|Mean|25.7|25.7|Standard Deviation|5.01|5.01|||
4171668|NCT00814489|3992779|B3|||Age||Years|Mean|26.6|26.6|Standard Deviation|5.50|5.5|||
4171669|NCT00814489|3992780|B2|||Age||Years|Mean|24.3|24.3|Standard Deviation|3.69|3.69|||
4171670|NCT00814489|3992781|B1|||Age||Years|Mean|26.9|26.9|Standard Deviation|5.91|5.91|||
4171671|NCT00814463|3992815|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4171672|NCT00814463|3992815|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4171673|NCT00814463|3992815|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4171674|NCT00814463|3992815|B1|||Age||years|Mean|67|67.0|Standard Deviation|||||
4171675|NCT00814463|3992815|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4171676|NCT00814463|3992815|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4171677|NCT00814463|3992815|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4171678|NCT00814346|3992819|B3|Level 4: University||Educational Level||participants|Number|32|32.0||||||
4171679|NCT00814346|3992820|B2|Level 4: University||Educational Level||participants|Number|15|15.0||||||
4171680|NCT00814346|3992821|B1|Level 4: University||Educational Level||participants|Number|17|17.0||||||
4171681|NCT00814346|3992819|B3|Level 3: Completed secondary||Educational Level||participants|Number|9|9.0||||||
4171682|NCT00814346|3992820|B2|Level 3: Completed secondary||Educational Level||participants|Number|6|6.0||||||
4171683|NCT00814346|3992821|B1|Level 3: Completed secondary||Educational Level||participants|Number|3|3.0||||||
4171684|NCT00814346|3992819|B3|Level 2: School certificate||Educational Level||participants|Number|7|7.0||||||
4171685|NCT00814346|3992820|B2|Level 2: School certificate||Educational Level||participants|Number|5|5.0||||||
4171686|NCT00814346|3992821|B1|Level 2: School certificate||Educational Level||participants|Number|2|2.0||||||
4171687|NCT00814346|3992819|B3|Level 1: Primary only||Educational Level||participants|Number|1|1.0||||||
4171688|NCT00814346|3992820|B2|Level 1: Primary only||Educational Level||participants|Number|0|0.0||||||
4171689|NCT00814346|3992821|B1|Level 1: Primary only||Educational Level||participants|Number|1|1.0||||||
4171690|NCT00814346|3992819|B3|||Body Mass Index (BMI)||kg/m^2|Mean|24.76|24.76|Standard Deviation|4.43|4.43|||
4171691|NCT00814346|3992820|B2|||Body Mass Index (BMI)||kg/m^2|Mean|25.03|25.03|Standard Deviation|4.40|4.4|||
4171692|NCT00814346|3992821|B1|||Body Mass Index (BMI)||kg/m^2|Mean|24.49|24.49|Standard Deviation|4.46|4.46|||
4171693|NCT00814346|3992819|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4171694|NCT00814346|3992820|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4171695|NCT00814346|3992821|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4171696|NCT00814346|3992819|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4171697|NCT00814346|3992820|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4171698|NCT00814346|3992821|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4171699|NCT00814346|3992819|B3|||Age||years|Mean|75.85|75.85|Standard Deviation|5.25|5.25|||
4171700|NCT00814346|3992820|B2|||Age||years|Mean|76.6|76.6|Standard Deviation|5.3|5.3|||
4171701|NCT00814346|3992821|B1|||Age||years|Mean|75.1|75.1|Standard Deviation|6.2|6.2|||
4171702|NCT00814333|3992886|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4171703|NCT00814333|3992888|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4171704|NCT00814333|3992886|B3|Male||Gender||participants|Number|1|1.0||||||
4171705|NCT00814333|3992888|B1|Male||Gender||participants|Number|1|1.0||||||
4171706|NCT00814333|3992886|B3|Female||Gender||participants|Number|0|0.0||||||
4171709|NCT00814333|3992888|B1|>=65 years||Age||participants|Number|0|0.0||||||
4171710|NCT00814333|3992886|B3|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
4171711|NCT00814333|3992888|B1|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
4171712|NCT00814333|3992886|B3|<=18 years||Age||participants|Number|0|0.0||||||
4171713|NCT00814333|3992888|B1|<=18 years||Age||participants|Number|0|0.0||||||
4171714|NCT00814320|3992895|B3|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4171715|NCT00814320|3992896|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4171716|NCT00814320|3992897|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4171717|NCT00814320|3992895|B3|United States||Region of Enrollment||participants|Number|86|86.0||||||
4171718|NCT00814320|3992896|B2|United States||Region of Enrollment||participants|Number|72|72.0||||||
4171719|NCT00814320|3992897|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4171720|NCT00814320|3992895|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4171721|NCT00814320|3992896|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4171722|NCT00814320|3992897|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4171723|NCT00814320|3992895|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4171724|NCT00814320|3992896|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4171725|NCT00814320|3992897|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4171726|NCT00814320|3992895|B3|||Age||years|Median|35.0|35.0|Full Range|||4.0|78.0|
4171727|NCT00814320|3992896|B2|||Age||years|Median|44.0|44.0|Full Range|||12.0|78.0|
4171728|NCT00814320|3992897|B1|||Age||years|Median|8.0|8.0|Full Range|||4.0|11.0|
4171729|NCT00814307|3993026|B5||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4171730|NCT00814307|3993027|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4171731|NCT00814307|3993028|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4171732|NCT00814307|3993029|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4171733|NCT00814307|3993030|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4171734|NCT00814307|3993026|B5||Female|Sex: Female, Male||Participants|Count of Participants|528|528.0||||||
4171735|NCT00814307|3993027|B4||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4171736|NCT00814307|3993028|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4171737|NCT00814307|3993029|B2||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4171738|NCT00814307|3993030|B1||Female|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4171739|NCT00814307|3993026|B5|||Age||Years|Mean|51.8|51.8|Standard Deviation|11.8|11.8|||
4171740|NCT00814307|3993027|B4|||Age||Years|Mean|48.8|48.8|Standard Deviation|11.9|11.9|||
4171741|NCT00814307|3993028|B3|||Age||Years|Mean|50.7|50.7|Standard Deviation|12.8|12.8|||
4171742|NCT00814307|3993029|B2|||Age||Years|Mean|52.4|52.4|Standard Deviation|11.7|11.7|||
4171743|NCT00814307|3993030|B1|||Age||Years|Mean|52.2|52.2|Standard Deviation|11.5|11.5|||
4171744|NCT00814255|3993195|B4|United States||Region of Enrollment||participants|Number|21|21.0||||||
4171745|NCT00814255|3993196|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4171746|NCT00814255|3993197|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4171747|NCT00814255|3993198|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4171748|NCT00814255|3993195|B4|African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4171749|NCT00814255|3993196|B3|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4171750|NCT00814255|3993197|B2|African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4171751|NCT00814255|3993198|B1|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4171752|NCT00814255|3993195|B4|hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4171753|NCT00814255|3993196|B3|hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4171754|NCT00814255|3993197|B2|hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4171755|NCT00814255|3993198|B1|hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4171756|NCT00814255|3993195|B4|white||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4171757|NCT00814255|3993196|B3|white||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4171758|NCT00814255|3993197|B2|white||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4171759|NCT00814255|3993198|B1|white||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4171760|NCT00814255|3993195|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4171761|NCT00814255|3993196|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4171762|NCT00814255|3993197|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4171763|NCT00814255|3993198|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4171764|NCT00814255|3993195|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4171765|NCT00814255|3993196|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4171766|NCT00814255|3993197|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4171767|NCT00814255|3993198|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4171768|NCT00814255|3993195|B4|||Age||years|Mean|17.8|17.8|Full Range|||3.8|36.6|
4171769|NCT00814255|3993196|B3|||Age||years|Mean|15.8|15.8|Full Range|||13.0|21.0|
4171770|NCT00814255|3993197|B2|||Age||years|Mean|15.6|15.6|Full Range|||3.8|34.1|
4171771|NCT00814255|3993198|B1|||Age||years|Mean|21.9|21.9|Full Range|||7.2|36.7|
4171772|NCT00814255|3993195|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4171773|NCT00814255|3993196|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4171774|NCT00814255|3993197|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4171775|NCT00814255|3993198|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4171776|NCT00814255|3993195|B4||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4171777|NCT00814255|3993196|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4171778|NCT00814255|3993197|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4171779|NCT00814255|3993198|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4171780|NCT00814255|3993195|B4||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4171781|NCT00814255|3993196|B3||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4171782|NCT00814255|3993197|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4171783|NCT00814255|3993198|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4171784|NCT00814177|3993220|B3|Canada||Region of Enrollment||participants|Number|160|160.0||||||
4171785|NCT00814177|3993221|B2|Canada||Region of Enrollment||participants|Number|80|80.0||||||
4171786|NCT00814177|3993222|B1|Canada||Region of Enrollment||participants|Number|80|80.0||||||
4171787|NCT00814177|3993220|B3||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4171788|NCT00814177|3993221|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4171789|NCT00814177|3993222|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4171790|NCT00814177|3993220|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4171791|NCT00814177|3993221|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4171792|NCT00814177|3993222|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4171793|NCT00814177|3993220|B3|||Age||years|Mean|68.4|68.4|Standard Deviation|12.7|12.7|||
4171794|NCT00814177|3993221|B2|||Age||years|Mean|67.1|67.1|Standard Deviation|13.8|13.8|||
4171795|NCT00814177|3993222|B1|||Age||years|Mean|69.6|69.6|Standard Deviation|11.4|11.4|||
4171796|NCT00814177|3993220|B3||>=65 years|Age||Participants|Count of Participants|106|106.0||||||
4171797|NCT00814177|3993221|B2||>=65 years|Age||Participants|Count of Participants|47|47.0||||||
4171798|NCT00814177|3993222|B1||>=65 years|Age||Participants|Count of Participants|59|59.0||||||
4171799|NCT00814177|3993220|B3||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4171800|NCT00814177|3993221|B2||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4171801|NCT00814177|3993222|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4171802|NCT00814177|3993220|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4171803|NCT00814177|3993221|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4171804|NCT00814177|3993222|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4171805|NCT00814164|3993229|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4171806|NCT00814164|3993229|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4171807|NCT00814164|3993229|B1|||Age||years|Mean|70.6|70.6|Standard Deviation|6.7|6.7|||
4171808|NCT00814138|3993240|B3|United States||Region of Enrollment||participants|Number|43|43.0||||||
4171809|NCT00814138|3993241|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4171810|NCT00814138|3993242|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4171811|NCT00814138|3993240|B3|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4171812|NCT00814138|3993241|B2|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4171813|NCT00814138|3993242|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4171814|NCT00814138|3993240|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4171815|NCT00814138|3993241|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4171816|NCT00814138|3993242|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4171817|NCT00814138|3993240|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4171818|NCT00814138|3993241|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4171819|NCT00814138|3993242|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4171820|NCT00814138|3993240|B3|||Age||years|Mean|67.6|67.6|Full Range|||26.6|87.2|
4171821|NCT00814138|3993241|B2|||Age||years|Mean|68.6|68.6|Full Range|||26.6|87.2|
4171822|NCT00814138|3993242|B1|||Age||years|Mean|66.5|66.5|Full Range|||28.5|83.9|
4171823|NCT00814138|3993240|B3||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4171824|NCT00814138|3993241|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4171825|NCT00814138|3993242|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4171826|NCT00814138|3993240|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4171827|NCT00814138|3993241|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4171828|NCT00814138|3993242|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4171829|NCT00814138|3993240|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4171830|NCT00814138|3993241|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4171831|NCT00814138|3993242|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4171832|NCT00813995|3993261|B3|||Fasting Plasma Glucose||mg/dL|Mean|173.7|173.7|Standard Deviation|39.6|39.6|||
4171833|NCT00813995|3993262|B2|||Fasting Plasma Glucose||mg/dL|Mean|173.9|173.9|Standard Deviation|40.0|40.0|||
4171834|NCT00813995|3993263|B1|||Fasting Plasma Glucose||mg/dL|Mean|173.4|173.4|Standard Deviation|39.3|39.3|||
4171894|NCT00813904|3993326|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4171835|NCT00813995|3993261|B3|||2-hour Post-meal Glucose|392 participants with available data: sitagliptin, n=192; placebo, n=196|mg/dL|Mean|258.3|258.3|Standard Deviation|60.6|60.6|||
4171836|NCT00813995|3993262|B2|||2-hour Post-meal Glucose|392 participants with available data: sitagliptin, n=192; placebo, n=196|mg/dL|Mean|258.7|258.7|Standard Deviation|63.2|63.2|||
4171837|NCT00813995|3993263|B1|||2-hour Post-meal Glucose|392 participants with available data: sitagliptin, n=192; placebo, n=196|mg/dL|Mean|258.0|258.0|Standard Deviation|58.0|58.0|||
4171838|NCT00813995|3993261|B3|||Hemoglobin A1c (HbA1c)||Percent|Mean|8.5|8.5|Standard Deviation|0.9|0.9|||
4171839|NCT00813995|3993262|B2|||Hemoglobin A1c (HbA1c)||Percent|Mean|8.5|8.5|Standard Deviation|0.9|0.9|||
4171840|NCT00813995|3993263|B1|||Hemoglobin A1c (HbA1c)||Percent|Mean|8.5|8.5|Standard Deviation|0.9|0.9|||
4171841|NCT00813995|3993261|B3|China||Region of Enrollment||participants|Number|395|395.0||||||
4171842|NCT00813995|3993262|B2|China||Region of Enrollment||participants|Number|198|198.0||||||
4171843|NCT00813995|3993263|B1|China||Region of Enrollment||participants|Number|197|197.0||||||
4171844|NCT00813995|3993261|B3||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4171845|NCT00813995|3993262|B2||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4171846|NCT00813995|3993263|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4171847|NCT00813995|3993261|B3||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4171848|NCT00813995|3993262|B2||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4171849|NCT00813995|3993263|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4171850|NCT00813995|3993261|B3|||Age||years|Mean|54.6|54.6|Standard Deviation|9.4|9.4|||
4171851|NCT00813995|3993262|B2|||Age||years|Mean|55.1|55.1|Standard Deviation|9.8|9.8|||
4171852|NCT00813995|3993263|B1|||Age||years|Mean|54.1|54.1|Standard Deviation|9.0|9.0|||
4171853|NCT00813982|3993278|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4171854|NCT00813982|3993278|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4171855|NCT00813982|3993278|B1|||Age||years|Mean|30.7|30.7|Standard Deviation|10.3|10.3|||
4171856|NCT00813943|3993284|B4||Male|Gender||Participants|Count of Participants|155|155.0||||||
4171857|NCT00813943|3993285|B3||Male|Gender||Participants|Count of Participants|55|55.0||||||
4171858|NCT00813943|3993286|B2||Male|Gender||Participants|Count of Participants|50|50.0||||||
4171859|NCT00813943|3993287|B1||Male|Gender||Participants|Count of Participants|50|50.0||||||
4171860|NCT00813943|3993284|B4||Female|Gender||Participants|Count of Participants|110|110.0||||||
4171861|NCT00813943|3993285|B3||Female|Gender||Participants|Count of Participants|34|34.0||||||
4171862|NCT00813943|3993286|B2||Female|Gender||Participants|Count of Participants|38|38.0||||||
4171863|NCT00813943|3993287|B1||Female|Gender||Participants|Count of Participants|38|38.0||||||
4171864|NCT00813943|3993284|B4|||Age||years|Mean|54.8|54.8|Standard Deviation|10.57|10.57|||
4171865|NCT00813943|3993285|B3|||Age||years|Mean|54.5|54.5|Standard Deviation|11.64|11.64|||
4171866|NCT00813943|3993286|B2|||Age||years|Mean|55.2|55.2|Standard Deviation|10.44|10.44|||
4171867|NCT00813943|3993287|B1|||Age||years|Mean|54.6|54.6|Standard Deviation|9.63|9.63|||
4171868|NCT00813917|3993317|B3|||smokeless tobacco quantity|Amount of smokeless tobacco used per week|cans per week|Mean|3.6|3.6|Standard Deviation|2.9|2.9|||
4171869|NCT00813917|3993318|B2|||smokeless tobacco quantity|Amount of smokeless tobacco used per week|cans per week|Mean|3.2|3.2|Standard Deviation|2.0|2.0|||
4171870|NCT00813917|3993319|B1|||smokeless tobacco quantity|Amount of smokeless tobacco used per week|cans per week|Mean|4.0|4.0|Standard Deviation|3.5|3.5|||
4171871|NCT00813917|3993317|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4171872|NCT00813917|3993318|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4171873|NCT00813917|3993319|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4171874|NCT00813917|3993317|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4171875|NCT00813917|3993318|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4171876|NCT00813917|3993319|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4171877|NCT00813917|3993317|B3|||Age||years|Mean|40.9|40.9|Standard Deviation|11.2|11.2|||
4171878|NCT00813917|3993318|B2|||Age||years|Mean|40.7|40.7|Standard Deviation|10.1|10.1|||
4171879|NCT00813917|3993319|B1|||Age||years|Mean|41.0|41.0|Standard Deviation|12.4|12.4|||
4171880|NCT00813917|3993317|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4171881|NCT00813917|3993318|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4171882|NCT00813917|3993319|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4171883|NCT00813917|3993317|B3||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
4171884|NCT00813917|3993318|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4171885|NCT00813917|3993319|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4171886|NCT00813917|3993317|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4171887|NCT00813917|3993318|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4171888|NCT00813917|3993319|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4171889|NCT00813904|3993326|B1|Spinal||Type of surgery||Participants|Number|23|23.0||||||
4171890|NCT00813904|3993326|B1|Other||Type of surgery||Participants|Number|1|1.0||||||
4171891|NCT00813904|3993326|B1|Arteriovenous vascular access procedure||Type of surgery||Participants|Number|3|3.0||||||
4171892|NCT00813904|3993326|B1|Arterial reconstruction/peripheral arterial bypass||Type of surgery||Participants|Number|4|4.0||||||
4171893|NCT00813904|3993326|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4171895|NCT00813904|3993326|B1|Median||Age, Customized||Years|Median|61.0|61.0|Full Range|||22.0|81.0|
4171896|NCT00813904|3993326|B1|||Age, Customized||Years|Mean|59.5|59.5|Standard Deviation|12.3|12.3|||
4171897|NCT00813865|3993332|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4171898|NCT00813865|3993332|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4171899|NCT00813865|3993332|B1|||Age||years|Mean|41.3|41.3|Standard Deviation|20.74|20.74|||
4171900|NCT00813813|3993338|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4171901|NCT00813813|3993339|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4171902|NCT00813813|3993340|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4171903|NCT00813813|3993338|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4171904|NCT00813813|3993339|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4171905|NCT00813813|3993340|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4171906|NCT00813813|3993338|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4171907|NCT00813813|3993339|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4171908|NCT00813813|3993340|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4171909|NCT00813813|3993338|B3|||Age||years|Mean|41.7|41.7|Standard Deviation|9.56|9.56|||
4171910|NCT00813813|3993339|B2|||Age||years|Mean|44.4|44.4|Standard Deviation|8.63|8.63|||
4171911|NCT00813813|3993340|B1|||Age||years|Mean|32|32.0|Standard Deviation|5.92|5.92|||
4171912|NCT00813800|3993357|B1|||Young Mania Rating Scale (YMRS)|YMRS is an eleven-item, multiple choice diagnostic questionnaire which psychiatrists use to measure the severity of manic episodes in patients already diagnosed with mania. Lowest score = 0, normal subject; Highest score = 60, highly manic subject. For this scale the following scores are associated with these grades of severity: mania (YMRS = 20), hypomania (YMRS = 12), under 5 is classified as non-manic. Young RC, Biggs JT, Ziegler Ve, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. BR J Psychiatry 1978; 133:429-435.|Units on a scale|Mean|1.9|1.9|Standard Deviation|0.6|0.6|||
4171913|NCT00813800|3993357|B1|||Montgomery-Asberg Depression Rating Scale (MADRS)|MADRS is a ten-item diagnostic questionnaire which psychiatrists use to measure the severity of depressive episodes in patients with mood disorders. Each item on the MADRS is scaled 0 through 6. Lowest score = 0, would indicate no depressive symptoms. Highest score = 60, indicating extreme depression. MADRS score > 20 is syndromal depression. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134:382-389.|Units on a scale|Mean|9.9|9.9|Standard Deviation|1.5|1.5|||
4171914|NCT00813800|3993357|B1|||Carbon Monoxide Breath Level|Measured by expired breath in parts per million (ppm). (0-10 = non smoker; 11-20 = light smoker; >20 = heavy smoker)|ppm|Mean|20|20.0|Standard Deviation|4.6|4.6|||
4171915|NCT00813800|3993357|B1|||Cigarettes (per day)||Cigarettes|Mean|15.8|15.8|Standard Deviation|2|2.0|||
4171916|NCT00813800|3993357|B1|||Brief Questionnaire of Smoking Urges (QSU-brief)|The USU-brief is used as a measure of craving or desire to smoke. It uses 10 “agree-disagree” statements in a rating scale, five covering need to smoke for relief and five covering positive desire to smoke for reward. Maximum score = 1000, indicates a high level of craving. Minimum score = 0, indicates no craving for smoking. Cox LS, Tiffany ST, Christen AG. Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboaratory and clinical setting. Nicotine & Tobacco Research (2001)3(1):7-16.|Units on a scale|Mean|476|476.0|Standard Deviation|89.3|89.3|||
4171917|NCT00813800|3993357|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4171918|NCT00813800|3993357|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4171919|NCT00813800|3993357|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4171920|NCT00813800|3993357|B1|||Age||years|Mean|38.8|38.8|Standard Deviation|14|14.0|||
4171921|NCT00813761|3993363|B3|United Kingdom||Region of Enrollment||participants|Number|38|38.0||||||
4171922|NCT00813761|3993364|B2|United Kingdom||Region of Enrollment||participants|Number|19|19.0||||||
4171923|NCT00813761|3993365|B1|United Kingdom||Region of Enrollment||participants|Number|19|19.0||||||
4171924|NCT00813761|3993363|B3|United States||Region of Enrollment||participants|Number|387|387.0||||||
4171925|NCT00813761|3993364|B2|United States||Region of Enrollment||participants|Number|198|198.0||||||
4171926|NCT00813761|3993365|B1|United States||Region of Enrollment||participants|Number|189|189.0||||||
4171927|NCT00813761|3993363|B3||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4171928|NCT00813761|3993364|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4171929|NCT00813761|3993365|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4171930|NCT00813761|3993363|B3||Female|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
4171931|NCT00813761|3993364|B2||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4171932|NCT00813761|3993365|B1||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4171933|NCT00813761|3993363|B3|||Age||years|Mean|33.6|33.6|Standard Deviation|11.6|11.6|||
4171934|NCT00813761|3993364|B2|||Age||years|Mean|33.4|33.4|Standard Deviation|11.3|11.3|||
4171935|NCT00813761|3993365|B1|||Age||years|Mean|33.9|33.9|Standard Deviation|11.8|11.8|||
4171936|NCT00813748|3993416|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4171937|NCT00813748|3993417|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4171938|NCT00813748|3993418|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4171939|NCT00813748|3993416|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4171940|NCT00813748|3993417|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4171941|NCT00813748|3993418|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4171997|NCT00813488|3993542|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4171942|NCT00813748|3993416|B3|||Age|For Cases, age reported is the age at the time of the adjudicated event. For Controls, age reported is the age at the time of the adjudicated event experienced by the matched Case participant.|years|Mean|44.7|44.7|Standard Deviation|15.64|15.64|||
4171943|NCT00813748|3993417|B2|||Age|For Cases, age reported is the age at the time of the adjudicated event. For Controls, age reported is the age at the time of the adjudicated event experienced by the matched Case participant.|years|Mean|45.4|45.4|Standard Deviation|15.40|15.4|||
4171944|NCT00813748|3993418|B1|||Age|For Cases, age reported is the age at the time of the adjudicated event. For Controls, age reported is the age at the time of the adjudicated event experienced by the matched Case participant.|years|Mean|42.7|42.7|Standard Deviation|16.41|16.41|||
4171945|NCT00813709|3993445|B4|White||Race/Ethnicity, Customized||participants|Number|401|401.0||||||
4171946|NCT00813709|3993446|B3|White||Race/Ethnicity, Customized||participants|Number|127|127.0||||||
4171947|NCT00813709|3993447|B2|White||Race/Ethnicity, Customized||participants|Number|141|141.0||||||
4171948|NCT00813709|3993448|B1|White||Race/Ethnicity, Customized||participants|Number|133|133.0||||||
4171949|NCT00813709|3993445|B4|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4171950|NCT00813709|3993446|B3|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4171951|NCT00813709|3993447|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4171952|NCT00813709|3993448|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4171953|NCT00813709|3993445|B4||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4171954|NCT00813709|3993446|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4171955|NCT00813709|3993447|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4171956|NCT00813709|3993448|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4171957|NCT00813709|3993445|B4||Female|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
4171958|NCT00813709|3993446|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4171959|NCT00813709|3993447|B2||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4171960|NCT00813709|3993448|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4171961|NCT00813709|3993445|B4|Greater than or equal to 30 years||Age, Customized||participants|Number|214|214.0||||||
4171962|NCT00813709|3993446|B3|Greater than or equal to 30 years||Age, Customized||participants|Number|72|72.0||||||
4171963|NCT00813709|3993447|B2|Greater than or equal to 30 years||Age, Customized||participants|Number|76|76.0||||||
4171964|NCT00813709|3993448|B1|Greater than or equal to 30 years||Age, Customized||participants|Number|66|66.0||||||
4171965|NCT00813709|3993445|B4|Less than 30 years||Age, Customized||participants|Number|188|188.0||||||
4171966|NCT00813709|3993446|B3|Less than 30 years||Age, Customized||participants|Number|55|55.0||||||
4171967|NCT00813709|3993447|B2|Less than 30 years||Age, Customized||participants|Number|66|66.0||||||
4171968|NCT00813709|3993448|B1|Less than 30 years||Age, Customized||participants|Number|67|67.0||||||
4171969|NCT00813709|3993445|B4|||Age||years|Mean|31.4|31.4|Standard Deviation|8.3|8.3|||
4171970|NCT00813709|3993446|B3|||Age||years|Mean|31.8|31.8|Standard Deviation|8.6|8.6|||
4171971|NCT00813709|3993447|B2|||Age||years|Mean|31.4|31.4|Standard Deviation|8.2|8.2|||
4171972|NCT00813709|3993448|B1|||Age||years|Mean|31.0|31.0|Standard Deviation|8.2|8.2|||
4171973|NCT00813592|3993533|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4171974|NCT00813592|3993533|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171975|NCT00813592|3993533|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171976|NCT00813592|3993533|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4171977|NCT00813592|3993533|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171978|NCT00813592|3993533|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171979|NCT00813592|3993533|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171980|NCT00813592|3993533|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171981|NCT00813592|3993533|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171982|NCT00813592|3993533|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4171983|NCT00813592|3993533|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171984|NCT00813592|3993533|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4171985|NCT00813592|3993533|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4171986|NCT00813592|3993533|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4171987|NCT00813592|3993533|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4171988|NCT00813592|3993533|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4171989|NCT00813488|3993542|B1|||Body Mass Index (BMI)||kg/m^2|Mean|30.1|30.1|Standard Deviation|7.25|7.25|||
4171990|NCT00813488|3993542|B1|United States||Region of Enrollment||participants|Number|213|213.0||||||
4171991|NCT00813488|3993542|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4171992|NCT00813488|3993542|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171993|NCT00813488|3993542|B1||White|Race (NIH/OMB)||Participants|Count of Participants|191|191.0||||||
4171994|NCT00813488|3993542|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4171995|NCT00813488|3993542|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4171996|NCT00813488|3993542|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4171998|NCT00813488|3993542|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4171999|NCT00813488|3993542|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|195|195.0||||||
4172000|NCT00813488|3993542|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4172001|NCT00813488|3993542|B1||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4172002|NCT00813488|3993542|B1||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4172003|NCT00813488|3993542|B1|||Age||years|Mean|51.0|51.0|Standard Deviation|9.97|9.97|||
4172004|NCT00813319|3993639|B3|United States||Region of Enrollment||participants|Number|216|216.0||||||
4172005|NCT00813319|3993640|B2|United States||Region of Enrollment||participants|Number|108|108.0||||||
4172006|NCT00813319|3993641|B1|United States||Region of Enrollment||participants|Number|108|108.0||||||
4172007|NCT00813319|3993639|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4172008|NCT00813319|3993640|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4172009|NCT00813319|3993641|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4172010|NCT00813319|3993639|B3||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4172011|NCT00813319|3993640|B2||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4172012|NCT00813319|3993641|B1||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4172013|NCT00813319|3993639|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4172014|NCT00813319|3993640|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4172015|NCT00813319|3993641|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4172016|NCT00813319|3993639|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4172017|NCT00813319|3993640|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4172018|NCT00813319|3993641|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4172019|NCT00813319|3993639|B3||<=18 years|Age||Participants|Count of Participants|216|216.0||||||
4172020|NCT00813319|3993640|B2||<=18 years|Age||Participants|Count of Participants|108|108.0||||||
4172021|NCT00813319|3993641|B1||<=18 years|Age||Participants|Count of Participants|108|108.0||||||
4172022|NCT00813319|3993639|B3|||Age||Years|Mean|16.47|16.47|Standard Deviation|1.50|1.5|||
4172023|NCT00813319|3993640|B2|||Age||Years|Mean|16.26|16.26|Standard Deviation|1.54|1.54|||
4172024|NCT00813319|3993641|B1|||Age||Years|Mean|16.68|16.68|Standard Deviation|1.44|1.44|||
4172025|NCT00813176|3993652|B3|||Neck Circumference||Centimeters|Mean|46.3|46.3|Standard Deviation|5.9|5.9|||
4172026|NCT00813176|3993653|B2|||Neck Circumference||Centimeters|Mean|47|47.0|Standard Deviation|7|7.0|||
4172027|NCT00813176|3993654|B1|||Neck Circumference||Centimeters|Mean|46|46.0|Standard Deviation|4|4.0|||
4172028|NCT00813176|3993652|B3|||Body Weight||Kilograms|Mean|115.6|115.6|Standard Deviation|19.9|19.9|||
4172029|NCT00813176|3993653|B2|||Body Weight||Kilograms|Mean|116.5|116.5|Standard Deviation|22.4|22.4|||
4172030|NCT00813176|3993654|B1|||Body Weight||Kilograms|Mean|114.5|114.5|Standard Deviation|17.1|17.1|||
4172031|NCT00813176|3993652|B3|||Body Mass Index|Body Mass Index of obesity or being underweight. It is body weight divided by body height squared (BMI=kg/m^2)|kg/m^2|Mean|40|40.0|Standard Deviation|4.5|4.5|||
4172032|NCT00813176|3993653|B2|||Body Mass Index|Body Mass Index of obesity or being underweight. It is body weight divided by body height squared (BMI=kg/m^2)|kg/m^2|Mean|40.2|40.2|Standard Deviation|4.5|4.5|||
4172033|NCT00813176|3993654|B1|||Body Mass Index|Body Mass Index of obesity or being underweight. It is body weight divided by body height squared (BMI=kg/m^2)|kg/m^2|Mean|39.9|39.9|Standard Deviation|4.8|4.8|||
4172034|NCT00813176|3993652|B3|||double lumen tubes versus bronchial blockers||Participants|Count of Participants|50|50.0||||||
4172035|NCT00813176|3993653|B2|||double lumen tubes versus bronchial blockers||Participants|Count of Participants|25|25.0||||||
4172036|NCT00813176|3993654|B1|||double lumen tubes versus bronchial blockers||Participants|Count of Participants|25|25.0||||||
4172037|NCT00813176|3993652|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4172038|NCT00813176|3993653|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4172039|NCT00813176|3993654|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4172040|NCT00813176|3993652|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4172041|NCT00813176|3993653|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4172042|NCT00813176|3993654|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4172043|NCT00813176|3993652|B3|||Age||years|Mean|52|52.0|Full Range|||23.0|85.0|
4172044|NCT00813176|3993653|B2|||Age||years|Mean|53|53.0|Full Range|||23.0|85.0|
4172045|NCT00813176|3993654|B1|||Age||years|Mean|52|52.0|Full Range|||24.0|74.0|
4172046|NCT00813150|3993671|B3|African||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4172047|NCT00813150|3993672|B2|African||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4172048|NCT00813150|3993673|B1|African||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4172049|NCT00813150|3993671|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|89|89.0||||||
4172050|NCT00813150|3993672|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|47|47.0||||||
4172051|NCT00813150|3993673|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|42|42.0||||||
4172052|NCT00813150|3993671|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4172053|NCT00813150|3993672|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4172054|NCT00813150|3993673|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4172055|NCT00813150|3993671|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4172056|NCT00813150|3993672|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4172057|NCT00813150|3993673|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4172058|NCT00813150|3993671|B3|||Age||Years|Mean|69|69.0|Standard Deviation|9|9.0|||
4172059|NCT00813150|3993672|B2|||Age||Years|Mean|71|71.0|Standard Deviation|7|7.0|||
4172060|NCT00813150|3993673|B1|||Age||Years|Mean|68|68.0|Standard Deviation|10|10.0|||
4172061|NCT00813111|3993686|B3|United States||Region of Enrollment||participants|Number|136|136.0||||||
4172062|NCT00813111|3993687|B2|United States||Region of Enrollment||participants|Number|70|70.0||||||
4172063|NCT00813111|3993688|B1|United States||Region of Enrollment||participants|Number|66|66.0||||||
4172064|NCT00813111|3993686|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4172065|NCT00813111|3993687|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4172066|NCT00813111|3993688|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4172067|NCT00813111|3993686|B3||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4172068|NCT00813111|3993687|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4172069|NCT00813111|3993688|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4172070|NCT00813111|3993686|B3|||Age||years|Mean|30.7|30.7|Standard Deviation|7.4|7.4|||
4172071|NCT00813111|3993687|B2|||Age||years|Mean|30.6|30.6|Standard Deviation|7.6|7.6|||
4172072|NCT00813111|3993688|B1|||Age||years|Mean|30.8|30.8|Standard Deviation|7.3|7.3|||
4172073|NCT00813111|3993686|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4172074|NCT00813111|3993687|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4172075|NCT00813111|3993688|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4172076|NCT00813111|3993686|B3||Between 18 and 65 years|Age||Participants|Count of Participants|136|136.0||||||
4172077|NCT00813111|3993687|B2||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4172078|NCT00813111|3993688|B1||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4172079|NCT00813111|3993686|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4172080|NCT00813111|3993687|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4172081|NCT00813111|3993688|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4172082|NCT00813098|3993695|B4|IBS-D||IB Sub-type|Measure based upon the per protocol population. Non-constipating IBS patients entering the trial were classified into 2 groups: irritable bowel syndrome-diarrhea (IBS-D) or irritable bowel syndrome-mixed (IBS-M).|participant|Number|104|104.0||||||
4172083|NCT00813098|3993696|B3|IBS-D||IB Sub-type|Measure based upon the per protocol population. Non-constipating IBS patients entering the trial were classified into 2 groups: irritable bowel syndrome-diarrhea (IBS-D) or irritable bowel syndrome-mixed (IBS-M).|participant|Number|35|35.0||||||
4172084|NCT00813098|3993697|B2|IBS-D||IB Sub-type|Measure based upon the per protocol population. Non-constipating IBS patients entering the trial were classified into 2 groups: irritable bowel syndrome-diarrhea (IBS-D) or irritable bowel syndrome-mixed (IBS-M).|participant|Number|35|35.0||||||
4172085|NCT00813098|3993698|B1|IBS-D||IB Sub-type|Measure based upon the per protocol population. Non-constipating IBS patients entering the trial were classified into 2 groups: irritable bowel syndrome-diarrhea (IBS-D) or irritable bowel syndrome-mixed (IBS-M).|participant|Number|34|34.0||||||
4172086|NCT00813098|3993695|B4|IBS-M||IB Sub-type|Measure based upon the per protocol population. Non-constipating IBS patients entering the trial were classified into 2 groups: irritable bowel syndrome-diarrhea (IBS-D) or irritable bowel syndrome-mixed (IBS-M).|participant|Number|30|30.0||||||
4172087|NCT00813098|3993696|B3|IBS-M||IB Sub-type|Measure based upon the per protocol population. Non-constipating IBS patients entering the trial were classified into 2 groups: irritable bowel syndrome-diarrhea (IBS-D) or irritable bowel syndrome-mixed (IBS-M).|participant|Number|12|12.0||||||
4172088|NCT00813098|3993697|B2|IBS-M||IB Sub-type|Measure based upon the per protocol population. Non-constipating IBS patients entering the trial were classified into 2 groups: irritable bowel syndrome-diarrhea (IBS-D) or irritable bowel syndrome-mixed (IBS-M).|participant|Number|9|9.0||||||
4172089|NCT00813098|3993698|B1|IBS-M||IB Sub-type|Measure based upon the per protocol population. Non-constipating IBS patients entering the trial were classified into 2 groups: irritable bowel syndrome-diarrhea (IBS-D) or irritable bowel syndrome-mixed (IBS-M).|participant|Number|9|9.0||||||
4172090|NCT00813098|3993695|B4|United States||Region of Enrollment||participants|Number|134|134.0||||||
4172091|NCT00813098|3993696|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
4172092|NCT00813098|3993697|B2|United States||Region of Enrollment||participants|Number|44|44.0||||||
4172093|NCT00813098|3993698|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4172094|NCT00813098|3993695|B4|Other||Race/Ethnicity, Customized|Measure based upon the per protocol population.|participants|Number|2|2.0||||||
4172095|NCT00813098|3993696|B3|Other||Race/Ethnicity, Customized|Measure based upon the per protocol population.|participants|Number|1|1.0||||||
4172096|NCT00813098|3993697|B2|Other||Race/Ethnicity, Customized|Measure based upon the per protocol population.|participants|Number|1|1.0||||||
4172097|NCT00813098|3993698|B1|Other||Race/Ethnicity, Customized|Measure based upon the per protocol population.|participants|Number|0|0.0||||||
4172098|NCT00813098|3993695|B4|Asian||Race/Ethnicity, Customized|Measure based upon the per protocol population.|participants|Number|1|1.0||||||
4172099|NCT00813098|3993696|B3|Asian||Race/Ethnicity, Customized|Measure based upon the per protocol population.|participants|Number|1|1.0||||||
4172100|NCT00813098|3993697|B2|Asian||Race/Ethnicity, Customized|Measure based upon the per protocol population.|participants|Number|0|0.0||||||
4172101|NCT00813098|3993698|B1|Asian||Race/Ethnicity, Customized|Measure based upon the per protocol population.|participants|Number|0|0.0||||||
4172102|NCT00813098|3993695|B4|Black or African American||Race/Ethnicity, Customized|Measure based upon the per protocol population.|participants|Number|10|10.0||||||
4172103|NCT00813098|3993696|B3|Black or African American||Race/Ethnicity, Customized|Measure based upon the per protocol population.|participants|Number|1|1.0||||||
4172104|NCT00813098|3993697|B2|Black or African American||Race/Ethnicity, Customized|Measure based upon the per protocol population.|participants|Number|3|3.0||||||
4172105|NCT00813098|3993698|B1|Black or African American||Race/Ethnicity, Customized|Measure based upon the per protocol population.|participants|Number|6|6.0||||||
4172106|NCT00813098|3993695|B4|White||Race/Ethnicity, Customized|Measure based upon the per protocol population.|participants|Number|121|121.0||||||
4172107|NCT00813098|3993696|B3|White||Race/Ethnicity, Customized|Measure based upon the per protocol population.|participants|Number|44|44.0||||||
4172108|NCT00813098|3993697|B2|White||Race/Ethnicity, Customized|Measure based upon the per protocol population.|participants|Number|40|40.0||||||
4172109|NCT00813098|3993698|B1|White||Race/Ethnicity, Customized|Measure based upon the per protocol population.|participants|Number|37|37.0||||||
4172110|NCT00813098|3993695|B4||Male|Sex: Female, Male|Measure based upon the per protocol population|Participants|Count of Participants|57|57.0||||||
4172111|NCT00813098|3993696|B3||Male|Sex: Female, Male|Measure based upon the per protocol population|Participants|Count of Participants|40|40.0||||||
4172112|NCT00813098|3993697|B2||Male|Sex: Female, Male|Measure based upon the per protocol population|Participants|Count of Participants|8|8.0||||||
4172113|NCT00813098|3993698|B1||Male|Sex: Female, Male|Measure based upon the per protocol population|Participants|Count of Participants|9|9.0||||||
4172114|NCT00813098|3993695|B4||Female|Sex: Female, Male|Measure based upon the per protocol population|Participants|Count of Participants|77|77.0||||||
4172115|NCT00813098|3993696|B3||Female|Sex: Female, Male|Measure based upon the per protocol population|Participants|Count of Participants|7|7.0||||||
4172116|NCT00813098|3993697|B2||Female|Sex: Female, Male|Measure based upon the per protocol population|Participants|Count of Participants|36|36.0||||||
4172117|NCT00813098|3993698|B1||Female|Sex: Female, Male|Measure based upon the per protocol population|Participants|Count of Participants|34|34.0||||||
4172118|NCT00813098|3993695|B4|||Age||years|Mean|47.8|47.8|Standard Deviation|12.70|12.7|||
4172119|NCT00813098|3993696|B3|||Age||years|Mean|48.0|48.0|Standard Deviation|12.70|12.7|||
4172120|NCT00813098|3993697|B2|||Age||years|Mean|46.7|46.7|Standard Deviation|13.34|13.34|||
4172121|NCT00813098|3993698|B1|||Age||years|Mean|48.8|48.8|Standard Deviation|12.24|12.24|||
4172122|NCT00812981|3993723|B3|Asian - East-Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|320|320.0||||||
4172123|NCT00812981|3993724|B2|Asian - East-Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|160|160.0||||||
4172124|NCT00812981|3993725|B1|Asian - East-Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|160|160.0||||||
4172125|NCT00812981|3993723|B3||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4172126|NCT00812981|3993724|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4172127|NCT00812981|3993725|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4172128|NCT00812981|3993723|B3||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4172129|NCT00812981|3993724|B2||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4172130|NCT00812981|3993725|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4172131|NCT00812981|3993723|B3|||Age||Years|Mean|31.95|31.95|Standard Deviation|8.56|8.56|||
4172132|NCT00812981|3993724|B2|||Age||Years|Mean|32.60|32.6|Standard Deviation|9.10|9.1|||
4172133|NCT00812981|3993725|B1|||Age||Years|Mean|31.30|31.3|Standard Deviation|7.95|7.95|||
4172134|NCT00812968|3993764|B1|No||Transfusion Dependency||participants|Number|6|6.0||||||
4172135|NCT00812968|3993764|B1|Yes||Transfusion Dependency||participants|Number|5|5.0||||||
4172136|NCT00812968|3993764|B1|Missing||Bone Marrow Cellularity|Bone marrow cellularity is a measure of the percentage of hematopoietic stem cells relative to fat cells in the bone marrow.|participants|Number|1|1.0||||||
4172137|NCT00812968|3993764|B1|Packed (> 90% to ≤ 100%)||Bone Marrow Cellularity|Bone marrow cellularity is a measure of the percentage of hematopoietic stem cells relative to fat cells in the bone marrow.|participants|Number|0|0.0||||||
4172138|NCT00812968|3993764|B1|Hypercellular (> 60% to ≤ 90%)||Bone Marrow Cellularity|Bone marrow cellularity is a measure of the percentage of hematopoietic stem cells relative to fat cells in the bone marrow.|participants|Number|2|2.0||||||
4172139|NCT00812968|3993764|B1|Normocellular (> 30% to ≤ 60%)||Bone Marrow Cellularity|Bone marrow cellularity is a measure of the percentage of hematopoietic stem cells relative to fat cells in the bone marrow.|participants|Number|5|5.0||||||
4172140|NCT00812968|3993764|B1|Hypocellular (> 0% to ≤ 30%)||Bone Marrow Cellularity|Bone marrow cellularity is a measure of the percentage of hematopoietic stem cells relative to fat cells in the bone marrow.|participants|Number|3|3.0||||||
4172141|NCT00812968|3993764|B1|Aplastic (0%)||Bone Marrow Cellularity|Bone marrow cellularity is a measure of the percentage of hematopoietic stem cells relative to fat cells in the bone marrow.|participants|Number|0|0.0||||||
4172142|NCT00812968|3993764|B1|MDS associated with isolated del(5q)||World Health Organization Classification of MDS|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|8|8.0||||||
4172143|NCT00812968|3993764|B1|MDS, unclassified (MDS-U)||World Health Organization Classification of MDS|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|0|0.0||||||
4172144|NCT00812968|3993764|B1|RCMD and ringed sideroblasts (RCMD-RS)||World Health Organization Classification of MDS|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|0|0.0||||||
4172164|NCT00812955|3993795|B5|United States||Region of Enrollment||participants|Number|474|474.0||||||
4172145|NCT00812968|3993764|B1|Refractory cytopenia multilineage dysplasia (RCMD)||World Health Organization Classification of MDS|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|1|1.0||||||
4172146|NCT00812968|3993764|B1|Refractory anemia with excess blasts-2 (RAEB-2)||World Health Organization Classification of MDS|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|0|0.0||||||
4172147|NCT00812968|3993764|B1|Refractory anemia with excess blasts-1 (RAEB-1)||World Health Organization Classification of MDS|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|2|2.0||||||
4172148|NCT00812968|3993764|B1|RA with ringed sideroblasts (RARS)||World Health Organization Classification of MDS|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|0|0.0||||||
4172149|NCT00812968|3993764|B1|Refractory anemia (RA)||World Health Organization Classification of MDS|The World Health Organization (WHO) classification recognizes eight subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), presence of a monocytosis or a deletion 5q.|participants|Number|0|0.0||||||
4172150|NCT00812968|3993764|B1|RAEB in transformation (RAEB-t)||French-American-British (FAB) classification of MDS|The French-American-British (FAB) classification of MDS recognizes five subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), or a monocytosis.|participants|Number|0|0.0||||||
4172151|NCT00812968|3993764|B1|Chronic myelomonocytic leukemia (CMML)||French-American-British (FAB) classification of MDS|The French-American-British (FAB) classification of MDS recognizes five subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), or a monocytosis.|participants|Number|0|0.0||||||
4172152|NCT00812968|3993764|B1|Refractory anemia with excess blasts (RAEB)||French-American-British (FAB) classification of MDS|The French-American-British (FAB) classification of MDS recognizes five subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), or a monocytosis.|participants|Number|2|2.0||||||
4172153|NCT00812968|3993764|B1|Refractory anemia with ringed sideroblasts (RARS)||French-American-British (FAB) classification of MDS|The French-American-British (FAB) classification of MDS recognizes five subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), or a monocytosis.|participants|Number|0|0.0||||||
4172154|NCT00812968|3993764|B1|Refractory anemia (RA)||French-American-British (FAB) classification of MDS|The French-American-British (FAB) classification of MDS recognizes five subtypes of MDS that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts (i.e., erythroid precursors with iron deposits surrounding the nucleus), or a monocytosis.|participants|Number|9|9.0||||||
4172155|NCT00812968|3993764|B1|High risk||International Prognostic Scoring System (IPSS) Score|The MDS IPSS assesses the severity of MDS based on 3 prognostic factors each assigned a score: the proportion of bone marrow blasts, chromosome changes in the marrow cells (karyotype) and the presence of one or more low blood cell counts (cytopenias). The IPSS score is the sum of the bone marrow blast + karyotype + cytopenia score and ranges from 0 (low risk) to 3.5 (high risk). Prognosis is categorized as Low risk (score = 0), Intermediate-1 (score 0.5 to 1.0), Intermediate-2 (score 1.5 to 2.0) or High risk (score ≥ 2.5).|participants|Number|0|0.0||||||
4172156|NCT00812968|3993764|B1|Intermediate-2 risk||International Prognostic Scoring System (IPSS) Score|The MDS IPSS assesses the severity of MDS based on 3 prognostic factors each assigned a score: the proportion of bone marrow blasts, chromosome changes in the marrow cells (karyotype) and the presence of one or more low blood cell counts (cytopenias). The IPSS score is the sum of the bone marrow blast + karyotype + cytopenia score and ranges from 0 (low risk) to 3.5 (high risk). Prognosis is categorized as Low risk (score = 0), Intermediate-1 (score 0.5 to 1.0), Intermediate-2 (score 1.5 to 2.0) or High risk (score ≥ 2.5).|participants|Number|0|0.0||||||
4172157|NCT00812968|3993764|B1|Intermediate-1 risk||International Prognostic Scoring System (IPSS) Score|The MDS IPSS assesses the severity of MDS based on 3 prognostic factors each assigned a score: the proportion of bone marrow blasts, chromosome changes in the marrow cells (karyotype) and the presence of one or more low blood cell counts (cytopenias). The IPSS score is the sum of the bone marrow blast + karyotype + cytopenia score and ranges from 0 (low risk) to 3.5 (high risk). Prognosis is categorized as Low risk (score = 0), Intermediate-1 (score 0.5 to 1.0), Intermediate-2 (score 1.5 to 2.0) or High risk (score ≥ 2.5).|participants|Number|9|9.0||||||
4172158|NCT00812968|3993764|B1|Low risk||International Prognostic Scoring System (IPSS) Score|The MDS IPSS assesses the severity of MDS based on 3 prognostic factors each assigned a score: the proportion of bone marrow blasts, chromosome changes in the marrow cells (karyotype) and the presence of one or more low blood cell counts (cytopenias). The IPSS score is the sum of the bone marrow blast + karyotype + cytopenia score and ranges from 0 (low risk) to 3.5 (high risk). Prognosis is categorized as Low risk (score = 0), Intermediate-1 (score 0.5 to 1.0), Intermediate-2 (score 1.5 to 2.0) or High risk (score ≥ 2.5).|participants|Number|2|2.0||||||
4172159|NCT00812968|3993764|B1|||Duration of MDS||years|Mean|2.0|2.0|Standard Deviation|1.44|1.44|||
4172160|NCT00812968|3993764|B1|Japan||Region of Enrollment||participants|Number|11|11.0||||||
4172161|NCT00812968|3993764|B1||Male|Gender||Participants|Count of Participants|4|4.0||||||
4172162|NCT00812968|3993764|B1||Female|Gender||Participants|Count of Participants|7|7.0||||||
4172163|NCT00812968|3993764|B1|||Age||years|Mean|71.8|71.8|Standard Deviation|5.95|5.95|||
4172165|NCT00812955|3993796|B4|United States||Region of Enrollment||participants|Number|118|118.0||||||
4172166|NCT00812955|3993797|B3|United States||Region of Enrollment||participants|Number|119|119.0||||||
4172167|NCT00812955|3993798|B2|United States||Region of Enrollment||participants|Number|118|118.0||||||
4172168|NCT00812955|3993799|B1|United States||Region of Enrollment||participants|Number|119|119.0||||||
4172169|NCT00812955|3993795|B5||Male|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4172170|NCT00812955|3993796|B4||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4172171|NCT00812955|3993797|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4172172|NCT00812955|3993798|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4172173|NCT00812955|3993799|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4172174|NCT00812955|3993795|B5||Female|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
4172175|NCT00812955|3993796|B4||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4172176|NCT00812955|3993797|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4172177|NCT00812955|3993798|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4172178|NCT00812955|3993799|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4172179|NCT00812955|3993795|B5|||Age||years|Mean|56.6|56.6|Standard Deviation|9.58|9.58|||
4172180|NCT00812955|3993796|B4|||Age||years|Mean|56.0|56.0|Standard Deviation|10.41|10.41|||
4172181|NCT00812955|3993797|B3|||Age||years|Mean|56.6|56.6|Standard Deviation|9.27|9.27|||
4172182|NCT00812955|3993798|B2|||Age||years|Mean|56.8|56.8|Standard Deviation|8.91|8.91|||
4172183|NCT00812955|3993799|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|9.77|9.77|||
4172184|NCT00812955|3993795|B5||>=65 years|Age||Participants|Count of Participants|101|101.0||||||
4172185|NCT00812955|3993796|B4||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4172186|NCT00812955|3993797|B3||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4172187|NCT00812955|3993798|B2||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4172188|NCT00812955|3993799|B1||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4172189|NCT00812955|3993795|B5||Between 18 and 65 years|Age||Participants|Count of Participants|373|373.0||||||
4172190|NCT00812955|3993796|B4||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
4172191|NCT00812955|3993797|B3||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
4172192|NCT00812955|3993798|B2||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
4172193|NCT00812955|3993799|B1||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
4172194|NCT00812955|3993795|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4172195|NCT00812955|3993796|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4172196|NCT00812955|3993797|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4172197|NCT00812955|3993798|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4172198|NCT00812955|3993799|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4172199|NCT00812929|3993822|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4172200|NCT00812929|3993822|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4172201|NCT00812929|3993822|B1||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4172202|NCT00812929|3993822|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4172203|NCT00812929|3993822|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4172204|NCT00812929|3993822|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4172205|NCT00812929|3993822|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4172206|NCT00812929|3993822|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4172207|NCT00812929|3993822|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4172208|NCT00812929|3993822|B1|||Age||Years|Mean|28.4|28.4|Standard Deviation|8.57|8.57|||
4172209|NCT00812916|3993947|B1|Not Collected||Sex/Gender, Customized|Age and gender were not collected for this trial.|participants|Number|206|206.0||||||
4172210|NCT00812916|3993947|B1|Not Collected||Age, Customized|Age and gender were not collected for this trial.|participants|Number|206|206.0||||||
4172211|NCT00812877|3993956|B3|United States||Region of Enrollment||participants|Number|376|376.0||||||
4172212|NCT00812877|3993957|B2|United States||Region of Enrollment||participants|Number|181|181.0||||||
4172213|NCT00812877|3993958|B1|United States||Region of Enrollment||participants|Number|195|195.0||||||
4172214|NCT00812877|3993956|B3||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4172215|NCT00812877|3993957|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4172216|NCT00812877|3993958|B1||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4172217|NCT00812877|3993956|B3||Female|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4172218|NCT00812877|3993957|B2||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4172219|NCT00812877|3993958|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4172220|NCT00812877|3993956|B3|||Age||years|Mean|37.5|37.5|Standard Deviation|18.3|18.3|||
4172221|NCT00812877|3993957|B2|||Age||years|Mean|36.3|36.3|Standard Deviation|18.0|18.0|||
4172222|NCT00812877|3993958|B1|||Age||years|Mean|38.5|38.5|Standard Deviation|18.6|18.6|||
4172223|NCT00812877|3993956|B3||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4172224|NCT00812877|3993957|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4172225|NCT00812877|3993958|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4172226|NCT00812877|3993956|B3||Between 18 and 65 years|Age||Participants|Count of Participants|285|285.0||||||
4172227|NCT00812877|3993957|B2||Between 18 and 65 years|Age||Participants|Count of Participants|138|138.0||||||
4172228|NCT00812877|3993958|B1||Between 18 and 65 years|Age||Participants|Count of Participants|147|147.0||||||
4172229|NCT00812877|3993956|B3||<=18 years|Age||Participants|Count of Participants|65|65.0||||||
4172230|NCT00812877|3993957|B2||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
4172231|NCT00812877|3993958|B1||<=18 years|Age||Participants|Count of Participants|34|34.0||||||
4172232|NCT00812812|3993967|B3|||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
4172233|NCT00812812|3993968|B2|||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4172234|NCT00812812|3993969|B1|||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4172235|NCT00812812|3993967|B3||Male|Gender||Participants|Count of Participants|22|22.0||||||
4172236|NCT00812812|3993968|B2||Male|Gender||Participants|Count of Participants|13|13.0||||||
4172237|NCT00812812|3993969|B1||Male|Gender||Participants|Count of Participants|9|9.0||||||
4172238|NCT00812812|3993967|B3||Female|Gender||Participants|Count of Participants|34|34.0||||||
4172239|NCT00812812|3993968|B2||Female|Gender||Participants|Count of Participants|16|16.0||||||
4172240|NCT00812812|3993969|B1||Female|Gender||Participants|Count of Participants|18|18.0||||||
4172241|NCT00812812|3993967|B3|||Age||Years|Mean|14.6|14.6|Standard Deviation|2.30|2.3|||
4172242|NCT00812812|3993968|B2|||Age||Years|Mean|14.4|14.4|Standard Deviation|1.99|1.99|||
4172243|NCT00812812|3993969|B1|||Age||Years|Mean|14.8|14.8|Standard Deviation|2.62|2.62|||
4172244|NCT00812708|3993983|B1|United States||Region of Enrollment||Participants|Count of Participants|72|72.0||||||
4172245|NCT00812708|3993983|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4172246|NCT00812708|3993983|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4172247|NCT00812708|3993983|B1||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4172248|NCT00812708|3993983|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4172249|NCT00812708|3993983|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4172250|NCT00812708|3993983|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4172251|NCT00812708|3993983|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4172252|NCT00812708|3993983|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4172253|NCT00812708|3993983|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4172254|NCT00812708|3993983|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4172255|NCT00812708|3993983|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4172256|NCT00812708|3993983|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4172257|NCT00812604|3993992|B3|Hong Kong||Region of Enrollment||participants|Number|55|55.0||||||
4172258|NCT00812604|3993993|B2|Hong Kong||Region of Enrollment||participants|Number|27|27.0||||||
4172259|NCT00812604|3993994|B1|Hong Kong||Region of Enrollment||participants|Number|28|28.0||||||
4172260|NCT00812604|3993992|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4172261|NCT00812604|3993993|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4172262|NCT00812604|3993994|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4172263|NCT00812604|3993992|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4172264|NCT00812604|3993993|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4172265|NCT00812604|3993994|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4172266|NCT00812604|3993992|B3|||Age||years|Mean|45.51|45.51|Standard Deviation|11.401|11.401|||
4172267|NCT00812604|3993993|B2|||Age||years|Mean|43.96|43.96|Standard Deviation|13.127|13.127|||
4172268|NCT00812604|3993994|B1|||Age||years|Mean|47.14|47.14|Standard Deviation|9.296|9.296|||
4172269|NCT00812604|3993992|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4172270|NCT00812604|3993993|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4172271|NCT00812604|3993994|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4172272|NCT00812604|3993992|B3||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4172273|NCT00812604|3993993|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4172274|NCT00812604|3993994|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4172275|NCT00812604|3993992|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4172276|NCT00812604|3993993|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4172277|NCT00812604|3993994|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4172278|NCT00812565|3994003|B9||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4172279|NCT00812565|3994004|B8||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4172280|NCT00812565|3994005|B7||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4172281|NCT00812565|3994006|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4172282|NCT00812565|3994007|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4172283|NCT00812565|3994008|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4172284|NCT00812565|3994009|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4172285|NCT00812565|3994010|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4172286|NCT00812565|3994011|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4172287|NCT00812565|3994003|B9||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4172288|NCT00812565|3994004|B8||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4172289|NCT00812565|3994005|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4172290|NCT00812565|3994006|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4172291|NCT00812565|3994007|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4172292|NCT00812565|3994008|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4172293|NCT00812565|3994009|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4172294|NCT00812565|3994010|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4172295|NCT00812565|3994011|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4172296|NCT00812565|3994003|B9|||Age||Years|Mean|70.0|70.0|Standard Deviation|8.1|8.1|||
4172297|NCT00812565|3994004|B8|||Age||Years|Mean|68.4|68.4|Standard Deviation|8.6|8.6|||
4172298|NCT00812565|3994005|B7|||Age||Years|Mean|65.9|65.9|Standard Deviation|10.2|10.2|||
4172299|NCT00812565|3994006|B6|||Age||Years|Mean|74.8|74.8|Standard Deviation|5.5|5.5|||
4172300|NCT00812565|3994007|B5|||Age||Years|Mean|71.4|71.4|Standard Deviation|11.8|11.8|||
4172301|NCT00812565|3994008|B4|||Age||Years|Mean|72.9|72.9|Standard Deviation|5.0|5.0|||
4172302|NCT00812565|3994009|B3|||Age||Years|Mean|68.3|68.3|Standard Deviation|4.2|4.2|||
4172303|NCT00812565|3994010|B2|||Age||Years|Mean|66.8|66.8|Standard Deviation|5.5|5.5|||
4172304|NCT00812565|3994011|B1|||Age||Years|Mean|72.6|72.6|Standard Deviation|9.2|9.2|||
4172305|NCT00812487|3994140|B3|United States||Region of Enrollment||participants|Number|65|65.0||||||
4172306|NCT00812487|3994141|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
4172307|NCT00812487|3994142|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4172308|NCT00812487|3994140|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4172309|NCT00812487|3994141|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4172310|NCT00812487|3994142|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4172311|NCT00812487|3994140|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4172312|NCT00812487|3994141|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4172313|NCT00812487|3994142|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4172314|NCT00812487|3994140|B3|||Age||years|Mean|61|61.0|Standard Deviation|9.6|9.6|||
4172315|NCT00812487|3994141|B2|||Age||years|Mean|61.3|61.3|Standard Deviation|12.4|12.4|||
4172316|NCT00812487|3994142|B1|||Age||years|Mean|61|61.0|Standard Deviation|9.6|9.6|||
4172317|NCT00812487|3994140|B3||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4172318|NCT00812487|3994141|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4172319|NCT00812487|3994142|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4172320|NCT00812487|3994140|B3||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4172321|NCT00812487|3994141|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4172322|NCT00812487|3994142|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4172323|NCT00812487|3994140|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4172324|NCT00812487|3994141|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4172325|NCT00812487|3994142|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4172326|NCT00812461|3994167|B3|||Alanine Aminotransferase (ALAT)|APRS.|IU/L|Mean|34.26|34.26|Standard Deviation|24.42|24.42|||
4172327|NCT00812461|3994168|B2|||Alanine Aminotransferase (ALAT)|APRS.|IU/L|Mean|34.20|34.2|Standard Deviation|22.70|22.7|||
4172328|NCT00812461|3994169|B1|||Alanine Aminotransferase (ALAT)|APRS.|IU/L|Mean|34.32|34.32|Standard Deviation|26.06|26.06|||
4172329|NCT00812461|3994167|B3|||Gamma-glutamyl Transferase (GGT)|APRS.|international units per liter (IU/L)|Mean|94.69|94.69|Standard Deviation|159.09|159.09|||
4172330|NCT00812461|3994168|B2|||Gamma-glutamyl Transferase (GGT)|APRS.|international units per liter (IU/L)|Mean|91.98|91.98|Standard Deviation|153.01|153.01|||
4172331|NCT00812461|3994169|B1|||Gamma-glutamyl Transferase (GGT)|APRS.|international units per liter (IU/L)|Mean|97.39|97.39|Standard Deviation|165.12|165.12|||
4172332|NCT00812461|3994167|B3|||Clinical Global Impression - Severity of Illness (CGI-S)|"APRS.~The Clinical Global Impression - Severity of Illness (CGI-S) provides the clinician's impression of the patient's current state of mental illness. The clinician uses his or her clinical experience of this patient population to rate the severity of the patient's current mental illness on a 7-point scale ranging from 1 (Normal - not at all ill) to 7 (among the most extremely ill patients)."|units on a scale|Mean|4.02|4.02|Standard Deviation|1.44|1.44|||
4172333|NCT00812461|3994168|B2|||Clinical Global Impression - Severity of Illness (CGI-S)|"APRS.~The Clinical Global Impression - Severity of Illness (CGI-S) provides the clinician's impression of the patient's current state of mental illness. The clinician uses his or her clinical experience of this patient population to rate the severity of the patient's current mental illness on a 7-point scale ranging from 1 (Normal - not at all ill) to 7 (among the most extremely ill patients)."|units on a scale|Mean|4.05|4.05|Standard Deviation|1.45|1.45|||
4172334|NCT00812461|3994169|B1|||Clinical Global Impression - Severity of Illness (CGI-S)|"APRS.~The Clinical Global Impression - Severity of Illness (CGI-S) provides the clinician's impression of the patient's current state of mental illness. The clinician uses his or her clinical experience of this patient population to rate the severity of the patient's current mental illness on a 7-point scale ranging from 1 (Normal - not at all ill) to 7 (among the most extremely ill patients)."|units on a scale|Mean|3.99|3.99|Standard Deviation|1.42|1.42|||
4172335|NCT00812461|3994167|B3|Very High||Drinking Risk Level (DRL)|APRS.|participants|Number|294|294.0||||||
4172336|NCT00812461|3994168|B2|Very High||Drinking Risk Level (DRL)|APRS.|participants|Number|156|156.0||||||
4172337|NCT00812461|3994169|B1|Very High||Drinking Risk Level (DRL)|APRS.|participants|Number|138|138.0||||||
4172338|NCT00812461|3994167|B3|High||Drinking Risk Level (DRL)|APRS.|participants|Number|263|263.0||||||
4172339|NCT00812461|3994168|B2|High||Drinking Risk Level (DRL)|APRS.|participants|Number|129|129.0||||||
4172340|NCT00812461|3994169|B1|High||Drinking Risk Level (DRL)|APRS.|participants|Number|134|134.0||||||
4172341|NCT00812461|3994167|B3|Medium||Drinking Risk Level (DRL)|APRS.|participants|Number|150|150.0||||||
4172342|NCT00812461|3994168|B2|Medium||Drinking Risk Level (DRL)|APRS.|participants|Number|68|68.0||||||
4172343|NCT00812461|3994169|B1|Medium||Drinking Risk Level (DRL)|APRS.|participants|Number|82|82.0||||||
4172344|NCT00812461|3994167|B3|Low||Drinking Risk Level (DRL)|APRS.|participants|Number|11|11.0||||||
4172345|NCT00812461|3994168|B2|Low||Drinking Risk Level (DRL)|APRS.|participants|Number|5|5.0||||||
4172346|NCT00812461|3994169|B1|Low||Drinking Risk Level (DRL)|APRS.|participants|Number|6|6.0||||||
4172347|NCT00812461|3994167|B3|||Total Alcohol Consumption (TAC) g Alcohol/Day|"APRS.~Based on TLFB data from the month preceding the screening visit."|g|Mean|90.49|90.49|Standard Deviation|47.52|47.52|||
4172348|NCT00812461|3994168|B2|||Total Alcohol Consumption (TAC) g Alcohol/Day|"APRS.~Based on TLFB data from the month preceding the screening visit."|g|Mean|92.22|92.22|Standard Deviation|46.87|46.87|||
4172349|NCT00812461|3994169|B1|||Total Alcohol Consumption (TAC) g Alcohol/Day|"APRS.~Based on TLFB data from the month preceding the screening visit."|g|Mean|88.76|88.76|Standard Deviation|48.15|48.15|||
4172350|NCT00812461|3994167|B3|||Total Monthly Heavy Drinking Days (HDD)|"APRS.~Based on Timeline Followback (TLFB) data from the month preceding the screening visit."|days|Mean|19.04|19.04|Standard Deviation|7.03|7.03|||
4172351|NCT00812461|3994168|B2|||Total Monthly Heavy Drinking Days (HDD)|"APRS.~Based on Timeline Followback (TLFB) data from the month preceding the screening visit."|days|Mean|19.71|19.71|Standard Deviation|6.96|6.96|||
4172352|NCT00812461|3994169|B1|||Total Monthly Heavy Drinking Days (HDD)|"APRS.~Based on Timeline Followback (TLFB) data from the month preceding the screening visit."|days|Mean|18.37|18.37|Standard Deviation|7.03|7.03|||
4172353|NCT00812461|3994167|B3|UNKNOWN||Previously Treated for Alcohol Withdrawal Symptoms]|APRS.|participants|Number|1|1.0||||||
4172354|NCT00812461|3994168|B2|UNKNOWN||Previously Treated for Alcohol Withdrawal Symptoms]|APRS.|participants|Number|1|1.0||||||
4172355|NCT00812461|3994169|B1|UNKNOWN||Previously Treated for Alcohol Withdrawal Symptoms]|APRS.|participants|Number|0|0.0||||||
4172356|NCT00812461|3994167|B3|YES||Previously Treated for Alcohol Withdrawal Symptoms]|APRS.|participants|Number|125|125.0||||||
4172357|NCT00812461|3994168|B2|YES||Previously Treated for Alcohol Withdrawal Symptoms]|APRS.|participants|Number|57|57.0||||||
4172358|NCT00812461|3994169|B1|YES||Previously Treated for Alcohol Withdrawal Symptoms]|APRS.|participants|Number|68|68.0||||||
4172359|NCT00812461|3994167|B3|NO||Previously Treated for Alcohol Withdrawal Symptoms]|APRS.|participants|Number|592|592.0||||||
4172360|NCT00812461|3994168|B2|NO||Previously Treated for Alcohol Withdrawal Symptoms]|APRS.|participants|Number|300|300.0||||||
4172361|NCT00812461|3994169|B1|NO||Previously Treated for Alcohol Withdrawal Symptoms]|APRS.|participants|Number|292|292.0||||||
4172362|NCT00812461|3994167|B3|UNKNOWN||Previously Treated for Alcohol Dependence|APRS|participants|Number|1|1.0||||||
4172363|NCT00812461|3994168|B2|UNKNOWN||Previously Treated for Alcohol Dependence|APRS|participants|Number|1|1.0||||||
4172364|NCT00812461|3994169|B1|UNKNOWN||Previously Treated for Alcohol Dependence|APRS|participants|Number|0|0.0||||||
4172365|NCT00812461|3994167|B3|YES||Previously Treated for Alcohol Dependence|APRS|participants|Number|289|289.0||||||
4172366|NCT00812461|3994168|B2|YES||Previously Treated for Alcohol Dependence|APRS|participants|Number|142|142.0||||||
4172367|NCT00812461|3994169|B1|YES||Previously Treated for Alcohol Dependence|APRS|participants|Number|147|147.0||||||
4172368|NCT00812461|3994167|B3|NO||Previously Treated for Alcohol Dependence|APRS|participants|Number|428|428.0||||||
4172369|NCT00812461|3994168|B2|NO||Previously Treated for Alcohol Dependence|APRS|participants|Number|215|215.0||||||
4172370|NCT00812461|3994169|B1|NO||Previously Treated for Alcohol Dependence|APRS|participants|Number|213|213.0||||||
4172371|NCT00812461|3994167|B3||Male|Sex: Female, Male|APRS.|Participants|Count of Participants|522|522.0||||||
4172372|NCT00812461|3994168|B2||Male|Sex: Female, Male|APRS.|Participants|Count of Participants|266|266.0||||||
4172373|NCT00812461|3994169|B1||Male|Sex: Female, Male|APRS.|Participants|Count of Participants|256|256.0||||||
4172374|NCT00812461|3994167|B3||Female|Sex: Female, Male|APRS.|Participants|Count of Participants|196|196.0||||||
4172375|NCT00812461|3994168|B2||Female|Sex: Female, Male|APRS.|Participants|Count of Participants|92|92.0||||||
4172376|NCT00812461|3994169|B1||Female|Sex: Female, Male|APRS.|Participants|Count of Participants|104|104.0||||||
4172377|NCT00812461|3994167|B3|||Age|All-patients-randomised set (APRS).|years|Mean|44.8|44.8|Standard Deviation|10.7|10.7|||
4172378|NCT00812461|3994168|B2|||Age|All-patients-randomised set (APRS).|years|Mean|45.1|45.1|Standard Deviation|10.7|10.7|||
4172379|NCT00812461|3994169|B1|||Age|All-patients-randomised set (APRS).|years|Mean|44.4|44.4|Standard Deviation|10.7|10.7|||
4172380|NCT00812331|3994188|B6|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4172381|NCT00812331|3994189|B5|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4172382|NCT00812331|3994190|B4|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4172383|NCT00812331|3994191|B3|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4172384|NCT00812331|3994192|B2|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4172385|NCT00812331|3994193|B1|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4172386|NCT00812331|3994188|B6|Asian||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4172387|NCT00812331|3994189|B5|Asian||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4172388|NCT00812331|3994190|B4|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4172389|NCT00812331|3994191|B3|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4172390|NCT00812331|3994192|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4172391|NCT00812331|3994193|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4172392|NCT00812331|3994188|B6|White||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
4172393|NCT00812331|3994189|B5|White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4172394|NCT00812331|3994190|B4|White||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4172395|NCT00812331|3994191|B3|White||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4172396|NCT00812331|3994192|B2|White||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4172397|NCT00812331|3994193|B1|White||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4172398|NCT00812331|3994188|B6||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4172399|NCT00812331|3994189|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4172400|NCT00812331|3994190|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4172401|NCT00812331|3994191|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4172402|NCT00812331|3994192|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4172403|NCT00812331|3994193|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4172404|NCT00812331|3994188|B6||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4172405|NCT00812331|3994189|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4172406|NCT00812331|3994190|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4172407|NCT00812331|3994191|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4172408|NCT00812331|3994192|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4172409|NCT00812331|3994193|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4172410|NCT00812331|3994188|B6|||Age||years|Median|48|48.0|Full Range|||18.0|69.0|
4172411|NCT00812331|3994189|B5|||Age||years|Median|49|49.0|Full Range|||30.0|53.0|
4172412|NCT00812331|3994190|B4|||Age||years|Median|65|65.0|Full Range|||48.0|69.0|
4172413|NCT00812331|3994191|B3|||Age||years|Median|47|47.0|Full Range|||26.0|55.0|
4172414|NCT00812331|3994192|B2|||Age||years|Median|42|42.0|Full Range|||18.0|56.0|
4172415|NCT00812331|3994193|B1|||Age||years|Median|43|43.0|Full Range|||27.0|61.0|
4172416|NCT00812253|3994270|B3|||HbA1c||Percentage of hemoglobin|Mean|8.0|8.0|Standard Deviation|1.7|1.7|||
4172417|NCT00812253|3994271|B2|||HbA1c||Percentage of hemoglobin|Mean|7.7|7.7|Standard Deviation|1.4|1.4|||
4172418|NCT00812253|3994272|B1|||HbA1c||Percentage of hemoglobin|Mean|8.4|8.4|Standard Deviation|2.0|2.0|||
4172419|NCT00812253|3994270|B3|Reduced Ejection Fraction||Preserved ejection fraction|Preserved ejection fraction was defined as greater than 50%|participants|Number|48|48.0||||||
4172420|NCT00812253|3994271|B2|Reduced Ejection Fraction||Preserved ejection fraction|Preserved ejection fraction was defined as greater than 50%|participants|Number|28|28.0||||||
4172421|NCT00812253|3994272|B1|Reduced Ejection Fraction||Preserved ejection fraction|Preserved ejection fraction was defined as greater than 50%|participants|Number|20|20.0||||||
4172422|NCT00812253|3994270|B3|Preserved Ejection Fraction||Preserved ejection fraction|Preserved ejection fraction was defined as greater than 50%|participants|Number|17|17.0||||||
4172423|NCT00812253|3994271|B2|Preserved Ejection Fraction||Preserved ejection fraction|Preserved ejection fraction was defined as greater than 50%|participants|Number|11|11.0||||||
4172424|NCT00812253|3994272|B1|Preserved Ejection Fraction||Preserved ejection fraction|Preserved ejection fraction was defined as greater than 50%|participants|Number|6|6.0||||||
4172425|NCT00812253|3994270|B3|United States||Region of Enrollment||participants|Number|65|65.0||||||
4172426|NCT00812253|3994271|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
4172427|NCT00812253|3994272|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4172428|NCT00812253|3994270|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4172429|NCT00812253|3994271|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4172430|NCT00812253|3994272|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4172431|NCT00812253|3994270|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4172432|NCT00812253|3994271|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4172433|NCT00812253|3994272|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4172434|NCT00812253|3994270|B3|||Age||years|Mean|62|62.0|Standard Deviation|11|11.0|||
4172435|NCT00812253|3994271|B2|||Age||years|Mean|63|63.0|Standard Deviation|12|12.0|||
4172436|NCT00812253|3994272|B1|||Age||years|Mean|61|61.0|Standard Deviation|10|10.0|||
4172437|NCT00812110|3994289|B1|United States||Region of Enrollment||participants|Number|292|292.0||||||
4172438|NCT00812110|3994289|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4172439|NCT00812110|3994289|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4172440|NCT00812110|3994289|B1||White|Race (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
4172441|NCT00812110|3994289|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|171|171.0||||||
4172442|NCT00812110|3994289|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4172443|NCT00812110|3994289|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4172444|NCT00812110|3994289|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4172445|NCT00812110|3994289|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4172446|NCT00812110|3994289|B1||Female|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4172447|NCT00812110|3994289|B1|||Age||years|Mean|30.5|30.5|Standard Deviation|10.6|10.6|||
4172448|NCT00812097|3994294|B5|United States||Region of Enrollment||participants|Number|955|955.0||||||
4172449|NCT00812097|3994295|B4|United States||Region of Enrollment||participants|Number|69|69.0||||||
4172450|NCT00812097|3994296|B3|United States||Region of Enrollment||participants|Number|124|124.0||||||
4172451|NCT00812097|3994297|B2|United States||Region of Enrollment||participants|Number|190|190.0||||||
4172452|NCT00812097|3994298|B1|United States||Region of Enrollment||participants|Number|572|572.0||||||
4172453|NCT00812097|3994294|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4172454|NCT00812097|3994295|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4172455|NCT00812097|3994296|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4172456|NCT00812097|3994297|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4172457|NCT00812097|3994298|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4172458|NCT00812097|3994294|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4172459|NCT00812097|3994295|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4172460|NCT00812097|3994296|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4172461|NCT00812097|3994297|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4172462|NCT00812097|3994298|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4172463|NCT00812097|3994294|B5||White|Race (NIH/OMB)||Participants|Count of Participants|881|881.0||||||
4172464|NCT00812097|3994295|B4||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4172465|NCT00812097|3994296|B3||White|Race (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
4172466|NCT00812097|3994297|B2||White|Race (NIH/OMB)||Participants|Count of Participants|178|178.0||||||
4172467|NCT00812097|3994298|B1||White|Race (NIH/OMB)||Participants|Count of Participants|518|518.0||||||
4172468|NCT00812097|3994294|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4172469|NCT00812097|3994295|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4172470|NCT00812097|3994296|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4172471|NCT00812097|3994297|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4172472|NCT00812097|3994298|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4172473|NCT00812097|3994294|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4172474|NCT00812097|3994295|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4172475|NCT00812097|3994296|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4172476|NCT00812097|3994297|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4172477|NCT00812097|3994298|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4172478|NCT00812097|3994294|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4172479|NCT00812097|3994295|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4172480|NCT00812097|3994296|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4172481|NCT00812097|3994297|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4172482|NCT00812097|3994298|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4172483|NCT00812097|3994294|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4172484|NCT00812097|3994295|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4172485|NCT00812097|3994296|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4172486|NCT00812097|3994297|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4172487|NCT00812097|3994298|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4172488|NCT00812097|3994294|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4172489|NCT00812097|3994295|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4172490|NCT00812097|3994296|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4172491|NCT00812097|3994297|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4172492|NCT00812097|3994298|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4172493|NCT00812097|3994294|B5||Female|Sex: Female, Male||Participants|Count of Participants|955|955.0||||||
4172494|NCT00812097|3994295|B4||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4172495|NCT00812097|3994296|B3||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4172496|NCT00812097|3994297|B2||Female|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4172497|NCT00812097|3994298|B1||Female|Sex: Female, Male||Participants|Count of Participants|572|572.0||||||
4172498|NCT00812097|3994294|B5|||Age||years|Mean|40.7|40.7|Standard Deviation|11.00|11.0|||
4172499|NCT00812097|3994295|B4|||Age||years|Mean|53.2|53.2|Standard Deviation|9.57|9.57|||
4172500|NCT00812097|3994296|B3|||Age||years|Mean|45.4|45.4|Standard Deviation|9.50|9.5|||
4172501|NCT00812097|3994297|B2|||Age||years|Mean|47.6|47.6|Standard Deviation|10.37|10.37|||
4172502|NCT00812097|3994298|B1|||Age||years|Mean|35.9|35.9|Standard Deviation|8.58|8.58|||
4172503|NCT00812006|3994327|B4|Not Hispanic or Latino||Racial Origin||participants|Number|78|78.0||||||
4172504|NCT00812006|3994328|B3|Not Hispanic or Latino||Racial Origin||participants|Number|26|26.0||||||
4172505|NCT00812006|3994329|B2|Not Hispanic or Latino||Racial Origin||participants|Number|27|27.0||||||
4172506|NCT00812006|3994330|B1|Not Hispanic or Latino||Racial Origin||participants|Number|25|25.0||||||
4172507|NCT00812006|3994327|B4|Hispanic or Latino||Racial Origin||participants|Number|30|30.0||||||
4172508|NCT00812006|3994328|B3|Hispanic or Latino||Racial Origin||participants|Number|10|10.0||||||
4172509|NCT00812006|3994329|B2|Hispanic or Latino||Racial Origin||participants|Number|9|9.0||||||
4172510|NCT00812006|3994330|B1|Hispanic or Latino||Racial Origin||participants|Number|11|11.0||||||
4172511|NCT00812006|3994327|B4|White||Ethnicity Origin||participants|Number|107|107.0||||||
4172512|NCT00812006|3994328|B3|White||Ethnicity Origin||participants|Number|36|36.0||||||
4172513|NCT00812006|3994329|B2|White||Ethnicity Origin||participants|Number|35|35.0||||||
4172514|NCT00812006|3994330|B1|White||Ethnicity Origin||participants|Number|36|36.0||||||
4172515|NCT00812006|3994327|B4|Black||Ethnicity Origin||participants|Number|1|1.0||||||
4172516|NCT00812006|3994328|B3|Black||Ethnicity Origin||participants|Number|0|0.0||||||
4172517|NCT00812006|3994329|B2|Black||Ethnicity Origin||participants|Number|1|1.0||||||
4172518|NCT00812006|3994330|B1|Black||Ethnicity Origin||participants|Number|0|0.0||||||
4172519|NCT00812006|3994327|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4172520|NCT00812006|3994328|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4172521|NCT00812006|3994329|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4172522|NCT00812006|3994330|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4172523|NCT00812006|3994327|B4||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4172524|NCT00812006|3994328|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4172525|NCT00812006|3994329|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4172526|NCT00812006|3994330|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4172527|NCT00812006|3994327|B4|||Age||years|Mean|44.0|44.0|Standard Deviation|11.9|11.9|||
4172528|NCT00812006|3994328|B3|||Age||years|Mean|40.0|40.0|Standard Deviation|11.6|11.6|||
4172529|NCT00812006|3994329|B2|||Age||years|Mean|43.9|43.9|Standard Deviation|10.8|10.8|||
4172530|NCT00812006|3994330|B1|||Age||years|Mean|48.3|48.3|Standard Deviation|12.0|12.0|||
4172531|NCT00811954|3994346|B4|||CD4+ T-cell count|CD4+ T-cell counts were calculated as the mean of the two most recent values available on or before study entry.|cells/mm^3|Mean|308|308.0|Standard Deviation|192|192.0|||
4172532|NCT00811954|3994347|B3|||CD4+ T-cell count|CD4+ T-cell counts were calculated as the mean of the two most recent values available on or before study entry.|cells/mm^3|Mean|310|310.0|Standard Deviation|189|189.0|||
4172533|NCT00811954|3994348|B2|||CD4+ T-cell count|CD4+ T-cell counts were calculated as the mean of the two most recent values available on or before study entry.|cells/mm^3|Mean|306|306.0|Standard Deviation|199|199.0|||
4172534|NCT00811954|3994349|B1|||CD4+ T-cell count|CD4+ T-cell counts were calculated as the mean of the two most recent values available on or before study entry.|cells/mm^3|Mean|309|309.0|Standard Deviation|189|189.0|||
4172535|NCT00811954|3994346|B4|||HIV-1 RNA|HIV-1 RNA was calculated as the geometric mean of the two most recent HIV-1 RNA (log 10 copies/mL) obtained on or before study entry. In the event that these two values differed by more than 1log10 copy/mL, the outlying value (based on review of all HIV-1 RNA levels available prior to study entry by the study virologist) was excluded and baseline determined by the remaining sample. Note that screening HIV-1 RNA values were not sued in the calculation of baseline HIV-1 RNA levels.|log10 copies/mL|Mean|4.6|4.6|Standard Deviation|0.7|0.7|||
4172536|NCT00811954|3994347|B3|||HIV-1 RNA|HIV-1 RNA was calculated as the geometric mean of the two most recent HIV-1 RNA (log 10 copies/mL) obtained on or before study entry. In the event that these two values differed by more than 1log10 copy/mL, the outlying value (based on review of all HIV-1 RNA levels available prior to study entry by the study virologist) was excluded and baseline determined by the remaining sample. Note that screening HIV-1 RNA values were not sued in the calculation of baseline HIV-1 RNA levels.|log10 copies/mL|Mean|4.6|4.6|Standard Deviation|0.7|0.7|||
4172537|NCT00811954|3994348|B2|||HIV-1 RNA|HIV-1 RNA was calculated as the geometric mean of the two most recent HIV-1 RNA (log 10 copies/mL) obtained on or before study entry. In the event that these two values differed by more than 1log10 copy/mL, the outlying value (based on review of all HIV-1 RNA levels available prior to study entry by the study virologist) was excluded and baseline determined by the remaining sample. Note that screening HIV-1 RNA values were not sued in the calculation of baseline HIV-1 RNA levels.|log10 copies/mL|Mean|4.6|4.6|Standard Deviation|0.7|0.7|||
4172538|NCT00811954|3994349|B1|||HIV-1 RNA|HIV-1 RNA was calculated as the geometric mean of the two most recent HIV-1 RNA (log 10 copies/mL) obtained on or before study entry. In the event that these two values differed by more than 1log10 copy/mL, the outlying value (based on review of all HIV-1 RNA levels available prior to study entry by the study virologist) was excluded and baseline determined by the remaining sample. Note that screening HIV-1 RNA values were not sued in the calculation of baseline HIV-1 RNA levels.|log10 copies/mL|Mean|4.6|4.6|Standard Deviation|0.7|0.7|||
4172539|NCT00811954|3994346|B4|Unknown/missing||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry|participants|Number|4|4.0||||||
4172540|NCT00811954|3994347|B3|Unknown/missing||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry|participants|Number|1|1.0||||||
4172541|NCT00811954|3994348|B2|Unknown/missing||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry|participants|Number|2|2.0||||||
4172542|NCT00811954|3994349|B1|Unknown/missing||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry|participants|Number|1|1.0||||||
4172543|NCT00811954|3994346|B4|More than one race||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry|participants|Number|7|7.0||||||
4172544|NCT00811954|3994347|B3|More than one race||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry|participants|Number|2|2.0||||||
4172545|NCT00811954|3994348|B2|More than one race||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry|participants|Number|3|3.0||||||
4172546|NCT00811954|3994349|B1|More than one race||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry|participants|Number|2|2.0||||||
4172547|NCT00811954|3994346|B4|American Indian, Alaskan Native||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry|participants|Number|6|6.0||||||
4172548|NCT00811954|3994347|B3|American Indian, Alaskan Native||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry|participants|Number|2|2.0||||||
4172549|NCT00811954|3994348|B2|American Indian, Alaskan Native||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry|participants|Number|2|2.0||||||
4172550|NCT00811954|3994349|B1|American Indian, Alaskan Native||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry|participants|Number|2|2.0||||||
4172551|NCT00811954|3994346|B4|Asian, Pacific Islander||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry|participants|Number|30|30.0||||||
4172552|NCT00811954|3994347|B3|Asian, Pacific Islander||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry|participants|Number|6|6.0||||||
4172553|NCT00811954|3994348|B2|Asian, Pacific Islander||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry|participants|Number|13|13.0||||||
4172554|NCT00811954|3994349|B1|Asian, Pacific Islander||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry|participants|Number|11|11.0||||||
4172555|NCT00811954|3994346|B4|Hispanic (Regardless of Race)||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry|participants|Number|390|390.0||||||
4172556|NCT00811954|3994347|B3|Hispanic (Regardless of Race)||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry|participants|Number|148|148.0||||||
4172557|NCT00811954|3994348|B2|Hispanic (Regardless of Race)||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry|participants|Number|117|117.0||||||
4172558|NCT00811954|3994349|B1|Hispanic (Regardless of Race)||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry|participants|Number|125|125.0||||||
4172559|NCT00811954|3994346|B4|Black Non-Hispanic||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry|participants|Number|757|757.0||||||
4172560|NCT00811954|3994347|B3|Black Non-Hispanic||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry|participants|Number|251|251.0||||||
4172561|NCT00811954|3994348|B2|Black Non-Hispanic||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry|participants|Number|254|254.0||||||
4172562|NCT00811954|3994349|B1|Black Non-Hispanic||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry|participants|Number|252|252.0||||||
4172563|NCT00811954|3994346|B4|White Non-Hispanic||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry|participants|Number|615|615.0||||||
4172564|NCT00811954|3994347|B3|White Non-Hispanic||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry|participants|Number|191|191.0||||||
4172565|NCT00811954|3994348|B2|White Non-Hispanic||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry|participants|Number|212|212.0||||||
4172566|NCT00811954|3994349|B1|White Non-Hispanic||Race/Ethnicity, Customized|Race/Ethnicity was collected prior to study entry|participants|Number|212|212.0||||||
4172567|NCT00811954|3994346|B4||Male|Sex: Female, Male||Participants|Count of Participants|1374|1374.0||||||
4172568|NCT00811954|3994347|B3||Male|Sex: Female, Male||Participants|Count of Participants|458|458.0||||||
4172569|NCT00811954|3994348|B2||Male|Sex: Female, Male||Participants|Count of Participants|455|455.0||||||
4172570|NCT00811954|3994349|B1||Male|Sex: Female, Male||Participants|Count of Participants|461|461.0||||||
4172571|NCT00811954|3994346|B4||Female|Sex: Female, Male||Participants|Count of Participants|435|435.0||||||
4172572|NCT00811954|3994347|B3||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4172573|NCT00811954|3994348|B2||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4172574|NCT00811954|3994349|B1||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4172575|NCT00811954|3994346|B4|||Age||years|Mean|37|37.0|Standard Deviation|11|11.0|||
4172576|NCT00811954|3994347|B3|||Age||years|Mean|38|38.0|Standard Deviation|11|11.0|||
4172577|NCT00811954|3994348|B2|||Age||years|Mean|37|37.0|Standard Deviation|11|11.0|||
4172578|NCT00811954|3994349|B1|||Age||years|Mean|38|38.0|Standard Deviation|11|11.0|||
4172579|NCT00811954|3994346|B4||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4172580|NCT00811954|3994347|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4172581|NCT00811954|3994348|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4172582|NCT00811954|3994349|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4172583|NCT00811954|3994346|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1790|1790.0||||||
4172584|NCT00811954|3994347|B3||Between 18 and 65 years|Age||Participants|Count of Participants|595|595.0||||||
4172585|NCT00811954|3994348|B2||Between 18 and 65 years|Age||Participants|Count of Participants|598|598.0||||||
4172586|NCT00811954|3994349|B1||Between 18 and 65 years|Age||Participants|Count of Participants|597|597.0||||||
4172587|NCT00811954|3994346|B4||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4172588|NCT00811954|3994347|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4172589|NCT00811954|3994348|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4172590|NCT00811954|3994349|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4172591|NCT00811941|3994413|B3|||Alanine Aminotransferase (ALAT)|APRS.|IU/L|Mean|33.28|33.28|Standard Deviation|22.05|22.05|||
4172592|NCT00811941|3994414|B2|||Alanine Aminotransferase (ALAT)|APRS.|IU/L|Mean|33.87|33.87|Standard Deviation|22.61|22.61|||
4172593|NCT00811941|3994415|B1|||Alanine Aminotransferase (ALAT)|APRS.|IU/L|Mean|31.46|31.46|Standard Deviation|20.20|20.2|||
4172594|NCT00811941|3994413|B3|||Gamma-glutamyl Transferase (GGT)|APRS.|international units per liter (IU/L)|Mean|69.36|69.36|Standard Deviation|111.39|111.39|||
4172595|NCT00811941|3994414|B2|||Gamma-glutamyl Transferase (GGT)|APRS.|international units per liter (IU/L)|Mean|68.82|68.82|Standard Deviation|109.87|109.87|||
4172596|NCT00811941|3994415|B1|||Gamma-glutamyl Transferase (GGT)|APRS.|international units per liter (IU/L)|Mean|71.03|71.03|Standard Deviation|116.25|116.25|||
4172640|NCT00811941|3994414|B2|||Age|All-patients-randomised set (APRS).|years|Mean|44.3|44.3|Standard Deviation|11.2|11.2|||
4172641|NCT00811941|3994415|B1|||Age|All-patients-randomised set (APRS).|years|Mean|44.3|44.3|Standard Deviation|12.0|12.0|||
4172597|NCT00811941|3994413|B3|||Clinical Global Impression - Severity of Illness (CGI-S)|"APRS.~The Clinical Global Impression - Severity of Illness (CGI-S) provides the clinician's impression of the patient's current state of mental illness. The clinician uses his or her clinical experience of this patient population to rate the severity of the patient's current mental illness on a 7-point scale ranging from 1 (Normal - not at all ill) to 7 (among the most extremely ill patients)."|units on a scale|Mean|3.94|3.94|Standard Deviation|1.09|1.09|||
4172598|NCT00811941|3994414|B2|||Clinical Global Impression - Severity of Illness (CGI-S)|"APRS.~The Clinical Global Impression - Severity of Illness (CGI-S) provides the clinician's impression of the patient's current state of mental illness. The clinician uses his or her clinical experience of this patient population to rate the severity of the patient's current mental illness on a 7-point scale ranging from 1 (Normal - not at all ill) to 7 (among the most extremely ill patients)."|units on a scale|Mean|3.95|3.95|Standard Deviation|1.12|1.12|||
4172599|NCT00811941|3994415|B1|||Clinical Global Impression - Severity of Illness (CGI-S)|"APRS.~The Clinical Global Impression - Severity of Illness (CGI-S) provides the clinician's impression of the patient's current state of mental illness. The clinician uses his or her clinical experience of this patient population to rate the severity of the patient's current mental illness on a 7-point scale ranging from 1 (Normal - not at all ill) to 7 (among the most extremely ill patients)."|units on a scale|Mean|3.88|3.88|Standard Deviation|1.03|1.03|||
4172600|NCT00811941|3994413|B3|VERY HIGH||Drinking Risk Level (DRL)|APRS.|participants|Number|146|146.0||||||
4172601|NCT00811941|3994414|B2|VERY HIGH||Drinking Risk Level (DRL)|APRS.|participants|Number|114|114.0||||||
4172602|NCT00811941|3994415|B1|VERY HIGH||Drinking Risk Level (DRL)|APRS.|participants|Number|32|32.0||||||
4172603|NCT00811941|3994413|B3|HIGH||Drinking Risk Level (DRL)|APRS.|participants|Number|207|207.0||||||
4172604|NCT00811941|3994414|B2|HIGH||Drinking Risk Level (DRL)|APRS.|participants|Number|148|148.0||||||
4172605|NCT00811941|3994415|B1|HIGH||Drinking Risk Level (DRL)|APRS.|participants|Number|59|59.0||||||
4172606|NCT00811941|3994413|B3|MEDIUM||Drinking Risk Level (DRL)|APRS.|participants|Number|216|216.0||||||
4172607|NCT00811941|3994414|B2|MEDIUM||Drinking Risk Level (DRL)|APRS.|participants|Number|167|167.0||||||
4172608|NCT00811941|3994415|B1|MEDIUM||Drinking Risk Level (DRL)|APRS.|participants|Number|49|49.0||||||
4172609|NCT00811941|3994413|B3|LOW||Drinking Risk Level (DRL)|APRS.|participants|Number|105|105.0||||||
4172610|NCT00811941|3994414|B2|LOW||Drinking Risk Level (DRL)|APRS.|participants|Number|79|79.0||||||
4172611|NCT00811941|3994415|B1|LOW||Drinking Risk Level (DRL)|APRS.|participants|Number|26|26.0||||||
4172612|NCT00811941|3994413|B3|UNKNOWN||Drinking Risk Level (DRL)|APRS.|participants|Number|1|1.0||||||
4172613|NCT00811941|3994414|B2|UNKNOWN||Drinking Risk Level (DRL)|APRS.|participants|Number|1|1.0||||||
4172614|NCT00811941|3994415|B1|UNKNOWN||Drinking Risk Level (DRL)|APRS.|participants|Number|0|0.0||||||
4172615|NCT00811941|3994413|B3|||Total Alcohol Consumption (TAC) g Alcohol/Day|"APRS.~Based on TLFB data from the month preceding the screening visit."|g|Mean|68.49|68.49|Standard Deviation|40.11|40.11|||
4172616|NCT00811941|3994414|B2|||Total Alcohol Consumption (TAC) g Alcohol/Day|"APRS.~Based on TLFB data from the month preceding the screening visit."|g|Mean|68.64|68.64|Standard Deviation|39.98|39.98|||
4172617|NCT00811941|3994415|B1|||Total Alcohol Consumption (TAC) g Alcohol/Day|"APRS.~Based on TLFB data from the month preceding the screening visit."|g|Mean|68.00|68.0|Standard Deviation|40.62|40.62|||
4172618|NCT00811941|3994413|B3|||Total Monthly Heavy Drinking Days (HDD)|"APRS.~Based on Timeline Followback (TLFB) data from the month preceding the screening visit."|days|Mean|13.98|13.98|Standard Deviation|6.17|6.17|||
4172619|NCT00811941|3994414|B2|||Total Monthly Heavy Drinking Days (HDD)|"APRS.~Based on Timeline Followback (TLFB) data from the month preceding the screening visit."|days|Mean|14.08|14.08|Standard Deviation|6.22|6.22|||
4172620|NCT00811941|3994415|B1|||Total Monthly Heavy Drinking Days (HDD)|"APRS.~Based on Timeline Followback (TLFB) data from the month preceding the screening visit."|days|Mean|13.69|13.69|Standard Deviation|6.03|6.03|||
4172621|NCT00811941|3994413|B3|YES||Previously Treated for Alcohol Withdrawal Symptoms|APRS.|participants|Number|185|185.0||||||
4172622|NCT00811941|3994414|B2|YES||Previously Treated for Alcohol Withdrawal Symptoms|APRS.|participants|Number|137|137.0||||||
4172623|NCT00811941|3994415|B1|YES||Previously Treated for Alcohol Withdrawal Symptoms|APRS.|participants|Number|48|48.0||||||
4172624|NCT00811941|3994413|B3|NO||Previously Treated for Alcohol Withdrawal Symptoms|APRS.|participants|Number|490|490.0||||||
4172625|NCT00811941|3994414|B2|NO||Previously Treated for Alcohol Withdrawal Symptoms|APRS.|participants|Number|372|372.0||||||
4172626|NCT00811941|3994415|B1|NO||Previously Treated for Alcohol Withdrawal Symptoms|APRS.|participants|Number|118|118.0||||||
4172627|NCT00811941|3994413|B3|YES||Previously Treated for Alcohol Dependence|APRS.|participants|Number|232|232.0||||||
4172628|NCT00811941|3994414|B2|YES||Previously Treated for Alcohol Dependence|APRS.|participants|Number|171|171.0||||||
4172629|NCT00811941|3994415|B1|YES||Previously Treated for Alcohol Dependence|APRS.|participants|Number|61|61.0||||||
4172630|NCT00811941|3994413|B3|NO||Previously Treated for Alcohol Dependence|APRS.|participants|Number|443|443.0||||||
4172631|NCT00811941|3994414|B2|NO||Previously Treated for Alcohol Dependence|APRS.|participants|Number|338|338.0||||||
4172632|NCT00811941|3994415|B1|NO||Previously Treated for Alcohol Dependence|APRS.|participants|Number|105|105.0||||||
4172633|NCT00811941|3994413|B3||Male|Sex: Female, Male|APRS.|Participants|Count of Participants|520|520.0||||||
4172634|NCT00811941|3994414|B2||Male|Sex: Female, Male|APRS.|Participants|Count of Participants|393|393.0||||||
4172635|NCT00811941|3994415|B1||Male|Sex: Female, Male|APRS.|Participants|Count of Participants|127|127.0||||||
4172636|NCT00811941|3994413|B3||Female|Sex: Female, Male|APRS.|Participants|Count of Participants|155|155.0||||||
4172637|NCT00811941|3994414|B2||Female|Sex: Female, Male|APRS.|Participants|Count of Participants|116|116.0||||||
4172638|NCT00811941|3994415|B1||Female|Sex: Female, Male|APRS.|Participants|Count of Participants|39|39.0||||||
4172639|NCT00811941|3994413|B3|||Age|All-patients-randomised set (APRS).|years|Mean|44.3|44.3|Standard Deviation|11.4|11.4|||
4172642|NCT00811928|3994452|B3||Male|Sex: Female, Male|The full analysis set (FAS) included all of those randomized participants who received at least one dose of study drug, and had at least one post-treatment follow-up data of primary efficacy variable.|Participants|Count of Participants|107|107.0||||||
4172643|NCT00811928|3994453|B2||Male|Sex: Female, Male|The full analysis set (FAS) included all of those randomized participants who received at least one dose of study drug, and had at least one post-treatment follow-up data of primary efficacy variable.|Participants|Count of Participants|52|52.0||||||
4172644|NCT00811928|3994454|B1||Male|Sex: Female, Male|The full analysis set (FAS) included all of those randomized participants who received at least one dose of study drug, and had at least one post-treatment follow-up data of primary efficacy variable.|Participants|Count of Participants|55|55.0||||||
4172645|NCT00811928|3994452|B3||Female|Sex: Female, Male|The full analysis set (FAS) included all of those randomized participants who received at least one dose of study drug, and had at least one post-treatment follow-up data of primary efficacy variable.|Participants|Count of Participants|127|127.0||||||
4172646|NCT00811928|3994453|B2||Female|Sex: Female, Male|The full analysis set (FAS) included all of those randomized participants who received at least one dose of study drug, and had at least one post-treatment follow-up data of primary efficacy variable.|Participants|Count of Participants|65|65.0||||||
4172647|NCT00811928|3994454|B1||Female|Sex: Female, Male|The full analysis set (FAS) included all of those randomized participants who received at least one dose of study drug, and had at least one post-treatment follow-up data of primary efficacy variable.|Participants|Count of Participants|62|62.0||||||
4172648|NCT00811928|3994452|B3|||Age|The full analysis set (FAS) included all of those randomized participants who received at least one dose of study drug, and had at least one post-treatment follow-up data of primary efficacy variable.|participants|Mean|40.4|40.4|Standard Deviation|12.73|12.73|||
4172649|NCT00811928|3994453|B2|||Age|The full analysis set (FAS) included all of those randomized participants who received at least one dose of study drug, and had at least one post-treatment follow-up data of primary efficacy variable.|participants|Mean|40.6|40.6|Standard Deviation|12.50|12.5|||
4172650|NCT00811928|3994454|B1|||Age|The full analysis set (FAS) included all of those randomized participants who received at least one dose of study drug, and had at least one post-treatment follow-up data of primary efficacy variable.|participants|Mean|39.3|39.3|Standard Deviation|13.01|13.01|||
4172651|NCT00811850|3994473|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4172652|NCT00811850|3994473|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4172653|NCT00811850|3994473|B1|||Age||years|Mean|68.1|68.1|Standard Deviation|NA||||Simple mean (average) was calculated for age. Standard deviation was not calculated. No other measure of dispersion was calculated.
4172654|NCT00811798|3994493|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4172655|NCT00811798|3994493|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4172656|NCT00811798|3994493|B1|||Age||Years|Mean|30.8|30.8|Standard Deviation|4.14|4.14|||
4172657|NCT00811733|3994497|B3|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4172658|NCT00811733|3994498|B2|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4172659|NCT00811733|3994499|B1|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4172660|NCT00811733|3994497|B3|White - White/Caucasian/European||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4172661|NCT00811733|3994498|B2|White - White/Caucasian/European||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4172662|NCT00811733|3994499|B1|White - White/Caucasian/European||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4172663|NCT00811733|3994497|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4172664|NCT00811733|3994498|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4172665|NCT00811733|3994499|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4172666|NCT00811733|3994497|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4172667|NCT00811733|3994498|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4172668|NCT00811733|3994499|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4172669|NCT00811733|3994497|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4172670|NCT00811733|3994498|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4172671|NCT00811733|3994499|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4172672|NCT00811733|3994497|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4172673|NCT00811733|3994498|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4172674|NCT00811733|3994499|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4172675|NCT00811733|3994497|B3|||Age||Years|Mean|63.3|63.3|Standard Deviation|9.85|9.85|||
4172676|NCT00811733|3994498|B2|||Age||Years|Mean|64.0|64.0|Standard Deviation|9.36|9.36|||
4172677|NCT00811733|3994499|B1|||Age||Years|Mean|62.3|62.3|Standard Deviation|10.78|10.78|||
4172678|NCT00811720|3994546|B3|||Alanine Aminotransferase (ALAT)|APRS.|IU/L|Mean|33.63|33.63|Standard Deviation|19.98|19.98|||
4172679|NCT00811720|3994547|B2|||Alanine Aminotransferase (ALAT)|APRS.|IU/L|Mean|33.15|33.15|Standard Deviation|18.09|18.09|||
4172680|NCT00811720|3994548|B1|||Alanine Aminotransferase (ALAT)|APRS.|IU/L|Mean|34.13|34.13|Standard Deviation|21.77|21.77|||
4172681|NCT00811720|3994546|B3|||Gamma-glutamyl Transferase (GGT)|APRS.|international units per liter (IU/L)|Mean|81.90|81.9|Standard Deviation|97.39|97.39|||
4172682|NCT00811720|3994547|B2|||Gamma-glutamyl Transferase (GGT)|APRS.|international units per liter (IU/L)|Mean|80.29|80.29|Standard Deviation|103.51|103.51|||
4172683|NCT00811720|3994548|B1|||Gamma-glutamyl Transferase (GGT)|APRS.|international units per liter (IU/L)|Mean|83.55|83.55|Standard Deviation|90.83|90.83|||
4172727|NCT00811720|3994547|B2|||Age|All-patients-randomised set (APRS).|years|Mean|51.0|51.0|Standard Deviation|10.1|10.1|||
4172684|NCT00811720|3994546|B3|||Clinical Global Impression - Severity of Illness (CGI-S)|"APRS.~The Clinical Global Impression - Severity of Illness (CGI-S) provides the clinician's impression of the patient's current state of mental illness. The clinician uses his or her clinical experience of this patient population to rate the severity of the patient's current mental illness on a 7-point scale ranging from 1 (Normal - not at all ill) to 7 (among the most extremely ill patients)."|units on a scale|Mean|3.99|3.99|Standard Deviation|1.50|1.5|||
4172685|NCT00811720|3994547|B2|||Clinical Global Impression - Severity of Illness (CGI-S)|"APRS.~The Clinical Global Impression - Severity of Illness (CGI-S) provides the clinician's impression of the patient's current state of mental illness. The clinician uses his or her clinical experience of this patient population to rate the severity of the patient's current mental illness on a 7-point scale ranging from 1 (Normal - not at all ill) to 7 (among the most extremely ill patients)."|units on a scale|Mean|4.02|4.02|Standard Deviation|1.48|1.48|||
4172686|NCT00811720|3994548|B1|||Clinical Global Impression - Severity of Illness (CGI-S)|"APRS.~The Clinical Global Impression - Severity of Illness (CGI-S) provides the clinician's impression of the patient's current state of mental illness. The clinician uses his or her clinical experience of this patient population to rate the severity of the patient's current mental illness on a 7-point scale ranging from 1 (Normal - not at all ill) to 7 (among the most extremely ill patients)."|units on a scale|Mean|3.96|3.96|Standard Deviation|1.52|1.52|||
4172687|NCT00811720|3994546|B3|Very High||Drinking Risk Level (DRL)|APRS.|participants|Number|239|239.0||||||
4172688|NCT00811720|3994547|B2|Very High||Drinking Risk Level (DRL)|APRS.|participants|Number|122|122.0||||||
4172689|NCT00811720|3994548|B1|Very High||Drinking Risk Level (DRL)|APRS.|participants|Number|117|117.0||||||
4172690|NCT00811720|3994546|B3|High||Drinking Risk Level (DRL)|APRS.|participants|Number|233|233.0||||||
4172691|NCT00811720|3994547|B2|High||Drinking Risk Level (DRL)|APRS.|participants|Number|114|114.0||||||
4172692|NCT00811720|3994548|B1|High||Drinking Risk Level (DRL)|APRS.|participants|Number|119|119.0||||||
4172693|NCT00811720|3994546|B3|Medium||Drinking Risk Level (DRL)|APRS.|participants|Number|128|128.0||||||
4172694|NCT00811720|3994547|B2|Medium||Drinking Risk Level (DRL)|APRS.|participants|Number|68|68.0||||||
4172695|NCT00811720|3994548|B1|Medium||Drinking Risk Level (DRL)|APRS.|participants|Number|60|60.0||||||
4172696|NCT00811720|3994546|B3|Low||Drinking Risk Level (DRL)|APRS.|participants|Number|3|3.0||||||
4172697|NCT00811720|3994547|B2|Low||Drinking Risk Level (DRL)|APRS.|participants|Number|1|1.0||||||
4172698|NCT00811720|3994548|B1|Low||Drinking Risk Level (DRL)|APRS.|participants|Number|2|2.0||||||
4172699|NCT00811720|3994546|B3|Unknown||Drinking Risk Level (DRL)|APRS.|participants|Number|1|1.0||||||
4172700|NCT00811720|3994547|B2|Unknown||Drinking Risk Level (DRL)|APRS.|participants|Number|1|1.0||||||
4172701|NCT00811720|3994548|B1|Unknown||Drinking Risk Level (DRL)|APRS.|participants|Number|0|0.0||||||
4172702|NCT00811720|3994546|B3|||Total Alcohol Consumption (TAC) g Alcohol/Day|"APRS.~Based on TLFB data from the month preceding the screening visit."|g|Mean|84.45|84.45|Standard Deviation|41.75|41.75|||
4172703|NCT00811720|3994547|B2|||Total Alcohol Consumption (TAC) g Alcohol/Day|"APRS.~Based on TLFB data from the month preceding the screening visit."|g|Mean|84.79|84.79|Standard Deviation|42.07|42.07|||
4172704|NCT00811720|3994548|B1|||Total Alcohol Consumption (TAC) g Alcohol/Day|"APRS.~Based on TLFB data from the month preceding the screening visit."|g|Mean|84.11|84.11|Standard Deviation|41.49|41.49|||
4172705|NCT00811720|3994546|B3|||Total Monthly Heavy Drinking Days (HDD)|"APRS.~Based on Timeline Followback (TLFB) data from the month preceding the screening visit."|days|Mean|19.52|19.52|Standard Deviation|7.12|7.12|||
4172706|NCT00811720|3994547|B2|||Total Monthly Heavy Drinking Days (HDD)|"APRS.~Based on Timeline Followback (TLFB) data from the month preceding the screening visit."|days|Mean|19.51|19.51|Standard Deviation|7.29|7.29|||
4172707|NCT00811720|3994548|B1|||Total Monthly Heavy Drinking Days (HDD)|"APRS.~Based on Timeline Followback (TLFB) data from the month preceding the screening visit."|days|Mean|19.53|19.53|Standard Deviation|6.96|6.96|||
4172708|NCT00811720|3994546|B3|YES||Previously Treated for Alcohol Withdrawal Symptoms|APRS.|participants|Number|113|113.0||||||
4172709|NCT00811720|3994547|B2|YES||Previously Treated for Alcohol Withdrawal Symptoms|APRS.|participants|Number|60|60.0||||||
4172710|NCT00811720|3994548|B1|YES||Previously Treated for Alcohol Withdrawal Symptoms|APRS.|participants|Number|53|53.0||||||
4172711|NCT00811720|3994546|B3|NO||Previously Treated for Alcohol Withdrawal Symptoms|APRS.|participants|Number|491|491.0||||||
4172712|NCT00811720|3994547|B2|NO||Previously Treated for Alcohol Withdrawal Symptoms|APRS.|participants|Number|246|246.0||||||
4172713|NCT00811720|3994548|B1|NO||Previously Treated for Alcohol Withdrawal Symptoms|APRS.|participants|Number|245|245.0||||||
4172714|NCT00811720|3994546|B3|YES||Previously Treated for Alcohol Dependence|APRS.|participants|Number|180|180.0||||||
4172715|NCT00811720|3994547|B2|YES||Previously Treated for Alcohol Dependence|APRS.|participants|Number|91|91.0||||||
4172716|NCT00811720|3994548|B1|YES||Previously Treated for Alcohol Dependence|APRS.|participants|Number|89|89.0||||||
4172717|NCT00811720|3994546|B3|NO||Previously Treated for Alcohol Dependence|APRS.|participants|Number|424|424.0||||||
4172718|NCT00811720|3994547|B2|NO||Previously Treated for Alcohol Dependence|APRS.|participants|Number|215|215.0||||||
4172719|NCT00811720|3994548|B1|NO||Previously Treated for Alcohol Dependence|APRS.|participants|Number|209|209.0||||||
4172720|NCT00811720|3994546|B3||Male|Sex: Female, Male|APRS.|Participants|Count of Participants|406|406.0||||||
4172721|NCT00811720|3994547|B2||Male|Sex: Female, Male|APRS.|Participants|Count of Participants|204|204.0||||||
4172722|NCT00811720|3994548|B1||Male|Sex: Female, Male|APRS.|Participants|Count of Participants|202|202.0||||||
4172723|NCT00811720|3994546|B3||Female|Sex: Female, Male|APRS.|Participants|Count of Participants|198|198.0||||||
4172724|NCT00811720|3994547|B2||Female|Sex: Female, Male|APRS.|Participants|Count of Participants|102|102.0||||||
4172725|NCT00811720|3994548|B1||Female|Sex: Female, Male|APRS.|Participants|Count of Participants|96|96.0||||||
4172726|NCT00811720|3994546|B3|||Age|All-patients-randomised set (APRS).|years|Mean|51.6|51.6|Standard Deviation|9.6|9.6|||
4172728|NCT00811720|3994548|B1|||Age|All-patients-randomised set (APRS).|years|Mean|52.1|52.1|Standard Deviation|9.1|9.1|||
4172729|NCT00811655|3994567|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4172730|NCT00811655|3994567|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4172731|NCT00811655|3994567|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4172732|NCT00811655|3994567|B1|||Age||Years|Mean|55.7|55.7|Standard Deviation|15.1|15.1|||
4172733|NCT00811642|3994579|B1|China||Region of Enrollment||participants|Number|62|62.0||||||
4172734|NCT00811642|3994579|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4172735|NCT00811642|3994579|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4172736|NCT00811642|3994579|B1|||Age||years|Mean|40.41|40.41|Standard Deviation|14.752|14.752|||
4172737|NCT00811590|3994589|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4172738|NCT00811590|3994589|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4172739|NCT00811590|3994589|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4172740|NCT00811590|3994589|B1|||Age||years|Mean|34.6667|34.6667|Standard Deviation|18.71719|18.71719|||
4172741|NCT00811590|3994589|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4172742|NCT00811590|3994589|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4172743|NCT00811590|3994589|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4172744|NCT00811577|3994593|B3|United States||Region of Enrollment||participants|Number|150|150.0||||||
4172745|NCT00811577|3994594|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4172746|NCT00811577|3994595|B1|United States||Region of Enrollment||participants|Number|126|126.0||||||
4172747|NCT00811577|3994593|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4172748|NCT00811577|3994594|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4172749|NCT00811577|3994595|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4172750|NCT00811577|3994593|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4172751|NCT00811577|3994594|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4172752|NCT00811577|3994595|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4172753|NCT00811577|3994593|B3|||Age||years|Mean|51.4|51.4|Standard Deviation|12.0|12.0|||
4172754|NCT00811577|3994594|B2|||Age||years|Mean|51.8|51.8|Standard Deviation|13.2|13.2|||
4172755|NCT00811577|3994595|B1|||Age||years|Mean|51.3|51.3|Standard Deviation|11.8|11.8|||
4172756|NCT00811577|3994593|B3||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4172757|NCT00811577|3994594|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4172758|NCT00811577|3994595|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4172759|NCT00811577|3994593|B3||Between 18 and 65 years|Age||Participants|Count of Participants|131|131.0||||||
4172760|NCT00811577|3994594|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4172761|NCT00811577|3994595|B1||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
4172762|NCT00811577|3994593|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4172763|NCT00811577|3994594|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4172764|NCT00811577|3994595|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4172765|NCT00811564|3994645|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4172766|NCT00811564|3994646|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4172767|NCT00811564|3994647|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4172768|NCT00811564|3994645|B3||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4172769|NCT00811564|3994646|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4172770|NCT00811564|3994647|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4172771|NCT00811564|3994645|B3|||Age||years|Median|65|65.0|Full Range|||27.0|88.0|
4172772|NCT00811564|3994646|B2|||Age||years|Median|65|65.0|Full Range|||33.0|87.0|
4172773|NCT00811564|3994647|B1|||Age||years|Median|65|65.0|Full Range|||27.0|88.0|
4172774|NCT00811473|3994654|B3||Male|Sex: Female, Male|Safety analysis set|Participants|Count of Participants|97|97.0||||||
4172775|NCT00811473|3994655|B2||Male|Sex: Female, Male|Safety analysis set|Participants|Count of Participants|52|52.0||||||
4172776|NCT00811473|3994656|B1||Male|Sex: Female, Male|Safety analysis set|Participants|Count of Participants|45|45.0||||||
4172777|NCT00811473|3994654|B3||Female|Sex: Female, Male|Safety analysis set|Participants|Count of Participants|95|95.0||||||
4172778|NCT00811473|3994655|B2||Female|Sex: Female, Male|Safety analysis set|Participants|Count of Participants|48|48.0||||||
4172779|NCT00811473|3994656|B1||Female|Sex: Female, Male|Safety analysis set|Participants|Count of Participants|47|47.0||||||
4172780|NCT00811473|3994654|B3|||Age|Safety analysis set|years|Mean|14.0|14.0|Standard Deviation|2.11|2.11|||
4172781|NCT00811473|3994655|B2|||Age|Safety analysis set|years|Mean|14.0|14.0|Standard Deviation|2.05|2.05|||
4172782|NCT00811473|3994656|B1|||Age|Safety analysis set|years|Mean|13.9|13.9|Standard Deviation|2.18|2.18|||
4172783|NCT00811434|3994673|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4172784|NCT00811434|3994673|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4172785|NCT00811434|3994673|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4172786|NCT00811434|3994673|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4172787|NCT00811434|3994673|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4172788|NCT00811434|3994673|B1||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4172789|NCT00811395|3994682|B7|North America||Region of Enrollment|"Europe: Austria, Germany, Italy, Spain and United Kingdom~North America: Canada and United States"|participants|Number|96|96.0||||||
4172790|NCT00811395|3994683|B6|North America||Region of Enrollment|"Europe: Austria, Germany, Italy, Spain and United Kingdom~North America: Canada and United States"|participants|Number|19|19.0||||||
4172791|NCT00811395|3994684|B5|North America||Region of Enrollment|"Europe: Austria, Germany, Italy, Spain and United Kingdom~North America: Canada and United States"|participants|Number|20|20.0||||||
4172792|NCT00811395|3994685|B4|North America||Region of Enrollment|"Europe: Austria, Germany, Italy, Spain and United Kingdom~North America: Canada and United States"|participants|Number|18|18.0||||||
4172793|NCT00811395|3994686|B3|North America||Region of Enrollment|"Europe: Austria, Germany, Italy, Spain and United Kingdom~North America: Canada and United States"|participants|Number|14|14.0||||||
4172794|NCT00811395|3994687|B2|North America||Region of Enrollment|"Europe: Austria, Germany, Italy, Spain and United Kingdom~North America: Canada and United States"|participants|Number|12|12.0||||||
4172795|NCT00811395|3994688|B1|North America||Region of Enrollment|"Europe: Austria, Germany, Italy, Spain and United Kingdom~North America: Canada and United States"|participants|Number|13|13.0||||||
4172796|NCT00811395|3994682|B7|Europe||Region of Enrollment|"Europe: Austria, Germany, Italy, Spain and United Kingdom~North America: Canada and United States"|participants|Number|143|143.0||||||
4172797|NCT00811395|3994683|B6|Europe||Region of Enrollment|"Europe: Austria, Germany, Italy, Spain and United Kingdom~North America: Canada and United States"|participants|Number|22|22.0||||||
4172798|NCT00811395|3994684|B5|Europe||Region of Enrollment|"Europe: Austria, Germany, Italy, Spain and United Kingdom~North America: Canada and United States"|participants|Number|22|22.0||||||
4172799|NCT00811395|3994685|B4|Europe||Region of Enrollment|"Europe: Austria, Germany, Italy, Spain and United Kingdom~North America: Canada and United States"|participants|Number|22|22.0||||||
4172800|NCT00811395|3994686|B3|Europe||Region of Enrollment|"Europe: Austria, Germany, Italy, Spain and United Kingdom~North America: Canada and United States"|participants|Number|24|24.0||||||
4172801|NCT00811395|3994687|B2|Europe||Region of Enrollment|"Europe: Austria, Germany, Italy, Spain and United Kingdom~North America: Canada and United States"|participants|Number|25|25.0||||||
4172802|NCT00811395|3994688|B1|Europe||Region of Enrollment|"Europe: Austria, Germany, Italy, Spain and United Kingdom~North America: Canada and United States"|participants|Number|28|28.0||||||
4172803|NCT00811395|3994682|B7||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4172804|NCT00811395|3994683|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4172805|NCT00811395|3994684|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4172806|NCT00811395|3994685|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4172807|NCT00811395|3994686|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4172808|NCT00811395|3994687|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4172809|NCT00811395|3994688|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4172810|NCT00811395|3994682|B7||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4172811|NCT00811395|3994683|B6||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4172812|NCT00811395|3994684|B5||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4172813|NCT00811395|3994685|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4172814|NCT00811395|3994686|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4172815|NCT00811395|3994687|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4172816|NCT00811395|3994688|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4172817|NCT00811395|3994682|B7|>=38 years||Age, Customized|Baseline characteristics before randomization in the initial study (PDY6045 or PDY6046)|participants|Number|162|162.0||||||
4172818|NCT00811395|3994683|B6|>=38 years||Age, Customized|Baseline characteristics before randomization in the initial study (PDY6045 or PDY6046)|participants|Number|28|28.0||||||
4172819|NCT00811395|3994684|B5|>=38 years||Age, Customized|Baseline characteristics before randomization in the initial study (PDY6045 or PDY6046)|participants|Number|30|30.0||||||
4172820|NCT00811395|3994685|B4|>=38 years||Age, Customized|Baseline characteristics before randomization in the initial study (PDY6045 or PDY6046)|participants|Number|29|29.0||||||
4172821|NCT00811395|3994686|B3|>=38 years||Age, Customized|Baseline characteristics before randomization in the initial study (PDY6045 or PDY6046)|participants|Number|23|23.0||||||
4172822|NCT00811395|3994687|B2|>=38 years||Age, Customized|Baseline characteristics before randomization in the initial study (PDY6045 or PDY6046)|participants|Number|28|28.0||||||
4172823|NCT00811395|3994688|B1|>=38 years||Age, Customized|Baseline characteristics before randomization in the initial study (PDY6045 or PDY6046)|participants|Number|24|24.0||||||
4172824|NCT00811395|3994682|B7|<38 years||Age, Customized|Baseline characteristics before randomization in the initial study (PDY6045 or PDY6046)|participants|Number|77|77.0||||||
4172825|NCT00811395|3994683|B6|<38 years||Age, Customized|Baseline characteristics before randomization in the initial study (PDY6045 or PDY6046)|participants|Number|13|13.0||||||
4172826|NCT00811395|3994684|B5|<38 years||Age, Customized|Baseline characteristics before randomization in the initial study (PDY6045 or PDY6046)|participants|Number|12|12.0||||||
4172827|NCT00811395|3994685|B4|<38 years||Age, Customized|Baseline characteristics before randomization in the initial study (PDY6045 or PDY6046)|participants|Number|11|11.0||||||
4172828|NCT00811395|3994686|B3|<38 years||Age, Customized|Baseline characteristics before randomization in the initial study (PDY6045 or PDY6046)|participants|Number|15|15.0||||||
4172829|NCT00811395|3994687|B2|<38 years||Age, Customized|Baseline characteristics before randomization in the initial study (PDY6045 or PDY6046)|participants|Number|9|9.0||||||
4172830|NCT00811395|3994688|B1|<38 years||Age, Customized|Baseline characteristics before randomization in the initial study (PDY6045 or PDY6046)|participants|Number|17|17.0||||||
4172831|NCT00811382|3994755|B3|Other medication||Medication at Enrollment||patients|Number|44|44.0||||||
4172832|NCT00811382|3994756|B2|Other medication||Medication at Enrollment||patients|Number|21|21.0||||||
4172833|NCT00811382|3994757|B1|Other medication||Medication at Enrollment||patients|Number|23|23.0||||||
4172834|NCT00811382|3994755|B3|Other diuretic||Medication at Enrollment||patients|Number|135|135.0||||||
4172835|NCT00811382|3994756|B2|Other diuretic||Medication at Enrollment||patients|Number|63|63.0||||||
4172836|NCT00811382|3994757|B1|Other diuretic||Medication at Enrollment||patients|Number|72|72.0||||||
4172837|NCT00811382|3994755|B3|Spironolactone||Medication at Enrollment||patients|Number|70|70.0||||||
4172838|NCT00811382|3994756|B2|Spironolactone||Medication at Enrollment||patients|Number|28|28.0||||||
4172839|NCT00811382|3994757|B1|Spironolactone||Medication at Enrollment||patients|Number|42|42.0||||||
4172840|NCT00811382|3994755|B3|Nitrate||Medication at Enrollment||patients|Number|11|11.0||||||
4172841|NCT00811382|3994756|B2|Nitrate||Medication at Enrollment||patients|Number|4|4.0||||||
4172842|NCT00811382|3994757|B1|Nitrate||Medication at Enrollment||patients|Number|7|7.0||||||
4172843|NCT00811382|3994755|B3|Lipid-lowering drug||Medication at Enrollment||patients|Number|110|110.0||||||
4172844|NCT00811382|3994756|B2|Lipid-lowering drug||Medication at Enrollment||patients|Number|47|47.0||||||
4172845|NCT00811382|3994757|B1|Lipid-lowering drug||Medication at Enrollment||patients|Number|63|63.0||||||
4172846|NCT00811382|3994755|B3|Antiplatelet||Medication at Enrollment||patients|Number|64|64.0||||||
4172847|NCT00811382|3994756|B2|Antiplatelet||Medication at Enrollment||patients|Number|25|25.0||||||
4172848|NCT00811382|3994757|B1|Antiplatelet||Medication at Enrollment||patients|Number|39|39.0||||||
4172849|NCT00811382|3994755|B3|Anticoagulants||Medication at Enrollment||patients|Number|115|115.0||||||
4172850|NCT00811382|3994756|B2|Anticoagulants||Medication at Enrollment||patients|Number|54|54.0||||||
4172851|NCT00811382|3994757|B1|Anticoagulants||Medication at Enrollment||patients|Number|61|61.0||||||
4172852|NCT00811382|3994755|B3|Other antiarrhythmic||Medication at Enrollment||patients|Number|2|2.0||||||
4172853|NCT00811382|3994756|B2|Other antiarrhythmic||Medication at Enrollment||patients|Number|1|1.0||||||
4172854|NCT00811382|3994757|B1|Other antiarrhythmic||Medication at Enrollment||patients|Number|1|1.0||||||
4172855|NCT00811382|3994755|B3|Sotalol||Medication at Enrollment||patients|Number|7|7.0||||||
4172856|NCT00811382|3994756|B2|Sotalol||Medication at Enrollment||patients|Number|2|2.0||||||
4172857|NCT00811382|3994757|B1|Sotalol||Medication at Enrollment||patients|Number|5|5.0||||||
4172858|NCT00811382|3994755|B3|Digitalis||Medication at Enrollment||patients|Number|19|19.0||||||
4172859|NCT00811382|3994756|B2|Digitalis||Medication at Enrollment||patients|Number|6|6.0||||||
4172860|NCT00811382|3994757|B1|Digitalis||Medication at Enrollment||patients|Number|13|13.0||||||
4172861|NCT00811382|3994755|B3|Calcium channel blocker||Medication at Enrollment||patients|Number|8|8.0||||||
4172862|NCT00811382|3994756|B2|Calcium channel blocker||Medication at Enrollment||patients|Number|3|3.0||||||
4172863|NCT00811382|3994757|B1|Calcium channel blocker||Medication at Enrollment||patients|Number|5|5.0||||||
4172864|NCT00811382|3994755|B3|Beta blocker||Medication at Enrollment||patients|Number|132|132.0||||||
4172865|NCT00811382|3994756|B2|Beta blocker||Medication at Enrollment||patients|Number|63|63.0||||||
4172866|NCT00811382|3994757|B1|Beta blocker||Medication at Enrollment||patients|Number|69|69.0||||||
4172867|NCT00811382|3994755|B3|Amiodarone||Medication at Enrollment||patients|Number|72|72.0||||||
4172868|NCT00811382|3994756|B2|Amiodarone||Medication at Enrollment||patients|Number|36|36.0||||||
4172869|NCT00811382|3994757|B1|Amiodarone||Medication at Enrollment||patients|Number|36|36.0||||||
4172870|NCT00811382|3994755|B3|ACE inhibitor or ARB||Medication at Enrollment||patients|Number|135|135.0||||||
4172871|NCT00811382|3994756|B2|ACE inhibitor or ARB||Medication at Enrollment||patients|Number|63|63.0||||||
4172872|NCT00811382|3994757|B1|ACE inhibitor or ARB||Medication at Enrollment||patients|Number|72|72.0||||||
4172873|NCT00811382|3994755|B3|not reported||AF treatment at enrollment|some patients underwent both rate control and rhythm control|patients|Number|11|11.0||||||
4172874|NCT00811382|3994756|B2|not reported||AF treatment at enrollment|some patients underwent both rate control and rhythm control|patients|Number|7|7.0||||||
4172875|NCT00811382|3994757|B1|not reported||AF treatment at enrollment|some patients underwent both rate control and rhythm control|patients|Number|4|4.0||||||
4172876|NCT00811382|3994755|B3|No AF treatment||AF treatment at enrollment|some patients underwent both rate control and rhythm control|patients|Number|38|38.0||||||
4172877|NCT00811382|3994756|B2|No AF treatment||AF treatment at enrollment|some patients underwent both rate control and rhythm control|patients|Number|17|17.0||||||
4172878|NCT00811382|3994757|B1|No AF treatment||AF treatment at enrollment|some patients underwent both rate control and rhythm control|patients|Number|21|21.0||||||
4172879|NCT00811382|3994755|B3|Rhythm control||AF treatment at enrollment|some patients underwent both rate control and rhythm control|patients|Number|84|84.0||||||
4172880|NCT00811382|3994756|B2|Rhythm control||AF treatment at enrollment|some patients underwent both rate control and rhythm control|patients|Number|37|37.0||||||
4172881|NCT00811382|3994757|B1|Rhythm control||AF treatment at enrollment|some patients underwent both rate control and rhythm control|patients|Number|47|47.0||||||
4172882|NCT00811382|3994755|B3|Rate control||AF treatment at enrollment|some patients underwent both rate control and rhythm control|patients|Number|30|30.0||||||
4172883|NCT00811382|3994756|B2|Rate control||AF treatment at enrollment|some patients underwent both rate control and rhythm control|patients|Number|14|14.0||||||
4172884|NCT00811382|3994757|B1|Rate control||AF treatment at enrollment|some patients underwent both rate control and rhythm control|patients|Number|16|16.0||||||
4172885|NCT00811382|3994755|B3|not reported||History AV node ablation||patients|Number|16|16.0||||||
4172886|NCT00811382|3994756|B2|not reported||History AV node ablation||patients|Number|9|9.0||||||
4172887|NCT00811382|3994757|B1|not reported||History AV node ablation||patients|Number|7|7.0||||||
4172888|NCT00811382|3994755|B3|not tried||History AV node ablation||patients|Number|145|145.0||||||
4172889|NCT00811382|3994756|B2|not tried||History AV node ablation||patients|Number|65|65.0||||||
4172890|NCT00811382|3994757|B1|not tried||History AV node ablation||patients|Number|80|80.0||||||
4172891|NCT00811382|3994755|B3|not successful||History AV node ablation||patients|Number|1|1.0||||||
4172892|NCT00811382|3994756|B2|not successful||History AV node ablation||patients|Number|0|0.0||||||
4172893|NCT00811382|3994757|B1|not successful||History AV node ablation||patients|Number|1|1.0||||||
4172894|NCT00811382|3994755|B3|successful||History AV node ablation||patients|Number|1|1.0||||||
4172895|NCT00811382|3994756|B2|successful||History AV node ablation||patients|Number|1|1.0||||||
4172896|NCT00811382|3994757|B1|successful||History AV node ablation||patients|Number|0|0.0||||||
4172897|NCT00811382|3994755|B3|not reported||History of atrial ablation||patients|Number|16|16.0||||||
4172898|NCT00811382|3994756|B2|not reported||History of atrial ablation||patients|Number|9|9.0||||||
4172899|NCT00811382|3994757|B1|not reported||History of atrial ablation||patients|Number|7|7.0||||||
4172900|NCT00811382|3994755|B3|not tried||History of atrial ablation||patients|Number|137|137.0||||||
4172901|NCT00811382|3994756|B2|not tried||History of atrial ablation||patients|Number|62|62.0||||||
4172902|NCT00811382|3994757|B1|not tried||History of atrial ablation||patients|Number|75|75.0||||||
4172903|NCT00811382|3994755|B3|not successful||History of atrial ablation||patients|Number|4|4.0||||||
4172904|NCT00811382|3994756|B2|not successful||History of atrial ablation||patients|Number|1|1.0||||||
4172905|NCT00811382|3994757|B1|not successful||History of atrial ablation||patients|Number|3|3.0||||||
4172906|NCT00811382|3994755|B3|partly successful||History of atrial ablation||patients|Number|6|6.0||||||
4172907|NCT00811382|3994756|B2|partly successful||History of atrial ablation||patients|Number|3|3.0||||||
4172908|NCT00811382|3994757|B1|partly successful||History of atrial ablation||patients|Number|3|3.0||||||
4172909|NCT00811382|3994755|B3|successful ablation||History of atrial ablation||patients|Number|0|0.0||||||
4172910|NCT00811382|3994756|B2|successful ablation||History of atrial ablation||patients|Number|0|0.0||||||
4172911|NCT00811382|3994757|B1|successful ablation||History of atrial ablation||patients|Number|0|0.0||||||
4172912|NCT00811382|3994755|B3|not reported||History of electrical cardioversion||patients|Number|16|16.0||||||
4172913|NCT00811382|3994756|B2|not reported||History of electrical cardioversion||patients|Number|9|9.0||||||
4172914|NCT00811382|3994757|B1|not reported||History of electrical cardioversion||patients|Number|7|7.0||||||
4172915|NCT00811382|3994755|B3|not tried||History of electrical cardioversion||patients|Number|92|92.0||||||
4172916|NCT00811382|3994756|B2|not tried||History of electrical cardioversion||patients|Number|42|42.0||||||
4172917|NCT00811382|3994757|B1|not tried||History of electrical cardioversion||patients|Number|50|50.0||||||
4172918|NCT00811382|3994755|B3|not successful||History of electrical cardioversion||patients|Number|1|1.0||||||
4172919|NCT00811382|3994756|B2|not successful||History of electrical cardioversion||patients|Number|0|0.0||||||
4172920|NCT00811382|3994757|B1|not successful||History of electrical cardioversion||patients|Number|1|1.0||||||
4172921|NCT00811382|3994755|B3|successful||History of electrical cardioversion||patients|Number|54|54.0||||||
4172922|NCT00811382|3994756|B2|successful||History of electrical cardioversion||patients|Number|24|24.0||||||
4172923|NCT00811382|3994757|B1|successful||History of electrical cardioversion||patients|Number|30|30.0||||||
4172924|NCT00811382|3994755|B3|not reported||History of pharmacological cardioversion||patients|Number|16|16.0||||||
4172925|NCT00811382|3994756|B2|not reported||History of pharmacological cardioversion||patients|Number|9|9.0||||||
4172926|NCT00811382|3994757|B1|not reported||History of pharmacological cardioversion||patients|Number|7|7.0||||||
4172927|NCT00811382|3994755|B3|not tried||History of pharmacological cardioversion||patients|Number|115|115.0||||||
4172928|NCT00811382|3994756|B2|not tried||History of pharmacological cardioversion||patients|Number|54|54.0||||||
4172929|NCT00811382|3994757|B1|not tried||History of pharmacological cardioversion||patients|Number|61|61.0||||||
4172930|NCT00811382|3994755|B3|not successful||History of pharmacological cardioversion||patients|Number|8|8.0||||||
4172931|NCT00811382|3994756|B2|not successful||History of pharmacological cardioversion||patients|Number|3|3.0||||||
4172932|NCT00811382|3994757|B1|not successful||History of pharmacological cardioversion||patients|Number|5|5.0||||||
4172933|NCT00811382|3994755|B3|successful||History of pharmacological cardioversion||patients|Number|24|24.0||||||
4172934|NCT00811382|3994756|B2|successful||History of pharmacological cardioversion||patients|Number|9|9.0||||||
4172935|NCT00811382|3994757|B1|successful||History of pharmacological cardioversion||patients|Number|15|15.0||||||
4172936|NCT00811382|3994755|B3|||Days since AF is known||days|Mean|974|974.0|Standard Deviation|1701|1701.0|||
4172937|NCT00811382|3994756|B2|||Days since AF is known||days|Mean|644|644.0|Standard Deviation|930|930.0|||
4172938|NCT00811382|3994757|B1|||Days since AF is known||days|Mean|1222|1222.0|Standard Deviation|2076|2076.0|||
4172939|NCT00811382|3994755|B3|||Ventricular Rate during AF||beats/min|Mean|102|102.0|Standard Deviation|33|33.0|||
4172940|NCT00811382|3994756|B2|||Ventricular Rate during AF||beats/min|Mean|100|100.0|Standard Deviation|32|32.0|||
4172941|NCT00811382|3994757|B1|||Ventricular Rate during AF||beats/min|Mean|104|104.0|Standard Deviation|33|33.0|||
4172942|NCT00811382|3994755|B3|no History of AF||History of AF||patients|Number|16|16.0||||||
4172943|NCT00811382|3994756|B2|no History of AF||History of AF||patients|Number|9|9.0||||||
4172944|NCT00811382|3994757|B1|no History of AF||History of AF||patients|Number|7|7.0||||||
4172945|NCT00811382|3994755|B3|Persistent||History of AF||patients|Number|40|40.0||||||
4172946|NCT00811382|3994756|B2|Persistent||History of AF||patients|Number|19|19.0||||||
4172947|NCT00811382|3994757|B1|Persistent||History of AF||patients|Number|21|21.0||||||
4172948|NCT00811382|3994755|B3|Paroxysmal||History of AF||patients|Number|107|107.0||||||
4172949|NCT00811382|3994756|B2|Paroxysmal||History of AF||patients|Number|47|47.0||||||
4172950|NCT00811382|3994757|B1|Paroxysmal||History of AF||patients|Number|60|60.0||||||
4172951|NCT00811382|3994755|B3|Other||Non-CV (cardiovascular) Morbidity at Enrollment|the sum of participants in all categories for the measure does not equal the overall number of baseline participants due to the fact that patients have sometimes more than 1 non-cv morbidity at enrollment|patients|Number|47|47.0||||||
4172952|NCT00811382|3994756|B2|Other||Non-CV (cardiovascular) Morbidity at Enrollment|the sum of participants in all categories for the measure does not equal the overall number of baseline participants due to the fact that patients have sometimes more than 1 non-cv morbidity at enrollment|patients|Number|19|19.0||||||
4172953|NCT00811382|3994757|B1|Other||Non-CV (cardiovascular) Morbidity at Enrollment|the sum of participants in all categories for the measure does not equal the overall number of baseline participants due to the fact that patients have sometimes more than 1 non-cv morbidity at enrollment|patients|Number|28|28.0||||||
4172954|NCT00811382|3994755|B3|Mental disorder||Non-CV (cardiovascular) Morbidity at Enrollment|the sum of participants in all categories for the measure does not equal the overall number of baseline participants due to the fact that patients have sometimes more than 1 non-cv morbidity at enrollment|patients|Number|6|6.0||||||
4172955|NCT00811382|3994756|B2|Mental disorder||Non-CV (cardiovascular) Morbidity at Enrollment|the sum of participants in all categories for the measure does not equal the overall number of baseline participants due to the fact that patients have sometimes more than 1 non-cv morbidity at enrollment|patients|Number|2|2.0||||||
4172956|NCT00811382|3994757|B1|Mental disorder||Non-CV (cardiovascular) Morbidity at Enrollment|the sum of participants in all categories for the measure does not equal the overall number of baseline participants due to the fact that patients have sometimes more than 1 non-cv morbidity at enrollment|patients|Number|4|4.0||||||
4172957|NCT00811382|3994755|B3|Hepatic disease||Non-CV (cardiovascular) Morbidity at Enrollment|the sum of participants in all categories for the measure does not equal the overall number of baseline participants due to the fact that patients have sometimes more than 1 non-cv morbidity at enrollment|patients|Number|3|3.0||||||
4172958|NCT00811382|3994756|B2|Hepatic disease||Non-CV (cardiovascular) Morbidity at Enrollment|the sum of participants in all categories for the measure does not equal the overall number of baseline participants due to the fact that patients have sometimes more than 1 non-cv morbidity at enrollment|patients|Number|1|1.0||||||
4172959|NCT00811382|3994757|B1|Hepatic disease||Non-CV (cardiovascular) Morbidity at Enrollment|the sum of participants in all categories for the measure does not equal the overall number of baseline participants due to the fact that patients have sometimes more than 1 non-cv morbidity at enrollment|patients|Number|2|2.0||||||
4172960|NCT00811382|3994755|B3|Thyroid disease||Non-CV (cardiovascular) Morbidity at Enrollment|the sum of participants in all categories for the measure does not equal the overall number of baseline participants due to the fact that patients have sometimes more than 1 non-cv morbidity at enrollment|patients|Number|24|24.0||||||
4172961|NCT00811382|3994756|B2|Thyroid disease||Non-CV (cardiovascular) Morbidity at Enrollment|the sum of participants in all categories for the measure does not equal the overall number of baseline participants due to the fact that patients have sometimes more than 1 non-cv morbidity at enrollment|patients|Number|9|9.0||||||
4172962|NCT00811382|3994757|B1|Thyroid disease||Non-CV (cardiovascular) Morbidity at Enrollment|the sum of participants in all categories for the measure does not equal the overall number of baseline participants due to the fact that patients have sometimes more than 1 non-cv morbidity at enrollment|patients|Number|15|15.0||||||
4172963|NCT00811382|3994755|B3|COPD||Non-CV (cardiovascular) Morbidity at Enrollment|the sum of participants in all categories for the measure does not equal the overall number of baseline participants due to the fact that patients have sometimes more than 1 non-cv morbidity at enrollment|patients|Number|31|31.0||||||
4172964|NCT00811382|3994756|B2|COPD||Non-CV (cardiovascular) Morbidity at Enrollment|the sum of participants in all categories for the measure does not equal the overall number of baseline participants due to the fact that patients have sometimes more than 1 non-cv morbidity at enrollment|patients|Number|13|13.0||||||
4172965|NCT00811382|3994757|B1|COPD||Non-CV (cardiovascular) Morbidity at Enrollment|the sum of participants in all categories for the measure does not equal the overall number of baseline participants due to the fact that patients have sometimes more than 1 non-cv morbidity at enrollment|patients|Number|18|18.0||||||
4172966|NCT00811382|3994755|B3|Renal insufficiency||Non-CV (cardiovascular) Morbidity at Enrollment|the sum of participants in all categories for the measure does not equal the overall number of baseline participants due to the fact that patients have sometimes more than 1 non-cv morbidity at enrollment|patients|Number|25|25.0||||||
4172967|NCT00811382|3994756|B2|Renal insufficiency||Non-CV (cardiovascular) Morbidity at Enrollment|the sum of participants in all categories for the measure does not equal the overall number of baseline participants due to the fact that patients have sometimes more than 1 non-cv morbidity at enrollment|patients|Number|10|10.0||||||
4172968|NCT00811382|3994757|B1|Renal insufficiency||Non-CV (cardiovascular) Morbidity at Enrollment|the sum of participants in all categories for the measure does not equal the overall number of baseline participants due to the fact that patients have sometimes more than 1 non-cv morbidity at enrollment|patients|Number|15|15.0||||||
4172969|NCT00811382|3994755|B3|Diabetes mellitus||Non-CV (cardiovascular) Morbidity at Enrollment|the sum of participants in all categories for the measure does not equal the overall number of baseline participants due to the fact that patients have sometimes more than 1 non-cv morbidity at enrollment|patients|Number|55|55.0||||||
4172970|NCT00811382|3994756|B2|Diabetes mellitus||Non-CV (cardiovascular) Morbidity at Enrollment|the sum of participants in all categories for the measure does not equal the overall number of baseline participants due to the fact that patients have sometimes more than 1 non-cv morbidity at enrollment|patients|Number|20|20.0||||||
4172971|NCT00811382|3994757|B1|Diabetes mellitus||Non-CV (cardiovascular) Morbidity at Enrollment|the sum of participants in all categories for the measure does not equal the overall number of baseline participants due to the fact that patients have sometimes more than 1 non-cv morbidity at enrollment|patients|Number|35|35.0||||||
4172972|NCT00811382|3994755|B3|Other||Rhythm at enrollment|Sinus Rhythm: with heart rate in the normal range of 60 – 100 beats/min AF: generally at a rate between 110 and 180 beats/min.|patients|Number|12|12.0||||||
4172973|NCT00811382|3994756|B2|Other||Rhythm at enrollment|Sinus Rhythm: with heart rate in the normal range of 60 – 100 beats/min AF: generally at a rate between 110 and 180 beats/min.|patients|Number|3|3.0||||||
4172974|NCT00811382|3994757|B1|Other||Rhythm at enrollment|Sinus Rhythm: with heart rate in the normal range of 60 – 100 beats/min AF: generally at a rate between 110 and 180 beats/min.|patients|Number|9|9.0||||||
4172975|NCT00811382|3994755|B3|AF||Rhythm at enrollment|Sinus Rhythm: with heart rate in the normal range of 60 – 100 beats/min AF: generally at a rate between 110 and 180 beats/min.|patients|Number|10|10.0||||||
4172976|NCT00811382|3994756|B2|AF||Rhythm at enrollment|Sinus Rhythm: with heart rate in the normal range of 60 – 100 beats/min AF: generally at a rate between 110 and 180 beats/min.|patients|Number|6|6.0||||||
4172977|NCT00811382|3994757|B1|AF||Rhythm at enrollment|Sinus Rhythm: with heart rate in the normal range of 60 – 100 beats/min AF: generally at a rate between 110 and 180 beats/min.|patients|Number|4|4.0||||||
4172978|NCT00811382|3994755|B3|Sinus Rhythm||Rhythm at enrollment|Sinus Rhythm: with heart rate in the normal range of 60 – 100 beats/min AF: generally at a rate between 110 and 180 beats/min.|patients|Number|141|141.0||||||
4172979|NCT00811382|3994756|B2|Sinus Rhythm||Rhythm at enrollment|Sinus Rhythm: with heart rate in the normal range of 60 – 100 beats/min AF: generally at a rate between 110 and 180 beats/min.|patients|Number|66|66.0||||||
4172980|NCT00811382|3994757|B1|Sinus Rhythm||Rhythm at enrollment|Sinus Rhythm: with heart rate in the normal range of 60 – 100 beats/min AF: generally at a rate between 110 and 180 beats/min.|patients|Number|75|75.0||||||
4172981|NCT00811382|3994755|B3|Other||AV (atrioventricular) Block|"The classification of atrioventricular block as 1st, 2nd and 3rd degree follows the standard textbook definition. It is not possible to describe their meaning for laypersons.~This classification is not outcome but a patient characteristic at enrollment. A lower grade is better."|patients|Number|37|37.0||||||
4172982|NCT00811382|3994756|B2|Other||AV (atrioventricular) Block|"The classification of atrioventricular block as 1st, 2nd and 3rd degree follows the standard textbook definition. It is not possible to describe their meaning for laypersons.~This classification is not outcome but a patient characteristic at enrollment. A lower grade is better."|patients|Number|19|19.0||||||
4172983|NCT00811382|3994757|B1|Other||AV (atrioventricular) Block|"The classification of atrioventricular block as 1st, 2nd and 3rd degree follows the standard textbook definition. It is not possible to describe their meaning for laypersons.~This classification is not outcome but a patient characteristic at enrollment. A lower grade is better."|patients|Number|18|18.0||||||
4172984|NCT00811382|3994755|B3|Third Degree||AV (atrioventricular) Block|"The classification of atrioventricular block as 1st, 2nd and 3rd degree follows the standard textbook definition. It is not possible to describe their meaning for laypersons.~This classification is not outcome but a patient characteristic at enrollment. A lower grade is better."|patients|Number|13|13.0||||||
4172985|NCT00811382|3994756|B2|Third Degree||AV (atrioventricular) Block|"The classification of atrioventricular block as 1st, 2nd and 3rd degree follows the standard textbook definition. It is not possible to describe their meaning for laypersons.~This classification is not outcome but a patient characteristic at enrollment. A lower grade is better."|patients|Number|4|4.0||||||
4172986|NCT00811382|3994757|B1|Third Degree||AV (atrioventricular) Block|"The classification of atrioventricular block as 1st, 2nd and 3rd degree follows the standard textbook definition. It is not possible to describe their meaning for laypersons.~This classification is not outcome but a patient characteristic at enrollment. A lower grade is better."|patients|Number|9|9.0||||||
4172987|NCT00811382|3994755|B3|Second Degree||AV (atrioventricular) Block|"The classification of atrioventricular block as 1st, 2nd and 3rd degree follows the standard textbook definition. It is not possible to describe their meaning for laypersons.~This classification is not outcome but a patient characteristic at enrollment. A lower grade is better."|patients|Number|5|5.0||||||
4172988|NCT00811382|3994756|B2|Second Degree||AV (atrioventricular) Block|"The classification of atrioventricular block as 1st, 2nd and 3rd degree follows the standard textbook definition. It is not possible to describe their meaning for laypersons.~This classification is not outcome but a patient characteristic at enrollment. A lower grade is better."|patients|Number|3|3.0||||||
4172989|NCT00811382|3994757|B1|Second Degree||AV (atrioventricular) Block|"The classification of atrioventricular block as 1st, 2nd and 3rd degree follows the standard textbook definition. It is not possible to describe their meaning for laypersons.~This classification is not outcome but a patient characteristic at enrollment. A lower grade is better."|patients|Number|2|2.0||||||
4172990|NCT00811382|3994755|B3|First Degree||AV (atrioventricular) Block|"The classification of atrioventricular block as 1st, 2nd and 3rd degree follows the standard textbook definition. It is not possible to describe their meaning for laypersons.~This classification is not outcome but a patient characteristic at enrollment. A lower grade is better."|patients|Number|40|40.0||||||
4172991|NCT00811382|3994756|B2|First Degree||AV (atrioventricular) Block|"The classification of atrioventricular block as 1st, 2nd and 3rd degree follows the standard textbook definition. It is not possible to describe their meaning for laypersons.~This classification is not outcome but a patient characteristic at enrollment. A lower grade is better."|patients|Number|17|17.0||||||
4172992|NCT00811382|3994757|B1|First Degree||AV (atrioventricular) Block|"The classification of atrioventricular block as 1st, 2nd and 3rd degree follows the standard textbook definition. It is not possible to describe their meaning for laypersons.~This classification is not outcome but a patient characteristic at enrollment. A lower grade is better."|patients|Number|23|23.0||||||
4172993|NCT00811382|3994755|B3|No relevant finding||AV (atrioventricular) Block|"The classification of atrioventricular block as 1st, 2nd and 3rd degree follows the standard textbook definition. It is not possible to describe their meaning for laypersons.~This classification is not outcome but a patient characteristic at enrollment. A lower grade is better."|patients|Number|68|68.0||||||
4172994|NCT00811382|3994756|B2|No relevant finding||AV (atrioventricular) Block|"The classification of atrioventricular block as 1st, 2nd and 3rd degree follows the standard textbook definition. It is not possible to describe their meaning for laypersons.~This classification is not outcome but a patient characteristic at enrollment. A lower grade is better."|patients|Number|32|32.0||||||
4173152|NCT00811057|3994936|B4|||Age||years|Mean|22.5|22.5|Standard Deviation|4.4|4.4|||
4173153|NCT00811057|3994937|B3|||Age||years|Mean|22.9|22.9|Standard Deviation|4.8|4.8|||
4173154|NCT00811057|3994938|B2|||Age||years|Mean|22.2|22.2|Standard Deviation|4.3|4.3|||
4172995|NCT00811382|3994757|B1|No relevant finding||AV (atrioventricular) Block|"The classification of atrioventricular block as 1st, 2nd and 3rd degree follows the standard textbook definition. It is not possible to describe their meaning for laypersons.~This classification is not outcome but a patient characteristic at enrollment. A lower grade is better."|patients|Number|36|36.0||||||
4172996|NCT00811382|3994755|B3|||Heart Rate||beats/min|Mean|70|70.0|Standard Deviation|15|15.0|||
4172997|NCT00811382|3994756|B2|||Heart Rate||beats/min|Mean|68|68.0|Standard Deviation|16|16.0|||
4172998|NCT00811382|3994757|B1|||Heart Rate||beats/min|Mean|71|71.0|Standard Deviation|14|14.0|||
4172999|NCT00811382|3994755|B3|||QRS duration||ms|Median|158|158.0|Standard Deviation|25|25.0|||
4173000|NCT00811382|3994756|B2|||QRS duration||ms|Median|159|159.0|Standard Deviation|26|26.0|||
4173001|NCT00811382|3994757|B1|||QRS duration||ms|Median|158|158.0|Standard Deviation|24|24.0|||
4173002|NCT00811382|3994755|B3|Patients with No VT/VF||History of VT/VF||patients|Number|126|126.0||||||
4173003|NCT00811382|3994756|B2|Patients with No VT/VF||History of VT/VF||patients|Number|60|60.0||||||
4173004|NCT00811382|3994757|B1|Patients with No VT/VF||History of VT/VF||patients|Number|66|66.0||||||
4173005|NCT00811382|3994755|B3|Patients with VT/VF||History of VT/VF||patients|Number|37|37.0||||||
4173006|NCT00811382|3994756|B2|Patients with VT/VF||History of VT/VF||patients|Number|15|15.0||||||
4173007|NCT00811382|3994757|B1|Patients with VT/VF||History of VT/VF||patients|Number|22|22.0||||||
4173008|NCT00811382|3994755|B3|not reported||Mitral regurgitation|A definition of the severity of Mitral Regurgitation can not be given, because the study did enforce a specific one and physicians used their standard definitions. It is not possible to describe their meaning for laypersons better that with the term used (mild, moderate, severe)|Participants|Count of Participants|4|4.0||||||
4173009|NCT00811382|3994756|B2|not reported||Mitral regurgitation|A definition of the severity of Mitral Regurgitation can not be given, because the study did enforce a specific one and physicians used their standard definitions. It is not possible to describe their meaning for laypersons better that with the term used (mild, moderate, severe)|Participants|Count of Participants|2|2.0||||||
4173010|NCT00811382|3994757|B1|not reported||Mitral regurgitation|A definition of the severity of Mitral Regurgitation can not be given, because the study did enforce a specific one and physicians used their standard definitions. It is not possible to describe their meaning for laypersons better that with the term used (mild, moderate, severe)|Participants|Count of Participants|2|2.0||||||
4173011|NCT00811382|3994755|B3|No regurgitation||Mitral regurgitation|A definition of the severity of Mitral Regurgitation can not be given, because the study did enforce a specific one and physicians used their standard definitions. It is not possible to describe their meaning for laypersons better that with the term used (mild, moderate, severe)|Participants|Count of Participants|34|34.0||||||
4173012|NCT00811382|3994756|B2|No regurgitation||Mitral regurgitation|A definition of the severity of Mitral Regurgitation can not be given, because the study did enforce a specific one and physicians used their standard definitions. It is not possible to describe their meaning for laypersons better that with the term used (mild, moderate, severe)|Participants|Count of Participants|17|17.0||||||
4173013|NCT00811382|3994757|B1|No regurgitation||Mitral regurgitation|A definition of the severity of Mitral Regurgitation can not be given, because the study did enforce a specific one and physicians used their standard definitions. It is not possible to describe their meaning for laypersons better that with the term used (mild, moderate, severe)|Participants|Count of Participants|17|17.0||||||
4173014|NCT00811382|3994755|B3|Severe||Mitral regurgitation|A definition of the severity of Mitral Regurgitation can not be given, because the study did enforce a specific one and physicians used their standard definitions. It is not possible to describe their meaning for laypersons better that with the term used (mild, moderate, severe)|Participants|Count of Participants|5|5.0||||||
4173015|NCT00811382|3994756|B2|Severe||Mitral regurgitation|A definition of the severity of Mitral Regurgitation can not be given, because the study did enforce a specific one and physicians used their standard definitions. It is not possible to describe their meaning for laypersons better that with the term used (mild, moderate, severe)|Participants|Count of Participants|2|2.0||||||
4173016|NCT00811382|3994757|B1|Severe||Mitral regurgitation|A definition of the severity of Mitral Regurgitation can not be given, because the study did enforce a specific one and physicians used their standard definitions. It is not possible to describe their meaning for laypersons better that with the term used (mild, moderate, severe)|Participants|Count of Participants|3|3.0||||||
4173017|NCT00811382|3994755|B3|Moderate||Mitral regurgitation|A definition of the severity of Mitral Regurgitation can not be given, because the study did enforce a specific one and physicians used their standard definitions. It is not possible to describe their meaning for laypersons better that with the term used (mild, moderate, severe)|Participants|Count of Participants|43|43.0||||||
4173018|NCT00811382|3994756|B2|Moderate||Mitral regurgitation|A definition of the severity of Mitral Regurgitation can not be given, because the study did enforce a specific one and physicians used their standard definitions. It is not possible to describe their meaning for laypersons better that with the term used (mild, moderate, severe)|Participants|Count of Participants|15|15.0||||||
4173019|NCT00811382|3994757|B1|Moderate||Mitral regurgitation|A definition of the severity of Mitral Regurgitation can not be given, because the study did enforce a specific one and physicians used their standard definitions. It is not possible to describe their meaning for laypersons better that with the term used (mild, moderate, severe)|Participants|Count of Participants|28|28.0||||||
4173020|NCT00811382|3994755|B3|Mild||Mitral regurgitation|A definition of the severity of Mitral Regurgitation can not be given, because the study did enforce a specific one and physicians used their standard definitions. It is not possible to describe their meaning for laypersons better that with the term used (mild, moderate, severe)|Participants|Count of Participants|77|77.0||||||
4173021|NCT00811382|3994756|B2|Mild||Mitral regurgitation|A definition of the severity of Mitral Regurgitation can not be given, because the study did enforce a specific one and physicians used their standard definitions. It is not possible to describe their meaning for laypersons better that with the term used (mild, moderate, severe)|Participants|Count of Participants|39|39.0||||||
4173155|NCT00811057|3994939|B1|||Age||years|Mean|23.9|23.9|Standard Deviation|5.4|5.4|||
4173156|NCT00811057|3994936|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4173022|NCT00811382|3994757|B1|Mild||Mitral regurgitation|A definition of the severity of Mitral Regurgitation can not be given, because the study did enforce a specific one and physicians used their standard definitions. It is not possible to describe their meaning for laypersons better that with the term used (mild, moderate, severe)|Participants|Count of Participants|38|38.0||||||
4173023|NCT00811382|3994755|B3|||Left atrial diameter (LAD)||mm|Mean|48|48.0|Standard Deviation|9|9.0|||
4173024|NCT00811382|3994756|B2|||Left atrial diameter (LAD)||mm|Mean|48|48.0|Standard Deviation|8|8.0|||
4173025|NCT00811382|3994757|B1|||Left atrial diameter (LAD)||mm|Mean|49|49.0|Standard Deviation|10|10.0|||
4173026|NCT00811382|3994755|B3|||Left Ventricular End-Systolic Volume (LVESV)||ml|Median|146|146.0|Standard Deviation|64|64.0|||
4173027|NCT00811382|3994756|B2|||Left Ventricular End-Systolic Volume (LVESV)||ml|Median|159|159.0|Standard Deviation|70|70.0|||
4173028|NCT00811382|3994757|B1|||Left Ventricular End-Systolic Volume (LVESV)||ml|Median|135|135.0|Standard Deviation|58|58.0|||
4173029|NCT00811382|3994755|B3|||Left ventricular ejection fraction (LVEF)|"The Left ventricular ejection fraction (EF) is always reported in the unit of percentage (%). It is the ratio of pumped blood volume divided by the maximal filling volume. The EF refers to the amount, or percentage, of blood that is pumped (or ejected) out of the ventricles with each contraction.~An EF of 27 percent means that 27 percent of the total amount of blood in the left ventricle is pushed out with each heartbeat."|Percentage %|Median|27|27.0|Standard Deviation|7|7.0|||
4173030|NCT00811382|3994756|B2|||Left ventricular ejection fraction (LVEF)|"The Left ventricular ejection fraction (EF) is always reported in the unit of percentage (%). It is the ratio of pumped blood volume divided by the maximal filling volume. The EF refers to the amount, or percentage, of blood that is pumped (or ejected) out of the ventricles with each contraction.~An EF of 27 percent means that 27 percent of the total amount of blood in the left ventricle is pushed out with each heartbeat."|Percentage %|Median|26|26.0|Standard Deviation|7|7.0|||
4173031|NCT00811382|3994757|B1|||Left ventricular ejection fraction (LVEF)|"The Left ventricular ejection fraction (EF) is always reported in the unit of percentage (%). It is the ratio of pumped blood volume divided by the maximal filling volume. The EF refers to the amount, or percentage, of blood that is pumped (or ejected) out of the ventricles with each contraction.~An EF of 27 percent means that 27 percent of the total amount of blood in the left ventricle is pushed out with each heartbeat."|Percentage %|Median|27|27.0|Standard Deviation|7|7.0|||
4173032|NCT00811382|3994755|B3|Non-ischemic||Cardiomyopathy||participants|Number|74|74.0||||||
4173033|NCT00811382|3994756|B2|Non-ischemic||Cardiomyopathy||participants|Number|35|35.0||||||
4173034|NCT00811382|3994757|B1|Non-ischemic||Cardiomyopathy||participants|Number|39|39.0||||||
4173035|NCT00811382|3994755|B3|Ischemic||Cardiomyopathy||participants|Number|89|89.0||||||
4173036|NCT00811382|3994756|B2|Ischemic||Cardiomyopathy||participants|Number|40|40.0||||||
4173037|NCT00811382|3994757|B1|Ischemic||Cardiomyopathy||participants|Number|49|49.0||||||
4173038|NCT00811382|3994755|B3|Class IV||New York Heart Association functional class (NYHA class)|"Class I: No limitation of physical activity.~Class II: Slight limitation of physical activity.~Class III: Marked limitation of physical activity, but comfortable at rest.~Class IV: Unable to carry on any physical activity without discomfort and symptoms of heart failure at rest.~This classification is not an outcome but a patient characteristic at enrollment. From the given explanation, it is obvious that lower classes are better."|Participants|Count of Participants|9|9.0||||||
4173039|NCT00811382|3994756|B2|Class IV||New York Heart Association functional class (NYHA class)|"Class I: No limitation of physical activity.~Class II: Slight limitation of physical activity.~Class III: Marked limitation of physical activity, but comfortable at rest.~Class IV: Unable to carry on any physical activity without discomfort and symptoms of heart failure at rest.~This classification is not an outcome but a patient characteristic at enrollment. From the given explanation, it is obvious that lower classes are better."|Participants|Count of Participants|3|3.0||||||
4173040|NCT00811382|3994757|B1|Class IV||New York Heart Association functional class (NYHA class)|"Class I: No limitation of physical activity.~Class II: Slight limitation of physical activity.~Class III: Marked limitation of physical activity, but comfortable at rest.~Class IV: Unable to carry on any physical activity without discomfort and symptoms of heart failure at rest.~This classification is not an outcome but a patient characteristic at enrollment. From the given explanation, it is obvious that lower classes are better."|Participants|Count of Participants|6|6.0||||||
4173041|NCT00811382|3994755|B3|Class III||New York Heart Association functional class (NYHA class)|"Class I: No limitation of physical activity.~Class II: Slight limitation of physical activity.~Class III: Marked limitation of physical activity, but comfortable at rest.~Class IV: Unable to carry on any physical activity without discomfort and symptoms of heart failure at rest.~This classification is not an outcome but a patient characteristic at enrollment. From the given explanation, it is obvious that lower classes are better."|Participants|Count of Participants|142|142.0||||||
4173042|NCT00811382|3994756|B2|Class III||New York Heart Association functional class (NYHA class)|"Class I: No limitation of physical activity.~Class II: Slight limitation of physical activity.~Class III: Marked limitation of physical activity, but comfortable at rest.~Class IV: Unable to carry on any physical activity without discomfort and symptoms of heart failure at rest.~This classification is not an outcome but a patient characteristic at enrollment. From the given explanation, it is obvious that lower classes are better."|Participants|Count of Participants|67|67.0||||||
4173043|NCT00811382|3994757|B1|Class III||New York Heart Association functional class (NYHA class)|"Class I: No limitation of physical activity.~Class II: Slight limitation of physical activity.~Class III: Marked limitation of physical activity, but comfortable at rest.~Class IV: Unable to carry on any physical activity without discomfort and symptoms of heart failure at rest.~This classification is not an outcome but a patient characteristic at enrollment. From the given explanation, it is obvious that lower classes are better."|Participants|Count of Participants|75|75.0||||||
4173044|NCT00811382|3994755|B3|Class II||New York Heart Association functional class (NYHA class)|"Class I: No limitation of physical activity.~Class II: Slight limitation of physical activity.~Class III: Marked limitation of physical activity, but comfortable at rest.~Class IV: Unable to carry on any physical activity without discomfort and symptoms of heart failure at rest.~This classification is not an outcome but a patient characteristic at enrollment. From the given explanation, it is obvious that lower classes are better."|Participants|Count of Participants|12|12.0||||||
4173045|NCT00811382|3994756|B2|Class II||New York Heart Association functional class (NYHA class)|"Class I: No limitation of physical activity.~Class II: Slight limitation of physical activity.~Class III: Marked limitation of physical activity, but comfortable at rest.~Class IV: Unable to carry on any physical activity without discomfort and symptoms of heart failure at rest.~This classification is not an outcome but a patient characteristic at enrollment. From the given explanation, it is obvious that lower classes are better."|Participants|Count of Participants|5|5.0||||||
4173046|NCT00811382|3994757|B1|Class II||New York Heart Association functional class (NYHA class)|"Class I: No limitation of physical activity.~Class II: Slight limitation of physical activity.~Class III: Marked limitation of physical activity, but comfortable at rest.~Class IV: Unable to carry on any physical activity without discomfort and symptoms of heart failure at rest.~This classification is not an outcome but a patient characteristic at enrollment. From the given explanation, it is obvious that lower classes are better."|Participants|Count of Participants|7|7.0||||||
4173047|NCT00811382|3994755|B3|Class I||New York Heart Association functional class (NYHA class)|"Class I: No limitation of physical activity.~Class II: Slight limitation of physical activity.~Class III: Marked limitation of physical activity, but comfortable at rest.~Class IV: Unable to carry on any physical activity without discomfort and symptoms of heart failure at rest.~This classification is not an outcome but a patient characteristic at enrollment. From the given explanation, it is obvious that lower classes are better."|Participants|Count of Participants|0|0.0||||||
4173048|NCT00811382|3994756|B2|Class I||New York Heart Association functional class (NYHA class)|"Class I: No limitation of physical activity.~Class II: Slight limitation of physical activity.~Class III: Marked limitation of physical activity, but comfortable at rest.~Class IV: Unable to carry on any physical activity without discomfort and symptoms of heart failure at rest.~This classification is not an outcome but a patient characteristic at enrollment. From the given explanation, it is obvious that lower classes are better."|Participants|Count of Participants|0|0.0||||||
4173049|NCT00811382|3994757|B1|Class I||New York Heart Association functional class (NYHA class)|"Class I: No limitation of physical activity.~Class II: Slight limitation of physical activity.~Class III: Marked limitation of physical activity, but comfortable at rest.~Class IV: Unable to carry on any physical activity without discomfort and symptoms of heart failure at rest.~This classification is not an outcome but a patient characteristic at enrollment. From the given explanation, it is obvious that lower classes are better."|Participants|Count of Participants|0|0.0||||||
4173050|NCT00811382|3994755|B3|||Body Mass Index (BMI)||kg/m^2|Mean|27.6|27.6|Standard Deviation|4.4|4.4|||
4173051|NCT00811382|3994756|B2|||Body Mass Index (BMI)||kg/m^2|Mean|27.6|27.6|Standard Deviation|4.4|4.4|||
4173052|NCT00811382|3994757|B1|||Body Mass Index (BMI)||kg/m^2|Mean|27.6|27.6|Standard Deviation|4.4|4.4|||
4173053|NCT00811382|3994755|B3|||Weight, kilogram (kg)||kg|Mean|81|81.0|Standard Deviation|15|15.0|||
4173054|NCT00811382|3994756|B2|||Weight, kilogram (kg)||kg|Mean|81|81.0|Standard Deviation|15|15.0|||
4173055|NCT00811382|3994757|B1|||Weight, kilogram (kg)||kg|Mean|82|82.0|Standard Deviation|16|16.0|||
4173056|NCT00811382|3994755|B3|||Height,centimeter (cm)||cm|Median|172|172.0|Standard Deviation|9|9.0|||
4173057|NCT00811382|3994756|B2|||Height,centimeter (cm)||cm|Median|171|171.0|Standard Deviation|8|8.0|||
4173058|NCT00811382|3994757|B1|||Height,centimeter (cm)||cm|Median|172|172.0|Standard Deviation|9|9.0|||
4173059|NCT00811382|3994755|B3||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4173060|NCT00811382|3994756|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4173061|NCT00811382|3994757|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4173062|NCT00811382|3994755|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4173063|NCT00811382|3994756|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4173064|NCT00811382|3994757|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4173065|NCT00811382|3994755|B3|||Age||years|Mean|68.1|68.1|Standard Deviation|9.2|9.2|||
4173066|NCT00811382|3994756|B2|||Age||years|Mean|67.3|67.3|Standard Deviation|10|10.0|||
4173067|NCT00811382|3994757|B1|||Age||years|Mean|68.7|68.7|Standard Deviation|8.5|8.5|||
4173068|NCT00811317|3994770|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4173069|NCT00811317|3994770|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4173070|NCT00811317|3994770|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4173071|NCT00811317|3994770|B1|||Age||years|Mean|40|40.0|Standard Deviation|16|16.0|||
4173072|NCT00811252|3994796|B4|||GDS|The Geriatric Depression Scale (GDS) is a patient self-rating scale designed for the screening of depression in the elderly. It has also been validated as a measure of depression severity. The original version consists of 30 questions with a yes/no answer. In this study, the short 15-item version was used. The total score ranges from 0 to 15, with 15 representing maximum severity.|units on a scale|Mean|7.6|7.6|Standard Deviation|2.2|2.2|||
4173073|NCT00811252|3994797|B3|||GDS|The Geriatric Depression Scale (GDS) is a patient self-rating scale designed for the screening of depression in the elderly. It has also been validated as a measure of depression severity. The original version consists of 30 questions with a yes/no answer. In this study, the short 15-item version was used. The total score ranges from 0 to 15, with 15 representing maximum severity.|units on a scale|Mean|7.7|7.7|Standard Deviation|2.3|2.3|||
4173074|NCT00811252|3994798|B2|||GDS|The Geriatric Depression Scale (GDS) is a patient self-rating scale designed for the screening of depression in the elderly. It has also been validated as a measure of depression severity. The original version consists of 30 questions with a yes/no answer. In this study, the short 15-item version was used. The total score ranges from 0 to 15, with 15 representing maximum severity.|units on a scale|Mean|7.4|7.4|Standard Deviation|2.2|2.2|||
4173075|NCT00811252|3994799|B1|||GDS|The Geriatric Depression Scale (GDS) is a patient self-rating scale designed for the screening of depression in the elderly. It has also been validated as a measure of depression severity. The original version consists of 30 questions with a yes/no answer. In this study, the short 15-item version was used. The total score ranges from 0 to 15, with 15 representing maximum severity.|units on a scale|Mean|7.7|7.7|Standard Deviation|2.0|2.0|||
4173076|NCT00811252|3994796|B4|||CGI-S|The Clinical Global Impression - Severity of Illness (CGI-S) is a 7-point scale rated from 1 (normal, not at all ill) to 7 (among the most extremely ill patients). The investigator should use his/her total clinical experience with this patient population to judge how mentally ill the patient is at the time of rating.|units on a scale|Mean|4.7|4.7|Standard Deviation|0.7|0.7|||
4173077|NCT00811252|3994797|B3|||CGI-S|The Clinical Global Impression - Severity of Illness (CGI-S) is a 7-point scale rated from 1 (normal, not at all ill) to 7 (among the most extremely ill patients). The investigator should use his/her total clinical experience with this patient population to judge how mentally ill the patient is at the time of rating.|units on a scale|Mean|4.7|4.7|Standard Deviation|0.8|0.8|||
4173078|NCT00811252|3994798|B2|||CGI-S|The Clinical Global Impression - Severity of Illness (CGI-S) is a 7-point scale rated from 1 (normal, not at all ill) to 7 (among the most extremely ill patients). The investigator should use his/her total clinical experience with this patient population to judge how mentally ill the patient is at the time of rating.|units on a scale|Mean|4.8|4.8|Standard Deviation|0.7|0.7|||
4173079|NCT00811252|3994799|B1|||CGI-S|The Clinical Global Impression - Severity of Illness (CGI-S) is a 7-point scale rated from 1 (normal, not at all ill) to 7 (among the most extremely ill patients). The investigator should use his/her total clinical experience with this patient population to judge how mentally ill the patient is at the time of rating.|units on a scale|Mean|4.7|4.7|Standard Deviation|0.7|0.7|||
4173080|NCT00811252|3994796|B4|||HAM-A|The Hamilton Anxiety Rating Scale (HAM-A) consists of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behaviour at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic, and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total score from 0 to 56. The higher the score, the more severe.|units on a scale|Mean|19.5|19.5|Standard Deviation|6.0|6.0|||
4173081|NCT00811252|3994797|B3|||HAM-A|The Hamilton Anxiety Rating Scale (HAM-A) consists of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behaviour at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic, and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total score from 0 to 56. The higher the score, the more severe.|units on a scale|Mean|19.2|19.2|Standard Deviation|6.5|6.5|||
4173082|NCT00811252|3994798|B2|||HAM-A|The Hamilton Anxiety Rating Scale (HAM-A) consists of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behaviour at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic, and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total score from 0 to 56. The higher the score, the more severe.|units on a scale|Mean|19.9|19.9|Standard Deviation|5.8|5.8|||
4173083|NCT00811252|3994799|B1|||HAM-A|The Hamilton Anxiety Rating Scale (HAM-A) consists of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behaviour at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic, and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total score from 0 to 56. The higher the score, the more severe.|units on a scale|Mean|19.5|19.5|Standard Deviation|5.7|5.7|||
4173084|NCT00811252|3994796|B4|||MADRS|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 (no symptom) to 6 (severe symptom). The 10 items represent the core symptoms of depressive illness. The rating should be based on a clinical interview with the patient, moving from broadly phrased questions about symptoms to more detailed ones, which allow a precise rating of severity, covering the last 7 days. Total score from 0 to 60. The higher the score, the more severe.|units on a scale|Mean|30.5|30.5|Standard Deviation|3.3|3.3|||
4173085|NCT00811252|3994797|B3|||MADRS|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 (no symptom) to 6 (severe symptom). The 10 items represent the core symptoms of depressive illness. The rating should be based on a clinical interview with the patient, moving from broadly phrased questions about symptoms to more detailed ones, which allow a precise rating of severity, covering the last 7 days. Total score from 0 to 60. The higher the score, the more severe.|units on a scale|Mean|30.4|30.4|Standard Deviation|3.1|3.1|||
4173086|NCT00811252|3994798|B2|||MADRS|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 (no symptom) to 6 (severe symptom). The 10 items represent the core symptoms of depressive illness. The rating should be based on a clinical interview with the patient, moving from broadly phrased questions about symptoms to more detailed ones, which allow a precise rating of severity, covering the last 7 days. Total score from 0 to 60. The higher the score, the more severe.|units on a scale|Mean|30.7|30.7|Standard Deviation|3.6|3.6|||
4173087|NCT00811252|3994799|B1|||MADRS|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 (no symptom) to 6 (severe symptom). The 10 items represent the core symptoms of depressive illness. The rating should be based on a clinical interview with the patient, moving from broadly phrased questions about symptoms to more detailed ones, which allow a precise rating of severity, covering the last 7 days. Total score from 0 to 60. The higher the score, the more severe.|units on a scale|Mean|30.3|30.3|Standard Deviation|3.2|3.2|||
4173088|NCT00811252|3994796|B4|||HAM-D-24|The Hamilton Depression Scale - 24 Items (HAM-D-24) measures depression severity. Items are rated on a scale from 0 (symptoms not present) to a maximum of 2 to 4 (symptom extremely severe) for a total score range of 0 to 76. The higher the score, the more severe.|units on a scale|Mean|29.0|29.0|Standard Deviation|5.0|5.0|||
4173089|NCT00811252|3994797|B3|||HAM-D-24|The Hamilton Depression Scale - 24 Items (HAM-D-24) measures depression severity. Items are rated on a scale from 0 (symptoms not present) to a maximum of 2 to 4 (symptom extremely severe) for a total score range of 0 to 76. The higher the score, the more severe.|units on a scale|Mean|28.5|28.5|Standard Deviation|4.9|4.9|||
4173090|NCT00811252|3994798|B2|||HAM-D-24|The Hamilton Depression Scale - 24 Items (HAM-D-24) measures depression severity. Items are rated on a scale from 0 (symptoms not present) to a maximum of 2 to 4 (symptom extremely severe) for a total score range of 0 to 76. The higher the score, the more severe.|units on a scale|Mean|29.2|29.2|Standard Deviation|5.0|5.0|||
4173157|NCT00811057|3994937|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4173158|NCT00811057|3994938|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4173091|NCT00811252|3994799|B1|||HAM-D-24|The Hamilton Depression Scale - 24 Items (HAM-D-24) measures depression severity. Items are rated on a scale from 0 (symptoms not present) to a maximum of 2 to 4 (symptom extremely severe) for a total score range of 0 to 76. The higher the score, the more severe.|units on a scale|Mean|29.4|29.4|Standard Deviation|5.1|5.1|||
4173092|NCT00811252|3994796|B4||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4173093|NCT00811252|3994797|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4173094|NCT00811252|3994798|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4173095|NCT00811252|3994799|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4173096|NCT00811252|3994796|B4||Female|Sex: Female, Male||Participants|Count of Participants|297|297.0||||||
4173097|NCT00811252|3994797|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4173098|NCT00811252|3994798|B2||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4173099|NCT00811252|3994799|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4173100|NCT00811252|3994796|B4|||Age||years|Mean|70.6|70.6|Standard Deviation|4.9|4.9|||
4173101|NCT00811252|3994797|B3|||Age||years|Mean|70.9|70.9|Standard Deviation|5.5|5.5|||
4173102|NCT00811252|3994798|B2|||Age||years|Mean|70.5|70.5|Standard Deviation|4.8|4.8|||
4173103|NCT00811252|3994799|B1|||Age||years|Mean|70.3|70.3|Standard Deviation|4.4|4.4|||
4173104|NCT00811174|3994845|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4173105|NCT00811174|3994845|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4173106|NCT00811174|3994845|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4173107|NCT00811174|3994845|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4173108|NCT00811174|3994845|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4173109|NCT00811135|3994856|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4173110|NCT00811135|3994856|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4173111|NCT00811135|3994856|B1|||Age||years|Mean|53.0|53.0|Standard Deviation|10.94|10.94|||
4173112|NCT00811070|3994868|B7||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4173113|NCT00811070|3994869|B6||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4173114|NCT00811070|3994870|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4173115|NCT00811070|3994871|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4173116|NCT00811070|3994872|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4173117|NCT00811070|3994873|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4173118|NCT00811070|3994874|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4173119|NCT00811070|3994868|B7||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4173120|NCT00811070|3994869|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4173121|NCT00811070|3994870|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4173122|NCT00811070|3994871|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4173123|NCT00811070|3994872|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4173124|NCT00811070|3994873|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4173125|NCT00811070|3994874|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4173126|NCT00811070|3994868|B7|>= 65 years||Age, Customized||Participants|Number|18|18.0||||||
4173127|NCT00811070|3994869|B6|>= 65 years||Age, Customized||Participants|Number|2|2.0||||||
4173128|NCT00811070|3994870|B5|>= 65 years||Age, Customized||Participants|Number|4|4.0||||||
4173129|NCT00811070|3994871|B4|>= 65 years||Age, Customized||Participants|Number|8|8.0||||||
4173130|NCT00811070|3994872|B3|>= 65 years||Age, Customized||Participants|Number|1|1.0||||||
4173131|NCT00811070|3994873|B2|>= 65 years||Age, Customized||Participants|Number|3|3.0||||||
4173132|NCT00811070|3994874|B1|>= 65 years||Age, Customized||Participants|Number|0|0.0||||||
4173133|NCT00811070|3994868|B7|< 65 years||Age, Customized||Participants|Number|45|45.0||||||
4173134|NCT00811070|3994869|B6|< 65 years||Age, Customized||Participants|Number|9|9.0||||||
4173135|NCT00811070|3994870|B5|< 65 years||Age, Customized||Participants|Number|3|3.0||||||
4173136|NCT00811070|3994871|B4|< 65 years||Age, Customized||Participants|Number|20|20.0||||||
4173137|NCT00811070|3994872|B3|< 65 years||Age, Customized||Participants|Number|2|2.0||||||
4173138|NCT00811070|3994873|B2|< 65 years||Age, Customized||Participants|Number|4|4.0||||||
4173139|NCT00811070|3994874|B1|< 65 years||Age, Customized||Participants|Number|7|7.0||||||
4173140|NCT00811057|3994936|B4|United States||Region of Enrollment||participants|Number|301|301.0||||||
4173141|NCT00811057|3994937|B3|United States||Region of Enrollment||participants|Number|97|97.0||||||
4173142|NCT00811057|3994938|B2|United States||Region of Enrollment||participants|Number|114|114.0||||||
4173143|NCT00811057|3994939|B1|United States||Region of Enrollment||participants|Number|90|90.0||||||
4173144|NCT00811057|3994936|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4173145|NCT00811057|3994937|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4173146|NCT00811057|3994938|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4173147|NCT00811057|3994939|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4173148|NCT00811057|3994936|B4||Female|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
4173149|NCT00811057|3994937|B3||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4173150|NCT00811057|3994938|B2||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4173151|NCT00811057|3994939|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4173159|NCT00811057|3994939|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4173160|NCT00811057|3994936|B4||Between 18 and 65 years|Age||Participants|Count of Participants|301|301.0||||||
4173161|NCT00811057|3994937|B3||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
4173162|NCT00811057|3994938|B2||Between 18 and 65 years|Age||Participants|Count of Participants|114|114.0||||||
4173163|NCT00811057|3994939|B1||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
4173164|NCT00811057|3994936|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4173165|NCT00811057|3994937|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4173166|NCT00811057|3994938|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4173167|NCT00811057|3994939|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4173168|NCT00811018|3994952|B1||Male|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
4173169|NCT00811018|3994952|B1||Female|Sex: Female, Male||Participants|Count of Participants|914|914.0||||||
4173170|NCT00811018|3994952|B1|greater than or equal to 65 years||Age, Customized||participants|Number|256|256.0||||||
4173171|NCT00811018|3994952|B1|45-64 years||Age, Customized||participants|Number|468|468.0||||||
4173172|NCT00811018|3994952|B1|18-44 years||Age, Customized||participants|Number|433|433.0||||||
4173173|NCT00811018|3994952|B1|less than (<) 18 years||Age, Customized||participants|Number|35|35.0||||||
4173174|NCT00810901|3994968|B3|Not organ donor on license at baseline||Designated organ donor on driver's license||participants|Number|338|338.0||||||
4173175|NCT00810901|3994969|B2|Not organ donor on license at baseline||Designated organ donor on driver's license||participants|Number|137|137.0||||||
4173176|NCT00810901|3994970|B1|Not organ donor on license at baseline||Designated organ donor on driver's license||participants|Number|201|201.0||||||
4173177|NCT00810901|3994968|B3|Organ donor on license at baseline||Designated organ donor on driver's license||participants|Number|91|91.0||||||
4173178|NCT00810901|3994969|B2|Organ donor on license at baseline||Designated organ donor on driver's license||participants|Number|39|39.0||||||
4173179|NCT00810901|3994970|B1|Organ donor on license at baseline||Designated organ donor on driver's license||participants|Number|52|52.0||||||
4173180|NCT00810901|3994968|B3|United States||Region of Enrollment||participants|Number|429|429.0||||||
4173181|NCT00810901|3994969|B2|United States||Region of Enrollment||participants|Number|176|176.0||||||
4173182|NCT00810901|3994970|B1|United States||Region of Enrollment||participants|Number|253|253.0||||||
4173183|NCT00810901|3994968|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173184|NCT00810901|3994969|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173185|NCT00810901|3994970|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173186|NCT00810901|3994968|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4173187|NCT00810901|3994969|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4173188|NCT00810901|3994970|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4173189|NCT00810901|3994968|B3||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4173190|NCT00810901|3994969|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4173191|NCT00810901|3994970|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4173192|NCT00810901|3994968|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4173193|NCT00810901|3994969|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4173194|NCT00810901|3994970|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173195|NCT00810901|3994968|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4173196|NCT00810901|3994969|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4173197|NCT00810901|3994970|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4173198|NCT00810901|3994968|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|242|242.0||||||
4173199|NCT00810901|3994969|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
4173200|NCT00810901|3994970|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|147|147.0||||||
4173201|NCT00810901|3994968|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4173202|NCT00810901|3994969|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4173203|NCT00810901|3994970|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173204|NCT00810901|3994968|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4173205|NCT00810901|3994969|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4173206|NCT00810901|3994970|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4173207|NCT00810901|3994968|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|339|339.0||||||
4173208|NCT00810901|3994969|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
4173209|NCT00810901|3994970|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|209|209.0||||||
4173210|NCT00810901|3994968|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4173211|NCT00810901|3994969|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4173212|NCT00810901|3994970|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4173213|NCT00810901|3994968|B3||Male|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4173214|NCT00810901|3994969|B2||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4173215|NCT00810901|3994970|B1||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4173216|NCT00810901|3994968|B3||Female|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
4173217|NCT00810901|3994969|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4173218|NCT00810901|3994970|B1||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4173219|NCT00810901|3994968|B3|||Age|mean age by study condition|years|Mean|15.9|15.9|Standard Deviation|1.25|1.25|||
4173220|NCT00810901|3994969|B2|||Age|mean age by study condition|years|Mean|16.1|16.1|Standard Deviation|1.3|1.3|||
4173221|NCT00810901|3994970|B1|||Age|mean age by study condition|years|Mean|15.8|15.8|Standard Deviation|1.2|1.2|||
4173222|NCT00810888|3994979|B4|||Time from Stroke to Study Drug Administration||minutes|Mean|222.5|222.5|Standard Deviation|70.4|70.4|||
4173223|NCT00810888|3994981|B2|||Time from Stroke to Study Drug Administration||minutes|Mean|181.1|181.1|Standard Deviation|47.1|47.1|||
4173224|NCT00810888|3994982|B1|||Time from Stroke to Study Drug Administration||minutes|Mean|269.9|269.9|Standard Deviation|68.3|68.3|||
4173225|NCT00810888|3994979|B4|||Time from Stroke to Computed Tomography (CT) Scan||minutes|Mean|152.9|152.9|Standard Deviation|80.9|80.9|||
4173226|NCT00810888|3994980|B3|||Time from Stroke to Computed Tomography (CT) Scan||minutes|Mean|159.8|159.8|Standard Deviation|81.9|81.9|||
4173227|NCT00810888|3994981|B2|||Time from Stroke to Computed Tomography (CT) Scan||minutes|Mean|90.2|90.2|Standard Deviation|49.9|49.9|||
4173228|NCT00810888|3994982|B1|||Time from Stroke to Computed Tomography (CT) Scan||minutes|Mean|158.8|158.8|Standard Deviation|77.0|77.0|||
4173229|NCT00810888|3994979|B4|||National Institute of Health Stroke Scale (NIHSS) Score|The National Institute of Health Stroke Scale (NIHSS) Score is a scale which measures stroke severity (0=best, 42=worst)|units on a scale|Mean|10.9|10.9|Standard Deviation|6.0|6.0|||
4173230|NCT00810888|3994980|B3|||National Institute of Health Stroke Scale (NIHSS) Score|The National Institute of Health Stroke Scale (NIHSS) Score is a scale which measures stroke severity (0=best, 42=worst)|units on a scale|Mean|10.3|10.3|Standard Deviation|6.2|6.2|||
4173231|NCT00810888|3994981|B2|||National Institute of Health Stroke Scale (NIHSS) Score|The National Institute of Health Stroke Scale (NIHSS) Score is a scale which measures stroke severity (0=best, 42=worst)|units on a scale|Mean|12.1|12.1|Standard Deviation|4.9|4.9|||
4173232|NCT00810888|3994982|B1|||National Institute of Health Stroke Scale (NIHSS) Score|The National Institute of Health Stroke Scale (NIHSS) Score is a scale which measures stroke severity (0=best, 42=worst)|units on a scale|Mean|14.1|14.1|Standard Deviation|3.9|3.9|||
4173233|NCT00810888|3994979|B4|||Glasgow Coma Score/Scale (GCS)|Scale to measure severity due to coma status (0=worst, 15=best)|units on a scale|Median|15|15.0|Inter-Quartile Range|||14.0|15.0|
4173234|NCT00810888|3994980|B3|||Glasgow Coma Score/Scale (GCS)|Scale to measure severity due to coma status (0=worst, 15=best)|units on a scale|Median|15|15.0|Inter-Quartile Range|||14.0|15.0|
4173235|NCT00810888|3994981|B2|||Glasgow Coma Score/Scale (GCS)|Scale to measure severity due to coma status (0=worst, 15=best)|units on a scale|Median|15|15.0|Inter-Quartile Range|||14.0|15.0|
4173236|NCT00810888|3994982|B1|||Glasgow Coma Score/Scale (GCS)|Scale to measure severity due to coma status (0=worst, 15=best)|units on a scale|Median|15|15.0|Inter-Quartile Range|||14.0|15.0|
4173237|NCT00810888|3994979|B4||2|Modified Rankin Score (mRS)|Measure of mobility prior to stroke (0=best, 5=worst)|Participants|Count of Participants|2|2.0||||||
4173238|NCT00810888|3994980|B3||2|Modified Rankin Score (mRS)|Measure of mobility prior to stroke (0=best, 5=worst)|Participants|Count of Participants|2|2.0||||||
4173239|NCT00810888|3994981|B2||2|Modified Rankin Score (mRS)|Measure of mobility prior to stroke (0=best, 5=worst)|Participants|Count of Participants|0|0.0||||||
4173240|NCT00810888|3994982|B1||2|Modified Rankin Score (mRS)|Measure of mobility prior to stroke (0=best, 5=worst)|Participants|Count of Participants|0|0.0||||||
4173241|NCT00810888|3994979|B4||1|Modified Rankin Score (mRS)|Measure of mobility prior to stroke (0=best, 5=worst)|Participants|Count of Participants|9|9.0||||||
4173242|NCT00810888|3994980|B3||1|Modified Rankin Score (mRS)|Measure of mobility prior to stroke (0=best, 5=worst)|Participants|Count of Participants|6|6.0||||||
4173243|NCT00810888|3994981|B2||1|Modified Rankin Score (mRS)|Measure of mobility prior to stroke (0=best, 5=worst)|Participants|Count of Participants|3|3.0||||||
4173244|NCT00810888|3994982|B1||1|Modified Rankin Score (mRS)|Measure of mobility prior to stroke (0=best, 5=worst)|Participants|Count of Participants|0|0.0||||||
4173245|NCT00810888|3994979|B4||0|Modified Rankin Score (mRS)|Measure of mobility prior to stroke (0=best, 5=worst)|Participants|Count of Participants|81|81.0||||||
4173246|NCT00810888|3994980|B3||0|Modified Rankin Score (mRS)|Measure of mobility prior to stroke (0=best, 5=worst)|Participants|Count of Participants|65|65.0||||||
4173247|NCT00810888|3994981|B2||0|Modified Rankin Score (mRS)|Measure of mobility prior to stroke (0=best, 5=worst)|Participants|Count of Participants|6|6.0||||||
4173248|NCT00810888|3994982|B1||0|Modified Rankin Score (mRS)|Measure of mobility prior to stroke (0=best, 5=worst)|Participants|Count of Participants|10|10.0||||||
4173249|NCT00810888|3994979|B4|United States||Region of Enrollment||Participants|Count of Participants|65|65.0||||||
4173250|NCT00810888|3994980|B3|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
4173251|NCT00810888|3994981|B2|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4173252|NCT00810888|3994982|B1|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4173253|NCT00810888|3994979|B4|Canada||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
4173254|NCT00810888|3994980|B3|Canada||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4173255|NCT00810888|3994981|B2|Canada||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4173256|NCT00810888|3994982|B1|Canada||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4173257|NCT00810888|3994979|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173258|NCT00810888|3994980|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173259|NCT00810888|3994981|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173260|NCT00810888|3994982|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173261|NCT00810888|3994979|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173262|NCT00810888|3994980|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173263|NCT00810888|3994981|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173264|NCT00810888|3994982|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173265|NCT00810888|3994979|B4||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
4173266|NCT00810888|3994980|B3||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4173267|NCT00810888|3994981|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4173268|NCT00810888|3994982|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4173269|NCT00810888|3994979|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4173270|NCT00810888|3994980|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4173271|NCT00810888|3994981|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4173272|NCT00810888|3994982|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4173273|NCT00810888|3994979|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173274|NCT00810888|3994980|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173275|NCT00810888|3994981|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173276|NCT00810888|3994982|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173277|NCT00810888|3994979|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173278|NCT00810888|3994980|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173279|NCT00810888|3994981|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173280|NCT00810888|3994982|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173281|NCT00810888|3994979|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173282|NCT00810888|3994980|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173283|NCT00810888|3994981|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173284|NCT00810888|3994982|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173285|NCT00810888|3994979|B4||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4173286|NCT00810888|3994980|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4173287|NCT00810888|3994981|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4173288|NCT00810888|3994982|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4173289|NCT00810888|3994979|B4||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4173290|NCT00810888|3994980|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4173291|NCT00810888|3994981|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4173292|NCT00810888|3994982|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4173293|NCT00810888|3994979|B4|||Age||years|Mean|61.3|61.3|Standard Deviation|11.0|11.0|||
4173294|NCT00810888|3994980|B3|||Age||years|Mean|60.7|60.7|Standard Deviation|34.7|34.7|||
4173295|NCT00810888|3994981|B2|||Age||years|Mean|62.4|62.4|Standard Deviation|12.2|12.2|||
4173296|NCT00810888|3994982|B1|||Age||years|Mean|65.4|65.4|Standard Deviation|13.1|13.1|||
4173297|NCT00810810|3995013|B5|United States||Region of Enrollment||participants|Number|245|245.0||||||
4173298|NCT00810810|3995014|B4|United States||Region of Enrollment||participants|Number|38|38.0||||||
4173299|NCT00810810|3995015|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
4173300|NCT00810810|3995016|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
4173301|NCT00810810|3995017|B1|United States||Region of Enrollment||participants|Number|124|124.0||||||
4173302|NCT00810810|3995013|B5|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4173303|NCT00810810|3995013|B5|unknown||Sex/Gender, Customized|"Data on sex/gender was not recorded as neither the primary nor the secondary outcomes used those measures in the analysis.~All patients presenting to the service who did not have one or more exclusionary criteria were approached for consent to the study."|Participants|Count of Participants|245|245.0||||||
4173304|NCT00810810|3995014|B4|unknown||Sex/Gender, Customized|"Data on sex/gender was not recorded as neither the primary nor the secondary outcomes used those measures in the analysis.~All patients presenting to the service who did not have one or more exclusionary criteria were approached for consent to the study."|Participants|Count of Participants|38|38.0||||||
4173305|NCT00810810|3995015|B3|unknown||Sex/Gender, Customized|"Data on sex/gender was not recorded as neither the primary nor the secondary outcomes used those measures in the analysis.~All patients presenting to the service who did not have one or more exclusionary criteria were approached for consent to the study."|Participants|Count of Participants|45|45.0||||||
4173306|NCT00810810|3995016|B2|unknown||Sex/Gender, Customized|"Data on sex/gender was not recorded as neither the primary nor the secondary outcomes used those measures in the analysis.~All patients presenting to the service who did not have one or more exclusionary criteria were approached for consent to the study."|Participants|Count of Participants|38|38.0||||||
4173307|NCT00810810|3995017|B1|unknown||Sex/Gender, Customized|"Data on sex/gender was not recorded as neither the primary nor the secondary outcomes used those measures in the analysis.~All patients presenting to the service who did not have one or more exclusionary criteria were approached for consent to the study."|Participants|Count of Participants|124|124.0||||||
4173308|NCT00810810|3995013|B5|18 Years and older||Age, Customized||Participants|Count of Participants|245|245.0||||||
4173309|NCT00810810|3995014|B4|18 Years and older||Age, Customized||Participants|Count of Participants|38|38.0||||||
4173310|NCT00810810|3995015|B3|18 Years and older||Age, Customized||Participants|Count of Participants|45|45.0||||||
4173311|NCT00810810|3995016|B2|18 Years and older||Age, Customized||Participants|Count of Participants|38|38.0||||||
4173312|NCT00810810|3995017|B1|18 Years and older||Age, Customized||Participants|Count of Participants|124|124.0||||||
4173313|NCT00810771|3995034|B4|United States||Region of Enrollment||participants|Number|479|479.0||||||
4173314|NCT00810771|3995035|B3|United States||Region of Enrollment||participants|Number|84|84.0||||||
4173315|NCT00810771|3995036|B2|United States||Region of Enrollment||participants|Number|197|197.0||||||
4173316|NCT00810771|3995037|B1|United States||Region of Enrollment||participants|Number|198|198.0||||||
4173317|NCT00810771|3995034|B4||Male|Sex: Female, Male||Participants|Count of Participants|461|461.0||||||
4173318|NCT00810771|3995035|B3||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4173319|NCT00810771|3995036|B2||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4173320|NCT00810771|3995037|B1||Male|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4173321|NCT00810771|3995034|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4173322|NCT00810771|3995035|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4173323|NCT00810771|3995036|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4173324|NCT00810771|3995037|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4173325|NCT00810771|3995034|B4|||Age||Years|Mean|60.35|60.35|Full Range|||50.0|79.0|
4173326|NCT00810771|3995035|B3|||Age||Years|Mean|59.5|59.5|Full Range|||50.0|78.0|
4173327|NCT00810771|3995036|B2|||Age||Years|Mean|60.6|60.6|Full Range|||50.0|79.0|
4173328|NCT00810771|3995037|B1|||Age||Years|Mean|60.1|60.1|Full Range|||50.0|79.0|
4173329|NCT00810771|3995034|B4||>=65 years|Age||Participants|Count of Participants|109|109.0||||||
4173330|NCT00810771|3995035|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4173331|NCT00810771|3995036|B2||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
4173332|NCT00810771|3995037|B1||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
4173333|NCT00810771|3995034|B4||Between 18 and 65 years|Age||Participants|Count of Participants|370|370.0||||||
4173334|NCT00810771|3995035|B3||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
4173335|NCT00810771|3995036|B2||Between 18 and 65 years|Age||Participants|Count of Participants|147|147.0||||||
4173336|NCT00810771|3995037|B1||Between 18 and 65 years|Age||Participants|Count of Participants|155|155.0||||||
4173337|NCT00810771|3995034|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4173338|NCT00810771|3995035|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4173339|NCT00810771|3995036|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4173340|NCT00810771|3995037|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4173341|NCT00810719|3995059|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4173342|NCT00810719|3995059|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4173343|NCT00810719|3995059|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4173344|NCT00810719|3995059|B1|||Age||years|Median|67|67.0|Full Range|||46.0|84.0|
4173345|NCT00810693|3995065|B4|||Pulmonary vascular resistance|The pulmonary vascular resistance (PVR) is a calculated hemodynamic parameter. PVR is derived from the directly measured parameters mean pulmonary arterial pressure (PAPmean) and pulmonary capillary wedge pressure (PCWP), divided by the cardiac output (CO). PVR and PAPmean are acquired during a right heart catheterization. CO is a calculated hemodynamic parameter, too. Formula: PVR = 80*(PAPmean - PCWP)/CO|dn*s*cm^-5|Mean|810.89|810.89|Standard Deviation|473.45|473.45|||
4173346|NCT00810693|3995066|B3|||Pulmonary vascular resistance|The pulmonary vascular resistance (PVR) is a calculated hemodynamic parameter. PVR is derived from the directly measured parameters mean pulmonary arterial pressure (PAPmean) and pulmonary capillary wedge pressure (PCWP), divided by the cardiac output (CO). PVR and PAPmean are acquired during a right heart catheterization. CO is a calculated hemodynamic parameter, too. Formula: PVR = 80*(PAPmean - PCWP)/CO|dn*s*cm^-5|Mean|834.06|834.06|Standard Deviation|476.71|476.71|||
4173347|NCT00810693|3995067|B2|||Pulmonary vascular resistance|The pulmonary vascular resistance (PVR) is a calculated hemodynamic parameter. PVR is derived from the directly measured parameters mean pulmonary arterial pressure (PAPmean) and pulmonary capillary wedge pressure (PCWP), divided by the cardiac output (CO). PVR and PAPmean are acquired during a right heart catheterization. CO is a calculated hemodynamic parameter, too. Formula: PVR = 80*(PAPmean - PCWP)/CO|dn*s*cm^-5|Mean|847.81|847.81|Standard Deviation|548.17|548.17|||
4173348|NCT00810693|3995068|B1|||Pulmonary vascular resistance|The pulmonary vascular resistance (PVR) is a calculated hemodynamic parameter. PVR is derived from the directly measured parameters mean pulmonary arterial pressure (PAPmean) and pulmonary capillary wedge pressure (PCWP), divided by the cardiac output (CO). PVR and PAPmean are acquired during a right heart catheterization. CO is a calculated hemodynamic parameter, too. Formula: PVR = 80*(PAPmean - PCWP)/CO|dn*s*cm^-5|Mean|790.96|790.96|Standard Deviation|452.60|452.6|||
4173349|NCT00810693|3995065|B4|missing||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (participants with PH but without resulting limitation of physical activity) to class IV (participants with PH with inability to carry out any physical activity without symptoms. These participants manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement; changes to a higher functional class resemble deterioration of PAH.|Participants|Number|1|1.0||||||
4173384|NCT00810693|3995068|B1|Portal Pulmonary hypertension||PAH subtype|Subtypes acc. to the Venice Clinical Classification of PH, Group 1 (idiopathic PAH, familial PAH, associated PAH due to [1] connective tissue disease, [2] congenital heart disease, [3] portal hypertension with liver cirrhosis, or [4] anorexigen or amphetamine use)|Participants|Number|11|11.0||||||
4173470|NCT00810641|3995100|B3|||Age||years|Mean|61.5|61.5|Standard Deviation|14.9|14.9|||
4173350|NCT00810693|3995066|B3|missing||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (participants with PH but without resulting limitation of physical activity) to class IV (participants with PH with inability to carry out any physical activity without symptoms. These participants manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement; changes to a higher functional class resemble deterioration of PAH.|Participants|Number|1|1.0||||||
4173351|NCT00810693|3995067|B2|missing||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (participants with PH but without resulting limitation of physical activity) to class IV (participants with PH with inability to carry out any physical activity without symptoms. These participants manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement; changes to a higher functional class resemble deterioration of PAH.|Participants|Number|0|0.0||||||
4173352|NCT00810693|3995068|B1|missing||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (participants with PH but without resulting limitation of physical activity) to class IV (participants with PH with inability to carry out any physical activity without symptoms. These participants manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement; changes to a higher functional class resemble deterioration of PAH.|Participants|Number|0|0.0||||||
4173353|NCT00810693|3995065|B4|IV||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (participants with PH but without resulting limitation of physical activity) to class IV (participants with PH with inability to carry out any physical activity without symptoms. These participants manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement; changes to a higher functional class resemble deterioration of PAH.|Participants|Number|4|4.0||||||
4173354|NCT00810693|3995066|B3|IV||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (participants with PH but without resulting limitation of physical activity) to class IV (participants with PH with inability to carry out any physical activity without symptoms. These participants manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement; changes to a higher functional class resemble deterioration of PAH.|Participants|Number|3|3.0||||||
4173355|NCT00810693|3995067|B2|IV||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (participants with PH but without resulting limitation of physical activity) to class IV (participants with PH with inability to carry out any physical activity without symptoms. These participants manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement; changes to a higher functional class resemble deterioration of PAH.|Participants|Number|0|0.0||||||
4173356|NCT00810693|3995068|B1|IV||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (participants with PH but without resulting limitation of physical activity) to class IV (participants with PH with inability to carry out any physical activity without symptoms. These participants manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement; changes to a higher functional class resemble deterioration of PAH.|Participants|Number|1|1.0||||||
4173357|NCT00810693|3995065|B4|III||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (participants with PH but without resulting limitation of physical activity) to class IV (participants with PH with inability to carry out any physical activity without symptoms. These participants manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement; changes to a higher functional class resemble deterioration of PAH.|Participants|Number|237|237.0||||||
4173358|NCT00810693|3995066|B3|III||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (participants with PH but without resulting limitation of physical activity) to class IV (participants with PH with inability to carry out any physical activity without symptoms. These participants manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement; changes to a higher functional class resemble deterioration of PAH.|Participants|Number|58|58.0||||||
4173359|NCT00810693|3995067|B2|III||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (participants with PH but without resulting limitation of physical activity) to class IV (participants with PH with inability to carry out any physical activity without symptoms. These participants manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement; changes to a higher functional class resemble deterioration of PAH.|Participants|Number|39|39.0||||||
4173360|NCT00810693|3995068|B1|III||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (participants with PH but without resulting limitation of physical activity) to class IV (participants with PH with inability to carry out any physical activity without symptoms. These participants manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement; changes to a higher functional class resemble deterioration of PAH.|Participants|Number|140|140.0||||||
4173361|NCT00810693|3995065|B4|II||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (participants with PH but without resulting limitation of physical activity) to class IV (participants with PH with inability to carry out any physical activity without symptoms. These participants manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement; changes to a higher functional class resemble deterioration of PAH.|Participants|Number|187|187.0||||||
4173362|NCT00810693|3995066|B3|II||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (participants with PH but without resulting limitation of physical activity) to class IV (participants with PH with inability to carry out any physical activity without symptoms. These participants manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement; changes to a higher functional class resemble deterioration of PAH.|Participants|Number|60|60.0||||||
4173468|NCT00810641|3995102|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4173363|NCT00810693|3995067|B2|II||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (participants with PH but without resulting limitation of physical activity) to class IV (participants with PH with inability to carry out any physical activity without symptoms. These participants manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement; changes to a higher functional class resemble deterioration of PAH.|Participants|Number|19|19.0||||||
4173364|NCT00810693|3995068|B1|II||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (participants with PH but without resulting limitation of physical activity) to class IV (participants with PH with inability to carry out any physical activity without symptoms. These participants manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement; changes to a higher functional class resemble deterioration of PAH.|Participants|Number|108|108.0||||||
4173365|NCT00810693|3995065|B4|I||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (participants with PH but without resulting limitation of physical activity) to class IV (participants with PH with inability to carry out any physical activity without symptoms. These participants manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement; changes to a higher functional class resemble deterioration of PAH.|Participants|Number|14|14.0||||||
4173366|NCT00810693|3995066|B3|I||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (participants with PH but without resulting limitation of physical activity) to class IV (participants with PH with inability to carry out any physical activity without symptoms. These participants manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement; changes to a higher functional class resemble deterioration of PAH.|Participants|Number|4|4.0||||||
4173367|NCT00810693|3995067|B2|I||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (participants with PH but without resulting limitation of physical activity) to class IV (participants with PH with inability to carry out any physical activity without symptoms. These participants manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement; changes to a higher functional class resemble deterioration of PAH.|Participants|Number|5|5.0||||||
4173368|NCT00810693|3995068|B1|I||WHO (World Health Organization) functional class|The WHO functional assessment of pulmonary arterial hypertension ranged from functional class I (participants with PH but without resulting limitation of physical activity) to class IV (participants with PH with inability to carry out any physical activity without symptoms. These participants manifest signs of right-heart failure.). Changes to a lower WHO functional class resemble improvement; changes to a higher functional class resemble deterioration of PAH.|Participants|Number|5|5.0||||||
4173369|NCT00810693|3995065|B4|||Baseline 6MWD|6-minute walking distance (6MWD) is a measure for the objective evaluation of a patient's functional exercise capacity.|meters|Mean|363.5|363.5|Standard Deviation|69.5|69.5|||
4173370|NCT00810693|3995066|B3|||Baseline 6MWD|6-minute walking distance (6MWD) is a measure for the objective evaluation of a patient's functional exercise capacity.|meters|Mean|367.8|367.8|Standard Deviation|74.6|74.6|||
4173371|NCT00810693|3995067|B2|||Baseline 6MWD|6-minute walking distance (6MWD) is a measure for the objective evaluation of a patient's functional exercise capacity.|meters|Mean|363.2|363.2|Standard Deviation|66.6|66.6|||
4173372|NCT00810693|3995068|B1|||Baseline 6MWD|6-minute walking distance (6MWD) is a measure for the objective evaluation of a patient's functional exercise capacity.|meters|Mean|361.4|361.4|Standard Deviation|67.7|67.7|||
4173373|NCT00810693|3995065|B4|||BMI||kg/m^2|Mean|26.14|26.14|Standard Deviation|5.59|5.59|||
4173374|NCT00810693|3995066|B3|||BMI||kg/m^2|Mean|26.26|26.26|Standard Deviation|5.92|5.92|||
4173375|NCT00810693|3995067|B2|||BMI||kg/m^2|Mean|26.85|26.85|Standard Deviation|5.35|5.35|||
4173376|NCT00810693|3995068|B1|||BMI||kg/m^2|Mean|25.91|25.91|Standard Deviation|5.48|5.48|||
4173377|NCT00810693|3995065|B4|Anorexigen or Amphtamin assoc: PAH||PAH subtype|Subtypes acc. to the Venice Clinical Classification of PH, Group 1 (idiopathic PAH, familial PAH, associated PAH due to [1] connective tissue disease, [2] congenital heart disease, [3] portal hypertension with liver cirrhosis, or [4] anorexigen or amphetamine use)|Participants|Number|3|3.0||||||
4173378|NCT00810693|3995066|B3|Anorexigen or Amphtamin assoc: PAH||PAH subtype|Subtypes acc. to the Venice Clinical Classification of PH, Group 1 (idiopathic PAH, familial PAH, associated PAH due to [1] connective tissue disease, [2] congenital heart disease, [3] portal hypertension with liver cirrhosis, or [4] anorexigen or amphetamine use)|Participants|Number|2|2.0||||||
4173379|NCT00810693|3995067|B2|Anorexigen or Amphtamin assoc: PAH||PAH subtype|Subtypes acc. to the Venice Clinical Classification of PH, Group 1 (idiopathic PAH, familial PAH, associated PAH due to [1] connective tissue disease, [2] congenital heart disease, [3] portal hypertension with liver cirrhosis, or [4] anorexigen or amphetamine use)|Participants|Number|0|0.0||||||
4173380|NCT00810693|3995068|B1|Anorexigen or Amphtamin assoc: PAH||PAH subtype|Subtypes acc. to the Venice Clinical Classification of PH, Group 1 (idiopathic PAH, familial PAH, associated PAH due to [1] connective tissue disease, [2] congenital heart disease, [3] portal hypertension with liver cirrhosis, or [4] anorexigen or amphetamine use)|Participants|Number|1|1.0||||||
4173381|NCT00810693|3995065|B4|Portal Pulmonary hypertension||PAH subtype|Subtypes acc. to the Venice Clinical Classification of PH, Group 1 (idiopathic PAH, familial PAH, associated PAH due to [1] connective tissue disease, [2] congenital heart disease, [3] portal hypertension with liver cirrhosis, or [4] anorexigen or amphetamine use)|Participants|Number|13|13.0||||||
4173382|NCT00810693|3995066|B3|Portal Pulmonary hypertension||PAH subtype|Subtypes acc. to the Venice Clinical Classification of PH, Group 1 (idiopathic PAH, familial PAH, associated PAH due to [1] connective tissue disease, [2] congenital heart disease, [3] portal hypertension with liver cirrhosis, or [4] anorexigen or amphetamine use)|Participants|Number|2|2.0||||||
4173383|NCT00810693|3995067|B2|Portal Pulmonary hypertension||PAH subtype|Subtypes acc. to the Venice Clinical Classification of PH, Group 1 (idiopathic PAH, familial PAH, associated PAH due to [1] connective tissue disease, [2] congenital heart disease, [3] portal hypertension with liver cirrhosis, or [4] anorexigen or amphetamine use)|Participants|Number|0|0.0||||||
4173469|NCT00810641|3995099|B4|||Age||years|Mean|59.9|59.9|Standard Deviation|13.6|13.6|||
4173385|NCT00810693|3995065|B4|Congenital heart disease (operated) assoc. PAH||PAH subtype|Subtypes acc. to the Venice Clinical Classification of PH, Group 1 (idiopathic PAH, familial PAH, associated PAH due to [1] connective tissue disease, [2] congenital heart disease, [3] portal hypertension with liver cirrhosis, or [4] anorexigen or amphetamine use)|Participants|Number|35|35.0||||||
4173386|NCT00810693|3995066|B3|Congenital heart disease (operated) assoc. PAH||PAH subtype|Subtypes acc. to the Venice Clinical Classification of PH, Group 1 (idiopathic PAH, familial PAH, associated PAH due to [1] connective tissue disease, [2] congenital heart disease, [3] portal hypertension with liver cirrhosis, or [4] anorexigen or amphetamine use)|Participants|Number|12|12.0||||||
4173387|NCT00810693|3995067|B2|Congenital heart disease (operated) assoc. PAH||PAH subtype|Subtypes acc. to the Venice Clinical Classification of PH, Group 1 (idiopathic PAH, familial PAH, associated PAH due to [1] connective tissue disease, [2] congenital heart disease, [3] portal hypertension with liver cirrhosis, or [4] anorexigen or amphetamine use)|Participants|Number|8|8.0||||||
4173388|NCT00810693|3995068|B1|Congenital heart disease (operated) assoc. PAH||PAH subtype|Subtypes acc. to the Venice Clinical Classification of PH, Group 1 (idiopathic PAH, familial PAH, associated PAH due to [1] connective tissue disease, [2] congenital heart disease, [3] portal hypertension with liver cirrhosis, or [4] anorexigen or amphetamine use)|Participants|Number|15|15.0||||||
4173389|NCT00810693|3995065|B4|Connective tissue disease assoc. PAH||PAH subtype|Subtypes acc. to the Venice Clinical Classification of PH, Group 1 (idiopathic PAH, familial PAH, associated PAH due to [1] connective tissue disease, [2] congenital heart disease, [3] portal hypertension with liver cirrhosis, or [4] anorexigen or amphetamine use)|Participants|Number|111|111.0||||||
4173390|NCT00810693|3995066|B3|Connective tissue disease assoc. PAH||PAH subtype|Subtypes acc. to the Venice Clinical Classification of PH, Group 1 (idiopathic PAH, familial PAH, associated PAH due to [1] connective tissue disease, [2] congenital heart disease, [3] portal hypertension with liver cirrhosis, or [4] anorexigen or amphetamine use)|Participants|Number|25|25.0||||||
4173391|NCT00810693|3995067|B2|Connective tissue disease assoc. PAH||PAH subtype|Subtypes acc. to the Venice Clinical Classification of PH, Group 1 (idiopathic PAH, familial PAH, associated PAH due to [1] connective tissue disease, [2] congenital heart disease, [3] portal hypertension with liver cirrhosis, or [4] anorexigen or amphetamine use)|Participants|Number|15|15.0||||||
4173392|NCT00810693|3995068|B1|Connective tissue disease assoc. PAH||PAH subtype|Subtypes acc. to the Venice Clinical Classification of PH, Group 1 (idiopathic PAH, familial PAH, associated PAH due to [1] connective tissue disease, [2] congenital heart disease, [3] portal hypertension with liver cirrhosis, or [4] anorexigen or amphetamine use)|Participants|Number|71|71.0||||||
4173393|NCT00810693|3995065|B4|Familial PAH||PAH subtype|Subtypes acc. to the Venice Clinical Classification of PH, Group 1 (idiopathic PAH, familial PAH, associated PAH due to [1] connective tissue disease, [2] congenital heart disease, [3] portal hypertension with liver cirrhosis, or [4] anorexigen or amphetamine use)|Participants|Number|9|9.0||||||
4173394|NCT00810693|3995066|B3|Familial PAH||PAH subtype|Subtypes acc. to the Venice Clinical Classification of PH, Group 1 (idiopathic PAH, familial PAH, associated PAH due to [1] connective tissue disease, [2] congenital heart disease, [3] portal hypertension with liver cirrhosis, or [4] anorexigen or amphetamine use)|Participants|Number|1|1.0||||||
4173395|NCT00810693|3995067|B2|Familial PAH||PAH subtype|Subtypes acc. to the Venice Clinical Classification of PH, Group 1 (idiopathic PAH, familial PAH, associated PAH due to [1] connective tissue disease, [2] congenital heart disease, [3] portal hypertension with liver cirrhosis, or [4] anorexigen or amphetamine use)|Participants|Number|1|1.0||||||
4173396|NCT00810693|3995068|B1|Familial PAH||PAH subtype|Subtypes acc. to the Venice Clinical Classification of PH, Group 1 (idiopathic PAH, familial PAH, associated PAH due to [1] connective tissue disease, [2] congenital heart disease, [3] portal hypertension with liver cirrhosis, or [4] anorexigen or amphetamine use)|Participants|Number|7|7.0||||||
4173397|NCT00810693|3995065|B4|Idiopathic PAH||PAH subtype|Subtypes acc. to the Venice Clinical Classification of PH, Group 1 (idiopathic PAH, familial PAH, associated PAH due to [1] connective tissue disease, [2] congenital heart disease, [3] portal hypertension with liver cirrhosis, or [4] anorexigen or amphetamine use)|Participants|Number|272|272.0||||||
4173398|NCT00810693|3995066|B3|Idiopathic PAH||PAH subtype|Subtypes acc. to the Venice Clinical Classification of PH, Group 1 (idiopathic PAH, familial PAH, associated PAH due to [1] connective tissue disease, [2] congenital heart disease, [3] portal hypertension with liver cirrhosis, or [4] anorexigen or amphetamine use)|Participants|Number|84|84.0||||||
4173399|NCT00810693|3995067|B2|Idiopathic PAH||PAH subtype|Subtypes acc. to the Venice Clinical Classification of PH, Group 1 (idiopathic PAH, familial PAH, associated PAH due to [1] connective tissue disease, [2] congenital heart disease, [3] portal hypertension with liver cirrhosis, or [4] anorexigen or amphetamine use)|Participants|Number|39|39.0||||||
4173400|NCT00810693|3995068|B1|Idiopathic PAH||PAH subtype|Subtypes acc. to the Venice Clinical Classification of PH, Group 1 (idiopathic PAH, familial PAH, associated PAH due to [1] connective tissue disease, [2] congenital heart disease, [3] portal hypertension with liver cirrhosis, or [4] anorexigen or amphetamine use)|Participants|Number|149|149.0||||||
4173401|NCT00810693|3995065|B4|No||pre-treated with prostacyclin analogue|Subjects pre-treated with a prostacyclin analogue.|Participants|Number|412|412.0||||||
4173402|NCT00810693|3995066|B3|No||pre-treated with prostacyclin analogue|Subjects pre-treated with a prostacyclin analogue.|Participants|Number|119|119.0||||||
4173403|NCT00810693|3995067|B2|No||pre-treated with prostacyclin analogue|Subjects pre-treated with a prostacyclin analogue.|Participants|Number|59|59.0||||||
4173404|NCT00810693|3995068|B1|No||pre-treated with prostacyclin analogue|Subjects pre-treated with a prostacyclin analogue.|Participants|Number|234|234.0||||||
4173405|NCT00810693|3995065|B4|Yes||pre-treated with prostacyclin analogue|Subjects pre-treated with a prostacyclin analogue.|Participants|Number|31|31.0||||||
4173406|NCT00810693|3995066|B3|Yes||pre-treated with prostacyclin analogue|Subjects pre-treated with a prostacyclin analogue.|Participants|Number|7|7.0||||||
4173407|NCT00810693|3995067|B2|Yes||pre-treated with prostacyclin analogue|Subjects pre-treated with a prostacyclin analogue.|Participants|Number|4|4.0||||||
4173408|NCT00810693|3995068|B1|Yes||pre-treated with prostacyclin analogue|Subjects pre-treated with a prostacyclin analogue.|Participants|Number|20|20.0||||||
4173409|NCT00810693|3995065|B4|No||pre-treated with endothelin receptor antagonist|Subjects pre-treated with an endothelin receptor antagonist.|Participants|Number|249|249.0||||||
4173410|NCT00810693|3995066|B3|No||pre-treated with endothelin receptor antagonist|Subjects pre-treated with an endothelin receptor antagonist.|Participants|Number|72|72.0||||||
4173411|NCT00810693|3995067|B2|No||pre-treated with endothelin receptor antagonist|Subjects pre-treated with an endothelin receptor antagonist.|Participants|Number|36|36.0||||||
4173412|NCT00810693|3995068|B1|No||pre-treated with endothelin receptor antagonist|Subjects pre-treated with an endothelin receptor antagonist.|Participants|Number|141|141.0||||||
4173413|NCT00810693|3995065|B4|Yes||pre-treated with endothelin receptor antagonist|Subjects pre-treated with an endothelin receptor antagonist.|Participants|Number|194|194.0||||||
4173414|NCT00810693|3995066|B3|Yes||pre-treated with endothelin receptor antagonist|Subjects pre-treated with an endothelin receptor antagonist.|Participants|Number|54|54.0||||||
4173415|NCT00810693|3995067|B2|Yes||pre-treated with endothelin receptor antagonist|Subjects pre-treated with an endothelin receptor antagonist.|Participants|Number|27|27.0||||||
4173416|NCT00810693|3995068|B1|Yes||pre-treated with endothelin receptor antagonist|Subjects pre-treated with an endothelin receptor antagonist.|Participants|Number|113|113.0||||||
4173417|NCT00810693|3995065|B4|Pre-Treated||Prior PH therapy||Participants|Number|222|222.0||||||
4173418|NCT00810693|3995066|B3|Pre-Treated||Prior PH therapy||Participants|Number|60|60.0||||||
4173419|NCT00810693|3995067|B2|Pre-Treated||Prior PH therapy||Participants|Number|31|31.0||||||
4173420|NCT00810693|3995068|B1|Pre-Treated||Prior PH therapy||Participants|Number|131|131.0||||||
4173421|NCT00810693|3995065|B4|Therapy-Naive||Prior PH therapy||Participants|Number|221|221.0||||||
4173422|NCT00810693|3995066|B3|Therapy-Naive||Prior PH therapy||Participants|Number|66|66.0||||||
4173423|NCT00810693|3995067|B2|Therapy-Naive||Prior PH therapy||Participants|Number|32|32.0||||||
4173424|NCT00810693|3995068|B1|Therapy-Naive||Prior PH therapy||Participants|Number|123|123.0||||||
4173425|NCT00810693|3995065|B4|Not reported||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
4173426|NCT00810693|3995066|B3|Not reported||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4173427|NCT00810693|3995067|B2|Not reported||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4173428|NCT00810693|3995068|B1|Not reported||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4173429|NCT00810693|3995065|B4|Mixed||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4173430|NCT00810693|3995066|B3|Mixed||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4173431|NCT00810693|3995067|B2|Mixed||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4173432|NCT00810693|3995068|B1|Mixed||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4173433|NCT00810693|3995065|B4|Asian||Race/Ethnicity, Customized||Participants|Number|139|139.0||||||
4173434|NCT00810693|3995066|B3|Asian||Race/Ethnicity, Customized||Participants|Number|38|38.0||||||
4173435|NCT00810693|3995067|B2|Asian||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4173436|NCT00810693|3995068|B1|Asian||Race/Ethnicity, Customized||Participants|Number|79|79.0||||||
4173437|NCT00810693|3995065|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4173438|NCT00810693|3995066|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4173439|NCT00810693|3995067|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4173440|NCT00810693|3995068|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4173441|NCT00810693|3995065|B4|White||Race/Ethnicity, Customized||Participants|Number|272|272.0||||||
4173442|NCT00810693|3995066|B3|White||Race/Ethnicity, Customized||Participants|Number|78|78.0||||||
4173443|NCT00810693|3995067|B2|White||Race/Ethnicity, Customized||Participants|Number|33|33.0||||||
4173444|NCT00810693|3995068|B1|White||Race/Ethnicity, Customized||Participants|Number|161|161.0||||||
4173445|NCT00810693|3995065|B4||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4173446|NCT00810693|3995066|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4173447|NCT00810693|3995067|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4173448|NCT00810693|3995068|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4173449|NCT00810693|3995065|B4||Female|Sex: Female, Male||Participants|Count of Participants|350|350.0||||||
4173450|NCT00810693|3995066|B3||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4173451|NCT00810693|3995067|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4173452|NCT00810693|3995068|B1||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4173453|NCT00810693|3995065|B4|||Age||Years|Mean|50.6|50.6|Standard Deviation|16.5|16.5|||
4173454|NCT00810693|3995066|B3|||Age||Years|Mean|50.7|50.7|Standard Deviation|16.5|16.5|||
4173455|NCT00810693|3995067|B2|||Age||Years|Mean|48.8|48.8|Standard Deviation|16.1|16.1|||
4173456|NCT00810693|3995068|B1|||Age||Years|Mean|51.1|51.1|Standard Deviation|16.6|16.6|||
4173457|NCT00810641|3995099|B4|Korea, Republic of||Region of Enrollment||participants|Number|157|157.0||||||
4173458|NCT00810641|3995100|B3|Korea, Republic of||Region of Enrollment||participants|Number|51|51.0||||||
4173459|NCT00810641|3995101|B2|Korea, Republic of||Region of Enrollment||participants|Number|54|54.0||||||
4173460|NCT00810641|3995102|B1|Korea, Republic of||Region of Enrollment||participants|Number|52|52.0||||||
4173461|NCT00810641|3995099|B4||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4173462|NCT00810641|3995100|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4173463|NCT00810641|3995101|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4173464|NCT00810641|3995102|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4173465|NCT00810641|3995099|B4||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4173466|NCT00810641|3995100|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4173467|NCT00810641|3995101|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4173471|NCT00810641|3995101|B2|||Age||years|Mean|60.5|60.5|Standard Deviation|12.4|12.4|||
4173472|NCT00810641|3995102|B1|||Age||years|Mean|57.8|57.8|Standard Deviation|13.5|13.5|||
4173473|NCT00810641|3995099|B4||>=65 years|Age||Participants|Count of Participants|67|67.0||||||
4173474|NCT00810641|3995100|B3||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4173475|NCT00810641|3995101|B2||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4173476|NCT00810641|3995102|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4173477|NCT00810641|3995099|B4||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
4173478|NCT00810641|3995100|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4173479|NCT00810641|3995101|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4173480|NCT00810641|3995102|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4173481|NCT00810641|3995099|B4||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4173482|NCT00810641|3995100|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4173483|NCT00810641|3995101|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4173484|NCT00810641|3995102|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4173485|NCT00810615|3995112|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4173486|NCT00810615|3995113|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4173487|NCT00810615|3995114|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4173488|NCT00810615|3995112|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4173489|NCT00810615|3995113|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4173490|NCT00810615|3995114|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4173491|NCT00810615|3995112|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4173492|NCT00810615|3995113|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4173493|NCT00810615|3995114|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4173494|NCT00810615|3995112|B3|||Age||years|Mean|28.3|28.3|Standard Deviation|7.7|7.7|||
4173495|NCT00810615|3995113|B2|||Age||years|Mean|28.3|28.3|Standard Deviation|8.1|8.1|||
4173496|NCT00810615|3995114|B1|||Age||years|Mean|28.4|28.4|Standard Deviation|7.4|7.4|||
4173497|NCT00810615|3995112|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4173498|NCT00810615|3995113|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4173499|NCT00810615|3995114|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4173500|NCT00810615|3995112|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4173501|NCT00810615|3995113|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4173502|NCT00810615|3995114|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4173503|NCT00810615|3995112|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4173504|NCT00810615|3995113|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4173505|NCT00810615|3995114|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4173506|NCT00810602|3995165|B1|Platelet||Engraftment Day|Median time to platelet and neutrophil engraftment.|days|Median|12|12.0|Full Range|||9.0|30.0|
4173507|NCT00810602|3995165|B1|Neutrophil||Engraftment Day|Median time to platelet and neutrophil engraftment.|days|Median|12|12.0|Full Range|||8.0|19.0|
4173508|NCT00810602|3995165|B1|||CD34+ Count (10^6 cells/kg)||Count (10^6 cells/kg)|Median|5.0|5.0|Full Range|||1.9|8.0|
4173509|NCT00810602|3995165|B1|Recipient and Donor negative||CMV Status|Recipient(R),Donor (D), positive (+), negative(-)|participants|Number|20|20.0||||||
4173510|NCT00810602|3995165|B1|R+, D-||CMV Status|Recipient(R),Donor (D), positive (+), negative(-)|participants|Number|7|7.0||||||
4173511|NCT00810602|3995165|B1|R-, D+||CMV Status|Recipient(R),Donor (D), positive (+), negative(-)|participants|Number|6|6.0||||||
4173512|NCT00810602|3995165|B1|R+, D+||CMV Status|Recipient(R),Donor (D), positive (+), negative(-)|participants|Number|17|17.0||||||
4173513|NCT00810602|3995165|B1|Recipient or Donor positive (detailed below)||CMV Status|Recipient(R),Donor (D), positive (+), negative(-)|participants|Number|30|30.0||||||
4173514|NCT00810602|3995165|B1|One-antigen mismatched related||Donor Type||participants|Number|4|4.0||||||
4173515|NCT00810602|3995165|B1|Matched related||Donor Type||participants|Number|46|46.0||||||
4173516|NCT00810602|3995165|B1|High||Comorbidity index|Hematopoietic Cell Transplant – Comorbidity Index: Low = 0, Intermediate = 1 or 2, High ≥ 3|participants|Number|27|27.0||||||
4173517|NCT00810602|3995165|B1|Intermediate||Comorbidity index|Hematopoietic Cell Transplant – Comorbidity Index: Low = 0, Intermediate = 1 or 2, High ≥ 3|participants|Number|15|15.0||||||
4173518|NCT00810602|3995165|B1|Low||Comorbidity index|Hematopoietic Cell Transplant – Comorbidity Index: Low = 0, Intermediate = 1 or 2, High ≥ 3|participants|Number|8|8.0||||||
4173519|NCT00810602|3995165|B1|High||Disease Status||participants|Number|5|5.0||||||
4173520|NCT00810602|3995165|B1|Intermediate||Disease Status||participants|Number|20|20.0||||||
4173521|NCT00810602|3995165|B1|Low||Disease Status||participants|Number|25|25.0||||||
4173522|NCT00810602|3995165|B1|Acute biphenotypic leukemia||Diagnosis||participants|Number|1|1.0||||||
4173523|NCT00810602|3995165|B1|Myeloproliferative disorder or myelofibrosis||Diagnosis||participants|Number|4|4.0||||||
4173524|NCT00810602|3995165|B1|Chronic lymphocytic leukemia||Diagnosis||participants|Number|4|4.0||||||
4173525|NCT00810602|3995165|B1|Non-Hodgkin's lymphoma||Diagnosis||participants|Number|12|12.0||||||
4173526|NCT00810602|3995165|B1|Myelodysplastic syndrome||Diagnosis||participants|Number|10|10.0||||||
4173527|NCT00810602|3995165|B1|Acute myelogenous leukemia||Diagnosis||participants|Number|19|19.0||||||
4173528|NCT00810602|3995165|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4173529|NCT00810602|3995165|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4173530|NCT00810602|3995165|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4173531|NCT00810602|3995165|B1||Male|Sex: Female, Male|(44%, 56% of evaluable subjects, respectively)|Participants|Count of Participants|28|28.0||||||
4173532|NCT00810602|3995165|B1||Female|Sex: Female, Male|(44%, 56% of evaluable subjects, respectively)|Participants|Count of Participants|22|22.0||||||
4173533|NCT00810602|3995165|B1|||Age||years|Median|59|59.0|Full Range|||43.0|69.0|
4173534|NCT00810576|3995173|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4173535|NCT00810576|3995173|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4173536|NCT00810576|3995173|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4173537|NCT00810576|3995173|B1|||Age||years|Median|48|48.0|Full Range|||48.0|48.0|
4173538|NCT00810511|3995177|B3|United States||Region of Enrollment||participants|Number|213|213.0||||||
4173539|NCT00810511|3995178|B2|United States||Region of Enrollment||participants|Number|106|106.0||||||
4173540|NCT00810511|3995179|B1|United States||Region of Enrollment||participants|Number|107|107.0||||||
4173541|NCT00810511|3995177|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4173542|NCT00810511|3995178|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4173543|NCT00810511|3995179|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4173544|NCT00810511|3995177|B3||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4173545|NCT00810511|3995178|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4173546|NCT00810511|3995179|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4173547|NCT00810511|3995177|B3|||Age||years|Mean|31.2|31.2|Standard Deviation|10.4|10.4|||
4173548|NCT00810511|3995178|B2|||Age||years|Mean|31.8|31.8|Standard Deviation|11.0|11.0|||
4173549|NCT00810511|3995179|B1|||Age||years|Mean|30.6|30.6|Standard Deviation|9.8|9.8|||
4173550|NCT00810511|3995177|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4173551|NCT00810511|3995178|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4173552|NCT00810511|3995179|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4173553|NCT00810511|3995177|B3||Between 18 and 65 years|Age||Participants|Count of Participants|192|192.0||||||
4173554|NCT00810511|3995178|B2||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
4173555|NCT00810511|3995179|B1||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
4173556|NCT00810511|3995177|B3||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
4173557|NCT00810511|3995178|B2||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4173558|NCT00810511|3995179|B1||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4173559|NCT00810394|3995186|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4173560|NCT00810394|3995186|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4173561|NCT00810394|3995186|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4173562|NCT00810394|3995186|B1|||Age||years|Median|61|61.0|Full Range|||25.0|88.0|
4173563|NCT00810368|3995192|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
4173564|NCT00810368|3995193|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4173565|NCT00810368|3995194|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4173566|NCT00810368|3995192|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4173567|NCT00810368|3995193|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4173568|NCT00810368|3995194|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4173569|NCT00810368|3995192|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4173570|NCT00810368|3995193|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4173571|NCT00810368|3995194|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4173572|NCT00810368|3995192|B3|||Age||years|Mean|49.5|49.5|Standard Deviation|10.2|10.2|||
4173573|NCT00810368|3995193|B2|||Age||years|Mean|47.2|47.2|Standard Deviation|8.7|8.7|||
4173574|NCT00810368|3995194|B1|||Age||years|Mean|51.8|51.8|Standard Deviation|11.6|11.6|||
4173575|NCT00810355|3995213|B4|United States||Region of Enrollment||participants|Number|75|75.0||||||
4173576|NCT00810355|3995214|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4173577|NCT00810355|3995215|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4173578|NCT00810355|3995216|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4173579|NCT00810355|3995213|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173580|NCT00810355|3995214|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173581|NCT00810355|3995215|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173582|NCT00810355|3995216|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173583|NCT00810355|3995213|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4173584|NCT00810355|3995214|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4173585|NCT00810355|3995215|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173586|NCT00810355|3995216|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173587|NCT00810355|3995213|B4||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4173588|NCT00810355|3995214|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4173589|NCT00810355|3995215|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4173590|NCT00810355|3995216|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4173591|NCT00810355|3995213|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4173592|NCT00810355|3995214|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4173593|NCT00810355|3995215|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4173594|NCT00810355|3995216|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4173595|NCT00810355|3995213|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173596|NCT00810355|3995214|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173597|NCT00810355|3995215|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173598|NCT00810355|3995216|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173599|NCT00810355|3995213|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173600|NCT00810355|3995214|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173601|NCT00810355|3995215|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173602|NCT00810355|3995216|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173603|NCT00810355|3995213|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173604|NCT00810355|3995214|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173605|NCT00810355|3995215|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173606|NCT00810355|3995216|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173607|NCT00810355|3995213|B4||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4173608|NCT00810355|3995214|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4173609|NCT00810355|3995215|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4173610|NCT00810355|3995216|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4173611|NCT00810355|3995213|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4173612|NCT00810355|3995214|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4173613|NCT00810355|3995215|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4173614|NCT00810355|3995216|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4173615|NCT00810355|3995213|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4173616|NCT00810355|3995214|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4173617|NCT00810355|3995215|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4173618|NCT00810355|3995216|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4173619|NCT00810355|3995213|B4||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4173620|NCT00810355|3995214|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4173621|NCT00810355|3995215|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4173622|NCT00810355|3995216|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4173623|NCT00810355|3995213|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4173624|NCT00810355|3995214|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4173625|NCT00810355|3995215|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4173626|NCT00810355|3995216|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4173627|NCT00810342|3995232|B3|||Minutes per week of moderate-to-vigorous physical activity||minutes per week|Mean|45|45.0|Inter-Quartile Range|||41.5|48.0|
4173628|NCT00810342|3995233|B2|||Minutes per week of moderate-to-vigorous physical activity||minutes per week|Mean|46|46.0|Inter-Quartile Range|||42.0|49.0|
4173629|NCT00810342|3995234|B1|||Minutes per week of moderate-to-vigorous physical activity||minutes per week|Mean|44|44.0|Inter-Quartile Range|||41.0|47.0|
4173630|NCT00810342|3995232|B3|United States||Region of Enrollment||participants|Number|311|311.0||||||
4173631|NCT00810342|3995233|B2|United States||Region of Enrollment||participants|Number|157|157.0||||||
4173632|NCT00810342|3995234|B1|United States||Region of Enrollment||participants|Number|154|154.0||||||
4173633|NCT00810342|3995232|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4173634|NCT00810342|3995233|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4173635|NCT00810342|3995234|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4173636|NCT00810342|3995232|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4173637|NCT00810342|3995233|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4173638|NCT00810342|3995234|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4173639|NCT00810342|3995232|B3||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4173640|NCT00810342|3995233|B2||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4173641|NCT00810342|3995234|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4173642|NCT00810342|3995232|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4173643|NCT00810342|3995233|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4173644|NCT00810342|3995234|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4173645|NCT00810342|3995232|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
4173646|NCT00810342|3995233|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4173647|NCT00810342|3995234|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4173648|NCT00810342|3995232|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
4173649|NCT00810342|3995233|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4173650|NCT00810342|3995234|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4173651|NCT00810342|3995232|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173652|NCT00810342|3995233|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173653|NCT00810342|3995234|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4173654|NCT00810342|3995232|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4173655|NCT00810342|3995233|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4173656|NCT00810342|3995234|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4173657|NCT00810342|3995232|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|252|252.0||||||
4173658|NCT00810342|3995233|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
4173659|NCT00810342|3995234|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
4173660|NCT00810342|3995232|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4173661|NCT00810342|3995233|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4173662|NCT00810342|3995234|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4173663|NCT00810342|3995232|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4173664|NCT00810342|3995233|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4173665|NCT00810342|3995234|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4173666|NCT00810342|3995232|B3||Female|Sex: Female, Male||Participants|Count of Participants|311|311.0||||||
4173667|NCT00810342|3995233|B2||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4173668|NCT00810342|3995234|B1||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4173669|NCT00810342|3995232|B3|||Age||years|Mean|31.8|31.8|Standard Deviation|5.7|5.7|||
4173670|NCT00810342|3995233|B2|||Age||years|Mean|32.1|32.1|Standard Deviation|5.9|5.9|||
4173671|NCT00810342|3995234|B1|||Age||years|Mean|31.6|31.6|Standard Deviation|5.5|5.5|||
4173672|NCT00810303|3995243|B1|Germany||Region of Enrollment||participants|Number|12|12.0||||||
4173673|NCT00810303|3995243|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4173674|NCT00810303|3995243|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4173675|NCT00810303|3995243|B1|||Age||years|Mean|26|26.0|Standard Deviation|4.6|4.6|||
4173676|NCT00810303|3995243|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4173677|NCT00810303|3995243|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4173678|NCT00810303|3995243|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4173679|NCT00810277|3995268|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4173680|NCT00810277|3995268|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4173681|NCT00810277|3995268|B1|||Age||years|Mean|53.86|53.86|Standard Deviation|9.662|9.662|||
4173682|NCT00810199|3995281|B3||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4173683|NCT00810199|3995282|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4173684|NCT00810199|3995283|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4173685|NCT00810199|3995281|B3||Female|Sex: Female, Male||Participants|Count of Participants|444|444.0||||||
4173686|NCT00810199|3995282|B2||Female|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
4173687|NCT00810199|3995283|B1||Female|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
4173688|NCT00810199|3995281|B3|||Age||years|Mean|53.3|53.3|Standard Deviation|12.67|12.67|||
4173689|NCT00810199|3995282|B2|||Age||years|Mean|53.6|53.6|Standard Deviation|11.91|11.91|||
4173690|NCT00810199|3995283|B1|||Age||years|Mean|53.0|53.0|Standard Deviation|13.40|13.4|||
4173691|NCT00810108|3995360|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4173692|NCT00810108|3995361|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4173693|NCT00810108|3995362|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4173694|NCT00810108|3995360|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4173695|NCT00810108|3995361|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4173696|NCT00810108|3995362|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4173697|NCT00810108|3995360|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4173698|NCT00810108|3995361|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4173699|NCT00810108|3995362|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4173700|NCT00810108|3995360|B3|||Age||Years|Median|13|13.0|Full Range|||10.0|16.0|
4173701|NCT00810108|3995361|B2|||Age||Years|Median|13|13.0|Full Range|||12.0|16.0|
4173702|NCT00810108|3995362|B1|||Age||Years|Median|12|12.0|Full Range|||10.0|16.0|
4173703|NCT00810108|3995360|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4173704|NCT00810108|3995361|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4173705|NCT00810108|3995362|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4173706|NCT00810108|3995360|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4173707|NCT00810108|3995361|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4173708|NCT00810108|3995362|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4173709|NCT00810108|3995360|B3||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4173710|NCT00810108|3995361|B2||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4173711|NCT00810108|3995362|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4173712|NCT00810095|3995368|B1|||Median Baseline NIHSS score|"The NIH stroke scale (abbreviated NIHSS)is a scale developed by National Institutes of Health that communicates several different neurological deficits upon a single axis, represented by a score from 0 to 42 with 0 being no deficits and 42 being death."|NIHSS units|Median|16|16.0|Full Range|||8.0|26.0|
4173713|NCT00810095|3995368|B1|||Mean Baseline National Institutes of Health Stroke Scale (NIHSS) score|"The NIH stroke scale (abbreviated NIHSS)is a scale developed by National Institutes of Health that communicates several different neurological deficits upon a single axis, represented by a score from 0 to 42 with 0 being no deficits and 42 being death."|NIHSS units|Mean|16.5|16.5|Standard Deviation|4.7|4.7|||
4173714|NCT00810095|3995368|B1|Poland||Region of Enrollment||participants|Number|3|3.0||||||
4173715|NCT00810095|3995368|B1|Germany||Region of Enrollment||participants|Number|14|14.0||||||
4173716|NCT00810095|3995368|B1|Sweden||Region of Enrollment||participants|Number|23|23.0||||||
4173717|NCT00810095|3995368|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4173718|NCT00810095|3995368|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4173719|NCT00810095|3995368|B1|||Age||years|Mean|63.8|63.8|Standard Deviation|13.6|13.6|||
4173720|NCT00810095|3995368|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4173721|NCT00810095|3995368|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4173722|NCT00810095|3995368|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4173723|NCT00810082|3995375|B3|United States||Region of Enrollment||participants|Number|65|65.0||||||
4173724|NCT00810082|3995376|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
4173725|NCT00810082|3995377|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4173726|NCT00810082|3995375|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4173727|NCT00810082|3995376|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4173728|NCT00810082|3995377|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4173729|NCT00810082|3995375|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4173730|NCT00810082|3995376|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4173731|NCT00810082|3995377|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4173732|NCT00810082|3995375|B3|||Age||years|Mean|80.5|80.5|Standard Deviation|7.3|7.3|||
4173733|NCT00810082|3995376|B2|||Age||years|Mean|81.1|81.1|Standard Deviation|7.53|7.53|||
4173734|NCT00810082|3995377|B1|||Age||years|Mean|79.2|79.2|Standard Deviation|7.65|7.65|||
4173735|NCT00810069|3995384|B3|Missing||Has the participant been hospitalized due to depression in the last 4 weeks||participants|Number|1|1.0||||||
4173736|NCT00810069|3995385|B2|Missing||Has the participant been hospitalized due to depression in the last 4 weeks||participants|Number|1|1.0||||||
4173737|NCT00810069|3995386|B1|Missing||Has the participant been hospitalized due to depression in the last 4 weeks||participants|Number|0|0.0||||||
4173738|NCT00810069|3995384|B3|Unknown||Has the participant been hospitalized due to depression in the last 4 weeks||participants|Number|1|1.0||||||
4173739|NCT00810069|3995385|B2|Unknown||Has the participant been hospitalized due to depression in the last 4 weeks||participants|Number|0|0.0||||||
4173740|NCT00810069|3995386|B1|Unknown||Has the participant been hospitalized due to depression in the last 4 weeks||participants|Number|1|1.0||||||
4173741|NCT00810069|3995384|B3|No||Has the participant been hospitalized due to depression in the last 4 weeks||participants|Number|555|555.0||||||
4173742|NCT00810069|3995385|B2|No||Has the participant been hospitalized due to depression in the last 4 weeks||participants|Number|278|278.0||||||
4173743|NCT00810069|3995386|B1|No||Has the participant been hospitalized due to depression in the last 4 weeks||participants|Number|277|277.0||||||
4173744|NCT00810069|3995384|B3|Yes||Has the participant been hospitalized due to depression in the last 4 weeks||participants|Number|9|9.0||||||
4173745|NCT00810069|3995385|B2|Yes||Has the participant been hospitalized due to depression in the last 4 weeks||participants|Number|5|5.0||||||
4173746|NCT00810069|3995386|B1|Yes||Has the participant been hospitalized due to depression in the last 4 weeks||participants|Number|4|4.0||||||
4173747|NCT00810069|3995384|B3|||Number of visits to other specialists due to depression in the last 4 weeks||visits|Mean|1.8|1.8|Standard Deviation|1.26|1.26|||
4173748|NCT00810069|3995385|B2|||Number of visits to other specialists due to depression in the last 4 weeks||visits|Mean|1.6|1.6|Standard Deviation|0.98|0.98|||
4173749|NCT00810069|3995386|B1|||Number of visits to other specialists due to depression in the last 4 weeks||visits|Mean|2.0|2.0|Standard Deviation|1.44|1.44|||
4173750|NCT00810069|3995384|B3|||Number of visits to emergency room or equivalent facility due to depression in the last 4 weeks||visits|Mean|1.1|1.1|Standard Deviation|0.40|0.4|||
4173751|NCT00810069|3995385|B2|||Number of visits to emergency room or equivalent facility due to depression in the last 4 weeks||visits|Mean|1.1|1.1|Standard Deviation|0.48|0.48|||
4173752|NCT00810069|3995386|B1|||Number of visits to emergency room or equivalent facility due to depression in the last 4 weeks||visits|Mean|1.1|1.1|Standard Deviation|0.27|0.27|||
4173753|NCT00810069|3995384|B3|||Number of visits to primary healthcare provider due to depression in the last 4 weeks||visits|Mean|1.7|1.7|Standard Deviation|1.03|1.03|||
4173754|NCT00810069|3995385|B2|||Number of visits to primary healthcare provider due to depression in the last 4 weeks||visits|Mean|1.8|1.8|Standard Deviation|1.10|1.1|||
4173755|NCT00810069|3995386|B1|||Number of visits to primary healthcare provider due to depression in the last 4 weeks||visits|Mean|1.6|1.6|Standard Deviation|0.95|0.95|||
4173756|NCT00810069|3995384|B3|||Number of work hours missed due to depression in the last 4 weeks|Only those participants who missed at least 1 hour of work due to depression were included: 73 participants in the Early Intervention Strategy group and 90 participants in the Delayed Intervention Strategy group.|hours|Mean|88.6|88.6|Standard Deviation|65.56|65.56|||
4173757|NCT00810069|3995385|B2|||Number of work hours missed due to depression in the last 4 weeks|Only those participants who missed at least 1 hour of work due to depression were included: 73 participants in the Early Intervention Strategy group and 90 participants in the Delayed Intervention Strategy group.|hours|Mean|88.5|88.5|Standard Deviation|67.05|67.05|||
4173758|NCT00810069|3995386|B1|||Number of work hours missed due to depression in the last 4 weeks|Only those participants who missed at least 1 hour of work due to depression were included: 73 participants in the Early Intervention Strategy group and 90 participants in the Delayed Intervention Strategy group.|hours|Mean|88.8|88.8|Standard Deviation|64.14|64.14|||
4173759|NCT00810069|3995384|B3|||Number of work hours missed in the last 4 weeks|Only those participants who missed at least 1 hour of work were included: 79 participants in the Early Intervention Strategy group and 93 participants in the Delayed Intervention Strategy group.|hours|Mean|87.2|87.2|Standard Deviation|64.67|64.67|||
4173760|NCT00810069|3995385|B2|||Number of work hours missed in the last 4 weeks|Only those participants who missed at least 1 hour of work were included: 79 participants in the Early Intervention Strategy group and 93 participants in the Delayed Intervention Strategy group.|hours|Mean|87.5|87.5|Standard Deviation|66.32|66.32|||
4173761|NCT00810069|3995386|B1|||Number of work hours missed in the last 4 weeks|Only those participants who missed at least 1 hour of work were included: 79 participants in the Early Intervention Strategy group and 93 participants in the Delayed Intervention Strategy group.|hours|Mean|86.9|86.9|Standard Deviation|63.09|63.09|||
4173762|NCT00810069|3995384|B3|||Number of work hours worked per week||hours|Mean|37.6|37.6|Standard Deviation|8.94|8.94|||
4173763|NCT00810069|3995385|B2|||Number of work hours worked per week||hours|Mean|37.2|37.2|Standard Deviation|9.53|9.53|||
4173764|NCT00810069|3995386|B1|||Number of work hours worked per week||hours|Mean|38.0|38.0|Standard Deviation|8.30|8.3|||
4173765|NCT00810069|3995384|B3|Health State Score||Euro Quality of Life-5 Dimensions Questionnaire (EQ-5D) Score|EQ-5D: a generic, multidimensional, health-related, quality of life instrument. Participants rate health state in 5 domains: mobility, self-care, usual activities, pain/discomfort, mood. A single score between 1-3 is generated for each domain. Outcome rating on 5 domains is mapped to a single index through an algorithm. Index ranges between 0-1 with higher score indicating better health state perceived by participant. Health State Score: self-rated health on a vertical visual analogue scale measured in centimeters. Best imaginable health state=10 and worst imaginable health state=0.|units on a scale|Mean|4.05|4.05|Standard Deviation|1.798|1.798|||
4173766|NCT00810069|3995385|B2|Health State Score||Euro Quality of Life-5 Dimensions Questionnaire (EQ-5D) Score|EQ-5D: a generic, multidimensional, health-related, quality of life instrument. Participants rate health state in 5 domains: mobility, self-care, usual activities, pain/discomfort, mood. A single score between 1-3 is generated for each domain. Outcome rating on 5 domains is mapped to a single index through an algorithm. Index ranges between 0-1 with higher score indicating better health state perceived by participant. Health State Score: self-rated health on a vertical visual analogue scale measured in centimeters. Best imaginable health state=10 and worst imaginable health state=0.|units on a scale|Mean|3.86|3.86|Standard Deviation|1.704|1.704|||
4173767|NCT00810069|3995386|B1|Health State Score||Euro Quality of Life-5 Dimensions Questionnaire (EQ-5D) Score|EQ-5D: a generic, multidimensional, health-related, quality of life instrument. Participants rate health state in 5 domains: mobility, self-care, usual activities, pain/discomfort, mood. A single score between 1-3 is generated for each domain. Outcome rating on 5 domains is mapped to a single index through an algorithm. Index ranges between 0-1 with higher score indicating better health state perceived by participant. Health State Score: self-rated health on a vertical visual analogue scale measured in centimeters. Best imaginable health state=10 and worst imaginable health state=0.|units on a scale|Mean|4.23|4.23|Standard Deviation|1.873|1.873|||
4173768|NCT00810069|3995384|B3|EQ-5D UK Population-based Index Score||Euro Quality of Life-5 Dimensions Questionnaire (EQ-5D) Score|EQ-5D: a generic, multidimensional, health-related, quality of life instrument. Participants rate health state in 5 domains: mobility, self-care, usual activities, pain/discomfort, mood. A single score between 1-3 is generated for each domain. Outcome rating on 5 domains is mapped to a single index through an algorithm. Index ranges between 0-1 with higher score indicating better health state perceived by participant. Health State Score: self-rated health on a vertical visual analogue scale measured in centimeters. Best imaginable health state=10 and worst imaginable health state=0.|units on a scale|Mean|0.37|0.37|Standard Deviation|0.303|0.303|||
4173769|NCT00810069|3995385|B2|EQ-5D UK Population-based Index Score||Euro Quality of Life-5 Dimensions Questionnaire (EQ-5D) Score|EQ-5D: a generic, multidimensional, health-related, quality of life instrument. Participants rate health state in 5 domains: mobility, self-care, usual activities, pain/discomfort, mood. A single score between 1-3 is generated for each domain. Outcome rating on 5 domains is mapped to a single index through an algorithm. Index ranges between 0-1 with higher score indicating better health state perceived by participant. Health State Score: self-rated health on a vertical visual analogue scale measured in centimeters. Best imaginable health state=10 and worst imaginable health state=0.|units on a scale|Mean|0.34|0.34|Standard Deviation|0.312|0.312|||
4173770|NCT00810069|3995386|B1|EQ-5D UK Population-based Index Score||Euro Quality of Life-5 Dimensions Questionnaire (EQ-5D) Score|EQ-5D: a generic, multidimensional, health-related, quality of life instrument. Participants rate health state in 5 domains: mobility, self-care, usual activities, pain/discomfort, mood. A single score between 1-3 is generated for each domain. Outcome rating on 5 domains is mapped to a single index through an algorithm. Index ranges between 0-1 with higher score indicating better health state perceived by participant. Health State Score: self-rated health on a vertical visual analogue scale measured in centimeters. Best imaginable health state=10 and worst imaginable health state=0.|units on a scale|Mean|0.40|0.4|Standard Deviation|0.291|0.291|||
4173771|NCT00810069|3995384|B3|||Sheehan Disability Scale (SDS) Total Score|The SDS is completed by the participant and is used to assess the effect of the participant's symptoms on their work/social/family life. Total scores range from 0 to 30 with higher values indicating greater disruption in the participant's work/social/family life.|units on a scale|Mean|19.9|19.9|Standard Deviation|5.32|5.32|||
4173772|NCT00810069|3995385|B2|||Sheehan Disability Scale (SDS) Total Score|The SDS is completed by the participant and is used to assess the effect of the participant's symptoms on their work/social/family life. Total scores range from 0 to 30 with higher values indicating greater disruption in the participant's work/social/family life.|units on a scale|Mean|19.9|19.9|Standard Deviation|5.52|5.52|||
4173773|NCT00810069|3995386|B1|||Sheehan Disability Scale (SDS) Total Score|The SDS is completed by the participant and is used to assess the effect of the participant's symptoms on their work/social/family life. Total scores range from 0 to 30 with higher values indicating greater disruption in the participant's work/social/family life.|units on a scale|Mean|19.9|19.9|Standard Deviation|5.12|5.12|||
4173774|NCT00810069|3995384|B3|||Visual Analog Scale (VAS) Overall Pain Severity|VAS for pain consists of 6 questions that assess overall pain, headache, back pain, shoulder pain, pain interference with daily activities, and pain while awake. Participant rates pain on a 10 centimeter (cm) line between two anchors (0= no pain and 10=very severe pain).|units on a scale|Mean|3.7|3.7|Standard Deviation|2.78|2.78|||
4173775|NCT00810069|3995385|B2|||Visual Analog Scale (VAS) Overall Pain Severity|VAS for pain consists of 6 questions that assess overall pain, headache, back pain, shoulder pain, pain interference with daily activities, and pain while awake. Participant rates pain on a 10 centimeter (cm) line between two anchors (0= no pain and 10=very severe pain).|units on a scale|Mean|3.8|3.8|Standard Deviation|2.81|2.81|||
4173776|NCT00810069|3995386|B1|||Visual Analog Scale (VAS) Overall Pain Severity|VAS for pain consists of 6 questions that assess overall pain, headache, back pain, shoulder pain, pain interference with daily activities, and pain while awake. Participant rates pain on a 10 centimeter (cm) line between two anchors (0= no pain and 10=very severe pain).|units on a scale|Mean|3.6|3.6|Standard Deviation|2.76|2.76|||
4173777|NCT00810069|3995384|B3|||17-item Hamilton Depression Rating Scale (HAMD-17) Total Score|The 17-item HAMD measures depression severity. Each item was evaluated and scored using either a 5-point scale (e.g. absent, mild, moderate, severe, very severe) or a 3-point scale (e.g. absent, mild, marked). The total score of HAMD-17 may range from 0 (normal) to 52 (severe).|units on a scale|Mean|24.2|24.2|Standard Deviation|3.70|3.7|||
4173778|NCT00810069|3995385|B2|||17-item Hamilton Depression Rating Scale (HAMD-17) Total Score|The 17-item HAMD measures depression severity. Each item was evaluated and scored using either a 5-point scale (e.g. absent, mild, moderate, severe, very severe) or a 3-point scale (e.g. absent, mild, marked). The total score of HAMD-17 may range from 0 (normal) to 52 (severe).|units on a scale|Mean|24.4|24.4|Standard Deviation|3.83|3.83|||
4173779|NCT00810069|3995386|B1|||17-item Hamilton Depression Rating Scale (HAMD-17) Total Score|The 17-item HAMD measures depression severity. Each item was evaluated and scored using either a 5-point scale (e.g. absent, mild, moderate, severe, very severe) or a 3-point scale (e.g. absent, mild, marked). The total score of HAMD-17 may range from 0 (normal) to 52 (severe).|units on a scale|Mean|24.0|24.0|Standard Deviation|3.57|3.57|||
4173780|NCT00810069|3995384|B3|||Quick Inventory of Depressive Symptomatology-Self Reported (QIDS16SR) Total Score|A 16-item participant-rated measure of depressive symptomatology. The total score ranges from 0 to 27 with higher scores indicative of greater severity.|units on a scale|Mean|16.5|16.5|Standard Deviation|3.63|3.63|||
4173781|NCT00810069|3995385|B2|||Quick Inventory of Depressive Symptomatology-Self Reported (QIDS16SR) Total Score|A 16-item participant-rated measure of depressive symptomatology. The total score ranges from 0 to 27 with higher scores indicative of greater severity.|units on a scale|Mean|16.7|16.7|Standard Deviation|3.43|3.43|||
4173782|NCT00810069|3995386|B1|||Quick Inventory of Depressive Symptomatology-Self Reported (QIDS16SR) Total Score|A 16-item participant-rated measure of depressive symptomatology. The total score ranges from 0 to 27 with higher scores indicative of greater severity.|units on a scale|Mean|16.4|16.4|Standard Deviation|3.82|3.82|||
4173783|NCT00810069|3995384|B3|||Clinical Global Impression-Major Depressive Disorder-Severity (CGI-MDD-S) Score|Measures severity of illness at the time of assessment compared with start of treatment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill participants.|units on a scale|Mean|4.6|4.6|Standard Deviation|0.62|0.62|||
4173784|NCT00810069|3995385|B2|||Clinical Global Impression-Major Depressive Disorder-Severity (CGI-MDD-S) Score|Measures severity of illness at the time of assessment compared with start of treatment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill participants.|units on a scale|Mean|4.6|4.6|Standard Deviation|0.64|0.64|||
4173785|NCT00810069|3995386|B1|||Clinical Global Impression-Major Depressive Disorder-Severity (CGI-MDD-S) Score|Measures severity of illness at the time of assessment compared with start of treatment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill participants.|units on a scale|Mean|4.6|4.6|Standard Deviation|0.59|0.59|||
4173786|NCT00810069|3995384|B3|White||Race||participants|Number|562|562.0||||||
4173787|NCT00810069|3995385|B2|White||Race||participants|Number|282|282.0||||||
4173788|NCT00810069|3995386|B1|White||Race||participants|Number|280|280.0||||||
4173789|NCT00810069|3995384|B3|Black or African American||Race||participants|Number|4|4.0||||||
4173790|NCT00810069|3995385|B2|Black or African American||Race||participants|Number|2|2.0||||||
4173791|NCT00810069|3995386|B1|Black or African American||Race||participants|Number|2|2.0||||||
4173792|NCT00810069|3995384|B3|Sweden||Region of Enrollment||participants|Number|142|142.0||||||
4173793|NCT00810069|3995385|B2|Sweden||Region of Enrollment||participants|Number|71|71.0||||||
4173794|NCT00810069|3995386|B1|Sweden||Region of Enrollment||participants|Number|71|71.0||||||
4173795|NCT00810069|3995384|B3|Italy||Region of Enrollment||participants|Number|39|39.0||||||
4173796|NCT00810069|3995385|B2|Italy||Region of Enrollment||participants|Number|20|20.0||||||
4173797|NCT00810069|3995386|B1|Italy||Region of Enrollment||participants|Number|19|19.0||||||
4173798|NCT00810069|3995384|B3|Netherlands||Region of Enrollment||participants|Number|9|9.0||||||
4173799|NCT00810069|3995385|B2|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
4173800|NCT00810069|3995386|B1|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
4173801|NCT00810069|3995384|B3|Denmark||Region of Enrollment||participants|Number|26|26.0||||||
4173802|NCT00810069|3995385|B2|Denmark||Region of Enrollment||participants|Number|14|14.0||||||
4173803|NCT00810069|3995386|B1|Denmark||Region of Enrollment||participants|Number|12|12.0||||||
4173804|NCT00810069|3995384|B3|Romania||Region of Enrollment||participants|Number|36|36.0||||||
4173805|NCT00810069|3995385|B2|Romania||Region of Enrollment||participants|Number|18|18.0||||||
4173806|NCT00810069|3995386|B1|Romania||Region of Enrollment||participants|Number|18|18.0||||||
4173807|NCT00810069|3995384|B3|Turkey||Region of Enrollment||participants|Number|20|20.0||||||
4173808|NCT00810069|3995385|B2|Turkey||Region of Enrollment||participants|Number|10|10.0||||||
4173809|NCT00810069|3995386|B1|Turkey||Region of Enrollment||participants|Number|10|10.0||||||
4173810|NCT00810069|3995384|B3|Spain||Region of Enrollment||participants|Number|144|144.0||||||
4173811|NCT00810069|3995385|B2|Spain||Region of Enrollment||participants|Number|73|73.0||||||
4173812|NCT00810069|3995386|B1|Spain||Region of Enrollment||participants|Number|71|71.0||||||
4173813|NCT00810069|3995384|B3|Greece||Region of Enrollment||participants|Number|20|20.0||||||
4173814|NCT00810069|3995385|B2|Greece||Region of Enrollment||participants|Number|10|10.0||||||
4173815|NCT00810069|3995386|B1|Greece||Region of Enrollment||participants|Number|10|10.0||||||
4173816|NCT00810069|3995384|B3|Slovenia||Region of Enrollment||participants|Number|10|10.0||||||
4173817|NCT00810069|3995385|B2|Slovenia||Region of Enrollment||participants|Number|4|4.0||||||
4173818|NCT00810069|3995386|B1|Slovenia||Region of Enrollment||participants|Number|6|6.0||||||
4173819|NCT00810069|3995384|B3|Hungary||Region of Enrollment||participants|Number|12|12.0||||||
4173820|NCT00810069|3995385|B2|Hungary||Region of Enrollment||participants|Number|6|6.0||||||
4173821|NCT00810069|3995386|B1|Hungary||Region of Enrollment||participants|Number|6|6.0||||||
4173822|NCT00810069|3995384|B3|France||Region of Enrollment||participants|Number|108|108.0||||||
4173823|NCT00810069|3995385|B2|France||Region of Enrollment||participants|Number|54|54.0||||||
4173824|NCT00810069|3995386|B1|France||Region of Enrollment||participants|Number|54|54.0||||||
4173825|NCT00810069|3995384|B3||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4173826|NCT00810069|3995385|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4173827|NCT00810069|3995386|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4173828|NCT00810069|3995384|B3||Female|Sex: Female, Male||Participants|Count of Participants|393|393.0||||||
4173829|NCT00810069|3995385|B2||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4173830|NCT00810069|3995386|B1||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4173831|NCT00810069|3995384|B3|||Age||years|Mean|47.9|47.9|Standard Deviation|13.10|13.1|||
4173832|NCT00810069|3995385|B2|||Age||years|Mean|47.4|47.4|Standard Deviation|12.72|12.72|||
4173833|NCT00810069|3995386|B1|||Age||years|Mean|48.3|48.3|Standard Deviation|13.48|13.48|||
4173834|NCT00810043|3995431|B3|Former Smoker||Smoking history||Participants|Number|28|28.0||||||
4173835|NCT00810043|3995432|B2|Former Smoker||Smoking history||Participants|Number|14|14.0||||||
4173836|NCT00810043|3995433|B1|Former Smoker||Smoking history||Participants|Number|14|14.0||||||
4173837|NCT00810043|3995431|B3|Current Smoker||Smoking history||Participants|Number|12|12.0||||||
4173838|NCT00810043|3995432|B2|Current Smoker||Smoking history||Participants|Number|5|5.0||||||
4173839|NCT00810043|3995433|B1|Current Smoker||Smoking history||Participants|Number|7|7.0||||||
4173840|NCT00810043|3995431|B3|Never Smoked||Smoking history||Participants|Number|72|72.0||||||
4173841|NCT00810043|3995432|B2|Never Smoked||Smoking history||Participants|Number|36|36.0||||||
4173842|NCT00810043|3995433|B1|Never Smoked||Smoking history||Participants|Number|36|36.0||||||
4173843|NCT00810043|3995431|B3|Germany||Region of Enrollment||participants|Number|47|47.0||||||
4173844|NCT00810043|3995432|B2|Germany||Region of Enrollment||participants|Number|21|21.0||||||
4173845|NCT00810043|3995433|B1|Germany||Region of Enrollment||participants|Number|26|26.0||||||
4173846|NCT00810043|3995431|B3|Belgium||Region of Enrollment||participants|Number|34|34.0||||||
4173847|NCT00810043|3995432|B2|Belgium||Region of Enrollment||participants|Number|16|16.0||||||
4173848|NCT00810043|3995433|B1|Belgium||Region of Enrollment||participants|Number|18|18.0||||||
4173849|NCT00810043|3995431|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4173850|NCT00810043|3995432|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4173851|NCT00810043|3995433|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4173852|NCT00810043|3995431|B3|Middle Eastern||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4173853|NCT00810043|3995432|B2|Middle Eastern||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4173854|NCT00810043|3995433|B1|Middle Eastern||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4173855|NCT00810043|3995431|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4173856|NCT00810043|3995432|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4173857|NCT00810043|3995433|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4173858|NCT00810043|3995431|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|110|110.0||||||
4173859|NCT00810043|3995432|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
4173860|NCT00810043|3995433|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
4173861|NCT00810043|3995431|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4173862|NCT00810043|3995432|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4173863|NCT00810043|3995433|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4173864|NCT00810043|3995431|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4173865|NCT00810043|3995432|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4173866|NCT00810043|3995433|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4173867|NCT00810043|3995431|B3|||Age||years|Mean|74.8|74.8|Standard Deviation|8.9|8.9|||
4173868|NCT00810043|3995432|B2|||Age||years|Mean|76.0|76.0|Standard Deviation|9.4|9.4|||
4173869|NCT00810043|3995433|B1|||Age||years|Mean|73.6|73.6|Standard Deviation|8.4|8.4|||
4173870|NCT00809965|3995454|B4|United States||Region of Enrollment||participants|Number|678|678.0||||||
4173871|NCT00809965|3995455|B3|United States||Region of Enrollment||participants|Number|224|224.0||||||
4173872|NCT00809965|3995456|B2|United States||Region of Enrollment||participants|Number|211|211.0||||||
4173873|NCT00809965|3995457|B1|United States||Region of Enrollment||participants|Number|243|243.0||||||
4173874|NCT00809965|3995454|B4|United Kingdom||Region of Enrollment||participants|Number|245|245.0||||||
4173875|NCT00809965|3995455|B3|United Kingdom||Region of Enrollment||participants|Number|75|75.0||||||
4173876|NCT00809965|3995456|B2|United Kingdom||Region of Enrollment||participants|Number|91|91.0||||||
4173877|NCT00809965|3995457|B1|United Kingdom||Region of Enrollment||participants|Number|79|79.0||||||
4173878|NCT00809965|3995454|B4|Ukraine||Region of Enrollment||participants|Number|628|628.0||||||
4173879|NCT00809965|3995455|B3|Ukraine||Region of Enrollment||participants|Number|213|213.0||||||
4173880|NCT00809965|3995456|B2|Ukraine||Region of Enrollment||participants|Number|210|210.0||||||
4173881|NCT00809965|3995457|B1|Ukraine||Region of Enrollment||participants|Number|205|205.0||||||
4173882|NCT00809965|3995454|B4|Turkey||Region of Enrollment||participants|Number|117|117.0||||||
4173883|NCT00809965|3995455|B3|Turkey||Region of Enrollment||participants|Number|41|41.0||||||
4173884|NCT00809965|3995456|B2|Turkey||Region of Enrollment||participants|Number|39|39.0||||||
4173885|NCT00809965|3995457|B1|Turkey||Region of Enrollment||participants|Number|37|37.0||||||
4173886|NCT00809965|3995454|B4|Tunisia||Region of Enrollment||participants|Number|174|174.0||||||
4173887|NCT00809965|3995455|B3|Tunisia||Region of Enrollment||participants|Number|52|52.0||||||
4173888|NCT00809965|3995456|B2|Tunisia||Region of Enrollment||participants|Number|62|62.0||||||
4173889|NCT00809965|3995457|B1|Tunisia||Region of Enrollment||participants|Number|60|60.0||||||
4173890|NCT00809965|3995454|B4|Thailand||Region of Enrollment||participants|Number|140|140.0||||||
4173891|NCT00809965|3995455|B3|Thailand||Region of Enrollment||participants|Number|38|38.0||||||
4173892|NCT00809965|3995456|B2|Thailand||Region of Enrollment||participants|Number|50|50.0||||||
4173893|NCT00809965|3995457|B1|Thailand||Region of Enrollment||participants|Number|52|52.0||||||
4173894|NCT00809965|3995454|B4|Sweden||Region of Enrollment||participants|Number|143|143.0||||||
4173895|NCT00809965|3995455|B3|Sweden||Region of Enrollment||participants|Number|44|44.0||||||
4173896|NCT00809965|3995456|B2|Sweden||Region of Enrollment||participants|Number|41|41.0||||||
4173897|NCT00809965|3995457|B1|Sweden||Region of Enrollment||participants|Number|58|58.0||||||
4173898|NCT00809965|3995454|B4|Spain||Region of Enrollment||participants|Number|220|220.0||||||
4173899|NCT00809965|3995455|B3|Spain||Region of Enrollment||participants|Number|76|76.0||||||
4173900|NCT00809965|3995456|B2|Spain||Region of Enrollment||participants|Number|73|73.0||||||
4173901|NCT00809965|3995457|B1|Spain||Region of Enrollment||participants|Number|71|71.0||||||
4173902|NCT00809965|3995454|B4|South Korea||Region of Enrollment||participants|Number|146|146.0||||||
4173903|NCT00809965|3995455|B3|South Korea||Region of Enrollment||participants|Number|49|49.0||||||
4173904|NCT00809965|3995456|B2|South Korea||Region of Enrollment||participants|Number|40|40.0||||||
4173905|NCT00809965|3995457|B1|South Korea||Region of Enrollment||participants|Number|57|57.0||||||
4173906|NCT00809965|3995454|B4|Slovakia||Region of Enrollment||participants|Number|178|178.0||||||
4173907|NCT00809965|3995455|B3|Slovakia||Region of Enrollment||participants|Number|53|53.0||||||
4173908|NCT00809965|3995456|B2|Slovakia||Region of Enrollment||participants|Number|58|58.0||||||
4173909|NCT00809965|3995457|B1|Slovakia||Region of Enrollment||participants|Number|67|67.0||||||
4173910|NCT00809965|3995454|B4|Serbia||Region of Enrollment||participants|Number|117|117.0||||||
4173911|NCT00809965|3995455|B3|Serbia||Region of Enrollment||participants|Number|29|29.0||||||
4173912|NCT00809965|3995456|B2|Serbia||Region of Enrollment||participants|Number|45|45.0||||||
4173913|NCT00809965|3995457|B1|Serbia||Region of Enrollment||participants|Number|43|43.0||||||
4173914|NCT00809965|3995454|B4|Russian Federation||Region of Enrollment||participants|Number|1751|1751.0||||||
4173915|NCT00809965|3995455|B3|Russian Federation||Region of Enrollment||participants|Number|569|569.0||||||
4173916|NCT00809965|3995456|B2|Russian Federation||Region of Enrollment||participants|Number|596|596.0||||||
4173917|NCT00809965|3995457|B1|Russian Federation||Region of Enrollment||participants|Number|586|586.0||||||
4173918|NCT00809965|3995454|B4|Romania||Region of Enrollment||participants|Number|304|304.0||||||
4173919|NCT00809965|3995455|B3|Romania||Region of Enrollment||participants|Number|107|107.0||||||
4173920|NCT00809965|3995456|B2|Romania||Region of Enrollment||participants|Number|94|94.0||||||
4173921|NCT00809965|3995457|B1|Romania||Region of Enrollment||participants|Number|103|103.0||||||
4173922|NCT00809965|3995454|B4|Portugal||Region of Enrollment||participants|Number|115|115.0||||||
4173923|NCT00809965|3995455|B3|Portugal||Region of Enrollment||participants|Number|43|43.0||||||
4173924|NCT00809965|3995456|B2|Portugal||Region of Enrollment||participants|Number|36|36.0||||||
4173925|NCT00809965|3995457|B1|Portugal||Region of Enrollment||participants|Number|36|36.0||||||
4173926|NCT00809965|3995454|B4|Poland||Region of Enrollment||participants|Number|1049|1049.0||||||
4173927|NCT00809965|3995455|B3|Poland||Region of Enrollment||participants|Number|356|356.0||||||
4173928|NCT00809965|3995456|B2|Poland||Region of Enrollment||participants|Number|361|361.0||||||
4173929|NCT00809965|3995457|B1|Poland||Region of Enrollment||participants|Number|332|332.0||||||
4173930|NCT00809965|3995454|B4|Philippines||Region of Enrollment||participants|Number|38|38.0||||||
4173931|NCT00809965|3995455|B3|Philippines||Region of Enrollment||participants|Number|8|8.0||||||
4173932|NCT00809965|3995456|B2|Philippines||Region of Enrollment||participants|Number|11|11.0||||||
4173933|NCT00809965|3995457|B1|Philippines||Region of Enrollment||participants|Number|19|19.0||||||
4173934|NCT00809965|3995454|B4|New Zealand||Region of Enrollment||participants|Number|97|97.0||||||
4173935|NCT00809965|3995455|B3|New Zealand||Region of Enrollment||participants|Number|38|38.0||||||
4173936|NCT00809965|3995456|B2|New Zealand||Region of Enrollment||participants|Number|31|31.0||||||
4173937|NCT00809965|3995457|B1|New Zealand||Region of Enrollment||participants|Number|28|28.0||||||
4173938|NCT00809965|3995454|B4|Netherlands||Region of Enrollment||participants|Number|368|368.0||||||
4173939|NCT00809965|3995455|B3|Netherlands||Region of Enrollment||participants|Number|124|124.0||||||
4173940|NCT00809965|3995456|B2|Netherlands||Region of Enrollment||participants|Number|113|113.0||||||
4173941|NCT00809965|3995457|B1|Netherlands||Region of Enrollment||participants|Number|131|131.0||||||
4173942|NCT00809965|3995454|B4|Morocco||Region of Enrollment||participants|Number|56|56.0||||||
4173943|NCT00809965|3995455|B3|Morocco||Region of Enrollment||participants|Number|22|22.0||||||
4173944|NCT00809965|3995456|B2|Morocco||Region of Enrollment||participants|Number|22|22.0||||||
4173945|NCT00809965|3995457|B1|Morocco||Region of Enrollment||participants|Number|12|12.0||||||
4173946|NCT00809965|3995454|B4|Mexico||Region of Enrollment||participants|Number|253|253.0||||||
4173947|NCT00809965|3995455|B3|Mexico||Region of Enrollment||participants|Number|86|86.0||||||
4173948|NCT00809965|3995456|B2|Mexico||Region of Enrollment||participants|Number|96|96.0||||||
4173949|NCT00809965|3995457|B1|Mexico||Region of Enrollment||participants|Number|71|71.0||||||
4173950|NCT00809965|3995454|B4|Malaysia||Region of Enrollment||participants|Number|95|95.0||||||
4173951|NCT00809965|3995455|B3|Malaysia||Region of Enrollment||participants|Number|26|26.0||||||
4173952|NCT00809965|3995456|B2|Malaysia||Region of Enrollment||participants|Number|33|33.0||||||
4173953|NCT00809965|3995457|B1|Malaysia||Region of Enrollment||participants|Number|36|36.0||||||
4173954|NCT00809965|3995454|B4|Lithuania||Region of Enrollment||participants|Number|176|176.0||||||
4173955|NCT00809965|3995455|B3|Lithuania||Region of Enrollment||participants|Number|66|66.0||||||
4173956|NCT00809965|3995456|B2|Lithuania||Region of Enrollment||participants|Number|51|51.0||||||
4173957|NCT00809965|3995457|B1|Lithuania||Region of Enrollment||participants|Number|59|59.0||||||
4173958|NCT00809965|3995454|B4|Latvia||Region of Enrollment||participants|Number|100|100.0||||||
4173959|NCT00809965|3995455|B3|Latvia||Region of Enrollment||participants|Number|40|40.0||||||
4173960|NCT00809965|3995456|B2|Latvia||Region of Enrollment||participants|Number|33|33.0||||||
4173961|NCT00809965|3995457|B1|Latvia||Region of Enrollment||participants|Number|27|27.0||||||
4173962|NCT00809965|3995454|B4|Japan||Region of Enrollment||participants|Number|397|397.0||||||
4173963|NCT00809965|3995455|B3|Japan||Region of Enrollment||participants|Number|131|131.0||||||
4173964|NCT00809965|3995456|B2|Japan||Region of Enrollment||participants|Number|135|135.0||||||
4173965|NCT00809965|3995457|B1|Japan||Region of Enrollment||participants|Number|131|131.0||||||
4173966|NCT00809965|3995454|B4|Italy||Region of Enrollment||participants|Number|232|232.0||||||
4173967|NCT00809965|3995455|B3|Italy||Region of Enrollment||participants|Number|77|77.0||||||
4173968|NCT00809965|3995456|B2|Italy||Region of Enrollment||participants|Number|77|77.0||||||
4173969|NCT00809965|3995457|B1|Italy||Region of Enrollment||participants|Number|78|78.0||||||
4173970|NCT00809965|3995454|B4|Israel||Region of Enrollment||participants|Number|337|337.0||||||
4173971|NCT00809965|3995455|B3|Israel||Region of Enrollment||participants|Number|101|101.0||||||
4173972|NCT00809965|3995456|B2|Israel||Region of Enrollment||participants|Number|122|122.0||||||
4173973|NCT00809965|3995457|B1|Israel||Region of Enrollment||participants|Number|114|114.0||||||
4173974|NCT00809965|3995454|B4|India||Region of Enrollment||participants|Number|1459|1459.0||||||
4173975|NCT00809965|3995455|B3|India||Region of Enrollment||participants|Number|473|473.0||||||
4173976|NCT00809965|3995456|B2|India||Region of Enrollment||participants|Number|507|507.0||||||
4173977|NCT00809965|3995457|B1|India||Region of Enrollment||participants|Number|479|479.0||||||
4173978|NCT00809965|3995454|B4|Hungary||Region of Enrollment||participants|Number|411|411.0||||||
4173979|NCT00809965|3995455|B3|Hungary||Region of Enrollment||participants|Number|122|122.0||||||
4173980|NCT00809965|3995456|B2|Hungary||Region of Enrollment||participants|Number|142|142.0||||||
4173981|NCT00809965|3995457|B1|Hungary||Region of Enrollment||participants|Number|147|147.0||||||
4173982|NCT00809965|3995454|B4|Greece||Region of Enrollment||participants|Number|67|67.0||||||
4173983|NCT00809965|3995455|B3|Greece||Region of Enrollment||participants|Number|27|27.0||||||
4173984|NCT00809965|3995456|B2|Greece||Region of Enrollment||participants|Number|21|21.0||||||
4173985|NCT00809965|3995457|B1|Greece||Region of Enrollment||participants|Number|19|19.0||||||
4173986|NCT00809965|3995454|B4|Germany||Region of Enrollment||participants|Number|319|319.0||||||
4173987|NCT00809965|3995455|B3|Germany||Region of Enrollment||participants|Number|122|122.0||||||
4173988|NCT00809965|3995456|B2|Germany||Region of Enrollment||participants|Number|96|96.0||||||
4173989|NCT00809965|3995457|B1|Germany||Region of Enrollment||participants|Number|101|101.0||||||
4173990|NCT00809965|3995454|B4|France||Region of Enrollment||participants|Number|207|207.0||||||
4173991|NCT00809965|3995455|B3|France||Region of Enrollment||participants|Number|72|72.0||||||
4173992|NCT00809965|3995456|B2|France||Region of Enrollment||participants|Number|67|67.0||||||
4173993|NCT00809965|3995457|B1|France||Region of Enrollment||participants|Number|68|68.0||||||
4173994|NCT00809965|3995454|B4|Egypt||Region of Enrollment||participants|Number|156|156.0||||||
4173995|NCT00809965|3995455|B3|Egypt||Region of Enrollment||participants|Number|46|46.0||||||
4173996|NCT00809965|3995456|B2|Egypt||Region of Enrollment||participants|Number|47|47.0||||||
4173997|NCT00809965|3995457|B1|Egypt||Region of Enrollment||participants|Number|63|63.0||||||
4173998|NCT00809965|3995454|B4|Denmark||Region of Enrollment||participants|Number|97|97.0||||||
4173999|NCT00809965|3995455|B3|Denmark||Region of Enrollment||participants|Number|41|41.0||||||
4174000|NCT00809965|3995456|B2|Denmark||Region of Enrollment||participants|Number|21|21.0||||||
4174001|NCT00809965|3995457|B1|Denmark||Region of Enrollment||participants|Number|35|35.0||||||
4174002|NCT00809965|3995454|B4|Czech Republic||Region of Enrollment||participants|Number|482|482.0||||||
4174003|NCT00809965|3995455|B3|Czech Republic||Region of Enrollment||participants|Number|170|170.0||||||
4174004|NCT00809965|3995456|B2|Czech Republic||Region of Enrollment||participants|Number|158|158.0||||||
4174005|NCT00809965|3995457|B1|Czech Republic||Region of Enrollment||participants|Number|154|154.0||||||
4174006|NCT00809965|3995454|B4|Croatia||Region of Enrollment||participants|Number|62|62.0||||||
4174007|NCT00809965|3995455|B3|Croatia||Region of Enrollment||participants|Number|22|22.0||||||
4174008|NCT00809965|3995456|B2|Croatia||Region of Enrollment||participants|Number|19|19.0||||||
4174009|NCT00809965|3995457|B1|Croatia||Region of Enrollment||participants|Number|21|21.0||||||
4174010|NCT00809965|3995454|B4|Colombia||Region of Enrollment||participants|Number|268|268.0||||||
4174011|NCT00809965|3995455|B3|Colombia||Region of Enrollment||participants|Number|87|87.0||||||
4174012|NCT00809965|3995456|B2|Colombia||Region of Enrollment||participants|Number|84|84.0||||||
4174013|NCT00809965|3995457|B1|Colombia||Region of Enrollment||participants|Number|97|97.0||||||
4174014|NCT00809965|3995454|B4|China||Region of Enrollment||participants|Number|882|882.0||||||
4174015|NCT00809965|3995455|B3|China||Region of Enrollment||participants|Number|302|302.0||||||
4174016|NCT00809965|3995456|B2|China||Region of Enrollment||participants|Number|299|299.0||||||
4174017|NCT00809965|3995457|B1|China||Region of Enrollment||participants|Number|281|281.0||||||
4174018|NCT00809965|3995454|B4|Chile||Region of Enrollment||participants|Number|210|210.0||||||
4174019|NCT00809965|3995455|B3|Chile||Region of Enrollment||participants|Number|78|78.0||||||
4174020|NCT00809965|3995456|B2|Chile||Region of Enrollment||participants|Number|65|65.0||||||
4174021|NCT00809965|3995457|B1|Chile||Region of Enrollment||participants|Number|67|67.0||||||
4174022|NCT00809965|3995454|B4|Canada||Region of Enrollment||participants|Number|188|188.0||||||
4174023|NCT00809965|3995455|B3|Canada||Region of Enrollment||participants|Number|63|63.0||||||
4174024|NCT00809965|3995456|B2|Canada||Region of Enrollment||participants|Number|58|58.0||||||
4174025|NCT00809965|3995457|B1|Canada||Region of Enrollment||participants|Number|67|67.0||||||
4174026|NCT00809965|3995454|B4|Bulgaria||Region of Enrollment||participants|Number|790|790.0||||||
4174027|NCT00809965|3995455|B3|Bulgaria||Region of Enrollment||participants|Number|268|268.0||||||
4174028|NCT00809965|3995456|B2|Bulgaria||Region of Enrollment||participants|Number|264|264.0||||||
4174029|NCT00809965|3995457|B1|Bulgaria||Region of Enrollment||participants|Number|258|258.0||||||
4174030|NCT00809965|3995454|B4|Brazil||Region of Enrollment||participants|Number|523|523.0||||||
4174031|NCT00809965|3995455|B3|Brazil||Region of Enrollment||participants|Number|168|168.0||||||
4174032|NCT00809965|3995456|B2|Brazil||Region of Enrollment||participants|Number|171|171.0||||||
4174033|NCT00809965|3995457|B1|Brazil||Region of Enrollment||participants|Number|184|184.0||||||
4174034|NCT00809965|3995454|B4|Belgium||Region of Enrollment||participants|Number|169|169.0||||||
4174035|NCT00809965|3995455|B3|Belgium||Region of Enrollment||participants|Number|53|53.0||||||
4174036|NCT00809965|3995456|B2|Belgium||Region of Enrollment||participants|Number|57|57.0||||||
4174037|NCT00809965|3995457|B1|Belgium||Region of Enrollment||participants|Number|59|59.0||||||
4174038|NCT00809965|3995454|B4|Australia||Region of Enrollment||participants|Number|504|504.0||||||
4174039|NCT00809965|3995455|B3|Australia||Region of Enrollment||participants|Number|150|150.0||||||
4174040|NCT00809965|3995456|B2|Australia||Region of Enrollment||participants|Number|182|182.0||||||
4174041|NCT00809965|3995457|B1|Australia||Region of Enrollment||participants|Number|172|172.0||||||
4174042|NCT00809965|3995454|B4|Argentina||Region of Enrollment||participants|Number|402|402.0||||||
4174043|NCT00809965|3995455|B3|Argentina||Region of Enrollment||participants|Number|158|158.0||||||
4174044|NCT00809965|3995456|B2|Argentina||Region of Enrollment||participants|Number|126|126.0||||||
4174045|NCT00809965|3995457|B1|Argentina||Region of Enrollment||participants|Number|118|118.0||||||
4174046|NCT00809965|3995454|B4||Male|Sex: Female, Male||Participants|Count of Participants|11471|11471.0||||||
4174047|NCT00809965|3995455|B3||Male|Sex: Female, Male||Participants|Count of Participants|3794|3794.0||||||
4174048|NCT00809965|3995456|B2||Male|Sex: Female, Male||Participants|Count of Participants|3832|3832.0||||||
4174049|NCT00809965|3995457|B1||Male|Sex: Female, Male||Participants|Count of Participants|3845|3845.0||||||
4174050|NCT00809965|3995454|B4||Female|Sex: Female, Male||Participants|Count of Participants|3879|3879.0||||||
4174051|NCT00809965|3995455|B3||Female|Sex: Female, Male||Participants|Count of Participants|1316|1316.0||||||
4174052|NCT00809965|3995456|B2||Female|Sex: Female, Male||Participants|Count of Participants|1283|1283.0||||||
4174053|NCT00809965|3995457|B1||Female|Sex: Female, Male||Participants|Count of Participants|1280|1280.0||||||
4174054|NCT00809965|3995454|B4|||Age||years|Mean|61.7|61.7|Standard Deviation|9.20|9.2|||
4174055|NCT00809965|3995455|B3|||Age||years|Mean|61.9|61.9|Standard Deviation|9.00|9.0|||
4174056|NCT00809965|3995456|B2|||Age||years|Mean|61.8|61.8|Standard Deviation|9.22|9.22|||
4174057|NCT00809965|3995457|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|9.38|9.38|||
4174058|NCT00809965|3995454|B4||>=65 years|Age||Participants|Count of Participants|5581|5581.0||||||
4174059|NCT00809965|3995455|B3||>=65 years|Age||Participants|Count of Participants|1900|1900.0||||||
4174060|NCT00809965|3995456|B2||>=65 years|Age||Participants|Count of Participants|1876|1876.0||||||
4174061|NCT00809965|3995457|B1||>=65 years|Age||Participants|Count of Participants|1805|1805.0||||||
4174062|NCT00809965|3995454|B4||Between 18 and 65 years|Age||Participants|Count of Participants|9769|9769.0||||||
4174063|NCT00809965|3995455|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3210|3210.0||||||
4174064|NCT00809965|3995456|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3239|3239.0||||||
4174065|NCT00809965|3995457|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3320|3320.0||||||
4174066|NCT00809965|3995454|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4174067|NCT00809965|3995455|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4174068|NCT00809965|3995456|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4174069|NCT00809965|3995457|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4174070|NCT00809926|3995479|B3||Male|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
4174071|NCT00809926|3995480|B2||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4174072|NCT00809926|3995481|B1||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4174073|NCT00809926|3995479|B3||Female|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4174074|NCT00809926|3995480|B2||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4174075|NCT00809926|3995481|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4174076|NCT00809926|3995479|B3|||Age||years|Mean|57.1|57.1|Standard Deviation|11.0|11.0|||
4174077|NCT00809926|3995480|B2|||Age||years|Mean|56.7|56.7|Standard Deviation|11.0|11.0|||
4174078|NCT00809926|3995481|B1|||Age||years|Mean|57.5|57.5|Standard Deviation|11.1|11.1|||
4174079|NCT00809848|3995506|B6||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4174080|NCT00809848|3995507|B5||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4174081|NCT00809848|3995508|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4174082|NCT00809848|3995509|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4174083|NCT00809848|3995510|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4174084|NCT00809848|3995511|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4174085|NCT00809848|3995506|B6||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4174086|NCT00809848|3995507|B5||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4174087|NCT00809848|3995508|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4174088|NCT00809848|3995509|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4174089|NCT00809848|3995510|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4174090|NCT00809848|3995511|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4174091|NCT00809848|3995506|B6|>65 years||Age, Customized||Participants|Number|68|68.0||||||
4174092|NCT00809848|3995507|B5|>65 years||Age, Customized||Participants|Number|16|16.0||||||
4174093|NCT00809848|3995508|B4|>65 years||Age, Customized||Participants|Number|12|12.0||||||
4174094|NCT00809848|3995509|B3|>65 years||Age, Customized||Participants|Number|14|14.0||||||
4174095|NCT00809848|3995510|B2|>65 years||Age, Customized||Participants|Number|14|14.0||||||
4174096|NCT00809848|3995511|B1|>65 years||Age, Customized||Participants|Number|12|12.0||||||
4174097|NCT00809848|3995506|B6|Between 45 and 65 years||Age, Customized||Participants|Number|97|97.0||||||
4174098|NCT00809848|3995507|B5|Between 45 and 65 years||Age, Customized||Participants|Number|18|18.0||||||
4174099|NCT00809848|3995508|B4|Between 45 and 65 years||Age, Customized||Participants|Number|18|18.0||||||
4174100|NCT00809848|3995509|B3|Between 45 and 65 years||Age, Customized||Participants|Number|18|18.0||||||
4174101|NCT00809848|3995510|B2|Between 45 and 65 years||Age, Customized||Participants|Number|20|20.0||||||
4174102|NCT00809848|3995511|B1|Between 45 and 65 years||Age, Customized||Participants|Number|23|23.0||||||
4174103|NCT00809848|3995506|B6|<45 years||Age, Customized||Participants|Number|7|7.0||||||
4174104|NCT00809848|3995507|B5|<45 years||Age, Customized||Participants|Number|3|3.0||||||
4174105|NCT00809848|3995508|B4|<45 years||Age, Customized||Participants|Number|1|1.0||||||
4174106|NCT00809848|3995509|B3|<45 years||Age, Customized||Participants|Number|2|2.0||||||
4174107|NCT00809848|3995510|B2|<45 years||Age, Customized||Participants|Number|0|0.0||||||
4174108|NCT00809848|3995511|B1|<45 years||Age, Customized||Participants|Number|1|1.0||||||
4174109|NCT00809835|3995532|B5|Multiracial/Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4174110|NCT00809835|3995533|B4|Multiracial/Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4174111|NCT00809835|3995534|B3|Multiracial/Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4174112|NCT00809835|3995535|B2|Multiracial/Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4174113|NCT00809835|3995536|B1|Multiracial/Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4174114|NCT00809835|3995532|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4174115|NCT00809835|3995533|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4174116|NCT00809835|3995534|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4174117|NCT00809835|3995535|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4174118|NCT00809835|3995536|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4174119|NCT00809835|3995532|B5|African-American||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4174120|NCT00809835|3995533|B4|African-American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4174121|NCT00809835|3995534|B3|African-American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4174122|NCT00809835|3995535|B2|African-American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4174123|NCT00809835|3995536|B1|African-American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4174124|NCT00809835|3995532|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
4174125|NCT00809835|3995533|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4174126|NCT00809835|3995534|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4174127|NCT00809835|3995535|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4174128|NCT00809835|3995536|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4174129|NCT00809835|3995532|B5||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4174130|NCT00809835|3995533|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4174131|NCT00809835|3995534|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4174132|NCT00809835|3995535|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4174133|NCT00809835|3995536|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4174134|NCT00809835|3995532|B5||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4174135|NCT00809835|3995533|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4174136|NCT00809835|3995534|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4174137|NCT00809835|3995535|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4174138|NCT00809835|3995536|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4174139|NCT00809835|3995532|B5|||Age||years|Mean|38.36|38.36|Standard Deviation|9.43|9.43|||
4174140|NCT00809835|3995533|B4|||Age||years|Mean|36.30|36.3|Standard Deviation|9.41|9.41|||
4174141|NCT00809835|3995534|B3|||Age||years|Mean|39.82|39.82|Standard Deviation|8.99|8.99|||
4174142|NCT00809835|3995535|B2|||Age||years|Mean|38.70|38.7|Standard Deviation|10.79|10.79|||
4174143|NCT00809835|3995536|B1|||Age||years|Mean|38.04|38.04|Standard Deviation|8.72|8.72|||
4174144|NCT00809809|3995557|B3|United States||Region of Enrollment||participants|Number|157|157.0||||||
4174145|NCT00809809|3995558|B2|United States||Region of Enrollment||participants|Number|79|79.0||||||
4174146|NCT00809809|3995559|B1|United States||Region of Enrollment||participants|Number|78|78.0||||||
4174147|NCT00809809|3995557|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4174148|NCT00809809|3995558|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4174149|NCT00809809|3995559|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4174150|NCT00809809|3995557|B3||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4174151|NCT00809809|3995558|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4174152|NCT00809809|3995559|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4174153|NCT00809809|3995557|B3|||Age||years|Mean|43.1|43.1|Standard Deviation|12.0|12.0|||
4174154|NCT00809809|3995558|B2|||Age||years|Mean|43.8|43.8|Standard Deviation|12.5|12.5|||
4174155|NCT00809809|3995559|B1|||Age||years|Mean|42.6|42.6|Standard Deviation|11.8|11.8|||
4174156|NCT00809809|3995557|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4174157|NCT00809809|3995558|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4174158|NCT00809809|3995559|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4174159|NCT00809809|3995557|B3||Between 18 and 65 years|Age||Participants|Count of Participants|157|157.0||||||
4174160|NCT00809809|3995558|B2||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
4174161|NCT00809809|3995559|B1||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
4174162|NCT00809809|3995557|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4174163|NCT00809809|3995558|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4174164|NCT00809809|3995559|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4174165|NCT00809757|3995566|B4|United States||Region of Enrollment||participants|Number|196|196.0||||||
4174166|NCT00809757|3995567|B3|United States||Region of Enrollment||participants|Number|63|63.0||||||
4174167|NCT00809757|3995568|B2|United States||Region of Enrollment||participants|Number|65|65.0||||||
4174168|NCT00809757|3995569|B1|United States||Region of Enrollment||participants|Number|68|68.0||||||
4174169|NCT00809757|3995566|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174170|NCT00809757|3995567|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174171|NCT00809757|3995568|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174172|NCT00809757|3995569|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174173|NCT00809757|3995566|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4174174|NCT00809757|3995567|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4174175|NCT00809757|3995568|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4174176|NCT00809757|3995569|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4174177|NCT00809757|3995566|B4||White|Race (NIH/OMB)||Participants|Count of Participants|121|121.0||||||
4174178|NCT00809757|3995567|B3||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4174179|NCT00809757|3995568|B2||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4174180|NCT00809757|3995569|B1||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4174181|NCT00809757|3995566|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4174182|NCT00809757|3995567|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4174183|NCT00809757|3995568|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4174184|NCT00809757|3995569|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4174185|NCT00809757|3995566|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174186|NCT00809757|3995567|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174187|NCT00809757|3995568|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174188|NCT00809757|3995569|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174189|NCT00809757|3995566|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4174190|NCT00809757|3995567|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4174191|NCT00809757|3995568|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174192|NCT00809757|3995569|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174193|NCT00809757|3995566|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4174194|NCT00809757|3995567|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174195|NCT00809757|3995568|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4174196|NCT00809757|3995569|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174197|NCT00809757|3995566|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174198|NCT00809757|3995567|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174199|NCT00809757|3995568|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174200|NCT00809757|3995569|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174201|NCT00809757|3995566|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
4174202|NCT00809757|3995567|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4174203|NCT00809757|3995568|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4174204|NCT00809757|3995569|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4174205|NCT00809757|3995566|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4174206|NCT00809757|3995567|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4174207|NCT00809757|3995568|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4174208|NCT00809757|3995569|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4174209|NCT00809757|3995566|B4||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4174210|NCT00809757|3995567|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4174211|NCT00809757|3995568|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4174212|NCT00809757|3995569|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4174213|NCT00809757|3995566|B4||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4174214|NCT00809757|3995567|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4174215|NCT00809757|3995568|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4174216|NCT00809757|3995569|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4174217|NCT00809757|3995566|B4|24 to < 48 months||Age, Customized||participants|Number|128|128.0||||||
4174218|NCT00809757|3995567|B3|24 to < 48 months||Age, Customized||participants|Number|41|41.0||||||
4174219|NCT00809757|3995568|B2|24 to < 48 months||Age, Customized||participants|Number|42|42.0||||||
4174220|NCT00809757|3995569|B1|24 to < 48 months||Age, Customized||participants|Number|45|45.0||||||
4174221|NCT00809757|3995566|B4|0 to < 24 months||Age, Customized||participants|Number|68|68.0||||||
4174222|NCT00809757|3995567|B3|0 to < 24 months||Age, Customized||participants|Number|22|22.0||||||
4174223|NCT00809757|3995568|B2|0 to < 24 months||Age, Customized||participants|Number|23|23.0||||||
4174224|NCT00809757|3995569|B1|0 to < 24 months||Age, Customized||participants|Number|23|23.0||||||
4174225|NCT00809757|3995566|B4|0 to < 12 months||Age, Customized||participants|Number|27|27.0||||||
4174226|NCT00809757|3995567|B3|0 to < 12 months||Age, Customized||participants|Number|9|9.0||||||
4174227|NCT00809757|3995568|B2|0 to < 12 months||Age, Customized||participants|Number|9|9.0||||||
4174228|NCT00809757|3995569|B1|0 to < 12 months||Age, Customized||participants|Number|9|9.0||||||
4174229|NCT00809757|3995566|B4|||Age||Months|Median|29.0|29.0|Standard Deviation|12.35|12.35|||
4174230|NCT00809757|3995567|B3|||Age||Months|Median|28.4|28.4|Standard Deviation|12.48|12.48|||
4174231|NCT00809757|3995568|B2|||Age||Months|Median|29.3|29.3|Standard Deviation|12.57|12.57|||
4174232|NCT00809757|3995569|B1|||Age||Months|Median|29.2|29.2|Standard Deviation|12.17|12.17|||
4174233|NCT00809757|3995566|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4174234|NCT00809757|3995567|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4174235|NCT00809757|3995568|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4174236|NCT00809757|3995569|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4174237|NCT00809757|3995566|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4174238|NCT00809757|3995567|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4174239|NCT00809757|3995568|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4174240|NCT00809757|3995569|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4174241|NCT00809757|3995566|B4||<=18 years|Age||Participants|Count of Participants|196|196.0||||||
4174242|NCT00809757|3995567|B3||<=18 years|Age||Participants|Count of Participants|63|63.0||||||
4174243|NCT00809757|3995568|B2||<=18 years|Age||Participants|Count of Participants|65|65.0||||||
4174244|NCT00809757|3995569|B1||<=18 years|Age||Participants|Count of Participants|68|68.0||||||
4174245|NCT00809614|3995654|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4174246|NCT00809614|3995655|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4174247|NCT00809614|3995656|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4174248|NCT00809614|3995654|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4174249|NCT00809614|3995655|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4174250|NCT00809614|3995656|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4174251|NCT00809614|3995654|B3|||Age||Years|Mean|47.0|47.0|Standard Deviation|10.2|10.2|||
4174252|NCT00809614|3995655|B2|||Age||Years|Mean|47.6|47.6|Standard Deviation|8.1|8.1|||
4174253|NCT00809614|3995656|B1|||Age||Years|Mean|46.7|46.7|Standard Deviation|11.3|11.3|||
4174254|NCT00809523|3995685|B3|Canada||Region of Enrollment||participants|Number|51|51.0||||||
4174255|NCT00809523|3995686|B2|Canada||Region of Enrollment||participants|Number|25|25.0||||||
4174256|NCT00809523|3995687|B1|Canada||Region of Enrollment||participants|Number|26|26.0||||||
4174257|NCT00809523|3995685|B3|Netherlands||Region of Enrollment||participants|Number|17|17.0||||||
4174258|NCT00809523|3995686|B2|Netherlands||Region of Enrollment||participants|Number|9|9.0||||||
4174259|NCT00809523|3995687|B1|Netherlands||Region of Enrollment||participants|Number|8|8.0||||||
4174260|NCT00809523|3995685|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
4174261|NCT00809523|3995686|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4174262|NCT00809523|3995687|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4174263|NCT00809523|3995685|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4174264|NCT00809523|3995686|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4174265|NCT00809523|3995687|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4174266|NCT00809523|3995685|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4174267|NCT00809523|3995686|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4174268|NCT00809523|3995687|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4174269|NCT00809523|3995685|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4174270|NCT00809523|3995686|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4174271|NCT00809523|3995687|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4174272|NCT00809523|3995685|B3||Between 18 and 65 years|Age||Participants|Count of Participants|106|106.0||||||
4174273|NCT00809523|3995686|B2||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4174274|NCT00809523|3995687|B1||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4174275|NCT00809523|3995685|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4174276|NCT00809523|3995686|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4174277|NCT00809523|3995687|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4174278|NCT00809471|3995698|B4|United States||Region of Enrollment||participants|Number|390|390.0||||||
4174279|NCT00809471|3995699|B3|United States||Region of Enrollment||participants|Number|131|131.0||||||
4174280|NCT00809471|3995700|B2|United States||Region of Enrollment||participants|Number|129|129.0||||||
4174281|NCT00809471|3995701|B1|United States||Region of Enrollment||participants|Number|130|130.0||||||
4174282|NCT00809471|3995698|B4||Male|Sex: Female, Male||Participants|Count of Participants|390|390.0||||||
4174283|NCT00809471|3995699|B3||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4174284|NCT00809471|3995700|B2||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4174285|NCT00809471|3995701|B1||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4174286|NCT00809471|3995698|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4174287|NCT00809471|3995699|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4174288|NCT00809471|3995700|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4174289|NCT00809471|3995701|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4174290|NCT00809471|3995698|B4|||Age||years|Mean|58.0|58.0|Standard Deviation|9.07|9.07|||
4174291|NCT00809471|3995699|B3|||Age||years|Mean|57.5|57.5|Standard Deviation|8.99|8.99|||
4174292|NCT00809471|3995700|B2|||Age||years|Mean|58.2|58.2|Standard Deviation|9.62|9.62|||
4174293|NCT00809471|3995701|B1|||Age||years|Mean|58.2|58.2|Standard Deviation|8.62|8.62|||
4174294|NCT00809458|3995717|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4174295|NCT00809458|3995718|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4174296|NCT00809458|3995719|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4174297|NCT00809458|3995717|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4174298|NCT00809458|3995718|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4174299|NCT00809458|3995719|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4174300|NCT00809458|3995717|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4174301|NCT00809458|3995718|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4174302|NCT00809458|3995719|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4174303|NCT00809458|3995717|B3|||Age||years|Median|60|60.0|Full Range|||51.0|73.0|
4174304|NCT00809458|3995718|B2|||Age||years|Median|60.5|60.5|Full Range|||52.0|66.0|
4174305|NCT00809458|3995719|B1|||Age||years|Median|60|60.0|Full Range|||51.0|73.0|
4174306|NCT00809458|3995717|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4174307|NCT00809458|3995718|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4174308|NCT00809458|3995719|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4174309|NCT00809458|3995717|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4174310|NCT00809458|3995718|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4174311|NCT00809458|3995719|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4174312|NCT00809458|3995717|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4174313|NCT00809458|3995718|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4174314|NCT00809458|3995719|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4174315|NCT00809445|3995730|B4|United States||Region of Enrollment||participants|Number|1281|1281.0||||||
4174316|NCT00809445|3995731|B3|United States||Region of Enrollment||participants|Number|419|419.0||||||
4174317|NCT00809445|3995732|B2|United States||Region of Enrollment||participants|Number|433|433.0||||||
4174318|NCT00809445|3995733|B1|United States||Region of Enrollment||participants|Number|429|429.0||||||
4174319|NCT00809445|3995730|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|147|147.0||||||
4174320|NCT00809445|3995731|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4174321|NCT00809445|3995732|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4174322|NCT00809445|3995733|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4174323|NCT00809445|3995730|B4|Other||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
4174324|NCT00809445|3995731|B3|Other||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4174325|NCT00809445|3995732|B2|Other||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4174326|NCT00809445|3995733|B1|Other||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4174327|NCT00809445|3995730|B4|Mixed race||Race/Ethnicity, Customized||participants|Number|98|98.0||||||
4174328|NCT00809445|3995731|B3|Mixed race||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4174329|NCT00809445|3995732|B2|Mixed race||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4174330|NCT00809445|3995733|B1|Mixed race||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4174331|NCT00809445|3995730|B4|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4174332|NCT00809445|3995731|B3|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4174333|NCT00809445|3995732|B2|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4174334|NCT00809445|3995733|B1|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4174335|NCT00809445|3995730|B4|White||Race/Ethnicity, Customized||participants|Number|826|826.0||||||
4174336|NCT00809445|3995731|B3|White||Race/Ethnicity, Customized||participants|Number|271|271.0||||||
4174337|NCT00809445|3995732|B2|White||Race/Ethnicity, Customized||participants|Number|277|277.0||||||
4174338|NCT00809445|3995733|B1|White||Race/Ethnicity, Customized||participants|Number|278|278.0||||||
4174339|NCT00809445|3995730|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|263|263.0||||||
4174340|NCT00809445|3995731|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|86|86.0||||||
4174341|NCT00809445|3995732|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|88|88.0||||||
4174342|NCT00809445|3995733|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|89|89.0||||||
4174343|NCT00809445|3995730|B4||Male|Sex: Female, Male||Participants|Count of Participants|778|778.0||||||
4174344|NCT00809445|3995731|B3||Male|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
4174345|NCT00809445|3995732|B2||Male|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
4174346|NCT00809445|3995733|B1||Male|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
4174347|NCT00809445|3995730|B4||Female|Sex: Female, Male||Participants|Count of Participants|503|503.0||||||
4174348|NCT00809445|3995731|B3||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4174349|NCT00809445|3995732|B2||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4174350|NCT00809445|3995733|B1||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4174351|NCT00809445|3995730|B4|||Age||years|Mean|40.00|40.0|Standard Deviation|11.35|11.35|||
4174352|NCT00809445|3995731|B3|||Age||years|Mean|39.56|39.56|Standard Deviation|11.77|11.77|||
4174353|NCT00809445|3995732|B2|||Age||years|Mean|39.62|39.62|Standard Deviation|11.19|11.19|||
4174354|NCT00809445|3995733|B1|||Age||years|Mean|40.81|40.81|Standard Deviation|10.76|10.76|||
4174355|NCT00809445|3995730|B4||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4174356|NCT00809445|3995731|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4174357|NCT00809445|3995732|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4174358|NCT00809445|3995733|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4174359|NCT00809445|3995730|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1269|1269.0||||||
4174360|NCT00809445|3995731|B3||Between 18 and 65 years|Age||Participants|Count of Participants|415|415.0||||||
4174361|NCT00809445|3995732|B2||Between 18 and 65 years|Age||Participants|Count of Participants|429|429.0||||||
4174362|NCT00809445|3995733|B1||Between 18 and 65 years|Age||Participants|Count of Participants|425|425.0||||||
4174363|NCT00809445|3995730|B4||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4174364|NCT00809445|3995731|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4174365|NCT00809445|3995732|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4174366|NCT00809445|3995733|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4174367|NCT00809341|3995752|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4174368|NCT00809341|3995753|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4174369|NCT00809341|3995754|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4174370|NCT00809341|3995752|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4174371|NCT00809341|3995753|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4174372|NCT00809341|3995754|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4174373|NCT00809341|3995752|B3|||Age||years|Median|52|52.0|Full Range|||23.0|72.0|
4174374|NCT00809341|3995753|B2|||Age||years|Median|50|50.0|Full Range|||26.0|66.0|
4174375|NCT00809341|3995754|B1|||Age||years|Median|52.5|52.5|Full Range|||23.0|72.0|
4174376|NCT00809341|3995752|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4174377|NCT00809341|3995753|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4174378|NCT00809341|3995754|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4174379|NCT00809341|3995752|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4174380|NCT00809341|3995753|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4174381|NCT00809341|3995754|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4174382|NCT00809341|3995752|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4174383|NCT00809341|3995753|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4174384|NCT00809341|3995754|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4174385|NCT00809328|3995763|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4174386|NCT00809328|3995763|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4174387|NCT00809328|3995763|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|18.6|18.6|||
4174388|NCT00809276|3995771|B1|United States||Region of Enrollment||participants|Number|92|92.0||||||
4174389|NCT00809276|3995771|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4174390|NCT00809276|3995771|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4174391|NCT00809276|3995771|B1|||Age||years|Median|49|49.0|Full Range|||21.0|65.0|
4174392|NCT00809185|3995775|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4174393|NCT00809185|3995775|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4174394|NCT00809185|3995775|B1|||Age||participants|Median|67|67.0|Full Range|||60.0|81.0|
4174395|NCT00809159|3995779|B5||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4174396|NCT00809159|3995780|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4174397|NCT00809159|3995781|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4174398|NCT00809159|3995782|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4174399|NCT00809159|3995783|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4174400|NCT00809159|3995779|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4174401|NCT00809159|3995780|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4174402|NCT00809159|3995781|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4174403|NCT00809159|3995782|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4174404|NCT00809159|3995783|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4174405|NCT00809159|3995779|B5|||Age||Years|Mean|42.8|42.8|Standard Deviation|9.88|9.88|||
4174406|NCT00809159|3995780|B4|||Age||Years|Mean|45.0|45.0|Standard Deviation|9.96|9.96|||
4174407|NCT00809159|3995781|B3|||Age||Years|Mean|42.8|42.8|Standard Deviation|9.17|9.17|||
4174408|NCT00809159|3995782|B2|||Age||Years|Mean|47.2|47.2|Standard Deviation|10.50|10.5|||
4174409|NCT00809159|3995783|B1|||Age||Years|Mean|40.7|40.7|Standard Deviation|9.69|9.69|||
4174410|NCT00809146|3995852|B3|Undetermined||Final diagnosis|Determined by medical record review at the time of hospital discharge|participants|Number|27|27.0||||||
4174411|NCT00809146|3995853|B2|Undetermined||Final diagnosis|Determined by medical record review at the time of hospital discharge|participants|Number|14|14.0||||||
4174412|NCT00809146|3995854|B1|Undetermined||Final diagnosis|Determined by medical record review at the time of hospital discharge|participants|Number|13|13.0||||||
4174413|NCT00809146|3995852|B3|Nonepileptic spell||Final diagnosis|Determined by medical record review at the time of hospital discharge|participants|Number|63|63.0||||||
4174414|NCT00809146|3995853|B2|Nonepileptic spell||Final diagnosis|Determined by medical record review at the time of hospital discharge|participants|Number|32|32.0||||||
4174415|NCT00809146|3995854|B1|Nonepileptic spell||Final diagnosis|Determined by medical record review at the time of hospital discharge|participants|Number|31|31.0||||||
4174416|NCT00809146|3995852|B3|Status epilepticus||Final diagnosis|Determined by medical record review at the time of hospital discharge|participants|Number|803|803.0||||||
4174417|NCT00809146|3995853|B2|Status epilepticus||Final diagnosis|Determined by medical record review at the time of hospital discharge|participants|Number|399|399.0||||||
4174418|NCT00809146|3995854|B1|Status epilepticus||Final diagnosis|Determined by medical record review at the time of hospital discharge|participants|Number|404|404.0||||||
4174419|NCT00809146|3995852|B3|Not documented||History of epilepsy||participants|Number|91|91.0||||||
4174420|NCT00809146|3995853|B2|Not documented||History of epilepsy||participants|Number|47|47.0||||||
4174421|NCT00809146|3995854|B1|Not documented||History of epilepsy||participants|Number|44|44.0||||||
4174422|NCT00809146|3995852|B3|No||History of epilepsy||participants|Number|214|214.0||||||
4174423|NCT00809146|3995853|B2|No||History of epilepsy||participants|Number|103|103.0||||||
4174424|NCT00809146|3995854|B1|No||History of epilepsy||participants|Number|111|111.0||||||
4174425|NCT00809146|3995852|B3|Yes||History of epilepsy||participants|Number|588|588.0||||||
4174426|NCT00809146|3995853|B2|Yes||History of epilepsy||participants|Number|295|295.0||||||
4174427|NCT00809146|3995854|B1|Yes||History of epilepsy||participants|Number|293|293.0||||||
4174428|NCT00809146|3995852|B3|Children estimated >40kg and All Adults||Dose tier|All adults and those children with an estimated body weight of more than 40 kg received either 10 mg of intramuscular midazolam followed by intravenous placebo or intramuscular placebo followed by 4 mg of intravenous lorazepam. Children with an estimated weight of 13 to 40 kg received either 5 mg of intramuscular midazolam followed by intravenous placebo or intramuscular placebo followed by 2 mg of intravenous lorazepam.|participants|Number|772|772.0||||||
4174429|NCT00809146|3995853|B2|Children estimated >40kg and All Adults||Dose tier|All adults and those children with an estimated body weight of more than 40 kg received either 10 mg of intramuscular midazolam followed by intravenous placebo or intramuscular placebo followed by 4 mg of intravenous lorazepam. Children with an estimated weight of 13 to 40 kg received either 5 mg of intramuscular midazolam followed by intravenous placebo or intramuscular placebo followed by 2 mg of intravenous lorazepam.|participants|Number|386|386.0||||||
4174430|NCT00809146|3995854|B1|Children estimated >40kg and All Adults||Dose tier|All adults and those children with an estimated body weight of more than 40 kg received either 10 mg of intramuscular midazolam followed by intravenous placebo or intramuscular placebo followed by 4 mg of intravenous lorazepam. Children with an estimated weight of 13 to 40 kg received either 5 mg of intramuscular midazolam followed by intravenous placebo or intramuscular placebo followed by 2 mg of intravenous lorazepam.|participants|Number|386|386.0||||||
4174431|NCT00809146|3995852|B3|children with an estimated weight of 13 to 40 kg||Dose tier|All adults and those children with an estimated body weight of more than 40 kg received either 10 mg of intramuscular midazolam followed by intravenous placebo or intramuscular placebo followed by 4 mg of intravenous lorazepam. Children with an estimated weight of 13 to 40 kg received either 5 mg of intramuscular midazolam followed by intravenous placebo or intramuscular placebo followed by 2 mg of intravenous lorazepam.|participants|Number|121|121.0||||||
4174432|NCT00809146|3995853|B2|children with an estimated weight of 13 to 40 kg||Dose tier|All adults and those children with an estimated body weight of more than 40 kg received either 10 mg of intramuscular midazolam followed by intravenous placebo or intramuscular placebo followed by 4 mg of intravenous lorazepam. Children with an estimated weight of 13 to 40 kg received either 5 mg of intramuscular midazolam followed by intravenous placebo or intramuscular placebo followed by 2 mg of intravenous lorazepam.|participants|Number|59|59.0||||||
4174433|NCT00809146|3995854|B1|children with an estimated weight of 13 to 40 kg||Dose tier|All adults and those children with an estimated body weight of more than 40 kg received either 10 mg of intramuscular midazolam followed by intravenous placebo or intramuscular placebo followed by 4 mg of intravenous lorazepam. Children with an estimated weight of 13 to 40 kg received either 5 mg of intramuscular midazolam followed by intravenous placebo or intramuscular placebo followed by 2 mg of intravenous lorazepam.|participants|Number|62|62.0||||||
4174434|NCT00809146|3995852|B3|United States||Region of Enrollment||participants|Number|893|893.0||||||
4174435|NCT00809146|3995853|B2|United States||Region of Enrollment||participants|Number|445|445.0||||||
4174436|NCT00809146|3995854|B1|United States||Region of Enrollment||participants|Number|448|448.0||||||
4174437|NCT00809146|3995852|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4174438|NCT00809146|3995853|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4174439|NCT00809146|3995854|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4174440|NCT00809146|3995852|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4174441|NCT00809146|3995853|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4174442|NCT00809146|3995854|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4174443|NCT00809146|3995852|B3||White|Race (NIH/OMB)||Participants|Count of Participants|348|348.0||||||
4174444|NCT00809146|3995853|B2||White|Race (NIH/OMB)||Participants|Count of Participants|183|183.0||||||
4174445|NCT00809146|3995854|B1||White|Race (NIH/OMB)||Participants|Count of Participants|165|165.0||||||
4174446|NCT00809146|3995852|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|453|453.0||||||
4174447|NCT00809146|3995853|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|224|224.0||||||
4174448|NCT00809146|3995854|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|229|229.0||||||
4174449|NCT00809146|3995852|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4174450|NCT00809146|3995853|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4174451|NCT00809146|3995854|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4174452|NCT00809146|3995852|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4174453|NCT00809146|3995853|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4174454|NCT00809146|3995854|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4174455|NCT00809146|3995852|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4174456|NCT00809146|3995853|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4174457|NCT00809146|3995854|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4174458|NCT00809146|3995852|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|187|187.0||||||
4174459|NCT00809146|3995853|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
4174460|NCT00809146|3995854|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
4174461|NCT00809146|3995852|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|600|600.0||||||
4174462|NCT00809146|3995853|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|290|290.0||||||
4174463|NCT00809146|3995854|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|310|310.0||||||
4174464|NCT00809146|3995852|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
4174465|NCT00809146|3995853|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4174466|NCT00809146|3995854|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4174467|NCT00809146|3995852|B3||Male|Sex: Female, Male||Participants|Count of Participants|488|488.0||||||
4174468|NCT00809146|3995853|B2||Male|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
4174469|NCT00809146|3995854|B1||Male|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
4174470|NCT00809146|3995852|B3||Female|Sex: Female, Male||Participants|Count of Participants|405|405.0||||||
4174471|NCT00809146|3995853|B2||Female|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4174472|NCT00809146|3995854|B1||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4174473|NCT00809146|3995852|B3|>61 years||Age, Customized||participants|Number|184|184.0||||||
4174474|NCT00809146|3995853|B2|>61 years||Age, Customized||participants|Number|94|94.0||||||
4174475|NCT00809146|3995854|B1|>61 years||Age, Customized||participants|Number|90|90.0||||||
4174476|NCT00809146|3995852|B3|41-60 years||Age, Customized||participants|Number|338|338.0||||||
4174477|NCT00809146|3995853|B2|41-60 years||Age, Customized||participants|Number|169|169.0||||||
4174478|NCT00809146|3995854|B1|41-60 years||Age, Customized||participants|Number|169|169.0||||||
4174479|NCT00809146|3995852|B3|21-40 years||Age, Customized||participants|Number|226|226.0||||||
4174480|NCT00809146|3995853|B2|21-40 years||Age, Customized||participants|Number|112|112.0||||||
4174481|NCT00809146|3995854|B1|21-40 years||Age, Customized||participants|Number|114|114.0||||||
4174482|NCT00809146|3995852|B3|11-20 years||Age, Customized||participants|Number|49|49.0||||||
4174483|NCT00809146|3995853|B2|11-20 years||Age, Customized||participants|Number|21|21.0||||||
4174484|NCT00809146|3995854|B1|11-20 years||Age, Customized||participants|Number|28|28.0||||||
4174485|NCT00809146|3995852|B3|6-10 years||Age, Customized||participants|Number|35|35.0||||||
4174486|NCT00809146|3995853|B2|6-10 years||Age, Customized||participants|Number|20|20.0||||||
4174487|NCT00809146|3995854|B1|6-10 years||Age, Customized||participants|Number|15|15.0||||||
4174488|NCT00809146|3995852|B3|0-5 years||Age, Customized||participants|Number|61|61.0||||||
4174489|NCT00809146|3995853|B2|0-5 years||Age, Customized||participants|Number|29|29.0||||||
4174490|NCT00809146|3995854|B1|0-5 years||Age, Customized||participants|Number|32|32.0||||||
4174491|NCT00809146|3995852|B3|||Age||years|Mean|43|43.0|Standard Deviation|22|22.0|||
4174492|NCT00809146|3995853|B2|||Age||years|Mean|44|44.0|Standard Deviation|22|22.0|||
4174493|NCT00809146|3995854|B1|||Age||years|Mean|43|43.0|Standard Deviation|22|22.0|||
4174494|NCT00809133|3995879|B15||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4174495|NCT00809133|3995880|B14||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4174496|NCT00809133|3995881|B13||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4174497|NCT00809133|3995882|B12||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4174498|NCT00809133|3995883|B11||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4174499|NCT00809133|3995884|B10||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4174500|NCT00809133|3995885|B9||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4174501|NCT00809133|3995886|B8||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4174502|NCT00809133|3995887|B7||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4174503|NCT00809133|3995888|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4174504|NCT00809133|3995889|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4174505|NCT00809133|3995890|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4174506|NCT00809133|3995891|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4174507|NCT00809133|3995892|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4174508|NCT00809133|3995893|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4174509|NCT00809133|3995879|B15||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4174510|NCT00809133|3995880|B14||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4174511|NCT00809133|3995881|B13||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4174512|NCT00809133|3995882|B12||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4174513|NCT00809133|3995883|B11||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4174514|NCT00809133|3995884|B10||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4174515|NCT00809133|3995885|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4174516|NCT00809133|3995886|B8||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4174517|NCT00809133|3995887|B7||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4174518|NCT00809133|3995888|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4174519|NCT00809133|3995889|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4174520|NCT00809133|3995890|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4174521|NCT00809133|3995891|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4174522|NCT00809133|3995892|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4174523|NCT00809133|3995893|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4174524|NCT00809133|3995879|B15|||Age||Years|Mean|56.3|56.3|Standard Deviation|12.3|12.3|||
4174525|NCT00809133|3995880|B14|||Age||Years|Mean|64.6|64.6|Standard Deviation|8.6|8.6|||
4174526|NCT00809133|3995881|B13|||Age||Years|Mean|62.4|62.4|Standard Deviation|11.1|11.1|||
4174527|NCT00809133|3995882|B12|||Age||Years|Mean|53.1|53.1|Standard Deviation|14.2|14.2|||
4174528|NCT00809133|3995883|B11|||Age||Years|Mean|52.0|52.0|Standard Deviation|9.8|9.8|||
4174529|NCT00809133|3995884|B10|||Age||Years|Mean|54.4|54.4|Standard Deviation|14.7|14.7|||
4174530|NCT00809133|3995885|B9|||Age||Years|Mean|73.3|73.3|Standard Deviation|8.3|8.3|||
4174531|NCT00809133|3995886|B8|||Age||Years|Mean|56.6|56.6|Standard Deviation|9.0|9.0|||
4174532|NCT00809133|3995887|B7|||Age||Years|Mean|55.0|55.0|Standard Deviation|20.5|20.5|||
4174533|NCT00809133|3995888|B6|||Age||Years|Mean|52.3|52.3|Standard Deviation|10.4|10.4|||
4174534|NCT00809133|3995889|B5|||Age||Years|Mean|59.0|59.0|Standard Deviation|6.8|6.8|||
4174535|NCT00809133|3995890|B4|||Age||Years|Mean|46.0|46.0|Standard Deviation|11.1|11.1|||
4174536|NCT00809133|3995891|B3|||Age||Years|Mean|56.2|56.2|Standard Deviation|10.5|10.5|||
4174537|NCT00809133|3995892|B2|||Age||Years|Mean|53.6|53.6|Standard Deviation|11.2|11.2|||
4174538|NCT00809133|3995893|B1|||Age||Years|Mean|56.3|56.3|Standard Deviation|12.9|12.9|||
4174539|NCT00809094|3996058|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4174540|NCT00809094|3996059|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4174541|NCT00809094|3996060|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4174542|NCT00809094|3996058|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4174543|NCT00809094|3996059|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4174544|NCT00809094|3996060|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4174545|NCT00809094|3996058|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4174546|NCT00809094|3996059|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4174547|NCT00809094|3996060|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4174548|NCT00809094|3996058|B3||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4174549|NCT00809094|3996059|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4174550|NCT00809094|3996060|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4174551|NCT00809094|3996058|B3||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
4174552|NCT00809094|3996059|B2||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4174553|NCT00809094|3996060|B1||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4174554|NCT00809055|3996079|B3|United States||Region of Enrollment||participants|Number|74|74.0||||||
4174555|NCT00809055|3996080|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4174556|NCT00809055|3996081|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4174557|NCT00809055|3996079|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174558|NCT00809055|3996080|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174559|NCT00809055|3996081|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174560|NCT00809055|3996079|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174561|NCT00809055|3996080|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174562|NCT00809055|3996081|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174563|NCT00809055|3996079|B3||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4174564|NCT00809055|3996080|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4174565|NCT00809055|3996081|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4174566|NCT00809055|3996079|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4174567|NCT00809055|3996080|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4174568|NCT00809055|3996081|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4174569|NCT00809055|3996079|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174570|NCT00809055|3996080|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174571|NCT00809055|3996081|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174572|NCT00809055|3996079|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4174573|NCT00809055|3996080|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4174574|NCT00809055|3996081|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4174575|NCT00809055|3996079|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174576|NCT00809055|3996080|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174577|NCT00809055|3996081|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174578|NCT00809055|3996079|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4174579|NCT00809055|3996080|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4174580|NCT00809055|3996081|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4174581|NCT00809055|3996079|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4174582|NCT00809055|3996080|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4174583|NCT00809055|3996081|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4174584|NCT00809055|3996079|B3|||Age|Reported as weeks of gestational age at birth|weeks|Mean|26.7|26.7|Standard Deviation|1.8|1.8|||
4174585|NCT00809055|3996080|B2|||Age|Reported as weeks of gestational age at birth|weeks|Mean|26.8|26.8|Standard Deviation|1.8|1.8|||
4174756|NCT00808249|3996383|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4174586|NCT00809055|3996081|B1|||Age|Reported as weeks of gestational age at birth|weeks|Mean|26.3|26.3|Standard Deviation|1.9|1.9|||
4174587|NCT00808899|3996106|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4174588|NCT00808899|3996106|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4174589|NCT00808899|3996106|B1|||Age||years|Mean|3.5|3.5|Standard Deviation|1.21|1.21|||
4174590|NCT00808834|3996110|B1|United States||Region of Enrollment||participants|Number|196|196.0||||||
4174591|NCT00808834|3996110|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4174592|NCT00808834|3996110|B1||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4174593|NCT00808834|3996110|B1|||Age||years|Mean|30.7|30.7|Standard Deviation|12.9|12.9|||
4174594|NCT00808808|3996117|B4|Female||Sex/Gender, Customized|Includes all vaccinated employees, not only participants who completed surveys.|participants|Number|2643|2643.0||||||
4174595|NCT00808808|3996118|B3|Female||Sex/Gender, Customized|Includes all vaccinated employees, not only participants who completed surveys.|participants|Number|1324|1324.0||||||
4174596|NCT00808808|3996119|B2|Female||Sex/Gender, Customized|Includes all vaccinated employees, not only participants who completed surveys.|participants|Number|675|675.0||||||
4174597|NCT00808808|3996120|B1|Female||Sex/Gender, Customized|Includes all vaccinated employees, not only participants who completed surveys.|participants|Number|644|644.0||||||
4174598|NCT00808808|3996117|B4|Male||Sex/Gender, Customized|Includes all vaccinated employees, not only participants who completed surveys.|participants|Number|2370|2370.0||||||
4174599|NCT00808808|3996118|B3|Male||Sex/Gender, Customized|Includes all vaccinated employees, not only participants who completed surveys.|participants|Number|808|808.0||||||
4174600|NCT00808808|3996119|B2|Male||Sex/Gender, Customized|Includes all vaccinated employees, not only participants who completed surveys.|participants|Number|814|814.0||||||
4174601|NCT00808808|3996120|B1|Male||Sex/Gender, Customized|Includes all vaccinated employees, not only participants who completed surveys.|participants|Number|748|748.0||||||
4174602|NCT00808808|3996117|B4|≥ 50 years||Age, Customized||participants|Number|1644|1644.0||||||
4174603|NCT00808808|3996118|B3|≥ 50 years||Age, Customized||participants|Number|734|734.0||||||
4174604|NCT00808808|3996119|B2|≥ 50 years||Age, Customized||participants|Number|501|501.0||||||
4174605|NCT00808808|3996120|B1|≥ 50 years||Age, Customized||participants|Number|409|409.0||||||
4174606|NCT00808808|3996117|B4|18 to 49 years||Age, Customized||participants|Number|3369|3369.0||||||
4174607|NCT00808808|3996118|B3|18 to 49 years||Age, Customized||participants|Number|1398|1398.0||||||
4174608|NCT00808808|3996119|B2|18 to 49 years||Age, Customized||participants|Number|988|988.0||||||
4174609|NCT00808808|3996120|B1|18 to 49 years||Age, Customized||participants|Number|983|983.0||||||
4174610|NCT00808769|3996148|B1|United States||Region of Enrollment|The study was a cross-over study with 30 subjects receiving each treatment; therefore, baseline characteristics are identical for each treatment.|participants|Number|30|30.0||||||
4174611|NCT00808769|3996148|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4174612|NCT00808769|3996148|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4174613|NCT00808769|3996148|B1|||Age||years|Mean|26.4|26.4|Standard Deviation|4.47|4.47|||
4174614|NCT00808769|3996148|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4174615|NCT00808769|3996148|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4174616|NCT00808769|3996148|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4174617|NCT00808665|3996155|B3|United States||Region of Enrollment||participants|Number|63|63.0||||||
4174618|NCT00808665|3996156|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
4174619|NCT00808665|3996157|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4174620|NCT00808665|3996155|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4174621|NCT00808665|3996156|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4174622|NCT00808665|3996157|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4174623|NCT00808665|3996155|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4174624|NCT00808665|3996156|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4174625|NCT00808665|3996157|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4174626|NCT00808665|3996155|B3|||Age||years|Median|60|60.0|Inter-Quartile Range|||55.0|67.0|
4174627|NCT00808665|3996156|B2|||Age||years|Median|58|58.0|Inter-Quartile Range|||52.0|64.0|
4174628|NCT00808665|3996157|B1|||Age||years|Median|63|63.0|Inter-Quartile Range|||59.0|68.0|
4174629|NCT00808639|3996164|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4174630|NCT00808639|3996164|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174631|NCT00808639|3996164|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174632|NCT00808639|3996164|B1||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4174633|NCT00808639|3996164|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174634|NCT00808639|3996164|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174635|NCT00808639|3996164|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174636|NCT00808639|3996164|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174637|NCT00808639|3996164|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4174638|NCT00808639|3996164|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4174639|NCT00808639|3996164|B1|||Age||years|Median|57|57.0|Full Range|||43.0|76.0|
4174693|NCT00808470|3996294|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174694|NCT00808470|3996292|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4174640|NCT00808509|3996170|B3|||Disease Activity Score (DAS) 28|The DAS28 is a validated index of rheumatoid arthritis disease activity. Twenty-eight tender joint counts, 28 swollen joint counts, C-reactive protein, and general health are included in the DAS28 score. Scores on the DAS28 range from 0 to 10, with higher scores indicating higher disease activity.|units on a scale|Mean|1.86|1.86|Standard Deviation|0.55|0.55|||
4174641|NCT00808509|3996171|B2|||Disease Activity Score (DAS) 28|The DAS28 is a validated index of rheumatoid arthritis disease activity. Twenty-eight tender joint counts, 28 swollen joint counts, C-reactive protein, and general health are included in the DAS28 score. Scores on the DAS28 range from 0 to 10, with higher scores indicating higher disease activity.|units on a scale|Mean|1.73|1.73|Standard Deviation|0.61|0.61|||
4174642|NCT00808509|3996172|B1|||Disease Activity Score (DAS) 28|The DAS28 is a validated index of rheumatoid arthritis disease activity. Twenty-eight tender joint counts, 28 swollen joint counts, C-reactive protein, and general health are included in the DAS28 score. Scores on the DAS28 range from 0 to 10, with higher scores indicating higher disease activity.|units on a scale|Mean|1.98|1.98|Standard Deviation|0.48|0.48|||
4174643|NCT00808509|3996170|B3|||Disease duration||years|Mean|11.7|11.7|Standard Deviation|10.7|10.7|||
4174644|NCT00808509|3996171|B2|||Disease duration||years|Mean|13.2|13.2|Standard Deviation|12.5|12.5|||
4174645|NCT00808509|3996172|B1|||Disease duration||years|Mean|10.4|10.4|Standard Deviation|8.9|8.9|||
4174646|NCT00808509|3996170|B3|Sweden||Region of Enrollment||participants|Number|33|33.0||||||
4174647|NCT00808509|3996171|B2|Sweden||Region of Enrollment||participants|Number|16|16.0||||||
4174648|NCT00808509|3996172|B1|Sweden||Region of Enrollment||participants|Number|17|17.0||||||
4174649|NCT00808509|3996170|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4174650|NCT00808509|3996171|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4174651|NCT00808509|3996172|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4174652|NCT00808509|3996170|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4174653|NCT00808509|3996171|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4174654|NCT00808509|3996172|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4174655|NCT00808509|3996170|B3|||Age||years|Mean|56.8|56.8|Standard Deviation|12.2|12.2|||
4174656|NCT00808509|3996171|B2|||Age||years|Mean|61.3|61.3|Standard Deviation|9.9|9.9|||
4174657|NCT00808509|3996172|B1|||Age||years|Mean|52.5|52.5|Standard Deviation|13.0|13.0|||
4174658|NCT00808483|3996269|B3|||BMI||kg/m^2|Mean|27|27.0|Full Range|||20.0|37.0|
4174659|NCT00808483|3996270|B2|||BMI||kg/m^2|Mean|27|27.0|Full Range|||21.0|36.0|
4174660|NCT00808483|3996271|B1|||BMI||kg/m^2|Mean|27|27.0|Full Range|||20.0|37.0|
4174661|NCT00808483|3996269|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4174662|NCT00808483|3996270|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4174663|NCT00808483|3996271|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4174664|NCT00808483|3996269|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4174665|NCT00808483|3996270|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4174666|NCT00808483|3996271|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4174667|NCT00808483|3996269|B3|||Age||years|Mean|66|66.0|Full Range|||45.0|81.0|
4174668|NCT00808483|3996270|B2|||Age||years|Mean|66|66.0|Full Range|||45.0|81.0|
4174669|NCT00808483|3996271|B1|||Age||years|Mean|65|65.0|Full Range|||49.0|78.0|
4174670|NCT00808470|3996292|B3|United States||Region of Enrollment||participants|Number|72|72.0||||||
4174671|NCT00808470|3996293|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
4174672|NCT00808470|3996294|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4174673|NCT00808470|3996292|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4174674|NCT00808470|3996293|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174675|NCT00808470|3996294|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4174676|NCT00808470|3996292|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4174677|NCT00808470|3996293|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4174678|NCT00808470|3996294|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4174679|NCT00808470|3996292|B3||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4174680|NCT00808470|3996293|B2||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4174681|NCT00808470|3996294|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4174682|NCT00808470|3996292|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4174683|NCT00808470|3996293|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4174684|NCT00808470|3996294|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4174685|NCT00808470|3996292|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174686|NCT00808470|3996293|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174687|NCT00808470|3996294|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174688|NCT00808470|3996292|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4174689|NCT00808470|3996293|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4174690|NCT00808470|3996294|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4174691|NCT00808470|3996292|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174692|NCT00808470|3996293|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174695|NCT00808470|3996293|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174696|NCT00808470|3996294|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4174697|NCT00808470|3996292|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4174698|NCT00808470|3996293|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4174699|NCT00808470|3996294|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4174700|NCT00808470|3996292|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4174701|NCT00808470|3996293|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4174702|NCT00808470|3996294|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4174703|NCT00808470|3996292|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4174704|NCT00808470|3996293|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4174705|NCT00808470|3996294|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4174706|NCT00808470|3996292|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4174707|NCT00808470|3996293|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4174708|NCT00808470|3996294|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4174709|NCT00808470|3996292|B3|||Age||years|Mean|21.6|21.6|Standard Deviation|2.4|2.4|||
4174710|NCT00808470|3996293|B2|||Age||years|Mean|21.3|21.3|Standard Deviation|2.4|2.4|||
4174711|NCT00808470|3996294|B1|||Age||years|Mean|22.0|22.0|Standard Deviation|2.4|2.4|||
4174712|NCT00808444|3996307|B3||Male|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
4174713|NCT00808444|3996308|B2||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4174714|NCT00808444|3996309|B1||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4174715|NCT00808444|3996307|B3||Female|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
4174716|NCT00808444|3996308|B2||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4174717|NCT00808444|3996309|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4174718|NCT00808444|3996307|B3|||Age||Weeks|Mean|7.3|7.3|Standard Deviation|1.32|1.32|||
4174719|NCT00808444|3996308|B2|||Age||Weeks|Mean|7.2|7.2|Standard Deviation|1.30|1.3|||
4174720|NCT00808444|3996309|B1|||Age||Weeks|Mean|7.3|7.3|Standard Deviation|1.35|1.35|||
4174721|NCT00808405|3996348|B3|South Africa||Region of Enrollment||participants|Number|44|44.0||||||
4174722|NCT00808405|3996349|B2|South Africa||Region of Enrollment||participants|Number|14|14.0||||||
4174723|NCT00808405|3996350|B1|South Africa||Region of Enrollment||participants|Number|30|30.0||||||
4174724|NCT00808405|3996348|B3|Zambia||Region of Enrollment||participants|Number|44|44.0||||||
4174725|NCT00808405|3996349|B2|Zambia||Region of Enrollment||participants|Number|13|13.0||||||
4174726|NCT00808405|3996350|B1|Zambia||Region of Enrollment||participants|Number|31|31.0||||||
4174727|NCT00808405|3996348|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4174728|NCT00808405|3996349|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4174729|NCT00808405|3996350|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4174730|NCT00808405|3996348|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4174731|NCT00808405|3996349|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4174732|NCT00808405|3996350|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4174733|NCT00808405|3996348|B3|||Age||years|Mean|38.5|38.5|Standard Deviation|10.23|10.23|||
4174734|NCT00808405|3996349|B2|||Age||years|Mean|38.15|38.15|Standard Deviation|10.31|10.31|||
4174735|NCT00808405|3996350|B1|||Age||years|Mean|38.66|38.66|Standard Deviation|10.28|10.28|||
4174736|NCT00808405|3996348|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4174737|NCT00808405|3996349|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4174738|NCT00808405|3996350|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4174739|NCT00808405|3996348|B3||Between 18 and 65 years|Age||Participants|Count of Participants|88|88.0||||||
4174740|NCT00808405|3996349|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4174741|NCT00808405|3996350|B1||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4174742|NCT00808405|3996348|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4174743|NCT00808405|3996349|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4174744|NCT00808405|3996350|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4174745|NCT00808340|3996359|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4174746|NCT00808340|3996359|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4174747|NCT00808340|3996359|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4174748|NCT00808340|3996359|B1|||Age|Overall completed study population|years|Mean|50.5|50.5|Standard Deviation|6.3|6.3|||
4174749|NCT00808249|3996381|B5||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4174750|NCT00808249|3996382|B4||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4174751|NCT00808249|3996383|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4174752|NCT00808249|3996384|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4174753|NCT00808249|3996385|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4174754|NCT00808249|3996381|B5||Female|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
4174755|NCT00808249|3996382|B4||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4174757|NCT00808249|3996384|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4174758|NCT00808249|3996385|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4174759|NCT00808249|3996381|B5|40-65||Age, Customized||Participants|Number|236|236.0||||||
4174760|NCT00808249|3996382|B4|40-65||Age, Customized||Participants|Number|53|53.0||||||
4174761|NCT00808249|3996383|B3|40-65||Age, Customized||Participants|Number|57|57.0||||||
4174762|NCT00808249|3996384|B2|40-65||Age, Customized||Participants|Number|63|63.0||||||
4174763|NCT00808249|3996385|B1|40-65||Age, Customized||Participants|Number|63|63.0||||||
4174764|NCT00808249|3996381|B5|18-39||Age, Customized||Participants|Number|188|188.0||||||
4174765|NCT00808249|3996382|B4|18-39||Age, Customized||Participants|Number|53|53.0||||||
4174766|NCT00808249|3996383|B3|18-39||Age, Customized||Participants|Number|48|48.0||||||
4174767|NCT00808249|3996384|B2|18-39||Age, Customized||Participants|Number|43|43.0||||||
4174768|NCT00808249|3996385|B1|18-39||Age, Customized||Participants|Number|44|44.0||||||
4174769|NCT00808236|3996414|B3|Arrived at Hospital||Elapsed time from collapse until:||minutes|Median|60|60.0|Inter-Quartile Range|||45.0|71.0|
4174770|NCT00808236|3996415|B2|Arrived at Hospital||Elapsed time from collapse until:||minutes|Median|60|60.0|Inter-Quartile Range|||42.0|70.0|
4174771|NCT00808236|3996416|B1|Arrived at Hospital||Elapsed time from collapse until:||minutes|Median|59|59.0|Inter-Quartile Range|||51.0|75.0|
4174772|NCT00808236|3996414|B3|ROSC Achieved||Elapsed time from collapse until:||minutes|Median|31|31.0|Inter-Quartile Range|||23.0|38.0|
4174773|NCT00808236|3996415|B2|ROSC Achieved||Elapsed time from collapse until:||minutes|Median|30|30.0|Inter-Quartile Range|||22.0|38.0|
4174774|NCT00808236|3996416|B1|ROSC Achieved||Elapsed time from collapse until:||minutes|Median|32|32.0|Inter-Quartile Range|||29.0|38.0|
4174775|NCT00808236|3996414|B3|Cooling Initiated||Elapsed time from collapse until:||minutes|Median|30|30.0|Inter-Quartile Range|||20.0|64.0|
4174776|NCT00808236|3996415|B2|Cooling Initiated||Elapsed time from collapse until:||minutes|Median|113|113.0|Inter-Quartile Range|||71.0|200.0|
4174777|NCT00808236|3996416|B1|Cooling Initiated||Elapsed time from collapse until:||minutes|Median|23|23.0|Inter-Quartile Range|||18.0|30.0|
4174778|NCT00808236|3996414|B3|Randomized||Elapsed time from collapse until:||minutes|Median|19|19.0|Inter-Quartile Range|||15.0|19.0|
4174779|NCT00808236|3996415|B2|Randomized||Elapsed time from collapse until:||minutes|Median|18|18.0|Inter-Quartile Range|||14.0|22.0|
4174780|NCT00808236|3996416|B1|Randomized||Elapsed time from collapse until:||minutes|Median|20|20.0|Inter-Quartile Range|||16.0|25.0|
4174781|NCT00808236|3996414|B3|Airway Protected||Elapsed time from collapse until:||minutes|Median|17|17.0|Inter-Quartile Range|||13.0|21.0|
4174782|NCT00808236|3996415|B2|Airway Protected||Elapsed time from collapse until:||minutes|Median|16|16.0|Inter-Quartile Range|||12.0|20.0|
4174783|NCT00808236|3996416|B1|Airway Protected||Elapsed time from collapse until:||minutes|Median|18|18.0|Inter-Quartile Range|||14.0|22.0|
4174784|NCT00808236|3996414|B3|Intravenous (IV) Access Acquired||Elapsed time from collapse until:||minutes|Median|16|16.0|Inter-Quartile Range|||12.0|16.0|
4174785|NCT00808236|3996415|B2|Intravenous (IV) Access Acquired||Elapsed time from collapse until:||minutes|Median|15|15.0|Inter-Quartile Range|||12.0|20.0|
4174786|NCT00808236|3996416|B1|Intravenous (IV) Access Acquired||Elapsed time from collapse until:||minutes|Median|16|16.0|Inter-Quartile Range|||14.0|20.0|
4174787|NCT00808236|3996414|B3|Advanced Life Support (ALS) Arrived||Elapsed time from collapse until:||minutes|Median|12|12.0|Inter-Quartile Range|||9.0|16.0|
4174788|NCT00808236|3996415|B2|Advanced Life Support (ALS) Arrived||Elapsed time from collapse until:||minutes|Median|11|11.0|Inter-Quartile Range|||8.0|16.0|
4174789|NCT00808236|3996416|B1|Advanced Life Support (ALS) Arrived||Elapsed time from collapse until:||minutes|Median|12|12.0|Inter-Quartile Range|||9.0|16.0|
4174790|NCT00808236|3996414|B3|First Defibrillation Shock (VF only)||Elapsed time from collapse until:||minutes|Median|12|12.0|Inter-Quartile Range|||8.0|15.0|
4174791|NCT00808236|3996415|B2|First Defibrillation Shock (VF only)||Elapsed time from collapse until:||minutes|Median|12|12.0|Inter-Quartile Range|||7.0|16.0|
4174792|NCT00808236|3996416|B1|First Defibrillation Shock (VF only)||Elapsed time from collapse until:||minutes|Median|12|12.0|Inter-Quartile Range|||8.0|14.0|
4174793|NCT00808236|3996414|B3|EMS CPR Initiated||Elapsed time from collapse until:||minutes|Median|8|8.0|Inter-Quartile Range|||5.0|10.0|
4174794|NCT00808236|3996415|B2|EMS CPR Initiated||Elapsed time from collapse until:||minutes|Median|8|8.0|Inter-Quartile Range|||5.0|10.0|
4174795|NCT00808236|3996416|B1|EMS CPR Initiated||Elapsed time from collapse until:||minutes|Median|8|8.0|Inter-Quartile Range|||5.0|10.0|
4174796|NCT00808236|3996414|B3|PEA/EMD||First Rhythm|First rhythm was defined as ventricular fibrillation/non-perfusing ventricular tacchycardia (VF/VT), asystole, or pulseless electrical activity/electro-mechanical dissociation (PEA/EMD)|participants|Number|41|41.0||||||
4174797|NCT00808236|3996415|B2|PEA/EMD||First Rhythm|First rhythm was defined as ventricular fibrillation/non-perfusing ventricular tacchycardia (VF/VT), asystole, or pulseless electrical activity/electro-mechanical dissociation (PEA/EMD)|participants|Number|23|23.0||||||
4174798|NCT00808236|3996416|B1|PEA/EMD||First Rhythm|First rhythm was defined as ventricular fibrillation/non-perfusing ventricular tacchycardia (VF/VT), asystole, or pulseless electrical activity/electro-mechanical dissociation (PEA/EMD)|participants|Number|18|18.0||||||
4174799|NCT00808236|3996414|B3|Asystole||First Rhythm|First rhythm was defined as ventricular fibrillation/non-perfusing ventricular tacchycardia (VF/VT), asystole, or pulseless electrical activity/electro-mechanical dissociation (PEA/EMD)|participants|Number|84|84.0||||||
4174800|NCT00808236|3996415|B2|Asystole||First Rhythm|First rhythm was defined as ventricular fibrillation/non-perfusing ventricular tacchycardia (VF/VT), asystole, or pulseless electrical activity/electro-mechanical dissociation (PEA/EMD)|participants|Number|44|44.0||||||
4174801|NCT00808236|3996416|B1|Asystole||First Rhythm|First rhythm was defined as ventricular fibrillation/non-perfusing ventricular tacchycardia (VF/VT), asystole, or pulseless electrical activity/electro-mechanical dissociation (PEA/EMD)|participants|Number|40|40.0||||||
4174834|NCT00808236|3996416|B1|Czech Republic||Region of Enrollment||participants|Number|2|2.0||||||
4174802|NCT00808236|3996414|B3|VF/VT||First Rhythm|First rhythm was defined as ventricular fibrillation/non-perfusing ventricular tacchycardia (VF/VT), asystole, or pulseless electrical activity/electro-mechanical dissociation (PEA/EMD)|participants|Number|56|56.0||||||
4174803|NCT00808236|3996415|B2|VF/VT||First Rhythm|First rhythm was defined as ventricular fibrillation/non-perfusing ventricular tacchycardia (VF/VT), asystole, or pulseless electrical activity/electro-mechanical dissociation (PEA/EMD)|participants|Number|32|32.0||||||
4174804|NCT00808236|3996416|B1|VF/VT||First Rhythm|First rhythm was defined as ventricular fibrillation/non-perfusing ventricular tacchycardia (VF/VT), asystole, or pulseless electrical activity/electro-mechanical dissociation (PEA/EMD)|participants|Number|24|24.0||||||
4174805|NCT00808236|3996414|B3|Total evaluable||Evaluable Participants|Eligible participants were those included in the analyses. These excluded those particiapnts found not meet all of the inclusion criteria or to have a pre-defined exclsion criteria as well as those lost to follow-up for whom no data was obtained.|participants|Number|181|181.0||||||
4174806|NCT00808236|3996415|B2|Total evaluable||Evaluable Participants|Eligible participants were those included in the analyses. These excluded those particiapnts found not meet all of the inclusion criteria or to have a pre-defined exclsion criteria as well as those lost to follow-up for whom no data was obtained.|participants|Number|99|99.0||||||
4174807|NCT00808236|3996416|B1|Total evaluable||Evaluable Participants|Eligible participants were those included in the analyses. These excluded those particiapnts found not meet all of the inclusion criteria or to have a pre-defined exclsion criteria as well as those lost to follow-up for whom no data was obtained.|participants|Number|82|82.0||||||
4174808|NCT00808236|3996414|B3|No data obtained||Evaluable Participants|Eligible participants were those included in the analyses. These excluded those particiapnts found not meet all of the inclusion criteria or to have a pre-defined exclsion criteria as well as those lost to follow-up for whom no data was obtained.|participants|Number|3|3.0||||||
4174809|NCT00808236|3996415|B2|No data obtained||Evaluable Participants|Eligible participants were those included in the analyses. These excluded those particiapnts found not meet all of the inclusion criteria or to have a pre-defined exclsion criteria as well as those lost to follow-up for whom no data was obtained.|participants|Number|2|2.0||||||
4174810|NCT00808236|3996416|B1|No data obtained||Evaluable Participants|Eligible participants were those included in the analyses. These excluded those particiapnts found not meet all of the inclusion criteria or to have a pre-defined exclsion criteria as well as those lost to follow-up for whom no data was obtained.|participants|Number|1|1.0||||||
4174811|NCT00808236|3996414|B3|Did not meet all Inclusion/Exclusion Criteria||Evaluable Participants|Eligible participants were those included in the analyses. These excluded those particiapnts found not meet all of the inclusion criteria or to have a pre-defined exclsion criteria as well as those lost to follow-up for whom no data was obtained.|participants|Number|16|16.0||||||
4174812|NCT00808236|3996415|B2|Did not meet all Inclusion/Exclusion Criteria||Evaluable Participants|Eligible participants were those included in the analyses. These excluded those particiapnts found not meet all of the inclusion criteria or to have a pre-defined exclsion criteria as well as those lost to follow-up for whom no data was obtained.|participants|Number|3|3.0||||||
4174813|NCT00808236|3996416|B1|Did not meet all Inclusion/Exclusion Criteria||Evaluable Participants|Eligible participants were those included in the analyses. These excluded those particiapnts found not meet all of the inclusion criteria or to have a pre-defined exclsion criteria as well as those lost to follow-up for whom no data was obtained.|participants|Number|13|13.0||||||
4174814|NCT00808236|3996414|B3|Did not receive bystander CPR||Bystander CPR|The is the number of those participants that received bystander rescue cardiopulmonary resuscitation (CPR) efforts prior to the arrival of emergency medical service (EMS) personnel|participants|Number|105|105.0||||||
4174815|NCT00808236|3996415|B2|Did not receive bystander CPR||Bystander CPR|The is the number of those participants that received bystander rescue cardiopulmonary resuscitation (CPR) efforts prior to the arrival of emergency medical service (EMS) personnel|participants|Number|54|54.0||||||
4174816|NCT00808236|3996416|B1|Did not receive bystander CPR||Bystander CPR|The is the number of those participants that received bystander rescue cardiopulmonary resuscitation (CPR) efforts prior to the arrival of emergency medical service (EMS) personnel|participants|Number|51|51.0||||||
4174817|NCT00808236|3996414|B3|Received bystander CPR||Bystander CPR|The is the number of those participants that received bystander rescue cardiopulmonary resuscitation (CPR) efforts prior to the arrival of emergency medical service (EMS) personnel|participants|Number|76|76.0||||||
4174818|NCT00808236|3996415|B2|Received bystander CPR||Bystander CPR|The is the number of those participants that received bystander rescue cardiopulmonary resuscitation (CPR) efforts prior to the arrival of emergency medical service (EMS) personnel|participants|Number|45|45.0||||||
4174819|NCT00808236|3996416|B1|Received bystander CPR||Bystander CPR|The is the number of those participants that received bystander rescue cardiopulmonary resuscitation (CPR) efforts prior to the arrival of emergency medical service (EMS) personnel|participants|Number|31|31.0||||||
4174820|NCT00808236|3996414|B3|Sweden||Region of Enrollment||participants|Number|23|23.0||||||
4174821|NCT00808236|3996415|B2|Sweden||Region of Enrollment||participants|Number|10|10.0||||||
4174822|NCT00808236|3996416|B1|Sweden||Region of Enrollment||participants|Number|13|13.0||||||
4174823|NCT00808236|3996414|B3|Italy||Region of Enrollment||participants|Number|9|9.0||||||
4174824|NCT00808236|3996415|B2|Italy||Region of Enrollment||participants|Number|6|6.0||||||
4174825|NCT00808236|3996416|B1|Italy||Region of Enrollment||participants|Number|3|3.0||||||
4174826|NCT00808236|3996414|B3|Germany||Region of Enrollment||participants|Number|65|65.0||||||
4174827|NCT00808236|3996415|B2|Germany||Region of Enrollment||participants|Number|33|33.0||||||
4174828|NCT00808236|3996416|B1|Germany||Region of Enrollment||participants|Number|32|32.0||||||
4174829|NCT00808236|3996414|B3|Belgium||Region of Enrollment||participants|Number|97|97.0||||||
4174830|NCT00808236|3996415|B2|Belgium||Region of Enrollment||participants|Number|51|51.0||||||
4174831|NCT00808236|3996416|B1|Belgium||Region of Enrollment||participants|Number|46|46.0||||||
4174832|NCT00808236|3996414|B3|Czech Republic||Region of Enrollment||participants|Number|6|6.0||||||
4174833|NCT00808236|3996415|B2|Czech Republic||Region of Enrollment||participants|Number|4|4.0||||||
4174835|NCT00808236|3996414|B3|Male||Gender||participants|Number|136|136.0||||||
4174836|NCT00808236|3996415|B2|Male||Gender||participants|Number|77|77.0||||||
4174837|NCT00808236|3996416|B1|Male||Gender||participants|Number|59|59.0||||||
4174838|NCT00808236|3996414|B3|Female||Gender||participants|Number|45|45.0||||||
4174839|NCT00808236|3996415|B2|Female||Gender||participants|Number|22|22.0||||||
4174840|NCT00808236|3996416|B1|Female||Gender||participants|Number|23|23.0||||||
4174841|NCT00808236|3996414|B3|||Age||years|Mean|65|65.0|Standard Deviation|14|14.0|||
4174842|NCT00808236|3996415|B2|||Age||years|Mean|64.8|64.8|Standard Deviation|13.5|13.5|||
4174843|NCT00808236|3996416|B1|||Age||years|Mean|66.4|66.4|Standard Deviation|13.2|13.2|||
4174844|NCT00808236|3996414|B3|>=65 years||Age|Overall number of participants included in analysis was 181: 82 RhinoChill patients and 99 Control patients|participants|Number|102|102.0||||||
4174845|NCT00808236|3996415|B2|>=65 years||Age|Overall number of participants included in analysis was 181: 82 RhinoChill patients and 99 Control patients|participants|Number|55|55.0||||||
4174846|NCT00808236|3996416|B1|>=65 years||Age|Overall number of participants included in analysis was 181: 82 RhinoChill patients and 99 Control patients|participants|Number|47|47.0||||||
4174847|NCT00808236|3996414|B3|Between 18 and 65 years||Age|Overall number of participants included in analysis was 181: 82 RhinoChill patients and 99 Control patients|participants|Number|79|79.0||||||
4174848|NCT00808236|3996415|B2|Between 18 and 65 years||Age|Overall number of participants included in analysis was 181: 82 RhinoChill patients and 99 Control patients|participants|Number|44|44.0||||||
4174849|NCT00808236|3996416|B1|Between 18 and 65 years||Age|Overall number of participants included in analysis was 181: 82 RhinoChill patients and 99 Control patients|participants|Number|35|35.0||||||
4174850|NCT00808236|3996414|B3|<=18 years||Age|Overall number of participants included in analysis was 181: 82 RhinoChill patients and 99 Control patients|participants|Number|0|0.0||||||
4174851|NCT00808236|3996415|B2|<=18 years||Age|Overall number of participants included in analysis was 181: 82 RhinoChill patients and 99 Control patients|participants|Number|0|0.0||||||
4174852|NCT00808236|3996416|B1|<=18 years||Age|Overall number of participants included in analysis was 181: 82 RhinoChill patients and 99 Control patients|participants|Number|0|0.0||||||
4174853|NCT00808132|3996445|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4174854|NCT00808132|3996446|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4174855|NCT00808132|3996447|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4174856|NCT00808132|3996448|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4174857|NCT00808132|3996449|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4174858|NCT00808132|3996450|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4174859|NCT00808132|3996445|B6||Female|Sex: Female, Male||Participants|Count of Participants|1843|1843.0||||||
4174860|NCT00808132|3996446|B5||Female|Sex: Female, Male||Participants|Count of Participants|474|474.0||||||
4174861|NCT00808132|3996447|B4||Female|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
4174862|NCT00808132|3996448|B3||Female|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4174863|NCT00808132|3996449|B2||Female|Sex: Female, Male||Participants|Count of Participants|474|474.0||||||
4174864|NCT00808132|3996450|B1||Female|Sex: Female, Male||Participants|Count of Participants|445|445.0||||||
4174865|NCT00808132|3996445|B6|||Age||Years|Mean|54.15|54.15|Standard Deviation|4.09|4.09|||
4174866|NCT00808132|3996446|B5|||Age||Years|Mean|54.19|54.19|Standard Deviation|4.07|4.07|||
4174867|NCT00808132|3996447|B4|||Age||Years|Mean|54.15|54.15|Standard Deviation|4.50|4.5|||
4174868|NCT00808132|3996448|B3|||Age||Years|Mean|54.07|54.07|Standard Deviation|4.01|4.01|||
4174869|NCT00808132|3996449|B2|||Age||Years|Mean|53.89|53.89|Standard Deviation|4.00|4.0|||
4174870|NCT00808132|3996450|B1|||Age||Years|Mean|54.43|54.43|Standard Deviation|4.02|4.02|||
4174871|NCT00808080|3996526|B1|||ANC at Baseline||1000 cells/mm^3|Mean|2460.7|2460.7|Full Range|||480.0|7398.0|
4174872|NCT00808080|3996526|B1|||WBC at Baseline||1000 cells/mm^3|Mean|18.4|18.4|Full Range|||4.0|66.0|
4174873|NCT00808080|3996526|B1|||Percent Blast Cells in Bone Marrow||percentage of bone marrow|Mean|67.4|67.4|Full Range|||45.0|80.0|
4174874|NCT00808080|3996526|B1|||Percent Circulating Blasts In Peripheral Blood||percentage of peripheral blood|Mean|52.7|52.7|Full Range|||26.0|90.0|
4174875|NCT00808080|3996526|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4174876|NCT00808080|3996526|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4174877|NCT00808080|3996526|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4174878|NCT00808080|3996526|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4174879|NCT00808080|3996526|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4174880|NCT00808080|3996526|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4174881|NCT00808080|3996526|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4174882|NCT00808080|3996526|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4174883|NCT00808080|3996526|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4174884|NCT00808067|3996530|B3||Male|Sex: Female, Male||Participants|Count of Participants|3825|3825.0||||||
4174885|NCT00808067|3996531|B2||Male|Sex: Female, Male||Participants|Count of Participants|1911|1911.0||||||
4174886|NCT00808067|3996532|B1||Male|Sex: Female, Male||Participants|Count of Participants|1914|1914.0||||||
4174887|NCT00808067|3996530|B3||Female|Sex: Female, Male||Participants|Count of Participants|2026|2026.0||||||
4174888|NCT00808067|3996531|B2||Female|Sex: Female, Male||Participants|Count of Participants|1026|1026.0||||||
4174889|NCT00808067|3996532|B1||Female|Sex: Female, Male||Participants|Count of Participants|1000|1000.0||||||
4174890|NCT00808067|3996530|B3|||Age||years|Mean|73.1|73.1|Standard Deviation|8.4|8.4|||
4174891|NCT00808067|3996531|B2|||Age||years|Mean|73.1|73.1|Standard Deviation|8.4|8.4|||
4174892|NCT00808067|3996532|B1|||Age||years|Mean|73.1|73.1|Standard Deviation|8.4|8.4|||
4174893|NCT00808028|3996565|B5||Male|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4174894|NCT00808028|3996566|B4||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4174895|NCT00808028|3996567|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4174896|NCT00808028|3996568|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4174897|NCT00808028|3996569|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4174898|NCT00808028|3996565|B5||Female|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
4174899|NCT00808028|3996566|B4||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4174900|NCT00808028|3996567|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4174901|NCT00808028|3996568|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4174902|NCT00808028|3996569|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4174903|NCT00808028|3996565|B5|||Age||Years|Mean|14.0|14.0|Standard Deviation|2.05|2.05|||
4174904|NCT00808028|3996566|B4|||Age||Years|Mean|14.0|14.0|Standard Deviation|2.01|2.01|||
4174905|NCT00808028|3996567|B3|||Age||Years|Mean|14.3|14.3|Standard Deviation|2.11|2.11|||
4174906|NCT00808028|3996568|B2|||Age||Years|Mean|13.3|13.3|Standard Deviation|1.84|1.84|||
4174907|NCT00808028|3996569|B1|||Age||Years|Mean|13.8|13.8|Standard Deviation|2.05|2.05|||
4174908|NCT00808015|3996608|B1|Vasculitis||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174909|NCT00808015|3996608|B1|Thromboangiitis obliterans||Medical History|N=129 for the parameter analyzed.|participants|Number|2|2.0||||||
4174910|NCT00808015|3996608|B1|Peripheral vascular disorder||Medical History|N=129 for the parameter analyzed.|participants|Number|2|2.0||||||
4174911|NCT00808015|3996608|B1|Hypertension||Medical History|N=129 for the parameter analyzed.|participants|Number|229|229.0||||||
4174912|NCT00808015|3996608|B1|Arteriosclerosis||Medical History|N=129 for the parameter analyzed.|participants|Number|2|2.0||||||
4174913|NCT00808015|3996608|B1|Haemorrhoid operation||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174914|NCT00808015|3996608|B1|Aortic valve replacement||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174915|NCT00808015|3996608|B1|Alcoholic||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174916|NCT00808015|3996608|B1|Urticaria||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174917|NCT00808015|3996608|B1|Pruritus||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174918|NCT00808015|3996608|B1|Dermatitis contact||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174919|NCT00808015|3996608|B1|Alopecia areata||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174920|NCT00808015|3996608|B1|Acne||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174921|NCT00808015|3996608|B1|Snoring||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174922|NCT00808015|3996608|B1|Sleep apnoea syndrome||Medical History|N=129 for the parameter analyzed.|participants|Number|5|5.0||||||
4174923|NCT00808015|3996608|B1|Rhinitis allergic||Medical History|N=129 for the parameter analyzed.|participants|Number|7|7.0||||||
4174924|NCT00808015|3996608|B1|Respiratory disorder||Medical History|N=129 for the parameter analyzed.|participants|Number|2|2.0||||||
4174925|NCT00808015|3996608|B1|Pulmonary mass||Medical History|N=129 for the parameter analyzed.|participants|Number|3|3.0||||||
4174926|NCT00808015|3996608|B1|Pulmonary embolism||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174927|NCT00808015|3996608|B1|Pulmonary bulla||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174928|NCT00808015|3996608|B1|Pneumothorax||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174929|NCT00808015|3996608|B1|Pleural effusion||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174930|NCT00808015|3996608|B1|Interstitial lung disease||Medical History|N=129 for the parameter analyzed.|participants|Number|3|3.0||||||
4174931|NCT00808015|3996608|B1|Idiopathic pulmonary fibrosis||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174932|NCT00808015|3996608|B1|Haemoptysis||Medical History|N=129 for the parameter analyzed.|participants|Number|3|3.0||||||
4174933|NCT00808015|3996608|B1|Epistaxis||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174934|NCT00808015|3996608|B1|Emphysema||Medical History|N=129 for the parameter analyzed.|participants|Number|7|7.0||||||
4174935|NCT00808015|3996608|B1|Dyspnoea||Medical History|N=129 for the parameter analyzed.|participants|Number|3|3.0||||||
4174936|NCT00808015|3996608|B1|Cough||Medical History|N=129 for the parameter analyzed.|participants|Number|6|6.0||||||
4174937|NCT00808015|3996608|B1|Chronic obstructive pulmonary disease||Medical History|N=129 for the parameter analyzed.|participants|Number|116|116.0||||||
4174938|NCT00808015|3996608|B1|Bronchitis chronic||Medical History|N=129 for the parameter analyzed.|participants|Number|19|19.0||||||
4174939|NCT00808015|3996608|B1|Asthma||Medical History|N=129 for the parameter analyzed.|participants|Number|65|65.0||||||
4174940|NCT00808015|3996608|B1|Organic erectile dysfunction||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174941|NCT00808015|3996608|B1|Erectile dysfunction||Medical History|N=129 for the parameter analyzed.|participants|Number|2|2.0||||||
4174942|NCT00808015|3996608|B1|Benign prostatic hyperplasia||Medical History|N=129 for the parameter analyzed.|participants|Number|9|9.0||||||
4174943|NCT00808015|3996608|B1|Renal failure chronic||Medical History|N=129 for the parameter analyzed.|participants|Number|2|2.0||||||
4174944|NCT00808015|3996608|B1|Proteinuria||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174945|NCT00808015|3996608|B1|Nephrolithiasis||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174946|NCT00808015|3996608|B1|Bladder irritation||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174947|NCT00808015|3996608|B1|Substance abuse||Medical History|N=129 for the parameter analyzed.|participants|Number|14|14.0||||||
4174948|NCT00808015|3996608|B1|Social phobia||Medical History|N=129 for the parameter analyzed.|participants|Number|2|2.0||||||
4174949|NCT00808015|3996608|B1|Sleep disorder||Medical History|N=129 for the parameter analyzed.|participants|Number|4|4.0||||||
4174950|NCT00808015|3996608|B1|Schizophrenia||Medical History|N=129 for the parameter analyzed.|participants|Number|3|3.0||||||
4174951|NCT00808015|3996608|B1|Schizoaffective disorder||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174952|NCT00808015|3996608|B1|Psychotic disorder||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174953|NCT00808015|3996608|B1|Personality disorder||Medical History|N=129 for the parameter analyzed.|participants|Number|5|5.0||||||
4174954|NCT00808015|3996608|B1|Panic disorder||Medical History|N=129 for the parameter analyzed.|participants|Number|6|6.0||||||
4174955|NCT00808015|3996608|B1|Panic attack||Medical History|N=129 for the parameter analyzed.|participants|Number|5|5.0||||||
4174956|NCT00808015|3996608|B1|Obsessive-compulsive disorder||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174957|NCT00808015|3996608|B1|Major depression||Medical History|N=129 for the parameter analyzed.|participants|Number|17|17.0||||||
4174958|NCT00808015|3996608|B1|Insomnia||Medical History|N=129 for the parameter analyzed.|participants|Number|5|5.0||||||
4174959|NCT00808015|3996608|B1|Generalised anxiety disorder||Medical History|N=129 for the parameter analyzed.|participants|Number|11|11.0||||||
4174960|NCT00808015|3996608|B1|Dysthymic disorder||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174961|NCT00808015|3996608|B1|Depression||Medical History|N=129 for the parameter analyzed.|participants|Number|8|8.0||||||
4174962|NCT00808015|3996608|B1|Depressed mood||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174963|NCT00808015|3996608|B1|Bipolar disorder||Medical History|N=129 for the parameter analyzed.|participants|Number|2|2.0||||||
4174964|NCT00808015|3996608|B1|Alcohol abuse||Medical History|N=129 for the parameter analyzed.|participants|Number|46|46.0||||||
4174965|NCT00808015|3996608|B1|Transient ischaemic attack||Medical History|N=129 for the parameter analyzed.|participants|Number|2|2.0||||||
4174966|NCT00808015|3996608|B1|Sedation||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174967|NCT00808015|3996608|B1|Parkinson’s disease||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174968|NCT00808015|3996608|B1|Neuropathy peripheral||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174969|NCT00808015|3996608|B1|Myasthenia gravis||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174970|NCT00808015|3996608|B1|Headache||Medical History|N=129 for the parameter analyzed.|participants|Number|6|6.0||||||
4174971|NCT00808015|3996608|B1|Dizziness||Medical History|N=129 for the parameter analyzed.|participants|Number|2|2.0||||||
4174972|NCT00808015|3996608|B1|Dementia||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174973|NCT00808015|3996608|B1|Cerebrovascular accident||Medical History|N=129 for the parameter analyzed.|participants|Number|21|21.0||||||
4174974|NCT00808015|3996608|B1|Cerebral ischaemia||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174975|NCT00808015|3996608|B1|Cerebral infarction||Medical History|N=129 for the parameter analyzed.|participants|Number|4|4.0||||||
4174976|NCT00808015|3996608|B1|Cerebral arteriosclerosis||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174977|NCT00808015|3996608|B1|Carotid artery stenosis||Medical History|N=129 for the parameter analyzed.|participants|Number|3|3.0||||||
4174978|NCT00808015|3996608|B1|Carotid artery occlusion||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174979|NCT00808015|3996608|B1|Renal neoplasm||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174980|NCT00808015|3996608|B1|Renal cell carcinoma||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174981|NCT00808015|3996608|B1|Renal cancer||Medical History|N=129 for the parameter analyzed.|participants|Number|2|2.0||||||
4174982|NCT00808015|3996608|B1|Rectal cancer||Medical History|N=129 for the parameter analyzed.|participants|Number|2|2.0||||||
4174983|NCT00808015|3996608|B1|Prostate cancer||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174984|NCT00808015|3996608|B1|Lung neoplasm malignant||Medical History|N=129 for the parameter analyzed.|participants|Number|8|8.0||||||
4174985|NCT00808015|3996608|B1|Lung neoplasm||Medical History|N=129 for the parameter analyzed.|participants|Number|9|9.0||||||
4174986|NCT00808015|3996608|B1|Leiomyosarcoma||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174987|NCT00808015|3996608|B1|Laryngeal cancer||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174988|NCT00808015|3996608|B1|Histiocytosis haematophagic||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174989|NCT00808015|3996608|B1|Hepatic neoplasm malignant||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174990|NCT00808015|3996608|B1|Head and neck cancer||Medical History|N=129 for the parameter analyzed.|participants|Number|2|2.0||||||
4174991|NCT00808015|3996608|B1|Gastric cancer||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174992|NCT00808015|3996608|B1|Gastric adenoma||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174993|NCT00808015|3996608|B1|Extranodal marginal zone B-cell lymphoma||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174994|NCT00808015|3996608|B1|Cervix carcinoma||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175613|NCT00807885|3996674|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4174995|NCT00808015|3996608|B1|Brain neoplasm||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174996|NCT00808015|3996608|B1|Benign lung neoplasm||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174997|NCT00808015|3996608|B1|Acute lymphocytic leukaemia||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4174998|NCT00808015|3996608|B1|Rheumatoid arthritis||Medical History|N=129 for the parameter analyzed.|participants|Number|4|4.0||||||
4174999|NCT00808015|3996608|B1|Osteoporosis||Medical History|N=129 for the parameter analyzed.|participants|Number|4|4.0||||||
4175000|NCT00808015|3996608|B1|Osteopenia||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175001|NCT00808015|3996608|B1|Osteoarthritis||Medical History|N=129 for the parameter analyzed.|participants|Number|2|2.0||||||
4175002|NCT00808015|3996608|B1|Neck pain||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175003|NCT00808015|3996608|B1|Intervertebral disc disorder||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175004|NCT00808015|3996608|B1|Back pain||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175005|NCT00808015|3996608|B1|Arthritis||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175006|NCT00808015|3996608|B1|Ankylosing spondylitis||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175007|NCT00808015|3996608|B1|Obesity||Medical History|N=129 for the parameter analyzed.|participants|Number|7|7.0||||||
4175008|NCT00808015|3996608|B1|Iron deficiency||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175009|NCT00808015|3996608|B1|Impaired fasting glucose||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175010|NCT00808015|3996608|B1|Hyperuricaemia||Medical History|N=129 for the parameter analyzed.|participants|Number|5|5.0||||||
4175011|NCT00808015|3996608|B1|Hyperlipidaemia||Medical History|N=129 for the parameter analyzed.|participants|Number|19|19.0||||||
4175012|NCT00808015|3996608|B1|Hyperhomocysteinaemia||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175013|NCT00808015|3996608|B1|Hypercholesterolaemia||Medical History|N=129 for the parameter analyzed.|participants|Number|2|2.0||||||
4175014|NCT00808015|3996608|B1|Gout||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175015|NCT00808015|3996608|B1|Dyslipidaemia||Medical History|N=129 for the parameter analyzed.|participants|Number|167|167.0||||||
4175016|NCT00808015|3996608|B1|Diabetes mellitus||Medical History|N=129 for the parameter analyzed.|participants|Number|132|132.0||||||
4175017|NCT00808015|3996608|B1|Calcium deficiency||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175018|NCT00808015|3996608|B1|Liver function test abnormal||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175019|NCT00808015|3996608|B1|Hepatitis B virus test||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175020|NCT00808015|3996608|B1|HIV test positive||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175021|NCT00808015|3996608|B1|Blood viscosity increased||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175022|NCT00808015|3996608|B1|Blood cholesterol increased||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175023|NCT00808015|3996608|B1|Meniscus lesion||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175024|NCT00808015|3996608|B1|Upper respiratory tract infection||Medical History|N=129 for the parameter analyzed.|participants|Number|2|2.0||||||
4175025|NCT00808015|3996608|B1|Tuberculous pleurisy||Medical History|N=129 for the parameter analyzed.|participants|Number|2|2.0||||||
4175026|NCT00808015|3996608|B1|Tuberculosis gastrointestinal||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175027|NCT00808015|3996608|B1|Tuberculosis||Medical History|N=129 for the parameter analyzed.|participants|Number|3|3.0||||||
4175028|NCT00808015|3996608|B1|Tonsillitis||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175029|NCT00808015|3996608|B1|Tinea pedis||Medical History|N=129 for the parameter analyzed.|participants|Number|2|2.0||||||
4175030|NCT00808015|3996608|B1|Rhinitis||Medical History|N=129 for the parameter analyzed.|participants|Number|7|7.0||||||
4175031|NCT00808015|3996608|B1|Pyelonephritis acute||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175032|NCT00808015|3996608|B1|Pulmonary tuberculosis||Medical History|N=129 for the parameter analyzed.|participants|Number|8|8.0||||||
4175033|NCT00808015|3996608|B1|Pneumonia||Medical History|N=129 for the parameter analyzed.|participants|Number|7|7.0||||||
4175034|NCT00808015|3996608|B1|Pharyngitis||Medical History|N=129 for the parameter analyzed.|participants|Number|12|12.0||||||
4175035|NCT00808015|3996608|B1|Onychomycosis||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175036|NCT00808015|3996608|B1|Nasopharyngitis||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175037|NCT00808015|3996608|B1|Lung abscess||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175038|NCT00808015|3996608|B1|Lower respiratory tract infection||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175039|NCT00808015|3996608|B1|Hepatitis B||Medical History|N=129 for the parameter analyzed.|participants|Number|3|3.0||||||
4175040|NCT00808015|3996608|B1|Helicobacter infection||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175041|NCT00808015|3996608|B1|Cystitis||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175042|NCT00808015|3996608|B1|Chronic sinusitis||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175043|NCT00808015|3996608|B1|Bronchitis||Medical History|N=129 for the parameter analyzed.|participants|Number|15|15.0||||||
4175044|NCT00808015|3996608|B1|Bronchiectasis||Medical History|N=129 for the parameter analyzed.|participants|Number|5|5.0||||||
4175614|NCT00807885|3996675|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4175045|NCT00808015|3996608|B1|Body tinea||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175046|NCT00808015|3996608|B1|Appendicitis||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175047|NCT00808015|3996608|B1|Sarcoidosis||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175048|NCT00808015|3996608|B1|Behcet’s syndrome||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175049|NCT00808015|3996608|B1|Hepatitis alcoholic||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175050|NCT00808015|3996608|B1|Hepatitis||Medical History|N=129 for the parameter analyzed.|participants|Number|2|2.0||||||
4175051|NCT00808015|3996608|B1|Hepatic steatosis||Medical History|N=129 for the parameter analyzed.|participants|Number|12|12.0||||||
4175052|NCT00808015|3996608|B1|Hepatic cyst||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175053|NCT00808015|3996608|B1|Chronic hepatitis||Medical History|N=129 for the parameter analyzed.|participants|Number|2|2.0||||||
4175054|NCT00808015|3996608|B1|Cholelithiasis||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175055|NCT00808015|3996608|B1|Cholecystitis||Medical History|N=129 for the parameter analyzed.|participants|Number|2|2.0||||||
4175056|NCT00808015|3996608|B1|Alcoholic liver disease||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175057|NCT00808015|3996608|B1|Pain||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175058|NCT00808015|3996608|B1|Malaise||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175059|NCT00808015|3996608|B1|Fatigue||Medical History|N=129 for the parameter analyzed.|participants|Number|3|3.0||||||
4175060|NCT00808015|3996608|B1|Chest pain||Medical History|N=129 for the parameter analyzed.|participants|Number|2|2.0||||||
4175061|NCT00808015|3996608|B1|Reflux oesophagitis||Medical History|N=129 for the parameter analyzed.|participants|Number|11|11.0||||||
4175062|NCT00808015|3996608|B1|Periodontitis||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175063|NCT00808015|3996608|B1|Peptic ulcer||Medical History|N=129 for the parameter analyzed.|participants|Number|50|50.0||||||
4175064|NCT00808015|3996608|B1|Pancreatitis chronic||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175065|NCT00808015|3996608|B1|Pancreatitis||Medical History|N=129 for the parameter analyzed.|participants|Number|2|2.0||||||
4175066|NCT00808015|3996608|B1|Oesophagitis||Medical History|N=129 for the parameter analyzed.|participants|Number|2|2.0||||||
4175067|NCT00808015|3996608|B1|Nausea||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175068|NCT00808015|3996608|B1|Irritable bowel syndrome||Medical History|N=129 for the parameter analyzed.|participants|Number|2|2.0||||||
4175069|NCT00808015|3996608|B1|Intestinal polyp||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175070|NCT00808015|3996608|B1|Haemorrhoids||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175071|NCT00808015|3996608|B1|Gastrooesophageal reflux disease||Medical History|N=129 for the parameter analyzed.|participants|Number|11|11.0||||||
4175072|NCT00808015|3996608|B1|Gastritis erosive||Medical History|N=129 for the parameter analyzed.|participants|Number|4|4.0||||||
4175073|NCT00808015|3996608|B1|Gastritis atrophic||Medical History|N=129 for the parameter analyzed.|participants|Number|4|4.0||||||
4175074|NCT00808015|3996608|B1|Gastritis||Medical History|N=129 for the parameter analyzed.|participants|Number|53|53.0||||||
4175075|NCT00808015|3996608|B1|Gastric ulcer||Medical History|N=129 for the parameter analyzed.|participants|Number|6|6.0||||||
4175076|NCT00808015|3996608|B1|Gastric haemorrhage||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175077|NCT00808015|3996608|B1|Dyspepsia||Medical History|N=129 for the parameter analyzed.|participants|Number|5|5.0||||||
4175078|NCT00808015|3996608|B1|Duodenitis||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175079|NCT00808015|3996608|B1|Duodenal ulcer||Medical History|N=129 for the parameter analyzed.|participants|Number|6|6.0||||||
4175080|NCT00808015|3996608|B1|Diverticulum intestinal||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175081|NCT00808015|3996608|B1|Crohn’s disease||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175082|NCT00808015|3996608|B1|Constipation||Medical History|N=129 for the parameter analyzed.|participants|Number|3|3.0||||||
4175083|NCT00808015|3996608|B1|Colonic polyp||Medical History|N=129 for the parameter analyzed.|participants|Number|3|3.0||||||
4175084|NCT00808015|3996608|B1|Colitis||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175085|NCT00808015|3996608|B1|Abdominal pain upper||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175086|NCT00808015|3996608|B1|Abdominal discomfort||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175087|NCT00808015|3996608|B1|Visual impairment||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175088|NCT00808015|3996608|B1|Blindness unilateral||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175089|NCT00808015|3996608|B1|Thyroid cyst||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175090|NCT00808015|3996608|B1|Hypothyroidism||Medical History|N=129 for the parameter analyzed.|participants|Number|5|5.0||||||
4175091|NCT00808015|3996608|B1|Hyperthyroidism||Medical History|N=129 for the parameter analyzed.|participants|Number|3|3.0||||||
4175092|NCT00808015|3996608|B1|Goitre||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175093|NCT00808015|3996608|B1|Basedow’s disease||Medical History|N=129 for the parameter analyzed.|participants|Number|2|2.0||||||
4175094|NCT00808015|3996608|B1|Hearing impaired||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175095|NCT00808015|3996608|B1|Ventricular extrasystoles||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175096|NCT00808015|3996608|B1|Sinus tachycardia||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175097|NCT00808015|3996608|B1|Prinzmetal angina||Medical History|N=129 for the parameter analyzed.|participants|Number|2|2.0||||||
4175098|NCT00808015|3996608|B1|Myocardial ischaemia||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175099|NCT00808015|3996608|B1|Myocardial infarction||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175100|NCT00808015|3996608|B1|Mitral valve calcification||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175101|NCT00808015|3996608|B1|Left ventricular hypertrophy||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175102|NCT00808015|3996608|B1|Coronary artery stenosis||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175103|NCT00808015|3996608|B1|Coronary artery disease||Medical History|N=129 for the parameter analyzed.|participants|Number|72|72.0||||||
4175104|NCT00808015|3996608|B1|Cor pulmonale chronic||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175105|NCT00808015|3996608|B1|Congestive cardiomyopathy||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175106|NCT00808015|3996608|B1|Cardiac valve disease||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175107|NCT00808015|3996608|B1|Cardiac failure congestive||Medical History|N=129 for the parameter analyzed.|participants|Number|2|2.0||||||
4175108|NCT00808015|3996608|B1|Cardiac failure||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175109|NCT00808015|3996608|B1|Bundle branch block right||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175110|NCT00808015|3996608|B1|Atrial fibrillation||Medical History|N=129 for the parameter analyzed.|participants|Number|5|5.0||||||
4175111|NCT00808015|3996608|B1|Arteriosclerosis coronary artery||Medical History|N=129 for the parameter analyzed.|participants|Number|1|1.0||||||
4175112|NCT00808015|3996608|B1|Arrhythmia||Medical History|N=129 for the parameter analyzed.|participants|Number|3|3.0||||||
4175113|NCT00808015|3996608|B1|Angina pectoris||Medical History|N=129 for the parameter analyzed.|participants|Number|18|18.0||||||
4175114|NCT00808015|3996608|B1|Acute myocardial infarction||Medical History|N=129 for the parameter analyzed.|participants|Number|2|2.0||||||
4175115|NCT00808015|3996608|B1|Zolpidem tartrate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|3|3.0||||||
4175116|NCT00808015|3996608|B1|Zolpidem||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|5|5.0||||||
4175117|NCT00808015|3996608|B1|Zevit||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175118|NCT00808015|3996608|B1|Yeast||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175119|NCT00808015|3996608|B1|Warfarin||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|6|6.0||||||
4175120|NCT00808015|3996608|B1|Voglibose||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|3|3.0||||||
4175121|NCT00808015|3996608|B1|Vitamins with minerals||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175122|NCT00808015|3996608|B1|Vitamins||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175123|NCT00808015|3996608|B1|Vildagliptin||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175124|NCT00808015|3996608|B1|Verapamil||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175125|NCT00808015|3996608|B1|Valsartan||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|9|9.0||||||
4175126|NCT00808015|3996608|B1|Valproate semisodium||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175127|NCT00808015|3996608|B1|Ursodeoxycholic acid||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|4|4.0||||||
4175128|NCT00808015|3996608|B1|Ultracet||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|3|3.0||||||
4175129|NCT00808015|3996608|B1|Udenafil||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175130|NCT00808015|3996608|B1|Trimetazidine hydrochloride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175131|NCT00808015|3996608|B1|Trimetazidine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175132|NCT00808015|3996608|B1|Triflusal||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175133|NCT00808015|3996608|B1|Triaprin||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175134|NCT00808015|3996608|B1|Trazodone||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175135|NCT00808015|3996608|B1|Travad phosphate enema||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175136|NCT00808015|3996608|B1|Tranexamic acid||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|3|3.0||||||
4175137|NCT00808015|3996608|B1|Tramadol hydrochloride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175138|NCT00808015|3996608|B1|Tocopherol||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175139|NCT00808015|3996608|B1|Tiropramide hydrochloride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175140|NCT00808015|3996608|B1|Tiotropium bromide/formoterol fumarate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175141|NCT00808015|3996608|B1|Tiotropium bromide||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175142|NCT00808015|3996608|B1|Tiotropium||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|10|10.0||||||
4175143|NCT00808015|3996608|B1|Ticlopidine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175144|NCT00808015|3996608|B1|Tianeptine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175615|NCT00807885|3996666|B10||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4175145|NCT00808015|3996608|B1|Throat preparations||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175146|NCT00808015|3996608|B1|Thioctic acid||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175147|NCT00808015|3996608|B1|Thiamazole||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175148|NCT00808015|3996608|B1|Theophylline||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|7|7.0||||||
4175149|NCT00808015|3996608|B1|Terbutaline sulfate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175150|NCT00808015|3996608|B1|Terazosin hydrochloride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175151|NCT00808015|3996608|B1|Terazosin||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175152|NCT00808015|3996608|B1|Telmisartan||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|8|8.0||||||
4175153|NCT00808015|3996608|B1|Tazobactam sodium||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175154|NCT00808015|3996608|B1|Tamsulosin hydrochloride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|3|3.0||||||
4175155|NCT00808015|3996608|B1|Tamsulosin||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|5|5.0||||||
4175156|NCT00808015|3996608|B1|"Symbicort turbuhaler draco"||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|6|6.0||||||
4175157|NCT00808015|3996608|B1|Sulodexide||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175158|NCT00808015|3996608|B1|Sulglicotide||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175159|NCT00808015|3996608|B1|Sucralfate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175160|NCT00808015|3996608|B1|Streptomycin||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175161|NCT00808015|3996608|B1|Spironolactone||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175162|NCT00808015|3996608|B1|Sotalol hydrochloride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175163|NCT00808015|3996608|B1|Sodium chloride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175164|NCT00808015|3996608|B1|Sitagliptin||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|6|6.0||||||
4175165|NCT00808015|3996608|B1|Sinilgel||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175166|NCT00808015|3996608|B1|Sinemet||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175167|NCT00808015|3996608|B1|Simvastatin||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|19|19.0||||||
4175168|NCT00808015|3996608|B1|Silymarin||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175169|NCT00808015|3996608|B1|Sildenafil citrate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175170|NCT00808015|3996608|B1|Sibutramine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175171|NCT00808015|3996608|B1|Sertraline||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175172|NCT00808015|3996608|B1|Seretide mite||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|15|15.0||||||
4175173|NCT00808015|3996608|B1|Selegiline hydrochloride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175174|NCT00808015|3996608|B1|Selective beta-2-adrenoreceptor agonists||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175175|NCT00808015|3996608|B1|Sarpogrelate hydrochloride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175176|NCT00808015|3996608|B1|Salvia miltiorrhiza||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175177|NCT00808015|3996608|B1|Salmeterol xinafoate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|3|3.0||||||
4175178|NCT00808015|3996608|B1|Salmeterol||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175179|NCT00808015|3996608|B1|Salbutamol sulfate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175180|NCT00808015|3996608|B1|Salbutamol||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|7|7.0||||||
4175181|NCT00808015|3996608|B1|Roxithromycin||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175182|NCT00808015|3996608|B1|Rosuvastatin calcium||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175183|NCT00808015|3996608|B1|Rosuvastatin||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|14|14.0||||||
4175184|NCT00808015|3996608|B1|Rosiglitazone maleate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175185|NCT00808015|3996608|B1|Risperidone||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175186|NCT00808015|3996608|B1|Risedronic acid||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175187|NCT00808015|3996608|B1|Repaglinide||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|3|3.0||||||
4175188|NCT00808015|3996608|B1|Rebamipide||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|12|12.0||||||
4175189|NCT00808015|3996608|B1|Ranitidine hydrochloride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|3|3.0||||||
4175190|NCT00808015|3996608|B1|Ranitidine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175191|NCT00808015|3996608|B1|Ramipril||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|4|4.0||||||
4175192|NCT00808015|3996608|B1|Rabeprazole sodium||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175193|NCT00808015|3996608|B1|Rabeprazole||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|3|3.0||||||
4175194|NCT00808015|3996608|B1|Quetiapine fumarate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175195|NCT00808015|3996608|B1|Pyridoxine hydrochloride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175196|NCT00808015|3996608|B1|Pseudoephedrine hydrochloride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175197|NCT00808015|3996608|B1|Propranolol hydrochloride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175198|NCT00808015|3996608|B1|Propranolol||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175199|NCT00808015|3996608|B1|Procaterol||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175200|NCT00808015|3996608|B1|Pregabalin||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175201|NCT00808015|3996608|B1|Prednisolone||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|4|4.0||||||
4175202|NCT00808015|3996608|B1|Pravastatin sodium||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|4|4.0||||||
4175203|NCT00808015|3996608|B1|Pravastatin||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|7|7.0||||||
4175204|NCT00808015|3996608|B1|Pranlukast hydrate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175205|NCT00808015|3996608|B1|Polycarbophil calcium||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175206|NCT00808015|3996608|B1|Platelets, human blood||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175207|NCT00808015|3996608|B1|Pip/tazo||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175208|NCT00808015|3996608|B1|Pioglitazone hydrochloride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|3|3.0||||||
4175209|NCT00808015|3996608|B1|Pioglitazone||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|3|3.0||||||
4175210|NCT00808015|3996608|B1|Phosphatidyl choline||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175211|NCT00808015|3996608|B1|Phenytoin sodium||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175212|NCT00808015|3996608|B1|Pethidine hydrochloride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175213|NCT00808015|3996608|B1|Perindopril||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|8|8.0||||||
4175214|NCT00808015|3996608|B1|Penicillin NOS||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175215|NCT00808015|3996608|B1|Paroxetine hydrochloride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175216|NCT00808015|3996608|B1|Paroxetine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175217|NCT00808015|3996608|B1|Paracetamol||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|5|5.0||||||
4175218|NCT00808015|3996608|B1|Pantoprazole sodium||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|4|4.0||||||
4175219|NCT00808015|3996608|B1|Pantoprazole||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175220|NCT00808015|3996608|B1|Oxycodone hydrochloride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175221|NCT00808015|3996608|B1|Oxcarbazepine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175222|NCT00808015|3996608|B1|Oxazepam||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175223|NCT00808015|3996608|B1|Orlistat||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175224|NCT00808015|3996608|B1|Omeprazole||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|3|3.0||||||
4175225|NCT00808015|3996608|B1|Omega-3 triglycerides||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|3|3.0||||||
4175226|NCT00808015|3996608|B1|Omega-3 marine triglycerides||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175227|NCT00808015|3996608|B1|Olmesartan||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|5|5.0||||||
4175228|NCT00808015|3996608|B1|Olanzapine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175229|NCT00808015|3996608|B1|Nitrendipine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175230|NCT00808015|3996608|B1|Nisoldipine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175231|NCT00808015|3996608|B1|Nimodipine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175232|NCT00808015|3996608|B1|Nifedipine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|16|16.0||||||
4175233|NCT00808015|3996608|B1|Nicotinic acid||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175234|NCT00808015|3996608|B1|Nicorandil||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|5|5.0||||||
4175235|NCT00808015|3996608|B1|Nebivolol||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175236|NCT00808015|3996608|B1|Nateglinide||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|4|4.0||||||
4175237|NCT00808015|3996608|B1|Naltrexone||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175238|NCT00808015|3996608|B1|Myrtol||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|3|3.0||||||
4175239|NCT00808015|3996608|B1|Multivitamins, plain||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175240|NCT00808015|3996608|B1|Moxifloxacin hydrochloride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175241|NCT00808015|3996608|B1|Mosapride citrate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|4|4.0||||||
4175242|NCT00808015|3996608|B1|Mosapride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175243|NCT00808015|3996608|B1|Montelukast sodium||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|4|4.0||||||
4175244|NCT00808015|3996608|B1|Montelukast||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|3|3.0||||||
4175245|NCT00808015|3996608|B1|Mometasone||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175246|NCT00808015|3996608|B1|Molsidomine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175247|NCT00808015|3996608|B1|Mirtazapine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175248|NCT00808015|3996608|B1|Milnacipran hydrochloride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175249|NCT00808015|3996608|B1|Midazolam||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175250|NCT00808015|3996608|B1|Metoprolol tartrate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|6|6.0||||||
4175251|NCT00808015|3996608|B1|Metoprolol succinate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|3|3.0||||||
4175252|NCT00808015|3996608|B1|Metoprolol||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|11|11.0||||||
4175253|NCT00808015|3996608|B1|Methylprednisolone||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|3|3.0||||||
4175254|NCT00808015|3996608|B1|Methoxyphenamine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175255|NCT00808015|3996608|B1|Metformin hydrochloride/sitagliptin||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175256|NCT00808015|3996608|B1|Metformin hydrochloride/rosiglitazone||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175257|NCT00808015|3996608|B1|Metformin hydrochloride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|15|15.0||||||
4175258|NCT00808015|3996608|B1|Metformin||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|29|29.0||||||
4175259|NCT00808015|3996608|B1|Mesalazine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175260|NCT00808015|3996608|B1|Medilac-S||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175261|NCT00808015|3996608|B1|Mecobalamin||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175262|NCT00808015|3996608|B1|Magnesium hydroxide||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175263|NCT00808015|3996608|B1|Losartan potassium||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|8|8.0||||||
4175264|NCT00808015|3996608|B1|Losartan||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|7|7.0||||||
4175265|NCT00808015|3996608|B1|Lorazepam||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175266|NCT00808015|3996608|B1|Loratadine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175267|NCT00808015|3996608|B1|Lithium carbonate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175268|NCT00808015|3996608|B1|Lisinopril||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175269|NCT00808015|3996608|B1|Liquorice||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175270|NCT00808015|3996608|B1|Levothyroxine sodium||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|3|3.0||||||
4175271|NCT00808015|3996608|B1|Levosulpiride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|3|3.0||||||
4175272|NCT00808015|3996608|B1|Levosalbutamol hydrochloride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175273|NCT00808015|3996608|B1|Levofloxacin hydrochloride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|5|5.0||||||
4175274|NCT00808015|3996608|B1|Levofloxacin||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|8|8.0||||||
4175275|NCT00808015|3996608|B1|Levodropropizine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|4|4.0||||||
4175276|NCT00808015|3996608|B1|Levocloperastine fendizoate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|3|3.0||||||
4175277|NCT00808015|3996608|B1|Levamlodipine besylate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175278|NCT00808015|3996608|B1|Lercanidipine hydrochloride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175279|NCT00808015|3996608|B1|Lercanidipine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175280|NCT00808015|3996608|B1|Lekovit Ca||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175281|NCT00808015|3996608|B1|Lansoprazole||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175282|NCT00808015|3996608|B1|Lamivudine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|3|3.0||||||
4175283|NCT00808015|3996608|B1|Lactitol||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175284|NCT00808015|3996608|B1|Lacidipine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175285|NCT00808015|3996608|B1|Kombipak II||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175286|NCT00808015|3996608|B1|Karvea hct||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|3|3.0||||||
4175287|NCT00808015|3996608|B1|Itopride hydrochloride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175288|NCT00808015|3996608|B1|Itopride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175289|NCT00808015|3996608|B1|Itavastatin||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|6|6.0||||||
4175290|NCT00808015|3996608|B1|Isotretinoin||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175291|NCT00808015|3996608|B1|Isosorbide mononitrate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|11|11.0||||||
4175292|NCT00808015|3996608|B1|Isosorbide dinitrate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175293|NCT00808015|3996608|B1|Irbesartan||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|13|13.0||||||
4175294|NCT00808015|3996608|B1|Ipratropium bromide||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|4|4.0||||||
4175295|NCT00808015|3996608|B1|Ipratropium||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175296|NCT00808015|3996608|B1|Insulin human injection, isophane||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175297|NCT00808015|3996608|B1|Insulin human||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|3|3.0||||||
4175298|NCT00808015|3996608|B1|Insulin glulisine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175299|NCT00808015|3996608|B1|Insulin glargine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175300|NCT00808015|3996608|B1|Insulin aspart||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175301|NCT00808015|3996608|B1|Insulin||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|8|8.0||||||
4175302|NCT00808015|3996608|B1|Inosine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175303|NCT00808015|3996608|B1|Infliximab||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175304|NCT00808015|3996608|B1|Indometacin||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175305|NCT00808015|3996608|B1|Indapamide||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175306|NCT00808015|3996608|B1|Hyzaar||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175307|NCT00808015|3996608|B1|Hydrotalcite||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175308|NCT00808015|3996608|B1|Hydrocortisone||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175309|NCT00808015|3996608|B1|Hydrochlorothiazide||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|7|7.0||||||
4175310|NCT00808015|3996608|B1|Hyaluronate sodium||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175311|NCT00808015|3996608|B1|Homeopatic preparation||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|8|8.0||||||
4175312|NCT00808015|3996608|B1|Herbal preparation||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|13|13.0||||||
4175313|NCT00808015|3996608|B1|Hedera helix||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|4|4.0||||||
4175314|NCT00808015|3996608|B1|Guaifenesin||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175315|NCT00808015|3996608|B1|Glyceryl trinitrate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|4|4.0||||||
4175316|NCT00808015|3996608|B1|Glucose||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175317|NCT00808015|3996608|B1|Gliquidone||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175318|NCT00808015|3996608|B1|Glipizide||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|3|3.0||||||
4175319|NCT00808015|3996608|B1|Glimepiride/metformin hydrochloride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175320|NCT00808015|3996608|B1|Glimepiride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|12|12.0||||||
4175321|NCT00808015|3996608|B1|Gliclazide||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|10|10.0||||||
4175322|NCT00808015|3996608|B1|Glibenclamide||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175323|NCT00808015|3996608|B1|Ginkgo biloba||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175324|NCT00808015|3996608|B1|General nutrients/herbal NOS||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175325|NCT00808015|3996608|B1|Gefarnate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175326|NCT00808015|3996608|B1|Gabapentin||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175327|NCT00808015|3996608|B1|Furosemide||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175328|NCT00808015|3996608|B1|Fosinopril sodium||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175329|NCT00808015|3996608|B1|Fosinopril||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|3|3.0||||||
4175330|NCT00808015|3996608|B1|Formoterol fumarate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175331|NCT00808015|3996608|B1|Formoterol||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|3|3.0||||||
4175332|NCT00808015|3996608|B1|Folic acid||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|4|4.0||||||
4175333|NCT00808015|3996608|B1|Fluoxetine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175334|NCT00808015|3996608|B1|Flunarizine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175335|NCT00808015|3996608|B1|Flumazenil||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175336|NCT00808015|3996608|B1|Fish oil||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175337|NCT00808015|3996608|B1|Fexofenadine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175338|NCT00808015|3996608|B1|Ferrous sulfate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175339|NCT00808015|3996608|B1|Ferric hydroxide polymaltose complex||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175340|NCT00808015|3996608|B1|Fenofibrate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|10|10.0||||||
4175341|NCT00808015|3996608|B1|Felodipine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|7|7.0||||||
4175342|NCT00808015|3996608|B1|Famotidine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175343|NCT00808015|3996608|B1|Ezetimibe/simvastatin||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|4|4.0||||||
4175344|NCT00808015|3996608|B1|Ezetimibe||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175345|NCT00808015|3996608|B1|Etoricoxib||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175346|NCT00808015|3996608|B1|Etoposide||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175347|NCT00808015|3996608|B1|Etizolam||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175348|NCT00808015|3996608|B1|Esomeprazole magnesium||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|3|3.0||||||
4175349|NCT00808015|3996608|B1|Esomeprazole||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|3|3.0||||||
4175350|NCT00808015|3996608|B1|Escitalopram||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|3|3.0||||||
4175351|NCT00808015|3996608|B1|Erythromycin ethylsuccinate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175352|NCT00808015|3996608|B1|Erlotinib hydrochloride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175353|NCT00808015|3996608|B1|Ergenyl chrono||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175354|NCT00808015|3996608|B1|Erdosteine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|6|6.0||||||
4175355|NCT00808015|3996608|B1|Eprosartan mesilate/hydrochlorothiazide||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175356|NCT00808015|3996608|B1|Eprosartan mesilate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175357|NCT00808015|3996608|B1|Eprosartan||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175358|NCT00808015|3996608|B1|Epoprostenol||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175359|NCT00808015|3996608|B1|Enzymes||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175360|NCT00808015|3996608|B1|Enalapril maleate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175361|NCT00808015|3996608|B1|Enalapril||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175362|NCT00808015|3996608|B1|Efonidipine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175363|NCT00808015|3996608|B1|Efavirenz/emtricitabine/tenofovir||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175364|NCT00808015|3996608|B1|Ecabet monosodium||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175365|NCT00808015|3996608|B1|Duloxetine hydrochloride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175366|NCT00808015|3996608|B1|Drug, unspecified||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|3|3.0||||||
4175367|NCT00808015|3996608|B1|Doxofylline||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|14|14.0||||||
4175368|NCT00808015|3996608|B1|Doxazosin mesilate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175369|NCT00808015|3996608|B1|Donepezil||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175370|NCT00808015|3996608|B1|Domperidone||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|4|4.0||||||
4175371|NCT00808015|3996608|B1|Disulfiram||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175372|NCT00808015|3996608|B1|Diprophylline||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175373|NCT00808015|3996608|B1|Dimenhydrinate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175374|NCT00808015|3996608|B1|Diltiazem hydrochloride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175375|NCT00808015|3996608|B1|Diltiazem||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|6|6.0||||||
4175376|NCT00808015|3996608|B1|Dihydrocodeine bitartrate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175377|NCT00808015|3996608|B1|Digoxin||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175378|NCT00808015|3996608|B1|Diclofenac||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175379|NCT00808015|3996608|B1|Diazepam||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175380|NCT00808015|3996608|B1|Diacerein||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175381|NCT00808015|3996608|B1|Dexamethasone/neomycin sulfate/polymyxin B sulfate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175382|NCT00808015|3996608|B1|Dexamethasone||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175383|NCT00808015|3996608|B1|Cough syrup||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175384|NCT00808015|3996608|B1|Cordalin /old form||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175385|NCT00808015|3996608|B1|Colchicine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175386|NCT00808015|3996608|B1|Co-diovan||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175387|NCT00808015|3996608|B1|Clopidogrel sulfate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|16|16.0||||||
4175388|NCT00808015|3996608|B1|Clopidogrel||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|19|19.0||||||
4175389|NCT00808015|3996608|B1|Clonazepam||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|3|3.0||||||
4175390|NCT00808015|3996608|B1|Clobazam||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175391|NCT00808015|3996608|B1|Clarithromycin||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|5|5.0||||||
4175392|NCT00808015|3996608|B1|Citalopram||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175393|NCT00808015|3996608|B1|Ciprofloxacin||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175394|NCT00808015|3996608|B1|Cimetidine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175395|NCT00808015|3996608|B1|Cilostazol||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|3|3.0||||||
4175396|NCT00808015|3996608|B1|Cilnidipine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|6|6.0||||||
4175397|NCT00808015|3996608|B1|Cilazapril||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175398|NCT00808015|3996608|B1|Chondroitin/glucosamine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175399|NCT00808015|3996608|B1|Choline alfoscerate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|5|5.0||||||
4175400|NCT00808015|3996608|B1|Chlormadinone acetate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175401|NCT00808015|3996608|B1|Cetirizine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175402|NCT00808015|3996608|B1|Cephalosporins and related substances||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175403|NCT00808015|3996608|B1|Cefuroxime sodium||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175404|NCT00808015|3996608|B1|Cefuroxime||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|3|3.0||||||
4175405|NCT00808015|3996608|B1|Ceftriaxone sodium||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175406|NCT00808015|3996608|B1|Cefradine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175407|NCT00808015|3996608|B1|Cefpodoxime proxetil||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175408|NCT00808015|3996608|B1|Cefpodoxime||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175409|NCT00808015|3996608|B1|Cefoperazone sodium||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175410|NCT00808015|3996608|B1|Cefaclor||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|5|5.0||||||
4175411|NCT00808015|3996608|B1|Carvedilol||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|7|7.0||||||
4175412|NCT00808015|3996608|B1|Cardiovascular system drugs||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175413|NCT00808015|3996608|B1|Carbazochrome||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175414|NCT00808015|3996608|B1|Candesartan cilexetil||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175415|NCT00808015|3996608|B1|Candesartan||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|6|6.0||||||
4175416|NCT00808015|3996608|B1|Calcium lactate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175417|NCT00808015|3996608|B1|Calcium citrate/colecalciferol||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175418|NCT00808015|3996608|B1|Calcium chloride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175419|NCT00808015|3996608|B1|Buspirone||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175420|NCT00808015|3996608|B1|Buspiron||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175421|NCT00808015|3996608|B1|Bupropion hydrochloride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175422|NCT00808015|3996608|B1|Bupropion||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175423|NCT00808015|3996608|B1|Budesonide||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175424|NCT00808015|3996608|B1|Broncho-vaxom||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175425|NCT00808015|3996608|B1|Bromelains/dehydrocholic/pancreatin/simeticone||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175426|NCT00808015|3996608|B1|Borneol/notoginseng/salvia miltiorrhiza||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175427|NCT00808015|3996608|B1|Bisoprolol fumarate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|12|12.0||||||
4175428|NCT00808015|3996608|B1|Bisoprolol||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|6|6.0||||||
4175429|NCT00808015|3996608|B1|Bismuth subcitrate tripotassium/ranitidine HCl||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175430|NCT00808015|3996608|B1|Bismuth subcitrate tripotassium||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175431|NCT00808015|3996608|B1|Biselect||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175432|NCT00808015|3996608|B1|Biphenyl dimethyl dicarboxylate/garlic||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175433|NCT00808015|3996608|B1|Bevantolol||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175434|NCT00808015|3996608|B1|Betahistine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175435|NCT00808015|3996608|B1|Beraprost||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175436|NCT00808015|3996608|B1|Bepotastine besilate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175437|NCT00808015|3996608|B1|Benproperine phosphate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175438|NCT00808015|3996608|B1|Benproperine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175439|NCT00808015|3996608|B1|Benazepril hydrochloride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175440|NCT00808015|3996608|B1|Benazepril||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175441|NCT00808015|3996608|B1|Becotal||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175442|NCT00808015|3996608|B1|Becosym forte||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175443|NCT00808015|3996608|B1|Becosules syrup||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175444|NCT00808015|3996608|B1|Bambuterol hydrochloride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175445|NCT00808015|3996608|B1|"B-komplex leciva"||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175446|NCT00808015|3996608|B1|Aztreonam||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175447|NCT00808015|3996608|B1|Azithromycin||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|3|3.0||||||
4175448|NCT00808015|3996608|B1|Azelastine hydrochloride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175449|NCT00808015|3996608|B1|Azelastine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175450|NCT00808015|3996608|B1|Azathioprine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175451|NCT00808015|3996608|B1|Atorvastatin calcium||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|9|9.0||||||
4175452|NCT00808015|3996608|B1|Atorvastatin||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|44|44.0||||||
4175453|NCT00808015|3996608|B1|Atenolol||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175454|NCT00808015|3996608|B1|Asmeton||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|9|9.0||||||
4175455|NCT00808015|3996608|B1|Artemisia asiatica/ethanol||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175456|NCT00808015|3996608|B1|Artemisia asiatica||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175457|NCT00808015|3996608|B1|Arotinolol hydrochloride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175458|NCT00808015|3996608|B1|Aronamin gold||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175459|NCT00808015|3996608|B1|Aripiprazole||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175460|NCT00808015|3996608|B1|Antisterone||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175461|NCT00808015|3996608|B1|Amoxicillin sodium||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175462|NCT00808015|3996608|B1|Amoxicillin||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|6|6.0||||||
4175463|NCT00808015|3996608|B1|Amlodipine/valsartan||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|3|3.0||||||
4175464|NCT00808015|3996608|B1|Amlodipine orotate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175465|NCT00808015|3996608|B1|Amlodipine maleate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175466|NCT00808015|3996608|B1|Amlodipine camsilate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175467|NCT00808015|3996608|B1|Amlodipine besylate/valsartan||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175468|NCT00808015|3996608|B1|Amlodipine besilate/atorvastatin calcium||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175469|NCT00808015|3996608|B1|Amlodipine besilate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|17|17.0||||||
4175470|NCT00808015|3996608|B1|Amlodipine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|17|17.0||||||
4175471|NCT00808015|3996608|B1|Amitriptyline hydrochloride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175472|NCT00808015|3996608|B1|Amisulpride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175473|NCT00808015|3996608|B1|Aminophylline||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175474|NCT00808015|3996608|B1|Ambroxol hydrochloride||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|8|8.0||||||
4175475|NCT00808015|3996608|B1|Ambroxol acefyllinate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175476|NCT00808015|3996608|B1|Ambroxol||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|4|4.0||||||
4175477|NCT00808015|3996608|B1|Alprazolam||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|6|6.0||||||
4175478|NCT00808015|3996608|B1|Almagate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|4|4.0||||||
4175479|NCT00808015|3996608|B1|Allopurinol||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175480|NCT00808015|3996608|B1|All other therapeutic products||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|6|6.0||||||
4175481|NCT00808015|3996608|B1|Alfuzosin||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175482|NCT00808015|3996608|B1|Adenine/biphenyldimethyldicarboxylate/vitamins||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175483|NCT00808015|3996608|B1|Acetylsalicylic acid/clopidogrel||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175484|NCT00808015|3996608|B1|Acetylsalicylic acid/atorvastatin/ramipril||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175485|NCT00808015|3996608|B1|Acetylsalicylic acid||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|99|99.0||||||
4175486|NCT00808015|3996608|B1|Acetylcysteine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|11|11.0||||||
4175487|NCT00808015|3996608|B1|Acetylcarnitine||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175488|NCT00808015|3996608|B1|Aceclofenac||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|1|1.0||||||
4175489|NCT00808015|3996608|B1|Acarbose||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|14|14.0||||||
4175490|NCT00808015|3996608|B1|Acamprosate||Prior Drug Treatment|N=435 for the parameter analyzed.|participants|Number|2|2.0||||||
4175491|NCT00808015|3996608|B1|Other unspecified||Nondrug treatments / procedures for primary diagnosis|N=701 for the parameter analyzed.|participants|Number|1|1.0||||||
4175616|NCT00807885|3996667|B9||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4175492|NCT00808015|3996608|B1|Quit Smoking Clinic||Nondrug treatments / procedures for primary diagnosis|N=701 for the parameter analyzed.|participants|Number|190|190.0||||||
4175493|NCT00808015|3996608|B1|Smoking Cessation Counseling||Nondrug treatments / procedures for primary diagnosis|N=701 for the parameter analyzed.|participants|Number|661|661.0||||||
4175494|NCT00808015|3996608|B1|Schizophrenia (n=120)||Family history of mental illness|Family members who were considered for the following parameter were Biological Parents, Biological Siblings, Children and Grandparents. The 'n' is signifying those participants who were evaluated for this measure respectively.|participants|Number|4|4.0||||||
4175495|NCT00808015|3996608|B1|Parkinson’s disease (n=1)||Family history of mental illness|Family members who were considered for the following parameter were Biological Parents, Biological Siblings, Children and Grandparents. The 'n' is signifying those participants who were evaluated for this measure respectively.|participants|Number|1|1.0||||||
4175496|NCT00808015|3996608|B1|Nicotine addiction (n=8)||Family history of mental illness|Family members who were considered for the following parameter were Biological Parents, Biological Siblings, Children and Grandparents. The 'n' is signifying those participants who were evaluated for this measure respectively.|participants|Number|8|8.0||||||
4175497|NCT00808015|3996608|B1|Mental disorder (n=1)||Family history of mental illness|Family members who were considered for the following parameter were Biological Parents, Biological Siblings, Children and Grandparents. The 'n' is signifying those participants who were evaluated for this measure respectively.|participants|Number|1|1.0||||||
4175498|NCT00808015|3996608|B1|Major depression (n=120)||Family history of mental illness|Family members who were considered for the following parameter were Biological Parents, Biological Siblings, Children and Grandparents. The 'n' is signifying those participants who were evaluated for this measure respectively.|participants|Number|1|1.0||||||
4175499|NCT00808015|3996608|B1|Dissociative disorder (n=1)||Family history of mental illness|Family members who were considered for the following parameter were Biological Parents, Biological Siblings, Children and Grandparents. The 'n' is signifying those participants who were evaluated for this measure respectively.|participants|Number|1|1.0||||||
4175500|NCT00808015|3996608|B1|Depression (Chronic or recurrent) (n=119)||Family history of mental illness|Family members who were considered for the following parameter were Biological Parents, Biological Siblings, Children and Grandparents. The 'n' is signifying those participants who were evaluated for this measure respectively.|participants|Number|2|2.0||||||
4175501|NCT00808015|3996608|B1|Dementia (n=120)||Family history of mental illness|Family members who were considered for the following parameter were Biological Parents, Biological Siblings, Children and Grandparents. The 'n' is signifying those participants who were evaluated for this measure respectively.|participants|Number|2|2.0||||||
4175502|NCT00808015|3996608|B1|Cerebral apoplexy (n=1)||Family history of mental illness|Family members who were considered for the following parameter were Biological Parents, Biological Siblings, Children and Grandparents. The 'n' is signifying those participants who were evaluated for this measure respectively.|participants|Number|1|1.0||||||
4175503|NCT00808015|3996608|B1|Alcohol abuse (n=122)||Family history of mental illness|Family members who were considered for the following parameter were Biological Parents, Biological Siblings, Children and Grandparents. The 'n' is signifying those participants who were evaluated for this measure respectively.|participants|Number|12|12.0||||||
4175504|NCT00808015|3996608|B1|Part-time employed||Health care utilization: Employment status|N=1266 for the parameter analyzed.|participants|Number|15|15.0||||||
4175505|NCT00808015|3996608|B1|Full-time employed||Health care utilization: Employment status|N=1266 for the parameter analyzed.|participants|Number|1016|1016.0||||||
4175506|NCT00808015|3996608|B1|Not employed||Health care utilization: Employment status|N=1266 for the parameter analyzed.|participants|Number|235|235.0||||||
4175507|NCT00808015|3996608|B1|Other unspecified||Healthcare utilization status: Reimbursement type|N=1287 for the parameter analyzed.|participants|Number|23|23.0||||||
4175508|NCT00808015|3996608|B1|Public Insurance||Healthcare utilization status: Reimbursement type|N=1287 for the parameter analyzed.|participants|Number|877|877.0||||||
4175509|NCT00808015|3996608|B1|No Insurance||Healthcare utilization status: Reimbursement type|N=1287 for the parameter analyzed.|participants|Number|276|276.0||||||
4175510|NCT00808015|3996608|B1|Private Insurance||Healthcare utilization status: Reimbursement type|N=1287 for the parameter analyzed.|participants|Number|111|111.0||||||
4175511|NCT00808015|3996608|B1|Other unspecified||Participant social status : Current Living Situation|N = 1243 for the parameter analyzed.|participants|Number|1|1.0||||||
4175512|NCT00808015|3996608|B1|Living in institution||Participant social status : Current Living Situation|N = 1243 for the parameter analyzed.|participants|Number|1|1.0||||||
4175513|NCT00808015|3996608|B1|Living in residential treatment center||Participant social status : Current Living Situation|N = 1243 for the parameter analyzed.|participants|Number|1|1.0||||||
4175514|NCT00808015|3996608|B1|Living alone||Participant social status : Current Living Situation|N = 1243 for the parameter analyzed.|participants|Number|45|45.0||||||
4175515|NCT00808015|3996608|B1|Living with other family member(s) or roommate(s)||Participant social status : Current Living Situation|N = 1243 for the parameter analyzed.|participants|Number|193|193.0||||||
4175516|NCT00808015|3996608|B1|Living with a spouse or significant other||Participant social status : Current Living Situation|N = 1243 for the parameter analyzed.|participants|Number|1002|1002.0||||||
4175517|NCT00808015|3996608|B1|Cohabitating||Participant social status : Current Marital Status|N = 1258 for the parameter analyzed.|participants|Number|1|1.0||||||
4175518|NCT00808015|3996608|B1|Separated||Participant social status : Current Marital Status|N = 1258 for the parameter analyzed.|participants|Number|4|4.0||||||
4175519|NCT00808015|3996608|B1|Widowed||Participant social status : Current Marital Status|N = 1258 for the parameter analyzed.|participants|Number|12|12.0||||||
4175520|NCT00808015|3996608|B1|Divorced||Participant social status : Current Marital Status|N = 1258 for the parameter analyzed.|participants|Number|13|13.0||||||
4175521|NCT00808015|3996608|B1|Never Married||Participant social status : Current Marital Status|N = 1258 for the parameter analyzed.|participants|Number|104|104.0||||||
4175522|NCT00808015|3996608|B1|Married||Participant social status : Current Marital Status|N = 1258 for the parameter analyzed.|participants|Number|1124|1124.0||||||
4175617|NCT00807885|3996668|B8||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4175523|NCT00808015|3996608|B1|Documented Ankle Brachial Index (ABI) <0.9||Cardiovascular risk factors|N=138 for the parameter analyzed.|participants|Number|3|3.0||||||
4175524|NCT00808015|3996608|B1|History of microalbuminuria||Cardiovascular risk factors|N=138 for the parameter analyzed.|participants|Number|9|9.0||||||
4175525|NCT00808015|3996608|B1|Unspecified||Cardiovascular risk factors|N=138 for the parameter analyzed.|participants|Number|13|13.0||||||
4175526|NCT00808015|3996608|B1|Left ventricular hypertrophy||Cardiovascular risk factors|N=138 for the parameter analyzed.|participants|Number|13|13.0||||||
4175527|NCT00808015|3996608|B1|Family history of Cardiovascular disease or stroke||Cardiovascular risk factors|N=138 for the parameter analyzed.|participants|Number|111|111.0||||||
4175528|NCT00808015|3996608|B1|Atherosclerotic vascular disease (n=1181)||Smoking related concurrent diseases|The 'n' is signifying those participants who were evaluated for this measure respectively.|participants|Number|138|138.0||||||
4175529|NCT00808015|3996608|B1|Occlusive disease of non-coronary arteries(n=1183)||Smoking related concurrent diseases|The 'n' is signifying those participants who were evaluated for this measure respectively.|participants|Number|21|21.0||||||
4175530|NCT00808015|3996608|B1|||Average number of cigarettes smoked per day in the previous 7 day period at baseline|The average number of cigarettes smoked per day over the last 7 days was collected as a part of nicotine use inventory assessment through consent record form module which included a questionnaire: Did the participant smoke any cigarettes (even a puff) in last 7 days (Yes/No) and Did the participant use any other tobacco products (example- pipe, cigars, chew, snuff) in last 7 days (Yes/No). N=1256 for the parameter analyzed.|cigarettes|Median|20.0|20.0|Full Range|||1.0|80.0|
4175531|NCT00808015|3996608|B1|||Exhaled Carbon monoxide (CO) level|The CO level was measured from exhaled air of the participant using CO analyzer at the last observed study visit which was the last available CO level recorded after baseline. The CO level was only measured if it was a part of the usual practice at the site. N= 361 for the parameter analyzed.|parts per million (ppm)|Mean|14.20|14.2|Standard Deviation|7.69|7.69|||
4175532|NCT00808015|3996608|B1|||Fagerstrom Test of Nicotine Dependence (FTND)|FTND was designed to provide measure of nicotine dependence related to cigarette smoking. It contains 4 yes-no and 2 multiple choice questions. Items are scored 0-3 for multiple choice items, items are summed to yield total score of 0-10 (0=minimum to 10=maximum nicotine dependence).N= 268 for the parameter analyzed.|Scores on a scale|Mean|5.50|5.5|Standard Deviation|2.43|2.43|||
4175533|NCT00808015|3996608|B1|Smoking ban in public places||Quit History : Reasons motivated participant to quit smoking|N = 1299 for the parameter analyzed.|participants|Number|37|37.0||||||
4175534|NCT00808015|3996608|B1|Body image / appearance||Quit History : Reasons motivated participant to quit smoking|N = 1299 for the parameter analyzed.|participants|Number|78|78.0||||||
4175535|NCT00808015|3996608|B1|Money / cost||Quit History : Reasons motivated participant to quit smoking|N = 1299 for the parameter analyzed.|participants|Number|72|72.0||||||
4175536|NCT00808015|3996608|B1|Family / Friends||Quit History : Reasons motivated participant to quit smoking|N = 1299 for the parameter analyzed.|participants|Number|902|902.0||||||
4175537|NCT00808015|3996608|B1|Health reasons||Quit History : Reasons motivated participant to quit smoking|N = 1299 for the parameter analyzed.|participants|Number|1218|1218.0||||||
4175538|NCT00808015|3996608|B1|Exposure to smoke environment||Quit History : Main reasons for relapses after previous attempts|N = 813 for the parameter analyzed.|participants|Number|227|227.0||||||
4175539|NCT00808015|3996608|B1|Weight gain||Quit History : Main reasons for relapses after previous attempts|N = 813 for the parameter analyzed.|participants|Number|20|20.0||||||
4175540|NCT00808015|3996608|B1|Urge to smoke is too strong||Quit History : Main reasons for relapses after previous attempts|N = 813 for the parameter analyzed.|participants|Number|449|449.0||||||
4175541|NCT00808015|3996608|B1|Smoking is a habitual response to stress/pressure||Quit History : Main reasons for relapses after previous attempts|N = 813 for the parameter analyzed.|participants|Number|381|381.0||||||
4175542|NCT00808015|3996608|B1|Family / Friends||Quit History : Main reasons for relapses after previous attempts|N = 813 for the parameter analyzed.|participants|Number|164|164.0||||||
4175543|NCT00808015|3996608|B1|Three or more||Smoking history: Lifetime serious quit attempts|A serious quit attempt was defined as smoking cessation for more than 24 hours. Scores were graded as none (no attempt) to 3 or more attempts). N = 649 for the parameter analyzed.|participants|Number|194|194.0||||||
4175544|NCT00808015|3996608|B1|Two||Smoking history: Lifetime serious quit attempts|A serious quit attempt was defined as smoking cessation for more than 24 hours. Scores were graded as none (no attempt) to 3 or more attempts). N = 649 for the parameter analyzed.|participants|Number|117|117.0||||||
4175545|NCT00808015|3996608|B1|One||Smoking history: Lifetime serious quit attempts|A serious quit attempt was defined as smoking cessation for more than 24 hours. Scores were graded as none (no attempt) to 3 or more attempts). N = 649 for the parameter analyzed.|participants|Number|322|322.0||||||
4175546|NCT00808015|3996608|B1|None||Smoking history: Lifetime serious quit attempts|A serious quit attempt was defined as smoking cessation for more than 24 hours. Scores were graded as none (no attempt) to 3 or more attempts). N = 649 for the parameter analyzed.|participants|Number|16|16.0||||||
4175547|NCT00808015|3996608|B1|No||Smoking history : Did participant have frequent contact with someone who smoked|N = 1270 for the parameter analyzed.|participants|Number|199|199.0||||||
4175548|NCT00808015|3996608|B1|Yes||Smoking history : Did participant have frequent contact with someone who smoked|N = 1270 for the parameter analyzed.|participants|Number|1071|1071.0||||||
4175549|NCT00808015|3996608|B1|No||Smoking history : Did participant live with someone who smoked|N = 1287 for the parameter analyzed.|participants|Number|1040|1040.0||||||
4175550|NCT00808015|3996608|B1|Yes||Smoking history : Did participant live with someone who smoked|N = 1287 for the parameter analyzed.|participants|Number|247|247.0||||||
4175551|NCT00808015|3996608|B1|Three or more||Smoking history : Participant categorized based on number of attempt to quit in the past year|N = 1257 for the parameter analyzed.|participants|Number|127|127.0||||||
4175552|NCT00808015|3996608|B1|Two||Smoking history : Participant categorized based on number of attempt to quit in the past year|N = 1257 for the parameter analyzed.|participants|Number|107|107.0||||||
4175553|NCT00808015|3996608|B1|One||Smoking history : Participant categorized based on number of attempt to quit in the past year|N = 1257 for the parameter analyzed.|participants|Number|285|285.0||||||
4175554|NCT00808015|3996608|B1|None||Smoking history : Participant categorized based on number of attempt to quit in the past year|N = 1257 for the parameter analyzed.|participants|Number|738|738.0||||||
4175555|NCT00808015|3996608|B1|||Smoking history : Number of times the participant has attempted to quit in past year|N = 1257 for the parameter analyzed. Scores were graded as none [(no attempt) to 3 or more attempts].|Quit attempts|Median|0.0|0.0|Full Range|||0.0|30.0|
4175556|NCT00808015|3996608|B1|||Smoking history: Longest period of abstinence in the last year|N = 1269 for the parameter analyzed.|Days|Median|0.0|0.0|Full Range|||0.0|365.0|
4175557|NCT00808015|3996608|B1|||Smoking history: Average number of cigarettes smoked per day in the last year|N = 1299 for the parameter analyzed.|cigarettes|Median|20.00|20.0|Full Range|||1.0|90.0|
4175558|NCT00808015|3996608|B1|||Smoking history: Total number of years participant smoked|N = 1308 for the parameter analyzed.|Years|Median|20.0|20.0|Full Range|||1.0|70.0|
4175559|NCT00808015|3996608|B1|Unspecified||Sex/Gender, Customized||Participants|Number|6|6.0||||||
4175560|NCT00808015|3996608|B1|Female||Sex/Gender, Customized||Participants|Number|88|88.0||||||
4175561|NCT00808015|3996608|B1|Male||Sex/Gender, Customized||Participants|Number|1279|1279.0||||||
4175562|NCT00808015|3996608|B1|||Age||Years|Mean|45.2|45.2|Standard Deviation|12.5|12.5|||
4175563|NCT00807989|3996620|B3|Korea, Republic of||Region of Enrollment||participants|Number|202|202.0||||||
4175564|NCT00807989|3996621|B2|Korea, Republic of||Region of Enrollment||participants|Number|98|98.0||||||
4175565|NCT00807989|3996622|B1|Korea, Republic of||Region of Enrollment||participants|Number|104|104.0||||||
4175566|NCT00807989|3996620|B3||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4175567|NCT00807989|3996621|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4175568|NCT00807989|3996622|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4175569|NCT00807989|3996620|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4175570|NCT00807989|3996621|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4175571|NCT00807989|3996622|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4175572|NCT00807989|3996620|B3|||Age||Year|Mean|34.8|34.8|Standard Deviation|14.2|14.2|||
4175573|NCT00807989|3996621|B2|||Age||Year|Mean|36.5|36.5|Standard Deviation|13.7|13.7|||
4175574|NCT00807989|3996622|B1|||Age||Year|Mean|33.2|33.2|Standard Deviation|14.6|14.6|||
4175575|NCT00807937|3996633|B5||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4175576|NCT00807937|3996634|B4||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4175577|NCT00807937|3996635|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4175578|NCT00807937|3996636|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4175579|NCT00807937|3996637|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4175580|NCT00807937|3996633|B5||Female|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4175581|NCT00807937|3996634|B4||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4175582|NCT00807937|3996635|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4175583|NCT00807937|3996636|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4175584|NCT00807937|3996637|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4175585|NCT00807937|3996633|B5|40-65 years||Age, Customized||Participants|Number|194|194.0||||||
4175586|NCT00807937|3996634|B4|40-65 years||Age, Customized||Participants|Number|48|48.0||||||
4175587|NCT00807937|3996635|B3|40-65 years||Age, Customized||Participants|Number|49|49.0||||||
4175588|NCT00807937|3996636|B2|40-65 years||Age, Customized||Participants|Number|50|50.0||||||
4175589|NCT00807937|3996637|B1|40-65 years||Age, Customized||Participants|Number|47|47.0||||||
4175590|NCT00807937|3996633|B5|18-39 years||Age, Customized||Participants|Number|175|175.0||||||
4175591|NCT00807937|3996634|B4|18-39 years||Age, Customized||Participants|Number|44|44.0||||||
4175592|NCT00807937|3996635|B3|18-39 years||Age, Customized||Participants|Number|43|43.0||||||
4175593|NCT00807937|3996636|B2|18-39 years||Age, Customized||Participants|Number|42|42.0||||||
4175594|NCT00807937|3996637|B1|18-39 years||Age, Customized||Participants|Number|46|46.0||||||
4175595|NCT00807885|3996666|B10|United States||Region of Enrollment||participants|Number|100|100.0||||||
4175596|NCT00807885|3996667|B9|United States||Region of Enrollment||participants|Number|11|11.0||||||
4175597|NCT00807885|3996668|B8|United States||Region of Enrollment||participants|Number|11|11.0||||||
4175598|NCT00807885|3996669|B7|United States||Region of Enrollment||participants|Number|12|12.0||||||
4175599|NCT00807885|3996670|B6|United States||Region of Enrollment||participants|Number|12|12.0||||||
4175600|NCT00807885|3996671|B5|United States||Region of Enrollment||participants|Number|12|12.0||||||
4175601|NCT00807885|3996672|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
4175602|NCT00807885|3996673|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4175603|NCT00807885|3996674|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4175604|NCT00807885|3996675|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4175605|NCT00807885|3996666|B10||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4175606|NCT00807885|3996667|B9||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4175607|NCT00807885|3996668|B8||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4175608|NCT00807885|3996669|B7||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4175609|NCT00807885|3996670|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4175610|NCT00807885|3996671|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4175611|NCT00807885|3996672|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4175612|NCT00807885|3996673|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4175618|NCT00807885|3996669|B7||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4175619|NCT00807885|3996670|B6||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4175620|NCT00807885|3996671|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4175621|NCT00807885|3996672|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4175622|NCT00807885|3996673|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4175623|NCT00807885|3996674|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4175624|NCT00807885|3996675|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4175625|NCT00807885|3996666|B10|||Age||years|Mean|34.5|34.5|Standard Deviation|10.8|10.8|||
4175626|NCT00807885|3996667|B9|||Age||years|Mean|36.6|36.6|Standard Deviation|12.3|12.3|||
4175627|NCT00807885|3996668|B8|||Age||years|Mean|32.4|32.4|Standard Deviation|12.7|12.7|||
4175628|NCT00807885|3996669|B7|||Age||years|Mean|33.6|33.6|Standard Deviation|10.7|10.7|||
4175629|NCT00807885|3996670|B6|||Age||years|Mean|34.3|34.3|Standard Deviation|10.3|10.3|||
4175630|NCT00807885|3996671|B5|||Age||years|Mean|34.0|34.0|Standard Deviation|12.5|12.5|||
4175631|NCT00807885|3996672|B4|||Age||years|Mean|35.3|35.3|Standard Deviation|10.9|10.9|||
4175632|NCT00807885|3996673|B3|||Age||years|Mean|33.8|33.8|Standard Deviation|10.4|10.4|||
4175633|NCT00807885|3996674|B2|||Age||years|Mean|36.0|36.0|Standard Deviation|10.6|10.6|||
4175634|NCT00807885|3996675|B1|||Age||years|Mean|34.6|34.6|Standard Deviation|9.39|9.39|||
4175635|NCT00807885|3996666|B10||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4175636|NCT00807885|3996667|B9||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4175637|NCT00807885|3996668|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4175638|NCT00807885|3996669|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4175639|NCT00807885|3996670|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4175640|NCT00807885|3996671|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4175641|NCT00807885|3996672|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4175642|NCT00807885|3996673|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4175643|NCT00807885|3996674|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4175644|NCT00807885|3996675|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4175645|NCT00807885|3996666|B10||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4175646|NCT00807885|3996667|B9||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4175647|NCT00807885|3996668|B8||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4175648|NCT00807885|3996669|B7||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4175649|NCT00807885|3996670|B6||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4175650|NCT00807885|3996671|B5||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4175651|NCT00807885|3996672|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4175652|NCT00807885|3996673|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4175653|NCT00807885|3996674|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4175654|NCT00807885|3996675|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4175655|NCT00807885|3996666|B10||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4175656|NCT00807885|3996667|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4175657|NCT00807885|3996668|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4175658|NCT00807885|3996669|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4175659|NCT00807885|3996670|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4175660|NCT00807885|3996671|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4175661|NCT00807885|3996672|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4175662|NCT00807885|3996673|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4175663|NCT00807885|3996674|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4175664|NCT00807885|3996675|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4175665|NCT00807846|3996730|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4175666|NCT00807846|3996731|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4175667|NCT00807846|3996732|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4175668|NCT00807846|3996730|B3||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4175669|NCT00807846|3996731|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4175670|NCT00807846|3996732|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4175671|NCT00807846|3996730|B3|>=13 - <18 Years||Age, Customized||Participants|Number|77|77.0||||||
4175672|NCT00807846|3996731|B2|>=13 - <18 Years||Age, Customized||Participants|Number|33|33.0||||||
4175673|NCT00807846|3996732|B1|>=13 - <18 Years||Age, Customized||Participants|Number|44|44.0||||||
4175674|NCT00807846|3996730|B3|>=8 - <13 Years||Age, Customized||Participants|Number|81|81.0||||||
4175675|NCT00807846|3996731|B2|>=8 - <13 Years||Age, Customized||Participants|Number|47|47.0||||||
4175676|NCT00807846|3996732|B1|>=8 - <13 Years||Age, Customized||Participants|Number|34|34.0||||||
4175677|NCT00807846|3996730|B3|>=2 - <8 Years||Age, Customized||Participants|Number|40|40.0||||||
4175678|NCT00807846|3996731|B2|>=2 - <8 Years||Age, Customized||Participants|Number|18|18.0||||||
4175679|NCT00807846|3996732|B1|>=2 - <8 Years||Age, Customized||Participants|Number|22|22.0||||||
4175707|NCT00807768|3996765|B3|>=70 years||Age, Customized||Participants|Count of Participants|144|144.0||||||
4175680|NCT00807768|3996765|B3|Other||Cell Type|Grade 1 endometrioid endometrial cancers are well differentiated. Grade 2 tumors are moderately differentiated. Grade 3 tumors are poorly differentiated. Lower grades have a higher relapse free survival rate..|Participants|Count of Participants|10|10.0||||||
4175681|NCT00807768|3996766|B2|Other||Cell Type|Grade 1 endometrioid endometrial cancers are well differentiated. Grade 2 tumors are moderately differentiated. Grade 3 tumors are poorly differentiated. Lower grades have a higher relapse free survival rate..|Participants|Count of Participants|6|6.0||||||
4175682|NCT00807768|3996767|B1|Other||Cell Type|Grade 1 endometrioid endometrial cancers are well differentiated. Grade 2 tumors are moderately differentiated. Grade 3 tumors are poorly differentiated. Lower grades have a higher relapse free survival rate..|Participants|Count of Participants|4|4.0||||||
4175683|NCT00807768|3996765|B3|Mixed||Cell Type|Grade 1 endometrioid endometrial cancers are well differentiated. Grade 2 tumors are moderately differentiated. Grade 3 tumors are poorly differentiated. Lower grades have a higher relapse free survival rate..|Participants|Count of Participants|31|31.0||||||
4175684|NCT00807768|3996766|B2|Mixed||Cell Type|Grade 1 endometrioid endometrial cancers are well differentiated. Grade 2 tumors are moderately differentiated. Grade 3 tumors are poorly differentiated. Lower grades have a higher relapse free survival rate..|Participants|Count of Participants|17|17.0||||||
4175685|NCT00807768|3996767|B1|Mixed||Cell Type|Grade 1 endometrioid endometrial cancers are well differentiated. Grade 2 tumors are moderately differentiated. Grade 3 tumors are poorly differentiated. Lower grades have a higher relapse free survival rate..|Participants|Count of Participants|14|14.0||||||
4175686|NCT00807768|3996765|B3|Clear Cell||Cell Type|Grade 1 endometrioid endometrial cancers are well differentiated. Grade 2 tumors are moderately differentiated. Grade 3 tumors are poorly differentiated. Lower grades have a higher relapse free survival rate..|Participants|Count of Participants|28|28.0||||||
4175687|NCT00807768|3996766|B2|Clear Cell||Cell Type|Grade 1 endometrioid endometrial cancers are well differentiated. Grade 2 tumors are moderately differentiated. Grade 3 tumors are poorly differentiated. Lower grades have a higher relapse free survival rate..|Participants|Count of Participants|13|13.0||||||
4175688|NCT00807768|3996767|B1|Clear Cell||Cell Type|Grade 1 endometrioid endometrial cancers are well differentiated. Grade 2 tumors are moderately differentiated. Grade 3 tumors are poorly differentiated. Lower grades have a higher relapse free survival rate..|Participants|Count of Participants|15|15.0||||||
4175689|NCT00807768|3996765|B3|Serous||Cell Type|Grade 1 endometrioid endometrial cancers are well differentiated. Grade 2 tumors are moderately differentiated. Grade 3 tumors are poorly differentiated. Lower grades have a higher relapse free survival rate..|Participants|Count of Participants|88|88.0||||||
4175690|NCT00807768|3996766|B2|Serous||Cell Type|Grade 1 endometrioid endometrial cancers are well differentiated. Grade 2 tumors are moderately differentiated. Grade 3 tumors are poorly differentiated. Lower grades have a higher relapse free survival rate..|Participants|Count of Participants|42|42.0||||||
4175691|NCT00807768|3996767|B1|Serous||Cell Type|Grade 1 endometrioid endometrial cancers are well differentiated. Grade 2 tumors are moderately differentiated. Grade 3 tumors are poorly differentiated. Lower grades have a higher relapse free survival rate..|Participants|Count of Participants|46|46.0||||||
4175692|NCT00807768|3996765|B3|Endometrioid, grade 3 or not graded||Cell Type|Grade 1 endometrioid endometrial cancers are well differentiated. Grade 2 tumors are moderately differentiated. Grade 3 tumors are poorly differentiated. Lower grades have a higher relapse free survival rate..|Participants|Count of Participants|126|126.0||||||
4175693|NCT00807768|3996766|B2|Endometrioid, grade 3 or not graded||Cell Type|Grade 1 endometrioid endometrial cancers are well differentiated. Grade 2 tumors are moderately differentiated. Grade 3 tumors are poorly differentiated. Lower grades have a higher relapse free survival rate..|Participants|Count of Participants|63|63.0||||||
4175694|NCT00807768|3996767|B1|Endometrioid, grade 3 or not graded||Cell Type|Grade 1 endometrioid endometrial cancers are well differentiated. Grade 2 tumors are moderately differentiated. Grade 3 tumors are poorly differentiated. Lower grades have a higher relapse free survival rate..|Participants|Count of Participants|63|63.0||||||
4175695|NCT00807768|3996765|B3|Endometrioid, grade 2||Cell Type|Grade 1 endometrioid endometrial cancers are well differentiated. Grade 2 tumors are moderately differentiated. Grade 3 tumors are poorly differentiated. Lower grades have a higher relapse free survival rate..|Participants|Count of Participants|212|212.0||||||
4175696|NCT00807768|3996766|B2|Endometrioid, grade 2||Cell Type|Grade 1 endometrioid endometrial cancers are well differentiated. Grade 2 tumors are moderately differentiated. Grade 3 tumors are poorly differentiated. Lower grades have a higher relapse free survival rate..|Participants|Count of Participants|103|103.0||||||
4175697|NCT00807768|3996767|B1|Endometrioid, grade 2||Cell Type|Grade 1 endometrioid endometrial cancers are well differentiated. Grade 2 tumors are moderately differentiated. Grade 3 tumors are poorly differentiated. Lower grades have a higher relapse free survival rate..|Participants|Count of Participants|109|109.0||||||
4175698|NCT00807768|3996765|B3|Endometrioid, grade 1||Cell Type|Grade 1 endometrioid endometrial cancers are well differentiated. Grade 2 tumors are moderately differentiated. Grade 3 tumors are poorly differentiated. Lower grades have a higher relapse free survival rate..|Participants|Count of Participants|106|106.0||||||
4175699|NCT00807768|3996766|B2|Endometrioid, grade 1||Cell Type|Grade 1 endometrioid endometrial cancers are well differentiated. Grade 2 tumors are moderately differentiated. Grade 3 tumors are poorly differentiated. Lower grades have a higher relapse free survival rate..|Participants|Count of Participants|56|56.0||||||
4175700|NCT00807768|3996767|B1|Endometrioid, grade 1||Cell Type|Grade 1 endometrioid endometrial cancers are well differentiated. Grade 2 tumors are moderately differentiated. Grade 3 tumors are poorly differentiated. Lower grades have a higher relapse free survival rate..|Participants|Count of Participants|50|50.0||||||
4175701|NCT00807768|3996765|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4175702|NCT00807768|3996766|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4175703|NCT00807768|3996767|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4175704|NCT00807768|3996765|B3||Female|Sex: Female, Male||Participants|Count of Participants|601|601.0||||||
4175705|NCT00807768|3996766|B2||Female|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
4175706|NCT00807768|3996767|B1||Female|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
4175708|NCT00807768|3996766|B2|>=70 years||Age, Customized||Participants|Count of Participants|75|75.0||||||
4175709|NCT00807768|3996767|B1|>=70 years||Age, Customized||Participants|Count of Participants|69|69.0||||||
4175710|NCT00807768|3996765|B3|60-69 years||Age, Customized||Participants|Count of Participants|252|252.0||||||
4175711|NCT00807768|3996766|B2|60-69 years||Age, Customized||Participants|Count of Participants|137|137.0||||||
4175712|NCT00807768|3996767|B1|60-69 years||Age, Customized||Participants|Count of Participants|115|115.0||||||
4175713|NCT00807768|3996765|B3|50-59 years||Age, Customized||Participants|Count of Participants|167|167.0||||||
4175714|NCT00807768|3996766|B2|50-59 years||Age, Customized||Participants|Count of Participants|72|72.0||||||
4175715|NCT00807768|3996767|B1|50-59 years||Age, Customized||Participants|Count of Participants|95|95.0||||||
4175716|NCT00807768|3996765|B3|<50 years||Age, Customized||Participants|Count of Participants|38|38.0||||||
4175717|NCT00807768|3996766|B2|<50 years||Age, Customized||Participants|Count of Participants|16|16.0||||||
4175718|NCT00807768|3996767|B1|<50 years||Age, Customized||Participants|Count of Participants|22|22.0||||||
4175719|NCT00807664|3996784|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4175720|NCT00807664|3996785|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4175721|NCT00807664|3996786|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4175722|NCT00807664|3996784|B3|Denmark||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
4175723|NCT00807664|3996785|B2|Denmark||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
4175724|NCT00807664|3996786|B1|Denmark||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4175725|NCT00807664|3996784|B3|Belgium||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4175726|NCT00807664|3996785|B2|Belgium||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4175727|NCT00807664|3996786|B1|Belgium||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4175728|NCT00807664|3996784|B3|Germany||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
4175729|NCT00807664|3996785|B2|Germany||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
4175730|NCT00807664|3996786|B1|Germany||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4175731|NCT00807664|3996784|B3|France||Region of Enrollment||Participants|Count of Participants|76|76.0||||||
4175732|NCT00807664|3996785|B2|France||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
4175733|NCT00807664|3996786|B1|France||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
4175734|NCT00807664|3996784|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4175735|NCT00807664|3996785|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4175736|NCT00807664|3996786|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4175737|NCT00807664|3996784|B3||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4175738|NCT00807664|3996785|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4175739|NCT00807664|3996786|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4175740|NCT00807664|3996784|B3|||Age||years|Mean|73.5|73.5|Standard Deviation|12.2|12.2|||
4175741|NCT00807664|3996785|B2|||Age||years|Mean|72.1|72.1|Standard Deviation|12.4|12.4|||
4175742|NCT00807664|3996786|B1|||Age||years|Mean|75.1|75.1|Standard Deviation|11.8|11.8|||
4175743|NCT00807664|3996784|B3||>=65 years|Age||Participants|Count of Participants|139|139.0||||||
4175744|NCT00807664|3996785|B2||>=65 years|Age||Participants|Count of Participants|69|69.0||||||
4175745|NCT00807664|3996786|B1||>=65 years|Age||Participants|Count of Participants|70|70.0||||||
4175746|NCT00807664|3996784|B3||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4175747|NCT00807664|3996785|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4175748|NCT00807664|3996786|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4175749|NCT00807664|3996784|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4175750|NCT00807664|3996785|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4175751|NCT00807664|3996786|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4175752|NCT00807573|3996797|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4175753|NCT00807573|3996797|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4175754|NCT00807573|3996797|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4175755|NCT00807573|3996797|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4175756|NCT00807573|3996797|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4175757|NCT00807573|3996797|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4175758|NCT00807560|3996801|B3|United States||Region of Enrollment||participants|Number|77|77.0||||||
4175759|NCT00807560|3996802|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
4175760|NCT00807560|3996803|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4175761|NCT00807560|3996801|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4175762|NCT00807560|3996802|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4175763|NCT00807560|3996803|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4175764|NCT00807560|3996801|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4175765|NCT00807560|3996802|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4175766|NCT00807560|3996803|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4175767|NCT00807560|3996801|B3|||Age||years|Mean|15.1|15.1|Standard Deviation|1.56|1.56|||
4175768|NCT00807560|3996802|B2|||Age||years|Mean|15.2|15.2|Standard Deviation|1.6|1.6|||
4175769|NCT00807560|3996803|B1|||Age||years|Mean|15.0|15.0|Standard Deviation|1.52|1.52|||
4175770|NCT00807495|3996838|B6|||Weight||kg|Mean|89.88|89.88|Standard Deviation|24.737|24.737|||
4175771|NCT00807495|3996839|B5|||Weight||kg|Mean|84.45|84.45|Standard Deviation|14.494|14.494|||
4175772|NCT00807495|3996840|B4|||Weight||kg|Mean|72.58|72.58|Standard Deviation|NA||||Standard deviation was not estimable as only 1 participant was analyzed in this arm group.
4175773|NCT00807495|3996841|B3|||Weight||kg|Mean|89.06|89.06|Standard Deviation|29.724|29.724|||
4175774|NCT00807495|3996842|B2|||Weight||kg|Mean|96.18|96.18|Standard Deviation|25.139|25.139|||
4175775|NCT00807495|3996843|B1|||Weight||kg|Mean|88.85|88.85|Standard Deviation|27.022|27.022|||
4175776|NCT00807495|3996838|B6|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4175777|NCT00807495|3996839|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4175778|NCT00807495|3996840|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4175779|NCT00807495|3996841|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4175780|NCT00807495|3996842|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4175781|NCT00807495|3996843|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4175782|NCT00807495|3996838|B6|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4175783|NCT00807495|3996839|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4175784|NCT00807495|3996840|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4175785|NCT00807495|3996841|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4175786|NCT00807495|3996842|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4175787|NCT00807495|3996843|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4175788|NCT00807495|3996838|B6|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4175789|NCT00807495|3996839|B5|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4175790|NCT00807495|3996840|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4175791|NCT00807495|3996841|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4175792|NCT00807495|3996842|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4175793|NCT00807495|3996843|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4175794|NCT00807495|3996838|B6|White||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4175795|NCT00807495|3996839|B5|White||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4175796|NCT00807495|3996840|B4|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4175797|NCT00807495|3996841|B3|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4175798|NCT00807495|3996842|B2|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4175799|NCT00807495|3996843|B1|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4175800|NCT00807495|3996838|B6||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4175801|NCT00807495|3996839|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4175802|NCT00807495|3996840|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4175803|NCT00807495|3996841|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4175804|NCT00807495|3996842|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4175805|NCT00807495|3996843|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4175806|NCT00807495|3996838|B6||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4175807|NCT00807495|3996839|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4175808|NCT00807495|3996840|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4175809|NCT00807495|3996841|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4175810|NCT00807495|3996842|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4175811|NCT00807495|3996843|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4175812|NCT00807495|3996838|B6|||Age||years|Mean|65.1|65.1|Standard Deviation|11.56|11.56|||
4175813|NCT00807495|3996839|B5|||Age||years|Mean|54.4|54.4|Standard Deviation|16.90|16.9|||
4175814|NCT00807495|3996840|B4|||Age||years|Mean|76.0|76.0|Standard Deviation|NA||||Standard deviation was not estimable as only 1 participant was analyzed in this arm group.
4175815|NCT00807495|3996841|B3|||Age||years|Mean|65.2|65.2|Standard Deviation|9.96|9.96|||
4175816|NCT00807495|3996842|B2|||Age||years|Mean|67.2|67.2|Standard Deviation|6.71|6.71|||
4175817|NCT00807495|3996843|B1|||Age||years|Mean|66.8|66.8|Standard Deviation|11.11|11.11|||
4175818|NCT00807456|3996889|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4175819|NCT00807456|3996889|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4175820|NCT00807456|3996889|B1|||Age||years|Mean|49.05|49.05|Standard Deviation|13.974|13.974|||
4175821|NCT00807365|3996893|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4175822|NCT00807365|3996893|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4175823|NCT00807365|3996893|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4175824|NCT00807365|3996893|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4175825|NCT00807365|3996893|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4175826|NCT00807365|3996893|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4175904|NCT00807209|3996981|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4175905|NCT00807209|3996982|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4175827|NCT00807248|3996897|B5|||Clinical Global Impression - Severity of Illness (CGI-S)|The CGI-S provides the clinician's impression of the patient's current state of mental illness. The clinician uses his or her clinical experience of this patient population to rate the severity of the patient's current mental illness on a 7-point scale ranging from 1 (Normal - not at all ill) to 7 (among the most extremely ill patients).|Scores on a scale|Mean|4.4|4.4|Standard Deviation|0.9|0.9|||
4175828|NCT00807248|3996898|B4|||Clinical Global Impression - Severity of Illness (CGI-S)|The CGI-S provides the clinician's impression of the patient's current state of mental illness. The clinician uses his or her clinical experience of this patient population to rate the severity of the patient's current mental illness on a 7-point scale ranging from 1 (Normal - not at all ill) to 7 (among the most extremely ill patients).|Scores on a scale|Mean|4.4|4.4|Standard Deviation|0.9|0.9|||
4175829|NCT00807248|3996899|B3|||Clinical Global Impression - Severity of Illness (CGI-S)|The CGI-S provides the clinician's impression of the patient's current state of mental illness. The clinician uses his or her clinical experience of this patient population to rate the severity of the patient's current mental illness on a 7-point scale ranging from 1 (Normal - not at all ill) to 7 (among the most extremely ill patients).|Scores on a scale|Mean|4.3|4.3|Standard Deviation|0.9|0.9|||
4175830|NCT00807248|3996900|B2|||Clinical Global Impression - Severity of Illness (CGI-S)|The CGI-S provides the clinician's impression of the patient's current state of mental illness. The clinician uses his or her clinical experience of this patient population to rate the severity of the patient's current mental illness on a 7-point scale ranging from 1 (Normal - not at all ill) to 7 (among the most extremely ill patients).|Scores on a scale|Mean|4.5|4.5|Standard Deviation|0.9|0.9|||
4175831|NCT00807248|3996901|B1|||Clinical Global Impression - Severity of Illness (CGI-S)|The CGI-S provides the clinician's impression of the patient's current state of mental illness. The clinician uses his or her clinical experience of this patient population to rate the severity of the patient's current mental illness on a 7-point scale ranging from 1 (Normal - not at all ill) to 7 (among the most extremely ill patients).|Scores on a scale|Mean|4.4|4.4|Standard Deviation|0.9|0.9|||
4175832|NCT00807248|3996897|B5|||SDS: Social Subscale|The SDS comprises self-rated items designed to measure impairment. The patient rates the extent to which his or her (1) work, (2) social life or leisure activities and (3) home life or family responsibilities are impaired on a 10-point visual analogue scales, on which 0 = normal functioning and 10 = severe functional impairment.|Scores on a scale|Mean|7.0|7.0|Standard Deviation|1.5|1.5|||
4175833|NCT00807248|3996898|B4|||SDS: Social Subscale|The SDS comprises self-rated items designed to measure impairment. The patient rates the extent to which his or her (1) work, (2) social life or leisure activities and (3) home life or family responsibilities are impaired on a 10-point visual analogue scales, on which 0 = normal functioning and 10 = severe functional impairment.|Scores on a scale|Mean|6.9|6.9|Standard Deviation|1.6|1.6|||
4175834|NCT00807248|3996899|B3|||SDS: Social Subscale|The SDS comprises self-rated items designed to measure impairment. The patient rates the extent to which his or her (1) work, (2) social life or leisure activities and (3) home life or family responsibilities are impaired on a 10-point visual analogue scales, on which 0 = normal functioning and 10 = severe functional impairment.|Scores on a scale|Mean|7.1|7.1|Standard Deviation|1.5|1.5|||
4175835|NCT00807248|3996900|B2|||SDS: Social Subscale|The SDS comprises self-rated items designed to measure impairment. The patient rates the extent to which his or her (1) work, (2) social life or leisure activities and (3) home life or family responsibilities are impaired on a 10-point visual analogue scales, on which 0 = normal functioning and 10 = severe functional impairment.|Scores on a scale|Mean|7.1|7.1|Standard Deviation|1.4|1.4|||
4175836|NCT00807248|3996901|B1|||SDS: Social Subscale|The SDS comprises self-rated items designed to measure impairment. The patient rates the extent to which his or her (1) work, (2) social life or leisure activities and (3) home life or family responsibilities are impaired on a 10-point visual analogue scales, on which 0 = normal functioning and 10 = severe functional impairment.|Scores on a scale|Mean|7.0|7.0|Standard Deviation|1.4|1.4|||
4175837|NCT00807248|3996897|B5|||SDS: Work Subscale|The SDS comprises self-rated items designed to measure impairment. The patient rates the extent to which his or her (1) work, (2) social life or leisure activities and (3) home life or family responsibilities are impaired on a 10-point visual analogue scales, on which 0 = normal functioning and 10 = severe functional impairment.|Scores on a scale|Mean|7.2|7.2|Standard Deviation|1.4|1.4|||
4175838|NCT00807248|3996898|B4|||SDS: Work Subscale|The SDS comprises self-rated items designed to measure impairment. The patient rates the extent to which his or her (1) work, (2) social life or leisure activities and (3) home life or family responsibilities are impaired on a 10-point visual analogue scales, on which 0 = normal functioning and 10 = severe functional impairment.|Scores on a scale|Mean|7.0|7.0|Standard Deviation|1.4|1.4|||
4175839|NCT00807248|3996899|B3|||SDS: Work Subscale|The SDS comprises self-rated items designed to measure impairment. The patient rates the extent to which his or her (1) work, (2) social life or leisure activities and (3) home life or family responsibilities are impaired on a 10-point visual analogue scales, on which 0 = normal functioning and 10 = severe functional impairment.|Scores on a scale|Mean|7.3|7.3|Standard Deviation|1.5|1.5|||
4175840|NCT00807248|3996900|B2|||SDS: Work Subscale|The SDS comprises self-rated items designed to measure impairment. The patient rates the extent to which his or her (1) work, (2) social life or leisure activities and (3) home life or family responsibilities are impaired on a 10-point visual analogue scales, on which 0 = normal functioning and 10 = severe functional impairment.|Scores on a scale|Mean|7.4|7.4|Standard Deviation|1.3|1.3|||
4175841|NCT00807248|3996901|B1|||SDS: Work Subscale|The SDS comprises self-rated items designed to measure impairment. The patient rates the extent to which his or her (1) work, (2) social life or leisure activities and (3) home life or family responsibilities are impaired on a 10-point visual analogue scales, on which 0 = normal functioning and 10 = severe functional impairment.|Scores on a scale|Mean|7.3|7.3|Standard Deviation|1.2|1.2|||
4175842|NCT00807248|3996897|B5|||Sheehan Disability Scale (SDS): Family Subscale|The SDS comprises self-rated items designed to measure impairment. The patient rates the extent to which his or her (1) work, (2) social life or leisure activities and (3) home life or family responsibilities are impaired on a 10-point visual analogue scales, on which 0 = normal functioning and 10 = severe functional impairment.|Scores on a scale|Mean|7.1|7.1|Standard Deviation|1.4|1.4|||
4175906|NCT00807209|3996979|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4175843|NCT00807248|3996898|B4|||Sheehan Disability Scale (SDS): Family Subscale|The SDS comprises self-rated items designed to measure impairment. The patient rates the extent to which his or her (1) work, (2) social life or leisure activities and (3) home life or family responsibilities are impaired on a 10-point visual analogue scales, on which 0 = normal functioning and 10 = severe functional impairment.|Scores on a scale|Mean|6.9|6.9|Standard Deviation|1.4|1.4|||
4175844|NCT00807248|3996899|B3|||Sheehan Disability Scale (SDS): Family Subscale|The SDS comprises self-rated items designed to measure impairment. The patient rates the extent to which his or her (1) work, (2) social life or leisure activities and (3) home life or family responsibilities are impaired on a 10-point visual analogue scales, on which 0 = normal functioning and 10 = severe functional impairment.|Scores on a scale|Mean|7.2|7.2|Standard Deviation|1.3|1.3|||
4175845|NCT00807248|3996900|B2|||Sheehan Disability Scale (SDS): Family Subscale|The SDS comprises self-rated items designed to measure impairment. The patient rates the extent to which his or her (1) work, (2) social life or leisure activities and (3) home life or family responsibilities are impaired on a 10-point visual analogue scales, on which 0 = normal functioning and 10 = severe functional impairment.|Scores on a scale|Mean|7.1|7.1|Standard Deviation|1.6|1.6|||
4175846|NCT00807248|3996901|B1|||Sheehan Disability Scale (SDS): Family Subscale|The SDS comprises self-rated items designed to measure impairment. The patient rates the extent to which his or her (1) work, (2) social life or leisure activities and (3) home life or family responsibilities are impaired on a 10-point visual analogue scales, on which 0 = normal functioning and 10 = severe functional impairment.|Scores on a scale|Mean|7.0|7.0|Standard Deviation|1.4|1.4|||
4175847|NCT00807248|3996897|B5|||Insomnia Severity Index (ISI)|The ISI is both a brief screening measure of insomnia and an outcomes measure for use in treatment research. It is a brief self-report instrument measuring the patient's perception of his or her insomnia, and it comprises 7 items. Each item is rated on a 0-4 scale and the total score ranges from 0 to 28. 0 = no symptoms and 28 = severe symptoms.|Scores on a scale|Mean|18.3|18.3|Standard Deviation|4.7|4.7|||
4175848|NCT00807248|3996898|B4|||Insomnia Severity Index (ISI)|The ISI is both a brief screening measure of insomnia and an outcomes measure for use in treatment research. It is a brief self-report instrument measuring the patient's perception of his or her insomnia, and it comprises 7 items. Each item is rated on a 0-4 scale and the total score ranges from 0 to 28. 0 = no symptoms and 28 = severe symptoms.|Scores on a scale|Mean|18.1|18.1|Standard Deviation|4.8|4.8|||
4175849|NCT00807248|3996899|B3|||Insomnia Severity Index (ISI)|The ISI is both a brief screening measure of insomnia and an outcomes measure for use in treatment research. It is a brief self-report instrument measuring the patient's perception of his or her insomnia, and it comprises 7 items. Each item is rated on a 0-4 scale and the total score ranges from 0 to 28. 0 = no symptoms and 28 = severe symptoms.|Scores on a scale|Mean|18.2|18.2|Standard Deviation|4.4|4.4|||
4175850|NCT00807248|3996900|B2|||Insomnia Severity Index (ISI)|The ISI is both a brief screening measure of insomnia and an outcomes measure for use in treatment research. It is a brief self-report instrument measuring the patient's perception of his or her insomnia, and it comprises 7 items. Each item is rated on a 0-4 scale and the total score ranges from 0 to 28. 0 = no symptoms and 28 = severe symptoms.|Scores on a scale|Mean|18.6|18.6|Standard Deviation|4.7|4.7|||
4175851|NCT00807248|3996901|B1|||Insomnia Severity Index (ISI)|The ISI is both a brief screening measure of insomnia and an outcomes measure for use in treatment research. It is a brief self-report instrument measuring the patient's perception of his or her insomnia, and it comprises 7 items. Each item is rated on a 0-4 scale and the total score ranges from 0 to 28. 0 = no symptoms and 28 = severe symptoms.|Scores on a scale|Mean|18.4|18.4|Standard Deviation|5.0|5.0|||
4175852|NCT00807248|3996897|B5|||Hospital Anxiety and Depression Scale (HADS)|The HADS is a patient-rated scale designed to screen for anxiety and depressive states in medical patients. It consists of two sub-scales: the D-scale measures depression and the A-scale measures anxiety. Each sub-scale contains 7 items, and each item is rated from 0 (absent) to 3 (maximum severity). The score of each sub-scale ranges from 0 to 21, and are analysed separately. The total HADS score ranges from 0 to 42.|Scores on a scale|Mean|27.8|27.8|Standard Deviation|5.5|5.5|||
4175853|NCT00807248|3996898|B4|||Hospital Anxiety and Depression Scale (HADS)|The HADS is a patient-rated scale designed to screen for anxiety and depressive states in medical patients. It consists of two sub-scales: the D-scale measures depression and the A-scale measures anxiety. Each sub-scale contains 7 items, and each item is rated from 0 (absent) to 3 (maximum severity). The score of each sub-scale ranges from 0 to 21, and are analysed separately. The total HADS score ranges from 0 to 42.|Scores on a scale|Mean|27.4|27.4|Standard Deviation|5.5|5.5|||
4175854|NCT00807248|3996899|B3|||Hospital Anxiety and Depression Scale (HADS)|The HADS is a patient-rated scale designed to screen for anxiety and depressive states in medical patients. It consists of two sub-scales: the D-scale measures depression and the A-scale measures anxiety. Each sub-scale contains 7 items, and each item is rated from 0 (absent) to 3 (maximum severity). The score of each sub-scale ranges from 0 to 21, and are analysed separately. The total HADS score ranges from 0 to 42.|Scores on a scale|Mean|28.1|28.1|Standard Deviation|5.5|5.5|||
4175855|NCT00807248|3996900|B2|||Hospital Anxiety and Depression Scale (HADS)|The HADS is a patient-rated scale designed to screen for anxiety and depressive states in medical patients. It consists of two sub-scales: the D-scale measures depression and the A-scale measures anxiety. Each sub-scale contains 7 items, and each item is rated from 0 (absent) to 3 (maximum severity). The score of each sub-scale ranges from 0 to 21, and are analysed separately. The total HADS score ranges from 0 to 42.|Scores on a scale|Mean|28.2|28.2|Standard Deviation|5.3|5.3|||
4175856|NCT00807248|3996901|B1|||Hospital Anxiety and Depression Scale (HADS)|The HADS is a patient-rated scale designed to screen for anxiety and depressive states in medical patients. It consists of two sub-scales: the D-scale measures depression and the A-scale measures anxiety. Each sub-scale contains 7 items, and each item is rated from 0 (absent) to 3 (maximum severity). The score of each sub-scale ranges from 0 to 21, and are analysed separately. The total HADS score ranges from 0 to 42.|Scores on a scale|Mean|27.5|27.5|Standard Deviation|5.9|5.9|||
4175907|NCT00807209|3996980|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4175908|NCT00807209|3996981|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4175909|NCT00807209|3996982|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4175910|NCT00807209|3996979|B4|||Age||years|Mean|73.3|73.3|Standard Deviation|0|0.0|||
4175857|NCT00807248|3996897|B5|||Montgomery and Åsberg Depression Rating Scale (MADRS)|The MADRS is a 10-item rating scale designed to assess the severity of the symptoms in depressive illness and to be sensitive to treatment effects. Symptoms are rated on a 7-point scale from 0 (no symptom) to 6 (severe symptom). Definitions of severity are provided at 2-point intervals. The total score of the 10 items ranges from 0 to 60.|Scores on a scale|Mean|35.1|35.1|Standard Deviation|3.9|3.9|||
4175858|NCT00807248|3996898|B4|||Montgomery and Åsberg Depression Rating Scale (MADRS)|The MADRS is a 10-item rating scale designed to assess the severity of the symptoms in depressive illness and to be sensitive to treatment effects. Symptoms are rated on a 7-point scale from 0 (no symptom) to 6 (severe symptom). Definitions of severity are provided at 2-point intervals. The total score of the 10 items ranges from 0 to 60.|Scores on a scale|Mean|34.7|34.7|Standard Deviation|3.8|3.8|||
4175859|NCT00807248|3996899|B3|||Montgomery and Åsberg Depression Rating Scale (MADRS)|The MADRS is a 10-item rating scale designed to assess the severity of the symptoms in depressive illness and to be sensitive to treatment effects. Symptoms are rated on a 7-point scale from 0 (no symptom) to 6 (severe symptom). Definitions of severity are provided at 2-point intervals. The total score of the 10 items ranges from 0 to 60.|Scores on a scale|Mean|35.3|35.3|Standard Deviation|3.4|3.4|||
4175860|NCT00807248|3996900|B2|||Montgomery and Åsberg Depression Rating Scale (MADRS)|The MADRS is a 10-item rating scale designed to assess the severity of the symptoms in depressive illness and to be sensitive to treatment effects. Symptoms are rated on a 7-point scale from 0 (no symptom) to 6 (severe symptom). Definitions of severity are provided at 2-point intervals. The total score of the 10 items ranges from 0 to 60.|Scores on a scale|Mean|35.4|35.4|Standard Deviation|4.3|4.3|||
4175861|NCT00807248|3996901|B1|||Montgomery and Åsberg Depression Rating Scale (MADRS)|The MADRS is a 10-item rating scale designed to assess the severity of the symptoms in depressive illness and to be sensitive to treatment effects. Symptoms are rated on a 7-point scale from 0 (no symptom) to 6 (severe symptom). Definitions of severity are provided at 2-point intervals. The total score of the 10 items ranges from 0 to 60.|Scores on a scale|Mean|34.7|34.7|Standard Deviation|4.2|4.2|||
4175862|NCT00807248|3996897|B5||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4175863|NCT00807248|3996898|B4||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4175864|NCT00807248|3996899|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4175865|NCT00807248|3996900|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4175866|NCT00807248|3996901|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4175867|NCT00807248|3996897|B5||Female|Sex: Female, Male||Participants|Count of Participants|338|338.0||||||
4175868|NCT00807248|3996898|B4||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4175869|NCT00807248|3996899|B3||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4175870|NCT00807248|3996900|B2||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4175871|NCT00807248|3996901|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4175872|NCT00807248|3996897|B5|||Age||years|Mean|42.0|42.0|Standard Deviation|11.7|11.7|||
4175873|NCT00807248|3996898|B4|||Age||years|Mean|41.5|41.5|Standard Deviation|10.5|10.5|||
4175874|NCT00807248|3996899|B3|||Age||years|Mean|42.6|42.6|Standard Deviation|11.8|11.8|||
4175875|NCT00807248|3996900|B2|||Age||years|Mean|41.6|41.6|Standard Deviation|12.6|12.6|||
4175876|NCT00807248|3996901|B1|||Age||years|Mean|42.6|42.6|Standard Deviation|11.6|11.6|||
4175877|NCT00807235|3996946|B3|||Gestational Age||weeks|Mean|30.1|30.1|Standard Deviation|1.31|1.31|||
4175878|NCT00807235|3996947|B2|||Gestational Age||weeks|Mean|30.7|30.7|Standard Deviation|0.99|0.99|||
4175879|NCT00807235|3996948|B1|||Gestational Age||weeks|Mean|29.8|29.8|Standard Deviation|1.40|1.4|||
4175880|NCT00807235|3996946|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4175881|NCT00807235|3996947|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4175882|NCT00807235|3996948|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4175883|NCT00807235|3996946|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4175884|NCT00807235|3996947|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4175885|NCT00807235|3996948|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4175886|NCT00807235|3996946|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4175887|NCT00807235|3996947|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4175888|NCT00807235|3996948|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4175889|NCT00807235|3996946|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4175890|NCT00807235|3996947|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4175891|NCT00807235|3996948|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4175892|NCT00807235|3996946|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4175893|NCT00807235|3996947|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4175894|NCT00807235|3996948|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4175895|NCT00807235|3996946|B3||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
4175896|NCT00807235|3996947|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4175897|NCT00807235|3996948|B1||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4175898|NCT00807209|3996979|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
4175899|NCT00807209|3996980|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4175900|NCT00807209|3996981|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4175901|NCT00807209|3996982|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4175902|NCT00807209|3996979|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4175903|NCT00807209|3996980|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4175911|NCT00807209|3996980|B3|||Age||years|Mean|64|64.0|Standard Deviation|0|0.0|||
4175912|NCT00807209|3996981|B2|||Age||years|Mean|75|75.0|Standard Deviation|0|0.0|||
4175913|NCT00807209|3996982|B1|||Age||years|Mean|81|81.0|Standard Deviation|0|0.0|||
4175914|NCT00807209|3996979|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4175915|NCT00807209|3996980|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4175916|NCT00807209|3996981|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4175917|NCT00807209|3996982|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4175918|NCT00807209|3996979|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4175919|NCT00807209|3996980|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4175920|NCT00807209|3996981|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4175921|NCT00807209|3996982|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4175922|NCT00807209|3996979|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4175923|NCT00807209|3996980|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4175924|NCT00807209|3996981|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4175925|NCT00807209|3996982|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4175926|NCT00807092|3996992|B3|Metformin Combination Therapy||Metformin monotherapy or combination therapy at randomisation|OAD treatment at randomisation|participants|Number|106|106.0||||||
4175927|NCT00807092|3996993|B2|Metformin Combination Therapy||Metformin monotherapy or combination therapy at randomisation|OAD treatment at randomisation|participants|Number|55|55.0||||||
4175928|NCT00807092|3996994|B1|Metformin Combination Therapy||Metformin monotherapy or combination therapy at randomisation|OAD treatment at randomisation|participants|Number|51|51.0||||||
4175929|NCT00807092|3996992|B3|Metformin Monotherapy||Metformin monotherapy or combination therapy at randomisation|OAD treatment at randomisation|participants|Number|38|38.0||||||
4175930|NCT00807092|3996993|B2|Metformin Monotherapy||Metformin monotherapy or combination therapy at randomisation|OAD treatment at randomisation|participants|Number|18|18.0||||||
4175931|NCT00807092|3996994|B1|Metformin Monotherapy||Metformin monotherapy or combination therapy at randomisation|OAD treatment at randomisation|participants|Number|20|20.0||||||
4175932|NCT00807092|3996992|B3|||HbA1c at screening||percentage of total haemoglobin|Mean|9.13|9.13|Standard Deviation|1.06|1.06|||
4175933|NCT00807092|3996993|B2|||HbA1c at screening||percentage of total haemoglobin|Mean|9.08|9.08|Standard Deviation|1.08|1.08|||
4175934|NCT00807092|3996994|B1|||HbA1c at screening||percentage of total haemoglobin|Mean|9.19|9.19|Standard Deviation|1.05|1.05|||
4175935|NCT00807092|3996992|B3|||Duration of diagnosed diabetes||years|Mean|7.36|7.36|Standard Deviation|5.3|5.3|||
4175936|NCT00807092|3996993|B2|||Duration of diagnosed diabetes||years|Mean|7|7.0|Standard Deviation|5.2|5.2|||
4175937|NCT00807092|3996994|B1|||Duration of diagnosed diabetes||years|Mean|7.74|7.74|Standard Deviation|5.5|5.5|||
4175938|NCT00807092|3996992|B3|||BMI (Body Mass Index)||kg/m^2|Mean|24.71|24.71|Standard Deviation|3|3.0|||
4175939|NCT00807092|3996993|B2|||BMI (Body Mass Index)||kg/m^2|Mean|24.74|24.74|Standard Deviation|3|3.0|||
4175940|NCT00807092|3996994|B1|||BMI (Body Mass Index)||kg/m^2|Mean|24.68|24.68|Standard Deviation|3|3.0|||
4175941|NCT00807092|3996992|B3|||Height at screening||m|Mean|1.628|1.628|Standard Deviation|0.09|0.09|||
4175942|NCT00807092|3996993|B2|||Height at screening||m|Mean|1.623|1.623|Standard Deviation|0.09|0.09|||
4175943|NCT00807092|3996994|B1|||Height at screening||m|Mean|1.634|1.634|Standard Deviation|0.09|0.09|||
4175944|NCT00807092|3996992|B3|||Weight||kg|Mean|65.88|65.88|Standard Deviation|11.7|11.7|||
4175945|NCT00807092|3996993|B2|||Weight||kg|Mean|65.49|65.49|Standard Deviation|11.4|11.4|||
4175946|NCT00807092|3996994|B1|||Weight||kg|Mean|66.28|66.28|Standard Deviation|12|12.0|||
4175947|NCT00807092|3996992|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4175948|NCT00807092|3996993|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4175949|NCT00807092|3996994|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4175950|NCT00807092|3996992|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4175951|NCT00807092|3996993|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4175952|NCT00807092|3996994|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4175953|NCT00807092|3996992|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4175954|NCT00807092|3996993|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4175955|NCT00807092|3996994|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4175956|NCT00807092|3996992|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4175957|NCT00807092|3996993|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4175958|NCT00807092|3996994|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4175959|NCT00807092|3996992|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4175960|NCT00807092|3996993|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4175961|NCT00807092|3996994|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4175962|NCT00807092|3996992|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
4175963|NCT00807092|3996993|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
4175964|NCT00807092|3996994|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
4175965|NCT00807092|3996992|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176087|NCT00807001|3997068|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4175966|NCT00807092|3996993|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4175967|NCT00807092|3996994|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4175968|NCT00807092|3996992|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4175969|NCT00807092|3996993|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4175970|NCT00807092|3996994|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4175971|NCT00807092|3996992|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4175972|NCT00807092|3996993|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4175973|NCT00807092|3996994|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4175974|NCT00807092|3996992|B3|||Age||years|Mean|55.5|55.5|Standard Deviation|9.8|9.8|||
4175975|NCT00807092|3996993|B2|||Age||years|Mean|54.4|54.4|Standard Deviation|10.4|10.4|||
4175976|NCT00807092|3996994|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|9|9.0|||
4175977|NCT00807040|3997023|B3|United States||Region of Enrollment||participants|Number|200|200.0||||||
4175978|NCT00807040|3997024|B2|United States||Region of Enrollment||participants|Number|99|99.0||||||
4175979|NCT00807040|3997025|B1|United States||Region of Enrollment||participants|Number|101|101.0||||||
4175980|NCT00807040|3997023|B3|Canada||Region of Enrollment||participants|Number|51|51.0||||||
4175981|NCT00807040|3997024|B2|Canada||Region of Enrollment||participants|Number|26|26.0||||||
4175982|NCT00807040|3997025|B1|Canada||Region of Enrollment||participants|Number|25|25.0||||||
4175983|NCT00807040|3997023|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4175984|NCT00807040|3997024|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4175985|NCT00807040|3997025|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4175986|NCT00807040|3997023|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4175987|NCT00807040|3997024|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4175988|NCT00807040|3997025|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4175989|NCT00807040|3997023|B3||White|Race (NIH/OMB)||Participants|Count of Participants|202|202.0||||||
4175990|NCT00807040|3997024|B2||White|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
4175991|NCT00807040|3997025|B1||White|Race (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
4175992|NCT00807040|3997023|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4175993|NCT00807040|3997024|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4175994|NCT00807040|3997025|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4175995|NCT00807040|3997023|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4175996|NCT00807040|3997024|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4175997|NCT00807040|3997025|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4175998|NCT00807040|3997023|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4175999|NCT00807040|3997024|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4176000|NCT00807040|3997025|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4176001|NCT00807040|3997023|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4176002|NCT00807040|3997024|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4176003|NCT00807040|3997025|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176004|NCT00807040|3997023|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176005|NCT00807040|3997024|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176006|NCT00807040|3997025|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176007|NCT00807040|3997023|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|227|227.0||||||
4176008|NCT00807040|3997024|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|114|114.0||||||
4176009|NCT00807040|3997025|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
4176010|NCT00807040|3997023|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4176011|NCT00807040|3997024|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4176012|NCT00807040|3997025|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4176013|NCT00807040|3997023|B3||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4176014|NCT00807040|3997024|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4176015|NCT00807040|3997025|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4176016|NCT00807040|3997023|B3||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4176017|NCT00807040|3997024|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4176018|NCT00807040|3997025|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4176019|NCT00807040|3997023|B3|||Age||years|Mean|68.4|68.4|Standard Deviation|9.6|9.6|||
4176020|NCT00807040|3997024|B2|||Age||years|Mean|67.9|67.9|Standard Deviation|9.0|9.0|||
4176021|NCT00807040|3997025|B1|||Age||years|Mean|68.9|68.9|Standard Deviation|10.2|10.2|||
4176022|NCT00807014|3997034|B3|"Captured as Other on Case Report Form"||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4176023|NCT00807014|3997035|B2|"Captured as Other on Case Report Form"||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4176024|NCT00807014|3997036|B1|"Captured as Other on Case Report Form"||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4176025|NCT00807014|3997034|B3|Mixed or Multiracial||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4176026|NCT00807014|3997035|B2|Mixed or Multiracial||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4176027|NCT00807014|3997036|B1|Mixed or Multiracial||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4176028|NCT00807014|3997034|B3|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4176029|NCT00807014|3997035|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4176030|NCT00807014|3997036|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4176031|NCT00807014|3997034|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4176032|NCT00807014|3997035|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4176033|NCT00807014|3997036|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4176034|NCT00807014|3997034|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|152|152.0||||||
4176035|NCT00807014|3997035|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
4176036|NCT00807014|3997036|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|75|75.0||||||
4176037|NCT00807014|3997034|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4176038|NCT00807014|3997035|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4176039|NCT00807014|3997036|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4176040|NCT00807014|3997034|B3||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4176041|NCT00807014|3997035|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4176042|NCT00807014|3997036|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4176043|NCT00807014|3997034|B3|||Age||Years|Mean|19.1|19.1|Standard Deviation|5.3|5.3|||
4176044|NCT00807014|3997035|B2|||Age||Years|Mean|19.2|19.2|Standard Deviation|5.3|5.3|||
4176045|NCT00807014|3997036|B1|||Age||Years|Mean|18.9|18.9|Standard Deviation|5.3|5.3|||
4176046|NCT00807001|3997063|B6|Austria||Region of Enrollment||participants|Number|2|2.0||||||
4176047|NCT00807001|3997064|B5|Austria||Region of Enrollment||participants|Number|0|0.0||||||
4176048|NCT00807001|3997065|B4|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4176049|NCT00807001|3997066|B3|Austria||Region of Enrollment||participants|Number|0|0.0||||||
4176050|NCT00807001|3997067|B2|Austria||Region of Enrollment||participants|Number|0|0.0||||||
4176051|NCT00807001|3997068|B1|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4176052|NCT00807001|3997063|B6|Argentina||Region of Enrollment||participants|Number|3|3.0||||||
4176053|NCT00807001|3997064|B5|Argentina||Region of Enrollment||participants|Number|2|2.0||||||
4176054|NCT00807001|3997065|B4|Argentina||Region of Enrollment||participants|Number|0|0.0||||||
4176055|NCT00807001|3997066|B3|Argentina||Region of Enrollment||participants|Number|0|0.0||||||
4176056|NCT00807001|3997067|B2|Argentina||Region of Enrollment||participants|Number|0|0.0||||||
4176057|NCT00807001|3997068|B1|Argentina||Region of Enrollment||participants|Number|1|1.0||||||
4176058|NCT00807001|3997063|B6|United States||Region of Enrollment||participants|Number|36|36.0||||||
4176059|NCT00807001|3997064|B5|United States||Region of Enrollment||participants|Number|7|7.0||||||
4176060|NCT00807001|3997065|B4|United States||Region of Enrollment||participants|Number|7|7.0||||||
4176061|NCT00807001|3997066|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4176062|NCT00807001|3997067|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4176063|NCT00807001|3997068|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4176064|NCT00807001|3997063|B6||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4176065|NCT00807001|3997064|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4176066|NCT00807001|3997065|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4176067|NCT00807001|3997066|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4176068|NCT00807001|3997067|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4176069|NCT00807001|3997068|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4176070|NCT00807001|3997063|B6||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4176071|NCT00807001|3997064|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4176072|NCT00807001|3997065|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4176073|NCT00807001|3997066|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4176074|NCT00807001|3997067|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4176075|NCT00807001|3997068|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4176076|NCT00807001|3997063|B6|||Age||years|Mean|48.1|48.1|Standard Deviation|6.94|6.94|||
4176077|NCT00807001|3997064|B5|||Age||years|Mean|47.2|47.2|Standard Deviation|7.89|7.89|||
4176078|NCT00807001|3997065|B4|||Age||years|Mean|47.3|47.3|Standard Deviation|8.12|8.12|||
4176079|NCT00807001|3997066|B3|||Age||years|Mean|48.8|48.8|Standard Deviation|5.85|5.85|||
4176080|NCT00807001|3997067|B2|||Age||years|Mean|48.3|48.3|Standard Deviation|6.50|6.5|||
4176081|NCT00807001|3997068|B1|||Age||years|Mean|49.3|49.3|Standard Deviation|7.63|7.63|||
4176082|NCT00807001|3997063|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4176083|NCT00807001|3997064|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4176084|NCT00807001|3997065|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4176085|NCT00807001|3997066|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4176086|NCT00807001|3997067|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4176088|NCT00807001|3997063|B6||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4176089|NCT00807001|3997064|B5||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4176090|NCT00807001|3997065|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4176091|NCT00807001|3997066|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4176092|NCT00807001|3997067|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4176093|NCT00807001|3997068|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4176094|NCT00807001|3997063|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4176095|NCT00807001|3997064|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4176096|NCT00807001|3997065|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4176097|NCT00807001|3997066|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4176098|NCT00807001|3997067|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4176099|NCT00807001|3997068|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4176100|NCT00806988|3997089|B3|Denmark||Region of Enrollment||participants|Number|2|2.0||||||
4176101|NCT00806988|3997090|B2|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
4176102|NCT00806988|3997091|B1|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
4176103|NCT00806988|3997089|B3|United States||Region of Enrollment||participants|Number|228|228.0||||||
4176104|NCT00806988|3997090|B2|United States||Region of Enrollment||participants|Number|114|114.0||||||
4176105|NCT00806988|3997091|B1|United States||Region of Enrollment||participants|Number|114|114.0||||||
4176106|NCT00806988|3997089|B3|Canada||Region of Enrollment||participants|Number|71|71.0||||||
4176107|NCT00806988|3997090|B2|Canada||Region of Enrollment||participants|Number|36|36.0||||||
4176108|NCT00806988|3997091|B1|Canada||Region of Enrollment||participants|Number|35|35.0||||||
4176109|NCT00806988|3997089|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4176110|NCT00806988|3997090|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176111|NCT00806988|3997091|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4176112|NCT00806988|3997089|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176113|NCT00806988|3997090|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176114|NCT00806988|3997091|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176115|NCT00806988|3997089|B3||White|Race (NIH/OMB)||Participants|Count of Participants|237|237.0||||||
4176116|NCT00806988|3997090|B2||White|Race (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
4176117|NCT00806988|3997091|B1||White|Race (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
4176118|NCT00806988|3997089|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4176119|NCT00806988|3997090|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4176120|NCT00806988|3997091|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4176121|NCT00806988|3997089|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176122|NCT00806988|3997090|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176123|NCT00806988|3997091|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176124|NCT00806988|3997089|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4176125|NCT00806988|3997090|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4176126|NCT00806988|3997091|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4176127|NCT00806988|3997089|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4176128|NCT00806988|3997090|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4176129|NCT00806988|3997091|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4176130|NCT00806988|3997089|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176131|NCT00806988|3997090|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176132|NCT00806988|3997091|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176133|NCT00806988|3997089|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|275|275.0||||||
4176134|NCT00806988|3997090|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|137|137.0||||||
4176135|NCT00806988|3997091|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
4176136|NCT00806988|3997089|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4176137|NCT00806988|3997090|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4176138|NCT00806988|3997091|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4176139|NCT00806988|3997089|B3||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4176140|NCT00806988|3997090|B2||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4176141|NCT00806988|3997091|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4176142|NCT00806988|3997089|B3||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4176143|NCT00806988|3997090|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4176144|NCT00806988|3997091|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4176145|NCT00806988|3997089|B3|||Age||years|Mean|64.7|64.7|Standard Deviation|10.5|10.5|||
4176146|NCT00806988|3997090|B2|||Age||years|Mean|65.2|65.2|Standard Deviation|11.3|11.3|||
4176147|NCT00806988|3997091|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|9.6|9.6|||
4176148|NCT00806819|3997100|B3||Male|Gender||Participants|Count of Participants|403|403.0||||||
4176149|NCT00806819|3997101|B2||Male|Gender||Participants|Count of Participants|208|208.0||||||
4176150|NCT00806819|3997102|B1||Male|Gender||Participants|Count of Participants|195|195.0||||||
4176151|NCT00806819|3997100|B3||Female|Gender||Participants|Count of Participants|310|310.0||||||
4176152|NCT00806819|3997101|B2||Female|Gender||Participants|Count of Participants|152|152.0||||||
4176153|NCT00806819|3997102|B1||Female|Gender||Participants|Count of Participants|158|158.0||||||
4176154|NCT00806819|3997100|B3|||Age||years|Mean|59.0|59.0|Standard Deviation|10.6|10.6|||
4176155|NCT00806819|3997101|B2|||Age||years|Mean|58.7|58.7|Standard Deviation|10.9|10.9|||
4176156|NCT00806819|3997102|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|10.3|10.3|||
4176157|NCT00806676|3997135|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4176158|NCT00806676|3997136|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4176159|NCT00806676|3997137|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4176160|NCT00806676|3997138|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4176161|NCT00806676|3997135|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176162|NCT00806676|3997136|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176163|NCT00806676|3997137|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176164|NCT00806676|3997138|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176165|NCT00806676|3997135|B4||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4176166|NCT00806676|3997136|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4176167|NCT00806676|3997137|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4176168|NCT00806676|3997138|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4176169|NCT00806676|3997135|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4176170|NCT00806676|3997136|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4176171|NCT00806676|3997137|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4176172|NCT00806676|3997138|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4176173|NCT00806676|3997135|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176174|NCT00806676|3997136|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176175|NCT00806676|3997137|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176176|NCT00806676|3997138|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176177|NCT00806676|3997135|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176178|NCT00806676|3997136|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176179|NCT00806676|3997137|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176180|NCT00806676|3997138|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176181|NCT00806676|3997135|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176182|NCT00806676|3997136|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176183|NCT00806676|3997137|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176184|NCT00806676|3997138|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176185|NCT00806676|3997135|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4176186|NCT00806676|3997136|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4176187|NCT00806676|3997137|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4176188|NCT00806676|3997138|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4176189|NCT00806676|3997135|B4||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4176190|NCT00806676|3997136|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4176191|NCT00806676|3997137|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4176192|NCT00806676|3997138|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4176193|NCT00806676|3997135|B4|>=11, <=21, years||Age, Customized||Participants|Count of Participants|57|57.0||||||
4176194|NCT00806676|3997136|B3|>=11, <=21, years||Age, Customized||Participants|Count of Participants|23|23.0||||||
4176195|NCT00806676|3997137|B2|>=11, <=21, years||Age, Customized||Participants|Count of Participants|9|9.0||||||
4176196|NCT00806676|3997138|B1|>=11, <=21, years||Age, Customized||Participants|Count of Participants|25|25.0||||||
4176197|NCT00806624|3997169|B4|Korea, Republic of||Region of Enrollment||participants|Number|95|95.0||||||
4176198|NCT00806624|3997170|B3|Korea, Republic of||Region of Enrollment||participants|Number|30|30.0||||||
4176199|NCT00806624|3997171|B2|Korea, Republic of||Region of Enrollment||participants|Number|33|33.0||||||
4176200|NCT00806624|3997172|B1|Korea, Republic of||Region of Enrollment||participants|Number|32|32.0||||||
4176201|NCT00806624|3997169|B4|China||Region of Enrollment||participants|Number|22|22.0||||||
4176202|NCT00806624|3997170|B3|China||Region of Enrollment||participants|Number|7|7.0||||||
4176203|NCT00806624|3997171|B2|China||Region of Enrollment||participants|Number|8|8.0||||||
4176204|NCT00806624|3997172|B1|China||Region of Enrollment||participants|Number|7|7.0||||||
4176205|NCT00806624|3997169|B4|Singapore||Region of Enrollment||participants|Number|13|13.0||||||
4176206|NCT00806624|3997170|B3|Singapore||Region of Enrollment||participants|Number|4|4.0||||||
4176207|NCT00806624|3997171|B2|Singapore||Region of Enrollment||participants|Number|4|4.0||||||
4176208|NCT00806624|3997172|B1|Singapore||Region of Enrollment||participants|Number|5|5.0||||||
4176209|NCT00806624|3997169|B4|Taiwan||Region of Enrollment||participants|Number|104|104.0||||||
4176210|NCT00806624|3997170|B3|Taiwan||Region of Enrollment||participants|Number|34|34.0||||||
4176211|NCT00806624|3997171|B2|Taiwan||Region of Enrollment||participants|Number|35|35.0||||||
4176212|NCT00806624|3997172|B1|Taiwan||Region of Enrollment||participants|Number|35|35.0||||||
4176213|NCT00806624|3997169|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176214|NCT00806624|3997170|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176215|NCT00806624|3997171|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176216|NCT00806624|3997172|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176217|NCT00806624|3997169|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176218|NCT00806624|3997170|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176219|NCT00806624|3997171|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176220|NCT00806624|3997172|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176221|NCT00806624|3997169|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176222|NCT00806624|3997170|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176223|NCT00806624|3997171|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176224|NCT00806624|3997172|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176225|NCT00806624|3997169|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176226|NCT00806624|3997170|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176227|NCT00806624|3997171|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176228|NCT00806624|3997172|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176229|NCT00806624|3997169|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176230|NCT00806624|3997170|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176231|NCT00806624|3997171|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176232|NCT00806624|3997172|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176233|NCT00806624|3997169|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|234|234.0||||||
4176234|NCT00806624|3997170|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4176235|NCT00806624|3997171|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
4176236|NCT00806624|3997172|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
4176237|NCT00806624|3997169|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176238|NCT00806624|3997170|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176239|NCT00806624|3997171|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176240|NCT00806624|3997172|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176241|NCT00806624|3997169|B4||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4176242|NCT00806624|3997170|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4176243|NCT00806624|3997171|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4176244|NCT00806624|3997172|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4176245|NCT00806624|3997169|B4||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4176246|NCT00806624|3997170|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4176247|NCT00806624|3997171|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4176248|NCT00806624|3997172|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4176249|NCT00806624|3997169|B4|||Age||years|Mean|65.1|65.1|Standard Deviation|8.78|8.78|||
4176250|NCT00806624|3997170|B3|||Age||years|Mean|64.5|64.5|Standard Deviation|9.51|9.51|||
4176251|NCT00806624|3997171|B2|||Age||years|Mean|65.9|65.9|Standard Deviation|7.71|7.71|||
4176252|NCT00806624|3997172|B1|||Age||years|Mean|64.9|64.9|Standard Deviation|9.12|9.12|||
4176253|NCT00806598|3997182|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4176254|NCT00806598|3997182|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4176255|NCT00806598|3997182|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4176256|NCT00806598|3997182|B1|||Age||years|Median|59|59.0|Full Range|||19.0|81.0|
4176257|NCT00806585|3997186|B6||Male|Sex: Female, Male||Participants|Count of Participants|370|370.0||||||
4176258|NCT00806585|3997187|B5||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4176259|NCT00806585|3997188|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4176260|NCT00806585|3997189|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4176261|NCT00806585|3997190|B2||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4176262|NCT00806585|3997191|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4176263|NCT00806585|3997186|B6||Female|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
4176264|NCT00806585|3997187|B5||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4176265|NCT00806585|3997188|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4176266|NCT00806585|3997189|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4176267|NCT00806585|3997190|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4176268|NCT00806585|3997191|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4176269|NCT00806585|3997186|B6|||Age||years|Median|58.0|58.0|Full Range|||20.0|75.0|
4176270|NCT00806585|3997187|B5|||Age||years|Median|58.0|58.0|Full Range|||30.0|75.0|
4176271|NCT00806585|3997188|B4|||Age||years|Median|57.0|57.0|Full Range|||37.0|74.0|
4176272|NCT00806585|3997189|B3|||Age||years|Median|58.0|58.0|Full Range|||20.0|74.0|
4176273|NCT00806585|3997190|B2|||Age||years|Median|60.0|60.0|Full Range|||36.0|74.0|
4176274|NCT00806585|3997191|B1|||Age||years|Median|58.0|58.0|Full Range|||37.0|75.0|
4176275|NCT00806546|3997227|B1|United States||Region of Enrollment||participants|Number|479|479.0||||||
4176276|NCT00806546|3997227|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4176277|NCT00806546|3997227|B1||Female|Sex: Female, Male||Participants|Count of Participants|392|392.0||||||
4176278|NCT00806546|3997227|B1|||Age||years|Mean|41.7|41.7|Standard Deviation|11.85|11.85|||
4176279|NCT00806546|3997227|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4176280|NCT00806546|3997227|B1||Between 18 and 65 years|Age||Participants|Count of Participants|479|479.0||||||
4176281|NCT00806546|3997227|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4176282|NCT00806494|3997231|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4176283|NCT00806494|3997231|B1||Female|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
4176284|NCT00806494|3997231|B1|>= 65 Years||Age, Customized||Participants|Number|131|131.0||||||
4176285|NCT00806494|3997231|B1|Between 45 to 64 Years||Age, Customized||Participants|Number|163|163.0||||||
4176286|NCT00806494|3997231|B1|Between 18 to 44 Years||Age, Customized||Participants|Number|37|37.0||||||
4176287|NCT00806442|3997255|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4176288|NCT00806442|3997255|B1|Gender|Male|Sex/Gender, Customized||Participants|Count of Participants|12|12.0||||||
4176289|NCT00806442|3997255|B1|Gender|Female|Sex/Gender, Customized||Participants|Count of Participants|27|27.0||||||
4176290|NCT00806442|3997255|B1|Age Category|>=65 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
4176291|NCT00806442|3997255|B1|Age Category|Between 18 and 65 years|Age, Customized||Participants|Count of Participants|39|39.0||||||
4176292|NCT00806442|3997255|B1|Age Category|<=18 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
4176293|NCT00806442|3997255|B1|Age||Age, Customized||years|Median|43|43.0|Full Range|||22.0|64.0|
4176294|NCT00806416|3997276|B3|||Weight||Kilograms|Mean|72.6|72.6|Full Range|||48.0|105.4|
4176295|NCT00806416|3997277|B2|||Weight||Kilograms|Mean|71.2|71.2|Full Range|||49.9|98.4|
4176296|NCT00806416|3997278|B1|||Weight||Kilograms|Mean|72.8|72.8|Full Range|||48.0|105.4|
4176297|NCT00806416|3997276|B3|||Height||Centimeters|Mean|167.5|167.5|Full Range|||144.8|190.5|
4176298|NCT00806416|3997277|B2|||Height||Centimeters|Mean|170.4|170.4|Full Range|||156.2|190.5|
4176299|NCT00806416|3997278|B1|||Height||Centimeters|Mean|167.2|167.2|Full Range|||144.8|190.5|
4176300|NCT00806416|3997276|B3||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4176301|NCT00806416|3997277|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4176302|NCT00806416|3997278|B1||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4176303|NCT00806416|3997276|B3||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4176304|NCT00806416|3997277|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4176305|NCT00806416|3997278|B1||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4176306|NCT00806416|3997276|B3|||Age||years|Mean|40.8|40.8|Full Range|||18.0|65.0|
4176307|NCT00806416|3997277|B2|||Age||years|Mean|35.2|35.2|Full Range|||19.0|54.0|
4176308|NCT00806416|3997278|B1|||Age||years|Mean|41.6|41.6|Full Range|||18.0|65.0|
4176309|NCT00806403|3997292|B3|Sweden||Region of Enrollment||participants|Number|205|205.0||||||
4176310|NCT00806403|3997293|B2|Sweden||Region of Enrollment||participants|Number|101|101.0||||||
4176311|NCT00806403|3997294|B1|Sweden||Region of Enrollment||participants|Number|104|104.0||||||
4176312|NCT00806403|3997292|B3||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4176313|NCT00806403|3997293|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4176314|NCT00806403|3997294|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4176315|NCT00806403|3997292|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4176316|NCT00806403|3997293|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4176317|NCT00806403|3997294|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4176318|NCT00806403|3997292|B3|||Age||years|Mean|64.8|64.8|Standard Deviation|11.7|11.7|||
4176319|NCT00806403|3997293|B2|||Age||years|Mean|65.3|65.3|Standard Deviation|10.9|10.9|||
4176320|NCT00806403|3997294|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|12.4|12.4|||
4176321|NCT00806403|3997292|B3||>=65 years|Age||Participants|Count of Participants|101|101.0||||||
4176322|NCT00806403|3997293|B2||>=65 years|Age||Participants|Count of Participants|52|52.0||||||
4176323|NCT00806403|3997294|B1||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
4176324|NCT00806403|3997292|B3||Between 18 and 65 years|Age||Participants|Count of Participants|104|104.0||||||
4176325|NCT00806403|3997293|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4176326|NCT00806403|3997294|B1||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4176327|NCT00806403|3997292|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4176328|NCT00806403|3997293|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4176329|NCT00806403|3997294|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4176330|NCT00806390|3997307|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4176331|NCT00806390|3997308|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4176332|NCT00806390|3997309|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4176333|NCT00806390|3997307|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4176334|NCT00806390|3997308|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4176335|NCT00806390|3997309|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4176336|NCT00806390|3997307|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4176337|NCT00806390|3997308|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4176338|NCT00806390|3997309|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4176339|NCT00806390|3997307|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4176340|NCT00806390|3997308|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4176341|NCT00806390|3997309|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4176342|NCT00806390|3997307|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4176343|NCT00806390|3997308|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4176344|NCT00806390|3997309|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4176345|NCT00806390|3997307|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4176346|NCT00806390|3997308|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4176347|NCT00806390|3997309|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4176348|NCT00806390|3997307|B3|||Age||years|Mean|49|49.0|Standard Deviation|10|10.0|||
4176349|NCT00806390|3997308|B2|||Age||years|Mean|47|47.0|Standard Deviation|8|8.0|||
4176350|NCT00806390|3997309|B1|||Age||years|Mean|51|51.0|Standard Deviation|11|11.0|||
4176351|NCT00806351|3997316|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4176352|NCT00806351|3997317|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4176353|NCT00806351|3997318|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4176354|NCT00806351|3997316|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4176355|NCT00806351|3997317|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4176356|NCT00806351|3997318|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4176357|NCT00806351|3997316|B3|greater than or equal to (≥) 65 years||Age, Customized||participants|Number|6|6.0||||||
4176358|NCT00806351|3997317|B2|greater than or equal to (≥) 65 years||Age, Customized||participants|Number|2|2.0||||||
4176359|NCT00806351|3997318|B1|greater than or equal to (≥) 65 years||Age, Customized||participants|Number|4|4.0||||||
4176360|NCT00806351|3997316|B3|45 to 64 years||Age, Customized||participants|Number|11|11.0||||||
4176361|NCT00806351|3997317|B2|45 to 64 years||Age, Customized||participants|Number|2|2.0||||||
4176362|NCT00806351|3997318|B1|45 to 64 years||Age, Customized||participants|Number|9|9.0||||||
4176363|NCT00806351|3997316|B3|18 to 44 years||Age, Customized||participants|Number|4|4.0||||||
4176364|NCT00806351|3997317|B2|18 to 44 years||Age, Customized||participants|Number|2|2.0||||||
4176365|NCT00806351|3997318|B1|18 to 44 years||Age, Customized||participants|Number|2|2.0||||||
4176366|NCT00806260|3997350|B7|United States||Region of Enrollment||participants|Number|80|80.0||||||
4176367|NCT00806260|3997351|B6|United States||Region of Enrollment||participants|Number|17|17.0||||||
4176368|NCT00806260|3997352|B5|United States||Region of Enrollment||participants|Number|18|18.0||||||
4176369|NCT00806260|3997353|B4|United States||Region of Enrollment||participants|Number|14|14.0||||||
4176370|NCT00806260|3997354|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4176371|NCT00806260|3997355|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4176372|NCT00806260|3997356|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4176373|NCT00806260|3997350|B7||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4176374|NCT00806260|3997351|B6||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4176375|NCT00806260|3997352|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4176376|NCT00806260|3997353|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4176377|NCT00806260|3997354|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4176378|NCT00806260|3997355|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4176379|NCT00806260|3997356|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4176380|NCT00806260|3997350|B7||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4176381|NCT00806260|3997351|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4176382|NCT00806260|3997352|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4176383|NCT00806260|3997353|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4176384|NCT00806260|3997354|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4176385|NCT00806260|3997355|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4176386|NCT00806260|3997356|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4176387|NCT00806260|3997350|B7|||Age||years|Mean|28.5|28.5|Standard Deviation|6.8|6.8|||
4176388|NCT00806260|3997351|B6|||Age||years|Mean|27.4|27.4|Standard Deviation|6.3|6.3|||
4176389|NCT00806260|3997352|B5|||Age||years|Mean|30.1|30.1|Standard Deviation|7.7|7.7|||
4176390|NCT00806260|3997353|B4|||Age||years|Mean|27.4|27.4|Standard Deviation|6.1|6.1|||
4176391|NCT00806260|3997354|B3|||Age||years|Mean|31.1|31.1|Standard Deviation|8.6|8.6|||
4176392|NCT00806260|3997355|B2|||Age||years|Mean|29.9|29.9|Standard Deviation|7.8|7.8|||
4176393|NCT00806260|3997356|B1|||Age||years|Mean|26.7|26.7|Standard Deviation|5.4|5.4|||
4176394|NCT00806234|3997373|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4176395|NCT00806234|3997374|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4176396|NCT00806234|3997375|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4176397|NCT00806234|3997376|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4176398|NCT00806234|3997373|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176399|NCT00806234|3997374|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176400|NCT00806234|3997375|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176401|NCT00806234|3997376|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176402|NCT00806234|3997373|B4||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4176403|NCT00806234|3997374|B3||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4176404|NCT00806234|3997375|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4176405|NCT00806234|3997376|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4176406|NCT00806234|3997373|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4176407|NCT00806234|3997374|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4176408|NCT00806234|3997375|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4176409|NCT00806234|3997376|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4176410|NCT00806234|3997373|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176411|NCT00806234|3997374|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176412|NCT00806234|3997375|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176413|NCT00806234|3997376|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176414|NCT00806234|3997373|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176415|NCT00806234|3997374|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176416|NCT00806234|3997375|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176417|NCT00806234|3997376|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176418|NCT00806234|3997373|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176419|NCT00806234|3997374|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176420|NCT00806234|3997375|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176421|NCT00806234|3997376|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176422|NCT00806234|3997373|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176423|NCT00806234|3997374|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176424|NCT00806234|3997375|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176425|NCT00806234|3997376|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176426|NCT00806234|3997373|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
4176427|NCT00806234|3997374|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4176428|NCT00806234|3997375|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4176429|NCT00806234|3997376|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4176430|NCT00806234|3997373|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4176431|NCT00806234|3997374|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4176432|NCT00806234|3997375|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4176433|NCT00806234|3997376|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4176434|NCT00806234|3997373|B4||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4176435|NCT00806234|3997374|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4176436|NCT00806234|3997375|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4176437|NCT00806234|3997376|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4176438|NCT00806234|3997373|B4||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4176439|NCT00806234|3997374|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4176440|NCT00806234|3997375|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4176441|NCT00806234|3997376|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4176442|NCT00806234|3997373|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4176443|NCT00806234|3997374|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4176444|NCT00806234|3997375|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4176445|NCT00806234|3997376|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4176446|NCT00806234|3997373|B4||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4176447|NCT00806234|3997374|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4176448|NCT00806234|3997375|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4176449|NCT00806234|3997376|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4176450|NCT00806234|3997373|B4||<=18 years|Age||Participants|Count of Participants|112|112.0||||||
4176451|NCT00806234|3997374|B3||<=18 years|Age||Participants|Count of Participants|45|45.0||||||
4176452|NCT00806234|3997375|B2||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
4176453|NCT00806234|3997376|B1||<=18 years|Age||Participants|Count of Participants|41|41.0||||||
4176454|NCT00806221|3997395|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4176455|NCT00806221|3997395|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4176456|NCT00806221|3997395|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4176457|NCT00806221|3997395|B1|Hispanic Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4176458|NCT00806221|3997395|B1|non-Hispanic Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
4176459|NCT00806221|3997395|B1|gender/sex was not recorded||Sex/Gender, Customized||participants|Number|22|22.0||||||
4176460|NCT00806221|3997395|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4176461|NCT00806221|3997395|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4176462|NCT00806221|3997395|B1||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
4176463|NCT00806195|3997402|B5||Male|Sex: Female, Male||Participants|Count of Participants|3958|3958.0||||||
4176464|NCT00806195|3997403|B4||Male|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
4176465|NCT00806195|3997404|B3||Male|Sex: Female, Male||Participants|Count of Participants|693|693.0||||||
4176466|NCT00806195|3997405|B2||Male|Sex: Female, Male||Participants|Count of Participants|780|780.0||||||
4176467|NCT00806195|3997406|B1||Male|Sex: Female, Male||Participants|Count of Participants|2228|2228.0||||||
4176468|NCT00806195|3997402|B5||Female|Sex: Female, Male||Participants|Count of Participants|3786|3786.0||||||
4176469|NCT00806195|3997403|B4||Female|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
4176470|NCT00806195|3997404|B3||Female|Sex: Female, Male||Participants|Count of Participants|716|716.0||||||
4176471|NCT00806195|3997405|B2||Female|Sex: Female, Male||Participants|Count of Participants|703|703.0||||||
4176472|NCT00806195|3997406|B1||Female|Sex: Female, Male||Participants|Count of Participants|2135|2135.0||||||
4176473|NCT00806195|3997402|B5|||Age||Days|Mean|65.0|65.0|Standard Deviation|7.1|7.1|||
4176474|NCT00806195|3997403|B4|||Age||Days|Mean|65.2|65.2|Standard Deviation|6.3|6.3|||
4176475|NCT00806195|3997404|B3|||Age||Days|Mean|65.5|65.5|Standard Deviation|6.5|6.5|||
4176476|NCT00806195|3997405|B2|||Age||Days|Mean|64.7|64.7|Standard Deviation|7.1|7.1|||
4176477|NCT00806195|3997406|B1|||Age||Days|Mean|64.9|64.9|Standard Deviation|7.4|7.4|||
4176478|NCT00806078|3997421|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4176479|NCT00806078|3997422|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4176480|NCT00806078|3997423|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4176481|NCT00806078|3997421|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4176482|NCT00806078|3997422|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4176483|NCT00806078|3997423|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4176484|NCT00806078|3997421|B3|||Age||years|Mean|35.5|35.5|Standard Deviation|8.4|8.4|||
4176485|NCT00806078|3997422|B2|||Age||years|Mean|35.5|35.5|Standard Deviation|8.4|8.4|||
4176486|NCT00806078|3997423|B1|||Age||years|Mean|35.5|35.5|Standard Deviation|8.4|8.4|||
4176487|NCT00806078|3997421|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4176488|NCT00806078|3997422|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4176489|NCT00806078|3997423|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4176490|NCT00806078|3997421|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4176491|NCT00806078|3997422|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4176492|NCT00806078|3997423|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4176493|NCT00806078|3997421|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4176494|NCT00806078|3997422|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4176495|NCT00806078|3997423|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4176496|NCT00806026|3997434|B7||Male|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
4176497|NCT00806026|3997435|B6||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4176498|NCT00806026|3997436|B5||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4176499|NCT00806026|3997437|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4176500|NCT00806026|3997438|B3||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4176501|NCT00806026|3997439|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4176502|NCT00806026|3997440|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4176503|NCT00806026|3997434|B7||Female|Sex: Female, Male||Participants|Count of Participants|441|441.0||||||
4176504|NCT00806026|3997435|B6||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4176505|NCT00806026|3997436|B5||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4176506|NCT00806026|3997437|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4176507|NCT00806026|3997438|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4176508|NCT00806026|3997439|B2||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4176509|NCT00806026|3997440|B1||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4176510|NCT00806026|3997434|B7|Greater than and equal to 65 years||Age, Customized||Participants|Number|193|193.0||||||
4176511|NCT00806026|3997435|B6|Greater than and equal to 65 years||Age, Customized||Participants|Number|10|10.0||||||
4176512|NCT00806026|3997436|B5|Greater than and equal to 65 years||Age, Customized||Participants|Number|10|10.0||||||
4176513|NCT00806026|3997437|B4|Greater than and equal to 65 years||Age, Customized||Participants|Number|19|19.0||||||
4176514|NCT00806026|3997438|B3|Greater than and equal to 65 years||Age, Customized||Participants|Number|51|51.0||||||
4176515|NCT00806026|3997439|B2|Greater than and equal to 65 years||Age, Customized||Participants|Number|59|59.0||||||
4176516|NCT00806026|3997440|B1|Greater than and equal to 65 years||Age, Customized||Participants|Number|44|44.0||||||
4176517|NCT00806026|3997434|B7|45 to 64 years||Age, Customized||Participants|Number|362|362.0||||||
4176518|NCT00806026|3997435|B6|45 to 64 years||Age, Customized||Participants|Number|31|31.0||||||
4176519|NCT00806026|3997436|B5|45 to 64 years||Age, Customized||Participants|Number|32|32.0||||||
4176520|NCT00806026|3997437|B4|45 to 64 years||Age, Customized||Participants|Number|29|29.0||||||
4176521|NCT00806026|3997438|B3|45 to 64 years||Age, Customized||Participants|Number|84|84.0||||||
4176522|NCT00806026|3997439|B2|45 to 64 years||Age, Customized||Participants|Number|85|85.0||||||
4176523|NCT00806026|3997440|B1|45 to 64 years||Age, Customized||Participants|Number|101|101.0||||||
4176524|NCT00806026|3997434|B7|18 to 44 years||Age, Customized||Participants|Number|164|164.0||||||
4176525|NCT00806026|3997435|B6|18 to 44 years||Age, Customized||Participants|Number|20|20.0||||||
4176526|NCT00806026|3997436|B5|18 to 44 years||Age, Customized||Participants|Number|17|17.0||||||
4176527|NCT00806026|3997437|B4|18 to 44 years||Age, Customized||Participants|Number|11|11.0||||||
4176528|NCT00806026|3997438|B3|18 to 44 years||Age, Customized||Participants|Number|45|45.0||||||
4176529|NCT00806026|3997439|B2|18 to 44 years||Age, Customized||Participants|Number|34|34.0||||||
4176530|NCT00806026|3997440|B1|18 to 44 years||Age, Customized||Participants|Number|37|37.0||||||
4176531|NCT00806026|3997434|B7|Less than 18 years||Age, Customized||Participants|Number|0|0.0||||||
4176532|NCT00806026|3997435|B6|Less than 18 years||Age, Customized||Participants|Number|0|0.0||||||
4176533|NCT00806026|3997436|B5|Less than 18 years||Age, Customized||Participants|Number|0|0.0||||||
4176534|NCT00806026|3997437|B4|Less than 18 years||Age, Customized||Participants|Number|0|0.0||||||
4176535|NCT00806026|3997438|B3|Less than 18 years||Age, Customized||Participants|Number|0|0.0||||||
4176536|NCT00806026|3997439|B2|Less than 18 years||Age, Customized||Participants|Number|0|0.0||||||
4176537|NCT00806026|3997440|B1|Less than 18 years||Age, Customized||Participants|Number|0|0.0||||||
4176538|NCT00805961|3997540|B1|United States||Region of Enrollment||participants|Number|68|68.0||||||
4176539|NCT00805961|3997540|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4176540|NCT00805961|3997540|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4176541|NCT00805961|3997540|B1|||Age||years|Median|59|59.0|Full Range|||24.0|80.0|
4176542|NCT00805935|3997546|B5|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4176543|NCT00805935|3997547|B4|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4176544|NCT00805935|3997548|B3|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4176545|NCT00805935|3997549|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4176546|NCT00805935|3997550|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4176547|NCT00805935|3997546|B5|Hispanic||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4176548|NCT00805935|3997547|B4|Hispanic||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4176549|NCT00805935|3997548|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4176550|NCT00805935|3997549|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4176551|NCT00805935|3997550|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4176552|NCT00805935|3997546|B5|Asian||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4176553|NCT00805935|3997547|B4|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4176554|NCT00805935|3997548|B3|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4176555|NCT00805935|3997549|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4176556|NCT00805935|3997550|B1|Asian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4176557|NCT00805935|3997546|B5|African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4176558|NCT00805935|3997547|B4|African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4176559|NCT00805935|3997548|B3|African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4176560|NCT00805935|3997549|B2|African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4176561|NCT00805935|3997550|B1|African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4176562|NCT00805935|3997546|B5|Caucasian||Race/Ethnicity, Customized||Participants|Number|81|81.0||||||
4176563|NCT00805935|3997547|B4|Caucasian||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
4176564|NCT00805935|3997548|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
4176565|NCT00805935|3997549|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4176566|NCT00805935|3997550|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4176567|NCT00805935|3997546|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4176568|NCT00805935|3997547|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4176569|NCT00805935|3997548|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4176570|NCT00805935|3997549|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4176571|NCT00805935|3997550|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4176572|NCT00805935|3997546|B5||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4176573|NCT00805935|3997547|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4176574|NCT00805935|3997548|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4176575|NCT00805935|3997549|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4176576|NCT00805935|3997550|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4176577|NCT00805935|3997546|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4176578|NCT00805935|3997547|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4176579|NCT00805935|3997548|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4176580|NCT00805935|3997549|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4176581|NCT00805935|3997550|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4176582|NCT00805935|3997546|B5||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
4176583|NCT00805935|3997547|B4||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4176584|NCT00805935|3997548|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4176585|NCT00805935|3997549|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4176586|NCT00805935|3997550|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4176587|NCT00805935|3997546|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4176588|NCT00805935|3997547|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4176589|NCT00805935|3997548|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4176590|NCT00805935|3997549|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4176591|NCT00805935|3997550|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4176592|NCT00805870|3997605|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4176593|NCT00805870|3997606|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4176594|NCT00805870|3997607|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4176595|NCT00805870|3997605|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4176596|NCT00805870|3997606|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4176597|NCT00805870|3997607|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4176598|NCT00805870|3997605|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4176599|NCT00805870|3997606|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4176600|NCT00805870|3997607|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4176601|NCT00805870|3997605|B3|||Age||years|Mean|22.7|22.7|Standard Deviation|2.1|2.1|||
4176602|NCT00805870|3997606|B2|||Age||years|Mean|23.4|23.4|Standard Deviation|2.3|2.3|||
4176603|NCT00805870|3997607|B1|||Age||years|Mean|21.9|21.9|Standard Deviation|1.7|1.7|||
4176604|NCT00805870|3997605|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4176605|NCT00805870|3997606|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4176606|NCT00805870|3997607|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4176607|NCT00805870|3997605|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4176608|NCT00805870|3997606|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4176609|NCT00805870|3997607|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4176610|NCT00805870|3997605|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4176611|NCT00805870|3997606|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4176612|NCT00805870|3997607|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4176613|NCT00805792|3997620|B1|Severe (>13)||Participant Scores on National Institutes of Health Stroke Scale|The National Institutes of Health Stroke Scale (NIHSS) is a 15-item neurologic examination stroke scale used to evaluate the effect of acute cerebral infarction on the levels of consciousness, language, neglect, visual-field loss, extraocular movement, motor strength, ataxia, dysarthria, and sensory loss. A trained observer rates the patent’s ability to answer questions and perform activities. Ratings for each item are scored with 3 to 5 grades with 0 as normal, and there is an allowance for untestable items. The range of scores is from 0 (normal) to 42 (profound effect of stroke on patient).|participants|Number|5|5.0||||||
4176614|NCT00805792|3997620|B1|Moderate (6-13)||Participant Scores on National Institutes of Health Stroke Scale|The National Institutes of Health Stroke Scale (NIHSS) is a 15-item neurologic examination stroke scale used to evaluate the effect of acute cerebral infarction on the levels of consciousness, language, neglect, visual-field loss, extraocular movement, motor strength, ataxia, dysarthria, and sensory loss. A trained observer rates the patent’s ability to answer questions and perform activities. Ratings for each item are scored with 3 to 5 grades with 0 as normal, and there is an allowance for untestable items. The range of scores is from 0 (normal) to 42 (profound effect of stroke on patient).|participants|Number|12|12.0||||||
4176615|NCT00805792|3997620|B1|Mild (<6)||Participant Scores on National Institutes of Health Stroke Scale|The National Institutes of Health Stroke Scale (NIHSS) is a 15-item neurologic examination stroke scale used to evaluate the effect of acute cerebral infarction on the levels of consciousness, language, neglect, visual-field loss, extraocular movement, motor strength, ataxia, dysarthria, and sensory loss. A trained observer rates the patent’s ability to answer questions and perform activities. Ratings for each item are scored with 3 to 5 grades with 0 as normal, and there is an allowance for untestable items. The range of scores is from 0 (normal) to 42 (profound effect of stroke on patient).|participants|Number|16|16.0||||||
4176616|NCT00805792|3997620|B1|||Body Mass Index||kg/m^2|Median|27.1|27.1|Inter-Quartile Range|||24.7|30.6|
4176617|NCT00805792|3997620|B1|No previous ischemic stroke||Number of Participants with Previous Ischemic Stroke||participants|Number|28|28.0||||||
4176618|NCT00805792|3997620|B1|Previous ischemic stroke||Number of Participants with Previous Ischemic Stroke||participants|Number|5|5.0||||||
4176619|NCT00805792|3997620|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4176620|NCT00805792|3997620|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4176621|NCT00805792|3997620|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4176622|NCT00805792|3997620|B1|||Age||years|Median|66|66.0|Inter-Quartile Range|||54.0|84.0|
4176623|NCT00805766|3997628|B1||Male|Sex: Female, Male|Screening period:|Participants|Count of Participants|31|31.0||||||
4176624|NCT00805766|3997628|B1||Female|Sex: Female, Male|Screening period:|Participants|Count of Participants|14|14.0||||||
4176625|NCT00805766|3997628|B1|||Age|Screening period:|years|Mean|29.5|29.5|Standard Deviation|7.3|7.3|||
4176626|NCT00805740|3997640|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4176627|NCT00805740|3997641|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4176628|NCT00805740|3997642|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4176629|NCT00805740|3997640|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4176630|NCT00805740|3997641|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4176631|NCT00805740|3997642|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4176632|NCT00805740|3997640|B3|||Age||years|Mean|58.6|58.6|Standard Deviation|16.4|16.4|||
4176633|NCT00805740|3997641|B2|||Age||years|Mean|63.4|63.4|Standard Deviation|16.3|16.3|||
4176634|NCT00805740|3997642|B1|||Age||years|Mean|56.3|56.3|Standard Deviation|16.2|16.2|||
4176635|NCT00805675|3997665|B4|China||Region of Enrollment||participants|Number|46|46.0||||||
4176636|NCT00805675|3997666|B3|China||Region of Enrollment||participants|Number|16|16.0||||||
4176637|NCT00805675|3997667|B2|China||Region of Enrollment||participants|Number|14|14.0||||||
4176638|NCT00805675|3997668|B1|China||Region of Enrollment||participants|Number|16|16.0||||||
4176639|NCT00805675|3997665|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4176640|NCT00805675|3997666|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4176641|NCT00805675|3997667|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4176642|NCT00805675|3997668|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4176643|NCT00805675|3997665|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4176644|NCT00805675|3997666|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4176645|NCT00805675|3997667|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4176646|NCT00805675|3997668|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4176647|NCT00805675|3997665|B4|||Age||years|Mean|28.1|28.1|Standard Deviation|6.07|6.07|||
4176648|NCT00805675|3997666|B3|||Age||years|Mean|28.9|28.9|Standard Deviation|5.55|5.55|||
4176649|NCT00805675|3997667|B2|||Age||years|Mean|27.3|27.3|Standard Deviation|4.94|4.94|||
4176650|NCT00805675|3997668|B1|||Age||years|Mean|28.0|28.0|Standard Deviation|7.58|7.58|||
4176651|NCT00805545|3997702|B3|United States||Region of Enrollment||participants|Number|400|400.0||||||
4176652|NCT00805545|3997703|B2|United States||Region of Enrollment||participants|Number|200|200.0||||||
4176653|NCT00805545|3997704|B1|United States||Region of Enrollment||participants|Number|200|200.0||||||
4176654|NCT00805545|3997702|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4176655|NCT00805545|3997703|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4176656|NCT00805545|3997704|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4176657|NCT00805545|3997702|B3||Female|Sex: Female, Male||Participants|Count of Participants|400|400.0||||||
4176658|NCT00805545|3997703|B2||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4176659|NCT00805545|3997704|B1||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4176660|NCT00805545|3997702|B3|||Age||years|Mean|28.9|28.9|Standard Deviation|6.2|6.2|||
4176661|NCT00805545|3997703|B2|||Age||years|Mean|28.9|28.9|Standard Deviation|5.8|5.8|||
4176662|NCT00805545|3997704|B1|||Age||years|Mean|28.04|28.04|Standard Deviation|6.6|6.6|||
4176663|NCT00805545|3997702|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4176664|NCT00805545|3997703|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4176665|NCT00805545|3997704|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4176666|NCT00805545|3997702|B3||Between 18 and 65 years|Age||Participants|Count of Participants|400|400.0||||||
4176667|NCT00805545|3997703|B2||Between 18 and 65 years|Age||Participants|Count of Participants|200|200.0||||||
4176668|NCT00805545|3997704|B1||Between 18 and 65 years|Age||Participants|Count of Participants|200|200.0||||||
4176669|NCT00805545|3997702|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4176670|NCT00805545|3997703|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4176671|NCT00805545|3997704|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4176672|NCT00805532|3997711|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
4176673|NCT00805532|3997712|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
4176674|NCT00805532|3997713|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4176675|NCT00805532|3997711|B3|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4176676|NCT00805532|3997712|B2|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4176677|NCT00805532|3997713|B1|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4176678|NCT00805532|3997711|B3|Race/Ethnicity|White Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4176679|NCT00805532|3997712|B2|Race/Ethnicity|White Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4176680|NCT00805532|3997713|B1|Race/Ethnicity|White Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4176681|NCT00805532|3997711|B3|Race/Ethnicity|White Not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|62|62.0||||||
4176682|NCT00805532|3997712|B2|Race/Ethnicity|White Not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
4176683|NCT00805532|3997713|B1|Race/Ethnicity|White Not Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
4176684|NCT00805532|3997711|B3|Race/Ethnicity|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4176685|NCT00805532|3997712|B2|Race/Ethnicity|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4176686|NCT00805532|3997713|B1|Race/Ethnicity|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4176687|NCT00805532|3997711|B3|Race/Ethnicity|Asian or Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4176688|NCT00805532|3997712|B2|Race/Ethnicity|Asian or Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4176689|NCT00805532|3997713|B1|Race/Ethnicity|Asian or Native Hawaiian or Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4176690|NCT00805532|3997711|B3|Race/Ethnicity|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4176691|NCT00805532|3997712|B2|Race/Ethnicity|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4176692|NCT00805532|3997713|B1|Race/Ethnicity|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4176693|NCT00805532|3997711|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4176694|NCT00805532|3997712|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4176695|NCT00805532|3997713|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4176696|NCT00805532|3997711|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4176697|NCT00805532|3997712|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4176698|NCT00805532|3997713|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4176699|NCT00805532|3997711|B3|||Age||years|Mean|30.1|30.1|Standard Deviation|6.7|6.7|||
4176700|NCT00805532|3997712|B2|||Age||years|Mean|30.0|30.0|Standard Deviation|7.1|7.1|||
4176701|NCT00805532|3997713|B1|||Age||years|Mean|30.2|30.2|Standard Deviation|6.4|6.4|||
4176702|NCT00805493|3997728|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4176703|NCT00805493|3997729|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176704|NCT00805493|3997730|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176705|NCT00805493|3997731|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4176706|NCT00805493|3997728|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176707|NCT00805493|3997729|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176708|NCT00805493|3997730|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176709|NCT00805493|3997731|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176710|NCT00805493|3997728|B4||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4176711|NCT00805493|3997729|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4176712|NCT00805493|3997730|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4176713|NCT00805493|3997731|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4176714|NCT00805493|3997728|B4||Black|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176715|NCT00805493|3997729|B3||Black|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176716|NCT00805493|3997730|B2||Black|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176717|NCT00805493|3997731|B1||Black|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176718|NCT00805493|3997728|B4||Hawaiian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176719|NCT00805493|3997729|B3||Hawaiian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176720|NCT00805493|3997730|B2||Hawaiian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176721|NCT00805493|3997731|B1||Hawaiian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176722|NCT00805493|3997728|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176723|NCT00805493|3997729|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176724|NCT00805493|3997730|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176725|NCT00805493|3997731|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176726|NCT00805493|3997728|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176727|NCT00805493|3997729|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176728|NCT00805493|3997730|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176729|NCT00805493|3997731|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176730|NCT00805493|3997728|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176731|NCT00805493|3997729|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176732|NCT00805493|3997730|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176733|NCT00805493|3997731|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176734|NCT00805493|3997728|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4176735|NCT00805493|3997729|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4176736|NCT00805493|3997730|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4176737|NCT00805493|3997731|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4176738|NCT00805493|3997728|B4||Hispanic|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176739|NCT00805493|3997729|B3||Hispanic|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176740|NCT00805493|3997730|B2||Hispanic|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176741|NCT00805493|3997731|B1||Hispanic|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176742|NCT00805493|3997728|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4176743|NCT00805493|3997729|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4176744|NCT00805493|3997730|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4176745|NCT00805493|3997731|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4176746|NCT00805493|3997728|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4176747|NCT00805493|3997729|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4176748|NCT00805493|3997730|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4176749|NCT00805493|3997731|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4176750|NCT00805493|3997728|B4||GTE65|Age||Participants|Count of Participants|0|0.0||||||
4176751|NCT00805493|3997729|B3||GTE65|Age||Participants|Count of Participants|0|0.0||||||
4176752|NCT00805493|3997730|B2||GTE65|Age||Participants|Count of Participants|0|0.0||||||
4176753|NCT00805493|3997731|B1||GTE65|Age||Participants|Count of Participants|0|0.0||||||
4176754|NCT00805493|3997728|B4||BTWN|Age||Participants|Count of Participants|0|0.0||||||
4176755|NCT00805493|3997729|B3||BTWN|Age||Participants|Count of Participants|0|0.0||||||
4176756|NCT00805493|3997730|B2||BTWN|Age||Participants|Count of Participants|0|0.0||||||
4176757|NCT00805493|3997731|B1||BTWN|Age||Participants|Count of Participants|0|0.0||||||
4176758|NCT00805493|3997728|B4||LTE18|Age||Participants|Count of Participants|6|6.0||||||
4176759|NCT00805493|3997729|B3||LTE18|Age||Participants|Count of Participants|1|1.0||||||
4176760|NCT00805493|3997730|B2||LTE18|Age||Participants|Count of Participants|2|2.0||||||
4176761|NCT00805493|3997731|B1||LTE18|Age||Participants|Count of Participants|3|3.0||||||
4176762|NCT00805480|3997744|B5||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4176763|NCT00805480|3997745|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4176764|NCT00805480|3997746|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4176765|NCT00805480|3997747|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4176766|NCT00805480|3997748|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4176767|NCT00805480|3997744|B5||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4176768|NCT00805480|3997745|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4176769|NCT00805480|3997746|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4176770|NCT00805480|3997747|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4176771|NCT00805480|3997748|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4176772|NCT00805480|3997744|B5|||Age||Years|Mean|43.8|43.8|Standard Deviation|11.09|11.09|||
4176773|NCT00805480|3997745|B4|||Age||Years|Mean|40.1|40.1|Standard Deviation|14.89|14.89|||
4176774|NCT00805480|3997746|B3|||Age||Years|Mean|43.4|43.4|Standard Deviation|10.90|10.9|||
4176775|NCT00805480|3997747|B2|||Age||Years|Mean|43.5|43.5|Standard Deviation|11.75|11.75|||
4176776|NCT00805480|3997748|B1|||Age||Years|Mean|45.7|45.7|Standard Deviation|9.29|9.29|||
4176777|NCT00805467|3997776|B5|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4176778|NCT00805467|3997777|B4|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4176779|NCT00805467|3997778|B3|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4176780|NCT00805467|3997779|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4176781|NCT00805467|3997780|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4176782|NCT00805467|3997776|B5|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4176783|NCT00805467|3997777|B4|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4176784|NCT00805467|3997778|B3|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4176785|NCT00805467|3997779|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4176786|NCT00805467|3997780|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4176787|NCT00805467|3997776|B5|Hispanic||Race/Ethnicity, Customized||Participants|Number|307|307.0||||||
4176788|NCT00805467|3997777|B4|Hispanic||Race/Ethnicity, Customized||Participants|Number|179|179.0||||||
4176789|NCT00805467|3997778|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|88|88.0||||||
4176790|NCT00805467|3997779|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
4176791|NCT00805467|3997780|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4176792|NCT00805467|3997776|B5|Black||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4176793|NCT00805467|3997777|B4|Black||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4176794|NCT00805467|3997778|B3|Black||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4176795|NCT00805467|3997779|B2|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4176796|NCT00805467|3997780|B1|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4176797|NCT00805467|3997776|B5|Caucasian||Race/Ethnicity, Customized||Participants|Number|290|290.0||||||
4176798|NCT00805467|3997777|B4|Caucasian||Race/Ethnicity, Customized||Participants|Number|184|184.0||||||
4176799|NCT00805467|3997778|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|88|88.0||||||
4176800|NCT00805467|3997779|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4176801|NCT00805467|3997780|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4176802|NCT00805467|3997776|B5||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4176803|NCT00805467|3997777|B4||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4176804|NCT00805467|3997778|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4176805|NCT00805467|3997779|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4176806|NCT00805467|3997780|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4176807|NCT00805467|3997776|B5||Female|Sex: Female, Male||Participants|Count of Participants|535|535.0||||||
4176808|NCT00805467|3997777|B4||Female|Sex: Female, Male||Participants|Count of Participants|324|324.0||||||
4176809|NCT00805467|3997778|B3||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4176810|NCT00805467|3997779|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4176811|NCT00805467|3997780|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4176812|NCT00805467|3997776|B5|||Age||years|Mean|53.0|53.0|Standard Deviation|12.58|12.58|||
4176813|NCT00805467|3997777|B4|||Age||years|Mean|53.8|53.8|Standard Deviation|12.36|12.36|||
4176814|NCT00805467|3997778|B3|||Age||years|Mean|51.7|51.7|Standard Deviation|13.32|13.32|||
4176815|NCT00805467|3997779|B2|||Age||years|Mean|51.4|51.4|Standard Deviation|11.15|11.15|||
4176816|NCT00805467|3997780|B1|||Age||years|Mean|70|70.0|Standard Deviation|NA||||Standard deviation cannot be defined for a single patient.
4176817|NCT00805441|3997801|B3|United States||Region of Enrollment||Participants|Count of Participants|183|183.0||||||
4176818|NCT00805441|3997802|B2|United States||Region of Enrollment||Participants|Count of Participants|91|91.0||||||
4176819|NCT00805441|3997803|B1|United States||Region of Enrollment||Participants|Count of Participants|92|92.0||||||
4176820|NCT00805441|3997801|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4176821|NCT00805441|3997802|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4176822|NCT00805441|3997803|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4176823|NCT00805441|3997801|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176824|NCT00805441|3997802|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176825|NCT00805441|3997803|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176826|NCT00805441|3997801|B3||White|Race (NIH/OMB)||Participants|Count of Participants|136|136.0||||||
4176827|NCT00805441|3997802|B2||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4176828|NCT00805441|3997803|B1||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
4176829|NCT00805441|3997801|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4176830|NCT00805441|3997802|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4176831|NCT00805441|3997803|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4176832|NCT00805441|3997801|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176833|NCT00805441|3997802|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176834|NCT00805441|3997803|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176835|NCT00805441|3997801|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4176836|NCT00805441|3997802|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176837|NCT00805441|3997803|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4176838|NCT00805441|3997801|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4176839|NCT00805441|3997802|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176840|NCT00805441|3997803|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4176841|NCT00805441|3997801|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176842|NCT00805441|3997802|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176843|NCT00805441|3997803|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176844|NCT00805441|3997801|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|173|173.0||||||
4176845|NCT00805441|3997802|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
4176846|NCT00805441|3997803|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4176847|NCT00805441|3997801|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4176848|NCT00805441|3997802|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4176849|NCT00805441|3997803|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4176850|NCT00805441|3997801|B3||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4176851|NCT00805441|3997802|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4176852|NCT00805441|3997803|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4176853|NCT00805441|3997801|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4176854|NCT00805441|3997802|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4176855|NCT00805441|3997803|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4176856|NCT00805441|3997801|B3|||Age||years|Mean|43.7|43.7|Standard Deviation|10.8|10.8|||
4176857|NCT00805441|3997802|B2|||Age||years|Mean|43.0|43.0|Standard Deviation|11.1|11.1|||
4176858|NCT00805441|3997803|B1|||Age||years|Mean|44.3|44.3|Standard Deviation|10.5|10.5|||
4176859|NCT00805389|3997834|B6|White - Caucasian / European heritage||Race/Ethnicity, Customized|White - Caucasian / European heritage|Participants|Count of Participants|689|689.0||||||
4176860|NCT00805389|3997835|B5|White - Caucasian / European heritage||Race/Ethnicity, Customized|White - Caucasian / European heritage|Participants|Count of Participants|136|136.0||||||
4176861|NCT00805389|3997836|B4|White - Caucasian / European heritage||Race/Ethnicity, Customized|White - Caucasian / European heritage|Participants|Count of Participants|142|142.0||||||
4176862|NCT00805389|3997837|B3|White - Caucasian / European heritage||Race/Ethnicity, Customized|White - Caucasian / European heritage|Participants|Count of Participants|138|138.0||||||
4176863|NCT00805389|3997838|B2|White - Caucasian / European heritage||Race/Ethnicity, Customized|White - Caucasian / European heritage|Participants|Count of Participants|138|138.0||||||
4176864|NCT00805389|3997839|B1|White - Caucasian / European heritage||Race/Ethnicity, Customized|White - Caucasian / European heritage|Participants|Count of Participants|135|135.0||||||
4176865|NCT00805389|3997834|B6||Male|Sex: Female, Male||Participants|Count of Participants|386|386.0||||||
4176866|NCT00805389|3997835|B5||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4176867|NCT00805389|3997836|B4||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4176868|NCT00805389|3997837|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4176869|NCT00805389|3997838|B2||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4176870|NCT00805389|3997839|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4176871|NCT00805389|3997834|B6||Female|Sex: Female, Male||Participants|Count of Participants|327|327.0||||||
4176872|NCT00805389|3997835|B5||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4176873|NCT00805389|3997836|B4||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4176874|NCT00805389|3997837|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4176875|NCT00805389|3997838|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4176876|NCT00805389|3997839|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4176877|NCT00805389|3997834|B6|||Age||Years|Mean|33.5|33.5|Standard Deviation|7.34|7.34|||
4176878|NCT00805389|3997835|B5|||Age||Years|Mean|32.9|32.9|Standard Deviation|7.50|7.5|||
4176879|NCT00805389|3997836|B4|||Age||Years|Mean|33.5|33.5|Standard Deviation|7.41|7.41|||
4176880|NCT00805389|3997837|B3|||Age||Years|Mean|32.9|32.9|Standard Deviation|7.58|7.58|||
4176881|NCT00805389|3997838|B2|||Age||Years|Mean|33.7|33.7|Standard Deviation|7.28|7.28|||
4176882|NCT00805389|3997839|B1|||Age||Years|Mean|34.7|34.7|Standard Deviation|6.94|6.94|||
4176883|NCT00805285|3998090|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4176884|NCT00805285|3998090|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4176885|NCT00805285|3998090|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4176886|NCT00805285|3998090|B1|||Age||years|Mean|45|45.0|Standard Deviation|0|0.0|||
4176887|NCT00805285|3998090|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4176888|NCT00805285|3998090|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4176889|NCT00805285|3998090|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4176890|NCT00805207|3998098|B10|United States||Region of Enrollment||participants|Number|61|61.0||||||
4176891|NCT00805207|3998099|B9|United States||Region of Enrollment||participants|Number|6|6.0||||||
4176892|NCT00805207|3998100|B8|United States||Region of Enrollment||participants|Number|6|6.0||||||
4176893|NCT00805207|3998101|B7|United States||Region of Enrollment||participants|Number|6|6.0||||||
4176894|NCT00805207|3998102|B6|United States||Region of Enrollment||participants|Number|12|12.0||||||
4176895|NCT00805207|3998103|B5|United States||Region of Enrollment||participants|Number|3|3.0||||||
4176896|NCT00805207|3998104|B4|United States||Region of Enrollment||participants|Number|9|9.0||||||
4176897|NCT00805207|3998105|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4176898|NCT00805207|3998106|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4176899|NCT00805207|3998107|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4176900|NCT00805207|3998098|B10||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176901|NCT00805207|3998099|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176902|NCT00805207|3998100|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176903|NCT00805207|3998101|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176904|NCT00805207|3998102|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176905|NCT00805207|3998103|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176906|NCT00805207|3998104|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176907|NCT00805207|3998105|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176908|NCT00805207|3998106|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176909|NCT00805207|3998107|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176910|NCT00805207|3998098|B10||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176911|NCT00805207|3998099|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176912|NCT00805207|3998100|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176913|NCT00805207|3998101|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176914|NCT00805207|3998102|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176915|NCT00805207|3998103|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176916|NCT00805207|3998104|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176917|NCT00805207|3998105|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176918|NCT00805207|3998106|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176919|NCT00805207|3998107|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176920|NCT00805207|3998098|B10||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4176921|NCT00805207|3998099|B9||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4176922|NCT00805207|3998100|B8||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4176923|NCT00805207|3998101|B7||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4176924|NCT00805207|3998102|B6||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4176925|NCT00805207|3998103|B5||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4176926|NCT00805207|3998104|B4||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4176927|NCT00805207|3998105|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4176928|NCT00805207|3998106|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4176929|NCT00805207|3998107|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4176930|NCT00805207|3998098|B10||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4176931|NCT00805207|3998099|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4176932|NCT00805207|3998100|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176933|NCT00805207|3998101|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176934|NCT00805207|3998102|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4176935|NCT00805207|3998103|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4176936|NCT00805207|3998104|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4176937|NCT00805207|3998105|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176938|NCT00805207|3998106|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4176939|NCT00805207|3998107|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4176940|NCT00805207|3998098|B10||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176941|NCT00805207|3998099|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176942|NCT00805207|3998100|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176943|NCT00805207|3998101|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176944|NCT00805207|3998102|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176945|NCT00805207|3998103|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176946|NCT00805207|3998104|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176947|NCT00805207|3998105|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176948|NCT00805207|3998106|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176949|NCT00805207|3998107|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176950|NCT00805207|3998098|B10||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4176951|NCT00805207|3998099|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176952|NCT00805207|3998100|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176953|NCT00805207|3998101|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176954|NCT00805207|3998102|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4176955|NCT00805207|3998103|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176956|NCT00805207|3998104|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176957|NCT00805207|3998105|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176958|NCT00805207|3998106|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176959|NCT00805207|3998107|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176960|NCT00805207|3998098|B10||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176961|NCT00805207|3998099|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176962|NCT00805207|3998100|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176963|NCT00805207|3998101|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176964|NCT00805207|3998102|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176965|NCT00805207|3998103|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176966|NCT00805207|3998104|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176967|NCT00805207|3998105|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176968|NCT00805207|3998106|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176969|NCT00805207|3998107|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4176970|NCT00805207|3998098|B10||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4176971|NCT00805207|3998099|B9||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4176972|NCT00805207|3998100|B8||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4176973|NCT00805207|3998101|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4176974|NCT00805207|3998102|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4176975|NCT00805207|3998103|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4176976|NCT00805207|3998104|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4176977|NCT00805207|3998105|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4176978|NCT00805207|3998106|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4176979|NCT00805207|3998107|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4176980|NCT00805207|3998098|B10||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4176981|NCT00805207|3998099|B9||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4176982|NCT00805207|3998100|B8||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4176983|NCT00805207|3998101|B7||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4176984|NCT00805207|3998102|B6||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4176985|NCT00805207|3998103|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4176986|NCT00805207|3998104|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4176987|NCT00805207|3998105|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4176988|NCT00805207|3998106|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4176989|NCT00805207|3998107|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4176990|NCT00805207|3998098|B10|||Age||years|Mean|49|49.0|Standard Deviation|16|16.0|||
4176991|NCT00805207|3998099|B9|||Age||years|Mean|41|41.0|Standard Deviation|15|15.0|||
4176992|NCT00805207|3998100|B8|||Age||years|Mean|64|64.0|Standard Deviation|6|6.0|||
4176993|NCT00805207|3998101|B7|||Age||years|Mean|59|59.0|Standard Deviation|10|10.0|||
4176994|NCT00805207|3998102|B6|||Age||years|Mean|38|38.0|Standard Deviation|13|13.0|||
4176995|NCT00805207|3998103|B5|||Age||years|Mean|62|62.0|Standard Deviation|12|12.0|||
4176996|NCT00805207|3998104|B4|||Age||years|Mean|63|63.0|Standard Deviation|7|7.0|||
4176997|NCT00805207|3998105|B3|||Age||years|Mean|22|22.0|Standard Deviation|0|0.0|||
4176998|NCT00805207|3998106|B2|||Age||years|Mean|57|57.0|Standard Deviation|6|6.0|||
4176999|NCT00805207|3998107|B1|||Age||years|Mean|35|35.0|Standard Deviation|8|8.0|||
4177000|NCT00805194|3998171|B3||Missing|Number of patients with adenocarcinoma and time since first line therapy in categories||Participants|Count of Participants|7|7.0||||||
4177001|NCT00805194|3998172|B2||Missing|Number of patients with adenocarcinoma and time since first line therapy in categories||Participants|Count of Participants|3|3.0||||||
4177002|NCT00805194|3998173|B1||Missing|Number of patients with adenocarcinoma and time since first line therapy in categories||Participants|Count of Participants|4|4.0||||||
4177003|NCT00805194|3998171|B3||>=9 month|Number of patients with adenocarcinoma and time since first line therapy in categories||Participants|Count of Participants|246|246.0||||||
4177004|NCT00805194|3998172|B2||>=9 month|Number of patients with adenocarcinoma and time since first line therapy in categories||Participants|Count of Participants|134|134.0||||||
4177005|NCT00805194|3998173|B1||>=9 month|Number of patients with adenocarcinoma and time since first line therapy in categories||Participants|Count of Participants|112|112.0||||||
4177006|NCT00805194|3998171|B3||<9 month|Number of patients with adenocarcinoma and time since first line therapy in categories||Participants|Count of Participants|405|405.0||||||
4177007|NCT00805194|3998172|B2||<9 month|Number of patients with adenocarcinoma and time since first line therapy in categories||Participants|Count of Participants|199|199.0||||||
4177008|NCT00805194|3998173|B1||<9 month|Number of patients with adenocarcinoma and time since first line therapy in categories||Participants|Count of Participants|206|206.0||||||
4177009|NCT00805194|3998171|B3||Other|Tumour histology||Participants|Count of Participants|101|101.0||||||
4177010|NCT00805194|3998172|B2||Other|Tumour histology||Participants|Count of Participants|44|44.0||||||
4177011|NCT00805194|3998173|B1||Other|Tumour histology||Participants|Count of Participants|57|57.0||||||
4177012|NCT00805194|3998171|B3||Squamous cell carcinoma|Tumour histology||Participants|Count of Participants|555|555.0||||||
4177013|NCT00805194|3998172|B2||Squamous cell carcinoma|Tumour histology||Participants|Count of Participants|279|279.0||||||
4177014|NCT00805194|3998173|B1||Squamous cell carcinoma|Tumour histology||Participants|Count of Participants|276|276.0||||||
4177015|NCT00805194|3998171|B3||Adenocarcinoma|Tumour histology||Participants|Count of Participants|658|658.0||||||
4177016|NCT00805194|3998172|B2||Adenocarcinoma|Tumour histology||Participants|Count of Participants|336|336.0||||||
4177017|NCT00805194|3998173|B1||Adenocarcinoma|Tumour histology||Participants|Count of Participants|322|322.0||||||
4177018|NCT00805194|3998171|B3||Male|Sex: Female, Male||Participants|Count of Participants|955|955.0||||||
4177019|NCT00805194|3998172|B2||Male|Sex: Female, Male||Participants|Count of Participants|479|479.0||||||
4177020|NCT00805194|3998173|B1||Male|Sex: Female, Male||Participants|Count of Participants|476|476.0||||||
4177021|NCT00805194|3998171|B3||Female|Sex: Female, Male||Participants|Count of Participants|359|359.0||||||
4177022|NCT00805194|3998172|B2||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4177023|NCT00805194|3998173|B1||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4177024|NCT00805194|3998171|B3|||Age||years|Mean|59.7|59.7|Standard Deviation|9.3|9.3|||
4177025|NCT00805194|3998172|B2|||Age||years|Mean|59.8|59.8|Standard Deviation|9.0|9.0|||
4177026|NCT00805194|3998173|B1|||Age||years|Mean|59.7|59.7|Standard Deviation|9.7|9.7|||
4177027|NCT00805142|3998206|B3||Male|Sex: Female, Male|Out of a total of 78 participants, Baseline characteristic (Gender) was available for only 66 participants who were included in PP population|Participants|Count of Participants|42|42.0||||||
4177028|NCT00805142|3998207|B2||Male|Sex: Female, Male|Out of a total of 78 participants, Baseline characteristic (Gender) was available for only 66 participants who were included in PP population|Participants|Count of Participants|22|22.0||||||
4177029|NCT00805142|3998208|B1||Male|Sex: Female, Male|Out of a total of 78 participants, Baseline characteristic (Gender) was available for only 66 participants who were included in PP population|Participants|Count of Participants|20|20.0||||||
4177030|NCT00805142|3998206|B3||Female|Sex: Female, Male|Out of a total of 78 participants, Baseline characteristic (Gender) was available for only 66 participants who were included in PP population|Participants|Count of Participants|24|24.0||||||
4177031|NCT00805142|3998207|B2||Female|Sex: Female, Male|Out of a total of 78 participants, Baseline characteristic (Gender) was available for only 66 participants who were included in PP population|Participants|Count of Participants|14|14.0||||||
4177032|NCT00805142|3998208|B1||Female|Sex: Female, Male|Out of a total of 78 participants, Baseline characteristic (Gender) was available for only 66 participants who were included in PP population|Participants|Count of Participants|10|10.0||||||
4177033|NCT00805142|3998206|B3|||Age|Out of a total of 78 participants, Baseline characteristic (Age) was available for only 66 participants who were included in per protocol (PP) population.|years|Mean|70.7|70.7|Standard Deviation|9.14|9.14|||
4177034|NCT00805142|3998207|B2|||Age|Out of a total of 78 participants, Baseline characteristic (Age) was available for only 66 participants who were included in per protocol (PP) population.|years|Mean|70.0|70.0|Standard Deviation|8.44|8.44|||
4177035|NCT00805142|3998208|B1|||Age|Out of a total of 78 participants, Baseline characteristic (Age) was available for only 66 participants who were included in per protocol (PP) population.|years|Mean|71.7|71.7|Standard Deviation|9.97|9.97|||
4177036|NCT00805038|3998233|B3|United States||Region of Enrollment||participants|Number|167|167.0||||||
4177037|NCT00805038|3998234|B2|United States||Region of Enrollment||participants|Number|92|92.0||||||
4177038|NCT00805038|3998235|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
4177039|NCT00805038|3998233|B3||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4177040|NCT00805038|3998234|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4177041|NCT00805038|3998235|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4177042|NCT00805038|3998233|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4177043|NCT00805038|3998234|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4177044|NCT00805038|3998235|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4177045|NCT00805038|3998233|B3|||Age||years|Mean|56|56.0|Standard Deviation|10|10.0|||
4177046|NCT00805038|3998234|B2|||Age||years|Mean|54|54.0|Standard Deviation|10|10.0|||
4177047|NCT00805038|3998235|B1|||Age||years|Mean|57|57.0|Standard Deviation|9|9.0|||
4177048|NCT00805038|3998233|B3||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4177049|NCT00805038|3998234|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4177050|NCT00805038|3998235|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4177051|NCT00805038|3998233|B3||Between 18 and 65 years|Age||Participants|Count of Participants|141|141.0||||||
4177052|NCT00805038|3998234|B2||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
4177053|NCT00805038|3998235|B1||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4177054|NCT00805038|3998233|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4177055|NCT00805038|3998234|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4177056|NCT00805038|3998235|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4177057|NCT00805025|3998242|B1|White||Race/Ethnicity, Customized||participants|Number|84|84.0||||||
4177058|NCT00805025|3998242|B1|African-American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4177059|NCT00805025|3998242|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4177060|NCT00805025|3998242|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4177061|NCT00805025|3998242|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4177062|NCT00805025|3998242|B1|||Age||years|Mean|64|64.0|Standard Deviation|14.7|14.7|||
4177063|NCT00804999|3998248|B5|United States||Region of Enrollment||Participants|Count of Participants|51|51.0||||||
4177064|NCT00804999|3998249|B4|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4177065|NCT00804999|3998250|B3|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4177066|NCT00804999|3998251|B2|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4177067|NCT00804999|3998252|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4177068|NCT00804999|3998248|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4177069|NCT00804999|3998249|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4177070|NCT00804999|3998250|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4177071|NCT00804999|3998251|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4177072|NCT00804999|3998252|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4177073|NCT00804999|3998248|B5||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4177074|NCT00804999|3998249|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4177075|NCT00804999|3998250|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4177076|NCT00804999|3998251|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4177077|NCT00804999|3998252|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4177078|NCT00804999|3998248|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4177079|NCT00804999|3998249|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4177080|NCT00804999|3998250|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4177081|NCT00804999|3998251|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4177082|NCT00804999|3998252|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4177083|NCT00804999|3998248|B5||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4177084|NCT00804999|3998249|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4177085|NCT00804999|3998250|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4177086|NCT00804999|3998251|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4177087|NCT00804999|3998252|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4177088|NCT00804999|3998248|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4177089|NCT00804999|3998249|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4177090|NCT00804999|3998250|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4177091|NCT00804999|3998251|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4177092|NCT00804999|3998252|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4177093|NCT00804986|3998265|B7|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4177094|NCT00804986|3998266|B6|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4177095|NCT00804986|3998267|B5|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4177096|NCT00804986|3998268|B4|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4177097|NCT00804986|3998269|B3|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4177098|NCT00804986|3998270|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4177099|NCT00804986|3998271|B1|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4177100|NCT00804986|3998265|B7|Germany||Region of Enrollment||participants|Number|17|17.0||||||
4177101|NCT00804986|3998266|B6|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4177102|NCT00804986|3998267|B5|Germany||Region of Enrollment||participants|Number|5|5.0||||||
4177103|NCT00804986|3998268|B4|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4177104|NCT00804986|3998269|B3|Germany||Region of Enrollment||participants|Number|3|3.0||||||
4177105|NCT00804986|3998270|B2|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4177106|NCT00804986|3998271|B1|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4177107|NCT00804986|3998265|B7|South Africa||Region of Enrollment||participants|Number|49|49.0||||||
4177108|NCT00804986|3998266|B6|South Africa||Region of Enrollment||participants|Number|7|7.0||||||
4177109|NCT00804986|3998267|B5|South Africa||Region of Enrollment||participants|Number|8|8.0||||||
4177110|NCT00804986|3998268|B4|South Africa||Region of Enrollment||participants|Number|6|6.0||||||
4177111|NCT00804986|3998269|B3|South Africa||Region of Enrollment||participants|Number|10|10.0||||||
4177112|NCT00804986|3998270|B2|South Africa||Region of Enrollment||participants|Number|8|8.0||||||
4177113|NCT00804986|3998271|B1|South Africa||Region of Enrollment||participants|Number|10|10.0||||||
4177114|NCT00804986|3998265|B7|Austria||Region of Enrollment||participants|Number|7|7.0||||||
4177115|NCT00804986|3998266|B6|Austria||Region of Enrollment||participants|Number|0|0.0||||||
4177116|NCT00804986|3998267|B5|Austria||Region of Enrollment||participants|Number|0|0.0||||||
4177117|NCT00804986|3998268|B4|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4177118|NCT00804986|3998269|B3|Austria||Region of Enrollment||participants|Number|0|0.0||||||
4177119|NCT00804986|3998270|B2|Austria||Region of Enrollment||participants|Number|2|2.0||||||
4177120|NCT00804986|3998271|B1|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4177121|NCT00804986|3998265|B7|Romania||Region of Enrollment||participants|Number|24|24.0||||||
4177122|NCT00804986|3998266|B6|Romania||Region of Enrollment||participants|Number|1|1.0||||||
4177123|NCT00804986|3998267|B5|Romania||Region of Enrollment||participants|Number|3|3.0||||||
4177124|NCT00804986|3998268|B4|Romania||Region of Enrollment||participants|Number|5|5.0||||||
4177125|NCT00804986|3998269|B3|Romania||Region of Enrollment||participants|Number|6|6.0||||||
4177126|NCT00804986|3998270|B2|Romania||Region of Enrollment||participants|Number|5|5.0||||||
4177127|NCT00804986|3998271|B1|Romania||Region of Enrollment||participants|Number|4|4.0||||||
4177128|NCT00804986|3998265|B7|Ukraine||Region of Enrollment||participants|Number|34|34.0||||||
4177129|NCT00804986|3998266|B6|Ukraine||Region of Enrollment||participants|Number|5|5.0||||||
4177130|NCT00804986|3998267|B5|Ukraine||Region of Enrollment||participants|Number|7|7.0||||||
4177131|NCT00804986|3998268|B4|Ukraine||Region of Enrollment||participants|Number|5|5.0||||||
4177132|NCT00804986|3998269|B3|Ukraine||Region of Enrollment||participants|Number|9|9.0||||||
4177133|NCT00804986|3998270|B2|Ukraine||Region of Enrollment||participants|Number|4|4.0||||||
4177134|NCT00804986|3998271|B1|Ukraine||Region of Enrollment||participants|Number|4|4.0||||||
4177135|NCT00804986|3998265|B7|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4177136|NCT00804986|3998266|B6|Spain||Region of Enrollment||participants|Number|0|0.0||||||
4177137|NCT00804986|3998267|B5|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4177138|NCT00804986|3998268|B4|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4177139|NCT00804986|3998269|B3|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4177140|NCT00804986|3998270|B2|Spain||Region of Enrollment||participants|Number|0|0.0||||||
4177141|NCT00804986|3998271|B1|Spain||Region of Enrollment||participants|Number|0|0.0||||||
4177142|NCT00804986|3998265|B7|Mexico||Region of Enrollment||participants|Number|17|17.0||||||
4177143|NCT00804986|3998266|B6|Mexico||Region of Enrollment||participants|Number|4|4.0||||||
4177144|NCT00804986|3998267|B5|Mexico||Region of Enrollment||participants|Number|2|2.0||||||
4177145|NCT00804986|3998268|B4|Mexico||Region of Enrollment||participants|Number|4|4.0||||||
4177146|NCT00804986|3998269|B3|Mexico||Region of Enrollment||participants|Number|1|1.0||||||
4177147|NCT00804986|3998270|B2|Mexico||Region of Enrollment||participants|Number|4|4.0||||||
4177148|NCT00804986|3998271|B1|Mexico||Region of Enrollment||participants|Number|2|2.0||||||
4177149|NCT00804986|3998265|B7|United States||Region of Enrollment||participants|Number|93|93.0||||||
4177150|NCT00804986|3998266|B6|United States||Region of Enrollment||participants|Number|19|19.0||||||
4177151|NCT00804986|3998267|B5|United States||Region of Enrollment||participants|Number|16|16.0||||||
4177152|NCT00804986|3998268|B4|United States||Region of Enrollment||participants|Number|18|18.0||||||
4177153|NCT00804986|3998269|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4177154|NCT00804986|3998270|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4177155|NCT00804986|3998271|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4177156|NCT00804986|3998265|B7|Multiple Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4177157|NCT00804986|3998266|B6|Multiple Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4177158|NCT00804986|3998267|B5|Multiple Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4177159|NCT00804986|3998268|B4|Multiple Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4177160|NCT00804986|3998269|B3|Multiple Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4177161|NCT00804986|3998270|B2|Multiple Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4177162|NCT00804986|3998271|B1|Multiple Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4177163|NCT00804986|3998265|B7|White||Race/Ethnicity, Customized||participants|Number|174|174.0||||||
4177164|NCT00804986|3998266|B6|White||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4177165|NCT00804986|3998267|B5|White||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4177166|NCT00804986|3998268|B4|White||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4177167|NCT00804986|3998269|B3|White||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4177168|NCT00804986|3998270|B2|White||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4177169|NCT00804986|3998271|B1|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4177170|NCT00804986|3998265|B7|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4177171|NCT00804986|3998266|B6|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4177172|NCT00804986|3998267|B5|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4177173|NCT00804986|3998268|B4|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4177174|NCT00804986|3998269|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4177175|NCT00804986|3998270|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4177176|NCT00804986|3998271|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4177177|NCT00804986|3998265|B7|Black or African American||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4177178|NCT00804986|3998266|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4177179|NCT00804986|3998267|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4177180|NCT00804986|3998268|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4177181|NCT00804986|3998269|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4177182|NCT00804986|3998270|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4177183|NCT00804986|3998271|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4177184|NCT00804986|3998265|B7|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4177185|NCT00804986|3998266|B6|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4177186|NCT00804986|3998267|B5|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4177187|NCT00804986|3998268|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4177188|NCT00804986|3998269|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4177189|NCT00804986|3998270|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4177190|NCT00804986|3998271|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4177191|NCT00804986|3998265|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4177192|NCT00804986|3998266|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4177193|NCT00804986|3998267|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4177194|NCT00804986|3998268|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4177195|NCT00804986|3998269|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4177196|NCT00804986|3998270|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4177197|NCT00804986|3998271|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4177198|NCT00804986|3998265|B7||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4177199|NCT00804986|3998266|B6||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4177200|NCT00804986|3998267|B5||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4177201|NCT00804986|3998268|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4177202|NCT00804986|3998269|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4177203|NCT00804986|3998270|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4177204|NCT00804986|3998271|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4177205|NCT00804986|3998265|B7||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4177206|NCT00804986|3998266|B6||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4177207|NCT00804986|3998267|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4177208|NCT00804986|3998268|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4177209|NCT00804986|3998269|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4177210|NCT00804986|3998270|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4177211|NCT00804986|3998271|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4177212|NCT00804986|3998265|B7|||Age||years|Mean|55.2|55.2|Standard Deviation|8.93|8.93|||
4177213|NCT00804986|3998266|B6|||Age||years|Mean|56.3|56.3|Standard Deviation|9.88|9.88|||
4177214|NCT00804986|3998267|B5|||Age||years|Mean|54.0|54.0|Standard Deviation|9.45|9.45|||
4177215|NCT00804986|3998268|B4|||Age||years|Mean|55.2|55.2|Standard Deviation|9.78|9.78|||
4177216|NCT00804986|3998269|B3|||Age||years|Mean|56.4|56.4|Standard Deviation|8.07|8.07|||
4177217|NCT00804986|3998270|B2|||Age||years|Mean|54.6|54.6|Standard Deviation|8.33|8.33|||
4177218|NCT00804986|3998271|B1|||Age||years|Mean|54.5|54.5|Standard Deviation|8.06|8.06|||
4177219|NCT00804908|3998368|B4||Male|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
4177220|NCT00804908|3998369|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4177221|NCT00804908|3998370|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4177222|NCT00804908|3998371|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4177223|NCT00804908|3998368|B4||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4177224|NCT00804908|3998369|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4177225|NCT00804908|3998370|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4177226|NCT00804908|3998371|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4177227|NCT00804908|3998368|B4|||Age||years|Mean|59.8|59.8|Standard Deviation|13.49|13.49|||
4177228|NCT00804908|3998369|B3|||Age||years|Mean|62.3|62.3|Standard Deviation|13.50|13.5|||
4177229|NCT00804908|3998370|B2|||Age||years|Mean|58.6|58.6|Standard Deviation|12.55|12.55|||
4177230|NCT00804908|3998371|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|14.13|14.13|||
4177231|NCT00804843|3998402|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4177232|NCT00804843|3998403|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4177233|NCT00804843|3998404|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4177234|NCT00804843|3998402|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4177235|NCT00804843|3998403|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4177236|NCT00804843|3998404|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4177237|NCT00804843|3998402|B3|||Age||years|Mean|69.47|69.47|Standard Deviation|8.99|8.99|||
4177238|NCT00804843|3998403|B2|||Age||years|Mean|69.20|69.2|Standard Deviation|8.63|8.63|||
4177239|NCT00804843|3998404|B1|||Age||years|Mean|69.68|69.68|Standard Deviation|9.42|9.42|||
4177240|NCT00804713|3998415|B1|>=100 per 100,000||Prevalence of tuberculosis (TB) in country of birth|Prevalence of TB per 100,000 population|participants|Number|105|105.0||||||
4177241|NCT00804713|3998415|B1|20-99 per 100,000||Prevalence of tuberculosis (TB) in country of birth|Prevalence of TB per 100,000 population|participants|Number|62|62.0||||||
4177242|NCT00804713|3998415|B1|<20 per 100,000||Prevalence of tuberculosis (TB) in country of birth|Prevalence of TB per 100,000 population|participants|Number|1811|1811.0||||||
4177243|NCT00804713|3998415|B1|Male||Gender|sex of participants. The number doesn not equal 1978 because of missing responses on the questionnaire.|participants|Number|1294|1294.0||||||
4177244|NCT00804713|3998415|B1|Female||Gender|sex of participants. The number doesn not equal 1978 because of missing responses on the questionnaire.|participants|Number|681|681.0||||||
4177245|NCT00804713|3998415|B1|||Age||years|Mean|21.8|21.8|Standard Deviation|4.6|4.6|||
4177246|NCT00804687|3998423|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4177247|NCT00804687|3998423|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4177248|NCT00804687|3998423|B1|||Age||years|Mean|41.9|41.9|Standard Deviation|11.8|11.8|||
4177249|NCT00804648|3998445|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4177250|NCT00804648|3998445|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4177251|NCT00804648|3998445|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4177252|NCT00804648|3998445|B1|||Age||years|Mean|66.3|66.3|Standard Deviation|8.9|8.9|||
4177253|NCT00804609|3998491|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4177254|NCT00804609|3998492|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4177255|NCT00804609|3998493|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4177256|NCT00804609|3998491|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4177257|NCT00804609|3998492|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4177258|NCT00804609|3998493|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4177259|NCT00804609|3998491|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4177260|NCT00804609|3998492|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4177261|NCT00804609|3998493|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4177262|NCT00804609|3998491|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4177263|NCT00804609|3998492|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4177264|NCT00804609|3998493|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4177265|NCT00804609|3998491|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4177266|NCT00804609|3998492|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4177267|NCT00804609|3998493|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4177268|NCT00804609|3998491|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4177269|NCT00804609|3998492|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4177270|NCT00804609|3998493|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4177271|NCT00804609|3998491|B3|||Age||years|Mean|34|34.0|Standard Deviation|4|4.0|||
4177272|NCT00804609|3998492|B2|||Age||years|Mean|36|36.0|Standard Deviation|3|3.0|||
4177273|NCT00804609|3998493|B1|||Age||years|Mean|32|32.0|Standard Deviation|5|5.0|||
4177274|NCT00804596|3998500|B1|United States||Region of Enrollment||participants|Number|74|74.0||||||
4177275|NCT00804596|3998500|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4177276|NCT00804596|3998500|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4177277|NCT00804596|3998500|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4177278|NCT00804596|3998500|B1||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4177279|NCT00804596|3998500|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4177280|NCT00804570|3998505|B3|||Years of Heavy Drinking|Heavy drinking is defined as ≥4 drinks/day for women and ≥5 drinks/day for men.|years|Mean|24.94|24.94|Standard Deviation|12.05|12.05|||
4177281|NCT00804570|3998506|B2|||Years of Heavy Drinking|Heavy drinking is defined as ≥4 drinks/day for women and ≥5 drinks/day for men.|years|Mean|24.83|24.83|Standard Deviation|11.00|11.0|||
4177282|NCT00804570|3998507|B1|||Years of Heavy Drinking|Heavy drinking is defined as ≥4 drinks/day for women and ≥5 drinks/day for men.|years|Mean|25.06|25.06|Standard Deviation|13.20|13.2|||
4177283|NCT00804570|3998505|B3|||Years of Alcohol Use||years|Mean|29.53|29.53|Standard Deviation|10.02|10.02|||
4177284|NCT00804570|3998506|B2|||Years of Alcohol Use||years|Mean|28.60|28.6|Standard Deviation|10.44|10.44|||
4177285|NCT00804570|3998507|B1|||Years of Alcohol Use||years|Mean|30.64|30.64|Standard Deviation|9.50|9.5|||
4177286|NCT00804570|3998505|B3|United States||Region of Enrollment||participants|Number|375|375.0||||||
4177287|NCT00804570|3998506|B2|United States||Region of Enrollment||participants|Number|188|188.0||||||
4177288|NCT00804570|3998507|B1|United States||Region of Enrollment||participants|Number|187|187.0||||||
4177289|NCT00804570|3998505|B3|Unknown/Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4177290|NCT00804570|3998506|B2|Unknown/Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4177291|NCT00804570|3998507|B1|Unknown/Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4177292|NCT00804570|3998505|B3|Multiple races||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4177293|NCT00804570|3998506|B2|Multiple races||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4177294|NCT00804570|3998507|B1|Multiple races||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4177295|NCT00804570|3998505|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4177296|NCT00804570|3998506|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4177297|NCT00804570|3998507|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4177298|NCT00804570|3998505|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4177299|NCT00804570|3998506|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4177300|NCT00804570|3998507|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4177301|NCT00804570|3998505|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
4177302|NCT00804570|3998506|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4177303|NCT00804570|3998507|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4177304|NCT00804570|3998505|B3|White||Race/Ethnicity, Customized||participants|Number|286|286.0||||||
4177305|NCT00804570|3998506|B2|White||Race/Ethnicity, Customized||participants|Number|134|134.0||||||
4177306|NCT00804570|3998507|B1|White||Race/Ethnicity, Customized||participants|Number|152|152.0||||||
4177307|NCT00804570|3998505|B3||Male|Gender||Participants|Count of Participants|243|243.0||||||
4177308|NCT00804570|3998506|B2||Male|Gender||Participants|Count of Participants|122|122.0||||||
4177309|NCT00804570|3998507|B1||Male|Gender||Participants|Count of Participants|121|121.0||||||
4177310|NCT00804570|3998505|B3||Female|Gender||Participants|Count of Participants|132|132.0||||||
4177311|NCT00804570|3998506|B2||Female|Gender||Participants|Count of Participants|66|66.0||||||
4177312|NCT00804570|3998507|B1||Female|Gender||Participants|Count of Participants|66|66.0||||||
4177313|NCT00804570|3998505|B3|||Age||years|Mean|44.85|44.85|Standard Deviation|10.34|10.34|||
4177314|NCT00804570|3998506|B2|||Age||years|Mean|44.79|44.79|Standard Deviation|10.08|10.08|||
4177315|NCT00804570|3998507|B1|||Age||years|Mean|44.92|44.92|Standard Deviation|10.62|10.62|||
4177316|NCT00804193|3998564|B4|United States||Region of Enrollment||participants|Number|553|553.0||||||
4177317|NCT00804193|3998565|B3|United States||Region of Enrollment||participants|Number|109|109.0||||||
4177318|NCT00804193|3998566|B2|United States||Region of Enrollment||participants|Number|224|224.0||||||
4177319|NCT00804193|3998567|B1|United States||Region of Enrollment||participants|Number|220|220.0||||||
4177320|NCT00804193|3998564|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4177321|NCT00804193|3998565|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4177322|NCT00804193|3998566|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4177323|NCT00804193|3998567|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4177324|NCT00804193|3998564|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177325|NCT00804193|3998565|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177326|NCT00804193|3998566|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177327|NCT00804193|3998567|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177328|NCT00804193|3998564|B4||White|Race (NIH/OMB)||Participants|Count of Participants|452|452.0||||||
4177329|NCT00804193|3998565|B3||White|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
4177330|NCT00804193|3998566|B2||White|Race (NIH/OMB)||Participants|Count of Participants|192|192.0||||||
4177331|NCT00804193|3998567|B1||White|Race (NIH/OMB)||Participants|Count of Participants|178|178.0||||||
4177332|NCT00804193|3998564|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
4177333|NCT00804193|3998565|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4177334|NCT00804193|3998566|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4177335|NCT00804193|3998567|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4177336|NCT00804193|3998564|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4177337|NCT00804193|3998565|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4177338|NCT00804193|3998566|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177339|NCT00804193|3998567|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177340|NCT00804193|3998564|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4177341|NCT00804193|3998565|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4177342|NCT00804193|3998566|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4177343|NCT00804193|3998567|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4177344|NCT00804193|3998564|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4177345|NCT00804193|3998565|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4177346|NCT00804193|3998566|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177347|NCT00804193|3998567|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4177348|NCT00804193|3998564|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177349|NCT00804193|3998565|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177350|NCT00804193|3998566|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177351|NCT00804193|3998567|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177352|NCT00804193|3998564|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|412|412.0||||||
4177353|NCT00804193|3998565|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
4177354|NCT00804193|3998566|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|164|164.0||||||
4177355|NCT00804193|3998567|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|165|165.0||||||
4177356|NCT00804193|3998564|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|141|141.0||||||
4177357|NCT00804193|3998565|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4177358|NCT00804193|3998566|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4177359|NCT00804193|3998567|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4177360|NCT00804193|3998564|B4||Male|Sex: Female, Male||Participants|Count of Participants|387|387.0||||||
4177361|NCT00804193|3998565|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4177362|NCT00804193|3998566|B2||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4177363|NCT00804193|3998567|B1||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4177364|NCT00804193|3998564|B4||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4177365|NCT00804193|3998565|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4177366|NCT00804193|3998566|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4177367|NCT00804193|3998567|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4177368|NCT00804193|3998564|B4|||Age||years|Mean|45.1|45.1|Standard Deviation|16.3|16.3|||
4177369|NCT00804193|3998565|B3|||Age||years|Mean|47.7|47.7|Standard Deviation|16.5|16.5|||
4177370|NCT00804193|3998566|B2|||Age||years|Mean|44.1|44.1|Standard Deviation|16.5|16.5|||
4177371|NCT00804193|3998567|B1|||Age||years|Mean|43.5|43.5|Standard Deviation|16.0|16.0|||
4177372|NCT00804193|3998564|B4||>=65 years|Age||Participants|Count of Participants|71|71.0||||||
4177373|NCT00804193|3998565|B3||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4177374|NCT00804193|3998566|B2||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4177375|NCT00804193|3998567|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4177376|NCT00804193|3998564|B4||Between 18 and 65 years|Age||Participants|Count of Participants|455|455.0||||||
4177377|NCT00804193|3998565|B3||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
4177378|NCT00804193|3998566|B2||Between 18 and 65 years|Age||Participants|Count of Participants|181|181.0||||||
4177379|NCT00804193|3998567|B1||Between 18 and 65 years|Age||Participants|Count of Participants|188|188.0||||||
4177380|NCT00804193|3998564|B4||<=18 years|Age||Participants|Count of Participants|27|27.0||||||
4177381|NCT00804193|3998565|B3||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4177382|NCT00804193|3998566|B2||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4177383|NCT00804193|3998567|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4177384|NCT00803959|3998583|B3|United States||Region of Enrollment||participants|Number|523|523.0||||||
4177385|NCT00803959|3998584|B2|United States||Region of Enrollment||participants|Number|264|264.0||||||
4177386|NCT00803959|3998585|B1|United States||Region of Enrollment||participants|Number|259|259.0||||||
4177387|NCT00803959|3998583|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4177388|NCT00803959|3998584|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4177389|NCT00803959|3998585|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4177390|NCT00803959|3998583|B3||Female|Sex: Female, Male||Participants|Count of Participants|523|523.0||||||
4177391|NCT00803959|3998584|B2||Female|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
4177392|NCT00803959|3998585|B1||Female|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
4177393|NCT00803959|3998583|B3|||Age||years|Mean|51.7|51.7|Standard Deviation|10.2|10.2|||
4177394|NCT00803959|3998584|B2|||Age||years|Mean|51.9|51.9|Standard Deviation|10.4|10.4|||
4177395|NCT00803959|3998585|B1|||Age||years|Mean|51.6|51.6|Standard Deviation|10.0|10.0|||
4177396|NCT00803790|3998616|B3||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4177397|NCT00803790|3998617|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4177398|NCT00803790|3998618|B1||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4177399|NCT00803790|3998616|B3||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4177400|NCT00803790|3998617|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4177401|NCT00803790|3998618|B1||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4177402|NCT00803790|3998616|B3|Between 18 and 78 years||Age, Customized||participants|Number|318|318.0||||||
4177403|NCT00803790|3998617|B2|Between 18 and 78 years||Age, Customized||participants|Number|67|67.0||||||
4177404|NCT00803790|3998618|B1|Between 18 and 78 years||Age, Customized||participants|Number|251|251.0||||||
4177405|NCT00803777|3998632|B1|United States||Region of Enrollment||participants|Number|147|147.0||||||
4177406|NCT00803777|3998632|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4177407|NCT00803777|3998632|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4177408|NCT00803777|3998632|B1|18-24 years of age||Age, Customized||participants|Number|38|38.0||||||
4177409|NCT00803777|3998632|B1|13-17 years of age||Age, Customized||participants|Number|54|54.0||||||
4177410|NCT00803777|3998632|B1|4-12 years of age||Age, Customized||participants|Number|55|55.0||||||
4177411|NCT00803751|3998640|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
4177412|NCT00803751|3998641|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4177413|NCT00803751|3998642|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4177414|NCT00803751|3998640|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4177415|NCT00803751|3998641|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4177416|NCT00803751|3998642|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4177417|NCT00803751|3998640|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4177418|NCT00803751|3998641|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4177419|NCT00803751|3998642|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4177420|NCT00803751|3998640|B3|||Age||months|Mean|6.39|6.39|Standard Deviation|3.13|3.13|||
4177421|NCT00803751|3998641|B2|||Age||months|Mean|6.42|6.42|Standard Deviation|3.2|3.2|||
4177422|NCT00803751|3998642|B1|||Age||months|Mean|6.35|6.35|Standard Deviation|3.1|3.1|||
4177423|NCT00803751|3998640|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4177424|NCT00803751|3998641|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4177425|NCT00803751|3998642|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4177426|NCT00803751|3998640|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4177427|NCT00803751|3998641|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4177428|NCT00803751|3998642|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4177429|NCT00803751|3998640|B3||<=18 years|Age||Participants|Count of Participants|49|49.0||||||
4177430|NCT00803751|3998641|B2||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
4177431|NCT00803751|3998642|B1||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
4177432|NCT00803738|3998659|B3|United States||Region of Enrollment||participants|Number|572|572.0||||||
4177433|NCT00803738|3998660|B2|United States||Region of Enrollment||participants|Number|286|286.0||||||
4177434|NCT00803738|3998661|B1|United States||Region of Enrollment||participants|Number|286|286.0||||||
4177435|NCT00803738|3998659|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4177436|NCT00803738|3998660|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4177437|NCT00803738|3998661|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4177438|NCT00803738|3998659|B3||Female|Sex: Female, Male||Participants|Count of Participants|572|572.0||||||
4177439|NCT00803738|3998660|B2||Female|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
4177440|NCT00803738|3998661|B1||Female|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
4177441|NCT00803738|3998659|B3|||Age||years|Mean|32.5|32.5|Standard Deviation|13.2|13.2|||
4177442|NCT00803738|3998660|B2|||Age||years|Mean|31.6|31.6|Standard Deviation|13.1|13.1|||
4177443|NCT00803738|3998661|B1|||Age||years|Mean|33.4|33.4|Standard Deviation|13.3|13.3|||
4177444|NCT00803738|3998659|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4177445|NCT00803738|3998660|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4177446|NCT00803738|3998661|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4177447|NCT00803738|3998659|B3||Between 18 and 65 years|Age||Participants|Count of Participants|554|554.0||||||
4177448|NCT00803738|3998660|B2||Between 18 and 65 years|Age||Participants|Count of Participants|276|276.0||||||
4177449|NCT00803738|3998661|B1||Between 18 and 65 years|Age||Participants|Count of Participants|278|278.0||||||
4177450|NCT00803738|3998659|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4177451|NCT00803738|3998660|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4177452|NCT00803738|3998661|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4177453|NCT00803712|3998672|B3|||Dialysis Vintage|Time since dialysis started|months|Mean|7.16|7.16|Standard Deviation|2.66|2.66|||
4177454|NCT00803712|3998673|B2|||Dialysis Vintage|Time since dialysis started|months|Mean|7.02|7.02|Standard Deviation|2.78|2.78|||
4177455|NCT00803712|3998674|B1|||Dialysis Vintage|Time since dialysis started|months|Mean|7.29|7.29|Standard Deviation|2.54|2.54|||
4177456|NCT00803712|3998672|B3|||Albumin|Albumin at baseline|g/dL|Mean|3.91|3.91|Standard Deviation|0.39|0.39|||
4177457|NCT00803712|3998673|B2|||Albumin|Albumin at baseline|g/dL|Mean|3.89|3.89|Standard Deviation|0.40|0.4|||
4177458|NCT00803712|3998674|B1|||Albumin|Albumin at baseline|g/dL|Mean|3.93|3.93|Standard Deviation|0.39|0.39|||
4177459|NCT00803712|3998672|B3|||Serum Phosphorus|serum phosphorus at baseline|mg/dL|Mean|5.52|5.52|Standard Deviation|1.65|1.65|||
4177460|NCT00803712|3998673|B2|||Serum Phosphorus|serum phosphorus at baseline|mg/dL|Mean|5.49|5.49|Standard Deviation|1.60|1.6|||
4177461|NCT00803712|3998674|B1|||Serum Phosphorus|serum phosphorus at baseline|mg/dL|Mean|5.55|5.55|Standard Deviation|1.70|1.7|||
4177462|NCT00803712|3998672|B3|||Corrected Serum Calcium|Corrected serum calcium at baseline|mg/dL|Mean|9.22|9.22|Standard Deviation|0.60|0.6|||
4177463|NCT00803712|3998673|B2|||Corrected Serum Calcium|Corrected serum calcium at baseline|mg/dL|Mean|9.14|9.14|Standard Deviation|0.49|0.49|||
4177464|NCT00803712|3998674|B1|||Corrected Serum Calcium|Corrected serum calcium at baseline|mg/dL|Mean|9.30|9.3|Standard Deviation|0.69|0.69|||
4177465|NCT00803712|3998672|B3|||iPTH|iPTH value at baseline|pg/mL|Mean|535.5|535.5|Standard Deviation|299.6|299.6|||
4177466|NCT00803712|3998673|B2|||iPTH|iPTH value at baseline|pg/mL|Mean|511.6|511.6|Standard Deviation|253.6|253.6|||
4177467|NCT00803712|3998674|B1|||iPTH|iPTH value at baseline|pg/mL|Mean|559.2|559.2|Standard Deviation|338.2|338.2|||
4177468|NCT00803712|3998672|B3|No active Vitamin D use||Active Vitamin D Use|Active Vitamin D use at baseline|participants|Number|158|158.0||||||
4177469|NCT00803712|3998673|B2|No active Vitamin D use||Active Vitamin D Use|Active Vitamin D use at baseline|participants|Number|79|79.0||||||
4177470|NCT00803712|3998674|B1|No active Vitamin D use||Active Vitamin D Use|Active Vitamin D use at baseline|participants|Number|79|79.0||||||
4177471|NCT00803712|3998672|B3|Active Vitamin D use||Active Vitamin D Use|Active Vitamin D use at baseline|participants|Number|146|146.0||||||
4177472|NCT00803712|3998673|B2|Active Vitamin D use||Active Vitamin D Use|Active Vitamin D use at baseline|participants|Number|72|72.0||||||
4177473|NCT00803712|3998674|B1|Active Vitamin D use||Active Vitamin D Use|Active Vitamin D use at baseline|participants|Number|74|74.0||||||
4177474|NCT00803712|3998672|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4177475|NCT00803712|3998673|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4177476|NCT00803712|3998674|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4177477|NCT00803712|3998672|B3|Aborigine||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4177478|NCT00803712|3998673|B2|Aborigine||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4177479|NCT00803712|3998674|B1|Aborigine||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4177480|NCT00803712|3998672|B3|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4177481|NCT00803712|3998673|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4177482|NCT00803712|3998674|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4177483|NCT00803712|3998672|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4177484|NCT00803712|3998673|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4177485|NCT00803712|3998674|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4177486|NCT00803712|3998672|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
4177487|NCT00803712|3998673|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4177488|NCT00803712|3998674|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4177489|NCT00803712|3998672|B3|White or Caucasian||Race/Ethnicity, Customized||participants|Number|231|231.0||||||
4177490|NCT00803712|3998673|B2|White or Caucasian||Race/Ethnicity, Customized||participants|Number|111|111.0||||||
4177491|NCT00803712|3998674|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|120|120.0||||||
4177492|NCT00803712|3998672|B3||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4177493|NCT00803712|3998673|B2||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4177494|NCT00803712|3998674|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4177495|NCT00803712|3998672|B3||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4177496|NCT00803712|3998673|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4177497|NCT00803712|3998674|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4177498|NCT00803712|3998672|B3|>=65 years||Age, Customized||participants|Number|100|100.0||||||
4177499|NCT00803712|3998673|B2|>=65 years||Age, Customized||participants|Number|52|52.0||||||
4177500|NCT00803712|3998674|B1|>=65 years||Age, Customized||participants|Number|48|48.0||||||
4177501|NCT00803712|3998672|B3|Between 18 and 65 years||Age, Customized||participants|Number|204|204.0||||||
4177502|NCT00803712|3998673|B2|Between 18 and 65 years||Age, Customized||participants|Number|99|99.0||||||
4177503|NCT00803712|3998674|B1|Between 18 and 65 years||Age, Customized||participants|Number|105|105.0||||||
4177504|NCT00803712|3998672|B3|||Age||years|Mean|57.4|57.4|Standard Deviation|14.1|14.1|||
4177505|NCT00803712|3998673|B2|||Age||years|Mean|57.0|57.0|Standard Deviation|14.6|14.6|||
4177506|NCT00803712|3998674|B1|||Age||years|Mean|57.9|57.9|Standard Deviation|13.6|13.6|||
4177507|NCT00803686|3998739|B5|||post-menopausal females||participants|Number|12|12.0||||||
4177508|NCT00803686|3998742|B2|||post-menopausal females||participants|Number|6|6.0||||||
4177509|NCT00803686|3998743|B1|||post-menopausal females||participants|Number|6|6.0||||||
4177510|NCT00803686|3998739|B5|||post-menopausal healthy females||participants|Number|12|12.0||||||
4177511|NCT00803686|3998742|B2|||post-menopausal healthy females||participants|Number|6|6.0||||||
4177512|NCT00803686|3998743|B1|||post-menopausal healthy females||participants|Number|6|6.0||||||
4177513|NCT00803686|3998739|B5|United States||Region of Enrollment||participants|Number|12|12.0||||||
4177514|NCT00803686|3998742|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4177515|NCT00803686|3998743|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4177516|NCT00803686|3998739|B5|Male||Gender||participants|Number|0|0.0||||||
4177517|NCT00803686|3998742|B2|Male||Gender||participants|Number|0|0.0||||||
4177518|NCT00803686|3998743|B1|Male||Gender||participants|Number|0|0.0||||||
4177519|NCT00803686|3998739|B5|Female||Gender||participants|Number|12|12.0||||||
4177520|NCT00803686|3998742|B2|Female||Gender||participants|Number|6|6.0||||||
4177521|NCT00803686|3998743|B1|Female||Gender||participants|Number|6|6.0||||||
4177522|NCT00803686|3998739|B5|||Age||years|Mean|59.3|59.3|Standard Deviation|4.7|4.7|||
4177523|NCT00803686|3998742|B2|||Age||years|Mean|59.3|59.3|Standard Deviation|4.7|4.7|||
4177524|NCT00803686|3998743|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|4.7|4.7|||
4177525|NCT00803647|3998764|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177526|NCT00803647|3998764|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177527|NCT00803647|3998764|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4177528|NCT00803647|3998764|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177529|NCT00803647|3998764|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177530|NCT00803647|3998764|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4177531|NCT00803647|3998764|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177532|NCT00803647|3998764|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177533|NCT00803647|3998764|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4177534|NCT00803647|3998764|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4177535|NCT00803647|3998764|B1|||Sex/Gender, Customized||participants|Number|NA|||||||Gender data were not collected.
4177536|NCT00803647|3998764|B1|||Age||years|Mean|52.8|52.8|Standard Deviation|8.4|8.4|||
4177537|NCT00803634|3998772|B3|||Diastolic Blood Pressure (DBP)||mm Hg|Mean|100.7|100.7|Standard Deviation|24.14|24.14|||
4177538|NCT00803634|3998773|B2|||Diastolic Blood Pressure (DBP)||mm Hg|Mean|99.2|99.2|Standard Deviation|24.28|24.28|||
4177539|NCT00803634|3998774|B1|||Diastolic Blood Pressure (DBP)||mm Hg|Mean|102.2|102.2|Standard Deviation|24.14|24.14|||
4177540|NCT00803634|3998772|B3|||Systolic Blood Pressure (SBP)||mm Hg|Mean|186.5|186.5|Standard Deviation|23.44|23.44|||
4177541|NCT00803634|3998773|B2|||Systolic Blood Pressure (SBP)||mm Hg|Mean|184.8|184.8|Standard Deviation|21.92|21.92|||
4177542|NCT00803634|3998774|B1|||Systolic Blood Pressure (SBP)||mm Hg|Mean|188.2|188.2|Standard Deviation|25.02|25.02|||
4177543|NCT00803634|3998772|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177544|NCT00803634|3998773|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177545|NCT00803634|3998774|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177546|NCT00803634|3998772|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177547|NCT00803634|3998773|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177548|NCT00803634|3998774|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177549|NCT00803634|3998772|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4177550|NCT00803634|3998773|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4177551|NCT00803634|3998774|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4177552|NCT00803634|3998772|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
4177553|NCT00803634|3998773|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4177554|NCT00803634|3998774|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4177555|NCT00803634|3998772|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177556|NCT00803634|3998773|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177557|NCT00803634|3998774|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177558|NCT00803634|3998772|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177559|NCT00803634|3998773|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177560|NCT00803634|3998774|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177561|NCT00803634|3998772|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177562|NCT00803634|3998773|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177563|NCT00803634|3998774|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177564|NCT00803634|3998772|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177565|NCT00803634|3998773|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177566|NCT00803634|3998774|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177567|NCT00803634|3998772|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
4177568|NCT00803634|3998773|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4177569|NCT00803634|3998774|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4177570|NCT00803634|3998772|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4177571|NCT00803634|3998773|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177572|NCT00803634|3998774|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4177573|NCT00803634|3998772|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4177574|NCT00803634|3998773|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4177575|NCT00803634|3998774|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4177576|NCT00803634|3998772|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4177577|NCT00803634|3998773|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4177578|NCT00803634|3998774|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4177579|NCT00803634|3998772|B3|||Age||years|Mean|61.0|61.0|Standard Deviation|14.87|14.87|||
4177580|NCT00803634|3998773|B2|||Age||years|Mean|60.2|60.2|Standard Deviation|14.89|14.89|||
4177581|NCT00803634|3998774|B1|||Age||years|Mean|61.8|61.8|Standard Deviation|14.95|14.95|||
4177582|NCT00803595|3998801|B4|Negative||Laboratory confirmed influenza||Participants|Number|26|26.0||||||
4177583|NCT00803595|3998802|B3|Negative||Laboratory confirmed influenza||Participants|Number|11|11.0||||||
4177584|NCT00803595|3998803|B2|Negative||Laboratory confirmed influenza||Participants|Number|7|7.0||||||
4177585|NCT00803595|3998804|B1|Negative||Laboratory confirmed influenza||Participants|Number|8|8.0||||||
4177586|NCT00803595|3998801|B4|Virus B||Laboratory confirmed influenza||Participants|Number|3|3.0||||||
4177587|NCT00803595|3998802|B3|Virus B||Laboratory confirmed influenza||Participants|Number|1|1.0||||||
4177588|NCT00803595|3998803|B2|Virus B||Laboratory confirmed influenza||Participants|Number|2|2.0||||||
4177589|NCT00803595|3998804|B1|Virus B||Laboratory confirmed influenza||Participants|Number|0|0.0||||||
4177590|NCT00803595|3998801|B4|Virus A/H3N2||Laboratory confirmed influenza||Participants|Number|322|322.0||||||
4177591|NCT00803595|3998802|B3|Virus A/H3N2||Laboratory confirmed influenza||Participants|Number|112|112.0||||||
4177592|NCT00803595|3998803|B2|Virus A/H3N2||Laboratory confirmed influenza||Participants|Number|102|102.0||||||
4177593|NCT00803595|3998804|B1|Virus A/H3N2||Laboratory confirmed influenza||Participants|Number|108|108.0||||||
4177594|NCT00803595|3998801|B4|Virus A/H1N1||Laboratory confirmed influenza||Participants|Number|645|645.0||||||
4177595|NCT00803595|3998802|B3|Virus A/H1N1||Laboratory confirmed influenza||Participants|Number|212|212.0||||||
4177596|NCT00803595|3998803|B2|Virus A/H1N1||Laboratory confirmed influenza||Participants|Number|215|215.0||||||
4177597|NCT00803595|3998804|B1|Virus A/H1N1||Laboratory confirmed influenza||Participants|Number|218|218.0||||||
4177598|NCT00803595|3998801|B4|Korea, Republic of||Region of Enrollment||participants|Number|18|18.0||||||
4177599|NCT00803595|3998802|B3|Korea, Republic of||Region of Enrollment||participants|Number|5|5.0||||||
4177600|NCT00803595|3998803|B2|Korea, Republic of||Region of Enrollment||participants|Number|7|7.0||||||
4177601|NCT00803595|3998804|B1|Korea, Republic of||Region of Enrollment||participants|Number|6|6.0||||||
4177602|NCT00803595|3998801|B4|Japan||Region of Enrollment||participants|Number|785|785.0||||||
4177603|NCT00803595|3998802|B3|Japan||Region of Enrollment||participants|Number|266|266.0||||||
4177604|NCT00803595|3998803|B2|Japan||Region of Enrollment||participants|Number|256|256.0||||||
4177605|NCT00803595|3998804|B1|Japan||Region of Enrollment||participants|Number|263|263.0||||||
4177606|NCT00803595|3998801|B4|China||Region of Enrollment||participants|Number|7|7.0||||||
4177607|NCT00803595|3998802|B3|China||Region of Enrollment||participants|Number|2|2.0||||||
4177608|NCT00803595|3998803|B2|China||Region of Enrollment||participants|Number|2|2.0||||||
4177609|NCT00803595|3998804|B1|China||Region of Enrollment||participants|Number|3|3.0||||||
4177610|NCT00803595|3998801|B4|Taiwan||Region of Enrollment||participants|Number|186|186.0||||||
4177611|NCT00803595|3998802|B3|Taiwan||Region of Enrollment||participants|Number|63|63.0||||||
4177612|NCT00803595|3998803|B2|Taiwan||Region of Enrollment||participants|Number|61|61.0||||||
4177613|NCT00803595|3998804|B1|Taiwan||Region of Enrollment||participants|Number|62|62.0||||||
4177614|NCT00803595|3998801|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177615|NCT00803595|3998802|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177616|NCT00803595|3998803|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177617|NCT00803595|3998804|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177618|NCT00803595|3998801|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177619|NCT00803595|3998802|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177620|NCT00803595|3998803|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177621|NCT00803595|3998804|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177622|NCT00803595|3998801|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177623|NCT00803595|3998802|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177624|NCT00803595|3998803|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177625|NCT00803595|3998804|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177626|NCT00803595|3998801|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177627|NCT00803595|3998802|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177628|NCT00803595|3998803|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177629|NCT00803595|3998804|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177630|NCT00803595|3998801|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177631|NCT00803595|3998802|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177632|NCT00803595|3998803|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177633|NCT00803595|3998804|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177634|NCT00803595|3998801|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|996|996.0||||||
4177635|NCT00803595|3998802|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|336|336.0||||||
4177636|NCT00803595|3998803|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|326|326.0||||||
4177637|NCT00803595|3998804|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|334|334.0||||||
4177638|NCT00803595|3998801|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177639|NCT00803595|3998802|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177640|NCT00803595|3998803|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177641|NCT00803595|3998804|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177642|NCT00803595|3998801|B4||Male|Sex: Female, Male||Participants|Count of Participants|519|519.0||||||
4177643|NCT00803595|3998802|B3||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4177644|NCT00803595|3998803|B2||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4177645|NCT00803595|3998804|B1||Male|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4177646|NCT00803595|3998801|B4||Female|Sex: Female, Male||Participants|Count of Participants|477|477.0||||||
4177647|NCT00803595|3998802|B3||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4177648|NCT00803595|3998803|B2||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4177649|NCT00803595|3998804|B1||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4177650|NCT00803595|3998801|B4|||Age||years|Mean|35.0|35.0|Standard Deviation|11.5|11.5|||
4177651|NCT00803595|3998802|B3|||Age||years|Mean|34.7|34.7|Standard Deviation|11.3|11.3|||
4177652|NCT00803595|3998803|B2|||Age||years|Mean|35.6|35.6|Standard Deviation|11.7|11.7|||
4177653|NCT00803595|3998804|B1|||Age||years|Mean|34.9|34.9|Standard Deviation|11.5|11.5|||
4177654|NCT00803543|3998817|B3|||Number with Undetectable Viral Load||participants|Number|59|59.0||||||
4177655|NCT00803543|3998818|B2|||Number with Undetectable Viral Load||participants|Number|19|19.0||||||
4177656|NCT00803543|3998819|B1|||Number with Undetectable Viral Load||participants|Number|40|40.0||||||
4177657|NCT00803543|3998817|B3|||Absolute CD4 (cluster of differentiation 4) Count||cell/ml|Mean|582|582.0|Full Range|||165.0|1272.0|
4177658|NCT00803543|3998818|B2|||Absolute CD4 (cluster of differentiation 4) Count||cell/ml|Mean|693|693.0|Full Range|||198.0|1272.0|
4177659|NCT00803543|3998819|B1|||Absolute CD4 (cluster of differentiation 4) Count||cell/ml|Mean|528|528.0|Full Range|||165.0|1135.0|
4177660|NCT00803543|3998817|B3|United States||Region of Enrollment||participants|Number|67|67.0||||||
4177661|NCT00803543|3998818|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4177662|NCT00803543|3998819|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4177663|NCT00803543|3998817|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177664|NCT00803543|3998818|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177665|NCT00803543|3998819|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177666|NCT00803543|3998817|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177667|NCT00803543|3998818|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177668|NCT00803543|3998819|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177669|NCT00803543|3998817|B3||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4177670|NCT00803543|3998818|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4177671|NCT00803543|3998819|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4177672|NCT00803543|3998817|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4177673|NCT00803543|3998818|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4177674|NCT00803543|3998819|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4177675|NCT00803543|3998817|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177676|NCT00803543|3998818|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177677|NCT00803543|3998819|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177678|NCT00803543|3998817|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177679|NCT00803543|3998818|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177680|NCT00803543|3998819|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177681|NCT00803543|3998817|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177682|NCT00803543|3998818|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177683|NCT00803543|3998819|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177684|NCT00803543|3998817|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177685|NCT00803543|3998818|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177686|NCT00803543|3998819|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177687|NCT00803543|3998817|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4177688|NCT00803543|3998818|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4177689|NCT00803543|3998819|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4177690|NCT00803543|3998817|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177691|NCT00803543|3998818|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177692|NCT00803543|3998819|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177693|NCT00803543|3998817|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4177694|NCT00803543|3998818|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4177695|NCT00803543|3998819|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4177696|NCT00803543|3998817|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4177697|NCT00803543|3998818|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4177698|NCT00803543|3998819|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4177699|NCT00803543|3998817|B3|||Age||years|Mean|45|45.0|Full Range|||23.0|68.0|
4177700|NCT00803543|3998818|B2|||Age||years|Mean|43|43.0|Full Range|||27.0|61.0|
4177701|NCT00803543|3998819|B1|||Age||years|Mean|45|45.0|Full Range|||23.0|68.0|
4177702|NCT00803517|3998832|B3|Korea, Republic of||Region of Enrollment||participants|Number|24|24.0||||||
4177703|NCT00803517|3998833|B2|Korea, Republic of||Region of Enrollment||participants|Number|12|12.0||||||
4177704|NCT00803517|3998834|B1|Korea, Republic of||Region of Enrollment||participants|Number|12|12.0||||||
4177705|NCT00803517|3998832|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4177706|NCT00803517|3998833|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4177707|NCT00803517|3998834|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4177708|NCT00803517|3998832|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4177709|NCT00803517|3998833|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4177710|NCT00803517|3998834|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4177711|NCT00803517|3998832|B3|||Age||years|Mean|43.31|43.31|Standard Deviation|7.89|7.89|||
4177712|NCT00803517|3998833|B2|||Age||years|Mean|44.26|44.26|Standard Deviation|5.89|5.89|||
4177713|NCT00803517|3998834|B1|||Age||years|Mean|42.35|42.35|Standard Deviation|6.89|6.89|||
4177714|NCT00803517|3998832|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4177715|NCT00803517|3998833|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4177716|NCT00803517|3998834|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4177717|NCT00803517|3998832|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4177718|NCT00803517|3998833|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4177719|NCT00803517|3998834|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4177720|NCT00803517|3998832|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4177721|NCT00803517|3998833|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4177722|NCT00803517|3998834|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4177723|NCT00803452|3998841|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4177724|NCT00803452|3998842|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4177725|NCT00803452|3998843|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4177726|NCT00803452|3998841|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4177727|NCT00803452|3998842|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4177728|NCT00803452|3998843|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4177729|NCT00803452|3998841|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4177730|NCT00803452|3998842|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4177731|NCT00803452|3998843|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4177732|NCT00803452|3998841|B3|||Age||years|Mean|65|65.0|Standard Deviation|3|3.0|||
4177733|NCT00803452|3998842|B2|||Age||years|Mean|64|64.0|Standard Deviation|3|3.0|||
4177734|NCT00803452|3998843|B1|||Age||years|Mean|68|68.0|Standard Deviation|4|4.0|||
4177735|NCT00803413|3998850|B5|Brazil||Region of Enrollment||participants|Number|119|119.0||||||
4177736|NCT00803413|3998851|B4|Brazil||Region of Enrollment||participants|Number|30|30.0||||||
4177737|NCT00803413|3998852|B3|Brazil||Region of Enrollment||participants|Number|32|32.0||||||
4177738|NCT00803413|3998853|B2|Brazil||Region of Enrollment||participants|Number|29|29.0||||||
4177739|NCT00803413|3998854|B1|Brazil||Region of Enrollment||participants|Number|28|28.0||||||
4177740|NCT00803413|3998850|B5|Male||Gender||participants|Number|0|0.0||||||
4177741|NCT00803413|3998851|B4|Male||Gender||participants|Number|0|0.0||||||
4177742|NCT00803413|3998852|B3|Male||Gender||participants|Number|0|0.0||||||
4177743|NCT00803413|3998853|B2|Male||Gender||participants|Number|0|0.0||||||
4177744|NCT00803413|3998854|B1|Male||Gender||participants|Number|0|0.0||||||
4177745|NCT00803413|3998850|B5|Female||Gender||participants|Number|119|119.0||||||
4177746|NCT00803413|3998851|B4|Female||Gender||participants|Number|30|30.0||||||
4177747|NCT00803413|3998852|B3|Female||Gender||participants|Number|32|32.0||||||
4177748|NCT00803413|3998853|B2|Female||Gender||participants|Number|29|29.0||||||
4177749|NCT00803413|3998854|B1|Female||Gender||participants|Number|28|28.0||||||
4177750|NCT00803413|3998850|B5|||Age||years|Mean|46.6|46.6|Standard Deviation|7.4|7.4|||
4177751|NCT00803413|3998851|B4|||Age||years|Mean|46.8|46.8|Standard Deviation|7.2|7.2|||
4177752|NCT00803413|3998852|B3|||Age||years|Mean|46.5|46.5|Standard Deviation|7.5|7.5|||
4177753|NCT00803413|3998853|B2|||Age||years|Mean|47.2|47.2|Standard Deviation|7.1|7.1|||
4177754|NCT00803413|3998854|B1|||Age||years|Mean|44.8|44.8|Standard Deviation|7.3|7.3|||
4177755|NCT00803413|3998850|B5|>=65 years||Age||participants|Number|0|0.0||||||
4177756|NCT00803413|3998851|B4|>=65 years||Age||participants|Number|0|0.0||||||
4177757|NCT00803413|3998852|B3|>=65 years||Age||participants|Number|0|0.0||||||
4177758|NCT00803413|3998853|B2|>=65 years||Age||participants|Number|0|0.0||||||
4177759|NCT00803413|3998854|B1|>=65 years||Age||participants|Number|0|0.0||||||
4177760|NCT00803413|3998850|B5|Between 18 and 65 years||Age||participants|Number|119|119.0||||||
4177761|NCT00803413|3998851|B4|Between 18 and 65 years||Age||participants|Number|30|30.0||||||
4177762|NCT00803413|3998852|B3|Between 18 and 65 years||Age||participants|Number|32|32.0||||||
4177763|NCT00803413|3998853|B2|Between 18 and 65 years||Age||participants|Number|29|29.0||||||
4177764|NCT00803413|3998854|B1|Between 18 and 65 years||Age||participants|Number|28|28.0||||||
4177765|NCT00803413|3998850|B5|<=18 years||Age||participants|Number|0|0.0||||||
4177766|NCT00803413|3998851|B4|<=18 years||Age||participants|Number|0|0.0||||||
4177767|NCT00803413|3998852|B3|<=18 years||Age||participants|Number|0|0.0||||||
4177768|NCT00803413|3998853|B2|<=18 years||Age||participants|Number|0|0.0||||||
4177769|NCT00803413|3998854|B1|<=18 years||Age||participants|Number|0|0.0||||||
4177770|NCT00803400|3998867|B3|Argentina||Region of Enrollment||participants|Number|150|150.0||||||
4177771|NCT00803400|3998868|B2|Argentina||Region of Enrollment||participants|Number|75|75.0||||||
4177772|NCT00803400|3998869|B1|Argentina||Region of Enrollment||participants|Number|75|75.0||||||
4177773|NCT00803400|3998867|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4177774|NCT00803400|3998868|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4177775|NCT00803400|3998869|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4177776|NCT00803400|3998867|B3||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4177777|NCT00803400|3998868|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4177778|NCT00803400|3998869|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4177779|NCT00803400|3998867|B3|||Age||years|Mean|34.85|34.85|Standard Deviation|7.89|7.89|||
4177780|NCT00803400|3998868|B2|||Age||years|Mean|35.68|35.68|Standard Deviation|7.67|7.67|||
4177781|NCT00803400|3998869|B1|||Age||years|Mean|34.01|34.01|Standard Deviation|8.07|8.07|||
4177782|NCT00803400|3998867|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4177783|NCT00803400|3998868|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4177784|NCT00803400|3998869|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4177785|NCT00803400|3998867|B3||Between 18 and 65 years|Age||Participants|Count of Participants|150|150.0||||||
4177786|NCT00803400|3998868|B2||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4177787|NCT00803400|3998869|B1||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4177788|NCT00803400|3998867|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4177789|NCT00803400|3998868|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4177790|NCT00803400|3998869|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4177791|NCT00803361|3998880|B3|China||Region of Enrollment||participants|Number|210|210.0||||||
4177792|NCT00803361|3998881|B2|China||Region of Enrollment||participants|Number|102|102.0||||||
4177793|NCT00803361|3998882|B1|China||Region of Enrollment||participants|Number|108|108.0||||||
4177794|NCT00803361|3998880|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177795|NCT00803361|3998881|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177796|NCT00803361|3998882|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177797|NCT00803361|3998880|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177798|NCT00803361|3998881|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177799|NCT00803361|3998882|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177800|NCT00803361|3998880|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177801|NCT00803361|3998881|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177802|NCT00803361|3998882|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177803|NCT00803361|3998880|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177804|NCT00803361|3998881|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177805|NCT00803361|3998882|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177806|NCT00803361|3998880|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177807|NCT00803361|3998881|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177808|NCT00803361|3998882|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177809|NCT00803361|3998880|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|210|210.0||||||
4177810|NCT00803361|3998881|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
4177811|NCT00803361|3998882|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
4177812|NCT00803361|3998880|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177813|NCT00803361|3998881|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177814|NCT00803361|3998882|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177815|NCT00803361|3998880|B3||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4177816|NCT00803361|3998881|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4177817|NCT00803361|3998882|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4177818|NCT00803361|3998880|B3||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4177819|NCT00803361|3998881|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4177820|NCT00803361|3998882|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4177821|NCT00803361|3998880|B3|||Age||years|Mean|37.63|37.63|Standard Deviation|11.92|11.92|||
4177822|NCT00803361|3998881|B2|||Age||years|Mean|38.02|38.02|Standard Deviation|12.03|12.03|||
4177823|NCT00803361|3998882|B1|||Age||years|Mean|37.26|37.26|Standard Deviation|11.85|11.85|||
4177824|NCT00803283|3998901|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4177825|NCT00803283|3998902|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4177826|NCT00803283|3998903|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4177827|NCT00803283|3998901|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4177828|NCT00803283|3998902|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4177829|NCT00803283|3998903|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4177830|NCT00803283|3998901|B3|>=41 to <=60 years||Age, Customized||Participants|Number|1|1.0||||||
4177831|NCT00803283|3998902|B2|>=41 to <=60 years||Age, Customized||Participants|Number|0|0.0||||||
4177832|NCT00803283|3998903|B1|>=41 to <=60 years||Age, Customized||Participants|Number|1|1.0||||||
4177833|NCT00803283|3998901|B3|>=18 to <=40 years||Age, Customized||Participants|Number|1|1.0||||||
4177834|NCT00803283|3998902|B2|>=18 to <=40 years||Age, Customized||Participants|Number|1|1.0||||||
4177835|NCT00803283|3998903|B1|>=18 to <=40 years||Age, Customized||Participants|Number|0|0.0||||||
4177836|NCT00803270|3998928|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
4177837|NCT00803270|3998929|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4177838|NCT00803270|3998930|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4177839|NCT00803270|3998928|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4177840|NCT00803270|3998929|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4177841|NCT00803270|3998930|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4177842|NCT00803270|3998928|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4177843|NCT00803270|3998929|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4177844|NCT00803270|3998930|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4177845|NCT00803270|3998928|B3|||Age||years|Mean|56|56.0|Standard Deviation|14|14.0|||
4177846|NCT00803270|3998929|B2|||Age||years|Mean|59|59.0|Standard Deviation|14|14.0|||
4177847|NCT00803270|3998930|B1|||Age||years|Mean|53|53.0|Standard Deviation|14|14.0|||
4177848|NCT00803270|3998928|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4177849|NCT00803270|3998929|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4177850|NCT00803270|3998930|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4177851|NCT00803270|3998928|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4177852|NCT00803270|3998929|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4177853|NCT00803270|3998930|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4177854|NCT00803270|3998928|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4177855|NCT00803270|3998929|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4177856|NCT00803270|3998930|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4177857|NCT00803244|3998939|B3||Male|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4177858|NCT00803244|3998940|B2||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4177859|NCT00803244|3998941|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4177860|NCT00803244|3998939|B3||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4177861|NCT00803244|3998940|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4177862|NCT00803244|3998941|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4177863|NCT00803244|3998939|B3|||Age||years|Mean|30.0|30.0|Standard Deviation|10.20|10.2|||
4177864|NCT00803244|3998940|B2|||Age||years|Mean|29.6|29.6|Standard Deviation|9.87|9.87|||
4177865|NCT00803244|3998941|B1|||Age||years|Mean|30.5|30.5|Standard Deviation|10.53|10.53|||
4177866|NCT00803179|3998950|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4177867|NCT00803179|3998950|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4177868|NCT00803179|3998950|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4177869|NCT00803179|3998950|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4177870|NCT00803179|3998950|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4177871|NCT00803179|3998950|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4177872|NCT00803114|3998954|B3|||Neonatal Birth Weight||kilograms|Mean|3.4|3.4|Standard Deviation|0.48|0.48|||
4177873|NCT00803114|3998955|B2|||Neonatal Birth Weight||kilograms|Mean|3.4|3.4|Standard Deviation|0.46|0.46|||
4177874|NCT00803114|3998956|B1|||Neonatal Birth Weight||kilograms|Mean|3.4|3.4|Standard Deviation|0.51|0.51|||
4177875|NCT00803114|3998954|B3|||Maternal Body Mass Index (BMI)||kg/m2|Mean|29.0|29.0|Standard Deviation|6.2|6.2|||
4177876|NCT00803114|3998955|B2|||Maternal Body Mass Index (BMI)||kg/m2|Mean|29.0|29.0|Standard Deviation|6.6|6.6|||
4177877|NCT00803114|3998956|B1|||Maternal Body Mass Index (BMI)||kg/m2|Mean|29.0|29.0|Standard Deviation|5.9|5.9|||
4177878|NCT00803114|3998954|B3|First degree tear or less||Perineal Trauma|Number of subjects with minimal, major perineal tears|Participants|Number|59|59.0||||||
4177879|NCT00803114|3998955|B2|First degree tear or less||Perineal Trauma|Number of subjects with minimal, major perineal tears|Participants|Number|28|28.0||||||
4177880|NCT00803114|3998956|B1|First degree tear or less||Perineal Trauma|Number of subjects with minimal, major perineal tears|Participants|Number|31|31.0||||||
4177881|NCT00803114|3998954|B3|Second degree tear or greater||Perineal Trauma|Number of subjects with minimal, major perineal tears|Participants|Number|169|169.0||||||
4177882|NCT00803114|3998955|B2|Second degree tear or greater||Perineal Trauma|Number of subjects with minimal, major perineal tears|Participants|Number|87|87.0||||||
4177883|NCT00803114|3998956|B1|Second degree tear or greater||Perineal Trauma|Number of subjects with minimal, major perineal tears|Participants|Number|82|82.0||||||
4177884|NCT00803114|3998954|B3|Multiparous||Parity|Number of primiparous, multiparous study subjects|participants|Number|73|73.0||||||
4177885|NCT00803114|3998955|B2|Multiparous||Parity|Number of primiparous, multiparous study subjects|participants|Number|36|36.0||||||
4177886|NCT00803114|3998956|B1|Multiparous||Parity|Number of primiparous, multiparous study subjects|participants|Number|37|37.0||||||
4177887|NCT00803114|3998954|B3|Primiparous||Parity|Number of primiparous, multiparous study subjects|participants|Number|155|155.0||||||
4177888|NCT00803114|3998955|B2|Primiparous||Parity|Number of primiparous, multiparous study subjects|participants|Number|79|79.0||||||
4177889|NCT00803114|3998956|B1|Primiparous||Parity|Number of primiparous, multiparous study subjects|participants|Number|76|76.0||||||
4177890|NCT00803114|3998954|B3|Spontaneous vaginal delivery||Operative vaginal delivery|Number of study subjects with spontaneous, operative vaginal delivery|participants|Number|156|156.0||||||
4177891|NCT00803114|3998955|B2|Spontaneous vaginal delivery||Operative vaginal delivery|Number of study subjects with spontaneous, operative vaginal delivery|participants|Number|81|81.0||||||
4177892|NCT00803114|3998956|B1|Spontaneous vaginal delivery||Operative vaginal delivery|Number of study subjects with spontaneous, operative vaginal delivery|participants|Number|75|75.0||||||
4177893|NCT00803114|3998954|B3|Operative vaginal delivery||Operative vaginal delivery|Number of study subjects with spontaneous, operative vaginal delivery|participants|Number|72|72.0||||||
4177894|NCT00803114|3998955|B2|Operative vaginal delivery||Operative vaginal delivery|Number of study subjects with spontaneous, operative vaginal delivery|participants|Number|34|34.0||||||
4177895|NCT00803114|3998956|B1|Operative vaginal delivery||Operative vaginal delivery|Number of study subjects with spontaneous, operative vaginal delivery|participants|Number|38|38.0||||||
4177896|NCT00803114|3998954|B3|Missing information||Race/Ethnicity, Customized|Number of caucasian, non-caucasian study subjects|Participants|Number|14|14.0||||||
4177897|NCT00803114|3998955|B2|Missing information||Race/Ethnicity, Customized|Number of caucasian, non-caucasian study subjects|Participants|Number|5|5.0||||||
4177898|NCT00803114|3998956|B1|Missing information||Race/Ethnicity, Customized|Number of caucasian, non-caucasian study subjects|Participants|Number|9|9.0||||||
4177899|NCT00803114|3998954|B3|Non-caucasian||Race/Ethnicity, Customized|Number of caucasian, non-caucasian study subjects|Participants|Number|28|28.0||||||
4177900|NCT00803114|3998955|B2|Non-caucasian||Race/Ethnicity, Customized|Number of caucasian, non-caucasian study subjects|Participants|Number|11|11.0||||||
4177901|NCT00803114|3998956|B1|Non-caucasian||Race/Ethnicity, Customized|Number of caucasian, non-caucasian study subjects|Participants|Number|17|17.0||||||
4177902|NCT00803114|3998954|B3|Caucasian||Race/Ethnicity, Customized|Number of caucasian, non-caucasian study subjects|Participants|Number|186|186.0||||||
4177903|NCT00803114|3998955|B2|Caucasian||Race/Ethnicity, Customized|Number of caucasian, non-caucasian study subjects|Participants|Number|99|99.0||||||
4177904|NCT00803114|3998956|B1|Caucasian||Race/Ethnicity, Customized|Number of caucasian, non-caucasian study subjects|Participants|Number|87|87.0||||||
4177905|NCT00803114|3998954|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4177906|NCT00803114|3998955|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4177907|NCT00803114|3998956|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4177908|NCT00803114|3998954|B3||Female|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
4177909|NCT00803114|3998955|B2||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4177910|NCT00803114|3998956|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4177911|NCT00803114|3998954|B3|||Age||years|Mean|32.0|32.0|Standard Deviation|4.9|4.9|||
4177912|NCT00803114|3998955|B2|||Age||years|Mean|31.8|31.8|Standard Deviation|4.9|4.9|||
4177913|NCT00803114|3998956|B1|||Age||years|Mean|32.1|32.1|Standard Deviation|4.9|4.9|||
4177914|NCT00803101|3998967|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4177915|NCT00803101|3998968|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4177916|NCT00803101|3998969|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4177917|NCT00803101|3998967|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4177918|NCT00803101|3998968|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4177919|NCT00803101|3998969|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4177920|NCT00803101|3998967|B3|>= 75 years||Age, Customized||participants|Number|57|57.0||||||
4177921|NCT00803101|3998968|B2|>= 75 years||Age, Customized||participants|Number|23|23.0||||||
4177922|NCT00803101|3998969|B1|>= 75 years||Age, Customized||participants|Number|34|34.0||||||
4177923|NCT00803101|3998967|B3|>= 65 to < 75 years||Age, Customized||participants|Number|40|40.0||||||
4177924|NCT00803101|3998968|B2|>= 65 to < 75 years||Age, Customized||participants|Number|19|19.0||||||
4177925|NCT00803101|3998969|B1|>= 65 to < 75 years||Age, Customized||participants|Number|21|21.0||||||
4177926|NCT00803101|3998967|B3|< 65 years||Age, Customized||participants|Number|71|71.0||||||
4177927|NCT00803101|3998968|B2|< 65 years||Age, Customized||participants|Number|39|39.0||||||
4177928|NCT00803101|3998969|B1|< 65 years||Age, Customized||participants|Number|32|32.0||||||
4177929|NCT00803062|3998988|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4177930|NCT00803062|3998989|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4177931|NCT00803062|3998990|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4177932|NCT00803062|3998991|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4177933|NCT00803062|3998992|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4177934|NCT00803062|3998988|B5||Female|Sex: Female, Male||Participants|Count of Participants|452|452.0||||||
4177935|NCT00803062|3998989|B4||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4177936|NCT00803062|3998990|B3||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4177937|NCT00803062|3998991|B2||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4177938|NCT00803062|3998992|B1||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4177939|NCT00803062|3998988|B5|80-89 years||Age, Customized||participants|Number|5|5.0||||||
4177940|NCT00803062|3998989|B4|80-89 years||Age, Customized||participants|Number|0|0.0||||||
4177941|NCT00803062|3998990|B3|80-89 years||Age, Customized||participants|Number|1|1.0||||||
4177942|NCT00803062|3998991|B2|80-89 years||Age, Customized||participants|Number|3|3.0||||||
4177943|NCT00803062|3998992|B1|80-89 years||Age, Customized||participants|Number|1|1.0||||||
4177944|NCT00803062|3998988|B5|70-79 years||Age, Customized||participants|Number|19|19.0||||||
4177945|NCT00803062|3998989|B4|70-79 years||Age, Customized||participants|Number|4|4.0||||||
4177946|NCT00803062|3998990|B3|70-79 years||Age, Customized||participants|Number|5|5.0||||||
4177947|NCT00803062|3998991|B2|70-79 years||Age, Customized||participants|Number|5|5.0||||||
4177948|NCT00803062|3998992|B1|70-79 years||Age, Customized||participants|Number|5|5.0||||||
4177949|NCT00803062|3998988|B5|60-69 years||Age, Customized||participants|Number|56|56.0||||||
4177950|NCT00803062|3998989|B4|60-69 years||Age, Customized||participants|Number|12|12.0||||||
4177951|NCT00803062|3998990|B3|60-69 years||Age, Customized||participants|Number|17|17.0||||||
4177952|NCT00803062|3998991|B2|60-69 years||Age, Customized||participants|Number|13|13.0||||||
4177953|NCT00803062|3998992|B1|60-69 years||Age, Customized||participants|Number|14|14.0||||||
4177954|NCT00803062|3998988|B5|50-59 years||Age, Customized||participants|Number|116|116.0||||||
4177955|NCT00803062|3998989|B4|50-59 years||Age, Customized||participants|Number|37|37.0||||||
4177956|NCT00803062|3998990|B3|50-59 years||Age, Customized||participants|Number|24|24.0||||||
4177957|NCT00803062|3998991|B2|50-59 years||Age, Customized||participants|Number|28|28.0||||||
4177958|NCT00803062|3998992|B1|50-59 years||Age, Customized||participants|Number|27|27.0||||||
4177959|NCT00803062|3998988|B5|40-49 years||Age, Customized||participants|Number|144|144.0||||||
4177960|NCT00803062|3998989|B4|40-49 years||Age, Customized||participants|Number|41|41.0||||||
4177961|NCT00803062|3998990|B3|40-49 years||Age, Customized||participants|Number|33|33.0||||||
4177962|NCT00803062|3998991|B2|40-49 years||Age, Customized||participants|Number|34|34.0||||||
4177963|NCT00803062|3998992|B1|40-49 years||Age, Customized||participants|Number|36|36.0||||||
4177964|NCT00803062|3998988|B5|30-39 years||Age, Customized||participants|Number|94|94.0||||||
4177965|NCT00803062|3998989|B4|30-39 years||Age, Customized||participants|Number|12|12.0||||||
4177966|NCT00803062|3998990|B3|30-39 years||Age, Customized||participants|Number|30|30.0||||||
4177967|NCT00803062|3998991|B2|30-39 years||Age, Customized||participants|Number|27|27.0||||||
4177968|NCT00803062|3998992|B1|30-39 years||Age, Customized||participants|Number|25|25.0||||||
4177969|NCT00803062|3998988|B5|20-29 years||Age, Customized||participants|Number|18|18.0||||||
4177970|NCT00803062|3998989|B4|20-29 years||Age, Customized||participants|Number|6|6.0||||||
4177971|NCT00803062|3998990|B3|20-29 years||Age, Customized||participants|Number|1|1.0||||||
4177972|NCT00803062|3998991|B2|20-29 years||Age, Customized||participants|Number|5|5.0||||||
4177973|NCT00803062|3998992|B1|20-29 years||Age, Customized||participants|Number|6|6.0||||||
4177974|NCT00803049|3999017|B5||Male|Gender||Participants|Count of Participants|206|206.0||||||
4177975|NCT00803049|3999018|B4||Male|Gender||Participants|Count of Participants|71|71.0||||||
4177976|NCT00803049|3999019|B3||Male|Gender||Participants|Count of Participants|23|23.0||||||
4177977|NCT00803049|3999020|B2||Male|Gender||Participants|Count of Participants|77|77.0||||||
4177978|NCT00803049|3999021|B1||Male|Gender||Participants|Count of Participants|35|35.0||||||
4177979|NCT00803049|3999017|B5||Female|Gender||Participants|Count of Participants|536|536.0||||||
4177980|NCT00803049|3999018|B4||Female|Gender||Participants|Count of Participants|182|182.0||||||
4177981|NCT00803049|3999019|B3||Female|Gender||Participants|Count of Participants|85|85.0||||||
4177982|NCT00803049|3999020|B2||Female|Gender||Participants|Count of Participants|175|175.0||||||
4177983|NCT00803049|3999021|B1||Female|Gender||Participants|Count of Participants|94|94.0||||||
4177984|NCT00803049|3999017|B5|||Age||years|Mean|38.4|38.4|Standard Deviation|8.6|8.6|||
4177985|NCT00803049|3999018|B4|||Age||years|Mean|38.6|38.6|Standard Deviation|8.4|8.4|||
4177986|NCT00803049|3999019|B3|||Age||years|Mean|37.6|37.6|Standard Deviation|8.5|8.5|||
4177987|NCT00803049|3999020|B2|||Age||years|Mean|38.0|38.0|Standard Deviation|8.8|8.8|||
4177988|NCT00803049|3999021|B1|||Age||years|Mean|39.6|39.6|Standard Deviation|8.5|8.5|||
4177989|NCT00803023|3999054|B5|United States||Region of Enrollment||participants|Number|129|129.0||||||
4177990|NCT00803023|3999055|B4|United States||Region of Enrollment||participants|Number|33|33.0||||||
4177991|NCT00803023|3999056|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4177992|NCT00803023|3999057|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4177993|NCT00803023|3999058|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4177994|NCT00803023|3999054|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4177995|NCT00803023|3999055|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177996|NCT00803023|3999056|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4177997|NCT00803023|3999057|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4177998|NCT00803023|3999058|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4177999|NCT00803023|3999054|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178000|NCT00803023|3999055|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178001|NCT00803023|3999056|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178002|NCT00803023|3999057|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178003|NCT00803023|3999058|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178004|NCT00803023|3999054|B5||White|Race (NIH/OMB)||Participants|Count of Participants|118|118.0||||||
4178005|NCT00803023|3999055|B4||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4178006|NCT00803023|3999056|B3||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4178007|NCT00803023|3999057|B2||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4178008|NCT00803023|3999058|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4178009|NCT00803023|3999054|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4178010|NCT00803023|3999055|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4178011|NCT00803023|3999056|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4178012|NCT00803023|3999057|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4178013|NCT00803023|3999058|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4178014|NCT00803023|3999054|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178015|NCT00803023|3999055|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178016|NCT00803023|3999056|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178017|NCT00803023|3999057|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178018|NCT00803023|3999058|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178019|NCT00803023|3999054|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4178020|NCT00803023|3999055|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4178021|NCT00803023|3999056|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178022|NCT00803023|3999057|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178023|NCT00803023|3999058|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4178024|NCT00803023|3999054|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4178025|NCT00803023|3999055|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4178026|NCT00803023|3999056|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178027|NCT00803023|3999057|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178028|NCT00803023|3999058|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178029|NCT00803023|3999054|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178030|NCT00803023|3999055|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178031|NCT00803023|3999056|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178032|NCT00803023|3999057|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178033|NCT00803023|3999058|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178034|NCT00803023|3999054|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|109|109.0||||||
4178035|NCT00803023|3999055|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4178036|NCT00803023|3999056|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4178037|NCT00803023|3999057|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4178038|NCT00803023|3999058|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4178039|NCT00803023|3999054|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4178040|NCT00803023|3999055|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4178041|NCT00803023|3999056|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4178042|NCT00803023|3999057|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4178043|NCT00803023|3999058|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4178044|NCT00803023|3999054|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4178045|NCT00803023|3999055|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4178046|NCT00803023|3999056|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4178047|NCT00803023|3999057|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4178048|NCT00803023|3999058|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4178049|NCT00803023|3999054|B5||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4178050|NCT00803023|3999055|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4178051|NCT00803023|3999056|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4178052|NCT00803023|3999057|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4178053|NCT00803023|3999058|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4178054|NCT00803023|3999054|B5|>=65||Age, Customized||Participants|Number|11|11.0||||||
4178055|NCT00803023|3999055|B4|>=65||Age, Customized||Participants|Number|3|3.0||||||
4178056|NCT00803023|3999056|B3|>=65||Age, Customized||Participants|Number|4|4.0||||||
4178057|NCT00803023|3999057|B2|>=65||Age, Customized||Participants|Number|2|2.0||||||
4178058|NCT00803023|3999058|B1|>=65||Age, Customized||Participants|Number|2|2.0||||||
4178059|NCT00803023|3999054|B5|50 - 64||Age, Customized||Participants|Number|62|62.0||||||
4178060|NCT00803023|3999055|B4|50 - 64||Age, Customized||Participants|Number|17|17.0||||||
4178061|NCT00803023|3999056|B3|50 - 64||Age, Customized||Participants|Number|12|12.0||||||
4178062|NCT00803023|3999057|B2|50 - 64||Age, Customized||Participants|Number|18|18.0||||||
4178063|NCT00803023|3999058|B1|50 - 64||Age, Customized||Participants|Number|15|15.0||||||
4178064|NCT00803023|3999054|B5|40 - 49||Age, Customized||Participants|Number|28|28.0||||||
4178065|NCT00803023|3999055|B4|40 - 49||Age, Customized||Participants|Number|8|8.0||||||
4178066|NCT00803023|3999056|B3|40 - 49||Age, Customized||Participants|Number|8|8.0||||||
4178067|NCT00803023|3999057|B2|40 - 49||Age, Customized||Participants|Number|6|6.0||||||
4178068|NCT00803023|3999058|B1|40 - 49||Age, Customized||Participants|Number|6|6.0||||||
4178069|NCT00803023|3999054|B5|18 - 39||Age, Customized||Participants|Number|28|28.0||||||
4178070|NCT00803023|3999055|B4|18 - 39||Age, Customized||Participants|Number|5|5.0||||||
4178071|NCT00803023|3999056|B3|18 - 39||Age, Customized||Participants|Number|7|7.0||||||
4178072|NCT00803023|3999057|B2|18 - 39||Age, Customized||Participants|Number|7|7.0||||||
4178073|NCT00803023|3999058|B1|18 - 39||Age, Customized||Participants|Number|9|9.0||||||
4178074|NCT00803023|3999054|B5|||Age||years|Mean|49.5|49.5|Standard Deviation|12.13|12.13|||
4178075|NCT00803023|3999055|B4|||Age||years|Mean|50.7|50.7|Standard Deviation|12.24|12.24|||
4178076|NCT00803023|3999056|B3|||Age||years|Mean|49.3|49.3|Standard Deviation|12.76|12.76|||
4178077|NCT00803023|3999057|B2|||Age||years|Mean|49.6|49.6|Standard Deviation|11.69|11.69|||
4178078|NCT00803023|3999058|B1|||Age||years|Mean|48.3|48.3|Standard Deviation|12.31|12.31|||
4178079|NCT00803010|3999071|B3|United States||Region of Enrollment||participants|Number|74|74.0||||||
4178080|NCT00803010|3999072|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4178081|NCT00803010|3999073|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4178082|NCT00803010|3999071|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4178083|NCT00803010|3999072|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4178084|NCT00803010|3999073|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4178085|NCT00803010|3999071|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4178086|NCT00803010|3999072|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4178087|NCT00803010|3999073|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4178088|NCT00803010|3999071|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4178089|NCT00803010|3999072|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4178090|NCT00803010|3999073|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4178091|NCT00803010|3999071|B3||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
4178092|NCT00803010|3999072|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4178093|NCT00803010|3999073|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4178094|NCT00803010|3999071|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4178095|NCT00803010|3999072|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4178096|NCT00803010|3999073|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4178097|NCT00803010|3999071|B3|||Age||years|Median|49|49.0|Full Range|||23.0|69.0|
4178098|NCT00803010|3999072|B2|||Age||years|Median|48|48.0|Full Range|||23.0|69.0|
4178099|NCT00803010|3999073|B1|||Age||years|Median|49|49.0|Full Range|||25.0|68.0|
4178100|NCT00802997|3999084|B3|||Sacroiliac Joint Pain Intensity|Scale ranges from 0 to 10. A score of 0 represents no pain and a score of 10 represents the highest level of pain.|Units on a scale|Mean|6.0|6.0|Standard Deviation|1.3|1.3|||
4178101|NCT00802997|3999085|B2|||Sacroiliac Joint Pain Intensity|Scale ranges from 0 to 10. A score of 0 represents no pain and a score of 10 represents the highest level of pain.|Units on a scale|Mean|5.8|5.8|Standard Deviation|1.3|1.3|||
4178102|NCT00802997|3999086|B1|||Sacroiliac Joint Pain Intensity|Scale ranges from 0 to 10. A score of 0 represents no pain and a score of 10 represents the highest level of pain.|Units on a scale|Mean|6.1|6.1|Standard Deviation|1.3|1.3|||
4178103|NCT00802997|3999084|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
4178104|NCT00802997|3999085|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4178105|NCT00802997|3999086|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4178106|NCT00802997|3999084|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4178107|NCT00802997|3999085|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4178108|NCT00802997|3999086|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4178109|NCT00802997|3999084|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4178110|NCT00802997|3999085|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4178111|NCT00802997|3999086|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4178112|NCT00802997|3999084|B3|||Age||years|Mean|59|59.0|Standard Deviation|15|15.0|||
4178113|NCT00802997|3999085|B2|||Age||years|Mean|64|64.0|Standard Deviation|14|14.0|||
4178114|NCT00802997|3999086|B1|||Age||years|Mean|56|56.0|Standard Deviation|15|15.0|||
4178115|NCT00802945|3999097|B3|United Kingdom||Region of Enrollment||participants|Number|27|27.0||||||
4178116|NCT00802945|3999098|B2|United Kingdom||Region of Enrollment||participants|Number|13|13.0||||||
4178117|NCT00802945|3999099|B1|United Kingdom||Region of Enrollment||participants|Number|14|14.0||||||
4178118|NCT00802945|3999097|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4178119|NCT00802945|3999098|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4178120|NCT00802945|3999099|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4178121|NCT00802945|3999097|B3|Belgium||Region of Enrollment||participants|Number|26|26.0||||||
4178122|NCT00802945|3999098|B2|Belgium||Region of Enrollment||participants|Number|12|12.0||||||
4178123|NCT00802945|3999099|B1|Belgium||Region of Enrollment||participants|Number|14|14.0||||||
4178124|NCT00802945|3999097|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4178125|NCT00802945|3999098|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4178126|NCT00802945|3999099|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4178127|NCT00802945|3999097|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4178128|NCT00802945|3999098|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4178129|NCT00802945|3999099|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4178130|NCT00802945|3999097|B3|||Age||years|Mean|54.5|54.5|Standard Deviation|0|0.0|||
4178131|NCT00802945|3999098|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|10.5|10.5|||
4178132|NCT00802945|3999099|B1|||Age||years|Mean|53.1|53.1|Standard Deviation|12.3|12.3|||
4178133|NCT00802945|3999097|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4178134|NCT00802945|3999098|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4178135|NCT00802945|3999099|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4178136|NCT00802945|3999097|B3||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4178137|NCT00802945|3999098|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4178138|NCT00802945|3999099|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4178139|NCT00802945|3999097|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4178140|NCT00802945|3999098|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4178141|NCT00802945|3999099|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4178142|NCT00802919|3999116|B3|Israel||Region of Enrollment||participants|Number|22|22.0||||||
4178143|NCT00802919|3999117|B2|Israel||Region of Enrollment||participants|Number|10|10.0||||||
4178144|NCT00802919|3999118|B1|Israel||Region of Enrollment||participants|Number|12|12.0||||||
4178145|NCT00802919|3999116|B3|China||Region of Enrollment||participants|Number|16|16.0||||||
4178146|NCT00802919|3999117|B2|China||Region of Enrollment||participants|Number|8|8.0||||||
4178147|NCT00802919|3999118|B1|China||Region of Enrollment||participants|Number|8|8.0||||||
4178148|NCT00802919|3999116|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
4178149|NCT00802919|3999117|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4178150|NCT00802919|3999118|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4178151|NCT00802919|3999116|B3|chinese han||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
4178152|NCT00802919|3999117|B2|chinese han||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4178153|NCT00802919|3999118|B1|chinese han||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4178154|NCT00802919|3999116|B3|hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4178155|NCT00802919|3999117|B2|hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4178156|NCT00802919|3999118|B1|hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4178157|NCT00802919|3999116|B3|black-AA||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
4178158|NCT00802919|3999117|B2|black-AA||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4178159|NCT00802919|3999118|B1|black-AA||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
4178160|NCT00802919|3999116|B3|white||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
4178161|NCT00802919|3999117|B2|white||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4178162|NCT00802919|3999118|B1|white||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4178163|NCT00802919|3999116|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4178164|NCT00802919|3999117|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4178165|NCT00802919|3999118|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4178166|NCT00802919|3999116|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4178167|NCT00802919|3999117|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4178168|NCT00802919|3999118|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4178169|NCT00802919|3999116|B3|||Age||years|Mean|44.7|44.7|Standard Deviation|9.9|9.9|||
4178170|NCT00802919|3999117|B2|||Age||years|Mean|43.6|43.6|Standard Deviation|10.6|10.6|||
4178171|NCT00802919|3999118|B1|||Age||years|Mean|46.6|46.6|Standard Deviation|8.9|8.9|||
4178172|NCT00802893|3999131|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4178173|NCT00802893|3999131|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4178174|NCT00802893|3999131|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4178175|NCT00802893|3999131|B1|>=40, years||Age, Customized||Participants|Count of Participants|3|3.0||||||
4178176|NCT00802880|3999136|B1|United States||Region of Enrollment||participants|Number|80|80.0||||||
4178177|NCT00802880|3999136|B1||Male|Gender||Participants|Count of Participants|40|40.0||||||
4178178|NCT00802880|3999136|B1||Female|Gender||Participants|Count of Participants|40|40.0||||||
4178179|NCT00802880|3999136|B1|||Age||years|Median|53|53.0|Full Range|||20.0|82.0|
4178180|NCT00802867|3999155|B1|United States||Region of Enrollment||participants|Number|989|989.0||||||
4178181|NCT00802867|3999155|B1||Male|Sex: Female, Male||Participants|Count of Participants|475|475.0||||||
4178182|NCT00802867|3999155|B1||Female|Sex: Female, Male||Participants|Count of Participants|514|514.0||||||
4178183|NCT00802867|3999155|B1|||Age||Years|Mean|4.2|4.2|Standard Deviation|0.15|0.15|||
4178184|NCT00802867|3999155|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4178185|NCT00802867|3999155|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4178186|NCT00802867|3999155|B1||<=18 years|Age||Participants|Count of Participants|989|989.0||||||
4178187|NCT00802854|3999163|B1||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4178188|NCT00802854|3999163|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4178189|NCT00802854|3999163|B1||Greater than or equal to (>=) 65 years|Age, Customized||Participants|Count of Participants|109|109.0||||||
4178190|NCT00802854|3999163|B1||50-64 years|Age, Customized||Participants|Count of Participants|84|84.0||||||
4178191|NCT00802854|3999163|B1||40-49 years|Age, Customized||Participants|Count of Participants|26|26.0||||||
4178192|NCT00802854|3999163|B1||30-39 years|Age, Customized||Participants|Count of Participants|19|19.0||||||
4178193|NCT00802854|3999163|B1||Less than (<) 30 years|Age, Customized||Participants|Count of Participants|6|6.0||||||
4178194|NCT00802841|3999176|B3||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4178195|NCT00802841|3999177|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4178196|NCT00802841|3999178|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4178197|NCT00802841|3999176|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4178198|NCT00802841|3999177|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4178199|NCT00802841|3999178|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4178200|NCT00802841|3999176|B3|||Age||Years|Mean|44.4|44.4|Standard Deviation|14.75|14.75|||
4178201|NCT00802841|3999177|B2|||Age||Years|Mean|44.2|44.2|Standard Deviation|15.02|15.02|||
4178202|NCT00802841|3999178|B1|||Age||Years|Mean|44.6|44.6|Standard Deviation|14.47|14.47|||
4178203|NCT00802737|3999201|B4|White||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4178204|NCT00802737|3999202|B3|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4178205|NCT00802737|3999203|B2|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4178206|NCT00802737|3999204|B1|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4178207|NCT00802737|3999201|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4178208|NCT00802737|3999202|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4178209|NCT00802737|3999203|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4178210|NCT00802737|3999204|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4178211|NCT00802737|3999201|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4178212|NCT00802737|3999202|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4178213|NCT00802737|3999203|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4178214|NCT00802737|3999204|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4178215|NCT00802737|3999201|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4178216|NCT00802737|3999202|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4178217|NCT00802737|3999203|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4178218|NCT00802737|3999204|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4178219|NCT00802737|3999201|B4|||Age||Years|Mean|66.3|66.3|Standard Deviation|7.85|7.85|||
4178220|NCT00802737|3999202|B3|||Age||Years|Mean|84.0|84.0|Standard Deviation|NA||||A standard deviation of the mean was not calculated for one participant.
4178221|NCT00802737|3999203|B2|||Age||Years|Mean|66.9|66.9|Standard Deviation|9.08|9.08|||
4178222|NCT00802737|3999204|B1|||Age||Years|Mean|64.8|64.8|Standard Deviation|5.83|5.83|||
4178223|NCT00802685|3999252|B3|United States||Region of Enrollment||participants|Number|105|105.0||||||
4178224|NCT00802685|3999253|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
4178225|NCT00802685|3999254|B1|United States||Region of Enrollment||participants|Number|54|54.0||||||
4178226|NCT00802685|3999252|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4178227|NCT00802685|3999253|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4178228|NCT00802685|3999254|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4178229|NCT00802685|3999252|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4178230|NCT00802685|3999253|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4178231|NCT00802685|3999254|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4178232|NCT00802685|3999252|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4178233|NCT00802685|3999253|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4178234|NCT00802685|3999254|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4178235|NCT00802685|3999252|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4178236|NCT00802685|3999253|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4178237|NCT00802685|3999254|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4178238|NCT00802685|3999252|B3||<=18 years|Age||Participants|Count of Participants|105|105.0||||||
4178239|NCT00802685|3999253|B2||<=18 years|Age||Participants|Count of Participants|51|51.0||||||
4178240|NCT00802685|3999254|B1||<=18 years|Age||Participants|Count of Participants|54|54.0||||||
4178241|NCT00802672|3999263|B4|United States||Region of Enrollment||participants|Number|561|561.0||||||
4178242|NCT00802672|3999264|B3|United States||Region of Enrollment||participants|Number|111|111.0||||||
4178243|NCT00802672|3999265|B2|United States||Region of Enrollment||participants|Number|226|226.0||||||
4178244|NCT00802672|3999266|B1|United States||Region of Enrollment||participants|Number|224|224.0||||||
4178245|NCT00802672|3999263|B4||Male|Sex: Female, Male||Participants|Count of Participants|417|417.0||||||
4178246|NCT00802672|3999264|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4178247|NCT00802672|3999265|B2||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4178248|NCT00802672|3999266|B1||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4178249|NCT00802672|3999263|B4||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4178250|NCT00802672|3999264|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4178251|NCT00802672|3999265|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4178252|NCT00802672|3999266|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4178253|NCT00802672|3999263|B4|||Age||years|Mean|43.5|43.5|Standard Deviation|15.4|15.4|||
4178254|NCT00802672|3999264|B3|||Age||years|Mean|43.1|43.1|Standard Deviation|15.1|15.1|||
4178255|NCT00802672|3999265|B2|||Age||years|Mean|42.3|42.3|Standard Deviation|15.6|15.6|||
4178256|NCT00802672|3999266|B1|||Age||years|Mean|45.2|45.2|Standard Deviation|15.6|15.6|||
4178257|NCT00802672|3999263|B4||>=65 years|Age||Participants|Count of Participants|53|53.0||||||
4178258|NCT00802672|3999264|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4178259|NCT00802672|3999265|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4178260|NCT00802672|3999266|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4178261|NCT00802672|3999263|B4||Between 18 and 65 years|Age||Participants|Count of Participants|475|475.0||||||
4178262|NCT00802672|3999264|B3||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
4178263|NCT00802672|3999265|B2||Between 18 and 65 years|Age||Participants|Count of Participants|189|189.0||||||
4178264|NCT00802672|3999266|B1||Between 18 and 65 years|Age||Participants|Count of Participants|194|194.0||||||
4178265|NCT00802672|3999263|B4||<=18 years|Age||Participants|Count of Participants|33|33.0||||||
4178266|NCT00802672|3999264|B3||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4178267|NCT00802672|3999265|B2||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4178268|NCT00802672|3999266|B1||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4178269|NCT00802659|3999282|B5|United States||Region of Enrollment||participants|Number|1|1.0||||||
4178270|NCT00802659|3999285|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4178271|NCT00802659|3999282|B5|Male||Gender||participants|Number|0|0.0||||||
4178272|NCT00802659|3999285|B2|Male||Gender||participants|Number|0|0.0||||||
4178273|NCT00802659|3999282|B5|Female||Gender||participants|Number|1|1.0||||||
4178274|NCT00802659|3999285|B2|Female||Gender||participants|Number|1|1.0||||||
4178275|NCT00802659|3999282|B5|>=65 years||Age||participants|Number|0|0.0||||||
4178276|NCT00802659|3999285|B2|>=65 years||Age||participants|Number|0|0.0||||||
4178277|NCT00802659|3999282|B5|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
4178278|NCT00802659|3999285|B2|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
4178279|NCT00802659|3999282|B5|<=18 years||Age||participants|Number|0|0.0||||||
4178280|NCT00802659|3999285|B2|<=18 years||Age||participants|Number|0|0.0||||||
4178281|NCT00802633|3999315|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
4178282|NCT00802633|3999316|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4178283|NCT00802633|3999317|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4178284|NCT00802633|3999315|B3||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4178285|NCT00802633|3999316|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4178286|NCT00802633|3999317|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4178287|NCT00802633|3999315|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4178288|NCT00802633|3999316|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4178289|NCT00802633|3999317|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4178290|NCT00802633|3999315|B3|||Age||years|Mean|67.15|67.15|Standard Deviation|8.75|8.75|||
4178291|NCT00802633|3999316|B2|||Age||years|Mean|68.5|68.5|Standard Deviation|7.9|7.9|||
4178292|NCT00802633|3999317|B1|||Age||years|Mean|65.8|65.8|Standard Deviation|9.6|9.6|||
4178293|NCT00802529|3999326|B3|United Kingdom||Region of Enrollment||participants|Number|60|60.0||||||
4178294|NCT00802529|3999327|B2|United Kingdom||Region of Enrollment||participants|Number|30|30.0||||||
4178295|NCT00802529|3999328|B1|United Kingdom||Region of Enrollment||participants|Number|30|30.0||||||
4178296|NCT00802529|3999326|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4178297|NCT00802529|3999327|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4178298|NCT00802529|3999328|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4178299|NCT00802529|3999326|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4178300|NCT00802529|3999327|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4178301|NCT00802529|3999328|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4178302|NCT00802529|3999326|B3|||Age||Years|Mean|52.5|52.5|Standard Deviation|10.5|10.5|||
4178303|NCT00802529|3999327|B2|||Age||Years|Mean|53.3|53.3|Standard Deviation|10.8|10.8|||
4178304|NCT00802529|3999328|B1|||Age||Years|Mean|51.6|51.6|Standard Deviation|10.2|10.2|||
4178305|NCT00802529|3999326|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4178306|NCT00802529|3999327|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4178307|NCT00802529|3999328|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4178308|NCT00802529|3999326|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4178309|NCT00802529|3999327|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4178310|NCT00802529|3999328|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4178311|NCT00802529|3999326|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4178312|NCT00802529|3999327|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4178313|NCT00802529|3999328|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4178314|NCT00802503|3999339|B3|Switzerland||Region of Enrollment||participants|Number|305|305.0||||||
4178315|NCT00802503|3999340|B2|Switzerland||Region of Enrollment||participants|Number|153|153.0||||||
4178316|NCT00802503|3999341|B1|Switzerland||Region of Enrollment||participants|Number|152|152.0||||||
4178317|NCT00802503|3999339|B3||Male|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
4178318|NCT00802503|3999340|B2||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4178319|NCT00802503|3999341|B1||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4178320|NCT00802503|3999339|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4178321|NCT00802503|3999340|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4178322|NCT00802503|3999341|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4178323|NCT00802503|3999339|B3|||Age||years|Mean|60|60.0|Standard Deviation|17|17.0|||
4178324|NCT00802503|3999340|B2|||Age||years|Mean|61|61.0|Standard Deviation|16|16.0|||
4178325|NCT00802503|3999341|B1|||Age||years|Mean|60|60.0|Standard Deviation|16|16.0|||
4178326|NCT00802503|3999339|B3||>=65 years|Age||Participants|Count of Participants|131|131.0||||||
4178327|NCT00802503|3999340|B2||>=65 years|Age||Participants|Count of Participants|70|70.0||||||
4178328|NCT00802503|3999341|B1||>=65 years|Age||Participants|Count of Participants|61|61.0||||||
4178329|NCT00802503|3999339|B3||Between 18 and 65 years|Age||Participants|Count of Participants|174|174.0||||||
4178330|NCT00802503|3999340|B2||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
4178331|NCT00802503|3999341|B1||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
4178332|NCT00802503|3999339|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4178333|NCT00802503|3999340|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4178334|NCT00802503|3999341|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4178335|NCT00802464|3999364|B5|Race/Ethnicity|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|396|396.0||||||
4178336|NCT00802464|3999365|B4|Race/Ethnicity|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|141|141.0||||||
4178337|NCT00802464|3999366|B3|Race/Ethnicity|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|145|145.0||||||
4178449|NCT00802360|3999473|B5||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4178338|NCT00802464|3999367|B2|Race/Ethnicity|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|72|72.0||||||
4178339|NCT00802464|3999368|B1|Race/Ethnicity|White - Caucasian / European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
4178340|NCT00802464|3999364|B5|Race/Ethnicity|White - Arabic / North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4178341|NCT00802464|3999365|B4|Race/Ethnicity|White - Arabic / North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4178342|NCT00802464|3999366|B3|Race/Ethnicity|White - Arabic / North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4178343|NCT00802464|3999367|B2|Race/Ethnicity|White - Arabic / North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4178344|NCT00802464|3999368|B1|Race/Ethnicity|White - Arabic / North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4178345|NCT00802464|3999364|B5|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4178346|NCT00802464|3999365|B4|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4178347|NCT00802464|3999366|B3|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4178348|NCT00802464|3999367|B2|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4178349|NCT00802464|3999368|B1|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4178350|NCT00802464|3999364|B5|Race/Ethnicity|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4178351|NCT00802464|3999365|B4|Race/Ethnicity|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4178352|NCT00802464|3999366|B3|Race/Ethnicity|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4178353|NCT00802464|3999367|B2|Race/Ethnicity|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4178354|NCT00802464|3999368|B1|Race/Ethnicity|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4178355|NCT00802464|3999364|B5|Race/Ethnicity|African Heritage / African American|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4178356|NCT00802464|3999365|B4|Race/Ethnicity|African Heritage / African American|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4178357|NCT00802464|3999366|B3|Race/Ethnicity|African Heritage / African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4178358|NCT00802464|3999367|B2|Race/Ethnicity|African Heritage / African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4178359|NCT00802464|3999368|B1|Race/Ethnicity|African Heritage / African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4178360|NCT00802464|3999364|B5||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4178361|NCT00802464|3999365|B4||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4178362|NCT00802464|3999366|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4178363|NCT00802464|3999367|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4178364|NCT00802464|3999368|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4178365|NCT00802464|3999364|B5||Female|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
4178366|NCT00802464|3999365|B4||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4178367|NCT00802464|3999366|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4178368|NCT00802464|3999367|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4178369|NCT00802464|3999368|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4178370|NCT00802464|3999364|B5|||Age||Years|Mean|65.0|65.0|Standard Deviation|9.2|9.2|||
4178371|NCT00802464|3999365|B4|||Age||Years|Mean|65.0|65.0|Standard Deviation|8.9|8.9|||
4178372|NCT00802464|3999366|B3|||Age||Years|Mean|65.1|65.1|Standard Deviation|9.9|9.9|||
4178373|NCT00802464|3999367|B2|||Age||Years|Mean|65.1|65.1|Standard Deviation|8.7|8.7|||
4178374|NCT00802464|3999368|B1|||Age||Years|Mean|65.0|65.0|Standard Deviation|9.0|9.0|||
4178375|NCT00802438|3999457|B1|United States||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
4178376|NCT00802438|3999457|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178377|NCT00802438|3999457|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178378|NCT00802438|3999457|B1||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4178379|NCT00802438|3999457|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4178380|NCT00802438|3999457|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178381|NCT00802438|3999457|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4178382|NCT00802438|3999457|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178383|NCT00802438|3999457|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178384|NCT00802438|3999457|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4178385|NCT00802438|3999457|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4178386|NCT00802438|3999457|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4178387|NCT00802438|3999457|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4178388|NCT00802438|3999457|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4178389|NCT00802438|3999457|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4178390|NCT00802438|3999457|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4178391|NCT00802412|3999462|B3|||Fagerstrom|Scores on the Fagerstrom Test for Nicotine Dependence range from 0 to 10, with higher scores indicating greater nicotine dependence.|units on a scale|Mean|5.8|5.8|Standard Deviation|1.7|1.7|||
4178392|NCT00802412|3999463|B2|||Fagerstrom|Scores on the Fagerstrom Test for Nicotine Dependence range from 0 to 10, with higher scores indicating greater nicotine dependence.|units on a scale|Mean|6.1|6.1|Standard Deviation|1.6|1.6|||
4178393|NCT00802412|3999464|B1|||Fagerstrom|Scores on the Fagerstrom Test for Nicotine Dependence range from 0 to 10, with higher scores indicating greater nicotine dependence.|units on a scale|Mean|5.4|5.4|Standard Deviation|2.0|2.0|||
4178394|NCT00802412|3999462|B3|United States||Region of Enrollment||participants|Number|129|129.0||||||
4178395|NCT00802412|3999463|B2|United States||Region of Enrollment||participants|Number|66|66.0||||||
4178396|NCT00802412|3999464|B1|United States||Region of Enrollment||participants|Number|63|63.0||||||
4178397|NCT00802412|3999462|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
4178398|NCT00802412|3999463|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4178399|NCT00802412|3999464|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4178400|NCT00802412|3999462|B3||Male|Gender||Participants|Count of Participants|129|129.0||||||
4178401|NCT00802412|3999463|B2||Male|Gender||Participants|Count of Participants|66|66.0||||||
4178402|NCT00802412|3999464|B1||Male|Gender||Participants|Count of Participants|63|63.0||||||
4178403|NCT00802412|3999462|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
4178404|NCT00802412|3999463|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
4178405|NCT00802412|3999464|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
4178406|NCT00802412|3999462|B3|||Age||years|Mean|47.0|47.0|Standard Deviation|9.4|9.4|||
4178407|NCT00802412|3999463|B2|||Age||years|Mean|46.9|46.9|Standard Deviation|9.8|9.8|||
4178408|NCT00802412|3999464|B1|||Age||years|Mean|47.2|47.2|Standard Deviation|9.0|9.0|||
4178409|NCT00802360|3999473|B5|||Follicle-stimulating hormone level||mIU/mL|Mean|7.3|7.3|Standard Deviation|2.3|2.3|||
4178410|NCT00802360|3999474|B4|||Follicle-stimulating hormone level||mIU/mL|Mean|6.9|6.9|Standard Deviation|2.9|2.9|||
4178411|NCT00802360|3999475|B3|||Follicle-stimulating hormone level||mIU/mL|Mean|6.9|6.9|Standard Deviation|2.0|2.0|||
4178412|NCT00802360|3999476|B2|||Follicle-stimulating hormone level||mIU/mL|Mean|7.1|7.1|Standard Deviation|2.2|2.2|||
4178413|NCT00802360|3999477|B1|||Follicle-stimulating hormone level||mIU/mL|Mean|7.4|7.4|Standard Deviation|2.3|2.3|||
4178414|NCT00802360|3999473|B5|||Body Mass Index (BMI)||kg/m^2|Mean|24.6|24.6|Standard Deviation|3.8|3.8|||
4178415|NCT00802360|3999474|B4|||Body Mass Index (BMI)||kg/m^2|Mean|25.6|25.6|Standard Deviation|4.5|4.5|||
4178416|NCT00802360|3999475|B3|||Body Mass Index (BMI)||kg/m^2|Mean|25.0|25.0|Standard Deviation|3.3|3.3|||
4178417|NCT00802360|3999476|B2|||Body Mass Index (BMI)||kg/m^2|Mean|23.8|23.8|Standard Deviation|3.0|3.0|||
4178418|NCT00802360|3999477|B1|||Body Mass Index (BMI)||kg/m^2|Mean|24.6|24.6|Standard Deviation|4.1|4.1|||
4178419|NCT00802360|3999473|B5|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4178420|NCT00802360|3999474|B4|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4178421|NCT00802360|3999475|B3|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4178422|NCT00802360|3999476|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4178423|NCT00802360|3999477|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4178424|NCT00802360|3999473|B5|Hispanic||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4178425|NCT00802360|3999474|B4|Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4178426|NCT00802360|3999475|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4178427|NCT00802360|3999476|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4178428|NCT00802360|3999477|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4178429|NCT00802360|3999473|B5|Asian||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4178430|NCT00802360|3999474|B4|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4178431|NCT00802360|3999475|B3|Asian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4178432|NCT00802360|3999476|B2|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4178433|NCT00802360|3999477|B1|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4178434|NCT00802360|3999473|B5|African American||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4178435|NCT00802360|3999474|B4|African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4178436|NCT00802360|3999475|B3|African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4178437|NCT00802360|3999476|B2|African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4178438|NCT00802360|3999477|B1|African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4178439|NCT00802360|3999473|B5|Caucasian||Race/Ethnicity, Customized||Participants|Number|130|130.0||||||
4178440|NCT00802360|3999474|B4|Caucasian||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
4178441|NCT00802360|3999475|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|31|31.0||||||
4178442|NCT00802360|3999476|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
4178443|NCT00802360|3999477|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
4178444|NCT00802360|3999473|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4178445|NCT00802360|3999474|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4178446|NCT00802360|3999475|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4178447|NCT00802360|3999476|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4178448|NCT00802360|3999477|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4178450|NCT00802360|3999474|B4||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4178451|NCT00802360|3999475|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4178452|NCT00802360|3999476|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4178453|NCT00802360|3999477|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4178454|NCT00802360|3999473|B5|||Age||years|Mean|33.9|33.9|Standard Deviation|7.4|7.4|||
4178455|NCT00802360|3999474|B4|||Age||years|Mean|33.9|33.9|Standard Deviation|4.3|4.3|||
4178456|NCT00802360|3999475|B3|||Age||years|Mean|34.0|34.0|Standard Deviation|4.3|4.3|||
4178457|NCT00802360|3999476|B2|||Age||years|Mean|33.2|33.2|Standard Deviation|4.8|4.8|||
4178458|NCT00802360|3999477|B1|||Age||years|Mean|33.5|33.5|Standard Deviation|4.1|4.1|||
4178459|NCT00802204|3999520|B3|||Acyl Ghrelin||pg/ml|Mean|132|132.0|Standard Deviation|106|106.0|||
4178460|NCT00802204|3999521|B2|||Acyl Ghrelin||pg/ml|Mean|78|78.0|Standard Deviation|55|55.0|||
4178461|NCT00802204|3999522|B1|||Acyl Ghrelin||pg/ml|Mean|235|235.0|Standard Deviation|104|104.0|||
4178462|NCT00802204|3999520|B3|||Leptin||ng/ml|Mean|34|34.0|Standard Deviation|18|18.0|||
4178463|NCT00802204|3999521|B2|||Leptin||ng/ml|Mean|43|43.0|Standard Deviation|12|12.0|||
4178464|NCT00802204|3999522|B1|||Leptin||ng/ml|Mean|13|13.0|Standard Deviation|5|5.0|||
4178465|NCT00802204|3999520|B3|||Glucose||mg/dl|Mean|86|86.0|Standard Deviation|8|8.0|||
4178466|NCT00802204|3999521|B2|||Glucose||mg/dl|Mean|87|87.0|Standard Deviation|9|9.0|||
4178467|NCT00802204|3999522|B1|||Glucose||mg/dl|Mean|82|82.0|Standard Deviation|6|6.0|||
4178468|NCT00802204|3999520|B3|||Insulin||(µU/ml)|Mean|14|14.0|Standard Deviation|10|10.0|||
4178469|NCT00802204|3999521|B2|||Insulin||(µU/ml)|Mean|18|18.0|Standard Deviation|9|9.0|||
4178470|NCT00802204|3999522|B1|||Insulin||(µU/ml)|Mean|6|6.0|Standard Deviation|2|2.0|||
4178471|NCT00802204|3999520|B3|||OGTT_SI (Insulin Sensitivity from OGTT)|Insulin Sensitivity from Oral Glucose Tolerance Test was estimated using the oral minimal model method|(10-4min-1/µU*mL)|Mean|6|6.0|Standard Deviation|5|5.0|||
4178472|NCT00802204|3999521|B2|||OGTT_SI (Insulin Sensitivity from OGTT)|Insulin Sensitivity from Oral Glucose Tolerance Test was estimated using the oral minimal model method|(10-4min-1/µU*mL)|Mean|3.98|3.98|Standard Deviation|2.7|2.7|||
4178473|NCT00802204|3999522|B1|||OGTT_SI (Insulin Sensitivity from OGTT)|Insulin Sensitivity from Oral Glucose Tolerance Test was estimated using the oral minimal model method|(10-4min-1/µU*mL)|Mean|11.2|11.2|Standard Deviation|4.1|4.1|||
4178474|NCT00802204|3999520|B3|||Beck Depression Inventory II(BDI-II)|0-63 with higher scores indicating increased depressive symptoms. Scores above 20 indicate moderate depressive symptoms.|scores on a scale|Mean|6|6.0|Standard Deviation|6|6.0|||
4178475|NCT00802204|3999521|B2|||Beck Depression Inventory II(BDI-II)|0-63 with higher scores indicating increased depressive symptoms. Scores above 20 indicate moderate depressive symptoms.|scores on a scale|Mean|7|7.0|Standard Deviation|6|6.0|||
4178476|NCT00802204|3999522|B1|||Beck Depression Inventory II(BDI-II)|0-63 with higher scores indicating increased depressive symptoms. Scores above 20 indicate moderate depressive symptoms.|scores on a scale|Mean|3|3.0|Standard Deviation|5|5.0|||
4178477|NCT00802204|3999520|B3|||BMI||kg/m2|Mean|33|33.0|Standard Deviation|9|9.0|||
4178478|NCT00802204|3999521|B2|||BMI||kg/m2|Mean|39|39.0|Standard Deviation|6|6.0|||
4178479|NCT00802204|3999522|B1|||BMI||kg/m2|Mean|23|23.0|Standard Deviation|2|2.0|||
4178480|NCT00802204|3999520|B3|||Weight||kg|Mean|91|91.0|Standard Deviation|26|26.0|||
4178481|NCT00802204|3999521|B2|||Weight||kg|Mean|104|104.0|Standard Deviation|17|17.0|||
4178482|NCT00802204|3999522|B1|||Weight||kg|Mean|60|60.0|Standard Deviation|7|7.0|||
4178483|NCT00802204|3999520|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4178484|NCT00802204|3999521|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4178485|NCT00802204|3999522|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4178486|NCT00802204|3999520|B3|Caucasian Participants||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4178487|NCT00802204|3999521|B2|Caucasian Participants||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4178488|NCT00802204|3999522|B1|Caucasian Participants||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4178489|NCT00802204|3999520|B3|African American Participants||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4178490|NCT00802204|3999521|B2|African American Participants||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4178491|NCT00802204|3999522|B1|African American Participants||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4178492|NCT00802204|3999520|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4178493|NCT00802204|3999521|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4178494|NCT00802204|3999522|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4178495|NCT00802204|3999520|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4178496|NCT00802204|3999521|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4178497|NCT00802204|3999522|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4178498|NCT00802204|3999520|B3|||Age||years|Mean|39|39.0|Standard Deviation|8|8.0|||
4178499|NCT00802204|3999521|B2|||Age||years|Mean|39|39.0|Standard Deviation|8|8.0|||
4178500|NCT00802204|3999522|B1|||Age||years|Mean|41|41.0|Standard Deviation|9|9.0|||
4178501|NCT00802178|3999547|B1|missing||Sex/Gender, Customized||participants|Number|29|29.0||||||
4178502|NCT00802178|3999547|B1|Male||Sex/Gender, Customized||participants|Number|1274|1274.0||||||
4178503|NCT00802178|3999547|B1|Female||Sex/Gender, Customized||participants|Number|1145|1145.0||||||
4178504|NCT00802178|3999547|B1|||Age||years|Mean|67.23|67.23|Full Range|||31.0|97.0|
4178505|NCT00802100|3999554|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4178506|NCT00802100|3999555|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4178507|NCT00802100|3999556|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4178508|NCT00802100|3999557|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4178509|NCT00802100|3999554|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4178510|NCT00802100|3999555|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4178511|NCT00802100|3999556|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4178512|NCT00802100|3999557|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4178513|NCT00802100|3999554|B4|||Age||years|Mean|29|29.0|Standard Deviation|8.2|8.2|||
4178514|NCT00802100|3999555|B3|||Age||years|Mean|27|27.0|Standard Deviation|7.9|7.9|||
4178515|NCT00802100|3999556|B2|||Age||years|Mean|30|30.0|Standard Deviation|8.1|8.1|||
4178516|NCT00802100|3999557|B1|||Age||years|Mean|30|30.0|Standard Deviation|9.7|9.7|||
4178517|NCT00802074|3999568|B7|United States||Region of Enrollment||participants|Number|41|41.0||||||
4178518|NCT00802074|3999569|B6|United States||Region of Enrollment||participants|Number|7|7.0||||||
4178519|NCT00802074|3999570|B5|United States||Region of Enrollment||participants|Number|7|7.0||||||
4178520|NCT00802074|3999571|B4|United States||Region of Enrollment||participants|Number|7|7.0||||||
4178521|NCT00802074|3999572|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4178522|NCT00802074|3999573|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4178523|NCT00802074|3999574|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4178524|NCT00802074|3999568|B7||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4178525|NCT00802074|3999569|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4178526|NCT00802074|3999570|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4178527|NCT00802074|3999571|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4178528|NCT00802074|3999572|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4178529|NCT00802074|3999573|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4178530|NCT00802074|3999574|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4178531|NCT00802074|3999568|B7||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4178532|NCT00802074|3999569|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4178533|NCT00802074|3999570|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4178534|NCT00802074|3999571|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4178535|NCT00802074|3999572|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4178536|NCT00802074|3999573|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4178537|NCT00802074|3999574|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4178538|NCT00802074|3999568|B7|50 and older||Age, Customized||participants|Number|3|3.0||||||
4178539|NCT00802074|3999569|B6|50 and older||Age, Customized||participants|Number|1|1.0||||||
4178540|NCT00802074|3999570|B5|50 and older||Age, Customized||participants|Number|0|0.0||||||
4178541|NCT00802074|3999571|B4|50 and older||Age, Customized||participants|Number|1|1.0||||||
4178542|NCT00802074|3999572|B3|50 and older||Age, Customized||participants|Number|0|0.0||||||
4178543|NCT00802074|3999573|B2|50 and older||Age, Customized||participants|Number|1|1.0||||||
4178544|NCT00802074|3999574|B1|50 and older||Age, Customized||participants|Number|0|0.0||||||
4178545|NCT00802074|3999568|B7|42-49||Age, Customized||participants|Number|2|2.0||||||
4178546|NCT00802074|3999569|B6|42-49||Age, Customized||participants|Number|0|0.0||||||
4178547|NCT00802074|3999570|B5|42-49||Age, Customized||participants|Number|0|0.0||||||
4178548|NCT00802074|3999571|B4|42-49||Age, Customized||participants|Number|1|1.0||||||
4178549|NCT00802074|3999572|B3|42-49||Age, Customized||participants|Number|0|0.0||||||
4178550|NCT00802074|3999573|B2|42-49||Age, Customized||participants|Number|0|0.0||||||
4178551|NCT00802074|3999574|B1|42-49||Age, Customized||participants|Number|1|1.0||||||
4178552|NCT00802074|3999568|B7|34-41||Age, Customized||participants|Number|4|4.0||||||
4178553|NCT00802074|3999569|B6|34-41||Age, Customized||participants|Number|0|0.0||||||
4178554|NCT00802074|3999570|B5|34-41||Age, Customized||participants|Number|0|0.0||||||
4178555|NCT00802074|3999571|B4|34-41||Age, Customized||participants|Number|1|1.0||||||
4178556|NCT00802074|3999572|B3|34-41||Age, Customized||participants|Number|1|1.0||||||
4178557|NCT00802074|3999573|B2|34-41||Age, Customized||participants|Number|2|2.0||||||
4178558|NCT00802074|3999574|B1|34-41||Age, Customized||participants|Number|0|0.0||||||
4178559|NCT00802074|3999568|B7|26-33||Age, Customized||participants|Number|12|12.0||||||
4178560|NCT00802074|3999569|B6|26-33||Age, Customized||participants|Number|3|3.0||||||
4178561|NCT00802074|3999570|B5|26-33||Age, Customized||participants|Number|4|4.0||||||
4178562|NCT00802074|3999571|B4|26-33||Age, Customized||participants|Number|1|1.0||||||
4178563|NCT00802074|3999572|B3|26-33||Age, Customized||participants|Number|2|2.0||||||
4178564|NCT00802074|3999573|B2|26-33||Age, Customized||participants|Number|0|0.0||||||
4178565|NCT00802074|3999574|B1|26-33||Age, Customized||participants|Number|2|2.0||||||
4178566|NCT00802074|3999568|B7|18-25||Age, Customized||participants|Number|20|20.0||||||
4178567|NCT00802074|3999569|B6|18-25||Age, Customized||participants|Number|3|3.0||||||
4178568|NCT00802074|3999570|B5|18-25||Age, Customized||participants|Number|3|3.0||||||
4178569|NCT00802074|3999571|B4|18-25||Age, Customized||participants|Number|3|3.0||||||
4178570|NCT00802074|3999572|B3|18-25||Age, Customized||participants|Number|3|3.0||||||
4178571|NCT00802074|3999573|B2|18-25||Age, Customized||participants|Number|4|4.0||||||
4178572|NCT00802074|3999574|B1|18-25||Age, Customized||participants|Number|4|4.0||||||
4178573|NCT00801983|3999611|B3|Left Arm hand (Yes)||Baseline Discomfort||participants|Number|46|46.0||||||
4178574|NCT00801983|3999612|B2|Left Arm hand (Yes)||Baseline Discomfort||participants|Number|24|24.0||||||
4178575|NCT00801983|3999613|B1|Left Arm hand (Yes)||Baseline Discomfort||participants|Number|22|22.0||||||
4178576|NCT00801983|3999611|B3|Right arm hand (Yes)||Baseline Discomfort||participants|Number|69|69.0||||||
4178577|NCT00801983|3999612|B2|Right arm hand (Yes)||Baseline Discomfort||participants|Number|36|36.0||||||
4178578|NCT00801983|3999613|B1|Right arm hand (Yes)||Baseline Discomfort||participants|Number|33|33.0||||||
4178579|NCT00801983|3999611|B3|Back (Yes)||Baseline Discomfort||participants|Number|66|66.0||||||
4178580|NCT00801983|3999612|B2|Back (Yes)||Baseline Discomfort||participants|Number|33|33.0||||||
4178581|NCT00801983|3999613|B1|Back (Yes)||Baseline Discomfort||participants|Number|33|33.0||||||
4178582|NCT00801983|3999611|B3|Neck (Yes)||Baseline Discomfort||participants|Number|72|72.0||||||
4178583|NCT00801983|3999612|B2|Neck (Yes)||Baseline Discomfort||participants|Number|36|36.0||||||
4178584|NCT00801983|3999613|B1|Neck (Yes)||Baseline Discomfort||participants|Number|36|36.0||||||
4178585|NCT00801983|3999611|B3|Don't know||Typing Speed||participants|Number|14|14.0||||||
4178586|NCT00801983|3999612|B2|Don't know||Typing Speed||participants|Number|8|8.0||||||
4178587|NCT00801983|3999613|B1|Don't know||Typing Speed||participants|Number|6|6.0||||||
4178588|NCT00801983|3999611|B3|Fast||Typing Speed||participants|Number|23|23.0||||||
4178589|NCT00801983|3999612|B2|Fast||Typing Speed||participants|Number|12|12.0||||||
4178590|NCT00801983|3999613|B1|Fast||Typing Speed||participants|Number|11|11.0||||||
4178591|NCT00801983|3999611|B3|Moderately Fast||Typing Speed||participants|Number|30|30.0||||||
4178592|NCT00801983|3999612|B2|Moderately Fast||Typing Speed||participants|Number|14|14.0||||||
4178593|NCT00801983|3999613|B1|Moderately Fast||Typing Speed||participants|Number|16|16.0||||||
4178594|NCT00801983|3999611|B3|Slow||Typing Speed||participants|Number|10|10.0||||||
4178595|NCT00801983|3999612|B2|Slow||Typing Speed||participants|Number|3|3.0||||||
4178596|NCT00801983|3999613|B1|Slow||Typing Speed||participants|Number|7|7.0||||||
4178597|NCT00801983|3999611|B3|||Avg Computer Use||hrs/day|Mean|6.2|6.2|Standard Deviation|1.3|1.3|||
4178598|NCT00801983|3999612|B2|||Avg Computer Use||hrs/day|Mean|6.1|6.1|Standard Deviation|1.5|1.5|||
4178599|NCT00801983|3999613|B1|||Avg Computer Use||hrs/day|Mean|6.3|6.3|Standard Deviation|1.1|1.1|||
4178600|NCT00801983|3999611|B3|United States||Region of Enrollment||participants|Number|77|77.0||||||
4178601|NCT00801983|3999612|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4178602|NCT00801983|3999613|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4178603|NCT00801983|3999611|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178604|NCT00801983|3999612|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178605|NCT00801983|3999613|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178606|NCT00801983|3999611|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
4178607|NCT00801983|3999612|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4178608|NCT00801983|3999613|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4178609|NCT00801983|3999611|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4178610|NCT00801983|3999612|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178611|NCT00801983|3999613|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4178612|NCT00801983|3999611|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178613|NCT00801983|3999612|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178614|NCT00801983|3999613|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178615|NCT00801983|3999611|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4178616|NCT00801983|3999612|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4178617|NCT00801983|3999613|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178618|NCT00801983|3999611|B3||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4178619|NCT00801983|3999612|B2||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4178620|NCT00801983|3999613|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4178621|NCT00801983|3999611|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4178622|NCT00801983|3999612|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4178623|NCT00801983|3999613|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4178624|NCT00801983|3999611|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178625|NCT00801983|3999612|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178626|NCT00801983|3999613|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178627|NCT00801983|3999611|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4178628|NCT00801983|3999612|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178629|NCT00801983|3999613|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4178630|NCT00801983|3999611|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178631|NCT00801983|3999612|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178632|NCT00801983|3999613|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178633|NCT00801983|3999611|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4178634|NCT00801983|3999612|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4178635|NCT00801983|3999613|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4178636|NCT00801983|3999611|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4178637|NCT00801983|3999612|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4178638|NCT00801983|3999613|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4178639|NCT00801983|3999611|B3|||Age||years|Mean|44.4|44.4|Standard Deviation|12.4|12.4|||
4178640|NCT00801983|3999612|B2|||Age||years|Mean|45.6|45.6|Standard Deviation|11.9|11.9|||
4178641|NCT00801983|3999613|B1|||Age||years|Mean|43.3|43.3|Standard Deviation|12.9|12.9|||
4178642|NCT00801892|3999620|B3|||Education||years|Mean|14.1|14.1|Standard Deviation|3.2|3.2|||
4178643|NCT00801892|3999621|B2|||Education||years|Mean|14.4|14.4|Standard Deviation|2.9|2.9|||
4178644|NCT00801892|3999622|B1|||Education||years|Mean|13.9|13.9|Standard Deviation|3.5|3.5|||
4178645|NCT00801892|3999620|B3|||BMI||kg/m2|Mean|35.5|35.5|Standard Deviation|6.2|6.2|||
4178646|NCT00801892|3999621|B2|||BMI||kg/m2|Mean|34.8|34.8|Standard Deviation|5.6|5.6|||
4178647|NCT00801892|3999622|B1|||BMI||kg/m2|Mean|36.2|36.2|Standard Deviation|6.9|6.9|||
4178648|NCT00801892|3999620|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4178649|NCT00801892|3999621|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4178650|NCT00801892|3999622|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4178651|NCT00801892|3999620|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4178652|NCT00801892|3999621|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4178653|NCT00801892|3999622|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4178654|NCT00801892|3999620|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4178655|NCT00801892|3999621|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4178656|NCT00801892|3999622|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4178657|NCT00801892|3999620|B3|||Age||years|Mean|55.6|55.6|Standard Deviation|10.6|10.6|||
4178658|NCT00801892|3999621|B2|||Age||years|Mean|53.45|53.45|Standard Deviation|10.33|10.33|||
4178659|NCT00801892|3999622|B1|||Age||years|Mean|57.58|57.58|Standard Deviation|10.98|10.98|||
4178660|NCT00801827|3999639|B1|||Preop BMI||kg/m^2|Mean|43.2|43.2|Standard Deviation|6.26|6.26|||
4178661|NCT00801827|3999639|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4178662|NCT00801827|3999639|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178663|NCT00801827|3999639|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178664|NCT00801827|3999639|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4178665|NCT00801827|3999639|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4178666|NCT00801827|3999639|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178667|NCT00801827|3999639|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178668|NCT00801827|3999639|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178669|NCT00801827|3999639|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4178670|NCT00801827|3999639|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4178671|NCT00801827|3999639|B1|||Age||years|Mean|45.8|45.8|Standard Deviation|4.27|4.27|||
4178672|NCT00801801|3999643|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4178673|NCT00801801|3999643|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4178674|NCT00801801|3999643|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4178675|NCT00801801|3999643|B1|||Age||years|Mean|63|63.0|Standard Deviation|12.62|12.62|||
4178676|NCT00801801|3999643|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4178677|NCT00801801|3999643|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4178678|NCT00801801|3999643|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4178679|NCT00801684|3999648|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4178680|NCT00801684|3999648|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4178681|NCT00801684|3999648|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4178682|NCT00801684|3999648|B1|||Age||years|Mean|63.0|63.0|Standard Deviation|8.9|8.9|||
4178683|NCT00801684|3999648|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4178684|NCT00801684|3999648|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4178685|NCT00801684|3999648|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4178686|NCT00801632|3999670|B1|||Baseline Creatinine Level|Baseline creatinine is defined as the lowest serum creatinine collected during the stabilization period or in the 4 weeks following the end of the stabilization period. The stabilization period is defined as 4 consecutive creatinine values close in value (not differing more than 0.3). A normal result is 0.7 to 1.3 mg/dL for men and 0.6 to 1.1 mg/dL for women. Higher results indicate poorer kidney function, as creatinine is removed from the body by the kidneys.|mg/dL|Mean|1.9|1.9|Standard Deviation|1.2|1.2|||
4178687|NCT00801632|3999670|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4178688|NCT00801632|3999670|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178689|NCT00801632|3999670|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178690|NCT00801632|3999670|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4178691|NCT00801632|3999670|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178692|NCT00801632|3999670|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178693|NCT00801632|3999670|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4178694|NCT00801632|3999670|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178695|NCT00801632|3999670|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178696|NCT00801632|3999670|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4178697|NCT00801632|3999670|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178698|NCT00801632|3999670|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4178699|NCT00801632|3999670|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4178700|NCT00801632|3999670|B1|||Age||years|Mean|32.8|32.8|Standard Deviation|8.6|8.6|||
4178701|NCT00801632|3999670|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4178702|NCT00801632|3999670|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4178703|NCT00801632|3999670|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4178704|NCT00801242|3999681|B1|Overall Satisfaction||Baseline IIEF Scores during Cycle 1|The International Index of Erectile Function (IIEF) addresses the relevant domains of male sexual function (i.e. erectile function, orgasmic function, sexual desire, intercourse satisfaction and overall satisfaction). It consists of the following domains (number of items per domain; ranges from x [worst possible outcome] to y [best possible outcome]: erectile function (6; 1-30), orgasmic function (2; 0-10), sexual desire (2; 2-10), intercourse satisfaction (3; 0-15) and overall satisfaction (2; 2-10).|units on a scale|Mean|5.17|5.17|Standard Deviation|2.91|2.91|||
4178705|NCT00801242|3999681|B1|Intercourse Satisfaction||Baseline IIEF Scores during Cycle 1|The International Index of Erectile Function (IIEF) addresses the relevant domains of male sexual function (i.e. erectile function, orgasmic function, sexual desire, intercourse satisfaction and overall satisfaction). It consists of the following domains (number of items per domain; ranges from x [worst possible outcome] to y [best possible outcome]: erectile function (6; 1-30), orgasmic function (2; 0-10), sexual desire (2; 2-10), intercourse satisfaction (3; 0-15) and overall satisfaction (2; 2-10).|units on a scale|Mean|2.65|2.65|Standard Deviation|4.2|4.2|||
4178706|NCT00801242|3999681|B1|Sexual Desire||Baseline IIEF Scores during Cycle 1|The International Index of Erectile Function (IIEF) addresses the relevant domains of male sexual function (i.e. erectile function, orgasmic function, sexual desire, intercourse satisfaction and overall satisfaction). It consists of the following domains (number of items per domain; ranges from x [worst possible outcome] to y [best possible outcome]: erectile function (6; 1-30), orgasmic function (2; 0-10), sexual desire (2; 2-10), intercourse satisfaction (3; 0-15) and overall satisfaction (2; 2-10).|units on a scale|Mean|4.22|4.22|Standard Deviation|2.26|2.26|||
4178707|NCT00801242|3999681|B1|Orgasmic Function||Baseline IIEF Scores during Cycle 1|The International Index of Erectile Function (IIEF) addresses the relevant domains of male sexual function (i.e. erectile function, orgasmic function, sexual desire, intercourse satisfaction and overall satisfaction). It consists of the following domains (number of items per domain; ranges from x [worst possible outcome] to y [best possible outcome]: erectile function (6; 1-30), orgasmic function (2; 0-10), sexual desire (2; 2-10), intercourse satisfaction (3; 0-15) and overall satisfaction (2; 2-10).|units on a scale|Mean|2.31|2.31|Standard Deviation|3.43|3.43|||
4178708|NCT00801242|3999681|B1|Erectile Function||Baseline IIEF Scores during Cycle 1|The International Index of Erectile Function (IIEF) addresses the relevant domains of male sexual function (i.e. erectile function, orgasmic function, sexual desire, intercourse satisfaction and overall satisfaction). It consists of the following domains (number of items per domain; ranges from x [worst possible outcome] to y [best possible outcome]: erectile function (6; 1-30), orgasmic function (2; 0-10), sexual desire (2; 2-10), intercourse satisfaction (3; 0-15) and overall satisfaction (2; 2-10).|units on a scale|Mean|7.02|7.02|Standard Deviation|8.96|8.96|||
4178709|NCT00801242|3999681|B1|Sexual Functioning||Baseline EORTC QLQ-PR25 Scores during Cycle 1|The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Prostate Module (EORTC QLQ-PR25) assesses urinary, bowel, and sexual symptoms and functioning, and the side-effects of treatment. It consists of 25 questions distributed on these domains (number of items per domain, ranges from x [best possible outcome] to y [worst possible outcome]: urinary symptoms (8, 0-100), bother due to use of incontinence aid (1, 0-100), bowel symptoms (4, 0-100), hormonal treatment-related symptoms (6, 0-100), sexual activity (2, 100-0), and sexual functioning (4, 100-0).|units on a scale|Mean|25.8|25.8|Standard Deviation|26.7|26.7|||
4178710|NCT00801242|3999681|B1|Sexual Activity||Baseline EORTC QLQ-PR25 Scores during Cycle 1|The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Prostate Module (EORTC QLQ-PR25) assesses urinary, bowel, and sexual symptoms and functioning, and the side-effects of treatment. It consists of 25 questions distributed on these domains (number of items per domain, ranges from x [best possible outcome] to y [worst possible outcome]: urinary symptoms (8, 0-100), bother due to use of incontinence aid (1, 0-100), bowel symptoms (4, 0-100), hormonal treatment-related symptoms (6, 0-100), sexual activity (2, 100-0), and sexual functioning (4, 100-0).|units on a scale|Mean|58.0|58.0|Standard Deviation|26.8|26.8|||
4178711|NCT00801242|3999681|B1|Hormonal Treatment-related Symptoms||Baseline EORTC QLQ-PR25 Scores during Cycle 1|The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Prostate Module (EORTC QLQ-PR25) assesses urinary, bowel, and sexual symptoms and functioning, and the side-effects of treatment. It consists of 25 questions distributed on these domains (number of items per domain, ranges from x [best possible outcome] to y [worst possible outcome]: urinary symptoms (8, 0-100), bother due to use of incontinence aid (1, 0-100), bowel symptoms (4, 0-100), hormonal treatment-related symptoms (6, 0-100), sexual activity (2, 100-0), and sexual functioning (4, 100-0).|units on a scale|Mean|7.09|7.09|Standard Deviation|10.4|10.4|||
4178758|NCT00801138|3999705|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4178759|NCT00801138|3999701|B5||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4178760|NCT00801138|3999702|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4178712|NCT00801242|3999681|B1|Bowel Symptoms||Baseline EORTC QLQ-PR25 Scores during Cycle 1|The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Prostate Module (EORTC QLQ-PR25) assesses urinary, bowel, and sexual symptoms and functioning, and the side-effects of treatment. It consists of 25 questions distributed on these domains (number of items per domain, ranges from x [best possible outcome] to y [worst possible outcome]: urinary symptoms (8, 0-100), bother due to use of incontinence aid (1, 0-100), bowel symptoms (4, 0-100), hormonal treatment-related symptoms (6, 0-100), sexual activity (2, 100-0), and sexual functioning (4, 100-0).|units on a scale|Mean|4.05|4.05|Standard Deviation|9.65|9.65|||
4178713|NCT00801242|3999681|B1|Bother due to Incontinence aid||Baseline EORTC QLQ-PR25 Scores during Cycle 1|The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Prostate Module (EORTC QLQ-PR25) assesses urinary, bowel, and sexual symptoms and functioning, and the side-effects of treatment. It consists of 25 questions distributed on these domains (number of items per domain, ranges from x [best possible outcome] to y [worst possible outcome]: urinary symptoms (8, 0-100), bother due to use of incontinence aid (1, 0-100), bowel symptoms (4, 0-100), hormonal treatment-related symptoms (6, 0-100), sexual activity (2, 100-0), and sexual functioning (4, 100-0).|units on a scale|Mean|18.5|18.5|Standard Deviation|28.0|28.0|||
4178714|NCT00801242|3999681|B1|Urinary Symptoms||Baseline EORTC QLQ-PR25 Scores during Cycle 1|The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Prostate Module (EORTC QLQ-PR25) assesses urinary, bowel, and sexual symptoms and functioning, and the side-effects of treatment. It consists of 25 questions distributed on these domains (number of items per domain, ranges from x [best possible outcome] to y [worst possible outcome]: urinary symptoms (8, 0-100), bother due to use of incontinence aid (1, 0-100), bowel symptoms (4, 0-100), hormonal treatment-related symptoms (6, 0-100), sexual activity (2, 100-0), and sexual functioning (4, 100-0).|units on a scale|Mean|23.1|23.1|Standard Deviation|16.0|16.0|||
4178715|NCT00801242|3999681|B1|||Median Baseline Serum Prostate-specific Antigen Levels||ng/mL|Median|7.9|7.9|Full Range|||0.05|61.6|
4178716|NCT00801242|3999681|B1|||Median Baseline Serum Testosterone Levels||ng/mL|Median|4.09|4.09|Full Range|||0.1|10.0|
4178717|NCT00801242|3999681|B1|Italy||Region of Enrollment||participants|Number|32|32.0||||||
4178718|NCT00801242|3999681|B1|Germany||Region of Enrollment||participants|Number|63|63.0||||||
4178719|NCT00801242|3999681|B1|Netherlands||Region of Enrollment||participants|Number|25|25.0||||||
4178720|NCT00801242|3999681|B1|Belgium||Region of Enrollment||participants|Number|26|26.0||||||
4178721|NCT00801242|3999681|B1|Spain||Region of Enrollment||participants|Number|24|24.0||||||
4178722|NCT00801242|3999681|B1|France||Region of Enrollment||participants|Number|43|43.0||||||
4178723|NCT00801242|3999681|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178724|NCT00801242|3999681|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178725|NCT00801242|3999681|B1||White|Race (NIH/OMB)||Participants|Count of Participants|212|212.0||||||
4178726|NCT00801242|3999681|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178727|NCT00801242|3999681|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178728|NCT00801242|3999681|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178729|NCT00801242|3999681|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4178730|NCT00801242|3999681|B1||Male|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
4178731|NCT00801242|3999681|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4178732|NCT00801242|3999681|B1|||Age||years|Mean|73.1|73.1|Standard Deviation|7.73|7.73|||
4178733|NCT00801229|3999692|B3|United States||Region of Enrollment||participants|Number|69|69.0||||||
4178734|NCT00801229|3999693|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
4178735|NCT00801229|3999694|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4178736|NCT00801229|3999692|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4178737|NCT00801229|3999693|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4178738|NCT00801229|3999694|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4178739|NCT00801229|3999692|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4178740|NCT00801229|3999693|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4178741|NCT00801229|3999694|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4178742|NCT00801229|3999692|B3|||Age||Years|Mean|22.20|22.2|Standard Deviation|2.04|2.04|||
4178743|NCT00801229|3999693|B2|||Age||Years|Mean|22.15|22.15|Standard Deviation|1.99|1.99|||
4178744|NCT00801229|3999694|B1|||Age||Years|Mean|22.26|22.26|Standard Deviation|2.12|2.12|||
4178745|NCT00801229|3999692|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4178746|NCT00801229|3999693|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4178747|NCT00801229|3999694|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4178748|NCT00801229|3999692|B3||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
4178749|NCT00801229|3999693|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4178750|NCT00801229|3999694|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4178751|NCT00801229|3999692|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4178752|NCT00801229|3999693|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4178753|NCT00801229|3999694|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4178754|NCT00801138|3999701|B5||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4178755|NCT00801138|3999702|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4178756|NCT00801138|3999703|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4178757|NCT00801138|3999704|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4178761|NCT00801138|3999703|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4178762|NCT00801138|3999704|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4178763|NCT00801138|3999705|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4178764|NCT00801138|3999701|B5|||Age||years|Median|58|58.0|Inter-Quartile Range|||50.0|66.0|
4178765|NCT00801138|3999702|B4|||Age||years|Median|58|58.0|Inter-Quartile Range|||53.0|64.0|
4178766|NCT00801138|3999703|B3|||Age||years|Median|59|59.0|Inter-Quartile Range|||49.0|68.0|
4178767|NCT00801138|3999704|B2|||Age||years|Median|60|60.0|Inter-Quartile Range|||51.0|68.0|
4178768|NCT00801138|3999705|B1|||Age||years|Median|55|55.0|Inter-Quartile Range|||44.0|65.0|
4178769|NCT00801099|3999730|B1|Tanzania||Region of Enrollment||participants|Number|276|276.0||||||
4178770|NCT00801099|3999730|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4178771|NCT00801099|3999730|B1||Female|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4178772|NCT00801099|3999730|B1|||Age||years|Mean|32|32.0|Standard Deviation|13.9|13.9|||
4178773|NCT00800982|3999734|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4178774|NCT00800982|3999735|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4178775|NCT00800982|3999736|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4178776|NCT00800982|3999734|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4178777|NCT00800982|3999735|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4178778|NCT00800982|3999736|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4178779|NCT00800982|3999734|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4178780|NCT00800982|3999735|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4178781|NCT00800982|3999736|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4178782|NCT00800982|3999734|B3|||Age||years|Mean|44.2|44.2|Standard Deviation|1.9|1.9|||
4178783|NCT00800982|3999735|B2|||Age||years|Mean|43.8|43.8|Standard Deviation|2.1|2.1|||
4178784|NCT00800982|3999736|B1|||Age||years|Mean|44.7|44.7|Standard Deviation|1.8|1.8|||
4178785|NCT00800982|3999734|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4178786|NCT00800982|3999735|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4178787|NCT00800982|3999736|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4178788|NCT00800982|3999734|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4178789|NCT00800982|3999735|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4178790|NCT00800982|3999736|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4178791|NCT00800982|3999734|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4178792|NCT00800982|3999735|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4178793|NCT00800982|3999736|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4178794|NCT00800865|3999743|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4178795|NCT00800865|3999744|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4178796|NCT00800865|3999745|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4178797|NCT00800865|3999743|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4178798|NCT00800865|3999744|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4178799|NCT00800865|3999745|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4178800|NCT00800865|3999743|B3|34-88 years||Age, Customized||participants|Number|16|16.0||||||
4178801|NCT00800865|3999744|B2|34-88 years||Age, Customized||participants|Number|16|16.0||||||
4178802|NCT00800865|3999745|B1|34-88 years||Age, Customized||participants|Number|0|0.0||||||
4178803|NCT00800865|3999743|B3|29-77 years||Age, Customized||participants|Number|15|15.0||||||
4178804|NCT00800865|3999744|B2|29-77 years||Age, Customized||participants|Number|0|0.0||||||
4178805|NCT00800865|3999745|B1|29-77 years||Age, Customized||participants|Number|15|15.0||||||
4178806|NCT00800839|3999754|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
4178807|NCT00800839|3999754|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4178808|NCT00800839|3999754|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4178809|NCT00800839|3999754|B1|||Age||years|Median|61|61.0|Full Range|||39.0|72.0|
4178810|NCT00800735|3999763|B1|||Body Mass Index (BMI)||kg/m^2|Mean|26.5|26.5|Standard Deviation|4.53|4.53|||
4178811|NCT00800735|3999763|B1|||Weight||kg|Mean|76.97|76.97|Standard Deviation|16.146|16.146|||
4178812|NCT00800735|3999763|B1|||Height||cm|Mean|170.0|170.0|Standard Deviation|7.28|7.28|||
4178813|NCT00800735|3999763|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4178814|NCT00800735|3999763|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4178815|NCT00800735|3999763|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4178816|NCT00800735|3999763|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4178817|NCT00800735|3999763|B1|||Age||years|Mean|48.5|48.5|Standard Deviation|9.35|9.35|||
4178818|NCT00800683|3999767|B3|||Body Mass Index (BMI) Continuous||kg/m²|Mean|32.0|32.0|Standard Deviation|5.8|5.8|||
4178819|NCT00800683|3999768|B2|||Body Mass Index (BMI) Continuous||kg/m²|Mean|32.3|32.3|Standard Deviation|5.9|5.9|||
4178820|NCT00800683|3999769|B1|||Body Mass Index (BMI) Continuous||kg/m²|Mean|31.7|31.7|Standard Deviation|5.9|5.9|||
4178821|NCT00800683|3999767|B3|||Fasting plasma glucose (FPG) at baseline|Described in the patients of the Full Analysis Set : 62 in placebo group versus 66 in Linagliptin group|mg/dL|Mean|154.6|154.6|Standard Deviation|72.9|72.9|||
4178822|NCT00800683|3999768|B2|||Fasting plasma glucose (FPG) at baseline|Described in the patients of the Full Analysis Set : 62 in placebo group versus 66 in Linagliptin group|mg/dL|Mean|149.5|149.5|Standard Deviation|79.5|79.5|||
4178823|NCT00800683|3999769|B1|||Fasting plasma glucose (FPG) at baseline|Described in the patients of the Full Analysis Set : 62 in placebo group versus 66 in Linagliptin group|mg/dL|Mean|160.1|160.1|Standard Deviation|65.4|65.4|||
4178824|NCT00800683|3999767|B3|||Glycosylated haemoglobin (HbA1c) at baseline|Described in the patients of the Full Analysis Set : 62 in placebo group versus 66 in Linagliptin group|percentage|Mean|8.2|8.2|Standard Deviation|1.0|1.0|||
4178825|NCT00800683|3999768|B2|||Glycosylated haemoglobin (HbA1c) at baseline|Described in the patients of the Full Analysis Set : 62 in placebo group versus 66 in Linagliptin group|percentage|Mean|8.2|8.2|Standard Deviation|1.1|1.1|||
4178826|NCT00800683|3999769|B1|||Glycosylated haemoglobin (HbA1c) at baseline|Described in the patients of the Full Analysis Set : 62 in placebo group versus 66 in Linagliptin group|percentage|Mean|8.2|8.2|Standard Deviation|0.9|0.9|||
4178827|NCT00800683|3999767|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4178828|NCT00800683|3999768|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4178829|NCT00800683|3999769|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4178830|NCT00800683|3999767|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4178831|NCT00800683|3999768|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4178832|NCT00800683|3999769|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4178833|NCT00800683|3999767|B3|||Age||years|Mean|64.4|64.4|Standard Deviation|10.3|10.3|||
4178834|NCT00800683|3999768|B2|||Age||years|Mean|64.0|64.0|Standard Deviation|10.9|10.9|||
4178835|NCT00800683|3999769|B1|||Age||years|Mean|64.9|64.9|Standard Deviation|9.6|9.6|||
4178836|NCT00800540|3999816|B1|Greece||Region of Enrollment||participants|Number|35|35.0||||||
4178837|NCT00800540|3999816|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4178838|NCT00800540|3999816|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4178839|NCT00800540|3999816|B1|||Age||years|Mean|65.2|65.2|Standard Deviation|10.3|10.3|||
4178840|NCT00800436|3999845|B8||Male|Gender||Participants|Count of Participants|24|24.0||||||
4178841|NCT00800436|3999846|B7||Male|Gender||Participants|Count of Participants|0|0.0||||||
4178842|NCT00800436|3999847|B6||Male|Gender||Participants|Count of Participants|0|0.0||||||
4178843|NCT00800436|3999848|B5||Male|Gender||Participants|Count of Participants|6|6.0||||||
4178844|NCT00800436|3999849|B4||Male|Gender||Participants|Count of Participants|6|6.0||||||
4178845|NCT00800436|3999850|B3||Male|Gender||Participants|Count of Participants|6|6.0||||||
4178846|NCT00800436|3999851|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
4178847|NCT00800436|3999852|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
4178848|NCT00800436|3999845|B8||Female|Gender||Participants|Count of Participants|46|46.0||||||
4178849|NCT00800436|3999846|B7||Female|Gender||Participants|Count of Participants|20|20.0||||||
4178850|NCT00800436|3999847|B6||Female|Gender||Participants|Count of Participants|20|20.0||||||
4178851|NCT00800436|3999848|B5||Female|Gender||Participants|Count of Participants|0|0.0||||||
4178852|NCT00800436|3999849|B4||Female|Gender||Participants|Count of Participants|0|0.0||||||
4178853|NCT00800436|3999850|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
4178854|NCT00800436|3999851|B2||Female|Gender||Participants|Count of Participants|6|6.0||||||
4178855|NCT00800436|3999852|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
4178856|NCT00800436|3999845|B8|||Age||years|Mean|41.2|41.2|Standard Deviation|14.85|14.85|||
4178857|NCT00800436|3999846|B7|||Age||years|Mean|51.6|51.6|Standard Deviation|9.04|9.04|||
4178858|NCT00800436|3999847|B6|||Age||years|Mean|50.7|50.7|Standard Deviation|7.21|7.21|||
4178859|NCT00800436|3999848|B5|||Age||years|Mean|22.0|22.0|Standard Deviation|4.34|4.34|||
4178860|NCT00800436|3999849|B4|||Age||years|Mean|23.0|23.0|Standard Deviation|6.16|6.16|||
4178861|NCT00800436|3999850|B3|||Age||years|Mean|25.7|25.7|Standard Deviation|9.29|9.29|||
4178862|NCT00800436|3999851|B2|||Age||years|Mean|46.2|46.2|Standard Deviation|5.19|5.19|||
4178863|NCT00800436|3999852|B1|||Age||years|Mean|22.7|22.7|Standard Deviation|2.58|2.58|||
4178864|NCT00800384|3999902|B3||Male|Sex: Female, Male||Participants|Count of Participants|2024|2024.0||||||
4178865|NCT00800384|3999903|B2||Male|Sex: Female, Male||Participants|Count of Participants|1009|1009.0||||||
4178866|NCT00800384|3999904|B1||Male|Sex: Female, Male||Participants|Count of Participants|1015|1015.0||||||
4178867|NCT00800384|3999902|B3||Female|Sex: Female, Male||Participants|Count of Participants|476|476.0||||||
4178868|NCT00800384|3999903|B2||Female|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
4178869|NCT00800384|3999904|B1||Female|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
4178870|NCT00800384|3999902|B3|||Age||years|Mean|62.78|62.78|Standard Deviation|11.60|11.6|||
4178871|NCT00800384|3999903|B2|||Age||years|Mean|62.98|62.98|Standard Deviation|11.69|11.69|||
4178872|NCT00800384|3999904|B1|||Age||years|Mean|62.58|62.58|Standard Deviation|11.51|11.51|||
4178873|NCT00800345|3999913|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4178874|NCT00800345|3999913|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4178875|NCT00800345|3999913|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4178876|NCT00800345|3999913|B1|||Age||years|Mean|61.88|61.88|Standard Deviation|12.81|12.81|||
4178877|NCT00800254|3999918|B3|||Body Mass Index (BMI)||kg/m^2|Mean|29.2|29.2|Standard Deviation|4.6|4.6|||
4178878|NCT00800254|3999919|B2|||Body Mass Index (BMI)||kg/m^2|Mean|31.2|31.2|Standard Deviation|4.2|4.2|||
4178879|NCT00800254|3999920|B1|||Body Mass Index (BMI)||kg/m^2|Mean|27.1|27.1|Standard Deviation|4.9|4.9|||
4178880|NCT00800254|3999918|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4178881|NCT00800254|3999919|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4178882|NCT00800254|3999920|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4178883|NCT00800254|3999918|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4178884|NCT00800254|3999919|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4178885|NCT00800254|3999920|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4178886|NCT00800254|3999918|B3|||Age||years|Mean|65.5|65.5|Standard Deviation|8.4|8.4|||
4178887|NCT00800254|3999919|B2|||Age||years|Mean|64.8|64.8|Standard Deviation|7.7|7.7|||
4178888|NCT00800254|3999920|B1|||Age||years|Mean|66.2|66.2|Standard Deviation|9.1|9.1|||
4178889|NCT00800202|3999941|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4178890|NCT00800202|3999942|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4178891|NCT00800202|3999943|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4178892|NCT00800202|3999941|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4178893|NCT00800202|3999942|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4178894|NCT00800202|3999943|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4178895|NCT00800202|3999941|B3|||Age||years|Mean|58.74|58.74|Standard Deviation|9.07|9.07|||
4178896|NCT00800202|3999942|B2|||Age||years|Mean|54.17|54.17|Standard Deviation|9.73|9.73|||
4178897|NCT00800202|3999943|B1|||Age||years|Mean|60.37|60.37|Standard Deviation|8.31|8.31|||
4178898|NCT00799903|3999962|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178899|NCT00799903|3999963|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178900|NCT00799903|3999964|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4178901|NCT00799903|3999962|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
4178902|NCT00799903|3999963|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4178903|NCT00799903|3999964|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4178904|NCT00799903|3999962|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12410|12410.0||||||
4178905|NCT00799903|3999963|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6233|6233.0||||||
4178906|NCT00799903|3999964|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6177|6177.0||||||
4178907|NCT00799903|3999962|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|366|366.0||||||
4178908|NCT00799903|3999963|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|175|175.0||||||
4178909|NCT00799903|3999964|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|191|191.0||||||
4178910|NCT00799903|3999962|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4178911|NCT00799903|3999963|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4178912|NCT00799903|3999964|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4178913|NCT00799903|3999962|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2717|2717.0||||||
4178914|NCT00799903|3999963|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1351|1351.0||||||
4178915|NCT00799903|3999964|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1366|1366.0||||||
4178916|NCT00799903|3999962|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|214|214.0||||||
4178917|NCT00799903|3999963|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
4178918|NCT00799903|3999964|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
4178919|NCT00799903|3999962|B3||Male|Sex: Female, Male||Participants|Count of Participants|12861|12861.0||||||
4178920|NCT00799903|3999963|B2||Male|Sex: Female, Male||Participants|Count of Participants|6463|6463.0||||||
4178921|NCT00799903|3999964|B1||Male|Sex: Female, Male||Participants|Count of Participants|6398|6398.0||||||
4178922|NCT00799903|3999962|B3||Female|Sex: Female, Male||Participants|Count of Participants|2967|2967.0||||||
4178923|NCT00799903|3999963|B2||Female|Sex: Female, Male||Participants|Count of Participants|1461|1461.0||||||
4178924|NCT00799903|3999964|B1||Female|Sex: Female, Male||Participants|Count of Participants|1506|1506.0||||||
4178925|NCT00799903|3999962|B3|||Age||years|Mean|64.4|64.4|Standard Deviation|9.35|9.35|||
4178926|NCT00799903|3999963|B2|||Age||years|Mean|64.5|64.5|Standard Deviation|9.31|9.31|||
4178927|NCT00799903|3999964|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|9.39|9.39|||
4178928|NCT00799825|3999985|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4178929|NCT00799825|3999985|B1||Female|Sex: Female, Male||Participants|Count of Participants|344|344.0||||||
4178930|NCT00799825|3999985|B1|||Age||Years|Mean|25.4|25.4|Standard Deviation|2.81|2.81|||
4178931|NCT00799773|3999991|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4178932|NCT00799773|3999992|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4178933|NCT00799773|3999993|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4178934|NCT00799773|3999991|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4178935|NCT00799773|3999992|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4178936|NCT00799773|3999993|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4178937|NCT00799773|3999991|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4178938|NCT00799773|3999992|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4178939|NCT00799773|3999993|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4178940|NCT00799773|3999991|B3|||Age||years|Mean|37|37.0|Standard Deviation|22|22.0|||
4178941|NCT00799773|3999992|B2|||Age||years|Mean|24|24.0|Standard Deviation|||||
4178942|NCT00799773|3999993|B1|||Age||years|Mean|43.5|43.5|Standard Deviation|26.2|26.2|||
4178943|NCT00799773|3999991|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4178944|NCT00799773|3999992|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4178945|NCT00799773|3999993|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4178946|NCT00799773|3999991|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4178947|NCT00799773|3999992|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4178948|NCT00799773|3999993|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4178949|NCT00799773|3999991|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4178950|NCT00799773|3999992|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4178951|NCT00799773|3999993|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4178952|NCT00799708|4000022|B4|||Body Mass Index (BMI)||kg/m^2|Mean|29.0|29.0|Standard Deviation|4.9|4.9|||
4178953|NCT00799708|4000023|B3|||Body Mass Index (BMI)||kg/m^2|Mean|29.2|29.2|Standard Deviation|4.8|4.8|||
4178954|NCT00799708|4000024|B2|||Body Mass Index (BMI)||kg/m^2|Mean|28.7|28.7|Standard Deviation|3.2|3.2|||
4178955|NCT00799708|4000025|B1|||Body Mass Index (BMI)||kg/m^2|Mean|29.1|29.1|Standard Deviation|6.1|6.1|||
4178956|NCT00799708|4000022|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4178957|NCT00799708|4000023|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4178958|NCT00799708|4000024|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4178959|NCT00799708|4000025|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4178960|NCT00799708|4000022|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4178961|NCT00799708|4000023|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4178962|NCT00799708|4000024|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4178963|NCT00799708|4000025|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4178964|NCT00799708|4000022|B4|||Age||years|Mean|54.2|54.2|Standard Deviation|4.6|4.6|||
4178965|NCT00799708|4000023|B3|||Age||years|Mean|54.4|54.4|Standard Deviation|4.8|4.8|||
4178966|NCT00799708|4000024|B2|||Age||years|Mean|53.8|53.8|Standard Deviation|4.4|4.4|||
4178967|NCT00799708|4000025|B1|||Age||years|Mean|54.3|54.3|Standard Deviation|5.0|5.0|||
4178968|NCT00799643|4000037|B3|United States||Region of Enrollment||participants|Number|286|286.0||||||
4178969|NCT00799643|4000038|B2|United States||Region of Enrollment||participants|Number|146|146.0||||||
4178970|NCT00799643|4000039|B1|United States||Region of Enrollment||participants|Number|140|140.0||||||
4178971|NCT00799643|4000037|B3||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4178972|NCT00799643|4000038|B2||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4178973|NCT00799643|4000039|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4178974|NCT00799643|4000037|B3||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4178975|NCT00799643|4000038|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4178976|NCT00799643|4000039|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4178977|NCT00799643|4000037|B3|||Age||years|Mean|55.8|55.8|Standard Deviation|9.6|9.6|||
4178978|NCT00799643|4000038|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|9.2|9.2|||
4178979|NCT00799643|4000039|B1|||Age||years|Mean|55.8|55.8|Standard Deviation|10|10.0|||
4178980|NCT00799643|4000037|B3||>=65 years|Age||Participants|Count of Participants|56|56.0||||||
4178981|NCT00799643|4000038|B2||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4178982|NCT00799643|4000039|B1||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4178983|NCT00799643|4000037|B3||Between 18 and 65 years|Age||Participants|Count of Participants|230|230.0||||||
4178984|NCT00799643|4000038|B2||Between 18 and 65 years|Age||Participants|Count of Participants|118|118.0||||||
4178985|NCT00799643|4000039|B1||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
4178986|NCT00799643|4000037|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4178987|NCT00799643|4000038|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4178988|NCT00799643|4000039|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4178989|NCT00799617|4000048|B3|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|49|49.0||||||
4178990|NCT00799617|4000049|B2|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
4178991|NCT00799617|4000050|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
4178992|NCT00799617|4000048|B3|Race|African-American|Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
4178993|NCT00799617|4000049|B2|Race|African-American|Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
4178994|NCT00799617|4000050|B1|Race|African-American|Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
4178995|NCT00799617|4000048|B3|Race|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|698|698.0||||||
4178996|NCT00799617|4000049|B2|Race|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|350|350.0||||||
4178997|NCT00799617|4000050|B1|Race|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|348|348.0||||||
4178998|NCT00799617|4000048|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4178999|NCT00799617|4000049|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179000|NCT00799617|4000050|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4179001|NCT00799617|4000048|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|759|759.0||||||
4179002|NCT00799617|4000049|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|384|384.0||||||
4179003|NCT00799617|4000050|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|375|375.0||||||
4179004|NCT00799617|4000048|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4179005|NCT00799617|4000049|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4179006|NCT00799617|4000050|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4179007|NCT00799617|4000048|B3||Male|Sex: Female, Male|All of the participants in this trial of testosterone gel use are men.|Participants|Count of Participants|788|788.0||||||
4179008|NCT00799617|4000049|B2||Male|Sex: Female, Male|All of the participants in this trial of testosterone gel use are men.|Participants|Count of Participants|394|394.0||||||
4179009|NCT00799617|4000050|B1||Male|Sex: Female, Male|All of the participants in this trial of testosterone gel use are men.|Participants|Count of Participants|394|394.0||||||
4179010|NCT00799617|4000048|B3||Female|Sex: Female, Male|All of the participants in this trial of testosterone gel use are men.|Participants|Count of Participants|0|0.0||||||
4179011|NCT00799617|4000049|B2||Female|Sex: Female, Male|All of the participants in this trial of testosterone gel use are men.|Participants|Count of Participants|0|0.0||||||
4179012|NCT00799617|4000050|B1||Female|Sex: Female, Male|All of the participants in this trial of testosterone gel use are men.|Participants|Count of Participants|0|0.0||||||
4179013|NCT00799617|4000048|B3|Anemia Trial||Age|Men in the trial were 65 years of age or older.|years|Mean|75.2|75.2|Standard Deviation|6.8|6.8|||
4179014|NCT00799617|4000049|B2|Anemia Trial||Age|Men in the trial were 65 years of age or older.|years|Mean|75.6|75.6|Standard Deviation|7.5|7.5|||
4179015|NCT00799617|4000050|B1|Anemia Trial||Age|Men in the trial were 65 years of age or older.|years|Mean|74.8|74.8|Standard Deviation|6.0|6.0|||
4179016|NCT00799617|4000048|B3|Cognitive Function Trial||Age|Men in the trial were 65 years of age or older.|years|Mean|72.6|72.6|Standard Deviation|5.9|5.9|||
4179017|NCT00799617|4000049|B2|Cognitive Function Trial||Age|Men in the trial were 65 years of age or older.|years|Mean|72.8|72.8|Standard Deviation|6.1|6.1|||
4179018|NCT00799617|4000050|B1|Cognitive Function Trial||Age|Men in the trial were 65 years of age or older.|years|Mean|72.3|72.3|Standard Deviation|5.8|5.8|||
4179019|NCT00799617|4000048|B3|Bone Trial||Age|Men in the trial were 65 years of age or older.|years|Mean|72.4|72.4|Standard Deviation|5.9|5.9|||
4179020|NCT00799617|4000049|B2|Bone Trial||Age|Men in the trial were 65 years of age or older.|years|Mean|72.4|72.4|Standard Deviation|5.5|5.5|||
4179021|NCT00799617|4000050|B1|Bone Trial||Age|Men in the trial were 65 years of age or older.|years|Mean|72.3|72.3|Standard Deviation|6.3|6.3|||
4179022|NCT00799617|4000048|B3|Cardiovascular Trial||Age|Men in the trial were 65 years of age or older.|years|Mean|71.2|71.2|Standard Deviation|5.7|5.7|||
4179023|NCT00799617|4000049|B2|Cardiovascular Trial||Age|Men in the trial were 65 years of age or older.|years|Mean|72.0|72.0|Standard Deviation|5.7|5.7|||
4179024|NCT00799617|4000050|B1|Cardiovascular Trial||Age|Men in the trial were 65 years of age or older.|years|Mean|70.5|70.5|Standard Deviation|5.7|5.7|||
4179025|NCT00799617|4000048|B3|Main Testosterone Trial||Age|Men in the trial were 65 years of age or older.|years|Mean|72.2|72.2|Standard Deviation|5.8|5.8|||
4179026|NCT00799617|4000049|B2|Main Testosterone Trial||Age|Men in the trial were 65 years of age or older.|years|Mean|72.1|72.1|Standard Deviation|5.7|5.7|||
4179027|NCT00799617|4000050|B1|Main Testosterone Trial||Age|Men in the trial were 65 years of age or older.|years|Mean|72.3|72.3|Standard Deviation|5.8|5.8|||
4179028|NCT00799604|4000129|B4|||Screening Heart Rate|These results represent the participant groupings during Treatment Period 1 (Bolus 1 - pre-anesthesia).|Beats Per Minute (BPM)|Mean|70.3|70.3|Standard Deviation|13.43|13.43|||
4179029|NCT00799604|4000130|B3|||Screening Heart Rate|These results represent the participant groupings during Treatment Period 1 (Bolus 1 - pre-anesthesia).|Beats Per Minute (BPM)|Mean|69.3|69.3|Standard Deviation|10.49|10.49|||
4179030|NCT00799604|4000131|B2|||Screening Heart Rate|These results represent the participant groupings during Treatment Period 1 (Bolus 1 - pre-anesthesia).|Beats Per Minute (BPM)|Mean|68.5|68.5|Standard Deviation|10.42|10.42|||
4179031|NCT00799604|4000132|B1|||Screening Heart Rate|These results represent the participant groupings during Treatment Period 1 (Bolus 1 - pre-anesthesia).|Beats Per Minute (BPM)|Mean|73.1|73.1|Standard Deviation|18.69|18.69|||
4179032|NCT00799604|4000129|B4|Diastolic Blood Pressure (DBP)||Screening Blood Pressure|These results represent the participant groupings in Treatment Period 1 (Bolus 1 - pre-anesthesia).|mm Hg|Mean|77.3|77.3|Standard Deviation|10.18|10.18|||
4179033|NCT00799604|4000130|B3|Diastolic Blood Pressure (DBP)||Screening Blood Pressure|These results represent the participant groupings in Treatment Period 1 (Bolus 1 - pre-anesthesia).|mm Hg|Mean|77.7|77.7|Standard Deviation|11.51|11.51|||
4179034|NCT00799604|4000131|B2|Diastolic Blood Pressure (DBP)||Screening Blood Pressure|These results represent the participant groupings in Treatment Period 1 (Bolus 1 - pre-anesthesia).|mm Hg|Mean|74.1|74.1|Standard Deviation|10.29|10.29|||
4179035|NCT00799604|4000132|B1|Diastolic Blood Pressure (DBP)||Screening Blood Pressure|These results represent the participant groupings in Treatment Period 1 (Bolus 1 - pre-anesthesia).|mm Hg|Mean|80.0|80.0|Standard Deviation|8.71|8.71|||
4179036|NCT00799604|4000129|B4|Systolic Blood Pressure (SBP)||Screening Blood Pressure|These results represent the participant groupings in Treatment Period 1 (Bolus 1 - pre-anesthesia).|mm Hg|Mean|168.2|168.2|Standard Deviation|18.53|18.53|||
4179037|NCT00799604|4000130|B3|Systolic Blood Pressure (SBP)||Screening Blood Pressure|These results represent the participant groupings in Treatment Period 1 (Bolus 1 - pre-anesthesia).|mm Hg|Mean|175.5|175.5|Standard Deviation|19.43|19.43|||
4179038|NCT00799604|4000131|B2|Systolic Blood Pressure (SBP)||Screening Blood Pressure|These results represent the participant groupings in Treatment Period 1 (Bolus 1 - pre-anesthesia).|mm Hg|Mean|170.2|170.2|Standard Deviation|16.33|16.33|||
4179192|NCT00799435|4000265|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179039|NCT00799604|4000132|B1|Systolic Blood Pressure (SBP)||Screening Blood Pressure|These results represent the participant groupings in Treatment Period 1 (Bolus 1 - pre-anesthesia).|mm Hg|Mean|159.0|159.0|Standard Deviation|17.45|17.45|||
4179040|NCT00799604|4000129|B4|||Weight|These results represent the participant groupings during Treatment Period 1 (Bolus 1 - pre-anesthesia).|kilograms (kg)|Mean|88.65|88.65|Standard Deviation|21.279|21.279|||
4179041|NCT00799604|4000130|B3|||Weight|These results represent the participant groupings during Treatment Period 1 (Bolus 1 - pre-anesthesia).|kilograms (kg)|Mean|105.05|105.05|Standard Deviation|24.724|24.724|||
4179042|NCT00799604|4000131|B2|||Weight|These results represent the participant groupings during Treatment Period 1 (Bolus 1 - pre-anesthesia).|kilograms (kg)|Mean|79.24|79.24|Standard Deviation|12.639|12.639|||
4179043|NCT00799604|4000132|B1|||Weight|These results represent the participant groupings during Treatment Period 1 (Bolus 1 - pre-anesthesia).|kilograms (kg)|Mean|81.65|81.65|Standard Deviation|15.374|15.374|||
4179044|NCT00799604|4000129|B4|||Height|These results represent the participant groupings during Treatment Period 1 (Bolus 1 - pre-anesthesia).|centimeters (cm)|Mean|173.15|173.15|Standard Deviation|10.792|10.792|||
4179045|NCT00799604|4000130|B3|||Height|These results represent the participant groupings during Treatment Period 1 (Bolus 1 - pre-anesthesia).|centimeters (cm)|Mean|176.35|176.35|Standard Deviation|9.663|9.663|||
4179046|NCT00799604|4000131|B2|||Height|These results represent the participant groupings during Treatment Period 1 (Bolus 1 - pre-anesthesia).|centimeters (cm)|Mean|168.15|168.15|Standard Deviation|11.462|11.462|||
4179047|NCT00799604|4000132|B1|||Height|These results represent the participant groupings during Treatment Period 1 (Bolus 1 - pre-anesthesia).|centimeters (cm)|Mean|174.96|174.96|Standard Deviation|10.381|10.381|||
4179048|NCT00799604|4000129|B4|United States||Region of Enrollment|These results represent patient groupings during Treatment Period 1 (Bolus 1 - pre-anesthesia).|participants|Number|30|30.0||||||
4179049|NCT00799604|4000130|B3|United States||Region of Enrollment|These results represent patient groupings during Treatment Period 1 (Bolus 1 - pre-anesthesia).|participants|Number|10|10.0||||||
4179050|NCT00799604|4000131|B2|United States||Region of Enrollment|These results represent patient groupings during Treatment Period 1 (Bolus 1 - pre-anesthesia).|participants|Number|10|10.0||||||
4179051|NCT00799604|4000132|B1|United States||Region of Enrollment|These results represent patient groupings during Treatment Period 1 (Bolus 1 - pre-anesthesia).|participants|Number|10|10.0||||||
4179052|NCT00799604|4000129|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179053|NCT00799604|4000130|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179054|NCT00799604|4000131|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179055|NCT00799604|4000132|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179056|NCT00799604|4000129|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179057|NCT00799604|4000130|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179058|NCT00799604|4000131|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179059|NCT00799604|4000132|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179060|NCT00799604|4000129|B4||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4179061|NCT00799604|4000130|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4179062|NCT00799604|4000131|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4179063|NCT00799604|4000132|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4179064|NCT00799604|4000129|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179065|NCT00799604|4000130|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179066|NCT00799604|4000131|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179067|NCT00799604|4000132|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179068|NCT00799604|4000129|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179069|NCT00799604|4000130|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179070|NCT00799604|4000131|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179071|NCT00799604|4000132|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179072|NCT00799604|4000129|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179073|NCT00799604|4000130|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179074|NCT00799604|4000131|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179075|NCT00799604|4000132|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179076|NCT00799604|4000129|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179077|NCT00799604|4000130|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179078|NCT00799604|4000131|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179079|NCT00799604|4000132|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179080|NCT00799604|4000129|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)|These results represent participant groupings during Treatment Period 1 (Bolus 1 - pre-anesthesia).|Participants|Count of Participants|0|0.0||0|0.0|||
4179081|NCT00799604|4000130|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)|These results represent participant groupings during Treatment Period 1 (Bolus 1 - pre-anesthesia).|Participants|Count of Participants|0|0.0||0|0.0|||
4179082|NCT00799604|4000131|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)|These results represent participant groupings during Treatment Period 1 (Bolus 1 - pre-anesthesia).|Participants|Count of Participants|0|0.0||0|0.0|||
4179193|NCT00799435|4000266|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4179083|NCT00799604|4000132|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|These results represent participant groupings during Treatment Period 1 (Bolus 1 - pre-anesthesia).|Participants|Count of Participants|0|0.0||0|0.0|||
4179084|NCT00799604|4000129|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)|These results represent participant groupings during Treatment Period 1 (Bolus 1 - pre-anesthesia).|Participants|Count of Participants|30|30.0||100.0|100.0|||
4179085|NCT00799604|4000130|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)|These results represent participant groupings during Treatment Period 1 (Bolus 1 - pre-anesthesia).|Participants|Count of Participants|10|10.0||100.0|100.0|||
4179086|NCT00799604|4000131|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)|These results represent participant groupings during Treatment Period 1 (Bolus 1 - pre-anesthesia).|Participants|Count of Participants|10|10.0||100.0|100.0|||
4179087|NCT00799604|4000132|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|These results represent participant groupings during Treatment Period 1 (Bolus 1 - pre-anesthesia).|Participants|Count of Participants|10|10.0||100.0|100.0|||
4179088|NCT00799604|4000129|B4||Hispanic or Latino|Ethnicity (NIH/OMB)|These results represent participant groupings during Treatment Period 1 (Bolus 1 - pre-anesthesia).|Participants|Count of Participants|0|0.0||0|0.0|||
4179089|NCT00799604|4000130|B3||Hispanic or Latino|Ethnicity (NIH/OMB)|These results represent participant groupings during Treatment Period 1 (Bolus 1 - pre-anesthesia).|Participants|Count of Participants|0|0.0||0|0.0|||
4179090|NCT00799604|4000131|B2||Hispanic or Latino|Ethnicity (NIH/OMB)|These results represent participant groupings during Treatment Period 1 (Bolus 1 - pre-anesthesia).|Participants|Count of Participants|0|0.0||0|0.0|||
4179091|NCT00799604|4000132|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|These results represent participant groupings during Treatment Period 1 (Bolus 1 - pre-anesthesia).|Participants|Count of Participants|0|0.0||0|0.0|||
4179092|NCT00799604|4000129|B4||Male|Sex: Female, Male|These results represent Treatment Period 1 (Bolus 1 - pre-anesthesia).|Participants|Count of Participants|24|24.0||||||
4179093|NCT00799604|4000130|B3||Male|Sex: Female, Male|These results represent Treatment Period 1 (Bolus 1 - pre-anesthesia).|Participants|Count of Participants|9|9.0||||||
4179094|NCT00799604|4000131|B2||Male|Sex: Female, Male|These results represent Treatment Period 1 (Bolus 1 - pre-anesthesia).|Participants|Count of Participants|7|7.0||||||
4179095|NCT00799604|4000132|B1||Male|Sex: Female, Male|These results represent Treatment Period 1 (Bolus 1 - pre-anesthesia).|Participants|Count of Participants|8|8.0||||||
4179096|NCT00799604|4000129|B4||Female|Sex: Female, Male|These results represent Treatment Period 1 (Bolus 1 - pre-anesthesia).|Participants|Count of Participants|6|6.0||||||
4179097|NCT00799604|4000130|B3||Female|Sex: Female, Male|These results represent Treatment Period 1 (Bolus 1 - pre-anesthesia).|Participants|Count of Participants|1|1.0||||||
4179098|NCT00799604|4000131|B2||Female|Sex: Female, Male|These results represent Treatment Period 1 (Bolus 1 - pre-anesthesia).|Participants|Count of Participants|3|3.0||||||
4179099|NCT00799604|4000132|B1||Female|Sex: Female, Male|These results represent Treatment Period 1 (Bolus 1 - pre-anesthesia).|Participants|Count of Participants|2|2.0||||||
4179100|NCT00799604|4000129|B4|||Age||years|Mean|62.4|62.4|Standard Deviation|9.98|9.98|||
4179101|NCT00799604|4000130|B3|||Age||years|Mean|60.2|60.2|Standard Deviation|8.85|8.85|||
4179102|NCT00799604|4000131|B2|||Age||years|Mean|66.4|66.4|Standard Deviation|8.62|8.62|||
4179103|NCT00799604|4000132|B1|||Age||years|Mean|60.5|60.5|Standard Deviation|11.88|11.88|||
4179104|NCT00799591|4000158|B1|Polymicrobial||Percentage of participants with microbiological sampling results: direct examination|Microbiological sampling results categorized according to direct examination (identification of the class of germs). Participants may be represented in >1 category. N=87|percentage of participants|Number|33.3|33.3||||||
4179105|NCT00799591|4000158|B1|Gram positive cocci||Percentage of participants with microbiological sampling results: direct examination|Microbiological sampling results categorized according to direct examination (identification of the class of germs). Participants may be represented in >1 category. N=87|percentage of participants|Number|47.1|47.1||||||
4179106|NCT00799591|4000158|B1|Gram negative bacilli||Percentage of participants with microbiological sampling results: direct examination|Microbiological sampling results categorized according to direct examination (identification of the class of germs). Participants may be represented in >1 category. N=87|percentage of participants|Number|59.8|59.8||||||
4179107|NCT00799591|4000158|B1|||Percentage of participants with microbiological sampling results: positive blood culture|Microbiological sampling results categorized as a positive blood culture (presence of infection); N=145|percentage of participants|Number|11.7|11.7||||||
4179108|NCT00799591|4000158|B1|Treatment within 30 days prior=Yes||Percentage of participants with antibiotic treatment(s) taken 30 days prior to Tigecycline treatment||percentage of participants|Number|92.9|92.9||||||
4179109|NCT00799591|4000158|B1|Treatment within 30 days prior=No||Percentage of participants with antibiotic treatment(s) taken 30 days prior to Tigecycline treatment||percentage of participants|Number|7.1|7.1||||||
4179110|NCT00799591|4000158|B1|Immuno > 10%: Other Immuno||Percentage of participants per co-morbid (concomitant) diseases|Participants may be represented in > 1 category. Immunosuppression (Immuno).|percentage of participants|Number|13.5|13.5||||||
4179111|NCT00799591|4000158|B1|Immuno > 10%: Corticoids plus other Immuno||Percentage of participants per co-morbid (concomitant) diseases|Participants may be represented in > 1 category. Immunosuppression (Immuno).|percentage of participants|Number|15.4|15.4||||||
4179112|NCT00799591|4000158|B1|Immuno > 10%: Use of corticoids||Percentage of participants per co-morbid (concomitant) diseases|Participants may be represented in > 1 category. Immunosuppression (Immuno).|percentage of participants|Number|15.4|15.4||||||
4179113|NCT00799591|4000158|B1|Immuno > 10%: Cancer||Percentage of participants per co-morbid (concomitant) diseases|Participants may be represented in > 1 category. Immunosuppression (Immuno).|percentage of participants|Number|53.8|53.8||||||
4179114|NCT00799591|4000158|B1|Chronic hepatic failure Type C||Percentage of participants per co-morbid (concomitant) diseases|Participants may be represented in > 1 category. Immunosuppression (Immuno).|percentage of participants|Number|20.0|20.0||||||
4179115|NCT00799591|4000158|B1|Chronic hepatic failure Type A||Percentage of participants per co-morbid (concomitant) diseases|Participants may be represented in > 1 category. Immunosuppression (Immuno).|percentage of participants|Number|80.0|80.0||||||
4179116|NCT00799591|4000158|B1|Chronic renal failure||Percentage of participants per co-morbid (concomitant) diseases|Participants may be represented in > 1 category. Immunosuppression (Immuno).|percentage of participants|Number|10.3|10.3||||||
4179117|NCT00799591|4000158|B1|Non-insulin dependent diabetes||Percentage of participants per co-morbid (concomitant) diseases|Participants may be represented in > 1 category. Immunosuppression (Immuno).|percentage of participants|Number|14.1|14.1||||||
4179118|NCT00799591|4000158|B1|Diabetes mellitus||Percentage of participants per co-morbid (concomitant) diseases|Participants may be represented in > 1 category. Immunosuppression (Immuno).|percentage of participants|Number|5.1|5.1||||||
4179119|NCT00799591|4000158|B1|Other||Percentage of participants per reason for choice of treatment with Tigecycline|Participants may be represented in > 1 category. Multi-resistant bacteria (MRB).|percentage of participants|Number|6.4|6.4||||||
4179120|NCT00799591|4000158|B1|Rescue medication||Percentage of participants per reason for choice of treatment with Tigecycline|Participants may be represented in > 1 category. Multi-resistant bacteria (MRB).|percentage of participants|Number|8.3|8.3||||||
4179121|NCT00799591|4000158|B1|Allergy or intolerance to other antiobiotics||Percentage of participants per reason for choice of treatment with Tigecycline|Participants may be represented in > 1 category. Multi-resistant bacteria (MRB).|percentage of participants|Number|9.6|9.6||||||
4179122|NCT00799591|4000158|B1|Failure of previous treatment||Percentage of participants per reason for choice of treatment with Tigecycline|Participants may be represented in > 1 category. Multi-resistant bacteria (MRB).|percentage of participants|Number|12.2|12.2||||||
4179123|NCT00799591|4000158|B1|Multiple sites||Percentage of participants per reason for choice of treatment with Tigecycline|Participants may be represented in > 1 category. Multi-resistant bacteria (MRB).|percentage of participants|Number|15.4|15.4||||||
4179124|NCT00799591|4000158|B1|Renal impairment||Percentage of participants per reason for choice of treatment with Tigecycline|Participants may be represented in > 1 category. Multi-resistant bacteria (MRB).|percentage of participants|Number|17.9|17.9||||||
4179125|NCT00799591|4000158|B1|MRB suspected or identified||Percentage of participants per reason for choice of treatment with Tigecycline|Participants may be represented in > 1 category. Multi-resistant bacteria (MRB).|percentage of participants|Number|40.4|40.4||||||
4179126|NCT00799591|4000158|B1|Polymicrobial infection||Percentage of participants per reason for choice of treatment with Tigecycline|Participants may be represented in > 1 category. Multi-resistant bacteria (MRB).|percentage of participants|Number|55.1|55.1||||||
4179127|NCT00799591|4000158|B1|||Mean Sepsis-related Organ Failure Assessment (SOFA) score|Assess extent of organ function or rate of failure during ICU admission. Based on scores for 6 systems (respiratory, cardiovascular, hepatic, coagulation, renal, and neurological) graded from 0 (normal) to 4 (most abnormal) with a potential total score of 0 to 24; higher score indicates greater system abnormality.|scores on a scale|Mean|7.0|7.0|Standard Deviation|4.5|4.5|||
4179128|NCT00799591|4000158|B1|||Mean Simplified Acute Physiology Score II (SAPSII): Integer score|Severity of disease measurement 24 hours after ICU admission based on 17 variables. Result values transformed to an integer point score from 0 (less severe disease state) to 163 (more severe disease state) and can also be used to calculate a corresponding mortality between 0% (no predicted mortality) and 100% (greatest predicted mortality). N=147|scores on a scale|Mean|43.3|43.3|Standard Deviation|16.4|16.4|||
4179129|NCT00799591|4000158|B1|Localization ≥ 10%: Miscellaneous||Percentage of participants per type of infection: Other infections|Nosocomial=hospital acquired infection. Participants may be represented in > 1 category. Infection N=56, Localization N=56.|percentage of participants|Number|32.1|32.1||||||
4179130|NCT00799591|4000158|B1|Localization ≥ 10%: Lung||Percentage of participants per type of infection: Other infections|Nosocomial=hospital acquired infection. Participants may be represented in > 1 category. Infection N=56, Localization N=56.|percentage of participants|Number|67.9|67.9||||||
4179131|NCT00799591|4000158|B1|Infections: Community||Percentage of participants per type of infection: Other infections|Nosocomial=hospital acquired infection. Participants may be represented in > 1 category. Infection N=56, Localization N=56.|percentage of participants|Number|10.7|10.7||||||
4179132|NCT00799591|4000158|B1|Infection: Nosocomial||Percentage of participants per type of infection: Other infections|Nosocomial=hospital acquired infection. Participants may be represented in > 1 category. Infection N=56, Localization N=56.|percentage of participants|Number|89.3|89.3||||||
4179133|NCT00799591|4000158|B1|Localization ≥ 10%: Perineum||Percentage of participants per type of infection: Infection of skin and soft tissue|Nosocomial=hospital acquired infection. Participants may be represented in > 1 category. Infection N=29, Dermo-panniculis N=29, Localization N=17.|percentage of participants|Number|11.8|11.8||||||
4179134|NCT00799591|4000158|B1|Localization ≥ 10%: Head and neck||Percentage of participants per type of infection: Infection of skin and soft tissue|Nosocomial=hospital acquired infection. Participants may be represented in > 1 category. Infection N=29, Dermo-panniculis N=29, Localization N=17.|percentage of participants|Number|29.4|29.4||||||
4179135|NCT00799591|4000158|B1|Localization ≥ 10%: Abdomen||Percentage of participants per type of infection: Infection of skin and soft tissue|Nosocomial=hospital acquired infection. Participants may be represented in > 1 category. Infection N=29, Dermo-panniculis N=29, Localization N=17.|percentage of participants|Number|52.9|52.9||||||
4179136|NCT00799591|4000158|B1|Dermo-panniculis||Percentage of participants per type of infection: Infection of skin and soft tissue|Nosocomial=hospital acquired infection. Participants may be represented in > 1 category. Infection N=29, Dermo-panniculis N=29, Localization N=17.|percentage of participants|Number|96.6|96.6||||||
4179137|NCT00799591|4000158|B1|Infection: Community||Percentage of participants per type of infection: Infection of skin and soft tissue|Nosocomial=hospital acquired infection. Participants may be represented in > 1 category. Infection N=29, Dermo-panniculis N=29, Localization N=17.|percentage of participants|Number|31.0|31.0||||||
4179138|NCT00799591|4000158|B1|Infection: Nosocomial||Percentage of participants per type of infection: Infection of skin and soft tissue|Nosocomial=hospital acquired infection. Participants may be represented in > 1 category. Infection N=29, Dermo-panniculis N=29, Localization N=17.|percentage of participants|Number|69.0|69.0||||||
4179139|NCT00799591|4000158|B1|Localization ≥ 10%: Other||Percentage of participants per type of infection: Intra-abdominal|Nosocomial=hospital acquired infection. Participants may be represented in > 1 category. Infection N=88, Peritonitis N=68, Localization N=88.|percentage of participants|Number|12.5|12.5||||||
4179140|NCT00799591|4000158|B1|Localization ≥ 10%: Colon||Percentage of participants per type of infection: Intra-abdominal|Nosocomial=hospital acquired infection. Participants may be represented in > 1 category. Infection N=88, Peritonitis N=68, Localization N=88.|percentage of participants|Number|37.5|37.5||||||
4179141|NCT00799591|4000158|B1|Peritonitis: Localized||Percentage of participants per type of infection: Intra-abdominal|Nosocomial=hospital acquired infection. Participants may be represented in > 1 category. Infection N=88, Peritonitis N=68, Localization N=88.|percentage of participants|Number|14.7|14.7||||||
4179142|NCT00799591|4000158|B1|Peritonitis: Abscess without peritonitis||Percentage of participants per type of infection: Intra-abdominal|Nosocomial=hospital acquired infection. Participants may be represented in > 1 category. Infection N=88, Peritonitis N=68, Localization N=88.|percentage of participants|Number|22.1|22.1||||||
4179143|NCT00799591|4000158|B1|Peritonitis: Generalized||Percentage of participants per type of infection: Intra-abdominal|Nosocomial=hospital acquired infection. Participants may be represented in > 1 category. Infection N=88, Peritonitis N=68, Localization N=88.|percentage of participants|Number|63.2|63.2||||||
4179144|NCT00799591|4000158|B1|Infection: Community||Percentage of participants per type of infection: Intra-abdominal|Nosocomial=hospital acquired infection. Participants may be represented in > 1 category. Infection N=88, Peritonitis N=68, Localization N=88.|percentage of participants|Number|30.7|30.7||||||
4179145|NCT00799591|4000158|B1|Infection: Nosocomial||Percentage of participants per type of infection: Intra-abdominal|Nosocomial=hospital acquired infection. Participants may be represented in > 1 category. Infection N=88, Peritonitis N=68, Localization N=88.|percentage of participants|Number|69.3|69.3||||||
4179146|NCT00799591|4000158|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4179147|NCT00799591|4000158|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4179148|NCT00799591|4000158|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|15.4|15.4|||
4179149|NCT00799578|4000169|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4179150|NCT00799578|4000169|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4179151|NCT00799578|4000169|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4179152|NCT00799578|4000169|B1|||Age||years|Mean|14|14.0|Standard Deviation|1|1.0|||
4179153|NCT00799578|4000169|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4179154|NCT00799578|4000169|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4179155|NCT00799578|4000169|B1||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4179156|NCT00799487|4000173|B4|USA||Region of Enrollment||participants|Number|89|89.0||||||
4179157|NCT00799487|4000174|B3|USA||Region of Enrollment||participants|Number|34|34.0||||||
4179158|NCT00799487|4000175|B2|USA||Region of Enrollment||participants|Number|34|34.0||||||
4179159|NCT00799487|4000176|B1|USA||Region of Enrollment||participants|Number|21|21.0||||||
4179160|NCT00799487|4000173|B4||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4179161|NCT00799487|4000174|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4179162|NCT00799487|4000175|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4179163|NCT00799487|4000176|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4179164|NCT00799487|4000173|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4179165|NCT00799487|4000174|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4179166|NCT00799487|4000175|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4179167|NCT00799487|4000176|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4179168|NCT00799487|4000173|B4|||Age||years|Mean|10.2|10.2|Standard Deviation|1.03|1.03|||
4179169|NCT00799487|4000174|B3|||Age||years|Mean|10.4|10.4|Standard Deviation|0.99|0.99|||
4179170|NCT00799487|4000175|B2|||Age||years|Mean|10.1|10.1|Standard Deviation|1.07|1.07|||
4179171|NCT00799487|4000176|B1|||Age||years|Mean|10.0|10.0|Standard Deviation|1.00|1.0|||
4179172|NCT00799474|4000258|B1|United States||Region of Enrollment||participants|Number|609|609.0||||||
4179173|NCT00799474|4000258|B1||Male|Sex: Female, Male||Participants|Count of Participants|609|609.0||||||
4179174|NCT00799474|4000258|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4179175|NCT00799474|4000258|B1|||Age||years|Mean|44.5|44.5|Standard Deviation|10.2|10.2|||
4179176|NCT00799474|4000258|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4179177|NCT00799474|4000258|B1||Between 18 and 65 years|Age||Participants|Count of Participants|609|609.0||||||
4179178|NCT00799474|4000258|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4179179|NCT00799435|4000264|B3|United States||Region of Enrollment|texas|Participants|Count of Participants|2|2.0||||||
4179180|NCT00799435|4000265|B2|United States||Region of Enrollment|texas|Participants|Count of Participants|1|1.0||||||
4179181|NCT00799435|4000266|B1|United States||Region of Enrollment|texas|Participants|Count of Participants|1|1.0||||||
4179182|NCT00799435|4000264|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179183|NCT00799435|4000265|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179184|NCT00799435|4000266|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179185|NCT00799435|4000264|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179186|NCT00799435|4000265|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179187|NCT00799435|4000266|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179188|NCT00799435|4000264|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4179189|NCT00799435|4000265|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4179190|NCT00799435|4000266|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179191|NCT00799435|4000264|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4179194|NCT00799435|4000264|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179195|NCT00799435|4000265|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179196|NCT00799435|4000266|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179197|NCT00799435|4000264|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179198|NCT00799435|4000265|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179199|NCT00799435|4000266|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179200|NCT00799435|4000264|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179201|NCT00799435|4000265|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179202|NCT00799435|4000266|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179203|NCT00799435|4000264|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4179204|NCT00799435|4000265|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4179205|NCT00799435|4000266|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4179206|NCT00799435|4000264|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4179207|NCT00799435|4000265|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4179208|NCT00799435|4000266|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4179209|NCT00799435|4000264|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4179210|NCT00799435|4000265|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4179211|NCT00799435|4000266|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4179212|NCT00799435|4000264|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4179213|NCT00799435|4000265|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4179214|NCT00799435|4000266|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4179215|NCT00799435|4000264|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4179216|NCT00799435|4000265|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4179217|NCT00799435|4000266|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4179218|NCT00799422|4000273|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4179219|NCT00799422|4000273|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4179220|NCT00799422|4000273|B1|||Age||years|Mean|41.6|41.6|Standard Deviation|10.1|10.1|||
4179221|NCT00799409|4000292|B4|USA||Region of Enrollment||participants|Number|78|78.0||||||
4179222|NCT00799409|4000293|B3|USA||Region of Enrollment||participants|Number|35|35.0||||||
4179223|NCT00799409|4000294|B2|USA||Region of Enrollment||participants|Number|36|36.0||||||
4179224|NCT00799409|4000295|B1|USA||Region of Enrollment||participants|Number|7|7.0||||||
4179225|NCT00799409|4000292|B4||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4179226|NCT00799409|4000293|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4179227|NCT00799409|4000294|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4179228|NCT00799409|4000295|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4179229|NCT00799409|4000292|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4179230|NCT00799409|4000293|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4179231|NCT00799409|4000294|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4179232|NCT00799409|4000295|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4179233|NCT00799409|4000292|B4|||Age||years|Mean|10.1|10.1|Standard Deviation|1.08|1.08|||
4179234|NCT00799409|4000293|B3|||Age||years|Mean|10.0|10.0|Standard Deviation|1.14|1.14|||
4179235|NCT00799409|4000294|B2|||Age||years|Mean|10.3|10.3|Standard Deviation|1.07|1.07|||
4179236|NCT00799409|4000295|B1|||Age||years|Mean|9.9|9.9|Standard Deviation|0.69|0.69|||
4179237|NCT00799396|4000377|B1|United States||Region of Enrollment||participants|Number|682|682.0||||||
4179238|NCT00799396|4000377|B1||Male|Sex: Female, Male||Participants|Count of Participants|339|339.0||||||
4179239|NCT00799396|4000377|B1||Female|Sex: Female, Male||Participants|Count of Participants|343|343.0||||||
4179240|NCT00799396|4000377|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|13.5|13.5|||
4179241|NCT00799383|4000382|B3|||Trabecular Bone Mineral Density, mg/cm3||mg/cm3|Mean|195.0|195.0|Standard Deviation|37.5|37.5|||
4179242|NCT00799383|4000383|B2|||Trabecular Bone Mineral Density, mg/cm3||mg/cm3|Mean|197.2|197.2|Standard Deviation|43.9|43.9|||
4179243|NCT00799383|4000384|B1|||Trabecular Bone Mineral Density, mg/cm3||mg/cm3|Mean|192.9|192.9|Standard Deviation|31.1|31.1|||
4179244|NCT00799383|4000382|B3|||Total Body Less Head Bone Mineral Content Z-score|This measure is based on a whole-body dual energy x-ray absorptiometry (DXA) scan.|Z-score|Mean|0.11|0.11|Standard Deviation|0.73|0.73|||
4179245|NCT00799383|4000383|B2|||Total Body Less Head Bone Mineral Content Z-score|This measure is based on a whole-body dual energy x-ray absorptiometry (DXA) scan.|Z-score|Mean|0.12|0.12|Standard Deviation|0.68|0.68|||
4179246|NCT00799383|4000384|B1|||Total Body Less Head Bone Mineral Content Z-score|This measure is based on a whole-body dual energy x-ray absorptiometry (DXA) scan.|Z-score|Mean|0.10|0.1|Standard Deviation|0.79|0.79|||
4179247|NCT00799383|4000382|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4179248|NCT00799383|4000383|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179249|NCT00799383|4000384|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4179250|NCT00799383|4000382|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179251|NCT00799383|4000383|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179252|NCT00799383|4000384|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179253|NCT00799383|4000382|B3||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4179254|NCT00799383|4000383|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4179255|NCT00799383|4000384|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4179256|NCT00799383|4000382|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4179257|NCT00799383|4000383|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4179258|NCT00799383|4000384|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4179259|NCT00799383|4000382|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179260|NCT00799383|4000383|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179261|NCT00799383|4000384|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179262|NCT00799383|4000382|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179263|NCT00799383|4000383|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179264|NCT00799383|4000384|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179265|NCT00799383|4000382|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179266|NCT00799383|4000383|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179267|NCT00799383|4000384|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179268|NCT00799383|4000382|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179269|NCT00799383|4000383|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179270|NCT00799383|4000384|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179271|NCT00799383|4000382|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4179272|NCT00799383|4000383|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4179273|NCT00799383|4000384|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4179274|NCT00799383|4000382|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4179275|NCT00799383|4000383|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179276|NCT00799383|4000384|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4179277|NCT00799383|4000382|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4179278|NCT00799383|4000383|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4179279|NCT00799383|4000384|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4179280|NCT00799383|4000382|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4179281|NCT00799383|4000383|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4179282|NCT00799383|4000384|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4179283|NCT00799383|4000382|B3|||Age||years|Mean|11.5|11.5|Standard Deviation|3.0|3.0|||
4179284|NCT00799383|4000383|B2|||Age||years|Mean|12.1|12.1|Standard Deviation|3.0|3.0|||
4179285|NCT00799383|4000384|B1|||Age||years|Mean|10.8|10.8|Standard Deviation|3.0|3.0|||
4179286|NCT00799292|4000405|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
4179287|NCT00799292|4000406|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4179288|NCT00799292|4000407|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4179289|NCT00799292|4000405|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4179290|NCT00799292|4000406|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4179291|NCT00799292|4000407|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4179292|NCT00799292|4000405|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4179293|NCT00799292|4000406|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4179294|NCT00799292|4000407|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4179295|NCT00799292|4000405|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4179296|NCT00799292|4000406|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4179297|NCT00799292|4000407|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4179298|NCT00799292|4000405|B3||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4179299|NCT00799292|4000406|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4179300|NCT00799292|4000407|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4179301|NCT00799292|4000405|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4179302|NCT00799292|4000406|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4179303|NCT00799292|4000407|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4179304|NCT00799227|4000412|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4179305|NCT00799227|4000412|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4179306|NCT00799227|4000412|B1|>65 years||Age, Customized||Participants|Number|19|19.0||||||
4179307|NCT00799227|4000412|B1|18 to 65 years||Age, Customized||Participants|Number|37|37.0||||||
4179308|NCT00798967|4000419|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4179309|NCT00798967|4000420|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4179310|NCT00798967|4000421|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4179311|NCT00798967|4000419|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4179312|NCT00798967|4000420|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4179313|NCT00798967|4000421|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4179314|NCT00798967|4000419|B3|||Age||years|Mean|50.3|50.3|Standard Deviation|14.1|14.1|||
4179315|NCT00798967|4000420|B2|||Age||years|Mean|49.7|49.7|Standard Deviation|15.6|15.6|||
4179316|NCT00798967|4000421|B1|||Age||years|Mean|50.9|50.9|Standard Deviation|12.6|12.6|||
4179317|NCT00798889|4000430|B1||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4179318|NCT00798889|4000430|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4179319|NCT00798889|4000430|B1|||Age||Years|Mean|58.5|58.5|Standard Deviation|11.62|11.62|||
4179320|NCT00798759|4000434|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4179321|NCT00798759|4000435|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4179322|NCT00798759|4000436|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4179323|NCT00798759|4000434|B3||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4179324|NCT00798759|4000435|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4179325|NCT00798759|4000436|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4179326|NCT00798759|4000434|B3|||Age||years|Mean|67.6|67.6|Standard Deviation|11.4|11.4|||
4179327|NCT00798759|4000435|B2|||Age||years|Mean|69.0|69.0|Standard Deviation|10.4|10.4|||
4179328|NCT00798759|4000436|B1|||Age||years|Mean|66.3|66.3|Standard Deviation|12.1|12.1|||
4179329|NCT00798720|4000445|B1|||Prior thoracic radiation therapy||participants|Number|6|6.0||||||
4179330|NCT00798720|4000445|B1|Not reported||Response to second-line therapy||participants|Number|1|1.0||||||
4179331|NCT00798720|4000445|B1|Progressive disease||Response to second-line therapy||participants|Number|13|13.0||||||
4179332|NCT00798720|4000445|B1|Stable disease||Response to second-line therapy||participants|Number|3|3.0||||||
4179333|NCT00798720|4000445|B1|Partial response||Response to second-line therapy||participants|Number|1|1.0||||||
4179334|NCT00798720|4000445|B1|Platinum doublets||Prior second-line systemic therapy||participants|Number|2|2.0||||||
4179335|NCT00798720|4000445|B1|Erlotinib||Prior second-line systemic therapy||participants|Number|4|4.0||||||
4179336|NCT00798720|4000445|B1|Docetaxel/Investigational drug||Prior second-line systemic therapy||participants|Number|1|1.0||||||
4179337|NCT00798720|4000445|B1|Pemetrexed/Investigational drug||Prior second-line systemic therapy||participants|Number|1|1.0||||||
4179338|NCT00798720|4000445|B1|Pemetrexed||Prior second-line systemic therapy||participants|Number|10|10.0||||||
4179339|NCT00798720|4000445|B1|Not reported||Response to first-line therapy||participants|Number|1|1.0||||||
4179340|NCT00798720|4000445|B1|Progressive disease||Response to first-line therapy||participants|Number|6|6.0||||||
4179341|NCT00798720|4000445|B1|Stable disease||Response to first-line therapy||participants|Number|4|4.0||||||
4179342|NCT00798720|4000445|B1|Partial response||Response to first-line therapy||participants|Number|7|7.0||||||
4179343|NCT00798720|4000445|B1|Vinorelbine/Platinum||Prior first-line systemic therapy||participants|Number|1|1.0||||||
4179344|NCT00798720|4000445|B1|Pemetrexed/Platinum||Prior first-line systemic therapy||participants|Number|3|3.0||||||
4179345|NCT00798720|4000445|B1|Paclitaxel/Platinum/Investigational Drug||Prior first-line systemic therapy||participants|Number|2|2.0||||||
4179346|NCT00798720|4000445|B1|Paclitaxel/Platinum/Bevacizumab||Prior first-line systemic therapy||participants|Number|2|2.0||||||
4179347|NCT00798720|4000445|B1|Paclitaxel/Platinum||Prior first-line systemic therapy||participants|Number|10|10.0||||||
4179348|NCT00798720|4000445|B1|Brain Metastases||Disease Stage|Disease stage per American Joint Committee on Cancer (AJCC) Lung Cancer Staging|participants|Number|6|6.0||||||
4179349|NCT00798720|4000445|B1|Recurrent||Disease Stage|Disease stage per American Joint Committee on Cancer (AJCC) Lung Cancer Staging|participants|Number|2|2.0||||||
4179350|NCT00798720|4000445|B1|Metastatic||Disease Stage|Disease stage per American Joint Committee on Cancer (AJCC) Lung Cancer Staging|participants|Number|16|16.0||||||
4179351|NCT00798720|4000445|B1|2||Performance Status|Assigned following the Eastern Cooperative Oncology Group (ECOG) scale. Scores range from 0 (fully active) to 5 (dead).|participants|Number|1|1.0||||||
4179352|NCT00798720|4000445|B1|1||Performance Status|Assigned following the Eastern Cooperative Oncology Group (ECOG) scale. Scores range from 0 (fully active) to 5 (dead).|participants|Number|12|12.0||||||
4179353|NCT00798720|4000445|B1|0||Performance Status|Assigned following the Eastern Cooperative Oncology Group (ECOG) scale. Scores range from 0 (fully active) to 5 (dead).|participants|Number|5|5.0||||||
4179354|NCT00798720|4000445|B1|NSCLC, NOS||Histology||participants|Number|7|7.0||||||
4179355|NCT00798720|4000445|B1|Squamous Cell||Histology||participants|Number|2|2.0||||||
4179356|NCT00798720|4000445|B1|Adenocarcinoma||Histology||participants|Number|9|9.0||||||
4179357|NCT00798720|4000445|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4179358|NCT00798720|4000445|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179359|NCT00798720|4000445|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179360|NCT00798720|4000445|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4179361|NCT00798720|4000445|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4179362|NCT00798720|4000445|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179363|NCT00798720|4000445|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179364|NCT00798720|4000445|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179365|NCT00798720|4000445|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4179366|NCT00798720|4000445|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4179367|NCT00798720|4000445|B1|||Age||years|Median|57|57.0|Full Range|||45.0|78.0|
4179368|NCT00798707|4000452|B4|Suicidal ideation||Participants with Columbia Suicide-Severity Rating Scale (C-SSRS) total score|C-SSRS was mapped into Columbia Classification Algorithm of Suicide Assessment (C-CASA)(1-4) to prospectively assess whether participants experienced: completed suicide(1),suicide attempt(2),preparatory acts toward imminent suicidal behavior(3),suicidal ideation,any suicidal behavior and ideation(4).Participants with “yes” response were reported.|Participants|Number|113|113.0||||||
4179369|NCT00798707|4000453|B3|Suicidal ideation||Participants with Columbia Suicide-Severity Rating Scale (C-SSRS) total score|C-SSRS was mapped into Columbia Classification Algorithm of Suicide Assessment (C-CASA)(1-4) to prospectively assess whether participants experienced: completed suicide(1),suicide attempt(2),preparatory acts toward imminent suicidal behavior(3),suicidal ideation,any suicidal behavior and ideation(4).Participants with “yes” response were reported.|Participants|Number|37|37.0||||||
4179370|NCT00798707|4000454|B2|Suicidal ideation||Participants with Columbia Suicide-Severity Rating Scale (C-SSRS) total score|C-SSRS was mapped into Columbia Classification Algorithm of Suicide Assessment (C-CASA)(1-4) to prospectively assess whether participants experienced: completed suicide(1),suicide attempt(2),preparatory acts toward imminent suicidal behavior(3),suicidal ideation,any suicidal behavior and ideation(4).Participants with “yes” response were reported.|Participants|Number|45|45.0||||||
4179371|NCT00798707|4000455|B1|Suicidal ideation||Participants with Columbia Suicide-Severity Rating Scale (C-SSRS) total score|C-SSRS was mapped into Columbia Classification Algorithm of Suicide Assessment (C-CASA)(1-4) to prospectively assess whether participants experienced: completed suicide(1),suicide attempt(2),preparatory acts toward imminent suicidal behavior(3),suicidal ideation,any suicidal behavior and ideation(4).Participants with “yes” response were reported.|Participants|Number|31|31.0||||||
4179372|NCT00798707|4000452|B4|Preparatory acts toward imminent suicidal behavior||Participants with Columbia Suicide-Severity Rating Scale (C-SSRS) total score|C-SSRS was mapped into Columbia Classification Algorithm of Suicide Assessment (C-CASA)(1-4) to prospectively assess whether participants experienced: completed suicide(1),suicide attempt(2),preparatory acts toward imminent suicidal behavior(3),suicidal ideation,any suicidal behavior and ideation(4).Participants with “yes” response were reported.|Participants|Number|0|0.0||||||
4179373|NCT00798707|4000453|B3|Preparatory acts toward imminent suicidal behavior||Participants with Columbia Suicide-Severity Rating Scale (C-SSRS) total score|C-SSRS was mapped into Columbia Classification Algorithm of Suicide Assessment (C-CASA)(1-4) to prospectively assess whether participants experienced: completed suicide(1),suicide attempt(2),preparatory acts toward imminent suicidal behavior(3),suicidal ideation,any suicidal behavior and ideation(4).Participants with “yes” response were reported.|Participants|Number|0|0.0||||||
4179374|NCT00798707|4000454|B2|Preparatory acts toward imminent suicidal behavior||Participants with Columbia Suicide-Severity Rating Scale (C-SSRS) total score|C-SSRS was mapped into Columbia Classification Algorithm of Suicide Assessment (C-CASA)(1-4) to prospectively assess whether participants experienced: completed suicide(1),suicide attempt(2),preparatory acts toward imminent suicidal behavior(3),suicidal ideation,any suicidal behavior and ideation(4).Participants with “yes” response were reported.|Participants|Number|0|0.0||||||
4179375|NCT00798707|4000455|B1|Preparatory acts toward imminent suicidal behavior||Participants with Columbia Suicide-Severity Rating Scale (C-SSRS) total score|C-SSRS was mapped into Columbia Classification Algorithm of Suicide Assessment (C-CASA)(1-4) to prospectively assess whether participants experienced: completed suicide(1),suicide attempt(2),preparatory acts toward imminent suicidal behavior(3),suicidal ideation,any suicidal behavior and ideation(4).Participants with “yes” response were reported.|Participants|Number|0|0.0||||||
4179376|NCT00798707|4000452|B4|Suicide attempt||Participants with Columbia Suicide-Severity Rating Scale (C-SSRS) total score|C-SSRS was mapped into Columbia Classification Algorithm of Suicide Assessment (C-CASA)(1-4) to prospectively assess whether participants experienced: completed suicide(1),suicide attempt(2),preparatory acts toward imminent suicidal behavior(3),suicidal ideation,any suicidal behavior and ideation(4).Participants with “yes” response were reported.|Participants|Number|0|0.0||||||
4179377|NCT00798707|4000453|B3|Suicide attempt||Participants with Columbia Suicide-Severity Rating Scale (C-SSRS) total score|C-SSRS was mapped into Columbia Classification Algorithm of Suicide Assessment (C-CASA)(1-4) to prospectively assess whether participants experienced: completed suicide(1),suicide attempt(2),preparatory acts toward imminent suicidal behavior(3),suicidal ideation,any suicidal behavior and ideation(4).Participants with “yes” response were reported.|Participants|Number|0|0.0||||||
4179378|NCT00798707|4000454|B2|Suicide attempt||Participants with Columbia Suicide-Severity Rating Scale (C-SSRS) total score|C-SSRS was mapped into Columbia Classification Algorithm of Suicide Assessment (C-CASA)(1-4) to prospectively assess whether participants experienced: completed suicide(1),suicide attempt(2),preparatory acts toward imminent suicidal behavior(3),suicidal ideation,any suicidal behavior and ideation(4).Participants with “yes” response were reported.|Participants|Number|0|0.0||||||
4179379|NCT00798707|4000455|B1|Suicide attempt||Participants with Columbia Suicide-Severity Rating Scale (C-SSRS) total score|C-SSRS was mapped into Columbia Classification Algorithm of Suicide Assessment (C-CASA)(1-4) to prospectively assess whether participants experienced: completed suicide(1),suicide attempt(2),preparatory acts toward imminent suicidal behavior(3),suicidal ideation,any suicidal behavior and ideation(4).Participants with “yes” response were reported.|Participants|Number|0|0.0||||||
4179380|NCT00798707|4000452|B4|Completed Suicide||Participants with Columbia Suicide-Severity Rating Scale (C-SSRS) total score|C-SSRS was mapped into Columbia Classification Algorithm of Suicide Assessment (C-CASA)(1-4) to prospectively assess whether participants experienced: completed suicide(1),suicide attempt(2),preparatory acts toward imminent suicidal behavior(3),suicidal ideation,any suicidal behavior and ideation(4).Participants with “yes” response were reported.|Participants|Number|0|0.0||||||
4179381|NCT00798707|4000453|B3|Completed Suicide||Participants with Columbia Suicide-Severity Rating Scale (C-SSRS) total score|C-SSRS was mapped into Columbia Classification Algorithm of Suicide Assessment (C-CASA)(1-4) to prospectively assess whether participants experienced: completed suicide(1),suicide attempt(2),preparatory acts toward imminent suicidal behavior(3),suicidal ideation,any suicidal behavior and ideation(4).Participants with “yes” response were reported.|Participants|Number|0|0.0||||||
4179429|NCT00798694|4000509|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4179382|NCT00798707|4000454|B2|Completed Suicide||Participants with Columbia Suicide-Severity Rating Scale (C-SSRS) total score|C-SSRS was mapped into Columbia Classification Algorithm of Suicide Assessment (C-CASA)(1-4) to prospectively assess whether participants experienced: completed suicide(1),suicide attempt(2),preparatory acts toward imminent suicidal behavior(3),suicidal ideation,any suicidal behavior and ideation(4).Participants with “yes” response were reported.|Participants|Number|0|0.0||||||
4179383|NCT00798707|4000455|B1|Completed Suicide||Participants with Columbia Suicide-Severity Rating Scale (C-SSRS) total score|C-SSRS was mapped into Columbia Classification Algorithm of Suicide Assessment (C-CASA)(1-4) to prospectively assess whether participants experienced: completed suicide(1),suicide attempt(2),preparatory acts toward imminent suicidal behavior(3),suicidal ideation,any suicidal behavior and ideation(4).Participants with “yes” response were reported.|Participants|Number|0|0.0||||||
4179384|NCT00798707|4000452|B4|||Participants with Sexual dysfunction|Arizona Sexual Experiences Scale (ASEX) includes 5 questions that evaluate sexual function exclusively during week prior to completion in the following areas: libido, excitability and ability to reach orgasm. Sexual dysfunction=ASEX total score of 19 or greater, or a score of 5 or greater on any item, or a score of 4 or greater on any 3 items.|Percentage of Participants|Number|194.8|194.8||||||
4179385|NCT00798707|4000453|B3|||Participants with Sexual dysfunction|Arizona Sexual Experiences Scale (ASEX) includes 5 questions that evaluate sexual function exclusively during week prior to completion in the following areas: libido, excitability and ability to reach orgasm. Sexual dysfunction=ASEX total score of 19 or greater, or a score of 5 or greater on any item, or a score of 4 or greater on any 3 items.|Percentage of Participants|Number|62.3|62.3||||||
4179386|NCT00798707|4000454|B2|||Participants with Sexual dysfunction|Arizona Sexual Experiences Scale (ASEX) includes 5 questions that evaluate sexual function exclusively during week prior to completion in the following areas: libido, excitability and ability to reach orgasm. Sexual dysfunction=ASEX total score of 19 or greater, or a score of 5 or greater on any item, or a score of 4 or greater on any 3 items.|Percentage of Participants|Number|66.1|66.1||||||
4179387|NCT00798707|4000455|B1|||Participants with Sexual dysfunction|Arizona Sexual Experiences Scale (ASEX) includes 5 questions that evaluate sexual function exclusively during week prior to completion in the following areas: libido, excitability and ability to reach orgasm. Sexual dysfunction=ASEX total score of 19 or greater, or a score of 5 or greater on any item, or a score of 4 or greater on any 3 items.|Percentage of Participants|Number|66.4|66.4||||||
4179388|NCT00798707|4000452|B4|||World Health Organization 5-Item Well-Being Index (WHO-5)|WHO-5 evaluates positive psychological well-being. WHO-5 consists of 5 questions and each is rated on a 6-point scale. The total score ranges from 0 to 25 ( 0= worst possible quality of life; 25=best possible quality of life).|Units on a scale|Mean|7.09|7.09|Standard Deviation|4.27|4.27|||
4179389|NCT00798707|4000453|B3|||World Health Organization 5-Item Well-Being Index (WHO-5)|WHO-5 evaluates positive psychological well-being. WHO-5 consists of 5 questions and each is rated on a 6-point scale. The total score ranges from 0 to 25 ( 0= worst possible quality of life; 25=best possible quality of life).|Units on a scale|Mean|7.18|7.18|Standard Deviation|4.34|4.34|||
4179390|NCT00798707|4000454|B2|||World Health Organization 5-Item Well-Being Index (WHO-5)|WHO-5 evaluates positive psychological well-being. WHO-5 consists of 5 questions and each is rated on a 6-point scale. The total score ranges from 0 to 25 ( 0= worst possible quality of life; 25=best possible quality of life).|Units on a scale|Mean|6.89|6.89|Standard Deviation|3.99|3.99|||
4179391|NCT00798707|4000455|B1|||World Health Organization 5-Item Well-Being Index (WHO-5)|WHO-5 evaluates positive psychological well-being. WHO-5 consists of 5 questions and each is rated on a 6-point scale. The total score ranges from 0 to 25 ( 0= worst possible quality of life; 25=best possible quality of life).|Units on a scale|Mean|7.21|7.21|Standard Deviation|4.47|4.47|||
4179392|NCT00798707|4000452|B4|||Sheehan Disability Scale (SDS) Total Score|SDS: a self-administered tool that measures functional impairment in 3 domains: Work/School, Social Life, and Family Life/Home Responsibilities.Participant rates extent to which each of these domains are impaired by his/her symptoms using 10 point visual analog scale:(0=not at all impaired,10=extremely impaired) for total maximum score of 30.|Units on a scale|Mean|16.57|16.57|Standard Deviation|7.46|7.46|||
4179393|NCT00798707|4000453|B3|||Sheehan Disability Scale (SDS) Total Score|SDS: a self-administered tool that measures functional impairment in 3 domains: Work/School, Social Life, and Family Life/Home Responsibilities.Participant rates extent to which each of these domains are impaired by his/her symptoms using 10 point visual analog scale:(0=not at all impaired,10=extremely impaired) for total maximum score of 30.|Units on a scale|Mean|16.39|16.39|Standard Deviation|7.27|7.27|||
4179394|NCT00798707|4000454|B2|||Sheehan Disability Scale (SDS) Total Score|SDS: a self-administered tool that measures functional impairment in 3 domains: Work/School, Social Life, and Family Life/Home Responsibilities.Participant rates extent to which each of these domains are impaired by his/her symptoms using 10 point visual analog scale:(0=not at all impaired,10=extremely impaired) for total maximum score of 30.|Units on a scale|Mean|17.02|17.02|Standard Deviation|7.34|7.34|||
4179395|NCT00798707|4000455|B1|||Sheehan Disability Scale (SDS) Total Score|SDS: a self-administered tool that measures functional impairment in 3 domains: Work/School, Social Life, and Family Life/Home Responsibilities.Participant rates extent to which each of these domains are impaired by his/her symptoms using 10 point visual analog scale:(0=not at all impaired,10=extremely impaired) for total maximum score of 30.|Units on a scale|Mean|16.31|16.31|Standard Deviation|7.78|7.78|||
4179396|NCT00798707|4000452|B4|||HAM-D6 total score|HAM-D6: a standardized, clinician-administered rating scale that assesses 6 items associated with major depression and is a subset of the HAM-D17. HAM-D6 score ranges from 0-22. The scale uses HAM-D17 items: 1, 2, 7, 8, 10 and 13. Item 13 is scored 0-2 and all others are scored 0-4.|Units on a scale|Mean|12.54|12.54|Standard Deviation|1.77|1.77|||
4179397|NCT00798707|4000453|B3|||HAM-D6 total score|HAM-D6: a standardized, clinician-administered rating scale that assesses 6 items associated with major depression and is a subset of the HAM-D17. HAM-D6 score ranges from 0-22. The scale uses HAM-D17 items: 1, 2, 7, 8, 10 and 13. Item 13 is scored 0-2 and all others are scored 0-4.|Units on a scale|Mean|12.43|12.43|Standard Deviation|1.75|1.75|||
4179398|NCT00798707|4000454|B2|||HAM-D6 total score|HAM-D6: a standardized, clinician-administered rating scale that assesses 6 items associated with major depression and is a subset of the HAM-D17. HAM-D6 score ranges from 0-22. The scale uses HAM-D17 items: 1, 2, 7, 8, 10 and 13. Item 13 is scored 0-2 and all others are scored 0-4.|Units on a scale|Mean|12.61|12.61|Standard Deviation|1.77|1.77|||
4179399|NCT00798707|4000455|B1|||HAM-D6 total score|HAM-D6: a standardized, clinician-administered rating scale that assesses 6 items associated with major depression and is a subset of the HAM-D17. HAM-D6 score ranges from 0-22. The scale uses HAM-D17 items: 1, 2, 7, 8, 10 and 13. Item 13 is scored 0-2 and all others are scored 0-4.|Units on a scale|Mean|12.58|12.58|Standard Deviation|1.79|1.79|||
4179400|NCT00798707|4000452|B4|||Montgomery-Asberg Depression Rating Scale (MADRS) total score|MADRS measures the overall severity of depressive symptoms. The MADRS has a 10-item checklist. Items are rated on a scale of 0-6, for a total score range of 0 (low severity of depressive symptoms) to 60 (high severity of depressive symptoms).|Units on a scale|Mean|28.16|28.16|Standard Deviation|5.52|5.52|||
4179401|NCT00798707|4000453|B3|||Montgomery-Asberg Depression Rating Scale (MADRS) total score|MADRS measures the overall severity of depressive symptoms. The MADRS has a 10-item checklist. Items are rated on a scale of 0-6, for a total score range of 0 (low severity of depressive symptoms) to 60 (high severity of depressive symptoms).|Units on a scale|Mean|28.21|28.21|Standard Deviation|5.38|5.38|||
4179402|NCT00798707|4000454|B2|||Montgomery-Asberg Depression Rating Scale (MADRS) total score|MADRS measures the overall severity of depressive symptoms. The MADRS has a 10-item checklist. Items are rated on a scale of 0-6, for a total score range of 0 (low severity of depressive symptoms) to 60 (high severity of depressive symptoms).|Units on a scale|Mean|28.08|28.08|Standard Deviation|5.46|5.46|||
4179403|NCT00798707|4000455|B1|||Montgomery-Asberg Depression Rating Scale (MADRS) total score|MADRS measures the overall severity of depressive symptoms. The MADRS has a 10-item checklist. Items are rated on a scale of 0-6, for a total score range of 0 (low severity of depressive symptoms) to 60 (high severity of depressive symptoms).|Units on a scale|Mean|28.19|28.19|Standard Deviation|5.74|5.74|||
4179404|NCT00798707|4000452|B4|||Clinical Global Impressions Scale-Severity of Illness (CGI-S) Score|CGI-S: 7-point clinician rated scale to assess severity of participant's current illness state; range: 1 (normal - not ill at all) to 7 (among the most extremely ill patients). Higher score = more affected.|Units on a scale|Mean|4.36|4.36|Standard Deviation|0.58|0.58|||
4179405|NCT00798707|4000453|B3|||Clinical Global Impressions Scale-Severity of Illness (CGI-S) Score|CGI-S: 7-point clinician rated scale to assess severity of participant's current illness state; range: 1 (normal - not ill at all) to 7 (among the most extremely ill patients). Higher score = more affected.|Units on a scale|Mean|4.33|4.33|Standard Deviation|0.56|0.56|||
4179406|NCT00798707|4000454|B2|||Clinical Global Impressions Scale-Severity of Illness (CGI-S) Score|CGI-S: 7-point clinician rated scale to assess severity of participant's current illness state; range: 1 (normal - not ill at all) to 7 (among the most extremely ill patients). Higher score = more affected.|Units on a scale|Mean|4.35|4.35|Standard Deviation|0.57|0.57|||
4179407|NCT00798707|4000455|B1|||Clinical Global Impressions Scale-Severity of Illness (CGI-S) Score|CGI-S: 7-point clinician rated scale to assess severity of participant's current illness state; range: 1 (normal - not ill at all) to 7 (among the most extremely ill patients). Higher score = more affected.|Units on a scale|Mean|4.39|4.39|Standard Deviation|0.59|0.59|||
4179408|NCT00798707|4000452|B4|||Hamilton Psychiatric Scale for Depression-17 item (HAM-D17) total score|HAM-D17: a standardized, clinician-administered rating scale that assesses 17 items characteristically associated with major depression. Items are scored on either a 3 point (0 to 2) or a 5 point scale (0 to 4), with 0=none/absent and 4=most severe, for a maximum total score of 50.|Units on a scale|Mean|22.98|22.98|Standard Deviation|2.71|2.71|||
4179409|NCT00798707|4000453|B3|||Hamilton Psychiatric Scale for Depression-17 item (HAM-D17) total score|HAM-D17: a standardized, clinician-administered rating scale that assesses 17 items characteristically associated with major depression. Items are scored on either a 3 point (0 to 2) or a 5 point scale (0 to 4), with 0=none/absent and 4=most severe, for a maximum total score of 50.|Units on a scale|Mean|22.81|22.81|Standard Deviation|2.61|2.61|||
4179410|NCT00798707|4000454|B2|||Hamilton Psychiatric Scale for Depression-17 item (HAM-D17) total score|HAM-D17: a standardized, clinician-administered rating scale that assesses 17 items characteristically associated with major depression. Items are scored on either a 3 point (0 to 2) or a 5 point scale (0 to 4), with 0=none/absent and 4=most severe, for a maximum total score of 50.|Units on a scale|Mean|23.08|23.08|Standard Deviation|2.93|2.93|||
4179411|NCT00798707|4000455|B1|||Hamilton Psychiatric Scale for Depression-17 item (HAM-D17) total score|HAM-D17: a standardized, clinician-administered rating scale that assesses 17 items characteristically associated with major depression. Items are scored on either a 3 point (0 to 2) or a 5 point scale (0 to 4), with 0=none/absent and 4=most severe, for a maximum total score of 50.|Units on a scale|Mean|23.06|23.06|Standard Deviation|2.59|2.59|||
4179412|NCT00798707|4000452|B4||Male|Sex: Female, Male||Participants|Count of Participants|313|313.0||||||
4179413|NCT00798707|4000453|B3||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4179414|NCT00798707|4000454|B2||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4179415|NCT00798707|4000455|B1||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4179416|NCT00798707|4000452|B4||Female|Sex: Female, Male||Participants|Count of Participants|386|386.0||||||
4179417|NCT00798707|4000453|B3||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4179418|NCT00798707|4000454|B2||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4179419|NCT00798707|4000455|B1||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4179420|NCT00798707|4000452|B4|||Age||Years|Mean|39.67|39.67|Standard Deviation|12.10|12.1|||
4179421|NCT00798707|4000453|B3|||Age||Years|Mean|38.59|38.59|Standard Deviation|12.08|12.08|||
4179422|NCT00798707|4000454|B2|||Age||Years|Mean|40.19|40.19|Standard Deviation|11.88|11.88|||
4179423|NCT00798707|4000455|B1|||Age||Years|Mean|40.26|40.26|Standard Deviation|12.32|12.32|||
4179424|NCT00798694|4000507|B3|United States||Region of Enrollment||participants|Number|55|55.0||||||
4179425|NCT00798694|4000508|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4179426|NCT00798694|4000509|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4179427|NCT00798694|4000507|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4179428|NCT00798694|4000508|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4179430|NCT00798694|4000507|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4179431|NCT00798694|4000508|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4179432|NCT00798694|4000509|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4179433|NCT00798694|4000507|B3||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4179434|NCT00798694|4000508|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4179435|NCT00798694|4000509|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4179436|NCT00798694|4000507|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4179437|NCT00798694|4000508|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4179438|NCT00798694|4000509|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4179439|NCT00798694|4000507|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179440|NCT00798694|4000508|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179441|NCT00798694|4000509|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179442|NCT00798694|4000507|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179443|NCT00798694|4000508|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179444|NCT00798694|4000509|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179445|NCT00798694|4000507|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179446|NCT00798694|4000508|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179447|NCT00798694|4000509|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179448|NCT00798694|4000507|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4179449|NCT00798694|4000508|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4179450|NCT00798694|4000509|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4179451|NCT00798694|4000507|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4179452|NCT00798694|4000508|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4179453|NCT00798694|4000509|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4179454|NCT00798694|4000507|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4179455|NCT00798694|4000508|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4179456|NCT00798694|4000509|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4179457|NCT00798694|4000507|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4179458|NCT00798694|4000508|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4179459|NCT00798694|4000509|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4179460|NCT00798694|4000507|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4179461|NCT00798694|4000508|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4179462|NCT00798694|4000509|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4179463|NCT00798694|4000507|B3|||Age||years|Mean|61.4|61.4|Standard Deviation|12.4|12.4|||
4179464|NCT00798694|4000508|B2|||Age||years|Mean|61.2|61.2|Standard Deviation|13.2|13.2|||
4179465|NCT00798694|4000509|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|11.7|11.7|||
4179466|NCT00798655|4000534|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4179467|NCT00798655|4000534|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4179468|NCT00798655|4000534|B1|||Age||years|Median|58|58.0|Full Range|||23.0|81.0|
4179469|NCT00798603|4000539|B1||Stage IV|Non–small-cell lung cancer stage (TNM 6th edition)|"Stage IIIB: The cancer is continuing to spread from the lungs to the lymph nodes or to nearby structures and organs, such as the heart, trachea and esophagus.~Stage IV: The cancer has metastasized throughout the body and may now affect the liver, bones or brain."|Participants|Count of Participants|53|53.0||||||
4179470|NCT00798603|4000539|B1||Stage IIIB|Non–small-cell lung cancer stage (TNM 6th edition)|"Stage IIIB: The cancer is continuing to spread from the lungs to the lymph nodes or to nearby structures and organs, such as the heart, trachea and esophagus.~Stage IV: The cancer has metastasized throughout the body and may now affect the liver, bones or brain."|Participants|Count of Participants|9|9.0||||||
4179471|NCT00798603|4000539|B1||Other|Histologic type||Participants|Count of Participants|18|18.0||||||
4179472|NCT00798603|4000539|B1||Adenocarcinoma|Histologic type||Participants|Count of Participants|44|44.0||||||
4179473|NCT00798603|4000539|B1||1=Symptomatic and fully ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|32|32.0||||||
4179474|NCT00798603|4000539|B1||0=Asymptomatic and fully active|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|30|30.0||||||
4179475|NCT00798603|4000539|B1|United States||Region of Enrollment||participants|Number|62|62.0||||||
4179476|NCT00798603|4000539|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4179477|NCT00798603|4000539|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179478|NCT00798603|4000539|B1||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4179479|NCT00798603|4000539|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4179480|NCT00798603|4000539|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179481|NCT00798603|4000539|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179482|NCT00798603|4000539|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179483|NCT00798603|4000539|B1||Male|Gender||Participants|Count of Participants|31|31.0||||||
4179484|NCT00798603|4000539|B1||Female|Gender||Participants|Count of Participants|31|31.0||||||
4179485|NCT00798603|4000539|B1|||Age||years|Median|74.5|74.5|Full Range|||70.0|86.0|
4179486|NCT00798590|4000559|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4179487|NCT00798590|4000560|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4179488|NCT00798590|4000561|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4179489|NCT00798590|4000559|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4179490|NCT00798590|4000560|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4179491|NCT00798590|4000561|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4179492|NCT00798590|4000559|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4179493|NCT00798590|4000560|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4179494|NCT00798590|4000561|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4179495|NCT00798590|4000559|B3|>=21 and <=75||Age, Customized||participants|Number|19|19.0||||||
4179496|NCT00798590|4000560|B2|>=21 and <=75||Age, Customized||participants|Number|8|8.0||||||
4179497|NCT00798590|4000561|B1|>=21 and <=75||Age, Customized||participants|Number|11|11.0||||||
4179498|NCT00798577|4000570|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4179499|NCT00798577|4000571|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4179500|NCT00798577|4000572|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4179501|NCT00798577|4000570|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4179502|NCT00798577|4000571|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4179503|NCT00798577|4000572|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4179504|NCT00798577|4000570|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4179505|NCT00798577|4000571|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4179506|NCT00798577|4000572|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4179507|NCT00798577|4000570|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4179508|NCT00798577|4000571|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4179509|NCT00798577|4000572|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4179510|NCT00798577|4000570|B3||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4179511|NCT00798577|4000571|B2||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4179512|NCT00798577|4000572|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4179513|NCT00798486|4000587|B1|United States||Region of Enrollment||participants|Number|110|110.0||||||
4179514|NCT00798486|4000587|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4179515|NCT00798486|4000587|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4179516|NCT00798486|4000587|B1|||Age||years|Median|46|46.0|Full Range|||18.0|77.0|
4179517|NCT00798434|4000594|B3|||UUI Episodes per 24 Hours|UUI episodes defined as those with the USS rating of 5 (unable to hold; leak urine) in the diary.|Episodes per 24 hours|Median|0.0|0.0|Full Range|||0.0|26.7|
4179518|NCT00798434|4000595|B2|||UUI Episodes per 24 Hours|UUI episodes defined as those with the USS rating of 5 (unable to hold; leak urine) in the diary.|Episodes per 24 hours|Median|0.0|0.0|Full Range|||0.0|14.3|
4179519|NCT00798434|4000596|B1|||UUI Episodes per 24 Hours|UUI episodes defined as those with the USS rating of 5 (unable to hold; leak urine) in the diary.|Episodes per 24 hours|Median|0.0|0.0|Full Range|||0.0|26.7|
4179520|NCT00798434|4000594|B3|||Nocturnal Micturitions per 24 Hours|Nocturnal micturitions defined as micturitions with USS rating 1-5 that occurred between time participant went to bed and time he or she arose to start the next day. USS rating: 1. No feeling of urgency, 2. Mild feeling of urgency, 3. Moderate feeling of urgency, 4. Severe feeling of urgency, 5. Unable to hold; leak urine.|Episodes per 24 hours|Median|2.7|2.7|Full Range|||0.0|12.3|
4179521|NCT00798434|4000595|B2|||Nocturnal Micturitions per 24 Hours|Nocturnal micturitions defined as micturitions with USS rating 1-5 that occurred between time participant went to bed and time he or she arose to start the next day. USS rating: 1. No feeling of urgency, 2. Mild feeling of urgency, 3. Moderate feeling of urgency, 4. Severe feeling of urgency, 5. Unable to hold; leak urine.|Episodes per 24 hours|Median|2.7|2.7|Full Range|||0.0|12.3|
4179522|NCT00798434|4000596|B1|||Nocturnal Micturitions per 24 Hours|Nocturnal micturitions defined as micturitions with USS rating 1-5 that occurred between time participant went to bed and time he or she arose to start the next day. USS rating: 1. No feeling of urgency, 2. Mild feeling of urgency, 3. Moderate feeling of urgency, 4. Severe feeling of urgency, 5. Unable to hold; leak urine.|Episodes per 24 hours|Median|2.7|2.7|Full Range|||0.0|10.0|
4179523|NCT00798434|4000594|B3|||Micturitions per 24 Hours|Micturitions included episodes of voluntary micturition and episodes of Urgency Urinary Incontinence (UUI).|Episodes per 24 hours|Median|11.3|11.3|Full Range|||7.0|28.7|
4179524|NCT00798434|4000595|B2|||Micturitions per 24 Hours|Micturitions included episodes of voluntary micturition and episodes of Urgency Urinary Incontinence (UUI).|Episodes per 24 hours|Median|11.3|11.3|Full Range|||7.5|25.7|
4179525|NCT00798434|4000596|B1|||Micturitions per 24 Hours|Micturitions included episodes of voluntary micturition and episodes of Urgency Urinary Incontinence (UUI).|Episodes per 24 hours|Median|11.5|11.5|Full Range|||7.0|28.7|
4179526|NCT00798434|4000594|B3|||Severe Micturition-Related Urgency Episodes per 24 Hours|Severe micturition-related urgency episodes defined as those with USS rating >=4. USS rating of 4: Severe feeling of urgency and 5: Unable to hold; leak urine.|Episodes per 24 hours|Median|2.7|2.7|Full Range|||0.0|28.7|
4179584|NCT00798369|4000682|B2|≥ 75 years||Age, Customized||participants|Number|1|1.0||||||
4179585|NCT00798369|4000683|B1|≥ 75 years||Age, Customized||participants|Number|1|1.0||||||
4179527|NCT00798434|4000595|B2|||Severe Micturition-Related Urgency Episodes per 24 Hours|Severe micturition-related urgency episodes defined as those with USS rating >=4. USS rating of 4: Severe feeling of urgency and 5: Unable to hold; leak urine.|Episodes per 24 hours|Median|2.7|2.7|Full Range|||0.0|19.0|
4179528|NCT00798434|4000596|B1|||Severe Micturition-Related Urgency Episodes per 24 Hours|Severe micturition-related urgency episodes defined as those with USS rating >=4. USS rating of 4: Severe feeling of urgency and 5: Unable to hold; leak urine.|Episodes per 24 hours|Median|3.0|3.0|Full Range|||0.0|28.7|
4179529|NCT00798434|4000594|B3|||Micturition-Related Urgency Episodes per 24 Hours|Micturition-related urgency episodes per 24 hours defined as those with Urinary Sensation Scale (USS) rating of >=3 marked for corresponding micturition in diary. USS rating of 3: Moderate feeling of urgency, 4: Severe feeling of urgency, 5: Unable to hold; leak urine.|Episodes per 24 hours|Median|8.7|8.7|Full Range|||0.0|28.7|
4179530|NCT00798434|4000595|B2|||Micturition-Related Urgency Episodes per 24 Hours|Micturition-related urgency episodes per 24 hours defined as those with Urinary Sensation Scale (USS) rating of >=3 marked for corresponding micturition in diary. USS rating of 3: Moderate feeling of urgency, 4: Severe feeling of urgency, 5: Unable to hold; leak urine.|Episodes per 24 hours|Median|8.5|8.5|Full Range|||1.3|21.0|
4179531|NCT00798434|4000596|B1|||Micturition-Related Urgency Episodes per 24 Hours|Micturition-related urgency episodes per 24 hours defined as those with Urinary Sensation Scale (USS) rating of >=3 marked for corresponding micturition in diary. USS rating of 3: Moderate feeling of urgency, 4: Severe feeling of urgency, 5: Unable to hold; leak urine.|Episodes per 24 hours|Median|8.7|8.7|Full Range|||0.0|28.7|
4179532|NCT00798434|4000594|B3|many severe problems||Patient Perception of Bladder Condition (PPBC) at Baseline|Participants who contributed to baseline score; PPBC: self-administered, single-item, questionnaire asked participants to describe their perception of their bladder-related problems; Rated on a 6-point scale: 1=no problems at all, 2=some very minor problems, 3=some minor problems, 4=moderate problems, 5=severe problems, 6=many severe problems|Participants|Number|60|60.0||||||
4179533|NCT00798434|4000595|B2|many severe problems||Patient Perception of Bladder Condition (PPBC) at Baseline|Participants who contributed to baseline score; PPBC: self-administered, single-item, questionnaire asked participants to describe their perception of their bladder-related problems; Rated on a 6-point scale: 1=no problems at all, 2=some very minor problems, 3=some minor problems, 4=moderate problems, 5=severe problems, 6=many severe problems|Participants|Number|23|23.0||||||
4179534|NCT00798434|4000596|B1|many severe problems||Patient Perception of Bladder Condition (PPBC) at Baseline|Participants who contributed to baseline score; PPBC: self-administered, single-item, questionnaire asked participants to describe their perception of their bladder-related problems; Rated on a 6-point scale: 1=no problems at all, 2=some very minor problems, 3=some minor problems, 4=moderate problems, 5=severe problems, 6=many severe problems|Participants|Number|37|37.0||||||
4179535|NCT00798434|4000594|B3|severe problems||Patient Perception of Bladder Condition (PPBC) at Baseline|Participants who contributed to baseline score; PPBC: self-administered, single-item, questionnaire asked participants to describe their perception of their bladder-related problems; Rated on a 6-point scale: 1=no problems at all, 2=some very minor problems, 3=some minor problems, 4=moderate problems, 5=severe problems, 6=many severe problems|Participants|Number|315|315.0||||||
4179536|NCT00798434|4000595|B2|severe problems||Patient Perception of Bladder Condition (PPBC) at Baseline|Participants who contributed to baseline score; PPBC: self-administered, single-item, questionnaire asked participants to describe their perception of their bladder-related problems; Rated on a 6-point scale: 1=no problems at all, 2=some very minor problems, 3=some minor problems, 4=moderate problems, 5=severe problems, 6=many severe problems|Participants|Number|158|158.0||||||
4179537|NCT00798434|4000596|B1|severe problems||Patient Perception of Bladder Condition (PPBC) at Baseline|Participants who contributed to baseline score; PPBC: self-administered, single-item, questionnaire asked participants to describe their perception of their bladder-related problems; Rated on a 6-point scale: 1=no problems at all, 2=some very minor problems, 3=some minor problems, 4=moderate problems, 5=severe problems, 6=many severe problems|Participants|Number|157|157.0||||||
4179538|NCT00798434|4000594|B3|some moderate problems||Patient Perception of Bladder Condition (PPBC) at Baseline|Participants who contributed to baseline score; PPBC: self-administered, single-item, questionnaire asked participants to describe their perception of their bladder-related problems; Rated on a 6-point scale: 1=no problems at all, 2=some very minor problems, 3=some minor problems, 4=moderate problems, 5=severe problems, 6=many severe problems|Participants|Number|375|375.0||||||
4179539|NCT00798434|4000595|B2|some moderate problems||Patient Perception of Bladder Condition (PPBC) at Baseline|Participants who contributed to baseline score; PPBC: self-administered, single-item, questionnaire asked participants to describe their perception of their bladder-related problems; Rated on a 6-point scale: 1=no problems at all, 2=some very minor problems, 3=some minor problems, 4=moderate problems, 5=severe problems, 6=many severe problems|Participants|Number|190|190.0||||||
4179540|NCT00798434|4000596|B1|some moderate problems||Patient Perception of Bladder Condition (PPBC) at Baseline|Participants who contributed to baseline score; PPBC: self-administered, single-item, questionnaire asked participants to describe their perception of their bladder-related problems; Rated on a 6-point scale: 1=no problems at all, 2=some very minor problems, 3=some minor problems, 4=moderate problems, 5=severe problems, 6=many severe problems|Participants|Number|185|185.0||||||
4179541|NCT00798434|4000594|B3|some minor problems||Patient Perception of Bladder Condition (PPBC) at Baseline|Participants who contributed to baseline score; PPBC: self-administered, single-item, questionnaire asked participants to describe their perception of their bladder-related problems; Rated on a 6-point scale: 1=no problems at all, 2=some very minor problems, 3=some minor problems, 4=moderate problems, 5=severe problems, 6=many severe problems|Participants|Number|4|4.0||||||
4179542|NCT00798434|4000595|B2|some minor problems||Patient Perception of Bladder Condition (PPBC) at Baseline|Participants who contributed to baseline score; PPBC: self-administered, single-item, questionnaire asked participants to describe their perception of their bladder-related problems; Rated on a 6-point scale: 1=no problems at all, 2=some very minor problems, 3=some minor problems, 4=moderate problems, 5=severe problems, 6=many severe problems|Participants|Number|2|2.0||||||
4179586|NCT00798369|4000677|B7|≥ 65 - 74 years||Age, Customized||participants|Number|24|24.0||||||
4179587|NCT00798369|4000678|B6|≥ 65 - 74 years||Age, Customized||participants|Number|10|10.0||||||
4179543|NCT00798434|4000596|B1|some minor problems||Patient Perception of Bladder Condition (PPBC) at Baseline|Participants who contributed to baseline score; PPBC: self-administered, single-item, questionnaire asked participants to describe their perception of their bladder-related problems; Rated on a 6-point scale: 1=no problems at all, 2=some very minor problems, 3=some minor problems, 4=moderate problems, 5=severe problems, 6=many severe problems|Participants|Number|2|2.0||||||
4179544|NCT00798434|4000594|B3|some very minor problems||Patient Perception of Bladder Condition (PPBC) at Baseline|Participants who contributed to baseline score; PPBC: self-administered, single-item, questionnaire asked participants to describe their perception of their bladder-related problems; Rated on a 6-point scale: 1=no problems at all, 2=some very minor problems, 3=some minor problems, 4=moderate problems, 5=severe problems, 6=many severe problems|Participants|Number|1|1.0||||||
4179545|NCT00798434|4000595|B2|some very minor problems||Patient Perception of Bladder Condition (PPBC) at Baseline|Participants who contributed to baseline score; PPBC: self-administered, single-item, questionnaire asked participants to describe their perception of their bladder-related problems; Rated on a 6-point scale: 1=no problems at all, 2=some very minor problems, 3=some minor problems, 4=moderate problems, 5=severe problems, 6=many severe problems|Participants|Number|0|0.0||||||
4179546|NCT00798434|4000596|B1|some very minor problems||Patient Perception of Bladder Condition (PPBC) at Baseline|Participants who contributed to baseline score; PPBC: self-administered, single-item, questionnaire asked participants to describe their perception of their bladder-related problems; Rated on a 6-point scale: 1=no problems at all, 2=some very minor problems, 3=some minor problems, 4=moderate problems, 5=severe problems, 6=many severe problems|Participants|Number|1|1.0||||||
4179547|NCT00798434|4000594|B3|no problems at all||Patient Perception of Bladder Condition (PPBC) at Baseline|Participants who contributed to baseline score; PPBC: self-administered, single-item, questionnaire asked participants to describe their perception of their bladder-related problems; Rated on a 6-point scale: 1=no problems at all, 2=some very minor problems, 3=some minor problems, 4=moderate problems, 5=severe problems, 6=many severe problems|Participants|Number|0|0.0||||||
4179548|NCT00798434|4000595|B2|no problems at all||Patient Perception of Bladder Condition (PPBC) at Baseline|Participants who contributed to baseline score; PPBC: self-administered, single-item, questionnaire asked participants to describe their perception of their bladder-related problems; Rated on a 6-point scale: 1=no problems at all, 2=some very minor problems, 3=some minor problems, 4=moderate problems, 5=severe problems, 6=many severe problems|Participants|Number|0|0.0||||||
4179549|NCT00798434|4000596|B1|no problems at all||Patient Perception of Bladder Condition (PPBC) at Baseline|Participants who contributed to baseline score; PPBC: self-administered, single-item, questionnaire asked participants to describe their perception of their bladder-related problems; Rated on a 6-point scale: 1=no problems at all, 2=some very minor problems, 3=some minor problems, 4=moderate problems, 5=severe problems, 6=many severe problems|Participants|Number|0|0.0||||||
4179550|NCT00798434|4000594|B3||Male|Sex: Female, Male||Participants|Count of Participants|367|367.0||||||
4179551|NCT00798434|4000595|B2||Male|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4179552|NCT00798434|4000596|B1||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4179553|NCT00798434|4000594|B3||Female|Sex: Female, Male||Participants|Count of Participants|418|418.0||||||
4179554|NCT00798434|4000595|B2||Female|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
4179555|NCT00798434|4000596|B1||Female|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4179556|NCT00798434|4000594|B3|greater than or equal to 85 years||Age, Customized||participants|Number|24|24.0||||||
4179557|NCT00798434|4000595|B2|greater than or equal to 85 years||Age, Customized||participants|Number|12|12.0||||||
4179558|NCT00798434|4000596|B1|greater than or equal to 85 years||Age, Customized||participants|Number|12|12.0||||||
4179559|NCT00798434|4000594|B3|76-84 years||Age, Customized||participants|Number|230|230.0||||||
4179560|NCT00798434|4000595|B2|76-84 years||Age, Customized||participants|Number|116|116.0||||||
4179561|NCT00798434|4000596|B1|76-84 years||Age, Customized||participants|Number|114|114.0||||||
4179562|NCT00798434|4000594|B3|65-75 years||Age, Customized||participants|Number|531|531.0||||||
4179563|NCT00798434|4000595|B2|65-75 years||Age, Customized||participants|Number|264|264.0||||||
4179564|NCT00798434|4000596|B1|65-75 years||Age, Customized||participants|Number|267|267.0||||||
4179565|NCT00798369|4000677|B7||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4179566|NCT00798369|4000678|B6||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4179567|NCT00798369|4000679|B5||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4179568|NCT00798369|4000680|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4179569|NCT00798369|4000681|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4179570|NCT00798369|4000682|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4179571|NCT00798369|4000683|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4179572|NCT00798369|4000677|B7||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4179573|NCT00798369|4000678|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4179574|NCT00798369|4000679|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4179575|NCT00798369|4000680|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4179576|NCT00798369|4000681|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4179577|NCT00798369|4000682|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4179578|NCT00798369|4000683|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4179579|NCT00798369|4000677|B7|≥ 75 years||Age, Customized||participants|Number|8|8.0||||||
4179580|NCT00798369|4000678|B6|≥ 75 years||Age, Customized||participants|Number|1|1.0||||||
4179581|NCT00798369|4000679|B5|≥ 75 years||Age, Customized||participants|Number|2|2.0||||||
4179582|NCT00798369|4000680|B4|≥ 75 years||Age, Customized||participants|Number|2|2.0||||||
4179583|NCT00798369|4000681|B3|≥ 75 years||Age, Customized||participants|Number|1|1.0||||||
4179588|NCT00798369|4000679|B5|≥ 65 - 74 years||Age, Customized||participants|Number|3|3.0||||||
4179589|NCT00798369|4000680|B4|≥ 65 - 74 years||Age, Customized||participants|Number|2|2.0||||||
4179590|NCT00798369|4000681|B3|≥ 65 - 74 years||Age, Customized||participants|Number|6|6.0||||||
4179591|NCT00798369|4000682|B2|≥ 65 - 74 years||Age, Customized||participants|Number|3|3.0||||||
4179592|NCT00798369|4000683|B1|≥ 65 - 74 years||Age, Customized||participants|Number|0|0.0||||||
4179593|NCT00798369|4000677|B7|≥ 41 - 64 years||Age, Customized||participants|Number|135|135.0||||||
4179594|NCT00798369|4000678|B6|≥ 41 - 64 years||Age, Customized||participants|Number|39|39.0||||||
4179595|NCT00798369|4000679|B5|≥ 41 - 64 years||Age, Customized||participants|Number|15|15.0||||||
4179596|NCT00798369|4000680|B4|≥ 41 - 64 years||Age, Customized||participants|Number|20|20.0||||||
4179597|NCT00798369|4000681|B3|≥ 41 - 64 years||Age, Customized||participants|Number|19|19.0||||||
4179598|NCT00798369|4000682|B2|≥ 41 - 64 years||Age, Customized||participants|Number|21|21.0||||||
4179599|NCT00798369|4000683|B1|≥ 41 - 64 years||Age, Customized||participants|Number|21|21.0||||||
4179600|NCT00798369|4000677|B7|≥18 years - 40 years||Age, Customized||participants|Number|33|33.0||||||
4179601|NCT00798369|4000678|B6|≥18 years - 40 years||Age, Customized||participants|Number|7|7.0||||||
4179602|NCT00798369|4000679|B5|≥18 years - 40 years||Age, Customized||participants|Number|8|8.0||||||
4179603|NCT00798369|4000680|B4|≥18 years - 40 years||Age, Customized||participants|Number|5|5.0||||||
4179604|NCT00798369|4000681|B3|≥18 years - 40 years||Age, Customized||participants|Number|3|3.0||||||
4179605|NCT00798369|4000682|B2|≥18 years - 40 years||Age, Customized||participants|Number|4|4.0||||||
4179606|NCT00798369|4000683|B1|≥18 years - 40 years||Age, Customized||participants|Number|6|6.0||||||
4179607|NCT00798317|4000733|B3||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4179608|NCT00798317|4000734|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4179609|NCT00798317|4000735|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4179610|NCT00798317|4000733|B3||Female|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4179611|NCT00798317|4000734|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4179612|NCT00798317|4000735|B1||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4179613|NCT00798317|4000733|B3|||Age||years|Mean|72.0|72.0|Standard Deviation|8.54|8.54|||
4179614|NCT00798317|4000734|B2|||Age||years|Mean|70.2|70.2|Standard Deviation|10.85|10.85|||
4179615|NCT00798317|4000735|B1|||Age||years|Mean|72.6|72.6|Standard Deviation|7.56|7.56|||
4179616|NCT00798304|4000744|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4179617|NCT00798304|4000745|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4179618|NCT00798304|4000746|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4179619|NCT00798304|4000747|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4179620|NCT00798304|4000744|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4179621|NCT00798304|4000745|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4179622|NCT00798304|4000746|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4179623|NCT00798304|4000747|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4179624|NCT00798304|4000744|B4|||Age||days|Mean|65.5|65.5|Standard Deviation|11.03|11.03|||
4179625|NCT00798304|4000745|B3|||Age||days|Mean|71.6|71.6|Standard Deviation|11.35|11.35|||
4179626|NCT00798304|4000746|B2|||Age||days|Mean|64.0|64.0|Standard Deviation|10.02|10.02|||
4179627|NCT00798304|4000747|B1|||Age||days|Mean|63.6|63.6|Standard Deviation|11.57|11.57|||
4179628|NCT00798174|4000775|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4179629|NCT00798174|4000775|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4179630|NCT00798174|4000775|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4179631|NCT00798174|4000775|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4179632|NCT00798174|4000775|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4179633|NCT00798174|4000775|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4179634|NCT00798161|4000780|B8|||Fasting plasma glucose (FPG)||mg/dL|Mean|200.2|200.2|Standard Deviation|57.3|57.3|||
4179635|NCT00798161|4000781|B7|||Fasting plasma glucose (FPG)||mg/dL|Mean|261.8|261.8|Standard Deviation|80.9|80.9|||
4179636|NCT00798161|4000782|B6|||Fasting plasma glucose (FPG)||mg/dL|Mean|196.9|196.9|Standard Deviation|51.2|51.2|||
4179637|NCT00798161|4000783|B5|||Fasting plasma glucose (FPG)||mg/dL|Mean|198.6|198.6|Standard Deviation|60.2|60.2|||
4179638|NCT00798161|4000784|B4|||Fasting plasma glucose (FPG)||mg/dL|Mean|195.3|195.3|Standard Deviation|50.2|50.2|||
4179639|NCT00798161|4000785|B3|||Fasting plasma glucose (FPG)||mg/dL|Mean|192.3|192.3|Standard Deviation|52.8|52.8|||
4179640|NCT00798161|4000786|B2|||Fasting plasma glucose (FPG)||mg/dL|Mean|191.2|191.2|Standard Deviation|46.9|46.9|||
4179641|NCT00798161|4000787|B1|||Fasting plasma glucose (FPG)||mg/dL|Mean|203.7|203.7|Standard Deviation|51.2|51.2|||
4179642|NCT00798161|4000780|B8|||Glycosylated Hemoglobin A1 (HbA1C)||Percent|Mean|8.91|8.91|Standard Deviation|1.31|1.31|||
4179643|NCT00798161|4000781|B7|||Glycosylated Hemoglobin A1 (HbA1C)||Percent|Mean|11.84|11.84|Standard Deviation|1.42|1.42|||
4179644|NCT00798161|4000782|B6|||Glycosylated Hemoglobin A1 (HbA1C)||Percent|Mean|8.68|8.68|Standard Deviation|1.03|1.03|||
4179645|NCT00798161|4000783|B5|||Glycosylated Hemoglobin A1 (HbA1C)||Percent|Mean|8.71|8.71|Standard Deviation|0.95|0.95|||
4179646|NCT00798161|4000784|B4|||Glycosylated Hemoglobin A1 (HbA1C)||Percent|Mean|8.70|8.7|Standard Deviation|0.97|0.97|||
4179647|NCT00798161|4000785|B3|||Glycosylated Hemoglobin A1 (HbA1C)||Percent|Mean|8.52|8.52|Standard Deviation|0.87|0.87|||
4179648|NCT00798161|4000786|B2|||Glycosylated Hemoglobin A1 (HbA1C)||Percent|Mean|8.66|8.66|Standard Deviation|0.90|0.9|||
4179649|NCT00798161|4000787|B1|||Glycosylated Hemoglobin A1 (HbA1C)||Percent|Mean|8.67|8.67|Standard Deviation|0.95|0.95|||
4179650|NCT00798161|4000780|B8|||Body Mass Index (BMI) continuous||kg/m^2|Mean|29.07|29.07|Standard Deviation|4.97|4.97|||
4179651|NCT00798161|4000781|B7|||Body Mass Index (BMI) continuous||kg/m^2|Mean|28.81|28.81|Standard Deviation|4.93|4.93|||
4179652|NCT00798161|4000782|B6|||Body Mass Index (BMI) continuous||kg/m^2|Mean|28.55|28.55|Standard Deviation|4.80|4.8|||
4179653|NCT00798161|4000783|B5|||Body Mass Index (BMI) continuous||kg/m^2|Mean|29.66|29.66|Standard Deviation|5.31|5.31|||
4179654|NCT00798161|4000784|B4|||Body Mass Index (BMI) continuous||kg/m^2|Mean|28.95|28.95|Standard Deviation|4.67|4.67|||
4179655|NCT00798161|4000785|B3|||Body Mass Index (BMI) continuous||kg/m^2|Mean|29.52|29.52|Standard Deviation|5.31|5.31|||
4179656|NCT00798161|4000786|B2|||Body Mass Index (BMI) continuous||kg/m^2|Mean|28.92|28.92|Standard Deviation|4.83|4.83|||
4179657|NCT00798161|4000787|B1|||Body Mass Index (BMI) continuous||kg/m^2|Mean|28.62|28.62|Standard Deviation|5.17|5.17|||
4179658|NCT00798161|4000780|B8||Male|Sex: Female, Male||Participants|Count of Participants|452|452.0||||||
4179659|NCT00798161|4000781|B7||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4179660|NCT00798161|4000782|B6||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4179661|NCT00798161|4000783|B5||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4179662|NCT00798161|4000784|B4||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4179663|NCT00798161|4000785|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4179664|NCT00798161|4000786|B2||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4179665|NCT00798161|4000787|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4179666|NCT00798161|4000780|B8||Female|Sex: Female, Male||Participants|Count of Participants|405|405.0||||||
4179667|NCT00798161|4000781|B7||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4179668|NCT00798161|4000782|B6||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4179669|NCT00798161|4000783|B5||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4179670|NCT00798161|4000784|B4||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4179671|NCT00798161|4000785|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4179672|NCT00798161|4000786|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4179673|NCT00798161|4000787|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4179674|NCT00798161|4000780|B8|||Age||Years|Mean|55.2|55.2|Standard Deviation|10.8|10.8|||
4179675|NCT00798161|4000781|B7|||Age||Years|Mean|53.5|53.5|Standard Deviation|11.1|11.1|||
4179676|NCT00798161|4000782|B6|||Age||Years|Mean|56.4|56.4|Standard Deviation|10.7|10.7|||
4179677|NCT00798161|4000783|B5|||Age||Years|Mean|55.6|55.6|Standard Deviation|11.2|11.2|||
4179678|NCT00798161|4000784|B4|||Age||Years|Mean|56.2|56.2|Standard Deviation|10.8|10.8|||
4179679|NCT00798161|4000785|B3|||Age||Years|Mean|55.2|55.2|Standard Deviation|10.6|10.6|||
4179680|NCT00798161|4000786|B2|||Age||Years|Mean|52.9|52.9|Standard Deviation|10.4|10.4|||
4179681|NCT00798161|4000787|B1|||Age||Years|Mean|55.7|55.7|Standard Deviation|11.0|11.0|||
4179682|NCT00798135|4000900|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179683|NCT00798135|4000900|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179684|NCT00798135|4000900|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4179685|NCT00798135|4000900|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4179686|NCT00798135|4000900|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179687|NCT00798135|4000900|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179688|NCT00798135|4000900|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179689|NCT00798135|4000900|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179690|NCT00798135|4000900|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4179691|NCT00798135|4000900|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4179692|NCT00798135|4000900|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4179693|NCT00798135|4000900|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4179694|NCT00798135|4000900|B1|||Age||Years|Mean|59.8|59.8|Standard Deviation|14.3|14.3|||
4179695|NCT00798135|4000900|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4179696|NCT00798135|4000900|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4179697|NCT00798135|4000900|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4179698|NCT00798096|4000906|B1|Other - Unknown||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4179699|NCT00798096|4000906|B1|White||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4179700|NCT00798096|4000906|B1|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4179701|NCT00798096|4000906|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4179702|NCT00798096|4000906|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4179703|NCT00798096|4000906|B1|||Age||Years|Mean|68.5|68.5|Standard Deviation|12|12.0|44.0|78.0|
4179704|NCT00798018|4000913|B5|China||Region of Enrollment||participants|Number|100|100.0||||||
4179705|NCT00798018|4000914|B4|China||Region of Enrollment||participants|Number|25|25.0||||||
4179706|NCT00798018|4000915|B3|China||Region of Enrollment||participants|Number|25|25.0||||||
4179707|NCT00798018|4000916|B2|China||Region of Enrollment||participants|Number|25|25.0||||||
4179708|NCT00798018|4000917|B1|China||Region of Enrollment||participants|Number|25|25.0||||||
4179709|NCT00798018|4000913|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4179710|NCT00798018|4000914|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4179711|NCT00798018|4000915|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4179712|NCT00798018|4000916|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4179713|NCT00798018|4000917|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4179714|NCT00798018|4000913|B5||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4179715|NCT00798018|4000914|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4179716|NCT00798018|4000915|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4179717|NCT00798018|4000916|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4179718|NCT00798018|4000917|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4179719|NCT00798018|4000913|B5|||Age||years|Mean|42|42.0|Standard Deviation|9|9.0|||
4179720|NCT00798018|4000914|B4|||Age||years|Mean|41|41.0|Standard Deviation|10|10.0|||
4179721|NCT00798018|4000915|B3|||Age||years|Mean|42|42.0|Standard Deviation|7|7.0|||
4179722|NCT00798018|4000916|B2|||Age||years|Mean|44|44.0|Standard Deviation|9|9.0|||
4179723|NCT00798018|4000917|B1|||Age||years|Mean|39|39.0|Standard Deviation|8|8.0|||
4179724|NCT00798018|4000913|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4179725|NCT00798018|4000914|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4179726|NCT00798018|4000915|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4179727|NCT00798018|4000916|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4179728|NCT00798018|4000917|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4179729|NCT00798018|4000913|B5||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4179730|NCT00798018|4000914|B4||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4179731|NCT00798018|4000915|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4179732|NCT00798018|4000916|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4179733|NCT00798018|4000917|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4179734|NCT00798018|4000913|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4179735|NCT00798018|4000914|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4179736|NCT00798018|4000915|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4179737|NCT00798018|4000916|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4179738|NCT00798018|4000917|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4179739|NCT00797966|4000930|B5||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4179740|NCT00797966|4000931|B4||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4179741|NCT00797966|4000932|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4179742|NCT00797966|4000933|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4179743|NCT00797966|4000934|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4179744|NCT00797966|4000930|B5||Female|Sex: Female, Male||Participants|Count of Participants|289|289.0||||||
4179745|NCT00797966|4000931|B4||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4179746|NCT00797966|4000932|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4179747|NCT00797966|4000933|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4179748|NCT00797966|4000934|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4179749|NCT00797966|4000930|B5|||Age||Years|Mean|43.7|43.7|Standard Deviation|11.5|11.5|||
4179750|NCT00797966|4000931|B4|||Age||Years|Mean|43.3|43.3|Standard Deviation|11.5|11.5|||
4179751|NCT00797966|4000932|B3|||Age||Years|Mean|43.7|43.7|Standard Deviation|11.6|11.6|||
4179752|NCT00797966|4000933|B2|||Age||Years|Mean|44.0|44.0|Standard Deviation|11.8|11.8|||
4179753|NCT00797966|4000934|B1|||Age||Years|Mean|43.9|43.9|Standard Deviation|10.8|10.8|||
4179754|NCT00797862|4001001|B4||Male|Sex: Female, Male||Participants|Count of Participants|635|635.0||||||
4179755|NCT00797862|4001002|B3||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4179756|NCT00797862|4001003|B2||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4179757|NCT00797862|4001004|B1||Male|Sex: Female, Male||Participants|Count of Participants|315|315.0||||||
4179758|NCT00797862|4001001|B4||Female|Sex: Female, Male||Participants|Count of Participants|619|619.0||||||
4179759|NCT00797862|4001002|B3||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4179760|NCT00797862|4001003|B2||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4179761|NCT00797862|4001004|B1||Female|Sex: Female, Male||Participants|Count of Participants|305|305.0||||||
4179762|NCT00797862|4001001|B4|||Age||years|Mean|58.1|58.1|Standard Deviation|10.84|10.84|||
4179763|NCT00797862|4001002|B3|||Age||years|Mean|58.1|58.1|Standard Deviation|10.93|10.93|||
4179764|NCT00797862|4001003|B2|||Age||years|Mean|58.4|58.4|Standard Deviation|10.83|10.83|||
4179765|NCT00797862|4001004|B1|||Age||years|Mean|58.1|58.1|Standard Deviation|10.81|10.81|||
4179766|NCT00797823|4001032|B4|United States||Region of Enrollment||participants|Number|14|14.0||||||
4179767|NCT00797823|4001033|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4179768|NCT00797823|4001034|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4179769|NCT00797823|4001035|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4179770|NCT00797823|4001032|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4179771|NCT00797823|4001033|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4179772|NCT00797823|4001034|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4179773|NCT00797823|4001035|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4179774|NCT00797823|4001032|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4179775|NCT00797823|4001033|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4179776|NCT00797823|4001034|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4179777|NCT00797823|4001035|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4179778|NCT00797823|4001032|B4|||Age||years|Mean|36.7|36.7|Standard Deviation|13.7|13.7|||
4179779|NCT00797823|4001033|B3|||Age||years|Mean|35.1|35.1|Standard Deviation|17.4|17.4|||
4179780|NCT00797823|4001034|B2|||Age||years|Mean|39.8|39.8|Standard Deviation|10.7|10.7|||
4179781|NCT00797823|4001035|B1|||Age||years|Mean|33.3|33.3|Standard Deviation|10.5|10.5|||
4179782|NCT00797823|4001032|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4179783|NCT00797823|4001033|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4179784|NCT00797823|4001034|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4179785|NCT00797823|4001035|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4179786|NCT00797823|4001032|B4||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4179787|NCT00797823|4001033|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4179788|NCT00797823|4001034|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4179789|NCT00797823|4001035|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4179790|NCT00797823|4001032|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4179791|NCT00797823|4001033|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4179792|NCT00797823|4001034|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4179793|NCT00797823|4001035|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4179794|NCT00797797|4001046|B3|United States||Region of Enrollment||participants|Number|362|362.0||||||
4179795|NCT00797797|4001047|B2|United States||Region of Enrollment||participants|Number|184|184.0||||||
4179796|NCT00797797|4001048|B1|United States||Region of Enrollment||participants|Number|178|178.0||||||
4179797|NCT00797797|4001046|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4179798|NCT00797797|4001047|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4179799|NCT00797797|4001048|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4179800|NCT00797797|4001046|B3||Female|Sex: Female, Male||Participants|Count of Participants|329|329.0||||||
4179801|NCT00797797|4001047|B2||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4179802|NCT00797797|4001048|B1||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4179803|NCT00797797|4001046|B3|||Age||years|Mean|49.3|49.3|Standard Deviation|10.3|10.3|||
4179804|NCT00797797|4001047|B2|||Age||years|Mean|49.8|49.8|Standard Deviation|10.3|10.3|||
4179805|NCT00797797|4001048|B1|||Age||years|Mean|48.8|48.8|Standard Deviation|10.4|10.4|||
4179806|NCT00797797|4001046|B3|>=60 years||Age||participants|Number|65|65.0||||||
4179807|NCT00797797|4001047|B2|>=60 years||Age||participants|Number|38|38.0||||||
4179808|NCT00797797|4001048|B1|>=60 years||Age||participants|Number|27|27.0||||||
4179809|NCT00797797|4001046|B3|Between 18 and 60 years||Age||participants|Number|297|297.0||||||
4179810|NCT00797797|4001047|B2|Between 18 and 60 years||Age||participants|Number|146|146.0||||||
4179811|NCT00797797|4001048|B1|Between 18 and 60 years||Age||participants|Number|151|151.0||||||
4179812|NCT00797732|4001057|B3||70 Gy|Total IMRT dose (Gy)|IMRT, intensity modulated radiation therapy, dose received|Participants|Count of Participants|35|35.0||||||
4179813|NCT00797732|4001058|B2||70 Gy|Total IMRT dose (Gy)|IMRT, intensity modulated radiation therapy, dose received|Participants|Count of Participants|16|16.0||||||
4179814|NCT00797732|4001059|B1||70 Gy|Total IMRT dose (Gy)|IMRT, intensity modulated radiation therapy, dose received|Participants|Count of Participants|19|19.0||||||
4179815|NCT00797732|4001057|B3||66 Gy|Total IMRT dose (Gy)|IMRT, intensity modulated radiation therapy, dose received|Participants|Count of Participants|3|3.0||||||
4179816|NCT00797732|4001058|B2||66 Gy|Total IMRT dose (Gy)|IMRT, intensity modulated radiation therapy, dose received|Participants|Count of Participants|2|2.0||||||
4179817|NCT00797732|4001059|B1||66 Gy|Total IMRT dose (Gy)|IMRT, intensity modulated radiation therapy, dose received|Participants|Count of Participants|1|1.0||||||
4179818|NCT00797732|4001057|B3||64 GY|Total IMRT dose (Gy)|IMRT, intensity modulated radiation therapy, dose received|Participants|Count of Participants|3|3.0||||||
4179819|NCT00797732|4001058|B2||64 GY|Total IMRT dose (Gy)|IMRT, intensity modulated radiation therapy, dose received|Participants|Count of Participants|3|3.0||||||
4179820|NCT00797732|4001059|B1||64 GY|Total IMRT dose (Gy)|IMRT, intensity modulated radiation therapy, dose received|Participants|Count of Participants|0|0.0||||||
4179821|NCT00797732|4001057|B3||58 Gy|Total IMRT dose (Gy)|IMRT, intensity modulated radiation therapy, dose received|Participants|Count of Participants|1|1.0||||||
4179822|NCT00797732|4001058|B2||58 Gy|Total IMRT dose (Gy)|IMRT, intensity modulated radiation therapy, dose received|Participants|Count of Participants|0|0.0||||||
4179823|NCT00797732|4001059|B1||58 Gy|Total IMRT dose (Gy)|IMRT, intensity modulated radiation therapy, dose received|Participants|Count of Participants|1|1.0||||||
4179824|NCT00797732|4001057|B3|United States||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
4179825|NCT00797732|4001058|B2|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
4179826|NCT00797732|4001059|B1|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
4179827|NCT00797732|4001057|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4179828|NCT00797732|4001058|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4179829|NCT00797732|4001059|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4179830|NCT00797732|4001057|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4179831|NCT00797732|4001058|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4179832|NCT00797732|4001059|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4179833|NCT00797732|4001057|B3|||Age||years|Mean|58.2|58.2|Standard Deviation|10.6|10.6|||
4179834|NCT00797732|4001058|B2|||Age||years|Mean|59.1|59.1|Standard Deviation|8.3|8.3|||
4179835|NCT00797732|4001059|B1|||Age||years|Mean|57.2|57.2|Standard Deviation|12.8|12.8|||
4179836|NCT00797667|4001073|B4||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4179837|NCT00797667|4001074|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4179838|NCT00797667|4001075|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4179839|NCT00797667|4001076|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4179840|NCT00797667|4001073|B4||Female|Sex: Female, Male||Participants|Count of Participants|551|551.0||||||
4179841|NCT00797667|4001074|B3||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4179842|NCT00797667|4001075|B2||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4179843|NCT00797667|4001076|B1||Female|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4179844|NCT00797667|4001073|B4|>=65 years||Age, Customized||Participants|Number|8|8.0||||||
4179845|NCT00797667|4001074|B3|>=65 years||Age, Customized||Participants|Number|4|4.0||||||
4179846|NCT00797667|4001075|B2|>=65 years||Age, Customized||Participants|Number|3|3.0||||||
4179847|NCT00797667|4001076|B1|>=65 years||Age, Customized||Participants|Number|1|1.0||||||
4179848|NCT00797667|4001073|B4|60-64 years||Age, Customized||Participants|Number|19|19.0||||||
4179849|NCT00797667|4001074|B3|60-64 years||Age, Customized||Participants|Number|2|2.0||||||
4179850|NCT00797667|4001075|B2|60-64 years||Age, Customized||Participants|Number|10|10.0||||||
4179851|NCT00797667|4001076|B1|60-64 years||Age, Customized||Participants|Number|7|7.0||||||
4179852|NCT00797667|4001073|B4|50-59 years||Age, Customized||Participants|Number|146|146.0||||||
4179853|NCT00797667|4001074|B3|50-59 years||Age, Customized||Participants|Number|30|30.0||||||
4179854|NCT00797667|4001075|B2|50-59 years||Age, Customized||Participants|Number|50|50.0||||||
4179855|NCT00797667|4001076|B1|50-59 years||Age, Customized||Participants|Number|66|66.0||||||
4179856|NCT00797667|4001073|B4|40-49 years||Age, Customized||Participants|Number|193|193.0||||||
4179857|NCT00797667|4001074|B3|40-49 years||Age, Customized||Participants|Number|32|32.0||||||
4179858|NCT00797667|4001075|B2|40-49 years||Age, Customized||Participants|Number|80|80.0||||||
4179859|NCT00797667|4001076|B1|40-49 years||Age, Customized||Participants|Number|81|81.0||||||
4179860|NCT00797667|4001073|B4|30-39 years||Age, Customized||Participants|Number|165|165.0||||||
4179861|NCT00797667|4001074|B3|30-39 years||Age, Customized||Participants|Number|43|43.0||||||
4179862|NCT00797667|4001075|B2|30-39 years||Age, Customized||Participants|Number|70|70.0||||||
4179863|NCT00797667|4001076|B1|30-39 years||Age, Customized||Participants|Number|52|52.0||||||
4179864|NCT00797667|4001073|B4|20-29 years||Age, Customized||Participants|Number|118|118.0||||||
4179865|NCT00797667|4001074|B3|20-29 years||Age, Customized||Participants|Number|17|17.0||||||
4179866|NCT00797667|4001075|B2|20-29 years||Age, Customized||Participants|Number|47|47.0||||||
4179867|NCT00797667|4001076|B1|20-29 years||Age, Customized||Participants|Number|54|54.0||||||
4179868|NCT00797667|4001073|B4|< 20 years||Age, Customized||Participants|Number|7|7.0||||||
4179869|NCT00797667|4001074|B3|< 20 years||Age, Customized||Participants|Number|2|2.0||||||
4179870|NCT00797667|4001075|B2|< 20 years||Age, Customized||Participants|Number|3|3.0||||||
4179871|NCT00797667|4001076|B1|< 20 years||Age, Customized||Participants|Number|2|2.0||||||
4179872|NCT00797563|4001104|B1|United States||Region of Enrollment||participants|Number|102|102.0||||||
4179873|NCT00797563|4001104|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4179874|NCT00797563|4001104|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4179875|NCT00797563|4001104|B1||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4179876|NCT00797563|4001104|B1||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4179877|NCT00797563|4001104|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4179878|NCT00797511|4001110|B1|Taiwan||Region of Enrollment||participants|Number|132|132.0||||||
4179879|NCT00797511|4001110|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4179880|NCT00797511|4001110|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4179881|NCT00797511|4001110|B1|||Age||Years|Mean|6.89|6.89|Standard Deviation|0.3|0.3|||
4179882|NCT00797511|4001110|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4179883|NCT00797511|4001110|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4179884|NCT00797511|4001110|B1||<=18 years|Age||Participants|Count of Participants|132|132.0||||||
4179885|NCT00797459|4001118|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4179886|NCT00797459|4001118|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4179887|NCT00797459|4001118|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4179888|NCT00797459|4001118|B1|||Age||years|Mean|52.1|52.1|Standard Deviation|6.6|6.6|||
4179889|NCT00797459|4001118|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4179890|NCT00797459|4001118|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4179891|NCT00797459|4001118|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4179892|NCT00797316|4001126|B3||Male|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4179893|NCT00797316|4001127|B2||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4179894|NCT00797316|4001128|B1||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4179895|NCT00797316|4001126|B3||Female|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
4179896|NCT00797316|4001127|B2||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4179897|NCT00797316|4001128|B1||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4179898|NCT00797316|4001126|B3|>= 65||Age, Customized||participants|Number|82|82.0||||||
4179899|NCT00797316|4001127|B2|>= 65||Age, Customized||participants|Number|32|32.0||||||
4179900|NCT00797316|4001128|B1|>= 65||Age, Customized||participants|Number|50|50.0||||||
4179901|NCT00797316|4001126|B3|< 65||Age, Customized||participants|Number|450|450.0||||||
4179902|NCT00797316|4001127|B2|< 65||Age, Customized||participants|Number|233|233.0||||||
4179903|NCT00797316|4001128|B1|< 65||Age, Customized||participants|Number|217|217.0||||||
4179904|NCT00797316|4001126|B3|||Age||years|Mean|53.9|53.9|Standard Deviation|10.98|10.98|||
4179905|NCT00797316|4001127|B2|||Age||years|Mean|53.5|53.5|Standard Deviation|10.87|10.87|||
4179906|NCT00797316|4001128|B1|||Age||years|Mean|54.4|54.4|Standard Deviation|11.09|11.09|||
4179907|NCT00797277|4001143|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4179908|NCT00797277|4001144|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4179909|NCT00797277|4001145|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4179910|NCT00797277|4001143|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4179911|NCT00797277|4001144|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4179912|NCT00797277|4001145|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4179913|NCT00797277|4001143|B3|||Age||years|Mean|39.0|39.0|Standard Deviation|11.0|11.0|||
4179914|NCT00797277|4001144|B2|||Age||years|Mean|41.3|41.3|Standard Deviation|11.3|11.3|||
4179915|NCT00797277|4001145|B1|||Age||years|Mean|37.1|37.1|Standard Deviation|10.8|10.8|||
4179916|NCT00797225|4001154|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|174|174.0||||||
4179917|NCT00797225|4001155|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
4179918|NCT00797225|4001156|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
4179919|NCT00797225|4001157|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
4179920|NCT00797225|4001158|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
4179921|NCT00797225|4001154|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4179922|NCT00797225|4001155|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4179923|NCT00797225|4001156|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4179924|NCT00797225|4001157|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4179925|NCT00797225|4001158|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4179926|NCT00797225|4001154|B5||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4179927|NCT00797225|4001155|B4||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4179928|NCT00797225|4001156|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4179929|NCT00797225|4001157|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4179930|NCT00797225|4001158|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4179931|NCT00797225|4001154|B5|||Age||years|Mean|31.7|31.7|Standard Deviation|0.4|0.4|||
4179932|NCT00797225|4001155|B4|||Age||years|Mean|31.4|31.4|Standard Deviation|0.7|0.7|||
4179933|NCT00797225|4001156|B3|||Age||years|Mean|31.7|31.7|Standard Deviation|1.0|1.0|||
4179934|NCT00797225|4001157|B2|||Age||years|Mean|32.1|32.1|Standard Deviation|0.9|0.9|||
4179935|NCT00797225|4001158|B1|||Age||years|Mean|31.4|31.4|Standard Deviation|0.8|0.8|||
4179936|NCT00797212|4001273|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4179937|NCT00797212|4001273|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4179938|NCT00797212|4001273|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4179939|NCT00797212|4001273|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4179940|NCT00797212|4001273|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4179941|NCT00797212|4001273|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4179942|NCT00797108|4001279|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4179943|NCT00797108|4001280|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4179944|NCT00797108|4001281|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4179945|NCT00797108|4001282|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4179946|NCT00797108|4001279|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4179947|NCT00797108|4001280|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4179948|NCT00797108|4001281|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4179949|NCT00797108|4001282|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4179950|NCT00797108|4001279|B4|greater than or equal to (>=) 65 years||Age, Customized||participants|Number|21|21.0||||||
4179951|NCT00797108|4001280|B3|greater than or equal to (>=) 65 years||Age, Customized||participants|Number|7|7.0||||||
4179952|NCT00797108|4001281|B2|greater than or equal to (>=) 65 years||Age, Customized||participants|Number|6|6.0||||||
4179953|NCT00797108|4001282|B1|greater than or equal to (>=) 65 years||Age, Customized||participants|Number|8|8.0||||||
4179954|NCT00797108|4001279|B4|45 to 64 years||Age, Customized||participants|Number|11|11.0||||||
4179955|NCT00797108|4001280|B3|45 to 64 years||Age, Customized||participants|Number|5|5.0||||||
4179956|NCT00797108|4001281|B2|45 to 64 years||Age, Customized||participants|Number|4|4.0||||||
4179957|NCT00797108|4001282|B1|45 to 64 years||Age, Customized||participants|Number|2|2.0||||||
4179958|NCT00797108|4001279|B4|18 to 44 years||Age, Customized||participants|Number|1|1.0||||||
4179959|NCT00797108|4001280|B3|18 to 44 years||Age, Customized||participants|Number|0|0.0||||||
4179960|NCT00797108|4001281|B2|18 to 44 years||Age, Customized||participants|Number|1|1.0||||||
4179961|NCT00797108|4001282|B1|18 to 44 years||Age, Customized||participants|Number|0|0.0||||||
4179962|NCT00796991|4001316|B4|>=5 lesions||Number of Target Lesions|Number of participants with 1, 2, 3, 4, or greater than or equal to (>=) 5 lesions which were targeted for the study.|Participants|Number|24|24.0||||||
4179963|NCT00796991|4001317|B3|>=5 lesions||Number of Target Lesions|Number of participants with 1, 2, 3, 4, or greater than or equal to (>=) 5 lesions which were targeted for the study.|Participants|Number|7|7.0||||||
4179964|NCT00796991|4001318|B2|>=5 lesions||Number of Target Lesions|Number of participants with 1, 2, 3, 4, or greater than or equal to (>=) 5 lesions which were targeted for the study.|Participants|Number|7|7.0||||||
4179965|NCT00796991|4001319|B1|>=5 lesions||Number of Target Lesions|Number of participants with 1, 2, 3, 4, or greater than or equal to (>=) 5 lesions which were targeted for the study.|Participants|Number|10|10.0||||||
4179966|NCT00796991|4001316|B4|4 lesions||Number of Target Lesions|Number of participants with 1, 2, 3, 4, or greater than or equal to (>=) 5 lesions which were targeted for the study.|Participants|Number|7|7.0||||||
4179967|NCT00796991|4001317|B3|4 lesions||Number of Target Lesions|Number of participants with 1, 2, 3, 4, or greater than or equal to (>=) 5 lesions which were targeted for the study.|Participants|Number|5|5.0||||||
4179968|NCT00796991|4001318|B2|4 lesions||Number of Target Lesions|Number of participants with 1, 2, 3, 4, or greater than or equal to (>=) 5 lesions which were targeted for the study.|Participants|Number|2|2.0||||||
4179969|NCT00796991|4001319|B1|4 lesions||Number of Target Lesions|Number of participants with 1, 2, 3, 4, or greater than or equal to (>=) 5 lesions which were targeted for the study.|Participants|Number|0|0.0||||||
4179970|NCT00796991|4001316|B4|3 lesions||Number of Target Lesions|Number of participants with 1, 2, 3, 4, or greater than or equal to (>=) 5 lesions which were targeted for the study.|Participants|Number|11|11.0||||||
4179971|NCT00796991|4001317|B3|3 lesions||Number of Target Lesions|Number of participants with 1, 2, 3, 4, or greater than or equal to (>=) 5 lesions which were targeted for the study.|Participants|Number|4|4.0||||||
4179972|NCT00796991|4001318|B2|3 lesions||Number of Target Lesions|Number of participants with 1, 2, 3, 4, or greater than or equal to (>=) 5 lesions which were targeted for the study.|Participants|Number|4|4.0||||||
4179973|NCT00796991|4001319|B1|3 lesions||Number of Target Lesions|Number of participants with 1, 2, 3, 4, or greater than or equal to (>=) 5 lesions which were targeted for the study.|Participants|Number|3|3.0||||||
4179974|NCT00796991|4001316|B4|2 lesions||Number of Target Lesions|Number of participants with 1, 2, 3, 4, or greater than or equal to (>=) 5 lesions which were targeted for the study.|Participants|Number|6|6.0||||||
4179975|NCT00796991|4001317|B3|2 lesions||Number of Target Lesions|Number of participants with 1, 2, 3, 4, or greater than or equal to (>=) 5 lesions which were targeted for the study.|Participants|Number|0|0.0||||||
4179976|NCT00796991|4001318|B2|2 lesions||Number of Target Lesions|Number of participants with 1, 2, 3, 4, or greater than or equal to (>=) 5 lesions which were targeted for the study.|Participants|Number|3|3.0||||||
4179977|NCT00796991|4001319|B1|2 lesions||Number of Target Lesions|Number of participants with 1, 2, 3, 4, or greater than or equal to (>=) 5 lesions which were targeted for the study.|Participants|Number|3|3.0||||||
4179978|NCT00796991|4001316|B4|1 lesion||Number of Target Lesions|Number of participants with 1, 2, 3, 4, or greater than or equal to (>=) 5 lesions which were targeted for the study.|Participants|Number|11|11.0||||||
4179979|NCT00796991|4001317|B3|1 lesion||Number of Target Lesions|Number of participants with 1, 2, 3, 4, or greater than or equal to (>=) 5 lesions which were targeted for the study.|Participants|Number|4|4.0||||||
4179980|NCT00796991|4001318|B2|1 lesion||Number of Target Lesions|Number of participants with 1, 2, 3, 4, or greater than or equal to (>=) 5 lesions which were targeted for the study.|Participants|Number|3|3.0||||||
4179981|NCT00796991|4001319|B1|1 lesion||Number of Target Lesions|Number of participants with 1, 2, 3, 4, or greater than or equal to (>=) 5 lesions which were targeted for the study.|Participants|Number|4|4.0||||||
4179982|NCT00796991|4001316|B4|Not Reported||Eastern Cooperative Oncology Group (ECOG)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|1|1.0||||||
4179983|NCT00796991|4001317|B3|Not Reported||Eastern Cooperative Oncology Group (ECOG)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|0|0.0||||||
4179984|NCT00796991|4001318|B2|Not Reported||Eastern Cooperative Oncology Group (ECOG)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|1|1.0||||||
4179985|NCT00796991|4001319|B1|Not Reported||Eastern Cooperative Oncology Group (ECOG)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|0|0.0||||||
4179986|NCT00796991|4001316|B4|2||Eastern Cooperative Oncology Group (ECOG)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|0|0.0||||||
4179987|NCT00796991|4001317|B3|2||Eastern Cooperative Oncology Group (ECOG)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|0|0.0||||||
4179988|NCT00796991|4001318|B2|2||Eastern Cooperative Oncology Group (ECOG)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|0|0.0||||||
4179989|NCT00796991|4001319|B1|2||Eastern Cooperative Oncology Group (ECOG)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|0|0.0||||||
4179990|NCT00796991|4001316|B4|1||Eastern Cooperative Oncology Group (ECOG)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|11|11.0||||||
4179991|NCT00796991|4001317|B3|1||Eastern Cooperative Oncology Group (ECOG)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|4|4.0||||||
4179992|NCT00796991|4001318|B2|1||Eastern Cooperative Oncology Group (ECOG)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|1|1.0||||||
4179993|NCT00796991|4001319|B1|1||Eastern Cooperative Oncology Group (ECOG)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|6|6.0||||||
4179994|NCT00796991|4001316|B4|0||Eastern Cooperative Oncology Group (ECOG)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|47|47.0||||||
4179995|NCT00796991|4001317|B3|0||Eastern Cooperative Oncology Group (ECOG)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|16|16.0||||||
4179996|NCT00796991|4001318|B2|0||Eastern Cooperative Oncology Group (ECOG)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|17|17.0||||||
4179997|NCT00796991|4001319|B1|0||Eastern Cooperative Oncology Group (ECOG)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|14|14.0||||||
4179998|NCT00796991|4001316|B4|United States||Region of Enrollment||participants|Number|59|59.0||||||
4179999|NCT00796991|4001317|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4180000|NCT00796991|4001318|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4180001|NCT00796991|4001319|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4180002|NCT00796991|4001316|B4||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4180003|NCT00796991|4001317|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4180004|NCT00796991|4001318|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4180005|NCT00796991|4001319|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4180006|NCT00796991|4001316|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4180007|NCT00796991|4001317|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4180008|NCT00796991|4001318|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4180009|NCT00796991|4001319|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4180010|NCT00796991|4001316|B4|||Age||years|Mean|57|57.0|Standard Deviation|14|14.0|||
4180011|NCT00796991|4001317|B3|||Age||years|Mean|60|60.0|Standard Deviation|11|11.0|||
4180012|NCT00796991|4001318|B2|||Age||years|Mean|54|54.0|Standard Deviation|17|17.0|||
4180013|NCT00796991|4001319|B1|||Age||years|Mean|55|55.0|Standard Deviation|14|14.0|||
4180014|NCT00796991|4001316|B4||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4180015|NCT00796991|4001317|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4180016|NCT00796991|4001318|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4180017|NCT00796991|4001319|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4180018|NCT00796991|4001316|B4||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4180019|NCT00796991|4001317|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4180020|NCT00796991|4001318|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4180021|NCT00796991|4001319|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4180022|NCT00796991|4001316|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180023|NCT00796991|4001317|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180024|NCT00796991|4001318|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180025|NCT00796991|4001319|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180026|NCT00796926|4001419|B3|Singapore||Region of Enrollment||participants|Number|30|30.0||||||
4180027|NCT00796926|4001420|B2|Singapore||Region of Enrollment||participants|Number|15|15.0||||||
4180028|NCT00796926|4001421|B1|Singapore||Region of Enrollment||participants|Number|15|15.0||||||
4180029|NCT00796926|4001419|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4180030|NCT00796926|4001420|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4180031|NCT00796926|4001421|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4180032|NCT00796926|4001419|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4180033|NCT00796926|4001420|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4180034|NCT00796926|4001421|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4180035|NCT00796926|4001419|B3|||Age||years|Mean|55.9|55.9|Standard Deviation|5.6|5.6|||
4180036|NCT00796926|4001420|B2|||Age||years|Mean|55.7|55.7|Standard Deviation|5.5|5.5|||
4180037|NCT00796926|4001421|B1|||Age||years|Mean|56.2|56.2|Standard Deviation|5.8|5.8|||
4180038|NCT00796926|4001419|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4180039|NCT00796926|4001420|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4180040|NCT00796926|4001421|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4180041|NCT00796926|4001419|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4180042|NCT00796926|4001420|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4180043|NCT00796926|4001421|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4180044|NCT00796926|4001419|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180045|NCT00796926|4001420|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180046|NCT00796926|4001421|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180047|NCT00796861|4001428|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180048|NCT00796861|4001428|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180049|NCT00796861|4001428|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4180050|NCT00796861|4001428|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180051|NCT00796861|4001428|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180052|NCT00796861|4001428|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180053|NCT00796861|4001428|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180054|NCT00796861|4001428|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180055|NCT00796861|4001428|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4180056|NCT00796861|4001428|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180057|NCT00796861|4001428|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4180058|NCT00796861|4001428|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4180059|NCT00796861|4001428|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4180060|NCT00796861|4001428|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4180061|NCT00796861|4001428|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180062|NCT00796822|4001432|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4180063|NCT00796822|4001433|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4180064|NCT00796822|4001434|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4180065|NCT00796822|4001432|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4180066|NCT00796822|4001433|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4180067|NCT00796822|4001434|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4180068|NCT00796822|4001432|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4180069|NCT00796822|4001433|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4180070|NCT00796822|4001434|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4180071|NCT00796822|4001432|B3|||Age||years|Mean|37|37.0|Standard Deviation|11.5|11.5|||
4180072|NCT00796822|4001433|B2|||Age||years|Mean|40|40.0|Standard Deviation|11.6|11.6|||
4180073|NCT00796822|4001434|B1|||Age||years|Mean|34|34.0|Standard Deviation|10.9|10.9|||
4180074|NCT00796822|4001432|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4180075|NCT00796822|4001433|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4180076|NCT00796822|4001434|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4180077|NCT00796822|4001432|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4180078|NCT00796822|4001433|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4180079|NCT00796822|4001434|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4180080|NCT00796822|4001432|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180081|NCT00796822|4001433|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180082|NCT00796822|4001434|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180083|NCT00796757|4001443|B1||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4180084|NCT00796757|4001443|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4180085|NCT00796757|4001443|B1|||Age||years|Mean|61.1|61.1|Standard Deviation|10.37|10.37|||
4180086|NCT00796744|4001455|B4|United States||Region of Enrollment||participants|Number|78|78.0||||||
4180087|NCT00796744|4001456|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
4180088|NCT00796744|4001457|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4180089|NCT00796744|4001458|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4180090|NCT00796744|4001455|B4||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4180091|NCT00796744|4001456|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4180092|NCT00796744|4001457|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4180093|NCT00796744|4001458|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4180094|NCT00796744|4001455|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4180095|NCT00796744|4001456|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4180096|NCT00796744|4001457|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4180097|NCT00796744|4001458|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4180098|NCT00796744|4001455|B4|||Age||years|Mean|55.3|55.3|Standard Deviation|11.87|11.87|||
4180099|NCT00796744|4001456|B3|||Age||years|Mean|53.1|53.1|Standard Deviation|12.47|12.47|||
4180100|NCT00796744|4001457|B2|||Age||years|Mean|56.3|56.3|Standard Deviation|10.35|10.35|||
4180101|NCT00796744|4001458|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|12.77|12.77|||
4180102|NCT00796744|4001455|B4||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4180103|NCT00796744|4001456|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4180104|NCT00796744|4001457|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4180105|NCT00796744|4001458|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4180106|NCT00796744|4001455|B4||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4180107|NCT00796744|4001456|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4180108|NCT00796744|4001457|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4180109|NCT00796744|4001458|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4180110|NCT00796744|4001455|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180111|NCT00796744|4001456|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180112|NCT00796744|4001457|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180113|NCT00796744|4001458|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180114|NCT00796718|4001477|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4180115|NCT00796718|4001477|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4180116|NCT00796718|4001477|B1|||Age||years|Mean|59.0|59.0|Standard Deviation|9.4|9.4|||
4180117|NCT00796705|4001484|B5|||Disease Activity Score Using C-reactive Protein (DAS28[CRP])|The DAS28 is: a score on a scale (0 to 10) indicating current activity of rheumatoid arthritis (>5.1=high disease activity; <=3.2=low disease activity; <2.6=remission); a continuous variable which is a composite of 4 variables(the number of tender joints out of 28, the number of swollen joints out of 28 joints, serum C-reactive protein in mg/L (CRP) and subject assessment of disease activity measure on a visual analogue scale (VAS) of 100 mm).|Scores on a scale|Mean|5.3|5.3|Standard Deviation|0.56|0.56|||
4180118|NCT00796705|4001485|B4|||Disease Activity Score Using C-reactive Protein (DAS28[CRP])|The DAS28 is: a score on a scale (0 to 10) indicating current activity of rheumatoid arthritis (>5.1=high disease activity; <=3.2=low disease activity; <2.6=remission); a continuous variable which is a composite of 4 variables(the number of tender joints out of 28, the number of swollen joints out of 28 joints, serum C-reactive protein in mg/L (CRP) and subject assessment of disease activity measure on a visual analogue scale (VAS) of 100 mm).|Scores on a scale|Mean|5.3|5.3|Standard Deviation|0.19|0.19|||
4180119|NCT00796705|4001486|B3|||Disease Activity Score Using C-reactive Protein (DAS28[CRP])|The DAS28 is: a score on a scale (0 to 10) indicating current activity of rheumatoid arthritis (>5.1=high disease activity; <=3.2=low disease activity; <2.6=remission); a continuous variable which is a composite of 4 variables(the number of tender joints out of 28, the number of swollen joints out of 28 joints, serum C-reactive protein in mg/L (CRP) and subject assessment of disease activity measure on a visual analogue scale (VAS) of 100 mm).|Scores on a scale|Mean|4.8|4.8|Standard Deviation|0.62|0.62|||
4180120|NCT00796705|4001487|B2|||Disease Activity Score Using C-reactive Protein (DAS28[CRP])|The DAS28 is: a score on a scale (0 to 10) indicating current activity of rheumatoid arthritis (>5.1=high disease activity; <=3.2=low disease activity; <2.6=remission); a continuous variable which is a composite of 4 variables(the number of tender joints out of 28, the number of swollen joints out of 28 joints, serum C-reactive protein in mg/L (CRP) and subject assessment of disease activity measure on a visual analogue scale (VAS) of 100 mm).|Scores on a scale|Mean|5.4|5.4|Standard Deviation|0.44|0.44|||
4180121|NCT00796705|4001488|B1|||Disease Activity Score Using C-reactive Protein (DAS28[CRP])|The DAS28 is: a score on a scale (0 to 10) indicating current activity of rheumatoid arthritis (>5.1=high disease activity; <=3.2=low disease activity; <2.6=remission); a continuous variable which is a composite of 4 variables(the number of tender joints out of 28, the number of swollen joints out of 28 joints, serum C-reactive protein in mg/L (CRP) and subject assessment of disease activity measure on a visual analogue scale (VAS) of 100 mm).|Scores on a scale|Mean|5.6|5.6|Standard Deviation|0.66|0.66|||
4180122|NCT00796705|4001484|B5|United States||Region of Enrollment||participants|Number|13|13.0||||||
4180123|NCT00796705|4001485|B4|United States||Region of Enrollment||participants|Number|2|2.0||||||
4180124|NCT00796705|4001486|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4180125|NCT00796705|4001487|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4180126|NCT00796705|4001488|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4180127|NCT00796705|4001484|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4180128|NCT00796705|4001485|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4180129|NCT00796705|4001486|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4180130|NCT00796705|4001487|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4180131|NCT00796705|4001488|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4180132|NCT00796705|4001484|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4180133|NCT00796705|4001485|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4180134|NCT00796705|4001486|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4180135|NCT00796705|4001487|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4180136|NCT00796705|4001488|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4180137|NCT00796705|4001484|B5|||Age||years|Mean|53|53.0|Standard Deviation|14.0|14.0|||
4180138|NCT00796705|4001485|B4|||Age||years|Mean|60|60.0|Standard Deviation|6.4|6.4|||
4180139|NCT00796705|4001486|B3|||Age||years|Mean|39|39.0|Standard Deviation|13.7|13.7|||
4180140|NCT00796705|4001487|B2|||Age||years|Mean|65|65.0|Standard Deviation|9.4|9.4|||
4180141|NCT00796705|4001488|B1|||Age||years|Mean|53|53.0|Standard Deviation|4.0|4.0|||
4180142|NCT00796705|4001484|B5||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4180143|NCT00796705|4001485|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4180144|NCT00796705|4001486|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4180145|NCT00796705|4001487|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4180146|NCT00796705|4001488|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4180147|NCT00796705|4001484|B5||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4180148|NCT00796705|4001485|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4180149|NCT00796705|4001486|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4180150|NCT00796705|4001487|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4180151|NCT00796705|4001488|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4180152|NCT00796705|4001484|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180153|NCT00796705|4001485|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180154|NCT00796705|4001486|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180155|NCT00796705|4001487|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180156|NCT00796705|4001488|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180185|NCT00796666|4001528|B2|less than 18 years||Age, Customized||participants|Number|0|0.0||||||
4180186|NCT00796666|4001529|B1|less than 18 years||Age, Customized||participants|Number|1|1.0||||||
4180187|NCT00796653|4001560|B5|Tiotropium||Tiotropium (Tio) Use Stratum||Number of participants|Number|241|241.0||||||
4180157|NCT00796666|4001527|B3|Functional Class IV||World Health Organization (WHO) Functional Classification|WHO Pulmonary Atrial Hypertension (PAH) Functional Classification: I (no limitation on physical activity), II (slight limitation on ordinary physical activity), III (marked limitations on physical activity comfortable at rest) and IV (unable to carry out any physical activity without symptoms, dyspnea and fatigue present at rest).|number|Number|1|1.0||||||
4180158|NCT00796666|4001528|B2|Functional Class IV||World Health Organization (WHO) Functional Classification|WHO Pulmonary Atrial Hypertension (PAH) Functional Classification: I (no limitation on physical activity), II (slight limitation on ordinary physical activity), III (marked limitations on physical activity comfortable at rest) and IV (unable to carry out any physical activity without symptoms, dyspnea and fatigue present at rest).|number|Number|1|1.0||||||
4180159|NCT00796666|4001529|B1|Functional Class IV||World Health Organization (WHO) Functional Classification|WHO Pulmonary Atrial Hypertension (PAH) Functional Classification: I (no limitation on physical activity), II (slight limitation on ordinary physical activity), III (marked limitations on physical activity comfortable at rest) and IV (unable to carry out any physical activity without symptoms, dyspnea and fatigue present at rest).|number|Number|0|0.0||||||
4180160|NCT00796666|4001527|B3|Functional Class III||World Health Organization (WHO) Functional Classification|WHO Pulmonary Atrial Hypertension (PAH) Functional Classification: I (no limitation on physical activity), II (slight limitation on ordinary physical activity), III (marked limitations on physical activity comfortable at rest) and IV (unable to carry out any physical activity without symptoms, dyspnea and fatigue present at rest).|number|Number|107|107.0||||||
4180161|NCT00796666|4001528|B2|Functional Class III||World Health Organization (WHO) Functional Classification|WHO Pulmonary Atrial Hypertension (PAH) Functional Classification: I (no limitation on physical activity), II (slight limitation on ordinary physical activity), III (marked limitations on physical activity comfortable at rest) and IV (unable to carry out any physical activity without symptoms, dyspnea and fatigue present at rest).|number|Number|52|52.0||||||
4180162|NCT00796666|4001529|B1|Functional Class III||World Health Organization (WHO) Functional Classification|WHO Pulmonary Atrial Hypertension (PAH) Functional Classification: I (no limitation on physical activity), II (slight limitation on ordinary physical activity), III (marked limitations on physical activity comfortable at rest) and IV (unable to carry out any physical activity without symptoms, dyspnea and fatigue present at rest).|number|Number|55|55.0||||||
4180163|NCT00796666|4001527|B3|Functional Class II||World Health Organization (WHO) Functional Classification|WHO Pulmonary Atrial Hypertension (PAH) Functional Classification: I (no limitation on physical activity), II (slight limitation on ordinary physical activity), III (marked limitations on physical activity comfortable at rest) and IV (unable to carry out any physical activity without symptoms, dyspnea and fatigue present at rest).|number|Number|23|23.0||||||
4180164|NCT00796666|4001528|B2|Functional Class II||World Health Organization (WHO) Functional Classification|WHO Pulmonary Atrial Hypertension (PAH) Functional Classification: I (no limitation on physical activity), II (slight limitation on ordinary physical activity), III (marked limitations on physical activity comfortable at rest) and IV (unable to carry out any physical activity without symptoms, dyspnea and fatigue present at rest).|number|Number|11|11.0||||||
4180165|NCT00796666|4001529|B1|Functional Class II||World Health Organization (WHO) Functional Classification|WHO Pulmonary Atrial Hypertension (PAH) Functional Classification: I (no limitation on physical activity), II (slight limitation on ordinary physical activity), III (marked limitations on physical activity comfortable at rest) and IV (unable to carry out any physical activity without symptoms, dyspnea and fatigue present at rest).|number|Number|12|12.0||||||
4180166|NCT00796666|4001527|B3|Functional Class I||World Health Organization (WHO) Functional Classification|WHO Pulmonary Atrial Hypertension (PAH) Functional Classification: I (no limitation on physical activity), II (slight limitation on ordinary physical activity), III (marked limitations on physical activity comfortable at rest) and IV (unable to carry out any physical activity without symptoms, dyspnea and fatigue present at rest).|number|Number|0|0.0||||||
4180167|NCT00796666|4001528|B2|Functional Class I||World Health Organization (WHO) Functional Classification|WHO Pulmonary Atrial Hypertension (PAH) Functional Classification: I (no limitation on physical activity), II (slight limitation on ordinary physical activity), III (marked limitations on physical activity comfortable at rest) and IV (unable to carry out any physical activity without symptoms, dyspnea and fatigue present at rest).|number|Number|0|0.0||||||
4180168|NCT00796666|4001529|B1|Functional Class I||World Health Organization (WHO) Functional Classification|WHO Pulmonary Atrial Hypertension (PAH) Functional Classification: I (no limitation on physical activity), II (slight limitation on ordinary physical activity), III (marked limitations on physical activity comfortable at rest) and IV (unable to carry out any physical activity without symptoms, dyspnea and fatigue present at rest).|number|Number|0|0.0||||||
4180169|NCT00796666|4001527|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4180170|NCT00796666|4001528|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4180171|NCT00796666|4001529|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4180172|NCT00796666|4001527|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4180173|NCT00796666|4001528|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4180174|NCT00796666|4001529|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4180175|NCT00796666|4001527|B3|>= 65 years||Age, Customized||participants|Number|13|13.0||||||
4180176|NCT00796666|4001528|B2|>= 65 years||Age, Customized||participants|Number|5|5.0||||||
4180177|NCT00796666|4001529|B1|>= 65 years||Age, Customized||participants|Number|8|8.0||||||
4180178|NCT00796666|4001527|B3|45-64 years||Age, Customized||participants|Number|38|38.0||||||
4180179|NCT00796666|4001528|B2|45-64 years||Age, Customized||participants|Number|18|18.0||||||
4180180|NCT00796666|4001529|B1|45-64 years||Age, Customized||participants|Number|20|20.0||||||
4180181|NCT00796666|4001527|B3|18-44 years||Age, Customized||participants|Number|79|79.0||||||
4180182|NCT00796666|4001528|B2|18-44 years||Age, Customized||participants|Number|41|41.0||||||
4180183|NCT00796666|4001529|B1|18-44 years||Age, Customized||participants|Number|38|38.0||||||
4180184|NCT00796666|4001527|B3|less than 18 years||Age, Customized||participants|Number|1|1.0||||||
4180188|NCT00796653|4001561|B4|Tiotropium||Tiotropium (Tio) Use Stratum||Number of participants|Number|59|59.0||||||
4180189|NCT00796653|4001562|B3|Tiotropium||Tiotropium (Tio) Use Stratum||Number of participants|Number|62|62.0||||||
4180190|NCT00796653|4001563|B2|Tiotropium||Tiotropium (Tio) Use Stratum||Number of participants|Number|58|58.0||||||
4180191|NCT00796653|4001564|B1|Tiotropium||Tiotropium (Tio) Use Stratum||Number of participants|Number|62|62.0||||||
4180192|NCT00796653|4001560|B5|Non-tiotropium||Tiotropium (Tio) Use Stratum||Number of participants|Number|693|693.0||||||
4180193|NCT00796653|4001561|B4|Non-tiotropium||Tiotropium (Tio) Use Stratum||Number of participants|Number|174|174.0||||||
4180194|NCT00796653|4001562|B3|Non-tiotropium||Tiotropium (Tio) Use Stratum||Number of participants|Number|172|172.0||||||
4180195|NCT00796653|4001563|B2|Non-tiotropium||Tiotropium (Tio) Use Stratum||Number of participants|Number|174|174.0||||||
4180196|NCT00796653|4001564|B1|Non-tiotropium||Tiotropium (Tio) Use Stratum||Number of participants|Number|173|173.0||||||
4180197|NCT00796653|4001560|B5||Male|Sex: Female, Male||Participants|Count of Participants|758|758.0||||||
4180198|NCT00796653|4001561|B4||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4180199|NCT00796653|4001562|B3||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4180200|NCT00796653|4001563|B2||Male|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4180201|NCT00796653|4001564|B1||Male|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4180202|NCT00796653|4001560|B5||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4180203|NCT00796653|4001561|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4180204|NCT00796653|4001562|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4180205|NCT00796653|4001563|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4180206|NCT00796653|4001564|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4180207|NCT00796653|4001560|B5|||Age||years|Mean|64.183|64.183|Standard Deviation|8.7|8.7|||
4180208|NCT00796653|4001561|B4|||Age||years|Mean|65.0|65.0|Standard Deviation|8.2|8.2|||
4180209|NCT00796653|4001562|B3|||Age||years|Mean|63.8|63.8|Standard Deviation|8.5|8.5|||
4180210|NCT00796653|4001563|B2|||Age||years|Mean|63.7|63.7|Standard Deviation|8.8|8.8|||
4180211|NCT00796653|4001564|B1|||Age||years|Mean|63.9|63.9|Standard Deviation|7.8|7.8|||
4180212|NCT00796627|4001833|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
4180213|NCT00796627|4001834|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
4180214|NCT00796627|4001835|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4180215|NCT00796627|4001833|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4180216|NCT00796627|4001833|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4180217|NCT00796627|4001834|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4180218|NCT00796627|4001835|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4180219|NCT00796627|4001833|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4180220|NCT00796627|4001834|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4180221|NCT00796627|4001835|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4180222|NCT00796627|4001833|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4180223|NCT00796627|4001834|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4180224|NCT00796627|4001835|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4180225|NCT00796627|4001833|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4180226|NCT00796627|4001834|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4180227|NCT00796627|4001835|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4180228|NCT00796627|4001833|B3|>=14, <=75||Age, Customized||Participants|Count of Participants|41|41.0||||||
4180229|NCT00796627|4001834|B2|>=14, <=75||Age, Customized||Participants|Count of Participants|31|31.0||||||
4180230|NCT00796627|4001835|B1|>=14, <=75||Age, Customized||Participants|Count of Participants|10|10.0||||||
4180231|NCT00796614|4001848|B5||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4180232|NCT00796614|4001849|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4180233|NCT00796614|4001850|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4180234|NCT00796614|4001851|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4180235|NCT00796614|4001852|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4180236|NCT00796614|4001848|B5||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4180237|NCT00796614|4001849|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4180238|NCT00796614|4001850|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4180239|NCT00796614|4001851|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4180240|NCT00796614|4001852|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4180241|NCT00796614|4001848|B5|10 to 16 years||Age, Customized||participants|Number|61|61.0||||||
4180242|NCT00796614|4001849|B4|10 to 16 years||Age, Customized||participants|Number|15|15.0||||||
4180243|NCT00796614|4001850|B3|10 to 16 years||Age, Customized||participants|Number|15|15.0||||||
4180244|NCT00796614|4001851|B2|10 to 16 years||Age, Customized||participants|Number|15|15.0||||||
4180245|NCT00796614|4001852|B1|10 to 16 years||Age, Customized||participants|Number|16|16.0||||||
4180246|NCT00796614|4001848|B5|5 to < 10 years||Age, Customized||participants|Number|70|70.0||||||
4180247|NCT00796614|4001849|B4|5 to < 10 years||Age, Customized||participants|Number|18|18.0||||||
4180248|NCT00796614|4001850|B3|5 to < 10 years||Age, Customized||participants|Number|17|17.0||||||
4180249|NCT00796614|4001851|B2|5 to < 10 years||Age, Customized||participants|Number|17|17.0||||||
4180250|NCT00796614|4001852|B1|5 to < 10 years||Age, Customized||participants|Number|18|18.0||||||
4180251|NCT00796614|4001848|B5|2 to < 5 years||Age, Customized||participants|Number|30|30.0||||||
4180252|NCT00796614|4001849|B4|2 to < 5 years||Age, Customized||participants|Number|8|8.0||||||
4180253|NCT00796614|4001850|B3|2 to < 5 years||Age, Customized||participants|Number|7|7.0||||||
4180254|NCT00796614|4001851|B2|2 to < 5 years||Age, Customized||participants|Number|8|8.0||||||
4180255|NCT00796614|4001852|B1|2 to < 5 years||Age, Customized||participants|Number|7|7.0||||||
4180256|NCT00796614|4001848|B5|||Age||Years|Mean|8.2|8.2|Standard Deviation|4.0|4.0|||
4180257|NCT00796614|4001849|B4|||Age||Years|Mean|8.2|8.2|Standard Deviation|4.3|4.3|||
4180258|NCT00796614|4001850|B3|||Age||Years|Mean|8.1|8.1|Standard Deviation|3.8|3.8|||
4180259|NCT00796614|4001851|B2|||Age||Years|Mean|8.1|8.1|Standard Deviation|4.2|4.2|||
4180260|NCT00796614|4001852|B1|||Age||Years|Mean|8.4|8.4|Standard Deviation|3.7|3.7|||
4180261|NCT00796549|4001897|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4180262|NCT00796549|4001897|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4180263|NCT00796549|4001897|B1|||Age||years|Mean|63.8|63.8|Standard Deviation|11.3|11.3|||
4180264|NCT00796523|4001912|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
4180265|NCT00796523|4001913|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4180266|NCT00796523|4001914|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4180267|NCT00796523|4001912|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4180268|NCT00796523|4001913|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4180269|NCT00796523|4001914|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4180270|NCT00796523|4001912|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4180271|NCT00796523|4001913|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4180272|NCT00796523|4001914|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4180273|NCT00796523|4001912|B3|>5 days||Age, Customized|(babies)|participants|Number|0|0.0||||||
4180274|NCT00796523|4001913|B2|>5 days||Age, Customized|(babies)|participants|Number|0|0.0||||||
4180275|NCT00796523|4001914|B1|>5 days||Age, Customized|(babies)|participants|Number|0|0.0||||||
4180276|NCT00796523|4001912|B3|<=5 days||Age, Customized|(babies)|participants|Number|51|51.0||||||
4180277|NCT00796523|4001913|B2|<=5 days||Age, Customized|(babies)|participants|Number|24|24.0||||||
4180278|NCT00796523|4001914|B1|<=5 days||Age, Customized|(babies)|participants|Number|27|27.0||||||
4180279|NCT00796523|4001912|B3|||Age|(babies)|days|Mean|3|3.0|Standard Deviation|1|1.0|||
4180280|NCT00796523|4001913|B2|||Age|(babies)|days|Mean|3|3.0|Standard Deviation|1|1.0|||
4180281|NCT00796523|4001914|B1|||Age|(babies)|days|Mean|3|3.0|Standard Deviation|1|1.0|||
4180282|NCT00796523|4001912|B3|||Age|(mothers)|years|Mean|29|29.0|Standard Deviation|5|5.0|||
4180283|NCT00796523|4001913|B2|||Age|(mothers)|years|Mean|30|30.0|Standard Deviation|4|4.0|||
4180284|NCT00796523|4001914|B1|||Age|(mothers)|years|Mean|29|29.0|Standard Deviation|6|6.0|||
4180285|NCT00796523|4001912|B3||>=65 years|Age|(mothers)|Participants|Count of Participants|0|0.0||||||
4180286|NCT00796523|4001913|B2||>=65 years|Age|(mothers)|Participants|Count of Participants|0|0.0||||||
4180287|NCT00796523|4001914|B1||>=65 years|Age|(mothers)|Participants|Count of Participants|0|0.0||||||
4180288|NCT00796523|4001912|B3||Between 18 and 65 years|Age|(mothers)|Participants|Count of Participants|51|51.0||||||
4180289|NCT00796523|4001913|B2||Between 18 and 65 years|Age|(mothers)|Participants|Count of Participants|24|24.0||||||
4180290|NCT00796523|4001914|B1||Between 18 and 65 years|Age|(mothers)|Participants|Count of Participants|27|27.0||||||
4180291|NCT00796523|4001912|B3||<=18 years|Age|(mothers)|Participants|Count of Participants|0|0.0||||||
4180292|NCT00796523|4001913|B2||<=18 years|Age|(mothers)|Participants|Count of Participants|0|0.0||||||
4180293|NCT00796523|4001914|B1||<=18 years|Age|(mothers)|Participants|Count of Participants|0|0.0||||||
4180294|NCT00796510|4001923|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4180295|NCT00796510|4001925|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4180296|NCT00796510|4001923|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4180297|NCT00796510|4001925|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4180298|NCT00796510|4001923|B3|||Age||years|Mean|42.3|42.3|Full Range|||29.0|54.0|
4180299|NCT00796510|4001925|B1|||Age||years|Mean|42.3|42.3|Full Range|||29.0|54.0|
4180300|NCT00796419|4001936|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4180301|NCT00796419|4001937|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4180302|NCT00796419|4001938|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4180303|NCT00796419|4001936|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4180304|NCT00796419|4001937|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180305|NCT00796419|4001938|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4180306|NCT00796419|4001936|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180307|NCT00796419|4001937|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180308|NCT00796419|4001938|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180309|NCT00796419|4001936|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4180310|NCT00796419|4001937|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4180311|NCT00796419|4001938|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4180312|NCT00796419|4001936|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4180313|NCT00796419|4001937|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4180314|NCT00796419|4001938|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4180315|NCT00796419|4001936|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180316|NCT00796419|4001937|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180317|NCT00796419|4001938|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180318|NCT00796419|4001936|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180319|NCT00796419|4001937|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180320|NCT00796419|4001938|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180321|NCT00796419|4001936|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180322|NCT00796419|4001937|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180323|NCT00796419|4001938|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180324|NCT00796419|4001936|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180325|NCT00796419|4001937|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180326|NCT00796419|4001938|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180327|NCT00796419|4001936|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4180328|NCT00796419|4001937|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4180329|NCT00796419|4001938|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4180330|NCT00796419|4001936|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4180331|NCT00796419|4001937|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180332|NCT00796419|4001938|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4180333|NCT00796419|4001936|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4180334|NCT00796419|4001937|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4180335|NCT00796419|4001938|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4180336|NCT00796419|4001936|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4180337|NCT00796419|4001937|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4180338|NCT00796419|4001938|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4180339|NCT00796419|4001936|B3|||Age||years|Mean|49|49.0|Standard Deviation|15|15.0|||
4180340|NCT00796419|4001937|B2|||Age||years|Mean|50|50.0|Standard Deviation|16|16.0|||
4180341|NCT00796419|4001938|B1|||Age||years|Mean|49|49.0|Standard Deviation|16|16.0|||
4180342|NCT00796367|4001949|B4|United States||Region of Enrollment||participants|Number|675|675.0||||||
4180343|NCT00796367|4001950|B3|United States||Region of Enrollment||participants|Number|295|295.0||||||
4180344|NCT00796367|4001951|B2|United States||Region of Enrollment||participants|Number|153|153.0||||||
4180345|NCT00796367|4001952|B1|United States||Region of Enrollment||participants|Number|227|227.0||||||
4180346|NCT00796367|4001949|B4||Male|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
4180347|NCT00796367|4001950|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4180348|NCT00796367|4001951|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4180349|NCT00796367|4001952|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4180350|NCT00796367|4001949|B4||Female|Sex: Female, Male||Participants|Count of Participants|448|448.0||||||
4180351|NCT00796367|4001950|B3||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4180352|NCT00796367|4001951|B2||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4180353|NCT00796367|4001952|B1||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4180354|NCT00796367|4001949|B4|||Age||years|Mean|51.9|51.9|Standard Deviation|10.2|10.2|||
4180355|NCT00796367|4001950|B3|||Age||years|Mean|51.2|51.2|Standard Deviation|10.4|10.4|||
4180356|NCT00796367|4001951|B2|||Age||years|Mean|52.2|52.2|Standard Deviation|10.6|10.6|||
4180357|NCT00796367|4001952|B1|||Age||years|Mean|52.7|52.7|Standard Deviation|9.8|9.8|||
4180358|NCT00796328|4001965|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4180359|NCT00796328|4001965|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4180360|NCT00796328|4001965|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4180361|NCT00796328|4001965|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4180362|NCT00796328|4001965|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180363|NCT00796315|4001969|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4180364|NCT00796315|4001969|B1|Female, Ages 12-17||Sex/Gender, Customized||participants|Number|6|6.0||||||
4180365|NCT00796315|4001969|B1|Male, Ages 12-17||Sex/Gender, Customized||participants|Number|9|9.0||||||
4180366|NCT00796315|4001969|B1|Female, Ages 6-11||Sex/Gender, Customized||participants|Number|8|8.0||||||
4180367|NCT00796315|4001969|B1|Male, Ages 6-11||Sex/Gender, Customized||participants|Number|9|9.0||||||
4180368|NCT00796315|4001969|B1|Female, Ages 2-5||Sex/Gender, Customized||participants|Number|2|2.0||||||
4180369|NCT00796315|4001969|B1|Male, Ages 2-5||Sex/Gender, Customized||participants|Number|7|7.0||||||
4180370|NCT00796315|4001969|B1|Subjects Aged 12-17 years||Age||years|Mean|14.5|14.5|Standard Deviation|1.8|1.8|||
4180371|NCT00796315|4001969|B1|Subjects Aged 6-11 years||Age||years|Mean|8.5|8.5|Standard Deviation|1.5|1.5|||
4180372|NCT00796315|4001969|B1|Subjects Aged 2-5 years||Age||years|Mean|3.6|3.6|Standard Deviation|1.1|1.1|||
4180373|NCT00796315|4001969|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4180374|NCT00796315|4001969|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4180375|NCT00796315|4001969|B1||<=18 years|Age||Participants|Count of Participants|41|41.0||||||
4180376|NCT00796302|4001982|B3|United States||Region of Enrollment||participants|Number|168|168.0||||||
4180377|NCT00796302|4001983|B2|United States||Region of Enrollment||participants|Number|84|84.0||||||
4180378|NCT00796302|4001984|B1|United States||Region of Enrollment||participants|Number|84|84.0||||||
4180379|NCT00796302|4001982|B3||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4180380|NCT00796302|4001983|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4180381|NCT00796302|4001984|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4180382|NCT00796302|4001982|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4180383|NCT00796302|4001983|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4180384|NCT00796302|4001984|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4180385|NCT00796302|4001982|B3|||Age||years|Mean|8.9|8.9|Standard Deviation|2.01|2.01|||
4180386|NCT00796302|4001983|B2|||Age||years|Mean|9.0|9.0|Standard Deviation|2.05|2.05|||
4180387|NCT00796302|4001984|B1|||Age||years|Mean|8.8|8.8|Standard Deviation|1.98|1.98|||
4180388|NCT00796302|4001982|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4180389|NCT00796302|4001983|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4180390|NCT00796302|4001984|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4180391|NCT00796302|4001982|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4180392|NCT00796302|4001983|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4180393|NCT00796302|4001984|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4180394|NCT00796302|4001982|B3||<=18 years|Age||Participants|Count of Participants|168|168.0||||||
4180395|NCT00796302|4001983|B2||<=18 years|Age||Participants|Count of Participants|84|84.0||||||
4180396|NCT00796302|4001984|B1||<=18 years|Age||Participants|Count of Participants|84|84.0||||||
4180397|NCT00796224|4001997|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4180398|NCT00796224|4001998|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4180399|NCT00796224|4001999|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4180400|NCT00796224|4001997|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4180401|NCT00796224|4001998|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4180402|NCT00796224|4001999|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4180403|NCT00796224|4001997|B3|2 years to <12 years||Age, Customized||participants|Number|19|19.0||||||
4180404|NCT00796224|4001998|B2|2 years to <12 years||Age, Customized||participants|Number|13|13.0||||||
4180405|NCT00796224|4001999|B1|2 years to <12 years||Age, Customized||participants|Number|6|6.0||||||
4180406|NCT00796224|4001997|B3|1 month to <2 years||Age, Customized||participants|Number|19|19.0||||||
4180407|NCT00796224|4001998|B2|1 month to <2 years||Age, Customized||participants|Number|6|6.0||||||
4180408|NCT00796224|4001999|B1|1 month to <2 years||Age, Customized||participants|Number|13|13.0||||||
4180409|NCT00796120|4002018|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4180410|NCT00796120|4002019|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4180411|NCT00796120|4002020|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4180412|NCT00796120|4002018|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4180413|NCT00796120|4002019|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4180414|NCT00796120|4002020|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4180415|NCT00796120|4002018|B3|>=65 years||Age, Customized||participants|Number|18|18.0||||||
4180416|NCT00796120|4002019|B2|>=65 years||Age, Customized||participants|Number|9|9.0||||||
4180417|NCT00796120|4002020|B1|>=65 years||Age, Customized||participants|Number|9|9.0||||||
4180418|NCT00796120|4002018|B3|>=50 to <=65 years||Age, Customized||participants|Number|40|40.0||||||
4180419|NCT00796120|4002019|B2|>=50 to <=65 years||Age, Customized||participants|Number|21|21.0||||||
4180420|NCT00796120|4002020|B1|>=50 to <=65 years||Age, Customized||participants|Number|19|19.0||||||
4180421|NCT00796120|4002018|B3|>=18 to <=49 years||Age, Customized||participants|Number|63|63.0||||||
4180422|NCT00796120|4002019|B2|>=18 to <=49 years||Age, Customized||participants|Number|30|30.0||||||
4180423|NCT00796120|4002020|B1|>=18 to <=49 years||Age, Customized||participants|Number|33|33.0||||||
4180424|NCT00796003|4002035|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4180425|NCT00796003|4002036|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4180426|NCT00796003|4002037|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4180427|NCT00796003|4002035|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4180428|NCT00796003|4002036|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4180429|NCT00796003|4002037|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4180430|NCT00796003|4002035|B3|>=75 years||Age, Customized||Participants|Number|7|7.0||||||
4180431|NCT00796003|4002036|B2|>=75 years||Age, Customized||Participants|Number|7|7.0||||||
4180432|NCT00796003|4002037|B1|>=75 years||Age, Customized||Participants|Number|0|0.0||||||
4180433|NCT00796003|4002035|B3|>= 65 and <= 74 years||Age, Customized||Participants|Number|20|20.0||||||
4180434|NCT00796003|4002036|B2|>= 65 and <= 74 years||Age, Customized||Participants|Number|17|17.0||||||
4180435|NCT00796003|4002037|B1|>= 65 and <= 74 years||Age, Customized||Participants|Number|3|3.0||||||
4180436|NCT00796003|4002035|B3|<65 years||Age, Customized||Participants|Number|10|10.0||||||
4180437|NCT00796003|4002036|B2|<65 years||Age, Customized||Participants|Number|10|10.0||||||
4180438|NCT00796003|4002037|B1|<65 years||Age, Customized||Participants|Number|0|0.0||||||
4180439|NCT00796003|4002035|B3|||Age||Years|Mean|68.5|68.5|Standard Deviation|6.81|6.81|||
4180440|NCT00796003|4002036|B2|||Age||Years|Mean|68.5|68.5|Standard Deviation|7.09|7.09|||
4180441|NCT00796003|4002037|B1|||Age||Years|Mean|68.7|68.7|Standard Deviation|2.08|2.08|67.0|71.0|
4180442|NCT00795951|4002059|B1|United States||Region of Enrollment||participants|Number|102|102.0||||||
4180443|NCT00795951|4002059|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4180444|NCT00795951|4002059|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4180445|NCT00795951|4002059|B1|||Age||years|Mean|11.6|11.6|Standard Deviation|3.61|3.61|||
4180446|NCT00795951|4002059|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4180447|NCT00795951|4002059|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4180448|NCT00795951|4002059|B1||<=18 years|Age||Participants|Count of Participants|102|102.0||||||
4180449|NCT00795886|4002096|B1|United States||Region of Enrollment||participants|Number|63|63.0||||||
4180450|NCT00795886|4002096|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4180451|NCT00795886|4002096|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4180452|NCT00795886|4002096|B1|||Age||years|Mean|9.9|9.9|Standard Deviation|5.3|5.3|||
4180453|NCT00795886|4002096|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4180454|NCT00795886|4002096|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4180455|NCT00795886|4002096|B1||<=18 years|Age||Participants|Count of Participants|61|61.0||||||
4180456|NCT00795821|4002102|B3|Russia||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4180457|NCT00795821|4002103|B2|Russia||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4180458|NCT00795821|4002104|B1|Russia||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4180459|NCT00795821|4002102|B3|Poland||Region of Enrollment||Participants|Count of Participants|89|89.0||||||
4180460|NCT00795821|4002103|B2|Poland||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
4180461|NCT00795821|4002104|B1|Poland||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
4180462|NCT00795821|4002102|B3|Argentina||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
4180463|NCT00795821|4002103|B2|Argentina||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4180464|NCT00795821|4002104|B1|Argentina||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4180465|NCT00795821|4002102|B3|Finland||Region of Enrollment||Participants|Count of Participants|85|85.0||||||
4180466|NCT00795821|4002103|B2|Finland||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
4180467|NCT00795821|4002104|B1|Finland||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
4180468|NCT00795821|4002102|B3|United States||Region of Enrollment||Participants|Count of Participants|275|275.0||||||
4180469|NCT00795821|4002103|B2|United States||Region of Enrollment||Participants|Count of Participants|135|135.0||||||
4180470|NCT00795821|4002104|B1|United States||Region of Enrollment||Participants|Count of Participants|140|140.0||||||
4180471|NCT00795821|4002102|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4180472|NCT00795821|4002103|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4180473|NCT00795821|4002104|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4180474|NCT00795821|4002102|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4180475|NCT00795821|4002103|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4180476|NCT00795821|4002104|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4180477|NCT00795821|4002102|B3||White|Race (NIH/OMB)||Participants|Count of Participants|378|378.0||||||
4180478|NCT00795821|4002103|B2||White|Race (NIH/OMB)||Participants|Count of Participants|187|187.0||||||
4180479|NCT00795821|4002104|B1||White|Race (NIH/OMB)||Participants|Count of Participants|191|191.0||||||
4180480|NCT00795821|4002102|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
4180481|NCT00795821|4002103|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4180482|NCT00795821|4002104|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4180483|NCT00795821|4002102|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4180484|NCT00795821|4002103|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4180485|NCT00795821|4002104|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180486|NCT00795821|4002102|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4180487|NCT00795821|4002103|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4180488|NCT00795821|4002104|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4180489|NCT00795821|4002102|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4180490|NCT00795821|4002103|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4180491|NCT00795821|4002104|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180492|NCT00795821|4002102|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4180493|NCT00795821|4002103|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4180494|NCT00795821|4002104|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4180495|NCT00795821|4002102|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|400|400.0||||||
4180496|NCT00795821|4002103|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|200|200.0||||||
4180497|NCT00795821|4002104|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|200|200.0||||||
4180498|NCT00795821|4002102|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4180499|NCT00795821|4002103|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4180500|NCT00795821|4002104|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4180501|NCT00795821|4002102|B3||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4180502|NCT00795821|4002103|B2||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4180503|NCT00795821|4002104|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4180504|NCT00795821|4002102|B3||Female|Sex: Female, Male||Participants|Count of Participants|303|303.0||||||
4180505|NCT00795821|4002103|B2||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4180506|NCT00795821|4002104|B1||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4180507|NCT00795821|4002102|B3|||Age||years|Mean|44.8|44.8|Standard Deviation|11.47|11.47|||
4180508|NCT00795821|4002103|B2|||Age||years|Mean|45.5|45.5|Standard Deviation|11.61|11.61|||
4180509|NCT00795821|4002104|B1|||Age||years|Mean|44.2|44.2|Standard Deviation|11.32|11.32|||
4180510|NCT00795769|4002174|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
4180511|NCT00795769|4002174|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4180512|NCT00795769|4002174|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4180513|NCT00795769|4002174|B1|||Age||years|Median|52|52.0|Full Range|||27.0|67.0|
4180514|NCT00795769|4002174|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4180515|NCT00795769|4002174|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4180516|NCT00795769|4002174|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180517|NCT00795717|4002178|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
4180518|NCT00795717|4002179|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4180519|NCT00795717|4002180|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4180520|NCT00795717|4002178|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4180521|NCT00795717|4002179|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4180522|NCT00795717|4002180|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4180523|NCT00795717|4002178|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4180524|NCT00795717|4002179|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4180525|NCT00795717|4002180|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4180526|NCT00795717|4002178|B3|||Age||years|Median|52.0|52.0|Inter-Quartile Range|||45.0|58.0|
4180527|NCT00795717|4002179|B2|||Age||years|Median|55.0|55.0|Inter-Quartile Range|||44.0|58.0|
4180528|NCT00795717|4002180|B1|||Age||years|Median|51.5|51.5|Inter-Quartile Range|||46.5|55.0|
4180529|NCT00795704|4002191|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4180530|NCT00795704|4002192|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4180531|NCT00795704|4002193|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4180532|NCT00795704|4002191|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4180533|NCT00795704|4002192|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4180534|NCT00795704|4002193|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4180535|NCT00795704|4002191|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4180536|NCT00795704|4002192|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4180537|NCT00795704|4002193|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4180538|NCT00795704|4002191|B3|||Age||years|Mean|56.7|56.7|Standard Deviation|6.2|6.2|||
4180539|NCT00795704|4002192|B2|||Age||years|Mean|57.3|57.3|Standard Deviation|5.5|5.5|||
4180540|NCT00795704|4002193|B1|||Age||years|Mean|56|56.0|Standard Deviation|7|7.0|||
4180541|NCT00795704|4002191|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4180542|NCT00795704|4002192|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4180543|NCT00795704|4002193|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4180544|NCT00795704|4002191|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4180545|NCT00795704|4002192|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4180546|NCT00795704|4002193|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4180547|NCT00795704|4002191|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180548|NCT00795704|4002192|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180549|NCT00795704|4002193|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180569|NCT00795639|4002205|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4180570|NCT00795639|4002206|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4180550|NCT00795639|4002204|B3|Functional Class Unknown||World Health Organization (WHO) Functional Class|WHO Pulmonary Arterial Hypertension (PAH) Functional Classification: I (no limitation on physical activity), II (slight limitation on ordinary physical activity), III (marked limitations on physical activity comfortable at rest) and IV (unable to carry out any physical activity without symptoms, dyspnea and fatigue present at rest).|Participants|Number|5|5.0||||||
4180551|NCT00795639|4002205|B2|Functional Class Unknown||World Health Organization (WHO) Functional Class|WHO Pulmonary Arterial Hypertension (PAH) Functional Classification: I (no limitation on physical activity), II (slight limitation on ordinary physical activity), III (marked limitations on physical activity comfortable at rest) and IV (unable to carry out any physical activity without symptoms, dyspnea and fatigue present at rest).|Participants|Number|4|4.0||||||
4180552|NCT00795639|4002206|B1|Functional Class Unknown||World Health Organization (WHO) Functional Class|WHO Pulmonary Arterial Hypertension (PAH) Functional Classification: I (no limitation on physical activity), II (slight limitation on ordinary physical activity), III (marked limitations on physical activity comfortable at rest) and IV (unable to carry out any physical activity without symptoms, dyspnea and fatigue present at rest).|Participants|Number|1|1.0||||||
4180553|NCT00795639|4002204|B3|Functional Class IV||World Health Organization (WHO) Functional Class|WHO Pulmonary Arterial Hypertension (PAH) Functional Classification: I (no limitation on physical activity), II (slight limitation on ordinary physical activity), III (marked limitations on physical activity comfortable at rest) and IV (unable to carry out any physical activity without symptoms, dyspnea and fatigue present at rest).|Participants|Number|0|0.0||||||
4180554|NCT00795639|4002205|B2|Functional Class IV||World Health Organization (WHO) Functional Class|WHO Pulmonary Arterial Hypertension (PAH) Functional Classification: I (no limitation on physical activity), II (slight limitation on ordinary physical activity), III (marked limitations on physical activity comfortable at rest) and IV (unable to carry out any physical activity without symptoms, dyspnea and fatigue present at rest).|Participants|Number|0|0.0||||||
4180555|NCT00795639|4002206|B1|Functional Class IV||World Health Organization (WHO) Functional Class|WHO Pulmonary Arterial Hypertension (PAH) Functional Classification: I (no limitation on physical activity), II (slight limitation on ordinary physical activity), III (marked limitations on physical activity comfortable at rest) and IV (unable to carry out any physical activity without symptoms, dyspnea and fatigue present at rest).|Participants|Number|0|0.0||||||
4180556|NCT00795639|4002204|B3|Functional Class III||World Health Organization (WHO) Functional Class|WHO Pulmonary Arterial Hypertension (PAH) Functional Classification: I (no limitation on physical activity), II (slight limitation on ordinary physical activity), III (marked limitations on physical activity comfortable at rest) and IV (unable to carry out any physical activity without symptoms, dyspnea and fatigue present at rest).|Participants|Number|175|175.0||||||
4180557|NCT00795639|4002205|B2|Functional Class III||World Health Organization (WHO) Functional Class|WHO Pulmonary Arterial Hypertension (PAH) Functional Classification: I (no limitation on physical activity), II (slight limitation on ordinary physical activity), III (marked limitations on physical activity comfortable at rest) and IV (unable to carry out any physical activity without symptoms, dyspnea and fatigue present at rest).|Participants|Number|87|87.0||||||
4180558|NCT00795639|4002206|B1|Functional Class III||World Health Organization (WHO) Functional Class|WHO Pulmonary Arterial Hypertension (PAH) Functional Classification: I (no limitation on physical activity), II (slight limitation on ordinary physical activity), III (marked limitations on physical activity comfortable at rest) and IV (unable to carry out any physical activity without symptoms, dyspnea and fatigue present at rest).|Participants|Number|88|88.0||||||
4180559|NCT00795639|4002204|B3|Functional Class II||World Health Organization (WHO) Functional Class|WHO Pulmonary Arterial Hypertension (PAH) Functional Classification: I (no limitation on physical activity), II (slight limitation on ordinary physical activity), III (marked limitations on physical activity comfortable at rest) and IV (unable to carry out any physical activity without symptoms, dyspnea and fatigue present at rest).|Participants|Number|2|2.0||||||
4180560|NCT00795639|4002205|B2|Functional Class II||World Health Organization (WHO) Functional Class|WHO Pulmonary Arterial Hypertension (PAH) Functional Classification: I (no limitation on physical activity), II (slight limitation on ordinary physical activity), III (marked limitations on physical activity comfortable at rest) and IV (unable to carry out any physical activity without symptoms, dyspnea and fatigue present at rest).|Participants|Number|0|0.0||||||
4180561|NCT00795639|4002206|B1|Functional Class II||World Health Organization (WHO) Functional Class|WHO Pulmonary Arterial Hypertension (PAH) Functional Classification: I (no limitation on physical activity), II (slight limitation on ordinary physical activity), III (marked limitations on physical activity comfortable at rest) and IV (unable to carry out any physical activity without symptoms, dyspnea and fatigue present at rest).|Participants|Number|2|2.0||||||
4180562|NCT00795639|4002204|B3|Functional Class I||World Health Organization (WHO) Functional Class|WHO Pulmonary Arterial Hypertension (PAH) Functional Classification: I (no limitation on physical activity), II (slight limitation on ordinary physical activity), III (marked limitations on physical activity comfortable at rest) and IV (unable to carry out any physical activity without symptoms, dyspnea and fatigue present at rest).|Participants|Number|0|0.0||||||
4180563|NCT00795639|4002205|B2|Functional Class I||World Health Organization (WHO) Functional Class|WHO Pulmonary Arterial Hypertension (PAH) Functional Classification: I (no limitation on physical activity), II (slight limitation on ordinary physical activity), III (marked limitations on physical activity comfortable at rest) and IV (unable to carry out any physical activity without symptoms, dyspnea and fatigue present at rest).|Participants|Number|0|0.0||||||
4180564|NCT00795639|4002206|B1|Functional Class I||World Health Organization (WHO) Functional Class|WHO Pulmonary Arterial Hypertension (PAH) Functional Classification: I (no limitation on physical activity), II (slight limitation on ordinary physical activity), III (marked limitations on physical activity comfortable at rest) and IV (unable to carry out any physical activity without symptoms, dyspnea and fatigue present at rest).|Participants|Number|0|0.0||||||
4180565|NCT00795639|4002204|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4180566|NCT00795639|4002205|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4180567|NCT00795639|4002206|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4180568|NCT00795639|4002204|B3||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4180571|NCT00795639|4002204|B3|greater than or equal to 65 years||Age, Customized||participants|Number|17|17.0||||||
4180572|NCT00795639|4002205|B2|greater than or equal to 65 years||Age, Customized||participants|Number|9|9.0||||||
4180573|NCT00795639|4002206|B1|greater than or equal to 65 years||Age, Customized||participants|Number|8|8.0||||||
4180574|NCT00795639|4002204|B3|45 to 64 years||Age, Customized||participants|Number|56|56.0||||||
4180575|NCT00795639|4002205|B2|45 to 64 years||Age, Customized||participants|Number|26|26.0||||||
4180576|NCT00795639|4002206|B1|45 to 64 years||Age, Customized||participants|Number|30|30.0||||||
4180577|NCT00795639|4002204|B3|18 to 44 years||Age, Customized||participants|Number|106|106.0||||||
4180578|NCT00795639|4002205|B2|18 to 44 years||Age, Customized||participants|Number|53|53.0||||||
4180579|NCT00795639|4002206|B1|18 to 44 years||Age, Customized||participants|Number|53|53.0||||||
4180580|NCT00795639|4002204|B3|less than 18 years||Age, Customized||participants|Number|3|3.0||||||
4180581|NCT00795639|4002205|B2|less than 18 years||Age, Customized||participants|Number|3|3.0||||||
4180582|NCT00795639|4002206|B1|less than 18 years||Age, Customized||participants|Number|0|0.0||||||
4180583|NCT00795600|4002217|B3|No||Diabetic complication at baseline, macroangiopathy||participants|Number|43|43.0||||||
4180584|NCT00795600|4002218|B2|No||Diabetic complication at baseline, macroangiopathy||participants|Number|23|23.0||||||
4180585|NCT00795600|4002219|B1|No||Diabetic complication at baseline, macroangiopathy||participants|Number|20|20.0||||||
4180586|NCT00795600|4002217|B3|Yes||Diabetic complication at baseline, macroangiopathy||participants|Number|16|16.0||||||
4180587|NCT00795600|4002218|B2|Yes||Diabetic complication at baseline, macroangiopathy||participants|Number|12|12.0||||||
4180588|NCT00795600|4002219|B1|Yes||Diabetic complication at baseline, macroangiopathy||participants|Number|4|4.0||||||
4180589|NCT00795600|4002217|B3|No||Diabetic complication at baseline, retinopathy (common risk factor in uncontrolled diabetes)||participants|Number|32|32.0||||||
4180590|NCT00795600|4002218|B2|No||Diabetic complication at baseline, retinopathy (common risk factor in uncontrolled diabetes)||participants|Number|19|19.0||||||
4180591|NCT00795600|4002219|B1|No||Diabetic complication at baseline, retinopathy (common risk factor in uncontrolled diabetes)||participants|Number|13|13.0||||||
4180592|NCT00795600|4002217|B3|Yes||Diabetic complication at baseline, retinopathy (common risk factor in uncontrolled diabetes)||participants|Number|27|27.0||||||
4180593|NCT00795600|4002218|B2|Yes||Diabetic complication at baseline, retinopathy (common risk factor in uncontrolled diabetes)||participants|Number|16|16.0||||||
4180594|NCT00795600|4002219|B1|Yes||Diabetic complication at baseline, retinopathy (common risk factor in uncontrolled diabetes)||participants|Number|11|11.0||||||
4180595|NCT00795600|4002217|B3|No||Diabetic complication at baseline, neuropathy (common risk factor in uncontrolled diabetes)||participants|Number|47|47.0||||||
4180596|NCT00795600|4002218|B2|No||Diabetic complication at baseline, neuropathy (common risk factor in uncontrolled diabetes)||participants|Number|28|28.0||||||
4180597|NCT00795600|4002219|B1|No||Diabetic complication at baseline, neuropathy (common risk factor in uncontrolled diabetes)||participants|Number|19|19.0||||||
4180598|NCT00795600|4002217|B3|Yes||Diabetic complication at baseline, neuropathy (common risk factor in uncontrolled diabetes)||participants|Number|12|12.0||||||
4180599|NCT00795600|4002218|B2|Yes||Diabetic complication at baseline, neuropathy (common risk factor in uncontrolled diabetes)||participants|Number|7|7.0||||||
4180600|NCT00795600|4002219|B1|Yes||Diabetic complication at baseline, neuropathy (common risk factor in uncontrolled diabetes)||participants|Number|5|5.0||||||
4180601|NCT00795600|4002217|B3|No||Diabetic complication at baseline, nephropathy (common risk factor in uncontrolled diabetes)||participants|Number|50|50.0||||||
4180602|NCT00795600|4002218|B2|No||Diabetic complication at baseline, nephropathy (common risk factor in uncontrolled diabetes)||participants|Number|30|30.0||||||
4180603|NCT00795600|4002219|B1|No||Diabetic complication at baseline, nephropathy (common risk factor in uncontrolled diabetes)||participants|Number|20|20.0||||||
4180604|NCT00795600|4002217|B3|Yes||Diabetic complication at baseline, nephropathy (common risk factor in uncontrolled diabetes)||participants|Number|9|9.0||||||
4180605|NCT00795600|4002218|B2|Yes||Diabetic complication at baseline, nephropathy (common risk factor in uncontrolled diabetes)||participants|Number|5|5.0||||||
4180606|NCT00795600|4002219|B1|Yes||Diabetic complication at baseline, nephropathy (common risk factor in uncontrolled diabetes)||participants|Number|4|4.0||||||
4180607|NCT00795600|4002217|B3|||Duration of diabetes|Number of years since diagnosis|years|Mean|15.86|15.86|Standard Deviation|8.29|8.29|||
4180608|NCT00795600|4002218|B2|||Duration of diabetes|Number of years since diagnosis|years|Mean|17.43|17.43|Standard Deviation|9.00|9.0|||
4180609|NCT00795600|4002219|B1|||Duration of diabetes|Number of years since diagnosis|years|Mean|13.58|13.58|Standard Deviation|6.68|6.68|||
4180610|NCT00795600|4002217|B3|Spain||Region of Enrollment||participants|Number|59|59.0||||||
4180611|NCT00795600|4002218|B2|Spain||Region of Enrollment||participants|Number|35|35.0||||||
4180612|NCT00795600|4002219|B1|Spain||Region of Enrollment||participants|Number|24|24.0||||||
4180613|NCT00795600|4002217|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180614|NCT00795600|4002218|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180615|NCT00795600|4002219|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180616|NCT00795600|4002217|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180617|NCT00795600|4002218|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180618|NCT00795600|4002219|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180619|NCT00795600|4002217|B3||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4180620|NCT00795600|4002218|B2||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4180621|NCT00795600|4002219|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4180622|NCT00795600|4002217|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180623|NCT00795600|4002218|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180624|NCT00795600|4002219|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180625|NCT00795600|4002217|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180626|NCT00795600|4002218|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180627|NCT00795600|4002219|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180628|NCT00795600|4002217|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180629|NCT00795600|4002218|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180630|NCT00795600|4002219|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180631|NCT00795600|4002217|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180632|NCT00795600|4002218|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180633|NCT00795600|4002219|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180634|NCT00795600|4002217|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4180635|NCT00795600|4002218|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4180636|NCT00795600|4002219|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4180637|NCT00795600|4002217|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180638|NCT00795600|4002218|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180639|NCT00795600|4002219|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180640|NCT00795600|4002217|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180641|NCT00795600|4002218|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180642|NCT00795600|4002219|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180643|NCT00795600|4002217|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4180644|NCT00795600|4002218|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4180645|NCT00795600|4002219|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4180646|NCT00795600|4002217|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4180647|NCT00795600|4002218|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4180648|NCT00795600|4002219|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4180649|NCT00795600|4002217|B3|||Age||years|Mean|62.47|62.47|Standard Deviation|9.24|9.24|||
4180650|NCT00795600|4002218|B2|||Age||years|Mean|63.74|63.74|Standard Deviation|9.39|9.39|||
4180651|NCT00795600|4002219|B1|||Age||years|Mean|60.63|60.63|Standard Deviation|8.87|8.87|||
4180652|NCT00795600|4002217|B3||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4180653|NCT00795600|4002218|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4180654|NCT00795600|4002219|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4180655|NCT00795600|4002217|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4180656|NCT00795600|4002218|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4180657|NCT00795600|4002219|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4180658|NCT00795600|4002217|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180659|NCT00795600|4002218|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180660|NCT00795600|4002219|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180661|NCT00795535|4002340|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4180662|NCT00795535|4002340|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4180663|NCT00795535|4002340|B1|||Age||years|Mean|47|47.0|Standard Deviation|20|20.0|||
4180664|NCT00795509|4002347|B1|Over 104 weeks||Treatment Period||participants|Number|7|7.0||||||
4180665|NCT00795509|4002347|B1|76 to 104 weeks||Treatment Period||participants|Number|31|31.0||||||
4180666|NCT00795509|4002347|B1|52 to 76 weeks||Treatment Period||participants|Number|172|172.0||||||
4180667|NCT00795509|4002347|B1|24 to 52 weeks||Treatment Period||participants|Number|88|88.0||||||
4180668|NCT00795509|4002347|B1|12 to 24 weeks||Treatment Period||participants|Number|44|44.0||||||
4180669|NCT00795509|4002347|B1|Less than 12 weeks||Treatment Period||participants|Number|1|1.0||||||
4180670|NCT00795509|4002347|B1|Absent||Concomitant drug||participants|Number|87|87.0||||||
4180671|NCT00795509|4002347|B1|Present||Concomitant drug||participants|Number|256|256.0||||||
4180672|NCT00795509|4002347|B1|Absent||Complications||participants|Number|77|77.0||||||
4180673|NCT00795509|4002347|B1|Present||Complications||participants|Number|266|266.0||||||
4180674|NCT00795509|4002347|B1|Severe||Target disease severity|The severity of Overactive Bladder which was diagnosed by investigator.|participants|Number|14|14.0||||||
4180675|NCT00795509|4002347|B1|Moderate||Target disease severity|The severity of Overactive Bladder which was diagnosed by investigator.|participants|Number|194|194.0||||||
4180676|NCT00795509|4002347|B1|Mild||Target disease severity|The severity of Overactive Bladder which was diagnosed by investigator.|participants|Number|135|135.0||||||
4180677|NCT00795509|4002347|B1||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4180678|NCT00795509|4002347|B1||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4180679|NCT00795509|4002347|B1|>= 65 years||Age, Customized||participants|Number|245|245.0||||||
4180680|NCT00795509|4002347|B1|<65 years||Age, Customized||participants|Number|98|98.0||||||
4180731|NCT00795340|4002363|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4180681|NCT00795366|4002352|B3|||ISS (Injury Severity Score)|ISS is an anatomical scoring system that provides an overall score for patients with multiple injuries. Each injury is assigned an Abbreviated Injury Scale (AIS) score and is allocated to one of six body regions (Head, Face, Chest, Abdomen, Extremities (including Pelvis), External). Only the highest AIS score in each body region is used. The 3 most severely injured body regions have their score squared and added together to produce the ISS score. The ISS scores range from 1 to 75, being one the least severe and 75 the most severe trauma injury.|units on a scale|Mean|28|28.0|Standard Deviation|10|10.0|||
4180682|NCT00795366|4002353|B2|||ISS (Injury Severity Score)|ISS is an anatomical scoring system that provides an overall score for patients with multiple injuries. Each injury is assigned an Abbreviated Injury Scale (AIS) score and is allocated to one of six body regions (Head, Face, Chest, Abdomen, Extremities (including Pelvis), External). Only the highest AIS score in each body region is used. The 3 most severely injured body regions have their score squared and added together to produce the ISS score. The ISS scores range from 1 to 75, being one the least severe and 75 the most severe trauma injury.|units on a scale|Mean|28|28.0|Standard Deviation|10|10.0|||
4180683|NCT00795366|4002354|B1|||ISS (Injury Severity Score)|ISS is an anatomical scoring system that provides an overall score for patients with multiple injuries. Each injury is assigned an Abbreviated Injury Scale (AIS) score and is allocated to one of six body regions (Head, Face, Chest, Abdomen, Extremities (including Pelvis), External). Only the highest AIS score in each body region is used. The 3 most severely injured body regions have their score squared and added together to produce the ISS score. The ISS scores range from 1 to 75, being one the least severe and 75 the most severe trauma injury.|units on a scale|Mean|29|29.0|Standard Deviation|9|9.0|||
4180684|NCT00795366|4002352|B3|United States||Region of Enrollment||participants|Number|96|96.0||||||
4180685|NCT00795366|4002353|B2|United States||Region of Enrollment||participants|Number|54|54.0||||||
4180686|NCT00795366|4002354|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4180687|NCT00795366|4002352|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4180688|NCT00795366|4002353|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4180689|NCT00795366|4002354|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4180690|NCT00795366|4002352|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4180691|NCT00795366|4002353|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4180692|NCT00795366|4002354|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4180693|NCT00795366|4002352|B3|||Age||years|Mean|39|39.0|Standard Deviation|17|17.0|||
4180694|NCT00795366|4002353|B2|||Age||years|Mean|38|38.0|Standard Deviation|18|18.0|||
4180695|NCT00795366|4002354|B1|||Age||years|Mean|40|40.0|Standard Deviation|16|16.0|||
4180696|NCT00795340|4002361|B3|Australia||Region of Enrollment||participants|Number|88|88.0||||||
4180697|NCT00795340|4002362|B2|Australia||Region of Enrollment||participants|Number|44|44.0||||||
4180698|NCT00795340|4002363|B1|Australia||Region of Enrollment||participants|Number|44|44.0||||||
4180699|NCT00795340|4002361|B3|Brazil||Region of Enrollment||participants|Number|18|18.0||||||
4180700|NCT00795340|4002362|B2|Brazil||Region of Enrollment||participants|Number|11|11.0||||||
4180701|NCT00795340|4002363|B1|Brazil||Region of Enrollment||participants|Number|7|7.0||||||
4180702|NCT00795340|4002361|B3|Canada||Region of Enrollment||participants|Number|200|200.0||||||
4180703|NCT00795340|4002362|B2|Canada||Region of Enrollment||participants|Number|98|98.0||||||
4180704|NCT00795340|4002363|B1|Canada||Region of Enrollment||participants|Number|102|102.0||||||
4180705|NCT00795340|4002361|B3|Not Reported||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4180706|NCT00795340|4002362|B2|Not Reported||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4180707|NCT00795340|4002363|B1|Not Reported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4180708|NCT00795340|4002361|B3|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4180709|NCT00795340|4002362|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4180710|NCT00795340|4002363|B1|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4180711|NCT00795340|4002361|B3|Aboriginal||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4180712|NCT00795340|4002362|B2|Aboriginal||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4180713|NCT00795340|4002363|B1|Aboriginal||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4180714|NCT00795340|4002361|B3|Asian||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4180715|NCT00795340|4002362|B2|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4180716|NCT00795340|4002363|B1|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4180717|NCT00795340|4002361|B3|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4180718|NCT00795340|4002362|B2|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4180719|NCT00795340|4002363|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4180720|NCT00795340|4002361|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4180721|NCT00795340|4002362|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4180722|NCT00795340|4002363|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4180723|NCT00795340|4002361|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|261|261.0||||||
4180724|NCT00795340|4002362|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|132|132.0||||||
4180725|NCT00795340|4002363|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|129|129.0||||||
4180726|NCT00795340|4002361|B3||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4180727|NCT00795340|4002362|B2||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4180728|NCT00795340|4002363|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4180729|NCT00795340|4002361|B3||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4180730|NCT00795340|4002362|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4180732|NCT00795340|4002361|B3|||Age||years|Median|62|62.0|Full Range|||23.0|85.0|
4180733|NCT00795340|4002362|B2|||Age||years|Median|62|62.0|Full Range|||36.0|77.0|
4180734|NCT00795340|4002363|B1|||Age||years|Median|63|63.0|Full Range|||23.0|85.0|
4180735|NCT00795288|4002374|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4180736|NCT00795288|4002375|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4180737|NCT00795288|4002376|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4180738|NCT00795288|4002374|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180739|NCT00795288|4002375|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180740|NCT00795288|4002376|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180741|NCT00795288|4002374|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180742|NCT00795288|4002375|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180743|NCT00795288|4002376|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180744|NCT00795288|4002374|B3||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4180745|NCT00795288|4002375|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4180746|NCT00795288|4002376|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4180747|NCT00795288|4002374|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4180748|NCT00795288|4002375|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4180749|NCT00795288|4002376|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4180750|NCT00795288|4002374|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180751|NCT00795288|4002375|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180752|NCT00795288|4002376|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180753|NCT00795288|4002374|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180754|NCT00795288|4002375|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180755|NCT00795288|4002376|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180756|NCT00795288|4002374|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180757|NCT00795288|4002375|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180758|NCT00795288|4002376|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4180759|NCT00795288|4002374|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4180760|NCT00795288|4002375|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4180761|NCT00795288|4002376|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4180762|NCT00795288|4002374|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4180763|NCT00795288|4002375|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4180764|NCT00795288|4002376|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4180765|NCT00795288|4002374|B3|||Age||years|Mean|60|60.0|Standard Deviation|11|11.0|||
4180766|NCT00795288|4002375|B2|||Age||years|Mean|60|60.0|Standard Deviation|10|10.0|||
4180767|NCT00795288|4002376|B1|||Age||years|Mean|59|59.0|Standard Deviation|12|12.0|||
4180768|NCT00795288|4002374|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4180769|NCT00795288|4002375|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4180770|NCT00795288|4002376|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4180771|NCT00795288|4002374|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4180772|NCT00795288|4002375|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4180773|NCT00795288|4002376|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4180774|NCT00795288|4002374|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180775|NCT00795288|4002375|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180776|NCT00795288|4002376|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180777|NCT00795210|4002387|B4|United States||Region of Enrollment||participants|Number|25|25.0||||||
4180778|NCT00795210|4002388|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4180779|NCT00795210|4002389|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4180780|NCT00795210|4002390|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4180781|NCT00795210|4002387|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4180782|NCT00795210|4002388|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4180783|NCT00795210|4002389|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4180784|NCT00795210|4002390|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4180785|NCT00795210|4002387|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4180786|NCT00795210|4002388|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4180787|NCT00795210|4002389|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4180788|NCT00795210|4002390|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4180789|NCT00795210|4002387|B4|||Age||years|Mean|48|48.0|Standard Deviation|6|6.0|||
4180790|NCT00795210|4002388|B3|||Age||years|Mean|47|47.0|Standard Deviation|4|4.0|||
4180791|NCT00795210|4002389|B2|||Age||years|Mean|49|49.0|Standard Deviation|6|6.0|||
4180792|NCT00795210|4002390|B1|||Age||years|Mean|49|49.0|Standard Deviation|7|7.0|||
4180793|NCT00795210|4002387|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4180794|NCT00795210|4002388|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4180795|NCT00795210|4002389|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4180796|NCT00795210|4002390|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4180797|NCT00795210|4002387|B4||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4180798|NCT00795210|4002388|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4180799|NCT00795210|4002389|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4180800|NCT00795210|4002390|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4180801|NCT00795210|4002387|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180802|NCT00795210|4002388|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180803|NCT00795210|4002389|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180804|NCT00795210|4002390|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180805|NCT00795184|4002403|B1|Germany||Region of Enrollment||participants|Number|30|30.0||||||
4180806|NCT00795184|4002403|B1|United States||Region of Enrollment||participants|Number|62|62.0||||||
4180807|NCT00795184|4002403|B1|France||Region of Enrollment||participants|Number|9|9.0||||||
4180808|NCT00795184|4002403|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4180809|NCT00795184|4002403|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4180810|NCT00795184|4002403|B1|||Age||years|Mean|65.1|65.1|Standard Deviation|11.52|11.52|||
4180811|NCT00795145|4002413|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4180812|NCT00795145|4002414|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4180813|NCT00795145|4002415|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4180814|NCT00795145|4002413|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4180815|NCT00795145|4002414|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4180816|NCT00795145|4002415|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4180817|NCT00795145|4002413|B3|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4180818|NCT00795145|4002414|B2|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4180819|NCT00795145|4002415|B1|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4180820|NCT00795145|4002413|B3|45 - 64 years||Age, Customized||participants|Number|5|5.0||||||
4180821|NCT00795145|4002414|B2|45 - 64 years||Age, Customized||participants|Number|4|4.0||||||
4180822|NCT00795145|4002415|B1|45 - 64 years||Age, Customized||participants|Number|1|1.0||||||
4180823|NCT00795145|4002413|B3|18 - 44 years||Age, Customized||participants|Number|44|44.0||||||
4180824|NCT00795145|4002414|B2|18 - 44 years||Age, Customized||participants|Number|36|36.0||||||
4180825|NCT00795145|4002415|B1|18 - 44 years||Age, Customized||participants|Number|8|8.0||||||
4180826|NCT00795145|4002413|B3|<18 years||Age, Customized||participants|Number|0|0.0||||||
4180827|NCT00795145|4002414|B2|<18 years||Age, Customized||participants|Number|0|0.0||||||
4180828|NCT00795145|4002415|B1|<18 years||Age, Customized||participants|Number|0|0.0||||||
4180829|NCT00795132|4002465|B1|Australia||Region of Enrollment||participants|Number|4|4.0||||||
4180830|NCT00795132|4002465|B1|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4180831|NCT00795132|4002465|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4180832|NCT00795132|4002465|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4180833|NCT00795132|4002465|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4180834|NCT00795132|4002465|B1|||Age||years|Mean|13|13.0|Standard Deviation|9.899|9.899|||
4180835|NCT00795132|4002465|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4180836|NCT00795132|4002465|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4180837|NCT00795132|4002465|B1||<=18 years|Age||Participants|Count of Participants|35|35.0||||||
4180838|NCT00795002|4002477|B3|United States||Region of Enrollment||participants|Number|78|78.0||||||
4180839|NCT00795002|4002478|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
4180840|NCT00795002|4002479|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4180841|NCT00795002|4002477|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4180842|NCT00795002|4002478|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4180843|NCT00795002|4002479|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4180844|NCT00795002|4002477|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4180845|NCT00795002|4002478|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4180846|NCT00795002|4002479|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4180847|NCT00795002|4002477|B3|||Age||years|Mean|60|60.0|Standard Deviation|58|58.0|||
4180848|NCT00795002|4002478|B2|||Age||years|Mean|59|59.0|Standard Deviation|53|53.0|||
4180849|NCT00795002|4002479|B1|||Age||years|Mean|61|61.0|Standard Deviation|54|54.0|||
4180850|NCT00795002|4002477|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4180851|NCT00795002|4002478|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4180852|NCT00795002|4002479|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4180853|NCT00795002|4002477|B3||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4180854|NCT00795002|4002478|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4180855|NCT00795002|4002479|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4180856|NCT00795002|4002477|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180857|NCT00795002|4002478|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180858|NCT00795002|4002479|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180859|NCT00794963|4002490|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4180860|NCT00794963|4002491|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4180861|NCT00794963|4002492|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4180862|NCT00794963|4002490|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4180863|NCT00794963|4002491|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4180864|NCT00794963|4002492|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4180865|NCT00794963|4002490|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4180866|NCT00794963|4002491|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4180867|NCT00794963|4002492|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4180868|NCT00794963|4002490|B3|||Age||years|Mean|48.6|48.6|Standard Deviation|4.9|4.9|||
4180869|NCT00794963|4002491|B2|||Age||years|Mean|43.5|43.5|Standard Deviation|5.6|5.6|||
4180870|NCT00794963|4002492|B1|||Age||years|Mean|53.7|53.7|Standard Deviation|4.8|4.8|||
4180871|NCT00794963|4002490|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4180872|NCT00794963|4002491|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4180873|NCT00794963|4002492|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4180874|NCT00794963|4002490|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4180875|NCT00794963|4002491|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4180876|NCT00794963|4002492|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4180877|NCT00794963|4002490|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180878|NCT00794963|4002491|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180879|NCT00794963|4002492|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180880|NCT00794924|4002499|B3||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4180881|NCT00794924|4002500|B2||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4180882|NCT00794924|4002501|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4180883|NCT00794924|4002499|B3||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4180884|NCT00794924|4002500|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4180885|NCT00794924|4002501|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4180886|NCT00794924|4002499|B3|||Age||years|Mean|76.05|76.05|Standard Deviation|8.6|8.6|||
4180887|NCT00794924|4002500|B2|||Age||years|Mean|75.7|75.7|Standard Deviation|8.6|8.6|||
4180888|NCT00794924|4002501|B1|||Age||years|Mean|76.4|76.4|Standard Deviation|8.5|8.5|||
4180889|NCT00794924|4002499|B3||>=65 years|Age||Participants|Count of Participants|334|334.0||||||
4180890|NCT00794924|4002500|B2||>=65 years|Age||Participants|Count of Participants|165|165.0||||||
4180891|NCT00794924|4002501|B1||>=65 years|Age||Participants|Count of Participants|169|169.0||||||
4180892|NCT00794924|4002499|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4180893|NCT00794924|4002500|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4180894|NCT00794924|4002501|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4180895|NCT00794924|4002499|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180896|NCT00794924|4002500|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180897|NCT00794924|4002501|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180898|NCT00794820|4002506|B1|United States||Region of Enrollment||participants|Number|66|66.0||||||
4180899|NCT00794820|4002506|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4180900|NCT00794820|4002506|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4180901|NCT00794820|4002506|B1|||Age||years|Median|58|58.0|Full Range|||27.0|82.0|
4180902|NCT00794677|4002512|B3|United States||Region of Enrollment||participants|Number|24.0|24.0||||||
4180903|NCT00794677|4002513|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4180904|NCT00794677|4002514|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4180905|NCT00794677|4002512|B3||Male|Sex: Female, Male||Participants|Count of Participants|18.0|18.0||||||
4180906|NCT00794677|4002513|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4180907|NCT00794677|4002514|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4180908|NCT00794677|4002512|B3||Female|Sex: Female, Male||Participants|Count of Participants|6.0|6.0||||||
4180909|NCT00794677|4002513|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4180910|NCT00794677|4002514|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4180911|NCT00794677|4002512|B3|||Age||years|Mean|50.99|50.99|Standard Deviation|11.49|11.49|||
4180912|NCT00794677|4002513|B2|||Age||years|Mean|50.09|50.09|Standard Deviation|14.28|14.28|||
4180913|NCT00794677|4002514|B1|||Age||years|Mean|52.05|52.05|Standard Deviation|7.54|7.54|||
4180914|NCT00794677|4002512|B3||>=65 years|Age||Participants|Count of Participants|2.0|2.0||||||
4180915|NCT00794677|4002513|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4180916|NCT00794677|4002514|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4180917|NCT00794677|4002512|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22.0|22.0||||||
4180918|NCT00794677|4002513|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4180919|NCT00794677|4002514|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4180920|NCT00794677|4002512|B3||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4180921|NCT00794677|4002513|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180922|NCT00794677|4002514|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4180923|NCT00794664|4002535|B3|Never||Alcohol Use||participants|Number|15|15.0||||||
4180924|NCT00794664|4002536|B2|Never||Alcohol Use||participants|Number|7|7.0||||||
4180925|NCT00794664|4002537|B1|Never||Alcohol Use||participants|Number|8|8.0||||||
4180926|NCT00794664|4002535|B3|Non-current||Alcohol Use||participants|Number|9|9.0||||||
4180927|NCT00794664|4002536|B2|Non-current||Alcohol Use||participants|Number|5|5.0||||||
4180928|NCT00794664|4002537|B1|Non-current||Alcohol Use||participants|Number|4|4.0||||||
4180929|NCT00794664|4002535|B3|Current||Alcohol Use||participants|Number|34|34.0||||||
4180930|NCT00794664|4002536|B2|Current||Alcohol Use||participants|Number|27|27.0||||||
4180931|NCT00794664|4002537|B1|Current||Alcohol Use||participants|Number|7|7.0||||||
4180932|NCT00794664|4002535|B3|Never||Tobacco Use||participants|Number|31|31.0||||||
4180933|NCT00794664|4002536|B2|Never||Tobacco Use||participants|Number|24|24.0||||||
4180934|NCT00794664|4002537|B1|Never||Tobacco Use||participants|Number|7|7.0||||||
4180935|NCT00794664|4002535|B3|Non-current||Tobacco Use||participants|Number|18|18.0||||||
4180936|NCT00794664|4002536|B2|Non-current||Tobacco Use||participants|Number|11|11.0||||||
4180937|NCT00794664|4002537|B1|Non-current||Tobacco Use||participants|Number|7|7.0||||||
4180938|NCT00794664|4002535|B3|Current||Tobacco Use||participants|Number|9|9.0||||||
4180939|NCT00794664|4002536|B2|Current||Tobacco Use||participants|Number|4|4.0||||||
4180940|NCT00794664|4002537|B1|Current||Tobacco Use||participants|Number|5|5.0||||||
4180941|NCT00794664|4002535|B3|Yes||Metabolic syndrome|Yes if 3 or more risk factors are present: 1) Abdominal obesity 2) Triglycerides >=150 mg/dl * 3) High density lipoprotein cholesterol (men <40 mg/dl) (women <50 mg/dl) * 4) Systolic blood pressure >=130 or diastolic >=85 mmHg * 5) Fasting glucose >=100 mg/dl * * = or on medication for condition|participants|Number|23|23.0||||||
4180942|NCT00794664|4002536|B2|Yes||Metabolic syndrome|Yes if 3 or more risk factors are present: 1) Abdominal obesity 2) Triglycerides >=150 mg/dl * 3) High density lipoprotein cholesterol (men <40 mg/dl) (women <50 mg/dl) * 4) Systolic blood pressure >=130 or diastolic >=85 mmHg * 5) Fasting glucose >=100 mg/dl * * = or on medication for condition|participants|Number|14|14.0||||||
4180943|NCT00794664|4002537|B1|Yes||Metabolic syndrome|Yes if 3 or more risk factors are present: 1) Abdominal obesity 2) Triglycerides >=150 mg/dl * 3) High density lipoprotein cholesterol (men <40 mg/dl) (women <50 mg/dl) * 4) Systolic blood pressure >=130 or diastolic >=85 mmHg * 5) Fasting glucose >=100 mg/dl * * = or on medication for condition|participants|Number|9|9.0||||||
4180944|NCT00794664|4002535|B3|No||Metabolic syndrome|Yes if 3 or more risk factors are present: 1) Abdominal obesity 2) Triglycerides >=150 mg/dl * 3) High density lipoprotein cholesterol (men <40 mg/dl) (women <50 mg/dl) * 4) Systolic blood pressure >=130 or diastolic >=85 mmHg * 5) Fasting glucose >=100 mg/dl * * = or on medication for condition|participants|Number|35|35.0||||||
4180945|NCT00794664|4002536|B2|No||Metabolic syndrome|Yes if 3 or more risk factors are present: 1) Abdominal obesity 2) Triglycerides >=150 mg/dl * 3) High density lipoprotein cholesterol (men <40 mg/dl) (women <50 mg/dl) * 4) Systolic blood pressure >=130 or diastolic >=85 mmHg * 5) Fasting glucose >=100 mg/dl * * = or on medication for condition|participants|Number|25|25.0||||||
4180946|NCT00794664|4002537|B1|No||Metabolic syndrome|Yes if 3 or more risk factors are present: 1) Abdominal obesity 2) Triglycerides >=150 mg/dl * 3) High density lipoprotein cholesterol (men <40 mg/dl) (women <50 mg/dl) * 4) Systolic blood pressure >=130 or diastolic >=85 mmHg * 5) Fasting glucose >=100 mg/dl * * = or on medication for condition|participants|Number|10|10.0||||||
4180947|NCT00794664|4002535|B3|||Waist/hip ratio||ratio|Mean|0.93|0.93|Standard Deviation|0.08|0.08|||
4180948|NCT00794664|4002536|B2|||Waist/hip ratio||ratio|Mean|0.92|0.92|Standard Deviation|0.09|0.09|||
4180949|NCT00794664|4002537|B1|||Waist/hip ratio||ratio|Mean|0.94|0.94|Standard Deviation|0.06|0.06|||
4180950|NCT00794664|4002535|B3|||Body Mass Index||kg/m^2|Mean|28.9|28.9|Standard Deviation|4.98|4.98|||
4180951|NCT00794664|4002536|B2|||Body Mass Index||kg/m^2|Mean|28.4|28.4|Standard Deviation|5.35|5.35|||
4180952|NCT00794664|4002537|B1|||Body Mass Index||kg/m^2|Mean|29.9|29.9|Standard Deviation|4.10|4.1|||
4180953|NCT00794664|4002535|B3|Hispanic or Latino||Ethnicity||participants|Number|0|0.0||||||
4180954|NCT00794664|4002536|B2|Hispanic or Latino||Ethnicity||participants|Number|0|0.0||||||
4180955|NCT00794664|4002537|B1|Hispanic or Latino||Ethnicity||participants|Number|0|0.0||||||
4180956|NCT00794664|4002535|B3|Not Hispanic or Latino||Ethnicity||participants|Number|58|58.0||||||
4180957|NCT00794664|4002536|B2|Not Hispanic or Latino||Ethnicity||participants|Number|39|39.0||||||
4180958|NCT00794664|4002537|B1|Not Hispanic or Latino||Ethnicity||participants|Number|19|19.0||||||
4180959|NCT00794664|4002535|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4180960|NCT00794664|4002536|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4180961|NCT00794664|4002537|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4180962|NCT00794664|4002535|B3|Multiple||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4180963|NCT00794664|4002536|B2|Multiple||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4180964|NCT00794664|4002537|B1|Multiple||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4180965|NCT00794664|4002535|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4180966|NCT00794664|4002536|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4180967|NCT00794664|4002537|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4180968|NCT00794664|4002535|B3|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4180969|NCT00794664|4002536|B2|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4180970|NCT00794664|4002537|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4180971|NCT00794664|4002535|B3|White||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4180972|NCT00794664|4002536|B2|White||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4180973|NCT00794664|4002537|B1|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4180974|NCT00794664|4002535|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4180975|NCT00794664|4002536|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4180976|NCT00794664|4002537|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4180977|NCT00794664|4002535|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4180978|NCT00794664|4002536|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4180979|NCT00794664|4002537|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4180980|NCT00794664|4002535|B3|||Age||years|Mean|50.5|50.5|Standard Deviation|14.0|14.0|||
4180981|NCT00794664|4002536|B2|||Age||years|Mean|51.8|51.8|Standard Deviation|14.3|14.3|||
4180982|NCT00794664|4002537|B1|||Age||years|Mean|47.9|47.9|Standard Deviation|13.5|13.5|||
4180983|NCT00794560|4002582|B5||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4180984|NCT00794560|4002583|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4180985|NCT00794560|4002584|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4180986|NCT00794560|4002585|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4180987|NCT00794560|4002586|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4180988|NCT00794560|4002582|B5||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4180989|NCT00794560|4002583|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4180990|NCT00794560|4002584|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4180991|NCT00794560|4002585|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4180992|NCT00794560|4002586|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4180993|NCT00794560|4002582|B5|||Age||years|Median|54|54.0|Inter-Quartile Range|||40.0|65.0|
4180994|NCT00794560|4002583|B4|||Age||years|Median|54|54.0|Inter-Quartile Range|||43.0|67.0|
4180995|NCT00794560|4002584|B3|||Age||years|Median|51|51.0|Inter-Quartile Range|||36.0|65.0|
4180996|NCT00794560|4002585|B2|||Age||years|Median|56|56.0|Inter-Quartile Range|||42.0|66.0|
4180997|NCT00794560|4002586|B1|||Age||years|Median|56|56.0|Inter-Quartile Range|||34.0|60.0|
4180998|NCT00794547|4002603|B1|Unknown||Smoking Status||participants|Number|3|3.0||||||
4180999|NCT00794547|4002603|B1|Ever Smoker||Smoking Status||participants|Number|29|29.0||||||
4181000|NCT00794547|4002603|B1|Never Smoker||Smoking Status||participants|Number|2|2.0||||||
4181001|NCT00794547|4002603|B1|Performance Status 1||Performance Status|Eastern Cooperative Oncology Group Performance Status at baseline. Scores may be 0 (Asymptomatic; fully active, able to carry on all predisease activities without restriction) or 1 (Symptomatic but completely ambulatory; restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. For example, light housework, office work)|participants|Number|18|18.0||||||
4181002|NCT00794547|4002603|B1|Performance Status 0||Performance Status|Eastern Cooperative Oncology Group Performance Status at baseline. Scores may be 0 (Asymptomatic; fully active, able to carry on all predisease activities without restriction) or 1 (Symptomatic but completely ambulatory; restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. For example, light housework, office work)|participants|Number|16|16.0||||||
4181003|NCT00794547|4002603|B1|NSCLC NOS||Histology|Tumor histology results. Categories include Adenocarcinoma, Squamous Carcinoma and Non-Small-Cell Lung Cancer Not Otherwise Specified (NSCLC NOS).|participants|Number|1|1.0||||||
4181004|NCT00794547|4002603|B1|Squamous carcinoma||Histology|Tumor histology results. Categories include Adenocarcinoma, Squamous Carcinoma and Non-Small-Cell Lung Cancer Not Otherwise Specified (NSCLC NOS).|participants|Number|12|12.0||||||
4181005|NCT00794547|4002603|B1|Adenocarcinoma||Histology|Tumor histology results. Categories include Adenocarcinoma, Squamous Carcinoma and Non-Small-Cell Lung Cancer Not Otherwise Specified (NSCLC NOS).|participants|Number|21|21.0||||||
4181006|NCT00794547|4002603|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4181007|NCT00794547|4002603|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4181008|NCT00794547|4002603|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4181009|NCT00794547|4002603|B1|||Age||years|Median|54|54.0|Full Range|||34.0|79.0|
4181010|NCT00794508|4002612|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4181011|NCT00794508|4002612|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181012|NCT00794508|4002612|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4181013|NCT00794508|4002612|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4181014|NCT00794508|4002612|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4181015|NCT00794508|4002612|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181016|NCT00794508|4002612|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181017|NCT00794508|4002612|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181018|NCT00794508|4002612|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4181019|NCT00794508|4002612|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4181020|NCT00794508|4002612|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4181021|NCT00794508|4002612|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4181022|NCT00794508|4002612|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4181023|NCT00794469|4002618|B1|||resting metabolic rate|resting metabolic rate|kcal/d|Mean|1109|1109.0|Standard Deviation|385|385.0|||
4181024|NCT00794469|4002618|B1|Israel||Region of Enrollment||participants|Number|21|21.0||||||
4181025|NCT00794469|4002618|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4181026|NCT00794469|4002618|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4181027|NCT00794469|4002618|B1|||Age||years|Mean|9.8|9.8|Standard Deviation|1.4|1.4|||
4181028|NCT00794469|4002618|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4181029|NCT00794469|4002618|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4181030|NCT00794469|4002618|B1||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
4181031|NCT00794365|4002623|B1|No information||Fagerstrom Test for Nicotine Dependence: Smoking when ill|"FTND: responses to Did the subject smoke if he is so ill that he is almost in bed most of the day? Yes = smoked when so ill participant was almost in bed most of the day; No = did not smoke when so ill participant was almost in bed most of the day; No information = no response given. Percentage of participants in each category."|percentage of participants|Number|0.9|0.9||||||
4181032|NCT00794365|4002623|B1|No||Fagerstrom Test for Nicotine Dependence: Smoking when ill|"FTND: responses to Did the subject smoke if he is so ill that he is almost in bed most of the day? Yes = smoked when so ill participant was almost in bed most of the day; No = did not smoke when so ill participant was almost in bed most of the day; No information = no response given. Percentage of participants in each category."|percentage of participants|Number|72.7|72.7||||||
4181033|NCT00794365|4002623|B1|Yes||Fagerstrom Test for Nicotine Dependence: Smoking when ill|"FTND: responses to Did the subject smoke if he is so ill that he is almost in bed most of the day? Yes = smoked when so ill participant was almost in bed most of the day; No = did not smoke when so ill participant was almost in bed most of the day; No information = no response given. Percentage of participants in each category."|percentage of participants|Number|26.4|26.4||||||
4181034|NCT00794365|4002623|B1|No information||Fagerstrom Test for Nicotine Dependence: Frequency of smoking during first hours after waking|"FTND: responses to Did the subject smoke more frequently during first hours after waking than during the rest of the day? Yes = smoked more frequently during first hours after waking; No = did not smoke more frequently during first hours after waking; No information = no response given. Percentage of participants in each category."|percentage of participants|Number|0.6|0.6||||||
4181035|NCT00794365|4002623|B1|No||Fagerstrom Test for Nicotine Dependence: Frequency of smoking during first hours after waking|"FTND: responses to Did the subject smoke more frequently during first hours after waking than during the rest of the day? Yes = smoked more frequently during first hours after waking; No = did not smoke more frequently during first hours after waking; No information = no response given. Percentage of participants in each category."|percentage of participants|Number|52.1|52.1||||||
4181036|NCT00794365|4002623|B1|Yes||Fagerstrom Test for Nicotine Dependence: Frequency of smoking during first hours after waking|"FTND: responses to Did the subject smoke more frequently during first hours after waking than during the rest of the day? Yes = smoked more frequently during first hours after waking; No = did not smoke more frequently during first hours after waking; No information = no response given. Percentage of participants in each category."|percentage of participants|Number|47.3|47.3||||||
4181037|NCT00794365|4002623|B1|No information||Fagerstrom Test for Nicotine Dependence: Cigarettes a day|"FTND: responses to How many cigarettes/day did the subject smoke? Response categories for number of cigarettes smoked a day = 10 or less, 11 to 20, 21 to 30, 31 or more, and No information (no response given). Percentage of participants in each category."|percentage of participants|Number|1.2|1.2||||||
4181038|NCT00794365|4002623|B1|31 or more cigarettes||Fagerstrom Test for Nicotine Dependence: Cigarettes a day|"FTND: responses to How many cigarettes/day did the subject smoke? Response categories for number of cigarettes smoked a day = 10 or less, 11 to 20, 21 to 30, 31 or more, and No information (no response given). Percentage of participants in each category."|percentage of participants|Number|7.9|7.9||||||
4181039|NCT00794365|4002623|B1|21 to 30 cigarettes||Fagerstrom Test for Nicotine Dependence: Cigarettes a day|"FTND: responses to How many cigarettes/day did the subject smoke? Response categories for number of cigarettes smoked a day = 10 or less, 11 to 20, 21 to 30, 31 or more, and No information (no response given). Percentage of participants in each category."|percentage of participants|Number|20.3|20.3||||||
4181040|NCT00794365|4002623|B1|11 to 20 cigarettes||Fagerstrom Test for Nicotine Dependence: Cigarettes a day|"FTND: responses to How many cigarettes/day did the subject smoke? Response categories for number of cigarettes smoked a day = 10 or less, 11 to 20, 21 to 30, 31 or more, and No information (no response given). Percentage of participants in each category."|percentage of participants|Number|49.4|49.4||||||
4181041|NCT00794365|4002623|B1|10 cigarettes or less||Fagerstrom Test for Nicotine Dependence: Cigarettes a day|"FTND: responses to How many cigarettes/day did the subject smoke? Response categories for number of cigarettes smoked a day = 10 or less, 11 to 20, 21 to 30, 31 or more, and No information (no response given). Percentage of participants in each category."|percentage of participants|Number|21.2|21.2||||||
4181042|NCT00794365|4002623|B1|No information||Fagerstrom Test for Nicotine Dependence: Most difficult cigarette to give up|"FTND: responses to Which cigarette would the subject hate the most to give up? Response categories = First cigarette in the morning, Any other cigarette, and No information (no response given). Percentage of participants in each category."|percentage of participants|Number|3.0|3.0||||||
4181043|NCT00794365|4002623|B1|Any other cigarette||Fagerstrom Test for Nicotine Dependence: Most difficult cigarette to give up|"FTND: responses to Which cigarette would the subject hate the most to give up? Response categories = First cigarette in the morning, Any other cigarette, and No information (no response given). Percentage of participants in each category."|percentage of participants|Number|58.8|58.8||||||
4181044|NCT00794365|4002623|B1|The first cigarette in the morning||Fagerstrom Test for Nicotine Dependence: Most difficult cigarette to give up|"FTND: responses to Which cigarette would the subject hate the most to give up? Response categories = First cigarette in the morning, Any other cigarette, and No information (no response given). Percentage of participants in each category."|percentage of participants|Number|38.2|38.2||||||
4181045|NCT00794365|4002623|B1|No||Fagerstrom Test for Nicotine Dependence: Ability to refrain from smoking where it is forbidden|"FTND: responses to Did the subject find it difficult to refrain from smoking in places where it is forbidden eg, in church, at the library, in cinema, etc? Yes = found it difficult to refrain; No = did not find it difficult to refrain. Percentage of participants in each category."|percentage of participants|Number|50.9|50.9||||||
4181046|NCT00794365|4002623|B1|Yes||Fagerstrom Test for Nicotine Dependence: Ability to refrain from smoking where it is forbidden|"FTND: responses to Did the subject find it difficult to refrain from smoking in places where it is forbidden eg, in church, at the library, in cinema, etc? Yes = found it difficult to refrain; No = did not find it difficult to refrain. Percentage of participants in each category."|percentage of participants|Number|49.1|49.1||||||
4181047|NCT00794365|4002623|B1|More than 60 minutes after waking||Fagerstrom Test for Nicotine Dependence (FTND): Time to first cigarette after waking|"FTND: responses to How soon after waking up, did the subject smoke his first cigarette? Response categories = within 5 minutes after waking, 6 to 30 minutes after waking, 31 to 60 minutes after waking, and after 60 minutes of awakening. Percentage of participants in each category."|percentage of participants|Number|25.5|25.5||||||
4181048|NCT00794365|4002623|B1|31 to 60 minutes after waking||Fagerstrom Test for Nicotine Dependence (FTND): Time to first cigarette after waking|"FTND: responses to How soon after waking up, did the subject smoke his first cigarette? Response categories = within 5 minutes after waking, 6 to 30 minutes after waking, 31 to 60 minutes after waking, and after 60 minutes of awakening. Percentage of participants in each category."|percentage of participants|Number|18.2|18.2||||||
4181049|NCT00794365|4002623|B1|6 to 30 minutes after waking||Fagerstrom Test for Nicotine Dependence (FTND): Time to first cigarette after waking|"FTND: responses to How soon after waking up, did the subject smoke his first cigarette? Response categories = within 5 minutes after waking, 6 to 30 minutes after waking, 31 to 60 minutes after waking, and after 60 minutes of awakening. Percentage of participants in each category."|percentage of participants|Number|35.2|35.2||||||
4181050|NCT00794365|4002623|B1|Within 5 minutes after waking||Fagerstrom Test for Nicotine Dependence (FTND): Time to first cigarette after waking|"FTND: responses to How soon after waking up, did the subject smoke his first cigarette? Response categories = within 5 minutes after waking, 6 to 30 minutes after waking, 31 to 60 minutes after waking, and after 60 minutes of awakening. Percentage of participants in each category."|percentage of participants|Number|21.2|21.2||||||
4181051|NCT00794365|4002623|B1|||Total score on the Fagerstrom Test for Nicotine Dependence|The self-administered Fagerstrom Test for Nicotine Dependence questionnaire assesses level of nicotine dependence. Total score: 0 to 2=very low dependence; 3 to 4=low dependence; 5=medium dependence; 6 to 7=high dependence; 8 to 10=very high dependence.|scores on a scale|Mean|4.2|4.2|Standard Deviation|2.4|2.4|||
4181052|NCT00794365|4002623|B1||Male|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4181053|NCT00794365|4002623|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4181054|NCT00794365|4002623|B1|Unspecified||Age, Customized|This study intended to enroll adult smokers aged ≥18 years; however, 2 participants enrolled were younger than 18 years (17 years).|participants|Number|32|32.0||||||
4181055|NCT00794365|4002623|B1|65 years and older||Age, Customized|This study intended to enroll adult smokers aged ≥18 years; however, 2 participants enrolled were younger than 18 years (17 years).|participants|Number|22|22.0||||||
4181056|NCT00794365|4002623|B1|45 to 64 years||Age, Customized|This study intended to enroll adult smokers aged ≥18 years; however, 2 participants enrolled were younger than 18 years (17 years).|participants|Number|137|137.0||||||
4181057|NCT00794365|4002623|B1|18 to 44 years||Age, Customized|This study intended to enroll adult smokers aged ≥18 years; however, 2 participants enrolled were younger than 18 years (17 years).|participants|Number|137|137.0||||||
4181058|NCT00794365|4002623|B1|Less than 18 years||Age, Customized|This study intended to enroll adult smokers aged ≥18 years; however, 2 participants enrolled were younger than 18 years (17 years).|participants|Number|2|2.0||||||
4181059|NCT00794313|4002629|B1|||mAIMS|Modified Abnormal Involuntary Movment Rating Scale (mAIMS) is a commonly utilized scale that is completed by an observer who judges the severity of dyskinesia in 7 body parts (face, neck, trunk, both legs, and both arms). All body parts are rated separately on this 0 (none) to 4 (severe – markedly impairs activities) scale. Thus, the total score can range from 0 – 28 with 28 indicating severe dyskinesia.|units on a scale|Mean|7|7.0|Standard Deviation|7.2|7.2|||
4181060|NCT00794313|4002629|B1|||UPDRS (Part III) Total Score|This is the motor subsection of the UPDRS and is a commonly used tool to rate the symptoms of Parkinson‘s disease. Each item on the scale is rated from 0 (normal) to 4 (Can barely perform the task) several motor areas including speech, facial expression, tremor, rigidity, hand movements, agility, posture, and gait. Total score ranges from 0 to 108 with higher values on this scale represent a more severe stage of the disease.|units on a scale|Mean|16.0|16.0|Standard Deviation|1.0|1.0|||
4181061|NCT00794313|4002629|B1|||MoCA total|The MoCA is a short cognitive screening test designed to assist health care professionals for the detection of mild cognitive impairment. The MoCA assesses cognitive function across a variety of domains. The MoCA is scored on a 0 to 30 scale, with lower numbers indicating more cognitive impairment. A point is added to the MoCA if the subject's education high school or less (12 years or less education). Scores ranging from 26 - 30 are normal, 18 - 26 mild impairment, 10 - 17 moderate impairment, and less than 10 severe cognitive impairment.|units on a scale|Mean|27.7|27.7|Standard Deviation|1.3|1.3|||
4181062|NCT00794313|4002629|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4181063|NCT00794313|4002629|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4181064|NCT00794313|4002629|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4181065|NCT00794313|4002629|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4181066|NCT00794313|4002629|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4181067|NCT00794313|4002629|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181068|NCT00794196|4002642|B3|Spain||Region of Enrollment||participants|Number|179|179.0||||||
4181069|NCT00794196|4002643|B2|Spain||Region of Enrollment||participants|Number|87|87.0||||||
4181070|NCT00794196|4002644|B1|Spain||Region of Enrollment||participants|Number|92|92.0||||||
4181071|NCT00794196|4002642|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4181072|NCT00794196|4002643|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4181073|NCT00794196|4002644|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4181074|NCT00794196|4002642|B3||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4181075|NCT00794196|4002643|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4181076|NCT00794196|4002644|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4181077|NCT00794196|4002642|B3||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
4181078|NCT00794196|4002643|B2||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4181079|NCT00794196|4002644|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4181080|NCT00794196|4002642|B3||Between 18 and 65 years|Age||Participants|Count of Participants|130|130.0||||||
4181081|NCT00794196|4002643|B2||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4181082|NCT00794196|4002644|B1||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4181083|NCT00794196|4002642|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181084|NCT00794196|4002643|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181085|NCT00794196|4002644|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181086|NCT00794196|4002642|B3|||Age||years|Mean|48.9|48.9|Standard Deviation|15.5|15.5|||
4181087|NCT00794196|4002643|B2|||Age||years|Mean|49.4|49.4|Standard Deviation|15.1|15.1|||
4181088|NCT00794196|4002644|B1|||Age||years|Mean|48.4|48.4|Standard Deviation|15.9|15.9|||
4181089|NCT00794170|4002653|B3|United States||Region of Enrollment||participants|Number|312|312.0||||||
4181090|NCT00794170|4002654|B2|United States||Region of Enrollment||participants|Number|155|155.0||||||
4181091|NCT00794170|4002655|B1|United States||Region of Enrollment||participants|Number|157|157.0||||||
4181092|NCT00794170|4002653|B3||Male|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4181093|NCT00794170|4002654|B2||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4181094|NCT00794170|4002655|B1||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4181095|NCT00794170|4002653|B3||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4181096|NCT00794170|4002654|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4181097|NCT00794170|4002655|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4181098|NCT00794170|4002653|B3||>=65 years|Age||Participants|Count of Participants|126|126.0||||||
4181099|NCT00794170|4002654|B2||>=65 years|Age||Participants|Count of Participants|60|60.0||||||
4181100|NCT00794170|4002655|B1||>=65 years|Age||Participants|Count of Participants|66|66.0||||||
4181101|NCT00794170|4002653|B3||Between 18 and 65 years|Age||Participants|Count of Participants|186|186.0||||||
4181102|NCT00794170|4002654|B2||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
4181103|NCT00794170|4002655|B1||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
4181104|NCT00794170|4002653|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181105|NCT00794170|4002654|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181106|NCT00794170|4002655|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181107|NCT00794157|4002662|B4||Male|Sex: Female, Male||Participants|Count of Participants|335|335.0||||||
4181108|NCT00794157|4002663|B3||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4181109|NCT00794157|4002664|B2||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4181110|NCT00794157|4002665|B1||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4181111|NCT00794157|4002662|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4181112|NCT00794157|4002663|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4181113|NCT00794157|4002664|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4181114|NCT00794157|4002665|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4181115|NCT00794157|4002662|B4|||Age||years|Mean|66.7|66.7|Standard Deviation|8.38|8.38|||
4181116|NCT00794157|4002663|B3|||Age||years|Mean|66.5|66.5|Standard Deviation|8.74|8.74|||
4181117|NCT00794157|4002664|B2|||Age||years|Mean|67.1|67.1|Standard Deviation|7.67|7.67|||
4181118|NCT00794157|4002665|B1|||Age||years|Mean|66.4|66.4|Standard Deviation|8.75|8.75|||
4181119|NCT00794144|4002687|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4181120|NCT00794144|4002688|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4181121|NCT00794144|4002689|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4181122|NCT00794144|4002687|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4181123|NCT00794144|4002688|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4181124|NCT00794144|4002689|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4181125|NCT00794144|4002687|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4181126|NCT00794144|4002688|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4181127|NCT00794144|4002689|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4181128|NCT00794144|4002687|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4181129|NCT00794144|4002688|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4181130|NCT00794144|4002689|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4181131|NCT00794144|4002687|B3||<=18 years|Age||Participants|Count of Participants|132|132.0||||||
4181132|NCT00794144|4002688|B2||<=18 years|Age||Participants|Count of Participants|66|66.0||||||
4181133|NCT00794144|4002689|B1||<=18 years|Age||Participants|Count of Participants|66|66.0||||||
4181134|NCT00794118|4002696|B1|||Percentage of participants given Disease Modifying Anti-Rheumatoid Drugs (DMARD)||Percentage of participants|Number|98.3|98.3||||||
4181135|NCT00794118|4002696|B1|||Number of swollen joints (SJC)|The mean number of swollen joints was evaluated based on the number of swollen joints in a standard 28 joint count.|Swollen joints|Mean|7.3|7.3|Standard Deviation|5.3|5.3|||
4181136|NCT00794118|4002696|B1|||Number of tender joints|The mean number of tender joints was evaluated based on the number of tender joints in a standard 28 joint count.|Tender joints|Mean|11.0|11.0|Standard Deviation|7.1|7.1|||
4181137|NCT00794118|4002696|B1|||Disease duration||Years|Median|5.0|5.0|Inter-Quartile Range|||2.0|10.0|
4181138|NCT00794118|4002696|B1|Indice sintetico salute mentale del (ISM)||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical and social functioning, physical and emotional role limitations, bodily pain, general health, vitality, mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning).|Units on a Scale|Mean|48.0|48.0|Standard Deviation|13.2|13.2|||
4181139|NCT00794118|4002696|B1|Indice sintetico salute fisica del (ISF)||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical and social functioning, physical and emotional role limitations, bodily pain, general health, vitality, mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning).|Units on a Scale|Mean|38.8|38.8|Standard Deviation|10.6|10.6|||
4181140|NCT00794118|4002696|B1|||Stanford Health Assessment Questionnaire (HAQ)|HAQ is a measure of functional limitations. Participants were rated on 4 point scale with scores: 0=no difficulty, 1=some difficulty, 2=much difficulty, 3=unable to do based on degree of difficulty experienced with 20 tasks grouped into 8 areas of dressing, rising, hygiene, reach, walking, eating, grip and activities. Average score range: 0 to 3.|Units on a scale|Mean|1.4|1.4|Standard Deviation|0.7|0.7|||
4181141|NCT00794118|4002696|B1|||Duration of morning stiffness|Duration of morning stiffness: Time elapsed when participant woke up in morning and was able to resume normal activities without stiffness in minutes. Increase in stiffness duration from baseline represented disease progression and/or joint worsening, no change represented halting of disease progression, and a decrease represented improvement.|minutes|Mean|61.8|61.8|Standard Deviation|48.0|48.0|||
4181142|NCT00794118|4002696|B1|NA||Anti-deoxyribonucleic Acid (Anti-DNA) antibodies|Anti-DNA antibodies are auto antibodies directed against DNA and are present in higher than normal numbers in autoimmune disease. Anti-DNA antibodies value higher than 1:20 is considered positive.|Participants|Number|120|120.0||||||
4181143|NCT00794118|4002696|B1|Negative||Anti-deoxyribonucleic Acid (Anti-DNA) antibodies|Anti-DNA antibodies are auto antibodies directed against DNA and are present in higher than normal numbers in autoimmune disease. Anti-DNA antibodies value higher than 1:20 is considered positive.|Participants|Number|173|173.0||||||
4181144|NCT00794118|4002696|B1|Positive||Anti-deoxyribonucleic Acid (Anti-DNA) antibodies|Anti-DNA antibodies are auto antibodies directed against DNA and are present in higher than normal numbers in autoimmune disease. Anti-DNA antibodies value higher than 1:20 is considered positive.|Participants|Number|6|6.0||||||
4181145|NCT00794118|4002696|B1|NA||Anti-nuclear antibodies|Anti-nuclear antibodies are auto antibodies directed against contents of the nucleus and are present in higher than normal numbers in autoimmune disease. Anti-nuclear antibodies value higher than 1:160 is considered positive.|Participants|Number|91|91.0||||||
4181146|NCT00794118|4002696|B1|Negative||Anti-nuclear antibodies|Anti-nuclear antibodies are auto antibodies directed against contents of the nucleus and are present in higher than normal numbers in autoimmune disease. Anti-nuclear antibodies value higher than 1:160 is considered positive.|Participants|Number|170|170.0||||||
4181147|NCT00794118|4002696|B1|Positive||Anti-nuclear antibodies|Anti-nuclear antibodies are auto antibodies directed against contents of the nucleus and are present in higher than normal numbers in autoimmune disease. Anti-nuclear antibodies value higher than 1:160 is considered positive.|Participants|Number|38|38.0||||||
4181148|NCT00794118|4002696|B1|NA||Anti-cyclic Citrullinated Protein (Anti-CCP) antibodies|Anti-CCP antibodies are auto antibodies (antibodies directed against 1 or more of an individual’s own proteins) that are frequently detected in the blood of rheumatoid arthritis participants. Anti-CCP antibodies value higher than 10 U/mL is considered positive.|Participants|Number|78|78.0||||||
4181149|NCT00794118|4002696|B1|Negative||Anti-cyclic Citrullinated Protein (Anti-CCP) antibodies|Anti-CCP antibodies are auto antibodies (antibodies directed against 1 or more of an individual’s own proteins) that are frequently detected in the blood of rheumatoid arthritis participants. Anti-CCP antibodies value higher than 10 U/mL is considered positive.|Participants|Number|97|97.0||||||
4181150|NCT00794118|4002696|B1|Positive||Anti-cyclic Citrullinated Protein (Anti-CCP) antibodies|Anti-CCP antibodies are auto antibodies (antibodies directed against 1 or more of an individual’s own proteins) that are frequently detected in the blood of rheumatoid arthritis participants. Anti-CCP antibodies value higher than 10 U/mL is considered positive.|Participants|Number|124|124.0||||||
4181151|NCT00794118|4002696|B1|Not available (NA)||Rheumatoid Factor (RF)|RF is the auto antibody directed against immunoglobulin G (IgG) and its concentration is observed in human serum or plasma. RF value higher than 20 unit/milliliter (U/mL) is considered positive.|Participants|Number|18|18.0||||||
4181152|NCT00794118|4002696|B1|Negative||Rheumatoid Factor (RF)|RF is the auto antibody directed against immunoglobulin G (IgG) and its concentration is observed in human serum or plasma. RF value higher than 20 unit/milliliter (U/mL) is considered positive.|Participants|Number|118|118.0||||||
4181153|NCT00794118|4002696|B1|Positive||Rheumatoid Factor (RF)|RF is the auto antibody directed against immunoglobulin G (IgG) and its concentration is observed in human serum or plasma. RF value higher than 20 unit/milliliter (U/mL) is considered positive.|Participants|Number|163|163.0||||||
4181154|NCT00794118|4002696|B1|||Erythrocyte Sedimentation Rate (ESR)|ESR is a laboratory test that provides a non-specific measure of inflammation. The test assesses the rate at which red blood cells fall in a test tube. Normal range is 0-30 mm/hr. A higher rate is consistent with inflammation.|millimeter/hour (mm/hr)|Mean|32.9|32.9|Standard Deviation|22.0|22.0|||
4181155|NCT00794118|4002696|B1|||C-reactive Protein (CRP)|CRP is a marker of inflammation. CRP value higher than 0.5 mg/dL is consistent with inflammation. Number of participants analyzed (N) = 272 for this parameter.|milligram/deciliter (mg/dL)|Mean|3.3|3.3|Standard Deviation|6.3|6.3|||
4181156|NCT00794118|4002696|B1|||Visual Analogue Scale for Pain (VAS-pain)|10 cm line (VAS) marked by participant. Intensity of pain range: 0 cm = no pain to 10 cm = worst possible pain.|cm|Mean|6.7|6.7|Standard Deviation|2.2|2.2|||
4181212|NCT00793793|4002790|B13||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4181157|NCT00794118|4002696|B1|||Physician Global Assessment (PGA)|PGA was measured on a 0 to 10 cm VAS, with 0 cm = no disease activity to 10 cm = worst disease activity possible.|cm|Mean|6.1|6.1|Standard Deviation|1.7|1.7|||
4181158|NCT00794118|4002696|B1|||Patient Global Assessment (PtGA)|PtGA measured using a 10 cm Visual Analog Scale (VAS) ranging from 0 cm = very good to 10 cm = very bad.|centimeter (cm)|Mean|6.6|6.6|Standard Deviation|2.1|2.1|||
4181159|NCT00794118|4002696|B1|||Disease Activity Score Based on 28-joints count (DAS28)|DAS28 calculated from the SJC and PJC using the 28 joints count, the ESR and PtGA of disease activity. DAS28 <=3.2 = low disease activity, DAS28 >3.2 to 5.1 = moderate to high disease activity. Number of participants analyzed (N)=272 for this parameter.|Units on a scale|Mean|5.4|5.4|Standard Deviation|1.2|1.2|||
4181160|NCT00794118|4002696|B1|||Percentage of participants with Disease Activity Score Based on 28-joints count (DAS28) remission|DAS28 calculated from the number of swollen joints (SJC) and painful joints (PJC) using the 28 joints count, the ESR and PtGA of disease activity. DAS28 <=3.2 = low disease activity, DAS28 >3.2 to 5.1 = moderate to high disease activity. A participant is considered to be in remission if they have a DAS28 <2.6.|Percentage of participants|Number|1.7|1.7||||||
4181161|NCT00794118|4002696|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4181162|NCT00794118|4002696|B1||Female|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4181163|NCT00794118|4002696|B1|Greater than or equal to (>=) 65 years||Age, Customized||Participants|Number|65|65.0||||||
4181164|NCT00794118|4002696|B1|50 to 64 years||Age, Customized||Participants|Number|133|133.0||||||
4181165|NCT00794118|4002696|B1|35 to 49 years||Age, Customized||Participants|Number|72|72.0||||||
4181166|NCT00794118|4002696|B1|18 to 34 years||Age, Customized||Participants|Number|29|29.0||||||
4181167|NCT00793910|4002752|B3|United States||Region of Enrollment||participants|Number|94|94.0||||||
4181168|NCT00793910|4002753|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
4181169|NCT00793910|4002754|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4181170|NCT00793910|4002752|B3||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4181171|NCT00793910|4002753|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4181172|NCT00793910|4002754|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4181173|NCT00793910|4002752|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4181174|NCT00793910|4002753|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4181175|NCT00793910|4002754|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4181176|NCT00793910|4002752|B3|||Age||years|Mean|31.9|31.9|Standard Deviation|8|8.0|||
4181177|NCT00793910|4002753|B2|||Age||years|Mean|33.2|33.2|Standard Deviation|7.9|7.9|||
4181178|NCT00793910|4002754|B1|||Age||years|Mean|30.7|30.7|Standard Deviation|8|8.0|||
4181179|NCT00793910|4002752|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4181180|NCT00793910|4002753|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4181181|NCT00793910|4002754|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4181182|NCT00793910|4002752|B3||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
4181183|NCT00793910|4002753|B2||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4181184|NCT00793910|4002754|B1||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4181185|NCT00793910|4002752|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181186|NCT00793910|4002753|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181187|NCT00793910|4002754|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181188|NCT00793871|4002769|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4181189|NCT00793871|4002769|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4181190|NCT00793871|4002769|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|12.2|12.2|||
4181191|NCT00793819|4002781|B3|United States||Region of Enrollment||participants|Number|209|209.0||||||
4181192|NCT00793819|4002782|B2|United States||Region of Enrollment||participants|Number|98|98.0||||||
4181193|NCT00793819|4002783|B1|United States||Region of Enrollment||participants|Number|111|111.0||||||
4181194|NCT00793819|4002781|B3||Male|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4181195|NCT00793819|4002782|B2||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4181196|NCT00793819|4002783|B1||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4181197|NCT00793819|4002781|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4181198|NCT00793819|4002782|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4181199|NCT00793819|4002783|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4181200|NCT00793819|4002781|B3|||Age||years|Mean|64.4|64.4|Standard Deviation|8.44|8.44|||
4181201|NCT00793819|4002782|B2|||Age||years|Mean|64.2|64.2|Standard Deviation|8.92|8.92|||
4181202|NCT00793819|4002783|B1|||Age||years|Mean|64.6|64.6|Standard Deviation|8.03|8.03|||
4181203|NCT00793819|4002781|B3||>=65 years|Age||Participants|Count of Participants|84|84.0||||||
4181204|NCT00793819|4002782|B2||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4181205|NCT00793819|4002783|B1||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4181206|NCT00793819|4002781|B3||Between 18 and 65 years|Age||Participants|Count of Participants|125|125.0||||||
4181207|NCT00793819|4002782|B2||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4181208|NCT00793819|4002783|B1||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4181209|NCT00793819|4002781|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181210|NCT00793819|4002782|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181211|NCT00793819|4002783|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181213|NCT00793793|4002791|B12||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4181214|NCT00793793|4002792|B11||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4181215|NCT00793793|4002793|B10||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4181216|NCT00793793|4002794|B9||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4181217|NCT00793793|4002795|B8||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4181218|NCT00793793|4002796|B7||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4181219|NCT00793793|4002797|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4181220|NCT00793793|4002798|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4181221|NCT00793793|4002799|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4181222|NCT00793793|4002800|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4181223|NCT00793793|4002801|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4181224|NCT00793793|4002802|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4181225|NCT00793793|4002790|B13||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4181226|NCT00793793|4002791|B12||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4181227|NCT00793793|4002792|B11||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4181228|NCT00793793|4002793|B10||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4181229|NCT00793793|4002794|B9||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4181230|NCT00793793|4002795|B8||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4181231|NCT00793793|4002796|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4181232|NCT00793793|4002797|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4181233|NCT00793793|4002798|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4181234|NCT00793793|4002799|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4181235|NCT00793793|4002800|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4181236|NCT00793793|4002801|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4181237|NCT00793793|4002802|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4181238|NCT00793793|4002790|B13|||Age||years|Mean|49.59|49.59|Standard Deviation|10.08|10.08|||
4181239|NCT00793793|4002791|B12|||Age||years|Mean|53.57|53.57|Standard Deviation|8.36|8.36|||
4181240|NCT00793793|4002792|B11|||Age||years|Mean|53.67|53.67|Standard Deviation|5.32|5.32|||
4181241|NCT00793793|4002793|B10|||Age||years|Mean|48.93|48.93|Standard Deviation|13.10|13.1|||
4181242|NCT00793793|4002794|B9|||Age||years|Mean|50.93|50.93|Standard Deviation|8.13|8.13|||
4181243|NCT00793793|4002795|B8|||Age||years|Mean|49.33|49.33|Standard Deviation|10.11|10.11|||
4181244|NCT00793793|4002796|B7|||Age||years|Mean|46.71|46.71|Standard Deviation|4.79|4.79|||
4181245|NCT00793793|4002797|B6|||Age||years|Mean|46.83|46.83|Standard Deviation|11.82|11.82|||
4181246|NCT00793793|4002798|B5|||Age||years|Mean|47.83|47.83|Standard Deviation|9.26|9.26|||
4181247|NCT00793793|4002799|B4|||Age||years|Mean|48.57|48.57|Standard Deviation|16.31|16.31|||
4181248|NCT00793793|4002800|B3|||Age||years|Mean|47.14|47.14|Standard Deviation|13.84|13.84|||
4181249|NCT00793793|4002801|B2|||Age||years|Mean|51.00|51.0|Standard Deviation|7.97|7.97|||
4181250|NCT00793793|4002802|B1|||Age||years|Mean|49.88|49.88|Standard Deviation|8.36|8.36|||
4181251|NCT00793780|4003186|B3|||Years of education||years|Mean|13.52|13.52|Standard Deviation|3.89|3.89|||
4181252|NCT00793780|4003187|B2|||Years of education||years|Mean|13.7|13.7|Standard Deviation|3.9|3.9|||
4181253|NCT00793780|4003188|B1|||Years of education||years|Mean|13.4|13.4|Standard Deviation|4.1|4.1|||
4181254|NCT00793780|4003186|B3|Non-Diabetic||Diabetes||participants|Number|16|16.0||||||
4181255|NCT00793780|4003187|B2|Non-Diabetic||Diabetes||participants|Number|11|11.0||||||
4181256|NCT00793780|4003188|B1|Non-Diabetic||Diabetes||participants|Number|5|5.0||||||
4181257|NCT00793780|4003186|B3|Diabetic||Diabetes||participants|Number|7|7.0||||||
4181258|NCT00793780|4003187|B2|Diabetic||Diabetes||participants|Number|1|1.0||||||
4181259|NCT00793780|4003188|B1|Diabetic||Diabetes||participants|Number|6|6.0||||||
4181260|NCT00793780|4003186|B3|||PANSS Total Score|The PANSS or the Positive and Negative Syndrome Scale is a medical scale used for measuring symptom severity of patients with schizophrenia. The scores for these scales are arrived at by summation of ratings across component items. Total score ranges from a minimum of 30 to a maximum of 210. A higher score indicates more severe symptoms.|units on a scale|Mean|59.78|59.78|Standard Deviation|16.42|16.42|||
4181261|NCT00793780|4003187|B2|||PANSS Total Score|The PANSS or the Positive and Negative Syndrome Scale is a medical scale used for measuring symptom severity of patients with schizophrenia. The scores for these scales are arrived at by summation of ratings across component items. Total score ranges from a minimum of 30 to a maximum of 210. A higher score indicates more severe symptoms.|units on a scale|Mean|56.0|56.0|Standard Deviation|16.7|16.7|||
4181262|NCT00793780|4003188|B1|||PANSS Total Score|The PANSS or the Positive and Negative Syndrome Scale is a medical scale used for measuring symptom severity of patients with schizophrenia. The scores for these scales are arrived at by summation of ratings across component items. Total score ranges from a minimum of 30 to a maximum of 210. A higher score indicates more severe symptoms.|units on a scale|Mean|64.7|64.7|Standard Deviation|17.2|17.2|||
4181263|NCT00793780|4003186|B3|Schizoaffective||Diagnosis||participants|Number|11|11.0||||||
4181264|NCT00793780|4003187|B2|Schizoaffective||Diagnosis||participants|Number|7|7.0||||||
4181265|NCT00793780|4003188|B1|Schizoaffective||Diagnosis||participants|Number|4|4.0||||||
4181266|NCT00793780|4003186|B3|Schizophrenia||Diagnosis||participants|Number|12|12.0||||||
4181267|NCT00793780|4003187|B2|Schizophrenia||Diagnosis||participants|Number|5|5.0||||||
4181268|NCT00793780|4003188|B1|Schizophrenia||Diagnosis||participants|Number|7|7.0||||||
4181269|NCT00793780|4003186|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4181270|NCT00793780|4003187|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4181271|NCT00793780|4003188|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4181272|NCT00793780|4003186|B3|Black||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4181273|NCT00793780|4003187|B2|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4181274|NCT00793780|4003188|B1|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4181275|NCT00793780|4003186|B3|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4181276|NCT00793780|4003187|B2|White||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4181277|NCT00793780|4003188|B1|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4181278|NCT00793780|4003186|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4181279|NCT00793780|4003187|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4181280|NCT00793780|4003188|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4181281|NCT00793780|4003186|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4181282|NCT00793780|4003187|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4181283|NCT00793780|4003188|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4181284|NCT00793780|4003186|B3|||Age||years|Mean|46.93|46.93|Standard Deviation|10.73|10.73|||
4181285|NCT00793780|4003187|B2|||Age||years|Mean|41.4|41.4|Standard Deviation|11.6|11.6|||
4181286|NCT00793780|4003188|B1|||Age||years|Mean|50|50.0|Standard Deviation|9.6|9.6|||
4181287|NCT00793650|4003205|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
4181288|NCT00793650|4003206|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4181289|NCT00793650|4003207|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4181290|NCT00793650|4003205|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4181291|NCT00793650|4003206|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4181292|NCT00793650|4003207|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4181293|NCT00793650|4003205|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4181294|NCT00793650|4003206|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4181295|NCT00793650|4003207|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4181296|NCT00793650|4003205|B3|||Age||years|Mean|58.54|58.54|Standard Deviation|7.88|7.88|||
4181297|NCT00793650|4003206|B2|||Age||years|Mean|58.75|58.75|Standard Deviation|8.05|8.05|||
4181298|NCT00793650|4003207|B1|||Age||years|Mean|58.32|58.32|Standard Deviation|7.92|7.92|||
4181299|NCT00793650|4003205|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4181300|NCT00793650|4003206|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4181301|NCT00793650|4003207|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4181302|NCT00793650|4003205|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4181303|NCT00793650|4003206|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4181304|NCT00793650|4003207|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4181305|NCT00793650|4003205|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181306|NCT00793650|4003206|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181307|NCT00793650|4003207|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181308|NCT00793624|4003216|B5|Tiotropium||Tiotropium (Tio) Use Stratum||Number of participants|Number|231|231.0||||||
4181309|NCT00793624|4003217|B4|Tiotropium||Tiotropium (Tio) Use Stratum||Number of participants|Number|58|58.0||||||
4181310|NCT00793624|4003218|B3|Tiotropium||Tiotropium (Tio) Use Stratum||Number of participants|Number|58|58.0||||||
4181311|NCT00793624|4003219|B2|Tiotropium||Tiotropium (Tio) Use Stratum||Number of participants|Number|59|59.0||||||
4181312|NCT00793624|4003220|B1|Tiotropium||Tiotropium (Tio) Use Stratum||Number of participants|Number|56|56.0||||||
4181313|NCT00793624|4003216|B5|Non-tiotropium||Tiotropium (Tio) Use Stratum||Number of participants|Number|673|673.0||||||
4181314|NCT00793624|4003217|B4|Non-tiotropium||Tiotropium (Tio) Use Stratum||Number of participants|Number|169|169.0||||||
4181315|NCT00793624|4003218|B3|Non-tiotropium||Tiotropium (Tio) Use Stratum||Number of participants|Number|167|167.0||||||
4181316|NCT00793624|4003219|B2|Non-tiotropium||Tiotropium (Tio) Use Stratum||Number of participants|Number|168|168.0||||||
4181317|NCT00793624|4003220|B1|Non-tiotropium||Tiotropium (Tio) Use Stratum||Number of participants|Number|169|169.0||||||
4181318|NCT00793624|4003216|B5||Male|Sex: Female, Male||Participants|Count of Participants|706|706.0||||||
4181319|NCT00793624|4003217|B4||Male|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4181320|NCT00793624|4003218|B3||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4181321|NCT00793624|4003219|B2||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4181322|NCT00793624|4003220|B1||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4181323|NCT00793624|4003216|B5||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4181324|NCT00793624|4003217|B4||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4181325|NCT00793624|4003218|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4181326|NCT00793624|4003219|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4181327|NCT00793624|4003220|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4181328|NCT00793624|4003216|B5|||Age||years|Mean|63.8|63.8|Standard Deviation|8.7|8.7|||
4181329|NCT00793624|4003217|B4|||Age||years|Mean|64.8|64.8|Standard Deviation|8.6|8.6|||
4181330|NCT00793624|4003218|B3|||Age||years|Mean|62.6|62.6|Standard Deviation|8.8|8.8|||
4181331|NCT00793624|4003219|B2|||Age||years|Mean|63.7|63.7|Standard Deviation|9.1|9.1|||
4181332|NCT00793624|4003220|B1|||Age||years|Mean|64.0|64.0|Standard Deviation|8.4|8.4|||
4181333|NCT00793611|4003489|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4181334|NCT00793611|4003490|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4181335|NCT00793611|4003491|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4181336|NCT00793611|4003489|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4181337|NCT00793611|4003490|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4181338|NCT00793611|4003491|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4181339|NCT00793611|4003489|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4181340|NCT00793611|4003490|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4181341|NCT00793611|4003491|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4181342|NCT00793611|4003489|B3|||Age||years|Mean|54|54.0|Standard Deviation|11|11.0|||
4181343|NCT00793611|4003490|B2|||Age||years|Mean|51.1|51.1|Standard Deviation|14|14.0|||
4181344|NCT00793611|4003491|B1|||Age||years|Mean|56.4|56.4|Standard Deviation|7.4|7.4|||
4181345|NCT00793585|4003502|B3|China||Region of Enrollment||participants|Number|40|40.0||||||
4181346|NCT00793585|4003503|B2|China||Region of Enrollment||participants|Number|21|21.0||||||
4181347|NCT00793585|4003504|B1|China||Region of Enrollment||participants|Number|19|19.0||||||
4181348|NCT00793585|4003502|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4181349|NCT00793585|4003503|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4181350|NCT00793585|4003504|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4181351|NCT00793585|4003502|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4181352|NCT00793585|4003503|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4181353|NCT00793585|4003504|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4181354|NCT00793585|4003502|B3|||Age||years|Mean|39.9|39.9|Standard Deviation|10.1|10.1|||
4181355|NCT00793585|4003503|B2|||Age||years|Mean|39.7|39.7|Standard Deviation|10.0|10.0|||
4181356|NCT00793585|4003504|B1|||Age||years|Mean|40.1|40.1|Standard Deviation|10.3|10.3|||
4181357|NCT00793585|4003502|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4181358|NCT00793585|4003503|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4181359|NCT00793585|4003504|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4181360|NCT00793585|4003502|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4181361|NCT00793585|4003503|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4181362|NCT00793585|4003504|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4181363|NCT00793585|4003502|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181364|NCT00793585|4003503|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181365|NCT00793585|4003504|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181366|NCT00793572|4003513|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4181367|NCT00793572|4003513|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4181368|NCT00793572|4003513|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4181369|NCT00793572|4003513|B1|||Age||years|Median|49.2|49.2|Full Range|||32.8|69.3|
4181370|NCT00793572|4003513|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4181371|NCT00793572|4003513|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4181372|NCT00793572|4003513|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181373|NCT00793546|4003522|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4181374|NCT00793546|4003523|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4181375|NCT00793546|4003524|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4181376|NCT00793546|4003522|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4181377|NCT00793546|4003523|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4181378|NCT00793546|4003524|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4181379|NCT00793546|4003522|B3|||Age||years|Mean|60.2|60.2|Standard Deviation|9.75|9.75|||
4181380|NCT00793546|4003523|B2|||Age||years|Mean|58.2|58.2|Standard Deviation|10.02|10.02|||
4181381|NCT00793546|4003524|B1|||Age||years|Mean|64.1|64.1|Standard Deviation|8.16|8.16|||
4181382|NCT00793520|4003553|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4181383|NCT00793520|4003554|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4181384|NCT00793520|4003555|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4181385|NCT00793520|4003553|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4181386|NCT00793520|4003554|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4181387|NCT00793520|4003555|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4181388|NCT00793520|4003553|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4181389|NCT00793520|4003554|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4181390|NCT00793520|4003555|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4181391|NCT00793520|4003553|B3|||Age||years|Mean|42.5|42.5|Standard Deviation|7.78|7.78|||
4181392|NCT00793520|4003554|B2|||Age||years|Mean|48|48.0|Standard Deviation|||||
4181393|NCT00793520|4003555|B1|||Age||years|Mean|37|37.0|Standard Deviation|||||
4181394|NCT00793520|4003553|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4181395|NCT00793520|4003554|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4181396|NCT00793520|4003555|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4181397|NCT00793520|4003553|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4181398|NCT00793520|4003554|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4181399|NCT00793520|4003555|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4181400|NCT00793520|4003553|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181401|NCT00793520|4003554|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181402|NCT00793520|4003555|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181403|NCT00793455|4003564|B3|Uninsured||Insurance Status||Participants|Number|8|8.0||||||
4181404|NCT00793455|4003565|B2|Uninsured||Insurance Status||Participants|Number|5|5.0||||||
4181405|NCT00793455|4003566|B1|Uninsured||Insurance Status||Participants|Number|3|3.0||||||
4181406|NCT00793455|4003564|B3|Medicaid||Insurance Status||Participants|Number|20|20.0||||||
4181407|NCT00793455|4003565|B2|Medicaid||Insurance Status||Participants|Number|10|10.0||||||
4181408|NCT00793455|4003566|B1|Medicaid||Insurance Status||Participants|Number|10|10.0||||||
4181409|NCT00793455|4003564|B3|Medicare||Insurance Status||Participants|Number|119|119.0||||||
4181410|NCT00793455|4003565|B2|Medicare||Insurance Status||Participants|Number|63|63.0||||||
4181411|NCT00793455|4003566|B1|Medicare||Insurance Status||Participants|Number|56|56.0||||||
4181412|NCT00793455|4003564|B3|Private||Insurance Status||Participants|Number|481|481.0||||||
4181413|NCT00793455|4003565|B2|Private||Insurance Status||Participants|Number|236|236.0||||||
4181414|NCT00793455|4003566|B1|Private||Insurance Status||Participants|Number|245|245.0||||||
4181415|NCT00793455|4003564|B3|Never screened||Colorectal Cancer (CRC) screening history||Participants|Number|582|582.0||||||
4181416|NCT00793455|4003565|B2|Never screened||Colorectal Cancer (CRC) screening history||Participants|Number|290|290.0||||||
4181417|NCT00793455|4003566|B1|Never screened||Colorectal Cancer (CRC) screening history||Participants|Number|292|292.0||||||
4181418|NCT00793455|4003564|B3|Ever screened||Colorectal Cancer (CRC) screening history||Participants|Number|46|46.0||||||
4181419|NCT00793455|4003565|B2|Ever screened||Colorectal Cancer (CRC) screening history||Participants|Number|24|24.0||||||
4181420|NCT00793455|4003566|B1|Ever screened||Colorectal Cancer (CRC) screening history||Participants|Number|22|22.0||||||
4181421|NCT00793455|4003564|B3|>=5||Number of visits in past 2 years||Participants|Number|219|219.0||||||
4181422|NCT00793455|4003565|B2|>=5||Number of visits in past 2 years||Participants|Number|108|108.0||||||
4181423|NCT00793455|4003566|B1|>=5||Number of visits in past 2 years||Participants|Number|111|111.0||||||
4181424|NCT00793455|4003564|B3|4||Number of visits in past 2 years||Participants|Number|102|102.0||||||
4181425|NCT00793455|4003565|B2|4||Number of visits in past 2 years||Participants|Number|48|48.0||||||
4181426|NCT00793455|4003566|B1|4||Number of visits in past 2 years||Participants|Number|54|54.0||||||
4181427|NCT00793455|4003564|B3|3||Number of visits in past 2 years||Participants|Number|159|159.0||||||
4181428|NCT00793455|4003565|B2|3||Number of visits in past 2 years||Participants|Number|79|79.0||||||
4181429|NCT00793455|4003566|B1|3||Number of visits in past 2 years||Participants|Number|80|80.0||||||
4181430|NCT00793455|4003564|B3|1-2||Number of visits in past 2 years||Participants|Number|148|148.0||||||
4181431|NCT00793455|4003565|B2|1-2||Number of visits in past 2 years||Participants|Number|79|79.0||||||
4181432|NCT00793455|4003566|B1|1-2||Number of visits in past 2 years||Participants|Number|69|69.0||||||
4181433|NCT00793455|4003564|B3|United States||Region of Enrollment||participants|Number|628|628.0||||||
4181434|NCT00793455|4003565|B2|United States||Region of Enrollment||participants|Number|314|314.0||||||
4181435|NCT00793455|4003566|B1|United States||Region of Enrollment||participants|Number|314|314.0||||||
4181436|NCT00793455|4003564|B3|Other/unknown||Race/Ethnicity, Customized||participants|Number|173|173.0||||||
4181437|NCT00793455|4003565|B2|Other/unknown||Race/Ethnicity, Customized||participants|Number|91|91.0||||||
4181438|NCT00793455|4003566|B1|Other/unknown||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
4181439|NCT00793455|4003564|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4181440|NCT00793455|4003565|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4181441|NCT00793455|4003566|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4181442|NCT00793455|4003564|B3|Black||Race/Ethnicity, Customized||participants|Number|156|156.0||||||
4181443|NCT00793455|4003565|B2|Black||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
4181444|NCT00793455|4003566|B1|Black||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
4181445|NCT00793455|4003564|B3|White||Race/Ethnicity, Customized||participants|Number|276|276.0||||||
4181446|NCT00793455|4003565|B2|White||Race/Ethnicity, Customized||participants|Number|132|132.0||||||
4181447|NCT00793455|4003566|B1|White||Race/Ethnicity, Customized||participants|Number|144|144.0||||||
4181448|NCT00793455|4003564|B3||Male|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
4181449|NCT00793455|4003565|B2||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4181450|NCT00793455|4003566|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4181451|NCT00793455|4003564|B3||Female|Sex: Female, Male||Participants|Count of Participants|389|389.0||||||
4181452|NCT00793455|4003565|B2||Female|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4181453|NCT00793455|4003566|B1||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4181454|NCT00793455|4003564|B3|||Age||years|Mean|58.0|58.0|Standard Deviation|6.9|6.9|||
4181455|NCT00793455|4003565|B2|||Age||years|Mean|58.03|58.03|Standard Deviation|6.6|6.6|||
4181456|NCT00793455|4003566|B1|||Age||years|Mean|57.90|57.9|Standard Deviation|7.1|7.1|||
4181457|NCT00793403|4003575|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4181458|NCT00793403|4003575|B1||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4181459|NCT00793403|4003575|B1|||Age||Years|Mean|55.65|55.65|Standard Deviation|12.18|12.18|||
4181460|NCT00793325|4003622|B1||Male|Sex: Female, Male||Participants|Count of Participants|467|467.0||||||
4181461|NCT00793325|4003622|B1||Female|Sex: Female, Male||Participants|Count of Participants|423|423.0||||||
4181462|NCT00793325|4003622|B1|>=15 years||Age, Customized||participants|Number|6|6.0||||||
4181463|NCT00793325|4003622|B1|<15 years||Age, Customized||participants|Number|884|884.0||||||
4181464|NCT00793182|4003646|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4181465|NCT00793182|4003646|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4181466|NCT00793182|4003646|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4181467|NCT00793182|4003646|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4181468|NCT00793182|4003646|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181469|NCT00793169|4003650|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4181470|NCT00793169|4003650|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4181471|NCT00793169|4003650|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4181472|NCT00793169|4003650|B1|||Age||years|Mean|60|60.0|Full Range|||42.0|96.0|
4181473|NCT00793104|4003654|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4181474|NCT00793104|4003654|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4181475|NCT00793104|4003654|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4181476|NCT00793104|4003654|B1|||Age||years|Mean|36.9|36.9|Standard Deviation|8.2|8.2|||
4181477|NCT00793104|4003654|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4181478|NCT00793104|4003654|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4181479|NCT00793104|4003654|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181480|NCT00792948|4003662|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4181481|NCT00792948|4003662|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4181482|NCT00792948|4003662|B1|||Age||years|Median|44|44.0|Full Range|||20.5|60.7|
4181483|NCT00792935|4003671|B3|||Mean 24-Hour Weighted Mean Glucose at Baseline|"Weighted Mean Glucose (WMG) is a measure of the amount of glucose in the blood over a period of 24 hours. The WMG was derived from multiple glucose values collected during both fasting and post-meal periods. The weighted mean was used to avoid over-representation of post-meal glucose values."|mg/dL|Mean|181.6|181.6|Standard Deviation|36.2|36.2|||
4181484|NCT00792935|4003672|B2|||Mean 24-Hour Weighted Mean Glucose at Baseline|"Weighted Mean Glucose (WMG) is a measure of the amount of glucose in the blood over a period of 24 hours. The WMG was derived from multiple glucose values collected during both fasting and post-meal periods. The weighted mean was used to avoid over-representation of post-meal glucose values."|mg/dL|Mean|184.4|184.4|Standard Deviation|38.4|38.4|||
4181485|NCT00792935|4003673|B1|||Mean 24-Hour Weighted Mean Glucose at Baseline|"Weighted Mean Glucose (WMG) is a measure of the amount of glucose in the blood over a period of 24 hours. The WMG was derived from multiple glucose values collected during both fasting and post-meal periods. The weighted mean was used to avoid over-representation of post-meal glucose values."|mg/dL|Mean|178.8|178.8|Standard Deviation|33.9|33.9|||
4181486|NCT00792935|4003671|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4181487|NCT00792935|4003672|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4181488|NCT00792935|4003673|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4181489|NCT00792935|4003671|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4181490|NCT00792935|4003672|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4181491|NCT00792935|4003673|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4181492|NCT00792935|4003671|B3|||Age||years|Mean|55|55.0|Standard Deviation|9.6|9.6|||
4181493|NCT00792935|4003672|B2|||Age||years|Mean|55.2|55.2|Standard Deviation|9.8|9.8|||
4181494|NCT00792935|4003673|B1|||Age||years|Mean|54.8|54.8|Standard Deviation|9.5|9.5|||
4181495|NCT00792922|4003682|B5|Niger||Region of Enrollment||community|Number|48|48.0||||||
4181496|NCT00792922|4003683|B4|Niger||Region of Enrollment||community|Number|12|12.0||||||
4181497|NCT00792922|4003684|B3|Niger||Region of Enrollment||community|Number|12|12.0||||||
4181498|NCT00792922|4003685|B2|Niger||Region of Enrollment||community|Number|12|12.0||||||
4181499|NCT00792922|4003686|B1|Niger||Region of Enrollment||community|Number|12|12.0||||||
4181500|NCT00792922|4003682|B5|Gambia||Region of Enrollment||community|Number|48|48.0||||||
4181501|NCT00792922|4003683|B4|Gambia||Region of Enrollment||community|Number|12|12.0||||||
4181502|NCT00792922|4003684|B3|Gambia||Region of Enrollment||community|Number|12|12.0||||||
4181503|NCT00792922|4003685|B2|Gambia||Region of Enrollment||community|Number|12|12.0||||||
4181504|NCT00792922|4003686|B1|Gambia||Region of Enrollment||community|Number|12|12.0||||||
4181505|NCT00792922|4003682|B5|Tanzania||Region of Enrollment||community|Number|32|32.0||||||
4181506|NCT00792922|4003683|B4|Tanzania||Region of Enrollment||community|Number|0|0.0||||||
4181507|NCT00792922|4003684|B3|Tanzania||Region of Enrollment||community|Number|0|0.0||||||
4181508|NCT00792922|4003685|B2|Tanzania||Region of Enrollment||community|Number|16|16.0||||||
4181509|NCT00792922|4003686|B1|Tanzania||Region of Enrollment||community|Number|16|16.0||||||
4181510|NCT00792922|4003682|B5|Sex/Gender not analyzed||Sex/Gender, Customized||community|Count of Units|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4181511|NCT00792922|4003683|B4|Sex/Gender not analyzed||Sex/Gender, Customized||community|Count of Units|NA|||||||We analyzed the data on community level. Gender was not part of final analyses
4181512|NCT00792922|4003684|B3|Sex/Gender not analyzed||Sex/Gender, Customized||community|Count of Units|NA|||||||We analyzed the data on community level. Gender was not part of final analyses
4181513|NCT00792922|4003685|B2|Sex/Gender not analyzed||Sex/Gender, Customized||community|Count of Units|NA|||||||We analyzed the data on community level. Gender was not part of final analyses
4181514|NCT00792922|4003686|B1|Sex/Gender not analyzed||Sex/Gender, Customized||community|Count of Units|NA|||||||We analyzed the data on community level. Gender was not part of final analyses
4181515|NCT00792922|4003682|B5|Age not analyzed||Age, Customized||community|Count of Units|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4181516|NCT00792922|4003683|B4|Age not analyzed||Age, Customized||community|Count of Units|NA|||||||We collected and analyzed data at community level.Age was not part of final analysis.
4181517|NCT00792922|4003684|B3|Age not analyzed||Age, Customized||community|Count of Units|NA|||||||We collected and analyzed data at community level.Age was not part of final analysis.
4181518|NCT00792922|4003685|B2|Age not analyzed||Age, Customized||community|Count of Units|NA|||||||We collected and analyzed data at community level.Age was not part of final analysis.
4181519|NCT00792922|4003686|B1|Age not analyzed||Age, Customized||community|Count of Units|NA|||||||We collected and analyzed data at community level.Age was not part of final analysis.
4181520|NCT00792909|4003703|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4181521|NCT00792909|4003704|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4181522|NCT00792909|4003705|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4181523|NCT00792909|4003706|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4181524|NCT00792909|4003703|B4|Asian - south east Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4181525|NCT00792909|4003704|B3|Asian - south east Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4181526|NCT00792909|4003705|B2|Asian - south east Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4181527|NCT00792909|4003706|B1|Asian - south east Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4181528|NCT00792909|4003703|B4|Asian - east Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4181529|NCT00792909|4003704|B3|Asian - east Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4181530|NCT00792909|4003705|B2|Asian - east Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4181531|NCT00792909|4003706|B1|Asian - east Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4181532|NCT00792909|4003703|B4|Asian - central/ south Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4181533|NCT00792909|4003704|B3|Asian - central/ south Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4181534|NCT00792909|4003705|B2|Asian - central/ south Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4181535|NCT00792909|4003706|B1|Asian - central/ south Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4181536|NCT00792909|4003703|B4|White – Caucasian / European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|168|168.0||||||
4181537|NCT00792909|4003704|B3|White – Caucasian / European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|59|59.0||||||
4181538|NCT00792909|4003705|B2|White – Caucasian / European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|59|59.0||||||
4181539|NCT00792909|4003706|B1|White – Caucasian / European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
4181540|NCT00792909|4003703|B4||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4181541|NCT00792909|4003704|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4181542|NCT00792909|4003705|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4181543|NCT00792909|4003706|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4181544|NCT00792909|4003703|B4||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4181545|NCT00792909|4003704|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4181546|NCT00792909|4003705|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4181547|NCT00792909|4003706|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4181548|NCT00792909|4003703|B4|||Age||Months|Geometric Mean|38.82|38.82|Standard Deviation|2.35|2.35|||
4181549|NCT00792909|4003704|B3|||Age||Months|Geometric Mean|40.1|40.1|Standard Deviation|2.64|2.64|||
4181550|NCT00792909|4003705|B2|||Age||Months|Geometric Mean|38.0|38.0|Standard Deviation|1.81|1.81|||
4181551|NCT00792909|4003706|B1|||Age||Months|Geometric Mean|38.2|38.2|Standard Deviation|1.83|1.83|||
4181552|NCT00792805|4003761|B4||Male|Sex: Female, Male||Participants|Count of Participants|529|529.0||||||
4181553|NCT00792805|4003762|B3||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4181554|NCT00792805|4003763|B2||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4181555|NCT00792805|4003764|B1||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4181556|NCT00792805|4003761|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4181557|NCT00792805|4003762|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4181558|NCT00792805|4003763|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4181559|NCT00792805|4003764|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4181560|NCT00792805|4003761|B4|||Age||years|Mean|65.4|65.4|Standard Deviation|8.75|8.75|||
4181561|NCT00792805|4003762|B3|||Age||years|Mean|64.6|64.6|Standard Deviation|9.30|9.3|||
4181562|NCT00792805|4003763|B2|||Age||years|Mean|65.5|65.5|Standard Deviation|8.86|8.86|||
4181563|NCT00792805|4003764|B1|||Age||years|Mean|66.2|66.2|Standard Deviation|8.01|8.01|||
4181564|NCT00792701|4003774|B3||Unknown|Weight Loss Last 6 Months||Participants|Count of Participants|3|3.0||||||
4181565|NCT00792701|4003775|B2||Unknown|Weight Loss Last 6 Months||Participants|Count of Participants|3|3.0||||||
4181566|NCT00792701|4003776|B1||Unknown|Weight Loss Last 6 Months||Participants|Count of Participants|0|0.0||||||
4181567|NCT00792701|4003774|B3||>20%|Weight Loss Last 6 Months||Participants|Count of Participants|1|1.0||||||
4181568|NCT00792701|4003775|B2||>20%|Weight Loss Last 6 Months||Participants|Count of Participants|1|1.0||||||
4181569|NCT00792701|4003776|B1||>20%|Weight Loss Last 6 Months||Participants|Count of Participants|0|0.0||||||
4181570|NCT00792701|4003774|B3||10-20%|Weight Loss Last 6 Months||Participants|Count of Participants|4|4.0||||||
4181571|NCT00792701|4003775|B2||10-20%|Weight Loss Last 6 Months||Participants|Count of Participants|3|3.0||||||
4181572|NCT00792701|4003776|B1||10-20%|Weight Loss Last 6 Months||Participants|Count of Participants|1|1.0||||||
4181573|NCT00792701|4003774|B3||5-<10%|Weight Loss Last 6 Months||Participants|Count of Participants|9|9.0||||||
4181574|NCT00792701|4003775|B2||5-<10%|Weight Loss Last 6 Months||Participants|Count of Participants|7|7.0||||||
4181575|NCT00792701|4003776|B1||5-<10%|Weight Loss Last 6 Months||Participants|Count of Participants|2|2.0||||||
4181576|NCT00792701|4003774|B3||<5%|Weight Loss Last 6 Months||Participants|Count of Participants|64|64.0||||||
4181577|NCT00792701|4003775|B2||<5%|Weight Loss Last 6 Months||Participants|Count of Participants|49|49.0||||||
4181578|NCT00792701|4003776|B1||<5%|Weight Loss Last 6 Months||Participants|Count of Participants|15|15.0||||||
4181579|NCT00792701|4003774|B3||IB|Stage|"At the time of surgery, patients must have Stage IA (with the longest tumor diameter ≥ 2 cm) or Stage IB disease as outlined below (AJCC Cancer Staging Manual, 6th Edition, 2002):~Stage IA (with longest tumor diameter ≥ 2 cm)~T1~N0~M0~Stage IB~T2~N0~M0"|Participants|Count of Participants|56|56.0||||||
4181580|NCT00792701|4003775|B2||IB|Stage|"At the time of surgery, patients must have Stage IA (with the longest tumor diameter ≥ 2 cm) or Stage IB disease as outlined below (AJCC Cancer Staging Manual, 6th Edition, 2002):~Stage IA (with longest tumor diameter ≥ 2 cm)~T1~N0~M0~Stage IB~T2~N0~M0"|Participants|Count of Participants|41|41.0||||||
4181581|NCT00792701|4003776|B1||IB|Stage|"At the time of surgery, patients must have Stage IA (with the longest tumor diameter ≥ 2 cm) or Stage IB disease as outlined below (AJCC Cancer Staging Manual, 6th Edition, 2002):~Stage IA (with longest tumor diameter ≥ 2 cm)~T1~N0~M0~Stage IB~T2~N0~M0"|Participants|Count of Participants|15|15.0||||||
4181582|NCT00792701|4003774|B3||IA|Stage|"At the time of surgery, patients must have Stage IA (with the longest tumor diameter ≥ 2 cm) or Stage IB disease as outlined below (AJCC Cancer Staging Manual, 6th Edition, 2002):~Stage IA (with longest tumor diameter ≥ 2 cm)~T1~N0~M0~Stage IB~T2~N0~M0"|Participants|Count of Participants|25|25.0||||||
4181583|NCT00792701|4003775|B2||IA|Stage|"At the time of surgery, patients must have Stage IA (with the longest tumor diameter ≥ 2 cm) or Stage IB disease as outlined below (AJCC Cancer Staging Manual, 6th Edition, 2002):~Stage IA (with longest tumor diameter ≥ 2 cm)~T1~N0~M0~Stage IB~T2~N0~M0"|Participants|Count of Participants|22|22.0||||||
4181584|NCT00792701|4003776|B1||IA|Stage|"At the time of surgery, patients must have Stage IA (with the longest tumor diameter ≥ 2 cm) or Stage IB disease as outlined below (AJCC Cancer Staging Manual, 6th Edition, 2002):~Stage IA (with longest tumor diameter ≥ 2 cm)~T1~N0~M0~Stage IB~T2~N0~M0"|Participants|Count of Participants|3|3.0||||||
4181585|NCT00792701|4003774|B3||Never|Smoking History||Participants|Count of Participants|9|9.0||||||
4181586|NCT00792701|4003775|B2||Never|Smoking History||Participants|Count of Participants|7|7.0||||||
4181587|NCT00792701|4003776|B1||Never|Smoking History||Participants|Count of Participants|2|2.0||||||
4181588|NCT00792701|4003774|B3||Former|Smoking History||Participants|Count of Participants|39|39.0||||||
4181589|NCT00792701|4003775|B2||Former|Smoking History||Participants|Count of Participants|30|30.0||||||
4181590|NCT00792701|4003776|B1||Former|Smoking History||Participants|Count of Participants|9|9.0||||||
4181591|NCT00792701|4003774|B3||Current|Smoking History||Participants|Count of Participants|33|33.0||||||
4181592|NCT00792701|4003775|B2||Current|Smoking History||Participants|Count of Participants|26|26.0||||||
4181593|NCT00792701|4003776|B1||Current|Smoking History||Participants|Count of Participants|7|7.0||||||
4181594|NCT00792701|4003774|B3||1|Performance Status|"0: Fully active, able to carry on all pre-disease performance without restriction.~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours.~Capable of limited self-care, confined to bed or chair more than 50% of waking hours.~Completely disabled; cannot carry on any self-care; totally confined to bed or chair."|Participants|Count of Participants|37|37.0||||||
4181595|NCT00792701|4003775|B2||1|Performance Status|"0: Fully active, able to carry on all pre-disease performance without restriction.~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours.~Capable of limited self-care, confined to bed or chair more than 50% of waking hours.~Completely disabled; cannot carry on any self-care; totally confined to bed or chair."|Participants|Count of Participants|32|32.0||||||
4181596|NCT00792701|4003776|B1||1|Performance Status|"0: Fully active, able to carry on all pre-disease performance without restriction.~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours.~Capable of limited self-care, confined to bed or chair more than 50% of waking hours.~Completely disabled; cannot carry on any self-care; totally confined to bed or chair."|Participants|Count of Participants|5|5.0||||||
4181597|NCT00792701|4003774|B3||0|Performance Status|"0: Fully active, able to carry on all pre-disease performance without restriction.~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours.~Capable of limited self-care, confined to bed or chair more than 50% of waking hours.~Completely disabled; cannot carry on any self-care; totally confined to bed or chair."|Participants|Count of Participants|44|44.0||||||
4181598|NCT00792701|4003775|B2||0|Performance Status|"0: Fully active, able to carry on all pre-disease performance without restriction.~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours.~Capable of limited self-care, confined to bed or chair more than 50% of waking hours.~Completely disabled; cannot carry on any self-care; totally confined to bed or chair."|Participants|Count of Participants|31|31.0||||||
4181599|NCT00792701|4003776|B1||0|Performance Status|"0: Fully active, able to carry on all pre-disease performance without restriction.~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours.~Capable of limited self-care, confined to bed or chair more than 50% of waking hours.~Completely disabled; cannot carry on any self-care; totally confined to bed or chair."|Participants|Count of Participants|13|13.0||||||
4181600|NCT00792701|4003774|B3||Other|Histology||Participants|Count of Participants|2|2.0||||||
4181601|NCT00792701|4003775|B2||Other|Histology||Participants|Count of Participants|1|1.0||||||
4181602|NCT00792701|4003776|B1||Other|Histology||Participants|Count of Participants|1|1.0||||||
4181603|NCT00792701|4003774|B3||Bronchioloalveolar|Histology||Participants|Count of Participants|1|1.0||||||
4181604|NCT00792701|4003775|B2||Bronchioloalveolar|Histology||Participants|Count of Participants|0|0.0||||||
4181605|NCT00792701|4003776|B1||Bronchioloalveolar|Histology||Participants|Count of Participants|1|1.0||||||
4181606|NCT00792701|4003774|B3||Large Cell|Histology||Participants|Count of Participants|1|1.0||||||
4181607|NCT00792701|4003775|B2||Large Cell|Histology||Participants|Count of Participants|1|1.0||||||
4181608|NCT00792701|4003776|B1||Large Cell|Histology||Participants|Count of Participants|0|0.0||||||
4181609|NCT00792701|4003774|B3||Squamous|Histology||Participants|Count of Participants|25|25.0||||||
4181610|NCT00792701|4003775|B2||Squamous|Histology||Participants|Count of Participants|17|17.0||||||
4181611|NCT00792701|4003776|B1||Squamous|Histology||Participants|Count of Participants|8|8.0||||||
4181612|NCT00792701|4003774|B3||Adenocarcinoma|Histology||Participants|Count of Participants|52|52.0||||||
4181613|NCT00792701|4003775|B2||Adenocarcinoma|Histology||Participants|Count of Participants|44|44.0||||||
4181614|NCT00792701|4003776|B1||Adenocarcinoma|Histology||Participants|Count of Participants|8|8.0||||||
4181615|NCT00792701|4003774|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4181616|NCT00792701|4003775|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181617|NCT00792701|4003776|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4181618|NCT00792701|4003774|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181619|NCT00792701|4003775|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181620|NCT00792701|4003776|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181621|NCT00792701|4003774|B3||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4181622|NCT00792701|4003775|B2||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4181623|NCT00792701|4003776|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4181624|NCT00792701|4003774|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4181625|NCT00792701|4003775|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4181626|NCT00792701|4003776|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181627|NCT00792701|4003774|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4181628|NCT00792701|4003775|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4181629|NCT00792701|4003776|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4181630|NCT00792701|4003774|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4181631|NCT00792701|4003775|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4181632|NCT00792701|4003776|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4181633|NCT00792701|4003774|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181634|NCT00792701|4003775|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181635|NCT00792701|4003776|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181636|NCT00792701|4003774|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4181637|NCT00792701|4003775|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4181638|NCT00792701|4003776|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4181639|NCT00792701|4003774|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4181640|NCT00792701|4003775|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4181641|NCT00792701|4003776|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4181642|NCT00792701|4003774|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181643|NCT00792701|4003775|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181644|NCT00792701|4003776|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181645|NCT00792701|4003774|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4181646|NCT00792701|4003775|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4181647|NCT00792701|4003776|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4181648|NCT00792701|4003774|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4181649|NCT00792701|4003775|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4181650|NCT00792701|4003776|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4181651|NCT00792701|4003774|B3|||Age||years|Median|64|64.0|Full Range|||41.6|84.2|
4181652|NCT00792701|4003775|B2|||Age||years|Median|63.3|63.3|Full Range|||41.6|84.2|
4181653|NCT00792701|4003776|B1|||Age||years|Median|68.8|68.8|Full Range|||41.6|81.7|
4181654|NCT00792688|4003788|B4|United States||Region of Enrollment||participants|Number|26|26.0||||||
4181655|NCT00792688|4003789|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4181656|NCT00792688|4003790|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4181657|NCT00792688|4003791|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4181658|NCT00792688|4003788|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4181659|NCT00792688|4003789|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4181660|NCT00792688|4003790|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4181661|NCT00792688|4003791|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4181662|NCT00792688|4003788|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4181663|NCT00792688|4003789|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4181664|NCT00792688|4003790|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4181665|NCT00792688|4003791|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4181666|NCT00792688|4003788|B4|||Age||years|Mean|51.1|51.1|Standard Deviation|10.25|10.25|||
4181667|NCT00792688|4003789|B3|||Age||years|Mean|53.3|53.3|Standard Deviation|9.41|9.41|||
4181668|NCT00792688|4003790|B2|||Age||years|Mean|46.4|46.4|Standard Deviation|12.83|12.83|||
4181669|NCT00792688|4003791|B1|||Age||years|Mean|53.1|53.1|Standard Deviation|7.98|7.98|||
4181670|NCT00792688|4003788|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4181671|NCT00792688|4003789|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4181672|NCT00792688|4003790|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4181673|NCT00792688|4003791|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4181674|NCT00792688|4003788|B4||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4181675|NCT00792688|4003789|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4181676|NCT00792688|4003790|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4181677|NCT00792688|4003791|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4181678|NCT00792688|4003788|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181679|NCT00792688|4003789|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181680|NCT00792688|4003790|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181681|NCT00792688|4003791|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181682|NCT00792636|4003804|B4|||Average Number of Migraine Attacks per Month|Intent-to-Treat (ITT) Population: all randomized participants who took at least one dose of investigational product and had at least one valid post-baseline at-home blood pressure assessment. The average number of migraines per month for the 6-month period prior to Screening is presented.|migraines|Mean|4.4|4.4|Standard Deviation|1.75|1.75|||
4181683|NCT00792636|4003805|B3|||Average Number of Migraine Attacks per Month|Intent-to-Treat (ITT) Population: all randomized participants who took at least one dose of investigational product and had at least one valid post-baseline at-home blood pressure assessment. The average number of migraines per month for the 6-month period prior to Screening is presented.|migraines|Mean|4.6|4.6|Standard Deviation|1.8|1.8|||
4181684|NCT00792636|4003806|B2|||Average Number of Migraine Attacks per Month|Intent-to-Treat (ITT) Population: all randomized participants who took at least one dose of investigational product and had at least one valid post-baseline at-home blood pressure assessment. The average number of migraines per month for the 6-month period prior to Screening is presented.|migraines|Mean|4.2|4.2|Standard Deviation|1.67|1.67|||
4181685|NCT00792636|4003807|B1|||Average Number of Migraine Attacks per Month|Intent-to-Treat (ITT) Population: all randomized participants who took at least one dose of investigational product and had at least one valid post-baseline at-home blood pressure assessment. The average number of migraines per month for the 6-month period prior to Screening is presented.|migraines|Mean|4.5|4.5|Standard Deviation|1.76|1.76|||
4181686|NCT00792636|4003804|B4|American Indian or Alaska Native||Race/Ethnicity, Customized|Intent-to-Treat (ITT) Population: all randomized participants who took at least one dose of investigational product and had at least one valid post-baseline at-home blood pressure assessment. Not all participants were enrolled in the ITT Population.|participants|Number|1|1.0||||||
4181687|NCT00792636|4003805|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|Intent-to-Treat (ITT) Population: all randomized participants who took at least one dose of investigational product and had at least one valid post-baseline at-home blood pressure assessment. Not all participants were enrolled in the ITT Population.|participants|Number|0|0.0||||||
4181688|NCT00792636|4003806|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|Intent-to-Treat (ITT) Population: all randomized participants who took at least one dose of investigational product and had at least one valid post-baseline at-home blood pressure assessment. Not all participants were enrolled in the ITT Population.|participants|Number|1|1.0||||||
4181689|NCT00792636|4003807|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Intent-to-Treat (ITT) Population: all randomized participants who took at least one dose of investigational product and had at least one valid post-baseline at-home blood pressure assessment. Not all participants were enrolled in the ITT Population.|participants|Number|0|0.0||||||
4181690|NCT00792636|4003804|B4|Asian and White||Race/Ethnicity, Customized|Intent-to-Treat (ITT) Population: all randomized participants who took at least one dose of investigational product and had at least one valid post-baseline at-home blood pressure assessment. Not all participants were enrolled in the ITT Population.|participants|Number|1|1.0||||||
4181691|NCT00792636|4003805|B3|Asian and White||Race/Ethnicity, Customized|Intent-to-Treat (ITT) Population: all randomized participants who took at least one dose of investigational product and had at least one valid post-baseline at-home blood pressure assessment. Not all participants were enrolled in the ITT Population.|participants|Number|0|0.0||||||
4181692|NCT00792636|4003806|B2|Asian and White||Race/Ethnicity, Customized|Intent-to-Treat (ITT) Population: all randomized participants who took at least one dose of investigational product and had at least one valid post-baseline at-home blood pressure assessment. Not all participants were enrolled in the ITT Population.|participants|Number|1|1.0||||||
4181693|NCT00792636|4003807|B1|Asian and White||Race/Ethnicity, Customized|Intent-to-Treat (ITT) Population: all randomized participants who took at least one dose of investigational product and had at least one valid post-baseline at-home blood pressure assessment. Not all participants were enrolled in the ITT Population.|participants|Number|0|0.0||||||
4181694|NCT00792636|4003804|B4|Asian||Race/Ethnicity, Customized|Intent-to-Treat (ITT) Population: all randomized participants who took at least one dose of investigational product and had at least one valid post-baseline at-home blood pressure assessment. Not all participants were enrolled in the ITT Population.|participants|Number|8|8.0||||||
4181695|NCT00792636|4003805|B3|Asian||Race/Ethnicity, Customized|Intent-to-Treat (ITT) Population: all randomized participants who took at least one dose of investigational product and had at least one valid post-baseline at-home blood pressure assessment. Not all participants were enrolled in the ITT Population.|participants|Number|3|3.0||||||
4181696|NCT00792636|4003806|B2|Asian||Race/Ethnicity, Customized|Intent-to-Treat (ITT) Population: all randomized participants who took at least one dose of investigational product and had at least one valid post-baseline at-home blood pressure assessment. Not all participants were enrolled in the ITT Population.|participants|Number|3|3.0||||||
4181697|NCT00792636|4003807|B1|Asian||Race/Ethnicity, Customized|Intent-to-Treat (ITT) Population: all randomized participants who took at least one dose of investigational product and had at least one valid post-baseline at-home blood pressure assessment. Not all participants were enrolled in the ITT Population.|participants|Number|2|2.0||||||
4181698|NCT00792636|4003804|B4|African American/African Heritage||Race/Ethnicity, Customized|Intent-to-Treat (ITT) Population: all randomized participants who took at least one dose of investigational product and had at least one valid post-baseline at-home blood pressure assessment. Not all participants were enrolled in the ITT Population.|participants|Number|33|33.0||||||
4181699|NCT00792636|4003805|B3|African American/African Heritage||Race/Ethnicity, Customized|Intent-to-Treat (ITT) Population: all randomized participants who took at least one dose of investigational product and had at least one valid post-baseline at-home blood pressure assessment. Not all participants were enrolled in the ITT Population.|participants|Number|10|10.0||||||
4181700|NCT00792636|4003806|B2|African American/African Heritage||Race/Ethnicity, Customized|Intent-to-Treat (ITT) Population: all randomized participants who took at least one dose of investigational product and had at least one valid post-baseline at-home blood pressure assessment. Not all participants were enrolled in the ITT Population.|participants|Number|11|11.0||||||
4181701|NCT00792636|4003807|B1|African American/African Heritage||Race/Ethnicity, Customized|Intent-to-Treat (ITT) Population: all randomized participants who took at least one dose of investigational product and had at least one valid post-baseline at-home blood pressure assessment. Not all participants were enrolled in the ITT Population.|participants|Number|12|12.0||||||
4181702|NCT00792636|4003804|B4|White||Race/Ethnicity, Customized|Intent-to-Treat (ITT) Population: all randomized participants who took at least one dose of investigational product and had at least one valid post-baseline at-home blood pressure assessment. Not all participants were enrolled in the ITT Population.|participants|Number|309|309.0||||||
4181703|NCT00792636|4003805|B3|White||Race/Ethnicity, Customized|Intent-to-Treat (ITT) Population: all randomized participants who took at least one dose of investigational product and had at least one valid post-baseline at-home blood pressure assessment. Not all participants were enrolled in the ITT Population.|participants|Number|105|105.0||||||
4181704|NCT00792636|4003806|B2|White||Race/Ethnicity, Customized|Intent-to-Treat (ITT) Population: all randomized participants who took at least one dose of investigational product and had at least one valid post-baseline at-home blood pressure assessment. Not all participants were enrolled in the ITT Population.|participants|Number|96|96.0||||||
4181705|NCT00792636|4003807|B1|White||Race/Ethnicity, Customized|Intent-to-Treat (ITT) Population: all randomized participants who took at least one dose of investigational product and had at least one valid post-baseline at-home blood pressure assessment. Not all participants were enrolled in the ITT Population.|participants|Number|108|108.0||||||
4181706|NCT00792636|4003804|B4||Male|Sex: Female, Male|Intent-to-Treat (ITT) Population: all randomized participants who took at least one dose of investigational product and had at least one valid post-baseline at-home blood pressure assessment. Not all randomized participants were part of the ITT Population.|Participants|Count of Participants|64|64.0||||||
4181707|NCT00792636|4003805|B3||Male|Sex: Female, Male|Intent-to-Treat (ITT) Population: all randomized participants who took at least one dose of investigational product and had at least one valid post-baseline at-home blood pressure assessment. Not all randomized participants were part of the ITT Population.|Participants|Count of Participants|22|22.0||||||
4181708|NCT00792636|4003806|B2||Male|Sex: Female, Male|Intent-to-Treat (ITT) Population: all randomized participants who took at least one dose of investigational product and had at least one valid post-baseline at-home blood pressure assessment. Not all randomized participants were part of the ITT Population.|Participants|Count of Participants|14|14.0||||||
4181750|NCT00792428|4003864|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4181751|NCT00792428|4003865|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4181709|NCT00792636|4003807|B1||Male|Sex: Female, Male|Intent-to-Treat (ITT) Population: all randomized participants who took at least one dose of investigational product and had at least one valid post-baseline at-home blood pressure assessment. Not all randomized participants were part of the ITT Population.|Participants|Count of Participants|28|28.0||||||
4181710|NCT00792636|4003804|B4||Female|Sex: Female, Male|Intent-to-Treat (ITT) Population: all randomized participants who took at least one dose of investigational product and had at least one valid post-baseline at-home blood pressure assessment. Not all randomized participants were part of the ITT Population.|Participants|Count of Participants|288|288.0||||||
4181711|NCT00792636|4003805|B3||Female|Sex: Female, Male|Intent-to-Treat (ITT) Population: all randomized participants who took at least one dose of investigational product and had at least one valid post-baseline at-home blood pressure assessment. Not all randomized participants were part of the ITT Population.|Participants|Count of Participants|96|96.0||||||
4181712|NCT00792636|4003806|B2||Female|Sex: Female, Male|Intent-to-Treat (ITT) Population: all randomized participants who took at least one dose of investigational product and had at least one valid post-baseline at-home blood pressure assessment. Not all randomized participants were part of the ITT Population.|Participants|Count of Participants|98|98.0||||||
4181713|NCT00792636|4003807|B1||Female|Sex: Female, Male|Intent-to-Treat (ITT) Population: all randomized participants who took at least one dose of investigational product and had at least one valid post-baseline at-home blood pressure assessment. Not all randomized participants were part of the ITT Population.|Participants|Count of Participants|94|94.0||||||
4181714|NCT00792636|4003804|B4|||Age|Intent-to-Treat (ITT) Population: all randomized participants who took at least one dose of investigational product and had at least one valid post-baseline at-home blood pressure assessment. Not all randomized participants were part of the ITT Population.|Years|Mean|39.3|39.3|Standard Deviation|11.58|11.58|||
4181715|NCT00792636|4003805|B3|||Age|Intent-to-Treat (ITT) Population: all randomized participants who took at least one dose of investigational product and had at least one valid post-baseline at-home blood pressure assessment. Not all randomized participants were part of the ITT Population.|Years|Mean|39.1|39.1|Standard Deviation|11.92|11.92|||
4181716|NCT00792636|4003806|B2|||Age|Intent-to-Treat (ITT) Population: all randomized participants who took at least one dose of investigational product and had at least one valid post-baseline at-home blood pressure assessment. Not all randomized participants were part of the ITT Population.|Years|Mean|39.8|39.8|Standard Deviation|11.22|11.22|||
4181717|NCT00792636|4003807|B1|||Age|Intent-to-Treat (ITT) Population: all randomized participants who took at least one dose of investigational product and had at least one valid post-baseline at-home blood pressure assessment. Not all randomized participants were part of the ITT Population.|Years|Mean|39.0|39.0|Standard Deviation|11.64|11.64|||
4181718|NCT00792623|4003846|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181719|NCT00792623|4003846|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181720|NCT00792623|4003846|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4181721|NCT00792623|4003846|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181722|NCT00792623|4003846|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181723|NCT00792623|4003846|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181724|NCT00792623|4003846|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181725|NCT00792623|4003846|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4181726|NCT00792623|4003846|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4181727|NCT00792623|4003846|B1|||Age||Years|Mean|48.7|48.7|Standard Deviation|9.65|9.65|||
4181728|NCT00792610|4003859|B1|Unknown||Family history of hepatitis B carrier||participants|Number|38|38.0||||||
4181729|NCT00792610|4003859|B1|NO||Family history of hepatitis B carrier||participants|Number|71|71.0||||||
4181730|NCT00792610|4003859|B1|Yes||Family history of hepatitis B carrier||participants|Number|18|18.0||||||
4181731|NCT00792610|4003859|B1|BMI >= 24||Body Mass Index(BMI) category|if BMI< 18.5 then BMIgr3=0; else if BMI >= 18.5 and BMI< 24 then BMIgr3=1; else if BMI >=24 then BMIgr3=2;|participants|Number|12|12.0||||||
4181732|NCT00792610|4003859|B1|18.5<= BMI < 24||Body Mass Index(BMI) category|if BMI< 18.5 then BMIgr3=0; else if BMI >= 18.5 and BMI< 24 then BMIgr3=1; else if BMI >=24 then BMIgr3=2;|participants|Number|94|94.0||||||
4181733|NCT00792610|4003859|B1|BMI< 18.5||Body Mass Index(BMI) category|if BMI< 18.5 then BMIgr3=0; else if BMI >= 18.5 and BMI< 24 then BMIgr3=1; else if BMI >=24 then BMIgr3=2;|participants|Number|21|21.0||||||
4181734|NCT00792610|4003859|B1|unknown||Blood type||participants|Number|7|7.0||||||
4181735|NCT00792610|4003859|B1|O||Blood type||participants|Number|53|53.0||||||
4181736|NCT00792610|4003859|B1|AB||Blood type||participants|Number|8|8.0||||||
4181737|NCT00792610|4003859|B1|B||Blood type||participants|Number|31|31.0||||||
4181738|NCT00792610|4003859|B1|A||Blood type||participants|Number|28|28.0||||||
4181739|NCT00792610|4003859|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4181740|NCT00792610|4003859|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4181741|NCT00792610|4003859|B1|>= 20 years old||Age, Customized||participants|Number|73|73.0||||||
4181742|NCT00792610|4003859|B1|< 20 years old||Age, Customized||participants|Number|54|54.0||||||
4181743|NCT00792428|4003863|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181744|NCT00792428|4003864|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181745|NCT00792428|4003865|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181746|NCT00792428|4003863|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181747|NCT00792428|4003864|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181748|NCT00792428|4003865|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181749|NCT00792428|4003863|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4181752|NCT00792428|4003863|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181753|NCT00792428|4003864|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181754|NCT00792428|4003865|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181755|NCT00792428|4003863|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181756|NCT00792428|4003864|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181757|NCT00792428|4003865|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181758|NCT00792428|4003863|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181759|NCT00792428|4003864|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181760|NCT00792428|4003865|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181761|NCT00792428|4003863|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181762|NCT00792428|4003864|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181763|NCT00792428|4003865|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181764|NCT00792428|4003863|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4181765|NCT00792428|4003864|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4181766|NCT00792428|4003865|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4181767|NCT00792428|4003863|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4181768|NCT00792428|4003864|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4181769|NCT00792428|4003865|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4181770|NCT00792428|4003863|B3|||Age||years|Mean|58.7|58.7|Standard Deviation|13.8|13.8|||
4181771|NCT00792428|4003864|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|12.9|12.9|||
4181772|NCT00792428|4003865|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|14.7|14.7|||
4181773|NCT00792298|4003874|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4181774|NCT00792298|4003874|B1||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4181775|NCT00792298|4003874|B1|||Age||years|Mean|44.4|44.4|Standard Deviation|11.5|11.5|||
4181776|NCT00792259|4003908|B4|United States||Region of Enrollment||participants|Number|48|48.0||||||
4181777|NCT00792259|4003909|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4181778|NCT00792259|4003910|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4181779|NCT00792259|4003911|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4181780|NCT00792259|4003908|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4181781|NCT00792259|4003909|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4181782|NCT00792259|4003910|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4181783|NCT00792259|4003911|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4181784|NCT00792259|4003908|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4181785|NCT00792259|4003909|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4181786|NCT00792259|4003910|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4181787|NCT00792259|4003911|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4181788|NCT00792259|4003908|B4|||Age||years|Mean|50.52|50.52|Standard Deviation|20.05|20.05|||
4181789|NCT00792259|4003909|B3|||Age||years|Mean|59.1|59.1|Standard Deviation|17.63|17.63|||
4181790|NCT00792259|4003910|B2|||Age||years|Mean|66.6|66.6|Standard Deviation|13.92|13.92|||
4181791|NCT00792259|4003911|B1|||Age||years|Mean|33.45|33.45|Standard Deviation|10.36|10.36|||
4181792|NCT00792259|4003908|B4||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4181793|NCT00792259|4003909|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4181794|NCT00792259|4003910|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4181795|NCT00792259|4003911|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4181796|NCT00792259|4003908|B4||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4181797|NCT00792259|4003909|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4181798|NCT00792259|4003910|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4181799|NCT00792259|4003911|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4181800|NCT00792259|4003908|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181801|NCT00792259|4003909|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181802|NCT00792259|4003910|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181803|NCT00792259|4003911|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181804|NCT00792116|4003921|B3|United States||Region of Enrollment||participants|Number|108|108.0||||||
4181805|NCT00792116|4003922|B2|United States||Region of Enrollment||participants|Number|55|55.0||||||
4181806|NCT00792116|4003923|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
4181807|NCT00792116|4003921|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4181808|NCT00792116|4003922|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4181809|NCT00792116|4003923|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4181810|NCT00792116|4003921|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4181811|NCT00792116|4003922|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4181812|NCT00792116|4003923|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4181813|NCT00792116|4003921|B3|||Age||years|Mean|14.6|14.6|Standard Deviation|.7|0.7|||
4181814|NCT00792116|4003922|B2|||Age||years|Mean|14.6|14.6|Standard Deviation|.7|0.7|||
4181815|NCT00792116|4003923|B1|||Age||years|Mean|14.7|14.7|Standard Deviation|.8|0.8|||
4181816|NCT00792116|4003921|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4181817|NCT00792116|4003922|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4181818|NCT00792116|4003923|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4181819|NCT00792116|4003921|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4181820|NCT00792116|4003922|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4181821|NCT00792116|4003923|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4181822|NCT00792116|4003921|B3||<=18 years|Age||Participants|Count of Participants|108|108.0||||||
4181823|NCT00792116|4003922|B2||<=18 years|Age||Participants|Count of Participants|55|55.0||||||
4181824|NCT00792116|4003923|B1||<=18 years|Age||Participants|Count of Participants|53|53.0||||||
4181825|NCT00792103|4003934|B1|United States||Region of Enrollment||participants|Number|183|183.0||||||
4181826|NCT00792103|4003934|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4181827|NCT00792103|4003934|B1||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4181828|NCT00792103|4003934|B1|||Age||years|Mean|42.0|42.0|Standard Deviation|10.28|10.28|||
4181829|NCT00792103|4003934|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4181830|NCT00792103|4003934|B1||Between 18 and 65 years|Age||Participants|Count of Participants|183|183.0||||||
4181831|NCT00792103|4003934|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181832|NCT00791999|4003942|B5|Japan||Region of Enrollment||participants|Number|316|316.0||||||
4181833|NCT00791999|4003943|B4|Japan||Region of Enrollment||participants|Number|77|77.0||||||
4181834|NCT00791999|4003944|B3|Japan||Region of Enrollment||participants|Number|85|85.0||||||
4181835|NCT00791999|4003945|B2|Japan||Region of Enrollment||participants|Number|82|82.0||||||
4181836|NCT00791999|4003946|B1|Japan||Region of Enrollment||participants|Number|72|72.0||||||
4181837|NCT00791999|4003942|B5||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4181838|NCT00791999|4003943|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4181839|NCT00791999|4003944|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4181840|NCT00791999|4003945|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4181841|NCT00791999|4003946|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4181842|NCT00791999|4003942|B5||Female|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
4181843|NCT00791999|4003943|B4||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4181844|NCT00791999|4003944|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4181845|NCT00791999|4003945|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4181846|NCT00791999|4003946|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4181847|NCT00791999|4003942|B5|||Age||years|Mean|53.0|53.0|Standard Deviation|11.0|11.0|||
4181848|NCT00791999|4003943|B4|||Age||years|Mean|51.9|51.9|Standard Deviation|11.1|11.1|||
4181849|NCT00791999|4003944|B3|||Age||years|Mean|55.4|55.4|Standard Deviation|10.3|10.3|||
4181850|NCT00791999|4003945|B2|||Age||years|Mean|50.6|50.6|Standard Deviation|11.4|11.4|||
4181851|NCT00791999|4003946|B1|||Age||years|Mean|54.3|54.3|Standard Deviation|10.6|10.6|||
4181852|NCT00791999|4003942|B5||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
4181853|NCT00791999|4003943|B4||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4181854|NCT00791999|4003944|B3||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4181855|NCT00791999|4003945|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4181856|NCT00791999|4003946|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4181857|NCT00791999|4003942|B5||Between 18 and 65 years|Age||Participants|Count of Participants|272|272.0||||||
4181858|NCT00791999|4003943|B4||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
4181859|NCT00791999|4003944|B3||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4181860|NCT00791999|4003945|B2||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
4181861|NCT00791999|4003946|B1||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4181862|NCT00791999|4003942|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181863|NCT00791999|4003943|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181864|NCT00791999|4003944|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181865|NCT00791999|4003945|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181866|NCT00791999|4003946|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181867|NCT00791973|4003963|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4181868|NCT00791973|4003964|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4181869|NCT00791973|4003965|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4181870|NCT00791973|4003963|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4181871|NCT00791973|4003964|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4181872|NCT00791973|4003965|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4181873|NCT00791973|4003963|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4181874|NCT00791973|4003964|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4181875|NCT00791973|4003965|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4181876|NCT00791973|4003963|B3|||Age||years|Mean|30|30.0|Standard Deviation|9|9.0|||
4181877|NCT00791973|4003964|B2|||Age||years|Mean|29|29.0|Standard Deviation|6|6.0|||
4181878|NCT00791973|4003965|B1|||Age||years|Mean|32|32.0|Standard Deviation|11|11.0|||
4181879|NCT00791934|4003974|B1|United States||Region of Enrollment||participants|Number|63|63.0||||||
4181880|NCT00791934|4003974|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4181881|NCT00791934|4003974|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181882|NCT00791934|4003974|B1||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4181883|NCT00791934|4003974|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4181884|NCT00791934|4003974|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181885|NCT00791934|4003974|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4181886|NCT00791934|4003974|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4181887|NCT00791934|4003974|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4181888|NCT00791934|4003974|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4181889|NCT00791934|4003974|B1|||Age||years|Mean|47.24|47.24|Standard Deviation|14.87|14.87|||
4181890|NCT00791921|4003982|B3|Japan||Region of Enrollment||participants|Number|230|230.0||||||
4181891|NCT00791921|4003983|B2|Japan||Region of Enrollment||participants|Number|114|114.0||||||
4181892|NCT00791921|4003984|B1|Japan||Region of Enrollment||participants|Number|116|116.0||||||
4181893|NCT00791921|4003982|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4181894|NCT00791921|4003983|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4181895|NCT00791921|4003984|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4181896|NCT00791921|4003982|B3||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4181897|NCT00791921|4003983|B2||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4181898|NCT00791921|4003984|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4181899|NCT00791921|4003982|B3|||Age||years|Mean|55.7|55.7|Standard Deviation|10.0|10.0|||
4181900|NCT00791921|4003983|B2|||Age||years|Mean|55.4|55.4|Standard Deviation|9.8|9.8|||
4181901|NCT00791921|4003984|B1|||Age||years|Mean|56.0|56.0|Standard Deviation|10.2|10.2|||
4181902|NCT00791921|4003982|B3||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4181903|NCT00791921|4003983|B2||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4181904|NCT00791921|4003984|B1||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4181905|NCT00791921|4003982|B3||Between 18 and 65 years|Age||Participants|Count of Participants|182|182.0||||||
4181906|NCT00791921|4003983|B2||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
4181907|NCT00791921|4003984|B1||Between 18 and 65 years|Age||Participants|Count of Participants|88|88.0||||||
4181908|NCT00791921|4003982|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181909|NCT00791921|4003983|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181910|NCT00791921|4003984|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181911|NCT00791908|4003993|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4181912|NCT00791908|4003993|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4181913|NCT00791908|4003993|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4181914|NCT00791908|4003993|B1|||Age||years|Mean|48|48.0|Full Range|||21.0|65.0|
4181915|NCT00791908|4003993|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4181916|NCT00791908|4003993|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4181917|NCT00791908|4003993|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181918|NCT00791817|4004001|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4181919|NCT00791817|4004002|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4181920|NCT00791817|4004003|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4181921|NCT00791817|4004001|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4181922|NCT00791817|4004002|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4181923|NCT00791817|4004003|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4181924|NCT00791817|4004001|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4181925|NCT00791817|4004002|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4181926|NCT00791817|4004003|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4181927|NCT00791817|4004001|B3|||Age|Study is a crossover study. All subjects received Investigational Product in BOTH the Fed and Fasted state|years|Mean|31.8|31.8|Standard Deviation|10.0|10.0|||
4181928|NCT00791817|4004002|B2|||Age|Study is a crossover study. All subjects received Investigational Product in BOTH the Fed and Fasted state|years|Mean|31.8|31.8|Standard Deviation|10.0|10.0|||
4181929|NCT00791817|4004003|B1|||Age|Study is a crossover study. All subjects received Investigational Product in BOTH the Fed and Fasted state|years|Mean|31.8|31.8|Standard Deviation|10.0|10.0|||
4181930|NCT00791817|4004001|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4181931|NCT00791817|4004002|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4181932|NCT00791817|4004003|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4181933|NCT00791817|4004001|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4181934|NCT00791817|4004002|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4181935|NCT00791817|4004003|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4181936|NCT00791817|4004001|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181937|NCT00791817|4004002|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181938|NCT00791817|4004003|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4181939|NCT00791778|4004010|B3|Missing||Surgical cytoreduction|The degree of residual disease following initial diagnosis and surgical debulkment: optimal surgical cytoreduction (any/each lesion remaining after surgery ≤1 cm) or suboptimal surgical cytoreduction (any/each lesion remaining after surgery >1cm)|Participants|Number|16|16.0||||||
4181940|NCT00791778|4004011|B2|Missing||Surgical cytoreduction|The degree of residual disease following initial diagnosis and surgical debulkment: optimal surgical cytoreduction (any/each lesion remaining after surgery ≤1 cm) or suboptimal surgical cytoreduction (any/each lesion remaining after surgery >1cm)|Participants|Number|8|8.0||||||
4181941|NCT00791778|4004012|B1|Missing||Surgical cytoreduction|The degree of residual disease following initial diagnosis and surgical debulkment: optimal surgical cytoreduction (any/each lesion remaining after surgery ≤1 cm) or suboptimal surgical cytoreduction (any/each lesion remaining after surgery >1cm)|Participants|Number|8|8.0||||||
4181942|NCT00791778|4004010|B3|Suboptimal||Surgical cytoreduction|The degree of residual disease following initial diagnosis and surgical debulkment: optimal surgical cytoreduction (any/each lesion remaining after surgery ≤1 cm) or suboptimal surgical cytoreduction (any/each lesion remaining after surgery >1cm)|Participants|Number|20|20.0||||||
4181943|NCT00791778|4004011|B2|Suboptimal||Surgical cytoreduction|The degree of residual disease following initial diagnosis and surgical debulkment: optimal surgical cytoreduction (any/each lesion remaining after surgery ≤1 cm) or suboptimal surgical cytoreduction (any/each lesion remaining after surgery >1cm)|Participants|Number|10|10.0||||||
4181944|NCT00791778|4004012|B1|Suboptimal||Surgical cytoreduction|The degree of residual disease following initial diagnosis and surgical debulkment: optimal surgical cytoreduction (any/each lesion remaining after surgery ≤1 cm) or suboptimal surgical cytoreduction (any/each lesion remaining after surgery >1cm)|Participants|Number|10|10.0||||||
4181945|NCT00791778|4004010|B3|Optimal||Surgical cytoreduction|The degree of residual disease following initial diagnosis and surgical debulkment: optimal surgical cytoreduction (any/each lesion remaining after surgery ≤1 cm) or suboptimal surgical cytoreduction (any/each lesion remaining after surgery >1cm)|Participants|Number|210|210.0||||||
4181946|NCT00791778|4004011|B2|Optimal||Surgical cytoreduction|The degree of residual disease following initial diagnosis and surgical debulkment: optimal surgical cytoreduction (any/each lesion remaining after surgery ≤1 cm) or suboptimal surgical cytoreduction (any/each lesion remaining after surgery >1cm)|Participants|Number|105|105.0||||||
4181947|NCT00791778|4004012|B1|Optimal||Surgical cytoreduction|The degree of residual disease following initial diagnosis and surgical debulkment: optimal surgical cytoreduction (any/each lesion remaining after surgery ≤1 cm) or suboptimal surgical cytoreduction (any/each lesion remaining after surgery >1cm)|Participants|Number|105|105.0||||||
4181948|NCT00791778|4004010|B3|No||Previous Intra-peritoneal (IP) chemotherapy|The presence or absence of any IP chemotherapy before enrollment into the study.|Participants|Number|237|237.0||||||
4181949|NCT00791778|4004011|B2|No||Previous Intra-peritoneal (IP) chemotherapy|The presence or absence of any IP chemotherapy before enrollment into the study.|Participants|Number|119|119.0||||||
4181950|NCT00791778|4004012|B1|No||Previous Intra-peritoneal (IP) chemotherapy|The presence or absence of any IP chemotherapy before enrollment into the study.|Participants|Number|118|118.0||||||
4181951|NCT00791778|4004010|B3|Yes||Previous Intra-peritoneal (IP) chemotherapy|The presence or absence of any IP chemotherapy before enrollment into the study.|Participants|Number|9|9.0||||||
4181952|NCT00791778|4004011|B2|Yes||Previous Intra-peritoneal (IP) chemotherapy|The presence or absence of any IP chemotherapy before enrollment into the study.|Participants|Number|4|4.0||||||
4181953|NCT00791778|4004012|B1|Yes||Previous Intra-peritoneal (IP) chemotherapy|The presence or absence of any IP chemotherapy before enrollment into the study.|Participants|Number|5|5.0||||||
4181954|NCT00791778|4004010|B3|Peritoneal cancer||Type of cancer|Patients were to have either ovarian epithelial cancer or primary peritoneal cancer. Primary peritoneal carcinoma involves the extra-ovarian peritoneum significantly and the ovarian surface minimally or not at all.|Participants|Number|17|17.0||||||
4181955|NCT00791778|4004011|B2|Peritoneal cancer||Type of cancer|Patients were to have either ovarian epithelial cancer or primary peritoneal cancer. Primary peritoneal carcinoma involves the extra-ovarian peritoneum significantly and the ovarian surface minimally or not at all.|Participants|Number|9|9.0||||||
4181956|NCT00791778|4004012|B1|Peritoneal cancer||Type of cancer|Patients were to have either ovarian epithelial cancer or primary peritoneal cancer. Primary peritoneal carcinoma involves the extra-ovarian peritoneum significantly and the ovarian surface minimally or not at all.|Participants|Number|8|8.0||||||
4181957|NCT00791778|4004010|B3|Ovarian cancer||Type of cancer|Patients were to have either ovarian epithelial cancer or primary peritoneal cancer. Primary peritoneal carcinoma involves the extra-ovarian peritoneum significantly and the ovarian surface minimally or not at all.|Participants|Number|229|229.0||||||
4181958|NCT00791778|4004011|B2|Ovarian cancer||Type of cancer|Patients were to have either ovarian epithelial cancer or primary peritoneal cancer. Primary peritoneal carcinoma involves the extra-ovarian peritoneum significantly and the ovarian surface minimally or not at all.|Participants|Number|114|114.0||||||
4181959|NCT00791778|4004012|B1|Ovarian cancer||Type of cancer|Patients were to have either ovarian epithelial cancer or primary peritoneal cancer. Primary peritoneal carcinoma involves the extra-ovarian peritoneum significantly and the ovarian surface minimally or not at all.|Participants|Number|115|115.0||||||
4181960|NCT00791778|4004010|B3|Missing||Performance status, Eastern Cooperative Oncology Group (ECOG)|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|2|2.0||||||
4181961|NCT00791778|4004011|B2|Missing||Performance status, Eastern Cooperative Oncology Group (ECOG)|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|1|1.0||||||
4182004|NCT00791765|4004067|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4181962|NCT00791778|4004012|B1|Missing||Performance status, Eastern Cooperative Oncology Group (ECOG)|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|1|1.0||||||
4181963|NCT00791778|4004010|B3|2=Ambulatory, capable of all selfcare||Performance status, Eastern Cooperative Oncology Group (ECOG)|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|1|1.0||||||
4181964|NCT00791778|4004011|B2|2=Ambulatory, capable of all selfcare||Performance status, Eastern Cooperative Oncology Group (ECOG)|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|0|0.0||||||
4181965|NCT00791778|4004012|B1|2=Ambulatory, capable of all selfcare||Performance status, Eastern Cooperative Oncology Group (ECOG)|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|1|1.0||||||
4181966|NCT00791778|4004010|B3|1=Restricted in physically strenuous activity||Performance status, Eastern Cooperative Oncology Group (ECOG)|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|62|62.0||||||
4181967|NCT00791778|4004011|B2|1=Restricted in physically strenuous activity||Performance status, Eastern Cooperative Oncology Group (ECOG)|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|30|30.0||||||
4181968|NCT00791778|4004012|B1|1=Restricted in physically strenuous activity||Performance status, Eastern Cooperative Oncology Group (ECOG)|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|32|32.0||||||
4181969|NCT00791778|4004010|B3|0=Fully active without restriction||Performance status, Eastern Cooperative Oncology Group (ECOG)|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|181|181.0||||||
4181970|NCT00791778|4004011|B2|0=Fully active without restriction||Performance status, Eastern Cooperative Oncology Group (ECOG)|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|92|92.0||||||
4181971|NCT00791778|4004012|B1|0=Fully active without restriction||Performance status, Eastern Cooperative Oncology Group (ECOG)|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst).|Participants|Number|89|89.0||||||
4181972|NCT00791778|4004010|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4181973|NCT00791778|4004011|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4181974|NCT00791778|4004012|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4181975|NCT00791778|4004010|B3||Female|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
4181976|NCT00791778|4004011|B2||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4181977|NCT00791778|4004012|B1||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4181978|NCT00791778|4004010|B3|≥ 75 years||Age, Customized||Participants|Number|6|6.0||||||
4181979|NCT00791778|4004011|B2|≥ 75 years||Age, Customized||Participants|Number|1|1.0||||||
4181980|NCT00791778|4004012|B1|≥ 75 years||Age, Customized||Participants|Number|5|5.0||||||
4181981|NCT00791778|4004010|B3|≥ 65 - < 75 years||Age, Customized||Participants|Number|46|46.0||||||
4181982|NCT00791778|4004011|B2|≥ 65 - < 75 years||Age, Customized||Participants|Number|23|23.0||||||
4181983|NCT00791778|4004012|B1|≥ 65 - < 75 years||Age, Customized||Participants|Number|23|23.0||||||
4181984|NCT00791778|4004010|B3|< 65 years||Age, Customized||Participants|Number|194|194.0||||||
4181985|NCT00791778|4004011|B2|< 65 years||Age, Customized||Participants|Number|99|99.0||||||
4181986|NCT00791778|4004012|B1|< 65 years||Age, Customized||Participants|Number|95|95.0||||||
4181987|NCT00791778|4004010|B3|||Age||Years|Mean|55.7|55.7|Standard Deviation|10.4|10.4|||
4181988|NCT00791778|4004011|B2|||Age||Years|Mean|54.4|54.4|Standard Deviation|10.3|10.3|||
4181989|NCT00791778|4004012|B1|||Age||Years|Mean|56.9|56.9|Standard Deviation|10.4|10.4|||
4181990|NCT00791765|4004065|B3|> 35 kg/m^2||Body Mass Index Group||participants|Number|34|34.0||||||
4181991|NCT00791765|4004066|B2|> 35 kg/m^2||Body Mass Index Group||participants|Number|18|18.0||||||
4181992|NCT00791765|4004067|B1|> 35 kg/m^2||Body Mass Index Group||participants|Number|16|16.0||||||
4181993|NCT00791765|4004065|B3|≤ 35 kg/m^2||Body Mass Index Group||participants|Number|90|90.0||||||
4181994|NCT00791765|4004066|B2|≤ 35 kg/m^2||Body Mass Index Group||participants|Number|44|44.0||||||
4181995|NCT00791765|4004067|B1|≤ 35 kg/m^2||Body Mass Index Group||participants|Number|46|46.0||||||
4181996|NCT00791765|4004065|B3|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4181997|NCT00791765|4004066|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4181998|NCT00791765|4004067|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4181999|NCT00791765|4004065|B3|Aborigine||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4182000|NCT00791765|4004066|B2|Aborigine||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4182001|NCT00791765|4004067|B1|Aborigine||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4182002|NCT00791765|4004065|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4182003|NCT00791765|4004066|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4182005|NCT00791765|4004065|B3|Asian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4182006|NCT00791765|4004066|B2|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4182007|NCT00791765|4004067|B1|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4182008|NCT00791765|4004065|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4182009|NCT00791765|4004066|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4182010|NCT00791765|4004067|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4182011|NCT00791765|4004065|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4182012|NCT00791765|4004066|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4182013|NCT00791765|4004067|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4182014|NCT00791765|4004065|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|90|90.0||||||
4182015|NCT00791765|4004066|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|43|43.0||||||
4182016|NCT00791765|4004067|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|47|47.0||||||
4182017|NCT00791765|4004065|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4182018|NCT00791765|4004066|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4182019|NCT00791765|4004067|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4182020|NCT00791765|4004065|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4182021|NCT00791765|4004066|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4182022|NCT00791765|4004067|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4182023|NCT00791765|4004065|B3|||Age||years|Mean|42.11|42.11|Standard Deviation|13.81|13.81|||
4182024|NCT00791765|4004066|B2|||Age||years|Mean|41.55|41.55|Standard Deviation|13.93|13.93|||
4182025|NCT00791765|4004067|B1|||Age||years|Mean|42.68|42.68|Standard Deviation|13.79|13.79|||
4182026|NCT00791700|4004079|B5||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4182027|NCT00791700|4004080|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4182028|NCT00791700|4004081|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4182029|NCT00791700|4004082|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4182030|NCT00791700|4004083|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4182031|NCT00791700|4004079|B5||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4182032|NCT00791700|4004080|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4182033|NCT00791700|4004081|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4182034|NCT00791700|4004082|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4182035|NCT00791700|4004083|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4182036|NCT00791700|4004079|B5|||Age||Years|Mean|10.3|10.3|Standard Deviation|4.1|4.1|||
4182037|NCT00791700|4004080|B4|||Age||Years|Mean|14.0|14.0|Standard Deviation|1.6|1.6|||
4182038|NCT00791700|4004081|B3|||Age||Years|Mean|8.9|8.9|Standard Deviation|2.0|2.0|||
4182039|NCT00791700|4004082|B2|||Age||Years|Mean|9.1|9.1|Standard Deviation|1.7|1.7|||
4182040|NCT00791700|4004083|B1|||Age||Years|Mean|3.4|3.4|Standard Deviation|0.9|0.9|||
4182041|NCT00791661|4004171|B4|Japan||Region of Enrollment||participants|Number|24|24.0||||||
4182042|NCT00791661|4004172|B3|Japan||Region of Enrollment||participants|Number|8|8.0||||||
4182043|NCT00791661|4004173|B2|Japan||Region of Enrollment||participants|Number|8|8.0||||||
4182044|NCT00791661|4004174|B1|Japan||Region of Enrollment||participants|Number|8|8.0||||||
4182045|NCT00791661|4004171|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4182046|NCT00791661|4004172|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4182047|NCT00791661|4004173|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4182048|NCT00791661|4004174|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4182049|NCT00791661|4004171|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4182050|NCT00791661|4004172|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4182051|NCT00791661|4004173|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4182052|NCT00791661|4004174|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4182053|NCT00791661|4004171|B4|>64 years||Age, Customized||Participants|Number|0|0.0||||||
4182054|NCT00791661|4004172|B3|>64 years||Age, Customized||Participants|Number|0|0.0||||||
4182055|NCT00791661|4004173|B2|>64 years||Age, Customized||Participants|Number|0|0.0||||||
4182056|NCT00791661|4004174|B1|>64 years||Age, Customized||Participants|Number|0|0.0||||||
4182057|NCT00791661|4004171|B4|>= 41 years and <=64 years||Age, Customized||Participants|Number|24|24.0||||||
4182058|NCT00791661|4004172|B3|>= 41 years and <=64 years||Age, Customized||Participants|Number|8|8.0||||||
4182059|NCT00791661|4004173|B2|>= 41 years and <=64 years||Age, Customized||Participants|Number|8|8.0||||||
4182060|NCT00791661|4004174|B1|>= 41 years and <=64 years||Age, Customized||Participants|Number|8|8.0||||||
4182061|NCT00791661|4004171|B4|<41 years||Age, Customized||Participants|Number|0|0.0||||||
4182062|NCT00791661|4004172|B3|<41 years||Age, Customized||Participants|Number|0|0.0||||||
4182063|NCT00791661|4004173|B2|<41 years||Age, Customized||Participants|Number|0|0.0||||||
4182064|NCT00791661|4004174|B1|<41 years||Age, Customized||Participants|Number|0|0.0||||||
4182065|NCT00791648|4004267|B3|United States||Region of Enrollment||participants|Number|615|615.0||||||
4182066|NCT00791648|4004268|B2|United States||Region of Enrollment||participants|Number|307|307.0||||||
4182067|NCT00791648|4004269|B1|United States||Region of Enrollment||participants|Number|308|308.0||||||
4182068|NCT00791648|4004267|B3||Male|Sex: Female, Male||Participants|Count of Participants|427|427.0||||||
4182069|NCT00791648|4004268|B2||Male|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
4182070|NCT00791648|4004269|B1||Male|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4182071|NCT00791648|4004267|B3||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4182072|NCT00791648|4004268|B2||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4182073|NCT00791648|4004269|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4182074|NCT00791648|4004267|B3|||Age||years|Median|66|66.0|Inter-Quartile Range|||49.0|81.0|
4182075|NCT00791648|4004268|B2|||Age||years|Median|67|67.0|Inter-Quartile Range|||51.0|81.0|
4182076|NCT00791648|4004269|B1|||Age||years|Median|66|66.0|Inter-Quartile Range|||49.0|81.0|
4182077|NCT00791557|4004286|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4182078|NCT00791557|4004286|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4182079|NCT00791557|4004286|B1|>=75 years||Age, Customized||participants|Number|0|0.0||||||
4182080|NCT00791557|4004286|B1|Between 18 and 75 years||Age, Customized||participants|Number|2|2.0||||||
4182081|NCT00791557|4004286|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4182082|NCT00791518|4004290|B1|American Indian or Alaska Native and White||Race/Ethnicity, Customized|One participant chose more than one race category; this participant was counted twice.|participants|Number|1|1.0||||||
4182083|NCT00791518|4004290|B1|Japanese East Asian Heritage||Race/Ethnicity, Customized|One participant chose more than one race category; this participant was counted twice.|participants|Number|1|1.0||||||
4182084|NCT00791518|4004290|B1|Asian||Race/Ethnicity, Customized|One participant chose more than one race category; this participant was counted twice.|participants|Number|1|1.0||||||
4182085|NCT00791518|4004290|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|One participant chose more than one race category; this participant was counted twice.|participants|Number|3|3.0||||||
4182086|NCT00791518|4004290|B1|African American/African Heritage||Race/Ethnicity, Customized|One participant chose more than one race category; this participant was counted twice.|participants|Number|146|146.0||||||
4182087|NCT00791518|4004290|B1|White||Race/Ethnicity, Customized|One participant chose more than one race category; this participant was counted twice.|participants|Number|933|933.0||||||
4182088|NCT00791518|4004290|B1||Male|Sex: Female, Male||Participants|Count of Participants|547|547.0||||||
4182089|NCT00791518|4004290|B1||Female|Sex: Female, Male||Participants|Count of Participants|537|537.0||||||
4182090|NCT00791518|4004290|B1|||Age||years|Mean|61.2|61.2|Standard Deviation|10.90|10.9|||
4182091|NCT00791492|4004316|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4182092|NCT00791492|4004317|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4182093|NCT00791492|4004318|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4182094|NCT00791492|4004316|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4182095|NCT00791492|4004317|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4182096|NCT00791492|4004318|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4182097|NCT00791492|4004316|B3|||Age||years|Mean|40.4|40.4|Standard Deviation|13.3|13.3|||
4182098|NCT00791492|4004317|B2|||Age||years|Mean|39.6|39.6|Standard Deviation|13.2|13.2|||
4182099|NCT00791492|4004318|B1|||Age||years|Mean|41.3|41.3|Standard Deviation|13.4|13.4|||
4182100|NCT00791479|4004361|B7|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|7.24|7.24|Standard Deviation|0.58|0.58|||
4182101|NCT00791479|4004362|B6|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|7.36|7.36|Standard Deviation|0.63|0.63|||
4182102|NCT00791479|4004363|B5|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|7.63|7.63|Standard Deviation|0.15|0.15|||
4182103|NCT00791479|4004364|B4|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|7.25|7.25|Standard Deviation|0.43|0.43|||
4182104|NCT00791479|4004365|B3|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|7.28|7.28|Standard Deviation|0.66|0.66|||
4182105|NCT00791479|4004366|B2|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|7.18|7.18|Standard Deviation|0.60|0.6|||
4182106|NCT00791479|4004367|B1|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|7.13|7.13|Standard Deviation|0.55|0.55|||
4182107|NCT00791479|4004361|B7|||Body Weight||kilogram (kg)|Mean|88.43|88.43|Standard Deviation|18.68|18.68|||
4182108|NCT00791479|4004362|B6|||Body Weight||kilogram (kg)|Mean|90.87|90.87|Standard Deviation|18.94|18.94|||
4182109|NCT00791479|4004363|B5|||Body Weight||kilogram (kg)|Mean|100.90|100.9|Standard Deviation|25.51|25.51|||
4182110|NCT00791479|4004364|B4|||Body Weight||kilogram (kg)|Mean|85.81|85.81|Standard Deviation|18.63|18.63|||
4182111|NCT00791479|4004365|B3|||Body Weight||kilogram (kg)|Mean|86.89|86.89|Standard Deviation|16.95|16.95|||
4182112|NCT00791479|4004366|B2|||Body Weight||kilogram (kg)|Mean|90.20|90.2|Standard Deviation|21.34|21.34|||
4182113|NCT00791479|4004367|B1|||Body Weight||kilogram (kg)|Mean|87.08|87.08|Standard Deviation|17.28|17.28|||
4182114|NCT00791479|4004361|B7|||Duration of Diabetes||years|Mean|3.88|3.88|Standard Deviation|3.68|3.68|||
4182115|NCT00791479|4004362|B6|||Duration of Diabetes||years|Mean|3.91|3.91|Standard Deviation|4.74|4.74|||
4182116|NCT00791479|4004363|B5|||Duration of Diabetes||years|Mean|5.00|5.0|Standard Deviation|3.04|3.04|||
4182117|NCT00791479|4004364|B4|||Duration of Diabetes||years|Mean|4.62|4.62|Standard Deviation|4.08|4.08|||
4182118|NCT00791479|4004365|B3|||Duration of Diabetes||years|Mean|3.28|3.28|Standard Deviation|2.54|2.54|||
4182119|NCT00791479|4004366|B2|||Duration of Diabetes||years|Mean|3.72|3.72|Standard Deviation|3.80|3.8|||
4182120|NCT00791479|4004367|B1|||Duration of Diabetes||years|Mean|3.90|3.9|Standard Deviation|3.19|3.19|||
4182121|NCT00791479|4004361|B7|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters (kg/m^2)|Mean|32.20|32.2|Standard Deviation|4.83|4.83|||
4182122|NCT00791479|4004362|B6|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters (kg/m^2)|Mean|32.07|32.07|Standard Deviation|5.23|5.23|||
4182123|NCT00791479|4004363|B5|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters (kg/m^2)|Mean|35.38|35.38|Standard Deviation|3.96|3.96|||
4182124|NCT00791479|4004364|B4|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters (kg/m^2)|Mean|31.04|31.04|Standard Deviation|4.29|4.29|||
4182125|NCT00791479|4004365|B3|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters (kg/m^2)|Mean|32.22|32.22|Standard Deviation|4.50|4.5|||
4182126|NCT00791479|4004366|B2|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters (kg/m^2)|Mean|32.26|32.26|Standard Deviation|5.39|5.39|||
4182127|NCT00791479|4004367|B1|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters (kg/m^2)|Mean|32.92|32.92|Standard Deviation|4.75|4.75|||
4182128|NCT00791479|4004361|B7|India||Region of Enrollment||participants|Number|21|21.0||||||
4182129|NCT00791479|4004362|B6|India||Region of Enrollment||participants|Number|4|4.0||||||
4182130|NCT00791479|4004363|B5|India||Region of Enrollment||participants|Number|0|0.0||||||
4182131|NCT00791479|4004364|B4|India||Region of Enrollment||participants|Number|3|3.0||||||
4182132|NCT00791479|4004365|B3|India||Region of Enrollment||participants|Number|5|5.0||||||
4182133|NCT00791479|4004366|B2|India||Region of Enrollment||participants|Number|5|5.0||||||
4182134|NCT00791479|4004367|B1|India||Region of Enrollment||participants|Number|4|4.0||||||
4182135|NCT00791479|4004361|B7|Russian Federation||Region of Enrollment||participants|Number|5|5.0||||||
4182136|NCT00791479|4004362|B6|Russian Federation||Region of Enrollment||participants|Number|0|0.0||||||
4182137|NCT00791479|4004363|B5|Russian Federation||Region of Enrollment||participants|Number|0|0.0||||||
4182138|NCT00791479|4004364|B4|Russian Federation||Region of Enrollment||participants|Number|0|0.0||||||
4182139|NCT00791479|4004365|B3|Russian Federation||Region of Enrollment||participants|Number|2|2.0||||||
4182140|NCT00791479|4004366|B2|Russian Federation||Region of Enrollment||participants|Number|1|1.0||||||
4182141|NCT00791479|4004367|B1|Russian Federation||Region of Enrollment||participants|Number|2|2.0||||||
4182142|NCT00791479|4004361|B7|Croatia||Region of Enrollment||participants|Number|14|14.0||||||
4182143|NCT00791479|4004362|B6|Croatia||Region of Enrollment||participants|Number|3|3.0||||||
4182144|NCT00791479|4004363|B5|Croatia||Region of Enrollment||participants|Number|0|0.0||||||
4182145|NCT00791479|4004364|B4|Croatia||Region of Enrollment||participants|Number|3|3.0||||||
4182146|NCT00791479|4004365|B3|Croatia||Region of Enrollment||participants|Number|2|2.0||||||
4182147|NCT00791479|4004366|B2|Croatia||Region of Enrollment||participants|Number|2|2.0||||||
4182148|NCT00791479|4004367|B1|Croatia||Region of Enrollment||participants|Number|4|4.0||||||
4182149|NCT00791479|4004361|B7|Poland||Region of Enrollment||participants|Number|16|16.0||||||
4182150|NCT00791479|4004362|B6|Poland||Region of Enrollment||participants|Number|2|2.0||||||
4182151|NCT00791479|4004363|B5|Poland||Region of Enrollment||participants|Number|0|0.0||||||
4182152|NCT00791479|4004364|B4|Poland||Region of Enrollment||participants|Number|5|5.0||||||
4182153|NCT00791479|4004365|B3|Poland||Region of Enrollment||participants|Number|5|5.0||||||
4182154|NCT00791479|4004366|B2|Poland||Region of Enrollment||participants|Number|2|2.0||||||
4182155|NCT00791479|4004367|B1|Poland||Region of Enrollment||participants|Number|2|2.0||||||
4182156|NCT00791479|4004361|B7|Spain||Region of Enrollment||participants|Number|8|8.0||||||
4182157|NCT00791479|4004362|B6|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4182158|NCT00791479|4004363|B5|Spain||Region of Enrollment||participants|Number|0|0.0||||||
4182159|NCT00791479|4004364|B4|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4182160|NCT00791479|4004365|B3|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4182161|NCT00791479|4004366|B2|Spain||Region of Enrollment||participants|Number|3|3.0||||||
4182162|NCT00791479|4004367|B1|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4182163|NCT00791479|4004361|B7|Puerto Rico||Region of Enrollment||participants|Number|5|5.0||||||
4182164|NCT00791479|4004362|B6|Puerto Rico||Region of Enrollment||participants|Number|0|0.0||||||
4182165|NCT00791479|4004363|B5|Puerto Rico||Region of Enrollment||participants|Number|0|0.0||||||
4182166|NCT00791479|4004364|B4|Puerto Rico||Region of Enrollment||participants|Number|2|2.0||||||
4182167|NCT00791479|4004365|B3|Puerto Rico||Region of Enrollment||participants|Number|2|2.0||||||
4182168|NCT00791479|4004366|B2|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
4182169|NCT00791479|4004367|B1|Puerto Rico||Region of Enrollment||participants|Number|0|0.0||||||
4182170|NCT00791479|4004361|B7|Mexico||Region of Enrollment||participants|Number|23|23.0||||||
4182171|NCT00791479|4004362|B6|Mexico||Region of Enrollment||participants|Number|5|5.0||||||
4182172|NCT00791479|4004363|B5|Mexico||Region of Enrollment||participants|Number|0|0.0||||||
4182173|NCT00791479|4004364|B4|Mexico||Region of Enrollment||participants|Number|4|4.0||||||
4182174|NCT00791479|4004365|B3|Mexico||Region of Enrollment||participants|Number|4|4.0||||||
4182175|NCT00791479|4004366|B2|Mexico||Region of Enrollment||participants|Number|5|5.0||||||
4182176|NCT00791479|4004367|B1|Mexico||Region of Enrollment||participants|Number|5|5.0||||||
4182177|NCT00791479|4004361|B7|United States||Region of Enrollment||participants|Number|75|75.0||||||
4182178|NCT00791479|4004362|B6|United States||Region of Enrollment||participants|Number|17|17.0||||||
4182179|NCT00791479|4004363|B5|United States||Region of Enrollment||participants|Number|3|3.0||||||
4182180|NCT00791479|4004364|B4|United States||Region of Enrollment||participants|Number|11|11.0||||||
4182181|NCT00791479|4004365|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4182182|NCT00791479|4004366|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4182183|NCT00791479|4004367|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4182184|NCT00791479|4004361|B7|Multiple||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4182185|NCT00791479|4004362|B6|Multiple||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4182186|NCT00791479|4004363|B5|Multiple||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4182187|NCT00791479|4004364|B4|Multiple||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4182188|NCT00791479|4004365|B3|Multiple||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4182189|NCT00791479|4004366|B2|Multiple||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4182190|NCT00791479|4004367|B1|Multiple||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4182191|NCT00791479|4004361|B7|White||Race/Ethnicity, Customized||participants|Number|134|134.0||||||
4182192|NCT00791479|4004362|B6|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4182193|NCT00791479|4004363|B5|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4182194|NCT00791479|4004364|B4|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4182195|NCT00791479|4004365|B3|White||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4182196|NCT00791479|4004366|B2|White||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4182197|NCT00791479|4004367|B1|White||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4182198|NCT00791479|4004361|B7|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4182199|NCT00791479|4004362|B6|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4182200|NCT00791479|4004363|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4182201|NCT00791479|4004364|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4182202|NCT00791479|4004365|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4182203|NCT00791479|4004366|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4182204|NCT00791479|4004367|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4182205|NCT00791479|4004361|B7|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4182206|NCT00791479|4004362|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4182207|NCT00791479|4004363|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4182208|NCT00791479|4004364|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4182209|NCT00791479|4004365|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4182210|NCT00791479|4004366|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4182211|NCT00791479|4004367|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4182212|NCT00791479|4004361|B7|Asian||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4182213|NCT00791479|4004362|B6|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4182214|NCT00791479|4004363|B5|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4182215|NCT00791479|4004364|B4|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4182216|NCT00791479|4004365|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4182217|NCT00791479|4004366|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4182218|NCT00791479|4004367|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4182219|NCT00791479|4004361|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4182220|NCT00791479|4004362|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4182221|NCT00791479|4004363|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4182222|NCT00791479|4004364|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4182223|NCT00791479|4004365|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4182224|NCT00791479|4004366|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4182225|NCT00791479|4004367|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4182226|NCT00791479|4004361|B7||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4182227|NCT00791479|4004362|B6||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4182228|NCT00791479|4004363|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4182229|NCT00791479|4004364|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4182230|NCT00791479|4004365|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4182231|NCT00791479|4004366|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4182232|NCT00791479|4004367|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4182233|NCT00791479|4004361|B7||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4182234|NCT00791479|4004362|B6||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4182235|NCT00791479|4004363|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4182236|NCT00791479|4004364|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4182237|NCT00791479|4004365|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4182238|NCT00791479|4004366|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4182239|NCT00791479|4004367|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4182240|NCT00791479|4004361|B7|||Age||years|Mean|56.64|56.64|Standard Deviation|8.78|8.78|||
4182241|NCT00791479|4004362|B6|||Age||years|Mean|55.03|55.03|Standard Deviation|9.33|9.33|||
4182242|NCT00791479|4004363|B5|||Age||years|Mean|60.82|60.82|Standard Deviation|7.15|7.15|||
4182243|NCT00791479|4004364|B4|||Age||years|Mean|57.45|57.45|Standard Deviation|7.88|7.88|||
4182244|NCT00791479|4004365|B3|||Age||years|Mean|57.16|57.16|Standard Deviation|8.76|8.76|||
4182245|NCT00791479|4004366|B2|||Age||years|Mean|56.91|56.91|Standard Deviation|9.06|9.06|||
4182246|NCT00791479|4004367|B1|||Age||years|Mean|56.33|56.33|Standard Deviation|9.15|9.15|||
4182247|NCT00791388|4004466|B6|United States||Region of Enrollment|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|participants|Number|45|45.0||||||
4182248|NCT00791388|4004467|B5|United States||Region of Enrollment|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|participants|Number|8|8.0||||||
4182249|NCT00791388|4004468|B4|United States||Region of Enrollment|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|participants|Number|8|8.0||||||
4182250|NCT00791388|4004469|B3|United States||Region of Enrollment|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|participants|Number|8|8.0||||||
4182251|NCT00791388|4004470|B2|United States||Region of Enrollment|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|participants|Number|8|8.0||||||
4182252|NCT00791388|4004471|B1|United States||Region of Enrollment|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|participants|Number|13|13.0||||||
4182253|NCT00791388|4004466|B6||Male|Sex: Female, Male|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|Participants|Count of Participants|43|43.0||||||
4182254|NCT00791388|4004467|B5||Male|Sex: Female, Male|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|Participants|Count of Participants|7|7.0||||||
4182255|NCT00791388|4004468|B4||Male|Sex: Female, Male|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|Participants|Count of Participants|8|8.0||||||
4182256|NCT00791388|4004469|B3||Male|Sex: Female, Male|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|Participants|Count of Participants|8|8.0||||||
4182257|NCT00791388|4004470|B2||Male|Sex: Female, Male|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|Participants|Count of Participants|8|8.0||||||
4182258|NCT00791388|4004471|B1||Male|Sex: Female, Male|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|Participants|Count of Participants|12|12.0||||||
4182259|NCT00791388|4004466|B6||Female|Sex: Female, Male|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|Participants|Count of Participants|2|2.0||||||
4182260|NCT00791388|4004467|B5||Female|Sex: Female, Male|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|Participants|Count of Participants|1|1.0||||||
4182261|NCT00791388|4004468|B4||Female|Sex: Female, Male|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|Participants|Count of Participants|0|0.0||||||
4182262|NCT00791388|4004469|B3||Female|Sex: Female, Male|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|Participants|Count of Participants|0|0.0||||||
4182263|NCT00791388|4004470|B2||Female|Sex: Female, Male|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|Participants|Count of Participants|0|0.0||||||
4182264|NCT00791388|4004471|B1||Female|Sex: Female, Male|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|Participants|Count of Participants|1|1.0||||||
4182265|NCT00791388|4004466|B6|||Age|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|years|Mean|34.5|34.5|Standard Deviation|6.8|6.8|||
4182266|NCT00791388|4004467|B5|||Age|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|years|Mean|36.9|36.9|Standard Deviation|5.8|5.8|||
4182267|NCT00791388|4004468|B4|||Age|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|years|Mean|36.3|36.3|Standard Deviation|6.5|6.5|||
4182268|NCT00791388|4004469|B3|||Age|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|years|Mean|29.9|29.9|Standard Deviation|7.4|7.4|||
4182269|NCT00791388|4004470|B2|||Age|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|years|Mean|35.0|35.0|Standard Deviation|5.8|5.8|||
4182270|NCT00791388|4004471|B1|||Age|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|years|Mean|34.6|34.6|Standard Deviation|7.3|7.3|||
4182271|NCT00791388|4004466|B6||>=65 years|Age|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|Participants|Count of Participants|0|0.0||||||
4182272|NCT00791388|4004467|B5||>=65 years|Age|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|Participants|Count of Participants|0|0.0||||||
4182273|NCT00791388|4004468|B4||>=65 years|Age|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|Participants|Count of Participants|0|0.0||||||
4182274|NCT00791388|4004469|B3||>=65 years|Age|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|Participants|Count of Participants|0|0.0||||||
4182275|NCT00791388|4004470|B2||>=65 years|Age|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|Participants|Count of Participants|0|0.0||||||
4182276|NCT00791388|4004471|B1||>=65 years|Age|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|Participants|Count of Participants|0|0.0||||||
4182277|NCT00791388|4004466|B6||Between 18 and 65 years|Age|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|Participants|Count of Participants|45|45.0||||||
4182278|NCT00791388|4004467|B5||Between 18 and 65 years|Age|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|Participants|Count of Participants|8|8.0||||||
4182279|NCT00791388|4004468|B4||Between 18 and 65 years|Age|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|Participants|Count of Participants|8|8.0||||||
4182280|NCT00791388|4004469|B3||Between 18 and 65 years|Age|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|Participants|Count of Participants|8|8.0||||||
4182281|NCT00791388|4004470|B2||Between 18 and 65 years|Age|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|Participants|Count of Participants|8|8.0||||||
4182282|NCT00791388|4004471|B1||Between 18 and 65 years|Age|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|Participants|Count of Participants|13|13.0||||||
4182283|NCT00791388|4004466|B6||<=18 years|Age|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|Participants|Count of Participants|0|0.0||||||
4182329|NCT00791258|4004517|B1||Between 18 and 65 years|Age||Participants|Count of Participants|771|771.0||||||
4182284|NCT00791388|4004467|B5||<=18 years|Age|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|Participants|Count of Participants|0|0.0||||||
4182285|NCT00791388|4004468|B4||<=18 years|Age|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|Participants|Count of Participants|0|0.0||||||
4182286|NCT00791388|4004469|B3||<=18 years|Age|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|Participants|Count of Participants|0|0.0||||||
4182287|NCT00791388|4004470|B2||<=18 years|Age|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|Participants|Count of Participants|0|0.0||||||
4182288|NCT00791388|4004471|B1||<=18 years|Age|This study consisted of 4 sequential periods testing rising doses of PG 760564. Each period randomized participants to receive either placebo or a specific dose of PG 760564. Subjects enrolled in a single period (i.e., no subject participated in more than one period)|Participants|Count of Participants|0|0.0||||||
4182289|NCT00791336|4004502|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4182290|NCT00791336|4004502|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4182291|NCT00791336|4004502|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4182292|NCT00791336|4004502|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4182293|NCT00791336|4004502|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4182294|NCT00791336|4004502|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4182295|NCT00791323|4004508|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4182296|NCT00791323|4004509|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4182297|NCT00791323|4004510|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4182298|NCT00791323|4004508|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4182299|NCT00791323|4004509|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4182300|NCT00791323|4004510|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4182301|NCT00791323|4004508|B3|||Age||years|Mean|31.75|31.75|Standard Deviation|6.1|6.1|||
4182302|NCT00791323|4004509|B2|||Age||years|Mean|33.3|33.3|Standard Deviation|2.5|2.5|||
4182303|NCT00791323|4004510|B1|||Age||years|Mean|30.2|30.2|Standard Deviation|9.7|9.7|||
4182304|NCT00791258|4004517|B1|||24-Hour mean diastolic ambulatory blood pressure||mm Hg|Mean|81.09|81.09|Standard Deviation|9.346|9.346|||
4182305|NCT00791258|4004517|B1|||24-Hour mean systolic ambulatory blood pressure||mm Hg|Mean|135.74|135.74|Standard Deviation|11.698|11.698|||
4182306|NCT00791258|4004517|B1|||Pulse rate||beats/minute|Mean|74.77|74.77|Standard Deviation|11.621|11.621|||
4182307|NCT00791258|4004517|B1|||Mean seated diastolic blood pressure||mm Hg|Mean|91.92|91.92|Standard Deviation|8.616|8.616|||
4182308|NCT00791258|4004517|B1|||Mean seated systolic blood pressure||mm Hg|Mean|153.66|153.66|Standard Deviation|9.178|9.178|||
4182309|NCT00791258|4004517|B1|No||Metabolic syndrome|Metabolic syndrome is defined as having at least 3 of the following parameters: waist circumference ≥40 inches (males) or ≥35 inches (females); triglycerides ≥150 mg/dL; high density lipoprotein cholesterol <40 mg/dL (males) or <50 mg/dL (females); blood pressure ≥130/85 mmHg; fasting glucose ≥100mg/dL; BMI ≥30kg/m2.|Participants|Number|537|537.0||||||
4182310|NCT00791258|4004517|B1|Yes||Metabolic syndrome|Metabolic syndrome is defined as having at least 3 of the following parameters: waist circumference ≥40 inches (males) or ≥35 inches (females); triglycerides ≥150 mg/dL; high density lipoprotein cholesterol <40 mg/dL (males) or <50 mg/dL (females); blood pressure ≥130/85 mmHg; fasting glucose ≥100mg/dL; BMI ≥30kg/m2.|Participants|Number|462|462.0||||||
4182311|NCT00791258|4004517|B1|||Body Mass Index||Kg/m٨2|Mean|31.02|31.02|Standard Deviation|6.370|6.37|||
4182312|NCT00791258|4004517|B1|||Weight||kg|Mean|88.20|88.2|Standard Deviation|21.466|21.466|||
4182313|NCT00791258|4004517|B1|No||Type 2 Diabetes||Participants|Number|807|807.0||||||
4182314|NCT00791258|4004517|B1|Yes||Type 2 Diabetes||Participants|Number|192|192.0||||||
4182315|NCT00791258|4004517|B1|Non-Hispanic or Latino||Hispanic or Latino||Participants|Number|894|894.0||||||
4182316|NCT00791258|4004517|B1|Hispanic or Latino||Hispanic or Latino||Participants|Number|105|105.0||||||
4182317|NCT00791258|4004517|B1|South Africa||Region of Enrollment||participants|Number|267|267.0||||||
4182318|NCT00791258|4004517|B1|United States||Region of Enrollment||participants|Number|732|732.0||||||
4182319|NCT00791258|4004517|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182320|NCT00791258|4004517|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182321|NCT00791258|4004517|B1||White|Race (NIH/OMB)||Participants|Count of Participants|630|630.0||||||
4182322|NCT00791258|4004517|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|234|234.0||||||
4182323|NCT00791258|4004517|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182324|NCT00791258|4004517|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
4182325|NCT00791258|4004517|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4182326|NCT00791258|4004517|B1||Male|Sex: Female, Male||Participants|Count of Participants|508|508.0||||||
4182327|NCT00791258|4004517|B1||Female|Sex: Female, Male||Participants|Count of Participants|491|491.0||||||
4182328|NCT00791258|4004517|B1||>=65 years|Age||Participants|Count of Participants|228|228.0||||||
4182330|NCT00791258|4004517|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4182331|NCT00791128|4004579|B1|||Percent of glycosylated hemoglobin||Percent of glycosylated hemoglobin|Mean|8.9|8.9|Standard Deviation|1.66|1.66|||
4182332|NCT00791128|4004579|B1|||Baseline Weight||kg|Mean|119.2|119.2|Standard Deviation|22.87|22.87|||
4182333|NCT00791128|4004579|B1|Brazil||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4182334|NCT00791128|4004579|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4182335|NCT00791128|4004579|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4182336|NCT00791128|4004579|B1|||Age||years|Mean|46.2|46.2|Standard Deviation|10.45|10.45|||
4182337|NCT00791102|4004584|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4182338|NCT00791102|4004584|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4182339|NCT00791102|4004584|B1|||Age||years|Mean|33|33.0|Standard Deviation|9.4|9.4|||
4182340|NCT00791089|4004601|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4182341|NCT00791089|4004602|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4182342|NCT00791089|4004603|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4182343|NCT00791089|4004601|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4182344|NCT00791089|4004602|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4182345|NCT00791089|4004603|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4182346|NCT00791089|4004601|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4182347|NCT00791089|4004602|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4182348|NCT00791089|4004603|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4182349|NCT00791089|4004601|B3|||Age||years|Mean|52.7|52.7|Full Range|||26.0|65.0|
4182350|NCT00791089|4004602|B2|||Age||years|Mean|48.8|48.8|Full Range|||26.0|65.0|
4182351|NCT00791089|4004603|B1|||Age||years|Mean|56|56.0|Full Range|||43.0|64.0|
4182352|NCT00791076|4004610|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4182353|NCT00791076|4004610|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4182354|NCT00791076|4004610|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4182355|NCT00791076|4004610|B1|>=18 and <=75||Age, Customized||participants|Number|8|8.0||||||
4182356|NCT00791037|4004618|B1|Canada||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4182357|NCT00791037|4004618|B1|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4182358|NCT00791037|4004618|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4182359|NCT00791037|4004618|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4182360|NCT00791037|4004618|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4182361|NCT00791037|4004618|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4182362|NCT00791037|4004618|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4182363|NCT00790907|4004625|B4|Missing||Race/Ethnicity, Customized|CRF, case report form.|participants|Number|2|2.0||||||
4182364|NCT00790907|4004626|B3|Missing||Race/Ethnicity, Customized|CRF, case report form.|participants|Number|1|1.0||||||
4182365|NCT00790907|4004627|B2|Missing||Race/Ethnicity, Customized|CRF, case report form.|participants|Number|0|0.0||||||
4182366|NCT00790907|4004628|B1|Missing||Race/Ethnicity, Customized|CRF, case report form.|participants|Number|1|1.0||||||
4182367|NCT00790907|4004625|B4|Other - verbatim reason collected on the CRF||Race/Ethnicity, Customized|CRF, case report form.|participants|Number|5|5.0||||||
4182368|NCT00790907|4004626|B3|Other - verbatim reason collected on the CRF||Race/Ethnicity, Customized|CRF, case report form.|participants|Number|2|2.0||||||
4182369|NCT00790907|4004627|B2|Other - verbatim reason collected on the CRF||Race/Ethnicity, Customized|CRF, case report form.|participants|Number|1|1.0||||||
4182370|NCT00790907|4004628|B1|Other - verbatim reason collected on the CRF||Race/Ethnicity, Customized|CRF, case report form.|participants|Number|2|2.0||||||
4182371|NCT00790907|4004625|B4|Native Latin||Race/Ethnicity, Customized|CRF, case report form.|participants|Number|127|127.0||||||
4182372|NCT00790907|4004626|B3|Native Latin||Race/Ethnicity, Customized|CRF, case report form.|participants|Number|33|33.0||||||
4182373|NCT00790907|4004627|B2|Native Latin||Race/Ethnicity, Customized|CRF, case report form.|participants|Number|37|37.0||||||
4182374|NCT00790907|4004628|B1|Native Latin||Race/Ethnicity, Customized|CRF, case report form.|participants|Number|57|57.0||||||
4182375|NCT00790907|4004625|B4|European||Race/Ethnicity, Customized|CRF, case report form.|participants|Number|2347|2347.0||||||
4182376|NCT00790907|4004626|B3|European||Race/Ethnicity, Customized|CRF, case report form.|participants|Number|749|749.0||||||
4182377|NCT00790907|4004627|B2|European||Race/Ethnicity, Customized|CRF, case report form.|participants|Number|768|768.0||||||
4182378|NCT00790907|4004628|B1|European||Race/Ethnicity, Customized|CRF, case report form.|participants|Number|830|830.0||||||
4182379|NCT00790907|4004625|B4|Black African||Race/Ethnicity, Customized|CRF, case report form.|participants|Number|8|8.0||||||
4182380|NCT00790907|4004626|B3|Black African||Race/Ethnicity, Customized|CRF, case report form.|participants|Number|3|3.0||||||
4182381|NCT00790907|4004627|B2|Black African||Race/Ethnicity, Customized|CRF, case report form.|participants|Number|1|1.0||||||
4182382|NCT00790907|4004628|B1|Black African||Race/Ethnicity, Customized|CRF, case report form.|participants|Number|4|4.0||||||
4182383|NCT00790907|4004625|B4|Arab||Race/Ethnicity, Customized|CRF, case report form.|participants|Number|11|11.0||||||
4182384|NCT00790907|4004626|B3|Arab||Race/Ethnicity, Customized|CRF, case report form.|participants|Number|3|3.0||||||
4182385|NCT00790907|4004627|B2|Arab||Race/Ethnicity, Customized|CRF, case report form.|participants|Number|5|5.0||||||
4182386|NCT00790907|4004628|B1|Arab||Race/Ethnicity, Customized|CRF, case report form.|participants|Number|3|3.0||||||
4182387|NCT00790907|4004625|B4|Other Asian||Race/Ethnicity, Customized|CRF, case report form.|participants|Number|185|185.0||||||
4182388|NCT00790907|4004626|B3|Other Asian||Race/Ethnicity, Customized|CRF, case report form.|participants|Number|61|61.0||||||
4182389|NCT00790907|4004627|B2|Other Asian||Race/Ethnicity, Customized|CRF, case report form.|participants|Number|61|61.0||||||
4182390|NCT00790907|4004628|B1|Other Asian||Race/Ethnicity, Customized|CRF, case report form.|participants|Number|63|63.0||||||
4182391|NCT00790907|4004625|B4|South Asian||Race/Ethnicity, Customized|CRF, case report form.|participants|Number|550|550.0||||||
4182392|NCT00790907|4004626|B3|South Asian||Race/Ethnicity, Customized|CRF, case report form.|participants|Number|150|150.0||||||
4182393|NCT00790907|4004627|B2|South Asian||Race/Ethnicity, Customized|CRF, case report form.|participants|Number|151|151.0||||||
4182394|NCT00790907|4004628|B1|South Asian||Race/Ethnicity, Customized|CRF, case report form.|participants|Number|249|249.0||||||
4182395|NCT00790907|4004625|B4||Male|Sex: Female, Male||Participants|Count of Participants|2098|2098.0||||||
4182396|NCT00790907|4004626|B3||Male|Sex: Female, Male||Participants|Count of Participants|686|686.0||||||
4182397|NCT00790907|4004627|B2||Male|Sex: Female, Male||Participants|Count of Participants|689|689.0||||||
4182398|NCT00790907|4004628|B1||Male|Sex: Female, Male||Participants|Count of Participants|723|723.0||||||
4182399|NCT00790907|4004625|B4||Female|Sex: Female, Male||Participants|Count of Participants|1137|1137.0||||||
4182400|NCT00790907|4004626|B3||Female|Sex: Female, Male||Participants|Count of Participants|316|316.0||||||
4182401|NCT00790907|4004627|B2||Female|Sex: Female, Male||Participants|Count of Participants|335|335.0||||||
4182402|NCT00790907|4004628|B1||Female|Sex: Female, Male||Participants|Count of Participants|486|486.0||||||
4182403|NCT00790907|4004625|B4|||Age||Years|Mean|65.5|65.5|Standard Deviation|11.14|11.14|||
4182404|NCT00790907|4004626|B3|||Age||Years|Mean|65.5|65.5|Standard Deviation|11.10|11.1|||
4182405|NCT00790907|4004627|B2|||Age||Years|Mean|65.3|65.3|Standard Deviation|11.25|11.25|||
4182406|NCT00790907|4004628|B1|||Age||Years|Mean|65.8|65.8|Standard Deviation|11.07|11.07|||
4182407|NCT00790868|4004651|B3|United States|Massachusetts General Hospital/Rush|Region of Enrollment||Participants|Count of Participants|53|53.0||||||
4182408|NCT00790868|4004652|B2|United States|Massachusetts General Hospital/Rush|Region of Enrollment||Participants|Count of Participants|27|27.0||||||
4182409|NCT00790868|4004653|B1|United States|Massachusetts General Hospital/Rush|Region of Enrollment||Participants|Count of Participants|26|26.0||||||
4182410|NCT00790868|4004651|B3|United States|Institute of Living in Hartford, Connecticut|Region of Enrollment||Participants|Count of Participants|59|59.0||||||
4182411|NCT00790868|4004652|B2|United States|Institute of Living in Hartford, Connecticut|Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4182412|NCT00790868|4004653|B1|United States|Institute of Living in Hartford, Connecticut|Region of Enrollment||Participants|Count of Participants|29|29.0||||||
4182413|NCT00790868|4004651|B3|United States|Boston University|Region of Enrollment||Participants|Count of Participants|68|68.0||||||
4182414|NCT00790868|4004652|B2|United States|Boston University|Region of Enrollment||Participants|Count of Participants|35|35.0||||||
4182415|NCT00790868|4004653|B1|United States|Boston University|Region of Enrollment||Participants|Count of Participants|33|33.0||||||
4182416|NCT00790868|4004651|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4182417|NCT00790868|4004652|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182418|NCT00790868|4004653|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4182419|NCT00790868|4004651|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4182420|NCT00790868|4004652|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4182421|NCT00790868|4004653|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4182422|NCT00790868|4004651|B3||White|Race (NIH/OMB)||Participants|Count of Participants|166|166.0||||||
4182423|NCT00790868|4004652|B2||White|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
4182424|NCT00790868|4004653|B1||White|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
4182425|NCT00790868|4004651|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4182426|NCT00790868|4004652|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4182427|NCT00790868|4004653|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4182428|NCT00790868|4004651|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182429|NCT00790868|4004652|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182430|NCT00790868|4004653|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182431|NCT00790868|4004651|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4182432|NCT00790868|4004652|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4182433|NCT00790868|4004653|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4182434|NCT00790868|4004651|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182435|NCT00790868|4004652|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182436|NCT00790868|4004653|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182437|NCT00790868|4004651|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4182438|NCT00790868|4004652|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4182439|NCT00790868|4004653|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182440|NCT00790868|4004651|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|160|160.0||||||
4182441|NCT00790868|4004652|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
4182442|NCT00790868|4004653|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
4182443|NCT00790868|4004651|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4182444|NCT00790868|4004652|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4182445|NCT00790868|4004653|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4182446|NCT00790868|4004651|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4182447|NCT00790868|4004652|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4182448|NCT00790868|4004653|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4182449|NCT00790868|4004651|B3||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4182450|NCT00790868|4004652|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4182451|NCT00790868|4004653|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4182452|NCT00790868|4004651|B3|||Age||Years|Mean|35.4|35.4|Standard Deviation|12.1|12.1|||
4182453|NCT00790868|4004652|B2|||Age||Years|Mean|35.18|35.18|Standard Deviation|12.84|12.84|||
4182454|NCT00790868|4004653|B1|||Age||Years|Mean|35.75|35.75|Standard Deviation|11.59|11.59|||
4182455|NCT00790868|4004651|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4182456|NCT00790868|4004652|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4182457|NCT00790868|4004653|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4182458|NCT00790868|4004651|B3||Between 18 and 65 years|Age||Participants|Count of Participants|175|175.0||||||
4182459|NCT00790868|4004652|B2||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
4182460|NCT00790868|4004653|B1||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
4182461|NCT00790868|4004651|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4182462|NCT00790868|4004652|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4182463|NCT00790868|4004653|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4182464|NCT00790855|4004668|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4182465|NCT00790855|4004668|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4182466|NCT00790855|4004668|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4182467|NCT00790855|4004668|B1|||Age||years|Median|57|57.0|Full Range|||22.0|88.0|
4182468|NCT00790842|4004673|B4|||Creatinine Clearance|Serum creatinine clearance, mL/minute|mL/min|Median|27.4|27.4|Inter-Quartile Range|||15.7|42.1|
4182469|NCT00790842|4004674|B3|||Creatinine Clearance|Serum creatinine clearance, mL/minute|mL/min|Median|11.5|11.5|Inter-Quartile Range|||9.7|17.2|
4182470|NCT00790842|4004675|B2|||Creatinine Clearance|Serum creatinine clearance, mL/minute|mL/min|Median|22.8|22.8|Inter-Quartile Range|||15.7|25.4|
4182471|NCT00790842|4004676|B1|||Creatinine Clearance|Serum creatinine clearance, mL/minute|mL/min|Median|42.6|42.6|Inter-Quartile Range|||37.0|51.2|
4182472|NCT00790842|4004673|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4182473|NCT00790842|4004674|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182474|NCT00790842|4004675|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4182475|NCT00790842|4004676|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182476|NCT00790842|4004673|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182477|NCT00790842|4004674|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182478|NCT00790842|4004675|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182479|NCT00790842|4004676|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182480|NCT00790842|4004673|B4||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4182481|NCT00790842|4004674|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4182482|NCT00790842|4004675|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4182483|NCT00790842|4004676|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4182484|NCT00790842|4004673|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4182485|NCT00790842|4004674|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4182486|NCT00790842|4004675|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4182487|NCT00790842|4004676|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4182488|NCT00790842|4004673|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182489|NCT00790842|4004674|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182490|NCT00790842|4004675|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182491|NCT00790842|4004676|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182492|NCT00790842|4004673|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182493|NCT00790842|4004674|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182494|NCT00790842|4004675|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182495|NCT00790842|4004676|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182496|NCT00790842|4004673|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4182497|NCT00790842|4004674|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4182498|NCT00790842|4004675|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182499|NCT00790842|4004676|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182500|NCT00790842|4004673|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4182501|NCT00790842|4004674|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182502|NCT00790842|4004675|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4182503|NCT00790842|4004676|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182504|NCT00790842|4004673|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4182505|NCT00790842|4004674|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4182506|NCT00790842|4004675|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4182507|NCT00790842|4004676|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4182508|NCT00790842|4004673|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182509|NCT00790842|4004674|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182510|NCT00790842|4004675|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182511|NCT00790842|4004676|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182512|NCT00790842|4004673|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4182513|NCT00790842|4004674|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4182514|NCT00790842|4004675|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4182515|NCT00790842|4004676|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4182516|NCT00790842|4004673|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4182517|NCT00790842|4004674|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4182518|NCT00790842|4004675|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4182519|NCT00790842|4004676|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4182520|NCT00790842|4004673|B4|||Age||years|Median|71.5|71.5|Inter-Quartile Range|||64.0|77.0|
4182521|NCT00790842|4004674|B3|||Age||years|Median|64|64.0|Inter-Quartile Range|||57.0|70.0|
4182522|NCT00790842|4004675|B2|||Age||years|Median|72|72.0|Inter-Quartile Range|||62.0|79.0|
4182523|NCT00790842|4004676|B1|||Age||years|Median|73|73.0|Inter-Quartile Range|||68.0|78.0|
4182524|NCT00790803|4004743|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4182525|NCT00790803|4004743|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4182526|NCT00790803|4004743|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4182527|NCT00790803|4004743|B1|||Age||years|Mean|50.8|50.8|Standard Deviation|19.05781|19.05781|||
4182528|NCT00790803|4004743|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4182529|NCT00790803|4004743|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4182530|NCT00790803|4004743|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4182531|NCT00790790|4004751|B4|Romania||Region of Enrollment||participants|Number|30|30.0||||||
4182532|NCT00790790|4004752|B3|Romania||Region of Enrollment||participants|Number|9|9.0||||||
4182533|NCT00790790|4004753|B2|Romania||Region of Enrollment||participants|Number|10|10.0||||||
4182534|NCT00790790|4004754|B1|Romania||Region of Enrollment||participants|Number|11|11.0||||||
4182535|NCT00790790|4004751|B4|Puerto Rico||Region of Enrollment||participants|Number|23|23.0||||||
4182536|NCT00790790|4004752|B3|Puerto Rico||Region of Enrollment||participants|Number|8|8.0||||||
4182537|NCT00790790|4004753|B2|Puerto Rico||Region of Enrollment||participants|Number|8|8.0||||||
4182538|NCT00790790|4004754|B1|Puerto Rico||Region of Enrollment||participants|Number|7|7.0||||||
4182539|NCT00790790|4004751|B4|United States||Region of Enrollment||participants|Number|94|94.0||||||
4182540|NCT00790790|4004752|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4182541|NCT00790790|4004753|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
4182542|NCT00790790|4004754|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4182543|NCT00790790|4004751|B4|White||Race/Ethnicity, Customized||participants|Number|124|124.0||||||
4182544|NCT00790790|4004752|B3|White||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4182545|NCT00790790|4004753|B2|White||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4182546|NCT00790790|4004754|B1|White||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4182547|NCT00790790|4004751|B4|Multiple||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4182548|NCT00790790|4004752|B3|Multiple||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4182549|NCT00790790|4004753|B2|Multiple||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4182550|NCT00790790|4004754|B1|Multiple||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4182551|NCT00790790|4004751|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4182552|NCT00790790|4004752|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4182553|NCT00790790|4004753|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4182554|NCT00790790|4004754|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4182555|NCT00790790|4004751|B4|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4182556|NCT00790790|4004752|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4182557|NCT00790790|4004753|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4182558|NCT00790790|4004754|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4182559|NCT00790790|4004751|B4||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4182560|NCT00790790|4004752|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4182561|NCT00790790|4004753|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4182562|NCT00790790|4004754|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4182563|NCT00790790|4004751|B4||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4182564|NCT00790790|4004752|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4182565|NCT00790790|4004753|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4182566|NCT00790790|4004754|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4182567|NCT00790790|4004751|B4|||Age||years|Mean|59.06|59.06|Standard Deviation|7.26|7.26|||
4182568|NCT00790790|4004752|B3|||Age||years|Mean|59.96|59.96|Standard Deviation|6.98|6.98|||
4182569|NCT00790790|4004753|B2|||Age||years|Mean|57.68|57.68|Standard Deviation|7.88|7.88|||
4182570|NCT00790790|4004754|B1|||Age||years|Mean|59.59|59.59|Standard Deviation|6.81|6.81|||
4182571|NCT00790751|4004829|B5|United States||Region of Enrollment||participants|Number|646|646.0||||||
4182572|NCT00790751|4004830|B4|United States||Region of Enrollment||participants|Number|162|162.0||||||
4182573|NCT00790751|4004831|B3|United States||Region of Enrollment||participants|Number|161|161.0||||||
4182574|NCT00790751|4004832|B2|United States||Region of Enrollment||participants|Number|161|161.0||||||
4182575|NCT00790751|4004833|B1|United States||Region of Enrollment||participants|Number|162|162.0||||||
4182576|NCT00790751|4004829|B5||Male|Sex: Female, Male||Participants|Count of Participants|646|646.0||||||
4182577|NCT00790751|4004830|B4||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4182578|NCT00790751|4004831|B3||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4182579|NCT00790751|4004832|B2||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4182580|NCT00790751|4004833|B1||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4182581|NCT00790751|4004829|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4182582|NCT00790751|4004830|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4182583|NCT00790751|4004831|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4182584|NCT00790751|4004832|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4182585|NCT00790751|4004833|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4182586|NCT00790751|4004829|B5|||Age||years|Mean|55.7|55.7|Standard Deviation|10.89|10.89|||
4182587|NCT00790751|4004830|B4|||Age||years|Mean|55.7|55.7|Standard Deviation|11.33|11.33|||
4182588|NCT00790751|4004831|B3|||Age||years|Mean|56.5|56.5|Standard Deviation|10.32|10.32|||
4182589|NCT00790751|4004832|B2|||Age||years|Mean|55.4|55.4|Standard Deviation|10.81|10.81|||
4182590|NCT00790751|4004833|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|11.13|11.13|||
4182591|NCT00790738|4004854|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4182592|NCT00790738|4004855|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4182593|NCT00790738|4004856|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4182594|NCT00790738|4004854|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4182595|NCT00790738|4004855|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4182596|NCT00790738|4004856|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4182597|NCT00790738|4004854|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4182598|NCT00790738|4004855|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4182599|NCT00790738|4004856|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4182600|NCT00790738|4004854|B3|||Age||years|Mean|45.2|45.2|Standard Deviation|7.4|7.4|||
4182601|NCT00790738|4004855|B2|||Age||years|Mean|46.4|46.4|Standard Deviation|5.9|5.9|||
4182602|NCT00790738|4004856|B1|||Age||years|Mean|43.8|43.8|Standard Deviation|9.5|9.5|||
4182603|NCT00790673|4004867|B5||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4182604|NCT00790673|4004868|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4182605|NCT00790673|4004869|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4182606|NCT00790673|4004870|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4182607|NCT00790673|4004871|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4182608|NCT00790673|4004867|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4182609|NCT00790673|4004868|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4182610|NCT00790673|4004869|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4182611|NCT00790673|4004870|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4182612|NCT00790673|4004871|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4182613|NCT00790673|4004867|B5|||Age||years|Mean|47.3|47.3|Standard Deviation|11.8|11.8|||
4182614|NCT00790673|4004868|B4|||Age||years|Mean|42.1|42.1|Standard Deviation|11.2|11.2|||
4182615|NCT00790673|4004869|B3|||Age||years|Mean|48.3|48.3|Standard Deviation|12.4|12.4|||
4182616|NCT00790673|4004870|B2|||Age||years|Mean|54.5|54.5|Standard Deviation|8.43|8.43|||
4182617|NCT00790673|4004871|B1|||Age||years|Mean|45.3|45.3|Standard Deviation|12.7|12.7|||
4182618|NCT00790647|4004884|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
4182619|NCT00790647|4004884|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
4182620|NCT00790647|4004884|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4182621|NCT00790647|4004884|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4182622|NCT00790647|4004884|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4182623|NCT00790569|4004891|B4|||Years of Education||years|Mean|11.8|11.8|Standard Deviation|1.9|1.9|||
4182624|NCT00790569|4004892|B3|||Years of Education||years|Mean|11.9|11.9|Standard Deviation|2.2|2.2|||
4182625|NCT00790569|4004893|B2|||Years of Education||years|Mean|11.4|11.4|Standard Deviation|1.9|1.9|||
4182626|NCT00790569|4004894|B1|||Years of Education||years|Mean|11.8|11.8|Standard Deviation|2.0|2.0|||
4182627|NCT00790569|4004891|B4|United States||Region of Enrollment||participants|Number|315|315.0||||||
4182628|NCT00790569|4004892|B3|United States||Region of Enrollment||participants|Number|133|133.0||||||
4182629|NCT00790569|4004893|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
4182630|NCT00790569|4004894|B1|United States||Region of Enrollment||participants|Number|137|137.0||||||
4182631|NCT00790569|4004891|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182632|NCT00790569|4004892|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182633|NCT00790569|4004893|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182634|NCT00790569|4004894|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182635|NCT00790569|4004891|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|277|277.0||||||
4182636|NCT00790569|4004892|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|116|116.0||||||
4182637|NCT00790569|4004893|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4182638|NCT00790569|4004894|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
4182639|NCT00790569|4004891|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4182640|NCT00790569|4004892|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4182641|NCT00790569|4004893|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4182642|NCT00790569|4004894|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4182643|NCT00790569|4004891|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4182644|NCT00790569|4004892|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4182645|NCT00790569|4004893|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4182646|NCT00790569|4004894|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4182647|NCT00790569|4004891|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4182648|NCT00790569|4004892|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4182649|NCT00790569|4004893|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4182650|NCT00790569|4004894|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4182651|NCT00790569|4004891|B4||White|Race (NIH/OMB)||Participants|Count of Participants|250|250.0||||||
4182652|NCT00790569|4004892|B3||White|Race (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
4182653|NCT00790569|4004893|B2||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4182654|NCT00790569|4004894|B1||White|Race (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
4182655|NCT00790569|4004891|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4182656|NCT00790569|4004892|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4182657|NCT00790569|4004893|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4182658|NCT00790569|4004894|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4182659|NCT00790569|4004891|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182660|NCT00790569|4004892|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182661|NCT00790569|4004893|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182662|NCT00790569|4004894|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182663|NCT00790569|4004891|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182664|NCT00790569|4004892|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182665|NCT00790569|4004893|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182666|NCT00790569|4004894|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182667|NCT00790569|4004891|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182668|NCT00790569|4004892|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182669|NCT00790569|4004893|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182670|NCT00790569|4004894|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182671|NCT00790569|4004891|B4||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4182672|NCT00790569|4004892|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4182673|NCT00790569|4004893|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4182674|NCT00790569|4004894|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4182675|NCT00790569|4004891|B4||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4182676|NCT00790569|4004892|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4182677|NCT00790569|4004893|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4182678|NCT00790569|4004894|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4182679|NCT00790569|4004891|B4|||Age||years|Mean|39.9|39.9|Standard Deviation|9.7|9.7|||
4182680|NCT00790569|4004892|B3|||Age||years|Mean|40.3|40.3|Standard Deviation|9.3|9.3|||
4182681|NCT00790569|4004893|B2|||Age||years|Mean|40.6|40.6|Standard Deviation|10.6|10.6|||
4182682|NCT00790569|4004894|B1|||Age||years|Mean|39.2|39.2|Standard Deviation|9.7|9.7|||
4182683|NCT00790556|4004937|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4182684|NCT00790556|4004937|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4182685|NCT00790556|4004937|B1|||Age||years|Mean|49.43|49.43|Full Range|||30.0|62.0|
4182686|NCT00790452|4004948|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4182687|NCT00790452|4004950|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4182688|NCT00790452|4004948|B3|Male||Gender||participants|Number|0|0.0||||||
4182689|NCT00790452|4004950|B1|Male||Gender||participants|Number|0|0.0||||||
4182690|NCT00790452|4004948|B3|Female||Gender||participants|Number|1|1.0||||||
4182691|NCT00790452|4004950|B1|Female||Gender||participants|Number|1|1.0||||||
4182692|NCT00790452|4004948|B3|||Age||years|Median|53|53.0|Full Range|||53.0|53.0|
4182693|NCT00790452|4004950|B1|||Age||years|Median|53|53.0|Full Range|||53.0|53.0|
4182694|NCT00790400|4004957|B3||Male|Gender||Participants|Count of Participants|40|40.0||||||
4182695|NCT00790400|4004958|B2||Male|Gender||Participants|Count of Participants|13|13.0||||||
4182696|NCT00790400|4004959|B1||Male|Gender||Participants|Count of Participants|27|27.0||||||
4182697|NCT00790400|4004957|B3||Female|Gender||Participants|Count of Participants|78|78.0||||||
4182698|NCT00790400|4004958|B2||Female|Gender||Participants|Count of Participants|26|26.0||||||
4182699|NCT00790400|4004959|B1||Female|Gender||Participants|Count of Participants|52|52.0||||||
4182700|NCT00790400|4004957|B3|≥ 30 years||Age, Customized||Participants|Number|63|63.0||||||
4182701|NCT00790400|4004958|B2|≥ 30 years||Age, Customized||Participants|Number|19|19.0||||||
4182702|NCT00790400|4004959|B1|≥ 30 years||Age, Customized||Participants|Number|44|44.0||||||
4182703|NCT00790400|4004957|B3|<30 years||Age, Customized||Participants|Number|55|55.0||||||
4182704|NCT00790400|4004958|B2|<30 years||Age, Customized||Participants|Number|20|20.0||||||
4182705|NCT00790400|4004959|B1|<30 years||Age, Customized||Participants|Number|35|35.0||||||
4182706|NCT00790400|4004957|B3|||Age||years|Mean|32.0|32.0|Standard Deviation|10.12|10.12|||
4182707|NCT00790400|4004958|B2|||Age||years|Mean|31.0|31.0|Standard Deviation|9.64|9.64|||
4182708|NCT00790400|4004959|B1|||Age||years|Mean|32.5|32.5|Standard Deviation|10.37|10.37|||
4182709|NCT00790335|4004987|B3|||Weight||kilograms|Mean|97|97.0|Standard Deviation|24|24.0|||
4182710|NCT00790335|4004988|B2|||Weight||kilograms|Mean|96|96.0|Standard Deviation|24|24.0|||
4182711|NCT00790335|4004989|B1|||Weight||kilograms|Mean|97|97.0|Standard Deviation|25|25.0|||
4182712|NCT00790335|4004987|B3|||Height||centimeters|Mean|174|174.0|Standard Deviation|11|11.0|||
4182713|NCT00790335|4004988|B2|||Height||centimeters|Mean|174|174.0|Standard Deviation|10|10.0|||
4182714|NCT00790335|4004989|B1|||Height||centimeters|Mean|174|174.0|Standard Deviation|11|11.0|||
4182715|NCT00790335|4004987|B3|||Congestive heart failure||Participants|Count of Participants|32|32.0||||||
4182716|NCT00790335|4004988|B2|||Congestive heart failure||Participants|Count of Participants|19|19.0||||||
4182717|NCT00790335|4004989|B1|||Congestive heart failure||Participants|Count of Participants|13|13.0||||||
4182718|NCT00790335|4004987|B3|||Angina or myocardial infarction|MI = myocardial infarction|Participants|Count of Participants|28|28.0||||||
4182719|NCT00790335|4004988|B2|||Angina or myocardial infarction|MI = myocardial infarction|Participants|Count of Participants|15|15.0||||||
4182720|NCT00790335|4004989|B1|||Angina or myocardial infarction|MI = myocardial infarction|Participants|Count of Participants|13|13.0||||||
4182721|NCT00790335|4004987|B3|||Chronic obstructive pulmonary disease|COPD = chronic obstructive pulmonary disease|Participants|Count of Participants|24|24.0||||||
4182722|NCT00790335|4004988|B2|||Chronic obstructive pulmonary disease|COPD = chronic obstructive pulmonary disease|Participants|Count of Participants|15|15.0||||||
4182723|NCT00790335|4004989|B1|||Chronic obstructive pulmonary disease|COPD = chronic obstructive pulmonary disease|Participants|Count of Participants|9|9.0||||||
4182724|NCT00790335|4004987|B3|||Asthma||Participants|Count of Participants|74|74.0||||||
4182725|NCT00790335|4004988|B2|||Asthma||Participants|Count of Participants|38|38.0||||||
4182726|NCT00790335|4004989|B1|||Asthma||Participants|Count of Participants|36|36.0||||||
4182727|NCT00790335|4004987|B3|||High cholesterol||Participants|Count of Participants|202|202.0||||||
4182728|NCT00790335|4004988|B2|||High cholesterol||Participants|Count of Participants|105|105.0||||||
4182729|NCT00790335|4004989|B1|||High cholesterol||Participants|Count of Participants|97|97.0||||||
4182730|NCT00790335|4004987|B3|||Diabetes||Participants|Count of Participants|113|113.0||||||
4182731|NCT00790335|4004988|B2|||Diabetes||Participants|Count of Participants|54|54.0||||||
4182732|NCT00790335|4004989|B1|||Diabetes||Participants|Count of Participants|59|59.0||||||
4182733|NCT00790335|4004987|B3|||Hypertension||Participants|Count of Participants|282|282.0||||||
4182734|NCT00790335|4004988|B2|||Hypertension||Participants|Count of Participants|139|139.0||||||
4182735|NCT00790335|4004989|B1|||Hypertension||Participants|Count of Participants|143|143.0||||||
4182736|NCT00790335|4004987|B3|||Estimated glomerular filtration rate||milliliters per minute|Median|86|86.0|Inter-Quartile Range|||71.0|102.0|
4182737|NCT00790335|4004988|B2|||Estimated glomerular filtration rate||milliliters per minute|Median|86|86.0|Inter-Quartile Range|||71.0|102.0|
4182738|NCT00790335|4004989|B1|||Estimated glomerular filtration rate||milliliters per minute|Median|86|86.0|Inter-Quartile Range|||70.0|102.0|
4182739|NCT00790335|4004987|B3|||Aspirin use within past 7 days||Participants|Count of Participants|142|142.0||||||
4182740|NCT00790335|4004988|B2|||Aspirin use within past 7 days||Participants|Count of Participants|74|74.0||||||
4182741|NCT00790335|4004989|B1|||Aspirin use within past 7 days||Participants|Count of Participants|68|68.0||||||
4182742|NCT00790335|4004987|B3|||Time from symptom start to randomization||days|Median|6|6.0|Inter-Quartile Range|||4.0|10.0|
4182743|NCT00790335|4004988|B2|||Time from symptom start to randomization||days|Median|6|6.0|Inter-Quartile Range|||4.0|9.0|
4182744|NCT00790335|4004989|B1|||Time from symptom start to randomization||days|Median|6|6.0|Inter-Quartile Range|||4.0|10.0|
4182745|NCT00790335|4004987|B3|||Outpatient||Participants|Count of Participants|568|568.0||||||
4182746|NCT00790335|4004988|B2|||Outpatient||Participants|Count of Participants|300|300.0||||||
4182747|NCT00790335|4004989|B1|||Outpatient||Participants|Count of Participants|268|268.0||||||
4182748|NCT00790335|4004987|B3||None of the above risk factors|DVT risk factors||Participants|Count of Participants|541|541.0||||||
4182749|NCT00790335|4004988|B2||None of the above risk factors|DVT risk factors||Participants|Count of Participants|269|269.0||||||
4182750|NCT00790335|4004989|B1||None of the above risk factors|DVT risk factors||Participants|Count of Participants|272|272.0||||||
4182751|NCT00790335|4004987|B3||Childbirth|DVT risk factors||Participants|Count of Participants|8|8.0||||||
4182752|NCT00790335|4004988|B2||Childbirth|DVT risk factors||Participants|Count of Participants|5|5.0||||||
4182753|NCT00790335|4004989|B1||Childbirth|DVT risk factors||Participants|Count of Participants|3|3.0||||||
4182754|NCT00790335|4004987|B3||Plaster cast immobilization|DVT risk factors||Participants|Count of Participants|17|17.0||||||
4182755|NCT00790335|4004988|B2||Plaster cast immobilization|DVT risk factors||Participants|Count of Participants|9|9.0||||||
4182756|NCT00790335|4004989|B1||Plaster cast immobilization|DVT risk factors||Participants|Count of Participants|8|8.0||||||
4182757|NCT00790335|4004987|B3||Hospitalization|DVT risk factors||Participants|Count of Participants|64|64.0||||||
4182758|NCT00790335|4004988|B2||Hospitalization|DVT risk factors||Participants|Count of Participants|38|38.0||||||
4182759|NCT00790335|4004989|B1||Hospitalization|DVT risk factors||Participants|Count of Participants|26|26.0||||||
4182760|NCT00790335|4004987|B3||Major surgery|DVT risk factors||Participants|Count of Participants|61|61.0||||||
4182761|NCT00790335|4004988|B2||Major surgery|DVT risk factors||Participants|Count of Participants|34|34.0||||||
4182762|NCT00790335|4004989|B1||Major surgery|DVT risk factors||Participants|Count of Participants|27|27.0||||||
4182763|NCT00790335|4004987|B3|||DVT extends into iliac or common femoral vein|"Patients with DVT extending into the iliac or common femoral vein are termed iliofemoral DVT and those whose DVT did not extend that high are termed femoropopliteal DVT."|Participants|Count of Participants|391|391.0||||||
4182764|NCT00790335|4004988|B2|||DVT extends into iliac or common femoral vein|"Patients with DVT extending into the iliac or common femoral vein are termed iliofemoral DVT and those whose DVT did not extend that high are termed femoropopliteal DVT."|Participants|Count of Participants|196|196.0||||||
4182765|NCT00790335|4004989|B1|||DVT extends into iliac or common femoral vein|"Patients with DVT extending into the iliac or common femoral vein are termed iliofemoral DVT and those whose DVT did not extend that high are termed femoropopliteal DVT."|Participants|Count of Participants|195|195.0||||||
4182766|NCT00790335|4004987|B3|||Previous ipsilateral DVT|DVT = deep vein thrombosis|Participants|Count of Participants|19|19.0||||||
4182767|NCT00790335|4004988|B2|||Previous ipsilateral DVT|DVT = deep vein thrombosis|Participants|Count of Participants|14|14.0||||||
4182768|NCT00790335|4004989|B1|||Previous ipsilateral DVT|DVT = deep vein thrombosis|Participants|Count of Participants|5|5.0||||||
4182769|NCT00790335|4004987|B3|||Previous DVT or PE|DVT = deep vein thrombosis; PE = pulmonary embolism|Participants|Count of Participants|170|170.0||||||
4182770|NCT00790335|4004988|B2|||Previous DVT or PE|DVT = deep vein thrombosis; PE = pulmonary embolism|Participants|Count of Participants|87|87.0||||||
4182771|NCT00790335|4004989|B1|||Previous DVT or PE|DVT = deep vein thrombosis; PE = pulmonary embolism|Participants|Count of Participants|83|83.0||||||
4182772|NCT00790335|4004987|B3||Right leg|Side of index DVT||Participants|Count of Participants|266|266.0||||||
4182773|NCT00790335|4004988|B2||Right leg|Side of index DVT||Participants|Count of Participants|137|137.0||||||
4182774|NCT00790335|4004989|B1||Right leg|Side of index DVT||Participants|Count of Participants|129|129.0||||||
4182775|NCT00790335|4004987|B3||Left leg|Side of index DVT||Participants|Count of Participants|425|425.0||||||
4182776|NCT00790335|4004988|B2||Left leg|Side of index DVT||Participants|Count of Participants|218|218.0||||||
4182777|NCT00790335|4004989|B1||Left leg|Side of index DVT||Participants|Count of Participants|207|207.0||||||
4182778|NCT00790335|4004987|B3||Not documented|Symptom severity score|The Villalta scale was used to define baseline symptom severity|Participants|Count of Participants|2|2.0||||||
4182779|NCT00790335|4004988|B2||Not documented|Symptom severity score|The Villalta scale was used to define baseline symptom severity|Participants|Count of Participants|2|2.0||||||
4182780|NCT00790335|4004989|B1||Not documented|Symptom severity score|The Villalta scale was used to define baseline symptom severity|Participants|Count of Participants|0|0.0||||||
4182781|NCT00790335|4004987|B3||Severe (> 14)|Symptom severity score|The Villalta scale was used to define baseline symptom severity|Participants|Count of Participants|132|132.0||||||
4182782|NCT00790335|4004988|B2||Severe (> 14)|Symptom severity score|The Villalta scale was used to define baseline symptom severity|Participants|Count of Participants|66|66.0||||||
4182783|NCT00790335|4004989|B1||Severe (> 14)|Symptom severity score|The Villalta scale was used to define baseline symptom severity|Participants|Count of Participants|66|66.0||||||
4182784|NCT00790335|4004987|B3||Moderate (10-14)|Symptom severity score|The Villalta scale was used to define baseline symptom severity|Participants|Count of Participants|192|192.0||||||
4182785|NCT00790335|4004988|B2||Moderate (10-14)|Symptom severity score|The Villalta scale was used to define baseline symptom severity|Participants|Count of Participants|94|94.0||||||
4182786|NCT00790335|4004989|B1||Moderate (10-14)|Symptom severity score|The Villalta scale was used to define baseline symptom severity|Participants|Count of Participants|98|98.0||||||
4182787|NCT00790335|4004987|B3||Mild (5-9)|Symptom severity score|The Villalta scale was used to define baseline symptom severity|Participants|Count of Participants|239|239.0||||||
4182788|NCT00790335|4004988|B2||Mild (5-9)|Symptom severity score|The Villalta scale was used to define baseline symptom severity|Participants|Count of Participants|124|124.0||||||
4182789|NCT00790335|4004989|B1||Mild (5-9)|Symptom severity score|The Villalta scale was used to define baseline symptom severity|Participants|Count of Participants|115|115.0||||||
4182790|NCT00790335|4004987|B3||None or very mild (0-4)|Symptom severity score|The Villalta scale was used to define baseline symptom severity|Participants|Count of Participants|126|126.0||||||
4182791|NCT00790335|4004988|B2||None or very mild (0-4)|Symptom severity score|The Villalta scale was used to define baseline symptom severity|Participants|Count of Participants|69|69.0||||||
4182792|NCT00790335|4004989|B1||None or very mild (0-4)|Symptom severity score|The Villalta scale was used to define baseline symptom severity|Participants|Count of Participants|57|57.0||||||
4182793|NCT00790335|4004987|B3|||Body-mass index||kilograms per square meter|Median|31|31.0|Inter-Quartile Range|||27.0|35.0|
4182794|NCT00790335|4004988|B2|||Body-mass index||kilograms per square meter|Median|30|30.0|Inter-Quartile Range|||26.0|35.0|
4182795|NCT00790335|4004989|B1|||Body-mass index||kilograms per square meter|Median|31|31.0|Inter-Quartile Range|||27.0|36.0|
4182796|NCT00790335|4004987|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4182797|NCT00790335|4004988|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4182798|NCT00790335|4004989|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4182799|NCT00790335|4004987|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182800|NCT00790335|4004988|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182801|NCT00790335|4004989|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182802|NCT00790335|4004987|B3||White|Race (NIH/OMB)||Participants|Count of Participants|541|541.0||||||
4182803|NCT00790335|4004988|B2||White|Race (NIH/OMB)||Participants|Count of Participants|276|276.0||||||
4182804|NCT00790335|4004989|B1||White|Race (NIH/OMB)||Participants|Count of Participants|265|265.0||||||
4182805|NCT00790335|4004987|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
4182806|NCT00790335|4004988|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4182807|NCT00790335|4004989|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4182808|NCT00790335|4004987|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182809|NCT00790335|4004988|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182810|NCT00790335|4004989|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4182811|NCT00790335|4004987|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4182812|NCT00790335|4004988|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4182813|NCT00790335|4004989|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4182814|NCT00790335|4004987|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4182815|NCT00790335|4004988|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4182816|NCT00790335|4004989|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4182817|NCT00790335|4004987|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4182818|NCT00790335|4004988|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4182819|NCT00790335|4004989|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4182820|NCT00790335|4004987|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|629|629.0||||||
4182821|NCT00790335|4004988|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|319|319.0||||||
4182822|NCT00790335|4004989|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|310|310.0||||||
4182823|NCT00790335|4004987|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4182824|NCT00790335|4004988|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4182825|NCT00790335|4004989|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4182826|NCT00790335|4004987|B3||Male|Sex: Female, Male||Participants|Count of Participants|426|426.0||||||
4182827|NCT00790335|4004988|B2||Male|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
4182828|NCT00790335|4004989|B1||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4182829|NCT00790335|4004987|B3||Female|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
4182830|NCT00790335|4004988|B2||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4182831|NCT00790335|4004989|B1||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4182832|NCT00790335|4004987|B3|||Age||years|Median|53|53.0|Inter-Quartile Range|||42.0|62.0|
4182833|NCT00790335|4004988|B2|||Age||years|Median|53|53.0|Inter-Quartile Range|||43.0|62.0|
4182834|NCT00790335|4004989|B1|||Age||years|Median|52|52.0|Inter-Quartile Range|||41.0|62.0|
4182835|NCT00790296|4005048|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4182836|NCT00790296|4005049|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4182837|NCT00790296|4005050|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4182838|NCT00790296|4005048|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4182839|NCT00790296|4005049|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4182840|NCT00790296|4005050|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4182841|NCT00790296|4005048|B3|||Age||years|Mean|58|58.0|Standard Deviation|9.4|9.4|||
4182842|NCT00790296|4005049|B2|||Age||years|Mean|58|58.0|Standard Deviation|9.4|9.4|||
4182843|NCT00790296|4005050|B1|||Age||years|Mean|58|58.0|Standard Deviation|9.4|9.4|||
4182844|NCT00790270|4005057|B4|United States||Region of Enrollment||participants|Number|61|61.0||||||
4182845|NCT00790270|4005058|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4182846|NCT00790270|4005059|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4182847|NCT00790270|4005060|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4182848|NCT00790270|4005057|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4182849|NCT00790270|4005058|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4182850|NCT00790270|4005059|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4182851|NCT00790270|4005060|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4182852|NCT00790270|4005057|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4182853|NCT00790270|4005058|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4182854|NCT00790270|4005059|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4182855|NCT00790270|4005060|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4182856|NCT00790270|4005057|B4|||Age||years|Mean|33|33.0|Standard Deviation|13|13.0|||
4182857|NCT00790270|4005058|B3|||Age||years|Mean|32|32.0|Standard Deviation|10|10.0|||
4182858|NCT00790270|4005059|B2|||Age||years|Mean|32|32.0|Standard Deviation|10|10.0|||
4182859|NCT00790270|4005060|B1|||Age||years|Mean|36|36.0|Standard Deviation|13|13.0|||
4182860|NCT00790270|4005057|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4182861|NCT00790270|4005058|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4182862|NCT00790270|4005059|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4182863|NCT00790270|4005060|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4182864|NCT00790270|4005057|B4||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4182865|NCT00790270|4005058|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4182866|NCT00790270|4005059|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4182867|NCT00790270|4005060|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4182868|NCT00790270|4005057|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4182869|NCT00790270|4005058|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4182870|NCT00790270|4005059|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4182871|NCT00790270|4005060|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4182872|NCT00790218|4005073|B1|Israel||Region of Enrollment||participants|Number|19|19.0||||||
4182873|NCT00790218|4005073|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4182874|NCT00790218|4005073|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4182875|NCT00790218|4005073|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4182876|NCT00790218|4005073|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4182877|NCT00790218|4005073|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4182878|NCT00790205|4005083|B3|||Urine albumin creatinine ratio|Sitagliptin, n= 2606; Placebo, n= 2542; Total, n= 5148|g/mol Creatinine|Mean|8.5|8.5|Standard Deviation|36.7|36.7|||
4182879|NCT00790205|4005084|B2|||Urine albumin creatinine ratio|Sitagliptin, n= 2606; Placebo, n= 2542; Total, n= 5148|g/mol Creatinine|Mean|8.4|8.4|Standard Deviation|36.0|36.0|||
4182880|NCT00790205|4005085|B1|||Urine albumin creatinine ratio|Sitagliptin, n= 2606; Placebo, n= 2542; Total, n= 5148|g/mol Creatinine|Mean|8.6|8.6|Standard Deviation|37.4|37.4|||
4182881|NCT00790205|4005083|B3|||Hemoglobin A1c (HbA1c)|Sitagliptin, n= 7330; Placebo, n= 7336; Total, n= 14666|Percentage of HbA1c|Mean|7.2|7.2|Standard Deviation|0.5|0.5|||
4182882|NCT00790205|4005084|B2|||Hemoglobin A1c (HbA1c)|Sitagliptin, n= 7330; Placebo, n= 7336; Total, n= 14666|Percentage of HbA1c|Mean|7.2|7.2|Standard Deviation|0.5|0.5|||
4182883|NCT00790205|4005085|B1|||Hemoglobin A1c (HbA1c)|Sitagliptin, n= 7330; Placebo, n= 7336; Total, n= 14666|Percentage of HbA1c|Mean|7.2|7.2|Standard Deviation|0.5|0.5|||
4182884|NCT00790205|4005083|B3|||Estimated Glomerular Filtration Rate (eGFR)|Sitagliptin, n= 7254; Placebo, n= 7274; Total, n=14528|mL/min/1.73 m^2|Mean|74.9|74.9|Standard Deviation|21.1|21.1|||
4182885|NCT00790205|4005084|B2|||Estimated Glomerular Filtration Rate (eGFR)|Sitagliptin, n= 7254; Placebo, n= 7274; Total, n=14528|mL/min/1.73 m^2|Mean|74.9|74.9|Standard Deviation|20.9|20.9|||
4182886|NCT00790205|4005085|B1|||Estimated Glomerular Filtration Rate (eGFR)|Sitagliptin, n= 7254; Placebo, n= 7274; Total, n=14528|mL/min/1.73 m^2|Mean|74.9|74.9|Standard Deviation|21.3|21.3|||
4182887|NCT00790205|4005083|B3||Male|Sex: Female, Male||Participants|Count of Participants|10374|10374.0||||||
4182888|NCT00790205|4005084|B2||Male|Sex: Female, Male||Participants|Count of Participants|5176|5176.0||||||
4182889|NCT00790205|4005085|B1||Male|Sex: Female, Male||Participants|Count of Participants|5198|5198.0||||||
4182890|NCT00790205|4005083|B3||Female|Sex: Female, Male||Participants|Count of Participants|4297|4297.0||||||
4182891|NCT00790205|4005084|B2||Female|Sex: Female, Male||Participants|Count of Participants|2163|2163.0||||||
4182892|NCT00790205|4005085|B1||Female|Sex: Female, Male||Participants|Count of Participants|2134|2134.0||||||
4182893|NCT00790205|4005083|B3|Unknown age||Age, Customized|Age is unknown for 320 participants|Participants|Number|320|320.0||||||
4182894|NCT00790205|4005084|B2|Unknown age||Age, Customized|Age is unknown for 320 participants|Participants|Number|162|162.0||||||
4182895|NCT00790205|4005085|B1|Unknown age||Age, Customized|Age is unknown for 320 participants|Participants|Number|158|158.0||||||
4182896|NCT00790205|4005083|B3|85 years and over||Age, Customized|Age is unknown for 320 participants|Participants|Number|101|101.0||||||
4182897|NCT00790205|4005084|B2|85 years and over||Age, Customized|Age is unknown for 320 participants|Participants|Number|55|55.0||||||
4182898|NCT00790205|4005085|B1|85 years and over||Age, Customized|Age is unknown for 320 participants|Participants|Number|46|46.0||||||
4182899|NCT00790205|4005083|B3|From 65 - 84 years||Age, Customized|Age is unknown for 320 participants|Participants|Number|7634|7634.0||||||
4182900|NCT00790205|4005084|B2|From 65 - 84 years||Age, Customized|Age is unknown for 320 participants|Participants|Number|3821|3821.0||||||
4182901|NCT00790205|4005085|B1|From 65 - 84 years||Age, Customized|Age is unknown for 320 participants|Participants|Number|3813|3813.0||||||
4182902|NCT00790205|4005083|B3|Adults 18 - 64 years||Age, Customized|Age is unknown for 320 participants|Participants|Number|6616|6616.0||||||
4182903|NCT00790205|4005084|B2|Adults 18 - 64 years||Age, Customized|Age is unknown for 320 participants|Participants|Number|3301|3301.0||8.0|8.0|||
4182904|NCT00790205|4005085|B1|Adults 18 - 64 years||Age, Customized|Age is unknown for 320 participants|Participants|Number|3315|3315.0||7.9|7.9|||
4182905|NCT00790192|4005126|B5|Colombia||Region of Enrollment|There were two subjects, one randomized to the Quetiapine 600 mg group and one subject randomized to placebo that did not take study drug. Thus you see a discrepancy between the participant population and the overall baseline population(1 less patient in each treatment arm).|participants|Number|26|26.0||||||
4182906|NCT00790192|4005127|B4|Colombia||Region of Enrollment|There were two subjects, one randomized to the Quetiapine 600 mg group and one subject randomized to placebo that did not take study drug. Thus you see a discrepancy between the participant population and the overall baseline population(1 less patient in each treatment arm).|participants|Number|7|7.0||||||
4182907|NCT00790192|4005128|B3|Colombia||Region of Enrollment|There were two subjects, one randomized to the Quetiapine 600 mg group and one subject randomized to placebo that did not take study drug. Thus you see a discrepancy between the participant population and the overall baseline population(1 less patient in each treatment arm).|participants|Number|6|6.0||||||
4182908|NCT00790192|4005129|B2|Colombia||Region of Enrollment|There were two subjects, one randomized to the Quetiapine 600 mg group and one subject randomized to placebo that did not take study drug. Thus you see a discrepancy between the participant population and the overall baseline population(1 less patient in each treatment arm).|participants|Number|6|6.0||||||
4182909|NCT00790192|4005130|B1|Colombia||Region of Enrollment|There were two subjects, one randomized to the Quetiapine 600 mg group and one subject randomized to placebo that did not take study drug. Thus you see a discrepancy between the participant population and the overall baseline population(1 less patient in each treatment arm).|participants|Number|7|7.0||||||
4182910|NCT00790192|4005126|B5|India||Region of Enrollment|There were two subjects, one randomized to the Quetiapine 600 mg group and one subject randomized to placebo that did not take study drug. Thus you see a discrepancy between the participant population and the overall baseline population(1 less patient in each treatment arm).|participants|Number|98|98.0||||||
4182911|NCT00790192|4005127|B4|India||Region of Enrollment|There were two subjects, one randomized to the Quetiapine 600 mg group and one subject randomized to placebo that did not take study drug. Thus you see a discrepancy between the participant population and the overall baseline population(1 less patient in each treatment arm).|participants|Number|24|24.0||||||
4182912|NCT00790192|4005128|B3|India||Region of Enrollment|There were two subjects, one randomized to the Quetiapine 600 mg group and one subject randomized to placebo that did not take study drug. Thus you see a discrepancy between the participant population and the overall baseline population(1 less patient in each treatment arm).|participants|Number|25|25.0||||||
4182913|NCT00790192|4005129|B2|India||Region of Enrollment|There were two subjects, one randomized to the Quetiapine 600 mg group and one subject randomized to placebo that did not take study drug. Thus you see a discrepancy between the participant population and the overall baseline population(1 less patient in each treatment arm).|participants|Number|25|25.0||||||
4182914|NCT00790192|4005130|B1|India||Region of Enrollment|There were two subjects, one randomized to the Quetiapine 600 mg group and one subject randomized to placebo that did not take study drug. Thus you see a discrepancy between the participant population and the overall baseline population(1 less patient in each treatment arm).|participants|Number|24|24.0||||||
4182915|NCT00790192|4005126|B5|Russian Federation||Region of Enrollment|There were two subjects, one randomized to the Quetiapine 600 mg group and one subject randomized to placebo that did not take study drug. Thus you see a discrepancy between the participant population and the overall baseline population(1 less patient in each treatment arm).|participants|Number|87|87.0||||||
4182916|NCT00790192|4005127|B4|Russian Federation||Region of Enrollment|There were two subjects, one randomized to the Quetiapine 600 mg group and one subject randomized to placebo that did not take study drug. Thus you see a discrepancy between the participant population and the overall baseline population(1 less patient in each treatment arm).|participants|Number|22|22.0||||||
4182917|NCT00790192|4005128|B3|Russian Federation||Region of Enrollment|There were two subjects, one randomized to the Quetiapine 600 mg group and one subject randomized to placebo that did not take study drug. Thus you see a discrepancy between the participant population and the overall baseline population(1 less patient in each treatment arm).|participants|Number|21|21.0||||||
4182918|NCT00790192|4005129|B2|Russian Federation||Region of Enrollment|There were two subjects, one randomized to the Quetiapine 600 mg group and one subject randomized to placebo that did not take study drug. Thus you see a discrepancy between the participant population and the overall baseline population(1 less patient in each treatment arm).|participants|Number|22|22.0||||||
4182919|NCT00790192|4005130|B1|Russian Federation||Region of Enrollment|There were two subjects, one randomized to the Quetiapine 600 mg group and one subject randomized to placebo that did not take study drug. Thus you see a discrepancy between the participant population and the overall baseline population(1 less patient in each treatment arm).|participants|Number|22|22.0||||||
4182920|NCT00790192|4005126|B5|Romania||Region of Enrollment|There were two subjects, one randomized to the Quetiapine 600 mg group and one subject randomized to placebo that did not take study drug. Thus you see a discrepancy between the participant population and the overall baseline population(1 less patient in each treatment arm).|participants|Number|49|49.0||||||
4182990|NCT00790023|4005198|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
4182991|NCT00790023|4005195|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|320|320.0||||||
4182921|NCT00790192|4005127|B4|Romania||Region of Enrollment|There were two subjects, one randomized to the Quetiapine 600 mg group and one subject randomized to placebo that did not take study drug. Thus you see a discrepancy between the participant population and the overall baseline population(1 less patient in each treatment arm).|participants|Number|12|12.0||||||
4182922|NCT00790192|4005128|B3|Romania||Region of Enrollment|There were two subjects, one randomized to the Quetiapine 600 mg group and one subject randomized to placebo that did not take study drug. Thus you see a discrepancy between the participant population and the overall baseline population(1 less patient in each treatment arm).|participants|Number|13|13.0||||||
4182923|NCT00790192|4005129|B2|Romania||Region of Enrollment|There were two subjects, one randomized to the Quetiapine 600 mg group and one subject randomized to placebo that did not take study drug. Thus you see a discrepancy between the participant population and the overall baseline population(1 less patient in each treatment arm).|participants|Number|11|11.0||||||
4182924|NCT00790192|4005130|B1|Romania||Region of Enrollment|There were two subjects, one randomized to the Quetiapine 600 mg group and one subject randomized to placebo that did not take study drug. Thus you see a discrepancy between the participant population and the overall baseline population(1 less patient in each treatment arm).|participants|Number|13|13.0||||||
4182925|NCT00790192|4005126|B5|Ukraine||Region of Enrollment|There were two subjects, one randomized to the Quetiapine 600 mg group and one subject randomized to placebo that did not take study drug. Thus you see a discrepancy between the participant population and the overall baseline population(1 less patient in each treatment arm).|participants|Number|75|75.0||||||
4182926|NCT00790192|4005127|B4|Ukraine||Region of Enrollment|There were two subjects, one randomized to the Quetiapine 600 mg group and one subject randomized to placebo that did not take study drug. Thus you see a discrepancy between the participant population and the overall baseline population(1 less patient in each treatment arm).|participants|Number|17|17.0||||||
4182927|NCT00790192|4005128|B3|Ukraine||Region of Enrollment|There were two subjects, one randomized to the Quetiapine 600 mg group and one subject randomized to placebo that did not take study drug. Thus you see a discrepancy between the participant population and the overall baseline population(1 less patient in each treatment arm).|participants|Number|19|19.0||||||
4182928|NCT00790192|4005129|B2|Ukraine||Region of Enrollment|There were two subjects, one randomized to the Quetiapine 600 mg group and one subject randomized to placebo that did not take study drug. Thus you see a discrepancy between the participant population and the overall baseline population(1 less patient in each treatment arm).|participants|Number|20|20.0||||||
4182929|NCT00790192|4005130|B1|Ukraine||Region of Enrollment|There were two subjects, one randomized to the Quetiapine 600 mg group and one subject randomized to placebo that did not take study drug. Thus you see a discrepancy between the participant population and the overall baseline population(1 less patient in each treatment arm).|participants|Number|19|19.0||||||
4182930|NCT00790192|4005126|B5|United States||Region of Enrollment|There were two subjects, one randomized to the Quetiapine 600 mg group and one subject randomized to placebo that did not take study drug. Thus you see a discrepancy between the participant population and the overall baseline population(1 less patient in each treatment arm).|participants|Number|151|151.0||||||
4182931|NCT00790192|4005127|B4|United States||Region of Enrollment|There were two subjects, one randomized to the Quetiapine 600 mg group and one subject randomized to placebo that did not take study drug. Thus you see a discrepancy between the participant population and the overall baseline population(1 less patient in each treatment arm).|participants|Number|39|39.0||||||
4182932|NCT00790192|4005128|B3|United States||Region of Enrollment|There were two subjects, one randomized to the Quetiapine 600 mg group and one subject randomized to placebo that did not take study drug. Thus you see a discrepancy between the participant population and the overall baseline population(1 less patient in each treatment arm).|participants|Number|35|35.0||||||
4182933|NCT00790192|4005129|B2|United States||Region of Enrollment|There were two subjects, one randomized to the Quetiapine 600 mg group and one subject randomized to placebo that did not take study drug. Thus you see a discrepancy between the participant population and the overall baseline population(1 less patient in each treatment arm).|participants|Number|37|37.0||||||
4182934|NCT00790192|4005130|B1|United States||Region of Enrollment|There were two subjects, one randomized to the Quetiapine 600 mg group and one subject randomized to placebo that did not take study drug. Thus you see a discrepancy between the participant population and the overall baseline population(1 less patient in each treatment arm).|participants|Number|40|40.0||||||
4182935|NCT00790192|4005126|B5|Male||Gender|There were two subjects, one randomized to the Quetiapine 600 mg group and one subject randomized to placebo that did not take study drug. Thus you see a discrepancy between the participant population and the overall baseline population for the two treatment groups (1 less patient in each treatment arm).|participants|Number|332|332.0||||||
4182936|NCT00790192|4005127|B4|Male||Gender|There were two subjects, one randomized to the Quetiapine 600 mg group and one subject randomized to placebo that did not take study drug. Thus you see a discrepancy between the participant population and the overall baseline population for the two treatment groups (1 less patient in each treatment arm).|participants|Number|77|77.0||||||
4182937|NCT00790192|4005128|B3|Male||Gender|There were two subjects, one randomized to the Quetiapine 600 mg group and one subject randomized to placebo that did not take study drug. Thus you see a discrepancy between the participant population and the overall baseline population for the two treatment groups (1 less patient in each treatment arm).|participants|Number|77|77.0||||||
4182938|NCT00790192|4005129|B2|Male||Gender|There were two subjects, one randomized to the Quetiapine 600 mg group and one subject randomized to placebo that did not take study drug. Thus you see a discrepancy between the participant population and the overall baseline population for the two treatment groups (1 less patient in each treatment arm).|participants|Number|82|82.0||||||
4182939|NCT00790192|4005130|B1|Male||Gender|There were two subjects, one randomized to the Quetiapine 600 mg group and one subject randomized to placebo that did not take study drug. Thus you see a discrepancy between the participant population and the overall baseline population for the two treatment groups (1 less patient in each treatment arm).|participants|Number|96|96.0||||||
4182992|NCT00790023|4005196|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|109|109.0||||||
4182993|NCT00790023|4005197|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
4182940|NCT00790192|4005126|B5|Female||Gender|There were two subjects, one randomized to the Quetiapine 600 mg group and one subject randomized to placebo that did not take study drug. Thus you see a discrepancy between the participant population and the overall baseline population for the two treatment groups (1 less patient in each treatment arm).|participants|Number|154|154.0||||||
4182941|NCT00790192|4005127|B4|Female||Gender|There were two subjects, one randomized to the Quetiapine 600 mg group and one subject randomized to placebo that did not take study drug. Thus you see a discrepancy between the participant population and the overall baseline population for the two treatment groups (1 less patient in each treatment arm).|participants|Number|44|44.0||||||
4182942|NCT00790192|4005128|B3|Female||Gender|There were two subjects, one randomized to the Quetiapine 600 mg group and one subject randomized to placebo that did not take study drug. Thus you see a discrepancy between the participant population and the overall baseline population for the two treatment groups (1 less patient in each treatment arm).|participants|Number|42|42.0||||||
4182943|NCT00790192|4005129|B2|Female||Gender|There were two subjects, one randomized to the Quetiapine 600 mg group and one subject randomized to placebo that did not take study drug. Thus you see a discrepancy between the participant population and the overall baseline population for the two treatment groups (1 less patient in each treatment arm).|participants|Number|39|39.0||||||
4182944|NCT00790192|4005130|B1|Female||Gender|There were two subjects, one randomized to the Quetiapine 600 mg group and one subject randomized to placebo that did not take study drug. Thus you see a discrepancy between the participant population and the overall baseline population for the two treatment groups (1 less patient in each treatment arm).|participants|Number|29|29.0||||||
4182945|NCT00790192|4005126|B5|||Age||years|Mean|37.2|37.2|Standard Deviation|10.8|10.8|||
4182946|NCT00790192|4005127|B4|||Age||years|Mean|37.4|37.4|Standard Deviation|10.8|10.8|||
4182947|NCT00790192|4005128|B3|||Age||years|Mean|37.4|37.4|Standard Deviation|10.4|10.4|||
4182948|NCT00790192|4005129|B2|||Age||years|Mean|37.9|37.9|Standard Deviation|11.3|11.3|||
4182949|NCT00790192|4005130|B1|||Age||years|Mean|36.2|36.2|Standard Deviation|10.9|10.9|||
4182950|NCT00790062|4005147|B4|United States||Region of Enrollment||participants|Number|1798|1798.0||||||
4182951|NCT00790062|4005148|B3|United States||Region of Enrollment||participants|Number|658|658.0||||||
4182952|NCT00790062|4005149|B2|United States||Region of Enrollment||participants|Number|481|481.0||||||
4182953|NCT00790062|4005150|B1|United States||Region of Enrollment||participants|Number|659|659.0||||||
4182954|NCT00790062|4005147|B4|Other (not specified)||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4182955|NCT00790062|4005148|B3|Other (not specified)||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4182956|NCT00790062|4005149|B2|Other (not specified)||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4182957|NCT00790062|4005150|B1|Other (not specified)||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4182958|NCT00790062|4005147|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|327|327.0||||||
4182959|NCT00790062|4005148|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|120|120.0||||||
4182960|NCT00790062|4005149|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|101|101.0||||||
4182961|NCT00790062|4005150|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|106|106.0||||||
4182962|NCT00790062|4005147|B4|African American||Race/Ethnicity, Customized||participants|Number|1061|1061.0||||||
4182963|NCT00790062|4005148|B3|African American||Race/Ethnicity, Customized||participants|Number|379|379.0||||||
4182964|NCT00790062|4005149|B2|African American||Race/Ethnicity, Customized||participants|Number|278|278.0||||||
4182965|NCT00790062|4005150|B1|African American||Race/Ethnicity, Customized||participants|Number|404|404.0||||||
4182966|NCT00790062|4005147|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|396|396.0||||||
4182967|NCT00790062|4005148|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|156|156.0||||||
4182968|NCT00790062|4005149|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|97|97.0||||||
4182969|NCT00790062|4005150|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|143|143.0||||||
4182970|NCT00790062|4005147|B4|Female||Sex/Gender, Customized||participants|Number|1798|1798.0||||||
4182971|NCT00790062|4005148|B3|Female||Sex/Gender, Customized||participants|Number|658|658.0||||||
4182972|NCT00790062|4005149|B2|Female||Sex/Gender, Customized||participants|Number|481|481.0||||||
4182973|NCT00790062|4005150|B1|Female||Sex/Gender, Customized||participants|Number|659|659.0||||||
4182974|NCT00790062|4005147|B4|Age (years)||Age||years|Mean|24.2|24.2|Standard Deviation|5.4|5.4|||
4182975|NCT00790062|4005148|B3|Age (years)||Age||years|Mean|24.4|24.4|Standard Deviation|5.5|5.5|||
4182976|NCT00790062|4005149|B2|Age (years)||Age||years|Mean|23.9|23.9|Standard Deviation|5.1|5.1|||
4182977|NCT00790062|4005150|B1|Age (years)||Age||years|Mean|23.9|23.9|Standard Deviation|5.4|5.4|||
4182978|NCT00790036|4005181|B3||Male|Sex: Female, Male||Participants|Count of Participants|372|372.0||||||
4182979|NCT00790036|4005182|B2||Male|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4182980|NCT00790036|4005183|B1||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4182981|NCT00790036|4005181|B3||Female|Sex: Female, Male||Participants|Count of Participants|370|370.0||||||
4182982|NCT00790036|4005182|B2||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4182983|NCT00790036|4005183|B1||Female|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4182984|NCT00790036|4005181|B3|||Age||Years|Mean|60.7|60.7|Standard Deviation|13.66|13.66|||
4182985|NCT00790036|4005182|B2|||Age||Years|Mean|60.9|60.9|Standard Deviation|13.61|13.61|||
4182986|NCT00790036|4005183|B1|||Age||Years|Mean|60.6|60.6|Standard Deviation|13.72|13.72|||
4182987|NCT00790023|4005195|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|387|387.0||||||
4182988|NCT00790023|4005196|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
4182989|NCT00790023|4005197|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|133|133.0||||||
4182994|NCT00790023|4005198|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|109|109.0||||||
4182995|NCT00790023|4005195|B4|||Baseline Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) in subject with RQLQ(S) score ≥3.|RQLQ(S)consists of 28 questions, each question measured on a scale of 0-6 where a higher score indicates poor quality of life. Domains: Activities (questions 1-3), Sleep (questions 4-6), Non-Nose/Eye Symptoms (questions 7-13), Practical Problems (questions 14-16), Nasal Symptoms (questions 17-20), Eye Symptoms (questions 21-24), and Emotional (questions 25-28). The overall RQLQ(S) score was calculated as the average of the mean domain scores.|units on a scale|Mean|4.48|4.48|Standard Deviation|0.79|0.79|||
4182996|NCT00790023|4005196|B3|||Baseline Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) in subject with RQLQ(S) score ≥3.|RQLQ(S)consists of 28 questions, each question measured on a scale of 0-6 where a higher score indicates poor quality of life. Domains: Activities (questions 1-3), Sleep (questions 4-6), Non-Nose/Eye Symptoms (questions 7-13), Practical Problems (questions 14-16), Nasal Symptoms (questions 17-20), Eye Symptoms (questions 21-24), and Emotional (questions 25-28). The overall RQLQ(S) score was calculated as the average of the mean domain scores.|units on a scale|Mean|4.43|4.43|Standard Deviation|0.83|0.83|||
4182997|NCT00790023|4005197|B2|||Baseline Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) in subject with RQLQ(S) score ≥3.|RQLQ(S)consists of 28 questions, each question measured on a scale of 0-6 where a higher score indicates poor quality of life. Domains: Activities (questions 1-3), Sleep (questions 4-6), Non-Nose/Eye Symptoms (questions 7-13), Practical Problems (questions 14-16), Nasal Symptoms (questions 17-20), Eye Symptoms (questions 21-24), and Emotional (questions 25-28). The overall RQLQ(S) score was calculated as the average of the mean domain scores.|units on a scale|Mean|4.49|4.49|Standard Deviation|0.78|0.78|||
4182998|NCT00790023|4005198|B1|||Baseline Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) in subject with RQLQ(S) score ≥3.|RQLQ(S)consists of 28 questions, each question measured on a scale of 0-6 where a higher score indicates poor quality of life. Domains: Activities (questions 1-3), Sleep (questions 4-6), Non-Nose/Eye Symptoms (questions 7-13), Practical Problems (questions 14-16), Nasal Symptoms (questions 17-20), Eye Symptoms (questions 21-24), and Emotional (questions 25-28). The overall RQLQ(S) score was calculated as the average of the mean domain scores.|units on a scale|Mean|4.52|4.52|Standard Deviation|0.77|0.77|||
4182999|NCT00790023|4005195|B4|||Baseline Instantaneous Total Ocular Symptoms Scores (iTOSS)] for Onset of Nasal Improvement|Baseline is the last non-missing instantaneous AM assessment on or before Day 1. Onset of nasal improvement is defined as the first assessment at which instantaneous TNSS for active treatment demonstrates an improvement over placebo from baseline with one-sided p-value of <= 0.025.|Hours|Mean|6.95|6.95|Standard Deviation|1.62|1.62|||
4183000|NCT00790023|4005196|B3|||Baseline Instantaneous Total Ocular Symptoms Scores (iTOSS)] for Onset of Nasal Improvement|Baseline is the last non-missing instantaneous AM assessment on or before Day 1. Onset of nasal improvement is defined as the first assessment at which instantaneous TNSS for active treatment demonstrates an improvement over placebo from baseline with one-sided p-value of <= 0.025.|Hours|Mean|6.98|6.98|Standard Deviation|1.60|1.6|||
4183001|NCT00790023|4005197|B2|||Baseline Instantaneous Total Ocular Symptoms Scores (iTOSS)] for Onset of Nasal Improvement|Baseline is the last non-missing instantaneous AM assessment on or before Day 1. Onset of nasal improvement is defined as the first assessment at which instantaneous TNSS for active treatment demonstrates an improvement over placebo from baseline with one-sided p-value of <= 0.025.|Hours|Mean|7.02|7.02|Standard Deviation|1.54|1.54|||
4183002|NCT00790023|4005198|B1|||Baseline Instantaneous Total Ocular Symptoms Scores (iTOSS)] for Onset of Nasal Improvement|Baseline is the last non-missing instantaneous AM assessment on or before Day 1. Onset of nasal improvement is defined as the first assessment at which instantaneous TNSS for active treatment demonstrates an improvement over placebo from baseline with one-sided p-value of <= 0.025.|Hours|Mean|6.85|6.85|Standard Deviation|1.72|1.72|||
4183003|NCT00790023|4005195|B4|AM and PM Tearing Eyes||Baseline individual instantaneous ocular symtom score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on scale|Mean|2.23|2.23|Standard Deviation|0.47|0.47|||
4183004|NCT00790023|4005196|B3|AM and PM Tearing Eyes||Baseline individual instantaneous ocular symtom score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on scale|Mean|2.26|2.26|Standard Deviation|0.51|0.51|||
4183005|NCT00790023|4005197|B2|AM and PM Tearing Eyes||Baseline individual instantaneous ocular symtom score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on scale|Mean|2.23|2.23|Standard Deviation|0.45|0.45|||
4183006|NCT00790023|4005198|B1|AM and PM Tearing Eyes||Baseline individual instantaneous ocular symtom score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on scale|Mean|2.21|2.21|Standard Deviation|0.47|0.47|||
4183273|NCT00789997|4005288|B3|||Age||years|Mean|67.1|67.1|Standard Deviation|9.3|9.3|||
4183007|NCT00790023|4005195|B4|AM and PM Redness of Eyes||Baseline individual instantaneous ocular symtom score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on scale|Mean|2.25|2.25|Standard Deviation|0.51|0.51|||
4183008|NCT00790023|4005196|B3|AM and PM Redness of Eyes||Baseline individual instantaneous ocular symtom score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on scale|Mean|2.32|2.32|Standard Deviation|0.51|0.51|||
4183009|NCT00790023|4005197|B2|AM and PM Redness of Eyes||Baseline individual instantaneous ocular symtom score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on scale|Mean|2.27|2.27|Standard Deviation|0.49|0.49|||
4183010|NCT00790023|4005198|B1|AM and PM Redness of Eyes||Baseline individual instantaneous ocular symtom score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on scale|Mean|2.17|2.17|Standard Deviation|0.54|0.54|||
4183011|NCT00790023|4005195|B4|AM and PM Itching Eyes||Baseline individual instantaneous ocular symtom score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on scale|Mean|2.42|2.42|Standard Deviation|0.42|0.42|||
4183012|NCT00790023|4005196|B3|AM and PM Itching Eyes||Baseline individual instantaneous ocular symtom score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on scale|Mean|2.43|2.43|Standard Deviation|0.45|0.45|||
4183013|NCT00790023|4005197|B2|AM and PM Itching Eyes||Baseline individual instantaneous ocular symtom score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on scale|Mean|2.42|2.42|Standard Deviation|0.43|0.43|||
4183014|NCT00790023|4005198|B1|AM and PM Itching Eyes||Baseline individual instantaneous ocular symtom score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on scale|Mean|2.41|2.41|Standard Deviation|0.38|0.38|||
4183015|NCT00790023|4005195|B4|PM Tearing Eyes||Baseline individual instantaneous ocular symtom score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on scale|Mean|2.18|2.18|Standard Deviation|0.52|0.52|||
4183016|NCT00790023|4005196|B3|PM Tearing Eyes||Baseline individual instantaneous ocular symtom score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on scale|Mean|2.19|2.19|Standard Deviation|0.56|0.56|||
4183274|NCT00789997|4005289|B2|||Age||years|Mean|65.1|65.1|Standard Deviation|9.7|9.7|||
4183275|NCT00789997|4005290|B1|||Age||years|Mean|69.0|69.0|Standard Deviation|8.6|8.6|||
4183017|NCT00790023|4005197|B2|PM Tearing Eyes||Baseline individual instantaneous ocular symtom score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on scale|Mean|2.19|2.19|Standard Deviation|0.49|0.49|||
4183018|NCT00790023|4005198|B1|PM Tearing Eyes||Baseline individual instantaneous ocular symtom score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on scale|Mean|2.17|2.17|Standard Deviation|0.52|0.52|||
4183019|NCT00790023|4005195|B4|PM Redness of Eyes||Baseline individual instantaneous ocular symtom score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on scale|Mean|2.20|2.2|Standard Deviation|0.55|0.55|||
4183020|NCT00790023|4005196|B3|PM Redness of Eyes||Baseline individual instantaneous ocular symtom score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on scale|Mean|2.28|2.28|Standard Deviation|0.55|0.55|||
4183021|NCT00790023|4005197|B2|PM Redness of Eyes||Baseline individual instantaneous ocular symtom score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on scale|Mean|2.22|2.22|Standard Deviation|0.52|0.52|||
4183022|NCT00790023|4005198|B1|PM Redness of Eyes||Baseline individual instantaneous ocular symtom score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on scale|Mean|2.12|2.12|Standard Deviation|0.58|0.58|||
4183023|NCT00790023|4005195|B4|PM Itching Eyes||Baseline individual instantaneous ocular symtom score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on scale|Mean|2.39|2.39|Standard Deviation|0.46|0.46|||
4183024|NCT00790023|4005196|B3|PM Itching Eyes||Baseline individual instantaneous ocular symtom score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on scale|Mean|2.39|2.39|Standard Deviation|0.49|0.49|||
4183025|NCT00790023|4005197|B2|PM Itching Eyes||Baseline individual instantaneous ocular symtom score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on scale|Mean|2.40|2.4|Standard Deviation|0.47|0.47|||
4183026|NCT00790023|4005198|B1|PM Itching Eyes||Baseline individual instantaneous ocular symtom score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on scale|Mean|2.38|2.38|Standard Deviation|0.41|0.41|||
4183276|NCT00789958|4005299|B1|Microscopically positive (R1)||Margin of Resection||participants|Number|25|25.0||||||
4183277|NCT00789958|4005299|B1|Negative (R0)||Margin of Resection||participants|Number|54|54.0||||||
4183027|NCT00790023|4005195|B4|AM Tearing Eyes||Baseline individual instantaneous ocular symtom score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on scale|Mean|2.28|2.28|Standard Deviation|0.51|0.51|||
4183028|NCT00790023|4005196|B3|AM Tearing Eyes||Baseline individual instantaneous ocular symtom score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on scale|Mean|2.33|2.33|Standard Deviation|0.54|0.54|||
4183029|NCT00790023|4005197|B2|AM Tearing Eyes||Baseline individual instantaneous ocular symtom score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on scale|Mean|2.27|2.27|Standard Deviation|0.48|0.48|||
4183030|NCT00790023|4005198|B1|AM Tearing Eyes||Baseline individual instantaneous ocular symtom score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on scale|Mean|2.25|2.25|Standard Deviation|0.50|0.5|||
4183031|NCT00790023|4005195|B4|AM Redness of Eyes||Baseline individual instantaneous ocular symtom score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on scale|Mean|2.30|2.3|Standard Deviation|0.53|0.53|||
4183032|NCT00790023|4005196|B3|AM Redness of Eyes||Baseline individual instantaneous ocular symtom score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on scale|Mean|2.36|2.36|Standard Deviation|0.52|0.52|||
4183033|NCT00790023|4005197|B2|AM Redness of Eyes||Baseline individual instantaneous ocular symtom score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on scale|Mean|2.32|2.32|Standard Deviation|0.51|0.51|||
4183034|NCT00790023|4005198|B1|AM Redness of Eyes||Baseline individual instantaneous ocular symtom score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on scale|Mean|2.22|2.22|Standard Deviation|0.56|0.56|||
4183035|NCT00790023|4005195|B4|AM Itching Eyes||Baseline individual instantaneous ocular symtom score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on scale|Mean|2.45|2.45|Standard Deviation|0.45|0.45|||
4183036|NCT00790023|4005196|B3|AM Itching Eyes||Baseline individual instantaneous ocular symtom score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on scale|Mean|2.48|2.48|Standard Deviation|0.45|0.45|||
4183278|NCT00789958|4005299|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4183279|NCT00789958|4005299|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4183037|NCT00790023|4005197|B2|AM Itching Eyes||Baseline individual instantaneous ocular symtom score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on scale|Mean|2.44|2.44|Standard Deviation|0.46|0.46|||
4183038|NCT00790023|4005198|B1|AM Itching Eyes||Baseline individual instantaneous ocular symtom score (iOSS) in subjects with (iTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Instantaneous OSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on scale|Mean|2.44|2.44|Standard Deviation|0.44|0.44|||
4183039|NCT00790023|4005195|B4|AM and PM Tearing Eyes||Baseline individual reflective ocular symptom score (rOSS) in subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on a scale|Median|2.27|2.27|Standard Deviation|0.47|0.47|||
4183040|NCT00790023|4005196|B3|AM and PM Tearing Eyes||Baseline individual reflective ocular symptom score (rOSS) in subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on a scale|Median|2.26|2.26|Standard Deviation|0.49|0.49|||
4183041|NCT00790023|4005197|B2|AM and PM Tearing Eyes||Baseline individual reflective ocular symptom score (rOSS) in subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on a scale|Median|2.29|2.29|Standard Deviation|0.44|0.44|||
4183042|NCT00790023|4005198|B1|AM and PM Tearing Eyes||Baseline individual reflective ocular symptom score (rOSS) in subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on a scale|Median|2.27|2.27|Standard Deviation|0.48|0.48|||
4183043|NCT00790023|4005195|B4|AM and PM Redness of Eyes||Baseline individual reflective ocular symptom score (rOSS) in subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on a scale|Median|2.22|2.22|Standard Deviation|0.53|0.53|||
4183044|NCT00790023|4005196|B3|AM and PM Redness of Eyes||Baseline individual reflective ocular symptom score (rOSS) in subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on a scale|Median|2.27|2.27|Standard Deviation|0.53|0.53|||
4183045|NCT00790023|4005197|B2|AM and PM Redness of Eyes||Baseline individual reflective ocular symptom score (rOSS) in subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on a scale|Median|2.25|2.25|Standard Deviation|0.50|0.5|||
4183046|NCT00790023|4005198|B1|AM and PM Redness of Eyes||Baseline individual reflective ocular symptom score (rOSS) in subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on a scale|Median|2.14|2.14|Standard Deviation|0.56|0.56|||
4183280|NCT00789958|4005299|B1||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4183047|NCT00790023|4005195|B4|AM and PM Itching Eyes||Baseline individual reflective ocular symptom score (rOSS) in subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on a scale|Median|2.46|2.46|Standard Deviation|0.42|0.42|||
4183048|NCT00790023|4005196|B3|AM and PM Itching Eyes||Baseline individual reflective ocular symptom score (rOSS) in subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on a scale|Median|2.42|2.42|Standard Deviation|0.45|0.45|||
4183049|NCT00790023|4005197|B2|AM and PM Itching Eyes||Baseline individual reflective ocular symptom score (rOSS) in subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on a scale|Median|2.47|2.47|Standard Deviation|0.44|0.44|||
4183050|NCT00790023|4005198|B1|AM and PM Itching Eyes||Baseline individual reflective ocular symptom score (rOSS) in subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on a scale|Median|2.48|2.48|Standard Deviation|0.39|0.39|||
4183051|NCT00790023|4005195|B4|PM Tearing Eyes||Baseline individual reflective ocular symptom score (rOSS) in subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on a scale|Median|2.28|2.28|Standard Deviation|0.48|0.48|||
4183052|NCT00790023|4005196|B3|PM Tearing Eyes||Baseline individual reflective ocular symptom score (rOSS) in subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on a scale|Median|2.26|2.26|Standard Deviation|0.50|0.5|||
4183053|NCT00790023|4005197|B2|PM Tearing Eyes||Baseline individual reflective ocular symptom score (rOSS) in subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on a scale|Median|2.31|2.31|Standard Deviation|0.46|0.46|||
4183054|NCT00790023|4005198|B1|PM Tearing Eyes||Baseline individual reflective ocular symptom score (rOSS) in subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on a scale|Median|2.28|2.28|Standard Deviation|0.50|0.5|||
4183055|NCT00790023|4005195|B4|PM Redness of Eyes||Baseline individual reflective ocular symptom score (rOSS) in subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on a scale|Median|2.22|2.22|Standard Deviation|0.54|0.54|||
4183056|NCT00790023|4005196|B3|PM Redness of Eyes||Baseline individual reflective ocular symptom score (rOSS) in subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on a scale|Median|2.28|2.28|Standard Deviation|0.55|0.55|||
4183281|NCT00789958|4005299|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4183282|NCT00789958|4005299|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4183057|NCT00790023|4005197|B2|PM Redness of Eyes||Baseline individual reflective ocular symptom score (rOSS) in subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on a scale|Median|2.25|2.25|Standard Deviation|0.50|0.5|||
4183058|NCT00790023|4005198|B1|PM Redness of Eyes||Baseline individual reflective ocular symptom score (rOSS) in subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on a scale|Median|2.15|2.15|Standard Deviation|0.57|0.57|||
4183059|NCT00790023|4005195|B4|PM Itching of Eyes||Baseline individual reflective ocular symptom score (rOSS) in subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on a scale|Median|2.46|2.46|Standard Deviation|0.43|0.43|||
4183060|NCT00790023|4005196|B3|PM Itching of Eyes||Baseline individual reflective ocular symptom score (rOSS) in subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on a scale|Median|2.42|2.42|Standard Deviation|0.45|0.45|||
4183061|NCT00790023|4005197|B2|PM Itching of Eyes||Baseline individual reflective ocular symptom score (rOSS) in subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on a scale|Median|2.48|2.48|Standard Deviation|0.43|0.43|||
4183062|NCT00790023|4005198|B1|PM Itching of Eyes||Baseline individual reflective ocular symptom score (rOSS) in subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on a scale|Median|2.47|2.47|Standard Deviation|0.40|0.4|||
4183063|NCT00790023|4005195|B4|AM Tearing Eyes||Baseline individual reflective ocular symptom score (rOSS) in subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on a scale|Median|2.27|2.27|Standard Deviation|0.51|0.51|||
4183064|NCT00790023|4005196|B3|AM Tearing Eyes||Baseline individual reflective ocular symptom score (rOSS) in subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on a scale|Median|2.27|2.27|Standard Deviation|0.53|0.53|||
4183065|NCT00790023|4005197|B2|AM Tearing Eyes||Baseline individual reflective ocular symptom score (rOSS) in subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on a scale|Median|2.27|2.27|Standard Deviation|0.48|0.48|||
4183066|NCT00790023|4005198|B1|AM Tearing Eyes||Baseline individual reflective ocular symptom score (rOSS) in subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on a scale|Median|2.26|2.26|Standard Deviation|0.52|0.52|||
4183283|NCT00789958|4005299|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4183284|NCT00789958|4005299|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4183067|NCT00790023|4005195|B4|AM Redness of Eyes||Baseline individual reflective ocular symptom score (rOSS) in subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on a scale|Median|2.22|2.22|Standard Deviation|0.56|0.56|||
4183068|NCT00790023|4005196|B3|AM Redness of Eyes||Baseline individual reflective ocular symptom score (rOSS) in subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on a scale|Median|2.25|2.25|Standard Deviation|0.55|0.55|||
4183069|NCT00790023|4005197|B2|AM Redness of Eyes||Baseline individual reflective ocular symptom score (rOSS) in subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on a scale|Median|2.26|2.26|Standard Deviation|0.53|0.53|||
4183070|NCT00790023|4005198|B1|AM Redness of Eyes||Baseline individual reflective ocular symptom score (rOSS) in subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on a scale|Median|2.14|2.14|Standard Deviation|0.59|0.59|||
4183071|NCT00790023|4005195|B4|AM Itching Eyes||Baseline individual reflective ocular symptom score (rOSS) in subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on a scale|Median|2.45|2.45|Standard Deviation|0.47|0.47|||
4183072|NCT00790023|4005196|B3|AM Itching Eyes||Baseline individual reflective ocular symptom score (rOSS) in subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on a scale|Median|2.42|2.42|Standard Deviation|0.49|0.49|||
4183073|NCT00790023|4005197|B2|AM Itching Eyes||Baseline individual reflective ocular symptom score (rOSS) in subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on a scale|Median|2.45|2.45|Standard Deviation|0.50|0.5|||
4183074|NCT00790023|4005198|B1|AM Itching Eyes||Baseline individual reflective ocular symptom score (rOSS) in subjects with (rTOSS) ≥5.0|"OSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective OSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization. rTOSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms)."|Units on a scale|Median|2.48|2.48|Standard Deviation|0.42|0.42|||
4183075|NCT00790023|4005195|B4|AM and PM Nasal Congestion||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.44|2.44|Standard Deviation|0.49|0.49|||
4183076|NCT00790023|4005196|B3|AM and PM Nasal Congestion||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.40|2.4|Standard Deviation|0.52|0.52|||
4183285|NCT00789958|4005299|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4183286|NCT00789958|4005299|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4183287|NCT00789958|4005299|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4183077|NCT00790023|4005197|B2|AM and PM Nasal Congestion||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.49|2.49|Standard Deviation|0.47|0.47|||
4183078|NCT00790023|4005198|B1|AM and PM Nasal Congestion||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.43|2.43|Standard Deviation|0.49|0.49|||
4183079|NCT00790023|4005195|B4|AM and PM Nasal Itching||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.21|2.21|Standard Deviation|0.61|0.61|||
4183080|NCT00790023|4005196|B3|AM and PM Nasal Itching||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.15|2.15|Standard Deviation|0.61|0.61|||
4183081|NCT00790023|4005197|B2|AM and PM Nasal Itching||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.27|2.27|Standard Deviation|0.60|0.6|||
4183082|NCT00790023|4005198|B1|AM and PM Nasal Itching||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.21|2.21|Standard Deviation|0.62|0.62|||
4183083|NCT00790023|4005195|B4|AM and PM Runny Nose||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.29|2.29|Standard Deviation|0.60|0.6|||
4183084|NCT00790023|4005196|B3|AM and PM Runny Nose||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.27|2.27|Standard Deviation|0.59|0.59|||
4183085|NCT00790023|4005197|B2|AM and PM Runny Nose||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.30|2.3|Standard Deviation|0.62|0.62|||
4183086|NCT00790023|4005198|B1|AM and PM Runny Nose||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.29|2.29|Standard Deviation|0.60|0.6|||
4183087|NCT00790023|4005195|B4|AM and PM Sneezing||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|1.80|1.8|Standard Deviation|0.83|0.83|||
4183088|NCT00790023|4005196|B3|AM and PM Sneezing||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|1.79|1.79|Standard Deviation|0.85|0.85|||
4183288|NCT00789958|4005299|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4183289|NCT00789958|4005299|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4183089|NCT00790023|4005197|B2|AM and PM Sneezing||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|1.88|1.88|Standard Deviation|0.78|0.78|||
4183090|NCT00790023|4005198|B1|AM and PM Sneezing||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|1.75|1.75|Standard Deviation|0.86|0.86|||
4183091|NCT00790023|4005195|B4|PM Nasal Congestion||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.36|2.36|Standard Deviation|0.55|0.55|||
4183092|NCT00790023|4005196|B3|PM Nasal Congestion||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.33|2.33|Standard Deviation|0.57|0.57|||
4183093|NCT00790023|4005197|B2|PM Nasal Congestion||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.39|2.39|Standard Deviation|0.53|0.53|||
4183094|NCT00790023|4005198|B1|PM Nasal Congestion||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.36|2.36|Standard Deviation|0.57|0.57|||
4183095|NCT00790023|4005195|B4|PM Nasal Itching||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.17|2.17|Standard Deviation|0.66|0.66|||
4183096|NCT00790023|4005196|B3|PM Nasal Itching||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.11|2.11|Standard Deviation|0.66|0.66|||
4183097|NCT00790023|4005197|B2|PM Nasal Itching||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.24|2.24|Standard Deviation|0.64|0.64|||
4183098|NCT00790023|4005198|B1|PM Nasal Itching||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.17|2.17|Standard Deviation|0.67|0.67|||
4183099|NCT00790023|4005195|B4|PM Runny Nose||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.24|2.24|Standard Deviation|0.65|0.65|||
4183100|NCT00790023|4005196|B3|PM Runny Nose||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.23|2.23|Standard Deviation|0.63|0.63|||
4183290|NCT00789958|4005299|B1|||Age||years|Median|62|62.0|Full Range|||26.0|86.0|
4183351|NCT00789880|4005316|B3|Olive Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|2|2.0||||||
4183101|NCT00790023|4005197|B2|PM Runny Nose||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.26|2.26|Standard Deviation|0.66|0.66|||
4183102|NCT00790023|4005198|B1|PM Runny Nose||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.23|2.23|Standard Deviation|0.66|0.66|||
4183103|NCT00790023|4005195|B4|PM Sneezing||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|1.83|1.83|Standard Deviation|0.84|0.84|||
4183104|NCT00790023|4005196|B3|PM Sneezing||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|1.81|1.81|Standard Deviation|0.86|0.86|||
4183105|NCT00790023|4005197|B2|PM Sneezing||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|1.92|1.92|Standard Deviation|0.79|0.79|||
4183106|NCT00790023|4005198|B1|PM Sneezing||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|1.77|1.77|Standard Deviation|0.85|0.85|||
4183107|NCT00790023|4005195|B4|AM Nasal Congestion||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.52|2.52|Standard Deviation|0.49|0.49|||
4183108|NCT00790023|4005196|B3|AM Nasal Congestion||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.47|2.47|Standard Deviation|0.52|0.52|||
4183109|NCT00790023|4005197|B2|AM Nasal Congestion||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.58|2.58|Standard Deviation|0.48|0.48|||
4183110|NCT00790023|4005198|B1|AM Nasal Congestion||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.50|2.5|Standard Deviation|0.48|0.48|||
4183111|NCT00790023|4005195|B4|AM Nasal Itching||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.24|2.24|Standard Deviation|0.62|0.62|||
4183112|NCT00790023|4005196|B3|AM Nasal Itching||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.18|2.18|Standard Deviation|0.61|0.61|||
4183320|NCT00789880|4005313|B6|||Serum Vitamin D 25-Hydroxy (ng/mL)|Measurement of the amount of Vitamin D in the blood. The normal range used for our study is between 20 and 80 ng/mL.|ng/mL|Mean|28.3|28.3|Standard Deviation|10.7|10.7|||
4183545|NCT00789815|4005484|B3||>=65 years|Age||Participants|Count of Participants|231|231.0||||||
4183113|NCT00790023|4005197|B2|AM Nasal Itching||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.30|2.3|Standard Deviation|0.61|0.61|||
4183114|NCT00790023|4005198|B1|AM Nasal Itching||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.26|2.26|Standard Deviation|0.62|0.62|||
4183115|NCT00790023|4005195|B4|AM Runny Nose||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.34|2.34|Standard Deviation|0.61|0.61|||
4183116|NCT00790023|4005196|B3|AM Runny Nose||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.32|2.32|Standard Deviation|0.61|0.61|||
4183117|NCT00790023|4005197|B2|AM Runny Nose||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.35|2.35|Standard Deviation|0.64|0.64|||
4183118|NCT00790023|4005198|B1|AM Runny Nose||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.35|2.35|Standard Deviation|0.59|0.59|||
4183119|NCT00790023|4005195|B4|AM Sneezing||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|1.77|1.77|Standard Deviation|0.88|0.88|||
4183120|NCT00790023|4005196|B3|AM Sneezing||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|1.77|1.77|Standard Deviation|0.89|0.89|||
4183121|NCT00790023|4005197|B2|AM Sneezing||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|1.83|1.83|Standard Deviation|0.83|0.83|||
4183122|NCT00790023|4005198|B1|AM Sneezing||Baseline instantaneous nasal symptom score (iNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where: 0 = absent (no sign/symptom evident);~= mild~= moderate~= severe Instantaneous NSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|1.72|1.72|Standard Deviation|0.91|0.91|||
4183123|NCT00790023|4005195|B4|AM and PM Nasal Congestion||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.51|2.51|Standard Deviation|0.46|0.46|||
4183124|NCT00790023|4005196|B3|AM and PM Nasal Congestion||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.45|2.45|Standard Deviation|0.50|0.5|||
4183291|NCT00789880|4005312|B7|||Total Serum Immunoglobulin E (IgE)|Total amount of IgE in the blood, which is a measurement of allergen sensitization. Higher IgE is indicative of greater allergen sensitization. There is no “normal” level for total serum IgE since a wide overlap exists between the total serum IgE in healthy non-allergic and allergic individuals.|kU/L|Mean|553.3|553.3|Standard Deviation|1825.2|1825.2|||
4183125|NCT00790023|4005197|B2|AM and PM Nasal Congestion||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.56|2.56|Standard Deviation|0.43|0.43|||
4183126|NCT00790023|4005198|B1|AM and PM Nasal Congestion||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.53|2.53|Standard Deviation|0.44|0.44|||
4183127|NCT00790023|4005195|B4|AM and PM Nasal Itching||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.30|2.3|Standard Deviation|0.57|0.57|||
4183128|NCT00790023|4005196|B3|AM and PM Nasal Itching||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.23|2.23|Standard Deviation|0.59|0.59|||
4183129|NCT00790023|4005197|B2|AM and PM Nasal Itching||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.36|2.36|Standard Deviation|0.53|0.53|||
4183130|NCT00790023|4005198|B1|AM and PM Nasal Itching||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.32|2.32|Standard Deviation|0.58|0.58|||
4183131|NCT00790023|4005195|B4|AM and PM Runny Nose||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.39|2.39|Standard Deviation|0.55|0.55|||
4183132|NCT00790023|4005196|B3|AM and PM Runny Nose||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.36|2.36|Standard Deviation|0.56|0.56|||
4183133|NCT00790023|4005197|B2|AM and PM Runny Nose||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.40|2.4|Standard Deviation|0.55|0.55|||
4183134|NCT00790023|4005198|B1|AM and PM Runny Nose||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.41|2.41|Standard Deviation|0.55|0.55|||
4183135|NCT00790023|4005195|B4|AM and PM Sneezing||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.08|2.08|Standard Deviation|0.65|0.65|||
4183136|NCT00790023|4005196|B3|AM and PM Sneezing||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.05|2.05|Standard Deviation|0.65|0.65|||
4183137|NCT00790023|4005197|B2|AM and PM Sneezing||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.14|2.14|Standard Deviation|0.59|0.59|||
4183546|NCT00789815|4005485|B2||>=65 years|Age||Participants|Count of Participants|125|125.0||||||
4183138|NCT00790023|4005198|B1|AM and PM Sneezing||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.05|2.05|Standard Deviation|0.69|0.69|||
4183139|NCT00790023|4005195|B4|PM Nasal Congestion||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.48|2.48|Standard Deviation|0.51|0.51|||
4183140|NCT00790023|4005196|B3|PM Nasal Congestion||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.42|2.42|Standard Deviation|0.53|0.53|||
4183141|NCT00790023|4005197|B2|PM Nasal Congestion||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.52|2.52|Standard Deviation|0.48|0.48|||
4183142|NCT00790023|4005198|B1|PM Nasal Congestion||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.49|2.49|Standard Deviation|0.51|0.51|||
4183143|NCT00790023|4005195|B4|PM Nasal Itching||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.31|2.31|Standard Deviation|0.59|0.59|||
4183144|NCT00790023|4005196|B3|PM Nasal Itching||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.25|2.25|Standard Deviation|0.62|0.62|||
4183145|NCT00790023|4005197|B2|PM Nasal Itching||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.36|2.36|Standard Deviation|0.54|0.54|||
4183146|NCT00790023|4005198|B1|PM Nasal Itching||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.32|2.32|Standard Deviation|0.61|0.61|||
4183147|NCT00790023|4005195|B4|PM Runny Nose||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.38|2.38|Standard Deviation|0.58|0.58|||
4183148|NCT00790023|4005196|B3|PM Runny Nose||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.35|2.35|Standard Deviation|0.58|0.58|||
4183149|NCT00790023|4005197|B2|PM Runny Nose||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.39|2.39|Standard Deviation|0.58|0.58|||
4183150|NCT00790023|4005198|B1|PM Runny Nose||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.39|2.39|Standard Deviation|0.59|0.59|||
4183410|NCT00789880|4005312|B7|Other||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|9|9.0||||||
4183151|NCT00790023|4005195|B4|PM Sneezing||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.12|2.12|Standard Deviation|0.65|0.65|||
4183152|NCT00790023|4005196|B3|PM Sneezing||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.11|2.11|Standard Deviation|0.64|0.64|||
4183153|NCT00790023|4005197|B2|PM Sneezing||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.17|2.17|Standard Deviation|0.61|0.61|||
4183154|NCT00790023|4005198|B1|PM Sneezing||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.08|2.08|Standard Deviation|0.69|0.69|||
4183155|NCT00790023|4005195|B4|AM Nasal Congestion||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.55|2.55|Standard Deviation|0.46|0.46|||
4183156|NCT00790023|4005196|B3|AM Nasal Congestion||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.48|2.48|Standard Deviation|0.50|0.5|||
4183157|NCT00790023|4005197|B2|AM Nasal Congestion||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.60|2.6|Standard Deviation|0.43|0.43|||
4183158|NCT00790023|4005198|B1|AM Nasal Congestion||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.57|2.57|Standard Deviation|0.43|0.43|||
4183159|NCT00790023|4005195|B4|AM Nasal Itching||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.30|2.3|Standard Deviation|0.58|0.58|||
4183160|NCT00790023|4005196|B3|AM Nasal Itching||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.22|2.22|Standard Deviation|0.61|0.61|||
4183161|NCT00790023|4005197|B2|AM Nasal Itching||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.35|2.35|Standard Deviation|0.54|0.54|||
4183162|NCT00790023|4005198|B1|AM Nasal Itching||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.33|2.33|Standard Deviation|0.59|0.59|||
4183163|NCT00790023|4005195|B4|AM Runny Nose||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.41|2.41|Standard Deviation|0.56|0.56|||
4183411|NCT00789880|4005313|B6|Other||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|1|1.0||||||
4183164|NCT00790023|4005196|B3|AM Runny Nose||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.37|2.37|Standard Deviation|0.57|0.57|||
4183165|NCT00790023|4005197|B2|AM Runny Nose||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.41|2.41|Standard Deviation|0.56|0.56|||
4183166|NCT00790023|4005198|B1|AM Runny Nose||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.44|2.44|Standard Deviation|0.55|0.55|||
4183167|NCT00790023|4005195|B4|AM Sneezing||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.04|2.04|Standard Deviation|0.69|0.69|||
4183168|NCT00790023|4005196|B3|AM Sneezing||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.00|2.0|Standard Deviation|0.71|0.71|||
4183169|NCT00790023|4005197|B2|AM Sneezing||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.11|2.11|Standard Deviation|0.62|0.62|||
4183170|NCT00790023|4005198|B1|AM Sneezing||Baseline reflective nasal symptom score (rNSS)|"NSS is the assessment of the individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Reflective NSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|2.02|2.02|Standard Deviation|0.73|0.73|||
4183171|NCT00790023|4005195|B4|AM and PM||Baseline instantaneous total ocular symptom score (iTOSS) in subjects with (iTOSS) ≥5.0|"TOSS is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TOSS symptom scores assess symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|6.90|6.9|Standard Deviation|1.15|1.15|||
4183172|NCT00790023|4005196|B3|AM and PM||Baseline instantaneous total ocular symptom score (iTOSS) in subjects with (iTOSS) ≥5.0|"TOSS is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TOSS symptom scores assess symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|7.01|7.01|Standard Deviation|1.19|1.19|||
4183173|NCT00790023|4005197|B2|AM and PM||Baseline instantaneous total ocular symptom score (iTOSS) in subjects with (iTOSS) ≥5.0|"TOSS is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TOSS symptom scores assess symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|6.92|6.92|Standard Deviation|1.11|1.11|||
4183174|NCT00790023|4005198|B1|AM and PM||Baseline instantaneous total ocular symptom score (iTOSS) in subjects with (iTOSS) ≥5.0|"TOSS is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TOSS symptom scores assess symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|6.79|6.79|Standard Deviation|1.14|1.14|||
4183175|NCT00790023|4005195|B4|PM||Baseline instantaneous total ocular symptom score (iTOSS) in subjects with (iTOSS) ≥5.0|"TOSS is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TOSS symptom scores assess symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|6.78|6.78|Standard Deviation|1.29|1.29|||
4183176|NCT00790023|4005196|B3|PM||Baseline instantaneous total ocular symptom score (iTOSS) in subjects with (iTOSS) ≥5.0|"TOSS is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TOSS symptom scores assess symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|6.86|6.86|Standard Deviation|1.35|1.35|||
4183177|NCT00790023|4005197|B2|PM||Baseline instantaneous total ocular symptom score (iTOSS) in subjects with (iTOSS) ≥5.0|"TOSS is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TOSS symptom scores assess symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|6.81|6.81|Standard Deviation|1.24|1.24|||
4183178|NCT00790023|4005198|B1|PM||Baseline instantaneous total ocular symptom score (iTOSS) in subjects with (iTOSS) ≥5.0|"TOSS is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TOSS symptom scores assess symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|6.67|6.67|Standard Deviation|1.29|1.29|||
4183179|NCT00790023|4005195|B4|AM||Baseline instantaneous total ocular symptom score (iTOSS) in subjects with (iTOSS) ≥5.0|"TOSS is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TOSS symptom scores assess symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|7.03|7.03|Standard Deviation|1.18|1.18|||
4183180|NCT00790023|4005196|B3|AM||Baseline instantaneous total ocular symptom score (iTOSS) in subjects with (iTOSS) ≥5.0|"TOSS is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TOSS symptom scores assess symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|7.17|7.17|Standard Deviation|1.19|1.19|||
4183181|NCT00790023|4005197|B2|AM||Baseline instantaneous total ocular symptom score (iTOSS) in subjects with (iTOSS) ≥5.0|"TOSS is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TOSS symptom scores assess symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|7.04|7.04|Standard Deviation|1.16|1.16|||
4183182|NCT00790023|4005198|B1|AM||Baseline instantaneous total ocular symptom score (iTOSS) in subjects with (iTOSS) ≥5.0|"TOSS is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TOSS symptom scores assess symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|6.91|6.91|Standard Deviation|1.19|1.19|||
4183183|NCT00790023|4005195|B4|AM and PM||Baseline reflective total ocular symptom score (rTOSS) in subjects with (rTOSS) ≥5.0|"Total Ocular Symptom Score(TOSS) is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TOSS symptom scores assess symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|6.95|6.95|Standard Deviation|1.18|1.18|||
4183184|NCT00790023|4005196|B3|AM and PM||Baseline reflective total ocular symptom score (rTOSS) in subjects with (rTOSS) ≥5.0|"Total Ocular Symptom Score(TOSS) is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TOSS symptom scores assess symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|6.95|6.95|Standard Deviation|1.23|1.23|||
4183185|NCT00790023|4005197|B2|AM and PM||Baseline reflective total ocular symptom score (rTOSS) in subjects with (rTOSS) ≥5.0|"Total Ocular Symptom Score(TOSS) is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TOSS symptom scores assess symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|7.01|7.01|Standard Deviation|1.11|1.11|||
4183292|NCT00789880|4005313|B6|||Total Serum Immunoglobulin E (IgE)|Total amount of IgE in the blood, which is a measurement of allergen sensitization. Higher IgE is indicative of greater allergen sensitization. There is no “normal” level for total serum IgE since a wide overlap exists between the total serum IgE in healthy non-allergic and allergic individuals.|kU/L|Mean|69.7|69.7|Standard Deviation|109.0|109.0|||
4183186|NCT00790023|4005198|B1|AM and PM||Baseline reflective total ocular symptom score (rTOSS) in subjects with (rTOSS) ≥5.0|"Total Ocular Symptom Score(TOSS) is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TOSS symptom scores assess symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|6.89|6.89|Standard Deviation|1.19|1.19|||
4183187|NCT00790023|4005195|B4|PM||Baseline reflective total ocular symptom score (rTOSS) in subjects with (rTOSS) ≥5.0|"Total Ocular Symptom Score(TOSS) is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TOSS symptom scores assess symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|6.97|6.97|Standard Deviation|1.21|1.21|||
4183188|NCT00790023|4005196|B3|PM||Baseline reflective total ocular symptom score (rTOSS) in subjects with (rTOSS) ≥5.0|"Total Ocular Symptom Score(TOSS) is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TOSS symptom scores assess symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|6.96|6.96|Standard Deviation|1.25|1.25|||
4183189|NCT00790023|4005197|B2|PM||Baseline reflective total ocular symptom score (rTOSS) in subjects with (rTOSS) ≥5.0|"Total Ocular Symptom Score(TOSS) is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TOSS symptom scores assess symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|7.04|7.04|Standard Deviation|1.13|1.13|||
4183190|NCT00790023|4005198|B1|PM||Baseline reflective total ocular symptom score (rTOSS) in subjects with (rTOSS) ≥5.0|"Total Ocular Symptom Score(TOSS) is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TOSS symptom scores assess symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|6.90|6.9|Standard Deviation|1.24|1.24|||
4183191|NCT00790023|4005195|B4|AM||Baseline reflective total ocular symptom score (rTOSS) in subjects with (rTOSS) ≥5.0|"Total Ocular Symptom Score(TOSS) is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TOSS symptom scores assess symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|6.94|6.94|Standard Deviation|1.27|1.27|||
4183192|NCT00790023|4005196|B3|AM||Baseline reflective total ocular symptom score (rTOSS) in subjects with (rTOSS) ≥5.0|"Total Ocular Symptom Score(TOSS) is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TOSS symptom scores assess symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|6.95|6.95|Standard Deviation|1.33|1.33|||
4183193|NCT00790023|4005197|B2|AM||Baseline reflective total ocular symptom score (rTOSS) in subjects with (rTOSS) ≥5.0|"Total Ocular Symptom Score(TOSS) is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TOSS symptom scores assess symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|6.98|6.98|Standard Deviation|1.22|1.22|||
4183194|NCT00790023|4005198|B1|AM||Baseline reflective total ocular symptom score (rTOSS) in subjects with (rTOSS) ≥5.0|"Total Ocular Symptom Score(TOSS) is the sum of individual ocular symptoms of itching, tearing, and redness. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe Therefore, TOSS ranges from 0-9 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TOSS symptom scores assess symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|6.89|6.89|Standard Deviation|1.27|1.27|||
4183195|NCT00790023|4005195|B4|AM and PM||Baseline instantaneous total nasal symptom score (iTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe. Therefore, iTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TNSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|8.74|8.74|Standard Deviation|2.04|2.04|||
4183319|NCT00789880|4005312|B7|||Serum Vitamin D 25-Hydroxy (ng/mL)|Measurement of the amount of Vitamin D in the blood. The normal range used for our study is between 20 and 80 ng/mL.|ng/mL|Mean|29.2|29.2|Standard Deviation|11.2|11.2|||
4183412|NCT00789880|4005314|B5|Other||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|1|1.0||||||
4183196|NCT00790023|4005196|B3|AM and PM||Baseline instantaneous total nasal symptom score (iTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe. Therefore, iTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TNSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|8.61|8.61|Standard Deviation|2.06|2.06|||
4183197|NCT00790023|4005197|B2|AM and PM||Baseline instantaneous total nasal symptom score (iTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe. Therefore, iTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TNSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|8.94|8.94|Standard Deviation|2.00|2.0|||
4183198|NCT00790023|4005198|B1|AM and PM||Baseline instantaneous total nasal symptom score (iTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe. Therefore, iTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TNSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|8.68|8.68|Standard Deviation|2.05|2.05|||
4183199|NCT00790023|4005195|B4|PM||Baseline instantaneous total nasal symptom score (iTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe. Therefore, iTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TNSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|8.61|8.61|Standard Deviation|2.19|2.19|||
4183200|NCT00790023|4005196|B3|PM||Baseline instantaneous total nasal symptom score (iTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe. Therefore, iTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TNSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|8.48|8.48|Standard Deviation|2.21|2.21|||
4183201|NCT00790023|4005197|B2|PM||Baseline instantaneous total nasal symptom score (iTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe. Therefore, iTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TNSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|8.82|8.82|Standard Deviation|2.14|2.14|||
4183202|NCT00790023|4005198|B1|PM||Baseline instantaneous total nasal symptom score (iTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe. Therefore, iTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TNSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|8.53|8.53|Standard Deviation|2.22|2.22|||
4183203|NCT00790023|4005195|B4|AM||Baseline instantaneous total nasal symptom score (iTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe. Therefore, iTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TNSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|8.87|8.87|Standard Deviation|2.03|2.03|||
4183204|NCT00790023|4005196|B3|AM||Baseline instantaneous total nasal symptom score (iTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe. Therefore, iTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TNSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|8.74|8.74|Standard Deviation|2.05|2.05|||
4183205|NCT00790023|4005197|B2|AM||Baseline instantaneous total nasal symptom score (iTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe. Therefore, iTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TNSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|9.05|9.05|Standard Deviation|2.02|2.02|||
4183206|NCT00790023|4005198|B1|AM||Baseline instantaneous total nasal symptom score (iTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe. Therefore, iTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Instantaneous TNSS measures these symptoms over the previous 10 minute time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|8.83|8.83|Standard Deviation|2.03|2.03|||
4183207|NCT00790023|4005195|B4|AM and PM||Baseline reflective total nasal symptom score (rTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe. Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|9.29|9.29|Standard Deviation|1.75|1.75|||
4183208|NCT00790023|4005196|B3|AM and PM||Baseline reflective total nasal symptom score (rTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe. Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|9.10|9.1|Standard Deviation|1.80|1.8|||
4183209|NCT00790023|4005197|B2|AM and PM||Baseline reflective total nasal symptom score (rTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe. Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|9.46|9.46|Standard Deviation|1.67|1.67|||
4183210|NCT00790023|4005198|B1|AM and PM||Baseline reflective total nasal symptom score (rTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe. Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|9.32|9.32|Standard Deviation|1.77|1.77|||
4183211|NCT00790023|4005195|B4|PM||Baseline reflective total nasal symptom score (rTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe. Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|9.28|9.28|Standard Deviation|1.87|1.87|||
4183212|NCT00790023|4005196|B3|PM||Baseline reflective total nasal symptom score (rTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe. Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|9.13|9.13|Standard Deviation|1.87|1.87|||
4183213|NCT00790023|4005197|B2|PM||Baseline reflective total nasal symptom score (rTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe. Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|9.44|9.44|Standard Deviation|1.80|1.8|||
4183214|NCT00790023|4005198|B1|PM||Baseline reflective total nasal symptom score (rTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe. Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|9.28|9.28|Standard Deviation|1.92|1.92|||
4183215|NCT00790023|4005195|B4|AM||Baseline reflective total nasal symptom score (rTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe. Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|9.31|9.31|Standard Deviation|1.77|1.77|||
4183216|NCT00790023|4005196|B3|AM||Baseline reflective total nasal symptom score (rTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe. Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|9.08|9.08|Standard Deviation|1.85|1.85|||
4183217|NCT00790023|4005197|B2|AM||Baseline reflective total nasal symptom score (rTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe. Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|9.47|9.47|Standard Deviation|1.68|1.68|||
4183218|NCT00790023|4005198|B1|AM||Baseline reflective total nasal symptom score (rTNSS)|"TNSS is the sum of individual symptoms of runny nose, sneezing, itchy nose, and nasal congestions. Subjects assess each individual symptoms on a scale of 0-3 where:~0 = absent~= mild~= moderate~= severe. Therefore, rTNSS values range from 0-12 (with 0 representing an absence of symptoms and higher scores reflecting more severe symptoms). Reflective TNSS measures these symptoms over the previous 12-hour time interval. Baseline was the average of the AM and PM responses obtained during the run-in period up to 6 days prior to randomization."|Units on a scale|Mean|9.36|9.36|Standard Deviation|1.76|1.76|||
4183219|NCT00790023|4005195|B4|Multiple||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4183220|NCT00790023|4005196|B3|Multiple||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4183221|NCT00790023|4005197|B2|Multiple||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4183222|NCT00790023|4005198|B1|Multiple||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4183223|NCT00790023|4005195|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4183224|NCT00790023|4005196|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4183225|NCT00790023|4005197|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4183226|NCT00790023|4005198|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4183227|NCT00790023|4005195|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4183228|NCT00790023|4005196|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4183229|NCT00790023|4005197|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4183230|NCT00790023|4005198|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4183231|NCT00790023|4005195|B4|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4183232|NCT00790023|4005196|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4183233|NCT00790023|4005197|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4183234|NCT00790023|4005198|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4183235|NCT00790023|4005195|B4|Black/African American||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4183236|NCT00790023|4005196|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4183237|NCT00790023|4005197|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4183238|NCT00790023|4005198|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4183239|NCT00790023|4005195|B4|White/Caucasian||Race/Ethnicity, Customized||participants|Number|658|658.0||||||
4183240|NCT00790023|4005196|B3|White/Caucasian||Race/Ethnicity, Customized||participants|Number|220|220.0||||||
4183241|NCT00790023|4005197|B2|White/Caucasian||Race/Ethnicity, Customized||participants|Number|220|220.0||||||
4183242|NCT00790023|4005198|B1|White/Caucasian||Race/Ethnicity, Customized||participants|Number|218|218.0||||||
4183243|NCT00790023|4005195|B4||Male|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
4183244|NCT00790023|4005196|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4183245|NCT00790023|4005197|B2||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4183246|NCT00790023|4005198|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4183247|NCT00790023|4005195|B4||Female|Sex: Female, Male||Participants|Count of Participants|469|469.0||||||
4183248|NCT00790023|4005196|B3||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4183249|NCT00790023|4005197|B2||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4183250|NCT00790023|4005198|B1||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4183251|NCT00790023|4005195|B4|||Age||years|Mean|41.8|41.8|Standard Deviation|13.2|13.2|||
4183252|NCT00790023|4005196|B3|||Age||years|Mean|42.2|42.2|Standard Deviation|13.9|13.9|||
4183253|NCT00790023|4005197|B2|||Age||years|Mean|42.1|42.1|Standard Deviation|12.9|12.9|||
4183254|NCT00790023|4005198|B1|||Age||years|Mean|41.1|41.1|Standard Deviation|12.7|12.7|||
4183255|NCT00790023|4005195|B4||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4183256|NCT00790023|4005196|B3||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4183257|NCT00790023|4005197|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4183258|NCT00790023|4005198|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4183259|NCT00790023|4005195|B4||Between 18 and 65 years|Age||Participants|Count of Participants|640|640.0||||||
4183260|NCT00790023|4005196|B3||Between 18 and 65 years|Age||Participants|Count of Participants|203|203.0||||||
4183261|NCT00790023|4005197|B2||Between 18 and 65 years|Age||Participants|Count of Participants|217|217.0||||||
4183262|NCT00790023|4005198|B1||Between 18 and 65 years|Age||Participants|Count of Participants|220|220.0||||||
4183263|NCT00790023|4005195|B4||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
4183264|NCT00790023|4005196|B3||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4183265|NCT00790023|4005197|B2||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4183266|NCT00790023|4005198|B1||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4183267|NCT00789997|4005288|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4183268|NCT00789997|4005289|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4183269|NCT00789997|4005290|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4183270|NCT00789997|4005288|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4183271|NCT00789997|4005289|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4183272|NCT00789997|4005290|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4183293|NCT00789880|4005314|B5|||Total Serum Immunoglobulin E (IgE)|Total amount of IgE in the blood, which is a measurement of allergen sensitization. Higher IgE is indicative of greater allergen sensitization. There is no “normal” level for total serum IgE since a wide overlap exists between the total serum IgE in healthy non-allergic and allergic individuals.|kU/L|Mean|724.9|724.9|Standard Deviation|2030.6|2030.6|||
4183294|NCT00789880|4005315|B4|||Total Serum Immunoglobulin E (IgE)|Total amount of IgE in the blood, which is a measurement of allergen sensitization. Higher IgE is indicative of greater allergen sensitization. There is no “normal” level for total serum IgE since a wide overlap exists between the total serum IgE in healthy non-allergic and allergic individuals.|kU/L|Mean|45.7|45.7|Standard Deviation|58.8|58.8|||
4183295|NCT00789880|4005316|B3|||Total Serum Immunoglobulin E (IgE)|Total amount of IgE in the blood, which is a measurement of allergen sensitization. Higher IgE is indicative of greater allergen sensitization. There is no “normal” level for total serum IgE since a wide overlap exists between the total serum IgE in healthy non-allergic and allergic individuals.|kU/L|Mean|85.1|85.1|Standard Deviation|82.0|82.0|||
4183296|NCT00789880|4005317|B2|||Total Serum Immunoglobulin E (IgE)|Total amount of IgE in the blood, which is a measurement of allergen sensitization. Higher IgE is indicative of greater allergen sensitization. There is no “normal” level for total serum IgE since a wide overlap exists between the total serum IgE in healthy non-allergic and allergic individuals.|kU/L|Mean|1870.1|1870.1|Standard Deviation|3310.5|3310.5|||
4183297|NCT00789880|4005318|B1|||Total Serum Immunoglobulin E (IgE)|Total amount of IgE in the blood, which is a measurement of allergen sensitization. Higher IgE is indicative of greater allergen sensitization. There is no “normal” level for total serum IgE since a wide overlap exists between the total serum IgE in healthy non-allergic and allergic individuals.|kU/L|Mean|68.4|68.4|Standard Deviation|127.3|127.3|||
4183298|NCT00789880|4005312|B7|||Serum Calcium (mg/dL)|Measurement of the amount of calcium in the blood. The normal range used for our study is between 8.4 and 10.2 mg/dL.|mg/dL|Mean|9.4|9.4|Standard Deviation|0.4|0.4|||
4183299|NCT00789880|4005313|B6|||Serum Calcium (mg/dL)|Measurement of the amount of calcium in the blood. The normal range used for our study is between 8.4 and 10.2 mg/dL.|mg/dL|Mean|9.2|9.2|Standard Deviation|0.3|0.3|||
4183300|NCT00789880|4005314|B5|||Serum Calcium (mg/dL)|Measurement of the amount of calcium in the blood. The normal range used for our study is between 8.4 and 10.2 mg/dL.|mg/dL|Mean|9.5|9.5|Standard Deviation|0.3|0.3|||
4183301|NCT00789880|4005315|B4|||Serum Calcium (mg/dL)|Measurement of the amount of calcium in the blood. The normal range used for our study is between 8.4 and 10.2 mg/dL.|mg/dL|Mean|9.3|9.3|Standard Deviation|0.4|0.4|||
4183302|NCT00789880|4005316|B3|||Serum Calcium (mg/dL)|Measurement of the amount of calcium in the blood. The normal range used for our study is between 8.4 and 10.2 mg/dL.|mg/dL|Mean|9.4|9.4|Standard Deviation|0.4|0.4|||
4183303|NCT00789880|4005317|B2|||Serum Calcium (mg/dL)|Measurement of the amount of calcium in the blood. The normal range used for our study is between 8.4 and 10.2 mg/dL.|mg/dL|Mean|9.4|9.4|Standard Deviation|0.4|0.4|||
4183304|NCT00789880|4005318|B1|||Serum Calcium (mg/dL)|Measurement of the amount of calcium in the blood. The normal range used for our study is between 8.4 and 10.2 mg/dL.|mg/dL|Mean|9.3|9.3|Standard Deviation|0.3|0.3|||
4183305|NCT00789880|4005312|B7|||Serum Parathyroid Hormone (pg/mL)|Serum Parathyroid hormone level in the blood is a measure of parathyroid gland function. The normal range used for our study is between 15 and 75 pg/mL.|pg/mL|Mean|34.4|34.4|Standard Deviation|11.4|11.4|||
4183306|NCT00789880|4005313|B6|||Serum Parathyroid Hormone (pg/mL)|Serum Parathyroid hormone level in the blood is a measure of parathyroid gland function. The normal range used for our study is between 15 and 75 pg/mL.|pg/mL|Mean|35.6|35.6|Standard Deviation|12.6|12.6|||
4183307|NCT00789880|4005314|B5|||Serum Parathyroid Hormone (pg/mL)|Serum Parathyroid hormone level in the blood is a measure of parathyroid gland function. The normal range used for our study is between 15 and 75 pg/mL.|pg/mL|Mean|34.2|34.2|Standard Deviation|8.6|8.6|||
4183308|NCT00789880|4005315|B4|||Serum Parathyroid Hormone (pg/mL)|Serum Parathyroid hormone level in the blood is a measure of parathyroid gland function. The normal range used for our study is between 15 and 75 pg/mL.|pg/mL|Mean|31.4|31.4|Standard Deviation|11.8|11.8|||
4183309|NCT00789880|4005316|B3|||Serum Parathyroid Hormone (pg/mL)|Serum Parathyroid hormone level in the blood is a measure of parathyroid gland function. The normal range used for our study is between 15 and 75 pg/mL.|pg/mL|Mean|27.6|27.6|Standard Deviation|7.2|7.2|||
4183310|NCT00789880|4005317|B2|||Serum Parathyroid Hormone (pg/mL)|Serum Parathyroid hormone level in the blood is a measure of parathyroid gland function. The normal range used for our study is between 15 and 75 pg/mL.|pg/mL|Mean|37.8|37.8|Standard Deviation|13.7|13.7|||
4183311|NCT00789880|4005318|B1|||Serum Parathyroid Hormone (pg/mL)|Serum Parathyroid hormone level in the blood is a measure of parathyroid gland function. The normal range used for our study is between 15 and 75 pg/mL.|pg/mL|Mean|37.2|37.2|Standard Deviation|11.8|11.8|||
4183312|NCT00789880|4005312|B7|||Serum Creatinine (mg/dL)|Creatinine level in the blood is used as a measurement of kidney function. The normal range used for our study is 0.4 to 1.2 mg/dL.|mg/dL|Mean|0.8|0.8|Standard Deviation|0.2|0.2|||
4183313|NCT00789880|4005313|B6|||Serum Creatinine (mg/dL)|Creatinine level in the blood is used as a measurement of kidney function. The normal range used for our study is 0.4 to 1.2 mg/dL.|mg/dL|Mean|0.8|0.8|Standard Deviation|0.1|0.1|||
4183314|NCT00789880|4005314|B5|||Serum Creatinine (mg/dL)|Creatinine level in the blood is used as a measurement of kidney function. The normal range used for our study is 0.4 to 1.2 mg/dL.|mg/dL|Mean|0.8|0.8|Standard Deviation|0.2|0.2|||
4183315|NCT00789880|4005315|B4|||Serum Creatinine (mg/dL)|Creatinine level in the blood is used as a measurement of kidney function. The normal range used for our study is 0.4 to 1.2 mg/dL.|mg/dL|Mean|0.8|0.8|Standard Deviation|0.2|0.2|||
4183316|NCT00789880|4005316|B3|||Serum Creatinine (mg/dL)|Creatinine level in the blood is used as a measurement of kidney function. The normal range used for our study is 0.4 to 1.2 mg/dL.|mg/dL|Mean|0.8|0.8|Standard Deviation|0.2|0.2|||
4183317|NCT00789880|4005317|B2|||Serum Creatinine (mg/dL)|Creatinine level in the blood is used as a measurement of kidney function. The normal range used for our study is 0.4 to 1.2 mg/dL.|mg/dL|Mean|0.8|0.8|Standard Deviation|0.1|0.1|||
4183318|NCT00789880|4005318|B1|||Serum Creatinine (mg/dL)|Creatinine level in the blood is used as a measurement of kidney function. The normal range used for our study is 0.4 to 1.2 mg/dL.|mg/dL|Mean|0.8|0.8|Standard Deviation|0.1|0.1|||
4183321|NCT00789880|4005314|B5|||Serum Vitamin D 25-Hydroxy (ng/mL)|Measurement of the amount of Vitamin D in the blood. The normal range used for our study is between 20 and 80 ng/mL.|ng/mL|Mean|29.3|29.3|Standard Deviation|12.2|12.2|||
4183322|NCT00789880|4005315|B4|||Serum Vitamin D 25-Hydroxy (ng/mL)|Measurement of the amount of Vitamin D in the blood. The normal range used for our study is between 20 and 80 ng/mL.|ng/mL|Mean|30.4|30.4|Standard Deviation|11.2|11.2|||
4183323|NCT00789880|4005316|B3|||Serum Vitamin D 25-Hydroxy (ng/mL)|Measurement of the amount of Vitamin D in the blood. The normal range used for our study is between 20 and 80 ng/mL.|ng/mL|Mean|31.3|31.3|Standard Deviation|8.5|8.5|||
4183324|NCT00789880|4005317|B2|||Serum Vitamin D 25-Hydroxy (ng/mL)|Measurement of the amount of Vitamin D in the blood. The normal range used for our study is between 20 and 80 ng/mL.|ng/mL|Mean|27.9|27.9|Standard Deviation|9.7|9.7|||
4183325|NCT00789880|4005318|B1|||Serum Vitamin D 25-Hydroxy (ng/mL)|Measurement of the amount of Vitamin D in the blood. The normal range used for our study is between 20 and 80 ng/mL.|ng/mL|Mean|28.8|28.8|Standard Deviation|13.9|13.9|||
4183326|NCT00789880|4005312|B7|Unknown||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|1|1.0||||||
4183327|NCT00789880|4005313|B6|Unknown||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|0|0.0||||||
4183328|NCT00789880|4005314|B5|Unknown||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|1|1.0||||||
4183329|NCT00789880|4005315|B4|Unknown||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|0|0.0||||||
4183330|NCT00789880|4005316|B3|Unknown||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|0|0.0||||||
4183331|NCT00789880|4005317|B2|Unknown||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|0|0.0||||||
4183332|NCT00789880|4005318|B1|Unknown||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|0|0.0||||||
4183333|NCT00789880|4005312|B7|Markedly Black Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|6|6.0||||||
4183334|NCT00789880|4005313|B6|Markedly Black Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|0|0.0||||||
4183335|NCT00789880|4005314|B5|Markedly Black Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|1|1.0||||||
4183336|NCT00789880|4005315|B4|Markedly Black Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|2|2.0||||||
4183337|NCT00789880|4005316|B3|Markedly Black Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|0|0.0||||||
4183338|NCT00789880|4005317|B2|Markedly Black Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|1|1.0||||||
4183339|NCT00789880|4005318|B1|Markedly Black Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|2|2.0||||||
4183340|NCT00789880|4005312|B7|Moderately Brown Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|4|4.0||||||
4183341|NCT00789880|4005313|B6|Moderately Brown Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|1|1.0||||||
4183342|NCT00789880|4005314|B5|Moderately Brown Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|3|3.0||||||
4183343|NCT00789880|4005315|B4|Moderately Brown Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|0|0.0||||||
4183344|NCT00789880|4005316|B3|Moderately Brown Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|0|0.0||||||
4183345|NCT00789880|4005317|B2|Moderately Brown Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|0|0.0||||||
4183346|NCT00789880|4005318|B1|Moderately Brown Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|0|0.0||||||
4183347|NCT00789880|4005312|B7|Olive Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|22|22.0||||||
4183348|NCT00789880|4005313|B6|Olive Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|1|1.0||||||
4183349|NCT00789880|4005314|B5|Olive Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|2|2.0||||||
4183350|NCT00789880|4005315|B4|Olive Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|5|5.0||||||
4183413|NCT00789880|4005315|B4|Other||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|2|2.0||||||
4183352|NCT00789880|4005317|B2|Olive Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|7|7.0||||||
4183353|NCT00789880|4005318|B1|Olive Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|5|5.0||||||
4183354|NCT00789880|4005312|B7|Medium Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|26|26.0||||||
4183355|NCT00789880|4005313|B6|Medium Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|4|4.0||||||
4183356|NCT00789880|4005314|B5|Medium Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|7|7.0||||||
4183357|NCT00789880|4005315|B4|Medium Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|4|4.0||||||
4183358|NCT00789880|4005316|B3|Medium Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|2|2.0||||||
4183359|NCT00789880|4005317|B2|Medium Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|5|5.0||||||
4183360|NCT00789880|4005318|B1|Medium Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|4|4.0||||||
4183361|NCT00789880|4005312|B7|Fair Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|20|20.0||||||
4183362|NCT00789880|4005313|B6|Fair Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|2|2.0||||||
4183363|NCT00789880|4005314|B5|Fair Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|3|3.0||||||
4183364|NCT00789880|4005315|B4|Fair Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|5|5.0||||||
4183365|NCT00789880|4005316|B3|Fair Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|4|4.0||||||
4183366|NCT00789880|4005317|B2|Fair Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|2|2.0||||||
4183367|NCT00789880|4005318|B1|Fair Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|4|4.0||||||
4183368|NCT00789880|4005312|B7|Extremely Fair Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|3|3.0||||||
4183369|NCT00789880|4005313|B6|Extremely Fair Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|0|0.0||||||
4183370|NCT00789880|4005314|B5|Extremely Fair Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|1|1.0||||||
4183371|NCT00789880|4005315|B4|Extremely Fair Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|0|0.0||||||
4183372|NCT00789880|4005316|B3|Extremely Fair Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|0|0.0||||||
4183373|NCT00789880|4005317|B2|Extremely Fair Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|1|1.0||||||
4183374|NCT00789880|4005318|B1|Extremely Fair Skin||Fitzpatrick Skin Scale|This scale classifies skin type categorically based on an individual's genetic disposition and skin’s response to sun exposure.|Participants|Number|1|1.0||||||
4183375|NCT00789880|4005312|B7|||Body Mass Index (BMI; kg/m^2)|"BMI is a number calculated from a person’s height and weight that provides a reliable indicator of body fatness for most people. Higher values reflect greater amount of body fat. [1] In adults, a BMI less than 18.5 is underweight; 18.5 to 24.9 is a normal or healthy weight; greater than or equal to 25.0 is overweight. The height and weight was collected at baseline only.~[1]: Healthy Weight, Assessing Your Weight, Body Mass Index http://www.cdc.gov/healthyweight/assessing/bmi/index.html"|kg/m^2|Mean|25.3|25.3|Standard Deviation|4.9|4.9|||
4183376|NCT00789880|4005313|B6|||Body Mass Index (BMI; kg/m^2)|"BMI is a number calculated from a person’s height and weight that provides a reliable indicator of body fatness for most people. Higher values reflect greater amount of body fat. [1] In adults, a BMI less than 18.5 is underweight; 18.5 to 24.9 is a normal or healthy weight; greater than or equal to 25.0 is overweight. The height and weight was collected at baseline only.~[1]: Healthy Weight, Assessing Your Weight, Body Mass Index http://www.cdc.gov/healthyweight/assessing/bmi/index.html"|kg/m^2|Mean|27.1|27.1|Standard Deviation|4.6|4.6|||
4183377|NCT00789880|4005314|B5|||Body Mass Index (BMI; kg/m^2)|"BMI is a number calculated from a person’s height and weight that provides a reliable indicator of body fatness for most people. Higher values reflect greater amount of body fat. [1] In adults, a BMI less than 18.5 is underweight; 18.5 to 24.9 is a normal or healthy weight; greater than or equal to 25.0 is overweight. The height and weight was collected at baseline only.~[1]: Healthy Weight, Assessing Your Weight, Body Mass Index http://www.cdc.gov/healthyweight/assessing/bmi/index.html"|kg/m^2|Mean|24.9|24.9|Standard Deviation|3.5|3.5|||
4183414|NCT00789880|4005316|B3|Other||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|1|1.0||||||
4183378|NCT00789880|4005315|B4|||Body Mass Index (BMI; kg/m^2)|"BMI is a number calculated from a person’s height and weight that provides a reliable indicator of body fatness for most people. Higher values reflect greater amount of body fat. [1] In adults, a BMI less than 18.5 is underweight; 18.5 to 24.9 is a normal or healthy weight; greater than or equal to 25.0 is overweight. The height and weight was collected at baseline only.~[1]: Healthy Weight, Assessing Your Weight, Body Mass Index http://www.cdc.gov/healthyweight/assessing/bmi/index.html"|kg/m^2|Mean|24.5|24.5|Standard Deviation|5.0|5.0|||
4183379|NCT00789880|4005316|B3|||Body Mass Index (BMI; kg/m^2)|"BMI is a number calculated from a person’s height and weight that provides a reliable indicator of body fatness for most people. Higher values reflect greater amount of body fat. [1] In adults, a BMI less than 18.5 is underweight; 18.5 to 24.9 is a normal or healthy weight; greater than or equal to 25.0 is overweight. The height and weight was collected at baseline only.~[1]: Healthy Weight, Assessing Your Weight, Body Mass Index http://www.cdc.gov/healthyweight/assessing/bmi/index.html"|kg/m^2|Mean|28|28.0|Standard Deviation|6.9|6.9|||
4183380|NCT00789880|4005317|B2|||Body Mass Index (BMI; kg/m^2)|"BMI is a number calculated from a person’s height and weight that provides a reliable indicator of body fatness for most people. Higher values reflect greater amount of body fat. [1] In adults, a BMI less than 18.5 is underweight; 18.5 to 24.9 is a normal or healthy weight; greater than or equal to 25.0 is overweight. The height and weight was collected at baseline only.~[1]: Healthy Weight, Assessing Your Weight, Body Mass Index http://www.cdc.gov/healthyweight/assessing/bmi/index.html"|kg/m^2|Mean|25.2|25.2|Standard Deviation|4.7|4.7|||
4183381|NCT00789880|4005318|B1|||Body Mass Index (BMI; kg/m^2)|"BMI is a number calculated from a person’s height and weight that provides a reliable indicator of body fatness for most people. Higher values reflect greater amount of body fat. [1] In adults, a BMI less than 18.5 is underweight; 18.5 to 24.9 is a normal or healthy weight; greater than or equal to 25.0 is overweight. The height and weight was collected at baseline only.~[1]: Healthy Weight, Assessing Your Weight, Body Mass Index http://www.cdc.gov/healthyweight/assessing/bmi/index.html"|kg/m^2|Mean|24.6|24.6|Standard Deviation|5.5|5.5|||
4183382|NCT00789880|4005312|B7|United States||Region of Enrollment||participants|Number|82|82.0||||||
4183383|NCT00789880|4005313|B6|United States||Region of Enrollment||participants|Number|8|8.0||||||
4183384|NCT00789880|4005314|B5|United States||Region of Enrollment||participants|Number|18|18.0||||||
4183385|NCT00789880|4005315|B4|United States||Region of Enrollment||participants|Number|16|16.0||||||
4183386|NCT00789880|4005316|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4183387|NCT00789880|4005317|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4183388|NCT00789880|4005318|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4183389|NCT00789880|4005312|B7|Unknown or Not Reported||Race/Ethnicity, Customized|Ethnicity (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|0|0.0||||||
4183390|NCT00789880|4005313|B6|Unknown or Not Reported||Race/Ethnicity, Customized|Ethnicity (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|0|0.0||||||
4183391|NCT00789880|4005314|B5|Unknown or Not Reported||Race/Ethnicity, Customized|Ethnicity (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|0|0.0||||||
4183392|NCT00789880|4005315|B4|Unknown or Not Reported||Race/Ethnicity, Customized|Ethnicity (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|0|0.0||||||
4183393|NCT00789880|4005316|B3|Unknown or Not Reported||Race/Ethnicity, Customized|Ethnicity (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|0|0.0||||||
4183394|NCT00789880|4005317|B2|Unknown or Not Reported||Race/Ethnicity, Customized|Ethnicity (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|0|0.0||||||
4183395|NCT00789880|4005318|B1|Unknown or Not Reported||Race/Ethnicity, Customized|Ethnicity (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|0|0.0||||||
4183396|NCT00789880|4005312|B7|Not Hispanic or Latino||Race/Ethnicity, Customized|Ethnicity (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|73|73.0||||||
4183397|NCT00789880|4005313|B6|Not Hispanic or Latino||Race/Ethnicity, Customized|Ethnicity (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|7|7.0||||||
4183398|NCT00789880|4005314|B5|Not Hispanic or Latino||Race/Ethnicity, Customized|Ethnicity (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|18|18.0||||||
4183399|NCT00789880|4005315|B4|Not Hispanic or Latino||Race/Ethnicity, Customized|Ethnicity (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|14|14.0||||||
4183400|NCT00789880|4005316|B3|Not Hispanic or Latino||Race/Ethnicity, Customized|Ethnicity (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|7|7.0||||||
4183401|NCT00789880|4005317|B2|Not Hispanic or Latino||Race/Ethnicity, Customized|Ethnicity (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|15|15.0||||||
4183402|NCT00789880|4005318|B1|Not Hispanic or Latino||Race/Ethnicity, Customized|Ethnicity (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|12|12.0||||||
4183403|NCT00789880|4005312|B7|Hispanic or Latino||Race/Ethnicity, Customized|Ethnicity (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|9|9.0||||||
4183404|NCT00789880|4005313|B6|Hispanic or Latino||Race/Ethnicity, Customized|Ethnicity (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|1|1.0||||||
4183405|NCT00789880|4005314|B5|Hispanic or Latino||Race/Ethnicity, Customized|Ethnicity (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|0|0.0||||||
4183406|NCT00789880|4005315|B4|Hispanic or Latino||Race/Ethnicity, Customized|Ethnicity (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|2|2.0||||||
4183407|NCT00789880|4005316|B3|Hispanic or Latino||Race/Ethnicity, Customized|Ethnicity (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|1|1.0||||||
4183408|NCT00789880|4005317|B2|Hispanic or Latino||Race/Ethnicity, Customized|Ethnicity (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|1|1.0||||||
4183409|NCT00789880|4005318|B1|Hispanic or Latino||Race/Ethnicity, Customized|Ethnicity (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|4|4.0||||||
4183415|NCT00789880|4005317|B2|Other||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|2|2.0||||||
4183416|NCT00789880|4005318|B1|Other||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|2|2.0||||||
4183417|NCT00789880|4005312|B7|Unknown or Not Reported||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|0|0.0||||||
4183418|NCT00789880|4005313|B6|Unknown or Not Reported||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|0|0.0||||||
4183419|NCT00789880|4005314|B5|Unknown or Not Reported||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|0|0.0||||||
4183420|NCT00789880|4005315|B4|Unknown or Not Reported||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|0|0.0||||||
4183421|NCT00789880|4005316|B3|Unknown or Not Reported||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|0|0.0||||||
4183422|NCT00789880|4005317|B2|Unknown or Not Reported||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|0|0.0||||||
4183423|NCT00789880|4005318|B1|Unknown or Not Reported||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|0|0.0||||||
4183424|NCT00789880|4005312|B7|More than one race||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|0|0.0||||||
4183425|NCT00789880|4005313|B6|More than one race||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|0|0.0||||||
4183426|NCT00789880|4005314|B5|More than one race||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|0|0.0||||||
4183427|NCT00789880|4005315|B4|More than one race||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|0|0.0||||||
4183428|NCT00789880|4005316|B3|More than one race||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|0|0.0||||||
4183429|NCT00789880|4005317|B2|More than one race||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|0|0.0||||||
4183430|NCT00789880|4005318|B1|More than one race||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|0|0.0||||||
4183431|NCT00789880|4005312|B7|White||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|54|54.0||||||
4183432|NCT00789880|4005313|B6|White||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|5|5.0||||||
4183433|NCT00789880|4005314|B5|White||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|11|11.0||||||
4183434|NCT00789880|4005315|B4|White||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|11|11.0||||||
4183435|NCT00789880|4005316|B3|White||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|6|6.0||||||
4183436|NCT00789880|4005317|B2|White||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|9|9.0||||||
4183437|NCT00789880|4005318|B1|White||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|12|12.0||||||
4183438|NCT00789880|4005312|B7|Black||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|9|9.0||||||
4183439|NCT00789880|4005313|B6|Black||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|0|0.0||||||
4183440|NCT00789880|4005314|B5|Black||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|4|4.0||||||
4183441|NCT00789880|4005315|B4|Black||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|2|2.0||||||
4183442|NCT00789880|4005316|B3|Black||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|0|0.0||||||
4183443|NCT00789880|4005317|B2|Black||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|1|1.0||||||
4183444|NCT00789880|4005318|B1|Black||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|2|2.0||||||
4183445|NCT00789880|4005312|B7|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|0|0.0||||||
4183446|NCT00789880|4005313|B6|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|0|0.0||||||
4183447|NCT00789880|4005314|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|0|0.0||||||
4183448|NCT00789880|4005315|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|0|0.0||||||
4183449|NCT00789880|4005316|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|0|0.0||||||
4183450|NCT00789880|4005317|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|0|0.0||||||
4183451|NCT00789880|4005318|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|0|0.0||||||
4183452|NCT00789880|4005312|B7|Asian||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|10|10.0||||||
4183453|NCT00789880|4005313|B6|Asian||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|2|2.0||||||
4183543|NCT00789815|4005485|B2|||Age||years|Mean|62.0|62.0|Standard Deviation|14.7|14.7|||
4183454|NCT00789880|4005314|B5|Asian||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|2|2.0||||||
4183455|NCT00789880|4005315|B4|Asian||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|1|1.0||||||
4183456|NCT00789880|4005316|B3|Asian||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|1|1.0||||||
4183457|NCT00789880|4005317|B2|Asian||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|4|4.0||||||
4183458|NCT00789880|4005318|B1|Asian||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|0|0.0||||||
4183459|NCT00789880|4005312|B7|American Indian or Alaska Native||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|0|0.0||||||
4183460|NCT00789880|4005313|B6|American Indian or Alaska Native||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|0|0.0||||||
4183461|NCT00789880|4005314|B5|American Indian or Alaska Native||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|0|0.0||||||
4183462|NCT00789880|4005315|B4|American Indian or Alaska Native||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|0|0.0||||||
4183463|NCT00789880|4005316|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|0|0.0||||||
4183464|NCT00789880|4005317|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|0|0.0||||||
4183465|NCT00789880|4005318|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Race (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|0|0.0||||||
4183466|NCT00789880|4005312|B7||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4183467|NCT00789880|4005313|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4183468|NCT00789880|4005314|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4183469|NCT00789880|4005315|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4183470|NCT00789880|4005316|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4183471|NCT00789880|4005317|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4183472|NCT00789880|4005318|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4183473|NCT00789880|4005312|B7||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4183474|NCT00789880|4005313|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4183475|NCT00789880|4005314|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4183476|NCT00789880|4005315|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4183477|NCT00789880|4005316|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4183478|NCT00789880|4005317|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4183479|NCT00789880|4005318|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4183480|NCT00789880|4005312|B7|||Age||years|Mean|32.5|32.5|Standard Deviation|10.9|10.9|||
4183481|NCT00789880|4005313|B6|||Age||years|Mean|37.1|37.1|Standard Deviation|11.4|11.4|||
4183482|NCT00789880|4005314|B5|||Age||years|Mean|28.6|28.6|Standard Deviation|9.8|9.8|||
4183483|NCT00789880|4005315|B4|||Age||years|Mean|32.2|32.2|Standard Deviation|8.9|8.9|||
4183484|NCT00789880|4005316|B3|||Age||years|Mean|40.5|40.5|Standard Deviation|11.6|11.6|||
4183485|NCT00789880|4005317|B2|||Age||years|Mean|32.2|32.2|Standard Deviation|10.5|10.5|||
4183486|NCT00789880|4005318|B1|||Age||years|Mean|31.4|31.4|Standard Deviation|12.3|12.3|||
4183487|NCT00789854|4005349|B4|||Weight||kg|Mean|75.8|75.8|Standard Deviation|16.65|16.65|||
4183488|NCT00789854|4005350|B3|||Weight||kg|Mean|76.4|76.4|Standard Deviation|16.1|16.1|||
4183489|NCT00789854|4005351|B2|||Weight||kg|Mean|75.2|75.2|Standard Deviation|17|17.0|||
4183490|NCT00789854|4005352|B1|||Weight||kg|Mean|75.3|75.3|Standard Deviation|17.2|17.2|||
4183491|NCT00789854|4005349|B4|||Montgomery-Asberg Depression Rating Scale (MADRS) total score|Units on a scale from 0 to 60. Lower score indicates a better health status.|Units on a scale|Mean|33.32|33.32|Standard Deviation|5.4|5.4|||
4183492|NCT00789854|4005350|B3|||Montgomery-Asberg Depression Rating Scale (MADRS) total score|Units on a scale from 0 to 60. Lower score indicates a better health status.|Units on a scale|Mean|32.91|32.91|Standard Deviation|5.2|5.2|||
4183493|NCT00789854|4005351|B2|||Montgomery-Asberg Depression Rating Scale (MADRS) total score|Units on a scale from 0 to 60. Lower score indicates a better health status.|Units on a scale|Mean|33.15|33.15|Standard Deviation|5.34|5.34|||
4183494|NCT00789854|4005352|B1|||Montgomery-Asberg Depression Rating Scale (MADRS) total score|Units on a scale from 0 to 60. Lower score indicates a better health status.|Units on a scale|Mean|33.74|33.74|Standard Deviation|5.6|5.6|||
4183495|NCT00789854|4005349|B4|Diagnose code 296.3x MDD, Recurrent||Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)||Participants|Number|548|548.0||||||
4183496|NCT00789854|4005350|B3|Diagnose code 296.3x MDD, Recurrent||Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)||Participants|Number|180|180.0||||||
4183497|NCT00789854|4005351|B2|Diagnose code 296.3x MDD, Recurrent||Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)||Participants|Number|193|193.0||||||
4183498|NCT00789854|4005352|B1|Diagnose code 296.3x MDD, Recurrent||Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)||Participants|Number|175|175.0||||||
4183499|NCT00789854|4005349|B4|Diagnose code 296.2x Major Depressive Disorder (MD||Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)||Participants|Number|127|127.0||||||
4183500|NCT00789854|4005350|B3|Diagnose code 296.2x Major Depressive Disorder (MD||Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)||Participants|Number|41|41.0||||||
4183544|NCT00789815|4005486|B1|||Age||years|Mean|59.9|59.9|Standard Deviation|13.1|13.1|||
4183501|NCT00789854|4005351|B2|Diagnose code 296.2x Major Depressive Disorder (MD||Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)||Participants|Number|36|36.0||||||
4183502|NCT00789854|4005352|B1|Diagnose code 296.2x Major Depressive Disorder (MD||Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)||Participants|Number|50|50.0||||||
4183503|NCT00789854|4005349|B4||Male|Sex: Female, Male|Baseline characteristics are presented using the ITT population (Quetiapine XR mono 225 participants, Add-on Quetiapine XR 229 participants and Add-on Lithium 221 participants) and not all randomized patients|Participants|Count of Participants|209|209.0||||||
4183504|NCT00789854|4005350|B3||Male|Sex: Female, Male|Baseline characteristics are presented using the ITT population (Quetiapine XR mono 225 participants, Add-on Quetiapine XR 229 participants and Add-on Lithium 221 participants) and not all randomized patients|Participants|Count of Participants|69|69.0||||||
4183505|NCT00789854|4005351|B2||Male|Sex: Female, Male|Baseline characteristics are presented using the ITT population (Quetiapine XR mono 225 participants, Add-on Quetiapine XR 229 participants and Add-on Lithium 221 participants) and not all randomized patients|Participants|Count of Participants|67|67.0||||||
4183506|NCT00789854|4005352|B1||Male|Sex: Female, Male|Baseline characteristics are presented using the ITT population (Quetiapine XR mono 225 participants, Add-on Quetiapine XR 229 participants and Add-on Lithium 221 participants) and not all randomized patients|Participants|Count of Participants|73|73.0||||||
4183507|NCT00789854|4005349|B4||Female|Sex: Female, Male|Baseline characteristics are presented using the ITT population (Quetiapine XR mono 225 participants, Add-on Quetiapine XR 229 participants and Add-on Lithium 221 participants) and not all randomized patients|Participants|Count of Participants|466|466.0||||||
4183508|NCT00789854|4005350|B3||Female|Sex: Female, Male|Baseline characteristics are presented using the ITT population (Quetiapine XR mono 225 participants, Add-on Quetiapine XR 229 participants and Add-on Lithium 221 participants) and not all randomized patients|Participants|Count of Participants|152|152.0||||||
4183509|NCT00789854|4005351|B2||Female|Sex: Female, Male|Baseline characteristics are presented using the ITT population (Quetiapine XR mono 225 participants, Add-on Quetiapine XR 229 participants and Add-on Lithium 221 participants) and not all randomized patients|Participants|Count of Participants|162|162.0||||||
4183510|NCT00789854|4005352|B1||Female|Sex: Female, Male|Baseline characteristics are presented using the ITT population (Quetiapine XR mono 225 participants, Add-on Quetiapine XR 229 participants and Add-on Lithium 221 participants) and not all randomized patients|Participants|Count of Participants|152|152.0||||||
4183511|NCT00789854|4005349|B4|||Age|Baseline characteristics are presented using the ITT population (Quetiapine XR mono 225 participants, Add-on Quetiapine XR 229 participants and Add-on Lithium 221 participants) and not all randomized patients|years|Mean|47|47.0|Full Range|||19.0|67.0|
4183512|NCT00789854|4005350|B3|||Age|Baseline characteristics are presented using the ITT population (Quetiapine XR mono 225 participants, Add-on Quetiapine XR 229 participants and Add-on Lithium 221 participants) and not all randomized patients|years|Mean|47|47.0|Full Range|||19.0|67.0|
4183513|NCT00789854|4005351|B2|||Age|Baseline characteristics are presented using the ITT population (Quetiapine XR mono 225 participants, Add-on Quetiapine XR 229 participants and Add-on Lithium 221 participants) and not all randomized patients|years|Mean|47|47.0|Full Range|||20.0|67.0|
4183514|NCT00789854|4005352|B1|||Age|Baseline characteristics are presented using the ITT population (Quetiapine XR mono 225 participants, Add-on Quetiapine XR 229 participants and Add-on Lithium 221 participants) and not all randomized patients|years|Mean|47|47.0|Full Range|||20.0|65.0|
4183515|NCT00789828|4005449|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4183516|NCT00789828|4005450|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4183517|NCT00789828|4005451|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4183518|NCT00789828|4005449|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4183519|NCT00789828|4005450|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4183520|NCT00789828|4005451|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4183521|NCT00789828|4005449|B3|≥18 years||Age, Customized||Participants|Number|16|16.0||||||
4183522|NCT00789828|4005450|B2|≥18 years||Age, Customized||Participants|Number|6|6.0||||||
4183523|NCT00789828|4005451|B1|≥18 years||Age, Customized||Participants|Number|10|10.0||||||
4183524|NCT00789828|4005449|B3|3-18 years||Age, Customized||Participants|Number|81|81.0||||||
4183525|NCT00789828|4005450|B2|3-18 years||Age, Customized||Participants|Number|26|26.0||||||
4183526|NCT00789828|4005451|B1|3-18 years||Age, Customized||Participants|Number|55|55.0||||||
4183527|NCT00789828|4005449|B3|<3 years||Age, Customized||Participants|Number|20|20.0||||||
4183528|NCT00789828|4005450|B2|<3 years||Age, Customized||Participants|Number|7|7.0||||||
4183529|NCT00789828|4005451|B1|<3 years||Age, Customized||Participants|Number|13|13.0||||||
4183530|NCT00789828|4005449|B3|||Age||years|Mean|10.2|10.2|Standard Deviation|6.4|6.4|||
4183531|NCT00789828|4005450|B2|||Age||years|Mean|10.3|10.3|Standard Deviation|7.3|7.3|||
4183532|NCT00789828|4005451|B1|||Age||years|Mean|10.1|10.1|Standard Deviation|5.9|5.9|||
4183533|NCT00789815|4005484|B3|Taiwan||Region of Enrollment||participants|Number|500|500.0||||||
4183534|NCT00789815|4005485|B2|Taiwan||Region of Enrollment||participants|Number|250|250.0||||||
4183535|NCT00789815|4005486|B1|Taiwan||Region of Enrollment||participants|Number|250|250.0||||||
4183536|NCT00789815|4005484|B3||Male|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
4183537|NCT00789815|4005485|B2||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4183538|NCT00789815|4005486|B1||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4183539|NCT00789815|4005484|B3||Female|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
4183540|NCT00789815|4005485|B2||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4183541|NCT00789815|4005486|B1||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4183542|NCT00789815|4005484|B3|||Age||years|Mean|60.9|60.9|Standard Deviation|14.0|14.0|||
4183547|NCT00789815|4005486|B1||>=65 years|Age||Participants|Count of Participants|106|106.0||||||
4183548|NCT00789815|4005484|B3||Between 18 and 65 years|Age||Participants|Count of Participants|268|268.0||||||
4183549|NCT00789815|4005485|B2||Between 18 and 65 years|Age||Participants|Count of Participants|124|124.0||||||
4183550|NCT00789815|4005486|B1||Between 18 and 65 years|Age||Participants|Count of Participants|144|144.0||||||
4183551|NCT00789815|4005484|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4183552|NCT00789815|4005485|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4183553|NCT00789815|4005486|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4183554|NCT00789802|4005507|B4|United States||Region of Enrollment||participants|Number|129|129.0||||||
4183555|NCT00789802|4005508|B3|United States||Region of Enrollment||participants|Number|43|43.0||||||
4183556|NCT00789802|4005509|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
4183557|NCT00789802|4005510|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4183558|NCT00789802|4005507|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4183559|NCT00789802|4005508|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4183560|NCT00789802|4005509|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4183561|NCT00789802|4005510|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4183562|NCT00789802|4005507|B4||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4183563|NCT00789802|4005508|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4183564|NCT00789802|4005509|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4183565|NCT00789802|4005510|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4183566|NCT00789802|4005507|B4|||Age||years|Mean|25.8|25.8|Standard Deviation|4.7|4.7|||
4183567|NCT00789802|4005508|B3|||Age||years|Mean|26.2|26.2|Standard Deviation|5.1|5.1|||
4183568|NCT00789802|4005509|B2|||Age||years|Mean|25|25.0|Standard Deviation|4.2|4.2|||
4183569|NCT00789802|4005510|B1|||Age||years|Mean|26.3|26.3|Standard Deviation|4.7|4.7|||
4183570|NCT00789802|4005507|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4183571|NCT00789802|4005508|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4183572|NCT00789802|4005509|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4183573|NCT00789802|4005510|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4183574|NCT00789802|4005507|B4||Between 18 and 65 years|Age||Participants|Count of Participants|129|129.0||||||
4183575|NCT00789802|4005508|B3||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4183576|NCT00789802|4005509|B2||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4183577|NCT00789802|4005510|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4183578|NCT00789802|4005507|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4183579|NCT00789802|4005508|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4183580|NCT00789802|4005509|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4183581|NCT00789802|4005510|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4183582|NCT00789776|4005529|B3|United States||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
4183583|NCT00789776|4005530|B2|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
4183584|NCT00789776|4005531|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4183585|NCT00789776|4005529|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4183586|NCT00789776|4005530|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4183587|NCT00789776|4005531|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4183588|NCT00789776|4005529|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4183589|NCT00789776|4005530|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4183590|NCT00789776|4005531|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4183591|NCT00789776|4005529|B3||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4183592|NCT00789776|4005530|B2||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4183593|NCT00789776|4005531|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4183594|NCT00789776|4005529|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4183595|NCT00789776|4005530|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4183596|NCT00789776|4005531|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4183597|NCT00789776|4005529|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4183598|NCT00789776|4005530|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4183599|NCT00789776|4005531|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4183600|NCT00789776|4005529|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4183601|NCT00789776|4005530|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4183602|NCT00789776|4005531|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4183603|NCT00789776|4005529|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4183604|NCT00789776|4005530|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4183605|NCT00789776|4005531|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4183664|NCT00789750|4005551|B2||>=65 years|Age||Participants|Count of Participants|60|60.0||||||
4183606|NCT00789776|4005529|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4183607|NCT00789776|4005530|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4183608|NCT00789776|4005531|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4183609|NCT00789776|4005529|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4183610|NCT00789776|4005530|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4183611|NCT00789776|4005531|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4183612|NCT00789776|4005529|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4183613|NCT00789776|4005530|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4183614|NCT00789776|4005531|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4183615|NCT00789776|4005529|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4183616|NCT00789776|4005530|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4183617|NCT00789776|4005531|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4183618|NCT00789776|4005529|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4183619|NCT00789776|4005530|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4183620|NCT00789776|4005531|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4183621|NCT00789776|4005529|B3|||Age||years|Median|47.6|47.6|Full Range|||8.1|75.2|
4183622|NCT00789776|4005530|B2|||Age||years|Median|55.65|55.65|Full Range|||8.1|75.2|
4183623|NCT00789776|4005531|B1|||Age||years|Median|22.2|22.2|Full Range|||14.5|43.7|
4183624|NCT00789776|4005529|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4183625|NCT00789776|4005530|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4183626|NCT00789776|4005531|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4183627|NCT00789776|4005529|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4183628|NCT00789776|4005530|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4183629|NCT00789776|4005531|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4183630|NCT00789776|4005529|B3||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4183631|NCT00789776|4005530|B2||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4183632|NCT00789776|4005531|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4183633|NCT00789750|4005550|B3|United States||Region of Enrollment||participants|Number|562|562.0||||||
4183634|NCT00789750|4005551|B2|United States||Region of Enrollment||participants|Number|282|282.0||||||
4183635|NCT00789750|4005552|B1|United States||Region of Enrollment||participants|Number|280|280.0||||||
4183636|NCT00789750|4005550|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4183637|NCT00789750|4005551|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4183638|NCT00789750|4005552|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4183639|NCT00789750|4005550|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4183640|NCT00789750|4005551|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4183641|NCT00789750|4005552|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4183642|NCT00789750|4005550|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
4183643|NCT00789750|4005551|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
4183644|NCT00789750|4005552|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
4183645|NCT00789750|4005550|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|53|53.0||||||
4183646|NCT00789750|4005551|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
4183647|NCT00789750|4005552|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
4183648|NCT00789750|4005550|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|115|115.0||||||
4183649|NCT00789750|4005551|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|56|56.0||||||
4183650|NCT00789750|4005552|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|59|59.0||||||
4183651|NCT00789750|4005550|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|351|351.0||||||
4183652|NCT00789750|4005551|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|172|172.0||||||
4183653|NCT00789750|4005552|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|179|179.0||||||
4183654|NCT00789750|4005550|B3||Male|Sex: Female, Male||Participants|Count of Participants|320|320.0||||||
4183655|NCT00789750|4005551|B2||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4183656|NCT00789750|4005552|B1||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4183657|NCT00789750|4005550|B3||Female|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
4183658|NCT00789750|4005551|B2||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4183659|NCT00789750|4005552|B1||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4183660|NCT00789750|4005550|B3|||Age||years|Mean|56.0|56.0|Standard Deviation|10.41|10.41|||
4183661|NCT00789750|4005551|B2|||Age||years|Mean|55.6|55.6|Standard Deviation|10.61|10.61|||
4183662|NCT00789750|4005552|B1|||Age||years|Mean|56.3|56.3|Standard Deviation|10.22|10.22|||
4183663|NCT00789750|4005550|B3||>=65 years|Age||Participants|Count of Participants|120|120.0||||||
4183665|NCT00789750|4005552|B1||>=65 years|Age||Participants|Count of Participants|60|60.0||||||
4183666|NCT00789750|4005550|B3||Between 18 and 65 years|Age||Participants|Count of Participants|442|442.0||||||
4183667|NCT00789750|4005551|B2||Between 18 and 65 years|Age||Participants|Count of Participants|222|222.0||||||
4183668|NCT00789750|4005552|B1||Between 18 and 65 years|Age||Participants|Count of Participants|220|220.0||||||
4183669|NCT00789750|4005550|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4183670|NCT00789750|4005551|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4183671|NCT00789750|4005552|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4183672|NCT00789737|4005595|B3|||Duration of type 2 diabetes||years|Mean|4.1|4.1|Standard Deviation|4.54|4.54|||
4183673|NCT00789737|4005596|B2|||Duration of type 2 diabetes||years|Mean|3.9|3.9|Standard Deviation|4.39|4.39|||
4183674|NCT00789737|4005597|B1|||Duration of type 2 diabetes||years|Mean|4.3|4.3|Standard Deviation|4.69|4.69|||
4183675|NCT00789737|4005595|B3|>= 30 kg/m*2||baseline body mass index category|number >= 30 kg/m*2 and number <30 kg/m*2|participants|Number|223|223.0||||||
4183676|NCT00789737|4005596|B2|>= 30 kg/m*2||baseline body mass index category|number >= 30 kg/m*2 and number <30 kg/m*2|participants|Number|115|115.0||||||
4183677|NCT00789737|4005597|B1|>= 30 kg/m*2||baseline body mass index category|number >= 30 kg/m*2 and number <30 kg/m*2|participants|Number|108|108.0||||||
4183678|NCT00789737|4005595|B3|<30 kg/m*2||baseline body mass index category|number >= 30 kg/m*2 and number <30 kg/m*2|participants|Number|134|134.0||||||
4183679|NCT00789737|4005596|B2|<30 kg/m*2||baseline body mass index category|number >= 30 kg/m*2 and number <30 kg/m*2|participants|Number|66|66.0||||||
4183680|NCT00789737|4005597|B1|<30 kg/m*2||baseline body mass index category|number >= 30 kg/m*2 and number <30 kg/m*2|participants|Number|68|68.0||||||
4183681|NCT00789737|4005595|B3|||Body mass index||kg/m*2|Mean|31.9|31.9|Standard Deviation|5.75|5.75|||
4183682|NCT00789737|4005596|B2|||Body mass index||kg/m*2|Mean|31.8|31.8|Standard Deviation|4.94|4.94|||
4183683|NCT00789737|4005597|B1|||Body mass index||kg/m*2|Mean|32.0|32.0|Standard Deviation|6.5|6.5|||
4183684|NCT00789737|4005595|B3|United States||Region of Enrollment||participants|Number|357|357.0||||||
4183685|NCT00789737|4005596|B2|United States||Region of Enrollment||participants|Number|181|181.0||||||
4183686|NCT00789737|4005597|B1|United States||Region of Enrollment||participants|Number|176|176.0||||||
4183687|NCT00789737|4005595|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4183688|NCT00789737|4005596|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4183689|NCT00789737|4005597|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4183690|NCT00789737|4005595|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4183691|NCT00789737|4005596|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4183692|NCT00789737|4005597|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4183693|NCT00789737|4005595|B3||White|Race (NIH/OMB)||Participants|Count of Participants|253|253.0||||||
4183694|NCT00789737|4005596|B2||White|Race (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
4183695|NCT00789737|4005597|B1||White|Race (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
4183696|NCT00789737|4005595|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4183697|NCT00789737|4005596|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4183698|NCT00789737|4005597|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4183699|NCT00789737|4005595|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4183700|NCT00789737|4005596|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4183701|NCT00789737|4005597|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4183702|NCT00789737|4005595|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4183703|NCT00789737|4005596|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4183704|NCT00789737|4005597|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4183705|NCT00789737|4005595|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4183706|NCT00789737|4005596|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4183707|NCT00789737|4005597|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4183708|NCT00789737|4005595|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4183709|NCT00789737|4005596|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4183710|NCT00789737|4005597|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4183711|NCT00789737|4005595|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|191|191.0||||||
4183712|NCT00789737|4005596|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
4183713|NCT00789737|4005597|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4183714|NCT00789737|4005595|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|166|166.0||||||
4183715|NCT00789737|4005596|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
4183716|NCT00789737|4005597|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4183717|NCT00789737|4005595|B3||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4183718|NCT00789737|4005596|B2||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4183719|NCT00789737|4005597|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4183720|NCT00789737|4005595|B3||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4183721|NCT00789737|4005596|B2||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4183722|NCT00789737|4005597|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4183723|NCT00789737|4005595|B3|||Age||years|Mean|52.2|52.2|Standard Deviation|10.38|10.38|||
4183724|NCT00789737|4005596|B2|||Age||years|Mean|51.8|51.8|Standard Deviation|10.52|10.52|||
4183725|NCT00789737|4005597|B1|||Age||years|Mean|52.6|52.6|Standard Deviation|10.25|10.25|||
4183726|NCT00789737|4005595|B3||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4183727|NCT00789737|4005596|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4183728|NCT00789737|4005597|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4183729|NCT00789737|4005595|B3||Between 18 and 65 years|Age||Participants|Count of Participants|332|332.0||||||
4183730|NCT00789737|4005596|B2||Between 18 and 65 years|Age||Participants|Count of Participants|167|167.0||||||
4183731|NCT00789737|4005597|B1||Between 18 and 65 years|Age||Participants|Count of Participants|165|165.0||||||
4183732|NCT00789737|4005595|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4183733|NCT00789737|4005596|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4183734|NCT00789737|4005597|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4183735|NCT00789724|4005628|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4183736|NCT00789724|4005629|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4183737|NCT00789724|4005630|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4183738|NCT00789724|4005628|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4183739|NCT00789724|4005629|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4183740|NCT00789724|4005630|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4183741|NCT00789724|4005628|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4183742|NCT00789724|4005629|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4183743|NCT00789724|4005630|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4183744|NCT00789724|4005628|B3|||Age||years|Mean|48|48.0|Standard Deviation|13|13.0|||
4183745|NCT00789724|4005629|B2|||Age||years|Mean|52|52.0|Standard Deviation|15|15.0|||
4183746|NCT00789724|4005630|B1|||Age||years|Mean|45|45.0|Standard Deviation|13|13.0|||
4183747|NCT00789724|4005628|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4183748|NCT00789724|4005629|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4183749|NCT00789724|4005630|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4183750|NCT00789724|4005628|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4183751|NCT00789724|4005629|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4183752|NCT00789724|4005630|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4183753|NCT00789724|4005628|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4183754|NCT00789724|4005629|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4183755|NCT00789724|4005630|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4183756|NCT00789698|4005637|B5|India||Region of Enrollment||participants|Number|66|66.0||||||
4183757|NCT00789698|4005638|B4|India||Region of Enrollment||participants|Number|13|13.0||||||
4183758|NCT00789698|4005639|B3|India||Region of Enrollment||participants|Number|16|16.0||||||
4183759|NCT00789698|4005640|B2|India||Region of Enrollment||participants|Number|22|22.0||||||
4183760|NCT00789698|4005641|B1|India||Region of Enrollment||participants|Number|15|15.0||||||
4183761|NCT00789698|4005637|B5|Colombia||Region of Enrollment||participants|Number|15|15.0||||||
4183762|NCT00789698|4005638|B4|Colombia||Region of Enrollment||participants|Number|4|4.0||||||
4183763|NCT00789698|4005639|B3|Colombia||Region of Enrollment||participants|Number|3|3.0||||||
4183764|NCT00789698|4005640|B2|Colombia||Region of Enrollment||participants|Number|3|3.0||||||
4183765|NCT00789698|4005641|B1|Colombia||Region of Enrollment||participants|Number|5|5.0||||||
4183766|NCT00789698|4005637|B5|Russian Federation||Region of Enrollment||participants|Number|55|55.0||||||
4183767|NCT00789698|4005638|B4|Russian Federation||Region of Enrollment||participants|Number|17|17.0||||||
4183768|NCT00789698|4005639|B3|Russian Federation||Region of Enrollment||participants|Number|12|12.0||||||
4183769|NCT00789698|4005640|B2|Russian Federation||Region of Enrollment||participants|Number|15|15.0||||||
4183770|NCT00789698|4005641|B1|Russian Federation||Region of Enrollment||participants|Number|11|11.0||||||
4183771|NCT00789698|4005637|B5|Romania||Region of Enrollment||participants|Number|27|27.0||||||
4183772|NCT00789698|4005638|B4|Romania||Region of Enrollment||participants|Number|10|10.0||||||
4183773|NCT00789698|4005639|B3|Romania||Region of Enrollment||participants|Number|2|2.0||||||
4183774|NCT00789698|4005640|B2|Romania||Region of Enrollment||participants|Number|9|9.0||||||
4183775|NCT00789698|4005641|B1|Romania||Region of Enrollment||participants|Number|6|6.0||||||
4183776|NCT00789698|4005637|B5|Ukraine||Region of Enrollment||participants|Number|59|59.0||||||
4183777|NCT00789698|4005638|B4|Ukraine||Region of Enrollment||participants|Number|18|18.0||||||
4183778|NCT00789698|4005639|B3|Ukraine||Region of Enrollment||participants|Number|9|9.0||||||
4183779|NCT00789698|4005640|B2|Ukraine||Region of Enrollment||participants|Number|15|15.0||||||
4183780|NCT00789698|4005641|B1|Ukraine||Region of Enrollment||participants|Number|17|17.0||||||
4183781|NCT00789698|4005637|B5|United States||Region of Enrollment||participants|Number|70|70.0||||||
4183782|NCT00789698|4005638|B4|United States||Region of Enrollment||participants|Number|23|23.0||||||
4183783|NCT00789698|4005639|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4183784|NCT00789698|4005640|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4183785|NCT00789698|4005641|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4183786|NCT00789698|4005637|B5||Male|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4183787|NCT00789698|4005638|B4||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4183788|NCT00789698|4005639|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4183789|NCT00789698|4005640|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4183790|NCT00789698|4005641|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4183791|NCT00789698|4005637|B5||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4183792|NCT00789698|4005638|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4183793|NCT00789698|4005639|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4183794|NCT00789698|4005640|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4183795|NCT00789698|4005641|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4183796|NCT00789698|4005637|B5|||Age||years|Mean|37.6|37.6|Standard Deviation|11.3|11.3|||
4183797|NCT00789698|4005638|B4|||Age||years|Mean|38.5|38.5|Standard Deviation|10.4|10.4|||
4183798|NCT00789698|4005639|B3|||Age||years|Mean|37.5|37.5|Standard Deviation|11.4|11.4|||
4183799|NCT00789698|4005640|B2|||Age||years|Mean|37.6|37.6|Standard Deviation|11.7|11.7|||
4183800|NCT00789698|4005641|B1|||Age||years|Mean|36.6|36.6|Standard Deviation|11.7|11.7|||
4183801|NCT00789685|4005658|B1|United Kingdom||Region of Enrollment||participants|Number|37|37.0||||||
4183802|NCT00789685|4005658|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4183803|NCT00789685|4005658|B1|South American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4183804|NCT00789685|4005658|B1|Black or African||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4183805|NCT00789685|4005658|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4183806|NCT00789685|4005658|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4183807|NCT00789685|4005658|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4183808|NCT00789685|4005658|B1|||Age||years|Mean|52.6|52.6|Full Range|||18.0|83.0|
4183809|NCT00789672|4005664|B3|||Weight in Kilograms||kilograms|Median|42|42.0|Full Range|||23.0|74.0|
4183810|NCT00789672|4005665|B2|||Weight in Kilograms||kilograms|Median|34|34.0|Full Range|||23.0|74.0|
4183811|NCT00789672|4005666|B1|||Weight in Kilograms||kilograms|Median|47|47.0|Full Range|||25.0|71.0|
4183812|NCT00789672|4005664|B3|||Mean (SD) Spherical Equivalent Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopters|Mean|1.12|1.12|Standard Deviation|1.07|1.07|||
4183813|NCT00789672|4005665|B2|||Mean (SD) Spherical Equivalent Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopters|Mean|1.04|1.04|Standard Deviation|0.99|0.99|||
4183814|NCT00789672|4005666|B1|||Mean (SD) Spherical Equivalent Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopters|Mean|1.20|1.2|Standard Deviation|1.17|1.17|||
4183815|NCT00789672|4005664|B3|||Mean (SD) Spherical Equivalent Refractive Error in Amblyopic Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopters|Mean|3.65|3.65|Standard Deviation|1.93|1.93|||
4183816|NCT00789672|4005665|B2|||Mean (SD) Spherical Equivalent Refractive Error in Amblyopic Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopters|Mean|3.28|3.28|Standard Deviation|1.93|1.93|||
4183817|NCT00789672|4005666|B1|||Mean (SD) Spherical Equivalent Refractive Error in Amblyopic Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopters|Mean|4.05|4.05|Standard Deviation|1.92|1.92|||
4183818|NCT00789672|4005664|B3|||Mean (SD) Intereye Acuity Difference|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score in each eye that could range from 0 to 97 letters. Intereye difference calculated as the difference in letters between the sound eye and amblyopic eye (positive difference indicates sound eye better).|letters|Mean|32.7|32.7|Standard Deviation|12.7|12.7|||
4183819|NCT00789672|4005665|B2|||Mean (SD) Intereye Acuity Difference|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score in each eye that could range from 0 to 97 letters. Intereye difference calculated as the difference in letters between the sound eye and amblyopic eye (positive difference indicates sound eye better).|letters|Mean|35.1|35.1|Standard Deviation|13.6|13.6|||
4183820|NCT00789672|4005666|B1|||Mean (SD) Intereye Acuity Difference|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score in each eye that could range from 0 to 97 letters. Intereye difference calculated as the difference in letters between the sound eye and amblyopic eye (positive difference indicates sound eye better).|letters|Mean|30.2|30.2|Standard Deviation|11.7|11.7|||
4183821|NCT00789672|4005664|B3|||Mean (SD) Distance Visual Acuity in Fellow Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|letters|Mean|85.9|85.9|Standard Deviation|3.9|3.9|||
4183822|NCT00789672|4005665|B2|||Mean (SD) Distance Visual Acuity in Fellow Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|letters|Mean|85.5|85.5|Standard Deviation|3.3|3.3|||
4183823|NCT00789672|4005666|B1|||Mean (SD) Distance Visual Acuity in Fellow Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|letters|Mean|86.4|86.4|Standard Deviation|4.5|4.5|||
4183824|NCT00789672|4005664|B3|||Mean (SD) Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|letters|Mean|53.2|53.2|Standard Deviation|10.9|10.9|||
4183825|NCT00789672|4005665|B2|||Mean (SD) Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|letters|Mean|50.5|50.5|Standard Deviation|12.2|12.2|||
4183826|NCT00789672|4005666|B1|||Mean (SD) Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|letters|Mean|56.2|56.2|Standard Deviation|8.8|8.8|||
4183827|NCT00789672|4005664|B3|greater than or equal to +4.00D||Refractive Error in Fellow Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|0|0.0||||||
4183828|NCT00789672|4005665|B2|greater than or equal to +4.00D||Refractive Error in Fellow Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|0|0.0||||||
4183829|NCT00789672|4005666|B1|greater than or equal to +4.00D||Refractive Error in Fellow Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|0|0.0||||||
4183830|NCT00789672|4005664|B3|+3.00 to <+4.00D||Refractive Error in Fellow Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|3|3.0||||||
4183831|NCT00789672|4005665|B2|+3.00 to <+4.00D||Refractive Error in Fellow Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|1|1.0||||||
4183832|NCT00789672|4005666|B1|+3.00 to <+4.00D||Refractive Error in Fellow Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|2|2.0||||||
4183833|NCT00789672|4005664|B3|+2.00 to <+3.00D||Refractive Error in Fellow Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|5|5.0||||||
4183834|NCT00789672|4005665|B2|+2.00 to <+3.00D||Refractive Error in Fellow Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|3|3.0||||||
4183835|NCT00789672|4005666|B1|+2.00 to <+3.00D||Refractive Error in Fellow Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|2|2.0||||||
4183836|NCT00789672|4005664|B3|+1.00 to <+2.00D||Refractive Error in Fellow Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|8|8.0||||||
4183837|NCT00789672|4005665|B2|+1.00 to <+2.00D||Refractive Error in Fellow Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|3|3.0||||||
4183838|NCT00789672|4005666|B1|+1.00 to <+2.00D||Refractive Error in Fellow Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|5|5.0||||||
4183839|NCT00789672|4005664|B3|0 to < +1.00D||Refractive Error in Fellow Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|16|16.0||||||
4183840|NCT00789672|4005665|B2|0 to < +1.00D||Refractive Error in Fellow Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|10|10.0||||||
4183841|NCT00789672|4005666|B1|0 to < +1.00D||Refractive Error in Fellow Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|6|6.0||||||
4183842|NCT00789672|4005664|B3|<0.00D||Refractive Error in Fellow Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|1|1.0||||||
4183843|NCT00789672|4005665|B2|<0.00D||Refractive Error in Fellow Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|0|0.0||||||
4183844|NCT00789672|4005666|B1|<0.00D||Refractive Error in Fellow Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|1|1.0||||||
4183845|NCT00789672|4005664|B3|greater than or equal to +4.00D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|18|18.0||||||
4183846|NCT00789672|4005665|B2|greater than or equal to +4.00D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|9|9.0||||||
4183847|NCT00789672|4005666|B1|greater than or equal to +4.00D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|9|9.0||||||
4183848|NCT00789672|4005664|B3|+3.00 to <+4.00D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|5|5.0||||||
4183849|NCT00789672|4005665|B2|+3.00 to <+4.00D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|2|2.0||||||
4183850|NCT00789672|4005666|B1|+3.00 to <+4.00D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|3|3.0||||||
4183930|NCT00789672|4005665|B2|Strabismus||Cause of Amblyopia||participants|Number|5|5.0||||||
4183851|NCT00789672|4005664|B3|+2.00 to <+3.00D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|4|4.0||||||
4183852|NCT00789672|4005665|B2|+2.00 to <+3.00D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|2|2.0||||||
4183853|NCT00789672|4005666|B1|+2.00 to <+3.00D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|2|2.0||||||
4183854|NCT00789672|4005664|B3|+1.00 to <+2.00D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|2|2.0||||||
4183855|NCT00789672|4005665|B2|+1.00 to <+2.00D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|1|1.0||||||
4183856|NCT00789672|4005666|B1|+1.00 to <+2.00D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|1|1.0||||||
4183857|NCT00789672|4005664|B3|0 to < +1.00D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|3|3.0||||||
4183858|NCT00789672|4005665|B2|0 to < +1.00D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|2|2.0||||||
4183859|NCT00789672|4005666|B1|0 to < +1.00D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|1|1.0||||||
4183860|NCT00789672|4005664|B3|<0.00D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|1|1.0||||||
4183861|NCT00789672|4005665|B2|<0.00D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|1|1.0||||||
4183862|NCT00789672|4005666|B1|<0.00D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|0|0.0||||||
4183863|NCT00789672|4005664|B3|Unknown/Not reported||Race/Ethnicity||participants|Number|0|0.0||||||
4183864|NCT00789672|4005665|B2|Unknown/Not reported||Race/Ethnicity||participants|Number|0|0.0||||||
4183865|NCT00789672|4005666|B1|Unknown/Not reported||Race/Ethnicity||participants|Number|0|0.0||||||
4183866|NCT00789672|4005664|B3|More than one race||Race/Ethnicity||participants|Number|0|0.0||||||
4183867|NCT00789672|4005665|B2|More than one race||Race/Ethnicity||participants|Number|0|0.0||||||
4183868|NCT00789672|4005666|B1|More than one race||Race/Ethnicity||participants|Number|0|0.0||||||
4183869|NCT00789672|4005664|B3|Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4183870|NCT00789672|4005665|B2|Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4183871|NCT00789672|4005666|B1|Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4183872|NCT00789672|4005664|B3|Hispanic or Latino||Race/Ethnicity||participants|Number|1|1.0||||||
4183873|NCT00789672|4005665|B2|Hispanic or Latino||Race/Ethnicity||participants|Number|0|0.0||||||
4183874|NCT00789672|4005666|B1|Hispanic or Latino||Race/Ethnicity||participants|Number|1|1.0||||||
4183875|NCT00789672|4005664|B3|African-American||Race/Ethnicity||participants|Number|1|1.0||||||
4183876|NCT00789672|4005665|B2|African-American||Race/Ethnicity||participants|Number|0|0.0||||||
4183877|NCT00789672|4005666|B1|African-American||Race/Ethnicity||participants|Number|1|1.0||||||
4183878|NCT00789672|4005664|B3|White||Race/Ethnicity||participants|Number|31|31.0||||||
4183879|NCT00789672|4005665|B2|White||Race/Ethnicity||participants|Number|17|17.0||||||
4183880|NCT00789672|4005666|B1|White||Race/Ethnicity||participants|Number|14|14.0||||||
4183881|NCT00789672|4005664|B3|20/12 (93 to 97 letters)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|1|1.0||||||
4183882|NCT00789672|4005665|B2|20/12 (93 to 97 letters)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|0|0.0||||||
4183883|NCT00789672|4005666|B1|20/12 (93 to 97 letters)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|1|1.0||||||
4183884|NCT00789672|4005664|B3|20/16 (88 to 92 letters)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|10|10.0||||||
4183931|NCT00789672|4005666|B1|Strabismus||Cause of Amblyopia||participants|Number|2|2.0||||||
4183885|NCT00789672|4005665|B2|20/16 (88 to 92 letters)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|5|5.0||||||
4183886|NCT00789672|4005666|B1|20/16 (88 to 92 letters)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|5|5.0||||||
4183887|NCT00789672|4005664|B3|20/20 (83 to 87 letters)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|14|14.0||||||
4183888|NCT00789672|4005665|B2|20/20 (83 to 87 letters)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|8|8.0||||||
4183889|NCT00789672|4005666|B1|20/20 (83 to 87 letters)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|6|6.0||||||
4183890|NCT00789672|4005664|B3|20/25 (78 to 82 letters)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|8|8.0||||||
4183891|NCT00789672|4005665|B2|20/25 (78 to 82 letters)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|4|4.0||||||
4183892|NCT00789672|4005666|B1|20/25 (78 to 82 letters)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|4|4.0||||||
4183893|NCT00789672|4005664|B3|20/50 (63 to 67 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|5|5.0||||||
4183894|NCT00789672|4005665|B2|20/50 (63 to 67 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|1|1.0||||||
4183895|NCT00789672|4005666|B1|20/50 (63 to 67 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|4|4.0||||||
4183896|NCT00789672|4005664|B3|20/63 (58 to 62 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|9|9.0||||||
4183897|NCT00789672|4005665|B2|20/63 (58 to 62 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|5|5.0||||||
4183932|NCT00789672|4005664|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
4183933|NCT00789672|4005665|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4183898|NCT00789672|4005666|B1|20/63 (58 to 62 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|4|4.0||||||
4183899|NCT00789672|4005664|B3|20/80 (53 to 57 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|10|10.0||||||
4183900|NCT00789672|4005665|B2|20/80 (53 to 57 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|6|6.0||||||
4183901|NCT00789672|4005666|B1|20/80 (53 to 57 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|4|4.0||||||
4183902|NCT00789672|4005664|B3|20/100 (48 to 52 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|2|2.0||||||
4183903|NCT00789672|4005665|B2|20/100 (48 to 52 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|0|0.0||||||
4183904|NCT00789672|4005666|B1|20/100 (48 to 52 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|2|2.0||||||
4183905|NCT00789672|4005664|B3|20/125 (43 to 47 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|1|1.0||||||
4183906|NCT00789672|4005665|B2|20/125 (43 to 47 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|1|1.0||||||
4183907|NCT00789672|4005666|B1|20/125 (43 to 47 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|0|0.0||||||
4183908|NCT00789672|4005664|B3|20/160 (38 to 42 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|2|2.0||||||
4183909|NCT00789672|4005665|B2|20/160 (38 to 42 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|1|1.0||||||
4183910|NCT00789672|4005666|B1|20/160 (38 to 42 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|1|1.0||||||
4183934|NCT00789672|4005666|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4183935|NCT00789672|4005664|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4183911|NCT00789672|4005664|B3|20/200 (33 to 37 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|2|2.0||||||
4183912|NCT00789672|4005665|B2|20/200 (33 to 37 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|1|1.0||||||
4183913|NCT00789672|4005666|B1|20/200 (33 to 37 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|1|1.0||||||
4183914|NCT00789672|4005664|B3|20/250 (28 to 32 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|1|1.0||||||
4183915|NCT00789672|4005665|B2|20/250 (28 to 32 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|1|1.0||||||
4183916|NCT00789672|4005666|B1|20/250 (28 to 32 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|0|0.0||||||
4183917|NCT00789672|4005664|B3|20/320 (23 to 27 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|0|0.0||||||
4183918|NCT00789672|4005665|B2|20/320 (23 to 27 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|0|0.0||||||
4183919|NCT00789672|4005666|B1|20/320 (23 to 27 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|0|0.0||||||
4183920|NCT00789672|4005664|B3|20/400 (18 to 22 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|1|1.0||||||
4183921|NCT00789672|4005665|B2|20/400 (18 to 22 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|1|1.0||||||
4183922|NCT00789672|4005666|B1|20/400 (18 to 22 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured with the electronic early treatment diabetic retinopathy study (E-ETDRS) method and resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Letter scores are presented as Snellen Equivalents for presentation (i.e. 20/20 includes those with letter scores between 83 and 87 letters, 20/25 includes those with letter scores between 78 to 82 letters, etc.).|participants|Number|0|0.0||||||
4183923|NCT00789672|4005664|B3|Strabismus and anisometropia||Cause of Amblyopia||participants|Number|15|15.0||||||
4183924|NCT00789672|4005665|B2|Strabismus and anisometropia||Cause of Amblyopia||participants|Number|7|7.0||||||
4183925|NCT00789672|4005666|B1|Strabismus and anisometropia||Cause of Amblyopia||participants|Number|8|8.0||||||
4183926|NCT00789672|4005664|B3|Anisometropia||Cause of Amblyopia||participants|Number|11|11.0||||||
4183927|NCT00789672|4005665|B2|Anisometropia||Cause of Amblyopia||participants|Number|5|5.0||||||
4183928|NCT00789672|4005666|B1|Anisometropia||Cause of Amblyopia||participants|Number|6|6.0||||||
4183929|NCT00789672|4005664|B3|Strabismus||Cause of Amblyopia||participants|Number|7|7.0||||||
4183936|NCT00789672|4005665|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4183937|NCT00789672|4005666|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4183938|NCT00789672|4005664|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4183939|NCT00789672|4005665|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4183940|NCT00789672|4005666|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4183941|NCT00789672|4005664|B3|17 to <18||Age, Customized|Age at enrollment in years|participants|Number|0|0.0||||||
4183942|NCT00789672|4005665|B2|17 to <18||Age, Customized|Age at enrollment in years|participants|Number|0|0.0||||||
4183943|NCT00789672|4005666|B1|17 to <18||Age, Customized|Age at enrollment in years|participants|Number|0|0.0||||||
4183944|NCT00789672|4005664|B3|16 to <17||Age, Customized|Age at enrollment in years|participants|Number|0|0.0||||||
4183945|NCT00789672|4005665|B2|16 to <17||Age, Customized|Age at enrollment in years|participants|Number|0|0.0||||||
4183946|NCT00789672|4005666|B1|16 to <17||Age, Customized|Age at enrollment in years|participants|Number|0|0.0||||||
4183947|NCT00789672|4005664|B3|15 to <16||Age, Customized|Age at enrollment in years|participants|Number|2|2.0||||||
4183948|NCT00789672|4005665|B2|15 to <16||Age, Customized|Age at enrollment in years|participants|Number|2|2.0||||||
4183949|NCT00789672|4005666|B1|15 to <16||Age, Customized|Age at enrollment in years|participants|Number|0|0.0||||||
4183950|NCT00789672|4005664|B3|14 to <15||Age, Customized|Age at enrollment in years|participants|Number|2|2.0||||||
4183951|NCT00789672|4005665|B2|14 to <15||Age, Customized|Age at enrollment in years|participants|Number|0|0.0||||||
4183952|NCT00789672|4005666|B1|14 to <15||Age, Customized|Age at enrollment in years|participants|Number|2|2.0||||||
4183953|NCT00789672|4005664|B3|13 to <14||Age, Customized|Age at enrollment in years|participants|Number|4|4.0||||||
4183954|NCT00789672|4005665|B2|13 to <14||Age, Customized|Age at enrollment in years|participants|Number|1|1.0||||||
4183955|NCT00789672|4005666|B1|13 to <14||Age, Customized|Age at enrollment in years|participants|Number|3|3.0||||||
4183956|NCT00789672|4005664|B3|12 to <13||Age, Customized|Age at enrollment in years|participants|Number|3|3.0||||||
4183957|NCT00789672|4005665|B2|12 to <13||Age, Customized|Age at enrollment in years|participants|Number|3|3.0||||||
4183958|NCT00789672|4005666|B1|12 to <13||Age, Customized|Age at enrollment in years|participants|Number|0|0.0||||||
4183959|NCT00789672|4005664|B3|11 to <12||Age, Customized|Age at enrollment in years|participants|Number|4|4.0||||||
4183960|NCT00789672|4005665|B2|11 to <12||Age, Customized|Age at enrollment in years|participants|Number|1|1.0||||||
4183961|NCT00789672|4005666|B1|11 to <12||Age, Customized|Age at enrollment in years|participants|Number|3|3.0||||||
4183962|NCT00789672|4005664|B3|10 to <11||Age, Customized|Age at enrollment in years|participants|Number|7|7.0||||||
4183963|NCT00789672|4005665|B2|10 to <11||Age, Customized|Age at enrollment in years|participants|Number|4|4.0||||||
4183964|NCT00789672|4005666|B1|10 to <11||Age, Customized|Age at enrollment in years|participants|Number|3|3.0||||||
4183965|NCT00789672|4005664|B3|9 to <10||Age, Customized|Age at enrollment in years|participants|Number|5|5.0||||||
4183966|NCT00789672|4005665|B2|9 to <10||Age, Customized|Age at enrollment in years|participants|Number|3|3.0||||||
4183967|NCT00789672|4005666|B1|9 to <10||Age, Customized|Age at enrollment in years|participants|Number|2|2.0||||||
4183968|NCT00789672|4005664|B3|8 to <9||Age, Customized|Age at enrollment in years|participants|Number|6|6.0||||||
4183969|NCT00789672|4005665|B2|8 to <9||Age, Customized|Age at enrollment in years|participants|Number|3|3.0||||||
4183970|NCT00789672|4005666|B1|8 to <9||Age, Customized|Age at enrollment in years|participants|Number|3|3.0||||||
4183971|NCT00789672|4005664|B3|||Age||years|Mean|11.1|11.1|Standard Deviation|2.2|2.2|||
4183972|NCT00789672|4005665|B2|||Age||years|Mean|11.0|11.0|Standard Deviation|2.2|2.2|||
4183973|NCT00789672|4005666|B1|||Age||years|Mean|11.3|11.3|Standard Deviation|2.2|2.2|||
4183974|NCT00789581|4005697|B3|Postmenopausal||Menopausal Status||Participants|Count of Participants|430|430.0||||||
4183975|NCT00789581|4005698|B2|Postmenopausal||Menopausal Status||Participants|Count of Participants|224|224.0||||||
4183976|NCT00789581|4005699|B1|Postmenopausal||Menopausal Status||Participants|Count of Participants|206|206.0||||||
4183977|NCT00789581|4005697|B3|Premenopausal||Menopausal Status||Participants|Count of Participants|184|184.0||||||
4183978|NCT00789581|4005698|B2|Premenopausal||Menopausal Status||Participants|Count of Participants|84|84.0||||||
4183979|NCT00789581|4005699|B1|Premenopausal||Menopausal Status||Participants|Count of Participants|100|100.0||||||
4183980|NCT00789581|4005697|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4183981|NCT00789581|4005698|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4183982|NCT00789581|4005699|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4183983|NCT00789581|4005697|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4183984|NCT00789581|4005698|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4183985|NCT00789581|4005699|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4183986|NCT00789581|4005697|B3||White|Race (NIH/OMB)||Participants|Count of Participants|488|488.0||||||
4183987|NCT00789581|4005698|B2||White|Race (NIH/OMB)||Participants|Count of Participants|251|251.0||||||
4183988|NCT00789581|4005699|B1||White|Race (NIH/OMB)||Participants|Count of Participants|237|237.0||||||
4183989|NCT00789581|4005697|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
4183990|NCT00789581|4005698|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4183991|NCT00789581|4005699|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4183992|NCT00789581|4005697|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4183993|NCT00789581|4005698|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4183994|NCT00789581|4005699|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4183995|NCT00789581|4005697|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4183996|NCT00789581|4005698|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4183997|NCT00789581|4005699|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4183998|NCT00789581|4005697|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4183999|NCT00789581|4005698|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184000|NCT00789581|4005699|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4184001|NCT00789581|4005697|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4184002|NCT00789581|4005698|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4184003|NCT00789581|4005699|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4184004|NCT00789581|4005697|B3||Female|Sex: Female, Male||Participants|Count of Participants|614|614.0||||||
4184005|NCT00789581|4005698|B2||Female|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
4184006|NCT00789581|4005699|B1||Female|Sex: Female, Male||Participants|Count of Participants|306|306.0||||||
4184007|NCT00789581|4005697|B3|≥50 years||Age, Customized||Participants|Count of Participants|397|397.0||||||
4184008|NCT00789581|4005698|B2|≥50 years||Age, Customized||Participants|Count of Participants|215|215.0||||||
4184009|NCT00789581|4005699|B1|≥50 years||Age, Customized||Participants|Count of Participants|182|182.0||||||
4184010|NCT00789581|4005697|B3|<50 years||Age, Customized||Participants|Count of Participants|217|217.0||||||
4184011|NCT00789581|4005698|B2|<50 years||Age, Customized||Participants|Count of Participants|93|93.0||||||
4184012|NCT00789581|4005699|B1|<50 years||Age, Customized||Participants|Count of Participants|124|124.0||||||
4184013|NCT00789555|4005708|B4|United States||Region of Enrollment||participants|Number|1260|1260.0||||||
4184014|NCT00789555|4005709|B3|United States||Region of Enrollment||participants|Number|422|422.0||||||
4184015|NCT00789555|4005710|B2|United States||Region of Enrollment||participants|Number|417|417.0||||||
4184016|NCT00789555|4005711|B1|United States||Region of Enrollment||participants|Number|421|421.0||||||
4184017|NCT00789555|4005708|B4||Male|Sex: Female, Male||Participants|Count of Participants|471|471.0||||||
4184018|NCT00789555|4005709|B3||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4184019|NCT00789555|4005710|B2||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4184020|NCT00789555|4005711|B1||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4184021|NCT00789555|4005708|B4||Female|Sex: Female, Male||Participants|Count of Participants|789|789.0||||||
4184022|NCT00789555|4005709|B3||Female|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
4184023|NCT00789555|4005710|B2||Female|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
4184024|NCT00789555|4005711|B1||Female|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4184025|NCT00789555|4005708|B4|||Age||years|Mean|37.1|37.1|Standard Deviation|14.4|14.4|||
4184026|NCT00789555|4005709|B3|||Age||years|Mean|38.3|38.3|Standard Deviation|14.6|14.6|||
4184027|NCT00789555|4005710|B2|||Age||years|Mean|36.2|36.2|Standard Deviation|14.2|14.2|||
4184028|NCT00789555|4005711|B1|||Age||years|Mean|36.8|36.8|Standard Deviation|14.5|14.5|||
4184029|NCT00789529|4005736|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4184030|NCT00789529|4005737|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4184031|NCT00789529|4005738|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4184032|NCT00789529|4005736|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4184033|NCT00789529|4005737|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4184034|NCT00789529|4005738|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4184035|NCT00789529|4005736|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4184036|NCT00789529|4005737|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4184037|NCT00789529|4005738|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4184038|NCT00789529|4005736|B3|||Age||years|Mean|27.3|27.3|Standard Deviation|4.4|4.4|||
4184039|NCT00789529|4005737|B2|||Age||years|Mean|27.4|27.4|Standard Deviation|5.1|5.1|||
4184040|NCT00789529|4005738|B1|||Age||years|Mean|27.3|27.3|Standard Deviation|3.8|3.8|||
4184041|NCT00789529|4005736|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4184042|NCT00789529|4005737|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4184043|NCT00789529|4005738|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4184044|NCT00789529|4005736|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4184045|NCT00789529|4005737|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4184046|NCT00789529|4005738|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4184047|NCT00789529|4005736|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4184048|NCT00789529|4005737|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4184049|NCT00789529|4005738|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4184050|NCT00789477|4005747|B6||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4184051|NCT00789477|4005748|B5||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4184052|NCT00789477|4005749|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4184053|NCT00789477|4005750|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4184054|NCT00789477|4005751|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4184055|NCT00789477|4005752|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4184056|NCT00789477|4005747|B6||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4184057|NCT00789477|4005748|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4184058|NCT00789477|4005749|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4184059|NCT00789477|4005750|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4184060|NCT00789477|4005751|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4184061|NCT00789477|4005752|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4184062|NCT00789477|4005747|B6|||Age||years|Mean|62.3|62.3|Standard Deviation|9.92|9.92|||
4184063|NCT00789477|4005748|B5|||Age||years|Mean|60.7|60.7|Standard Deviation|8.66|8.66|||
4184064|NCT00789477|4005749|B4|||Age||years|Mean|62.5|62.5|Standard Deviation|11.49|11.49|||
4184065|NCT00789477|4005750|B3|||Age||years|Mean|62.1|62.1|Standard Deviation|10.50|10.5|||
4184066|NCT00789477|4005751|B2|||Age||years|Mean|62.3|62.3|Standard Deviation|10.70|10.7|||
4184067|NCT00789477|4005752|B1|||Age||years|Mean|64.0|64.0|Standard Deviation|8.12|8.12|||
4184068|NCT00789438|4005788|B4|Germany||Region of Enrollment||participants|Number|69|69.0||||||
4184069|NCT00789438|4005789|B3|Germany||Region of Enrollment||participants|Number|28|28.0||||||
4184070|NCT00789438|4005790|B2|Germany||Region of Enrollment||participants|Number|20|20.0||||||
4184071|NCT00789438|4005791|B1|Germany||Region of Enrollment||participants|Number|21|21.0||||||
4184072|NCT00789438|4005788|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4184073|NCT00789438|4005789|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4184074|NCT00789438|4005790|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4184075|NCT00789438|4005791|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4184076|NCT00789438|4005788|B4||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4184077|NCT00789438|4005789|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4184078|NCT00789438|4005790|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4184079|NCT00789438|4005791|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4184080|NCT00789438|4005788|B4|||Age||years|Mean|60|60.0|Standard Deviation|17|17.0|||
4184081|NCT00789438|4005789|B3|||Age||years|Mean|62|62.0|Standard Deviation|17|17.0|||
4184082|NCT00789438|4005790|B2|||Age||years|Mean|61|61.0|Standard Deviation|18|18.0|||
4184083|NCT00789438|4005791|B1|||Age||years|Mean|59|59.0|Standard Deviation|16|16.0|||
4184084|NCT00789438|4005788|B4||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4184085|NCT00789438|4005789|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4184086|NCT00789438|4005790|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4184087|NCT00789438|4005791|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4184088|NCT00789438|4005788|B4||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4184089|NCT00789438|4005789|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4184090|NCT00789438|4005790|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4184091|NCT00789438|4005791|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4184092|NCT00789438|4005788|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4184093|NCT00789438|4005789|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4184094|NCT00789438|4005790|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4184095|NCT00789438|4005791|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4184096|NCT00789373|4005801|B1|Unknown||Smoking Status||participants|Number|7|7.0||||||
4184097|NCT00789373|4005801|B1|Never Smoker||Smoking Status||participants|Number|175|175.0||||||
4184098|NCT00789373|4005801|B1|Ever Smoker||Smoking Status||participants|Number|757|757.0||||||
4184099|NCT00789373|4005801|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4184100|NCT00789373|4005801|B1|Germany||Region of Enrollment||participants|Number|126|126.0||||||
4184101|NCT00789373|4005801|B1|Netherlands||Region of Enrollment||participants|Number|48|48.0||||||
4184102|NCT00789373|4005801|B1|Australia||Region of Enrollment||participants|Number|26|26.0||||||
4184103|NCT00789373|4005801|B1|Romania||Region of Enrollment||participants|Number|55|55.0||||||
4184104|NCT00789373|4005801|B1|Belgium||Region of Enrollment||participants|Number|53|53.0||||||
4184105|NCT00789373|4005801|B1|Poland||Region of Enrollment||participants|Number|34|34.0||||||
4184106|NCT00789373|4005801|B1|France||Region of Enrollment||participants|Number|106|106.0||||||
4184107|NCT00789373|4005801|B1|India||Region of Enrollment||participants|Number|54|54.0||||||
4184108|NCT00789373|4005801|B1|Italy||Region of Enrollment||participants|Number|175|175.0||||||
4184109|NCT00789373|4005801|B1|United Kingdom||Region of Enrollment||participants|Number|71|71.0||||||
4184110|NCT00789373|4005801|B1|Turkey||Region of Enrollment||participants|Number|33|33.0||||||
4184111|NCT00789373|4005801|B1|Spain||Region of Enrollment||participants|Number|65|65.0||||||
4184112|NCT00789373|4005801|B1|Finland||Region of Enrollment||participants|Number|18|18.0||||||
4184113|NCT00789373|4005801|B1|Greece||Region of Enrollment||participants|Number|34|34.0||||||
4184114|NCT00789373|4005801|B1|Portugal||Region of Enrollment||participants|Number|38|38.0||||||
4184115|NCT00789373|4005801|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|871|871.0||||||
4184116|NCT00789373|4005801|B1|Multiple||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4184117|NCT00789373|4005801|B1|African||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4184118|NCT00789373|4005801|B1|Asian||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
4184119|NCT00789373|4005801|B1||Male|Sex: Female, Male||Participants|Count of Participants|577|577.0||||||
4184120|NCT00789373|4005801|B1||Female|Sex: Female, Male||Participants|Count of Participants|362|362.0||||||
4184121|NCT00789373|4005801|B1|||Age||years|Median|61.3|61.3|Full Range|||24.4|83.0|
4184122|NCT00789321|4005828|B3|||Body Mass Index||kg/m^2|Mean|28.6|28.6|Standard Deviation|2.8|2.8|||
4184123|NCT00789321|4005829|B2|||Body Mass Index||kg/m^2|Mean|29.0|29.0|Standard Deviation|2.7|2.7|||
4184124|NCT00789321|4005830|B1|||Body Mass Index||kg/m^2|Mean|28.2|28.2|Standard Deviation|2.9|2.9|||
4184125|NCT00789321|4005828|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4184126|NCT00789321|4005829|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4184127|NCT00789321|4005830|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4184128|NCT00789321|4005828|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4184129|NCT00789321|4005829|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4184130|NCT00789321|4005830|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4184131|NCT00789321|4005828|B3|||Age||years|Mean|59.0|59.0|Standard Deviation|5.9|5.9|||
4184132|NCT00789321|4005829|B2|||Age||years|Mean|59.6|59.6|Standard Deviation|6.2|6.2|||
4184133|NCT00789321|4005830|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|5.6|5.6|||
4184134|NCT00789256|4005839|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4184135|NCT00789256|4005840|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4184136|NCT00789256|4005841|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4184137|NCT00789256|4005839|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4184138|NCT00789256|4005840|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4184139|NCT00789256|4005841|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4184140|NCT00789256|4005839|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4184141|NCT00789256|4005840|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4184142|NCT00789256|4005841|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4184143|NCT00789256|4005839|B3|||Age||years|Mean|71|71.0|Standard Deviation|7.69|7.69|||
4184144|NCT00789256|4005840|B2|||Age||years|Mean|68|68.0|Standard Deviation|9.07|9.07|||
4184145|NCT00789256|4005841|B1|||Age||years|Mean|73|73.0|Standard Deviation|4.53|4.53|||
4184146|NCT00789256|4005839|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4184147|NCT00789256|4005840|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4184148|NCT00789256|4005841|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4184149|NCT00789256|4005839|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4184150|NCT00789256|4005840|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4184151|NCT00789256|4005841|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4184152|NCT00789256|4005839|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4184153|NCT00789256|4005840|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4184154|NCT00789256|4005841|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4184155|NCT00789191|4005851|B3|||Diabetes History|No. of years subject has been diagnosed with diabetes|years|Mean|9.74|9.74|Standard Deviation|5.63|5.63|||
4184156|NCT00789191|4005852|B2|||Diabetes History|No. of years subject has been diagnosed with diabetes|years|Mean|9.90|9.9|Standard Deviation|5.65|5.65|||
4184157|NCT00789191|4005853|B1|||Diabetes History|No. of years subject has been diagnosed with diabetes|years|Mean|9.58|9.58|Standard Deviation|5.62|5.62|||
4184158|NCT00789191|4005851|B3|||FPG|FPG = Fasting Plasma Glucose|mmol/L|Mean|9.74|9.74|Standard Deviation|2.29|2.29|||
4184159|NCT00789191|4005852|B2|||FPG|FPG = Fasting Plasma Glucose|mmol/L|Mean|9.79|9.79|Standard Deviation|2.36|2.36|||
4184160|NCT00789191|4005853|B1|||FPG|FPG = Fasting Plasma Glucose|mmol/L|Mean|9.69|9.69|Standard Deviation|2.23|2.23|||
4184161|NCT00789191|4005851|B3|Previous Metformin Monotherapy||Stratification|Previous OAD treatment|participants|Number|48|48.0||||||
4184162|NCT00789191|4005852|B2|Previous Metformin Monotherapy||Stratification|Previous OAD treatment|participants|Number|24|24.0||||||
4184163|NCT00789191|4005853|B1|Previous Metformin Monotherapy||Stratification|Previous OAD treatment|participants|Number|24|24.0||||||
4184164|NCT00789191|4005851|B3|Previous Metformin + Other OAD therapy||Stratification|Previous OAD treatment|participants|Number|169|169.0||||||
4184165|NCT00789191|4005852|B2|Previous Metformin + Other OAD therapy||Stratification|Previous OAD treatment|participants|Number|86|86.0||||||
4184166|NCT00789191|4005853|B1|Previous Metformin + Other OAD therapy||Stratification|Previous OAD treatment|participants|Number|83|83.0||||||
4184167|NCT00789191|4005851|B3|||BMI|BMI = Body Mass Index|kg/m^2|Mean|31.85|31.85|Standard Deviation|5.56|5.56|||
4184168|NCT00789191|4005852|B2|||BMI|BMI = Body Mass Index|kg/m^2|Mean|31.90|31.9|Standard Deviation|5.91|5.91|||
4184169|NCT00789191|4005853|B1|||BMI|BMI = Body Mass Index|kg/m^2|Mean|31.79|31.79|Standard Deviation|5.20|5.2|||
4184170|NCT00789191|4005851|B3|||Body Weight||kg|Mean|90.6|90.6|Standard Deviation|19.8|19.8|||
4184171|NCT00789191|4005852|B2|||Body Weight||kg|Mean|88.2|88.2|Standard Deviation|19.2|19.2|||
4184172|NCT00789191|4005853|B1|||Body Weight||kg|Mean|93.1|93.1|Standard Deviation|20.2|20.2|||
4184173|NCT00789191|4005851|B3|||Height||meters|Mean|1.68|1.68|Standard Deviation|0.10|0.1|||
4184174|NCT00789191|4005852|B2|||Height||meters|Mean|1.66|1.66|Standard Deviation|0.09|0.09|||
4184175|NCT00789191|4005853|B1|||Height||meters|Mean|1.71|1.71|Standard Deviation|0.10|0.1|||
4184176|NCT00789191|4005851|B3|||HbA1c|HbA1c = glycosylated haemoglobin A1c|Percent (%) glycosylated haemoglobin|Mean|8.52|8.52|Standard Deviation|0.65|0.65|||
4184177|NCT00789191|4005852|B2|||HbA1c|HbA1c = glycosylated haemoglobin A1c|Percent (%) glycosylated haemoglobin|Mean|8.52|8.52|Standard Deviation|0.65|0.65|||
4184178|NCT00789191|4005853|B1|||HbA1c|HbA1c = glycosylated haemoglobin A1c|Percent (%) glycosylated haemoglobin|Mean|8.52|8.52|Standard Deviation|0.65|0.65|||
4184179|NCT00789191|4005851|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4184180|NCT00789191|4005852|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4184181|NCT00789191|4005853|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4184182|NCT00789191|4005851|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184183|NCT00789191|4005852|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184184|NCT00789191|4005853|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184185|NCT00789191|4005851|B3||White|Race (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
4184186|NCT00789191|4005852|B2||White|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
4184187|NCT00789191|4005853|B1||White|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
4184188|NCT00789191|4005851|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4184189|NCT00789191|4005852|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4184190|NCT00789191|4005853|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4184191|NCT00789191|4005851|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184192|NCT00789191|4005852|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184193|NCT00789191|4005853|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184194|NCT00789191|4005851|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4184195|NCT00789191|4005852|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4184196|NCT00789191|4005853|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4184197|NCT00789191|4005851|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184198|NCT00789191|4005852|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184199|NCT00789191|4005853|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184200|NCT00789191|4005851|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4184201|NCT00789191|4005852|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4184202|NCT00789191|4005853|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4184203|NCT00789191|4005851|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|197|197.0||||||
4184204|NCT00789191|4005852|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
4184205|NCT00789191|4005853|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4184206|NCT00789191|4005851|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4184207|NCT00789191|4005852|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4184208|NCT00789191|4005853|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4184209|NCT00789191|4005851|B3||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4184210|NCT00789191|4005852|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4184211|NCT00789191|4005853|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4184212|NCT00789191|4005851|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4184213|NCT00789191|4005852|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4184214|NCT00789191|4005853|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4184215|NCT00789191|4005851|B3|||Age||years|Mean|56.90|56.9|Standard Deviation|9.19|9.19|||
4184216|NCT00789191|4005852|B2|||Age||years|Mean|57.10|57.1|Standard Deviation|8.41|8.41|||
4184217|NCT00789191|4005853|B1|||Age||years|Mean|56.70|56.7|Standard Deviation|9.96|9.96|||
4184218|NCT00789113|4005882|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4184219|NCT00789113|4005882|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4184220|NCT00789113|4005882|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4184221|NCT00789113|4005882|B1|Age 65 and older||Age, Customized||participants|Number|12|12.0||||||
4184222|NCT00789074|4005887|B3|United Kingdom||Region of Enrollment||participants|Number|101|101.0||||||
4184223|NCT00789074|4005888|B2|United Kingdom||Region of Enrollment||participants|Number|48|48.0||||||
4184224|NCT00789074|4005889|B1|United Kingdom||Region of Enrollment||participants|Number|53|53.0||||||
4184225|NCT00789074|4005887|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4184226|NCT00789074|4005888|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4184227|NCT00789074|4005889|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4184228|NCT00789074|4005887|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4184229|NCT00789074|4005888|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4184230|NCT00789074|4005889|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4184231|NCT00789074|4005887|B3|||Age||years|Mean|45.61|45.61|Standard Deviation|11.153|11.153|||
4184232|NCT00789074|4005888|B2|||Age||years|Mean|45.29|45.29|Standard Deviation|10.941|10.941|||
4184233|NCT00789074|4005889|B1|||Age||years|Mean|45.91|45.91|Standard Deviation|11.439|11.439|||
4184234|NCT00789074|4005887|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4184235|NCT00789074|4005888|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4184236|NCT00789074|4005889|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4184237|NCT00789074|4005887|B3||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
4184238|NCT00789074|4005888|B2||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4184239|NCT00789074|4005889|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4184240|NCT00789074|4005887|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4184241|NCT00789074|4005888|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4184242|NCT00789074|4005889|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4184243|NCT00789035|4005906|B6||Male|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4184244|NCT00789035|4005907|B5||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4184245|NCT00789035|4005908|B4||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4184246|NCT00789035|4005909|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4184247|NCT00789035|4005910|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4184248|NCT00789035|4005911|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4184249|NCT00789035|4005906|B6||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4184250|NCT00789035|4005907|B5||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4184251|NCT00789035|4005908|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4184252|NCT00789035|4005909|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4184253|NCT00789035|4005910|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4184254|NCT00789035|4005911|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4184255|NCT00789035|4005906|B6|||Age||years|Mean|57.5|57.5|Standard Deviation|9.8|9.8|||
4184256|NCT00789035|4005907|B5|||Age||years|Mean|57.0|57.0|Standard Deviation|8.9|8.9|||
4184257|NCT00789035|4005908|B4|||Age||years|Mean|56.4|56.4|Standard Deviation|10.3|10.3|||
4184258|NCT00789035|4005909|B3|||Age||years|Mean|58.2|58.2|Standard Deviation|9.9|9.9|||
4184259|NCT00789035|4005910|B2|||Age||years|Mean|58.4|58.4|Standard Deviation|9.7|9.7|||
4184260|NCT00789035|4005911|B1|||Age||years|Mean|57.5|57.5|Standard Deviation|10.2|10.2|||
4184261|NCT00788957|4005970|B5|Part 2 Participants||Months Since Metastatic Disease Diagnosis||months|Mean|22.9|22.9|Standard Deviation|19.5|19.5|||
4184262|NCT00788957|4005971|B4|Part 2 Participants||Months Since Metastatic Disease Diagnosis||months|Mean|21.1|21.1|Standard Deviation|16.0|16.0|||
4184263|NCT00788957|4005972|B3|Part 2 Participants||Months Since Metastatic Disease Diagnosis||months|Mean|25.8|25.8|Standard Deviation|27.0|27.0|||
4184264|NCT00788957|4005973|B2|Part 2 Participants||Months Since Metastatic Disease Diagnosis||months|Mean|21.8|21.8|Standard Deviation|12.6|12.6|||
4184265|NCT00788957|4005974|B1|Part 2 Participants||Months Since Metastatic Disease Diagnosis||months|Mean|NA||Standard Deviation|NA||||
4184266|NCT00788957|4005970|B5|Part 1 Participants||Months Since Metastatic Disease Diagnosis||months|Mean|29.7|29.7|Standard Deviation|27.6|27.6|||
4184267|NCT00788957|4005971|B4|Part 1 Participants||Months Since Metastatic Disease Diagnosis||months|Mean|NA||Standard Deviation|NA||||
4184268|NCT00788957|4005972|B3|Part 1 Participants||Months Since Metastatic Disease Diagnosis||months|Mean|NA||Standard Deviation|NA||||
4184269|NCT00788957|4005973|B2|Part 1 Participants||Months Since Metastatic Disease Diagnosis||months|Mean|NA||Standard Deviation|NA||||
4184270|NCT00788957|4005974|B1|Part 1 Participants||Months Since Metastatic Disease Diagnosis||months|Mean|29.7|29.7|Standard Deviation|27.6|27.6|||
4184271|NCT00788957|4005970|B5|Part 2 Participants||Months Since Primary Diagnosis|Data available for 9, 46, 46, and 45 participants in each treatment group respectively|months|Mean|33.7|33.7|Standard Deviation|26.9|26.9|||
4184272|NCT00788957|4005971|B4|Part 2 Participants||Months Since Primary Diagnosis|Data available for 9, 46, 46, and 45 participants in each treatment group respectively|months|Mean|34.7|34.7|Standard Deviation|28.7|28.7|||
4184273|NCT00788957|4005972|B3|Part 2 Participants||Months Since Primary Diagnosis|Data available for 9, 46, 46, and 45 participants in each treatment group respectively|months|Mean|36.2|36.2|Standard Deviation|31.8|31.8|||
4184274|NCT00788957|4005973|B2|Part 2 Participants||Months Since Primary Diagnosis|Data available for 9, 46, 46, and 45 participants in each treatment group respectively|months|Mean|30.3|30.3|Standard Deviation|18.5|18.5|||
4184275|NCT00788957|4005974|B1|Part 2 Participants||Months Since Primary Diagnosis|Data available for 9, 46, 46, and 45 participants in each treatment group respectively|months|Mean|NA||Standard Deviation|NA||||
4184276|NCT00788957|4005970|B5|Part 1 Participants||Months Since Primary Diagnosis|Data available for 9, 46, 46, and 45 participants in each treatment group respectively|months|Mean|41.7|41.7|Standard Deviation|29.7|29.7|||
4184277|NCT00788957|4005971|B4|Part 1 Participants||Months Since Primary Diagnosis|Data available for 9, 46, 46, and 45 participants in each treatment group respectively|months|Mean|NA||Standard Deviation|NA||||
4184278|NCT00788957|4005972|B3|Part 1 Participants||Months Since Primary Diagnosis|Data available for 9, 46, 46, and 45 participants in each treatment group respectively|months|Mean|NA||Standard Deviation|NA||||
4184279|NCT00788957|4005973|B2|Part 1 Participants||Months Since Primary Diagnosis|Data available for 9, 46, 46, and 45 participants in each treatment group respectively|months|Mean|NA||Standard Deviation|NA||||
4184280|NCT00788957|4005974|B1|Part 1 Participants||Months Since Primary Diagnosis|Data available for 9, 46, 46, and 45 participants in each treatment group respectively|months|Mean|41.7|41.7|Standard Deviation|29.7|29.7|||
4184281|NCT00788957|4005970|B5|Unknown||Adenocarcinoma Differential of Primary Tumor||participants|Number|15|15.0||||||
4184282|NCT00788957|4005971|B4|Unknown||Adenocarcinoma Differential of Primary Tumor||participants|Number|3|3.0||||||
4184283|NCT00788957|4005972|B3|Unknown||Adenocarcinoma Differential of Primary Tumor||participants|Number|8|8.0||||||
4184284|NCT00788957|4005973|B2|Unknown||Adenocarcinoma Differential of Primary Tumor||participants|Number|4|4.0||||||
4184285|NCT00788957|4005974|B1|Unknown||Adenocarcinoma Differential of Primary Tumor||participants|Number|0|0.0||||||
4184286|NCT00788957|4005970|B5|Undifferentiated||Adenocarcinoma Differential of Primary Tumor||participants|Number|1|1.0||||||
4184287|NCT00788957|4005971|B4|Undifferentiated||Adenocarcinoma Differential of Primary Tumor||participants|Number|1|1.0||||||
4184288|NCT00788957|4005972|B3|Undifferentiated||Adenocarcinoma Differential of Primary Tumor||participants|Number|0|0.0||||||
4184289|NCT00788957|4005973|B2|Undifferentiated||Adenocarcinoma Differential of Primary Tumor||participants|Number|0|0.0||||||
4184290|NCT00788957|4005974|B1|Undifferentiated||Adenocarcinoma Differential of Primary Tumor||participants|Number|0|0.0||||||
4184291|NCT00788957|4005970|B5|Poorly differentiated||Adenocarcinoma Differential of Primary Tumor||participants|Number|31|31.0||||||
4184292|NCT00788957|4005971|B4|Poorly differentiated||Adenocarcinoma Differential of Primary Tumor||participants|Number|11|11.0||||||
4184293|NCT00788957|4005972|B3|Poorly differentiated||Adenocarcinoma Differential of Primary Tumor||participants|Number|6|6.0||||||
4184294|NCT00788957|4005973|B2|Poorly differentiated||Adenocarcinoma Differential of Primary Tumor||participants|Number|9|9.0||||||
4184295|NCT00788957|4005974|B1|Poorly differentiated||Adenocarcinoma Differential of Primary Tumor||participants|Number|5|5.0||||||
4184296|NCT00788957|4005970|B5|Moderately differentiated||Adenocarcinoma Differential of Primary Tumor||participants|Number|85|85.0||||||
4184297|NCT00788957|4005971|B4|Moderately differentiated||Adenocarcinoma Differential of Primary Tumor||participants|Number|25|25.0||||||
4184298|NCT00788957|4005972|B3|Moderately differentiated||Adenocarcinoma Differential of Primary Tumor||participants|Number|27|27.0||||||
4184299|NCT00788957|4005973|B2|Moderately differentiated||Adenocarcinoma Differential of Primary Tumor||participants|Number|27|27.0||||||
4184300|NCT00788957|4005974|B1|Moderately differentiated||Adenocarcinoma Differential of Primary Tumor||participants|Number|6|6.0||||||
4184301|NCT00788957|4005970|B5|Well differentiated||Adenocarcinoma Differential of Primary Tumor||participants|Number|21|21.0||||||
4184302|NCT00788957|4005971|B4|Well differentiated||Adenocarcinoma Differential of Primary Tumor||participants|Number|6|6.0||||||
4184303|NCT00788957|4005972|B3|Well differentiated||Adenocarcinoma Differential of Primary Tumor||participants|Number|7|7.0||||||
4184304|NCT00788957|4005973|B2|Well differentiated||Adenocarcinoma Differential of Primary Tumor||participants|Number|8|8.0||||||
4184305|NCT00788957|4005974|B1|Well differentiated||Adenocarcinoma Differential of Primary Tumor||participants|Number|0|0.0||||||
4184306|NCT00788957|4005970|B5|Rectal cancer||Primary Tumor Type||participants|Number|55|55.0||||||
4184307|NCT00788957|4005971|B4|Rectal cancer||Primary Tumor Type||participants|Number|18|18.0||||||
4184308|NCT00788957|4005972|B3|Rectal cancer||Primary Tumor Type||participants|Number|15|15.0||||||
4184309|NCT00788957|4005973|B2|Rectal cancer||Primary Tumor Type||participants|Number|17|17.0||||||
4184310|NCT00788957|4005974|B1|Rectal cancer||Primary Tumor Type||participants|Number|5|5.0||||||
4184311|NCT00788957|4005970|B5|Colon cancer||Primary Tumor Type||participants|Number|98|98.0||||||
4184312|NCT00788957|4005971|B4|Colon cancer||Primary Tumor Type||participants|Number|28|28.0||||||
4184313|NCT00788957|4005972|B3|Colon cancer||Primary Tumor Type||participants|Number|33|33.0||||||
4184314|NCT00788957|4005973|B2|Colon cancer||Primary Tumor Type||participants|Number|31|31.0||||||
4184315|NCT00788957|4005974|B1|Colon cancer||Primary Tumor Type||participants|Number|6|6.0||||||
4184316|NCT00788957|4005970|B5|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4184317|NCT00788957|4005971|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4184318|NCT00788957|4005972|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4184319|NCT00788957|4005973|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4184320|NCT00788957|4005974|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4184321|NCT00788957|4005970|B5|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4184322|NCT00788957|4005971|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4184323|NCT00788957|4005972|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4184324|NCT00788957|4005973|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4184325|NCT00788957|4005974|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4184326|NCT00788957|4005970|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4184327|NCT00788957|4005971|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4184328|NCT00788957|4005972|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4184329|NCT00788957|4005973|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4184330|NCT00788957|4005974|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4184331|NCT00788957|4005970|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4184332|NCT00788957|4005971|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4184333|NCT00788957|4005972|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4184334|NCT00788957|4005973|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4184335|NCT00788957|4005974|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4184336|NCT00788957|4005970|B5|White or Caucasian||Race/Ethnicity, Customized||participants|Number|148|148.0||||||
4184337|NCT00788957|4005971|B4|White or Caucasian||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4184338|NCT00788957|4005972|B3|White or Caucasian||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4184339|NCT00788957|4005973|B2|White or Caucasian||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4184340|NCT00788957|4005974|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4184341|NCT00788957|4005970|B5||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4184342|NCT00788957|4005971|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4184343|NCT00788957|4005972|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4184344|NCT00788957|4005973|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4184345|NCT00788957|4005974|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4184346|NCT00788957|4005970|B5||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4184347|NCT00788957|4005971|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4184348|NCT00788957|4005972|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4184349|NCT00788957|4005973|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4184350|NCT00788957|4005974|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4184351|NCT00788957|4005970|B5|Part 2 Participants||Age||years|Mean|59.7|59.7|Standard Deviation|10.6|10.6|||
4184352|NCT00788957|4005971|B4|Part 2 Participants||Age||years|Mean|62.0|62.0|Standard Deviation|9.7|9.7|||
4184353|NCT00788957|4005972|B3|Part 2 Participants||Age||years|Mean|62.1|62.1|Standard Deviation|7.5|7.5|||
4184354|NCT00788957|4005973|B2|Part 2 Participants||Age||years|Mean|55.0|55.0|Standard Deviation|12.5|12.5|||
4184355|NCT00788957|4005974|B1|Part 2 Participants||Age||years|Mean|NA||Standard Deviation|NA||||
4184356|NCT00788957|4005970|B5|Part 1 Participants||Age||years|Mean|56.5|56.5|Standard Deviation|13.8|13.8|||
4184357|NCT00788957|4005971|B4|Part 1 Participants||Age||years|Mean|NA||Standard Deviation|NA||||
4184358|NCT00788957|4005972|B3|Part 1 Participants||Age||years|Mean|NA||Standard Deviation|NA||||
4184359|NCT00788957|4005973|B2|Part 1 Participants||Age||years|Mean|NA||Standard Deviation|NA||||
4184360|NCT00788957|4005974|B1|Part 1 Participants||Age||years|Mean|56.5|56.5|Standard Deviation|13.8|13.8|||
4184361|NCT00788892|4006033|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4184362|NCT00788892|4006034|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4184363|NCT00788892|4006035|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4184364|NCT00788892|4006033|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4184365|NCT00788892|4006034|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4184366|NCT00788892|4006035|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4184367|NCT00788892|4006033|B3|||Age||years|Mean|67.9|67.9|Standard Deviation|4.69|4.69|||
4184368|NCT00788892|4006034|B2|||Age||years|Mean|68.2|68.2|Standard Deviation|4.88|4.88|||
4184369|NCT00788892|4006035|B1|||Age||years|Mean|67.8|67.8|Standard Deviation|4.63|4.63|||
4184370|NCT00788775|4006052|B3||CNS Metastaic: Yes|CNS Metastatic Status|Central Nervous System (CNS)|Participants|Count of Participants|8|8.0||||||
4184371|NCT00788775|4006053|B2||CNS Metastaic: Yes|CNS Metastatic Status|Central Nervous System (CNS)|Participants|Count of Participants|8|8.0||||||
4184372|NCT00788775|4006054|B1||CNS Metastaic: Yes|CNS Metastatic Status|Central Nervous System (CNS)|Participants|Count of Participants|0|0.0||||||
4184373|NCT00788775|4006052|B3||CNS Metastaic: No|CNS Metastatic Status|Central Nervous System (CNS)|Participants|Count of Participants|11|11.0||||||
4184374|NCT00788775|4006053|B2||CNS Metastaic: No|CNS Metastatic Status|Central Nervous System (CNS)|Participants|Count of Participants|0|0.0||||||
4184375|NCT00788775|4006054|B1||CNS Metastaic: No|CNS Metastatic Status|Central Nervous System (CNS)|Participants|Count of Participants|11|11.0||||||
4184376|NCT00788775|4006052|B3||ECOG PS2|ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) PS: (PS0) Fully active, able to carry on all pre-disease performance without restriction (PS1) Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (PS2) Ambulatory and capable of all self-care but unable to carry out any work activities; Up and about >50% of waking hours|Participants|Count of Participants|0|0.0||||||
4184377|NCT00788775|4006053|B2||ECOG PS2|ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) PS: (PS0) Fully active, able to carry on all pre-disease performance without restriction (PS1) Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (PS2) Ambulatory and capable of all self-care but unable to carry out any work activities; Up and about >50% of waking hours|Participants|Count of Participants|0|0.0||||||
4184378|NCT00788775|4006054|B1||ECOG PS2|ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) PS: (PS0) Fully active, able to carry on all pre-disease performance without restriction (PS1) Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (PS2) Ambulatory and capable of all self-care but unable to carry out any work activities; Up and about >50% of waking hours|Participants|Count of Participants|0|0.0||||||
4184379|NCT00788775|4006052|B3||ECOG PS1|ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) PS: (PS0) Fully active, able to carry on all pre-disease performance without restriction (PS1) Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (PS2) Ambulatory and capable of all self-care but unable to carry out any work activities; Up and about >50% of waking hours|Participants|Count of Participants|8|8.0||||||
4184380|NCT00788775|4006053|B2||ECOG PS1|ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) PS: (PS0) Fully active, able to carry on all pre-disease performance without restriction (PS1) Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (PS2) Ambulatory and capable of all self-care but unable to carry out any work activities; Up and about >50% of waking hours|Participants|Count of Participants|4|4.0||||||
4184381|NCT00788775|4006054|B1||ECOG PS1|ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) PS: (PS0) Fully active, able to carry on all pre-disease performance without restriction (PS1) Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (PS2) Ambulatory and capable of all self-care but unable to carry out any work activities; Up and about >50% of waking hours|Participants|Count of Participants|4|4.0||||||
4184382|NCT00788775|4006052|B3||ECOG PS0|ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) PS: (PS0) Fully active, able to carry on all pre-disease performance without restriction (PS1) Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (PS2) Ambulatory and capable of all self-care but unable to carry out any work activities; Up and about >50% of waking hours|Participants|Count of Participants|11|11.0||||||
4184383|NCT00788775|4006053|B2||ECOG PS0|ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) PS: (PS0) Fully active, able to carry on all pre-disease performance without restriction (PS1) Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (PS2) Ambulatory and capable of all self-care but unable to carry out any work activities; Up and about >50% of waking hours|Participants|Count of Participants|4|4.0||||||
4184384|NCT00788775|4006054|B1||ECOG PS0|ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) PS: (PS0) Fully active, able to carry on all pre-disease performance without restriction (PS1) Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (PS2) Ambulatory and capable of all self-care but unable to carry out any work activities; Up and about >50% of waking hours|Participants|Count of Participants|7|7.0||||||
4184385|NCT00788775|4006052|B3|Chronically Sun-Damaged (CSD)||Melanoma Type||participants|Number|3|3.0||||||
4184386|NCT00788775|4006053|B2|Chronically Sun-Damaged (CSD)||Melanoma Type||participants|Number|1|1.0||||||
4184387|NCT00788775|4006054|B1|Chronically Sun-Damaged (CSD)||Melanoma Type||participants|Number|2|2.0||||||
4184388|NCT00788775|4006052|B3|Mucosal||Melanoma Type||participants|Number|10|10.0||||||
4184389|NCT00788775|4006053|B2|Mucosal||Melanoma Type||participants|Number|4|4.0||||||
4184390|NCT00788775|4006054|B1|Mucosal||Melanoma Type||participants|Number|6|6.0||||||
4184391|NCT00788775|4006052|B3|Acral||Melanoma Type||participants|Number|6|6.0||||||
4184392|NCT00788775|4006053|B2|Acral||Melanoma Type||participants|Number|3|3.0||||||
4184393|NCT00788775|4006054|B1|Acral||Melanoma Type||participants|Number|3|3.0||||||
4184394|NCT00788775|4006052|B3|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4184395|NCT00788775|4006053|B2|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4184396|NCT00788775|4006054|B1|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4184397|NCT00788775|4006052|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4184398|NCT00788775|4006053|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4184399|NCT00788775|4006054|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184400|NCT00788775|4006052|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184401|NCT00788775|4006053|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184402|NCT00788775|4006054|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184403|NCT00788775|4006052|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4184404|NCT00788775|4006053|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4184405|NCT00788775|4006054|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4184406|NCT00788775|4006052|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4184407|NCT00788775|4006053|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184408|NCT00788775|4006054|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4184409|NCT00788775|4006052|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184410|NCT00788775|4006053|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184411|NCT00788775|4006054|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184412|NCT00788775|4006052|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184413|NCT00788775|4006053|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184414|NCT00788775|4006054|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184415|NCT00788775|4006052|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184416|NCT00788775|4006053|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184417|NCT00788775|4006054|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184418|NCT00788775|4006052|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4184419|NCT00788775|4006053|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4184420|NCT00788775|4006054|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4184421|NCT00788775|4006052|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4184422|NCT00788775|4006053|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4184423|NCT00788775|4006054|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4184424|NCT00788775|4006052|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4184425|NCT00788775|4006053|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4184426|NCT00788775|4006054|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4184427|NCT00788775|4006052|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4184428|NCT00788775|4006053|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4184429|NCT00788775|4006054|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4184430|NCT00788775|4006052|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4184431|NCT00788775|4006053|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4184432|NCT00788775|4006054|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4184433|NCT00788775|4006052|B3|||Age||years|Median|67|67.0|Full Range|||38.0|85.0|
4184434|NCT00788775|4006053|B2|||Age||years|Median|60|60.0|Full Range|||38.0|85.0|
4184435|NCT00788775|4006054|B1|||Age||years|Median|68|68.0|Full Range|||55.0|82.0|
4184436|NCT00788710|4006067|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4184437|NCT00788710|4006068|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4184438|NCT00788710|4006069|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4184439|NCT00788710|4006070|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4184440|NCT00788710|4006067|B4||Female|Sex: Female, Male||Participants|Count of Participants|430|430.0||||||
4184441|NCT00788710|4006068|B3||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4184442|NCT00788710|4006069|B2||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4184443|NCT00788710|4006070|B1||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4184444|NCT00788710|4006067|B4|||Age||years|Mean|46.3|46.3|Standard Deviation|7.0|7.0|||
4184445|NCT00788710|4006068|B3|||Age||years|Mean|45.7|45.7|Standard Deviation|7.0|7.0|||
4184446|NCT00788710|4006069|B2|||Age||years|Mean|47.0|47.0|Standard Deviation|7.2|7.2|||
4184447|NCT00788710|4006070|B1|||Age||years|Mean|46.3|46.3|Standard Deviation|6.9|6.9|||
4184448|NCT00788697|4006086|B1|Europe||Region of Enrollment||participants|Number|15|15.0||||||
4184449|NCT00788697|4006086|B1|United States||Region of Enrollment||participants|Number|225|225.0||||||
4184450|NCT00788697|4006086|B1|Other||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4184451|NCT00788697|4006086|B1|Asian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4184452|NCT00788697|4006086|B1|Black||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4184453|NCT00788697|4006086|B1|White||Race/Ethnicity, Customized||participants|Number|161|161.0||||||
4184454|NCT00788697|4006086|B1||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4184455|NCT00788697|4006086|B1||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4184456|NCT00788697|4006086|B1||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
4184457|NCT00788697|4006086|B1||Between 18 and 65 years|Age||Participants|Count of Participants|190|190.0||||||
4184458|NCT00788697|4006086|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4184459|NCT00788593|4006133|B1|||Body Mass Index (BMI)|BMI was calculated by weight divided by height squared and measured as kilogram per square meter (kg/m^2).|kg/m^2|Mean|23.36|23.36|Standard Deviation|4.44|4.44|||
4184460|NCT00788593|4006133|B1|||Body Weight||kilogram (kg)|Mean|68.75|68.75|Standard Deviation|14.12|14.12|||
4184461|NCT00788593|4006133|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4184462|NCT00788593|4006133|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4184463|NCT00788593|4006133|B1|||Age||years|Mean|51.91|51.91|Standard Deviation|12.08|12.08|||
4184464|NCT00788372|4006152|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4184465|NCT00788372|4006152|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4184466|NCT00788372|4006152|B1|||Age||years|Mean|61.4|61.4|Standard Deviation|14.98|14.98|||
4184467|NCT00788255|4006166|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4184468|NCT00788255|4006166|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4184469|NCT00788255|4006166|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4184470|NCT00788255|4006166|B1||>=65 years|Age|Our cohort comprised healthy adult pregnant women|Participants|Count of Participants|0|0.0||||||
4184471|NCT00788255|4006166|B1||Between 18 and 65 years|Age|Our cohort comprised healthy adult pregnant women|Participants|Count of Participants|25|25.0||||||
4184472|NCT00788255|4006166|B1||<=18 years|Age|Our cohort comprised healthy adult pregnant women|Participants|Count of Participants|0|0.0||||||
4184473|NCT00788073|4006179|B3|United States||Region of Enrollment||participants|Number|63|63.0||||||
4184474|NCT00788073|4006180|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4184475|NCT00788073|4006181|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4184476|NCT00788073|4006179|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4184477|NCT00788073|4006180|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4184478|NCT00788073|4006181|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4184479|NCT00788073|4006179|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4184480|NCT00788073|4006180|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4184481|NCT00788073|4006181|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4184482|NCT00788073|4006179|B3|||Age||years|Mean|14.1|14.1|Standard Deviation|6.78|6.78|||
4184483|NCT00788073|4006180|B2|||Age||years|Mean|13.9|13.9|Standard Deviation|6.39|6.39|||
4184484|NCT00788073|4006181|B1|||Age||years|Mean|14.2|14.2|Standard Deviation|7.29|7.29|||
4184485|NCT00788073|4006179|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4184486|NCT00788073|4006180|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4184487|NCT00788073|4006181|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4184488|NCT00788073|4006179|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4184489|NCT00788073|4006180|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4184490|NCT00788073|4006181|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4184491|NCT00788073|4006179|B3||<=18 years|Age||Participants|Count of Participants|46|46.0||||||
4184492|NCT00788073|4006180|B2||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
4184493|NCT00788073|4006181|B1||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
4184494|NCT00788008|4006190|B3|United States||Region of Enrollment||participants|Number|199|199.0||||||
4184495|NCT00788008|4006191|B2|United States||Region of Enrollment||participants|Number|101|101.0||||||
4184496|NCT00788008|4006192|B1|United States||Region of Enrollment||participants|Number|98|98.0||||||
4184497|NCT00788008|4006190|B3||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4184498|NCT00788008|4006191|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4184499|NCT00788008|4006192|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4184500|NCT00788008|4006190|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4184501|NCT00788008|4006191|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4184502|NCT00788008|4006192|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4184503|NCT00788008|4006190|B3|||Age||years|Mean|73.25|73.25|Full Range|||65.0|91.0|
4184504|NCT00788008|4006191|B2|||Age||years|Mean|73.13|73.13|Full Range|||65.0|91.0|
4184505|NCT00788008|4006192|B1|||Age||years|Mean|73.38|73.38|Full Range|||66.0|86.0|
4184506|NCT00787943|4006199|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4184507|NCT00787943|4006199|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4184508|NCT00787943|4006199|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4184509|NCT00787943|4006199|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4184510|NCT00787943|4006199|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4184511|NCT00787943|4006199|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4184512|NCT00787930|4006207|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4184513|NCT00787930|4006207|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4184514|NCT00787930|4006207|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4184515|NCT00787930|4006207|B1|||Age||years|Mean|49.68|49.68|Standard Deviation|17.84|17.84|||
4184516|NCT00787930|4006207|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4184517|NCT00787930|4006207|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4184518|NCT00787930|4006207|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4184519|NCT00787917|4006220|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4184520|NCT00787917|4006221|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4184521|NCT00787917|4006222|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4184522|NCT00787917|4006220|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4184523|NCT00787917|4006221|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4184524|NCT00787917|4006222|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4184525|NCT00787917|4006220|B3|||Age||years|Mean|23|23.0|Standard Deviation|7.1|7.1|||
4184526|NCT00787917|4006221|B2|||Age||years|Mean|28|28.0|Standard Deviation|9.5|9.5|||
4184527|NCT00787917|4006222|B1|||Age||years|Mean|21|21.0|Standard Deviation|4.1|4.1|||
4184528|NCT00787904|4006240|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184529|NCT00787904|4006241|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184530|NCT00787904|4006242|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184531|NCT00787904|4006240|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184532|NCT00787904|4006241|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184533|NCT00787904|4006242|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184534|NCT00787904|4006240|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4184535|NCT00787904|4006241|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4184536|NCT00787904|4006242|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4184537|NCT00787904|4006240|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4184538|NCT00787904|4006241|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4184539|NCT00787904|4006242|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4184540|NCT00787904|4006240|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184541|NCT00787904|4006241|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184542|NCT00787904|4006242|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184543|NCT00787904|4006240|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184544|NCT00787904|4006241|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184545|NCT00787904|4006242|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184546|NCT00787904|4006240|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184547|NCT00787904|4006241|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184548|NCT00787904|4006242|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184549|NCT00787904|4006240|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4184550|NCT00787904|4006241|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4184551|NCT00787904|4006242|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4184552|NCT00787904|4006240|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4184553|NCT00787904|4006241|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4184554|NCT00787904|4006242|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4184555|NCT00787904|4006240|B3|||Age||years|Mean|42.9|42.9|Standard Deviation|6.5|6.5|||
4184556|NCT00787904|4006241|B2|||Age||years|Mean|41.4|41.4|Standard Deviation|7.1|7.1|||
4184557|NCT00787904|4006242|B1|||Age||years|Mean|46.3|46.3|Standard Deviation|5.1|5.1|||
4184558|NCT00787891|4006251|B3|||Baseline BMI||kg/cm2|Mean|17.2|17.2|Standard Deviation|3.64|3.64|||
4184559|NCT00787891|4006252|B2|||Baseline BMI||kg/cm2|Mean|16.8|16.8|Standard Deviation|3.11|3.11|||
4184560|NCT00787891|4006253|B1|||Baseline BMI||kg/cm2|Mean|17.5|17.5|Standard Deviation|4.08|4.08|||
4184561|NCT00787891|4006251|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4184562|NCT00787891|4006252|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4184563|NCT00787891|4006253|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4184564|NCT00787891|4006251|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4184565|NCT00787891|4006252|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4184566|NCT00787891|4006253|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4184567|NCT00787891|4006251|B3|||Age||years|Mean|5.7|5.7|Standard Deviation|3.37|3.37|||
4184568|NCT00787891|4006252|B2|||Age||years|Mean|5.4|5.4|Standard Deviation|3.26|3.26|||
4184569|NCT00787891|4006253|B1|||Age||years|Mean|5.9|5.9|Standard Deviation|3.49|3.49|||
4184570|NCT00787891|4006251|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4184571|NCT00787891|4006252|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4184572|NCT00787891|4006253|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4184573|NCT00787891|4006251|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4184574|NCT00787891|4006252|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4184575|NCT00787891|4006253|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4184576|NCT00787891|4006251|B3||<=18 years|Age||Participants|Count of Participants|127|127.0||||||
4184577|NCT00787891|4006252|B2||<=18 years|Age||Participants|Count of Participants|62|62.0||||||
4184578|NCT00787891|4006253|B1||<=18 years|Age||Participants|Count of Participants|65|65.0||||||
4184579|NCT00787852|4006272|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4184580|NCT00787852|4006274|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4184581|NCT00787852|4006272|B3|Male||Gender||participants|Number|8|8.0||||||
4184582|NCT00787852|4006274|B1|Male||Gender||participants|Number|8|8.0||||||
4184583|NCT00787852|4006272|B3|Female||Gender||participants|Number|3|3.0||||||
4184584|NCT00787852|4006274|B1|Female||Gender||participants|Number|3|3.0||||||
4184585|NCT00787852|4006272|B3|||Age||years|Mean|65.5|65.5|Standard Deviation|5.38|5.38|||
4184586|NCT00787852|4006274|B1|||Age||years|Mean|65.5|65.5|Standard Deviation|5.38|5.38|||
4184587|NCT00787852|4006272|B3|>=65 years||Age||participants|Number|5|5.0||||||
4184588|NCT00787852|4006274|B1|>=65 years||Age||participants|Number|5|5.0||||||
4184589|NCT00787852|4006272|B3|Between 18 and 65 years||Age||participants|Number|6|6.0||||||
4184590|NCT00787852|4006274|B1|Between 18 and 65 years||Age||participants|Number|6|6.0||||||
4184591|NCT00787852|4006272|B3|<=18 years||Age||participants|Number|0|0.0||||||
4184592|NCT00787852|4006274|B1|<=18 years||Age||participants|Number|0|0.0||||||
4184593|NCT00787839|4006281|B1|||BMI||kg/m2|Mean|30.3|30.3|Standard Deviation|5.20|5.2|||
4184594|NCT00787839|4006281|B1|United States||Region of Enrollment|Individuals receiving care at the Atlanta VA Medical Center|participants|Number|1535|1535.0||||||
4184595|NCT00787839|4006281|B1||Male|Sex: Female, Male||Participants|Count of Participants|1441|1441.0||||||
4184596|NCT00787839|4006281|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4184597|NCT00787839|4006281|B1|||Age||years|Mean|56.1|56.1|Standard Deviation|9.93|9.93|||
4184598|NCT00787800|4006302|B3|||Ventricular Depolarization (QRS) Duration|Note:QRS baseline data is missing for one Israeli subject. As the heart undergoes depolarization and repolarization, the electrical currents that are generated spread within the heart & throughout the body. This electrical activity can be measured by electrodes placed on the body surface & produce a tracing called an electrocardiogram (ECG, or EKG). The different waves that comprise the ECG represent the sequence of depolarization and repolarization of the atria and ventricles. Certain points on the ECG tracing are assigned letters. The QRS complex represents ventricular depolarization.|milliseconds|Mean|108.4|108.4|Standard Deviation|23.1|23.1|||
4184599|NCT00787800|4006303|B2|||Ventricular Depolarization (QRS) Duration|Note:QRS baseline data is missing for one Israeli subject. As the heart undergoes depolarization and repolarization, the electrical currents that are generated spread within the heart & throughout the body. This electrical activity can be measured by electrodes placed on the body surface & produce a tracing called an electrocardiogram (ECG, or EKG). The different waves that comprise the ECG represent the sequence of depolarization and repolarization of the atria and ventricles. Certain points on the ECG tracing are assigned letters. The QRS complex represents ventricular depolarization.|milliseconds|Mean|103.9|103.9|Standard Deviation|18.2|18.2|||
4184600|NCT00787800|4006304|B1|||Ventricular Depolarization (QRS) Duration|Note:QRS baseline data is missing for one Israeli subject. As the heart undergoes depolarization and repolarization, the electrical currents that are generated spread within the heart & throughout the body. This electrical activity can be measured by electrodes placed on the body surface & produce a tracing called an electrocardiogram (ECG, or EKG). The different waves that comprise the ECG represent the sequence of depolarization and repolarization of the atria and ventricles. Certain points on the ECG tracing are assigned letters. The QRS complex represents ventricular depolarization.|milliseconds|Mean|112.1|112.1|Standard Deviation|26.3|26.3|||
4184601|NCT00787800|4006302|B3|Amiodarone||Concomitant Medications|Each category lists the number of participants taking each medication.|Participants|Number|4|4.0||||||
4184602|NCT00787800|4006303|B2|Amiodarone||Concomitant Medications|Each category lists the number of participants taking each medication.|Participants|Number|3|3.0||||||
4184603|NCT00787800|4006304|B1|Amiodarone||Concomitant Medications|Each category lists the number of participants taking each medication.|Participants|Number|1|1.0||||||
4184604|NCT00787800|4006302|B3|Calcium Channel Blocker||Concomitant Medications|Each category lists the number of participants taking each medication.|Participants|Number|5|5.0||||||
4184605|NCT00787800|4006303|B2|Calcium Channel Blocker||Concomitant Medications|Each category lists the number of participants taking each medication.|Participants|Number|3|3.0||||||
4184606|NCT00787800|4006304|B1|Calcium Channel Blocker||Concomitant Medications|Each category lists the number of participants taking each medication.|Participants|Number|2|2.0||||||
4184607|NCT00787800|4006302|B3|Beta Blocker||Concomitant Medications|Each category lists the number of participants taking each medication.|Participants|Number|91|91.0||||||
4184608|NCT00787800|4006303|B2|Beta Blocker||Concomitant Medications|Each category lists the number of participants taking each medication.|Participants|Number|44|44.0||||||
4184609|NCT00787800|4006304|B1|Beta Blocker||Concomitant Medications|Each category lists the number of participants taking each medication.|Participants|Number|47|47.0||||||
4184610|NCT00787800|4006302|B3|Dilated Cardiomyopathy||Cardiac Disease|Participants could have more than one concomitant cardiac disease event/diagnosis, therefore the sum total of all cardiac conditions will not equal the total number of participants.|Participants|Number|23|23.0||||||
4184611|NCT00787800|4006303|B2|Dilated Cardiomyopathy||Cardiac Disease|Participants could have more than one concomitant cardiac disease event/diagnosis, therefore the sum total of all cardiac conditions will not equal the total number of participants.|Participants|Number|10|10.0||||||
4184612|NCT00787800|4006304|B1|Dilated Cardiomyopathy||Cardiac Disease|Participants could have more than one concomitant cardiac disease event/diagnosis, therefore the sum total of all cardiac conditions will not equal the total number of participants.|Participants|Number|13|13.0||||||
4184613|NCT00787800|4006302|B3|Hypertrophic Cardiomyopathy||Cardiac Disease|Participants could have more than one concomitant cardiac disease event/diagnosis, therefore the sum total of all cardiac conditions will not equal the total number of participants.|Participants|Number|12|12.0||||||
4184614|NCT00787800|4006303|B2|Hypertrophic Cardiomyopathy||Cardiac Disease|Participants could have more than one concomitant cardiac disease event/diagnosis, therefore the sum total of all cardiac conditions will not equal the total number of participants.|Participants|Number|6|6.0||||||
4184615|NCT00787800|4006304|B1|Hypertrophic Cardiomyopathy||Cardiac Disease|Participants could have more than one concomitant cardiac disease event/diagnosis, therefore the sum total of all cardiac conditions will not equal the total number of participants.|Participants|Number|6|6.0||||||
4184616|NCT00787800|4006302|B3|Coronary Artery Bypass Graft||Cardiac Disease|Participants could have more than one concomitant cardiac disease event/diagnosis, therefore the sum total of all cardiac conditions will not equal the total number of participants.|Participants|Number|36|36.0||||||
4184617|NCT00787800|4006303|B2|Coronary Artery Bypass Graft||Cardiac Disease|Participants could have more than one concomitant cardiac disease event/diagnosis, therefore the sum total of all cardiac conditions will not equal the total number of participants.|Participants|Number|20|20.0||||||
4184618|NCT00787800|4006304|B1|Coronary Artery Bypass Graft||Cardiac Disease|Participants could have more than one concomitant cardiac disease event/diagnosis, therefore the sum total of all cardiac conditions will not equal the total number of participants.|Participants|Number|16|16.0||||||
4184619|NCT00787800|4006302|B3|Percutaneous Coronary Intervention||Cardiac Disease|Participants could have more than one concomitant cardiac disease event/diagnosis, therefore the sum total of all cardiac conditions will not equal the total number of participants.|Participants|Number|50|50.0||||||
4184620|NCT00787800|4006303|B2|Percutaneous Coronary Intervention||Cardiac Disease|Participants could have more than one concomitant cardiac disease event/diagnosis, therefore the sum total of all cardiac conditions will not equal the total number of participants.|Participants|Number|27|27.0||||||
4184621|NCT00787800|4006304|B1|Percutaneous Coronary Intervention||Cardiac Disease|Participants could have more than one concomitant cardiac disease event/diagnosis, therefore the sum total of all cardiac conditions will not equal the total number of participants.|Participants|Number|23|23.0||||||
4184622|NCT00787800|4006302|B3|Myocardial Infarction||Cardiac Disease|Participants could have more than one concomitant cardiac disease event/diagnosis, therefore the sum total of all cardiac conditions will not equal the total number of participants.|Participants|Number|66|66.0||||||
4184623|NCT00787800|4006303|B2|Myocardial Infarction||Cardiac Disease|Participants could have more than one concomitant cardiac disease event/diagnosis, therefore the sum total of all cardiac conditions will not equal the total number of participants.|Participants|Number|35|35.0||||||
4184624|NCT00787800|4006304|B1|Myocardial Infarction||Cardiac Disease|Participants could have more than one concomitant cardiac disease event/diagnosis, therefore the sum total of all cardiac conditions will not equal the total number of participants.|Participants|Number|31|31.0||||||
4184625|NCT00787800|4006302|B3|Coronary Artery Disease||Cardiac Disease|Participants could have more than one concomitant cardiac disease event/diagnosis, therefore the sum total of all cardiac conditions will not equal the total number of participants.|Participants|Number|71|71.0||||||
4184626|NCT00787800|4006303|B2|Coronary Artery Disease||Cardiac Disease|Participants could have more than one concomitant cardiac disease event/diagnosis, therefore the sum total of all cardiac conditions will not equal the total number of participants.|Participants|Number|36|36.0||||||
4184627|NCT00787800|4006304|B1|Coronary Artery Disease||Cardiac Disease|Participants could have more than one concomitant cardiac disease event/diagnosis, therefore the sum total of all cardiac conditions will not equal the total number of participants.|Participants|Number|35|35.0||||||
4184628|NCT00787800|4006302|B3|History of Paroxysmal Atrial Fibrillation||Co-morbidities|Participants could have had more than one co-morbidity, therefore the sum total of co-morbid conditions will not equal the total number of participants.|participants|Number|9|9.0||||||
4184725|NCT00787644|4006339|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184629|NCT00787800|4006303|B2|History of Paroxysmal Atrial Fibrillation||Co-morbidities|Participants could have had more than one co-morbidity, therefore the sum total of co-morbid conditions will not equal the total number of participants.|participants|Number|3|3.0||||||
4184630|NCT00787800|4006304|B1|History of Paroxysmal Atrial Fibrillation||Co-morbidities|Participants could have had more than one co-morbidity, therefore the sum total of co-morbid conditions will not equal the total number of participants.|participants|Number|6|6.0||||||
4184631|NCT00787800|4006302|B3|Transient Ischemic Attack||Co-morbidities|Participants could have had more than one co-morbidity, therefore the sum total of co-morbid conditions will not equal the total number of participants.|participants|Number|3|3.0||||||
4184632|NCT00787800|4006303|B2|Transient Ischemic Attack||Co-morbidities|Participants could have had more than one co-morbidity, therefore the sum total of co-morbid conditions will not equal the total number of participants.|participants|Number|3|3.0||||||
4184633|NCT00787800|4006304|B1|Transient Ischemic Attack||Co-morbidities|Participants could have had more than one co-morbidity, therefore the sum total of co-morbid conditions will not equal the total number of participants.|participants|Number|0|0.0||||||
4184634|NCT00787800|4006302|B3|Stroke||Co-morbidities|Participants could have had more than one co-morbidity, therefore the sum total of co-morbid conditions will not equal the total number of participants.|participants|Number|5|5.0||||||
4184635|NCT00787800|4006303|B2|Stroke||Co-morbidities|Participants could have had more than one co-morbidity, therefore the sum total of co-morbid conditions will not equal the total number of participants.|participants|Number|3|3.0||||||
4184636|NCT00787800|4006304|B1|Stroke||Co-morbidities|Participants could have had more than one co-morbidity, therefore the sum total of co-morbid conditions will not equal the total number of participants.|participants|Number|2|2.0||||||
4184637|NCT00787800|4006302|B3|Hyperlipidemia||Co-morbidities|Participants could have had more than one co-morbidity, therefore the sum total of co-morbid conditions will not equal the total number of participants.|participants|Number|70|70.0||||||
4184638|NCT00787800|4006303|B2|Hyperlipidemia||Co-morbidities|Participants could have had more than one co-morbidity, therefore the sum total of co-morbid conditions will not equal the total number of participants.|participants|Number|36|36.0||||||
4184639|NCT00787800|4006304|B1|Hyperlipidemia||Co-morbidities|Participants could have had more than one co-morbidity, therefore the sum total of co-morbid conditions will not equal the total number of participants.|participants|Number|34|34.0||||||
4184640|NCT00787800|4006302|B3|Hypertension||Co-morbidities|Participants could have had more than one co-morbidity, therefore the sum total of co-morbid conditions will not equal the total number of participants.|participants|Number|58|58.0||||||
4184641|NCT00787800|4006303|B2|Hypertension||Co-morbidities|Participants could have had more than one co-morbidity, therefore the sum total of co-morbid conditions will not equal the total number of participants.|participants|Number|26|26.0||||||
4184642|NCT00787800|4006304|B1|Hypertension||Co-morbidities|Participants could have had more than one co-morbidity, therefore the sum total of co-morbid conditions will not equal the total number of participants.|participants|Number|32|32.0||||||
4184643|NCT00787800|4006302|B3|Diabetes||Co-morbidities|Participants could have had more than one co-morbidity, therefore the sum total of co-morbid conditions will not equal the total number of participants.|participants|Number|33|33.0||||||
4184644|NCT00787800|4006303|B2|Diabetes||Co-morbidities|Participants could have had more than one co-morbidity, therefore the sum total of co-morbid conditions will not equal the total number of participants.|participants|Number|18|18.0||||||
4184645|NCT00787800|4006304|B1|Diabetes||Co-morbidities|Participants could have had more than one co-morbidity, therefore the sum total of co-morbid conditions will not equal the total number of participants.|participants|Number|15|15.0||||||
4184646|NCT00787800|4006302|B3|Pulmonary Disease||Co-morbidities|Participants could have had more than one co-morbidity, therefore the sum total of co-morbid conditions will not equal the total number of participants.|participants|Number|8|8.0||||||
4184647|NCT00787800|4006303|B2|Pulmonary Disease||Co-morbidities|Participants could have had more than one co-morbidity, therefore the sum total of co-morbid conditions will not equal the total number of participants.|participants|Number|7|7.0||||||
4184648|NCT00787800|4006304|B1|Pulmonary Disease||Co-morbidities|Participants could have had more than one co-morbidity, therefore the sum total of co-morbid conditions will not equal the total number of participants.|participants|Number|1|1.0||||||
4184649|NCT00787800|4006302|B3|||LV Ejection Fraction|Left ventricular Ejection Fraction (LVEF) is a clinical parameter used by cardiologists to describe how well the heart is pumping. LVEF is a calculated measure of the amount of blood pumped out of the lower chamber of the heart during a heartbeat, measured using echocardiography. A normal LVEF ranges from 55-70%. A LVEF of 65, for example, means that 65% of the total amount of blood in the left ventricle is pumped out with each heartbeat. Note: LVEF baseline data is missing for one Israeli subject, arm unknown.|Percentage of LV blood volume|Mean|29.9|29.9|Standard Deviation|13.7|13.7|||
4184650|NCT00787800|4006303|B2|||LV Ejection Fraction|Left ventricular Ejection Fraction (LVEF) is a clinical parameter used by cardiologists to describe how well the heart is pumping. LVEF is a calculated measure of the amount of blood pumped out of the lower chamber of the heart during a heartbeat, measured using echocardiography. A normal LVEF ranges from 55-70%. A LVEF of 65, for example, means that 65% of the total amount of blood in the left ventricle is pumped out with each heartbeat. Note: LVEF baseline data is missing for one Israeli subject, arm unknown.|Percentage of LV blood volume|Mean|29.6|29.6|Standard Deviation|13.3|13.3|||
4184651|NCT00787800|4006304|B1|||LV Ejection Fraction|Left ventricular Ejection Fraction (LVEF) is a clinical parameter used by cardiologists to describe how well the heart is pumping. LVEF is a calculated measure of the amount of blood pumped out of the lower chamber of the heart during a heartbeat, measured using echocardiography. A normal LVEF ranges from 55-70%. A LVEF of 65, for example, means that 65% of the total amount of blood in the left ventricle is pumped out with each heartbeat. Note: LVEF baseline data is missing for one Israeli subject, arm unknown.|Percentage of LV blood volume|Mean|30.1|30.1|Standard Deviation|14.1|14.1|||
4184726|NCT00787644|4006340|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184727|NCT00787644|4006338|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184728|NCT00787644|4006339|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184652|NCT00787800|4006302|B3|Heart Failure present but NYHA class not recorded||NYHA Classification|"New York Heart Association (NYHA) classification of Heart Failure is used to describe the degree of limitation due to heart failure at baseline.~I. No limitation, II. Limitation with ordinary activity, III. Limitation with less than daily activity, IV. Symptoms at rest, (NA-Not applicable; participants without heart failure)"|Participants|Number|3|3.0||||||
4184653|NCT00787800|4006303|B2|Heart Failure present but NYHA class not recorded||NYHA Classification|"New York Heart Association (NYHA) classification of Heart Failure is used to describe the degree of limitation due to heart failure at baseline.~I. No limitation, II. Limitation with ordinary activity, III. Limitation with less than daily activity, IV. Symptoms at rest, (NA-Not applicable; participants without heart failure)"|Participants|Number|1|1.0||||||
4184654|NCT00787800|4006304|B1|Heart Failure present but NYHA class not recorded||NYHA Classification|"New York Heart Association (NYHA) classification of Heart Failure is used to describe the degree of limitation due to heart failure at baseline.~I. No limitation, II. Limitation with ordinary activity, III. Limitation with less than daily activity, IV. Symptoms at rest, (NA-Not applicable; participants without heart failure)"|Participants|Number|2|2.0||||||
4184655|NCT00787800|4006302|B3|NA-No heart failure||NYHA Classification|"New York Heart Association (NYHA) classification of Heart Failure is used to describe the degree of limitation due to heart failure at baseline.~I. No limitation, II. Limitation with ordinary activity, III. Limitation with less than daily activity, IV. Symptoms at rest, (NA-Not applicable; participants without heart failure)"|Participants|Number|12|12.0||||||
4184656|NCT00787800|4006303|B2|NA-No heart failure||NYHA Classification|"New York Heart Association (NYHA) classification of Heart Failure is used to describe the degree of limitation due to heart failure at baseline.~I. No limitation, II. Limitation with ordinary activity, III. Limitation with less than daily activity, IV. Symptoms at rest, (NA-Not applicable; participants without heart failure)"|Participants|Number|5|5.0||||||
4184657|NCT00787800|4006304|B1|NA-No heart failure||NYHA Classification|"New York Heart Association (NYHA) classification of Heart Failure is used to describe the degree of limitation due to heart failure at baseline.~I. No limitation, II. Limitation with ordinary activity, III. Limitation with less than daily activity, IV. Symptoms at rest, (NA-Not applicable; participants without heart failure)"|Participants|Number|7|7.0||||||
4184658|NCT00787800|4006302|B3|IV-Symptoms at rest||NYHA Classification|"New York Heart Association (NYHA) classification of Heart Failure is used to describe the degree of limitation due to heart failure at baseline.~I. No limitation, II. Limitation with ordinary activity, III. Limitation with less than daily activity, IV. Symptoms at rest, (NA-Not applicable; participants without heart failure)"|Participants|Number|1|1.0||||||
4184659|NCT00787800|4006303|B2|IV-Symptoms at rest||NYHA Classification|"New York Heart Association (NYHA) classification of Heart Failure is used to describe the degree of limitation due to heart failure at baseline.~I. No limitation, II. Limitation with ordinary activity, III. Limitation with less than daily activity, IV. Symptoms at rest, (NA-Not applicable; participants without heart failure)"|Participants|Number|0|0.0||||||
4184660|NCT00787800|4006304|B1|IV-Symptoms at rest||NYHA Classification|"New York Heart Association (NYHA) classification of Heart Failure is used to describe the degree of limitation due to heart failure at baseline.~I. No limitation, II. Limitation with ordinary activity, III. Limitation with less than daily activity, IV. Symptoms at rest, (NA-Not applicable; participants without heart failure)"|Participants|Number|1|1.0||||||
4184661|NCT00787800|4006302|B3|III-Limitation with less than daily activity||NYHA Classification|"New York Heart Association (NYHA) classification of Heart Failure is used to describe the degree of limitation due to heart failure at baseline.~I. No limitation, II. Limitation with ordinary activity, III. Limitation with less than daily activity, IV. Symptoms at rest, (NA-Not applicable; participants without heart failure)"|Participants|Number|18|18.0||||||
4184662|NCT00787800|4006303|B2|III-Limitation with less than daily activity||NYHA Classification|"New York Heart Association (NYHA) classification of Heart Failure is used to describe the degree of limitation due to heart failure at baseline.~I. No limitation, II. Limitation with ordinary activity, III. Limitation with less than daily activity, IV. Symptoms at rest, (NA-Not applicable; participants without heart failure)"|Participants|Number|10|10.0||||||
4184663|NCT00787800|4006304|B1|III-Limitation with less than daily activity||NYHA Classification|"New York Heart Association (NYHA) classification of Heart Failure is used to describe the degree of limitation due to heart failure at baseline.~I. No limitation, II. Limitation with ordinary activity, III. Limitation with less than daily activity, IV. Symptoms at rest, (NA-Not applicable; participants without heart failure)"|Participants|Number|8|8.0||||||
4184664|NCT00787800|4006302|B3|II- Limitation with ordinary activity||NYHA Classification|"New York Heart Association (NYHA) classification of Heart Failure is used to describe the degree of limitation due to heart failure at baseline.~I. No limitation, II. Limitation with ordinary activity, III. Limitation with less than daily activity, IV. Symptoms at rest, (NA-Not applicable; participants without heart failure)"|Participants|Number|47|47.0||||||
4184665|NCT00787800|4006303|B2|II- Limitation with ordinary activity||NYHA Classification|"New York Heart Association (NYHA) classification of Heart Failure is used to describe the degree of limitation due to heart failure at baseline.~I. No limitation, II. Limitation with ordinary activity, III. Limitation with less than daily activity, IV. Symptoms at rest, (NA-Not applicable; participants without heart failure)"|Participants|Number|23|23.0||||||
4184666|NCT00787800|4006304|B1|II- Limitation with ordinary activity||NYHA Classification|"New York Heart Association (NYHA) classification of Heart Failure is used to describe the degree of limitation due to heart failure at baseline.~I. No limitation, II. Limitation with ordinary activity, III. Limitation with less than daily activity, IV. Symptoms at rest, (NA-Not applicable; participants without heart failure)"|Participants|Number|24|24.0||||||
4184667|NCT00787800|4006302|B3|I- No limitation||NYHA Classification|"New York Heart Association (NYHA) classification of Heart Failure is used to describe the degree of limitation due to heart failure at baseline.~I. No limitation, II. Limitation with ordinary activity, III. Limitation with less than daily activity, IV. Symptoms at rest, (NA-Not applicable; participants without heart failure)"|Participants|Number|19|19.0||||||
4184668|NCT00787800|4006303|B2|I- No limitation||NYHA Classification|"New York Heart Association (NYHA) classification of Heart Failure is used to describe the degree of limitation due to heart failure at baseline.~I. No limitation, II. Limitation with ordinary activity, III. Limitation with less than daily activity, IV. Symptoms at rest, (NA-Not applicable; participants without heart failure)"|Participants|Number|11|11.0||||||
4184669|NCT00787800|4006304|B1|I- No limitation||NYHA Classification|"New York Heart Association (NYHA) classification of Heart Failure is used to describe the degree of limitation due to heart failure at baseline.~I. No limitation, II. Limitation with ordinary activity, III. Limitation with less than daily activity, IV. Symptoms at rest, (NA-Not applicable; participants without heart failure)"|Participants|Number|8|8.0||||||
4184670|NCT00787800|4006302|B3|Israel||Region of Enrollment||participants|Number|50|50.0||||||
4184671|NCT00787800|4006303|B2|Israel||Region of Enrollment||participants|Number|25|25.0||||||
4184672|NCT00787800|4006304|B1|Israel||Region of Enrollment||participants|Number|25|25.0||||||
4184673|NCT00787800|4006302|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4184674|NCT00787800|4006303|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4184675|NCT00787800|4006304|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4184676|NCT00787800|4006302|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4184677|NCT00787800|4006303|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4184678|NCT00787800|4006304|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4184679|NCT00787800|4006302|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4184680|NCT00787800|4006303|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4184681|NCT00787800|4006304|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4184682|NCT00787800|4006302|B3|||Age|Date of birth not obtained for 4 Israeli subjects (treatment arm unknown).|years|Mean|61.2|61.2|Standard Deviation|13.7|13.7|||
4184683|NCT00787800|4006303|B2|||Age|Date of birth not obtained for 4 Israeli subjects (treatment arm unknown).|years|Mean|59.9|59.9|Standard Deviation|14.8|14.8|||
4184684|NCT00787800|4006304|B1|||Age|Date of birth not obtained for 4 Israeli subjects (treatment arm unknown).|years|Mean|62.6|62.6|Standard Deviation|12.4|12.4|||
4184685|NCT00787787|4006321|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4184686|NCT00787787|4006321|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184687|NCT00787787|4006321|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184688|NCT00787787|4006321|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4184689|NCT00787787|4006321|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184690|NCT00787787|4006321|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184691|NCT00787787|4006321|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4184692|NCT00787787|4006321|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184693|NCT00787787|4006321|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184694|NCT00787787|4006321|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4184695|NCT00787787|4006321|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184696|NCT00787787|4006321|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4184697|NCT00787787|4006321|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4184698|NCT00787787|4006321|B1|||Age||years|Median|57|57.0|Full Range|||28.0|66.0|
4184699|NCT00787761|4006327|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4184700|NCT00787761|4006327|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4184701|NCT00787761|4006327|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4184702|NCT00787761|4006327|B1|||Age||years|Mean|54.5|54.5|Standard Deviation|11.9|11.9|||
4184703|NCT00787761|4006327|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4184704|NCT00787761|4006327|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4184705|NCT00787761|4006327|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4184706|NCT00787644|4006338|B3|||PC20||mg/ml|Median|1.90|1.9|Standard Deviation|3.08|3.08|||
4184707|NCT00787644|4006339|B2|||PC20||mg/ml|Median|1.99|1.99|Standard Deviation|3.08|3.08|||
4184708|NCT00787644|4006340|B1|||PC20||mg/ml|Median|1.60|1.6|Standard Deviation|5.91|5.91|||
4184709|NCT00787644|4006338|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4184710|NCT00787644|4006339|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4184711|NCT00787644|4006340|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4184712|NCT00787644|4006338|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184713|NCT00787644|4006339|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184714|NCT00787644|4006340|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184715|NCT00787644|4006338|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184716|NCT00787644|4006339|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184717|NCT00787644|4006340|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184718|NCT00787644|4006338|B3||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4184719|NCT00787644|4006339|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4184720|NCT00787644|4006340|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4184721|NCT00787644|4006338|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4184722|NCT00787644|4006339|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4184723|NCT00787644|4006340|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4184724|NCT00787644|4006338|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184729|NCT00787644|4006340|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184730|NCT00787644|4006338|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184731|NCT00787644|4006339|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184732|NCT00787644|4006340|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184733|NCT00787644|4006338|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4184734|NCT00787644|4006339|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4184735|NCT00787644|4006340|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4184736|NCT00787644|4006338|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4184737|NCT00787644|4006339|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4184738|NCT00787644|4006340|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4184739|NCT00787644|4006338|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4184740|NCT00787644|4006339|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4184741|NCT00787644|4006340|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4184742|NCT00787644|4006338|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4184743|NCT00787644|4006339|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4184744|NCT00787644|4006340|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4184745|NCT00787644|4006338|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4184746|NCT00787644|4006339|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4184747|NCT00787644|4006340|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4184748|NCT00787605|4006360|B3||Male|Sex: Female, Male||Participants|Count of Participants|439|439.0||||||
4184749|NCT00787605|4006361|B2||Male|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4184750|NCT00787605|4006362|B1||Male|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4184751|NCT00787605|4006360|B3||Female|Sex: Female, Male||Participants|Count of Participants|421|421.0||||||
4184752|NCT00787605|4006361|B2||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4184753|NCT00787605|4006362|B1||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4184754|NCT00787605|4006360|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|9.91|9.91|||
4184755|NCT00787605|4006361|B2|||Age||years|Mean|59.8|59.8|Standard Deviation|10.01|10.01|||
4184756|NCT00787605|4006362|B1|||Age||years|Mean|59.7|59.7|Standard Deviation|9.83|9.83|||
4184757|NCT00787566|4006379|B4|United States||Region of Enrollment||participants|Number|68|68.0||||||
4184758|NCT00787566|4006380|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4184759|NCT00787566|4006381|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4184760|NCT00787566|4006382|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4184761|NCT00787566|4006379|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4184762|NCT00787566|4006380|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4184763|NCT00787566|4006381|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4184764|NCT00787566|4006382|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4184765|NCT00787566|4006379|B4||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4184766|NCT00787566|4006380|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4184767|NCT00787566|4006381|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4184768|NCT00787566|4006382|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4184769|NCT00787566|4006379|B4|||Age||years|Mean|58.9|58.9|Standard Deviation|12.8|12.8|||
4184770|NCT00787566|4006380|B3|||Age||years|Mean|61.0|61.0|Standard Deviation|12.0|12.0|||
4184771|NCT00787566|4006381|B2|||Age||years|Mean|60.0|60.0|Standard Deviation|10.2|10.2|||
4184772|NCT00787566|4006382|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|15.9|15.9|||
4184773|NCT00787566|4006379|B4||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4184774|NCT00787566|4006380|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4184775|NCT00787566|4006381|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4184776|NCT00787566|4006382|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4184777|NCT00787566|4006379|B4||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4184778|NCT00787566|4006380|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4184779|NCT00787566|4006381|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4184780|NCT00787566|4006382|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4184781|NCT00787566|4006379|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4184782|NCT00787566|4006380|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4184783|NCT00787566|4006381|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4184784|NCT00787566|4006382|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4184785|NCT00787527|4006392|B1|300 mg three times daily on Days -2 to 3||Vorinostat Treatment (Schedule A/Schedule B)|Number of participants who received either Vorinostat treatment Schedule A (300 mg once daily or 200 mg twice daily) for Phase I or Schedule B (300 mg three times daily) for Phase II.|participants|Number|6|6.0||||||
4184786|NCT00787527|4006392|B1|200 mg twice daily on Days 5 to14||Vorinostat Treatment (Schedule A/Schedule B)|Number of participants who received either Vorinostat treatment Schedule A (300 mg once daily or 200 mg twice daily) for Phase I or Schedule B (300 mg three times daily) for Phase II.|participants|Number|2|2.0||||||
4184787|NCT00787527|4006392|B1|300 mg once daily on Days 5 to14||Vorinostat Treatment (Schedule A/Schedule B)|Number of participants who received either Vorinostat treatment Schedule A (300 mg once daily or 200 mg twice daily) for Phase I or Schedule B (300 mg three times daily) for Phase II.|participants|Number|6|6.0||||||
4184788|NCT00787527|4006392|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4184789|NCT00787527|4006392|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4184790|NCT00787527|4006392|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4184791|NCT00787527|4006392|B1|||Age||years|Median|55|55.0|Full Range|||29.0|83.0|
4184792|NCT00787332|4006400|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4184793|NCT00787332|4006401|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4184794|NCT00787332|4006402|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4184795|NCT00787332|4006400|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4184796|NCT00787332|4006401|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4184797|NCT00787332|4006402|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4184798|NCT00787332|4006400|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4184799|NCT00787332|4006401|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4184800|NCT00787332|4006402|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4184801|NCT00787332|4006400|B3|||Age||years|Mean|65|65.0|Standard Deviation|9|9.0|||
4184802|NCT00787332|4006401|B2|||Age||years|Mean|62|62.0|Standard Deviation|9.3|9.3|||
4184803|NCT00787332|4006402|B1|||Age||years|Mean|69|69.0|Standard Deviation|9.5|9.5|||
4184804|NCT00787332|4006400|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4184805|NCT00787332|4006401|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4184806|NCT00787332|4006402|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4184807|NCT00787332|4006400|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4184808|NCT00787332|4006401|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4184809|NCT00787332|4006402|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4184810|NCT00787332|4006400|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4184811|NCT00787332|4006401|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4184812|NCT00787332|4006402|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4184813|NCT00787319|4006409|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4184814|NCT00787319|4006409|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4184815|NCT00787319|4006409|B1|||Age||years|Mean|75.8|75.8|Standard Deviation|8.3|8.3|||
4184816|NCT00787267|4006421|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4184817|NCT00787267|4006421|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184818|NCT00787267|4006421|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184819|NCT00787267|4006421|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4184820|NCT00787267|4006421|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4184821|NCT00787267|4006421|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184822|NCT00787267|4006421|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4184823|NCT00787267|4006421|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4184824|NCT00787267|4006421|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4184825|NCT00787267|4006421|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4184826|NCT00787267|4006421|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|8.0|8.0|||
4184827|NCT00787254|4006429|B3|Japan||Region of Enrollment||participants|Number|366|366.0||||||
4184828|NCT00787254|4006430|B2|Japan||Region of Enrollment||participants|Number|181|181.0||||||
4184829|NCT00787254|4006431|B1|Japan||Region of Enrollment||participants|Number|185|185.0||||||
4184830|NCT00787254|4006429|B3||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4184831|NCT00787254|4006430|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4184832|NCT00787254|4006431|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4184833|NCT00787254|4006429|B3||Female|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
4184834|NCT00787254|4006430|B2||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4184835|NCT00787254|4006431|B1||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4184836|NCT00787254|4006429|B3|≤80 years||Age, Customized||participants|Number|25|25.0||6.8|6.8|||
4184837|NCT00787254|4006430|B2|≤80 years||Age, Customized||participants|Number|12|12.0||6.6|6.6|||
4184838|NCT00787254|4006431|B1|≤80 years||Age, Customized||participants|Number|13|13.0||7.0|7.0|||
4184839|NCT00787254|4006429|B3|Between 70 and 79 years||Age, Customized||participants|Number|91|91.0||24.9|24.9|||
4184840|NCT00787254|4006430|B2|Between 70 and 79 years||Age, Customized||participants|Number|48|48.0||26.5|26.5|||
4184841|NCT00787254|4006431|B1|Between 70 and 79 years||Age, Customized||participants|Number|43|43.0||23.2|23.2|||
4184842|NCT00787254|4006429|B3|Between 65 and 69 years||Age, Customized||participants|Number|63|63.0||17.2|17.2|||
4184843|NCT00787254|4006430|B2|Between 65 and 69 years||Age, Customized||participants|Number|30|30.0||16.6|16.6|||
4184844|NCT00787254|4006431|B1|Between 65 and 69 years||Age, Customized||participants|Number|33|33.0||17.8|17.8|||
4184845|NCT00787254|4006429|B3|Between 60 and 64 years||Age, Customized||participants|Number|62|62.0||16.9|16.9|||
4184846|NCT00787254|4006430|B2|Between 60 and 64 years||Age, Customized||participants|Number|29|29.0||16.0|16.0|||
4184847|NCT00787254|4006431|B1|Between 60 and 64 years||Age, Customized||participants|Number|33|33.0||17.8|17.8|||
4184848|NCT00787254|4006429|B3|Between 50 and 59 years||Age, Customized||participants|Number|81|81.0||22.1|22.1|||
4184849|NCT00787254|4006430|B2|Between 50 and 59 years||Age, Customized||participants|Number|43|43.0||23.8|23.8|||
4184850|NCT00787254|4006431|B1|Between 50 and 59 years||Age, Customized||participants|Number|38|38.0||20.5|20.5|||
4184851|NCT00787254|4006429|B3|Between 40 and 49 years||Age, Customized||participants|Number|31|31.0||8.5|8.5|||
4184852|NCT00787254|4006430|B2|Between 40 and 49 years||Age, Customized||participants|Number|13|13.0||7.2|7.2|||
4184853|NCT00787254|4006431|B1|Between 40 and 49 years||Age, Customized||participants|Number|18|18.0||9.7|9.7|||
4184854|NCT00787254|4006429|B3|≤39 years||Age, Customized||participants|Number|13|13.0||3.6|3.6|||
4184855|NCT00787254|4006430|B2|≤39 years||Age, Customized||participants|Number|6|6.0||3.3|3.3|||
4184856|NCT00787254|4006431|B1|≤39 years||Age, Customized||participants|Number|7|7.0||3.8|3.8|||
4184857|NCT00787241|4006532|B4|United States||Region of Enrollment||participants|Number|445|445.0||||||
4184858|NCT00787241|4006533|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
4184859|NCT00787241|4006534|B2|United States||Region of Enrollment||participants|Number|143|143.0||||||
4184860|NCT00787241|4006535|B1|United States||Region of Enrollment||participants|Number|261|261.0||||||
4184861|NCT00787241|4006532|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4184862|NCT00787241|4006533|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4184863|NCT00787241|4006534|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4184864|NCT00787241|4006535|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4184865|NCT00787241|4006532|B4||Female|Sex: Female, Male||Participants|Count of Participants|445|445.0||||||
4184866|NCT00787241|4006533|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4184867|NCT00787241|4006534|B2||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4184868|NCT00787241|4006535|B1||Female|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
4184869|NCT00787241|4006532|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4184870|NCT00787241|4006533|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4184871|NCT00787241|4006534|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4184872|NCT00787241|4006535|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4184873|NCT00787241|4006532|B4||Between 18 and 65 years|Age||Participants|Count of Participants|445|445.0||||||
4184874|NCT00787241|4006533|B3||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4184875|NCT00787241|4006534|B2||Between 18 and 65 years|Age||Participants|Count of Participants|143|143.0||||||
4184876|NCT00787241|4006535|B1||Between 18 and 65 years|Age||Participants|Count of Participants|261|261.0||||||
4184877|NCT00787241|4006532|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4184878|NCT00787241|4006533|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4184879|NCT00787241|4006534|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4184880|NCT00787241|4006535|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4184881|NCT00787202|4006551|B6||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4184882|NCT00787202|4006552|B5||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4184883|NCT00787202|4006553|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4184884|NCT00787202|4006554|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4184885|NCT00787202|4006555|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4184886|NCT00787202|4006556|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4184887|NCT00787202|4006551|B6||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4184888|NCT00787202|4006552|B5||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4184889|NCT00787202|4006553|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4184890|NCT00787202|4006554|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4184891|NCT00787202|4006555|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4184892|NCT00787202|4006556|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4184893|NCT00787202|4006551|B6|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|11|11.0||||||
4184894|NCT00787202|4006552|B5|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|2|2.0||||||
4184895|NCT00787202|4006553|B4|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|1|1.0||||||
4184896|NCT00787202|4006554|B3|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|2|2.0||||||
4184897|NCT00787202|4006555|B2|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|1|1.0||||||
4184898|NCT00787202|4006556|B1|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|5|5.0||||||
4184899|NCT00787202|4006551|B6|45 to 64 years||Age, Customized||participants|Number|74|74.0||||||
4184900|NCT00787202|4006552|B5|45 to 64 years||Age, Customized||participants|Number|16|16.0||||||
4184901|NCT00787202|4006553|B4|45 to 64 years||Age, Customized||participants|Number|15|15.0||||||
4184902|NCT00787202|4006554|B3|45 to 64 years||Age, Customized||participants|Number|13|13.0||||||
4184903|NCT00787202|4006555|B2|45 to 64 years||Age, Customized||participants|Number|14|14.0||||||
4184904|NCT00787202|4006556|B1|45 to 64 years||Age, Customized||participants|Number|16|16.0||||||
4184905|NCT00787202|4006551|B6|18 to 44 years||Age, Customized||participants|Number|110|110.0||||||
4184906|NCT00787202|4006552|B5|18 to 44 years||Age, Customized||participants|Number|31|31.0||||||
4184907|NCT00787202|4006553|B4|18 to 44 years||Age, Customized||participants|Number|17|17.0||||||
4184908|NCT00787202|4006554|B3|18 to 44 years||Age, Customized||participants|Number|18|18.0||||||
4184909|NCT00787202|4006555|B2|18 to 44 years||Age, Customized||participants|Number|16|16.0||||||
4184910|NCT00787202|4006556|B1|18 to 44 years||Age, Customized||participants|Number|28|28.0||||||
4184911|NCT00787189|4006611|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4184912|NCT00787189|4006612|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4184913|NCT00787189|4006613|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4184914|NCT00787189|4006611|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4184915|NCT00787189|4006612|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4184916|NCT00787189|4006613|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4184917|NCT00787189|4006611|B3|||Age||years|Mean|77.47|77.47|Standard Deviation|8.265|8.265|||
4184918|NCT00787189|4006612|B2|||Age||years|Mean|76.00|76.0|Standard Deviation|9.86|9.86|||
4184919|NCT00787189|4006613|B1|||Age||years|Mean|78.94|78.94|Standard Deviation|5.92|5.92|||
4184920|NCT00787189|4006611|B3||>=65 years|Age||Participants|Count of Participants|58|58.0||||||
4184921|NCT00787189|4006612|B2||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4184922|NCT00787189|4006613|B1||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4184923|NCT00787189|4006611|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4184924|NCT00787189|4006612|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4184925|NCT00787189|4006613|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4184926|NCT00787189|4006611|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4184927|NCT00787189|4006612|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4184928|NCT00787189|4006613|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4184929|NCT00787150|4006620|B4||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4184930|NCT00787150|4006621|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4184931|NCT00787150|4006622|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4184932|NCT00787150|4006623|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4184933|NCT00787150|4006620|B4||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4184934|NCT00787150|4006621|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4184935|NCT00787150|4006622|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4184936|NCT00787150|4006623|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4184937|NCT00787150|4006620|B4|||Age||years|Mean|70.3|70.3|Standard Deviation|7.9|7.9|||
4184938|NCT00787150|4006621|B3|||Age||years|Mean|70.0|70.0|Standard Deviation|8.1|8.1|||
4184939|NCT00787150|4006622|B2|||Age||years|Mean|69.3|69.3|Standard Deviation|8.4|8.4|||
4184940|NCT00787150|4006623|B1|||Age||years|Mean|71.7|71.7|Standard Deviation|7.0|7.0|||
4184941|NCT00787137|4006667|B4|Hungary||Region of Enrollment||Participants|Number|8|8.0||||||
4184942|NCT00787137|4006668|B3|Hungary||Region of Enrollment||Participants|Number|3|3.0||||||
4184943|NCT00787137|4006669|B2|Hungary||Region of Enrollment||Participants|Number|1|1.0||||||
4184944|NCT00787137|4006670|B1|Hungary||Region of Enrollment||Participants|Number|4|4.0||||||
4184945|NCT00787137|4006667|B4|Serbia||Region of Enrollment||Participants|Number|9|9.0||||||
4184946|NCT00787137|4006668|B3|Serbia||Region of Enrollment||Participants|Number|2|2.0||||||
4184947|NCT00787137|4006669|B2|Serbia||Region of Enrollment||Participants|Number|5|5.0||||||
4184948|NCT00787137|4006670|B1|Serbia||Region of Enrollment||Participants|Number|2|2.0||||||
4184949|NCT00787137|4006667|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4184950|NCT00787137|4006668|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4184951|NCT00787137|4006669|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4184952|NCT00787137|4006670|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4184953|NCT00787137|4006667|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4184954|NCT00787137|4006668|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4184955|NCT00787137|4006669|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4184956|NCT00787137|4006670|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4184957|NCT00787137|4006667|B4|||Age||years|Mean|44.0|44.0|Full Range|||27.0|59.0|
4184958|NCT00787137|4006668|B3|||Age||years|Mean|45.2|45.2|Full Range|13.20|13.2|31.0|58.0|
4184959|NCT00787137|4006669|B2|||Age||years|Mean|43.8|43.8|Full Range|10.85|10.85|27.0|59.0|
4184960|NCT00787137|4006670|B1|||Age||years|Mean|43.3|43.3|Full Range|9.77|9.77|32.0|54.0|
4184961|NCT00787137|4006667|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4184962|NCT00787137|4006668|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4184963|NCT00787137|4006669|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4184964|NCT00787137|4006670|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4184965|NCT00787137|4006667|B4||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4184966|NCT00787137|4006668|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4184967|NCT00787137|4006669|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4184968|NCT00787137|4006670|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4184969|NCT00787137|4006667|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4184970|NCT00787137|4006668|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4184971|NCT00787137|4006669|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4184972|NCT00787137|4006670|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4184973|NCT00787124|4006692|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4184974|NCT00787124|4006693|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4184975|NCT00787124|4006694|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4184976|NCT00787124|4006692|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4184977|NCT00787124|4006693|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4184978|NCT00787124|4006694|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4184979|NCT00787124|4006692|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4184980|NCT00787124|4006693|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4184981|NCT00787124|4006694|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4184982|NCT00787124|4006692|B3|||Age||days|Mean|40|40.0|Standard Deviation|40|40.0|||
4184983|NCT00787124|4006693|B2|||Age||days|Mean|60|60.0|Standard Deviation|37|37.0|||
4184984|NCT00787124|4006694|B1|||Age||days|Mean|20|20.0|Standard Deviation|45|45.0|||
4184985|NCT00787124|4006692|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4184986|NCT00787124|4006693|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4184987|NCT00787124|4006694|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4184988|NCT00787124|4006692|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4184989|NCT00787124|4006693|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4184990|NCT00787124|4006694|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4184991|NCT00787124|4006692|B3||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4184992|NCT00787124|4006693|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4184993|NCT00787124|4006694|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4184994|NCT00787020|4006703|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
4184995|NCT00787020|4006704|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4184996|NCT00787020|4006705|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4184997|NCT00787020|4006703|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4184998|NCT00787020|4006704|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4184999|NCT00787020|4006705|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4185000|NCT00787020|4006703|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4185001|NCT00787020|4006704|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4185002|NCT00787020|4006705|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4185003|NCT00787020|4006703|B3|||Age||years|Mean|54.11|54.11|Standard Deviation|11.85|11.85|||
4185004|NCT00787020|4006704|B2|||Age||years|Mean|53.13|53.13|Standard Deviation|11.13|11.13|||
4185005|NCT00787020|4006705|B1|||Age||years|Mean|55.92|55.92|Standard Deviation|13.35|13.35|||
4185006|NCT00787020|4006703|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4185007|NCT00787020|4006704|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4185008|NCT00787020|4006705|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4185009|NCT00787020|4006703|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4185010|NCT00787020|4006704|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4185011|NCT00787020|4006705|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4185012|NCT00787020|4006703|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4185013|NCT00787020|4006704|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4185014|NCT00787020|4006705|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4185015|NCT00786994|4006716|B5|not done||Histopathological grading||participants|Number|3|3.0||||||
4185016|NCT00786994|4006717|B4|not done||Histopathological grading||participants|Number|1|1.0||||||
4185017|NCT00786994|4006718|B3|not done||Histopathological grading||participants|Number|0|0.0||||||
4185018|NCT00786994|4006719|B2|not done||Histopathological grading||participants|Number|1|1.0||||||
4185019|NCT00786994|4006720|B1|not done||Histopathological grading||participants|Number|1|1.0||||||
4185020|NCT00786994|4006716|B5|Grade III||Histopathological grading||participants|Number|100|100.0||||||
4185021|NCT00786994|4006717|B4|Grade III||Histopathological grading||participants|Number|13|13.0||||||
4185022|NCT00786994|4006718|B3|Grade III||Histopathological grading||participants|Number|19|19.0||||||
4185023|NCT00786994|4006719|B2|Grade III||Histopathological grading||participants|Number|36|36.0||||||
4185024|NCT00786994|4006720|B1|Grade III||Histopathological grading||participants|Number|32|32.0||||||
4185025|NCT00786994|4006716|B5|Grade II||Histopathological grading||participants|Number|37|37.0||||||
4185026|NCT00786994|4006717|B4|Grade II||Histopathological grading||participants|Number|12|12.0||||||
4185027|NCT00786994|4006718|B3|Grade II||Histopathological grading||participants|Number|4|4.0||||||
4185028|NCT00786994|4006719|B2|Grade II||Histopathological grading||participants|Number|10|10.0||||||
4185029|NCT00786994|4006720|B1|Grade II||Histopathological grading||participants|Number|11|11.0||||||
4185030|NCT00786994|4006716|B5|Grade I||Histopathological grading||participants|Number|17|17.0||||||
4185031|NCT00786994|4006717|B4|Grade I||Histopathological grading||participants|Number|2|2.0||||||
4185032|NCT00786994|4006718|B3|Grade I||Histopathological grading||participants|Number|2|2.0||||||
4185033|NCT00786994|4006719|B2|Grade I||Histopathological grading||participants|Number|4|4.0||||||
4185034|NCT00786994|4006720|B1|Grade I||Histopathological grading||participants|Number|9|9.0||||||
4185035|NCT00786994|4006716|B5|Moderate||Actinic keratosis baseline severity index||participants|Number|95|95.0||||||
4185036|NCT00786994|4006717|B4|Moderate||Actinic keratosis baseline severity index||participants|Number|15|15.0||||||
4185037|NCT00786994|4006718|B3|Moderate||Actinic keratosis baseline severity index||participants|Number|16|16.0||||||
4185038|NCT00786994|4006719|B2|Moderate||Actinic keratosis baseline severity index||participants|Number|33|33.0||||||
4185039|NCT00786994|4006720|B1|Moderate||Actinic keratosis baseline severity index||participants|Number|31|31.0||||||
4185040|NCT00786994|4006716|B5|Mild||Actinic keratosis baseline severity index||participants|Number|62|62.0||||||
4185041|NCT00786994|4006717|B4|Mild||Actinic keratosis baseline severity index||participants|Number|13|13.0||||||
4185042|NCT00786994|4006718|B3|Mild||Actinic keratosis baseline severity index||participants|Number|9|9.0||||||
4185043|NCT00786994|4006719|B2|Mild||Actinic keratosis baseline severity index||participants|Number|18|18.0||||||
4185044|NCT00786994|4006720|B1|Mild||Actinic keratosis baseline severity index||participants|Number|22|22.0||||||
4185045|NCT00786994|4006716|B5||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4185046|NCT00786994|4006717|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4185047|NCT00786994|4006718|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4185048|NCT00786994|4006719|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4185049|NCT00786994|4006720|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4185050|NCT00786994|4006716|B5||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4185051|NCT00786994|4006717|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4185052|NCT00786994|4006718|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4185053|NCT00786994|4006719|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4185054|NCT00786994|4006720|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4185055|NCT00786994|4006716|B5|||Age||years|Median|72|72.0|Full Range|||51.0|88.0|
4185056|NCT00786994|4006717|B4|||Age||years|Median|72|72.0|Full Range|||51.0|83.0|
4185057|NCT00786994|4006718|B3|||Age||years|Median|69|69.0|Full Range|||57.0|81.0|
4185058|NCT00786994|4006719|B2|||Age||years|Median|74|74.0|Full Range|||56.0|85.0|
4185059|NCT00786994|4006720|B1|||Age||years|Median|72|72.0|Full Range|||61.0|88.0|
4185060|NCT00786916|4006732|B4|United States||Region of Enrollment||participants|Number|109|109.0||||||
4185061|NCT00786916|4006733|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
4185062|NCT00786916|4006734|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
4185063|NCT00786916|4006735|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4185064|NCT00786916|4006732|B4||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4185065|NCT00786916|4006733|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4185066|NCT00786916|4006734|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4185067|NCT00786916|4006735|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4185068|NCT00786916|4006732|B4||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4185069|NCT00786916|4006733|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4185070|NCT00786916|4006734|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4185071|NCT00786916|4006735|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4185072|NCT00786916|4006732|B4|||Age||years|Mean|4.67|4.67|Standard Deviation|1.58|1.58|||
4185073|NCT00786916|4006733|B3|||Age||years|Mean|5.0|5.0|Standard Deviation|1.63|1.63|||
4185074|NCT00786916|4006734|B2|||Age||years|Mean|4.3|4.3|Standard Deviation|1.50|1.5|||
4185075|NCT00786916|4006735|B1|||Age||years|Mean|4.7|4.7|Standard Deviation|1.61|1.61|||
4185076|NCT00786916|4006732|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4185077|NCT00786916|4006733|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4185078|NCT00786916|4006734|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4185079|NCT00786916|4006735|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4185080|NCT00786916|4006732|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4185081|NCT00786916|4006733|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4185082|NCT00786916|4006734|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4185083|NCT00786916|4006735|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4185084|NCT00786916|4006732|B4||<=18 years|Age||Participants|Count of Participants|109|109.0||||||
4185085|NCT00786916|4006733|B3||<=18 years|Age||Participants|Count of Participants|34|34.0||||||
4185086|NCT00786916|4006734|B2||<=18 years|Age||Participants|Count of Participants|36|36.0||||||
4185087|NCT00786916|4006735|B1||<=18 years|Age||Participants|Count of Participants|39|39.0||||||
4185088|NCT00786864|4006745|B3|South Africa||Region of Enrollment||participants|Number|72|72.0||||||
4185089|NCT00786864|4006746|B2|South Africa||Region of Enrollment||participants|Number|33|33.0||||||
4185090|NCT00786864|4006747|B1|South Africa||Region of Enrollment||participants|Number|39|39.0||||||
4185091|NCT00786864|4006745|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4185092|NCT00786864|4006746|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4185093|NCT00786864|4006747|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4185094|NCT00786864|4006745|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4185095|NCT00786864|4006746|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4185096|NCT00786864|4006747|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4185097|NCT00786864|4006745|B3|||Age||years|Mean|12.29|12.29|Standard Deviation|0.68|0.68|||
4185098|NCT00786864|4006746|B2|||Age||years|Mean|12.39|12.39|Standard Deviation|0.70|0.7|||
4185099|NCT00786864|4006747|B1|||Age||years|Mean|12.21|12.21|Standard Deviation|0.66|0.66|||
4185100|NCT00786864|4006745|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4185101|NCT00786864|4006746|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4185102|NCT00786864|4006747|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4185103|NCT00786864|4006745|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4185104|NCT00786864|4006746|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4185105|NCT00786864|4006747|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4185106|NCT00786864|4006745|B3||<=18 years|Age||Participants|Count of Participants|72|72.0||||||
4185107|NCT00786864|4006746|B2||<=18 years|Age||Participants|Count of Participants|33|33.0||||||
4185108|NCT00786864|4006747|B1||<=18 years|Age||Participants|Count of Participants|39|39.0||||||
4185109|NCT00786838|4006760|B1|United States Of America||Region of Enrollment||participants|Number|11|11.0||||||
4185110|NCT00786838|4006760|B1|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4185111|NCT00786838|4006760|B1|Russia||Region of Enrollment||participants|Number|17|17.0||||||
4185112|NCT00786838|4006760|B1|Republic Of Korea||Region of Enrollment||participants|Number|15|15.0||||||
4185113|NCT00786838|4006760|B1|India||Region of Enrollment||participants|Number|8|8.0||||||
4185114|NCT00786838|4006760|B1|France||Region of Enrollment||participants|Number|3|3.0||||||
4185115|NCT00786838|4006760|B1|Belgium||Region of Enrollment||participants|Number|17|17.0||||||
4185116|NCT00786838|4006760|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4185117|NCT00786838|4006760|B1|Asian||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4185118|NCT00786838|4006760|B1|White||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4185119|NCT00786838|4006760|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4185120|NCT00786838|4006760|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4185121|NCT00786838|4006760|B1|||Age||years|Mean|50.2|50.2|Standard Deviation|11.04|11.04|||
4185122|NCT00786799|4006785|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
4185123|NCT00786799|4006786|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4185124|NCT00786799|4006787|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4185125|NCT00786799|4006785|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4185126|NCT00786799|4006786|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4185127|NCT00786799|4006787|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4185128|NCT00786799|4006785|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4185129|NCT00786799|4006786|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4185130|NCT00786799|4006787|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4185131|NCT00786799|4006785|B3|||Age||years|Mean|5.83|5.83|Standard Deviation|1.67|1.67|||
4185132|NCT00786799|4006786|B2|||Age||years|Mean|5.82|5.82|Standard Deviation|1.42|1.42|||
4185133|NCT00786799|4006787|B1|||Age||years|Mean|5.85|5.85|Standard Deviation|1.83|1.83|||
4185134|NCT00786799|4006785|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4185135|NCT00786799|4006786|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4185136|NCT00786799|4006787|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4185137|NCT00786799|4006785|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4185138|NCT00786799|4006786|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4185139|NCT00786799|4006787|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4185140|NCT00786799|4006785|B3||<=18 years|Age||Participants|Count of Participants|27|27.0||||||
4185141|NCT00786799|4006786|B2||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4185142|NCT00786799|4006787|B1||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4185143|NCT00786682|4006799|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4185144|NCT00786682|4006799|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4185145|NCT00786682|4006799|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4185146|NCT00786682|4006799|B1|||Age||years|Mean|65.7|65.7|Standard Deviation|6.0|6.0|||
4185147|NCT00786682|4006799|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4185148|NCT00786682|4006799|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4185149|NCT00786682|4006799|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4185150|NCT00786643|4006805|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
4185151|NCT00786643|4006806|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4185152|NCT00786643|4006807|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4185153|NCT00786643|4006805|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4185154|NCT00786643|4006806|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4185155|NCT00786643|4006807|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4185156|NCT00786643|4006805|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4185157|NCT00786643|4006806|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4185158|NCT00786643|4006807|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4185159|NCT00786643|4006805|B3|||Age||years|Mean|62.50|62.5|Standard Deviation|10.85|10.85|||
4185160|NCT00786643|4006806|B2|||Age||years|Mean|62.32|62.32|Standard Deviation|10.13|10.13|||
4185161|NCT00786643|4006807|B1|||Age||years|Mean|62.75|62.75|Standard Deviation|12.05|12.05|||
4185162|NCT00786643|4006805|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4185163|NCT00786643|4006806|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4185164|NCT00786643|4006807|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4185165|NCT00786643|4006805|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4185166|NCT00786643|4006806|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4185167|NCT00786643|4006807|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4185168|NCT00786643|4006805|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4185169|NCT00786643|4006806|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4185170|NCT00786643|4006807|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4185171|NCT00786565|4006818|B1|Europe||Region of Enrollment||participants|Number|69|69.0||||||
4185172|NCT00786565|4006818|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4185173|NCT00786565|4006818|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4185174|NCT00786565|4006818|B1|Between 50 and 85 years||Age, Customized|69 participants (138 eyes)were randomised to receive Akreos Advanced Optic Aspheric Intraocular Lens in one eye (69 eyes) and Akreos Adapt Spherical Intraocular Lens in the fellow eye (69 eyes).|years|Mean|73.0|73.0|Standard Deviation|7.21|7.21|||
4185175|NCT00786487|4006856|B5|||insulin sensitivity||M value|Mean|10.7|10.7|Standard Deviation|3.6|3.6|||
4185176|NCT00786487|4006857|B4|||insulin sensitivity||M value|Mean|9|9.0|Standard Deviation|3|3.0|||
4185177|NCT00786487|4006858|B3|||insulin sensitivity||M value|Mean|7|7.0|Standard Deviation|1.6|1.6|||
4185178|NCT00786487|4006859|B2|||insulin sensitivity||M value|Mean|12|12.0|Standard Deviation|3|3.0|||
4185179|NCT00786487|4006860|B1|||insulin sensitivity||M value|Mean|13.5|13.5|Standard Deviation|3.5|3.5|||
4185180|NCT00786487|4006856|B5|United States||Region of Enrollment||participants|Number|33|33.0||||||
4185181|NCT00786487|4006857|B4|United States||Region of Enrollment||participants|Number|7|7.0||||||
4185182|NCT00786487|4006858|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4185183|NCT00786487|4006859|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4185184|NCT00786487|4006860|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4185185|NCT00786487|4006856|B5||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4185186|NCT00786487|4006857|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4185187|NCT00786487|4006858|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4185188|NCT00786487|4006859|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4185189|NCT00786487|4006860|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4185190|NCT00786487|4006856|B5||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4185191|NCT00786487|4006857|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4185192|NCT00786487|4006858|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4185193|NCT00786487|4006859|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4185194|NCT00786487|4006860|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4185195|NCT00786487|4006856|B5|||Age||years|Mean|23|23.0|Standard Deviation|4|4.0|||
4185196|NCT00786487|4006857|B4|||Age||years|Mean|21|21.0|Standard Deviation|2|2.0|||
4185197|NCT00786487|4006858|B3|||Age||years|Mean|21|21.0|Standard Deviation|2|2.0|||
4185198|NCT00786487|4006859|B2|||Age||years|Mean|24|24.0|Standard Deviation|3|3.0|||
4185199|NCT00786487|4006860|B1|||Age||years|Mean|25|25.0|Standard Deviation|6|6.0|||
4185200|NCT00786487|4006856|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4185201|NCT00786487|4006857|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4185202|NCT00786487|4006858|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4185203|NCT00786487|4006859|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4185204|NCT00786487|4006860|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4185205|NCT00786487|4006856|B5||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4185206|NCT00786487|4006857|B4||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4185207|NCT00786487|4006858|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4185208|NCT00786487|4006859|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4185209|NCT00786487|4006860|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4185210|NCT00786487|4006856|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4185211|NCT00786487|4006857|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4185212|NCT00786487|4006858|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4185213|NCT00786487|4006859|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4185214|NCT00786487|4006860|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4185215|NCT00786474|4006873|B3|Unknown||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4185216|NCT00786474|4006874|B2|Unknown||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4185217|NCT00786474|4006875|B1|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4185218|NCT00786474|4006873|B3|Nonwhite||Race/Ethnicity, Customized||participants|Number|170|170.0||||||
4185219|NCT00786474|4006874|B2|Nonwhite||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
4185220|NCT00786474|4006875|B1|Nonwhite||Race/Ethnicity, Customized||participants|Number|88|88.0||||||
4185221|NCT00786474|4006873|B3|White||Race/Ethnicity, Customized||participants|Number|1709|1709.0||||||
4185222|NCT00786474|4006874|B2|White||Race/Ethnicity, Customized||participants|Number|849|849.0||||||
4185223|NCT00786474|4006875|B1|White||Race/Ethnicity, Customized||participants|Number|860|860.0||||||
4185224|NCT00786474|4006873|B3||Male|Sex: Female, Male||Participants|Count of Participants|1382|1382.0||||||
4185225|NCT00786474|4006874|B2||Male|Sex: Female, Male||Participants|Count of Participants|686|686.0||||||
4185226|NCT00786474|4006875|B1||Male|Sex: Female, Male||Participants|Count of Participants|696|696.0||||||
4185227|NCT00786474|4006873|B3||Female|Sex: Female, Male||Participants|Count of Participants|502|502.0||||||
4185228|NCT00786474|4006874|B2||Female|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
4185229|NCT00786474|4006875|B1||Female|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
4185230|NCT00786474|4006873|B3|||Age||years|Mean|71.7|71.7|Standard Deviation|8.8|8.8|||
4185231|NCT00786474|4006874|B2|||Age||years|Mean|71.6|71.6|Standard Deviation|8.88|8.88|||
4185232|NCT00786474|4006875|B1|||Age||years|Mean|71.8|71.8|Standard Deviation|8.74|8.74|||
4185233|NCT00786422|4006888|B1|No history of tuberculosis||Participants with history of tuberculosis||Participants|Number|5|5.0||||||
4185234|NCT00786422|4006888|B1|History of tuberculosis||Participants with history of tuberculosis||Participants|Number|20|20.0||||||
4185235|NCT00786422|4006888|B1|South Africa - No||Region of recruitment||Participants|Number|0|0.0||||||
4185236|NCT00786422|4006888|B1|South Africa - Yes||Region of recruitment||Participants|Number|25|25.0||||||
4185237|NCT00786422|4006888|B1|> 80 mL/min||Creatinine clearance|Volume of blood plasma cleared of creatinine per time unit|Participants|Number|21|21.0||||||
4185238|NCT00786422|4006888|B1|50 - <80 mL/min||Creatinine clearance|Volume of blood plasma cleared of creatinine per time unit|Participants|Number|4|4.0||||||
4185239|NCT00786422|4006888|B1|30 - <50 mL/min||Creatinine clearance|Volume of blood plasma cleared of creatinine per time unit|Participants|Number|0|0.0||||||
4185240|NCT00786422|4006888|B1|<30 mL/min||Creatinine clearance|Volume of blood plasma cleared of creatinine per time unit|Participants|Number|0|0.0||||||
4185241|NCT00786422|4006888|B1|Other (mixed South African descent)||Race||Participants|Number|1|1.0||||||
4185242|NCT00786422|4006888|B1|Black||Race||Participants|Number|23|23.0||||||
4185243|NCT00786422|4006888|B1|White||Race||Participants|Number|1|1.0||||||
4185244|NCT00786422|4006888|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4185245|NCT00786422|4006888|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4185246|NCT00786422|4006888|B1|> 75 years||Age, Customized||Participants|Number|1|1.0||||||
4185247|NCT00786422|4006888|B1|65 - 75 years||Age, Customized||Participants|Number|1|1.0||||||
4185248|NCT00786422|4006888|B1|< 65 years||Age, Customized||Participants|Number|23|23.0||||||
4185249|NCT00786409|4006904|B1|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
4185250|NCT00786409|4006904|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4185251|NCT00786409|4006904|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4185252|NCT00786409|4006904|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4185253|NCT00786409|4006904|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4185254|NCT00786409|4006904|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4185255|NCT00786409|4006904|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4185256|NCT00786409|4006904|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4185257|NCT00786409|4006904|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4185258|NCT00786409|4006904|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4185259|NCT00786409|4006904|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4185260|NCT00786409|4006904|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4185261|NCT00786409|4006904|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4185262|NCT00786409|4006904|B1|||Age||years|Mean|20.5|20.5|Full Range|||12.0|26.0|
4185263|NCT00786188|4006919|B3|United States||Region of Enrollment||participants|Number|102|102.0||||||
4185264|NCT00786188|4006920|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
4185265|NCT00786188|4006921|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4185266|NCT00786188|4006919|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4185267|NCT00786188|4006920|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4185268|NCT00786188|4006921|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4185269|NCT00786188|4006919|B3||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4185270|NCT00786188|4006920|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4185271|NCT00786188|4006921|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4185272|NCT00786188|4006919|B3|||Age||years|Mean|55.0|55.0|Standard Deviation|55.1|55.1|||
4185273|NCT00786188|4006920|B2|||Age||years|Mean|55.0|55.0|Standard Deviation|54.6|54.6|||
4185274|NCT00786188|4006921|B1|||Age||years|Mean|56|56.0|Standard Deviation|55.8|55.8|||
4185275|NCT00786188|4006919|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4185276|NCT00786188|4006920|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4185277|NCT00786188|4006921|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4185278|NCT00786188|4006919|B3||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
4185279|NCT00786188|4006920|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4185280|NCT00786188|4006921|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4185281|NCT00786188|4006919|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4185282|NCT00786188|4006920|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4185283|NCT00786188|4006921|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4185284|NCT00786032|4006948|B1|||ALS-Functional Rating Scale-R (ALSFRS)|The ALS Functional Rating Scale revised includes 12 questions. Each task is rated on a five-point scale from 0 = can't do, to 4 = normal ability. Individual item scores are summed to produce a reported score of between 0=worst and 48=best.|units on a scale|Mean|15|15.0|Standard Deviation|13|13.0|||
4185285|NCT00786032|4006948|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4185286|NCT00786032|4006948|B1||Unknown or Not Reported|Race (NIH/OMB)|No preference on race during recruitment.|Participants|Count of Participants|0|0.0||||||
4185287|NCT00786032|4006948|B1||More than one race|Race (NIH/OMB)|No preference on race during recruitment.|Participants|Count of Participants|0|0.0||||||
4185288|NCT00786032|4006948|B1||White|Race (NIH/OMB)|No preference on race during recruitment.|Participants|Count of Participants|24|24.0||||||
4185289|NCT00786032|4006948|B1||Black or African American|Race (NIH/OMB)|No preference on race during recruitment.|Participants|Count of Participants|2|2.0||||||
4185290|NCT00786032|4006948|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|No preference on race during recruitment.|Participants|Count of Participants|0|0.0||||||
4185291|NCT00786032|4006948|B1||Asian|Race (NIH/OMB)|No preference on race during recruitment.|Participants|Count of Participants|1|1.0||||||
4185292|NCT00786032|4006948|B1||American Indian or Alaska Native|Race (NIH/OMB)|No preference on race during recruitment.|Participants|Count of Participants|0|0.0||||||
4185293|NCT00786032|4006948|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4185294|NCT00786032|4006948|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4185295|NCT00786032|4006948|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4185296|NCT00786032|4006948|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4185297|NCT00786032|4006948|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4185298|NCT00786032|4006948|B1|||Age||years|Mean|61.32|61.32|Standard Deviation|11.67|11.67|||
4185299|NCT00786019|4006958|B3|||Peak VO2 (absolute)||mL/min|Mean|2055.81|2055.81|Standard Deviation|525.3|525.3|||
4185300|NCT00786019|4006959|B2|||Peak VO2 (absolute)||mL/min|Mean|2076.67|2076.67|Standard Deviation|531.6|531.6|||
4185301|NCT00786019|4006960|B1|||Peak VO2 (absolute)||mL/min|Mean|2027.65|2027.65|Standard Deviation|529.2|529.2|||
4185302|NCT00786019|4006958|B3|||Peak VO2 (relative)||mL/kg/min|Mean|21.52|21.52|Standard Deviation|4.3|4.3|||
4185303|NCT00786019|4006959|B2|||Peak VO2 (relative)||mL/kg/min|Mean|20.93|20.93|Standard Deviation|3.8|3.8|||
4185304|NCT00786019|4006960|B1|||Peak VO2 (relative)||mL/kg/min|Mean|22.32|22.32|Standard Deviation|4.9|4.9|||
4185305|NCT00786019|4006958|B3|||Hemoglobin A1c||percentage|Mean|6.22|6.22|Standard Deviation|1.0|1.0|||
4185306|NCT00786019|4006959|B2|||Hemoglobin A1c||percentage|Mean|6.85|6.85|Standard Deviation|0.7|0.7|||
4185307|NCT00786019|4006960|B1|||Hemoglobin A1c||percentage|Mean|5.37|5.37|Standard Deviation|0.4|0.4|||
4185308|NCT00786019|4006958|B3|||HDL Cholesterol (mg/dL)||mg/dL|Mean|44.19|44.19|Standard Deviation|12.5|12.5|||
4185309|NCT00786019|4006959|B2|||HDL Cholesterol (mg/dL)||mg/dL|Mean|38.26|38.26|Standard Deviation|8.1|8.1|||
4185310|NCT00786019|4006960|B1|||HDL Cholesterol (mg/dL)||mg/dL|Mean|52.2|52.2|Standard Deviation|13.0|13.0|||
4185311|NCT00786019|4006958|B3|||LDL Cholesterol (mg/dL)||mg/dL|Mean|94.85|94.85|Standard Deviation|22.2|22.2|||
4185312|NCT00786019|4006959|B2|||LDL Cholesterol (mg/dL)||mg/dL|Mean|87.33|87.33|Standard Deviation|19.2|19.2|||
4185313|NCT00786019|4006960|B1|||LDL Cholesterol (mg/dL)||mg/dL|Mean|105.00|105.0|Standard Deviation|22.4|22.4|||
4185314|NCT00786019|4006958|B3|||Triglycerides (mg/dL)||mg/dL|Mean|133.23|133.23|Standard Deviation|58.8|58.8|||
4185315|NCT00786019|4006959|B2|||Triglycerides (mg/dL)||mg/dL|Mean|151.52|151.52|Standard Deviation|65.5|65.5|||
4185316|NCT00786019|4006960|B1|||Triglycerides (mg/dL)||mg/dL|Mean|108.55|108.55|Standard Deviation|37.1|37.1|||
4185317|NCT00786019|4006958|B3|||Total Cholesterol (mg/dL)||mg/dL|Mean|158.43|158.43|Standard Deviation|27.5|27.5|||
4185318|NCT00786019|4006959|B2|||Total Cholesterol (mg/dL)||mg/dL|Mean|147.30|147.3|Standard Deviation|20.6|20.6|||
4185319|NCT00786019|4006960|B1|||Total Cholesterol (mg/dL)||mg/dL|Mean|173.45|173.45|Standard Deviation|28.8|28.8|||
4185320|NCT00786019|4006958|B3|||Insulin (uIU/mL)||uIU/mL|Mean|23.77|23.77|Standard Deviation|17.1|17.1|||
4185321|NCT00786019|4006959|B2|||Insulin (uIU/mL)||uIU/mL|Mean|29.93|29.93|Standard Deviation|19.6|19.6|||
4185322|NCT00786019|4006960|B1|||Insulin (uIU/mL)||uIU/mL|Mean|15.45|15.45|Standard Deviation|7.7|7.7|||
4185323|NCT00786019|4006958|B3|||Glucose (mg/dL)||mg/dL|Mean|105.06|105.06|Standard Deviation|23.1|23.1|||
4185324|NCT00786019|4006959|B2|||Glucose (mg/dL)||mg/dL|Mean|118.33|118.33|Standard Deviation|22.2|22.2|||
4185325|NCT00786019|4006960|B1|||Glucose (mg/dL)||mg/dL|Mean|87.15|87.15|Standard Deviation|5.7|5.7|||
4185326|NCT00786019|4006958|B3|||Body Fat Percentage (%)||percentage|Mean|33.63|33.63|Standard Deviation|6.5|6.5|||
4185327|NCT00786019|4006959|B2|||Body Fat Percentage (%)||percentage|Mean|32.61|32.61|Standard Deviation|6.1|6.1|||
4185328|NCT00786019|4006960|B1|||Body Fat Percentage (%)||percentage|Mean|35.00|35.0|Standard Deviation|7.0|7.0|||
4185329|NCT00786019|4006958|B3|||Body Mass Index (BMI)||kg/m^2|Mean|31.26|31.26|Standard Deviation|4.0|4.0|||
4185330|NCT00786019|4006959|B2|||Body Mass Index (BMI)||kg/m^2|Mean|31.75|31.75|Standard Deviation|4.7|4.7|||
4185331|NCT00786019|4006960|B1|||Body Mass Index (BMI)||kg/m^2|Mean|30.60|30.6|Standard Deviation|3.0|3.0|||
4185332|NCT00786019|4006958|B3|||Weight (kg)||kilograms|Mean|94.39|94.39|Standard Deviation|15.8|15.8|||
4185333|NCT00786019|4006959|B2|||Weight (kg)||kilograms|Mean|97.89|97.89|Standard Deviation|18.0|18.0|||
4185334|NCT00786019|4006960|B1|||Weight (kg)||kilograms|Mean|89.67|89.67|Standard Deviation|10.8|10.8|||
4185335|NCT00786019|4006958|B3|||Height (cm)||centimeters|Mean|173.52|173.52|Standard Deviation|9.7|9.7|||
4185336|NCT00786019|4006959|B2|||Height (cm)||centimeters|Mean|175.17|175.17|Standard Deviation|8.7|8.7|||
4185337|NCT00786019|4006960|B1|||Height (cm)||centimeters|Mean|171.30|171.3|Standard Deviation|10.8|10.8|||
4185338|NCT00786019|4006958|B3|United States||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
4185339|NCT00786019|4006959|B2|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
4185340|NCT00786019|4006960|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4185341|NCT00786019|4006958|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4185342|NCT00786019|4006959|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4185343|NCT00786019|4006960|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4185344|NCT00786019|4006958|B3|American Indian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4185345|NCT00786019|4006959|B2|American Indian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4185346|NCT00786019|4006960|B1|American Indian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4185347|NCT00786019|4006958|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
4185348|NCT00786019|4006959|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4185349|NCT00786019|4006960|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4185350|NCT00786019|4006958|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4185351|NCT00786019|4006959|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4185352|NCT00786019|4006960|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4185353|NCT00786019|4006958|B3|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4185354|NCT00786019|4006959|B2|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4185355|NCT00786019|4006960|B1|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4185356|NCT00786019|4006958|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4185357|NCT00786019|4006959|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4185358|NCT00786019|4006960|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4185359|NCT00786019|4006958|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4185360|NCT00786019|4006959|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4185361|NCT00786019|4006960|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4185362|NCT00786019|4006958|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4185363|NCT00786019|4006959|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4185364|NCT00786019|4006960|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4185365|NCT00786019|4006958|B3|||Age||years|Mean|46.0|46.0|Standard Deviation|6.0|6.0|||
4185366|NCT00786019|4006959|B2|||Age||years|Mean|46.5|46.5|Standard Deviation|5.7|5.7|||
4185367|NCT00786019|4006960|B1|||Age||years|Mean|45.4|45.4|Standard Deviation|6.0|6.0|||
4185368|NCT00785980|4006969|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4185369|NCT00785980|4006969|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4185370|NCT00785980|4006969|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4185371|NCT00785980|4006969|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4185372|NCT00785980|4006969|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4185373|NCT00785980|4006969|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4185374|NCT00785980|4006969|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4185375|NCT00785980|4006969|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4185376|NCT00785980|4006969|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4185377|NCT00785980|4006969|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4185378|NCT00785980|4006969|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4185379|NCT00785980|4006969|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4185380|NCT00785980|4006969|B1|||Age||years|Mean|25.9|25.9|Standard Deviation|7.44|7.44|||
4185381|NCT00785980|4006969|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4185382|NCT00785980|4006969|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4185383|NCT00785980|4006969|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4185384|NCT00785928|4006980|B8|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4185385|NCT00785928|4006981|B7|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4185386|NCT00785928|4006982|B6|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4185387|NCT00785928|4006983|B5|United States||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4185388|NCT00785928|4006984|B4|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4185389|NCT00785928|4006985|B3|United States||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4185390|NCT00785928|4006986|B2|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4185391|NCT00785928|4006987|B1|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4185392|NCT00785928|4006980|B8|Ukraine||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4185393|NCT00785928|4006981|B7|Ukraine||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4185394|NCT00785928|4006982|B6|Ukraine||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4185395|NCT00785928|4006983|B5|Ukraine||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4185396|NCT00785928|4006984|B4|Ukraine||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4185397|NCT00785928|4006985|B3|Ukraine||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4185398|NCT00785928|4006986|B2|Ukraine||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4185399|NCT00785928|4006987|B1|Ukraine||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4185400|NCT00785928|4006980|B8|Slovakia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4185401|NCT00785928|4006981|B7|Slovakia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4185402|NCT00785928|4006982|B6|Slovakia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4185403|NCT00785928|4006983|B5|Slovakia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4185404|NCT00785928|4006984|B4|Slovakia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4185405|NCT00785928|4006985|B3|Slovakia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4185406|NCT00785928|4006986|B2|Slovakia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4185407|NCT00785928|4006987|B1|Slovakia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4185408|NCT00785928|4006980|B8|Romania||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4185409|NCT00785928|4006981|B7|Romania||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4185410|NCT00785928|4006982|B6|Romania||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4185411|NCT00785928|4006983|B5|Romania||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4185412|NCT00785928|4006984|B4|Romania||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4185413|NCT00785928|4006985|B3|Romania||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4185414|NCT00785928|4006986|B2|Romania||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4185415|NCT00785928|4006987|B1|Romania||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4185416|NCT00785928|4006980|B8|Poland||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
4185417|NCT00785928|4006981|B7|Poland||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4185418|NCT00785928|4006982|B6|Poland||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4185419|NCT00785928|4006983|B5|Poland||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4185420|NCT00785928|4006984|B4|Poland||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4185421|NCT00785928|4006985|B3|Poland||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4185422|NCT00785928|4006986|B2|Poland||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4185423|NCT00785928|4006987|B1|Poland||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4185424|NCT00785928|4006980|B8|Mexico||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4185425|NCT00785928|4006981|B7|Mexico||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4185426|NCT00785928|4006982|B6|Mexico||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4185427|NCT00785928|4006983|B5|Mexico||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4185428|NCT00785928|4006984|B4|Mexico||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4185429|NCT00785928|4006985|B3|Mexico||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4185430|NCT00785928|4006986|B2|Mexico||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4185431|NCT00785928|4006987|B1|Mexico||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4185432|NCT00785928|4006980|B8|India||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4185433|NCT00785928|4006981|B7|India||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4185434|NCT00785928|4006982|B6|India||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4185435|NCT00785928|4006983|B5|India||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4185436|NCT00785928|4006984|B4|India||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4185437|NCT00785928|4006985|B3|India||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4185438|NCT00785928|4006986|B2|India||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4185439|NCT00785928|4006987|B1|India||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4185440|NCT00785928|4006980|B8|Hungary||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4185441|NCT00785928|4006981|B7|Hungary||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4185442|NCT00785928|4006982|B6|Hungary||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4185443|NCT00785928|4006983|B5|Hungary||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4185444|NCT00785928|4006984|B4|Hungary||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4185445|NCT00785928|4006985|B3|Hungary||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4185446|NCT00785928|4006986|B2|Hungary||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4185447|NCT00785928|4006987|B1|Hungary||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4185448|NCT00785928|4006980|B8|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4185449|NCT00785928|4006981|B7|Germany||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4185450|NCT00785928|4006982|B6|Germany||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4185451|NCT00785928|4006983|B5|Germany||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4185452|NCT00785928|4006984|B4|Germany||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4185453|NCT00785928|4006985|B3|Germany||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4185454|NCT00785928|4006986|B2|Germany||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4185455|NCT00785928|4006987|B1|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4185456|NCT00785928|4006980|B8|Chile||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
4185457|NCT00785928|4006981|B7|Chile||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4185458|NCT00785928|4006982|B6|Chile||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4185459|NCT00785928|4006983|B5|Chile||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4185460|NCT00785928|4006984|B4|Chile||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4185461|NCT00785928|4006985|B3|Chile||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4185462|NCT00785928|4006986|B2|Chile||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4185463|NCT00785928|4006987|B1|Chile||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4185464|NCT00785928|4006980|B8|Australia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4185465|NCT00785928|4006981|B7|Australia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4185466|NCT00785928|4006982|B6|Australia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4185467|NCT00785928|4006983|B5|Australia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4185468|NCT00785928|4006984|B4|Australia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4185469|NCT00785928|4006985|B3|Australia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4185470|NCT00785928|4006986|B2|Australia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4185471|NCT00785928|4006987|B1|Australia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4185472|NCT00785928|4006980|B8|Argentina||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4185473|NCT00785928|4006981|B7|Argentina||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4185474|NCT00785928|4006982|B6|Argentina||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4185475|NCT00785928|4006983|B5|Argentina||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4185476|NCT00785928|4006984|B4|Argentina||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4185477|NCT00785928|4006985|B3|Argentina||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4185478|NCT00785928|4006986|B2|Argentina||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4185479|NCT00785928|4006987|B1|Argentina||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4185480|NCT00785928|4006980|B8|West Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4185481|NCT00785928|4006981|B7|West Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4185482|NCT00785928|4006982|B6|West Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4185483|NCT00785928|4006983|B5|West Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4185484|NCT00785928|4006984|B4|West Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4185485|NCT00785928|4006985|B3|West Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4185486|NCT00785928|4006986|B2|West Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4185487|NCT00785928|4006987|B1|West Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4185488|NCT00785928|4006980|B8|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4185489|NCT00785928|4006981|B7|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4185490|NCT00785928|4006982|B6|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4185491|NCT00785928|4006983|B5|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4185492|NCT00785928|4006984|B4|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4185493|NCT00785928|4006985|B3|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4185494|NCT00785928|4006986|B2|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4185495|NCT00785928|4006987|B1|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4185496|NCT00785928|4006980|B8|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
4185497|NCT00785928|4006981|B7|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4185498|NCT00785928|4006982|B6|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4185499|NCT00785928|4006983|B5|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4185500|NCT00785928|4006984|B4|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4185501|NCT00785928|4006985|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4185502|NCT00785928|4006986|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4185503|NCT00785928|4006987|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4185504|NCT00785928|4006980|B8|African||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4185505|NCT00785928|4006981|B7|African||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4185506|NCT00785928|4006982|B6|African||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4185507|NCT00785928|4006983|B5|African||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4185508|NCT00785928|4006984|B4|African||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4185509|NCT00785928|4006985|B3|African||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4185510|NCT00785928|4006986|B2|African||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4185511|NCT00785928|4006987|B1|African||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4185512|NCT00785928|4006980|B8|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|101|101.0||||||
4185513|NCT00785928|4006981|B7|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4185514|NCT00785928|4006982|B6|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4185515|NCT00785928|4006983|B5|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4185516|NCT00785928|4006984|B4|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4185517|NCT00785928|4006985|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4185518|NCT00785928|4006986|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
4185519|NCT00785928|4006987|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
4185520|NCT00785928|4006980|B8||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4185521|NCT00785928|4006981|B7||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4185522|NCT00785928|4006982|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4185523|NCT00785928|4006983|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4185524|NCT00785928|4006984|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4185525|NCT00785928|4006985|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4185526|NCT00785928|4006986|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4185527|NCT00785928|4006987|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4185528|NCT00785928|4006980|B8||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4185529|NCT00785928|4006981|B7||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4185530|NCT00785928|4006982|B6||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4185531|NCT00785928|4006983|B5||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4185532|NCT00785928|4006984|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4185533|NCT00785928|4006985|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4185534|NCT00785928|4006986|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4185535|NCT00785928|4006987|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4185536|NCT00785928|4006980|B8|||Age||years|Mean|51.7|51.7|Standard Deviation|12.13|12.13|||
4185537|NCT00785928|4006981|B7|||Age||years|Mean|50.7|50.7|Standard Deviation|12.02|12.02|||
4185538|NCT00785928|4006982|B6|||Age||years|Mean|44.4|44.4|Standard Deviation|13.83|13.83|||
4185539|NCT00785928|4006983|B5|||Age||years|Mean|54.5|54.5|Standard Deviation|11.75|11.75|||
4185540|NCT00785928|4006984|B4|||Age||years|Mean|51.2|51.2|Standard Deviation|13.78|13.78|||
4185541|NCT00785928|4006985|B3|||Age||years|Mean|53.4|53.4|Standard Deviation|10.78|10.78|||
4185542|NCT00785928|4006986|B2|||Age||years|Mean|54.6|54.6|Standard Deviation|11.67|11.67|||
4185543|NCT00785928|4006987|B1|||Age||years|Mean|50.6|50.6|Standard Deviation|11.74|11.74|||
4185544|NCT00785798|4007133|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4185545|NCT00785798|4007133|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4185546|NCT00785798|4007133|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|19.0|19.0|||
4185547|NCT00785785|4007138|B3||Male|Sex: Female, Male||Participants|Count of Participants|366|366.0||||||
4185548|NCT00785785|4007139|B2||Male|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4185549|NCT00785785|4007140|B1||Male|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4185550|NCT00785785|4007138|B3||Female|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
4185551|NCT00785785|4007139|B2||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4185552|NCT00785785|4007140|B1||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4185553|NCT00785785|4007138|B3|||Age||years|Mean|57.35|57.35|Standard Deviation|12.77|12.77|||
4185554|NCT00785785|4007139|B2|||Age||years|Mean|57.3|57.3|Standard Deviation|12.63|12.63|||
4185555|NCT00785785|4007140|B1|||Age||years|Mean|57.4|57.4|Standard Deviation|12.91|12.91|||
4185556|NCT00785772|4007149|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4185557|NCT00785772|4007149|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4185558|NCT00785772|4007149|B1|>=65 years||Age, Customized||Participant|Number|0|0.0||||||
4185559|NCT00785772|4007149|B1|20-64 years||Age, Customized||Participant|Number|1|1.0||||||
4185560|NCT00785772|4007149|B1|<=19 years||Age, Customized||Participant|Number|0|0.0||||||
4185561|NCT00785707|4007155|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4185562|NCT00785707|4007155|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4185563|NCT00785707|4007155|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4185564|NCT00785707|4007155|B1|||Age||months|Mean|16.2|16.2|Full Range|||11.1|24.7|
4185565|NCT00785629|4007160|B5|United States||Region of Enrollment||participants|Number|145|145.0||||||
4185566|NCT00785629|4007161|B4|United States||Region of Enrollment||participants|Number|57|57.0||||||
4185567|NCT00785629|4007162|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
4185568|NCT00785629|4007163|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4185569|NCT00785629|4007164|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4185570|NCT00785629|4007160|B5||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4185571|NCT00785629|4007161|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4185572|NCT00785629|4007162|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4185573|NCT00785629|4007163|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4185574|NCT00785629|4007164|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4185575|NCT00785629|4007160|B5||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4185576|NCT00785629|4007161|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4185577|NCT00785629|4007162|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4185578|NCT00785629|4007163|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4185579|NCT00785629|4007164|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4185580|NCT00785629|4007160|B5|||Age||years|Mean|67|67.0|Standard Deviation|12|12.0|||
4185581|NCT00785629|4007161|B4|||Age||years|Mean|65|65.0|Standard Deviation|12|12.0|||
4185582|NCT00785629|4007162|B3|||Age||years|Mean|70|70.0|Standard Deviation|10|10.0|||
4185583|NCT00785629|4007163|B2|||Age||years|Mean|66|66.0|Standard Deviation|12|12.0|||
4185584|NCT00785629|4007164|B1|||Age||years|Mean|68|68.0|Standard Deviation|12|12.0|||
4185585|NCT00785577|4007175|B6|Puerto Rico||Region of Enrollment||participants|Number|19|19.0||||||
4185586|NCT00785577|4007176|B5|Puerto Rico||Region of Enrollment||participants|Number|3|3.0||||||
4185587|NCT00785577|4007177|B4|Puerto Rico||Region of Enrollment||participants|Number|4|4.0||||||
4185588|NCT00785577|4007178|B3|Puerto Rico||Region of Enrollment||participants|Number|3|3.0||||||
4185589|NCT00785577|4007179|B2|Puerto Rico||Region of Enrollment||participants|Number|3|3.0||||||
4185590|NCT00785577|4007180|B1|Puerto Rico||Region of Enrollment||participants|Number|6|6.0||||||
4185591|NCT00785577|4007175|B6|Mexico||Region of Enrollment||participants|Number|83|83.0||||||
4185592|NCT00785577|4007176|B5|Mexico||Region of Enrollment||participants|Number|16|16.0||||||
4185593|NCT00785577|4007177|B4|Mexico||Region of Enrollment||participants|Number|16|16.0||||||
4185594|NCT00785577|4007178|B3|Mexico||Region of Enrollment||participants|Number|12|12.0||||||
4185595|NCT00785577|4007179|B2|Mexico||Region of Enrollment||participants|Number|13|13.0||||||
4185596|NCT00785577|4007180|B1|Mexico||Region of Enrollment||participants|Number|26|26.0||||||
4185597|NCT00785577|4007175|B6|United States||Region of Enrollment||participants|Number|171|171.0||||||
4185598|NCT00785577|4007176|B5|United States||Region of Enrollment||participants|Number|28|28.0||||||
4185599|NCT00785577|4007177|B4|United States||Region of Enrollment||participants|Number|29|29.0||||||
4185600|NCT00785577|4007178|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
4185601|NCT00785577|4007179|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4185602|NCT00785577|4007180|B1|United States||Region of Enrollment||participants|Number|57|57.0||||||
4185603|NCT00785577|4007175|B6|White||Race/Ethnicity, Customized||participants|Number|211|211.0||||||
4185604|NCT00785577|4007176|B5|White||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4185605|NCT00785577|4007177|B4|White||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4185606|NCT00785577|4007178|B3|White||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4185607|NCT00785577|4007179|B2|White||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4185608|NCT00785577|4007180|B1|White||Race/Ethnicity, Customized||participants|Number|71|71.0||||||
4185609|NCT00785577|4007175|B6|Multiple||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4185610|NCT00785577|4007176|B5|Multiple||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4185611|NCT00785577|4007177|B4|Multiple||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4185612|NCT00785577|4007178|B3|Multiple||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4185613|NCT00785577|4007179|B2|Multiple||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4185614|NCT00785577|4007180|B1|Multiple||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4185615|NCT00785577|4007175|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4185616|NCT00785577|4007176|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4185617|NCT00785577|4007177|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4185618|NCT00785577|4007178|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4185619|NCT00785577|4007179|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4185620|NCT00785577|4007180|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4185621|NCT00785577|4007175|B6|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4185622|NCT00785577|4007176|B5|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4185623|NCT00785577|4007177|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4185624|NCT00785577|4007178|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4185625|NCT00785577|4007179|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4185626|NCT00785577|4007180|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4185627|NCT00785577|4007175|B6|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4185628|NCT00785577|4007176|B5|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4185629|NCT00785577|4007177|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4185630|NCT00785577|4007178|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4185631|NCT00785577|4007179|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4185632|NCT00785577|4007180|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4185633|NCT00785577|4007175|B6||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4185634|NCT00785577|4007176|B5||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4185635|NCT00785577|4007177|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4185636|NCT00785577|4007178|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4185637|NCT00785577|4007179|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4185638|NCT00785577|4007180|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4185639|NCT00785577|4007175|B6||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4185640|NCT00785577|4007176|B5||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4185641|NCT00785577|4007177|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4185642|NCT00785577|4007178|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4185643|NCT00785577|4007179|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4185644|NCT00785577|4007180|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4185645|NCT00785577|4007175|B6|||Age||years|Mean|56.62|56.62|Standard Deviation|8.71|8.71|||
4185646|NCT00785577|4007176|B5|||Age||years|Mean|56.47|56.47|Standard Deviation|7.77|7.77|||
4185647|NCT00785577|4007177|B4|||Age||years|Mean|58.59|58.59|Standard Deviation|7.71|7.71|||
4185648|NCT00785577|4007178|B3|||Age||years|Mean|56.95|56.95|Standard Deviation|8.35|8.35|||
4185649|NCT00785577|4007179|B2|||Age||years|Mean|56.89|56.89|Standard Deviation|8.19|8.19|||
4185650|NCT00785577|4007180|B1|||Age||years|Mean|55.32|55.32|Standard Deviation|10.00|10.0|||
4185651|NCT00785538|4007320|B5|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
4185652|NCT00785538|4007321|B4|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4185653|NCT00785538|4007322|B3|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4185654|NCT00785538|4007323|B2|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4185655|NCT00785538|4007324|B1|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4185656|NCT00785538|4007320|B5|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4185657|NCT00785538|4007321|B4|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4185658|NCT00785538|4007322|B3|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4185659|NCT00785538|4007323|B2|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4185660|NCT00785538|4007324|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4185661|NCT00785538|4007320|B5|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4185662|NCT00785538|4007321|B4|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4185663|NCT00785538|4007322|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4185664|NCT00785538|4007323|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4185665|NCT00785538|4007324|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4185666|NCT00785538|4007320|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4185667|NCT00785538|4007321|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4185668|NCT00785538|4007322|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4185669|NCT00785538|4007323|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4185670|NCT00785538|4007324|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4185671|NCT00785538|4007320|B5|Black||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4185672|NCT00785538|4007321|B4|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4185673|NCT00785538|4007322|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4185674|NCT00785538|4007323|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4185675|NCT00785538|4007324|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4185676|NCT00785538|4007320|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
4185677|NCT00785538|4007321|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4185678|NCT00785538|4007322|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4185679|NCT00785538|4007323|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4185680|NCT00785538|4007324|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4185681|NCT00785538|4007320|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4185682|NCT00785538|4007321|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4185683|NCT00785538|4007322|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4185684|NCT00785538|4007323|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4185685|NCT00785538|4007324|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4185686|NCT00785538|4007320|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4185687|NCT00785538|4007321|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4185688|NCT00785538|4007322|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4185689|NCT00785538|4007323|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4185690|NCT00785538|4007324|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4185691|NCT00785538|4007320|B5|||Age||years|Median|57.2|57.2|Full Range|11.13|11.13|25.0|70.0|
4185692|NCT00785538|4007321|B4|||Age||years|Median|42.9|42.9|Full Range|15.13|15.13|32.0|54.0|
4185693|NCT00785538|4007322|B3|||Age||years|Median|59.4|59.4|Full Range|15.17|15.17|25.0|69.0|
4185694|NCT00785538|4007323|B2|||Age||years|Median|56.4|56.4|Full Range|6.30|6.3|47.0|67.0|
4185695|NCT00785538|4007324|B1|||Age||years|Median|65.7|65.7|Full Range|10.43|10.43|45.0|70.0|
4185696|NCT00785512|4007373|B3|United States||Region of Enrollment||participants|Number|207|207.0||||||
4185697|NCT00785512|4007374|B2|United States||Region of Enrollment||participants|Number|105|105.0||||||
4185698|NCT00785512|4007375|B1|United States||Region of Enrollment||participants|Number|102|102.0||||||
4185699|NCT00785512|4007373|B3||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4185700|NCT00785512|4007374|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4185701|NCT00785512|4007375|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4185702|NCT00785512|4007373|B3||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4185703|NCT00785512|4007374|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4185704|NCT00785512|4007375|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4185705|NCT00785512|4007373|B3|||Age||years|Mean|52.8|52.8|Standard Deviation|10.6|10.6|||
4185706|NCT00785512|4007374|B2|||Age||years|Mean|52.9|52.9|Standard Deviation|10.2|10.2|||
4185707|NCT00785512|4007375|B1|||Age||years|Mean|52.6|52.6|Standard Deviation|11.2|11.2|||
4185708|NCT00785512|4007373|B3|>=65 years||Age||participants|Number|30|30.0||||||
4185709|NCT00785512|4007374|B2|>=65 years||Age||participants|Number|14|14.0||||||
4185710|NCT00785512|4007375|B1|>=65 years||Age||participants|Number|16|16.0||||||
4185711|NCT00785512|4007373|B3|Ages 18 to 64 years||Age||participants|Number|177|177.0||||||
4185712|NCT00785512|4007374|B2|Ages 18 to 64 years||Age||participants|Number|91|91.0||||||
4185713|NCT00785512|4007375|B1|Ages 18 to 64 years||Age||participants|Number|86|86.0||||||
4185714|NCT00785512|4007373|B3|<18 years||Age||participants|Number|0|0.0||||||
4185715|NCT00785512|4007374|B2|<18 years||Age||participants|Number|0|0.0||||||
4185716|NCT00785512|4007375|B1|<18 years||Age||participants|Number|0|0.0||||||
4185717|NCT00785486|4007385|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4185718|NCT00785486|4007385|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4185719|NCT00785486|4007385|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4185720|NCT00785486|4007385|B1|||Age||years|Mean|31.1|31.1|Standard Deviation|5.6|5.6|||
4185721|NCT00785291|4007417|B4|Bevacizumab required||Physician's Decision to use Bevacizumab||participants|Number|669|669.0||||||
4185722|NCT00785291|4007418|B3|Bevacizumab required||Physician's Decision to use Bevacizumab||participants|Number|222|222.0||||||
4185723|NCT00785291|4007419|B2|Bevacizumab required||Physician's Decision to use Bevacizumab||participants|Number|223|223.0||||||
4185724|NCT00785291|4007420|B1|Bevacizumab required||Physician's Decision to use Bevacizumab||participants|Number|224|224.0||||||
4185725|NCT00785291|4007417|B4|Bevacizumab not planned||Physician's Decision to use Bevacizumab||participants|Number|20|20.0||||||
4185726|NCT00785291|4007418|B3|Bevacizumab not planned||Physician's Decision to use Bevacizumab||participants|Number|8|8.0||||||
4185727|NCT00785291|4007419|B2|Bevacizumab not planned||Physician's Decision to use Bevacizumab||participants|Number|4|4.0||||||
4185728|NCT00785291|4007420|B1|Bevacizumab not planned||Physician's Decision to use Bevacizumab||participants|Number|8|8.0||||||
4185729|NCT00785291|4007417|B4|Bevacizumab planned||Physician's Decision to use Bevacizumab||participants|Number|110|110.0||||||
4185730|NCT00785291|4007418|B3|Bevacizumab planned||Physician's Decision to use Bevacizumab||participants|Number|15|15.0||||||
4185731|NCT00785291|4007419|B2|Bevacizumab planned||Physician's Decision to use Bevacizumab||participants|Number|44|44.0||||||
4185732|NCT00785291|4007420|B1|Bevacizumab planned||Physician's Decision to use Bevacizumab||participants|Number|51|51.0||||||
4185733|NCT00785291|4007417|B4|ER/PgR Negative||Hormone Receptor Status||participants|Number|225|225.0||||||
4185734|NCT00785291|4007418|B3|ER/PgR Negative||Hormone Receptor Status||participants|Number|67|67.0||||||
4185735|NCT00785291|4007419|B2|ER/PgR Negative||Hormone Receptor Status||participants|Number|76|76.0||||||
4185736|NCT00785291|4007420|B1|ER/PgR Negative||Hormone Receptor Status||participants|Number|82|82.0||||||
4185737|NCT00785291|4007417|B4|ER/PgR Positive||Hormone Receptor Status||participants|Number|574|574.0||||||
4185738|NCT00785291|4007418|B3|ER/PgR Positive||Hormone Receptor Status||participants|Number|178|178.0||||||
4185739|NCT00785291|4007419|B2|ER/PgR Positive||Hormone Receptor Status||participants|Number|195|195.0||||||
4185740|NCT00785291|4007420|B1|ER/PgR Positive||Hormone Receptor Status||participants|Number|201|201.0||||||
4185741|NCT00785291|4007417|B4|No||Prior Adjuvant Taxane||participants|Number|447|447.0||||||
4185742|NCT00785291|4007418|B3|No||Prior Adjuvant Taxane||participants|Number|138|138.0||||||
4185743|NCT00785291|4007419|B2|No||Prior Adjuvant Taxane||participants|Number|151|151.0||||||
4185744|NCT00785291|4007420|B1|No||Prior Adjuvant Taxane||participants|Number|158|158.0||||||
4185745|NCT00785291|4007417|B4|Yes||Prior Adjuvant Taxane||participants|Number|352|352.0||||||
4185746|NCT00785291|4007418|B3|Yes||Prior Adjuvant Taxane||participants|Number|107|107.0||||||
4185747|NCT00785291|4007419|B2|Yes||Prior Adjuvant Taxane||participants|Number|120|120.0||||||
4185748|NCT00785291|4007420|B1|Yes||Prior Adjuvant Taxane||participants|Number|125|125.0||||||
4185749|NCT00785291|4007417|B4|United States||Region of Enrollment||participants|Number|799|799.0||||||
4185750|NCT00785291|4007418|B3|United States||Region of Enrollment||participants|Number|245|245.0||||||
4185751|NCT00785291|4007419|B2|United States||Region of Enrollment||participants|Number|271|271.0||||||
4185752|NCT00785291|4007420|B1|United States||Region of Enrollment||participants|Number|283|283.0||||||
4185753|NCT00785291|4007417|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4185754|NCT00785291|4007418|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4185755|NCT00785291|4007419|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4185756|NCT00785291|4007420|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4185757|NCT00785291|4007417|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4185758|NCT00785291|4007418|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4185759|NCT00785291|4007419|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4185760|NCT00785291|4007420|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4185761|NCT00785291|4007417|B4||White|Race (NIH/OMB)||Participants|Count of Participants|640|640.0||||||
4185762|NCT00785291|4007418|B3||White|Race (NIH/OMB)||Participants|Count of Participants|206|206.0||||||
4185763|NCT00785291|4007419|B2||White|Race (NIH/OMB)||Participants|Count of Participants|214|214.0||||||
4185764|NCT00785291|4007420|B1||White|Race (NIH/OMB)||Participants|Count of Participants|220|220.0||||||
4185765|NCT00785291|4007417|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
4185766|NCT00785291|4007418|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4185767|NCT00785291|4007419|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4185768|NCT00785291|4007420|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4185769|NCT00785291|4007417|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4185770|NCT00785291|4007418|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4185771|NCT00785291|4007419|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4185772|NCT00785291|4007420|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4185773|NCT00785291|4007417|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4185774|NCT00785291|4007418|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4185775|NCT00785291|4007419|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4185776|NCT00785291|4007420|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4185777|NCT00785291|4007417|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4185778|NCT00785291|4007418|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4185779|NCT00785291|4007419|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4185780|NCT00785291|4007420|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4185781|NCT00785291|4007417|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4185782|NCT00785291|4007418|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4185783|NCT00785291|4007419|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4185784|NCT00785291|4007420|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4185785|NCT00785291|4007417|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|712|712.0||||||
4185786|NCT00785291|4007418|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|221|221.0||||||
4185787|NCT00785291|4007419|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|239|239.0||||||
4185788|NCT00785291|4007420|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|252|252.0||||||
4185789|NCT00785291|4007417|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4185790|NCT00785291|4007418|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4185791|NCT00785291|4007419|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4185792|NCT00785291|4007420|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4185793|NCT00785291|4007417|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4185794|NCT00785291|4007418|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4185795|NCT00785291|4007419|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4185796|NCT00785291|4007420|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4185797|NCT00785291|4007417|B4||Female|Sex: Female, Male||Participants|Count of Participants|788|788.0||||||
4185798|NCT00785291|4007418|B3||Female|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
4185799|NCT00785291|4007419|B2||Female|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
4185800|NCT00785291|4007420|B1||Female|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
4185801|NCT00785291|4007417|B4|80+||Age, Customized||participants|Number|14|14.0||||||
4185802|NCT00785291|4007418|B3|80+||Age, Customized||participants|Number|3|3.0||||||
4185803|NCT00785291|4007419|B2|80+||Age, Customized||participants|Number|4|4.0||||||
4185804|NCT00785291|4007420|B1|80+||Age, Customized||participants|Number|7|7.0||||||
4185805|NCT00785291|4007417|B4|70-79||Age, Customized||participants|Number|67|67.0||||||
4185806|NCT00785291|4007418|B3|70-79||Age, Customized||participants|Number|15|15.0||||||
4185807|NCT00785291|4007419|B2|70-79||Age, Customized||participants|Number|28|28.0||||||
4185808|NCT00785291|4007420|B1|70-79||Age, Customized||participants|Number|24|24.0||||||
4185809|NCT00785291|4007417|B4|60-69||Age, Customized||participants|Number|216|216.0||||||
4185810|NCT00785291|4007418|B3|60-69||Age, Customized||participants|Number|68|68.0||||||
4185811|NCT00785291|4007419|B2|60-69||Age, Customized||participants|Number|74|74.0||||||
4185812|NCT00785291|4007420|B1|60-69||Age, Customized||participants|Number|74|74.0||||||
4185813|NCT00785291|4007417|B4|50-59||Age, Customized||participants|Number|284|284.0||||||
4185814|NCT00785291|4007418|B3|50-59||Age, Customized||participants|Number|86|86.0||||||
4185815|NCT00785291|4007419|B2|50-59||Age, Customized||participants|Number|89|89.0||||||
4185816|NCT00785291|4007420|B1|50-59||Age, Customized||participants|Number|109|109.0||||||
4185817|NCT00785291|4007417|B4|40-49||Age, Customized||participants|Number|163|163.0||||||
4185818|NCT00785291|4007418|B3|40-49||Age, Customized||participants|Number|55|55.0||||||
4185819|NCT00785291|4007419|B2|40-49||Age, Customized||participants|Number|56|56.0||||||
4185820|NCT00785291|4007420|B1|40-49||Age, Customized||participants|Number|52|52.0||||||
4185821|NCT00785291|4007417|B4|30-39||Age, Customized||participants|Number|50|50.0||||||
4185822|NCT00785291|4007418|B3|30-39||Age, Customized||participants|Number|17|17.0||||||
4185823|NCT00785291|4007419|B2|30-39||Age, Customized||participants|Number|18|18.0||||||
4185824|NCT00785291|4007420|B1|30-39||Age, Customized||participants|Number|15|15.0||||||
4185825|NCT00785291|4007417|B4|20-29||Age, Customized||participants|Number|5|5.0||||||
4185826|NCT00785291|4007418|B3|20-29||Age, Customized||participants|Number|1|1.0||||||
4185827|NCT00785291|4007419|B2|20-29||Age, Customized||participants|Number|2|2.0||||||
4185828|NCT00785291|4007420|B1|20-29||Age, Customized||participants|Number|2|2.0||||||
4185829|NCT00785213|4007442|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4185830|NCT00785213|4007442|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4185831|NCT00785213|4007442|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4185832|NCT00785213|4007442|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4185833|NCT00785213|4007442|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4185834|NCT00785213|4007442|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4185835|NCT00785213|4007442|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4185836|NCT00785213|4007442|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4185837|NCT00785213|4007442|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4185838|NCT00785213|4007442|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4185839|NCT00785213|4007442|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4185840|NCT00785213|4007442|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4185841|NCT00785213|4007442|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4185842|NCT00785213|4007442|B1|||Age||years|Mean|25.61|25.61|Standard Deviation|7.07|7.07|||
4185843|NCT00785213|4007442|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4185844|NCT00785213|4007442|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4185845|NCT00785213|4007442|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4185846|NCT00785044|4007453|B1||Male|Sex: Female, Male||Participants|Count of Participants|772|772.0||||||
4185847|NCT00785044|4007453|B1||Female|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4185848|NCT00785044|4007453|B1|||Age||years|Mean|62.4|62.4|Standard Deviation|11.85|11.85|||
4185849|NCT00784979|4007458|B1|||Percent of subjects with PRA >/= 20% in last 12 months||percent of subjects with elevated PRA|Number|76|76.0||||||
4185850|NCT00784979|4007458|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4185851|NCT00784979|4007458|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4185852|NCT00784979|4007458|B1|||Age|>/= 18 years old|years|Mean|42|42.0|Standard Deviation|10.6|10.6|||
4185853|NCT00784927|4007462|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4185854|NCT00784927|4007462|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4185855|NCT00784927|4007462|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4185856|NCT00784927|4007462|B1|||Age||years|Median|68|68.0|Full Range|||43.0|83.0|
4185857|NCT00784875|4007470|B5|United States||Region of Enrollment||participants|Number|407|407.0||||||
4185858|NCT00784875|4007471|B4|United States||Region of Enrollment||participants|Number|101|101.0||||||
4185859|NCT00784875|4007472|B3|United States||Region of Enrollment||participants|Number|102|102.0||||||
4185860|NCT00784875|4007473|B2|United States||Region of Enrollment||participants|Number|102|102.0||||||
4185861|NCT00784875|4007474|B1|United States||Region of Enrollment||participants|Number|102|102.0||||||
4185862|NCT00784875|4007470|B5|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4185863|NCT00784875|4007471|B4|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4185864|NCT00784875|4007472|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4185865|NCT00784875|4007473|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4185866|NCT00784875|4007474|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4185867|NCT00784875|4007470|B5|East Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4185868|NCT00784875|4007471|B4|East Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4185869|NCT00784875|4007472|B3|East Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4185870|NCT00784875|4007473|B2|East Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4185871|NCT00784875|4007474|B1|East Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4185872|NCT00784875|4007470|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4185873|NCT00784875|4007471|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4185874|NCT00784875|4007472|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4185875|NCT00784875|4007473|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4185876|NCT00784875|4007474|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4185877|NCT00784875|4007470|B5|African||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
4185878|NCT00784875|4007471|B4|African||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4185879|NCT00784875|4007472|B3|African||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4185880|NCT00784875|4007473|B2|African||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4185881|NCT00784875|4007474|B1|African||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4185882|NCT00784875|4007470|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|306|306.0||||||
4185883|NCT00784875|4007471|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
4185884|NCT00784875|4007472|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|85|85.0||||||
4185885|NCT00784875|4007473|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
4185886|NCT00784875|4007474|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|75|75.0||||||
4185887|NCT00784875|4007470|B5||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4185888|NCT00784875|4007471|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4185889|NCT00784875|4007472|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4185890|NCT00784875|4007473|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4185891|NCT00784875|4007474|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4185892|NCT00784875|4007470|B5||Female|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
4185893|NCT00784875|4007471|B4||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4185894|NCT00784875|4007472|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4185895|NCT00784875|4007473|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4185896|NCT00784875|4007474|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4185897|NCT00784875|4007470|B5|||Age||years|Mean|52.27|52.27|Standard Deviation|14.35|14.35|||
4185898|NCT00784875|4007471|B4|||Age||years|Mean|52.86|52.86|Standard Deviation|13.66|13.66|||
4185899|NCT00784875|4007472|B3|||Age||years|Mean|50.65|50.65|Standard Deviation|15|15.0|||
4185900|NCT00784875|4007473|B2|||Age||years|Mean|52.77|52.77|Standard Deviation|14.73|14.73|||
4185901|NCT00784875|4007474|B1|||Age||years|Mean|52.81|52.81|Standard Deviation|14.07|14.07|||
4185902|NCT00784849|4007591|B1|United States||Region of Enrollment||participants|Number|62|62.0||||||
4185903|NCT00784849|4007591|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4185904|NCT00784849|4007591|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4185905|NCT00784849|4007591|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4185906|NCT00784849|4007591|B1||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4185907|NCT00784849|4007591|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4185908|NCT00784836|4007597|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4185909|NCT00784836|4007597|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4185910|NCT00784836|4007597|B1|> 60 years||Age, Customized||participants|Number|0|0.0||||||
4185911|NCT00784836|4007597|B1|Between 18 and 60 years||Age, Customized||participants|Number|3|3.0||||||
4185912|NCT00784836|4007597|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4185913|NCT00784810|4007602|B3|United Kingdom||Region of Enrollment||participants|Number|247|247.0||||||
4185914|NCT00784810|4007603|B2|United Kingdom||Region of Enrollment||participants|Number|123|123.0||||||
4185915|NCT00784810|4007604|B1|United Kingdom||Region of Enrollment||participants|Number|124|124.0||||||
4185916|NCT00784810|4007602|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4185917|NCT00784810|4007603|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4185918|NCT00784810|4007604|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4185919|NCT00784810|4007602|B3||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4185920|NCT00784810|4007603|B2||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4185921|NCT00784810|4007604|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4185922|NCT00784810|4007602|B3|||Age||years|Mean|64.1|64.1|Standard Deviation|10.73|10.73|||
4185923|NCT00784810|4007603|B2|||Age||years|Mean|63.9|63.9|Standard Deviation|10.97|10.97|||
4185924|NCT00784810|4007604|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|10.53|10.53|||
4185925|NCT00784810|4007602|B3||>=65 years|Age||Participants|Count of Participants|111|111.0||||||
4185926|NCT00784810|4007603|B2||>=65 years|Age||Participants|Count of Participants|53|53.0||||||
4185927|NCT00784810|4007604|B1||>=65 years|Age||Participants|Count of Participants|58|58.0||||||
4185928|NCT00784810|4007602|B3||Between 18 and 65 years|Age||Participants|Count of Participants|136|136.0||||||
4185929|NCT00784810|4007603|B2||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4185930|NCT00784810|4007604|B1||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4185931|NCT00784810|4007602|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4185932|NCT00784810|4007603|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4185933|NCT00784810|4007604|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4185934|NCT00784784|4007613|B3|Canada||Region of Enrollment||participants|Number|64|64.0||||||
4185935|NCT00784784|4007614|B2|Canada||Region of Enrollment||participants|Number|42|42.0||||||
4185936|NCT00784784|4007615|B1|Canada||Region of Enrollment||participants|Number|22|22.0||||||
4185937|NCT00784784|4007613|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4185938|NCT00784784|4007614|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4185939|NCT00784784|4007615|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4185940|NCT00784784|4007613|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4185941|NCT00784784|4007614|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4185942|NCT00784784|4007615|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4185943|NCT00784784|4007613|B3|||Age||years|Mean|40|40.0|Standard Deviation|10|10.0|||
4185944|NCT00784784|4007614|B2|||Age||years|Mean|40|40.0|Standard Deviation|10|10.0|||
4185945|NCT00784784|4007615|B1|||Age||years|Mean|40|40.0|Standard Deviation|10|10.0|||
4185946|NCT00784784|4007613|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4185947|NCT00784784|4007614|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4185948|NCT00784784|4007615|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4185949|NCT00784784|4007613|B3||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4185950|NCT00784784|4007614|B2||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4185951|NCT00784784|4007615|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4185952|NCT00784784|4007613|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4185953|NCT00784784|4007614|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4185954|NCT00784784|4007615|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4185955|NCT00784719|4007624|B8||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4185956|NCT00784719|4007625|B7||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4185957|NCT00784719|4007626|B6||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4185958|NCT00784719|4007627|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4185959|NCT00784719|4007628|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4185960|NCT00784719|4007629|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4185961|NCT00784719|4007630|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4185962|NCT00784719|4007631|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4185963|NCT00784719|4007624|B8||Female|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
4185964|NCT00784719|4007625|B7||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4185965|NCT00784719|4007626|B6||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4185966|NCT00784719|4007627|B5||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4185967|NCT00784719|4007628|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4185968|NCT00784719|4007629|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4185969|NCT00784719|4007630|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4185970|NCT00784719|4007631|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4185971|NCT00784719|4007624|B8|||Age||years|Mean|60.0|60.0|Standard Deviation|13.02|13.02|||
4185972|NCT00784719|4007625|B7|||Age||years|Mean|58.9|58.9|Standard Deviation|14.25|14.25|||
4185973|NCT00784719|4007626|B6|||Age||years|Mean|59.8|59.8|Standard Deviation|14.83|14.83|||
4185974|NCT00784719|4007627|B5|||Age||years|Mean|59.9|59.9|Standard Deviation|11.69|11.69|||
4185975|NCT00784719|4007628|B4|||Age||years|Mean|58.7|58.7|Standard Deviation|14.57|14.57|||
4185976|NCT00784719|4007629|B3|||Age||years|Mean|60.7|60.7|Standard Deviation|11.73|11.73|||
4185977|NCT00784719|4007630|B2|||Age||years|Mean|59.5|59.5|Standard Deviation|11.57|11.57|||
4185978|NCT00784719|4007631|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|12.54|12.54|||
4185979|NCT00784654|4007807|B1|Sweden||Region of Enrollment||participants|Number|49|49.0||||||
4185980|NCT00784654|4007807|B1|Germany||Region of Enrollment||participants|Number|95|95.0||||||
4185981|NCT00784654|4007807|B1|Poland||Region of Enrollment||participants|Number|8|8.0||||||
4185982|NCT00784654|4007807|B1|Belgium||Region of Enrollment||participants|Number|9|9.0||||||
4185983|NCT00784654|4007807|B1|Hungary||Region of Enrollment||participants|Number|28|28.0||||||
4185984|NCT00784654|4007807|B1|France||Region of Enrollment||participants|Number|11|11.0||||||
4185985|NCT00784654|4007807|B1|United Kingdom||Region of Enrollment||participants|Number|16|16.0||||||
4185986|NCT00784654|4007807|B1|Italy||Region of Enrollment||participants|Number|20|20.0||||||
4185987|NCT00784654|4007807|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4185988|NCT00784654|4007807|B1||Male|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4185989|NCT00784654|4007807|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4185990|NCT00784654|4007807|B1|13-17 years||Age, Customized||participants|Number|85|85.0||||||
4185991|NCT00784654|4007807|B1|6-12 years||Age, Customized||participants|Number|191|191.0||||||
4185992|NCT00784654|4007807|B1|||Age||years|Mean|10.9|10.9|Standard Deviation|2.82|2.82|||
4185993|NCT00784563|4007841|B4|||Montreal Cognitive Assessment|Score ranges from 0-30. Higher scores are better.|units on a scale|Mean|24.5|24.5|Standard Deviation|2.9|2.9|||
4185994|NCT00784563|4007842|B3|||Montreal Cognitive Assessment|Score ranges from 0-30. Higher scores are better.|units on a scale|Mean|24.5|24.5|Standard Deviation|2.9|2.9|||
4185995|NCT00784563|4007843|B2|||Montreal Cognitive Assessment|Score ranges from 0-30. Higher scores are better.|units on a scale|Mean|24.2|24.2|Standard Deviation|3.0|3.0|||
4185996|NCT00784563|4007844|B1|||Montreal Cognitive Assessment|Score ranges from 0-30. Higher scores are better.|units on a scale|Mean|24.7|24.7|Standard Deviation|2.8|2.8|||
4185997|NCT00784563|4007841|B4|||VO2max||ml/min/kg|Mean|25.2|25.2|Standard Deviation|6.5|6.5|||
4185998|NCT00784563|4007842|B3|||VO2max||ml/min/kg|Mean|27.8|27.8|Standard Deviation|3.7|3.7|||
4185999|NCT00784563|4007843|B2|||VO2max||ml/min/kg|Mean|25.1|25.1|Standard Deviation|8.2|8.2|||
4186000|NCT00784563|4007844|B1|||VO2max||ml/min/kg|Mean|23.4|23.4|Standard Deviation|5.6|5.6|||
4186001|NCT00784563|4007841|B4|||Levodopa equivalent/day|Total antiparkinsonian treatment daily dose expressed in levodopa equivalents per Tomlinson et al (PMID:21069833)|mg/day|Mean|540|540.0|Standard Deviation|380|380.0|||
4186002|NCT00784563|4007842|B3|||Levodopa equivalent/day|Total antiparkinsonian treatment daily dose expressed in levodopa equivalents per Tomlinson et al (PMID:21069833)|mg/day|Mean|394|394.0|Standard Deviation|334|334.0|||
4186003|NCT00784563|4007843|B2|||Levodopa equivalent/day|Total antiparkinsonian treatment daily dose expressed in levodopa equivalents per Tomlinson et al (PMID:21069833)|mg/day|Mean|601|601.0|Standard Deviation|273|273.0|||
4186004|NCT00784563|4007844|B1|||Levodopa equivalent/day|Total antiparkinsonian treatment daily dose expressed in levodopa equivalents per Tomlinson et al (PMID:21069833)|mg/day|Mean|531|531.0|Standard Deviation|383|383.0|||
4186005|NCT00784563|4007841|B4|||UPDRS- Section III score|Unified Parkinson’s Disease Rating Scale (UPDRS) is an ordinal scale with all items scored from 0=normal function to 4=very severely disabled. Section III: UPDRS motor section is based on physical examination evaluates the components of parkinsonism (tremor, rigidity, bradykinesia, gait/posture). There are 27 items resulting in a maximum score of 108 (range 0-108). Higher scores are worse.|units on a scale|Mean|18.6|18.6|Standard Deviation|10.0|10.0|||
4186006|NCT00784563|4007842|B3|||UPDRS- Section III score|Unified Parkinson’s Disease Rating Scale (UPDRS) is an ordinal scale with all items scored from 0=normal function to 4=very severely disabled. Section III: UPDRS motor section is based on physical examination evaluates the components of parkinsonism (tremor, rigidity, bradykinesia, gait/posture). There are 27 items resulting in a maximum score of 108 (range 0-108). Higher scores are worse.|units on a scale|Mean|17.0|17.0|Standard Deviation|10.0|10.0|||
4186007|NCT00784563|4007843|B2|||UPDRS- Section III score|Unified Parkinson’s Disease Rating Scale (UPDRS) is an ordinal scale with all items scored from 0=normal function to 4=very severely disabled. Section III: UPDRS motor section is based on physical examination evaluates the components of parkinsonism (tremor, rigidity, bradykinesia, gait/posture). There are 27 items resulting in a maximum score of 108 (range 0-108). Higher scores are worse.|units on a scale|Mean|18.9|18.9|Standard Deviation|10.5|10.5|||
4186008|NCT00784563|4007844|B1|||UPDRS- Section III score|Unified Parkinson’s Disease Rating Scale (UPDRS) is an ordinal scale with all items scored from 0=normal function to 4=very severely disabled. Section III: UPDRS motor section is based on physical examination evaluates the components of parkinsonism (tremor, rigidity, bradykinesia, gait/posture). There are 27 items resulting in a maximum score of 108 (range 0-108). Higher scores are worse.|units on a scale|Mean|19.6|19.6|Standard Deviation|9.9|9.9|||
4186009|NCT00784563|4007841|B4|||modified Hoehn-Yahr Scale|Modified Hoehn and Yahr Scale (higher values are worse) 1.0: Unilateral involvement only 1.5: Unilateral and axial involvement 2.0: Bilateral involvement without impairment of balance 2.5: Mild bilateral disease with recovery on pull test 3.0: Mild to moderate bilateral disease; some postural instability; physically independent 4.0: Severe disability; still able to walk or stand unassisted 5.0: Wheelchair bound or bedridden unless aided|units on a scale|Median|2.0|2.0|Full Range|||1.0|3.0|
4186010|NCT00784563|4007842|B3|||modified Hoehn-Yahr Scale|Modified Hoehn and Yahr Scale (higher values are worse) 1.0: Unilateral involvement only 1.5: Unilateral and axial involvement 2.0: Bilateral involvement without impairment of balance 2.5: Mild bilateral disease with recovery on pull test 3.0: Mild to moderate bilateral disease; some postural instability; physically independent 4.0: Severe disability; still able to walk or stand unassisted 5.0: Wheelchair bound or bedridden unless aided|units on a scale|Median|1.0|1.0|Full Range|||1.0|2.0|
4186011|NCT00784563|4007843|B2|||modified Hoehn-Yahr Scale|Modified Hoehn and Yahr Scale (higher values are worse) 1.0: Unilateral involvement only 1.5: Unilateral and axial involvement 2.0: Bilateral involvement without impairment of balance 2.5: Mild bilateral disease with recovery on pull test 3.0: Mild to moderate bilateral disease; some postural instability; physically independent 4.0: Severe disability; still able to walk or stand unassisted 5.0: Wheelchair bound or bedridden unless aided|units on a scale|Median|2.0|2.0|Full Range|||1.0|2.5|
4186012|NCT00784563|4007844|B1|||modified Hoehn-Yahr Scale|Modified Hoehn and Yahr Scale (higher values are worse) 1.0: Unilateral involvement only 1.5: Unilateral and axial involvement 2.0: Bilateral involvement without impairment of balance 2.5: Mild bilateral disease with recovery on pull test 3.0: Mild to moderate bilateral disease; some postural instability; physically independent 4.0: Severe disability; still able to walk or stand unassisted 5.0: Wheelchair bound or bedridden unless aided|units on a scale|Median|2.0|2.0|Full Range|||1.0|3.0|
4186013|NCT00784563|4007841|B4|||Disease duration (years)||years|Mean|5.5|5.5|Standard Deviation|4.9|4.9|||
4186014|NCT00784563|4007842|B3|||Disease duration (years)||years|Mean|2.8|2.8|Standard Deviation|2.5|2.5|||
4186015|NCT00784563|4007843|B2|||Disease duration (years)||years|Mean|5.3|5.3|Standard Deviation|3.5|3.5|||
4186016|NCT00784563|4007844|B1|||Disease duration (years)||years|Mean|8.0|8.0|Standard Deviation|6.3|6.3|||
4186017|NCT00784563|4007841|B4|||Education||years|Mean|15.1|15.1|Standard Deviation|2.3|2.3|||
4186018|NCT00784563|4007842|B3|||Education||years|Mean|14.8|14.8|Standard Deviation|2.1|2.1|||
4186019|NCT00784563|4007843|B2|||Education||years|Mean|14.6|14.6|Standard Deviation|2.3|2.3|||
4186020|NCT00784563|4007844|B1|||Education||years|Mean|15.9|15.9|Standard Deviation|2.3|2.3|||
4186021|NCT00784563|4007841|B4|United States||Region of Enrollment||participants|Number|60|60.0||||||
4186022|NCT00784563|4007842|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4186023|NCT00784563|4007843|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4186024|NCT00784563|4007844|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4186025|NCT00784563|4007841|B4||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4186026|NCT00784563|4007842|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4186027|NCT00784563|4007843|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4186028|NCT00784563|4007844|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4186029|NCT00784563|4007841|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4186030|NCT00784563|4007842|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4186031|NCT00784563|4007843|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4186032|NCT00784563|4007844|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4186033|NCT00784563|4007841|B4|||Age||Years|Mean|65.4|65.4|Standard Deviation|6.2|6.2|||
4186034|NCT00784563|4007842|B3|||Age||Years|Mean|63.7|63.7|Standard Deviation|4.9|4.9|||
4186035|NCT00784563|4007843|B2|||Age||Years|Mean|64.7|64.7|Standard Deviation|5.2|5.2|||
4186036|NCT00784563|4007844|B1|||Age||Years|Mean|67.6|67.6|Standard Deviation|7.5|7.5|||
4186037|NCT00784550|4007862|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4186038|NCT00784550|4007863|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4186039|NCT00784550|4007864|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4186040|NCT00784550|4007862|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4186041|NCT00784550|4007863|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4186042|NCT00784550|4007864|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4186043|NCT00784550|4007862|B3|White||Race/Ethnicity, Customized||participants|Number|327|327.0||||||
4186044|NCT00784550|4007863|B2|White||Race/Ethnicity, Customized||participants|Number|162|162.0||||||
4186045|NCT00784550|4007864|B1|White||Race/Ethnicity, Customized||participants|Number|165|165.0||||||
4186046|NCT00784550|4007862|B3||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4186047|NCT00784550|4007863|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4186048|NCT00784550|4007864|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4186049|NCT00784550|4007862|B3||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4186050|NCT00784550|4007863|B2||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4186051|NCT00784550|4007864|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4186052|NCT00784550|4007862|B3|||Age||Years|Mean|61.2|61.2|Standard Deviation|8.98|8.98|||
4186053|NCT00784550|4007863|B2|||Age||Years|Mean|61.0|61.0|Standard Deviation|9.41|9.41|||
4186054|NCT00784550|4007864|B1|||Age||Years|Mean|61.3|61.3|Standard Deviation|8.56|8.56|||
4186055|NCT00784459|4007881|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4186056|NCT00784459|4007882|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4186057|NCT00784459|4007883|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4186058|NCT00784459|4007881|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4186059|NCT00784459|4007882|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4186060|NCT00784459|4007883|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4186061|NCT00784459|4007881|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4186062|NCT00784459|4007882|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4186063|NCT00784459|4007883|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4186064|NCT00784459|4007881|B3|||Age||years|Mean|31|31.0|Standard Deviation|4|4.0|||
4186065|NCT00784459|4007882|B2|||Age||years|Mean|35|35.0|Standard Deviation|9.8|9.8|||
4186066|NCT00784459|4007883|B1|||Age||years|Mean|28|28.0|Standard Deviation|7.8|7.8|||
4186067|NCT00784459|4007881|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4186068|NCT00784459|4007882|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4186069|NCT00784459|4007883|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4186070|NCT00784459|4007881|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4186071|NCT00784459|4007882|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4186072|NCT00784459|4007883|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4186073|NCT00784459|4007881|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4186074|NCT00784459|4007882|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4186075|NCT00784459|4007883|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4186076|NCT00784368|4007892|B4||Male|Sex: Female, Male|Data for Baseline characteristic (Gender) was available for 53 participants who were included in FAS population. FAS population included all participants except those who did not meet main eligibility criteria, who did not receive ITCZ-IV or ITCZ-OS and participants without efficacy data. One participant without any infection evidence was not included in FAS for SFI (ITCZ OS Monotherapy).|Participants|Count of Participants|39|39.0||||||
4186106|NCT00784277|4007934|B2||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4186107|NCT00784277|4007935|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4186077|NCT00784368|4007893|B3||Male|Sex: Female, Male|Data for Baseline characteristic (Gender) was available for 53 participants who were included in FAS population. FAS population included all participants except those who did not meet main eligibility criteria, who did not receive ITCZ-IV or ITCZ-OS and participants without efficacy data. One participant without any infection evidence was not included in FAS for SFI (ITCZ OS Monotherapy).|Participants|Count of Participants|15|15.0||||||
4186078|NCT00784368|4007894|B2||Male|Sex: Female, Male|Data for Baseline characteristic (Gender) was available for 53 participants who were included in FAS population. FAS population included all participants except those who did not meet main eligibility criteria, who did not receive ITCZ-IV or ITCZ-OS and participants without efficacy data. One participant without any infection evidence was not included in FAS for SFI (ITCZ OS Monotherapy).|Participants|Count of Participants|10|10.0||||||
4186079|NCT00784368|4007895|B1||Male|Sex: Female, Male|Data for Baseline characteristic (Gender) was available for 53 participants who were included in FAS population. FAS population included all participants except those who did not meet main eligibility criteria, who did not receive ITCZ-IV or ITCZ-OS and participants without efficacy data. One participant without any infection evidence was not included in FAS for SFI (ITCZ OS Monotherapy).|Participants|Count of Participants|14|14.0||||||
4186080|NCT00784368|4007892|B4||Female|Sex: Female, Male|Data for Baseline characteristic (Gender) was available for 53 participants who were included in FAS population. FAS population included all participants except those who did not meet main eligibility criteria, who did not receive ITCZ-IV or ITCZ-OS and participants without efficacy data. One participant without any infection evidence was not included in FAS for SFI (ITCZ OS Monotherapy).|Participants|Count of Participants|14|14.0||||||
4186081|NCT00784368|4007893|B3||Female|Sex: Female, Male|Data for Baseline characteristic (Gender) was available for 53 participants who were included in FAS population. FAS population included all participants except those who did not meet main eligibility criteria, who did not receive ITCZ-IV or ITCZ-OS and participants without efficacy data. One participant without any infection evidence was not included in FAS for SFI (ITCZ OS Monotherapy).|Participants|Count of Participants|7|7.0||||||
4186082|NCT00784368|4007894|B2||Female|Sex: Female, Male|Data for Baseline characteristic (Gender) was available for 53 participants who were included in FAS population. FAS population included all participants except those who did not meet main eligibility criteria, who did not receive ITCZ-IV or ITCZ-OS and participants without efficacy data. One participant without any infection evidence was not included in FAS for SFI (ITCZ OS Monotherapy).|Participants|Count of Participants|6|6.0||||||
4186083|NCT00784368|4007895|B1||Female|Sex: Female, Male|Data for Baseline characteristic (Gender) was available for 53 participants who were included in FAS population. FAS population included all participants except those who did not meet main eligibility criteria, who did not receive ITCZ-IV or ITCZ-OS and participants without efficacy data. One participant without any infection evidence was not included in FAS for SFI (ITCZ OS Monotherapy).|Participants|Count of Participants|1|1.0||||||
4186084|NCT00784368|4007892|B4|||Age|Data for Baseline characteristic (Age) was available for 53 participants who were included in Full Analysis Set (FAS) population. FAS population included all participants except those who did not meet main eligibility criteria, who did not receive ITCZ-IV or ITCZ oral solution (ITCZ-OS) and participants without efficacy data. One participant without any infection evidence was not included in FAS for SFI (ITCZ OS Monotherapy).|years|Mean|61.1|61.1|Standard Deviation|12.8|12.8|||
4186085|NCT00784368|4007893|B3|||Age|Data for Baseline characteristic (Age) was available for 53 participants who were included in Full Analysis Set (FAS) population. FAS population included all participants except those who did not meet main eligibility criteria, who did not receive ITCZ-IV or ITCZ oral solution (ITCZ-OS) and participants without efficacy data. One participant without any infection evidence was not included in FAS for SFI (ITCZ OS Monotherapy).|years|Mean|58.3|58.3|Standard Deviation|12.7|12.7|||
4186086|NCT00784368|4007894|B2|||Age|Data for Baseline characteristic (Age) was available for 53 participants who were included in Full Analysis Set (FAS) population. FAS population included all participants except those who did not meet main eligibility criteria, who did not receive ITCZ-IV or ITCZ oral solution (ITCZ-OS) and participants without efficacy data. One participant without any infection evidence was not included in FAS for SFI (ITCZ OS Monotherapy).|years|Mean|64.2|64.2|Standard Deviation|12.0|12.0|||
4186087|NCT00784368|4007895|B1|||Age|Data for Baseline characteristic (Age) was available for 53 participants who were included in Full Analysis Set (FAS) population. FAS population included all participants except those who did not meet main eligibility criteria, who did not receive ITCZ-IV or ITCZ oral solution (ITCZ-OS) and participants without efficacy data. One participant without any infection evidence was not included in FAS for SFI (ITCZ OS Monotherapy).|years|Mean|61.7|61.7|Standard Deviation|13.6|13.6|||
4186088|NCT00784277|4007931|B5|USA||Region Enroll||Participants|Number|457|457.0||||||
4186089|NCT00784277|4007932|B4|USA||Region Enroll||Participants|Number|109|109.0||||||
4186090|NCT00784277|4007933|B3|USA||Region Enroll||Participants|Number|117|117.0||||||
4186091|NCT00784277|4007934|B2|USA||Region Enroll||Participants|Number|115|115.0||||||
4186092|NCT00784277|4007935|B1|USA||Region Enroll||Participants|Number|116|116.0||||||
4186093|NCT00784277|4007931|B5|Canada||Region Enroll||Participants|Number|139|139.0||||||
4186094|NCT00784277|4007932|B4|Canada||Region Enroll||Participants|Number|34|34.0||||||
4186095|NCT00784277|4007933|B3|Canada||Region Enroll||Participants|Number|37|37.0||||||
4186096|NCT00784277|4007934|B2|Canada||Region Enroll||Participants|Number|36|36.0||||||
4186097|NCT00784277|4007935|B1|Canada||Region Enroll||Participants|Number|32|32.0||||||
4186098|NCT00784277|4007931|B5||Male|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
4186099|NCT00784277|4007932|B4||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4186100|NCT00784277|4007933|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4186101|NCT00784277|4007934|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4186102|NCT00784277|4007935|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4186103|NCT00784277|4007931|B5||Female|Sex: Female, Male||Participants|Count of Participants|349|349.0||||||
4186104|NCT00784277|4007932|B4||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4186105|NCT00784277|4007933|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4186108|NCT00784277|4007931|B5|||Age||years|Mean|58.7|58.7|Standard Deviation|8.70|8.7|||
4186109|NCT00784277|4007932|B4|||Age||years|Mean|59.4|59.4|Standard Deviation|7.94|7.94|||
4186110|NCT00784277|4007933|B3|||Age||years|Mean|58.4|58.4|Standard Deviation|7.66|7.66|||
4186111|NCT00784277|4007934|B2|||Age||years|Mean|58|58.0|Standard Deviation|9.47|9.47|||
4186112|NCT00784277|4007935|B1|||Age||years|Mean|58.8|58.8|Standard Deviation|9.57|9.57|||
4186113|NCT00784277|4007931|B5||>=65 years|Age||Participants|Count of Participants|150|150.0||||||
4186114|NCT00784277|4007932|B4||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
4186115|NCT00784277|4007933|B3||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
4186116|NCT00784277|4007934|B2||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4186117|NCT00784277|4007935|B1||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4186118|NCT00784277|4007931|B5||Between 18 and 65 years|Age||Participants|Count of Participants|446|446.0||||||
4186119|NCT00784277|4007932|B4||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
4186120|NCT00784277|4007933|B3||Between 18 and 65 years|Age||Participants|Count of Participants|114|114.0||||||
4186121|NCT00784277|4007934|B2||Between 18 and 65 years|Age||Participants|Count of Participants|113|113.0||||||
4186122|NCT00784277|4007935|B1||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
4186123|NCT00784277|4007931|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4186124|NCT00784277|4007932|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4186125|NCT00784277|4007933|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4186126|NCT00784277|4007934|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4186127|NCT00784277|4007935|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4186128|NCT00784238|4007958|B1||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4186129|NCT00784238|4007958|B1||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4186130|NCT00784238|4007958|B1|||Age||years|Mean|36.4|36.4|Standard Deviation|10.09|10.09|||
4186131|NCT00784147|4007999|B3|||Time from initial documented HIV infection|Time elapsed from initial documentation of HIV infection - when known - to the first administration of study drug. This information was available and recorded for slightly less than half of the study participants (N = 52).|years|Mean|17.0|17.0|Standard Deviation|5.4|5.4|||
4186132|NCT00784147|4008000|B2|||Time from initial documented HIV infection|Time elapsed from initial documentation of HIV infection - when known - to the first administration of study drug. This information was available and recorded for slightly less than half of the study participants (N = 52).|years|Mean|16.9|16.9|Standard Deviation|6.2|6.2|||
4186133|NCT00784147|4008001|B1|||Time from initial documented HIV infection|Time elapsed from initial documentation of HIV infection - when known - to the first administration of study drug. This information was available and recorded for slightly less than half of the study participants (N = 52).|years|Mean|17.0|17.0|Standard Deviation|4.4|4.4|||
4186134|NCT00784147|4007999|B3|||Number of active agents in OBR||Pharmaceutical Agents|Mean|1.8|1.8|Standard Deviation|0.7|0.7|||
4186135|NCT00784147|4008000|B2|||Number of active agents in OBR||Pharmaceutical Agents|Mean|1.8|1.8|Standard Deviation|0.7|0.7|||
4186136|NCT00784147|4008001|B1|||Number of active agents in OBR||Pharmaceutical Agents|Mean|1.9|1.9|Standard Deviation|0.8|0.8|||
4186137|NCT00784147|4007999|B3|||CD4+ T-cell count||cells/mL|Mean|109.3|109.3|Standard Deviation|104.7|104.7|||
4186138|NCT00784147|4008000|B2|||CD4+ T-cell count||cells/mL|Mean|112.4|112.4|Standard Deviation|118.5|118.5|||
4186139|NCT00784147|4008001|B1|||CD4+ T-cell count||cells/mL|Mean|106.4|106.4|Standard Deviation|91.3|91.3|||
4186140|NCT00784147|4007999|B3|||HIV-1 RNA (viral load)||copies/mL|Mean|125,082.2|125.0|Full Range|||58.0|1.0|
4186141|NCT00784147|4008000|B2|||HIV-1 RNA (viral load)||copies/mL|Mean|136,452.8|136.0|Full Range|||1.0|1.0|
4186142|NCT00784147|4008001|B1|||HIV-1 RNA (viral load)||copies/mL|Mean|114,675.3|114.0|Full Range|||58.0|1.0|
4186143|NCT00784147|4007999|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4186144|NCT00784147|4008000|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4186145|NCT00784147|4008001|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4186146|NCT00784147|4007999|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186147|NCT00784147|4008000|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186148|NCT00784147|4008001|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186149|NCT00784147|4007999|B3||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4186150|NCT00784147|4008000|B2||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4186151|NCT00784147|4008001|B1||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4186152|NCT00784147|4007999|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4186153|NCT00784147|4008000|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4186154|NCT00784147|4008001|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4186155|NCT00784147|4007999|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186156|NCT00784147|4008000|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186157|NCT00784147|4008001|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186158|NCT00784147|4007999|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4186159|NCT00784147|4008000|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4186160|NCT00784147|4008001|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4186280|NCT00784095|4008122|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4186161|NCT00784147|4007999|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186162|NCT00784147|4008000|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186163|NCT00784147|4008001|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186164|NCT00784147|4007999|B3||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4186165|NCT00784147|4008000|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4186166|NCT00784147|4008001|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4186167|NCT00784147|4007999|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4186168|NCT00784147|4008000|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4186169|NCT00784147|4008001|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4186170|NCT00784147|4007999|B3|||Age||years|Mean|48.1|48.1|Full Range|||29.6|69.5|
4186171|NCT00784147|4008000|B2|||Age||years|Mean|47.9|47.9|Full Range|||32.6|62.3|
4186172|NCT00784147|4008001|B1|||Age||years|Mean|48.3|48.3|Full Range|||29.6|69.5|
4186173|NCT00784147|4007999|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4186174|NCT00784147|4008000|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4186175|NCT00784147|4008001|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4186176|NCT00784147|4007999|B3||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
4186177|NCT00784147|4008000|B2||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4186178|NCT00784147|4008001|B1||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4186179|NCT00784147|4007999|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4186180|NCT00784147|4008000|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4186181|NCT00784147|4008001|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4186182|NCT00784134|4008020|B3|Spain||Region of Enrollment||participants|Number|16|16.0||||||
4186183|NCT00784134|4008021|B2|Spain||Region of Enrollment||participants|Number|7|7.0||||||
4186184|NCT00784134|4008022|B1|Spain||Region of Enrollment||participants|Number|9|9.0||||||
4186185|NCT00784134|4008020|B3|Germany||Region of Enrollment||participants|Number|39|39.0||||||
4186186|NCT00784134|4008021|B2|Germany||Region of Enrollment||participants|Number|18|18.0||||||
4186187|NCT00784134|4008022|B1|Germany||Region of Enrollment||participants|Number|21|21.0||||||
4186188|NCT00784134|4008020|B3|Switzerland||Region of Enrollment||participants|Number|4|4.0||||||
4186189|NCT00784134|4008021|B2|Switzerland||Region of Enrollment||participants|Number|3|3.0||||||
4186190|NCT00784134|4008022|B1|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4186191|NCT00784134|4008020|B3|Israel||Region of Enrollment||participants|Number|37|37.0||||||
4186192|NCT00784134|4008021|B2|Israel||Region of Enrollment||participants|Number|24|24.0||||||
4186193|NCT00784134|4008022|B1|Israel||Region of Enrollment||participants|Number|13|13.0||||||
4186194|NCT00784134|4008020|B3|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
4186195|NCT00784134|4008021|B2|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4186196|NCT00784134|4008022|B1|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4186197|NCT00784134|4008020|B3|Brazil||Region of Enrollment||participants|Number|4|4.0||||||
4186198|NCT00784134|4008021|B2|Brazil||Region of Enrollment||participants|Number|3|3.0||||||
4186199|NCT00784134|4008022|B1|Brazil||Region of Enrollment||participants|Number|1|1.0||||||
4186200|NCT00784134|4008020|B3|United States||Region of Enrollment||participants|Number|370|370.0||||||
4186201|NCT00784134|4008021|B2|United States||Region of Enrollment||participants|Number|180|180.0||||||
4186202|NCT00784134|4008022|B1|United States||Region of Enrollment||participants|Number|190|190.0||||||
4186203|NCT00784134|4008020|B3|Hungary||Region of Enrollment||participants|Number|13|13.0||||||
4186204|NCT00784134|4008021|B2|Hungary||Region of Enrollment||participants|Number|6|6.0||||||
4186205|NCT00784134|4008022|B1|Hungary||Region of Enrollment||participants|Number|7|7.0||||||
4186206|NCT00784134|4008020|B3|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4186207|NCT00784134|4008021|B2|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4186208|NCT00784134|4008022|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4186209|NCT00784134|4008020|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4186210|NCT00784134|4008021|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4186211|NCT00784134|4008022|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4186212|NCT00784134|4008020|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4186213|NCT00784134|4008021|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4186214|NCT00784134|4008022|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186215|NCT00784134|4008020|B3||White|Race (NIH/OMB)||Participants|Count of Participants|305|305.0||||||
4186216|NCT00784134|4008021|B2||White|Race (NIH/OMB)||Participants|Count of Participants|161|161.0||||||
4186217|NCT00784134|4008022|B1||White|Race (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
4186218|NCT00784134|4008020|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|170|170.0||||||
4186219|NCT00784134|4008021|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
4186220|NCT00784134|4008022|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
4186221|NCT00784134|4008020|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4186281|NCT00784095|4008119|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4186222|NCT00784134|4008021|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4186223|NCT00784134|4008022|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4186224|NCT00784134|4008020|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4186225|NCT00784134|4008021|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4186226|NCT00784134|4008022|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4186227|NCT00784134|4008020|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4186228|NCT00784134|4008021|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4186229|NCT00784134|4008022|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186230|NCT00784134|4008020|B3||Male|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
4186231|NCT00784134|4008021|B2||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4186232|NCT00784134|4008022|B1||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4186233|NCT00784134|4008020|B3||Female|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4186234|NCT00784134|4008021|B2||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4186235|NCT00784134|4008022|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4186236|NCT00784134|4008020|B3||>=65 years|Age||Participants|Count of Participants|146|146.0||||||
4186237|NCT00784134|4008021|B2||>=65 years|Age||Participants|Count of Participants|79|79.0||||||
4186238|NCT00784134|4008022|B1||>=65 years|Age||Participants|Count of Participants|67|67.0||||||
4186239|NCT00784134|4008020|B3||Between 18 and 65 years|Age||Participants|Count of Participants|354|354.0||||||
4186240|NCT00784134|4008021|B2||Between 18 and 65 years|Age||Participants|Count of Participants|172|172.0||||||
4186241|NCT00784134|4008022|B1||Between 18 and 65 years|Age||Participants|Count of Participants|182|182.0||||||
4186242|NCT00784134|4008020|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4186243|NCT00784134|4008021|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4186244|NCT00784134|4008022|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4186245|NCT00784095|4008119|B4|United States||Region of Enrollment||participants|Number|36|36.0||||||
4186246|NCT00784095|4008120|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4186247|NCT00784095|4008121|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4186248|NCT00784095|4008122|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4186249|NCT00784095|4008119|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4186250|NCT00784095|4008120|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4186251|NCT00784095|4008121|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4186252|NCT00784095|4008122|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186253|NCT00784095|4008119|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186254|NCT00784095|4008120|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186255|NCT00784095|4008121|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186256|NCT00784095|4008122|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186257|NCT00784095|4008119|B4||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4186258|NCT00784095|4008120|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4186259|NCT00784095|4008121|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4186260|NCT00784095|4008122|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4186261|NCT00784095|4008119|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4186262|NCT00784095|4008120|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4186263|NCT00784095|4008121|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4186264|NCT00784095|4008122|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4186265|NCT00784095|4008119|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186266|NCT00784095|4008120|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186267|NCT00784095|4008121|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186268|NCT00784095|4008122|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186269|NCT00784095|4008119|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186270|NCT00784095|4008120|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186271|NCT00784095|4008121|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186272|NCT00784095|4008122|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186273|NCT00784095|4008119|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186274|NCT00784095|4008120|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186275|NCT00784095|4008121|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186276|NCT00784095|4008122|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186277|NCT00784095|4008119|B4||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4186278|NCT00784095|4008120|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4186279|NCT00784095|4008121|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4186282|NCT00784095|4008120|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4186283|NCT00784095|4008121|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4186284|NCT00784095|4008122|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4186285|NCT00784095|4008119|B4|||Age||years|Mean|67|67.0|Standard Deviation|11|11.0|||
4186286|NCT00784095|4008120|B3|||Age||years|Mean|69|69.0|Standard Deviation|14|14.0|||
4186287|NCT00784095|4008121|B2|||Age||years|Mean|68|68.0|Standard Deviation|10|10.0|||
4186288|NCT00784095|4008122|B1|||Age||years|Mean|64|64.0|Standard Deviation|10|10.0|||
4186289|NCT00784043|4008144|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4186290|NCT00784043|4008145|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4186291|NCT00784043|4008146|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4186292|NCT00784043|4008144|B3|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4186293|NCT00784043|4008145|B2|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4186294|NCT00784043|4008146|B1|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4186295|NCT00784043|4008144|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4186296|NCT00784043|4008144|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4186297|NCT00784043|4008145|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4186298|NCT00784043|4008146|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4186299|NCT00784043|4008144|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4186300|NCT00784043|4008145|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4186301|NCT00784043|4008146|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4186302|NCT00784043|4008144|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4186303|NCT00784043|4008145|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4186304|NCT00784043|4008146|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4186305|NCT00784043|4008144|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4186306|NCT00784043|4008145|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4186307|NCT00784043|4008146|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4186308|NCT00784043|4008144|B3||<=18 years|Age||Participants|Count of Participants|37|37.0||||||
4186309|NCT00784043|4008145|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4186310|NCT00784043|4008146|B1||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
4186311|NCT00784030|4008157|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4186312|NCT00784030|4008158|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4186313|NCT00784030|4008159|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4186314|NCT00784030|4008157|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4186315|NCT00784030|4008158|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4186316|NCT00784030|4008159|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4186317|NCT00784030|4008157|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4186318|NCT00784030|4008158|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4186319|NCT00784030|4008159|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4186320|NCT00784030|4008157|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4186321|NCT00784030|4008158|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4186322|NCT00784030|4008159|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4186323|NCT00784030|4008157|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4186324|NCT00784030|4008158|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4186325|NCT00784030|4008159|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4186326|NCT00783965|4008166|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
4186327|NCT00783965|4008167|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4186328|NCT00783965|4008168|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4186329|NCT00783965|4008166|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4186330|NCT00783965|4008167|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4186331|NCT00783965|4008168|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4186332|NCT00783965|4008166|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4186333|NCT00783965|4008167|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4186334|NCT00783965|4008168|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4186335|NCT00783965|4008166|B3|||Age||years|Mean|53|53.0|Standard Deviation|10|10.0|||
4186336|NCT00783965|4008167|B2|||Age||years|Mean|51|51.0|Standard Deviation|13|13.0|||
4186337|NCT00783965|4008168|B1|||Age||years|Mean|54|54.0|Standard Deviation|7|7.0|||
4186338|NCT00783965|4008166|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4186339|NCT00783965|4008167|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4186340|NCT00783965|4008168|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4186341|NCT00783965|4008166|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4186342|NCT00783965|4008167|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4186343|NCT00783965|4008168|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4186344|NCT00783965|4008166|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4186345|NCT00783965|4008167|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4186346|NCT00783965|4008168|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4186347|NCT00783952|4008177|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4186348|NCT00783952|4008177|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4186349|NCT00783952|4008177|B1|||Age||years|Mean|59|59.0|Standard Deviation|15|15.0|||
4186350|NCT00783835|4008182|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4186351|NCT00783835|4008182|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4186352|NCT00783835|4008182|B1|||Age||Years|Mean|31.1|31.1|Standard Deviation|9.6|9.6|||
4186353|NCT00783796|4008194|B1|United States||Region of Enrollment||participants|Number|150|150.0||||||
4186354|NCT00783796|4008194|B1|Male||Gender|One participant was de-registered from the study without recording their gender.|participants|Number|92|92.0||||||
4186355|NCT00783796|4008194|B1|Female||Gender|One participant was de-registered from the study without recording their gender.|participants|Number|57|57.0||||||
4186356|NCT00783796|4008194|B1|||Age|This calculation is based on the FAS population (144 subjects), this removes 6 subjects who did not receive the 2.25mm XIENCE V® stent.|years|Mean|62.97|62.97|Standard Deviation|10.59|10.59|||
4186357|NCT00783796|4008194|B1||>=65 years|Age||Participants|Count of Participants|65|65.0||||||
4186358|NCT00783796|4008194|B1||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
4186359|NCT00783796|4008194|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4186360|NCT00783718|4008296|B4|No||History of Extraintestinal Manifestations||participants|Number|597|597.0||||||
4186361|NCT00783718|4008297|B3|No||History of Extraintestinal Manifestations||participants|Number|341|341.0||||||
4186362|NCT00783718|4008298|B2|No||History of Extraintestinal Manifestations||participants|Number|151|151.0||||||
4186363|NCT00783718|4008299|B1|No||History of Extraintestinal Manifestations||participants|Number|105|105.0||||||
4186364|NCT00783718|4008296|B4|Yes||History of Extraintestinal Manifestations||participants|Number|298|298.0||||||
4186365|NCT00783718|4008297|B3|Yes||History of Extraintestinal Manifestations||participants|Number|180|180.0||||||
4186366|NCT00783718|4008298|B2|Yes||History of Extraintestinal Manifestations||participants|Number|74|74.0||||||
4186367|NCT00783718|4008299|B1|Yes||History of Extraintestinal Manifestations||participants|Number|44|44.0||||||
4186368|NCT00783718|4008296|B4|Former smoker||Smoking Status||participants|Number|285|285.0||||||
4186369|NCT00783718|4008297|B3|Former smoker||Smoking Status||participants|Number|167|167.0||||||
4186370|NCT00783718|4008298|B2|Former smoker||Smoking Status||participants|Number|68|68.0||||||
4186371|NCT00783718|4008299|B1|Former smoker||Smoking Status||participants|Number|50|50.0||||||
4186372|NCT00783718|4008296|B4|Nonsmoker||Smoking Status||participants|Number|555|555.0||||||
4186373|NCT00783718|4008297|B3|Nonsmoker||Smoking Status||participants|Number|322|322.0||||||
4186374|NCT00783718|4008298|B2|Nonsmoker||Smoking Status||participants|Number|145|145.0||||||
4186375|NCT00783718|4008299|B1|Nonsmoker||Smoking Status||participants|Number|88|88.0||||||
4186376|NCT00783718|4008296|B4|Current smoker||Smoking Status||participants|Number|55|55.0||||||
4186377|NCT00783718|4008297|B3|Current smoker||Smoking Status||participants|Number|32|32.0||||||
4186378|NCT00783718|4008298|B2|Current smoker||Smoking Status||participants|Number|12|12.0||||||
4186379|NCT00783718|4008299|B1|Current smoker||Smoking Status||participants|Number|11|11.0||||||
4186380|NCT00783718|4008296|B4|Pancolitis||Disease Localization||participants|Number|331|331.0||||||
4186381|NCT00783718|4008297|B3|Pancolitis||Disease Localization||participants|Number|198|198.0||||||
4186382|NCT00783718|4008298|B2|Pancolitis||Disease Localization||participants|Number|83|83.0||||||
4186383|NCT00783718|4008299|B1|Pancolitis||Disease Localization||participants|Number|50|50.0||||||
4186384|NCT00783718|4008296|B4|Extensive colitis||Disease Localization||participants|Number|109|109.0||||||
4186385|NCT00783718|4008297|B3|Extensive colitis||Disease Localization||participants|Number|66|66.0||||||
4186386|NCT00783718|4008298|B2|Extensive colitis||Disease Localization||participants|Number|25|25.0||||||
4186387|NCT00783718|4008299|B1|Extensive colitis||Disease Localization||participants|Number|18|18.0||||||
4186388|NCT00783718|4008296|B4|Left-sided colitis||Disease Localization||participants|Number|339|339.0||||||
4186389|NCT00783718|4008297|B3|Left-sided colitis||Disease Localization||participants|Number|188|188.0||||||
4186390|NCT00783718|4008298|B2|Left-sided colitis||Disease Localization||participants|Number|92|92.0||||||
4186391|NCT00783718|4008299|B1|Left-sided colitis||Disease Localization||participants|Number|59|59.0||||||
4186392|NCT00783718|4008296|B4|Proctosigmoiditis||Disease Localization||participants|Number|116|116.0||||||
4186393|NCT00783718|4008297|B3|Proctosigmoiditis||Disease Localization||participants|Number|69|69.0||||||
4186394|NCT00783718|4008298|B2|Proctosigmoiditis||Disease Localization||participants|Number|25|25.0||||||
4186395|NCT00783718|4008299|B1|Proctosigmoiditis||Disease Localization||participants|Number|22|22.0||||||
4186396|NCT00783718|4008296|B4|Missing||Categorical Baseline Fecal Calprotectin||participants|Number|38|38.0||||||
4186397|NCT00783718|4008297|B3|Missing||Categorical Baseline Fecal Calprotectin||participants|Number|16|16.0||||||
4186398|NCT00783718|4008298|B2|Missing||Categorical Baseline Fecal Calprotectin||participants|Number|12|12.0||||||
4186399|NCT00783718|4008299|B1|Missing||Categorical Baseline Fecal Calprotectin||participants|Number|10|10.0||||||
4186400|NCT00783718|4008296|B4|> 500 μg/g||Categorical Baseline Fecal Calprotectin||participants|Number|577|577.0||||||
4186401|NCT00783718|4008297|B3|> 500 μg/g||Categorical Baseline Fecal Calprotectin||participants|Number|329|329.0||||||
4186402|NCT00783718|4008298|B2|> 500 μg/g||Categorical Baseline Fecal Calprotectin||participants|Number|156|156.0||||||
4186403|NCT00783718|4008299|B1|> 500 μg/g||Categorical Baseline Fecal Calprotectin||participants|Number|92|92.0||||||
4186404|NCT00783718|4008296|B4|> 250 to ≤ 500 μg/g||Categorical Baseline Fecal Calprotectin||participants|Number|122|122.0||||||
4186405|NCT00783718|4008297|B3|> 250 to ≤ 500 μg/g||Categorical Baseline Fecal Calprotectin||participants|Number|82|82.0||||||
4186406|NCT00783718|4008298|B2|> 250 to ≤ 500 μg/g||Categorical Baseline Fecal Calprotectin||participants|Number|20|20.0||||||
4186407|NCT00783718|4008299|B1|> 250 to ≤ 500 μg/g||Categorical Baseline Fecal Calprotectin||participants|Number|20|20.0||||||
4186408|NCT00783718|4008296|B4|≤ 250 μg/g||Categorical Baseline Fecal Calprotectin||participants|Number|158|158.0||||||
4186409|NCT00783718|4008297|B3|≤ 250 μg/g||Categorical Baseline Fecal Calprotectin||participants|Number|94|94.0||||||
4186410|NCT00783718|4008298|B2|≤ 250 μg/g||Categorical Baseline Fecal Calprotectin||participants|Number|37|37.0||||||
4186411|NCT00783718|4008299|B1|≤ 250 μg/g||Categorical Baseline Fecal Calprotectin||participants|Number|27|27.0||||||
4186412|NCT00783718|4008296|B4|||Baseline Fecal Calprotectin|Number of participants for whom baseline fecal calprotectin data were available were 139, 213, and 505, respectively.|μg/g|Mean|1868.8|1868.8|Standard Deviation|2753.28|2753.28|||
4186413|NCT00783718|4008297|B3|||Baseline Fecal Calprotectin|Number of participants for whom baseline fecal calprotectin data were available were 139, 213, and 505, respectively.|μg/g|Mean|1442.7|1442.7|Standard Deviation|1855.61|1855.61|||
4186414|NCT00783718|4008298|B2|||Baseline Fecal Calprotectin|Number of participants for whom baseline fecal calprotectin data were available were 139, 213, and 505, respectively.|μg/g|Mean|2552.2|2552.2|Standard Deviation|3800.36|3800.36|||
4186415|NCT00783718|4008299|B1|||Baseline Fecal Calprotectin|Number of participants for whom baseline fecal calprotectin data were available were 139, 213, and 505, respectively.|μg/g|Mean|2369.9|2369.9|Standard Deviation|3258.82|3258.82|||
4186416|NCT00783718|4008296|B4|Complete Mayo score of 9 to 12 (inclusive)||Baseline Disease Activity||participants|Number|446|446.0||||||
4186417|NCT00783718|4008297|B3|Complete Mayo score of 9 to 12 (inclusive)||Baseline Disease Activity||participants|Number|258|258.0||||||
4186418|NCT00783718|4008298|B2|Complete Mayo score of 9 to 12 (inclusive)||Baseline Disease Activity||participants|Number|114|114.0||||||
4186419|NCT00783718|4008299|B1|Complete Mayo score of 9 to 12 (inclusive)||Baseline Disease Activity||participants|Number|74|74.0||||||
4186420|NCT00783718|4008296|B4|Complete Mayo score of 6 to 8 (inclusive)||Baseline Disease Activity||participants|Number|424|424.0||||||
4186421|NCT00783718|4008297|B3|Complete Mayo score of 6 to 8 (inclusive)||Baseline Disease Activity||participants|Number|249|249.0||||||
4186422|NCT00783718|4008298|B2|Complete Mayo score of 6 to 8 (inclusive)||Baseline Disease Activity||participants|Number|105|105.0||||||
4186423|NCT00783718|4008299|B1|Complete Mayo score of 6 to 8 (inclusive)||Baseline Disease Activity||participants|Number|70|70.0||||||
4186424|NCT00783718|4008296|B4|Complete Mayo score < 6||Baseline Disease Activity||participants|Number|25|25.0||||||
4186425|NCT00783718|4008297|B3|Complete Mayo score < 6||Baseline Disease Activity||participants|Number|14|14.0||||||
4186426|NCT00783718|4008298|B2|Complete Mayo score < 6||Baseline Disease Activity||participants|Number|6|6.0||||||
4186427|NCT00783718|4008299|B1|Complete Mayo score < 6||Baseline Disease Activity||participants|Number|5|5.0||||||
4186428|NCT00783718|4008296|B4|||Baseline Mayo Score|The Mayo Score is a standard assessment tool to measure ulcerative colitis disease activity in clinical trials. The index consists of 4 components: two that are patient reported (rectal bleeding and stool frequency), a global assessment by the physician, and an endoscopic subscore. Each component is scored on a scale from 0 to 3 and the complete score ranges from 1 to 12 (higher scores indicate greater disease activity).|units on a scale|Mean|8.6|8.6|Standard Deviation|1.75|1.75|||
4186429|NCT00783718|4008297|B3|||Baseline Mayo Score|The Mayo Score is a standard assessment tool to measure ulcerative colitis disease activity in clinical trials. The index consists of 4 components: two that are patient reported (rectal bleeding and stool frequency), a global assessment by the physician, and an endoscopic subscore. Each component is scored on a scale from 0 to 3 and the complete score ranges from 1 to 12 (higher scores indicate greater disease activity).|units on a scale|Mean|8.6|8.6|Standard Deviation|1.76|1.76|||
4186430|NCT00783718|4008298|B2|||Baseline Mayo Score|The Mayo Score is a standard assessment tool to measure ulcerative colitis disease activity in clinical trials. The index consists of 4 components: two that are patient reported (rectal bleeding and stool frequency), a global assessment by the physician, and an endoscopic subscore. Each component is scored on a scale from 0 to 3 and the complete score ranges from 1 to 12 (higher scores indicate greater disease activity).|units on a scale|Mean|8.5|8.5|Standard Deviation|1.78|1.78|||
4186431|NCT00783718|4008299|B1|||Baseline Mayo Score|The Mayo Score is a standard assessment tool to measure ulcerative colitis disease activity in clinical trials. The index consists of 4 components: two that are patient reported (rectal bleeding and stool frequency), a global assessment by the physician, and an endoscopic subscore. Each component is scored on a scale from 0 to 3 and the complete score ranges from 1 to 12 (higher scores indicate greater disease activity).|units on a scale|Mean|8.6|8.6|Standard Deviation|1.68|1.68|||
4186432|NCT00783718|4008296|B4|Missing||Categorical Duration of Ulcerative Colitis||participants|Number|2|2.0||||||
4186433|NCT00783718|4008297|B3|Missing||Categorical Duration of Ulcerative Colitis||participants|Number|2|2.0||||||
4186434|NCT00783718|4008298|B2|Missing||Categorical Duration of Ulcerative Colitis||participants|Number|0|0.0||||||
4186435|NCT00783718|4008299|B1|Missing||Categorical Duration of Ulcerative Colitis||participants|Number|0|0.0||||||
4186436|NCT00783718|4008296|B4|≥ 7 years||Categorical Duration of Ulcerative Colitis||participants|Number|322|322.0||||||
4186437|NCT00783718|4008297|B3|≥ 7 years||Categorical Duration of Ulcerative Colitis||participants|Number|197|197.0||||||
4186438|NCT00783718|4008298|B2|≥ 7 years||Categorical Duration of Ulcerative Colitis||participants|Number|72|72.0||||||
4186439|NCT00783718|4008299|B1|≥ 7 years||Categorical Duration of Ulcerative Colitis||participants|Number|53|53.0||||||
4186440|NCT00783718|4008296|B4|≥ 3 - < 7 years||Categorical Duration of Ulcerative Colitis||participants|Number|279|279.0||||||
4186441|NCT00783718|4008297|B3|≥ 3 - < 7 years||Categorical Duration of Ulcerative Colitis||participants|Number|163|163.0||||||
4186442|NCT00783718|4008298|B2|≥ 3 - < 7 years||Categorical Duration of Ulcerative Colitis||participants|Number|77|77.0||||||
4186443|NCT00783718|4008299|B1|≥ 3 - < 7 years||Categorical Duration of Ulcerative Colitis||participants|Number|39|39.0||||||
4186444|NCT00783718|4008296|B4|≥1 - < 3 years||Categorical Duration of Ulcerative Colitis||participants|Number|228|228.0||||||
4186445|NCT00783718|4008297|B3|≥1 - < 3 years||Categorical Duration of Ulcerative Colitis||participants|Number|121|121.0||||||
4186446|NCT00783718|4008298|B2|≥1 - < 3 years||Categorical Duration of Ulcerative Colitis||participants|Number|63|63.0||||||
4186447|NCT00783718|4008299|B1|≥1 - < 3 years||Categorical Duration of Ulcerative Colitis||participants|Number|44|44.0||||||
4186448|NCT00783718|4008296|B4|< 1 year||Categorical Duration of Ulcerative Colitis||participants|Number|64|64.0||||||
4186449|NCT00783718|4008297|B3|< 1 year||Categorical Duration of Ulcerative Colitis||participants|Number|38|38.0||||||
4186450|NCT00783718|4008298|B2|< 1 year||Categorical Duration of Ulcerative Colitis||participants|Number|13|13.0||||||
4186451|NCT00783718|4008299|B1|< 1 year||Categorical Duration of Ulcerative Colitis||participants|Number|13|13.0||||||
4186452|NCT00783718|4008296|B4|||Duration of Ulcerative Colitis|Duration of ulcerative colitis data only available for 519 participants in the Induction Phase: OL Vedolizumab arm.|years|Mean|6.9|6.9|Standard Deviation|6.39|6.39|||
4186453|NCT00783718|4008297|B3|||Duration of Ulcerative Colitis|Duration of ulcerative colitis data only available for 519 participants in the Induction Phase: OL Vedolizumab arm.|years|Mean|7.2|7.2|Standard Deviation|6.61|6.61|||
4186454|NCT00783718|4008298|B2|||Duration of Ulcerative Colitis|Duration of ulcerative colitis data only available for 519 participants in the Induction Phase: OL Vedolizumab arm.|years|Mean|6.1|6.1|Standard Deviation|5.08|5.08|||
4186455|NCT00783718|4008299|B1|||Duration of Ulcerative Colitis|Duration of ulcerative colitis data only available for 519 participants in the Induction Phase: OL Vedolizumab arm.|years|Mean|7.1|7.1|Standard Deviation|7.25|7.25|||
4186456|NCT00783718|4008296|B4|||Body Mass Index (BMI)|BMI data only available for 148 participants in the placebo arm.|kg/m^2|Mean|25.1|25.1|Standard Deviation|5.62|5.62|||
4186457|NCT00783718|4008297|B3|||Body Mass Index (BMI)|BMI data only available for 148 participants in the placebo arm.|kg/m^2|Mean|25.3|25.3|Standard Deviation|6.05|6.05|||
4186458|NCT00783718|4008298|B2|||Body Mass Index (BMI)|BMI data only available for 148 participants in the placebo arm.|kg/m^2|Mean|24.9|24.9|Standard Deviation|4.85|4.85|||
4186459|NCT00783718|4008299|B1|||Body Mass Index (BMI)|BMI data only available for 148 participants in the placebo arm.|kg/m^2|Mean|24.6|24.6|Standard Deviation|5.11|5.11|||
4186460|NCT00783718|4008296|B4|||Body Weight|Body weight data only available for 148 participants in the placebo arm.|kg|Mean|73.4|73.4|Standard Deviation|18.51|18.51|||
4186461|NCT00783718|4008297|B3|||Body Weight|Body weight data only available for 148 participants in the placebo arm.|kg|Mean|74.2|74.2|Standard Deviation|19.32|19.32|||
4186462|NCT00783718|4008298|B2|||Body Weight|Body weight data only available for 148 participants in the placebo arm.|kg|Mean|72.4|72.4|Standard Deviation|17.11|17.11|||
4186463|NCT00783718|4008299|B1|||Body Weight|Body weight data only available for 148 participants in the placebo arm.|kg|Mean|72.4|72.4|Standard Deviation|17.65|17.65|||
4186464|NCT00783718|4008296|B4|United States||Region of Enrollment||participants|Number|238|238.0||||||
4186465|NCT00783718|4008297|B3|United States||Region of Enrollment||participants|Number|127|127.0||||||
4186466|NCT00783718|4008298|B2|United States||Region of Enrollment||participants|Number|64|64.0||||||
4186467|NCT00783718|4008299|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
4186468|NCT00783718|4008296|B4|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4186469|NCT00783718|4008297|B3|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4186470|NCT00783718|4008298|B2|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4186471|NCT00783718|4008299|B1|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4186472|NCT00783718|4008296|B4|Turkey||Region of Enrollment||participants|Number|6|6.0||||||
4186473|NCT00783718|4008297|B3|Turkey||Region of Enrollment||participants|Number|3|3.0||||||
4186474|NCT00783718|4008298|B2|Turkey||Region of Enrollment||participants|Number|3|3.0||||||
4186475|NCT00783718|4008299|B1|Turkey||Region of Enrollment||participants|Number|0|0.0||||||
4186476|NCT00783718|4008296|B4|Switzerland||Region of Enrollment||participants|Number|6|6.0||||||
4186477|NCT00783718|4008297|B3|Switzerland||Region of Enrollment||participants|Number|3|3.0||||||
4186478|NCT00783718|4008298|B2|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4186479|NCT00783718|4008299|B1|Switzerland||Region of Enrollment||participants|Number|2|2.0||||||
4186480|NCT00783718|4008296|B4|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4186481|NCT00783718|4008297|B3|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4186482|NCT00783718|4008298|B2|Spain||Region of Enrollment||participants|Number|0|0.0||||||
4186483|NCT00783718|4008299|B1|Spain||Region of Enrollment||participants|Number|0|0.0||||||
4186484|NCT00783718|4008296|B4|South Africa||Region of Enrollment||participants|Number|19|19.0||||||
4186485|NCT00783718|4008297|B3|South Africa||Region of Enrollment||participants|Number|10|10.0||||||
4186486|NCT00783718|4008298|B2|South Africa||Region of Enrollment||participants|Number|5|5.0||||||
4186487|NCT00783718|4008299|B1|South Africa||Region of Enrollment||participants|Number|4|4.0||||||
4186488|NCT00783718|4008296|B4|Singapore||Region of Enrollment||participants|Number|1|1.0||||||
4186489|NCT00783718|4008297|B3|Singapore||Region of Enrollment||participants|Number|1|1.0||||||
4186490|NCT00783718|4008298|B2|Singapore||Region of Enrollment||participants|Number|0|0.0||||||
4186491|NCT00783718|4008299|B1|Singapore||Region of Enrollment||participants|Number|0|0.0||||||
4186492|NCT00783718|4008296|B4|Russian Federation||Region of Enrollment||participants|Number|49|49.0||||||
4186493|NCT00783718|4008297|B3|Russian Federation||Region of Enrollment||participants|Number|25|25.0||||||
4186494|NCT00783718|4008298|B2|Russian Federation||Region of Enrollment||participants|Number|15|15.0||||||
4186495|NCT00783718|4008299|B1|Russian Federation||Region of Enrollment||participants|Number|9|9.0||||||
4186496|NCT00783718|4008296|B4|Poland||Region of Enrollment||participants|Number|60|60.0||||||
4186497|NCT00783718|4008297|B3|Poland||Region of Enrollment||participants|Number|52|52.0||||||
4186498|NCT00783718|4008298|B2|Poland||Region of Enrollment||participants|Number|6|6.0||||||
4186499|NCT00783718|4008299|B1|Poland||Region of Enrollment||participants|Number|2|2.0||||||
4186500|NCT00783718|4008296|B4|Norway||Region of Enrollment||participants|Number|9|9.0||||||
4186501|NCT00783718|4008297|B3|Norway||Region of Enrollment||participants|Number|6|6.0||||||
4186502|NCT00783718|4008298|B2|Norway||Region of Enrollment||participants|Number|1|1.0||||||
4186503|NCT00783718|4008299|B1|Norway||Region of Enrollment||participants|Number|2|2.0||||||
4186504|NCT00783718|4008296|B4|New Zealand||Region of Enrollment||participants|Number|11|11.0||||||
4186505|NCT00783718|4008297|B3|New Zealand||Region of Enrollment||participants|Number|6|6.0||||||
4186506|NCT00783718|4008298|B2|New Zealand||Region of Enrollment||participants|Number|5|5.0||||||
4186507|NCT00783718|4008299|B1|New Zealand||Region of Enrollment||participants|Number|0|0.0||||||
4186508|NCT00783718|4008296|B4|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
4186509|NCT00783718|4008297|B3|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
4186510|NCT00783718|4008298|B2|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4186511|NCT00783718|4008299|B1|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4186512|NCT00783718|4008296|B4|Malaysia||Region of Enrollment||participants|Number|9|9.0||||||
4186513|NCT00783718|4008297|B3|Malaysia||Region of Enrollment||participants|Number|2|2.0||||||
4186514|NCT00783718|4008298|B2|Malaysia||Region of Enrollment||participants|Number|2|2.0||||||
4186515|NCT00783718|4008299|B1|Malaysia||Region of Enrollment||participants|Number|5|5.0||||||
4186516|NCT00783718|4008296|B4|Latvia||Region of Enrollment||participants|Number|3|3.0||||||
4186517|NCT00783718|4008297|B3|Latvia||Region of Enrollment||participants|Number|0|0.0||||||
4186518|NCT00783718|4008298|B2|Latvia||Region of Enrollment||participants|Number|2|2.0||||||
4186519|NCT00783718|4008299|B1|Latvia||Region of Enrollment||participants|Number|1|1.0||||||
4186520|NCT00783718|4008296|B4|Korea, Republic of||Region of Enrollment||participants|Number|41|41.0||||||
4186521|NCT00783718|4008297|B3|Korea, Republic of||Region of Enrollment||participants|Number|26|26.0||||||
4186522|NCT00783718|4008298|B2|Korea, Republic of||Region of Enrollment||participants|Number|10|10.0||||||
4186523|NCT00783718|4008299|B1|Korea, Republic of||Region of Enrollment||participants|Number|5|5.0||||||
4186524|NCT00783718|4008296|B4|Italy||Region of Enrollment||participants|Number|21|21.0||||||
4186525|NCT00783718|4008297|B3|Italy||Region of Enrollment||participants|Number|11|11.0||||||
4186526|NCT00783718|4008298|B2|Italy||Region of Enrollment||participants|Number|9|9.0||||||
4186527|NCT00783718|4008299|B1|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4186528|NCT00783718|4008296|B4|Israel||Region of Enrollment||participants|Number|2|2.0||||||
4186529|NCT00783718|4008297|B3|Israel||Region of Enrollment||participants|Number|1|1.0||||||
4186530|NCT00783718|4008298|B2|Israel||Region of Enrollment||participants|Number|1|1.0||||||
4186531|NCT00783718|4008299|B1|Israel||Region of Enrollment||participants|Number|0|0.0||||||
4186532|NCT00783718|4008296|B4|Ireland||Region of Enrollment||participants|Number|1|1.0||||||
4186533|NCT00783718|4008297|B3|Ireland||Region of Enrollment||participants|Number|1|1.0||||||
4186534|NCT00783718|4008298|B2|Ireland||Region of Enrollment||participants|Number|0|0.0||||||
4186535|NCT00783718|4008299|B1|Ireland||Region of Enrollment||participants|Number|0|0.0||||||
4186536|NCT00783718|4008296|B4|India||Region of Enrollment||participants|Number|58|58.0||||||
4186537|NCT00783718|4008297|B3|India||Region of Enrollment||participants|Number|24|24.0||||||
4186538|NCT00783718|4008298|B2|India||Region of Enrollment||participants|Number|16|16.0||||||
4186539|NCT00783718|4008299|B1|India||Region of Enrollment||participants|Number|18|18.0||||||
4186540|NCT00783718|4008296|B4|Iceland||Region of Enrollment||participants|Number|3|3.0||||||
4186541|NCT00783718|4008297|B3|Iceland||Region of Enrollment||participants|Number|2|2.0||||||
4186542|NCT00783718|4008298|B2|Iceland||Region of Enrollment||participants|Number|1|1.0||||||
4186543|NCT00783718|4008299|B1|Iceland||Region of Enrollment||participants|Number|0|0.0||||||
4186544|NCT00783718|4008296|B4|Hungary||Region of Enrollment||participants|Number|16|16.0||||||
4186545|NCT00783718|4008297|B3|Hungary||Region of Enrollment||participants|Number|8|8.0||||||
4186546|NCT00783718|4008298|B2|Hungary||Region of Enrollment||participants|Number|6|6.0||||||
4186547|NCT00783718|4008299|B1|Hungary||Region of Enrollment||participants|Number|2|2.0||||||
4186548|NCT00783718|4008296|B4|Hong Kong||Region of Enrollment||participants|Number|1|1.0||||||
4186549|NCT00783718|4008297|B3|Hong Kong||Region of Enrollment||participants|Number|1|1.0||||||
4186550|NCT00783718|4008298|B2|Hong Kong||Region of Enrollment||participants|Number|0|0.0||||||
4186551|NCT00783718|4008299|B1|Hong Kong||Region of Enrollment||participants|Number|0|0.0||||||
4186552|NCT00783718|4008296|B4|Greece||Region of Enrollment||participants|Number|5|5.0||||||
4186553|NCT00783718|4008297|B3|Greece||Region of Enrollment||participants|Number|4|4.0||||||
4186554|NCT00783718|4008298|B2|Greece||Region of Enrollment||participants|Number|1|1.0||||||
4186555|NCT00783718|4008299|B1|Greece||Region of Enrollment||participants|Number|0|0.0||||||
4186556|NCT00783718|4008296|B4|Germany||Region of Enrollment||participants|Number|17|17.0||||||
4186557|NCT00783718|4008297|B3|Germany||Region of Enrollment||participants|Number|16|16.0||||||
4186558|NCT00783718|4008298|B2|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4186559|NCT00783718|4008299|B1|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4186560|NCT00783718|4008296|B4|France||Region of Enrollment||participants|Number|17|17.0||||||
4186561|NCT00783718|4008297|B3|France||Region of Enrollment||participants|Number|13|13.0||||||
4186562|NCT00783718|4008298|B2|France||Region of Enrollment||participants|Number|3|3.0||||||
4186563|NCT00783718|4008299|B1|France||Region of Enrollment||participants|Number|1|1.0||||||
4186564|NCT00783718|4008296|B4|Estonia||Region of Enrollment||participants|Number|10|10.0||||||
4186565|NCT00783718|4008297|B3|Estonia||Region of Enrollment||participants|Number|5|5.0||||||
4186566|NCT00783718|4008298|B2|Estonia||Region of Enrollment||participants|Number|4|4.0||||||
4186567|NCT00783718|4008299|B1|Estonia||Region of Enrollment||participants|Number|1|1.0||||||
4186568|NCT00783718|4008296|B4|Denmark||Region of Enrollment||participants|Number|14|14.0||||||
4186569|NCT00783718|4008297|B3|Denmark||Region of Enrollment||participants|Number|5|5.0||||||
4186570|NCT00783718|4008298|B2|Denmark||Region of Enrollment||participants|Number|7|7.0||||||
4186571|NCT00783718|4008299|B1|Denmark||Region of Enrollment||participants|Number|2|2.0||||||
4186572|NCT00783718|4008296|B4|Czech Republic||Region of Enrollment||participants|Number|38|38.0||||||
4186573|NCT00783718|4008297|B3|Czech Republic||Region of Enrollment||participants|Number|19|19.0||||||
4186574|NCT00783718|4008298|B2|Czech Republic||Region of Enrollment||participants|Number|12|12.0||||||
4186575|NCT00783718|4008299|B1|Czech Republic||Region of Enrollment||participants|Number|7|7.0||||||
4186576|NCT00783718|4008296|B4|Canada||Region of Enrollment||participants|Number|92|92.0||||||
4186577|NCT00783718|4008297|B3|Canada||Region of Enrollment||participants|Number|62|62.0||||||
4186578|NCT00783718|4008298|B2|Canada||Region of Enrollment||participants|Number|14|14.0||||||
4186579|NCT00783718|4008299|B1|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4186580|NCT00783718|4008296|B4|Bulgaria||Region of Enrollment||participants|Number|6|6.0||||||
4186581|NCT00783718|4008297|B3|Bulgaria||Region of Enrollment||participants|Number|3|3.0||||||
4186582|NCT00783718|4008298|B2|Bulgaria||Region of Enrollment||participants|Number|1|1.0||||||
4186583|NCT00783718|4008299|B1|Bulgaria||Region of Enrollment||participants|Number|2|2.0||||||
4186584|NCT00783718|4008296|B4|Belgium||Region of Enrollment||participants|Number|56|56.0||||||
4186585|NCT00783718|4008297|B3|Belgium||Region of Enrollment||participants|Number|35|35.0||||||
4186586|NCT00783718|4008298|B2|Belgium||Region of Enrollment||participants|Number|14|14.0||||||
4186587|NCT00783718|4008299|B1|Belgium||Region of Enrollment||participants|Number|7|7.0||||||
4186588|NCT00783718|4008296|B4|Austria||Region of Enrollment||participants|Number|19|19.0||||||
4186589|NCT00783718|4008297|B3|Austria||Region of Enrollment||participants|Number|12|12.0||||||
4186590|NCT00783718|4008298|B2|Austria||Region of Enrollment||participants|Number|3|3.0||||||
4186591|NCT00783718|4008299|B1|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4186592|NCT00783718|4008296|B4|Australia||Region of Enrollment||participants|Number|53|53.0||||||
4186593|NCT00783718|4008297|B3|Australia||Region of Enrollment||participants|Number|29|29.0||||||
4186594|NCT00783718|4008298|B2|Australia||Region of Enrollment||participants|Number|17|17.0||||||
4186595|NCT00783718|4008299|B1|Australia||Region of Enrollment||participants|Number|7|7.0||||||
4186596|NCT00783718|4008296|B4|Not reported||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4186597|NCT00783718|4008297|B3|Not reported||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4186598|NCT00783718|4008298|B2|Not reported||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4186599|NCT00783718|4008299|B1|Not reported||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4186600|NCT00783718|4008296|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|832|832.0||||||
4186601|NCT00783718|4008297|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|481|481.0||||||
4186602|NCT00783718|4008298|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|211|211.0||||||
4186603|NCT00783718|4008299|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|140|140.0||||||
4186604|NCT00783718|4008296|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4186605|NCT00783718|4008297|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4186606|NCT00783718|4008298|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4186607|NCT00783718|4008299|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4186608|NCT00783718|4008296|B4|Other||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4186609|NCT00783718|4008297|B3|Other||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4186610|NCT00783718|4008298|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4186611|NCT00783718|4008299|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4186612|NCT00783718|4008296|B4|Asian||Race/Ethnicity, Customized||participants|Number|135|135.0||||||
4186613|NCT00783718|4008297|B3|Asian||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
4186614|NCT00783718|4008298|B2|Asian||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4186615|NCT00783718|4008299|B1|Asian||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4186616|NCT00783718|4008296|B4|Black||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4186617|NCT00783718|4008297|B3|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4186618|NCT00783718|4008298|B2|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4186619|NCT00783718|4008299|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4186620|NCT00783718|4008296|B4|White||Race/Ethnicity, Customized||participants|Number|734|734.0||||||
4186621|NCT00783718|4008297|B3|White||Race/Ethnicity, Customized||participants|Number|436|436.0||||||
4186622|NCT00783718|4008298|B2|White||Race/Ethnicity, Customized||participants|Number|183|183.0||||||
4186623|NCT00783718|4008299|B1|White||Race/Ethnicity, Customized||participants|Number|115|115.0||||||
4186624|NCT00783718|4008296|B4||Male|Sex: Female, Male||Participants|Count of Participants|525|525.0||||||
4186625|NCT00783718|4008297|B3||Male|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
4186626|NCT00783718|4008298|B2||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4186627|NCT00783718|4008299|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4186628|NCT00783718|4008296|B4||Female|Sex: Female, Male||Participants|Count of Participants|370|370.0||||||
4186629|NCT00783718|4008297|B3||Female|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
4186630|NCT00783718|4008298|B2||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4186631|NCT00783718|4008299|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4186632|NCT00783718|4008296|B4|≥ 65||Age, Customized||participants|Number|33|33.0||||||
4186633|NCT00783718|4008297|B3|≥ 65||Age, Customized||participants|Number|18|18.0||||||
4186634|NCT00783718|4008298|B2|≥ 65||Age, Customized||participants|Number|8|8.0||||||
4186635|NCT00783718|4008299|B1|≥ 65||Age, Customized||participants|Number|7|7.0||||||
4186636|NCT00783718|4008296|B4|< 65||Age, Customized||participants|Number|862|862.0||||||
4186637|NCT00783718|4008297|B3|< 65||Age, Customized||participants|Number|503|503.0||||||
4186638|NCT00783718|4008298|B2|< 65||Age, Customized||participants|Number|217|217.0||||||
4186639|NCT00783718|4008299|B1|< 65||Age, Customized||participants|Number|142|142.0||||||
4186640|NCT00783718|4008296|B4|≥ 35||Age, Customized||participants|Number|542|542.0||||||
4186641|NCT00783718|4008297|B3|≥ 35||Age, Customized||participants|Number|307|307.0||||||
4186642|NCT00783718|4008298|B2|≥ 35||Age, Customized||participants|Number|139|139.0||||||
4186643|NCT00783718|4008299|B1|≥ 35||Age, Customized||participants|Number|96|96.0||||||
4186644|NCT00783718|4008296|B4|< 35||Age, Customized||participants|Number|353|353.0||||||
4186645|NCT00783718|4008297|B3|< 35||Age, Customized||participants|Number|214|214.0||||||
4186646|NCT00783718|4008298|B2|< 35||Age, Customized||participants|Number|86|86.0||||||
4186647|NCT00783718|4008299|B1|< 35||Age, Customized||participants|Number|53|53.0||||||
4186648|NCT00783718|4008296|B4|||Age||years|Mean|40.3|40.3|Standard Deviation|13.09|13.09|||
4186649|NCT00783718|4008297|B3|||Age||years|Mean|40.1|40.1|Standard Deviation|13.27|13.27|||
4186650|NCT00783718|4008298|B2|||Age||years|Mean|40.1|40.1|Standard Deviation|13.11|13.11|||
4186651|NCT00783718|4008299|B1|||Age||years|Mean|41.2|41.2|Standard Deviation|12.50|12.5|||
4186652|NCT00783705|4008331|B3|Severe dysplasia||Most Advanced Histology||participants|Number|7|7.0||||||
4186653|NCT00783705|4008332|B2|Severe dysplasia||Most Advanced Histology||participants|Number|6|6.0||||||
4186654|NCT00783705|4008333|B1|Severe dysplasia||Most Advanced Histology||participants|Number|1|1.0||||||
4186655|NCT00783705|4008331|B3|Moderate dysplasia||Most Advanced Histology||participants|Number|50|50.0||||||
4186656|NCT00783705|4008332|B2|Moderate dysplasia||Most Advanced Histology||participants|Number|22|22.0||||||
4186657|NCT00783705|4008333|B1|Moderate dysplasia||Most Advanced Histology||participants|Number|28|28.0||||||
4186658|NCT00783705|4008331|B3|Mild dysplasia||Most Advanced Histology||participants|Number|28|28.0||||||
4186659|NCT00783705|4008332|B2|Mild dysplasia||Most Advanced Histology||participants|Number|13|13.0||||||
4186660|NCT00783705|4008333|B1|Mild dysplasia||Most Advanced Histology||participants|Number|15|15.0||||||
4186661|NCT00783705|4008331|B3|||Mucosal Biopsies Obtained||biopsies|Median|7.0|7.0|Full Range|||1.0|14.0|
4186662|NCT00783705|4008332|B2|||Mucosal Biopsies Obtained||biopsies|Median|7.0|7.0|Full Range|||1.0|14.0|
4186663|NCT00783705|4008333|B1|||Mucosal Biopsies Obtained||biopsies|Median|6.0|6.0|Full Range|||1.0|14.0|
4186664|NCT00783705|4008331|B3|>1 Dysplastic lesions||Dysplastic Lesions Identified||participants|Number|44|44.0||||||
4186665|NCT00783705|4008332|B2|>1 Dysplastic lesions||Dysplastic Lesions Identified||participants|Number|22|22.0||||||
4186666|NCT00783705|4008333|B1|>1 Dysplastic lesions||Dysplastic Lesions Identified||participants|Number|22|22.0||||||
4186667|NCT00783705|4008331|B3|1 Dysplastic lesion||Dysplastic Lesions Identified||participants|Number|41|41.0||||||
4186668|NCT00783705|4008332|B2|1 Dysplastic lesion||Dysplastic Lesions Identified||participants|Number|19|19.0||||||
4186669|NCT00783705|4008333|B1|1 Dysplastic lesion||Dysplastic Lesions Identified||participants|Number|22|22.0||||||
4186670|NCT00783705|4008331|B3|None||Alcohol Intake||participants|Number|22|22.0||||||
4186671|NCT00783705|4008332|B2|None||Alcohol Intake||participants|Number|13|13.0||||||
4186672|NCT00783705|4008333|B1|None||Alcohol Intake||participants|Number|9|9.0||||||
4186673|NCT00783705|4008331|B3|4 or more drinks per day||Alcohol Intake||participants|Number|5|5.0||||||
4186674|NCT00783705|4008332|B2|4 or more drinks per day||Alcohol Intake||participants|Number|4|4.0||||||
4186675|NCT00783705|4008333|B1|4 or more drinks per day||Alcohol Intake||participants|Number|1|1.0||||||
4186676|NCT00783705|4008331|B3|2-3 drinks per day||Alcohol Intake||participants|Number|20|20.0||||||
4186677|NCT00783705|4008332|B2|2-3 drinks per day||Alcohol Intake||participants|Number|13|13.0||||||
4186678|NCT00783705|4008333|B1|2-3 drinks per day||Alcohol Intake||participants|Number|7|7.0||||||
4186679|NCT00783705|4008331|B3|1 or fewer drinks per day||Alcohol Intake||participants|Number|38|38.0||||||
4186680|NCT00783705|4008332|B2|1 or fewer drinks per day||Alcohol Intake||participants|Number|11|11.0||||||
4186681|NCT00783705|4008333|B1|1 or fewer drinks per day||Alcohol Intake||participants|Number|27|27.0||||||
4186682|NCT00783705|4008331|B3|Yes||Prior NSAID (nonsteroidal anti-inflammatory drugs) Use||participants|Number|28|28.0||||||
4186683|NCT00783705|4008332|B2|Yes||Prior NSAID (nonsteroidal anti-inflammatory drugs) Use||participants|Number|12|12.0||||||
4186684|NCT00783705|4008333|B1|Yes||Prior NSAID (nonsteroidal anti-inflammatory drugs) Use||participants|Number|16|16.0||||||
4186685|NCT00783705|4008331|B3|No||Prior NSAID (nonsteroidal anti-inflammatory drugs) Use||participants|Number|57|57.0||||||
4186686|NCT00783705|4008332|B2|No||Prior NSAID (nonsteroidal anti-inflammatory drugs) Use||participants|Number|29|29.0||||||
4186687|NCT00783705|4008333|B1|No||Prior NSAID (nonsteroidal anti-inflammatory drugs) Use||participants|Number|28|28.0||||||
4186688|NCT00783705|4008331|B3|Former||Smoking Status||participants|Number|32|32.0||||||
4186689|NCT00783705|4008332|B2|Former||Smoking Status||participants|Number|15|15.0||||||
4186690|NCT00783705|4008333|B1|Former||Smoking Status||participants|Number|17|17.0||||||
4186691|NCT00783705|4008331|B3|Current||Smoking Status||participants|Number|53|53.0||||||
4186692|NCT00783705|4008332|B2|Current||Smoking Status||participants|Number|26|26.0||||||
4186693|NCT00783705|4008333|B1|Current||Smoking Status||participants|Number|27|27.0||||||
4186694|NCT00783705|4008331|B3|||Body Mass Index, kg/m^2||kg/m^2|Median|26.5|26.5|Full Range|||21.0|36.3|
4186695|NCT00783705|4008332|B2|||Body Mass Index, kg/m^2||kg/m^2|Median|26.0|26.0|Full Range|||21.0|35.2|
4186696|NCT00783705|4008333|B1|||Body Mass Index, kg/m^2||kg/m^2|Median|27.2|27.2|Full Range|||21.1|36.3|
4186697|NCT00783705|4008331|B3|Canada||Region of Enrollment||participants|Number|69|69.0||||||
4186698|NCT00783705|4008332|B2|Canada||Region of Enrollment||participants|Number|33|33.0||||||
4186699|NCT00783705|4008333|B1|Canada||Region of Enrollment||participants|Number|36|36.0||||||
4186700|NCT00783705|4008331|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4186701|NCT00783705|4008332|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4186702|NCT00783705|4008333|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4186703|NCT00783705|4008331|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186704|NCT00783705|4008332|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186705|NCT00783705|4008333|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186706|NCT00783705|4008331|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186707|NCT00783705|4008332|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186708|NCT00783705|4008333|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186709|NCT00783705|4008331|B3||White|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
4186710|NCT00783705|4008332|B2||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4186711|NCT00783705|4008333|B1||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4186712|NCT00783705|4008331|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186713|NCT00783705|4008332|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186714|NCT00783705|4008333|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186715|NCT00783705|4008331|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186716|NCT00783705|4008332|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186717|NCT00783705|4008333|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186718|NCT00783705|4008331|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4186719|NCT00783705|4008332|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4186720|NCT00783705|4008333|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4186721|NCT00783705|4008331|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186722|NCT00783705|4008332|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186723|NCT00783705|4008333|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4186724|NCT00783705|4008331|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4186725|NCT00783705|4008332|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4186726|NCT00783705|4008333|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4186727|NCT00783705|4008331|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4186728|NCT00783705|4008332|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4186729|NCT00783705|4008333|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4186730|NCT00783705|4008331|B3|||Age||years|Median|58.0|58.0|Full Range|||45.0|79.0|
4186731|NCT00783705|4008332|B2|||Age||years|Median|58.0|58.0|Full Range|||46.0|79.0|
4186732|NCT00783705|4008333|B1|||Age||years|Median|58.5|58.5|Full Range|||45.0|75.0|
4186733|NCT00783692|4008378|B4|No||History of Extraintestinal Manifestations||participants|Number|196|196.0||||||
4186734|NCT00783692|4008379|B3|No||History of Extraintestinal Manifestations||participants|Number|128|128.0||||||
4186735|NCT00783692|4008380|B2|No||History of Extraintestinal Manifestations||participants|Number|43|43.0||||||
4186736|NCT00783692|4008381|B1|No||History of Extraintestinal Manifestations||participants|Number|25|25.0||||||
4186737|NCT00783692|4008378|B4|Yes||History of Extraintestinal Manifestations||participants|Number|919|919.0||||||
4186738|NCT00783692|4008379|B3|Yes||History of Extraintestinal Manifestations||participants|Number|619|619.0||||||
4186739|NCT00783692|4008380|B2|Yes||History of Extraintestinal Manifestations||participants|Number|177|177.0||||||
4186740|NCT00783692|4008381|B1|Yes||History of Extraintestinal Manifestations||participants|Number|123|123.0||||||
4186741|NCT00783692|4008378|B4|No||Baseline Extraintestinal Manifestations||participants|Number|419|419.0||||||
4186742|NCT00783692|4008379|B3|No||Baseline Extraintestinal Manifestations||participants|Number|291|291.0||||||
4186743|NCT00783692|4008380|B2|No||Baseline Extraintestinal Manifestations||participants|Number|87|87.0||||||
4186744|NCT00783692|4008381|B1|No||Baseline Extraintestinal Manifestations||participants|Number|41|41.0||||||
4186745|NCT00783692|4008378|B4|Yes||Baseline Extraintestinal Manifestations||participants|Number|696|696.0||||||
4186746|NCT00783692|4008379|B3|Yes||Baseline Extraintestinal Manifestations||participants|Number|456|456.0||||||
4186747|NCT00783692|4008380|B2|Yes||Baseline Extraintestinal Manifestations||participants|Number|133|133.0||||||
4186748|NCT00783692|4008381|B1|Yes||Baseline Extraintestinal Manifestations||participants|Number|107|107.0||||||
4186749|NCT00783692|4008378|B4|Missing||Smoking Status||participants|Number|1|1.0||||||
4186750|NCT00783692|4008379|B3|Missing||Smoking Status||participants|Number|1|1.0||||||
4186751|NCT00783692|4008380|B2|Missing||Smoking Status||participants|Number|0|0.0||||||
4186752|NCT00783692|4008381|B1|Missing||Smoking Status||participants|Number|0|0.0||||||
4186753|NCT00783692|4008378|B4|Former smoker||Smoking Status||participants|Number|260|260.0||||||
4186754|NCT00783692|4008379|B3|Former smoker||Smoking Status||participants|Number|185|185.0||||||
4186755|NCT00783692|4008380|B2|Former smoker||Smoking Status||participants|Number|46|46.0||||||
4186756|NCT00783692|4008381|B1|Former smoker||Smoking Status||participants|Number|29|29.0||||||
4186757|NCT00783692|4008378|B4|Nonsmoker (never smoked)||Smoking Status||participants|Number|556|556.0||||||
4186758|NCT00783692|4008379|B3|Nonsmoker (never smoked)||Smoking Status||participants|Number|351|351.0||||||
4186759|NCT00783692|4008380|B2|Nonsmoker (never smoked)||Smoking Status||participants|Number|120|120.0||||||
4186760|NCT00783692|4008381|B1|Nonsmoker (never smoked)||Smoking Status||participants|Number|85|85.0||||||
4186761|NCT00783692|4008378|B4|Current smoker||Smoking Status||participants|Number|298|298.0||||||
4186762|NCT00783692|4008379|B3|Current smoker||Smoking Status||participants|Number|210|210.0||||||
4186763|NCT00783692|4008380|B2|Current smoker||Smoking Status||participants|Number|54|54.0||||||
4186764|NCT00783692|4008381|B1|Current smoker||Smoking Status||participants|Number|34|34.0||||||
4186765|NCT00783692|4008378|B4|No||Draining Fistula at Baseline||participants|Number|939|939.0||||||
4186766|NCT00783692|4008379|B3|No||Draining Fistula at Baseline||participants|Number|635|635.0||||||
4186767|NCT00783692|4008380|B2|No||Draining Fistula at Baseline||participants|Number|181|181.0||||||
4186768|NCT00783692|4008381|B1|No||Draining Fistula at Baseline||participants|Number|123|123.0||||||
4186769|NCT00783692|4008378|B4|All Closed||Draining Fistula at Baseline||participants|Number|11|11.0||||||
4186770|NCT00783692|4008379|B3|All Closed||Draining Fistula at Baseline||participants|Number|8|8.0||||||
4186771|NCT00783692|4008380|B2|All Closed||Draining Fistula at Baseline||participants|Number|1|1.0||||||
4186772|NCT00783692|4008381|B1|All Closed||Draining Fistula at Baseline||participants|Number|2|2.0||||||
4186773|NCT00783692|4008378|B4|Yes||Draining Fistula at Baseline||participants|Number|165|165.0||||||
4186774|NCT00783692|4008379|B3|Yes||Draining Fistula at Baseline||participants|Number|104|104.0||||||
4186775|NCT00783692|4008380|B2|Yes||Draining Fistula at Baseline||participants|Number|38|38.0||||||
4186776|NCT00783692|4008381|B1|Yes||Draining Fistula at Baseline||participants|Number|23|23.0||||||
4186777|NCT00783692|4008378|B4|No||History of Fistulizing Disease||participants|Number|705|705.0||||||
4186778|NCT00783692|4008379|B3|No||History of Fistulizing Disease||participants|Number|483|483.0||||||
4186779|NCT00783692|4008380|B2|No||History of Fistulizing Disease||participants|Number|130|130.0||||||
4186780|NCT00783692|4008381|B1|No||History of Fistulizing Disease||participants|Number|92|92.0||||||
4186781|NCT00783692|4008378|B4|Yes||History of Fistulizing Disease||participants|Number|410|410.0||||||
4186782|NCT00783692|4008379|B3|Yes||History of Fistulizing Disease||participants|Number|264|264.0||||||
4186783|NCT00783692|4008380|B2|Yes||History of Fistulizing Disease||participants|Number|90|90.0||||||
4186784|NCT00783692|4008381|B1|Yes||History of Fistulizing Disease||participants|Number|56|56.0||||||
4186785|NCT00783692|4008378|B4|No||History of Prior Surgery for Crohn's Disease||participants|Number|649|649.0||||||
4186786|NCT00783692|4008379|B3|No||History of Prior Surgery for Crohn's Disease||participants|Number|433|433.0||||||
4186787|NCT00783692|4008380|B2|No||History of Prior Surgery for Crohn's Disease||participants|Number|122|122.0||||||
4186788|NCT00783692|4008381|B1|No||History of Prior Surgery for Crohn's Disease||participants|Number|94|94.0||||||
4186789|NCT00783692|4008378|B4|Yes||History of Prior Surgery for Crohn's Disease||participants|Number|466|466.0||||||
4186790|NCT00783692|4008379|B3|Yes||History of Prior Surgery for Crohn's Disease||participants|Number|314|314.0||||||
4186791|NCT00783692|4008380|B2|Yes||History of Prior Surgery for Crohn's Disease||participants|Number|98|98.0||||||
4186792|NCT00783692|4008381|B1|Yes||History of Prior Surgery for Crohn's Disease||participants|Number|54|54.0||||||
4186793|NCT00783692|4008378|B4|Ileocolonic (both ileum and colon)||Disease Localization||participants|Number|618|618.0||||||
4186794|NCT00783692|4008379|B3|Ileocolonic (both ileum and colon)||Disease Localization||participants|Number|413|413.0||||||
4186795|NCT00783692|4008380|B2|Ileocolonic (both ileum and colon)||Disease Localization||participants|Number|121|121.0||||||
4186796|NCT00783692|4008381|B1|Ileocolonic (both ileum and colon)||Disease Localization||participants|Number|84|84.0||||||
4186797|NCT00783692|4008378|B4|Colon only||Disease Localization||participants|Number|316|316.0||||||
4186798|NCT00783692|4008379|B3|Colon only||Disease Localization||participants|Number|211|211.0||||||
4186799|NCT00783692|4008380|B2|Colon only||Disease Localization||participants|Number|62|62.0||||||
4186800|NCT00783692|4008381|B1|Colon only||Disease Localization||participants|Number|43|43.0||||||
4186801|NCT00783692|4008378|B4|Ileum only||Disease Localization||participants|Number|181|181.0||||||
4186802|NCT00783692|4008379|B3|Ileum only||Disease Localization||participants|Number|123|123.0||||||
4186803|NCT00783692|4008380|B2|Ileum only||Disease Localization||participants|Number|37|37.0||||||
4186804|NCT00783692|4008381|B1|Ileum only||Disease Localization||participants|Number|21|21.0||||||
4186805|NCT00783692|4008378|B4|Missing||Baseline Fecal Calprotectin - Categorical||participants|Number|44|44.0||||||
4186806|NCT00783692|4008379|B3|Missing||Baseline Fecal Calprotectin - Categorical||participants|Number|28|28.0||||||
4186807|NCT00783692|4008380|B2|Missing||Baseline Fecal Calprotectin - Categorical||participants|Number|10|10.0||||||
4186808|NCT00783692|4008381|B1|Missing||Baseline Fecal Calprotectin - Categorical||participants|Number|6|6.0||||||
4186809|NCT00783692|4008378|B4|> 500 μg/g||Baseline Fecal Calprotectin - Categorical||participants|Number|621|621.0||||||
4186810|NCT00783692|4008379|B3|> 500 μg/g||Baseline Fecal Calprotectin - Categorical||participants|Number|406|406.0||||||
4186811|NCT00783692|4008380|B2|> 500 μg/g||Baseline Fecal Calprotectin - Categorical||participants|Number|134|134.0||||||
4186812|NCT00783692|4008381|B1|> 500 μg/g||Baseline Fecal Calprotectin - Categorical||participants|Number|81|81.0||||||
4186813|NCT00783692|4008378|B4|> 250 to ≤ 500 μg/g||Baseline Fecal Calprotectin - Categorical||participants|Number|164|164.0||||||
4186814|NCT00783692|4008379|B3|> 250 to ≤ 500 μg/g||Baseline Fecal Calprotectin - Categorical||participants|Number|112|112.0||||||
4186815|NCT00783692|4008380|B2|> 250 to ≤ 500 μg/g||Baseline Fecal Calprotectin - Categorical||participants|Number|25|25.0||||||
4186816|NCT00783692|4008381|B1|> 250 to ≤ 500 μg/g||Baseline Fecal Calprotectin - Categorical||participants|Number|27|27.0||||||
4186817|NCT00783692|4008378|B4|≤ 250 μg/g||Baseline Fecal Calprotectin - Categorical||participants|Number|286|286.0||||||
4186818|NCT00783692|4008379|B3|≤ 250 μg/g||Baseline Fecal Calprotectin - Categorical||participants|Number|201|201.0||||||
4186819|NCT00783692|4008380|B2|≤ 250 μg/g||Baseline Fecal Calprotectin - Categorical||participants|Number|51|51.0||||||
4186820|NCT00783692|4008381|B1|≤ 250 μg/g||Baseline Fecal Calprotectin - Categorical||participants|Number|34|34.0||||||
4186821|NCT00783692|4008378|B4|||Baseline Fecal Calprotectin|Number of participants for whom baseline fecal calprotectin data were available were 142, 210, and 719, respectively.|μg/g|Mean|1254.2|1254.2|Standard Deviation|1908.82|1908.82|||
4186822|NCT00783692|4008379|B3|||Baseline Fecal Calprotectin|Number of participants for whom baseline fecal calprotectin data were available were 142, 210, and 719, respectively.|μg/g|Mean|1050.1|1050.1|Standard Deviation|1558.93|1558.93|||
4186823|NCT00783692|4008380|B2|||Baseline Fecal Calprotectin|Number of participants for whom baseline fecal calprotectin data were available were 142, 210, and 719, respectively.|μg/g|Mean|1839.9|1839.9|Standard Deviation|2624.92|2624.92|||
4186824|NCT00783692|4008381|B1|||Baseline Fecal Calprotectin|Number of participants for whom baseline fecal calprotectin data were available were 142, 210, and 719, respectively.|μg/g|Mean|1421.2|1421.2|Standard Deviation|2076.11|2076.11|||
4186825|NCT00783692|4008378|B4|Missing||Baseline CRP - Categorical||participants|Number|1|1.0||||||
4186826|NCT00783692|4008379|B3|Missing||Baseline CRP - Categorical||participants|Number|0|0.0||||||
4186827|NCT00783692|4008380|B2|Missing||Baseline CRP - Categorical||participants|Number|0|0.0||||||
4186828|NCT00783692|4008381|B1|Missing||Baseline CRP - Categorical||participants|Number|1|1.0||||||
4186829|NCT00783692|4008378|B4|> 10 mg/L||Baseline CRP - Categorical||participants|Number|587|587.0||||||
4186830|NCT00783692|4008379|B3|> 10 mg/L||Baseline CRP - Categorical||participants|Number|382|382.0||||||
4186831|NCT00783692|4008380|B2|> 10 mg/L||Baseline CRP - Categorical||participants|Number|120|120.0||||||
4186832|NCT00783692|4008381|B1|> 10 mg/L||Baseline CRP - Categorical||participants|Number|85|85.0||||||
4186833|NCT00783692|4008378|B4|> 5 to ≤ 10 mg/L||Baseline CRP - Categorical||participants|Number|226|226.0||||||
4186834|NCT00783692|4008379|B3|> 5 to ≤ 10 mg/L||Baseline CRP - Categorical||participants|Number|160|160.0||||||
4186835|NCT00783692|4008380|B2|> 5 to ≤ 10 mg/L||Baseline CRP - Categorical||participants|Number|38|38.0||||||
4186836|NCT00783692|4008381|B1|> 5 to ≤ 10 mg/L||Baseline CRP - Categorical||participants|Number|28|28.0||||||
4186837|NCT00783692|4008378|B4|> 2.87 to ≤ 5 mg/L||Baseline CRP - Categorical||participants|Number|114|114.0||||||
4186838|NCT00783692|4008379|B3|> 2.87 to ≤ 5 mg/L||Baseline CRP - Categorical||participants|Number|75|75.0||||||
4186839|NCT00783692|4008380|B2|> 2.87 to ≤ 5 mg/L||Baseline CRP - Categorical||participants|Number|25|25.0||||||
4186840|NCT00783692|4008381|B1|> 2.87 to ≤ 5 mg/L||Baseline CRP - Categorical||participants|Number|14|14.0||||||
4186841|NCT00783692|4008378|B4|≤ 2.87 mg/L||Baseline CRP - Categorical||participants|Number|187|187.0||||||
4186842|NCT00783692|4008379|B3|≤ 2.87 mg/L||Baseline CRP - Categorical||participants|Number|130|130.0||||||
4186843|NCT00783692|4008380|B2|≤ 2.87 mg/L||Baseline CRP - Categorical||participants|Number|37|37.0||||||
4186844|NCT00783692|4008381|B1|≤ 2.87 mg/L||Baseline CRP - Categorical||participants|Number|20|20.0||||||
4186845|NCT00783692|4008378|B4|||Baseline C-reactive Protein (CRP)|Baseline CRP data was only available for 147 participants in the placebo arm.|mg/L|Mean|21.5|21.5|Standard Deviation|27.45|27.45|||
4186846|NCT00783692|4008379|B3|||Baseline C-reactive Protein (CRP)|Baseline CRP data was only available for 147 participants in the placebo arm.|mg/L|Mean|20.4|20.4|Standard Deviation|27.40|27.4|||
4186847|NCT00783692|4008380|B2|||Baseline C-reactive Protein (CRP)|Baseline CRP data was only available for 147 participants in the placebo arm.|mg/L|Mean|24.1|24.1|Standard Deviation|27.23|27.23|||
4186848|NCT00783692|4008381|B1|||Baseline C-reactive Protein (CRP)|Baseline CRP data was only available for 147 participants in the placebo arm.|mg/L|Mean|23.6|23.6|Standard Deviation|27.85|27.85|||
4186849|NCT00783692|4008378|B4|Missing||Baseline Disease Activity – Categorical||participants|Number|6|6.0||||||
4186850|NCT00783692|4008379|B3|Missing||Baseline Disease Activity – Categorical||participants|Number|4|4.0||||||
4186851|NCT00783692|4008380|B2|Missing||Baseline Disease Activity – Categorical||participants|Number|1|1.0||||||
4186852|NCT00783692|4008381|B1|Missing||Baseline Disease Activity – Categorical||participants|Number|1|1.0||||||
4186853|NCT00783692|4008378|B4|CDAI > 330||Baseline Disease Activity – Categorical||participants|Number|491|491.0||||||
4186854|NCT00783692|4008379|B3|CDAI > 330||Baseline Disease Activity – Categorical||participants|Number|325|325.0||||||
4186855|NCT00783692|4008380|B2|CDAI > 330||Baseline Disease Activity – Categorical||participants|Number|100|100.0||||||
4186856|NCT00783692|4008381|B1|CDAI > 330||Baseline Disease Activity – Categorical||participants|Number|66|66.0||||||
4186857|NCT00783692|4008378|B4|CDAI ≤ 330||Baseline Disease Activity – Categorical||participants|Number|618|618.0||||||
4186858|NCT00783692|4008379|B3|CDAI ≤ 330||Baseline Disease Activity – Categorical||participants|Number|418|418.0||||||
4186859|NCT00783692|4008380|B2|CDAI ≤ 330||Baseline Disease Activity – Categorical||participants|Number|119|119.0||||||
4186860|NCT00783692|4008381|B1|CDAI ≤ 330||Baseline Disease Activity – Categorical||participants|Number|81|81.0||||||
4186861|NCT00783692|4008378|B4|||Baseline Disease Activity – Crohn’s Disease Activity Index (CDAI)|"Number of participants for whom baseline CDAI scores were available were 147, 219, and 743, respectively.~The CDAI is a numerical calculation derived from the sum of products from a list of 8 disease variables: number of liquid stools, extent of abdominal pain, general well-being, occurrence of extraintestinal symptoms, need for antidiarrheal drugs, presence of abdominal masses, hematocrit, and body weight. CDAI scores range from 0 to ~600 points with lower scores indicating disease remission and higher scores indicating disease worsening."|units on a scale|Mean|323.6|323.6|Standard Deviation|69.37|69.37|||
4186862|NCT00783692|4008379|B3|||Baseline Disease Activity – Crohn’s Disease Activity Index (CDAI)|"Number of participants for whom baseline CDAI scores were available were 147, 219, and 743, respectively.~The CDAI is a numerical calculation derived from the sum of products from a list of 8 disease variables: number of liquid stools, extent of abdominal pain, general well-being, occurrence of extraintestinal symptoms, need for antidiarrheal drugs, presence of abdominal masses, hematocrit, and body weight. CDAI scores range from 0 to ~600 points with lower scores indicating disease remission and higher scores indicating disease worsening."|units on a scale|Mean|322.2|322.2|Standard Deviation|67.17|67.17|||
4186863|NCT00783692|4008380|B2|||Baseline Disease Activity – Crohn’s Disease Activity Index (CDAI)|"Number of participants for whom baseline CDAI scores were available were 147, 219, and 743, respectively.~The CDAI is a numerical calculation derived from the sum of products from a list of 8 disease variables: number of liquid stools, extent of abdominal pain, general well-being, occurrence of extraintestinal symptoms, need for antidiarrheal drugs, presence of abdominal masses, hematocrit, and body weight. CDAI scores range from 0 to ~600 points with lower scores indicating disease remission and higher scores indicating disease worsening."|units on a scale|Mean|327.3|327.3|Standard Deviation|70.67|70.67|||
4186864|NCT00783692|4008381|B1|||Baseline Disease Activity – Crohn’s Disease Activity Index (CDAI)|"Number of participants for whom baseline CDAI scores were available were 147, 219, and 743, respectively.~The CDAI is a numerical calculation derived from the sum of products from a list of 8 disease variables: number of liquid stools, extent of abdominal pain, general well-being, occurrence of extraintestinal symptoms, need for antidiarrheal drugs, presence of abdominal masses, hematocrit, and body weight. CDAI scores range from 0 to ~600 points with lower scores indicating disease remission and higher scores indicating disease worsening."|units on a scale|Mean|324.6|324.6|Standard Deviation|78.08|78.08|||
4186865|NCT00783692|4008378|B4|≥ 7 years||Duration of Crohn's Disease - Categorical||participants|Number|560|560.0||||||
4186866|NCT00783692|4008379|B3|≥ 7 years||Duration of Crohn's Disease - Categorical||participants|Number|385|385.0||||||
4186867|NCT00783692|4008380|B2|≥ 7 years||Duration of Crohn's Disease - Categorical||participants|Number|111|111.0||||||
4186868|NCT00783692|4008381|B1|≥ 7 years||Duration of Crohn's Disease - Categorical||participants|Number|64|64.0||||||
4186869|NCT00783692|4008378|B4|≥ 3 to < 7 years||Duration of Crohn's Disease - Categorical||participants|Number|285|285.0||||||
4186870|NCT00783692|4008379|B3|≥ 3 to < 7 years||Duration of Crohn's Disease - Categorical||participants|Number|191|191.0||||||
4186871|NCT00783692|4008380|B2|≥ 3 to < 7 years||Duration of Crohn's Disease - Categorical||participants|Number|49|49.0||||||
4186872|NCT00783692|4008381|B1|≥ 3 to < 7 years||Duration of Crohn's Disease - Categorical||participants|Number|45|45.0||||||
4186873|NCT00783692|4008378|B4|≥ 1 to < 3 years||Duration of Crohn's Disease - Categorical||participants|Number|201|201.0||||||
4186874|NCT00783692|4008379|B3|≥ 1 to < 3 years||Duration of Crohn's Disease - Categorical||participants|Number|126|126.0||||||
4186875|NCT00783692|4008380|B2|≥ 1 to < 3 years||Duration of Crohn's Disease - Categorical||participants|Number|48|48.0||||||
4186876|NCT00783692|4008381|B1|≥ 1 to < 3 years||Duration of Crohn's Disease - Categorical||participants|Number|27|27.0||||||
4186877|NCT00783692|4008378|B4|< 1 year||Duration of Crohn's Disease - Categorical||participants|Number|69|69.0||||||
4186878|NCT00783692|4008379|B3|< 1 year||Duration of Crohn's Disease - Categorical||participants|Number|45|45.0||||||
4186879|NCT00783692|4008380|B2|< 1 year||Duration of Crohn's Disease - Categorical||participants|Number|12|12.0||||||
4186880|NCT00783692|4008381|B1|< 1 year||Duration of Crohn's Disease - Categorical||participants|Number|12|12.0||||||
4186881|NCT00783692|4008378|B4|||Duration of Crohn's Disease (CD)||years|Mean|9.0|9.0|Standard Deviation|7.77|7.77|||
4186882|NCT00783692|4008379|B3|||Duration of Crohn's Disease (CD)||years|Mean|9.2|9.2|Standard Deviation|7.63|7.63|||
4186883|NCT00783692|4008380|B2|||Duration of Crohn's Disease (CD)||years|Mean|9.2|9.2|Standard Deviation|8.18|8.18|||
4186884|NCT00783692|4008381|B1|||Duration of Crohn's Disease (CD)||years|Mean|8.2|8.2|Standard Deviation|7.80|7.8|||
4186885|NCT00783692|4008378|B4|||Body Mass Index (BMI)||kg/m^2|Mean|23.9|23.9|Standard Deviation|5.93|5.93|||
4186886|NCT00783692|4008379|B3|||Body Mass Index (BMI)||kg/m^2|Mean|24.2|24.2|Standard Deviation|6.02|6.02|||
4186887|NCT00783692|4008380|B2|||Body Mass Index (BMI)||kg/m^2|Mean|23.1|23.1|Standard Deviation|5.62|5.62|||
4186888|NCT00783692|4008381|B1|||Body Mass Index (BMI)||kg/m^2|Mean|23.7|23.7|Standard Deviation|5.77|5.77|||
4186889|NCT00783692|4008378|B4|||Body Weight||kg|Mean|69.8|69.8|Standard Deviation|19.42|19.42|||
4186890|NCT00783692|4008379|B3|||Body Weight||kg|Mean|70.8|70.8|Standard Deviation|19.56|19.56|||
4186891|NCT00783692|4008380|B2|||Body Weight||kg|Mean|67.1|67.1|Standard Deviation|19.07|19.07|||
4186892|NCT00783692|4008381|B1|||Body Weight||kg|Mean|68.7|68.7|Standard Deviation|18.90|18.9|||
4186893|NCT00783692|4008378|B4|United States||Region of Enrollment||participants|Number|268|268.0||||||
4186894|NCT00783692|4008379|B3|United States||Region of Enrollment||participants|Number|188|188.0||||||
4186895|NCT00783692|4008380|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
4186896|NCT00783692|4008381|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4186897|NCT00783692|4008378|B4|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4186898|NCT00783692|4008379|B3|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4186899|NCT00783692|4008380|B2|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4186900|NCT00783692|4008381|B1|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4186901|NCT00783692|4008378|B4|Ukraine||Region of Enrollment||participants|Number|16|16.0||||||
4186902|NCT00783692|4008379|B3|Ukraine||Region of Enrollment||participants|Number|9|9.0||||||
4186903|NCT00783692|4008380|B2|Ukraine||Region of Enrollment||participants|Number|4|4.0||||||
4186904|NCT00783692|4008381|B1|Ukraine||Region of Enrollment||participants|Number|3|3.0||||||
4186905|NCT00783692|4008378|B4|Turkey||Region of Enrollment||participants|Number|6|6.0||||||
4186906|NCT00783692|4008379|B3|Turkey||Region of Enrollment||participants|Number|1|1.0||||||
4186907|NCT00783692|4008380|B2|Turkey||Region of Enrollment||participants|Number|3|3.0||||||
4186908|NCT00783692|4008381|B1|Turkey||Region of Enrollment||participants|Number|2|2.0||||||
4186909|NCT00783692|4008378|B4|Taiwan||Region of Enrollment||participants|Number|3|3.0||||||
4186910|NCT00783692|4008379|B3|Taiwan||Region of Enrollment||participants|Number|3|3.0||||||
4186911|NCT00783692|4008380|B2|Taiwan||Region of Enrollment||participants|Number|0|0.0||||||
4186912|NCT00783692|4008381|B1|Taiwan||Region of Enrollment||participants|Number|0|0.0||||||
4186913|NCT00783692|4008378|B4|Switzerland||Region of Enrollment||participants|Number|10|10.0||||||
4186914|NCT00783692|4008379|B3|Switzerland||Region of Enrollment||participants|Number|9|9.0||||||
4186915|NCT00783692|4008380|B2|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4186916|NCT00783692|4008381|B1|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
4186917|NCT00783692|4008378|B4|Sweden||Region of Enrollment||participants|Number|9|9.0||||||
4186918|NCT00783692|4008379|B3|Sweden||Region of Enrollment||participants|Number|8|8.0||||||
4186919|NCT00783692|4008380|B2|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
4186920|NCT00783692|4008381|B1|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
4186921|NCT00783692|4008378|B4|Spain||Region of Enrollment||participants|Number|7|7.0||||||
4186922|NCT00783692|4008379|B3|Spain||Region of Enrollment||participants|Number|6|6.0||||||
4186923|NCT00783692|4008380|B2|Spain||Region of Enrollment||participants|Number|0|0.0||||||
4186924|NCT00783692|4008381|B1|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4186925|NCT00783692|4008378|B4|South Africa||Region of Enrollment||participants|Number|20|20.0||||||
4186926|NCT00783692|4008379|B3|South Africa||Region of Enrollment||participants|Number|14|14.0||||||
4186927|NCT00783692|4008380|B2|South Africa||Region of Enrollment||participants|Number|3|3.0||||||
4186928|NCT00783692|4008381|B1|South Africa||Region of Enrollment||participants|Number|3|3.0||||||
4186929|NCT00783692|4008378|B4|Slovakia||Region of Enrollment||participants|Number|18|18.0||||||
4186930|NCT00783692|4008379|B3|Slovakia||Region of Enrollment||participants|Number|10|10.0||||||
4186931|NCT00783692|4008380|B2|Slovakia||Region of Enrollment||participants|Number|5|5.0||||||
4186932|NCT00783692|4008381|B1|Slovakia||Region of Enrollment||participants|Number|3|3.0||||||
4186933|NCT00783692|4008378|B4|Singapore||Region of Enrollment||participants|Number|1|1.0||||||
4186934|NCT00783692|4008379|B3|Singapore||Region of Enrollment||participants|Number|0|0.0||||||
4186935|NCT00783692|4008380|B2|Singapore||Region of Enrollment||participants|Number|0|0.0||||||
4186936|NCT00783692|4008381|B1|Singapore||Region of Enrollment||participants|Number|1|1.0||||||
4186937|NCT00783692|4008378|B4|Serbia||Region of Enrollment||participants|Number|3|3.0||||||
4186938|NCT00783692|4008379|B3|Serbia||Region of Enrollment||participants|Number|3|3.0||||||
4186939|NCT00783692|4008380|B2|Serbia||Region of Enrollment||participants|Number|0|0.0||||||
4186940|NCT00783692|4008381|B1|Serbia||Region of Enrollment||participants|Number|0|0.0||||||
4186941|NCT00783692|4008378|B4|Russian Federation||Region of Enrollment||participants|Number|28|28.0||||||
4186942|NCT00783692|4008379|B3|Russian Federation||Region of Enrollment||participants|Number|15|15.0||||||
4186943|NCT00783692|4008380|B2|Russian Federation||Region of Enrollment||participants|Number|9|9.0||||||
4186944|NCT00783692|4008381|B1|Russian Federation||Region of Enrollment||participants|Number|4|4.0||||||
4186945|NCT00783692|4008378|B4|Romania||Region of Enrollment||participants|Number|5|5.0||||||
4186946|NCT00783692|4008379|B3|Romania||Region of Enrollment||participants|Number|4|4.0||||||
4186947|NCT00783692|4008380|B2|Romania||Region of Enrollment||participants|Number|1|1.0||||||
4186948|NCT00783692|4008381|B1|Romania||Region of Enrollment||participants|Number|0|0.0||||||
4186949|NCT00783692|4008378|B4|Poland||Region of Enrollment||participants|Number|27|27.0||||||
4186950|NCT00783692|4008379|B3|Poland||Region of Enrollment||participants|Number|14|14.0||||||
4186951|NCT00783692|4008380|B2|Poland||Region of Enrollment||participants|Number|6|6.0||||||
4186952|NCT00783692|4008381|B1|Poland||Region of Enrollment||participants|Number|7|7.0||||||
4186953|NCT00783692|4008378|B4|Norway||Region of Enrollment||participants|Number|13|13.0||||||
4186954|NCT00783692|4008379|B3|Norway||Region of Enrollment||participants|Number|13|13.0||||||
4186955|NCT00783692|4008380|B2|Norway||Region of Enrollment||participants|Number|0|0.0||||||
4186956|NCT00783692|4008381|B1|Norway||Region of Enrollment||participants|Number|0|0.0||||||
4186957|NCT00783692|4008378|B4|New Zealand||Region of Enrollment||participants|Number|12|12.0||||||
4186958|NCT00783692|4008379|B3|New Zealand||Region of Enrollment||participants|Number|3|3.0||||||
4186959|NCT00783692|4008380|B2|New Zealand||Region of Enrollment||participants|Number|5|5.0||||||
4186960|NCT00783692|4008381|B1|New Zealand||Region of Enrollment||participants|Number|4|4.0||||||
4186961|NCT00783692|4008378|B4|Netherlands||Region of Enrollment||participants|Number|7|7.0||||||
4186962|NCT00783692|4008379|B3|Netherlands||Region of Enrollment||participants|Number|7|7.0||||||
4186963|NCT00783692|4008380|B2|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4186964|NCT00783692|4008381|B1|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4186965|NCT00783692|4008378|B4|Malaysia||Region of Enrollment||participants|Number|9|9.0||||||
4186966|NCT00783692|4008379|B3|Malaysia||Region of Enrollment||participants|Number|5|5.0||||||
4186967|NCT00783692|4008380|B2|Malaysia||Region of Enrollment||participants|Number|3|3.0||||||
4186968|NCT00783692|4008381|B1|Malaysia||Region of Enrollment||participants|Number|1|1.0||||||
4186969|NCT00783692|4008378|B4|Latvia||Region of Enrollment||participants|Number|2|2.0||||||
4186970|NCT00783692|4008379|B3|Latvia||Region of Enrollment||participants|Number|0|0.0||||||
4186971|NCT00783692|4008380|B2|Latvia||Region of Enrollment||participants|Number|2|2.0||||||
4186972|NCT00783692|4008381|B1|Latvia||Region of Enrollment||participants|Number|0|0.0||||||
4186973|NCT00783692|4008378|B4|Korea, Republic of||Region of Enrollment||participants|Number|26|26.0||||||
4186974|NCT00783692|4008379|B3|Korea, Republic of||Region of Enrollment||participants|Number|11|11.0||||||
4186975|NCT00783692|4008380|B2|Korea, Republic of||Region of Enrollment||participants|Number|12|12.0||||||
4186976|NCT00783692|4008381|B1|Korea, Republic of||Region of Enrollment||participants|Number|3|3.0||||||
4186977|NCT00783692|4008378|B4|Italy||Region of Enrollment||participants|Number|14|14.0||||||
4186978|NCT00783692|4008379|B3|Italy||Region of Enrollment||participants|Number|13|13.0||||||
4186979|NCT00783692|4008380|B2|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4186980|NCT00783692|4008381|B1|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4186981|NCT00783692|4008378|B4|Israel||Region of Enrollment||participants|Number|18|18.0||||||
4186982|NCT00783692|4008379|B3|Israel||Region of Enrollment||participants|Number|12|12.0||||||
4186983|NCT00783692|4008380|B2|Israel||Region of Enrollment||participants|Number|4|4.0||||||
4186984|NCT00783692|4008381|B1|Israel||Region of Enrollment||participants|Number|2|2.0||||||
4186985|NCT00783692|4008378|B4|Ireland||Region of Enrollment||participants|Number|2|2.0||||||
4186986|NCT00783692|4008379|B3|Ireland||Region of Enrollment||participants|Number|2|2.0||||||
4186987|NCT00783692|4008380|B2|Ireland||Region of Enrollment||participants|Number|0|0.0||||||
4186988|NCT00783692|4008381|B1|Ireland||Region of Enrollment||participants|Number|0|0.0||||||
4186989|NCT00783692|4008378|B4|India||Region of Enrollment||participants|Number|34|34.0||||||
4186990|NCT00783692|4008379|B3|India||Region of Enrollment||participants|Number|5|5.0||||||
4186991|NCT00783692|4008380|B2|India||Region of Enrollment||participants|Number|19|19.0||||||
4186992|NCT00783692|4008381|B1|India||Region of Enrollment||participants|Number|10|10.0||||||
4186993|NCT00783692|4008378|B4|Iceland||Region of Enrollment||participants|Number|4|4.0||||||
4186994|NCT00783692|4008379|B3|Iceland||Region of Enrollment||participants|Number|4|4.0||||||
4186995|NCT00783692|4008380|B2|Iceland||Region of Enrollment||participants|Number|0|0.0||||||
4186996|NCT00783692|4008381|B1|Iceland||Region of Enrollment||participants|Number|0|0.0||||||
4186997|NCT00783692|4008378|B4|Hungary||Region of Enrollment||participants|Number|73|73.0||||||
4186998|NCT00783692|4008379|B3|Hungary||Region of Enrollment||participants|Number|47|47.0||||||
4186999|NCT00783692|4008380|B2|Hungary||Region of Enrollment||participants|Number|17|17.0||||||
4187000|NCT00783692|4008381|B1|Hungary||Region of Enrollment||participants|Number|9|9.0||||||
4187001|NCT00783692|4008378|B4|Hong Kong||Region of Enrollment||participants|Number|2|2.0||||||
4187002|NCT00783692|4008379|B3|Hong Kong||Region of Enrollment||participants|Number|0|0.0||||||
4187003|NCT00783692|4008380|B2|Hong Kong||Region of Enrollment||participants|Number|0|0.0||||||
4187004|NCT00783692|4008381|B1|Hong Kong||Region of Enrollment||participants|Number|2|2.0||||||
4187005|NCT00783692|4008378|B4|Greece||Region of Enrollment||participants|Number|2|2.0||||||
4187006|NCT00783692|4008379|B3|Greece||Region of Enrollment||participants|Number|2|2.0||||||
4187007|NCT00783692|4008380|B2|Greece||Region of Enrollment||participants|Number|0|0.0||||||
4187008|NCT00783692|4008381|B1|Greece||Region of Enrollment||participants|Number|0|0.0||||||
4187009|NCT00783692|4008378|B4|Germany||Region of Enrollment||participants|Number|50|50.0||||||
4187010|NCT00783692|4008379|B3|Germany||Region of Enrollment||participants|Number|49|49.0||||||
4187011|NCT00783692|4008380|B2|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4187012|NCT00783692|4008381|B1|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4187013|NCT00783692|4008378|B4|France||Region of Enrollment||participants|Number|44|44.0||||||
4187014|NCT00783692|4008379|B3|France||Region of Enrollment||participants|Number|37|37.0||||||
4187015|NCT00783692|4008380|B2|France||Region of Enrollment||participants|Number|3|3.0||||||
4187016|NCT00783692|4008381|B1|France||Region of Enrollment||participants|Number|4|4.0||||||
4187017|NCT00783692|4008378|B4|Estonia||Region of Enrollment||participants|Number|6|6.0||||||
4187018|NCT00783692|4008379|B3|Estonia||Region of Enrollment||participants|Number|3|3.0||||||
4187019|NCT00783692|4008380|B2|Estonia||Region of Enrollment||participants|Number|2|2.0||||||
4187020|NCT00783692|4008381|B1|Estonia||Region of Enrollment||participants|Number|1|1.0||||||
4187021|NCT00783692|4008378|B4|Denmark||Region of Enrollment||participants|Number|10|10.0||||||
4187022|NCT00783692|4008379|B3|Denmark||Region of Enrollment||participants|Number|8|8.0||||||
4187023|NCT00783692|4008380|B2|Denmark||Region of Enrollment||participants|Number|2|2.0||||||
4187024|NCT00783692|4008381|B1|Denmark||Region of Enrollment||participants|Number|0|0.0||||||
4187025|NCT00783692|4008378|B4|Czech Republic||Region of Enrollment||participants|Number|80|80.0||||||
4187026|NCT00783692|4008379|B3|Czech Republic||Region of Enrollment||participants|Number|53|53.0||||||
4187027|NCT00783692|4008380|B2|Czech Republic||Region of Enrollment||participants|Number|16|16.0||||||
4187028|NCT00783692|4008381|B1|Czech Republic||Region of Enrollment||participants|Number|11|11.0||||||
4187029|NCT00783692|4008378|B4|Canada||Region of Enrollment||participants|Number|137|137.0||||||
4187030|NCT00783692|4008379|B3|Canada||Region of Enrollment||participants|Number|103|103.0||||||
4187031|NCT00783692|4008380|B2|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4187032|NCT00783692|4008381|B1|Canada||Region of Enrollment||participants|Number|22|22.0||||||
4187033|NCT00783692|4008378|B4|Bulgaria||Region of Enrollment||participants|Number|14|14.0||||||
4187034|NCT00783692|4008379|B3|Bulgaria||Region of Enrollment||participants|Number|2|2.0||||||
4187035|NCT00783692|4008380|B2|Bulgaria||Region of Enrollment||participants|Number|7|7.0||||||
4187036|NCT00783692|4008381|B1|Bulgaria||Region of Enrollment||participants|Number|5|5.0||||||
4187037|NCT00783692|4008378|B4|Belgium||Region of Enrollment||participants|Number|70|70.0||||||
4187038|NCT00783692|4008379|B3|Belgium||Region of Enrollment||participants|Number|41|41.0||||||
4187039|NCT00783692|4008380|B2|Belgium||Region of Enrollment||participants|Number|17|17.0||||||
4187040|NCT00783692|4008381|B1|Belgium||Region of Enrollment||participants|Number|12|12.0||||||
4187041|NCT00783692|4008378|B4|Austria||Region of Enrollment||participants|Number|14|14.0||||||
4187042|NCT00783692|4008379|B3|Austria||Region of Enrollment||participants|Number|7|7.0||||||
4187043|NCT00783692|4008380|B2|Austria||Region of Enrollment||participants|Number|3|3.0||||||
4187044|NCT00783692|4008381|B1|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4187045|NCT00783692|4008378|B4|Australia||Region of Enrollment||participants|Number|45|45.0||||||
4187046|NCT00783692|4008379|B3|Australia||Region of Enrollment||participants|Number|30|30.0||||||
4187047|NCT00783692|4008380|B2|Australia||Region of Enrollment||participants|Number|10|10.0||||||
4187048|NCT00783692|4008381|B1|Australia||Region of Enrollment||participants|Number|5|5.0||||||
4187049|NCT00783692|4008378|B4|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4187050|NCT00783692|4008379|B3|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4187051|NCT00783692|4008380|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4187052|NCT00783692|4008381|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4187053|NCT00783692|4008378|B4|Asian||Race/Ethnicity, Customized||participants|Number|89|89.0||||||
4187054|NCT00783692|4008379|B3|Asian||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4187055|NCT00783692|4008380|B2|Asian||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4187056|NCT00783692|4008381|B1|Asian||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4187057|NCT00783692|4008378|B4|Black||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4187058|NCT00783692|4008379|B3|Black||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4187059|NCT00783692|4008380|B2|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4187060|NCT00783692|4008381|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4187061|NCT00783692|4008378|B4|White||Race/Ethnicity, Customized||participants|Number|995|995.0||||||
4187062|NCT00783692|4008379|B3|White||Race/Ethnicity, Customized||participants|Number|689|689.0||||||
4187063|NCT00783692|4008380|B2|White||Race/Ethnicity, Customized||participants|Number|182|182.0||||||
4187064|NCT00783692|4008381|B1|White||Race/Ethnicity, Customized||participants|Number|124|124.0||||||
4187065|NCT00783692|4008378|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4187066|NCT00783692|4008379|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4187067|NCT00783692|4008380|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4187068|NCT00783692|4008381|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4187069|NCT00783692|4008378|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1065|1065.0||||||
4187070|NCT00783692|4008379|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|712|712.0||||||
4187071|NCT00783692|4008380|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|214|214.0||||||
4187072|NCT00783692|4008381|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|139|139.0||||||
4187073|NCT00783692|4008378|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4187074|NCT00783692|4008379|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4187075|NCT00783692|4008380|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4187076|NCT00783692|4008381|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4187077|NCT00783692|4008378|B4||Male|Sex: Female, Male||Participants|Count of Participants|520|520.0||||||
4187078|NCT00783692|4008379|B3||Male|Sex: Female, Male||Participants|Count of Participants|346|346.0||||||
4187079|NCT00783692|4008380|B2||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4187080|NCT00783692|4008381|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4187081|NCT00783692|4008378|B4||Female|Sex: Female, Male||Participants|Count of Participants|595|595.0||||||
4187082|NCT00783692|4008379|B3||Female|Sex: Female, Male||Participants|Count of Participants|401|401.0||||||
4187083|NCT00783692|4008380|B2||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4187084|NCT00783692|4008381|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4187085|NCT00783692|4008378|B4|≥ 65 years||Age, Customized||participants|Number|23|23.0||||||
4187086|NCT00783692|4008379|B3|≥ 65 years||Age, Customized||participants|Number|15|15.0||||||
4187087|NCT00783692|4008380|B2|≥ 65 years||Age, Customized||participants|Number|2|2.0||||||
4187088|NCT00783692|4008381|B1|≥ 65 years||Age, Customized||participants|Number|6|6.0||||||
4187089|NCT00783692|4008378|B4|< 65 years||Age, Customized||participants|Number|1092|1092.0||||||
4187090|NCT00783692|4008379|B3|< 65 years||Age, Customized||participants|Number|732|732.0||||||
4187091|NCT00783692|4008380|B2|< 65 years||Age, Customized||participants|Number|218|218.0||||||
4187092|NCT00783692|4008381|B1|< 65 years||Age, Customized||participants|Number|142|142.0||||||
4187093|NCT00783692|4008378|B4|≥ 35 years||Age, Customized||participants|Number|533|533.0||||||
4187094|NCT00783692|4008379|B3|≥ 35 years||Age, Customized||participants|Number|343|343.0||||||
4187095|NCT00783692|4008380|B2|≥ 35 years||Age, Customized||participants|Number|109|109.0||||||
4187096|NCT00783692|4008381|B1|≥ 35 years||Age, Customized||participants|Number|81|81.0||||||
4187097|NCT00783692|4008378|B4|< 35 years||Age, Customized||participants|Number|582|582.0||||||
4187098|NCT00783692|4008379|B3|< 35 years||Age, Customized||participants|Number|404|404.0||||||
4187099|NCT00783692|4008380|B2|< 35 years||Age, Customized||participants|Number|111|111.0||||||
4187100|NCT00783692|4008381|B1|< 35 years||Age, Customized||participants|Number|67|67.0||||||
4187101|NCT00783692|4008378|B4|||Age||years|Mean|36.1|36.1|Standard Deviation|12.12|12.12|||
4187102|NCT00783692|4008379|B3|||Age||years|Mean|35.6|35.6|Standard Deviation|12.01|12.01|||
4187103|NCT00783692|4008380|B2|||Age||years|Mean|36.3|36.3|Standard Deviation|11.57|11.57|||
4187104|NCT00783692|4008381|B1|||Age||years|Mean|38.6|38.6|Standard Deviation|13.16|13.16|||
4187105|NCT00783614|4008410|B5|United States||Region of Enrollment||participants|Number|22|22.0||||||
4187106|NCT00783614|4008411|B4|United States||Region of Enrollment||participants|Number|5|5.0||||||
4187107|NCT00783614|4008412|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4187108|NCT00783614|4008413|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4187109|NCT00783614|4008414|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4187110|NCT00783614|4008410|B5||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4187111|NCT00783614|4008411|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4187112|NCT00783614|4008412|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4187113|NCT00783614|4008413|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4187114|NCT00783614|4008414|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4187115|NCT00783614|4008410|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4187116|NCT00783614|4008411|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4187117|NCT00783614|4008412|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4187118|NCT00783614|4008413|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4187119|NCT00783614|4008414|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4187120|NCT00783614|4008410|B5|||Age||years|Mean|37.6|37.6|Standard Deviation|9.6|9.6|||
4187121|NCT00783614|4008411|B4|||Age||years|Mean|37.5|37.5|Standard Deviation|11.1|11.1|||
4187122|NCT00783614|4008412|B3|||Age||years|Mean|36.0|36.0|Standard Deviation|9.3|9.3|||
4187123|NCT00783614|4008413|B2|||Age||years|Mean|38.4|38.4|Standard Deviation|10.6|10.6|||
4187124|NCT00783614|4008414|B1|||Age||years|Mean|36.7|36.7|Standard Deviation|9.0|9.0|||
4187125|NCT00783614|4008410|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4187126|NCT00783614|4008411|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4187127|NCT00783614|4008412|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4187128|NCT00783614|4008413|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4187129|NCT00783614|4008414|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4187130|NCT00783614|4008410|B5||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4187131|NCT00783614|4008411|B4||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4187132|NCT00783614|4008412|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4187133|NCT00783614|4008413|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4187134|NCT00783614|4008414|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4187135|NCT00783614|4008410|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4187136|NCT00783614|4008411|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4187137|NCT00783614|4008412|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4187138|NCT00783614|4008413|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4187139|NCT00783614|4008414|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4187140|NCT00783432|4008431|B3|||Total Nasal Symptom Score (AM + PM)|TNSS scale: 0=no symptoms, 1=mild symptoms, 2=moderate symptoms and 3 = severe symptoms scored twice daily such that the maximum daily score is 24.|units on a scale (0-3)|Mean|9.82|9.82|Standard Deviation|4.617|4.617|||
4187141|NCT00783432|4008432|B2|||Total Nasal Symptom Score (AM + PM)|TNSS scale: 0=no symptoms, 1=mild symptoms, 2=moderate symptoms and 3 = severe symptoms scored twice daily such that the maximum daily score is 24.|units on a scale (0-3)|Mean|9.96|9.96|Standard Deviation|4.725|4.725|||
4187142|NCT00783432|4008433|B1|||Total Nasal Symptom Score (AM + PM)|TNSS scale: 0=no symptoms, 1=mild symptoms, 2=moderate symptoms and 3 = severe symptoms scored twice daily such that the maximum daily score is 24.|units on a scale (0-3)|Mean|9.69|9.69|Standard Deviation|4.506|4.506|||
4187143|NCT00783432|4008431|B3|||Duration of Rhinitis||years|Mean|10.9|10.9|Standard Deviation|10.95|10.95|||
4187144|NCT00783432|4008432|B2|||Duration of Rhinitis||years|Mean|11.3|11.3|Standard Deviation|10.85|10.85|||
4187145|NCT00783432|4008433|B1|||Duration of Rhinitis||years|Mean|10.5|10.5|Standard Deviation|11.04|11.04|||
4187146|NCT00783432|4008431|B3|Europe||Region of Enrollment||participants|Number|779|779.0||||||
4187147|NCT00783432|4008432|B2|Europe||Region of Enrollment||participants|Number|391|391.0||||||
4187148|NCT00783432|4008433|B1|Europe||Region of Enrollment||participants|Number|388|388.0||||||
4187149|NCT00783432|4008431|B3|Australia||Region of Enrollment||participants|Number|79|79.0||||||
4187150|NCT00783432|4008432|B2|Australia||Region of Enrollment||participants|Number|39|39.0||||||
4187151|NCT00783432|4008433|B1|Australia||Region of Enrollment||participants|Number|40|40.0||||||
4187152|NCT00783432|4008431|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4187153|NCT00783432|4008432|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4187154|NCT00783432|4008433|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4187155|NCT00783432|4008431|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187156|NCT00783432|4008432|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187157|NCT00783432|4008433|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187158|NCT00783432|4008431|B3||White|Race (NIH/OMB)||Participants|Count of Participants|815|815.0||||||
4187159|NCT00783432|4008432|B2||White|Race (NIH/OMB)||Participants|Count of Participants|405|405.0||||||
4187160|NCT00783432|4008433|B1||White|Race (NIH/OMB)||Participants|Count of Participants|410|410.0||||||
4187161|NCT00783432|4008431|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4187162|NCT00783432|4008432|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4187163|NCT00783432|4008433|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4187164|NCT00783432|4008431|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4187165|NCT00783432|4008432|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187166|NCT00783432|4008433|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4187167|NCT00783432|4008431|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4187168|NCT00783432|4008432|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4187169|NCT00783432|4008433|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4187170|NCT00783432|4008431|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187171|NCT00783432|4008432|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187172|NCT00783432|4008433|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187173|NCT00783432|4008431|B3||Male|Sex: Female, Male||Participants|Count of Participants|401|401.0||||||
4187174|NCT00783432|4008432|B2||Male|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4187175|NCT00783432|4008433|B1||Male|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4187176|NCT00783432|4008431|B3||Female|Sex: Female, Male||Participants|Count of Participants|457|457.0||||||
4187177|NCT00783432|4008432|B2||Female|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
4187178|NCT00783432|4008433|B1||Female|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
4187179|NCT00783432|4008431|B3|||Age||years|Mean|41.2|41.2|Standard Deviation|15.03|15.03|||
4187180|NCT00783432|4008432|B2|||Age||years|Mean|41.3|41.3|Standard Deviation|15.12|15.12|||
4187181|NCT00783432|4008433|B1|||Age||years|Mean|41.2|41.2|Standard Deviation|14.95|14.95|||
4187182|NCT00783432|4008431|B3||>=65 years|Age||Participants|Count of Participants|57|57.0||||||
4187183|NCT00783432|4008432|B2||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4187184|NCT00783432|4008433|B1||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4187185|NCT00783432|4008431|B3||Between 18 and 65 years|Age||Participants|Count of Participants|780|780.0||||||
4187186|NCT00783432|4008432|B2||Between 18 and 65 years|Age||Participants|Count of Participants|391|391.0||||||
4187187|NCT00783432|4008433|B1||Between 18 and 65 years|Age||Participants|Count of Participants|389|389.0||||||
4187188|NCT00783432|4008431|B3||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
4187189|NCT00783432|4008432|B2||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4187190|NCT00783432|4008433|B1||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4187191|NCT00783302|4008444|B1|Canada||Region of Enrollment||participants|Number|138|138.0||||||
4187192|NCT00783302|4008444|B1|United States||Region of Enrollment||participants|Number|736|736.0||||||
4187193|NCT00783302|4008444|B1||Male|Sex: Female, Male||Participants|Count of Participants|443|443.0||||||
4187194|NCT00783302|4008444|B1||Female|Sex: Female, Male||Participants|Count of Participants|431|431.0||||||
4187195|NCT00783302|4008444|B1||>=65 years|Age||Participants|Count of Participants|306|306.0||||||
4187196|NCT00783302|4008444|B1||Between 18 and 65 years|Age||Participants|Count of Participants|568|568.0||||||
4187197|NCT00783302|4008444|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4187198|NCT00783302|4008444|B1|||Age||years|Mean|58.8|58.8|Standard Deviation|11.96|11.96|||
4187199|NCT00783263|4008462|B5||Male|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
4187200|NCT00783263|4008463|B4||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4187201|NCT00783263|4008464|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4187202|NCT00783263|4008465|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4187203|NCT00783263|4008466|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4187204|NCT00783263|4008462|B5||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4187205|NCT00783263|4008463|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4187206|NCT00783263|4008464|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4187207|NCT00783263|4008465|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4187208|NCT00783263|4008466|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4187209|NCT00783263|4008462|B5|≥ 65 years||Age, Customized||participants|Number|173|173.0||||||
4187210|NCT00783263|4008463|B4|≥ 65 years||Age, Customized||participants|Number|50|50.0||||||
4187211|NCT00783263|4008464|B3|≥ 65 years||Age, Customized||participants|Number|51|51.0||||||
4187212|NCT00783263|4008465|B2|≥ 65 years||Age, Customized||participants|Number|36|36.0||||||
4187213|NCT00783263|4008466|B1|≥ 65 years||Age, Customized||participants|Number|36|36.0||||||
4187214|NCT00783263|4008462|B5|< 65 years||Age, Customized||participants|Number|267|267.0||||||
4187215|NCT00783263|4008463|B4|< 65 years||Age, Customized||participants|Number|71|71.0||||||
4187216|NCT00783263|4008464|B3|< 65 years||Age, Customized||participants|Number|71|71.0||||||
4187217|NCT00783263|4008465|B2|< 65 years||Age, Customized||participants|Number|62|62.0||||||
4187218|NCT00783263|4008466|B1|< 65 years||Age, Customized||participants|Number|63|63.0||||||
4187219|NCT00783224|4008495|B5||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4187220|NCT00783224|4008496|B4||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4187221|NCT00783224|4008497|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4187222|NCT00783224|4008498|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4187223|NCT00783224|4008499|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4187224|NCT00783224|4008495|B5||Female|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4187225|NCT00783224|4008496|B4||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4187226|NCT00783224|4008497|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4187227|NCT00783224|4008498|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4187228|NCT00783224|4008499|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4187229|NCT00783224|4008495|B5|>=60 years old||Age, Customized||participants|Number|5|5.0||||||
4187230|NCT00783224|4008496|B4|>=60 years old||Age, Customized||participants|Number|1|1.0||||||
4187231|NCT00783224|4008497|B3|>=60 years old||Age, Customized||participants|Number|4|4.0||||||
4187232|NCT00783224|4008498|B2|>=60 years old||Age, Customized||participants|Number|0|0.0||||||
4187233|NCT00783224|4008499|B1|>=60 years old||Age, Customized||participants|Number|0|0.0||||||
4187234|NCT00783224|4008495|B5|40-59 years old||Age, Customized||participants|Number|45|45.0||||||
4187235|NCT00783224|4008496|B4|40-59 years old||Age, Customized||participants|Number|21|21.0||||||
4187236|NCT00783224|4008497|B3|40-59 years old||Age, Customized||participants|Number|19|19.0||||||
4187237|NCT00783224|4008498|B2|40-59 years old||Age, Customized||participants|Number|5|5.0||||||
4187238|NCT00783224|4008499|B1|40-59 years old||Age, Customized||participants|Number|0|0.0||||||
4187239|NCT00783224|4008495|B5|30-39 years old||Age, Customized||participants|Number|114|114.0||||||
4187240|NCT00783224|4008496|B4|30-39 years old||Age, Customized||participants|Number|33|33.0||||||
4187241|NCT00783224|4008497|B3|30-39 years old||Age, Customized||participants|Number|54|54.0||||||
4187242|NCT00783224|4008498|B2|30-39 years old||Age, Customized||participants|Number|16|16.0||||||
4187243|NCT00783224|4008499|B1|30-39 years old||Age, Customized||participants|Number|11|11.0||||||
4187244|NCT00783224|4008495|B5|20-29 years old||Age, Customized||participants|Number|168|168.0||||||
4187245|NCT00783224|4008496|B4|20-29 years old||Age, Customized||participants|Number|76|76.0||||||
4187246|NCT00783224|4008497|B3|20-29 years old||Age, Customized||participants|Number|59|59.0||||||
4187247|NCT00783224|4008498|B2|20-29 years old||Age, Customized||participants|Number|13|13.0||||||
4187248|NCT00783224|4008499|B1|20-29 years old||Age, Customized||participants|Number|20|20.0||||||
4187249|NCT00783224|4008495|B5|<20 years old||Age, Customized||participants|Number|19|19.0||||||
4187250|NCT00783224|4008496|B4|<20 years old||Age, Customized||participants|Number|11|11.0||||||
4187251|NCT00783224|4008497|B3|<20 years old||Age, Customized||participants|Number|7|7.0||||||
4187252|NCT00783224|4008498|B2|<20 years old||Age, Customized||participants|Number|0|0.0||||||
4187253|NCT00783224|4008499|B1|<20 years old||Age, Customized||participants|Number|1|1.0||||||
4187254|NCT00783198|4008511|B4||Male|Gender||Participants|Count of Participants|279|279.0||||||
4187255|NCT00783198|4008512|B3||Male|Gender||Participants|Count of Participants|95|95.0||||||
4187256|NCT00783198|4008513|B2||Male|Gender||Participants|Count of Participants|78|78.0||||||
4187257|NCT00783198|4008514|B1||Male|Gender||Participants|Count of Participants|106|106.0||||||
4187258|NCT00783198|4008511|B4||Female|Gender||Participants|Count of Participants|286|286.0||||||
4187259|NCT00783198|4008512|B3||Female|Gender||Participants|Count of Participants|93|93.0||||||
4187260|NCT00783198|4008513|B2||Female|Gender||Participants|Count of Participants|109|109.0||||||
4187261|NCT00783198|4008514|B1||Female|Gender||Participants|Count of Participants|84|84.0||||||
4187262|NCT00783198|4008511|B4|||Age||years|Mean|35.4|35.4|Standard Deviation|9.17|9.17|||
4187263|NCT00783198|4008512|B3|||Age||years|Mean|35.9|35.9|Standard Deviation|9.13|9.13|||
4187264|NCT00783198|4008513|B2|||Age||years|Mean|34.9|34.9|Standard Deviation|9.41|9.41|||
4187265|NCT00783198|4008514|B1|||Age||years|Mean|35.3|35.3|Standard Deviation|9.00|9.0|||
4187266|NCT00783094|4008536|B4|||Weight||kilograms|Mean|65.1|65.1|Standard Deviation|9.1|9.1|||
4187267|NCT00783094|4008537|B3|||Weight||kilograms|Mean|65.4|65.4|Standard Deviation|10.2|10.2|||
4187268|NCT00783094|4008538|B2|||Weight||kilograms|Mean|65.4|65.4|Standard Deviation|8.3|8.3|||
4187269|NCT00783094|4008539|B1|||Weight||kilograms|Mean|64.4|64.4|Standard Deviation|8.6|8.6|||
4187270|NCT00783094|4008536|B4|||Postvoid Residual Volume|Postvoid residual volume (PVR) was measured by ultrasound at regular intervals.|mililiters|Mean|33.0|33.0|Standard Deviation|42.1|42.1|||
4187271|NCT00783094|4008537|B3|||Postvoid Residual Volume|Postvoid residual volume (PVR) was measured by ultrasound at regular intervals.|mililiters|Mean|31.6|31.6|Standard Deviation|42.7|42.7|||
4187272|NCT00783094|4008538|B2|||Postvoid Residual Volume|Postvoid residual volume (PVR) was measured by ultrasound at regular intervals.|mililiters|Mean|32.2|32.2|Standard Deviation|36.4|36.4|||
4187273|NCT00783094|4008539|B1|||Postvoid Residual Volume|Postvoid residual volume (PVR) was measured by ultrasound at regular intervals.|mililiters|Mean|35.2|35.2|Standard Deviation|46.6|46.6|||
4187274|NCT00783094|4008536|B4|||Height||centimeters|Mean|166.4|166.4|Standard Deviation|6.1|6.1|||
4187275|NCT00783094|4008537|B3|||Height||centimeters|Mean|166.3|166.3|Standard Deviation|6.3|6.3|||
4187276|NCT00783094|4008538|B2|||Height||centimeters|Mean|166.9|166.9|Standard Deviation|6.1|6.1|||
4187277|NCT00783094|4008539|B1|||Height||centimeters|Mean|166.0|166.0|Standard Deviation|5.9|5.9|||
4187278|NCT00783094|4008536|B4|||Duration of BPH|Participants had signs and symptoms of benign prostatic hyperplasia (BPH) (as diagnosed by a qualified physician) >6 months at Visit 1.|years|Mean|4.2|4.2|Standard Deviation|3.1|3.1|||
4187279|NCT00783094|4008537|B3|||Duration of BPH|Participants had signs and symptoms of benign prostatic hyperplasia (BPH) (as diagnosed by a qualified physician) >6 months at Visit 1.|years|Mean|4.1|4.1|Standard Deviation|2.9|2.9|||
4187280|NCT00783094|4008538|B2|||Duration of BPH|Participants had signs and symptoms of benign prostatic hyperplasia (BPH) (as diagnosed by a qualified physician) >6 months at Visit 1.|years|Mean|4.5|4.5|Standard Deviation|3.3|3.3|||
4187281|NCT00783094|4008539|B1|||Duration of BPH|Participants had signs and symptoms of benign prostatic hyperplasia (BPH) (as diagnosed by a qualified physician) >6 months at Visit 1.|years|Mean|4.1|4.1|Standard Deviation|3.0|3.0|||
4187282|NCT00783094|4008536|B4|||Body Mass Index|Body mass index (BMI) is an estimate of body fat based on body weight divided by height squared.|kilograms/meters squared|Mean|23.5|23.5|Standard Deviation|2.6|2.6|||
4187283|NCT00783094|4008537|B3|||Body Mass Index|Body mass index (BMI) is an estimate of body fat based on body weight divided by height squared.|kilograms/meters squared|Mean|23.6|23.6|Standard Deviation|2.9|2.9|||
4187284|NCT00783094|4008538|B2|||Body Mass Index|Body mass index (BMI) is an estimate of body fat based on body weight divided by height squared.|kilograms/meters squared|Mean|23.5|23.5|Standard Deviation|2.6|2.6|||
4187285|NCT00783094|4008539|B1|||Body Mass Index|Body mass index (BMI) is an estimate of body fat based on body weight divided by height squared.|kilograms/meters squared|Mean|23.3|23.3|Standard Deviation|2.4|2.4|||
4187286|NCT00783094|4008536|B4|No||Previous Overactive Bladder Therapy|Actual overactive bladder (OAB) therapy within the previous 12 months.|participants|Number|393|393.0||||||
4187287|NCT00783094|4008537|B3|No||Previous Overactive Bladder Therapy|Actual overactive bladder (OAB) therapy within the previous 12 months.|participants|Number|133|133.0||||||
4187288|NCT00783094|4008538|B2|No||Previous Overactive Bladder Therapy|Actual overactive bladder (OAB) therapy within the previous 12 months.|participants|Number|128|128.0||||||
4187289|NCT00783094|4008539|B1|No||Previous Overactive Bladder Therapy|Actual overactive bladder (OAB) therapy within the previous 12 months.|participants|Number|132|132.0||||||
4187290|NCT00783094|4008536|B4|Yes||Previous Overactive Bladder Therapy|Actual overactive bladder (OAB) therapy within the previous 12 months.|participants|Number|29|29.0||||||
4187291|NCT00783094|4008537|B3|Yes||Previous Overactive Bladder Therapy|Actual overactive bladder (OAB) therapy within the previous 12 months.|participants|Number|7|7.0||||||
4187292|NCT00783094|4008538|B2|Yes||Previous Overactive Bladder Therapy|Actual overactive bladder (OAB) therapy within the previous 12 months.|participants|Number|12|12.0||||||
4187293|NCT00783094|4008539|B1|Yes||Previous Overactive Bladder Therapy|Actual overactive bladder (OAB) therapy within the previous 12 months.|participants|Number|10|10.0||||||
4187294|NCT00783094|4008536|B4|No||Previous Benign Prostatic Hyperplasia Therapy|Actual benign prostatic hyperplasia (BPH) therapy within the previous 12 months.|participants|Number|339|339.0||||||
4187295|NCT00783094|4008537|B3|No||Previous Benign Prostatic Hyperplasia Therapy|Actual benign prostatic hyperplasia (BPH) therapy within the previous 12 months.|participants|Number|117|117.0||||||
4187296|NCT00783094|4008538|B2|No||Previous Benign Prostatic Hyperplasia Therapy|Actual benign prostatic hyperplasia (BPH) therapy within the previous 12 months.|participants|Number|107|107.0||||||
4187297|NCT00783094|4008539|B1|No||Previous Benign Prostatic Hyperplasia Therapy|Actual benign prostatic hyperplasia (BPH) therapy within the previous 12 months.|participants|Number|115|115.0||||||
4187298|NCT00783094|4008536|B4|Yes||Previous Benign Prostatic Hyperplasia Therapy|Actual benign prostatic hyperplasia (BPH) therapy within the previous 12 months.|participants|Number|83|83.0||||||
4187299|NCT00783094|4008537|B3|Yes||Previous Benign Prostatic Hyperplasia Therapy|Actual benign prostatic hyperplasia (BPH) therapy within the previous 12 months.|participants|Number|23|23.0||||||
4187300|NCT00783094|4008538|B2|Yes||Previous Benign Prostatic Hyperplasia Therapy|Actual benign prostatic hyperplasia (BPH) therapy within the previous 12 months.|participants|Number|33|33.0||||||
4187301|NCT00783094|4008539|B1|Yes||Previous Benign Prostatic Hyperplasia Therapy|Actual benign prostatic hyperplasia (BPH) therapy within the previous 12 months.|participants|Number|27|27.0||||||
4187302|NCT00783094|4008536|B4|No||Previous Alpha-blocker Use|Actual use of alpha-blockers within the previous 12 months.|participants|Number|97|97.0||||||
4187303|NCT00783094|4008537|B3|No||Previous Alpha-blocker Use|Actual use of alpha-blockers within the previous 12 months.|participants|Number|34|34.0||||||
4187304|NCT00783094|4008538|B2|No||Previous Alpha-blocker Use|Actual use of alpha-blockers within the previous 12 months.|participants|Number|32|32.0||||||
4187305|NCT00783094|4008539|B1|No||Previous Alpha-blocker Use|Actual use of alpha-blockers within the previous 12 months.|participants|Number|31|31.0||||||
4187306|NCT00783094|4008536|B4|Yes||Previous Alpha-blocker Use|Actual use of alpha-blockers within the previous 12 months.|participants|Number|325|325.0||||||
4187307|NCT00783094|4008537|B3|Yes||Previous Alpha-blocker Use|Actual use of alpha-blockers within the previous 12 months.|participants|Number|106|106.0||||||
4187308|NCT00783094|4008538|B2|Yes||Previous Alpha-blocker Use|Actual use of alpha-blockers within the previous 12 months.|participants|Number|108|108.0||||||
4187309|NCT00783094|4008539|B1|Yes||Previous Alpha-blocker Use|Actual use of alpha-blockers within the previous 12 months.|participants|Number|111|111.0||||||
4187310|NCT00783094|4008536|B4|Unknown or Not Recorded||Current Tobacco Use||participants|Number|135|135.0||||||
4187311|NCT00783094|4008537|B3|Unknown or Not Recorded||Current Tobacco Use||participants|Number|45|45.0||||||
4187312|NCT00783094|4008538|B2|Unknown or Not Recorded||Current Tobacco Use||participants|Number|40|40.0||||||
4187313|NCT00783094|4008539|B1|Unknown or Not Recorded||Current Tobacco Use||participants|Number|50|50.0||||||
4187314|NCT00783094|4008536|B4|No||Current Tobacco Use||participants|Number|203|203.0||||||
4187315|NCT00783094|4008537|B3|No||Current Tobacco Use||participants|Number|70|70.0||||||
4187316|NCT00783094|4008538|B2|No||Current Tobacco Use||participants|Number|72|72.0||||||
4187317|NCT00783094|4008539|B1|No||Current Tobacco Use||participants|Number|61|61.0||||||
4187318|NCT00783094|4008536|B4|Yes||Current Tobacco Use||participants|Number|84|84.0||||||
4187319|NCT00783094|4008537|B3|Yes||Current Tobacco Use||participants|Number|25|25.0||||||
4187320|NCT00783094|4008538|B2|Yes||Current Tobacco Use||participants|Number|28|28.0||||||
4187321|NCT00783094|4008539|B1|Yes||Current Tobacco Use||participants|Number|31|31.0||||||
4187322|NCT00783094|4008536|B4|No||Current Alcohol Use||participants|Number|141|141.0||||||
4187323|NCT00783094|4008537|B3|No||Current Alcohol Use||participants|Number|47|47.0||||||
4187324|NCT00783094|4008538|B2|No||Current Alcohol Use||participants|Number|48|48.0||||||
4187325|NCT00783094|4008539|B1|No||Current Alcohol Use||participants|Number|46|46.0||||||
4187326|NCT00783094|4008536|B4|Yes||Current Alcohol Use||participants|Number|281|281.0||||||
4187327|NCT00783094|4008537|B3|Yes||Current Alcohol Use||participants|Number|93|93.0||||||
4187328|NCT00783094|4008538|B2|Yes||Current Alcohol Use||participants|Number|92|92.0||||||
4187329|NCT00783094|4008539|B1|Yes||Current Alcohol Use||participants|Number|96|96.0||||||
4187330|NCT00783094|4008536|B4|Severe||Baseline (Visit 3) Benign Prostatic Hyperplasia Severity|Participants with BPH were defined as having had signs and symptoms of benign prostatic hyperplasia (BPH) (as diagnosed by a qualified physician) >6 months at Visit 1. Signs and symptoms of BPH included those associated with voiding (obstructive symptoms, such as incomplete emptying, intermittency, weak stream, straining)and/or storage (irritative symptoms, such as frequency, urgency, or nocturia).|participants|Number|120|120.0||||||
4187331|NCT00783094|4008537|B3|Severe||Baseline (Visit 3) Benign Prostatic Hyperplasia Severity|Participants with BPH were defined as having had signs and symptoms of benign prostatic hyperplasia (BPH) (as diagnosed by a qualified physician) >6 months at Visit 1. Signs and symptoms of BPH included those associated with voiding (obstructive symptoms, such as incomplete emptying, intermittency, weak stream, straining)and/or storage (irritative symptoms, such as frequency, urgency, or nocturia).|participants|Number|40|40.0||||||
4187332|NCT00783094|4008538|B2|Severe||Baseline (Visit 3) Benign Prostatic Hyperplasia Severity|Participants with BPH were defined as having had signs and symptoms of benign prostatic hyperplasia (BPH) (as diagnosed by a qualified physician) >6 months at Visit 1. Signs and symptoms of BPH included those associated with voiding (obstructive symptoms, such as incomplete emptying, intermittency, weak stream, straining)and/or storage (irritative symptoms, such as frequency, urgency, or nocturia).|participants|Number|38|38.0||||||
4187333|NCT00783094|4008539|B1|Severe||Baseline (Visit 3) Benign Prostatic Hyperplasia Severity|Participants with BPH were defined as having had signs and symptoms of benign prostatic hyperplasia (BPH) (as diagnosed by a qualified physician) >6 months at Visit 1. Signs and symptoms of BPH included those associated with voiding (obstructive symptoms, such as incomplete emptying, intermittency, weak stream, straining)and/or storage (irritative symptoms, such as frequency, urgency, or nocturia).|participants|Number|42|42.0||||||
4187334|NCT00783094|4008536|B4|Moderate||Baseline (Visit 3) Benign Prostatic Hyperplasia Severity|Participants with BPH were defined as having had signs and symptoms of benign prostatic hyperplasia (BPH) (as diagnosed by a qualified physician) >6 months at Visit 1. Signs and symptoms of BPH included those associated with voiding (obstructive symptoms, such as incomplete emptying, intermittency, weak stream, straining)and/or storage (irritative symptoms, such as frequency, urgency, or nocturia).|participants|Number|302|302.0||||||
4187335|NCT00783094|4008537|B3|Moderate||Baseline (Visit 3) Benign Prostatic Hyperplasia Severity|Participants with BPH were defined as having had signs and symptoms of benign prostatic hyperplasia (BPH) (as diagnosed by a qualified physician) >6 months at Visit 1. Signs and symptoms of BPH included those associated with voiding (obstructive symptoms, such as incomplete emptying, intermittency, weak stream, straining)and/or storage (irritative symptoms, such as frequency, urgency, or nocturia).|participants|Number|100|100.0||||||
4187336|NCT00783094|4008538|B2|Moderate||Baseline (Visit 3) Benign Prostatic Hyperplasia Severity|Participants with BPH were defined as having had signs and symptoms of benign prostatic hyperplasia (BPH) (as diagnosed by a qualified physician) >6 months at Visit 1. Signs and symptoms of BPH included those associated with voiding (obstructive symptoms, such as incomplete emptying, intermittency, weak stream, straining)and/or storage (irritative symptoms, such as frequency, urgency, or nocturia).|participants|Number|102|102.0||||||
4187337|NCT00783094|4008539|B1|Moderate||Baseline (Visit 3) Benign Prostatic Hyperplasia Severity|Participants with BPH were defined as having had signs and symptoms of benign prostatic hyperplasia (BPH) (as diagnosed by a qualified physician) >6 months at Visit 1. Signs and symptoms of BPH included those associated with voiding (obstructive symptoms, such as incomplete emptying, intermittency, weak stream, straining)and/or storage (irritative symptoms, such as frequency, urgency, or nocturia).|participants|Number|100|100.0||||||
4187338|NCT00783094|4008536|B4|Japan||Region of Enrollment||participants|Number|422|422.0||||||
4187339|NCT00783094|4008537|B3|Japan||Region of Enrollment||participants|Number|140|140.0||||||
4187340|NCT00783094|4008538|B2|Japan||Region of Enrollment||participants|Number|140|140.0||||||
4187341|NCT00783094|4008539|B1|Japan||Region of Enrollment||participants|Number|142|142.0||||||
4187342|NCT00783094|4008536|B4|Japanese||Race/Ethnicity, Customized||participants|Number|422|422.0||||||
4187343|NCT00783094|4008537|B3|Japanese||Race/Ethnicity, Customized||participants|Number|140|140.0||||||
4187344|NCT00783094|4008538|B2|Japanese||Race/Ethnicity, Customized||participants|Number|140|140.0||||||
4187345|NCT00783094|4008539|B1|Japanese||Race/Ethnicity, Customized||participants|Number|142|142.0||||||
4187346|NCT00783094|4008536|B4||Male|Sex: Female, Male||Participants|Count of Participants|422|422.0||||||
4187347|NCT00783094|4008537|B3||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4187348|NCT00783094|4008538|B2||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4187349|NCT00783094|4008539|B1||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4187350|NCT00783094|4008536|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4187351|NCT00783094|4008537|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4187352|NCT00783094|4008538|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4187353|NCT00783094|4008539|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4187354|NCT00783094|4008536|B4|||Age||years|Mean|66.8|66.8|Standard Deviation|7.3|7.3|||
4187355|NCT00783094|4008537|B3|||Age||years|Mean|67.0|67.0|Standard Deviation|6.9|6.9|||
4187356|NCT00783094|4008538|B2|||Age||years|Mean|66.9|66.9|Standard Deviation|7.7|7.7|||
4187357|NCT00783094|4008539|B1|||Age||years|Mean|66.4|66.4|Standard Deviation|7.4|7.4|||
4187358|NCT00782834|4008617|B1|IM, SU, RT and CT||Prior Tyrosine Kinase Inhibitor (TKI)|Imatinib (IM) + Sunitinib (SU); Imatinib + Sunitinib + Nasatinib (NA); Imatinib +Sunitinib + Radiotherapy (RT) + Chemotherapy (CT)|Participants|Number|1|1.0||||||
4187359|NCT00782834|4008617|B1|IM, SU and NA||Prior Tyrosine Kinase Inhibitor (TKI)|Imatinib (IM) + Sunitinib (SU); Imatinib + Sunitinib + Nasatinib (NA); Imatinib +Sunitinib + Radiotherapy (RT) + Chemotherapy (CT)|Participants|Number|1|1.0||||||
4187360|NCT00782834|4008617|B1|IM and SU||Prior Tyrosine Kinase Inhibitor (TKI)|Imatinib (IM) + Sunitinib (SU); Imatinib + Sunitinib + Nasatinib (NA); Imatinib +Sunitinib + Radiotherapy (RT) + Chemotherapy (CT)|Participants|Number|11|11.0||||||
4187361|NCT00782834|4008617|B1|Rectum||Primary Site of Cancer|Stomach 6; Small bowel 5; Colon 1; Rectum 1|Participants|Number|1|1.0||||||
4187362|NCT00782834|4008617|B1|Colon||Primary Site of Cancer|Stomach 6; Small bowel 5; Colon 1; Rectum 1|Participants|Number|1|1.0||||||
4187363|NCT00782834|4008617|B1|Small Bowel||Primary Site of Cancer|Stomach 6; Small bowel 5; Colon 1; Rectum 1|Participants|Number|5|5.0||||||
4187364|NCT00782834|4008617|B1|Stomach||Primary Site of Cancer|Stomach 6; Small bowel 5; Colon 1; Rectum 1|Participants|Number|6|6.0||||||
4187365|NCT00782834|4008617|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4187366|NCT00782834|4008617|B1|Male||Gender||participants|Number|9|9.0||||||
4187367|NCT00782834|4008617|B1|Female||Gender||participants|Number|4|4.0||||||
4187368|NCT00782834|4008617|B1|>=65 years||Age||participants|Number|4|4.0||||68.0|78.0|
4187369|NCT00782834|4008617|B1|Between 18 and 65 years||Age||participants|Number|9|9.0||||54.0|63.0|
4187370|NCT00782834|4008617|B1|<=18 years||Age||participants|Number|0|0.0||||0.0|18.0|
4187371|NCT00782821|4008622|B5|||Dialysis pre-transplant||participants|Number|34|34.0||||||
4187372|NCT00782821|4008623|B4|||Dialysis pre-transplant||participants|Number|10|10.0||||||
4187373|NCT00782821|4008624|B3|||Dialysis pre-transplant||participants|Number|8|8.0||||||
4187374|NCT00782821|4008625|B2|||Dialysis pre-transplant||participants|Number|7|7.0||||||
4187375|NCT00782821|4008626|B1|||Dialysis pre-transplant||participants|Number|9|9.0||||||
4187376|NCT00782821|4008622|B5|||Pre-transplant diabetes mellitus||participants|Number|9|9.0||||||
4187377|NCT00782821|4008623|B4|||Pre-transplant diabetes mellitus||participants|Number|1|1.0||||||
4187378|NCT00782821|4008624|B3|||Pre-transplant diabetes mellitus||participants|Number|3|3.0||||||
4187379|NCT00782821|4008625|B2|||Pre-transplant diabetes mellitus||participants|Number|4|4.0||||||
4187380|NCT00782821|4008626|B1|||Pre-transplant diabetes mellitus||participants|Number|1|1.0||||||
4187381|NCT00782821|4008622|B5|United States||Region of Enrollment||participants|Number|40|40.0||||||
4187382|NCT00782821|4008623|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
4187383|NCT00782821|4008624|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4187384|NCT00782821|4008625|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4187385|NCT00782821|4008626|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4187386|NCT00782821|4008622|B5||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4187387|NCT00782821|4008623|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4187388|NCT00782821|4008624|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4187389|NCT00782821|4008625|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4187390|NCT00782821|4008626|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4187391|NCT00782821|4008622|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4187392|NCT00782821|4008623|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4187393|NCT00782821|4008624|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4187394|NCT00782821|4008625|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4187395|NCT00782821|4008626|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4187396|NCT00782821|4008622|B5|||Age||years|Mean|50.9|50.9|Full Range|||34.5|63.3|
4187397|NCT00782821|4008623|B4|||Age||years|Mean|50.1|50.1|Full Range|||45.3|56.9|
4187398|NCT00782821|4008624|B3|||Age||years|Mean|50.6|50.6|Full Range|||34.5|63.3|
4187399|NCT00782821|4008625|B2|||Age||years|Mean|52.8|52.8|Full Range|||45.6|62.7|
4187400|NCT00782821|4008626|B1|||Age||years|Mean|49.9|49.9|Full Range|||46.3|53.8|
4187401|NCT00782795|4008655|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4187402|NCT00782795|4008656|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4187403|NCT00782795|4008657|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4187404|NCT00782795|4008655|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4187405|NCT00782795|4008656|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4187406|NCT00782795|4008657|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4187407|NCT00782795|4008655|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4187408|NCT00782795|4008656|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4187409|NCT00782795|4008657|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4187410|NCT00782795|4008655|B3|||Age||years|Mean|51.08|51.08|Standard Deviation|8.39|8.39|||
4187411|NCT00782795|4008656|B2|||Age||years|Mean|48.37|48.37|Standard Deviation|9.83|9.83|||
4187412|NCT00782795|4008657|B1|||Age||years|Mean|52.35|52.35|Standard Deviation|7.61|7.61|||
4187413|NCT00782756|4008690|B1|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
4187414|NCT00782756|4008690|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4187415|NCT00782756|4008690|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187416|NCT00782756|4008690|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4187417|NCT00782756|4008690|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187418|NCT00782756|4008690|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187419|NCT00782756|4008690|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4187420|NCT00782756|4008690|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187421|NCT00782756|4008690|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187422|NCT00782756|4008690|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4187423|NCT00782756|4008690|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187424|NCT00782756|4008690|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4187425|NCT00782756|4008690|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4187426|NCT00782756|4008690|B1|||Age||years|Median|55|55.0|Full Range|||18.0|75.0|
4187427|NCT00782717|4008696|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4187428|NCT00782717|4008697|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4187429|NCT00782717|4008698|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4187430|NCT00782717|4008696|B3||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4187431|NCT00782717|4008697|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4187432|NCT00782717|4008698|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4187433|NCT00782717|4008696|B3||>=65 years|Age||Participants|Count of Participants|151|151.0||||||
4187434|NCT00782717|4008697|B2||>=65 years|Age||Participants|Count of Participants|72|72.0||||||
4187435|NCT00782717|4008698|B1||>=65 years|Age||Participants|Count of Participants|79|79.0||||||
4187436|NCT00782717|4008696|B3||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4187437|NCT00782717|4008697|B2||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4187438|NCT00782717|4008698|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4187439|NCT00782717|4008696|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4187440|NCT00782717|4008697|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4187441|NCT00782717|4008698|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4187442|NCT00782639|4008707|B3|China||Region of Enrollment||participants|Number|23|23.0||||||
4187443|NCT00782639|4008708|B2|China||Region of Enrollment||participants|Number|11|11.0||||||
4187444|NCT00782639|4008709|B1|China||Region of Enrollment||participants|Number|12|12.0||||||
4187445|NCT00782639|4008707|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4187446|NCT00782639|4008708|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4187447|NCT00782639|4008709|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4187448|NCT00782639|4008707|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4187449|NCT00782639|4008708|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4187450|NCT00782639|4008709|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4187451|NCT00782639|4008707|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4187452|NCT00782639|4008708|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4187453|NCT00782639|4008709|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4187454|NCT00782639|4008707|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4187455|NCT00782639|4008708|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4187456|NCT00782639|4008709|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4187457|NCT00782639|4008707|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4187458|NCT00782639|4008708|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4187459|NCT00782639|4008709|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4187460|NCT00782626|4008726|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4187461|NCT00782626|4008726|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4187462|NCT00782626|4008726|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4187463|NCT00782626|4008726|B1|||Age||years|Median|9|9.0|Full Range|||3.0|17.0|
4187464|NCT00782626|4008726|B1||>=65 years|Age|The analysis dataset is comprised of all eligible and treated patients.|Participants|Count of Participants|0|0.0||||||
4187465|NCT00782626|4008726|B1||Between 18 and 65 years|Age|The analysis dataset is comprised of all eligible and treated patients.|Participants|Count of Participants|0|0.0||||||
4187466|NCT00782626|4008726|B1||<=18 years|Age|The analysis dataset is comprised of all eligible and treated patients.|Participants|Count of Participants|23|23.0||||||
4187467|NCT00782509|4008730|B4|Tiotropium||Tiotropium (Tio) Use Stratum||Number of participants|Number|124|124.0||||||
4187468|NCT00782509|4008731|B3|Tiotropium||Tiotropium (Tio) Use Stratum||Number of participants|Number|44|44.0||||||
4187469|NCT00782509|4008732|B2|Tiotropium||Tiotropium (Tio) Use Stratum||Number of participants|Number|39|39.0||||||
4187470|NCT00782509|4008733|B1|Tiotropium||Tiotropium (Tio) Use Stratum||Number of participants|Number|41|41.0||||||
4187471|NCT00782509|4008730|B4|Non-tiotropium||Tiotropium (Tio) Use Stratum||Number of participants|Number|518|518.0||||||
4187472|NCT00782509|4008731|B3|Non-tiotropium||Tiotropium (Tio) Use Stratum||Number of participants|Number|173|173.0||||||
4187473|NCT00782509|4008732|B2|Non-tiotropium||Tiotropium (Tio) Use Stratum||Number of participants|Number|170|170.0||||||
4187474|NCT00782509|4008733|B1|Non-tiotropium||Tiotropium (Tio) Use Stratum||Number of participants|Number|175|175.0||||||
4187475|NCT00782509|4008730|B4||Male|Sex: Female, Male||Participants|Count of Participants|456|456.0||||||
4187476|NCT00782509|4008731|B3||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4187477|NCT00782509|4008732|B2||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4187478|NCT00782509|4008733|B1||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4187479|NCT00782509|4008730|B4||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4187480|NCT00782509|4008731|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4187481|NCT00782509|4008732|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4187482|NCT00782509|4008733|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4187483|NCT00782509|4008730|B4|||Age||years|Mean|64.6|64.6|Standard Deviation|8.8|8.8|||
4187484|NCT00782509|4008731|B3|||Age||years|Mean|65.4|65.4|Standard Deviation|9.7|9.7|||
4187485|NCT00782509|4008732|B2|||Age||years|Mean|64.7|64.7|Standard Deviation|8.1|8.1|||
4187486|NCT00782509|4008733|B1|||Age||years|Mean|63.8|63.8|Standard Deviation|8.3|8.3|||
4187487|NCT00782496|4008926|B3|United States||Region of Enrollment||participants|Number|211|211.0||||||
4187488|NCT00782496|4008927|B2|United States||Region of Enrollment||participants|Number|105|105.0||||||
4187489|NCT00782496|4008928|B1|United States||Region of Enrollment||participants|Number|106|106.0||||||
4187490|NCT00782496|4008926|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4187491|NCT00782496|4008927|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4187492|NCT00782496|4008928|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4187493|NCT00782496|4008926|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4187494|NCT00782496|4008927|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4187495|NCT00782496|4008928|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4187496|NCT00782496|4008926|B3|||Age, Customized||years|Median|55|55.0|Full Range|||22.0|81.0|
4187497|NCT00782496|4008927|B2|||Age, Customized||years|Median|56|56.0|Full Range|||23.0|80.0|
4187498|NCT00782496|4008928|B1|||Age, Customized||years|Median|53|53.0|Full Range|||22.0|81.0|
4187499|NCT00782483|4008936|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4187500|NCT00782483|4008936|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4187501|NCT00782483|4008936|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4187502|NCT00782483|4008936|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4187503|NCT00782483|4008936|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4187504|NCT00782483|4008936|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4187505|NCT00782418|4008940|B1|||Body Mass Index||kg/m^2|Mean|23.3|23.3|Standard Deviation|2.1|2.1|||
4187506|NCT00782418|4008940|B1||Male|Gender||Participants|Count of Participants|27|27.0||||||
4187507|NCT00782418|4008940|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
4187508|NCT00782418|4008940|B1|||Age||years|Mean|29.3|29.3|Standard Deviation|9.1|9.1|||
4187509|NCT00782379|4008966|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4187510|NCT00782379|4008966|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4187511|NCT00782379|4008966|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4187512|NCT00782379|4008966|B1|||Age||years|Mean|41.75|41.75|Standard Deviation|8.67|8.67|||
4187513|NCT00782379|4008966|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4187514|NCT00782379|4008966|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4187515|NCT00782379|4008966|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4187516|NCT00782340|4008980|B4|Other Diagnosis||Primary Clinical Diagnosis||participants|Number|11|11.0||||||
4187517|NCT00782340|4008981|B3|Other Diagnosis||Primary Clinical Diagnosis||participants|Number|4|4.0||||||
4187518|NCT00782340|4008982|B2|Other Diagnosis||Primary Clinical Diagnosis||participants|Number|4|4.0||||||
4187519|NCT00782340|4008983|B1|Other Diagnosis||Primary Clinical Diagnosis||participants|Number|3|3.0||||||
4187520|NCT00782340|4008980|B4|Non-Diabetic Autonomic Neuropathy||Primary Clinical Diagnosis||participants|Number|10|10.0||||||
4187521|NCT00782340|4008981|B3|Non-Diabetic Autonomic Neuropathy||Primary Clinical Diagnosis||participants|Number|6|6.0||||||
4187522|NCT00782340|4008982|B2|Non-Diabetic Autonomic Neuropathy||Primary Clinical Diagnosis||participants|Number|2|2.0||||||
4187523|NCT00782340|4008983|B1|Non-Diabetic Autonomic Neuropathy||Primary Clinical Diagnosis||participants|Number|2|2.0||||||
4187524|NCT00782340|4008980|B4|Pure Autonomic Failure||Primary Clinical Diagnosis||participants|Number|87|87.0||||||
4187525|NCT00782340|4008981|B3|Pure Autonomic Failure||Primary Clinical Diagnosis||participants|Number|28|28.0||||||
4187526|NCT00782340|4008982|B2|Pure Autonomic Failure||Primary Clinical Diagnosis||participants|Number|26|26.0||||||
4187527|NCT00782340|4008983|B1|Pure Autonomic Failure||Primary Clinical Diagnosis||participants|Number|33|33.0||||||
4187528|NCT00782340|4008980|B4|Multiple System Atrophy||Primary Clinical Diagnosis||participants|Number|44|44.0||||||
4187529|NCT00782340|4008981|B3|Multiple System Atrophy||Primary Clinical Diagnosis||participants|Number|11|11.0||||||
4187530|NCT00782340|4008982|B2|Multiple System Atrophy||Primary Clinical Diagnosis||participants|Number|15|15.0||||||
4187531|NCT00782340|4008983|B1|Multiple System Atrophy||Primary Clinical Diagnosis||participants|Number|18|18.0||||||
4187532|NCT00782340|4008980|B4|Parkinson's Disease||Primary Clinical Diagnosis||participants|Number|111|111.0||||||
4187533|NCT00782340|4008981|B3|Parkinson's Disease||Primary Clinical Diagnosis||participants|Number|31|31.0||||||
4187534|NCT00782340|4008982|B2|Parkinson's Disease||Primary Clinical Diagnosis||participants|Number|35|35.0||||||
4187535|NCT00782340|4008983|B1|Parkinson's Disease||Primary Clinical Diagnosis||participants|Number|45|45.0||||||
4187536|NCT00782340|4008980|B4|Europe||Region of Enrollment||participants|Number|143|143.0||||||
4187537|NCT00782340|4008981|B3|Europe||Region of Enrollment||participants|Number|44|44.0||||||
4187538|NCT00782340|4008982|B2|Europe||Region of Enrollment||participants|Number|49|49.0||||||
4187539|NCT00782340|4008983|B1|Europe||Region of Enrollment||participants|Number|50|50.0||||||
4187540|NCT00782340|4008980|B4|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4187541|NCT00782340|4008981|B3|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4187542|NCT00782340|4008982|B2|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4187543|NCT00782340|4008983|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4187544|NCT00782340|4008980|B4|United States||Region of Enrollment||participants|Number|113|113.0||||||
4187545|NCT00782340|4008981|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4187546|NCT00782340|4008982|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4187547|NCT00782340|4008983|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4187548|NCT00782340|4008980|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187549|NCT00782340|4008981|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187550|NCT00782340|4008982|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187551|NCT00782340|4008983|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187552|NCT00782340|4008980|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187553|NCT00782340|4008981|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187554|NCT00782340|4008982|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187555|NCT00782340|4008983|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187556|NCT00782340|4008980|B4||White|Race (NIH/OMB)||Participants|Count of Participants|259|259.0||||||
4187557|NCT00782340|4008981|B3||White|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
4187558|NCT00782340|4008982|B2||White|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
4187559|NCT00782340|4008983|B1||White|Race (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
4187560|NCT00782340|4008980|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4187561|NCT00782340|4008981|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4187562|NCT00782340|4008982|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187563|NCT00782340|4008983|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4187564|NCT00782340|4008980|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187565|NCT00782340|4008981|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187566|NCT00782340|4008982|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187567|NCT00782340|4008983|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187568|NCT00782340|4008980|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4187569|NCT00782340|4008981|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4187570|NCT00782340|4008982|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187571|NCT00782340|4008983|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187572|NCT00782340|4008980|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187573|NCT00782340|4008981|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187574|NCT00782340|4008982|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187575|NCT00782340|4008983|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187576|NCT00782340|4008980|B4||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4187577|NCT00782340|4008981|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4187578|NCT00782340|4008982|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4187579|NCT00782340|4008983|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4187580|NCT00782340|4008980|B4||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4187581|NCT00782340|4008981|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4187582|NCT00782340|4008982|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4187583|NCT00782340|4008983|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4187584|NCT00782340|4008980|B4|||Age||years|Mean|59.6|59.6|Standard Deviation|17.8|17.8|||
4187585|NCT00782340|4008981|B3|||Age||years|Mean|55.7|55.7|Standard Deviation|20.03|20.03|||
4187586|NCT00782340|4008982|B2|||Age||years|Mean|57.4|57.4|Standard Deviation|16.90|16.9|||
4187587|NCT00782340|4008983|B1|||Age||years|Mean|64.6|64.6|Standard Deviation|15.4|15.4|||
4187588|NCT00782288|4009008|B4|United States||Region of Enrollment||participants|Number|24|24.0||||||
4187589|NCT00782288|4009009|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4187590|NCT00782288|4009010|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4187591|NCT00782288|4009011|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4187592|NCT00782288|4009008|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187593|NCT00782288|4009009|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187594|NCT00782288|4009010|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187595|NCT00782288|4009011|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187596|NCT00782288|4009008|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4187597|NCT00782288|4009009|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4187598|NCT00782288|4009010|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4187599|NCT00782288|4009011|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4187600|NCT00782288|4009008|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187601|NCT00782288|4009009|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187602|NCT00782288|4009010|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187603|NCT00782288|4009011|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187604|NCT00782288|4009008|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4187605|NCT00782288|4009009|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4187606|NCT00782288|4009010|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4187607|NCT00782288|4009011|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4187608|NCT00782288|4009008|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4187609|NCT00782288|4009009|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4187610|NCT00782288|4009010|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4187611|NCT00782288|4009011|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4187612|NCT00782288|4009008|B4|||Age||years|Mean|26.2|26.2|Full Range|||18.2|42.8|
4187613|NCT00782288|4009009|B3|||Age||years|Mean|30.3|30.3|Full Range|||19.8|42.8|
4187614|NCT00782288|4009010|B2|||Age||years|Mean|23.5|23.5|Full Range|||18.2|37.7|
4187615|NCT00782288|4009011|B1|||Age||years|Mean|24.8|24.8|Full Range|||18.2|39.7|
4187616|NCT00782288|4009008|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4187617|NCT00782288|4009009|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4187618|NCT00782288|4009010|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4187619|NCT00782288|4009011|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4187620|NCT00782288|4009008|B4||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4187621|NCT00782288|4009009|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4187622|NCT00782288|4009010|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4187623|NCT00782288|4009011|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4187624|NCT00782288|4009008|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4187625|NCT00782288|4009009|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4187626|NCT00782288|4009010|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4187627|NCT00782288|4009011|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4187628|NCT00782275|4009055|B1||Poor|MSKCC Risk Category|The Memorial Sloan Kettering Cancer Center (MSKCC) risk score is based on the sum of positive answers to the following criteria: 1) time from the earliest of initial or metastatic diagnosis to first prior treatment < 1 year; 2) Karnofsky Performance Score < 80%; 3) HgB < LLN; 4) Corrected Calcium > 10 mg/dL; and 5) NLDH> 1.5xULN. Patients were further classified into risk groups based on the score of 0=Favorable, 1-2=Intermediate and 3-5=Poor Risk. (Motzer et al. Cancer 2008; 113)|Participants|Count of Participants|4|4.0||||||
4187629|NCT00782275|4009055|B1||Intermediate|MSKCC Risk Category|The Memorial Sloan Kettering Cancer Center (MSKCC) risk score is based on the sum of positive answers to the following criteria: 1) time from the earliest of initial or metastatic diagnosis to first prior treatment < 1 year; 2) Karnofsky Performance Score < 80%; 3) HgB < LLN; 4) Corrected Calcium > 10 mg/dL; and 5) NLDH> 1.5xULN. Patients were further classified into risk groups based on the score of 0=Favorable, 1-2=Intermediate and 3-5=Poor Risk. (Motzer et al. Cancer 2008; 113)|Participants|Count of Participants|31|31.0||||||
4187630|NCT00782275|4009055|B1||Favorable|MSKCC Risk Category|The Memorial Sloan Kettering Cancer Center (MSKCC) risk score is based on the sum of positive answers to the following criteria: 1) time from the earliest of initial or metastatic diagnosis to first prior treatment < 1 year; 2) Karnofsky Performance Score < 80%; 3) HgB < LLN; 4) Corrected Calcium > 10 mg/dL; and 5) NLDH> 1.5xULN. Patients were further classified into risk groups based on the score of 0=Favorable, 1-2=Intermediate and 3-5=Poor Risk. (Motzer et al. Cancer 2008; 113)|Participants|Count of Participants|5|5.0||||||
4187631|NCT00782275|4009055|B1|Unevaluable||Primary VEGF Refractory Status|Primary VEGF refractory status was based on the prior therapy form; patients were considered refractory if response on prior therapy was progressive disease OR prior therapy duration was < 3 months and patient experienced progression at the end of therapy.|Participants|Count of Participants|1|1.0||||||
4187632|NCT00782275|4009055|B1|VEGF Refractory-Yes||Primary VEGF Refractory Status|Primary VEGF refractory status was based on the prior therapy form; patients were considered refractory if response on prior therapy was progressive disease OR prior therapy duration was < 3 months and patient experienced progression at the end of therapy.|Participants|Count of Participants|19|19.0||||||
4187633|NCT00782275|4009055|B1|VEGF Refractory-No||Primary VEGF Refractory Status|Primary VEGF refractory status was based on the prior therapy form; patients were considered refractory if response on prior therapy was progressive disease OR prior therapy duration was < 3 months and patient experienced progression at the end of therapy.|Participants|Count of Participants|20|20.0||||||
4187634|NCT00782275|4009055|B1|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
4187635|NCT00782275|4009055|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4187636|NCT00782275|4009055|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4187637|NCT00782275|4009055|B1|||Age||years|Median|60|60.0|Full Range|||32.0|80.0|
4187638|NCT00782210|4009061|B4|Tiotropium||Tiotropium (Tio) Use Stratum||Number of participants|Number|147|147.0||||||
4187639|NCT00782210|4009062|B3|Tiotropium||Tiotropium (Tio) Use Stratum||Number of participants|Number|51|51.0||||||
4187640|NCT00782210|4009063|B2|Tiotropium||Tiotropium (Tio) Use Stratum||Number of participants|Number|47|47.0||||||
4187641|NCT00782210|4009064|B1|Tiotropium||Tiotropium (Tio) Use Stratum||Number of participants|Number|49|49.0||||||
4187642|NCT00782210|4009061|B4|Non-tiotropium||Tiotropium (Tio) Use Stratum||Number of participants|Number|477|477.0||||||
4187643|NCT00782210|4009062|B3|Non-tiotropium||Tiotropium (Tio) Use Stratum||Number of participants|Number|156|156.0||||||
4187644|NCT00782210|4009063|B2|Non-tiotropium||Tiotropium (Tio) Use Stratum||Number of participants|Number|161|161.0||||||
4187645|NCT00782210|4009064|B1|Non-tiotropium||Tiotropium (Tio) Use Stratum||Number of participants|Number|160|160.0||||||
4187646|NCT00782210|4009061|B4||Male|Sex: Female, Male||Participants|Count of Participants|457|457.0||||||
4187647|NCT00782210|4009062|B3||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4187648|NCT00782210|4009063|B2||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4187649|NCT00782210|4009064|B1||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4187650|NCT00782210|4009061|B4||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4187651|NCT00782210|4009062|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4187652|NCT00782210|4009063|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4187653|NCT00782210|4009064|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4187654|NCT00782210|4009061|B4|||Age||years|Mean|64.9|64.9|Standard Deviation|8.5|8.5|||
4187655|NCT00782210|4009062|B3|||Age||years|Mean|65.0|65.0|Standard Deviation|8.2|8.2|||
4187656|NCT00782210|4009063|B2|||Age||years|Mean|64.0|64.0|Standard Deviation|8.6|8.6|||
4187657|NCT00782210|4009064|B1|||Age||years|Mean|65.8|65.8|Standard Deviation|8.5|8.5|||
4187658|NCT00782184|4009257|B3||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4187659|NCT00782184|4009258|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4187660|NCT00782184|4009259|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4187661|NCT00782184|4009257|B3||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4187662|NCT00782184|4009258|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4187663|NCT00782184|4009259|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4187664|NCT00782184|4009257|B3|||Age||years|Mean|59.3|59.3|Standard Deviation|9.2|9.2|||
4187665|NCT00782184|4009258|B2|||Age||years|Mean|59.7|59.7|Standard Deviation|8.4|8.4|||
4187666|NCT00782184|4009259|B1|||Age||years|Mean|58.9|58.9|Standard Deviation|10.0|10.0|||
4187667|NCT00782171|4009295|B3|||Number of implants placed||implants|Number|383|383.0||||||
4187668|NCT00782171|4009296|B2|||Number of implants placed||implants|Number|186|186.0||||||
4187669|NCT00782171|4009297|B1|||Number of implants placed||implants|Number|197|197.0||||||
4187670|NCT00782171|4009295|B3|patients with implants in both jaws||implant distribution maxilla, mandible||participants|Number|31|31.0||||||
4187671|NCT00782171|4009296|B2|patients with implants in both jaws||implant distribution maxilla, mandible||participants|Number|12|12.0||||||
4187672|NCT00782171|4009297|B1|patients with implants in both jaws||implant distribution maxilla, mandible||participants|Number|19|19.0||||||
4187673|NCT00782171|4009295|B3|patients with implants in the mandible||implant distribution maxilla, mandible||participants|Number|151|151.0||||||
4187674|NCT00782171|4009296|B2|patients with implants in the mandible||implant distribution maxilla, mandible||participants|Number|79|79.0||||||
4187675|NCT00782171|4009297|B1|patients with implants in the mandible||implant distribution maxilla, mandible||participants|Number|72|72.0||||||
4187676|NCT00782171|4009295|B3|patients with implants in the maxilla||implant distribution maxilla, mandible||participants|Number|84|84.0||||||
4187677|NCT00782171|4009296|B2|patients with implants in the maxilla||implant distribution maxilla, mandible||participants|Number|37|37.0||||||
4187678|NCT00782171|4009297|B1|patients with implants in the maxilla||implant distribution maxilla, mandible||participants|Number|47|47.0||||||
4187679|NCT00782171|4009295|B3||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4187680|NCT00782171|4009296|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4187681|NCT00782171|4009297|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4187682|NCT00782171|4009295|B3||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4187683|NCT00782171|4009296|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4187684|NCT00782171|4009297|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4187685|NCT00782171|4009295|B3|||Age||years|Mean|46.3|46.3|Standard Deviation|12.8|12.8|||
4187686|NCT00782171|4009296|B2|||Age||years|Mean|46.6|46.6|Standard Deviation|12.4|12.4|||
4187687|NCT00782171|4009297|B1|||Age||years|Mean|46.1|46.1|Standard Deviation|13.3|13.3|||
4187688|NCT00782067|4009330|B1|PEP (n=89) - Other/Missing||Race (PEP)||Participants|Number|2|2.0||||||
4187689|NCT00782067|4009330|B1|PEP (n=89) - White||Race (PEP)||Participants|Number|86|86.0||||||
4187690|NCT00782067|4009330|B1|PEP (n=89) - Black||Race (PEP)||Participants|Number|1|1.0||||||
4187691|NCT00782067|4009330|B1|PEP (n=89) - Male||Sex: Female, Male (PEP)||Participants|Number|57|57.0||||||
4187692|NCT00782067|4009330|B1|PEP (n=89) - Female||Sex: Female, Male (PEP)||Participants|Number|32|32.0||||||
4187693|NCT00782067|4009330|B1|||Age Continuous (PEP)||Years|Mean|63.0|63.0|Standard Deviation|11.59|11.59|||
4187694|NCT00782067|4009330|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4187695|NCT00782067|4009330|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187696|NCT00782067|4009330|B1||White|Race (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
4187697|NCT00782067|4009330|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4187698|NCT00782067|4009330|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187699|NCT00782067|4009330|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187700|NCT00782067|4009330|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187701|NCT00782067|4009330|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4187702|NCT00782067|4009330|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4187703|NCT00782067|4009330|B1|||Age||Years|Mean|61.8|61.8|Standard Deviation|11.76|11.76|||
4187704|NCT00781963|4009340|B4||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4187705|NCT00781963|4009341|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4187706|NCT00781963|4009342|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4187707|NCT00781963|4009343|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4187708|NCT00781963|4009340|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4187709|NCT00781963|4009341|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4187710|NCT00781963|4009342|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4187711|NCT00781963|4009343|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4187712|NCT00781963|4009340|B4|||Age||years|Mean|72.2|72.2|Standard Deviation|7.7|7.7|||
4187713|NCT00781963|4009341|B3|||Age||years|Mean|72.4|72.4|Standard Deviation|7.3|7.3|||
4187714|NCT00781963|4009342|B2|||Age||years|Mean|72.9|72.9|Standard Deviation|8.3|8.3|||
4187715|NCT00781963|4009343|B1|||Age||years|Mean|71.2|71.2|Standard Deviation|7.4|7.4|||
4187716|NCT00781950|4009353|B3|Canada||Region of Enrollment||participants|Number|110|110.0||||||
4187717|NCT00781950|4009354|B2|Canada||Region of Enrollment||participants|Number|58|58.0||||||
4187718|NCT00781950|4009355|B1|Canada||Region of Enrollment||participants|Number|52|52.0||||||
4187719|NCT00781950|4009353|B3||Male|Gender||Participants|Count of Participants|81|81.0||||||
4187720|NCT00781950|4009354|B2||Male|Gender||Participants|Count of Participants|43|43.0||||||
4187721|NCT00781950|4009355|B1||Male|Gender||Participants|Count of Participants|38|38.0||||||
4187722|NCT00781950|4009353|B3||Female|Gender||Participants|Count of Participants|29|29.0||||||
4187723|NCT00781950|4009354|B2||Female|Gender||Participants|Count of Participants|15|15.0||||||
4187724|NCT00781950|4009355|B1||Female|Gender||Participants|Count of Participants|14|14.0||||||
4187725|NCT00781950|4009353|B3|||Age||years|Mean|67.3|67.3|Standard Deviation|8.5|8.5|||
4187726|NCT00781950|4009354|B2|||Age||years|Mean|67.4|67.4|Standard Deviation|8.06|8.06|||
4187727|NCT00781950|4009355|B1|||Age||years|Mean|65.3|65.3|Standard Deviation|9.4|9.4|||
4187728|NCT00781937|4009364|B3|||Body Mass Index (BMI) at randomisation||kg/m^2|Mean|35.6|35.6|Standard Deviation|5.9|5.9|||
4187729|NCT00781937|4009365|B2|||Body Mass Index (BMI) at randomisation||kg/m^2|Mean|35.2|35.2|Standard Deviation|5.9|5.9|||
4187730|NCT00781937|4009366|B1|||Body Mass Index (BMI) at randomisation||kg/m^2|Mean|36.0|36.0|Standard Deviation|5.9|5.9|||
4187731|NCT00781937|4009364|B3|Greater than or equal to 40||Body Mass Index (BMI) group (kg/m^2) at screening||participants|Number|137|137.0||||||
4187732|NCT00781937|4009365|B2|Greater than or equal to 40||Body Mass Index (BMI) group (kg/m^2) at screening||participants|Number|66|66.0||||||
4187733|NCT00781937|4009366|B1|Greater than or equal to 40||Body Mass Index (BMI) group (kg/m^2) at screening||participants|Number|71|71.0||||||
4187734|NCT00781937|4009364|B3|35-40||Body Mass Index (BMI) group (kg/m^2) at screening||participants|Number|127|127.0||||||
4187735|NCT00781937|4009365|B2|35-40||Body Mass Index (BMI) group (kg/m^2) at screening||participants|Number|58|58.0||||||
4187736|NCT00781937|4009366|B1|35-40||Body Mass Index (BMI) group (kg/m^2) at screening||participants|Number|69|69.0||||||
4187737|NCT00781937|4009364|B3|30-35||Body Mass Index (BMI) group (kg/m^2) at screening||participants|Number|149|149.0||||||
4187738|NCT00781937|4009365|B2|30-35||Body Mass Index (BMI) group (kg/m^2) at screening||participants|Number|80|80.0||||||
4187739|NCT00781937|4009366|B1|30-35||Body Mass Index (BMI) group (kg/m^2) at screening||participants|Number|69|69.0||||||
4187740|NCT00781937|4009364|B3|27-30||Body Mass Index (BMI) group (kg/m^2) at screening||participants|Number|9|9.0||||||
4187741|NCT00781937|4009365|B2|27-30||Body Mass Index (BMI) group (kg/m^2) at screening||participants|Number|6|6.0||||||
4187742|NCT00781937|4009366|B1|27-30||Body Mass Index (BMI) group (kg/m^2) at screening||participants|Number|3|3.0||||||
4187743|NCT00781937|4009364|B3|||Body Mass Index (BMI) at screening||kg/m^2|Mean|37.9|37.9|Standard Deviation|6.2|6.2|||
4187744|NCT00781937|4009365|B2|||Body Mass Index (BMI) at screening||kg/m^2|Mean|37.5|37.5|Standard Deviation|6.2|6.2|||
4187745|NCT00781937|4009366|B1|||Body Mass Index (BMI) at screening||kg/m^2|Mean|38.2|38.2|Standard Deviation|6.2|6.2|||
4187746|NCT00781937|4009364|B3|||Weight at randomisation||kg|Mean|99.6|99.6|Standard Deviation|21.0|21.0|||
4187747|NCT00781937|4009365|B2|||Weight at randomisation||kg|Mean|98.7|98.7|Standard Deviation|21.2|21.2|||
4187748|NCT00781937|4009366|B1|||Weight at randomisation||kg|Mean|100.4|100.4|Standard Deviation|20.8|20.8|||
4187749|NCT00781937|4009364|B3|||Weight at screening||kg|Mean|105.9|105.9|Standard Deviation|22.1|22.1|||
4187750|NCT00781937|4009365|B2|||Weight at screening||kg|Mean|105.0|105.0|Standard Deviation|22.4|22.4|||
4187751|NCT00781937|4009366|B1|||Weight at screening||kg|Mean|106.7|106.7|Standard Deviation|21.8|21.8|||
4187752|NCT00781937|4009364|B3|||Height||meters|Mean|1.67|1.67|Standard Deviation|0.09|0.09|||
4187753|NCT00781937|4009365|B2|||Height||meters|Mean|1.67|1.67|Standard Deviation|0.09|0.09|||
4187754|NCT00781937|4009366|B1|||Height||meters|Mean|1.67|1.67|Standard Deviation|0.09|0.09|||
4187755|NCT00781937|4009364|B3|No||Smoking||participants|Number|380|380.0||||||
4187756|NCT00781937|4009365|B2|No||Smoking||participants|Number|188|188.0||||||
4187757|NCT00781937|4009366|B1|No||Smoking||participants|Number|192|192.0||||||
4187758|NCT00781937|4009364|B3|Yes||Smoking||participants|Number|42|42.0||||||
4187759|NCT00781937|4009365|B2|Yes||Smoking||participants|Number|22|22.0||||||
4187760|NCT00781937|4009366|B1|Yes||Smoking||participants|Number|20|20.0||||||
4187761|NCT00781937|4009364|B3|Absent and BMI >=30 kg/m^2||Co-morbidity status and Body Mass Index (BMI)|Presence or absence of treated or untreated hypertension or dyslipidaemia|participants|Number|232|232.0||||||
4187762|NCT00781937|4009365|B2|Absent and BMI >=30 kg/m^2||Co-morbidity status and Body Mass Index (BMI)|Presence or absence of treated or untreated hypertension or dyslipidaemia|participants|Number|114|114.0||||||
4187763|NCT00781937|4009366|B1|Absent and BMI >=30 kg/m^2||Co-morbidity status and Body Mass Index (BMI)|Presence or absence of treated or untreated hypertension or dyslipidaemia|participants|Number|118|118.0||||||
4187764|NCT00781937|4009364|B3|Present and BMI >=30 kg/m^2||Co-morbidity status and Body Mass Index (BMI)|Presence or absence of treated or untreated hypertension or dyslipidaemia|participants|Number|181|181.0||||||
4187765|NCT00781937|4009365|B2|Present and BMI >=30 kg/m^2||Co-morbidity status and Body Mass Index (BMI)|Presence or absence of treated or untreated hypertension or dyslipidaemia|participants|Number|90|90.0||||||
4187766|NCT00781937|4009366|B1|Present and BMI >=30 kg/m^2||Co-morbidity status and Body Mass Index (BMI)|Presence or absence of treated or untreated hypertension or dyslipidaemia|participants|Number|91|91.0||||||
4187767|NCT00781937|4009364|B3|Present and BMI (27-30) kg/m^2||Co-morbidity status and Body Mass Index (BMI)|Presence or absence of treated or untreated hypertension or dyslipidaemia|participants|Number|9|9.0||||||
4187768|NCT00781937|4009365|B2|Present and BMI (27-30) kg/m^2||Co-morbidity status and Body Mass Index (BMI)|Presence or absence of treated or untreated hypertension or dyslipidaemia|participants|Number|6|6.0||||||
4187769|NCT00781937|4009366|B1|Present and BMI (27-30) kg/m^2||Co-morbidity status and Body Mass Index (BMI)|Presence or absence of treated or untreated hypertension or dyslipidaemia|participants|Number|3|3.0||||||
4187770|NCT00781937|4009364|B3|Absent||Co-morbidity status|Presence or absence of treated or untreated hypertension or dyslipidaemia|participants|Number|232|232.0||||||
4187771|NCT00781937|4009365|B2|Absent||Co-morbidity status|Presence or absence of treated or untreated hypertension or dyslipidaemia|participants|Number|114|114.0||||||
4187772|NCT00781937|4009366|B1|Absent||Co-morbidity status|Presence or absence of treated or untreated hypertension or dyslipidaemia|participants|Number|118|118.0||||||
4187773|NCT00781937|4009364|B3|Present||Co-morbidity status|Presence or absence of treated or untreated hypertension or dyslipidaemia|participants|Number|190|190.0||||||
4187774|NCT00781937|4009365|B2|Present||Co-morbidity status|Presence or absence of treated or untreated hypertension or dyslipidaemia|participants|Number|96|96.0||||||
4187775|NCT00781937|4009366|B1|Present||Co-morbidity status|Presence or absence of treated or untreated hypertension or dyslipidaemia|participants|Number|94|94.0||||||
4187776|NCT00781937|4009364|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4187777|NCT00781937|4009365|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4187778|NCT00781937|4009366|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4187779|NCT00781937|4009364|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187780|NCT00781937|4009365|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187781|NCT00781937|4009366|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187782|NCT00781937|4009364|B3||White|Race (NIH/OMB)||Participants|Count of Participants|355|355.0||||||
4187783|NCT00781937|4009365|B2||White|Race (NIH/OMB)||Participants|Count of Participants|185|185.0||||||
4187784|NCT00781937|4009366|B1||White|Race (NIH/OMB)||Participants|Count of Participants|170|170.0||||||
4187785|NCT00781937|4009364|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4187786|NCT00781937|4009365|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4187787|NCT00781937|4009366|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4187788|NCT00781937|4009364|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4187789|NCT00781937|4009365|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187790|NCT00781937|4009366|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4187791|NCT00781937|4009364|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4187792|NCT00781937|4009365|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187793|NCT00781937|4009366|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4187794|NCT00781937|4009364|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187795|NCT00781937|4009365|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187796|NCT00781937|4009366|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187797|NCT00781937|4009364|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187798|NCT00781937|4009365|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187799|NCT00781937|4009366|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187800|NCT00781937|4009364|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|394|394.0||||||
4187801|NCT00781937|4009365|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|199|199.0||||||
4187802|NCT00781937|4009366|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|195|195.0||||||
4187803|NCT00781937|4009364|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4187804|NCT00781937|4009365|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4187805|NCT00781937|4009366|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4187806|NCT00781937|4009364|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4187807|NCT00781937|4009365|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4187808|NCT00781937|4009366|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4187809|NCT00781937|4009364|B3||Female|Sex: Female, Male||Participants|Count of Participants|343|343.0||||||
4187810|NCT00781937|4009365|B2||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4187811|NCT00781937|4009366|B1||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4187812|NCT00781937|4009364|B3|||Age||years|Mean|46.2|46.2|Standard Deviation|11.5|11.5|||
4187813|NCT00781937|4009365|B2|||Age||years|Mean|46.5|46.5|Standard Deviation|11.0|11.0|||
4187814|NCT00781937|4009366|B1|||Age||years|Mean|45.9|45.9|Standard Deviation|11.9|11.9|||
4187815|NCT00781911|4009423|B3|United States||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
4187816|NCT00781911|4009424|B2|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4187817|NCT00781911|4009425|B1|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
4187818|NCT00781911|4009423|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187819|NCT00781911|4009424|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187820|NCT00781911|4009425|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187821|NCT00781911|4009423|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187822|NCT00781911|4009424|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187823|NCT00781911|4009425|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187824|NCT00781911|4009423|B3||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4187825|NCT00781911|4009424|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4187826|NCT00781911|4009425|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4187827|NCT00781911|4009423|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4187828|NCT00781911|4009424|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187829|NCT00781911|4009425|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4187830|NCT00781911|4009423|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187831|NCT00781911|4009424|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187832|NCT00781911|4009425|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187833|NCT00781911|4009423|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187834|NCT00781911|4009424|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187835|NCT00781911|4009425|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187836|NCT00781911|4009423|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187837|NCT00781911|4009424|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187838|NCT00781911|4009425|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187839|NCT00781911|4009423|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187840|NCT00781911|4009424|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187841|NCT00781911|4009425|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4187842|NCT00781911|4009423|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4187843|NCT00781911|4009424|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4187844|NCT00781911|4009425|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4187845|NCT00781911|4009423|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4187846|NCT00781911|4009424|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4187847|NCT00781911|4009425|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4187848|NCT00781911|4009423|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4187849|NCT00781911|4009424|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4187850|NCT00781911|4009425|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4187851|NCT00781911|4009423|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4187852|NCT00781911|4009424|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4187853|NCT00781911|4009425|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4187854|NCT00781911|4009423|B3|||Age||years|Mean|60.6|60.6|Standard Deviation|9.60|9.6|||
4187855|NCT00781911|4009424|B2|||Age||years|Mean|61.3|61.3|Standard Deviation|9.85|9.85|||
4187856|NCT00781911|4009425|B1|||Age||years|Mean|60.3|60.3|Standard Deviation|9.65|9.65|||
4187857|NCT00781898|4009452|B3|United States||Region of Enrollment||Participants|Count of Participants|308|308.0||||||
4187858|NCT00781898|4009453|B2|United States||Region of Enrollment||Participants|Count of Participants|155|155.0||||||
4187859|NCT00781898|4009454|B1|United States||Region of Enrollment||Participants|Count of Participants|153|153.0||||||
4187860|NCT00781898|4009452|B3||Male|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
4187861|NCT00781898|4009453|B2||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4187862|NCT00781898|4009454|B1||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4187863|NCT00781898|4009452|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4187864|NCT00781898|4009453|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4187865|NCT00781898|4009454|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4187866|NCT00781898|4009452|B3|||Age||years|Mean|43.5|43.5|Standard Deviation|9.3|9.3|||
4187867|NCT00781898|4009453|B2|||Age||years|Mean|43|43.0|Standard Deviation|9.4|9.4|||
4187868|NCT00781898|4009454|B1|||Age||years|Mean|44|44.0|Standard Deviation|9.2|9.2|||
4187869|NCT00781898|4009452|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4187870|NCT00781898|4009453|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4187871|NCT00781898|4009454|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4187872|NCT00781898|4009452|B3||Between 18 and 65 years|Age||Participants|Count of Participants|308|308.0||||||
4187873|NCT00781898|4009453|B2||Between 18 and 65 years|Age||Participants|Count of Participants|155|155.0||||||
4187874|NCT00781898|4009454|B1||Between 18 and 65 years|Age||Participants|Count of Participants|153|153.0||||||
4187875|NCT00781898|4009452|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4187876|NCT00781898|4009453|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4187877|NCT00781898|4009454|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4187878|NCT00781859|4009461|B3||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4187879|NCT00781859|4009462|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4187880|NCT00781859|4009463|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4187881|NCT00781859|4009461|B3||Female|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4187882|NCT00781859|4009462|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4187883|NCT00781859|4009463|B1||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4187884|NCT00781859|4009461|B3|||Age||years|Mean|71.3|71.3|Standard Deviation|10.17|10.17|||
4187885|NCT00781859|4009462|B2|||Age||years|Mean|71.1|71.1|Standard Deviation|10.04|10.04|||
4187886|NCT00781859|4009463|B1|||Age||years|Mean|71.5|71.5|Standard Deviation|10.25|10.25|||
4187887|NCT00781768|4009472|B3||Unknown|History of prior nausea or vomiting with radiation therapy||Participants|Count of Participants|11|11.0||||||
4187888|NCT00781768|4009473|B2||Unknown|History of prior nausea or vomiting with radiation therapy||Participants|Count of Participants|7|7.0||||||
4187889|NCT00781768|4009474|B1||Unknown|History of prior nausea or vomiting with radiation therapy||Participants|Count of Participants|4|4.0||||||
4187890|NCT00781768|4009472|B3||No|History of prior nausea or vomiting with radiation therapy||Participants|Count of Participants|85|85.0||||||
4187891|NCT00781768|4009473|B2||No|History of prior nausea or vomiting with radiation therapy||Participants|Count of Participants|42|42.0||||||
4187892|NCT00781768|4009474|B1||No|History of prior nausea or vomiting with radiation therapy||Participants|Count of Participants|43|43.0||||||
4187893|NCT00781768|4009472|B3||Yes|History of prior nausea or vomiting with radiation therapy||Participants|Count of Participants|83|83.0||||||
4187894|NCT00781768|4009473|B2||Yes|History of prior nausea or vomiting with radiation therapy||Participants|Count of Participants|41|41.0||||||
4187895|NCT00781768|4009474|B1||Yes|History of prior nausea or vomiting with radiation therapy||Participants|Count of Participants|42|42.0||||||
4187896|NCT00781768|4009472|B3||Unknown|History of prior nausea or vomiting with chemotherapy||Participants|Count of Participants|10|10.0||||||
4187897|NCT00781768|4009473|B2||Unknown|History of prior nausea or vomiting with chemotherapy||Participants|Count of Participants|6|6.0||||||
4187898|NCT00781768|4009474|B1||Unknown|History of prior nausea or vomiting with chemotherapy||Participants|Count of Participants|4|4.0||||||
4187899|NCT00781768|4009472|B3||No|History of prior nausea or vomiting with chemotherapy||Participants|Count of Participants|55|55.0||||||
4187900|NCT00781768|4009473|B2||No|History of prior nausea or vomiting with chemotherapy||Participants|Count of Participants|25|25.0||||||
4187901|NCT00781768|4009474|B1||No|History of prior nausea or vomiting with chemotherapy||Participants|Count of Participants|30|30.0||||||
4187902|NCT00781768|4009472|B3||Yes|History of prior nausea or vomiting with chemotherapy||Participants|Count of Participants|114|114.0||||||
4187903|NCT00781768|4009473|B2||Yes|History of prior nausea or vomiting with chemotherapy||Participants|Count of Participants|59|59.0||||||
4187904|NCT00781768|4009474|B1||Yes|History of prior nausea or vomiting with chemotherapy||Participants|Count of Participants|55|55.0||||||
4187905|NCT00781768|4009472|B3||BCV|Preparative Regimen||Participants|Count of Participants|16|16.0||||||
4187906|NCT00781768|4009473|B2||BCV|Preparative Regimen||Participants|Count of Participants|5|5.0||||||
4187907|NCT00781768|4009474|B1||BCV|Preparative Regimen||Participants|Count of Participants|11|11.0||||||
4187908|NCT00781768|4009472|B3||TBI/Etoposide/Cy|Preparative Regimen||Participants|Count of Participants|36|36.0||||||
4187909|NCT00781768|4009473|B2||TBI/Etoposide/Cy|Preparative Regimen||Participants|Count of Participants|19|19.0||||||
4187910|NCT00781768|4009474|B1||TBI/Etoposide/Cy|Preparative Regimen||Participants|Count of Participants|17|17.0||||||
4187911|NCT00781768|4009472|B3||Prescribed orally Bu/Cy|Preparative Regimen||Participants|Count of Participants|34|34.0||||||
4187912|NCT00781768|4009473|B2||Prescribed orally Bu/Cy|Preparative Regimen||Participants|Count of Participants|13|13.0||||||
4187913|NCT00781768|4009474|B1||Prescribed orally Bu/Cy|Preparative Regimen||Participants|Count of Participants|21|21.0||||||
4187914|NCT00781768|4009472|B3||I.V. Busulfan/Cy|Preparative Regimen||Participants|Count of Participants|14|14.0||||||
4187915|NCT00781768|4009473|B2||I.V. Busulfan/Cy|Preparative Regimen||Participants|Count of Participants|7|7.0||||||
4187916|NCT00781768|4009474|B1||I.V. Busulfan/Cy|Preparative Regimen||Participants|Count of Participants|7|7.0||||||
4187917|NCT00781768|4009472|B3||Total body irradiation/Cyclophosphamide|Preparative Regimen||Participants|Count of Participants|79|79.0||||||
4187918|NCT00781768|4009473|B2||Total body irradiation/Cyclophosphamide|Preparative Regimen||Participants|Count of Participants|46|46.0||||||
4187919|NCT00781768|4009474|B1||Total body irradiation/Cyclophosphamide|Preparative Regimen||Participants|Count of Participants|33|33.0||||||
4187920|NCT00781768|4009472|B3||Cord as in umbilical cord|Graft Type||Participants|Count of Participants|13|13.0||||||
4187921|NCT00781768|4009473|B2||Cord as in umbilical cord|Graft Type||Participants|Count of Participants|6|6.0||||||
4187922|NCT00781768|4009474|B1||Cord as in umbilical cord|Graft Type||Participants|Count of Participants|7|7.0||||||
4187923|NCT00781768|4009472|B3||Matched unrelated donor BMT|Graft Type||Participants|Count of Participants|14|14.0||||||
4187924|NCT00781768|4009473|B2||Matched unrelated donor BMT|Graft Type||Participants|Count of Participants|8|8.0||||||
4187925|NCT00781768|4009474|B1||Matched unrelated donor BMT|Graft Type||Participants|Count of Participants|6|6.0||||||
4187926|NCT00781768|4009472|B3||Matched unrelated donor PBPCT|Graft Type||Participants|Count of Participants|20|20.0||||||
4187927|NCT00781768|4009473|B2||Matched unrelated donor PBPCT|Graft Type||Participants|Count of Participants|12|12.0||||||
4187928|NCT00781768|4009474|B1||Matched unrelated donor PBPCT|Graft Type||Participants|Count of Participants|8|8.0||||||
4187929|NCT00781768|4009472|B3||Related autologous bone marrow transplant|Graft Type||Participants|Count of Participants|2|2.0||||||
4187930|NCT00781768|4009473|B2||Related autologous bone marrow transplant|Graft Type||Participants|Count of Participants|1|1.0||||||
4187931|NCT00781768|4009474|B1||Related autologous bone marrow transplant|Graft Type||Participants|Count of Participants|1|1.0||||||
4187932|NCT00781768|4009472|B3||Related Allo-PBPCT|Graft Type||Participants|Count of Participants|41|41.0||||||
4187933|NCT00781768|4009473|B2||Related Allo-PBPCT|Graft Type||Participants|Count of Participants|22|22.0||||||
4187934|NCT00781768|4009474|B1||Related Allo-PBPCT|Graft Type||Participants|Count of Participants|19|19.0||||||
4187935|NCT00781768|4009472|B3||Autologous-peripheral blood stem cell transplant|Graft Type||Participants|Count of Participants|89|89.0||||||
4187936|NCT00781768|4009473|B2||Autologous-peripheral blood stem cell transplant|Graft Type||Participants|Count of Participants|41|41.0||||||
4187937|NCT00781768|4009474|B1||Autologous-peripheral blood stem cell transplant|Graft Type||Participants|Count of Participants|48|48.0||||||
4187938|NCT00781768|4009472|B3||Outpatient|Setting||Participants|Count of Participants|36|36.0||||||
4187939|NCT00781768|4009473|B2||Outpatient|Setting||Participants|Count of Participants|16|16.0||||||
4187940|NCT00781768|4009474|B1||Outpatient|Setting||Participants|Count of Participants|20|20.0||||||
4187941|NCT00781768|4009472|B3||Inpatient|Setting||Participants|Count of Participants|143|143.0||||||
4187942|NCT00781768|4009473|B2||Inpatient|Setting||Participants|Count of Participants|74|74.0||||||
4187943|NCT00781768|4009474|B1||Inpatient|Setting||Participants|Count of Participants|69|69.0||||||
4187944|NCT00781768|4009472|B3||Other|Diagnosis||Participants|Count of Participants|11|11.0||||||
4187945|NCT00781768|4009473|B2||Other|Diagnosis||Participants|Count of Participants|7|7.0||||||
4187946|NCT00781768|4009474|B1||Other|Diagnosis||Participants|Count of Participants|4|4.0||||||
4187947|NCT00781768|4009472|B3||Chronic Myelogenous Leukemia|Diagnosis||Participants|Count of Participants|6|6.0||||||
4187948|NCT00781768|4009473|B2||Chronic Myelogenous Leukemia|Diagnosis||Participants|Count of Participants|2|2.0||||||
4187949|NCT00781768|4009474|B1||Chronic Myelogenous Leukemia|Diagnosis||Participants|Count of Participants|4|4.0||||||
4187950|NCT00781768|4009472|B3||Hodgkin's lymphoma|Diagnosis||Participants|Count of Participants|12|12.0||||||
4187951|NCT00781768|4009473|B2||Hodgkin's lymphoma|Diagnosis||Participants|Count of Participants|5|5.0||||||
4187952|NCT00781768|4009474|B1||Hodgkin's lymphoma|Diagnosis||Participants|Count of Participants|7|7.0||||||
4187953|NCT00781768|4009472|B3||Acut Lymphoblastic Lymphoma|Diagnosis||Participants|Count of Participants|13|13.0||||||
4187954|NCT00781768|4009473|B2||Acut Lymphoblastic Lymphoma|Diagnosis||Participants|Count of Participants|10|10.0||||||
4187955|NCT00781768|4009474|B1||Acut Lymphoblastic Lymphoma|Diagnosis||Participants|Count of Participants|3|3.0||||||
4187956|NCT00781768|4009472|B3||Multiple Myeloma|Diagnosis||Participants|Count of Participants|34|34.0||||||
4187957|NCT00781768|4009473|B2||Multiple Myeloma|Diagnosis||Participants|Count of Participants|13|13.0||||||
4187958|NCT00781768|4009474|B1||Multiple Myeloma|Diagnosis||Participants|Count of Participants|21|21.0||||||
4187959|NCT00781768|4009472|B3||Acute Myelogenous Leukemia|Diagnosis||Participants|Count of Participants|46|46.0||||||
4187960|NCT00781768|4009473|B2||Acute Myelogenous Leukemia|Diagnosis||Participants|Count of Participants|24|24.0||||||
4187961|NCT00781768|4009474|B1||Acute Myelogenous Leukemia|Diagnosis||Participants|Count of Participants|22|22.0||||||
4187962|NCT00781768|4009472|B3||Non-Hodgkin lymphoma|Diagnosis||Participants|Count of Participants|57|57.0||||||
4187963|NCT00781768|4009473|B2||Non-Hodgkin lymphoma|Diagnosis||Participants|Count of Participants|29|29.0||||||
4187964|NCT00781768|4009474|B1||Non-Hodgkin lymphoma|Diagnosis||Participants|Count of Participants|28|28.0||||||
4187965|NCT00781768|4009472|B3||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4187966|NCT00781768|4009473|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4187967|NCT00781768|4009474|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4187968|NCT00781768|4009472|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4187969|NCT00781768|4009473|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4187970|NCT00781768|4009474|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4187971|NCT00781768|4009472|B3|||Age||years|Median|50|50.0|Full Range|||19.0|79.0|
4187972|NCT00781768|4009473|B2|||Age||years|Median|50|50.0|Full Range|||20.0|75.0|
4187973|NCT00781768|4009474|B1|||Age||years|Median|51|51.0|Full Range|||19.0|79.0|
4187974|NCT00781599|4009481|B3|United States||Region of Enrollment||participants|Number|72|72.0||||||
4187975|NCT00781599|4009482|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
4187976|NCT00781599|4009483|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4187977|NCT00781599|4009481|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4187978|NCT00781599|4009482|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4187979|NCT00781599|4009483|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4187980|NCT00781599|4009481|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4187981|NCT00781599|4009482|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4187982|NCT00781599|4009483|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4187983|NCT00781599|4009481|B3|||Age||years|Mean|46.788|46.788|Standard Deviation|11.320|11.32|||
4187984|NCT00781599|4009482|B2|||Age||years|Mean|49.1980|49.198|Standard Deviation|11.222|11.222|||
4187985|NCT00781599|4009483|B1|||Age||years|Mean|44.3786|44.3786|Standard Deviation|11.046|11.046|||
4187986|NCT00781599|4009481|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4187987|NCT00781599|4009482|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4187988|NCT00781599|4009483|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4187989|NCT00781599|4009481|B3||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4187990|NCT00781599|4009482|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4187991|NCT00781599|4009483|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4187992|NCT00781599|4009481|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4187993|NCT00781599|4009482|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4187994|NCT00781599|4009483|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4187995|NCT00781508|4009496|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4187996|NCT00781508|4009497|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4187997|NCT00781508|4009498|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4187998|NCT00781508|4009496|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4187999|NCT00781508|4009497|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4188000|NCT00781508|4009498|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4188001|NCT00781508|4009496|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4188002|NCT00781508|4009497|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4188003|NCT00781508|4009498|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4188004|NCT00781508|4009496|B3|||Age||years|Mean|64|64.0|Standard Deviation|12|12.0|||
4188005|NCT00781508|4009497|B2|||Age||years|Mean|64|64.0|Standard Deviation|12|12.0|||
4188006|NCT00781508|4009498|B1|||Age||years|Mean|64|64.0|Standard Deviation|12|12.0|||
4188007|NCT00781508|4009496|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4188008|NCT00781508|4009497|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4188009|NCT00781508|4009498|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4188010|NCT00781508|4009496|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4188011|NCT00781508|4009497|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4188012|NCT00781508|4009498|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4188013|NCT00781508|4009496|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4188014|NCT00781508|4009497|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4188015|NCT00781508|4009498|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4188016|NCT00781456|4009507|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4188017|NCT00781456|4009508|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4188018|NCT00781456|4009509|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4188019|NCT00781456|4009507|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4188020|NCT00781456|4009508|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4188021|NCT00781456|4009509|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4188022|NCT00781456|4009507|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4188023|NCT00781456|4009508|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4188024|NCT00781456|4009509|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4188025|NCT00781456|4009507|B3|Black||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4188026|NCT00781456|4009508|B2|Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4188027|NCT00781456|4009509|B1|Black||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4188028|NCT00781456|4009507|B3|White||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4188029|NCT00781456|4009508|B2|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4188030|NCT00781456|4009509|B1|White||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4188031|NCT00781456|4009507|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
4188032|NCT00781456|4009508|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
4188033|NCT00781456|4009509|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4188034|NCT00781456|4009507|B3||Female|Gender||Participants|Count of Participants|99|99.0||||||
4188035|NCT00781456|4009508|B2||Female|Gender||Participants|Count of Participants|45|45.0||||||
4188036|NCT00781456|4009509|B1||Female|Gender||Participants|Count of Participants|54|54.0||||||
4188037|NCT00781456|4009507|B3|||Age||years|Mean|27.1|27.1|Standard Deviation|4.32|4.32|||
4188038|NCT00781456|4009508|B2|||Age||years|Mean|27.4|27.4|Standard Deviation|3.83|3.83|||
4188039|NCT00781456|4009509|B1|||Age||years|Mean|26.7|26.7|Standard Deviation|4.70|4.7|||
4188040|NCT00781391|4009530|B4|Sweden||Region of Enrollment||participants|Number|253|253.0||||||
4188041|NCT00781391|4009531|B3|Sweden||Region of Enrollment||participants|Number|86|86.0||||||
4188042|NCT00781391|4009532|B2|Sweden||Region of Enrollment||participants|Number|78|78.0||||||
4188043|NCT00781391|4009533|B1|Sweden||Region of Enrollment||participants|Number|89|89.0||||||
4188044|NCT00781391|4009530|B4|New Zealand||Region of Enrollment||participants|Number|130|130.0||||||
4188045|NCT00781391|4009531|B3|New Zealand||Region of Enrollment||participants|Number|40|40.0||||||
4188046|NCT00781391|4009532|B2|New Zealand||Region of Enrollment||participants|Number|50|50.0||||||
4188047|NCT00781391|4009533|B1|New Zealand||Region of Enrollment||participants|Number|40|40.0||||||
4188048|NCT00781391|4009530|B4|Japan||Region of Enrollment||participants|Number|1010|1010.0||||||
4188049|NCT00781391|4009531|B3|Japan||Region of Enrollment||participants|Number|337|337.0||||||
4188050|NCT00781391|4009532|B2|Japan||Region of Enrollment||participants|Number|336|336.0||||||
4188051|NCT00781391|4009533|B1|Japan||Region of Enrollment||participants|Number|337|337.0||||||
4188052|NCT00781391|4009530|B4|Germany||Region of Enrollment||participants|Number|908|908.0||||||
4188053|NCT00781391|4009531|B3|Germany||Region of Enrollment||participants|Number|307|307.0||||||
4188054|NCT00781391|4009532|B2|Germany||Region of Enrollment||participants|Number|293|293.0||||||
4188055|NCT00781391|4009533|B1|Germany||Region of Enrollment||participants|Number|308|308.0||||||
4188056|NCT00781391|4009530|B4|Norway||Region of Enrollment||participants|Number|34|34.0||||||
4188057|NCT00781391|4009531|B3|Norway||Region of Enrollment||participants|Number|15|15.0||||||
4188058|NCT00781391|4009532|B2|Norway||Region of Enrollment||participants|Number|8|8.0||||||
4188059|NCT00781391|4009533|B1|Norway||Region of Enrollment||participants|Number|11|11.0||||||
4188060|NCT00781391|4009530|B4|Bulgaria||Region of Enrollment||participants|Number|518|518.0||||||
4188061|NCT00781391|4009531|B3|Bulgaria||Region of Enrollment||participants|Number|165|165.0||||||
4188062|NCT00781391|4009532|B2|Bulgaria||Region of Enrollment||participants|Number|174|174.0||||||
4188063|NCT00781391|4009533|B1|Bulgaria||Region of Enrollment||participants|Number|179|179.0||||||
4188064|NCT00781391|4009530|B4|Romania||Region of Enrollment||participants|Number|409|409.0||||||
4188065|NCT00781391|4009531|B3|Romania||Region of Enrollment||participants|Number|124|124.0||||||
4188066|NCT00781391|4009532|B2|Romania||Region of Enrollment||participants|Number|144|144.0||||||
4188067|NCT00781391|4009533|B1|Romania||Region of Enrollment||participants|Number|141|141.0||||||
4188068|NCT00781391|4009530|B4|Croatia||Region of Enrollment||participants|Number|125|125.0||||||
4188069|NCT00781391|4009531|B3|Croatia||Region of Enrollment||participants|Number|39|39.0||||||
4188070|NCT00781391|4009532|B2|Croatia||Region of Enrollment||participants|Number|33|33.0||||||
4188071|NCT00781391|4009533|B1|Croatia||Region of Enrollment||participants|Number|53|53.0||||||
4188072|NCT00781391|4009530|B4|Poland||Region of Enrollment||participants|Number|1273|1273.0||||||
4188073|NCT00781391|4009531|B3|Poland||Region of Enrollment||participants|Number|454|454.0||||||
4188074|NCT00781391|4009532|B2|Poland||Region of Enrollment||participants|Number|424|424.0||||||
4188075|NCT00781391|4009533|B1|Poland||Region of Enrollment||participants|Number|395|395.0||||||
4188076|NCT00781391|4009530|B4|Belgium||Region of Enrollment||participants|Number|149|149.0||||||
4188077|NCT00781391|4009531|B3|Belgium||Region of Enrollment||participants|Number|64|64.0||||||
4188078|NCT00781391|4009532|B2|Belgium||Region of Enrollment||participants|Number|44|44.0||||||
4188079|NCT00781391|4009533|B1|Belgium||Region of Enrollment||participants|Number|41|41.0||||||
4188080|NCT00781391|4009530|B4|Brazil||Region of Enrollment||participants|Number|703|703.0||||||
4188081|NCT00781391|4009531|B3|Brazil||Region of Enrollment||participants|Number|225|225.0||||||
4188082|NCT00781391|4009532|B2|Brazil||Region of Enrollment||participants|Number|242|242.0||||||
4188083|NCT00781391|4009533|B1|Brazil||Region of Enrollment||participants|Number|236|236.0||||||
4188084|NCT00781391|4009530|B4|Argentina||Region of Enrollment||participants|Number|1059|1059.0||||||
4188085|NCT00781391|4009531|B3|Argentina||Region of Enrollment||participants|Number|362|362.0||||||
4188086|NCT00781391|4009532|B2|Argentina||Region of Enrollment||participants|Number|345|345.0||||||
4188087|NCT00781391|4009533|B1|Argentina||Region of Enrollment||participants|Number|352|352.0||||||
4188088|NCT00781391|4009530|B4|Canada||Region of Enrollment||participants|Number|772|772.0||||||
4188089|NCT00781391|4009531|B3|Canada||Region of Enrollment||participants|Number|242|242.0||||||
4188090|NCT00781391|4009532|B2|Canada||Region of Enrollment||participants|Number|271|271.0||||||
4188091|NCT00781391|4009533|B1|Canada||Region of Enrollment||participants|Number|259|259.0||||||
4188092|NCT00781391|4009530|B4|Mexico||Region of Enrollment||participants|Number|190|190.0||||||
4188093|NCT00781391|4009531|B3|Mexico||Region of Enrollment||participants|Number|60|60.0||||||
4188094|NCT00781391|4009532|B2|Mexico||Region of Enrollment||participants|Number|70|70.0||||||
4188095|NCT00781391|4009533|B1|Mexico||Region of Enrollment||participants|Number|60|60.0||||||
4188096|NCT00781391|4009530|B4|Czech Republic||Region of Enrollment||participants|Number|1165|1165.0||||||
4188097|NCT00781391|4009531|B3|Czech Republic||Region of Enrollment||participants|Number|386|386.0||||||
4188098|NCT00781391|4009532|B2|Czech Republic||Region of Enrollment||participants|Number|369|369.0||||||
4188099|NCT00781391|4009533|B1|Czech Republic||Region of Enrollment||participants|Number|410|410.0||||||
4188100|NCT00781391|4009530|B4|Hungary||Region of Enrollment||participants|Number|461|461.0||||||
4188101|NCT00781391|4009531|B3|Hungary||Region of Enrollment||participants|Number|167|167.0||||||
4188102|NCT00781391|4009532|B2|Hungary||Region of Enrollment||participants|Number|143|143.0||||||
4188103|NCT00781391|4009533|B1|Hungary||Region of Enrollment||participants|Number|151|151.0||||||
4188104|NCT00781391|4009530|B4|United Kingdom||Region of Enrollment||participants|Number|398|398.0||||||
4188105|NCT00781391|4009531|B3|United Kingdom||Region of Enrollment||participants|Number|145|145.0||||||
4188106|NCT00781391|4009532|B2|United Kingdom||Region of Enrollment||participants|Number|121|121.0||||||
4188107|NCT00781391|4009533|B1|United Kingdom||Region of Enrollment||participants|Number|132|132.0||||||
4188108|NCT00781391|4009530|B4|Turkey||Region of Enrollment||participants|Number|110|110.0||||||
4188109|NCT00781391|4009531|B3|Turkey||Region of Enrollment||participants|Number|31|31.0||||||
4188110|NCT00781391|4009532|B2|Turkey||Region of Enrollment||participants|Number|39|39.0||||||
4188111|NCT00781391|4009533|B1|Turkey||Region of Enrollment||participants|Number|40|40.0||||||
4188112|NCT00781391|4009530|B4|Guatemala||Region of Enrollment||participants|Number|135|135.0||||||
4188113|NCT00781391|4009531|B3|Guatemala||Region of Enrollment||participants|Number|39|39.0||||||
4188114|NCT00781391|4009532|B2|Guatemala||Region of Enrollment||participants|Number|48|48.0||||||
4188115|NCT00781391|4009533|B1|Guatemala||Region of Enrollment||participants|Number|48|48.0||||||
4188116|NCT00781391|4009530|B4|Finland||Region of Enrollment||participants|Number|42|42.0||||||
4188117|NCT00781391|4009531|B3|Finland||Region of Enrollment||participants|Number|15|15.0||||||
4188118|NCT00781391|4009532|B2|Finland||Region of Enrollment||participants|Number|18|18.0||||||
4188119|NCT00781391|4009533|B1|Finland||Region of Enrollment||participants|Number|9|9.0||||||
4188120|NCT00781391|4009530|B4|Korea, Republic of||Region of Enrollment||participants|Number|226|226.0||||||
4188121|NCT00781391|4009531|B3|Korea, Republic of||Region of Enrollment||participants|Number|78|78.0||||||
4188122|NCT00781391|4009532|B2|Korea, Republic of||Region of Enrollment||participants|Number|84|84.0||||||
4188123|NCT00781391|4009533|B1|Korea, Republic of||Region of Enrollment||participants|Number|64|64.0||||||
4188124|NCT00781391|4009530|B4|China||Region of Enrollment||participants|Number|465|465.0||||||
4188125|NCT00781391|4009531|B3|China||Region of Enrollment||participants|Number|152|152.0||||||
4188126|NCT00781391|4009532|B2|China||Region of Enrollment||participants|Number|150|150.0||||||
4188127|NCT00781391|4009533|B1|China||Region of Enrollment||participants|Number|163|163.0||||||
4188128|NCT00781391|4009530|B4|Netherlands||Region of Enrollment||participants|Number|153|153.0||||||
4188129|NCT00781391|4009531|B3|Netherlands||Region of Enrollment||participants|Number|40|40.0||||||
4188130|NCT00781391|4009532|B2|Netherlands||Region of Enrollment||participants|Number|49|49.0||||||
4188131|NCT00781391|4009533|B1|Netherlands||Region of Enrollment||participants|Number|64|64.0||||||
4188132|NCT00781391|4009530|B4|South Africa||Region of Enrollment||participants|Number|279|279.0||||||
4188133|NCT00781391|4009531|B3|South Africa||Region of Enrollment||participants|Number|90|90.0||||||
4188134|NCT00781391|4009532|B2|South Africa||Region of Enrollment||participants|Number|92|92.0||||||
4188135|NCT00781391|4009533|B1|South Africa||Region of Enrollment||participants|Number|97|97.0||||||
4188136|NCT00781391|4009530|B4|Australia||Region of Enrollment||participants|Number|102|102.0||||||
4188137|NCT00781391|4009531|B3|Australia||Region of Enrollment||participants|Number|32|32.0||||||
4188138|NCT00781391|4009532|B2|Australia||Region of Enrollment||participants|Number|40|40.0||||||
4188139|NCT00781391|4009533|B1|Australia||Region of Enrollment||participants|Number|30|30.0||||||
4188140|NCT00781391|4009530|B4|Denmark||Region of Enrollment||participants|Number|218|218.0||||||
4188141|NCT00781391|4009531|B3|Denmark||Region of Enrollment||participants|Number|70|70.0||||||
4188142|NCT00781391|4009532|B2|Denmark||Region of Enrollment||participants|Number|80|80.0||||||
4188143|NCT00781391|4009533|B1|Denmark||Region of Enrollment||participants|Number|68|68.0||||||
4188144|NCT00781391|4009530|B4|Peru||Region of Enrollment||participants|Number|170|170.0||||||
4188145|NCT00781391|4009531|B3|Peru||Region of Enrollment||participants|Number|60|60.0||||||
4188146|NCT00781391|4009532|B2|Peru||Region of Enrollment||participants|Number|46|46.0||||||
4188147|NCT00781391|4009533|B1|Peru||Region of Enrollment||participants|Number|64|64.0||||||
4188148|NCT00781391|4009530|B4|France||Region of Enrollment||participants|Number|110|110.0||||||
4188149|NCT00781391|4009531|B3|France||Region of Enrollment||participants|Number|32|32.0||||||
4188150|NCT00781391|4009532|B2|France||Region of Enrollment||participants|Number|38|38.0||||||
4188151|NCT00781391|4009533|B1|France||Region of Enrollment||participants|Number|40|40.0||||||
4188152|NCT00781391|4009530|B4|India||Region of Enrollment||participants|Number|686|686.0||||||
4188153|NCT00781391|4009531|B3|India||Region of Enrollment||participants|Number|234|234.0||||||
4188154|NCT00781391|4009532|B2|India||Region of Enrollment||participants|Number|220|220.0||||||
4188155|NCT00781391|4009533|B1|India||Region of Enrollment||participants|Number|232|232.0||||||
4188156|NCT00781391|4009530|B4|Italy||Region of Enrollment||participants|Number|169|169.0||||||
4188157|NCT00781391|4009531|B3|Italy||Region of Enrollment||participants|Number|54|54.0||||||
4188158|NCT00781391|4009532|B2|Italy||Region of Enrollment||participants|Number|55|55.0||||||
4188159|NCT00781391|4009533|B1|Italy||Region of Enrollment||participants|Number|60|60.0||||||
4188160|NCT00781391|4009530|B4|Switzerland||Region of Enrollment||participants|Number|5|5.0||||||
4188161|NCT00781391|4009531|B3|Switzerland||Region of Enrollment||participants|Number|4|4.0||||||
4188162|NCT00781391|4009532|B2|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4188163|NCT00781391|4009533|B1|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
4188164|NCT00781391|4009530|B4|Colombia||Region of Enrollment||participants|Number|141|141.0||||||
4188165|NCT00781391|4009531|B3|Colombia||Region of Enrollment||participants|Number|48|48.0||||||
4188166|NCT00781391|4009532|B2|Colombia||Region of Enrollment||participants|Number|42|42.0||||||
4188167|NCT00781391|4009533|B1|Colombia||Region of Enrollment||participants|Number|51|51.0||||||
4188168|NCT00781391|4009530|B4|Russian Federation||Region of Enrollment||participants|Number|1150|1150.0||||||
4188169|NCT00781391|4009531|B3|Russian Federation||Region of Enrollment||participants|Number|369|369.0||||||
4188170|NCT00781391|4009532|B2|Russian Federation||Region of Enrollment||participants|Number|406|406.0||||||
4188171|NCT00781391|4009533|B1|Russian Federation||Region of Enrollment||participants|Number|375|375.0||||||
4188172|NCT00781391|4009530|B4|Chile||Region of Enrollment||participants|Number|253|253.0||||||
4188173|NCT00781391|4009531|B3|Chile||Region of Enrollment||participants|Number|88|88.0||||||
4188174|NCT00781391|4009532|B2|Chile||Region of Enrollment||participants|Number|91|91.0||||||
4188175|NCT00781391|4009533|B1|Chile||Region of Enrollment||participants|Number|74|74.0||||||
4188176|NCT00781391|4009530|B4|Israel||Region of Enrollment||participants|Number|280|280.0||||||
4188177|NCT00781391|4009531|B3|Israel||Region of Enrollment||participants|Number|88|88.0||||||
4188178|NCT00781391|4009532|B2|Israel||Region of Enrollment||participants|Number|88|88.0||||||
4188179|NCT00781391|4009533|B1|Israel||Region of Enrollment||participants|Number|104|104.0||||||
4188180|NCT00781391|4009530|B4|Ukraine||Region of Enrollment||participants|Number|1148|1148.0||||||
4188181|NCT00781391|4009531|B3|Ukraine||Region of Enrollment||participants|Number|402|402.0||||||
4188182|NCT00781391|4009532|B2|Ukraine||Region of Enrollment||participants|Number|386|386.0||||||
4188183|NCT00781391|4009533|B1|Ukraine||Region of Enrollment||participants|Number|360|360.0||||||
4188184|NCT00781391|4009530|B4|Thailand||Region of Enrollment||participants|Number|113|113.0||||||
4188185|NCT00781391|4009531|B3|Thailand||Region of Enrollment||participants|Number|33|33.0||||||
4188186|NCT00781391|4009532|B2|Thailand||Region of Enrollment||participants|Number|40|40.0||||||
4188187|NCT00781391|4009533|B1|Thailand||Region of Enrollment||participants|Number|40|40.0||||||
4188188|NCT00781391|4009530|B4|Spain||Region of Enrollment||participants|Number|163|163.0||||||
4188189|NCT00781391|4009531|B3|Spain||Region of Enrollment||participants|Number|54|54.0||||||
4188190|NCT00781391|4009532|B2|Spain||Region of Enrollment||participants|Number|65|65.0||||||
4188191|NCT00781391|4009533|B1|Spain||Region of Enrollment||participants|Number|44|44.0||||||
4188192|NCT00781391|4009530|B4|Greece||Region of Enrollment||participants|Number|50|50.0||||||
4188193|NCT00781391|4009531|B3|Greece||Region of Enrollment||participants|Number|9|9.0||||||
4188194|NCT00781391|4009532|B2|Greece||Region of Enrollment||participants|Number|27|27.0||||||
4188195|NCT00781391|4009533|B1|Greece||Region of Enrollment||participants|Number|14|14.0||||||
4188196|NCT00781391|4009530|B4|Slovakia||Region of Enrollment||participants|Number|405|405.0||||||
4188197|NCT00781391|4009531|B3|Slovakia||Region of Enrollment||participants|Number|129|129.0||||||
4188198|NCT00781391|4009532|B2|Slovakia||Region of Enrollment||participants|Number|133|133.0||||||
4188199|NCT00781391|4009533|B1|Slovakia||Region of Enrollment||participants|Number|143|143.0||||||
4188200|NCT00781391|4009530|B4|Taiwan||Region of Enrollment||participants|Number|234|234.0||||||
4188201|NCT00781391|4009531|B3|Taiwan||Region of Enrollment||participants|Number|85|85.0||||||
4188202|NCT00781391|4009532|B2|Taiwan||Region of Enrollment||participants|Number|72|72.0||||||
4188203|NCT00781391|4009533|B1|Taiwan||Region of Enrollment||participants|Number|77|77.0||||||
4188204|NCT00781391|4009530|B4|Estonia||Region of Enrollment||participants|Number|191|191.0||||||
4188205|NCT00781391|4009531|B3|Estonia||Region of Enrollment||participants|Number|60|60.0||||||
4188206|NCT00781391|4009532|B2|Estonia||Region of Enrollment||participants|Number|55|55.0||||||
4188207|NCT00781391|4009533|B1|Estonia||Region of Enrollment||participants|Number|76|76.0||||||
4188208|NCT00781391|4009530|B4|Philippines||Region of Enrollment||participants|Number|124|124.0||||||
4188209|NCT00781391|4009531|B3|Philippines||Region of Enrollment||participants|Number|45|45.0||||||
4188210|NCT00781391|4009532|B2|Philippines||Region of Enrollment||participants|Number|36|36.0||||||
4188211|NCT00781391|4009533|B1|Philippines||Region of Enrollment||participants|Number|43|43.0||||||
4188212|NCT00781391|4009530|B4|Serbia||Region of Enrollment||participants|Number|276|276.0||||||
4188213|NCT00781391|4009531|B3|Serbia||Region of Enrollment||participants|Number|74|74.0||||||
4188214|NCT00781391|4009532|B2|Serbia||Region of Enrollment||participants|Number|107|107.0||||||
4188215|NCT00781391|4009533|B1|Serbia||Region of Enrollment||participants|Number|95|95.0||||||
4188216|NCT00781391|4009530|B4|United States||Region of Enrollment||participants|Number|3893|3893.0||||||
4188217|NCT00781391|4009531|B3|United States||Region of Enrollment||participants|Number|1308|1308.0||||||
4188218|NCT00781391|4009532|B2|United States||Region of Enrollment||participants|Number|1288|1288.0||||||
4188219|NCT00781391|4009533|B1|United States||Region of Enrollment||participants|Number|1297|1297.0||||||
4188220|NCT00781391|4009530|B4|Portugal||Region of Enrollment||participants|Number|178|178.0||||||
4188221|NCT00781391|4009531|B3|Portugal||Region of Enrollment||participants|Number|61|61.0||||||
4188222|NCT00781391|4009532|B2|Portugal||Region of Enrollment||participants|Number|71|71.0||||||
4188223|NCT00781391|4009533|B1|Portugal||Region of Enrollment||participants|Number|46|46.0||||||
4188224|NCT00781391|4009530|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|846|846.0||||||
4188225|NCT00781391|4009531|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|283|283.0||||||
4188226|NCT00781391|4009532|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|281|281.0||||||
4188227|NCT00781391|4009533|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|282|282.0||||||
4188228|NCT00781391|4009530|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188229|NCT00781391|4009531|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188230|NCT00781391|4009532|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188231|NCT00781391|4009533|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188232|NCT00781391|4009530|B4||White|Race (NIH/OMB)||Participants|Count of Participants|17008|17008.0||||||
4188233|NCT00781391|4009531|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5650|5650.0||||||
4188234|NCT00781391|4009532|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5679|5679.0||||||
4188235|NCT00781391|4009533|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5679|5679.0||||||
4188236|NCT00781391|4009530|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|278|278.0||||||
4188237|NCT00781391|4009531|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
4188238|NCT00781391|4009532|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4188239|NCT00781391|4009533|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
4188240|NCT00781391|4009530|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188241|NCT00781391|4009531|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188242|NCT00781391|4009532|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188243|NCT00781391|4009533|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188244|NCT00781391|4009530|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2894|2894.0||||||
4188245|NCT00781391|4009531|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|975|975.0||||||
4188246|NCT00781391|4009532|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|956|956.0||||||
4188247|NCT00781391|4009533|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|963|963.0||||||
4188248|NCT00781391|4009530|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188249|NCT00781391|4009531|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188250|NCT00781391|4009532|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188251|NCT00781391|4009533|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188252|NCT00781391|4009530|B4||Male|Sex: Female, Male||Participants|Count of Participants|13020|13020.0||||||
4188253|NCT00781391|4009531|B3||Male|Sex: Female, Male||Participants|Count of Participants|4284|4284.0||||||
4188254|NCT00781391|4009532|B2||Male|Sex: Female, Male||Participants|Count of Participants|4353|4353.0||||||
4188255|NCT00781391|4009533|B1||Male|Sex: Female, Male||Participants|Count of Participants|4383|4383.0||||||
4188256|NCT00781391|4009530|B4||Female|Sex: Female, Male||Participants|Count of Participants|8006|8006.0||||||
4188257|NCT00781391|4009531|B3||Female|Sex: Female, Male||Participants|Count of Participants|2718|2718.0||||||
4188258|NCT00781391|4009532|B2||Female|Sex: Female, Male||Participants|Count of Participants|2659|2659.0||||||
4188259|NCT00781391|4009533|B1||Female|Sex: Female, Male||Participants|Count of Participants|2629|2629.0||||||
4188260|NCT00781391|4009530|B4|||Age||years|Mean|70.6|70.6|Standard Deviation|9.42|9.42|||
4188261|NCT00781391|4009531|B3|||Age||years|Mean|70.6|70.6|Standard Deviation|9.31|9.31|||
4188262|NCT00781391|4009532|B2|||Age||years|Mean|70.6|70.6|Standard Deviation|9.51|9.51|||
4188263|NCT00781391|4009533|B1|||Age||years|Mean|70.5|70.5|Standard Deviation|9.44|9.44|||
4188264|NCT00781391|4009530|B4||>=65 years|Age||Participants|Count of Participants|15543|15543.0||||||
4188265|NCT00781391|4009531|B3||>=65 years|Age||Participants|Count of Participants|5218|5218.0||||||
4188266|NCT00781391|4009532|B2||>=65 years|Age||Participants|Count of Participants|5182|5182.0||||||
4188267|NCT00781391|4009533|B1||>=65 years|Age||Participants|Count of Participants|5143|5143.0||||||
4188268|NCT00781391|4009530|B4||Between 18 and 65 years|Age||Participants|Count of Participants|5483|5483.0||||||
4188269|NCT00781391|4009531|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1784|1784.0||||||
4188270|NCT00781391|4009532|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1830|1830.0||||||
4188271|NCT00781391|4009533|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1869|1869.0||||||
4188272|NCT00781391|4009530|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4188273|NCT00781391|4009531|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4188274|NCT00781391|4009532|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4188275|NCT00781391|4009533|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4188276|NCT00781365|4009567|B3|Other||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4188277|NCT00781365|4009568|B2|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4188278|NCT00781365|4009569|B1|Other||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4188279|NCT00781365|4009567|B3|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4188280|NCT00781365|4009568|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4188281|NCT00781365|4009569|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4188282|NCT00781365|4009567|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
4188283|NCT00781365|4009568|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4188284|NCT00781365|4009569|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4188285|NCT00781365|4009567|B3|White||Race/Ethnicity, Customized||participants|Number|368|368.0||||||
4188286|NCT00781365|4009568|B2|White||Race/Ethnicity, Customized||participants|Number|191|191.0||||||
4188287|NCT00781365|4009569|B1|White||Race/Ethnicity, Customized||participants|Number|177|177.0||||||
4188288|NCT00781365|4009567|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188289|NCT00781365|4009568|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188290|NCT00781365|4009569|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188291|NCT00781365|4009567|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|440|440.0||||||
4188292|NCT00781365|4009568|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|227|227.0||||||
4188293|NCT00781365|4009569|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|213|213.0||||||
4188294|NCT00781365|4009567|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4188295|NCT00781365|4009568|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4188296|NCT00781365|4009569|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4188297|NCT00781365|4009567|B3||Male|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
4188298|NCT00781365|4009568|B2||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4188299|NCT00781365|4009569|B1||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4188300|NCT00781365|4009567|B3||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4188301|NCT00781365|4009568|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4188302|NCT00781365|4009569|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4188303|NCT00781365|4009567|B3|||Age||years|Mean|61.1|61.1|Standard Deviation|12.0|12.0|||
4188304|NCT00781365|4009568|B2|||Age||years|Mean|62.0|62.0|Standard Deviation|11.7|11.7|||
4188305|NCT00781365|4009569|B1|||Age||years|Mean|60.2|60.2|Standard Deviation|12.2|12.2|||
4188306|NCT00781365|4009567|B3||>=65 years|Age||Participants|Count of Participants|151|151.0||||||
4188307|NCT00781365|4009568|B2||>=65 years|Age||Participants|Count of Participants|81|81.0||||||
4188308|NCT00781365|4009569|B1||>=65 years|Age||Participants|Count of Participants|70|70.0||||||
4188309|NCT00781365|4009567|B3||Between 18 and 65 years|Age||Participants|Count of Participants|299|299.0||||||
4188310|NCT00781365|4009568|B2||Between 18 and 65 years|Age||Participants|Count of Participants|147|147.0||||||
4188311|NCT00781365|4009569|B1||Between 18 and 65 years|Age||Participants|Count of Participants|152|152.0||||||
4188312|NCT00781365|4009567|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4188313|NCT00781365|4009568|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4188314|NCT00781365|4009569|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4188315|NCT00781326|4009580|B1|||Cumulative Illness Rating Scale (Geriatric) total|Cumulative Illness Rating Scale (Geriatric Version) is a measure of medical illness burden across 14 body systems. For the purposes of this study, we do not include the “psychiatric body system”. Within each body system, the burden of medical illness is scored 0 – 4. The total score reported here is the sum of medical burden scores across 13 body systems. Total score range is 0 to 52 with higher scores indicating greater overall burden of medical illness.|units on a scale|Mean|8.3|8.3|Standard Deviation|2.0|2.0|||
4188316|NCT00781326|4009580|B1|||Hamilton Depression Rating Scale (24 item)|Hamilton Depression Rating Scale (24 item) measures symptoms of major depression. We report total score which is the sum of all items. Total score range is 0 to 76 with higher scores indicating more severe depression.|units on a scale|Mean|20.5|20.5|Standard Deviation|2.4|2.4|||
4188317|NCT00781326|4009580|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4188318|NCT00781326|4009580|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188319|NCT00781326|4009580|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188320|NCT00781326|4009580|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4188321|NCT00781326|4009580|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4188322|NCT00781326|4009580|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188323|NCT00781326|4009580|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4188324|NCT00781326|4009580|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188325|NCT00781326|4009580|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4188326|NCT00781326|4009580|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4188327|NCT00781326|4009580|B1|||Age||years|Mean|66.2|66.2|Standard Deviation|8.7|8.7|||
4188328|NCT00781326|4009580|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4188329|NCT00781326|4009580|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4188330|NCT00781326|4009580|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4188331|NCT00781274|4009584|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4188332|NCT00781274|4009584|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4188333|NCT00781274|4009584|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|6.4|6.4|||
4188334|NCT00781079|4009588|B3|United States||Region of Enrollment||Participants|Count of Participants|282|282.0||||||
4188335|NCT00781079|4009589|B2|United States||Region of Enrollment||Participants|Count of Participants|133|133.0||||||
4188336|NCT00781079|4009590|B1|United States||Region of Enrollment||Participants|Count of Participants|149|149.0||||||
4188337|NCT00781079|4009588|B3|Unknown||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4188338|NCT00781079|4009589|B2|Unknown||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4188339|NCT00781079|4009590|B1|Unknown||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4188340|NCT00781079|4009588|B3|White Hispanic||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4188341|NCT00781079|4009589|B2|White Hispanic||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4188342|NCT00781079|4009590|B1|White Hispanic||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4188343|NCT00781079|4009588|B3|African American Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4188344|NCT00781079|4009589|B2|African American Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4188345|NCT00781079|4009590|B1|African American Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4188346|NCT00781079|4009588|B3|Bi racial non hispanic||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4188347|NCT00781079|4009589|B2|Bi racial non hispanic||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4188348|NCT00781079|4009590|B1|Bi racial non hispanic||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4188349|NCT00781079|4009588|B3|White non hispanic||Race/Ethnicity, Customized||participants|Number|152|152.0||||||
4188350|NCT00781079|4009589|B2|White non hispanic||Race/Ethnicity, Customized||participants|Number|78|78.0||||||
4188351|NCT00781079|4009590|B1|White non hispanic||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
4188352|NCT00781079|4009588|B3|African American non-Hispanic||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
4188353|NCT00781079|4009589|B2|African American non-Hispanic||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4188354|NCT00781079|4009590|B1|African American non-Hispanic||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4188355|NCT00781079|4009588|B3||Male|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
4188356|NCT00781079|4009589|B2||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4188357|NCT00781079|4009590|B1||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4188358|NCT00781079|4009588|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4188359|NCT00781079|4009589|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4188360|NCT00781079|4009590|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4188361|NCT00781079|4009588|B3|||Age|Age at time of enrollment|years|Mean|52.95|52.95|Standard Deviation|10.15|10.15|||
4188362|NCT00781079|4009589|B2|||Age|Age at time of enrollment|years|Mean|51.89|51.89|Standard Deviation|11.13|11.13|||
4188363|NCT00781079|4009590|B1|||Age|Age at time of enrollment|years|Mean|54.59|54.59|Standard Deviation|9.19|9.19|||
4188364|NCT00780962|4009607|B3|||Baseline Creatinine||mg/dL|Mean|0.99|0.99|Full Range|||0.5|1.9|
4188365|NCT00780962|4009608|B2|||Baseline Creatinine||mg/dL|Mean|0.99|0.99|Full Range|||0.5|1.8|
4188366|NCT00780962|4009609|B1|||Baseline Creatinine||mg/dL|Mean|1.0|1.0|Full Range|||0.5|1.9|
4188367|NCT00780962|4009607|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4188368|NCT00780962|4009608|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4188369|NCT00780962|4009609|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4188370|NCT00780962|4009607|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188371|NCT00780962|4009608|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188372|NCT00780962|4009609|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188373|NCT00780962|4009607|B3||White|Race (NIH/OMB)||Participants|Count of Participants|280|280.0||||||
4188374|NCT00780962|4009608|B2||White|Race (NIH/OMB)||Participants|Count of Participants|142|142.0||||||
4188375|NCT00780962|4009609|B1||White|Race (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
4188376|NCT00780962|4009607|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
4188377|NCT00780962|4009608|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4188378|NCT00780962|4009609|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4188379|NCT00780962|4009607|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188380|NCT00780962|4009608|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188381|NCT00780962|4009609|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188382|NCT00780962|4009607|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4188383|NCT00780962|4009608|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4188384|NCT00780962|4009609|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4188385|NCT00780962|4009607|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188386|NCT00780962|4009608|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188387|NCT00780962|4009609|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188388|NCT00780962|4009607|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188389|NCT00780962|4009608|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188390|NCT00780962|4009609|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188391|NCT00780962|4009607|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|398|398.0||||||
4188392|NCT00780962|4009608|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|199|199.0||||||
4188393|NCT00780962|4009609|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|199|199.0||||||
4188394|NCT00780962|4009607|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4188395|NCT00780962|4009608|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188396|NCT00780962|4009609|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4188397|NCT00780962|4009607|B3||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4188398|NCT00780962|4009608|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4188399|NCT00780962|4009609|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4188400|NCT00780962|4009607|B3||Female|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
4188401|NCT00780962|4009608|B2||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4188402|NCT00780962|4009609|B1||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4188403|NCT00780962|4009607|B3|||Age||years|Mean|60.6|60.6|Full Range|||18.0|95.0|
4188404|NCT00780962|4009608|B2|||Age||years|Mean|59.7|59.7|Full Range|||18.0|94.0|
4188405|NCT00780962|4009609|B1|||Age||years|Mean|61.5|61.5|Full Range|||28.0|95.0|
4188406|NCT00780910|4009616|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4188407|NCT00780910|4009616|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4188408|NCT00780910|4009616|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|8.6|8.6|||
4188409|NCT00780741|4009620|B3|Absent||Mucous discharge||participants|Number|40|40.0||||||
4188410|NCT00780741|4009621|B2|Absent||Mucous discharge||participants|Number|18|18.0||||||
4188411|NCT00780741|4009622|B1|Absent||Mucous discharge||participants|Number|22|22.0||||||
4188412|NCT00780741|4009620|B3|Present||Mucous discharge||participants|Number|123|123.0||||||
4188413|NCT00780741|4009621|B2|Present||Mucous discharge||participants|Number|63|63.0||||||
4188414|NCT00780741|4009622|B1|Present||Mucous discharge||participants|Number|60|60.0||||||
4188415|NCT00780741|4009620|B3|Absent||Increased tear film||participants|Number|3|3.0||||||
4188416|NCT00780741|4009621|B2|Absent||Increased tear film||participants|Number|0|0.0||||||
4188417|NCT00780741|4009622|B1|Absent||Increased tear film||participants|Number|3|3.0||||||
4188418|NCT00780741|4009620|B3|Present||Increased tear film||participants|Number|160|160.0||||||
4188419|NCT00780741|4009621|B2|Present||Increased tear film||participants|Number|81|81.0||||||
4188420|NCT00780741|4009622|B1|Present||Increased tear film||participants|Number|79|79.0||||||
4188421|NCT00780741|4009620|B3|Absent||Epiphora||participants|Number|30|30.0||||||
4188422|NCT00780741|4009621|B2|Absent||Epiphora||participants|Number|11|11.0||||||
4188423|NCT00780741|4009622|B1|Absent||Epiphora||participants|Number|19|19.0||||||
4188424|NCT00780741|4009620|B3|Present||Epiphora||participants|Number|133|133.0||||||
4188425|NCT00780741|4009621|B2|Present||Epiphora||participants|Number|70|70.0||||||
4188426|NCT00780741|4009622|B1|Present||Epiphora||participants|Number|63|63.0||||||
4188427|NCT00780741|4009620|B3|Unknown||Previous treatment for NLDO||participants|Number|1|1.0||||||
4188428|NCT00780741|4009621|B2|Unknown||Previous treatment for NLDO||participants|Number|1|1.0||||||
4188429|NCT00780741|4009622|B1|Unknown||Previous treatment for NLDO||participants|Number|0|0.0||||||
4188430|NCT00780741|4009620|B3|None||Previous treatment for NLDO||participants|Number|30|30.0||||||
4188431|NCT00780741|4009621|B2|None||Previous treatment for NLDO||participants|Number|15|15.0||||||
4188432|NCT00780741|4009622|B1|None||Previous treatment for NLDO||participants|Number|15|15.0||||||
4188433|NCT00780741|4009620|B3|Topical antibiotics only||Previous treatment for NLDO||participants|Number|24|24.0||||||
4188434|NCT00780741|4009621|B2|Topical antibiotics only||Previous treatment for NLDO||participants|Number|14|14.0||||||
4188435|NCT00780741|4009622|B1|Topical antibiotics only||Previous treatment for NLDO||participants|Number|10|10.0||||||
4188436|NCT00780741|4009620|B3|Lacrimal massage only||Previous treatment for NLDO||participants|Number|33|33.0||||||
4188437|NCT00780741|4009621|B2|Lacrimal massage only||Previous treatment for NLDO||participants|Number|15|15.0||||||
4188438|NCT00780741|4009622|B1|Lacrimal massage only||Previous treatment for NLDO||participants|Number|18|18.0||||||
4188439|NCT00780741|4009620|B3|Lacrimal massage and topical antibiotics||Previous treatment for NLDO||participants|Number|75|75.0||||||
4188440|NCT00780741|4009621|B2|Lacrimal massage and topical antibiotics||Previous treatment for NLDO||participants|Number|36|36.0||||||
4188441|NCT00780741|4009622|B1|Lacrimal massage and topical antibiotics||Previous treatment for NLDO||participants|Number|39|39.0||||||
4188442|NCT00780741|4009620|B3|United States||Region of Enrollment||participants|Number|163|163.0||||||
4188443|NCT00780741|4009621|B2|United States||Region of Enrollment||participants|Number|81|81.0||||||
4188444|NCT00780741|4009622|B1|United States||Region of Enrollment||participants|Number|82|82.0||||||
4188445|NCT00780741|4009620|B3|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4188446|NCT00780741|4009621|B2|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4188447|NCT00780741|4009622|B1|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4188448|NCT00780741|4009620|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4188449|NCT00780741|4009621|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4188450|NCT00780741|4009622|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4188451|NCT00780741|4009620|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4188452|NCT00780741|4009621|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4188453|NCT00780741|4009622|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4188454|NCT00780741|4009620|B3|African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4188455|NCT00780741|4009621|B2|African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4188456|NCT00780741|4009622|B1|African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4188457|NCT00780741|4009620|B3|White||Race/Ethnicity, Customized||participants|Number|134|134.0||||||
4188458|NCT00780741|4009621|B2|White||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
4188459|NCT00780741|4009622|B1|White||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
4188460|NCT00780741|4009620|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4188461|NCT00780741|4009621|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4188462|NCT00780741|4009622|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4188463|NCT00780741|4009620|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4188464|NCT00780741|4009621|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4188465|NCT00780741|4009622|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4188466|NCT00780741|4009620|B3|9 to <10 months||Age, Customized||participants|Number|35|35.0||||||
4188467|NCT00780741|4009621|B2|9 to <10 months||Age, Customized||participants|Number|21|21.0||||||
4188468|NCT00780741|4009622|B1|9 to <10 months||Age, Customized||participants|Number|14|14.0||||||
4188469|NCT00780741|4009620|B3|8 to <9 months||Age, Customized||participants|Number|28|28.0||||||
4188470|NCT00780741|4009621|B2|8 to <9 months||Age, Customized||participants|Number|13|13.0||||||
4188471|NCT00780741|4009622|B1|8 to <9 months||Age, Customized||participants|Number|15|15.0||||||
4188472|NCT00780741|4009620|B3|7 to <8 months||Age, Customized||participants|Number|48|48.0||||||
4188473|NCT00780741|4009621|B2|7 to <8 months||Age, Customized||participants|Number|20|20.0||||||
4188474|NCT00780741|4009622|B1|7 to <8 months||Age, Customized||participants|Number|28|28.0||||||
4188475|NCT00780741|4009620|B3|6 to <7 months||Age, Customized||participants|Number|52|52.0||||||
4188476|NCT00780741|4009621|B2|6 to <7 months||Age, Customized||participants|Number|27|27.0||||||
4188477|NCT00780741|4009622|B1|6 to <7 months||Age, Customized||participants|Number|25|25.0||||||
4188478|NCT00780741|4009620|B3|||Age||months|Mean|7.7|7.7|Standard Deviation|1.2|1.2|||
4188479|NCT00780741|4009621|B2|||Age||months|Mean|7.8|7.8|Standard Deviation|1.3|1.3|||
4188480|NCT00780741|4009622|B1|||Age||months|Mean|7.6|7.6|Standard Deviation|1.2|1.2|||
4188481|NCT00780715|4009635|B5|United Kingdom||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
4188482|NCT00780715|4009636|B4|United Kingdom||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4188483|NCT00780715|4009637|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4188484|NCT00780715|4009638|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4188485|NCT00780715|4009639|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4188486|NCT00780715|4009635|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4188487|NCT00780715|4009636|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4188488|NCT00780715|4009637|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4188489|NCT00780715|4009638|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4188490|NCT00780715|4009639|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4188491|NCT00780715|4009635|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4188492|NCT00780715|4009636|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4188493|NCT00780715|4009637|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4188494|NCT00780715|4009638|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4188495|NCT00780715|4009639|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4188496|NCT00780715|4009635|B5|||Age||years|Mean|60.9|60.9|Standard Deviation|9.2|9.2|||
4188497|NCT00780715|4009636|B4|||Age||years|Mean|59.6|59.6|Standard Deviation|8.8|8.8|||
4188498|NCT00780715|4009637|B3|||Age||years|Mean|61.3|61.3|Standard Deviation|11.8|11.8|||
4188499|NCT00780715|4009638|B2|||Age||years|Mean|61.5|61.5|Standard Deviation|9.9|9.9|||
4188500|NCT00780715|4009639|B1|||Age||years|Mean|62.4|62.4|Standard Deviation|4.6|4.6|||
4188501|NCT00780676|4009655|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4188502|NCT00780676|4009656|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4188503|NCT00780676|4009657|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4188504|NCT00780676|4009652|B6|Male||Gender||participants|Number|0|0.0||||||
4188505|NCT00780676|4009655|B3|Male||Gender||participants|Number|0|0.0||||||
4188506|NCT00780676|4009656|B2|Male||Gender||participants|Number|0|0.0||||||
4188507|NCT00780676|4009657|B1|Male||Gender||participants|Number|0|0.0||||||
4188508|NCT00780676|4009652|B6|Female||Gender||participants|Number|30|30.0||||||
4188509|NCT00780676|4009655|B3|Female||Gender||participants|Number|13|13.0||||||
4188510|NCT00780676|4009656|B2|Female||Gender||participants|Number|8|8.0||||||
4188511|NCT00780676|4009657|B1|Female||Gender||participants|Number|9|9.0||||||
4188512|NCT00780676|4009652|B6|||Age||years|Median|51|51.0|Full Range|||33.0|69.0|
4188513|NCT00780676|4009655|B3|||Age||years|Median|54.3|54.3|Full Range|||42.0|62.0|
4188514|NCT00780676|4009656|B2|||Age||years|Median|51.6|51.6|Full Range|||36.0|60.0|
4188515|NCT00780676|4009657|B1|||Age||years|Median|46.5|46.5|Full Range|||33.0|69.0|
4188516|NCT00780572|4009667|B3|United States||Region of Enrollment||participants|Number|595|595.0||||||
4188517|NCT00780572|4009668|B2|United States||Region of Enrollment||participants|Number|298|298.0||||||
4188518|NCT00780572|4009669|B1|United States||Region of Enrollment||participants|Number|297|297.0||||||
4188519|NCT00780572|4009667|B3|Female or Male||Sex/Gender, Customized|No demographics were collected including gender.|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4188520|NCT00780572|4009668|B2|Female or Male||Sex/Gender, Customized|No demographics were collected including gender.|participants|Number|NA|||||||No demographics were collected including gender.
4188521|NCT00780572|4009669|B1|Female or Male||Sex/Gender, Customized|No demographics were collected including gender.|participants|Number|NA|||||||No demographics were collected including gender.
4188522|NCT00780572|4009667|B3|18+||Age, Customized||participants|Number|595|595.0||||||
4188523|NCT00780572|4009668|B2|18+||Age, Customized||participants|Number|298|298.0||||||
4188524|NCT00780572|4009669|B1|18+||Age, Customized||participants|Number|297|297.0||||||
4188525|NCT00780481|4009676|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4188526|NCT00780481|4009676|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4188527|NCT00780481|4009676|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4188528|NCT00780481|4009676|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4188529|NCT00780455|4009683|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4188530|NCT00780455|4009684|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4188531|NCT00780455|4009685|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4188532|NCT00780455|4009683|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4188533|NCT00780455|4009684|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4188534|NCT00780455|4009685|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4188535|NCT00780455|4009683|B3|||Age||years|Mean|42.3|42.3|Standard Deviation|13.4|13.4|||
4188536|NCT00780455|4009684|B2|||Age||years|Mean|45|45.0|Standard Deviation|15.6|15.6|||
4188537|NCT00780455|4009685|B1|||Age||years|Mean|39.5|39.5|Standard Deviation|16.3|16.3|||
4188538|NCT00780442|4009710|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188539|NCT00780442|4009711|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188540|NCT00780442|4009712|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188541|NCT00780442|4009710|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188542|NCT00780442|4009711|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188543|NCT00780442|4009712|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188544|NCT00780442|4009710|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4188545|NCT00780442|4009711|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4188546|NCT00780442|4009712|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4188547|NCT00780442|4009710|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4188548|NCT00780442|4009711|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4188549|NCT00780442|4009712|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4188550|NCT00780442|4009710|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188551|NCT00780442|4009711|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188552|NCT00780442|4009712|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188553|NCT00780442|4009710|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4188554|NCT00780442|4009711|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4188555|NCT00780442|4009712|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188556|NCT00780442|4009710|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188557|NCT00780442|4009711|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188558|NCT00780442|4009712|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188559|NCT00780442|4009710|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4188560|NCT00780442|4009711|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4188561|NCT00780442|4009712|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4188562|NCT00780442|4009710|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4188563|NCT00780442|4009711|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4188564|NCT00780442|4009712|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4188565|NCT00780442|4009710|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4188566|NCT00780442|4009711|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4188567|NCT00780442|4009712|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4188568|NCT00780442|4009710|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4188569|NCT00780442|4009711|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4188570|NCT00780442|4009712|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4188571|NCT00780442|4009710|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4188572|NCT00780442|4009711|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4188573|NCT00780442|4009712|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4188574|NCT00780416|4009719|B3||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4188575|NCT00780416|4009720|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4188576|NCT00780416|4009721|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4188577|NCT00780416|4009719|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4188578|NCT00780416|4009720|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4188579|NCT00780416|4009721|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4188580|NCT00780416|4009719|B3|||Age||years|Mean|51.3|51.3|Standard Deviation|10.2|10.2|||
4188581|NCT00780416|4009720|B2|||Age||years|Mean|52.2|52.2|Standard Deviation|9.7|9.7|||
4188582|NCT00780416|4009721|B1|||Age||years|Mean|50.8|50.8|Standard Deviation|10.4|10.4|||
4188583|NCT00780403|4009728|B1||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4188584|NCT00780403|4009728|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4188585|NCT00780403|4009728|B1|||Age||years|Mean|8.9|8.9|Standard Deviation|1.65|1.65|||
4188586|NCT00780338|4009736|B3|United States||Region of Enrollment||participants|Number|376|376.0||||||
4188587|NCT00780338|4009737|B2|United States||Region of Enrollment||participants|Number|202|202.0||||||
4188588|NCT00780338|4009738|B1|United States||Region of Enrollment||participants|Number|174|174.0||||||
4188589|NCT00780338|4009736|B3||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4188590|NCT00780338|4009737|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4188591|NCT00780338|4009738|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4188592|NCT00780338|4009736|B3||Female|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
4188593|NCT00780338|4009737|B2||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4188594|NCT00780338|4009738|B1||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4188595|NCT00780338|4009736|B3|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4188596|NCT00780338|4009737|B2|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4188597|NCT00780338|4009738|B1|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4188598|NCT00780338|4009736|B3|Between 18 and 65 years||Age, Customized||participants|Number|376|376.0||||||
4188599|NCT00780338|4009737|B2|Between 18 and 65 years||Age, Customized||participants|Number|202|202.0||||||
4188600|NCT00780338|4009738|B1|Between 18 and 65 years||Age, Customized||participants|Number|174|174.0||||||
4188601|NCT00780338|4009736|B3|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4188602|NCT00780338|4009737|B2|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4188603|NCT00780338|4009738|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4188604|NCT00780273|4009767|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4188605|NCT00780273|4009767|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4188606|NCT00780273|4009767|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4188607|NCT00780273|4009767|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4188608|NCT00780273|4009767|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4188609|NCT00780273|4009767|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4188610|NCT00780208|4009776|B1|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4188611|NCT00780208|4009776|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188612|NCT00780208|4009776|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188613|NCT00780208|4009776|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4188614|NCT00780208|4009776|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188615|NCT00780208|4009776|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188616|NCT00780208|4009776|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188617|NCT00780208|4009776|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188618|NCT00780208|4009776|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4188619|NCT00780208|4009776|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4188620|NCT00780208|4009776|B1|||Age||years|Median|28.5|28.5|Full Range|||22.0|44.0|
4188621|NCT00780208|4009776|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4188622|NCT00780208|4009776|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4188623|NCT00780208|4009776|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4188624|NCT00780143|4009781|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4188625|NCT00780143|4009781|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4188626|NCT00780143|4009781|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4188627|NCT00780143|4009781|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4188628|NCT00780143|4009781|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4188629|NCT00780143|4009781|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4188630|NCT00780026|4009787|B3|Coronary Artery Disease(CAD)||Pre-existing conditions|Preexisting diagnosis for Coronary Artery Disease (CAD)|Participants|Count of Participants|5|5.0||||||
4188631|NCT00780026|4009788|B2|Coronary Artery Disease(CAD)||Pre-existing conditions|Preexisting diagnosis for Coronary Artery Disease (CAD)|Participants|Count of Participants|2|2.0||||||
4188632|NCT00780026|4009789|B1|Coronary Artery Disease(CAD)||Pre-existing conditions|Preexisting diagnosis for Coronary Artery Disease (CAD)|Participants|Count of Participants|3|3.0||||||
4188633|NCT00780026|4009787|B3|Diabetes||Pre-existing conditions|Preexisting diagnosis for Coronary Artery Disease (CAD)|Participants|Count of Participants|27|27.0||||||
4188634|NCT00780026|4009788|B2|Diabetes||Pre-existing conditions|Preexisting diagnosis for Coronary Artery Disease (CAD)|Participants|Count of Participants|15|15.0||||||
4188635|NCT00780026|4009789|B1|Diabetes||Pre-existing conditions|Preexisting diagnosis for Coronary Artery Disease (CAD)|Participants|Count of Participants|12|12.0||||||
4188636|NCT00780026|4009787|B3|||BMI|The BMI is defined as the body mass (in kilograms) divided by the square of the body height (in meters).|kg/m2|Median|25.8|25.8|Inter-Quartile Range|||23.1|28.5|
4188637|NCT00780026|4009788|B2|||BMI|The BMI is defined as the body mass (in kilograms) divided by the square of the body height (in meters).|kg/m2|Median|26.3|26.3|Inter-Quartile Range|||23.1|28.8|
4188638|NCT00780026|4009789|B1|||BMI|The BMI is defined as the body mass (in kilograms) divided by the square of the body height (in meters).|kg/m2|Median|25.6|25.6|Inter-Quartile Range|||22.7|27.6|
4188639|NCT00780026|4009787|B3|United States||Region of Enrollment||Participants|Count of Participants|86|86.0||||||
4188640|NCT00780026|4009788|B2|United States||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
4188641|NCT00780026|4009789|B1|United States||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
4188642|NCT00780026|4009787|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4188643|NCT00780026|4009788|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4188644|NCT00780026|4009789|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4188645|NCT00780026|4009787|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4188646|NCT00780026|4009788|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4188647|NCT00780026|4009789|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4188648|NCT00780026|4009787|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4188649|NCT00780026|4009788|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4188650|NCT00780026|4009789|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4188651|NCT00780026|4009787|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|71|71.0||||||
4188652|NCT00780026|4009788|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
4188653|NCT00780026|4009789|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
4188654|NCT00780026|4009787|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4188655|NCT00780026|4009788|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4188656|NCT00780026|4009789|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4188657|NCT00780026|4009787|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188658|NCT00780026|4009788|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188659|NCT00780026|4009789|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188660|NCT00780026|4009787|B3||White|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
4188661|NCT00780026|4009788|B2||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4188662|NCT00780026|4009789|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4188663|NCT00780026|4009787|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4188664|NCT00780026|4009788|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4188665|NCT00780026|4009789|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4188666|NCT00780026|4009787|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188667|NCT00780026|4009788|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188668|NCT00780026|4009789|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188669|NCT00780026|4009787|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4188670|NCT00780026|4009788|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4188671|NCT00780026|4009789|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188672|NCT00780026|4009787|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188673|NCT00780026|4009788|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188674|NCT00780026|4009789|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188675|NCT00780026|4009787|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4188676|NCT00780026|4009788|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4188677|NCT00780026|4009789|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4188678|NCT00780026|4009787|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4188679|NCT00780026|4009788|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4188680|NCT00780026|4009789|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4188681|NCT00780026|4009787|B3|||Age||years|Median|54|54.0|Inter-Quartile Range|||49.0|59.0|
4188682|NCT00780026|4009788|B2|||Age||years|Median|55|55.0|Inter-Quartile Range|||49.5|59.5|
4188683|NCT00780026|4009789|B1|||Age||years|Median|53|53.0|Inter-Quartile Range|||46.0|57.0|
4188684|NCT00779909|4009808|B5|United States||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
4188685|NCT00779909|4009809|B4|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4188686|NCT00779909|4009810|B3|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4188687|NCT00779909|4009811|B2|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4188688|NCT00779909|4009812|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4188689|NCT00779909|4009808|B5|Non-Hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
4188690|NCT00779909|4009809|B4|Non-Hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4188691|NCT00779909|4009810|B3|Non-Hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4188692|NCT00779909|4009811|B2|Non-Hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4188693|NCT00779909|4009812|B1|Non-Hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4188694|NCT00779909|4009808|B5|non-Hispanic Black||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
4188695|NCT00779909|4009809|B4|non-Hispanic Black||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4188696|NCT00779909|4009810|B3|non-Hispanic Black||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4188697|NCT00779909|4009811|B2|non-Hispanic Black||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4188698|NCT00779909|4009812|B1|non-Hispanic Black||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4188699|NCT00779909|4009808|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4188700|NCT00779909|4009809|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4188701|NCT00779909|4009810|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4188702|NCT00779909|4009811|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4188703|NCT00779909|4009812|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4188704|NCT00779909|4009808|B5||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4188705|NCT00779909|4009809|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4188706|NCT00779909|4009810|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4188707|NCT00779909|4009811|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4188708|NCT00779909|4009812|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4188709|NCT00779909|4009808|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4188710|NCT00779909|4009809|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4188711|NCT00779909|4009810|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4188712|NCT00779909|4009811|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4188713|NCT00779909|4009812|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4188714|NCT00779909|4009808|B5||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4188715|NCT00779909|4009809|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4188716|NCT00779909|4009810|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4188717|NCT00779909|4009811|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4188718|NCT00779909|4009812|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4188719|NCT00779909|4009808|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4188720|NCT00779909|4009809|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4188721|NCT00779909|4009810|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4188722|NCT00779909|4009811|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4188723|NCT00779909|4009812|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4188724|NCT00779857|4009857|B1|United States||Region of Enrollment||participants|Number|70|70.0||||||
4188725|NCT00779857|4009857|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4188726|NCT00779857|4009857|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4188727|NCT00779857|4009857|B1|||Age||years|Mean|73.1|73.1|Standard Deviation|8.1|8.1|||
4188728|NCT00779857|4009857|B1||>=65 years|Age||Participants|Count of Participants|62|62.0||||||
4188729|NCT00779857|4009857|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4188730|NCT00779857|4009857|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4188731|NCT00779779|4009862|B1||Male|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
4188732|NCT00779779|4009862|B1||Female|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
4188733|NCT00779779|4009862|B1|||Age||weeks|Mean|12.5|12.5|Standard Deviation|5.62|5.62|||
4188734|NCT00779766|4009869|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4188735|NCT00779766|4009870|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4188736|NCT00779766|4009871|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4188737|NCT00779766|4009869|B3||Female|Sex: Female, Male||Participants|Count of Participants|6051|6051.0||||||
4188738|NCT00779766|4009870|B2||Female|Sex: Female, Male||Participants|Count of Participants|3025|3025.0||||||
4188739|NCT00779766|4009871|B1||Female|Sex: Female, Male||Participants|Count of Participants|3026|3026.0||||||
4188740|NCT00779766|4009869|B3|||Age||Years|Mean|23.0|23.0|Standard Deviation|1.73|1.73|||
4188741|NCT00779766|4009870|B2|||Age||Years|Mean|23.0|23.0|Standard Deviation|1.75|1.75|||
4188742|NCT00779766|4009871|B1|||Age||Years|Mean|23.0|23.0|Standard Deviation|1.70|1.7|||
4188743|NCT00779701|4009950|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4188744|NCT00779701|4009950|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4188745|NCT00779701|4009950|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4188746|NCT00779701|4009950|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4188747|NCT00779701|4009950|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4188748|NCT00779701|4009950|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4188749|NCT00779675|4009954|B1||Male|Sex: Female, Male||Participants|Count of Participants|430|430.0||||||
4188750|NCT00779675|4009954|B1||Female|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4188751|NCT00779675|4009954|B1|||Age||years|Mean|46.3|46.3|Standard Deviation|13.5|13.5|||
4188752|NCT00779584|4009973|B10||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4188753|NCT00779584|4009974|B9||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4188754|NCT00779584|4009975|B8||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4188755|NCT00779584|4009976|B7||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4188756|NCT00779584|4009977|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4188757|NCT00779584|4009978|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4188758|NCT00779584|4009979|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4188759|NCT00779584|4009980|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4188760|NCT00779584|4009981|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4188761|NCT00779584|4009982|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4188762|NCT00779584|4009973|B10||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4188763|NCT00779584|4009974|B9||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4188764|NCT00779584|4009975|B8||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4188765|NCT00779584|4009976|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4188766|NCT00779584|4009977|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4188767|NCT00779584|4009978|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4188768|NCT00779584|4009979|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4188769|NCT00779584|4009980|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4188770|NCT00779584|4009981|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4188771|NCT00779584|4009982|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4188772|NCT00779584|4009973|B10|||Age||Years|Mean|58.8|58.8|Standard Deviation|11.2|11.2|||
4188773|NCT00779584|4009974|B9|||Age||Years|Mean|69.0|69.0|Standard Deviation|8.5|8.5|||
4188774|NCT00779584|4009975|B8|||Age||Years|Mean|69.3|69.3|Standard Deviation|5.5|5.5|||
4188775|NCT00779584|4009976|B7|||Age||Years|Mean|59.9|59.9|Standard Deviation|9.1|9.1|||
4188776|NCT00779584|4009977|B6|||Age||Years|Mean|59.0|59.0|Standard Deviation|13.4|13.4|||
4188777|NCT00779584|4009978|B5|||Age||Years|Mean|51.1|51.1|Standard Deviation|5.7|5.7|||
4188778|NCT00779584|4009979|B4|||Age||Years|Mean|55.5|55.5|Standard Deviation|5.0|5.0|||
4188779|NCT00779584|4009980|B3|||Age||Years|Mean|64.0|64.0|Standard Deviation|16.1|16.1|||
4188780|NCT00779584|4009981|B2|||Age||Years|Mean|54.3|54.3|Standard Deviation|8.6|8.6|||
4188781|NCT00779584|4009982|B1|||Age||Years|Mean|54.3|54.3|Standard Deviation|16.0|16.0|||
4188782|NCT00779558|4010064|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188783|NCT00779558|4010065|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188784|NCT00779558|4010066|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188785|NCT00779558|4010064|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4188786|NCT00779558|4010065|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4188787|NCT00779558|4010066|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4188788|NCT00779558|4010064|B3||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4188789|NCT00779558|4010065|B2||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4188790|NCT00779558|4010066|B1||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4188791|NCT00779558|4010064|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4188792|NCT00779558|4010065|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188793|NCT00779558|4010066|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4188794|NCT00779558|4010064|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188795|NCT00779558|4010065|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188796|NCT00779558|4010066|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188797|NCT00779558|4010064|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4188798|NCT00779558|4010065|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4188799|NCT00779558|4010066|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4188800|NCT00779558|4010064|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4188801|NCT00779558|4010065|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188802|NCT00779558|4010066|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4188803|NCT00779558|4010064|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4188804|NCT00779558|4010065|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4188805|NCT00779558|4010066|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4188806|NCT00779558|4010064|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4188807|NCT00779558|4010065|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4188808|NCT00779558|4010066|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4188809|NCT00779558|4010064|B3|||Age||months|Mean|4.2|4.2|Standard Deviation|3|3.0|||
4188810|NCT00779558|4010065|B2|||Age||months|Mean|4.3|4.3|Standard Deviation|3.2|3.2|||
4188811|NCT00779558|4010066|B1|||Age||months|Mean|4.1|4.1|Standard Deviation|2.7|2.7|||
4188812|NCT00779506|4010081|B1|Total||Weight||kg|Mean|63.5|63.5|Standard Deviation|12.6|12.6|||
4188813|NCT00779506|4010081|B1|Male||Weight||kg|Mean|66.6|66.6|Standard Deviation|11.4|11.4|||
4188814|NCT00779506|4010081|B1|Female||Weight||kg|Mean|59.1|59.1|Standard Deviation|13|13.0|||
4188815|NCT00779506|4010081|B1|Total||Height||cm|Mean|164.2|164.2|Standard Deviation|8.2|8.2|||
4188816|NCT00779506|4010081|B1|Male||Height||cm|Mean|168.7|168.7|Standard Deviation|6.6|6.6|||
4188817|NCT00779506|4010081|B1|Female||Height||cm|Mean|158|158.0|Standard Deviation|5.9|5.9|||
4188818|NCT00779506|4010081|B1|Total||BMI||kg/m2|Mean|23.5|23.5|Standard Deviation|4.4|4.4|||
4188819|NCT00779506|4010081|B1|Male||BMI||kg/m2|Mean|23.4|23.4|Standard Deviation|3.5|3.5|||
4188820|NCT00779506|4010081|B1|Female||BMI||kg/m2|Mean|23.7|23.7|Standard Deviation|5.4|5.4|||
4188821|NCT00779506|4010081|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4188822|NCT00779506|4010081|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4188823|NCT00779506|4010081|B1|Total||Age||Years|Mean|39.7|39.7|Standard Deviation|11.6|11.6|||
4188824|NCT00779506|4010081|B1|Male||Age||Years|Mean|42.4|42.4|Standard Deviation|9.8|9.8|||
4188825|NCT00779506|4010081|B1|Female||Age||Years|Mean|35.8|35.8|Standard Deviation|13|13.0|||
4188826|NCT00779467|4010091|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4188827|NCT00779467|4010092|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4188828|NCT00779467|4010093|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4188829|NCT00779467|4010094|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4188830|NCT00779467|4010095|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4188831|NCT00779467|4010091|B5||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4188832|NCT00779467|4010092|B4||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4188833|NCT00779467|4010093|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4188834|NCT00779467|4010094|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4188835|NCT00779467|4010095|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4188836|NCT00779467|4010091|B5|||Age||years|Mean|27.5|27.5|Standard Deviation|5.75|5.75|||
4188837|NCT00779467|4010092|B4|||Age||years|Mean|27|27.0|Standard Deviation|6|6.0|||
4188838|NCT00779467|4010093|B3|||Age||years|Mean|28|28.0|Standard Deviation|6|6.0|||
4188839|NCT00779467|4010094|B2|||Age||years|Mean|27|27.0|Standard Deviation|6|6.0|||
4188840|NCT00779467|4010095|B1|||Age||years|Mean|28|28.0|Standard Deviation|5|5.0|||
4188841|NCT00779402|4010136|B3|||Time from diagnosis to randomization||years|Mean|6.01|6.01|Standard Deviation|2.76|2.76|||
4188842|NCT00779402|4010137|B2|||Time from diagnosis to randomization||years|Mean|6.34|6.34|Standard Deviation|2.76|2.76|||
4188843|NCT00779402|4010138|B1|||Time from diagnosis to randomization||years|Mean|5.84|5.84|Standard Deviation|2.76|2.76|||
4188844|NCT00779402|4010136|B3|Gleason Score ≥ 8||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|40|40.0||||||
4188845|NCT00779402|4010137|B2|Gleason Score ≥ 8||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|12|12.0||||||
4188846|NCT00779402|4010138|B1|Gleason Score ≥ 8||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|28|28.0||||||
4188847|NCT00779402|4010136|B3|Gleason Score =7||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|103|103.0||||||
4188900|NCT00779311|4010147|B6|Male||Gender||participants|Number|5|5.0||||||
4188901|NCT00779311|4010152|B1|Male||Gender||participants|Number|5|5.0||||||
4188902|NCT00779311|4010147|B6|Female||Gender||participants|Number|3|3.0||||||
4188903|NCT00779311|4010152|B1|Female||Gender||participants|Number|3|3.0||||||
4188848|NCT00779402|4010137|B2|Gleason Score =7||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|34|34.0||||||
4188849|NCT00779402|4010138|B1|Gleason Score =7||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|69|69.0||||||
4188850|NCT00779402|4010136|B3|Gleason Score ≤ 6||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|33|33.0||||||
4188851|NCT00779402|4010137|B2|Gleason Score ≤ 6||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|13|13.0||||||
4188852|NCT00779402|4010138|B1|Gleason Score ≤ 6||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|20|20.0||||||
4188853|NCT00779402|4010136|B3|||Weight||Kg|Mean|90.21|90.21|Standard Deviation|14.95|14.95|||
4188854|NCT00779402|4010137|B2|||Weight||Kg|Mean|89.70|89.7|Standard Deviation|13.85|13.85|||
4188855|NCT00779402|4010138|B1|||Weight||Kg|Mean|90.45|90.45|Standard Deviation|15.52|15.52|||
4188856|NCT00779402|4010136|B3|ECOG Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|3|3.0||||||
4188857|NCT00779402|4010137|B2|ECOG Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|1|1.0||||||
4188858|NCT00779402|4010138|B1|ECOG Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|2|2.0||||||
4188859|NCT00779402|4010136|B3|ECOG 1= Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|7|7.0||||||
4188860|NCT00779402|4010137|B2|ECOG 1= Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|1|1.0||||||
4188861|NCT00779402|4010138|B1|ECOG 1= Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|6|6.0||||||
4188862|NCT00779402|4010136|B3|ECOG 0=Fully Active; No restrictions.||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|166|166.0||||||
4188863|NCT00779402|4010137|B2|ECOG 0=Fully Active; No restrictions.||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|57|57.0||||||
4188864|NCT00779402|4010138|B1|ECOG 0=Fully Active; No restrictions.||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|109|109.0||||||
4188865|NCT00779402|4010136|B3|United States||Region of Enrollment||Participants|Count of Participants|176|176.0||||||
4188866|NCT00779402|4010137|B2|United States||Region of Enrollment||Participants|Count of Participants|59|59.0||||||
4188867|NCT00779402|4010138|B1|United States||Region of Enrollment||Participants|Count of Participants|117|117.0||||||
4188868|NCT00779402|4010136|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4188869|NCT00779402|4010137|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4188870|NCT00779402|4010138|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4188871|NCT00779402|4010136|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188872|NCT00779402|4010137|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188873|NCT00779402|4010138|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188874|NCT00779402|4010136|B3||White|Race (NIH/OMB)||Participants|Count of Participants|162|162.0||||||
4188875|NCT00779402|4010137|B2||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4188876|NCT00779402|4010138|B1||White|Race (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
4188877|NCT00779402|4010136|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4188878|NCT00779402|4010137|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4188879|NCT00779402|4010138|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4188880|NCT00779402|4010136|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188881|NCT00779402|4010137|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188882|NCT00779402|4010138|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188883|NCT00779402|4010136|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188884|NCT00779402|4010137|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188885|NCT00779402|4010138|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188886|NCT00779402|4010136|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188887|NCT00779402|4010137|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188888|NCT00779402|4010138|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188889|NCT00779402|4010136|B3||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4188890|NCT00779402|4010137|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4188891|NCT00779402|4010138|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4188892|NCT00779402|4010136|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4188893|NCT00779402|4010137|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4188894|NCT00779402|4010138|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4188895|NCT00779402|4010136|B3|||Age||years|Mean|64.7|64.7|Standard Deviation|7.18|7.18|||
4188896|NCT00779402|4010137|B2|||Age||years|Mean|65.2|65.2|Standard Deviation|6.75|6.75|||
4188897|NCT00779402|4010138|B1|||Age||years|Mean|64.4|64.4|Standard Deviation|7.40|7.4|||
4188898|NCT00779311|4010147|B6|United States||Region of Enrollment||participants|Number|8|8.0||||||
4188899|NCT00779311|4010152|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4188904|NCT00779311|4010147|B6|||Age||years|Mean|62.0|62.0|Standard Deviation|11.40|11.4|||
4188905|NCT00779311|4010152|B1|||Age||years|Mean|62.0|62.0|Standard Deviation|11.40|11.4|||
4188906|NCT00779311|4010147|B6|>=65 years||Age||participants|Number|5|5.0||||||
4188907|NCT00779311|4010152|B1|>=65 years||Age||participants|Number|5|5.0||||||
4188908|NCT00779311|4010147|B6|Between 18 and 65 years||Age||participants|Number|3|3.0||||||
4188909|NCT00779311|4010152|B1|Between 18 and 65 years||Age||participants|Number|3|3.0||||||
4188910|NCT00779311|4010147|B6|<=18 years||Age||participants|Number|0|0.0||||||
4188911|NCT00779311|4010152|B1|<=18 years||Age||participants|Number|0|0.0||||||
4188912|NCT00779285|4010178|B1|Hungary||Region of Enrollment||participants|Number|1|1.0||||||
4188913|NCT00779285|4010178|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4188914|NCT00779285|4010178|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4188915|NCT00779285|4010178|B1|||Age, Customized||participants|Number|1|1.0||||||
4188916|NCT00779259|4010182|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4188917|NCT00779259|4010182|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188918|NCT00779259|4010182|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4188919|NCT00779259|4010182|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4188920|NCT00779259|4010182|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4188921|NCT00779259|4010182|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4188922|NCT00779259|4010182|B1|||Age||years|Mean|27.25|27.25|Standard Deviation|6.038|6.038|||
4188923|NCT00779259|4010182|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4188924|NCT00779259|4010182|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4188925|NCT00779259|4010182|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4188926|NCT00779246|4010201|B3|United States||Region of Enrollment||participants|Number|1518|1518.0||||||
4188927|NCT00779246|4010202|B2|United States||Region of Enrollment||participants|Number|768|768.0||||||
4188928|NCT00779246|4010203|B1|United States||Region of Enrollment||participants|Number|750|750.0||||||
4188929|NCT00779246|4010201|B3||Male|Sex: Female, Male||Participants|Count of Participants|744|744.0||||||
4188930|NCT00779246|4010202|B2||Male|Sex: Female, Male||Participants|Count of Participants|384|384.0||||||
4188931|NCT00779246|4010203|B1||Male|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
4188932|NCT00779246|4010201|B3||Female|Sex: Female, Male||Participants|Count of Participants|774|774.0||||||
4188933|NCT00779246|4010202|B2||Female|Sex: Female, Male||Participants|Count of Participants|384|384.0||||||
4188934|NCT00779246|4010203|B1||Female|Sex: Female, Male||Participants|Count of Participants|390|390.0||||||
4188935|NCT00779246|4010201|B3|||Age||years|Mean|61|61.0|Standard Deviation|15|15.0|||
4188936|NCT00779246|4010202|B2|||Age||years|Mean|60|60.0|Standard Deviation|15|15.0|||
4188937|NCT00779246|4010203|B1|||Age||years|Mean|61|61.0|Standard Deviation|15|15.0|||
4188938|NCT00779246|4010201|B3||>=65 years|Age||Participants|Count of Participants|675|675.0||||||
4188939|NCT00779246|4010202|B2||>=65 years|Age||Participants|Count of Participants|330|330.0||||||
4188940|NCT00779246|4010203|B1||>=65 years|Age||Participants|Count of Participants|345|345.0||||||
4188941|NCT00779246|4010201|B3||Between 18 and 65 years|Age||Participants|Count of Participants|843|843.0||||||
4188942|NCT00779246|4010202|B2||Between 18 and 65 years|Age||Participants|Count of Participants|438|438.0||||||
4188943|NCT00779246|4010203|B1||Between 18 and 65 years|Age||Participants|Count of Participants|405|405.0||||||
4188944|NCT00779246|4010201|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4188945|NCT00779246|4010202|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4188946|NCT00779246|4010203|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4188947|NCT00779155|4010214|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4188948|NCT00779155|4010215|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4188949|NCT00779155|4010216|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4188950|NCT00779155|4010214|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4188951|NCT00779155|4010215|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4188952|NCT00779155|4010216|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4188953|NCT00779155|4010214|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4188954|NCT00779155|4010215|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4188955|NCT00779155|4010216|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4188956|NCT00779155|4010214|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4188957|NCT00779155|4010215|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4188958|NCT00779155|4010216|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4188959|NCT00779155|4010214|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4188960|NCT00779155|4010215|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4188961|NCT00779155|4010216|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4188962|NCT00779142|4010223|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4188963|NCT00779142|4010223|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4188964|NCT00779142|4010223|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4188965|NCT00779142|4010223|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4188966|NCT00779142|4010223|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4188967|NCT00779142|4010223|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4188968|NCT00779142|4010223|B1|||Age||years|Mean|50.8|50.8|Standard Deviation|19.05781|19.05781|||
4188969|NCT00779116|4010229|B1||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4188970|NCT00779116|4010229|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4188971|NCT00779116|4010229|B1|||Age||years|Mean|8.6|8.6|Standard Deviation|1.69|1.69|||
4188972|NCT00779038|4010237|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4188973|NCT00779038|4010237|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4188974|NCT00779038|4010237|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4188975|NCT00779038|4010237|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4188976|NCT00779038|4010237|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4188977|NCT00779025|4010246|B1|United States||Region of Enrollment||participants|Number|82|82.0||||||
4188978|NCT00779025|4010246|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4188979|NCT00779025|4010246|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4188980|NCT00779025|4010246|B1|Female||Age, Customized||Years|Mean|40.0|40.0|Standard Deviation|13.3|13.3|||
4188981|NCT00779025|4010246|B1|Male||Age, Customized||Years|Mean|42.3|42.3|Standard Deviation|14.5|14.5|||
4188982|NCT00778999|4010255|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4188983|NCT00778999|4010256|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4188984|NCT00778999|4010257|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4188985|NCT00778999|4010255|B3||Female|Sex: Female, Male||Participants|Count of Participants|442|442.0||||||
4188986|NCT00778999|4010256|B2||Female|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
4188987|NCT00778999|4010257|B1||Female|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4188988|NCT00778999|4010255|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4188989|NCT00778999|4010256|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4188990|NCT00778999|4010257|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4188991|NCT00778999|4010255|B3||Between 18 and 65 years|Age||Participants|Count of Participants|442|442.0||||||
4188992|NCT00778999|4010256|B2||Between 18 and 65 years|Age||Participants|Count of Participants|219|219.0||||||
4188993|NCT00778999|4010257|B1||Between 18 and 65 years|Age||Participants|Count of Participants|223|223.0||||||
4188994|NCT00778999|4010255|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4188995|NCT00778999|4010256|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4188996|NCT00778999|4010257|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4188997|NCT00778921|4010264|B4||Male|Sex: Female, Male||Participants|Count of Participants|519|519.0||||||
4188998|NCT00778921|4010265|B3||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4188999|NCT00778921|4010266|B2||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4189000|NCT00778921|4010267|B1||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4189001|NCT00778921|4010264|B4||Female|Sex: Female, Male||Participants|Count of Participants|328|328.0||||||
4189002|NCT00778921|4010265|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4189003|NCT00778921|4010266|B2||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4189004|NCT00778921|4010267|B1||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4189005|NCT00778921|4010264|B4|||Age||years|Mean|54.6|54.6|Standard Deviation|10.60|10.6|||
4189006|NCT00778921|4010265|B3|||Age||years|Mean|54.3|54.3|Standard Deviation|10.92|10.92|||
4189007|NCT00778921|4010266|B2|||Age||years|Mean|54.4|54.4|Standard Deviation|10.70|10.7|||
4189008|NCT00778921|4010267|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|10.19|10.19|||
4189009|NCT00778895|4010283|B4||Male|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4189010|NCT00778895|4010284|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4189011|NCT00778895|4010285|B2||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4189012|NCT00778895|4010286|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4189013|NCT00778895|4010283|B4||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4189014|NCT00778895|4010284|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4189015|NCT00778895|4010285|B2||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4189016|NCT00778895|4010286|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4189017|NCT00778895|4010283|B4|||Age||Years|Mean|17.7|17.7|Standard Deviation|8.62|8.62|||
4189018|NCT00778895|4010284|B3|||Age||Years|Mean|17.0|17.0|Standard Deviation|8.33|8.33|||
4189019|NCT00778895|4010285|B2|||Age||Years|Mean|17.5|17.5|Standard Deviation|8.27|8.27|||
4189020|NCT00778895|4010286|B1|||Age||Years|Mean|18.2|18.2|Standard Deviation|9.06|9.06|||
4189021|NCT00778869|4010326|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4189022|NCT00778869|4010326|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4189023|NCT00778869|4010326|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4189024|NCT00778869|4010326|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4189025|NCT00778869|4010326|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4189026|NCT00778830|4010330|B3||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4189027|NCT00778830|4010331|B2||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4189028|NCT00778830|4010332|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4189029|NCT00778830|4010330|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4189030|NCT00778830|4010331|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4189031|NCT00778830|4010332|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4189032|NCT00778830|4010330|B3||>=65 years|Age||Participants|Count of Participants|74|74.0||||||
4189033|NCT00778830|4010331|B2||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
4189034|NCT00778830|4010332|B1||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4189035|NCT00778830|4010330|B3||Between 18 and 65 years|Age||Participants|Count of Participants|215|215.0||||||
4189036|NCT00778830|4010331|B2||Between 18 and 65 years|Age||Participants|Count of Participants|145|145.0||||||
4189037|NCT00778830|4010332|B1||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4189038|NCT00778830|4010330|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4189039|NCT00778830|4010331|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4189040|NCT00778830|4010332|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4189041|NCT00778817|4010345|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4189042|NCT00778817|4010345|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4189043|NCT00778817|4010345|B1|||Age||years|Mean|49.2|49.2|Standard Deviation|16.8|16.8|||
4189044|NCT00778648|4010360|B3|Germany||Region of Enrollment||participants|Number|543|543.0||||||
4189045|NCT00778648|4010361|B2|Germany||Region of Enrollment||participants|Number|271|271.0||||||
4189046|NCT00778648|4010362|B1|Germany||Region of Enrollment||participants|Number|272|272.0||||||
4189047|NCT00778648|4010360|B3|Male||Gender||participants|Number|105|105.0||||||
4189048|NCT00778648|4010361|B2|Male||Gender||participants|Number|44|44.0||||||
4189049|NCT00778648|4010362|B1|Male||Gender||participants|Number|61|61.0||||||
4189050|NCT00778648|4010360|B3|Female||Gender||participants|Number|424|424.0||||||
4189051|NCT00778648|4010361|B2|Female||Gender||participants|Number|222|222.0||||||
4189052|NCT00778648|4010362|B1|Female||Gender||participants|Number|202|202.0||||||
4189053|NCT00778648|4010360|B3|||Age||years|Mean|40.9|40.9|Standard Deviation|10.2|10.2|||
4189054|NCT00778648|4010361|B2|||Age||years|Mean|38.8|38.8|Standard Deviation|10.3|10.3|||
4189055|NCT00778648|4010362|B1|||Age||years|Mean|40.9|40.9|Standard Deviation|10.2|10.2|||
4189056|NCT00778622|4010369|B4|China||Region of Enrollment||participants|Number|371|371.0||||||
4189057|NCT00778622|4010370|B3|China||Region of Enrollment||participants|Number|124|124.0||||||
4189058|NCT00778622|4010371|B2|China||Region of Enrollment||participants|Number|122|122.0||||||
4189059|NCT00778622|4010372|B1|China||Region of Enrollment||participants|Number|125|125.0||||||
4189060|NCT00778622|4010369|B4||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4189061|NCT00778622|4010370|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4189062|NCT00778622|4010371|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4189063|NCT00778622|4010372|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4189064|NCT00778622|4010369|B4||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4189065|NCT00778622|4010370|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4189066|NCT00778622|4010371|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4189067|NCT00778622|4010372|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4189068|NCT00778622|4010369|B4|||Age||years|Median|52.0|52.0|Full Range|10.17|10.17|23.0|77.0|
4189069|NCT00778622|4010370|B3|||Age||years|Median|52.5|52.5|Full Range|10.97|10.97|23.0|74.0|
4189070|NCT00778622|4010371|B2|||Age||years|Median|51.0|51.0|Full Range|9.21|9.21|32.0|77.0|
4189071|NCT00778622|4010372|B1|||Age||years|Median|53.0|53.0|Full Range|10.32|10.32|28.0|77.0|
4189072|NCT00778375|4010427|B1|United States||Region of Enrollment||participants|Number|122|122.0||||||
4189073|NCT00778375|4010427|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4189074|NCT00778375|4010427|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4189075|NCT00778375|4010427|B1|||Age||years|Median|68|68.0|Full Range|||60.0|81.0|
4189076|NCT00778336|4010437|B5|United States||Region of Enrollment||participants|Number|452|452.0||||||
4189077|NCT00778336|4010438|B4|United States||Region of Enrollment||participants|Number|12|12.0||||||
4189078|NCT00778336|4010439|B3|United States||Region of Enrollment||participants|Number|72|72.0||||||
4189079|NCT00778336|4010440|B2|United States||Region of Enrollment||participants|Number|170|170.0||||||
4189080|NCT00778336|4010441|B1|United States||Region of Enrollment||participants|Number|198|198.0||||||
4189081|NCT00778336|4010437|B5||Male|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
4189082|NCT00778336|4010438|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4189083|NCT00778336|4010439|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4189084|NCT00778336|4010440|B2||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4189085|NCT00778336|4010441|B1||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4189086|NCT00778336|4010437|B5||Female|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4189087|NCT00778336|4010438|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4189088|NCT00778336|4010439|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4189089|NCT00778336|4010440|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4189090|NCT00778336|4010441|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4189091|NCT00778336|4010437|B5|||Age||years|Mean|61|61.0|Standard Deviation|16|16.0|||
4189092|NCT00778336|4010438|B4|||Age||years|Mean|63|63.0|Standard Deviation|18|18.0|||
4189093|NCT00778336|4010439|B3|||Age||years|Mean|63|63.0|Standard Deviation|13|13.0|||
4189094|NCT00778336|4010440|B2|||Age||years|Mean|52|52.0|Standard Deviation|17|17.0|||
4189095|NCT00778336|4010441|B1|||Age||years|Mean|67|67.0|Standard Deviation|14|14.0|||
4189096|NCT00778310|4010462|B3|United States||Region of Enrollment||participants|Number|43|43.0||||||
4189097|NCT00778310|4010463|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4189098|NCT00778310|4010464|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4189099|NCT00778310|4010462|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4189100|NCT00778310|4010463|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4189101|NCT00778310|4010464|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4189102|NCT00778310|4010462|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4189103|NCT00778310|4010463|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4189104|NCT00778310|4010464|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4189105|NCT00778310|4010462|B3|||Age||years|Mean|15.6|15.6|Standard Deviation|5.7|5.7|||
4189106|NCT00778310|4010463|B2|||Age||years|Mean|11.3|11.3|Standard Deviation|2.1|2.1|||
4189107|NCT00778310|4010464|B1|||Age||years|Mean|22.2|22.2|Standard Deviation|1.78|1.78|||
4189108|NCT00778310|4010462|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4189109|NCT00778310|4010463|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4189110|NCT00778310|4010464|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4189111|NCT00778310|4010462|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4189112|NCT00778310|4010463|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4189113|NCT00778310|4010464|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4189114|NCT00778310|4010462|B3||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
4189115|NCT00778310|4010463|B2||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
4189116|NCT00778310|4010464|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4189117|NCT00778258|4010473|B10|||Baseline Cow’s Milk IgE|When cow’s milk immunoglobulin E (IgE) antibodies are present in serum samples, this is indicative of a potential for an allergic reaction to cow’s milk. The greater the concentration of IgE antibodies present, the more likely an allergic reaction to cow’s milk is to occur.|kUa/L|Mean|10.6|10.6|Standard Deviation|13.6|13.6|||
4189118|NCT00778258|4010474|B9|||Baseline Cow’s Milk IgE|When cow’s milk immunoglobulin E (IgE) antibodies are present in serum samples, this is indicative of a potential for an allergic reaction to cow’s milk. The greater the concentration of IgE antibodies present, the more likely an allergic reaction to cow’s milk is to occur.|kUa/L|Mean|4.9|4.9|Standard Deviation|8.1|8.1|||
4189119|NCT00778258|4010475|B8|||Baseline Cow’s Milk IgE|When cow’s milk immunoglobulin E (IgE) antibodies are present in serum samples, this is indicative of a potential for an allergic reaction to cow’s milk. The greater the concentration of IgE antibodies present, the more likely an allergic reaction to cow’s milk is to occur.|kUa/L|Mean|15.1|15.1|Standard Deviation|12.7|12.7|||
4189120|NCT00778258|4010476|B7|||Baseline Cow’s Milk IgE|When cow’s milk immunoglobulin E (IgE) antibodies are present in serum samples, this is indicative of a potential for an allergic reaction to cow’s milk. The greater the concentration of IgE antibodies present, the more likely an allergic reaction to cow’s milk is to occur.|kUa/L|Mean|14.7|14.7|Standard Deviation|21.3|21.3|||
4189121|NCT00778258|4010477|B6|||Baseline Cow’s Milk IgE|When cow’s milk immunoglobulin E (IgE) antibodies are present in serum samples, this is indicative of a potential for an allergic reaction to cow’s milk. The greater the concentration of IgE antibodies present, the more likely an allergic reaction to cow’s milk is to occur.|kUa/L|Mean|4.1|4.1|Standard Deviation|4.5|4.5|||
4189122|NCT00778258|4010478|B5|||Baseline Cow’s Milk IgE|When cow’s milk immunoglobulin E (IgE) antibodies are present in serum samples, this is indicative of a potential for an allergic reaction to cow’s milk. The greater the concentration of IgE antibodies present, the more likely an allergic reaction to cow’s milk is to occur.|kUa/L|Mean|13.7|13.7|Standard Deviation|13.1|13.1|||
4189123|NCT00778258|4010479|B4|||Baseline Cow’s Milk IgE|When cow’s milk immunoglobulin E (IgE) antibodies are present in serum samples, this is indicative of a potential for an allergic reaction to cow’s milk. The greater the concentration of IgE antibodies present, the more likely an allergic reaction to cow’s milk is to occur.|kUa/L|Mean|7.8|7.8|Standard Deviation|9.7|9.7|||
4189124|NCT00778258|4010480|B3|||Baseline Cow’s Milk IgE|When cow’s milk immunoglobulin E (IgE) antibodies are present in serum samples, this is indicative of a potential for an allergic reaction to cow’s milk. The greater the concentration of IgE antibodies present, the more likely an allergic reaction to cow’s milk is to occur.|kUa/L|Mean|5.3|5.3|Standard Deviation|5.4|5.4|||
4189125|NCT00778258|4010481|B2|||Baseline Cow’s Milk IgE|When cow’s milk immunoglobulin E (IgE) antibodies are present in serum samples, this is indicative of a potential for an allergic reaction to cow’s milk. The greater the concentration of IgE antibodies present, the more likely an allergic reaction to cow’s milk is to occur.|kUa/L|Mean|10.5|10.5|Standard Deviation|7.8|7.8|||
4189126|NCT00778258|4010482|B1|||Baseline Cow’s Milk IgE|When cow’s milk immunoglobulin E (IgE) antibodies are present in serum samples, this is indicative of a potential for an allergic reaction to cow’s milk. The greater the concentration of IgE antibodies present, the more likely an allergic reaction to cow’s milk is to occur.|kUa/L|Mean|10.3|10.3|Standard Deviation|11.5|11.5|||
4189127|NCT00778258|4010473|B10|||Baseline Unheated Milk Wheal|A skin prick test (SPT) measured the presence of immunoglobulin E (IgE) antibodies for the food tested. During the SPT, a drop of solution containing the food allergen was placed on the forearm. Using a small plastic needle, the skin was gently pricked or scratched to allow a tiny amount of the solution to enter just below the surface. After 15 minutes, positive results were indicated by a wheal, a raised white bump surrounded by a small circle of red skin. The wheal was measured in millimeters. Larger sizes indicated a greater chance of experiencing an allergic reaction to the food tested.|Mm|Mean|9.3|9.3|Standard Deviation|3.4|3.4|||
4189128|NCT00778258|4010474|B9|||Baseline Unheated Milk Wheal|A skin prick test (SPT) measured the presence of immunoglobulin E (IgE) antibodies for the food tested. During the SPT, a drop of solution containing the food allergen was placed on the forearm. Using a small plastic needle, the skin was gently pricked or scratched to allow a tiny amount of the solution to enter just below the surface. After 15 minutes, positive results were indicated by a wheal, a raised white bump surrounded by a small circle of red skin. The wheal was measured in millimeters. Larger sizes indicated a greater chance of experiencing an allergic reaction to the food tested.|Mm|Mean|5.6|5.6|Standard Deviation|2.8|2.8|||
4189129|NCT00778258|4010475|B8|||Baseline Unheated Milk Wheal|A skin prick test (SPT) measured the presence of immunoglobulin E (IgE) antibodies for the food tested. During the SPT, a drop of solution containing the food allergen was placed on the forearm. Using a small plastic needle, the skin was gently pricked or scratched to allow a tiny amount of the solution to enter just below the surface. After 15 minutes, positive results were indicated by a wheal, a raised white bump surrounded by a small circle of red skin. The wheal was measured in millimeters. Larger sizes indicated a greater chance of experiencing an allergic reaction to the food tested.|Mm|Mean|10.1|10.1|Standard Deviation|2.6|2.6|||
4189130|NCT00778258|4010476|B7|||Baseline Unheated Milk Wheal|A skin prick test (SPT) measured the presence of immunoglobulin E (IgE) antibodies for the food tested. During the SPT, a drop of solution containing the food allergen was placed on the forearm. Using a small plastic needle, the skin was gently pricked or scratched to allow a tiny amount of the solution to enter just below the surface. After 15 minutes, positive results were indicated by a wheal, a raised white bump surrounded by a small circle of red skin. The wheal was measured in millimeters. Larger sizes indicated a greater chance of experiencing an allergic reaction to the food tested.|Mm|Mean|9.6|9.6|Standard Deviation|4.3|4.3|||
4189131|NCT00778258|4010477|B6|||Baseline Unheated Milk Wheal|A skin prick test (SPT) measured the presence of immunoglobulin E (IgE) antibodies for the food tested. During the SPT, a drop of solution containing the food allergen was placed on the forearm. Using a small plastic needle, the skin was gently pricked or scratched to allow a tiny amount of the solution to enter just below the surface. After 15 minutes, positive results were indicated by a wheal, a raised white bump surrounded by a small circle of red skin. The wheal was measured in millimeters. Larger sizes indicated a greater chance of experiencing an allergic reaction to the food tested.|Mm|Mean|9.7|9.7|Standard Deviation|4.0|4.0|||
4189132|NCT00778258|4010478|B5|||Baseline Unheated Milk Wheal|A skin prick test (SPT) measured the presence of immunoglobulin E (IgE) antibodies for the food tested. During the SPT, a drop of solution containing the food allergen was placed on the forearm. Using a small plastic needle, the skin was gently pricked or scratched to allow a tiny amount of the solution to enter just below the surface. After 15 minutes, positive results were indicated by a wheal, a raised white bump surrounded by a small circle of red skin. The wheal was measured in millimeters. Larger sizes indicated a greater chance of experiencing an allergic reaction to the food tested.|Mm|Mean|10.0|10.0|Standard Deviation|2.7|2.7|||
4189133|NCT00778258|4010479|B4|||Baseline Unheated Milk Wheal|A skin prick test (SPT) measured the presence of immunoglobulin E (IgE) antibodies for the food tested. During the SPT, a drop of solution containing the food allergen was placed on the forearm. Using a small plastic needle, the skin was gently pricked or scratched to allow a tiny amount of the solution to enter just below the surface. After 15 minutes, positive results were indicated by a wheal, a raised white bump surrounded by a small circle of red skin. The wheal was measured in millimeters. Larger sizes indicated a greater chance of experiencing an allergic reaction to the food tested.|Mm|Mean|8.8|8.8|Standard Deviation|2.3|2.3|||
4189134|NCT00778258|4010480|B3|||Baseline Unheated Milk Wheal|A skin prick test (SPT) measured the presence of immunoglobulin E (IgE) antibodies for the food tested. During the SPT, a drop of solution containing the food allergen was placed on the forearm. Using a small plastic needle, the skin was gently pricked or scratched to allow a tiny amount of the solution to enter just below the surface. After 15 minutes, positive results were indicated by a wheal, a raised white bump surrounded by a small circle of red skin. The wheal was measured in millimeters. Larger sizes indicated a greater chance of experiencing an allergic reaction to the food tested.|Mm|Mean|8.3|8.3|Standard Deviation|2.5|2.5|||
4189135|NCT00778258|4010481|B2|||Baseline Unheated Milk Wheal|A skin prick test (SPT) measured the presence of immunoglobulin E (IgE) antibodies for the food tested. During the SPT, a drop of solution containing the food allergen was placed on the forearm. Using a small plastic needle, the skin was gently pricked or scratched to allow a tiny amount of the solution to enter just below the surface. After 15 minutes, positive results were indicated by a wheal, a raised white bump surrounded by a small circle of red skin. The wheal was measured in millimeters. Larger sizes indicated a greater chance of experiencing an allergic reaction to the food tested.|Mm|Mean|11.6|11.6|Standard Deviation|4.2|4.2|||
4189136|NCT00778258|4010482|B1|||Baseline Unheated Milk Wheal|A skin prick test (SPT) measured the presence of immunoglobulin E (IgE) antibodies for the food tested. During the SPT, a drop of solution containing the food allergen was placed on the forearm. Using a small plastic needle, the skin was gently pricked or scratched to allow a tiny amount of the solution to enter just below the surface. After 15 minutes, positive results were indicated by a wheal, a raised white bump surrounded by a small circle of red skin. The wheal was measured in millimeters. Larger sizes indicated a greater chance of experiencing an allergic reaction to the food tested.|Mm|Mean|10.4|10.4|Standard Deviation|4.2|4.2|||
4189137|NCT00778258|4010473|B10|||Baseline Milk Extract Wheal|A skin prick test (SPT) measured the presence of immunoglobulin E (IgE) antibodies for the food tested. During the SPT, a drop of solution containing the food allergen was placed on the forearm. Using a small plastic needle, the skin was gently pricked or scratched to allow a tiny amount of the solution to enter just below the surface. After 15 minutes, positive results were indicated by a wheal, a raised white bump surrounded by a small circle of red skin. The wheal was measured in millimeters. Larger sizes indicated a greater chance of experiencing an allergic reaction to the food tested.|Mm|Mean|8.9|8.9|Standard Deviation|3.4|3.4|||
4189168|NCT00778258|4010474|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189169|NCT00778258|4010475|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4189170|NCT00778258|4010476|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4189171|NCT00778258|4010477|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4189138|NCT00778258|4010474|B9|||Baseline Milk Extract Wheal|A skin prick test (SPT) measured the presence of immunoglobulin E (IgE) antibodies for the food tested. During the SPT, a drop of solution containing the food allergen was placed on the forearm. Using a small plastic needle, the skin was gently pricked or scratched to allow a tiny amount of the solution to enter just below the surface. After 15 minutes, positive results were indicated by a wheal, a raised white bump surrounded by a small circle of red skin. The wheal was measured in millimeters. Larger sizes indicated a greater chance of experiencing an allergic reaction to the food tested.|Mm|Mean|5.0|5.0|Standard Deviation|2.6|2.6|||
4189139|NCT00778258|4010475|B8|||Baseline Milk Extract Wheal|A skin prick test (SPT) measured the presence of immunoglobulin E (IgE) antibodies for the food tested. During the SPT, a drop of solution containing the food allergen was placed on the forearm. Using a small plastic needle, the skin was gently pricked or scratched to allow a tiny amount of the solution to enter just below the surface. After 15 minutes, positive results were indicated by a wheal, a raised white bump surrounded by a small circle of red skin. The wheal was measured in millimeters. Larger sizes indicated a greater chance of experiencing an allergic reaction to the food tested.|Mm|Mean|10.5|10.5|Standard Deviation|3.7|3.7|||
4189140|NCT00778258|4010476|B7|||Baseline Milk Extract Wheal|A skin prick test (SPT) measured the presence of immunoglobulin E (IgE) antibodies for the food tested. During the SPT, a drop of solution containing the food allergen was placed on the forearm. Using a small plastic needle, the skin was gently pricked or scratched to allow a tiny amount of the solution to enter just below the surface. After 15 minutes, positive results were indicated by a wheal, a raised white bump surrounded by a small circle of red skin. The wheal was measured in millimeters. Larger sizes indicated a greater chance of experiencing an allergic reaction to the food tested.|Mm|Mean|9.0|9.0|Standard Deviation|3.8|3.8|||
4189141|NCT00778258|4010477|B6|||Baseline Milk Extract Wheal|A skin prick test (SPT) measured the presence of immunoglobulin E (IgE) antibodies for the food tested. During the SPT, a drop of solution containing the food allergen was placed on the forearm. Using a small plastic needle, the skin was gently pricked or scratched to allow a tiny amount of the solution to enter just below the surface. After 15 minutes, positive results were indicated by a wheal, a raised white bump surrounded by a small circle of red skin. The wheal was measured in millimeters. Larger sizes indicated a greater chance of experiencing an allergic reaction to the food tested.|Mm|Mean|8.5|8.5|Standard Deviation|3.4|3.4|||
4189142|NCT00778258|4010478|B5|||Baseline Milk Extract Wheal|A skin prick test (SPT) measured the presence of immunoglobulin E (IgE) antibodies for the food tested. During the SPT, a drop of solution containing the food allergen was placed on the forearm. Using a small plastic needle, the skin was gently pricked or scratched to allow a tiny amount of the solution to enter just below the surface. After 15 minutes, positive results were indicated by a wheal, a raised white bump surrounded by a small circle of red skin. The wheal was measured in millimeters. Larger sizes indicated a greater chance of experiencing an allergic reaction to the food tested.|Mm|Mean|8.1|8.1|Standard Deviation|2.7|2.7|||
4189143|NCT00778258|4010479|B4|||Baseline Milk Extract Wheal|A skin prick test (SPT) measured the presence of immunoglobulin E (IgE) antibodies for the food tested. During the SPT, a drop of solution containing the food allergen was placed on the forearm. Using a small plastic needle, the skin was gently pricked or scratched to allow a tiny amount of the solution to enter just below the surface. After 15 minutes, positive results were indicated by a wheal, a raised white bump surrounded by a small circle of red skin. The wheal was measured in millimeters. Larger sizes indicated a greater chance of experiencing an allergic reaction to the food tested.|Mm|Mean|8.9|8.9|Standard Deviation|2.8|2.8|||
4189144|NCT00778258|4010480|B3|||Baseline Milk Extract Wheal|A skin prick test (SPT) measured the presence of immunoglobulin E (IgE) antibodies for the food tested. During the SPT, a drop of solution containing the food allergen was placed on the forearm. Using a small plastic needle, the skin was gently pricked or scratched to allow a tiny amount of the solution to enter just below the surface. After 15 minutes, positive results were indicated by a wheal, a raised white bump surrounded by a small circle of red skin. The wheal was measured in millimeters. Larger sizes indicated a greater chance of experiencing an allergic reaction to the food tested.|Mm|Mean|9.1|9.1|Standard Deviation|3.4|3.4|||
4189145|NCT00778258|4010481|B2|||Baseline Milk Extract Wheal|A skin prick test (SPT) measured the presence of immunoglobulin E (IgE) antibodies for the food tested. During the SPT, a drop of solution containing the food allergen was placed on the forearm. Using a small plastic needle, the skin was gently pricked or scratched to allow a tiny amount of the solution to enter just below the surface. After 15 minutes, positive results were indicated by a wheal, a raised white bump surrounded by a small circle of red skin. The wheal was measured in millimeters. Larger sizes indicated a greater chance of experiencing an allergic reaction to the food tested.|Mm|Mean|8.6|8.6|Standard Deviation|1.2|1.2|||
4189146|NCT00778258|4010482|B1|||Baseline Milk Extract Wheal|A skin prick test (SPT) measured the presence of immunoglobulin E (IgE) antibodies for the food tested. During the SPT, a drop of solution containing the food allergen was placed on the forearm. Using a small plastic needle, the skin was gently pricked or scratched to allow a tiny amount of the solution to enter just below the surface. After 15 minutes, positive results were indicated by a wheal, a raised white bump surrounded by a small circle of red skin. The wheal was measured in millimeters. Larger sizes indicated a greater chance of experiencing an allergic reaction to the food tested.|Mm|Mean|8.9|8.9|Standard Deviation|2.4|2.4|||
4189147|NCT00778258|4010473|B10|||Baseline Boiled Milk Wheal|A skin prick test (SPT) measured the presence of immunoglobulin E (IgE) antibodies for the food tested. During the SPT, a drop of solution containing the food allergen was placed on the forearm. Using a small plastic needle, the skin was gently pricked or scratched to allow a tiny amount of the solution to enter just below the surface. After 15 minutes, positive results were indicated by a wheal, a raised white bump surrounded by a small circle of red skin. The wheal was measured in millimeters. Larger sizes indicated a greater chance of experiencing an allergic reaction to the food tested.|Mm|Mean|6.9|6.9|Standard Deviation|3.2|3.2|||
4189172|NCT00778258|4010478|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189173|NCT00778258|4010479|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189174|NCT00778258|4010480|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189175|NCT00778258|4010481|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189148|NCT00778258|4010474|B9|||Baseline Boiled Milk Wheal|A skin prick test (SPT) measured the presence of immunoglobulin E (IgE) antibodies for the food tested. During the SPT, a drop of solution containing the food allergen was placed on the forearm. Using a small plastic needle, the skin was gently pricked or scratched to allow a tiny amount of the solution to enter just below the surface. After 15 minutes, positive results were indicated by a wheal, a raised white bump surrounded by a small circle of red skin. The wheal was measured in millimeters. Larger sizes indicated a greater chance of experiencing an allergic reaction to the food tested.|Mm|Mean|3.4|3.4|Standard Deviation|2.5|2.5|||
4189149|NCT00778258|4010475|B8|||Baseline Boiled Milk Wheal|A skin prick test (SPT) measured the presence of immunoglobulin E (IgE) antibodies for the food tested. During the SPT, a drop of solution containing the food allergen was placed on the forearm. Using a small plastic needle, the skin was gently pricked or scratched to allow a tiny amount of the solution to enter just below the surface. After 15 minutes, positive results were indicated by a wheal, a raised white bump surrounded by a small circle of red skin. The wheal was measured in millimeters. Larger sizes indicated a greater chance of experiencing an allergic reaction to the food tested.|Mm|Mean|7.9|7.9|Standard Deviation|2.6|2.6|||
4189150|NCT00778258|4010476|B7|||Baseline Boiled Milk Wheal|A skin prick test (SPT) measured the presence of immunoglobulin E (IgE) antibodies for the food tested. During the SPT, a drop of solution containing the food allergen was placed on the forearm. Using a small plastic needle, the skin was gently pricked or scratched to allow a tiny amount of the solution to enter just below the surface. After 15 minutes, positive results were indicated by a wheal, a raised white bump surrounded by a small circle of red skin. The wheal was measured in millimeters. Larger sizes indicated a greater chance of experiencing an allergic reaction to the food tested.|Mm|Mean|7.7|7.7|Standard Deviation|4.5|4.5|||
4189151|NCT00778258|4010477|B6|||Baseline Boiled Milk Wheal|A skin prick test (SPT) measured the presence of immunoglobulin E (IgE) antibodies for the food tested. During the SPT, a drop of solution containing the food allergen was placed on the forearm. Using a small plastic needle, the skin was gently pricked or scratched to allow a tiny amount of the solution to enter just below the surface. After 15 minutes, positive results were indicated by a wheal, a raised white bump surrounded by a small circle of red skin. The wheal was measured in millimeters. Larger sizes indicated a greater chance of experiencing an allergic reaction to the food tested.|Mm|Mean|5.5|5.5|Standard Deviation|3.2|3.2|||
4189152|NCT00778258|4010478|B5|||Baseline Boiled Milk Wheal|A skin prick test (SPT) measured the presence of immunoglobulin E (IgE) antibodies for the food tested. During the SPT, a drop of solution containing the food allergen was placed on the forearm. Using a small plastic needle, the skin was gently pricked or scratched to allow a tiny amount of the solution to enter just below the surface. After 15 minutes, positive results were indicated by a wheal, a raised white bump surrounded by a small circle of red skin. The wheal was measured in millimeters. Larger sizes indicated a greater chance of experiencing an allergic reaction to the food tested.|Mm|Mean|7.6|7.6|Standard Deviation|2.0|2.0|||
4189153|NCT00778258|4010479|B4|||Baseline Boiled Milk Wheal|A skin prick test (SPT) measured the presence of immunoglobulin E (IgE) antibodies for the food tested. During the SPT, a drop of solution containing the food allergen was placed on the forearm. Using a small plastic needle, the skin was gently pricked or scratched to allow a tiny amount of the solution to enter just below the surface. After 15 minutes, positive results were indicated by a wheal, a raised white bump surrounded by a small circle of red skin. The wheal was measured in millimeters. Larger sizes indicated a greater chance of experiencing an allergic reaction to the food tested.|Mm|Mean|7.6|7.6|Standard Deviation|1.9|1.9|||
4189154|NCT00778258|4010480|B3|||Baseline Boiled Milk Wheal|A skin prick test (SPT) measured the presence of immunoglobulin E (IgE) antibodies for the food tested. During the SPT, a drop of solution containing the food allergen was placed on the forearm. Using a small plastic needle, the skin was gently pricked or scratched to allow a tiny amount of the solution to enter just below the surface. After 15 minutes, positive results were indicated by a wheal, a raised white bump surrounded by a small circle of red skin. The wheal was measured in millimeters. Larger sizes indicated a greater chance of experiencing an allergic reaction to the food tested.|Mm|Mean|6.6|6.6|Standard Deviation|2.8|2.8|||
4189155|NCT00778258|4010481|B2|||Baseline Boiled Milk Wheal|A skin prick test (SPT) measured the presence of immunoglobulin E (IgE) antibodies for the food tested. During the SPT, a drop of solution containing the food allergen was placed on the forearm. Using a small plastic needle, the skin was gently pricked or scratched to allow a tiny amount of the solution to enter just below the surface. After 15 minutes, positive results were indicated by a wheal, a raised white bump surrounded by a small circle of red skin. The wheal was measured in millimeters. Larger sizes indicated a greater chance of experiencing an allergic reaction to the food tested.|Mm|Mean|6.1|6.1|Standard Deviation|3.5|3.5|||
4189156|NCT00778258|4010482|B1|||Baseline Boiled Milk Wheal|A skin prick test (SPT) measured the presence of immunoglobulin E (IgE) antibodies for the food tested. During the SPT, a drop of solution containing the food allergen was placed on the forearm. Using a small plastic needle, the skin was gently pricked or scratched to allow a tiny amount of the solution to enter just below the surface. After 15 minutes, positive results were indicated by a wheal, a raised white bump surrounded by a small circle of red skin. The wheal was measured in millimeters. Larger sizes indicated a greater chance of experiencing an allergic reaction to the food tested.|Mm|Mean|7.3|7.3|Standard Deviation|2.4|2.4|||
4189157|NCT00778258|4010473|B10|United States||Region of Enrollment||participants|Number|170|170.0||||||
4189158|NCT00778258|4010474|B9|United States||Region of Enrollment||participants|Number|10|10.0||||||
4189159|NCT00778258|4010475|B8|United States||Region of Enrollment||participants|Number|41|41.0||||||
4189160|NCT00778258|4010476|B7|United States||Region of Enrollment||participants|Number|34|34.0||||||
4189161|NCT00778258|4010477|B6|United States||Region of Enrollment||participants|Number|23|23.0||||||
4189162|NCT00778258|4010478|B5|United States||Region of Enrollment||participants|Number|6|6.0||||||
4189163|NCT00778258|4010479|B4|United States||Region of Enrollment||participants|Number|15|15.0||||||
4189164|NCT00778258|4010480|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4189165|NCT00778258|4010481|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4189166|NCT00778258|4010482|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4189167|NCT00778258|4010473|B10||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4189176|NCT00778258|4010482|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189177|NCT00778258|4010473|B10||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4189178|NCT00778258|4010474|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189179|NCT00778258|4010475|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4189180|NCT00778258|4010476|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189181|NCT00778258|4010477|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189182|NCT00778258|4010478|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189183|NCT00778258|4010479|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189184|NCT00778258|4010480|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189185|NCT00778258|4010481|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189186|NCT00778258|4010482|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189187|NCT00778258|4010473|B10||White|Race (NIH/OMB)||Participants|Count of Participants|141|141.0||||||
4189188|NCT00778258|4010474|B9||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4189189|NCT00778258|4010475|B8||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4189190|NCT00778258|4010476|B7||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4189191|NCT00778258|4010477|B6||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4189192|NCT00778258|4010478|B5||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4189193|NCT00778258|4010479|B4||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4189194|NCT00778258|4010480|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4189195|NCT00778258|4010481|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4189196|NCT00778258|4010482|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4189197|NCT00778258|4010473|B10||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4189198|NCT00778258|4010474|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189199|NCT00778258|4010475|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4189200|NCT00778258|4010476|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189201|NCT00778258|4010477|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189202|NCT00778258|4010478|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189203|NCT00778258|4010479|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189204|NCT00778258|4010480|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4189205|NCT00778258|4010481|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189206|NCT00778258|4010482|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189207|NCT00778258|4010473|B10||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189208|NCT00778258|4010474|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189209|NCT00778258|4010475|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189210|NCT00778258|4010476|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189211|NCT00778258|4010477|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189212|NCT00778258|4010478|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189213|NCT00778258|4010479|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189214|NCT00778258|4010480|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189215|NCT00778258|4010481|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189216|NCT00778258|4010482|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189217|NCT00778258|4010473|B10||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4189218|NCT00778258|4010474|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4189219|NCT00778258|4010475|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4189220|NCT00778258|4010476|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189221|NCT00778258|4010477|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4189222|NCT00778258|4010478|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189223|NCT00778258|4010479|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4189224|NCT00778258|4010480|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4189225|NCT00778258|4010481|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4189226|NCT00778258|4010482|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4189227|NCT00778258|4010473|B10||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189228|NCT00778258|4010474|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189229|NCT00778258|4010475|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189230|NCT00778258|4010476|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189231|NCT00778258|4010477|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189232|NCT00778258|4010478|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189233|NCT00778258|4010479|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189234|NCT00778258|4010480|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189235|NCT00778258|4010481|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189236|NCT00778258|4010482|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189237|NCT00778258|4010473|B10||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4189238|NCT00778258|4010474|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189239|NCT00778258|4010475|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4189240|NCT00778258|4010476|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4189241|NCT00778258|4010477|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4189242|NCT00778258|4010478|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189243|NCT00778258|4010479|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189244|NCT00778258|4010480|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189245|NCT00778258|4010481|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189246|NCT00778258|4010482|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189247|NCT00778258|4010473|B10||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|159|159.0||||||
4189248|NCT00778258|4010474|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4189249|NCT00778258|4010475|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4189250|NCT00778258|4010476|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4189251|NCT00778258|4010477|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4189252|NCT00778258|4010478|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4189253|NCT00778258|4010479|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4189254|NCT00778258|4010480|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4189255|NCT00778258|4010481|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4189256|NCT00778258|4010482|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4189257|NCT00778258|4010473|B10||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189258|NCT00778258|4010474|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189259|NCT00778258|4010475|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189260|NCT00778258|4010476|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189261|NCT00778258|4010477|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189262|NCT00778258|4010478|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189263|NCT00778258|4010479|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189264|NCT00778258|4010480|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189265|NCT00778258|4010481|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189266|NCT00778258|4010482|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189267|NCT00778258|4010473|B10||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4189268|NCT00778258|4010474|B9||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4189269|NCT00778258|4010475|B8||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4189270|NCT00778258|4010476|B7||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4189271|NCT00778258|4010477|B6||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4189272|NCT00778258|4010478|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4189273|NCT00778258|4010479|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4189274|NCT00778258|4010480|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4189275|NCT00778258|4010481|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4189276|NCT00778258|4010482|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4189277|NCT00778258|4010473|B10||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4189278|NCT00778258|4010474|B9||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4189279|NCT00778258|4010475|B8||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4189280|NCT00778258|4010476|B7||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4189281|NCT00778258|4010477|B6||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4189282|NCT00778258|4010478|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4189283|NCT00778258|4010479|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4189284|NCT00778258|4010480|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4189285|NCT00778258|4010481|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4189286|NCT00778258|4010482|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4189287|NCT00778258|4010473|B10|||Age||years|Mean|6.9|6.9|Standard Deviation|2.2|2.2|||
4189288|NCT00778258|4010474|B9|||Age||years|Mean|6.5|6.5|Standard Deviation|2.2|2.2|||
4189289|NCT00778258|4010475|B8|||Age||years|Mean|7.5|7.5|Standard Deviation|1.9|1.9|||
4189290|NCT00778258|4010476|B7|||Age||years|Mean|6.5|6.5|Standard Deviation|2.3|2.3|||
4189291|NCT00778258|4010477|B6|||Age||years|Mean|6.3|6.3|Standard Deviation|2.1|2.1|||
4189292|NCT00778258|4010478|B5|||Age||years|Mean|6.7|6.7|Standard Deviation|2.7|2.7|||
4189293|NCT00778258|4010479|B4|||Age||years|Mean|7.3|7.3|Standard Deviation|2.2|2.2|||
4189294|NCT00778258|4010480|B3|||Age||years|Mean|7.7|7.7|Standard Deviation|2.1|2.1|||
4189295|NCT00778258|4010481|B2|||Age||years|Mean|6.2|6.2|Standard Deviation|1.6|1.6|||
4189296|NCT00778258|4010482|B1|||Age||years|Mean|6.6|6.6|Standard Deviation|2.3|2.3|||
4189297|NCT00778167|4010542|B4|United States||Region of Enrollment||participants|Number|18|18.0||||||
4189298|NCT00778167|4010543|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4189299|NCT00778167|4010544|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4189300|NCT00778167|4010545|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4189301|NCT00778167|4010542|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4189302|NCT00778167|4010543|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4189303|NCT00778167|4010544|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4189304|NCT00778167|4010545|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4189305|NCT00778167|4010542|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4189306|NCT00778167|4010543|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4189307|NCT00778167|4010544|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4189308|NCT00778167|4010545|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4189309|NCT00778167|4010542|B4|>=77 years||Age, Customized||participants|Number|0|0.0||||||
4189310|NCT00778167|4010543|B3|>=77 years||Age, Customized||participants|Number|0|0.0||||||
4189311|NCT00778167|4010544|B2|>=77 years||Age, Customized||participants|Number|0|0.0||||||
4189312|NCT00778167|4010545|B1|>=77 years||Age, Customized||participants|Number|0|0.0||||||
4189313|NCT00778167|4010542|B4|Between 48 and 77 years||Age, Customized||participants|Number|18|18.0||||||
4189314|NCT00778167|4010543|B3|Between 48 and 77 years||Age, Customized||participants|Number|4|4.0||||||
4189315|NCT00778167|4010544|B2|Between 48 and 77 years||Age, Customized||participants|Number|8|8.0||||||
4189316|NCT00778167|4010545|B1|Between 48 and 77 years||Age, Customized||participants|Number|6|6.0||||||
4189317|NCT00778167|4010542|B4|<=48 years||Age, Customized||participants|Number|0|0.0||||||
4189318|NCT00778167|4010543|B3|<=48 years||Age, Customized||participants|Number|0|0.0||||||
4189319|NCT00778167|4010544|B2|<=48 years||Age, Customized||participants|Number|0|0.0||||||
4189320|NCT00778167|4010545|B1|<=48 years||Age, Customized||participants|Number|0|0.0||||||
4189321|NCT00778102|4010555|B3||Male|Gender||Participants|Count of Participants|47|47.0||||||
4189322|NCT00778102|4010556|B2||Male|Gender||Participants|Count of Participants|29|29.0||||||
4189323|NCT00778102|4010557|B1||Male|Gender||Participants|Count of Participants|18|18.0||||||
4189324|NCT00778102|4010555|B3||Female|Gender||Participants|Count of Participants|33|33.0||||||
4189325|NCT00778102|4010556|B2||Female|Gender||Participants|Count of Participants|12|12.0||||||
4189326|NCT00778102|4010557|B1||Female|Gender||Participants|Count of Participants|21|21.0||||||
4189327|NCT00778102|4010555|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|10.87|10.87|||
4189328|NCT00778102|4010556|B2|||Age||years|Mean|61.8|61.8|Standard Deviation|11.02|11.02|||
4189329|NCT00778102|4010557|B1|||Age||years|Mean|57.1|57.1|Standard Deviation|10.32|10.32|||
4189330|NCT00777946|4010590|B4||Male|Sex: Female, Male||Participants|Count of Participants|496|496.0||||||
4189331|NCT00777946|4010591|B3||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4189332|NCT00777946|4010592|B2||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4189333|NCT00777946|4010593|B1||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4189334|NCT00777946|4010590|B4||Female|Sex: Female, Male||Participants|Count of Participants|324|324.0||||||
4189335|NCT00777946|4010591|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4189336|NCT00777946|4010592|B2||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4189337|NCT00777946|4010593|B1||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4189338|NCT00777946|4010590|B4|||Age||years|Mean|54.6|54.6|Standard Deviation|10.77|10.77|||
4189339|NCT00777946|4010591|B3|||Age||years|Mean|54.7|54.7|Standard Deviation|10.99|10.99|||
4189340|NCT00777946|4010592|B2|||Age||years|Mean|54.4|54.4|Standard Deviation|10.69|10.69|||
4189341|NCT00777946|4010593|B1|||Age||years|Mean|54.6|54.6|Standard Deviation|10.67|10.67|||
4189342|NCT00777855|4010618|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4189343|NCT00777855|4010618|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4189344|NCT00777855|4010618|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4189345|NCT00777855|4010618|B1|||Age||years|Mean|30.1|30.1|Standard Deviation|9.9|9.9|||
4189346|NCT00777855|4010618|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4189347|NCT00777855|4010618|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4189348|NCT00777855|4010618|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4189349|NCT00777803|4010628|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4189350|NCT00777803|4010629|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4189351|NCT00777803|4010630|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4189352|NCT00777803|4010628|B3||Female|Sex: Female, Male||Participants|Count of Participants|381|381.0||||||
4189353|NCT00777803|4010629|B2||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4189354|NCT00777803|4010630|B1||Female|Sex: Female, Male||Participants|Count of Participants|284|284.0||||||
4189355|NCT00777803|4010628|B3|||Age||years|Mean|41.7|41.7|Standard Deviation|5.8|5.8|||
4189356|NCT00777803|4010629|B2|||Age||years|Mean|42.0|42.0|Standard Deviation|6.0|6.0|||
4189357|NCT00777803|4010630|B1|||Age||years|Mean|41.6|41.6|Standard Deviation|5.7|5.7|||
4189358|NCT00777790|4010663|B4|United States||Region of Enrollment||participants|Number|241|241.0||||||
4189359|NCT00777790|4010664|B3|United States||Region of Enrollment||participants|Number|88|88.0||||||
4189360|NCT00777790|4010665|B2|United States||Region of Enrollment||participants|Number|77|77.0||||||
4189361|NCT00777790|4010666|B1|United States||Region of Enrollment||participants|Number|76|76.0||||||
4189362|NCT00777790|4010663|B4||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4189363|NCT00777790|4010664|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4189364|NCT00777790|4010665|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4189365|NCT00777790|4010666|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4189366|NCT00777790|4010663|B4||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4189367|NCT00777790|4010664|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4189368|NCT00777790|4010665|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4189369|NCT00777790|4010666|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4189370|NCT00777790|4010663|B4|||Age||years|Mean|16.4|16.4|Standard Deviation|1.97|1.97|||
4189371|NCT00777790|4010664|B3|||Age||years|Mean|15.7|15.7|Standard Deviation|1.97|1.97|||
4189372|NCT00777790|4010665|B2|||Age||years|Mean|16.8|16.8|Standard Deviation|1.85|1.85|||
4189373|NCT00777790|4010666|B1|||Age||years|Mean|16.6|16.6|Standard Deviation|1.91|1.91|||
4189374|NCT00777790|4010663|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4189375|NCT00777790|4010664|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4189376|NCT00777790|4010665|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4189377|NCT00777790|4010666|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4189378|NCT00777790|4010663|B4||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4189379|NCT00777790|4010664|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4189380|NCT00777790|4010665|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4189381|NCT00777790|4010666|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4189382|NCT00777790|4010663|B4||<=18 years|Age||Participants|Count of Participants|181|181.0||||||
4189383|NCT00777790|4010664|B3||<=18 years|Age||Participants|Count of Participants|68|68.0||||||
4189384|NCT00777790|4010665|B2||<=18 years|Age||Participants|Count of Participants|57|57.0||||||
4189385|NCT00777790|4010666|B1||<=18 years|Age||Participants|Count of Participants|56|56.0||||||
4189386|NCT00777764|4010676|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4189387|NCT00777764|4010677|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4189388|NCT00777764|4010678|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4189389|NCT00777764|4010676|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4189390|NCT00777764|4010677|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4189391|NCT00777764|4010678|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4189392|NCT00777764|4010676|B3|||Age||years|Mean|32.9|32.9|Standard Deviation|11.97|11.97|||
4189393|NCT00777764|4010677|B2|||Age||years|Mean|32.0|32.0|Standard Deviation|10.88|10.88|||
4189394|NCT00777764|4010678|B1|||Age||years|Mean|33.8|33.8|Standard Deviation|13.10|13.1|||
4189395|NCT00777634|4010689|B3|United States||Region of Enrollment||participants|Number|268|268.0||||||
4189396|NCT00777634|4010690|B2|United States||Region of Enrollment||participants|Number|134|134.0||||||
4189397|NCT00777634|4010691|B1|United States||Region of Enrollment||participants|Number|134|134.0||||||
4189398|NCT00777634|4010689|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4189399|NCT00777634|4010690|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4189400|NCT00777634|4010691|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4189401|NCT00777634|4010689|B3||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4189402|NCT00777634|4010690|B2||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4189403|NCT00777634|4010691|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4189404|NCT00777634|4010689|B3|||Age||years|Mean|47.4|47.4|Standard Deviation|13.1|13.1|||
4189405|NCT00777634|4010690|B2|||Age||years|Mean|47.8|47.8|Standard Deviation|12.9|12.9|||
4189406|NCT00777634|4010691|B1|||Age||years|Mean|47.0|47.0|Standard Deviation|13.2|13.2|||
4189407|NCT00777634|4010689|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4189408|NCT00777634|4010690|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4189409|NCT00777634|4010691|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4189410|NCT00777634|4010689|B3||Between 18 and 65 years|Age||Participants|Count of Participants|268|268.0||||||
4189411|NCT00777634|4010690|B2||Between 18 and 65 years|Age||Participants|Count of Participants|134|134.0||||||
4189412|NCT00777634|4010691|B1||Between 18 and 65 years|Age||Participants|Count of Participants|134|134.0||||||
4189413|NCT00777634|4010689|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4189414|NCT00777634|4010690|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4189415|NCT00777634|4010691|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4189416|NCT00777608|4010708|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4189417|NCT00777608|4010709|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4189418|NCT00777608|4010710|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4189419|NCT00777608|4010708|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4189420|NCT00777608|4010709|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4189421|NCT00777608|4010710|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4189422|NCT00777608|4010708|B3|||Age, Customized|Age >= 55 years|Participants|Number|106|106.0||||||
4189423|NCT00777608|4010709|B2|||Age, Customized|Age >= 55 years|Participants|Number|53|53.0||||||
4189424|NCT00777608|4010710|B1|||Age, Customized|Age >= 55 years|Participants|Number|53|53.0||||||
4189425|NCT00777556|4010721|B1|Don't know||Ethnic Latina/Hispanic|Do you describe yourself as ethnic Latina/Hispanic?|participants|Number|6|6.0||||||
4189426|NCT00777556|4010721|B1|No||Ethnic Latina/Hispanic|Do you describe yourself as ethnic Latina/Hispanic?|participants|Number|151|151.0||||||
4189427|NCT00777556|4010721|B1|Yes||Ethnic Latina/Hispanic|Do you describe yourself as ethnic Latina/Hispanic?|participants|Number|169|169.0||||||
4189428|NCT00777556|4010721|B1|No answer||Ethnic Latina/Hispanic|Do you describe yourself as ethnic Latina/Hispanic?|participants|Number|17|17.0||||||
4189429|NCT00777556|4010721|B1|Other||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4189430|NCT00777556|4010721|B1|Native American/Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4189431|NCT00777556|4010721|B1|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
4189432|NCT00777556|4010721|B1|White||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4189433|NCT00777556|4010721|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4189434|NCT00777556|4010721|B1|African-American||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
4189435|NCT00777556|4010721|B1|Latina||Race/Ethnicity, Customized||participants|Number|147|147.0||||||
4189436|NCT00777556|4010721|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4189437|NCT00777556|4010721|B1||Female|Sex: Female, Male||Participants|Count of Participants|343|343.0||||||
4189438|NCT00777556|4010721|B1|17 years old||Age, Customized||participants|Number|65|65.0||||||
4189439|NCT00777556|4010721|B1|16 years old||Age, Customized||participants|Number|140|140.0||||||
4189440|NCT00777556|4010721|B1|15 years old||Age, Customized||participants|Number|100|100.0||||||
4189441|NCT00777556|4010721|B1|14 years old||Age, Customized||participants|Number|35|35.0||||||
4189442|NCT00777556|4010721|B1|11-13 years old||Age, Customized||participants|Number|3|3.0||||||
4189443|NCT00777556|4010721|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4189444|NCT00777556|4010721|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4189445|NCT00777556|4010721|B1||<=18 years|Age||Participants|Count of Participants|343|343.0||||||
4189446|NCT00777335|4010728|B3|3 lines of prior chemotherapy||Number of lines of prior chemotherapy in metastatic setting||Participants|Number|1|1.0||||||
4189447|NCT00777335|4010729|B2|3 lines of prior chemotherapy||Number of lines of prior chemotherapy in metastatic setting||Participants|Number|0|0.0||||||
4189448|NCT00777335|4010730|B1|3 lines of prior chemotherapy||Number of lines of prior chemotherapy in metastatic setting||Participants|Number|1|1.0||||||
4189449|NCT00777335|4010728|B3|2 lines of prior chemotherapy||Number of lines of prior chemotherapy in metastatic setting||Participants|Number|1|1.0||||||
4189450|NCT00777335|4010729|B2|2 lines of prior chemotherapy||Number of lines of prior chemotherapy in metastatic setting||Participants|Number|0|0.0||||||
4189451|NCT00777335|4010730|B1|2 lines of prior chemotherapy||Number of lines of prior chemotherapy in metastatic setting||Participants|Number|1|1.0||||||
4189452|NCT00777335|4010728|B3|1 line of prior chemotherapy||Number of lines of prior chemotherapy in metastatic setting||Participants|Number|2|2.0||||||
4189453|NCT00777335|4010729|B2|1 line of prior chemotherapy||Number of lines of prior chemotherapy in metastatic setting||Participants|Number|2|2.0||||||
4189454|NCT00777335|4010730|B1|1 line of prior chemotherapy||Number of lines of prior chemotherapy in metastatic setting||Participants|Number|0|0.0||||||
4189455|NCT00777335|4010728|B3|PS 5 (Dead)||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|6-point (0 to 5)ordinal scale to assess how the disease affects the daily living abilities of the patient and determine appropriate treatment and prognosis.|Participants|Number|0|0.0||||||
4189456|NCT00777335|4010729|B2|PS 5 (Dead)||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|6-point (0 to 5)ordinal scale to assess how the disease affects the daily living abilities of the patient and determine appropriate treatment and prognosis.|Participants|Number|0|0.0||||||
4189457|NCT00777335|4010730|B1|PS 5 (Dead)||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|6-point (0 to 5)ordinal scale to assess how the disease affects the daily living abilities of the patient and determine appropriate treatment and prognosis.|Participants|Number|0|0.0||||||
4189458|NCT00777335|4010728|B3|PS 4 (Completely disabled)||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|6-point (0 to 5)ordinal scale to assess how the disease affects the daily living abilities of the patient and determine appropriate treatment and prognosis.|Participants|Number|0|0.0||||||
4189459|NCT00777335|4010729|B2|PS 4 (Completely disabled)||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|6-point (0 to 5)ordinal scale to assess how the disease affects the daily living abilities of the patient and determine appropriate treatment and prognosis.|Participants|Number|0|0.0||||||
4189460|NCT00777335|4010730|B1|PS 4 (Completely disabled)||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|6-point (0 to 5)ordinal scale to assess how the disease affects the daily living abilities of the patient and determine appropriate treatment and prognosis.|Participants|Number|0|0.0||||||
4189502|NCT00777257|4010739|B4||Female|Sex: Female, Male||Participants|Count of Participants|599.0|599.0||||||
4189503|NCT00777257|4010740|B3||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4189461|NCT00777335|4010728|B3|PS 3 (Capable of only limited selfcare)||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|6-point (0 to 5)ordinal scale to assess how the disease affects the daily living abilities of the patient and determine appropriate treatment and prognosis.|Participants|Number|0|0.0||||||
4189462|NCT00777335|4010729|B2|PS 3 (Capable of only limited selfcare)||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|6-point (0 to 5)ordinal scale to assess how the disease affects the daily living abilities of the patient and determine appropriate treatment and prognosis.|Participants|Number|0|0.0||||||
4189463|NCT00777335|4010730|B1|PS 3 (Capable of only limited selfcare)||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|6-point (0 to 5)ordinal scale to assess how the disease affects the daily living abilities of the patient and determine appropriate treatment and prognosis.|Participants|Number|0|0.0||||||
4189464|NCT00777335|4010728|B3|PS 2 (Ambulatory and capable of all selfcare)||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|6-point (0 to 5)ordinal scale to assess how the disease affects the daily living abilities of the patient and determine appropriate treatment and prognosis.|Participants|Number|1|1.0||||||
4189465|NCT00777335|4010729|B2|PS 2 (Ambulatory and capable of all selfcare)||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|6-point (0 to 5)ordinal scale to assess how the disease affects the daily living abilities of the patient and determine appropriate treatment and prognosis.|Participants|Number|0|0.0||||||
4189466|NCT00777335|4010730|B1|PS 2 (Ambulatory and capable of all selfcare)||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|6-point (0 to 5)ordinal scale to assess how the disease affects the daily living abilities of the patient and determine appropriate treatment and prognosis.|Participants|Number|1|1.0||||||
4189467|NCT00777335|4010728|B3|PS 1 (Restricted in physically strenuous activity)||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|6-point (0 to 5)ordinal scale to assess how the disease affects the daily living abilities of the patient and determine appropriate treatment and prognosis.|Participants|Number|3|3.0||||||
4189468|NCT00777335|4010729|B2|PS 1 (Restricted in physically strenuous activity)||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|6-point (0 to 5)ordinal scale to assess how the disease affects the daily living abilities of the patient and determine appropriate treatment and prognosis.|Participants|Number|2|2.0||||||
4189469|NCT00777335|4010730|B1|PS 1 (Restricted in physically strenuous activity)||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|6-point (0 to 5)ordinal scale to assess how the disease affects the daily living abilities of the patient and determine appropriate treatment and prognosis.|Participants|Number|1|1.0||||||
4189470|NCT00777335|4010728|B3|PS 0 (Fully active)||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|6-point (0 to 5)ordinal scale to assess how the disease affects the daily living abilities of the patient and determine appropriate treatment and prognosis.|Participants|Number|0|0.0||||||
4189471|NCT00777335|4010729|B2|PS 0 (Fully active)||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|6-point (0 to 5)ordinal scale to assess how the disease affects the daily living abilities of the patient and determine appropriate treatment and prognosis.|Participants|Number|0|0.0||||||
4189472|NCT00777335|4010730|B1|PS 0 (Fully active)||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|6-point (0 to 5)ordinal scale to assess how the disease affects the daily living abilities of the patient and determine appropriate treatment and prognosis.|Participants|Number|0|0.0||||||
4189473|NCT00777335|4010728|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4189474|NCT00777335|4010729|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4189475|NCT00777335|4010730|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4189476|NCT00777335|4010728|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4189477|NCT00777335|4010729|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4189478|NCT00777335|4010730|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4189479|NCT00777335|4010728|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4189480|NCT00777335|4010729|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4189481|NCT00777335|4010730|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4189482|NCT00777335|4010728|B3|||Age||years|Mean|53.5|53.5|Standard Deviation|15.1|15.1|||
4189483|NCT00777335|4010729|B2|||Age||years|Mean|59.0|59.0|Standard Deviation|11.5|11.5|||
4189484|NCT00777335|4010730|B1|||Age||years|Mean|48.1|48.1|Standard Deviation|20.8|20.8|||
4189485|NCT00777335|4010728|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4189486|NCT00777335|4010729|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4189487|NCT00777335|4010730|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4189488|NCT00777335|4010728|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4189489|NCT00777335|4010729|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4189490|NCT00777335|4010730|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4189491|NCT00777335|4010728|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4189492|NCT00777335|4010729|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4189493|NCT00777335|4010730|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4189494|NCT00777257|4010739|B4|United States||Region of Enrollment||participants|Number|1345.0|1345.0||||||
4189495|NCT00777257|4010740|B3|United States||Region of Enrollment||participants|Number|451|451.0||||||
4189496|NCT00777257|4010741|B2|United States||Region of Enrollment||participants|Number|450|450.0||||||
4189497|NCT00777257|4010742|B1|United States||Region of Enrollment||participants|Number|444|444.0||||||
4189498|NCT00777257|4010739|B4||Male|Sex: Female, Male||Participants|Count of Participants|746.0|746.0||||||
4189499|NCT00777257|4010740|B3||Male|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
4189500|NCT00777257|4010741|B2||Male|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
4189501|NCT00777257|4010742|B1||Male|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
4189504|NCT00777257|4010741|B2||Female|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4189505|NCT00777257|4010742|B1||Female|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
4189506|NCT00777257|4010739|B4|||Age||years|Mean|13.1|13.1|Standard Deviation|1.95|1.95|||
4189507|NCT00777257|4010740|B3|||Age||years|Mean|13.3|13.3|Standard Deviation|2.05|2.05|||
4189508|NCT00777257|4010741|B2|||Age||years|Mean|13.0|13.0|Standard Deviation|1.93|1.93|||
4189509|NCT00777257|4010742|B1|||Age||years|Mean|13.0|13.0|Standard Deviation|1.87|1.87|||
4189510|NCT00777257|4010739|B4||>=65 years|Age||Participants|Count of Participants|0.0|0.0||||||
4189511|NCT00777257|4010740|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4189512|NCT00777257|4010741|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4189513|NCT00777257|4010742|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4189514|NCT00777257|4010739|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0.0|0.0||||||
4189515|NCT00777257|4010740|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4189516|NCT00777257|4010741|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4189517|NCT00777257|4010742|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4189518|NCT00777257|4010739|B4||<=18 years|Age||Participants|Count of Participants|1345.0|1345.0||||||
4189519|NCT00777257|4010740|B3||<=18 years|Age||Participants|Count of Participants|451|451.0||||||
4189520|NCT00777257|4010741|B2||<=18 years|Age||Participants|Count of Participants|450|450.0||||||
4189521|NCT00777257|4010742|B1||<=18 years|Age||Participants|Count of Participants|444|444.0||||||
4189522|NCT00777205|4010761|B3||Male|Sex: Female, Male||Participants|Count of Participants|313|313.0||||||
4189523|NCT00777205|4010762|B2||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4189524|NCT00777205|4010763|B1||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4189525|NCT00777205|4010761|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4189526|NCT00777205|4010762|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4189527|NCT00777205|4010763|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4189528|NCT00777205|4010761|B3|> 65 years||Age, Customized||participants|Number|62|62.0||||||
4189529|NCT00777205|4010762|B2|> 65 years||Age, Customized||participants|Number|28|28.0||||||
4189530|NCT00777205|4010763|B1|> 65 years||Age, Customized||participants|Number|34|34.0||||||
4189531|NCT00777205|4010761|B3|45-64 years||Age, Customized||participants|Number|252|252.0||||||
4189532|NCT00777205|4010762|B2|45-64 years||Age, Customized||participants|Number|91|91.0||||||
4189533|NCT00777205|4010763|B1|45-64 years||Age, Customized||participants|Number|161|161.0||||||
4189534|NCT00777205|4010761|B3|18-44 years||Age, Customized||participants|Number|73|73.0||||||
4189535|NCT00777205|4010762|B2|18-44 years||Age, Customized||participants|Number|25|25.0||||||
4189536|NCT00777205|4010763|B1|18-44 years||Age, Customized||participants|Number|48|48.0||||||
4189537|NCT00777179|4010778|B3|Stage IV||Classification of lung tumor stage|Classification (Stage IIIb: Any T - N3 - M0 or T4 - Any N - M0, Stage IV: Any T - Any N - M1)|Participants|Number|90|90.0||||||
4189538|NCT00777179|4010779|B2|Stage IV||Classification of lung tumor stage|Classification (Stage IIIb: Any T - N3 - M0 or T4 - Any N - M0, Stage IV: Any T - Any N - M1)|Participants|Number|30|30.0||||||
4189539|NCT00777179|4010780|B1|Stage IV||Classification of lung tumor stage|Classification (Stage IIIb: Any T - N3 - M0 or T4 - Any N - M0, Stage IV: Any T - Any N - M1)|Participants|Number|60|60.0||||||
4189540|NCT00777179|4010778|B3|Stage IIIb||Classification of lung tumor stage|Classification (Stage IIIb: Any T - N3 - M0 or T4 - Any N - M0, Stage IV: Any T - Any N - M1)|Participants|Number|27|27.0||||||
4189541|NCT00777179|4010779|B2|Stage IIIb||Classification of lung tumor stage|Classification (Stage IIIb: Any T - N3 - M0 or T4 - Any N - M0, Stage IV: Any T - Any N - M1)|Participants|Number|12|12.0||||||
4189542|NCT00777179|4010780|B1|Stage IIIb||Classification of lung tumor stage|Classification (Stage IIIb: Any T - N3 - M0 or T4 - Any N - M0, Stage IV: Any T - Any N - M1)|Participants|Number|15|15.0||||||
4189543|NCT00777179|4010778|B3|Other||Histology|Histology|Participants|Number|10|10.0||||||
4189544|NCT00777179|4010779|B2|Other||Histology|Histology|Participants|Number|2|2.0||||||
4189545|NCT00777179|4010780|B1|Other||Histology|Histology|Participants|Number|8|8.0||||||
4189546|NCT00777179|4010778|B3|Squamous cell carcinoma||Histology|Histology|Participants|Number|20|20.0||||||
4189547|NCT00777179|4010779|B2|Squamous cell carcinoma||Histology|Histology|Participants|Number|9|9.0||||||
4189548|NCT00777179|4010780|B1|Squamous cell carcinoma||Histology|Histology|Participants|Number|11|11.0||||||
4189549|NCT00777179|4010778|B3|Adenocarcinoma||Histology|Histology|Participants|Number|87|87.0||||||
4189550|NCT00777179|4010779|B2|Adenocarcinoma||Histology|Histology|Participants|Number|31|31.0||||||
4189551|NCT00777179|4010780|B1|Adenocarcinoma||Histology|Histology|Participants|Number|56|56.0||||||
4189552|NCT00777179|4010778|B3|1||WHO Performance status|WHO PS (0: Fully active, able to carry out all usual activities without restrictions and without the aid of analgesia. 1: Restricted in strenuous activity, but ambulatory and able to carry out light work or pursue a sedentary occupation. This group also contains subjects who are fully active, as in grade 0, but only with the aid of analgesics.)|Participants|Number|87|87.0||||||
4189553|NCT00777179|4010779|B2|1||WHO Performance status|WHO PS (0: Fully active, able to carry out all usual activities without restrictions and without the aid of analgesia. 1: Restricted in strenuous activity, but ambulatory and able to carry out light work or pursue a sedentary occupation. This group also contains subjects who are fully active, as in grade 0, but only with the aid of analgesics.)|Participants|Number|32|32.0||||||
4189554|NCT00777179|4010780|B1|1||WHO Performance status|WHO PS (0: Fully active, able to carry out all usual activities without restrictions and without the aid of analgesia. 1: Restricted in strenuous activity, but ambulatory and able to carry out light work or pursue a sedentary occupation. This group also contains subjects who are fully active, as in grade 0, but only with the aid of analgesics.)|Participants|Number|55|55.0||||||
4189555|NCT00777179|4010778|B3|0||WHO Performance status|WHO PS (0: Fully active, able to carry out all usual activities without restrictions and without the aid of analgesia. 1: Restricted in strenuous activity, but ambulatory and able to carry out light work or pursue a sedentary occupation. This group also contains subjects who are fully active, as in grade 0, but only with the aid of analgesics.)|Participants|Number|30|30.0||||||
4189556|NCT00777179|4010779|B2|0||WHO Performance status|WHO PS (0: Fully active, able to carry out all usual activities without restrictions and without the aid of analgesia. 1: Restricted in strenuous activity, but ambulatory and able to carry out light work or pursue a sedentary occupation. This group also contains subjects who are fully active, as in grade 0, but only with the aid of analgesics.)|Participants|Number|10|10.0||||||
4189557|NCT00777179|4010780|B1|0||WHO Performance status|WHO PS (0: Fully active, able to carry out all usual activities without restrictions and without the aid of analgesia. 1: Restricted in strenuous activity, but ambulatory and able to carry out light work or pursue a sedentary occupation. This group also contains subjects who are fully active, as in grade 0, but only with the aid of analgesics.)|Participants|Number|20|20.0||||||
4189558|NCT00777179|4010778|B3|Stable Disease (SD)||Overall response at screening|completion of 4 cycles of chemotherapy of gemcitabine (1,000mg/m^2/day or 1,250mg/m^2/day on day 1 and 8) and cisplatin (70mg/m^2/day~80mg/m^2/day on day 1) every 3 weeks and have shown responses (CR, PR) or stable disease (SD) by RECIST 1.0.|Participants|Number|43|43.0||||||
4189559|NCT00777179|4010779|B2|Stable Disease (SD)||Overall response at screening|completion of 4 cycles of chemotherapy of gemcitabine (1,000mg/m^2/day or 1,250mg/m^2/day on day 1 and 8) and cisplatin (70mg/m^2/day~80mg/m^2/day on day 1) every 3 weeks and have shown responses (CR, PR) or stable disease (SD) by RECIST 1.0.|Participants|Number|12|12.0||||||
4189560|NCT00777179|4010780|B1|Stable Disease (SD)||Overall response at screening|completion of 4 cycles of chemotherapy of gemcitabine (1,000mg/m^2/day or 1,250mg/m^2/day on day 1 and 8) and cisplatin (70mg/m^2/day~80mg/m^2/day on day 1) every 3 weeks and have shown responses (CR, PR) or stable disease (SD) by RECIST 1.0.|Participants|Number|31|31.0||||||
4189561|NCT00777179|4010778|B3|Partial Response (PR)||Overall response at screening|completion of 4 cycles of chemotherapy of gemcitabine (1,000mg/m^2/day or 1,250mg/m^2/day on day 1 and 8) and cisplatin (70mg/m^2/day~80mg/m^2/day on day 1) every 3 weeks and have shown responses (CR, PR) or stable disease (SD) by RECIST 1.0.|Participants|Number|74|74.0||||||
4189562|NCT00777179|4010779|B2|Partial Response (PR)||Overall response at screening|completion of 4 cycles of chemotherapy of gemcitabine (1,000mg/m^2/day or 1,250mg/m^2/day on day 1 and 8) and cisplatin (70mg/m^2/day~80mg/m^2/day on day 1) every 3 weeks and have shown responses (CR, PR) or stable disease (SD) by RECIST 1.0.|Participants|Number|30|30.0||||||
4189563|NCT00777179|4010780|B1|Partial Response (PR)||Overall response at screening|completion of 4 cycles of chemotherapy of gemcitabine (1,000mg/m^2/day or 1,250mg/m^2/day on day 1 and 8) and cisplatin (70mg/m^2/day~80mg/m^2/day on day 1) every 3 weeks and have shown responses (CR, PR) or stable disease (SD) by RECIST 1.0.|Participants|Number|44|44.0||||||
4189564|NCT00777179|4010778|B3|Non-smoker||Smoking history||Participants|Number|42|42.0||||||
4189565|NCT00777179|4010779|B2|Non-smoker||Smoking history||Participants|Number|14|14.0||||||
4189566|NCT00777179|4010780|B1|Non-smoker||Smoking history||Participants|Number|28|28.0||||||
4189567|NCT00777179|4010778|B3|Smoker||Smoking history||Participants|Number|75|75.0||||||
4189568|NCT00777179|4010779|B2|Smoker||Smoking history||Participants|Number|28|28.0||||||
4189569|NCT00777179|4010780|B1|Smoker||Smoking history||Participants|Number|47|47.0||||||
4189570|NCT00777179|4010778|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4189571|NCT00777179|4010779|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4189572|NCT00777179|4010780|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4189573|NCT00777179|4010778|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4189574|NCT00777179|4010779|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4189575|NCT00777179|4010780|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4189576|NCT00777179|4010778|B3|Median (min-Max Range)||Age, Customized||year|Median|61|61.0|Full Range|||29.0|76.0|
4189577|NCT00777179|4010779|B2|Median (min-Max Range)||Age, Customized||year|Median|60.5|60.5|Full Range|||29.0|70.0|
4189578|NCT00777179|4010780|B1|Median (min-Max Range)||Age, Customized||year|Median|61|61.0|Full Range|||33.0|76.0|
4189579|NCT00777153|4010795|B4||Male|Gender|Gender at informed consent|Participants|Count of Participants|211|211.0||||||
4189580|NCT00777153|4010796|B3||Male|Gender|Gender at informed consent|Participants|Count of Participants|41|41.0||||||
4189581|NCT00777153|4010797|B2||Male|Gender|Gender at informed consent|Participants|Count of Participants|85|85.0||||||
4189582|NCT00777153|4010798|B1||Male|Gender|Gender at informed consent|Participants|Count of Participants|85|85.0||||||
4189583|NCT00777153|4010795|B4||Female|Gender|Gender at informed consent|Participants|Count of Participants|114|114.0||||||
4189584|NCT00777153|4010796|B3||Female|Gender|Gender at informed consent|Participants|Count of Participants|24|24.0||||||
4189585|NCT00777153|4010797|B2||Female|Gender|Gender at informed consent|Participants|Count of Participants|44|44.0||||||
4189586|NCT00777153|4010798|B1||Female|Gender|Gender at informed consent|Participants|Count of Participants|46|46.0||||||
4189587|NCT00777153|4010795|B4|||Age|Age at Informed Consent|years|Mean|53.3|53.3|Standard Deviation|11.67|11.67|||
4189588|NCT00777153|4010796|B3|||Age|Age at Informed Consent|years|Mean|52.0|52.0|Standard Deviation|13.09|13.09|||
4189589|NCT00777153|4010797|B2|||Age|Age at Informed Consent|years|Mean|53.7|53.7|Standard Deviation|10.78|10.78|||
4189590|NCT00777153|4010798|B1|||Age|Age at Informed Consent|years|Mean|53.4|53.4|Standard Deviation|11.81|11.81|||
4189591|NCT00777101|4010823|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4189592|NCT00777101|4010824|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4189593|NCT00777101|4010825|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4189594|NCT00777101|4010823|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189595|NCT00777101|4010824|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189596|NCT00777101|4010825|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189597|NCT00777101|4010823|B3||White|Race (NIH/OMB)||Participants|Count of Participants|141|141.0||||||
4189598|NCT00777101|4010824|B2||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4189599|NCT00777101|4010825|B1||White|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
4189600|NCT00777101|4010823|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4189601|NCT00777101|4010824|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4189602|NCT00777101|4010825|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4189603|NCT00777101|4010823|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189604|NCT00777101|4010824|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189605|NCT00777101|4010825|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189606|NCT00777101|4010823|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
4189607|NCT00777101|4010824|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4189608|NCT00777101|4010825|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4189609|NCT00777101|4010823|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189610|NCT00777101|4010824|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189611|NCT00777101|4010825|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189612|NCT00777101|4010823|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4189613|NCT00777101|4010824|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4189614|NCT00777101|4010825|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4189615|NCT00777101|4010823|B3||Female|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
4189616|NCT00777101|4010824|B2||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4189617|NCT00777101|4010825|B1||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4189618|NCT00777101|4010823|B3|||Age||years|Mean|54.3|54.3|Standard Deviation|12.1|12.1|||
4189619|NCT00777101|4010824|B2|||Age||years|Mean|54.7|54.7|Standard Deviation|13.8|13.8|||
4189620|NCT00777101|4010825|B1|||Age||years|Mean|53.1|53.1|Standard Deviation|10.11|10.11|||
4189621|NCT00777101|4010823|B3||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4189622|NCT00777101|4010824|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4189623|NCT00777101|4010825|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4189624|NCT00777101|4010823|B3||Between 18 and 65 years|Age||Participants|Count of Participants|204|204.0||||||
4189625|NCT00777101|4010824|B2||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4189626|NCT00777101|4010825|B1||Between 18 and 65 years|Age||Participants|Count of Participants|104|104.0||||||
4189627|NCT00777101|4010823|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4189628|NCT00777101|4010824|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4189629|NCT00777101|4010825|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4189630|NCT00777088|4010844|B1|United States||Region of Enrollment||Participants|Count of Participants|76|76.0||||||
4189631|NCT00777088|4010844|B1|Hungary||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4189632|NCT00777088|4010844|B1|Turkey||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4189633|NCT00777088|4010844|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4189634|NCT00777088|4010844|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4189635|NCT00777088|4010844|B1|||Age||Years|Mean|57|57.0|Standard Deviation|11.3|11.3|||
4189636|NCT00777062|4010856|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
4189637|NCT00777062|4010857|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
4189638|NCT00777062|4010858|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4189639|NCT00777062|4010856|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4189640|NCT00777062|4010857|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4189641|NCT00777062|4010858|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4189642|NCT00777062|4010856|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4189643|NCT00777062|4010857|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4189644|NCT00777062|4010858|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4189645|NCT00777062|4010856|B3|||Age||years|Mean|47.9|47.9|Standard Deviation|6.6|6.6|||
4189646|NCT00777062|4010857|B2|||Age||years|Mean|48.4|48.4|Standard Deviation|6.3|6.3|||
4189647|NCT00777062|4010858|B1|||Age||years|Mean|47.5|47.5|Standard Deviation|7.0|7.0|||
4189648|NCT00777062|4010856|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4189649|NCT00777062|4010857|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4189650|NCT00777062|4010858|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4189651|NCT00777062|4010856|B3||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4189652|NCT00777062|4010857|B2||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4189653|NCT00777062|4010858|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4189654|NCT00777062|4010856|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4189655|NCT00777062|4010857|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4189656|NCT00777062|4010858|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4189657|NCT00777049|4010867|B3|Postmenopausal||Menopausal Status||participants|Number|49|49.0||||||
4189658|NCT00777049|4010868|B2|Postmenopausal||Menopausal Status||participants|Number|16|16.0||||||
4189659|NCT00777049|4010869|B1|Postmenopausal||Menopausal Status||participants|Number|33|33.0||||||
4189660|NCT00777049|4010867|B3|Premenopausal||Menopausal Status||participants|Number|5|5.0||||||
4189661|NCT00777049|4010868|B2|Premenopausal||Menopausal Status||participants|Number|5|5.0||||||
4189662|NCT00777049|4010869|B1|Premenopausal||Menopausal Status||participants|Number|0|0.0||||||
4189663|NCT00777049|4010867|B3|Not Hispanic or Latino||Ethnicity||participants|Number|49|49.0||||||
4189664|NCT00777049|4010868|B2|Not Hispanic or Latino||Ethnicity||participants|Number|18|18.0||||||
4189665|NCT00777049|4010869|B1|Not Hispanic or Latino||Ethnicity||participants|Number|31|31.0||||||
4189666|NCT00777049|4010867|B3|Hispanic or Latino||Ethnicity||participants|Number|5|5.0||||||
4189667|NCT00777049|4010868|B2|Hispanic or Latino||Ethnicity||participants|Number|3|3.0||||||
4189668|NCT00777049|4010869|B1|Hispanic or Latino||Ethnicity||participants|Number|2|2.0||||||
4189669|NCT00777049|4010867|B3|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4189670|NCT00777049|4010868|B2|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4189671|NCT00777049|4010869|B1|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4189672|NCT00777049|4010867|B3|Ireland||Region of Enrollment||participants|Number|11|11.0||||||
4189673|NCT00777049|4010868|B2|Ireland||Region of Enrollment||participants|Number|1|1.0||||||
4189674|NCT00777049|4010869|B1|Ireland||Region of Enrollment||participants|Number|10|10.0||||||
4189675|NCT00777049|4010867|B3|France||Region of Enrollment||participants|Number|6|6.0||||||
4189676|NCT00777049|4010868|B2|France||Region of Enrollment||participants|Number|1|1.0||||||
4189677|NCT00777049|4010869|B1|France||Region of Enrollment||participants|Number|5|5.0||||||
4189678|NCT00777049|4010867|B3|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4189679|NCT00777049|4010868|B2|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4189680|NCT00777049|4010869|B1|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4189681|NCT00777049|4010867|B3|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4189682|NCT00777049|4010868|B2|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
4189683|NCT00777049|4010869|B1|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4189684|NCT00777049|4010867|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4189685|NCT00777049|4010868|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4189686|NCT00777049|4010869|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4189687|NCT00777049|4010867|B3|Race - Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4189688|NCT00777049|4010868|B2|Race - Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4189689|NCT00777049|4010869|B1|Race - Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4189690|NCT00777049|4010867|B3|Race - Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4189691|NCT00777049|4010868|B2|Race - Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4189692|NCT00777049|4010869|B1|Race - Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4189693|NCT00777049|4010867|B3|Race - White||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4189694|NCT00777049|4010868|B2|Race - White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4189695|NCT00777049|4010869|B1|Race - White||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4189696|NCT00777049|4010867|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4189697|NCT00777049|4010868|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4189698|NCT00777049|4010869|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4189699|NCT00777049|4010867|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4189700|NCT00777049|4010868|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4189701|NCT00777049|4010869|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4189702|NCT00777049|4010867|B3|||Age||years|Mean|57.4|57.4|Standard Deviation|10.5|10.5|||
4189703|NCT00777049|4010868|B2|||Age||years|Mean|52.8|52.8|Standard Deviation|10.7|10.7|||
4189704|NCT00777049|4010869|B1|||Age||years|Mean|60.3|60.3|Standard Deviation|9.5|9.5|||
4189705|NCT00777049|4010867|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4189706|NCT00777049|4010868|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4189707|NCT00777049|4010869|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4189708|NCT00777049|4010867|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4189709|NCT00777049|4010868|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4189710|NCT00777049|4010869|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4189711|NCT00777049|4010867|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4189712|NCT00777049|4010868|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4189713|NCT00777049|4010869|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4189714|NCT00777036|4010876|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4189715|NCT00777036|4010877|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4189716|NCT00777036|4010878|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4189717|NCT00777036|4010879|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4189718|NCT00777036|4010876|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4189719|NCT00777036|4010877|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4189720|NCT00777036|4010878|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4189721|NCT00777036|4010879|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4189722|NCT00777036|4010876|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
4189723|NCT00777036|4010877|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
4189724|NCT00777036|4010878|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4189725|NCT00777036|4010879|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4189726|NCT00777036|4010876|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4189727|NCT00777036|4010877|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4189728|NCT00777036|4010878|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4189729|NCT00777036|4010879|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4189730|NCT00777036|4010876|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|89|89.0||||||
4189731|NCT00777036|4010877|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|56|56.0||||||
4189732|NCT00777036|4010878|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4189733|NCT00777036|4010879|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
4189734|NCT00777036|4010876|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
4189735|NCT00777036|4010877|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4189736|NCT00777036|4010878|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4189737|NCT00777036|4010879|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4189738|NCT00777036|4010876|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4189739|NCT00777036|4010877|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4189740|NCT00777036|4010878|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189741|NCT00777036|4010879|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4189742|NCT00777036|4010876|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4189743|NCT00777036|4010877|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4189744|NCT00777036|4010878|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4189745|NCT00777036|4010879|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4189746|NCT00777036|4010876|B4||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4189747|NCT00777036|4010877|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4189748|NCT00777036|4010878|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4189749|NCT00777036|4010879|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4189750|NCT00777036|4010876|B4||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4189751|NCT00777036|4010877|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4189752|NCT00777036|4010878|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4189753|NCT00777036|4010879|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4189754|NCT00777036|4010876|B4|>= 18 years||Age, Customized||participants|Number|2|2.0||||||
4189755|NCT00777036|4010877|B3|>= 18 years||Age, Customized||participants|Number|0|0.0||||||
4189756|NCT00777036|4010878|B2|>= 18 years||Age, Customized||participants|Number|0|0.0||||||
4189757|NCT00777036|4010879|B1|>= 18 years||Age, Customized||participants|Number|2|2.0||||||
4189758|NCT00777036|4010876|B4|>= 12 to < 18 years||Age, Customized||participants|Number|70|70.0||||||
4189759|NCT00777036|4010877|B3|>= 12 to < 18 years||Age, Customized||participants|Number|44|44.0||||||
4189760|NCT00777036|4010878|B2|>= 12 to < 18 years||Age, Customized||participants|Number|9|9.0||||||
4189761|NCT00777036|4010879|B1|>= 12 to < 18 years||Age, Customized||participants|Number|17|17.0||||||
4189762|NCT00777036|4010876|B4|>= 7 to < 12 years||Age, Customized||participants|Number|40|40.0||||||
4189763|NCT00777036|4010877|B3|>= 7 to < 12 years||Age, Customized||participants|Number|28|28.0||||||
4189764|NCT00777036|4010878|B2|>= 7 to < 12 years||Age, Customized||participants|Number|6|6.0||||||
4189765|NCT00777036|4010879|B1|>= 7 to < 12 years||Age, Customized||participants|Number|6|6.0||||||
4189766|NCT00777036|4010876|B4|>= 2 to < 7 years||Age, Customized||participants|Number|15|15.0||||||
4189767|NCT00777036|4010877|B3|>= 2 to < 7 years||Age, Customized||participants|Number|10|10.0||||||
4189768|NCT00777036|4010878|B2|>= 2 to < 7 years||Age, Customized||participants|Number|2|2.0||||||
4189769|NCT00777036|4010879|B1|>= 2 to < 7 years||Age, Customized||participants|Number|3|3.0||||||
4189770|NCT00777036|4010876|B4|< 2 years||Age, Customized||participants|Number|3|3.0||||||
4189771|NCT00777036|4010877|B3|< 2 years||Age, Customized||participants|Number|2|2.0||||||
4189772|NCT00777036|4010878|B2|< 2 years||Age, Customized||participants|Number|0|0.0||||||
4189773|NCT00777036|4010879|B1|< 2 years||Age, Customized||participants|Number|1|1.0||||||
4189774|NCT00777036|4010876|B4|||Age||years|Mean|12.12|12.12|Standard Deviation|4.388|4.388|||
4189775|NCT00777036|4010877|B3|||Age||years|Mean|11.95|11.95|Standard Deviation|4.418|4.418|||
4189776|NCT00777036|4010878|B2|||Age||years|Mean|12.10|12.1|Standard Deviation|3.680|3.68|||
4189777|NCT00777036|4010879|B1|||Age||years|Mean|12.60|12.6|Standard Deviation|4.774|4.774|||
4189778|NCT00777023|4010974|B4|Severe||Frequency of hot flashes|Number of hot flashes in a 24-hour period.|Hot flashes|Mean|6.8|6.8|Standard Deviation|5.2|5.2|||
4189779|NCT00777023|4010975|B3|Severe||Frequency of hot flashes|Number of hot flashes in a 24-hour period.|Hot flashes|Mean|6.6|6.6|Standard Deviation|4.9|4.9|||
4189780|NCT00777023|4010976|B2|Severe||Frequency of hot flashes|Number of hot flashes in a 24-hour period.|Hot flashes|Mean|6.9|6.9|Standard Deviation|5.5|5.5|||
4189781|NCT00777023|4010977|B1|Severe||Frequency of hot flashes|Number of hot flashes in a 24-hour period.|Hot flashes|Mean|6.7|6.7|Standard Deviation|5.1|5.1|||
4189782|NCT00777023|4010974|B4|Moderate||Frequency of hot flashes|Number of hot flashes in a 24-hour period.|Hot flashes|Mean|5.9|5.9|Standard Deviation|5.0|5.0|||
4189783|NCT00777023|4010975|B3|Moderate||Frequency of hot flashes|Number of hot flashes in a 24-hour period.|Hot flashes|Mean|6.2|6.2|Standard Deviation|5.1|5.1|||
4189784|NCT00777023|4010976|B2|Moderate||Frequency of hot flashes|Number of hot flashes in a 24-hour period.|Hot flashes|Mean|5.4|5.4|Standard Deviation|4.0|4.0|||
4189785|NCT00777023|4010977|B1|Moderate||Frequency of hot flashes|Number of hot flashes in a 24-hour period.|Hot flashes|Mean|6.1|6.1|Standard Deviation|5.8|5.8|||
4189786|NCT00777023|4010974|B4|Mild||Frequency of hot flashes|Number of hot flashes in a 24-hour period.|Hot flashes|Mean|1.2|1.2|Standard Deviation|2.3|2.3|||
4189787|NCT00777023|4010975|B3|Mild||Frequency of hot flashes|Number of hot flashes in a 24-hour period.|Hot flashes|Mean|1.7|1.7|Standard Deviation|2.9|2.9|||
4189788|NCT00777023|4010976|B2|Mild||Frequency of hot flashes|Number of hot flashes in a 24-hour period.|Hot flashes|Mean|1.0|1.0|Standard Deviation|2.0|2.0|||
4189789|NCT00777023|4010977|B1|Mild||Frequency of hot flashes|Number of hot flashes in a 24-hour period.|Hot flashes|Mean|1.1|1.1|Standard Deviation|2.0|2.0|||
4189790|NCT00777023|4010974|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4189791|NCT00777023|4010975|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4189792|NCT00777023|4010976|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4189793|NCT00777023|4010977|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4189794|NCT00777023|4010974|B4||Female|Sex: Female, Male||Participants|Count of Participants|559|559.0||||||
4189795|NCT00777023|4010975|B3||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4189796|NCT00777023|4010976|B2||Female|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4189797|NCT00777023|4010977|B1||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4189798|NCT00777023|4010974|B4|>=65 years||Age, Customized||participants|Number|26|26.0||||||
4189799|NCT00777023|4010975|B3|>=65 years||Age, Customized||participants|Number|6|6.0||||||
4189800|NCT00777023|4010976|B2|>=65 years||Age, Customized||participants|Number|9|9.0||||||
4189801|NCT00777023|4010977|B1|>=65 years||Age, Customized||participants|Number|11|11.0||||||
4189802|NCT00777023|4010974|B4|<65 years||Age, Customized||participants|Number|533|533.0||||||
4189803|NCT00777023|4010975|B3|<65 years||Age, Customized||participants|Number|177|177.0||||||
4189804|NCT00777023|4010976|B2|<65 years||Age, Customized||participants|Number|181|181.0||||||
4189805|NCT00777023|4010977|B1|<65 years||Age, Customized||participants|Number|175|175.0||||||
4189806|NCT00777023|4010974|B4|||Age||years|Mean|53.2|53.2|Standard Deviation|6.4|6.4|||
4189807|NCT00777023|4010975|B3|||Age||years|Mean|52.9|52.9|Standard Deviation|6.0|6.0|||
4189808|NCT00777023|4010976|B2|||Age||years|Mean|53.6|53.6|Standard Deviation|6.1|6.1|||
4189809|NCT00777023|4010977|B1|||Age||years|Mean|53.1|53.1|Standard Deviation|7.0|7.0|||
4189810|NCT00776997|4010996|B1|||Years of proton-pump inhibitor use||years|Mean|6.3|6.3|Standard Deviation|4.8|4.8|||
4189811|NCT00776997|4010996|B1|||Use of daily proton-pump inhibitors (PPIs)|At time of enrollment, all medications used by a subject were documented.|participants|Number|100|100.0||||||
4189812|NCT00776997|4010996|B1|||Gastroesophageal Reflux Disease-Health-Related Quality of Life (GERD-HRQL) total score|"The GERD-HRQL scale was administered at baseline with GERD medications discontinued for at least seven days. GERD-HRQL scale objectively quantifies symptom severity. The GERD-HRQL scale consists of 10 questions with the following Responses Scale:~0 = No Symptoms~= Symptoms noticeable, but not bothersome~= Symptoms noticeable and bothersome, but not every day~= Symptoms bothersome every day~= Symptoms affect daily activities~= Symptoms are incapacitating, unable to do daily activities~The worst possible score is 50 based on a response of 5 to all 10 questions."|Total Score|Mean|26.6|26.6|Standard Deviation|6.6|6.6|||
4189813|NCT00776997|4010996|B1|||Percentage of total monitoring time esophageal pH <4|At baseline, all subjects were evaluated with esophageal pH monitoring with GERD medications discontinued for at least 7 days using the BRAVO System|Percentage of total monitoring time|Mean|11.6|11.6|Standard Deviation|4.7|4.7|||
4189814|NCT00776997|4010996|B1|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
4189815|NCT00776997|4010996|B1|United States||Region of Enrollment||participants|Number|96|96.0||||||
4189816|NCT00776997|4010996|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4189817|NCT00776997|4010996|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4189818|NCT00776997|4010996|B1|||Age||years|Mean|50.4|50.4|Standard Deviation|12.4|12.4|||
4189819|NCT00776997|4010996|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4189820|NCT00776997|4010996|B1||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
4189821|NCT00776997|4010996|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4189822|NCT00776984|4011003|B3||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4189823|NCT00776984|4011004|B2||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4189824|NCT00776984|4011005|B1||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4189825|NCT00776984|4011003|B3||Female|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
4189826|NCT00776984|4011004|B2||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4189827|NCT00776984|4011005|B1||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4189828|NCT00776984|4011003|B3|||Age||Years|Mean|52.5|52.5|Standard Deviation|12.1|12.1|||
4189829|NCT00776984|4011004|B2|||Age||Years|Mean|51.4|51.4|Standard Deviation|12.5|12.5|||
4189830|NCT00776984|4011005|B1|||Age||Years|Mean|53.6|53.6|Standard Deviation|11.7|11.7|||
4189831|NCT00776919|4011076|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4189832|NCT00776919|4011077|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4189833|NCT00776919|4011078|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4189834|NCT00776919|4011079|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4189835|NCT00776919|4011080|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4189836|NCT00776919|4011076|B5|Multiracial||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4189837|NCT00776919|4011077|B4|Multiracial||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4189838|NCT00776919|4011078|B3|Multiracial||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4189839|NCT00776919|4011079|B2|Multiracial||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4189840|NCT00776919|4011080|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4189841|NCT00776919|4011076|B5|Asian||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
4189842|NCT00776919|4011077|B4|Asian||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4189843|NCT00776919|4011078|B3|Asian||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4189844|NCT00776919|4011079|B2|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4189845|NCT00776919|4011080|B1|Asian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4189846|NCT00776919|4011076|B5|Black||Race/Ethnicity, Customized||participants|Number|192|192.0||||||
4189847|NCT00776919|4011077|B4|Black||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
4189848|NCT00776919|4011078|B3|Black||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
4189849|NCT00776919|4011079|B2|Black||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4189850|NCT00776919|4011080|B1|Black||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4189851|NCT00776919|4011076|B5|White||Race/Ethnicity, Customized||participants|Number|1042|1042.0||||||
4189852|NCT00776919|4011077|B4|White||Race/Ethnicity, Customized||participants|Number|258|258.0||||||
4189853|NCT00776919|4011078|B3|White||Race/Ethnicity, Customized||participants|Number|251|251.0||||||
4189854|NCT00776919|4011079|B2|White||Race/Ethnicity, Customized||participants|Number|274|274.0||||||
4189855|NCT00776919|4011080|B1|White||Race/Ethnicity, Customized||participants|Number|259|259.0||||||
4189856|NCT00776919|4011076|B5||Male|Sex: Female, Male||Participants|Count of Participants|520|520.0||||||
4189857|NCT00776919|4011077|B4||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4189858|NCT00776919|4011078|B3||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4189859|NCT00776919|4011079|B2||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4189860|NCT00776919|4011080|B1||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4189861|NCT00776919|4011076|B5||Female|Sex: Female, Male||Participants|Count of Participants|795|795.0||||||
4189862|NCT00776919|4011077|B4||Female|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4189863|NCT00776919|4011078|B3||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4189864|NCT00776919|4011079|B2||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4189865|NCT00776919|4011080|B1||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4189866|NCT00776919|4011076|B5|||Age||Years|Mean|20.4|20.4|Standard Deviation|7.1|7.1|||
4189867|NCT00776919|4011077|B4|||Age||Years|Mean|20.7|20.7|Standard Deviation|7.4|7.4|||
4189868|NCT00776919|4011078|B3|||Age||Years|Mean|20.6|20.6|Standard Deviation|7.1|7.1|||
4189869|NCT00776919|4011079|B2|||Age||Years|Mean|20.2|20.2|Standard Deviation|6.9|6.9|||
4189870|NCT00776919|4011080|B1|||Age||Years|Mean|20.0|20.0|Standard Deviation|7.0|7.0|||
4189871|NCT00776789|4011145|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4189872|NCT00776789|4011146|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4189873|NCT00776789|4011147|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4189874|NCT00776789|4011145|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4189875|NCT00776789|4011146|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4189876|NCT00776789|4011147|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4189877|NCT00776789|4011145|B3|||Age|gestation age in weeks|weeks|Mean|38|38.0|Standard Deviation|0.98|0.98|||
4189878|NCT00776789|4011146|B2|||Age|gestation age in weeks|weeks|Mean|38|38.0|Standard Deviation|1.2|1.2|||
4189879|NCT00776789|4011147|B1|||Age|gestation age in weeks|weeks|Mean|38|38.0|Standard Deviation|0.91|0.91|||
4189880|NCT00776789|4011145|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4189881|NCT00776789|4011146|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4189882|NCT00776789|4011147|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4189883|NCT00776789|4011145|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4189884|NCT00776789|4011146|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4189885|NCT00776789|4011147|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4189886|NCT00776789|4011145|B3||<=18 years|Age||Participants|Count of Participants|41|41.0||||||
4189887|NCT00776789|4011146|B2||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
4189888|NCT00776789|4011147|B1||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
4189889|NCT00776659|4011160|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4189890|NCT00776659|4011160|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4189891|NCT00776659|4011160|B1|||Age||years|Mean|60.0|60.0|Standard Deviation|10.7|10.7|||
4189892|NCT00776594|4011170|B3||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4189893|NCT00776594|4011171|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4189894|NCT00776594|4011172|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4189895|NCT00776594|4011170|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4189896|NCT00776594|4011171|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4189897|NCT00776594|4011172|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4189898|NCT00776594|4011170|B3|||Age||years|Median|65|65.0|Inter-Quartile Range|||65.0|69.0|
4189899|NCT00776594|4011171|B2|||Age||years|Median|63|63.0|Inter-Quartile Range|||60.0|68.0|
4189900|NCT00776594|4011172|B1|||Age||years|Median|66|66.0|Inter-Quartile Range|||60.0|69.0|
4189901|NCT00776555|4011185|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4189902|NCT00776555|4011187|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4189903|NCT00776555|4011185|B3|Male||Gender||participants|Number|2|2.0||||||
4189904|NCT00776555|4011187|B1|Male||Gender||participants|Number|2|2.0||||||
4189905|NCT00776555|4011185|B3|Female||Gender||participants|Number|1|1.0||||||
4189906|NCT00776555|4011187|B1|Female||Gender||participants|Number|1|1.0||||||
4189907|NCT00776555|4011185|B3|>=65 years||Age||participants|Number|0|0.0||||||
4189908|NCT00776555|4011187|B1|>=65 years||Age||participants|Number|0|0.0||||||
4189909|NCT00776555|4011185|B3|Between 18 and 65 years||Age||participants|Number|3|3.0||||||
4189910|NCT00776555|4011187|B1|Between 18 and 65 years||Age||participants|Number|3|3.0||||||
4189911|NCT00776555|4011185|B3|<=18 years||Age||participants|Number|0|0.0||||||
4189912|NCT00776555|4011187|B1|<=18 years||Age||participants|Number|0|0.0||||||
4189913|NCT00776295|4011198|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4189914|NCT00776295|4011198|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4189915|NCT00776295|4011198|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4189916|NCT00776295|4011198|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4189917|NCT00776295|4011198|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4189918|NCT00776295|4011198|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4189919|NCT00776295|4011198|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4189920|NCT00776295|4011198|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4189921|NCT00776295|4011198|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4189922|NCT00776230|4011203|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4189923|NCT00776230|4011204|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4189924|NCT00776230|4011205|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4189925|NCT00776230|4011206|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4189926|NCT00776230|4011203|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4189927|NCT00776230|4011204|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4189928|NCT00776230|4011205|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4189929|NCT00776230|4011206|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4189930|NCT00776230|4011203|B4|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4189931|NCT00776230|4011204|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4189932|NCT00776230|4011205|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4189933|NCT00776230|4011206|B1|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4189934|NCT00776230|4011203|B4|Caucasian/ White||Race/Ethnicity, Customized||participants|Number|293|293.0||||||
4189935|NCT00776230|4011204|B3|Caucasian/ White||Race/Ethnicity, Customized||participants|Number|102|102.0||||||
4189936|NCT00776230|4011205|B2|Caucasian/ White||Race/Ethnicity, Customized||participants|Number|98|98.0||||||
4189937|NCT00776230|4011206|B1|Caucasian/ White||Race/Ethnicity, Customized||participants|Number|93|93.0||||||
4189938|NCT00776230|4011203|B4||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4189939|NCT00776230|4011204|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4189940|NCT00776230|4011205|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4189941|NCT00776230|4011206|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4189942|NCT00776230|4011203|B4||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4189943|NCT00776230|4011204|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4189944|NCT00776230|4011205|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4189945|NCT00776230|4011206|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4189946|NCT00776230|4011203|B4|||Age||years|Mean|29.2|29.2|Standard Deviation|10.0|10.0|||
4189947|NCT00776230|4011204|B3|||Age||years|Mean|31.6|31.6|Standard Deviation|10.7|10.7|||
4189948|NCT00776230|4011205|B2|||Age||years|Mean|28.6|28.6|Standard Deviation|10.7|10.7|||
4189949|NCT00776230|4011206|B1|||Age||years|Mean|27.3|27.3|Standard Deviation|7.6|7.6|||
4189950|NCT00776100|4011216|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4189951|NCT00776100|4011217|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4189952|NCT00776100|4011218|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4189953|NCT00776100|4011216|B3||Male|Gender||Participants|Count of Participants|2|2.0||||||
4189954|NCT00776100|4011217|B2||Male|Gender||Participants|Count of Participants|1|1.0||||||
4189955|NCT00776100|4011218|B1||Male|Gender||Participants|Count of Participants|1|1.0||||||
4189956|NCT00776100|4011216|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
4189957|NCT00776100|4011217|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
4189958|NCT00776100|4011218|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
4189959|NCT00776100|4011216|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4189960|NCT00776100|4011217|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4189961|NCT00776100|4011218|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4189962|NCT00776100|4011216|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4189963|NCT00776100|4011217|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4189964|NCT00776100|4011218|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4189965|NCT00776100|4011216|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4189966|NCT00776100|4011217|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4189967|NCT00776100|4011218|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4189968|NCT00776009|4011235|B7|United States||Region of Enrollment||participants|Number|165|165.0||||||
4189969|NCT00776009|4011236|B6|United States||Region of Enrollment||participants|Number|27|27.0||||||
4189970|NCT00776009|4011237|B5|United States||Region of Enrollment||participants|Number|28|28.0||||||
4189971|NCT00776009|4011238|B4|United States||Region of Enrollment||participants|Number|27|27.0||||||
4189972|NCT00776009|4011239|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
4189973|NCT00776009|4011240|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4189974|NCT00776009|4011241|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4189975|NCT00776009|4011235|B7||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4189976|NCT00776009|4011236|B6||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4189977|NCT00776009|4011237|B5||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4189978|NCT00776009|4011238|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4189979|NCT00776009|4011239|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4189980|NCT00776009|4011240|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4189981|NCT00776009|4011241|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4189982|NCT00776009|4011235|B7||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4189983|NCT00776009|4011236|B6||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4189984|NCT00776009|4011237|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4189985|NCT00776009|4011238|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4189986|NCT00776009|4011239|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4189987|NCT00776009|4011240|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4189988|NCT00776009|4011241|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4189989|NCT00776009|4011235|B7|||Age||Years|Mean|9.6|9.6|Standard Deviation|1.8|1.8|||
4189990|NCT00776009|4011236|B6|||Age||Years|Mean|9.6|9.6|Standard Deviation|2.0|2.0|||
4189991|NCT00776009|4011237|B5|||Age||Years|Mean|9.5|9.5|Standard Deviation|1.8|1.8|||
4189992|NCT00776009|4011238|B4|||Age||Years|Mean|9.4|9.4|Standard Deviation|2.0|2.0|||
4189993|NCT00776009|4011239|B3|||Age||Years|Mean|10.0|10.0|Standard Deviation|1.8|1.8|||
4189994|NCT00776009|4011240|B2|||Age||Years|Mean|9.4|9.4|Standard Deviation|1.7|1.7|||
4189995|NCT00776009|4011241|B1|||Age||Years|Mean|9.3|9.3|Standard Deviation|1.7|1.7|||
4189996|NCT00775983|4011266|B3|United States||Region of Enrollment||participants|Number|69|69.0||||||
4189997|NCT00775983|4011267|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
4189998|NCT00775983|4011268|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4189999|NCT00775983|4011266|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4190000|NCT00775983|4011267|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4190001|NCT00775983|4011268|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4190002|NCT00775983|4011266|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4190003|NCT00775983|4011267|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4190004|NCT00775983|4011268|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4190005|NCT00775983|4011266|B3|||Age||years|Mean|26|26.0|Standard Deviation|6|6.0|||
4190006|NCT00775983|4011267|B2|||Age||years|Mean|27|27.0|Standard Deviation|6|6.0|||
4190007|NCT00775983|4011268|B1|||Age||years|Mean|24|24.0|Standard Deviation|7|7.0|||
4190008|NCT00775983|4011266|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4190009|NCT00775983|4011267|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4190010|NCT00775983|4011268|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4190011|NCT00775983|4011266|B3||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4190012|NCT00775983|4011267|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4190013|NCT00775983|4011268|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4190014|NCT00775983|4011266|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4190015|NCT00775983|4011267|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4190016|NCT00775983|4011268|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4190017|NCT00775944|4011277|B5|United Kingdom||Region of Enrollment||participants|Number|2591|2591.0||||||
4190018|NCT00775944|4011278|B4|United Kingdom||Region of Enrollment||participants|Number|648|648.0||||||
4190019|NCT00775944|4011279|B3|United Kingdom||Region of Enrollment||participants|Number|647|647.0||||||
4190020|NCT00775944|4011280|B2|United Kingdom||Region of Enrollment||participants|Number|648|648.0||||||
4190021|NCT00775944|4011281|B1|United Kingdom||Region of Enrollment||participants|Number|648|648.0||||||
4190022|NCT00775944|4011277|B5|Unknown||Sex/Gender, Customized||participants|Number|99|99.0||||||
4190023|NCT00775944|4011278|B4|Unknown||Sex/Gender, Customized||participants|Number|24|24.0||||||
4190024|NCT00775944|4011279|B3|Unknown||Sex/Gender, Customized||participants|Number|22|22.0||||||
4190025|NCT00775944|4011280|B2|Unknown||Sex/Gender, Customized||participants|Number|26|26.0||||||
4190026|NCT00775944|4011281|B1|Unknown||Sex/Gender, Customized||participants|Number|27|27.0||||||
4190027|NCT00775944|4011277|B5|Male||Sex/Gender, Customized||participants|Number|1137|1137.0||||||
4190028|NCT00775944|4011278|B4|Male||Sex/Gender, Customized||participants|Number|268|268.0||||||
4190029|NCT00775944|4011279|B3|Male||Sex/Gender, Customized||participants|Number|275|275.0||||||
4190030|NCT00775944|4011280|B2|Male||Sex/Gender, Customized||participants|Number|301|301.0||||||
4190031|NCT00775944|4011281|B1|Male||Sex/Gender, Customized||participants|Number|293|293.0||||||
4190032|NCT00775944|4011277|B5|Female||Sex/Gender, Customized||participants|Number|1355|1355.0||||||
4190033|NCT00775944|4011278|B4|Female||Sex/Gender, Customized||participants|Number|356|356.0||||||
4190034|NCT00775944|4011279|B3|Female||Sex/Gender, Customized||participants|Number|350|350.0||||||
4190035|NCT00775944|4011280|B2|Female||Sex/Gender, Customized||participants|Number|321|321.0||||||
4190036|NCT00775944|4011281|B1|Female||Sex/Gender, Customized||participants|Number|328|328.0||||||
4190037|NCT00775944|4011277|B5|Unknown||Age, Customized||participants|Number|122|122.0||||||
4190038|NCT00775944|4011278|B4|Unknown||Age, Customized||participants|Number|31|31.0||||||
4190039|NCT00775944|4011279|B3|Unknown||Age, Customized||participants|Number|26|26.0||||||
4190040|NCT00775944|4011280|B2|Unknown||Age, Customized||participants|Number|31|31.0||||||
4190041|NCT00775944|4011281|B1|Unknown||Age, Customized||participants|Number|34|34.0||||||
4190042|NCT00775944|4011277|B5|>=65 years||Age, Customized||participants|Number|149|149.0||||||
4190043|NCT00775944|4011278|B4|>=65 years||Age, Customized||participants|Number|31|31.0||||||
4190044|NCT00775944|4011279|B3|>=65 years||Age, Customized||participants|Number|44|44.0||||||
4190045|NCT00775944|4011280|B2|>=65 years||Age, Customized||participants|Number|41|41.0||||||
4190046|NCT00775944|4011281|B1|>=65 years||Age, Customized||participants|Number|33|33.0||||||
4190047|NCT00775944|4011277|B5|18-64 years||Age, Customized||participants|Number|2270|2270.0||||||
4190048|NCT00775944|4011278|B4|18-64 years||Age, Customized||participants|Number|575|575.0||||||
4190049|NCT00775944|4011279|B3|18-64 years||Age, Customized||participants|Number|564|564.0||||||
4190050|NCT00775944|4011280|B2|18-64 years||Age, Customized||participants|Number|562|562.0||||||
4190051|NCT00775944|4011281|B1|18-64 years||Age, Customized||participants|Number|569|569.0||||||
4190052|NCT00775944|4011277|B5|< 18 years||Age, Customized||participants|Number|50|50.0||||||
4190053|NCT00775944|4011278|B4|< 18 years||Age, Customized||participants|Number|11|11.0||||||
4190054|NCT00775944|4011279|B3|< 18 years||Age, Customized||participants|Number|13|13.0||||||
4190055|NCT00775944|4011280|B2|< 18 years||Age, Customized||participants|Number|14|14.0||||||
4190056|NCT00775944|4011281|B1|< 18 years||Age, Customized||participants|Number|12|12.0||||||
4190057|NCT00775944|4011277|B5|||Age||years|Mean|39.6|39.6|Standard Deviation|14.5|14.5|||
4190058|NCT00775944|4011278|B4|||Age||years|Mean|39.6|39.6|Standard Deviation|14.1|14.1|||
4190059|NCT00775944|4011279|B3|||Age||years|Mean|38.6|38.6|Standard Deviation|14.8|14.8|||
4190060|NCT00775944|4011280|B2|||Age||years|Mean|39.7|39.7|Standard Deviation|14.8|14.8|||
4190061|NCT00775944|4011281|B1|||Age||years|Mean|40.3|40.3|Standard Deviation|14.5|14.5|||
4190062|NCT00775684|4011310|B4|United States||Region of Enrollment||participants|Number|47|47.0||||||
4190063|NCT00775684|4011311|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4190064|NCT00775684|4011312|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4190065|NCT00775684|4011313|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4190066|NCT00775684|4011310|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4190067|NCT00775684|4011311|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4190068|NCT00775684|4011312|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4190069|NCT00775684|4011313|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4190070|NCT00775684|4011310|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4190071|NCT00775684|4011311|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4190072|NCT00775684|4011312|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4190073|NCT00775684|4011313|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4190074|NCT00775684|4011310|B4|||Age||years|Mean|55.3|55.3|Standard Deviation|2.6|2.6|||
4190075|NCT00775684|4011311|B3|||Age||years|Mean|52|52.0|Standard Deviation|3|3.0|||
4190076|NCT00775684|4011312|B2|||Age||years|Mean|57|57.0|Standard Deviation|3|3.0|||
4190077|NCT00775684|4011313|B1|||Age||years|Mean|57|57.0|Standard Deviation|2|2.0|||
4190078|NCT00775684|4011310|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4190079|NCT00775684|4011311|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4190080|NCT00775684|4011312|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4190081|NCT00775684|4011313|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4190082|NCT00775684|4011310|B4||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4190083|NCT00775684|4011311|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4190084|NCT00775684|4011312|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4190085|NCT00775684|4011313|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4190086|NCT00775684|4011310|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190087|NCT00775684|4011311|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190088|NCT00775684|4011312|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190089|NCT00775684|4011313|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190090|NCT00775671|4011335|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
4190091|NCT00775671|4011336|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4190092|NCT00775671|4011337|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4190093|NCT00775671|4011335|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4190094|NCT00775671|4011336|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4190095|NCT00775671|4011337|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4190096|NCT00775671|4011335|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4190097|NCT00775671|4011336|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4190098|NCT00775671|4011337|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4190099|NCT00775671|4011335|B3|||Age||years|Mean|44.4|44.4|Standard Deviation|10.0|10.0|||
4190100|NCT00775671|4011336|B2|||Age||years|Mean|47.4|47.4|Standard Deviation|8.5|8.5|||
4190101|NCT00775671|4011337|B1|||Age||years|Mean|41.3|41.3|Standard Deviation|11.5|11.5|||
4190102|NCT00775671|4011335|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4190103|NCT00775671|4011336|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4190104|NCT00775671|4011337|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4190105|NCT00775671|4011335|B3||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4190106|NCT00775671|4011336|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4190107|NCT00775671|4011337|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4190108|NCT00775671|4011335|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190109|NCT00775671|4011336|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190110|NCT00775671|4011337|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190111|NCT00775658|4011346|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4190112|NCT00775658|4011346|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4190113|NCT00775658|4011346|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4190114|NCT00775658|4011346|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4190115|NCT00775658|4011346|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4190116|NCT00775658|4011346|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190117|NCT00775645|4011355|B3||Not measurable/measured|Taxane regiment||Participants|Count of Participants|1|1.0||||||
4190118|NCT00775645|4011356|B2||Not measurable/measured|Taxane regiment||Participants|Count of Participants|1|1.0||||||
4190119|NCT00775645|4011357|B1||Not measurable/measured|Taxane regiment||Participants|Count of Participants|0|0.0||||||
4190120|NCT00775645|4011355|B3||Docetaxel|Taxane regiment||Participants|Count of Participants|161|161.0||||||
4190121|NCT00775645|4011356|B2||Docetaxel|Taxane regiment||Participants|Count of Participants|77|77.0||||||
4190122|NCT00775645|4011357|B1||Docetaxel|Taxane regiment||Participants|Count of Participants|84|84.0||||||
4190123|NCT00775645|4011355|B3||Paclitaxel|Taxane regiment||Participants|Count of Participants|247|247.0||||||
4190124|NCT00775645|4011356|B2||Paclitaxel|Taxane regiment||Participants|Count of Participants|123|123.0||||||
4190125|NCT00775645|4011357|B1||Paclitaxel|Taxane regiment||Participants|Count of Participants|124|124.0||||||
4190126|NCT00775645|4011355|B3||Not measurable/measured|Breast cancer stage|"As per AJCC 6th ed, 2002:~https://cancerstaging.org/references-tools/deskreferences/Documents/AJCC6thEdCancerStagingManualPart2.pdf"|Participants|Count of Participants|1|1.0||||||
4190127|NCT00775645|4011356|B2||Not measurable/measured|Breast cancer stage|"As per AJCC 6th ed, 2002:~https://cancerstaging.org/references-tools/deskreferences/Documents/AJCC6thEdCancerStagingManualPart2.pdf"|Participants|Count of Participants|1|1.0||||||
4190128|NCT00775645|4011357|B1||Not measurable/measured|Breast cancer stage|"As per AJCC 6th ed, 2002:~https://cancerstaging.org/references-tools/deskreferences/Documents/AJCC6thEdCancerStagingManualPart2.pdf"|Participants|Count of Participants|0|0.0||||||
4190129|NCT00775645|4011355|B3||III|Breast cancer stage|"As per AJCC 6th ed, 2002:~https://cancerstaging.org/references-tools/deskreferences/Documents/AJCC6thEdCancerStagingManualPart2.pdf"|Participants|Count of Participants|84|84.0||||||
4190130|NCT00775645|4011356|B2||III|Breast cancer stage|"As per AJCC 6th ed, 2002:~https://cancerstaging.org/references-tools/deskreferences/Documents/AJCC6thEdCancerStagingManualPart2.pdf"|Participants|Count of Participants|43|43.0||||||
4190131|NCT00775645|4011357|B1||III|Breast cancer stage|"As per AJCC 6th ed, 2002:~https://cancerstaging.org/references-tools/deskreferences/Documents/AJCC6thEdCancerStagingManualPart2.pdf"|Participants|Count of Participants|41|41.0||||||
4190159|NCT00775645|4011355|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4190132|NCT00775645|4011355|B3||II|Breast cancer stage|"As per AJCC 6th ed, 2002:~https://cancerstaging.org/references-tools/deskreferences/Documents/AJCC6thEdCancerStagingManualPart2.pdf"|Participants|Count of Participants|217|217.0||||||
4190133|NCT00775645|4011356|B2||II|Breast cancer stage|"As per AJCC 6th ed, 2002:~https://cancerstaging.org/references-tools/deskreferences/Documents/AJCC6thEdCancerStagingManualPart2.pdf"|Participants|Count of Participants|107|107.0||||||
4190134|NCT00775645|4011357|B1||II|Breast cancer stage|"As per AJCC 6th ed, 2002:~https://cancerstaging.org/references-tools/deskreferences/Documents/AJCC6thEdCancerStagingManualPart2.pdf"|Participants|Count of Participants|110|110.0||||||
4190135|NCT00775645|4011355|B3||I|Breast cancer stage|"As per AJCC 6th ed, 2002:~https://cancerstaging.org/references-tools/deskreferences/Documents/AJCC6thEdCancerStagingManualPart2.pdf"|Participants|Count of Participants|107|107.0||||||
4190136|NCT00775645|4011356|B2||I|Breast cancer stage|"As per AJCC 6th ed, 2002:~https://cancerstaging.org/references-tools/deskreferences/Documents/AJCC6thEdCancerStagingManualPart2.pdf"|Participants|Count of Participants|50|50.0||||||
4190137|NCT00775645|4011357|B1||I|Breast cancer stage|"As per AJCC 6th ed, 2002:~https://cancerstaging.org/references-tools/deskreferences/Documents/AJCC6thEdCancerStagingManualPart2.pdf"|Participants|Count of Participants|57|57.0||||||
4190138|NCT00775645|4011355|B3||2|Zubrod Performance Status|"0 – Asymptomatic (Fully active, able to carry on all predisease activities without restriction)~– Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~– Symptomatic, <50% in bed during the day (Ambulatory and capable of all self care but unable to carry out any work activities."|Participants|Count of Participants|2|2.0||||||
4190139|NCT00775645|4011356|B2||2|Zubrod Performance Status|"0 – Asymptomatic (Fully active, able to carry on all predisease activities without restriction)~– Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~– Symptomatic, <50% in bed during the day (Ambulatory and capable of all self care but unable to carry out any work activities."|Participants|Count of Participants|1|1.0||||||
4190140|NCT00775645|4011357|B1||2|Zubrod Performance Status|"0 – Asymptomatic (Fully active, able to carry on all predisease activities without restriction)~– Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~– Symptomatic, <50% in bed during the day (Ambulatory and capable of all self care but unable to carry out any work activities."|Participants|Count of Participants|1|1.0||||||
4190141|NCT00775645|4011355|B3||1|Zubrod Performance Status|"0 – Asymptomatic (Fully active, able to carry on all predisease activities without restriction)~– Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~– Symptomatic, <50% in bed during the day (Ambulatory and capable of all self care but unable to carry out any work activities."|Participants|Count of Participants|105|105.0||||||
4190142|NCT00775645|4011356|B2||1|Zubrod Performance Status|"0 – Asymptomatic (Fully active, able to carry on all predisease activities without restriction)~– Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~– Symptomatic, <50% in bed during the day (Ambulatory and capable of all self care but unable to carry out any work activities."|Participants|Count of Participants|54|54.0||||||
4190143|NCT00775645|4011357|B1||1|Zubrod Performance Status|"0 – Asymptomatic (Fully active, able to carry on all predisease activities without restriction)~– Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~– Symptomatic, <50% in bed during the day (Ambulatory and capable of all self care but unable to carry out any work activities."|Participants|Count of Participants|51|51.0||||||
4190144|NCT00775645|4011355|B3||0|Zubrod Performance Status|"0 – Asymptomatic (Fully active, able to carry on all predisease activities without restriction)~– Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~– Symptomatic, <50% in bed during the day (Ambulatory and capable of all self care but unable to carry out any work activities."|Participants|Count of Participants|302|302.0||||||
4190145|NCT00775645|4011356|B2||0|Zubrod Performance Status|"0 – Asymptomatic (Fully active, able to carry on all predisease activities without restriction)~– Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~– Symptomatic, <50% in bed during the day (Ambulatory and capable of all self care but unable to carry out any work activities."|Participants|Count of Participants|146|146.0||||||
4190146|NCT00775645|4011357|B1||0|Zubrod Performance Status|"0 – Asymptomatic (Fully active, able to carry on all predisease activities without restriction)~– Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~– Symptomatic, <50% in bed during the day (Ambulatory and capable of all self care but unable to carry out any work activities."|Participants|Count of Participants|156|156.0||||||
4190147|NCT00775645|4011355|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4190148|NCT00775645|4011356|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4190149|NCT00775645|4011357|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4190150|NCT00775645|4011355|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4190151|NCT00775645|4011356|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4190152|NCT00775645|4011357|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4190153|NCT00775645|4011355|B3||White|Race (NIH/OMB)||Participants|Count of Participants|325|325.0||||||
4190154|NCT00775645|4011356|B2||White|Race (NIH/OMB)||Participants|Count of Participants|165|165.0||||||
4190155|NCT00775645|4011357|B1||White|Race (NIH/OMB)||Participants|Count of Participants|160|160.0||||||
4190156|NCT00775645|4011355|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4190157|NCT00775645|4011356|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4190158|NCT00775645|4011357|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4190160|NCT00775645|4011356|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4190161|NCT00775645|4011357|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4190162|NCT00775645|4011355|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4190163|NCT00775645|4011356|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4190164|NCT00775645|4011357|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4190165|NCT00775645|4011355|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4190166|NCT00775645|4011356|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4190167|NCT00775645|4011357|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4190168|NCT00775645|4011355|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4190169|NCT00775645|4011356|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4190170|NCT00775645|4011357|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4190171|NCT00775645|4011355|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|358|358.0||||||
4190172|NCT00775645|4011356|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|177|177.0||||||
4190173|NCT00775645|4011357|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|181|181.0||||||
4190174|NCT00775645|4011355|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4190175|NCT00775645|4011356|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4190176|NCT00775645|4011357|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4190177|NCT00775645|4011355|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4190178|NCT00775645|4011356|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4190179|NCT00775645|4011357|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4190180|NCT00775645|4011355|B3||Female|Sex: Female, Male||Participants|Count of Participants|409|409.0||||||
4190181|NCT00775645|4011356|B2||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4190182|NCT00775645|4011357|B1||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4190183|NCT00775645|4011355|B3|||Age||years|Median|52|52.0|Full Range|||26.0|80.0|
4190184|NCT00775645|4011356|B2|||Age||years|Median|50|50.0|Full Range|||26.0|77.0|
4190185|NCT00775645|4011357|B1|||Age||years|Median|52|52.0|Full Range|||27.0|80.0|
4190186|NCT00775606|4011378|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4190187|NCT00775606|4011379|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4190188|NCT00775606|4011380|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4190189|NCT00775606|4011378|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4190190|NCT00775606|4011379|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4190191|NCT00775606|4011380|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4190192|NCT00775606|4011378|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4190193|NCT00775606|4011379|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4190194|NCT00775606|4011380|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4190195|NCT00775606|4011378|B3|||Age||years|Mean|33|33.0|Standard Deviation|8.5|8.5|||
4190196|NCT00775606|4011379|B2|||Age||years|Mean|30.6|30.6|Standard Deviation|7.1|7.1|||
4190197|NCT00775606|4011380|B1|||Age||years|Mean|34.5|34.5|Standard Deviation|9.4|9.4|||
4190198|NCT00775606|4011378|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4190199|NCT00775606|4011379|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4190200|NCT00775606|4011380|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4190201|NCT00775606|4011378|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4190202|NCT00775606|4011379|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4190203|NCT00775606|4011380|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4190204|NCT00775606|4011378|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190205|NCT00775606|4011379|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190206|NCT00775606|4011380|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190207|NCT00775593|4011391|B1|Italy||Region of Enrollment||participants|Number|53|53.0||||||
4190208|NCT00775593|4011391|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4190209|NCT00775593|4011391|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4190210|NCT00775593|4011391|B1|||Age, Customized||Years|Mean|69|69.0|Full Range|||60.0|78.0|
4190211|NCT00775528|4011398|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4190212|NCT00775528|4011398|B1||Male|Sex: Female, Male|The Baseline characteristics are presented on the Full Analysis Set meaning patients having taken the study drug and with Post-baseline efficacy data|Participants|Count of Participants|13|13.0||||||
4190213|NCT00775528|4011398|B1||Female|Sex: Female, Male|The Baseline characteristics are presented on the Full Analysis Set meaning patients having taken the study drug and with Post-baseline efficacy data|Participants|Count of Participants|5|5.0||||||
4190214|NCT00775528|4011398|B1|||Age|The Baseline characteristics are presented on the Full Analysis Set meaning patients having taken the study drug and with Post-baseline efficacy data|months|Mean|27.3|27.3|Standard Deviation|21.9|21.9|||
4190215|NCT00775463|4011405|B3|||Years since SSc diagnosis||years|Mean|10.5|10.5|Full Range|||0.0|35.0|
4190216|NCT00775463|4011406|B2|||Years since SSc diagnosis||years|Mean|10.3|10.3|Full Range|||0.0|35.0|
4190217|NCT00775463|4011407|B1|||Years since SSc diagnosis||years|Mean|10.7|10.7|Full Range|||0.0|30.0|
4190218|NCT00775463|4011405|B3|Diffuse||SSc Classification||participants|Number|52|52.0||||||
4190219|NCT00775463|4011406|B2|Diffuse||SSc Classification||participants|Number|31|31.0||||||
4190220|NCT00775463|4011407|B1|Diffuse||SSc Classification||participants|Number|21|21.0||||||
4190221|NCT00775463|4011405|B3|Limited||SSc Classification||participants|Number|95|95.0||||||
4190222|NCT00775463|4011406|B2|Limited||SSc Classification||participants|Number|40|40.0||||||
4190223|NCT00775463|4011407|B1|Limited||SSc Classification||participants|Number|55|55.0||||||
4190224|NCT00775463|4011405|B3|Unknown or Not Reported||Race/Ethnicity, Customized|Note: A Subject can be included in more than one race category.|participants|Number|2|2.0||||||
4190225|NCT00775463|4011406|B2|Unknown or Not Reported||Race/Ethnicity, Customized|Note: A Subject can be included in more than one race category.|participants|Number|1|1.0||||||
4190226|NCT00775463|4011407|B1|Unknown or Not Reported||Race/Ethnicity, Customized|Note: A Subject can be included in more than one race category.|participants|Number|1|1.0||||||
4190227|NCT00775463|4011405|B3|White||Race/Ethnicity, Customized|Note: A Subject can be included in more than one race category.|participants|Number|121|121.0||||||
4190228|NCT00775463|4011406|B2|White||Race/Ethnicity, Customized|Note: A Subject can be included in more than one race category.|participants|Number|59|59.0||||||
4190229|NCT00775463|4011407|B1|White||Race/Ethnicity, Customized|Note: A Subject can be included in more than one race category.|participants|Number|62|62.0||||||
4190230|NCT00775463|4011405|B3|Black or African American||Race/Ethnicity, Customized|Note: A Subject can be included in more than one race category.|participants|Number|17|17.0||||||
4190231|NCT00775463|4011406|B2|Black or African American||Race/Ethnicity, Customized|Note: A Subject can be included in more than one race category.|participants|Number|7|7.0||||||
4190232|NCT00775463|4011407|B1|Black or African American||Race/Ethnicity, Customized|Note: A Subject can be included in more than one race category.|participants|Number|10|10.0||||||
4190233|NCT00775463|4011405|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Note: A Subject can be included in more than one race category.|participants|Number|1|1.0||||||
4190234|NCT00775463|4011406|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Note: A Subject can be included in more than one race category.|participants|Number|1|1.0||||||
4190235|NCT00775463|4011407|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Note: A Subject can be included in more than one race category.|participants|Number|0|0.0||||||
4190236|NCT00775463|4011405|B3|Asian||Race/Ethnicity, Customized|Note: A Subject can be included in more than one race category.|participants|Number|7|7.0||||||
4190237|NCT00775463|4011406|B2|Asian||Race/Ethnicity, Customized|Note: A Subject can be included in more than one race category.|participants|Number|4|4.0||||||
4190238|NCT00775463|4011407|B1|Asian||Race/Ethnicity, Customized|Note: A Subject can be included in more than one race category.|participants|Number|3|3.0||||||
4190239|NCT00775463|4011405|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4190240|NCT00775463|4011406|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4190241|NCT00775463|4011407|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4190242|NCT00775463|4011405|B3||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4190243|NCT00775463|4011406|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4190244|NCT00775463|4011407|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4190245|NCT00775463|4011405|B3|||Age||years|Mean|48.8|48.8|Full Range|||19.0|82.0|
4190246|NCT00775463|4011406|B2|||Age||years|Mean|49.8|49.8|Full Range|||19.0|82.0|
4190247|NCT00775463|4011407|B1|||Age||years|Mean|47.8|47.8|Full Range|||20.0|74.0|
4190248|NCT00775450|4011440|B6|United States||Region of Enrollment||participants|Number|807|807.0||||||
4190249|NCT00775450|4011441|B5|United States||Region of Enrollment||participants|Number|201|201.0||||||
4190250|NCT00775450|4011442|B4|United States||Region of Enrollment||participants|Number|108|108.0||||||
4190251|NCT00775450|4011443|B3|United States||Region of Enrollment||participants|Number|105|105.0||||||
4190252|NCT00775450|4011444|B2|United States||Region of Enrollment||participants|Number|98|98.0||||||
4190253|NCT00775450|4011445|B1|United States||Region of Enrollment||participants|Number|295|295.0||||||
4190254|NCT00775450|4011440|B6||Male|Sex: Female, Male||Participants|Count of Participants|348|348.0||||||
4190255|NCT00775450|4011441|B5||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4190256|NCT00775450|4011442|B4||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4190257|NCT00775450|4011443|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4190258|NCT00775450|4011444|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4190259|NCT00775450|4011445|B1||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4190260|NCT00775450|4011440|B6||Female|Sex: Female, Male||Participants|Count of Participants|459|459.0||||||
4190261|NCT00775450|4011441|B5||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4190262|NCT00775450|4011442|B4||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4190263|NCT00775450|4011443|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4190264|NCT00775450|4011444|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4190265|NCT00775450|4011445|B1||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4190266|NCT00775450|4011440|B6|||Age||Years|Mean|73.8|73.8|Standard Deviation|5.74|5.74|||
4190267|NCT00775450|4011441|B5|||Age||Years|Mean|73.5|73.5|Standard Deviation|5.74|5.74|||
4190268|NCT00775450|4011442|B4|||Age||Years|Mean|74.3|74.3|Standard Deviation|5.11|5.11|||
4190269|NCT00775450|4011443|B3|||Age||Years|Mean|73.0|73.0|Standard Deviation|5.37|5.37|||
4190270|NCT00775450|4011444|B2|||Age||Years|Mean|74.2|74.2|Standard Deviation|5.97|5.97|||
4190271|NCT00775450|4011445|B1|||Age||Years|Mean|73.9|73.9|Standard Deviation|5.99|5.99|||
4190272|NCT00775450|4011440|B6||>=65 years|Age||Participants|Count of Participants|807|807.0||||||
4190273|NCT00775450|4011441|B5||>=65 years|Age||Participants|Count of Participants|201|201.0||||||
4190274|NCT00775450|4011442|B4||>=65 years|Age||Participants|Count of Participants|108|108.0||||||
4190275|NCT00775450|4011443|B3||>=65 years|Age||Participants|Count of Participants|105|105.0||||||
4190276|NCT00775450|4011444|B2||>=65 years|Age||Participants|Count of Participants|98|98.0||||||
4190277|NCT00775450|4011445|B1||>=65 years|Age||Participants|Count of Participants|295|295.0||||||
4190278|NCT00775450|4011440|B6||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4190279|NCT00775450|4011441|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4190280|NCT00775450|4011442|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4190281|NCT00775450|4011443|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4190282|NCT00775450|4011444|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4190283|NCT00775450|4011445|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4190284|NCT00775450|4011440|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190285|NCT00775450|4011441|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190286|NCT00775450|4011442|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190287|NCT00775450|4011443|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190288|NCT00775450|4011444|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190289|NCT00775450|4011445|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190290|NCT00775437|4011476|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4190291|NCT00775437|4011476|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4190292|NCT00775437|4011476|B1|≥ 4 years||Age, Customized||participants|Number|4|4.0||||||
4190293|NCT00775437|4011476|B1|< 4 years||Age, Customized||participants|Number|28|28.0||||||
4190294|NCT00775437|4011476|B1|||Age||years|Mean|3.04|3.04|Standard Deviation|0.723|0.723|||
4190295|NCT00775411|4011526|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4190296|NCT00775411|4011526|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4190297|NCT00775411|4011526|B1|||Age||Years|Mean|72.3|72.3|Standard Deviation|10.43|10.43|||
4190298|NCT00775346|4011532|B1|United States||Region of Enrollment||participants|Number|92|92.0||||||
4190299|NCT00775346|4011532|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4190300|NCT00775346|4011532|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4190301|NCT00775346|4011532|B1|||Age||years|Mean|52.7|52.7|Standard Deviation|13|13.0|||
4190302|NCT00775346|4011532|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4190303|NCT00775346|4011532|B1||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
4190304|NCT00775346|4011532|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190305|NCT00775229|4011536|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
4190306|NCT00775229|4011537|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4190307|NCT00775229|4011538|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4190308|NCT00775229|4011536|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4190309|NCT00775229|4011537|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4190310|NCT00775229|4011538|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4190311|NCT00775229|4011536|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4190312|NCT00775229|4011537|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4190313|NCT00775229|4011538|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4190314|NCT00775229|4011536|B3|||Age||years|Mean|32.7|32.7|Standard Deviation|7.2|7.2|||
4190315|NCT00775229|4011537|B2|||Age||years|Mean|34.0|34.0|Standard Deviation|10.1|10.1|||
4190316|NCT00775229|4011538|B1|||Age||years|Mean|32.2|32.2|Standard Deviation|9.4|9.4|||
4190317|NCT00775229|4011536|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4190318|NCT00775229|4011537|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4190319|NCT00775229|4011538|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4190320|NCT00775229|4011536|B3||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4190321|NCT00775229|4011537|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4190322|NCT00775229|4011538|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4190323|NCT00775229|4011536|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190324|NCT00775229|4011537|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190325|NCT00775229|4011538|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190326|NCT00775203|4011549|B3|Canada||Region of Enrollment||participants|Number|71|71.0||||||
4190327|NCT00775203|4011550|B2|Canada||Region of Enrollment||participants|Number|38|38.0||||||
4190328|NCT00775203|4011551|B1|Canada||Region of Enrollment||participants|Number|33|33.0||||||
4190329|NCT00775203|4011549|B3|United States||Region of Enrollment||participants|Number|335|335.0||||||
4190330|NCT00775203|4011550|B2|United States||Region of Enrollment||participants|Number|166|166.0||||||
4190331|NCT00775203|4011551|B1|United States||Region of Enrollment||participants|Number|169|169.0||||||
4190332|NCT00775203|4011549|B3||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4190333|NCT00775203|4011550|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4190334|NCT00775203|4011551|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4190335|NCT00775203|4011549|B3||Female|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
4190336|NCT00775203|4011550|B2||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4190337|NCT00775203|4011551|B1||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4190338|NCT00775203|4011549|B3|||Age||years|Mean|43.9|43.9|Standard Deviation|13.12|13.12|||
4190339|NCT00775203|4011550|B2|||Age||years|Mean|44.0|44.0|Standard Deviation|13.45|13.45|||
4190340|NCT00775203|4011551|B1|||Age||years|Mean|43.8|43.8|Standard Deviation|12.83|12.83|||
4190341|NCT00775203|4011549|B3||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4190342|NCT00775203|4011550|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4190343|NCT00775203|4011551|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4190344|NCT00775203|4011549|B3||Between 18 and 65 years|Age||Participants|Count of Participants|379|379.0||||||
4190345|NCT00775203|4011550|B2||Between 18 and 65 years|Age||Participants|Count of Participants|186|186.0||||||
4190346|NCT00775203|4011551|B1||Between 18 and 65 years|Age||Participants|Count of Participants|193|193.0||||||
4190347|NCT00775203|4011549|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4190348|NCT00775203|4011550|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4190349|NCT00775203|4011551|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190350|NCT00775190|4011584|B3|United States||Region of Enrollment|Beaumont Health System patient population|participants|Number|12|12.0||||||
4190351|NCT00775190|4011585|B2|United States||Region of Enrollment|Beaumont Health System patient population|participants|Number|5|5.0||||||
4190352|NCT00775190|4011586|B1|United States||Region of Enrollment|Beaumont Health System patient population|participants|Number|7|7.0||||||
4190353|NCT00775190|4011584|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4190354|NCT00775190|4011585|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4190355|NCT00775190|4011586|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4190356|NCT00775190|4011584|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4190357|NCT00775190|4011585|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4190358|NCT00775190|4011586|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4190359|NCT00775190|4011584|B3|||Age|target population females ages 18-65|years|Mean|24|24.0|Full Range|||21.0|31.0|
4190360|NCT00775190|4011585|B2|||Age|target population females ages 18-65|years|Mean|24|24.0|Full Range|||21.0|31.0|
4190361|NCT00775190|4011586|B1|||Age|target population females ages 18-65|years|Mean|24|24.0|Full Range|||21.0|31.0|
4190362|NCT00775190|4011584|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4190363|NCT00775190|4011585|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4190364|NCT00775190|4011586|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4190365|NCT00775190|4011584|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4190366|NCT00775190|4011585|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4190367|NCT00775190|4011586|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4190368|NCT00775190|4011584|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190369|NCT00775190|4011585|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190370|NCT00775190|4011586|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190371|NCT00775021|4011609|B1|United Kingdom||Region of Enrollment||participants|Number|121|121.0||||||
4190372|NCT00775021|4011609|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4190373|NCT00775021|4011609|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4190374|NCT00775021|4011609|B1|||Age||years|Mean|28.7|28.7|Standard Deviation|8.5|8.5|||
4190375|NCT00774995|4011624|B5||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4190376|NCT00774995|4011625|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4190377|NCT00774995|4011626|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4190378|NCT00774995|4011627|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4190379|NCT00774995|4011628|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4190380|NCT00774995|4011624|B5||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4190381|NCT00774995|4011625|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4190382|NCT00774995|4011626|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4190383|NCT00774995|4011627|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4190384|NCT00774995|4011628|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4190385|NCT00774995|4011624|B5|||Age||Years|Mean|19.5|19.5|Standard Deviation|0.51|0.51|||
4190386|NCT00774995|4011625|B4|||Age||Years|Mean|19.5|19.5|Standard Deviation|0.52|0.52|||
4190387|NCT00774995|4011626|B3|||Age||Years|Mean|19.8|19.8|Standard Deviation|0.46|0.46|||
4190388|NCT00774995|4011627|B2|||Age||Years|Mean|19.6|19.6|Standard Deviation|0.5|0.5|||
4190389|NCT00774995|4011628|B1|||Age||Years|Mean|19.3|19.3|Standard Deviation|0.5|0.5|||
4190390|NCT00774930|4011669|B3|Multi race||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4190391|NCT00774930|4011670|B2|Multi race||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4190392|NCT00774930|4011671|B1|Multi race||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4190393|NCT00774930|4011669|B3|White||Race/Ethnicity, Customized||participants|Number|88|88.0||||||
4190394|NCT00774930|4011670|B2|White||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4190395|NCT00774930|4011671|B1|White||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4190396|NCT00774930|4011669|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4190397|NCT00774930|4011670|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4190398|NCT00774930|4011671|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4190399|NCT00774930|4011669|B3|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4190400|NCT00774930|4011670|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4190401|NCT00774930|4011671|B1|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4190402|NCT00774930|4011669|B3||Male|Gender||Participants|Count of Participants|48|48.0||||||
4190403|NCT00774930|4011670|B2||Male|Gender||Participants|Count of Participants|21|21.0||||||
4190404|NCT00774930|4011671|B1||Male|Gender||Participants|Count of Participants|27|27.0||||||
4190405|NCT00774930|4011669|B3||Female|Gender||Participants|Count of Participants|67|67.0||||||
4190406|NCT00774930|4011670|B2||Female|Gender||Participants|Count of Participants|35|35.0||||||
4190407|NCT00774930|4011671|B1||Female|Gender||Participants|Count of Participants|32|32.0||||||
4190408|NCT00774930|4011669|B3|||Age||years|Mean|58.6|58.6|Standard Deviation|11.1|11.1|||
4190409|NCT00774930|4011670|B2|||Age||years|Mean|59.3|59.3|Standard Deviation|11.6|11.6|||
4190410|NCT00774930|4011671|B1|||Age||years|Mean|57.9|57.9|Standard Deviation|10.6|10.6|||
4190411|NCT00774852|4011698|B3|CH50 hypocomplementemia||Participants with Hypocomplementemia|Participants were categorized as having hypocomplementemia if their serum complement test results (C3, C4 and/or CH50) were below the normal range at the site. Below normal complement test results are indicative of active lupus erythematosus.Not all subjects had available data.|participants|Number|52|52.0||||||
4190412|NCT00774852|4011699|B2|CH50 hypocomplementemia||Participants with Hypocomplementemia|Participants were categorized as having hypocomplementemia if their serum complement test results (C3, C4 and/or CH50) were below the normal range at the site. Below normal complement test results are indicative of active lupus erythematosus.Not all subjects had available data.|participants|Number|23|23.0||||||
4190413|NCT00774852|4011700|B1|CH50 hypocomplementemia||Participants with Hypocomplementemia|Participants were categorized as having hypocomplementemia if their serum complement test results (C3, C4 and/or CH50) were below the normal range at the site. Below normal complement test results are indicative of active lupus erythematosus.Not all subjects had available data.|participants|Number|29|29.0||||||
4190414|NCT00774852|4011698|B3|C4 hypocomplementemia||Participants with Hypocomplementemia|Participants were categorized as having hypocomplementemia if their serum complement test results (C3, C4 and/or CH50) were below the normal range at the site. Below normal complement test results are indicative of active lupus erythematosus.Not all subjects had available data.|participants|Number|76|76.0||||||
4190415|NCT00774852|4011699|B2|C4 hypocomplementemia||Participants with Hypocomplementemia|Participants were categorized as having hypocomplementemia if their serum complement test results (C3, C4 and/or CH50) were below the normal range at the site. Below normal complement test results are indicative of active lupus erythematosus.Not all subjects had available data.|participants|Number|37|37.0||||||
4190416|NCT00774852|4011700|B1|C4 hypocomplementemia||Participants with Hypocomplementemia|Participants were categorized as having hypocomplementemia if their serum complement test results (C3, C4 and/or CH50) were below the normal range at the site. Below normal complement test results are indicative of active lupus erythematosus.Not all subjects had available data.|participants|Number|39|39.0||||||
4190417|NCT00774852|4011698|B3|C3 hypocomplementemia||Participants with Hypocomplementemia|Participants were categorized as having hypocomplementemia if their serum complement test results (C3, C4 and/or CH50) were below the normal range at the site. Below normal complement test results are indicative of active lupus erythematosus.Not all subjects had available data.|participants|Number|91|91.0||||||
4190418|NCT00774852|4011699|B2|C3 hypocomplementemia||Participants with Hypocomplementemia|Participants were categorized as having hypocomplementemia if their serum complement test results (C3, C4 and/or CH50) were below the normal range at the site. Below normal complement test results are indicative of active lupus erythematosus.Not all subjects had available data.|participants|Number|44|44.0||||||
4190419|NCT00774852|4011700|B1|C3 hypocomplementemia||Participants with Hypocomplementemia|Participants were categorized as having hypocomplementemia if their serum complement test results (C3, C4 and/or CH50) were below the normal range at the site. Below normal complement test results are indicative of active lupus erythematosus.Not all subjects had available data.|participants|Number|47|47.0||||||
4190420|NCT00774852|4011698|B3|||Serum Complement Test CH50|Serum complement tests (complement C3, -C4 and -CD50) measure a group of proteins in the blood. Low blood levels of complement are common in people who have active lupus. Harrison's Principles of Internal Medicine normal values: CD50 (a measure of total complement activity) 41 - 90 hemolytic units/mL.|units/mL|Mean|54.3|54.3|Standard Deviation|47.5|47.5|||
4190421|NCT00774852|4011699|B2|||Serum Complement Test CH50|Serum complement tests (complement C3, -C4 and -CD50) measure a group of proteins in the blood. Low blood levels of complement are common in people who have active lupus. Harrison's Principles of Internal Medicine normal values: CD50 (a measure of total complement activity) 41 - 90 hemolytic units/mL.|units/mL|Mean|61.3|61.3|Standard Deviation|52.2|52.2|||
4190422|NCT00774852|4011700|B1|||Serum Complement Test CH50|Serum complement tests (complement C3, -C4 and -CD50) measure a group of proteins in the blood. Low blood levels of complement are common in people who have active lupus. Harrison's Principles of Internal Medicine normal values: CD50 (a measure of total complement activity) 41 - 90 hemolytic units/mL.|units/mL|Mean|47.0|47.0|Standard Deviation|41.3|41.3|||
4190423|NCT00774852|4011698|B3|||Serum Complement Test C4|Serum complement tests (complement C3, -C4 and -CD50) measure a group of proteins in the blood. Low blood levels of complement are common in people who have active lupus. Harrison's Principles of Internal Medicine normal values: C4 = 16 - 47 mg/dL.|mg/dL|Mean|13.2|13.2|Standard Deviation|7.9|7.9|||
4190440|NCT00774852|4011700|B1|||Average Daily Prednisone Dose|Average daily prednisone dose taken by participants during 14 days prior to initiation of study drug.|mg/day|Mean|47.0|47.0|Standard Deviation|18.5|18.5|||
4190424|NCT00774852|4011699|B2|||Serum Complement Test C4|Serum complement tests (complement C3, -C4 and -CD50) measure a group of proteins in the blood. Low blood levels of complement are common in people who have active lupus. Harrison's Principles of Internal Medicine normal values: C4 = 16 - 47 mg/dL.|mg/dL|Mean|13.4|13.4|Standard Deviation|6.8|6.8|||
4190425|NCT00774852|4011700|B1|||Serum Complement Test C4|Serum complement tests (complement C3, -C4 and -CD50) measure a group of proteins in the blood. Low blood levels of complement are common in people who have active lupus. Harrison's Principles of Internal Medicine normal values: C4 = 16 - 47 mg/dL.|mg/dL|Mean|13.0|13.0|Standard Deviation|8.9|8.9|||
4190426|NCT00774852|4011698|B3|||Serum Complement Test C3|Serum complement tests (complement C3, -C4 and -CD50) measure a group of proteins in the blood. Low blood levels of complement are common in people who have active lupus. Harrison’s Principles of Internal Medicine normal values: C3 83 – 177 mg/dL.|mg/dL|Mean|67.3|67.3|Standard Deviation|28.1|28.1|||
4190427|NCT00774852|4011699|B2|||Serum Complement Test C3|Serum complement tests (complement C3, -C4 and -CD50) measure a group of proteins in the blood. Low blood levels of complement are common in people who have active lupus. Harrison’s Principles of Internal Medicine normal values: C3 83 – 177 mg/dL.|mg/dL|Mean|70.4|70.4|Standard Deviation|30.4|30.4|||
4190428|NCT00774852|4011700|B1|||Serum Complement Test C3|Serum complement tests (complement C3, -C4 and -CD50) measure a group of proteins in the blood. Low blood levels of complement are common in people who have active lupus. Harrison’s Principles of Internal Medicine normal values: C3 83 – 177 mg/dL.|mg/dL|Mean|64.2|64.2|Standard Deviation|25.5|25.5|||
4190429|NCT00774852|4011698|B3|Positive||Anti-dsDNA|Participants with systemic lupus erythematosus (SLE) may have autoantibodies (e.g., self against self) to double-stranded DNA. Double-stranded DNA is one of multiple diagnostic tests for SLE and levels may be associated with disease activity. A positive test for autoantibodies to double-stranded DNA is based on the normal range from the local laboratory. Baseline is defined as the last measurement taken on or prior to the first day of dosing. Not all subjects had available data.|participants|Number|99|99.0||||||
4190430|NCT00774852|4011699|B2|Positive||Anti-dsDNA|Participants with systemic lupus erythematosus (SLE) may have autoantibodies (e.g., self against self) to double-stranded DNA. Double-stranded DNA is one of multiple diagnostic tests for SLE and levels may be associated with disease activity. A positive test for autoantibodies to double-stranded DNA is based on the normal range from the local laboratory. Baseline is defined as the last measurement taken on or prior to the first day of dosing. Not all subjects had available data.|participants|Number|50|50.0||||||
4190431|NCT00774852|4011700|B1|Positive||Anti-dsDNA|Participants with systemic lupus erythematosus (SLE) may have autoantibodies (e.g., self against self) to double-stranded DNA. Double-stranded DNA is one of multiple diagnostic tests for SLE and levels may be associated with disease activity. A positive test for autoantibodies to double-stranded DNA is based on the normal range from the local laboratory. Baseline is defined as the last measurement taken on or prior to the first day of dosing. Not all subjects had available data.|participants|Number|49|49.0||||||
4190432|NCT00774852|4011698|B3|Equivocal (“borderline”)||Anti-dsDNA|Participants with systemic lupus erythematosus (SLE) may have autoantibodies (e.g., self against self) to double-stranded DNA. Double-stranded DNA is one of multiple diagnostic tests for SLE and levels may be associated with disease activity. A positive test for autoantibodies to double-stranded DNA is based on the normal range from the local laboratory. Baseline is defined as the last measurement taken on or prior to the first day of dosing. Not all subjects had available data.|participants|Number|4|4.0||||||
4190433|NCT00774852|4011699|B2|Equivocal (“borderline”)||Anti-dsDNA|Participants with systemic lupus erythematosus (SLE) may have autoantibodies (e.g., self against self) to double-stranded DNA. Double-stranded DNA is one of multiple diagnostic tests for SLE and levels may be associated with disease activity. A positive test for autoantibodies to double-stranded DNA is based on the normal range from the local laboratory. Baseline is defined as the last measurement taken on or prior to the first day of dosing. Not all subjects had available data.|participants|Number|2|2.0||||||
4190434|NCT00774852|4011700|B1|Equivocal (“borderline”)||Anti-dsDNA|Participants with systemic lupus erythematosus (SLE) may have autoantibodies (e.g., self against self) to double-stranded DNA. Double-stranded DNA is one of multiple diagnostic tests for SLE and levels may be associated with disease activity. A positive test for autoantibodies to double-stranded DNA is based on the normal range from the local laboratory. Baseline is defined as the last measurement taken on or prior to the first day of dosing. Not all subjects had available data.|participants|Number|2|2.0||||||
4190435|NCT00774852|4011698|B3|Negative||Anti-dsDNA|Participants with systemic lupus erythematosus (SLE) may have autoantibodies (e.g., self against self) to double-stranded DNA. Double-stranded DNA is one of multiple diagnostic tests for SLE and levels may be associated with disease activity. A positive test for autoantibodies to double-stranded DNA is based on the normal range from the local laboratory. Baseline is defined as the last measurement taken on or prior to the first day of dosing. Not all subjects had available data.|participants|Number|29|29.0||||||
4190436|NCT00774852|4011699|B2|Negative||Anti-dsDNA|Participants with systemic lupus erythematosus (SLE) may have autoantibodies (e.g., self against self) to double-stranded DNA. Double-stranded DNA is one of multiple diagnostic tests for SLE and levels may be associated with disease activity. A positive test for autoantibodies to double-stranded DNA is based on the normal range from the local laboratory. Baseline is defined as the last measurement taken on or prior to the first day of dosing. Not all subjects had available data.|participants|Number|15|15.0||||||
4190437|NCT00774852|4011700|B1|Negative||Anti-dsDNA|Participants with systemic lupus erythematosus (SLE) may have autoantibodies (e.g., self against self) to double-stranded DNA. Double-stranded DNA is one of multiple diagnostic tests for SLE and levels may be associated with disease activity. A positive test for autoantibodies to double-stranded DNA is based on the normal range from the local laboratory. Baseline is defined as the last measurement taken on or prior to the first day of dosing. Not all subjects had available data.|participants|Number|14|14.0||||||
4190438|NCT00774852|4011698|B3|||Average Daily Prednisone Dose|Average daily prednisone dose taken by participants during 14 days prior to initiation of study drug.|mg/day|Mean|42.8|42.8|Standard Deviation|19.8|19.8|||
4190439|NCT00774852|4011699|B2|||Average Daily Prednisone Dose|Average daily prednisone dose taken by participants during 14 days prior to initiation of study drug.|mg/day|Mean|39.0|39.0|Standard Deviation|20.3|20.3|||
4190507|NCT00774800|4011749|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4190441|NCT00774852|4011698|B3|<= 3 mg:mg||Urine Protein-to-Creatinine Ratio|Urine protein: creatinine ratio is a comparison of protein to creatinine in urine which is an indicator of proteinuria. A ratio greater than 0.2 mg:mg is considered an indicator of poor kidney function. Participants are stratified as either 1.) greater than or 2.) <=3 mg:mg.|participants|Number|76|76.0||||||
4190442|NCT00774852|4011699|B2|<= 3 mg:mg||Urine Protein-to-Creatinine Ratio|Urine protein: creatinine ratio is a comparison of protein to creatinine in urine which is an indicator of proteinuria. A ratio greater than 0.2 mg:mg is considered an indicator of poor kidney function. Participants are stratified as either 1.) greater than or 2.) <=3 mg:mg.|participants|Number|37|37.0||||||
4190443|NCT00774852|4011700|B1|<= 3 mg:mg||Urine Protein-to-Creatinine Ratio|Urine protein: creatinine ratio is a comparison of protein to creatinine in urine which is an indicator of proteinuria. A ratio greater than 0.2 mg:mg is considered an indicator of poor kidney function. Participants are stratified as either 1.) greater than or 2.) <=3 mg:mg.|participants|Number|39|39.0||||||
4190444|NCT00774852|4011698|B3|> 3 mg:mg||Urine Protein-to-Creatinine Ratio|Urine protein: creatinine ratio is a comparison of protein to creatinine in urine which is an indicator of proteinuria. A ratio greater than 0.2 mg:mg is considered an indicator of poor kidney function. Participants are stratified as either 1.) greater than or 2.) <=3 mg:mg.|participants|Number|58|58.0||||||
4190445|NCT00774852|4011699|B2|> 3 mg:mg||Urine Protein-to-Creatinine Ratio|Urine protein: creatinine ratio is a comparison of protein to creatinine in urine which is an indicator of proteinuria. A ratio greater than 0.2 mg:mg is considered an indicator of poor kidney function. Participants are stratified as either 1.) greater than or 2.) <=3 mg:mg.|participants|Number|31|31.0||||||
4190446|NCT00774852|4011700|B1|> 3 mg:mg||Urine Protein-to-Creatinine Ratio|Urine protein: creatinine ratio is a comparison of protein to creatinine in urine which is an indicator of proteinuria. A ratio greater than 0.2 mg:mg is considered an indicator of poor kidney function. Participants are stratified as either 1.) greater than or 2.) <=3 mg:mg.|participants|Number|27|27.0||||||
4190447|NCT00774852|4011698|B3|||Urine Protein-to-Creatinine Ratio (24 hour collection)|Several measures of kidney (renal) function were obtained from a 24 hour urine collection: urine protein (mg/day), -creatinine (mg/day), -protein: -creatinine ratio (mg:mg). Urine protein-to-creatinine ratio is an indicator of proteinuria. A ratio greater than 0.2 mg:mg is considered an indicator of poor kidney function.|mg:mg|Mean|3.9|3.9|Standard Deviation|3.0|3.0|||
4190448|NCT00774852|4011699|B2|||Urine Protein-to-Creatinine Ratio (24 hour collection)|Several measures of kidney (renal) function were obtained from a 24 hour urine collection: urine protein (mg/day), -creatinine (mg/day), -protein: -creatinine ratio (mg:mg). Urine protein-to-creatinine ratio is an indicator of proteinuria. A ratio greater than 0.2 mg:mg is considered an indicator of poor kidney function.|mg:mg|Mean|4.1|4.1|Standard Deviation|3.4|3.4|||
4190449|NCT00774852|4011700|B1|||Urine Protein-to-Creatinine Ratio (24 hour collection)|Several measures of kidney (renal) function were obtained from a 24 hour urine collection: urine protein (mg/day), -creatinine (mg/day), -protein: -creatinine ratio (mg:mg). Urine protein-to-creatinine ratio is an indicator of proteinuria. A ratio greater than 0.2 mg:mg is considered an indicator of poor kidney function.|mg:mg|Mean|3.6|3.6|Standard Deviation|2.6|2.6|||
4190450|NCT00774852|4011698|B3|||Urine Creatinine (24 hour collection)|Several measures of kidney (renal) function were obtained from a 24 hour urine collection: urine protein (mg/day), -creatinine (mg/day), -protein: -creatinine ratio (mg:mg). Urine creatinine normal range: 500 to 2000 mg/day. An abnormal result may indicate poorer kidney function.|mg/day|Mean|1107.6|1107.6|Standard Deviation|472.8|472.8|||
4190451|NCT00774852|4011699|B2|||Urine Creatinine (24 hour collection)|Several measures of kidney (renal) function were obtained from a 24 hour urine collection: urine protein (mg/day), -creatinine (mg/day), -protein: -creatinine ratio (mg:mg). Urine creatinine normal range: 500 to 2000 mg/day. An abnormal result may indicate poorer kidney function.|mg/day|Mean|1132.8|1132.8|Standard Deviation|409.3|409.3|||
4190452|NCT00774852|4011700|B1|||Urine Creatinine (24 hour collection)|Several measures of kidney (renal) function were obtained from a 24 hour urine collection: urine protein (mg/day), -creatinine (mg/day), -protein: -creatinine ratio (mg:mg). Urine creatinine normal range: 500 to 2000 mg/day. An abnormal result may indicate poorer kidney function.|mg/day|Mean|1081.5|1081.5|Standard Deviation|532.4|532.4|||
4190453|NCT00774852|4011698|B3|||Urine Protein (24 hour collection)|Several measures of kidney (renal) function were obtained from a 24 hour urine collection: urine protein (mg/day), -creatinine (mg/day), -protein: -creatinine ratio (mg:mg). Urine protein normal values: less than 80 mg/day. Greater levels of urine protein may indicate kidney disease.|mg/day|Mean|4167.3|4167.3|Standard Deviation|3566.4|3566.4|||
4190454|NCT00774852|4011699|B2|||Urine Protein (24 hour collection)|Several measures of kidney (renal) function were obtained from a 24 hour urine collection: urine protein (mg/day), -creatinine (mg/day), -protein: -creatinine ratio (mg:mg). Urine protein normal values: less than 80 mg/day. Greater levels of urine protein may indicate kidney disease.|mg/day|Mean|4509.4|4509.4|Standard Deviation|3987.7|3987.7|||
4190455|NCT00774852|4011700|B1|||Urine Protein (24 hour collection)|Several measures of kidney (renal) function were obtained from a 24 hour urine collection: urine protein (mg/day), -creatinine (mg/day), -protein: -creatinine ratio (mg:mg). Urine protein normal values: less than 80 mg/day. Greater levels of urine protein may indicate kidney disease.|mg/day|Mean|3814.8|3814.8|Standard Deviation|3063.6|3063.6|||
4190456|NCT00774852|4011698|B3|||eGFR|Estimated glomerular filtration rate (eGFR) is a calculation based on serum creatinine result, age, sex and race. GFR is a marker of kidney function. Normal GFR is approximately 100mL/min/1.73m^2. Lower GFRs reflect poorer kidney function.|mL/min/1.73m^2|Mean|61.4|61.4|Standard Deviation|32.2|32.2|||
4190457|NCT00774852|4011699|B2|||eGFR|Estimated glomerular filtration rate (eGFR) is a calculation based on serum creatinine result, age, sex and race. GFR is a marker of kidney function. Normal GFR is approximately 100mL/min/1.73m^2. Lower GFRs reflect poorer kidney function.|mL/min/1.73m^2|Mean|58.4|58.4|Standard Deviation|27.8|27.8|||
4190458|NCT00774852|4011700|B1|||eGFR|Estimated glomerular filtration rate (eGFR) is a calculation based on serum creatinine result, age, sex and race. GFR is a marker of kidney function. Normal GFR is approximately 100mL/min/1.73m^2. Lower GFRs reflect poorer kidney function.|mL/min/1.73m^2|Mean|64.6|64.6|Standard Deviation|36.2|36.2|||
4190508|NCT00774800|4011749|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4190509|NCT00774800|4011749|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4190459|NCT00774852|4011698|B3|||Serum Creatinine|The highest serum creatinine reading from either screening or baseline visit was used for this measure. According to Harrison's Principles of Internal Medicine, normal results are 0.6 to 1.2 mg/dL for men and 0.5 to 0.9 mg/dL for women. This test measures kidney function. Abnormal kidney function results in increased levels of serum creatinine.|mg/dL|Mean|1.2|1.2|Standard Deviation|0.7|0.7|||
4190460|NCT00774852|4011699|B2|||Serum Creatinine|The highest serum creatinine reading from either screening or baseline visit was used for this measure. According to Harrison's Principles of Internal Medicine, normal results are 0.6 to 1.2 mg/dL for men and 0.5 to 0.9 mg/dL for women. This test measures kidney function. Abnormal kidney function results in increased levels of serum creatinine.|mg/dL|Mean|1.2|1.2|Standard Deviation|0.6|0.6|||
4190461|NCT00774852|4011700|B1|||Serum Creatinine|The highest serum creatinine reading from either screening or baseline visit was used for this measure. According to Harrison's Principles of Internal Medicine, normal results are 0.6 to 1.2 mg/dL for men and 0.5 to 0.9 mg/dL for women. This test measures kidney function. Abnormal kidney function results in increased levels of serum creatinine.|mg/dL|Mean|1.3|1.3|Standard Deviation|0.7|0.7|||
4190462|NCT00774852|4011698|B3|>=1 Year||Duration of Lupus Nephritis|Years since lupus nephritis was diagnosed by a physician. This information was obtained by medical history during the Baseline Visit.|participants|Number|39|39.0||||||
4190463|NCT00774852|4011699|B2|>=1 Year||Duration of Lupus Nephritis|Years since lupus nephritis was diagnosed by a physician. This information was obtained by medical history during the Baseline Visit.|participants|Number|20|20.0||||||
4190464|NCT00774852|4011700|B1|>=1 Year||Duration of Lupus Nephritis|Years since lupus nephritis was diagnosed by a physician. This information was obtained by medical history during the Baseline Visit.|participants|Number|19|19.0||||||
4190465|NCT00774852|4011698|B3|<1 Year||Duration of Lupus Nephritis|Years since lupus nephritis was diagnosed by a physician. This information was obtained by medical history during the Baseline Visit.|participants|Number|95|95.0||||||
4190466|NCT00774852|4011699|B2|<1 Year||Duration of Lupus Nephritis|Years since lupus nephritis was diagnosed by a physician. This information was obtained by medical history during the Baseline Visit.|participants|Number|48|48.0||||||
4190467|NCT00774852|4011700|B1|<1 Year||Duration of Lupus Nephritis|Years since lupus nephritis was diagnosed by a physician. This information was obtained by medical history during the Baseline Visit.|participants|Number|47|47.0||||||
4190468|NCT00774852|4011698|B3|Mexico||Region of Enrollment||participants|Number|17|17.0||||||
4190469|NCT00774852|4011699|B2|Mexico||Region of Enrollment||participants|Number|9|9.0||||||
4190470|NCT00774852|4011700|B1|Mexico||Region of Enrollment||participants|Number|8|8.0||||||
4190471|NCT00774852|4011698|B3|United States||Region of Enrollment||participants|Number|117|117.0||||||
4190472|NCT00774852|4011699|B2|United States||Region of Enrollment||participants|Number|59|59.0||||||
4190473|NCT00774852|4011700|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
4190474|NCT00774852|4011698|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4190475|NCT00774852|4011699|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4190476|NCT00774852|4011700|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4190477|NCT00774852|4011698|B3||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4190478|NCT00774852|4011699|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4190479|NCT00774852|4011700|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4190480|NCT00774852|4011698|B3|>24 Years||Age, Customized||participants|Number|96|96.0||||||
4190481|NCT00774852|4011699|B2|>24 Years||Age, Customized||participants|Number|48|48.0||||||
4190482|NCT00774852|4011700|B1|>24 Years||Age, Customized||participants|Number|48|48.0||||||
4190483|NCT00774852|4011698|B3|21-24 Years||Age, Customized||participants|Number|25|25.0||||||
4190484|NCT00774852|4011699|B2|21-24 Years||Age, Customized||participants|Number|15|15.0||||||
4190485|NCT00774852|4011700|B1|21-24 Years||Age, Customized||participants|Number|10|10.0||||||
4190486|NCT00774852|4011698|B3|18-20 Years||Age, Customized||participants|Number|12|12.0||||||
4190487|NCT00774852|4011699|B2|18-20 Years||Age, Customized||participants|Number|5|5.0||||||
4190488|NCT00774852|4011700|B1|18-20 Years||Age, Customized||participants|Number|7|7.0||||||
4190489|NCT00774852|4011698|B3|<18 Years||Age, Customized||participants|Number|1|1.0||||||
4190490|NCT00774852|4011699|B2|<18 Years||Age, Customized||participants|Number|0|0.0||||||
4190491|NCT00774852|4011700|B1|<18 Years||Age, Customized||participants|Number|1|1.0||||||
4190492|NCT00774852|4011698|B3|||Age||years|Mean|32.4|32.4|Standard Deviation|11.1|11.1|||
4190493|NCT00774852|4011699|B2|||Age||years|Mean|32.7|32.7|Standard Deviation|12.0|12.0|||
4190494|NCT00774852|4011700|B1|||Age||years|Mean|32.0|32.0|Standard Deviation|10.1|10.1|||
4190495|NCT00774852|4011698|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4190496|NCT00774852|4011699|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4190497|NCT00774852|4011700|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4190498|NCT00774852|4011698|B3||Between 18 and 65 years|Age||Participants|Count of Participants|132|132.0||||||
4190499|NCT00774852|4011699|B2||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
4190500|NCT00774852|4011700|B1||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4190501|NCT00774852|4011698|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4190502|NCT00774852|4011699|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190503|NCT00774852|4011700|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4190504|NCT00774800|4011749|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4190505|NCT00774800|4011749|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4190506|NCT00774800|4011749|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4190510|NCT00774800|4011749|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4190511|NCT00774800|4011749|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4190512|NCT00774800|4011749|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4190513|NCT00774800|4011749|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4190514|NCT00774800|4011749|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4190515|NCT00774800|4011749|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4190516|NCT00774800|4011749|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4190517|NCT00774800|4011749|B1|||Age||years|Mean|40.7|40.7|Standard Deviation|10.73|10.73|||
4190518|NCT00774787|4011771|B1|||Actinic keratoses, Observation Side|Count of actinic keratoses on side of target treatment area randomly assigned to observation following cryotherapy|Lesions|Mean|8.5|8.5|Standard Deviation|2.3|2.3|||
4190519|NCT00774787|4011771|B1|||Actinic keratoses, Imiquimod side|Count of actinic keratoses on side of target treatment area randomly assigned to imiquimod 5% cream following cryotherapy|Lesions|Mean|8.7|8.7|Standard Deviation|2.2|2.2|||
4190520|NCT00774787|4011771|B1|||Actinic keratoses, total|Total count of clinically diagnosed actinic keratoses in target treatment area|Lesions|Mean|17.3|17.3|Standard Deviation|4.1|4.1|||
4190521|NCT00774787|4011771|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4190522|NCT00774787|4011771|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4190523|NCT00774787|4011771|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4190524|NCT00774787|4011771|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4190525|NCT00774787|4011771|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4190526|NCT00774787|4011771|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4190527|NCT00774787|4011771|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4190528|NCT00774787|4011771|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4190529|NCT00774787|4011771|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4190530|NCT00774787|4011771|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4190531|NCT00774787|4011771|B1|||Age||years|Mean|67.8|67.8|Standard Deviation|9.2|9.2|||
4190532|NCT00774787|4011771|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4190533|NCT00774787|4011771|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4190534|NCT00774787|4011771|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190535|NCT00774748|4011778|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4190536|NCT00774748|4011778|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4190537|NCT00774748|4011778|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4190538|NCT00774748|4011778|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|15.6|15.6|||
4190539|NCT00774748|4011778|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4190540|NCT00774748|4011778|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4190541|NCT00774748|4011778|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190542|NCT00774397|4011786|B8||Male|Sex: Female, Male||Participants|Count of Participants|426|426.0||||||
4190543|NCT00774397|4011787|B7||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4190544|NCT00774397|4011788|B6||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4190545|NCT00774397|4011789|B5||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4190546|NCT00774397|4011790|B4||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4190547|NCT00774397|4011791|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4190548|NCT00774397|4011792|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4190549|NCT00774397|4011793|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4190550|NCT00774397|4011786|B8||Female|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
4190551|NCT00774397|4011787|B7||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4190552|NCT00774397|4011788|B6||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4190553|NCT00774397|4011789|B5||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4190554|NCT00774397|4011790|B4||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4190555|NCT00774397|4011791|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4190556|NCT00774397|4011792|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4190557|NCT00774397|4011793|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4190558|NCT00774397|4011786|B8|||Age||years|Mean|47.14|47.14|Standard Deviation|9.91|9.91|||
4190559|NCT00774397|4011787|B7|||Age||years|Mean|50.1|50.1|Standard Deviation|8.34|8.34|||
4190560|NCT00774397|4011788|B6|||Age||years|Mean|49.6|49.6|Standard Deviation|8.42|8.42|||
4190561|NCT00774397|4011789|B5|||Age||years|Mean|48.7|48.7|Standard Deviation|9.58|9.58|||
4190562|NCT00774397|4011790|B4|||Age||years|Mean|46.3|46.3|Standard Deviation|10.48|10.48|||
4190563|NCT00774397|4011791|B3|||Age||years|Mean|44.7|44.7|Standard Deviation|10.18|10.18|||
4190564|NCT00774397|4011792|B2|||Age||years|Mean|46.3|46.3|Standard Deviation|10.92|10.92|||
4190565|NCT00774397|4011793|B1|||Age||years|Mean|45.6|45.6|Standard Deviation|10.86|10.86|||
4190566|NCT00774306|4012031|B5|United States||Region of Enrollment||participants|Number|52|52.0||||||
4190567|NCT00774306|4012032|B4|United States||Region of Enrollment||participants|Number|7|7.0||||||
4190568|NCT00774306|4012033|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4190569|NCT00774306|4012034|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4190570|NCT00774306|4012035|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4190571|NCT00774306|4012031|B5||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4190572|NCT00774306|4012032|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4190573|NCT00774306|4012033|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4190574|NCT00774306|4012034|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4190575|NCT00774306|4012035|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4190576|NCT00774306|4012031|B5||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4190577|NCT00774306|4012032|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4190578|NCT00774306|4012033|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4190579|NCT00774306|4012034|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4190580|NCT00774306|4012035|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4190581|NCT00774306|4012031|B5||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4190582|NCT00774306|4012032|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4190583|NCT00774306|4012033|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4190584|NCT00774306|4012034|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4190585|NCT00774306|4012035|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4190586|NCT00774306|4012031|B5||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4190587|NCT00774306|4012032|B4||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4190588|NCT00774306|4012033|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4190589|NCT00774306|4012034|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4190590|NCT00774306|4012035|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4190591|NCT00774306|4012031|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190592|NCT00774306|4012032|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190593|NCT00774306|4012033|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190594|NCT00774306|4012034|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190595|NCT00774306|4012035|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190596|NCT00774306|4012031|B5|||Age||years|Median|48|48.0|Full Range|||26.0|75.0|
4190597|NCT00774306|4012032|B4|||Age||years|Median|49|49.0|Full Range|||44.0|75.0|
4190598|NCT00774306|4012033|B3|||Age||years|Median|51|51.0|Full Range|||30.0|71.0|
4190599|NCT00774306|4012034|B2|||Age||years|Median|46|46.0|Full Range|||26.0|62.0|
4190600|NCT00774306|4012035|B1|||Age||years|Median|48.5|48.5|Full Range|||31.0|71.0|
4190601|NCT00774267|4012048|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4190602|NCT00774267|4012049|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4190603|NCT00774267|4012050|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4190604|NCT00774267|4012051|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4190605|NCT00774267|4012052|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4190606|NCT00774267|4012048|B5||Female|Sex: Female, Male||Participants|Count of Participants|507|507.0||||||
4190607|NCT00774267|4012049|B4||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4190608|NCT00774267|4012050|B3||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4190609|NCT00774267|4012051|B2||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4190610|NCT00774267|4012052|B1||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4190611|NCT00774267|4012048|B5|Greater than or equal to 65 years||Age, Customized||participants|Number|44|44.0||||||
4190612|NCT00774267|4012049|B4|Greater than or equal to 65 years||Age, Customized||participants|Number|15|15.0||||||
4190613|NCT00774267|4012050|B3|Greater than or equal to 65 years||Age, Customized||participants|Number|14|14.0||||||
4190614|NCT00774267|4012051|B2|Greater than or equal to 65 years||Age, Customized||participants|Number|8|8.0||||||
4190615|NCT00774267|4012052|B1|Greater than or equal to 65 years||Age, Customized||participants|Number|7|7.0||||||
4190616|NCT00774267|4012048|B5|50 to 65 years||Age, Customized||participants|Number|386|386.0||||||
4190617|NCT00774267|4012049|B4|50 to 65 years||Age, Customized||participants|Number|96|96.0||||||
4190618|NCT00774267|4012050|B3|50 to 65 years||Age, Customized||participants|Number|101|101.0||||||
4190619|NCT00774267|4012051|B2|50 to 65 years||Age, Customized||participants|Number|84|84.0||||||
4190620|NCT00774267|4012052|B1|50 to 65 years||Age, Customized||participants|Number|105|105.0||||||
4190621|NCT00774267|4012048|B5|Less than 50 years||Age, Customized||participants|Number|77|77.0||||||
4190622|NCT00774267|4012049|B4|Less than 50 years||Age, Customized||participants|Number|24|24.0||||||
4190623|NCT00774267|4012050|B3|Less than 50 years||Age, Customized||participants|Number|14|14.0||||||
4190624|NCT00774267|4012051|B2|Less than 50 years||Age, Customized||participants|Number|19|19.0||||||
4190625|NCT00774267|4012052|B1|Less than 50 years||Age, Customized||participants|Number|20|20.0||||||
4190626|NCT00774202|4012065|B3|No Response (NR)||Initial response to treatment with standard dose rituximab|complete response (CR) is a stable platelet count > 100,000/uL on no ongoing treatment a partial response (PR) is a platelet count > 30,000/uL and doubling of baseline platelet count on no ongoing treatment that is not a CR non-response is neither a CR or a PR|Participants|Count of Participants|7|7.0||||||
4190668|NCT00774046|4012119|B1|||Age||years|Median|56|56.0|Full Range|||23.0|83.0|
4190627|NCT00774202|4012066|B2|No Response (NR)||Initial response to treatment with standard dose rituximab|complete response (CR) is a stable platelet count > 100,000/uL on no ongoing treatment a partial response (PR) is a platelet count > 30,000/uL and doubling of baseline platelet count on no ongoing treatment that is not a CR non-response is neither a CR or a PR|Participants|Count of Participants|3|3.0||||||
4190628|NCT00774202|4012067|B1|No Response (NR)||Initial response to treatment with standard dose rituximab|complete response (CR) is a stable platelet count > 100,000/uL on no ongoing treatment a partial response (PR) is a platelet count > 30,000/uL and doubling of baseline platelet count on no ongoing treatment that is not a CR non-response is neither a CR or a PR|Participants|Count of Participants|4|4.0||||||
4190629|NCT00774202|4012065|B3|Partial Response (PR)||Initial response to treatment with standard dose rituximab|complete response (CR) is a stable platelet count > 100,000/uL on no ongoing treatment a partial response (PR) is a platelet count > 30,000/uL and doubling of baseline platelet count on no ongoing treatment that is not a CR non-response is neither a CR or a PR|Participants|Count of Participants|2|2.0||||||
4190630|NCT00774202|4012066|B2|Partial Response (PR)||Initial response to treatment with standard dose rituximab|complete response (CR) is a stable platelet count > 100,000/uL on no ongoing treatment a partial response (PR) is a platelet count > 30,000/uL and doubling of baseline platelet count on no ongoing treatment that is not a CR non-response is neither a CR or a PR|Participants|Count of Participants|1|1.0||||||
4190631|NCT00774202|4012067|B1|Partial Response (PR)||Initial response to treatment with standard dose rituximab|complete response (CR) is a stable platelet count > 100,000/uL on no ongoing treatment a partial response (PR) is a platelet count > 30,000/uL and doubling of baseline platelet count on no ongoing treatment that is not a CR non-response is neither a CR or a PR|Participants|Count of Participants|1|1.0||||||
4190632|NCT00774202|4012065|B3|Complete Response (CR)||Initial response to treatment with standard dose rituximab|complete response (CR) is a stable platelet count > 100,000/uL on no ongoing treatment a partial response (PR) is a platelet count > 30,000/uL and doubling of baseline platelet count on no ongoing treatment that is not a CR non-response is neither a CR or a PR|Participants|Count of Participants|8|8.0||||||
4190633|NCT00774202|4012066|B2|Complete Response (CR)||Initial response to treatment with standard dose rituximab|complete response (CR) is a stable platelet count > 100,000/uL on no ongoing treatment a partial response (PR) is a platelet count > 30,000/uL and doubling of baseline platelet count on no ongoing treatment that is not a CR non-response is neither a CR or a PR|Participants|Count of Participants|4|4.0||||||
4190634|NCT00774202|4012067|B1|Complete Response (CR)||Initial response to treatment with standard dose rituximab|complete response (CR) is a stable platelet count > 100,000/uL on no ongoing treatment a partial response (PR) is a platelet count > 30,000/uL and doubling of baseline platelet count on no ongoing treatment that is not a CR non-response is neither a CR or a PR|Participants|Count of Participants|4|4.0||||||
4190635|NCT00774202|4012065|B3|Females entered at baseline||Sex/Gender, Customized||Participants|Count of Participants|9|9.0||||||
4190636|NCT00774202|4012066|B2|Females entered at baseline||Sex/Gender, Customized||Participants|Count of Participants|4|4.0||||||
4190637|NCT00774202|4012067|B1|Females entered at baseline||Sex/Gender, Customized||Participants|Count of Participants|5|5.0||||||
4190638|NCT00774202|4012065|B3|Males entered at Baseline||Sex/Gender, Customized||Participants|Count of Participants|8|8.0||||||
4190639|NCT00774202|4012066|B2|Males entered at Baseline||Sex/Gender, Customized||Participants|Count of Participants|4|4.0||||||
4190640|NCT00774202|4012067|B1|Males entered at Baseline||Sex/Gender, Customized||Participants|Count of Participants|4|4.0||||||
4190641|NCT00774202|4012065|B3|age continuous||Age, Customized|age > 12 years of age|years|Mean|40|40.0|Standard Deviation|10|10.0|||
4190642|NCT00774202|4012066|B2|age continuous||Age, Customized|age > 12 years of age|years|Mean|44|44.0|Standard Deviation|19|19.0|||
4190643|NCT00774202|4012067|B1|age continuous||Age, Customized|age > 12 years of age|years|Mean|36|36.0|Standard Deviation|17|17.0|||
4190644|NCT00774163|4012078|B3|Peru||Region of Enrollment||participants|Number|45|45.0||||||
4190645|NCT00774163|4012079|B2|Peru||Region of Enrollment||participants|Number|15|15.0||||||
4190646|NCT00774163|4012080|B1|Peru||Region of Enrollment||participants|Number|30|30.0||||||
4190647|NCT00774163|4012078|B3||Male|Gender||Participants|Count of Participants|13|13.0||||||
4190648|NCT00774163|4012079|B2||Male|Gender||Participants|Count of Participants|6|6.0||||||
4190649|NCT00774163|4012080|B1||Male|Gender||Participants|Count of Participants|7|7.0||||||
4190650|NCT00774163|4012078|B3||Female|Gender||Participants|Count of Participants|32|32.0||||||
4190651|NCT00774163|4012079|B2||Female|Gender||Participants|Count of Participants|9|9.0||||||
4190652|NCT00774163|4012080|B1||Female|Gender||Participants|Count of Participants|23|23.0||||||
4190653|NCT00774163|4012078|B3|||Age||years|Mean|36.8|36.8|Standard Deviation|1.8|1.8|||
4190654|NCT00774163|4012079|B2|||Age||years|Mean|32.3|32.3|Standard Deviation|2.3|2.3|||
4190655|NCT00774163|4012080|B1|||Age||years|Mean|39.1|39.1|Standard Deviation|2.0|2.0|||
4190656|NCT00774163|4012078|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4190657|NCT00774163|4012079|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4190658|NCT00774163|4012080|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4190659|NCT00774163|4012078|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4190660|NCT00774163|4012079|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4190661|NCT00774163|4012080|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4190662|NCT00774163|4012078|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190663|NCT00774163|4012079|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190664|NCT00774163|4012080|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190665|NCT00774046|4012119|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4190666|NCT00774046|4012119|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4190667|NCT00774046|4012119|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4190669|NCT00773968|4012129|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4190670|NCT00773968|4012129|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4190671|NCT00773968|4012129|B1|||Age||years|Mean|68.1|68.1|Standard Deviation|13.49|13.49|||
4190672|NCT00773955|4012138|B1|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4190673|NCT00773955|4012138|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4190674|NCT00773955|4012138|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4190675|NCT00773955|4012138|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4190676|NCT00773955|4012138|B1|||Age||years|Median|67.0|67.0|Full Range|||46.0|76.0|
4190677|NCT00773786|4012145|B1|||Forced Expiratory Volume in 1 second (FEV1)||percent-predicted|Mean|53|53.0|Standard Deviation|9|9.0|||
4190678|NCT00773786|4012145|B1|||Body Mass Index (BMI)||Kg/m2|Mean|26|26.0|Standard Deviation|6|6.0|||
4190679|NCT00773786|4012145|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4190680|NCT00773786|4012145|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4190681|NCT00773786|4012145|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4190682|NCT00773786|4012145|B1|||Age||years|Mean|68|68.0|Standard Deviation|9|9.0|||
4190683|NCT00773734|4012156|B5|||Duration of Plaque Psoriasis|A diagnosis of chronic plaque psoriasis for ≥ 6 months was required prior to screening. Those with moderate to severe plaque psoriasis must have had a Psoriasis Area Severity Index (PASI) score ≥ 12, (PASI was a measure of psoriatic disease severity taking into account lesion characteristics (erythema, thickness, and scaling) and degree of skin and body surface area involvement (BSA) on defined anatomical regions), BSA ≥ 10. Duration of plaque psoriasis was calculated from the date of diagnosis to the date of informed consent. The dates of diagnosis were not available for some participants|years|Mean|18.99|18.99|Standard Deviation|12.004|12.004|||
4190684|NCT00773734|4012157|B4|||Duration of Plaque Psoriasis|A diagnosis of chronic plaque psoriasis for ≥ 6 months was required prior to screening. Those with moderate to severe plaque psoriasis must have had a Psoriasis Area Severity Index (PASI) score ≥ 12, (PASI was a measure of psoriatic disease severity taking into account lesion characteristics (erythema, thickness, and scaling) and degree of skin and body surface area involvement (BSA) on defined anatomical regions), BSA ≥ 10. Duration of plaque psoriasis was calculated from the date of diagnosis to the date of informed consent. The dates of diagnosis were not available for some participants|years|Mean|19.18|19.18|Standard Deviation|12.015|12.015|||
4190685|NCT00773734|4012158|B3|||Duration of Plaque Psoriasis|A diagnosis of chronic plaque psoriasis for ≥ 6 months was required prior to screening. Those with moderate to severe plaque psoriasis must have had a Psoriasis Area Severity Index (PASI) score ≥ 12, (PASI was a measure of psoriatic disease severity taking into account lesion characteristics (erythema, thickness, and scaling) and degree of skin and body surface area involvement (BSA) on defined anatomical regions), BSA ≥ 10. Duration of plaque psoriasis was calculated from the date of diagnosis to the date of informed consent. The dates of diagnosis were not available for some participants|years|Mean|19.51|19.51|Standard Deviation|12.151|12.151|||
4190686|NCT00773734|4012159|B2|||Duration of Plaque Psoriasis|A diagnosis of chronic plaque psoriasis for ≥ 6 months was required prior to screening. Those with moderate to severe plaque psoriasis must have had a Psoriasis Area Severity Index (PASI) score ≥ 12, (PASI was a measure of psoriatic disease severity taking into account lesion characteristics (erythema, thickness, and scaling) and degree of skin and body surface area involvement (BSA) on defined anatomical regions), BSA ≥ 10. Duration of plaque psoriasis was calculated from the date of diagnosis to the date of informed consent. The dates of diagnosis were not available for some participants|years|Mean|18.01|18.01|Standard Deviation|12.366|12.366|||
4190687|NCT00773734|4012160|B1|||Duration of Plaque Psoriasis|A diagnosis of chronic plaque psoriasis for ≥ 6 months was required prior to screening. Those with moderate to severe plaque psoriasis must have had a Psoriasis Area Severity Index (PASI) score ≥ 12, (PASI was a measure of psoriatic disease severity taking into account lesion characteristics (erythema, thickness, and scaling) and degree of skin and body surface area involvement (BSA) on defined anatomical regions), BSA ≥ 10. Duration of plaque psoriasis was calculated from the date of diagnosis to the date of informed consent. The dates of diagnosis were not available for some participants|years|Mean|19.61|19.61|Standard Deviation|11.632|11.632|||
4190688|NCT00773734|4012156|B5|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4190689|NCT00773734|4012157|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4190690|NCT00773734|4012158|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4190691|NCT00773734|4012159|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4190692|NCT00773734|4012160|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4190693|NCT00773734|4012156|B5|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4190694|NCT00773734|4012157|B4|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4190695|NCT00773734|4012158|B3|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4190696|NCT00773734|4012159|B2|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4190697|NCT00773734|4012160|B1|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4190698|NCT00773734|4012156|B5|Native Hawaiian/Pacific Islanders||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4190699|NCT00773734|4012157|B4|Native Hawaiian/Pacific Islanders||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4190700|NCT00773734|4012158|B3|Native Hawaiian/Pacific Islanders||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4190701|NCT00773734|4012159|B2|Native Hawaiian/Pacific Islanders||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4190702|NCT00773734|4012160|B1|Native Hawaiian/Pacific Islanders||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4190703|NCT00773734|4012156|B5|Asian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4190704|NCT00773734|4012157|B4|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4190705|NCT00773734|4012158|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4190706|NCT00773734|4012159|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4190707|NCT00773734|4012160|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4190708|NCT00773734|4012156|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4190709|NCT00773734|4012157|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4190710|NCT00773734|4012158|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4190711|NCT00773734|4012159|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4190712|NCT00773734|4012160|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4190713|NCT00773734|4012156|B5|White||Race/Ethnicity, Customized||participants|Number|327|327.0||||||
4190714|NCT00773734|4012157|B4|White||Race/Ethnicity, Customized||participants|Number|80|80.0||||||
4190715|NCT00773734|4012158|B3|White||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
4190716|NCT00773734|4012159|B2|White||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
4190717|NCT00773734|4012160|B1|White||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
4190718|NCT00773734|4012156|B5||Male|Gender||Participants|Count of Participants|221|221.0||||||
4190719|NCT00773734|4012157|B4||Male|Gender||Participants|Count of Participants|50|50.0||||||
4190720|NCT00773734|4012158|B3||Male|Gender||Participants|Count of Participants|55|55.0||||||
4190721|NCT00773734|4012159|B2||Male|Gender||Participants|Count of Participants|63|63.0||||||
4190722|NCT00773734|4012160|B1||Male|Gender||Participants|Count of Participants|53|53.0||||||
4190723|NCT00773734|4012156|B5||Female|Gender||Participants|Count of Participants|131|131.0||||||
4190724|NCT00773734|4012157|B4||Female|Gender||Participants|Count of Participants|38|38.0||||||
4190725|NCT00773734|4012158|B3||Female|Gender||Participants|Count of Participants|32|32.0||||||
4190726|NCT00773734|4012159|B2||Female|Gender||Participants|Count of Participants|26|26.0||||||
4190727|NCT00773734|4012160|B1||Female|Gender||Participants|Count of Participants|35|35.0||||||
4190728|NCT00773734|4012156|B5|||Age||years|Mean|44.3|44.3|Standard Deviation|13.70|13.7|||
4190729|NCT00773734|4012157|B4|||Age||years|Mean|44.1|44.1|Standard Deviation|14.67|14.67|||
4190730|NCT00773734|4012158|B3|||Age||years|Mean|44.6|44.6|Standard Deviation|12.62|12.62|||
4190731|NCT00773734|4012159|B2|||Age||years|Mean|44.4|44.4|Standard Deviation|13.96|13.96|||
4190732|NCT00773734|4012160|B1|||Age||years|Mean|44.1|44.1|Standard Deviation|13.68|13.68|||
4190733|NCT00773513|4012727|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|79|79.0||||||
4190734|NCT00773513|4012728|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
4190735|NCT00773513|4012729|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
4190736|NCT00773513|4012727|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|77|77.0||||||
4190737|NCT00773513|4012728|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
4190738|NCT00773513|4012729|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
4190739|NCT00773513|4012727|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|230|230.0||||||
4190740|NCT00773513|4012728|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|119|119.0||||||
4190741|NCT00773513|4012729|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|111|111.0||||||
4190742|NCT00773513|4012727|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|2439|2439.0||||||
4190743|NCT00773513|4012728|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|1218|1218.0||||||
4190744|NCT00773513|4012729|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|1221|1221.0||||||
4190745|NCT00773513|4012727|B3||Male|Sex: Female, Male||Participants|Count of Participants|1639|1639.0||||||
4190746|NCT00773513|4012728|B2||Male|Sex: Female, Male||Participants|Count of Participants|807|807.0||||||
4190747|NCT00773513|4012729|B1||Male|Sex: Female, Male||Participants|Count of Participants|832|832.0||||||
4190748|NCT00773513|4012727|B3||Female|Sex: Female, Male||Participants|Count of Participants|1186|1186.0||||||
4190749|NCT00773513|4012728|B2||Female|Sex: Female, Male||Participants|Count of Participants|605|605.0||||||
4190750|NCT00773513|4012729|B1||Female|Sex: Female, Male||Participants|Count of Participants|581|581.0||||||
4190751|NCT00773513|4012727|B3|||Age||years|Mean|62.4|62.4|Standard Deviation|14.9|14.9|||
4190752|NCT00773513|4012728|B2|||Age||years|Mean|62.2|62.2|Standard Deviation|15.0|15.0|||
4190753|NCT00773513|4012729|B1|||Age||years|Mean|62.6|62.6|Standard Deviation|14.8|14.8|||
4190754|NCT00773474|4012750|B1|||Number of Prior Therapies||Prior Therapies|Median|8.4|8.4|Full Range|||0.0|20.0|
4190755|NCT00773474|4012750|B1|Unknown||Estrogen Receptor (ER)/Progesterone Receptor (PR)/ HER2 Status|Hormone Receptor Status. Each participant can have 0-3 possible HR statuses, consequently the sum of all HR statuses will be greater than the number of participants.|participants|Number|4|4.0||||||
4190756|NCT00773474|4012750|B1|HER2+||Estrogen Receptor (ER)/Progesterone Receptor (PR)/ HER2 Status|Hormone Receptor Status. Each participant can have 0-3 possible HR statuses, consequently the sum of all HR statuses will be greater than the number of participants.|participants|Number|3|3.0||||||
4190757|NCT00773474|4012750|B1|HER2-||Estrogen Receptor (ER)/Progesterone Receptor (PR)/ HER2 Status|Hormone Receptor Status. Each participant can have 0-3 possible HR statuses, consequently the sum of all HR statuses will be greater than the number of participants.|participants|Number|17|17.0||||||
4190758|NCT00773474|4012750|B1|PR+||Estrogen Receptor (ER)/Progesterone Receptor (PR)/ HER2 Status|Hormone Receptor Status. Each participant can have 0-3 possible HR statuses, consequently the sum of all HR statuses will be greater than the number of participants.|participants|Number|11|11.0||||||
4190845|NCT00773370|4012836|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4190846|NCT00773370|4012834|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4190759|NCT00773474|4012750|B1|PR-||Estrogen Receptor (ER)/Progesterone Receptor (PR)/ HER2 Status|Hormone Receptor Status. Each participant can have 0-3 possible HR statuses, consequently the sum of all HR statuses will be greater than the number of participants.|participants|Number|13|13.0||||||
4190760|NCT00773474|4012750|B1|ER+||Estrogen Receptor (ER)/Progesterone Receptor (PR)/ HER2 Status|Hormone Receptor Status. Each participant can have 0-3 possible HR statuses, consequently the sum of all HR statuses will be greater than the number of participants.|participants|Number|15|15.0||||||
4190761|NCT00773474|4012750|B1|ER-||Estrogen Receptor (ER)/Progesterone Receptor (PR)/ HER2 Status|Hormone Receptor Status. Each participant can have 0-3 possible HR statuses, consequently the sum of all HR statuses will be greater than the number of participants.|participants|Number|9|9.0||||||
4190762|NCT00773474|4012750|B1|Other||Primary Tumor Diagnosis|Participants can have more than one primary tumor diagnosis. The sum of all tumor diagnoses can/will be greater than the number of participants.|participants|Number|1|1.0||||||
4190763|NCT00773474|4012750|B1|Lobular Breast Carcinoma||Primary Tumor Diagnosis|Participants can have more than one primary tumor diagnosis. The sum of all tumor diagnoses can/will be greater than the number of participants.|participants|Number|1|1.0||||||
4190764|NCT00773474|4012750|B1|Ductal Breast Carcinoma||Primary Tumor Diagnosis|Participants can have more than one primary tumor diagnosis. The sum of all tumor diagnoses can/will be greater than the number of participants.|participants|Number|20|20.0||||||
4190765|NCT00773474|4012750|B1|Breast Carcinoma||Primary Tumor Diagnosis|Participants can have more than one primary tumor diagnosis. The sum of all tumor diagnoses can/will be greater than the number of participants.|participants|Number|14|14.0||||||
4190766|NCT00773474|4012750|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4190767|NCT00773474|4012750|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4190768|NCT00773474|4012750|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4190769|NCT00773474|4012750|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4190770|NCT00773474|4012750|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4190771|NCT00773474|4012750|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4190772|NCT00773474|4012750|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4190773|NCT00773474|4012750|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4190774|NCT00773474|4012750|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4190775|NCT00773474|4012750|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4190776|NCT00773474|4012750|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4190777|NCT00773474|4012750|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4190778|NCT00773474|4012750|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4190779|NCT00773474|4012750|B1|||Age||years|Median|56|56.0|Full Range|||41.0|76.0|
4190780|NCT00773461|4012757|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4190781|NCT00773461|4012758|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4190782|NCT00773461|4012759|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4190783|NCT00773461|4012757|B3||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4190784|NCT00773461|4012758|B2||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4190785|NCT00773461|4012759|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4190786|NCT00773461|4012757|B3|||Age||years|Mean|47.1|47.1|Standard Deviation|11.22|11.22|||
4190787|NCT00773461|4012758|B2|||Age||years|Mean|46.8|46.8|Standard Deviation|11.01|11.01|||
4190788|NCT00773461|4012759|B1|||Age||years|Mean|47.8|47.8|Standard Deviation|11.68|11.68|||
4190789|NCT00773422|4012798|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4190790|NCT00773422|4012799|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4190791|NCT00773422|4012800|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4190792|NCT00773422|4012801|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4190793|NCT00773422|4012798|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4190794|NCT00773422|4012799|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4190795|NCT00773422|4012800|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4190796|NCT00773422|4012801|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4190797|NCT00773422|4012798|B4|||Age||years|Mean|33.33|33.33|Standard Deviation|10.71|10.71|||
4190798|NCT00773422|4012799|B3|||Age||years|Mean|33.20|33.2|Standard Deviation|9.73|9.73|||
4190799|NCT00773422|4012800|B2|||Age||years|Mean|37.67|37.67|Standard Deviation|10.85|10.85|||
4190800|NCT00773422|4012801|B1|||Age||years|Mean|29.91|29.91|Standard Deviation|8.99|8.99|||
4190801|NCT00773383|4012814|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4190802|NCT00773383|4012814|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4190803|NCT00773383|4012814|B1|||Age|All baseline measures are based on the safety population that includes all participants who received at least one dose of study drug.|years|Mean|59.9|59.9|Standard Deviation|11.43|11.43|||
4190804|NCT00773370|4012834|B3|||Stroke Impact Scale (SIS)|SIS Version 3.0 is a self report scale that includes 59 items and assesses 8 domains (strength, hand function, ADL/IADL, mobility, communication, emotion, memory and thinking, and participation/role function). Summative scores for each domain range from 0-100. Total scores range from 0-800. A higher score reflects better function.|units on a scale|Mean|476.29|476.29|Standard Deviation|201.75|201.75|||
4190847|NCT00773370|4012835|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4190848|NCT00773370|4012836|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4190805|NCT00773370|4012835|B2|||Stroke Impact Scale (SIS)|SIS Version 3.0 is a self report scale that includes 59 items and assesses 8 domains (strength, hand function, ADL/IADL, mobility, communication, emotion, memory and thinking, and participation/role function). Summative scores for each domain range from 0-100. Total scores range from 0-800. A higher score reflects better function.|units on a scale|Mean|490.79|490.79|Standard Deviation|201.76|201.76|||
4190806|NCT00773370|4012836|B1|||Stroke Impact Scale (SIS)|SIS Version 3.0 is a self report scale that includes 59 items and assesses 8 domains (strength, hand function, ADL/IADL, mobility, communication, emotion, memory and thinking, and participation/role function). Summative scores for each domain range from 0-100. Total scores range from 0-800. A higher score reflects better function.|units on a scale|Mean|466.62|466.62|Standard Deviation|201.75|201.75|||
4190807|NCT00773370|4012834|B3|||6 Minute Walk Test (MWT)||meters|Mean|181.52|181.52|Standard Deviation|97.40|97.4|||
4190808|NCT00773370|4012835|B2|||6 Minute Walk Test (MWT)||meters|Mean|171.69|171.69|Standard Deviation|97.42|97.42|||
4190809|NCT00773370|4012836|B1|||6 Minute Walk Test (MWT)||meters|Mean|189.07|189.07|Standard Deviation|97.38|97.38|||
4190810|NCT00773370|4012834|B3|||Short Physical Performance Battery (SPPB)|Components include gait speed, a repeated chair stand, and a standing balance test. Scores for gait speed, chair stand, and total balance are calculated and then summed for the total score. Each component can range from 0-4 points, thus the maximum composite score can range from 0-12 points, with 0 reflecting the lowest functioning while a score of 12 indicates the subject reached the maximum measured competency in all three domains.|units on a scale|Mean|6.36|6.36|Standard Deviation|2.65|2.65|||
4190811|NCT00773370|4012835|B2|||Short Physical Performance Battery (SPPB)|Components include gait speed, a repeated chair stand, and a standing balance test. Scores for gait speed, chair stand, and total balance are calculated and then summed for the total score. Each component can range from 0-4 points, thus the maximum composite score can range from 0-12 points, with 0 reflecting the lowest functioning while a score of 12 indicates the subject reached the maximum measured competency in all three domains.|units on a scale|Mean|6.06|6.06|Standard Deviation|2.64|2.64|||
4190812|NCT00773370|4012836|B1|||Short Physical Performance Battery (SPPB)|Components include gait speed, a repeated chair stand, and a standing balance test. Scores for gait speed, chair stand, and total balance are calculated and then summed for the total score. Each component can range from 0-4 points, thus the maximum composite score can range from 0-12 points, with 0 reflecting the lowest functioning while a score of 12 indicates the subject reached the maximum measured competency in all three domains.|units on a scale|Mean|6.60|6.6|Standard Deviation|2.66|2.66|||
4190813|NCT00773370|4012834|B3|||Berg Balance|The Berg consists of 14 items, each graded on a scale of 0-4. A score for the Berg could in theory range from a minimum of 0 to a maximum of 56. A score below 45 is indicative of balance impairment; thus the lower the score the greater the fall risk.|units on a scale|Mean|44.58|44.58|Standard Deviation|9.03|9.03|||
4190814|NCT00773370|4012835|B2|||Berg Balance|The Berg consists of 14 items, each graded on a scale of 0-4. A score for the Berg could in theory range from a minimum of 0 to a maximum of 56. A score below 45 is indicative of balance impairment; thus the lower the score the greater the fall risk.|units on a scale|Mean|43.00|43.0|Standard Deviation|9.02|9.02|||
4190815|NCT00773370|4012836|B1|||Berg Balance|The Berg consists of 14 items, each graded on a scale of 0-4. A score for the Berg could in theory range from a minimum of 0 to a maximum of 56. A score below 45 is indicative of balance impairment; thus the lower the score the greater the fall risk.|units on a scale|Mean|44.76|44.76|Standard Deviation|9.03|9.03|||
4190816|NCT00773370|4012834|B3|||Year since stroke||years|Mean|5.2|5.2|Standard Deviation|6.6|6.6|||
4190817|NCT00773370|4012835|B2|||Year since stroke||years|Mean|4.7|4.7|Standard Deviation|8.5|8.5|||
4190818|NCT00773370|4012836|B1|||Year since stroke||years|Mean|5.5|5.5|Standard Deviation|5.2|5.2|||
4190819|NCT00773370|4012834|B3|Missing||Hemiparesis||participants|Number|5|5.0||||||
4190820|NCT00773370|4012835|B2|Missing||Hemiparesis||participants|Number|2|2.0||||||
4190821|NCT00773370|4012836|B1|Missing||Hemiparesis||participants|Number|3|3.0||||||
4190822|NCT00773370|4012834|B3|Right||Hemiparesis||participants|Number|26|26.0||||||
4190823|NCT00773370|4012835|B2|Right||Hemiparesis||participants|Number|13|13.0||||||
4190824|NCT00773370|4012836|B1|Right||Hemiparesis||participants|Number|13|13.0||||||
4190825|NCT00773370|4012834|B3|Left||Hemiparesis||participants|Number|45|45.0||||||
4190826|NCT00773370|4012835|B2|Left||Hemiparesis||participants|Number|18|18.0||||||
4190827|NCT00773370|4012836|B1|Left||Hemiparesis||participants|Number|27|27.0||||||
4190828|NCT00773370|4012834|B3|United States||Region of Enrollment||participants|Number|76|76.0||||||
4190829|NCT00773370|4012835|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4190830|NCT00773370|4012836|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4190831|NCT00773370|4012834|B3|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4190832|NCT00773370|4012835|B2|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4190833|NCT00773370|4012836|B1|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4190834|NCT00773370|4012834|B3|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4190835|NCT00773370|4012835|B2|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4190836|NCT00773370|4012836|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4190837|NCT00773370|4012834|B3|Black||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4190838|NCT00773370|4012835|B2|Black||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4190839|NCT00773370|4012836|B1|Black||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4190840|NCT00773370|4012834|B3|White||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4190841|NCT00773370|4012835|B2|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4190842|NCT00773370|4012836|B1|White||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4190843|NCT00773370|4012834|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4190844|NCT00773370|4012835|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4190849|NCT00773370|4012834|B3|||Age||years|Mean|64|64.0|Standard Deviation|10.3|10.3|||
4190850|NCT00773370|4012835|B2|||Age||years|Mean|65|65.0|Standard Deviation|11.7|11.7|||
4190851|NCT00773370|4012836|B1|||Age||years|Mean|63|63.0|Standard Deviation|9.2|9.2|||
4190852|NCT00773279|4012849|B1|||HbA1c (glycosylated haemoglobin)||percentage (%) of total haemoglobin|Mean|7.3|7.3|Standard Deviation|0.9|0.9|||
4190853|NCT00773279|4012849|B1|United States||Region of Enrollment||participants|Number|242|242.0||||||
4190854|NCT00773279|4012849|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4190855|NCT00773279|4012849|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4190856|NCT00773279|4012849|B1||White|Race (NIH/OMB)||Participants|Count of Participants|199|199.0||||||
4190857|NCT00773279|4012849|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4190858|NCT00773279|4012849|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4190859|NCT00773279|4012849|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4190860|NCT00773279|4012849|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4190861|NCT00773279|4012849|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4190862|NCT00773279|4012849|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|226|226.0||||||
4190863|NCT00773279|4012849|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4190864|NCT00773279|4012849|B1||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4190865|NCT00773279|4012849|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4190866|NCT00773279|4012849|B1|||Age||years|Mean|58|58.0|Standard Deviation|13.9|13.9|||
4190867|NCT00773253|4012869|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4190868|NCT00773253|4012870|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4190869|NCT00773253|4012871|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4190870|NCT00773253|4012869|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4190871|NCT00773253|4012870|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4190872|NCT00773253|4012871|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4190873|NCT00773253|4012869|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4190874|NCT00773253|4012870|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4190875|NCT00773253|4012871|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4190876|NCT00773253|4012869|B3|||Age||years|Mean|55.4|55.4|Standard Deviation|5.2|5.2|||
4190877|NCT00773253|4012870|B2|||Age||years|Mean|54.7|54.7|Standard Deviation|5.1|5.1|||
4190878|NCT00773253|4012871|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|5.2|5.2|||
4190879|NCT00773253|4012869|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4190880|NCT00773253|4012870|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4190881|NCT00773253|4012871|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4190882|NCT00773253|4012869|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4190883|NCT00773253|4012870|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4190884|NCT00773253|4012871|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4190885|NCT00773253|4012869|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190886|NCT00773253|4012870|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190887|NCT00773253|4012871|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190888|NCT00773175|4012878|B3|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
4190889|NCT00773175|4012879|B2|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4190890|NCT00773175|4012880|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4190891|NCT00773175|4012878|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4190892|NCT00773175|4012879|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4190893|NCT00773175|4012880|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4190894|NCT00773175|4012878|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|79|79.0||||||
4190895|NCT00773175|4012879|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
4190896|NCT00773175|4012880|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
4190897|NCT00773175|4012878|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
4190898|NCT00773175|4012879|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
4190899|NCT00773175|4012880|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
4190900|NCT00773175|4012878|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4190901|NCT00773175|4012879|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4190902|NCT00773175|4012880|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4190903|NCT00773175|4012878|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4190904|NCT00773175|4012879|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4190905|NCT00773175|4012880|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4190906|NCT00773175|4012878|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4190907|NCT00773175|4012879|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4190908|NCT00773175|4012880|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4190909|NCT00773175|4012878|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4190910|NCT00773175|4012879|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4190911|NCT00773175|4012880|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4190912|NCT00773175|4012878|B3|||Age||years|Mean|2.3|2.3|Standard Deviation|1.91|1.91|||
4190913|NCT00773175|4012879|B2|||Age||years|Mean|2.4|2.4|Standard Deviation|2.07|2.07|||
4190914|NCT00773175|4012880|B1|||Age||years|Mean|2.1|2.1|Standard Deviation|1.72|1.72|||
4190915|NCT00773136|4012973|B1|>69 years||Eyelash length|Lash length was measured using calipers and photos during the study, and the longest measured eyelashes were plucked from the upper eyelid of 13 of the 14 total enrolled patients at the end of the six weeks for comparison. Throughout the study, we used the same measuring technique, always measuring the length of the longest lash uncurled using a surgical caliper. Visual acuity, ocular symptoms, intraocular pressure and slit lamp exam were recorded at these same intervals.|mm|Number|0|0.0||||||
4190916|NCT00773136|4012973|B1|Between 23 and 69 years||Eyelash length|Lash length was measured using calipers and photos during the study, and the longest measured eyelashes were plucked from the upper eyelid of 13 of the 14 total enrolled patients at the end of the six weeks for comparison. Throughout the study, we used the same measuring technique, always measuring the length of the longest lash uncurled using a surgical caliper. Visual acuity, ocular symptoms, intraocular pressure and slit lamp exam were recorded at these same intervals.|mm|Number|21|21.0||||||
4190917|NCT00773136|4012973|B1|<=18 years||Eyelash length|Lash length was measured using calipers and photos during the study, and the longest measured eyelashes were plucked from the upper eyelid of 13 of the 14 total enrolled patients at the end of the six weeks for comparison. Throughout the study, we used the same measuring technique, always measuring the length of the longest lash uncurled using a surgical caliper. Visual acuity, ocular symptoms, intraocular pressure and slit lamp exam were recorded at these same intervals.|mm|Number|0|0.0||||||
4190918|NCT00773136|4012973|B1|United States||Region of Enrollment|Patients were enrolled in the Bascom Palmer Eye Institute in Miami, FL.|participants|Number|21|21.0||||||
4190919|NCT00773136|4012973|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4190920|NCT00773136|4012973|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4190921|NCT00773136|4012973|B1|||Age||participants|Mean|46|46.0|Full Range|||23.0|69.0|
4190922|NCT00773097|4012978|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4190923|NCT00773097|4012978|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4190924|NCT00773097|4012978|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4190925|NCT00773097|4012978|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4190926|NCT00773097|4012978|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190927|NCT00772967|4012984|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4190928|NCT00772967|4012984|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4190929|NCT00772967|4012984|B1|||Age||Years|Mean|59.6|59.6|Standard Deviation|7.92|7.92|45.0|73.0|
4190930|NCT00772954|4013006|B4|United States||Region of Enrollment||participants|Number|36|36.0||||||
4190931|NCT00772954|4013007|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4190932|NCT00772954|4013008|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4190933|NCT00772954|4013009|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4190934|NCT00772954|4013006|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4190935|NCT00772954|4013007|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4190936|NCT00772954|4013008|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4190937|NCT00772954|4013009|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4190938|NCT00772954|4013006|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4190939|NCT00772954|4013007|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4190940|NCT00772954|4013008|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4190941|NCT00772954|4013009|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4190942|NCT00772954|4013006|B4|||Age||Years|Mean|35.1|35.1|Standard Deviation|11.84|11.84|||
4190943|NCT00772954|4013007|B3|||Age||Years|Mean|30.0|30.0|Standard Deviation|8.57|8.57|||
4190944|NCT00772954|4013008|B2|||Age||Years|Mean|36.9|36.9|Standard Deviation|12.67|12.67|||
4190945|NCT00772954|4013009|B1|||Age||Years|Mean|38.3|38.3|Standard Deviation|12.98|12.98|||
4190946|NCT00772954|4013006|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4190947|NCT00772954|4013007|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4190948|NCT00772954|4013008|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4190949|NCT00772954|4013009|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4190950|NCT00772954|4013006|B4||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4190951|NCT00772954|4013007|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4190952|NCT00772954|4013008|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4190953|NCT00772954|4013009|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4190954|NCT00772954|4013006|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190955|NCT00772954|4013007|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190956|NCT00772954|4013008|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190957|NCT00772954|4013009|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4190958|NCT00772941|4013019|B1||Male|Sex: Female, Male||Participants|Count of Participants|2179|2179.0||||||
4190959|NCT00772941|4013019|B1||Female|Sex: Female, Male||Participants|Count of Participants|1078|1078.0||||||
4190960|NCT00772941|4013019|B1|>=65 years||Age, Customized||Participants|Number|489|489.0||||||
4190961|NCT00772941|4013019|B1|<65 years||Age, Customized||Participants|Number|2768|2768.0||||||
4190962|NCT00772928|4013048|B3|United States||Region of Enrollment||participants|Number|1166|1166.0||||||
4190963|NCT00772928|4013049|B2|United States||Region of Enrollment||participants|Number|579|579.0||||||
4190964|NCT00772928|4013050|B1|United States||Region of Enrollment||participants|Number|587|587.0||||||
4190965|NCT00772928|4013048|B3||Male|Sex: Female, Male||Participants|Count of Participants|629|629.0||||||
4190966|NCT00772928|4013049|B2||Male|Sex: Female, Male||Participants|Count of Participants|320|320.0||||||
4190967|NCT00772928|4013050|B1||Male|Sex: Female, Male||Participants|Count of Participants|309|309.0||||||
4190968|NCT00772928|4013048|B3||Female|Sex: Female, Male||Participants|Count of Participants|537|537.0||||||
4190969|NCT00772928|4013049|B2||Female|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
4190970|NCT00772928|4013050|B1||Female|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
4190971|NCT00772928|4013048|B3|||Age||Months|Mean|2.1|2.1|Standard Deviation|0.29|0.29|||
4190972|NCT00772928|4013049|B2|||Age||Months|Mean|2.1|2.1|Standard Deviation|0.28|0.28|||
4190973|NCT00772928|4013050|B1|||Age||Months|Mean|2.2|2.2|Standard Deviation|0.29|0.29|||
4190974|NCT00772928|4013048|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4190975|NCT00772928|4013049|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4190976|NCT00772928|4013050|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4190977|NCT00772928|4013048|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4190978|NCT00772928|4013049|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4190979|NCT00772928|4013050|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4190980|NCT00772928|4013048|B3||<=18 years|Age||Participants|Count of Participants|1166|1166.0||||||
4190981|NCT00772928|4013049|B2||<=18 years|Age||Participants|Count of Participants|579|579.0||||||
4190982|NCT00772928|4013050|B1||<=18 years|Age||Participants|Count of Participants|587|587.0||||||
4190983|NCT00772915|4013061|B1|No||Parameter of Hematologic Response: Urine M-Spike >= 200 mg/24 hours||participants|Number|24|24.0||||||
4190984|NCT00772915|4013061|B1|Yes||Parameter of Hematologic Response: Urine M-Spike >= 200 mg/24 hours||participants|Number|14|14.0||||||
4190985|NCT00772915|4013061|B1|No||Parameter of Hematologic Response: Serum Immunoglobulin Free Light Chain >= 10 mg/dL||participants|Number|13|13.0||||||
4190986|NCT00772915|4013061|B1|Yes||Parameter of Hematologic Response: Serum Immunoglobulin Free Light Chain >= 10 mg/dL||participants|Number|25|25.0||||||
4190987|NCT00772915|4013061|B1|No||Parameter of Hematologic Response: Serum M-Spike >= 1 mg/dL||participants|Number|12|12.0||||||
4190988|NCT00772915|4013061|B1|Yes||Parameter of Hematologic Response: Serum M-Spike >= 1 mg/dL||participants|Number|26|26.0||||||
4190989|NCT00772915|4013061|B1|Not Assessed||Durie Salmon Stage at Diagnosis||participants|Number|3|3.0||||||
4190990|NCT00772915|4013061|B1|Stage III: High Cell Mass||Durie Salmon Stage at Diagnosis||participants|Number|12|12.0||||||
4190991|NCT00772915|4013061|B1|Stage II: Intermediate Cell Mass||Durie Salmon Stage at Diagnosis||participants|Number|15|15.0||||||
4190992|NCT00772915|4013061|B1|Stage I: Low Cell Mass||Durie Salmon Stage at Diagnosis||participants|Number|8|8.0||||||
4190993|NCT00772915|4013061|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4190994|NCT00772915|4013061|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4190995|NCT00772915|4013061|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4190996|NCT00772915|4013061|B1|||Age||years|Median|66|66.0|Full Range|||45.0|78.0|
4190997|NCT00772889|4013065|B4||Male|Sex: Female, Male||Participants|Count of Participants|460|460.0||||||
4190998|NCT00772889|4013066|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4190999|NCT00772889|4013067|B2||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4191000|NCT00772889|4013068|B1||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4191001|NCT00772889|4013065|B4||Female|Sex: Female, Male||Participants|Count of Participants|511|511.0||||||
4191002|NCT00772889|4013066|B3||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4191003|NCT00772889|4013067|B2||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4191004|NCT00772889|4013068|B1||Female|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4191005|NCT00772889|4013065|B4|||Age||Years|Mean|65.7|65.7|Standard Deviation|18.10|18.1|||
4191006|NCT00772889|4013066|B3|||Age||Years|Mean|32.4|32.4|Standard Deviation|6.78|6.78|||
4191007|NCT00772889|4013067|B2|||Age||Years|Mean|74.7|74.7|Standard Deviation|5.74|5.74|||
4191008|NCT00772889|4013068|B1|||Age||Years|Mean|74.4|74.4|Standard Deviation|5.23|5.23|||
4191009|NCT00772772|4013123|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4191010|NCT00772772|4013123|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4191011|NCT00772772|4013123|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4191012|NCT00772772|4013123|B1|||Age||years|Mean|61|61.0|Standard Deviation|7|7.0|||
4191013|NCT00772707|4013128|B1|United States||Region of Enrollment||participants|Number|114|114.0||||||
4191014|NCT00772707|4013128|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4191015|NCT00772707|4013128|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4191016|NCT00772707|4013128|B1|||Age||years|Mean|36|36.0|Full Range|||18.0|69.0|
4191017|NCT00772668|4013133|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4191018|NCT00772668|4013133|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4191019|NCT00772668|4013133|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4191020|NCT00772668|4013133|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4191021|NCT00772668|4013133|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4191022|NCT00772668|4013133|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191023|NCT00772629|4013140|B3|United Kingdom||Region of Enrollment||participants|Number|18|18.0||||||
4191024|NCT00772629|4013141|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4191025|NCT00772629|4013142|B1|United Kingdom||Region of Enrollment||participants|Number|17|17.0||||||
4191026|NCT00772629|4013140|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4191027|NCT00772629|4013141|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4191028|NCT00772629|4013142|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4191029|NCT00772629|4013140|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4191030|NCT00772629|4013141|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4191031|NCT00772629|4013142|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4191032|NCT00772629|4013140|B3|||Age||Years|Mean|36.2|36.2|Standard Deviation|10.03|10.03|||
4191033|NCT00772629|4013141|B2|||Age||Years|Mean|43.0|43.0|Standard Deviation|0|0.0|||
4191034|NCT00772629|4013142|B1|||Age||Years|Mean|35.8|35.8|Standard Deviation|10.20|10.2|||
4191035|NCT00772629|4013140|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4191036|NCT00772629|4013141|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4191037|NCT00772629|4013142|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4191038|NCT00772629|4013140|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4191039|NCT00772629|4013141|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4191040|NCT00772629|4013142|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4191041|NCT00772629|4013140|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191042|NCT00772629|4013141|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191043|NCT00772629|4013142|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191044|NCT00772603|4013149|B4|Bulgaria||Region of Enrollment||participants|Number|53|53.0||||||
4191045|NCT00772603|4013150|B3|Bulgaria||Region of Enrollment||participants|Number|18|18.0||||||
4191046|NCT00772603|4013151|B2|Bulgaria||Region of Enrollment||participants|Number|18|18.0||||||
4191047|NCT00772603|4013152|B1|Bulgaria||Region of Enrollment||participants|Number|17|17.0||||||
4191048|NCT00772603|4013149|B4|Russian Federation||Region of Enrollment||participants|Number|90|90.0||||||
4191049|NCT00772603|4013150|B3|Russian Federation||Region of Enrollment||participants|Number|31|31.0||||||
4191050|NCT00772603|4013151|B2|Russian Federation||Region of Enrollment||participants|Number|31|31.0||||||
4191051|NCT00772603|4013152|B1|Russian Federation||Region of Enrollment||participants|Number|28|28.0||||||
4191052|NCT00772603|4013149|B4|Croatia||Region of Enrollment||participants|Number|29|29.0||||||
4191053|NCT00772603|4013150|B3|Croatia||Region of Enrollment||participants|Number|12|12.0||||||
4191054|NCT00772603|4013151|B2|Croatia||Region of Enrollment||participants|Number|7|7.0||||||
4191055|NCT00772603|4013152|B1|Croatia||Region of Enrollment||participants|Number|10|10.0||||||
4191056|NCT00772603|4013149|B4|Romania||Region of Enrollment||participants|Number|24|24.0||||||
4191057|NCT00772603|4013150|B3|Romania||Region of Enrollment||participants|Number|6|6.0||||||
4191058|NCT00772603|4013151|B2|Romania||Region of Enrollment||participants|Number|10|10.0||||||
4191059|NCT00772603|4013152|B1|Romania||Region of Enrollment||participants|Number|8|8.0||||||
4191060|NCT00772603|4013149|B4|Poland||Region of Enrollment||participants|Number|54|54.0||||||
4191061|NCT00772603|4013150|B3|Poland||Region of Enrollment||participants|Number|13|13.0||||||
4191062|NCT00772603|4013151|B2|Poland||Region of Enrollment||participants|Number|16|16.0||||||
4191063|NCT00772603|4013152|B1|Poland||Region of Enrollment||participants|Number|25|25.0||||||
4191064|NCT00772603|4013149|B4|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4191065|NCT00772603|4013150|B3|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4191066|NCT00772603|4013151|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4191067|NCT00772603|4013152|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4191068|NCT00772603|4013149|B4|Mexico||Region of Enrollment||participants|Number|45|45.0||||||
4191069|NCT00772603|4013150|B3|Mexico||Region of Enrollment||participants|Number|14|14.0||||||
4191070|NCT00772603|4013151|B2|Mexico||Region of Enrollment||participants|Number|16|16.0||||||
4191071|NCT00772603|4013152|B1|Mexico||Region of Enrollment||participants|Number|15|15.0||||||
4191072|NCT00772603|4013149|B4|United States||Region of Enrollment||participants|Number|69|69.0||||||
4191073|NCT00772603|4013150|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4191074|NCT00772603|4013151|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4191075|NCT00772603|4013152|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4191076|NCT00772603|4013149|B4||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4191077|NCT00772603|4013150|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4191078|NCT00772603|4013151|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4191079|NCT00772603|4013152|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4191080|NCT00772603|4013149|B4||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4191081|NCT00772603|4013150|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4191082|NCT00772603|4013151|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4191083|NCT00772603|4013152|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4191084|NCT00772603|4013149|B4|||Age||years|Mean|38.9|38.9|Standard Deviation|11.84|11.84|||
4191085|NCT00772603|4013150|B3|||Age||years|Mean|39.1|39.1|Standard Deviation|12.49|12.49|||
4191086|NCT00772603|4013151|B2|||Age||years|Mean|39.1|39.1|Standard Deviation|11.51|11.51|||
4191087|NCT00772603|4013152|B1|||Age||years|Mean|38.5|38.5|Standard Deviation|11.58|11.58|||
4191088|NCT00772603|4013149|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4191089|NCT00772603|4013150|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4191090|NCT00772603|4013151|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4191091|NCT00772603|4013152|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4191092|NCT00772603|4013149|B4||Between 18 and 65 years|Age||Participants|Count of Participants|366|366.0||||||
4191093|NCT00772603|4013150|B3||Between 18 and 65 years|Age||Participants|Count of Participants|121|121.0||||||
4191094|NCT00772603|4013151|B2||Between 18 and 65 years|Age||Participants|Count of Participants|122|122.0||||||
4191095|NCT00772603|4013152|B1||Between 18 and 65 years|Age||Participants|Count of Participants|123|123.0||||||
4191096|NCT00772603|4013149|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191097|NCT00772603|4013150|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191098|NCT00772603|4013151|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191099|NCT00772603|4013152|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191100|NCT00772590|4013174|B5|Australia||Region of Enrollment||participants|Number|73|73.0||||||
4191101|NCT00772590|4013175|B4|Australia||Region of Enrollment||participants|Number|17|17.0||||||
4191102|NCT00772590|4013176|B3|Australia||Region of Enrollment||participants|Number|18|18.0||||||
4191103|NCT00772590|4013177|B2|Australia||Region of Enrollment||participants|Number|19|19.0||||||
4191104|NCT00772590|4013178|B1|Australia||Region of Enrollment||participants|Number|19|19.0||||||
4191105|NCT00772590|4013174|B5||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4191106|NCT00772590|4013175|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4191107|NCT00772590|4013176|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4191108|NCT00772590|4013177|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4191109|NCT00772590|4013178|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4191110|NCT00772590|4013174|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4191111|NCT00772590|4013175|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4191112|NCT00772590|4013176|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4191113|NCT00772590|4013177|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4191114|NCT00772590|4013178|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4191115|NCT00772590|4013174|B5|||Age||years|Mean|53|53.0|Standard Deviation|10|10.0|||
4191116|NCT00772590|4013175|B4|||Age||years|Mean|55|55.0|Standard Deviation|10|10.0|||
4191117|NCT00772590|4013176|B3|||Age||years|Mean|50|50.0|Standard Deviation|10|10.0|||
4191118|NCT00772590|4013177|B2|||Age||years|Mean|56|56.0|Standard Deviation|9|9.0|||
4191119|NCT00772590|4013178|B1|||Age||years|Mean|52|52.0|Standard Deviation|11|11.0|||
4191120|NCT00772590|4013174|B5||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4191121|NCT00772590|4013175|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4191122|NCT00772590|4013176|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4191123|NCT00772590|4013177|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4191124|NCT00772590|4013178|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4191125|NCT00772590|4013174|B5||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
4191126|NCT00772590|4013175|B4||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4191127|NCT00772590|4013176|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4191128|NCT00772590|4013177|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4191129|NCT00772590|4013178|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4191130|NCT00772590|4013174|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191131|NCT00772590|4013175|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191132|NCT00772590|4013176|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191133|NCT00772590|4013177|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191134|NCT00772590|4013178|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191135|NCT00772577|4013191|B3||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4191136|NCT00772577|4013192|B2||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4191137|NCT00772577|4013193|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4191138|NCT00772577|4013191|B3||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
4191139|NCT00772577|4013192|B2||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4191140|NCT00772577|4013193|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4191141|NCT00772577|4013191|B3|||Age||years|Mean|54.9|54.9|Standard Deviation|11.02|11.02|||
4191142|NCT00772577|4013192|B2|||Age||years|Mean|54.4|54.4|Standard Deviation|10.90|10.9|||
4191143|NCT00772577|4013193|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|11.15|11.15|||
4191144|NCT00772538|4013208|B3||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4191145|NCT00772538|4013209|B2||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4191146|NCT00772538|4013210|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4191147|NCT00772538|4013208|B3||Female|Sex: Female, Male||Participants|Count of Participants|289|289.0||||||
4191148|NCT00772538|4013209|B2||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4191149|NCT00772538|4013210|B1||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4191150|NCT00772538|4013208|B3|||Age||Years|Mean|53.4|53.4|Standard Deviation|12.6|12.6|||
4191151|NCT00772538|4013209|B2|||Age||Years|Mean|52.9|52.9|Standard Deviation|12.4|12.4|||
4191152|NCT00772538|4013210|B1|||Age||Years|Mean|53.9|53.9|Standard Deviation|12.8|12.8|||
4191153|NCT00772447|4013281|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4191154|NCT00772447|4013282|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4191155|NCT00772447|4013283|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4191156|NCT00772447|4013281|B3||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4191157|NCT00772447|4013282|B2||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4191158|NCT00772447|4013283|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4191159|NCT00772447|4013281|B3|||Age||years|Mean|44.3|44.3|Standard Deviation|15.87|15.87|||
4191160|NCT00772447|4013282|B2|||Age||years|Mean|44.5|44.5|Standard Deviation|16.02|16.02|||
4191161|NCT00772447|4013283|B1|||Age||years|Mean|44.2|44.2|Standard Deviation|15.77|15.77|||
4191162|NCT00772382|4013312|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4191163|NCT00772382|4013312|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4191164|NCT00772382|4013312|B1|||Age||years|Mean|57.3|57.3|Standard Deviation|13.8|13.8|||
4191165|NCT00772369|4013317|B1|Canada||Region of Enrollment||participants|Number|3214|3214.0||||||
4191166|NCT00772369|4013317|B1||Male|Sex: Female, Male||Participants|Count of Participants|1676|1676.0||||||
4191167|NCT00772369|4013317|B1||Female|Sex: Female, Male||Participants|Count of Participants|1538|1538.0||||||
4191168|NCT00772369|4013317|B1|||Age||Months|Mean|19.5|19.5|Standard Deviation|1.45|1.45|||
4191169|NCT00772369|4013317|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4191170|NCT00772369|4013317|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4191171|NCT00772369|4013317|B1||<=18 years|Age||Participants|Count of Participants|3214|3214.0||||||
4191172|NCT00772304|4013322|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4191173|NCT00772304|4013322|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4191174|NCT00772304|4013322|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4191175|NCT00772304|4013322|B1||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
4191176|NCT00772304|4013322|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191177|NCT00772148|4013326|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
4191178|NCT00772148|4013327|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4191179|NCT00772148|4013328|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4191180|NCT00772148|4013326|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191181|NCT00772148|4013327|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191182|NCT00772148|4013328|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191183|NCT00772148|4013326|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191184|NCT00772148|4013327|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191185|NCT00772148|4013328|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191186|NCT00772148|4013326|B3||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4191187|NCT00772148|4013327|B2||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4191188|NCT00772148|4013328|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4191189|NCT00772148|4013326|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4191190|NCT00772148|4013327|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4191191|NCT00772148|4013328|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4191192|NCT00772148|4013326|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4191193|NCT00772148|4013327|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191194|NCT00772148|4013328|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4191195|NCT00772148|4013326|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4191196|NCT00772148|4013327|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4191197|NCT00772148|4013328|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4191198|NCT00772148|4013326|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4191199|NCT00772148|4013327|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4191200|NCT00772148|4013328|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191201|NCT00772148|4013326|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191202|NCT00772148|4013327|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191203|NCT00772148|4013328|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191265|NCT00772070|4013376|B1|||Age||years|Mean|4.5|4.5|Standard Deviation|0.52|0.52|||
4191204|NCT00772148|4013326|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4191205|NCT00772148|4013327|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4191206|NCT00772148|4013328|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4191207|NCT00772148|4013326|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4191208|NCT00772148|4013327|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4191209|NCT00772148|4013328|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4191210|NCT00772148|4013326|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4191211|NCT00772148|4013327|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4191212|NCT00772148|4013328|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4191213|NCT00772148|4013326|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4191214|NCT00772148|4013327|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4191215|NCT00772148|4013328|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4191216|NCT00772148|4013326|B3|||Age||years|Mean|54.4|54.4|Standard Deviation|8.55|8.55|||
4191217|NCT00772148|4013327|B2|||Age||years|Mean|54.6|54.6|Standard Deviation|9.78|9.78|||
4191218|NCT00772148|4013328|B1|||Age||years|Mean|54.1|54.1|Standard Deviation|7.27|7.27|||
4191219|NCT00772109|4013345|B5|United States||Region of Enrollment||Participants|Number|4292|4292.0||||||
4191220|NCT00772109|4013346|B4|United States||Region of Enrollment||Participants|Number|1428|1428.0||||||
4191221|NCT00772109|4013347|B3|United States||Region of Enrollment||Participants|Number|955|955.0||||||
4191222|NCT00772109|4013348|B2|United States||Region of Enrollment||Participants|Number|953|953.0||||||
4191223|NCT00772109|4013349|B1|United States||Region of Enrollment||Participants|Number|956|956.0||||||
4191224|NCT00772109|4013345|B5||Male|Sex: Female, Male||Participants|Count of Participants|1569|1569.0||||||
4191225|NCT00772109|4013346|B4||Male|Sex: Female, Male||Participants|Count of Participants|529|529.0||||||
4191226|NCT00772109|4013347|B3||Male|Sex: Female, Male||Participants|Count of Participants|361|361.0||||||
4191227|NCT00772109|4013348|B2||Male|Sex: Female, Male||Participants|Count of Participants|334|334.0||||||
4191228|NCT00772109|4013349|B1||Male|Sex: Female, Male||Participants|Count of Participants|345|345.0||||||
4191229|NCT00772109|4013345|B5||Female|Sex: Female, Male||Participants|Count of Participants|2723|2723.0||||||
4191230|NCT00772109|4013346|B4||Female|Sex: Female, Male||Participants|Count of Participants|899|899.0||||||
4191231|NCT00772109|4013347|B3||Female|Sex: Female, Male||Participants|Count of Participants|594|594.0||||||
4191232|NCT00772109|4013348|B2||Female|Sex: Female, Male||Participants|Count of Participants|619|619.0||||||
4191233|NCT00772109|4013349|B1||Female|Sex: Female, Male||Participants|Count of Participants|611|611.0||||||
4191234|NCT00772109|4013345|B5|||Age||Years|Mean|42.5|42.5|Standard Deviation|13.5175|13.5175|||
4191235|NCT00772109|4013346|B4|||Age||Years|Mean|42.5|42.5|Standard Deviation|13.55|13.55|||
4191236|NCT00772109|4013347|B3|||Age||Years|Mean|42.2|42.2|Standard Deviation|13.78|13.78|||
4191237|NCT00772109|4013348|B2|||Age||Years|Mean|42.8|42.8|Standard Deviation|13.33|13.33|||
4191238|NCT00772109|4013349|B1|||Age||Years|Mean|42.7|42.7|Standard Deviation|13.41|13.41|||
4191239|NCT00772109|4013345|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4191240|NCT00772109|4013346|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4191241|NCT00772109|4013347|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4191242|NCT00772109|4013348|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4191243|NCT00772109|4013349|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4191244|NCT00772109|4013345|B5||Between 18 and 65 years|Age||Participants|Count of Participants|4292|4292.0||||||
4191245|NCT00772109|4013346|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1428|1428.0||||||
4191246|NCT00772109|4013347|B3||Between 18 and 65 years|Age||Participants|Count of Participants|955|955.0||||||
4191247|NCT00772109|4013348|B2||Between 18 and 65 years|Age||Participants|Count of Participants|953|953.0||||||
4191248|NCT00772109|4013349|B1||Between 18 and 65 years|Age||Participants|Count of Participants|956|956.0||||||
4191249|NCT00772109|4013345|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191250|NCT00772109|4013346|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191251|NCT00772109|4013347|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191252|NCT00772109|4013348|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191253|NCT00772109|4013349|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191254|NCT00772070|4013374|B3|United States||Region of Enrollment||participants|Number|171.0|171.0||||||
4191255|NCT00772070|4013375|B2|United States||Region of Enrollment||participants|Number|71|71.0||||||
4191256|NCT00772070|4013376|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
4191257|NCT00772070|4013374|B3||Male|Sex: Female, Male||Participants|Count of Participants|85.0|85.0||||||
4191258|NCT00772070|4013375|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4191259|NCT00772070|4013376|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4191260|NCT00772070|4013374|B3||Female|Sex: Female, Male||Participants|Count of Participants|86.0|86.0||||||
4191261|NCT00772070|4013375|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4191262|NCT00772070|4013376|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4191263|NCT00772070|4013374|B3|||Age||years|Mean|4.2|4.2|Standard Deviation|0.76|0.76|||
4191264|NCT00772070|4013375|B2|||Age||years|Mean|3.8|3.8|Standard Deviation|0.87|0.87|||
4191266|NCT00772070|4013374|B3||>=65 years|Age||Participants|Count of Participants|0.0|0.0||||||
4191267|NCT00772070|4013375|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4191268|NCT00772070|4013376|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4191269|NCT00772070|4013374|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0.0|0.0||||||
4191270|NCT00772070|4013375|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4191271|NCT00772070|4013376|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4191272|NCT00772070|4013374|B3||<=18 years|Age||Participants|Count of Participants|171.0|171.0||||||
4191273|NCT00772070|4013375|B2||<=18 years|Age||Participants|Count of Participants|71|71.0||||||
4191274|NCT00772070|4013376|B1||<=18 years|Age||Participants|Count of Participants|100|100.0||||||
4191275|NCT00772031|4013387|B3|United States||Region of Enrollment||participants|Number|191|191.0||||||
4191276|NCT00772031|4013388|B2|United States||Region of Enrollment||participants|Number|95|95.0||||||
4191277|NCT00772031|4013389|B1|United States||Region of Enrollment||participants|Number|96|96.0||||||
4191278|NCT00772031|4013387|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4191279|NCT00772031|4013388|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4191280|NCT00772031|4013389|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4191281|NCT00772031|4013387|B3||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4191282|NCT00772031|4013388|B2||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4191283|NCT00772031|4013389|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4191284|NCT00772031|4013387|B3|||Age||years|Mean|40.5|40.5|Standard Deviation|0.79|0.79|||
4191285|NCT00772031|4013388|B2|||Age||years|Mean|41.2|41.2|Standard Deviation|1.15|1.15|||
4191286|NCT00772031|4013389|B1|||Age||years|Mean|39.8|39.8|Standard Deviation|1.09|1.09|||
4191287|NCT00772031|4013387|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4191288|NCT00772031|4013388|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4191289|NCT00772031|4013389|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4191290|NCT00772031|4013387|B3||Between 18 and 65 years|Age||Participants|Count of Participants|186|186.0||||||
4191291|NCT00772031|4013388|B2||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
4191292|NCT00772031|4013389|B1||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
4191293|NCT00772031|4013387|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4191294|NCT00772031|4013388|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4191295|NCT00772031|4013389|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4191296|NCT00772005|4013412|B5|United States||Region of Enrollment||participants|Number|285|285.0||||||
4191297|NCT00772005|4013413|B4|United States||Region of Enrollment||participants|Number|72|72.0||||||
4191298|NCT00772005|4013414|B3|United States||Region of Enrollment||participants|Number|72|72.0||||||
4191299|NCT00772005|4013415|B2|United States||Region of Enrollment||participants|Number|70|70.0||||||
4191300|NCT00772005|4013416|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
4191301|NCT00772005|4013412|B5||Male|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
4191302|NCT00772005|4013413|B4||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4191303|NCT00772005|4013414|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4191304|NCT00772005|4013415|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4191305|NCT00772005|4013416|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4191306|NCT00772005|4013412|B5||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4191307|NCT00772005|4013413|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4191308|NCT00772005|4013414|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4191309|NCT00772005|4013415|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4191310|NCT00772005|4013416|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4191311|NCT00772005|4013412|B5|||Age||years|Mean|43.4|43.4|Standard Deviation|10.43|10.43|||
4191312|NCT00772005|4013413|B4|||Age||years|Mean|42.4|42.4|Standard Deviation|10.07|10.07|||
4191313|NCT00772005|4013414|B3|||Age||years|Mean|44.4|44.4|Standard Deviation|9.43|9.43|||
4191314|NCT00772005|4013415|B2|||Age||years|Mean|43.1|43.1|Standard Deviation|11.07|11.07|||
4191315|NCT00772005|4013416|B1|||Age||years|Mean|43.7|43.7|Standard Deviation|11.19|11.19|||
4191316|NCT00772005|4013412|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4191317|NCT00772005|4013413|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4191318|NCT00772005|4013414|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4191319|NCT00772005|4013415|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4191320|NCT00772005|4013416|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4191321|NCT00772005|4013412|B5||Between 18 and 65 years|Age||Participants|Count of Participants|285|285.0||||||
4191322|NCT00772005|4013413|B4||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
4191323|NCT00772005|4013414|B3||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
4191324|NCT00772005|4013415|B2||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4191325|NCT00772005|4013416|B1||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4191326|NCT00772005|4013412|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191327|NCT00772005|4013413|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191328|NCT00772005|4013414|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191329|NCT00772005|4013415|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191330|NCT00772005|4013416|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191331|NCT00771953|4014105|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4191332|NCT00771953|4014106|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4191333|NCT00771953|4014107|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4191334|NCT00771953|4014105|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4191335|NCT00771953|4014106|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4191336|NCT00771953|4014107|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4191337|NCT00771953|4014105|B3|||Age, Customized||years|Median|64|64.0|Full Range|||42.0|87.0|
4191338|NCT00771953|4014106|B2|||Age, Customized||years|Median|66|66.0|Full Range|||49.0|76.0|
4191339|NCT00771953|4014107|B1|||Age, Customized||years|Median|62|62.0|Full Range|||42.0|87.0|
4191340|NCT00771927|4014116|B3|||Body Mass Index (BMI)||kilogram per square meter|Mean|26.1|26.1|Standard Deviation|5.59|5.59|||
4191341|NCT00771927|4014117|B2|||Body Mass Index (BMI)||kilogram per square meter|Mean|26.2|26.2|Standard Deviation|5.25|5.25|||
4191342|NCT00771927|4014118|B1|||Body Mass Index (BMI)||kilogram per square meter|Mean|26.0|26.0|Standard Deviation|5.89|5.89|||
4191343|NCT00771927|4014116|B3|||Height||centimeter|Mean|170.0|170.0|Standard Deviation|10.18|10.18|||
4191344|NCT00771927|4014117|B2|||Height||centimeter|Mean|169.5|169.5|Standard Deviation|9.24|9.24|||
4191345|NCT00771927|4014118|B1|||Height||centimeter|Mean|170.4|170.4|Standard Deviation|10.97|10.97|||
4191346|NCT00771927|4014116|B3|||Weight||kilogram|Mean|75.6|75.6|Standard Deviation|17.89|17.89|||
4191347|NCT00771927|4014117|B2|||Weight||kilogram|Mean|75.7|75.7|Standard Deviation|17.68|17.68|||
4191348|NCT00771927|4014118|B1|||Weight||kilogram|Mean|75.5|75.5|Standard Deviation|18.10|18.1|||
4191349|NCT00771927|4014116|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4191350|NCT00771927|4014117|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4191351|NCT00771927|4014118|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4191352|NCT00771927|4014116|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4191353|NCT00771927|4014117|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4191354|NCT00771927|4014118|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191355|NCT00771927|4014116|B3||White|Race (NIH/OMB)||Participants|Count of Participants|945|945.0||||||
4191356|NCT00771927|4014117|B2||White|Race (NIH/OMB)||Participants|Count of Participants|464|464.0||||||
4191357|NCT00771927|4014118|B1||White|Race (NIH/OMB)||Participants|Count of Participants|481|481.0||||||
4191358|NCT00771927|4014116|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4191359|NCT00771927|4014117|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4191360|NCT00771927|4014118|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191361|NCT00771927|4014116|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4191362|NCT00771927|4014117|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191363|NCT00771927|4014118|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4191364|NCT00771927|4014116|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4191365|NCT00771927|4014117|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4191366|NCT00771927|4014118|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4191367|NCT00771927|4014116|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4191368|NCT00771927|4014117|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4191369|NCT00771927|4014118|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191370|NCT00771927|4014116|B3||Male|Sex: Female, Male||Participants|Count of Participants|456|456.0||||||
4191371|NCT00771927|4014117|B2||Male|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4191372|NCT00771927|4014118|B1||Male|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4191373|NCT00771927|4014116|B3||Female|Sex: Female, Male||Participants|Count of Participants|548|548.0||||||
4191374|NCT00771927|4014117|B2||Female|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
4191375|NCT00771927|4014118|B1||Female|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
4191376|NCT00771927|4014116|B3|||Age||years|Mean|41.0|41.0|Standard Deviation|14.54|14.54|||
4191377|NCT00771927|4014117|B2|||Age||years|Mean|42.3|42.3|Standard Deviation|15.38|15.38|||
4191378|NCT00771927|4014118|B1|||Age||years|Mean|39.8|39.8|Standard Deviation|13.58|13.58|||
4191379|NCT00771927|4014116|B3||>=65 years|Age||Participants|Count of Participants|69|69.0||||||
4191380|NCT00771927|4014117|B2||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
4191381|NCT00771927|4014118|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4191382|NCT00771927|4014116|B3||Between 18 and 65 years|Age||Participants|Count of Participants|901|901.0||||||
4191383|NCT00771927|4014117|B2||Between 18 and 65 years|Age||Participants|Count of Participants|434|434.0||||||
4191384|NCT00771927|4014118|B1||Between 18 and 65 years|Age||Participants|Count of Participants|467|467.0||||||
4191385|NCT00771927|4014116|B3||<=18 years|Age||Participants|Count of Participants|34|34.0||||||
4191386|NCT00771927|4014117|B2||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4191387|NCT00771927|4014118|B1||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
4191388|NCT00771914|4014127|B5|United States||Region of Enrollment||participants|Number|27|27.0||||||
4191389|NCT00771914|4014128|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
4191390|NCT00771914|4014129|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4191391|NCT00771914|4014130|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4191392|NCT00771914|4014131|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4191393|NCT00771914|4014127|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4191394|NCT00771914|4014128|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4191395|NCT00771914|4014129|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4191396|NCT00771914|4014130|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4191397|NCT00771914|4014131|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4191398|NCT00771914|4014127|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4191399|NCT00771914|4014128|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4191400|NCT00771914|4014129|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4191401|NCT00771914|4014130|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4191402|NCT00771914|4014131|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4191403|NCT00771914|4014127|B5|||Age||years|Mean|29.3|29.3|Standard Deviation|9.1|9.1|||
4191404|NCT00771914|4014128|B4|||Age||years|Mean|29.3|29.3|Standard Deviation|10.2|10.2|||
4191405|NCT00771914|4014129|B3|||Age||years|Mean|25.9|25.9|Standard Deviation|3.4|3.4|||
4191406|NCT00771914|4014130|B2|||Age||years|Mean|32.9|32.9|Standard Deviation|11.6|11.6|||
4191407|NCT00771914|4014131|B1|||Age||years|Mean|29.7|29.7|Standard Deviation|9.7|9.7|||
4191408|NCT00771914|4014127|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4191409|NCT00771914|4014128|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4191410|NCT00771914|4014129|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4191411|NCT00771914|4014130|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4191412|NCT00771914|4014131|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4191413|NCT00771914|4014127|B5||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4191414|NCT00771914|4014128|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4191415|NCT00771914|4014129|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4191416|NCT00771914|4014130|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4191417|NCT00771914|4014131|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4191418|NCT00771914|4014127|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191419|NCT00771914|4014128|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191420|NCT00771914|4014129|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191421|NCT00771914|4014130|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191422|NCT00771914|4014131|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191423|NCT00771901|4014144|B4|United States||Region of Enrollment||participants|Number|26|26.0||||||
4191424|NCT00771901|4014145|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4191425|NCT00771901|4014146|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4191426|NCT00771901|4014147|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4191427|NCT00771901|4014144|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4191428|NCT00771901|4014145|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4191429|NCT00771901|4014146|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4191430|NCT00771901|4014147|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4191431|NCT00771901|4014144|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4191432|NCT00771901|4014145|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4191433|NCT00771901|4014146|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4191434|NCT00771901|4014147|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4191435|NCT00771901|4014144|B4|||Age||years|Mean|47|47.0|Standard Deviation|10.6|10.6|||
4191436|NCT00771901|4014145|B3|||Age||years|Mean|49|49.0|Standard Deviation|8|8.0|||
4191437|NCT00771901|4014146|B2|||Age||years|Mean|47|47.0|Standard Deviation|9|9.0|||
4191438|NCT00771901|4014147|B1|||Age||years|Mean|49|49.0|Standard Deviation|14|14.0|||
4191439|NCT00771901|4014144|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4191440|NCT00771901|4014145|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4191441|NCT00771901|4014146|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4191442|NCT00771901|4014147|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4191443|NCT00771901|4014144|B4||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4191444|NCT00771901|4014145|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4191445|NCT00771901|4014146|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4191446|NCT00771901|4014147|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4191447|NCT00771901|4014144|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191448|NCT00771901|4014145|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191449|NCT00771901|4014146|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191450|NCT00771901|4014147|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191451|NCT00771875|4014163|B4|Living Donor||Type of Transplant||participants|Number|19|19.0||||||
4191452|NCT00771875|4014164|B3|Living Donor||Type of Transplant||participants|Number|5|5.0||||||
4191453|NCT00771875|4014165|B2|Living Donor||Type of Transplant||participants|Number|7|7.0||||||
4191454|NCT00771875|4014166|B1|Living Donor||Type of Transplant||participants|Number|7|7.0||||||
4191455|NCT00771875|4014163|B4|Deceased Donor Simultaneous Pancreas/Kidney||Type of Transplant||participants|Number|4|4.0||||||
4191456|NCT00771875|4014164|B3|Deceased Donor Simultaneous Pancreas/Kidney||Type of Transplant||participants|Number|2|2.0||||||
4191457|NCT00771875|4014165|B2|Deceased Donor Simultaneous Pancreas/Kidney||Type of Transplant||participants|Number|1|1.0||||||
4191458|NCT00771875|4014166|B1|Deceased Donor Simultaneous Pancreas/Kidney||Type of Transplant||participants|Number|1|1.0||||||
4191459|NCT00771875|4014163|B4|Deceased Donor Kidney Transplant||Type of Transplant||participants|Number|6|6.0||||||
4191460|NCT00771875|4014164|B3|Deceased Donor Kidney Transplant||Type of Transplant||participants|Number|3|3.0||||||
4191461|NCT00771875|4014165|B2|Deceased Donor Kidney Transplant||Type of Transplant||participants|Number|1|1.0||||||
4191462|NCT00771875|4014166|B1|Deceased Donor Kidney Transplant||Type of Transplant||participants|Number|2|2.0||||||
4191463|NCT00771875|4014163|B4|United States||Region of Enrollment||participants|Number|29|29.0||||||
4191464|NCT00771875|4014164|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4191465|NCT00771875|4014165|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4191466|NCT00771875|4014166|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4191467|NCT00771875|4014163|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4191468|NCT00771875|4014164|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4191469|NCT00771875|4014165|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4191470|NCT00771875|4014166|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4191471|NCT00771875|4014163|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4191472|NCT00771875|4014164|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4191473|NCT00771875|4014165|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4191474|NCT00771875|4014166|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4191475|NCT00771875|4014163|B4|||Age||years|Mean|35.8|35.8|Standard Deviation|10.8|10.8|||
4191476|NCT00771875|4014164|B3|||Age||years|Mean|38.5|38.5|Standard Deviation|12.3|12.3|||
4191477|NCT00771875|4014165|B2|||Age||years|Mean|34.2|34.2|Standard Deviation|6.6|6.6|||
4191478|NCT00771875|4014166|B1|||Age||years|Mean|34.9|34.9|Standard Deviation|12.6|12.6|||
4191479|NCT00771849|4014194|B3|United Kingdom||Region of Enrollment||participants|Number|103|103.0||||||
4191480|NCT00771849|4014195|B2|United Kingdom||Region of Enrollment||participants|Number|51|51.0||||||
4191481|NCT00771849|4014196|B1|United Kingdom||Region of Enrollment||participants|Number|52|52.0||||||
4191482|NCT00771849|4014194|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4191483|NCT00771849|4014195|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4191484|NCT00771849|4014196|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4191485|NCT00771849|4014194|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4191486|NCT00771849|4014195|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4191487|NCT00771849|4014196|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4191488|NCT00771849|4014194|B3|||Age||Months|Mean|37.3|37.3|Standard Deviation|8.3|8.3|||
4191489|NCT00771849|4014195|B2|||Age||Months|Mean|37.6|37.6|Standard Deviation|8.3|8.3|||
4191490|NCT00771849|4014196|B1|||Age||Months|Mean|37.0|37.0|Standard Deviation|8.5|8.5|||
4191491|NCT00771849|4014194|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4191492|NCT00771849|4014195|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4191493|NCT00771849|4014196|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4191494|NCT00771849|4014194|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4191495|NCT00771849|4014195|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4191496|NCT00771849|4014196|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4191497|NCT00771849|4014194|B3||<=18 years|Age||Participants|Count of Participants|103|103.0||||||
4191498|NCT00771849|4014195|B2||<=18 years|Age||Participants|Count of Participants|51|51.0||||||
4191499|NCT00771849|4014196|B1||<=18 years|Age||Participants|Count of Participants|52|52.0||||||
4191500|NCT00771810|4014205|B4|United States||Region of Enrollment||participants|Number|34|34.0||||||
4191501|NCT00771810|4014206|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4191502|NCT00771810|4014207|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4191503|NCT00771810|4014208|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4191504|NCT00771810|4014205|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4191505|NCT00771810|4014206|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4191506|NCT00771810|4014207|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191507|NCT00771810|4014208|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4191508|NCT00771810|4014205|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191509|NCT00771810|4014206|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191510|NCT00771810|4014207|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191569|NCT00771758|4014246|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4191511|NCT00771810|4014208|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191512|NCT00771810|4014205|B4||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4191513|NCT00771810|4014206|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4191514|NCT00771810|4014207|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4191515|NCT00771810|4014208|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4191516|NCT00771810|4014205|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4191517|NCT00771810|4014206|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191518|NCT00771810|4014207|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4191519|NCT00771810|4014208|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191520|NCT00771810|4014205|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191521|NCT00771810|4014206|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191522|NCT00771810|4014207|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191523|NCT00771810|4014208|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191524|NCT00771810|4014205|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4191525|NCT00771810|4014206|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4191526|NCT00771810|4014207|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191527|NCT00771810|4014208|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4191528|NCT00771810|4014205|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191529|NCT00771810|4014206|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191530|NCT00771810|4014207|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191531|NCT00771810|4014208|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191532|NCT00771810|4014205|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4191533|NCT00771810|4014206|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4191534|NCT00771810|4014207|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4191535|NCT00771810|4014208|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4191536|NCT00771810|4014205|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191537|NCT00771810|4014206|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191538|NCT00771810|4014207|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191539|NCT00771810|4014208|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191540|NCT00771810|4014205|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191541|NCT00771810|4014206|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191542|NCT00771810|4014207|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191543|NCT00771810|4014208|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191544|NCT00771810|4014205|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4191545|NCT00771810|4014206|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4191546|NCT00771810|4014207|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4191547|NCT00771810|4014208|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4191548|NCT00771810|4014205|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4191549|NCT00771810|4014206|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4191550|NCT00771810|4014207|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4191551|NCT00771810|4014208|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4191552|NCT00771810|4014205|B4||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4191553|NCT00771810|4014206|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4191554|NCT00771810|4014207|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4191555|NCT00771810|4014208|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4191556|NCT00771810|4014205|B4||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4191557|NCT00771810|4014206|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4191558|NCT00771810|4014207|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4191559|NCT00771810|4014208|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4191560|NCT00771810|4014205|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191561|NCT00771810|4014206|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191562|NCT00771810|4014207|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191563|NCT00771810|4014208|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191564|NCT00771758|4014245|B4|USA||Region of Enrollment||participants|Number|108|108.0||||||
4191565|NCT00771758|4014246|B3|USA||Region of Enrollment||participants|Number|21|21.0||||||
4191566|NCT00771758|4014247|B2|USA||Region of Enrollment||participants|Number|43|43.0||||||
4191567|NCT00771758|4014248|B1|USA||Region of Enrollment||participants|Number|44|44.0||||||
4191568|NCT00771758|4014245|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4191570|NCT00771758|4014247|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4191571|NCT00771758|4014248|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4191572|NCT00771758|4014245|B4||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4191573|NCT00771758|4014246|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4191574|NCT00771758|4014247|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4191575|NCT00771758|4014248|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4191576|NCT00771758|4014245|B4|||Age||years|Mean|69.5|69.5|Standard Deviation|12.58|12.58|||
4191577|NCT00771758|4014246|B3|||Age||years|Mean|69.6|69.6|Standard Deviation|12.36|12.36|||
4191578|NCT00771758|4014247|B2|||Age||years|Mean|69.3|69.3|Standard Deviation|13.26|13.26|||
4191579|NCT00771758|4014248|B1|||Age||years|Mean|69.8|69.8|Standard Deviation|12.28|12.28|||
4191580|NCT00771758|4014245|B4||>=65 years|Age||Participants|Count of Participants|75|75.0||||||
4191581|NCT00771758|4014246|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4191582|NCT00771758|4014247|B2||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4191583|NCT00771758|4014248|B1||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4191584|NCT00771758|4014245|B4||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4191585|NCT00771758|4014246|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4191586|NCT00771758|4014247|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4191587|NCT00771758|4014248|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4191588|NCT00771758|4014245|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191589|NCT00771758|4014246|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191590|NCT00771758|4014247|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191591|NCT00771758|4014248|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191592|NCT00771745|4014398|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4191593|NCT00771745|4014399|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4191594|NCT00771745|4014400|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4191595|NCT00771745|4014398|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4191596|NCT00771745|4014399|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4191597|NCT00771745|4014400|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4191598|NCT00771745|4014398|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4191599|NCT00771745|4014399|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4191600|NCT00771745|4014400|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4191601|NCT00771745|4014398|B3|||Age||years|Mean|43.1|43.1|Standard Deviation|17.1|17.1|||
4191602|NCT00771745|4014399|B2|||Age||years|Mean|36.1|36.1|Standard Deviation|12.5|12.5|||
4191603|NCT00771745|4014400|B1|||Age||years|Mean|50.1|50.1|Standard Deviation|17.1|17.1|||
4191604|NCT00771745|4014398|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4191605|NCT00771745|4014399|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4191606|NCT00771745|4014400|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4191607|NCT00771745|4014398|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4191608|NCT00771745|4014399|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4191609|NCT00771745|4014400|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4191610|NCT00771745|4014398|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191611|NCT00771745|4014399|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191612|NCT00771745|4014400|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191613|NCT00771667|4014407|B5||Male|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
4191614|NCT00771667|4014408|B4||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4191615|NCT00771667|4014409|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4191616|NCT00771667|4014410|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4191617|NCT00771667|4014411|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4191618|NCT00771667|4014407|B5||Female|Sex: Female, Male||Participants|Count of Participants|309|309.0||||||
4191619|NCT00771667|4014408|B4||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4191620|NCT00771667|4014409|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4191621|NCT00771667|4014410|B2||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4191622|NCT00771667|4014411|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4191623|NCT00771667|4014407|B5|||Age||years|Mean|39|39.0|Standard Deviation|12.69|12.69|||
4191624|NCT00771667|4014408|B4|||Age||years|Mean|39.4|39.4|Standard Deviation|13.21|13.21|||
4191625|NCT00771667|4014409|B3|||Age||years|Mean|38.2|38.2|Standard Deviation|12.63|12.63|||
4191626|NCT00771667|4014410|B2|||Age||years|Mean|38.8|38.8|Standard Deviation|11.95|11.95|||
4191627|NCT00771667|4014411|B1|||Age||years|Mean|39.5|39.5|Standard Deviation|13.05|13.05|||
4191628|NCT00771615|4014456|B10||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4191629|NCT00771615|4014457|B9||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4191630|NCT00771615|4014458|B8||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4191631|NCT00771615|4014459|B7||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4191632|NCT00771615|4014460|B6||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4191633|NCT00771615|4014461|B5||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4191634|NCT00771615|4014462|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4191635|NCT00771615|4014463|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4191636|NCT00771615|4014464|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4191637|NCT00771615|4014465|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4191638|NCT00771615|4014456|B10||Female|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
4191639|NCT00771615|4014457|B9||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4191640|NCT00771615|4014458|B8||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4191641|NCT00771615|4014459|B7||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4191642|NCT00771615|4014460|B6||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4191643|NCT00771615|4014461|B5||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4191644|NCT00771615|4014462|B4||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4191645|NCT00771615|4014463|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4191646|NCT00771615|4014464|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4191647|NCT00771615|4014465|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4191648|NCT00771615|4014456|B10|||Age||Years|Mean|41.3|41.3|Standard Deviation|11.55|11.55|||
4191649|NCT00771615|4014457|B9|||Age||Years|Mean|41.6|41.6|Standard Deviation|11.60|11.6|||
4191650|NCT00771615|4014458|B8|||Age||Years|Mean|40.6|40.6|Standard Deviation|12.01|12.01|||
4191651|NCT00771615|4014459|B7|||Age||Years|Mean|41.2|41.2|Standard Deviation|9.78|9.78|||
4191652|NCT00771615|4014460|B6|||Age||Years|Mean|42.4|42.4|Standard Deviation|11.15|11.15|||
4191653|NCT00771615|4014461|B5|||Age||Years|Mean|41.1|41.1|Standard Deviation|12.46|12.46|||
4191654|NCT00771615|4014462|B4|||Age||Years|Mean|41.2|41.2|Standard Deviation|12.33|12.33|||
4191655|NCT00771615|4014463|B3|||Age||Years|Mean|41.1|41.1|Standard Deviation|11.82|11.82|||
4191656|NCT00771615|4014464|B2|||Age||Years|Mean|40.6|40.6|Standard Deviation|12.02|12.02|||
4191657|NCT00771615|4014465|B1|||Age||Years|Mean|42.3|42.3|Standard Deviation|11.47|11.47|||
4191658|NCT00771602|4014664|B4|United States||Region of Enrollment||participants|Number|1|1.0||||||
4191659|NCT00771602|4014667|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4191660|NCT00771602|4014664|B4|Male||Gender||participants|Number|1|1.0||||||
4191661|NCT00771602|4014667|B1|Male||Gender||participants|Number|1|1.0||||||
4191662|NCT00771602|4014664|B4|Female||Gender||participants|Number|0|0.0||||||
4191663|NCT00771602|4014667|B1|Female||Gender||participants|Number|0|0.0||||||
4191664|NCT00771602|4014664|B4|>=65 years||Age||years|Number|0|0.0||||||
4191665|NCT00771602|4014667|B1|>=65 years||Age||years|Number|0|0.0||||||
4191666|NCT00771602|4014664|B4|Between 18 and 65 years||Age||years|Number|1|1.0||||||
4191667|NCT00771602|4014667|B1|Between 18 and 65 years||Age||years|Number|1|1.0||||||
4191668|NCT00771602|4014664|B4|<=18 years||Age||years|Number|0|0.0||||||
4191669|NCT00771602|4014667|B1|<=18 years||Age||years|Number|0|0.0||||||
4191670|NCT00771537|4014677|B17|United States||Region of Enrollment||participants|Number|2031|2031.0||||||
4191671|NCT00771537|4014678|B16|United States||Region of Enrollment||participants|Number|122|122.0||||||
4191672|NCT00771537|4014679|B15|United States||Region of Enrollment||participants|Number|124|124.0||||||
4191673|NCT00771537|4014680|B14|United States||Region of Enrollment||participants|Number|124|124.0||||||
4191674|NCT00771537|4014681|B13|United States||Region of Enrollment||participants|Number|128|128.0||||||
4191675|NCT00771537|4014682|B12|United States||Region of Enrollment||participants|Number|137|137.0||||||
4191676|NCT00771537|4014683|B11|United States||Region of Enrollment||participants|Number|133|133.0||||||
4191677|NCT00771537|4014684|B10|United States||Region of Enrollment||participants|Number|119|119.0||||||
4191678|NCT00771537|4014685|B9|United States||Region of Enrollment||participants|Number|115|115.0||||||
4191679|NCT00771537|4014686|B8|United States||Region of Enrollment||participants|Number|132|132.0||||||
4191680|NCT00771537|4014687|B7|United States||Region of Enrollment||participants|Number|128|128.0||||||
4191681|NCT00771537|4014688|B6|United States||Region of Enrollment||participants|Number|118|118.0||||||
4191682|NCT00771537|4014689|B5|United States||Region of Enrollment||participants|Number|127|127.0||||||
4191683|NCT00771537|4014690|B4|United States||Region of Enrollment||participants|Number|114|114.0||||||
4191684|NCT00771537|4014691|B3|United States||Region of Enrollment||participants|Number|151|151.0||||||
4191685|NCT00771537|4014692|B2|United States||Region of Enrollment||participants|Number|124|124.0||||||
4191686|NCT00771537|4014693|B1|United States||Region of Enrollment||participants|Number|135|135.0||||||
4191687|NCT00771537|4014677|B17||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4191688|NCT00771537|4014678|B16||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4191689|NCT00771537|4014679|B15||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4191690|NCT00771537|4014680|B14||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4191691|NCT00771537|4014681|B13||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4191692|NCT00771537|4014682|B12||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4191693|NCT00771537|4014683|B11||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4191694|NCT00771537|4014684|B10||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4191695|NCT00771537|4014685|B9||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4191696|NCT00771537|4014686|B8||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4191697|NCT00771537|4014687|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4191698|NCT00771537|4014688|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4191699|NCT00771537|4014689|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4191700|NCT00771537|4014690|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4191701|NCT00771537|4014691|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4191702|NCT00771537|4014692|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4191703|NCT00771537|4014693|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4191704|NCT00771537|4014677|B17||Female|Sex: Female, Male||Participants|Count of Participants|2031|2031.0||||||
4191705|NCT00771537|4014678|B16||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4191706|NCT00771537|4014679|B15||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4191707|NCT00771537|4014680|B14||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4191708|NCT00771537|4014681|B13||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4191709|NCT00771537|4014682|B12||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4191710|NCT00771537|4014683|B11||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4191711|NCT00771537|4014684|B10||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4191712|NCT00771537|4014685|B9||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4191713|NCT00771537|4014686|B8||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4191714|NCT00771537|4014687|B7||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4191715|NCT00771537|4014688|B6||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4191716|NCT00771537|4014689|B5||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4191717|NCT00771537|4014690|B4||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4191718|NCT00771537|4014691|B3||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4191719|NCT00771537|4014692|B2||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4191720|NCT00771537|4014693|B1||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4191721|NCT00771537|4014677|B17|||Age||years|Mean|44|44.0|Standard Deviation|13|13.0|||
4191722|NCT00771537|4014678|B16|||Age||years|Mean|42|42.0|Standard Deviation|13|13.0|||
4191723|NCT00771537|4014679|B15|||Age||years|Mean|44|44.0|Standard Deviation|12|12.0|||
4191724|NCT00771537|4014680|B14|||Age||years|Mean|44|44.0|Standard Deviation|13|13.0|||
4191725|NCT00771537|4014681|B13|||Age||years|Mean|46|46.0|Standard Deviation|13|13.0|||
4191726|NCT00771537|4014682|B12|||Age||years|Mean|43|43.0|Standard Deviation|13|13.0|||
4191727|NCT00771537|4014683|B11|||Age||years|Mean|44|44.0|Standard Deviation|13|13.0|||
4191728|NCT00771537|4014684|B10|||Age||years|Mean|44|44.0|Standard Deviation|13|13.0|||
4191729|NCT00771537|4014685|B9|||Age||years|Mean|42|42.0|Standard Deviation|13|13.0|||
4191730|NCT00771537|4014686|B8|||Age||years|Mean|45|45.0|Standard Deviation|14|14.0|||
4191731|NCT00771537|4014687|B7|||Age||years|Mean|44|44.0|Standard Deviation|14|14.0|||
4191732|NCT00771537|4014688|B6|||Age||years|Mean|44|44.0|Standard Deviation|12|12.0|||
4191733|NCT00771537|4014689|B5|||Age||years|Mean|44|44.0|Standard Deviation|13|13.0|||
4191734|NCT00771537|4014690|B4|||Age||years|Mean|45|45.0|Standard Deviation|15|15.0|||
4191735|NCT00771537|4014691|B3|||Age||years|Mean|47|47.0|Standard Deviation|13|13.0|||
4191736|NCT00771537|4014692|B2|||Age||years|Mean|44|44.0|Standard Deviation|14|14.0|||
4191737|NCT00771537|4014693|B1|||Age||years|Mean|42|42.0|Standard Deviation|14|14.0|||
4191738|NCT00771537|4014677|B17||>=65 years|Age||Participants|Count of Participants|112|112.0||||||
4191739|NCT00771537|4014678|B16||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4191740|NCT00771537|4014679|B15||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4191741|NCT00771537|4014680|B14||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4191742|NCT00771537|4014681|B13||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4191743|NCT00771537|4014682|B12||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4191744|NCT00771537|4014683|B11||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4191745|NCT00771537|4014684|B10||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4191746|NCT00771537|4014685|B9||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4191747|NCT00771537|4014686|B8||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4191748|NCT00771537|4014687|B7||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4191749|NCT00771537|4014688|B6||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4191750|NCT00771537|4014689|B5||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4191751|NCT00771537|4014690|B4||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4191752|NCT00771537|4014691|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4191753|NCT00771537|4014692|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4191754|NCT00771537|4014693|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4191755|NCT00771537|4014677|B17||Between 18 and 65 years|Age||Participants|Count of Participants|1909|1909.0||||||
4191756|NCT00771537|4014678|B16||Between 18 and 65 years|Age||Participants|Count of Participants|119|119.0||||||
4191757|NCT00771537|4014679|B15||Between 18 and 65 years|Age||Participants|Count of Participants|118|118.0||||||
4191758|NCT00771537|4014680|B14||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
4191759|NCT00771537|4014681|B13||Between 18 and 65 years|Age||Participants|Count of Participants|118|118.0||||||
4191760|NCT00771537|4014682|B12||Between 18 and 65 years|Age||Participants|Count of Participants|128|128.0||||||
4191761|NCT00771537|4014683|B11||Between 18 and 65 years|Age||Participants|Count of Participants|126|126.0||||||
4191762|NCT00771537|4014684|B10||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
4191763|NCT00771537|4014685|B9||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
4191764|NCT00771537|4014686|B8||Between 18 and 65 years|Age||Participants|Count of Participants|124|124.0||||||
4191765|NCT00771537|4014687|B7||Between 18 and 65 years|Age||Participants|Count of Participants|121|121.0||||||
4191766|NCT00771537|4014688|B6||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
4191767|NCT00771537|4014689|B5||Between 18 and 65 years|Age||Participants|Count of Participants|119|119.0||||||
4191768|NCT00771537|4014690|B4||Between 18 and 65 years|Age||Participants|Count of Participants|104|104.0||||||
4191769|NCT00771537|4014691|B3||Between 18 and 65 years|Age||Participants|Count of Participants|137|137.0||||||
4191770|NCT00771537|4014692|B2||Between 18 and 65 years|Age||Participants|Count of Participants|115|115.0||||||
4191771|NCT00771537|4014693|B1||Between 18 and 65 years|Age||Participants|Count of Participants|126|126.0||||||
4191772|NCT00771537|4014677|B17||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4191773|NCT00771537|4014678|B16||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191774|NCT00771537|4014679|B15||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191775|NCT00771537|4014680|B14||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191776|NCT00771537|4014681|B13||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191777|NCT00771537|4014682|B12||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4191778|NCT00771537|4014683|B11||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4191779|NCT00771537|4014684|B10||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191780|NCT00771537|4014685|B9||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4191781|NCT00771537|4014686|B8||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4191782|NCT00771537|4014687|B7||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4191783|NCT00771537|4014688|B6||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4191784|NCT00771537|4014689|B5||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4191785|NCT00771537|4014690|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191786|NCT00771537|4014691|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191787|NCT00771537|4014692|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4191788|NCT00771537|4014693|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191789|NCT00771472|4014734|B1|Japan||Region of Enrollment||participants|Number|10|10.0||||||
4191790|NCT00771472|4014734|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4191791|NCT00771472|4014734|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4191792|NCT00771472|4014734|B1|||Age||years|Mean|55.5|55.5|Standard Deviation|12.0|12.0|||
4191793|NCT00771407|4014744|B3|United States||Region of Enrollment||participants|Number|113|113.0||||||
4191794|NCT00771407|4014745|B2|United States||Region of Enrollment||participants|Number|58|58.0||||||
4191795|NCT00771407|4014746|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4191796|NCT00771407|4014744|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4191797|NCT00771407|4014745|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191798|NCT00771407|4014746|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4191799|NCT00771407|4014744|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191800|NCT00771407|4014745|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191801|NCT00771407|4014746|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191802|NCT00771407|4014744|B3||White|Race (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
4191803|NCT00771407|4014745|B2||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4191804|NCT00771407|4014746|B1||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4191805|NCT00771407|4014744|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4191806|NCT00771407|4014745|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4191807|NCT00771407|4014746|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4191808|NCT00771407|4014744|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191809|NCT00771407|4014745|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191810|NCT00771407|4014746|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191811|NCT00771407|4014744|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191812|NCT00771407|4014745|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191813|NCT00771407|4014746|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191814|NCT00771407|4014744|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191815|NCT00771407|4014745|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191816|NCT00771407|4014746|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191817|NCT00771407|4014744|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4191818|NCT00771407|4014745|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4191819|NCT00771407|4014746|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4191820|NCT00771407|4014744|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4191821|NCT00771407|4014745|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4191822|NCT00771407|4014746|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4191823|NCT00771407|4014744|B3|||Age||years|Mean|59.7|59.7|Standard Deviation|13.97|13.97|||
4191824|NCT00771407|4014745|B2|||Age||years|Mean|59.14|59.14|Standard Deviation|14.36|14.36|||
4191825|NCT00771407|4014746|B1|||Age||years|Mean|60.25|60.25|Standard Deviation|13.65|13.65|||
4191826|NCT00771316|4014753|B3|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4191827|NCT00771316|4014754|B2|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4191828|NCT00771316|4014755|B1|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4191829|NCT00771316|4014753|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4191830|NCT00771316|4014754|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4191831|NCT00771316|4014755|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4191832|NCT00771316|4014753|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4191833|NCT00771316|4014754|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4191834|NCT00771316|4014755|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4191835|NCT00771316|4014753|B3|||Age||years|Mean|44.5|44.5|Full Range|||21.0|58.0|
4191836|NCT00771316|4014754|B2|||Age||years|Mean|58|58.0|Full Range|||58.0|58.0|
4191837|NCT00771316|4014755|B1|||Age||years|Mean|37.75|37.75|Full Range|||21.0|50.0|
4191838|NCT00771277|4014766|B1|grandmother||Relationship to patients||participants|Number|1|1.0||||||
4191839|NCT00771277|4014766|B1|husband||Relationship to patients||participants|Number|1|1.0||||||
4191840|NCT00771277|4014766|B1|wife||Relationship to patients||participants|Number|4|4.0||||||
4191841|NCT00771277|4014766|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4191842|NCT00771277|4014766|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4191843|NCT00771277|4014766|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4191844|NCT00771277|4014766|B1|||Age||years|Mean|45.3|45.3|Full Range|||32.0|71.0|
4191845|NCT00771264|4014772|B3|United States||Region of Enrollment||participants|Number|220|220.0||||||
4191846|NCT00771264|4014773|B2|United States||Region of Enrollment||participants|Number|110|110.0||||||
4191847|NCT00771264|4014774|B1|United States||Region of Enrollment||participants|Number|110|110.0||||||
4191848|NCT00771264|4014772|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4191849|NCT00771264|4014773|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4191850|NCT00771264|4014774|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4191851|NCT00771264|4014772|B3||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4191852|NCT00771264|4014773|B2||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4191853|NCT00771264|4014774|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4191854|NCT00771264|4014772|B3|||Age||years|Mean|61.3|61.3|Standard Deviation|14.9|14.9|||
4191855|NCT00771264|4014773|B2|||Age||years|Mean|60.2|60.2|Standard Deviation|15.2|15.2|||
4191856|NCT00771264|4014774|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|14.6|14.6|||
4191857|NCT00771264|4014772|B3||>=65 years|Age||Participants|Count of Participants|102|102.0||||||
4191858|NCT00771264|4014773|B2||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
4191859|NCT00771264|4014774|B1||>=65 years|Age||Participants|Count of Participants|56|56.0||||||
4191860|NCT00771264|4014772|B3||Between 18 and 65 years|Age||Participants|Count of Participants|118|118.0||||||
4191861|NCT00771264|4014773|B2||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4191862|NCT00771264|4014774|B1||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4191863|NCT00771264|4014772|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191864|NCT00771264|4014773|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191865|NCT00771264|4014774|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191866|NCT00771238|4014781|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4191867|NCT00771238|4014782|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4191868|NCT00771238|4014783|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4191869|NCT00771238|4014781|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4191870|NCT00771238|4014782|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4191871|NCT00771238|4014783|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4191872|NCT00771238|4014781|B3|||Age||Years|Mean|59.1|59.1|Standard Deviation|15.3|15.3|||
4191873|NCT00771238|4014782|B2|||Age||Years|Mean|54.8|54.8|Standard Deviation|19.1|19.1|||
4191874|NCT00771238|4014783|B1|||Age||Years|Mean|62.1|62.1|Standard Deviation|11.4|11.4|||
4191875|NCT00771173|4014792|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191876|NCT00771173|4014793|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191877|NCT00771173|4014794|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191878|NCT00771173|4014792|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4191879|NCT00771173|4014793|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4191880|NCT00771173|4014794|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4191881|NCT00771173|4014792|B3||White|Race (NIH/OMB)||Participants|Count of Participants|208|208.0||||||
4191882|NCT00771173|4014793|B2||White|Race (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
4191883|NCT00771173|4014794|B1||White|Race (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
4191884|NCT00771173|4014792|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4191885|NCT00771173|4014793|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4191886|NCT00771173|4014794|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4191887|NCT00771173|4014792|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191888|NCT00771173|4014793|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191889|NCT00771173|4014794|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191890|NCT00771173|4014792|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191891|NCT00771173|4014793|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191892|NCT00771173|4014794|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191893|NCT00771173|4014792|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191894|NCT00771173|4014793|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191895|NCT00771173|4014794|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191896|NCT00771173|4014792|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191897|NCT00771173|4014793|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191898|NCT00771173|4014794|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191899|NCT00771173|4014792|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|255|255.0||||||
4191900|NCT00771173|4014793|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
4191901|NCT00771173|4014794|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
4191902|NCT00771173|4014792|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4191903|NCT00771173|4014793|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4191904|NCT00771173|4014794|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4191905|NCT00771173|4014792|B3|Women||Sex/Gender, Customized||participants|Number|258|258.0||||||
4191906|NCT00771173|4014793|B2|Women||Sex/Gender, Customized||participants|Number|129|129.0||||||
4191907|NCT00771173|4014794|B1|Women||Sex/Gender, Customized||participants|Number|129|129.0||||||
4191908|NCT00771173|4014792|B3|||Age||years|Mean|54|54.0|Full Range|||40.0|75.0|
4191909|NCT00771173|4014793|B2|||Age||years|Mean|53|53.0|Full Range|||40.0|75.0|
4191910|NCT00771173|4014794|B1|||Age||years|Mean|54|54.0|Full Range|||40.0|75.0|
4191911|NCT00771056|4014801|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4191912|NCT00771056|4014801|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4191913|NCT00771056|4014801|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4191914|NCT00771056|4014801|B1|||Age||years|Mean|59|59.0|Full Range|||44.0|77.0|
4191915|NCT00771056|4014801|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4191916|NCT00771056|4014801|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4191917|NCT00771056|4014801|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191918|NCT00770991|4014806|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4191919|NCT00770991|4014807|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4191920|NCT00770991|4014808|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4191921|NCT00770991|4014806|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4191922|NCT00770991|4014807|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4191923|NCT00770991|4014808|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4191924|NCT00770991|4014806|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4191925|NCT00770991|4014807|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4191926|NCT00770991|4014808|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4191927|NCT00770991|4014806|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4191928|NCT00770991|4014807|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4191929|NCT00770991|4014808|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4191930|NCT00770991|4014806|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4191931|NCT00770991|4014807|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4191932|NCT00770991|4014808|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4191933|NCT00770991|4014806|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191934|NCT00770991|4014807|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191935|NCT00770991|4014808|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191936|NCT00770965|4014821|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4191937|NCT00770965|4014822|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4191938|NCT00770965|4014823|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4191939|NCT00770965|4014824|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4191940|NCT00770965|4014825|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4191941|NCT00770965|4014821|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4191942|NCT00770965|4014822|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4191943|NCT00770965|4014823|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4191944|NCT00770965|4014824|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4191945|NCT00770965|4014825|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4191946|NCT00770965|4014821|B5|||Age||Years|Mean|52.5|52.5|Standard Deviation|10.38|10.38|||
4191947|NCT00770965|4014822|B4|||Age||Years|Mean|52.4|52.4|Standard Deviation|14.05|14.05|||
4191948|NCT00770965|4014823|B3|||Age||Years|Mean|51.5|51.5|Standard Deviation|8.35|8.35|||
4191949|NCT00770965|4014824|B2|||Age||Years|Mean|53.3|53.3|Standard Deviation|11.79|11.79|||
4191950|NCT00770965|4014825|B1|||Age||Years|Mean|53.5|53.5|Standard Deviation|9.19|9.19|||
4191951|NCT00770913|4014846|B4|Asian||Race/Ethnicity, Customized||participants|Number|332|332.0||||||
4191952|NCT00770913|4014847|B3|Asian||Race/Ethnicity, Customized||participants|Number|111|111.0||||||
4191953|NCT00770913|4014848|B2|Asian||Race/Ethnicity, Customized||participants|Number|111|111.0||||||
4191954|NCT00770913|4014849|B1|Asian||Race/Ethnicity, Customized||participants|Number|110|110.0||||||
4191955|NCT00770913|4014846|B4||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4191956|NCT00770913|4014847|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4191957|NCT00770913|4014848|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4191958|NCT00770913|4014849|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4191959|NCT00770913|4014846|B4||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4191960|NCT00770913|4014847|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4191961|NCT00770913|4014848|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4191962|NCT00770913|4014849|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4191963|NCT00770913|4014846|B4|||Age|Full Analysis Population|years|Mean|65.5|65.5|Standard Deviation|13.6|13.6|||
4191964|NCT00770913|4014847|B3|||Age|Full Analysis Population|years|Mean|66.6|66.6|Standard Deviation|13.8|13.8|||
4191965|NCT00770913|4014848|B2|||Age|Full Analysis Population|years|Mean|65.5|65.5|Standard Deviation|13.3|13.3|||
4191966|NCT00770913|4014849|B1|||Age|Full Analysis Population|years|Mean|64.5|64.5|Standard Deviation|13.9|13.9|||
4191967|NCT00770861|4014859|B3|Puerto Rico||Region of Enrollment||participants|Number|12|12.0||||||
4191968|NCT00770861|4014860|B2|Puerto Rico||Region of Enrollment||participants|Number|5|5.0||||||
4191969|NCT00770861|4014861|B1|Puerto Rico||Region of Enrollment||participants|Number|7|7.0||||||
4191970|NCT00770861|4014859|B3|United States||Region of Enrollment||participants|Number|265|265.0||||||
4191971|NCT00770861|4014860|B2|United States||Region of Enrollment||participants|Number|131|131.0||||||
4191972|NCT00770861|4014861|B1|United States||Region of Enrollment||participants|Number|134|134.0||||||
4191973|NCT00770861|4014859|B3||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4191974|NCT00770861|4014860|B2||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4191975|NCT00770861|4014861|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4191976|NCT00770861|4014859|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4191977|NCT00770861|4014860|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4191978|NCT00770861|4014861|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4191979|NCT00770861|4014859|B3|||Age||years|Mean|50.4|50.4|Standard Deviation|8.7|8.7|||
4191980|NCT00770861|4014860|B2|||Age||years|Mean|50.4|50.4|Standard Deviation|8.7|8.7|||
4191981|NCT00770861|4014861|B1|||Age||years|Mean|50.4|50.4|Standard Deviation|8.7|8.7|||
4191982|NCT00770861|4014859|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4191983|NCT00770861|4014860|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4191984|NCT00770861|4014861|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4191985|NCT00770861|4014859|B3||Between 18 and 65 years|Age||Participants|Count of Participants|264|264.0||||||
4191986|NCT00770861|4014860|B2||Between 18 and 65 years|Age||Participants|Count of Participants|129|129.0||||||
4191987|NCT00770861|4014861|B1||Between 18 and 65 years|Age||Participants|Count of Participants|135|135.0||||||
4191988|NCT00770861|4014859|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191989|NCT00770861|4014860|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191990|NCT00770861|4014861|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4191991|NCT00770809|4014870|B4|ER/PgR or Negative||Hormone Receptor Status||participants|Number|126|126.0||||||
4191992|NCT00770809|4014871|B3|ER/PgR or Negative||Hormone Receptor Status||participants|Number|28|28.0||||||
4191993|NCT00770809|4014872|B2|ER/PgR or Negative||Hormone Receptor Status||participants|Number|50|50.0||||||
4191994|NCT00770809|4014873|B1|ER/PgR or Negative||Hormone Receptor Status||participants|Number|48|48.0||||||
4191995|NCT00770809|4014870|B4|ER/PgR Positive||Hormone Receptor Status||participants|Number|179|179.0||||||
4191996|NCT00770809|4014871|B3|ER/PgR Positive||Hormone Receptor Status||participants|Number|39|39.0||||||
4191997|NCT00770809|4014872|B2|ER/PgR Positive||Hormone Receptor Status||participants|Number|70|70.0||||||
4191998|NCT00770809|4014873|B1|ER/PgR Positive||Hormone Receptor Status||participants|Number|70|70.0||||||
4191999|NCT00770809|4014870|B4|Stage III||Clinical Stage|The American Joint Committee on Cancer (AJCC) has designated staging by tumor, node, and metastasis (TNM) classification. Stage II participants had primary tumors 0-5 cm and no regional lymph node metastases or metastases to movable ipsilateral level I, II axillary lymph node or primary tumors > 5.1 cm and no regional lymph node metastases. Stage III participants had primary tumors of any size but not any metastases in ipsilateral infraclavicular (level III axillary) lymph node(s) with or without level I, II axillary lymph node involvement|participants|Number|96|96.0||||||
4192000|NCT00770809|4014871|B3|Stage III||Clinical Stage|The American Joint Committee on Cancer (AJCC) has designated staging by tumor, node, and metastasis (TNM) classification. Stage II participants had primary tumors 0-5 cm and no regional lymph node metastases or metastases to movable ipsilateral level I, II axillary lymph node or primary tumors > 5.1 cm and no regional lymph node metastases. Stage III participants had primary tumors of any size but not any metastases in ipsilateral infraclavicular (level III axillary) lymph node(s) with or without level I, II axillary lymph node involvement|participants|Number|19|19.0||||||
4192001|NCT00770809|4014872|B2|Stage III||Clinical Stage|The American Joint Committee on Cancer (AJCC) has designated staging by tumor, node, and metastasis (TNM) classification. Stage II participants had primary tumors 0-5 cm and no regional lymph node metastases or metastases to movable ipsilateral level I, II axillary lymph node or primary tumors > 5.1 cm and no regional lymph node metastases. Stage III participants had primary tumors of any size but not any metastases in ipsilateral infraclavicular (level III axillary) lymph node(s) with or without level I, II axillary lymph node involvement|participants|Number|40|40.0||||||
4192002|NCT00770809|4014873|B1|Stage III||Clinical Stage|The American Joint Committee on Cancer (AJCC) has designated staging by tumor, node, and metastasis (TNM) classification. Stage II participants had primary tumors 0-5 cm and no regional lymph node metastases or metastases to movable ipsilateral level I, II axillary lymph node or primary tumors > 5.1 cm and no regional lymph node metastases. Stage III participants had primary tumors of any size but not any metastases in ipsilateral infraclavicular (level III axillary) lymph node(s) with or without level I, II axillary lymph node involvement|participants|Number|37|37.0||||||
4192003|NCT00770809|4014870|B4|Stage II||Clinical Stage|The American Joint Committee on Cancer (AJCC) has designated staging by tumor, node, and metastasis (TNM) classification. Stage II participants had primary tumors 0-5 cm and no regional lymph node metastases or metastases to movable ipsilateral level I, II axillary lymph node or primary tumors > 5.1 cm and no regional lymph node metastases. Stage III participants had primary tumors of any size but not any metastases in ipsilateral infraclavicular (level III axillary) lymph node(s) with or without level I, II axillary lymph node involvement|participants|Number|209|209.0||||||
4192004|NCT00770809|4014871|B3|Stage II||Clinical Stage|The American Joint Committee on Cancer (AJCC) has designated staging by tumor, node, and metastasis (TNM) classification. Stage II participants had primary tumors 0-5 cm and no regional lymph node metastases or metastases to movable ipsilateral level I, II axillary lymph node or primary tumors > 5.1 cm and no regional lymph node metastases. Stage III participants had primary tumors of any size but not any metastases in ipsilateral infraclavicular (level III axillary) lymph node(s) with or without level I, II axillary lymph node involvement|participants|Number|48|48.0||||||
4192005|NCT00770809|4014872|B2|Stage II||Clinical Stage|The American Joint Committee on Cancer (AJCC) has designated staging by tumor, node, and metastasis (TNM) classification. Stage II participants had primary tumors 0-5 cm and no regional lymph node metastases or metastases to movable ipsilateral level I, II axillary lymph node or primary tumors > 5.1 cm and no regional lymph node metastases. Stage III participants had primary tumors of any size but not any metastases in ipsilateral infraclavicular (level III axillary) lymph node(s) with or without level I, II axillary lymph node involvement|participants|Number|80|80.0||||||
4192006|NCT00770809|4014873|B1|Stage II||Clinical Stage|The American Joint Committee on Cancer (AJCC) has designated staging by tumor, node, and metastasis (TNM) classification. Stage II participants had primary tumors 0-5 cm and no regional lymph node metastases or metastases to movable ipsilateral level I, II axillary lymph node or primary tumors > 5.1 cm and no regional lymph node metastases. Stage III participants had primary tumors of any size but not any metastases in ipsilateral infraclavicular (level III axillary) lymph node(s) with or without level I, II axillary lymph node involvement|participants|Number|81|81.0||||||
4192007|NCT00770809|4014870|B4|United States||Region of Enrollment||participants|Number|305|305.0||||||
4192008|NCT00770809|4014871|B3|United States||Region of Enrollment||participants|Number|67|67.0||||||
4192009|NCT00770809|4014872|B2|United States||Region of Enrollment||participants|Number|120|120.0||||||
4192010|NCT00770809|4014873|B1|United States||Region of Enrollment||participants|Number|118|118.0||||||
4192011|NCT00770809|4014870|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4192012|NCT00770809|4014871|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4192013|NCT00770809|4014872|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4192014|NCT00770809|4014873|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4192015|NCT00770809|4014870|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4192016|NCT00770809|4014871|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192017|NCT00770809|4014872|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192018|NCT00770809|4014873|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4192019|NCT00770809|4014870|B4||White|Race (NIH/OMB)||Participants|Count of Participants|243|243.0||||||
4192020|NCT00770809|4014871|B3||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4192021|NCT00770809|4014872|B2||White|Race (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
4192022|NCT00770809|4014873|B1||White|Race (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
4192023|NCT00770809|4014870|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4192024|NCT00770809|4014871|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4192025|NCT00770809|4014872|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4192026|NCT00770809|4014873|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4192027|NCT00770809|4014870|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4192028|NCT00770809|4014871|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192029|NCT00770809|4014872|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4192030|NCT00770809|4014873|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192031|NCT00770809|4014870|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4192032|NCT00770809|4014871|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4192033|NCT00770809|4014872|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4192034|NCT00770809|4014873|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4192035|NCT00770809|4014870|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4192036|NCT00770809|4014871|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192037|NCT00770809|4014872|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4192038|NCT00770809|4014873|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4192039|NCT00770809|4014870|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4192040|NCT00770809|4014871|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4192041|NCT00770809|4014872|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4192042|NCT00770809|4014873|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4192043|NCT00770809|4014870|B4||Female|Sex: Female, Male||Participants|Count of Participants|303|303.0||||||
4192044|NCT00770809|4014871|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4192045|NCT00770809|4014872|B2||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4192046|NCT00770809|4014873|B1||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4192047|NCT00770809|4014870|B4|||Age||years|Median|49.4|49.4|Full Range|||24.7|75.8|
4192048|NCT00770809|4014871|B3|||Age||years|Median|48.3|48.3|Full Range|||25.8|74.3|
4192049|NCT00770809|4014872|B2|||Age||years|Median|50.3|50.3|Full Range|||30.2|75.8|
4192050|NCT00770809|4014873|B1|||Age||years|Median|48.5|48.5|Full Range|||24.7|70.8|
4192051|NCT00770770|4014883|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4192052|NCT00770770|4014884|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4192053|NCT00770770|4014885|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4192054|NCT00770770|4014883|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4192055|NCT00770770|4014884|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4192056|NCT00770770|4014885|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4192057|NCT00770770|4014883|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4192058|NCT00770770|4014884|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4192059|NCT00770770|4014885|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4192060|NCT00770770|4014883|B3|≥85 years||Age, Customized||participants|Number|2|2.0||||||
4192061|NCT00770770|4014884|B2|≥85 years||Age, Customized||participants|Number|1|1.0||||||
4192062|NCT00770770|4014885|B1|≥85 years||Age, Customized||participants|Number|1|1.0||||||
4192063|NCT00770770|4014883|B3|75-85 years||Age, Customized||participants|Number|5|5.0||||||
4192064|NCT00770770|4014884|B2|75-85 years||Age, Customized||participants|Number|3|3.0||||||
4192065|NCT00770770|4014885|B1|75-85 years||Age, Customized||participants|Number|2|2.0||||||
4192066|NCT00770770|4014883|B3|65-75 years||Age, Customized||participants|Number|6|6.0||||||
4192067|NCT00770770|4014884|B2|65-75 years||Age, Customized||participants|Number|0|0.0||||||
4192068|NCT00770770|4014885|B1|65-75 years||Age, Customized||participants|Number|6|6.0||||||
4192069|NCT00770770|4014883|B3|55-65 years||Age, Customized||participants|Number|5|5.0||||||
4192070|NCT00770770|4014884|B2|55-65 years||Age, Customized||participants|Number|2|2.0||||||
4192071|NCT00770770|4014885|B1|55-65 years||Age, Customized||participants|Number|3|3.0||||||
4192072|NCT00770770|4014883|B3|45-55 years||Age, Customized||participants|Number|2|2.0||||||
4192073|NCT00770770|4014884|B2|45-55 years||Age, Customized||participants|Number|0|0.0||||||
4192074|NCT00770770|4014885|B1|45-55 years||Age, Customized||participants|Number|2|2.0||||||
4192075|NCT00770770|4014883|B3|35-45 years||Age, Customized||participants|Number|0|0.0||||||
4192076|NCT00770770|4014884|B2|35-45 years||Age, Customized||participants|Number|0|0.0||||||
4192077|NCT00770770|4014885|B1|35-45 years||Age, Customized||participants|Number|0|0.0||||||
4192078|NCT00770770|4014883|B3|<35 years||Age, Customized||participants|Number|0|0.0||||||
4192079|NCT00770770|4014884|B2|<35 years||Age, Customized||participants|Number|0|0.0||||||
4192080|NCT00770770|4014885|B1|<35 years||Age, Customized||participants|Number|0|0.0||||||
4192081|NCT00770770|4014883|B3|||Age||years|Mean|69.30|69.3|Standard Deviation|10.589|10.589|||
4192082|NCT00770770|4014884|B2|||Age||years|Mean|73.52|73.52|Standard Deviation|13.091|13.091|||
4192083|NCT00770770|4014885|B1|||Age||years|Mean|67.50|67.5|Standard Deviation|9.287|9.287|||
4192084|NCT00770757|4014892|B1|Lungs||Major organ-systems involved||participants|Number|8|8.0||||||
4192085|NCT00770757|4014892|B1|Mouth||Major organ-systems involved||participants|Number|9|9.0||||||
4192086|NCT00770757|4014892|B1|Joint and Fascia||Major organ-systems involved||participants|Number|10|10.0||||||
4192087|NCT00770757|4014892|B1|Eyes||Major organ-systems involved||participants|Number|10|10.0||||||
4192088|NCT00770757|4014892|B1|Skin||Major organ-systems involved||participants|Number|13|13.0||||||
4192089|NCT00770757|4014892|B1|||Years since chronic graft-versus-host disease||years|Median|1.5|1.5|Full Range|||0.5|14.0|
4192090|NCT00770757|4014892|B1|||Years post-transplant||years|Median|2.5|2.5|Full Range|||1.5|15.0|
4192091|NCT00770757|4014892|B1|||Number of prior therapies||number of prior therapies|Median|4|4.0|Full Range|||2.0|5.0|
4192144|NCT00770588|4015010|B3||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4192092|NCT00770757|4014892|B1|Moderate||Global chronic graft-versus-host disease score|"Mild - Only 1 or 2 organs or site (except the lung) No clinically significant functional impairment (maximum of score 1 in all affected organs or sites)~Moderate - At least 1 organ or site with clinically significant but no major disability (maximum score of 2 in any affected organ or site), or 3 or more organs or sites with no clinically significant functional impairment (maximum score of 1 in all affected organs or sites)~Severe - Major disability caused by chronic GvHD (score of 3 in any organ or site) Lung function score ≥ 2"|participants|Number|2|2.0||||||
4192093|NCT00770757|4014892|B1|Severe||Global chronic graft-versus-host disease score|"Mild - Only 1 or 2 organs or site (except the lung) No clinically significant functional impairment (maximum of score 1 in all affected organs or sites)~Moderate - At least 1 organ or site with clinically significant but no major disability (maximum score of 2 in any affected organ or site), or 3 or more organs or sites with no clinically significant functional impairment (maximum score of 1 in all affected organs or sites)~Severe - Major disability caused by chronic GvHD (score of 3 in any organ or site) Lung function score ≥ 2"|participants|Number|11|11.0||||||
4192094|NCT00770757|4014892|B1|Quiescent||Chronic graft-versus-host disease onset||participants|Number|7|7.0||||||
4192095|NCT00770757|4014892|B1|Progressive||Chronic graft-versus-host disease onset||participants|Number|1|1.0||||||
4192096|NCT00770757|4014892|B1|De novo||Chronic graft-versus-host disease onset||participants|Number|5|5.0||||||
4192097|NCT00770757|4014892|B1|||Karnofsky performance status|"90 Able to carry on normal activity; Minor signs or symptoms of disease.~80 Normal activity with efforts; some signs or symptoms of disease.~70 Cares for self; unable to carry on normal activity or to do active work.~60 Requires occasional assistance, but is able to care for most of his personal needs."|scores on a scale|Median|80|80.0|Full Range|||60.0|90.0|
4192098|NCT00770757|4014892|B1|Matched unrelated donor||Donor type||participants|Number|6|6.0||||||
4192099|NCT00770757|4014892|B1|Matched related donor||Donor type||participants|Number|7|7.0||||||
4192100|NCT00770757|4014892|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4192101|NCT00770757|4014892|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4192102|NCT00770757|4014892|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4192103|NCT00770757|4014892|B1|||Age||years|Median|46|46.0|Full Range|||27.0|64.0|
4192104|NCT00770692|4014900|B5||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4192105|NCT00770692|4014901|B4||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4192106|NCT00770692|4014902|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4192107|NCT00770692|4014903|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4192108|NCT00770692|4014904|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4192109|NCT00770692|4014900|B5||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4192110|NCT00770692|4014901|B4||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4192111|NCT00770692|4014902|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4192112|NCT00770692|4014903|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4192113|NCT00770692|4014904|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4192114|NCT00770692|4014900|B5|||Age||years|Mean|55.6|55.6|Standard Deviation|17.1|17.1|||
4192115|NCT00770692|4014901|B4|||Age||years|Mean|41.9|41.9|Standard Deviation|11.5|11.5|||
4192116|NCT00770692|4014902|B3|||Age||years|Mean|40.1|40.1|Standard Deviation|10.8|10.8|||
4192117|NCT00770692|4014903|B2|||Age||years|Mean|70.7|70.7|Standard Deviation|4.7|4.7|||
4192118|NCT00770692|4014904|B1|||Age||years|Mean|70.4|70.4|Standard Deviation|4.5|4.5|||
4192119|NCT00770679|4014933|B1|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4192120|NCT00770679|4014933|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4192121|NCT00770679|4014933|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4192122|NCT00770679|4014933|B1|>=40, <=90, years||Age, Customized||Participants|Count of Participants|16|16.0||||||
4192123|NCT00770653|4014939|B3|Germany||Region of Enrollment||participants|Number|302|302.0||||||
4192124|NCT00770653|4014940|B2|Germany||Region of Enrollment||participants|Number|149|149.0||||||
4192125|NCT00770653|4014941|B1|Germany||Region of Enrollment||participants|Number|153|153.0||||||
4192126|NCT00770653|4014939|B3||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4192127|NCT00770653|4014940|B2||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4192128|NCT00770653|4014941|B1||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4192129|NCT00770653|4014939|B3||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4192130|NCT00770653|4014940|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4192131|NCT00770653|4014941|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4192132|NCT00770653|4014939|B3|||Age||years|Mean|58.6|58.6|Standard Deviation|9.8|9.8|||
4192133|NCT00770653|4014940|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|9.6|9.6|||
4192134|NCT00770653|4014941|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|10.0|10.0|||
4192135|NCT00770588|4015010|B3|current smoker||Smoking status||Participants|Number|24|24.0||||||
4192136|NCT00770588|4015011|B2|current smoker||Smoking status||Participants|Number|12|12.0||||||
4192137|NCT00770588|4015012|B1|current smoker||Smoking status||Participants|Number|12|12.0||||||
4192138|NCT00770588|4015010|B3|ex-smoker||Smoking status||Participants|Number|112|112.0||||||
4192139|NCT00770588|4015011|B2|ex-smoker||Smoking status||Participants|Number|55|55.0||||||
4192140|NCT00770588|4015012|B1|ex-smoker||Smoking status||Participants|Number|57|57.0||||||
4192141|NCT00770588|4015010|B3|non-smoker||Smoking status||Participants|Number|160|160.0||||||
4192142|NCT00770588|4015011|B2|non-smoker||Smoking status||Participants|Number|81|81.0||||||
4192143|NCT00770588|4015012|B1|non-smoker||Smoking status||Participants|Number|79|79.0||||||
4192145|NCT00770588|4015011|B2||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4192146|NCT00770588|4015012|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4192147|NCT00770588|4015010|B3||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4192148|NCT00770588|4015011|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4192149|NCT00770588|4015012|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4192150|NCT00770588|4015010|B3|>=75 years||Age, Customized||Participants|Number|2|2.0||||||
4192151|NCT00770588|4015011|B2|>=75 years||Age, Customized||Participants|Number|1|1.0||||||
4192152|NCT00770588|4015012|B1|>=75 years||Age, Customized||Participants|Number|1|1.0||||||
4192153|NCT00770588|4015010|B3|65-74 years||Age, Customized||Participants|Number|35|35.0||||||
4192154|NCT00770588|4015011|B2|65-74 years||Age, Customized||Participants|Number|17|17.0||||||
4192155|NCT00770588|4015012|B1|65-74 years||Age, Customized||Participants|Number|18|18.0||||||
4192156|NCT00770588|4015010|B3|45-64 years||Age, Customized||Participants|Number|215|215.0||||||
4192157|NCT00770588|4015011|B2|45-64 years||Age, Customized||Participants|Number|108|108.0||||||
4192158|NCT00770588|4015012|B1|45-64 years||Age, Customized||Participants|Number|107|107.0||||||
4192159|NCT00770588|4015010|B3|<45 years||Age, Customized||Participants|Number|44|44.0||||||
4192160|NCT00770588|4015011|B2|<45 years||Age, Customized||Participants|Number|22|22.0||||||
4192161|NCT00770588|4015012|B1|<45 years||Age, Customized||Participants|Number|22|22.0||||||
4192162|NCT00770562|4015027|B3||Male|Sex: Female, Male|Two participants were not accessed because they did not take the study drug after being randomized.|Participants|Count of Participants|41|41.0||||||
4192163|NCT00770562|4015028|B2||Male|Sex: Female, Male|Two participants were not accessed because they did not take the study drug after being randomized.|Participants|Count of Participants|22|22.0||||||
4192164|NCT00770562|4015029|B1||Male|Sex: Female, Male|Two participants were not accessed because they did not take the study drug after being randomized.|Participants|Count of Participants|19|19.0||||||
4192165|NCT00770562|4015027|B3||Female|Sex: Female, Male|Two participants were not accessed because they did not take the study drug after being randomized.|Participants|Count of Participants|60|60.0||||||
4192166|NCT00770562|4015028|B2||Female|Sex: Female, Male|Two participants were not accessed because they did not take the study drug after being randomized.|Participants|Count of Participants|27|27.0||||||
4192167|NCT00770562|4015029|B1||Female|Sex: Female, Male|Two participants were not accessed because they did not take the study drug after being randomized.|Participants|Count of Participants|33|33.0||||||
4192168|NCT00770562|4015027|B3|||Age||years|Mean|48.41|48.41|Standard Deviation|18.03|18.03|||
4192169|NCT00770562|4015028|B2|||Age||years|Mean|49|49.0|Standard Deviation|16|16.0|||
4192170|NCT00770562|4015029|B1|||Age||years|Mean|47|47.0|Standard Deviation|19|19.0|||
4192171|NCT00770510|4015041|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4192172|NCT00770510|4015041|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4192173|NCT00770510|4015041|B1|||Age||years|Mean|39.4|39.4|Standard Deviation|11.9|11.9|||
4192174|NCT00770484|4015078|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4192175|NCT00770484|4015079|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4192176|NCT00770484|4015080|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4192177|NCT00770484|4015078|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4192178|NCT00770484|4015079|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4192179|NCT00770484|4015080|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4192180|NCT00770484|4015078|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4192181|NCT00770484|4015079|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4192182|NCT00770484|4015080|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4192183|NCT00770484|4015078|B3|||Age||Years|Mean|32|32.0|Standard Deviation|3|3.0|||
4192184|NCT00770484|4015079|B2|||Age||Years|Mean|32|32.0|Standard Deviation|2|2.0|||
4192185|NCT00770484|4015080|B1|||Age||Years|Mean|31|31.0|Standard Deviation|3|3.0|||
4192186|NCT00770484|4015078|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4192187|NCT00770484|4015079|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4192188|NCT00770484|4015080|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4192189|NCT00770484|4015078|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4192190|NCT00770484|4015079|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4192191|NCT00770484|4015080|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4192192|NCT00770484|4015078|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4192193|NCT00770484|4015079|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4192194|NCT00770484|4015080|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4192195|NCT00770432|4015087|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4192196|NCT00770432|4015088|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4192197|NCT00770432|4015089|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4192198|NCT00770432|4015087|B3||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4192199|NCT00770432|4015088|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4192200|NCT00770432|4015089|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4192201|NCT00770432|4015087|B3|||Age||years|Mean|45.4|45.4|Standard Deviation|13.33|13.33|||
4192202|NCT00770432|4015088|B2|||Age||years|Mean|45.0|45.0|Standard Deviation|14.15|14.15|||
4192203|NCT00770432|4015089|B1|||Age||years|Mean|45.8|45.8|Standard Deviation|12.52|12.52|||
4192204|NCT00770367|4015096|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4192205|NCT00770367|4015097|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4192206|NCT00770367|4015098|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4192207|NCT00770367|4015096|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4192208|NCT00770367|4015097|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4192209|NCT00770367|4015098|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4192210|NCT00770367|4015096|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4192211|NCT00770367|4015097|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4192212|NCT00770367|4015098|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4192213|NCT00770367|4015096|B3|||Age||years|Mean|54|54.0|Standard Deviation|1.56|1.56|||
4192214|NCT00770367|4015097|B2|||Age||years|Mean|55.7|55.7|Standard Deviation|2.42|2.42|||
4192215|NCT00770367|4015098|B1|||Age||years|Mean|52.2|52.2|Standard Deviation|1.89|1.89|||
4192216|NCT00770367|4015096|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4192217|NCT00770367|4015097|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4192218|NCT00770367|4015098|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4192219|NCT00770367|4015096|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4192220|NCT00770367|4015097|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4192221|NCT00770367|4015098|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4192222|NCT00770367|4015096|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4192223|NCT00770367|4015097|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4192224|NCT00770367|4015098|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4192225|NCT00770341|4015107|B4|Japan||Region of Enrollment||participants|Number|121|121.0||||||
4192226|NCT00770341|4015108|B3|Japan||Region of Enrollment||participants|Number|11|11.0||||||
4192227|NCT00770341|4015109|B2|Japan||Region of Enrollment||participants|Number|22|22.0||||||
4192228|NCT00770341|4015110|B1|Japan||Region of Enrollment||participants|Number|88|88.0||||||
4192229|NCT00770341|4015107|B4||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4192230|NCT00770341|4015108|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4192231|NCT00770341|4015109|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4192232|NCT00770341|4015110|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4192233|NCT00770341|4015107|B4||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4192234|NCT00770341|4015108|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4192235|NCT00770341|4015109|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4192236|NCT00770341|4015110|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4192237|NCT00770341|4015107|B4|||Age|Age information was for all treated participants (N=121)|years|Mean|66.0|66.0|Standard Deviation|16.2|16.2|||
4192238|NCT00770341|4015108|B3|||Age|Age information was for all treated participants (N=121)|years|Mean|77.7|77.7|Standard Deviation|10.9|10.9|||
4192239|NCT00770341|4015109|B2|||Age|Age information was for all treated participants (N=121)|years|Mean|61.7|61.7|Standard Deviation|17.1|17.1|||
4192240|NCT00770341|4015110|B1|||Age|Age information was for all treated participants (N=121)|years|Mean|65.6|65.6|Standard Deviation|16.0|16.0|||
4192241|NCT00770328|4015136|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
4192242|NCT00770328|4015137|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4192243|NCT00770328|4015138|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4192244|NCT00770328|4015136|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4192245|NCT00770328|4015137|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4192246|NCT00770328|4015138|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4192247|NCT00770328|4015136|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4192248|NCT00770328|4015137|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4192249|NCT00770328|4015138|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4192250|NCT00770328|4015136|B3|||Age||years|Mean|38.2|38.2|Standard Deviation|1.9|1.9|||
4192251|NCT00770328|4015137|B2|||Age||years|Mean|38.6|38.6|Standard Deviation|2.5|2.5|||
4192252|NCT00770328|4015138|B1|||Age||years|Mean|37.7|37.7|Standard Deviation|3.1|3.1|||
4192253|NCT00770315|4015151|B5||Male|Gender||Participants|Count of Participants|384|384.0||||||
4192254|NCT00770315|4015152|B4||Male|Gender||Participants|Count of Participants|102|102.0||||||
4192255|NCT00770315|4015153|B3||Male|Gender||Participants|Count of Participants|103|103.0||||||
4192256|NCT00770315|4015154|B2||Male|Gender||Participants|Count of Participants|92|92.0||||||
4192257|NCT00770315|4015155|B1||Male|Gender||Participants|Count of Participants|87|87.0||||||
4192258|NCT00770315|4015151|B5||Female|Gender||Participants|Count of Participants|400|400.0||||||
4192259|NCT00770315|4015152|B4||Female|Gender||Participants|Count of Participants|96|96.0||||||
4192260|NCT00770315|4015153|B3||Female|Gender||Participants|Count of Participants|91|91.0||||||
4192261|NCT00770315|4015154|B2||Female|Gender||Participants|Count of Participants|103|103.0||||||
4192262|NCT00770315|4015155|B1||Female|Gender||Participants|Count of Participants|110|110.0||||||
4192263|NCT00770315|4015151|B5|||Age||years|Mean|36.4|36.4|Standard Deviation|8.73|8.73|||
4192264|NCT00770315|4015152|B4|||Age||years|Mean|36.7|36.7|Standard Deviation|8.54|8.54|||
4192265|NCT00770315|4015153|B3|||Age||years|Mean|35.6|35.6|Standard Deviation|8.75|8.75|||
4192266|NCT00770315|4015154|B2|||Age||years|Mean|36.9|36.9|Standard Deviation|8.80|8.8|||
4192267|NCT00770315|4015155|B1|||Age||years|Mean|36.2|36.2|Standard Deviation|8.83|8.83|||
4192268|NCT00770289|4015184|B1|Not available||Sex/Gender, Customized||participants|Number|1|1.0||||||
4192269|NCT00770289|4015184|B1|Male||Sex/Gender, Customized||participants|Number|322|322.0||||||
4192270|NCT00770289|4015184|B1|Female||Sex/Gender, Customized||participants|Number|528|528.0||||||
4192271|NCT00770289|4015184|B1|||Age|Out of 851 participants, data for the baseline measure, age, was available only for 849 participants.|years|Mean|46.2|46.2|Standard Deviation|13.2|13.2|||
4192272|NCT00770224|4015193|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4192273|NCT00770224|4015193|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192274|NCT00770224|4015193|B1||White|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
4192275|NCT00770224|4015193|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4192276|NCT00770224|4015193|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4192277|NCT00770224|4015193|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192278|NCT00770224|4015193|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192279|NCT00770224|4015193|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4192280|NCT00770224|4015193|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
4192281|NCT00770224|4015193|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4192282|NCT00770224|4015193|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4192283|NCT00770224|4015193|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4192284|NCT00770224|4015193|B1|||Age||years|Median|52.3|52.3|Full Range|||28.9|79.9|
4192285|NCT00770211|4015204|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4192286|NCT00770211|4015205|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4192287|NCT00770211|4015206|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4192288|NCT00770211|4015204|B3||Female|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
4192289|NCT00770211|4015205|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4192290|NCT00770211|4015206|B1||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4192291|NCT00770211|4015204|B3|||Age||years|Mean|46.5|46.5|Standard Deviation|10.05|10.05|||
4192292|NCT00770211|4015205|B2|||Age||years|Mean|45.7|45.7|Standard Deviation|11.41|11.41|||
4192293|NCT00770211|4015206|B1|||Age||years|Mean|46.9|46.9|Standard Deviation|9.32|9.32|||
4192294|NCT00770146|4015221|B3|CHD or other atherosclerotic disease||Cardiovascular history|Participants may be counted in more than one category.|participants|Number|82|82.0||||||
4192295|NCT00770146|4015222|B2|CHD or other atherosclerotic disease||Cardiovascular history|Participants may be counted in more than one category.|participants|Number|58|58.0||||||
4192296|NCT00770146|4015223|B1|CHD or other atherosclerotic disease||Cardiovascular history|Participants may be counted in more than one category.|participants|Number|24|24.0||||||
4192297|NCT00770146|4015221|B3|Carotid||Cardiovascular history|Participants may be counted in more than one category.|participants|Number|9|9.0||||||
4192298|NCT00770146|4015222|B2|Carotid||Cardiovascular history|Participants may be counted in more than one category.|participants|Number|8|8.0||||||
4192299|NCT00770146|4015223|B1|Carotid||Cardiovascular history|Participants may be counted in more than one category.|participants|Number|1|1.0||||||
4192300|NCT00770146|4015221|B3|Abdominal aortic aneurysm||Cardiovascular history|Participants may be counted in more than one category.|participants|Number|1|1.0||||||
4192301|NCT00770146|4015222|B2|Abdominal aortic aneurysm||Cardiovascular history|Participants may be counted in more than one category.|participants|Number|0|0.0||||||
4192302|NCT00770146|4015223|B1|Abdominal aortic aneurysm||Cardiovascular history|Participants may be counted in more than one category.|participants|Number|1|1.0||||||
4192303|NCT00770146|4015221|B3|Peripheral artery disease||Cardiovascular history|Participants may be counted in more than one category.|participants|Number|6|6.0||||||
4192304|NCT00770146|4015222|B2|Peripheral artery disease||Cardiovascular history|Participants may be counted in more than one category.|participants|Number|5|5.0||||||
4192305|NCT00770146|4015223|B1|Peripheral artery disease||Cardiovascular history|Participants may be counted in more than one category.|participants|Number|1|1.0||||||
4192306|NCT00770146|4015221|B3|Other clinical atherosclerotic disease||Cardiovascular history|Participants may be counted in more than one category.|participants|Number|14|14.0||||||
4192307|NCT00770146|4015222|B2|Other clinical atherosclerotic disease||Cardiovascular history|Participants may be counted in more than one category.|participants|Number|11|11.0||||||
4192308|NCT00770146|4015223|B1|Other clinical atherosclerotic disease||Cardiovascular history|Participants may be counted in more than one category.|participants|Number|3|3.0||||||
4192309|NCT00770146|4015221|B3|Coronary artery disease without event||Cardiovascular history|Participants may be counted in more than one category.|participants|Number|20|20.0||||||
4192310|NCT00770146|4015222|B2|Coronary artery disease without event||Cardiovascular history|Participants may be counted in more than one category.|participants|Number|14|14.0||||||
4192311|NCT00770146|4015223|B1|Coronary artery disease without event||Cardiovascular history|Participants may be counted in more than one category.|participants|Number|6|6.0||||||
4192312|NCT00770146|4015221|B3|Percutaneous coronary intervention||Cardiovascular history|Participants may be counted in more than one category.|participants|Number|22|22.0||||||
4192313|NCT00770146|4015222|B2|Percutaneous coronary intervention||Cardiovascular history|Participants may be counted in more than one category.|participants|Number|18|18.0||||||
4192314|NCT00770146|4015223|B1|Percutaneous coronary intervention||Cardiovascular history|Participants may be counted in more than one category.|participants|Number|4|4.0||||||
4192315|NCT00770146|4015221|B3|Coronary artery bypass graft surgery||Cardiovascular history|Participants may be counted in more than one category.|participants|Number|18|18.0||||||
4192316|NCT00770146|4015222|B2|Coronary artery bypass graft surgery||Cardiovascular history|Participants may be counted in more than one category.|participants|Number|14|14.0||||||
4192317|NCT00770146|4015223|B1|Coronary artery bypass graft surgery||Cardiovascular history|Participants may be counted in more than one category.|participants|Number|4|4.0||||||
4192318|NCT00770146|4015221|B3|Myocardial infarction||Cardiovascular history|Participants may be counted in more than one category.|participants|Number|28|28.0||||||
4192319|NCT00770146|4015222|B2|Myocardial infarction||Cardiovascular history|Participants may be counted in more than one category.|participants|Number|17|17.0||||||
4192320|NCT00770146|4015223|B1|Myocardial infarction||Cardiovascular history|Participants may be counted in more than one category.|participants|Number|11|11.0||||||
4192321|NCT00770146|4015221|B3|Coronary heart disease (CHD)||Cardiovascular history|Participants may be counted in more than one category.|participants|Number|73|73.0||||||
4192322|NCT00770146|4015222|B2|Coronary heart disease (CHD)||Cardiovascular history|Participants may be counted in more than one category.|participants|Number|52|52.0||||||
4192323|NCT00770146|4015223|B1|Coronary heart disease (CHD)||Cardiovascular history|Participants may be counted in more than one category.|participants|Number|21|21.0||||||
4192324|NCT00770146|4015221|B3|Angina||Cardiovascular history|Participants may be counted in more than one category.|participants|Number|14|14.0||||||
4192325|NCT00770146|4015222|B2|Angina||Cardiovascular history|Participants may be counted in more than one category.|participants|Number|9|9.0||||||
4192326|NCT00770146|4015223|B1|Angina||Cardiovascular history|Participants may be counted in more than one category.|participants|Number|5|5.0||||||
4192327|NCT00770146|4015221|B3|No||Diabetic status at screening||participants|Number|69|69.0||||||
4192328|NCT00770146|4015222|B2|No||Diabetic status at screening||participants|Number|47|47.0||||||
4192329|NCT00770146|4015223|B1|No||Diabetic status at screening||participants|Number|22|22.0||||||
4192330|NCT00770146|4015221|B3|Yes||Diabetic status at screening||participants|Number|88|88.0||||||
4192331|NCT00770146|4015222|B2|Yes||Diabetic status at screening||participants|Number|58|58.0||||||
4192332|NCT00770146|4015223|B1|Yes||Diabetic status at screening||participants|Number|30|30.0||||||
4192333|NCT00770146|4015221|B3|Never||Alcohol use||participants|Number|51|51.0||||||
4192334|NCT00770146|4015222|B2|Never||Alcohol use||participants|Number|31|31.0||||||
4192335|NCT00770146|4015223|B1|Never||Alcohol use||participants|Number|20|20.0||||||
4192336|NCT00770146|4015221|B3|Non-current||Alcohol use||participants|Number|36|36.0||||||
4192337|NCT00770146|4015222|B2|Non-current||Alcohol use||participants|Number|24|24.0||||||
4192338|NCT00770146|4015223|B1|Non-current||Alcohol use||participants|Number|12|12.0||||||
4192339|NCT00770146|4015221|B3|Current||Alcohol use||participants|Number|70|70.0||||||
4192340|NCT00770146|4015222|B2|Current||Alcohol use||participants|Number|50|50.0||||||
4192341|NCT00770146|4015223|B1|Current||Alcohol use||participants|Number|20|20.0||||||
4192342|NCT00770146|4015221|B3|Never||Tobacco use||participants|Number|78|78.0||||||
4192343|NCT00770146|4015222|B2|Never||Tobacco use||participants|Number|56|56.0||||||
4192344|NCT00770146|4015223|B1|Never||Tobacco use||participants|Number|22|22.0||||||
4192345|NCT00770146|4015221|B3|Non-current||Tobacco use||participants|Number|50|50.0||||||
4192346|NCT00770146|4015222|B2|Non-current||Tobacco use||participants|Number|31|31.0||||||
4192347|NCT00770146|4015223|B1|Non-current||Tobacco use||participants|Number|19|19.0||||||
4192348|NCT00770146|4015221|B3|Current||Tobacco use||participants|Number|29|29.0||||||
4192349|NCT00770146|4015222|B2|Current||Tobacco use||participants|Number|18|18.0||||||
4192350|NCT00770146|4015223|B1|Current||Tobacco use||participants|Number|11|11.0||||||
4192351|NCT00770146|4015221|B3|Yes||Metabolic syndrome|"A patient was classified as having metabolic syndrome if any 3 of the following risk factors existed: 1) Waist circumference ≥102 cm (men) or ≥88 cm (women); 2) Triglycerides ≥150 mg/dL*; 3) High density lipoprotein cholesterol <40 mg/dL (men) or <50 mg/dL (women)*; 4) Systolic blood pressure ≥130 or diastolic ≥85 mmHg *; 5) Fasting glucose ≥100 mg/dL *.~* = or on medication for the specified risk factor."|participants|Number|113|113.0||||||
4192352|NCT00770146|4015222|B2|Yes||Metabolic syndrome|"A patient was classified as having metabolic syndrome if any 3 of the following risk factors existed: 1) Waist circumference ≥102 cm (men) or ≥88 cm (women); 2) Triglycerides ≥150 mg/dL*; 3) High density lipoprotein cholesterol <40 mg/dL (men) or <50 mg/dL (women)*; 4) Systolic blood pressure ≥130 or diastolic ≥85 mmHg *; 5) Fasting glucose ≥100 mg/dL *.~* = or on medication for the specified risk factor."|participants|Number|73|73.0||||||
4192353|NCT00770146|4015223|B1|Yes||Metabolic syndrome|"A patient was classified as having metabolic syndrome if any 3 of the following risk factors existed: 1) Waist circumference ≥102 cm (men) or ≥88 cm (women); 2) Triglycerides ≥150 mg/dL*; 3) High density lipoprotein cholesterol <40 mg/dL (men) or <50 mg/dL (women)*; 4) Systolic blood pressure ≥130 or diastolic ≥85 mmHg *; 5) Fasting glucose ≥100 mg/dL *.~* = or on medication for the specified risk factor."|participants|Number|40|40.0||||||
4192354|NCT00770146|4015221|B3|No||Metabolic syndrome|"A patient was classified as having metabolic syndrome if any 3 of the following risk factors existed: 1) Waist circumference ≥102 cm (men) or ≥88 cm (women); 2) Triglycerides ≥150 mg/dL*; 3) High density lipoprotein cholesterol <40 mg/dL (men) or <50 mg/dL (women)*; 4) Systolic blood pressure ≥130 or diastolic ≥85 mmHg *; 5) Fasting glucose ≥100 mg/dL *.~* = or on medication for the specified risk factor."|participants|Number|44|44.0||||||
4192355|NCT00770146|4015222|B2|No||Metabolic syndrome|"A patient was classified as having metabolic syndrome if any 3 of the following risk factors existed: 1) Waist circumference ≥102 cm (men) or ≥88 cm (women); 2) Triglycerides ≥150 mg/dL*; 3) High density lipoprotein cholesterol <40 mg/dL (men) or <50 mg/dL (women)*; 4) Systolic blood pressure ≥130 or diastolic ≥85 mmHg *; 5) Fasting glucose ≥100 mg/dL *.~* = or on medication for the specified risk factor."|participants|Number|32|32.0||||||
4192405|NCT00770120|4015268|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192356|NCT00770146|4015223|B1|No||Metabolic syndrome|"A patient was classified as having metabolic syndrome if any 3 of the following risk factors existed: 1) Waist circumference ≥102 cm (men) or ≥88 cm (women); 2) Triglycerides ≥150 mg/dL*; 3) High density lipoprotein cholesterol <40 mg/dL (men) or <50 mg/dL (women)*; 4) Systolic blood pressure ≥130 or diastolic ≥85 mmHg *; 5) Fasting glucose ≥100 mg/dL *.~* = or on medication for the specified risk factor."|participants|Number|12|12.0||||||
4192357|NCT00770146|4015221|B3|||Waist/hip ratio||ratio|Mean|0.94|0.94|Standard Deviation|0.06|0.06|||
4192358|NCT00770146|4015222|B2|||Waist/hip ratio||ratio|Mean|0.94|0.94|Standard Deviation|0.06|0.06|||
4192359|NCT00770146|4015223|B1|||Waist/hip ratio||ratio|Mean|0.94|0.94|Standard Deviation|0.07|0.07|||
4192360|NCT00770146|4015221|B3|||Body Mass Index (BMI)||kg/m^2|Mean|30.4|30.4|Standard Deviation|4.55|4.55|||
4192361|NCT00770146|4015222|B2|||Body Mass Index (BMI)||kg/m^2|Mean|30.7|30.7|Standard Deviation|4.61|4.61|||
4192362|NCT00770146|4015223|B1|||Body Mass Index (BMI)||kg/m^2|Mean|30.0|30.0|Standard Deviation|4.42|4.42|||
4192363|NCT00770146|4015221|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|132|132.0||||||
4192364|NCT00770146|4015222|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|89|89.0||||||
4192365|NCT00770146|4015223|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4192366|NCT00770146|4015221|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4192367|NCT00770146|4015222|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4192368|NCT00770146|4015223|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4192369|NCT00770146|4015221|B3|Other race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4192370|NCT00770146|4015222|B2|Other race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4192371|NCT00770146|4015223|B1|Other race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4192372|NCT00770146|4015221|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4192373|NCT00770146|4015222|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4192374|NCT00770146|4015223|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4192375|NCT00770146|4015221|B3|Black||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4192376|NCT00770146|4015222|B2|Black||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4192377|NCT00770146|4015223|B1|Black||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4192378|NCT00770146|4015221|B3|White||Race/Ethnicity, Customized||participants|Number|123|123.0||||||
4192379|NCT00770146|4015222|B2|White||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
4192380|NCT00770146|4015223|B1|White||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4192381|NCT00770146|4015221|B3||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4192382|NCT00770146|4015222|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4192383|NCT00770146|4015223|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4192384|NCT00770146|4015221|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4192385|NCT00770146|4015222|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4192386|NCT00770146|4015223|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4192387|NCT00770146|4015221|B3|||Age|Baseline data are provided for the Safety Set.|years|Mean|59.3|59.3|Standard Deviation|9.8|9.8|||
4192388|NCT00770146|4015222|B2|||Age|Baseline data are provided for the Safety Set.|years|Mean|59.3|59.3|Standard Deviation|10.0|10.0|||
4192389|NCT00770146|4015223|B1|||Age|Baseline data are provided for the Safety Set.|years|Mean|59.3|59.3|Standard Deviation|9.5|9.5|||
4192390|NCT00770120|4015268|B1|10% - 20%||Weight Loss Last 6 Months||participants|Number|6|6.0||||||
4192391|NCT00770120|4015268|B1|5% - < 10%||Weight Loss Last 6 Months||participants|Number|6|6.0||||||
4192392|NCT00770120|4015268|B1|< 5%||Weight Loss Last 6 Months||participants|Number|47|47.0||||||
4192393|NCT00770120|4015268|B1|1||Performance Status|"0: Fully active, able to carry on all pre-disease performance without restriction.~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours.~Capable of limited self-care, confined to bed or chair more than 50% of waking hours.~Completely disabled; cannot carry on any self-care; totally confined to bed or chair."|participants|Number|46|46.0||||||
4192394|NCT00770120|4015268|B1|0||Performance Status|"0: Fully active, able to carry on all pre-disease performance without restriction.~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours.~Capable of limited self-care, confined to bed or chair more than 50% of waking hours.~Completely disabled; cannot carry on any self-care; totally confined to bed or chair."|participants|Number|13|13.0||||||
4192395|NCT00770120|4015268|B1|2 Regimens||Prior Systemic Regimens||participants|Number|25|25.0||||||
4192396|NCT00770120|4015268|B1|1 Regimen||Prior Systemic Regimens||participants|Number|34|34.0||||||
4192397|NCT00770120|4015268|B1|Multiple||Number of Metastatic Sites||participants|Number|31|31.0||||||
4192398|NCT00770120|4015268|B1|Single||Number of Metastatic Sites||participants|Number|23|23.0||||||
4192399|NCT00770120|4015268|B1|None||Number of Metastatic Sites||participants|Number|5|5.0||||||
4192400|NCT00770120|4015268|B1|Not Reported||Histology||participants|Number|2|2.0||||||
4192401|NCT00770120|4015268|B1|Biphasic||Histology||participants|Number|4|4.0||||||
4192402|NCT00770120|4015268|B1|Mesothelioma, NOS||Histology||participants|Number|17|17.0||||||
4192403|NCT00770120|4015268|B1|Epithelial||Histology||participants|Number|36|36.0||||||
4192404|NCT00770120|4015268|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4192406|NCT00770120|4015268|B1||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4192407|NCT00770120|4015268|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4192408|NCT00770120|4015268|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192409|NCT00770120|4015268|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192410|NCT00770120|4015268|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192411|NCT00770120|4015268|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4192412|NCT00770120|4015268|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4192413|NCT00770120|4015268|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4192414|NCT00770120|4015268|B1||Male|Gender||Participants|Count of Participants|45|45.0||||||
4192415|NCT00770120|4015268|B1||Female|Gender||Participants|Count of Participants|14|14.0||||||
4192416|NCT00770120|4015268|B1|||Age||years|Median|67|67.0|Full Range|||45.8|81.3|
4192417|NCT00770029|4015275|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4192418|NCT00770029|4015276|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4192419|NCT00770029|4015277|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4192420|NCT00770029|4015275|B3||Female|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
4192421|NCT00770029|4015276|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4192422|NCT00770029|4015277|B1||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4192423|NCT00770029|4015275|B3|||Age||years|Mean|46.6|46.6|Standard Deviation|10.09|10.09|||
4192424|NCT00770029|4015276|B2|||Age||years|Mean|46.4|46.4|Standard Deviation|10.56|10.56|||
4192425|NCT00770029|4015277|B1|||Age||years|Mean|46.6|46.6|Standard Deviation|9.87|9.87|||
4192426|NCT00769860|4015292|B3|||Maximum Isometric Voluntary Contraction Testing (MVICT) Score|Measured MVICT using the Quantitative Muscle Assessment (QMA) system designed by Computer Source, Atlanta, GA. The system uses an adjustable cuff to attach the patient’s arm or leg to an inelastic strap that is connected to force transducer with a load of 0.5 to 1,000 Newtons. Maximum force is recorded.|newtons|Mean|119.4|119.4|Standard Deviation|63.4|63.4|||
4192427|NCT00769860|4015293|B2|||Maximum Isometric Voluntary Contraction Testing (MVICT) Score|Measured MVICT using the Quantitative Muscle Assessment (QMA) system designed by Computer Source, Atlanta, GA. The system uses an adjustable cuff to attach the patient’s arm or leg to an inelastic strap that is connected to force transducer with a load of 0.5 to 1,000 Newtons. Maximum force is recorded.|newtons|Mean|94.4|94.4|Standard Deviation|39.8|39.8|||
4192428|NCT00769860|4015294|B1|||Maximum Isometric Voluntary Contraction Testing (MVICT) Score|Measured MVICT using the Quantitative Muscle Assessment (QMA) system designed by Computer Source, Atlanta, GA. The system uses an adjustable cuff to attach the patient’s arm or leg to an inelastic strap that is connected to force transducer with a load of 0.5 to 1,000 Newtons. Maximum force is recorded.|newtons|Mean|130.4|130.4|Standard Deviation|70.4|70.4|||
4192429|NCT00769860|4015292|B3|||Manual Muscle Testing (MMT) Score|The MMT score range is 0-5. A score of 0 is the lowest and represents no visible or palpable contraction. A score of 5 is the highest and represents full range of motion against gravity, maximul resistance.|units on a scale|Mean|4.2|4.2|Standard Deviation|0.4|0.4|||
4192430|NCT00769860|4015293|B2|||Manual Muscle Testing (MMT) Score|The MMT score range is 0-5. A score of 0 is the lowest and represents no visible or palpable contraction. A score of 5 is the highest and represents full range of motion against gravity, maximul resistance.|units on a scale|Mean|3.6|3.6|Standard Deviation|1.5|1.5|||
4192431|NCT00769860|4015294|B1|||Manual Muscle Testing (MMT) Score|The MMT score range is 0-5. A score of 0 is the lowest and represents no visible or palpable contraction. A score of 5 is the highest and represents full range of motion against gravity, maximul resistance.|units on a scale|Mean|4.2|4.2|Standard Deviation|0.5|0.5|||
4192432|NCT00769860|4015292|B3|||Inclusion Body Myositis-Functional Rating Scale (IBMFRS) Score|The questionnaire has 10 questions. The maximum score is 40. The higher the score the better the functional status of the patient.|units on a scale|Mean|26.6|26.6|Standard Deviation|6.4|6.4|||
4192433|NCT00769860|4015293|B2|||Inclusion Body Myositis-Functional Rating Scale (IBMFRS) Score|The questionnaire has 10 questions. The maximum score is 40. The higher the score the better the functional status of the patient.|units on a scale|Mean|24.6|24.6|Standard Deviation|5.1|5.1|||
4192434|NCT00769860|4015294|B1|||Inclusion Body Myositis-Functional Rating Scale (IBMFRS) Score|The questionnaire has 10 questions. The maximum score is 40. The higher the score the better the functional status of the patient.|units on a scale|Mean|27.5|27.5|Standard Deviation|7.0|7.0|||
4192435|NCT00769860|4015292|B3|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
4192436|NCT00769860|4015293|B2|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4192437|NCT00769860|4015294|B1|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
4192438|NCT00769860|4015292|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4192439|NCT00769860|4015293|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4192440|NCT00769860|4015294|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4192441|NCT00769860|4015292|B3||Male|Gender||Participants|Count of Participants|17|17.0||||||
4192442|NCT00769860|4015293|B2||Male|Gender||Participants|Count of Participants|5|5.0||||||
4192443|NCT00769860|4015294|B1||Male|Gender||Participants|Count of Participants|12|12.0||||||
4192444|NCT00769860|4015292|B3||Female|Gender||Participants|Count of Participants|7|7.0||||||
4192445|NCT00769860|4015293|B2||Female|Gender||Participants|Count of Participants|3|3.0||||||
4192446|NCT00769860|4015294|B1||Female|Gender||Participants|Count of Participants|4|4.0||||||
4192447|NCT00769860|4015292|B3|||Age||years|Mean|66.84|66.84|Standard Deviation|7.49|7.49|||
4192448|NCT00769860|4015293|B2|||Age||years|Mean|68.83|68.83|Standard Deviation|6.70|6.7|||
4192449|NCT00769860|4015294|B1|||Age||years|Mean|65.85|65.85|Standard Deviation|7.86|7.86|||
4192450|NCT00769704|4015321|B3|Second Line or Greater||Line of Therapy||participants|Number|234|234.0||||||
4192451|NCT00769704|4015322|B2|Second Line or Greater||Line of Therapy||participants|Number|158|158.0||||||
4192452|NCT00769704|4015323|B1|Second Line or Greater||Line of Therapy||participants|Number|76|76.0||||||
4192453|NCT00769704|4015321|B3|First Line||Line of Therapy||participants|Number|203|203.0||||||
4192454|NCT00769704|4015322|B2|First Line||Line of Therapy||participants|Number|138|138.0||||||
4192455|NCT00769704|4015323|B1|First Line||Line of Therapy||participants|Number|65|65.0||||||
4192456|NCT00769704|4015321|B3|Missing||Tumor, Node, Metastasis (TNM) Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs, normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|1|1.0||||||
4192457|NCT00769704|4015322|B2|Missing||Tumor, Node, Metastasis (TNM) Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs, normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|1|1.0||||||
4192458|NCT00769704|4015323|B1|Missing||Tumor, Node, Metastasis (TNM) Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs, normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|0|0.0||||||
4192459|NCT00769704|4015321|B3|Stage IV M1c||Tumor, Node, Metastasis (TNM) Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs, normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|96|96.0||||||
4192460|NCT00769704|4015322|B2|Stage IV M1c||Tumor, Node, Metastasis (TNM) Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs, normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|67|67.0||||||
4192461|NCT00769704|4015323|B1|Stage IV M1c||Tumor, Node, Metastasis (TNM) Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs, normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|29|29.0||||||
4192462|NCT00769704|4015321|B3|Stage IV M1b||Tumor, Node, Metastasis (TNM) Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs, normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|90|90.0||||||
4192463|NCT00769704|4015322|B2|Stage IV M1b||Tumor, Node, Metastasis (TNM) Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs, normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|64|64.0||||||
4192464|NCT00769704|4015323|B1|Stage IV M1b||Tumor, Node, Metastasis (TNM) Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs, normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|26|26.0||||||
4192499|NCT00769704|4015322|B2||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4192500|NCT00769704|4015323|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4192501|NCT00769704|4015321|B3||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4192465|NCT00769704|4015321|B3|Stage IV M1a||Tumor, Node, Metastasis (TNM) Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs, normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|119|119.0||||||
4192466|NCT00769704|4015322|B2|Stage IV M1a||Tumor, Node, Metastasis (TNM) Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs, normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|76|76.0||||||
4192467|NCT00769704|4015323|B1|Stage IV M1a||Tumor, Node, Metastasis (TNM) Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs, normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|43|43.0||||||
4192468|NCT00769704|4015321|B3|Stage IIIC||Tumor, Node, Metastasis (TNM) Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs, normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|97|97.0||||||
4192469|NCT00769704|4015322|B2|Stage IIIC||Tumor, Node, Metastasis (TNM) Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs, normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|66|66.0||||||
4192470|NCT00769704|4015323|B1|Stage IIIC||Tumor, Node, Metastasis (TNM) Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs, normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|31|31.0||||||
4192471|NCT00769704|4015321|B3|Stage IIIB||Tumor, Node, Metastasis (TNM) Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs, normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|34|34.0||||||
4192472|NCT00769704|4015322|B2|Stage IIIB||Tumor, Node, Metastasis (TNM) Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs, normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|22|22.0||||||
4192473|NCT00769704|4015323|B1|Stage IIIB||Tumor, Node, Metastasis (TNM) Disease Stage|Stage IIIB: Ulcerated lesion and 1 lymph node or 2-3 nodes with micrometastasis, or any-depth lesion with no ulceration, and 1 lymph node or 2-3 nodes with macrometastasis; Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs, normal LDH; M1c: Spread to all other visceral organs, normal LDH or any distant disease with elevated LDH.|participants|Number|12|12.0||||||
4192474|NCT00769704|4015321|B3|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|16|16.0||||||
4192502|NCT00769704|4015322|B2||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4192503|NCT00769704|4015323|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4192504|NCT00769704|4015321|B3|||Age||years|Mean|63.03|63.03|Standard Deviation|13.81|13.81|||
4192505|NCT00769704|4015322|B2|||Age||years|Mean|63.07|63.07|Standard Deviation|13.68|13.68|||
4192506|NCT00769704|4015323|B1|||Age||years|Mean|62.92|62.92|Standard Deviation|14.13|14.13|||
4192475|NCT00769704|4015322|B2|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|4|4.0||||||
4192476|NCT00769704|4015323|B1|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|12|12.0||||||
4192477|NCT00769704|4015321|B3|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|114|114.0||||||
4192478|NCT00769704|4015322|B2|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|82|82.0||||||
4192479|NCT00769704|4015323|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|32|32.0||||||
4192480|NCT00769704|4015321|B3|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|307|307.0||||||
4192481|NCT00769704|4015322|B2|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|210|210.0||||||
4192482|NCT00769704|4015323|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|97|97.0||||||
4192483|NCT00769704|4015321|B3|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4192484|NCT00769704|4015322|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4192485|NCT00769704|4015323|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4192486|NCT00769704|4015321|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4192487|NCT00769704|4015322|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4192488|NCT00769704|4015323|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4192489|NCT00769704|4015321|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4192490|NCT00769704|4015322|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4192491|NCT00769704|4015323|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4192492|NCT00769704|4015321|B3|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4192493|NCT00769704|4015322|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4192494|NCT00769704|4015323|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4192495|NCT00769704|4015321|B3|White||Race/Ethnicity, Customized||participants|Number|428|428.0||||||
4192496|NCT00769704|4015322|B2|White||Race/Ethnicity, Customized||participants|Number|290|290.0||||||
4192497|NCT00769704|4015323|B1|White||Race/Ethnicity, Customized||participants|Number|138|138.0||||||
4192498|NCT00769704|4015321|B3||Male|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
4192507|NCT00769652|4015342|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4192508|NCT00769652|4015343|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4192509|NCT00769652|4015344|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4192510|NCT00769652|4015342|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4192511|NCT00769652|4015343|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4192512|NCT00769652|4015344|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4192513|NCT00769652|4015342|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4192514|NCT00769652|4015343|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4192515|NCT00769652|4015344|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4192516|NCT00769652|4015342|B3|||Age||years|Mean|60.9|60.9|Standard Deviation|4.5|4.5|||
4192517|NCT00769652|4015343|B2|||Age||years|Mean|60|60.0|Standard Deviation|||||
4192518|NCT00769652|4015344|B1|||Age||years|Mean|61|61.0|Standard Deviation|4.9|4.9|||
4192519|NCT00769652|4015342|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4192520|NCT00769652|4015343|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4192521|NCT00769652|4015344|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4192522|NCT00769652|4015342|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4192523|NCT00769652|4015343|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4192524|NCT00769652|4015344|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4192525|NCT00769652|4015342|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4192526|NCT00769652|4015343|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4192527|NCT00769652|4015344|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4192528|NCT00769561|4015355|B3|Germany||Region of Enrollment||participants|Number|58|58.0||||||
4192529|NCT00769561|4015356|B2|Germany||Region of Enrollment||participants|Number|29|29.0||||||
4192530|NCT00769561|4015357|B1|Germany||Region of Enrollment||participants|Number|29|29.0||||||
4192531|NCT00769561|4015355|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4192532|NCT00769561|4015356|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4192533|NCT00769561|4015357|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4192534|NCT00769561|4015355|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4192535|NCT00769561|4015356|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4192536|NCT00769561|4015357|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4192537|NCT00769561|4015355|B3|||Age||years|Mean|35.3|35.3|Standard Deviation|12.9|12.9|||
4192538|NCT00769561|4015356|B2|||Age||years|Mean|34.3|34.3|Standard Deviation|12.5|12.5|||
4192539|NCT00769561|4015357|B1|||Age||years|Mean|36.3|36.3|Standard Deviation|13.4|13.4|||
4192540|NCT00769314|4015378|B3|United Kingdom||Region of Enrollment|Data are provided for the Intent-to-Treat population.|participants|Number|20|20.0||||||
4192541|NCT00769314|4015379|B2|United Kingdom||Region of Enrollment|Data are provided for the Intent-to-Treat population.|participants|Number|9|9.0||||||
4192542|NCT00769314|4015380|B1|United Kingdom||Region of Enrollment|Data are provided for the Intent-to-Treat population.|participants|Number|11|11.0||||||
4192543|NCT00769314|4015378|B3|Germany||Region of Enrollment|Data are provided for the Intent-to-Treat population.|participants|Number|156|156.0||||||
4192544|NCT00769314|4015379|B2|Germany||Region of Enrollment|Data are provided for the Intent-to-Treat population.|participants|Number|77|77.0||||||
4192545|NCT00769314|4015380|B1|Germany||Region of Enrollment|Data are provided for the Intent-to-Treat population.|participants|Number|79|79.0||||||
4192546|NCT00769314|4015378|B3|Australia||Region of Enrollment|Data are provided for the Intent-to-Treat population.|participants|Number|121|121.0||||||
4192547|NCT00769314|4015379|B2|Australia||Region of Enrollment|Data are provided for the Intent-to-Treat population.|participants|Number|68|68.0||||||
4192548|NCT00769314|4015380|B1|Australia||Region of Enrollment|Data are provided for the Intent-to-Treat population.|participants|Number|53|53.0||||||
4192549|NCT00769314|4015378|B3|Poland||Region of Enrollment|Data are provided for the Intent-to-Treat population.|participants|Number|144|144.0||||||
4192550|NCT00769314|4015379|B2|Poland||Region of Enrollment|Data are provided for the Intent-to-Treat population.|participants|Number|70|70.0||||||
4192551|NCT00769314|4015380|B1|Poland||Region of Enrollment|Data are provided for the Intent-to-Treat population.|participants|Number|74|74.0||||||
4192552|NCT00769314|4015378|B3|Czech Republic||Region of Enrollment|Data are provided for the Intent-to-Treat population.|participants|Number|97|97.0||||||
4192553|NCT00769314|4015379|B2|Czech Republic||Region of Enrollment|Data are provided for the Intent-to-Treat population.|participants|Number|50|50.0||||||
4192554|NCT00769314|4015380|B1|Czech Republic||Region of Enrollment|Data are provided for the Intent-to-Treat population.|participants|Number|47|47.0||||||
4192555|NCT00769314|4015378|B3|France||Region of Enrollment|Data are provided for the Intent-to-Treat population.|participants|Number|90|90.0||||||
4192556|NCT00769314|4015379|B2|France||Region of Enrollment|Data are provided for the Intent-to-Treat population.|participants|Number|49|49.0||||||
4192557|NCT00769314|4015380|B1|France||Region of Enrollment|Data are provided for the Intent-to-Treat population.|participants|Number|41|41.0||||||
4192558|NCT00769314|4015378|B3|United States||Region of Enrollment|Data are provided for the Intent-to-Treat population.|participants|Number|143|143.0||||||
4192559|NCT00769314|4015379|B2|United States||Region of Enrollment|Data are provided for the Intent-to-Treat population.|participants|Number|72|72.0||||||
4192560|NCT00769314|4015380|B1|United States||Region of Enrollment|Data are provided for the Intent-to-Treat population.|participants|Number|71|71.0||||||
4192561|NCT00769314|4015378|B3||Male|Sex: Female, Male|Data are provided for the Intent-to-Treat population.|Participants|Count of Participants|242|242.0||||||
4192562|NCT00769314|4015379|B2||Male|Sex: Female, Male|Data are provided for the Intent-to-Treat population.|Participants|Count of Participants|124|124.0||||||
4192563|NCT00769314|4015380|B1||Male|Sex: Female, Male|Data are provided for the Intent-to-Treat population.|Participants|Count of Participants|118|118.0||||||
4192564|NCT00769314|4015378|B3||Female|Sex: Female, Male|Data are provided for the Intent-to-Treat population.|Participants|Count of Participants|529|529.0||||||
4192565|NCT00769314|4015379|B2||Female|Sex: Female, Male|Data are provided for the Intent-to-Treat population.|Participants|Count of Participants|271|271.0||||||
4192566|NCT00769314|4015380|B1||Female|Sex: Female, Male|Data are provided for the Intent-to-Treat population.|Participants|Count of Participants|258|258.0||||||
4192567|NCT00769314|4015378|B3|||Age|Data are provided for the Intent-to-Treat population.|years|Mean|41.0|41.0|Standard Deviation|13.18|13.18|||
4192568|NCT00769314|4015379|B2|||Age|Data are provided for the Intent-to-Treat population.|years|Mean|41.9|41.9|Standard Deviation|13.33|13.33|||
4192569|NCT00769314|4015380|B1|||Age|Data are provided for the Intent-to-Treat population.|years|Mean|40|40.0|Standard Deviation|12.97|12.97|||
4192570|NCT00769184|4015407|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4192571|NCT00769184|4015407|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192572|NCT00769184|4015407|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192573|NCT00769184|4015407|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4192574|NCT00769184|4015407|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4192575|NCT00769184|4015407|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192576|NCT00769184|4015407|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192577|NCT00769184|4015407|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192578|NCT00769184|4015407|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4192579|NCT00769184|4015407|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4192580|NCT00769184|4015407|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4192581|NCT00769184|4015407|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4192582|NCT00769184|4015407|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4192583|NCT00769132|4015416|B1|||urinary PGI2-Metabolite|urinary levels of 2,3-dinor 6-keto-PGF1a (Prostaglandin I-M) 24-hour collection|pg/mg creatinine|Median|89.7|89.7|Full Range|||45.2|242.9|
4192584|NCT00769132|4015416|B1|||urinary 11-dTxB2|urinary levels of 11-dehydrothromboxane B2 (24 hour collection)|pg/mg creatinine|Median|418.5|418.5|Full Range|||142.0|783.1|
4192585|NCT00769132|4015416|B1|||Weight||kg|Mean|78.4|78.4|Full Range|||58.0|102.9|
4192586|NCT00769132|4015416|B1|||Height||cm|Mean|165.5|165.5|Full Range|||147.0|185.0|
4192587|NCT00769132|4015416|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4192588|NCT00769132|4015416|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4192589|NCT00769132|4015416|B1|||Age||years|Mean|48.1|48.1|Standard Deviation|11.6|11.6|22.0|64.0|
4192590|NCT00769119|4015433|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4192591|NCT00769119|4015434|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4192592|NCT00769119|4015435|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4192593|NCT00769119|4015433|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4192594|NCT00769119|4015434|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4192595|NCT00769119|4015435|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4192596|NCT00769119|4015433|B3|||Age||years|Median|62|62.0|Full Range|||42.0|79.0|
4192597|NCT00769119|4015434|B2|||Age||years|Median|62|62.0|Full Range|||54.0|73.0|
4192598|NCT00769119|4015435|B1|||Age||years|Median|61|61.0|Full Range|||42.0|79.0|
4192599|NCT00769067|4015480|B3||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4192600|NCT00769067|4015481|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4192601|NCT00769067|4015482|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4192602|NCT00769067|4015480|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4192603|NCT00769067|4015481|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4192604|NCT00769067|4015482|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4192605|NCT00769067|4015480|B3|||Age||years|Mean|60.0|60.0|Standard Deviation|10.8|10.8|||
4192606|NCT00769067|4015481|B2|||Age||years|Mean|59.9|59.9|Standard Deviation|9.5|9.5|||
4192607|NCT00769067|4015482|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|12.0|12.0|||
4192608|NCT00769015|4015508|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192609|NCT00769015|4015509|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192610|NCT00769015|4015510|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192611|NCT00769015|4015508|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|187|187.0||||||
4192612|NCT00769015|4015509|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
4192613|NCT00769015|4015510|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
4192614|NCT00769015|4015508|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4192615|NCT00769015|4015509|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192616|NCT00769015|4015510|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4192617|NCT00769015|4015508|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192618|NCT00769015|4015509|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192619|NCT00769015|4015510|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192620|NCT00769015|4015508|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192621|NCT00769015|4015509|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192622|NCT00769015|4015510|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192623|NCT00769015|4015508|B3||White|Race (NIH/OMB)||Participants|Count of Participants|184|184.0||||||
4192624|NCT00769015|4015509|B2||White|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4192625|NCT00769015|4015510|B1||White|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
4192626|NCT00769015|4015508|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4192627|NCT00769015|4015509|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4192628|NCT00769015|4015510|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4192629|NCT00769015|4015508|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192630|NCT00769015|4015509|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192631|NCT00769015|4015510|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192632|NCT00769015|4015508|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4192633|NCT00769015|4015509|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192634|NCT00769015|4015510|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4192635|NCT00769015|4015508|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192636|NCT00769015|4015509|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192637|NCT00769015|4015510|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192638|NCT00769015|4015508|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4192639|NCT00769015|4015509|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4192640|NCT00769015|4015510|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4192641|NCT00769015|4015508|B3||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4192642|NCT00769015|4015509|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4192643|NCT00769015|4015510|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4192644|NCT00769015|4015508|B3|||Age||years|Mean|84.0|84.0|Standard Deviation|6.8|6.8|||
4192645|NCT00769015|4015509|B2|||Age||years|Mean|82.7|82.7|Standard Deviation|6.9|6.9|||
4192646|NCT00769015|4015510|B1|||Age||years|Mean|85.2|85.2|Standard Deviation|6.6|6.6|||
4192647|NCT00768989|4015529|B3|>= 500 cells/mm^3||CD4 Distribution at Baseline||Participants|Number|1|1.0||||||
4192648|NCT00768989|4015530|B2|>= 500 cells/mm^3||CD4 Distribution at Baseline||Participants|Number|0|0.0||||||
4192649|NCT00768989|4015531|B1|>= 500 cells/mm^3||CD4 Distribution at Baseline||Participants|Number|1|1.0||||||
4192650|NCT00768989|4015529|B3|350 to < 500 cells/mm^3||CD4 Distribution at Baseline||Participants|Number|23|23.0||||||
4192651|NCT00768989|4015530|B2|350 to < 500 cells/mm^3||CD4 Distribution at Baseline||Participants|Number|9|9.0||||||
4192652|NCT00768989|4015531|B1|350 to < 500 cells/mm^3||CD4 Distribution at Baseline||Participants|Number|14|14.0||||||
4192653|NCT00768989|4015529|B3|200 to < 350 cells/mm^3||CD4 Distribution at Baseline||Participants|Number|42|42.0||||||
4192654|NCT00768989|4015530|B2|200 to < 350 cells/mm^3||CD4 Distribution at Baseline||Participants|Number|13|13.0||||||
4192655|NCT00768989|4015531|B1|200 to < 350 cells/mm^3||CD4 Distribution at Baseline||Participants|Number|29|29.0||||||
4192656|NCT00768989|4015529|B3|100 to < 200 cells/mm^3||CD4 Distribution at Baseline||Participants|Number|16|16.0||||||
4192657|NCT00768989|4015530|B2|100 to < 200 cells/mm^3||CD4 Distribution at Baseline||Participants|Number|3|3.0||||||
4192658|NCT00768989|4015531|B1|100 to < 200 cells/mm^3||CD4 Distribution at Baseline||Participants|Number|13|13.0||||||
4192659|NCT00768989|4015529|B3|50 to < 100 cells/mm^3||CD4 Distribution at Baseline||Participants|Number|2|2.0||||||
4192660|NCT00768989|4015530|B2|50 to < 100 cells/mm^3||CD4 Distribution at Baseline||Participants|Number|1|1.0||||||
4192661|NCT00768989|4015531|B1|50 to < 100 cells/mm^3||CD4 Distribution at Baseline||Participants|Number|1|1.0||||||
4192662|NCT00768989|4015529|B3|< 50 cells/mm^3||CD4 Distribution at Baseline||Participants|Number|9|9.0||||||
4192663|NCT00768989|4015530|B2|< 50 cells/mm^3||CD4 Distribution at Baseline||Participants|Number|4|4.0||||||
4192664|NCT00768989|4015531|B1|< 50 cells/mm^3||CD4 Distribution at Baseline||Participants|Number|5|5.0||||||
4192665|NCT00768989|4015529|B3|||Mean Cluster of Differentiation 4 (CD4) Cell Count at Baseline||cells/mm^3|Mean|257.8|257.8|Standard Deviation|122.21|122.21|||
4192666|NCT00768989|4015530|B2|||Mean Cluster of Differentiation 4 (CD4) Cell Count at Baseline||cells/mm^3|Mean|261.2|261.2|Standard Deviation|134.93|134.93|||
4192667|NCT00768989|4015531|B1|||Mean Cluster of Differentiation 4 (CD4) Cell Count at Baseline||cells/mm^3|Mean|256.2|256.2|Standard Deviation|116.79|116.79|||
4192668|NCT00768989|4015529|B3|>=500,000 copies/mL||HIV RNA Distribution at Baseline||Participants|Number|11|11.0||||||
4192669|NCT00768989|4015530|B2|>=500,000 copies/mL||HIV RNA Distribution at Baseline||Participants|Number|3|3.0||||||
4192670|NCT00768989|4015531|B1|>=500,000 copies/mL||HIV RNA Distribution at Baseline||Participants|Number|8|8.0||||||
4192671|NCT00768989|4015529|B3|100,000 to <500,000 copies/mL||HIV RNA Distribution at Baseline||Participants|Number|36|36.0||||||
4192672|NCT00768989|4015530|B2|100,000 to <500,000 copies/mL||HIV RNA Distribution at Baseline||Participants|Number|10|10.0||||||
4192673|NCT00768989|4015531|B1|100,000 to <500,000 copies/mL||HIV RNA Distribution at Baseline||Participants|Number|26|26.0||||||
4192674|NCT00768989|4015529|B3|30,000 to <100,000 copies/mL||HIV RNA Distribution at Baseline||Participants|Number|25|25.0||||||
4192675|NCT00768989|4015530|B2|30,000 to <100,000 copies/mL||HIV RNA Distribution at Baseline||Participants|Number|10|10.0||||||
4192676|NCT00768989|4015531|B1|30,000 to <100,000 copies/mL||HIV RNA Distribution at Baseline||Participants|Number|15|15.0||||||
4192677|NCT00768989|4015529|B3|< 30,000 copies/mL||HIV RNA Distribution at Baseline||Participants|Number|21|21.0||||||
4192678|NCT00768989|4015530|B2|< 30,000 copies/mL||HIV RNA Distribution at Baseline||Participants|Number|7|7.0||||||
4192679|NCT00768989|4015531|B1|< 30,000 copies/mL||HIV RNA Distribution at Baseline||Participants|Number|14|14.0||||||
4192680|NCT00768989|4015529|B3|||HIV RNA Level at Baseline||log10 copies/mL|Mean|4.9|4.9|Standard Deviation|0.60|0.6|||
4192681|NCT00768989|4015530|B2|||HIV RNA Level at Baseline||log10 copies/mL|Mean|4.9|4.9|Standard Deviation|0.66|0.66|||
4192682|NCT00768989|4015531|B1|||HIV RNA Level at Baseline||log10 copies/mL|Mean|4.9|4.9|Standard Deviation|0.57|0.57|||
4192683|NCT00768989|4015529|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4192684|NCT00768989|4015530|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192685|NCT00768989|4015531|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4192686|NCT00768989|4015529|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192687|NCT00768989|4015530|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192688|NCT00768989|4015531|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192689|NCT00768989|4015529|B3||White|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
4192690|NCT00768989|4015530|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4192691|NCT00768989|4015531|B1||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4192692|NCT00768989|4015529|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4192693|NCT00768989|4015530|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4192694|NCT00768989|4015531|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4192695|NCT00768989|4015529|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192696|NCT00768989|4015530|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192697|NCT00768989|4015531|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192698|NCT00768989|4015529|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4192699|NCT00768989|4015530|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4192700|NCT00768989|4015531|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192701|NCT00768989|4015529|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192702|NCT00768989|4015530|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192703|NCT00768989|4015531|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4192704|NCT00768989|4015529|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4192705|NCT00768989|4015530|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4192706|NCT00768989|4015531|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4192707|NCT00768989|4015529|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4192708|NCT00768989|4015530|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4192709|NCT00768989|4015531|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4192710|NCT00768989|4015529|B3|||Age||years|Mean|40.2|40.2|Standard Deviation|10.88|10.88|||
4192711|NCT00768989|4015530|B2|||Age||years|Mean|41.6|41.6|Standard Deviation|10.87|10.87|||
4192712|NCT00768989|4015531|B1|||Age||years|Mean|39.5|39.5|Standard Deviation|10.90|10.9|||
4192713|NCT00768898|4015580|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4192714|NCT00768898|4015580|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4192715|NCT00768898|4015580|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4192716|NCT00768898|4015580|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4192717|NCT00768898|4015580|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4192718|NCT00768755|4015600|B5||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4192719|NCT00768755|4015601|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4192720|NCT00768755|4015602|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4192721|NCT00768755|4015603|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4192722|NCT00768755|4015604|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4192723|NCT00768755|4015600|B5||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4192724|NCT00768755|4015601|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4192725|NCT00768755|4015602|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4192726|NCT00768755|4015603|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4192727|NCT00768755|4015604|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4192728|NCT00768755|4015600|B5|Greater Than or Equal to 65 Years||Age, Customized||participants|Number|63|63.0||||||
4192729|NCT00768755|4015601|B4|Greater Than or Equal to 65 Years||Age, Customized||participants|Number|14|14.0||||||
4192730|NCT00768755|4015602|B3|Greater Than or Equal to 65 Years||Age, Customized||participants|Number|24|24.0||||||
4192731|NCT00768755|4015603|B2|Greater Than or Equal to 65 Years||Age, Customized||participants|Number|20|20.0||||||
4192732|NCT00768755|4015604|B1|Greater Than or Equal to 65 Years||Age, Customized||participants|Number|5|5.0||||||
4192733|NCT00768755|4015600|B5|Less Than 65 Years||Age, Customized||participants|Number|117|117.0||||||
4192734|NCT00768755|4015601|B4|Less Than 65 Years||Age, Customized||participants|Number|43|43.0||||||
4192735|NCT00768755|4015602|B3|Less Than 65 Years||Age, Customized||participants|Number|34|34.0||||||
4192736|NCT00768755|4015603|B2|Less Than 65 Years||Age, Customized||participants|Number|35|35.0||||||
4192737|NCT00768755|4015604|B1|Less Than 65 Years||Age, Customized||participants|Number|5|5.0||||||
4192738|NCT00768651|4015631|B1|||Mycophenolate daily dose||mg|Mean|1406|1406.0|Standard Deviation|461|461.0|||
4192739|NCT00768651|4015631|B1|||Tacrolimus daily dose||mg|Mean|4.5|4.5|Standard Deviation|1.2|1.2|||
4192740|NCT00768651|4015631|B1|||Time insulin free||months|Median|47.8|47.8|Full Range|||15.4|135.3|
4192741|NCT00768651|4015631|B1|||Interval since last transplant||months|Median|53|53.0|Full Range|||17.0|136.0|
4192742|NCT00768651|4015631|B1|||Time since first transplant||months|Median|67|67.0|Full Range|||25.0|137.0|
4192743|NCT00768651|4015631|B1|||Islet equivalents infused||equivalents per kg|Mean|12,046|12.0|Standard Deviation|4,030|4.0|||
4192744|NCT00768651|4015631|B1|||Islet equivalents infused||equivalents total|Mean|814,061|814.0|Standard Deviation|231,463|231.0|||
4192745|NCT00768651|4015631|B1|||Number of islet infusions||number of islet infusions|Median|2|2.0|Full Range|||1.0|4.0|
4192746|NCT00768651|4015631|B1|||Diabetes Duration Prior to 1st Transplant||years|Mean|36.1|36.1|Full Range|||24.7|50.2|
4192747|NCT00768651|4015631|B1|||BMI||kg/m^2|Mean|22.6|22.6|Standard Deviation|3.4|3.4|||
4192748|NCT00768651|4015631|B1|||Weight||kg|Mean|69|69.0|Standard Deviation|15|15.0|||
4192749|NCT00768651|4015631|B1|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4192750|NCT00768651|4015631|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4192751|NCT00768651|4015631|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4192752|NCT00768651|4015631|B1|||Age||years|Median|54|54.0|Full Range|||40.0|64.0|
4192753|NCT00768599|4015636|B4|||Weight||lbs|Mean|200.4|200.4|Standard Deviation|50.42|50.42|||
4192754|NCT00768599|4015637|B3|||Weight||lbs|Mean|207.0|207.0|Standard Deviation|49.75|49.75|||
4192755|NCT00768599|4015638|B2|||Weight||lbs|Mean|199.5|199.5|Standard Deviation|56.06|56.06|||
4192756|NCT00768599|4015639|B1|||Weight||lbs|Mean|194.4|194.4|Standard Deviation|45.49|45.49|||
4192757|NCT00768599|4015636|B4|United States||Region of Enrollment||participants|Number|135|135.0||||||
4192758|NCT00768599|4015637|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
4192759|NCT00768599|4015638|B2|United States||Region of Enrollment||participants|Number|43|43.0||||||
4192760|NCT00768599|4015639|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4192761|NCT00768599|4015636|B4||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4192762|NCT00768599|4015637|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4192763|NCT00768599|4015638|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4192764|NCT00768599|4015639|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4192765|NCT00768599|4015636|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4192766|NCT00768599|4015637|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4192767|NCT00768599|4015638|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4192768|NCT00768599|4015639|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4192769|NCT00768599|4015636|B4|||Age||years|Mean|44.2|44.2|Standard Deviation|13.8|13.8|||
4192770|NCT00768599|4015637|B3|||Age||years|Mean|43.1|43.1|Standard Deviation|10.8|10.8|||
4192771|NCT00768599|4015638|B2|||Age||years|Mean|44.2|44.2|Standard Deviation|14.5|14.5|||
4192772|NCT00768599|4015639|B1|||Age||years|Mean|45.4|45.4|Standard Deviation|15.9|15.9|||
4192773|NCT00768599|4015636|B4||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4192774|NCT00768599|4015637|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4192775|NCT00768599|4015638|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4192776|NCT00768599|4015639|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4192777|NCT00768599|4015636|B4||Between 18 and 65 years|Age||Participants|Count of Participants|126|126.0||||||
4192778|NCT00768599|4015637|B3||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4192779|NCT00768599|4015638|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4192780|NCT00768599|4015639|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4192781|NCT00768599|4015636|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4192782|NCT00768599|4015637|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4192783|NCT00768599|4015638|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4192784|NCT00768599|4015639|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4192785|NCT00768560|4015664|B7|||Heart rate (HR) at Baseline|Heart rate (HR) before the start of baseline treatment. Subjects valid for safety analysis|beats / min|Mean|72.69|72.69|Standard Deviation|11.83|11.83|||
4192786|NCT00768560|4015665|B6|||Heart rate (HR) at Baseline|Heart rate (HR) before the start of baseline treatment. Subjects valid for safety analysis|beats / min|Mean|79.50|79.5|Standard Deviation|17.84|17.84|||
4192787|NCT00768560|4015666|B5|||Heart rate (HR) at Baseline|Heart rate (HR) before the start of baseline treatment. Subjects valid for safety analysis|beats / min|Mean|68.50|68.5|Standard Deviation|7.87|7.87|||
4192788|NCT00768560|4015667|B4|||Heart rate (HR) at Baseline|Heart rate (HR) before the start of baseline treatment. Subjects valid for safety analysis|beats / min|Mean|70.83|70.83|Standard Deviation|5.42|5.42|||
4192828|NCT00768521|4015701|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4192789|NCT00768560|4015668|B3|||Heart rate (HR) at Baseline|Heart rate (HR) before the start of baseline treatment. Subjects valid for safety analysis|beats / min|Mean|79.00|79.0|Standard Deviation|10.81|10.81|||
4192790|NCT00768560|4015669|B2|||Heart rate (HR) at Baseline|Heart rate (HR) before the start of baseline treatment. Subjects valid for safety analysis|beats / min|Mean|72.67|72.67|Standard Deviation|13.95|13.95|||
4192791|NCT00768560|4015670|B1|||Heart rate (HR) at Baseline|Heart rate (HR) before the start of baseline treatment. Subjects valid for safety analysis|beats / min|Mean|64.20|64.2|Standard Deviation|6.18|6.18|||
4192792|NCT00768560|4015664|B7|DBP at baseline||Blood Pressure (Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP)) at Baseline|Blood pressure (BP) before the start of baseline treatment. Subjects valid for safety analysis|mm Hg|Mean|93.43|93.43|Standard Deviation|6.40|6.4|||
4192793|NCT00768560|4015665|B6|DBP at baseline||Blood Pressure (Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP)) at Baseline|Blood pressure (BP) before the start of baseline treatment. Subjects valid for safety analysis|mm Hg|Mean|89.83|89.83|Standard Deviation|7.68|7.68|||
4192794|NCT00768560|4015666|B5|DBP at baseline||Blood Pressure (Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP)) at Baseline|Blood pressure (BP) before the start of baseline treatment. Subjects valid for safety analysis|mm Hg|Mean|92.50|92.5|Standard Deviation|3.45|3.45|||
4192795|NCT00768560|4015667|B4|DBP at baseline||Blood Pressure (Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP)) at Baseline|Blood pressure (BP) before the start of baseline treatment. Subjects valid for safety analysis|mm Hg|Mean|91.00|91.0|Standard Deviation|7.07|7.07|||
4192796|NCT00768560|4015668|B3|DBP at baseline||Blood Pressure (Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP)) at Baseline|Blood pressure (BP) before the start of baseline treatment. Subjects valid for safety analysis|mm Hg|Mean|98.00|98.0|Standard Deviation|6.45|6.45|||
4192797|NCT00768560|4015669|B2|DBP at baseline||Blood Pressure (Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP)) at Baseline|Blood pressure (BP) before the start of baseline treatment. Subjects valid for safety analysis|mm Hg|Mean|95.00|95.0|Standard Deviation|6.60|6.6|||
4192798|NCT00768560|4015670|B1|DBP at baseline||Blood Pressure (Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP)) at Baseline|Blood pressure (BP) before the start of baseline treatment. Subjects valid for safety analysis|mm Hg|Mean|94.40|94.4|Standard Deviation|4.98|4.98|||
4192799|NCT00768560|4015664|B7|SBP at baseline||Blood Pressure (Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP)) at Baseline|Blood pressure (BP) before the start of baseline treatment. Subjects valid for safety analysis|mm Hg|Mean|155.89|155.89|Standard Deviation|12.38|12.38|||
4192800|NCT00768560|4015665|B6|SBP at baseline||Blood Pressure (Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP)) at Baseline|Blood pressure (BP) before the start of baseline treatment. Subjects valid for safety analysis|mm Hg|Mean|154.83|154.83|Standard Deviation|13.53|13.53|||
4192801|NCT00768560|4015666|B5|SBP at baseline||Blood Pressure (Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP)) at Baseline|Blood pressure (BP) before the start of baseline treatment. Subjects valid for safety analysis|mm Hg|Mean|156.33|156.33|Standard Deviation|14.79|14.79|||
4192802|NCT00768560|4015667|B4|SBP at baseline||Blood Pressure (Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP)) at Baseline|Blood pressure (BP) before the start of baseline treatment. Subjects valid for safety analysis|mm Hg|Mean|155.83|155.83|Standard Deviation|10.96|10.96|||
4192803|NCT00768560|4015668|B3|SBP at baseline||Blood Pressure (Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP)) at Baseline|Blood pressure (BP) before the start of baseline treatment. Subjects valid for safety analysis|mm Hg|Mean|156.33|156.33|Standard Deviation|11.18|11.18|||
4192804|NCT00768560|4015669|B2|SBP at baseline||Blood Pressure (Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP)) at Baseline|Blood pressure (BP) before the start of baseline treatment. Subjects valid for safety analysis|mm Hg|Mean|161.00|161.0|Standard Deviation|16.67|16.67|||
4192805|NCT00768560|4015670|B1|SBP at baseline||Blood Pressure (Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP)) at Baseline|Blood pressure (BP) before the start of baseline treatment. Subjects valid for safety analysis|mm Hg|Mean|150.00|150.0|Standard Deviation|7.91|7.91|||
4192806|NCT00768560|4015664|B7||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4192807|NCT00768560|4015665|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4192808|NCT00768560|4015666|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4192809|NCT00768560|4015667|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4192810|NCT00768560|4015668|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4192811|NCT00768560|4015669|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4192812|NCT00768560|4015670|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4192813|NCT00768560|4015664|B7||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4192814|NCT00768560|4015665|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4192815|NCT00768560|4015666|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4192816|NCT00768560|4015667|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4192817|NCT00768560|4015668|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4192818|NCT00768560|4015669|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4192819|NCT00768560|4015670|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4192820|NCT00768560|4015664|B7|||Age||years|Mean|61.1|61.1|Full Range|||37.0|73.0|
4192821|NCT00768560|4015665|B6|||Age||years|Mean|59.7|59.7|Full Range|||56.0|68.0|
4192822|NCT00768560|4015666|B5|||Age||years|Mean|58.2|58.2|Full Range|||37.0|67.0|
4192823|NCT00768560|4015667|B4|||Age||years|Mean|64.3|64.3|Full Range|||60.0|70.0|
4192824|NCT00768560|4015668|B3|||Age||years|Mean|59.7|59.7|Full Range|||55.0|65.0|
4192825|NCT00768560|4015669|B2|||Age||years|Mean|63.6|63.6|Full Range|||55.0|73.0|
4192826|NCT00768560|4015670|B1|||Age||years|Mean|61.4|61.4|Full Range|||55.0|68.0|
4192827|NCT00768521|4015701|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4192829|NCT00768521|4015701|B1|||Age||years|Mean|59.1|59.1|Full Range|||45.0|70.0|
4192830|NCT00768469|4015710|B3|Japanese||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4192831|NCT00768469|4015711|B2|Japanese||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4192832|NCT00768469|4015712|B1|Japanese||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4192833|NCT00768469|4015710|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4192834|NCT00768469|4015711|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4192835|NCT00768469|4015712|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4192836|NCT00768469|4015710|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4192837|NCT00768469|4015711|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4192838|NCT00768469|4015712|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4192839|NCT00768469|4015710|B3|||Age||years|Mean|52.10|52.1|Standard Deviation|8.31|8.31|||
4192840|NCT00768469|4015711|B2|||Age||years|Mean|53.14|53.14|Standard Deviation|8.07|8.07|||
4192841|NCT00768469|4015712|B1|||Age||years|Mean|49.67|49.67|Standard Deviation|10.12|10.12|||
4192842|NCT00768469|4015710|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4192843|NCT00768469|4015711|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4192844|NCT00768469|4015712|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4192845|NCT00768469|4015710|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4192846|NCT00768469|4015711|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4192847|NCT00768469|4015712|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4192848|NCT00768469|4015710|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4192849|NCT00768469|4015711|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4192850|NCT00768469|4015712|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4192851|NCT00768430|4015726|B3|United States||Region of Enrollment||participants|Number|73|73.0||||||
4192852|NCT00768430|4015727|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4192853|NCT00768430|4015728|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4192854|NCT00768430|4015726|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4192855|NCT00768430|4015727|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4192856|NCT00768430|4015728|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4192857|NCT00768430|4015726|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4192858|NCT00768430|4015727|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4192859|NCT00768430|4015728|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4192860|NCT00768430|4015726|B3|||Age||years|Mean|44.8|44.8|Standard Deviation|12.2|12.2|||
4192861|NCT00768430|4015727|B2|||Age||years|Mean|42.7|42.7|Standard Deviation|11.6|11.6|||
4192862|NCT00768430|4015728|B1|||Age||years|Mean|46.9|46.9|Standard Deviation|12.8|12.8|||
4192863|NCT00768300|4015735|B3|Yes||N-acetylcysteine (NAC) Use|NAC is a therapy commonly used in the treatment of IPF. NAC use data is missing for two participants randomized to placebo.|participants|Number|27|27.0||||||
4192864|NCT00768300|4015736|B2|Yes||N-acetylcysteine (NAC) Use|NAC is a therapy commonly used in the treatment of IPF. NAC use data is missing for two participants randomized to placebo.|participants|Number|8|8.0||||||
4192865|NCT00768300|4015737|B1|Yes||N-acetylcysteine (NAC) Use|NAC is a therapy commonly used in the treatment of IPF. NAC use data is missing for two participants randomized to placebo.|participants|Number|19|19.0||||||
4192866|NCT00768300|4015735|B3|No||N-acetylcysteine (NAC) Use|NAC is a therapy commonly used in the treatment of IPF. NAC use data is missing for two participants randomized to placebo.|participants|Number|463|463.0||||||
4192867|NCT00768300|4015736|B2|No||N-acetylcysteine (NAC) Use|NAC is a therapy commonly used in the treatment of IPF. NAC use data is missing for two participants randomized to placebo.|participants|Number|153|153.0||||||
4192868|NCT00768300|4015737|B1|No||N-acetylcysteine (NAC) Use|NAC is a therapy commonly used in the treatment of IPF. NAC use data is missing for two participants randomized to placebo.|participants|Number|310|310.0||||||
4192869|NCT00768300|4015735|B3|Yes||Prior IPF Medications|Prior IPF Medications data is missing for one participant randomized to placebo.|participants|Number|189|189.0||||||
4192870|NCT00768300|4015736|B2|Yes||Prior IPF Medications|Prior IPF Medications data is missing for one participant randomized to placebo.|participants|Number|65|65.0||||||
4192871|NCT00768300|4015737|B1|Yes||Prior IPF Medications|Prior IPF Medications data is missing for one participant randomized to placebo.|participants|Number|124|124.0||||||
4192872|NCT00768300|4015735|B3|No||Prior IPF Medications|Prior IPF Medications data is missing for one participant randomized to placebo.|participants|Number|302|302.0||||||
4192873|NCT00768300|4015736|B2|No||Prior IPF Medications|Prior IPF Medications data is missing for one participant randomized to placebo.|participants|Number|97|97.0||||||
4192874|NCT00768300|4015737|B1|No||Prior IPF Medications|Prior IPF Medications data is missing for one participant randomized to placebo.|participants|Number|205|205.0||||||
4192875|NCT00768300|4015735|B3|||Hemoglobin Adjusted Diffusing lung capacity for carbon monoxide (DLCO) percent predicted||percentage of DLCO % predicted|Least Squares Mean|43.20|43.2|Standard Deviation|13.69|13.69|||
4192876|NCT00768300|4015736|B2|||Hemoglobin Adjusted Diffusing lung capacity for carbon monoxide (DLCO) percent predicted||percentage of DLCO % predicted|Least Squares Mean|45.57|45.57|Standard Deviation|13.25|13.25|||
4192877|NCT00768300|4015737|B1|||Hemoglobin Adjusted Diffusing lung capacity for carbon monoxide (DLCO) percent predicted||percentage of DLCO % predicted|Least Squares Mean|42.04|42.04|Standard Deviation|13.77|13.77|||
4192878|NCT00768300|4015735|B3|||Six mile walk test (6MWT)||meters|Mean|413.7|413.7|Standard Deviation|119.6|119.6|||
4192879|NCT00768300|4015736|B2|||Six mile walk test (6MWT)||meters|Mean|420.5|420.5|Standard Deviation|121.4|121.4|||
4192880|NCT00768300|4015737|B1|||Six mile walk test (6MWT)||meters|Mean|410.4|410.4|Standard Deviation|118.7|118.7|||
4192881|NCT00768300|4015735|B3|||Forced vital capacity (FVC) percent predicted||percentage of FVC % predicted|Least Squares Mean|69.11|69.11|Standard Deviation|13.33|13.33|||
4192882|NCT00768300|4015736|B2|||Forced vital capacity (FVC) percent predicted||percentage of FVC % predicted|Least Squares Mean|69.86|69.86|Standard Deviation|13.75|13.75|||
4192883|NCT00768300|4015737|B1|||Forced vital capacity (FVC) percent predicted||percentage of FVC % predicted|Least Squares Mean|68.74|68.74|Standard Deviation|13.12|13.12|||
4192884|NCT00768300|4015735|B3|||Disease duration||years|Mean|1.06|1.06|Standard Deviation|1.33|1.33|||
4192885|NCT00768300|4015736|B2|||Disease duration||years|Mean|0.91|0.91|Standard Deviation|1.19|1.19|||
4192886|NCT00768300|4015737|B1|||Disease duration||years|Mean|1.13|1.13|Standard Deviation|1.39|1.39|||
4192887|NCT00768300|4015735|B3|Yes||Surgical lung biopsy (SLB) to Confirm Diagnosis of IPF (per IVRS)||participants|Number|230|230.0||||||
4192888|NCT00768300|4015736|B2|Yes||Surgical lung biopsy (SLB) to Confirm Diagnosis of IPF (per IVRS)||participants|Number|76|76.0||||||
4192889|NCT00768300|4015737|B1|Yes||Surgical lung biopsy (SLB) to Confirm Diagnosis of IPF (per IVRS)||participants|Number|154|154.0||||||
4192890|NCT00768300|4015735|B3|No||Surgical lung biopsy (SLB) to Confirm Diagnosis of IPF (per IVRS)||participants|Number|262|262.0||||||
4192891|NCT00768300|4015736|B2|No||Surgical lung biopsy (SLB) to Confirm Diagnosis of IPF (per IVRS)||participants|Number|87|87.0||||||
4192892|NCT00768300|4015737|B1|No||Surgical lung biopsy (SLB) to Confirm Diagnosis of IPF (per IVRS)||participants|Number|175|175.0||||||
4192893|NCT00768300|4015735|B3|Former||Smoking status|Smoking status data is missing for one participant randomized to placebo.|participants|Number|321|321.0||||||
4192894|NCT00768300|4015736|B2|Former||Smoking status|Smoking status data is missing for one participant randomized to placebo.|participants|Number|104|104.0||||||
4192895|NCT00768300|4015737|B1|Former||Smoking status|Smoking status data is missing for one participant randomized to placebo.|participants|Number|217|217.0||||||
4192896|NCT00768300|4015735|B3|Current||Smoking status|Smoking status data is missing for one participant randomized to placebo.|participants|Number|12|12.0||||||
4192897|NCT00768300|4015736|B2|Current||Smoking status|Smoking status data is missing for one participant randomized to placebo.|participants|Number|5|5.0||||||
4192898|NCT00768300|4015737|B1|Current||Smoking status|Smoking status data is missing for one participant randomized to placebo.|participants|Number|7|7.0||||||
4192899|NCT00768300|4015735|B3|Never||Smoking status|Smoking status data is missing for one participant randomized to placebo.|participants|Number|158|158.0||||||
4192900|NCT00768300|4015736|B2|Never||Smoking status|Smoking status data is missing for one participant randomized to placebo.|participants|Number|53|53.0||||||
4192901|NCT00768300|4015737|B1|Never||Smoking status|Smoking status data is missing for one participant randomized to placebo.|participants|Number|105|105.0||||||
4192902|NCT00768300|4015735|B3|Yes||Baseline Pulmonary Hypertension (PH) per interactive voice response system (IVRS)||participants|Number|54|54.0||||||
4192903|NCT00768300|4015736|B2|Yes||Baseline Pulmonary Hypertension (PH) per interactive voice response system (IVRS)||participants|Number|18|18.0||||||
4192904|NCT00768300|4015737|B1|Yes||Baseline Pulmonary Hypertension (PH) per interactive voice response system (IVRS)||participants|Number|36|36.0||||||
4192905|NCT00768300|4015735|B3|No||Baseline Pulmonary Hypertension (PH) per interactive voice response system (IVRS)||participants|Number|438|438.0||||||
4192906|NCT00768300|4015736|B2|No||Baseline Pulmonary Hypertension (PH) per interactive voice response system (IVRS)||participants|Number|145|145.0||||||
4192907|NCT00768300|4015737|B1|No||Baseline Pulmonary Hypertension (PH) per interactive voice response system (IVRS)||participants|Number|293|293.0||||||
4192908|NCT00768300|4015735|B3|Ireland||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|1|1.0||||||
4192909|NCT00768300|4015736|B2|Ireland||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|0|0.0||||||
4192910|NCT00768300|4015737|B1|Ireland||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|1|1.0||||||
4192911|NCT00768300|4015735|B3|Argentina||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|3|3.0||||||
4192912|NCT00768300|4015736|B2|Argentina||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|2|2.0||||||
4192913|NCT00768300|4015737|B1|Argentina||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|1|1.0||||||
4192914|NCT00768300|4015735|B3|Chile||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|4|4.0||||||
4192915|NCT00768300|4015736|B2|Chile||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|1|1.0||||||
4192916|NCT00768300|4015737|B1|Chile||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|3|3.0||||||
4192917|NCT00768300|4015735|B3|Austria||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|4|4.0||||||
4192918|NCT00768300|4015736|B2|Austria||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|2|2.0||||||
4192919|NCT00768300|4015737|B1|Austria||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|2|2.0||||||
4192920|NCT00768300|4015735|B3|Switzerland||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|6|6.0||||||
4192921|NCT00768300|4015736|B2|Switzerland||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|1|1.0||||||
4192922|NCT00768300|4015737|B1|Switzerland||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|5|5.0||||||
4192923|NCT00768300|4015735|B3|Poland||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|6|6.0||||||
4192924|NCT00768300|4015736|B2|Poland||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|3|3.0||||||
4192925|NCT00768300|4015737|B1|Poland||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|3|3.0||||||
4192926|NCT00768300|4015735|B3|Spain||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|8|8.0||||||
4192927|NCT00768300|4015736|B2|Spain||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|1|1.0||||||
4192928|NCT00768300|4015737|B1|Spain||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|7|7.0||||||
4192929|NCT00768300|4015735|B3|United Kingdom||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|9|9.0||||||
4192930|NCT00768300|4015736|B2|United Kingdom||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|6|6.0||||||
4192931|NCT00768300|4015737|B1|United Kingdom||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|3|3.0||||||
4192932|NCT00768300|4015735|B3|Mexico||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|9|9.0||||||
4192933|NCT00768300|4015736|B2|Mexico||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|4|4.0||||||
4192934|NCT00768300|4015737|B1|Mexico||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|5|5.0||||||
4192935|NCT00768300|4015735|B3|Colombia||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|11|11.0||||||
4192936|NCT00768300|4015736|B2|Colombia||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|3|3.0||||||
4192937|NCT00768300|4015737|B1|Colombia||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|8|8.0||||||
4192938|NCT00768300|4015735|B3|Belgium||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|13|13.0||||||
4192939|NCT00768300|4015736|B2|Belgium||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|6|6.0||||||
4192940|NCT00768300|4015737|B1|Belgium||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|7|7.0||||||
4192941|NCT00768300|4015735|B3|Italy||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|14|14.0||||||
4192942|NCT00768300|4015736|B2|Italy||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|3|3.0||||||
4192943|NCT00768300|4015737|B1|Italy||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|11|11.0||||||
4192944|NCT00768300|4015735|B3|Israel||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|15|15.0||||||
4192945|NCT00768300|4015736|B2|Israel||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|7|7.0||||||
4192946|NCT00768300|4015737|B1|Israel||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|8|8.0||||||
4192947|NCT00768300|4015735|B3|Czech Republic||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|16|16.0||||||
4192948|NCT00768300|4015736|B2|Czech Republic||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|6|6.0||||||
4192949|NCT00768300|4015737|B1|Czech Republic||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|10|10.0||||||
4192950|NCT00768300|4015735|B3|Peru||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|18|18.0||||||
4192951|NCT00768300|4015736|B2|Peru||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|6|6.0||||||
4192952|NCT00768300|4015737|B1|Peru||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|12|12.0||||||
4192953|NCT00768300|4015735|B3|Brazil||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|24|24.0||||||
4192954|NCT00768300|4015736|B2|Brazil||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|6|6.0||||||
4192955|NCT00768300|4015737|B1|Brazil||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|18|18.0||||||
4192956|NCT00768300|4015735|B3|Germany||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|26|26.0||||||
4192957|NCT00768300|4015736|B2|Germany||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|9|9.0||||||
4192958|NCT00768300|4015737|B1|Germany||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|17|17.0||||||
4192959|NCT00768300|4015735|B3|France||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|31|31.0||||||
4192960|NCT00768300|4015736|B2|France||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|10|10.0||||||
4192961|NCT00768300|4015737|B1|France||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|21|21.0||||||
4192962|NCT00768300|4015735|B3|Australia||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|34|34.0||||||
4192963|NCT00768300|4015736|B2|Australia||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|12|12.0||||||
4192964|NCT00768300|4015737|B1|Australia||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|22|22.0||||||
4192965|NCT00768300|4015735|B3|Canada||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|39|39.0||||||
4192966|NCT00768300|4015736|B2|Canada||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|14|14.0||||||
4192967|NCT00768300|4015737|B1|Canada||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|25|25.0||||||
4192968|NCT00768300|4015735|B3|United States||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|203|203.0||||||
4192969|NCT00768300|4015736|B2|United States||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|62|62.0||||||
4192970|NCT00768300|4015737|B1|United States||Region of Enrollment|All participants who were randomized are presented in Region of Enrollment (ambrisentan = 330; placebo = 164)|participants|Number|141|141.0||||||
4192971|NCT00768300|4015735|B3|Not Permitted||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4192972|NCT00768300|4015736|B2|Not Permitted||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4192973|NCT00768300|4015737|B1|Not Permitted||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4192974|NCT00768300|4015735|B3|Other||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4192975|NCT00768300|4015736|B2|Other||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4192976|NCT00768300|4015737|B1|Other||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4192977|NCT00768300|4015735|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4192978|NCT00768300|4015736|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4192979|NCT00768300|4015737|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4192980|NCT00768300|4015735|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4192981|NCT00768300|4015736|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4192982|NCT00768300|4015737|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4192983|NCT00768300|4015735|B3|White||Race/Ethnicity, Customized||participants|Number|438|438.0||||||
4192984|NCT00768300|4015736|B2|White||Race/Ethnicity, Customized||participants|Number|145|145.0||||||
4192985|NCT00768300|4015737|B1|White||Race/Ethnicity, Customized||participants|Number|293|293.0||||||
4192986|NCT00768300|4015735|B3|Black or African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4192987|NCT00768300|4015736|B2|Black or African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4192988|NCT00768300|4015737|B1|Black or African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4192989|NCT00768300|4015735|B3||Male|Sex: Female, Male||Participants|Count of Participants|355|355.0||||||
4192990|NCT00768300|4015736|B2||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4192991|NCT00768300|4015737|B1||Male|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
4192992|NCT00768300|4015735|B3||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4192993|NCT00768300|4015736|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4192994|NCT00768300|4015737|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4192995|NCT00768300|4015735|B3|||Age||years|Mean|65.9|65.9|Standard Deviation|7.3|7.3|||
4192996|NCT00768300|4015736|B2|||Age||years|Mean|66.1|66.1|Standard Deviation|7.1|7.1|||
4192997|NCT00768300|4015737|B1|||Age||years|Mean|65.8|65.8|Standard Deviation|7.4|7.4|||
4192998|NCT00768287|4015760|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4192999|NCT00768287|4015760|B1|Race|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4193000|NCT00768287|4015760|B1|Race|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|61|61.0||||||
4193001|NCT00768287|4015760|B1|Race|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4193002|NCT00768287|4015760|B1|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4193003|NCT00768287|4015760|B1|Race|American Indian/Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4193004|NCT00768287|4015760|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4193005|NCT00768287|4015760|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
4193006|NCT00768287|4015760|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4193007|NCT00768287|4015760|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4193008|NCT00768287|4015760|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4193009|NCT00768287|4015760|B1|||Age||years|Mean|30.8|30.8|Standard Deviation|14.54|14.54|||
4193010|NCT00768261|4015800|B5|United States||Region of Enrollment||Participants|Count of Participants|102|102.0||||||
4193011|NCT00768261|4015801|B4|United States||Region of Enrollment||Participants|Count of Participants|56|56.0||||||
4193012|NCT00768261|4015802|B3|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4193013|NCT00768261|4015803|B2|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4193014|NCT00768261|4015804|B1|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4193015|NCT00768261|4015800|B5||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4193016|NCT00768261|4015801|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4193017|NCT00768261|4015802|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4193018|NCT00768261|4015803|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4193019|NCT00768261|4015804|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4193020|NCT00768261|4015800|B5||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4193021|NCT00768261|4015801|B4||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4193022|NCT00768261|4015802|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4193023|NCT00768261|4015803|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4193024|NCT00768261|4015804|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4193025|NCT00768261|4015800|B5||>=65 years|Age||Participants|Count of Participants|100|100.0||||||
4193026|NCT00768261|4015801|B4||>=65 years|Age||Participants|Count of Participants|56|56.0||||||
4193027|NCT00768261|4015802|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4193028|NCT00768261|4015803|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4193029|NCT00768261|4015804|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4193030|NCT00768261|4015800|B5||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4193031|NCT00768261|4015801|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4193032|NCT00768261|4015802|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4193033|NCT00768261|4015803|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4193034|NCT00768261|4015804|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4193035|NCT00768261|4015800|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4193036|NCT00768261|4015801|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4193037|NCT00768261|4015802|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4193038|NCT00768261|4015803|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4193039|NCT00768261|4015804|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4193040|NCT00768222|4015820|B3|China||Region of Enrollment||participants|Number|101|101.0||||||
4193041|NCT00768222|4015821|B2|China||Region of Enrollment||participants|Number|51|51.0||||||
4193042|NCT00768222|4015822|B1|China||Region of Enrollment||participants|Number|50|50.0||||||
4193043|NCT00768222|4015820|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4193044|NCT00768222|4015821|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4193045|NCT00768222|4015822|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4193046|NCT00768222|4015820|B3||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4193047|NCT00768222|4015821|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4193048|NCT00768222|4015822|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4193049|NCT00768222|4015820|B3|||Age||years|Mean|52.6|52.6|Standard Deviation|11.2|11.2|||
4193050|NCT00768222|4015821|B2|||Age||years|Mean|53.0|53.0|Standard Deviation|12.1|12.1|||
4193051|NCT00768222|4015822|B1|||Age||years|Mean|52.2|52.2|Standard Deviation|10.3|10.3|||
4193052|NCT00768144|4015845|B1|Other (adenocarcinoma/mixed histology)||Histology||participants|Number|3|3.0||||||
4193053|NCT00768144|4015845|B1|Mixed Mullerian tumor||Histology||participants|Number|3|3.0||||||
4193054|NCT00768144|4015845|B1|Clear cell||Histology||participants|Number|5|5.0||||||
4193055|NCT00768144|4015845|B1|Endometrioid||Histology||participants|Number|2|2.0||||||
4193056|NCT00768144|4015845|B1|Papillary serous||Histology||participants|Number|23|23.0||||||
4193057|NCT00768144|4015845|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4193058|NCT00768144|4015845|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4193059|NCT00768144|4015845|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4193060|NCT00768144|4015845|B1|||Age||years|Mean|61|61.0|Standard Deviation|8.8|8.8|||
4193061|NCT00768144|4015845|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4193062|NCT00768144|4015845|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4193063|NCT00768144|4015845|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4193064|NCT00768118|4015851|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4193065|NCT00768118|4015851|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4193066|NCT00768118|4015851|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4193067|NCT00768118|4015851|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4193068|NCT00768118|4015851|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4193069|NCT00768118|4015851|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4193070|NCT00768066|4015855|B4|CT||Imaging Modality|Type of cardiac imaging modality specified for the participant at baseline.|participants|Number|18|18.0||||||
4193071|NCT00768066|4015856|B3|CT||Imaging Modality|Type of cardiac imaging modality specified for the participant at baseline.|participants|Number|6|6.0||||||
4193072|NCT00768066|4015857|B2|CT||Imaging Modality|Type of cardiac imaging modality specified for the participant at baseline.|participants|Number|6|6.0||||||
4193073|NCT00768066|4015858|B1|CT||Imaging Modality|Type of cardiac imaging modality specified for the participant at baseline.|participants|Number|6|6.0||||||
4193074|NCT00768066|4015855|B4|MRI||Imaging Modality|Type of cardiac imaging modality specified for the participant at baseline.|participants|Number|41|41.0||||||
4193075|NCT00768066|4015856|B3|MRI||Imaging Modality|Type of cardiac imaging modality specified for the participant at baseline.|participants|Number|15|15.0||||||
4193076|NCT00768066|4015857|B2|MRI||Imaging Modality|Type of cardiac imaging modality specified for the participant at baseline.|participants|Number|13|13.0||||||
4193077|NCT00768066|4015858|B1|MRI||Imaging Modality|Type of cardiac imaging modality specified for the participant at baseline.|participants|Number|13|13.0||||||
4193078|NCT00768066|4015855|B4|None||Device|Type of cardiac device participant had at baseline.|participants|Number|26|26.0||||||
4193079|NCT00768066|4015856|B3|None||Device|Type of cardiac device participant had at baseline.|participants|Number|10|10.0||||||
4193080|NCT00768066|4015857|B2|None||Device|Type of cardiac device participant had at baseline.|participants|Number|8|8.0||||||
4193081|NCT00768066|4015858|B1|None||Device|Type of cardiac device participant had at baseline.|participants|Number|8|8.0||||||
4193082|NCT00768066|4015855|B4|Biventricular Pacing||Device|Type of cardiac device participant had at baseline.|participants|Number|5|5.0||||||
4193083|NCT00768066|4015856|B3|Biventricular Pacing||Device|Type of cardiac device participant had at baseline.|participants|Number|3|3.0||||||
4193084|NCT00768066|4015857|B2|Biventricular Pacing||Device|Type of cardiac device participant had at baseline.|participants|Number|1|1.0||||||
4193085|NCT00768066|4015858|B1|Biventricular Pacing||Device|Type of cardiac device participant had at baseline.|participants|Number|1|1.0||||||
4193086|NCT00768066|4015855|B4|Automatic implanted cardioverter-defribillator||Device|Type of cardiac device participant had at baseline.|participants|Number|28|28.0||||||
4193087|NCT00768066|4015856|B3|Automatic implanted cardioverter-defribillator||Device|Type of cardiac device participant had at baseline.|participants|Number|8|8.0||||||
4193088|NCT00768066|4015857|B2|Automatic implanted cardioverter-defribillator||Device|Type of cardiac device participant had at baseline.|participants|Number|10|10.0||||||
4193089|NCT00768066|4015858|B1|Automatic implanted cardioverter-defribillator||Device|Type of cardiac device participant had at baseline.|participants|Number|10|10.0||||||
4193090|NCT00768066|4015855|B4|||Predicted FEV1||percent|Mean|82.7|82.7|Standard Deviation|19.8|19.8|||
4193091|NCT00768066|4015856|B3|||Predicted FEV1||percent|Mean|79.1|79.1|Standard Deviation|20.1|20.1|||
4193092|NCT00768066|4015857|B2|||Predicted FEV1||percent|Mean|83.2|83.2|Standard Deviation|23.2|23.2|||
4193093|NCT00768066|4015858|B1|||Predicted FEV1||percent|Mean|86.2|86.2|Standard Deviation|15.7|15.7|||
4193094|NCT00768066|4015855|B4|||Peak VO2||mL/kg/min|Mean|16.7|16.7|Standard Deviation|5.0|5.0|||
4193095|NCT00768066|4015856|B3|||Peak VO2||mL/kg/min|Mean|14.6|14.6|Standard Deviation|5.6|5.6|||
4193096|NCT00768066|4015857|B2|||Peak VO2||mL/kg/min|Mean|17.3|17.3|Standard Deviation|4.4|4.4|||
4193097|NCT00768066|4015858|B1|||Peak VO2||mL/kg/min|Mean|18.8|18.8|Standard Deviation|3.8|3.8|||
4193098|NCT00768066|4015855|B4|||Distance Walked in 6-Minutes||meters|Mean|400.6|400.6|Standard Deviation|74.4|74.4|||
4193099|NCT00768066|4015856|B3|||Distance Walked in 6-Minutes||meters|Mean|388.1|388.1|Standard Deviation|58.4|58.4|||
4193100|NCT00768066|4015857|B2|||Distance Walked in 6-Minutes||meters|Mean|399.6|399.6|Standard Deviation|95.0|95.0|||
4193101|NCT00768066|4015858|B1|||Distance Walked in 6-Minutes||meters|Mean|415.3|415.3|Standard Deviation|67.9|67.9|||
4193102|NCT00768066|4015855|B4|Unknown||New York Heart Association Class|New York Heart Association Funcational classificaiton classifies the extent of heart failure in a patient. The 4 categories are based on how much patients are limited by physical activity, breathing, shortness of breath and/or angina pain. A class of 1 is a better New York Heart Association Class and a class of 4 is a worse New York Heart Association Class.|participants|Number|3|3.0||||||
4193103|NCT00768066|4015856|B3|Unknown||New York Heart Association Class|New York Heart Association Funcational classificaiton classifies the extent of heart failure in a patient. The 4 categories are based on how much patients are limited by physical activity, breathing, shortness of breath and/or angina pain. A class of 1 is a better New York Heart Association Class and a class of 4 is a worse New York Heart Association Class.|participants|Number|3|3.0||||||
4193104|NCT00768066|4015857|B2|Unknown||New York Heart Association Class|New York Heart Association Funcational classificaiton classifies the extent of heart failure in a patient. The 4 categories are based on how much patients are limited by physical activity, breathing, shortness of breath and/or angina pain. A class of 1 is a better New York Heart Association Class and a class of 4 is a worse New York Heart Association Class.|participants|Number|0|0.0||||||
4193105|NCT00768066|4015858|B1|Unknown||New York Heart Association Class|New York Heart Association Funcational classificaiton classifies the extent of heart failure in a patient. The 4 categories are based on how much patients are limited by physical activity, breathing, shortness of breath and/or angina pain. A class of 1 is a better New York Heart Association Class and a class of 4 is a worse New York Heart Association Class.|participants|Number|0|0.0||||||
4193136|NCT00768066|4015857|B2|No||History of Diabetes||participants|Number|15|15.0||||||
4193137|NCT00768066|4015858|B1|No||History of Diabetes||participants|Number|16|16.0||||||
4193138|NCT00768066|4015855|B4|Yes||History of Diabetes||participants|Number|14|14.0||||||
4193106|NCT00768066|4015855|B4|III||New York Heart Association Class|New York Heart Association Funcational classificaiton classifies the extent of heart failure in a patient. The 4 categories are based on how much patients are limited by physical activity, breathing, shortness of breath and/or angina pain. A class of 1 is a better New York Heart Association Class and a class of 4 is a worse New York Heart Association Class.|participants|Number|10|10.0||||||
4193107|NCT00768066|4015856|B3|III||New York Heart Association Class|New York Heart Association Funcational classificaiton classifies the extent of heart failure in a patient. The 4 categories are based on how much patients are limited by physical activity, breathing, shortness of breath and/or angina pain. A class of 1 is a better New York Heart Association Class and a class of 4 is a worse New York Heart Association Class.|participants|Number|4|4.0||||||
4193108|NCT00768066|4015857|B2|III||New York Heart Association Class|New York Heart Association Funcational classificaiton classifies the extent of heart failure in a patient. The 4 categories are based on how much patients are limited by physical activity, breathing, shortness of breath and/or angina pain. A class of 1 is a better New York Heart Association Class and a class of 4 is a worse New York Heart Association Class.|participants|Number|4|4.0||||||
4193109|NCT00768066|4015858|B1|III||New York Heart Association Class|New York Heart Association Funcational classificaiton classifies the extent of heart failure in a patient. The 4 categories are based on how much patients are limited by physical activity, breathing, shortness of breath and/or angina pain. A class of 1 is a better New York Heart Association Class and a class of 4 is a worse New York Heart Association Class.|participants|Number|2|2.0||||||
4193110|NCT00768066|4015855|B4|II||New York Heart Association Class|New York Heart Association Funcational classificaiton classifies the extent of heart failure in a patient. The 4 categories are based on how much patients are limited by physical activity, breathing, shortness of breath and/or angina pain. A class of 1 is a better New York Heart Association Class and a class of 4 is a worse New York Heart Association Class.|participants|Number|32|32.0||||||
4193111|NCT00768066|4015856|B3|II||New York Heart Association Class|New York Heart Association Funcational classificaiton classifies the extent of heart failure in a patient. The 4 categories are based on how much patients are limited by physical activity, breathing, shortness of breath and/or angina pain. A class of 1 is a better New York Heart Association Class and a class of 4 is a worse New York Heart Association Class.|participants|Number|10|10.0||||||
4193112|NCT00768066|4015857|B2|II||New York Heart Association Class|New York Heart Association Funcational classificaiton classifies the extent of heart failure in a patient. The 4 categories are based on how much patients are limited by physical activity, breathing, shortness of breath and/or angina pain. A class of 1 is a better New York Heart Association Class and a class of 4 is a worse New York Heart Association Class.|participants|Number|10|10.0||||||
4193113|NCT00768066|4015858|B1|II||New York Heart Association Class|New York Heart Association Funcational classificaiton classifies the extent of heart failure in a patient. The 4 categories are based on how much patients are limited by physical activity, breathing, shortness of breath and/or angina pain. A class of 1 is a better New York Heart Association Class and a class of 4 is a worse New York Heart Association Class.|participants|Number|12|12.0||||||
4193114|NCT00768066|4015855|B4|I||New York Heart Association Class|New York Heart Association Funcational classificaiton classifies the extent of heart failure in a patient. The 4 categories are based on how much patients are limited by physical activity, breathing, shortness of breath and/or angina pain. A class of 1 is a better New York Heart Association Class and a class of 4 is a worse New York Heart Association Class.|participants|Number|14|14.0||||||
4193115|NCT00768066|4015856|B3|I||New York Heart Association Class|New York Heart Association Funcational classificaiton classifies the extent of heart failure in a patient. The 4 categories are based on how much patients are limited by physical activity, breathing, shortness of breath and/or angina pain. A class of 1 is a better New York Heart Association Class and a class of 4 is a worse New York Heart Association Class.|participants|Number|4|4.0||||||
4193116|NCT00768066|4015857|B2|I||New York Heart Association Class|New York Heart Association Funcational classificaiton classifies the extent of heart failure in a patient. The 4 categories are based on how much patients are limited by physical activity, breathing, shortness of breath and/or angina pain. A class of 1 is a better New York Heart Association Class and a class of 4 is a worse New York Heart Association Class.|participants|Number|5|5.0||||||
4193117|NCT00768066|4015858|B1|I||New York Heart Association Class|New York Heart Association Funcational classificaiton classifies the extent of heart failure in a patient. The 4 categories are based on how much patients are limited by physical activity, breathing, shortness of breath and/or angina pain. A class of 1 is a better New York Heart Association Class and a class of 4 is a worse New York Heart Association Class.|participants|Number|5|5.0||||||
4193118|NCT00768066|4015855|B4|No||History of Smoking||participants|Number|19|19.0||||||
4193119|NCT00768066|4015856|B3|No||History of Smoking||participants|Number|5|5.0||||||
4193120|NCT00768066|4015857|B2|No||History of Smoking||participants|Number|9|9.0||||||
4193121|NCT00768066|4015858|B1|No||History of Smoking||participants|Number|5|5.0||||||
4193122|NCT00768066|4015855|B4|Yes||History of Smoking||participants|Number|40|40.0||||||
4193123|NCT00768066|4015856|B3|Yes||History of Smoking||participants|Number|16|16.0||||||
4193124|NCT00768066|4015857|B2|Yes||History of Smoking||participants|Number|10|10.0||||||
4193125|NCT00768066|4015858|B1|Yes||History of Smoking||participants|Number|14|14.0||||||
4193126|NCT00768066|4015855|B4|No||History of Congestive Heart Failure||participants|Number|16|16.0||||||
4193127|NCT00768066|4015856|B3|No||History of Congestive Heart Failure||participants|Number|5|5.0||||||
4193128|NCT00768066|4015857|B2|No||History of Congestive Heart Failure||participants|Number|3|3.0||||||
4193129|NCT00768066|4015858|B1|No||History of Congestive Heart Failure||participants|Number|8|8.0||||||
4193130|NCT00768066|4015855|B4|Yes||History of Congestive Heart Failure||participants|Number|43|43.0||||||
4193131|NCT00768066|4015856|B3|Yes||History of Congestive Heart Failure||participants|Number|16|16.0||||||
4193132|NCT00768066|4015857|B2|Yes||History of Congestive Heart Failure||participants|Number|16|16.0||||||
4193133|NCT00768066|4015858|B1|Yes||History of Congestive Heart Failure||participants|Number|11|11.0||||||
4193134|NCT00768066|4015855|B4|No||History of Diabetes||participants|Number|45|45.0||||||
4193135|NCT00768066|4015856|B3|No||History of Diabetes||participants|Number|14|14.0||||||
4193139|NCT00768066|4015856|B3|Yes||History of Diabetes||participants|Number|7|7.0||||||
4193140|NCT00768066|4015857|B2|Yes||History of Diabetes||participants|Number|4|4.0||||||
4193141|NCT00768066|4015858|B1|Yes||History of Diabetes||participants|Number|3|3.0||||||
4193142|NCT00768066|4015855|B4|No||History of Hyptertension||participants|Number|19|19.0||||||
4193143|NCT00768066|4015856|B3|No||History of Hyptertension||participants|Number|5|5.0||||||
4193144|NCT00768066|4015857|B2|No||History of Hyptertension||participants|Number|7|7.0||||||
4193145|NCT00768066|4015858|B1|No||History of Hyptertension||participants|Number|7|7.0||||||
4193146|NCT00768066|4015855|B4|Yes||History of Hyptertension||participants|Number|40|40.0||||||
4193147|NCT00768066|4015856|B3|Yes||History of Hyptertension||participants|Number|16|16.0||||||
4193148|NCT00768066|4015857|B2|Yes||History of Hyptertension||participants|Number|12|12.0||||||
4193149|NCT00768066|4015858|B1|Yes||History of Hyptertension||participants|Number|12|12.0||||||
4193150|NCT00768066|4015855|B4|No||History of Atrial/Ventricular Arrhythmia||participants|Number|44|44.0||||||
4193151|NCT00768066|4015856|B3|No||History of Atrial/Ventricular Arrhythmia||participants|Number|15|15.0||||||
4193152|NCT00768066|4015857|B2|No||History of Atrial/Ventricular Arrhythmia||participants|Number|15|15.0||||||
4193153|NCT00768066|4015858|B1|No||History of Atrial/Ventricular Arrhythmia||participants|Number|14|14.0||||||
4193154|NCT00768066|4015855|B4|Yes||History of Atrial/Ventricular Arrhythmia||participants|Number|15|15.0||||||
4193155|NCT00768066|4015856|B3|Yes||History of Atrial/Ventricular Arrhythmia||participants|Number|6|6.0||||||
4193156|NCT00768066|4015857|B2|Yes||History of Atrial/Ventricular Arrhythmia||participants|Number|4|4.0||||||
4193157|NCT00768066|4015858|B1|Yes||History of Atrial/Ventricular Arrhythmia||participants|Number|5|5.0||||||
4193158|NCT00768066|4015855|B4|No||History of Coronary Interventions||participants|Number|2|2.0||||||
4193159|NCT00768066|4015856|B3|No||History of Coronary Interventions||participants|Number|1|1.0||||||
4193160|NCT00768066|4015857|B2|No||History of Coronary Interventions||participants|Number|1|1.0||||||
4193161|NCT00768066|4015858|B1|No||History of Coronary Interventions||participants|Number|0|0.0||||||
4193162|NCT00768066|4015855|B4|Yes||History of Coronary Interventions||participants|Number|57|57.0||||||
4193163|NCT00768066|4015856|B3|Yes||History of Coronary Interventions||participants|Number|20|20.0||||||
4193164|NCT00768066|4015857|B2|Yes||History of Coronary Interventions||participants|Number|18|18.0||||||
4193165|NCT00768066|4015858|B1|Yes||History of Coronary Interventions||participants|Number|19|19.0||||||
4193166|NCT00768066|4015855|B4|||Qualifying ejection fraction, %||percent|Mean|34.9|34.9|Standard Deviation|9.7|9.7|||
4193167|NCT00768066|4015856|B3|||Qualifying ejection fraction, %||percent|Mean|33.0|33.0|Standard Deviation|9.6|9.6|||
4193168|NCT00768066|4015857|B2|||Qualifying ejection fraction, %||percent|Mean|36.3|36.3|Standard Deviation|11.1|11.1|||
4193169|NCT00768066|4015858|B1|||Qualifying ejection fraction, %||percent|Mean|35.8|35.8|Standard Deviation|8.5|8.5|||
4193170|NCT00768066|4015855|B4|United States||Region of Enrollment||participants|Number|59|59.0||||||
4193171|NCT00768066|4015856|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4193172|NCT00768066|4015857|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4193173|NCT00768066|4015858|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4193174|NCT00768066|4015855|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4193175|NCT00768066|4015856|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4193176|NCT00768066|4015857|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4193177|NCT00768066|4015858|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4193178|NCT00768066|4015855|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4193179|NCT00768066|4015856|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4193180|NCT00768066|4015857|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4193181|NCT00768066|4015858|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4193182|NCT00768066|4015855|B4||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4193183|NCT00768066|4015856|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4193184|NCT00768066|4015857|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4193185|NCT00768066|4015858|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4193186|NCT00768066|4015855|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4193187|NCT00768066|4015856|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4193188|NCT00768066|4015857|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4193189|NCT00768066|4015858|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4193190|NCT00768066|4015855|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4193191|NCT00768066|4015856|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4193192|NCT00768066|4015857|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4193193|NCT00768066|4015858|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4193194|NCT00768066|4015855|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4193195|NCT00768066|4015856|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4193196|NCT00768066|4015857|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4193197|NCT00768066|4015858|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4193198|NCT00768066|4015855|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4193199|NCT00768066|4015856|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4193200|NCT00768066|4015857|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4193201|NCT00768066|4015858|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4193202|NCT00768066|4015855|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4193203|NCT00768066|4015856|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4193204|NCT00768066|4015857|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4193205|NCT00768066|4015858|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4193206|NCT00768066|4015855|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4193207|NCT00768066|4015856|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4193208|NCT00768066|4015857|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4193209|NCT00768066|4015858|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4193210|NCT00768066|4015855|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4193211|NCT00768066|4015856|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4193212|NCT00768066|4015857|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4193213|NCT00768066|4015858|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4193214|NCT00768066|4015855|B4||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4193215|NCT00768066|4015856|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4193216|NCT00768066|4015857|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4193217|NCT00768066|4015858|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4193218|NCT00768066|4015855|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4193219|NCT00768066|4015856|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4193220|NCT00768066|4015857|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4193221|NCT00768066|4015858|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4193222|NCT00768066|4015855|B4|||Age||years|Mean|59.6|59.6|Standard Deviation|9.9|9.9|||
4193223|NCT00768066|4015856|B3|||Age||years|Mean|60.6|60.6|Standard Deviation|10.4|10.4|||
4193224|NCT00768066|4015857|B2|||Age||years|Mean|61.1|61.1|Standard Deviation|8.4|8.4|||
4193225|NCT00768066|4015858|B1|||Age||years|Mean|57.1|57.1|Standard Deviation|10.6|10.6|||
4193226|NCT00768053|4015892|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4193227|NCT00768053|4015892|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4193228|NCT00768053|4015892|B1|||Age||years|Mean|53.6|53.6|Standard Deviation|12.9|12.9|||
4193229|NCT00768040|4015921|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4193230|NCT00768040|4015922|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4193231|NCT00768040|4015923|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4193232|NCT00768040|4015921|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4193233|NCT00768040|4015922|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4193234|NCT00768040|4015923|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4193235|NCT00768040|4015921|B3|65 - 84 years||Age, Customized||participants|Number|17|17.0||||||
4193236|NCT00768040|4015922|B2|65 - 84 years||Age, Customized||participants|Number|6|6.0||||||
4193237|NCT00768040|4015923|B1|65 - 84 years||Age, Customized||participants|Number|11|11.0||||||
4193238|NCT00768040|4015921|B3|18 - 64 years||Age, Customized||participants|Number|22|22.0||||||
4193239|NCT00768040|4015922|B2|18 - 64 years||Age, Customized||participants|Number|13|13.0||||||
4193240|NCT00768040|4015923|B1|18 - 64 years||Age, Customized||participants|Number|9|9.0||||||
4193241|NCT00768040|4015921|B3|||Age||years|Mean|62.2|62.2|Standard Deviation|10.74|10.74|||
4193242|NCT00768040|4015922|B2|||Age||years|Mean|60.1|60.1|Standard Deviation|10.57|10.57|||
4193243|NCT00768040|4015923|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|10.76|10.76|||
4193244|NCT00767806|4015930|B3|||Weight||kilogram|Mean|78.83|78.83|Standard Deviation|15.23|15.23|||
4193245|NCT00767806|4015931|B2|||Weight||kilogram|Mean|79.35|79.35|Standard Deviation|14.65|14.65|||
4193246|NCT00767806|4015932|B1|||Weight||kilogram|Mean|78.30|78.3|Standard Deviation|15.83|15.83|||
4193247|NCT00767806|4015930|B3|||Weekly mean of 24-hour average pain rating using an 11-point numerical scale patient diary|24-hour average pain severity scores recorded daily on an 11-point Likert scale, an ordinal scale ranging from 0 (no pain) to 10 (worst possible pain). Patients should complete the electronic diary at bedtime. The 11-point Likert scale will also be used for assessment of night pain and worst pain each day, and evaluated as weekly means.|units on a scale|Mean|5.80|5.8|Standard Deviation|1.36|1.36|||
4193248|NCT00767806|4015931|B2|||Weekly mean of 24-hour average pain rating using an 11-point numerical scale patient diary|24-hour average pain severity scores recorded daily on an 11-point Likert scale, an ordinal scale ranging from 0 (no pain) to 10 (worst possible pain). Patients should complete the electronic diary at bedtime. The 11-point Likert scale will also be used for assessment of night pain and worst pain each day, and evaluated as weekly means.|units on a scale|Mean|5.80|5.8|Standard Deviation|1.37|1.37|||
4193275|NCT00767806|4015931|B2|Class 1||Quebec Task Force on Spinal Disorders|Quebec Task Force: class 1: pain; class 2: pain with radiation to lower limb proximally. Data was not available for all participants.|participants|Number|168|168.0||||||
4193249|NCT00767806|4015932|B1|||Weekly mean of 24-hour average pain rating using an 11-point numerical scale patient diary|24-hour average pain severity scores recorded daily on an 11-point Likert scale, an ordinal scale ranging from 0 (no pain) to 10 (worst possible pain). Patients should complete the electronic diary at bedtime. The 11-point Likert scale will also be used for assessment of night pain and worst pain each day, and evaluated as weekly means.|units on a scale|Mean|5.79|5.79|Standard Deviation|1.36|1.36|||
4193250|NCT00767806|4015930|B3|||Roland Morris Disability Questionnaire|Roland-Morris questionnaire will be completed by the patient and measures the degree of disability due to back pain. The questionnaire consists of 24 statements and the patient is instructed to put a mark next to each appropriate statement. The number of statements marked will be added up by the clinician and a total score is given. The total score ranges from 0 (no disability) to 24 (severe disability).|units on a scale|Mean|9.47|9.47|Standard Deviation|4.70|4.7|||
4193251|NCT00767806|4015931|B2|||Roland Morris Disability Questionnaire|Roland-Morris questionnaire will be completed by the patient and measures the degree of disability due to back pain. The questionnaire consists of 24 statements and the patient is instructed to put a mark next to each appropriate statement. The number of statements marked will be added up by the clinician and a total score is given. The total score ranges from 0 (no disability) to 24 (severe disability).|units on a scale|Mean|9.32|9.32|Standard Deviation|4.77|4.77|||
4193252|NCT00767806|4015932|B1|||Roland Morris Disability Questionnaire|Roland-Morris questionnaire will be completed by the patient and measures the degree of disability due to back pain. The questionnaire consists of 24 statements and the patient is instructed to put a mark next to each appropriate statement. The number of statements marked will be added up by the clinician and a total score is given. The total score ranges from 0 (no disability) to 24 (severe disability).|units on a scale|Mean|9.63|9.63|Standard Deviation|4.64|4.64|||
4193253|NCT00767806|4015930|B3|||Height||centimeter|Mean|168.07|168.07|Standard Deviation|9.22|9.22|||
4193254|NCT00767806|4015931|B2|||Height||centimeter|Mean|167.91|167.91|Standard Deviation|8.82|8.82|||
4193255|NCT00767806|4015932|B1|||Height||centimeter|Mean|168.24|168.24|Standard Deviation|9.64|9.64|||
4193256|NCT00767806|4015930|B3|||Duration of Chronic Lower Back Pain||years|Mean|8.51|8.51|Standard Deviation|8.57|8.57|||
4193257|NCT00767806|4015931|B2|||Duration of Chronic Lower Back Pain||years|Mean|8.74|8.74|Standard Deviation|8.95|8.95|||
4193258|NCT00767806|4015932|B1|||Duration of Chronic Lower Back Pain||years|Mean|8.28|8.28|Standard Deviation|8.18|8.18|||
4193259|NCT00767806|4015930|B3|||Clinical Global Impression - Severity (CGI-S)|CGI-S at baseline measures severity of illness at the start of treatment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|3.39|3.39|Standard Deviation|1.27|1.27|||
4193260|NCT00767806|4015931|B2|||Clinical Global Impression - Severity (CGI-S)|CGI-S at baseline measures severity of illness at the start of treatment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|3.29|3.29|Standard Deviation|1.28|1.28|||
4193261|NCT00767806|4015932|B1|||Clinical Global Impression - Severity (CGI-S)|CGI-S at baseline measures severity of illness at the start of treatment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|3.49|3.49|Standard Deviation|1.24|1.24|||
4193262|NCT00767806|4015930|B3|||Brief Pain Inventory Average Pain Rating|A self-reported scale that measures the severity of pain based on the average pain over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|5.79|5.79|Standard Deviation|1.40|1.4|||
4193263|NCT00767806|4015931|B2|||Brief Pain Inventory Average Pain Rating|A self-reported scale that measures the severity of pain based on the average pain over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|5.75|5.75|Standard Deviation|1.37|1.37|||
4193264|NCT00767806|4015932|B1|||Brief Pain Inventory Average Pain Rating|A self-reported scale that measures the severity of pain based on the average pain over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|5.84|5.84|Standard Deviation|1.43|1.43|||
4193265|NCT00767806|4015930|B3|||Body Mass Index (BMI)|The BMI is the weight of the participant divided by the squared height of the participant.|kilogram/meter squared|Mean|27.85|27.85|Standard Deviation|4.62|4.62|||
4193266|NCT00767806|4015931|B2|||Body Mass Index (BMI)|The BMI is the weight of the participant divided by the squared height of the participant.|kilogram/meter squared|Mean|28.14|28.14|Standard Deviation|4.72|4.72|||
4193267|NCT00767806|4015932|B1|||Body Mass Index (BMI)|The BMI is the weight of the participant divided by the squared height of the participant.|kilogram/meter squared|Mean|27.56|27.56|Standard Deviation|4.50|4.5|||
4193268|NCT00767806|4015930|B3|Not Available||Quebec Task Force on Spinal Disorders|Quebec Task Force: class 1: pain; class 2: pain with radiation to lower limb proximally. Data was not available for all participants.|participants|Number|9|9.0||||||
4193269|NCT00767806|4015931|B2|Not Available||Quebec Task Force on Spinal Disorders|Quebec Task Force: class 1: pain; class 2: pain with radiation to lower limb proximally. Data was not available for all participants.|participants|Number|5|5.0||||||
4193270|NCT00767806|4015932|B1|Not Available||Quebec Task Force on Spinal Disorders|Quebec Task Force: class 1: pain; class 2: pain with radiation to lower limb proximally. Data was not available for all participants.|participants|Number|4|4.0||||||
4193271|NCT00767806|4015930|B3|Class 2||Quebec Task Force on Spinal Disorders|Quebec Task Force: class 1: pain; class 2: pain with radiation to lower limb proximally. Data was not available for all participants.|participants|Number|51|51.0||||||
4193272|NCT00767806|4015931|B2|Class 2||Quebec Task Force on Spinal Disorders|Quebec Task Force: class 1: pain; class 2: pain with radiation to lower limb proximally. Data was not available for all participants.|participants|Number|30|30.0||||||
4193273|NCT00767806|4015932|B1|Class 2||Quebec Task Force on Spinal Disorders|Quebec Task Force: class 1: pain; class 2: pain with radiation to lower limb proximally. Data was not available for all participants.|participants|Number|21|21.0||||||
4193274|NCT00767806|4015930|B3|Class 1||Quebec Task Force on Spinal Disorders|Quebec Task Force: class 1: pain; class 2: pain with radiation to lower limb proximally. Data was not available for all participants.|participants|Number|341|341.0||||||
4193276|NCT00767806|4015932|B1|Class 1||Quebec Task Force on Spinal Disorders|Quebec Task Force: class 1: pain; class 2: pain with radiation to lower limb proximally. Data was not available for all participants.|participants|Number|173|173.0||||||
4193277|NCT00767806|4015930|B3|Germany||Region of Enrollment||participants|Number|49|49.0||||||
4193278|NCT00767806|4015931|B2|Germany||Region of Enrollment||participants|Number|26|26.0||||||
4193279|NCT00767806|4015932|B1|Germany||Region of Enrollment||participants|Number|23|23.0||||||
4193280|NCT00767806|4015930|B3|Netherlands||Region of Enrollment||participants|Number|32|32.0||||||
4193281|NCT00767806|4015931|B2|Netherlands||Region of Enrollment||participants|Number|16|16.0||||||
4193282|NCT00767806|4015932|B1|Netherlands||Region of Enrollment||participants|Number|16|16.0||||||
4193283|NCT00767806|4015930|B3|Russian Federation||Region of Enrollment||participants|Number|68|68.0||||||
4193284|NCT00767806|4015931|B2|Russian Federation||Region of Enrollment||participants|Number|33|33.0||||||
4193285|NCT00767806|4015932|B1|Russian Federation||Region of Enrollment||participants|Number|35|35.0||||||
4193286|NCT00767806|4015930|B3|Spain||Region of Enrollment||participants|Number|51|51.0||||||
4193287|NCT00767806|4015931|B2|Spain||Region of Enrollment||participants|Number|26|26.0||||||
4193288|NCT00767806|4015932|B1|Spain||Region of Enrollment||participants|Number|25|25.0||||||
4193289|NCT00767806|4015930|B3|Poland||Region of Enrollment||participants|Number|70|70.0||||||
4193290|NCT00767806|4015931|B2|Poland||Region of Enrollment||participants|Number|35|35.0||||||
4193291|NCT00767806|4015932|B1|Poland||Region of Enrollment||participants|Number|35|35.0||||||
4193292|NCT00767806|4015930|B3|United States||Region of Enrollment||participants|Number|131|131.0||||||
4193293|NCT00767806|4015931|B2|United States||Region of Enrollment||participants|Number|67|67.0||||||
4193294|NCT00767806|4015932|B1|United States||Region of Enrollment||participants|Number|64|64.0||||||
4193295|NCT00767806|4015930|B3|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4193296|NCT00767806|4015931|B2|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4193297|NCT00767806|4015932|B1|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4193298|NCT00767806|4015930|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4193299|NCT00767806|4015931|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4193300|NCT00767806|4015932|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4193301|NCT00767806|4015930|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|382|382.0||||||
4193302|NCT00767806|4015931|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|193|193.0||||||
4193303|NCT00767806|4015932|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|189|189.0||||||
4193304|NCT00767806|4015930|B3|African||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4193305|NCT00767806|4015931|B2|African||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4193306|NCT00767806|4015932|B1|African||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4193307|NCT00767806|4015930|B3||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4193308|NCT00767806|4015931|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4193309|NCT00767806|4015932|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4193310|NCT00767806|4015930|B3||Female|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
4193311|NCT00767806|4015931|B2||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4193312|NCT00767806|4015932|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4193313|NCT00767806|4015930|B3|||Age||years|Mean|54.14|54.14|Standard Deviation|13.73|13.73|||
4193314|NCT00767806|4015931|B2|||Age||years|Mean|53.43|53.43|Standard Deviation|14.17|14.17|||
4193315|NCT00767806|4015932|B1|||Age||years|Mean|54.87|54.87|Standard Deviation|13.27|13.27|||
4193316|NCT00767767|4015989|B6||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4193317|NCT00767767|4015990|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4193318|NCT00767767|4015991|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4193319|NCT00767767|4015992|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4193320|NCT00767767|4015993|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4193321|NCT00767767|4015994|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4193322|NCT00767767|4015989|B6||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4193323|NCT00767767|4015990|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4193324|NCT00767767|4015991|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4193325|NCT00767767|4015992|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4193326|NCT00767767|4015993|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4193327|NCT00767767|4015994|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4193328|NCT00767767|4015989|B6|||Age||years|Mean|25.2|25.2|Standard Deviation|4.4|4.4|||
4193329|NCT00767767|4015990|B5|||Age||years|Mean|26.3|26.3|Standard Deviation|5.8|5.8|||
4193330|NCT00767767|4015991|B4|||Age||years|Mean|23.7|23.7|Standard Deviation|3.4|3.4|||
4193331|NCT00767767|4015992|B3|||Age||years|Mean|25.6|25.6|Standard Deviation|4.5|4.5|||
4193332|NCT00767767|4015993|B2|||Age||years|Mean|25.4|25.4|Standard Deviation|4.1|4.1|||
4193333|NCT00767767|4015994|B1|||Age||years|Mean|25.1|25.1|Standard Deviation|4.4|4.4|||
4193334|NCT00767676|4016010|B1|United States||Region of Enrollment||participants|Number|259|259.0||||||
4193335|NCT00767676|4016010|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4193336|NCT00767676|4016010|B1||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4193337|NCT00767676|4016010|B1|||Age||years|Mean|40.9|40.9|Standard Deviation|12.0|12.0|||
4193338|NCT00767676|4016010|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4193339|NCT00767676|4016010|B1||Between 18 and 65 years|Age||Participants|Count of Participants|256|256.0||||||
4193340|NCT00767676|4016010|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4193341|NCT00767624|4016014|B3|||Hamilton Rating Scale for Depression (HRSD)|The HRSD is a 17-item semi-structured interview assessing the severity of depression in the past week. Items are rated on a 3 or 5 point scale. The total score is the sum of individual items, yielding a total score ranging from 0 to 52, with larger numbers representing greater severity. The total score is interpreted as follows: absence of depression (0-7); mild depression (8- 16); moderate depression (17-23); and severe depression (24-52).|units on a scale|Mean|21.7|21.7|Standard Deviation|3.7|3.7|||
4193342|NCT00767624|4016015|B2|||Hamilton Rating Scale for Depression (HRSD)|The HRSD is a 17-item semi-structured interview assessing the severity of depression in the past week. Items are rated on a 3 or 5 point scale. The total score is the sum of individual items, yielding a total score ranging from 0 to 52, with larger numbers representing greater severity. The total score is interpreted as follows: absence of depression (0-7); mild depression (8- 16); moderate depression (17-23); and severe depression (24-52).|units on a scale|Mean|21.9|21.9|Standard Deviation|3.8|3.8|||
4193343|NCT00767624|4016016|B1|||Hamilton Rating Scale for Depression (HRSD)|The HRSD is a 17-item semi-structured interview assessing the severity of depression in the past week. Items are rated on a 3 or 5 point scale. The total score is the sum of individual items, yielding a total score ranging from 0 to 52, with larger numbers representing greater severity. The total score is interpreted as follows: absence of depression (0-7); mild depression (8- 16); moderate depression (17-23); and severe depression (24-52).|units on a scale|Mean|21.5|21.5|Standard Deviation|3.7|3.7|||
4193344|NCT00767624|4016014|B3|||Insomnia Severity Index (ISI)|The ISI is a 7-item self-report questionnaire assessing the nature, severity, and impact of insomnia. A 5-point Likert scale is used to rate each item (e.g., 0 = no problem; 4 = very severe problem), yielding a total score ranging from 0 to 28, with larger numbers representing greater severity. The total score is interpreted as follows: absence of insomnia (0-7); sub-threshold insomnia (8- 14); moderate insomnia (15-21); and severe insomnia (22-28).|units on a scale|Mean|18.9|18.9|Standard Deviation|4.1|4.1|||
4193345|NCT00767624|4016015|B2|||Insomnia Severity Index (ISI)|The ISI is a 7-item self-report questionnaire assessing the nature, severity, and impact of insomnia. A 5-point Likert scale is used to rate each item (e.g., 0 = no problem; 4 = very severe problem), yielding a total score ranging from 0 to 28, with larger numbers representing greater severity. The total score is interpreted as follows: absence of insomnia (0-7); sub-threshold insomnia (8- 14); moderate insomnia (15-21); and severe insomnia (22-28).|units on a scale|Mean|19.4|19.4|Standard Deviation|4.3|4.3|||
4193346|NCT00767624|4016016|B1|||Insomnia Severity Index (ISI)|The ISI is a 7-item self-report questionnaire assessing the nature, severity, and impact of insomnia. A 5-point Likert scale is used to rate each item (e.g., 0 = no problem; 4 = very severe problem), yielding a total score ranging from 0 to 28, with larger numbers representing greater severity. The total score is interpreted as follows: absence of insomnia (0-7); sub-threshold insomnia (8- 14); moderate insomnia (15-21); and severe insomnia (22-28).|units on a scale|Mean|18.3|18.3|Standard Deviation|3.9|3.9|||
4193347|NCT00767624|4016014|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4193348|NCT00767624|4016015|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4193349|NCT00767624|4016016|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4193350|NCT00767624|4016014|B3||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4193351|NCT00767624|4016015|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4193352|NCT00767624|4016016|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4193353|NCT00767624|4016014|B3|||Age||years|Mean|46.6|46.6|Standard Deviation|12.6|12.6|||
4193354|NCT00767624|4016015|B2|||Age||years|Mean|48.3|48.3|Standard Deviation|12.7|12.7|||
4193355|NCT00767624|4016016|B1|||Age||years|Mean|45.0|45.0|Standard Deviation|12.3|12.3|||
4193356|NCT00767572|4016025|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4193357|NCT00767572|4016025|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4193358|NCT00767572|4016025|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4193359|NCT00767572|4016025|B1|||Age||years|Mean|35|35.0|Standard Deviation|8.8|8.8|||
4193360|NCT00767572|4016025|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4193361|NCT00767572|4016025|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4193362|NCT00767572|4016025|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4193363|NCT00767520|4016031|B3|Yes||Symptomatic Bone Disease||participants|Number|63|63.0||||||
4193364|NCT00767520|4016032|B2|Yes||Symptomatic Bone Disease||participants|Number|32|32.0||||||
4193365|NCT00767520|4016033|B1|Yes||Symptomatic Bone Disease||participants|Number|31|31.0||||||
4193366|NCT00767520|4016031|B3|No||Symptomatic Bone Disease||participants|Number|94|94.0||||||
4193367|NCT00767520|4016032|B2|No||Symptomatic Bone Disease||participants|Number|46|46.0||||||
4193368|NCT00767520|4016033|B1|No||Symptomatic Bone Disease||participants|Number|48|48.0||||||
4193369|NCT00767520|4016031|B3|Not reported||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG Performance Status (PS) is used to assess disease severity. A score of 0 is normal activity; 1 is symptoms, but fully ambulatory; 2 is symptomatic, but in bed < 50% of the day; 3 is needs to be in bed > 50% of the day, but not bedridden; 4 is unable to get out of bed; 5 is dead.|participants|Number|3|3.0||||||
4193370|NCT00767520|4016032|B2|Not reported||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG Performance Status (PS) is used to assess disease severity. A score of 0 is normal activity; 1 is symptoms, but fully ambulatory; 2 is symptomatic, but in bed < 50% of the day; 3 is needs to be in bed > 50% of the day, but not bedridden; 4 is unable to get out of bed; 5 is dead.|participants|Number|2|2.0||||||
4193411|NCT00767520|4016031|B3|Not reported||Age, Customized||participants|Number|1|1.0||||||
4193412|NCT00767520|4016032|B2|Not reported||Age, Customized||participants|Number|0|0.0||||||
4193371|NCT00767520|4016033|B1|Not reported||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG Performance Status (PS) is used to assess disease severity. A score of 0 is normal activity; 1 is symptoms, but fully ambulatory; 2 is symptomatic, but in bed < 50% of the day; 3 is needs to be in bed > 50% of the day, but not bedridden; 4 is unable to get out of bed; 5 is dead.|participants|Number|1|1.0||||||
4193372|NCT00767520|4016031|B3|1=symptoms, but fully ambulatory||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG Performance Status (PS) is used to assess disease severity. A score of 0 is normal activity; 1 is symptoms, but fully ambulatory; 2 is symptomatic, but in bed < 50% of the day; 3 is needs to be in bed > 50% of the day, but not bedridden; 4 is unable to get out of bed; 5 is dead.|participants|Number|62|62.0||||||
4193373|NCT00767520|4016032|B2|1=symptoms, but fully ambulatory||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG Performance Status (PS) is used to assess disease severity. A score of 0 is normal activity; 1 is symptoms, but fully ambulatory; 2 is symptomatic, but in bed < 50% of the day; 3 is needs to be in bed > 50% of the day, but not bedridden; 4 is unable to get out of bed; 5 is dead.|participants|Number|30|30.0||||||
4193374|NCT00767520|4016033|B1|1=symptoms, but fully ambulatory||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG Performance Status (PS) is used to assess disease severity. A score of 0 is normal activity; 1 is symptoms, but fully ambulatory; 2 is symptomatic, but in bed < 50% of the day; 3 is needs to be in bed > 50% of the day, but not bedridden; 4 is unable to get out of bed; 5 is dead.|participants|Number|32|32.0||||||
4193375|NCT00767520|4016031|B3|0=normal activity||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG Performance Status (PS) is used to assess disease severity. A score of 0 is normal activity; 1 is symptoms, but fully ambulatory; 2 is symptomatic, but in bed < 50% of the day; 3 is needs to be in bed > 50% of the day, but not bedridden; 4 is unable to get out of bed; 5 is dead.|participants|Number|92|92.0||||||
4193376|NCT00767520|4016032|B2|0=normal activity||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG Performance Status (PS) is used to assess disease severity. A score of 0 is normal activity; 1 is symptoms, but fully ambulatory; 2 is symptomatic, but in bed < 50% of the day; 3 is needs to be in bed > 50% of the day, but not bedridden; 4 is unable to get out of bed; 5 is dead.|participants|Number|46|46.0||||||
4193377|NCT00767520|4016033|B1|0=normal activity||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG Performance Status (PS) is used to assess disease severity. A score of 0 is normal activity; 1 is symptoms, but fully ambulatory; 2 is symptomatic, but in bed < 50% of the day; 3 is needs to be in bed > 50% of the day, but not bedridden; 4 is unable to get out of bed; 5 is dead.|participants|Number|46|46.0||||||
4193378|NCT00767520|4016031|B3|Advanced||Setting of Non-steroidal Aromatase Inhibitor||participants|Number|103|103.0||||||
4193379|NCT00767520|4016032|B2|Advanced||Setting of Non-steroidal Aromatase Inhibitor||participants|Number|51|51.0||||||
4193380|NCT00767520|4016033|B1|Advanced||Setting of Non-steroidal Aromatase Inhibitor||participants|Number|52|52.0||||||
4193381|NCT00767520|4016031|B3|Adjuvant||Setting of Non-steroidal Aromatase Inhibitor||participants|Number|54|54.0||||||
4193382|NCT00767520|4016032|B2|Adjuvant||Setting of Non-steroidal Aromatase Inhibitor||participants|Number|27|27.0||||||
4193383|NCT00767520|4016033|B1|Adjuvant||Setting of Non-steroidal Aromatase Inhibitor||participants|Number|27|27.0||||||
4193384|NCT00767520|4016031|B3|||Time from Initial diagnosis to randomization|Baseline data of 76 participants in Exemestane + Placebo Arm|months|Mean|92.46|92.46|Standard Deviation|70.058|70.058|||
4193385|NCT00767520|4016032|B2|||Time from Initial diagnosis to randomization|Baseline data of 76 participants in Exemestane + Placebo Arm|months|Mean|87.09|87.09|Standard Deviation|64.743|64.743|||
4193386|NCT00767520|4016033|B1|||Time from Initial diagnosis to randomization|Baseline data of 76 participants in Exemestane + Placebo Arm|months|Mean|97.63|97.63|Standard Deviation|74.866|74.866|||
4193387|NCT00767520|4016031|B3|Not reported||Race/Ethnicity, Customized||participants|Number|139|139.0||||||
4193388|NCT00767520|4016032|B2|Not reported||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
4193389|NCT00767520|4016033|B1|Not reported||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
4193390|NCT00767520|4016031|B3|Not Hispanic / Not Latino||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4193391|NCT00767520|4016032|B2|Not Hispanic / Not Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4193392|NCT00767520|4016033|B1|Not Hispanic / Not Latino||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4193393|NCT00767520|4016031|B3|Hispanic / Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4193394|NCT00767520|4016032|B2|Hispanic / Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4193395|NCT00767520|4016033|B1|Hispanic / Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4193396|NCT00767520|4016031|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4193397|NCT00767520|4016032|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4193398|NCT00767520|4016033|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4193399|NCT00767520|4016031|B3|Asian||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4193400|NCT00767520|4016032|B2|Asian||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4193401|NCT00767520|4016033|B1|Asian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4193402|NCT00767520|4016031|B3|White||Race/Ethnicity, Customized||participants|Number|126|126.0||||||
4193403|NCT00767520|4016032|B2|White||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
4193404|NCT00767520|4016033|B1|White||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
4193405|NCT00767520|4016031|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4193406|NCT00767520|4016032|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4193407|NCT00767520|4016033|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4193408|NCT00767520|4016031|B3||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4193409|NCT00767520|4016032|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4193410|NCT00767520|4016033|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4193413|NCT00767520|4016033|B1|Not reported||Age, Customized||participants|Number|1|1.0||||||
4193414|NCT00767520|4016031|B3|>=50 years||Age, Customized||participants|Number|137|137.0||||||
4193415|NCT00767520|4016032|B2|>=50 years||Age, Customized||participants|Number|68|68.0||||||
4193416|NCT00767520|4016033|B1|>=50 years||Age, Customized||participants|Number|69|69.0||||||
4193417|NCT00767520|4016031|B3|< 50 years||Age, Customized||participants|Number|19|19.0||||||
4193418|NCT00767520|4016032|B2|< 50 years||Age, Customized||participants|Number|10|10.0||||||
4193419|NCT00767520|4016033|B1|< 50 years||Age, Customized||participants|Number|9|9.0||||||
4193420|NCT00767520|4016031|B3|||Age|Baseline data of 78 participants in the Exemestane + Dasatinib Arm|Years|Mean|61.7|61.7|Standard Deviation|11.41|11.41|||
4193421|NCT00767520|4016032|B2|||Age|Baseline data of 78 participants in the Exemestane + Dasatinib Arm|Years|Mean|60.1|60.1|Standard Deviation|10.43|10.43|||
4193422|NCT00767520|4016033|B1|||Age|Baseline data of 78 participants in the Exemestane + Dasatinib Arm|Years|Mean|63.2|63.2|Standard Deviation|12.19|12.19|||
4193423|NCT00767507|4016056|B5|Austria||Region of Enrollment|This population in Region of Enrollment, represents the total number of subjects enrolled/randomized, and does not exclude any patients. Therefore there are more patients represented here versus in the Safety Population.|participants|Number|7|7.0||||||
4193424|NCT00767507|4016057|B4|Austria||Region of Enrollment|This population in Region of Enrollment, represents the total number of subjects enrolled/randomized, and does not exclude any patients. Therefore there are more patients represented here versus in the Safety Population.|participants|Number|6|6.0||||||
4193425|NCT00767507|4016058|B3|Austria||Region of Enrollment|This population in Region of Enrollment, represents the total number of subjects enrolled/randomized, and does not exclude any patients. Therefore there are more patients represented here versus in the Safety Population.|participants|Number|1|1.0||||||
4193426|NCT00767507|4016059|B2|Austria||Region of Enrollment|This population in Region of Enrollment, represents the total number of subjects enrolled/randomized, and does not exclude any patients. Therefore there are more patients represented here versus in the Safety Population.|participants|Number|0|0.0||||||
4193427|NCT00767507|4016060|B1|Austria||Region of Enrollment|This population in Region of Enrollment, represents the total number of subjects enrolled/randomized, and does not exclude any patients. Therefore there are more patients represented here versus in the Safety Population.|participants|Number|0|0.0||||||
4193428|NCT00767507|4016056|B5|United Kingdom||Region of Enrollment|This population in Region of Enrollment, represents the total number of subjects enrolled/randomized, and does not exclude any patients. Therefore there are more patients represented here versus in the Safety Population.|participants|Number|12|12.0||||||
4193429|NCT00767507|4016057|B4|United Kingdom||Region of Enrollment|This population in Region of Enrollment, represents the total number of subjects enrolled/randomized, and does not exclude any patients. Therefore there are more patients represented here versus in the Safety Population.|participants|Number|4|4.0||||||
4193430|NCT00767507|4016058|B3|United Kingdom||Region of Enrollment|This population in Region of Enrollment, represents the total number of subjects enrolled/randomized, and does not exclude any patients. Therefore there are more patients represented here versus in the Safety Population.|participants|Number|8|8.0||||||
4193431|NCT00767507|4016059|B2|United Kingdom||Region of Enrollment|This population in Region of Enrollment, represents the total number of subjects enrolled/randomized, and does not exclude any patients. Therefore there are more patients represented here versus in the Safety Population.|participants|Number|0|0.0||||||
4193432|NCT00767507|4016060|B1|United Kingdom||Region of Enrollment|This population in Region of Enrollment, represents the total number of subjects enrolled/randomized, and does not exclude any patients. Therefore there are more patients represented here versus in the Safety Population.|participants|Number|0|0.0||||||
4193433|NCT00767507|4016056|B5|Czech Republic||Region of Enrollment|This population in Region of Enrollment, represents the total number of subjects enrolled/randomized, and does not exclude any patients. Therefore there are more patients represented here versus in the Safety Population.|participants|Number|55|55.0||||||
4193434|NCT00767507|4016057|B4|Czech Republic||Region of Enrollment|This population in Region of Enrollment, represents the total number of subjects enrolled/randomized, and does not exclude any patients. Therefore there are more patients represented here versus in the Safety Population.|participants|Number|29|29.0||||||
4193435|NCT00767507|4016058|B3|Czech Republic||Region of Enrollment|This population in Region of Enrollment, represents the total number of subjects enrolled/randomized, and does not exclude any patients. Therefore there are more patients represented here versus in the Safety Population.|participants|Number|26|26.0||||||
4193436|NCT00767507|4016059|B2|Czech Republic||Region of Enrollment|This population in Region of Enrollment, represents the total number of subjects enrolled/randomized, and does not exclude any patients. Therefore there are more patients represented here versus in the Safety Population.|participants|Number|0|0.0||||||
4193437|NCT00767507|4016060|B1|Czech Republic||Region of Enrollment|This population in Region of Enrollment, represents the total number of subjects enrolled/randomized, and does not exclude any patients. Therefore there are more patients represented here versus in the Safety Population.|participants|Number|0|0.0||||||
4193438|NCT00767507|4016056|B5|Netherlands||Region of Enrollment|This population in Region of Enrollment, represents the total number of subjects enrolled/randomized, and does not exclude any patients. Therefore there are more patients represented here versus in the Safety Population.|participants|Number|11|11.0||||||
4193439|NCT00767507|4016057|B4|Netherlands||Region of Enrollment|This population in Region of Enrollment, represents the total number of subjects enrolled/randomized, and does not exclude any patients. Therefore there are more patients represented here versus in the Safety Population.|participants|Number|6|6.0||||||
4193440|NCT00767507|4016058|B3|Netherlands||Region of Enrollment|This population in Region of Enrollment, represents the total number of subjects enrolled/randomized, and does not exclude any patients. Therefore there are more patients represented here versus in the Safety Population.|participants|Number|5|5.0||||||
4193441|NCT00767507|4016059|B2|Netherlands||Region of Enrollment|This population in Region of Enrollment, represents the total number of subjects enrolled/randomized, and does not exclude any patients. Therefore there are more patients represented here versus in the Safety Population.|participants|Number|0|0.0||||||
4193442|NCT00767507|4016060|B1|Netherlands||Region of Enrollment|This population in Region of Enrollment, represents the total number of subjects enrolled/randomized, and does not exclude any patients. Therefore there are more patients represented here versus in the Safety Population.|participants|Number|0|0.0||||||
4193443|NCT00767507|4016056|B5|United States||Region of Enrollment|This population in Region of Enrollment, represents the total number of subjects enrolled/randomized, and does not exclude any patients. Therefore there are more patients represented here versus in the Safety Population.|participants|Number|136|136.0||||||
4193444|NCT00767507|4016057|B4|United States||Region of Enrollment|This population in Region of Enrollment, represents the total number of subjects enrolled/randomized, and does not exclude any patients. Therefore there are more patients represented here versus in the Safety Population.|participants|Number|59|59.0||||||
4193445|NCT00767507|4016058|B3|United States||Region of Enrollment|This population in Region of Enrollment, represents the total number of subjects enrolled/randomized, and does not exclude any patients. Therefore there are more patients represented here versus in the Safety Population.|participants|Number|66|66.0||||||
4193446|NCT00767507|4016059|B2|United States||Region of Enrollment|This population in Region of Enrollment, represents the total number of subjects enrolled/randomized, and does not exclude any patients. Therefore there are more patients represented here versus in the Safety Population.|participants|Number|6|6.0||||||
4193447|NCT00767507|4016060|B1|United States||Region of Enrollment|This population in Region of Enrollment, represents the total number of subjects enrolled/randomized, and does not exclude any patients. Therefore there are more patients represented here versus in the Safety Population.|participants|Number|5|5.0||||||
4193448|NCT00767507|4016056|B5||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4193449|NCT00767507|4016057|B4||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4193450|NCT00767507|4016058|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4193451|NCT00767507|4016059|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4193452|NCT00767507|4016060|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4193453|NCT00767507|4016056|B5||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4193454|NCT00767507|4016057|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4193455|NCT00767507|4016058|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4193456|NCT00767507|4016059|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4193457|NCT00767507|4016060|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4193458|NCT00767507|4016056|B5||>=65 years|Age||Participants|Count of Participants|101|101.0||||||
4193459|NCT00767507|4016057|B4||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
4193460|NCT00767507|4016058|B3||>=65 years|Age||Participants|Count of Participants|54|54.0||||||
4193461|NCT00767507|4016059|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4193462|NCT00767507|4016060|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4193463|NCT00767507|4016056|B5||Between 18 and 65 years|Age||Participants|Count of Participants|117|117.0||||||
4193464|NCT00767507|4016057|B4||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4193465|NCT00767507|4016058|B3||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4193466|NCT00767507|4016059|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4193467|NCT00767507|4016060|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4193468|NCT00767507|4016056|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4193469|NCT00767507|4016057|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4193470|NCT00767507|4016058|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4193471|NCT00767507|4016059|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4193472|NCT00767507|4016060|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4193473|NCT00767455|4016087|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
4193474|NCT00767455|4016087|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4193475|NCT00767455|4016087|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4193476|NCT00767455|4016087|B1|||Age||years|Mean|41.2|41.2|Standard Deviation|13.2|13.2|||
4193477|NCT00767455|4016087|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4193478|NCT00767455|4016087|B1||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4193479|NCT00767455|4016087|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4193480|NCT00767364|4016093|B3|||Rotavirus Anti-Immunoglobulin A (IgA) serum antibody level||U/ml|Geometric Mean|540|540.0|Full Range|||259.0|1018.0|
4193481|NCT00767364|4016094|B2|||Rotavirus Anti-Immunoglobulin A (IgA) serum antibody level||U/ml|Geometric Mean|431.02|431.02|Full Range|||272.0|935.0|
4193482|NCT00767364|4016095|B1|||Rotavirus Anti-Immunoglobulin A (IgA) serum antibody level||U/ml|Geometric Mean|618.61|618.61|Full Range|||259.0|1018.0|
4193483|NCT00767364|4016093|B3|Subject 5||Pre-vaccination serum IgA antirotavirus titer||U/ml|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4193484|NCT00767364|4016094|B2|Subject 5||Pre-vaccination serum IgA antirotavirus titer||U/ml|Number|NA|||||||There was no control subject for study Subject 5
4193485|NCT00767364|4016095|B1|Subject 5||Pre-vaccination serum IgA antirotavirus titer||U/ml|Number|1.56|1.56||||||
4193486|NCT00767364|4016093|B3|Subject 4||Pre-vaccination serum IgA antirotavirus titer||U/ml|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4193487|NCT00767364|4016094|B2|Subject 4||Pre-vaccination serum IgA antirotavirus titer||U/ml|Number|NA|||||||There was no control for study Subject 4
4193488|NCT00767364|4016095|B1|Subject 4||Pre-vaccination serum IgA antirotavirus titer||U/ml|Number|1.56|1.56||||||
4193489|NCT00767364|4016093|B3|Subject 3||Pre-vaccination serum IgA antirotavirus titer||U/ml|Number|3.12|3.12||||||
4193490|NCT00767364|4016094|B2|Subject 3||Pre-vaccination serum IgA antirotavirus titer||U/ml|Number|1.56|1.56||||||
4193491|NCT00767364|4016095|B1|Subject 3||Pre-vaccination serum IgA antirotavirus titer||U/ml|Number|1.56|1.56||||||
4193492|NCT00767364|4016093|B3|Subject 2||Pre-vaccination serum IgA antirotavirus titer||U/ml|Number|3.12|3.12||||||
4193493|NCT00767364|4016094|B2|Subject 2||Pre-vaccination serum IgA antirotavirus titer||U/ml|Number|1.56|1.56||||||
4193494|NCT00767364|4016095|B1|Subject 2||Pre-vaccination serum IgA antirotavirus titer||U/ml|Number|1.56|1.56||||||
4193495|NCT00767364|4016093|B3|Subject 1||Pre-vaccination serum IgA antirotavirus titer||U/ml|Number|3.12|3.12||||||
4193496|NCT00767364|4016094|B2|Subject 1||Pre-vaccination serum IgA antirotavirus titer||U/ml|Number|1.56|1.56||||||
4193497|NCT00767364|4016095|B1|Subject 1||Pre-vaccination serum IgA antirotavirus titer||U/ml|Number|1.56|1.56||||||
4193498|NCT00767364|4016093|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4193499|NCT00767364|4016094|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4193500|NCT00767364|4016095|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4193501|NCT00767364|4016093|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4193502|NCT00767364|4016094|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4193503|NCT00767364|4016095|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4193504|NCT00767364|4016093|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4193505|NCT00767364|4016094|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4193506|NCT00767364|4016095|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4193507|NCT00767364|4016093|B3|Gestational Age||Age, Customized||weeks|Mean|34.9|34.9|Full Range|||30.0|40.0|
4193508|NCT00767364|4016094|B2|Gestational Age||Age, Customized||weeks|Mean|38.6|38.6|Full Range|||37.0|40.0|
4193509|NCT00767364|4016095|B1|Gestational Age||Age, Customized||weeks|Mean|31.2|31.2|Full Range|||30.0|40.0|
4193510|NCT00767338|4016104|B5|United States||Region of Enrollment||participants|Number|3|3.0||||||
4193511|NCT00767338|4016107|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4193512|NCT00767338|4016108|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4193513|NCT00767338|4016104|B5|Male||Gender||participants|Number|3|3.0||||||
4193514|NCT00767338|4016107|B2|Male||Gender||participants|Number|2|2.0||||||
4193515|NCT00767338|4016108|B1|Male||Gender||participants|Number|1|1.0||||||
4193516|NCT00767338|4016104|B5|Female||Gender||participants|Number|0|0.0||||||
4193517|NCT00767338|4016107|B2|Female||Gender||participants|Number|0|0.0||||||
4193518|NCT00767338|4016108|B1|Female||Gender||participants|Number|0|0.0||||||
4193519|NCT00767338|4016104|B5|||Age||years|Mean|32|32.0|Standard Deviation|2|2.0|||
4193520|NCT00767338|4016107|B2|||Age||years|Mean|33|33.0|Standard Deviation|1|1.0|||
4193521|NCT00767338|4016108|B1|||Age||years|Mean|30|30.0|Standard Deviation|0|0.0|||
4193522|NCT00767338|4016104|B5|>=65 years||Age||participants|Number|0|0.0||||||
4193523|NCT00767338|4016107|B2|>=65 years||Age||participants|Number|0|0.0||||||
4193524|NCT00767338|4016108|B1|>=65 years||Age||participants|Number|0|0.0||||||
4193525|NCT00767338|4016104|B5|Between 18 and 65 years||Age||participants|Number|3|3.0||||||
4193526|NCT00767338|4016107|B2|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
4193527|NCT00767338|4016108|B1|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
4193528|NCT00767338|4016104|B5|<=18 years||Age||participants|Number|0|0.0||||||
4193529|NCT00767338|4016107|B2|<=18 years||Age||participants|Number|0|0.0||||||
4193530|NCT00767338|4016108|B1|<=18 years||Age||participants|Number|0|0.0||||||
4193531|NCT00767325|4016121|B1|||Global PDUS (MCP 2-5) score (n=96)|Power Doppler ultrasonography (PDUS) assessed synovial inflammation of metacarpophalangeal (MCP) joints (2-5) in both hands. Total PDUS score=sum of joints measured. Grade (Gr) 0, or normal=normal joint (no synovial hypertrophy(SH), no Doppler signal [[DS]); Gr 1 or minimal (min)=min synovitis (min SH with ≤Gr 1 Gr 2 or no DS); moderate (mod)=mod synovitis (mod SH with ≤Gr 2 Doppler signal or min SH and Gr 2 DS); Gr 3 or severe=severe synovitis (severe SH with ≤Gr 3 DS or min or mod SH and Gr 3 DS). Total possible score range: 8 to 24 (8*1, 8*3) for 2 hands. Higher grade=more severe disease.|Units on a scale|Mean|12.6|12.6|Standard Deviation|4.1|4.1|||
4193532|NCT00767325|4016121|B1|||DAS 28-CRP score|DAS28-CRP=Disease Activity Score 28 using C-Reactive Protein. The DAS28-CRP is a measure of disease activity in rheumatoid arthritis (RA) and assesses the 28 joints RA commonly affects; the score includes the number of tender and swollen joints (out of 28), CRP level (a measure of inflammation in the blood), and the patient’s global assessment of health (ranging from very good to very bad). These measures are then fed into a complex mathematical formula to produce the overall DAS (greater than 5.1 implies active disease; less than 3.2, well controlled disease; and less than 2.6, remission.)|Units on a scale|Mean|5.2888|5.2888|Standard Deviation|1.105|1.105|||
4193533|NCT00767325|4016121|B1|||Swollen joint count||Joints|Mean|13.0|13.0|Standard Deviation|7.6|7.6|||
4193534|NCT00767325|4016121|B1|||Duration of rheumatoid arthritis||Years|Mean|7.3|7.3|Standard Deviation|9.1|9.1|||
4193535|NCT00767325|4016121|B1|||Tender joint count||Joints|Mean|19.5|19.5|Standard Deviation|12.5|12.5|||
4193536|NCT00767325|4016121|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4193537|NCT00767325|4016121|B1|White||Race/Ethnicity, Customized||Participants|Number|101|101.0||||||
4193538|NCT00767325|4016121|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4193539|NCT00767325|4016121|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4193540|NCT00767325|4016121|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4193541|NCT00767325|4016121|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4193542|NCT00767325|4016121|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4193543|NCT00767325|4016121|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4193544|NCT00767325|4016121|B1|||Age||Years|Mean|56.4|56.4|Standard Deviation|14.1|14.1|||
4193545|NCT00767104|4016130|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4193546|NCT00767104|4016131|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4193547|NCT00767104|4016132|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4193548|NCT00767104|4016130|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4193549|NCT00767104|4016131|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4193550|NCT00767104|4016132|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4193551|NCT00767104|4016130|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4193552|NCT00767104|4016131|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4193553|NCT00767104|4016132|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4193554|NCT00767104|4016130|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4193555|NCT00767104|4016131|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4193556|NCT00767104|4016132|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4193557|NCT00767104|4016130|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4193558|NCT00767104|4016131|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4193559|NCT00767104|4016132|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4193560|NCT00767104|4016130|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4193561|NCT00767104|4016131|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4193562|NCT00767104|4016132|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4193563|NCT00767039|4016141|B3|||Gestational Age in weeks|All patients are enrolled on the first day of life. Therefore the mean +/- SD = 0 +/- 0 years.|weeks|Mean|26.9|26.9|Standard Deviation|1.6|1.6|||
4193564|NCT00767039|4016142|B2|||Gestational Age in weeks|All patients are enrolled on the first day of life. Therefore the mean +/- SD = 0 +/- 0 years.|weeks|Mean|27.1|27.1|Standard Deviation|1.6|1.6|||
4193565|NCT00767039|4016143|B1|||Gestational Age in weeks|All patients are enrolled on the first day of life. Therefore the mean +/- SD = 0 +/- 0 years.|weeks|Mean|26.7|26.7|Standard Deviation|1.7|1.7|||
4193566|NCT00767039|4016141|B3|United States||Region of Enrollment||participants|Number|52|52.0||||||
4193567|NCT00767039|4016142|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4193568|NCT00767039|4016143|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4193569|NCT00767039|4016141|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4193570|NCT00767039|4016142|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4193571|NCT00767039|4016143|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4193572|NCT00767039|4016141|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4193573|NCT00767039|4016142|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4193574|NCT00767039|4016143|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4193575|NCT00767039|4016141|B3||>=65 years|Age|The population is recruited from premature infants with Respiratory Distress Syndrome on the first day of life.|Participants|Count of Participants|0|0.0||||||
4193576|NCT00767039|4016142|B2||>=65 years|Age|The population is recruited from premature infants with Respiratory Distress Syndrome on the first day of life.|Participants|Count of Participants|0|0.0||||||
4193577|NCT00767039|4016143|B1||>=65 years|Age|The population is recruited from premature infants with Respiratory Distress Syndrome on the first day of life.|Participants|Count of Participants|0|0.0||||||
4193578|NCT00767039|4016141|B3||Between 18 and 65 years|Age|The population is recruited from premature infants with Respiratory Distress Syndrome on the first day of life.|Participants|Count of Participants|0|0.0||||||
4193579|NCT00767039|4016142|B2||Between 18 and 65 years|Age|The population is recruited from premature infants with Respiratory Distress Syndrome on the first day of life.|Participants|Count of Participants|0|0.0||||||
4193580|NCT00767039|4016143|B1||Between 18 and 65 years|Age|The population is recruited from premature infants with Respiratory Distress Syndrome on the first day of life.|Participants|Count of Participants|0|0.0||||||
4193581|NCT00767039|4016141|B3||<=18 years|Age|The population is recruited from premature infants with Respiratory Distress Syndrome on the first day of life.|Participants|Count of Participants|52|52.0||||||
4193582|NCT00767039|4016142|B2||<=18 years|Age|The population is recruited from premature infants with Respiratory Distress Syndrome on the first day of life.|Participants|Count of Participants|25|25.0||||||
4193583|NCT00767039|4016143|B1||<=18 years|Age|The population is recruited from premature infants with Respiratory Distress Syndrome on the first day of life.|Participants|Count of Participants|27|27.0||||||
4193584|NCT00767000|4016170|B6||Male|Sex: Female, Male||Participants|Count of Participants|397|397.0||||||
4193585|NCT00767000|4016171|B5||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4193586|NCT00767000|4016172|B4||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4193587|NCT00767000|4016173|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4193588|NCT00767000|4016174|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4193589|NCT00767000|4016175|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4193590|NCT00767000|4016170|B6||Female|Sex: Female, Male||Participants|Count of Participants|416|416.0||||||
4193591|NCT00767000|4016171|B5||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4193592|NCT00767000|4016172|B4||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4193593|NCT00767000|4016173|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4193594|NCT00767000|4016174|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4193595|NCT00767000|4016175|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4193596|NCT00767000|4016170|B6|26 to 71 years||Age, Customized||participants|Number|813|813.0||||||
4193597|NCT00767000|4016171|B5|26 to 71 years||Age, Customized||participants|Number|231|231.0||||||
4193598|NCT00767000|4016172|B4|26 to 71 years||Age, Customized||participants|Number|229|229.0||||||
4193599|NCT00767000|4016173|B3|26 to 71 years||Age, Customized||participants|Number|117|117.0||||||
4193600|NCT00767000|4016174|B2|26 to 71 years||Age, Customized||participants|Number|117|117.0||||||
4193601|NCT00767000|4016175|B1|26 to 71 years||Age, Customized||participants|Number|119|119.0||||||
4193602|NCT00766831|4016221|B1||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4193603|NCT00766831|4016221|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4193604|NCT00766831|4016221|B1|||Age||Years|Mean|56.1|56.1|Standard Deviation|11.20|11.2|||
4193605|NCT00766753|4016237|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4193606|NCT00766753|4016238|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4193607|NCT00766753|4016239|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4193608|NCT00766753|4016237|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4193609|NCT00766753|4016238|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4193610|NCT00766753|4016239|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4193611|NCT00766753|4016237|B3|||Age||years|Median|48|48.0|Full Range|||28.0|71.0|
4193612|NCT00766753|4016238|B2|||Age||years|Median|46|46.0|Full Range|||28.0|63.0|
4193613|NCT00766753|4016239|B1|||Age||years|Median|52|52.0|Full Range|||37.0|71.0|
4193614|NCT00766675|4016251|B1|||Pain Visual Analog Scale at Baseline|Assessed by 100 mm of VAS from 0 to 100, where 0 mm=no pain and 10 mm=worse pain.|Units on a scale|Mean|71.3|71.3|Standard Deviation|18.22|18.22|||
4193615|NCT00766675|4016251|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4193616|NCT00766675|4016251|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4193617|NCT00766675|4016251|B1|||Age||Years|Mean|50.4|50.4|Standard Deviation|10.01|10.01|||
4193618|NCT00766649|4016264|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4193619|NCT00766649|4016264|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4193620|NCT00766649|4016264|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4193621|NCT00766649|4016264|B1|||Age||years|Mean|78.4|78.4|Standard Deviation|7.1|7.1|||
4193622|NCT00766649|4016264|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4193623|NCT00766649|4016264|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4193624|NCT00766649|4016264|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4193625|NCT00766636|4016276|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4193626|NCT00766636|4016277|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4193627|NCT00766636|4016278|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4193628|NCT00766636|4016276|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4193629|NCT00766636|4016277|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4193630|NCT00766636|4016278|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4193631|NCT00766636|4016276|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4193632|NCT00766636|4016277|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4193633|NCT00766636|4016278|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4193634|NCT00766636|4016276|B3|||Age||years|Median|63|63.0|Full Range|||44.0|71.0|
4193635|NCT00766636|4016277|B2|||Age||years|Median|67.5|67.5|Full Range|||64.0|71.0|
4193636|NCT00766636|4016278|B1|||Age||years|Median|61|61.0|Full Range|||44.0|63.0|
4193637|NCT00766636|4016276|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4193638|NCT00766636|4016277|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4193639|NCT00766636|4016278|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4193640|NCT00766636|4016276|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4193641|NCT00766636|4016277|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4193642|NCT00766636|4016278|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4193643|NCT00766636|4016276|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4193644|NCT00766636|4016277|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4193645|NCT00766636|4016278|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4193646|NCT00766597|4016285|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4193647|NCT00766597|4016285|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4193648|NCT00766597|4016285|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4193649|NCT00766597|4016285|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4193650|NCT00766597|4016285|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4193651|NCT00766597|4016285|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4193652|NCT00766597|4016285|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4193653|NCT00766597|4016285|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4193654|NCT00766597|4016285|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4193655|NCT00766597|4016285|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4193656|NCT00766597|4016285|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4193657|NCT00766597|4016285|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4193658|NCT00766597|4016285|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4193659|NCT00766597|4016285|B1|||Age||years|Mean|15|15.0|Standard Deviation|2.2|2.2|||
4193660|NCT00766532|4016297|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4193661|NCT00766532|4016297|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4193662|NCT00766532|4016297|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4193663|NCT00766532|4016297|B1|||Age||years|Mean|66|66.0|Standard Deviation|7|7.0|||
4193664|NCT00766532|4016297|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4193665|NCT00766532|4016297|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4193666|NCT00766532|4016297|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4193667|NCT00766506|4016301|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4193668|NCT00766506|4016302|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4193669|NCT00766506|4016303|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4193670|NCT00766506|4016301|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4193671|NCT00766506|4016302|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4193672|NCT00766506|4016303|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4193673|NCT00766506|4016301|B3|||Age||Years|Mean|58.7|58.7|Standard Deviation|11.9|11.9|||
4193674|NCT00766506|4016302|B2|||Age||Years|Mean|58.9|58.9|Standard Deviation|11.8|11.8|||
4193675|NCT00766506|4016303|B1|||Age||Years|Mean|58.4|58.4|Standard Deviation|12.1|12.1|||
4193676|NCT00766493|4016328|B1|Asymptomatic||Symptomatology||Participants|Number|213|213.0||||||
4193677|NCT00766493|4016328|B1|Symptomatic||Symptomatology||Participants|Number|37|37.0||||||
4193678|NCT00766493|4016328|B1|Unknown||Previous Endarterectomy||Participants|Number|3|3.0||||||
4193679|NCT00766493|4016328|B1|1 Year or Greater||Previous Endarterectomy||Participants|Number|63|63.0||||||
4193680|NCT00766493|4016328|B1|Less than 1 Year||Previous Endarterectomy||Participants|Number|13|13.0||||||
4193681|NCT00766493|4016328|B1|None||Previous Endarterectomy||Participants|Number|171|171.0||||||
4193682|NCT00766493|4016328|B1|Unknown||History of Ischemic Stroke||Participants|Number|4|4.0||||||
4193683|NCT00766493|4016328|B1|Two or More||History of Ischemic Stroke||Participants|Number|12|12.0||||||
4193684|NCT00766493|4016328|B1|One||History of Ischemic Stroke||Participants|Number|34|34.0||||||
4193685|NCT00766493|4016328|B1|None||History of Ischemic Stroke||Participants|Number|200|200.0||||||
4193686|NCT00766493|4016328|B1|No||History of Hypertension||Participants|Number|14|14.0||||||
4193687|NCT00766493|4016328|B1|Yes||History of Hypertension||Participants|Number|236|236.0||||||
4193688|NCT00766493|4016328|B1|No||History of Diabetes||Participants|Number|163|163.0||||||
4193689|NCT00766493|4016328|B1|Yes||History of Diabetes||Participants|Number|87|87.0||||||
4193690|NCT00766493|4016328|B1||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4193691|NCT00766493|4016328|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4193692|NCT00766493|4016328|B1|||Age||Years|Median|74.7|74.7|Full Range|||51.3|92.6|
4193693|NCT00766493|4016328|B1|||Age||years|Mean|74.7|74.7|Standard Deviation|9.4|9.4|||
4193694|NCT00766493|4016328|B1||>=65 years|Age||Participants|Count of Participants|206|206.0||||||
4193695|NCT00766493|4016328|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4193696|NCT00766493|4016328|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4193697|NCT00766467|4016336|B3|Grade not defined||Glioma grade|Glioma is a broad category of brain and spinal cord. Gliomas can be grade I, II, III or IV. For the purposes of this study, Grade II, III, and IV were eligible for enrollment.|units on a scale|Number|3|3.0||||||
4193698|NCT00766467|4016337|B2|Grade not defined||Glioma grade|Glioma is a broad category of brain and spinal cord. Gliomas can be grade I, II, III or IV. For the purposes of this study, Grade II, III, and IV were eligible for enrollment.|units on a scale|Number|1|1.0||||||
4193699|NCT00766467|4016338|B1|Grade not defined||Glioma grade|Glioma is a broad category of brain and spinal cord. Gliomas can be grade I, II, III or IV. For the purposes of this study, Grade II, III, and IV were eligible for enrollment.|units on a scale|Number|2|2.0||||||
4193700|NCT00766467|4016336|B3|Grade 4||Glioma grade|Glioma is a broad category of brain and spinal cord. Gliomas can be grade I, II, III or IV. For the purposes of this study, Grade II, III, and IV were eligible for enrollment.|units on a scale|Number|47|47.0||||||
4193701|NCT00766467|4016337|B2|Grade 4||Glioma grade|Glioma is a broad category of brain and spinal cord. Gliomas can be grade I, II, III or IV. For the purposes of this study, Grade II, III, and IV were eligible for enrollment.|units on a scale|Number|22|22.0||||||
4193702|NCT00766467|4016338|B1|Grade 4||Glioma grade|Glioma is a broad category of brain and spinal cord. Gliomas can be grade I, II, III or IV. For the purposes of this study, Grade II, III, and IV were eligible for enrollment.|units on a scale|Number|25|25.0||||||
4193703|NCT00766467|4016336|B3|Grade 3||Glioma grade|Glioma is a broad category of brain and spinal cord. Gliomas can be grade I, II, III or IV. For the purposes of this study, Grade II, III, and IV were eligible for enrollment.|units on a scale|Number|26|26.0||||||
4193704|NCT00766467|4016337|B2|Grade 3||Glioma grade|Glioma is a broad category of brain and spinal cord. Gliomas can be grade I, II, III or IV. For the purposes of this study, Grade II, III, and IV were eligible for enrollment.|units on a scale|Number|12|12.0||||||
4193705|NCT00766467|4016338|B1|Grade 3||Glioma grade|Glioma is a broad category of brain and spinal cord. Gliomas can be grade I, II, III or IV. For the purposes of this study, Grade II, III, and IV were eligible for enrollment.|units on a scale|Number|14|14.0||||||
4193748|NCT00766363|4016406|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4193706|NCT00766467|4016336|B3|Grade 2||Glioma grade|Glioma is a broad category of brain and spinal cord. Gliomas can be grade I, II, III or IV. For the purposes of this study, Grade II, III, and IV were eligible for enrollment.|units on a scale|Number|5|5.0||||||
4193707|NCT00766467|4016337|B2|Grade 2||Glioma grade|Glioma is a broad category of brain and spinal cord. Gliomas can be grade I, II, III or IV. For the purposes of this study, Grade II, III, and IV were eligible for enrollment.|units on a scale|Number|4|4.0||||||
4193708|NCT00766467|4016338|B1|Grade 2||Glioma grade|Glioma is a broad category of brain and spinal cord. Gliomas can be grade I, II, III or IV. For the purposes of this study, Grade II, III, and IV were eligible for enrollment.|units on a scale|Number|1|1.0||||||
4193709|NCT00766467|4016336|B3|||Karnofsky Performance Status (KPS)|Karnofsky Performance Status ranges from 0 (Dead) to 100 (Normal, no complaints, no evidence of disease) in increments of 10. This was measured at baseline, prior to any treatment on study.|Units on a scale|Median|90|90.0|Full Range|||70.0|100.0|
4193710|NCT00766467|4016337|B2|||Karnofsky Performance Status (KPS)|Karnofsky Performance Status ranges from 0 (Dead) to 100 (Normal, no complaints, no evidence of disease) in increments of 10. This was measured at baseline, prior to any treatment on study.|Units on a scale|Median|90|90.0|Full Range|||70.0|100.0|
4193711|NCT00766467|4016338|B1|||Karnofsky Performance Status (KPS)|Karnofsky Performance Status ranges from 0 (Dead) to 100 (Normal, no complaints, no evidence of disease) in increments of 10. This was measured at baseline, prior to any treatment on study.|Units on a scale|Median|90|90.0|Full Range|||70.0|100.0|
4193712|NCT00766467|4016336|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4193713|NCT00766467|4016337|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4193714|NCT00766467|4016338|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4193715|NCT00766467|4016336|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4193716|NCT00766467|4016337|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4193717|NCT00766467|4016338|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4193718|NCT00766467|4016336|B3|||Age||years|Median|55|55.0|Full Range|||19.0|79.0|
4193719|NCT00766467|4016337|B2|||Age||years|Median|54|54.0|Full Range|||19.0|78.0|
4193720|NCT00766467|4016338|B1|||Age||years|Median|56|56.0|Full Range|||25.0|79.0|
4193721|NCT00766415|4016349|B3||Male|Sex: Female, Male|1 participant discontinued immediately following randomization, did not start treatment and have not been included in any of the efficacy or safety calculations.|Participants|Count of Participants|38|38.0||||||
4193722|NCT00766415|4016350|B2||Male|Sex: Female, Male|1 participant discontinued immediately following randomization, did not start treatment and have not been included in any of the efficacy or safety calculations.|Participants|Count of Participants|22|22.0||||||
4193723|NCT00766415|4016351|B1||Male|Sex: Female, Male|1 participant discontinued immediately following randomization, did not start treatment and have not been included in any of the efficacy or safety calculations.|Participants|Count of Participants|16|16.0||||||
4193724|NCT00766415|4016349|B3||Female|Sex: Female, Male|1 participant discontinued immediately following randomization, did not start treatment and have not been included in any of the efficacy or safety calculations.|Participants|Count of Participants|13|13.0||||||
4193725|NCT00766415|4016350|B2||Female|Sex: Female, Male|1 participant discontinued immediately following randomization, did not start treatment and have not been included in any of the efficacy or safety calculations.|Participants|Count of Participants|4|4.0||||||
4193726|NCT00766415|4016351|B1||Female|Sex: Female, Male|1 participant discontinued immediately following randomization, did not start treatment and have not been included in any of the efficacy or safety calculations.|Participants|Count of Participants|9|9.0||||||
4193727|NCT00766415|4016349|B3|||Age|1 participant discontinued immediately following randomization, did not start treatment and have not been included in any of the efficacy or safety calculations.|Years|Mean|61|61.0|Full Range|||41.0|80.0|
4193728|NCT00766415|4016350|B2|||Age|1 participant discontinued immediately following randomization, did not start treatment and have not been included in any of the efficacy or safety calculations.|Years|Mean|61.1|61.1|Full Range|||41.0|80.0|
4193729|NCT00766415|4016351|B1|||Age|1 participant discontinued immediately following randomization, did not start treatment and have not been included in any of the efficacy or safety calculations.|Years|Mean|61|61.0|Full Range|||50.0|75.0|
4193730|NCT00766376|4016400|B1|United States||Region of Enrollment||participants|Number|124|124.0||||||
4193731|NCT00766376|4016400|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4193732|NCT00766376|4016400|B1||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4193733|NCT00766376|4016400|B1|||Age||years|Mean|55|55.0|Standard Deviation|8.11|8.11|||
4193734|NCT00766376|4016400|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4193735|NCT00766376|4016400|B1||Between 18 and 65 years|Age||Participants|Count of Participants|113|113.0||||||
4193736|NCT00766376|4016400|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4193737|NCT00766363|4016405|B5|United States||Region of Enrollment||participants|Number|49|49.0||||||
4193738|NCT00766363|4016406|B4|United States||Region of Enrollment||participants|Number|13|13.0||||||
4193739|NCT00766363|4016407|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4193740|NCT00766363|4016408|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4193741|NCT00766363|4016409|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4193742|NCT00766363|4016405|B5||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4193743|NCT00766363|4016406|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4193744|NCT00766363|4016407|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4193745|NCT00766363|4016408|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4193746|NCT00766363|4016409|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4193747|NCT00766363|4016405|B5||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4193749|NCT00766363|4016407|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4193750|NCT00766363|4016408|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4193751|NCT00766363|4016409|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4193752|NCT00766363|4016405|B5|||Age||years|Mean|69.8|69.8|Standard Deviation|10.4|10.4|||
4193753|NCT00766363|4016406|B4|||Age||years|Mean|72.0|72.0|Standard Deviation|10.5|10.5|||
4193754|NCT00766363|4016407|B3|||Age||years|Mean|70.2|70.2|Standard Deviation|12.3|12.3|||
4193755|NCT00766363|4016408|B2|||Age||years|Mean|68.3|68.3|Standard Deviation|11.1|11.1|||
4193756|NCT00766363|4016409|B1|||Age||years|Mean|68.6|68.6|Standard Deviation|8.5|8.5|||
4193757|NCT00766363|4016405|B5||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4193758|NCT00766363|4016406|B4||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4193759|NCT00766363|4016407|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4193760|NCT00766363|4016408|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4193761|NCT00766363|4016409|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4193762|NCT00766363|4016405|B5||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4193763|NCT00766363|4016406|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4193764|NCT00766363|4016407|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4193765|NCT00766363|4016408|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4193766|NCT00766363|4016409|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4193767|NCT00766363|4016405|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4193768|NCT00766363|4016406|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4193769|NCT00766363|4016407|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4193770|NCT00766363|4016408|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4193771|NCT00766363|4016409|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4193772|NCT00766090|4016449|B3|African American/African Heritage & White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4193773|NCT00766090|4016450|B2|African American/African Heritage & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4193774|NCT00766090|4016451|B1|African American/African Heritage & White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4193775|NCT00766090|4016449|B3|African American/African HER & AI or AN & White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4193776|NCT00766090|4016450|B2|African American/African HER & AI or AN & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4193777|NCT00766090|4016451|B1|African American/African HER & AI or AN & White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4193778|NCT00766090|4016449|B3|White||Race/Ethnicity, Customized||participants|Number|112|112.0||||||
4193779|NCT00766090|4016450|B2|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4193780|NCT00766090|4016451|B1|White||Race/Ethnicity, Customized||participants|Number|90|90.0||||||
4193781|NCT00766090|4016449|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4193782|NCT00766090|4016450|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4193783|NCT00766090|4016451|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4193784|NCT00766090|4016449|B3|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4193785|NCT00766090|4016450|B2|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4193786|NCT00766090|4016451|B1|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4193787|NCT00766090|4016449|B3|American Indian (AI) or Alaska Native (AN)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4193788|NCT00766090|4016450|B2|American Indian (AI) or Alaska Native (AN)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4193789|NCT00766090|4016451|B1|American Indian (AI) or Alaska Native (AN)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4193790|NCT00766090|4016449|B3|African American/African Heritage (HER)||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
4193791|NCT00766090|4016450|B2|African American/African Heritage (HER)||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4193792|NCT00766090|4016451|B1|African American/African Heritage (HER)||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
4193793|NCT00766090|4016449|B3||Male|Gender||Participants|Count of Participants|82|82.0||||||
4193794|NCT00766090|4016450|B2||Male|Gender||Participants|Count of Participants|22|22.0||||||
4193795|NCT00766090|4016451|B1||Male|Gender||Participants|Count of Participants|60|60.0||||||
4193796|NCT00766090|4016449|B3||Female|Gender||Participants|Count of Participants|108|108.0||||||
4193797|NCT00766090|4016450|B2||Female|Gender||Participants|Count of Participants|21|21.0||||||
4193798|NCT00766090|4016451|B1||Female|Gender||Participants|Count of Participants|87|87.0||||||
4193799|NCT00766090|4016449|B3|||Age||Years|Mean|32.3|32.3|Standard Deviation|15.51|15.51|||
4193800|NCT00766090|4016450|B2|||Age||Years|Mean|35.2|35.2|Standard Deviation|16.03|16.03|||
4193801|NCT00766090|4016451|B1|||Age||Years|Mean|31.4|31.4|Standard Deviation|15.30|15.3|||
4193802|NCT00766051|4016501|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4193803|NCT00766051|4016502|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4193804|NCT00766051|4016503|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4193805|NCT00766051|4016501|B3||Male|Gender||Participants|Count of Participants|11|11.0||||||
4193806|NCT00766051|4016502|B2||Male|Gender||Participants|Count of Participants|6|6.0||||||
4193807|NCT00766051|4016503|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
4193808|NCT00766051|4016501|B3||Female|Gender||Participants|Count of Participants|9|9.0||||||
4193809|NCT00766051|4016502|B2||Female|Gender||Participants|Count of Participants|4|4.0||||||
4193810|NCT00766051|4016503|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
4193811|NCT00766051|4016501|B3|||Age||gestational age in weeks|Mean|32.4|32.4|Standard Deviation|5.8|5.8|||
4193812|NCT00766051|4016502|B2|||Age||gestational age in weeks|Mean|32.4|32.4|Standard Deviation|6|6.0|||
4193813|NCT00766051|4016503|B1|||Age||gestational age in weeks|Mean|34.4|34.4|Standard Deviation|5.8|5.8|||
4193814|NCT00766051|4016501|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4193815|NCT00766051|4016502|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4193816|NCT00766051|4016503|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4193817|NCT00766051|4016501|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4193818|NCT00766051|4016502|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4193819|NCT00766051|4016503|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4193820|NCT00766051|4016501|B3||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
4193821|NCT00766051|4016502|B2||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4193822|NCT00766051|4016503|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4193823|NCT00765947|4016514|B1||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4193824|NCT00765947|4016514|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4193825|NCT00765947|4016514|B1|≥ 65 yrs||Age, Customized||participants|Number|53|53.0||||||
4193826|NCT00765947|4016514|B1|< 65 yrs||Age, Customized||participants|Number|203|203.0||||||
4193827|NCT00765895|4016523|B3|||Patient Health Questionnaire-15|The Patient Health Questionnaire (PHQ) is a multiple-choice self-report inventory that is used as a screening and diagnostic tool for somatic symptoms. The sum of 15 items coded 0 (not bothered at all) to 2 (bothered a lot); total score range 0-30).Higher scores indicate higher somatic symptoms.|units on a scale|Mean|14|14.0|Standard Deviation|5|5.0|||
4193828|NCT00765895|4016524|B2|||Patient Health Questionnaire-15|The Patient Health Questionnaire (PHQ) is a multiple-choice self-report inventory that is used as a screening and diagnostic tool for somatic symptoms. The sum of 15 items coded 0 (not bothered at all) to 2 (bothered a lot); total score range 0-30).Higher scores indicate higher somatic symptoms.|units on a scale|Mean|14|14.0|Standard Deviation|5|5.0|||
4193829|NCT00765895|4016525|B1|||Patient Health Questionnaire-15|The Patient Health Questionnaire (PHQ) is a multiple-choice self-report inventory that is used as a screening and diagnostic tool for somatic symptoms. The sum of 15 items coded 0 (not bothered at all) to 2 (bothered a lot); total score range 0-30).Higher scores indicate higher somatic symptoms.|units on a scale|Mean|14|14.0|Standard Deviation|5|5.0|||
4193830|NCT00765895|4016523|B3|||State Trait Anxiety Inventory- Trait Anxiety score|The STAI measures trait anxiety, or anxiety level as a personal characteristic. The sum of 20 items coded 1 (almost never) to 4 (almost always)gives a total score range of 0-80. Higher scores are positively correlated with higher levels of trait anxiety.|units on a scale|Mean|43|43.0|Standard Deviation|12|12.0|||
4193831|NCT00765895|4016524|B2|||State Trait Anxiety Inventory- Trait Anxiety score|The STAI measures trait anxiety, or anxiety level as a personal characteristic. The sum of 20 items coded 1 (almost never) to 4 (almost always)gives a total score range of 0-80. Higher scores are positively correlated with higher levels of trait anxiety.|units on a scale|Mean|43|43.0|Standard Deviation|13|13.0|||
4193832|NCT00765895|4016525|B1|||State Trait Anxiety Inventory- Trait Anxiety score|The STAI measures trait anxiety, or anxiety level as a personal characteristic. The sum of 20 items coded 1 (almost never) to 4 (almost always)gives a total score range of 0-80. Higher scores are positively correlated with higher levels of trait anxiety.|units on a scale|Mean|43|43.0|Standard Deviation|12|12.0|||
4193833|NCT00765895|4016523|B3|||State Trait Anxiety Inventory- State Anxiety score|The STAI measures anxiety - state anxiety, or anxiety about an event. The sum of 20 items coded 1 (not at all) to 4 (very much so) for a total score range of 0-80. Higher scores are positively correlated with higher levels of anxiety.|units on a scale|Mean|42|42.0|Standard Deviation|12|12.0|||
4193834|NCT00765895|4016524|B2|||State Trait Anxiety Inventory- State Anxiety score|The STAI measures anxiety - state anxiety, or anxiety about an event. The sum of 20 items coded 1 (not at all) to 4 (very much so) for a total score range of 0-80. Higher scores are positively correlated with higher levels of anxiety.|units on a scale|Mean|41|41.0|Standard Deviation|12|12.0|||
4193835|NCT00765895|4016525|B1|||State Trait Anxiety Inventory- State Anxiety score|The STAI measures anxiety - state anxiety, or anxiety about an event. The sum of 20 items coded 1 (not at all) to 4 (very much so) for a total score range of 0-80. Higher scores are positively correlated with higher levels of anxiety.|units on a scale|Mean|42|42.0|Standard Deviation|13|13.0|||
4193836|NCT00765895|4016523|B3|||Brief Pain Inventory- interference score|Mean of 7 Brief Pain Inventory items where each item is coded 0 (does not interfere) to 10 (completely interferes) with higher scores indicating a higher degree to which pain interferes with daily life.|units on a scale|Mean|4.1|4.1|Standard Deviation|3.1|3.1|||
4193837|NCT00765895|4016524|B2|||Brief Pain Inventory- interference score|Mean of 7 Brief Pain Inventory items where each item is coded 0 (does not interfere) to 10 (completely interferes) with higher scores indicating a higher degree to which pain interferes with daily life.|units on a scale|Mean|4.1|4.1|Standard Deviation|3.3|3.3|||
4193838|NCT00765895|4016525|B1|||Brief Pain Inventory- interference score|Mean of 7 Brief Pain Inventory items where each item is coded 0 (does not interfere) to 10 (completely interferes) with higher scores indicating a higher degree to which pain interferes with daily life.|units on a scale|Mean|4.2|4.2|Standard Deviation|3.0|3.0|||
4193839|NCT00765895|4016523|B3|||Brief Pain Inventory- severity score|Mean of 4 Brief Pain Inventory items, where each item is coded 0 (no pain) to 10 (pain as bad as you can imagine) with higher scores meaning greater pain.|units on a scale|Mean|4.0|4.0|Standard Deviation|2.6|2.6|||
4193916|NCT00765895|4016525|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4193840|NCT00765895|4016524|B2|||Brief Pain Inventory- severity score|Mean of 4 Brief Pain Inventory items, where each item is coded 0 (no pain) to 10 (pain as bad as you can imagine) with higher scores meaning greater pain.|units on a scale|Mean|4.1|4.1|Standard Deviation|2.7|2.7|||
4193841|NCT00765895|4016525|B1|||Brief Pain Inventory- severity score|Mean of 4 Brief Pain Inventory items, where each item is coded 0 (no pain) to 10 (pain as bad as you can imagine) with higher scores meaning greater pain.|units on a scale|Mean|4.0|4.0|Standard Deviation|2.5|2.5|||
4193842|NCT00765895|4016523|B3|||Beck Depression Inventory- severe depression score|"Number of participants with a total score greater than 28 on the Beck Depression Inventory, or scoring a 2 or 3 on either of two items (pessimism and suicidal thoughts) which are indicative of severe depression."|participants|Number|27|27.0||||||
4193843|NCT00765895|4016524|B2|||Beck Depression Inventory- severe depression score|"Number of participants with a total score greater than 28 on the Beck Depression Inventory, or scoring a 2 or 3 on either of two items (pessimism and suicidal thoughts) which are indicative of severe depression."|participants|Number|15|15.0||||||
4193844|NCT00765895|4016525|B1|||Beck Depression Inventory- severe depression score|"Number of participants with a total score greater than 28 on the Beck Depression Inventory, or scoring a 2 or 3 on either of two items (pessimism and suicidal thoughts) which are indicative of severe depression."|participants|Number|12|12.0||||||
4193845|NCT00765895|4016523|B3|||Beck Depression Inventory- total score|Sum of 21 BDI items coded 0 (absence) to 3 (severe) with a total score range of 0-63. Higher scores mean greater depression symptom severity.|units on a scale|Mean|17|17.0|Standard Deviation|12|12.0|||
4193846|NCT00765895|4016524|B2|||Beck Depression Inventory- total score|Sum of 21 BDI items coded 0 (absence) to 3 (severe) with a total score range of 0-63. Higher scores mean greater depression symptom severity.|units on a scale|Mean|18|18.0|Standard Deviation|12|12.0|||
4193847|NCT00765895|4016525|B1|||Beck Depression Inventory- total score|Sum of 21 BDI items coded 0 (absence) to 3 (severe) with a total score range of 0-63. Higher scores mean greater depression symptom severity.|units on a scale|Mean|17|17.0|Standard Deviation|11|11.0|||
4193848|NCT00765895|4016523|B3|||SF-36 Quality of Life -Mental component|he SF-36 consists of scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.|units on a scale|Mean|40|40.0|Standard Deviation|13|13.0|||
4193849|NCT00765895|4016524|B2|||SF-36 Quality of Life -Mental component|he SF-36 consists of scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.|units on a scale|Mean|40|40.0|Standard Deviation|13|13.0|||
4193850|NCT00765895|4016525|B1|||SF-36 Quality of Life -Mental component|he SF-36 consists of scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.|units on a scale|Mean|41|41.0|Standard Deviation|13|13.0|||
4193851|NCT00765895|4016523|B3|||SF-36 Quality of Life - Physical component|he SF-36 consists of scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.|units on a scale|Mean|35|35.0|Standard Deviation|10|10.0|||
4193852|NCT00765895|4016524|B2|||SF-36 Quality of Life - Physical component|he SF-36 consists of scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.|units on a scale|Mean|36|36.0|Standard Deviation|10|10.0|||
4193853|NCT00765895|4016525|B1|||SF-36 Quality of Life - Physical component|he SF-36 consists of scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.|units on a scale|Mean|35|35.0|Standard Deviation|10|10.0|||
4193854|NCT00765895|4016523|B3|||Gastroparesis Symptom Rating Scale score|Gastrointestinal Symptom Rating Scale (GSRS) assesses gastrointestinal symptoms seen in irritable bowel syndrome and peptic ulcer disease. The mean of 15 items coded 1 (no discomfort) to 7 (very severe discomfort). Higher scores mean worse symptoms.|units on a scale|Mean|3.6|3.6|Standard Deviation|1.2|1.2|||
4193855|NCT00765895|4016524|B2|||Gastroparesis Symptom Rating Scale score|Gastrointestinal Symptom Rating Scale (GSRS) assesses gastrointestinal symptoms seen in irritable bowel syndrome and peptic ulcer disease. The mean of 15 items coded 1 (no discomfort) to 7 (very severe discomfort). Higher scores mean worse symptoms.|units on a scale|Mean|3.7|3.7|Standard Deviation|1.2|1.2|||
4193856|NCT00765895|4016525|B1|||Gastroparesis Symptom Rating Scale score|Gastrointestinal Symptom Rating Scale (GSRS) assesses gastrointestinal symptoms seen in irritable bowel syndrome and peptic ulcer disease. The mean of 15 items coded 1 (no discomfort) to 7 (very severe discomfort). Higher scores mean worse symptoms.|units on a scale|Mean|3.6|3.6|Standard Deviation|1.1|1.1|||
4193857|NCT00765895|4016523|B3|||clinical global patient impression score|"A Clinical Global Patient Impression (CGPI) question quantified overall relief of symptoms. This question asked, “Compared to the way you usually felt before entering the study,how would you rate your relief of symptoms during the past week? Items coded −3 (very considerably worse) to 3 (completely better). Lower scores mean worsening of symptoms."|units on a scale|Mean|-0.7|-0.7|Standard Deviation|1.0|1.0|||
4193917|NCT00765895|4016523|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4193858|NCT00765895|4016524|B2|||clinical global patient impression score|"A Clinical Global Patient Impression (CGPI) question quantified overall relief of symptoms. This question asked, “Compared to the way you usually felt before entering the study,how would you rate your relief of symptoms during the past week? Items coded −3 (very considerably worse) to 3 (completely better). Lower scores mean worsening of symptoms."|units on a scale|Mean|-0.7|-0.7|Standard Deviation|1.2|1.2|||
4193859|NCT00765895|4016525|B1|||clinical global patient impression score|"A Clinical Global Patient Impression (CGPI) question quantified overall relief of symptoms. This question asked, “Compared to the way you usually felt before entering the study,how would you rate your relief of symptoms during the past week? Items coded −3 (very considerably worse) to 3 (completely better). Lower scores mean worsening of symptoms."|units on a scale|Mean|-0.7|-0.7|Standard Deviation|0.9|0.9|||
4193860|NCT00765895|4016523|B3|||PAGI-SYM nausea/vomiting predominant symptom|Number of participants reporting either nausea or vomiting as their predominant symptom on the PAGI-SYM.|participants|Number|49|49.0||||||
4193861|NCT00765895|4016524|B2|||PAGI-SYM nausea/vomiting predominant symptom|Number of participants reporting either nausea or vomiting as their predominant symptom on the PAGI-SYM.|participants|Number|22|22.0||||||
4193862|NCT00765895|4016525|B1|||PAGI-SYM nausea/vomiting predominant symptom|Number of participants reporting either nausea or vomiting as their predominant symptom on the PAGI-SYM.|participants|Number|27|27.0||||||
4193863|NCT00765895|4016523|B3|||GI symptom diarrhea sub score|The diarrhea score ranges from 0-5; higher scores mean more severe symptoms.|units on a scale|Mean|1.9|1.9|Standard Deviation|1.8|1.8|||
4193864|NCT00765895|4016524|B2|||GI symptom diarrhea sub score|The diarrhea score ranges from 0-5; higher scores mean more severe symptoms.|units on a scale|Mean|2.0|2.0|Standard Deviation|1.8|1.8|||
4193865|NCT00765895|4016525|B1|||GI symptom diarrhea sub score|The diarrhea score ranges from 0-5; higher scores mean more severe symptoms.|units on a scale|Mean|1.8|1.8|Standard Deviation|1.7|1.7|||
4193866|NCT00765895|4016523|B3|||GI symptoms constipation sub score|The constipation symptom score ranges from 0-5, higher scores mean more severe symptoms.|units on a scale|Mean|2.6|2.6|Standard Deviation|1.8|1.8|||
4193867|NCT00765895|4016524|B2|||GI symptoms constipation sub score|The constipation symptom score ranges from 0-5, higher scores mean more severe symptoms.|units on a scale|Mean|2.4|2.4|Standard Deviation|1.7|1.7|||
4193868|NCT00765895|4016525|B1|||GI symptoms constipation sub score|The constipation symptom score ranges from 0-5, higher scores mean more severe symptoms.|units on a scale|Mean|2.8|2.8|Standard Deviation|1.9|1.9|||
4193869|NCT00765895|4016523|B3|||PAGI-SYM- GERD sub score|Sum of 7 PAGI-SYM items rating heartburn, discomfort in the chest, regurgitation/reflux and bitter acid taste in your mouth symptoms. Each symptom score ranges from 0-5, with a total GERD score range from 0-35. Higher scores mean more severe symptoms.|units on a scale|Mean|16.7|16.7|Standard Deviation|10.7|10.7|||
4193870|NCT00765895|4016524|B2|||PAGI-SYM- GERD sub score|Sum of 7 PAGI-SYM items rating heartburn, discomfort in the chest, regurgitation/reflux and bitter acid taste in your mouth symptoms. Each symptom score ranges from 0-5, with a total GERD score range from 0-35. Higher scores mean more severe symptoms.|units on a scale|Mean|17.9|17.9|Standard Deviation|10.5|10.5|||
4193871|NCT00765895|4016525|B1|||PAGI-SYM- GERD sub score|Sum of 7 PAGI-SYM items rating heartburn, discomfort in the chest, regurgitation/reflux and bitter acid taste in your mouth symptoms. Each symptom score ranges from 0-5, with a total GERD score range from 0-35. Higher scores mean more severe symptoms.|units on a scale|Mean|15.4|15.4|Standard Deviation|9.4|9.4|||
4193872|NCT00765895|4016523|B3|||PAGI-SYM- lower abdominal pain sub score|Sum 2 PAGI-SYM items: lower abdominal pain and lower abdominal discomfort symptoms. Each symptom score ranges from 0-5, with a total lower abdominal pain score range from 0-10. Higher scores mean more severe symptoms.|units on a scale|Mean|4.5|4.5|Standard Deviation|3.3|3.3|||
4193873|NCT00765895|4016524|B2|||PAGI-SYM- lower abdominal pain sub score|Sum 2 PAGI-SYM items: lower abdominal pain and lower abdominal discomfort symptoms. Each symptom score ranges from 0-5, with a total lower abdominal pain score range from 0-10. Higher scores mean more severe symptoms.|units on a scale|Mean|4.3|4.3|Standard Deviation|3.3|3.3|||
4193874|NCT00765895|4016525|B1|||PAGI-SYM- lower abdominal pain sub score|Sum 2 PAGI-SYM items: lower abdominal pain and lower abdominal discomfort symptoms. Each symptom score ranges from 0-5, with a total lower abdominal pain score range from 0-10. Higher scores mean more severe symptoms.|units on a scale|Mean|4.7|4.7|Standard Deviation|3.3|3.3|||
4193875|NCT00765895|4016523|B3|||PAGI-SYM- upper abdominal pain sub score|Sum of 2 PAGI-SYM items: upper abdominal pain and upper abdominal discomfort symptoms. Each symptom score ranges from 0-5, with a total upper abdominal pain score range from 0-10. Higher scores mean more severe symptoms.|units on a scale|Mean|6.6|6.6|Standard Deviation|2.9|2.9|||
4193876|NCT00765895|4016524|B2|||PAGI-SYM- upper abdominal pain sub score|Sum of 2 PAGI-SYM items: upper abdominal pain and upper abdominal discomfort symptoms. Each symptom score ranges from 0-5, with a total upper abdominal pain score range from 0-10. Higher scores mean more severe symptoms.|units on a scale|Mean|6.5|6.5|Standard Deviation|2.9|2.9|||
4193877|NCT00765895|4016525|B1|||PAGI-SYM- upper abdominal pain sub score|Sum of 2 PAGI-SYM items: upper abdominal pain and upper abdominal discomfort symptoms. Each symptom score ranges from 0-5, with a total upper abdominal pain score range from 0-10. Higher scores mean more severe symptoms.|units on a scale|Mean|6.8|6.8|Standard Deviation|2.9|2.9|||
4193878|NCT00765895|4016523|B3|||GSCI- bloating sub score|Sum of 2 GCSI items: bloating and stomach visibly larger symptoms. Each symptom score ranges from 0-5, with a total bloating subscore range from 0-10. Higher scores mean more severe symptoms.|units on a scale|Mean|7.1|7.1|Standard Deviation|2.8|2.8|||
4193879|NCT00765895|4016524|B2|||GSCI- bloating sub score|Sum of 2 GCSI items: bloating and stomach visibly larger symptoms. Each symptom score ranges from 0-5, with a total bloating subscore range from 0-10. Higher scores mean more severe symptoms.|units on a scale|Mean|7.0|7.0|Standard Deviation|2.7|2.7|||
4193880|NCT00765895|4016525|B1|||GSCI- bloating sub score|Sum of 2 GCSI items: bloating and stomach visibly larger symptoms. Each symptom score ranges from 0-5, with a total bloating subscore range from 0-10. Higher scores mean more severe symptoms.|units on a scale|Mean|7.2|7.2|Standard Deviation|2.9|2.9|||
4193918|NCT00765895|4016524|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4193881|NCT00765895|4016523|B3|||GSCI- satiety sub score|Sum of 4 GSCI items: fullness, not able to finish a normal size meal, feeling excessivley full and loss of appetite symptoms. The sub-score ranges from 0-20, with higher scores meaning worse symptom severity.|units on a scale|Mean|15.3|15.3|Standard Deviation|3.7|3.7|||
4193882|NCT00765895|4016524|B2|||GSCI- satiety sub score|Sum of 4 GSCI items: fullness, not able to finish a normal size meal, feeling excessivley full and loss of appetite symptoms. The sub-score ranges from 0-20, with higher scores meaning worse symptom severity.|units on a scale|Mean|15.1|15.1|Standard Deviation|4.1|4.1|||
4193883|NCT00765895|4016525|B1|||GSCI- satiety sub score|Sum of 4 GSCI items: fullness, not able to finish a normal size meal, feeling excessivley full and loss of appetite symptoms. The sub-score ranges from 0-20, with higher scores meaning worse symptom severity.|units on a scale|Mean|15.4|15.4|Standard Deviation|3.4|3.4|||
4193884|NCT00765895|4016523|B3|||GSCI- nausea sub score|Sum of 3 GCSI items: nausea, retching and vomiting symptoms. Each symptom score ranges from 0-5, with a total nausea subscore range from 0-15, with higher scores meaning worse symptom severity.|units on a scale|Mean|8.2|8.2|Standard Deviation|3.9|3.9|||
4193885|NCT00765895|4016524|B2|||GSCI- nausea sub score|Sum of 3 GCSI items: nausea, retching and vomiting symptoms. Each symptom score ranges from 0-5, with a total nausea subscore range from 0-15, with higher scores meaning worse symptom severity.|units on a scale|Mean|8.2|8.2|Standard Deviation|4.2|4.2|||
4193886|NCT00765895|4016525|B1|||GSCI- nausea sub score|Sum of 3 GCSI items: nausea, retching and vomiting symptoms. Each symptom score ranges from 0-5, with a total nausea subscore range from 0-15, with higher scores meaning worse symptom severity.|units on a scale|Mean|8.2|8.2|Standard Deviation|3.6|3.6|||
4193887|NCT00765895|4016523|B3|||GSCI total score|Sum of all 9 GCSI items (sum of nausea, satiety, and bloating subscores). Score ranges from 0-45;higher scores meaning more severe symptoms.|units on a scale|Mean|30.6|30.6|Standard Deviation|6.3|6.3|||
4193888|NCT00765895|4016524|B2|||GSCI total score|Sum of all 9 GCSI items (sum of nausea, satiety, and bloating subscores). Score ranges from 0-45;higher scores meaning more severe symptoms.|units on a scale|Mean|30.3|30.3|Standard Deviation|6.5|6.5|||
4193889|NCT00765895|4016525|B1|||GSCI total score|Sum of all 9 GCSI items (sum of nausea, satiety, and bloating subscores). Score ranges from 0-45;higher scores meaning more severe symptoms.|units on a scale|Mean|30.9|30.9|Standard Deviation|6.1|6.1|||
4193890|NCT00765895|4016523|B3|||selective serotonin reuptake inhibitor taken in last month|Number of participants reporting that they took a selective serotonin receptor reuptake inhibitor drug in the last month.|participants|Number|18|18.0||||||
4193891|NCT00765895|4016524|B2|||selective serotonin reuptake inhibitor taken in last month|Number of participants reporting that they took a selective serotonin receptor reuptake inhibitor drug in the last month.|participants|Number|11|11.0||||||
4193892|NCT00765895|4016525|B1|||selective serotonin reuptake inhibitor taken in last month|Number of participants reporting that they took a selective serotonin receptor reuptake inhibitor drug in the last month.|participants|Number|7|7.0||||||
4193893|NCT00765895|4016523|B3|||antiemetics taken in last month|Number of participants reporting that they took an antiemetic drug in the last month.|participants|Number|72|72.0||||||
4193894|NCT00765895|4016524|B2|||antiemetics taken in last month|Number of participants reporting that they took an antiemetic drug in the last month.|participants|Number|33|33.0||||||
4193895|NCT00765895|4016525|B1|||antiemetics taken in last month|Number of participants reporting that they took an antiemetic drug in the last month.|participants|Number|39|39.0||||||
4193896|NCT00765895|4016523|B3|||prokinetic taken in last month|Number of participants reporting that they took a prokinetic drug in the last month.|participants|Number|48|48.0||||||
4193897|NCT00765895|4016524|B2|||prokinetic taken in last month|Number of participants reporting that they took a prokinetic drug in the last month.|participants|Number|25|25.0||||||
4193898|NCT00765895|4016525|B1|||prokinetic taken in last month|Number of participants reporting that they took a prokinetic drug in the last month.|participants|Number|23|23.0||||||
4193899|NCT00765895|4016523|B3|||benzodiazepine taken in last month|Number of participants reporting that they used a benzodiazepine drug in the last month.|participants|Number|40|40.0||||||
4193900|NCT00765895|4016524|B2|||benzodiazepine taken in last month|Number of participants reporting that they used a benzodiazepine drug in the last month.|participants|Number|14|14.0||||||
4193901|NCT00765895|4016525|B1|||benzodiazepine taken in last month|Number of participants reporting that they used a benzodiazepine drug in the last month.|participants|Number|26|26.0||||||
4193902|NCT00765895|4016523|B3|||proton-pump inhibitor taken in last month|Number of participants reporting that they used a proton-pump inhibitor drug in the last month.|participants|Number|97|97.0||||||
4193903|NCT00765895|4016524|B2|||proton-pump inhibitor taken in last month|Number of participants reporting that they used a proton-pump inhibitor drug in the last month.|participants|Number|49|49.0||||||
4193904|NCT00765895|4016525|B1|||proton-pump inhibitor taken in last month|Number of participants reporting that they used a proton-pump inhibitor drug in the last month.|participants|Number|48|48.0||||||
4193905|NCT00765895|4016523|B3|||Body mass index||kg/m^2|Mean|27|27.0|Standard Deviation|6|6.0|||
4193906|NCT00765895|4016524|B2|||Body mass index||kg/m^2|Mean|28|28.0|Standard Deviation|7|7.0|||
4193907|NCT00765895|4016525|B1|||Body mass index||kg/m^2|Mean|27|27.0|Standard Deviation|5|5.0|||
4193908|NCT00765895|4016523|B3|United States||Region of Enrollment||participants|Number|130|130.0||||||
4193909|NCT00765895|4016524|B2|United States||Region of Enrollment||participants|Number|65|65.0||||||
4193910|NCT00765895|4016525|B1|United States||Region of Enrollment||participants|Number|65|65.0||||||
4193911|NCT00765895|4016523|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4193912|NCT00765895|4016524|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4193913|NCT00765895|4016525|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4193914|NCT00765895|4016523|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
4193915|NCT00765895|4016524|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4193919|NCT00765895|4016525|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4193920|NCT00765895|4016523|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4193921|NCT00765895|4016524|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4193922|NCT00765895|4016525|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4193923|NCT00765895|4016523|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4193924|NCT00765895|4016524|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4193925|NCT00765895|4016525|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4193926|NCT00765895|4016523|B3||White|Race (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
4193927|NCT00765895|4016524|B2||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4193928|NCT00765895|4016525|B1||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4193929|NCT00765895|4016523|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4193930|NCT00765895|4016524|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4193931|NCT00765895|4016525|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4193932|NCT00765895|4016523|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4193933|NCT00765895|4016524|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4193934|NCT00765895|4016525|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4193935|NCT00765895|4016523|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4193936|NCT00765895|4016524|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4193937|NCT00765895|4016525|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4193938|NCT00765895|4016523|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4193939|NCT00765895|4016524|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4193940|NCT00765895|4016525|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4193941|NCT00765895|4016523|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4193942|NCT00765895|4016524|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4193943|NCT00765895|4016525|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4193944|NCT00765895|4016523|B3||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4193945|NCT00765895|4016524|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4193946|NCT00765895|4016525|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4193947|NCT00765895|4016523|B3|||Age||years|Mean|41|41.0|Standard Deviation|12|12.0|||
4193948|NCT00765895|4016524|B2|||Age||years|Mean|40|40.0|Standard Deviation|12|12.0|||
4193949|NCT00765895|4016525|B1|||Age||years|Mean|42|42.0|Standard Deviation|12|12.0|||
4193950|NCT00765882|4016532|B4|Canada||Region of Enrollment||participants|Number|19|19.0||||||
4193951|NCT00765882|4016533|B3|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4193952|NCT00765882|4016534|B2|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4193953|NCT00765882|4016535|B1|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4193954|NCT00765882|4016532|B4|United States||Region of Enrollment||participants|Number|614|614.0||||||
4193955|NCT00765882|4016533|B3|United States||Region of Enrollment||participants|Number|198|198.0||||||
4193956|NCT00765882|4016534|B2|United States||Region of Enrollment||participants|Number|208|208.0||||||
4193957|NCT00765882|4016535|B1|United States||Region of Enrollment||participants|Number|208|208.0||||||
4193958|NCT00765882|4016532|B4||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4193959|NCT00765882|4016533|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4193960|NCT00765882|4016534|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4193961|NCT00765882|4016535|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4193962|NCT00765882|4016532|B4||Female|Sex: Female, Male||Participants|Count of Participants|572|572.0||||||
4193963|NCT00765882|4016533|B3||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4193964|NCT00765882|4016534|B2||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4193965|NCT00765882|4016535|B1||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4193966|NCT00765882|4016532|B4|65 years and older||Age, Customized||participants|Number|73|73.0||||||
4193967|NCT00765882|4016533|B3|65 years and older||Age, Customized||participants|Number|22|22.0||||||
4193968|NCT00765882|4016534|B2|65 years and older||Age, Customized||participants|Number|24|24.0||||||
4193969|NCT00765882|4016535|B1|65 years and older||Age, Customized||participants|Number|27|27.0||||||
4193970|NCT00765882|4016532|B4|18 years to 64 years||Age, Customized||participants|Number|560|560.0||||||
4193971|NCT00765882|4016533|B3|18 years to 64 years||Age, Customized||participants|Number|183|183.0||||||
4193972|NCT00765882|4016534|B2|18 years to 64 years||Age, Customized||participants|Number|189|189.0||||||
4193973|NCT00765882|4016535|B1|18 years to 64 years||Age, Customized||participants|Number|188|188.0||||||
4193974|NCT00765882|4016532|B4|||Age||years|Mean|47.6|47.6|Standard Deviation|13.0|13.0|||
4193975|NCT00765882|4016533|B3|||Age||years|Mean|47.3|47.3|Standard Deviation|13.3|13.3|||
4193976|NCT00765882|4016534|B2|||Age||years|Mean|48.5|48.5|Standard Deviation|12.3|12.3|||
4193977|NCT00765882|4016535|B1|||Age||years|Mean|47.0|47.0|Standard Deviation|13.5|13.5|||
4193978|NCT00765843|4016566|B4|||duration of plantar fasciitis||months|Mean|5.4|5.4|Standard Deviation|3.3|3.3|||
4193979|NCT00765843|4016567|B3|||duration of plantar fasciitis||months|Mean|5.7|5.7|Standard Deviation|3.6|3.6|||
4193980|NCT00765843|4016568|B2|||duration of plantar fasciitis||months|Mean|5.7|5.7|Standard Deviation|3.6|3.6|||
4193981|NCT00765843|4016569|B1|||duration of plantar fasciitis||months|Mean|4.9|4.9|Standard Deviation|2.7|2.7|||
4193982|NCT00765843|4016566|B4|||height||inches|Mean|65.91|65.91|Standard Deviation|3.8|3.8|||
4193983|NCT00765843|4016567|B3|||height||inches|Mean|66.2|66.2|Standard Deviation|4.7|4.7|||
4193984|NCT00765843|4016568|B2|||height||inches|Mean|65.8|65.8|Standard Deviation|3.4|3.4|||
4193985|NCT00765843|4016569|B1|||height||inches|Mean|65.8|65.8|Standard Deviation|3.3|3.3|||
4193986|NCT00765843|4016566|B4|||weight||pounds|Mean|196.2|196.2|Standard Deviation|44|44.0|||
4193987|NCT00765843|4016567|B3|||weight||pounds|Mean|203.2|203.2|Standard Deviation|49|49.0|||
4193988|NCT00765843|4016568|B2|||weight||pounds|Mean|187.4|187.4|Standard Deviation|41|41.0|||
4193989|NCT00765843|4016569|B1|||weight||pounds|Mean|197.6|197.6|Standard Deviation|42|42.0|||
4193990|NCT00765843|4016566|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4193991|NCT00765843|4016567|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4193992|NCT00765843|4016568|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4193993|NCT00765843|4016569|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4193994|NCT00765843|4016566|B4||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4193995|NCT00765843|4016567|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4193996|NCT00765843|4016568|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4193997|NCT00765843|4016569|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4193998|NCT00765843|4016566|B4|||Age||years|Mean|49.6|49.6|Standard Deviation|12|12.0|||
4193999|NCT00765843|4016567|B3|||Age||years|Mean|50.2|50.2|Standard Deviation|12|12.0|||
4194000|NCT00765843|4016568|B2|||Age||years|Mean|51.3|51.3|Standard Deviation|11|11.0|||
4194001|NCT00765843|4016569|B1|||Age||years|Mean|47.1|47.1|Standard Deviation|13|13.0|||
4194002|NCT00765817|4016579|B3||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4194003|NCT00765817|4016580|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4194004|NCT00765817|4016581|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4194005|NCT00765817|4016579|B3||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4194006|NCT00765817|4016580|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4194007|NCT00765817|4016581|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4194008|NCT00765817|4016579|B3|||Age||years|Mean|59.01|59.01|Standard Deviation|9.41|9.41|||
4194009|NCT00765817|4016580|B2|||Age||years|Mean|59.40|59.4|Standard Deviation|9.96|9.96|||
4194010|NCT00765817|4016581|B1|||Age||years|Mean|58.67|58.67|Standard Deviation|8.91|8.91|||
4194011|NCT00765817|4016579|B3||>=65 years|Age||Participants|Count of Participants|75|75.0||||||
4194012|NCT00765817|4016580|B2||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4194013|NCT00765817|4016581|B1||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
4194014|NCT00765817|4016579|B3||Between 18 and 65 years|Age||Participants|Count of Participants|184|184.0||||||
4194015|NCT00765817|4016580|B2||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
4194016|NCT00765817|4016581|B1||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4194017|NCT00765817|4016579|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194018|NCT00765817|4016580|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194019|NCT00765817|4016581|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194020|NCT00765765|4016620|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4194021|NCT00765765|4016620|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4194022|NCT00765765|4016620|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4194023|NCT00765765|4016620|B1|||Age||years|Mean|51.7|51.7|Standard Deviation|11.2|11.2|||
4194024|NCT00765765|4016620|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4194025|NCT00765765|4016620|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4194026|NCT00765765|4016620|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194027|NCT00765726|4016630|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4194028|NCT00765726|4016630|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4194029|NCT00765726|4016630|B1|||Age||Years|Mean|30|30.0|Standard Deviation|13.6|13.6|||
4194030|NCT00765674|4016634|B5||Male|Sex: Female, Male||Participants|Count of Participants|720|720.0||||||
4194031|NCT00765674|4016635|B4||Male|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4194032|NCT00765674|4016636|B3||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4194033|NCT00765674|4016637|B2||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4194034|NCT00765674|4016638|B1||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4194035|NCT00765674|4016634|B5||Female|Sex: Female, Male||Participants|Count of Participants|471|471.0||||||
4194036|NCT00765674|4016635|B4||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4194037|NCT00765674|4016636|B3||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4194038|NCT00765674|4016637|B2||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4194039|NCT00765674|4016638|B1||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4194040|NCT00765674|4016634|B5|>=65 years||Age, Customized||participants|Number|228|228.0||||||
4194041|NCT00765674|4016635|B4|>=65 years||Age, Customized||participants|Number|59|59.0||||||
4194042|NCT00765674|4016636|B3|>=65 years||Age, Customized||participants|Number|63|63.0||||||
4194043|NCT00765674|4016637|B2|>=65 years||Age, Customized||participants|Number|56|56.0||||||
4194044|NCT00765674|4016638|B1|>=65 years||Age, Customized||participants|Number|50|50.0||||||
4194045|NCT00765674|4016634|B5|< 65 years||Age, Customized||participants|Number|963|963.0||||||
4194046|NCT00765674|4016635|B4|< 65 years||Age, Customized||participants|Number|251|251.0||||||
4194047|NCT00765674|4016636|B3|< 65 years||Age, Customized||participants|Number|233|233.0||||||
4194048|NCT00765674|4016637|B2|< 65 years||Age, Customized||participants|Number|242|242.0||||||
4194049|NCT00765674|4016638|B1|< 65 years||Age, Customized||participants|Number|237|237.0||||||
4194050|NCT00765674|4016634|B5|||Age||years|Mean|55.1|55.1|Standard Deviation|10.86|10.86|||
4194051|NCT00765674|4016635|B4|||Age||years|Mean|55.4|55.4|Standard Deviation|10.54|10.54|||
4194052|NCT00765674|4016636|B3|||Age||years|Mean|55.1|55.1|Standard Deviation|10.86|10.86|||
4194053|NCT00765674|4016637|B2|||Age||years|Mean|55.5|55.5|Standard Deviation|10.75|10.75|||
4194054|NCT00765674|4016638|B1|||Age||years|Mean|54.4|54.4|Standard Deviation|11.33|11.33|||
4194055|NCT00765661|4016663|B3|United States||Region of Enrollment||participants|Number|63|63.0||||||
4194056|NCT00765661|4016664|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
4194057|NCT00765661|4016665|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4194058|NCT00765661|4016663|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4194059|NCT00765661|4016664|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4194060|NCT00765661|4016665|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4194061|NCT00765661|4016663|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4194062|NCT00765661|4016664|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4194063|NCT00765661|4016665|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4194064|NCT00765661|4016663|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4194065|NCT00765661|4016664|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4194066|NCT00765661|4016665|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4194067|NCT00765661|4016663|B3||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4194068|NCT00765661|4016664|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4194069|NCT00765661|4016665|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4194070|NCT00765661|4016663|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194071|NCT00765661|4016664|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194072|NCT00765661|4016665|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194073|NCT00765661|4016663|B3|||Age||years|Mean|47.7|47.7|Standard Deviation|12.94|12.94|||
4194074|NCT00765661|4016664|B2|||Age||years|Mean|46.1|46.1|Standard Deviation|13.87|13.87|||
4194075|NCT00765661|4016665|B1|||Age||years|Mean|49.3|49.3|Standard Deviation|12|12.0|||
4194076|NCT00765648|4016678|B3|United States||Region of Enrollment||participants|Number|226|226.0||||||
4194077|NCT00765648|4016679|B2|United States||Region of Enrollment||participants|Number|116|116.0||||||
4194078|NCT00765648|4016680|B1|United States||Region of Enrollment||participants|Number|110|110.0||||||
4194079|NCT00765648|4016678|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4194080|NCT00765648|4016679|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4194081|NCT00765648|4016680|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4194082|NCT00765648|4016678|B3||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4194083|NCT00765648|4016679|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4194084|NCT00765648|4016680|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4194085|NCT00765648|4016678|B3||>=65 years|Age||Participants|Count of Participants|47|47.0||||||
4194086|NCT00765648|4016679|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4194087|NCT00765648|4016680|B1||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4194088|NCT00765648|4016678|B3||Between 18 and 65 years|Age||Participants|Count of Participants|179|179.0||||||
4194089|NCT00765648|4016679|B2||Between 18 and 65 years|Age||Participants|Count of Participants|98|98.0||||||
4194090|NCT00765648|4016680|B1||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
4194091|NCT00765648|4016678|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194092|NCT00765648|4016679|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194093|NCT00765648|4016680|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194094|NCT00765570|4016697|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4194095|NCT00765570|4016698|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4194096|NCT00765570|4016699|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4194097|NCT00765570|4016697|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4194098|NCT00765570|4016698|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4194099|NCT00765570|4016699|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4194100|NCT00765570|4016697|B3|||Age||years|Mean|72|72.0|Standard Deviation|11|11.0|||
4194101|NCT00765570|4016698|B2|||Age||years|Mean|69|69.0|Standard Deviation|9|9.0|||
4194102|NCT00765570|4016699|B1|||Age||years|Mean|73|73.0|Standard Deviation|12|12.0|||
4194103|NCT00765570|4016697|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4194104|NCT00765570|4016698|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4194105|NCT00765570|4016699|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4194106|NCT00765570|4016697|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4194107|NCT00765570|4016698|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4194108|NCT00765570|4016699|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4194109|NCT00765570|4016697|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194110|NCT00765570|4016698|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194111|NCT00765570|4016699|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194112|NCT00765388|4016708|B1|United Kingdom||Region of Enrollment||participants|Number|27|27.0||||||
4194113|NCT00765388|4016708|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4194114|NCT00765388|4016708|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4194115|NCT00765388|4016708|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|11.5|11.5|||
4194116|NCT00765375|4016737|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4194117|NCT00765375|4016737|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4194118|NCT00765375|4016737|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4194119|NCT00765375|4016737|B1|||Age||years|Mean|21|21.0|Standard Deviation|2.236|2.236|||
4194120|NCT00765375|4016737|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4194121|NCT00765375|4016737|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4194122|NCT00765375|4016737|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194123|NCT00765362|4016743|B1|United States||Region of Enrollment||participants|Number|419|419.0||||||
4194124|NCT00765362|4016743|B1||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4194125|NCT00765362|4016743|B1||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4194126|NCT00765362|4016743|B1|||Age||years|Mean|66.8|66.8|Standard Deviation|10.2|10.2|||
4194127|NCT00765362|4016743|B1||>=65 years|Age||Participants|Count of Participants|238|238.0||||||
4194128|NCT00765362|4016743|B1||Between 18 and 65 years|Age||Participants|Count of Participants|181|181.0||||||
4194129|NCT00765362|4016743|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194130|NCT00765336|4016749|B3|United States||Region of Enrollment||participants|Number|180|180.0||||||
4194131|NCT00765336|4016750|B2|United States||Region of Enrollment||participants|Number|89|89.0||||||
4194132|NCT00765336|4016751|B1|United States||Region of Enrollment||participants|Number|91|91.0||||||
4194133|NCT00765336|4016749|B3||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4194134|NCT00765336|4016750|B2||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4194135|NCT00765336|4016751|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4194136|NCT00765336|4016749|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4194137|NCT00765336|4016750|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4194138|NCT00765336|4016751|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4194139|NCT00765336|4016749|B3|||Age||years|Mean|32.8|32.8|Standard Deviation|10.0|10.0|||
4194140|NCT00765336|4016750|B2|||Age||years|Mean|32.2|32.2|Standard Deviation|9.0|9.0|||
4194141|NCT00765336|4016751|B1|||Age||years|Mean|33.4|33.4|Standard Deviation|11.0|11.0|||
4194142|NCT00765336|4016749|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4194143|NCT00765336|4016750|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4194144|NCT00765336|4016751|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4194145|NCT00765336|4016749|B3||Between 18 and 65 years|Age||Participants|Count of Participants|180|180.0||||||
4194146|NCT00765336|4016750|B2||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
4194147|NCT00765336|4016751|B1||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
4194148|NCT00765336|4016749|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194149|NCT00765336|4016750|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194150|NCT00765336|4016751|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194151|NCT00765245|4016758|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
4194152|NCT00765245|4016759|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4194153|NCT00765245|4016760|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4194154|NCT00765245|4016758|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4194155|NCT00765245|4016759|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4194156|NCT00765245|4016760|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4194157|NCT00765245|4016758|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4194158|NCT00765245|4016759|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194159|NCT00765245|4016760|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4194160|NCT00765245|4016758|B3||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4194161|NCT00765245|4016759|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4194162|NCT00765245|4016760|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4194163|NCT00765245|4016758|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4194164|NCT00765245|4016759|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4194165|NCT00765245|4016760|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4194166|NCT00765245|4016758|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194167|NCT00765245|4016759|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194168|NCT00765245|4016760|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194169|NCT00765245|4016758|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194170|NCT00765245|4016759|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194171|NCT00765245|4016760|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194172|NCT00765245|4016758|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194173|NCT00765245|4016759|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194174|NCT00765245|4016760|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194175|NCT00765245|4016758|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4194176|NCT00765245|4016759|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4194177|NCT00765245|4016760|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4194178|NCT00765245|4016758|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4194179|NCT00765245|4016759|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4194180|NCT00765245|4016760|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4194181|NCT00765245|4016758|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4194182|NCT00765245|4016759|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4194183|NCT00765245|4016760|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194184|NCT00765245|4016758|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4194185|NCT00765245|4016759|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4194186|NCT00765245|4016760|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4194187|NCT00765245|4016758|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4194188|NCT00765245|4016759|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4194189|NCT00765245|4016760|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4194190|NCT00765245|4016758|B3|||Age||years|Median|59|59.0|Inter-Quartile Range|||52.0|65.0|
4194191|NCT00765245|4016759|B2|||Age||years|Median|59.0|59.0|Inter-Quartile Range|||49.5|62.5|
4194192|NCT00765245|4016760|B1|||Age||years|Median|60|60.0|Inter-Quartile Range|||54.8|69.5|
4194193|NCT00765245|4016758|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4194194|NCT00765245|4016759|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4194195|NCT00765245|4016760|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4194196|NCT00765245|4016758|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4194197|NCT00765245|4016759|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4194198|NCT00765245|4016760|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4194199|NCT00765245|4016758|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194200|NCT00765245|4016759|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194201|NCT00765245|4016760|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194202|NCT00765232|4016771|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4194203|NCT00765232|4016772|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4194204|NCT00765232|4016773|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4194205|NCT00765232|4016771|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4194206|NCT00765232|4016772|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4194207|NCT00765232|4016773|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4194208|NCT00765232|4016771|B3|||Age||years|Mean|43|43.0|Standard Deviation|12|12.0|||
4194209|NCT00765232|4016772|B2|||Age||years|Mean|43|43.0|Standard Deviation|13|13.0|||
4194210|NCT00765232|4016773|B1|||Age||years|Mean|43|43.0|Standard Deviation|11|11.0|||
4194211|NCT00765206|4016782|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4194212|NCT00765206|4016782|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4194213|NCT00765206|4016782|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4194214|NCT00765206|4016782|B1|||Age||years|Mean|26.6|26.6|Standard Deviation|8.04|8.04|||
4194215|NCT00765193|4016791|B1|Australia||Region of Enrollment||participants|Number|43|43.0||||||
4194216|NCT00765193|4016791|B1|Turkey||Region of Enrollment||participants|Number|984|984.0||||||
4194217|NCT00765193|4016791|B1|Spain||Region of Enrollment||participants|Number|179|179.0||||||
4194218|NCT00765193|4016791|B1|Netherlands||Region of Enrollment||participants|Number|787|787.0||||||
4194219|NCT00765193|4016791|B1|Argentina||Region of Enrollment||participants|Number|1001|1001.0||||||
4194220|NCT00765193|4016791|B1|France||Region of Enrollment||participants|Number|999|999.0||||||
4194221|NCT00765193|4016791|B1|Brazil||Region of Enrollment||participants|Number|2010|2010.0||||||
4194222|NCT00765193|4016791|B1|Italy||Region of Enrollment||participants|Number|7381|7381.0||||||
4194223|NCT00765193|4016791|B1|Austria||Region of Enrollment||participants|Number|997|997.0||||||
4194224|NCT00765193|4016791|B1||Male|Sex: Female, Male||Participants|Count of Participants|6397|6397.0||||||
4194225|NCT00765193|4016791|B1||Female|Sex: Female, Male||Participants|Count of Participants|7984|7984.0||||||
4194226|NCT00765193|4016791|B1|||Age||years|Mean|49.4|49.4|Standard Deviation|18.4|18.4|||
4194227|NCT00765193|4016791|B1||>=65 years|Age||Participants|Count of Participants|3354|3354.0||||||
4194228|NCT00765193|4016791|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11027|11027.0||||||
4194229|NCT00765193|4016791|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194230|NCT00765128|4016796|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4194231|NCT00765128|4016797|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4194232|NCT00765128|4016798|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4194233|NCT00765128|4016796|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4194234|NCT00765128|4016797|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4194235|NCT00765128|4016798|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4194236|NCT00765128|4016796|B3|||Age||years|Mean|60.6|60.6|Standard Deviation|9.0|9.0|||
4194237|NCT00765128|4016797|B2|||Age||years|Mean|62.0|62.0|Standard Deviation|9.8|9.8|||
4194238|NCT00765128|4016798|B1|||Age||years|Mean|59.0|59.0|Standard Deviation|8.0|8.0|||
4194239|NCT00765102|4016807|B1|Status 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. The scale ranges from 0 (fully active) to 5 (dead). 0=Fully active without restriction; 1= Restricted in physically strenuous activity; 2= Ambulatory, capable of all selfcare.|participants|Number|6|6.0||||||
4194240|NCT00765102|4016807|B1|Status 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. The scale ranges from 0 (fully active) to 5 (dead). 0=Fully active without restriction; 1= Restricted in physically strenuous activity; 2= Ambulatory, capable of all selfcare.|participants|Number|14|14.0||||||
4194241|NCT00765102|4016807|B1|Status 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. The scale ranges from 0 (fully active) to 5 (dead). 0=Fully active without restriction; 1= Restricted in physically strenuous activity; 2= Ambulatory, capable of all selfcare.|participants|Number|12|12.0||||||
4194242|NCT00765102|4016807|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4194243|NCT00765102|4016807|B1|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4194244|NCT00765102|4016807|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4194245|NCT00765102|4016807|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4194246|NCT00765102|4016807|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4194247|NCT00765102|4016807|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4194248|NCT00765102|4016807|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4194249|NCT00765102|4016807|B1|||Age||years|Mean|63.7|63.7|Standard Deviation|8.11|8.11|||
4194250|NCT00765076|4016829|B4||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4194251|NCT00765076|4016830|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4194252|NCT00765076|4016831|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4194253|NCT00765076|4016832|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4194254|NCT00765076|4016829|B4||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4194255|NCT00765076|4016830|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4194256|NCT00765076|4016831|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4194257|NCT00765076|4016832|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4194258|NCT00765076|4016829|B4|||Age||Years|Mean|59.7|59.7|Standard Deviation|20.69|20.69|||
4194259|NCT00765076|4016830|B3|||Age||Years|Mean|26.0|26.0|Standard Deviation|4.91|4.91|||
4194260|NCT00765076|4016831|B2|||Age||Years|Mean|71.5|71.5|Standard Deviation|5.32|5.32|||
4194261|NCT00765076|4016832|B1|||Age||Years|Mean|71.5|71.5|Standard Deviation|5.44|5.44|||
4194262|NCT00765063|4016887|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4194263|NCT00765063|4016887|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4194264|NCT00765063|4016887|B1|||Age||years|Mean|65.2|65.2|Standard Deviation|11.0|11.0|||
4194265|NCT00765037|4016903|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4194266|NCT00765037|4016903|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4194267|NCT00765037|4016903|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4194268|NCT00765037|4016903|B1|||Age||years|Mean|75|75.0|Standard Deviation|4|4.0|||
4194269|NCT00765037|4016903|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4194270|NCT00765037|4016903|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4194271|NCT00765037|4016903|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194272|NCT00764946|4016907|B4|Non-Black||Race|Participants who did not receive treatment are excluded from this measure.|Participants|Number|53|53.0||||||
4194273|NCT00764946|4016908|B3|Non-Black||Race|Participants who did not receive treatment are excluded from this measure.|Participants|Number|7|7.0||||||
4194274|NCT00764946|4016909|B2|Non-Black||Race|Participants who did not receive treatment are excluded from this measure.|Participants|Number|19|19.0||||||
4194275|NCT00764946|4016910|B1|Non-Black||Race|Participants who did not receive treatment are excluded from this measure.|Participants|Number|27|27.0||||||
4194276|NCT00764946|4016907|B4|Black||Race|Participants who did not receive treatment are excluded from this measure.|Participants|Number|153|153.0||||||
4194330|NCT00764790|4017171|B4|||Age||months|Mean|20.9|20.9|Standard Deviation|8.24|8.24|||
4194277|NCT00764946|4016908|B3|Black||Race|Participants who did not receive treatment are excluded from this measure.|Participants|Number|14|14.0||||||
4194278|NCT00764946|4016909|B2|Black||Race|Participants who did not receive treatment are excluded from this measure.|Participants|Number|69|69.0||||||
4194279|NCT00764946|4016910|B1|Black||Race|Participants who did not receive treatment are excluded from this measure.|Participants|Number|70|70.0||||||
4194280|NCT00764946|4016907|B4||Male|Sex: Female, Male|Participants who did not receive treatment are excluded from this measure.|Participants|Count of Participants|109|109.0||||||
4194281|NCT00764946|4016908|B3||Male|Sex: Female, Male|Participants who did not receive treatment are excluded from this measure.|Participants|Count of Participants|14|14.0||||||
4194282|NCT00764946|4016909|B2||Male|Sex: Female, Male|Participants who did not receive treatment are excluded from this measure.|Participants|Count of Participants|44|44.0||||||
4194283|NCT00764946|4016910|B1||Male|Sex: Female, Male|Participants who did not receive treatment are excluded from this measure.|Participants|Count of Participants|51|51.0||||||
4194284|NCT00764946|4016907|B4||Female|Sex: Female, Male|Participants who did not receive treatment are excluded from this measure.|Participants|Count of Participants|97|97.0||||||
4194285|NCT00764946|4016908|B3||Female|Sex: Female, Male|Participants who did not receive treatment are excluded from this measure.|Participants|Count of Participants|7|7.0||||||
4194286|NCT00764946|4016909|B2||Female|Sex: Female, Male|Participants who did not receive treatment are excluded from this measure.|Participants|Count of Participants|44|44.0||||||
4194287|NCT00764946|4016910|B1||Female|Sex: Female, Male|Participants who did not receive treatment are excluded from this measure.|Participants|Count of Participants|46|46.0||||||
4194288|NCT00764946|4016907|B4|||Age|Participants who did not receive treatment are excluded from this measure.|years|Mean|44.7|44.7|Standard Deviation|9.5|9.5|||
4194289|NCT00764946|4016908|B3|||Age|Participants who did not receive treatment are excluded from this measure.|years|Mean|38.5|38.5|Standard Deviation|10.1|10.1|||
4194290|NCT00764946|4016909|B2|||Age|Participants who did not receive treatment are excluded from this measure.|years|Mean|46.9|46.9|Standard Deviation|9.0|9.0|||
4194291|NCT00764946|4016910|B1|||Age|Participants who did not receive treatment are excluded from this measure.|years|Mean|44.0|44.0|Standard Deviation|9.2|9.2|||
4194292|NCT00764881|4016938|B3|||Body Mass Index (BMI)||kg/m^2|Mean|22.8|22.8|Standard Deviation|3.0|3.0|||
4194293|NCT00764881|4016939|B2|||Body Mass Index (BMI)||kg/m^2|Mean|22.7|22.7|Standard Deviation|2.9|2.9|||
4194294|NCT00764881|4016940|B1|||Body Mass Index (BMI)||kg/m^2|Mean|22.8|22.8|Standard Deviation|3.2|3.2|||
4194295|NCT00764881|4016938|B3|Other||Ethnic group||participants|Number|1|1.0||||||
4194296|NCT00764881|4016939|B2|Other||Ethnic group||participants|Number|1|1.0||||||
4194297|NCT00764881|4016940|B1|Other||Ethnic group||participants|Number|0|0.0||||||
4194298|NCT00764881|4016938|B3|Asian||Ethnic group||participants|Number|29|29.0||||||
4194299|NCT00764881|4016939|B2|Asian||Ethnic group||participants|Number|13|13.0||||||
4194300|NCT00764881|4016940|B1|Asian||Ethnic group||participants|Number|16|16.0||||||
4194301|NCT00764881|4016938|B3|Hispanic||Ethnic group||participants|Number|1|1.0||||||
4194302|NCT00764881|4016939|B2|Hispanic||Ethnic group||participants|Number|1|1.0||||||
4194303|NCT00764881|4016940|B1|Hispanic||Ethnic group||participants|Number|0|0.0||||||
4194304|NCT00764881|4016938|B3|Caucasian||Ethnic group||participants|Number|182|182.0||||||
4194305|NCT00764881|4016939|B2|Caucasian||Ethnic group||participants|Number|92|92.0||||||
4194306|NCT00764881|4016940|B1|Caucasian||Ethnic group||participants|Number|90|90.0||||||
4194307|NCT00764881|4016938|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4194308|NCT00764881|4016939|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4194309|NCT00764881|4016940|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4194310|NCT00764881|4016938|B3||Female|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
4194311|NCT00764881|4016939|B2||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4194312|NCT00764881|4016940|B1||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4194313|NCT00764881|4016938|B3|||Age||years|Mean|30.5|30.5|Standard Deviation|7.4|7.4|||
4194314|NCT00764881|4016939|B2|||Age||years|Mean|30.2|30.2|Standard Deviation|7.8|7.8|||
4194315|NCT00764881|4016940|B1|||Age||years|Mean|30.9|30.9|Standard Deviation|7.0|7.0|||
4194316|NCT00764868|4017165|B1|United States||Region of Enrollment||participants|Number|265|265.0||||||
4194317|NCT00764868|4017165|B1||Male|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4194318|NCT00764868|4017165|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4194319|NCT00764868|4017165|B1|15 to 17 years||Age, Customized||participants|Number|121|121.0||||||
4194320|NCT00764868|4017165|B1|13 to 14 years||Age, Customized||participants|Number|144|144.0||||||
4194321|NCT00764868|4017165|B1|||Age|Baseline characteristics were calculated from the Safety Population (n = 265) defined as all randomized subjects who received at least 1 dose of investigational product. Baseline and demographic characteristics are calculated from entry into the antecedent study (SPD489-305, NCT00735371).|years|Mean|14.5|14.5|Standard Deviation|1.30|1.3|||
4194322|NCT00764790|4017171|B4||Male|Sex: Female, Male||Participants|Count of Participants|1701|1701.0||||||
4194323|NCT00764790|4017172|B3||Male|Sex: Female, Male||Participants|Count of Participants|544|544.0||||||
4194324|NCT00764790|4017173|B2||Male|Sex: Female, Male||Participants|Count of Participants|589|589.0||||||
4194325|NCT00764790|4017174|B1||Male|Sex: Female, Male||Participants|Count of Participants|568|568.0||||||
4194326|NCT00764790|4017171|B4||Female|Sex: Female, Male||Participants|Count of Participants|1616|1616.0||||||
4194327|NCT00764790|4017172|B3||Female|Sex: Female, Male||Participants|Count of Participants|560|560.0||||||
4194328|NCT00764790|4017173|B2||Female|Sex: Female, Male||Participants|Count of Participants|517|517.0||||||
4194329|NCT00764790|4017174|B1||Female|Sex: Female, Male||Participants|Count of Participants|539|539.0||||||
4194331|NCT00764790|4017172|B3|||Age||months|Mean|21.0|21.0|Standard Deviation|8.23|8.23|||
4194332|NCT00764790|4017173|B2|||Age||months|Mean|20.9|20.9|Standard Deviation|8.42|8.42|||
4194333|NCT00764790|4017174|B1|||Age||months|Mean|20.9|20.9|Standard Deviation|8.07|8.07|||
4194334|NCT00764699|4017208|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4194335|NCT00764699|4017208|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4194336|NCT00764699|4017208|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4194337|NCT00764699|4017208|B1|||Age||years|Mean|12.67|12.67|Standard Deviation|2.52|2.52|||
4194338|NCT00764699|4017208|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4194339|NCT00764699|4017208|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4194340|NCT00764699|4017208|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4194341|NCT00764673|4017212|B1|Post-traumatic arthritis||Primary Diagnosis|Physician diagnosis of indication for receiving a total knee implant.|participants|Number|1|1.0||||||
4194342|NCT00764673|4017212|B1|Varus deformity||Primary Diagnosis|Physician diagnosis of indication for receiving a total knee implant.|participants|Number|1|1.0||||||
4194343|NCT00764673|4017212|B1|Osteoarthritis||Primary Diagnosis|Physician diagnosis of indication for receiving a total knee implant.|participants|Number|69|69.0||||||
4194344|NCT00764673|4017212|B1|Left knee||Operated Knee|Affected knee which received the implant|participants|Number|35|35.0||||||
4194345|NCT00764673|4017212|B1|Right knee||Operated Knee|Affected knee which received the implant|participants|Number|36|36.0||||||
4194346|NCT00764673|4017212|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
4194347|NCT00764673|4017212|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4194348|NCT00764673|4017212|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4194349|NCT00764673|4017212|B1|||Age||years|Mean|69|69.0|Standard Deviation|8.7|8.7|||
4194350|NCT00764673|4017212|B1||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
4194351|NCT00764673|4017212|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4194352|NCT00764673|4017212|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194353|NCT00764660|4017220|B3||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4194354|NCT00764660|4017221|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4194355|NCT00764660|4017222|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4194356|NCT00764660|4017220|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4194357|NCT00764660|4017221|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4194358|NCT00764660|4017222|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4194359|NCT00764660|4017220|B3|||Age||Years|Mean|49.3|49.3|Standard Deviation|9.8|9.8|||
4194360|NCT00764660|4017221|B2|||Age||Years|Mean|50.3|50.3|Standard Deviation|9.3|9.3|||
4194361|NCT00764660|4017222|B1|||Age||Years|Mean|48.5|48.5|Standard Deviation|10.3|10.3|||
4194362|NCT00764517|4017255|B3|United States||Region of Enrollment||Participants|Count of Participants|57|57.0||||||
4194363|NCT00764517|4017256|B2|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4194364|NCT00764517|4017257|B1|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
4194365|NCT00764517|4017255|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194366|NCT00764517|4017256|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194367|NCT00764517|4017257|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194368|NCT00764517|4017255|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4194369|NCT00764517|4017256|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194370|NCT00764517|4017257|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4194371|NCT00764517|4017255|B3||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4194372|NCT00764517|4017256|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4194373|NCT00764517|4017257|B1||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4194374|NCT00764517|4017255|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194375|NCT00764517|4017256|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194376|NCT00764517|4017257|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194377|NCT00764517|4017255|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194378|NCT00764517|4017256|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194379|NCT00764517|4017257|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194380|NCT00764517|4017255|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194381|NCT00764517|4017256|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194382|NCT00764517|4017257|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194383|NCT00764517|4017255|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4194384|NCT00764517|4017256|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194385|NCT00764517|4017257|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4194386|NCT00764517|4017255|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194387|NCT00764517|4017256|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194388|NCT00764517|4017257|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194389|NCT00764517|4017255|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4194390|NCT00764517|4017256|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4194391|NCT00764517|4017257|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4194392|NCT00764517|4017255|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4194393|NCT00764517|4017256|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194394|NCT00764517|4017257|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4194395|NCT00764517|4017255|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4194396|NCT00764517|4017256|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4194397|NCT00764517|4017257|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4194398|NCT00764517|4017255|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4194399|NCT00764517|4017256|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4194400|NCT00764517|4017257|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4194401|NCT00764517|4017255|B3|||Age||years|Median|61.5|61.5|Full Range|||35.0|87.0|
4194402|NCT00764517|4017256|B2|||Age||years|Median|60|60.0|Full Range|||46.0|85.0|
4194403|NCT00764517|4017257|B1|||Age||years|Median|62|62.0|Full Range|||35.0|87.0|
4194404|NCT00764504|4017276|B4|Left||Operative Shoulder||participants|Number|200|200.0||||||
4194405|NCT00764504|4017277|B3|Left||Operative Shoulder||participants|Number|88|88.0||||||
4194406|NCT00764504|4017278|B2|Left||Operative Shoulder||participants|Number|58|58.0||||||
4194407|NCT00764504|4017279|B1|Left||Operative Shoulder||participants|Number|54|54.0||||||
4194408|NCT00764504|4017276|B4|Right||Operative Shoulder||participants|Number|316|316.0||||||
4194409|NCT00764504|4017277|B3|Right||Operative Shoulder||participants|Number|146|146.0||||||
4194410|NCT00764504|4017278|B2|Right||Operative Shoulder||participants|Number|83|83.0||||||
4194411|NCT00764504|4017279|B1|Right||Operative Shoulder||participants|Number|87|87.0||||||
4194412|NCT00764504|4017276|B4|United States||Region of Enrollment||participants|Number|516|516.0||||||
4194413|NCT00764504|4017277|B3|United States||Region of Enrollment||participants|Number|234|234.0||||||
4194414|NCT00764504|4017278|B2|United States||Region of Enrollment||participants|Number|141|141.0||||||
4194415|NCT00764504|4017279|B1|United States||Region of Enrollment||participants|Number|141|141.0||||||
4194416|NCT00764504|4017276|B4||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4194417|NCT00764504|4017277|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4194418|NCT00764504|4017278|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4194419|NCT00764504|4017279|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4194420|NCT00764504|4017276|B4||Female|Sex: Female, Male||Participants|Count of Participants|320|320.0||||||
4194421|NCT00764504|4017277|B3||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4194422|NCT00764504|4017278|B2||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4194423|NCT00764504|4017279|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4194424|NCT00764504|4017276|B4|||Age||years|Mean|70.4|70.4|Standard Deviation|10.1|10.1|||
4194425|NCT00764504|4017277|B3|||Age||years|Mean|71.2|71.2|Standard Deviation|9.2|9.2|||
4194426|NCT00764504|4017278|B2|||Age||years|Mean|67.4|67.4|Standard Deviation|11.6|11.6|||
4194427|NCT00764504|4017279|B1|||Age||years|Mean|71.9|71.9|Standard Deviation|9.5|9.5|||
4194428|NCT00764504|4017276|B4||>=65 years|Age||Participants|Count of Participants|377|377.0||||||
4194429|NCT00764504|4017277|B3||>=65 years|Age||Participants|Count of Participants|177|177.0||||||
4194430|NCT00764504|4017278|B2||>=65 years|Age||Participants|Count of Participants|89|89.0||||||
4194431|NCT00764504|4017279|B1||>=65 years|Age||Participants|Count of Participants|111|111.0||||||
4194432|NCT00764504|4017276|B4||Between 18 and 65 years|Age||Participants|Count of Participants|139|139.0||||||
4194433|NCT00764504|4017277|B3||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4194434|NCT00764504|4017278|B2||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4194435|NCT00764504|4017279|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4194436|NCT00764504|4017276|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194437|NCT00764504|4017277|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194438|NCT00764504|4017278|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194439|NCT00764504|4017279|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194440|NCT00764478|4017307|B4||Male|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4194441|NCT00764478|4017308|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4194442|NCT00764478|4017309|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4194443|NCT00764478|4017310|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4194444|NCT00764478|4017307|B4||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4194445|NCT00764478|4017308|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4194446|NCT00764478|4017309|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4194447|NCT00764478|4017310|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4194448|NCT00764478|4017307|B4|||Age||Years|Mean|43.8|43.8|Standard Deviation|11.16|11.16|||
4194449|NCT00764478|4017308|B3|||Age||Years|Mean|44.6|44.6|Standard Deviation|11.54|11.54|||
4194450|NCT00764478|4017309|B2|||Age||Years|Mean|42.5|42.5|Standard Deviation|11.06|11.06|||
4194451|NCT00764478|4017310|B1|||Age||Years|Mean|44.3|44.3|Standard Deviation|10.82|10.82|||
4194452|NCT00764465|4017386|B7|United States||Region of Enrollment||participants|Number|38|38.0||||||
4194453|NCT00764465|4017387|B6|United States||Region of Enrollment||participants|Number|7|7.0||||||
4194454|NCT00764465|4017388|B5|United States||Region of Enrollment||participants|Number|6|6.0||||||
4194455|NCT00764465|4017389|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
4194456|NCT00764465|4017390|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4194457|NCT00764465|4017391|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4194458|NCT00764465|4017392|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4194459|NCT00764465|4017386|B7||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4194460|NCT00764465|4017387|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4194461|NCT00764465|4017388|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4194462|NCT00764465|4017389|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4194463|NCT00764465|4017390|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4194464|NCT00764465|4017391|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4194465|NCT00764465|4017392|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4194466|NCT00764465|4017386|B7||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4194467|NCT00764465|4017387|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4194468|NCT00764465|4017388|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4194469|NCT00764465|4017389|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4194470|NCT00764465|4017390|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4194471|NCT00764465|4017391|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4194472|NCT00764465|4017392|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4194473|NCT00764465|4017386|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4194474|NCT00764465|4017387|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4194475|NCT00764465|4017388|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4194476|NCT00764465|4017389|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4194477|NCT00764465|4017390|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4194478|NCT00764465|4017391|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4194479|NCT00764465|4017392|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4194480|NCT00764465|4017386|B7||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4194481|NCT00764465|4017387|B6||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4194482|NCT00764465|4017388|B5||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4194483|NCT00764465|4017389|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4194484|NCT00764465|4017390|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4194485|NCT00764465|4017391|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4194486|NCT00764465|4017392|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4194487|NCT00764465|4017386|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194488|NCT00764465|4017387|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194489|NCT00764465|4017388|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194490|NCT00764465|4017389|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194491|NCT00764465|4017390|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194492|NCT00764465|4017391|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194493|NCT00764465|4017392|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194494|NCT00764361|4017423|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4194495|NCT00764361|4017424|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4194496|NCT00764361|4017425|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4194497|NCT00764361|4017423|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4194498|NCT00764361|4017424|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4194499|NCT00764361|4017425|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4194500|NCT00764361|4017423|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4194501|NCT00764361|4017424|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4194502|NCT00764361|4017425|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4194503|NCT00764361|4017423|B3|||Age||years|Mean|66.33|66.33|Standard Deviation|10.53|10.53|||
4194504|NCT00764361|4017424|B2|||Age||years|Mean|68.86|68.86|Standard Deviation|9.75|9.75|||
4194505|NCT00764361|4017425|B1|||Age||years|Mean|64.99|64.99|Standard Deviation|11.53|11.53|||
4194506|NCT00764361|4017423|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4194507|NCT00764361|4017424|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4194508|NCT00764361|4017425|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4194509|NCT00764361|4017423|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4194510|NCT00764361|4017424|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4194511|NCT00764361|4017425|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4194512|NCT00764361|4017423|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194513|NCT00764361|4017424|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194514|NCT00764361|4017425|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194515|NCT00764322|4017432|B3||Other|Tamoxifen indication||Participants|Count of Participants|6|6.0||||||
4194516|NCT00764322|4017433|B2||Other|Tamoxifen indication||Participants|Count of Participants|6|6.0||||||
4194517|NCT00764322|4017434|B1||Other|Tamoxifen indication||Participants|Count of Participants|0|0.0||||||
4194518|NCT00764322|4017432|B3||DCIS|Tamoxifen indication||Participants|Count of Participants|66|66.0||||||
4194519|NCT00764322|4017433|B2||DCIS|Tamoxifen indication||Participants|Count of Participants|49|49.0||||||
4194520|NCT00764322|4017434|B1||DCIS|Tamoxifen indication||Participants|Count of Participants|17|17.0||||||
4194521|NCT00764322|4017432|B3||Invasive Disease|Tamoxifen indication||Participants|Count of Participants|407|407.0||||||
4194522|NCT00764322|4017433|B2||Invasive Disease|Tamoxifen indication||Participants|Count of Participants|263|263.0||||||
4194523|NCT00764322|4017434|B1||Invasive Disease|Tamoxifen indication||Participants|Count of Participants|144|144.0||||||
4194524|NCT00764322|4017432|B3||No|Prior chemotherapy||Participants|Count of Participants|219|219.0||||||
4194525|NCT00764322|4017433|B2||No|Prior chemotherapy||Participants|Count of Participants|150|150.0||||||
4194526|NCT00764322|4017434|B1||No|Prior chemotherapy||Participants|Count of Participants|69|69.0||||||
4194527|NCT00764322|4017432|B3||Yes|Prior chemotherapy||Participants|Count of Participants|261|261.0||||||
4194528|NCT00764322|4017433|B2||Yes|Prior chemotherapy||Participants|Count of Participants|169|169.0||||||
4194529|NCT00764322|4017434|B1||Yes|Prior chemotherapy||Participants|Count of Participants|92|92.0||||||
4194530|NCT00764322|4017432|B3|||Duration of Tamoxifen treatment (years)||years|Median|0.93|0.93|Full Range|||0.28|15.86|
4194531|NCT00764322|4017433|B2|||Duration of Tamoxifen treatment (years)||years|Median|0.98|0.98|Full Range|||0.28|15.86|
4194532|NCT00764322|4017434|B1|||Duration of Tamoxifen treatment (years)||years|Median|0.88|0.88|Full Range|||0.31|9.69|
4194533|NCT00764322|4017432|B3||Post-|Menopausal status||Participants|Count of Participants|256|256.0||||||
4194534|NCT00764322|4017433|B2||Post-|Menopausal status||Participants|Count of Participants|165|165.0||||||
4194535|NCT00764322|4017434|B1||Post-|Menopausal status||Participants|Count of Participants|91|91.0||||||
4194536|NCT00764322|4017432|B3||Pre/peri-|Menopausal status||Participants|Count of Participants|224|224.0||||||
4194537|NCT00764322|4017433|B2||Pre/peri-|Menopausal status||Participants|Count of Participants|154|154.0||||||
4194538|NCT00764322|4017434|B1||Pre/peri-|Menopausal status||Participants|Count of Participants|70|70.0||||||
4194539|NCT00764322|4017432|B3|United States||Region of Enrollment||Participants|Count of Participants|480|480.0||||||
4194540|NCT00764322|4017433|B2|United States||Region of Enrollment||Participants|Count of Participants|319|319.0||||||
4194541|NCT00764322|4017434|B1|United States||Region of Enrollment||Participants|Count of Participants|161|161.0||||||
4194542|NCT00764322|4017432|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4194543|NCT00764322|4017433|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4194544|NCT00764322|4017434|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4194545|NCT00764322|4017432|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194546|NCT00764322|4017433|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194547|NCT00764322|4017434|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194548|NCT00764322|4017432|B3||White|Race (NIH/OMB)||Participants|Count of Participants|390|390.0||||||
4194549|NCT00764322|4017433|B2||White|Race (NIH/OMB)||Participants|Count of Participants|250|250.0||||||
4194550|NCT00764322|4017434|B1||White|Race (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
4194551|NCT00764322|4017432|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4194552|NCT00764322|4017433|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4194553|NCT00764322|4017434|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4194554|NCT00764322|4017432|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194555|NCT00764322|4017433|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194556|NCT00764322|4017434|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194557|NCT00764322|4017432|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194558|NCT00764322|4017433|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194559|NCT00764322|4017434|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194560|NCT00764322|4017432|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194561|NCT00764322|4017433|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194562|NCT00764322|4017434|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4194563|NCT00764322|4017432|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4194564|NCT00764322|4017433|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4194565|NCT00764322|4017434|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4194566|NCT00764322|4017432|B3||Female|Sex: Female, Male||Participants|Count of Participants|480|480.0||||||
4194567|NCT00764322|4017433|B2||Female|Sex: Female, Male||Participants|Count of Participants|319|319.0||||||
4194568|NCT00764322|4017434|B1||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4194569|NCT00764322|4017432|B3|Median||Age||years|Median|50|50.0|Full Range|||25.0|95.0|
4194570|NCT00764322|4017433|B2|Median||Age||years|Median|50|50.0|Full Range|||25.0|88.0|
4194571|NCT00764322|4017434|B1|Median||Age||years|Median|51|51.0|Full Range|||30.0|95.0|
4194572|NCT00764309|4017451|B1|> 36 months||Time from Initial Scleroderma Diagnosis to Start of Study||Participants|Number|4|4.0||||||
4194573|NCT00764309|4017451|B1|24 - 36 months||Time from Initial Scleroderma Diagnosis to Start of Study||Participants|Number|7|7.0||||||
4194574|NCT00764309|4017451|B1|12 - 23 months||Time from Initial Scleroderma Diagnosis to Start of Study||Participants|Number|8|8.0||||||
4194575|NCT00764309|4017451|B1|< 12 months||Time from Initial Scleroderma Diagnosis to Start of Study||Participants|Number|12|12.0||||||
4194576|NCT00764309|4017451|B1|TLC, n=26||Baseline Pulmonary Function|"Forced vital capacity (FVC) is the volume of air that can forcibly be blown out after full inspiration; Forced expiratory volume in 1 second (FEV1) is volume that has been exhaled at the first second of forced expiration; Total lung capacity (TLC) is the maximum volume of air present in the lungs.~n=participants with observations"|Liters|Mean|4.292|4.292|Standard Deviation|1.1784|1.1784|||
4194577|NCT00764309|4017451|B1|FEV1, n=30||Baseline Pulmonary Function|"Forced vital capacity (FVC) is the volume of air that can forcibly be blown out after full inspiration; Forced expiratory volume in 1 second (FEV1) is volume that has been exhaled at the first second of forced expiration; Total lung capacity (TLC) is the maximum volume of air present in the lungs.~n=participants with observations"|Liters|Mean|2.614|2.614|Standard Deviation|1.3495|1.3495|||
4194578|NCT00764309|4017451|B1|FVC, n=30||Baseline Pulmonary Function|"Forced vital capacity (FVC) is the volume of air that can forcibly be blown out after full inspiration; Forced expiratory volume in 1 second (FEV1) is volume that has been exhaled at the first second of forced expiration; Total lung capacity (TLC) is the maximum volume of air present in the lungs.~n=participants with observations"|Liters|Mean|2.955|2.955|Standard Deviation|0.7978|0.7978|||
4194579|NCT00764309|4017451|B1|||Baseline Pulmonary Function: Diffusion capacity|"Diffusing capacity (DLCO) is the carbon monoxide uptake from a single inspiration in a standard time (usually 10 sec).~There were 29 participants with observations for this measure."|mL/min/mmHg|Mean|14.223|14.223|Standard Deviation|4.8012|4.8012|||
4194580|NCT00764309|4017451|B1|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4194581|NCT00764309|4017451|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4194582|NCT00764309|4017451|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4194583|NCT00764309|4017451|B1|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4194584|NCT00764309|4017451|B1|Black / African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4194585|NCT00764309|4017451|B1|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4194586|NCT00764309|4017451|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4194587|NCT00764309|4017451|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4194588|NCT00764309|4017451|B1|>=65 years||Age, Customized||Years|Number|5|5.0||||||
4194589|NCT00764309|4017451|B1|<65 years||Age, Customized||Years|Number|26|26.0||||||
4194590|NCT00764309|4017451|B1|||Age||years|Mean|50.8|50.8|Standard Deviation|12.44|12.44|||
4194591|NCT00763971|4017458|B4|Sweden||Region of Enrollment|This includes All Enrolled Subjects. Enrolled Population defined as all subjects who were randomized (n = 336).|participants|Number|52|52.0||||||
4194592|NCT00763971|4017459|B3|Sweden||Region of Enrollment|This includes All Enrolled Subjects. Enrolled Population defined as all subjects who were randomized (n = 336).|participants|Number|17|17.0||||||
4194593|NCT00763971|4017460|B2|Sweden||Region of Enrollment|This includes All Enrolled Subjects. Enrolled Population defined as all subjects who were randomized (n = 336).|participants|Number|17|17.0||||||
4194594|NCT00763971|4017461|B1|Sweden||Region of Enrollment|This includes All Enrolled Subjects. Enrolled Population defined as all subjects who were randomized (n = 336).|participants|Number|18|18.0||||||
4194595|NCT00763971|4017458|B4|Italy||Region of Enrollment|This includes All Enrolled Subjects. Enrolled Population defined as all subjects who were randomized (n = 336).|participants|Number|25|25.0||||||
4194596|NCT00763971|4017459|B3|Italy||Region of Enrollment|This includes All Enrolled Subjects. Enrolled Population defined as all subjects who were randomized (n = 336).|participants|Number|7|7.0||||||
4194597|NCT00763971|4017460|B2|Italy||Region of Enrollment|This includes All Enrolled Subjects. Enrolled Population defined as all subjects who were randomized (n = 336).|participants|Number|9|9.0||||||
4194598|NCT00763971|4017461|B1|Italy||Region of Enrollment|This includes All Enrolled Subjects. Enrolled Population defined as all subjects who were randomized (n = 336).|participants|Number|9|9.0||||||
4194599|NCT00763971|4017458|B4|United Kingdom||Region of Enrollment|This includes All Enrolled Subjects. Enrolled Population defined as all subjects who were randomized (n = 336).|participants|Number|27|27.0||||||
4194600|NCT00763971|4017459|B3|United Kingdom||Region of Enrollment|This includes All Enrolled Subjects. Enrolled Population defined as all subjects who were randomized (n = 336).|participants|Number|9|9.0||||||
4194601|NCT00763971|4017460|B2|United Kingdom||Region of Enrollment|This includes All Enrolled Subjects. Enrolled Population defined as all subjects who were randomized (n = 336).|participants|Number|10|10.0||||||
4194602|NCT00763971|4017461|B1|United Kingdom||Region of Enrollment|This includes All Enrolled Subjects. Enrolled Population defined as all subjects who were randomized (n = 336).|participants|Number|8|8.0||||||
4194603|NCT00763971|4017458|B4|Germany||Region of Enrollment|This includes All Enrolled Subjects. Enrolled Population defined as all subjects who were randomized (n = 336).|participants|Number|107|107.0||||||
4194604|NCT00763971|4017459|B3|Germany||Region of Enrollment|This includes All Enrolled Subjects. Enrolled Population defined as all subjects who were randomized (n = 336).|participants|Number|35|35.0||||||
4194605|NCT00763971|4017460|B2|Germany||Region of Enrollment|This includes All Enrolled Subjects. Enrolled Population defined as all subjects who were randomized (n = 336).|participants|Number|36|36.0||||||
4194606|NCT00763971|4017461|B1|Germany||Region of Enrollment|This includes All Enrolled Subjects. Enrolled Population defined as all subjects who were randomized (n = 336).|participants|Number|36|36.0||||||
4194607|NCT00763971|4017458|B4|Netherlands||Region of Enrollment|This includes All Enrolled Subjects. Enrolled Population defined as all subjects who were randomized (n = 336).|participants|Number|1|1.0||||||
4194608|NCT00763971|4017459|B3|Netherlands||Region of Enrollment|This includes All Enrolled Subjects. Enrolled Population defined as all subjects who were randomized (n = 336).|participants|Number|0|0.0||||||
4194609|NCT00763971|4017460|B2|Netherlands||Region of Enrollment|This includes All Enrolled Subjects. Enrolled Population defined as all subjects who were randomized (n = 336).|participants|Number|0|0.0||||||
4194610|NCT00763971|4017461|B1|Netherlands||Region of Enrollment|This includes All Enrolled Subjects. Enrolled Population defined as all subjects who were randomized (n = 336).|participants|Number|1|1.0||||||
4194611|NCT00763971|4017458|B4|Belgium||Region of Enrollment|This includes All Enrolled Subjects. Enrolled Population defined as all subjects who were randomized (n = 336).|participants|Number|11|11.0||||||
4194612|NCT00763971|4017459|B3|Belgium||Region of Enrollment|This includes All Enrolled Subjects. Enrolled Population defined as all subjects who were randomized (n = 336).|participants|Number|4|4.0||||||
4194613|NCT00763971|4017460|B2|Belgium||Region of Enrollment|This includes All Enrolled Subjects. Enrolled Population defined as all subjects who were randomized (n = 336).|participants|Number|3|3.0||||||
4194614|NCT00763971|4017461|B1|Belgium||Region of Enrollment|This includes All Enrolled Subjects. Enrolled Population defined as all subjects who were randomized (n = 336).|participants|Number|4|4.0||||||
4194615|NCT00763971|4017458|B4|Poland||Region of Enrollment|This includes All Enrolled Subjects. Enrolled Population defined as all subjects who were randomized (n = 336).|participants|Number|10|10.0||||||
4194616|NCT00763971|4017459|B3|Poland||Region of Enrollment|This includes All Enrolled Subjects. Enrolled Population defined as all subjects who were randomized (n = 336).|participants|Number|3|3.0||||||
4194617|NCT00763971|4017460|B2|Poland||Region of Enrollment|This includes All Enrolled Subjects. Enrolled Population defined as all subjects who were randomized (n = 336).|participants|Number|4|4.0||||||
4194618|NCT00763971|4017461|B1|Poland||Region of Enrollment|This includes All Enrolled Subjects. Enrolled Population defined as all subjects who were randomized (n = 336).|participants|Number|3|3.0||||||
4194619|NCT00763971|4017458|B4|Spain||Region of Enrollment|This includes All Enrolled Subjects. Enrolled Population defined as all subjects who were randomized (n = 336).|participants|Number|41|41.0||||||
4194620|NCT00763971|4017459|B3|Spain||Region of Enrollment|This includes All Enrolled Subjects. Enrolled Population defined as all subjects who were randomized (n = 336).|participants|Number|14|14.0||||||
4194621|NCT00763971|4017460|B2|Spain||Region of Enrollment|This includes All Enrolled Subjects. Enrolled Population defined as all subjects who were randomized (n = 336).|participants|Number|14|14.0||||||
4194622|NCT00763971|4017461|B1|Spain||Region of Enrollment|This includes All Enrolled Subjects. Enrolled Population defined as all subjects who were randomized (n = 336).|participants|Number|13|13.0||||||
4194623|NCT00763971|4017458|B4|Hungary||Region of Enrollment|This includes All Enrolled Subjects. Enrolled Population defined as all subjects who were randomized (n = 336).|participants|Number|32|32.0||||||
4194624|NCT00763971|4017459|B3|Hungary||Region of Enrollment|This includes All Enrolled Subjects. Enrolled Population defined as all subjects who were randomized (n = 336).|participants|Number|11|11.0||||||
4194625|NCT00763971|4017460|B2|Hungary||Region of Enrollment|This includes All Enrolled Subjects. Enrolled Population defined as all subjects who were randomized (n = 336).|participants|Number|10|10.0||||||
4194626|NCT00763971|4017461|B1|Hungary||Region of Enrollment|This includes All Enrolled Subjects. Enrolled Population defined as all subjects who were randomized (n = 336).|participants|Number|11|11.0||||||
4194627|NCT00763971|4017458|B4|France||Region of Enrollment|This includes All Enrolled Subjects. Enrolled Population defined as all subjects who were randomized (n = 336).|participants|Number|30|30.0||||||
4194628|NCT00763971|4017459|B3|France||Region of Enrollment|This includes All Enrolled Subjects. Enrolled Population defined as all subjects who were randomized (n = 336).|participants|Number|11|11.0||||||
4194629|NCT00763971|4017460|B2|France||Region of Enrollment|This includes All Enrolled Subjects. Enrolled Population defined as all subjects who were randomized (n = 336).|participants|Number|9|9.0||||||
4194630|NCT00763971|4017461|B1|France||Region of Enrollment|This includes All Enrolled Subjects. Enrolled Population defined as all subjects who were randomized (n = 336).|participants|Number|10|10.0||||||
4194631|NCT00763971|4017458|B4||Male|Sex: Female, Male|Safety Population was used for demographics. Safety Population defined as all subjects who took at least 1 dose of investigational product. Four randomized subjects (2 in the LDX group, 1 in the Methylphenidate group, and 1 in the placebo group) did not receive investigational product and were therefore excluded from the Safety Population( n = 332).|Participants|Count of Participants|268|268.0||||||
4194632|NCT00763971|4017459|B3||Male|Sex: Female, Male|Safety Population was used for demographics. Safety Population defined as all subjects who took at least 1 dose of investigational product. Four randomized subjects (2 in the LDX group, 1 in the Methylphenidate group, and 1 in the placebo group) did not receive investigational product and were therefore excluded from the Safety Population( n = 332).|Participants|Count of Participants|91|91.0||||||
4194633|NCT00763971|4017460|B2||Male|Sex: Female, Male|Safety Population was used for demographics. Safety Population defined as all subjects who took at least 1 dose of investigational product. Four randomized subjects (2 in the LDX group, 1 in the Methylphenidate group, and 1 in the placebo group) did not receive investigational product and were therefore excluded from the Safety Population( n = 332).|Participants|Count of Participants|90|90.0||||||
4194634|NCT00763971|4017461|B1||Male|Sex: Female, Male|Safety Population was used for demographics. Safety Population defined as all subjects who took at least 1 dose of investigational product. Four randomized subjects (2 in the LDX group, 1 in the Methylphenidate group, and 1 in the placebo group) did not receive investigational product and were therefore excluded from the Safety Population( n = 332).|Participants|Count of Participants|87|87.0||||||
4194635|NCT00763971|4017458|B4||Female|Sex: Female, Male|Safety Population was used for demographics. Safety Population defined as all subjects who took at least 1 dose of investigational product. Four randomized subjects (2 in the LDX group, 1 in the Methylphenidate group, and 1 in the placebo group) did not receive investigational product and were therefore excluded from the Safety Population( n = 332).|Participants|Count of Participants|64|64.0||||||
4194658|NCT00763958|4017493|B2|||Age||years|Mean|34.7|34.7|Standard Deviation|10.3|10.3|||
4194659|NCT00763958|4017494|B1|||Age||years|Mean|30.2|30.2|Standard Deviation|6.6|6.6|||
4194636|NCT00763971|4017459|B3||Female|Sex: Female, Male|Safety Population was used for demographics. Safety Population defined as all subjects who took at least 1 dose of investigational product. Four randomized subjects (2 in the LDX group, 1 in the Methylphenidate group, and 1 in the placebo group) did not receive investigational product and were therefore excluded from the Safety Population( n = 332).|Participants|Count of Participants|19|19.0||||||
4194637|NCT00763971|4017460|B2||Female|Sex: Female, Male|Safety Population was used for demographics. Safety Population defined as all subjects who took at least 1 dose of investigational product. Four randomized subjects (2 in the LDX group, 1 in the Methylphenidate group, and 1 in the placebo group) did not receive investigational product and were therefore excluded from the Safety Population( n = 332).|Participants|Count of Participants|21|21.0||||||
4194638|NCT00763971|4017461|B1||Female|Sex: Female, Male|Safety Population was used for demographics. Safety Population defined as all subjects who took at least 1 dose of investigational product. Four randomized subjects (2 in the LDX group, 1 in the Methylphenidate group, and 1 in the placebo group) did not receive investigational product and were therefore excluded from the Safety Population( n = 332).|Participants|Count of Participants|24|24.0||||||
4194639|NCT00763971|4017458|B4|13-17 years||Age, Customized|Safety Population was used for demographics. Safety Population defined as all subjects who took at least 1 dose of investigational product. Four randomized subjects (2 in the LDX group, 1 in the Methylphenidate group, and 1 in the placebo group) did not receive investigational product and were therefore excluded from the Safety Population (n = 332).|participants|Number|96|96.0||||||
4194640|NCT00763971|4017459|B3|13-17 years||Age, Customized|Safety Population was used for demographics. Safety Population defined as all subjects who took at least 1 dose of investigational product. Four randomized subjects (2 in the LDX group, 1 in the Methylphenidate group, and 1 in the placebo group) did not receive investigational product and were therefore excluded from the Safety Population (n = 332).|participants|Number|31|31.0||||||
4194641|NCT00763971|4017460|B2|13-17 years||Age, Customized|Safety Population was used for demographics. Safety Population defined as all subjects who took at least 1 dose of investigational product. Four randomized subjects (2 in the LDX group, 1 in the Methylphenidate group, and 1 in the placebo group) did not receive investigational product and were therefore excluded from the Safety Population (n = 332).|participants|Number|31|31.0||||||
4194642|NCT00763971|4017461|B1|13-17 years||Age, Customized|Safety Population was used for demographics. Safety Population defined as all subjects who took at least 1 dose of investigational product. Four randomized subjects (2 in the LDX group, 1 in the Methylphenidate group, and 1 in the placebo group) did not receive investigational product and were therefore excluded from the Safety Population (n = 332).|participants|Number|34|34.0||||||
4194643|NCT00763971|4017458|B4|6-12 years||Age, Customized|Safety Population was used for demographics. Safety Population defined as all subjects who took at least 1 dose of investigational product. Four randomized subjects (2 in the LDX group, 1 in the Methylphenidate group, and 1 in the placebo group) did not receive investigational product and were therefore excluded from the Safety Population (n = 332).|participants|Number|236|236.0||||||
4194644|NCT00763971|4017459|B3|6-12 years||Age, Customized|Safety Population was used for demographics. Safety Population defined as all subjects who took at least 1 dose of investigational product. Four randomized subjects (2 in the LDX group, 1 in the Methylphenidate group, and 1 in the placebo group) did not receive investigational product and were therefore excluded from the Safety Population (n = 332).|participants|Number|79|79.0||||||
4194645|NCT00763971|4017460|B2|6-12 years||Age, Customized|Safety Population was used for demographics. Safety Population defined as all subjects who took at least 1 dose of investigational product. Four randomized subjects (2 in the LDX group, 1 in the Methylphenidate group, and 1 in the placebo group) did not receive investigational product and were therefore excluded from the Safety Population (n = 332).|participants|Number|80|80.0||||||
4194646|NCT00763971|4017461|B1|6-12 years||Age, Customized|Safety Population was used for demographics. Safety Population defined as all subjects who took at least 1 dose of investigational product. Four randomized subjects (2 in the LDX group, 1 in the Methylphenidate group, and 1 in the placebo group) did not receive investigational product and were therefore excluded from the Safety Population (n = 332).|participants|Number|77|77.0||||||
4194647|NCT00763971|4017458|B4|||Age|Safety Population was used for demographics. Safety Population defined as all subjects who took at least 1 dose of investigational product. Four randomized subjects (2 in the LDX group, 1 in the Methylphenidate group, and 1 in the placebo group) did not receive investigational product and were therefore excluded from the Safety Population (n = 332).|years|Mean|10.9|10.9|Standard Deviation|2.77|2.77|||
4194648|NCT00763971|4017459|B3|||Age|Safety Population was used for demographics. Safety Population defined as all subjects who took at least 1 dose of investigational product. Four randomized subjects (2 in the LDX group, 1 in the Methylphenidate group, and 1 in the placebo group) did not receive investigational product and were therefore excluded from the Safety Population (n = 332).|years|Mean|11.0|11.0|Standard Deviation|2.82|2.82|||
4194649|NCT00763971|4017460|B2|||Age|Safety Population was used for demographics. Safety Population defined as all subjects who took at least 1 dose of investigational product. Four randomized subjects (2 in the LDX group, 1 in the Methylphenidate group, and 1 in the placebo group) did not receive investigational product and were therefore excluded from the Safety Population (n = 332).|years|Mean|10.9|10.9|Standard Deviation|2.63|2.63|||
4194650|NCT00763971|4017461|B1|||Age|Safety Population was used for demographics. Safety Population defined as all subjects who took at least 1 dose of investigational product. Four randomized subjects (2 in the LDX group, 1 in the Methylphenidate group, and 1 in the placebo group) did not receive investigational product and were therefore excluded from the Safety Population (n = 332).|years|Mean|10.9|10.9|Standard Deviation|2.87|2.87|||
4194651|NCT00763958|4017492|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4194652|NCT00763958|4017493|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4194653|NCT00763958|4017494|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4194654|NCT00763958|4017492|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4194655|NCT00763958|4017493|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4194656|NCT00763958|4017494|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4194657|NCT00763958|4017492|B3|||Age||years|Mean|31.8|31.8|Standard Deviation|8.3|8.3|||
4194660|NCT00763958|4017492|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4194661|NCT00763958|4017493|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4194662|NCT00763958|4017494|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4194663|NCT00763958|4017492|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4194664|NCT00763958|4017493|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4194665|NCT00763958|4017494|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4194666|NCT00763958|4017492|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194667|NCT00763958|4017493|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194668|NCT00763958|4017494|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194669|NCT00763919|4017505|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4194670|NCT00763919|4017505|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4194671|NCT00763919|4017505|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4194672|NCT00763919|4017505|B1|||Age||years|Mean|38.4|38.4|Standard Deviation|11.2|11.2|||
4194673|NCT00763919|4017505|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4194674|NCT00763919|4017505|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4194675|NCT00763919|4017505|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194676|NCT00763867|4017531|B3|Canada||Region of Enrollment||participants|Number|22|22.0||||||
4194677|NCT00763867|4017532|B2|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4194678|NCT00763867|4017533|B1|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4194679|NCT00763867|4017531|B3|United States||Region of Enrollment||participants|Number|194|194.0||||||
4194680|NCT00763867|4017532|B2|United States||Region of Enrollment||participants|Number|101|101.0||||||
4194681|NCT00763867|4017533|B1|United States||Region of Enrollment||participants|Number|93|93.0||||||
4194682|NCT00763867|4017531|B3||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4194683|NCT00763867|4017532|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4194684|NCT00763867|4017533|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4194685|NCT00763867|4017531|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4194686|NCT00763867|4017532|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4194687|NCT00763867|4017533|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4194688|NCT00763867|4017531|B3|||Age||years|Mean|68.5|68.5|Standard Deviation|10.3|10.3|||
4194689|NCT00763867|4017532|B2|||Age||years|Mean|68.4|68.4|Standard Deviation|10.5|10.5|||
4194690|NCT00763867|4017533|B1|||Age||years|Mean|68.7|68.7|Standard Deviation|10.1|10.1|||
4194691|NCT00763867|4017531|B3||>=65 years|Age||Participants|Count of Participants|136|136.0||||||
4194692|NCT00763867|4017532|B2||>=65 years|Age||Participants|Count of Participants|75|75.0||||||
4194693|NCT00763867|4017533|B1||>=65 years|Age||Participants|Count of Participants|61|61.0||||||
4194694|NCT00763867|4017531|B3||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4194695|NCT00763867|4017532|B2||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4194696|NCT00763867|4017533|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4194697|NCT00763867|4017531|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194698|NCT00763867|4017532|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194699|NCT00763867|4017533|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194700|NCT00763815|4017628|B3|||Body Mass Index (BMI)|BMI was calculated by dividing body weight (kilogram) by the height (meter) squared.|kilogram per square meter (kg/m^2)|Mean|33.92|33.92|Standard Deviation|6.82|6.82|||
4194701|NCT00763815|4017629|B2|||Body Mass Index (BMI)|BMI was calculated by dividing body weight (kilogram) by the height (meter) squared.|kilogram per square meter (kg/m^2)|Mean|33.66|33.66|Standard Deviation|6.71|6.71|||
4194702|NCT00763815|4017630|B1|||Body Mass Index (BMI)|BMI was calculated by dividing body weight (kilogram) by the height (meter) squared.|kilogram per square meter (kg/m^2)|Mean|34.44|34.44|Standard Deviation|7.04|7.04|||
4194703|NCT00763815|4017628|B3|||Metformin Use at Screening|Number of patients with metformin use at baseline was reported.|participants|Number|392|392.0||||||
4194704|NCT00763815|4017629|B2|||Metformin Use at Screening|Number of patients with metformin use at baseline was reported.|participants|Number|261|261.0||||||
4194705|NCT00763815|4017630|B1|||Metformin Use at Screening|Number of patients with metformin use at baseline was reported.|participants|Number|131|131.0||||||
4194706|NCT00763815|4017628|B3|>= 45 mg||Pioglitazone Daily Dose||participants|Number|116|116.0||||||
4194707|NCT00763815|4017629|B2|>= 45 mg||Pioglitazone Daily Dose||participants|Number|81|81.0||||||
4194708|NCT00763815|4017630|B1|>= 45 mg||Pioglitazone Daily Dose||participants|Number|35|35.0||||||
4194709|NCT00763815|4017628|B3|>=30 milligram (mg) to Less Than (<) 45 mg||Pioglitazone Daily Dose||participants|Number|368|368.0||||||
4194710|NCT00763815|4017629|B2|>=30 milligram (mg) to Less Than (<) 45 mg||Pioglitazone Daily Dose||participants|Number|242|242.0||||||
4194711|NCT00763815|4017630|B1|>=30 milligram (mg) to Less Than (<) 45 mg||Pioglitazone Daily Dose||participants|Number|126|126.0||||||
4194712|NCT00763815|4017628|B3|||Duration of Pioglitazone Treatment||years|Mean|1.72|1.72|Standard Deviation|2.18|2.18|||
4194713|NCT00763815|4017629|B2|||Duration of Pioglitazone Treatment||years|Mean|1.69|1.69|Standard Deviation|2.00|2.0|||
4194714|NCT00763815|4017630|B1|||Duration of Pioglitazone Treatment||years|Mean|1.79|1.79|Standard Deviation|2.51|2.51|||
4194715|NCT00763815|4017628|B3|||Duration of Diabetes||years|Mean|8.10|8.1|Standard Deviation|5.48|5.48|||
4194716|NCT00763815|4017629|B2|||Duration of Diabetes||years|Mean|8.11|8.11|Standard Deviation|5.44|5.44|||
4194717|NCT00763815|4017630|B1|||Duration of Diabetes||years|Mean|8.09|8.09|Standard Deviation|5.58|5.58|||
4194718|NCT00763815|4017628|B3|||Fasting Plasma Insulin (FPI)|Here, Number of patients analyzed = 142 and 300 for Placebo and Lixisenatide treatment arms, respectively.|picomole per liter (pmol/L)|Mean|64.21|64.21|Standard Deviation|54.76|54.76|||
4194719|NCT00763815|4017629|B2|||Fasting Plasma Insulin (FPI)|Here, Number of patients analyzed = 142 and 300 for Placebo and Lixisenatide treatment arms, respectively.|picomole per liter (pmol/L)|Mean|63.32|63.32|Standard Deviation|57.69|57.69|||
4194720|NCT00763815|4017630|B1|||Fasting Plasma Insulin (FPI)|Here, Number of patients analyzed = 142 and 300 for Placebo and Lixisenatide treatment arms, respectively.|picomole per liter (pmol/L)|Mean|66.07|66.07|Standard Deviation|48.12|48.12|||
4194721|NCT00763815|4017628|B3|||Beta-cell Function Assessed by Homeostasis Model Assessment for Beta-cell Function (HOMA-beta)|Beta cell function was assessed by HOMA-beta. HOMA-beta (% of normal beta cells function) = (20 multiplied by fasting plasma insulin [micro unit per milliliter]) divided by (fasting plasma glucose [mmol/L] minus 3.5). Here, Number of patients analyzed = 141 and 300 for Placebo and Lixisenatide treatment arms, respectively.|percentage of normal beta cells function|Mean|35.18|35.18|Standard Deviation|29.12|29.12|||
4194722|NCT00763815|4017629|B2|||Beta-cell Function Assessed by Homeostasis Model Assessment for Beta-cell Function (HOMA-beta)|Beta cell function was assessed by HOMA-beta. HOMA-beta (% of normal beta cells function) = (20 multiplied by fasting plasma insulin [micro unit per milliliter]) divided by (fasting plasma glucose [mmol/L] minus 3.5). Here, Number of patients analyzed = 141 and 300 for Placebo and Lixisenatide treatment arms, respectively.|percentage of normal beta cells function|Mean|34.69|34.69|Standard Deviation|30.30|30.3|||
4194723|NCT00763815|4017630|B1|||Beta-cell Function Assessed by Homeostasis Model Assessment for Beta-cell Function (HOMA-beta)|Beta cell function was assessed by HOMA-beta. HOMA-beta (% of normal beta cells function) = (20 multiplied by fasting plasma insulin [micro unit per milliliter]) divided by (fasting plasma glucose [mmol/L] minus 3.5). Here, Number of patients analyzed = 141 and 300 for Placebo and Lixisenatide treatment arms, respectively.|percentage of normal beta cells function|Mean|36.23|36.23|Standard Deviation|26.50|26.5|||
4194724|NCT00763815|4017628|B3|||Body Weight||kilogram|Mean|94.20|94.2|Standard Deviation|23.87|23.87|||
4194725|NCT00763815|4017629|B2|||Body Weight||kilogram|Mean|92.93|92.93|Standard Deviation|22.90|22.9|||
4194726|NCT00763815|4017630|B1|||Body Weight||kilogram|Mean|96.74|96.74|Standard Deviation|25.58|25.58|||
4194727|NCT00763815|4017628|B3|||Fasting Plasma Glucose (FPG)||millimole per liter (mmol/L)|Mean|9.12|9.12|Standard Deviation|2.16|2.16|||
4194728|NCT00763815|4017629|B2|||Fasting Plasma Glucose (FPG)||millimole per liter (mmol/L)|Mean|9.11|9.11|Standard Deviation|2.15|2.15|||
4194729|NCT00763815|4017630|B1|||Fasting Plasma Glucose (FPG)||millimole per liter (mmol/L)|Mean|9.13|9.13|Standard Deviation|2.20|2.2|||
4194730|NCT00763815|4017628|B3|||Glycosylated Hemoglobin (HbA1c)||percentage of hemoglobin|Mean|8.07|8.07|Standard Deviation|0.86|0.86|||
4194731|NCT00763815|4017629|B2|||Glycosylated Hemoglobin (HbA1c)||percentage of hemoglobin|Mean|8.08|8.08|Standard Deviation|0.90|0.9|||
4194732|NCT00763815|4017630|B1|||Glycosylated Hemoglobin (HbA1c)||percentage of hemoglobin|Mean|8.06|8.06|Standard Deviation|0.79|0.79|||
4194733|NCT00763815|4017628|B3|Ethnicity: Non Hispanic||Race/Ethnicity, Customized||participants|Number|356|356.0||||||
4194734|NCT00763815|4017629|B2|Ethnicity: Non Hispanic||Race/Ethnicity, Customized||participants|Number|236|236.0||||||
4194735|NCT00763815|4017630|B1|Ethnicity: Non Hispanic||Race/Ethnicity, Customized||participants|Number|120|120.0||||||
4194736|NCT00763815|4017628|B3|Ethnicity: Hispanic||Race/Ethnicity, Customized||participants|Number|128|128.0||||||
4194737|NCT00763815|4017629|B2|Ethnicity: Hispanic||Race/Ethnicity, Customized||participants|Number|87|87.0||||||
4194738|NCT00763815|4017630|B1|Ethnicity: Hispanic||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4194739|NCT00763815|4017628|B3|Race: Other||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4194740|NCT00763815|4017629|B2|Race: Other||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4194741|NCT00763815|4017630|B1|Race: Other||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4194742|NCT00763815|4017628|B3|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4194743|NCT00763815|4017629|B2|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4194744|NCT00763815|4017630|B1|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4194745|NCT00763815|4017628|B3|Race: Black||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4194746|NCT00763815|4017629|B2|Race: Black||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4194747|NCT00763815|4017630|B1|Race: Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4194748|NCT00763815|4017628|B3|Race: Caucasian/White||Race/Ethnicity, Customized||participants|Number|405|405.0||||||
4194749|NCT00763815|4017629|B2|Race: Caucasian/White||Race/Ethnicity, Customized||participants|Number|273|273.0||||||
4194750|NCT00763815|4017630|B1|Race: Caucasian/White||Race/Ethnicity, Customized||participants|Number|132|132.0||||||
4194751|NCT00763815|4017628|B3||Male|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
4194752|NCT00763815|4017629|B2||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4194753|NCT00763815|4017630|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4194754|NCT00763815|4017628|B3||Female|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4194755|NCT00763815|4017629|B2||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4194756|NCT00763815|4017630|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4194757|NCT00763815|4017628|B3|||Age||years|Mean|55.8|55.8|Standard Deviation|9.5|9.5|||
4194758|NCT00763815|4017629|B2|||Age||years|Mean|56.0|56.0|Standard Deviation|9.5|9.5|||
4194759|NCT00763815|4017630|B1|||Age||years|Mean|55.3|55.3|Standard Deviation|9.5|9.5|||
4194760|NCT00763750|4017655|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4194761|NCT00763750|4017655|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4194762|NCT00763750|4017655|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4194763|NCT00763750|4017655|B1|||Age||years|Mean|56|56.0|Standard Deviation|5.2|5.2|||
4194764|NCT00763750|4017655|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4194765|NCT00763750|4017655|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4194766|NCT00763750|4017655|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194767|NCT00763698|4017659|B1|United States||Region of Enrollment||participants|Number|86|86.0||||||
4194768|NCT00763698|4017659|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4194769|NCT00763698|4017659|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4194770|NCT00763698|4017659|B1|||Age||years|Mean|71.0|71.0|Standard Deviation|11.3|11.3|||
4194771|NCT00763698|4017659|B1||>=65 years|Age||Participants|Count of Participants|65|65.0||||||
4194772|NCT00763698|4017659|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4194773|NCT00763698|4017659|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4194774|NCT00763490|4017665|B1||Male|Gender||Participants|Count of Participants|11|11.0||||||
4194775|NCT00763490|4017665|B1||Female|Gender||Participants|Count of Participants|9|9.0||||||
4194776|NCT00763490|4017665|B1|||Age||years|Mean|41|41.0|Full Range|||11.0|64.0|
4194777|NCT00763451|4017672|B5|||Body Mass Index (BMI)|BMI was calculated by dividing body weight (kilogram) by the height (meter) squared.|kilogram per square meter (kg/m^2)|Mean|32.47|32.47|Standard Deviation|5.38|5.38|||
4194778|NCT00763451|4017673|B4|||Body Mass Index (BMI)|BMI was calculated by dividing body weight (kilogram) by the height (meter) squared.|kilogram per square meter (kg/m^2)|Mean|32.99|32.99|Standard Deviation|5.80|5.8|||
4194779|NCT00763451|4017674|B3|||Body Mass Index (BMI)|BMI was calculated by dividing body weight (kilogram) by the height (meter) squared.|kilogram per square meter (kg/m^2)|Mean|32.06|32.06|Standard Deviation|4.84|4.84|||
4194780|NCT00763451|4017675|B2|||Body Mass Index (BMI)|BMI was calculated by dividing body weight (kilogram) by the height (meter) squared.|kilogram per square meter (kg/m^2)|Mean|32.35|32.35|Standard Deviation|5.86|5.86|||
4194781|NCT00763451|4017676|B1|||Body Mass Index (BMI)|BMI was calculated by dividing body weight (kilogram) by the height (meter) squared.|kilogram per square meter (kg/m^2)|Mean|32.38|32.38|Standard Deviation|5.04|5.04|||
4194782|NCT00763451|4017672|B5|||Duration of Diabetes||years|Mean|6.00|6.0|Standard Deviation|4.40|4.4|||
4194783|NCT00763451|4017673|B4|||Duration of Diabetes||years|Mean|5.77|5.77|Standard Deviation|3.85|3.85|||
4194784|NCT00763451|4017674|B3|||Duration of Diabetes||years|Mean|6.01|6.01|Standard Deviation|4.60|4.6|||
4194785|NCT00763451|4017675|B2|||Duration of Diabetes||years|Mean|5.77|5.77|Standard Deviation|4.00|4.0|||
4194786|NCT00763451|4017676|B1|||Duration of Diabetes||years|Mean|6.68|6.68|Standard Deviation|5.33|5.33|||
4194787|NCT00763451|4017672|B5|||Body Weight||kilogram|Mean|88.50|88.5|Standard Deviation|17.77|17.77|||
4194788|NCT00763451|4017673|B4|||Body Weight||kilogram|Mean|90.21|90.21|Standard Deviation|18.95|18.95|||
4194789|NCT00763451|4017674|B3|||Body Weight||kilogram|Mean|87.41|87.41|Standard Deviation|16.90|16.9|||
4194790|NCT00763451|4017675|B2|||Body Weight||kilogram|Mean|88.28|88.28|Standard Deviation|18.43|18.43|||
4194791|NCT00763451|4017676|B1|||Body Weight||kilogram|Mean|87.45|87.45|Standard Deviation|16.32|16.32|||
4194792|NCT00763451|4017672|B5|||Fasting Plasma Glucose (FPG)||millimole per liter (mmol/L)|Mean|9.52|9.52|Standard Deviation|2.17|2.17|||
4194793|NCT00763451|4017673|B4|||Fasting Plasma Glucose (FPG)||millimole per liter (mmol/L)|Mean|9.56|9.56|Standard Deviation|2.02|2.02|||
4194794|NCT00763451|4017674|B3|||Fasting Plasma Glucose (FPG)||millimole per liter (mmol/L)|Mean|9.54|9.54|Standard Deviation|2.50|2.5|||
4194795|NCT00763451|4017675|B2|||Fasting Plasma Glucose (FPG)||millimole per liter (mmol/L)|Mean|9.31|9.31|Standard Deviation|1.82|1.82|||
4194796|NCT00763451|4017676|B1|||Fasting Plasma Glucose (FPG)||millimole per liter (mmol/L)|Mean|9.60|9.6|Standard Deviation|2.06|2.06|||
4194797|NCT00763451|4017672|B5|||Glycosylated Hemoglobin (HbA1c)||percentage of hemoglobin|Mean|8.04|8.04|Standard Deviation|0.86|0.86|||
4194798|NCT00763451|4017673|B4|||Glycosylated Hemoglobin (HbA1c)||percentage of hemoglobin|Mean|7.99|7.99|Standard Deviation|0.87|0.87|||
4194799|NCT00763451|4017674|B3|||Glycosylated Hemoglobin (HbA1c)||percentage of hemoglobin|Mean|8.10|8.1|Standard Deviation|0.88|0.88|||
4194800|NCT00763451|4017675|B2|||Glycosylated Hemoglobin (HbA1c)||percentage of hemoglobin|Mean|8.02|8.02|Standard Deviation|0.84|0.84|||
4194801|NCT00763451|4017676|B1|||Glycosylated Hemoglobin (HbA1c)||percentage of hemoglobin|Mean|8.03|8.03|Standard Deviation|0.81|0.81|||
4194802|NCT00763451|4017672|B5|Ethnicity: Non Hispanic||Race/Ethnicity, Customized||participants|Number|337|337.0||||||
4194803|NCT00763451|4017673|B4|Ethnicity: Non Hispanic||Race/Ethnicity, Customized||participants|Number|117|117.0||||||
4194804|NCT00763451|4017674|B3|Ethnicity: Non Hispanic||Race/Ethnicity, Customized||participants|Number|106|106.0||||||
4194805|NCT00763451|4017675|B2|Ethnicity: Non Hispanic||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
4194806|NCT00763451|4017676|B1|Ethnicity: Non Hispanic||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
4194807|NCT00763451|4017672|B5|Ethnicity: Hispanic||Race/Ethnicity, Customized||participants|Number|145|145.0||||||
4194808|NCT00763451|4017673|B4|Ethnicity: Hispanic||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4194809|NCT00763451|4017674|B3|Ethnicity: Hispanic||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
4194810|NCT00763451|4017675|B2|Ethnicity: Hispanic||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4194811|NCT00763451|4017676|B1|Ethnicity: Hispanic||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4194812|NCT00763451|4017672|B5|Race: Other||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4194813|NCT00763451|4017673|B4|Race: Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4194814|NCT00763451|4017674|B3|Race: Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4194815|NCT00763451|4017675|B2|Race: Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4194816|NCT00763451|4017676|B1|Race: Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4194817|NCT00763451|4017672|B5|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4194818|NCT00763451|4017673|B4|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4194819|NCT00763451|4017674|B3|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4194820|NCT00763451|4017675|B2|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4194821|NCT00763451|4017676|B1|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4194822|NCT00763451|4017672|B5|Race: Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4194823|NCT00763451|4017673|B4|Race: Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4194824|NCT00763451|4017674|B3|Race: Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4194825|NCT00763451|4017675|B2|Race: Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4194826|NCT00763451|4017676|B1|Race: Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4194827|NCT00763451|4017672|B5|Race: Caucasian/White||Race/Ethnicity, Customized||participants|Number|435|435.0||||||
4194828|NCT00763451|4017673|B4|Race: Caucasian/White||Race/Ethnicity, Customized||participants|Number|141|141.0||||||
4194829|NCT00763451|4017674|B3|Race: Caucasian/White||Race/Ethnicity, Customized||participants|Number|146|146.0||||||
4194830|NCT00763451|4017675|B2|Race: Caucasian/White||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
4194831|NCT00763451|4017676|B1|Race: Caucasian/White||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
4194832|NCT00763451|4017672|B5||Male|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
4194833|NCT00763451|4017673|B4||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4194834|NCT00763451|4017674|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4194835|NCT00763451|4017675|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4194836|NCT00763451|4017676|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4194837|NCT00763451|4017672|B5||Female|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
4194838|NCT00763451|4017673|B4||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4194839|NCT00763451|4017674|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4194840|NCT00763451|4017675|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4194841|NCT00763451|4017676|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4194842|NCT00763451|4017672|B5|||Age||years|Mean|56.1|56.1|Standard Deviation|9.3|9.3|||
4194843|NCT00763451|4017673|B4|||Age||years|Mean|55.4|55.4|Standard Deviation|8.9|8.9|||
4194844|NCT00763451|4017674|B3|||Age||years|Mean|54.6|54.6|Standard Deviation|8.9|8.9|||
4194845|NCT00763451|4017675|B2|||Age||years|Mean|57.5|57.5|Standard Deviation|10.8|10.8|||
4194846|NCT00763451|4017676|B1|||Age||years|Mean|58.9|58.9|Standard Deviation|8.8|8.8|||
4194847|NCT00763412|4017711|B3|||CRP|inflammatory marker|mg/L|Mean|1.95|1.95|Full Range|||0.2|3.3|
4194848|NCT00763412|4017712|B2|||CRP|inflammatory marker|mg/L|Mean|2.1|2.1|Full Range|||0.8|3.3|
4194849|NCT00763412|4017713|B1|||CRP|inflammatory marker|mg/L|Mean|1.8|1.8|Full Range|||0.2|2.5|
4194850|NCT00763412|4017711|B3|TNF Alpha||Inflammatory marker|baseline values collected during a 2 hour OGTT.|pg/ml|Mean|5.9|5.9|Full Range|||2.5|7.3|
4194851|NCT00763412|4017712|B2|TNF Alpha||Inflammatory marker|baseline values collected during a 2 hour OGTT.|pg/ml|Mean|4.5|4.5|Full Range|||2.5|6.4|
4194852|NCT00763412|4017713|B1|TNF Alpha||Inflammatory marker|baseline values collected during a 2 hour OGTT.|pg/ml|Mean|7.3|7.3|Full Range|||5.2|7.3|
4194853|NCT00763412|4017711|B3|IL8||Inflammatory marker|baseline values collected during a 2 hour OGTT.|pg/ml|Mean|7.75|7.75|Full Range|||2.7|17.8|
4194854|NCT00763412|4017712|B2|IL8||Inflammatory marker|baseline values collected during a 2 hour OGTT.|pg/ml|Mean|8.5|8.5|Full Range|||4.6|13.6|
4194855|NCT00763412|4017713|B1|IL8||Inflammatory marker|baseline values collected during a 2 hour OGTT.|pg/ml|Mean|7|7.0|Full Range|||2.7|17.8|
4194856|NCT00763412|4017711|B3|IL6||Inflammatory marker|baseline values collected during a 2 hour OGTT.|pg/ml|Mean|10.5|10.5|Full Range|||1.5|33.8|
4194857|NCT00763412|4017712|B2|IL6||Inflammatory marker|baseline values collected during a 2 hour OGTT.|pg/ml|Mean|12.6|12.6|Full Range|||3.7|33.8|
4194858|NCT00763412|4017713|B1|IL6||Inflammatory marker|baseline values collected during a 2 hour OGTT.|pg/ml|Mean|8.3|8.3|Full Range|||1.5|26.4|
4194859|NCT00763412|4017711|B3|IL1||Inflammatory marker|baseline values collected during a 2 hour OGTT.|pg/ml|Mean|0.5|0.5|Full Range|||0.1|1.9|
4194860|NCT00763412|4017712|B2|IL1||Inflammatory marker|baseline values collected during a 2 hour OGTT.|pg/ml|Mean|0.9|0.9|Full Range|||0.01|1.7|
4194861|NCT00763412|4017713|B1|IL1||Inflammatory marker|baseline values collected during a 2 hour OGTT.|pg/ml|Mean|0.1|0.1|Full Range|||0.1|1.9|
4194862|NCT00763412|4017711|B3|||2 hour c-peptide|final c-peptide measurement at the end of 2 hour OGTT.|mg/dl|Mean|9.6|9.6|Full Range|||5.0|15.5|
4194863|NCT00763412|4017712|B2|||2 hour c-peptide|final c-peptide measurement at the end of 2 hour OGTT.|mg/dl|Mean|9.5|9.5|Full Range|||5.0|12.6|
4194864|NCT00763412|4017713|B1|||2 hour c-peptide|final c-peptide measurement at the end of 2 hour OGTT.|mg/dl|Mean|9.7|9.7|Full Range|||6.0|15.5|
4194865|NCT00763412|4017711|B3|||Fasting C-Peptide||mg/dl|Mean|1.45|1.45|Full Range|||0.6|3.0|
4194866|NCT00763412|4017712|B2|||Fasting C-Peptide||mg/dl|Mean|1.7|1.7|Full Range|||1.0|3.0|
4194867|NCT00763412|4017713|B1|||Fasting C-Peptide||mg/dl|Mean|1.2|1.2|Full Range|||0.6|2.1|
4194868|NCT00763412|4017711|B3|||2 hour glucose|Final glucose sample in a 2 hour OGTT.|mg/dl|Mean|182.7|182.7|Full Range|||140.0|218.5|
4194869|NCT00763412|4017712|B2|||2 hour glucose|Final glucose sample in a 2 hour OGTT.|mg/dl|Mean|183|183.0|Full Range|||140.0|206.0|
4194870|NCT00763412|4017713|B1|||2 hour glucose|Final glucose sample in a 2 hour OGTT.|mg/dl|Mean|182.4|182.4|Full Range|||144.0|218.5|
4194871|NCT00763412|4017711|B3|||Fasting Glucose|This was the baseline glucose in a 2 hour oral glucose tolerance test. (OGTT)|mg/dl|Mean|99.6|99.6|Full Range|||87.0|114.5|
4194872|NCT00763412|4017712|B2|||Fasting Glucose|This was the baseline glucose in a 2 hour oral glucose tolerance test. (OGTT)|mg/dl|Mean|100|100.0|Full Range|||94.0|106.0|
4194873|NCT00763412|4017713|B1|||Fasting Glucose|This was the baseline glucose in a 2 hour oral glucose tolerance test. (OGTT)|mg/dl|Mean|99.1|99.1|Full Range|||87.0|114.5|
4194874|NCT00763412|4017711|B3|||FEV 1||% of lung function|Mean|95.25|95.25|Full Range|||70.0|121.0|
4194875|NCT00763412|4017712|B2|||FEV 1||% of lung function|Mean|92.75|92.75|Full Range|||70.0|105.0|
4194876|NCT00763412|4017713|B1|||FEV 1||% of lung function|Mean|97.75|97.75|Full Range|||92.0|121.0|
4194877|NCT00763412|4017711|B3|||Tanner stage|This is a measurement of puberty development. This is a 1-5 scale describing 1 as the least developed and 5 as the most developed in puberty.|units on a scale|Mean|3.5|3.5|Full Range|||1.0|5.0|
4194878|NCT00763412|4017712|B2|||Tanner stage|This is a measurement of puberty development. This is a 1-5 scale describing 1 as the least developed and 5 as the most developed in puberty.|units on a scale|Mean|3.25|3.25|Full Range|||1.0|5.0|
4194879|NCT00763412|4017713|B1|||Tanner stage|This is a measurement of puberty development. This is a 1-5 scale describing 1 as the least developed and 5 as the most developed in puberty.|units on a scale|Mean|3.75|3.75|Full Range|||2.0|5.0|
4194880|NCT00763412|4017711|B3|||Lean %||% Lean mass|Mean|75.9|75.9|Full Range|||58.6|89.67|
4194881|NCT00763412|4017712|B2|||Lean %||% Lean mass|Mean|75|75.0|Full Range|||68.22|87.11|
4194882|NCT00763412|4017713|B1|||Lean %||% Lean mass|Mean|76.71|76.71|Full Range|||58.6|89.67|
4194883|NCT00763412|4017711|B3|||Fat %||% Fat mass|Mean|21.2|21.2|Full Range|||7.36|38.74|
4194884|NCT00763412|4017712|B2|||Fat %||% Fat mass|Mean|22.06|22.06|Full Range|||9.76|28.81|
4194885|NCT00763412|4017713|B1|||Fat %||% Fat mass|Mean|20.34|20.34|Full Range|||7.36|38.74|
4194886|NCT00763412|4017711|B3|||Wt Z score||Z score|Mean|-0.7|-0.7|Full Range|||-1.84|0.33|
4194887|NCT00763412|4017712|B2|||Wt Z score||Z score|Mean|-0.29|-0.29|Full Range|||-0.75|0.19|
4194888|NCT00763412|4017713|B1|||Wt Z score||Z score|Mean|-1.11|-1.11|Full Range|||-1.84|0.33|
4194889|NCT00763412|4017711|B3|||BMI||Kg/m^2|Mean|18.94|18.94|Full Range|||14.55|22.96|
4194890|NCT00763412|4017712|B2|||BMI||Kg/m^2|Mean|18.38|18.38|Full Range|||16.78|20.3|
4194891|NCT00763412|4017713|B1|||BMI||Kg/m^2|Mean|19.45|19.45|Full Range|||14.55|22.96|
4194892|NCT00763412|4017711|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4194893|NCT00763412|4017712|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4194894|NCT00763412|4017713|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4194895|NCT00763412|4017711|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4194896|NCT00763412|4017712|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4194897|NCT00763412|4017713|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4194898|NCT00763412|4017711|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4194899|NCT00763412|4017712|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4194900|NCT00763412|4017713|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4194901|NCT00763412|4017711|B3|||Age||years|Median|15.5|15.5|Full Range|||12.0|22.0|
4194902|NCT00763412|4017712|B2|||Age||years|Median|15|15.0|Full Range|||12.0|22.0|
4194903|NCT00763412|4017713|B1|||Age||years|Median|16|16.0|Full Range|||12.0|18.0|
4194904|NCT00763412|4017711|B3||>=65 years|Age|Patients attended the Washington University CF Clinics between 2006 and 2008.|Participants|Count of Participants|0|0.0||||||
4194905|NCT00763412|4017712|B2||>=65 years|Age|Patients attended the Washington University CF Clinics between 2006 and 2008.|Participants|Count of Participants|0|0.0||||||
4194906|NCT00763412|4017713|B1||>=65 years|Age|Patients attended the Washington University CF Clinics between 2006 and 2008.|Participants|Count of Participants|0|0.0||||||
4194907|NCT00763412|4017711|B3||Between 18 and 65 years|Age|Patients attended the Washington University CF Clinics between 2006 and 2008.|Participants|Count of Participants|2|2.0||||||
4194908|NCT00763412|4017712|B2||Between 18 and 65 years|Age|Patients attended the Washington University CF Clinics between 2006 and 2008.|Participants|Count of Participants|1|1.0||||||
4194909|NCT00763412|4017713|B1||Between 18 and 65 years|Age|Patients attended the Washington University CF Clinics between 2006 and 2008.|Participants|Count of Participants|1|1.0||||||
4194910|NCT00763412|4017711|B3||<=18 years|Age|Patients attended the Washington University CF Clinics between 2006 and 2008.|Participants|Count of Participants|6|6.0||||||
4194911|NCT00763412|4017712|B2||<=18 years|Age|Patients attended the Washington University CF Clinics between 2006 and 2008.|Participants|Count of Participants|3|3.0||||||
4194912|NCT00763412|4017713|B1||<=18 years|Age|Patients attended the Washington University CF Clinics between 2006 and 2008.|Participants|Count of Participants|3|3.0||||||
4194913|NCT00763386|4017736|B3|Canada||Region of Enrollment||participants|Number|60|60.0||||||
4194914|NCT00763386|4017737|B2|Canada||Region of Enrollment||participants|Number|29|29.0||||||
4194915|NCT00763386|4017738|B1|Canada||Region of Enrollment||participants|Number|31|31.0||||||
4194916|NCT00763386|4017736|B3|United States||Region of Enrollment||participants|Number|271|271.0||||||
4194917|NCT00763386|4017737|B2|United States||Region of Enrollment||participants|Number|138|138.0||||||
4194918|NCT00763386|4017738|B1|United States||Region of Enrollment||participants|Number|133|133.0||||||
4194919|NCT00763386|4017736|B3|Male||Gender|An LPS Standard patient's demographic CRF is missing and therefore, the total numbers for this category will be off by one.|participants|Number|154|154.0||||||
4194920|NCT00763386|4017737|B2|Male||Gender|An LPS Standard patient's demographic CRF is missing and therefore, the total numbers for this category will be off by one.|participants|Number|82|82.0||||||
4194921|NCT00763386|4017738|B1|Male||Gender|An LPS Standard patient's demographic CRF is missing and therefore, the total numbers for this category will be off by one.|participants|Number|72|72.0||||||
4194922|NCT00763386|4017736|B3|Female||Gender|An LPS Standard patient's demographic CRF is missing and therefore, the total numbers for this category will be off by one.|participants|Number|176|176.0||||||
4194923|NCT00763386|4017737|B2|Female||Gender|An LPS Standard patient's demographic CRF is missing and therefore, the total numbers for this category will be off by one.|participants|Number|84|84.0||||||
4194924|NCT00763386|4017738|B1|Female||Gender|An LPS Standard patient's demographic CRF is missing and therefore, the total numbers for this category will be off by one.|participants|Number|92|92.0||||||
4194925|NCT00763386|4017736|B3|||Age|An LPS Standard patient's demographic CRF is missing and therefore, the total numbers for this category will be off by one.|years|Mean|64.7|64.7|Standard Deviation|8.3|8.3|||
4194926|NCT00763386|4017737|B2|||Age|An LPS Standard patient's demographic CRF is missing and therefore, the total numbers for this category will be off by one.|years|Mean|64.9|64.9|Standard Deviation|8.4|8.4|||
4194927|NCT00763386|4017738|B1|||Age|An LPS Standard patient's demographic CRF is missing and therefore, the total numbers for this category will be off by one.|years|Mean|64.6|64.6|Standard Deviation|8.1|8.1|||
4194928|NCT00763386|4017736|B3|>=65 years||Age|An LPS Standard patient's demographic CRF is missing and therefore, the total numbers for this category will be off by one.|participants|Number|165|165.0||||||
4194929|NCT00763386|4017737|B2|>=65 years||Age|An LPS Standard patient's demographic CRF is missing and therefore, the total numbers for this category will be off by one.|participants|Number|84|84.0||||||
4194930|NCT00763386|4017738|B1|>=65 years||Age|An LPS Standard patient's demographic CRF is missing and therefore, the total numbers for this category will be off by one.|participants|Number|81|81.0||||||
4194931|NCT00763386|4017736|B3|Between 18 and 65 years||Age|An LPS Standard patient's demographic CRF is missing and therefore, the total numbers for this category will be off by one.|participants|Number|165|165.0||||||
4194932|NCT00763386|4017737|B2|Between 18 and 65 years||Age|An LPS Standard patient's demographic CRF is missing and therefore, the total numbers for this category will be off by one.|participants|Number|82|82.0||||||
4194933|NCT00763386|4017738|B1|Between 18 and 65 years||Age|An LPS Standard patient's demographic CRF is missing and therefore, the total numbers for this category will be off by one.|participants|Number|83|83.0||||||
4194934|NCT00763386|4017736|B3|<=18 years||Age|An LPS Standard patient's demographic CRF is missing and therefore, the total numbers for this category will be off by one.|participants|Number|0|0.0||||||
4194935|NCT00763386|4017737|B2|<=18 years||Age|An LPS Standard patient's demographic CRF is missing and therefore, the total numbers for this category will be off by one.|participants|Number|0|0.0||||||
4194936|NCT00763386|4017738|B1|<=18 years||Age|An LPS Standard patient's demographic CRF is missing and therefore, the total numbers for this category will be off by one.|participants|Number|0|0.0||||||
4194937|NCT00763360|4017747|B4||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4194938|NCT00763360|4017748|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4194939|NCT00763360|4017749|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4194940|NCT00763360|4017750|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4194941|NCT00763360|4017747|B4||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4194942|NCT00763360|4017748|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4194943|NCT00763360|4017749|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4194944|NCT00763360|4017750|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4194945|NCT00763360|4017747|B4|||Age||years|Mean|75.01|75.01|Standard Deviation|8.39|8.39|||
4194946|NCT00763360|4017748|B3|||Age||years|Mean|75.51|75.51|Standard Deviation|8.49|8.49|||
4194947|NCT00763360|4017749|B2|||Age||years|Mean|75.56|75.56|Standard Deviation|7.6|7.6|||
4194948|NCT00763360|4017750|B1|||Age||years|Mean|73.97|73.97|Standard Deviation|9.03|9.03|||
4194949|NCT00763321|4017769|B4|||Double-blind Baseline Sleep Interference by Pain Scale|The last assessment of how much back pain interfered with their sleep on a scale of 0 (not at all) to 10 (completely) conducted before the first dose in the double-blind period.|scores on a scale|Mean|2.2|2.2|Standard Deviation|2.09|2.09|||
4194950|NCT00763321|4017770|B3|||Double-blind Baseline Sleep Interference by Pain Scale|The last assessment of how much back pain interfered with their sleep on a scale of 0 (not at all) to 10 (completely) conducted before the first dose in the double-blind period.|scores on a scale|Mean|2.3|2.3|Standard Deviation|2.16|2.16|||
4194951|NCT00763321|4017771|B2|||Double-blind Baseline Sleep Interference by Pain Scale|The last assessment of how much back pain interfered with their sleep on a scale of 0 (not at all) to 10 (completely) conducted before the first dose in the double-blind period.|scores on a scale|Mean|2.2|2.2|Standard Deviation|2.02|2.02|||
4194952|NCT00763321|4017772|B1|||Double-blind Baseline Sleep Interference by Pain Scale|The last assessment of how much back pain interfered with their sleep on a scale of 0 (not at all) to 10 (completely) conducted before the first dose in the double-blind period.|scores on a scale|Mean|NA||Standard Deviation|NA||||These subjects were not randomized to the double-blind period.
4194953|NCT00763321|4017769|B4|||Double-blind Baseline CLBP Intensity VAS|The last assessment using the CLBP Intensity Visual Analog Scale (VAS) (0 mm = No Pain and 100 mm = Worst Pain Imaginable) conducted before the first dose in the double-blind period.|scores on a scale|Mean|23.7|23.7|Standard Deviation|15.28|15.28|||
4194954|NCT00763321|4017770|B3|||Double-blind Baseline CLBP Intensity VAS|The last assessment using the CLBP Intensity Visual Analog Scale (VAS) (0 mm = No Pain and 100 mm = Worst Pain Imaginable) conducted before the first dose in the double-blind period.|scores on a scale|Mean|23.2|23.2|Standard Deviation|15.01|15.01|||
4194955|NCT00763321|4017771|B2|||Double-blind Baseline CLBP Intensity VAS|The last assessment using the CLBP Intensity Visual Analog Scale (VAS) (0 mm = No Pain and 100 mm = Worst Pain Imaginable) conducted before the first dose in the double-blind period.|scores on a scale|Mean|24.2|24.2|Standard Deviation|15.61|15.61|||
4194990|NCT00763282|4017783|B3|Sacrum||Locations of Current Pressure Ulcers|Patients can have more than one ulcer present at randomization|Pressure Ulcers|Number|28|28.0||||||
4194956|NCT00763321|4017772|B1|||Double-blind Baseline CLBP Intensity VAS|The last assessment using the CLBP Intensity Visual Analog Scale (VAS) (0 mm = No Pain and 100 mm = Worst Pain Imaginable) conducted before the first dose in the double-blind period.|scores on a scale|Mean|NA||Standard Deviation|NA||||These subjects were not randomized to the double-blind period.
4194957|NCT00763321|4017769|B4||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4194958|NCT00763321|4017770|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4194959|NCT00763321|4017771|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4194960|NCT00763321|4017772|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4194961|NCT00763321|4017769|B4||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4194962|NCT00763321|4017770|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4194963|NCT00763321|4017771|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4194964|NCT00763321|4017772|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4194965|NCT00763321|4017769|B4|||Age||years|Mean|48.2|48.2|Standard Deviation|11.95|11.95|||
4194966|NCT00763321|4017770|B3|||Age||years|Mean|48.1|48.1|Standard Deviation|11.21|11.21|||
4194967|NCT00763321|4017771|B2|||Age||years|Mean|49.6|49.6|Standard Deviation|12.44|12.44|||
4194968|NCT00763321|4017772|B1|||Age||years|Mean|46.1|46.1|Standard Deviation|12.25|12.25|||
4194969|NCT00763282|4017783|B3|Employed||Current Employment||participants|Number|22|22.0||||||
4194970|NCT00763282|4017784|B2|Employed||Current Employment||participants|Number|11|11.0||||||
4194971|NCT00763282|4017785|B1|Employed||Current Employment||participants|Number|11|11.0||||||
4194972|NCT00763282|4017783|B3|Unemployed||Current Employment||participants|Number|121|121.0||||||
4194973|NCT00763282|4017784|B2|Unemployed||Current Employment||participants|Number|61|61.0||||||
4194974|NCT00763282|4017785|B1|Unemployed||Current Employment||participants|Number|60|60.0||||||
4194975|NCT00763282|4017783|B3|||Hospital-acquired PrU||Pressure Ulcers|Number|21|21.0||||||
4194976|NCT00763282|4017784|B2|||Hospital-acquired PrU||Pressure Ulcers|Number|9|9.0||||||
4194977|NCT00763282|4017785|B1|||Hospital-acquired PrU||Pressure Ulcers|Number|12|12.0||||||
4194978|NCT00763282|4017783|B3|Stage IV = Full thickness||Stage of PrUs at randomization|"Patients can have more than one ulcer present at randomization. Stage III: Full thickness tissue loss. Subcutaneous fat may be visible but bone, tendon, or muscle are not exposed. Slough may be present but does not obscure the depth of tissue loss. May include undermining and tunneling.~Stage IV: Full thickness tissue loss with exposed bone, tendon, or muscle. Slough or eschar may be present on some parts of the wound bed. Often includes undermining and tunneling."|Pressure Ulcers|Number|97|97.0||||||
4194979|NCT00763282|4017784|B2|Stage IV = Full thickness||Stage of PrUs at randomization|"Patients can have more than one ulcer present at randomization. Stage III: Full thickness tissue loss. Subcutaneous fat may be visible but bone, tendon, or muscle are not exposed. Slough may be present but does not obscure the depth of tissue loss. May include undermining and tunneling.~Stage IV: Full thickness tissue loss with exposed bone, tendon, or muscle. Slough or eschar may be present on some parts of the wound bed. Often includes undermining and tunneling."|Pressure Ulcers|Number|43|43.0||||||
4194980|NCT00763282|4017785|B1|Stage IV = Full thickness||Stage of PrUs at randomization|"Patients can have more than one ulcer present at randomization. Stage III: Full thickness tissue loss. Subcutaneous fat may be visible but bone, tendon, or muscle are not exposed. Slough may be present but does not obscure the depth of tissue loss. May include undermining and tunneling.~Stage IV: Full thickness tissue loss with exposed bone, tendon, or muscle. Slough or eschar may be present on some parts of the wound bed. Often includes undermining and tunneling."|Pressure Ulcers|Number|54|54.0||||||
4194981|NCT00763282|4017783|B3|Stage III = Full thickness||Stage of PrUs at randomization|"Patients can have more than one ulcer present at randomization. Stage III: Full thickness tissue loss. Subcutaneous fat may be visible but bone, tendon, or muscle are not exposed. Slough may be present but does not obscure the depth of tissue loss. May include undermining and tunneling.~Stage IV: Full thickness tissue loss with exposed bone, tendon, or muscle. Slough or eschar may be present on some parts of the wound bed. Often includes undermining and tunneling."|Pressure Ulcers|Number|53|53.0||||||
4194982|NCT00763282|4017784|B2|Stage III = Full thickness||Stage of PrUs at randomization|"Patients can have more than one ulcer present at randomization. Stage III: Full thickness tissue loss. Subcutaneous fat may be visible but bone, tendon, or muscle are not exposed. Slough may be present but does not obscure the depth of tissue loss. May include undermining and tunneling.~Stage IV: Full thickness tissue loss with exposed bone, tendon, or muscle. Slough or eschar may be present on some parts of the wound bed. Often includes undermining and tunneling."|Pressure Ulcers|Number|31|31.0||||||
4194983|NCT00763282|4017785|B1|Stage III = Full thickness||Stage of PrUs at randomization|"Patients can have more than one ulcer present at randomization. Stage III: Full thickness tissue loss. Subcutaneous fat may be visible but bone, tendon, or muscle are not exposed. Slough may be present but does not obscure the depth of tissue loss. May include undermining and tunneling.~Stage IV: Full thickness tissue loss with exposed bone, tendon, or muscle. Slough or eschar may be present on some parts of the wound bed. Often includes undermining and tunneling."|Pressure Ulcers|Number|22|22.0||||||
4194984|NCT00763282|4017783|B3|Other locations (e.g., feet)||Locations of Current Pressure Ulcers|Patients can have more than one ulcer present at randomization|Pressure Ulcers|Number|32|32.0||||||
4194985|NCT00763282|4017784|B2|Other locations (e.g., feet)||Locations of Current Pressure Ulcers|Patients can have more than one ulcer present at randomization|Pressure Ulcers|Number|16|16.0||||||
4194986|NCT00763282|4017785|B1|Other locations (e.g., feet)||Locations of Current Pressure Ulcers|Patients can have more than one ulcer present at randomization|Pressure Ulcers|Number|16|16.0||||||
4194987|NCT00763282|4017783|B3|Coccyx||Locations of Current Pressure Ulcers|Patients can have more than one ulcer present at randomization|Pressure Ulcers|Number|15|15.0||||||
4194988|NCT00763282|4017784|B2|Coccyx||Locations of Current Pressure Ulcers|Patients can have more than one ulcer present at randomization|Pressure Ulcers|Number|6|6.0||||||
4194989|NCT00763282|4017785|B1|Coccyx||Locations of Current Pressure Ulcers|Patients can have more than one ulcer present at randomization|Pressure Ulcers|Number|9|9.0||||||
4194991|NCT00763282|4017784|B2|Sacrum||Locations of Current Pressure Ulcers|Patients can have more than one ulcer present at randomization|Pressure Ulcers|Number|13|13.0||||||
4194992|NCT00763282|4017785|B1|Sacrum||Locations of Current Pressure Ulcers|Patients can have more than one ulcer present at randomization|Pressure Ulcers|Number|15|15.0||||||
4194993|NCT00763282|4017783|B3|Trochanter||Locations of Current Pressure Ulcers|Patients can have more than one ulcer present at randomization|Pressure Ulcers|Number|20|20.0||||||
4194994|NCT00763282|4017784|B2|Trochanter||Locations of Current Pressure Ulcers|Patients can have more than one ulcer present at randomization|Pressure Ulcers|Number|9|9.0||||||
4194995|NCT00763282|4017785|B1|Trochanter||Locations of Current Pressure Ulcers|Patients can have more than one ulcer present at randomization|Pressure Ulcers|Number|11|11.0||||||
4194996|NCT00763282|4017783|B3|Ischium||Locations of Current Pressure Ulcers|Patients can have more than one ulcer present at randomization|Pressure Ulcers|Number|78|78.0||||||
4194997|NCT00763282|4017784|B2|Ischium||Locations of Current Pressure Ulcers|Patients can have more than one ulcer present at randomization|Pressure Ulcers|Number|38|38.0||||||
4194998|NCT00763282|4017785|B1|Ischium||Locations of Current Pressure Ulcers|Patients can have more than one ulcer present at randomization|Pressure Ulcers|Number|40|40.0||||||
4194999|NCT00763282|4017783|B3|||History of PrUs||participants|Number|112|112.0||||||
4195000|NCT00763282|4017784|B2|||History of PrUs||participants|Number|56|56.0||||||
4195001|NCT00763282|4017785|B1|||History of PrUs||participants|Number|56|56.0||||||
4195002|NCT00763282|4017783|B3|No||Prior PrU Surgery||participants|Number|46|46.0||||||
4195003|NCT00763282|4017784|B2|No||Prior PrU Surgery||participants|Number|26|26.0||||||
4195004|NCT00763282|4017785|B1|No||Prior PrU Surgery||participants|Number|20|20.0||||||
4195005|NCT00763282|4017783|B3|Yes||Prior PrU Surgery||participants|Number|97|97.0||||||
4195006|NCT00763282|4017784|B2|Yes||Prior PrU Surgery||participants|Number|46|46.0||||||
4195007|NCT00763282|4017785|B1|Yes||Prior PrU Surgery||participants|Number|51|51.0||||||
4195008|NCT00763282|4017783|B3|||PrU Duration for Largest PrU||days|Mean|307|307.0|Standard Deviation|482|482.0|||
4195009|NCT00763282|4017784|B2|||PrU Duration for Largest PrU||days|Mean|407|407.0|Standard Deviation|631|631.0|||
4195010|NCT00763282|4017785|B1|||PrU Duration for Largest PrU||days|Mean|213|213.0|Standard Deviation|244|244.0|||
4195011|NCT00763282|4017783|B3|||PrU Size of Largest Ulcer||cm^2|Mean|6.3|6.3|Full Range|||0.1|39.1|
4195012|NCT00763282|4017784|B2|||PrU Size of Largest Ulcer||cm^2|Mean|4.5|4.5|Full Range|||0.1|22.0|
4195013|NCT00763282|4017785|B1|||PrU Size of Largest Ulcer||cm^2|Mean|8.2|8.2|Full Range|||0.1|39.1|
4195014|NCT00763282|4017783|B3|Number of current PrUs||Pressure Ulcer (PrU) Characteristics||Pressure Ulcers|Mean|1.4|1.4|Full Range|||1.0|5.0|
4195015|NCT00763282|4017784|B2|Number of current PrUs||Pressure Ulcer (PrU) Characteristics||Pressure Ulcers|Mean|1.3|1.3|Full Range|||1.0|3.0|
4195016|NCT00763282|4017785|B1|Number of current PrUs||Pressure Ulcer (PrU) Characteristics||Pressure Ulcers|Mean|1.6|1.6|Full Range|||1.0|5.0|
4195017|NCT00763282|4017783|B3|Number of prior PrUs||Pressure Ulcer (PrU) Characteristics||Pressure Ulcers|Mean|2.41|2.41|Full Range|||0.0|25.0|
4195018|NCT00763282|4017784|B2|Number of prior PrUs||Pressure Ulcer (PrU) Characteristics||Pressure Ulcers|Mean|1.93|1.93|Full Range|||0.0|8.0|
4195019|NCT00763282|4017785|B1|Number of prior PrUs||Pressure Ulcer (PrU) Characteristics||Pressure Ulcers|Mean|2.89|2.89|Full Range|||0.0|25.0|
4195020|NCT00763282|4017783|B3|||Salzburg PrU Risk Score|"The Salzberg PrU risk scale was developed as a pressure ulcer risk assessment scale specifically for persons with SCI using a list of identified risk factors contributing to PrU development. Total individual scores range from 0 to 25, with a higher score indicating a greater risk of developing a PrU.~Salzberg, C. Andrew, et al. A New Pressure Ulcer Risk Assessment Scale for Individuals With Spinal Cord Injury. American Journal of Physical Medicine & Rehabilitation 75.2 (1996): 96-104."|Scores on a scale|Mean|9.5|9.5|Full Range|||4.0|18.0|
4195021|NCT00763282|4017784|B2|||Salzburg PrU Risk Score|"The Salzberg PrU risk scale was developed as a pressure ulcer risk assessment scale specifically for persons with SCI using a list of identified risk factors contributing to PrU development. Total individual scores range from 0 to 25, with a higher score indicating a greater risk of developing a PrU.~Salzberg, C. Andrew, et al. A New Pressure Ulcer Risk Assessment Scale for Individuals With Spinal Cord Injury. American Journal of Physical Medicine & Rehabilitation 75.2 (1996): 96-104."|Scores on a scale|Mean|9.3|9.3|Full Range|||5.0|17.0|
4195022|NCT00763282|4017785|B1|||Salzburg PrU Risk Score|"The Salzberg PrU risk scale was developed as a pressure ulcer risk assessment scale specifically for persons with SCI using a list of identified risk factors contributing to PrU development. Total individual scores range from 0 to 25, with a higher score indicating a greater risk of developing a PrU.~Salzberg, C. Andrew, et al. A New Pressure Ulcer Risk Assessment Scale for Individuals With Spinal Cord Injury. American Journal of Physical Medicine & Rehabilitation 75.2 (1996): 96-104."|Scores on a scale|Mean|9.8|9.8|Full Range|||4.0|18.0|
4195023|NCT00763282|4017783|B3|Osteomyelitis||Comorbid Conditions (baseline)||participants|Number|28|28.0||||||
4195024|NCT00763282|4017784|B2|Osteomyelitis||Comorbid Conditions (baseline)||participants|Number|10|10.0||||||
4195025|NCT00763282|4017785|B1|Osteomyelitis||Comorbid Conditions (baseline)||participants|Number|18|18.0||||||
4195026|NCT00763282|4017783|B3|Depression||Comorbid Conditions (baseline)||participants|Number|58|58.0||||||
4195027|NCT00763282|4017784|B2|Depression||Comorbid Conditions (baseline)||participants|Number|29|29.0||||||
4195028|NCT00763282|4017785|B1|Depression||Comorbid Conditions (baseline)||participants|Number|29|29.0||||||
4195029|NCT00763282|4017783|B3|Diabetes||Comorbid Conditions (baseline)||participants|Number|56|56.0||||||
4195030|NCT00763282|4017784|B2|Diabetes||Comorbid Conditions (baseline)||participants|Number|22|22.0||||||
4195031|NCT00763282|4017785|B1|Diabetes||Comorbid Conditions (baseline)||participants|Number|34|34.0||||||
4195032|NCT00763282|4017783|B3|No Regular Assistance||Source of Assistance|Participants can have more than one source of assistance.|participants|Number|23|23.0||||||
4195033|NCT00763282|4017784|B2|No Regular Assistance||Source of Assistance|Participants can have more than one source of assistance.|participants|Number|11|11.0||||||
4195034|NCT00763282|4017785|B1|No Regular Assistance||Source of Assistance|Participants can have more than one source of assistance.|participants|Number|12|12.0||||||
4195035|NCT00763282|4017783|B3|Other Regular Assistance||Source of Assistance|Participants can have more than one source of assistance.|participants|Number|13|13.0||||||
4195036|NCT00763282|4017784|B2|Other Regular Assistance||Source of Assistance|Participants can have more than one source of assistance.|participants|Number|8|8.0||||||
4195037|NCT00763282|4017785|B1|Other Regular Assistance||Source of Assistance|Participants can have more than one source of assistance.|participants|Number|5|5.0||||||
4195038|NCT00763282|4017783|B3|Paid Attendant||Source of Assistance|Participants can have more than one source of assistance.|participants|Number|48|48.0||||||
4195039|NCT00763282|4017784|B2|Paid Attendant||Source of Assistance|Participants can have more than one source of assistance.|participants|Number|18|18.0||||||
4195040|NCT00763282|4017785|B1|Paid Attendant||Source of Assistance|Participants can have more than one source of assistance.|participants|Number|30|30.0||||||
4195041|NCT00763282|4017783|B3|Spouse; partner/significant other; Relative||Source of Assistance|Participants can have more than one source of assistance.|participants|Number|95|95.0||||||
4195042|NCT00763282|4017784|B2|Spouse; partner/significant other; Relative||Source of Assistance|Participants can have more than one source of assistance.|participants|Number|45|45.0||||||
4195043|NCT00763282|4017785|B1|Spouse; partner/significant other; Relative||Source of Assistance|Participants can have more than one source of assistance.|participants|Number|50|50.0||||||
4195044|NCT00763282|4017783|B3|D = Motor Incomplete||American Spinal Injury Association (ASIA) Score|"The American Spinal Injury Association (ASIA) score is a scale to classify spinal cord injuries (SCI).~A= complete SCI where no motor or sensory function is in the sacral segments S4-S5.~B= incomplete SCI where sensory but not motor function is below the neurological level and includes the sacral segments S4-S5.~C= incomplete SCI where motor function is below the neurological level and fewer than half of key muscles have a muscle grade < 3.~D= incomplete spinal cord injury where motor function is below the neurological level and at least half of the key muscles have a muscle grade >3."|participants|Number|10|10.0||||||
4195045|NCT00763282|4017784|B2|D = Motor Incomplete||American Spinal Injury Association (ASIA) Score|"The American Spinal Injury Association (ASIA) score is a scale to classify spinal cord injuries (SCI).~A= complete SCI where no motor or sensory function is in the sacral segments S4-S5.~B= incomplete SCI where sensory but not motor function is below the neurological level and includes the sacral segments S4-S5.~C= incomplete SCI where motor function is below the neurological level and fewer than half of key muscles have a muscle grade < 3.~D= incomplete spinal cord injury where motor function is below the neurological level and at least half of the key muscles have a muscle grade >3."|participants|Number|6|6.0||||||
4195046|NCT00763282|4017785|B1|D = Motor Incomplete||American Spinal Injury Association (ASIA) Score|"The American Spinal Injury Association (ASIA) score is a scale to classify spinal cord injuries (SCI).~A= complete SCI where no motor or sensory function is in the sacral segments S4-S5.~B= incomplete SCI where sensory but not motor function is below the neurological level and includes the sacral segments S4-S5.~C= incomplete SCI where motor function is below the neurological level and fewer than half of key muscles have a muscle grade < 3.~D= incomplete spinal cord injury where motor function is below the neurological level and at least half of the key muscles have a muscle grade >3."|participants|Number|4|4.0||||||
4195047|NCT00763282|4017783|B3|C = Motor Incomplete||American Spinal Injury Association (ASIA) Score|"The American Spinal Injury Association (ASIA) score is a scale to classify spinal cord injuries (SCI).~A= complete SCI where no motor or sensory function is in the sacral segments S4-S5.~B= incomplete SCI where sensory but not motor function is below the neurological level and includes the sacral segments S4-S5.~C= incomplete SCI where motor function is below the neurological level and fewer than half of key muscles have a muscle grade < 3.~D= incomplete spinal cord injury where motor function is below the neurological level and at least half of the key muscles have a muscle grade >3."|participants|Number|17|17.0||||||
4195048|NCT00763282|4017784|B2|C = Motor Incomplete||American Spinal Injury Association (ASIA) Score|"The American Spinal Injury Association (ASIA) score is a scale to classify spinal cord injuries (SCI).~A= complete SCI where no motor or sensory function is in the sacral segments S4-S5.~B= incomplete SCI where sensory but not motor function is below the neurological level and includes the sacral segments S4-S5.~C= incomplete SCI where motor function is below the neurological level and fewer than half of key muscles have a muscle grade < 3.~D= incomplete spinal cord injury where motor function is below the neurological level and at least half of the key muscles have a muscle grade >3."|participants|Number|10|10.0||||||
4195049|NCT00763282|4017785|B1|C = Motor Incomplete||American Spinal Injury Association (ASIA) Score|"The American Spinal Injury Association (ASIA) score is a scale to classify spinal cord injuries (SCI).~A= complete SCI where no motor or sensory function is in the sacral segments S4-S5.~B= incomplete SCI where sensory but not motor function is below the neurological level and includes the sacral segments S4-S5.~C= incomplete SCI where motor function is below the neurological level and fewer than half of key muscles have a muscle grade < 3.~D= incomplete spinal cord injury where motor function is below the neurological level and at least half of the key muscles have a muscle grade >3."|participants|Number|7|7.0||||||
4195050|NCT00763282|4017783|B3|B = Sensory Incomplete||American Spinal Injury Association (ASIA) Score|"The American Spinal Injury Association (ASIA) score is a scale to classify spinal cord injuries (SCI).~A= complete SCI where no motor or sensory function is in the sacral segments S4-S5.~B= incomplete SCI where sensory but not motor function is below the neurological level and includes the sacral segments S4-S5.~C= incomplete SCI where motor function is below the neurological level and fewer than half of key muscles have a muscle grade < 3.~D= incomplete spinal cord injury where motor function is below the neurological level and at least half of the key muscles have a muscle grade >3."|participants|Number|15|15.0||||||
4195051|NCT00763282|4017784|B2|B = Sensory Incomplete||American Spinal Injury Association (ASIA) Score|"The American Spinal Injury Association (ASIA) score is a scale to classify spinal cord injuries (SCI).~A= complete SCI where no motor or sensory function is in the sacral segments S4-S5.~B= incomplete SCI where sensory but not motor function is below the neurological level and includes the sacral segments S4-S5.~C= incomplete SCI where motor function is below the neurological level and fewer than half of key muscles have a muscle grade < 3.~D= incomplete spinal cord injury where motor function is below the neurological level and at least half of the key muscles have a muscle grade >3."|participants|Number|8|8.0||||||
4195052|NCT00763282|4017785|B1|B = Sensory Incomplete||American Spinal Injury Association (ASIA) Score|"The American Spinal Injury Association (ASIA) score is a scale to classify spinal cord injuries (SCI).~A= complete SCI where no motor or sensory function is in the sacral segments S4-S5.~B= incomplete SCI where sensory but not motor function is below the neurological level and includes the sacral segments S4-S5.~C= incomplete SCI where motor function is below the neurological level and fewer than half of key muscles have a muscle grade < 3.~D= incomplete spinal cord injury where motor function is below the neurological level and at least half of the key muscles have a muscle grade >3."|participants|Number|7|7.0||||||
4195053|NCT00763282|4017783|B3|A = Complete||American Spinal Injury Association (ASIA) Score|"The American Spinal Injury Association (ASIA) score is a scale to classify spinal cord injuries (SCI).~A= complete SCI where no motor or sensory function is in the sacral segments S4-S5.~B= incomplete SCI where sensory but not motor function is below the neurological level and includes the sacral segments S4-S5.~C= incomplete SCI where motor function is below the neurological level and fewer than half of key muscles have a muscle grade < 3.~D= incomplete spinal cord injury where motor function is below the neurological level and at least half of the key muscles have a muscle grade >3."|participants|Number|101|101.0||||||
4195054|NCT00763282|4017784|B2|A = Complete||American Spinal Injury Association (ASIA) Score|"The American Spinal Injury Association (ASIA) score is a scale to classify spinal cord injuries (SCI).~A= complete SCI where no motor or sensory function is in the sacral segments S4-S5.~B= incomplete SCI where sensory but not motor function is below the neurological level and includes the sacral segments S4-S5.~C= incomplete SCI where motor function is below the neurological level and fewer than half of key muscles have a muscle grade < 3.~D= incomplete spinal cord injury where motor function is below the neurological level and at least half of the key muscles have a muscle grade >3."|participants|Number|48|48.0||||||
4195055|NCT00763282|4017785|B1|A = Complete||American Spinal Injury Association (ASIA) Score|"The American Spinal Injury Association (ASIA) score is a scale to classify spinal cord injuries (SCI).~A= complete SCI where no motor or sensory function is in the sacral segments S4-S5.~B= incomplete SCI where sensory but not motor function is below the neurological level and includes the sacral segments S4-S5.~C= incomplete SCI where motor function is below the neurological level and fewer than half of key muscles have a muscle grade < 3.~D= incomplete spinal cord injury where motor function is below the neurological level and at least half of the key muscles have a muscle grade >3."|participants|Number|53|53.0||||||
4195056|NCT00763282|4017783|B3|Lumbar||Level of Injury||participants|Number|7|7.0||||||
4195057|NCT00763282|4017784|B2|Lumbar||Level of Injury||participants|Number|6|6.0||||||
4195058|NCT00763282|4017785|B1|Lumbar||Level of Injury||participants|Number|1|1.0||||||
4195059|NCT00763282|4017783|B3|Thoracic||Level of Injury||participants|Number|76|76.0||||||
4195060|NCT00763282|4017784|B2|Thoracic||Level of Injury||participants|Number|36|36.0||||||
4195061|NCT00763282|4017785|B1|Thoracic||Level of Injury||participants|Number|40|40.0||||||
4195062|NCT00763282|4017783|B3|Cervical||Level of Injury||participants|Number|60|60.0||||||
4195063|NCT00763282|4017784|B2|Cervical||Level of Injury||participants|Number|30|30.0||||||
4195064|NCT00763282|4017785|B1|Cervical||Level of Injury||participants|Number|30|30.0||||||
4195065|NCT00763282|4017783|B3|Other||Etiology||participants|Number|36|36.0||||||
4195066|NCT00763282|4017784|B2|Other||Etiology||participants|Number|16|16.0||||||
4195067|NCT00763282|4017785|B1|Other||Etiology||participants|Number|20|20.0||||||
4195068|NCT00763282|4017783|B3|Gunshot Wound||Etiology||participants|Number|17|17.0||||||
4195069|NCT00763282|4017784|B2|Gunshot Wound||Etiology||participants|Number|11|11.0||||||
4195070|NCT00763282|4017785|B1|Gunshot Wound||Etiology||participants|Number|6|6.0||||||
4195071|NCT00763282|4017783|B3|Fall||Etiology||participants|Number|11|11.0||||||
4195072|NCT00763282|4017784|B2|Fall||Etiology||participants|Number|6|6.0||||||
4195073|NCT00763282|4017785|B1|Fall||Etiology||participants|Number|5|5.0||||||
4195074|NCT00763282|4017783|B3|Diving||Etiology||participants|Number|9|9.0||||||
4195075|NCT00763282|4017784|B2|Diving||Etiology||participants|Number|4|4.0||||||
4195076|NCT00763282|4017785|B1|Diving||Etiology||participants|Number|5|5.0||||||
4195077|NCT00763282|4017783|B3|Driving||Etiology||participants|Number|70|70.0||||||
4195078|NCT00763282|4017784|B2|Driving||Etiology||participants|Number|35|35.0||||||
4195079|NCT00763282|4017785|B1|Driving||Etiology||participants|Number|35|35.0||||||
4195080|NCT00763282|4017783|B3|||Duration of Spinal Cord Injury||years|Mean|24.0|24.0|Full Range|||0.5|61.3|
4195081|NCT00763282|4017784|B2|||Duration of Spinal Cord Injury||years|Mean|24.0|24.0|Full Range|||0.5|60.9|
4195082|NCT00763282|4017785|B1|||Duration of Spinal Cord Injury||years|Mean|23.8|23.8|Full Range|||0.5|61.3|
4195083|NCT00763282|4017783|B3|Graduate School||Educational Level||participants|Number|6|6.0||||||
4195084|NCT00763282|4017784|B2|Graduate School||Educational Level||participants|Number|3|3.0||||||
4195085|NCT00763282|4017785|B1|Graduate School||Educational Level||participants|Number|3|3.0||||||
4195086|NCT00763282|4017783|B3|College Graduate||Educational Level||participants|Number|19|19.0||||||
4195087|NCT00763282|4017784|B2|College Graduate||Educational Level||participants|Number|9|9.0||||||
4195088|NCT00763282|4017785|B1|College Graduate||Educational Level||participants|Number|10|10.0||||||
4195089|NCT00763282|4017783|B3|Some College||Educational Level||participants|Number|73|73.0||||||
4195090|NCT00763282|4017784|B2|Some College||Educational Level||participants|Number|38|38.0||||||
4195091|NCT00763282|4017785|B1|Some College||Educational Level||participants|Number|35|35.0||||||
4195092|NCT00763282|4017783|B3|High School Graduate or Lower||Educational Level||participants|Number|45|45.0||||||
4195093|NCT00763282|4017784|B2|High School Graduate or Lower||Educational Level||participants|Number|22|22.0||||||
4195094|NCT00763282|4017785|B1|High School Graduate or Lower||Educational Level||participants|Number|23|23.0||||||
4195095|NCT00763282|4017783|B3|Missing||Marital Status||participants|Number|1|1.0||||||
4195096|NCT00763282|4017784|B2|Missing||Marital Status||participants|Number|0|0.0||||||
4195097|NCT00763282|4017785|B1|Missing||Marital Status||participants|Number|1|1.0||||||
4195098|NCT00763282|4017783|B3|Live with Partner||Marital Status||participants|Number|1|1.0||||||
4195099|NCT00763282|4017784|B2|Live with Partner||Marital Status||participants|Number|1|1.0||||||
4195100|NCT00763282|4017785|B1|Live with Partner||Marital Status||participants|Number|0|0.0||||||
4195101|NCT00763282|4017783|B3|Divorced||Marital Status||participants|Number|52|52.0||||||
4195102|NCT00763282|4017784|B2|Divorced||Marital Status||participants|Number|27|27.0||||||
4195103|NCT00763282|4017785|B1|Divorced||Marital Status||participants|Number|25|25.0||||||
4195104|NCT00763282|4017783|B3|Widowed||Marital Status||participants|Number|11|11.0||||||
4195105|NCT00763282|4017784|B2|Widowed||Marital Status||participants|Number|6|6.0||||||
4195106|NCT00763282|4017785|B1|Widowed||Marital Status||participants|Number|5|5.0||||||
4195107|NCT00763282|4017783|B3|Never Married||Marital Status||participants|Number|21|21.0||||||
4195108|NCT00763282|4017784|B2|Never Married||Marital Status||participants|Number|10|10.0||||||
4195109|NCT00763282|4017785|B1|Never Married||Marital Status||participants|Number|11|11.0||||||
4195110|NCT00763282|4017783|B3|Married||Marital Status||participants|Number|57|57.0||||||
4195111|NCT00763282|4017784|B2|Married||Marital Status||participants|Number|28|28.0||||||
4195112|NCT00763282|4017785|B1|Married||Marital Status||participants|Number|29|29.0||||||
4195113|NCT00763282|4017783|B3|Other||Residence Type||participants|Number|9|9.0||||||
4195114|NCT00763282|4017784|B2|Other||Residence Type||participants|Number|4|4.0||||||
4195115|NCT00763282|4017785|B1|Other||Residence Type||participants|Number|5|5.0||||||
4195116|NCT00763282|4017783|B3|Nursing Home||Residence Type||participants|Number|1|1.0||||||
4195117|NCT00763282|4017784|B2|Nursing Home||Residence Type||participants|Number|0|0.0||||||
4195118|NCT00763282|4017785|B1|Nursing Home||Residence Type||participants|Number|1|1.0||||||
4195119|NCT00763282|4017783|B3|Apartment||Residence Type||participants|Number|27|27.0||||||
4195120|NCT00763282|4017784|B2|Apartment||Residence Type||participants|Number|12|12.0||||||
4195121|NCT00763282|4017785|B1|Apartment||Residence Type||participants|Number|15|15.0||||||
4195122|NCT00763282|4017783|B3|House||Residence Type||participants|Number|106|106.0||||||
4195123|NCT00763282|4017784|B2|House||Residence Type||participants|Number|56|56.0||||||
4195124|NCT00763282|4017785|B1|House||Residence Type||participants|Number|50|50.0||||||
4195125|NCT00763282|4017783|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4195126|NCT00763282|4017784|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4195127|NCT00763282|4017785|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4195128|NCT00763282|4017783|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4195129|NCT00763282|4017784|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4195130|NCT00763282|4017785|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4195131|NCT00763282|4017783|B3|Black||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4195132|NCT00763282|4017784|B2|Black||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4195133|NCT00763282|4017785|B1|Black||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4195134|NCT00763282|4017783|B3|White||Race/Ethnicity, Customized||participants|Number|98|98.0||||||
4195135|NCT00763282|4017784|B2|White||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
4195136|NCT00763282|4017785|B1|White||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4195137|NCT00763282|4017783|B3||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4195138|NCT00763282|4017784|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4195139|NCT00763282|4017785|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4195140|NCT00763282|4017783|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4195141|NCT00763282|4017784|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4195142|NCT00763282|4017785|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4195143|NCT00763282|4017783|B3|||Age||years|Mean|59.3|59.3|Full Range|||22.0|85.0|
4195144|NCT00763282|4017784|B2|||Age||years|Mean|59.0|59.0|Full Range|||22.0|85.0|
4195145|NCT00763282|4017785|B1|||Age||years|Mean|59.4|59.4|Full Range|||34.0|83.0|
4195146|NCT00763269|4017800|B3|United States||Region of Enrollment||participants|Number|626|626.0||||||
4195147|NCT00763269|4017801|B2|United States||Region of Enrollment||participants|Number|312|312.0||||||
4195148|NCT00763269|4017802|B1|United States||Region of Enrollment||participants|Number|314|314.0||||||
4195149|NCT00763269|4017800|B3||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4195150|NCT00763269|4017801|B2||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4195151|NCT00763269|4017802|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4195152|NCT00763269|4017800|B3||Female|Sex: Female, Male||Participants|Count of Participants|459|459.0||||||
4195153|NCT00763269|4017801|B2||Female|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
4195154|NCT00763269|4017802|B1||Female|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
4195155|NCT00763269|4017800|B3|||Age||years|Mean|41|41.0|Standard Deviation|12.7|12.7|||
4195156|NCT00763269|4017801|B2|||Age||years|Mean|41.4|41.4|Standard Deviation|12.1|12.1|||
4195157|NCT00763269|4017802|B1|||Age||years|Mean|40.6|40.6|Standard Deviation|13.4|13.4|||
4195158|NCT00763269|4017800|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4195159|NCT00763269|4017801|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4195160|NCT00763269|4017802|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4195161|NCT00763269|4017800|B3||Between 18 and 65 years|Age||Participants|Count of Participants|607|607.0||||||
4195162|NCT00763269|4017801|B2||Between 18 and 65 years|Age||Participants|Count of Participants|306|306.0||||||
4195163|NCT00763269|4017802|B1||Between 18 and 65 years|Age||Participants|Count of Participants|301|301.0||||||
4195164|NCT00763269|4017800|B3||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4195165|NCT00763269|4017801|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4195166|NCT00763269|4017802|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4195167|NCT00763256|4017815|B3|Australia||Region of Enrollment||participants|Number|33|33.0||||||
4195168|NCT00763256|4017816|B2|Australia||Region of Enrollment||participants|Number|18|18.0||||||
4195169|NCT00763256|4017817|B1|Australia||Region of Enrollment||participants|Number|15|15.0||||||
4195170|NCT00763256|4017815|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4195171|NCT00763256|4017816|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4195172|NCT00763256|4017817|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4195173|NCT00763256|4017815|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4195174|NCT00763256|4017816|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4195175|NCT00763256|4017817|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4195176|NCT00763256|4017815|B3|||Age||years|Mean|51|51.0|Standard Deviation|9.5|9.5|||
4195177|NCT00763256|4017816|B2|||Age||years|Mean|49|49.0|Standard Deviation|11|11.0|||
4195178|NCT00763256|4017817|B1|||Age||years|Mean|53|53.0|Standard Deviation|7.6|7.6|||
4195179|NCT00763256|4017815|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4195180|NCT00763256|4017816|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4195181|NCT00763256|4017817|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4195182|NCT00763256|4017815|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4195183|NCT00763256|4017816|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4195184|NCT00763256|4017817|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4195185|NCT00763256|4017815|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195186|NCT00763256|4017816|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195187|NCT00763256|4017817|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195188|NCT00763243|4017832|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4195189|NCT00763243|4017832|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4195190|NCT00763243|4017832|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4195191|NCT00763243|4017832|B1|||Age||years|Mean|10.2|10.2|Standard Deviation|2.2|2.2|||
4195192|NCT00763243|4017832|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4195193|NCT00763243|4017832|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4195194|NCT00763243|4017832|B1||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4195195|NCT00763139|4017854|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4195196|NCT00763139|4017854|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4195197|NCT00763139|4017854|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4195198|NCT00763139|4017854|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4195199|NCT00763139|4017854|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4195200|NCT00763139|4017854|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4195201|NCT00763139|4017854|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4195202|NCT00763139|4017854|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4195203|NCT00763139|4017854|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4195204|NCT00763139|4017854|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4195205|NCT00763139|4017854|B1|||Age||years|Mean|51.0|51.0|Standard Deviation|14.2|14.2|||
4195206|NCT00763061|4017875|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4195207|NCT00763061|4017876|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4195208|NCT00763061|4017877|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4195209|NCT00763061|4017875|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4195210|NCT00763061|4017876|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4195211|NCT00763061|4017877|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4195212|NCT00763061|4017875|B3||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
4195213|NCT00763061|4017876|B2||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4195214|NCT00763061|4017877|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4195215|NCT00763061|4017875|B3||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4195216|NCT00763061|4017876|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4195217|NCT00763061|4017877|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4195218|NCT00763061|4017875|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4195219|NCT00763061|4017876|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4195220|NCT00763061|4017877|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4195221|NCT00763048|4017890|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
4195222|NCT00763048|4017891|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4195223|NCT00763048|4017892|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4195224|NCT00763048|4017890|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4195225|NCT00763048|4017891|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4195226|NCT00763048|4017892|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4195227|NCT00763048|4017890|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4195228|NCT00763048|4017891|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4195229|NCT00763048|4017892|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4195230|NCT00763048|4017890|B3|||Age||years|Mean|48.9|48.9|Standard Deviation|12.6|12.6|||
4195231|NCT00763048|4017891|B2|||Age||years|Mean|49.8|49.8|Standard Deviation|12.8|12.8|||
4195232|NCT00763048|4017892|B1|||Age||years|Mean|48|48.0|Standard Deviation|12.7|12.7|||
4195233|NCT00763048|4017890|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4195234|NCT00763048|4017891|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4195235|NCT00763048|4017892|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4195236|NCT00763048|4017890|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4195237|NCT00763048|4017891|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4195238|NCT00763048|4017892|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4195239|NCT00763048|4017890|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195240|NCT00763048|4017891|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195241|NCT00763048|4017892|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195242|NCT00763035|4017917|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4195243|NCT00763035|4017917|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4195244|NCT00763035|4017917|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4195245|NCT00763035|4017917|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4195246|NCT00763035|4017917|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4195247|NCT00763035|4017917|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4195248|NCT00763035|4017917|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4195249|NCT00763035|4017917|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4195250|NCT00763035|4017917|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4195251|NCT00763035|4017917|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4195252|NCT00763035|4017917|B1|||Age||years|Mean|69|69.0|Full Range|||57.0|78.0|
4195253|NCT00763009|4017936|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4195254|NCT00763009|4017936|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4195255|NCT00763009|4017936|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4195256|NCT00763009|4017936|B1|||Age||years|Mean|65|65.0|Standard Deviation|7|7.0|||
4195257|NCT00763009|4017936|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4195258|NCT00763009|4017936|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4195259|NCT00763009|4017936|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195260|NCT00762996|4017941|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4195261|NCT00762996|4017941|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4195262|NCT00762996|4017941|B1|||Age||years|Mean|28.9|28.9|Standard Deviation|5.3|5.3|||
4195263|NCT00762970|4017954|B4|China|Ch|Region of Enrollment||Participants|Count of Participants|137|137.0||||||
4195264|NCT00762970|4017955|B3|China|Ch|Region of Enrollment||Participants|Count of Participants|47|47.0||||||
4195265|NCT00762970|4017956|B2|China|Ch|Region of Enrollment||Participants|Count of Participants|44|44.0||||||
4195266|NCT00762970|4017957|B1|China|Ch|Region of Enrollment||Participants|Count of Participants|46|46.0||||||
4195267|NCT00762970|4017954|B4||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4195268|NCT00762970|4017955|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4195269|NCT00762970|4017956|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4195270|NCT00762970|4017957|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4195271|NCT00762970|4017954|B4||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4195272|NCT00762970|4017955|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4195273|NCT00762970|4017956|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4195274|NCT00762970|4017957|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4195275|NCT00762970|4017954|B4|||Age||years|Mean|9.8|9.8|Standard Deviation|1.1|1.1|||
4195276|NCT00762970|4017955|B3|||Age||years|Mean|9.7|9.7|Standard Deviation|1.2|1.2|||
4195277|NCT00762970|4017956|B2|||Age||years|Mean|9.8|9.8|Standard Deviation|1.2|1.2|||
4195278|NCT00762970|4017957|B1|||Age||years|Mean|9.8|9.8|Standard Deviation|1.1|1.1|||
4195279|NCT00762970|4017954|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4195280|NCT00762970|4017955|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4195281|NCT00762970|4017956|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4195282|NCT00762970|4017957|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4195283|NCT00762970|4017954|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4195284|NCT00762970|4017955|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4195285|NCT00762970|4017956|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4195286|NCT00762970|4017957|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4195287|NCT00762970|4017954|B4||<=18 years|Age||Participants|Count of Participants|137|137.0||||||
4195288|NCT00762970|4017955|B3||<=18 years|Age||Participants|Count of Participants|47|47.0||||||
4195289|NCT00762970|4017956|B2||<=18 years|Age||Participants|Count of Participants|44|44.0||||||
4195290|NCT00762970|4017957|B1||<=18 years|Age||Participants|Count of Participants|46|46.0||||||
4195291|NCT00762931|4017970|B1|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4195292|NCT00762931|4017970|B1|Hispanic Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4195293|NCT00762931|4017970|B1|Hispanic Latino||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4195294|NCT00762931|4017970|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4195295|NCT00762931|4017970|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4195296|NCT00762931|4017970|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4195297|NCT00762931|4017970|B1|Hispanic and white||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4195298|NCT00762931|4017970|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
4195299|NCT00762931|4017970|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4195300|NCT00762931|4017970|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4195301|NCT00762931|4017970|B1|||Age||years|Mean|41|41.0|Full Range|||19.0|65.0|
4195302|NCT00762892|4017975|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
4195303|NCT00762892|4017976|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4195304|NCT00762892|4017977|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4195305|NCT00762892|4017975|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4195306|NCT00762892|4017976|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4195307|NCT00762892|4017977|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4195308|NCT00762892|4017975|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4195309|NCT00762892|4017976|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4195310|NCT00762892|4017977|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4195311|NCT00762892|4017975|B3|||Age||year|Mean|39.8|39.8|Standard Deviation|10.4|10.4|||
4195312|NCT00762892|4017976|B2|||Age||year|Mean|38.8|38.8|Standard Deviation|10|10.0|||
4195313|NCT00762892|4017977|B1|||Age||year|Mean|40.7|40.7|Standard Deviation|11|11.0|||
4195314|NCT00762892|4017975|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4195315|NCT00762892|4017976|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4195316|NCT00762892|4017977|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4195317|NCT00762892|4017975|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4195318|NCT00762892|4017976|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4195319|NCT00762892|4017977|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4195320|NCT00762892|4017975|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195321|NCT00762892|4017976|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195322|NCT00762892|4017977|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195323|NCT00762853|4017992|B3|Thailand||Region of Enrollment||participants|Number|20|20.0||||||
4195324|NCT00762853|4017993|B2|Thailand||Region of Enrollment||participants|Number|10|10.0||||||
4195325|NCT00762853|4017994|B1|Thailand||Region of Enrollment||participants|Number|10|10.0||||||
4195326|NCT00762853|4017992|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4195327|NCT00762853|4017993|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4195328|NCT00762853|4017994|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4195329|NCT00762853|4017992|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4195330|NCT00762853|4017993|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4195331|NCT00762853|4017994|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4195332|NCT00762853|4017992|B3|||Age||years|Mean|35.8|35.8|Standard Deviation|10.7|10.7|||
4195333|NCT00762853|4017993|B2|||Age||years|Mean|35.6|35.6|Standard Deviation|9.9|9.9|||
4195334|NCT00762853|4017994|B1|||Age||years|Mean|35.9|35.9|Standard Deviation|11.9|11.9|||
4195335|NCT00762853|4017992|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4195336|NCT00762853|4017993|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4195337|NCT00762853|4017994|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4195338|NCT00762853|4017992|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4195339|NCT00762853|4017993|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4195340|NCT00762853|4017994|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4195341|NCT00762853|4017992|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195342|NCT00762853|4017993|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195343|NCT00762853|4017994|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195344|NCT00762788|4018001|B7|India||Region of Enrollment||participants|Number|314|314.0||||||
4195345|NCT00762788|4018002|B6|India||Region of Enrollment||participants|Number|52|52.0||||||
4195346|NCT00762788|4018003|B5|India||Region of Enrollment||participants|Number|43|43.0||||||
4195347|NCT00762788|4018004|B4|India||Region of Enrollment||participants|Number|64|64.0||||||
4195348|NCT00762788|4018005|B3|India||Region of Enrollment||participants|Number|42|42.0||||||
4195349|NCT00762788|4018006|B2|India||Region of Enrollment||participants|Number|58|58.0||||||
4195350|NCT00762788|4018007|B1|India||Region of Enrollment||participants|Number|55|55.0||||||
4195351|NCT00762788|4018001|B7||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4195352|NCT00762788|4018002|B6||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4195353|NCT00762788|4018003|B5||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4195354|NCT00762788|4018004|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4195355|NCT00762788|4018005|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4195356|NCT00762788|4018006|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4195357|NCT00762788|4018007|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4195358|NCT00762788|4018001|B7||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4195359|NCT00762788|4018002|B6||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4195360|NCT00762788|4018003|B5||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4195361|NCT00762788|4018004|B4||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4195362|NCT00762788|4018005|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4195363|NCT00762788|4018006|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4195364|NCT00762788|4018007|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4195365|NCT00762788|4018001|B7|||Age||years|Mean|20.7|20.7|Standard Deviation|3.4|3.4|||
4195366|NCT00762788|4018002|B6|||Age||years|Mean|20.6|20.6|Standard Deviation|3.6|3.6|||
4195367|NCT00762788|4018003|B5|||Age||years|Mean|19.5|19.5|Standard Deviation|1.3|1.3|||
4195368|NCT00762788|4018004|B4|||Age||years|Mean|21.0|21.0|Standard Deviation|3.7|3.7|||
4195369|NCT00762788|4018005|B3|||Age||years|Mean|19.8|19.8|Standard Deviation|1.7|1.7|||
4195370|NCT00762788|4018006|B2|||Age||years|Mean|21.6|21.6|Standard Deviation|4.9|4.9|||
4195371|NCT00762788|4018007|B1|||Age||years|Mean|21.1|21.1|Standard Deviation|3.2|3.2|||
4195372|NCT00762788|4018001|B7||>=65 years|Age|Data was collected on those subjects 18 years and older, there were no pediatric patients enrolled in the study.|Participants|Count of Participants|0|0.0||||||
4195373|NCT00762788|4018002|B6||>=65 years|Age|Data was collected on those subjects 18 years and older, there were no pediatric patients enrolled in the study.|Participants|Count of Participants|0|0.0||||||
4195374|NCT00762788|4018003|B5||>=65 years|Age|Data was collected on those subjects 18 years and older, there were no pediatric patients enrolled in the study.|Participants|Count of Participants|0|0.0||||||
4195375|NCT00762788|4018004|B4||>=65 years|Age|Data was collected on those subjects 18 years and older, there were no pediatric patients enrolled in the study.|Participants|Count of Participants|0|0.0||||||
4195376|NCT00762788|4018005|B3||>=65 years|Age|Data was collected on those subjects 18 years and older, there were no pediatric patients enrolled in the study.|Participants|Count of Participants|0|0.0||||||
4195377|NCT00762788|4018006|B2||>=65 years|Age|Data was collected on those subjects 18 years and older, there were no pediatric patients enrolled in the study.|Participants|Count of Participants|0|0.0||||||
4195378|NCT00762788|4018007|B1||>=65 years|Age|Data was collected on those subjects 18 years and older, there were no pediatric patients enrolled in the study.|Participants|Count of Participants|0|0.0||||||
4195379|NCT00762788|4018001|B7||Between 18 and 65 years|Age|Data was collected on those subjects 18 years and older, there were no pediatric patients enrolled in the study.|Participants|Count of Participants|245|245.0||||||
4195380|NCT00762788|4018002|B6||Between 18 and 65 years|Age|Data was collected on those subjects 18 years and older, there were no pediatric patients enrolled in the study.|Participants|Count of Participants|40|40.0||||||
4195381|NCT00762788|4018003|B5||Between 18 and 65 years|Age|Data was collected on those subjects 18 years and older, there were no pediatric patients enrolled in the study.|Participants|Count of Participants|36|36.0||||||
4195382|NCT00762788|4018004|B4||Between 18 and 65 years|Age|Data was collected on those subjects 18 years and older, there were no pediatric patients enrolled in the study.|Participants|Count of Participants|49|49.0||||||
4195383|NCT00762788|4018005|B3||Between 18 and 65 years|Age|Data was collected on those subjects 18 years and older, there were no pediatric patients enrolled in the study.|Participants|Count of Participants|31|31.0||||||
4195384|NCT00762788|4018006|B2||Between 18 and 65 years|Age|Data was collected on those subjects 18 years and older, there were no pediatric patients enrolled in the study.|Participants|Count of Participants|45|45.0||||||
4195385|NCT00762788|4018007|B1||Between 18 and 65 years|Age|Data was collected on those subjects 18 years and older, there were no pediatric patients enrolled in the study.|Participants|Count of Participants|44|44.0||||||
4195386|NCT00762788|4018001|B7||<=18 years|Age|Data was collected on those subjects 18 years and older, there were no pediatric patients enrolled in the study.|Participants|Count of Participants|69|69.0||||||
4195387|NCT00762788|4018002|B6||<=18 years|Age|Data was collected on those subjects 18 years and older, there were no pediatric patients enrolled in the study.|Participants|Count of Participants|12|12.0||||||
4195388|NCT00762788|4018003|B5||<=18 years|Age|Data was collected on those subjects 18 years and older, there were no pediatric patients enrolled in the study.|Participants|Count of Participants|7|7.0||||||
4195389|NCT00762788|4018004|B4||<=18 years|Age|Data was collected on those subjects 18 years and older, there were no pediatric patients enrolled in the study.|Participants|Count of Participants|15|15.0||||||
4195390|NCT00762788|4018005|B3||<=18 years|Age|Data was collected on those subjects 18 years and older, there were no pediatric patients enrolled in the study.|Participants|Count of Participants|11|11.0||||||
4195391|NCT00762788|4018006|B2||<=18 years|Age|Data was collected on those subjects 18 years and older, there were no pediatric patients enrolled in the study.|Participants|Count of Participants|13|13.0||||||
4195392|NCT00762788|4018007|B1||<=18 years|Age|Data was collected on those subjects 18 years and older, there were no pediatric patients enrolled in the study.|Participants|Count of Participants|11|11.0||||||
4195393|NCT00762762|4018032|B3|Australia||Region of Enrollment||participants|Number|60|60.0||||||
4195394|NCT00762762|4018033|B2|Australia||Region of Enrollment||participants|Number|30|30.0||||||
4195395|NCT00762762|4018034|B1|Australia||Region of Enrollment||participants|Number|30|30.0||||||
4195396|NCT00762762|4018032|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4195397|NCT00762762|4018033|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4195398|NCT00762762|4018034|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4195399|NCT00762762|4018032|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4195400|NCT00762762|4018033|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4195401|NCT00762762|4018034|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4195402|NCT00762762|4018032|B3|||Age||years|Mean|49.7|49.7|Standard Deviation|8.1|8.1|||
4195403|NCT00762762|4018033|B2|||Age||years|Mean|48.8|48.8|Standard Deviation|8.7|8.7|||
4195404|NCT00762762|4018034|B1|||Age||years|Mean|50.6|50.6|Standard Deviation|7.5|7.5|||
4195405|NCT00762762|4018032|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4195406|NCT00762762|4018033|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4195407|NCT00762762|4018034|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4195408|NCT00762762|4018032|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4195409|NCT00762762|4018033|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4195410|NCT00762762|4018034|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4195411|NCT00762762|4018032|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195412|NCT00762762|4018033|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195413|NCT00762762|4018034|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195414|NCT00762723|4018049|B4||Male|Sex: Female, Male|Number|Participants|Count of Participants|11|11.0||||||
4195415|NCT00762723|4018050|B3||Male|Sex: Female, Male|Number|Participants|Count of Participants|2|2.0||||||
4195416|NCT00762723|4018051|B2||Male|Sex: Female, Male|Number|Participants|Count of Participants|5|5.0||||||
4195417|NCT00762723|4018052|B1||Male|Sex: Female, Male|Number|Participants|Count of Participants|4|4.0||||||
4195418|NCT00762723|4018049|B4||Female|Sex: Female, Male|Number|Participants|Count of Participants|8|8.0||||||
4195419|NCT00762723|4018050|B3||Female|Sex: Female, Male|Number|Participants|Count of Participants|1|1.0||||||
4195420|NCT00762723|4018051|B2||Female|Sex: Female, Male|Number|Participants|Count of Participants|6|6.0||||||
4195421|NCT00762723|4018052|B1||Female|Sex: Female, Male|Number|Participants|Count of Participants|1|1.0||||||
4195422|NCT00762723|4018049|B4|||Age||Years|Mean|51|51.0|Full Range|||33.0|74.0|
4195423|NCT00762723|4018050|B3|||Age||Years|Mean|45|45.0|Full Range|||33.0|55.0|
4195424|NCT00762723|4018051|B2|||Age||Years|Mean|51|51.0|Full Range|||35.0|74.0|
4195425|NCT00762723|4018052|B1|||Age||Years|Mean|54|54.0|Full Range|||45.0|66.0|
4195426|NCT00762645|4018062|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4195427|NCT00762645|4018063|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4195428|NCT00762645|4018064|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4195429|NCT00762645|4018062|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4195430|NCT00762645|4018063|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4195431|NCT00762645|4018064|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4195432|NCT00762645|4018062|B3||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4195433|NCT00762645|4018063|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4195434|NCT00762645|4018064|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4195435|NCT00762645|4018062|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4195436|NCT00762645|4018063|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4195437|NCT00762645|4018064|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4195438|NCT00762645|4018062|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195439|NCT00762645|4018063|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195440|NCT00762645|4018064|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195441|NCT00762619|4018073|B3|Israel||Region of Enrollment||participants|Number|105|105.0||||||
4195442|NCT00762619|4018074|B2|Israel||Region of Enrollment||participants|Number|50|50.0||||||
4195443|NCT00762619|4018075|B1|Israel||Region of Enrollment||participants|Number|55|55.0||||||
4195444|NCT00762619|4018073|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4195445|NCT00762619|4018074|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4195446|NCT00762619|4018075|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4195447|NCT00762619|4018073|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4195448|NCT00762619|4018074|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4195449|NCT00762619|4018075|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4195450|NCT00762619|4018073|B3|||Age||years|Mean|54.95|54.95|Standard Deviation|10.56|10.56|||
4195451|NCT00762619|4018074|B2|||Age||years|Mean|55.22|55.22|Standard Deviation|11.6|11.6|||
4195452|NCT00762619|4018075|B1|||Age||years|Mean|54.71|54.71|Standard Deviation|9.6|9.6|||
4195453|NCT00762619|4018073|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4195454|NCT00762619|4018074|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4195455|NCT00762619|4018075|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4195456|NCT00762619|4018073|B3||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
4195457|NCT00762619|4018074|B2||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4195458|NCT00762619|4018075|B1||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4195459|NCT00762619|4018073|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195460|NCT00762619|4018074|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195461|NCT00762619|4018075|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195462|NCT00762606|4018216|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4195463|NCT00762606|4018217|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4195464|NCT00762606|4018218|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4195465|NCT00762606|4018216|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4195466|NCT00762606|4018217|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4195467|NCT00762606|4018218|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4195468|NCT00762606|4018216|B3||>=65 years|Age||Participants|Count of Participants|87|87.0||||||
4195469|NCT00762606|4018217|B2||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
4195470|NCT00762606|4018218|B1||>=65 years|Age||Participants|Count of Participants|47|47.0||||||
4195471|NCT00762606|4018216|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4195472|NCT00762606|4018217|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4195473|NCT00762606|4018218|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4195474|NCT00762606|4018216|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195475|NCT00762606|4018217|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195476|NCT00762606|4018218|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195477|NCT00762528|4018227|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
4195478|NCT00762528|4018228|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4195479|NCT00762528|4018229|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4195480|NCT00762528|4018227|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4195481|NCT00762528|4018228|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4195482|NCT00762528|4018229|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4195483|NCT00762528|4018227|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4195484|NCT00762528|4018228|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4195485|NCT00762528|4018229|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4195486|NCT00762528|4018227|B3|||Age||years|Mean|28.4|28.4|Standard Deviation|10.1|10.1|||
4195487|NCT00762528|4018228|B2|||Age||years|Mean|29.2|29.2|Standard Deviation|9.6|9.6|||
4195488|NCT00762528|4018229|B1|||Age||years|Mean|27.5|27.5|Standard Deviation|10.7|10.7|||
4195489|NCT00762528|4018227|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4195490|NCT00762528|4018228|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4195491|NCT00762528|4018229|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4195492|NCT00762528|4018227|B3||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4195493|NCT00762528|4018228|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4195494|NCT00762528|4018229|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4195495|NCT00762528|4018227|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195496|NCT00762528|4018228|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195497|NCT00762528|4018229|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195498|NCT00762515|4018250|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
4195499|NCT00762515|4018251|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4195500|NCT00762515|4018252|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4195501|NCT00762515|4018250|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4195502|NCT00762515|4018251|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4195503|NCT00762515|4018252|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4195504|NCT00762515|4018250|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4195505|NCT00762515|4018251|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4195506|NCT00762515|4018252|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4195507|NCT00762515|4018250|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4195508|NCT00762515|4018251|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4195509|NCT00762515|4018252|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4195510|NCT00762515|4018250|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4195511|NCT00762515|4018251|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4195512|NCT00762515|4018252|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4195513|NCT00762515|4018250|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195514|NCT00762515|4018251|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195515|NCT00762515|4018252|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195516|NCT00762502|4018261|B4|Australia||Region of Enrollment||participants|Number|65|65.0||||||
4195517|NCT00762502|4018262|B3|Australia||Region of Enrollment||participants|Number|31|31.0||||||
4195518|NCT00762502|4018263|B2|Australia||Region of Enrollment||participants|Number|14|14.0||||||
4195519|NCT00762502|4018264|B1|Australia||Region of Enrollment||participants|Number|20|20.0||||||
4195520|NCT00762502|4018261|B4|United States||Region of Enrollment||participants|Number|47|47.0||||||
4195521|NCT00762502|4018262|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4195522|NCT00762502|4018263|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4195523|NCT00762502|4018264|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4195524|NCT00762502|4018261|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4195525|NCT00762502|4018262|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4195526|NCT00762502|4018263|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4195527|NCT00762502|4018264|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4195528|NCT00762502|4018261|B4||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4195529|NCT00762502|4018262|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4195530|NCT00762502|4018263|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4195531|NCT00762502|4018264|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4195532|NCT00762502|4018261|B4|||Age||years|Mean|29.8|29.8|Standard Deviation|7.9|7.9|||
4195533|NCT00762502|4018262|B3|||Age||years|Mean|29.6|29.6|Standard Deviation|8.6|8.6|||
4195534|NCT00762502|4018263|B2|||Age||years|Mean|30.4|30.4|Standard Deviation|7.8|7.8|||
4195535|NCT00762502|4018264|B1|||Age||years|Mean|29.8|29.8|Standard Deviation|6.9|6.9|||
4195536|NCT00762476|4018278|B3|United States||Region of Enrollment||participants|Number|411|411.0||||||
4195537|NCT00762476|4018279|B2|United States||Region of Enrollment||participants|Number|205|205.0||||||
4195538|NCT00762476|4018280|B1|United States||Region of Enrollment||participants|Number|206|206.0||||||
4195539|NCT00762476|4018278|B3||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4195540|NCT00762476|4018279|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4195541|NCT00762476|4018280|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4195542|NCT00762476|4018278|B3||Female|Sex: Female, Male||Participants|Count of Participants|305|305.0||||||
4195543|NCT00762476|4018279|B2||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4195544|NCT00762476|4018280|B1||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4195545|NCT00762476|4018278|B3|||Age||years|Mean|36.7|36.7|Standard Deviation|14.39|14.39|||
4195546|NCT00762476|4018279|B2|||Age||years|Mean|36.2|36.2|Standard Deviation|14.23|14.23|||
4195547|NCT00762476|4018280|B1|||Age||years|Mean|37.3|37.3|Standard Deviation|14.56|14.56|||
4195548|NCT00762476|4018278|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4195549|NCT00762476|4018279|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4195550|NCT00762476|4018280|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4195551|NCT00762476|4018278|B3||Between 18 and 65 years|Age||Participants|Count of Participants|403|403.0||||||
4195552|NCT00762476|4018279|B2||Between 18 and 65 years|Age||Participants|Count of Participants|200|200.0||||||
4195553|NCT00762476|4018280|B1||Between 18 and 65 years|Age||Participants|Count of Participants|203|203.0||||||
4195554|NCT00762476|4018278|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195555|NCT00762476|4018279|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195556|NCT00762476|4018280|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195557|NCT00762463|4018291|B3||Male|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
4195558|NCT00762463|4018292|B2||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4195559|NCT00762463|4018293|B1||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4195560|NCT00762463|4018291|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4195561|NCT00762463|4018292|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4195562|NCT00762463|4018293|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4195563|NCT00762463|4018291|B3|45 - 64 years||Age, Customized||participants|Number|22|22.0||||||
4195564|NCT00762463|4018292|B2|45 - 64 years||Age, Customized||participants|Number|11|11.0||||||
4195565|NCT00762463|4018293|B1|45 - 64 years||Age, Customized||participants|Number|11|11.0||||||
4195566|NCT00762463|4018291|B3|18 - 44 years||Age, Customized||participants|Number|218|218.0||||||
4195567|NCT00762463|4018292|B2|18 - 44 years||Age, Customized||participants|Number|109|109.0||||||
4195568|NCT00762463|4018293|B1|18 - 44 years||Age, Customized||participants|Number|109|109.0||||||
4195569|NCT00762450|4018378|B4|Switzerland||Region of Enrollment||participants|Number|6|6.0||||||
4195570|NCT00762450|4018379|B3|Switzerland||Region of Enrollment||participants|Number|2|2.0||||||
4195571|NCT00762450|4018380|B2|Switzerland||Region of Enrollment||participants|Number|2|2.0||||||
4195572|NCT00762450|4018381|B1|Switzerland||Region of Enrollment||participants|Number|2|2.0||||||
4195573|NCT00762450|4018378|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4195574|NCT00762450|4018379|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4195575|NCT00762450|4018380|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4195576|NCT00762450|4018381|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4195577|NCT00762450|4018378|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4195578|NCT00762450|4018379|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4195579|NCT00762450|4018380|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4195580|NCT00762450|4018381|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4195581|NCT00762450|4018378|B4|||Age||years|Mean|75.8|75.8|Standard Deviation|2.6|2.6|||
4195582|NCT00762450|4018379|B3|||Age||years|Mean|73.5|73.5|Standard Deviation|2.1|2.1|||
4195583|NCT00762450|4018380|B2|||Age||years|Mean|77.5|77.5|Standard Deviation|0.7|0.7|||
4195584|NCT00762450|4018381|B1|||Age||years|Mean|76.5|76.5|Standard Deviation|3.5|3.5|||
4195585|NCT00762450|4018378|B4||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4195586|NCT00762450|4018379|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4195587|NCT00762450|4018380|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4195588|NCT00762450|4018381|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4195589|NCT00762450|4018378|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4195590|NCT00762450|4018379|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4195591|NCT00762450|4018380|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4195592|NCT00762450|4018381|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4195593|NCT00762450|4018378|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195594|NCT00762450|4018379|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195595|NCT00762450|4018380|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195596|NCT00762450|4018381|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195597|NCT00762424|4018391|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4195598|NCT00762424|4018392|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4195599|NCT00762424|4018393|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4195600|NCT00762424|4018391|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4195601|NCT00762424|4018392|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4195602|NCT00762424|4018393|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4195603|NCT00762424|4018391|B3|>=18 years||Age, Customized||participants|Number|53|53.0||||||
4195604|NCT00762424|4018392|B2|>=18 years||Age, Customized||participants|Number|25|25.0||||||
4195605|NCT00762424|4018393|B1|>=18 years||Age, Customized||participants|Number|28|28.0||||||
4195606|NCT00762411|4018400|B3|||Alzheimer's Disease Cooperative Study Activities of Daily Living Inventory Score (n=505, 529)|The Alzheimer's Disease Cooperative Study Activities of Daily Living (ADCS-ADL) Inventory Score is a 23-item inventory developed as a rater-administered questionnaire that should be answered by the participant’s caregiver. The ADCS-ADL measures both basic and instrumental activities of daily living by participants. The total ADCS-ADL score ranges from 0 to 78, with lower scores indicating greater disease severity.|units on a scale|Mean|58.9|58.9|Standard Deviation|13.5|13.5|||
4195607|NCT00762411|4018401|B2|||Alzheimer's Disease Cooperative Study Activities of Daily Living Inventory Score (n=505, 529)|The Alzheimer's Disease Cooperative Study Activities of Daily Living (ADCS-ADL) Inventory Score is a 23-item inventory developed as a rater-administered questionnaire that should be answered by the participant’s caregiver. The ADCS-ADL measures both basic and instrumental activities of daily living by participants. The total ADCS-ADL score ranges from 0 to 78, with lower scores indicating greater disease severity.|units on a scale|Mean|59.1|59.1|Standard Deviation|13.8|13.8|||
4195608|NCT00762411|4018402|B1|||Alzheimer's Disease Cooperative Study Activities of Daily Living Inventory Score (n=505, 529)|The Alzheimer's Disease Cooperative Study Activities of Daily Living (ADCS-ADL) Inventory Score is a 23-item inventory developed as a rater-administered questionnaire that should be answered by the participant’s caregiver. The ADCS-ADL measures both basic and instrumental activities of daily living by participants. The total ADCS-ADL score ranges from 0 to 78, with lower scores indicating greater disease severity.|units on a scale|Mean|58.8|58.8|Standard Deviation|13.3|13.3|||
4195609|NCT00762411|4018400|B3|||Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog11) Score (n=507, 533)|The cognitive subscale of the ADAS (ADAS‑Cog11) consists of 11 items assessing areas of function most typically impaired in AD: orientation, verbal memory, language, and praxis. The scale ranges from 0 to 70, with higher scores indicating greater disease severity.|units on a scale|Mean|24.3|24.3|Standard Deviation|9.1|9.1|||
4195610|NCT00762411|4018401|B2|||Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog11) Score (n=507, 533)|The cognitive subscale of the ADAS (ADAS‑Cog11) consists of 11 items assessing areas of function most typically impaired in AD: orientation, verbal memory, language, and praxis. The scale ranges from 0 to 70, with higher scores indicating greater disease severity.|units on a scale|Mean|24.2|24.2|Standard Deviation|9.1|9.1|||
4195611|NCT00762411|4018402|B1|||Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog11) Score (n=507, 533)|The cognitive subscale of the ADAS (ADAS‑Cog11) consists of 11 items assessing areas of function most typically impaired in AD: orientation, verbal memory, language, and praxis. The scale ranges from 0 to 70, with higher scores indicating greater disease severity.|units on a scale|Mean|24.5|24.5|Standard Deviation|9.1|9.1|||
4195612|NCT00762411|4018400|B3|United States||Region of Enrollment||participants|Number|243|243.0||||||
4195613|NCT00762411|4018401|B2|United States||Region of Enrollment||participants|Number|120|120.0||||||
4195614|NCT00762411|4018402|B1|United States||Region of Enrollment||participants|Number|123|123.0||||||
4195615|NCT00762411|4018400|B3|Ukraine||Region of Enrollment||participants|Number|39|39.0||||||
4195616|NCT00762411|4018401|B2|Ukraine||Region of Enrollment||participants|Number|20|20.0||||||
4195617|NCT00762411|4018402|B1|Ukraine||Region of Enrollment||participants|Number|19|19.0||||||
4195618|NCT00762411|4018400|B3|Turkey||Region of Enrollment||participants|Number|48|48.0||||||
4195619|NCT00762411|4018401|B2|Turkey||Region of Enrollment||participants|Number|23|23.0||||||
4195620|NCT00762411|4018402|B1|Turkey||Region of Enrollment||participants|Number|25|25.0||||||
4195621|NCT00762411|4018400|B3|Taiwan||Region of Enrollment||participants|Number|49|49.0||||||
4195622|NCT00762411|4018401|B2|Taiwan||Region of Enrollment||participants|Number|24|24.0||||||
4195623|NCT00762411|4018402|B1|Taiwan||Region of Enrollment||participants|Number|25|25.0||||||
4195624|NCT00762411|4018400|B3|Serbia||Region of Enrollment||participants|Number|13|13.0||||||
4195625|NCT00762411|4018401|B2|Serbia||Region of Enrollment||participants|Number|8|8.0||||||
4195626|NCT00762411|4018402|B1|Serbia||Region of Enrollment||participants|Number|5|5.0||||||
4195627|NCT00762411|4018400|B3|Russian Federation||Region of Enrollment||participants|Number|34|34.0||||||
4195628|NCT00762411|4018401|B2|Russian Federation||Region of Enrollment||participants|Number|19|19.0||||||
4195629|NCT00762411|4018402|B1|Russian Federation||Region of Enrollment||participants|Number|15|15.0||||||
4195630|NCT00762411|4018400|B3|Romania||Region of Enrollment||participants|Number|37|37.0||||||
4195631|NCT00762411|4018401|B2|Romania||Region of Enrollment||participants|Number|17|17.0||||||
4195632|NCT00762411|4018402|B1|Romania||Region of Enrollment||participants|Number|20|20.0||||||
4195633|NCT00762411|4018400|B3|Mexico||Region of Enrollment||participants|Number|50|50.0||||||
4195634|NCT00762411|4018401|B2|Mexico||Region of Enrollment||participants|Number|24|24.0||||||
4195635|NCT00762411|4018402|B1|Mexico||Region of Enrollment||participants|Number|26|26.0||||||
4195636|NCT00762411|4018400|B3|Korea, Republic of||Region of Enrollment||participants|Number|81|81.0||||||
4195637|NCT00762411|4018401|B2|Korea, Republic of||Region of Enrollment||participants|Number|43|43.0||||||
4195638|NCT00762411|4018402|B1|Korea, Republic of||Region of Enrollment||participants|Number|38|38.0||||||
4195639|NCT00762411|4018400|B3|Japan||Region of Enrollment||participants|Number|133|133.0||||||
4195640|NCT00762411|4018401|B2|Japan||Region of Enrollment||participants|Number|69|69.0||||||
4195641|NCT00762411|4018402|B1|Japan||Region of Enrollment||participants|Number|64|64.0||||||
4195642|NCT00762411|4018400|B3|Italy||Region of Enrollment||participants|Number|25|25.0||||||
4195643|NCT00762411|4018401|B2|Italy||Region of Enrollment||participants|Number|11|11.0||||||
4195644|NCT00762411|4018402|B1|Italy||Region of Enrollment||participants|Number|14|14.0||||||
4195645|NCT00762411|4018400|B3|Hungary||Region of Enrollment||participants|Number|35|35.0||||||
4195646|NCT00762411|4018401|B2|Hungary||Region of Enrollment||participants|Number|16|16.0||||||
4195647|NCT00762411|4018402|B1|Hungary||Region of Enrollment||participants|Number|19|19.0||||||
4195648|NCT00762411|4018400|B3|Germany||Region of Enrollment||participants|Number|44|44.0||||||
4195649|NCT00762411|4018401|B2|Germany||Region of Enrollment||participants|Number|20|20.0||||||
4195650|NCT00762411|4018402|B1|Germany||Region of Enrollment||participants|Number|24|24.0||||||
4195651|NCT00762411|4018400|B3|France||Region of Enrollment||participants|Number|57|57.0||||||
4195652|NCT00762411|4018401|B2|France||Region of Enrollment||participants|Number|29|29.0||||||
4195653|NCT00762411|4018402|B1|France||Region of Enrollment||participants|Number|28|28.0||||||
4195654|NCT00762411|4018400|B3|China||Region of Enrollment||participants|Number|44|44.0||||||
4195655|NCT00762411|4018401|B2|China||Region of Enrollment||participants|Number|22|22.0||||||
4195656|NCT00762411|4018402|B1|China||Region of Enrollment||participants|Number|22|22.0||||||
4195657|NCT00762411|4018400|B3|Canada||Region of Enrollment||participants|Number|99|99.0||||||
4195658|NCT00762411|4018401|B2|Canada||Region of Enrollment||participants|Number|49|49.0||||||
4195659|NCT00762411|4018402|B1|Canada||Region of Enrollment||participants|Number|50|50.0||||||
4195660|NCT00762411|4018400|B3|Bulgaria||Region of Enrollment||participants|Number|38|38.0||||||
4195661|NCT00762411|4018401|B2|Bulgaria||Region of Enrollment||participants|Number|18|18.0||||||
4195662|NCT00762411|4018402|B1|Bulgaria||Region of Enrollment||participants|Number|20|20.0||||||
4195663|NCT00762411|4018400|B3|Brazil||Region of Enrollment||participants|Number|39|39.0||||||
4195664|NCT00762411|4018401|B2|Brazil||Region of Enrollment||participants|Number|21|21.0||||||
4195665|NCT00762411|4018402|B1|Brazil||Region of Enrollment||participants|Number|18|18.0||||||
4195666|NCT00762411|4018400|B3|West Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4195667|NCT00762411|4018401|B2|West Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4195668|NCT00762411|4018402|B1|West Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4195669|NCT00762411|4018400|B3|East Asian||Race/Ethnicity, Customized||participants|Number|310|310.0||||||
4195670|NCT00762411|4018401|B2|East Asian||Race/Ethnicity, Customized||participants|Number|160|160.0||||||
4195671|NCT00762411|4018402|B1|East Asian||Race/Ethnicity, Customized||participants|Number|150|150.0||||||
4195672|NCT00762411|4018400|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
4195673|NCT00762411|4018401|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4195674|NCT00762411|4018402|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4195675|NCT00762411|4018400|B3|African||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4195676|NCT00762411|4018401|B2|African||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4195677|NCT00762411|4018402|B1|African||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4195678|NCT00762411|4018400|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|712|712.0||||||
4195679|NCT00762411|4018401|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|354|354.0||||||
4195680|NCT00762411|4018402|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|358|358.0||||||
4195681|NCT00762411|4018400|B3||Male|Sex: Female, Male||Participants|Count of Participants|465|465.0||||||
4195682|NCT00762411|4018401|B2||Male|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
4195683|NCT00762411|4018402|B1||Male|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
4195684|NCT00762411|4018400|B3||Female|Sex: Female, Male||Participants|Count of Participants|643|643.0||||||
4195685|NCT00762411|4018401|B2||Female|Sex: Female, Male||Participants|Count of Participants|327|327.0||||||
4195686|NCT00762411|4018402|B1||Female|Sex: Female, Male||Participants|Count of Participants|316|316.0||||||
4195687|NCT00762411|4018400|B3|||Age||years|Mean|73.2|73.2|Standard Deviation|8.0|8.0|||
4195688|NCT00762411|4018401|B2|||Age||years|Mean|73.0|73.0|Standard Deviation|8.0|8.0|||
4195689|NCT00762411|4018402|B1|||Age||years|Mean|73.4|73.4|Standard Deviation|8.0|8.0|||
4195690|NCT00762385|4018467|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4195691|NCT00762385|4018467|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4195692|NCT00762385|4018467|B1|||Age||years|Mean|28.2|28.2|Standard Deviation|6.7|6.7|||
4195693|NCT00762359|4018478|B3|Japan||Region of Enrollment||participants|Number|461|461.0||||||
4195694|NCT00762359|4018479|B2|Japan||Region of Enrollment||participants|Number|235|235.0||||||
4195695|NCT00762359|4018480|B1|Japan||Region of Enrollment||participants|Number|226|226.0||||||
4195696|NCT00762359|4018478|B3||Male|Sex: Female, Male||Participants|Count of Participants|367|367.0||||||
4195697|NCT00762359|4018479|B2||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4195698|NCT00762359|4018480|B1||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4195699|NCT00762359|4018478|B3||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4195700|NCT00762359|4018479|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4195701|NCT00762359|4018480|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4195702|NCT00762359|4018478|B3|<=80 years||Age, Customized||participants|Number|51|51.0||||||
4195703|NCT00762359|4018479|B2|<=80 years||Age, Customized||participants|Number|29|29.0||||||
4195704|NCT00762359|4018480|B1|<=80 years||Age, Customized||participants|Number|22|22.0||||||
4195705|NCT00762359|4018478|B3|Between 70 and 79 years||Age, Customized||participants|Number|186|186.0||||||
4195706|NCT00762359|4018479|B2|Between 70 and 79 years||Age, Customized||participants|Number|81|81.0||||||
4195707|NCT00762359|4018480|B1|Between 70 and 79 years||Age, Customized||participants|Number|105|105.0||||||
4195708|NCT00762359|4018478|B3|Between 65 and 69 years||Age, Customized||participants|Number|91|91.0||||||
4195709|NCT00762359|4018479|B2|Between 65 and 69 years||Age, Customized||participants|Number|53|53.0||||||
4195710|NCT00762359|4018480|B1|Between 65 and 69 years||Age, Customized||participants|Number|38|38.0||||||
4195711|NCT00762359|4018478|B3|Between 60 and 64 years||Age, Customized||participants|Number|60|60.0||||||
4195712|NCT00762359|4018479|B2|Between 60 and 64 years||Age, Customized||participants|Number|32|32.0||||||
4195713|NCT00762359|4018480|B1|Between 60 and 64 years||Age, Customized||participants|Number|28|28.0||||||
4195714|NCT00762359|4018478|B3|Between 50 and 59 years||Age, Customized||participants|Number|67|67.0||||||
4195715|NCT00762359|4018479|B2|Between 50 and 59 years||Age, Customized||participants|Number|36|36.0||||||
4195716|NCT00762359|4018480|B1|Between 50 and 59 years||Age, Customized||participants|Number|31|31.0||||||
4195717|NCT00762359|4018478|B3|Between 40 and 49 years||Age, Customized||participants|Number|5|5.0||||||
4195718|NCT00762359|4018479|B2|Between 40 and 49 years||Age, Customized||participants|Number|4|4.0||||||
4195719|NCT00762359|4018480|B1|Between 40 and 49 years||Age, Customized||participants|Number|1|1.0||||||
4195720|NCT00762359|4018478|B3|<=39 years||Age, Customized||participants|Number|1|1.0||||||
4195721|NCT00762359|4018479|B2|<=39 years||Age, Customized||participants|Number|0|0.0||||||
4195722|NCT00762359|4018480|B1|<=39 years||Age, Customized||participants|Number|1|1.0||||||
4195723|NCT00762320|4018581|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4195724|NCT00762320|4018581|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4195725|NCT00762320|4018581|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4195726|NCT00762320|4018581|B1|||Age||years|Mean|7.18|7.18|Standard Deviation|1.79|1.79|||
4195727|NCT00762320|4018581|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4195728|NCT00762320|4018581|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4195729|NCT00762320|4018581|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4195730|NCT00762268|4018596|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4195731|NCT00762268|4018597|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4195732|NCT00762268|4018598|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4195733|NCT00762268|4018596|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4195734|NCT00762268|4018597|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4195735|NCT00762268|4018598|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4195736|NCT00762268|4018596|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4195737|NCT00762268|4018597|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4195738|NCT00762268|4018598|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4195739|NCT00762268|4018596|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4195740|NCT00762268|4018597|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4195741|NCT00762268|4018598|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4195742|NCT00762268|4018596|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4195743|NCT00762268|4018597|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4195744|NCT00762268|4018598|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4195745|NCT00762268|4018596|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195746|NCT00762268|4018597|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195747|NCT00762268|4018598|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195748|NCT00762229|4018605|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
4195749|NCT00762229|4018606|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4195750|NCT00762229|4018607|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4195751|NCT00762229|4018605|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4195752|NCT00762229|4018606|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4195753|NCT00762229|4018607|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4195754|NCT00762229|4018605|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4195755|NCT00762229|4018606|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4195756|NCT00762229|4018607|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4195757|NCT00762229|4018605|B3|||Age||years|Mean|70.5|70.5|Standard Deviation|9.7|9.7|||
4195758|NCT00762229|4018606|B2|||Age||years|Mean|72|72.0|Standard Deviation|10.1|10.1|||
4195759|NCT00762229|4018607|B1|||Age||years|Mean|69|69.0|Standard Deviation|9.2|9.2|||
4195760|NCT00762229|4018605|B3||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4195761|NCT00762229|4018606|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4195762|NCT00762229|4018607|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4195763|NCT00762229|4018605|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4195764|NCT00762229|4018606|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4195765|NCT00762229|4018607|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4195766|NCT00762229|4018605|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195767|NCT00762229|4018606|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195768|NCT00762229|4018607|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195769|NCT00762216|4018616|B1||Male|Sex: Female, Male|Gender data collected for 69 participants; not provided for 2 participants.|Participants|Count of Participants|38|38.0||||||
4195770|NCT00762216|4018616|B1||Female|Sex: Female, Male|Gender data collected for 69 participants; not provided for 2 participants.|Participants|Count of Participants|33|33.0||||||
4195771|NCT00762216|4018616|B1||>=65 years|Age|Age data collected for 69 participants; not provided for 2 participants.|Participants|Count of Participants|33|33.0||||||
4195772|NCT00762216|4018616|B1||Between 18 and 65 years|Age|Age data collected for 69 participants; not provided for 2 participants.|Participants|Count of Participants|38|38.0||||||
4195773|NCT00762216|4018616|B1||<=18 years|Age|Age data collected for 69 participants; not provided for 2 participants.|Participants|Count of Participants|0|0.0||||||
4195774|NCT00762177|4018621|B4|United States||Region of Enrollment||participants|Number|24|24.0||||||
4195775|NCT00762177|4018622|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4195776|NCT00762177|4018623|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4195777|NCT00762177|4018624|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4195778|NCT00762177|4018621|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4195779|NCT00762177|4018622|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4195780|NCT00762177|4018623|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4195781|NCT00762177|4018624|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4195782|NCT00762177|4018621|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4195783|NCT00762177|4018622|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4195784|NCT00762177|4018623|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4195785|NCT00762177|4018624|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4195786|NCT00762177|4018621|B4|||Age||years|Mean|38.83|38.83|Standard Deviation|9.03|9.03|||
4195787|NCT00762177|4018622|B3|||Age||years|Mean|36.5|36.5|Standard Deviation|7.46|7.46|||
4195788|NCT00762177|4018623|B2|||Age||years|Mean|40.12|40.12|Standard Deviation|9.38|9.38|||
4195789|NCT00762177|4018624|B1|||Age||years|Mean|39.87|39.87|Standard Deviation|10.72|10.72|||
4195790|NCT00762177|4018621|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4195791|NCT00762177|4018622|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4195792|NCT00762177|4018623|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4195793|NCT00762177|4018624|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4195794|NCT00762177|4018621|B4||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4195795|NCT00762177|4018622|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4195796|NCT00762177|4018623|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4195797|NCT00762177|4018624|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4195798|NCT00762177|4018621|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195799|NCT00762177|4018622|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195800|NCT00762177|4018623|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195801|NCT00762177|4018624|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195802|NCT00762164|4018703|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
4195803|NCT00762164|4018704|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4195804|NCT00762164|4018705|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4195805|NCT00762164|4018703|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4195806|NCT00762164|4018704|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4195807|NCT00762164|4018705|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4195808|NCT00762164|4018703|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4195809|NCT00762164|4018704|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4195810|NCT00762164|4018705|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4195811|NCT00762164|4018703|B3|||Age||years|Mean|59.1|59.1|Standard Deviation|10.8|10.8|||
4195812|NCT00762164|4018704|B2|||Age||years|Mean|62.7|62.7|Standard Deviation|7.8|7.8|||
4195813|NCT00762164|4018705|B1|||Age||years|Mean|55.3|55.3|Standard Deviation|12.6|12.6|||
4195814|NCT00762164|4018703|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4195815|NCT00762164|4018704|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4195816|NCT00762164|4018705|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4195817|NCT00762164|4018703|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4195818|NCT00762164|4018704|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4195819|NCT00762164|4018705|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4195820|NCT00762164|4018703|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195821|NCT00762164|4018704|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195822|NCT00762164|4018705|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195823|NCT00762086|4018714|B3|Germany||Region of Enrollment||participants|Number|19|19.0||||||
4195824|NCT00762086|4018715|B2|Germany||Region of Enrollment||participants|Number|5|5.0||||||
4195825|NCT00762086|4018716|B1|Germany||Region of Enrollment||participants|Number|14|14.0||||||
4195826|NCT00762086|4018714|B3|Israel||Region of Enrollment||participants|Number|48|48.0||||||
4195827|NCT00762086|4018715|B2|Israel||Region of Enrollment||participants|Number|23|23.0||||||
4195828|NCT00762086|4018716|B1|Israel||Region of Enrollment||participants|Number|25|25.0||||||
4195829|NCT00762086|4018714|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4195830|NCT00762086|4018715|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4195831|NCT00762086|4018716|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4195832|NCT00762086|4018714|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4195833|NCT00762086|4018715|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4195834|NCT00762086|4018716|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4195835|NCT00762086|4018714|B3|||Age||years|Mean|69.5|69.5|Standard Deviation|9.31|9.31|||
4195836|NCT00762086|4018715|B2|||Age||years|Mean|67.8|67.8|Standard Deviation|11.76|11.76|||
4195837|NCT00762086|4018716|B1|||Age||years|Mean|70.8|70.8|Standard Deviation|6.96|6.96|||
4195838|NCT00762086|4018714|B3||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
4195839|NCT00762086|4018715|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4195840|NCT00762086|4018716|B1||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4195841|NCT00762086|4018714|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4195842|NCT00762086|4018715|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4195843|NCT00762086|4018716|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4195844|NCT00762086|4018714|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195845|NCT00762086|4018715|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195846|NCT00762086|4018716|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195847|NCT00762073|4018723|B5||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4195848|NCT00762073|4018724|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4195849|NCT00762073|4018725|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4195850|NCT00762073|4018726|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4195851|NCT00762073|4018727|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4195852|NCT00762073|4018723|B5||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4195853|NCT00762073|4018724|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4195854|NCT00762073|4018725|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4195855|NCT00762073|4018726|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4195856|NCT00762073|4018727|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4195857|NCT00762073|4018723|B5|10 to 18 years||Age, Customized||participants|Number|35|35.0||||||
4195858|NCT00762073|4018724|B4|10 to 18 years||Age, Customized||participants|Number|8|8.0||||||
4195859|NCT00762073|4018725|B3|10 to 18 years||Age, Customized||participants|Number|9|9.0||||||
4195860|NCT00762073|4018726|B2|10 to 18 years||Age, Customized||participants|Number|9|9.0||||||
4195861|NCT00762073|4018727|B1|10 to 18 years||Age, Customized||participants|Number|9|9.0||||||
4195862|NCT00762073|4018723|B5|2 to 9 years||Age, Customized||participants|Number|46|46.0||||||
4195863|NCT00762073|4018724|B4|2 to 9 years||Age, Customized||participants|Number|12|12.0||||||
4195864|NCT00762073|4018725|B3|2 to 9 years||Age, Customized||participants|Number|10|10.0||||||
4195865|NCT00762073|4018726|B2|2 to 9 years||Age, Customized||participants|Number|12|12.0||||||
4195866|NCT00762073|4018727|B1|2 to 9 years||Age, Customized||participants|Number|12|12.0||||||
4195867|NCT00762073|4018723|B5|||Age||years|Mean|9.1|9.1|Standard Deviation|4.93|4.93|||
4195868|NCT00762073|4018724|B4|||Age||years|Mean|8.1|8.1|Standard Deviation|4.58|4.58|||
4195869|NCT00762073|4018725|B3|||Age||years|Mean|10.2|10.2|Standard Deviation|4.89|4.89|||
4195870|NCT00762073|4018726|B2|||Age||years|Mean|9.0|9.0|Standard Deviation|5.88|5.88|||
4195871|NCT00762073|4018727|B1|||Age||years|Mean|9.2|9.2|Standard Deviation|4.36|4.36|||
4195872|NCT00762034|4018792|B3|Unknown||Histological Category for Subgroup Analyses||participants|Number|1|1.0||||||
4195873|NCT00762034|4018793|B2|Unknown||Histological Category for Subgroup Analyses||participants|Number|1|1.0||||||
4195874|NCT00762034|4018794|B1|Unknown||Histological Category for Subgroup Analyses||participants|Number|0|0.0||||||
4195875|NCT00762034|4018792|B3|Other or Indeterminant||Histological Category for Subgroup Analyses||participants|Number|172|172.0||||||
4195876|NCT00762034|4018793|B2|Other or Indeterminant||Histological Category for Subgroup Analyses||participants|Number|86|86.0||||||
4195877|NCT00762034|4018794|B1|Other or Indeterminant||Histological Category for Subgroup Analyses||participants|Number|86|86.0||||||
4195878|NCT00762034|4018792|B3|Large Cell Carcinoma||Histological Category for Subgroup Analyses||participants|Number|23|23.0||||||
4195879|NCT00762034|4018793|B2|Large Cell Carcinoma||Histological Category for Subgroup Analyses||participants|Number|15|15.0||||||
4195880|NCT00762034|4018794|B1|Large Cell Carcinoma||Histological Category for Subgroup Analyses||participants|Number|8|8.0||||||
4195881|NCT00762034|4018792|B3|Adenocarcinoma||Histological Category for Subgroup Analyses||participants|Number|743|743.0||||||
4195882|NCT00762034|4018793|B2|Adenocarcinoma||Histological Category for Subgroup Analyses||participants|Number|365|365.0||||||
4195883|NCT00762034|4018794|B1|Adenocarcinoma||Histological Category for Subgroup Analyses||participants|Number|378|378.0||||||
4195884|NCT00762034|4018792|B3|Unknown||Histological Subtype|Non-small Cell Lung Carcinoma (NSCLC)|participants|Number|1|1.0||||||
4195885|NCT00762034|4018793|B2|Unknown||Histological Subtype|Non-small Cell Lung Carcinoma (NSCLC)|participants|Number|1|1.0||||||
4195886|NCT00762034|4018794|B1|Unknown||Histological Subtype|Non-small Cell Lung Carcinoma (NSCLC)|participants|Number|0|0.0||||||
4195887|NCT00762034|4018792|B3|Predominantly Adenocarcinoma||Histological Subtype|Non-small Cell Lung Carcinoma (NSCLC)|participants|Number|9|9.0||||||
4195888|NCT00762034|4018793|B2|Predominantly Adenocarcinoma||Histological Subtype|Non-small Cell Lung Carcinoma (NSCLC)|participants|Number|2|2.0||||||
4195889|NCT00762034|4018794|B1|Predominantly Adenocarcinoma||Histological Subtype|Non-small Cell Lung Carcinoma (NSCLC)|participants|Number|7|7.0||||||
4195890|NCT00762034|4018792|B3|NSCLC Poorly Differentiated||Histological Subtype|Non-small Cell Lung Carcinoma (NSCLC)|participants|Number|86|86.0||||||
4195891|NCT00762034|4018793|B2|NSCLC Poorly Differentiated||Histological Subtype|Non-small Cell Lung Carcinoma (NSCLC)|participants|Number|47|47.0||||||
4195892|NCT00762034|4018794|B1|NSCLC Poorly Differentiated||Histological Subtype|Non-small Cell Lung Carcinoma (NSCLC)|participants|Number|39|39.0||||||
4195893|NCT00762034|4018792|B3|NSCLC Not Otherwise Specified||Histological Subtype|Non-small Cell Lung Carcinoma (NSCLC)|participants|Number|86|86.0||||||
4195894|NCT00762034|4018793|B2|NSCLC Not Otherwise Specified||Histological Subtype|Non-small Cell Lung Carcinoma (NSCLC)|participants|Number|39|39.0||||||
4195895|NCT00762034|4018794|B1|NSCLC Not Otherwise Specified||Histological Subtype|Non-small Cell Lung Carcinoma (NSCLC)|participants|Number|47|47.0||||||
4195896|NCT00762034|4018792|B3|Large Cell Lung Carcinoma||Histological Subtype|Non-small Cell Lung Carcinoma (NSCLC)|participants|Number|23|23.0||||||
4195897|NCT00762034|4018793|B2|Large Cell Lung Carcinoma||Histological Subtype|Non-small Cell Lung Carcinoma (NSCLC)|participants|Number|15|15.0||||||
4195898|NCT00762034|4018794|B1|Large Cell Lung Carcinoma||Histological Subtype|Non-small Cell Lung Carcinoma (NSCLC)|participants|Number|8|8.0||||||
4195899|NCT00762034|4018792|B3|Bronchioalveolar Carcinoma||Histological Subtype|Non-small Cell Lung Carcinoma (NSCLC)|participants|Number|7|7.0||||||
4195900|NCT00762034|4018793|B2|Bronchioalveolar Carcinoma||Histological Subtype|Non-small Cell Lung Carcinoma (NSCLC)|participants|Number|3|3.0||||||
4195901|NCT00762034|4018794|B1|Bronchioalveolar Carcinoma||Histological Subtype|Non-small Cell Lung Carcinoma (NSCLC)|participants|Number|4|4.0||||||
4195902|NCT00762034|4018792|B3|Adenocarcinoma, Lung||Histological Subtype|Non-small Cell Lung Carcinoma (NSCLC)|participants|Number|727|727.0||||||
4195903|NCT00762034|4018793|B2|Adenocarcinoma, Lung||Histological Subtype|Non-small Cell Lung Carcinoma (NSCLC)|participants|Number|360|360.0||||||
4195904|NCT00762034|4018794|B1|Adenocarcinoma, Lung||Histological Subtype|Non-small Cell Lung Carcinoma (NSCLC)|participants|Number|367|367.0||||||
4195905|NCT00762034|4018792|B3|No||Previously Treated Brain Metastasis||participants|Number|835|835.0||||||
4195906|NCT00762034|4018793|B2|No||Previously Treated Brain Metastasis||participants|Number|415|415.0||||||
4195907|NCT00762034|4018794|B1|No||Previously Treated Brain Metastasis||participants|Number|420|420.0||||||
4195908|NCT00762034|4018792|B3|Yes||Previously Treated Brain Metastasis||participants|Number|104|104.0||||||
4195909|NCT00762034|4018793|B2|Yes||Previously Treated Brain Metastasis||participants|Number|52|52.0||||||
4195910|NCT00762034|4018794|B1|Yes||Previously Treated Brain Metastasis||participants|Number|52|52.0||||||
4195911|NCT00762034|4018792|B3|United States||Region of Enrollment||participants|Number|939|939.0||||||
4195912|NCT00762034|4018793|B2|United States||Region of Enrollment||participants|Number|467|467.0||||||
4195913|NCT00762034|4018794|B1|United States||Region of Enrollment||participants|Number|472|472.0||||||
4195914|NCT00762034|4018792|B3|Information not provided||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4195915|NCT00762034|4018793|B2|Information not provided||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4195916|NCT00762034|4018794|B1|Information not provided||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4195917|NCT00762034|4018792|B3|Multiple race/ethnicities||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4195918|NCT00762034|4018793|B2|Multiple race/ethnicities||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4195919|NCT00762034|4018794|B1|Multiple race/ethnicities||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4195920|NCT00762034|4018792|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4195921|NCT00762034|4018793|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4195922|NCT00762034|4018794|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4195923|NCT00762034|4018792|B3|Asian||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4195924|NCT00762034|4018793|B2|Asian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4195925|NCT00762034|4018794|B1|Asian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4196110|NCT00761631|4018974|B4||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4195926|NCT00762034|4018792|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|94|94.0||||||
4195927|NCT00762034|4018793|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
4195928|NCT00762034|4018794|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4195929|NCT00762034|4018792|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|805|805.0||||||
4195930|NCT00762034|4018793|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|396|396.0||||||
4195931|NCT00762034|4018794|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|409|409.0||||||
4195932|NCT00762034|4018792|B3||Male|Sex: Female, Male||Participants|Count of Participants|500|500.0||||||
4195933|NCT00762034|4018793|B2||Male|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
4195934|NCT00762034|4018794|B1||Male|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4195935|NCT00762034|4018792|B3||Female|Sex: Female, Male||Participants|Count of Participants|439|439.0||||||
4195936|NCT00762034|4018793|B2||Female|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4195937|NCT00762034|4018794|B1||Female|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
4195938|NCT00762034|4018792|B3|>65 years||Age, Customized||participants|Number|454|454.0||||||
4195939|NCT00762034|4018793|B2|>65 years||Age, Customized||participants|Number|231|231.0||||||
4195940|NCT00762034|4018794|B1|>65 years||Age, Customized||participants|Number|223|223.0||||||
4195941|NCT00762034|4018792|B3|<=65 years||Age, Customized||participants|Number|485|485.0||||||
4195942|NCT00762034|4018793|B2|<=65 years||Age, Customized||participants|Number|236|236.0||||||
4195943|NCT00762034|4018794|B1|<=65 years||Age, Customized||participants|Number|249|249.0||||||
4195944|NCT00762021|4018852|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4195945|NCT00762021|4018853|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4195946|NCT00762021|4018854|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4195947|NCT00762021|4018852|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4195948|NCT00762021|4018853|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4195949|NCT00762021|4018854|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4195950|NCT00762021|4018852|B3||>=65 years|Age||Participants|Count of Participants|80|80.0||||||
4195951|NCT00762021|4018853|B2||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
4195952|NCT00762021|4018854|B1||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
4195953|NCT00762021|4018852|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4195954|NCT00762021|4018853|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4195955|NCT00762021|4018854|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4195956|NCT00762021|4018852|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195957|NCT00762021|4018853|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195958|NCT00762021|4018854|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195959|NCT00761969|4018865|B3|Slovenia||Region of Enrollment||participants|Number|1455|1455.0||||||
4195960|NCT00761969|4018866|B2|Slovenia||Region of Enrollment||participants|Number|713|713.0||||||
4195961|NCT00761969|4018867|B1|Slovenia||Region of Enrollment||participants|Number|742|742.0||||||
4195962|NCT00761969|4018865|B3||Male|Sex: Female, Male||Participants|Count of Participants|903|903.0||||||
4195963|NCT00761969|4018866|B2||Male|Sex: Female, Male||Participants|Count of Participants|438|438.0||||||
4195964|NCT00761969|4018867|B1||Male|Sex: Female, Male||Participants|Count of Participants|465|465.0||||||
4195965|NCT00761969|4018865|B3||Female|Sex: Female, Male||Participants|Count of Participants|552|552.0||||||
4195966|NCT00761969|4018866|B2||Female|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4195967|NCT00761969|4018867|B1||Female|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
4195968|NCT00761969|4018865|B3|||Age||years|Mean|64.9|64.9|Standard Deviation|9.0|9.0|||
4195969|NCT00761969|4018866|B2|||Age||years|Mean|64.7|64.7|Standard Deviation|9.2|9.2|||
4195970|NCT00761969|4018867|B1|||Age||years|Mean|65.1|65.1|Standard Deviation|8.8|8.8|||
4195971|NCT00761956|4018876|B3|United States||Region of Enrollment||participants|Number|189|189.0||||||
4195972|NCT00761956|4018877|B2|United States||Region of Enrollment||participants|Number|102|102.0||||||
4195973|NCT00761956|4018878|B1|United States||Region of Enrollment||participants|Number|87|87.0||||||
4195974|NCT00761956|4018876|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4195975|NCT00761956|4018877|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4195976|NCT00761956|4018878|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4195977|NCT00761956|4018876|B3||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4195978|NCT00761956|4018877|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4195979|NCT00761956|4018878|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4195980|NCT00761956|4018876|B3|||Age||years|Mean|66.2|66.2|Standard Deviation|189|189.0|||
4195981|NCT00761956|4018877|B2|||Age||years|Mean|65.7|65.7|Standard Deviation|8.5|8.5|||
4195982|NCT00761956|4018878|B1|||Age||years|Mean|66.8|66.8|Standard Deviation|8.5|8.5|||
4195983|NCT00761956|4018876|B3||>=65 years|Age||Participants|Count of Participants|104|104.0||||||
4195984|NCT00761956|4018877|B2||>=65 years|Age||Participants|Count of Participants|54|54.0||||||
4195985|NCT00761956|4018878|B1||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
4195986|NCT00761956|4018876|B3||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
4195987|NCT00761956|4018877|B2||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4195988|NCT00761956|4018878|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4195989|NCT00761956|4018876|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195990|NCT00761956|4018877|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195991|NCT00761956|4018878|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4195992|NCT00761930|4018887|B4|United States||Region of Enrollment||participants|Number|103|103.0||||||
4195993|NCT00761930|4018888|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
4195994|NCT00761930|4018889|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
4195995|NCT00761930|4018890|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4195996|NCT00761930|4018887|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4195997|NCT00761930|4018888|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4195998|NCT00761930|4018889|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4195999|NCT00761930|4018890|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4196000|NCT00761930|4018887|B4||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4196001|NCT00761930|4018888|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4196002|NCT00761930|4018889|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4196003|NCT00761930|4018890|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4196004|NCT00761930|4018887|B4|||Age||years|Mean|41.3|41.3|Standard Deviation|11.8|11.8|||
4196005|NCT00761930|4018888|B3|||Age||years|Mean|40.8|40.8|Standard Deviation|11.7|11.7|||
4196006|NCT00761930|4018889|B2|||Age||years|Mean|42.68|42.68|Standard Deviation|11.83|11.83|||
4196007|NCT00761930|4018890|B1|||Age||years|Mean|40.3|40.3|Standard Deviation|12.2|12.2|||
4196008|NCT00761930|4018887|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4196009|NCT00761930|4018888|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4196010|NCT00761930|4018889|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4196011|NCT00761930|4018890|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4196012|NCT00761930|4018887|B4||Between 18 and 65 years|Age||Participants|Count of Participants|102|102.0||||||
4196013|NCT00761930|4018888|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4196014|NCT00761930|4018889|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4196015|NCT00761930|4018890|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4196016|NCT00761930|4018887|B4||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4196017|NCT00761930|4018888|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4196018|NCT00761930|4018889|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4196019|NCT00761930|4018890|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4196020|NCT00761865|4018906|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4196021|NCT00761865|4018907|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4196022|NCT00761865|4018908|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4196023|NCT00761865|4018906|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4196024|NCT00761865|4018907|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4196025|NCT00761865|4018908|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4196026|NCT00761865|4018906|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4196027|NCT00761865|4018907|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4196028|NCT00761865|4018908|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4196029|NCT00761865|4018906|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4196030|NCT00761865|4018907|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4196031|NCT00761865|4018908|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4196032|NCT00761865|4018906|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4196033|NCT00761865|4018907|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4196034|NCT00761865|4018908|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4196035|NCT00761813|4018917|B3|Australia||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
4196036|NCT00761813|4018918|B2|Australia||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
4196037|NCT00761813|4018919|B1|Australia||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
4196038|NCT00761813|4018917|B3|India||Region of Enrollment||Participants|Count of Participants|125|125.0||||||
4196039|NCT00761813|4018918|B2|India||Region of Enrollment||Participants|Count of Participants|63|63.0||||||
4196040|NCT00761813|4018919|B1|India||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
4196041|NCT00761813|4018917|B3|Germany||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4196042|NCT00761813|4018918|B2|Germany||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4196043|NCT00761813|4018919|B1|Germany||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4196044|NCT00761813|4018917|B3|Norway||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4196045|NCT00761813|4018918|B2|Norway||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4196046|NCT00761813|4018919|B1|Norway||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4196047|NCT00761813|4018917|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|247|247.0||||||
4196048|NCT00761813|4018918|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|126|126.0||||||
4196049|NCT00761813|4018919|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|121|121.0||||||
4196050|NCT00761813|4018917|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4196051|NCT00761813|4018918|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4196052|NCT00761813|4018919|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4196053|NCT00761813|4018917|B3|Canada||Region of Enrollment||Participants|Count of Participants|220|220.0||||||
4196054|NCT00761813|4018918|B2|Canada||Region of Enrollment||Participants|Count of Participants|109|109.0||||||
4196055|NCT00761813|4018919|B1|Canada||Region of Enrollment||Participants|Count of Participants|111|111.0||||||
4196056|NCT00761813|4018917|B3|United States||Region of Enrollment||Participants|Count of Participants|420|420.0||||||
4196057|NCT00761813|4018918|B2|United States||Region of Enrollment||Participants|Count of Participants|209|209.0||||||
4196058|NCT00761813|4018919|B1|United States||Region of Enrollment||Participants|Count of Participants|211|211.0||||||
4196059|NCT00761813|4018917|B3||Male|Sex: Female, Male||Participants|Count of Participants|422|422.0||||||
4196060|NCT00761813|4018918|B2||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4196061|NCT00761813|4018919|B1||Male|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4196062|NCT00761813|4018917|B3||Female|Sex: Female, Male||Participants|Count of Participants|657|657.0||||||
4196063|NCT00761813|4018918|B2||Female|Sex: Female, Male||Participants|Count of Participants|327|327.0||||||
4196064|NCT00761813|4018919|B1||Female|Sex: Female, Male||Participants|Count of Participants|330|330.0||||||
4196065|NCT00761813|4018917|B3|||Age||years|Mean|72.1|72.1|Standard Deviation|12.2|12.2|||
4196066|NCT00761813|4018918|B2|||Age||years|Mean|72.0|72.0|Standard Deviation|12.3|12.3|||
4196067|NCT00761813|4018919|B1|||Age||years|Mean|72.2|72.2|Standard Deviation|12.0|12.0|||
4196068|NCT00761774|4018930|B1||Other/Mixed|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4196069|NCT00761774|4018930|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|97|97.0||||||
4196070|NCT00761774|4018930|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4196071|NCT00761774|4018930|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4196072|NCT00761774|4018930|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4196073|NCT00761774|4018930|B1|||Age||years|Mean|40.8|40.8|Standard Deviation|13|13.0|||
4196074|NCT00761774|4018930|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4196075|NCT00761774|4018930|B1||Between 18 and 65 years|Age||Participants|Count of Participants|103|103.0||||||
4196076|NCT00761774|4018930|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4196077|NCT00761761|4018939|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4196078|NCT00761761|4018940|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4196079|NCT00761761|4018941|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4196080|NCT00761761|4018939|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4196081|NCT00761761|4018940|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4196082|NCT00761761|4018941|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4196083|NCT00761761|4018939|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4196084|NCT00761761|4018940|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4196085|NCT00761761|4018941|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4196086|NCT00761761|4018939|B3|||Age||years|Mean|46.42|46.42|Standard Deviation|10.49|10.49|||
4196087|NCT00761761|4018940|B2|||Age||years|Mean|45.93|45.93|Standard Deviation|10.40|10.4|||
4196088|NCT00761761|4018941|B1|||Age||years|Mean|46.9|46.9|Standard Deviation|10.38|10.38|||
4196089|NCT00761761|4018939|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4196090|NCT00761761|4018940|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4196091|NCT00761761|4018941|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4196092|NCT00761761|4018939|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4196093|NCT00761761|4018940|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4196094|NCT00761761|4018941|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4196095|NCT00761761|4018939|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4196096|NCT00761761|4018940|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4196097|NCT00761761|4018941|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4196098|NCT00761748|4018954|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4196099|NCT00761748|4018954|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4196100|NCT00761748|4018954|B1|||Age||years|Median|68|68.0|Full Range|||42.0|82.0|
4196101|NCT00761735|4018961|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4196102|NCT00761735|4018961|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4196103|NCT00761735|4018961|B1|||Age||years|Mean|9.9|9.9|Standard Deviation|3.9|3.9|||
4196104|NCT00761631|4018973|B5||Male|Sex: Female, Male||Participants|Count of Participants|622|622.0||||||
4196105|NCT00761631|4018974|B4||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4196106|NCT00761631|4018975|B3||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4196107|NCT00761631|4018976|B2||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4196108|NCT00761631|4018977|B1||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4196109|NCT00761631|4018973|B5||Female|Sex: Female, Male||Participants|Count of Participants|578|578.0||||||
4196111|NCT00761631|4018975|B3||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4196112|NCT00761631|4018976|B2||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4196113|NCT00761631|4018977|B1||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4196114|NCT00761631|4018973|B5|>10 years to <18 years||Age, Customized||Participants|Number|299|299.0||||||
4196115|NCT00761631|4018974|B4|>10 years to <18 years||Age, Customized||Participants|Number|299|299.0||||||
4196116|NCT00761631|4018975|B3|>10 years to <18 years||Age, Customized||Participants|Number|0|0.0||||||
4196117|NCT00761631|4018976|B2|>10 years to <18 years||Age, Customized||Participants|Number|0|0.0||||||
4196118|NCT00761631|4018977|B1|>10 years to <18 years||Age, Customized||Participants|Number|0|0.0||||||
4196119|NCT00761631|4018973|B5|>=5 years to <10 years||Age, Customized||Participants|Number|299|299.0||||||
4196120|NCT00761631|4018974|B4|>=5 years to <10 years||Age, Customized||Participants|Number|0|0.0||||||
4196121|NCT00761631|4018975|B3|>=5 years to <10 years||Age, Customized||Participants|Number|299|299.0||||||
4196122|NCT00761631|4018976|B2|>=5 years to <10 years||Age, Customized||Participants|Number|0|0.0||||||
4196123|NCT00761631|4018977|B1|>=5 years to <10 years||Age, Customized||Participants|Number|0|0.0||||||
4196124|NCT00761631|4018973|B5|>=2 years to <5 years||Age, Customized||Participants|Number|300|300.0||||||
4196125|NCT00761631|4018974|B4|>=2 years to <5 years||Age, Customized||Participants|Number|0|0.0||||||
4196126|NCT00761631|4018975|B3|>=2 years to <5 years||Age, Customized||Participants|Number|0|0.0||||||
4196127|NCT00761631|4018976|B2|>=2 years to <5 years||Age, Customized||Participants|Number|300|300.0||||||
4196128|NCT00761631|4018977|B1|>=2 years to <5 years||Age, Customized||Participants|Number|0|0.0||||||
4196129|NCT00761631|4018973|B5|>15 months to <2 years||Age, Customized||Participants|Number|302|302.0||||||
4196130|NCT00761631|4018974|B4|>15 months to <2 years||Age, Customized||Participants|Number|0|0.0||||||
4196131|NCT00761631|4018975|B3|>15 months to <2 years||Age, Customized||Participants|Number|0|0.0||||||
4196132|NCT00761631|4018976|B2|>15 months to <2 years||Age, Customized||Participants|Number|0|0.0||||||
4196133|NCT00761631|4018977|B1|>15 months to <2 years||Age, Customized||Participants|Number|302|302.0||||||
4196134|NCT00761605|4019017|B1||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4196135|NCT00761605|4019017|B1||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4196136|NCT00761605|4019017|B1|||Age||years|Mean|36.73|36.73|Standard Deviation|10.97|10.97|||
4196137|NCT00761592|4019044|B3||Male|Sex: Female, Male|One patient from group 1 withdrew consent after first injection, thus efficacy data was not gathered for this patient|Participants|Count of Participants|25|25.0||||||
4196138|NCT00761592|4019045|B2||Male|Sex: Female, Male|One patient from group 1 withdrew consent after first injection, thus efficacy data was not gathered for this patient|Participants|Count of Participants|14|14.0||||||
4196139|NCT00761592|4019046|B1||Male|Sex: Female, Male|One patient from group 1 withdrew consent after first injection, thus efficacy data was not gathered for this patient|Participants|Count of Participants|11|11.0||||||
4196140|NCT00761592|4019044|B3||Female|Sex: Female, Male|One patient from group 1 withdrew consent after first injection, thus efficacy data was not gathered for this patient|Participants|Count of Participants|39|39.0||||||
4196141|NCT00761592|4019045|B2||Female|Sex: Female, Male|One patient from group 1 withdrew consent after first injection, thus efficacy data was not gathered for this patient|Participants|Count of Participants|19|19.0||||||
4196142|NCT00761592|4019046|B1||Female|Sex: Female, Male|One patient from group 1 withdrew consent after first injection, thus efficacy data was not gathered for this patient|Participants|Count of Participants|20|20.0||||||
4196143|NCT00761592|4019044|B3|||Age||years|Mean|68.8|68.8|Standard Deviation|11.5|11.5|||
4196144|NCT00761592|4019045|B2|||Age||years|Mean|67.1|67.1|Standard Deviation|12.1|12.1|||
4196145|NCT00761592|4019046|B1|||Age||years|Mean|70.7|70.7|Standard Deviation|10.7|10.7|||
4196146|NCT00761579|4019061|B1|||Symptom Checklist 90-R (SCL90-R)|The SCL90-R (Derogatis, 1992) measures 9 domains, including somatization, obsessive-compulsive, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation, psychoticism, which provides a global index of distress, the Global Severity Index (GSI). SCL-90-R includes 90 items rated on 5-point scale, ranging from 0 (not at all) to 4 (extremely). Total scale score range from 0 to 360. Higher scores indicate worsening of disease.|Units on a scale|Mean|91.72|91.72|Standard Deviation|65.10|65.1|||
4196147|NCT00761579|4019061|B1|||Sleep Quality|Sleep quality was assessed by an 11-point visual analog scale. Participants indicated on the 11-point visual analog scale (score ranging from 0 to 100 millimeter) how well they have slept in the previous 7 days, from 0 (very badly) to 100 (very well); and how often they have felt drowsy within the previous 7 days, from 0 (not at all) to 100 (all the time). Scores were averaged for the previous 7 days.|Units on a scale|Mean|61.90|61.9|Standard Deviation|27.73|27.73|||
4196148|NCT00761579|4019061|B1|||Daytime Drowsiness|Daytime Drowsiness was assessed by an 11-point visual analog scale. Participants indicated on the 11-point visual analog scale (score ranging from 0 to 100 millimeter) how well they have slept in the previous 7 days, from 0 (very badly) to 100 (very well); and how often they have felt drowsy within the previous 7 days, from 0 (not at all) to 100 (all the time). Scores were averaged for the previous 7 days.|Units on a scale|Mean|45.65|45.65|Standard Deviation|29.97|29.97|||
4196149|NCT00761579|4019061|B1|||Subjective Well-being Under Neuroleptic (SWN-20) Scale Score|The SWN-20 scale is a 20 item scale that was originally designed to explore the subjective experience of psychotic participants. The SWN scale contains five sub-scales consisting of four items each: mental functioning (MF), self-control (SC), emotional regulation (ER), and social integration (SI), physical functioning (PF). The total score ranges from a minimum of 20 (poor subjective experience) to a maximum of 120 (excellent subjective experience). SWN scores appear to correlate with measure of objective psychopathology, quality of life and other self-ratings of mood.|Units on a scale|Mean|73.64|73.64|Standard Deviation|16.87|16.87|||
4196179|NCT00761462|4019106|B3|Category 17, Abscess with cellulitis||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|6|6.0||||||
4196150|NCT00761579|4019061|B1|||Drug Attitude Inventory (DAI-10)|DAI-10 is a 10-item questionnaire to assess 1) subjective experience of drug and 2) attitudes and beliefs toward neuroleptics which may influence compliance in schizophrenia participants. It is the binary scale assessing the participant's subjective response. A 'compliant' response is scored as +1; a dysphoric response is scored as -1. A positive sum of items indicates a positive subjective response (SR); a negative sum of scores indicates a negative SR (non-compliant). The final score is the grand total of the positive and negative points. Total score ranges from (-) 10 to (+) 10.|Units on a scale|Mean|3.01|3.01|Standard Deviation|4.31|4.31|||
4196151|NCT00761579|4019061|B1|||Personal and Social Performance Scale (PSP) Score|The PSP is 100-point validated clinician-rated scale that assesses degree of difficulty in 4 areas of functioning: socially useful activities, personal and social relationships, self-care, disturbing and aggressive behaviors rated on 6-point scale (1=absent to 6=very severe).Total transformed score from 1 to 100 is generated from raw score based on clinical interpretation of scores generated in 4 areas of functioning, with higher transformed score indicating better function. Total score is divided into 3 levels: 71-100 (mild difficulty); 31-70 (marked difficulty) and 1-30 (severe difficulty).|Units on a scale|Mean|54.08|54.08|Standard Deviation|14.84|14.84|||
4196152|NCT00761579|4019061|B1|||Positive and Negative Syndrome Scale (PANSS) - General Psychopathology Subscale Score|The PANSS General Psychopathology Subscale Score assesses 16 general psychopathology symptoms. The symptoms are rated on a 7-point scale, with a range of 16 (absent) to 112 (extreme psychopathology).|Units on a scale|Mean|18.00|18.0|Standard Deviation|5.56|5.56|||
4196153|NCT00761579|4019061|B1|||Positive and Negative Syndrome Scale (PANSS) - Negative Subscale Score|The PANSS Negative Subscale assesses seven negative-symptoms of schizophrenia. Negative symptoms represent a diminution or loss of normal functions. The symptoms are rated on a 7-point scale, with a range of 7 (absent) to 49 (extreme psychopathology).|Units on a scale|Mean|20.61|20.61|Standard Deviation|5.97|5.97|||
4196154|NCT00761579|4019061|B1|||Positive and Negative Syndrome Scale (PANSS) - Positive Subscale Score|The PANSS Positive Subscale assesses seven positive-symptoms of schizophrenia. Positive symptoms refer to an excess or distortion of normal functions. The symptoms are rated on a 7-point scale, with a range of 7 (absent) to 49 (extreme psychopathology).|Units on a scale|Mean|18.96|18.96|Standard Deviation|6.19|6.19|||
4196155|NCT00761579|4019061|B1|||Positive and Negative Syndrome Scale (PANSS) Total Score|The PANSS is a 30-item scale designed to assess various symptoms of schizophrenia including delusions, grandiosity, blunted affect, poor attention, and poor impulse control. The 30 symptoms are rated on a 7-point scale that ranges from 1 (absent) to 7 (extreme psychopathology). The PANSS total score consists of the sum of all 30 PANSS items and ranges from 30 to 210. Higher scores indicate worsening.|Units on a scale|Mean|79.42|79.42|Standard Deviation|19.64|19.64|||
4196156|NCT00761579|4019061|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4196157|NCT00761579|4019061|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4196158|NCT00761579|4019061|B1|||Age||years|Mean|33.9|33.9|Standard Deviation|10.54|10.54|||
4196159|NCT00761527|4019094|B1|Missing Data||Sex/Gender, Customized|Number of participants with non-missing data for the relevant variable in the safety population (N= 2968) which included all participants who had taken at least one dose of study medication.|Participants|Number|10|10.0||||||
4196160|NCT00761527|4019094|B1|Female||Sex/Gender, Customized|Number of participants with non-missing data for the relevant variable in the safety population (N= 2968) which included all participants who had taken at least one dose of study medication.|Participants|Number|1457|1457.0||||||
4196161|NCT00761527|4019094|B1|Male||Sex/Gender, Customized|Number of participants with non-missing data for the relevant variable in the safety population (N= 2968) which included all participants who had taken at least one dose of study medication.|Participants|Number|1511|1511.0||||||
4196162|NCT00761527|4019094|B1|||Age||years|Mean|5.74|5.74|Standard Deviation|3.272|3.272|||
4196163|NCT00761514|4019101|B1|Puerto Rico||Region of Enrollment||participants|Number|14|14.0||||||
4196164|NCT00761514|4019101|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4196165|NCT00761514|4019101|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4196166|NCT00761514|4019101|B1|||Age||years|Mean|61.29|61.29|Standard Deviation|12.14|12.14|||
4196167|NCT00761514|4019101|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4196168|NCT00761514|4019101|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4196169|NCT00761514|4019101|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4196170|NCT00761462|4019106|B3|Category 20, Other||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|82|82.0||||||
4196171|NCT00761462|4019107|B2|Category 20, Other||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|29|29.0||||||
4196172|NCT00761462|4019108|B1|Category 20, Other||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|53|53.0||||||
4196173|NCT00761462|4019106|B3|Category 19, Cystitis||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|5|5.0||||||
4196174|NCT00761462|4019107|B2|Category 19, Cystitis||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|0|0.0||||||
4196175|NCT00761462|4019108|B1|Category 19, Cystitis||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|5|5.0||||||
4196176|NCT00761462|4019106|B3|Category 18, Mastoiditis||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|5|5.0||||||
4196177|NCT00761462|4019107|B2|Category 18, Mastoiditis||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|0|0.0||||||
4196178|NCT00761462|4019108|B1|Category 18, Mastoiditis||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|5|5.0||||||
4196259|NCT00761345|4019117|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4196180|NCT00761462|4019107|B2|Category 17, Abscess with cellulitis||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|4|4.0||||||
4196181|NCT00761462|4019108|B1|Category 17, Abscess with cellulitis||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|2|2.0||||||
4196182|NCT00761462|4019106|B3|Category 16, Pseudomonas Infections||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|6|6.0||||||
4196183|NCT00761462|4019107|B2|Category 16, Pseudomonas Infections||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|0|0.0||||||
4196184|NCT00761462|4019108|B1|Category 16, Pseudomonas Infections||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|6|6.0||||||
4196185|NCT00761462|4019106|B3|Category 15, Acute Bronchitis||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|7|7.0||||||
4196186|NCT00761462|4019107|B2|Category 15, Acute Bronchitis||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|5|5.0||||||
4196187|NCT00761462|4019108|B1|Category 15, Acute Bronchitis||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|2|2.0||||||
4196188|NCT00761462|4019106|B3|Category 14, Shigellosis||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|7|7.0||||||
4196189|NCT00761462|4019107|B2|Category 14, Shigellosis||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|0|0.0||||||
4196190|NCT00761462|4019108|B1|Category 14, Shigellosis||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|7|7.0||||||
4196191|NCT00761462|4019106|B3|Category 13, Bacteremia||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|7|7.0||||||
4196192|NCT00761462|4019107|B2|Category 13, Bacteremia||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|1|1.0||||||
4196193|NCT00761462|4019108|B1|Category 13, Bacteremia||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|6|6.0||||||
4196194|NCT00761462|4019106|B3|Category 12, Other Respiratory Tract Infection||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|8|8.0||||||
4196195|NCT00761462|4019107|B2|Category 12, Other Respiratory Tract Infection||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|6|6.0||||||
4196196|NCT00761462|4019108|B1|Category 12, Other Respiratory Tract Infection||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|2|2.0||||||
4196197|NCT00761462|4019106|B3|Category 11, Wound Infection||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|9|9.0||||||
4196198|NCT00761462|4019107|B2|Category 11, Wound Infection||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|2|2.0||||||
4196199|NCT00761462|4019108|B1|Category 11, Wound Infection||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|7|7.0||||||
4196200|NCT00761462|4019106|B3|Category 10, External Otitis||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|11|11.0||||||
4196201|NCT00761462|4019107|B2|Category 10, External Otitis||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|1|1.0||||||
4196202|NCT00761462|4019108|B1|Category 10, External Otitis||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|10|10.0||||||
4196203|NCT00761462|4019106|B3|Category 9, Skin Infection||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|13|13.0||||||
4196204|NCT00761462|4019107|B2|Category 9, Skin Infection||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|7|7.0||||||
4196205|NCT00761462|4019108|B1|Category 9, Skin Infection||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|6|6.0||||||
4196206|NCT00761462|4019106|B3|Category 8, Abscess||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|13|13.0||||||
4196207|NCT00761462|4019107|B2|Category 8, Abscess||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|6|6.0||||||
4196208|NCT00761462|4019108|B1|Category 8, Abscess||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|7|7.0||||||
4196209|NCT00761462|4019106|B3|Category 7, Bronchitis||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|14|14.0||||||
4196210|NCT00761462|4019107|B2|Category 7, Bronchitis||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|7|7.0||||||
4196211|NCT00761462|4019108|B1|Category 7, Bronchitis||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|7|7.0||||||
4196212|NCT00761462|4019106|B3|Category 6, Pneumonia||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|29|29.0||||||
4196213|NCT00761462|4019107|B2|Category 6, Pneumonia||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|17|17.0||||||
4196214|NCT00761462|4019108|B1|Category 6, Pneumonia||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|12|12.0||||||
4196215|NCT00761462|4019106|B3|Category 5, Pyelonephritis||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|32|32.0||||||
4196216|NCT00761462|4019107|B2|Category 5, Pyelonephritis||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|8|8.0||||||
4196217|NCT00761462|4019108|B1|Category 5, Pyelonephritis||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|24|24.0||||||
4196218|NCT00761462|4019106|B3|Category 4, Sinusitis||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|86|86.0||||||
4196219|NCT00761462|4019107|B2|Category 4, Sinusitis||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|47|47.0||||||
4196220|NCT00761462|4019108|B1|Category 4, Sinusitis||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|39|39.0||||||
4196221|NCT00761462|4019106|B3|Category 3, Urinary Tract||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|117|117.0||||||
4196222|NCT00761462|4019107|B2|Category 3, Urinary Tract||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|12|12.0||||||
4196223|NCT00761462|4019108|B1|Category 3, Urinary Tract||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|105|105.0||||||
4196224|NCT00761462|4019106|B3|Category 2, Pharyngitis / Tonsillitis||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|187|187.0||||||
4196225|NCT00761462|4019107|B2|Category 2, Pharyngitis / Tonsillitis||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|148|148.0||||||
4196226|NCT00761462|4019108|B1|Category 2, Pharyngitis / Tonsillitis||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|39|39.0||||||
4196227|NCT00761462|4019106|B3|Category 1, Otitis Media||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|350|350.0||||||
4196228|NCT00761462|4019107|B2|Category 1, Otitis Media||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|207|207.0||||||
4196229|NCT00761462|4019108|B1|Category 1, Otitis Media||Type of infection, pre-treatment|Type of infection, pre-treatment, which qualified patients for long term safety evaluation|participants|Number|143|143.0||||||
4196230|NCT00761462|4019106|B3|Canada||Region of Enrollment||participants|Number|15|15.0||||||
4196231|NCT00761462|4019107|B2|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4196232|NCT00761462|4019108|B1|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4196233|NCT00761462|4019106|B3|United States||Region of Enrollment||participants|Number|979|979.0||||||
4196234|NCT00761462|4019107|B2|United States||Region of Enrollment||participants|Number|503|503.0||||||
4196235|NCT00761462|4019108|B1|United States||Region of Enrollment||participants|Number|476|476.0||||||
4196236|NCT00761462|4019106|B3||Male|Sex: Female, Male||Participants|Count of Participants|483|483.0||||||
4196237|NCT00761462|4019107|B2||Male|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
4196238|NCT00761462|4019108|B1||Male|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4196239|NCT00761462|4019106|B3||Female|Sex: Female, Male||Participants|Count of Participants|511|511.0||||||
4196240|NCT00761462|4019107|B2||Female|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
4196241|NCT00761462|4019108|B1||Female|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
4196242|NCT00761462|4019106|B3|>=12 years through 16 years||Age, Customized||participants|Number|77|77.0||||||
4196243|NCT00761462|4019107|B2|>=12 years through 16 years||Age, Customized||participants|Number|19|19.0||||||
4196244|NCT00761462|4019108|B1|>=12 years through 16 years||Age, Customized||participants|Number|58|58.0||||||
4196245|NCT00761462|4019106|B3|>= 6 years through 11 years||Age, Customized||participants|Number|417|417.0||||||
4196246|NCT00761462|4019107|B2|>= 6 years through 11 years||Age, Customized||participants|Number|223|223.0||||||
4196247|NCT00761462|4019108|B1|>= 6 years through 11 years||Age, Customized||participants|Number|194|194.0||||||
4196248|NCT00761462|4019106|B3|>=2 years through 5 years||Age, Customized||participants|Number|315|315.0||||||
4196249|NCT00761462|4019107|B2|>=2 years through 5 years||Age, Customized||participants|Number|165|165.0||||||
4196250|NCT00761462|4019108|B1|>=2 years through 5 years||Age, Customized||participants|Number|150|150.0||||||
4196251|NCT00761462|4019106|B3|>=13 months through 23 month||Age, Customized||participants|Number|100|100.0||||||
4196252|NCT00761462|4019107|B2|>=13 months through 23 month||Age, Customized||participants|Number|52|52.0||||||
4196253|NCT00761462|4019108|B1|>=13 months through 23 month||Age, Customized||participants|Number|48|48.0||||||
4196254|NCT00761462|4019106|B3|>= 2 months through 12 month||Age, Customized||participants|Number|85|85.0||||||
4196255|NCT00761462|4019107|B2|>= 2 months through 12 month||Age, Customized||participants|Number|48|48.0||||||
4196256|NCT00761462|4019108|B1|>= 2 months through 12 month||Age, Customized||participants|Number|37|37.0||||||
4196257|NCT00761345|4019117|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4196258|NCT00761345|4019117|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4196260|NCT00761345|4019117|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4196261|NCT00761345|4019117|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4196262|NCT00761345|4019117|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4196263|NCT00761319|4019121|B3|Male||Gender|One gender response is missing from the Travatan Z arm.|participants|Number|250|250.0||||||
4196264|NCT00761319|4019122|B2|Male||Gender|One gender response is missing from the Travatan Z arm.|participants|Number|118|118.0||||||
4196265|NCT00761319|4019123|B1|Male||Gender|One gender response is missing from the Travatan Z arm.|participants|Number|132|132.0||||||
4196266|NCT00761319|4019121|B3|Female||Gender|One gender response is missing from the Travatan Z arm.|participants|Number|401|401.0||||||
4196267|NCT00761319|4019122|B2|Female||Gender|One gender response is missing from the Travatan Z arm.|participants|Number|216|216.0||||||
4196268|NCT00761319|4019123|B1|Female||Gender|One gender response is missing from the Travatan Z arm.|participants|Number|185|185.0||||||
4196269|NCT00761319|4019121|B3|||Age||years|Mean|66.3|66.3|Standard Deviation|11.4|11.4|||
4196270|NCT00761319|4019122|B2|||Age||years|Mean|66.3|66.3|Standard Deviation|10.9|10.9|||
4196271|NCT00761319|4019123|B1|||Age||years|Mean|66.3|66.3|Standard Deviation|11.8|11.8|||
4196272|NCT00761306|4019132|B1|||HAM-D-24|The Hamilton Depression Scale - 24 Items (HAM-D-24) measures depression severity. Items are rated on a scale from 0 (symptoms not present) to a maximum of 2 to 4 (symptom extremely severe) for a total score range of 0 to 76. The higher the score, the more severe.|units on a scale|Mean|10.2|10.2|Standard Deviation|7.8|7.8|||
4196273|NCT00761306|4019132|B1|||MADRS|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 (no symptom) to 6 (severe symptom). The 10 items represent the core symptoms of depressive illness. The rating should be based on a clinical interview with the patient, moving from broadly phrased questions about symptoms to more detailed ones, which allow a precise rating of severity, covering the last 7 days. Total score from 0 to 60. The higher the score, the more severe.|units on a scale|Mean|10.7|10.7|Standard Deviation|8.4|8.4|||
4196274|NCT00761306|4019132|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4196275|NCT00761306|4019132|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4196276|NCT00761306|4019132|B1|||Age||years|Mean|44.5|44.5|Standard Deviation|11.5|11.5|||
4196277|NCT00761280|4019141|B3|No||One or more Prior Immunotherapy||participants|Number|25|25.0||||||
4196278|NCT00761280|4019142|B2|No||One or more Prior Immunotherapy||participants|Number|12|12.0||||||
4196279|NCT00761280|4019143|B1|No||One or more Prior Immunotherapy||participants|Number|13|13.0||||||
4196280|NCT00761280|4019141|B3|Yes||One or more Prior Immunotherapy||participants|Number|2|2.0||||||
4196281|NCT00761280|4019142|B2|Yes||One or more Prior Immunotherapy||participants|Number|1|1.0||||||
4196282|NCT00761280|4019143|B1|Yes||One or more Prior Immunotherapy||participants|Number|1|1.0||||||
4196283|NCT00761280|4019141|B3|No||One or more Prior Chemotherapy||participants|Number|8|8.0||||||
4196284|NCT00761280|4019142|B2|No||One or more Prior Chemotherapy||participants|Number|4|4.0||||||
4196285|NCT00761280|4019143|B1|No||One or more Prior Chemotherapy||participants|Number|4|4.0||||||
4196286|NCT00761280|4019141|B3|Yes||One or more Prior Chemotherapy||participants|Number|19|19.0||||||
4196287|NCT00761280|4019142|B2|Yes||One or more Prior Chemotherapy||participants|Number|9|9.0||||||
4196288|NCT00761280|4019143|B1|Yes||One or more Prior Chemotherapy||participants|Number|10|10.0||||||
4196289|NCT00761280|4019141|B3|||One or more Prior Radiotherapy Regimens||participants|Number|27|27.0||||||
4196290|NCT00761280|4019142|B2|||One or more Prior Radiotherapy Regimens||participants|Number|13|13.0||||||
4196291|NCT00761280|4019143|B1|||One or more Prior Radiotherapy Regimens||participants|Number|14|14.0||||||
4196292|NCT00761280|4019141|B3|No||One or more Prior Surgical Treatments||participants|Number|1|1.0||||||
4196293|NCT00761280|4019142|B2|No||One or more Prior Surgical Treatments||participants|Number|1|1.0||||||
4196294|NCT00761280|4019143|B1|No||One or more Prior Surgical Treatments||participants|Number|0|0.0||||||
4196295|NCT00761280|4019141|B3|Yes||One or more Prior Surgical Treatments||participants|Number|26|26.0||||||
4196296|NCT00761280|4019142|B2|Yes||One or more Prior Surgical Treatments||participants|Number|12|12.0||||||
4196297|NCT00761280|4019143|B1|Yes||One or more Prior Surgical Treatments||participants|Number|14|14.0||||||
4196298|NCT00761280|4019141|B3|Previous diagnosis of Anaplastic Astrocytoma||Previous diagnosis of Astrocytoma or AA before diagnosis of Secondary Glioblastoma Multiforme||participants|Number|1|1.0||||||
4196299|NCT00761280|4019142|B2|Previous diagnosis of Anaplastic Astrocytoma||Previous diagnosis of Astrocytoma or AA before diagnosis of Secondary Glioblastoma Multiforme||participants|Number|1|1.0||||||
4196300|NCT00761280|4019143|B1|Previous diagnosis of Anaplastic Astrocytoma||Previous diagnosis of Astrocytoma or AA before diagnosis of Secondary Glioblastoma Multiforme||participants|Number|0|0.0||||||
4196301|NCT00761280|4019141|B3|Previous diagnosis of Astrocytoma||Previous diagnosis of Astrocytoma or AA before diagnosis of Secondary Glioblastoma Multiforme||participants|Number|0|0.0||||||
4196302|NCT00761280|4019142|B2|Previous diagnosis of Astrocytoma||Previous diagnosis of Astrocytoma or AA before diagnosis of Secondary Glioblastoma Multiforme||participants|Number|0|0.0||||||
4196303|NCT00761280|4019143|B1|Previous diagnosis of Astrocytoma||Previous diagnosis of Astrocytoma or AA before diagnosis of Secondary Glioblastoma Multiforme||participants|Number|0|0.0||||||
4196304|NCT00761280|4019141|B3|||Time to first diagnosis of Secondary GBM (years) (Descriptive analysis, only)|Time of first diagnosis (in years before study entry) of Secondary Glioblastoma Multiforme. One participant in the Chemotherapy group was diagnosed with Secondary Glioblastoma Multiforme (GBM); all other participants were diagnosed with Anaplastic Astrocytoma (AA).|years|Mean|0.03|0.03|Standard Deviation|NA||||One participant in this group was diagnosed with Secondary Glioblastoma Multiforme.
4196385|NCT00761280|4019141|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4196386|NCT00761280|4019142|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4196305|NCT00761280|4019142|B2|||Time to first diagnosis of Secondary GBM (years) (Descriptive analysis, only)|Time of first diagnosis (in years before study entry) of Secondary Glioblastoma Multiforme. One participant in the Chemotherapy group was diagnosed with Secondary Glioblastoma Multiforme (GBM); all other participants were diagnosed with Anaplastic Astrocytoma (AA).|years|Mean|0.03|0.03|Standard Deviation|NA||||One participant in this group was diagnosed with Secondary Glioblastoma Multiforme.
4196306|NCT00761280|4019143|B1|||Time to first diagnosis of Secondary GBM (years) (Descriptive analysis, only)|Time of first diagnosis (in years before study entry) of Secondary Glioblastoma Multiforme. One participant in the Chemotherapy group was diagnosed with Secondary Glioblastoma Multiforme (GBM); all other participants were diagnosed with Anaplastic Astrocytoma (AA).|years|Mean|NA||Standard Deviation|NA||||No participants in this group were diagnosed with Secondary Glioblastoma Multiforme.
4196307|NCT00761280|4019141|B3|||Diagnosis of Secondary Glioblastoma Multiforme (GBM) (WHO Grade IV)||participants|Number|1|1.0||||||
4196308|NCT00761280|4019142|B2|||Diagnosis of Secondary Glioblastoma Multiforme (GBM) (WHO Grade IV)||participants|Number|1|1.0||||||
4196309|NCT00761280|4019143|B1|||Diagnosis of Secondary Glioblastoma Multiforme (GBM) (WHO Grade IV)||participants|Number|0|0.0||||||
4196310|NCT00761280|4019141|B3|Other diagnosis||Diagnosis of other brain tumor prior to diagnosis of Anaplastic Astrocytoma WHO Grade III|Twenty-six participants were diagnosed with Anaplastic Astrocytoma, and one participant was diagnosed with Secondary Glioblastoma Multiforme.|participants|Number|1|1.0||||||
4196311|NCT00761280|4019142|B2|Other diagnosis||Diagnosis of other brain tumor prior to diagnosis of Anaplastic Astrocytoma WHO Grade III|Twenty-six participants were diagnosed with Anaplastic Astrocytoma, and one participant was diagnosed with Secondary Glioblastoma Multiforme.|participants|Number|0|0.0||||||
4196312|NCT00761280|4019143|B1|Other diagnosis||Diagnosis of other brain tumor prior to diagnosis of Anaplastic Astrocytoma WHO Grade III|Twenty-six participants were diagnosed with Anaplastic Astrocytoma, and one participant was diagnosed with Secondary Glioblastoma Multiforme.|participants|Number|1|1.0||||||
4196313|NCT00761280|4019141|B3|Not diagnosed with Other Brain Tumor||Diagnosis of other brain tumor prior to diagnosis of Anaplastic Astrocytoma WHO Grade III|Twenty-six participants were diagnosed with Anaplastic Astrocytoma, and one participant was diagnosed with Secondary Glioblastoma Multiforme.|participants|Number|24|24.0||||||
4196314|NCT00761280|4019142|B2|Not diagnosed with Other Brain Tumor||Diagnosis of other brain tumor prior to diagnosis of Anaplastic Astrocytoma WHO Grade III|Twenty-six participants were diagnosed with Anaplastic Astrocytoma, and one participant was diagnosed with Secondary Glioblastoma Multiforme.|participants|Number|12|12.0||||||
4196315|NCT00761280|4019143|B1|Not diagnosed with Other Brain Tumor||Diagnosis of other brain tumor prior to diagnosis of Anaplastic Astrocytoma WHO Grade III|Twenty-six participants were diagnosed with Anaplastic Astrocytoma, and one participant was diagnosed with Secondary Glioblastoma Multiforme.|participants|Number|12|12.0||||||
4196316|NCT00761280|4019141|B3|AA WHO Grade II||Diagnosis of other brain tumor prior to diagnosis of Anaplastic Astrocytoma WHO Grade III|Twenty-six participants were diagnosed with Anaplastic Astrocytoma, and one participant was diagnosed with Secondary Glioblastoma Multiforme.|participants|Number|1|1.0||||||
4196317|NCT00761280|4019142|B2|AA WHO Grade II||Diagnosis of other brain tumor prior to diagnosis of Anaplastic Astrocytoma WHO Grade III|Twenty-six participants were diagnosed with Anaplastic Astrocytoma, and one participant was diagnosed with Secondary Glioblastoma Multiforme.|participants|Number|0|0.0||||||
4196318|NCT00761280|4019143|B1|AA WHO Grade II||Diagnosis of other brain tumor prior to diagnosis of Anaplastic Astrocytoma WHO Grade III|Twenty-six participants were diagnosed with Anaplastic Astrocytoma, and one participant was diagnosed with Secondary Glioblastoma Multiforme.|participants|Number|1|1.0||||||
4196319|NCT00761280|4019141|B3|AA WHO Grade I||Diagnosis of other brain tumor prior to diagnosis of Anaplastic Astrocytoma WHO Grade III|Twenty-six participants were diagnosed with Anaplastic Astrocytoma, and one participant was diagnosed with Secondary Glioblastoma Multiforme.|participants|Number|0|0.0||||||
4196320|NCT00761280|4019142|B2|AA WHO Grade I||Diagnosis of other brain tumor prior to diagnosis of Anaplastic Astrocytoma WHO Grade III|Twenty-six participants were diagnosed with Anaplastic Astrocytoma, and one participant was diagnosed with Secondary Glioblastoma Multiforme.|participants|Number|0|0.0||||||
4196321|NCT00761280|4019143|B1|AA WHO Grade I||Diagnosis of other brain tumor prior to diagnosis of Anaplastic Astrocytoma WHO Grade III|Twenty-six participants were diagnosed with Anaplastic Astrocytoma, and one participant was diagnosed with Secondary Glioblastoma Multiforme.|participants|Number|0|0.0||||||
4196322|NCT00761280|4019141|B3|||Time of first diagnosis of AA WHO Grade III (years) (Descriptive analysis, only)|Time of first diagnosis (in years before study entry) is available for all 14 participants in the Trabedersen group and 11 participants in the chemotherapy group.|years|Mean|1.75|1.75|Standard Deviation|1.124|1.124|||
4196323|NCT00761280|4019142|B2|||Time of first diagnosis of AA WHO Grade III (years) (Descriptive analysis, only)|Time of first diagnosis (in years before study entry) is available for all 14 participants in the Trabedersen group and 11 participants in the chemotherapy group.|years|Mean|1.81|1.81|Standard Deviation|1.194|1.194|||
4196324|NCT00761280|4019143|B1|||Time of first diagnosis of AA WHO Grade III (years) (Descriptive analysis, only)|Time of first diagnosis (in years before study entry) is available for all 14 participants in the Trabedersen group and 11 participants in the chemotherapy group.|years|Mean|1.71|1.71|Standard Deviation|1.110|1.11|||
4196325|NCT00761280|4019141|B3|Recurrent||Diagnosis of Anaplastic Astrocytoma (AA) World Health Organization (WHO) Grade III|Twenty-six participants were diagnosed with Anaplastic Astrocytoma, and one participant was diagnosed with Secondary Glioblastoma Multiforme.|participants|Number|21|21.0||||||
4196326|NCT00761280|4019142|B2|Recurrent||Diagnosis of Anaplastic Astrocytoma (AA) World Health Organization (WHO) Grade III|Twenty-six participants were diagnosed with Anaplastic Astrocytoma, and one participant was diagnosed with Secondary Glioblastoma Multiforme.|participants|Number|10|10.0||||||
4196327|NCT00761280|4019143|B1|Recurrent||Diagnosis of Anaplastic Astrocytoma (AA) World Health Organization (WHO) Grade III|Twenty-six participants were diagnosed with Anaplastic Astrocytoma, and one participant was diagnosed with Secondary Glioblastoma Multiforme.|participants|Number|11|11.0||||||
4196387|NCT00761280|4019143|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4196388|NCT00761280|4019141|B3|||Age||years|Mean|39.5|39.5|Standard Deviation|12.05|12.05|||
4196328|NCT00761280|4019141|B3|Refractory||Diagnosis of Anaplastic Astrocytoma (AA) World Health Organization (WHO) Grade III|Twenty-six participants were diagnosed with Anaplastic Astrocytoma, and one participant was diagnosed with Secondary Glioblastoma Multiforme.|participants|Number|5|5.0||||||
4196329|NCT00761280|4019142|B2|Refractory||Diagnosis of Anaplastic Astrocytoma (AA) World Health Organization (WHO) Grade III|Twenty-six participants were diagnosed with Anaplastic Astrocytoma, and one participant was diagnosed with Secondary Glioblastoma Multiforme.|participants|Number|2|2.0||||||
4196330|NCT00761280|4019143|B1|Refractory||Diagnosis of Anaplastic Astrocytoma (AA) World Health Organization (WHO) Grade III|Twenty-six participants were diagnosed with Anaplastic Astrocytoma, and one participant was diagnosed with Secondary Glioblastoma Multiforme.|participants|Number|3|3.0||||||
4196331|NCT00761280|4019141|B3|||Weight (kg) (Descriptive analysis, only)|Weight is missing for one participant in the Chemotherapy group.|kg|Mean|73.62|73.62|Standard Deviation|15.731|15.731|||
4196332|NCT00761280|4019142|B2|||Weight (kg) (Descriptive analysis, only)|Weight is missing for one participant in the Chemotherapy group.|kg|Mean|71.62|71.62|Standard Deviation|14.213|14.213|||
4196333|NCT00761280|4019143|B1|||Weight (kg) (Descriptive analysis, only)|Weight is missing for one participant in the Chemotherapy group.|kg|Mean|75.34|75.34|Standard Deviation|17.265|17.265|||
4196334|NCT00761280|4019141|B3|||Height (cm) (Descriptive analysis, only)|Height is missing for one participant in the Chemotherapy group.|cm|Mean|171.52|171.52|Standard Deviation|9.829|9.829|||
4196335|NCT00761280|4019142|B2|||Height (cm) (Descriptive analysis, only)|Height is missing for one participant in the Chemotherapy group.|cm|Mean|170.29|170.29|Standard Deviation|10.019|10.019|||
4196336|NCT00761280|4019143|B1|||Height (cm) (Descriptive analysis, only)|Height is missing for one participant in the Chemotherapy group.|cm|Mean|172.57|172.57|Standard Deviation|9.913|9.913|||
4196337|NCT00761280|4019141|B3|Poland||Region of Enrollment|Study was discontinued early because of the inability to recruit a sufficient number of suitable participants within the planned recruitment period, therefore not all planned sites recruited participants. Only those regions that recruited at least one participant are listed.|participants|Number|2|2.0||||||
4196338|NCT00761280|4019142|B2|Poland||Region of Enrollment|Study was discontinued early because of the inability to recruit a sufficient number of suitable participants within the planned recruitment period, therefore not all planned sites recruited participants. Only those regions that recruited at least one participant are listed.|participants|Number|0|0.0||||||
4196339|NCT00761280|4019143|B1|Poland||Region of Enrollment|Study was discontinued early because of the inability to recruit a sufficient number of suitable participants within the planned recruitment period, therefore not all planned sites recruited participants. Only those regions that recruited at least one participant are listed.|participants|Number|2|2.0||||||
4196340|NCT00761280|4019141|B3|Israel||Region of Enrollment|Study was discontinued early because of the inability to recruit a sufficient number of suitable participants within the planned recruitment period, therefore not all planned sites recruited participants. Only those regions that recruited at least one participant are listed.|participants|Number|1|1.0||||||
4196341|NCT00761280|4019142|B2|Israel||Region of Enrollment|Study was discontinued early because of the inability to recruit a sufficient number of suitable participants within the planned recruitment period, therefore not all planned sites recruited participants. Only those regions that recruited at least one participant are listed.|participants|Number|1|1.0||||||
4196342|NCT00761280|4019143|B1|Israel||Region of Enrollment|Study was discontinued early because of the inability to recruit a sufficient number of suitable participants within the planned recruitment period, therefore not all planned sites recruited participants. Only those regions that recruited at least one participant are listed.|participants|Number|0|0.0||||||
4196343|NCT00761280|4019141|B3|Germany||Region of Enrollment|Study was discontinued early because of the inability to recruit a sufficient number of suitable participants within the planned recruitment period, therefore not all planned sites recruited participants. Only those regions that recruited at least one participant are listed.|participants|Number|3|3.0||||||
4196344|NCT00761280|4019142|B2|Germany||Region of Enrollment|Study was discontinued early because of the inability to recruit a sufficient number of suitable participants within the planned recruitment period, therefore not all planned sites recruited participants. Only those regions that recruited at least one participant are listed.|participants|Number|2|2.0||||||
4196345|NCT00761280|4019143|B1|Germany||Region of Enrollment|Study was discontinued early because of the inability to recruit a sufficient number of suitable participants within the planned recruitment period, therefore not all planned sites recruited participants. Only those regions that recruited at least one participant are listed.|participants|Number|1|1.0||||||
4196346|NCT00761280|4019141|B3|Canada||Region of Enrollment|Study was discontinued early because of the inability to recruit a sufficient number of suitable participants within the planned recruitment period, therefore not all planned sites recruited participants. Only those regions that recruited at least one participant are listed.|participants|Number|1|1.0||||||
4196347|NCT00761280|4019142|B2|Canada||Region of Enrollment|Study was discontinued early because of the inability to recruit a sufficient number of suitable participants within the planned recruitment period, therefore not all planned sites recruited participants. Only those regions that recruited at least one participant are listed.|participants|Number|1|1.0||||||
4196348|NCT00761280|4019143|B1|Canada||Region of Enrollment|Study was discontinued early because of the inability to recruit a sufficient number of suitable participants within the planned recruitment period, therefore not all planned sites recruited participants. Only those regions that recruited at least one participant are listed.|participants|Number|0|0.0||||||
4196349|NCT00761280|4019141|B3|Mexico||Region of Enrollment|Study was discontinued early because of the inability to recruit a sufficient number of suitable participants within the planned recruitment period, therefore not all planned sites recruited participants. Only those regions that recruited at least one participant are listed.|participants|Number|1|1.0||||||
4196350|NCT00761280|4019142|B2|Mexico||Region of Enrollment|Study was discontinued early because of the inability to recruit a sufficient number of suitable participants within the planned recruitment period, therefore not all planned sites recruited participants. Only those regions that recruited at least one participant are listed.|participants|Number|1|1.0||||||
4196389|NCT00761280|4019142|B2|||Age||years|Mean|40.8|40.8|Standard Deviation|11.63|11.63|||
4196351|NCT00761280|4019143|B1|Mexico||Region of Enrollment|Study was discontinued early because of the inability to recruit a sufficient number of suitable participants within the planned recruitment period, therefore not all planned sites recruited participants. Only those regions that recruited at least one participant are listed.|participants|Number|0|0.0||||||
4196352|NCT00761280|4019141|B3|India||Region of Enrollment|Study was discontinued early because of the inability to recruit a sufficient number of suitable participants within the planned recruitment period, therefore not all planned sites recruited participants. Only those regions that recruited at least one participant are listed.|participants|Number|8|8.0||||||
4196353|NCT00761280|4019142|B2|India||Region of Enrollment|Study was discontinued early because of the inability to recruit a sufficient number of suitable participants within the planned recruitment period, therefore not all planned sites recruited participants. Only those regions that recruited at least one participant are listed.|participants|Number|2|2.0||||||
4196354|NCT00761280|4019143|B1|India||Region of Enrollment|Study was discontinued early because of the inability to recruit a sufficient number of suitable participants within the planned recruitment period, therefore not all planned sites recruited participants. Only those regions that recruited at least one participant are listed.|participants|Number|6|6.0||||||
4196355|NCT00761280|4019141|B3|Russian Federation||Region of Enrollment|Study was discontinued early because of the inability to recruit a sufficient number of suitable participants within the planned recruitment period, therefore not all planned sites recruited participants. Only those regions that recruited at least one participant are listed.|participants|Number|8|8.0||||||
4196356|NCT00761280|4019142|B2|Russian Federation||Region of Enrollment|Study was discontinued early because of the inability to recruit a sufficient number of suitable participants within the planned recruitment period, therefore not all planned sites recruited participants. Only those regions that recruited at least one participant are listed.|participants|Number|4|4.0||||||
4196357|NCT00761280|4019143|B1|Russian Federation||Region of Enrollment|Study was discontinued early because of the inability to recruit a sufficient number of suitable participants within the planned recruitment period, therefore not all planned sites recruited participants. Only those regions that recruited at least one participant are listed.|participants|Number|4|4.0||||||
4196358|NCT00761280|4019141|B3|Austria||Region of Enrollment|Study was discontinued early because of the inability to recruit a sufficient number of suitable participants within the planned recruitment period, therefore not all planned sites recruited participants. Only those regions that recruited at least one participant are listed.|participants|Number|1|1.0||||||
4196359|NCT00761280|4019142|B2|Austria||Region of Enrollment|Study was discontinued early because of the inability to recruit a sufficient number of suitable participants within the planned recruitment period, therefore not all planned sites recruited participants. Only those regions that recruited at least one participant are listed.|participants|Number|1|1.0||||||
4196360|NCT00761280|4019143|B1|Austria||Region of Enrollment|Study was discontinued early because of the inability to recruit a sufficient number of suitable participants within the planned recruitment period, therefore not all planned sites recruited participants. Only those regions that recruited at least one participant are listed.|participants|Number|0|0.0||||||
4196361|NCT00761280|4019141|B3|Spain||Region of Enrollment|Study was discontinued early because of the inability to recruit a sufficient number of suitable participants within the planned recruitment period, therefore not all planned sites recruited participants. Only those regions that recruited at least one participant are listed.|participants|Number|2|2.0||||||
4196362|NCT00761280|4019142|B2|Spain||Region of Enrollment|Study was discontinued early because of the inability to recruit a sufficient number of suitable participants within the planned recruitment period, therefore not all planned sites recruited participants. Only those regions that recruited at least one participant are listed.|participants|Number|1|1.0||||||
4196363|NCT00761280|4019143|B1|Spain||Region of Enrollment|Study was discontinued early because of the inability to recruit a sufficient number of suitable participants within the planned recruitment period, therefore not all planned sites recruited participants. Only those regions that recruited at least one participant are listed.|participants|Number|1|1.0||||||
4196364|NCT00761280|4019141|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4196365|NCT00761280|4019142|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4196366|NCT00761280|4019143|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4196367|NCT00761280|4019141|B3|American Indian or Native Alaskan||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4196368|NCT00761280|4019142|B2|American Indian or Native Alaskan||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4196369|NCT00761280|4019143|B1|American Indian or Native Alaskan||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4196370|NCT00761280|4019141|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4196371|NCT00761280|4019142|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4196372|NCT00761280|4019143|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4196373|NCT00761280|4019141|B3|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4196374|NCT00761280|4019142|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4196375|NCT00761280|4019143|B1|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4196376|NCT00761280|4019141|B3|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4196377|NCT00761280|4019142|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4196378|NCT00761280|4019143|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4196379|NCT00761280|4019141|B3|White||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4196380|NCT00761280|4019142|B2|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4196381|NCT00761280|4019143|B1|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4196382|NCT00761280|4019141|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4196383|NCT00761280|4019142|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4196384|NCT00761280|4019143|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4196390|NCT00761280|4019143|B1|||Age||years|Mean|38.2|38.2|Standard Deviation|12.72|12.72|||
4196391|NCT00761267|4019172|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4196392|NCT00761267|4019173|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4196393|NCT00761267|4019174|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4196394|NCT00761267|4019175|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196395|NCT00761267|4019172|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196396|NCT00761267|4019173|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196397|NCT00761267|4019174|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196398|NCT00761267|4019175|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196399|NCT00761267|4019172|B4||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4196400|NCT00761267|4019173|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4196401|NCT00761267|4019174|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4196402|NCT00761267|4019175|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4196403|NCT00761267|4019172|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4196404|NCT00761267|4019173|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196405|NCT00761267|4019174|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4196406|NCT00761267|4019175|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196407|NCT00761267|4019172|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196408|NCT00761267|4019173|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196409|NCT00761267|4019174|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196410|NCT00761267|4019175|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196411|NCT00761267|4019172|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4196412|NCT00761267|4019173|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4196413|NCT00761267|4019174|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4196414|NCT00761267|4019175|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196415|NCT00761267|4019172|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196416|NCT00761267|4019173|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196417|NCT00761267|4019174|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196418|NCT00761267|4019175|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196419|NCT00761267|4019172|B4||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4196420|NCT00761267|4019173|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4196421|NCT00761267|4019174|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4196422|NCT00761267|4019175|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4196423|NCT00761267|4019172|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4196424|NCT00761267|4019173|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4196425|NCT00761267|4019174|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4196426|NCT00761267|4019175|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4196427|NCT00761267|4019172|B4|||Age||years|Mean|5.83|5.83|Standard Deviation|5.05|5.05|||
4196428|NCT00761267|4019173|B3|||Age||years|Mean|10.67|10.67|Standard Deviation|3.68|3.68|||
4196429|NCT00761267|4019174|B2|||Age||years|Mean|3.09|3.09|Standard Deviation|0.68|0.68|||
4196430|NCT00761267|4019175|B1|||Age||years|Mean|0.93|0.93|Standard Deviation|0.52|0.52|||
4196431|NCT00761215|4019204|B4||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4196432|NCT00761215|4019205|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4196433|NCT00761215|4019206|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4196434|NCT00761215|4019207|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4196435|NCT00761215|4019204|B4||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4196436|NCT00761215|4019205|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4196437|NCT00761215|4019206|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4196438|NCT00761215|4019207|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4196439|NCT00761215|4019204|B4|||Age||years|Mean|36.4|36.4|Standard Deviation|12.1|12.1|||
4196440|NCT00761215|4019205|B3|||Age||years|Mean|35.8|35.8|Standard Deviation|12.0|12.0|||
4196441|NCT00761215|4019206|B2|||Age||years|Mean|36.0|36.0|Standard Deviation|12.4|12.4|||
4196442|NCT00761215|4019207|B1|||Age||years|Mean|37.3|37.3|Standard Deviation|12.1|12.1|||
4196443|NCT00761202|4019232|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4196444|NCT00761202|4019233|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4196445|NCT00761202|4019234|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4196446|NCT00761202|4019232|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4196447|NCT00761202|4019233|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4196448|NCT00761202|4019234|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4196449|NCT00761202|4019232|B3|||Age||years|Mean|42.0|42.0|Standard Deviation|16.0|16.0|||
4196450|NCT00761202|4019233|B2|||Age||years|Mean|39.9|39.9|Standard Deviation|14.8|14.8|||
4196451|NCT00761202|4019234|B1|||Age||years|Mean|44.8|44.8|Standard Deviation|16.4|16.4|||
4196452|NCT00761189|4019251|B1||Male|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
4196453|NCT00761189|4019251|B1||Female|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
4196454|NCT00761189|4019251|B1|||Age||years|Mean|36.7|36.7|Standard Deviation|10.44|10.44|||
4196455|NCT00761176|4019266|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4196456|NCT00761176|4019267|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4196457|NCT00761176|4019268|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4196458|NCT00761176|4019266|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4196459|NCT00761176|4019267|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4196460|NCT00761176|4019268|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4196461|NCT00761176|4019266|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4196462|NCT00761176|4019267|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4196463|NCT00761176|4019268|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4196464|NCT00761176|4019266|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4196465|NCT00761176|4019267|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4196466|NCT00761176|4019268|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4196467|NCT00761176|4019266|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4196468|NCT00761176|4019267|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4196469|NCT00761176|4019268|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4196470|NCT00761176|4019266|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4196471|NCT00761176|4019267|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4196472|NCT00761176|4019268|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4196473|NCT00761176|4019266|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4196474|NCT00761176|4019267|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4196475|NCT00761176|4019268|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4196476|NCT00761150|4019275|B4|||Double-blind Baseline Sleep Interference by Pain Scale|The last assessment of how much back pain interfered with their sleep on a scale of 0 (not at all) to 10 (completely) conducted before the first dose in the double-blind period.|scores on a scale|Mean|2.2|2.2|Standard Deviation|1.91|1.91|||
4196477|NCT00761150|4019276|B3|||Double-blind Baseline Sleep Interference by Pain Scale|The last assessment of how much back pain interfered with their sleep on a scale of 0 (not at all) to 10 (completely) conducted before the first dose in the double-blind period.|scores on a scale|Mean|2.1|2.1|Standard Deviation|1.82|1.82|||
4196478|NCT00761150|4019277|B2|||Double-blind Baseline Sleep Interference by Pain Scale|The last assessment of how much back pain interfered with their sleep on a scale of 0 (not at all) to 10 (completely) conducted before the first dose in the double-blind period.|scores on a scale|Mean|2.2|2.2|Standard Deviation|2.01|2.01|||
4196479|NCT00761150|4019278|B1|||Double-blind Baseline Sleep Interference by Pain Scale|The last assessment of how much back pain interfered with their sleep on a scale of 0 (not at all) to 10 (completely) conducted before the first dose in the double-blind period.|scores on a scale|Mean|NA||Standard Deviation|NA||||These subjects were not randomized to the double-blind period.
4196480|NCT00761150|4019275|B4|||Double-blind Baseline CLBP Intensity VAS|The last assessment using the CLBP Intensity Visual Analog Scale (VAS) (0 mm = No Pain and 100 mm = Worst Pain Imaginable) conducted before the first dose in the double-blind period.|scores on a scale|Mean|22.6|22.6|Standard Deviation|15.03|15.03|||
4196481|NCT00761150|4019276|B3|||Double-blind Baseline CLBP Intensity VAS|The last assessment using the CLBP Intensity Visual Analog Scale (VAS) (0 mm = No Pain and 100 mm = Worst Pain Imaginable) conducted before the first dose in the double-blind period.|scores on a scale|Mean|22.9|22.9|Standard Deviation|14.86|14.86|||
4196482|NCT00761150|4019277|B2|||Double-blind Baseline CLBP Intensity VAS|The last assessment using the CLBP Intensity Visual Analog Scale (VAS) (0 mm = No Pain and 100 mm = Worst Pain Imaginable) conducted before the first dose in the double-blind period.|scores on a scale|Mean|22.4|22.4|Standard Deviation|15.25|15.25|||
4196483|NCT00761150|4019278|B1|||Double-blind Baseline CLBP Intensity VAS|The last assessment using the CLBP Intensity Visual Analog Scale (VAS) (0 mm = No Pain and 100 mm = Worst Pain Imaginable) conducted before the first dose in the double-blind period.|scores on a scale|Mean|NA||Standard Deviation|NA||||These subjects were not randomized to the double-blind period.
4196484|NCT00761150|4019275|B4||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4196485|NCT00761150|4019276|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4196486|NCT00761150|4019277|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4196487|NCT00761150|4019278|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4196488|NCT00761150|4019275|B4||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4196489|NCT00761150|4019276|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4196490|NCT00761150|4019277|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4196491|NCT00761150|4019278|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4196492|NCT00761150|4019275|B4|||Age||years|Mean|49.0|49.0|Standard Deviation|12.44|12.44|||
4196493|NCT00761150|4019276|B3|||Age||years|Mean|48.4|48.4|Standard Deviation|12.24|12.24|||
4196494|NCT00761150|4019277|B2|||Age||years|Mean|48.1|48.1|Standard Deviation|12.64|12.64|||
4196495|NCT00761150|4019278|B1|||Age||years|Mean|51.3|51.3|Standard Deviation|12.31|12.31|||
4196496|NCT00761137|4019289|B1|Argentina||Region of Enrollment||participants|Number|19|19.0||||||
4196497|NCT00761137|4019289|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4196498|NCT00761137|4019289|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4196499|NCT00761137|4019289|B1|||Age||years|Mean|67|67.0|Standard Deviation|12|12.0|||
4196500|NCT00761007|4019300|B5|IBS-Unsubtyped||IBS-Subtype||participants|Number|34|34.0||||||
4196501|NCT00761007|4019301|B4|IBS-Unsubtyped||IBS-Subtype||participants|Number|10|10.0||||||
4196502|NCT00761007|4019302|B3|IBS-Unsubtyped||IBS-Subtype||participants|Number|8|8.0||||||
4196503|NCT00761007|4019303|B2|IBS-Unsubtyped||IBS-Subtype||participants|Number|7|7.0||||||
4196504|NCT00761007|4019304|B1|IBS-Unsubtyped||IBS-Subtype||participants|Number|9|9.0||||||
4196505|NCT00761007|4019300|B5|IBS-Mixed||IBS-Subtype||participants|Number|111|111.0||||||
4196506|NCT00761007|4019301|B4|IBS-Mixed||IBS-Subtype||participants|Number|22|22.0||||||
4196507|NCT00761007|4019302|B3|IBS-Mixed||IBS-Subtype||participants|Number|34|34.0||||||
4196508|NCT00761007|4019303|B2|IBS-Mixed||IBS-Subtype||participants|Number|29|29.0||||||
4196509|NCT00761007|4019304|B1|IBS-Mixed||IBS-Subtype||participants|Number|26|26.0||||||
4196510|NCT00761007|4019300|B5|IBS-Constipation||IBS-Subtype||participants|Number|165|165.0||||||
4196511|NCT00761007|4019301|B4|IBS-Constipation||IBS-Subtype||participants|Number|50|50.0||||||
4196512|NCT00761007|4019302|B3|IBS-Constipation||IBS-Subtype||participants|Number|34|34.0||||||
4196513|NCT00761007|4019303|B2|IBS-Constipation||IBS-Subtype||participants|Number|44|44.0||||||
4196514|NCT00761007|4019304|B1|IBS-Constipation||IBS-Subtype||participants|Number|37|37.0||||||
4196515|NCT00761007|4019300|B5|IBS-Diarrhea||IBS-Subtype||participants|Number|234|234.0||||||
4196516|NCT00761007|4019301|B4|IBS-Diarrhea||IBS-Subtype||participants|Number|54|54.0||||||
4196517|NCT00761007|4019302|B3|IBS-Diarrhea||IBS-Subtype||participants|Number|59|59.0||||||
4196518|NCT00761007|4019303|B2|IBS-Diarrhea||IBS-Subtype||participants|Number|53|53.0||||||
4196519|NCT00761007|4019304|B1|IBS-Diarrhea||IBS-Subtype||participants|Number|68|68.0||||||
4196520|NCT00761007|4019300|B5||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4196521|NCT00761007|4019301|B4||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4196522|NCT00761007|4019302|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4196523|NCT00761007|4019303|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4196524|NCT00761007|4019304|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4196525|NCT00761007|4019300|B5||Female|Sex: Female, Male||Participants|Count of Participants|367|367.0||||||
4196526|NCT00761007|4019301|B4||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4196527|NCT00761007|4019302|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4196528|NCT00761007|4019303|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4196529|NCT00761007|4019304|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4196530|NCT00761007|4019300|B5|||Age||years|Mean|44.2|44.2|Standard Deviation|13.18|13.18|||
4196531|NCT00761007|4019301|B4|||Age||years|Mean|43.7|43.7|Standard Deviation|13.73|13.73|||
4196532|NCT00761007|4019302|B3|||Age||years|Mean|44.4|44.4|Standard Deviation|12.97|12.97|||
4196533|NCT00761007|4019303|B2|||Age||years|Mean|45.0|45.0|Standard Deviation|12.66|12.66|||
4196534|NCT00761007|4019304|B1|||Age||years|Mean|43.9|43.9|Standard Deviation|13.43|13.43|||
4196535|NCT00760877|4019329|B3||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4196536|NCT00760877|4019330|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4196537|NCT00760877|4019331|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4196538|NCT00760877|4019329|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4196539|NCT00760877|4019330|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4196540|NCT00760877|4019331|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4196541|NCT00760877|4019329|B3|||Age||Years|Mean|49.1|49.1|Standard Deviation|13.16|13.16|||
4196542|NCT00760877|4019330|B2|||Age||Years|Mean|49.9|49.9|Standard Deviation|13.07|13.07|||
4196543|NCT00760877|4019331|B1|||Age||Years|Mean|48.3|48.3|Standard Deviation|13.26|13.26|||
4196544|NCT00760838|4019348|B3|Belgium||Region of Enrollment||participants|Number|109|109.0||||||
4196545|NCT00760838|4019349|B2|Belgium||Region of Enrollment||participants|Number|55|55.0||||||
4196546|NCT00760838|4019350|B1|Belgium||Region of Enrollment||participants|Number|54|54.0||||||
4196547|NCT00760838|4019348|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4196548|NCT00760838|4019349|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4196549|NCT00760838|4019350|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4196550|NCT00760838|4019348|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4196551|NCT00760838|4019349|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4196552|NCT00760838|4019350|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4196553|NCT00760838|4019348|B3|||Age||years|Median|53|53.0|Inter-Quartile Range|||46.0|64.0|
4196554|NCT00760838|4019349|B2|||Age||years|Median|53|53.0|Inter-Quartile Range|||46.0|64.0|
4196555|NCT00760838|4019350|B1|||Age||years|Median|53|53.0|Inter-Quartile Range|||36.0|60.0|
4196556|NCT00760838|4019348|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4196557|NCT00760838|4019349|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4196558|NCT00760838|4019350|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4196559|NCT00760838|4019348|B3||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
4196560|NCT00760838|4019349|B2||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4196561|NCT00760838|4019350|B1||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4196562|NCT00760838|4019348|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4196563|NCT00760838|4019349|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4196564|NCT00760838|4019350|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4196565|NCT00760747|4019367|B3|Not otherwise categorized||Attention Deficit Hyperactivity Disorder (ADHD) subtype|ADHD subtype was classified by Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) criteria.|participants|Number|1|1.0||||||
4196566|NCT00760747|4019368|B2|Not otherwise categorized||Attention Deficit Hyperactivity Disorder (ADHD) subtype|ADHD subtype was classified by Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) criteria.|participants|Number|0|0.0||||||
4196567|NCT00760747|4019369|B1|Not otherwise categorized||Attention Deficit Hyperactivity Disorder (ADHD) subtype|ADHD subtype was classified by Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) criteria.|participants|Number|1|1.0||||||
4196568|NCT00760747|4019367|B3|Inattentive||Attention Deficit Hyperactivity Disorder (ADHD) subtype|ADHD subtype was classified by Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) criteria.|participants|Number|32|32.0||||||
4196569|NCT00760747|4019368|B2|Inattentive||Attention Deficit Hyperactivity Disorder (ADHD) subtype|ADHD subtype was classified by Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) criteria.|participants|Number|15|15.0||||||
4196570|NCT00760747|4019369|B1|Inattentive||Attention Deficit Hyperactivity Disorder (ADHD) subtype|ADHD subtype was classified by Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) criteria.|participants|Number|17|17.0||||||
4196571|NCT00760747|4019367|B3|Hyperactive/Impulsive||Attention Deficit Hyperactivity Disorder (ADHD) subtype|ADHD subtype was classified by Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) criteria.|participants|Number|4|4.0||||||
4196572|NCT00760747|4019368|B2|Hyperactive/Impulsive||Attention Deficit Hyperactivity Disorder (ADHD) subtype|ADHD subtype was classified by Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) criteria.|participants|Number|3|3.0||||||
4196573|NCT00760747|4019369|B1|Hyperactive/Impulsive||Attention Deficit Hyperactivity Disorder (ADHD) subtype|ADHD subtype was classified by Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) criteria.|participants|Number|1|1.0||||||
4196574|NCT00760747|4019367|B3|Combined||Attention Deficit Hyperactivity Disorder (ADHD) subtype|ADHD subtype was classified by Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) criteria.|participants|Number|74|74.0||||||
4196575|NCT00760747|4019368|B2|Combined||Attention Deficit Hyperactivity Disorder (ADHD) subtype|ADHD subtype was classified by Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) criteria.|participants|Number|36|36.0||||||
4196576|NCT00760747|4019369|B1|Combined||Attention Deficit Hyperactivity Disorder (ADHD) subtype|ADHD subtype was classified by Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) criteria.|participants|Number|38|38.0||||||
4196577|NCT00760747|4019367|B3|Portugal||Region of Enrollment||participants|Number|7|7.0||||||
4196578|NCT00760747|4019368|B2|Portugal||Region of Enrollment||participants|Number|4|4.0||||||
4196579|NCT00760747|4019369|B1|Portugal||Region of Enrollment||participants|Number|3|3.0||||||
4196580|NCT00760747|4019367|B3|Spain||Region of Enrollment||participants|Number|57|57.0||||||
4196581|NCT00760747|4019368|B2|Spain||Region of Enrollment||participants|Number|28|28.0||||||
4196582|NCT00760747|4019369|B1|Spain||Region of Enrollment||participants|Number|29|29.0||||||
4196583|NCT00760747|4019367|B3|United Kingdom||Region of Enrollment||participants|Number|15|15.0||||||
4196584|NCT00760747|4019368|B2|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
4196585|NCT00760747|4019369|B1|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
4196586|NCT00760747|4019367|B3|Australia||Region of Enrollment||participants|Number|12|12.0||||||
4196587|NCT00760747|4019368|B2|Australia||Region of Enrollment||participants|Number|5|5.0||||||
4196588|NCT00760747|4019369|B1|Australia||Region of Enrollment||participants|Number|7|7.0||||||
4196589|NCT00760747|4019367|B3|Mexico||Region of Enrollment||participants|Number|20|20.0||||||
4196590|NCT00760747|4019368|B2|Mexico||Region of Enrollment||participants|Number|10|10.0||||||
4196591|NCT00760747|4019369|B1|Mexico||Region of Enrollment||participants|Number|10|10.0||||||
4196592|NCT00760747|4019367|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
4196593|NCT00760747|4019368|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4196594|NCT00760747|4019369|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4196595|NCT00760747|4019367|B3|African||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4196596|NCT00760747|4019368|B2|African||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4196597|NCT00760747|4019369|B1|African||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4196598|NCT00760747|4019367|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|89|89.0||||||
4196599|NCT00760747|4019368|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|43|43.0||||||
4196600|NCT00760747|4019369|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|46|46.0||||||
4196601|NCT00760747|4019367|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4196602|NCT00760747|4019368|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4196603|NCT00760747|4019369|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4196604|NCT00760747|4019367|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4196605|NCT00760747|4019368|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4196606|NCT00760747|4019369|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4196607|NCT00760747|4019367|B3|||Age||years|Mean|11.5|11.5|Standard Deviation|2.38|2.38|||
4196608|NCT00760747|4019368|B2|||Age||years|Mean|12.0|12.0|Standard Deviation|2.16|2.16|||
4196609|NCT00760747|4019369|B1|||Age||years|Mean|11.1|11.1|Standard Deviation|2.51|2.51|||
4196610|NCT00760669|4019398|B1||Male|Sex: Female, Male||Participants|Count of Participants|692|692.0||||||
4196611|NCT00760669|4019398|B1||Female|Sex: Female, Male||Participants|Count of Participants|363|363.0||||||
4196612|NCT00760669|4019398|B1|||Age||years|Mean|39.32|39.32|Standard Deviation|13.84|13.84|||
4196613|NCT00760617|4019412|B4||Male|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
4196614|NCT00760617|4019413|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4196615|NCT00760617|4019414|B2||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4196616|NCT00760617|4019415|B1||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4196617|NCT00760617|4019412|B4||Female|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
4196618|NCT00760617|4019413|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4196619|NCT00760617|4019414|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4196620|NCT00760617|4019415|B1||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4196621|NCT00760617|4019412|B4|||Age||Years|Mean|63.59|63.59|Standard Deviation|19.65|19.65|||
4196622|NCT00760617|4019413|B3|||Age||Years|Mean|28.2|28.2|Standard Deviation|6.34|6.34|||
4196623|NCT00760617|4019414|B2|||Age||Years|Mean|73.8|73.8|Standard Deviation|5.54|5.54|||
4196624|NCT00760617|4019415|B1|||Age||Years|Mean|73.5|73.5|Standard Deviation|5.27|5.27|||
4196625|NCT00760578|4019488|B5|United States||Region of Enrollment||participants|Number|86|86.0||||||
4196626|NCT00760578|4019489|B4|United States||Region of Enrollment||participants|Number|22|22.0||||||
4196627|NCT00760578|4019490|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4196628|NCT00760578|4019491|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4196629|NCT00760578|4019492|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4196630|NCT00760578|4019488|B5||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4196631|NCT00760578|4019489|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4196632|NCT00760578|4019490|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4196633|NCT00760578|4019491|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4196634|NCT00760578|4019492|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4196635|NCT00760578|4019488|B5||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4196636|NCT00760578|4019489|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4196637|NCT00760578|4019490|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4196638|NCT00760578|4019491|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4196639|NCT00760578|4019492|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4196640|NCT00760578|4019488|B5|||Age||years|Mean|55.5|55.5|Standard Deviation|8.15|8.15|||
4196641|NCT00760578|4019489|B4|||Age||years|Mean|54.5|54.5|Standard Deviation|8.79|8.79|||
4196642|NCT00760578|4019490|B3|||Age||years|Mean|57.7|57.7|Standard Deviation|6.38|6.38|||
4196643|NCT00760578|4019491|B2|||Age||years|Mean|53.7|53.7|Standard Deviation|9.22|9.22|||
4196644|NCT00760578|4019492|B1|||Age||years|Mean|56.3|56.3|Standard Deviation|8.20|8.2|||
4196645|NCT00760552|4019529|B3|United States||Region of Enrollment||participants|Number|123|123.0||||||
4196646|NCT00760552|4019530|B2|United States||Region of Enrollment||participants|Number|62|62.0||||||
4196647|NCT00760552|4019531|B1|United States||Region of Enrollment||participants|Number|61|61.0||||||
4196648|NCT00760552|4019529|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4196649|NCT00760552|4019530|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4196650|NCT00760552|4019531|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4196651|NCT00760552|4019529|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196652|NCT00760552|4019530|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196653|NCT00760552|4019531|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196654|NCT00760552|4019529|B3||White|Race (NIH/OMB)||Participants|Count of Participants|114|114.0||||||
4196655|NCT00760552|4019530|B2||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4196656|NCT00760552|4019531|B1||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4196657|NCT00760552|4019529|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196658|NCT00760552|4019530|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196659|NCT00760552|4019531|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196660|NCT00760552|4019529|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196661|NCT00760552|4019530|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196662|NCT00760552|4019531|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196663|NCT00760552|4019529|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196664|NCT00760552|4019530|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196665|NCT00760552|4019531|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196666|NCT00760552|4019529|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196667|NCT00760552|4019530|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196668|NCT00760552|4019531|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196669|NCT00760552|4019529|B3||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4196670|NCT00760552|4019530|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4196671|NCT00760552|4019531|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4196672|NCT00760552|4019529|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4196673|NCT00760552|4019530|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4196674|NCT00760552|4019531|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4196675|NCT00760552|4019529|B3|||Age||years|Mean|64.8|64.8|Standard Deviation|10.8|10.8|||
4196676|NCT00760552|4019530|B2|||Age||years|Mean|66.0|66.0|Standard Deviation|10.3|10.3|||
4196677|NCT00760552|4019531|B1|||Age||years|Mean|63.6|63.6|Standard Deviation|11.2|11.2|||
4196678|NCT00760526|4019538|B3|United States||Region of Enrollment||participants|Number|146|146.0||||||
4196679|NCT00760526|4019539|B2|United States||Region of Enrollment||participants|Number|72|72.0||||||
4196680|NCT00760526|4019540|B1|United States||Region of Enrollment||participants|Number|74|74.0||||||
4196681|NCT00760526|4019538|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4196682|NCT00760526|4019539|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4196683|NCT00760526|4019540|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4196684|NCT00760526|4019538|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4196685|NCT00760526|4019539|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4196686|NCT00760526|4019540|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4196687|NCT00760526|4019538|B3|||Age||years|Mean|7.5|7.5|Standard Deviation|1.7|1.7|||
4196688|NCT00760526|4019539|B2|||Age||years|Mean|7.5|7.5|Standard Deviation|1.7|1.7|||
4196689|NCT00760526|4019540|B1|||Age||years|Mean|7.5|7.5|Standard Deviation|1.8|1.8|||
4196690|NCT00760526|4019538|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4196691|NCT00760526|4019539|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4196692|NCT00760526|4019540|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4196693|NCT00760526|4019538|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4196694|NCT00760526|4019539|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4196695|NCT00760526|4019540|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4196696|NCT00760526|4019538|B3||<=18 years|Age||Participants|Count of Participants|146|146.0||||||
4196697|NCT00760526|4019539|B2||<=18 years|Age||Participants|Count of Participants|72|72.0||||||
4196698|NCT00760526|4019540|B1||<=18 years|Age||Participants|Count of Participants|74|74.0||||||
4196699|NCT00760487|4019566|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4196700|NCT00760487|4019566|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4196701|NCT00760487|4019566|B1||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
4196702|NCT00760487|4019566|B1||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
4196703|NCT00760487|4019566|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4196704|NCT00760474|4019572|B1|||Sex/Gender, Customized|Female|participants|Number|25|25.0||||||
4196705|NCT00760474|4019572|B1|||Age||years|Mean|38.6|38.6|Standard Deviation|12.0|12.0|||
4196706|NCT00760461|4019609|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4196707|NCT00760461|4019609|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4196708|NCT00760435|4019613|B3|United States||Region of Enrollment||participants|Number|196|196.0||||||
4196709|NCT00760435|4019614|B2|United States||Region of Enrollment||participants|Number|98|98.0||||||
4196710|NCT00760435|4019615|B1|United States||Region of Enrollment||participants|Number|98|98.0||||||
4196711|NCT00760435|4019613|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196712|NCT00760435|4019614|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196713|NCT00760435|4019615|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196714|NCT00760435|4019613|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4196715|NCT00760435|4019614|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4196716|NCT00760435|4019615|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4196717|NCT00760435|4019613|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|121|121.0||||||
4196718|NCT00760435|4019614|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4196719|NCT00760435|4019615|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4196720|NCT00760435|4019613|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196721|NCT00760435|4019614|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196722|NCT00760435|4019615|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196723|NCT00760435|4019613|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4196724|NCT00760435|4019614|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4196725|NCT00760435|4019615|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4196726|NCT00760435|4019613|B3||White|Race (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
4196727|NCT00760435|4019614|B2||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4196728|NCT00760435|4019615|B1||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4196729|NCT00760435|4019613|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4196730|NCT00760435|4019614|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4196731|NCT00760435|4019615|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4196732|NCT00760435|4019613|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4196733|NCT00760435|4019614|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196734|NCT00760435|4019615|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4196735|NCT00760435|4019613|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4196736|NCT00760435|4019614|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4196737|NCT00760435|4019615|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4196738|NCT00760435|4019613|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4196739|NCT00760435|4019614|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196740|NCT00760435|4019615|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4196741|NCT00760435|4019613|B3||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4196742|NCT00760435|4019614|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4196743|NCT00760435|4019615|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4196744|NCT00760435|4019613|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4196745|NCT00760435|4019614|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4196746|NCT00760435|4019615|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4196747|NCT00760435|4019613|B3|||Age||years|Median|2.9|2.9|Inter-Quartile Range|||1.8|4.6|
4196748|NCT00760435|4019614|B2|||Age||years|Median|2.8|2.8|Inter-Quartile Range|||1.8|4.2|
4196749|NCT00760435|4019615|B1|||Age||years|Median|3.0|3.0|Inter-Quartile Range|||1.9|4.8|
4196750|NCT00760383|4019628|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4196751|NCT00760383|4019629|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4196752|NCT00760383|4019630|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4196753|NCT00760383|4019628|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4196754|NCT00760383|4019629|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4196755|NCT00760383|4019630|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4196756|NCT00760383|4019628|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4196757|NCT00760383|4019629|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4196758|NCT00760383|4019630|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4196759|NCT00760383|4019628|B3||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4196760|NCT00760383|4019629|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4196761|NCT00760383|4019630|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4196762|NCT00760383|4019628|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4196763|NCT00760383|4019629|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4196764|NCT00760383|4019630|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4196765|NCT00760383|4019628|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4196766|NCT00760383|4019629|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4196767|NCT00760383|4019630|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4196768|NCT00760383|4019628|B3|||Age||years|Mean|69|69.0|Standard Deviation|5|5.0|||
4196769|NCT00760383|4019629|B2|||Age||years|Mean|70|70.0|Standard Deviation|5|5.0|||
4196770|NCT00760383|4019630|B1|||Age||years|Mean|68|68.0|Standard Deviation|5|5.0|||
4196771|NCT00760266|4019641|B3||Male|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
4196772|NCT00760266|4019642|B2||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4196773|NCT00760266|4019643|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4196774|NCT00760266|4019641|B3||Female|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
4196775|NCT00760266|4019642|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4196776|NCT00760266|4019643|B1||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4196777|NCT00760266|4019641|B3|||Age||years|Mean|64.8|64.8|Standard Deviation|7.27|7.27|||
4196778|NCT00760266|4019642|B2|||Age||years|Mean|65.1|65.1|Standard Deviation|6.96|6.96|||
4196779|NCT00760266|4019643|B1|||Age||years|Mean|64.5|64.5|Standard Deviation|7.57|7.57|||
4196780|NCT00760214|4019658|B4||Male|Sex: Female, Male||Participants|Count of Participants|463|463.0||||||
4196781|NCT00760214|4019659|B3||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4196782|NCT00760214|4019660|B2||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4196783|NCT00760214|4019661|B1||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4196784|NCT00760214|4019658|B4||Female|Sex: Female, Male||Participants|Count of Participants|421|421.0||||||
4196785|NCT00760214|4019659|B3||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4196786|NCT00760214|4019660|B2||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4196787|NCT00760214|4019661|B1||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4196788|NCT00760214|4019658|B4|≥65 years||Age, Customized||Participants|Number|240|240.0||||||
4196789|NCT00760214|4019659|B3|≥65 years||Age, Customized||Participants|Number|70|70.0||||||
4196790|NCT00760214|4019660|B2|≥65 years||Age, Customized||Participants|Number|81|81.0||||||
4196791|NCT00760214|4019661|B1|≥65 years||Age, Customized||Participants|Number|89|89.0||||||
4196792|NCT00760214|4019658|B4|Between 45 and 64 years||Age, Customized||Participants|Number|529|529.0||||||
4196793|NCT00760214|4019659|B3|Between 45 and 64 years||Age, Customized||Participants|Number|195|195.0||||||
4196794|NCT00760214|4019660|B2|Between 45 and 64 years||Age, Customized||Participants|Number|168|168.0||||||
4196795|NCT00760214|4019661|B1|Between 45 and 64 years||Age, Customized||Participants|Number|166|166.0||||||
4196796|NCT00760214|4019658|B4|<45 years||Age, Customized||Participants|Number|115|115.0||||||
4196797|NCT00760214|4019659|B3|<45 years||Age, Customized||Participants|Number|30|30.0||||||
4196798|NCT00760214|4019660|B2|<45 years||Age, Customized||Participants|Number|45|45.0||||||
4196799|NCT00760214|4019661|B1|<45 years||Age, Customized||Participants|Number|40|40.0||||||
4196800|NCT00760084|4019704|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4196801|NCT00760084|4019704|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4196802|NCT00760084|4019704|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196803|NCT00760084|4019704|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4196804|NCT00760084|4019704|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4196805|NCT00760084|4019704|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196806|NCT00760084|4019704|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196807|NCT00760084|4019704|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196808|NCT00760084|4019704|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4196809|NCT00760084|4019704|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4196810|NCT00760084|4019704|B1|||Age||years|Mean|68.5|68.5|Standard Deviation|11.15|11.15|||
4196811|NCT00760019|4019708|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4196812|NCT00760019|4019709|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4196813|NCT00760019|4019710|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4196814|NCT00760019|4019708|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4196815|NCT00760019|4019709|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4196816|NCT00760019|4019710|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4196817|NCT00760019|4019708|B3|||Age||years|Mean|56|56.0|Standard Deviation|11|11.0|||
4196818|NCT00760019|4019709|B2|||Age||years|Mean|52|52.0|Standard Deviation|13|13.0|||
4196819|NCT00760019|4019710|B1|||Age||years|Mean|60|60.0|Standard Deviation|9|9.0|||
4196820|NCT00760006|4019719|B3|United States||Region of Enrollment||Participants|Count of Participants|224|224.0||||||
4196821|NCT00760006|4019720|B2|United States||Region of Enrollment||Participants|Count of Participants|138|138.0||||||
4196822|NCT00760006|4019721|B1|United States||Region of Enrollment||Participants|Count of Participants|86|86.0||||||
4196823|NCT00760006|4019719|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4196824|NCT00760006|4019719|B3||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4196825|NCT00760006|4019720|B2||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4196826|NCT00760006|4019721|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4196827|NCT00760006|4019719|B3||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4196828|NCT00760006|4019720|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4196829|NCT00760006|4019721|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4196830|NCT00760006|4019719|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4196831|NCT00760006|4019720|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4196832|NCT00760006|4019721|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4196833|NCT00760006|4019719|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4196834|NCT00760006|4019720|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4196835|NCT00760006|4019721|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4196836|NCT00760006|4019719|B3||<=18 years|Age||Participants|Count of Participants|224|224.0||||||
4196837|NCT00760006|4019720|B2||<=18 years|Age||Participants|Count of Participants|138|138.0||||||
4196838|NCT00760006|4019721|B1||<=18 years|Age||Participants|Count of Participants|86|86.0||||||
4196839|NCT00759967|4019728|B1|Canada||Region of Enrollment||participants|Number|19|19.0||||||
4196840|NCT00759967|4019728|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4196841|NCT00759967|4019728|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4196842|NCT00759967|4019728|B1|||Age||years|Mean|53|53.0|Standard Deviation|13|13.0|||
4196843|NCT00759967|4019728|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4196844|NCT00759967|4019728|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4196845|NCT00759967|4019728|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4196846|NCT00759954|4019745|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4196847|NCT00759954|4019746|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4196848|NCT00759954|4019747|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4196849|NCT00759954|4019745|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4196850|NCT00759954|4019746|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4196851|NCT00759954|4019747|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4196852|NCT00759954|4019745|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4196853|NCT00759954|4019746|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4196854|NCT00759954|4019747|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4196855|NCT00759954|4019745|B3|||Age||years|Mean|28.06|28.06|Standard Deviation|7.57|7.57|||
4196856|NCT00759954|4019746|B2|||Age||years|Mean|29.61|29.61|Standard Deviation|8.81|8.81|||
4196857|NCT00759954|4019747|B1|||Age||years|Mean|26.50|26.5|Standard Deviation|5.93|5.93|||
4196858|NCT00759954|4019745|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4196859|NCT00759954|4019746|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4196860|NCT00759954|4019747|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4196861|NCT00759954|4019745|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4196862|NCT00759954|4019746|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4196863|NCT00759954|4019747|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4196864|NCT00759954|4019745|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4196865|NCT00759954|4019746|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4196866|NCT00759954|4019747|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4196867|NCT00759941|4019760|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4196868|NCT00759941|4019761|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4196869|NCT00759941|4019762|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4196870|NCT00759941|4019760|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4196871|NCT00759941|4019761|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4196872|NCT00759941|4019762|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4196873|NCT00759941|4019760|B3|||Age||years|Mean|65.58|65.58|Standard Deviation|11.75|11.75|||
4196874|NCT00759941|4019761|B2|||Age||years|Mean|68.13|68.13|Standard Deviation|11.59|11.59|||
4196875|NCT00759941|4019762|B1|||Age||years|Mean|62.90|62.9|Standard Deviation|11.43|11.43|||
4196876|NCT00759915|4019775|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4196877|NCT00759915|4019776|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4196878|NCT00759915|4019777|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4196879|NCT00759915|4019775|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4196880|NCT00759915|4019776|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4196881|NCT00759915|4019777|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4196882|NCT00759915|4019775|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4196883|NCT00759915|4019776|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4196884|NCT00759915|4019777|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4196885|NCT00759915|4019775|B3|||Age||years|Mean|33|33.0|Standard Deviation|12|12.0|||
4196886|NCT00759915|4019776|B2|||Age||years|Mean|29|29.0|Standard Deviation|10|10.0|||
4196887|NCT00759915|4019777|B1|||Age||years|Mean|36|36.0|Standard Deviation|12|12.0|||
4196888|NCT00759915|4019775|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4196889|NCT00759915|4019776|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4196890|NCT00759915|4019777|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4196891|NCT00759915|4019775|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4196892|NCT00759915|4019776|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4196893|NCT00759915|4019777|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4196894|NCT00759915|4019775|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4196895|NCT00759915|4019776|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4196896|NCT00759915|4019777|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4196897|NCT00759902|4019790|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4196898|NCT00759902|4019791|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4196899|NCT00759902|4019792|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4196900|NCT00759902|4019790|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4196901|NCT00759902|4019791|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4196902|NCT00759902|4019792|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4196903|NCT00759902|4019790|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4196904|NCT00759902|4019791|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4196905|NCT00759902|4019792|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4196906|NCT00759902|4019790|B3|||Age||years|Mean|31.7|31.7|Standard Deviation|9.2|9.2|||
4196907|NCT00759902|4019791|B2|||Age||years|Mean|31.7|31.7|Standard Deviation|8.9|8.9|||
4196908|NCT00759902|4019792|B1|||Age||years|Mean|31.6|31.6|Standard Deviation|9.6|9.6|||
4196909|NCT00759902|4019790|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4196910|NCT00759902|4019791|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4196911|NCT00759902|4019792|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4196912|NCT00759902|4019790|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4196913|NCT00759902|4019791|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4196914|NCT00759902|4019792|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4196915|NCT00759902|4019790|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4196916|NCT00759902|4019791|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4196917|NCT00759902|4019792|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4196918|NCT00759863|4019805|B3|United States||Region of Enrollment||participants|Number|242|242.0||||||
4196919|NCT00759863|4019806|B2|United States||Region of Enrollment||participants|Number|98|98.0||||||
4196920|NCT00759863|4019807|B1|United States||Region of Enrollment||participants|Number|144|144.0||||||
4196921|NCT00759863|4019805|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4196922|NCT00759863|4019806|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4196923|NCT00759863|4019807|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4196924|NCT00759863|4019805|B3||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4196925|NCT00759863|4019806|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4196926|NCT00759863|4019807|B1||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4196927|NCT00759863|4019805|B3|||Age||years|Mean|84.21|84.21|Standard Deviation|7.16|7.16|||
4196928|NCT00759863|4019806|B2|||Age||years|Mean|84.48|84.48|Standard Deviation|7.03|7.03|||
4196929|NCT00759863|4019807|B1|||Age||years|Mean|84.02|84.02|Standard Deviation|7.31|7.31|||
4196930|NCT00759811|4019818|B3|Brazil||Region of Enrollment||participants|Number|50|50.0||||||
4196931|NCT00759811|4019819|B2|Brazil||Region of Enrollment||participants|Number|25|25.0||||||
4196932|NCT00759811|4019820|B1|Brazil||Region of Enrollment||participants|Number|25|25.0||||||
4196933|NCT00759811|4019818|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4196934|NCT00759811|4019819|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4196935|NCT00759811|4019820|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4196936|NCT00759811|4019818|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4196937|NCT00759811|4019819|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4196938|NCT00759811|4019820|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4196939|NCT00759811|4019818|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|9.2|9.2|||
4196940|NCT00759811|4019819|B2|||Age||years|Mean|58.2|58.2|Standard Deviation|8.0|8.0|||
4196941|NCT00759811|4019820|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|10.3|10.3|||
4196942|NCT00759811|4019818|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4196943|NCT00759811|4019819|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4196944|NCT00759811|4019820|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4196945|NCT00759811|4019818|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4196946|NCT00759811|4019819|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4196947|NCT00759811|4019820|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4196948|NCT00759811|4019818|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4196949|NCT00759811|4019819|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4196950|NCT00759811|4019820|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4196951|NCT00759785|4019827|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4196952|NCT00759785|4019828|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4196953|NCT00759785|4019829|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4196954|NCT00759785|4019827|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4196955|NCT00759785|4019828|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4196956|NCT00759785|4019829|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4196957|NCT00759785|4019827|B3|||Age||Years|Mean|57.1|57.1|Standard Deviation|14.9|14.9|30.0|91.0|
4196958|NCT00759785|4019828|B2|||Age||Years|Mean|55.1|55.1|Standard Deviation|14.1|14.1|32.0|57.0|
4196959|NCT00759785|4019829|B1|||Age||Years|Mean|58.8|58.8|Standard Deviation|15.7|15.7|30.0|91.0|
4196960|NCT00759772|4019842|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4196961|NCT00759772|4019843|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4196962|NCT00759772|4019844|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4196963|NCT00759772|4019842|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4196964|NCT00759772|4019843|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4196965|NCT00759772|4019844|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4196966|NCT00759772|4019842|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4196967|NCT00759772|4019843|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4196968|NCT00759772|4019844|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4196969|NCT00759772|4019842|B3|||Age||years|Mean|47.3|47.3|Standard Deviation|8.5|8.5|||
4196970|NCT00759772|4019843|B2|||Age||years|Mean|47.1|47.1|Standard Deviation|7.6|7.6|||
4196971|NCT00759772|4019844|B1|||Age||years|Mean|47.6|47.6|Standard Deviation|9.6|9.6|||
4196972|NCT00759759|4019851|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4196973|NCT00759759|4019852|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4196974|NCT00759759|4019853|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4196975|NCT00759759|4019851|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4196976|NCT00759759|4019852|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4196977|NCT00759759|4019853|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4196978|NCT00759759|4019851|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4196979|NCT00759759|4019852|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4196980|NCT00759759|4019853|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4196981|NCT00759759|4019851|B3|||Age||years|Mean|33|33.0|Standard Deviation|8.8|8.8|||
4196982|NCT00759759|4019852|B2|||Age||years|Mean|34|34.0|Standard Deviation|9.2|9.2|||
4196983|NCT00759759|4019853|B1|||Age||years|Mean|31.8|31.8|Standard Deviation|8.5|8.5|||
4196984|NCT00759759|4019851|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4196985|NCT00759759|4019852|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4196986|NCT00759759|4019853|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4196987|NCT00759759|4019851|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4196988|NCT00759759|4019852|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4196989|NCT00759759|4019853|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4196990|NCT00759759|4019851|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4196991|NCT00759759|4019852|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4196992|NCT00759759|4019853|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4196993|NCT00759707|4019866|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4196994|NCT00759707|4019866|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4196995|NCT00759707|4019866|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196996|NCT00759707|4019866|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4196997|NCT00759707|4019866|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4196998|NCT00759707|4019866|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4196999|NCT00759707|4019866|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197000|NCT00759707|4019866|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197001|NCT00759707|4019866|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4197002|NCT00759707|4019866|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4197003|NCT00759707|4019866|B1|||Age||years|Mean|64.7|64.7|Standard Deviation|9|9.0|||
4197004|NCT00759681|4019870|B3|United States||Region of Enrollment||participants|Number|217|217.0||||||
4197005|NCT00759681|4019871|B2|United States||Region of Enrollment||participants|Number|110|110.0||||||
4197006|NCT00759681|4019872|B1|United States||Region of Enrollment||participants|Number|107|107.0||||||
4197007|NCT00759681|4019870|B3||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4197008|NCT00759681|4019871|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4197009|NCT00759681|4019872|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4197010|NCT00759681|4019870|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4197011|NCT00759681|4019871|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4197012|NCT00759681|4019872|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4197013|NCT00759681|4019870|B3|||Age||years|Mean|66.0|66.0|Standard Deviation|12.3|12.3|||
4197014|NCT00759681|4019871|B2|||Age||years|Mean|66.2|66.2|Standard Deviation|12.3|12.3|||
4197015|NCT00759681|4019872|B1|||Age||years|Mean|65.7|65.7|Standard Deviation|12.3|12.3|||
4197016|NCT00759668|4019881|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4197017|NCT00759668|4019882|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4197018|NCT00759668|4019883|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4197019|NCT00759668|4019881|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4197020|NCT00759668|4019882|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4197021|NCT00759668|4019883|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4197022|NCT00759668|4019881|B3||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4197023|NCT00759668|4019882|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4197024|NCT00759668|4019883|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4197025|NCT00759668|4019881|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4197026|NCT00759668|4019882|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4197027|NCT00759668|4019883|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4197028|NCT00759668|4019881|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197029|NCT00759668|4019882|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197030|NCT00759668|4019883|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197031|NCT00759655|4019900|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4197032|NCT00759655|4019900|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4197033|NCT00759655|4019900|B1|||Age||Month|Number|1|1.0||||||
4197034|NCT00759642|4019911|B1|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
4197035|NCT00759642|4019911|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197036|NCT00759642|4019911|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197037|NCT00759642|4019911|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4197038|NCT00759642|4019911|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4197039|NCT00759642|4019911|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197040|NCT00759642|4019911|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4197041|NCT00759642|4019911|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197042|NCT00759642|4019911|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4197043|NCT00759642|4019911|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4197044|NCT00759642|4019911|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4197045|NCT00759642|4019911|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4197046|NCT00759642|4019911|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197047|NCT00759603|4019915|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
4197048|NCT00759603|4019915|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4197049|NCT00759603|4019915|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4197050|NCT00759603|4019915|B1|||Age||years|Median|62|62.0|Full Range|||42.0|82.0|
4197051|NCT00759564|4019923|B6||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4197052|NCT00759564|4019924|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4197053|NCT00759564|4019925|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4197054|NCT00759564|4019926|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4197055|NCT00759564|4019927|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4197056|NCT00759564|4019928|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4197057|NCT00759564|4019923|B6||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4197058|NCT00759564|4019924|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4197059|NCT00759564|4019925|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4197060|NCT00759564|4019926|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4197061|NCT00759564|4019927|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4197062|NCT00759564|4019928|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4197063|NCT00759564|4019923|B6|||Age||years|Mean|62.5|62.5|Standard Deviation|9.9|9.9|||
4197064|NCT00759564|4019924|B5|||Age||years|Mean|69|69.0|Standard Deviation|9.4|9.4|||
4197065|NCT00759564|4019925|B4|||Age||years|Mean|55|55.0|Standard Deviation|NA||||Standard deviation was not calculated as single participant was analyzed.
4197066|NCT00759564|4019926|B3|||Age||years|Mean|64.3|64.3|Standard Deviation|15.7|15.7|||
4197067|NCT00759564|4019927|B2|||Age||years|Mean|60.6|60.6|Standard Deviation|7.3|7.3|||
4197068|NCT00759564|4019928|B1|||Age||years|Mean|60.4|60.4|Standard Deviation|3.2|3.2|||
4197069|NCT00759525|4020072|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4197070|NCT00759525|4020072|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4197071|NCT00759525|4020072|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4197072|NCT00759525|4020072|B1|||Age||years|Mean|27|27.0|Standard Deviation|7|7.0|||
4197073|NCT00759525|4020072|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4197074|NCT00759525|4020072|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4197075|NCT00759525|4020072|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197076|NCT00759473|4020079|B6|United States||Region of Enrollment||participants|Number|79|79.0||||||
4197077|NCT00759473|4020080|B5|United States||Region of Enrollment||participants|Number|24|24.0||||||
4197078|NCT00759473|4020081|B4|United States||Region of Enrollment||participants|Number|23|23.0||||||
4197079|NCT00759473|4020082|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4197080|NCT00759473|4020083|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4197081|NCT00759473|4020084|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4197082|NCT00759473|4020079|B6||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4197083|NCT00759473|4020080|B5||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4197084|NCT00759473|4020081|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4197085|NCT00759473|4020082|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4197086|NCT00759473|4020083|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4197087|NCT00759473|4020084|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4197088|NCT00759473|4020079|B6||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4197089|NCT00759473|4020080|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4197090|NCT00759473|4020081|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4197091|NCT00759473|4020082|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4197092|NCT00759473|4020083|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4197093|NCT00759473|4020084|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4197094|NCT00759473|4020079|B6|||Age||years|Mean|45.5|45.5|Standard Deviation|8.7|8.7|||
4197095|NCT00759473|4020080|B5|||Age||years|Mean|44.4|44.4|Standard Deviation|8.7|8.7|||
4197096|NCT00759473|4020081|B4|||Age||years|Mean|49.1|49.1|Standard Deviation|8.8|8.8|||
4197097|NCT00759473|4020082|B3|||Age||years|Mean|43.1|43.1|Standard Deviation|5.9|5.9|||
4197098|NCT00759473|4020083|B2|||Age||years|Mean|45.1|45.1|Standard Deviation|8.4|8.4|||
4197099|NCT00759473|4020084|B1|||Age||years|Mean|43.4|43.4|Standard Deviation|10.9|10.9|||
4197100|NCT00759473|4020079|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4197101|NCT00759473|4020080|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4197102|NCT00759473|4020081|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4197103|NCT00759473|4020082|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4197104|NCT00759473|4020083|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4197105|NCT00759473|4020084|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4197106|NCT00759473|4020079|B6||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
4197107|NCT00759473|4020080|B5||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4197108|NCT00759473|4020081|B4||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4197109|NCT00759473|4020082|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4197110|NCT00759473|4020083|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4197111|NCT00759473|4020084|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4197112|NCT00759473|4020079|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197113|NCT00759473|4020080|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197114|NCT00759473|4020081|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197115|NCT00759473|4020082|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197116|NCT00759473|4020083|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197117|NCT00759473|4020084|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197118|NCT00759408|4020100|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4197119|NCT00759408|4020100|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4197120|NCT00759408|4020100|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4197121|NCT00759408|4020100|B1|||Age||years|Mean|47|47.0|Standard Deviation|15|15.0|||
4197122|NCT00759408|4020100|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4197123|NCT00759408|4020100|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4197124|NCT00759408|4020100|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197125|NCT00759395|4020107|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4197126|NCT00759395|4020108|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4197127|NCT00759395|4020109|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4197128|NCT00759395|4020107|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4197129|NCT00759395|4020108|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4197130|NCT00759395|4020109|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4197131|NCT00759395|4020107|B3|||Age||Years|Mean|44.35|44.35|Standard Deviation|11.75|11.75|||
4197132|NCT00759395|4020108|B2|||Age||Years|Mean|48.7|48.7|Standard Deviation|11.3|11.3|||
4197133|NCT00759395|4020109|B1|||Age||Years|Mean|40|40.0|Standard Deviation|12.2|12.2|||
4197134|NCT00759356|4020124|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4197135|NCT00759356|4020125|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4197136|NCT00759356|4020126|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4197137|NCT00759356|4020124|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4197138|NCT00759356|4020125|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4197139|NCT00759356|4020126|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4197140|NCT00759356|4020124|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4197141|NCT00759356|4020125|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4197142|NCT00759356|4020126|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4197143|NCT00759356|4020124|B3|||Age||years|Mean|31.7|31.7|Standard Deviation|7.2|7.2|||
4197144|NCT00759356|4020125|B2|||Age||years|Mean|33.9|33.9|Standard Deviation|6.3|6.3|||
4197145|NCT00759356|4020126|B1|||Age||years|Mean|29.5|29.5|Standard Deviation|7.5|7.5|||
4197146|NCT00759356|4020124|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4197147|NCT00759356|4020125|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4197148|NCT00759356|4020126|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4197149|NCT00759356|4020124|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4197150|NCT00759356|4020125|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4197151|NCT00759356|4020126|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4197152|NCT00759356|4020124|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197153|NCT00759356|4020125|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197154|NCT00759356|4020126|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197155|NCT00759330|4020139|B5||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4197156|NCT00759330|4020140|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4197157|NCT00759330|4020141|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4197158|NCT00759330|4020142|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4197159|NCT00759330|4020143|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4197160|NCT00759330|4020139|B5||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4197161|NCT00759330|4020140|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4197162|NCT00759330|4020141|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4197163|NCT00759330|4020142|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4197164|NCT00759330|4020143|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4197165|NCT00759330|4020139|B5|||Age||years|Mean|52.1|52.1|Standard Deviation|13.2|13.2|||
4197166|NCT00759330|4020140|B4|||Age||years|Mean|53.0|53.0|Standard Deviation|11.98|11.98|||
4197167|NCT00759330|4020141|B3|||Age||years|Mean|53.6|53.6|Standard Deviation|13.46|13.46|||
4197168|NCT00759330|4020142|B2|||Age||years|Mean|50.1|50.1|Standard Deviation|13.02|13.02|||
4197169|NCT00759330|4020143|B1|||Age||years|Mean|51.8|51.8|Standard Deviation|14.47|14.47|||
4197170|NCT00759187|4020192|B4|United States||Region of Enrollment||participants|Number|25|25.0||||||
4197171|NCT00759187|4020193|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4197172|NCT00759187|4020194|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4197173|NCT00759187|4020195|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4197174|NCT00759187|4020192|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4197175|NCT00759187|4020193|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4197176|NCT00759187|4020194|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4197177|NCT00759187|4020195|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4197178|NCT00759187|4020192|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4197179|NCT00759187|4020193|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4197180|NCT00759187|4020194|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4197181|NCT00759187|4020195|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4197182|NCT00759187|4020192|B4|||Age||years|Mean|31.8|31.8|Standard Deviation|8.1|8.1|||
4197183|NCT00759187|4020193|B3|||Age||years|Mean|33.1|33.1|Standard Deviation|9.0|9.0|||
4197184|NCT00759187|4020194|B2|||Age||years|Mean|32.6|32.6|Standard Deviation|8.8|8.8|||
4197185|NCT00759187|4020195|B1|||Age||years|Mean|29.4|29.4|Standard Deviation|6.9|6.9|||
4197186|NCT00759187|4020192|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4197187|NCT00759187|4020193|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4197188|NCT00759187|4020194|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4197189|NCT00759187|4020195|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4197190|NCT00759187|4020192|B4||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4197191|NCT00759187|4020193|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4197192|NCT00759187|4020194|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4197193|NCT00759187|4020195|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4197194|NCT00759187|4020192|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197195|NCT00759187|4020193|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197196|NCT00759187|4020194|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197197|NCT00759187|4020195|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197198|NCT00759174|4020205|B3||Male|Sex: Female, Male||Participants|Count of Participants|673|673.0||||||
4197199|NCT00759174|4020206|B2||Male|Sex: Female, Male||Participants|Count of Participants|597|597.0||||||
4197200|NCT00759174|4020207|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4197201|NCT00759174|4020205|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4197202|NCT00759174|4020206|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4197203|NCT00759174|4020207|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4197204|NCT00759174|4020205|B3|||Age||years|Mean|62.3|62.3|Standard Deviation|9.9|9.9|||
4197205|NCT00759174|4020206|B2|||Age||years|Mean|62.3|62.3|Standard Deviation|10.2|10.2|||
4197206|NCT00759174|4020207|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|7.3|7.3|||
4197207|NCT00759161|4020217|B1||Male|Gender||Participants|Count of Participants|35|35.0||||||
4197208|NCT00759161|4020217|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
4197209|NCT00759161|4020217|B1|||Age||years|Mean|45.0|45.0|Standard Deviation|9.03|9.03|||
4197210|NCT00759148|4020230|B3||Male|Sex: Female, Male||Participants|Count of Participants|488|488.0||||||
4197211|NCT00759148|4020231|B2||Male|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
4197212|NCT00759148|4020232|B1||Male|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
4197213|NCT00759148|4020230|B3||Female|Sex: Female, Male||Participants|Count of Participants|691|691.0||||||
4197214|NCT00759148|4020231|B2||Female|Sex: Female, Male||Participants|Count of Participants|338|338.0||||||
4197215|NCT00759148|4020232|B1||Female|Sex: Female, Male||Participants|Count of Participants|353|353.0||||||
4197216|NCT00759148|4020230|B3|85 years and over||Age, Customized||Participants|Count of Participants|9|9.0||||||
4197217|NCT00759148|4020231|B2|85 years and over||Age, Customized||Participants|Count of Participants|5|5.0||||||
4197218|NCT00759148|4020232|B1|85 years and over||Age, Customized||Participants|Count of Participants|4|4.0||||||
4197219|NCT00759148|4020230|B3|From 65-84 years||Age, Customized||Participants|Count of Participants|86|86.0||||||
4197220|NCT00759148|4020231|B2|From 65-84 years||Age, Customized||Participants|Count of Participants|48|48.0||||||
4197221|NCT00759148|4020232|B1|From 65-84 years||Age, Customized||Participants|Count of Participants|38|38.0||||||
4197222|NCT00759148|4020230|B3|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|487|487.0||||||
4197223|NCT00759148|4020231|B2|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|230|230.0||||||
4197224|NCT00759148|4020232|B1|Adults (18-64 years)||Age, Customized||Participants|Count of Participants|257|257.0||||||
4197225|NCT00759148|4020230|B3|Adolescents (12-17 years)||Age, Customized||Participants|Count of Participants|143|143.0||||||
4197226|NCT00759148|4020231|B2|Adolescents (12-17 years)||Age, Customized||Participants|Count of Participants|72|72.0||||||
4197227|NCT00759148|4020232|B1|Adolescents (12-17 years)||Age, Customized||Participants|Count of Participants|71|71.0||||||
4197228|NCT00759148|4020230|B3|Children (2-11 years)||Age, Customized||Participants|Count of Participants|358|358.0||||||
4197229|NCT00759148|4020231|B2|Children (2-11 years)||Age, Customized||Participants|Count of Participants|184|184.0||||||
4197230|NCT00759148|4020232|B1|Children (2-11 years)||Age, Customized||Participants|Count of Participants|174|174.0||||||
4197231|NCT00759148|4020230|B3|Infants and toddlers (28 days-23 months)||Age, Customized||Participants|Count of Participants|96|96.0||||||
4197232|NCT00759148|4020231|B2|Infants and toddlers (28 days-23 months)||Age, Customized||Participants|Count of Participants|47|47.0||||||
4197233|NCT00759148|4020232|B1|Infants and toddlers (28 days-23 months)||Age, Customized||Participants|Count of Participants|49|49.0||||||
4197234|NCT00759109|4020241|B3||Male|Sex: Female, Male|ITT Population|Participants|Count of Participants|90|90.0||||||
4197235|NCT00759109|4020242|B2||Male|Sex: Female, Male|ITT Population|Participants|Count of Participants|38|38.0||||||
4197236|NCT00759109|4020243|B1||Male|Sex: Female, Male|ITT Population|Participants|Count of Participants|52|52.0||||||
4197237|NCT00759109|4020241|B3||Female|Sex: Female, Male|ITT Population|Participants|Count of Participants|56|56.0||||||
4197238|NCT00759109|4020242|B2||Female|Sex: Female, Male|ITT Population|Participants|Count of Participants|34|34.0||||||
4197239|NCT00759109|4020243|B1||Female|Sex: Female, Male|ITT Population|Participants|Count of Participants|22|22.0||||||
4197240|NCT00759109|4020241|B3|||Age|ITT Population|Years|Mean|58.3|58.3|Standard Deviation|8.1|8.1|||
4197241|NCT00759109|4020242|B2|||Age|ITT Population|Years|Mean|59.7|59.7|Standard Deviation|7.2|7.2|||
4197242|NCT00759109|4020243|B1|||Age|ITT Population|Years|Mean|57|57.0|Standard Deviation|8.7|8.7|||
4197243|NCT00759096|4020260|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4197244|NCT00759096|4020260|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4197245|NCT00759096|4020260|B1||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4197246|NCT00759096|4020260|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4197247|NCT00759096|4020260|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197248|NCT00759031|4020264|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4197249|NCT00759031|4020265|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4197250|NCT00759031|4020266|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4197251|NCT00759031|4020264|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4197252|NCT00759031|4020265|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4197253|NCT00759031|4020266|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4197254|NCT00759031|4020264|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4197255|NCT00759031|4020265|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4197256|NCT00759031|4020266|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4197257|NCT00759031|4020264|B3|||Age||years|Mean|32.53|32.53|Standard Deviation|9.78|9.78|||
4197258|NCT00759031|4020265|B2|||Age||years|Mean|33|33.0|Standard Deviation|8.7|8.7|||
4197259|NCT00759031|4020266|B1|||Age||years|Mean|32.1|32.1|Standard Deviation|11.14|11.14|||
4197260|NCT00759031|4020264|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4197261|NCT00759031|4020265|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4197262|NCT00759031|4020266|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4197263|NCT00759031|4020264|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4197264|NCT00759031|4020265|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4197265|NCT00759031|4020266|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4197266|NCT00759031|4020264|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197267|NCT00759031|4020265|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197268|NCT00759031|4020266|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197269|NCT00758862|4020273|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4197270|NCT00758862|4020273|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4197271|NCT00758862|4020273|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4197272|NCT00758862|4020273|B1|||Age||years|Mean|32.1|32.1|Standard Deviation|11.8|11.8|||
4197273|NCT00758836|4020289|B5||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4197274|NCT00758836|4020290|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4197275|NCT00758836|4020291|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4197276|NCT00758836|4020292|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4197277|NCT00758836|4020293|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4197278|NCT00758836|4020289|B5||Female|Sex: Female, Male||Participants|Count of Participants|583|583.0||||||
4197279|NCT00758836|4020290|B4||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4197280|NCT00758836|4020291|B3||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4197281|NCT00758836|4020292|B2||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4197282|NCT00758836|4020293|B1||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4197283|NCT00758836|4020289|B5|>=65 years||Age, Customized||participants|Number|18|18.0||||||
4197284|NCT00758836|4020290|B4|>=65 years||Age, Customized||participants|Number|5|5.0||||||
4197285|NCT00758836|4020291|B3|>=65 years||Age, Customized||participants|Number|2|2.0||||||
4197286|NCT00758836|4020292|B2|>=65 years||Age, Customized||participants|Number|5|5.0||||||
4197287|NCT00758836|4020293|B1|>=65 years||Age, Customized||participants|Number|6|6.0||||||
4197288|NCT00758836|4020289|B5|60-64 years||Age, Customized||participants|Number|18|18.0||||||
4197289|NCT00758836|4020290|B4|60-64 years||Age, Customized||participants|Number|2|2.0||||||
4197290|NCT00758836|4020291|B3|60-64 years||Age, Customized||participants|Number|6|6.0||||||
4197291|NCT00758836|4020292|B2|60-64 years||Age, Customized||participants|Number|6|6.0||||||
4197292|NCT00758836|4020293|B1|60-64 years||Age, Customized||participants|Number|4|4.0||||||
4197293|NCT00758836|4020289|B5|50-59 years||Age, Customized||participants|Number|116|116.0||||||
4197294|NCT00758836|4020290|B4|50-59 years||Age, Customized||participants|Number|23|23.0||||||
4197295|NCT00758836|4020291|B3|50-59 years||Age, Customized||participants|Number|42|42.0||||||
4197296|NCT00758836|4020292|B2|50-59 years||Age, Customized||participants|Number|19|19.0||||||
4197297|NCT00758836|4020293|B1|50-59 years||Age, Customized||participants|Number|32|32.0||||||
4197298|NCT00758836|4020289|B5|40-49 years||Age, Customized||participants|Number|209|209.0||||||
4197299|NCT00758836|4020290|B4|40-49 years||Age, Customized||participants|Number|51|51.0||||||
4197300|NCT00758836|4020291|B3|40-49 years||Age, Customized||participants|Number|49|49.0||||||
4197301|NCT00758836|4020292|B2|40-49 years||Age, Customized||participants|Number|51|51.0||||||
4197302|NCT00758836|4020293|B1|40-49 years||Age, Customized||participants|Number|58|58.0||||||
4197303|NCT00758836|4020289|B5|30-39 years||Age, Customized||participants|Number|170|170.0||||||
4197304|NCT00758836|4020290|B4|30-39 years||Age, Customized||participants|Number|53|53.0||||||
4197305|NCT00758836|4020291|B3|30-39 years||Age, Customized||participants|Number|37|37.0||||||
4197306|NCT00758836|4020292|B2|30-39 years||Age, Customized||participants|Number|47|47.0||||||
4197307|NCT00758836|4020293|B1|30-39 years||Age, Customized||participants|Number|33|33.0||||||
4197308|NCT00758836|4020289|B5|20-29 years||Age, Customized||participants|Number|142|142.0||||||
4197309|NCT00758836|4020290|B4|20-29 years||Age, Customized||participants|Number|33|33.0||||||
4197310|NCT00758836|4020291|B3|20-29 years||Age, Customized||participants|Number|32|32.0||||||
4197311|NCT00758836|4020292|B2|20-29 years||Age, Customized||participants|Number|43|43.0||||||
4197312|NCT00758836|4020293|B1|20-29 years||Age, Customized||participants|Number|34|34.0||||||
4197313|NCT00758836|4020289|B5|<20 years||Age, Customized||participants|Number|10|10.0||||||
4197314|NCT00758836|4020290|B4|<20 years||Age, Customized||participants|Number|3|3.0||||||
4197315|NCT00758836|4020291|B3|<20 years||Age, Customized||participants|Number|3|3.0||||||
4197316|NCT00758836|4020292|B2|<20 years||Age, Customized||participants|Number|0|0.0||||||
4197317|NCT00758836|4020293|B1|<20 years||Age, Customized||participants|Number|4|4.0||||||
4197318|NCT00758771|4020318|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4197319|NCT00758771|4020319|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4197320|NCT00758771|4020320|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4197321|NCT00758771|4020318|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4197322|NCT00758771|4020319|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4197323|NCT00758771|4020320|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4197324|NCT00758771|4020318|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4197325|NCT00758771|4020319|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4197326|NCT00758771|4020320|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4197327|NCT00758771|4020318|B3|||Age||years|Mean|38.8|38.8|Standard Deviation|11.9|11.9|||
4197328|NCT00758771|4020319|B2|||Age||years|Mean|41.9|41.9|Standard Deviation|10.8|10.8|||
4197329|NCT00758771|4020320|B1|||Age||years|Mean|36.6|36.6|Standard Deviation|12.8|12.8|||
4197330|NCT00758758|4020327|B9|United States||Region of Enrollment||participants|Number|231|231.0||||||
4197331|NCT00758758|4020328|B8|United States||Region of Enrollment||participants|Number|31|31.0||||||
4197332|NCT00758758|4020330|B6|United States||Region of Enrollment||participants|Number|50|50.0||||||
4197333|NCT00758758|4020331|B5|United States||Region of Enrollment||participants|Number|3|3.0||||||
4197334|NCT00758758|4020332|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
4197335|NCT00758758|4020333|B3|United States||Region of Enrollment||participants|Number|53|53.0||||||
4197336|NCT00758758|4020334|B2|United States||Region of Enrollment||participants|Number|74|74.0||||||
4197337|NCT00758758|4020335|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4197338|NCT00758758|4020327|B9|Male||Gender||participants|Number|110|110.0||||||
4197339|NCT00758758|4020328|B8|Male||Gender||participants|Number|11|11.0||||||
4197340|NCT00758758|4020330|B6|Male||Gender||participants|Number|25|25.0||||||
4197341|NCT00758758|4020331|B5|Male||Gender||participants|Number|3|3.0||||||
4197342|NCT00758758|4020332|B4|Male||Gender||participants|Number|4|4.0||||||
4197343|NCT00758758|4020333|B3|Male||Gender||participants|Number|25|25.0||||||
4197344|NCT00758758|4020334|B2|Male||Gender||participants|Number|31|31.0||||||
4197345|NCT00758758|4020335|B1|Male||Gender||participants|Number|11|11.0||||||
4197346|NCT00758758|4020327|B9|Female||Gender||participants|Number|121|121.0||||||
4197347|NCT00758758|4020328|B8|Female||Gender||participants|Number|20|20.0||||||
4197348|NCT00758758|4020330|B6|Female||Gender||participants|Number|25|25.0||||||
4197349|NCT00758758|4020331|B5|Female||Gender||participants|Number|0|0.0||||||
4197350|NCT00758758|4020332|B4|Female||Gender||participants|Number|2|2.0||||||
4197351|NCT00758758|4020333|B3|Female||Gender||participants|Number|28|28.0||||||
4197352|NCT00758758|4020334|B2|Female||Gender||participants|Number|43|43.0||||||
4197353|NCT00758758|4020335|B1|Female||Gender||participants|Number|3|3.0||||||
4197354|NCT00758758|4020327|B9|||Age||years|Mean|46.86|46.86|Standard Deviation|7.5|7.5|||
4197355|NCT00758758|4020328|B8|||Age||years|Mean|49.29|49.29|Standard Deviation|8.4|8.4|||
4197356|NCT00758758|4020330|B6|||Age||years|Mean|44.1|44.1|Standard Deviation|6.8|6.8|||
4197357|NCT00758758|4020331|B5|||Age||years|Mean|49.0|49.0|Standard Deviation|4.5|4.5|||
4197358|NCT00758758|4020332|B4|||Age||years|Mean|47.3|47.3|Standard Deviation|5.0|5.0|||
4197359|NCT00758758|4020333|B3|||Age||years|Mean|49.0|49.0|Standard Deviation|9.94|9.94|||
4197360|NCT00758758|4020334|B2|||Age||years|Mean|44.2|44.2|Standard Deviation|8.6|8.6|||
4197361|NCT00758758|4020335|B1|||Age||years|Mean|45.14|45.14|Standard Deviation|9.1|9.1|||
4197362|NCT00758758|4020327|B9|>=65 years||Age||participants|Number|0|0.0||||||
4197363|NCT00758758|4020328|B8|>=65 years||Age||participants|Number|0|0.0||||||
4197364|NCT00758758|4020330|B6|>=65 years||Age||participants|Number|0|0.0||||||
4197365|NCT00758758|4020331|B5|>=65 years||Age||participants|Number|0|0.0||||||
4197366|NCT00758758|4020332|B4|>=65 years||Age||participants|Number|0|0.0||||||
4197367|NCT00758758|4020333|B3|>=65 years||Age||participants|Number|0|0.0||||||
4197368|NCT00758758|4020334|B2|>=65 years||Age||participants|Number|0|0.0||||||
4197369|NCT00758758|4020335|B1|>=65 years||Age||participants|Number|0|0.0||||||
4197370|NCT00758758|4020327|B9|Between 18 and 65 years||Age||participants|Number|231|231.0||||||
4197371|NCT00758758|4020328|B8|Between 18 and 65 years||Age||participants|Number|31|31.0||||||
4197372|NCT00758758|4020330|B6|Between 18 and 65 years||Age||participants|Number|50|50.0||||||
4197373|NCT00758758|4020331|B5|Between 18 and 65 years||Age||participants|Number|3|3.0||||||
4197374|NCT00758758|4020332|B4|Between 18 and 65 years||Age||participants|Number|6|6.0||||||
4197375|NCT00758758|4020333|B3|Between 18 and 65 years||Age||participants|Number|53|53.0||||||
4197376|NCT00758758|4020334|B2|Between 18 and 65 years||Age||participants|Number|74|74.0||||||
4197377|NCT00758758|4020335|B1|Between 18 and 65 years||Age||participants|Number|14|14.0||||||
4197378|NCT00758758|4020327|B9|<=18 years||Age||participants|Number|0|0.0||||||
4197379|NCT00758758|4020328|B8|<=18 years||Age||participants|Number|0|0.0||||||
4197380|NCT00758758|4020330|B6|<=18 years||Age||participants|Number|0|0.0||||||
4197381|NCT00758758|4020331|B5|<=18 years||Age||participants|Number|0|0.0||||||
4197382|NCT00758758|4020332|B4|<=18 years||Age||participants|Number|0|0.0||||||
4197383|NCT00758758|4020333|B3|<=18 years||Age||participants|Number|0|0.0||||||
4197384|NCT00758758|4020334|B2|<=18 years||Age||participants|Number|0|0.0||||||
4197385|NCT00758758|4020335|B1|<=18 years||Age||participants|Number|0|0.0||||||
4197386|NCT00758745|4020368|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4197387|NCT00758745|4020369|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4197388|NCT00758745|4020370|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4197389|NCT00758745|4020368|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4197390|NCT00758745|4020369|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4197391|NCT00758745|4020370|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4197392|NCT00758745|4020368|B3||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
4197393|NCT00758745|4020369|B2||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4197394|NCT00758745|4020370|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4197395|NCT00758745|4020368|B3||Between 18 and 65 years|Age||Participants|Count of Participants|116|116.0||||||
4197396|NCT00758745|4020369|B2||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4197397|NCT00758745|4020370|B1||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4197398|NCT00758745|4020368|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197399|NCT00758745|4020369|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197400|NCT00758745|4020370|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197401|NCT00758706|4020377|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4197402|NCT00758706|4020378|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4197403|NCT00758706|4020379|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4197404|NCT00758706|4020377|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4197405|NCT00758706|4020378|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4197406|NCT00758706|4020379|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4197407|NCT00758706|4020377|B3|||Age||Year|Mean|64.1|64.1|Full Range|||47.0|80.0|
4197408|NCT00758706|4020378|B2|||Age||Year|Mean|65.7|65.7|Full Range|||49.0|79.0|
4197409|NCT00758706|4020379|B1|||Age||Year|Mean|62.9|62.9|Full Range|||47.0|80.0|
4197410|NCT00758680|4020416|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4197411|NCT00758680|4020416|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4197412|NCT00758680|4020416|B1|||Age||years|Mean|53.1|53.1|Standard Deviation|7.7|7.7|||
4197413|NCT00758667|4020465|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4197414|NCT00758667|4020466|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4197415|NCT00758667|4020467|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4197416|NCT00758667|4020465|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4197417|NCT00758667|4020466|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4197418|NCT00758667|4020467|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4197419|NCT00758667|4020465|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4197420|NCT00758667|4020466|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4197421|NCT00758667|4020467|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4197422|NCT00758667|4020465|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4197423|NCT00758667|4020466|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4197424|NCT00758667|4020467|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4197425|NCT00758667|4020465|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4197426|NCT00758667|4020466|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4197427|NCT00758667|4020467|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4197428|NCT00758667|4020465|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197429|NCT00758667|4020466|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197430|NCT00758667|4020467|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197431|NCT00758602|4020476|B3||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4197432|NCT00758602|4020477|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4197433|NCT00758602|4020478|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4197434|NCT00758602|4020476|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4197435|NCT00758602|4020477|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4197436|NCT00758602|4020478|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4197437|NCT00758602|4020476|B3|||Age||years|Mean|38.8|38.8|Standard Deviation|10.62|10.62|||
4197438|NCT00758602|4020477|B2|||Age||years|Mean|39.6|39.6|Standard Deviation|10.16|10.16|||
4197439|NCT00758602|4020478|B1|||Age||years|Mean|37.9|37.9|Standard Deviation|11.05|11.05|||
4197440|NCT00758589|4020501|B5||Male|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
4197441|NCT00758589|4020502|B4||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4197442|NCT00758589|4020503|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4197443|NCT00758589|4020504|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4197444|NCT00758589|4020505|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4197445|NCT00758589|4020501|B5||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4197446|NCT00758589|4020502|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4197447|NCT00758589|4020503|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4197448|NCT00758589|4020504|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4197449|NCT00758589|4020505|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4197450|NCT00758589|4020501|B5|||Age||Years|Mean|44.35|44.35|Full Range|||18.0|79.0|
4197451|NCT00758589|4020502|B4|||Age||Years|Mean|45.7|45.7|Full Range|||18.0|77.0|
4197452|NCT00758589|4020503|B3|||Age||Years|Mean|43.5|43.5|Full Range|||18.0|77.0|
4197453|NCT00758589|4020504|B2|||Age||Years|Mean|43|43.0|Full Range|||18.0|79.0|
4197454|NCT00758589|4020505|B1|||Age||Years|Mean|43.3|43.3|Full Range|||18.0|76.0|
4197455|NCT00758576|4020574|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4197456|NCT00758576|4020574|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4197457|NCT00758576|4020574|B1|>80 years of age||Age, Customized||Participants|Number|2|2.0||||||
4197458|NCT00758576|4020574|B1|70 - 79 years of age||Age, Customized||Participants|Number|33|33.0||||||
4197459|NCT00758576|4020574|B1|60 - 69 years of age||Age, Customized||Participants|Number|23|23.0||||||
4197460|NCT00758576|4020574|B1|<60 years of age||Age, Customized||Participants|Number|6|6.0||||||
4197461|NCT00758563|4020580|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4197462|NCT00758563|4020581|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4197463|NCT00758563|4020582|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4197464|NCT00758563|4020580|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4197465|NCT00758563|4020581|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4197466|NCT00758563|4020582|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4197467|NCT00758563|4020580|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4197468|NCT00758563|4020581|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4197469|NCT00758563|4020582|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4197470|NCT00758563|4020580|B3|||Age||years|Mean|33.1|33.1|Standard Deviation|14.1|14.1|||
4197471|NCT00758563|4020581|B2|||Age||years|Mean|32.1|32.1|Standard Deviation|11.5|11.5|||
4197472|NCT00758563|4020582|B1|||Age||years|Mean|34.3|34.3|Standard Deviation|17.4|17.4|||
4197473|NCT00758563|4020580|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4197474|NCT00758563|4020581|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4197475|NCT00758563|4020582|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4197476|NCT00758563|4020580|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4197477|NCT00758563|4020581|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4197478|NCT00758563|4020582|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4197479|NCT00758563|4020580|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197480|NCT00758563|4020581|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197481|NCT00758563|4020582|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197482|NCT00758550|4020587|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4197483|NCT00758550|4020588|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4197484|NCT00758550|4020589|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4197485|NCT00758550|4020587|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4197486|NCT00758550|4020588|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4197487|NCT00758550|4020589|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4197488|NCT00758550|4020587|B3||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
4197489|NCT00758550|4020588|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4197490|NCT00758550|4020589|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4197491|NCT00758550|4020587|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4197492|NCT00758550|4020588|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4197493|NCT00758550|4020589|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4197494|NCT00758550|4020587|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197495|NCT00758550|4020588|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197496|NCT00758550|4020589|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197497|NCT00758498|4020598|B4|United States||Region of Enrollment||participants|Number|427|427.0||||||
4197498|NCT00758498|4020599|B3|United States||Region of Enrollment||participants|Number|142|142.0||||||
4197499|NCT00758498|4020600|B2|United States||Region of Enrollment||participants|Number|143|143.0||||||
4197500|NCT00758498|4020601|B1|United States||Region of Enrollment||participants|Number|142|142.0||||||
4197501|NCT00758498|4020598|B4||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4197502|NCT00758498|4020599|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4197503|NCT00758498|4020600|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4197504|NCT00758498|4020601|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4197505|NCT00758498|4020598|B4||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4197506|NCT00758498|4020599|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4197507|NCT00758498|4020600|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4197508|NCT00758498|4020601|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4197509|NCT00758498|4020598|B4|||Age||years|Mean|35.8|35.8|Standard Deviation|10.86|10.86|||
4197510|NCT00758498|4020599|B3|||Age||years|Mean|36.0|36.0|Standard Deviation|10.06|10.06|||
4197511|NCT00758498|4020600|B2|||Age||years|Mean|34.6|34.6|Standard Deviation|10.38|10.38|||
4197512|NCT00758498|4020601|B1|||Age||years|Mean|36.7|36.7|Standard Deviation|12.01|12.01|||
4197513|NCT00758498|4020598|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4197514|NCT00758498|4020599|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4197515|NCT00758498|4020600|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4197516|NCT00758498|4020601|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4197517|NCT00758498|4020598|B4||Between 18 and 65 years|Age||Participants|Count of Participants|427|427.0||||||
4197518|NCT00758498|4020599|B3||Between 18 and 65 years|Age||Participants|Count of Participants|142|142.0||||||
4197519|NCT00758498|4020600|B2||Between 18 and 65 years|Age||Participants|Count of Participants|143|143.0||||||
4197520|NCT00758498|4020601|B1||Between 18 and 65 years|Age||Participants|Count of Participants|142|142.0||||||
4197521|NCT00758498|4020598|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197522|NCT00758498|4020599|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197523|NCT00758498|4020600|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197524|NCT00758498|4020601|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197525|NCT00758485|4020686|B3||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4197526|NCT00758485|4020687|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4197527|NCT00758485|4020688|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4197528|NCT00758485|4020686|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4197529|NCT00758485|4020687|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4197530|NCT00758485|4020688|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4197531|NCT00758485|4020686|B3|||Age||years|Mean|57|57.0|Standard Deviation|16|16.0|||
4197532|NCT00758485|4020687|B2|||Age||years|Mean|57|57.0|Standard Deviation|14|14.0|||
4197533|NCT00758485|4020688|B1|||Age||years|Mean|57|57.0|Standard Deviation|17|17.0|||
4197534|NCT00758459|4020699|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4197535|NCT00758459|4020700|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4197536|NCT00758459|4020701|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4197537|NCT00758459|4020699|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4197538|NCT00758459|4020700|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4197539|NCT00758459|4020701|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4197540|NCT00758459|4020699|B3|||Age||Year|Mean|61.7|61.7|Full Range|||46.0|77.0|
4197541|NCT00758459|4020700|B2|||Age||Year|Mean|61.7|61.7|Full Range|||46.0|77.0|
4197542|NCT00758459|4020701|B1|||Age||Year|Mean|61.7|61.7|Full Range|||48.0|76.0|
4197543|NCT00758420|4020734|B3|||VEINES-Sym Score|The VEINES-Sym summary score includes 10 items; 9 venous symptoms (heavy legs, aching legs, swelling, night cramps, heat or burning sensation, restless legs, throbbing, itching, tingling sensation), rated on a 6-point scale of frequency and leg pain rated on a 6-point scale of intensity (very severe, severe, moderate, mild, very mild, none). It can range from 0 to 100, with a ‘0’ score indicating all symptoms were present all of the time in the past week and a ‘100’ score indicating none of the symptoms were present at any time in the previous week.|units on a scale|Mean|60.6|60.6|Standard Deviation|25.94|25.94|||
4197544|NCT00758420|4020735|B2|||VEINES-Sym Score|The VEINES-Sym summary score includes 10 items; 9 venous symptoms (heavy legs, aching legs, swelling, night cramps, heat or burning sensation, restless legs, throbbing, itching, tingling sensation), rated on a 6-point scale of frequency and leg pain rated on a 6-point scale of intensity (very severe, severe, moderate, mild, very mild, none). It can range from 0 to 100, with a ‘0’ score indicating all symptoms were present all of the time in the past week and a ‘100’ score indicating none of the symptoms were present at any time in the previous week.|units on a scale|Mean|59.3|59.3|Standard Deviation|26.11|26.11|||
4197545|NCT00758420|4020736|B1|||VEINES-Sym Score|The VEINES-Sym summary score includes 10 items; 9 venous symptoms (heavy legs, aching legs, swelling, night cramps, heat or burning sensation, restless legs, throbbing, itching, tingling sensation), rated on a 6-point scale of frequency and leg pain rated on a 6-point scale of intensity (very severe, severe, moderate, mild, very mild, none). It can range from 0 to 100, with a ‘0’ score indicating all symptoms were present all of the time in the past week and a ‘100’ score indicating none of the symptoms were present at any time in the previous week.|units on a scale|Mean|61.9|61.9|Standard Deviation|26.05|26.05|||
4197546|NCT00758420|4020734|B3|||VVSymQ Score|The VVSymQ is a subset of the VEINES-Sym and consists of the 5 symptoms most relevant to patients. The raw score, which can range from 5 to 30, was transformed to a summary VVSymQ score that ranges from 0 (worst possible symptom health) to 100 (best symptom health) using the following formula: VVSymQ: (Transformed Score) = [(Raw Score) – 5] * 4|units on a scale|Mean|55.0|55.0|Standard Deviation|28.60|28.6|||
4197547|NCT00758420|4020735|B2|||VVSymQ Score|The VVSymQ is a subset of the VEINES-Sym and consists of the 5 symptoms most relevant to patients. The raw score, which can range from 5 to 30, was transformed to a summary VVSymQ score that ranges from 0 (worst possible symptom health) to 100 (best symptom health) using the following formula: VVSymQ: (Transformed Score) = [(Raw Score) – 5] * 4|units on a scale|Mean|52.6|52.6|Standard Deviation|29.37|29.37|||
4197548|NCT00758420|4020736|B1|||VVSymQ Score|The VVSymQ is a subset of the VEINES-Sym and consists of the 5 symptoms most relevant to patients. The raw score, which can range from 5 to 30, was transformed to a summary VVSymQ score that ranges from 0 (worst possible symptom health) to 100 (best symptom health) using the following formula: VVSymQ: (Transformed Score) = [(Raw Score) – 5] * 4|units on a scale|Mean|57.5|57.5|Standard Deviation|27.97|27.97|||
4197549|NCT00758420|4020734|B3|C5 - Skin Change With Healed Ulceration||CEAP Clinical classification|Patients were eligible for study if they had a clinical classification of C2–C5 as follows: C2 Varicose veins C3 Edema C4 Skin changes without ulceration C5 Skin changes with healed ulceration.|participants|Number|2|2.0||||||
4197550|NCT00758420|4020735|B2|C5 - Skin Change With Healed Ulceration||CEAP Clinical classification|Patients were eligible for study if they had a clinical classification of C2–C5 as follows: C2 Varicose veins C3 Edema C4 Skin changes without ulceration C5 Skin changes with healed ulceration.|participants|Number|2|2.0||||||
4197551|NCT00758420|4020736|B1|C5 - Skin Change With Healed Ulceration||CEAP Clinical classification|Patients were eligible for study if they had a clinical classification of C2–C5 as follows: C2 Varicose veins C3 Edema C4 Skin changes without ulceration C5 Skin changes with healed ulceration.|participants|Number|0|0.0||||||
4197552|NCT00758420|4020734|B3|C4 - Skin Change Without Ulceration||CEAP Clinical classification|Patients were eligible for study if they had a clinical classification of C2–C5 as follows: C2 Varicose veins C3 Edema C4 Skin changes without ulceration C5 Skin changes with healed ulceration.|participants|Number|6|6.0||||||
4197553|NCT00758420|4020735|B2|C4 - Skin Change Without Ulceration||CEAP Clinical classification|Patients were eligible for study if they had a clinical classification of C2–C5 as follows: C2 Varicose veins C3 Edema C4 Skin changes without ulceration C5 Skin changes with healed ulceration.|participants|Number|2|2.0||||||
4197554|NCT00758420|4020736|B1|C4 - Skin Change Without Ulceration||CEAP Clinical classification|Patients were eligible for study if they had a clinical classification of C2–C5 as follows: C2 Varicose veins C3 Edema C4 Skin changes without ulceration C5 Skin changes with healed ulceration.|participants|Number|4|4.0||||||
4197555|NCT00758420|4020734|B3|C3 – Edema||CEAP Clinical classification|Patients were eligible for study if they had a clinical classification of C2–C5 as follows: C2 Varicose veins C3 Edema C4 Skin changes without ulceration C5 Skin changes with healed ulceration.|participants|Number|69|69.0||||||
4197556|NCT00758420|4020735|B2|C3 – Edema||CEAP Clinical classification|Patients were eligible for study if they had a clinical classification of C2–C5 as follows: C2 Varicose veins C3 Edema C4 Skin changes without ulceration C5 Skin changes with healed ulceration.|participants|Number|35|35.0||||||
4197557|NCT00758420|4020736|B1|C3 – Edema||CEAP Clinical classification|Patients were eligible for study if they had a clinical classification of C2–C5 as follows: C2 Varicose veins C3 Edema C4 Skin changes without ulceration C5 Skin changes with healed ulceration.|participants|Number|34|34.0||||||
4197558|NCT00758420|4020734|B3|||Baseline VCSS|The Venous Clinical Severity Score (VCSS) was determined by a study staff member blinded to treatment assignment, (i.e., the ‘blinded assessor’). The VCSS rates 9 clinical characteristics of chronic venous disease (pain, varicose veins, venous edema, skin pigmentation, inflammation, induration, and number, duration, and size of ulcers) using Grades 0 to 3 (absent to severe). An additional 0 to 3 points are added for differences in use of compression therapy (compression and elevation) to produce a 30-point maximum flat scale.|units on a scale|Mean|6.3|6.3|Standard Deviation|2.01|2.01|||
4197613|NCT00758342|4020762|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4197614|NCT00758342|4020760|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4197615|NCT00758342|4020761|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4197616|NCT00758342|4020762|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4197559|NCT00758420|4020735|B2|||Baseline VCSS|The Venous Clinical Severity Score (VCSS) was determined by a study staff member blinded to treatment assignment, (i.e., the ‘blinded assessor’). The VCSS rates 9 clinical characteristics of chronic venous disease (pain, varicose veins, venous edema, skin pigmentation, inflammation, induration, and number, duration, and size of ulcers) using Grades 0 to 3 (absent to severe). An additional 0 to 3 points are added for differences in use of compression therapy (compression and elevation) to produce a 30-point maximum flat scale.|units on a scale|Mean|6.6|6.6|Standard Deviation|2.05|2.05|||
4197560|NCT00758420|4020736|B1|||Baseline VCSS|The Venous Clinical Severity Score (VCSS) was determined by a study staff member blinded to treatment assignment, (i.e., the ‘blinded assessor’). The VCSS rates 9 clinical characteristics of chronic venous disease (pain, varicose veins, venous edema, skin pigmentation, inflammation, induration, and number, duration, and size of ulcers) using Grades 0 to 3 (absent to severe). An additional 0 to 3 points are added for differences in use of compression therapy (compression and elevation) to produce a 30-point maximum flat scale.|units on a scale|Mean|6.0|6.0|Standard Deviation|1.95|1.95|||
4197561|NCT00758420|4020734|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4197562|NCT00758420|4020735|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4197563|NCT00758420|4020736|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4197564|NCT00758420|4020734|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4197565|NCT00758420|4020735|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4197566|NCT00758420|4020736|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4197567|NCT00758420|4020734|B3|||Age||years|Mean|45.1|45.1|Standard Deviation|10.66|10.66|||
4197568|NCT00758420|4020735|B2|||Age||years|Mean|45.3|45.3|Standard Deviation|10.75|10.75|||
4197569|NCT00758420|4020736|B1|||Age||years|Mean|44.9|44.9|Standard Deviation|10.71|10.71|||
4197570|NCT00758394|4020743|B5|United States||Region of Enrollment||participants|Number|29|29.0||||||
4197571|NCT00758394|4020744|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
4197572|NCT00758394|4020745|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4197573|NCT00758394|4020746|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4197574|NCT00758394|4020747|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4197575|NCT00758394|4020743|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4197576|NCT00758394|4020744|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4197577|NCT00758394|4020745|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4197578|NCT00758394|4020746|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4197579|NCT00758394|4020747|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4197580|NCT00758394|4020743|B5||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4197581|NCT00758394|4020744|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4197582|NCT00758394|4020745|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4197583|NCT00758394|4020746|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4197584|NCT00758394|4020747|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4197585|NCT00758394|4020743|B5|||Age||years|Mean|33.6|33.6|Standard Deviation|9.5|9.5|||
4197586|NCT00758394|4020744|B4|||Age||years|Mean|37.8|37.8|Standard Deviation|5.0|5.0|||
4197587|NCT00758394|4020745|B3|||Age||years|Mean|36.4|36.4|Standard Deviation|11.6|11.6|||
4197588|NCT00758394|4020746|B2|||Age||years|Mean|29.7|29.7|Standard Deviation|8.7|8.7|||
4197589|NCT00758394|4020747|B1|||Age||years|Mean|30.5|30.5|Standard Deviation|10.8|10.8|||
4197590|NCT00758394|4020743|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4197591|NCT00758394|4020744|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4197592|NCT00758394|4020745|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4197593|NCT00758394|4020746|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4197594|NCT00758394|4020747|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4197595|NCT00758394|4020743|B5||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4197596|NCT00758394|4020744|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4197597|NCT00758394|4020745|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4197598|NCT00758394|4020746|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4197599|NCT00758394|4020747|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4197600|NCT00758394|4020743|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197601|NCT00758394|4020744|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197602|NCT00758394|4020745|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197603|NCT00758394|4020746|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197604|NCT00758394|4020747|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197605|NCT00758342|4020760|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4197606|NCT00758342|4020761|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4197607|NCT00758342|4020762|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4197608|NCT00758342|4020760|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4197609|NCT00758342|4020761|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4197610|NCT00758342|4020762|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4197611|NCT00758342|4020760|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4197612|NCT00758342|4020761|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4197617|NCT00758342|4020760|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197618|NCT00758342|4020761|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197619|NCT00758342|4020762|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197620|NCT00758290|4020769|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4197621|NCT00758290|4020770|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4197622|NCT00758290|4020771|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4197623|NCT00758290|4020769|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4197624|NCT00758290|4020770|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4197625|NCT00758290|4020771|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4197626|NCT00758290|4020769|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4197627|NCT00758290|4020770|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4197628|NCT00758290|4020771|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4197629|NCT00758290|4020769|B3|||Age||years|Mean|31.4|31.4|Standard Deviation|9.4|9.4|||
4197630|NCT00758290|4020770|B2|||Age||years|Mean|30.3|30.3|Standard Deviation|7.1|7.1|||
4197631|NCT00758290|4020771|B1|||Age||years|Mean|32.5|32.5|Standard Deviation|11.7|11.7|||
4197632|NCT00758290|4020769|B3||>=65 years|Age|Twenty four panelists were enrolled, but 1 was discontinued due to non-compliance with study visits. Twenty three panelists comleted study.|Participants|Count of Participants|0|0.0||||||
4197633|NCT00758290|4020770|B2||>=65 years|Age|Twenty four panelists were enrolled, but 1 was discontinued due to non-compliance with study visits. Twenty three panelists comleted study.|Participants|Count of Participants|0|0.0||||||
4197634|NCT00758290|4020771|B1||>=65 years|Age|Twenty four panelists were enrolled, but 1 was discontinued due to non-compliance with study visits. Twenty three panelists comleted study.|Participants|Count of Participants|0|0.0||||||
4197635|NCT00758290|4020769|B3||Between 18 and 65 years|Age|Twenty four panelists were enrolled, but 1 was discontinued due to non-compliance with study visits. Twenty three panelists comleted study.|Participants|Count of Participants|23|23.0||||||
4197636|NCT00758290|4020770|B2||Between 18 and 65 years|Age|Twenty four panelists were enrolled, but 1 was discontinued due to non-compliance with study visits. Twenty three panelists comleted study.|Participants|Count of Participants|12|12.0||||||
4197637|NCT00758290|4020771|B1||Between 18 and 65 years|Age|Twenty four panelists were enrolled, but 1 was discontinued due to non-compliance with study visits. Twenty three panelists comleted study.|Participants|Count of Participants|11|11.0||||||
4197638|NCT00758290|4020769|B3||<=18 years|Age|Twenty four panelists were enrolled, but 1 was discontinued due to non-compliance with study visits. Twenty three panelists comleted study.|Participants|Count of Participants|0|0.0||||||
4197639|NCT00758290|4020770|B2||<=18 years|Age|Twenty four panelists were enrolled, but 1 was discontinued due to non-compliance with study visits. Twenty three panelists comleted study.|Participants|Count of Participants|0|0.0||||||
4197640|NCT00758290|4020771|B1||<=18 years|Age|Twenty four panelists were enrolled, but 1 was discontinued due to non-compliance with study visits. Twenty three panelists comleted study.|Participants|Count of Participants|0|0.0||||||
4197641|NCT00758264|4020776|B4|Asian - East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|180|180.0||||||
4197642|NCT00758264|4020777|B3|Asian - East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
4197643|NCT00758264|4020778|B2|Asian - East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|45|45.0||||||
4197644|NCT00758264|4020779|B1|Asian - East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|91|91.0||||||
4197645|NCT00758264|4020776|B4|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|183|183.0||||||
4197646|NCT00758264|4020777|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
4197647|NCT00758264|4020778|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
4197648|NCT00758264|4020779|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|91|91.0||||||
4197649|NCT00758264|4020776|B4||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4197650|NCT00758264|4020777|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4197651|NCT00758264|4020778|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4197652|NCT00758264|4020779|B1||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4197653|NCT00758264|4020776|B4||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4197654|NCT00758264|4020777|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4197655|NCT00758264|4020778|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4197656|NCT00758264|4020779|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4197657|NCT00758264|4020776|B4|||Age||Months|Mean|17.25|17.25|Standard Deviation|1.92|1.92|||
4197658|NCT00758264|4020777|B3|||Age||Months|Mean|17.4|17.4|Standard Deviation|1.86|1.86|||
4197659|NCT00758264|4020778|B2|||Age||Months|Mean|17.2|17.2|Standard Deviation|1.88|1.88|||
4197660|NCT00758264|4020779|B1|||Age||Months|Mean|17.2|17.2|Standard Deviation|1.97|1.97|||
4197661|NCT00758160|4020840|B1||Male|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
4197662|NCT00758160|4020840|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4197663|NCT00758160|4020840|B1|||Age||Years|Mean|9.5|9.5|Standard Deviation|2.4|2.4|||
4197664|NCT00758069|4020858|B4|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|159.9|159.9|Standard Deviation|39.3|39.3|||
4197665|NCT00758069|4020859|B3|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|164.1|164.1|Standard Deviation|36.9|36.9|||
4197666|NCT00758069|4020860|B2|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|156.4|156.4|Standard Deviation|41.3|41.3|||
4197667|NCT00758069|4020861|B1|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|158.6|158.6|Standard Deviation|41.0|41.0|||
4197668|NCT00758069|4020858|B4|||24-hour weighted mean plasma glucose (24hr-WMG)|The 24hr-WMG is the weighted mean of the blood glucose weighted by the intervals between time points for a day [i.e. the area under curve in glucose–time profile through 24-hours (AUC0-24 hr) divided by 24].|mg/dL|Mean|193.2|193.2|Standard Deviation|49.1|49.1|||
4197669|NCT00758069|4020859|B3|||24-hour weighted mean plasma glucose (24hr-WMG)|The 24hr-WMG is the weighted mean of the blood glucose weighted by the intervals between time points for a day [i.e. the area under curve in glucose–time profile through 24-hours (AUC0-24 hr) divided by 24].|mg/dL|Mean|195.4|195.4|Standard Deviation|46.2|46.2|||
4197670|NCT00758069|4020860|B2|||24-hour weighted mean plasma glucose (24hr-WMG)|The 24hr-WMG is the weighted mean of the blood glucose weighted by the intervals between time points for a day [i.e. the area under curve in glucose–time profile through 24-hours (AUC0-24 hr) divided by 24].|mg/dL|Mean|188.9|188.9|Standard Deviation|46.6|46.6|||
4197671|NCT00758069|4020861|B1|||24-hour weighted mean plasma glucose (24hr-WMG)|The 24hr-WMG is the weighted mean of the blood glucose weighted by the intervals between time points for a day [i.e. the area under curve in glucose–time profile through 24-hours (AUC0-24 hr) divided by 24].|mg/dL|Mean|195.0|195.0|Standard Deviation|55.6|55.6|||
4197672|NCT00758069|4020858|B4||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4197673|NCT00758069|4020859|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4197674|NCT00758069|4020860|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4197675|NCT00758069|4020861|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4197676|NCT00758069|4020858|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4197677|NCT00758069|4020859|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4197678|NCT00758069|4020860|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4197679|NCT00758069|4020861|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4197680|NCT00758069|4020858|B4|||Age||years|Mean|54.6|54.6|Standard Deviation|9.4|9.4|||
4197681|NCT00758069|4020859|B3|||Age||years|Mean|53.6|53.6|Standard Deviation|10.3|10.3|||
4197682|NCT00758069|4020860|B2|||Age||years|Mean|56.1|56.1|Standard Deviation|8.9|8.9|||
4197683|NCT00758069|4020861|B1|||Age||years|Mean|54.2|54.2|Standard Deviation|8.9|8.9|||
4197684|NCT00758043|4020874|B5|Europe||Region of Enrollment||participants|Number|31|31.0||||||
4197685|NCT00758043|4020875|B4|Europe||Region of Enrollment||participants|Number|2|2.0||||||
4197686|NCT00758043|4020876|B3|Europe||Region of Enrollment||participants|Number|12|12.0||||||
4197687|NCT00758043|4020877|B2|Europe||Region of Enrollment||participants|Number|9|9.0||||||
4197688|NCT00758043|4020878|B1|Europe||Region of Enrollment||participants|Number|8|8.0||||||
4197689|NCT00758043|4020874|B5|North America||Region of Enrollment||participants|Number|509|509.0||||||
4197690|NCT00758043|4020875|B4|North America||Region of Enrollment||participants|Number|98|98.0||||||
4197691|NCT00758043|4020876|B3|North America||Region of Enrollment||participants|Number|106|106.0||||||
4197692|NCT00758043|4020877|B2|North America||Region of Enrollment||participants|Number|151|151.0||||||
4197693|NCT00758043|4020878|B1|North America||Region of Enrollment||participants|Number|154|154.0||||||
4197694|NCT00758043|4020874|B5||Male|Sex: Female, Male||Participants|Count of Participants|325|325.0||||||
4197695|NCT00758043|4020875|B4||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4197696|NCT00758043|4020876|B3||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4197697|NCT00758043|4020877|B2||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4197698|NCT00758043|4020878|B1||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4197699|NCT00758043|4020874|B5||Female|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
4197700|NCT00758043|4020875|B4||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4197701|NCT00758043|4020876|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4197702|NCT00758043|4020877|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4197703|NCT00758043|4020878|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4197704|NCT00758043|4020874|B5|||Age||years|Mean|49.3|49.3|Standard Deviation|9.2|9.2|||
4197705|NCT00758043|4020875|B4|||Age||years|Mean|51.6|51.6|Standard Deviation|8.4|8.4|||
4197706|NCT00758043|4020876|B3|||Age||years|Mean|49.5|49.5|Standard Deviation|8.7|8.7|||
4197707|NCT00758043|4020877|B2|||Age||years|Mean|48.3|48.3|Standard Deviation|9.9|9.9|||
4197708|NCT00758043|4020878|B1|||Age||years|Mean|48.6|48.6|Standard Deviation|8.9|8.9|||
4197709|NCT00758043|4020874|B5||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4197710|NCT00758043|4020875|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4197711|NCT00758043|4020876|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4197712|NCT00758043|4020877|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4197713|NCT00758043|4020878|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4197714|NCT00758043|4020874|B5||Between 18 and 65 years|Age||Participants|Count of Participants|532|532.0||||||
4197715|NCT00758043|4020875|B4||Between 18 and 65 years|Age||Participants|Count of Participants|99|99.0||||||
4197716|NCT00758043|4020876|B3||Between 18 and 65 years|Age||Participants|Count of Participants|118|118.0||||||
4197717|NCT00758043|4020877|B2||Between 18 and 65 years|Age||Participants|Count of Participants|157|157.0||||||
4197718|NCT00758043|4020878|B1||Between 18 and 65 years|Age||Participants|Count of Participants|158|158.0||||||
4197719|NCT00758043|4020874|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197720|NCT00758043|4020875|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197721|NCT00758043|4020876|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197722|NCT00758043|4020877|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197723|NCT00758043|4020878|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197724|NCT00757848|4020907|B3||Male|Sex: Female, Male|Two patients excluded from analysis set. No data for patient who prematurely discontinued and for patient who did not receive any study medication.|Participants|Count of Participants|53|53.0||||||
4197725|NCT00757848|4020908|B2||Male|Sex: Female, Male|Two patients excluded from analysis set. No data for patient who prematurely discontinued and for patient who did not receive any study medication.|Participants|Count of Participants|29|29.0||||||
4197726|NCT00757848|4020909|B1||Male|Sex: Female, Male|Two patients excluded from analysis set. No data for patient who prematurely discontinued and for patient who did not receive any study medication.|Participants|Count of Participants|24|24.0||||||
4197727|NCT00757848|4020907|B3||Female|Sex: Female, Male|Two patients excluded from analysis set. No data for patient who prematurely discontinued and for patient who did not receive any study medication.|Participants|Count of Participants|1|1.0||||||
4197728|NCT00757848|4020908|B2||Female|Sex: Female, Male|Two patients excluded from analysis set. No data for patient who prematurely discontinued and for patient who did not receive any study medication.|Participants|Count of Participants|0|0.0||||||
4197729|NCT00757848|4020909|B1||Female|Sex: Female, Male|Two patients excluded from analysis set. No data for patient who prematurely discontinued and for patient who did not receive any study medication.|Participants|Count of Participants|1|1.0||||||
4197730|NCT00757848|4020907|B3|||Age||years|Median|25|25.0|Full Range|||17.0|53.0|
4197731|NCT00757848|4020908|B2|||Age||years|Median|25|25.0|Full Range|||17.0|53.0|
4197732|NCT00757848|4020909|B1|||Age||years|Median|25|25.0|Full Range|||20.0|51.0|
4197733|NCT00757822|4020954|B3|K score >2||Risk scores for PONV|Post-operative Nausea and Vomiting (PONV) risk score is defined as by adding risk factors on the Koivuranta scale ( e.g. where each of the following factors: surgery lasting more than 60 minutes, female, non-smoking status, history of PONV, and history of motion sickness is assigned a value of one if present and the risk score is the summation of each factor). A K score of 0-1 represents low risk for PONV. The risk increases with K scores of 2 or more, 5 being the maximum.|participants|Number|42|42.0||||||
4197734|NCT00757822|4020955|B2|K score >2||Risk scores for PONV|Post-operative Nausea and Vomiting (PONV) risk score is defined as by adding risk factors on the Koivuranta scale ( e.g. where each of the following factors: surgery lasting more than 60 minutes, female, non-smoking status, history of PONV, and history of motion sickness is assigned a value of one if present and the risk score is the summation of each factor). A K score of 0-1 represents low risk for PONV. The risk increases with K scores of 2 or more, 5 being the maximum.|participants|Number|22|22.0||||||
4197735|NCT00757822|4020956|B1|K score >2||Risk scores for PONV|Post-operative Nausea and Vomiting (PONV) risk score is defined as by adding risk factors on the Koivuranta scale ( e.g. where each of the following factors: surgery lasting more than 60 minutes, female, non-smoking status, history of PONV, and history of motion sickness is assigned a value of one if present and the risk score is the summation of each factor). A K score of 0-1 represents low risk for PONV. The risk increases with K scores of 2 or more, 5 being the maximum.|participants|Number|20|20.0||||||
4197736|NCT00757822|4020954|B3|K score=2||Risk scores for PONV|Post-operative Nausea and Vomiting (PONV) risk score is defined as by adding risk factors on the Koivuranta scale ( e.g. where each of the following factors: surgery lasting more than 60 minutes, female, non-smoking status, history of PONV, and history of motion sickness is assigned a value of one if present and the risk score is the summation of each factor). A K score of 0-1 represents low risk for PONV. The risk increases with K scores of 2 or more, 5 being the maximum.|participants|Number|79|79.0||||||
4197737|NCT00757822|4020955|B2|K score=2||Risk scores for PONV|Post-operative Nausea and Vomiting (PONV) risk score is defined as by adding risk factors on the Koivuranta scale ( e.g. where each of the following factors: surgery lasting more than 60 minutes, female, non-smoking status, history of PONV, and history of motion sickness is assigned a value of one if present and the risk score is the summation of each factor). A K score of 0-1 represents low risk for PONV. The risk increases with K scores of 2 or more, 5 being the maximum.|participants|Number|35|35.0||||||
4197738|NCT00757822|4020956|B1|K score=2||Risk scores for PONV|Post-operative Nausea and Vomiting (PONV) risk score is defined as by adding risk factors on the Koivuranta scale ( e.g. where each of the following factors: surgery lasting more than 60 minutes, female, non-smoking status, history of PONV, and history of motion sickness is assigned a value of one if present and the risk score is the summation of each factor). A K score of 0-1 represents low risk for PONV. The risk increases with K scores of 2 or more, 5 being the maximum.|participants|Number|44|44.0||||||
4197739|NCT00757822|4020954|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197740|NCT00757822|4020955|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197741|NCT00757822|4020956|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197742|NCT00757822|4020954|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4197743|NCT00757822|4020955|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4197744|NCT00757822|4020956|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197745|NCT00757822|4020954|B3||White|Race (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
4197746|NCT00757822|4020955|B2||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4197747|NCT00757822|4020956|B1||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4197748|NCT00757822|4020954|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4197749|NCT00757822|4020955|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4197750|NCT00757822|4020956|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4197751|NCT00757822|4020954|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197752|NCT00757822|4020955|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197753|NCT00757822|4020956|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197754|NCT00757822|4020954|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197755|NCT00757822|4020955|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197756|NCT00757822|4020956|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197757|NCT00757822|4020954|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197758|NCT00757822|4020955|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197759|NCT00757822|4020956|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197760|NCT00757822|4020954|B3||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4197761|NCT00757822|4020955|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4197762|NCT00757822|4020956|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4197763|NCT00757822|4020954|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4197764|NCT00757822|4020955|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4197765|NCT00757822|4020956|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4197766|NCT00757822|4020954|B3|||Age||years|Mean|57.7|57.7|Standard Deviation|12.7|12.7|||
4197767|NCT00757822|4020955|B2|||Age||years|Mean|57.6|57.6|Standard Deviation|13.2|13.2|||
4197768|NCT00757822|4020956|B1|||Age||years|Mean|57.8|57.8|Standard Deviation|12.5|12.5|||
4197769|NCT00757783|4020977|B3|US||Region of Enrollment||participants|Number|65|65.0||||||
4197770|NCT00757783|4020978|B2|US||Region of Enrollment||participants|Number|31|31.0||||||
4197771|NCT00757783|4020979|B1|US||Region of Enrollment||participants|Number|34|34.0||||||
4197772|NCT00757783|4020977|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4197773|NCT00757783|4020978|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4197774|NCT00757783|4020979|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4197775|NCT00757783|4020977|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4197776|NCT00757783|4020978|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4197777|NCT00757783|4020979|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4197778|NCT00757783|4020977|B3|||Age||years|Mean|36.4|36.4|Standard Deviation|10.92|10.92|||
4197779|NCT00757783|4020978|B2|||Age||years|Mean|36.9|36.9|Standard Deviation|11.66|11.66|||
4197780|NCT00757783|4020979|B1|||Age||years|Mean|35.9|35.9|Standard Deviation|10.35|10.35|||
4197781|NCT00757705|4021016|B1||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4197782|NCT00757705|4021016|B1||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4197783|NCT00757705|4021016|B1|||Age||years|Mean|40.1|40.1|Standard Deviation|11.85|11.85|||
4197784|NCT00757666|4021028|B3|United States||Region of Enrollment||participants|Number|68|68.0||||||
4197785|NCT00757666|4021029|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
4197786|NCT00757666|4021030|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4197787|NCT00757666|4021028|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4197788|NCT00757666|4021029|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4197789|NCT00757666|4021030|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4197790|NCT00757666|4021028|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4197791|NCT00757666|4021029|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4197792|NCT00757666|4021030|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4197793|NCT00757666|4021028|B3|||Age||years|Mean|70.4|70.4|Standard Deviation|8.2|8.2|||
4197794|NCT00757666|4021029|B2|||Age||years|Mean|70.7|70.7|Standard Deviation|8.2|8.2|||
4197795|NCT00757666|4021030|B1|||Age||years|Mean|70.0|70.0|Standard Deviation|8.4|8.4|||
4197796|NCT00757666|4021028|B3||>=65 years|Age||Participants|Count of Participants|53|53.0||||||
4197797|NCT00757666|4021029|B2||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4197798|NCT00757666|4021030|B1||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4197799|NCT00757666|4021028|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4197800|NCT00757666|4021029|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4197801|NCT00757666|4021030|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4197802|NCT00757666|4021028|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197803|NCT00757666|4021029|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197804|NCT00757666|4021030|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197805|NCT00757627|4021045|B1|WOMAC Physical Function subscale||The mean of patient WOMAC ( Western Ontario and McMaster Universities Osteoarthritis Index) subscale|The baseline domain scores of WOMAC included pain, stiffness, and difficult in doing daily activity. Each domain comprises of questions and VAS scales for scoring For pain domain, 0 represents no pain and 100 represents extreme pain; for stiffness domain, 0 represents no stiffness and 100 represents extreme stiffness; for difficult in doing daily activity domain, 0 represents no difficulty and 100 represents most difficulty.|Units on a Scale|Mean|38.0|38.0|Standard Deviation|24.8|24.8|||
4197806|NCT00757627|4021045|B1|WOMAC Stiffness subscale||The mean of patient WOMAC ( Western Ontario and McMaster Universities Osteoarthritis Index) subscale|The baseline domain scores of WOMAC included pain, stiffness, and difficult in doing daily activity. Each domain comprises of questions and VAS scales for scoring For pain domain, 0 represents no pain and 100 represents extreme pain; for stiffness domain, 0 represents no stiffness and 100 represents extreme stiffness; for difficult in doing daily activity domain, 0 represents no difficulty and 100 represents most difficulty.|Units on a Scale|Mean|36.3|36.3|Standard Deviation|26.9|26.9|||
4197870|NCT00757588|4021178|B3|65 years to younger than 75 years||Age, Customized||participants|Number|95|95.0||||||
4198017|NCT00756964|4021296|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197807|NCT00757627|4021045|B1|WOMAC Pain subscale||The mean of patient WOMAC ( Western Ontario and McMaster Universities Osteoarthritis Index) subscale|The baseline domain scores of WOMAC included pain, stiffness, and difficult in doing daily activity. Each domain comprises of questions and VAS scales for scoring For pain domain, 0 represents no pain and 100 represents extreme pain; for stiffness domain, 0 represents no stiffness and 100 represents extreme stiffness; for difficult in doing daily activity domain, 0 represents no difficulty and 100 represents most difficulty.|Units on a Scale|Mean|38.5|38.5|Standard Deviation|22.9|22.9|||
4197808|NCT00757627|4021045|B1|BPI - Enjoyment of life||The mean of patient BPI (Brief Pain Inventory) scores|BPI consists of pain and pain interference domains. For pain (0=no pain to 10=extreme pain); for Interference ( 0=no interference to 10= greatest interference).|Units on a scale|Mean|3.0|3.0|Standard Deviation|2.1|2.1|||
4197809|NCT00757627|4021045|B1|BPI - Sleep||The mean of patient BPI (Brief Pain Inventory) scores|BPI consists of pain and pain interference domains. For pain (0=no pain to 10=extreme pain); for Interference ( 0=no interference to 10= greatest interference).|Units on a scale|Mean|3.3|3.3|Standard Deviation|2.3|2.3|||
4197810|NCT00757627|4021045|B1|BPI- Relations with other people||The mean of patient BPI (Brief Pain Inventory) scores|BPI consists of pain and pain interference domains. For pain (0=no pain to 10=extreme pain); for Interference ( 0=no interference to 10= greatest interference).|Units on a scale|Mean|2.5|2.5|Standard Deviation|1.9|1.9|||
4197811|NCT00757627|4021045|B1|BPI - Normal work||The mean of patient BPI (Brief Pain Inventory) scores|BPI consists of pain and pain interference domains. For pain (0=no pain to 10=extreme pain); for Interference ( 0=no interference to 10= greatest interference).|Units on a scale|Mean|4.2|4.2|Standard Deviation|2.9|2.9|||
4197812|NCT00757627|4021045|B1|BPI -Walking||The mean of patient BPI (Brief Pain Inventory) scores|BPI consists of pain and pain interference domains. For pain (0=no pain to 10=extreme pain); for Interference ( 0=no interference to 10= greatest interference).|Units on a scale|Mean|4.3|4.3|Standard Deviation|2.9|2.9|||
4197813|NCT00757627|4021045|B1|BPI - Mood||The mean of patient BPI (Brief Pain Inventory) scores|BPI consists of pain and pain interference domains. For pain (0=no pain to 10=extreme pain); for Interference ( 0=no interference to 10= greatest interference).|Units on a scale|Mean|3.2|3.2|Standard Deviation|2.2|2.2|||
4197814|NCT00757627|4021045|B1|BPI -Interference on general activities||The mean of patient BPI (Brief Pain Inventory) scores|BPI consists of pain and pain interference domains. For pain (0=no pain to 10=extreme pain); for Interference ( 0=no interference to 10= greatest interference).|Units on a scale|Mean|2.9|2.9|Standard Deviation|2.1|2.1|||
4197815|NCT00757627|4021045|B1|BPI -Pain right now||The mean of patient BPI (Brief Pain Inventory) scores|BPI consists of pain and pain interference domains. For pain (0=no pain to 10=extreme pain); for Interference ( 0=no interference to 10= greatest interference).|Units on a scale|Mean|4.4|4.4|Standard Deviation|3.1|3.1|||
4197816|NCT00757627|4021045|B1|BPI-Average pain||The mean of patient BPI (Brief Pain Inventory) scores|BPI consists of pain and pain interference domains. For pain (0=no pain to 10=extreme pain); for Interference ( 0=no interference to 10= greatest interference).|Units on a scale|Mean|4.9|4.9|Standard Deviation|3.8|3.8|||
4197817|NCT00757627|4021045|B1|BPI -Least pain||The mean of patient BPI (Brief Pain Inventory) scores|BPI consists of pain and pain interference domains. For pain (0=no pain to 10=extreme pain); for Interference ( 0=no interference to 10= greatest interference).|Units on a scale|Mean|3.2|3.2|Standard Deviation|2.5|2.5|||
4197818|NCT00757627|4021045|B1|BPI -Worst pain||The mean of patient BPI (Brief Pain Inventory) scores|BPI consists of pain and pain interference domains. For pain (0=no pain to 10=extreme pain); for Interference ( 0=no interference to 10= greatest interference).|Units on a scale|Mean|6.4|6.4|Standard Deviation|4.9|4.9|||
4197819|NCT00757627|4021045|B1|TSQM – Overall satisfaction||TSQM (Treatment Satisfaction Questionnaire for Medication )domain scores|TSQM consists of four domains (effectiveness; side effect; convenience and overall satisfaction), domain scores ranged from 0(0=worst) to 100(100=best) were derived from converting the original Likert's scales to VAS scale.|Units on a scale|Mean|44.1|44.1|Standard Deviation|45.7|45.7|||
4197820|NCT00757627|4021045|B1|TSQM - Convenience||TSQM (Treatment Satisfaction Questionnaire for Medication )domain scores|TSQM consists of four domains (effectiveness; side effect; convenience and overall satisfaction), domain scores ranged from 0(0=worst) to 100(100=best) were derived from converting the original Likert's scales to VAS scale.|Units on a scale|Mean|68.0|68.0|Standard Deviation|68.8|68.8|||
4197821|NCT00757627|4021045|B1|TSQM - Side effect||TSQM (Treatment Satisfaction Questionnaire for Medication )domain scores|TSQM consists of four domains (effectiveness; side effect; convenience and overall satisfaction), domain scores ranged from 0(0=worst) to 100(100=best) were derived from converting the original Likert's scales to VAS scale.|Units on a scale|Mean|56.9|56.9|Standard Deviation|55.7|55.7|||
4197822|NCT00757627|4021045|B1|TSQM - Effectiveness||TSQM (Treatment Satisfaction Questionnaire for Medication )domain scores|TSQM consists of four domains (effectiveness; side effect; convenience and overall satisfaction), domain scores ranged from 0(0=worst) to 100(100=best) were derived from converting the original Likert's scales to VAS scale.|Units on a scale|Mean|52.1|52.1|Standard Deviation|55.6|55.6|||
4197823|NCT00757627|4021045|B1|SF-36 Mental health||Patient-SF36 (Short form 36) domain scores|SF36 consists of weighted scores of the 8 domains (physical functioning; role limitation due to physical problem; bodily pain; general health; vitality; social functioning; role limitation due to emotional problem; mental health), each is measured with scale score ranged from 0≈100, with 100 representing the best possible functioning).|Units on a scale|Mean|61.7|61.7|Standard Deviation|66.3|66.3|||
4197824|NCT00757627|4021045|B1|SF-36 Role limitation due to emotional problem||Patient-SF36 (Short form 36) domain scores|SF36 consists of weighted scores of the 8 domains (physical functioning; role limitation due to physical problem; bodily pain; general health; vitality; social functioning; role limitation due to emotional problem; mental health), each is measured with scale score ranged from 0≈100, with 100 representing the best possible functioning).|Units on a scale|Mean|41.3|41.3|Standard Deviation|56.6|56.6|||
4197825|NCT00757627|4021045|B1|SF-36 Social functioning||Patient-SF36 (Short form 36) domain scores|SF36 consists of weighted scores of the 8 domains (physical functioning; role limitation due to physical problem; bodily pain; general health; vitality; social functioning; role limitation due to emotional problem; mental health), each is measured with scale score ranged from 0≈100, with 100 representing the best possible functioning).|Units on a scale|Mean|69.0|69.0|Standard Deviation|78.3|78.3|||
4197826|NCT00757627|4021045|B1|SF-36 Vitality||Patient-SF36 (Short form 36) domain scores|SF36 consists of weighted scores of the 8 domains (physical functioning; role limitation due to physical problem; bodily pain; general health; vitality; social functioning; role limitation due to emotional problem; mental health), each is measured with scale score ranged from 0≈100, with 100 representing the best possible functioning).|Units on a scale|Mean|55.9|55.9|Standard Deviation|57.6|57.6|||
4197827|NCT00757627|4021045|B1|SF-36 General health||Patient-SF36 (Short form 36) domain scores|SF36 consists of weighted scores of the 8 domains (physical functioning; role limitation due to physical problem; bodily pain; general health; vitality; social functioning; role limitation due to emotional problem; mental health), each is measured with scale score ranged from 0≈100, with 100 representing the best possible functioning).|Units on a scale|Mean|52.7|52.7|Standard Deviation|54.5|54.5|||
4197828|NCT00757627|4021045|B1|SF-36 Bodily pain||Patient-SF36 (Short form 36) domain scores|SF36 consists of weighted scores of the 8 domains (physical functioning; role limitation due to physical problem; bodily pain; general health; vitality; social functioning; role limitation due to emotional problem; mental health), each is measured with scale score ranged from 0≈100, with 100 representing the best possible functioning).|Units on a scale|Mean|52.4|52.4|Standard Deviation|63.9|63.9|||
4197829|NCT00757627|4021045|B1|SF-36 Role limitation due to physical problem||Patient-SF36 (Short form 36) domain scores|SF36 consists of weighted scores of the 8 domains (physical functioning; role limitation due to physical problem; bodily pain; general health; vitality; social functioning; role limitation due to emotional problem; mental health), each is measured with scale score ranged from 0≈100, with 100 representing the best possible functioning).|Units on a scale|Mean|24.0|24.0|Standard Deviation|42.5|42.5|||
4197830|NCT00757627|4021045|B1|SF-36 Physical functional||Patient-SF36 (Short form 36) domain scores|SF36 consists of weighted scores of the 8 domains (physical functioning; role limitation due to physical problem; bodily pain; general health; vitality; social functioning; role limitation due to emotional problem; mental health), each is measured with scale score ranged from 0≈100, with 100 representing the best possible functioning).|Units on a scale|Mean|45.1|45.1|Standard Deviation|51.3|51.3|||
4197831|NCT00757627|4021045|B1||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4197832|NCT00757627|4021045|B1||Female|Sex: Female, Male||Participants|Count of Participants|365|365.0||||||
4197833|NCT00757627|4021045|B1|||Age||years|Mean|66.6|66.6|Standard Deviation|10.9|10.9|||
4197834|NCT00757601|4021058|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4197835|NCT00757601|4021058|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4197836|NCT00757601|4021058|B1|||Age||years|Mean|54.2|54.2|Standard Deviation|9.2|9.2|||
4197837|NCT00757588|4021178|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4197838|NCT00757588|4021179|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4197839|NCT00757588|4021180|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4197840|NCT00757588|4021178|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197841|NCT00757588|4021179|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197842|NCT00757588|4021180|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197843|NCT00757588|4021178|B3||White|Race (NIH/OMB)||Participants|Count of Participants|355|355.0||||||
4197844|NCT00757588|4021179|B2||White|Race (NIH/OMB)||Participants|Count of Participants|118|118.0||||||
4197845|NCT00757588|4021180|B1||White|Race (NIH/OMB)||Participants|Count of Participants|237|237.0||||||
4197846|NCT00757588|4021178|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4197847|NCT00757588|4021179|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4197848|NCT00757588|4021180|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4197849|NCT00757588|4021178|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197850|NCT00757588|4021179|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197851|NCT00757588|4021180|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197852|NCT00757588|4021178|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4197853|NCT00757588|4021179|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4197854|NCT00757588|4021180|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4197855|NCT00757588|4021178|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197856|NCT00757588|4021179|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197857|NCT00757588|4021180|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197858|NCT00757588|4021178|B3||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4197859|NCT00757588|4021179|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4197860|NCT00757588|4021180|B1||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4197861|NCT00757588|4021178|B3||Female|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
4197862|NCT00757588|4021179|B2||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4197863|NCT00757588|4021180|B1||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4197864|NCT00757588|4021178|B3|||Age, Customized||Years|Mean|57.2|57.2|Standard Deviation|9.37|9.37|||
4197865|NCT00757588|4021179|B2|||Age, Customized||Years|Mean|57.3|57.3|Standard Deviation|9.27|9.27|||
4197866|NCT00757588|4021180|B1|||Age, Customized||Years|Mean|57.2|57.2|Standard Deviation|9.43|9.43|||
4197867|NCT00757588|4021178|B3|75 years and older||Age, Customized||participants|Number|9|9.0||||||
4197868|NCT00757588|4021179|B2|75 years and older||Age, Customized||participants|Number|3|3.0||||||
4197869|NCT00757588|4021180|B1|75 years and older||Age, Customized||participants|Number|6|6.0||||||
4197871|NCT00757588|4021179|B2|65 years to younger than 75 years||Age, Customized||participants|Number|30|30.0||||||
4197872|NCT00757588|4021180|B1|65 years to younger than 75 years||Age, Customized||participants|Number|65|65.0||||||
4197873|NCT00757588|4021178|B3|Younger than 65 years||Age, Customized||participants|Number|351|351.0||||||
4197874|NCT00757588|4021179|B2|Younger than 65 years||Age, Customized||participants|Number|118|118.0||||||
4197875|NCT00757588|4021180|B1|Younger than 65 years||Age, Customized||participants|Number|233|233.0||||||
4197876|NCT00757588|4021178|B3|||Age, Customized||years|Median|58|58.0|Full Range|9.37|9.37|18.0|77.0|
4197877|NCT00757588|4021179|B2|||Age, Customized||years|Median|58|58.0|Full Range|9.27|9.27|30.0|77.0|
4197878|NCT00757588|4021180|B1|||Age, Customized||years|Median|58|58.0|Full Range|9.43|9.43|18.0|77.0|
4197879|NCT00757484|4021213|B1|||depression/anxiety||participants|Number|159|159.0||||||
4197880|NCT00757484|4021213|B1|||Gastroesophageal Reflux Disease||participants|Number|185|185.0||||||
4197881|NCT00757484|4021213|B1|||Diabetes||participants|Number|26|26.0||||||
4197882|NCT00757484|4021213|B1|||Hypertension||participants|Number|163|163.0||||||
4197883|NCT00757484|4021213|B1|||Postmenopausal||participants|Number|169|169.0||||||
4197884|NCT00757484|4021213|B1|United States||Region of Enrollment|This was a chart review study. 37 participants were not analyzed because the data in their chart was not available.|participants|Number|491|491.0||||||
4197885|NCT00757484|4021213|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4197886|NCT00757484|4021213|B1||Female|Sex: Female, Male||Participants|Count of Participants|491|491.0||||||
4197887|NCT00757484|4021213|B1|||Age||years|Mean|50|50.0|Full Range|||22.0|97.0|
4197888|NCT00757237|4021220|B3|||Cystic Fibrosis Questionnaire - Revised (CFQ-R) Respiratory Symptoms Scale (RSS) Score|The CFQ-R is a validated, patient-reported outcome tool measuring health-related quality of life for children and adults with CF. The CFQ-R contains both general and CF-specific scales. Respiratory symptoms (e.g., coughing, congestion, wheezing) are assessed with the CFQ-R Respiratory Symptoms Scale (RSS). The range of scores (units) is 0 to 100 with higher scores indicating fewer symptoms.|units on a scale|Mean|60.44|60.44|Standard Deviation|20.69|20.69|||
4197889|NCT00757237|4021221|B2|||Cystic Fibrosis Questionnaire - Revised (CFQ-R) Respiratory Symptoms Scale (RSS) Score|The CFQ-R is a validated, patient-reported outcome tool measuring health-related quality of life for children and adults with CF. The CFQ-R contains both general and CF-specific scales. Respiratory symptoms (e.g., coughing, congestion, wheezing) are assessed with the CFQ-R Respiratory Symptoms Scale (RSS). The range of scores (units) is 0 to 100 with higher scores indicating fewer symptoms.|units on a scale|Mean|58.02|58.02|Standard Deviation|20.76|20.76|||
4197890|NCT00757237|4021222|B1|||Cystic Fibrosis Questionnaire - Revised (CFQ-R) Respiratory Symptoms Scale (RSS) Score|The CFQ-R is a validated, patient-reported outcome tool measuring health-related quality of life for children and adults with CF. The CFQ-R contains both general and CF-specific scales. Respiratory symptoms (e.g., coughing, congestion, wheezing) are assessed with the CFQ-R Respiratory Symptoms Scale (RSS). The range of scores (units) is 0 to 100 with higher scores indicating fewer symptoms.|units on a scale|Mean|62.87|62.87|Standard Deviation|20.42|20.42|||
4197891|NCT00757237|4021220|B3|||Forced Expiratory Volume (FEV1) Percent Predicted|FEV1 percent predicted is a normalized value of FEV1 calculated using the Knudson equation and based upon participant age, gender, and height.|percent|Mean|52.27|52.27|Standard Deviation|15.06|15.06|||
4197892|NCT00757237|4021221|B2|||Forced Expiratory Volume (FEV1) Percent Predicted|FEV1 percent predicted is a normalized value of FEV1 calculated using the Knudson equation and based upon participant age, gender, and height.|percent|Mean|52.24|52.24|Standard Deviation|14.57|14.57|||
4197893|NCT00757237|4021222|B1|||Forced Expiratory Volume (FEV1) Percent Predicted|FEV1 percent predicted is a normalized value of FEV1 calculated using the Knudson equation and based upon participant age, gender, and height.|percent|Mean|52.30|52.3|Standard Deviation|15.56|15.56|||
4197894|NCT00757237|4021220|B3|> 50% predicted||Disease Severity|Forced Expiratory Volume (FEV1) percent predicted is a normalized value of FEV1 calculated using the Knudson equation and based upon participant age, gender, and height. This baseline measure indicates the number of participants with FEV1 greater than 50% and less than or equal to 50% of the predicted value based on age, gender, and height at screening.|participants|Number|151|151.0||||||
4197895|NCT00757237|4021221|B2|> 50% predicted||Disease Severity|Forced Expiratory Volume (FEV1) percent predicted is a normalized value of FEV1 calculated using the Knudson equation and based upon participant age, gender, and height. This baseline measure indicates the number of participants with FEV1 greater than 50% and less than or equal to 50% of the predicted value based on age, gender, and height at screening.|participants|Number|75|75.0||||||
4197896|NCT00757237|4021222|B1|> 50% predicted||Disease Severity|Forced Expiratory Volume (FEV1) percent predicted is a normalized value of FEV1 calculated using the Knudson equation and based upon participant age, gender, and height. This baseline measure indicates the number of participants with FEV1 greater than 50% and less than or equal to 50% of the predicted value based on age, gender, and height at screening.|participants|Number|76|76.0||||||
4197897|NCT00757237|4021220|B3|<= 50% predicted||Disease Severity|Forced Expiratory Volume (FEV1) percent predicted is a normalized value of FEV1 calculated using the Knudson equation and based upon participant age, gender, and height. This baseline measure indicates the number of participants with FEV1 greater than 50% and less than or equal to 50% of the predicted value based on age, gender, and height at screening.|participants|Number|117|117.0||||||
4197898|NCT00757237|4021221|B2|<= 50% predicted||Disease Severity|Forced Expiratory Volume (FEV1) percent predicted is a normalized value of FEV1 calculated using the Knudson equation and based upon participant age, gender, and height. This baseline measure indicates the number of participants with FEV1 greater than 50% and less than or equal to 50% of the predicted value based on age, gender, and height at screening.|participants|Number|57|57.0||||||
4197899|NCT00757237|4021222|B1|<= 50% predicted||Disease Severity|Forced Expiratory Volume (FEV1) percent predicted is a normalized value of FEV1 calculated using the Knudson equation and based upon participant age, gender, and height. This baseline measure indicates the number of participants with FEV1 greater than 50% and less than or equal to 50% of the predicted value based on age, gender, and height at screening.|participants|Number|60|60.0||||||
4197900|NCT00757237|4021220|B3|>= 84 days||Inhaled Tobramycin Use in the Previous 12 Months||participants|Number|228|228.0||||||
4197901|NCT00757237|4021221|B2|>= 84 days||Inhaled Tobramycin Use in the Previous 12 Months||participants|Number|113|113.0||||||
4197902|NCT00757237|4021222|B1|>= 84 days||Inhaled Tobramycin Use in the Previous 12 Months||participants|Number|115|115.0||||||
4197903|NCT00757237|4021220|B3|< 84 days||Inhaled Tobramycin Use in the Previous 12 Months||participants|Number|40|40.0||||||
4197904|NCT00757237|4021221|B2|< 84 days||Inhaled Tobramycin Use in the Previous 12 Months||participants|Number|19|19.0||||||
4197905|NCT00757237|4021222|B1|< 84 days||Inhaled Tobramycin Use in the Previous 12 Months||participants|Number|21|21.0||||||
4197906|NCT00757237|4021220|B3|||Body Mass Index (BMI)||kg/m^2|Mean|20.35|20.35|Standard Deviation|2.88|2.88|||
4197907|NCT00757237|4021221|B2|||Body Mass Index (BMI)||kg/m^2|Mean|20.49|20.49|Standard Deviation|2.82|2.82|||
4197908|NCT00757237|4021222|B1|||Body Mass Index (BMI)||kg/m^2|Mean|20.22|20.22|Standard Deviation|2.95|2.95|||
4197909|NCT00757237|4021220|B3|Europe||Region of Enrollment||participants|Number|174|174.0||||||
4197910|NCT00757237|4021221|B2|Europe||Region of Enrollment||participants|Number|82|82.0||||||
4197911|NCT00757237|4021222|B1|Europe||Region of Enrollment||participants|Number|92|92.0||||||
4197912|NCT00757237|4021220|B3|United States||Region of Enrollment||participants|Number|94|94.0||||||
4197913|NCT00757237|4021221|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
4197914|NCT00757237|4021222|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4197915|NCT00757237|4021220|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4197916|NCT00757237|4021221|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197917|NCT00757237|4021222|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4197918|NCT00757237|4021220|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197919|NCT00757237|4021221|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197920|NCT00757237|4021222|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197921|NCT00757237|4021220|B3||White|Race (NIH/OMB)||Participants|Count of Participants|261|261.0||||||
4197922|NCT00757237|4021221|B2||White|Race (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
4197923|NCT00757237|4021222|B1||White|Race (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
4197924|NCT00757237|4021220|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4197925|NCT00757237|4021221|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4197926|NCT00757237|4021222|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197927|NCT00757237|4021220|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197928|NCT00757237|4021221|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197929|NCT00757237|4021222|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197930|NCT00757237|4021220|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4197931|NCT00757237|4021221|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197932|NCT00757237|4021222|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4197933|NCT00757237|4021220|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197934|NCT00757237|4021221|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197935|NCT00757237|4021222|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197936|NCT00757237|4021220|B3||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4197937|NCT00757237|4021221|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4197938|NCT00757237|4021222|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4197939|NCT00757237|4021220|B3||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4197940|NCT00757237|4021221|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4197941|NCT00757237|4021222|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4197942|NCT00757237|4021220|B3|||Age||years|Mean|25.5|25.5|Standard Deviation|9.0|9.0|||
4197943|NCT00757237|4021221|B2|||Age||years|Mean|25.1|25.1|Standard Deviation|9.0|9.0|||
4197944|NCT00757237|4021222|B1|||Age||years|Mean|25.8|25.8|Standard Deviation|9.1|9.1|||
4197945|NCT00757237|4021220|B3|>= 18 years||Age||participants|Number|209|209.0||||||
4197946|NCT00757237|4021221|B2|>= 18 years||Age||participants|Number|101|101.0||||||
4197947|NCT00757237|4021222|B1|>= 18 years||Age||participants|Number|108|108.0||||||
4197948|NCT00757237|4021220|B3|> 12 years to < 18 years||Age||participants|Number|46|46.0||||||
4197949|NCT00757237|4021221|B2|> 12 years to < 18 years||Age||participants|Number|26|26.0||||||
4197950|NCT00757237|4021222|B1|> 12 years to < 18 years||Age||participants|Number|20|20.0||||||
4197951|NCT00757237|4021220|B3|>= 6 years to <= 12 years||Age||participants|Number|13|13.0||||||
4197952|NCT00757237|4021221|B2|>= 6 years to <= 12 years||Age||participants|Number|5|5.0||||||
4197953|NCT00757237|4021222|B1|>= 6 years to <= 12 years||Age||participants|Number|8|8.0||||||
4197954|NCT00757172|4021251|B1|M1a= Metastasis in celiac or cervical lymph nodes||Clinical M Stage||participants|Number|9|9.0||||||
4197955|NCT00757172|4021251|B1|M0= No distant metastasis||Clinical M Stage||participants|Number|56|56.0||||||
4197956|NCT00757172|4021251|B1|N1= Regional lymph node metastasis||Clinical N Stage||participants|Number|52|52.0||||||
4197957|NCT00757172|4021251|B1|N0= No regional lymph node metastasis||Clinical N Stage||participants|Number|13|13.0||||||
4198016|NCT00756964|4021295|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197958|NCT00757172|4021251|B1|T3= Tumor invades adventitia||Clinical T Stage||participants|Number|58|58.0||||||
4197959|NCT00757172|4021251|B1|T2 = Tumor invades muscularis propria||Clinical T Stage||participants|Number|7|7.0||||||
4197960|NCT00757172|4021251|B1|II||Tumor location (Siewert Type)|Siewert Type I= Adenocarcinoma of the distal esophagus; Siewert Type II= Adenocarcinoma of the esophagogastric junction/real cardia|participants|Number|29|29.0||||||
4197961|NCT00757172|4021251|B1|I||Tumor location (Siewert Type)|Siewert Type I= Adenocarcinoma of the distal esophagus; Siewert Type II= Adenocarcinoma of the esophagogastric junction/real cardia|participants|Number|36|36.0||||||
4197962|NCT00757172|4021251|B1|||Body Mass Index (BMI)||kg/m^2|Median|27.8|27.8|Full Range|||17.7|53.5|
4197963|NCT00757172|4021251|B1|1= Symptomatic; fully ambulatory||Eastern Cooperative Oncology Group (ECOG) performance status||participants|Number|28|28.0||||||
4197964|NCT00757172|4021251|B1|0= Asymptomatic and fully active||Eastern Cooperative Oncology Group (ECOG) performance status||participants|Number|37|37.0||||||
4197965|NCT00757172|4021251|B1|United States||Region of Enrollment||participants|Number|65|65.0||||||
4197966|NCT00757172|4021251|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197967|NCT00757172|4021251|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197968|NCT00757172|4021251|B1||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4197969|NCT00757172|4021251|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4197970|NCT00757172|4021251|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197971|NCT00757172|4021251|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197972|NCT00757172|4021251|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4197973|NCT00757172|4021251|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4197974|NCT00757172|4021251|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4197975|NCT00757172|4021251|B1|||Age||years|Median|61|61.0|Full Range|||30.0|76.0|
4197976|NCT00757003|4021259|B1||Male|Gender||Participants|Count of Participants|69|69.0||||||
4197977|NCT00757003|4021259|B1||Female|Gender||Participants|Count of Participants|31|31.0||||||
4197978|NCT00757003|4021259|B1|||Age||years|Mean|64.4|64.4|Standard Deviation|17.4|17.4|||
4197979|NCT00756977|4021265|B3|United States||Region of Enrollment||participants|Number|366|366.0||||||
4197980|NCT00756977|4021266|B2|United States||Region of Enrollment||participants|Number|190|190.0||||||
4197981|NCT00756977|4021267|B1|United States||Region of Enrollment||participants|Number|176|176.0||||||
4197982|NCT00756977|4021265|B3||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4197983|NCT00756977|4021266|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4197984|NCT00756977|4021267|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4197985|NCT00756977|4021265|B3||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4197986|NCT00756977|4021266|B2||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4197987|NCT00756977|4021267|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4197988|NCT00756977|4021265|B3|||Age||years|Mean|56.9|56.9|Standard Deviation|12.7|12.7|||
4197989|NCT00756977|4021266|B2|||Age||years|Mean|56.9|56.9|Standard Deviation|12.3|12.3|||
4197990|NCT00756977|4021267|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|13.1|13.1|||
4197991|NCT00756977|4021265|B3||>=65 years|Age||Participants|Count of Participants|97|97.0||||||
4197992|NCT00756977|4021266|B2||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
4197993|NCT00756977|4021267|B1||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4197994|NCT00756977|4021265|B3||Between 18 and 65 years|Age||Participants|Count of Participants|269|269.0||||||
4197995|NCT00756977|4021266|B2||Between 18 and 65 years|Age||Participants|Count of Participants|141|141.0||||||
4197996|NCT00756977|4021267|B1||Between 18 and 65 years|Age||Participants|Count of Participants|128|128.0||||||
4197997|NCT00756977|4021265|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197998|NCT00756977|4021266|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4197999|NCT00756977|4021267|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198000|NCT00756964|4021294|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4198001|NCT00756964|4021295|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4198002|NCT00756964|4021296|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4198003|NCT00756964|4021294|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4198004|NCT00756964|4021295|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4198005|NCT00756964|4021296|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4198006|NCT00756964|4021294|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4198007|NCT00756964|4021295|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4198008|NCT00756964|4021296|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4198009|NCT00756964|4021294|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4198010|NCT00756964|4021295|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4198011|NCT00756964|4021296|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4198012|NCT00756964|4021294|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4198013|NCT00756964|4021295|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4198014|NCT00756964|4021296|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4198015|NCT00756964|4021294|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198018|NCT00756938|4021303|B4||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4198019|NCT00756938|4021304|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4198020|NCT00756938|4021305|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4198021|NCT00756938|4021306|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4198022|NCT00756938|4021303|B4||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4198023|NCT00756938|4021304|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4198024|NCT00756938|4021305|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4198025|NCT00756938|4021306|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4198026|NCT00756938|4021303|B4|||Age||Months|Mean|42.0|42.0|Standard Deviation|22.3|22.3|||
4198027|NCT00756938|4021304|B3|||Age||Months|Mean|40.6|40.6|Standard Deviation|21.2|21.2|||
4198028|NCT00756938|4021305|B2|||Age||Months|Mean|45.0|45.0|Standard Deviation|21.5|21.5|||
4198029|NCT00756938|4021306|B1|||Age||Months|Mean|40.2|40.2|Standard Deviation|24.4|24.4|||
4198030|NCT00756886|4021335|B3|United States||Region of Enrollment||participants|Number|73|73.0||||||
4198031|NCT00756886|4021336|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
4198032|NCT00756886|4021337|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4198033|NCT00756886|4021335|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4198034|NCT00756886|4021336|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4198035|NCT00756886|4021337|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4198036|NCT00756886|4021335|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4198037|NCT00756886|4021336|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4198038|NCT00756886|4021337|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4198039|NCT00756886|4021335|B3|||Age||years|Median|61|61.0|Full Range|||27.0|81.0|
4198040|NCT00756886|4021336|B2|||Age||years|Median|61|61.0|Full Range|||30.0|81.0|
4198041|NCT00756886|4021337|B1|||Age||years|Median|62|62.0|Full Range|||27.0|79.0|
4198042|NCT00756730|4021344|B3|none||Lipid Lowering Medications||participants|Number|20|20.0||||||
4198043|NCT00756730|4021345|B2|none||Lipid Lowering Medications||participants|Number|11|11.0||||||
4198044|NCT00756730|4021346|B1|none||Lipid Lowering Medications||participants|Number|9|9.0||||||
4198045|NCT00756730|4021344|B3|niacin||Lipid Lowering Medications||participants|Number|1|1.0||||||
4198046|NCT00756730|4021345|B2|niacin||Lipid Lowering Medications||participants|Number|1|1.0||||||
4198047|NCT00756730|4021346|B1|niacin||Lipid Lowering Medications||participants|Number|0|0.0||||||
4198048|NCT00756730|4021344|B3|fish oil||Lipid Lowering Medications||participants|Number|8|8.0||||||
4198049|NCT00756730|4021345|B2|fish oil||Lipid Lowering Medications||participants|Number|3|3.0||||||
4198050|NCT00756730|4021346|B1|fish oil||Lipid Lowering Medications||participants|Number|5|5.0||||||
4198051|NCT00756730|4021344|B3|fibrate||Lipid Lowering Medications||participants|Number|11|11.0||||||
4198052|NCT00756730|4021345|B2|fibrate||Lipid Lowering Medications||participants|Number|6|6.0||||||
4198053|NCT00756730|4021346|B1|fibrate||Lipid Lowering Medications||participants|Number|5|5.0||||||
4198054|NCT00756730|4021344|B3|statin||Lipid Lowering Medications||participants|Number|9|9.0||||||
4198055|NCT00756730|4021345|B2|statin||Lipid Lowering Medications||participants|Number|3|3.0||||||
4198056|NCT00756730|4021346|B1|statin||Lipid Lowering Medications||participants|Number|6|6.0||||||
4198057|NCT00756730|4021344|B3|other||Baseline medications - Nucleoside analogs||Participants|Number|7|7.0||||||
4198058|NCT00756730|4021345|B2|other||Baseline medications - Nucleoside analogs||Participants|Number|2|2.0||||||
4198059|NCT00756730|4021346|B1|other||Baseline medications - Nucleoside analogs||Participants|Number|5|5.0||||||
4198060|NCT00756730|4021344|B3|ziagen (ABC)/Epivir (3TC)||Baseline medications - Nucleoside analogs||Participants|Number|10|10.0||||||
4198061|NCT00756730|4021345|B2|ziagen (ABC)/Epivir (3TC)||Baseline medications - Nucleoside analogs||Participants|Number|5|5.0||||||
4198062|NCT00756730|4021346|B1|ziagen (ABC)/Epivir (3TC)||Baseline medications - Nucleoside analogs||Participants|Number|5|5.0||||||
4198063|NCT00756730|4021344|B3|viread (TDF)/emtriva (FTC)||Baseline medications - Nucleoside analogs||Participants|Number|32|32.0||||||
4198064|NCT00756730|4021345|B2|viread (TDF)/emtriva (FTC)||Baseline medications - Nucleoside analogs||Participants|Number|17|17.0||||||
4198065|NCT00756730|4021346|B1|viread (TDF)/emtriva (FTC)||Baseline medications - Nucleoside analogs||Participants|Number|15|15.0||||||
4198066|NCT00756730|4021344|B3|fosamprenavir/ritonavir (FPV/r)||Baseline antiretroviral medications - Protease inhibitors||participants|Number|3|3.0||||||
4198067|NCT00756730|4021345|B2|fosamprenavir/ritonavir (FPV/r)||Baseline antiretroviral medications - Protease inhibitors||participants|Number|1|1.0||||||
4198068|NCT00756730|4021346|B1|fosamprenavir/ritonavir (FPV/r)||Baseline antiretroviral medications - Protease inhibitors||participants|Number|2|2.0||||||
4198069|NCT00756730|4021344|B3|Lopinavir/ritonavir (LPV/r)||Baseline antiretroviral medications - Protease inhibitors||participants|Number|46|46.0||||||
4198070|NCT00756730|4021345|B2|Lopinavir/ritonavir (LPV/r)||Baseline antiretroviral medications - Protease inhibitors||participants|Number|23|23.0||||||
4198071|NCT00756730|4021346|B1|Lopinavir/ritonavir (LPV/r)||Baseline antiretroviral medications - Protease inhibitors||participants|Number|23|23.0||||||
4198072|NCT00756730|4021344|B3|||Viral Load||copies/mL|Number|0|0.0||||0.0|0.0|
4198073|NCT00756730|4021345|B2|||Viral Load||copies/mL|Number|NA|||||0.0|0.0|VL was not detected. All values were reported less than 50 copies/ml, the lower limit of detection.
4198074|NCT00756730|4021346|B1|||Viral Load||copies/mL|Number|NA|||||0.0|0.0|VL was not detected. All values were reported less than 50 copies/ml, the lower limit of detection.
4198075|NCT00756730|4021344|B3|||CD4 Count||cells/mm3|Mean|569|569.0|Full Range|||31.0|1066.0|
4198076|NCT00756730|4021345|B2|||CD4 Count||cells/mm3|Mean|554|554.0|Full Range|||31.0|1066.0|
4198077|NCT00756730|4021346|B1|||CD4 Count||cells/mm3|Mean|584|584.0|Full Range|||249.0|996.0|
4198078|NCT00756730|4021344|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
4198079|NCT00756730|4021345|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4198080|NCT00756730|4021346|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4198081|NCT00756730|4021344|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4198082|NCT00756730|4021345|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4198083|NCT00756730|4021346|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198084|NCT00756730|4021344|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4198085|NCT00756730|4021345|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4198086|NCT00756730|4021346|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4198087|NCT00756730|4021344|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4198088|NCT00756730|4021345|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4198089|NCT00756730|4021346|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4198090|NCT00756730|4021344|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4198091|NCT00756730|4021345|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4198092|NCT00756730|4021346|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4198093|NCT00756730|4021344|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4198094|NCT00756730|4021345|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4198095|NCT00756730|4021346|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4198096|NCT00756730|4021344|B3|||Age, Customized||years|Mean|47|47.0|Full Range|||30.0|67.0|
4198097|NCT00756730|4021345|B2|||Age, Customized||years|Mean|46|46.0|Full Range|||30.0|60.0|
4198098|NCT00756730|4021346|B1|||Age, Customized||years|Mean|48|48.0|Full Range|||34.0|67.0|
4198099|NCT00756678|4021367|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4198100|NCT00756678|4021367|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4198101|NCT00756678|4021367|B1|>=65 years||Age, Customized||participants|Number|5|5.0||||||
4198102|NCT00756678|4021367|B1|Between 40 and 65 years||Age, Customized||participants|Number|24|24.0||||||
4198103|NCT00756678|4021367|B1|<=40 years||Age, Customized||participants|Number|22|22.0||||||
4198104|NCT00756574|4021378|B3|Canada||Region of Enrollment||participants|Number|446|446.0||||||
4198105|NCT00756574|4021379|B2|Canada||Region of Enrollment||participants|Number|221|221.0||||||
4198106|NCT00756574|4021380|B1|Canada||Region of Enrollment||participants|Number|225|225.0||||||
4198107|NCT00756574|4021378|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4198108|NCT00756574|4021379|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4198109|NCT00756574|4021380|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4198110|NCT00756574|4021378|B3||Female|Sex: Female, Male||Participants|Count of Participants|420|420.0||||||
4198111|NCT00756574|4021379|B2||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4198112|NCT00756574|4021380|B1||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4198113|NCT00756574|4021378|B3|||Age||years|Mean|36.2|36.2|Standard Deviation|10.6|10.6|||
4198114|NCT00756574|4021379|B2|||Age||years|Mean|35.8|35.8|Standard Deviation|10.6|10.6|||
4198115|NCT00756574|4021380|B1|||Age||years|Mean|36.5|36.5|Standard Deviation|10.6|10.6|||
4198116|NCT00756574|4021378|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4198117|NCT00756574|4021379|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4198118|NCT00756574|4021380|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4198119|NCT00756574|4021378|B3||Between 18 and 65 years|Age||Participants|Count of Participants|446|446.0||||||
4198120|NCT00756574|4021379|B2||Between 18 and 65 years|Age||Participants|Count of Participants|221|221.0||||||
4198121|NCT00756574|4021380|B1||Between 18 and 65 years|Age||Participants|Count of Participants|225|225.0||||||
4198122|NCT00756574|4021378|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198123|NCT00756574|4021379|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198124|NCT00756574|4021380|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198125|NCT00756561|4021391|B1|||Testis volume|volume for left and right testis|mL|Median|25|25.0|Inter-Quartile Range|||20.0|25.0|
4198126|NCT00756561|4021391|B1|||Serum Estradiol (E2)||ng/mL|Median|0.025|0.025|Inter-Quartile Range|||0.019|0.029|
4198127|NCT00756561|4021391|B1|||Serum Dihydrotestosterone (DHT)||ng/mL|Median|0.20|0.2|Inter-Quartile Range|||0.12|0.24|
4198128|NCT00756561|4021391|B1|||Serum Testosterone (T)||ng/mL|Median|3.0|3.0|Inter-Quartile Range|||2.3|3.9|
4198129|NCT00756561|4021391|B1|||Follicle Stimulating Hormone (FSH)||IU/L|Median|1.8|1.8|Inter-Quartile Range|||1.4|2.5|
4198130|NCT00756561|4021391|B1|||Luteinizing Hormone (LH)||IU/L|Median|3.7|3.7|Inter-Quartile Range|||2.1|5.4|
4198131|NCT00756561|4021391|B1|||Sperm concentration||millions/mL|Median|75|75.0|Inter-Quartile Range|||28.0|133.0|
4198132|NCT00756561|4021391|B1|||Body Mass Index (BMI)||kg/m^2|Median|25.9|25.9|Inter-Quartile Range|||23.4|28.7|
4198133|NCT00756561|4021391|B1|Male||Sex/Gender, Customized||participants|Number|10|10.0||||||
4198134|NCT00756561|4021391|B1|Between 18 and 50 years||Age||years|Median|23|23.0|Inter-Quartile Range|||21.0|32.0|
4198135|NCT00756548|4021396|B3|United States||Region of Enrollment||participants|Number|371|371.0||||||
4198136|NCT00756548|4021397|B2|United States||Region of Enrollment||participants|Number|185|185.0||||||
4198137|NCT00756548|4021398|B1|United States||Region of Enrollment||participants|Number|186|186.0||||||
4198138|NCT00756548|4021396|B3||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4198139|NCT00756548|4021397|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4198140|NCT00756548|4021398|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4198141|NCT00756548|4021396|B3||Female|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4198142|NCT00756548|4021397|B2||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4198143|NCT00756548|4021398|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4198144|NCT00756548|4021396|B3|||Age||years|Mean|56.9|56.9|Standard Deviation|11.2|11.2|||
4198145|NCT00756548|4021397|B2|||Age||years|Mean|56.8|56.8|Standard Deviation|11.0|11.0|||
4198146|NCT00756548|4021398|B1|||Age||years|Mean|56.9|56.9|Standard Deviation|11.4|11.4|||
4198147|NCT00756548|4021396|B3||>=65 years|Age||Participants|Count of Participants|91|91.0||||||
4198148|NCT00756548|4021397|B2||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
4198149|NCT00756548|4021398|B1||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
4198150|NCT00756548|4021396|B3||Between 18 and 65 years|Age||Participants|Count of Participants|280|280.0||||||
4198151|NCT00756548|4021397|B2||Between 18 and 65 years|Age||Participants|Count of Participants|136|136.0||||||
4198152|NCT00756548|4021398|B1||Between 18 and 65 years|Age||Participants|Count of Participants|144|144.0||||||
4198153|NCT00756548|4021396|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198154|NCT00756548|4021397|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198155|NCT00756548|4021398|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198156|NCT00756470|4021425|B1|IV||Clinical Stage: American Joint Committee on Cancer (AJCC) 2009|AJCC Breast cancer staging: Anatomic stage 0, IA or B, IIA or B, IIIA to C or IV. AJCC staging system provides strategy for grouping participants by prognosis, based on the extent of the tumor (T), the extent of spread to the lymph nodes (N), and the presence of metastasis (M). Once the T, N, and M are determined, they are combined , and an overall stage of 0, I, II, III, IV is assigned from least advanced to more advanced. Sometimes these stages are subdivided as well, using letters such as IIIA and IIIB.|participants|Number|4|4.0||||||
4198157|NCT00756470|4021425|B1|III C||Clinical Stage: American Joint Committee on Cancer (AJCC) 2009|AJCC Breast cancer staging: Anatomic stage 0, IA or B, IIA or B, IIIA to C or IV. AJCC staging system provides strategy for grouping participants by prognosis, based on the extent of the tumor (T), the extent of spread to the lymph nodes (N), and the presence of metastasis (M). Once the T, N, and M are determined, they are combined , and an overall stage of 0, I, II, III, IV is assigned from least advanced to more advanced. Sometimes these stages are subdivided as well, using letters such as IIIA and IIIB.|participants|Number|8|8.0||||||
4198158|NCT00756470|4021425|B1|III B||Clinical Stage: American Joint Committee on Cancer (AJCC) 2009|AJCC Breast cancer staging: Anatomic stage 0, IA or B, IIA or B, IIIA to C or IV. AJCC staging system provides strategy for grouping participants by prognosis, based on the extent of the tumor (T), the extent of spread to the lymph nodes (N), and the presence of metastasis (M). Once the T, N, and M are determined, they are combined , and an overall stage of 0, I, II, III, IV is assigned from least advanced to more advanced. Sometimes these stages are subdivided as well, using letters such as IIIA and IIIB.|participants|Number|3|3.0||||||
4198159|NCT00756470|4021425|B1|PS 1||ECOG (Performance Status)|Eastern Cooperative Oncology Group (ECOG) performance status (PS) performed at baseline. PS described as 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work; etc.|participants|Number|2|2.0||||||
4198160|NCT00756470|4021425|B1|PS 0||ECOG (Performance Status)|Eastern Cooperative Oncology Group (ECOG) performance status (PS) performed at baseline. PS described as 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work; etc.|participants|Number|13|13.0||||||
4198161|NCT00756470|4021425|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4198162|NCT00756470|4021425|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198163|NCT00756470|4021425|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198164|NCT00756470|4021425|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4198165|NCT00756470|4021425|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198166|NCT00756470|4021425|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198167|NCT00756470|4021425|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4198168|NCT00756470|4021425|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198169|NCT00756470|4021425|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198170|NCT00756470|4021425|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4198171|NCT00756470|4021425|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4198172|NCT00756470|4021425|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4198173|NCT00756470|4021425|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4198174|NCT00756470|4021425|B1|||Age||years|Median|53.8|53.8|Full Range|||39.0|70.0|
4198175|NCT00756457|4021430|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
4198176|NCT00756457|4021431|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4198177|NCT00756457|4021432|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4198178|NCT00756457|4021430|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4198179|NCT00756457|4021431|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4198180|NCT00756457|4021432|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4198181|NCT00756457|4021430|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4198182|NCT00756457|4021431|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4198183|NCT00756457|4021432|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4198184|NCT00756457|4021430|B3|||Age||years|Mean|57.7|57.7|Standard Deviation|10.6|10.6|||
4198185|NCT00756457|4021431|B2|||Age||years|Mean|58.1|58.1|Standard Deviation|9.3|9.3|||
4198186|NCT00756457|4021432|B1|||Age||years|Mean|57.4|57.4|Standard Deviation|11.9|11.9|||
4198187|NCT00756457|4021430|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4198188|NCT00756457|4021431|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4198189|NCT00756457|4021432|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4198190|NCT00756457|4021430|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4198191|NCT00756457|4021431|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4198192|NCT00756457|4021432|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4198193|NCT00756457|4021430|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198194|NCT00756457|4021431|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198195|NCT00756457|4021432|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198196|NCT00756444|4021461|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4198197|NCT00756444|4021462|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4198198|NCT00756444|4021463|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4198199|NCT00756444|4021461|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4198200|NCT00756444|4021462|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4198201|NCT00756444|4021463|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4198202|NCT00756444|4021461|B3|||Age||Years|Mean|57.3|57.3|Standard Deviation|8.4|8.4|||
4198203|NCT00756444|4021462|B2|||Age||Years|Mean|58.3|58.3|Standard Deviation|9.1|9.1|||
4198204|NCT00756444|4021463|B1|||Age||Years|Mean|56.2|56.2|Standard Deviation|7.5|7.5|||
4198205|NCT00756314|4021473|B3|Brazil||Region of Enrollment||participants|Number|246|246.0||||||
4198206|NCT00756314|4021474|B2|Brazil||Region of Enrollment||participants|Number|123|123.0||||||
4198207|NCT00756314|4021475|B1|Brazil||Region of Enrollment||participants|Number|123|123.0||||||
4198208|NCT00756314|4021473|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4198209|NCT00756314|4021474|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4198210|NCT00756314|4021475|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4198211|NCT00756314|4021473|B3||Female|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
4198212|NCT00756314|4021474|B2||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4198213|NCT00756314|4021475|B1||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4198214|NCT00756314|4021473|B3|||Age||years|Mean|26.6|26.6|Standard Deviation|6.8|6.8|||
4198215|NCT00756314|4021474|B2|||Age||years|Mean|27.6|27.6|Standard Deviation|6.8|6.8|||
4198216|NCT00756314|4021475|B1|||Age||years|Mean|26.2|26.2|Standard Deviation|6.8|6.8|||
4198217|NCT00756314|4021473|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4198218|NCT00756314|4021474|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4198219|NCT00756314|4021475|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4198220|NCT00756314|4021473|B3||Between 18 and 65 years|Age||Participants|Count of Participants|227|227.0||||||
4198221|NCT00756314|4021474|B2||Between 18 and 65 years|Age||Participants|Count of Participants|115|115.0||||||
4198222|NCT00756314|4021475|B1||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
4198223|NCT00756314|4021473|B3||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
4198224|NCT00756314|4021474|B2||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4198225|NCT00756314|4021475|B1||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4198226|NCT00756275|4021490|B3|United States||Region of Enrollment||participants|Number|137|137.0||||||
4198227|NCT00756275|4021491|B2|United States||Region of Enrollment||participants|Number|77|77.0||||||
4198228|NCT00756275|4021492|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4198229|NCT00756275|4021490|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4198230|NCT00756275|4021491|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4198231|NCT00756275|4021492|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4198232|NCT00756275|4021490|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4198233|NCT00756275|4021491|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4198234|NCT00756275|4021492|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4198235|NCT00756275|4021490|B3|||Age||years|Mean|39.6|39.6|Standard Deviation|10.0|10.0|||
4198236|NCT00756275|4021491|B2|||Age||years|Mean|39.96|39.96|Standard Deviation|10.51|10.51|||
4198237|NCT00756275|4021492|B1|||Age||years|Mean|39.20|39.2|Standard Deviation|9.7|9.7|||
4198238|NCT00756275|4021490|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4198239|NCT00756275|4021491|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4198240|NCT00756275|4021492|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4198241|NCT00756275|4021490|B3||Between 18 and 65 years|Age||Participants|Count of Participants|137|137.0||||||
4198242|NCT00756275|4021491|B2||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
4198243|NCT00756275|4021492|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4198244|NCT00756275|4021490|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198245|NCT00756275|4021491|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198246|NCT00756275|4021492|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198247|NCT00756236|4021517|B4|United States||Region of Enrollment||participants|Number|60|60.0||||||
4198248|NCT00756236|4021518|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4198249|NCT00756236|4021519|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4198250|NCT00756236|4021520|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4198251|NCT00756236|4021517|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4198252|NCT00756236|4021518|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4198253|NCT00756236|4021519|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4198254|NCT00756236|4021520|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4198255|NCT00756236|4021517|B4||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4198256|NCT00756236|4021518|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4198257|NCT00756236|4021519|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4198258|NCT00756236|4021520|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4198259|NCT00756236|4021517|B4|||Age||YEARS|Mean|46.8|46.8|Standard Deviation|13.2|13.2|||
4198260|NCT00756236|4021518|B3|||Age||YEARS|Mean|48|48.0|Standard Deviation|15.2|15.2|||
4198261|NCT00756236|4021519|B2|||Age||YEARS|Mean|49|49.0|Standard Deviation|11.8|11.8|||
4198262|NCT00756236|4021520|B1|||Age||YEARS|Mean|44|44.0|Standard Deviation|13.3|13.3|||
4198263|NCT00756236|4021517|B4||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4198264|NCT00756236|4021518|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4198265|NCT00756236|4021519|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4198266|NCT00756236|4021520|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4198267|NCT00756236|4021517|B4||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4198268|NCT00756236|4021518|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4198269|NCT00756236|4021519|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4198270|NCT00756236|4021520|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4198271|NCT00756236|4021517|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198272|NCT00756236|4021518|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198273|NCT00756236|4021519|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198274|NCT00756236|4021520|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198275|NCT00756093|4021530|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4198276|NCT00756093|4021530|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4198277|NCT00756093|4021530|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4198278|NCT00756093|4021530|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4198279|NCT00756093|4021530|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198280|NCT00756002|4021543|B3|White||Race/Ethnicity, Customized||participants|Number|257.0|257.0||||||
4198281|NCT00756002|4021544|B2|White||Race/Ethnicity, Customized||participants|Number|129|129.0||||||
4198282|NCT00756002|4021545|B1|White||Race/Ethnicity, Customized||participants|Number|128|128.0||||||
4198283|NCT00756002|4021543|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1.0|1.0||||||
4198284|NCT00756002|4021544|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4198285|NCT00756002|4021545|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4198286|NCT00756002|4021543|B3|Asian||Race/Ethnicity, Customized||participants|Number|1.0|1.0||||||
4198287|NCT00756002|4021544|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4198288|NCT00756002|4021545|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4198289|NCT00756002|4021543|B3||Male|Sex: Female, Male||Participants|Count of Participants|151.0|151.0||||||
4198290|NCT00756002|4021544|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4198291|NCT00756002|4021545|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4198292|NCT00756002|4021543|B3||Female|Sex: Female, Male||Participants|Count of Participants|108.0|108.0||||||
4198293|NCT00756002|4021544|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4198294|NCT00756002|4021545|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4198295|NCT00756002|4021543|B3|||Age||years|Mean|42.0|42.0|Standard Deviation|12.05|12.05|||
4198296|NCT00756002|4021544|B2|||Age||years|Mean|41.7|41.7|Standard Deviation|11.85|11.85|||
4198297|NCT00756002|4021545|B1|||Age||years|Mean|42.3|42.3|Standard Deviation|12.28|12.28|||
4198298|NCT00755937|4021640|B1|Canada||Region of Enrollment||participants|Number|556|556.0||||||
4198299|NCT00755937|4021640|B1||Male|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
4198300|NCT00755937|4021640|B1||Female|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
4198301|NCT00755937|4021640|B1|||Age||years|Mean|37.5|37.5|Standard Deviation|12.8|12.8|||
4198302|NCT00755911|4021650|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4198303|NCT00755911|4021651|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4198304|NCT00755911|4021652|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4198305|NCT00755911|4021650|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4198306|NCT00755911|4021651|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4198307|NCT00755911|4021652|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4198308|NCT00755911|4021650|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4198309|NCT00755911|4021651|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4198310|NCT00755911|4021652|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4198311|NCT00755911|4021650|B3|||Age||years|Mean|50|50.0|Standard Deviation|12|12.0|||
4198312|NCT00755911|4021651|B2|||Age||years|Mean|53|53.0|Standard Deviation|14|14.0|||
4198313|NCT00755911|4021652|B1|||Age||years|Mean|46|46.0|Standard Deviation|11|11.0|||
4198314|NCT00755846|4021661|B7||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4198315|NCT00755846|4021662|B6||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4198316|NCT00755846|4021663|B5||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4198317|NCT00755846|4021664|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4198318|NCT00755846|4021665|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4198319|NCT00755846|4021666|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4198320|NCT00755846|4021667|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4198321|NCT00755846|4021661|B7||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4198322|NCT00755846|4021662|B6||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4198323|NCT00755846|4021663|B5||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4198324|NCT00755846|4021664|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4198325|NCT00755846|4021665|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4198326|NCT00755846|4021666|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4198327|NCT00755846|4021667|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4198328|NCT00755846|4021661|B7|≥65 years||Age, Customized||participants|Number|60|60.0||||||
4198329|NCT00755846|4021662|B6|≥65 years||Age, Customized||participants|Number|11|11.0||||||
4198330|NCT00755846|4021663|B5|≥65 years||Age, Customized||participants|Number|13|13.0||||||
4198331|NCT00755846|4021664|B4|≥65 years||Age, Customized||participants|Number|9|9.0||||||
4198332|NCT00755846|4021665|B3|≥65 years||Age, Customized||participants|Number|11|11.0||||||
4198333|NCT00755846|4021666|B2|≥65 years||Age, Customized||participants|Number|6|6.0||||||
4198334|NCT00755846|4021667|B1|≥65 years||Age, Customized||participants|Number|10|10.0||||||
4198335|NCT00755846|4021661|B7|<65 years||Age, Customized||participants|Number|205|205.0||||||
4198336|NCT00755846|4021662|B6|<65 years||Age, Customized||participants|Number|34|34.0||||||
4198337|NCT00755846|4021663|B5|<65 years||Age, Customized||participants|Number|31|31.0||||||
4198338|NCT00755846|4021664|B4|<65 years||Age, Customized||participants|Number|36|36.0||||||
4198339|NCT00755846|4021665|B3|<65 years||Age, Customized||participants|Number|33|33.0||||||
4198340|NCT00755846|4021666|B2|<65 years||Age, Customized||participants|Number|38|38.0||||||
4198341|NCT00755846|4021667|B1|<65 years||Age, Customized||participants|Number|33|33.0||||||
4198342|NCT00755807|4021770|B3|||Expanded Disability Status Scale ([EDSS], n=118, 120)|The EDSS is a method of quantifying disability in multiple sclerosis. The EDSS quantifies disability in 8 Functional Systems (pyramidal, cerebellar, brain stem, sensory, bowel and bladder, visual, cerebral, and other) and allows neurologists to assign a functional system score in each. An EDSS of 0.0 is a normal neurological examination. The scores increase in increments of 0.5 starting with 1.0 (no disability, minimal signs in 1 functional system) to 10.0 (death due to MS).|units on a scale|Median|4.00|4.0|Standard Deviation|1.89|1.89|||
4198343|NCT00755807|4021771|B2|||Expanded Disability Status Scale ([EDSS], n=118, 120)|The EDSS is a method of quantifying disability in multiple sclerosis. The EDSS quantifies disability in 8 Functional Systems (pyramidal, cerebellar, brain stem, sensory, bowel and bladder, visual, cerebral, and other) and allows neurologists to assign a functional system score in each. An EDSS of 0.0 is a normal neurological examination. The scores increase in increments of 0.5 starting with 1.0 (no disability, minimal signs in 1 functional system) to 10.0 (death due to MS).|units on a scale|Median|4.00|4.0|Standard Deviation|1.78|1.78|||
4198344|NCT00755807|4021772|B1|||Expanded Disability Status Scale ([EDSS], n=118, 120)|The EDSS is a method of quantifying disability in multiple sclerosis. The EDSS quantifies disability in 8 Functional Systems (pyramidal, cerebellar, brain stem, sensory, bowel and bladder, visual, cerebral, and other) and allows neurologists to assign a functional system score in each. An EDSS of 0.0 is a normal neurological examination. The scores increase in increments of 0.5 starting with 1.0 (no disability, minimal signs in 1 functional system) to 10.0 (death due to MS).|units on a scale|Median|4.00|4.0|Standard Deviation|2.01|2.01|||
4198345|NCT00755807|4021770|B3|||Multiple Sclerosis Quality of Life (MS-QOL-54) Overall Quality of Life Subsection|The MS-QOL-54 is self-reported and consists of 54 questions covering 12 domains: physical function, role limitations due to physical problems, role limitations due to emotional problems, emotional wellbeing, energy, health perceptions, social function, cognitive function, health distress, satisfaction with sexual function, change in health, and overall quality of life. Each domain score is converted into a 0-100 score based on the individual item responses, with higher scores indicating better health status or functioning. Number of participants (n) for duloxetine=116; placebo=119.|units on a scale|Mean|59.94|59.94|Standard Deviation|18.76|18.76|||
4198432|NCT00755755|4021834|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4198433|NCT00755755|4021835|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4198434|NCT00755755|4021836|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4198346|NCT00755807|4021771|B2|||Multiple Sclerosis Quality of Life (MS-QOL-54) Overall Quality of Life Subsection|The MS-QOL-54 is self-reported and consists of 54 questions covering 12 domains: physical function, role limitations due to physical problems, role limitations due to emotional problems, emotional wellbeing, energy, health perceptions, social function, cognitive function, health distress, satisfaction with sexual function, change in health, and overall quality of life. Each domain score is converted into a 0-100 score based on the individual item responses, with higher scores indicating better health status or functioning. Number of participants (n) for duloxetine=116; placebo=119.|units on a scale|Mean|61.78|61.78|Standard Deviation|18.80|18.8|||
4198347|NCT00755807|4021772|B1|||Multiple Sclerosis Quality of Life (MS-QOL-54) Overall Quality of Life Subsection|The MS-QOL-54 is self-reported and consists of 54 questions covering 12 domains: physical function, role limitations due to physical problems, role limitations due to emotional problems, emotional wellbeing, energy, health perceptions, social function, cognitive function, health distress, satisfaction with sexual function, change in health, and overall quality of life. Each domain score is converted into a 0-100 score based on the individual item responses, with higher scores indicating better health status or functioning. Number of participants (n) for duloxetine=116; placebo=119.|units on a scale|Mean|58.06|58.06|Standard Deviation|18.61|18.61|||
4198348|NCT00755807|4021770|B3|||BPI Average Pain (Duloxetine n=116, Placebo n=119)|A self-reported scale that measures the severity of pain based on the average pain over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|6.00|6.0|Standard Deviation|1.42|1.42|||
4198349|NCT00755807|4021771|B2|||BPI Average Pain (Duloxetine n=116, Placebo n=119)|A self-reported scale that measures the severity of pain based on the average pain over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|5.91|5.91|Standard Deviation|1.33|1.33|||
4198350|NCT00755807|4021772|B1|||BPI Average Pain (Duloxetine n=116, Placebo n=119)|A self-reported scale that measures the severity of pain based on the average pain over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|6.09|6.09|Standard Deviation|1.50|1.5|||
4198351|NCT00755807|4021770|B3|||Brief Pain Inventory (BPI) Average Interference (Duloxetine n=116, Placebo n=119)|A self-reported scale that measures interference of pain on average of the 7 questions assessing the interference of pain for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. The average Interference scores range from 0 (does not interfere) to 10 (completely interferes).|Units on a scale|Mean|5.37|5.37|Standard Deviation|2.00|2.0|||
4198352|NCT00755807|4021771|B2|||Brief Pain Inventory (BPI) Average Interference (Duloxetine n=116, Placebo n=119)|A self-reported scale that measures interference of pain on average of the 7 questions assessing the interference of pain for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. The average Interference scores range from 0 (does not interfere) to 10 (completely interferes).|Units on a scale|Mean|5.24|5.24|Standard Deviation|2.01|2.01|||
4198353|NCT00755807|4021772|B1|||Brief Pain Inventory (BPI) Average Interference (Duloxetine n=116, Placebo n=119)|A self-reported scale that measures interference of pain on average of the 7 questions assessing the interference of pain for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. The average Interference scores range from 0 (does not interfere) to 10 (completely interferes).|Units on a scale|Mean|5.50|5.5|Standard Deviation|1.98|1.98|||
4198354|NCT00755807|4021770|B3|||Weekly 24-Hour Average Pain|This is an ordinal scale with scores from 0 (no pain) to 10 (worst possible pain). Data presented represent the weekly mean of the scores of the average pain severity over the last 24 hours. Scores are based on daily assessments recorded by participants in their diaries.|units on a scale|Mean|6.40|6.4|Standard Deviation|1.37|1.37|||
4198355|NCT00755807|4021771|B2|||Weekly 24-Hour Average Pain|This is an ordinal scale with scores from 0 (no pain) to 10 (worst possible pain). Data presented represent the weekly mean of the scores of the average pain severity over the last 24 hours. Scores are based on daily assessments recorded by participants in their diaries.|units on a scale|Mean|6.31|6.31|Standard Deviation|1.33|1.33|||
4198356|NCT00755807|4021772|B1|||Weekly 24-Hour Average Pain|This is an ordinal scale with scores from 0 (no pain) to 10 (worst possible pain). Data presented represent the weekly mean of the scores of the average pain severity over the last 24 hours. Scores are based on daily assessments recorded by participants in their diaries.|units on a scale|Mean|6.49|6.49|Standard Deviation|1.41|1.41|||
4198357|NCT00755807|4021770|B3|||Duration of central neuropathic pain (CNP) due to MS (n=118, 120)||years|Mean|6.88|6.88|Standard Deviation|6.33|6.33|||
4198358|NCT00755807|4021771|B2|||Duration of central neuropathic pain (CNP) due to MS (n=118, 120)||years|Mean|7.56|7.56|Standard Deviation|6.69|6.69|||
4198359|NCT00755807|4021772|B1|||Duration of central neuropathic pain (CNP) due to MS (n=118, 120)||years|Mean|6.18|6.18|Standard Deviation|5.88|5.88|||
4198360|NCT00755807|4021770|B3|||Duration of MS|How long the participants have had MS.|years|Mean|11.23|11.23|Standard Deviation|7.99|7.99|||
4198361|NCT00755807|4021771|B2|||Duration of MS|How long the participants have had MS.|years|Mean|11.40|11.4|Standard Deviation|8.49|8.49|||
4198362|NCT00755807|4021772|B1|||Duration of MS|How long the participants have had MS.|years|Mean|11.05|11.05|Standard Deviation|7.48|7.48|||
4198363|NCT00755807|4021770|B3|Secondary-Progressive||Multiple Sclerosis (MS) Diagnosis Subtype|"National MS Society diagnosis subtypes:~Primary progressive: initially progressive disease with no plateaus or remissions; or occasional plateau and acute, minor improvements.~Progressive-relapsing: initial disease progression, but with clear, acute relapses, with or without full recovery from such relapses over time.~Relapsing-remitting: clearly defined acute attacks with full or partial recovery; no disease progression between attacks.~Secondary-progressive: initially relapsing-remitting, then progressive at a variable rate, with possible occasional relapse and minor remission."|participants|Number|50|50.0||||||
4198435|NCT00755755|4021837|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4198436|NCT00755755|4021834|B4||Female|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
4198437|NCT00755755|4021835|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4198438|NCT00755755|4021836|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4198364|NCT00755807|4021771|B2|Secondary-Progressive||Multiple Sclerosis (MS) Diagnosis Subtype|"National MS Society diagnosis subtypes:~Primary progressive: initially progressive disease with no plateaus or remissions; or occasional plateau and acute, minor improvements.~Progressive-relapsing: initial disease progression, but with clear, acute relapses, with or without full recovery from such relapses over time.~Relapsing-remitting: clearly defined acute attacks with full or partial recovery; no disease progression between attacks.~Secondary-progressive: initially relapsing-remitting, then progressive at a variable rate, with possible occasional relapse and minor remission."|participants|Number|27|27.0||||||
4198365|NCT00755807|4021772|B1|Secondary-Progressive||Multiple Sclerosis (MS) Diagnosis Subtype|"National MS Society diagnosis subtypes:~Primary progressive: initially progressive disease with no plateaus or remissions; or occasional plateau and acute, minor improvements.~Progressive-relapsing: initial disease progression, but with clear, acute relapses, with or without full recovery from such relapses over time.~Relapsing-remitting: clearly defined acute attacks with full or partial recovery; no disease progression between attacks.~Secondary-progressive: initially relapsing-remitting, then progressive at a variable rate, with possible occasional relapse and minor remission."|participants|Number|23|23.0||||||
4198366|NCT00755807|4021770|B3|Relapsing-Remitting||Multiple Sclerosis (MS) Diagnosis Subtype|"National MS Society diagnosis subtypes:~Primary progressive: initially progressive disease with no plateaus or remissions; or occasional plateau and acute, minor improvements.~Progressive-relapsing: initial disease progression, but with clear, acute relapses, with or without full recovery from such relapses over time.~Relapsing-remitting: clearly defined acute attacks with full or partial recovery; no disease progression between attacks.~Secondary-progressive: initially relapsing-remitting, then progressive at a variable rate, with possible occasional relapse and minor remission."|participants|Number|153|153.0||||||
4198367|NCT00755807|4021771|B2|Relapsing-Remitting||Multiple Sclerosis (MS) Diagnosis Subtype|"National MS Society diagnosis subtypes:~Primary progressive: initially progressive disease with no plateaus or remissions; or occasional plateau and acute, minor improvements.~Progressive-relapsing: initial disease progression, but with clear, acute relapses, with or without full recovery from such relapses over time.~Relapsing-remitting: clearly defined acute attacks with full or partial recovery; no disease progression between attacks.~Secondary-progressive: initially relapsing-remitting, then progressive at a variable rate, with possible occasional relapse and minor remission."|participants|Number|72|72.0||||||
4198368|NCT00755807|4021772|B1|Relapsing-Remitting||Multiple Sclerosis (MS) Diagnosis Subtype|"National MS Society diagnosis subtypes:~Primary progressive: initially progressive disease with no plateaus or remissions; or occasional plateau and acute, minor improvements.~Progressive-relapsing: initial disease progression, but with clear, acute relapses, with or without full recovery from such relapses over time.~Relapsing-remitting: clearly defined acute attacks with full or partial recovery; no disease progression between attacks.~Secondary-progressive: initially relapsing-remitting, then progressive at a variable rate, with possible occasional relapse and minor remission."|participants|Number|81|81.0||||||
4198369|NCT00755807|4021770|B3|Progressive-Relapsing||Multiple Sclerosis (MS) Diagnosis Subtype|"National MS Society diagnosis subtypes:~Primary progressive: initially progressive disease with no plateaus or remissions; or occasional plateau and acute, minor improvements.~Progressive-relapsing: initial disease progression, but with clear, acute relapses, with or without full recovery from such relapses over time.~Relapsing-remitting: clearly defined acute attacks with full or partial recovery; no disease progression between attacks.~Secondary-progressive: initially relapsing-remitting, then progressive at a variable rate, with possible occasional relapse and minor remission."|participants|Number|10|10.0||||||
4198370|NCT00755807|4021771|B2|Progressive-Relapsing||Multiple Sclerosis (MS) Diagnosis Subtype|"National MS Society diagnosis subtypes:~Primary progressive: initially progressive disease with no plateaus or remissions; or occasional plateau and acute, minor improvements.~Progressive-relapsing: initial disease progression, but with clear, acute relapses, with or without full recovery from such relapses over time.~Relapsing-remitting: clearly defined acute attacks with full or partial recovery; no disease progression between attacks.~Secondary-progressive: initially relapsing-remitting, then progressive at a variable rate, with possible occasional relapse and minor remission."|participants|Number|6|6.0||||||
4198371|NCT00755807|4021772|B1|Progressive-Relapsing||Multiple Sclerosis (MS) Diagnosis Subtype|"National MS Society diagnosis subtypes:~Primary progressive: initially progressive disease with no plateaus or remissions; or occasional plateau and acute, minor improvements.~Progressive-relapsing: initial disease progression, but with clear, acute relapses, with or without full recovery from such relapses over time.~Relapsing-remitting: clearly defined acute attacks with full or partial recovery; no disease progression between attacks.~Secondary-progressive: initially relapsing-remitting, then progressive at a variable rate, with possible occasional relapse and minor remission."|participants|Number|4|4.0||||||
4198372|NCT00755807|4021770|B3|Primary-Progressive||Multiple Sclerosis (MS) Diagnosis Subtype|"National MS Society diagnosis subtypes:~Primary progressive: initially progressive disease with no plateaus or remissions; or occasional plateau and acute, minor improvements.~Progressive-relapsing: initial disease progression, but with clear, acute relapses, with or without full recovery from such relapses over time.~Relapsing-remitting: clearly defined acute attacks with full or partial recovery; no disease progression between attacks.~Secondary-progressive: initially relapsing-remitting, then progressive at a variable rate, with possible occasional relapse and minor remission."|participants|Number|26|26.0||||||
4198373|NCT00755807|4021771|B2|Primary-Progressive||Multiple Sclerosis (MS) Diagnosis Subtype|"National MS Society diagnosis subtypes:~Primary progressive: initially progressive disease with no plateaus or remissions; or occasional plateau and acute, minor improvements.~Progressive-relapsing: initial disease progression, but with clear, acute relapses, with or without full recovery from such relapses over time.~Relapsing-remitting: clearly defined acute attacks with full or partial recovery; no disease progression between attacks.~Secondary-progressive: initially relapsing-remitting, then progressive at a variable rate, with possible occasional relapse and minor remission."|participants|Number|16|16.0||||||
4198439|NCT00755755|4021837|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4198440|NCT00755755|4021834|B4|||Age||years|Mean|41.6|41.6|Standard Deviation|5.7|5.7|||
4198441|NCT00755755|4021835|B3|||Age||years|Mean|41.6|41.6|Standard Deviation|5.6|5.6|||
4198442|NCT00755755|4021836|B2|||Age||years|Mean|42.0|42.0|Standard Deviation|5.5|5.5|||
4198443|NCT00755755|4021837|B1|||Age||years|Mean|41.2|41.2|Standard Deviation|5.9|5.9|||
4198374|NCT00755807|4021772|B1|Primary-Progressive||Multiple Sclerosis (MS) Diagnosis Subtype|"National MS Society diagnosis subtypes:~Primary progressive: initially progressive disease with no plateaus or remissions; or occasional plateau and acute, minor improvements.~Progressive-relapsing: initial disease progression, but with clear, acute relapses, with or without full recovery from such relapses over time.~Relapsing-remitting: clearly defined acute attacks with full or partial recovery; no disease progression between attacks.~Secondary-progressive: initially relapsing-remitting, then progressive at a variable rate, with possible occasional relapse and minor remission."|participants|Number|10|10.0||||||
4198375|NCT00755807|4021770|B3|United States||Region of Enrollment||participants|Number|174|174.0||||||
4198376|NCT00755807|4021771|B2|United States||Region of Enrollment||participants|Number|87|87.0||||||
4198377|NCT00755807|4021772|B1|United States||Region of Enrollment||participants|Number|87|87.0||||||
4198378|NCT00755807|4021770|B3|Poland||Region of Enrollment||participants|Number|40|40.0||||||
4198379|NCT00755807|4021771|B2|Poland||Region of Enrollment||participants|Number|20|20.0||||||
4198380|NCT00755807|4021772|B1|Poland||Region of Enrollment||participants|Number|20|20.0||||||
4198381|NCT00755807|4021770|B3|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4198382|NCT00755807|4021771|B2|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4198383|NCT00755807|4021772|B1|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4198384|NCT00755807|4021770|B3|Belgium||Region of Enrollment||participants|Number|14|14.0||||||
4198385|NCT00755807|4021771|B2|Belgium||Region of Enrollment||participants|Number|7|7.0||||||
4198386|NCT00755807|4021772|B1|Belgium||Region of Enrollment||participants|Number|7|7.0||||||
4198387|NCT00755807|4021770|B3|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4198388|NCT00755807|4021771|B2|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4198389|NCT00755807|4021772|B1|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4198390|NCT00755807|4021770|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4198391|NCT00755807|4021771|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4198392|NCT00755807|4021772|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4198393|NCT00755807|4021770|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|221|221.0||||||
4198394|NCT00755807|4021771|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|112|112.0||||||
4198395|NCT00755807|4021772|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|109|109.0||||||
4198396|NCT00755807|4021770|B3|African||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4198397|NCT00755807|4021771|B2|African||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4198398|NCT00755807|4021772|B1|African||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4198399|NCT00755807|4021770|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4198400|NCT00755807|4021771|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4198401|NCT00755807|4021772|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4198402|NCT00755807|4021770|B3||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4198403|NCT00755807|4021771|B2||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4198404|NCT00755807|4021772|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4198405|NCT00755807|4021770|B3|||Age||years|Mean|51.73|51.73|Standard Deviation|9.40|9.4|||
4198406|NCT00755807|4021771|B2|||Age||years|Mean|52.67|52.67|Standard Deviation|9.07|9.07|||
4198407|NCT00755807|4021772|B1|||Age||years|Mean|50.77|50.77|Standard Deviation|9.67|9.67|||
4198408|NCT00755755|4021834|B4|Ukraine||Region of Enrollment||participants|Number|68|68.0||||||
4198409|NCT00755755|4021835|B3|Ukraine||Region of Enrollment||participants|Number|8|8.0||||||
4198410|NCT00755755|4021836|B2|Ukraine||Region of Enrollment||participants|Number|34|34.0||||||
4198411|NCT00755755|4021837|B1|Ukraine||Region of Enrollment||participants|Number|26|26.0||||||
4198412|NCT00755755|4021834|B4|Russian Federation||Region of Enrollment||participants|Number|60|60.0||||||
4198413|NCT00755755|4021835|B3|Russian Federation||Region of Enrollment||participants|Number|13|13.0||||||
4198414|NCT00755755|4021836|B2|Russian Federation||Region of Enrollment||participants|Number|19|19.0||||||
4198415|NCT00755755|4021837|B1|Russian Federation||Region of Enrollment||participants|Number|28|28.0||||||
4198416|NCT00755755|4021834|B4|Romania||Region of Enrollment||participants|Number|42|42.0||||||
4198417|NCT00755755|4021835|B3|Romania||Region of Enrollment||participants|Number|8|8.0||||||
4198418|NCT00755755|4021836|B2|Romania||Region of Enrollment||participants|Number|17|17.0||||||
4198419|NCT00755755|4021837|B1|Romania||Region of Enrollment||participants|Number|17|17.0||||||
4198420|NCT00755755|4021834|B4|India||Region of Enrollment||participants|Number|28|28.0||||||
4198421|NCT00755755|4021835|B3|India||Region of Enrollment||participants|Number|7|7.0||||||
4198422|NCT00755755|4021836|B2|India||Region of Enrollment||participants|Number|11|11.0||||||
4198423|NCT00755755|4021837|B1|India||Region of Enrollment||participants|Number|10|10.0||||||
4198424|NCT00755755|4021834|B4|Hungary||Region of Enrollment||participants|Number|27|27.0||||||
4198425|NCT00755755|4021835|B3|Hungary||Region of Enrollment||participants|Number|9|9.0||||||
4198426|NCT00755755|4021836|B2|Hungary||Region of Enrollment||participants|Number|11|11.0||||||
4198427|NCT00755755|4021837|B1|Hungary||Region of Enrollment||participants|Number|7|7.0||||||
4198428|NCT00755755|4021834|B4|Czech Republic||Region of Enrollment||participants|Number|16|16.0||||||
4198429|NCT00755755|4021835|B3|Czech Republic||Region of Enrollment||participants|Number|3|3.0||||||
4198430|NCT00755755|4021836|B2|Czech Republic||Region of Enrollment||participants|Number|6|6.0||||||
4198431|NCT00755755|4021837|B1|Czech Republic||Region of Enrollment||participants|Number|7|7.0||||||
4198444|NCT00755755|4021834|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4198445|NCT00755755|4021835|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4198446|NCT00755755|4021836|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4198447|NCT00755755|4021837|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4198448|NCT00755755|4021834|B4||Between 18 and 65 years|Age||Participants|Count of Participants|241|241.0||||||
4198449|NCT00755755|4021835|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4198450|NCT00755755|4021836|B2||Between 18 and 65 years|Age||Participants|Count of Participants|98|98.0||||||
4198451|NCT00755755|4021837|B1||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
4198452|NCT00755755|4021834|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198453|NCT00755755|4021835|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198454|NCT00755755|4021836|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198455|NCT00755755|4021837|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198456|NCT00755716|4021850|B4|United States||Region of Enrollment||Participants|Count of Participants|57|57.0||||||
4198457|NCT00755716|4021851|B3|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4198458|NCT00755716|4021852|B2|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4198459|NCT00755716|4021853|B1|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4198460|NCT00755716|4021850|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4198461|NCT00755716|4021851|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4198462|NCT00755716|4021852|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4198463|NCT00755716|4021853|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4198464|NCT00755716|4021850|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4198465|NCT00755716|4021851|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4198466|NCT00755716|4021852|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4198467|NCT00755716|4021853|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4198468|NCT00755716|4021850|B4|||Age||years|Mean|47.2|47.2|Standard Deviation|9.6|9.6|||
4198469|NCT00755716|4021851|B3|||Age||years|Mean|50.1|50.1|Standard Deviation|9.6|9.6|||
4198470|NCT00755716|4021852|B2|||Age||years|Mean|46.1|46.1|Standard Deviation|11.1|11.1|||
4198471|NCT00755716|4021853|B1|||Age||years|Mean|45.4|45.4|Standard Deviation|7.6|7.6|||
4198472|NCT00755716|4021850|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4198473|NCT00755716|4021851|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4198474|NCT00755716|4021852|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4198475|NCT00755716|4021853|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4198476|NCT00755716|4021850|B4||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4198477|NCT00755716|4021851|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4198478|NCT00755716|4021852|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4198479|NCT00755716|4021853|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4198480|NCT00755716|4021850|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198481|NCT00755716|4021851|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198482|NCT00755716|4021852|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198483|NCT00755716|4021853|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198484|NCT00755417|4021866|B4|Severe hot flashes||Number of hot flashes in 24-hour period|"Hot flashes categorized as:~Mild = sensation of heat without sweating Moderate = sensation of heat with sweating, able to continue activity Severe = sensation of heat with sweating, causing cessation of activity"|Hot flashes|Mean|7.0|7.0|Standard Deviation|5.5|5.5|||
4198485|NCT00755417|4021867|B3|Severe hot flashes||Number of hot flashes in 24-hour period|"Hot flashes categorized as:~Mild = sensation of heat without sweating Moderate = sensation of heat with sweating, able to continue activity Severe = sensation of heat with sweating, causing cessation of activity"|Hot flashes|Mean|7.1|7.1|Standard Deviation|5.9|5.9|||
4198486|NCT00755417|4021868|B2|Severe hot flashes||Number of hot flashes in 24-hour period|"Hot flashes categorized as:~Mild = sensation of heat without sweating Moderate = sensation of heat with sweating, able to continue activity Severe = sensation of heat with sweating, causing cessation of activity"|Hot flashes|Mean|7.4|7.4|Standard Deviation|5.8|5.8|||
4198487|NCT00755417|4021869|B1|Severe hot flashes||Number of hot flashes in 24-hour period|"Hot flashes categorized as:~Mild = sensation of heat without sweating Moderate = sensation of heat with sweating, able to continue activity Severe = sensation of heat with sweating, causing cessation of activity"|Hot flashes|Mean|6.4|6.4|Standard Deviation|4.6|4.6|||
4198488|NCT00755417|4021866|B4|Moderate hot flashes||Number of hot flashes in 24-hour period|"Hot flashes categorized as:~Mild = sensation of heat without sweating Moderate = sensation of heat with sweating, able to continue activity Severe = sensation of heat with sweating, causing cessation of activity"|Hot flashes|Mean|6.2|6.2|Standard Deviation|5.3|5.3|||
4198489|NCT00755417|4021867|B3|Moderate hot flashes||Number of hot flashes in 24-hour period|"Hot flashes categorized as:~Mild = sensation of heat without sweating Moderate = sensation of heat with sweating, able to continue activity Severe = sensation of heat with sweating, causing cessation of activity"|Hot flashes|Mean|6.3|6.3|Standard Deviation|5.6|5.6|||
4198490|NCT00755417|4021868|B2|Moderate hot flashes||Number of hot flashes in 24-hour period|"Hot flashes categorized as:~Mild = sensation of heat without sweating Moderate = sensation of heat with sweating, able to continue activity Severe = sensation of heat with sweating, causing cessation of activity"|Hot flashes|Mean|6.2|6.2|Standard Deviation|5.7|5.7|||
4198491|NCT00755417|4021869|B1|Moderate hot flashes||Number of hot flashes in 24-hour period|"Hot flashes categorized as:~Mild = sensation of heat without sweating Moderate = sensation of heat with sweating, able to continue activity Severe = sensation of heat with sweating, causing cessation of activity"|Hot flashes|Mean|6.1|6.1|Standard Deviation|4.5|4.5|||
4198492|NCT00755417|4021866|B4|Other||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4198493|NCT00755417|4021867|B3|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4198494|NCT00755417|4021868|B2|Other||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4198495|NCT00755417|4021869|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4198496|NCT00755417|4021866|B4|Hispanic||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
4198497|NCT00755417|4021867|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4198498|NCT00755417|4021868|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4198499|NCT00755417|4021869|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4198500|NCT00755417|4021866|B4|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4198501|NCT00755417|4021867|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4198502|NCT00755417|4021868|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4198503|NCT00755417|4021869|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4198504|NCT00755417|4021866|B4|Black||Race/Ethnicity, Customized||Participants|Number|126|126.0||||||
4198505|NCT00755417|4021867|B3|Black||Race/Ethnicity, Customized||Participants|Number|50|50.0||||||
4198506|NCT00755417|4021868|B2|Black||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
4198507|NCT00755417|4021869|B1|Black||Race/Ethnicity, Customized||Participants|Number|39|39.0||||||
4198508|NCT00755417|4021866|B4|White||Race/Ethnicity, Customized||Participants|Number|357|357.0||||||
4198509|NCT00755417|4021867|B3|White||Race/Ethnicity, Customized||Participants|Number|111|111.0||||||
4198510|NCT00755417|4021868|B2|White||Race/Ethnicity, Customized||Participants|Number|125|125.0||||||
4198511|NCT00755417|4021869|B1|White||Race/Ethnicity, Customized||Participants|Number|121|121.0||||||
4198512|NCT00755417|4021866|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4198513|NCT00755417|4021867|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4198514|NCT00755417|4021868|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4198515|NCT00755417|4021869|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4198516|NCT00755417|4021866|B4||Female|Sex: Female, Male||Participants|Count of Participants|532|532.0||||||
4198517|NCT00755417|4021867|B3||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4198518|NCT00755417|4021868|B2||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4198519|NCT00755417|4021869|B1||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4198520|NCT00755417|4021866|B4|>=65 years||Age, Customized||Participants|Number|16|16.0||||||
4198521|NCT00755417|4021867|B3|>=65 years||Age, Customized||Participants|Number|7|7.0||||||
4198522|NCT00755417|4021868|B2|>=65 years||Age, Customized||Participants|Number|5|5.0||||||
4198523|NCT00755417|4021869|B1|>=65 years||Age, Customized||Participants|Number|4|4.0||||||
4198524|NCT00755417|4021866|B4|<65 years||Age, Customized||Participants|Number|516|516.0||||||
4198525|NCT00755417|4021867|B3|<65 years||Age, Customized||Participants|Number|170|170.0||||||
4198526|NCT00755417|4021868|B2|<65 years||Age, Customized||Participants|Number|176|176.0||||||
4198527|NCT00755417|4021869|B1|<65 years||Age, Customized||Participants|Number|170|170.0||||||
4198528|NCT00755417|4021866|B4|||Age||Years|Mean|52.9|52.9|Standard Deviation|6.2|6.2|||
4198529|NCT00755417|4021867|B3|||Age||Years|Mean|53.0|53.0|Standard Deviation|6.6|6.6|||
4198530|NCT00755417|4021868|B2|||Age||Years|Mean|52.9|52.9|Standard Deviation|6.5|6.5|||
4198531|NCT00755417|4021869|B1|||Age||Years|Mean|52.9|52.9|Standard Deviation|5.3|5.3|||
4198532|NCT00755274|4021888|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4198533|NCT00755274|4021889|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4198534|NCT00755274|4021890|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4198535|NCT00755274|4021888|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4198536|NCT00755274|4021889|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4198537|NCT00755274|4021890|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4198538|NCT00755274|4021888|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4198539|NCT00755274|4021889|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4198540|NCT00755274|4021890|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4198541|NCT00755274|4021888|B3|||Age||Months|Mean|30.1|30.1|Standard Deviation|11.34|11.34|||
4198542|NCT00755274|4021889|B2|||Age||Months|Mean|22.1|22.1|Standard Deviation|10.36|10.36|||
4198543|NCT00755274|4021890|B1|||Age||Months|Mean|32.8|32.8|Standard Deviation|10.52|10.52|||
4198544|NCT00755274|4021888|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4198545|NCT00755274|4021889|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4198546|NCT00755274|4021890|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4198547|NCT00755274|4021888|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4198548|NCT00755274|4021889|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4198549|NCT00755274|4021890|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4198550|NCT00755274|4021888|B3||<=18 years|Age||Participants|Count of Participants|32|32.0||||||
4198551|NCT00755274|4021889|B2||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4198552|NCT00755274|4021890|B1||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
4198553|NCT00755261|4021911|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4198554|NCT00755261|4021911|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4198555|NCT00755261|4021911|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4198556|NCT00755261|4021911|B1|||Age||years|Median|58|58.0|Full Range|||45.0|65.0|
4198557|NCT00755235|4021915|B3|United States||Region of Enrollment||participants|Number|208|208.0||||||
4198558|NCT00755235|4021916|B2|United States||Region of Enrollment||participants|Number|102|102.0||||||
4198559|NCT00755235|4021917|B1|United States||Region of Enrollment||participants|Number|106|106.0||||||
4198560|NCT00755235|4021915|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4198561|NCT00755235|4021916|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4198562|NCT00755235|4021917|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4198563|NCT00755235|4021915|B3||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4198564|NCT00755235|4021916|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4198565|NCT00755235|4021917|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4198566|NCT00755235|4021915|B3|||Age||years|Mean|48|48.0|Standard Deviation|9|9.0|||
4198567|NCT00755235|4021916|B2|||Age||years|Mean|48|48.0|Standard Deviation|10|10.0|||
4198568|NCT00755235|4021917|B1|||Age||years|Mean|48|48.0|Standard Deviation|9|9.0|||
4198569|NCT00755235|4021915|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4198570|NCT00755235|4021916|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4198571|NCT00755235|4021917|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4198572|NCT00755235|4021915|B3||Between 18 and 65 years|Age||Participants|Count of Participants|190|190.0||||||
4198573|NCT00755235|4021916|B2||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
4198574|NCT00755235|4021917|B1||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
4198575|NCT00755235|4021915|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198576|NCT00755235|4021916|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198577|NCT00755235|4021917|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198578|NCT00755222|4021926|B3|United States||Region of Enrollment||participants|Number|147|147.0||||||
4198579|NCT00755222|4021927|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
4198580|NCT00755222|4021928|B1|United States||Region of Enrollment||participants|Number|111|111.0||||||
4198581|NCT00755222|4021926|B3||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4198582|NCT00755222|4021927|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4198583|NCT00755222|4021928|B1||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4198584|NCT00755222|4021926|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4198585|NCT00755222|4021927|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4198586|NCT00755222|4021928|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4198587|NCT00755222|4021926|B3|||Age||years|Mean|56.6|56.6|Standard Deviation|7.60|7.6|||
4198588|NCT00755222|4021927|B2|||Age||years|Mean|55.4|55.4|Standard Deviation|6.95|6.95|||
4198589|NCT00755222|4021928|B1|||Age||years|Mean|56.9|56.9|Standard Deviation|7.79|7.79|||
4198590|NCT00755222|4021926|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4198591|NCT00755222|4021927|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4198592|NCT00755222|4021928|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4198593|NCT00755222|4021926|B3||Between 18 and 65 years|Age||Participants|Count of Participants|129|129.0||||||
4198594|NCT00755222|4021927|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4198595|NCT00755222|4021928|B1||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
4198596|NCT00755222|4021926|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198597|NCT00755222|4021927|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198598|NCT00755222|4021928|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198599|NCT00755196|4021943|B1||Male|Gender||Participants|Count of Participants|30|30.0||||||
4198600|NCT00755196|4021943|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
4198601|NCT00755196|4021943|B1|||Age||years|Mean|48.4|48.4|Standard Deviation|8.63|8.63|||
4198602|NCT00755131|4021948|B3|Italy||Region of Enrollment||participants|Number|75|75.0||||||
4198603|NCT00755131|4021949|B2|Italy||Region of Enrollment||participants|Number|38|38.0||||||
4198604|NCT00755131|4021950|B1|Italy||Region of Enrollment||participants|Number|37|37.0||||||
4198605|NCT00755131|4021948|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4198606|NCT00755131|4021949|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4198607|NCT00755131|4021950|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4198608|NCT00755131|4021948|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4198609|NCT00755131|4021949|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4198610|NCT00755131|4021950|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4198611|NCT00755131|4021948|B3|||Age||years|Mean|60.4|60.4|Standard Deviation|7.5|7.5|||
4198612|NCT00755131|4021949|B2|||Age||years|Mean|59.5|59.5|Standard Deviation|7.7|7.7|||
4198613|NCT00755131|4021950|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|7.0|7.0|||
4198614|NCT00755131|4021948|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4198615|NCT00755131|4021949|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4198616|NCT00755131|4021950|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4198617|NCT00755131|4021948|B3||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4198618|NCT00755131|4021949|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4198619|NCT00755131|4021950|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4198620|NCT00755131|4021948|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198621|NCT00755131|4021949|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198622|NCT00755131|4021950|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198623|NCT00755105|4021961|B4||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4198624|NCT00755105|4021962|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4198625|NCT00755105|4021963|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4198626|NCT00755105|4021964|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4198627|NCT00755105|4021961|B4||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4198628|NCT00755105|4021962|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4198629|NCT00755105|4021963|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4198630|NCT00755105|4021964|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4198631|NCT00755105|4021961|B4|||Age||years|Mean|43|43.0|Standard Deviation|7|7.0|||
4198632|NCT00755105|4021962|B3|||Age||years|Mean|50|50.0|Standard Deviation|5|5.0|||
4198633|NCT00755105|4021963|B2|||Age||years|Mean|40|40.0|Standard Deviation|5|5.0|||
4198634|NCT00755105|4021964|B1|||Age||years|Mean|43|43.0|Standard Deviation|8|8.0|||
4198635|NCT00755079|4021974|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
4198636|NCT00755079|4021975|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4198637|NCT00755079|4021976|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4198638|NCT00755079|4021974|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4198639|NCT00755079|4021975|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4198640|NCT00755079|4021976|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4198641|NCT00755079|4021974|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4198642|NCT00755079|4021975|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4198643|NCT00755079|4021976|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4198644|NCT00755079|4021974|B3|||Age||years|Mean|42.48|42.48|Standard Deviation|12.14|12.14|||
4198645|NCT00755079|4021975|B2|||Age||years|Mean|42.75|42.75|Standard Deviation|14.74|14.74|||
4198646|NCT00755079|4021976|B1|||Age||years|Mean|42.24|42.24|Standard Deviation|9.53|9.53|||
4198647|NCT00755040|4021985|B3|United States||Region of Enrollment||participants|Number|164|164.0||||||
4198648|NCT00755040|4021986|B2|United States||Region of Enrollment||participants|Number|81|81.0||||||
4198649|NCT00755040|4021987|B1|United States||Region of Enrollment||participants|Number|83|83.0||||||
4198650|NCT00755040|4021985|B3||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4198651|NCT00755040|4021986|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4198652|NCT00755040|4021987|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4198653|NCT00755040|4021985|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4198654|NCT00755040|4021986|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4198655|NCT00755040|4021987|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4198656|NCT00755040|4021985|B3|||Age||Years|Mean|49|49.0|Standard Deviation|12.062|12.062|||
4198657|NCT00755040|4021986|B2|||Age||Years|Mean|49|49.0|Standard Deviation|11.707|11.707|||
4198658|NCT00755040|4021987|B1|||Age||Years|Mean|49|49.0|Standard Deviation|12.458|12.458|||
4198659|NCT00755040|4021985|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4198660|NCT00755040|4021986|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4198661|NCT00755040|4021987|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4198662|NCT00755040|4021985|B3||Between 18 and 65 years|Age||Participants|Count of Participants|156|156.0||||||
4198663|NCT00755040|4021986|B2||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4198664|NCT00755040|4021987|B1||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
4198665|NCT00755040|4021985|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198666|NCT00755040|4021986|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198667|NCT00755040|4021987|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198668|NCT00754923|4021996|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4198669|NCT00754923|4021996|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4198670|NCT00754923|4021996|B1|||Age||years|Median|70|70.0|Full Range|||49.0|87.0|
4198671|NCT00754845|4022001|B3||Grade 2|ECOG Performance Status|"ECOG Performance Status~Grade 0: Fully active, able to carry on all pre-disease performance without restriction~Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Grade 2: Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|Participants|Count of Participants|15|15.0||||||
4198706|NCT00754832|4022016|B1|||Age||years|Mean|46.5|46.5|Standard Deviation|10.4|10.4|||
4198707|NCT00754832|4022016|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4198708|NCT00754832|4022016|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4198672|NCT00754845|4022002|B2||Grade 2|ECOG Performance Status|"ECOG Performance Status~Grade 0: Fully active, able to carry on all pre-disease performance without restriction~Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Grade 2: Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|Participants|Count of Participants|8|8.0||||||
4198673|NCT00754845|4022003|B1||Grade 2|ECOG Performance Status|"ECOG Performance Status~Grade 0: Fully active, able to carry on all pre-disease performance without restriction~Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Grade 2: Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|Participants|Count of Participants|7|7.0||||||
4198674|NCT00754845|4022001|B3||Grade 1|ECOG Performance Status|"ECOG Performance Status~Grade 0: Fully active, able to carry on all pre-disease performance without restriction~Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Grade 2: Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|Participants|Count of Participants|195|195.0||||||
4198675|NCT00754845|4022002|B2||Grade 1|ECOG Performance Status|"ECOG Performance Status~Grade 0: Fully active, able to carry on all pre-disease performance without restriction~Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Grade 2: Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|Participants|Count of Participants|95|95.0||||||
4198676|NCT00754845|4022003|B1||Grade 1|ECOG Performance Status|"ECOG Performance Status~Grade 0: Fully active, able to carry on all pre-disease performance without restriction~Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Grade 2: Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|Participants|Count of Participants|100|100.0||||||
4198677|NCT00754845|4022001|B3||Grade 0|ECOG Performance Status|"ECOG Performance Status~Grade 0: Fully active, able to carry on all pre-disease performance without restriction~Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Grade 2: Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|Participants|Count of Participants|1708|1708.0||||||
4198678|NCT00754845|4022002|B2||Grade 0|ECOG Performance Status|"ECOG Performance Status~Grade 0: Fully active, able to carry on all pre-disease performance without restriction~Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Grade 2: Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|Participants|Count of Participants|856|856.0||||||
4198679|NCT00754845|4022003|B1||Grade 0|ECOG Performance Status|"ECOG Performance Status~Grade 0: Fully active, able to carry on all pre-disease performance without restriction~Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Grade 2: Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|Participants|Count of Participants|852|852.0||||||
4198680|NCT00754845|4022001|B3|United States||Region of Enrollment||Participants|Count of Participants|1357|1357.0||||||
4198681|NCT00754845|4022002|B2|United States||Region of Enrollment||Participants|Count of Participants|674|674.0||||||
4198682|NCT00754845|4022003|B1|United States||Region of Enrollment||Participants|Count of Participants|683|683.0||||||
4198683|NCT00754845|4022001|B3|Canada||Region of Enrollment||Participants|Count of Participants|561|561.0||||||
4198684|NCT00754845|4022002|B2|Canada||Region of Enrollment||Participants|Count of Participants|285|285.0||||||
4198685|NCT00754845|4022003|B1|Canada||Region of Enrollment||Participants|Count of Participants|276|276.0||||||
4198686|NCT00754845|4022001|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4198687|NCT00754845|4022002|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4198688|NCT00754845|4022003|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4198689|NCT00754845|4022001|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1879|1879.0||||||
4198690|NCT00754845|4022002|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|939|939.0||||||
4198691|NCT00754845|4022003|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|940|940.0||||||
4198692|NCT00754845|4022001|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4198693|NCT00754845|4022002|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4198694|NCT00754845|4022003|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4198695|NCT00754845|4022001|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4198696|NCT00754845|4022002|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4198697|NCT00754845|4022003|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4198698|NCT00754845|4022001|B3||Female|Sex: Female, Male||Participants|Count of Participants|1918|1918.0||||||
4198699|NCT00754845|4022002|B2||Female|Sex: Female, Male||Participants|Count of Participants|959|959.0||||||
4198700|NCT00754845|4022003|B1||Female|Sex: Female, Male||Participants|Count of Participants|959|959.0||||||
4198701|NCT00754845|4022001|B3|||Age||years|Median|65.1|65.1|Full Range|||43.0|92.2|
4198702|NCT00754845|4022002|B2|||Age||years|Median|64.8|64.8|Full Range|||43.4|89.9|
4198703|NCT00754845|4022003|B1|||Age||years|Median|65.6|65.6|Full Range|||43.0|92.2|
4198704|NCT00754832|4022016|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4198705|NCT00754832|4022016|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4198709|NCT00754832|4022016|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198710|NCT00754793|4022027|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4198711|NCT00754793|4022028|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4198712|NCT00754793|4022029|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4198713|NCT00754793|4022027|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4198714|NCT00754793|4022028|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4198715|NCT00754793|4022029|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4198716|NCT00754793|4022027|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4198717|NCT00754793|4022028|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4198718|NCT00754793|4022029|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4198719|NCT00754793|4022027|B3|||Age||years|Mean|48|48.0|Standard Deviation|48|48.0|||
4198720|NCT00754793|4022028|B2|||Age||years|Mean|50|50.0|Standard Deviation|50|50.0|||
4198721|NCT00754793|4022029|B1|||Age||years|Mean|45|45.0|Standard Deviation|45|45.0|||
4198722|NCT00754793|4022027|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4198723|NCT00754793|4022028|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4198724|NCT00754793|4022029|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4198725|NCT00754793|4022027|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4198726|NCT00754793|4022028|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4198727|NCT00754793|4022029|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4198728|NCT00754793|4022027|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198729|NCT00754793|4022028|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198730|NCT00754793|4022029|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198731|NCT00754767|4022036|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4198732|NCT00754767|4022036|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4198733|NCT00754767|4022037|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4198734|NCT00754767|4022038|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4198735|NCT00754767|4022036|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4198736|NCT00754767|4022037|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4198737|NCT00754767|4022038|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4198738|NCT00754767|4022036|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4198739|NCT00754767|4022037|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4198740|NCT00754767|4022038|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4198741|NCT00754767|4022036|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4198742|NCT00754767|4022037|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4198743|NCT00754767|4022038|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4198744|NCT00754767|4022036|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198745|NCT00754767|4022037|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198746|NCT00754767|4022038|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198747|NCT00754741|4022045|B4|||Lipid-lowering medication adherence|Adherence is the estimated proportion of the prescribed dose taken over a 3-month period. Therefore, each estimate of medication adherence represented a 3-month window of use prior to and including the assessment time (e.g., the adherence estimate at baseline represented use beginning 3 months before randomization and ending at the time of randomization). Pharmacy claims data (i.e., days supply and refill frequency) were used to estimate adherence.|Adherence - proportion|Mean|0.70|0.7|Standard Deviation|0.37|0.37|||
4198748|NCT00754741|4022046|B3|||Lipid-lowering medication adherence|Adherence is the estimated proportion of the prescribed dose taken over a 3-month period. Therefore, each estimate of medication adherence represented a 3-month window of use prior to and including the assessment time (e.g., the adherence estimate at baseline represented use beginning 3 months before randomization and ending at the time of randomization). Pharmacy claims data (i.e., days supply and refill frequency) were used to estimate adherence.|Adherence - proportion|Mean|0.69|0.69|Standard Deviation|0.37|0.37|||
4198749|NCT00754741|4022047|B2|||Lipid-lowering medication adherence|Adherence is the estimated proportion of the prescribed dose taken over a 3-month period. Therefore, each estimate of medication adherence represented a 3-month window of use prior to and including the assessment time (e.g., the adherence estimate at baseline represented use beginning 3 months before randomization and ending at the time of randomization). Pharmacy claims data (i.e., days supply and refill frequency) were used to estimate adherence.|Adherence - proportion|Mean|0.70|0.7|Standard Deviation|0.37|0.37|||
4198750|NCT00754741|4022048|B1|||Lipid-lowering medication adherence|Adherence is the estimated proportion of the prescribed dose taken over a 3-month period. Therefore, each estimate of medication adherence represented a 3-month window of use prior to and including the assessment time (e.g., the adherence estimate at baseline represented use beginning 3 months before randomization and ending at the time of randomization). Pharmacy claims data (i.e., days supply and refill frequency) were used to estimate adherence.|Adherence - proportion|Mean|0.71|0.71|Standard Deviation|0.37|0.37|||
4198751|NCT00754741|4022045|B4|||Oral diabetes medication adherence|Adherence is the estimated proportion of the prescribed dose taken over a 3-month period. Therefore, each estimate of medication adherence represented a 3-month window of use prior to and including the assessment time (e.g., the adherence estimate at baseline represented use beginning 3 months before randomization and ending at the time of randomization). Pharmacy claims data (i.e., days supply and refill frequency) were used to estimate adherence.|Adherence - proportion|Mean|0.75|0.75|Standard Deviation|0.36|0.36|||
4198752|NCT00754741|4022046|B3|||Oral diabetes medication adherence|Adherence is the estimated proportion of the prescribed dose taken over a 3-month period. Therefore, each estimate of medication adherence represented a 3-month window of use prior to and including the assessment time (e.g., the adherence estimate at baseline represented use beginning 3 months before randomization and ending at the time of randomization). Pharmacy claims data (i.e., days supply and refill frequency) were used to estimate adherence.|Adherence - proportion|Mean|0.75|0.75|Standard Deviation|0.36|0.36|||
4198753|NCT00754741|4022047|B2|||Oral diabetes medication adherence|Adherence is the estimated proportion of the prescribed dose taken over a 3-month period. Therefore, each estimate of medication adherence represented a 3-month window of use prior to and including the assessment time (e.g., the adherence estimate at baseline represented use beginning 3 months before randomization and ending at the time of randomization). Pharmacy claims data (i.e., days supply and refill frequency) were used to estimate adherence.|Adherence - proportion|Mean|0.76|0.76|Standard Deviation|0.35|0.35|||
4198754|NCT00754741|4022048|B1|||Oral diabetes medication adherence|Adherence is the estimated proportion of the prescribed dose taken over a 3-month period. Therefore, each estimate of medication adherence represented a 3-month window of use prior to and including the assessment time (e.g., the adherence estimate at baseline represented use beginning 3 months before randomization and ending at the time of randomization). Pharmacy claims data (i.e., days supply and refill frequency) were used to estimate adherence.|Adherence - proportion|Mean|0.76|0.76|Standard Deviation|0.35|0.35|||
4198755|NCT00754741|4022045|B4|||Bile acid sequestrant use||participants|Number|16|16.0||||||
4198756|NCT00754741|4022046|B3|||Bile acid sequestrant use||participants|Number|3|3.0||||||
4198757|NCT00754741|4022047|B2|||Bile acid sequestrant use||participants|Number|4|4.0||||||
4198758|NCT00754741|4022048|B1|||Bile acid sequestrant use||participants|Number|9|9.0||||||
4198759|NCT00754741|4022045|B4|||Niacin use||participants|Number|18|18.0||||||
4198760|NCT00754741|4022046|B3|||Niacin use||participants|Number|5|5.0||||||
4198761|NCT00754741|4022047|B2|||Niacin use||participants|Number|6|6.0||||||
4198762|NCT00754741|4022048|B1|||Niacin use||participants|Number|7|7.0||||||
4198763|NCT00754741|4022045|B4|||Fibrate use||participants|Number|160|160.0||||||
4198764|NCT00754741|4022046|B3|||Fibrate use||participants|Number|50|50.0||||||
4198765|NCT00754741|4022047|B2|||Fibrate use||participants|Number|51|51.0||||||
4198766|NCT00754741|4022048|B1|||Fibrate use||participants|Number|59|59.0||||||
4198767|NCT00754741|4022045|B4|||Ezetimibe use||participants|Number|240|240.0||||||
4198768|NCT00754741|4022046|B3|||Ezetimibe use||participants|Number|90|90.0||||||
4198769|NCT00754741|4022047|B2|||Ezetimibe use||participants|Number|77|77.0||||||
4198770|NCT00754741|4022048|B1|||Ezetimibe use||participants|Number|73|73.0||||||
4198771|NCT00754741|4022045|B4|||Statin use||participants|Number|1341|1341.0||||||
4198772|NCT00754741|4022046|B3|||Statin use||participants|Number|443|443.0||||||
4198773|NCT00754741|4022047|B2|||Statin use||participants|Number|452|452.0||||||
4198774|NCT00754741|4022048|B1|||Statin use||participants|Number|446|446.0||||||
4198775|NCT00754741|4022045|B4|||Meglitinide use||participants|Number|13|13.0||||||
4198776|NCT00754741|4022046|B3|||Meglitinide use||participants|Number|2|2.0||||||
4198777|NCT00754741|4022047|B2|||Meglitinide use||participants|Number|3|3.0||||||
4198778|NCT00754741|4022048|B1|||Meglitinide use||participants|Number|8|8.0||||||
4198779|NCT00754741|4022045|B4|||Alpha-glucosidase inhibitor use||participants|Number|12|12.0||||||
4198780|NCT00754741|4022046|B3|||Alpha-glucosidase inhibitor use||participants|Number|3|3.0||||||
4198781|NCT00754741|4022047|B2|||Alpha-glucosidase inhibitor use||participants|Number|4|4.0||||||
4198782|NCT00754741|4022048|B1|||Alpha-glucosidase inhibitor use||participants|Number|5|5.0||||||
4198783|NCT00754741|4022045|B4|||Sulfonylurea use||participants|Number|1005|1005.0||||||
4198784|NCT00754741|4022046|B3|||Sulfonylurea use||participants|Number|337|337.0||||||
4198785|NCT00754741|4022047|B2|||Sulfonylurea use||participants|Number|341|341.0||||||
4198786|NCT00754741|4022048|B1|||Sulfonylurea use||participants|Number|327|327.0||||||
4198787|NCT00754741|4022045|B4|||Thiazolidinedione use||participants|Number|236|236.0||||||
4198788|NCT00754741|4022046|B3|||Thiazolidinedione use||participants|Number|73|73.0||||||
4198789|NCT00754741|4022047|B2|||Thiazolidinedione use||participants|Number|85|85.0||||||
4198790|NCT00754741|4022048|B1|||Thiazolidinedione use||participants|Number|78|78.0||||||
4198791|NCT00754741|4022045|B4|||Biguanide use||participants|Number|1046|1046.0||||||
4198792|NCT00754741|4022046|B3|||Biguanide use||participants|Number|347|347.0||||||
4198793|NCT00754741|4022047|B2|||Biguanide use||participants|Number|364|364.0||||||
4198794|NCT00754741|4022048|B1|||Biguanide use||participants|Number|335|335.0||||||
4198795|NCT00754741|4022045|B4|||Insulin use||participants|Number|570|570.0||||||
4198796|NCT00754741|4022046|B3|||Insulin use||participants|Number|192|192.0||||||
4198797|NCT00754741|4022047|B2|||Insulin use||participants|Number|191|191.0||||||
4198798|NCT00754741|4022048|B1|||Insulin use||participants|Number|187|187.0||||||
4198799|NCT00754741|4022045|B4|||Diastolic blood pressure||mmHg|Mean|75.1|75.1|Standard Deviation|9.5|9.5|||
4198800|NCT00754741|4022046|B3|||Diastolic blood pressure||mmHg|Mean|75.0|75.0|Standard Deviation|9.2|9.2|||
4198801|NCT00754741|4022047|B2|||Diastolic blood pressure||mmHg|Mean|75.6|75.6|Standard Deviation|9.3|9.3|||
4198802|NCT00754741|4022048|B1|||Diastolic blood pressure||mmHg|Mean|74.8|74.8|Standard Deviation|10.0|10.0|||
4198803|NCT00754741|4022045|B4|||Systolic blood pressure||mmHg|Mean|133.0|133.0|Standard Deviation|15.5|15.5|||
4198804|NCT00754741|4022046|B3|||Systolic blood pressure||mmHg|Mean|133.2|133.2|Standard Deviation|15.8|15.8|||
4198805|NCT00754741|4022047|B2|||Systolic blood pressure||mmHg|Mean|132.3|132.3|Standard Deviation|15.3|15.3|||
4198806|NCT00754741|4022048|B1|||Systolic blood pressure||mmHg|Mean|133.6|133.6|Standard Deviation|15.4|15.4|||
4198807|NCT00754741|4022045|B4|||Serum creatinine||mg/dL|Mean|1.1|1.1|Standard Deviation|0.6|0.6|||
4198808|NCT00754741|4022046|B3|||Serum creatinine||mg/dL|Mean|1.2|1.2|Standard Deviation|0.9|0.9|||
4198809|NCT00754741|4022047|B2|||Serum creatinine||mg/dL|Mean|1.1|1.1|Standard Deviation|0.3|0.3|||
4198810|NCT00754741|4022048|B1|||Serum creatinine||mg/dL|Mean|1.1|1.1|Standard Deviation|0.4|0.4|||
4198811|NCT00754741|4022045|B4|||LDL-C||mg/dL|Mean|98.5|98.5|Standard Deviation|32.2|32.2|||
4198812|NCT00754741|4022046|B3|||LDL-C||mg/dL|Mean|97.1|97.1|Standard Deviation|31.5|31.5|||
4198813|NCT00754741|4022047|B2|||LDL-C||mg/dL|Mean|98.5|98.5|Standard Deviation|33.8|33.8|||
4198814|NCT00754741|4022048|B1|||LDL-C||mg/dL|Mean|99.9|99.9|Standard Deviation|31.4|31.4|||
4198815|NCT00754741|4022045|B4|||HbA1c||%|Mean|8.0|8.0|Standard Deviation|1.4|1.4|||
4198816|NCT00754741|4022046|B3|||HbA1c||%|Mean|8.0|8.0|Standard Deviation|1.3|1.3|||
4198817|NCT00754741|4022047|B2|||HbA1c||%|Mean|8.2|8.2|Standard Deviation|1.4|1.4|||
4198818|NCT00754741|4022048|B1|||HbA1c||%|Mean|8.0|8.0|Standard Deviation|1.4|1.4|||
4198819|NCT00754741|4022045|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|121|121.0||||||
4198820|NCT00754741|4022046|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4198821|NCT00754741|4022047|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4198822|NCT00754741|4022048|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4198823|NCT00754741|4022045|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198824|NCT00754741|4022046|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198825|NCT00754741|4022047|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198826|NCT00754741|4022048|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198827|NCT00754741|4022045|B4||White|Race (NIH/OMB)||Participants|Count of Participants|872|872.0||||||
4198828|NCT00754741|4022046|B3||White|Race (NIH/OMB)||Participants|Count of Participants|281|281.0||||||
4198829|NCT00754741|4022047|B2||White|Race (NIH/OMB)||Participants|Count of Participants|294|294.0||||||
4198830|NCT00754741|4022048|B1||White|Race (NIH/OMB)||Participants|Count of Participants|297|297.0||||||
4198831|NCT00754741|4022045|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|699|699.0||||||
4198832|NCT00754741|4022046|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|238|238.0||||||
4198833|NCT00754741|4022047|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|237|237.0||||||
4198834|NCT00754741|4022048|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|224|224.0||||||
4198835|NCT00754741|4022045|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198836|NCT00754741|4022046|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198837|NCT00754741|4022047|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198838|NCT00754741|4022048|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198839|NCT00754741|4022045|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198840|NCT00754741|4022046|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198841|NCT00754741|4022047|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198842|NCT00754741|4022048|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198843|NCT00754741|4022045|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198844|NCT00754741|4022046|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198845|NCT00754741|4022047|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198846|NCT00754741|4022048|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198847|NCT00754741|4022045|B4||Male|Sex: Female, Male||Participants|Count of Participants|854|854.0||||||
4198848|NCT00754741|4022046|B3||Male|Sex: Female, Male||Participants|Count of Participants|290|290.0||||||
4198849|NCT00754741|4022047|B2||Male|Sex: Female, Male||Participants|Count of Participants|299|299.0||||||
4198850|NCT00754741|4022048|B1||Male|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
4198851|NCT00754741|4022045|B4||Female|Sex: Female, Male||Participants|Count of Participants|838|838.0||||||
4198852|NCT00754741|4022046|B3||Female|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
4198853|NCT00754741|4022047|B2||Female|Sex: Female, Male||Participants|Count of Participants|270|270.0||||||
4198854|NCT00754741|4022048|B1||Female|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
4198855|NCT00754741|4022045|B4|||Age||years|Mean|64.3|64.3|Standard Deviation|11.0|11.0|||
4198856|NCT00754741|4022046|B3|||Age||years|Mean|64.5|64.5|Standard Deviation|10.5|10.5|||
4198857|NCT00754741|4022047|B2|||Age||years|Mean|63.3|63.3|Standard Deviation|10.9|10.9|||
4198858|NCT00754741|4022048|B1|||Age||years|Mean|64.9|64.9|Standard Deviation|11.5|11.5|||
4198859|NCT00754650|4022097|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4198860|NCT00754650|4022097|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4198861|NCT00754650|4022097|B1|||Age||years|Mean|60.0|60.0|Standard Deviation|9.9|9.9|||
4198862|NCT00754624|4022102|B1|||Weight|Weight in kg|kg|Mean|87.2|87.2|Standard Deviation|15.2|15.2|||
4198863|NCT00754624|4022102|B1|||HbA1c|Glycosylated Hemoglobin|%|Mean|7.97|7.97|Standard Deviation|1.20|1.2|||
4198864|NCT00754624|4022102|B1|||FVC|Forced Vital Capacity|Liters|Mean|3.85|3.85|Standard Deviation|0.89|0.89|||
4198865|NCT00754624|4022102|B1|||FPG|Fasting Plasma Glucose|mg/dL|Mean|167.7|167.7|Standard Deviation|42.1|42.1|||
4198866|NCT00754624|4022102|B1|||FEV1|Forced Expiratory Volumne in 1 sec.|Liters|Mean|2.99|2.99|Standard Deviation|0.70|0.7|||
4198867|NCT00754624|4022102|B1|||DLCo|Lung Diffusion Capacity|mL/min/mmHg|Mean|26.16|26.16|Standard Deviation|6.21|6.21|||
4198868|NCT00754624|4022102|B1||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4198869|NCT00754624|4022102|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4198870|NCT00754624|4022102|B1|||Age||years|Mean|56.4|56.4|Full Range|||34.0|76.0|
4198871|NCT00754572|4022112|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4198872|NCT00754572|4022112|B1||Female|Sex: Female, Male||Participants|Count of Participants|371|371.0||||||
4198873|NCT00754572|4022112|B1|||Age||years|Mean|48.69|48.69|Standard Deviation|12.36|12.36|||
4198874|NCT00754559|4022139|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4198875|NCT00754559|4022139|B1||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4198876|NCT00754559|4022139|B1|||Age||years|Mean|54.9|54.9|Standard Deviation|12.2|12.2|||
4198877|NCT00754546|4022163|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4198878|NCT00754546|4022163|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4198879|NCT00754546|4022163|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4198880|NCT00754546|4022163|B1|||Age||years|Mean|64|64.0|Standard Deviation|7|7.0|||
4198881|NCT00754546|4022163|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4198882|NCT00754546|4022163|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4198883|NCT00754546|4022163|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198884|NCT00754494|4022177|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4198885|NCT00754494|4022178|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4198886|NCT00754494|4022179|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4198887|NCT00754494|4022180|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4198888|NCT00754494|4022177|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4198889|NCT00754494|4022178|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4198890|NCT00754494|4022179|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4198891|NCT00754494|4022180|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4198892|NCT00754494|4022177|B4|||Age||years|Mean|62.27|62.27|Standard Deviation|6.08|6.08|||
4198893|NCT00754494|4022178|B3|||Age||years|Mean|60.67|60.67|Standard Deviation|7.42|7.42|||
4198894|NCT00754494|4022179|B2|||Age||years|Mean|62.47|62.47|Standard Deviation|6.03|6.03|||
4198895|NCT00754494|4022180|B1|||Age||years|Mean|63.67|63.67|Standard Deviation|4.43|4.43|||
4198896|NCT00754468|4022226|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4198897|NCT00754468|4022227|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4198898|NCT00754468|4022228|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4198899|NCT00754468|4022226|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198900|NCT00754468|4022227|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198901|NCT00754468|4022228|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198902|NCT00754468|4022226|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198903|NCT00754468|4022227|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198904|NCT00754468|4022228|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198905|NCT00754468|4022226|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4198906|NCT00754468|4022227|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4198907|NCT00754468|4022228|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4198908|NCT00754468|4022226|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198909|NCT00754468|4022227|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198910|NCT00754468|4022228|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198911|NCT00754468|4022226|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198912|NCT00754468|4022227|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198913|NCT00754468|4022228|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198914|NCT00754468|4022226|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198915|NCT00754468|4022227|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198916|NCT00754468|4022228|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198917|NCT00754468|4022226|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198918|NCT00754468|4022227|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198919|NCT00754468|4022228|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198920|NCT00754468|4022226|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198921|NCT00754468|4022227|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198922|NCT00754468|4022228|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198923|NCT00754468|4022226|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198924|NCT00754468|4022227|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198925|NCT00754468|4022228|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4198926|NCT00754468|4022226|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4198927|NCT00754468|4022227|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4198928|NCT00754468|4022228|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4198929|NCT00754468|4022226|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4198930|NCT00754468|4022227|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4198931|NCT00754468|4022228|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4198932|NCT00754468|4022226|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4198933|NCT00754468|4022227|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4198934|NCT00754468|4022228|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4198935|NCT00754468|4022226|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4198936|NCT00754468|4022227|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4198937|NCT00754468|4022228|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4198938|NCT00754468|4022226|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198939|NCT00754468|4022227|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198940|NCT00754468|4022228|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198941|NCT00754468|4022226|B3|||Age||years|Mean|55|55.0|Full Range|||22.0|66.0|
4198942|NCT00754468|4022227|B2|||Age||years|Mean|64|64.0|Full Range|||61.0|66.0|
4198943|NCT00754468|4022228|B1|||Age||years|Mean|48|48.0|Full Range|||22.0|63.0|
4198944|NCT00754442|4022237|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4198945|NCT00754442|4022238|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4198946|NCT00754442|4022239|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4198947|NCT00754442|4022237|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4198948|NCT00754442|4022238|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4198949|NCT00754442|4022239|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4198950|NCT00754442|4022237|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4198951|NCT00754442|4022238|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4198952|NCT00754442|4022239|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4198953|NCT00754442|4022237|B3|||Age||years|Mean|52.4|52.4|Standard Deviation|3.8|3.8|||
4198954|NCT00754442|4022238|B2|||Age||years|Mean|53.0|53.0|Standard Deviation|2.5|2.5|||
4198955|NCT00754442|4022239|B1|||Age||years|Mean|51.8|51.8|Standard Deviation|4.4|4.4|||
4198956|NCT00754442|4022237|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4198957|NCT00754442|4022238|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4198958|NCT00754442|4022239|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4198959|NCT00754442|4022237|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4198960|NCT00754442|4022238|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4198961|NCT00754442|4022239|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4198962|NCT00754442|4022237|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198963|NCT00754442|4022238|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198964|NCT00754442|4022239|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198965|NCT00754390|4022247|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4198966|NCT00754390|4022247|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4198967|NCT00754390|4022247|B1|||Age||years|Mean|32.7|32.7|Standard Deviation|9.5|9.5|||
4198968|NCT00754390|4022247|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4198969|NCT00754390|4022247|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4198970|NCT00754390|4022247|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4198971|NCT00754377|4022254|B3|||Sex/Gender, Customized|Gender was not collected|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4198972|NCT00754377|4022255|B2|||Sex/Gender, Customized|Gender was not collected|participants|Number|NA|||||||Gender of participants was not relevant to study focus.
4198973|NCT00754377|4022256|B1|||Sex/Gender, Customized|Gender was not collected|participants|Number|NA|||||||Gender of participants was not relevant to study focus.
4198974|NCT00754377|4022254|B3|||Age, Customized|Age was not collected|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4198975|NCT00754377|4022255|B2|||Age, Customized|Age was not collected|participants|Number|NA|||||||Age was not collected as it was not relevant to the study focus.
4198976|NCT00754377|4022256|B1|||Age, Customized|Age was not collected|participants|Number|NA|||||||Age was not collected as it was not relevant to the study focus.
4198977|NCT00754338|4022265|B5|Canada||Region of Enrollment||participants|Number|76|76.0||||||
4198978|NCT00754338|4022266|B4|Canada||Region of Enrollment||participants|Number|19|19.0||||||
4198979|NCT00754338|4022267|B3|Canada||Region of Enrollment||participants|Number|19|19.0||||||
4198980|NCT00754338|4022268|B2|Canada||Region of Enrollment||participants|Number|21|21.0||||||
4198981|NCT00754338|4022269|B1|Canada||Region of Enrollment||participants|Number|17|17.0||||||
4198982|NCT00754338|4022265|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4198983|NCT00754338|4022266|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4198984|NCT00754338|4022267|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4198985|NCT00754338|4022268|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4198986|NCT00754338|4022269|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4198987|NCT00754338|4022265|B5||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4198988|NCT00754338|4022266|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4198989|NCT00754338|4022267|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4198990|NCT00754338|4022268|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4198991|NCT00754338|4022269|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4198992|NCT00754338|4022265|B5|||Age||years|Mean|26|26.0|Standard Deviation|9|9.0|||
4198993|NCT00754338|4022266|B4|||Age||years|Mean|24|24.0|Standard Deviation|7|7.0|||
4198994|NCT00754338|4022267|B3|||Age||years|Mean|30|30.0|Standard Deviation|9|9.0|||
4198995|NCT00754338|4022268|B2|||Age||years|Mean|21|21.0|Standard Deviation|3|3.0|||
4198996|NCT00754338|4022269|B1|||Age||years|Mean|28|28.0|Standard Deviation|11|11.0|||
4198997|NCT00754338|4022265|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4198998|NCT00754338|4022266|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4198999|NCT00754338|4022267|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4199000|NCT00754338|4022268|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4199001|NCT00754338|4022269|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4199002|NCT00754338|4022265|B5||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
4199003|NCT00754338|4022266|B4||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4199004|NCT00754338|4022267|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4199005|NCT00754338|4022268|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4199006|NCT00754338|4022269|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4199007|NCT00754338|4022265|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4199008|NCT00754338|4022266|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4199009|NCT00754338|4022267|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4199010|NCT00754338|4022268|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4199011|NCT00754338|4022269|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4199012|NCT00754325|4022302|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
4199013|NCT00754325|4022303|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
4199014|NCT00754325|4022304|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4199015|NCT00754325|4022302|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4199016|NCT00754325|4022303|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4199017|NCT00754325|4022304|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4199018|NCT00754325|4022302|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4199019|NCT00754325|4022303|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4199020|NCT00754325|4022304|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4199021|NCT00754325|4022302|B3|||Age||years|Mean|62.0|62.0|Standard Deviation|11.3|11.3|||
4199022|NCT00754325|4022303|B2|||Age||years|Mean|61.4|61.4|Standard Deviation|10.3|10.3|||
4199023|NCT00754325|4022304|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|12.3|12.3|||
4199024|NCT00754234|4022324|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4199025|NCT00754234|4022324|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4199026|NCT00754234|4022324|B1|||Age||years|Mean|34|34.0|Standard Deviation|10|10.0|||
4199027|NCT00754208|4022328|B1|||Children's Global Assessment Scale|The children's global assessment scale is the clinician's assessment of the subject's level of functioning as rated from 0 to 100 (worst to best).|units on a scale|Mean|49.9|49.9|Standard Deviation|2.04|2.04|||
4199028|NCT00754208|4022328|B1|||Clinical Global Impression-Severity Score|"The CGI-S is the clinician's assessment of the subject's severity of illness based upon his/her knowledge and experience with the population and disorder under study. The CGI-S is rated on a scale of 1 to 6, with 1 representing normal, not ill, 2 representing borderline ill, 3 representing mildly ill, 4 representing moderately ill, 5 representing markedly ill, and 6 representing severely ill."|units on a scale|Mean|5.14|5.14|Standard Deviation|0.69|0.69|||
4199029|NCT00754208|4022328|B1||No prior treatment|Prior Treatment||Participants|Count of Participants|5|5.0||||||
4199030|NCT00754208|4022328|B1||Pharmacotherapy|Prior Treatment||Participants|Count of Participants|0|0.0||||||
4199031|NCT00754208|4022328|B1||Individual therapy|Prior Treatment||Participants|Count of Participants|2|2.0||||||
4199032|NCT00754208|4022328|B1||NO|Comorbid Oppositional Defiant Disorder||Participants|Count of Participants|3|3.0||||||
4199033|NCT00754208|4022328|B1||YES|Comorbid Oppositional Defiant Disorder||Participants|Count of Participants|4|4.0||||||
4199034|NCT00754208|4022328|B1||ADHD, hyperactive/impulsive subtype|ADHD Subtype|Diagnostic subtype identified on clinical interview and assessment of ADHD symptoms. There are a total of 18 symptoms of ADHD (9 inattentive and 9 hyperactive/impulsive). Subjects are identified as having combined subtype if >/= 6/9 inattentive and >/= 6/9 hyperactive/impulsive symptoms are endorsed. If only the inattentive criterion is met, subjects are identified as having inattentive subtype, and if only the hyperactive/impulsive criterion is met, subjects are identified as having hyperactive/impulsive subtype.|Participants|Count of Participants|0|0.0||||||
4199071|NCT00754156|4022337|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4199072|NCT00754156|4022335|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4199073|NCT00754156|4022336|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4199074|NCT00754156|4022337|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4199035|NCT00754208|4022328|B1||ADHD, inattentive subtype|ADHD Subtype|Diagnostic subtype identified on clinical interview and assessment of ADHD symptoms. There are a total of 18 symptoms of ADHD (9 inattentive and 9 hyperactive/impulsive). Subjects are identified as having combined subtype if >/= 6/9 inattentive and >/= 6/9 hyperactive/impulsive symptoms are endorsed. If only the inattentive criterion is met, subjects are identified as having inattentive subtype, and if only the hyperactive/impulsive criterion is met, subjects are identified as having hyperactive/impulsive subtype.|Participants|Count of Participants|0|0.0||||||
4199036|NCT00754208|4022328|B1||ADHD, combined subtype|ADHD Subtype|Diagnostic subtype identified on clinical interview and assessment of ADHD symptoms. There are a total of 18 symptoms of ADHD (9 inattentive and 9 hyperactive/impulsive). Subjects are identified as having combined subtype if >/= 6/9 inattentive and >/= 6/9 hyperactive/impulsive symptoms are endorsed. If only the inattentive criterion is met, subjects are identified as having inattentive subtype, and if only the hyperactive/impulsive criterion is met, subjects are identified as having hyperactive/impulsive subtype.|Participants|Count of Participants|7|7.0||||||
4199037|NCT00754208|4022328|B1|United States||Region of Enrollment|Child and adolescent psychiatry clinic outpatients|Participants|Count of Participants|7|7.0||||||
4199038|NCT00754208|4022328|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199039|NCT00754208|4022328|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199040|NCT00754208|4022328|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4199041|NCT00754208|4022328|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199042|NCT00754208|4022328|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199043|NCT00754208|4022328|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199044|NCT00754208|4022328|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199045|NCT00754208|4022328|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4199046|NCT00754208|4022328|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4199047|NCT00754208|4022328|B1|||Age||years|Median|4|4.0|Full Range|||4.0|5.0|
4199048|NCT00754208|4022328|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4199049|NCT00754208|4022328|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4199050|NCT00754208|4022328|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4199051|NCT00754156|4022335|B3|||Vascular/Splenectomy/AAA|Patients who met criteria for entry who had baseline conditions to include vascular issue or splenectomy|participants|Number|3|3.0||||||
4199052|NCT00754156|4022336|B2|||Vascular/Splenectomy/AAA|Patients who met criteria for entry who had baseline conditions to include vascular issue or splenectomy|participants|Number|0|0.0||||||
4199053|NCT00754156|4022337|B1|||Vascular/Splenectomy/AAA|Patients who met criteria for entry who had baseline conditions to include vascular issue or splenectomy|participants|Number|3|3.0||||||
4199054|NCT00754156|4022335|B3|||Trauma|Number of patients that are trauma patients|participants|Number|5|5.0||||||
4199055|NCT00754156|4022336|B2|||Trauma|Number of patients that are trauma patients|participants|Number|2|2.0||||||
4199056|NCT00754156|4022337|B1|||Trauma|Number of patients that are trauma patients|participants|Number|3|3.0||||||
4199057|NCT00754156|4022335|B3|||Starting Wound Dimension||cm^2|Mean|483|483.0|Standard Deviation|75.86|75.86|||
4199058|NCT00754156|4022336|B2|||Starting Wound Dimension||cm^2|Mean|359.2|359.2|Standard Deviation|245.3|245.3|||
4199059|NCT00754156|4022337|B1|||Starting Wound Dimension||cm^2|Mean|575.9|575.9|Standard Deviation|289.2|289.2|||
4199060|NCT00754156|4022335|B3|||APACHE II|APACHE II (Acute Physiology and Chronic Health Evaluation) scoring system is an objective assessment of severity of illness in patients in the ICU. Scores can range from 0 (low severity) to 71 (high severity).|score|Mean|19.00|19.0|Standard Deviation|2.81|2.81|||
4199061|NCT00754156|4022336|B2|||APACHE II|APACHE II (Acute Physiology and Chronic Health Evaluation) scoring system is an objective assessment of severity of illness in patients in the ICU. Scores can range from 0 (low severity) to 71 (high severity).|score|Mean|16|16.0|Standard Deviation|11.6|11.6|||
4199062|NCT00754156|4022337|B1|||APACHE II|APACHE II (Acute Physiology and Chronic Health Evaluation) scoring system is an objective assessment of severity of illness in patients in the ICU. Scores can range from 0 (low severity) to 71 (high severity).|score|Mean|21.25|21.25|Standard Deviation|9.8|9.8|||
4199063|NCT00754156|4022335|B3|||Base Excess/Base Deficit|In human physiology, base excess and base deficit refer to an excess or deficit, respectively, in the amount of base present in the blood. The value is usually reported as a concentration in units mmol/L, with a positive number indicating excess of base and a negative deficit. A range for base excess or base deficit is -3 to + 3 mmol/L|mmole/liter|Median|5.9|5.9|Inter-Quartile Range|||-4.9|19.8|
4199064|NCT00754156|4022336|B2|||Base Excess/Base Deficit|In human physiology, base excess and base deficit refer to an excess or deficit, respectively, in the amount of base present in the blood. The value is usually reported as a concentration in units mmol/L, with a positive number indicating excess of base and a negative deficit. A range for base excess or base deficit is -3 to + 3 mmol/L|mmole/liter|Median|5.1|5.1|Inter-Quartile Range|0.5-9.8|0.5|-2.4|15.0|
4199065|NCT00754156|4022337|B1|||Base Excess/Base Deficit|In human physiology, base excess and base deficit refer to an excess or deficit, respectively, in the amount of base present in the blood. The value is usually reported as a concentration in units mmol/L, with a positive number indicating excess of base and a negative deficit. A range for base excess or base deficit is -3 to + 3 mmol/L|mmole/liter|Median|5.9|5.9|Inter-Quartile Range|2.5-18.1|2.5|-4.9|19.8|
4199066|NCT00754156|4022335|B3|||BMI|Body Mass Index|Kg/m^2|Mean|30.99|30.99|Standard Deviation|2.95|2.95|||
4199067|NCT00754156|4022336|B2|||BMI|Body Mass Index|Kg/m^2|Mean|38.0|38.0|Standard Deviation|12.9|12.9|||
4199068|NCT00754156|4022337|B1|||BMI|Body Mass Index|Kg/m^2|Mean|25.7|25.7|Standard Deviation|5.8|5.8|||
4199069|NCT00754156|4022335|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4199070|NCT00754156|4022336|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4199075|NCT00754156|4022335|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4199076|NCT00754156|4022336|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4199077|NCT00754156|4022337|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4199078|NCT00754156|4022335|B3|||Age||years|Mean|51.14|51.14|Standard Deviation|3.4|3.4|||
4199079|NCT00754156|4022336|B2|||Age||years|Mean|52.8|52.8|Standard Deviation|14.1|14.1|||
4199080|NCT00754156|4022337|B1|||Age||years|Mean|49.9|49.9|Standard Deviation|12.4|12.4|||
4199081|NCT00754156|4022335|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4199082|NCT00754156|4022336|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4199083|NCT00754156|4022337|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4199084|NCT00754156|4022335|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4199085|NCT00754156|4022336|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4199086|NCT00754156|4022337|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4199087|NCT00754156|4022335|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4199088|NCT00754156|4022336|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4199089|NCT00754156|4022337|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4199090|NCT00754130|4022356|B7||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4199091|NCT00754130|4022357|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4199092|NCT00754130|4022358|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4199093|NCT00754130|4022359|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4199094|NCT00754130|4022360|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4199095|NCT00754130|4022361|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4199096|NCT00754130|4022362|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4199097|NCT00754130|4022356|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4199098|NCT00754130|4022357|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4199099|NCT00754130|4022358|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4199100|NCT00754130|4022359|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4199101|NCT00754130|4022360|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4199102|NCT00754130|4022361|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4199103|NCT00754130|4022362|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4199104|NCT00754130|4022356|B7|||Age||years|Mean|50.4|50.4|Standard Deviation|10.82|10.82|||
4199105|NCT00754130|4022357|B6|||Age||years|Mean|51.5|51.5|Standard Deviation|11.36|11.36|||
4199106|NCT00754130|4022358|B5|||Age||years|Mean|53.5|53.5|Standard Deviation|10.60|10.6|||
4199107|NCT00754130|4022359|B4|||Age||years|Mean|57.0|57.0|Standard Deviation|7.07|7.07|||
4199108|NCT00754130|4022360|B3|||Age||years|Mean|45.5|45.5|Standard Deviation|16.58|16.58|||
4199109|NCT00754130|4022361|B2|||Age||years|Mean|48.5|48.5|Standard Deviation|2.12|2.12|||
4199110|NCT00754130|4022362|B1|||Age||years|Mean|50.0|50.0|Standard Deviation|12.73|12.73|||
4199111|NCT00754065|4022408|B3|Other||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4199112|NCT00754065|4022409|B2|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4199113|NCT00754065|4022410|B1|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4199114|NCT00754065|4022408|B3|Asian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4199115|NCT00754065|4022409|B2|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4199116|NCT00754065|4022410|B1|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4199117|NCT00754065|4022408|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4199118|NCT00754065|4022409|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4199119|NCT00754065|4022410|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4199120|NCT00754065|4022408|B3|Black||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4199121|NCT00754065|4022409|B2|Black||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4199122|NCT00754065|4022410|B1|Black||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4199123|NCT00754065|4022408|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|348|348.0||||||
4199124|NCT00754065|4022409|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|180|180.0||||||
4199125|NCT00754065|4022410|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|168|168.0||||||
4199126|NCT00754065|4022408|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4199127|NCT00754065|4022409|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4199128|NCT00754065|4022410|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4199129|NCT00754065|4022408|B3||Female|Sex: Female, Male||Participants|Count of Participants|395|395.0||||||
4199130|NCT00754065|4022409|B2||Female|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4199131|NCT00754065|4022410|B1||Female|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4199132|NCT00754065|4022408|B3|||Age||Years|Mean|26.3|26.3|Standard Deviation|6.9|6.9|||
4199133|NCT00754065|4022409|B2|||Age||Years|Mean|26.5|26.5|Standard Deviation|7.2|7.2|||
4199134|NCT00754065|4022410|B1|||Age||Years|Mean|26.0|26.0|Standard Deviation|6.6|6.6|||
4199135|NCT00754052|4022649|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4199136|NCT00754052|4022650|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4199137|NCT00754052|4022651|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4199138|NCT00754052|4022649|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4199139|NCT00754052|4022650|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4199140|NCT00754052|4022651|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4199141|NCT00754052|4022649|B3|||Age||Years|Mean|13.6|13.6|Full Range|||11.0|17.0|
4199142|NCT00754052|4022650|B2|||Age||Years|Mean|15.0|15.0|Full Range|||13.0|17.0|
4199143|NCT00754052|4022651|B1|||Age||Years|Mean|12.8|12.8|Full Range|||11.0|16.0|
4199144|NCT00754013|4022664|B3|White (n)||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4199145|NCT00754013|4022665|B2|White (n)||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4199146|NCT00754013|4022666|B1|White (n)||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4199147|NCT00754013|4022664|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4199148|NCT00754013|4022665|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4199149|NCT00754013|4022666|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4199150|NCT00754013|4022664|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4199151|NCT00754013|4022665|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4199152|NCT00754013|4022666|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4199153|NCT00754013|4022664|B3|||Age||years|Mean|8.5|8.5|Standard Deviation|0.3|0.3|||
4199154|NCT00754013|4022665|B2|||Age||years|Mean|8.0|8.0|Standard Deviation|1.4|1.4|||
4199155|NCT00754013|4022666|B1|||Age||years|Mean|9.0|9.0|Standard Deviation|0.8|0.8|||
4199156|NCT00753948|4022675|B4|United States||Region of Enrollment||participants|Number|23|23.0||||||
4199157|NCT00753948|4022676|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4199158|NCT00753948|4022677|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4199159|NCT00753948|4022678|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4199160|NCT00753948|4022675|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4199161|NCT00753948|4022676|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4199162|NCT00753948|4022677|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4199163|NCT00753948|4022678|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4199164|NCT00753948|4022675|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4199165|NCT00753948|4022676|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4199166|NCT00753948|4022677|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4199167|NCT00753948|4022678|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4199168|NCT00753948|4022675|B4|||Age||years|Mean|40|40.0|Standard Deviation|10|10.0|||
4199169|NCT00753948|4022676|B3|||Age||years|Mean|37|37.0|Standard Deviation|10|10.0|||
4199170|NCT00753948|4022677|B2|||Age||years|Mean|42|42.0|Standard Deviation|9|9.0|||
4199171|NCT00753948|4022678|B1|||Age||years|Mean|42|42.0|Standard Deviation|10|10.0|||
4199172|NCT00753948|4022675|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4199173|NCT00753948|4022676|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4199174|NCT00753948|4022677|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4199175|NCT00753948|4022678|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4199176|NCT00753948|4022675|B4||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4199177|NCT00753948|4022676|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4199178|NCT00753948|4022677|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4199179|NCT00753948|4022678|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4199180|NCT00753948|4022675|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4199181|NCT00753948|4022676|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4199182|NCT00753948|4022677|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4199183|NCT00753948|4022678|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4199184|NCT00753935|4022688|B3|United States||Region of Enrollment||participants|Number|92|92.0||||||
4199185|NCT00753935|4022689|B2|United States||Region of Enrollment||participants|Number|47|47.0||||||
4199186|NCT00753935|4022690|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4199187|NCT00753935|4022688|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4199188|NCT00753935|4022689|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4199189|NCT00753935|4022690|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4199190|NCT00753935|4022688|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199191|NCT00753935|4022689|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199192|NCT00753935|4022690|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199193|NCT00753935|4022688|B3||White|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
4199194|NCT00753935|4022689|B2||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4199195|NCT00753935|4022690|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4199196|NCT00753935|4022688|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4199197|NCT00753935|4022689|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4199198|NCT00753935|4022690|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4199199|NCT00753935|4022688|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199200|NCT00753935|4022689|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199201|NCT00753935|4022690|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199202|NCT00753935|4022688|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199203|NCT00753935|4022689|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199204|NCT00753935|4022690|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199205|NCT00753935|4022688|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199206|NCT00753935|4022689|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199207|NCT00753935|4022690|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199208|NCT00753935|4022688|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4199209|NCT00753935|4022689|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4199210|NCT00753935|4022690|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4199211|NCT00753935|4022688|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4199212|NCT00753935|4022689|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4199213|NCT00753935|4022690|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4199214|NCT00753935|4022688|B3|||Age||years|Mean|65|65.0|Full Range|||56.0|75.0|
4199215|NCT00753935|4022689|B2|||Age||years|Mean|68|68.0|Full Range|||59.0|75.0|
4199216|NCT00753935|4022690|B1|||Age||years|Mean|62|62.0|Full Range|||56.0|69.0|
4199217|NCT00753922|4022697|B5|United States||Region of Enrollment||participants|Number|1008|1008.0||||||
4199218|NCT00753922|4022698|B4|United States||Region of Enrollment||participants|Number|60|60.0||||||
4199219|NCT00753922|4022699|B3|United States||Region of Enrollment||participants|Number|145|145.0||||||
4199220|NCT00753922|4022700|B2|United States||Region of Enrollment||participants|Number|251|251.0||||||
4199221|NCT00753922|4022701|B1|United States||Region of Enrollment||participants|Number|552|552.0||||||
4199222|NCT00753922|4022697|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4199223|NCT00753922|4022698|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4199224|NCT00753922|4022699|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4199225|NCT00753922|4022700|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4199226|NCT00753922|4022701|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4199227|NCT00753922|4022697|B5||Female|Sex: Female, Male||Participants|Count of Participants|1008|1008.0||||||
4199228|NCT00753922|4022698|B4||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4199229|NCT00753922|4022699|B3||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4199230|NCT00753922|4022700|B2||Female|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4199231|NCT00753922|4022701|B1||Female|Sex: Female, Male||Participants|Count of Participants|552|552.0||||||
4199232|NCT00753922|4022697|B5|||Age||years|Mean|39.2|39.2|Standard Deviation|10.74|10.74|||
4199233|NCT00753922|4022698|B4|||Age||years|Mean|50.8|50.8|Standard Deviation|10.82|10.82|||
4199234|NCT00753922|4022699|B3|||Age||years|Mean|41.8|41.8|Standard Deviation|9.66|9.66|||
4199235|NCT00753922|4022700|B2|||Age||years|Mean|45.3|45.3|Standard Deviation|10.87|10.87|||
4199236|NCT00753922|4022701|B1|||Age||years|Mean|34.5|34.5|Standard Deviation|8.09|8.09|||
4199237|NCT00753922|4022697|B5||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4199238|NCT00753922|4022698|B4||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4199239|NCT00753922|4022699|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4199240|NCT00753922|4022700|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4199241|NCT00753922|4022701|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4199242|NCT00753922|4022697|B5||Between 18 and 65 years|Age||Participants|Count of Participants|995|995.0||||||
4199243|NCT00753922|4022698|B4||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4199244|NCT00753922|4022699|B3||Between 18 and 65 years|Age||Participants|Count of Participants|145|145.0||||||
4199245|NCT00753922|4022700|B2||Between 18 and 65 years|Age||Participants|Count of Participants|245|245.0||||||
4199246|NCT00753922|4022701|B1||Between 18 and 65 years|Age||Participants|Count of Participants|551|551.0||||||
4199247|NCT00753922|4022697|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4199248|NCT00753922|4022698|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4199249|NCT00753922|4022699|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4199250|NCT00753922|4022700|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4199251|NCT00753922|4022701|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4199252|NCT00753896|4022734|B1|TZD||Background Oral Antidiabetic Agent||participants|Number|16|16.0||||||
4199253|NCT00753896|4022734|B1|Metformin + Thiazolidinedione (TZD)||Background Oral Antidiabetic Agent||participants|Number|118|118.0||||||
4199254|NCT00753896|4022734|B1|||Weight||kg|Mean|98.1|98.1|Standard Deviation|18.71|18.71|||
4199255|NCT00753896|4022734|B1|||Glycosylated hemoglobin (HbA1c)||percentage of total hemoglobin|Mean|7.2|7.2|Standard Deviation|0.95|0.95|||
4199256|NCT00753896|4022734|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4199257|NCT00753896|4022734|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4199258|NCT00753896|4022734|B1|||Age||years|Mean|55.0|55.0|Standard Deviation|9.74|9.74|||
4199259|NCT00753896|4022734|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4199260|NCT00753896|4022734|B1||Between 18 and 65 years|Age||Participants|Count of Participants|114|114.0||||||
4199261|NCT00753896|4022734|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4199262|NCT00753766|4022748|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4199263|NCT00753766|4022750|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4199264|NCT00753766|4022748|B3|Male||Gender||participants|Number|1|1.0||||||
4199265|NCT00753766|4022750|B1|Male||Gender||participants|Number|1|1.0||||||
4199266|NCT00753766|4022748|B3|Female||Gender||participants|Number|0|0.0||||||
4199267|NCT00753766|4022750|B1|Female||Gender||participants|Number|0|0.0||||||
4199268|NCT00753766|4022748|B3|>=65 years||Age||participants|Number|0|0.0||||||
4199269|NCT00753766|4022750|B1|>=65 years||Age||participants|Number|0|0.0||||||
4199270|NCT00753766|4022748|B3|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
4199271|NCT00753766|4022750|B1|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
4199272|NCT00753766|4022748|B3|<=18 years||Age||participants|Number|0|0.0||||||
4199273|NCT00753766|4022750|B1|<=18 years||Age||participants|Number|0|0.0||||||
4199274|NCT00753714|4022759|B3||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4199275|NCT00753714|4022760|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4199276|NCT00753714|4022761|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4199277|NCT00753714|4022759|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4199278|NCT00753714|4022760|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4199279|NCT00753714|4022761|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4199280|NCT00753714|4022759|B3|||Age||years|Mean|75.25|75.25|Standard Deviation|3.41|3.41|||
4199281|NCT00753714|4022760|B2|||Age||years|Mean|75.48|75.48|Standard Deviation|3.49|3.49|||
4199282|NCT00753714|4022761|B1|||Age||years|Mean|75.03|75.03|Standard Deviation|3.34|3.34|||
4199283|NCT00753688|4022776|B3|Other STS histologies||Number of participants in the indicated soft tissue sarcoma (STS) subgroups at Baseline|Participants were categorized in the following histology subgroups of STS (as per the World Health Organization [WHO] classification, 2008): leiomyosarcoma, defined as malignant cancer of smooth muscle; synovial sarcoma, defined as cancer near the joints of the arm or leg; and other STS, defined as sarcoma without the tumor type of leiomyosarcoma or synovial sarcoma.|participants|Number|173|173.0||||||
4199284|NCT00753688|4022777|B2|Other STS histologies||Number of participants in the indicated soft tissue sarcoma (STS) subgroups at Baseline|Participants were categorized in the following histology subgroups of STS (as per the World Health Organization [WHO] classification, 2008): leiomyosarcoma, defined as malignant cancer of smooth muscle; synovial sarcoma, defined as cancer near the joints of the arm or leg; and other STS, defined as sarcoma without the tumor type of leiomyosarcoma or synovial sarcoma.|participants|Number|112|112.0||||||
4199285|NCT00753688|4022778|B1|Other STS histologies||Number of participants in the indicated soft tissue sarcoma (STS) subgroups at Baseline|Participants were categorized in the following histology subgroups of STS (as per the World Health Organization [WHO] classification, 2008): leiomyosarcoma, defined as malignant cancer of smooth muscle; synovial sarcoma, defined as cancer near the joints of the arm or leg; and other STS, defined as sarcoma without the tumor type of leiomyosarcoma or synovial sarcoma.|participants|Number|61|61.0||||||
4199286|NCT00753688|4022776|B3|Synovial sarcoma||Number of participants in the indicated soft tissue sarcoma (STS) subgroups at Baseline|Participants were categorized in the following histology subgroups of STS (as per the World Health Organization [WHO] classification, 2008): leiomyosarcoma, defined as malignant cancer of smooth muscle; synovial sarcoma, defined as cancer near the joints of the arm or leg; and other STS, defined as sarcoma without the tumor type of leiomyosarcoma or synovial sarcoma.|participants|Number|38|38.0||||||
4199287|NCT00753688|4022777|B2|Synovial sarcoma||Number of participants in the indicated soft tissue sarcoma (STS) subgroups at Baseline|Participants were categorized in the following histology subgroups of STS (as per the World Health Organization [WHO] classification, 2008): leiomyosarcoma, defined as malignant cancer of smooth muscle; synovial sarcoma, defined as cancer near the joints of the arm or leg; and other STS, defined as sarcoma without the tumor type of leiomyosarcoma or synovial sarcoma.|participants|Number|25|25.0||||||
4199288|NCT00753688|4022778|B1|Synovial sarcoma||Number of participants in the indicated soft tissue sarcoma (STS) subgroups at Baseline|Participants were categorized in the following histology subgroups of STS (as per the World Health Organization [WHO] classification, 2008): leiomyosarcoma, defined as malignant cancer of smooth muscle; synovial sarcoma, defined as cancer near the joints of the arm or leg; and other STS, defined as sarcoma without the tumor type of leiomyosarcoma or synovial sarcoma.|participants|Number|13|13.0||||||
4199289|NCT00753688|4022776|B3|Leiomyosarcoma||Number of participants in the indicated soft tissue sarcoma (STS) subgroups at Baseline|Participants were categorized in the following histology subgroups of STS (as per the World Health Organization [WHO] classification, 2008): leiomyosarcoma, defined as malignant cancer of smooth muscle; synovial sarcoma, defined as cancer near the joints of the arm or leg; and other STS, defined as sarcoma without the tumor type of leiomyosarcoma or synovial sarcoma.|participants|Number|158|158.0||||||
4199290|NCT00753688|4022777|B2|Leiomyosarcoma||Number of participants in the indicated soft tissue sarcoma (STS) subgroups at Baseline|Participants were categorized in the following histology subgroups of STS (as per the World Health Organization [WHO] classification, 2008): leiomyosarcoma, defined as malignant cancer of smooth muscle; synovial sarcoma, defined as cancer near the joints of the arm or leg; and other STS, defined as sarcoma without the tumor type of leiomyosarcoma or synovial sarcoma.|participants|Number|109|109.0||||||
4199291|NCT00753688|4022778|B1|Leiomyosarcoma||Number of participants in the indicated soft tissue sarcoma (STS) subgroups at Baseline|Participants were categorized in the following histology subgroups of STS (as per the World Health Organization [WHO] classification, 2008): leiomyosarcoma, defined as malignant cancer of smooth muscle; synovial sarcoma, defined as cancer near the joints of the arm or leg; and other STS, defined as sarcoma without the tumor type of leiomyosarcoma or synovial sarcoma.|participants|Number|49|49.0||||||
4199292|NCT00753688|4022776|B3|Unknown||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4199293|NCT00753688|4022777|B2|Unknown||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4199294|NCT00753688|4022778|B1|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4199295|NCT00753688|4022776|B3|Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4199296|NCT00753688|4022777|B2|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4199297|NCT00753688|4022778|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4199298|NCT00753688|4022776|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|263|263.0||||||
4199299|NCT00753688|4022777|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|174|174.0||||||
4199300|NCT00753688|4022778|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|89|89.0||||||
4199301|NCT00753688|4022776|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4199302|NCT00753688|4022777|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4199303|NCT00753688|4022778|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4199304|NCT00753688|4022776|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4199305|NCT00753688|4022777|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4199306|NCT00753688|4022778|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4199307|NCT00753688|4022776|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4199308|NCT00753688|4022777|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4199309|NCT00753688|4022778|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4199310|NCT00753688|4022776|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4199311|NCT00753688|4022777|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4199312|NCT00753688|4022778|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4199313|NCT00753688|4022776|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4199314|NCT00753688|4022777|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4199315|NCT00753688|4022778|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4199316|NCT00753688|4022776|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4199317|NCT00753688|4022777|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4199318|NCT00753688|4022778|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4199319|NCT00753688|4022776|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4199320|NCT00753688|4022777|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4199321|NCT00753688|4022778|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4199322|NCT00753688|4022776|B3||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4199323|NCT00753688|4022777|B2||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4199324|NCT00753688|4022778|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4199325|NCT00753688|4022776|B3||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4199326|NCT00753688|4022777|B2||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4199327|NCT00753688|4022778|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4199328|NCT00753688|4022776|B3|||Age||Years|Mean|53.2|53.2|Standard Deviation|14.57|14.57|||
4199329|NCT00753688|4022777|B2|||Age||Years|Mean|54.0|54.0|Standard Deviation|14.92|14.92|||
4199330|NCT00753688|4022778|B1|||Age||Years|Mean|51.7|51.7|Standard Deviation|13.77|13.77|||
4199331|NCT00753675|4022805|B4||Male|Sex: Female, Male|Safety Population|Participants|Count of Participants|81|81.0||||||
4199332|NCT00753675|4022806|B3||Male|Sex: Female, Male|Safety Population|Participants|Count of Participants|25|25.0||||||
4199333|NCT00753675|4022807|B2||Male|Sex: Female, Male|Safety Population|Participants|Count of Participants|31|31.0||||||
4199334|NCT00753675|4022808|B1||Male|Sex: Female, Male|Safety Population|Participants|Count of Participants|25|25.0||||||
4199335|NCT00753675|4022805|B4||Female|Sex: Female, Male|Safety Population|Participants|Count of Participants|92|92.0||||||
4199336|NCT00753675|4022806|B3||Female|Sex: Female, Male|Safety Population|Participants|Count of Participants|31|31.0||||||
4199337|NCT00753675|4022807|B2||Female|Sex: Female, Male|Safety Population|Participants|Count of Participants|27|27.0||||||
4199338|NCT00753675|4022808|B1||Female|Sex: Female, Male|Safety Population|Participants|Count of Participants|34|34.0||||||
4199339|NCT00753675|4022805|B4|||Age|Safety Population|years|Mean|63.57|63.57|Standard Deviation|9.456|9.456|||
4199340|NCT00753675|4022806|B3|||Age|Safety Population|years|Mean|63.95|63.95|Standard Deviation|8.764|8.764|||
4199341|NCT00753675|4022807|B2|||Age|Safety Population|years|Mean|64.41|64.41|Standard Deviation|9.455|9.455|||
4199342|NCT00753675|4022808|B1|||Age|Safety Population|years|Mean|62.39|62.39|Standard Deviation|10.108|10.108|||
4199343|NCT00753649|4022830|B3||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4199344|NCT00753649|4022831|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4199345|NCT00753649|4022832|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4199346|NCT00753649|4022830|B3||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4199347|NCT00753649|4022831|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4199348|NCT00753649|4022832|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4199349|NCT00753649|4022830|B3|||Age||Weeks|Mean|9.25|9.25|Standard Deviation|1.34|1.34|||
4199350|NCT00753649|4022831|B2|||Age||Weeks|Mean|9.2|9.2|Standard Deviation|1.3|1.3|||
4199351|NCT00753649|4022832|B1|||Age||Weeks|Mean|9.3|9.3|Standard Deviation|1.38|1.38|||
4199352|NCT00753636|4022853|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4199353|NCT00753636|4022853|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4199354|NCT00753636|4022853|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4199355|NCT00753636|4022853|B1|||Age||years|Mean|58.87|58.87|Standard Deviation|8.23|8.23|||
4199356|NCT00753636|4022853|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4199357|NCT00753636|4022853|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4199358|NCT00753636|4022853|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4199359|NCT00753623|4022863|B3|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4199360|NCT00753623|4022864|B2|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4199361|NCT00753623|4022865|B1|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4199362|NCT00753623|4022863|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4199363|NCT00753623|4022864|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4199364|NCT00753623|4022865|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4199365|NCT00753623|4022863|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4199366|NCT00753623|4022864|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4199367|NCT00753623|4022865|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4199368|NCT00753623|4022863|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4199369|NCT00753623|4022864|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4199370|NCT00753623|4022865|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4199371|NCT00753623|4022863|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4199372|NCT00753623|4022864|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4199373|NCT00753623|4022865|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4199374|NCT00753623|4022863|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4199375|NCT00753623|4022864|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4199376|NCT00753623|4022865|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4199377|NCT00753545|4022872|B3|Partial response||Objective response|"Objective response to the last platinum containing regimen prior to enrolment on the study:~CR-Complete Response (defined as normal radiological findings and CA-125 within the normal range)~PR-Partial Response (defined as a RECIST PR and/or GCIG CA-125 response)"|Participants|Number|145|145.0||||||
4199378|NCT00753545|4022873|B2|Partial response||Objective response|"Objective response to the last platinum containing regimen prior to enrolment on the study:~CR-Complete Response (defined as normal radiological findings and CA-125 within the normal range)~PR-Partial Response (defined as a RECIST PR and/or GCIG CA-125 response)"|Participants|Number|66|66.0||||||
4199379|NCT00753545|4022874|B1|Partial response||Objective response|"Objective response to the last platinum containing regimen prior to enrolment on the study:~CR-Complete Response (defined as normal radiological findings and CA-125 within the normal range)~PR-Partial Response (defined as a RECIST PR and/or GCIG CA-125 response)"|Participants|Number|79|79.0||||||
4199380|NCT00753545|4022872|B3|Complete response||Objective response|"Objective response to the last platinum containing regimen prior to enrolment on the study:~CR-Complete Response (defined as normal radiological findings and CA-125 within the normal range)~PR-Partial Response (defined as a RECIST PR and/or GCIG CA-125 response)"|Participants|Number|120|120.0||||||
4199381|NCT00753545|4022873|B2|Complete response||Objective response|"Objective response to the last platinum containing regimen prior to enrolment on the study:~CR-Complete Response (defined as normal radiological findings and CA-125 within the normal range)~PR-Partial Response (defined as a RECIST PR and/or GCIG CA-125 response)"|Participants|Number|63|63.0||||||
4199382|NCT00753545|4022874|B1|Complete response||Objective response|"Objective response to the last platinum containing regimen prior to enrolment on the study:~CR-Complete Response (defined as normal radiological findings and CA-125 within the normal range)~PR-Partial Response (defined as a RECIST PR and/or GCIG CA-125 response)"|Participants|Number|57|57.0||||||
4199383|NCT00753545|4022872|B3|>12 months||Time to progression|The time to disease progression from the completion of the penultimate platinum containing therapy (last dose) prior to enrolment on the study.|participants|Number|158|158.0||||||
4199384|NCT00753545|4022873|B2|>12 months||Time to progression|The time to disease progression from the completion of the penultimate platinum containing therapy (last dose) prior to enrolment on the study.|participants|Number|75|75.0||||||
4199385|NCT00753545|4022874|B1|>12 months||Time to progression|The time to disease progression from the completion of the penultimate platinum containing therapy (last dose) prior to enrolment on the study.|participants|Number|83|83.0||||||
4199386|NCT00753545|4022872|B3|>6 to 12 months||Time to progression|The time to disease progression from the completion of the penultimate platinum containing therapy (last dose) prior to enrolment on the study.|participants|Number|107|107.0||||||
4199387|NCT00753545|4022873|B2|>6 to 12 months||Time to progression|The time to disease progression from the completion of the penultimate platinum containing therapy (last dose) prior to enrolment on the study.|participants|Number|54|54.0||||||
4199388|NCT00753545|4022874|B1|>6 to 12 months||Time to progression|The time to disease progression from the completion of the penultimate platinum containing therapy (last dose) prior to enrolment on the study.|participants|Number|53|53.0||||||
4199389|NCT00753545|4022872|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4199390|NCT00753545|4022873|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4199391|NCT00753545|4022874|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4199392|NCT00753545|4022872|B3||Female|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
4199393|NCT00753545|4022873|B2||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4199394|NCT00753545|4022874|B1||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4199395|NCT00753545|4022872|B3|||Age||years|Mean|58.7|58.7|Standard Deviation|10.43|10.43|||
4199396|NCT00753545|4022873|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|9.89|9.89|||
4199397|NCT00753545|4022874|B1|||Age||years|Mean|58.9|58.9|Standard Deviation|10.95|10.95|||
4199398|NCT00753519|4022911|B3|Absence of falls||Falls||participants|Number|25|25.0||||||
4199399|NCT00753519|4022912|B2|Absence of falls||Falls||participants|Number|13|13.0||||||
4199400|NCT00753519|4022913|B1|Absence of falls||Falls||participants|Number|12|12.0||||||
4199401|NCT00753519|4022911|B3|Presence of falls||Falls||participants|Number|1|1.0||||||
4199402|NCT00753519|4022912|B2|Presence of falls||Falls||participants|Number|0|0.0||||||
4199403|NCT00753519|4022913|B1|Presence of falls||Falls||participants|Number|1|1.0||||||
4199404|NCT00753519|4022911|B3|Absence of dyskinesias||Dyskinesias|Presence or absence of dyskinesias (diminished voluntary movements and the presence of involuntary movements).|participants|Number|15|15.0||||||
4199405|NCT00753519|4022912|B2|Absence of dyskinesias||Dyskinesias|Presence or absence of dyskinesias (diminished voluntary movements and the presence of involuntary movements).|participants|Number|11|11.0||||||
4199406|NCT00753519|4022913|B1|Absence of dyskinesias||Dyskinesias|Presence or absence of dyskinesias (diminished voluntary movements and the presence of involuntary movements).|participants|Number|4|4.0||||||
4199407|NCT00753519|4022911|B3|Presence of dyskinesias||Dyskinesias|Presence or absence of dyskinesias (diminished voluntary movements and the presence of involuntary movements).|participants|Number|11|11.0||||||
4199408|NCT00753519|4022912|B2|Presence of dyskinesias||Dyskinesias|Presence or absence of dyskinesias (diminished voluntary movements and the presence of involuntary movements).|participants|Number|2|2.0||||||
4199409|NCT00753519|4022913|B1|Presence of dyskinesias||Dyskinesias|Presence or absence of dyskinesias (diminished voluntary movements and the presence of involuntary movements).|participants|Number|9|9.0||||||
4199410|NCT00753519|4022911|B3|Absence of flucuations||Fluctuations||participants|Number|11|11.0||||||
4199411|NCT00753519|4022912|B2|Absence of flucuations||Fluctuations||participants|Number|9|9.0||||||
4199412|NCT00753519|4022913|B1|Absence of flucuations||Fluctuations||participants|Number|2|2.0||||||
4199413|NCT00753519|4022911|B3|Presence of fluctuations||Fluctuations||participants|Number|15|15.0||||||
4199414|NCT00753519|4022912|B2|Presence of fluctuations||Fluctuations||participants|Number|4|4.0||||||
4199415|NCT00753519|4022913|B1|Presence of fluctuations||Fluctuations||participants|Number|11|11.0||||||
4199416|NCT00753519|4022911|B3|Absence of gait freezing||Gait freezing||participants|Number|13|13.0||||||
4199417|NCT00753519|4022912|B2|Absence of gait freezing||Gait freezing||participants|Number|10|10.0||||||
4199418|NCT00753519|4022913|B1|Absence of gait freezing||Gait freezing||participants|Number|3|3.0||||||
4199419|NCT00753519|4022911|B3|Presence of gait freezing||Gait freezing||participants|Number|13|13.0||||||
4199420|NCT00753519|4022912|B2|Presence of gait freezing||Gait freezing||participants|Number|3|3.0||||||
4199421|NCT00753519|4022913|B1|Presence of gait freezing||Gait freezing||participants|Number|10|10.0||||||
4199422|NCT00753519|4022911|B3|Absence of tremor||Tremor||participants|Number|7|7.0||||||
4199423|NCT00753519|4022912|B2|Absence of tremor||Tremor||participants|Number|4|4.0||||||
4199424|NCT00753519|4022913|B1|Absence of tremor||Tremor||participants|Number|3|3.0||||||
4199425|NCT00753519|4022911|B3|Presence of tremor||Tremor||participants|Number|19|19.0||||||
4199426|NCT00753519|4022912|B2|Presence of tremor||Tremor||participants|Number|9|9.0||||||
4199427|NCT00753519|4022913|B1|Presence of tremor||Tremor||participants|Number|10|10.0||||||
4199428|NCT00753519|4022911|B3|||Total LED|Total levodopa equivalent dose|milligrams|Mean|956.6|956.6|Standard Deviation|565.7|565.7|||
4199429|NCT00753519|4022912|B2|||Total LED|Total levodopa equivalent dose|milligrams|Mean|732.3|732.3|Standard Deviation|344.8|344.8|||
4199430|NCT00753519|4022913|B1|||Total LED|Total levodopa equivalent dose|milligrams|Mean|1180.9|1180.9|Standard Deviation|662.4|662.4|||
4199431|NCT00753519|4022911|B3|||"Hoehn-Yahr off"|The Hoehn and Yahr scale is a system used to describe how the symptoms of Parkinson's disease progress. The scale ranges from 1-5 with 1 representing unilateral involvement with minimal or no functional disability and 5 representing confinement to bed or wheelchair unless aided. The Hoehn and Yahr measurement was taken while the subject was off dopaminergic medication for 12 hours or more (overnight).|units on a scale|Mean|2.90|2.9|Standard Deviation|0.32|0.32|||
4199432|NCT00753519|4022912|B2|||"Hoehn-Yahr off"|The Hoehn and Yahr scale is a system used to describe how the symptoms of Parkinson's disease progress. The scale ranges from 1-5 with 1 representing unilateral involvement with minimal or no functional disability and 5 representing confinement to bed or wheelchair unless aided. The Hoehn and Yahr measurement was taken while the subject was off dopaminergic medication for 12 hours or more (overnight).|units on a scale|Mean|2.9|2.9|Standard Deviation|0.2|0.2|||
4199433|NCT00753519|4022913|B1|||"Hoehn-Yahr off"|The Hoehn and Yahr scale is a system used to describe how the symptoms of Parkinson's disease progress. The scale ranges from 1-5 with 1 representing unilateral involvement with minimal or no functional disability and 5 representing confinement to bed or wheelchair unless aided. The Hoehn and Yahr measurement was taken while the subject was off dopaminergic medication for 12 hours or more (overnight).|units on a scale|Mean|3.0|3.0|Standard Deviation|0.4|0.4|||
4199434|NCT00753519|4022911|B3|||"Hoehn-Yahr on"|The Hoehn and Yahr scale is a system used to describe how the symptoms of Parkinson's disease progress. The scale ranges from 1-5 with 1 representing unilateral involvement with minimal or no functional disability and 5 representing confinement to bed or wheelchair unless aided. The Hoehn and Yahr measurement was taken while the subject was on dopaminergic medication.|units on a scale|Mean|2.52|2.52|Standard Deviation|0.17|0.17|||
4199491|NCT00753415|4022973|B5|||Age||Years|Mean|60.2|60.2|Standard Deviation|11.7|11.7|||
4199492|NCT00753415|4022974|B4|||Age||Years|Mean|58.8|58.8|Standard Deviation|11.7|11.7|||
4199493|NCT00753415|4022975|B3|||Age||Years|Mean|63.8|63.8|Standard Deviation|10.0|10.0|||
4199435|NCT00753519|4022912|B2|||"Hoehn-Yahr on"|The Hoehn and Yahr scale is a system used to describe how the symptoms of Parkinson's disease progress. The scale ranges from 1-5 with 1 representing unilateral involvement with minimal or no functional disability and 5 representing confinement to bed or wheelchair unless aided. The Hoehn and Yahr measurement was taken while the subject was on dopaminergic medication.|units on a scale|Mean|2.5|2.5|Standard Deviation|0.1|0.1|||
4199436|NCT00753519|4022913|B1|||"Hoehn-Yahr on"|The Hoehn and Yahr scale is a system used to describe how the symptoms of Parkinson's disease progress. The scale ranges from 1-5 with 1 representing unilateral involvement with minimal or no functional disability and 5 representing confinement to bed or wheelchair unless aided. The Hoehn and Yahr measurement was taken while the subject was on dopaminergic medication.|units on a scale|Mean|2.6|2.6|Standard Deviation|0.2|0.2|||
4199437|NCT00753519|4022911|B3|||Duration of disease||years|Mean|8.62|8.62|Standard Deviation|5.87|5.87|||
4199438|NCT00753519|4022912|B2|||Duration of disease||years|Mean|6.5|6.5|Standard Deviation|3.4|3.4|||
4199439|NCT00753519|4022913|B1|||Duration of disease||years|Mean|10.8|10.8|Standard Deviation|7.1|7.1|||
4199440|NCT00753519|4022911|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4199441|NCT00753519|4022912|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4199442|NCT00753519|4022913|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4199443|NCT00753519|4022911|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4199444|NCT00753519|4022912|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4199445|NCT00753519|4022913|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4199446|NCT00753519|4022911|B3|||Age||years|Mean|63.85|63.85|Standard Deviation|8.05|8.05|||
4199447|NCT00753519|4022912|B2|||Age||years|Mean|65.6|65.6|Standard Deviation|9.0|9.0|||
4199448|NCT00753519|4022913|B1|||Age||years|Mean|62.1|62.1|Standard Deviation|6.9|6.9|||
4199449|NCT00753506|4022934|B3|United States||Region of Enrollment||participants|Number|66|66.0||||||
4199450|NCT00753506|4022935|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4199451|NCT00753506|4022936|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4199452|NCT00753506|4022934|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4199453|NCT00753506|4022935|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4199454|NCT00753506|4022936|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4199455|NCT00753506|4022934|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4199456|NCT00753506|4022935|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4199457|NCT00753506|4022936|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4199458|NCT00753506|4022934|B3|||Age||years|Mean|47.3|47.3|Standard Deviation|9.3|9.3|||
4199459|NCT00753506|4022935|B2|||Age||years|Mean|49.2|49.2|Standard Deviation|9.2|9.2|||
4199460|NCT00753506|4022936|B1|||Age||years|Mean|45.4|45.4|Standard Deviation|9.0|9.0|||
4199461|NCT00753506|4022934|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4199462|NCT00753506|4022935|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4199463|NCT00753506|4022936|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4199464|NCT00753506|4022934|B3||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4199465|NCT00753506|4022935|B2||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4199466|NCT00753506|4022936|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4199467|NCT00753506|4022934|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4199468|NCT00753506|4022935|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4199469|NCT00753506|4022936|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4199470|NCT00753454|4022943|B1|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4199471|NCT00753454|4022943|B1|United States||Region of Enrollment||participants|Number|157|157.0||||||
4199472|NCT00753454|4022943|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4199473|NCT00753454|4022943|B1||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4199474|NCT00753454|4022943|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|12.8|12.8|||
4199475|NCT00753454|4022943|B1||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
4199476|NCT00753454|4022943|B1||Between 18 and 65 years|Age||Participants|Count of Participants|135|135.0||||||
4199477|NCT00753454|4022943|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4199478|NCT00753415|4022972|B6||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4199479|NCT00753415|4022973|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4199480|NCT00753415|4022974|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4199481|NCT00753415|4022975|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4199482|NCT00753415|4022976|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4199483|NCT00753415|4022977|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4199484|NCT00753415|4022972|B6||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4199485|NCT00753415|4022973|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4199486|NCT00753415|4022974|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4199487|NCT00753415|4022975|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4199488|NCT00753415|4022976|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4199489|NCT00753415|4022977|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4199490|NCT00753415|4022972|B6|||Age||Years|Mean|62.4|62.4|Standard Deviation|11.0|11.0|||
4199494|NCT00753415|4022976|B2|||Age||Years|Mean|70.0|70.0|Standard Deviation|6.2|6.2|||
4199495|NCT00753415|4022977|B1|||Age||Years|Mean|70.0|70.0|Standard Deviation|9.5|9.5|||
4199496|NCT00753363|4023028|B3|||Body Mass Index||kg/m2|Mean|34.1|34.1|Standard Deviation|5.6|5.6|||
4199497|NCT00753363|4023029|B2|||Body Mass Index||kg/m2|Mean|35.7|35.7|Standard Deviation|4.4|4.4|||
4199498|NCT00753363|4023030|B1|||Body Mass Index||kg/m2|Mean|32.4|32.4|Standard Deviation|6.0|6.0|||
4199499|NCT00753363|4023028|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4199500|NCT00753363|4023029|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4199501|NCT00753363|4023030|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4199502|NCT00753363|4023028|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4199503|NCT00753363|4023029|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4199504|NCT00753363|4023030|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4199505|NCT00753363|4023028|B3|Age||Age, Customized||years|Mean|61|61.0|Full Range|||45.0|81.0|
4199506|NCT00753363|4023029|B2|Age||Age, Customized||years|Mean|61|61.0|Full Range|||49.0|74.0|
4199507|NCT00753363|4023030|B1|Age||Age, Customized||years|Mean|62|62.0|Full Range|||45.0|81.0|
4199508|NCT00753337|4023041|B1|United States||Region of Enrollment||participants|Number|123|123.0||||||
4199509|NCT00753337|4023041|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4199510|NCT00753337|4023041|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4199511|NCT00753337|4023041|B1|Age||Age||years|Mean|65.5|65.5|Standard Deviation|10.6|10.6|||
4199512|NCT00753298|4023055|B3|Sweden||Region of Enrollment||participants|Number|28|28.0||||||
4199513|NCT00753298|4023056|B2|Sweden||Region of Enrollment||participants|Number|14|14.0||||||
4199514|NCT00753298|4023057|B1|Sweden||Region of Enrollment||participants|Number|14|14.0||||||
4199515|NCT00753298|4023055|B3|Italy||Region of Enrollment||participants|Number|44|44.0||||||
4199516|NCT00753298|4023056|B2|Italy||Region of Enrollment||participants|Number|23|23.0||||||
4199517|NCT00753298|4023057|B1|Italy||Region of Enrollment||participants|Number|21|21.0||||||
4199518|NCT00753298|4023055|B3|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4199519|NCT00753298|4023056|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4199520|NCT00753298|4023057|B1|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4199521|NCT00753298|4023055|B3|Netherlands||Region of Enrollment||participants|Number|44|44.0||||||
4199522|NCT00753298|4023056|B2|Netherlands||Region of Enrollment||participants|Number|22|22.0||||||
4199523|NCT00753298|4023057|B1|Netherlands||Region of Enrollment||participants|Number|22|22.0||||||
4199524|NCT00753298|4023055|B3|Germany||Region of Enrollment||participants|Number|42|42.0||||||
4199525|NCT00753298|4023056|B2|Germany||Region of Enrollment||participants|Number|20|20.0||||||
4199526|NCT00753298|4023057|B1|Germany||Region of Enrollment||participants|Number|22|22.0||||||
4199527|NCT00753298|4023055|B3|Austria||Region of Enrollment||participants|Number|34|34.0||||||
4199528|NCT00753298|4023056|B2|Austria||Region of Enrollment||participants|Number|18|18.0||||||
4199529|NCT00753298|4023057|B1|Austria||Region of Enrollment||participants|Number|16|16.0||||||
4199530|NCT00753298|4023055|B3||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4199531|NCT00753298|4023056|B2||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4199532|NCT00753298|4023057|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4199533|NCT00753298|4023055|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4199534|NCT00753298|4023056|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4199535|NCT00753298|4023057|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4199536|NCT00753298|4023055|B3|||Age||years|Mean|52|52.0|Standard Deviation|16.66|16.66|||
4199537|NCT00753298|4023056|B2|||Age||years|Mean|51.1|51.1|Standard Deviation|17.20|17.2|||
4199538|NCT00753298|4023057|B1|||Age||years|Mean|52.5|52.5|Standard Deviation|16.16|16.16|||
4199539|NCT00753298|4023055|B3||>=65 years|Age||Participants|Count of Participants|47|47.0||||||
4199540|NCT00753298|4023056|B2||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4199541|NCT00753298|4023057|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4199542|NCT00753298|4023055|B3||Between 18 and 65 years|Age||Participants|Count of Participants|148|148.0||||||
4199543|NCT00753298|4023056|B2||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
4199544|NCT00753298|4023057|B1||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
4199545|NCT00753298|4023055|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4199546|NCT00753298|4023056|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4199547|NCT00753298|4023057|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4199548|NCT00753272|4023074|B3||Male|Sex: Female, Male||Participants|Count of Participants|18724|18724.0||||||
4199549|NCT00753272|4023075|B2||Male|Sex: Female, Male||Participants|Count of Participants|9380|9380.0||||||
4199550|NCT00753272|4023076|B1||Male|Sex: Female, Male||Participants|Count of Participants|9344|9344.0||||||
4199551|NCT00753272|4023074|B3||Female|Sex: Female, Male||Participants|Count of Participants|24971|24971.0||||||
4199552|NCT00753272|4023075|B2||Female|Sex: Female, Male||Participants|Count of Participants|12422|12422.0||||||
4199553|NCT00753272|4023076|B1||Female|Sex: Female, Male||Participants|Count of Participants|12549|12549.0||||||
4199554|NCT00753272|4023074|B3|||Age||Years|Mean|73.5|73.5|Standard Deviation|6.13|6.13|||
4199555|NCT00753272|4023075|B2|||Age||Years|Mean|73.5|73.5|Standard Deviation|6.16|6.16|||
4199556|NCT00753272|4023076|B1|||Age||Years|Mean|73.5|73.5|Standard Deviation|6.09|6.09|||
4199557|NCT00753220|4023139|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4199558|NCT00753220|4023139|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4199559|NCT00753220|4023139|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4199560|NCT00753220|4023139|B1|||Age||years|Mean|72|72.0|Standard Deviation|10|10.0|||
4199561|NCT00753220|4023139|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4199562|NCT00753220|4023139|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4199563|NCT00753220|4023139|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4199564|NCT00753142|4023143|B4|United States||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
4199565|NCT00753142|4023144|B3|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4199566|NCT00753142|4023145|B2|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4199567|NCT00753142|4023146|B1|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4199568|NCT00753142|4023143|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199569|NCT00753142|4023144|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199570|NCT00753142|4023145|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199571|NCT00753142|4023146|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199572|NCT00753142|4023143|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199573|NCT00753142|4023144|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199574|NCT00753142|4023145|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199575|NCT00753142|4023146|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199576|NCT00753142|4023143|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199577|NCT00753142|4023144|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199578|NCT00753142|4023145|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199579|NCT00753142|4023146|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199580|NCT00753142|4023143|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4199581|NCT00753142|4023144|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4199582|NCT00753142|4023145|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4199583|NCT00753142|4023146|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4199584|NCT00753142|4023143|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199585|NCT00753142|4023144|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199586|NCT00753142|4023145|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199587|NCT00753142|4023146|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199588|NCT00753142|4023143|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199589|NCT00753142|4023144|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199590|NCT00753142|4023145|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199591|NCT00753142|4023146|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199592|NCT00753142|4023143|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199593|NCT00753142|4023144|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199594|NCT00753142|4023145|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199595|NCT00753142|4023146|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199596|NCT00753142|4023143|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4199597|NCT00753142|4023144|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4199598|NCT00753142|4023145|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4199599|NCT00753142|4023146|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4199600|NCT00753142|4023143|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4199601|NCT00753142|4023144|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4199602|NCT00753142|4023145|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4199603|NCT00753142|4023146|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4199604|NCT00753142|4023143|B4|||Age||years|Mean|44|44.0|Standard Deviation|9|9.0|||
4199605|NCT00753142|4023144|B3|||Age||years|Mean|40|40.0|Standard Deviation|9.3|9.3|||
4199606|NCT00753142|4023145|B2|||Age||years|Mean|49.7|49.7|Standard Deviation|8.1|8.1|||
4199607|NCT00753142|4023146|B1|||Age||years|Mean|42.8|42.8|Standard Deviation|10.6|10.6|||
4199608|NCT00753012|4023159|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4199609|NCT00753012|4023160|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4199610|NCT00753012|4023161|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4199611|NCT00753012|4023159|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4199612|NCT00753012|4023160|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4199613|NCT00753012|4023161|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4199614|NCT00753012|4023159|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4199615|NCT00753012|4023160|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4199616|NCT00753012|4023161|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4199617|NCT00753012|4023159|B3|||Age||years|Mean|41.00|41.0|Standard Deviation|13.05|13.05|||
4199618|NCT00753012|4023160|B2|||Age||years|Mean|51.33|51.33|Standard Deviation|7.87|7.87|||
4199619|NCT00753012|4023161|B1|||Age||years|Mean|34.80|34.8|Standard Deviation|11.59|11.59|||
4199620|NCT00753012|4023159|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4199621|NCT00753012|4023160|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4199622|NCT00753012|4023161|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4199623|NCT00753012|4023159|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4199624|NCT00753012|4023160|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4199625|NCT00753012|4023161|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4199626|NCT00753012|4023159|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4199627|NCT00753012|4023160|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4199628|NCT00753012|4023161|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4199629|NCT00752986|4023172|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4199630|NCT00752986|4023173|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4199631|NCT00752986|4023174|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4199632|NCT00752986|4023175|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4199633|NCT00752986|4023172|B4||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4199634|NCT00752986|4023173|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4199635|NCT00752986|4023174|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4199636|NCT00752986|4023175|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4199637|NCT00752986|4023172|B4|||Age||years|Mean|61.3|61.3|Full Range|||43.0|79.0|
4199638|NCT00752986|4023173|B3|||Age||years|Mean|59.6|59.6|Full Range|||43.0|74.0|
4199639|NCT00752986|4023174|B2|||Age||years|Mean|59.8|59.8|Full Range|||48.0|79.0|
4199640|NCT00752986|4023175|B1|||Age||years|Mean|63.6|63.6|Full Range|||44.0|78.0|
4199641|NCT00752973|4023194|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4199642|NCT00752973|4023194|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4199643|NCT00752973|4023194|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4199644|NCT00752973|4023194|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199645|NCT00752973|4023194|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199646|NCT00752973|4023194|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199647|NCT00752973|4023194|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199648|NCT00752973|4023194|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4199649|NCT00752973|4023194|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4199650|NCT00752973|4023194|B1|||Age||months|Mean|17.5|17.5|Standard Deviation|4.64|4.64|||
4199651|NCT00752895|4023204|B3|United States||Region of Enrollment||participants|Number|293|293.0||||||
4199652|NCT00752895|4023205|B2|United States||Region of Enrollment||participants|Number|146|146.0||||||
4199653|NCT00752895|4023206|B1|United States||Region of Enrollment||participants|Number|147|147.0||||||
4199654|NCT00752895|4023204|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4199655|NCT00752895|4023205|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4199656|NCT00752895|4023206|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199657|NCT00752895|4023204|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199658|NCT00752895|4023205|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199659|NCT00752895|4023206|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199660|NCT00752895|4023204|B3||White|Race (NIH/OMB)||Participants|Count of Participants|286|286.0||||||
4199661|NCT00752895|4023205|B2||White|Race (NIH/OMB)||Participants|Count of Participants|141|141.0||||||
4199662|NCT00752895|4023206|B1||White|Race (NIH/OMB)||Participants|Count of Participants|145|145.0||||||
4199663|NCT00752895|4023204|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4199664|NCT00752895|4023205|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4199665|NCT00752895|4023206|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4199666|NCT00752895|4023204|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199667|NCT00752895|4023205|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199668|NCT00752895|4023206|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199669|NCT00752895|4023204|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4199670|NCT00752895|4023205|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4199671|NCT00752895|4023206|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199672|NCT00752895|4023204|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199673|NCT00752895|4023205|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199674|NCT00752895|4023206|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199734|NCT00752622|4023253|B1|Female||Sex/Gender, Customized||participants|Number|54|54.0||||||
4199675|NCT00752895|4023204|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199676|NCT00752895|4023205|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199677|NCT00752895|4023206|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199678|NCT00752895|4023204|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|291|291.0||||||
4199679|NCT00752895|4023205|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
4199680|NCT00752895|4023206|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|147|147.0||||||
4199681|NCT00752895|4023204|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4199682|NCT00752895|4023205|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4199683|NCT00752895|4023206|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199684|NCT00752895|4023204|B3||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4199685|NCT00752895|4023205|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4199686|NCT00752895|4023206|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4199687|NCT00752895|4023204|B3||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4199688|NCT00752895|4023205|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4199689|NCT00752895|4023206|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4199690|NCT00752895|4023204|B3|||Age||years|Median|65|65.0|Full Range|||43.0|87.0|
4199691|NCT00752895|4023205|B2|||Age||years|Median|66|66.0|Full Range|||44.0|82.0|
4199692|NCT00752895|4023206|B1|||Age||years|Median|65|65.0|Full Range|||43.0|87.0|
4199693|NCT00752895|4023204|B3||>=65 years|Age||Participants|Count of Participants|158|158.0||||||
4199694|NCT00752895|4023205|B2||>=65 years|Age||Participants|Count of Participants|82|82.0||||||
4199695|NCT00752895|4023206|B1||>=65 years|Age||Participants|Count of Participants|76|76.0||||||
4199696|NCT00752895|4023204|B3||Between 18 and 65 years|Age||Participants|Count of Participants|135|135.0||||||
4199697|NCT00752895|4023205|B2||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4199698|NCT00752895|4023206|B1||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4199699|NCT00752895|4023204|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4199700|NCT00752895|4023205|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4199701|NCT00752895|4023206|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4199702|NCT00752791|4023215|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4199703|NCT00752791|4023215|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4199704|NCT00752791|4023215|B1|≥75 years||Age, Customized||participants|Number|7|7.0||||||
4199705|NCT00752791|4023215|B1|≥65 to <75 years||Age, Customized||participants|Number|10|10.0||||||
4199706|NCT00752791|4023215|B1|<65 years||Age, Customized||participants|Number|42|42.0||||||
4199707|NCT00752791|4023215|B1|||Age||years|Mean|54.0|54.0|Standard Deviation|15.99|15.99|||
4199708|NCT00752726|4023225|B3|||Visceral Abdominal Tissue (VAT) Mass||kg|Mean|3.83|3.83|Standard Deviation|1.832|1.832|||
4199709|NCT00752726|4023226|B2|||Visceral Abdominal Tissue (VAT) Mass||kg|Mean|3.92|3.92|Standard Deviation|1.806|1.806|||
4199710|NCT00752726|4023227|B1|||Visceral Abdominal Tissue (VAT) Mass||kg|Mean|3.75|3.75|Standard Deviation|1.870|1.87|||
4199711|NCT00752726|4023225|B3|||Waist Circumference||cm|Mean|100.35|100.35|Standard Deviation|7.427|7.427|||
4199712|NCT00752726|4023226|B2|||Waist Circumference||cm|Mean|100.60|100.6|Standard Deviation|6.892|6.892|||
4199713|NCT00752726|4023227|B1|||Waist Circumference||cm|Mean|100.10|100.1|Standard Deviation|7.967|7.967|||
4199714|NCT00752726|4023225|B3|||Body Mass Index (BMI)||Kilogram per meter square (kg/m^2)|Mean|31.03|31.03|Standard Deviation|2.155|2.155|||
4199715|NCT00752726|4023226|B2|||Body Mass Index (BMI)||Kilogram per meter square (kg/m^2)|Mean|31.04|31.04|Standard Deviation|2.064|2.064|||
4199716|NCT00752726|4023227|B1|||Body Mass Index (BMI)||Kilogram per meter square (kg/m^2)|Mean|31.03|31.03|Standard Deviation|2.259|2.259|||
4199717|NCT00752726|4023225|B3|||Height||Centimeter (cm)|Mean|168.19|168.19|Standard Deviation|8.164|8.164|||
4199718|NCT00752726|4023226|B2|||Height||Centimeter (cm)|Mean|168.08|168.08|Standard Deviation|8.117|8.117|||
4199719|NCT00752726|4023227|B1|||Height||Centimeter (cm)|Mean|168.30|168.3|Standard Deviation|8.275|8.275|||
4199720|NCT00752726|4023225|B3|||Body Weight||Kilogram (kg)|Mean|87.95|87.95|Standard Deviation|10.018|10.018|||
4199721|NCT00752726|4023226|B2|||Body Weight||Kilogram (kg)|Mean|87.79|87.79|Standard Deviation|9.354|9.354|||
4199722|NCT00752726|4023227|B1|||Body Weight||Kilogram (kg)|Mean|88.10|88.1|Standard Deviation|10.705|10.705|||
4199723|NCT00752726|4023225|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4199724|NCT00752726|4023226|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4199725|NCT00752726|4023227|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4199726|NCT00752726|4023225|B3||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4199727|NCT00752726|4023226|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4199728|NCT00752726|4023227|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4199729|NCT00752726|4023225|B3|||Age||Year|Mean|43.37|43.37|Standard Deviation|10.397|10.397|||
4199730|NCT00752726|4023226|B2|||Age||Year|Mean|43.84|43.84|Standard Deviation|11.682|11.682|||
4199731|NCT00752726|4023227|B1|||Age||Year|Mean|42.92|42.92|Standard Deviation|9.031|9.031|||
4199732|NCT00752622|4023253|B1|Excluded from analysis||Sex/Gender, Customized||participants|Number|2|2.0||||||
4199733|NCT00752622|4023253|B1|Male||Sex/Gender, Customized||participants|Number|44|44.0||||||
4199735|NCT00752622|4023253|B1|||Age|The mean age at baseline within the population of all eligible (ELIG) participants (Overall= 98).|years|Mean|38.4|38.4|Standard Deviation|13.16|13.16|||
4199736|NCT00752609|4023264|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4199737|NCT00752609|4023265|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4199738|NCT00752609|4023266|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4199739|NCT00752609|4023264|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4199740|NCT00752609|4023265|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4199741|NCT00752609|4023266|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4199742|NCT00752609|4023264|B3|≥ 75||Age, Customized||participants|Number|35|35.0||||||
4199743|NCT00752609|4023265|B2|≥ 75||Age, Customized||participants|Number|18|18.0||||||
4199744|NCT00752609|4023266|B1|≥ 75||Age, Customized||participants|Number|17|17.0||||||
4199745|NCT00752609|4023264|B3|≥65 - <75 years||Age, Customized||participants|Number|26|26.0||||||
4199746|NCT00752609|4023265|B2|≥65 - <75 years||Age, Customized||participants|Number|13|13.0||||||
4199747|NCT00752609|4023266|B1|≥65 - <75 years||Age, Customized||participants|Number|13|13.0||||||
4199748|NCT00752609|4023264|B3|< 65 years||Age, Customized||participants|Number|40|40.0||||||
4199749|NCT00752609|4023265|B2|< 65 years||Age, Customized||participants|Number|18|18.0||||||
4199750|NCT00752609|4023266|B1|< 65 years||Age, Customized||participants|Number|22|22.0||||||
4199751|NCT00752609|4023264|B3|||Age|Baseline characteristics are reported for the Full Analysis Set.|years|Mean|67.5|67.5|Standard Deviation|12.33|12.33|||
4199752|NCT00752609|4023265|B2|||Age|Baseline characteristics are reported for the Full Analysis Set.|years|Mean|68.6|68.6|Standard Deviation|12.07|12.07|||
4199753|NCT00752609|4023266|B1|||Age|Baseline characteristics are reported for the Full Analysis Set.|years|Mean|66.4|66.4|Standard Deviation|12.60|12.6|||
4199754|NCT00752232|4023286|B8||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4199755|NCT00752232|4023287|B7||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4199756|NCT00752232|4023288|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4199757|NCT00752232|4023289|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4199758|NCT00752232|4023290|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4199759|NCT00752232|4023291|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4199760|NCT00752232|4023292|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4199761|NCT00752232|4023293|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4199762|NCT00752232|4023286|B8||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4199763|NCT00752232|4023287|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4199764|NCT00752232|4023288|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4199765|NCT00752232|4023289|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4199766|NCT00752232|4023290|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4199767|NCT00752232|4023291|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4199768|NCT00752232|4023292|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4199769|NCT00752232|4023293|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4199770|NCT00752232|4023286|B8|||Age||Years|Mean|69.50|69.5|Standard Deviation|7.68|7.68|||
4199771|NCT00752232|4023287|B7|||Age||Years|Mean|69.50|69.5|Standard Deviation|4.80|4.8|||
4199772|NCT00752232|4023288|B6|||Age||Years|Mean|67.00|67.0|Standard Deviation|9.19|9.19|||
4199773|NCT00752232|4023289|B5|||Age||Years|Mean|66.00|66.0|Standard Deviation|10.79|10.79|||
4199774|NCT00752232|4023290|B4|||Age||Years|Mean|70.17|70.17|Standard Deviation|3.13|3.13|||
4199775|NCT00752232|4023291|B3|||Age||Years|Mean|73.00|73.0|Standard Deviation|7.67|7.67|||
4199776|NCT00752232|4023292|B2|||Age||Years|Mean|69.50|69.5|Standard Deviation|6.92|6.92|||
4199777|NCT00752232|4023293|B1|||Age||Years|Mean|71.33|71.33|Standard Deviation|9.35|9.35|||
4199778|NCT00752219|4023371|B3||Male|Sex: Female, Male|Gender at informed consent|Participants|Count of Participants|151|151.0||||||
4199779|NCT00752219|4023372|B2||Male|Sex: Female, Male|Gender at informed consent|Participants|Count of Participants|81|81.0||||||
4199780|NCT00752219|4023373|B1||Male|Sex: Female, Male|Gender at informed consent|Participants|Count of Participants|70|70.0||||||
4199781|NCT00752219|4023371|B3||Female|Sex: Female, Male|Gender at informed consent|Participants|Count of Participants|52|52.0||||||
4199782|NCT00752219|4023372|B2||Female|Sex: Female, Male|Gender at informed consent|Participants|Count of Participants|21|21.0||||||
4199783|NCT00752219|4023373|B1||Female|Sex: Female, Male|Gender at informed consent|Participants|Count of Participants|31|31.0||||||
4199784|NCT00752219|4023371|B3|||Age|Age at informed consent|years|Mean|42.8|42.8|Standard Deviation|17.01|17.01|||
4199785|NCT00752219|4023372|B2|||Age|Age at informed consent|years|Mean|42.6|42.6|Standard Deviation|18.09|18.09|||
4199786|NCT00752219|4023373|B1|||Age|Age at informed consent|years|Mean|43.0|43.0|Standard Deviation|15.93|15.93|||
4199787|NCT00752128|4023398|B1|South Africa||Region of Enrollment||participants|Number|40|40.0||||||
4199788|NCT00752128|4023398|B1|Argentina||Region of Enrollment||participants|Number|17|17.0||||||
4199789|NCT00752128|4023398|B1|India||Region of Enrollment||participants|Number|174|174.0||||||
4199790|NCT00752128|4023398|B1|Europe||Region of Enrollment||participants|Number|2118|2118.0||||||
4199791|NCT00752128|4023398|B1||Male|Sex: Female, Male||Participants|Count of Participants|1828|1828.0||||||
4199792|NCT00752128|4023398|B1||Female|Sex: Female, Male||Participants|Count of Participants|521|521.0||||||
4199793|NCT00752128|4023398|B1|||Age||years|Mean|63.5|63.5|Standard Deviation|11.2|11.2|||
4199794|NCT00752128|4023398|B1||>=65 years|Age||Participants|Count of Participants|1089|1089.0||||||
4199795|NCT00752128|4023398|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1260|1260.0||||||
4199796|NCT00752128|4023398|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4199797|NCT00752102|4023403|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
4199798|NCT00752102|4023404|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4199799|NCT00752102|4023405|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4199800|NCT00752102|4023403|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199801|NCT00752102|4023404|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199802|NCT00752102|4023405|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199803|NCT00752102|4023403|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199804|NCT00752102|4023404|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199805|NCT00752102|4023405|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199806|NCT00752102|4023403|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4199807|NCT00752102|4023404|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4199808|NCT00752102|4023405|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4199809|NCT00752102|4023403|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4199810|NCT00752102|4023404|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4199811|NCT00752102|4023405|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4199812|NCT00752102|4023403|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199813|NCT00752102|4023404|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199814|NCT00752102|4023405|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199815|NCT00752102|4023403|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199816|NCT00752102|4023404|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199817|NCT00752102|4023405|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199818|NCT00752102|4023403|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199819|NCT00752102|4023404|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199820|NCT00752102|4023405|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4199821|NCT00752102|4023403|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4199822|NCT00752102|4023404|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4199823|NCT00752102|4023405|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4199824|NCT00752102|4023403|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4199825|NCT00752102|4023404|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4199826|NCT00752102|4023405|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4199827|NCT00752102|4023403|B3|||Age||years|Geometric Mean|65.6|65.6|Standard Deviation|9.3|9.3|||
4199828|NCT00752102|4023404|B2|||Age||years|Geometric Mean|65.5|65.5|Standard Deviation|11|11.0|||
4199829|NCT00752102|4023405|B1|||Age||years|Geometric Mean|65.8|65.8|Standard Deviation|7.4|7.4|||
4199830|NCT00752089|4023412|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4199831|NCT00752089|4023412|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4199832|NCT00752089|4023412|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4199833|NCT00752089|4023412|B1|||Age||years|Mean|65.31|65.31|Standard Deviation|8.226|8.226|||
4199834|NCT00751998|4023426|B1|Italy||Region of Enrollment||participants|Number|11|11.0||||||
4199835|NCT00751998|4023426|B1|Germany||Region of Enrollment||participants|Number|26|26.0||||||
4199836|NCT00751998|4023426|B1|Denmark||Region of Enrollment||participants|Number|10|10.0||||||
4199837|NCT00751998|4023426|B1|Belgium||Region of Enrollment||participants|Number|11|11.0||||||
4199838|NCT00751998|4023426|B1|United States||Region of Enrollment||participants|Number|224|224.0||||||
4199839|NCT00751998|4023426|B1|France||Region of Enrollment||participants|Number|15|15.0||||||
4199840|NCT00751998|4023426|B1||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4199841|NCT00751998|4023426|B1||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4199842|NCT00751998|4023426|B1|||Age||years|Mean|62.9|62.9|Standard Deviation|16.2|16.2|||
4199843|NCT00751998|4023426|B1||>=65 years|Age||Participants|Count of Participants|140|140.0||||||
4199844|NCT00751998|4023426|B1||Between 18 and 65 years|Age||Participants|Count of Participants|157|157.0||||||
4199845|NCT00751998|4023426|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4199846|NCT00751972|4023430|B3|||Serum creatinine||µmol/L|Mean|120.2|120.2|Standard Deviation|47.9|47.9|||
4199847|NCT00751972|4023431|B2|||Serum creatinine||µmol/L|Mean|121.9|121.9|Standard Deviation|50|50.0|||
4199848|NCT00751972|4023432|B1|||Serum creatinine||µmol/L|Mean|114.1|114.1|Standard Deviation|39.1|39.1|||
4199849|NCT00751972|4023430|B3|||Right Atrial Pressure (RAP)||mmHg|Mean|11.84|11.84|Standard Deviation|6.82|6.82|||
4199850|NCT00751972|4023431|B2|||Right Atrial Pressure (RAP)||mmHg|Mean|11.91|11.91|Standard Deviation|6.79|6.79|||
4199851|NCT00751972|4023432|B1|||Right Atrial Pressure (RAP)||mmHg|Mean|11.14|11.14|Standard Deviation|7.18|7.18|||
4199852|NCT00751972|4023430|B3|||Blood Urea Nitrogen (BUN)||mmol/L|Mean|10.06|10.06|Standard Deviation|7.01|7.01|||
4199853|NCT00751972|4023431|B2|||Blood Urea Nitrogen (BUN)||mmol/L|Mean|10.32|10.32|Standard Deviation|7.48|7.48|||
4199854|NCT00751972|4023432|B1|||Blood Urea Nitrogen (BUN)||mmol/L|Mean|9.12|9.12|Standard Deviation|4.92|4.92|||
4199855|NCT00751972|4023430|B3|||Body Surface Area (BSA)||m^2|Mean|2.07|2.07|Standard Deviation|0.29|0.29|||
4199856|NCT00751972|4023431|B2|||Body Surface Area (BSA)||m^2|Mean|2.07|2.07|Standard Deviation|0.3|0.3|||
4199857|NCT00751972|4023432|B1|||Body Surface Area (BSA)||m^2|Mean|2.06|2.06|Standard Deviation|0.28|0.28|||
4199858|NCT00751972|4023430|B3|United States||Region of Enrollment||participants|Number|639|639.0||||||
4199859|NCT00751972|4023431|B2|United States||Region of Enrollment||participants|Number|499|499.0||||||
4199860|NCT00751972|4023432|B1|United States||Region of Enrollment||participants|Number|140|140.0||||||
4199861|NCT00751972|4023430|B3||Male|Sex: Female, Male||Participants|Count of Participants|480|480.0||||||
4199862|NCT00751972|4023431|B2||Male|Sex: Female, Male||Participants|Count of Participants|379|379.0||||||
4199863|NCT00751972|4023432|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4199864|NCT00751972|4023430|B3||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4199865|NCT00751972|4023431|B2||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4199866|NCT00751972|4023432|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4199867|NCT00751972|4023430|B3|||Age||years|Mean|52.2|52.2|Standard Deviation|13.1|13.1|||
4199868|NCT00751972|4023431|B2|||Age||years|Mean|52.2|52.2|Standard Deviation|12.2|12.2|||
4199869|NCT00751972|4023432|B1|||Age||years|Mean|53.3|53.3|Standard Deviation|10.3|10.3|||
4199870|NCT00751933|4023445|B1|Norway||Region of Enrollment||participants|Number|3|3.0||||||
4199871|NCT00751933|4023445|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4199872|NCT00751933|4023445|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4199873|NCT00751933|4023445|B1|||Age||years|Mean|32|32.0|Full Range|||24.0|41.0|
4199874|NCT00751933|4023445|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4199875|NCT00751933|4023445|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4199876|NCT00751933|4023445|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4199877|NCT00751881|4023453|B4|>3.5||Baseline EDSS score|"EDSS is an ordinal scale in half-point increments that qualifies disability in participants with MS. It consists of 8 ordinal rating scales assessing 7 functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation.~EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS)."|participants|Number|298|298.0||||||
4199878|NCT00751881|4023454|B3|>3.5||Baseline EDSS score|"EDSS is an ordinal scale in half-point increments that qualifies disability in participants with MS. It consists of 8 ordinal rating scales assessing 7 functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation.~EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS)."|participants|Number|96|96.0||||||
4199879|NCT00751881|4023455|B2|>3.5||Baseline EDSS score|"EDSS is an ordinal scale in half-point increments that qualifies disability in participants with MS. It consists of 8 ordinal rating scales assessing 7 functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation.~EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS)."|participants|Number|107|107.0||||||
4199880|NCT00751881|4023456|B1|>3.5||Baseline EDSS score|"EDSS is an ordinal scale in half-point increments that qualifies disability in participants with MS. It consists of 8 ordinal rating scales assessing 7 functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation.~EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS)."|participants|Number|95|95.0||||||
4199881|NCT00751881|4023453|B4|≤3.5||Baseline EDSS score|"EDSS is an ordinal scale in half-point increments that qualifies disability in participants with MS. It consists of 8 ordinal rating scales assessing 7 functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation.~EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS)."|participants|Number|871|871.0||||||
4199882|NCT00751881|4023454|B3|≤3.5||Baseline EDSS score|"EDSS is an ordinal scale in half-point increments that qualifies disability in participants with MS. It consists of 8 ordinal rating scales assessing 7 functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation.~EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS)."|participants|Number|276|276.0||||||
4199883|NCT00751881|4023455|B2|≤3.5||Baseline EDSS score|"EDSS is an ordinal scale in half-point increments that qualifies disability in participants with MS. It consists of 8 ordinal rating scales assessing 7 functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation.~EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS)."|participants|Number|301|301.0||||||
4199884|NCT00751881|4023456|B1|≤3.5||Baseline EDSS score|"EDSS is an ordinal scale in half-point increments that qualifies disability in participants with MS. It consists of 8 ordinal rating scales assessing 7 functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation.~EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS)."|participants|Number|294|294.0||||||
4199885|NCT00751881|4023453|B4|Information not available||MS subtype||participants|Number|2|2.0||||||
4199886|NCT00751881|4023454|B3|Information not available||MS subtype||participants|Number|2|2.0||||||
4199887|NCT00751881|4023455|B2|Information not available||MS subtype||participants|Number|0|0.0||||||
4199888|NCT00751881|4023456|B1|Information not available||MS subtype||participants|Number|0|0.0||||||
4199889|NCT00751881|4023453|B4|Progressive Relapsing||MS subtype||participants|Number|20|20.0||||||
4199890|NCT00751881|4023454|B3|Progressive Relapsing||MS subtype||participants|Number|2|2.0||||||
4199891|NCT00751881|4023455|B2|Progressive Relapsing||MS subtype||participants|Number|12|12.0||||||
4199892|NCT00751881|4023456|B1|Progressive Relapsing||MS subtype||participants|Number|6|6.0||||||
4199893|NCT00751881|4023453|B4|Secondary Progressive||MS subtype||participants|Number|9|9.0||||||
4199894|NCT00751881|4023454|B3|Secondary Progressive||MS subtype||participants|Number|2|2.0||||||
4199895|NCT00751881|4023455|B2|Secondary Progressive||MS subtype||participants|Number|3|3.0||||||
4199896|NCT00751881|4023456|B1|Secondary Progressive||MS subtype||participants|Number|4|4.0||||||
4199897|NCT00751881|4023453|B4|Relapsing Remitting||MS subtype||participants|Number|1138|1138.0||||||
4199898|NCT00751881|4023454|B3|Relapsing Remitting||MS subtype||participants|Number|366|366.0||||||
4199899|NCT00751881|4023455|B2|Relapsing Remitting||MS subtype||participants|Number|393|393.0||||||
4199900|NCT00751881|4023456|B1|Relapsing Remitting||MS subtype||participants|Number|379|379.0||||||
4199901|NCT00751881|4023453|B4|||Time since most recent MS relapse onset|The information was not available for one participant in the teriflunomide 14 mg group.|months|Mean|5.26|5.26|Standard Deviation|3.38|3.38|||
4199902|NCT00751881|4023454|B3|||Time since most recent MS relapse onset|The information was not available for one participant in the teriflunomide 14 mg group.|months|Mean|5.33|5.33|Standard Deviation|3.32|3.32|||
4199903|NCT00751881|4023455|B2|||Time since most recent MS relapse onset|The information was not available for one participant in the teriflunomide 14 mg group.|months|Mean|5.18|5.18|Standard Deviation|3.41|3.41|||
4199904|NCT00751881|4023456|B1|||Time since most recent MS relapse onset|The information was not available for one participant in the teriflunomide 14 mg group.|months|Mean|5.29|5.29|Standard Deviation|3.41|3.41|||
4199905|NCT00751881|4023453|B4|Within the past 2 years||Number of MS relapses|"The information was not available for:~'Within the past year': 1 participant in the placebo group and 1 participant in the teriflunomide 14 mg group~'Within the past 2 years': 2 participants in the teriflunomide 14 mg group"|relapses|Median|2|2.0|Full Range|||1.0|9.0|
4199906|NCT00751881|4023454|B3|Within the past 2 years||Number of MS relapses|"The information was not available for:~'Within the past year': 1 participant in the placebo group and 1 participant in the teriflunomide 14 mg group~'Within the past 2 years': 2 participants in the teriflunomide 14 mg group"|relapses|Median|2|2.0|Full Range|||1.0|9.0|
4199907|NCT00751881|4023455|B2|Within the past 2 years||Number of MS relapses|"The information was not available for:~'Within the past year': 1 participant in the placebo group and 1 participant in the teriflunomide 14 mg group~'Within the past 2 years': 2 participants in the teriflunomide 14 mg group"|relapses|Median|2|2.0|Full Range|||1.0|8.0|
4199908|NCT00751881|4023456|B1|Within the past 2 years||Number of MS relapses|"The information was not available for:~'Within the past year': 1 participant in the placebo group and 1 participant in the teriflunomide 14 mg group~'Within the past 2 years': 2 participants in the teriflunomide 14 mg group"|relapses|Median|2|2.0|Full Range|||1.0|8.0|
4199909|NCT00751881|4023453|B4|Within the past year||Number of MS relapses|"The information was not available for:~'Within the past year': 1 participant in the placebo group and 1 participant in the teriflunomide 14 mg group~'Within the past 2 years': 2 participants in the teriflunomide 14 mg group"|relapses|Median|1|1.0|Full Range|||0.0|7.0|
4199910|NCT00751881|4023454|B3|Within the past year||Number of MS relapses|"The information was not available for:~'Within the past year': 1 participant in the placebo group and 1 participant in the teriflunomide 14 mg group~'Within the past 2 years': 2 participants in the teriflunomide 14 mg group"|relapses|Median|1|1.0|Full Range|||0.0|5.0|
4199911|NCT00751881|4023455|B2|Within the past year||Number of MS relapses|"The information was not available for:~'Within the past year': 1 participant in the placebo group and 1 participant in the teriflunomide 14 mg group~'Within the past 2 years': 2 participants in the teriflunomide 14 mg group"|relapses|Median|1|1.0|Full Range|||0.0|5.0|
4199912|NCT00751881|4023456|B1|Within the past year||Number of MS relapses|"The information was not available for:~'Within the past year': 1 participant in the placebo group and 1 participant in the teriflunomide 14 mg group~'Within the past 2 years': 2 participants in the teriflunomide 14 mg group"|relapses|Median|1|1.0|Full Range|||0.0|7.0|
4199913|NCT00751881|4023453|B4|||Time since first diagnosis of Multiple Sclerosis (MS)|The information was not available for one participant in the teriflunomide 14 mg group|years|Mean|5.16|5.16|Standard Deviation|5.66|5.66|||
4199914|NCT00751881|4023454|B3|||Time since first diagnosis of Multiple Sclerosis (MS)|The information was not available for one participant in the teriflunomide 14 mg group|years|Mean|5.27|5.27|Standard Deviation|5.90|5.9|||
4199915|NCT00751881|4023455|B2|||Time since first diagnosis of Multiple Sclerosis (MS)|The information was not available for one participant in the teriflunomide 14 mg group|years|Mean|5.30|5.3|Standard Deviation|5.45|5.45|||
4199916|NCT00751881|4023456|B1|||Time since first diagnosis of Multiple Sclerosis (MS)|The information was not available for one participant in the teriflunomide 14 mg group|years|Mean|4.92|4.92|Standard Deviation|5.66|5.66|||
4199917|NCT00751881|4023453|B4|America||Region of Enrollment|"Due to the small sample size in some countries, the countries were pooled as follows:~Eastern Europe: Belarus, Czech Republic, Estonia, Greece, Poland, Romania, Slovakia and Ukraine~Western Europe and Africa: Austria, Belgium, France, Germany, Netherlands, Spain, Sweden and United Kingdom, Tunisia and Turkey~Asia and Australia: China, Philippines, Thailand and Australia~America: Canada, Chile, Mexico and the USA"|participants|Number|257|257.0||||||
4199918|NCT00751881|4023454|B3|America||Region of Enrollment|"Due to the small sample size in some countries, the countries were pooled as follows:~Eastern Europe: Belarus, Czech Republic, Estonia, Greece, Poland, Romania, Slovakia and Ukraine~Western Europe and Africa: Austria, Belgium, France, Germany, Netherlands, Spain, Sweden and United Kingdom, Tunisia and Turkey~Asia and Australia: China, Philippines, Thailand and Australia~America: Canada, Chile, Mexico and the USA"|participants|Number|81|81.0||||||
4199919|NCT00751881|4023455|B2|America||Region of Enrollment|"Due to the small sample size in some countries, the countries were pooled as follows:~Eastern Europe: Belarus, Czech Republic, Estonia, Greece, Poland, Romania, Slovakia and Ukraine~Western Europe and Africa: Austria, Belgium, France, Germany, Netherlands, Spain, Sweden and United Kingdom, Tunisia and Turkey~Asia and Australia: China, Philippines, Thailand and Australia~America: Canada, Chile, Mexico and the USA"|participants|Number|92|92.0||||||
4199940|NCT00751881|4023456|B1||Female|Sex: Female, Male||Participants|Count of Participants|273|273.0||||||
4199941|NCT00751881|4023453|B4|||Age||years|Mean|37.9|37.9|Standard Deviation|9.3|9.3|||
4199942|NCT00751881|4023454|B3|||Age||years|Mean|38.2|38.2|Standard Deviation|9.4|9.4|||
4199920|NCT00751881|4023456|B1|America||Region of Enrollment|"Due to the small sample size in some countries, the countries were pooled as follows:~Eastern Europe: Belarus, Czech Republic, Estonia, Greece, Poland, Romania, Slovakia and Ukraine~Western Europe and Africa: Austria, Belgium, France, Germany, Netherlands, Spain, Sweden and United Kingdom, Tunisia and Turkey~Asia and Australia: China, Philippines, Thailand and Australia~America: Canada, Chile, Mexico and the USA"|participants|Number|84|84.0||||||
4199921|NCT00751881|4023453|B4|Asia and Australia||Region of Enrollment|"Due to the small sample size in some countries, the countries were pooled as follows:~Eastern Europe: Belarus, Czech Republic, Estonia, Greece, Poland, Romania, Slovakia and Ukraine~Western Europe and Africa: Austria, Belgium, France, Germany, Netherlands, Spain, Sweden and United Kingdom, Tunisia and Turkey~Asia and Australia: China, Philippines, Thailand and Australia~America: Canada, Chile, Mexico and the USA"|participants|Number|187|187.0||||||
4199922|NCT00751881|4023454|B3|Asia and Australia||Region of Enrollment|"Due to the small sample size in some countries, the countries were pooled as follows:~Eastern Europe: Belarus, Czech Republic, Estonia, Greece, Poland, Romania, Slovakia and Ukraine~Western Europe and Africa: Austria, Belgium, France, Germany, Netherlands, Spain, Sweden and United Kingdom, Tunisia and Turkey~Asia and Australia: China, Philippines, Thailand and Australia~America: Canada, Chile, Mexico and the USA"|participants|Number|55|55.0||||||
4199923|NCT00751881|4023455|B2|Asia and Australia||Region of Enrollment|"Due to the small sample size in some countries, the countries were pooled as follows:~Eastern Europe: Belarus, Czech Republic, Estonia, Greece, Poland, Romania, Slovakia and Ukraine~Western Europe and Africa: Austria, Belgium, France, Germany, Netherlands, Spain, Sweden and United Kingdom, Tunisia and Turkey~Asia and Australia: China, Philippines, Thailand and Australia~America: Canada, Chile, Mexico and the USA"|participants|Number|65|65.0||||||
4199924|NCT00751881|4023456|B1|Asia and Australia||Region of Enrollment|"Due to the small sample size in some countries, the countries were pooled as follows:~Eastern Europe: Belarus, Czech Republic, Estonia, Greece, Poland, Romania, Slovakia and Ukraine~Western Europe and Africa: Austria, Belgium, France, Germany, Netherlands, Spain, Sweden and United Kingdom, Tunisia and Turkey~Asia and Australia: China, Philippines, Thailand and Australia~America: Canada, Chile, Mexico and the USA"|participants|Number|67|67.0||||||
4199925|NCT00751881|4023453|B4|Western Europe and Africa||Region of Enrollment|"Due to the small sample size in some countries, the countries were pooled as follows:~Eastern Europe: Belarus, Czech Republic, Estonia, Greece, Poland, Romania, Slovakia and Ukraine~Western Europe and Africa: Austria, Belgium, France, Germany, Netherlands, Spain, Sweden and United Kingdom, Tunisia and Turkey~Asia and Australia: China, Philippines, Thailand and Australia~America: Canada, Chile, Mexico and the USA"|participants|Number|368|368.0||||||
4199926|NCT00751881|4023454|B3|Western Europe and Africa||Region of Enrollment|"Due to the small sample size in some countries, the countries were pooled as follows:~Eastern Europe: Belarus, Czech Republic, Estonia, Greece, Poland, Romania, Slovakia and Ukraine~Western Europe and Africa: Austria, Belgium, France, Germany, Netherlands, Spain, Sweden and United Kingdom, Tunisia and Turkey~Asia and Australia: China, Philippines, Thailand and Australia~America: Canada, Chile, Mexico and the USA"|participants|Number|120|120.0||||||
4199927|NCT00751881|4023455|B2|Western Europe and Africa||Region of Enrollment|"Due to the small sample size in some countries, the countries were pooled as follows:~Eastern Europe: Belarus, Czech Republic, Estonia, Greece, Poland, Romania, Slovakia and Ukraine~Western Europe and Africa: Austria, Belgium, France, Germany, Netherlands, Spain, Sweden and United Kingdom, Tunisia and Turkey~Asia and Australia: China, Philippines, Thailand and Australia~America: Canada, Chile, Mexico and the USA"|participants|Number|127|127.0||||||
4199928|NCT00751881|4023456|B1|Western Europe and Africa||Region of Enrollment|"Due to the small sample size in some countries, the countries were pooled as follows:~Eastern Europe: Belarus, Czech Republic, Estonia, Greece, Poland, Romania, Slovakia and Ukraine~Western Europe and Africa: Austria, Belgium, France, Germany, Netherlands, Spain, Sweden and United Kingdom, Tunisia and Turkey~Asia and Australia: China, Philippines, Thailand and Australia~America: Canada, Chile, Mexico and the USA"|participants|Number|121|121.0||||||
4199929|NCT00751881|4023453|B4|Eastern Europe||Region of Enrollment|"Due to the small sample size in some countries, the countries were pooled as follows:~Eastern Europe: Belarus, Czech Republic, Estonia, Greece, Poland, Romania, Slovakia and Ukraine~Western Europe and Africa: Austria, Belgium, France, Germany, Netherlands, Spain, Sweden and United Kingdom, Tunisia and Turkey~Asia and Australia: China, Philippines, Thailand and Australia~America: Canada, Chile, Mexico and the USA"|participants|Number|357|357.0||||||
4199930|NCT00751881|4023454|B3|Eastern Europe||Region of Enrollment|"Due to the small sample size in some countries, the countries were pooled as follows:~Eastern Europe: Belarus, Czech Republic, Estonia, Greece, Poland, Romania, Slovakia and Ukraine~Western Europe and Africa: Austria, Belgium, France, Germany, Netherlands, Spain, Sweden and United Kingdom, Tunisia and Turkey~Asia and Australia: China, Philippines, Thailand and Australia~America: Canada, Chile, Mexico and the USA"|participants|Number|116|116.0||||||
4199931|NCT00751881|4023455|B2|Eastern Europe||Region of Enrollment|"Due to the small sample size in some countries, the countries were pooled as follows:~Eastern Europe: Belarus, Czech Republic, Estonia, Greece, Poland, Romania, Slovakia and Ukraine~Western Europe and Africa: Austria, Belgium, France, Germany, Netherlands, Spain, Sweden and United Kingdom, Tunisia and Turkey~Asia and Australia: China, Philippines, Thailand and Australia~America: Canada, Chile, Mexico and the USA"|participants|Number|124|124.0||||||
4199932|NCT00751881|4023456|B1|Eastern Europe||Region of Enrollment|"Due to the small sample size in some countries, the countries were pooled as follows:~Eastern Europe: Belarus, Czech Republic, Estonia, Greece, Poland, Romania, Slovakia and Ukraine~Western Europe and Africa: Austria, Belgium, France, Germany, Netherlands, Spain, Sweden and United Kingdom, Tunisia and Turkey~Asia and Australia: China, Philippines, Thailand and Australia~America: Canada, Chile, Mexico and the USA"|participants|Number|117|117.0||||||
4199933|NCT00751881|4023453|B4||Male|Sex: Female, Male||Participants|Count of Participants|338|338.0||||||
4199934|NCT00751881|4023454|B3||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4199935|NCT00751881|4023455|B2||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4199936|NCT00751881|4023456|B1||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4199937|NCT00751881|4023453|B4||Female|Sex: Female, Male||Participants|Count of Participants|831|831.0||||||
4199938|NCT00751881|4023454|B3||Female|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
4199939|NCT00751881|4023455|B2||Female|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
4199943|NCT00751881|4023455|B2|||Age||years|Mean|37.4|37.4|Standard Deviation|9.4|9.4|||
4199944|NCT00751881|4023456|B1|||Age||years|Mean|38.1|38.1|Standard Deviation|9.1|9.1|||
4199945|NCT00751790|4023505|B1|South Africa||Region of Enrollment||participants|Number|120|120.0||||||
4199946|NCT00751790|4023505|B1||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4199947|NCT00751790|4023505|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4199948|NCT00751790|4023505|B1|||Age||years|Mean|71.11|71.11|Standard Deviation|8.46|8.46|||
4199949|NCT00751790|4023505|B1||>=65 years|Age||Participants|Count of Participants|120|120.0||||||
4199950|NCT00751790|4023505|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4199951|NCT00751790|4023505|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4199952|NCT00751777|4023509|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4199953|NCT00751777|4023510|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4199954|NCT00751777|4023511|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4199955|NCT00751777|4023509|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4199956|NCT00751777|4023510|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4199957|NCT00751777|4023511|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4199958|NCT00751777|4023509|B3|||Age||years|Mean|34.5|34.5|Standard Deviation|11.2|11.2|||
4199959|NCT00751777|4023510|B2|||Age||years|Mean|35.3|35.3|Standard Deviation|13.0|13.0|||
4199960|NCT00751777|4023511|B1|||Age||years|Mean|34.1|34.1|Standard Deviation|10.2|10.2|||
4199961|NCT00751634|4023522|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4199962|NCT00751634|4023522|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4199963|NCT00751634|4023522|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4199964|NCT00751634|4023522|B1|||Age||years|Mean|54.3|54.3|Standard Deviation|15.4|15.4|||
4199965|NCT00751621|4023530|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4199966|NCT00751621|4023530|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4199967|NCT00751621|4023530|B1|≥ 65 years||Age, Customized||participants|Number|0|0.0||||||
4199968|NCT00751621|4023530|B1|16 to < 65 years||Age, Customized||participants|Number|21|21.0||||||
4199969|NCT00751621|4023530|B1|12 to < 16 years||Age, Customized||participants|Number|4|4.0||||||
4199970|NCT00751621|4023530|B1|2 to < 12 years||Age, Customized||participants|Number|15|15.0||||||
4199971|NCT00751530|4023547|B3|United States||Region of Enrollment||participants|Number|340|340.0||||||
4199972|NCT00751530|4023548|B2|United States||Region of Enrollment||participants|Number|86|86.0||||||
4199973|NCT00751530|4023549|B1|United States||Region of Enrollment||participants|Number|254|254.0||||||
4199974|NCT00751530|4023547|B3||Male|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
4199975|NCT00751530|4023548|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4199976|NCT00751530|4023549|B1||Male|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4199977|NCT00751530|4023547|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4199978|NCT00751530|4023548|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4199979|NCT00751530|4023549|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4199980|NCT00751530|4023547|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4199981|NCT00751530|4023548|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4199982|NCT00751530|4023549|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4199983|NCT00751530|4023547|B3||Between 18 and 65 years|Age||Participants|Count of Participants|329|329.0||||||
4199984|NCT00751530|4023548|B2||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
4199985|NCT00751530|4023549|B1||Between 18 and 65 years|Age||Participants|Count of Participants|247|247.0||||||
4199986|NCT00751530|4023547|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4199987|NCT00751530|4023548|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4199988|NCT00751530|4023549|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4199989|NCT00751400|4023564|B1|Missing||Race||participants|Number|0|0.0||||||
4199990|NCT00751400|4023564|B1|Other||Race||participants|Number|31|31.0||||||
4199991|NCT00751400|4023564|B1|Asian||Race||participants|Number|8|8.0||||||
4199992|NCT00751400|4023564|B1|Hispanic||Race||participants|Number|3|3.0||||||
4199993|NCT00751400|4023564|B1|Black||Race||participants|Number|56|56.0||||||
4199994|NCT00751400|4023564|B1|White||Race||participants|Number|399|399.0||||||
4199995|NCT00751400|4023564|B1|Regular||Prior Analgesic Use|Heavy analgesic user: 30 or more doses of Over The Counter (OTC) analgesics per month (self reported based on categorical responses). Regular analgesic user: 5 to 29 doses of OTC analgesics per month (self reported based on categorical responses).|participants|Number|349|349.0||||||
4199996|NCT00751400|4023564|B1|Heavy||Prior Analgesic Use|Heavy analgesic user: 30 or more doses of Over The Counter (OTC) analgesics per month (self reported based on categorical responses). Regular analgesic user: 5 to 29 doses of OTC analgesics per month (self reported based on categorical responses).|participants|Number|148|148.0||||||
4199997|NCT00751400|4023564|B1|No REALM Score||Literacy|Rapid Estimate of Adult Literacy in Medicine (REALM) scores range from 0-66 (single scale): a score of 61 or greater is considered normal literacy; a score of 60 or less is considered low literacy.|participants|Number|4|4.0||||||
4199998|NCT00751400|4023564|B1|Low||Literacy|Rapid Estimate of Adult Literacy in Medicine (REALM) scores range from 0-66 (single scale): a score of 61 or greater is considered normal literacy; a score of 60 or less is considered low literacy.|participants|Number|56|56.0||||||
4200083|NCT00751114|4023640|B1|||Systolic Blood Pressure|mITT population|mmHg|Mean|129.8|129.8|Standard Deviation|13.3|13.3|||
4199999|NCT00751400|4023564|B1|Normal||Literacy|Rapid Estimate of Adult Literacy in Medicine (REALM) scores range from 0-66 (single scale): a score of 61 or greater is considered normal literacy; a score of 60 or less is considered low literacy.|participants|Number|437|437.0||||||
4200000|NCT00751400|4023564|B1|Missing||Education||participants|Number|0|0.0||||||
4200001|NCT00751400|4023564|B1|Post-graduate degree||Education||participants|Number|49|49.0||||||
4200002|NCT00751400|4023564|B1|College graduate||Education||participants|Number|117|117.0||||||
4200003|NCT00751400|4023564|B1|Some college or technical school||Education||participants|Number|185|185.0||||||
4200004|NCT00751400|4023564|B1|High school graduate, GED, or certificate||Education||participants|Number|119|119.0||||||
4200005|NCT00751400|4023564|B1|Some high school||Education||participants|Number|21|21.0||||||
4200006|NCT00751400|4023564|B1|8th grade or less||Education||participants|Number|6|6.0||||||
4200007|NCT00751400|4023564|B1||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4200008|NCT00751400|4023564|B1||Female|Sex: Female, Male||Participants|Count of Participants|292|292.0||||||
4200009|NCT00751400|4023564|B1|||Age||years|Mean|49.8|49.8|Standard Deviation|15.1|15.1|||
4200010|NCT00751348|4023577|B3|Asian-South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4200011|NCT00751348|4023578|B2|Asian-South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4200012|NCT00751348|4023579|B1|Asian-South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4200013|NCT00751348|4023577|B3|Asian–East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|472|472.0||||||
4200014|NCT00751348|4023578|B2|Asian–East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|159|159.0||||||
4200015|NCT00751348|4023579|B1|Asian–East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|313|313.0||||||
4200016|NCT00751348|4023577|B3||Male|Sex: Female, Male||Participants|Count of Participants|270|270.0||||||
4200017|NCT00751348|4023578|B2||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4200018|NCT00751348|4023579|B1||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4200019|NCT00751348|4023577|B3||Female|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4200020|NCT00751348|4023578|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4200021|NCT00751348|4023579|B1||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4200022|NCT00751348|4023577|B3|||Age||Months|Mean|12.43|12.43|Standard Deviation|1.49|1.49|||
4200023|NCT00751348|4023578|B2|||Age||Months|Mean|12.5|12.5|Standard Deviation|1.65|1.65|||
4200024|NCT00751348|4023579|B1|||Age||Months|Mean|12.4|12.4|Standard Deviation|1.4|1.4|||
4200025|NCT00751296|4023602|B1|Canada||Region of Enrollment||participants|Number|25|25.0||||||
4200026|NCT00751296|4023602|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4200027|NCT00751296|4023602|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4200028|NCT00751296|4023602|B1|||Age||years|Median|60|60.0|Full Range|||33.0|78.0|
4200029|NCT00751296|4023602|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4200030|NCT00751296|4023602|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4200031|NCT00751296|4023602|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4200032|NCT00751179|4023607|B3||Male|Sex: Female, Male|Includes only participants who were randomized and treated with sugammadex or succinylcholine|Participants|Count of Participants|45|45.0||||||
4200033|NCT00751179|4023608|B2||Male|Sex: Female, Male|Includes only participants who were randomized and treated with sugammadex or succinylcholine|Participants|Count of Participants|27|27.0||||||
4200034|NCT00751179|4023609|B1||Male|Sex: Female, Male|Includes only participants who were randomized and treated with sugammadex or succinylcholine|Participants|Count of Participants|18|18.0||||||
4200035|NCT00751179|4023607|B3||Female|Sex: Female, Male|Includes only participants who were randomized and treated with sugammadex or succinylcholine|Participants|Count of Participants|101|101.0||||||
4200036|NCT00751179|4023608|B2||Female|Sex: Female, Male|Includes only participants who were randomized and treated with sugammadex or succinylcholine|Participants|Count of Participants|53|53.0||||||
4200037|NCT00751179|4023609|B1||Female|Sex: Female, Male|Includes only participants who were randomized and treated with sugammadex or succinylcholine|Participants|Count of Participants|48|48.0||||||
4200038|NCT00751179|4023607|B3|||Age|Includes only participants who were randomized and treated with sugammadex or succinylcholine|years|Mean|43|43.0|Standard Deviation|14|14.0|||
4200039|NCT00751179|4023608|B2|||Age|Includes only participants who were randomized and treated with sugammadex or succinylcholine|years|Mean|45|45.0|Standard Deviation|14|14.0|||
4200040|NCT00751179|4023609|B1|||Age|Includes only participants who were randomized and treated with sugammadex or succinylcholine|years|Mean|40|40.0|Standard Deviation|13|13.0|||
4200041|NCT00751140|4023630|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4200042|NCT00751140|4023630|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4200043|NCT00751140|4023630|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4200044|NCT00751140|4023630|B1|||Age||years|Mean|69|69.0|Full Range|||42.0|85.0|
4200045|NCT00751114|4023638|B3|||Triglycerides|mITT population but due to missing values, N=225 for Insulin Glargine and N=248 for Sitagliptin|mg/dL|Mean|188.2|188.2|Standard Deviation|128.3|128.3|||
4200046|NCT00751114|4023639|B2|||Triglycerides|mITT population but due to missing values, N=225 for Insulin Glargine and N=248 for Sitagliptin|mg/dL|Mean|185.7|185.7|Standard Deviation|114.6|114.6|||
4200047|NCT00751114|4023640|B1|||Triglycerides|mITT population but due to missing values, N=225 for Insulin Glargine and N=248 for Sitagliptin|mg/dL|Mean|190.9|190.9|Standard Deviation|142.0|142.0|||
4200048|NCT00751114|4023638|B3|||Low-Density Lipoprotein (LDL) Cholesterol|mITT population but due to missing values, N=225 for Insulin Glargine and N=248 for Sitagliptin|mg/dL|Mean|113.5|113.5|Standard Deviation|34.6|34.6|||
4200049|NCT00751114|4023639|B2|||Low-Density Lipoprotein (LDL) Cholesterol|mITT population but due to missing values, N=225 for Insulin Glargine and N=248 for Sitagliptin|mg/dL|Mean|114.2|114.2|Standard Deviation|33.2|33.2|||
4200050|NCT00751114|4023640|B1|||Low-Density Lipoprotein (LDL) Cholesterol|mITT population but due to missing values, N=225 for Insulin Glargine and N=248 for Sitagliptin|mg/dL|Mean|112.7|112.7|Standard Deviation|36.2|36.2|||
4200051|NCT00751114|4023638|B3|||High-Density Lipoprotein (HDL) Cholesterol|mITT population but due to missing values, N=225 for Insulin Glargine and N=248 for Sitagliptin|mg/dL|Mean|45.6|45.6|Standard Deviation|12.9|12.9|||
4200052|NCT00751114|4023639|B2|||High-Density Lipoprotein (HDL) Cholesterol|mITT population but due to missing values, N=225 for Insulin Glargine and N=248 for Sitagliptin|mg/dL|Mean|45.0|45.0|Standard Deviation|11.2|11.2|||
4200053|NCT00751114|4023640|B1|||High-Density Lipoprotein (HDL) Cholesterol|mITT population but due to missing values, N=225 for Insulin Glargine and N=248 for Sitagliptin|mg/dL|Mean|46.2|46.2|Standard Deviation|14.6|14.6|||
4200054|NCT00751114|4023638|B3|||Total Cholesterol|mITT population but due to missing values, N=225 for Insulin Glargine and N=248 for Sitagliptin|mg/dL|Mean|186.5|186.5|Standard Deviation|40.1|40.1|||
4200055|NCT00751114|4023639|B2|||Total Cholesterol|mITT population but due to missing values, N=225 for Insulin Glargine and N=248 for Sitagliptin|mg/dL|Mean|187.1|187.1|Standard Deviation|39.0|39.0|||
4200056|NCT00751114|4023640|B1|||Total Cholesterol|mITT population but due to missing values, N=225 for Insulin Glargine and N=248 for Sitagliptin|mg/dL|Mean|185.9|185.9|Standard Deviation|41.4|41.4|||
4200057|NCT00751114|4023638|B3|||Self-monitored Fasting Plasma Glucose|mITT population but due to missing values, N=216 for Insulin Glargine and N=244 for Sitagliptin|mg/dL|Mean|165.4|165.4|Standard Deviation|37.9|37.9|||
4200058|NCT00751114|4023639|B2|||Self-monitored Fasting Plasma Glucose|mITT population but due to missing values, N=216 for Insulin Glargine and N=244 for Sitagliptin|mg/dL|Mean|166.7|166.7|Standard Deviation|38.2|38.2|||
4200059|NCT00751114|4023640|B1|||Self-monitored Fasting Plasma Glucose|mITT population but due to missing values, N=216 for Insulin Glargine and N=244 for Sitagliptin|mg/dL|Mean|163.9|163.9|Standard Deviation|37.6|37.6|||
4200060|NCT00751114|4023638|B3|||Fasting Plasma Glucose|mITT population but due to missing values, N=225 for Insulin Glargine and N=248 for Sitagliptin|mg/dL|Mean|167.5|167.5|Standard Deviation|41.9|41.9|||
4200061|NCT00751114|4023639|B2|||Fasting Plasma Glucose|mITT population but due to missing values, N=225 for Insulin Glargine and N=248 for Sitagliptin|mg/dL|Mean|171.1|171.1|Standard Deviation|41.5|41.5|||
4200062|NCT00751114|4023640|B1|||Fasting Plasma Glucose|mITT population but due to missing values, N=225 for Insulin Glargine and N=248 for Sitagliptin|mg/dL|Mean|163.6|163.6|Standard Deviation|42.0|42.0|||
4200063|NCT00751114|4023638|B3|||Glycosylated Hemoglobin A1c (HbA1c)|mITT population|percent|Mean|8.5|8.5|Standard Deviation|1.1|1.1|||
4200064|NCT00751114|4023639|B2|||Glycosylated Hemoglobin A1c (HbA1c)|mITT population|percent|Mean|8.5|8.5|Standard Deviation|1.1|1.1|||
4200065|NCT00751114|4023640|B1|||Glycosylated Hemoglobin A1c (HbA1c)|mITT population|percent|Mean|8.5|8.5|Standard Deviation|1.0|1.0|||
4200066|NCT00751114|4023638|B3|No||At least one diabetic late complication|"mITT population~Diabetic late complications: myocardial infarction, angina pectoris, coronary artery disease, heart failure, stroke, transient ischemic attack, peripheral vascular disease, diabetic neuropathy, diabetic nephropathy, diabetic retinopathy"|participants|Number|348|348.0||||||
4200067|NCT00751114|4023639|B2|No||At least one diabetic late complication|"mITT population~Diabetic late complications: myocardial infarction, angina pectoris, coronary artery disease, heart failure, stroke, transient ischemic attack, peripheral vascular disease, diabetic neuropathy, diabetic nephropathy, diabetic retinopathy"|participants|Number|186|186.0||||||
4200068|NCT00751114|4023640|B1|No||At least one diabetic late complication|"mITT population~Diabetic late complications: myocardial infarction, angina pectoris, coronary artery disease, heart failure, stroke, transient ischemic attack, peripheral vascular disease, diabetic neuropathy, diabetic nephropathy, diabetic retinopathy"|participants|Number|162|162.0||||||
4200069|NCT00751114|4023638|B3|Yes||At least one diabetic late complication|"mITT population~Diabetic late complications: myocardial infarction, angina pectoris, coronary artery disease, heart failure, stroke, transient ischemic attack, peripheral vascular disease, diabetic neuropathy, diabetic nephropathy, diabetic retinopathy"|participants|Number|132|132.0||||||
4200070|NCT00751114|4023639|B2|Yes||At least one diabetic late complication|"mITT population~Diabetic late complications: myocardial infarction, angina pectoris, coronary artery disease, heart failure, stroke, transient ischemic attack, peripheral vascular disease, diabetic neuropathy, diabetic nephropathy, diabetic retinopathy"|participants|Number|67|67.0||||||
4200071|NCT00751114|4023640|B1|Yes||At least one diabetic late complication|"mITT population~Diabetic late complications: myocardial infarction, angina pectoris, coronary artery disease, heart failure, stroke, transient ischemic attack, peripheral vascular disease, diabetic neuropathy, diabetic nephropathy, diabetic retinopathy"|participants|Number|65|65.0||||||
4200072|NCT00751114|4023638|B3|||Duration of diabetes|mITT population|years|Median|4.5|4.5|Inter-Quartile Range|||1.9|8.2|
4200073|NCT00751114|4023639|B2|||Duration of diabetes|mITT population|years|Median|4.8|4.8|Inter-Quartile Range|||1.9|8.2|
4200074|NCT00751114|4023640|B1|||Duration of diabetes|mITT population|years|Median|3.9|3.9|Inter-Quartile Range|||1.9|8.2|
4200075|NCT00751114|4023638|B3|||Heart Rate|mITT population|beats/min|Mean|76.0|76.0|Standard Deviation|9.0|9.0|||
4200076|NCT00751114|4023639|B2|||Heart Rate|mITT population|beats/min|Mean|76.3|76.3|Standard Deviation|9.3|9.3|||
4200077|NCT00751114|4023640|B1|||Heart Rate|mITT population|beats/min|Mean|75.6|75.6|Standard Deviation|8.7|8.7|||
4200078|NCT00751114|4023638|B3|||Diastolic Blood Pressure|mITT population|mmHg|Mean|79.7|79.7|Standard Deviation|8.5|8.5|||
4200079|NCT00751114|4023639|B2|||Diastolic Blood Pressure|mITT population|mmHg|Mean|80.0|80.0|Standard Deviation|8.3|8.3|||
4200080|NCT00751114|4023640|B1|||Diastolic Blood Pressure|mITT population|mmHg|Mean|79.5|79.5|Standard Deviation|8.7|8.7|||
4200081|NCT00751114|4023638|B3|||Systolic Blood Pressure|mITT population|mmHg|Mean|130.8|130.8|Standard Deviation|14.3|14.3|||
4200082|NCT00751114|4023639|B2|||Systolic Blood Pressure|mITT population|mmHg|Mean|131.7|131.7|Standard Deviation|15.1|15.1|||
4200084|NCT00751114|4023638|B3|||Body Mass Index|mITT population|kg/m²|Mean|31.09|31.09|Standard Deviation|4.93|4.93|||
4200085|NCT00751114|4023639|B2|||Body Mass Index|mITT population|kg/m²|Mean|31.13|31.13|Standard Deviation|4.95|4.95|||
4200086|NCT00751114|4023640|B1|||Body Mass Index|mITT population|kg/m²|Mean|31.05|31.05|Standard Deviation|4.93|4.93|||
4200087|NCT00751114|4023638|B3|||Body Weight|mITT population|kg|Mean|83.8|83.8|Standard Deviation|18.2|18.2|||
4200088|NCT00751114|4023639|B2|||Body Weight|mITT population|kg|Mean|84.2|84.2|Standard Deviation|18.3|18.3|||
4200089|NCT00751114|4023640|B1|||Body Weight|mITT population|kg|Mean|83.4|83.4|Standard Deviation|18.2|18.2|||
4200090|NCT00751114|4023638|B3|Female||Sex/Gender, Customized|mITT population|participants|Number|234|234.0||||||
4200091|NCT00751114|4023639|B2|Female||Sex/Gender, Customized|mITT population|participants|Number|121|121.0||||||
4200092|NCT00751114|4023640|B1|Female||Sex/Gender, Customized|mITT population|participants|Number|113|113.0||||||
4200093|NCT00751114|4023638|B3|Male||Sex/Gender, Customized|mITT population|participants|Number|246|246.0||||||
4200094|NCT00751114|4023639|B2|Male||Sex/Gender, Customized|mITT population|participants|Number|132|132.0||||||
4200095|NCT00751114|4023640|B1|Male||Sex/Gender, Customized|mITT population|participants|Number|114|114.0||||||
4200096|NCT00751114|4023638|B3|||Age|mITT population|years|Mean|53.6|53.6|Standard Deviation|8.8|8.8|||
4200097|NCT00751114|4023639|B2|||Age|mITT population|years|Mean|53.3|53.3|Standard Deviation|8.7|8.7|||
4200098|NCT00751114|4023640|B1|||Age|mITT population|years|Mean|53.9|53.9|Standard Deviation|8.9|8.9|||
4200099|NCT00751036|4023664|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4200100|NCT00751036|4023665|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4200101|NCT00751036|4023666|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4200102|NCT00751036|4023664|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4200103|NCT00751036|4023665|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4200104|NCT00751036|4023666|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4200105|NCT00751036|4023664|B3|Missing||Age, Customized||Participants|Number|1|1.0||||||
4200106|NCT00751036|4023665|B2|Missing||Age, Customized||Participants|Number|0|0.0||||||
4200107|NCT00751036|4023666|B1|Missing||Age, Customized||Participants|Number|1|1.0||||||
4200108|NCT00751036|4023664|B3|≥ 65 years||Age, Customized||Participants|Number|20|20.0||||||
4200109|NCT00751036|4023665|B2|≥ 65 years||Age, Customized||Participants|Number|11|11.0||||||
4200110|NCT00751036|4023666|B1|≥ 65 years||Age, Customized||Participants|Number|9|9.0||||||
4200111|NCT00751036|4023664|B3|<65 years||Age, Customized||Participants|Number|73|73.0||||||
4200112|NCT00751036|4023665|B2|<65 years||Age, Customized||Participants|Number|35|35.0||||||
4200113|NCT00751036|4023666|B1|<65 years||Age, Customized||Participants|Number|38|38.0||||||
4200114|NCT00750919|4023679|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4200115|NCT00750919|4023679|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4200116|NCT00750919|4023679|B1|||Age||years|Mean|47.8|47.8|Standard Deviation|11.5|11.5|||
4200117|NCT00750893|4023687|B1||Male|Sex: Female, Male||Participants|Count of Participants|1586|1586.0||||||
4200118|NCT00750893|4023687|B1||Female|Sex: Female, Male||Participants|Count of Participants|1525|1525.0||||||
4200119|NCT00750893|4023687|B1|||Age||weeks|Mean|9.6|9.6|Standard Deviation|2.22|2.22|||
4200120|NCT00750880|4023702|B1||Male|Sex: Female, Male||Participants|Count of Participants|325|325.0||||||
4200121|NCT00750880|4023702|B1||Female|Sex: Female, Male||Participants|Count of Participants|1356|1356.0||||||
4200122|NCT00750880|4023702|B1|||Age||years|Mean|53.5|53.5|Standard Deviation|12.34|12.34|||
4200123|NCT00750867|4023725|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4200124|NCT00750867|4023725|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
4200125|NCT00750867|4023725|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
4200126|NCT00750867|4023725|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4200127|NCT00750867|4023725|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4200128|NCT00750867|4023725|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4200129|NCT00750867|4023725|B1|||Age||years|Mean|59|59.0|Full Range|||55.0|64.0|
4200130|NCT00750815|4023730|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
4200131|NCT00750815|4023731|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
4200132|NCT00750815|4023732|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4200133|NCT00750815|4023730|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4200134|NCT00750815|4023731|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4200135|NCT00750815|4023732|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4200136|NCT00750815|4023730|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4200137|NCT00750815|4023731|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4200138|NCT00750815|4023732|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4200139|NCT00750815|4023730|B3|||Age||years|Mean|57|57.0|Full Range|||25.0|77.0|
4200140|NCT00750815|4023731|B2|||Age||years|Mean|57|57.0|Full Range|||25.0|75.0|
4200141|NCT00750815|4023732|B1|||Age||years|Mean|58.75|58.75|Full Range|||46.0|77.0|
4200142|NCT00750815|4023730|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4200143|NCT00750815|4023731|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4200144|NCT00750815|4023732|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4200145|NCT00750815|4023730|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4200146|NCT00750815|4023731|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4200147|NCT00750815|4023732|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4200148|NCT00750815|4023730|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4200149|NCT00750815|4023731|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4200150|NCT00750815|4023732|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4200151|NCT00750737|4023744|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
4200152|NCT00750737|4023745|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4200153|NCT00750737|4023746|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4200154|NCT00750737|4023744|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4200155|NCT00750737|4023745|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4200156|NCT00750737|4023746|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4200157|NCT00750737|4023744|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4200158|NCT00750737|4023745|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4200159|NCT00750737|4023746|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4200160|NCT00750737|4023744|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4200161|NCT00750737|4023745|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4200162|NCT00750737|4023746|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4200163|NCT00750737|4023744|B3||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4200164|NCT00750737|4023745|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4200165|NCT00750737|4023746|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4200166|NCT00750737|4023744|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4200167|NCT00750737|4023745|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4200168|NCT00750737|4023746|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4200169|NCT00750737|4023744|B3|||Age||years|Median|55.5|55.5|Full Range|||21.0|70.0|
4200170|NCT00750737|4023745|B2|||Age||years|Median|56|56.0|Full Range|||22.0|70.0|
4200171|NCT00750737|4023746|B1|||Age||years|Median|55.5|55.5|Full Range|||21.0|67.0|
4200172|NCT00750373|4023755|B3|Korea, Republic of||Region of Enrollment||participants|Number|76|76.0||||||
4200173|NCT00750373|4023756|B2|Korea, Republic of||Region of Enrollment||participants|Number|37|37.0||||||
4200174|NCT00750373|4023757|B1|Korea, Republic of||Region of Enrollment||participants|Number|39|39.0||||||
4200175|NCT00750373|4023755|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4200176|NCT00750373|4023756|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4200177|NCT00750373|4023757|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4200178|NCT00750373|4023755|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4200179|NCT00750373|4023756|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4200180|NCT00750373|4023757|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4200181|NCT00750373|4023755|B3|||Age||years|Mean|47|47.0|Standard Deviation|16|16.0|||
4200182|NCT00750373|4023756|B2|||Age||years|Mean|46|46.0|Standard Deviation|15|15.0|||
4200183|NCT00750373|4023757|B1|||Age||years|Mean|48|48.0|Standard Deviation|17|17.0|||
4200184|NCT00750373|4023755|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4200185|NCT00750373|4023756|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4200186|NCT00750373|4023757|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4200187|NCT00750373|4023755|B3||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4200188|NCT00750373|4023756|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4200189|NCT00750373|4023757|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4200190|NCT00750373|4023755|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4200191|NCT00750373|4023756|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4200192|NCT00750373|4023757|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4200193|NCT00750360|4023764|B7||Male|Sex: Female, Male||Participants|Count of Participants|430|430.0||||||
4200194|NCT00750360|4023765|B6||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4200195|NCT00750360|4023766|B5||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4200196|NCT00750360|4023767|B4||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4200197|NCT00750360|4023768|B3||Male|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
4200198|NCT00750360|4023769|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4200199|NCT00750360|4023770|B1||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4200200|NCT00750360|4023764|B7||Female|Sex: Female, Male||Participants|Count of Participants|445|445.0||||||
4200201|NCT00750360|4023765|B6||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4200202|NCT00750360|4023766|B5||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4200203|NCT00750360|4023767|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4200204|NCT00750360|4023768|B3||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4200205|NCT00750360|4023769|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4200206|NCT00750360|4023770|B1||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4200207|NCT00750360|4023764|B7|||Age||months|Mean|73.2|73.2|Standard Deviation|128.07|128.07|||
4200208|NCT00750360|4023765|B6|||Age||months|Mean|454.5|454.5|Standard Deviation|174.40|174.4|||
4200209|NCT00750360|4023766|B5|||Age||months|Mean|132.7|132.7|Standard Deviation|22.00|22.0|||
4200210|NCT00750360|4023767|B4|||Age||months|Mean|86.4|86.4|Standard Deviation|10.60|10.6|||
4200211|NCT00750360|4023768|B3|||Age||months|Mean|38.3|38.3|Standard Deviation|18.80|18.8|||
4200212|NCT00750360|4023769|B2|||Age||months|Mean|85.0|85.0|Standard Deviation|0|0.0|||
4200213|NCT00750360|4023770|B1|||Age||months|Mean|13.7|13.7|Standard Deviation|10.60|10.6|||
4200214|NCT00750308|4023807|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4200215|NCT00750308|4023807|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4200216|NCT00750308|4023807|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4200217|NCT00750308|4023807|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4200218|NCT00750308|4023807|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4200219|NCT00750282|4023832|B5|Japan||Region of Enrollment||participants|Number|57|57.0||||||
4200220|NCT00750282|4023833|B4|Japan||Region of Enrollment||participants|Number|28|28.0||||||
4200221|NCT00750282|4023834|B3|Japan||Region of Enrollment||participants|Number|29|29.0||||||
4200222|NCT00750282|4023835|B2|Japan||Region of Enrollment||participants|Number|0|0.0||||||
4200223|NCT00750282|4023836|B1|Japan||Region of Enrollment||participants|Number|0|0.0||||||
4200224|NCT00750282|4023832|B5|Switzerland||Region of Enrollment||participants|Number|15|15.0||||||
4200225|NCT00750282|4023833|B4|Switzerland||Region of Enrollment||participants|Number|11|11.0||||||
4200226|NCT00750282|4023834|B3|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
4200227|NCT00750282|4023835|B2|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4200228|NCT00750282|4023836|B1|Switzerland||Region of Enrollment||participants|Number|3|3.0||||||
4200229|NCT00750282|4023832|B5|Germany||Region of Enrollment||participants|Number|255|255.0||||||
4200230|NCT00750282|4023833|B4|Germany||Region of Enrollment||participants|Number|72|72.0||||||
4200231|NCT00750282|4023834|B3|Germany||Region of Enrollment||participants|Number|63|63.0||||||
4200232|NCT00750282|4023835|B2|Germany||Region of Enrollment||participants|Number|71|71.0||||||
4200233|NCT00750282|4023836|B1|Germany||Region of Enrollment||participants|Number|49|49.0||||||
4200234|NCT00750282|4023832|B5|Australia||Region of Enrollment||participants|Number|31|31.0||||||
4200235|NCT00750282|4023833|B4|Australia||Region of Enrollment||participants|Number|5|5.0||||||
4200236|NCT00750282|4023834|B3|Australia||Region of Enrollment||participants|Number|11|11.0||||||
4200237|NCT00750282|4023835|B2|Australia||Region of Enrollment||participants|Number|6|6.0||||||
4200238|NCT00750282|4023836|B1|Australia||Region of Enrollment||participants|Number|9|9.0||||||
4200239|NCT00750282|4023832|B5|United States||Region of Enrollment||participants|Number|64|64.0||||||
4200240|NCT00750282|4023833|B4|United States||Region of Enrollment||participants|Number|31|31.0||||||
4200241|NCT00750282|4023834|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4200242|NCT00750282|4023835|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4200243|NCT00750282|4023836|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4200244|NCT00750282|4023832|B5||Male|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4200245|NCT00750282|4023833|B4||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4200246|NCT00750282|4023834|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4200247|NCT00750282|4023835|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4200248|NCT00750282|4023836|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4200249|NCT00750282|4023832|B5||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4200250|NCT00750282|4023833|B4||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4200251|NCT00750282|4023834|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4200252|NCT00750282|4023835|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4200253|NCT00750282|4023836|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4200254|NCT00750282|4023832|B5|||Age||years|Mean|71.4|71.4|Standard Deviation|7.36|7.36|||
4200255|NCT00750282|4023833|B4|||Age||years|Mean|73.9|73.9|Standard Deviation|7.30|7.3|||
4200256|NCT00750282|4023834|B3|||Age||years|Mean|70.7|70.7|Standard Deviation|6.30|6.3|||
4200257|NCT00750282|4023835|B2|||Age||years|Mean|70.7|70.7|Standard Deviation|7.82|7.82|||
4200258|NCT00750282|4023836|B1|||Age||years|Mean|68.2|68.2|Standard Deviation|6.86|6.86|||
4200259|NCT00750282|4023832|B5||>=65 years|Age||Participants|Count of Participants|344|344.0||||||
4200260|NCT00750282|4023833|B4||>=65 years|Age||Participants|Count of Participants|132|132.0||||||
4200261|NCT00750282|4023834|B3||>=65 years|Age||Participants|Count of Participants|104|104.0||||||
4200262|NCT00750282|4023835|B2||>=65 years|Age||Participants|Count of Participants|62|62.0||||||
4200263|NCT00750282|4023836|B1||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
4200264|NCT00750282|4023832|B5||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
4200265|NCT00750282|4023833|B4||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4200266|NCT00750282|4023834|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4200267|NCT00750282|4023835|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4200268|NCT00750282|4023836|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4200269|NCT00750282|4023832|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4200270|NCT00750282|4023833|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4200271|NCT00750282|4023834|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4200272|NCT00750282|4023835|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4200273|NCT00750282|4023836|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4200274|NCT00750269|4023863|B6||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4200275|NCT00750269|4023864|B5||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4200276|NCT00750269|4023865|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4200277|NCT00750269|4023866|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4200278|NCT00750269|4023867|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4200279|NCT00750269|4023868|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4200280|NCT00750269|4023863|B6||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4200281|NCT00750269|4023864|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4200282|NCT00750269|4023865|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4200283|NCT00750269|4023866|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4200284|NCT00750269|4023867|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4200285|NCT00750269|4023868|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4200286|NCT00750269|4023863|B6|||Age||years|Median|72|72.0|Full Range|||52.0|89.0|
4200287|NCT00750269|4023864|B5|||Age||years|Median|72|72.0|Full Range|||55.0|89.0|
4200288|NCT00750269|4023865|B4|||Age||years|Median|71|71.0|Full Range|||52.0|87.0|
4200289|NCT00750269|4023866|B3|||Age||years|Median|72|72.0|Full Range|||59.0|81.0|
4200290|NCT00750269|4023867|B2|||Age||years|Median|75|75.0|Full Range|||53.0|89.0|
4200291|NCT00750269|4023868|B1|||Age||years|Median|74|74.0|Full Range|||59.0|81.0|
4200292|NCT00750204|4023917|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4200293|NCT00750204|4023918|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4200294|NCT00750204|4023919|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4200295|NCT00750204|4023917|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200296|NCT00750204|4023918|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200297|NCT00750204|4023919|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200298|NCT00750204|4023917|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200299|NCT00750204|4023918|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200300|NCT00750204|4023919|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200301|NCT00750204|4023917|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4200302|NCT00750204|4023918|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4200303|NCT00750204|4023919|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4200304|NCT00750204|4023917|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200305|NCT00750204|4023918|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200306|NCT00750204|4023919|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200307|NCT00750204|4023917|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200308|NCT00750204|4023918|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200309|NCT00750204|4023919|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200310|NCT00750204|4023917|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200311|NCT00750204|4023918|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200312|NCT00750204|4023919|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200313|NCT00750204|4023917|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200314|NCT00750204|4023918|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200315|NCT00750204|4023919|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200316|NCT00750204|4023917|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4200317|NCT00750204|4023918|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4200318|NCT00750204|4023919|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4200319|NCT00750204|4023917|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4200320|NCT00750204|4023918|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4200321|NCT00750204|4023919|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4200322|NCT00750204|4023917|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4200323|NCT00750204|4023918|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4200324|NCT00750204|4023919|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4200325|NCT00750204|4023917|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4200326|NCT00750204|4023918|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4200327|NCT00750204|4023919|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4200328|NCT00750204|4023917|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4200329|NCT00750204|4023918|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4200330|NCT00750204|4023919|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4200331|NCT00750191|4023926|B3|United States||Region of Enrollment||participants|Number|57|57.0||||||
4200332|NCT00750191|4023927|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4200333|NCT00750191|4023928|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4200334|NCT00750191|4023926|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4200335|NCT00750191|4023927|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4200336|NCT00750191|4023928|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4200337|NCT00750191|4023926|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4200338|NCT00750191|4023927|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4200339|NCT00750191|4023928|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4200340|NCT00750191|4023926|B3|||Age||years|Mean|39|39.0|Standard Deviation|10|10.0|||
4200341|NCT00750191|4023927|B2|||Age||years|Mean|39|39.0|Standard Deviation|10|10.0|||
4200342|NCT00750191|4023928|B1|||Age||years|Mean|40|40.0|Standard Deviation|10|10.0|||
4200343|NCT00750191|4023926|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4200344|NCT00750191|4023927|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4200345|NCT00750191|4023928|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4200346|NCT00750191|4023926|B3||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4200347|NCT00750191|4023927|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4200348|NCT00750191|4023928|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4200349|NCT00750191|4023926|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4200350|NCT00750191|4023927|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4200351|NCT00750191|4023928|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4200352|NCT00750152|4023941|B3|Puerto Rico||Region of Enrollment||participants|Number|109|109.0||||||
4200353|NCT00750152|4023942|B2|Puerto Rico||Region of Enrollment||participants|Number|55|55.0||||||
4200354|NCT00750152|4023943|B1|Puerto Rico||Region of Enrollment||participants|Number|54|54.0||||||
4200355|NCT00750152|4023941|B3|United States||Region of Enrollment||participants|Number|225|225.0||||||
4200356|NCT00750152|4023942|B2|United States||Region of Enrollment||participants|Number|113|113.0||||||
4200357|NCT00750152|4023943|B1|United States||Region of Enrollment||participants|Number|112|112.0||||||
4200358|NCT00750152|4023941|B3||Male|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
4200359|NCT00750152|4023942|B2||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4200360|NCT00750152|4023943|B1||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4200361|NCT00750152|4023941|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4200362|NCT00750152|4023942|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4200363|NCT00750152|4023943|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4200364|NCT00750152|4023941|B3|||Age||years|Mean|46.7|46.7|Standard Deviation|15.03|15.03|||
4200365|NCT00750152|4023942|B2|||Age||years|Mean|46.2|46.2|Standard Deviation|14.53|14.53|||
4200366|NCT00750152|4023943|B1|||Age||years|Mean|47.2|47.2|Standard Deviation|15.54|15.54|||
4200367|NCT00750152|4023941|B3||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
4200368|NCT00750152|4023942|B2||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4200369|NCT00750152|4023943|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4200370|NCT00750152|4023941|B3||Between 18 and 65 years|Age||Participants|Count of Participants|288|288.0||||||
4200371|NCT00750152|4023942|B2||Between 18 and 65 years|Age||Participants|Count of Participants|149|149.0||||||
4200372|NCT00750152|4023943|B1||Between 18 and 65 years|Age||Participants|Count of Participants|139|139.0||||||
4200373|NCT00750152|4023941|B3||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4200374|NCT00750152|4023942|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4200375|NCT00750152|4023943|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4200376|NCT00750139|4023952|B5|United States||Region of Enrollment||participants|Number|707|707.0||||||
4200377|NCT00750139|4023953|B4|United States||Region of Enrollment||participants|Number|119|119.0||||||
4200378|NCT00750139|4023954|B3|United States||Region of Enrollment||participants|Number|236|236.0||||||
4200379|NCT00750139|4023955|B2|United States||Region of Enrollment||participants|Number|118|118.0||||||
4200380|NCT00750139|4023956|B1|United States||Region of Enrollment||participants|Number|234|234.0||||||
4200381|NCT00750139|4023952|B5||Male|Sex: Female, Male||Participants|Count of Participants|502|502.0||||||
4200382|NCT00750139|4023953|B4||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4200383|NCT00750139|4023954|B3||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4200384|NCT00750139|4023955|B2||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4200385|NCT00750139|4023956|B1||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4200386|NCT00750139|4023952|B5||Female|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4200387|NCT00750139|4023953|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4200388|NCT00750139|4023954|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4200389|NCT00750139|4023955|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4200390|NCT00750139|4023956|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4200391|NCT00750139|4023952|B5|||Age||years|Mean|41.7|41.7|Standard Deviation|13.52|13.52|||
4200392|NCT00750139|4023953|B4|||Age||years|Mean|41.4|41.4|Standard Deviation|14.00|14.0|||
4200393|NCT00750139|4023954|B3|||Age||years|Mean|41.4|41.4|Standard Deviation|14.08|14.08|||
4200394|NCT00750139|4023955|B2|||Age||years|Mean|41.0|41.0|Standard Deviation|12.91|12.91|||
4200395|NCT00750139|4023956|B1|||Age||years|Mean|42.7|42.7|Standard Deviation|13.03|13.03|||
4200396|NCT00750139|4023952|B5||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4200397|NCT00750139|4023953|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4200398|NCT00750139|4023954|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4200399|NCT00750139|4023955|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4200400|NCT00750139|4023956|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4200401|NCT00750139|4023952|B5||Between 18 and 65 years|Age||Participants|Count of Participants|658|658.0||||||
4200402|NCT00750139|4023953|B4||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
4200403|NCT00750139|4023954|B3||Between 18 and 65 years|Age||Participants|Count of Participants|212|212.0||||||
4200404|NCT00750139|4023955|B2||Between 18 and 65 years|Age||Participants|Count of Participants|115|115.0||||||
4200405|NCT00750139|4023956|B1||Between 18 and 65 years|Age||Participants|Count of Participants|220|220.0||||||
4200406|NCT00750139|4023952|B5||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
4200407|NCT00750139|4023953|B4||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4200408|NCT00750139|4023954|B3||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4200409|NCT00750139|4023955|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4200410|NCT00750139|4023956|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4200411|NCT00750061|4023973|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4200412|NCT00750061|4023974|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4200413|NCT00750061|4023975|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4200414|NCT00750061|4023973|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4200415|NCT00750061|4023974|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4200416|NCT00750061|4023975|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4200417|NCT00750061|4023973|B3|51-60 years-old||Age, Customized||participants|Number|4|4.0||||||
4200418|NCT00750061|4023974|B2|51-60 years-old||Age, Customized||participants|Number|1|1.0||||||
4200419|NCT00750061|4023975|B1|51-60 years-old||Age, Customized||participants|Number|3|3.0||||||
4200420|NCT00750061|4023973|B3|41-50 years-old||Age, Customized||participants|Number|14|14.0||||||
4200421|NCT00750061|4023974|B2|41-50 years-old||Age, Customized||participants|Number|10|10.0||||||
4200422|NCT00750061|4023975|B1|41-50 years-old||Age, Customized||participants|Number|4|4.0||||||
4200423|NCT00750061|4023973|B3|31-40 years-old||Age, Customized||participants|Number|17|17.0||||||
4200424|NCT00750061|4023974|B2|31-40 years-old||Age, Customized||participants|Number|8|8.0||||||
4200425|NCT00750061|4023975|B1|31-40 years-old||Age, Customized||participants|Number|9|9.0||||||
4200426|NCT00750061|4023973|B3|18-30 years-old||Age, Customized||participants|Number|5|5.0||||||
4200427|NCT00750061|4023974|B2|18-30 years-old||Age, Customized||participants|Number|1|1.0||||||
4200428|NCT00750061|4023975|B1|18-30 years-old||Age, Customized||participants|Number|4|4.0||||||
4200429|NCT00750061|4023973|B3|||Age||Year|Mean|39.624|39.624|Standard Deviation|8.617|8.617|||
4200430|NCT00750061|4023974|B2|||Age||Year|Mean|41.4|41.4|Standard Deviation|6.785|6.785|||
4200431|NCT00750061|4023975|B1|||Age||Year|Mean|38.05|38.05|Standard Deviation|10.092|10.092|||
4200432|NCT00749996|4023984|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4200433|NCT00749996|4023985|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4200434|NCT00749996|4023986|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4200435|NCT00749996|4023984|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4200436|NCT00749996|4023985|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4200437|NCT00749996|4023986|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4200438|NCT00749996|4023984|B3|||Age||years|Mean|41.0|41.0|Standard Deviation|10.3|10.3|||
4200439|NCT00749996|4023985|B2|||Age||years|Mean|40.7|40.7|Standard Deviation|10.7|10.7|||
4200440|NCT00749996|4023986|B1|||Age||years|Mean|41.3|41.3|Standard Deviation|10|10.0|||
4200441|NCT00749957|4023995|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4200442|NCT00749957|4023996|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4200443|NCT00749957|4023997|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4200444|NCT00749957|4023995|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200445|NCT00749957|4023996|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200446|NCT00749957|4023997|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200447|NCT00749957|4023995|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200448|NCT00749957|4023996|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200449|NCT00749957|4023997|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200450|NCT00749957|4023995|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4200451|NCT00749957|4023996|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4200452|NCT00749957|4023997|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4200453|NCT00749957|4023995|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4200454|NCT00749957|4023996|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200455|NCT00749957|4023997|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4200456|NCT00749957|4023995|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200632|NCT00749268|4024204|B4|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4200457|NCT00749957|4023996|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200458|NCT00749957|4023997|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200459|NCT00749957|4023995|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4200460|NCT00749957|4023996|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4200461|NCT00749957|4023997|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200462|NCT00749957|4023995|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200463|NCT00749957|4023996|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200464|NCT00749957|4023997|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200465|NCT00749957|4023995|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200466|NCT00749957|4023996|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200467|NCT00749957|4023997|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200468|NCT00749957|4023995|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4200469|NCT00749957|4023996|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4200470|NCT00749957|4023997|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4200471|NCT00749957|4023995|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4200472|NCT00749957|4023996|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4200473|NCT00749957|4023997|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4200474|NCT00749957|4023995|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4200475|NCT00749957|4023996|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4200476|NCT00749957|4023997|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4200477|NCT00749957|4023995|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4200478|NCT00749957|4023996|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4200479|NCT00749957|4023997|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4200480|NCT00749957|4023995|B3|||Age||years|Median|31|31.0|Full Range|||6.0|39.0|
4200481|NCT00749957|4023996|B2|||Age||years|Median|31|31.0|Full Range|||6.0|37.0|
4200482|NCT00749957|4023997|B1|||Age||years|Median|22|22.0|Full Range|||6.0|39.0|
4200483|NCT00749957|4023995|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4200484|NCT00749957|4023996|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4200485|NCT00749957|4023997|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4200486|NCT00749957|4023995|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4200487|NCT00749957|4023996|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4200488|NCT00749957|4023997|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4200489|NCT00749957|4023995|B3||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4200490|NCT00749957|4023996|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4200491|NCT00749957|4023997|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4200492|NCT00749944|4024008|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4200493|NCT00749944|4024009|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4200494|NCT00749944|4024010|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4200495|NCT00749944|4024008|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4200496|NCT00749944|4024009|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4200497|NCT00749944|4024010|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4200498|NCT00749944|4024008|B3|>= 65 years||Age, Customized||Participants|Number|1|1.0||||||
4200499|NCT00749944|4024009|B2|>= 65 years||Age, Customized||Participants|Number|0|0.0||||||
4200500|NCT00749944|4024010|B1|>= 65 years||Age, Customized||Participants|Number|1|1.0||||||
4200501|NCT00749944|4024008|B3|Between 45 and 64 years||Age, Customized||Participants|Number|15|15.0||||||
4200502|NCT00749944|4024009|B2|Between 45 and 64 years||Age, Customized||Participants|Number|8|8.0||||||
4200503|NCT00749944|4024010|B1|Between 45 and 64 years||Age, Customized||Participants|Number|7|7.0||||||
4200504|NCT00749944|4024008|B3|Between 18 and 44 years||Age, Customized||Participants|Number|94|94.0||||||
4200505|NCT00749944|4024009|B2|Between 18 and 44 years||Age, Customized||Participants|Number|47|47.0||||||
4200506|NCT00749944|4024010|B1|Between 18 and 44 years||Age, Customized||Participants|Number|47|47.0||||||
4200507|NCT00749931|4024077|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4200508|NCT00749931|4024078|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4200509|NCT00749931|4024079|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4200510|NCT00749931|4024077|B3||Female|Sex: Female, Male||Participants|Count of Participants|596|596.0||||||
4200511|NCT00749931|4024078|B2||Female|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
4200512|NCT00749931|4024079|B1||Female|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
4200513|NCT00749931|4024077|B3|||Age||years|Mean|60.3|60.3|Standard Deviation|11.3|11.3|||
4200514|NCT00749931|4024078|B2|||Age||years|Mean|60.3|60.3|Standard Deviation|11.4|11.4|||
4200515|NCT00749931|4024079|B1|||Age||years|Mean|60.2|60.2|Standard Deviation|11.1|11.1|||
4200516|NCT00749775|4024090|B1||Male|Sex: Female, Male||Participants|Count of Participants|1671|1671.0||||||
4200517|NCT00749775|4024090|B1||Female|Sex: Female, Male||Participants|Count of Participants|1539|1539.0||||||
4200518|NCT00749775|4024090|B1|>=65 years old||Age, Customized||participants|Number|1986|1986.0||||||
4200519|NCT00749775|4024090|B1|<65 years old||Age, Customized||participants|Number|1224|1224.0||||||
4200520|NCT00749684|4024106|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||12.91|12.91|||
4200521|NCT00749684|4024106|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||12.49|12.49|||
4200522|NCT00749684|4024106|B1|Female||Age||participants|Median|48.27|48.27|Standard Deviation|12.49|12.49|||
4200523|NCT00749684|4024106|B1|Male||Age||participants|Median|49.15|49.15|Standard Deviation|12.91|12.91|||
4200524|NCT00749684|4024106|B1|Total||Age||participants|Median|48.83|48.83|Standard Deviation|12.72|12.72|||
4200525|NCT00749671|4024111|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4200526|NCT00749671|4024112|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4200527|NCT00749671|4024113|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4200528|NCT00749671|4024111|B3||Male|Sex: Female, Male|While gender was recorded at baseline, we no longer have access to the dataset to tabulate|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4200529|NCT00749671|4024112|B2||Male|Sex: Female, Male|While gender was recorded at baseline, we no longer have access to the dataset to tabulate|Participants|Count of Participants|NA|||||||dataset not accessible
4200530|NCT00749671|4024113|B1||Male|Sex: Female, Male|While gender was recorded at baseline, we no longer have access to the dataset to tabulate|Participants|Count of Participants|NA|||||||dataset not accessible
4200531|NCT00749671|4024111|B3||Female|Sex: Female, Male|While gender was recorded at baseline, we no longer have access to the dataset to tabulate|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4200532|NCT00749671|4024112|B2||Female|Sex: Female, Male|While gender was recorded at baseline, we no longer have access to the dataset to tabulate|Participants|Count of Participants|NA|||||||dataset not accessible
4200533|NCT00749671|4024113|B1||Female|Sex: Female, Male|While gender was recorded at baseline, we no longer have access to the dataset to tabulate|Participants|Count of Participants|NA|||||||dataset not accessible
4200534|NCT00749671|4024111|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4200535|NCT00749671|4024112|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4200536|NCT00749671|4024113|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4200537|NCT00749671|4024111|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4200538|NCT00749671|4024112|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4200539|NCT00749671|4024113|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4200540|NCT00749671|4024111|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4200541|NCT00749671|4024112|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4200542|NCT00749671|4024113|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4200543|NCT00749606|4024122|B3|||Weight||kg|Mean|107.6|107.6|Standard Deviation|24.9|24.9|||
4200544|NCT00749606|4024123|B2|||Weight||kg|Mean|109.4|109.4|Standard Deviation|26.1|26.1|||
4200545|NCT00749606|4024124|B1|||Weight||kg|Mean|105.8|105.8|Standard Deviation|23.6|23.6|||
4200546|NCT00749606|4024122|B3|United States||Region of Enrollment||participants|Number|257|257.0||||||
4200547|NCT00749606|4024123|B2|United States||Region of Enrollment||participants|Number|128|128.0||||||
4200548|NCT00749606|4024124|B1|United States||Region of Enrollment||participants|Number|129|129.0||||||
4200549|NCT00749606|4024122|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4200550|NCT00749606|4024123|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200551|NCT00749606|4024124|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4200552|NCT00749606|4024122|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200553|NCT00749606|4024123|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200554|NCT00749606|4024124|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200555|NCT00749606|4024122|B3||White|Race (NIH/OMB)||Participants|Count of Participants|222|222.0||||||
4200556|NCT00749606|4024123|B2||White|Race (NIH/OMB)||Participants|Count of Participants|112|112.0||||||
4200557|NCT00749606|4024124|B1||White|Race (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
4200558|NCT00749606|4024122|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4200559|NCT00749606|4024123|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4200560|NCT00749606|4024124|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4200561|NCT00749606|4024122|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200562|NCT00749606|4024123|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200563|NCT00749606|4024124|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200564|NCT00749606|4024122|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4200565|NCT00749606|4024123|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4200566|NCT00749606|4024124|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200567|NCT00749606|4024122|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200568|NCT00749606|4024123|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200569|NCT00749606|4024124|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200633|NCT00749268|4024205|B3|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4200570|NCT00749606|4024122|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200571|NCT00749606|4024123|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200572|NCT00749606|4024124|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200573|NCT00749606|4024122|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|254|254.0||||||
4200574|NCT00749606|4024123|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
4200575|NCT00749606|4024124|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
4200576|NCT00749606|4024122|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4200577|NCT00749606|4024123|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4200578|NCT00749606|4024124|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4200579|NCT00749606|4024122|B3||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4200580|NCT00749606|4024123|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4200581|NCT00749606|4024124|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4200582|NCT00749606|4024122|B3||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4200583|NCT00749606|4024123|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4200584|NCT00749606|4024124|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4200585|NCT00749606|4024122|B3|||Age||years|Mean|51.7|51.7|Standard Deviation|12.9|12.9|||
4200586|NCT00749606|4024123|B2|||Age||years|Mean|52.7|52.7|Standard Deviation|12.8|12.8|||
4200587|NCT00749606|4024124|B1|||Age||years|Mean|50.7|50.7|Standard Deviation|13.1|13.1|||
4200588|NCT00749580|4024143|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
4200589|NCT00749580|4024144|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4200590|NCT00749580|4024145|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4200591|NCT00749580|4024143|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4200592|NCT00749580|4024144|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4200593|NCT00749580|4024145|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4200594|NCT00749580|4024143|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4200595|NCT00749580|4024144|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4200596|NCT00749580|4024145|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4200597|NCT00749580|4024143|B3|||Age||years|Mean|47|47.0|Standard Deviation|9|9.0|||
4200598|NCT00749580|4024144|B2|||Age||years|Mean|49|49.0|Standard Deviation|8|8.0|||
4200599|NCT00749580|4024145|B1|||Age||years|Mean|45|45.0|Standard Deviation|9|9.0|||
4200600|NCT00749580|4024143|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4200601|NCT00749580|4024144|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4200602|NCT00749580|4024145|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4200603|NCT00749580|4024143|B3||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4200604|NCT00749580|4024144|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4200605|NCT00749580|4024145|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4200606|NCT00749580|4024143|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4200607|NCT00749580|4024144|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4200608|NCT00749580|4024145|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4200609|NCT00749476|4024154|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4200610|NCT00749476|4024154|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4200611|NCT00749476|4024154|B1|||Age||years|Mean|27.0|27.0|Standard Deviation|0.0|0.0|||
4200612|NCT00749463|4024158|B4|China||Region of Enrollment||participants|Number|300|300.0||||||
4200613|NCT00749463|4024159|B3|China||Region of Enrollment||participants|Number|150|150.0||||||
4200614|NCT00749463|4024160|B2|China||Region of Enrollment||participants|Number|64|64.0||||||
4200615|NCT00749463|4024161|B1|China||Region of Enrollment||participants|Number|86|86.0||||||
4200616|NCT00749463|4024158|B4||Male|Sex: Female, Male||Participants|Count of Participants|297|297.0||||||
4200617|NCT00749463|4024159|B3||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4200618|NCT00749463|4024160|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4200619|NCT00749463|4024161|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4200620|NCT00749463|4024158|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4200621|NCT00749463|4024159|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4200622|NCT00749463|4024160|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4200623|NCT00749463|4024161|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4200624|NCT00749463|4024158|B4|||Age||years|Mean|41.1|41.1|Standard Deviation|10.9|10.9|||
4200625|NCT00749463|4024159|B3|||Age||years|Mean|41.7|41.7|Standard Deviation|11.6|11.6|||
4200626|NCT00749463|4024160|B2|||Age||years|Mean|40.3|40.3|Standard Deviation|10.0|10.0|||
4200627|NCT00749463|4024161|B1|||Age||years|Mean|40.6|40.6|Standard Deviation|10.2|10.2|||
4200628|NCT00749398|4024189|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4200629|NCT00749398|4024189|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4200630|NCT00749398|4024189|B1|||Age||years|Mean|46.9|46.9|Standard Deviation|13.7|13.7|||
4200631|NCT00749268|4024203|B5|Germany||Region of Enrollment||participants|Number|22|22.0||||||
4200634|NCT00749268|4024206|B2|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4200635|NCT00749268|4024207|B1|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4200636|NCT00749268|4024203|B5|France||Region of Enrollment||participants|Number|65|65.0||||||
4200637|NCT00749268|4024204|B4|France||Region of Enrollment||participants|Number|19|19.0||||||
4200638|NCT00749268|4024205|B3|France||Region of Enrollment||participants|Number|19|19.0||||||
4200639|NCT00749268|4024206|B2|France||Region of Enrollment||participants|Number|13|13.0||||||
4200640|NCT00749268|4024207|B1|France||Region of Enrollment||participants|Number|14|14.0||||||
4200641|NCT00749268|4024203|B5|United States||Region of Enrollment||participants|Number|127|127.0||||||
4200642|NCT00749268|4024204|B4|United States||Region of Enrollment||participants|Number|29|29.0||||||
4200643|NCT00749268|4024205|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4200644|NCT00749268|4024206|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4200645|NCT00749268|4024207|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4200646|NCT00749268|4024203|B5||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4200647|NCT00749268|4024204|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4200648|NCT00749268|4024205|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4200649|NCT00749268|4024206|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4200650|NCT00749268|4024207|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4200651|NCT00749268|4024203|B5||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4200652|NCT00749268|4024204|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4200653|NCT00749268|4024205|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4200654|NCT00749268|4024206|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4200655|NCT00749268|4024207|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4200656|NCT00749268|4024203|B5|||Age||years|Mean|51.49|51.49|Standard Deviation|13.15|13.15|||
4200657|NCT00749268|4024204|B4|||Age||years|Mean|53.8|53.8|Standard Deviation|12.9|12.9|||
4200658|NCT00749268|4024205|B3|||Age||years|Mean|50.3|50.3|Standard Deviation|11.3|11.3|||
4200659|NCT00749268|4024206|B2|||Age||years|Mean|53.3|53.3|Standard Deviation|12.3|12.3|||
4200660|NCT00749268|4024207|B1|||Age||years|Mean|48.6|48.6|Standard Deviation|15.5|15.5|||
4200661|NCT00749203|4024230|B3|||Quick Inventory of Depressive Symptomatology, Self-Report (QIDS-SR) score|Each item is rated 0 (no depression) to 3 (severe depression). The total score ranges from 0-27.|units on a scale|Mean|11.9|11.9|Standard Deviation|5.4|5.4|||
4200662|NCT00749203|4024231|B2|||Quick Inventory of Depressive Symptomatology, Self-Report (QIDS-SR) score|Each item is rated 0 (no depression) to 3 (severe depression). The total score ranges from 0-27.|units on a scale|Mean|11.3|11.3|Standard Deviation|5.6|5.6|||
4200663|NCT00749203|4024232|B1|||Quick Inventory of Depressive Symptomatology, Self-Report (QIDS-SR) score|Each item is rated 0 (no depression) to 3 (severe depression). The total score ranges from 0-27.|units on a scale|Mean|12.4|12.4|Standard Deviation|5.2|5.2|||
4200664|NCT00749203|4024230|B3|||Clinician-Administered PTSD Scale (CAPS) score (past month)|"frequency score - scale 0 = none of the time to 4 = most or all of the time intensity score - scale 0 = none to 4 = extreme To meet criteria for a symptom, a patient must meet criteria in both frequency and intensity score for each item. Frequency and intensity and then combined to form a single severity score.~30 questions scale, with total score ranging from 0 to 240."|units on a scale|Mean|80.0|80.0|Standard Deviation|13.0|13.0|||
4200665|NCT00749203|4024231|B2|||Clinician-Administered PTSD Scale (CAPS) score (past month)|"frequency score - scale 0 = none of the time to 4 = most or all of the time intensity score - scale 0 = none to 4 = extreme To meet criteria for a symptom, a patient must meet criteria in both frequency and intensity score for each item. Frequency and intensity and then combined to form a single severity score.~30 questions scale, with total score ranging from 0 to 240."|units on a scale|Mean|77.1|77.1|Standard Deviation|11.8|11.8|||
4200666|NCT00749203|4024232|B1|||Clinician-Administered PTSD Scale (CAPS) score (past month)|"frequency score - scale 0 = none of the time to 4 = most or all of the time intensity score - scale 0 = none to 4 = extreme To meet criteria for a symptom, a patient must meet criteria in both frequency and intensity score for each item. Frequency and intensity and then combined to form a single severity score.~30 questions scale, with total score ranging from 0 to 240."|units on a scale|Mean|82.5|82.5|Standard Deviation|14.1|14.1|||
4200667|NCT00749203|4024230|B3|||History of treatment with psychotropic medication||percentage of participants|Number|92.1|92.1||||||
4200668|NCT00749203|4024231|B2|||History of treatment with psychotropic medication||percentage of participants|Number|42.1|42.1||||||
4200669|NCT00749203|4024232|B1|||History of treatment with psychotropic medication||percentage of participants|Number|50|50.0||||||
4200670|NCT00749203|4024230|B3|||Duration of PTSD||years|Mean|13.1|13.1|Standard Deviation|13.1|13.1|||
4200671|NCT00749203|4024231|B2|||Duration of PTSD||years|Mean|11.9|11.9|Standard Deviation|14.0|14.0|||
4200672|NCT00749203|4024232|B1|||Duration of PTSD||years|Mean|14.2|14.2|Standard Deviation|12.3|12.3|||
4200673|NCT00749203|4024230|B3|Unknown||Primary Trauma||participants|Number|4|4.0||||||
4200674|NCT00749203|4024231|B2|Unknown||Primary Trauma||participants|Number|4|4.0||||||
4200675|NCT00749203|4024232|B1|Unknown||Primary Trauma||participants|Number|0|0.0||||||
4200676|NCT00749203|4024230|B3|Witnessed 9/11 terrorist attacks||Primary Trauma||participants|Number|2|2.0||||||
4200677|NCT00749203|4024231|B2|Witnessed 9/11 terrorist attacks||Primary Trauma||participants|Number|0|0.0||||||
4200678|NCT00749203|4024232|B1|Witnessed 9/11 terrorist attacks||Primary Trauma||participants|Number|2|2.0||||||
4200679|NCT00749203|4024230|B3|Witnessed violent assault or death||Primary Trauma||participants|Number|9|9.0||||||
4200680|NCT00749203|4024231|B2|Witnessed violent assault or death||Primary Trauma||participants|Number|5|5.0||||||
4200681|NCT00749203|4024232|B1|Witnessed violent assault or death||Primary Trauma||participants|Number|4|4.0||||||
4200682|NCT00749203|4024230|B3|Combat exposure||Primary Trauma||participants|Number|2|2.0||||||
4200683|NCT00749203|4024231|B2|Combat exposure||Primary Trauma||participants|Number|0|0.0||||||
4200684|NCT00749203|4024232|B1|Combat exposure||Primary Trauma||participants|Number|2|2.0||||||
4200685|NCT00749203|4024230|B3|Accident or fire||Primary Trauma||participants|Number|4|4.0||||||
4200686|NCT00749203|4024231|B2|Accident or fire||Primary Trauma||participants|Number|3|3.0||||||
4200687|NCT00749203|4024232|B1|Accident or fire||Primary Trauma||participants|Number|1|1.0||||||
4200688|NCT00749203|4024230|B3|Physical assault or abuse||Primary Trauma||participants|Number|11|11.0||||||
4200689|NCT00749203|4024231|B2|Physical assault or abuse||Primary Trauma||participants|Number|7|7.0||||||
4200690|NCT00749203|4024232|B1|Physical assault or abuse||Primary Trauma||participants|Number|4|4.0||||||
4200691|NCT00749203|4024230|B3|Sexual assault or molestation||Primary Trauma||participants|Number|9|9.0||||||
4200692|NCT00749203|4024231|B2|Sexual assault or molestation||Primary Trauma||participants|Number|0|0.0||||||
4200693|NCT00749203|4024232|B1|Sexual assault or molestation||Primary Trauma||participants|Number|9|9.0||||||
4200694|NCT00749203|4024230|B3|||Percentage Unemployed||percentage of participants|Number|123.7|123.7||||||
4200695|NCT00749203|4024231|B2|||Percentage Unemployed||percentage of participants|Number|73.7|73.7||||||
4200696|NCT00749203|4024232|B1|||Percentage Unemployed||percentage of participants|Number|50|50.0||||||
4200697|NCT00749203|4024230|B3|unknown||Education||participants|Number|1|1.0||||||
4200698|NCT00749203|4024231|B2|unknown||Education||participants|Number|0|0.0||||||
4200699|NCT00749203|4024232|B1|unknown||Education||participants|Number|1|1.0||||||
4200700|NCT00749203|4024230|B3|more than 4 years of college||Education||participants|Number|7|7.0||||||
4200701|NCT00749203|4024231|B2|more than 4 years of college||Education||participants|Number|2|2.0||||||
4200702|NCT00749203|4024232|B1|more than 4 years of college||Education||participants|Number|5|5.0||||||
4200703|NCT00749203|4024230|B3|some college||Education||participants|Number|26|26.0||||||
4200704|NCT00749203|4024231|B2|some college||Education||participants|Number|14|14.0||||||
4200705|NCT00749203|4024232|B1|some college||Education||participants|Number|12|12.0||||||
4200706|NCT00749203|4024230|B3|high school graduate||Education||participants|Number|6|6.0||||||
4200707|NCT00749203|4024231|B2|high school graduate||Education||participants|Number|3|3.0||||||
4200708|NCT00749203|4024232|B1|high school graduate||Education||participants|Number|3|3.0||||||
4200709|NCT00749203|4024230|B3|less than high school||Education||participants|Number|1|1.0||||||
4200710|NCT00749203|4024231|B2|less than high school||Education||participants|Number|0|0.0||||||
4200711|NCT00749203|4024232|B1|less than high school||Education||participants|Number|1|1.0||||||
4200712|NCT00749203|4024230|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4200713|NCT00749203|4024231|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4200714|NCT00749203|4024232|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4200715|NCT00749203|4024230|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200716|NCT00749203|4024231|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200717|NCT00749203|4024232|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200718|NCT00749203|4024230|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4200719|NCT00749203|4024231|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4200720|NCT00749203|4024232|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4200721|NCT00749203|4024230|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4200722|NCT00749203|4024231|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4200723|NCT00749203|4024232|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4200724|NCT00749203|4024230|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200725|NCT00749203|4024231|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200726|NCT00749203|4024232|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200727|NCT00749203|4024230|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200728|NCT00749203|4024231|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200729|NCT00749203|4024232|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200730|NCT00749203|4024230|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200731|NCT00749203|4024231|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200732|NCT00749203|4024232|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200733|NCT00749203|4024230|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4200734|NCT00749203|4024231|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4200735|NCT00749203|4024232|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4200736|NCT00749203|4024230|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4200737|NCT00749203|4024231|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4200738|NCT00749203|4024232|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4200739|NCT00749203|4024230|B3|||Age||years|Mean|36.05|36.05|Standard Deviation|10.3|10.3|||
4200740|NCT00749203|4024231|B2|||Age||years|Mean|35.7|35.7|Standard Deviation|10.0|10.0|||
4200741|NCT00749203|4024232|B1|||Age||years|Mean|36.4|36.4|Standard Deviation|10.8|10.8|||
4200742|NCT00749190|4024247|B8||Male|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
4200743|NCT00749190|4024248|B7||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4200744|NCT00749190|4024249|B6||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4200745|NCT00749190|4024250|B5||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4200746|NCT00749190|4024251|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4200747|NCT00749190|4024252|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4200748|NCT00749190|4024253|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4200749|NCT00749190|4024254|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4200750|NCT00749190|4024247|B8||Female|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4200751|NCT00749190|4024248|B7||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4200752|NCT00749190|4024249|B6||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4200753|NCT00749190|4024250|B5||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4200754|NCT00749190|4024251|B4||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4200755|NCT00749190|4024252|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4200756|NCT00749190|4024253|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4200757|NCT00749190|4024254|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4200758|NCT00749190|4024247|B8|||Age||years|Mean|58.3|58.3|Standard Deviation|8.8|8.8|||
4200759|NCT00749190|4024248|B7|||Age||years|Mean|57.6|57.6|Standard Deviation|10.1|10.1|||
4200760|NCT00749190|4024249|B6|||Age||years|Mean|55.9|55.9|Standard Deviation|9.4|9.4|||
4200761|NCT00749190|4024250|B5|||Age||years|Mean|58.7|58.7|Standard Deviation|8.1|8.1|||
4200762|NCT00749190|4024251|B4|||Age||years|Mean|59.0|59.0|Standard Deviation|9.0|9.0|||
4200763|NCT00749190|4024252|B3|||Age||years|Mean|59.7|59.7|Standard Deviation|7.3|7.3|||
4200764|NCT00749190|4024253|B2|||Age||years|Mean|57.4|57.4|Standard Deviation|8.8|8.8|||
4200765|NCT00749190|4024254|B1|||Age||years|Mean|59.7|59.7|Standard Deviation|8.5|8.5|||
4200766|NCT00749125|4024337|B3|United States||Region of Enrollment||participants|Number|99|99.0||||||
4200767|NCT00749125|4024338|B2|United States||Region of Enrollment||participants|Number|47|47.0||||||
4200768|NCT00749125|4024339|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
4200769|NCT00749125|4024337|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4200770|NCT00749125|4024338|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4200771|NCT00749125|4024339|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4200772|NCT00749125|4024337|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4200773|NCT00749125|4024338|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4200774|NCT00749125|4024339|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4200775|NCT00749125|4024337|B3|||Age||years|Mean|34.2|34.2|Standard Deviation|9.1|9.1|||
4200776|NCT00749125|4024338|B2|||Age||years|Mean|32.15|32.15|Standard Deviation|8.228|8.228|||
4200777|NCT00749125|4024339|B1|||Age||years|Mean|36.04|36.04|Standard Deviation|9.605|9.605|||
4200778|NCT00749125|4024337|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4200779|NCT00749125|4024338|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4200780|NCT00749125|4024339|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4200781|NCT00749125|4024337|B3||Between 18 and 65 years|Age||Participants|Count of Participants|99|99.0||||||
4200782|NCT00749125|4024338|B2||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4200783|NCT00749125|4024339|B1||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4200784|NCT00749125|4024337|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4200785|NCT00749125|4024338|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4200786|NCT00749125|4024339|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4200787|NCT00749073|4024346|B1|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4200788|NCT00749073|4024346|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4200789|NCT00749073|4024346|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4200790|NCT00749073|4024346|B1|||Age||years|Mean|62.9|62.9|Standard Deviation|12.84|12.84|||
4200791|NCT00749073|4024346|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4200792|NCT00749073|4024346|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4200793|NCT00749073|4024346|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4200794|NCT00748982|4024352|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4200795|NCT00748982|4024353|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4200796|NCT00748982|4024354|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4200797|NCT00748982|4024352|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4200798|NCT00748982|4024353|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4200799|NCT00748982|4024354|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4200800|NCT00748982|4024352|B3|||Age||Years|Mean|4|4.0|Standard Deviation|254|254.0|||
4200801|NCT00748982|4024353|B2|||Age||Years|Mean|3|3.0|Standard Deviation|65|65.0|||
4200802|NCT00748982|4024354|B1|||Age||Years|Mean|5|5.0|Standard Deviation|62|62.0|||
4200803|NCT00748969|4024367|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4200804|NCT00748969|4024368|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4200805|NCT00748969|4024369|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4200806|NCT00748969|4024367|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4200807|NCT00748969|4024368|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4200808|NCT00748969|4024369|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4200809|NCT00748969|4024367|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4200810|NCT00748969|4024368|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4200811|NCT00748969|4024369|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4200812|NCT00748969|4024367|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4200813|NCT00748969|4024368|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4200814|NCT00748969|4024369|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4200815|NCT00748969|4024367|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4200816|NCT00748969|4024368|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4200817|NCT00748969|4024369|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4200818|NCT00748969|4024367|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4200819|NCT00748969|4024368|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4200820|NCT00748969|4024369|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4200821|NCT00748969|4024367|B3|||Age||years|Mean|12.2|12.2|Full Range|||10.9|13.5|
4200822|NCT00748969|4024368|B2|||Age||years|Mean|13.5|13.5|Full Range|||13.5|13.5|
4200823|NCT00748969|4024369|B1|||Age||years|Mean|10.9|10.9|Full Range|||10.9|10.9|
4200824|NCT00748956|4024378|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4200825|NCT00748956|4024379|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4200826|NCT00748956|4024380|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4200827|NCT00748956|4024378|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4200828|NCT00748956|4024379|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4200829|NCT00748956|4024380|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4200830|NCT00748956|4024378|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4200831|NCT00748956|4024379|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4200832|NCT00748956|4024380|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4200833|NCT00748956|4024378|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4200834|NCT00748956|4024379|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4200835|NCT00748956|4024380|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4200836|NCT00748956|4024378|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4200837|NCT00748956|4024379|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4200838|NCT00748956|4024380|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4200839|NCT00748865|4024406|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4200840|NCT00748865|4024406|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4200841|NCT00748865|4024406|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4200842|NCT00748865|4024406|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4200843|NCT00748865|4024406|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4200844|NCT00748826|4024413|B1||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4200845|NCT00748826|4024413|B1||Female|Sex: Female, Male||Participants|Count of Participants|357|357.0||||||
4200846|NCT00748826|4024413|B1|||Age||years|Mean|52.80|52.8|Standard Deviation|13.56|13.56|||
4200847|NCT00748709|4024420|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4200848|NCT00748709|4024420|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4200849|NCT00748709|4024420|B1|||Age||years|Mean|64.1|64.1|Standard Deviation|6.2|6.2|||
4200850|NCT00748657|4024432|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4200851|NCT00748657|4024432|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4200852|NCT00748657|4024432|B1|80-89||Age, Customized||participants|Number|0|0.0||||||
4200853|NCT00748657|4024432|B1|70-79||Age, Customized||participants|Number|4|4.0||||||
4200854|NCT00748657|4024432|B1|60-69||Age, Customized||participants|Number|11|11.0||||||
4200855|NCT00748657|4024432|B1|50-59||Age, Customized||participants|Number|12|12.0||||||
4200856|NCT00748657|4024432|B1|40-49||Age, Customized||participants|Number|8|8.0||||||
4200857|NCT00748657|4024432|B1|30-39||Age, Customized||participants|Number|1|1.0||||||
4200858|NCT00748657|4024432|B1|20-29||Age, Customized||participants|Number|0|0.0||||||
4200859|NCT00748579|4024444|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4200860|NCT00748579|4024446|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4200861|NCT00748579|4024444|B3|Male||Gender||participants|Number|0|0.0||||||
4200862|NCT00748579|4024446|B1|Male||Gender||participants|Number|0|0.0||||||
4200863|NCT00748579|4024444|B3|Female||Gender||participants|Number|2|2.0||||||
4200864|NCT00748579|4024446|B1|Female||Gender||participants|Number|2|2.0||||||
4200865|NCT00748579|4024444|B3|||Age||years|Mean|69|69.0|Standard Deviation|13|13.0|||
4200866|NCT00748579|4024446|B1|||Age||years|Mean|69|69.0|Standard Deviation|13|13.0|||
4200867|NCT00748579|4024444|B3|>=65 years||Age||participants|Number|1|1.0||||||
4200868|NCT00748579|4024446|B1|>=65 years||Age||participants|Number|1|1.0||||||
4200869|NCT00748579|4024444|B3|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
4200870|NCT00748579|4024446|B1|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
4200871|NCT00748579|4024444|B3|<=18 years||Age||participants|Number|0|0.0||||||
4200872|NCT00748579|4024446|B1|<=18 years||Age||participants|Number|0|0.0||||||
4200873|NCT00748566|4024453|B1||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4200874|NCT00748566|4024453|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4200875|NCT00748566|4024453|B1|||Age||years|Mean|37.9|37.9|Standard Deviation|12.2|12.2|||
4200876|NCT00748553|4024481|B3|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4200877|NCT00748553|4024482|B2|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4200878|NCT00748553|4024483|B1|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4200879|NCT00748553|4024481|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200880|NCT00748553|4024482|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200881|NCT00748553|4024483|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200882|NCT00748553|4024481|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4200883|NCT00748553|4024482|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4200884|NCT00748553|4024483|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200885|NCT00748553|4024481|B3||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4200886|NCT00748553|4024482|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4200887|NCT00748553|4024483|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4200888|NCT00748553|4024481|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4200889|NCT00748553|4024482|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4200890|NCT00748553|4024483|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4200891|NCT00748553|4024481|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200892|NCT00748553|4024482|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200893|NCT00748553|4024483|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200894|NCT00748553|4024481|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200895|NCT00748553|4024482|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200896|NCT00748553|4024483|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200897|NCT00748553|4024481|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200898|NCT00748553|4024482|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200899|NCT00748553|4024483|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200900|NCT00748553|4024481|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4200901|NCT00748553|4024482|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4200902|NCT00748553|4024483|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4200903|NCT00748553|4024481|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4200904|NCT00748553|4024482|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4200905|NCT00748553|4024483|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4200906|NCT00748553|4024481|B3|||Age||years|Median|63.5|63.5|Full Range|||21.0|83.0|
4200907|NCT00748553|4024482|B2|||Age||years|Median|62|62.0|Full Range|||21.0|83.0|
4200908|NCT00748553|4024483|B1|||Age||years|Median|65|65.0|Full Range|||38.0|77.0|
4200909|NCT00748540|4024491|B1|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
4200910|NCT00748540|4024491|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4200911|NCT00748540|4024491|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4200912|NCT00748540|4024491|B1|||Age||years|Mean|46|46.0|Full Range|||18.0|75.0|
4200913|NCT00748540|4024491|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4200914|NCT00748540|4024491|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4200915|NCT00748540|4024491|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4200916|NCT00748410|4024498|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200917|NCT00748410|4024499|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200918|NCT00748410|4024500|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200919|NCT00748410|4024498|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4200920|NCT00748410|4024499|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4200921|NCT00748410|4024500|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4200922|NCT00748410|4024498|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200923|NCT00748410|4024499|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200924|NCT00748410|4024500|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200925|NCT00748410|4024498|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4200926|NCT00748410|4024499|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4200927|NCT00748410|4024500|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4200928|NCT00748410|4024498|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4200929|NCT00748410|4024499|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4200930|NCT00748410|4024500|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4200931|NCT00748410|4024498|B3|||Age||Years|Mean|46|46.0|Standard Deviation|15.95|15.95|||
4200932|NCT00748410|4024499|B2|||Age||Years|Mean|39|39.0|Standard Deviation|15.56|15.56|||
4200933|NCT00748410|4024500|B1|||Age||Years|Mean|59|59.0|Standard Deviation|0.00|0.0|||
4200934|NCT00748241|4024517|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4200935|NCT00748241|4024517|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4200936|NCT00748241|4024517|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4200937|NCT00748241|4024517|B1|||Age||years|Mean|61.0|61.0|Standard Deviation|11.3|11.3|||
4200938|NCT00748189|4024525|B3|White||Race/Ethnicity, Customized||Participants|Number|397|397.0||||||
4200939|NCT00748189|4024526|B2|White||Race/Ethnicity, Customized||Participants|Number|196|196.0||||||
4200940|NCT00748189|4024527|B1|White||Race/Ethnicity, Customized||Participants|Number|201|201.0||||||
4200941|NCT00748189|4024525|B3|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4200942|NCT00748189|4024526|B2|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4200943|NCT00748189|4024527|B1|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4200944|NCT00748189|4024525|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|41|41.0||||||
4200945|NCT00748189|4024526|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4200946|NCT00748189|4024527|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4200947|NCT00748189|4024525|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4200948|NCT00748189|4024526|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4200949|NCT00748189|4024527|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4200950|NCT00748189|4024525|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4200951|NCT00748189|4024526|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4200952|NCT00748189|4024527|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4200953|NCT00748189|4024525|B3||Male|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
4200954|NCT00748189|4024526|B2||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4200955|NCT00748189|4024527|B1||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4200956|NCT00748189|4024525|B3||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4200957|NCT00748189|4024526|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4200958|NCT00748189|4024527|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4200959|NCT00748189|4024525|B3|>=75 years||Age, Customized||Patients|Number|119|119.0||||||
4200960|NCT00748189|4024526|B2|>=75 years||Age, Customized||Patients|Number|56|56.0||||||
4200961|NCT00748189|4024527|B1|>=75 years||Age, Customized||Patients|Number|63|63.0||||||
4200962|NCT00748189|4024525|B3|>=65 years||Age, Customized||Patients|Number|307|307.0||||||
4200963|NCT00748189|4024526|B2|>=65 years||Age, Customized||Patients|Number|152|152.0||||||
4200964|NCT00748189|4024527|B1|>=65 years||Age, Customized||Patients|Number|155|155.0||||||
4200965|NCT00748189|4024525|B3|<65 years||Age, Customized||Patients|Number|140|140.0||||||
4200966|NCT00748189|4024526|B2|<65 years||Age, Customized||Patients|Number|69|69.0||||||
4200967|NCT00748189|4024527|B1|<65 years||Age, Customized||Patients|Number|71|71.0||||||
4200968|NCT00748189|4024525|B3|Years||Age, Customized||Years|Median|69|69.0|Full Range|||35.0|92.0|
4200969|NCT00748189|4024526|B2|Years||Age, Customized||Years|Median|69|69.0|Full Range|||35.0|92.0|
4200970|NCT00748189|4024527|B1|Years||Age, Customized||Years|Median|70|70.0|Full Range|||36.0|91.0|
4200971|NCT00748098|4024582|B1|Mixed Race||Race/Ethnicity, Customized|Baseline characteristics were collected for all participants prior to the Baseline period and are summarized independent of treatment sequence. The ITT Population consisted of all randomized participants who took at least one dose of investigational product, and had at least one post-baseline polysomnography (PSG) sleep efficacy assessment.|participants|Number|1|1.0||||||
4200972|NCT00748098|4024582|B1|White||Race/Ethnicity, Customized|Baseline characteristics were collected for all participants prior to the Baseline period and are summarized independent of treatment sequence. The ITT Population consisted of all randomized participants who took at least one dose of investigational product, and had at least one post-baseline polysomnography (PSG) sleep efficacy assessment.|participants|Number|120|120.0||||||
4200973|NCT00748098|4024582|B1|Asian||Race/Ethnicity, Customized|Baseline characteristics were collected for all participants prior to the Baseline period and are summarized independent of treatment sequence. The ITT Population consisted of all randomized participants who took at least one dose of investigational product, and had at least one post-baseline polysomnography (PSG) sleep efficacy assessment.|participants|Number|1|1.0||||||
4200974|NCT00748098|4024582|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Baseline characteristics were collected for all participants prior to the Baseline period and are summarized independent of treatment sequence. The ITT Population consisted of all randomized participants who took at least one dose of investigational product, and had at least one post-baseline polysomnography (PSG) sleep efficacy assessment.|participants|Number|2|2.0||||||
4200975|NCT00748098|4024582|B1|African American/African Heritage||Race/Ethnicity, Customized|Baseline characteristics were collected for all participants prior to the Baseline period and are summarized independent of treatment sequence. The ITT Population consisted of all randomized participants who took at least one dose of investigational product, and had at least one post-baseline polysomnography (PSG) sleep efficacy assessment.|participants|Number|7|7.0||||||
4201028|NCT00747812|4024662|B3|||Age||years|Mean|50.7|50.7|Standard Deviation|12.7|12.7|||
4201029|NCT00747812|4024663|B2|||Age||years|Mean|55.6|55.6|Standard Deviation|5.5|5.5|||
4200976|NCT00748098|4024582|B1||Male|Sex: Female, Male|Baseline characteristics were collected for all participants prior to the Baseline period and are summarized independent of treatment sequence. The ITT Population consisted of all randomized participants who took at least one dose of investigational product, and had at least one post-baseline polysomnography (PSG) sleep efficacy assessment.|Participants|Count of Participants|55|55.0||||||
4200977|NCT00748098|4024582|B1||Female|Sex: Female, Male|Baseline characteristics were collected for all participants prior to the Baseline period and are summarized independent of treatment sequence. The ITT Population consisted of all randomized participants who took at least one dose of investigational product, and had at least one post-baseline polysomnography (PSG) sleep efficacy assessment.|Participants|Count of Participants|76|76.0||||||
4200978|NCT00748098|4024582|B1|||Age|Baseline characteristics were collected for all participants prior to the Baseline period and are summarized independent of treatment sequence. The ITT Population consisted of all randomized participants who took at least one dose of investigational product, and had at least one post-baseline polysomnography (PSG) sleep efficacy assessment.|Years|Mean|52.0|52.0|Standard Deviation|12.70|12.7|||
4200979|NCT00748085|4024643|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200980|NCT00748085|4024643|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200981|NCT00748085|4024643|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4200982|NCT00748085|4024643|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200983|NCT00748085|4024643|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200984|NCT00748085|4024643|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200985|NCT00748085|4024643|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200986|NCT00748085|4024643|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200987|NCT00748085|4024643|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4200988|NCT00748085|4024643|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4200989|NCT00748085|4024643|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4200990|NCT00748085|4024643|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4200991|NCT00748085|4024643|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4200992|NCT00748085|4024643|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4200993|NCT00748085|4024643|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4200994|NCT00748072|4024648|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4200995|NCT00748072|4024649|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4200996|NCT00748072|4024650|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4200997|NCT00748072|4024648|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4200998|NCT00748072|4024649|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4200999|NCT00748072|4024650|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4201000|NCT00748072|4024648|B3|||Age||years|Mean|40.6|40.6|Standard Deviation|14.6|14.6|||
4201001|NCT00748072|4024649|B2|||Age||years|Mean|39.5|39.5|Standard Deviation|14.2|14.2|||
4201002|NCT00748072|4024650|B1|||Age||years|Mean|41.7|41.7|Standard Deviation|15.0|15.0|||
4201003|NCT00747916|4024657|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201004|NCT00747916|4024657|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201005|NCT00747916|4024657|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4201006|NCT00747916|4024657|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201007|NCT00747916|4024657|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201008|NCT00747916|4024657|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201009|NCT00747916|4024657|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201010|NCT00747916|4024657|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201011|NCT00747916|4024657|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4201012|NCT00747916|4024657|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201013|NCT00747916|4024657|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4201014|NCT00747916|4024657|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4201015|NCT00747916|4024657|B1|||Age||years|Mean|59|59.0|Full Range|||49.0|67.0|
4201016|NCT00747916|4024657|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4201017|NCT00747916|4024657|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4201018|NCT00747916|4024657|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201019|NCT00747812|4024662|B3|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
4201020|NCT00747812|4024663|B2|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4201021|NCT00747812|4024664|B1|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4201022|NCT00747812|4024662|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4201023|NCT00747812|4024663|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4201024|NCT00747812|4024664|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4201025|NCT00747812|4024662|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4201026|NCT00747812|4024663|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4201027|NCT00747812|4024664|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4201030|NCT00747812|4024664|B1|||Age||years|Mean|47.8|47.8|Standard Deviation|15.5|15.5|||
4201031|NCT00747747|4024673|B4|Italy||Region of Enrollment||participants|Number|49|49.0||||||
4201032|NCT00747747|4024674|B3|Italy||Region of Enrollment||participants|Number|21|21.0||||||
4201033|NCT00747747|4024675|B2|Italy||Region of Enrollment||participants|Number|14|14.0||||||
4201034|NCT00747747|4024676|B1|Italy||Region of Enrollment||participants|Number|14|14.0||||||
4201035|NCT00747747|4024673|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4201036|NCT00747747|4024674|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4201037|NCT00747747|4024675|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4201038|NCT00747747|4024676|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4201039|NCT00747747|4024673|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4201040|NCT00747747|4024674|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4201041|NCT00747747|4024675|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4201042|NCT00747747|4024676|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4201043|NCT00747747|4024673|B4|||Age||years|Mean|47|47.0|Standard Deviation|13|13.0|||
4201044|NCT00747747|4024674|B3|||Age||years|Mean|48|48.0|Standard Deviation|13|13.0|||
4201045|NCT00747747|4024675|B2|||Age||years|Mean|45|45.0|Standard Deviation|11|11.0|||
4201046|NCT00747747|4024676|B1|||Age||years|Mean|45|45.0|Standard Deviation|15|15.0|||
4201047|NCT00747747|4024673|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4201048|NCT00747747|4024674|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4201049|NCT00747747|4024675|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4201050|NCT00747747|4024676|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4201051|NCT00747747|4024673|B4||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4201052|NCT00747747|4024674|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4201053|NCT00747747|4024675|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4201054|NCT00747747|4024676|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4201055|NCT00747747|4024673|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201056|NCT00747747|4024674|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201057|NCT00747747|4024675|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201058|NCT00747747|4024676|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201059|NCT00747643|4024701|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
4201060|NCT00747643|4024702|B2|United States||Region of Enrollment||participants|Number|54|54.0||||||
4201061|NCT00747643|4024703|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4201062|NCT00747643|4024701|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4201063|NCT00747643|4024702|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4201064|NCT00747643|4024703|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4201065|NCT00747643|4024701|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4201066|NCT00747643|4024702|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4201067|NCT00747643|4024703|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4201068|NCT00747643|4024701|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4201069|NCT00747643|4024702|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4201070|NCT00747643|4024703|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4201071|NCT00747643|4024701|B3||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4201072|NCT00747643|4024702|B2||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4201073|NCT00747643|4024703|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4201074|NCT00747643|4024701|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201075|NCT00747643|4024702|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201076|NCT00747643|4024703|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201077|NCT00747617|4024716|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4201078|NCT00747617|4024717|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4201079|NCT00747617|4024718|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4201080|NCT00747617|4024716|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4201081|NCT00747617|4024717|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4201082|NCT00747617|4024718|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4201083|NCT00747617|4024716|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4201084|NCT00747617|4024717|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4201085|NCT00747617|4024718|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4201086|NCT00747617|4024716|B3|||Age||years|Mean|29|29.0|Standard Deviation|1.2|1.2|||
4201087|NCT00747617|4024717|B2|||Age||years|Mean|30|30.0|Standard Deviation|1.3|1.3|||
4201088|NCT00747617|4024718|B1|||Age||years|Mean|28.5|28.5|Standard Deviation|1.1|1.1|||
4201089|NCT00747617|4024716|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4201090|NCT00747617|4024717|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4201091|NCT00747617|4024718|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4201092|NCT00747617|4024716|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4201093|NCT00747617|4024717|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4201094|NCT00747617|4024718|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4201095|NCT00747617|4024716|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201096|NCT00747617|4024717|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201097|NCT00747617|4024718|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201098|NCT00747565|4024727|B3|United States||Region of Enrollment||participants|Number|470|470.0||||||
4201099|NCT00747565|4024728|B2|United States||Region of Enrollment||participants|Number|123|123.0||||||
4201100|NCT00747565|4024729|B1|United States||Region of Enrollment||participants|Number|347|347.0||||||
4201101|NCT00747565|4024727|B3||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4201102|NCT00747565|4024728|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4201103|NCT00747565|4024729|B1||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4201104|NCT00747565|4024727|B3||Female|Sex: Female, Male||Participants|Count of Participants|292|292.0||||||
4201105|NCT00747565|4024728|B2||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4201106|NCT00747565|4024729|B1||Female|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4201107|NCT00747565|4024727|B3|||Age||years|Mean|66.7|66.7|Standard Deviation|9.4|9.4|||
4201108|NCT00747565|4024728|B2|||Age||years|Mean|68.7|68.7|Standard Deviation|8.9|8.9|||
4201109|NCT00747565|4024729|B1|||Age||years|Mean|65.9|65.9|Standard Deviation|9.5|9.5|||
4201110|NCT00747565|4024727|B3||>=65 years|Age||Participants|Count of Participants|299|299.0||||||
4201111|NCT00747565|4024728|B2||>=65 years|Age||Participants|Count of Participants|96|96.0||||||
4201112|NCT00747565|4024729|B1||>=65 years|Age||Participants|Count of Participants|203|203.0||||||
4201113|NCT00747565|4024727|B3||Between 18 and 65 years|Age||Participants|Count of Participants|171|171.0||||||
4201114|NCT00747565|4024728|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4201115|NCT00747565|4024729|B1||Between 18 and 65 years|Age||Participants|Count of Participants|144|144.0||||||
4201116|NCT00747565|4024727|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201117|NCT00747565|4024728|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201118|NCT00747565|4024729|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201119|NCT00747552|4024738|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4201120|NCT00747552|4024738|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4201121|NCT00747552|4024738|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4201122|NCT00747552|4024738|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4201123|NCT00747552|4024738|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4201124|NCT00747552|4024738|B1||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4201125|NCT00747474|4024743|B1|Taiwan||Region of Enrollment||participants|Number|13|13.0||||||
4201126|NCT00747474|4024743|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4201127|NCT00747474|4024743|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4201128|NCT00747474|4024743|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4201129|NCT00747474|4024743|B1|||Age||years|Mean|60.5|60.5|Standard Deviation|11.6|11.6|||
4201130|NCT00747474|4024743|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4201131|NCT00747474|4024743|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4201132|NCT00747474|4024743|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201133|NCT00747461|4024780|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4201134|NCT00747461|4024780|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4201135|NCT00747461|4024780|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4201136|NCT00747461|4024780|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4201137|NCT00747461|4024780|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4201138|NCT00747461|4024780|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201139|NCT00747435|4024785|B1|||Duration of hearing loss||years|Mean|25.7|25.7|Full Range|||2.0|60.0|
4201140|NCT00747435|4024785|B1|United States||Region of Enrollment||participants|Number|73|73.0||||||
4201141|NCT00747435|4024785|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4201142|NCT00747435|4024785|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4201143|NCT00747435|4024785|B1|||Age||years|Mean|53.7|53.7|Full Range|||17.0|76.0|
4201144|NCT00747344|4024793|B3|Taiwan||Region of Enrollment||participants|Number|60|60.0||||||
4201145|NCT00747344|4024794|B2|Taiwan||Region of Enrollment||participants|Number|30|30.0||||||
4201146|NCT00747344|4024795|B1|Taiwan||Region of Enrollment||participants|Number|30|30.0||||||
4201147|NCT00747344|4024793|B3|Republic of Korea||Region of Enrollment||participants|Number|61|61.0||||||
4201148|NCT00747344|4024794|B2|Republic of Korea||Region of Enrollment||participants|Number|31|31.0||||||
4201149|NCT00747344|4024795|B1|Republic of Korea||Region of Enrollment||participants|Number|30|30.0||||||
4201150|NCT00747344|4024793|B3||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4201151|NCT00747344|4024794|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4201152|NCT00747344|4024795|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4201153|NCT00747344|4024793|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4201154|NCT00747344|4024794|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4201155|NCT00747344|4024795|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4201156|NCT00747344|4024793|B3|||Age||years|Mean|40.6|40.6|Standard Deviation|11.40|11.4|||
4201157|NCT00747344|4024794|B2|||Age||years|Mean|40.9|40.9|Standard Deviation|12.66|12.66|||
4201158|NCT00747344|4024795|B1|||Age||years|Mean|40.4|40.4|Standard Deviation|10.06|10.06|||
4201159|NCT00747227|4024810|B3|United States||Region of Enrollment||participants|Number|250|250.0||||||
4201160|NCT00747227|4024811|B2|United States||Region of Enrollment||participants|Number|124|124.0||||||
4201161|NCT00747227|4024812|B1|United States||Region of Enrollment||participants|Number|126|126.0||||||
4201162|NCT00747227|4024810|B3||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4201163|NCT00747227|4024811|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4201164|NCT00747227|4024812|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4201165|NCT00747227|4024810|B3||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4201166|NCT00747227|4024811|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4201167|NCT00747227|4024812|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4201168|NCT00747227|4024810|B3|>=80||Age, Customized||participants|Number|51|51.0||||||
4201169|NCT00747227|4024811|B2|>=80||Age, Customized||participants|Number|21|21.0||||||
4201170|NCT00747227|4024812|B1|>=80||Age, Customized||participants|Number|30|30.0||||||
4201171|NCT00747227|4024810|B3|Between 70 and 79 years||Age, Customized||participants|Number|111|111.0||||||
4201172|NCT00747227|4024811|B2|Between 70 and 79 years||Age, Customized||participants|Number|54|54.0||||||
4201173|NCT00747227|4024812|B1|Between 70 and 79 years||Age, Customized||participants|Number|57|57.0||||||
4201174|NCT00747227|4024810|B3|Between 60 and 69 years||Age, Customized||participants|Number|76|76.0||||||
4201175|NCT00747227|4024811|B2|Between 60 and 69 years||Age, Customized||participants|Number|41|41.0||||||
4201176|NCT00747227|4024812|B1|Between 60 and 69 years||Age, Customized||participants|Number|35|35.0||||||
4201177|NCT00747227|4024810|B3|<60 years||Age, Customized||participants|Number|12|12.0||||||
4201178|NCT00747227|4024811|B2|<60 years||Age, Customized||participants|Number|8|8.0||||||
4201179|NCT00747227|4024812|B1|<60 years||Age, Customized||participants|Number|4|4.0||||||
4201180|NCT00747227|4024810|B3|||Age||years|Mean|72.4|72.4|Standard Deviation|8.0|8.0|||
4201181|NCT00747227|4024811|B2|||Age||years|Mean|71.5|71.5|Standard Deviation|8.0|8.0|||
4201182|NCT00747227|4024812|B1|||Age||years|Mean|73.3|73.3|Standard Deviation|8.0|8.0|||
4201183|NCT00747214|4024825|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4201184|NCT00747214|4024826|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4201185|NCT00747214|4024827|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4201186|NCT00747214|4024825|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4201187|NCT00747214|4024826|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4201188|NCT00747214|4024827|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4201189|NCT00747214|4024825|B3|||Age||years|Mean|58.5|58.5|Standard Deviation|10.34|10.34|||
4201190|NCT00747214|4024826|B2|||Age||years|Mean|60.0|60.0|Standard Deviation|12.25|12.25|||
4201191|NCT00747214|4024827|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|6.53|6.53|||
4201192|NCT00747149|4024840|B3|||Waistline circumference||cm|Mean|106.7|106.7|Standard Deviation|15.4|15.4|||
4201193|NCT00747149|4024841|B2|||Waistline circumference||cm|Mean|106.7|106.7|Standard Deviation|15.9|15.9|||
4201194|NCT00747149|4024842|B1|||Waistline circumference||cm|Mean|106.7|106.7|Standard Deviation|14.9|14.9|||
4201195|NCT00747149|4024840|B3|BMI||Body Mass Index||kg/m^2|Mean|32.39|32.39|Standard Deviation|6.81|6.81|||
4201196|NCT00747149|4024841|B2|BMI||Body Mass Index||kg/m^2|Mean|32.27|32.27|Standard Deviation|6.72|6.72|||
4201197|NCT00747149|4024842|B1|BMI||Body Mass Index||kg/m^2|Mean|32.50|32.5|Standard Deviation|6.89|6.89|||
4201198|NCT00747149|4024840|B3|Other||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4201199|NCT00747149|4024841|B2|Other||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4201200|NCT00747149|4024842|B1|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4201201|NCT00747149|4024840|B3|Asian||Race/Ethnicity, Customized||Participants|Number|39|39.0||||||
4201202|NCT00747149|4024841|B2|Asian||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4201203|NCT00747149|4024842|B1|Asian||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4201204|NCT00747149|4024840|B3|Black/African American||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4201205|NCT00747149|4024841|B2|Black/African American||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4201206|NCT00747149|4024842|B1|Black/African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4201207|NCT00747149|4024840|B3|White||Race/Ethnicity, Customized||Participants|Number|533|533.0||||||
4201208|NCT00747149|4024841|B2|White||Race/Ethnicity, Customized||Participants|Number|245|245.0||||||
4201209|NCT00747149|4024842|B1|White||Race/Ethnicity, Customized||Participants|Number|288|288.0||||||
4201210|NCT00747149|4024840|B3||Male|Sex: Female, Male||Participants|Count of Participants|303|303.0||||||
4201211|NCT00747149|4024841|B2||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4201212|NCT00747149|4024842|B1||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4201213|NCT00747149|4024840|B3||Female|Sex: Female, Male||Participants|Count of Participants|295|295.0||||||
4201214|NCT00747149|4024841|B2||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4201215|NCT00747149|4024842|B1||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4201216|NCT00747149|4024840|B3|||Age||Years|Mean|62.9|62.9|Standard Deviation|10.7|10.7|||
4201217|NCT00747149|4024841|B2|||Age||Years|Mean|62.6|62.6|Standard Deviation|10.5|10.5|||
4201218|NCT00747149|4024842|B1|||Age||Years|Mean|63.2|63.2|Standard Deviation|10.9|10.9|||
4201219|NCT00747006|4024855|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4201220|NCT00747006|4024856|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4201221|NCT00747006|4024857|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4201222|NCT00747006|4024858|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4201223|NCT00747006|4024855|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4201224|NCT00747006|4024856|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4201225|NCT00747006|4024857|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4201226|NCT00747006|4024858|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4201227|NCT00747006|4024855|B4|||Age||years|Mean|50.7|50.7|Full Range|||18.0|70.0|
4201228|NCT00747006|4024856|B3|||Age||years|Mean|50.7|50.7|Full Range|||48.0|52.0|
4201229|NCT00747006|4024857|B2|||Age||years|Mean|59.4|59.4|Full Range|||50.0|70.0|
4201230|NCT00747006|4024858|B1|||Age||years|Mean|40.7|40.7|Full Range|||18.0|54.0|
4201231|NCT00746954|4024926|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4201232|NCT00746954|4024926|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4201233|NCT00746954|4024926|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4201234|NCT00746954|4024926|B1|||Age||years|Mean|59.7|59.7|Standard Deviation|6.2|6.2|||
4201235|NCT00746954|4024926|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4201236|NCT00746954|4024926|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4201237|NCT00746954|4024926|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201238|NCT00746941|4024934|B5|Missing||JVC Titer at Screening|JC virus (human polyomavirus) titer prior to study randomization.|participants|Number|1|1.0||||||
4201239|NCT00746941|4024935|B4|Missing||JVC Titer at Screening|JC virus (human polyomavirus) titer prior to study randomization.|participants|Number|1|1.0||||||
4201240|NCT00746941|4024936|B3|Missing||JVC Titer at Screening|JC virus (human polyomavirus) titer prior to study randomization.|participants|Number|0|0.0||||||
4201241|NCT00746941|4024937|B2|Missing||JVC Titer at Screening|JC virus (human polyomavirus) titer prior to study randomization.|participants|Number|0|0.0||||||
4201242|NCT00746941|4024938|B1|Missing||JVC Titer at Screening|JC virus (human polyomavirus) titer prior to study randomization.|participants|Number|0|0.0||||||
4201243|NCT00746941|4024934|B5|> 50 copies/mL||JVC Titer at Screening|JC virus (human polyomavirus) titer prior to study randomization.|participants|Number|32|32.0||||||
4201244|NCT00746941|4024935|B4|> 50 copies/mL||JVC Titer at Screening|JC virus (human polyomavirus) titer prior to study randomization.|participants|Number|15|15.0||||||
4201245|NCT00746941|4024936|B3|> 50 copies/mL||JVC Titer at Screening|JC virus (human polyomavirus) titer prior to study randomization.|participants|Number|5|5.0||||||
4201246|NCT00746941|4024937|B2|> 50 copies/mL||JVC Titer at Screening|JC virus (human polyomavirus) titer prior to study randomization.|participants|Number|5|5.0||||||
4201247|NCT00746941|4024938|B1|> 50 copies/mL||JVC Titer at Screening|JC virus (human polyomavirus) titer prior to study randomization.|participants|Number|7|7.0||||||
4201248|NCT00746941|4024934|B5|<= 50 copies/mL||JVC Titer at Screening|JC virus (human polyomavirus) titer prior to study randomization.|participants|Number|4|4.0||||||
4201249|NCT00746941|4024935|B4|<= 50 copies/mL||JVC Titer at Screening|JC virus (human polyomavirus) titer prior to study randomization.|participants|Number|4|4.0||||||
4201250|NCT00746941|4024936|B3|<= 50 copies/mL||JVC Titer at Screening|JC virus (human polyomavirus) titer prior to study randomization.|participants|Number|0|0.0||||||
4201251|NCT00746941|4024937|B2|<= 50 copies/mL||JVC Titer at Screening|JC virus (human polyomavirus) titer prior to study randomization.|participants|Number|0|0.0||||||
4201252|NCT00746941|4024938|B1|<= 50 copies/mL||JVC Titer at Screening|JC virus (human polyomavirus) titer prior to study randomization.|participants|Number|0|0.0||||||
4201253|NCT00746941|4024934|B5|HIV negative||Disease history|"Participants were stratified into the following groups~HAART-naïve stratum: human immunodeficiency virus (HIV) -positive participants who developed PML in the absence of highly active anti-retroviral therapy (HAART) were placed in this stratum.~History of HAART stratum: HIV-positive participants who developed PML while on HAART were placed in this stratum.~HIV-negative stratum: All participants who were HIV-negative were placed in this stratum."|participants|Number|8|8.0||||||
4201254|NCT00746941|4024935|B4|HIV negative||Disease history|"Participants were stratified into the following groups~HAART-naïve stratum: human immunodeficiency virus (HIV) -positive participants who developed PML in the absence of highly active anti-retroviral therapy (HAART) were placed in this stratum.~History of HAART stratum: HIV-positive participants who developed PML while on HAART were placed in this stratum.~HIV-negative stratum: All participants who were HIV-negative were placed in this stratum."|participants|Number|4|4.0||||||
4201255|NCT00746941|4024936|B3|HIV negative||Disease history|"Participants were stratified into the following groups~HAART-naïve stratum: human immunodeficiency virus (HIV) -positive participants who developed PML in the absence of highly active anti-retroviral therapy (HAART) were placed in this stratum.~History of HAART stratum: HIV-positive participants who developed PML while on HAART were placed in this stratum.~HIV-negative stratum: All participants who were HIV-negative were placed in this stratum."|participants|Number|1|1.0||||||
4201256|NCT00746941|4024937|B2|HIV negative||Disease history|"Participants were stratified into the following groups~HAART-naïve stratum: human immunodeficiency virus (HIV) -positive participants who developed PML in the absence of highly active anti-retroviral therapy (HAART) were placed in this stratum.~History of HAART stratum: HIV-positive participants who developed PML while on HAART were placed in this stratum.~HIV-negative stratum: All participants who were HIV-negative were placed in this stratum."|participants|Number|0|0.0||||||
4201279|NCT00746941|4024935|B4||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4201280|NCT00746941|4024936|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4201257|NCT00746941|4024938|B1|HIV negative||Disease history|"Participants were stratified into the following groups~HAART-naïve stratum: human immunodeficiency virus (HIV) -positive participants who developed PML in the absence of highly active anti-retroviral therapy (HAART) were placed in this stratum.~History of HAART stratum: HIV-positive participants who developed PML while on HAART were placed in this stratum.~HIV-negative stratum: All participants who were HIV-negative were placed in this stratum."|participants|Number|3|3.0||||||
4201258|NCT00746941|4024934|B5|HIV positive: History of HAART||Disease history|"Participants were stratified into the following groups~HAART-naïve stratum: human immunodeficiency virus (HIV) -positive participants who developed PML in the absence of highly active anti-retroviral therapy (HAART) were placed in this stratum.~History of HAART stratum: HIV-positive participants who developed PML while on HAART were placed in this stratum.~HIV-negative stratum: All participants who were HIV-negative were placed in this stratum."|participants|Number|5|5.0||||||
4201259|NCT00746941|4024935|B4|HIV positive: History of HAART||Disease history|"Participants were stratified into the following groups~HAART-naïve stratum: human immunodeficiency virus (HIV) -positive participants who developed PML in the absence of highly active anti-retroviral therapy (HAART) were placed in this stratum.~History of HAART stratum: HIV-positive participants who developed PML while on HAART were placed in this stratum.~HIV-negative stratum: All participants who were HIV-negative were placed in this stratum."|participants|Number|3|3.0||||||
4201260|NCT00746941|4024936|B3|HIV positive: History of HAART||Disease history|"Participants were stratified into the following groups~HAART-naïve stratum: human immunodeficiency virus (HIV) -positive participants who developed PML in the absence of highly active anti-retroviral therapy (HAART) were placed in this stratum.~History of HAART stratum: HIV-positive participants who developed PML while on HAART were placed in this stratum.~HIV-negative stratum: All participants who were HIV-negative were placed in this stratum."|participants|Number|1|1.0||||||
4201261|NCT00746941|4024937|B2|HIV positive: History of HAART||Disease history|"Participants were stratified into the following groups~HAART-naïve stratum: human immunodeficiency virus (HIV) -positive participants who developed PML in the absence of highly active anti-retroviral therapy (HAART) were placed in this stratum.~History of HAART stratum: HIV-positive participants who developed PML while on HAART were placed in this stratum.~HIV-negative stratum: All participants who were HIV-negative were placed in this stratum."|participants|Number|0|0.0||||||
4201262|NCT00746941|4024938|B1|HIV positive: History of HAART||Disease history|"Participants were stratified into the following groups~HAART-naïve stratum: human immunodeficiency virus (HIV) -positive participants who developed PML in the absence of highly active anti-retroviral therapy (HAART) were placed in this stratum.~History of HAART stratum: HIV-positive participants who developed PML while on HAART were placed in this stratum.~HIV-negative stratum: All participants who were HIV-negative were placed in this stratum."|participants|Number|1|1.0||||||
4201263|NCT00746941|4024934|B5|HIV positive: HAART Naive||Disease history|"Participants were stratified into the following groups~HAART-naïve stratum: human immunodeficiency virus (HIV) -positive participants who developed PML in the absence of highly active anti-retroviral therapy (HAART) were placed in this stratum.~History of HAART stratum: HIV-positive participants who developed PML while on HAART were placed in this stratum.~HIV-negative stratum: All participants who were HIV-negative were placed in this stratum."|participants|Number|24|24.0||||||
4201264|NCT00746941|4024935|B4|HIV positive: HAART Naive||Disease history|"Participants were stratified into the following groups~HAART-naïve stratum: human immunodeficiency virus (HIV) -positive participants who developed PML in the absence of highly active anti-retroviral therapy (HAART) were placed in this stratum.~History of HAART stratum: HIV-positive participants who developed PML while on HAART were placed in this stratum.~HIV-negative stratum: All participants who were HIV-negative were placed in this stratum."|participants|Number|13|13.0||||||
4201265|NCT00746941|4024936|B3|HIV positive: HAART Naive||Disease history|"Participants were stratified into the following groups~HAART-naïve stratum: human immunodeficiency virus (HIV) -positive participants who developed PML in the absence of highly active anti-retroviral therapy (HAART) were placed in this stratum.~History of HAART stratum: HIV-positive participants who developed PML while on HAART were placed in this stratum.~HIV-negative stratum: All participants who were HIV-negative were placed in this stratum."|participants|Number|3|3.0||||||
4201266|NCT00746941|4024937|B2|HIV positive: HAART Naive||Disease history|"Participants were stratified into the following groups~HAART-naïve stratum: human immunodeficiency virus (HIV) -positive participants who developed PML in the absence of highly active anti-retroviral therapy (HAART) were placed in this stratum.~History of HAART stratum: HIV-positive participants who developed PML while on HAART were placed in this stratum.~HIV-negative stratum: All participants who were HIV-negative were placed in this stratum."|participants|Number|5|5.0||||||
4201267|NCT00746941|4024938|B1|HIV positive: HAART Naive||Disease history|"Participants were stratified into the following groups~HAART-naïve stratum: human immunodeficiency virus (HIV) -positive participants who developed PML in the absence of highly active anti-retroviral therapy (HAART) were placed in this stratum.~History of HAART stratum: HIV-positive participants who developed PML while on HAART were placed in this stratum.~HIV-negative stratum: All participants who were HIV-negative were placed in this stratum."|participants|Number|3|3.0||||||
4201268|NCT00746941|4024934|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201269|NCT00746941|4024935|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201270|NCT00746941|4024936|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201271|NCT00746941|4024937|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201272|NCT00746941|4024938|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201273|NCT00746941|4024934|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201274|NCT00746941|4024935|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201275|NCT00746941|4024936|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201276|NCT00746941|4024937|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201277|NCT00746941|4024938|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201278|NCT00746941|4024934|B5||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4201281|NCT00746941|4024937|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4201282|NCT00746941|4024938|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4201283|NCT00746941|4024934|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4201284|NCT00746941|4024935|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4201285|NCT00746941|4024936|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4201286|NCT00746941|4024937|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4201287|NCT00746941|4024938|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4201288|NCT00746941|4024934|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201289|NCT00746941|4024935|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201290|NCT00746941|4024936|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201291|NCT00746941|4024937|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201292|NCT00746941|4024938|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201293|NCT00746941|4024934|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201294|NCT00746941|4024935|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201295|NCT00746941|4024936|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201296|NCT00746941|4024937|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201297|NCT00746941|4024938|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201298|NCT00746941|4024934|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201299|NCT00746941|4024935|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201300|NCT00746941|4024936|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201301|NCT00746941|4024937|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201302|NCT00746941|4024938|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201303|NCT00746941|4024934|B5||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4201304|NCT00746941|4024935|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4201305|NCT00746941|4024936|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4201306|NCT00746941|4024937|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4201307|NCT00746941|4024938|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4201308|NCT00746941|4024934|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4201309|NCT00746941|4024935|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4201310|NCT00746941|4024936|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4201311|NCT00746941|4024937|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4201312|NCT00746941|4024938|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4201313|NCT00746941|4024934|B5|||Age||years|Mean|47.2|47.2|Standard Deviation|12.16|12.16|||
4201314|NCT00746941|4024935|B4|||Age||years|Mean|48.1|48.1|Standard Deviation|9.4|9.4|||
4201315|NCT00746941|4024936|B3|||Age||years|Mean|47.4|47.4|Standard Deviation|10.06|10.06|||
4201316|NCT00746941|4024937|B2|||Age||years|Mean|41.6|41.6|Standard Deviation|11.37|11.37|||
4201317|NCT00746941|4024938|B1|||Age||years|Mean|48.7|48.7|Standard Deviation|20.56|20.56|||
4201318|NCT00746889|4024967|B3|United States||Region of Enrollment||participants|Number|79|79.0||||||
4201319|NCT00746889|4024968|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
4201320|NCT00746889|4024969|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4201321|NCT00746889|4024967|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4201322|NCT00746889|4024968|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4201323|NCT00746889|4024969|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4201324|NCT00746889|4024967|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4201325|NCT00746889|4024968|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4201326|NCT00746889|4024969|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4201327|NCT00746889|4024967|B3|||Age||years|Mean|63|63.0|Standard Deviation|12|12.0|||
4201328|NCT00746889|4024968|B2|||Age||years|Mean|63|63.0|Standard Deviation|12|12.0|||
4201329|NCT00746889|4024969|B1|||Age||years|Mean|64|64.0|Standard Deviation|12|12.0|||
4201330|NCT00746889|4024967|B3||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4201331|NCT00746889|4024968|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4201332|NCT00746889|4024969|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4201333|NCT00746889|4024967|B3||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4201334|NCT00746889|4024968|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4201335|NCT00746889|4024969|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4201336|NCT00746889|4024967|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201337|NCT00746889|4024968|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201338|NCT00746889|4024969|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201339|NCT00746863|4024978|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4201340|NCT00746863|4024979|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4201341|NCT00746863|4024980|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4201342|NCT00746863|4024978|B3||Male|Sex: Female, Male|Only female patients|Participants|Count of Participants|0|0.0||||||
4201343|NCT00746863|4024979|B2||Male|Sex: Female, Male|Only female patients|Participants|Count of Participants|0|0.0||||||
4201344|NCT00746863|4024980|B1||Male|Sex: Female, Male|Only female patients|Participants|Count of Participants|0|0.0||||||
4201345|NCT00746863|4024978|B3||Female|Sex: Female, Male|Only female patients|Participants|Count of Participants|42|42.0||||||
4201346|NCT00746863|4024979|B2||Female|Sex: Female, Male|Only female patients|Participants|Count of Participants|21|21.0||||||
4201347|NCT00746863|4024980|B1||Female|Sex: Female, Male|Only female patients|Participants|Count of Participants|21|21.0||||||
4201348|NCT00746863|4024978|B3|||Age||years|Mean|52|52.0|Standard Deviation|12|12.0|||
4201349|NCT00746863|4024979|B2|||Age||years|Mean|52.6|52.6|Standard Deviation|10.7|10.7|||
4201350|NCT00746863|4024980|B1|||Age||years|Mean|49.4|49.4|Standard Deviation|13.5|13.5|||
4201351|NCT00746863|4024978|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4201352|NCT00746863|4024979|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4201353|NCT00746863|4024980|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4201354|NCT00746863|4024978|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4201355|NCT00746863|4024979|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4201356|NCT00746863|4024980|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4201357|NCT00746863|4024978|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201358|NCT00746863|4024979|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201359|NCT00746863|4024980|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201360|NCT00746798|4024995|B5|United States||Region of Enrollment||Participants|Number|479|479.0||||||
4201361|NCT00746798|4024996|B4|United States||Region of Enrollment||Participants|Number|120|120.0||||||
4201362|NCT00746798|4024997|B3|United States||Region of Enrollment||Participants|Number|113|113.0||||||
4201363|NCT00746798|4024998|B2|United States||Region of Enrollment||Participants|Number|124|124.0||||||
4201364|NCT00746798|4024999|B1|United States||Region of Enrollment||Participants|Number|122|122.0||||||
4201365|NCT00746798|4024995|B5||Male|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4201366|NCT00746798|4024996|B4||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4201367|NCT00746798|4024997|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4201368|NCT00746798|4024998|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4201369|NCT00746798|4024999|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4201370|NCT00746798|4024995|B5||Female|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
4201371|NCT00746798|4024996|B4||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4201372|NCT00746798|4024997|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4201373|NCT00746798|4024998|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4201374|NCT00746798|4024999|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4201375|NCT00746798|4024995|B5|||Age||Years|Mean|62.9|62.9|Standard Deviation|8.69|8.69|||
4201376|NCT00746798|4024996|B4|||Age||Years|Mean|62.2|62.2|Standard Deviation|8.28|8.28|||
4201377|NCT00746798|4024997|B3|||Age||Years|Mean|63.4|63.4|Standard Deviation|9.01|9.01|||
4201378|NCT00746798|4024998|B2|||Age||Years|Mean|62.9|62.9|Standard Deviation|8.10|8.1|||
4201379|NCT00746798|4024999|B1|||Age||Years|Mean|63.1|63.1|Standard Deviation|9.39|9.39|||
4201380|NCT00746798|4024995|B5||>=65 years|Age||Participants|Count of Participants|194|194.0||||||
4201381|NCT00746798|4024996|B4||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
4201382|NCT00746798|4024997|B3||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
4201383|NCT00746798|4024998|B2||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
4201384|NCT00746798|4024999|B1||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
4201385|NCT00746798|4024995|B5||Between 18 and 65 years|Age||Participants|Count of Participants|285|285.0||||||
4201386|NCT00746798|4024996|B4||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
4201387|NCT00746798|4024997|B3||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4201388|NCT00746798|4024998|B2||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4201389|NCT00746798|4024999|B1||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
4201390|NCT00746798|4024995|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201391|NCT00746798|4024996|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201392|NCT00746798|4024997|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201393|NCT00746798|4024998|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201394|NCT00746798|4024999|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201395|NCT00746785|4025024|B4|United States||Region of Enrollment||participants|Number|129|129.0||||||
4201396|NCT00746785|4025025|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4201397|NCT00746785|4025026|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
4201398|NCT00746785|4025027|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4201399|NCT00746785|4025024|B4||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4201400|NCT00746785|4025025|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4201401|NCT00746785|4025026|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4201402|NCT00746785|4025027|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4201403|NCT00746785|4025024|B4||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4201404|NCT00746785|4025025|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4201405|NCT00746785|4025026|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4201406|NCT00746785|4025027|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4201407|NCT00746785|4025024|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4201408|NCT00746785|4025025|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4201409|NCT00746785|4025026|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4201410|NCT00746785|4025027|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4201411|NCT00746785|4025024|B4||Between 18 and 65 years|Age||Participants|Count of Participants|129|129.0||||||
4201412|NCT00746785|4025025|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4201413|NCT00746785|4025026|B2||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4201414|NCT00746785|4025027|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4201415|NCT00746785|4025024|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201416|NCT00746785|4025025|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201417|NCT00746785|4025026|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201418|NCT00746785|4025027|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201419|NCT00746733|4025037|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4201420|NCT00746733|4025037|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4201421|NCT00746733|4025037|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4201422|NCT00746733|4025037|B1|||Age||years|Mean|37.7|37.7|Standard Deviation|6.54|6.54|||
4201423|NCT00746733|4025037|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4201424|NCT00746733|4025037|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4201425|NCT00746733|4025037|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201426|NCT00746694|4025098|B1|Canada||Region of Enrollment||participants|Number|154|154.0||||||
4201427|NCT00746694|4025098|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4201428|NCT00746694|4025098|B1||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4201429|NCT00746694|4025098|B1|||Age||years|Mean|62.4|62.4|Standard Deviation|10.1|10.1|||
4201430|NCT00746668|4025103|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4201431|NCT00746668|4025103|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4201432|NCT00746668|4025103|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4201433|NCT00746668|4025103|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4201434|NCT00746668|4025103|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4201435|NCT00746668|4025103|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201436|NCT00746590|4025122|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4201437|NCT00746590|4025122|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4201438|NCT00746590|4025122|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4201439|NCT00746590|4025122|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4201440|NCT00746590|4025122|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201441|NCT00746564|4025126|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4201442|NCT00746564|4025126|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4201443|NCT00746564|4025126|B1|||Age||years|Mean|62|62.0|Full Range|||19.0|83.0|
4201444|NCT00746551|4025139|B3|||C-reactive protein||mg/L|Mean|3.9|3.9|Standard Deviation|2.2|2.2|||
4201445|NCT00746551|4025140|B2|||C-reactive protein||mg/L|Mean|4.0|4.0|Standard Deviation|2.3|2.3|||
4201446|NCT00746551|4025141|B1|||C-reactive protein||mg/L|Mean|3.7|3.7|Standard Deviation|2.0|2.0|||
4201447|NCT00746551|4025139|B3|||Body mass index||kg/sq.m|Mean|19.9|19.9|Standard Deviation|2.9|2.9|||
4201448|NCT00746551|4025140|B2|||Body mass index||kg/sq.m|Mean|20.1|20.1|Standard Deviation|2.2|2.2|||
4201449|NCT00746551|4025141|B1|||Body mass index||kg/sq.m|Mean|19.7|19.7|Standard Deviation|3.4|3.4|||
4201450|NCT00746551|4025139|B3|||Body weight||kg|Mean|49.2|49.2|Standard Deviation|7.4|7.4|||
4201451|NCT00746551|4025140|B2|||Body weight||kg|Mean|50.2|50.2|Standard Deviation|6.6|6.6|||
4201452|NCT00746551|4025141|B1|||Body weight||kg|Mean|48.1|48.1|Standard Deviation|8.1|8.1|||
4201453|NCT00746551|4025139|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4201454|NCT00746551|4025140|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4201455|NCT00746551|4025141|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4201456|NCT00746551|4025139|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4201457|NCT00746551|4025140|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4201458|NCT00746551|4025141|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4201459|NCT00746551|4025139|B3|||Age||years|Mean|24.6|24.6|Standard Deviation|5.4|5.4|||
4201460|NCT00746551|4025140|B2|||Age||years|Mean|24.9|24.9|Standard Deviation|5.9|5.9|||
4201461|NCT00746551|4025141|B1|||Age||years|Mean|24.3|24.3|Standard Deviation|4.9|4.9|||
4201462|NCT00746512|4025150|B5||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4201463|NCT00746512|4025151|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4201464|NCT00746512|4025152|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4201465|NCT00746512|4025153|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4201466|NCT00746512|4025154|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4201467|NCT00746512|4025150|B5||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4201468|NCT00746512|4025151|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4201469|NCT00746512|4025152|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4201470|NCT00746512|4025153|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4201471|NCT00746512|4025154|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4201472|NCT00746512|4025150|B5|||Age||years|Mean|58.1|58.1|Full Range|||32.0|86.0|
4201473|NCT00746512|4025151|B4|||Age||years|Mean|55.1|55.1|Full Range|||32.0|71.0|
4201474|NCT00746512|4025152|B3|||Age||years|Mean|57.9|57.9|Full Range|||37.0|81.0|
4201475|NCT00746512|4025153|B2|||Age||years|Mean|58.4|58.4|Full Range|||45.0|86.0|
4201476|NCT00746512|4025154|B1|||Age||years|Mean|61.6|61.6|Full Range|||48.0|69.0|
4201477|NCT00746421|4025171|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4201478|NCT00746421|4025172|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4201479|NCT00746421|4025173|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4201480|NCT00746421|4025171|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4201481|NCT00746421|4025172|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4201482|NCT00746421|4025173|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4201483|NCT00746421|4025171|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4201484|NCT00746421|4025172|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4201485|NCT00746421|4025173|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4201486|NCT00746421|4025171|B3|||Age||years|Mean|40|40.0|Standard Deviation|14.3|14.3|||
4201487|NCT00746421|4025172|B2|||Age||years|Mean|42.6|42.6|Standard Deviation|13.9|13.9|||
4201488|NCT00746421|4025173|B1|||Age||years|Mean|37.8|37.8|Standard Deviation|14.9|14.9|||
4201489|NCT00746421|4025171|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4201490|NCT00746421|4025172|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4201491|NCT00746421|4025173|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4201492|NCT00746421|4025171|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4201493|NCT00746421|4025172|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4201494|NCT00746421|4025173|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4201495|NCT00746421|4025171|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201496|NCT00746421|4025172|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201497|NCT00746421|4025173|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201498|NCT00746395|4025182|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4201499|NCT00746395|4025183|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4201500|NCT00746395|4025184|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4201501|NCT00746395|4025182|B3||Male|Gender||Participants|Count of Participants|13|13.0||||||
4201502|NCT00746395|4025183|B2||Male|Gender||Participants|Count of Participants|8|8.0||||||
4201503|NCT00746395|4025184|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
4201504|NCT00746395|4025182|B3||Female|Gender||Participants|Count of Participants|27|27.0||||||
4201505|NCT00746395|4025183|B2||Female|Gender||Participants|Count of Participants|12|12.0||||||
4201506|NCT00746395|4025184|B1||Female|Gender||Participants|Count of Participants|15|15.0||||||
4201507|NCT00746395|4025182|B3|||Age||years|Mean|37.07|37.07|Standard Deviation|2.36881|2.36881|||
4201508|NCT00746395|4025183|B2|||Age||years|Mean|35.4|35.4|Standard Deviation|10.86472|10.86472|||
4201509|NCT00746395|4025184|B1|||Age||years|Mean|38.75|38.75|Standard Deviation|13.15045|13.15045|||
4201510|NCT00746395|4025182|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4201511|NCT00746395|4025183|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4201512|NCT00746395|4025184|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4201513|NCT00746395|4025182|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4201514|NCT00746395|4025183|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4201515|NCT00746395|4025184|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4201516|NCT00746395|4025182|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201517|NCT00746395|4025183|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201518|NCT00746395|4025184|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201519|NCT00746356|4025193|B1|Non-Ischemic Etiology||Cardiomyopathy||Participants|Number|41|41.0||||||
4201520|NCT00746356|4025193|B1|Ischemic Etiology||Cardiomyopathy||Participants|Number|87|87.0||||||
4201521|NCT00746356|4025193|B1||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4201522|NCT00746356|4025193|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4201523|NCT00746356|4025193|B1|||Age||years|Mean|67|67.0|Standard Deviation|12|12.0|||
4201524|NCT00746330|4025202|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4201525|NCT00746330|4025203|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4201526|NCT00746330|4025204|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4201527|NCT00746330|4025205|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4201528|NCT00746330|4025206|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4201529|NCT00746330|4025202|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201530|NCT00746330|4025203|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201531|NCT00746330|4025204|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201532|NCT00746330|4025205|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201533|NCT00746330|4025206|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201534|NCT00746330|4025202|B5||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4201535|NCT00746330|4025203|B4||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4201536|NCT00746330|4025204|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4201537|NCT00746330|4025205|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4201538|NCT00746330|4025206|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4201539|NCT00746330|4025202|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4201540|NCT00746330|4025203|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201541|NCT00746330|4025204|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4201542|NCT00746330|4025205|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4201543|NCT00746330|4025206|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201544|NCT00746330|4025202|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201545|NCT00746330|4025203|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201546|NCT00746330|4025204|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201547|NCT00746330|4025205|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201548|NCT00746330|4025206|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201549|NCT00746330|4025202|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201550|NCT00746330|4025203|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201551|NCT00746330|4025204|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201552|NCT00746330|4025205|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201553|NCT00746330|4025206|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201554|NCT00746330|4025202|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4201555|NCT00746330|4025203|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4201556|NCT00746330|4025204|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201557|NCT00746330|4025205|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201558|NCT00746330|4025206|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201559|NCT00746330|4025202|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201560|NCT00746330|4025203|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201561|NCT00746330|4025204|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201562|NCT00746330|4025205|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201563|NCT00746330|4025206|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201564|NCT00746330|4025202|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4201565|NCT00746330|4025203|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4201566|NCT00746330|4025204|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4201567|NCT00746330|4025205|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4201568|NCT00746330|4025206|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4201569|NCT00746330|4025202|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4201570|NCT00746330|4025203|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4201571|NCT00746330|4025204|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4201572|NCT00746330|4025205|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4201573|NCT00746330|4025206|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4201574|NCT00746330|4025202|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4201575|NCT00746330|4025203|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4201576|NCT00746330|4025204|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4201577|NCT00746330|4025205|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4201578|NCT00746330|4025206|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4201579|NCT00746330|4025202|B5||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4201580|NCT00746330|4025203|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4201581|NCT00746330|4025204|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4201582|NCT00746330|4025205|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4201583|NCT00746330|4025206|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4201584|NCT00746330|4025202|B5|||Age||years|Mean|9.1|9.1|Standard Deviation|1.72|1.72|||
4201585|NCT00746330|4025203|B4|||Age||years|Mean|10.1|10.1|Standard Deviation|1.21|1.21|||
4201586|NCT00746330|4025204|B3|||Age||years|Mean|7.9|7.9|Standard Deviation|1.83|1.83|||
4201587|NCT00746330|4025205|B2|||Age||years|Mean|9.4|9.4|Standard Deviation|1.51|1.51|||
4201588|NCT00746330|4025206|B1|||Age||years|Mean|9.0|9.0|Standard Deviation|1.63|1.63|||
4201589|NCT00746330|4025202|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4201590|NCT00746330|4025203|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4201591|NCT00746330|4025204|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4201592|NCT00746330|4025205|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4201593|NCT00746330|4025206|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4201594|NCT00746330|4025202|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4201595|NCT00746330|4025203|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4201596|NCT00746330|4025204|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4201597|NCT00746330|4025205|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4201598|NCT00746330|4025206|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4201599|NCT00746330|4025202|B5||<=18 years|Age||Participants|Count of Participants|32|32.0||||||
4201600|NCT00746330|4025203|B4||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4201601|NCT00746330|4025204|B3||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4201602|NCT00746330|4025205|B2||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4201603|NCT00746330|4025206|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4201604|NCT00746252|4025237|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4201605|NCT00746252|4025238|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4201606|NCT00746252|4025239|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4201607|NCT00746252|4025237|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201608|NCT00746252|4025238|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201609|NCT00746252|4025239|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201610|NCT00746252|4025237|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201611|NCT00746252|4025238|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201612|NCT00746252|4025239|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201613|NCT00746252|4025237|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4201614|NCT00746252|4025238|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201615|NCT00746252|4025239|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4201616|NCT00746252|4025237|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4201617|NCT00746252|4025238|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4201618|NCT00746252|4025239|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201619|NCT00746252|4025237|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201620|NCT00746252|4025238|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201621|NCT00746252|4025239|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201622|NCT00746252|4025237|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201623|NCT00746252|4025238|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201624|NCT00746252|4025239|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201625|NCT00746252|4025237|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201626|NCT00746252|4025238|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201627|NCT00746252|4025239|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201628|NCT00746252|4025237|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4201629|NCT00746252|4025238|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4201630|NCT00746252|4025239|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4201631|NCT00746252|4025237|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4201632|NCT00746252|4025238|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4201633|NCT00746252|4025239|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4201634|NCT00746252|4025237|B3|||Age||years|Mean|10.9|10.9|Standard Deviation|2.78|2.78|||
4201635|NCT00746252|4025238|B2|||Age||years|Mean|12.5|12.5|Standard Deviation|0|0.0|||
4201636|NCT00746252|4025239|B1|||Age||years|Mean|7.75|7.75|Standard Deviation|0|0.0|||
4201637|NCT00746239|4025246|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4201638|NCT00746239|4025246|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4201639|NCT00746239|4025246|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4201640|NCT00746239|4025246|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4201641|NCT00746239|4025246|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4201642|NCT00746239|4025246|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201643|NCT00746187|4025251|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4201644|NCT00746187|4025252|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4201645|NCT00746187|4025253|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4201646|NCT00746187|4025251|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4201647|NCT00746187|4025252|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4201648|NCT00746187|4025253|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4201649|NCT00746187|4025251|B3|||Age||years|Mean|53|53.0|Standard Deviation|12|12.0|||
4201650|NCT00746187|4025252|B2|||Age||years|Mean|51|51.0|Standard Deviation|11|11.0|||
4201651|NCT00746187|4025253|B1|||Age||years|Mean|55|55.0|Standard Deviation|12|12.0|||
4201652|NCT00746096|4025260|B3|||VAS|VAS stands for Visual Analogue Scale of pain. The scale was rated as a graphic rating scale. as a 100mm baseline from 0:No pain to 100:Worst possible pain.|units on a scale|Mean|58.6|58.6|Standard Deviation|17.32|17.32|||
4201653|NCT00746096|4025261|B2|||VAS|VAS stands for Visual Analogue Scale of pain. The scale was rated as a graphic rating scale. as a 100mm baseline from 0:No pain to 100:Worst possible pain.|units on a scale|Mean|60.0|60.0|Standard Deviation|16.82|16.82|||
4201654|NCT00746096|4025262|B1|||VAS|VAS stands for Visual Analogue Scale of pain. The scale was rated as a graphic rating scale. as a 100mm baseline from 0:No pain to 100:Worst possible pain.|units on a scale|Mean|57.2|57.2|Standard Deviation|18.00|18.0|||
4201655|NCT00746096|4025260|B3|||Dysmenorrhea score|"The detail of dysmenorrhea score that was used in this study is the following. These subscales summed for a total dysmenorrhea score (minimum 0 to maximum 6). Pain score None 0 : None Mild 1 : There are some troubles for work Moderate 2 : Needing to rest in bed and/or affecting work Severe 3 : Morre than 1 day in bed and not possible to work~Drug score (during a menstrual period) None 0 : None Mild 1 : taking analgesics for 1 days Moderate 2 : taking analgesics for 2 days Severe 3 : taking analgesics more than 3 days"|units on a scale|Mean|3.7|3.7|Standard Deviation|0.83|0.83|||
4201656|NCT00746096|4025261|B2|||Dysmenorrhea score|"The detail of dysmenorrhea score that was used in this study is the following. These subscales summed for a total dysmenorrhea score (minimum 0 to maximum 6). Pain score None 0 : None Mild 1 : There are some troubles for work Moderate 2 : Needing to rest in bed and/or affecting work Severe 3 : Morre than 1 day in bed and not possible to work~Drug score (during a menstrual period) None 0 : None Mild 1 : taking analgesics for 1 days Moderate 2 : taking analgesics for 2 days Severe 3 : taking analgesics more than 3 days"|units on a scale|Mean|3.6|3.6|Standard Deviation|0.71|0.71|||
4201657|NCT00746096|4025262|B1|||Dysmenorrhea score|"The detail of dysmenorrhea score that was used in this study is the following. These subscales summed for a total dysmenorrhea score (minimum 0 to maximum 6). Pain score None 0 : None Mild 1 : There are some troubles for work Moderate 2 : Needing to rest in bed and/or affecting work Severe 3 : Morre than 1 day in bed and not possible to work~Drug score (during a menstrual period) None 0 : None Mild 1 : taking analgesics for 1 days Moderate 2 : taking analgesics for 2 days Severe 3 : taking analgesics more than 3 days"|units on a scale|Mean|3.8|3.8|Standard Deviation|0.94|0.94|||
4201658|NCT00746096|4025260|B3|Female||Sex/Gender, Customized||participants|Number|107|107.0||||||
4201659|NCT00746096|4025261|B2|Female||Sex/Gender, Customized||participants|Number|55|55.0||||||
4201660|NCT00746096|4025262|B1|Female||Sex/Gender, Customized||participants|Number|52|52.0||||||
4201661|NCT00746096|4025260|B3|||Age||years|Mean|29.1|29.1|Standard Deviation|6.71|6.71|||
4201662|NCT00746096|4025261|B2|||Age||years|Mean|29.2|29.2|Standard Deviation|7.15|7.15|||
4201663|NCT00746096|4025262|B1|||Age||years|Mean|29.1|29.1|Standard Deviation|6.28|6.28|||
4201664|NCT00746018|4025271|B1|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
4201665|NCT00746018|4025271|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201666|NCT00746018|4025271|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201667|NCT00746018|4025271|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4201668|NCT00746018|4025271|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4201669|NCT00746018|4025271|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201670|NCT00746018|4025271|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4201671|NCT00746018|4025271|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201672|NCT00746018|4025271|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4201673|NCT00746018|4025271|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4201674|NCT00746018|4025271|B1|||Age||years|Median|56|56.0|Full Range|||35.0|83.0|
4201675|NCT00745940|4025275|B3|Canada||Region of Enrollment||participants|Number|76|76.0||||||
4201676|NCT00745940|4025276|B2|Canada||Region of Enrollment||participants|Number|38|38.0||||||
4201677|NCT00745940|4025277|B1|Canada||Region of Enrollment||participants|Number|38|38.0||||||
4201678|NCT00745940|4025275|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4201679|NCT00745940|4025276|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4201680|NCT00745940|4025277|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4201681|NCT00745940|4025275|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4201682|NCT00745940|4025276|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4201683|NCT00745940|4025277|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4201684|NCT00745940|4025275|B3|||Age||years|Mean|46.46|46.46|Standard Deviation|13.06|13.06|||
4201685|NCT00745940|4025276|B2|||Age||years|Mean|45.81|45.81|Standard Deviation|14.80|14.8|||
4201686|NCT00745940|4025277|B1|||Age||years|Mean|47.10|47.1|Standard Deviation|12.03|12.03|||
4201687|NCT00745940|4025275|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4201688|NCT00745940|4025276|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4201689|NCT00745940|4025277|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4201690|NCT00745940|4025275|B3||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
4201691|NCT00745940|4025276|B2||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4201692|NCT00745940|4025277|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4201693|NCT00745940|4025275|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201694|NCT00745940|4025276|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201695|NCT00745940|4025277|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201696|NCT00745901|4025292|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4201697|NCT00745901|4025293|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4201698|NCT00745901|4025294|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4201699|NCT00745901|4025292|B3||Female|Sex: Female, Male||Participants|Count of Participants|355|355.0||||||
4201700|NCT00745901|4025293|B2||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4201701|NCT00745901|4025294|B1||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4201702|NCT00745901|4025292|B3|||Age||years|Mean|27.2|27.2|Standard Deviation|6.60|6.6|||
4201703|NCT00745901|4025293|B2|||Age||years|Mean|27.2|27.2|Standard Deviation|6.52|6.52|||
4201704|NCT00745901|4025294|B1|||Age||years|Mean|27.2|27.2|Standard Deviation|6.70|6.7|||
4201705|NCT00745901|4025292|B3|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4201706|NCT00745901|4025293|B2|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4201707|NCT00745901|4025294|B1|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4201708|NCT00745901|4025292|B3|>= 18 and < 65 years||Age, Customized||participants|Number|355|355.0||||||
4201709|NCT00745901|4025293|B2|>= 18 and < 65 years||Age, Customized||participants|Number|177|177.0||||||
4201710|NCT00745901|4025294|B1|>= 18 and < 65 years||Age, Customized||participants|Number|178|178.0||||||
4201711|NCT00745901|4025292|B3|<18 years||Age, Customized||participants|Number|0|0.0||||||
4201712|NCT00745901|4025293|B2|<18 years||Age, Customized||participants|Number|0|0.0||||||
4201713|NCT00745901|4025294|B1|<18 years||Age, Customized||participants|Number|0|0.0||||||
4201714|NCT00745875|4025339|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4201715|NCT00745875|4025340|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4201716|NCT00745875|4025341|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4201717|NCT00745875|4025339|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4201718|NCT00745875|4025340|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4201719|NCT00745875|4025341|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4201720|NCT00745875|4025339|B3|||Age||Years|Mean|57|57.0|Standard Deviation|11.25|11.25|||
4201721|NCT00745875|4025340|B2|||Age||Years|Mean|57.5|57.5|Standard Deviation|10.44|10.44|||
4201722|NCT00745875|4025341|B1|||Age||Years|Mean|56.6|56.6|Standard Deviation|12.06|12.06|||
4201723|NCT00745823|4025350|B3||Male|Sex: Female, Male||Participants|Count of Participants|617|617.0||||||
4201724|NCT00745823|4025351|B2||Male|Sex: Female, Male||Participants|Count of Participants|299|299.0||||||
4201725|NCT00745823|4025352|B1||Male|Sex: Female, Male||Participants|Count of Participants|318|318.0||||||
4201726|NCT00745823|4025350|B3||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4201727|NCT00745823|4025351|B2||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4201728|NCT00745823|4025352|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4201729|NCT00745823|4025350|B3|>=64 years||Age, Customized||participants|Number|11|11.0||||||
4201730|NCT00745823|4025351|B2|>=64 years||Age, Customized||participants|Number|7|7.0||||||
4201731|NCT00745823|4025352|B1|>=64 years||Age, Customized||participants|Number|4|4.0||||||
4201732|NCT00745823|4025350|B3|Between 18 and 64 years||Age, Customized||participants|Number|764|764.0||||||
4201733|NCT00745823|4025351|B2|Between 18 and 64 years||Age, Customized||participants|Number|382|382.0||||||
4201734|NCT00745823|4025352|B1|Between 18 and 64 years||Age, Customized||participants|Number|382|382.0||||||
4201735|NCT00745498|4025377|B4||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4201736|NCT00745498|4025378|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4201737|NCT00745498|4025379|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4201738|NCT00745498|4025380|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4201739|NCT00745498|4025377|B4||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4201740|NCT00745498|4025378|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4201741|NCT00745498|4025379|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4201742|NCT00745498|4025380|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4201743|NCT00745498|4025377|B4|||Age||years|Mean|53.9|53.9|Standard Deviation|10.5|10.5|||
4201744|NCT00745498|4025378|B3|||Age||years|Mean|55.0|55.0|Standard Deviation|11.4|11.4|||
4201745|NCT00745498|4025379|B2|||Age||years|Mean|55.6|55.6|Standard Deviation|10.3|10.3|||
4201746|NCT00745498|4025380|B1|||Age||years|Mean|51.0|51.0|Standard Deviation|9.5|9.5|||
4201747|NCT00745420|4025396|B1||Not Reported|Donor Race/Ethnicity||Participants|Count of Participants|2|2.0||||||
4201748|NCT00745420|4025396|B1||Multiracial|Donor Race/Ethnicity||Participants|Count of Participants|5|5.0||||||
4201749|NCT00745420|4025396|B1||Black or African American|Donor Race/Ethnicity||Participants|Count of Participants|11|11.0||||||
4201750|NCT00745420|4025396|B1||Caucasian|Donor Race/Ethnicity||Participants|Count of Participants|11|11.0||||||
4201751|NCT00745420|4025396|B1|||Donor Age||years|Median|35|35.0|Full Range|||21.0|55.0|
4201752|NCT00745420|4025396|B1|Male donor, female recipient||Donor Gender Match||Participants|Count of Participants|7|7.0||||||
4201753|NCT00745420|4025396|B1|Female donor, male recipient||Donor Gender Match||Participants|Count of Participants|7|7.0||||||
4201754|NCT00745420|4025396|B1|Gender matched transplants||Donor Gender Match||Participants|Count of Participants|15|15.0||||||
4201755|NCT00745420|4025396|B1|ABO Blood group minor mismatch||Donor Blood Type Match||Participants|Count of Participants|5|5.0||||||
4201756|NCT00745420|4025396|B1|ABO Blood group major mismatch||Donor Blood Type Match||Participants|Count of Participants|9|9.0||||||
4201757|NCT00745420|4025396|B1|ABO Blood group matched||Donor Blood Type Match||Participants|Count of Participants|15|15.0||||||
4201758|NCT00745420|4025396|B1|CMV + donor and CMV - recipient||Cytomegalovirus (CMV) Status||Participants|Count of Participants|9|9.0||||||
4201759|NCT00745420|4025396|B1|CMV - donor and CMV + recipient||Cytomegalovirus (CMV) Status||Participants|Count of Participants|3|3.0||||||
4201760|NCT00745420|4025396|B1|CMV + donor and recipient||Cytomegalovirus (CMV) Status||Participants|Count of Participants|9|9.0||||||
4201761|NCT00745420|4025396|B1|CMV - donor and recipient||Cytomegalovirus (CMV) Status||Participants|Count of Participants|8|8.0||||||
4201762|NCT00745420|4025396|B1|70||Karnofsky Performance Score|Assesses patient self-perceived global quality of life and functioning on a scale of 0 - 100; where 100 equals normal quality of life with no evidence of disease, 90 equals ability to carry on normal activity with minor signs/symptoms of disease, 80 equals normal activity with effort and some signs/symptoms of disease, and 70 equals ability to care for oneself but unable to carry on normal activity or to do active work.|Participants|Count of Participants|1|1.0||||||
4201763|NCT00745420|4025396|B1|80||Karnofsky Performance Score|Assesses patient self-perceived global quality of life and functioning on a scale of 0 - 100; where 100 equals normal quality of life with no evidence of disease, 90 equals ability to carry on normal activity with minor signs/symptoms of disease, 80 equals normal activity with effort and some signs/symptoms of disease, and 70 equals ability to care for oneself but unable to carry on normal activity or to do active work.|Participants|Count of Participants|2|2.0||||||
4201764|NCT00745420|4025396|B1|90||Karnofsky Performance Score|Assesses patient self-perceived global quality of life and functioning on a scale of 0 - 100; where 100 equals normal quality of life with no evidence of disease, 90 equals ability to carry on normal activity with minor signs/symptoms of disease, 80 equals normal activity with effort and some signs/symptoms of disease, and 70 equals ability to care for oneself but unable to carry on normal activity or to do active work.|Participants|Count of Participants|9|9.0||||||
4201765|NCT00745420|4025396|B1|100||Karnofsky Performance Score|Assesses patient self-perceived global quality of life and functioning on a scale of 0 - 100; where 100 equals normal quality of life with no evidence of disease, 90 equals ability to carry on normal activity with minor signs/symptoms of disease, 80 equals normal activity with effort and some signs/symptoms of disease, and 70 equals ability to care for oneself but unable to carry on normal activity or to do active work.|Participants|Count of Participants|17|17.0||||||
4201766|NCT00745420|4025396|B1|||Chronic Blood Transfusion Prior to Transplant||Participants|Count of Participants|14|14.0||||||
4201767|NCT00745420|4025396|B1|Vaso-occlusive pain crisis||Indications for Transplant|Some patients had more than 1 indication|Participants|Count of Participants|12|12.0||||||
4201768|NCT00745420|4025396|B1|Acute chest syndrome||Indications for Transplant|Some patients had more than 1 indication|Participants|Count of Participants|4|4.0||||||
4201769|NCT00745420|4025396|B1|Trans cranial doppler velocity > 200cm/s||Indications for Transplant|Some patients had more than 1 indication|Participants|Count of Participants|2|2.0||||||
4201770|NCT00745420|4025396|B1|Stroke||Indications for Transplant|Some patients had more than 1 indication|Participants|Count of Participants|12|12.0||||||
4201771|NCT00745420|4025396|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4201772|NCT00745420|4025396|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
4201773|NCT00745420|4025396|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4201774|NCT00745420|4025396|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4201775|NCT00745420|4025396|B1|||Age||years|Median|14|14.0|Full Range|||6.0|19.0|
4201776|NCT00745368|4025413|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4201777|NCT00745368|4025413|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4201778|NCT00745368|4025413|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4201779|NCT00745368|4025413|B1|||Age||years|Mean|47|47.0|Standard Deviation|8.8|8.8|||
4201780|NCT00745368|4025413|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4201781|NCT00745368|4025413|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4201782|NCT00745368|4025413|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201783|NCT00745290|4025424|B3|United States||Region of Enrollment||participants|Number|245|245.0||||||
4201784|NCT00745290|4025425|B2|United States||Region of Enrollment||participants|Number|122|122.0||||||
4201785|NCT00745290|4025426|B1|United States||Region of Enrollment||participants|Number|123|123.0||||||
4201786|NCT00745290|4025424|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4201787|NCT00745290|4025425|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4201788|NCT00745290|4025426|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4201789|NCT00745290|4025424|B3||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4201790|NCT00745290|4025425|B2||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4201791|NCT00745290|4025426|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4201792|NCT00745290|4025424|B3|||Age||years|Mean|65.8|65.8|Standard Deviation|10.5|10.5|||
4201793|NCT00745290|4025425|B2|||Age||years|Mean|66.8|66.8|Standard Deviation|10.6|10.6|||
4201794|NCT00745290|4025426|B1|||Age||years|Mean|64.8|64.8|Standard Deviation|10.4|10.4|||
4201795|NCT00745290|4025424|B3||>=65 years|Age||Participants|Count of Participants|126|126.0||||||
4201796|NCT00745290|4025425|B2||>=65 years|Age||Participants|Count of Participants|70|70.0||||||
4201797|NCT00745290|4025426|B1||>=65 years|Age||Participants|Count of Participants|56|56.0||||||
4201798|NCT00745290|4025424|B3||Between 18 and 65 years|Age||Participants|Count of Participants|119|119.0||||||
4201799|NCT00745290|4025425|B2||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4201800|NCT00745290|4025426|B1||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
4201801|NCT00745290|4025424|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201802|NCT00745290|4025425|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201803|NCT00745290|4025426|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201804|NCT00745251|4025433|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
4201805|NCT00745251|4025434|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4201806|NCT00745251|4025435|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4201807|NCT00745251|4025433|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4201808|NCT00745251|4025434|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4201809|NCT00745251|4025435|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4201810|NCT00745251|4025433|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4201811|NCT00745251|4025434|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4201812|NCT00745251|4025435|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4201813|NCT00745251|4025433|B3|||Age||years|Mean|52.4|52.4|Standard Deviation|6.37|6.37|||
4201814|NCT00745251|4025434|B2|||Age||years|Mean|53.4|53.4|Standard Deviation|6.95|6.95|||
4201815|NCT00745251|4025435|B1|||Age||years|Mean|51.4|51.4|Standard Deviation|5.74|5.74|||
4201816|NCT00745095|4025444|B7|United States||Region of Enrollment||participants|Number|106|106.0||||||
4201817|NCT00745095|4025445|B6|United States||Region of Enrollment||participants|Number|27|27.0||||||
4201818|NCT00745095|4025446|B5|United States||Region of Enrollment||participants|Number|28|28.0||||||
4201819|NCT00745095|4025447|B4|United States||Region of Enrollment||participants|Number|12|12.0||||||
4201820|NCT00745095|4025448|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4201821|NCT00745095|4025449|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4201822|NCT00745095|4025450|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4201823|NCT00745095|4025444|B7||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4201824|NCT00745095|4025445|B6||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4201825|NCT00745095|4025446|B5||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4201826|NCT00745095|4025447|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4201827|NCT00745095|4025448|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4201828|NCT00745095|4025449|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4201829|NCT00745095|4025450|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4201830|NCT00745095|4025444|B7||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4201831|NCT00745095|4025445|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4201832|NCT00745095|4025446|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4201833|NCT00745095|4025447|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4201834|NCT00745095|4025448|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4201835|NCT00745095|4025449|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4201836|NCT00745095|4025450|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4201837|NCT00745095|4025444|B7|||Age||years|Mean|60|60.0|Standard Deviation|8|8.0|||
4201838|NCT00745095|4025445|B6|||Age||years|Mean|60|60.0|Standard Deviation|9|9.0|||
4201839|NCT00745095|4025446|B5|||Age||years|Mean|58|58.0|Standard Deviation|10|10.0|||
4201840|NCT00745095|4025447|B4|||Age||years|Mean|58|58.0|Standard Deviation|5|5.0|||
4201841|NCT00745095|4025448|B3|||Age||years|Mean|61|61.0|Standard Deviation|11|11.0|||
4201842|NCT00745095|4025449|B2|||Age||years|Mean|65|65.0|Standard Deviation|6|6.0|||
4201843|NCT00745095|4025450|B1|||Age||years|Mean|59|59.0|Standard Deviation|8|8.0|||
4201844|NCT00745030|4025475|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4201845|NCT00745030|4025476|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4201846|NCT00745030|4025477|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4201847|NCT00745030|4025475|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4201848|NCT00745030|4025476|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4201849|NCT00745030|4025477|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4201850|NCT00745030|4025475|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4201851|NCT00745030|4025476|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4201852|NCT00745030|4025477|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4201853|NCT00745030|4025475|B3|||Age||years|Mean|57|57.0|Standard Deviation|7.85|7.85|||
4201854|NCT00745030|4025476|B2|||Age||years|Mean|57|57.0|Standard Deviation|7.85|7.85|||
4201855|NCT00745030|4025477|B1|||Age||years|Mean|57|57.0|Standard Deviation|0|0.0|||
4201856|NCT00745030|4025475|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4201857|NCT00745030|4025476|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4201858|NCT00745030|4025477|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4201859|NCT00745030|4025475|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4201860|NCT00745030|4025476|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4201861|NCT00745030|4025477|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4201862|NCT00745030|4025475|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201863|NCT00745030|4025476|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201864|NCT00745030|4025477|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4201865|NCT00744978|4025484|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4201866|NCT00744978|4025485|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4201867|NCT00744978|4025486|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4201868|NCT00744978|4025484|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4201869|NCT00744978|4025485|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4201870|NCT00744978|4025486|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4201871|NCT00744978|4025484|B3|||Age||years|Mean|72.7|72.7|Standard Deviation|7.4|7.4|||
4201872|NCT00744978|4025485|B2|||Age||years|Mean|73.9|73.9|Standard Deviation|5.8|5.8|||
4201873|NCT00744978|4025486|B1|||Age||years|Mean|71.5|71.5|Standard Deviation|8.7|8.7|||
4201874|NCT00744939|4025535|B5|Other||MRI region of main interest||Participants|Number|39|39.0||||||
4201875|NCT00744939|4025536|B4|Other||MRI region of main interest||Participants|Number|3|3.0||||||
4201876|NCT00744939|4025537|B3|Other||MRI region of main interest||Participants|Number|28|28.0||||||
4201877|NCT00744939|4025538|B2|Other||MRI region of main interest||Participants|Number|3|3.0||||||
4201878|NCT00744939|4025539|B1|Other||MRI region of main interest||Participants|Number|5|5.0||||||
4201879|NCT00744939|4025535|B5|Musculoskeletal||MRI region of main interest||Participants|Number|9|9.0||||||
4201880|NCT00744939|4025536|B4|Musculoskeletal||MRI region of main interest||Participants|Number|0|0.0||||||
4201881|NCT00744939|4025537|B3|Musculoskeletal||MRI region of main interest||Participants|Number|8|8.0||||||
4201882|NCT00744939|4025538|B2|Musculoskeletal||MRI region of main interest||Participants|Number|0|0.0||||||
4201883|NCT00744939|4025539|B1|Musculoskeletal||MRI region of main interest||Participants|Number|1|1.0||||||
4201884|NCT00744939|4025535|B5|Kidney||MRI region of main interest||Participants|Number|20|20.0||||||
4201885|NCT00744939|4025536|B4|Kidney||MRI region of main interest||Participants|Number|1|1.0||||||
4201886|NCT00744939|4025537|B3|Kidney||MRI region of main interest||Participants|Number|15|15.0||||||
4201887|NCT00744939|4025538|B2|Kidney||MRI region of main interest||Participants|Number|2|2.0||||||
4201888|NCT00744939|4025539|B1|Kidney||MRI region of main interest||Participants|Number|2|2.0||||||
4201889|NCT00744939|4025535|B5|Liver||MRI region of main interest||Participants|Number|24|24.0||||||
4201890|NCT00744939|4025536|B4|Liver||MRI region of main interest||Participants|Number|3|3.0||||||
4201891|NCT00744939|4025537|B3|Liver||MRI region of main interest||Participants|Number|19|19.0||||||
4201892|NCT00744939|4025538|B2|Liver||MRI region of main interest||Participants|Number|1|1.0||||||
4201893|NCT00744939|4025539|B1|Liver||MRI region of main interest||Participants|Number|1|1.0||||||
4201894|NCT00744939|4025535|B5|Spine||MRI region of main interest||Participants|Number|13|13.0||||||
4201895|NCT00744939|4025536|B4|Spine||MRI region of main interest||Participants|Number|1|1.0||||||
4201896|NCT00744939|4025537|B3|Spine||MRI region of main interest||Participants|Number|11|11.0||||||
4201897|NCT00744939|4025538|B2|Spine||MRI region of main interest||Participants|Number|0|0.0||||||
4201898|NCT00744939|4025539|B1|Spine||MRI region of main interest||Participants|Number|1|1.0||||||
4201899|NCT00744939|4025535|B5|Brain||MRI region of main interest||Participants|Number|36|36.0||||||
4201900|NCT00744939|4025536|B4|Brain||MRI region of main interest||Participants|Number|1|1.0||||||
4201901|NCT00744939|4025537|B3|Brain||MRI region of main interest||Participants|Number|28|28.0||||||
4201902|NCT00744939|4025538|B2|Brain||MRI region of main interest||Participants|Number|3|3.0||||||
4201903|NCT00744939|4025539|B1|Brain||MRI region of main interest||Participants|Number|4|4.0||||||
4201904|NCT00744939|4025535|B5|Other||Vascular injuries|Participants reporting more than one injury per injury type were counted only once for each type. Not all patients had vascular injuries reported.|Participants|Number|4|4.0||||||
4201905|NCT00744939|4025536|B4|Other||Vascular injuries|Participants reporting more than one injury per injury type were counted only once for each type. Not all patients had vascular injuries reported.|Participants|Number|0|0.0||||||
4201906|NCT00744939|4025537|B3|Other||Vascular injuries|Participants reporting more than one injury per injury type were counted only once for each type. Not all patients had vascular injuries reported.|Participants|Number|4|4.0||||||
4201907|NCT00744939|4025538|B2|Other||Vascular injuries|Participants reporting more than one injury per injury type were counted only once for each type. Not all patients had vascular injuries reported.|Participants|Number|0|0.0||||||
4201908|NCT00744939|4025539|B1|Other||Vascular injuries|Participants reporting more than one injury per injury type were counted only once for each type. Not all patients had vascular injuries reported.|Participants|Number|0|0.0||||||
4201909|NCT00744939|4025535|B5|Other surgeries||Vascular injuries|Participants reporting more than one injury per injury type were counted only once for each type. Not all patients had vascular injuries reported.|Participants|Number|15|15.0||||||
4201910|NCT00744939|4025536|B4|Other surgeries||Vascular injuries|Participants reporting more than one injury per injury type were counted only once for each type. Not all patients had vascular injuries reported.|Participants|Number|0|0.0||||||
4201911|NCT00744939|4025537|B3|Other surgeries||Vascular injuries|Participants reporting more than one injury per injury type were counted only once for each type. Not all patients had vascular injuries reported.|Participants|Number|13|13.0||||||
4201912|NCT00744939|4025538|B2|Other surgeries||Vascular injuries|Participants reporting more than one injury per injury type were counted only once for each type. Not all patients had vascular injuries reported.|Participants|Number|0|0.0||||||
4202177|NCT00744627|4025631|B3|Estonia||Region of Enrollment||participants|Number|10|10.0||||||
4201913|NCT00744939|4025539|B1|Other surgeries||Vascular injuries|Participants reporting more than one injury per injury type were counted only once for each type. Not all patients had vascular injuries reported.|Participants|Number|2|2.0||||||
4201914|NCT00744939|4025535|B5|Thrombotic events||Vascular injuries|Participants reporting more than one injury per injury type were counted only once for each type. Not all patients had vascular injuries reported.|Participants|Number|26|26.0||||||
4201915|NCT00744939|4025536|B4|Thrombotic events||Vascular injuries|Participants reporting more than one injury per injury type were counted only once for each type. Not all patients had vascular injuries reported.|Participants|Number|0|0.0||||||
4201916|NCT00744939|4025537|B3|Thrombotic events||Vascular injuries|Participants reporting more than one injury per injury type were counted only once for each type. Not all patients had vascular injuries reported.|Participants|Number|24|24.0||||||
4201917|NCT00744939|4025538|B2|Thrombotic events||Vascular injuries|Participants reporting more than one injury per injury type were counted only once for each type. Not all patients had vascular injuries reported.|Participants|Number|1|1.0||||||
4201918|NCT00744939|4025539|B1|Thrombotic events||Vascular injuries|Participants reporting more than one injury per injury type were counted only once for each type. Not all patients had vascular injuries reported.|Participants|Number|1|1.0||||||
4201919|NCT00744939|4025535|B5|Organ transplant surgery||Vascular injuries|Participants reporting more than one injury per injury type were counted only once for each type. Not all patients had vascular injuries reported.|Participants|Number|8|8.0||||||
4201920|NCT00744939|4025536|B4|Organ transplant surgery||Vascular injuries|Participants reporting more than one injury per injury type were counted only once for each type. Not all patients had vascular injuries reported.|Participants|Number|3|3.0||||||
4201921|NCT00744939|4025537|B3|Organ transplant surgery||Vascular injuries|Participants reporting more than one injury per injury type were counted only once for each type. Not all patients had vascular injuries reported.|Participants|Number|5|5.0||||||
4201922|NCT00744939|4025538|B2|Organ transplant surgery||Vascular injuries|Participants reporting more than one injury per injury type were counted only once for each type. Not all patients had vascular injuries reported.|Participants|Number|0|0.0||||||
4201923|NCT00744939|4025539|B1|Organ transplant surgery||Vascular injuries|Participants reporting more than one injury per injury type were counted only once for each type. Not all patients had vascular injuries reported.|Participants|Number|0|0.0||||||
4201924|NCT00744939|4025535|B5|Shunt surgery/repair||Vascular injuries|Participants reporting more than one injury per injury type were counted only once for each type. Not all patients had vascular injuries reported.|Participants|Number|6|6.0||||||
4201925|NCT00744939|4025536|B4|Shunt surgery/repair||Vascular injuries|Participants reporting more than one injury per injury type were counted only once for each type. Not all patients had vascular injuries reported.|Participants|Number|2|2.0||||||
4201926|NCT00744939|4025537|B3|Shunt surgery/repair||Vascular injuries|Participants reporting more than one injury per injury type were counted only once for each type. Not all patients had vascular injuries reported.|Participants|Number|4|4.0||||||
4201927|NCT00744939|4025538|B2|Shunt surgery/repair||Vascular injuries|Participants reporting more than one injury per injury type were counted only once for each type. Not all patients had vascular injuries reported.|Participants|Number|0|0.0||||||
4201928|NCT00744939|4025539|B1|Shunt surgery/repair||Vascular injuries|Participants reporting more than one injury per injury type were counted only once for each type. Not all patients had vascular injuries reported.|Participants|Number|0|0.0||||||
4201929|NCT00744939|4025535|B5|Any||Vascular injuries|Participants reporting more than one injury per injury type were counted only once for each type. Not all patients had vascular injuries reported.|Participants|Number|43|43.0||||||
4201930|NCT00744939|4025536|B4|Any||Vascular injuries|Participants reporting more than one injury per injury type were counted only once for each type. Not all patients had vascular injuries reported.|Participants|Number|3|3.0||||||
4201931|NCT00744939|4025537|B3|Any||Vascular injuries|Participants reporting more than one injury per injury type were counted only once for each type. Not all patients had vascular injuries reported.|Participants|Number|36|36.0||||||
4201932|NCT00744939|4025538|B2|Any||Vascular injuries|Participants reporting more than one injury per injury type were counted only once for each type. Not all patients had vascular injuries reported.|Participants|Number|1|1.0||||||
4201933|NCT00744939|4025539|B1|Any||Vascular injuries|Participants reporting more than one injury per injury type were counted only once for each type. Not all patients had vascular injuries reported.|Participants|Number|3|3.0||||||
4201934|NCT00744939|4025535|B5|Hemodialysis||Receiving dialysis|Not all participants were receiving dialysis at baseline.|Participants|Number|2|2.0||||||
4201935|NCT00744939|4025536|B4|Hemodialysis||Receiving dialysis|Not all participants were receiving dialysis at baseline.|Participants|Number|2|2.0||||||
4201936|NCT00744939|4025537|B3|Hemodialysis||Receiving dialysis|Not all participants were receiving dialysis at baseline.|Participants|Number|0|0.0||||||
4201937|NCT00744939|4025538|B2|Hemodialysis||Receiving dialysis|Not all participants were receiving dialysis at baseline.|Participants|Number|0|0.0||||||
4201938|NCT00744939|4025539|B1|Hemodialysis||Receiving dialysis|Not all participants were receiving dialysis at baseline.|Participants|Number|0|0.0||||||
4201939|NCT00744939|4025535|B5|Peritoneal dialysis||Receiving dialysis|Not all participants were receiving dialysis at baseline.|Participants|Number|0|0.0||||||
4201940|NCT00744939|4025536|B4|Peritoneal dialysis||Receiving dialysis|Not all participants were receiving dialysis at baseline.|Participants|Number|0|0.0||||||
4201941|NCT00744939|4025537|B3|Peritoneal dialysis||Receiving dialysis|Not all participants were receiving dialysis at baseline.|Participants|Number|0|0.0||||||
4201942|NCT00744939|4025538|B2|Peritoneal dialysis||Receiving dialysis|Not all participants were receiving dialysis at baseline.|Participants|Number|0|0.0||||||
4201943|NCT00744939|4025539|B1|Peritoneal dialysis||Receiving dialysis|Not all participants were receiving dialysis at baseline.|Participants|Number|0|0.0||||||
4201944|NCT00744939|4025535|B5|Any||Receiving dialysis|Not all participants were receiving dialysis at baseline.|Participants|Number|2|2.0||||||
4201945|NCT00744939|4025536|B4|Any||Receiving dialysis|Not all participants were receiving dialysis at baseline.|Participants|Number|2|2.0||||||
4202178|NCT00744627|4025632|B2|Estonia||Region of Enrollment||participants|Number|3|3.0||||||
4201946|NCT00744939|4025537|B3|Any||Receiving dialysis|Not all participants were receiving dialysis at baseline.|Participants|Number|0|0.0||||||
4201947|NCT00744939|4025538|B2|Any||Receiving dialysis|Not all participants were receiving dialysis at baseline.|Participants|Number|0|0.0||||||
4201948|NCT00744939|4025539|B1|Any||Receiving dialysis|Not all participants were receiving dialysis at baseline.|Participants|Number|0|0.0||||||
4201949|NCT00744939|4025535|B5|Other||Cause of renal disease|Participants might have more than one cause of renal disease reported.|Participants|Number|84|84.0||||||
4201950|NCT00744939|4025536|B4|Other||Cause of renal disease|Participants might have more than one cause of renal disease reported.|Participants|Number|3|3.0||||||
4201951|NCT00744939|4025537|B3|Other||Cause of renal disease|Participants might have more than one cause of renal disease reported.|Participants|Number|68|68.0||||||
4201952|NCT00744939|4025538|B2|Other||Cause of renal disease|Participants might have more than one cause of renal disease reported.|Participants|Number|5|5.0||||||
4201953|NCT00744939|4025539|B1|Other||Cause of renal disease|Participants might have more than one cause of renal disease reported.|Participants|Number|8|8.0||||||
4201954|NCT00744939|4025535|B5|Polycystic kidney disease||Cause of renal disease|Participants might have more than one cause of renal disease reported.|Participants|Number|5|5.0||||||
4201955|NCT00744939|4025536|B4|Polycystic kidney disease||Cause of renal disease|Participants might have more than one cause of renal disease reported.|Participants|Number|2|2.0||||||
4201956|NCT00744939|4025537|B3|Polycystic kidney disease||Cause of renal disease|Participants might have more than one cause of renal disease reported.|Participants|Number|3|3.0||||||
4201957|NCT00744939|4025538|B2|Polycystic kidney disease||Cause of renal disease|Participants might have more than one cause of renal disease reported.|Participants|Number|0|0.0||||||
4201958|NCT00744939|4025539|B1|Polycystic kidney disease||Cause of renal disease|Participants might have more than one cause of renal disease reported.|Participants|Number|0|0.0||||||
4201959|NCT00744939|4025535|B5|Hypertension||Cause of renal disease|Participants might have more than one cause of renal disease reported.|Participants|Number|53|53.0||||||
4201960|NCT00744939|4025536|B4|Hypertension||Cause of renal disease|Participants might have more than one cause of renal disease reported.|Participants|Number|2|2.0||||||
4201961|NCT00744939|4025537|B3|Hypertension||Cause of renal disease|Participants might have more than one cause of renal disease reported.|Participants|Number|41|41.0||||||
4201962|NCT00744939|4025538|B2|Hypertension||Cause of renal disease|Participants might have more than one cause of renal disease reported.|Participants|Number|3|3.0||||||
4201963|NCT00744939|4025539|B1|Hypertension||Cause of renal disease|Participants might have more than one cause of renal disease reported.|Participants|Number|7|7.0||||||
4201964|NCT00744939|4025535|B5|Collagen disease||Cause of renal disease|Participants might have more than one cause of renal disease reported.|Participants|Number|0|0.0||||||
4201965|NCT00744939|4025536|B4|Collagen disease||Cause of renal disease|Participants might have more than one cause of renal disease reported.|Participants|Number|0|0.0||||||
4201966|NCT00744939|4025537|B3|Collagen disease||Cause of renal disease|Participants might have more than one cause of renal disease reported.|Participants|Number|0|0.0||||||
4201967|NCT00744939|4025538|B2|Collagen disease||Cause of renal disease|Participants might have more than one cause of renal disease reported.|Participants|Number|0|0.0||||||
4201968|NCT00744939|4025539|B1|Collagen disease||Cause of renal disease|Participants might have more than one cause of renal disease reported.|Participants|Number|0|0.0||||||
4201969|NCT00744939|4025535|B5|Glomerulonephritis||Cause of renal disease|Participants might have more than one cause of renal disease reported.|Participants|Number|1|1.0||||||
4201970|NCT00744939|4025536|B4|Glomerulonephritis||Cause of renal disease|Participants might have more than one cause of renal disease reported.|Participants|Number|0|0.0||||||
4201971|NCT00744939|4025537|B3|Glomerulonephritis||Cause of renal disease|Participants might have more than one cause of renal disease reported.|Participants|Number|1|1.0||||||
4201972|NCT00744939|4025538|B2|Glomerulonephritis||Cause of renal disease|Participants might have more than one cause of renal disease reported.|Participants|Number|0|0.0||||||
4201973|NCT00744939|4025539|B1|Glomerulonephritis||Cause of renal disease|Participants might have more than one cause of renal disease reported.|Participants|Number|0|0.0||||||
4201974|NCT00744939|4025535|B5|Diabetes||Cause of renal disease|Participants might have more than one cause of renal disease reported.|Participants|Number|38|38.0||||||
4201975|NCT00744939|4025536|B4|Diabetes||Cause of renal disease|Participants might have more than one cause of renal disease reported.|Participants|Number|5|5.0||||||
4201976|NCT00744939|4025537|B3|Diabetes||Cause of renal disease|Participants might have more than one cause of renal disease reported.|Participants|Number|28|28.0||||||
4201977|NCT00744939|4025538|B2|Diabetes||Cause of renal disease|Participants might have more than one cause of renal disease reported.|Participants|Number|2|2.0||||||
4201978|NCT00744939|4025539|B1|Diabetes||Cause of renal disease|Participants might have more than one cause of renal disease reported.|Participants|Number|3|3.0||||||
4201979|NCT00744939|4025535|B5|||Years since renal diagnosis|Number of participants with information available: mild cohort is 5;extended moderate cohort is 1; moderate cohort is 38 ; severe cohort 3.|Years|Mean|2.4|2.4|Standard Deviation|3.4|3.4|||
4201980|NCT00744939|4025536|B4|||Years since renal diagnosis|Number of participants with information available: mild cohort is 5;extended moderate cohort is 1; moderate cohort is 38 ; severe cohort 3.|Years|Mean|3.1|3.1|Standard Deviation|4.6|4.6|||
4201981|NCT00744939|4025537|B3|||Years since renal diagnosis|Number of participants with information available: mild cohort is 5;extended moderate cohort is 1; moderate cohort is 38 ; severe cohort 3.|Years|Mean|2.2|2.2|Standard Deviation|3.2|3.2|||
4201982|NCT00744939|4025538|B2|||Years since renal diagnosis|Number of participants with information available: mild cohort is 5;extended moderate cohort is 1; moderate cohort is 38 ; severe cohort 3.|Years|Mean|0|0.0|Standard Deviation|0|0.0|||
4201983|NCT00744939|4025539|B1|||Years since renal diagnosis|Number of participants with information available: mild cohort is 5;extended moderate cohort is 1; moderate cohort is 38 ; severe cohort 3.|Years|Mean|4.4|4.4|Standard Deviation|4.5|4.5|||
4202179|NCT00744627|4025633|B1|Estonia||Region of Enrollment||participants|Number|7|7.0||||||
4201984|NCT00744939|4025535|B5|||Weight|Overall number of baseline participants for moderate cohort is 107|Kilograms|Mean|85.5|85.5|Standard Deviation|17.5|17.5|||
4201985|NCT00744939|4025536|B4|||Weight|Overall number of baseline participants for moderate cohort is 107|Kilograms|Mean|83.2|83.2|Standard Deviation|18.4|18.4|||
4201986|NCT00744939|4025537|B3|||Weight|Overall number of baseline participants for moderate cohort is 107|Kilograms|Mean|86.0|86.0|Standard Deviation|18.3|18.3|||
4201987|NCT00744939|4025538|B2|||Weight|Overall number of baseline participants for moderate cohort is 107|Kilograms|Mean|81.9|81.9|Standard Deviation|13.3|13.3|||
4201988|NCT00744939|4025539|B1|||Weight|Overall number of baseline participants for moderate cohort is 107|Kilograms|Mean|85.2|85.2|Standard Deviation|13.1|13.1|||
4201989|NCT00744939|4025535|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4201990|NCT00744939|4025536|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201991|NCT00744939|4025537|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4201992|NCT00744939|4025538|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201993|NCT00744939|4025539|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201994|NCT00744939|4025535|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201995|NCT00744939|4025536|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201996|NCT00744939|4025537|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201997|NCT00744939|4025538|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201998|NCT00744939|4025539|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4201999|NCT00744939|4025535|B5||White|Race (NIH/OMB)||Participants|Count of Participants|109|109.0||||||
4202000|NCT00744939|4025536|B4||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4202001|NCT00744939|4025537|B3||White|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
4202002|NCT00744939|4025538|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4202003|NCT00744939|4025539|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4202004|NCT00744939|4025535|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4202005|NCT00744939|4025536|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4202006|NCT00744939|4025537|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4202007|NCT00744939|4025538|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202008|NCT00744939|4025539|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4202009|NCT00744939|4025535|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4202010|NCT00744939|4025536|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202011|NCT00744939|4025537|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4202012|NCT00744939|4025538|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202013|NCT00744939|4025539|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202014|NCT00744939|4025535|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4202015|NCT00744939|4025536|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202016|NCT00744939|4025537|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4202017|NCT00744939|4025538|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202018|NCT00744939|4025539|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4202019|NCT00744939|4025535|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4202020|NCT00744939|4025536|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202021|NCT00744939|4025537|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4202022|NCT00744939|4025538|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202023|NCT00744939|4025539|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202024|NCT00744939|4025535|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202025|NCT00744939|4025536|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202026|NCT00744939|4025537|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202027|NCT00744939|4025538|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202028|NCT00744939|4025539|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202029|NCT00744939|4025535|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
4202030|NCT00744939|4025536|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4202031|NCT00744939|4025537|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
4202032|NCT00744939|4025538|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4202033|NCT00744939|4025539|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4202034|NCT00744939|4025535|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4202035|NCT00744939|4025536|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202036|NCT00744939|4025537|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4202037|NCT00744939|4025538|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4202038|NCT00744939|4025539|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4202039|NCT00744939|4025535|B5||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4202040|NCT00744939|4025536|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4202041|NCT00744939|4025537|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4202042|NCT00744939|4025538|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4202043|NCT00744939|4025539|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4202044|NCT00744939|4025535|B5||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4202045|NCT00744939|4025536|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4202046|NCT00744939|4025537|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4202047|NCT00744939|4025538|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4202048|NCT00744939|4025539|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4202049|NCT00744939|4025535|B5|>=65 years||Age, Customized||Participants|Number|78|78.0||||||
4202050|NCT00744939|4025536|B4|>=65 years||Age, Customized||Participants|Number|3|3.0||||||
4202051|NCT00744939|4025537|B3|>=65 years||Age, Customized||Participants|Number|62|62.0||||||
4202052|NCT00744939|4025538|B2|>=65 years||Age, Customized||Participants|Number|4|4.0||||||
4202053|NCT00744939|4025539|B1|>=65 years||Age, Customized||Participants|Number|9|9.0||||||
4202054|NCT00744939|4025535|B5|<65 years||Age, Customized||Participants|Number|63|63.0||||||
4202055|NCT00744939|4025536|B4|<65 years||Age, Customized||Participants|Number|6|6.0||||||
4202056|NCT00744939|4025537|B3|<65 years||Age, Customized||Participants|Number|47|47.0||||||
4202057|NCT00744939|4025538|B2|<65 years||Age, Customized||Participants|Number|5|5.0||||||
4202058|NCT00744939|4025539|B1|<65 years||Age, Customized||Participants|Number|5|5.0||||||
4202059|NCT00744939|4025535|B5|||Age||Years|Mean|66.0|66.0|Standard Deviation|11.75|11.75|||
4202060|NCT00744939|4025536|B4|||Age||Years|Mean|62.4|62.4|Standard Deviation|9.51|9.51|||
4202061|NCT00744939|4025537|B3|||Age||Years|Mean|66.4|66.4|Standard Deviation|12.09|12.09|||
4202062|NCT00744939|4025538|B2|||Age||Years|Mean|66.9|66.9|Standard Deviation|9.91|9.91|||
4202063|NCT00744939|4025539|B1|||Age||Years|Mean|65.0|65.0|Standard Deviation|12.03|12.03|||
4202064|NCT00744874|4025575|B1|Switzerland||Region of Enrollment||participants|Number|9|9.0||||||
4202065|NCT00744874|4025575|B1|Netherlands||Region of Enrollment||participants|Number|21|21.0||||||
4202066|NCT00744874|4025575|B1|Germany||Region of Enrollment||participants|Number|7|7.0||||||
4202067|NCT00744874|4025575|B1|Denmark||Region of Enrollment||participants|Number|18|18.0||||||
4202068|NCT00744874|4025575|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4202069|NCT00744874|4025575|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4202070|NCT00744874|4025575|B1|||Age||years|Mean|55.6|55.6|Standard Deviation|10.1|10.1|||
4202071|NCT00744848|4025591|B3|United States||Region of Enrollment||participants|Number|204|204.0||||||
4202072|NCT00744848|4025592|B2|United States||Region of Enrollment||participants|Number|101|101.0||||||
4202073|NCT00744848|4025593|B1|United States||Region of Enrollment||participants|Number|103|103.0||||||
4202074|NCT00744848|4025591|B3||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4202075|NCT00744848|4025592|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4202076|NCT00744848|4025593|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4202077|NCT00744848|4025591|B3||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4202078|NCT00744848|4025592|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4202079|NCT00744848|4025593|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4202080|NCT00744848|4025591|B3|||Age||years|Mean|49.6|49.6|Standard Deviation|11.3|11.3|||
4202081|NCT00744848|4025592|B2|||Age||years|Mean|50.2|50.2|Standard Deviation|11|11.0|||
4202082|NCT00744848|4025593|B1|||Age||years|Mean|49|49.0|Standard Deviation|11.6|11.6|||
4202083|NCT00744848|4025591|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4202084|NCT00744848|4025592|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4202085|NCT00744848|4025593|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4202086|NCT00744848|4025591|B3||Between 18 and 65 years|Age||Participants|Count of Participants|189|189.0||||||
4202087|NCT00744848|4025592|B2||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
4202088|NCT00744848|4025593|B1||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
4202089|NCT00744848|4025591|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4202090|NCT00744848|4025592|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4202091|NCT00744848|4025593|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4202092|NCT00744757|4025600|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4202093|NCT00744757|4025600|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4202094|NCT00744757|4025600|B1|||Age||Years|Mean|68.0|68.0|Standard Deviation|14.1|14.1|||
4202095|NCT00744692|4025613|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4202096|NCT00744692|4025613|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4202097|NCT00744692|4025613|B1||>=65 years|Age|Age (years) on the day of transplant|Participants|Count of Participants|0|0.0||||||
4202098|NCT00744692|4025613|B1||Between 18 and 65 years|Age|Age (years) on the day of transplant|Participants|Count of Participants|0|0.0||||||
4202099|NCT00744692|4025613|B1||<=18 years|Age|Age (years) on the day of transplant|Participants|Count of Participants|22|22.0||||||
4202100|NCT00744692|4025613|B1|||Age|Age (in years) on the day of transplant|years|Median|2.83|2.83|Full Range|||0.3|8.0|
4202101|NCT00744653|4025625|B1|Denmark||Region of Enrollment||participants|Number|17|17.0||||||
4202102|NCT00744653|4025625|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4202103|NCT00744653|4025625|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4202104|NCT00744653|4025625|B1|||Age||years|Mean|58.6|58.6|Standard Deviation|9.8|9.8|||
4202105|NCT00744653|4025625|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4202106|NCT00744653|4025625|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4202107|NCT00744653|4025625|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4202108|NCT00744627|4025631|B3|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|12.18|12.18|Standard Deviation|2.296|2.296|||
4202109|NCT00744627|4025632|B2|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|12.25|12.25|Standard Deviation|2.219|2.219|||
4202110|NCT00744627|4025633|B1|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|12.12|12.12|Standard Deviation|2.375|2.375|||
4202111|NCT00744627|4025631|B3|||Hospital Anxiety and Depression – Depression subscale|Hospital Anxiety and Depression (HAD) Depression sub-scale consists of 7 items that are assessed on a scale from 0 (no depression) to 3 (severe feeling of depression). The depression subscale focuses on the state of lost interest and diminished pleasure response. Scores are summed and range from 0 to 21 (maximal severity).|scores on a scale|Mean|7.5|7.5|Standard Deviation|3.96|3.96|||
4202112|NCT00744627|4025632|B2|||Hospital Anxiety and Depression – Depression subscale|Hospital Anxiety and Depression (HAD) Depression sub-scale consists of 7 items that are assessed on a scale from 0 (no depression) to 3 (severe feeling of depression). The depression subscale focuses on the state of lost interest and diminished pleasure response. Scores are summed and range from 0 to 21 (maximal severity).|scores on a scale|Mean|7.6|7.6|Standard Deviation|3.89|3.89|||
4202113|NCT00744627|4025633|B1|||Hospital Anxiety and Depression – Depression subscale|Hospital Anxiety and Depression (HAD) Depression sub-scale consists of 7 items that are assessed on a scale from 0 (no depression) to 3 (severe feeling of depression). The depression subscale focuses on the state of lost interest and diminished pleasure response. Scores are summed and range from 0 to 21 (maximal severity).|scores on a scale|Mean|7.5|7.5|Standard Deviation|4.03|4.03|||
4202114|NCT00744627|4025631|B3|||Hospital Anxiety and Depression – Anxiety subscale|Hospital Anxiety and Depression (HAD) Anxiety sub-scale consists of 7 items that are assessed on a scale from 0 (no anxiety) to 3 (severe feeling of anxiety). The anxiety subscale determines a state of generalized anxiety including anxious mood, restlessness, anxious thoughts and panic attacks. Scores are summed and range from 0 to 21 (maximal severity).|scores on a scale|Mean|14.1|14.1|Standard Deviation|3.04|3.04|||
4202115|NCT00744627|4025632|B2|||Hospital Anxiety and Depression – Anxiety subscale|Hospital Anxiety and Depression (HAD) Anxiety sub-scale consists of 7 items that are assessed on a scale from 0 (no anxiety) to 3 (severe feeling of anxiety). The anxiety subscale determines a state of generalized anxiety including anxious mood, restlessness, anxious thoughts and panic attacks. Scores are summed and range from 0 to 21 (maximal severity).|scores on a scale|Mean|13.8|13.8|Standard Deviation|2.99|2.99|||
4202116|NCT00744627|4025633|B1|||Hospital Anxiety and Depression – Anxiety subscale|Hospital Anxiety and Depression (HAD) Anxiety sub-scale consists of 7 items that are assessed on a scale from 0 (no anxiety) to 3 (severe feeling of anxiety). The anxiety subscale determines a state of generalized anxiety including anxious mood, restlessness, anxious thoughts and panic attacks. Scores are summed and range from 0 to 21 (maximal severity).|scores on a scale|Mean|14.4|14.4|Standard Deviation|3.08|3.08|||
4202117|NCT00744627|4025631|B3|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|scores on a scale|Mean|4.5|4.5|Standard Deviation|0.69|0.69|||
4202118|NCT00744627|4025632|B2|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|scores on a scale|Mean|4.5|4.5|Standard Deviation|0.70|0.7|||
4202119|NCT00744627|4025633|B1|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|scores on a scale|Mean|4.5|4.5|Standard Deviation|0.67|0.67|||
4202120|NCT00744627|4025631|B3|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 (absent) to 56 (maximum severity).|scores on a a scale|Mean|26.6|26.6|Standard Deviation|3.94|3.94|||
4202121|NCT00744627|4025632|B2|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 (absent) to 56 (maximum severity).|scores on a a scale|Mean|26.3|26.3|Standard Deviation|3.92|3.92|||
4202122|NCT00744627|4025633|B1|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 (absent) to 56 (maximum severity).|scores on a a scale|Mean|26.8|26.8|Standard Deviation|3.95|3.95|||
4202123|NCT00744627|4025631|B3|Daily||Alcohol Consumption||participants|Number|7|7.0||||||
4202124|NCT00744627|4025632|B2|Daily||Alcohol Consumption||participants|Number|3|3.0||||||
4202125|NCT00744627|4025633|B1|Daily||Alcohol Consumption||participants|Number|4|4.0||||||
4202126|NCT00744627|4025631|B3|2 to 6 times per week||Alcohol Consumption||participants|Number|16|16.0||||||
4202127|NCT00744627|4025632|B2|2 to 6 times per week||Alcohol Consumption||participants|Number|10|10.0||||||
4202128|NCT00744627|4025633|B1|2 to 6 times per week||Alcohol Consumption||participants|Number|6|6.0||||||
4202129|NCT00744627|4025631|B3|Once a week||Alcohol Consumption||participants|Number|33|33.0||||||
4202130|NCT00744627|4025632|B2|Once a week||Alcohol Consumption||participants|Number|18|18.0||||||
4202131|NCT00744627|4025633|B1|Once a week||Alcohol Consumption||participants|Number|15|15.0||||||
4202132|NCT00744627|4025631|B3|Once monthly or less often||Alcohol Consumption||participants|Number|149|149.0||||||
4202133|NCT00744627|4025632|B2|Once monthly or less often||Alcohol Consumption||participants|Number|72|72.0||||||
4202134|NCT00744627|4025633|B1|Once monthly or less often||Alcohol Consumption||participants|Number|77|77.0||||||
4202135|NCT00744627|4025631|B3|Never||Alcohol Consumption||participants|Number|96|96.0||||||
4202136|NCT00744627|4025632|B2|Never||Alcohol Consumption||participants|Number|47|47.0||||||
4202137|NCT00744627|4025633|B1|Never||Alcohol Consumption||participants|Number|49|49.0||||||
4202138|NCT00744627|4025631|B3|Ex-smoker||Smoking Classification||participants|Number|45|45.0||||||
4202139|NCT00744627|4025632|B2|Ex-smoker||Smoking Classification||participants|Number|22|22.0||||||
4202140|NCT00744627|4025633|B1|Ex-smoker||Smoking Classification||participants|Number|23|23.0||||||
4202141|NCT00744627|4025631|B3|Current Smoker||Smoking Classification||participants|Number|67|67.0||||||
4202142|NCT00744627|4025632|B2|Current Smoker||Smoking Classification||participants|Number|38|38.0||||||
4202143|NCT00744627|4025633|B1|Current Smoker||Smoking Classification||participants|Number|29|29.0||||||
4202144|NCT00744627|4025631|B3|Never Smoked||Smoking Classification||participants|Number|189|189.0||||||
4202145|NCT00744627|4025632|B2|Never Smoked||Smoking Classification||participants|Number|90|90.0||||||
4202146|NCT00744627|4025633|B1|Never Smoked||Smoking Classification||participants|Number|99|99.0||||||
4202147|NCT00744627|4025631|B3|||Body Mass Index||kg/m^2|Mean|25.99|25.99|Standard Deviation|4.710|4.71|||
4202148|NCT00744627|4025632|B2|||Body Mass Index||kg/m^2|Mean|25.69|25.69|Standard Deviation|4.419|4.419|||
4202149|NCT00744627|4025633|B1|||Body Mass Index||kg/m^2|Mean|26.29|26.29|Standard Deviation|4.980|4.98|||
4202150|NCT00744627|4025631|B3|||Height||cm|Mean|168.89|168.89|Standard Deviation|9.075|9.075|||
4202151|NCT00744627|4025632|B2|||Height||cm|Mean|168.21|168.21|Standard Deviation|8.653|8.653|||
4202152|NCT00744627|4025633|B1|||Height||cm|Mean|169.56|169.56|Standard Deviation|9.457|9.457|||
4202153|NCT00744627|4025631|B3|||Weight||kg|Mean|74.37|74.37|Standard Deviation|15.729|15.729|||
4202154|NCT00744627|4025632|B2|||Weight||kg|Mean|72.97|72.97|Standard Deviation|14.981|14.981|||
4202155|NCT00744627|4025633|B1|||Weight||kg|Mean|75.76|75.76|Standard Deviation|16.370|16.37|||
4202156|NCT00744627|4025631|B3|Ukraine||Region of Enrollment||participants|Number|25|25.0||||||
4202157|NCT00744627|4025632|B2|Ukraine||Region of Enrollment||participants|Number|11|11.0||||||
4202158|NCT00744627|4025633|B1|Ukraine||Region of Enrollment||participants|Number|14|14.0||||||
4202159|NCT00744627|4025631|B3|Russia||Region of Enrollment||participants|Number|97|97.0||||||
4202160|NCT00744627|4025632|B2|Russia||Region of Enrollment||participants|Number|49|49.0||||||
4202161|NCT00744627|4025633|B1|Russia||Region of Enrollment||participants|Number|48|48.0||||||
4202162|NCT00744627|4025631|B3|Romania||Region of Enrollment||participants|Number|8|8.0||||||
4202163|NCT00744627|4025632|B2|Romania||Region of Enrollment||participants|Number|3|3.0||||||
4202164|NCT00744627|4025633|B1|Romania||Region of Enrollment||participants|Number|5|5.0||||||
4202165|NCT00744627|4025631|B3|Poland||Region of Enrollment||participants|Number|59|59.0||||||
4202166|NCT00744627|4025632|B2|Poland||Region of Enrollment||participants|Number|31|31.0||||||
4202167|NCT00744627|4025633|B1|Poland||Region of Enrollment||participants|Number|28|28.0||||||
4202168|NCT00744627|4025631|B3|Lithuania||Region of Enrollment||participants|Number|19|19.0||||||
4202169|NCT00744627|4025632|B2|Lithuania||Region of Enrollment||participants|Number|11|11.0||||||
4202170|NCT00744627|4025633|B1|Lithuania||Region of Enrollment||participants|Number|8|8.0||||||
4202171|NCT00744627|4025631|B3|Latvia||Region of Enrollment||participants|Number|12|12.0||||||
4202172|NCT00744627|4025632|B2|Latvia||Region of Enrollment||participants|Number|5|5.0||||||
4202173|NCT00744627|4025633|B1|Latvia||Region of Enrollment||participants|Number|7|7.0||||||
4202174|NCT00744627|4025631|B3|Germany||Region of Enrollment||participants|Number|71|71.0||||||
4202175|NCT00744627|4025632|B2|Germany||Region of Enrollment||participants|Number|37|37.0||||||
4202176|NCT00744627|4025633|B1|Germany||Region of Enrollment||participants|Number|34|34.0||||||
4202180|NCT00744627|4025631|B3|Non-Hispanic/Non-Latino||Race/Ethnicity, Customized||participants|Number|288|288.0||||||
4202181|NCT00744627|4025632|B2|Non-Hispanic/Non-Latino||Race/Ethnicity, Customized||participants|Number|145|145.0||||||
4202182|NCT00744627|4025633|B1|Non-Hispanic/Non-Latino||Race/Ethnicity, Customized||participants|Number|143|143.0||||||
4202183|NCT00744627|4025631|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4202184|NCT00744627|4025632|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4202185|NCT00744627|4025633|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4202186|NCT00744627|4025631|B3|Native Hawaiian/ Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4202187|NCT00744627|4025632|B2|Native Hawaiian/ Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4202188|NCT00744627|4025633|B1|Native Hawaiian/ Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4202189|NCT00744627|4025631|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4202190|NCT00744627|4025632|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4202191|NCT00744627|4025633|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4202192|NCT00744627|4025631|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4202193|NCT00744627|4025632|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4202194|NCT00744627|4025633|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4202195|NCT00744627|4025631|B3|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4202196|NCT00744627|4025632|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4202197|NCT00744627|4025633|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4202198|NCT00744627|4025631|B3|Caucasian (White, including Hispanic)||Race/Ethnicity, Customized||participants|Number|301|301.0||||||
4202199|NCT00744627|4025632|B2|Caucasian (White, including Hispanic)||Race/Ethnicity, Customized||participants|Number|150|150.0||||||
4202200|NCT00744627|4025633|B1|Caucasian (White, including Hispanic)||Race/Ethnicity, Customized||participants|Number|151|151.0||||||
4202201|NCT00744627|4025631|B3||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4202202|NCT00744627|4025632|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4202203|NCT00744627|4025633|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4202204|NCT00744627|4025631|B3||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4202205|NCT00744627|4025632|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4202206|NCT00744627|4025633|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4202207|NCT00744627|4025631|B3|>55 years||Age, Customized||participants|Number|78|78.0||||||
4202208|NCT00744627|4025632|B2|>55 years||Age, Customized||participants|Number|39|39.0||||||
4202209|NCT00744627|4025633|B1|>55 years||Age, Customized||participants|Number|39|39.0||||||
4202210|NCT00744627|4025631|B3|≤55 years||Age, Customized||participants|Number|223|223.0||||||
4202211|NCT00744627|4025632|B2|≤55 years||Age, Customized||participants|Number|111|111.0||||||
4202212|NCT00744627|4025633|B1|≤55 years||Age, Customized||participants|Number|112|112.0||||||
4202213|NCT00744627|4025631|B3|||Age||years|Mean|45.1|45.1|Standard Deviation|13.76|13.76|||
4202214|NCT00744627|4025632|B2|||Age||years|Mean|45.0|45.0|Standard Deviation|14.07|14.07|||
4202215|NCT00744627|4025633|B1|||Age||years|Mean|45.3|45.3|Standard Deviation|13.49|13.49|||
4202216|NCT00744523|4025688|B3|Asymptomatic||Symptomatic [1]|[1]Presence of baseline neurological symptoms within 6 months prior to enrollment.|participants|Number|220|220.0||||||
4202217|NCT00744523|4025689|B2|Asymptomatic||Symptomatic [1]|[1]Presence of baseline neurological symptoms within 6 months prior to enrollment.|participants|Number|191|191.0||||||
4202218|NCT00744523|4025690|B1|Asymptomatic||Symptomatic [1]|[1]Presence of baseline neurological symptoms within 6 months prior to enrollment.|participants|Number|29|29.0||||||
4202219|NCT00744523|4025688|B3|Symptomatic||Symptomatic [1]|[1]Presence of baseline neurological symptoms within 6 months prior to enrollment.|participants|Number|42|42.0||||||
4202220|NCT00744523|4025689|B2|Symptomatic||Symptomatic [1]|[1]Presence of baseline neurological symptoms within 6 months prior to enrollment.|participants|Number|34|34.0||||||
4202221|NCT00744523|4025690|B1|Symptomatic||Symptomatic [1]|[1]Presence of baseline neurological symptoms within 6 months prior to enrollment.|participants|Number|8|8.0||||||
4202222|NCT00744523|4025688|B3|No||History of Hypertension||participants|Number|34|34.0||||||
4202223|NCT00744523|4025689|B2|No||History of Hypertension||participants|Number|29|29.0||||||
4202224|NCT00744523|4025690|B1|No||History of Hypertension||participants|Number|5|5.0||||||
4202225|NCT00744523|4025688|B3|Yes||History of Hypertension||participants|Number|228|228.0||||||
4202226|NCT00744523|4025689|B2|Yes||History of Hypertension||participants|Number|196|196.0||||||
4202227|NCT00744523|4025690|B1|Yes||History of Hypertension||participants|Number|32|32.0||||||
4202228|NCT00744523|4025688|B3|No Response||History of Diabetes||participants|Number|2|2.0||||||
4202229|NCT00744523|4025689|B2|No Response||History of Diabetes||participants|Number|1|1.0||||||
4202230|NCT00744523|4025690|B1|No Response||History of Diabetes||participants|Number|1|1.0||||||
4202231|NCT00744523|4025688|B3|No||History of Diabetes||participants|Number|162|162.0||||||
4202232|NCT00744523|4025689|B2|No||History of Diabetes||participants|Number|141|141.0||||||
4202233|NCT00744523|4025690|B1|No||History of Diabetes||participants|Number|21|21.0||||||
4202234|NCT00744523|4025688|B3|Yes||History of Diabetes||participants|Number|98|98.0||||||
4202235|NCT00744523|4025689|B2|Yes||History of Diabetes||participants|Number|83|83.0||||||
4202236|NCT00744523|4025690|B1|Yes||History of Diabetes||participants|Number|15|15.0||||||
4202237|NCT00744523|4025688|B3|Europe||Region of Enrollment||participants|Number|78|78.0||||||
4202238|NCT00744523|4025689|B2|Europe||Region of Enrollment||participants|Number|78|78.0||||||
4202239|NCT00744523|4025690|B1|Europe||Region of Enrollment||participants|Number|0|0.0||||||
4202240|NCT00744523|4025688|B3|United States||Region of Enrollment||participants|Number|184|184.0||||||
4202241|NCT00744523|4025689|B2|United States||Region of Enrollment||participants|Number|147|147.0||||||
4202242|NCT00744523|4025690|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4202243|NCT00744523|4025688|B3||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4202244|NCT00744523|4025689|B2||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4202245|NCT00744523|4025690|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4202246|NCT00744523|4025688|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4202247|NCT00744523|4025689|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4202248|NCT00744523|4025690|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4202249|NCT00744523|4025688|B3|||Age||years|Mean|74.61|74.61|Standard Deviation|8.80|8.8|||
4202250|NCT00744523|4025689|B2|||Age||years|Mean|74.66|74.66|Standard Deviation|8.54|8.54|||
4202251|NCT00744523|4025690|B1|||Age||years|Mean|74.28|74.28|Standard Deviation|10.38|10.38|||
4202252|NCT00744523|4025688|B3|>= 80 years||Age, Customized||participants|Number|76|76.0||||||
4202253|NCT00744523|4025689|B2|>= 80 years||Age, Customized||participants|Number|65|65.0||||||
4202254|NCT00744523|4025690|B1|>= 80 years||Age, Customized||participants|Number|11|11.0||||||
4202255|NCT00744523|4025688|B3|< 80 years||Age, Customized||participants|Number|186|186.0||||||
4202256|NCT00744523|4025689|B2|< 80 years||Age, Customized||participants|Number|160|160.0||||||
4202257|NCT00744523|4025690|B1|< 80 years||Age, Customized||participants|Number|26|26.0||||||
4202258|NCT00744523|4025688|B3||>=65 years|Age||Participants|Count of Participants|219|219.0||||||
4202259|NCT00744523|4025689|B2||>=65 years|Age||Participants|Count of Participants|188|188.0||||||
4202260|NCT00744523|4025690|B1||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4202261|NCT00744523|4025688|B3||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4202262|NCT00744523|4025689|B2||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4202263|NCT00744523|4025690|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4202264|NCT00744523|4025688|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4202265|NCT00744523|4025689|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4202266|NCT00744523|4025690|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4202267|NCT00744497|4025709|B3|No evidence of metastatic disease||Type of metastatic disease||Participants|Number|4|4.0||||||
4202268|NCT00744497|4025710|B2|No evidence of metastatic disease||Type of metastatic disease||Participants|Number|2|2.0||||||
4202269|NCT00744497|4025711|B1|No evidence of metastatic disease||Type of metastatic disease||Participants|Number|2|2.0||||||
4202270|NCT00744497|4025709|B3|Both bone and visceral/nodal disease||Type of metastatic disease||Participants|Number|772|772.0||||||
4202271|NCT00744497|4025710|B2|Both bone and visceral/nodal disease||Type of metastatic disease||Participants|Number|373|373.0||||||
4202272|NCT00744497|4025711|B1|Both bone and visceral/nodal disease||Type of metastatic disease||Participants|Number|399|399.0||||||
4202273|NCT00744497|4025709|B3|Visceral/nodal disease only||Type of metastatic disease||Participants|Number|153|153.0||||||
4202274|NCT00744497|4025710|B2|Visceral/nodal disease only||Type of metastatic disease||Participants|Number|80|80.0||||||
4202275|NCT00744497|4025711|B1|Visceral/nodal disease only||Type of metastatic disease||Participants|Number|73|73.0||||||
4202276|NCT00744497|4025709|B3|Bone disease only||Type of metastatic disease||Participants|Number|593|593.0||||||
4202277|NCT00744497|4025710|B2|Bone disease only||Type of metastatic disease||Participants|Number|307|307.0||||||
4202278|NCT00744497|4025711|B1|Bone disease only||Type of metastatic disease||Participants|Number|286|286.0||||||
4202279|NCT00744497|4025709|B3|Other||Race/Ethnicity, Customized||Participants|Number|51|51.0||||||
4202280|NCT00744497|4025710|B2|Other||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
4202281|NCT00744497|4025711|B1|Other||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
4202282|NCT00744497|4025709|B3|White||Race/Ethnicity, Customized||Participants|Number|1301|1301.0||||||
4202283|NCT00744497|4025710|B2|White||Race/Ethnicity, Customized||Participants|Number|656|656.0||||||
4202284|NCT00744497|4025711|B1|White||Race/Ethnicity, Customized||Participants|Number|645|645.0||||||
4202285|NCT00744497|4025709|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|57|57.0||||||
4202286|NCT00744497|4025710|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
4202287|NCT00744497|4025711|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|34|34.0||||||
4202288|NCT00744497|4025709|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4202289|NCT00744497|4025710|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4202290|NCT00744497|4025711|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4202291|NCT00744497|4025709|B3|Asian||Race/Ethnicity, Customized||Participants|Number|111|111.0||||||
4202292|NCT00744497|4025710|B2|Asian||Race/Ethnicity, Customized||Participants|Number|55|55.0||||||
4202293|NCT00744497|4025711|B1|Asian||Race/Ethnicity, Customized||Participants|Number|56|56.0||||||
4202294|NCT00744497|4025709|B3||Male|Sex: Female, Male||Participants|Count of Participants|1522|1522.0||||||
4202295|NCT00744497|4025710|B2||Male|Sex: Female, Male||Participants|Count of Participants|762|762.0||||||
4202296|NCT00744497|4025711|B1||Male|Sex: Female, Male||Participants|Count of Participants|760|760.0||||||
4202297|NCT00744497|4025709|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4202298|NCT00744497|4025710|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4202299|NCT00744497|4025711|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4202300|NCT00744497|4025709|B3|75 years or older||Age, Customized||participants|Number|352|352.0||||||
4202301|NCT00744497|4025710|B2|75 years or older||Age, Customized||participants|Number|178|178.0||||||
4202302|NCT00744497|4025711|B1|75 years or older||Age, Customized||participants|Number|174|174.0||||||
4202303|NCT00744497|4025709|B3|65 to younger than 75 years||Age, Customized||participants|Number|656|656.0||||||
4202304|NCT00744497|4025710|B2|65 to younger than 75 years||Age, Customized||participants|Number|333|333.0||||||
4202305|NCT00744497|4025711|B1|65 to younger than 75 years||Age, Customized||participants|Number|323|323.0||||||
4202306|NCT00744497|4025709|B3|Younger than 65 years||Age, Customized||participants|Number|514|514.0||||||
4202307|NCT00744497|4025710|B2|Younger than 65 years||Age, Customized||participants|Number|251|251.0||||||
4202308|NCT00744497|4025711|B1|Younger than 65 years||Age, Customized||participants|Number|263|263.0||||||
4202309|NCT00744380|4025746|B3|Lorazepam||Baseline Sedative||participants|Number|7|7.0||||||
4202310|NCT00744380|4025747|B2|Lorazepam||Baseline Sedative||participants|Number|5|5.0||||||
4202311|NCT00744380|4025748|B1|Lorazepam||Baseline Sedative||participants|Number|2|2.0||||||
4202312|NCT00744380|4025746|B3|Midazolam||Baseline Sedative||participants|Number|16|16.0||||||
4202313|NCT00744380|4025747|B2|Midazolam||Baseline Sedative||participants|Number|6|6.0||||||
4202314|NCT00744380|4025748|B1|Midazolam||Baseline Sedative||participants|Number|10|10.0||||||
4202315|NCT00744380|4025746|B3|||Time from qualifying to randomization||days|Median|0.9|0.9|Inter-Quartile Range|||0.5|1.1|
4202316|NCT00744380|4025747|B2|||Time from qualifying to randomization||days|Median|0.7|0.7|Inter-Quartile Range|||0.5|0.8|
4202317|NCT00744380|4025748|B1|||Time from qualifying to randomization||days|Median|1|1.0|Inter-Quartile Range|||0.7|1.1|
4202318|NCT00744380|4025746|B3|||Time in ICU before qualifying||days|Median|1.1|1.1|Inter-Quartile Range|||0.6|5.4|
4202319|NCT00744380|4025747|B2|||Time in ICU before qualifying||days|Median|1.2|1.2|Inter-Quartile Range|||0.9|5.4|
4202320|NCT00744380|4025748|B1|||Time in ICU before qualifying||days|Median|1.1|1.1|Inter-Quartile Range|||0.6|2.0|
4202321|NCT00744380|4025746|B3|Other||Primary Diagnosis||participants|Number|4|4.0||||||
4202322|NCT00744380|4025747|B2|Other||Primary Diagnosis||participants|Number|2|2.0||||||
4202323|NCT00744380|4025748|B1|Other||Primary Diagnosis||participants|Number|2|2.0||||||
4202324|NCT00744380|4025746|B3|Sepsis||Primary Diagnosis||participants|Number|9|9.0||||||
4202325|NCT00744380|4025747|B2|Sepsis||Primary Diagnosis||participants|Number|4|4.0||||||
4202326|NCT00744380|4025748|B1|Sepsis||Primary Diagnosis||participants|Number|5|5.0||||||
4202327|NCT00744380|4025746|B3|Respiratory failure||Primary Diagnosis||participants|Number|10|10.0||||||
4202328|NCT00744380|4025747|B2|Respiratory failure||Primary Diagnosis||participants|Number|5|5.0||||||
4202329|NCT00744380|4025748|B1|Respiratory failure||Primary Diagnosis||participants|Number|5|5.0||||||
4202330|NCT00744380|4025746|B3|||Acute Physiologic And Chronic Health Evaluation III Score|APACHE III measures the severity of disease for adult patients admitted to intensive care units. The point score is calculated as a summation from scores assigned to a patient's age, primary comorbidity, preexisting comorbidities, location prior to ICU admission, Glasgow Coma Scale, and 20 routine physiological measurements. APACHE III scores range from 0 to 299. This provides an initial risk classification of severely ill hospitalized patients in defined groups with higher scores indicating greater disease severity and correlated to higher mortality risk.|units on a scale|Mean|72.8|72.8|Standard Deviation|25|25.0|||
4202331|NCT00744380|4025747|B2|||Acute Physiologic And Chronic Health Evaluation III Score|APACHE III measures the severity of disease for adult patients admitted to intensive care units. The point score is calculated as a summation from scores assigned to a patient's age, primary comorbidity, preexisting comorbidities, location prior to ICU admission, Glasgow Coma Scale, and 20 routine physiological measurements. APACHE III scores range from 0 to 299. This provides an initial risk classification of severely ill hospitalized patients in defined groups with higher scores indicating greater disease severity and correlated to higher mortality risk.|units on a scale|Mean|74.1|74.1|Standard Deviation|18.2|18.2|||
4202332|NCT00744380|4025748|B1|||Acute Physiologic And Chronic Health Evaluation III Score|APACHE III measures the severity of disease for adult patients admitted to intensive care units. The point score is calculated as a summation from scores assigned to a patient's age, primary comorbidity, preexisting comorbidities, location prior to ICU admission, Glasgow Coma Scale, and 20 routine physiological measurements. APACHE III scores range from 0 to 299. This provides an initial risk classification of severely ill hospitalized patients in defined groups with higher scores indicating greater disease severity and correlated to higher mortality risk.|units on a scale|Mean|70.4|70.4|Standard Deviation|33.5|33.5|||
4202333|NCT00744380|4025746|B3|||Weight||kg|Mean|103|103.0|Standard Deviation|38.5|38.5|||
4202334|NCT00744380|4025747|B2|||Weight||kg|Mean|100.8|100.8|Standard Deviation|37.4|37.4|||
4202335|NCT00744380|4025748|B1|||Weight||kg|Mean|105.2|105.2|Standard Deviation|40.9|40.9|||
4202336|NCT00744380|4025746|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4202337|NCT00744380|4025747|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4202338|NCT00744380|4025748|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4202339|NCT00744380|4025746|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4202340|NCT00744380|4025747|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4202341|NCT00744380|4025748|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4202342|NCT00744380|4025746|B3|||Age||years|Mean|58.1|58.1|Standard Deviation|13.5|13.5|||
4202343|NCT00744380|4025747|B2|||Age||years|Mean|58.3|58.3|Standard Deviation|15.3|15.3|||
4202344|NCT00744380|4025748|B1|||Age||years|Mean|57.8|57.8|Standard Deviation|9.3|9.3|||
4202389|NCT00744328|4025769|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4202345|NCT00744328|4025769|B4|||SIGHADS29|Depression was assessed with the Structured Interview Guide for the Hamilton Depression Rating Scale - Atypical Depression Symptoms Version (SIGH-ADS29). The scale incorporates the 17 and 21-item Hamilton Rating Scales for Depression (HRSD) as well as 8 atypical symptoms of depression. Scores range from 0 to 90, where a higher score corresponds to a higher level of depressive symptomatology. A minimum SIGH-ADS29 score of 18 was required for enrollment.|Scores on a scale|Mean|23.9|23.9|Standard Deviation|4.56|4.56|||
4202346|NCT00744328|4025770|B3|||SIGHADS29|Depression was assessed with the Structured Interview Guide for the Hamilton Depression Rating Scale - Atypical Depression Symptoms Version (SIGH-ADS29). The scale incorporates the 17 and 21-item Hamilton Rating Scales for Depression (HRSD) as well as 8 atypical symptoms of depression. Scores range from 0 to 90, where a higher score corresponds to a higher level of depressive symptomatology. A minimum SIGH-ADS29 score of 18 was required for enrollment.|Scores on a scale|Mean|25.1|25.1|Standard Deviation|4.92|4.92|||
4202347|NCT00744328|4025771|B2|||SIGHADS29|Depression was assessed with the Structured Interview Guide for the Hamilton Depression Rating Scale - Atypical Depression Symptoms Version (SIGH-ADS29). The scale incorporates the 17 and 21-item Hamilton Rating Scales for Depression (HRSD) as well as 8 atypical symptoms of depression. Scores range from 0 to 90, where a higher score corresponds to a higher level of depressive symptomatology. A minimum SIGH-ADS29 score of 18 was required for enrollment.|Scores on a scale|Mean|23.3|23.3|Standard Deviation|3.67|3.67|||
4202348|NCT00744328|4025772|B1|||SIGHADS29|Depression was assessed with the Structured Interview Guide for the Hamilton Depression Rating Scale - Atypical Depression Symptoms Version (SIGH-ADS29). The scale incorporates the 17 and 21-item Hamilton Rating Scales for Depression (HRSD) as well as 8 atypical symptoms of depression. Scores range from 0 to 90, where a higher score corresponds to a higher level of depressive symptomatology. A minimum SIGH-ADS29 score of 18 was required for enrollment.|Scores on a scale|Mean|23.3|23.3|Standard Deviation|4.99|4.99|||
4202349|NCT00744328|4025769|B4|United States||Region of Enrollment||participants|Number|85|85.0||||||
4202350|NCT00744328|4025770|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
4202351|NCT00744328|4025771|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4202352|NCT00744328|4025772|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4202353|NCT00744328|4025769|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4202354|NCT00744328|4025770|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4202355|NCT00744328|4025771|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202356|NCT00744328|4025772|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4202357|NCT00744328|4025769|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202358|NCT00744328|4025770|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202359|NCT00744328|4025771|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202360|NCT00744328|4025772|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202361|NCT00744328|4025769|B4||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4202362|NCT00744328|4025770|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4202363|NCT00744328|4025771|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4202364|NCT00744328|4025772|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4202365|NCT00744328|4025769|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4202366|NCT00744328|4025770|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4202367|NCT00744328|4025771|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4202368|NCT00744328|4025772|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4202369|NCT00744328|4025769|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4202370|NCT00744328|4025770|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202371|NCT00744328|4025771|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4202372|NCT00744328|4025772|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202373|NCT00744328|4025769|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4202374|NCT00744328|4025770|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4202375|NCT00744328|4025771|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202376|NCT00744328|4025772|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202377|NCT00744328|4025769|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4202378|NCT00744328|4025770|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202379|NCT00744328|4025771|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4202380|NCT00744328|4025772|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202381|NCT00744328|4025769|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4202382|NCT00744328|4025770|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4202383|NCT00744328|4025771|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4202384|NCT00744328|4025772|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4202385|NCT00744328|4025769|B4||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4202386|NCT00744328|4025770|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4202387|NCT00744328|4025771|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4202388|NCT00744328|4025772|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4202390|NCT00744328|4025770|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4202391|NCT00744328|4025771|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4202392|NCT00744328|4025772|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4202393|NCT00744328|4025769|B4||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
4202394|NCT00744328|4025770|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4202395|NCT00744328|4025771|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4202396|NCT00744328|4025772|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4202397|NCT00744328|4025769|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4202398|NCT00744328|4025770|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4202399|NCT00744328|4025771|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4202400|NCT00744328|4025772|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4202401|NCT00744328|4025769|B4|||Age||years|Mean|26.6|26.6|Standard Deviation|5.74|5.74|||
4202402|NCT00744328|4025770|B3|||Age||years|Mean|27.4|27.4|Standard Deviation|5.48|5.48|||
4202403|NCT00744328|4025771|B2|||Age||years|Mean|26.2|26.2|Standard Deviation|5.89|5.89|||
4202404|NCT00744328|4025772|B1|||Age||years|Mean|26.2|26.2|Standard Deviation|5.98|5.98|||
4202405|NCT00744263|4025782|B3||Male|Sex: Female, Male||Participants|Count of Participants|47248|47248.0||||||
4202406|NCT00744263|4025783|B2||Male|Sex: Female, Male||Participants|Count of Participants|23801|23801.0||||||
4202407|NCT00744263|4025784|B1||Male|Sex: Female, Male||Participants|Count of Participants|23447|23447.0||||||
4202408|NCT00744263|4025782|B3||Female|Sex: Female, Male||Participants|Count of Participants|37244|37244.0||||||
4202409|NCT00744263|4025783|B2||Female|Sex: Female, Male||Participants|Count of Participants|18454|18454.0||||||
4202410|NCT00744263|4025784|B1||Female|Sex: Female, Male||Participants|Count of Participants|18790|18790.0||||||
4202411|NCT00744263|4025782|B3|||Age||years|Mean|72.8|72.8|Standard Deviation|5.7|5.7|||
4202412|NCT00744263|4025783|B2|||Age||years|Mean|72.8|72.8|Standard Deviation|5.6|5.6|||
4202413|NCT00744263|4025784|B1|||Age||years|Mean|72.8|72.8|Standard Deviation|5.7|5.7|||
4202414|NCT00744237|4025805|B4|Puerto Rico||Region of Enrollment||participants|Number|11|11.0||||||
4202415|NCT00744237|4025806|B3|Puerto Rico||Region of Enrollment||participants|Number|2|2.0||||||
4202416|NCT00744237|4025807|B2|Puerto Rico||Region of Enrollment||participants|Number|4|4.0||||||
4202417|NCT00744237|4025808|B1|Puerto Rico||Region of Enrollment||participants|Number|5|5.0||||||
4202418|NCT00744237|4025805|B4|United States||Region of Enrollment||participants|Number|219|219.0||||||
4202419|NCT00744237|4025806|B3|United States||Region of Enrollment||participants|Number|72|72.0||||||
4202420|NCT00744237|4025807|B2|United States||Region of Enrollment||participants|Number|69|69.0||||||
4202421|NCT00744237|4025808|B1|United States||Region of Enrollment||participants|Number|78|78.0||||||
4202422|NCT00744237|4025805|B4||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4202423|NCT00744237|4025806|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4202424|NCT00744237|4025807|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4202425|NCT00744237|4025808|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4202426|NCT00744237|4025805|B4||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4202427|NCT00744237|4025806|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4202428|NCT00744237|4025807|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4202429|NCT00744237|4025808|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4202430|NCT00744237|4025805|B4|Patients greater than or equal to 65 years of age.||Age, Customized||participants|Number|65|65.0||||||
4202431|NCT00744237|4025806|B3|Patients greater than or equal to 65 years of age.||Age, Customized||participants|Number|21|21.0||||||
4202432|NCT00744237|4025807|B2|Patients greater than or equal to 65 years of age.||Age, Customized||participants|Number|22|22.0||||||
4202433|NCT00744237|4025808|B1|Patients greater than or equal to 65 years of age.||Age, Customized||participants|Number|22|22.0||||||
4202434|NCT00744237|4025805|B4|Patients 18 to 64 years of age||Age, Customized||participants|Number|165|165.0||||||
4202435|NCT00744237|4025806|B3|Patients 18 to 64 years of age||Age, Customized||participants|Number|53|53.0||||||
4202436|NCT00744237|4025807|B2|Patients 18 to 64 years of age||Age, Customized||participants|Number|51|51.0||||||
4202437|NCT00744237|4025808|B1|Patients 18 to 64 years of age||Age, Customized||participants|Number|61|61.0||||||
4202438|NCT00744237|4025805|B4|||Age||years|Mean|58.9|58.9|Standard Deviation|8.9|8.9|||
4202439|NCT00744237|4025806|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|9.0|9.0|||
4202440|NCT00744237|4025807|B2|||Age||years|Mean|59.2|59.2|Standard Deviation|8.3|8.3|||
4202441|NCT00744237|4025808|B1|||Age||years|Mean|58.2|58.2|Standard Deviation|9.3|9.3|||
4202442|NCT00744211|4025821|B4|||Pulmonary vascular resistance||dyne*second/centimeter˄5|Mean|180|180.0|Standard Deviation|23|23.0|||
4202443|NCT00744211|4025822|B3|||Pulmonary vascular resistance||dyne*second/centimeter˄5|Mean|174.6|174.6|Standard Deviation|28.4|28.4|||
4202444|NCT00744211|4025823|B2|||Pulmonary vascular resistance||dyne*second/centimeter˄5|Mean|213.0|213.0|Standard Deviation|65.3|65.3|||
4202445|NCT00744211|4025824|B1|||Pulmonary vascular resistance||dyne*second/centimeter˄5|Mean|153.8|153.8|Standard Deviation|19.9|19.9|||
4202446|NCT00744211|4025821|B4|||Systemic vascular resistance||dyne*second/centimeter˄5|Mean|1358|1358.0|Standard Deviation|83|83.0|||
4202447|NCT00744211|4025822|B3|||Systemic vascular resistance||dyne*second/centimeter˄5|Mean|1307|1307.0|Standard Deviation|112|112.0|||
4202448|NCT00744211|4025823|B2|||Systemic vascular resistance||dyne*second/centimeter˄5|Mean|1359|1359.0|Standard Deviation|210|210.0|||
4202449|NCT00744211|4025824|B1|||Systemic vascular resistance||dyne*second/centimeter˄5|Mean|1408|1408.0|Standard Deviation|119|119.0|||
4202450|NCT00744211|4025821|B4|||Plasma Endothelin||fmol/mL|Mean|4.0|4.0|Standard Deviation|0.3|0.3|||
4202451|NCT00744211|4025822|B3|||Plasma Endothelin||fmol/mL|Mean|4.3|4.3|Standard Deviation|0.7|0.7|||
4202452|NCT00744211|4025823|B2|||Plasma Endothelin||fmol/mL|Mean|3.7|3.7|Standard Deviation|0.3|0.3|||
4202453|NCT00744211|4025824|B1|||Plasma Endothelin||fmol/mL|Mean|3.9|3.9|Standard Deviation|0.4|0.4|||
4202454|NCT00744211|4025821|B4|||Left Ventricular Ejection Fraction (LVEF)||percent|Mean|37|37.0|Standard Deviation|2|2.0|||
4202455|NCT00744211|4025822|B3|||Left Ventricular Ejection Fraction (LVEF)||percent|Mean|37|37.0|Standard Deviation|3|3.0|||
4202456|NCT00744211|4025823|B2|||Left Ventricular Ejection Fraction (LVEF)||percent|Mean|38|38.0|Standard Deviation|2|2.0|||
4202457|NCT00744211|4025824|B1|||Left Ventricular Ejection Fraction (LVEF)||percent|Mean|35|35.0|Standard Deviation|3|3.0|||
4202458|NCT00744211|4025821|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4202459|NCT00744211|4025822|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4202460|NCT00744211|4025823|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4202461|NCT00744211|4025824|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4202462|NCT00744211|4025821|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4202463|NCT00744211|4025822|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4202464|NCT00744211|4025823|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4202465|NCT00744211|4025824|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4202466|NCT00744211|4025821|B4|||Age||years|Mean|66|66.0|Standard Deviation|2|2.0|||
4202467|NCT00744211|4025822|B3|||Age||years|Mean|68|68.0|Standard Deviation|3|3.0|||
4202468|NCT00744211|4025823|B2|||Age||years|Mean|62|62.0|Standard Deviation|3|3.0|||
4202469|NCT00744211|4025824|B1|||Age||years|Mean|67|67.0|Standard Deviation|2|2.0|||
4202470|NCT00744055|4025842|B3|||Average Drinks Per Drinking Day||drinks per day|Mean|19.53|19.53|Standard Deviation|8.21|8.21|||
4202471|NCT00744055|4025843|B2|||Average Drinks Per Drinking Day||drinks per day|Mean|21.90|21.9|Standard Deviation|13.24|13.24|||
4202472|NCT00744055|4025844|B1|||Average Drinks Per Drinking Day||drinks per day|Mean|17.33|17.33|Standard Deviation|10.73|10.73|||
4202473|NCT00744055|4025842|B3|||PTSD Symptoms|"Clinician-Administered PTSD Scale for DSM-IV (CAPS-IV). The scale consists of 30 questions on a scale from 0-4.~The lowest possible score is 0 and the highest possible score is 120. A higher score is associated with higher severity of PTSD. The score is interpreted as follows: 0-19=Asymptomatic/few symptoms 20-39=Sub-threshold/mild PTSD 40-59=Threshold PTSD/moderate 60-79=Severe PTSD >80=Extreme PTSD"|units on a scale|Mean|73.7|73.7|Standard Deviation|17.86|17.86|||
4202474|NCT00744055|4025843|B2|||PTSD Symptoms|"Clinician-Administered PTSD Scale for DSM-IV (CAPS-IV). The scale consists of 30 questions on a scale from 0-4.~The lowest possible score is 0 and the highest possible score is 120. A higher score is associated with higher severity of PTSD. The score is interpreted as follows: 0-19=Asymptomatic/few symptoms 20-39=Sub-threshold/mild PTSD 40-59=Threshold PTSD/moderate 60-79=Severe PTSD >80=Extreme PTSD"|units on a scale|Mean|75.86|75.86|Standard Deviation|14.44|14.44|||
4202475|NCT00744055|4025844|B1|||PTSD Symptoms|"Clinician-Administered PTSD Scale for DSM-IV (CAPS-IV). The scale consists of 30 questions on a scale from 0-4.~The lowest possible score is 0 and the highest possible score is 120. A higher score is associated with higher severity of PTSD. The score is interpreted as follows: 0-19=Asymptomatic/few symptoms 20-39=Sub-threshold/mild PTSD 40-59=Threshold PTSD/moderate 60-79=Severe PTSD >80=Extreme PTSD"|units on a scale|Mean|71.86|71.86|Standard Deviation|20.32|20.32|||
4202476|NCT00744055|4025842|B3|Non-Caucasian||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4202477|NCT00744055|4025843|B2|Non-Caucasian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4202478|NCT00744055|4025844|B1|Non-Caucasian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4202479|NCT00744055|4025842|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|78|78.0||||||
4202480|NCT00744055|4025843|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4202481|NCT00744055|4025844|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4202482|NCT00744055|4025842|B3||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4202483|NCT00744055|4025843|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4202484|NCT00744055|4025844|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4202485|NCT00744055|4025842|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4202486|NCT00744055|4025843|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4202487|NCT00744055|4025844|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4202488|NCT00744055|4025842|B3|||Age||years|Mean|43.96|43.96|Standard Deviation|12.96|12.96|||
4202489|NCT00744055|4025843|B2|||Age||years|Mean|43.40|43.4|Standard Deviation|12.95|12.95|||
4202490|NCT00744055|4025844|B1|||Age||years|Mean|44.5|44.5|Standard Deviation|13.2|13.2|||
4202491|NCT00744042|4025853|B1|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4202492|NCT00744042|4025853|B1|United Arab Emirates||Region of Enrollment||participants|Number|1|1.0||||||
4202493|NCT00744042|4025853|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4202494|NCT00744042|4025853|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4202495|NCT00744042|4025853|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4202496|NCT00744042|4025853|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4202497|NCT00744042|4025853|B1|||Age||years|Mean|1.11|1.11|Standard Deviation|1.13|1.13|||
4202498|NCT00744042|4025853|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4202499|NCT00744042|4025853|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4202500|NCT00744042|4025853|B1||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4202501|NCT00743730|4025866|B4|United States||Region of Enrollment||participants|Number|80|80.0||||||
4202502|NCT00743730|4025867|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
4202503|NCT00743730|4025868|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4202504|NCT00743730|4025869|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4202505|NCT00743730|4025866|B4||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4202506|NCT00743730|4025867|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4202507|NCT00743730|4025868|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4202508|NCT00743730|4025869|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4202509|NCT00743730|4025866|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4202510|NCT00743730|4025867|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4202511|NCT00743730|4025868|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4202512|NCT00743730|4025869|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4202513|NCT00743730|4025866|B4|||Age||years|Median|12|12.0|Inter-Quartile Range|||9.0|15.0|
4202514|NCT00743730|4025867|B3|||Age||years|Median|12|12.0|Inter-Quartile Range|||9.0|15.0|
4202515|NCT00743730|4025868|B2|||Age||years|Median|12|12.0|Inter-Quartile Range|||9.75|15.0|
4202516|NCT00743730|4025869|B1|||Age||years|Median|10.5|10.5|Inter-Quartile Range|||7.75|15.5|
4202517|NCT00743730|4025866|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4202518|NCT00743730|4025867|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4202519|NCT00743730|4025868|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4202520|NCT00743730|4025869|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4202521|NCT00743730|4025866|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4202522|NCT00743730|4025867|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4202523|NCT00743730|4025868|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4202524|NCT00743730|4025869|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4202525|NCT00743730|4025866|B4||<=18 years|Age||Participants|Count of Participants|80|80.0||||||
4202526|NCT00743730|4025867|B3||<=18 years|Age||Participants|Count of Participants|28|28.0||||||
4202527|NCT00743730|4025868|B2||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4202528|NCT00743730|4025869|B1||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
4202529|NCT00743717|4025885|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4202530|NCT00743717|4025886|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4202531|NCT00743717|4025887|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4202532|NCT00743717|4025885|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4202533|NCT00743717|4025886|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4202534|NCT00743717|4025887|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4202535|NCT00743717|4025885|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4202536|NCT00743717|4025886|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4202537|NCT00743717|4025887|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4202538|NCT00743717|4025885|B3|||Age||years|Mean|64|64.0|Standard Deviation|8.45|8.45|||
4202539|NCT00743717|4025886|B2|||Age||years|Mean|65.5|65.5|Standard Deviation|4.94|4.94|||
4202540|NCT00743717|4025887|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|13.4|13.4|||
4202541|NCT00743717|4025885|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4202542|NCT00743717|4025886|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4202543|NCT00743717|4025887|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4202544|NCT00743717|4025885|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4202545|NCT00743717|4025886|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4202546|NCT00743717|4025887|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4202547|NCT00743717|4025885|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4202548|NCT00743717|4025886|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4202549|NCT00743717|4025887|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4202550|NCT00743652|4025894|B6||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4202551|NCT00743652|4025895|B5||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4202552|NCT00743652|4025896|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4202553|NCT00743652|4025897|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4202554|NCT00743652|4025898|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4202555|NCT00743652|4025899|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4202556|NCT00743652|4025894|B6||Female|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4202557|NCT00743652|4025895|B5||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4202558|NCT00743652|4025896|B4||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4202559|NCT00743652|4025897|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4202560|NCT00743652|4025898|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4202561|NCT00743652|4025899|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4202617|NCT00743288|4026021|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4202562|NCT00743652|4025894|B6|||Age, Customized||Months|Mean|12.9|12.9|Standard Deviation|15.9|15.9|||
4202563|NCT00743652|4025895|B5|||Age, Customized||Months|Mean|40.1|40.1|Standard Deviation|11.1|11.1|||
4202564|NCT00743652|4025896|B4|||Age, Customized||Months|Mean|15.2|15.2|Standard Deviation|3.4|3.4|||
4202565|NCT00743652|4025897|B3|||Age, Customized||Months|Mean|7.1|7.1|Standard Deviation|1.6|1.6|||
4202566|NCT00743652|4025898|B2|||Age, Customized||Months|Mean|4.4|4.4|Standard Deviation|0.8|0.8|||
4202567|NCT00743652|4025899|B1|||Age, Customized||Months|Mean|1.4|1.4|Standard Deviation|0.6|0.6|||
4202568|NCT00743574|4025978|B1|||Baseline C Reactive protein level|Fasting levels of Creactive protein levels were drawn during oral GTT|mg/L|Median|5.72|5.72|Inter-Quartile Range|1.51-13.93|1.51|1.51|13.93|
4202569|NCT00743574|4025978|B1|||Baseline AUC for glucose|Fasting level for AUC (Area under the curve at 0, 0.5, 1, 1.5 and 2 hours)glucose at baseline was drawn based on oral GTT|mg/min/120min|Mean|16648.41|16648.41|Standard Deviation|3949.98|3949.98|||
4202570|NCT00743574|4025978|B1|||Baseline AUC insulin|Fasting AUC (Area under the curve at 0, 0.5, 1, 1.5 and 2 hours)insulin was drawn at baseline during a oral GTT|µIU/ml/120 min|Mean|16136.50|16136.5|Standard Deviation|10086.29|10086.29|||
4202571|NCT00743574|4025978|B1|||Baseline glucose levels|Fasting glucose levels at baseline were drawn during an oral GTT|mg/dl|Mean|103.79|103.79|Standard Deviation|22.83|22.83|||
4202572|NCT00743574|4025978|B1|||Baseline insulin levels|Fasting insulin levels at baseline were drawn during an oral GTT|µIU/ml|Mean|24.92|24.92|Standard Deviation|15.42|15.42|||
4202573|NCT00743574|4025978|B1|||Baseline HbA1C levels|Fasting HbA1C levels were collected at baseline during a 2 hour oral Glucose Tolerance Test (GTT)|percentage|Mean|5.37|5.37|Standard Deviation|0.53|0.53|||
4202574|NCT00743574|4025978|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4202575|NCT00743574|4025978|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4202576|NCT00743574|4025978|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4202577|NCT00743574|4025978|B1|||Age||years|Mean|26.42|26.42|Standard Deviation|6.11|6.11|||
4202578|NCT00743574|4025978|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4202579|NCT00743574|4025978|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4202580|NCT00743574|4025978|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4202581|NCT00743509|4025987|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
4202582|NCT00743509|4025987|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4202583|NCT00743509|4025987|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4202584|NCT00743509|4025987|B1|||Age||years|Median|57|57.0|Full Range|||19.0|82.0|
4202585|NCT00743509|4025987|B1||>=65 years|Age|Age|Participants|Count of Participants|9|9.0||||||
4202586|NCT00743509|4025987|B1||Between 18 and 65 years|Age|Age|Participants|Count of Participants|40|40.0||||||
4202587|NCT00743509|4025987|B1||<=18 years|Age|Age|Participants|Count of Participants|0|0.0||||||
4202588|NCT00743483|4025992|B1|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
4202589|NCT00743483|4025992|B1|Poland||Region of Enrollment||participants|Number|12|12.0||||||
4202590|NCT00743483|4025992|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202591|NCT00743483|4025992|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4202592|NCT00743483|4025992|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202593|NCT00743483|4025992|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4202594|NCT00743483|4025992|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4202595|NCT00743483|4025992|B1|||Age||years|Mean|24.4|24.4|Standard Deviation|10.45|10.45|||
4202596|NCT00743444|4025996|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4202597|NCT00743444|4025996|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4202598|NCT00743444|4025996|B1|||Age||years|Mean|51.6|51.6|Standard Deviation|10.2|10.2|||
4202599|NCT00743431|4026006|B1|Austria||Region of Enrollment||participants|Number|224|224.0||||||
4202600|NCT00743431|4026006|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4202601|NCT00743431|4026006|B1||Female|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
4202602|NCT00743431|4026006|B1|||Age|Mean age was calculated for the Intent-to-Treat (ITT) population of 214.|years|Mean|62.4|62.4|Standard Deviation|10.95|10.95|||
4202603|NCT00743366|4026010|B1|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4202604|NCT00743366|4026010|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4202605|NCT00743366|4026010|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4202606|NCT00743366|4026010|B1|||Age||years|Mean|26|26.0|Standard Deviation|4|4.0|||
4202607|NCT00743366|4026010|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4202608|NCT00743366|4026010|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4202609|NCT00743366|4026010|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4202610|NCT00743340|4026017|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4202611|NCT00743340|4026017|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|49|49.0||||||
4202612|NCT00743340|4026017|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4202613|NCT00743340|4026017|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4202614|NCT00743340|4026017|B1|||Age||years|Mean|8|8.0|Standard Deviation|2.5|2.5|||
4202615|NCT00743288|4026021|B1|Number of Bortezomib-containing prior regimens||Prior regimens||number of prior regimens|Median|2|2.0|Full Range|||0.0|9.0|
4202616|NCT00743288|4026021|B1|Number of prior regimens||Prior regimens||number of prior regimens|Median|4|4.0|Full Range|||1.0|16.0|
4202618|NCT00743288|4026021|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4202619|NCT00743288|4026021|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202620|NCT00743288|4026021|B1||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4202621|NCT00743288|4026021|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4202622|NCT00743288|4026021|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202623|NCT00743288|4026021|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4202624|NCT00743288|4026021|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202625|NCT00743288|4026021|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4202626|NCT00743288|4026021|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4202627|NCT00743288|4026021|B1|||Age||years|Median|65.4|65.4|Full Range|||34.2|88.2|
4202628|NCT00743275|4026039|B3|United States||Region of Enrollment||participants|Number|120|120.0||||||
4202629|NCT00743275|4026040|B2|United States||Region of Enrollment||participants|Number|61|61.0||||||
4202630|NCT00743275|4026041|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
4202631|NCT00743275|4026039|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4202632|NCT00743275|4026040|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4202633|NCT00743275|4026041|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4202634|NCT00743275|4026039|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4202635|NCT00743275|4026040|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4202636|NCT00743275|4026041|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4202637|NCT00743275|4026039|B3|||Age||Years|Mean|59.2|59.2|Standard Deviation|18.74|18.74|||
4202638|NCT00743275|4026040|B2|||Age||Years|Mean|74.7|74.7|Standard Deviation|7.67|7.67|||
4202639|NCT00743275|4026041|B1|||Age||Years|Mean|43.2|43.2|Standard Deviation|12.14|12.14|||
4202640|NCT00743275|4026039|B3||>=65 years|Age||Participants|Count of Participants|53|53.0||||||
4202641|NCT00743275|4026040|B2||>=65 years|Age||Participants|Count of Participants|53|53.0||||||
4202642|NCT00743275|4026041|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4202643|NCT00743275|4026039|B3||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
4202644|NCT00743275|4026040|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4202645|NCT00743275|4026041|B1||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4202646|NCT00743275|4026039|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4202647|NCT00743275|4026040|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4202648|NCT00743275|4026041|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4202649|NCT00743262|4026054|B1|Netherlands||Region of Enrollment||patients|Number|15|15.0||||||
4202650|NCT00743262|4026054|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4202651|NCT00743262|4026054|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4202652|NCT00743262|4026054|B1|||Age||years|Mean|65.33|65.33|Standard Deviation|12.03|12.03|||
4202653|NCT00743262|4026054|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4202654|NCT00743262|4026054|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4202655|NCT00743262|4026054|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4202656|NCT00743249|4026060|B3|United States||Region of Enrollment||participants|Number|57|57.0||||||
4202657|NCT00743249|4026061|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4202658|NCT00743249|4026062|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4202659|NCT00743249|4026060|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4202660|NCT00743249|4026061|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4202661|NCT00743249|4026062|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4202662|NCT00743249|4026060|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4202663|NCT00743249|4026061|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4202664|NCT00743249|4026062|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4202665|NCT00743249|4026060|B3|||Age||years|Mean|62.6|62.6|Standard Deviation|10.6|10.6|||
4202666|NCT00743249|4026061|B2|||Age||years|Mean|62.2|62.2|Standard Deviation|10.8|10.8|||
4202667|NCT00743249|4026062|B1|||Age||years|Mean|63.0|63.0|Standard Deviation|10.5|10.5|||
4202668|NCT00743197|4026071|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4202669|NCT00743197|4026072|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4202670|NCT00743197|4026073|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4202671|NCT00743197|4026071|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4202672|NCT00743197|4026072|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4202673|NCT00743197|4026073|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4202674|NCT00743197|4026071|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4202675|NCT00743197|4026072|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4202676|NCT00743197|4026073|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4202677|NCT00743197|4026071|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4202678|NCT00743197|4026072|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4202679|NCT00743197|4026073|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4202680|NCT00743197|4026071|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4202681|NCT00743197|4026072|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4202682|NCT00743197|4026073|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4202683|NCT00743197|4026071|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4202684|NCT00743197|4026072|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4202685|NCT00743197|4026073|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4202686|NCT00743145|4026080|B1|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4202687|NCT00743145|4026080|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4202688|NCT00743145|4026080|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202689|NCT00743145|4026080|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4202690|NCT00743145|4026080|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4202691|NCT00743145|4026080|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202692|NCT00743145|4026080|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202693|NCT00743145|4026080|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202694|NCT00743145|4026080|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4202695|NCT00743145|4026080|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4202696|NCT00743145|4026080|B1|||Age||years|Mean|27.0|27.0|Standard Deviation|4.0|4.0|||
4202697|NCT00743145|4026080|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4202698|NCT00743145|4026080|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4202699|NCT00743145|4026080|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4202700|NCT00743119|4026094|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4202701|NCT00743119|4026094|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4202702|NCT00743119|4026094|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4202703|NCT00743119|4026094|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4202704|NCT00743119|4026094|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4202705|NCT00743119|4026094|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4202706|NCT00743106|4026106|B3|||creatinine||mg/dL|Median|1.2|1.2|Inter-Quartile Range|||1.0|1.4|
4202707|NCT00743106|4026107|B2|||creatinine||mg/dL|Median|1.2|1.2|Inter-Quartile Range|||1.0|1.4|
4202708|NCT00743106|4026108|B1|||creatinine||mg/dL|Median|1.2|1.2|Inter-Quartile Range|||1.0|1.4|
4202709|NCT00743106|4026106|B3|||GFR||mL/min|Mean|59|59.0|Standard Deviation|19|19.0|||
4202710|NCT00743106|4026107|B2|||GFR||mL/min|Mean|59|59.0|Standard Deviation|19|19.0|||
4202711|NCT00743106|4026108|B1|||GFR||mL/min|Mean|59|59.0|Standard Deviation|19|19.0|||
4202712|NCT00743106|4026106|B3|Others||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4202713|NCT00743106|4026107|B2|Others||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4202714|NCT00743106|4026108|B1|Others||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4202715|NCT00743106|4026106|B3|White||Race/Ethnicity, Customized||participants|Number|73|73.0||||||
4202716|NCT00743106|4026107|B2|White||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4202717|NCT00743106|4026108|B1|White||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4202718|NCT00743106|4026106|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4202719|NCT00743106|4026107|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4202720|NCT00743106|4026108|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4202721|NCT00743106|4026106|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4202722|NCT00743106|4026107|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4202723|NCT00743106|4026108|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4202724|NCT00743106|4026106|B3|||Age||years|Mean|59|59.0|Standard Deviation|10|10.0|||
4202725|NCT00743106|4026107|B2|||Age||years|Mean|59|59.0|Standard Deviation|10|10.0|||
4202726|NCT00743106|4026108|B1|||Age||years|Mean|59|59.0|Standard Deviation|9|9.0|||
4202727|NCT00743093|4026117|B3|United States||Region of Enrollment||participants|Number|276|276.0||||||
4202728|NCT00743093|4026118|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
4202729|NCT00743093|4026119|B1|United States||Region of Enrollment||participants|Number|224|224.0||||||
4202730|NCT00743093|4026117|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4202731|NCT00743093|4026118|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4202732|NCT00743093|4026119|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4202733|NCT00743093|4026117|B3||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4202734|NCT00743093|4026118|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4202735|NCT00743093|4026119|B1||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4202736|NCT00743093|4026117|B3|||Age||years|Mean|36.2|36.2|Standard Deviation|12.21|12.21|||
4202737|NCT00743093|4026118|B2|||Age||years|Mean|35.8|35.8|Standard Deviation|12.50|12.5|||
4202738|NCT00743093|4026119|B1|||Age||years|Mean|36.3|36.3|Standard Deviation|12.16|12.16|||
4202739|NCT00743093|4026117|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4202740|NCT00743093|4026118|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4202741|NCT00743093|4026119|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4202742|NCT00743093|4026117|B3||Between 18 and 65 years|Age||Participants|Count of Participants|273|273.0||||||
4202743|NCT00743093|4026118|B2||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4202744|NCT00743093|4026119|B1||Between 18 and 65 years|Age||Participants|Count of Participants|221|221.0||||||
4202745|NCT00743093|4026117|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4202746|NCT00743093|4026118|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4202747|NCT00743093|4026119|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4202748|NCT00742963|4026128|B1|United States||Region of Enrollment||Participants|Count of Participants|101|101.0||||||
4202749|NCT00742963|4026128|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4202750|NCT00742963|4026128|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202751|NCT00742963|4026128|B1||White|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4202752|NCT00742963|4026128|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4202753|NCT00742963|4026128|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202754|NCT00742963|4026128|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4202755|NCT00742963|4026128|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202756|NCT00742963|4026128|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4202757|NCT00742963|4026128|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4202758|NCT00742963|4026128|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4202759|NCT00742963|4026128|B1||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
4202760|NCT00742963|4026128|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4202761|NCT00742924|4026132|B5|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4202762|NCT00742924|4026133|B4|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4202763|NCT00742924|4026134|B3|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4202764|NCT00742924|4026135|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4202765|NCT00742924|4026136|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4202766|NCT00742924|4026132|B5|United States||Region of Enrollment||participants|Number|20|20.0||||||
4202767|NCT00742924|4026133|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
4202768|NCT00742924|4026134|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4202769|NCT00742924|4026135|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4202770|NCT00742924|4026136|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4202771|NCT00742924|4026132|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4202772|NCT00742924|4026133|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202773|NCT00742924|4026134|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202774|NCT00742924|4026135|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4202775|NCT00742924|4026136|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202776|NCT00742924|4026132|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4202777|NCT00742924|4026133|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4202778|NCT00742924|4026134|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4202779|NCT00742924|4026135|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4202780|NCT00742924|4026136|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4202781|NCT00742924|4026132|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4202782|NCT00742924|4026133|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4202783|NCT00742924|4026134|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4202784|NCT00742924|4026135|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202785|NCT00742924|4026136|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202786|NCT00742924|4026132|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4202787|NCT00742924|4026133|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4202788|NCT00742924|4026134|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4202789|NCT00742924|4026135|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4202790|NCT00742924|4026136|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202791|NCT00742924|4026132|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202792|NCT00742924|4026133|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202793|NCT00742924|4026134|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202794|NCT00742924|4026135|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202795|NCT00742924|4026136|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202796|NCT00742924|4026132|B5||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4202797|NCT00742924|4026133|B4||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4202798|NCT00742924|4026134|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4202799|NCT00742924|4026135|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4202800|NCT00742924|4026136|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4202801|NCT00742924|4026132|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4202802|NCT00742924|4026133|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4202803|NCT00742924|4026134|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4202804|NCT00742924|4026135|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4202805|NCT00742924|4026136|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4202806|NCT00742924|4026132|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202807|NCT00742924|4026133|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202808|NCT00742924|4026134|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202809|NCT00742924|4026135|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202810|NCT00742924|4026136|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202811|NCT00742924|4026132|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202812|NCT00742924|4026133|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202813|NCT00742924|4026134|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202814|NCT00742924|4026135|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202815|NCT00742924|4026136|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202816|NCT00742924|4026132|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4202817|NCT00742924|4026133|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4202818|NCT00742924|4026134|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202819|NCT00742924|4026135|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202820|NCT00742924|4026136|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202821|NCT00742924|4026132|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4202822|NCT00742924|4026133|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4202823|NCT00742924|4026134|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4202824|NCT00742924|4026135|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4202825|NCT00742924|4026136|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4202826|NCT00742924|4026132|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4202827|NCT00742924|4026133|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4202828|NCT00742924|4026134|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4202829|NCT00742924|4026135|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4202830|NCT00742924|4026136|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4202831|NCT00742924|4026132|B5|||Age||years|Median|13.5|13.5|Full Range|||7.0|22.0|
4202832|NCT00742924|4026133|B4|||Age||years|Median|14.5|14.5|Full Range|||7.0|22.0|
4202833|NCT00742924|4026134|B3|||Age||years|Median|14|14.0|Full Range|||10.0|19.0|
4202834|NCT00742924|4026135|B2|||Age||years|Median|15.5|15.5|Full Range|||9.0|21.0|
4202835|NCT00742924|4026136|B1|||Age||years|Median|11.5|11.5|Full Range|||8.0|20.0|
4202836|NCT00742885|4026149|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4202837|NCT00742885|4026150|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4202838|NCT00742885|4026151|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4202839|NCT00742885|4026149|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4202840|NCT00742885|4026150|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4202841|NCT00742885|4026151|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4202842|NCT00742885|4026149|B3|||Age||Years|Mean|40.3|40.3|Standard Deviation|10.98|10.98|||
4202843|NCT00742885|4026150|B2|||Age||Years|Mean|49.6|49.6|Standard Deviation|6.04|6.04|||
4202844|NCT00742885|4026151|B1|||Age||Years|Mean|31.1|31.1|Standard Deviation|5.69|5.69|||
4202845|NCT00742872|4026198|B3|Lebanon||Region of Enrollment||participants|Number|41|41.0||||||
4202846|NCT00742872|4026199|B2|Lebanon||Region of Enrollment||participants|Number|20|20.0||||||
4202847|NCT00742872|4026200|B1|Lebanon||Region of Enrollment||participants|Number|21|21.0||||||
4202848|NCT00742872|4026198|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4202849|NCT00742872|4026199|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4202850|NCT00742872|4026200|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4202851|NCT00742872|4026198|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4202852|NCT00742872|4026199|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4202853|NCT00742872|4026200|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4202854|NCT00742872|4026198|B3|||Age||years|Mean|43|43.0|Standard Deviation|16.5|16.5|||
4202855|NCT00742872|4026199|B2|||Age||years|Mean|41|41.0|Standard Deviation|16|16.0|||
4202856|NCT00742872|4026200|B1|||Age||years|Mean|44|44.0|Standard Deviation|17|17.0|||
4202857|NCT00742859|4026207|B5||Male|Sex: Female, Male||Participants|Count of Participants|338|338.0||||||
4202858|NCT00742859|4026208|B4||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4202859|NCT00742859|4026209|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4202860|NCT00742859|4026210|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4202861|NCT00742859|4026211|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4202862|NCT00742859|4026207|B5||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4202863|NCT00742859|4026208|B4||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4202864|NCT00742859|4026209|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4202865|NCT00742859|4026210|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4202866|NCT00742859|4026211|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4202867|NCT00742859|4026207|B5|>=75 years||Age, Customized||Count of Participants|Number|240|240.0||||||
4202868|NCT00742859|4026208|B4|>=75 years||Age, Customized||Count of Participants|Number|60|60.0||||||
4202869|NCT00742859|4026209|B3|>=75 years||Age, Customized||Count of Participants|Number|51|51.0||||||
4202870|NCT00742859|4026210|B2|>=75 years||Age, Customized||Count of Participants|Number|66|66.0||||||
4202871|NCT00742859|4026211|B1|>=75 years||Age, Customized||Count of Participants|Number|63|63.0||||||
4202872|NCT00742859|4026207|B5|<75 years||Age, Customized||Count of Participants|Number|268|268.0||||||
4202873|NCT00742859|4026208|B4|<75 years||Age, Customized||Count of Participants|Number|67|67.0||||||
4202874|NCT00742859|4026209|B3|<75 years||Age, Customized||Count of Participants|Number|76|76.0||||||
4202875|NCT00742859|4026210|B2|<75 years||Age, Customized||Count of Participants|Number|61|61.0||||||
4202876|NCT00742859|4026211|B1|<75 years||Age, Customized||Count of Participants|Number|64|64.0||||||
4202877|NCT00742859|4026207|B5|||Age||years|Mean|73.0|73.0|Standard Deviation|8.32|8.32|||
4202878|NCT00742859|4026208|B4|||Age||years|Mean|72.7|72.7|Standard Deviation|8.75|8.75|||
4202879|NCT00742859|4026209|B3|||Age||years|Mean|72.0|72.0|Standard Deviation|7.65|7.65|||
4202880|NCT00742859|4026210|B2|||Age||years|Mean|73.8|73.8|Standard Deviation|8.35|8.35|||
4202881|NCT00742859|4026211|B1|||Age||years|Mean|73.3|73.3|Standard Deviation|8.50|8.5|||
4202882|NCT00742781|4026228|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4202883|NCT00742781|4026228|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4202884|NCT00742781|4026228|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4202885|NCT00742781|4026228|B1|||Age||years|Mean|38|38.0|Standard Deviation|17|17.0|||
4202886|NCT00742781|4026228|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4202887|NCT00742781|4026228|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4202888|NCT00742781|4026228|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4202889|NCT00742625|4026237|B1|2 - Ambulatory, unable to perform work activities||ECOG Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|9|9.0||||||
4202890|NCT00742625|4026237|B1|1 - Ambulatory, restricted strenuous activity||ECOG Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|55|55.0||||||
4202891|NCT00742625|4026237|B1|0 - Fully Active||ECOG Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|31|31.0||||||
4202892|NCT00742625|4026237|B1|United States||Region of Enrollment||participants|Number|95|95.0||||||
4202893|NCT00742625|4026237|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4202894|NCT00742625|4026237|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4202895|NCT00742625|4026237|B1|||Age||years|Median|67|67.0|Full Range|||60.0|75.0|
4202896|NCT00742560|4026246|B6||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4202897|NCT00742560|4026247|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4202898|NCT00742560|4026248|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4202899|NCT00742560|4026249|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4202900|NCT00742560|4026250|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4202901|NCT00742560|4026251|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4202902|NCT00742560|4026246|B6||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4202903|NCT00742560|4026247|B5||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4202904|NCT00742560|4026248|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4202905|NCT00742560|4026249|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4202906|NCT00742560|4026250|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4202907|NCT00742560|4026251|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4202908|NCT00742560|4026246|B6|||Age||years|Mean|61.7|61.7|Standard Deviation|9.91|9.91|||
4202909|NCT00742560|4026247|B5|||Age||years|Mean|63.3|63.3|Standard Deviation|9.76|9.76|||
4202910|NCT00742560|4026248|B4|||Age||years|Mean|60.6|60.6|Standard Deviation|9.70|9.7|||
4202911|NCT00742560|4026249|B3|||Age||years|Mean|59.3|59.3|Standard Deviation|10.87|10.87|||
4202912|NCT00742560|4026250|B2|||Age||years|Mean|64.7|64.7|Standard Deviation|6.94|6.94|||
4202913|NCT00742560|4026251|B1|||Age||years|Mean|68.3|68.3|Standard Deviation|7.23|7.23|||
4202914|NCT00742508|4026327|B3|Asian-Japanese Heritage||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4202915|NCT00742508|4026328|B2|Asian-Japanese Heritage||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4202916|NCT00742508|4026329|B1|Asian-Japanese Heritage||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4202917|NCT00742508|4026327|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4202918|NCT00742508|4026328|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4202919|NCT00742508|4026329|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4202920|NCT00742508|4026327|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4202921|NCT00742508|4026328|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4202922|NCT00742508|4026329|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4202923|NCT00742508|4026327|B3|||Age||years|Mean|64.6|64.6|Standard Deviation|10.20|10.2|||
4202924|NCT00742508|4026328|B2|||Age||years|Mean|66.7|66.7|Standard Deviation|12.00|12.0|||
4202925|NCT00742508|4026329|B1|||Age||years|Mean|62.7|62.7|Standard Deviation|8.17|8.17|||
4202926|NCT00742417|4026392|B3|||Height||cm|Mean|158.3|158.3|Standard Deviation|10.1|10.1|||
4202927|NCT00742417|4026393|B2|||Height||cm|Mean|159.3|159.3|Standard Deviation|9.4|9.4|||
4202928|NCT00742417|4026394|B1|||Height||cm|Mean|156.8|156.8|Standard Deviation|11.2|11.2|||
4202929|NCT00742417|4026392|B3|||Weight||Kg|Mean|65.1|65.1|Standard Deviation|15.5|15.5|||
4202930|NCT00742417|4026393|B2|||Weight||Kg|Mean|66.0|66.0|Standard Deviation|16.6|16.6|||
4202931|NCT00742417|4026394|B1|||Weight||Kg|Mean|64.0|64.0|Standard Deviation|14.5|14.5|||
4202932|NCT00742417|4026392|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4202933|NCT00742417|4026393|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4202934|NCT00742417|4026394|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4202935|NCT00742417|4026392|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4202936|NCT00742417|4026393|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4202937|NCT00742417|4026394|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4202938|NCT00742417|4026392|B3||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4202939|NCT00742417|4026393|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4202940|NCT00742417|4026394|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4202941|NCT00742417|4026392|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4202942|NCT00742417|4026393|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4202943|NCT00742417|4026394|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4202944|NCT00742417|4026392|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4202945|NCT00742417|4026393|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4202946|NCT00742417|4026394|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4202947|NCT00742391|4026417|B3|Australia||Region of Enrollment||participants|Number|29|29.0||||||
4202948|NCT00742391|4026418|B2|Australia||Region of Enrollment||participants|Number|13|13.0||||||
4202949|NCT00742391|4026419|B1|Australia||Region of Enrollment||participants|Number|16|16.0||||||
4202950|NCT00742391|4026417|B3|United States||Region of Enrollment||participants|Number|226|226.0||||||
4202951|NCT00742391|4026418|B2|United States||Region of Enrollment||participants|Number|116|116.0||||||
4202952|NCT00742391|4026419|B1|United States||Region of Enrollment||participants|Number|110|110.0||||||
4202953|NCT00742391|4026417|B3||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4202954|NCT00742391|4026418|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4202955|NCT00742391|4026419|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4202956|NCT00742391|4026417|B3||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4202957|NCT00742391|4026418|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4202958|NCT00742391|4026419|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4202959|NCT00742391|4026417|B3|||Age||years|Mean|67.1|67.1|Standard Deviation|10.22|10.22|||
4202960|NCT00742391|4026418|B2|||Age||years|Mean|66.9|66.9|Standard Deviation|9.89|9.89|||
4202961|NCT00742391|4026419|B1|||Age||years|Mean|67.3|67.3|Standard Deviation|10.59|10.59|||
4202962|NCT00742326|4026428|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202963|NCT00742326|4026429|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202964|NCT00742326|4026430|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202965|NCT00742326|4026428|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202966|NCT00742326|4026429|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202967|NCT00742326|4026430|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202968|NCT00742326|4026428|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4202969|NCT00742326|4026429|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4202970|NCT00742326|4026430|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202971|NCT00742326|4026428|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4202972|NCT00742326|4026429|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4202973|NCT00742326|4026430|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4202974|NCT00742326|4026428|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202975|NCT00742326|4026429|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202976|NCT00742326|4026430|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202977|NCT00742326|4026428|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202978|NCT00742326|4026429|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202979|NCT00742326|4026430|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202980|NCT00742326|4026428|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202981|NCT00742326|4026429|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202982|NCT00742326|4026430|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202983|NCT00742326|4026428|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202984|NCT00742326|4026429|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202985|NCT00742326|4026430|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202986|NCT00742326|4026428|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4202987|NCT00742326|4026429|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4202988|NCT00742326|4026430|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4202989|NCT00742326|4026428|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4202990|NCT00742326|4026429|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4202991|NCT00742326|4026430|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4202992|NCT00742326|4026428|B3||Male|Gender||Participants|Count of Participants|9|9.0||||||
4202993|NCT00742326|4026429|B2||Male|Gender||Participants|Count of Participants|4|4.0||||||
4202994|NCT00742326|4026430|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
4202995|NCT00742326|4026428|B3||Female|Gender||Participants|Count of Participants|4|4.0||||||
4202996|NCT00742326|4026429|B2||Female|Gender||Participants|Count of Participants|3|3.0||||||
4202997|NCT00742326|4026430|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
4202998|NCT00742326|4026428|B3|||Age||years|Mean|52|52.0|Standard Deviation|6|6.0|||
4202999|NCT00742326|4026429|B2|||Age||years|Mean|53|53.0|Standard Deviation|6|6.0|||
4203000|NCT00742326|4026430|B1|||Age||years|Mean|52|52.0|Standard Deviation|5|5.0|||
4203001|NCT00742313|4026439|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
4203002|NCT00742313|4026440|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4203003|NCT00742313|4026441|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4203004|NCT00742313|4026439|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4203005|NCT00742313|4026440|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4203006|NCT00742313|4026441|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4203007|NCT00742313|4026439|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4203008|NCT00742313|4026440|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4203009|NCT00742313|4026441|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4203010|NCT00742313|4026439|B3|Greater than 18 years||Age, Customized||Participants|Number|44|44.0||||||
4203011|NCT00742313|4026440|B2|Greater than 18 years||Age, Customized||Participants|Number|19|19.0||||||
4203012|NCT00742313|4026441|B1|Greater than 18 years||Age, Customized||Participants|Number|25|25.0||||||
4203013|NCT00742274|4026448|B3|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4203014|NCT00742274|4026449|B2|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4203015|NCT00742274|4026450|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4203016|NCT00742274|4026448|B3|Sweden||Region of Enrollment||participants|Number|5|5.0||||||
4203017|NCT00742274|4026449|B2|Sweden||Region of Enrollment||participants|Number|4|4.0||||||
4203018|NCT00742274|4026450|B1|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
4203019|NCT00742274|4026448|B3|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
4203020|NCT00742274|4026449|B2|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
4203021|NCT00742274|4026450|B1|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
4203022|NCT00742274|4026448|B3|Italy||Region of Enrollment||participants|Number|4|4.0||||||
4203023|NCT00742274|4026449|B2|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4203024|NCT00742274|4026450|B1|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4203025|NCT00742274|4026448|B3|Germany||Region of Enrollment||participants|Number|31|31.0||||||
4203026|NCT00742274|4026449|B2|Germany||Region of Enrollment||participants|Number|17|17.0||||||
4203027|NCT00742274|4026450|B1|Germany||Region of Enrollment||participants|Number|14|14.0||||||
4203028|NCT00742274|4026448|B3|France||Region of Enrollment||participants|Number|10|10.0||||||
4203029|NCT00742274|4026449|B2|France||Region of Enrollment||participants|Number|3|3.0||||||
4203030|NCT00742274|4026450|B1|France||Region of Enrollment||participants|Number|7|7.0||||||
4203031|NCT00742274|4026448|B3|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
4203032|NCT00742274|4026449|B2|Denmark||Region of Enrollment||participants|Number|0|0.0||||||
4203033|NCT00742274|4026450|B1|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
4203034|NCT00742274|4026448|B3|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4203035|NCT00742274|4026449|B2|Austria||Region of Enrollment||participants|Number|0|0.0||||||
4203036|NCT00742274|4026450|B1|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4203037|NCT00742274|4026448|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4203038|NCT00742274|4026449|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4203039|NCT00742274|4026450|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4203040|NCT00742274|4026448|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4203041|NCT00742274|4026449|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4203042|NCT00742274|4026450|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4203043|NCT00742274|4026448|B3|||Age||years|Mean|60.4|60.4|Standard Deviation|12.0|12.0|||
4203044|NCT00742274|4026449|B2|||Age||years|Mean|60.7|60.7|Standard Deviation|13.4|13.4|||
4203045|NCT00742274|4026450|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|10.5|10.5|||
4203046|NCT00742274|4026448|B3||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4203047|NCT00742274|4026449|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4203048|NCT00742274|4026450|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4203049|NCT00742274|4026448|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4203050|NCT00742274|4026449|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4203051|NCT00742274|4026450|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4203052|NCT00742274|4026448|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203053|NCT00742274|4026449|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203054|NCT00742274|4026450|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203055|NCT00742235|4026457|B3|United States||Region of Enrollment||participants|Number|99|99.0||||||
4203056|NCT00742235|4026458|B2|United States||Region of Enrollment||participants|Number|67|67.0||||||
4203057|NCT00742235|4026459|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4203058|NCT00742235|4026457|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4203059|NCT00742235|4026458|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4203060|NCT00742235|4026459|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4203061|NCT00742235|4026457|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4203062|NCT00742235|4026458|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4203063|NCT00742235|4026459|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4203064|NCT00742235|4026457|B3|||Age||years|Mean|36.5|36.5|Standard Deviation|13.3|13.3|||
4203065|NCT00742235|4026458|B2|||Age||years|Mean|36.7|36.7|Standard Deviation|12.5|12.5|||
4203066|NCT00742235|4026459|B1|||Age||years|Mean|36.1|36.1|Standard Deviation|14.9|14.9|||
4203067|NCT00742235|4026457|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4203068|NCT00742235|4026458|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4203069|NCT00742235|4026459|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4203070|NCT00742235|4026457|B3||Between 18 and 65 years|Age||Participants|Count of Participants|98|98.0||||||
4203071|NCT00742235|4026458|B2||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4203072|NCT00742235|4026459|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4203073|NCT00742235|4026457|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203074|NCT00742235|4026458|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203075|NCT00742235|4026459|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203076|NCT00742209|4026468|B6|Asian and White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4203077|NCT00742209|4026469|B5|Asian and White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4203078|NCT00742209|4026470|B4|Asian and White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4203079|NCT00742209|4026471|B3|Asian and White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4203080|NCT00742209|4026472|B2|Asian and White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4203081|NCT00742209|4026473|B1|Asian and White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4203082|NCT00742209|4026468|B6|AI or AN and White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4203083|NCT00742209|4026469|B5|AI or AN and White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4203084|NCT00742209|4026470|B4|AI or AN and White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4203085|NCT00742209|4026471|B3|AI or AN and White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4203086|NCT00742209|4026472|B2|AI or AN and White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4203087|NCT00742209|4026473|B1|AI or AN and White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4203088|NCT00742209|4026468|B6|AA/African Heritage and White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4203089|NCT00742209|4026469|B5|AA/African Heritage and White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4203090|NCT00742209|4026470|B4|AA/African Heritage and White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4203091|NCT00742209|4026471|B3|AA/African Heritage and White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4203092|NCT00742209|4026472|B2|AA/African Heritage and White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4203093|NCT00742209|4026473|B1|AA/African Heritage and White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4203094|NCT00742209|4026468|B6|AA/African Heritage and AI or AN and White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4203095|NCT00742209|4026469|B5|AA/African Heritage and AI or AN and White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4203096|NCT00742209|4026470|B4|AA/African Heritage and AI or AN and White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4203097|NCT00742209|4026471|B3|AA/African Heritage and AI or AN and White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4203098|NCT00742209|4026472|B2|AA/African Heritage and AI or AN and White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4203099|NCT00742209|4026473|B1|AA/African Heritage and AI or AN and White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4203100|NCT00742209|4026468|B6|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4203101|NCT00742209|4026469|B5|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4203102|NCT00742209|4026470|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4203103|NCT00742209|4026471|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4203104|NCT00742209|4026472|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4203105|NCT00742209|4026473|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4203106|NCT00742209|4026468|B6|Asian||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4203107|NCT00742209|4026469|B5|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4203108|NCT00742209|4026470|B4|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4203109|NCT00742209|4026471|B3|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4203110|NCT00742209|4026472|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4203111|NCT00742209|4026473|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4203112|NCT00742209|4026468|B6|American Indian (AI) or Alaska Native (AN)||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4203113|NCT00742209|4026469|B5|American Indian (AI) or Alaska Native (AN)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4203114|NCT00742209|4026470|B4|American Indian (AI) or Alaska Native (AN)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4203115|NCT00742209|4026471|B3|American Indian (AI) or Alaska Native (AN)||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4203116|NCT00742209|4026472|B2|American Indian (AI) or Alaska Native (AN)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4203117|NCT00742209|4026473|B1|American Indian (AI) or Alaska Native (AN)||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4203118|NCT00742209|4026468|B6|African American/African Heritage (AA)||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4203119|NCT00742209|4026469|B5|African American/African Heritage (AA)||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4203120|NCT00742209|4026470|B4|African American/African Heritage (AA)||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4203121|NCT00742209|4026471|B3|African American/African Heritage (AA)||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4203122|NCT00742209|4026472|B2|African American/African Heritage (AA)||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4203123|NCT00742209|4026473|B1|African American/African Heritage (AA)||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4203124|NCT00742209|4026468|B6|White||Race/Ethnicity, Customized||participants|Number|434|434.0||||||
4203125|NCT00742209|4026469|B5|White||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
4203126|NCT00742209|4026470|B4|White||Race/Ethnicity, Customized||participants|Number|112|112.0||||||
4203127|NCT00742209|4026471|B3|White||Race/Ethnicity, Customized||participants|Number|107|107.0||||||
4203128|NCT00742209|4026472|B2|White||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
4203129|NCT00742209|4026473|B1|White||Race/Ethnicity, Customized||participants|Number|108|108.0||||||
4203130|NCT00742209|4026468|B6||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4203131|NCT00742209|4026469|B5||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4203132|NCT00742209|4026470|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4203133|NCT00742209|4026471|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4203134|NCT00742209|4026472|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4203135|NCT00742209|4026473|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4203136|NCT00742209|4026468|B6||Female|Sex: Female, Male||Participants|Count of Participants|429|429.0||||||
4203137|NCT00742209|4026469|B5||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4203138|NCT00742209|4026470|B4||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4203139|NCT00742209|4026471|B3||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4203140|NCT00742209|4026472|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4203141|NCT00742209|4026473|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4203142|NCT00742209|4026468|B6|||Age||years|Mean|39.2|39.2|Standard Deviation|11.61|11.61|||
4203143|NCT00742209|4026469|B5|||Age||years|Mean|39.1|39.1|Standard Deviation|11.78|11.78|||
4203144|NCT00742209|4026470|B4|||Age||years|Mean|39.0|39.0|Standard Deviation|12.04|12.04|||
4203145|NCT00742209|4026471|B3|||Age||years|Mean|37.7|37.7|Standard Deviation|11.75|11.75|||
4203146|NCT00742209|4026472|B2|||Age||years|Mean|39.4|39.4|Standard Deviation|9.74|9.74|||
4203147|NCT00742209|4026473|B1|||Age||years|Mean|41.1|41.1|Standard Deviation|11.72|11.72|||
4203148|NCT00742183|4026578|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
4203149|NCT00742183|4026579|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
4203150|NCT00742183|4026580|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
4203151|NCT00742183|4026578|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4203152|NCT00742183|4026579|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4203153|NCT00742183|4026580|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4203154|NCT00742183|4026578|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4203155|NCT00742183|4026579|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4203156|NCT00742183|4026580|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4203157|NCT00742183|4026578|B3|||Age||years|Mean|38.4|38.4|Standard Deviation|18.2|18.2|||
4203158|NCT00742183|4026579|B2|||Age||years|Mean|39.2|39.2|Standard Deviation|18.2|18.2|||
4203159|NCT00742183|4026580|B1|||Age||years|Mean|37.0|37.0|Standard Deviation|18.1|18.1|||
4203160|NCT00742183|4026578|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4203161|NCT00742183|4026579|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4203162|NCT00742183|4026580|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4203163|NCT00742183|4026578|B3||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
4203164|NCT00742183|4026579|B2||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4203165|NCT00742183|4026580|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4203166|NCT00742183|4026578|B3||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4203167|NCT00742183|4026579|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4203168|NCT00742183|4026580|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4203169|NCT00742170|4026587|B3|United States||Region of Enrollment||participants|Number|55|55.0||||||
4203170|NCT00742170|4026588|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4203171|NCT00742170|4026589|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4203172|NCT00742170|4026587|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203173|NCT00742170|4026588|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203174|NCT00742170|4026589|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203175|NCT00742170|4026587|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4203176|NCT00742170|4026588|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4203177|NCT00742170|4026589|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4203178|NCT00742170|4026587|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4203179|NCT00742170|4026588|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4203180|NCT00742170|4026589|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4203181|NCT00742170|4026587|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203182|NCT00742170|4026588|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203183|NCT00742170|4026589|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203184|NCT00742170|4026587|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203185|NCT00742170|4026588|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203186|NCT00742170|4026589|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203187|NCT00742170|4026587|B3||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4203188|NCT00742170|4026588|B2||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4203189|NCT00742170|4026589|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4203190|NCT00742170|4026587|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203191|NCT00742170|4026588|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203192|NCT00742170|4026589|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203193|NCT00742170|4026587|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203194|NCT00742170|4026588|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203195|NCT00742170|4026589|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203196|NCT00742170|4026587|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4203197|NCT00742170|4026588|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203198|NCT00742170|4026589|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4203199|NCT00742170|4026587|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4203200|NCT00742170|4026588|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4203201|NCT00742170|4026589|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4203202|NCT00742170|4026587|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4203203|NCT00742170|4026588|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4203204|NCT00742170|4026589|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4203205|NCT00742170|4026587|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4203206|NCT00742170|4026588|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4203207|NCT00742170|4026589|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4203208|NCT00742170|4026587|B3|||Age||years|Mean|27.4|27.4|Standard Deviation|8.7|8.7|||
4203209|NCT00742170|4026588|B2|||Age||years|Mean|27.0|27.0|Standard Deviation|8.6|8.6|||
4203210|NCT00742170|4026589|B1|||Age||years|Mean|27.7|27.7|Standard Deviation|8.9|8.9|||
4203211|NCT00742079|4026598|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4203212|NCT00742079|4026599|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4203213|NCT00742079|4026600|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4203214|NCT00742079|4026598|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203215|NCT00742079|4026599|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203216|NCT00742079|4026600|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203217|NCT00742079|4026598|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203218|NCT00742079|4026599|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203219|NCT00742079|4026600|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203220|NCT00742079|4026598|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4203221|NCT00742079|4026599|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4203222|NCT00742079|4026600|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4203223|NCT00742079|4026598|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4203224|NCT00742079|4026599|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4203225|NCT00742079|4026600|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4203226|NCT00742079|4026598|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203227|NCT00742079|4026599|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203228|NCT00742079|4026600|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203229|NCT00742079|4026598|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4203230|NCT00742079|4026599|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4203231|NCT00742079|4026600|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4203232|NCT00742079|4026598|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203233|NCT00742079|4026599|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203234|NCT00742079|4026600|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203235|NCT00742079|4026598|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4203236|NCT00742079|4026599|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4203237|NCT00742079|4026600|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4203238|NCT00742079|4026598|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4203239|NCT00742079|4026599|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4203240|NCT00742079|4026600|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4203241|NCT00742079|4026598|B3|||Age||years|Mean|50.2|50.2|Standard Deviation|10.7|10.7|||
4203242|NCT00742079|4026599|B2|||Age||years|Mean|51.4|51.4|Standard Deviation|13.0|13.0|||
4203243|NCT00742079|4026600|B1|||Age||years|Mean|49.2|49.2|Standard Deviation|9.0|9.0|||
4203244|NCT00742053|4026615|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4203245|NCT00742053|4026615|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4203246|NCT00742053|4026615|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4203247|NCT00742053|4026615|B1|||Age||years|Mean|58.86|58.86|Standard Deviation|15.48|15.48|||
4203248|NCT00742053|4026615|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4203249|NCT00742053|4026615|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4203250|NCT00742053|4026615|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203251|NCT00741988|4026619|B3|United States||Region of Enrollment||participants|Number|82|82.0||||||
4203252|NCT00741988|4026620|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4203253|NCT00741988|4026621|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4203254|NCT00741988|4026619|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4203255|NCT00741988|4026620|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4203256|NCT00741988|4026621|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4203257|NCT00741988|4026619|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4203258|NCT00741988|4026620|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4203259|NCT00741988|4026621|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4203260|NCT00741988|4026619|B3|||Age||years|Median|63|63.0|Full Range|||43.0|85.0|
4203261|NCT00741988|4026620|B2|||Age||years|Median|63|63.0|Full Range|||45.0|78.0|
4203262|NCT00741988|4026621|B1|||Age||years|Median|63|63.0|Full Range|||43.0|85.0|
4203263|NCT00741936|4026632|B3|||Severity of constipation|It was a 7-point ordinal scale from 0=not at all to 6=very severe.|Units on a scale|Mean|4.43|4.43|Standard Deviation|0.76|0.76|||
4203264|NCT00741936|4026633|B2|||Severity of constipation|It was a 7-point ordinal scale from 0=not at all to 6=very severe.|Units on a scale|Mean|4.40|4.4|Standard Deviation|0.10|0.1|||
4203265|NCT00741936|4026634|B1|||Severity of constipation|It was a 7-point ordinal scale from 0=not at all to 6=very severe.|Units on a scale|Mean|4.47|4.47|Standard Deviation|0.102|0.102|||
4203266|NCT00741936|4026632|B3|||No. of days taking rescue therapy||days per week|Mean|0.89|0.89|Standard Deviation|1.24|1.24|||
4203267|NCT00741936|4026633|B2|||No. of days taking rescue therapy||days per week|Mean|0.84|0.84|Standard Deviation|0.15|0.15|||
4203268|NCT00741936|4026634|B1|||No. of days taking rescue therapy||days per week|Mean|0.93|0.93|Standard Deviation|0.17|0.17|||
4203269|NCT00741936|4026632|B3|||Complete spontaneous bowel movement (CSBM)|CSBM referred to the feeling that defecation led to complete passage of stool rather than partial or incomplete evacuation without the use of any laxative or enema within 24 hours.|movements per week|Mean|0.42|0.42|Standard Deviation|0.68|0.68|||
4203270|NCT00741936|4026633|B2|||Complete spontaneous bowel movement (CSBM)|CSBM referred to the feeling that defecation led to complete passage of stool rather than partial or incomplete evacuation without the use of any laxative or enema within 24 hours.|movements per week|Mean|0.52|0.52|Standard Deviation|0.69|0.69|||
4203271|NCT00741936|4026634|B1|||Complete spontaneous bowel movement (CSBM)|CSBM referred to the feeling that defecation led to complete passage of stool rather than partial or incomplete evacuation without the use of any laxative or enema within 24 hours.|movements per week|Mean|0.33|0.33|Standard Deviation|0.66|0.66|||
4203272|NCT00741936|4026632|B3|||Bowel movement||movements per week|Mean|3.05|3.05|Standard Deviation|1.46|1.46|||
4203273|NCT00741936|4026633|B2|||Bowel movement||movements per week|Mean|3.31|3.31|Standard Deviation|1.61|1.61|||
4203274|NCT00741936|4026634|B1|||Bowel movement||movements per week|Mean|2.79|2.79|Standard Deviation|1.26|1.26|||
4203275|NCT00741936|4026632|B3|||Duration of constipation||years|Mean|14.38|14.38|Standard Deviation|10.39|10.39|||
4203276|NCT00741936|4026633|B2|||Duration of constipation||years|Mean|15.25|15.25|Standard Deviation|10.82|10.82|||
4203277|NCT00741936|4026634|B1|||Duration of constipation||years|Mean|13.50|13.5|Standard Deviation|9.96|9.96|||
4203278|NCT00741936|4026632|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4203279|NCT00741936|4026633|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4203280|NCT00741936|4026634|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4203281|NCT00741936|4026632|B3||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4203282|NCT00741936|4026633|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4203283|NCT00741936|4026634|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4203284|NCT00741936|4026632|B3|||Age||years|Mean|37.13|37.13|Standard Deviation|10.99|10.99|||
4203285|NCT00741936|4026633|B2|||Age||years|Mean|37.53|37.53|Standard Deviation|11.42|11.42|||
4203286|NCT00741936|4026634|B1|||Age||years|Mean|36.72|36.72|Standard Deviation|10.62|10.62|||
4203287|NCT00741858|4026661|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
4203288|NCT00741858|4026662|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4203289|NCT00741858|4026663|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4203290|NCT00741858|4026661|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4203291|NCT00741858|4026662|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4203292|NCT00741858|4026663|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4203293|NCT00741858|4026661|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4203294|NCT00741858|4026662|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4203295|NCT00741858|4026663|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4203296|NCT00741858|4026661|B3|||Age||years|Mean|38.7|38.7|Standard Deviation|12.2|12.2|||
4203297|NCT00741858|4026662|B2|||Age||years|Mean|39|39.0|Standard Deviation|12|12.0|||
4203298|NCT00741858|4026663|B1|||Age||years|Mean|38|38.0|Standard Deviation|12|12.0|||
4203299|NCT00741858|4026661|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4203300|NCT00741858|4026662|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4203301|NCT00741858|4026663|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4203302|NCT00741858|4026661|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4203303|NCT00741858|4026662|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4203304|NCT00741858|4026663|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4203305|NCT00741858|4026661|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203306|NCT00741858|4026662|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203307|NCT00741858|4026663|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203308|NCT00741819|4026670|B1|||N-terminal prohormone brain natriuretic peptide (NT-proBNP)||pg/mL|Median|626|626.0|Full Range|||26.0|8324.0|
4203309|NCT00741819|4026670|B1|||Six-minute walk distance (6MWD)||meters|Median|378|378.0|Full Range|78|78.0|259.0|600.0|
4203310|NCT00741819|4026670|B1|ERA and PDE-5i||Background PAH therapy||participants|Number|43|43.0||||||
4203311|NCT00741819|4026670|B1|Phosphodiesterase-5 inhibitor (PDE-5i)||Background PAH therapy||participants|Number|8|8.0||||||
4203312|NCT00741819|4026670|B1|Endothelin receptor antagonist (ERA)||Background PAH therapy||participants|Number|19|19.0||||||
4203313|NCT00741819|4026670|B1|None||Background PAH therapy||participants|Number|3|3.0||||||
4203314|NCT00741819|4026670|B1|HIV||Pulmonary Arterial Hypertension (PAH) etiology||participants|Number|3|3.0||||||
4203315|NCT00741819|4026670|B1|CHD-unrepaired shunt||Pulmonary Arterial Hypertension (PAH) etiology||participants|Number|15|15.0||||||
4203316|NCT00741819|4026670|B1|Congenital heart disease (CHD)-repaired shunt||Pulmonary Arterial Hypertension (PAH) etiology||participants|Number|4|4.0||||||
4203317|NCT00741819|4026670|B1|Connective Tissue Diseases (CTD)||Pulmonary Arterial Hypertension (PAH) etiology||participants|Number|16|16.0||||||
4203318|NCT00741819|4026670|B1|Idiopathic PAH or familial PAH||Pulmonary Arterial Hypertension (PAH) etiology||participants|Number|35|35.0||||||
4203319|NCT00741819|4026670|B1|United States||Region of Enrollment||participants|Number|73|73.0||||||
4203320|NCT00741819|4026670|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4203321|NCT00741819|4026670|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4203322|NCT00741819|4026670|B1|||Age||years|Mean|49.4|49.4|Standard Deviation|12.6|12.6|||
4203323|NCT00741819|4026670|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4203324|NCT00741819|4026670|B1||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4203325|NCT00741819|4026670|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203326|NCT00741611|4026681|B4|United States||Region of Enrollment||participants|Number|36|36.0||||||
4203327|NCT00741611|4026682|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
4203328|NCT00741611|4026683|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4203329|NCT00741611|4026684|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4203330|NCT00741611|4026681|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4203331|NCT00741611|4026682|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4203332|NCT00741611|4026683|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4203333|NCT00741611|4026684|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4203334|NCT00741611|4026681|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4203335|NCT00741611|4026682|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4203336|NCT00741611|4026683|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4203337|NCT00741611|4026684|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4203338|NCT00741611|4026681|B4|||Age||years|Mean|61.2|61.2|Standard Deviation|9.36|9.36|||
4203339|NCT00741611|4026682|B3|||Age||years|Mean|60.2|60.2|Standard Deviation|9.68|9.68|||
4203340|NCT00741611|4026683|B2|||Age||years|Mean|66.0|66.0|Standard Deviation|9.54|9.54|||
4203341|NCT00741611|4026684|B1|||Age||years|Mean|64.8|64.8|Standard Deviation|6.18|6.18|||
4203342|NCT00741598|4026703|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4203343|NCT00741598|4026704|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4203344|NCT00741598|4026705|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4203345|NCT00741598|4026703|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4203346|NCT00741598|4026704|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4203347|NCT00741598|4026705|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4203348|NCT00741598|4026703|B3|||Age||years|Mean|46.5|46.5|Standard Deviation|12.6|12.6|||
4203349|NCT00741598|4026704|B2|||Age||years|Mean|47.8|47.8|Standard Deviation|12.3|12.3|||
4203350|NCT00741598|4026705|B1|||Age||years|Mean|45.0|45.0|Standard Deviation|13.1|13.1|||
4203351|NCT00741468|4026720|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4203352|NCT00741468|4026720|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4203353|NCT00741468|4026720|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4203354|NCT00741468|4026720|B1|||Age||years|Mean|33.4|33.4|Standard Deviation|8.3|8.3|||
4203355|NCT00741390|4026728|B1|>10||Years Since Diagnosis||participants|Number|146|146.0||||||
4203356|NCT00741390|4026728|B1|6-10||Years Since Diagnosis||participants|Number|46|46.0||||||
4203357|NCT00741390|4026728|B1|1-5||Years Since Diagnosis||participants|Number|46|46.0||||||
4203358|NCT00741390|4026728|B1|<1||Years Since Diagnosis||participants|Number|12|12.0||||||
4203359|NCT00741390|4026728|B1|Type 2||Diabetes Type||participants|Number|155|155.0||||||
4203360|NCT00741390|4026728|B1|Type 1||Diabetes Type||participants|Number|95|95.0||||||
4203361|NCT00741390|4026728|B1|Other||Blood Glucose Meter Brand||participants|Number|16|16.0||||||
4203362|NCT00741390|4026728|B1|Roche||Blood Glucose Meter Brand||participants|Number|41|41.0||||||
4203363|NCT00741390|4026728|B1|Reli-on||Blood Glucose Meter Brand||participants|Number|2|2.0||||||
4203364|NCT00741390|4026728|B1|Private Label Walgreens||Blood Glucose Meter Brand||participants|Number|2|2.0||||||
4203365|NCT00741390|4026728|B1|Lifescan||Blood Glucose Meter Brand||participants|Number|106|106.0||||||
4203366|NCT00741390|4026728|B1|Bayer||Blood Glucose Meter Brand||participants|Number|20|20.0||||||
4203367|NCT00741390|4026728|B1|BD/Novamax||Blood Glucose Meter Brand||participants|Number|17|17.0||||||
4203368|NCT00741390|4026728|B1|Agamatrix||Blood Glucose Meter Brand||participants|Number|1|1.0||||||
4203369|NCT00741390|4026728|B1|Abbott||Blood Glucose Meter Brand||participants|Number|45|45.0||||||
4203370|NCT00741390|4026728|B1|United States||Region of Enrollment||participants|Number|250|250.0||||||
4203371|NCT00741390|4026728|B1||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4203372|NCT00741390|4026728|B1||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4203373|NCT00741390|4026728|B1|||Age||years|Mean|52.1|52.1|Standard Deviation|12.3|12.3|||
4203374|NCT00741338|4026750|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4203375|NCT00741338|4026751|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4203376|NCT00741338|4026752|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4203377|NCT00741338|4026750|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4203378|NCT00741338|4026751|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4203379|NCT00741338|4026752|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4203380|NCT00741338|4026750|B3|||Age||years|Mean|3.18|3.18|Full Range|||1.8|4.2|
4203381|NCT00741338|4026751|B2|||Age||years|Mean|3.77|3.77|Full Range|||3.0|4.2|
4203382|NCT00741338|4026752|B1|||Age||years|Mean|2.60|2.6|Full Range|||1.8|3.5|
4203383|NCT00741286|4026761|B3|Korea, Republic of||Region of Enrollment||participants|Number|203|203.0||||||
4203384|NCT00741286|4026762|B2|Korea, Republic of||Region of Enrollment||participants|Number|100|100.0||||||
4203385|NCT00741286|4026763|B1|Korea, Republic of||Region of Enrollment||participants|Number|103|103.0||||||
4203386|NCT00741286|4026761|B3||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4203387|NCT00741286|4026762|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4203388|NCT00741286|4026763|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4203389|NCT00741286|4026761|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4203390|NCT00741286|4026762|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4203391|NCT00741286|4026763|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4203392|NCT00741286|4026761|B3|||Age||years|Mean|65.06|65.06|Standard Deviation|9.50|9.5|||
4203393|NCT00741286|4026762|B2|||Age||years|Mean|64.63|64.63|Standard Deviation|9.07|9.07|||
4203394|NCT00741286|4026763|B1|||Age||years|Mean|65.48|65.48|Standard Deviation|9.92|9.92|||
4203395|NCT00741286|4026761|B3||>=65 years|Age||Participants|Count of Participants|111|111.0||||||
4203396|NCT00741286|4026762|B2||>=65 years|Age||Participants|Count of Participants|55|55.0||||||
4203397|NCT00741286|4026763|B1||>=65 years|Age||Participants|Count of Participants|56|56.0||||||
4203398|NCT00741286|4026761|B3||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
4203399|NCT00741286|4026762|B2||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4203400|NCT00741286|4026763|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4203401|NCT00741286|4026761|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203402|NCT00741286|4026762|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203403|NCT00741286|4026763|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203404|NCT00741273|4026772|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4203405|NCT00741273|4026773|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4203406|NCT00741273|4026774|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4203407|NCT00741273|4026772|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4203408|NCT00741273|4026773|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4203409|NCT00741273|4026774|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4203410|NCT00741273|4026772|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4203411|NCT00741273|4026773|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4203412|NCT00741273|4026774|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4203413|NCT00741273|4026772|B3|||Age||years|Mean|47.8|47.8|Standard Deviation|7.9|7.9|||
4203414|NCT00741273|4026773|B2|||Age||years|Mean|54.1|54.1|Standard Deviation|4.8|4.8|||
4203415|NCT00741273|4026774|B1|||Age||years|Mean|41.4|41.4|Standard Deviation|4.1|4.1|||
4203416|NCT00741260|4026791|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203417|NCT00741260|4026792|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203418|NCT00741260|4026793|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203419|NCT00741260|4026794|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203420|NCT00741260|4026795|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203421|NCT00741260|4026796|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203422|NCT00741260|4026797|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203423|NCT00741260|4026798|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203424|NCT00741260|4026791|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203425|NCT00741260|4026792|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203426|NCT00741260|4026793|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203427|NCT00741260|4026794|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203428|NCT00741260|4026795|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203429|NCT00741260|4026796|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203430|NCT00741260|4026797|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203431|NCT00741260|4026798|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203432|NCT00741260|4026791|B8||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4203433|NCT00741260|4026792|B7||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4203434|NCT00741260|4026793|B6||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4203435|NCT00741260|4026794|B5||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4203436|NCT00741260|4026795|B4||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4203437|NCT00741260|4026796|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4203438|NCT00741260|4026797|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4203439|NCT00741260|4026798|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4203440|NCT00741260|4026791|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4203441|NCT00741260|4026792|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203442|NCT00741260|4026793|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4203443|NCT00741260|4026794|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203444|NCT00741260|4026795|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203445|NCT00741260|4026796|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203446|NCT00741260|4026797|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203447|NCT00741260|4026798|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4203448|NCT00741260|4026791|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203449|NCT00741260|4026792|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203450|NCT00741260|4026793|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203451|NCT00741260|4026794|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203452|NCT00741260|4026795|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203453|NCT00741260|4026796|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203454|NCT00741260|4026797|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203455|NCT00741260|4026798|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203456|NCT00741260|4026791|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4203457|NCT00741260|4026792|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4203458|NCT00741260|4026793|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4203459|NCT00741260|4026794|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203460|NCT00741260|4026795|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203461|NCT00741260|4026796|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203462|NCT00741260|4026797|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203463|NCT00741260|4026798|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203464|NCT00741260|4026791|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203465|NCT00741260|4026792|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203466|NCT00741260|4026793|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203467|NCT00741260|4026794|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203468|NCT00741260|4026795|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203469|NCT00741260|4026796|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203470|NCT00741260|4026797|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203471|NCT00741260|4026798|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203472|NCT00741260|4026791|B8||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4203473|NCT00741260|4026792|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4203474|NCT00741260|4026793|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4203475|NCT00741260|4026794|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4203476|NCT00741260|4026795|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4203477|NCT00741260|4026796|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4203478|NCT00741260|4026797|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4203479|NCT00741260|4026798|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4203480|NCT00741260|4026791|B8||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4203481|NCT00741260|4026792|B7||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4203482|NCT00741260|4026793|B6||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4203483|NCT00741260|4026794|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4203484|NCT00741260|4026795|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4203485|NCT00741260|4026796|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4203486|NCT00741260|4026797|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4203487|NCT00741260|4026798|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4203488|NCT00741260|4026791|B8|||Age||years|Mean|52.4|52.4|Standard Deviation|10.77|10.77|||
4203489|NCT00741260|4026792|B7|||Age||years|Mean|50.9|50.9|Standard Deviation|10.65|10.65|||
4203490|NCT00741260|4026793|B6|||Age||years|Mean|51.5|51.5|Standard Deviation|10.48|10.48|||
4203491|NCT00741260|4026794|B5|||Age||years|Mean|55.7|55.7|Standard Deviation|10.64|10.64|||
4203492|NCT00741260|4026795|B4|||Age||years|Mean|59.0|59.0|Standard Deviation|10.88|10.88|||
4203493|NCT00741260|4026796|B3|||Age||years|Mean|56.3|56.3|Standard Deviation|17.15|17.15|||
4203494|NCT00741260|4026797|B2|||Age||years|Mean|53.3|53.3|Standard Deviation|10.42|10.42|||
4203495|NCT00741260|4026798|B1|||Age||years|Mean|49.7|49.7|Standard Deviation|11.50|11.5|||
4203496|NCT00741260|4026791|B8||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4203497|NCT00741260|4026792|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4203498|NCT00741260|4026793|B6||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4203499|NCT00741260|4026794|B5||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4203500|NCT00741260|4026795|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4203501|NCT00741260|4026796|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4203502|NCT00741260|4026797|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4203503|NCT00741260|4026798|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4203504|NCT00741260|4026791|B8||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
4203505|NCT00741260|4026792|B7||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4203506|NCT00741260|4026793|B6||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4203507|NCT00741260|4026794|B5||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4203508|NCT00741260|4026795|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4203509|NCT00741260|4026796|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4203510|NCT00741260|4026797|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4203511|NCT00741260|4026798|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4203512|NCT00741260|4026791|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203513|NCT00741260|4026792|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203514|NCT00741260|4026793|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203515|NCT00741260|4026794|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203516|NCT00741260|4026795|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203517|NCT00741260|4026796|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203518|NCT00741260|4026797|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203519|NCT00741260|4026798|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203520|NCT00741156|4026831|B1|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4203521|NCT00741156|4026831|B1||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||SEX WAS NOT IDENTIFIED
4203522|NCT00741156|4026831|B1||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||SEX WAS NOT IDENTIFIED
4203523|NCT00741156|4026831|B1|||Age||years|Mean|2.3|2.3|Standard Deviation|1|1.0|||
4203524|NCT00741156|4026831|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4203525|NCT00741156|4026831|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4203526|NCT00741156|4026831|B1||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4203527|NCT00741104|4026846|B1|Data unavailable||Change in dosing interval since previous doctor visit|Only 264 patients had this information available from the registry databases.|participants|Number|99|99.0||||||
4203528|NCT00741104|4026846|B1|Increased dosing interval||Change in dosing interval since previous doctor visit|Only 264 patients had this information available from the registry databases.|participants|Number|19|19.0||||||
4203529|NCT00741104|4026846|B1|No change||Change in dosing interval since previous doctor visit|Only 264 patients had this information available from the registry databases.|participants|Number|226|226.0||||||
4203530|NCT00741104|4026846|B1|Decreased dosing interval||Change in dosing interval since previous doctor visit|Only 264 patients had this information available from the registry databases.|participants|Number|19|19.0||||||
4203531|NCT00741104|4026846|B1|Sweden||Region of Enrollment||participants|Number|363|363.0||||||
4203532|NCT00741104|4026846|B1||Male|Gender||Participants|Count of Participants|109|109.0||||||
4203533|NCT00741104|4026846|B1||Female|Gender||Participants|Count of Participants|254|254.0||||||
4203534|NCT00741104|4026846|B1|||Age||years|Mean|61|61.0|Full Range|||23.0|89.0|
4203535|NCT00741091|4026853|B1|United States||Region of Enrollment||participants|Number|1097|1097.0||||||
4203536|NCT00741091|4026853|B1||Male|Sex: Female, Male||Participants|Count of Participants|683|683.0||||||
4203537|NCT00741091|4026853|B1||Female|Sex: Female, Male||Participants|Count of Participants|414|414.0||||||
4203538|NCT00741091|4026853|B1|||Age||years|Mean|71.3|71.3|Standard Deviation|9.2|9.2|||
4203539|NCT00741039|4026861|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4203540|NCT00741039|4026862|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4203541|NCT00741039|4026863|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4203542|NCT00741039|4026861|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4203543|NCT00741039|4026862|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4203544|NCT00741039|4026863|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4203545|NCT00741039|4026861|B3||>=65 years|Age||Participants|Count of Participants|124|124.0||||||
4203546|NCT00741039|4026862|B2||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4203547|NCT00741039|4026863|B1||>=65 years|Age||Participants|Count of Participants|99|99.0||||||
4203548|NCT00741039|4026861|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4203549|NCT00741039|4026862|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4203550|NCT00741039|4026863|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4203551|NCT00741039|4026861|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203552|NCT00741039|4026862|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203553|NCT00741039|4026863|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203554|NCT00741026|4026870|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4203555|NCT00741026|4026870|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4203556|NCT00741026|4026870|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4203557|NCT00741026|4026870|B1|||Age||years|Mean|26.6|26.6|Standard Deviation|0.5|0.5|||
4203558|NCT00741026|4026870|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4203559|NCT00741026|4026870|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4203560|NCT00741026|4026870|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203561|NCT00741013|4026898|B4|United States||Region of Enrollment||participants|Number|22|22.0||||||
4203562|NCT00741013|4026899|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4203563|NCT00741013|4026900|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4203564|NCT00741013|4026901|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4203565|NCT00741013|4026898|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4203566|NCT00741013|4026899|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4203567|NCT00741013|4026900|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4203568|NCT00741013|4026901|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4203569|NCT00741013|4026898|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4203570|NCT00741013|4026899|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4203571|NCT00741013|4026900|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4203572|NCT00741013|4026901|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4203573|NCT00741013|4026898|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4203574|NCT00741013|4026899|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4203575|NCT00741013|4026900|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4203576|NCT00741013|4026901|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4203577|NCT00741013|4026898|B4||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4203578|NCT00741013|4026899|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4203579|NCT00741013|4026900|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4203580|NCT00741013|4026901|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4203581|NCT00741013|4026898|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203582|NCT00741013|4026899|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203583|NCT00741013|4026900|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203584|NCT00741013|4026901|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203585|NCT00740870|4026914|B1|United States||Region of Enrollment||participants|Number|171|171.0||||||
4203586|NCT00740870|4026914|B1||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4203587|NCT00740870|4026914|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4203588|NCT00740870|4026914|B1|||Age||years|Mean|21.8|21.8|Standard Deviation|9.8|9.8|||
4203589|NCT00740857|4026926|B4||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4203590|NCT00740857|4026927|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4203591|NCT00740857|4026928|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4203592|NCT00740857|4026929|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4203593|NCT00740857|4026926|B4||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4203594|NCT00740857|4026927|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4203595|NCT00740857|4026928|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4203596|NCT00740857|4026929|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4203597|NCT00740857|4026926|B4|||Age||years|Mean|18.8|18.8|Standard Deviation|2.7|2.7|||
4203598|NCT00740857|4026927|B3|||Age||years|Mean|19.0|19.0|Standard Deviation|3.0|3.0|||
4203599|NCT00740857|4026928|B2|||Age||years|Mean|18.5|18.5|Standard Deviation|2.5|2.5|||
4203600|NCT00740857|4026929|B1|||Age||years|Mean|18.8|18.8|Standard Deviation|2.7|2.7|||
4203601|NCT00740831|4026960|B4|Poland||Region of Enrollment||participants|Number|126|126.0||||||
4203602|NCT00740831|4026961|B3|Poland||Region of Enrollment||participants|Number|50|50.0||||||
4203603|NCT00740831|4026962|B2|Poland||Region of Enrollment||participants|Number|34|34.0||||||
4203604|NCT00740831|4026963|B1|Poland||Region of Enrollment||participants|Number|42|42.0||||||
4203605|NCT00740831|4026960|B4|Italy||Region of Enrollment||participants|Number|20|20.0||||||
4203606|NCT00740831|4026961|B3|Italy||Region of Enrollment||participants|Number|7|7.0||||||
4203607|NCT00740831|4026962|B2|Italy||Region of Enrollment||participants|Number|7|7.0||||||
4203608|NCT00740831|4026963|B1|Italy||Region of Enrollment||participants|Number|6|6.0||||||
4203609|NCT00740831|4026960|B4|Israel||Region of Enrollment||participants|Number|12|12.0||||||
4203610|NCT00740831|4026961|B3|Israel||Region of Enrollment||participants|Number|2|2.0||||||
4203611|NCT00740831|4026962|B2|Israel||Region of Enrollment||participants|Number|6|6.0||||||
4203612|NCT00740831|4026963|B1|Israel||Region of Enrollment||participants|Number|4|4.0||||||
4203613|NCT00740831|4026960|B4|Spain||Region of Enrollment||participants|Number|67|67.0||||||
4203614|NCT00740831|4026961|B3|Spain||Region of Enrollment||participants|Number|18|18.0||||||
4203615|NCT00740831|4026962|B2|Spain||Region of Enrollment||participants|Number|28|28.0||||||
4203616|NCT00740831|4026963|B1|Spain||Region of Enrollment||participants|Number|21|21.0||||||
4203617|NCT00740831|4026960|B4|Germany||Region of Enrollment||participants|Number|7|7.0||||||
4203618|NCT00740831|4026961|B3|Germany||Region of Enrollment||participants|Number|3|3.0||||||
4203619|NCT00740831|4026962|B2|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4203620|NCT00740831|4026963|B1|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4203621|NCT00740831|4026960|B4|Belgium||Region of Enrollment||participants|Number|41|41.0||||||
4203622|NCT00740831|4026961|B3|Belgium||Region of Enrollment||participants|Number|13|13.0||||||
4203623|NCT00740831|4026962|B2|Belgium||Region of Enrollment||participants|Number|16|16.0||||||
4203624|NCT00740831|4026963|B1|Belgium||Region of Enrollment||participants|Number|12|12.0||||||
4203625|NCT00740831|4026960|B4|Austria||Region of Enrollment||participants|Number|28|28.0||||||
4203626|NCT00740831|4026961|B3|Austria||Region of Enrollment||participants|Number|8|8.0||||||
4203627|NCT00740831|4026962|B2|Austria||Region of Enrollment||participants|Number|12|12.0||||||
4203628|NCT00740831|4026963|B1|Austria||Region of Enrollment||participants|Number|8|8.0||||||
4203629|NCT00740831|4026960|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4203630|NCT00740831|4026961|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4203631|NCT00740831|4026962|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4203632|NCT00740831|4026963|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4203633|NCT00740831|4026960|B4||Female|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
4203634|NCT00740831|4026961|B3||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4203635|NCT00740831|4026962|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4203636|NCT00740831|4026963|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4203637|NCT00740831|4026960|B4|||Age||years|Mean|40.3|40.3|Standard Deviation|6.2|6.2|||
4203638|NCT00740831|4026961|B3|||Age||years|Mean|40.3|40.3|Standard Deviation|6.2|6.2|||
4203639|NCT00740831|4026962|B2|||Age||years|Mean|40.7|40.7|Standard Deviation|6.3|6.3|||
4203640|NCT00740831|4026963|B1|||Age||years|Mean|40.1|40.1|Standard Deviation|6.2|6.2|||
4203641|NCT00740831|4026960|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4203642|NCT00740831|4026961|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4203643|NCT00740831|4026962|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4203644|NCT00740831|4026963|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4203645|NCT00740831|4026960|B4||Between 18 and 65 years|Age||Participants|Count of Participants|301|301.0||||||
4203646|NCT00740831|4026961|B3||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
4203647|NCT00740831|4026962|B2||Between 18 and 65 years|Age||Participants|Count of Participants|103|103.0||||||
4203648|NCT00740831|4026963|B1||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
4203649|NCT00740831|4026960|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203650|NCT00740831|4026961|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203651|NCT00740831|4026962|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203652|NCT00740831|4026963|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203653|NCT00740792|4026982|B5|United States||Region of Enrollment||participants|Number|776|776.0||||||
4203654|NCT00740792|4026983|B4|United States||Region of Enrollment||participants|Number|200|200.0||||||
4203655|NCT00740792|4026984|B3|United States||Region of Enrollment||participants|Number|189|189.0||||||
4203656|NCT00740792|4026985|B2|United States||Region of Enrollment||participants|Number|194|194.0||||||
4203657|NCT00740792|4026986|B1|United States||Region of Enrollment||participants|Number|193|193.0||||||
4203658|NCT00740792|4026982|B5||Male|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
4203659|NCT00740792|4026983|B4||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4203660|NCT00740792|4026984|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4203661|NCT00740792|4026985|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4203662|NCT00740792|4026986|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4203663|NCT00740792|4026982|B5||Female|Sex: Female, Male||Participants|Count of Participants|494|494.0||||||
4203664|NCT00740792|4026983|B4||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4203665|NCT00740792|4026984|B3||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4203666|NCT00740792|4026985|B2||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4203667|NCT00740792|4026986|B1||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4203668|NCT00740792|4026982|B5|||Age||years|Mean|37.8|37.8|Standard Deviation|13.6|13.6|||
4203669|NCT00740792|4026983|B4|||Age||years|Mean|37.2|37.2|Standard Deviation|13.0|13.0|||
4203670|NCT00740792|4026984|B3|||Age||years|Mean|37.0|37.0|Standard Deviation|13.6|13.6|||
4203671|NCT00740792|4026985|B2|||Age||years|Mean|38.2|38.2|Standard Deviation|13.5|13.5|||
4203672|NCT00740792|4026986|B1|||Age||years|Mean|38.8|38.8|Standard Deviation|14.1|14.1|||
4203673|NCT00740792|4026982|B5||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4203674|NCT00740792|4026983|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4203675|NCT00740792|4026984|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4203676|NCT00740792|4026985|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4203677|NCT00740792|4026986|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4203678|NCT00740792|4026982|B5||Between 18 and 65 years|Age||Participants|Count of Participants|707|707.0||||||
4203679|NCT00740792|4026983|B4||Between 18 and 65 years|Age||Participants|Count of Participants|181|181.0||||||
4203680|NCT00740792|4026984|B3||Between 18 and 65 years|Age||Participants|Count of Participants|172|172.0||||||
4203681|NCT00740792|4026985|B2||Between 18 and 65 years|Age||Participants|Count of Participants|178|178.0||||||
4203682|NCT00740792|4026986|B1||Between 18 and 65 years|Age||Participants|Count of Participants|176|176.0||||||
4203683|NCT00740792|4026982|B5||<=18 years|Age||Participants|Count of Participants|55|55.0||||||
4203684|NCT00740792|4026983|B4||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
4203685|NCT00740792|4026984|B3||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4203686|NCT00740792|4026985|B2||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4203687|NCT00740792|4026986|B1||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4203688|NCT00740779|4027007|B4|United States||Region of Enrollment||participants|Number|151|151.0||||||
4203689|NCT00740779|4027008|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
4203690|NCT00740779|4027009|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
4203691|NCT00740779|4027010|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
4203692|NCT00740779|4027007|B4||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4203693|NCT00740779|4027008|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4203694|NCT00740779|4027009|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4203695|NCT00740779|4027010|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4203696|NCT00740779|4027007|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4203697|NCT00740779|4027008|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4203698|NCT00740779|4027009|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4203699|NCT00740779|4027010|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4203700|NCT00740779|4027007|B4|||Age||years|Mean|48.4|48.4|Standard Deviation|13.43|13.43|||
4203701|NCT00740779|4027008|B3|||Age||years|Mean|49.0|49.0|Standard Deviation|11.62|11.62|||
4203702|NCT00740779|4027009|B2|||Age||years|Mean|46.7|46.7|Standard Deviation|15.57|15.57|||
4203703|NCT00740779|4027010|B1|||Age||years|Mean|49.2|49.2|Standard Deviation|13.34|13.34|||
4203704|NCT00740779|4027007|B4||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4203705|NCT00740779|4027008|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4203706|NCT00740779|4027009|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4203707|NCT00740779|4027010|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4203708|NCT00740779|4027007|B4||Between 18 and 65 years|Age||Participants|Count of Participants|136|136.0||||||
4203709|NCT00740779|4027008|B3||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4203710|NCT00740779|4027009|B2||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4203711|NCT00740779|4027010|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4203712|NCT00740779|4027007|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203713|NCT00740779|4027008|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203714|NCT00740779|4027009|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203715|NCT00740779|4027010|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203716|NCT00740727|4027020|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4203717|NCT00740727|4027020|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4203718|NCT00740727|4027020|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4203719|NCT00740727|4027020|B1|||Age||years|Mean|25|25.0|Standard Deviation|7|7.0|||
4203720|NCT00740727|4027020|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4203721|NCT00740727|4027020|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4203722|NCT00740727|4027020|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203723|NCT00740714|4027026|B4|Canada||Region of Enrollment||participants|Number|90|90.0||||||
4203724|NCT00740714|4027027|B3|Canada||Region of Enrollment||participants|Number|29|29.0||||||
4203725|NCT00740714|4027028|B2|Canada||Region of Enrollment||participants|Number|30|30.0||||||
4203726|NCT00740714|4027029|B1|Canada||Region of Enrollment||participants|Number|31|31.0||||||
4203727|NCT00740714|4027026|B4|United States||Region of Enrollment||participants|Number|510|510.0||||||
4203728|NCT00740714|4027027|B3|United States||Region of Enrollment||participants|Number|174|174.0||||||
4203729|NCT00740714|4027028|B2|United States||Region of Enrollment||participants|Number|171|171.0||||||
4203730|NCT00740714|4027029|B1|United States||Region of Enrollment||participants|Number|165|165.0||||||
4203731|NCT00740714|4027026|B4||Male|Sex: Female, Male||Participants|Count of Participants|397|397.0||||||
4203732|NCT00740714|4027027|B3||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4203733|NCT00740714|4027028|B2||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4203734|NCT00740714|4027029|B1||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4203735|NCT00740714|4027026|B4||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4203736|NCT00740714|4027027|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4203737|NCT00740714|4027028|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4203738|NCT00740714|4027029|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4203739|NCT00740714|4027026|B4|||Age||years|Mean|62.5|62.5|Standard Deviation|10.03|10.03|||
4203740|NCT00740714|4027027|B3|||Age||years|Mean|61.3|61.3|Standard Deviation|10.5|10.5|||
4203741|NCT00740714|4027028|B2|||Age||years|Mean|63.3|63.3|Standard Deviation|9.83|9.83|||
4203742|NCT00740714|4027029|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|9.66|9.66|||
4203743|NCT00740714|4027026|B4||>=65 years|Age||Participants|Count of Participants|241|241.0||||||
4203744|NCT00740714|4027027|B3||>=65 years|Age||Participants|Count of Participants|70|70.0||||||
4203745|NCT00740714|4027028|B2||>=65 years|Age||Participants|Count of Participants|88|88.0||||||
4203746|NCT00740714|4027029|B1||>=65 years|Age||Participants|Count of Participants|83|83.0||||||
4203747|NCT00740714|4027026|B4||Between 18 and 65 years|Age||Participants|Count of Participants|359|359.0||||||
4203748|NCT00740714|4027027|B3||Between 18 and 65 years|Age||Participants|Count of Participants|133|133.0||||||
4203749|NCT00740714|4027028|B2||Between 18 and 65 years|Age||Participants|Count of Participants|113|113.0||||||
4203750|NCT00740714|4027029|B1||Between 18 and 65 years|Age||Participants|Count of Participants|113|113.0||||||
4203751|NCT00740714|4027026|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203752|NCT00740714|4027027|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203753|NCT00740714|4027028|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203754|NCT00740714|4027029|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203755|NCT00740636|4027105|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4203756|NCT00740636|4027106|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4203757|NCT00740636|4027107|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4203758|NCT00740636|4027105|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4203759|NCT00740636|4027106|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4203760|NCT00740636|4027107|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4203761|NCT00740636|4027105|B3||>=65 years|Age||Participants|Count of Participants|56|56.0||||||
4203762|NCT00740636|4027106|B2||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
4203763|NCT00740636|4027107|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4203764|NCT00740636|4027105|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4203765|NCT00740636|4027106|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4203766|NCT00740636|4027107|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4203767|NCT00740636|4027105|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203768|NCT00740636|4027106|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203769|NCT00740636|4027107|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203770|NCT00740597|4027114|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4203771|NCT00740597|4027114|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4203772|NCT00740597|4027114|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4203773|NCT00740597|4027114|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4203774|NCT00740597|4027114|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203775|NCT00740584|4027118|B1|Australia||Region of Enrollment||participants|Number|12|12.0||||||
4203776|NCT00740584|4027118|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4203777|NCT00740584|4027118|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4203778|NCT00740584|4027118|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4203779|NCT00740584|4027118|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4203780|NCT00740584|4027118|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203781|NCT00740480|4027123|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4203782|NCT00740480|4027123|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4203783|NCT00740480|4027123|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4203784|NCT00740480|4027123|B1|||Age||years|Mean|39.9|39.9|Standard Deviation|13.7|13.7|||
4203785|NCT00740480|4027123|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4203786|NCT00740480|4027123|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4203787|NCT00740480|4027123|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203788|NCT00740220|4027127|B1|United States||Region of Enrollment||participants|Number|97|97.0||||||
4203789|NCT00740220|4027127|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4203790|NCT00740220|4027127|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4203791|NCT00740220|4027127|B1|||Age||years|Mean|70|70.0|Standard Deviation|11|11.0|||
4203792|NCT00740220|4027127|B1||>=65 years|Age||Participants|Count of Participants|52|52.0||||||
4203793|NCT00740220|4027127|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4203794|NCT00740220|4027127|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203795|NCT00740207|4027131|B3|Canada||Region of Enrollment||participants|Number|20|20.0||||||
4203796|NCT00740207|4027132|B2|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4203797|NCT00740207|4027133|B1|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4203798|NCT00740207|4027131|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4203799|NCT00740207|4027132|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4203800|NCT00740207|4027133|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4203801|NCT00740207|4027131|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4203802|NCT00740207|4027132|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4203803|NCT00740207|4027133|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4203804|NCT00740207|4027131|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4203805|NCT00740207|4027132|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4203806|NCT00740207|4027133|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4203807|NCT00740207|4027131|B3|||Age||years|Mean|66.4|66.4|Standard Deviation|9.53|9.53|||
4203808|NCT00740207|4027132|B2|||Age||years|Mean|66.9|66.9|Standard Deviation|9.93|9.93|||
4203809|NCT00740207|4027133|B1|||Age||years|Mean|65.9|65.9|Standard Deviation|9.42|9.42|||
4203810|NCT00740207|4027131|B3||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4203811|NCT00740207|4027132|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4203812|NCT00740207|4027133|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4203813|NCT00740207|4027131|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4203814|NCT00740207|4027132|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4203815|NCT00740207|4027133|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4203816|NCT00740207|4027131|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203817|NCT00740207|4027132|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203818|NCT00740207|4027133|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203819|NCT00740181|4027146|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4203820|NCT00740181|4027146|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4203821|NCT00740181|4027146|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4203822|NCT00740181|4027146|B1|||Age||years|Mean|73|73.0|Standard Deviation|5|5.0|||
4203823|NCT00740181|4027146|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4203824|NCT00740181|4027146|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4203825|NCT00740181|4027146|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203826|NCT00740051|4027150|B3|||Fasting blood plasma (FPG) glucose|Baseline fasting blood plasma glucose was determined for the Full Analysis Set with a total of 73 patients treated with Placebo and 147 patients treated with Linagliptin (220 in total).|mg/dL|Mean|182.4|182.4|Standard Deviation|45.8|45.8|||
4203827|NCT00740051|4027151|B2|||Fasting blood plasma (FPG) glucose|Baseline fasting blood plasma glucose was determined for the Full Analysis Set with a total of 73 patients treated with Placebo and 147 patients treated with Linagliptin (220 in total).|mg/dL|Mean|183.3|183.3|Standard Deviation|46.4|46.4|||
4203828|NCT00740051|4027152|B1|||Fasting blood plasma (FPG) glucose|Baseline fasting blood plasma glucose was determined for the Full Analysis Set with a total of 73 patients treated with Placebo and 147 patients treated with Linagliptin (220 in total).|mg/dL|Mean|180.5|180.5|Standard Deviation|44.7|44.7|||
4203829|NCT00740051|4027150|B3|||Glycosylated hemoglobin (HbA1c) - Interim Analysis|Baseline HbA1c was determined for the Full Analysis Set with a total of 73 patients treated with Placebo and 147 patients treated with Linagliptin (220 in total).|percent|Mean|8.09|8.09|Standard Deviation|0.93|0.93|||
4203830|NCT00740051|4027151|B2|||Glycosylated hemoglobin (HbA1c) - Interim Analysis|Baseline HbA1c was determined for the Full Analysis Set with a total of 73 patients treated with Placebo and 147 patients treated with Linagliptin (220 in total).|percent|Mean|8.11|8.11|Standard Deviation|0.95|0.95|||
4203831|NCT00740051|4027152|B1|||Glycosylated hemoglobin (HbA1c) - Interim Analysis|Baseline HbA1c was determined for the Full Analysis Set with a total of 73 patients treated with Placebo and 147 patients treated with Linagliptin (220 in total).|percent|Mean|8.06|8.06|Standard Deviation|0.89|0.89|||
4203832|NCT00740051|4027150|B3|||Body Mass Index (BMI) continuous||kg/m^2|Mean|29.46|29.46|Standard Deviation|5.42|5.42|||
4203833|NCT00740051|4027151|B2|||Body Mass Index (BMI) continuous||kg/m^2|Mean|29.09|29.09|Standard Deviation|5.62|5.62|||
4203834|NCT00740051|4027152|B1|||Body Mass Index (BMI) continuous||kg/m^2|Mean|30.19|30.19|Standard Deviation|4.97|4.97|||
4203835|NCT00740051|4027150|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4203836|NCT00740051|4027151|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4203837|NCT00740051|4027152|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4203838|NCT00740051|4027150|B3||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4203839|NCT00740051|4027151|B2||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4203840|NCT00740051|4027152|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4203841|NCT00740051|4027150|B3|||Age||Years|Mean|56.5|56.5|Standard Deviation|10.3|10.3|||
4203842|NCT00740051|4027151|B2|||Age||Years|Mean|56.4|56.4|Standard Deviation|10.6|10.6|||
4203843|NCT00740051|4027152|B1|||Age||Years|Mean|56.7|56.7|Standard Deviation|9.7|9.7|||
4203844|NCT00739999|4027173|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4203845|NCT00739999|4027174|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4203846|NCT00739999|4027175|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4203847|NCT00739999|4027173|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4203848|NCT00739999|4027174|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4203849|NCT00739999|4027175|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4203850|NCT00739999|4027173|B3|15-17 years||Age, Customized||participants|Number|7|7.0||||||
4203851|NCT00739999|4027174|B2|15-17 years||Age, Customized||participants|Number|7|7.0||||||
4203852|NCT00739999|4027175|B1|15-17 years||Age, Customized||participants|Number|0|0.0||||||
4203853|NCT00739999|4027173|B3|11-14 years||Age, Customized||participants|Number|16|16.0||||||
4203854|NCT00739999|4027174|B2|11-14 years||Age, Customized||participants|Number|14|14.0||||||
4203855|NCT00739999|4027175|B1|11-14 years||Age, Customized||participants|Number|2|2.0||||||
4203856|NCT00739999|4027173|B3|9-10 years||Age, Customized||participants|Number|9|9.0||||||
4203857|NCT00739999|4027174|B2|9-10 years||Age, Customized||participants|Number|3|3.0||||||
4203858|NCT00739999|4027175|B1|9-10 years||Age, Customized||participants|Number|6|6.0||||||
4203859|NCT00739999|4027173|B3|6-8 years||Age, Customized||participants|Number|7|7.0||||||
4203860|NCT00739999|4027174|B2|6-8 years||Age, Customized||participants|Number|0|0.0||||||
4203861|NCT00739999|4027175|B1|6-8 years||Age, Customized||participants|Number|7|7.0||||||
4203862|NCT00739973|4027247|B10||Male|Sex: Female, Male||Participants|Count of Participants|858|858.0||||||
4203863|NCT00739973|4027248|B9||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4203864|NCT00739973|4027249|B8||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4203865|NCT00739973|4027250|B7||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4203866|NCT00739973|4027251|B6||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4203867|NCT00739973|4027252|B5||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4203868|NCT00739973|4027253|B4||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4203869|NCT00739973|4027254|B3||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4203870|NCT00739973|4027255|B2||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4203871|NCT00739973|4027256|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4203872|NCT00739973|4027247|B10||Female|Sex: Female, Male||Participants|Count of Participants|830|830.0||||||
4203873|NCT00739973|4027248|B9||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4203874|NCT00739973|4027249|B8||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4203875|NCT00739973|4027250|B7||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4203876|NCT00739973|4027251|B6||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4203877|NCT00739973|4027252|B5||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4203878|NCT00739973|4027253|B4||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4203879|NCT00739973|4027254|B3||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4203880|NCT00739973|4027255|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4203881|NCT00739973|4027256|B1||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4203882|NCT00739973|4027247|B10|||Age||years|Mean|54.1|54.1|Standard Deviation|10.65|10.65|||
4203883|NCT00739973|4027248|B9|||Age||years|Mean|54.4|54.4|Standard Deviation|10.86|10.86|||
4203884|NCT00739973|4027249|B8|||Age||years|Mean|54.8|54.8|Standard Deviation|10.29|10.29|||
4203885|NCT00739973|4027250|B7|||Age||years|Mean|53.0|53.0|Standard Deviation|10.59|10.59|||
4203886|NCT00739973|4027251|B6|||Age||years|Mean|53.9|53.9|Standard Deviation|10.82|10.82|||
4203887|NCT00739973|4027252|B5|||Age||years|Mean|55.0|55.0|Standard Deviation|10.34|10.34|||
4203888|NCT00739973|4027253|B4|||Age||years|Mean|54.2|54.2|Standard Deviation|11.61|11.61|||
4203889|NCT00739973|4027254|B3|||Age||years|Mean|54.0|54.0|Standard Deviation|9.99|9.99|||
4203890|NCT00739973|4027255|B2|||Age||years|Mean|54.3|54.3|Standard Deviation|11.07|11.07|||
4203891|NCT00739973|4027256|B1|||Age||years|Mean|53.7|53.7|Standard Deviation|10.32|10.32|||
4203892|NCT00739934|4027350|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4203893|NCT00739934|4027350|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4203894|NCT00739934|4027350|B1|6 to <12 years||Age, Customized||Participants|Number|16|16.0||||||
4203895|NCT00739934|4027350|B1|2 to <6 years||Age, Customized||Participants|Number|24|24.0||||||
4203896|NCT00739908|4027370|B3|United States||Region of Enrollment||participants|Number|285|285.0||||||
4203897|NCT00739908|4027371|B2|United States||Region of Enrollment||participants|Number|143|143.0||||||
4203898|NCT00739908|4027372|B1|United States||Region of Enrollment||participants|Number|142|142.0||||||
4203899|NCT00739908|4027370|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4203900|NCT00739908|4027371|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4203901|NCT00739908|4027372|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4203902|NCT00739908|4027370|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203903|NCT00739908|4027371|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203904|NCT00739908|4027372|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203905|NCT00739908|4027370|B3||White|Race (NIH/OMB)||Participants|Count of Participants|207|207.0||||||
4203906|NCT00739908|4027371|B2||White|Race (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
4203907|NCT00739908|4027372|B1||White|Race (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
4203908|NCT00739908|4027370|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4203909|NCT00739908|4027371|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4203910|NCT00739908|4027372|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4203911|NCT00739908|4027370|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203912|NCT00739908|4027371|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203913|NCT00739908|4027372|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203914|NCT00739908|4027370|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4203915|NCT00739908|4027371|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4203916|NCT00739908|4027372|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4203917|NCT00739908|4027370|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4203918|NCT00739908|4027371|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4203919|NCT00739908|4027372|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4203920|NCT00739908|4027370|B3||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4203921|NCT00739908|4027371|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4203922|NCT00739908|4027372|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4203923|NCT00739908|4027370|B3||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4203924|NCT00739908|4027371|B2||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4203925|NCT00739908|4027372|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4203926|NCT00739908|4027370|B3|||Age||years|Mean|38.8|38.8|Standard Deviation|11.14|11.14|||
4203927|NCT00739908|4027371|B2|||Age||years|Mean|38.5|38.5|Standard Deviation|11.16|11.16|||
4203928|NCT00739908|4027372|B1|||Age||years|Mean|39.1|39.1|Standard Deviation|11.14|11.14|||
4203929|NCT00739908|4027370|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4203930|NCT00739908|4027371|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4203931|NCT00739908|4027372|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4203932|NCT00739908|4027370|B3||Between 18 and 65 years|Age||Participants|Count of Participants|280|280.0||||||
4203933|NCT00739908|4027371|B2||Between 18 and 65 years|Age||Participants|Count of Participants|138|138.0||||||
4203934|NCT00739908|4027372|B1||Between 18 and 65 years|Age||Participants|Count of Participants|142|142.0||||||
4203935|NCT00739908|4027370|B3||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4203936|NCT00739908|4027371|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4203937|NCT00739908|4027372|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4203938|NCT00739882|4027391|B3|Turkey||Region of Enrollment||participants|Number|13|13.0||||||
4203939|NCT00739882|4027392|B2|Turkey||Region of Enrollment||participants|Number|4|4.0||||||
4203940|NCT00739882|4027393|B1|Turkey||Region of Enrollment||participants|Number|9|9.0||||||
4203941|NCT00739882|4027391|B3|Spain||Region of Enrollment||participants|Number|11|11.0||||||
4203942|NCT00739882|4027392|B2|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4203943|NCT00739882|4027393|B1|Spain||Region of Enrollment||participants|Number|7|7.0||||||
4203944|NCT00739882|4027391|B3|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
4203945|NCT00739882|4027392|B2|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
4203946|NCT00739882|4027393|B1|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4203947|NCT00739882|4027391|B3|Italy||Region of Enrollment||participants|Number|4|4.0||||||
4203948|NCT00739882|4027392|B2|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4203949|NCT00739882|4027393|B1|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4203950|NCT00739882|4027391|B3|Germany||Region of Enrollment||participants|Number|18|18.0||||||
4203951|NCT00739882|4027392|B2|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4203952|NCT00739882|4027393|B1|Germany||Region of Enrollment||participants|Number|14|14.0||||||
4203953|NCT00739882|4027391|B3|France||Region of Enrollment||participants|Number|13|13.0||||||
4203954|NCT00739882|4027392|B2|France||Region of Enrollment||participants|Number|5|5.0||||||
4203955|NCT00739882|4027393|B1|France||Region of Enrollment||participants|Number|8|8.0||||||
4203956|NCT00739882|4027391|B3|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
4203957|NCT00739882|4027392|B2|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
4203958|NCT00739882|4027393|B1|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
4203959|NCT00739882|4027391|B3|Austria||Region of Enrollment||participants|Number|11|11.0||||||
4203960|NCT00739882|4027392|B2|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4203961|NCT00739882|4027393|B1|Austria||Region of Enrollment||participants|Number|7|7.0||||||
4203962|NCT00739882|4027391|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4203963|NCT00739882|4027392|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4203964|NCT00739882|4027393|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4203965|NCT00739882|4027391|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4203966|NCT00739882|4027392|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4203967|NCT00739882|4027393|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4203968|NCT00739882|4027391|B3|||Age||years|Mean|49.9|49.9|Standard Deviation|13.1|13.1|||
4203969|NCT00739882|4027392|B2|||Age||years|Mean|51.7|51.7|Standard Deviation|12.9|12.9|||
4203970|NCT00739882|4027393|B1|||Age||years|Mean|49.0|49.0|Standard Deviation|13.3|13.3|||
4203971|NCT00739882|4027391|B3|>64 years||Age, Customized||participants|Number|10|10.0||||||
4203972|NCT00739882|4027392|B2|>64 years||Age, Customized||participants|Number|4|4.0||||||
4203973|NCT00739882|4027393|B1|>64 years||Age, Customized||participants|Number|6|6.0||||||
4203974|NCT00739882|4027391|B3|41-64 years||Age, Customized||participants|Number|46|46.0||||||
4203975|NCT00739882|4027392|B2|41-64 years||Age, Customized||participants|Number|17|17.0||||||
4203976|NCT00739882|4027393|B1|41-64 years||Age, Customized||participants|Number|29|29.0||||||
4203977|NCT00739882|4027391|B3|18-40 years||Age, Customized||participants|Number|20|20.0||||||
4203978|NCT00739882|4027392|B2|18-40 years||Age, Customized||participants|Number|4|4.0||||||
4203979|NCT00739882|4027393|B1|18-40 years||Age, Customized||participants|Number|16|16.0||||||
4203980|NCT00739765|4027412|B4|United States||Region of Enrollment||participants|Number|110|110.0||||||
4203981|NCT00739765|4027413|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4203982|NCT00739765|4027414|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
4203983|NCT00739765|4027415|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4203984|NCT00739765|4027412|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203985|NCT00739765|4027413|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203986|NCT00739765|4027414|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203987|NCT00739765|4027415|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4203988|NCT00739765|4027412|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4203989|NCT00739765|4027413|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4203990|NCT00739765|4027414|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4203991|NCT00739765|4027415|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4203992|NCT00739765|4027412|B4||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4203993|NCT00739765|4027413|B3||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4203994|NCT00739765|4027414|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4203995|NCT00739765|4027415|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4203996|NCT00739765|4027412|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4203997|NCT00739765|4027413|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4203998|NCT00739765|4027414|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4203999|NCT00739765|4027415|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4204000|NCT00739765|4027412|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204001|NCT00739765|4027413|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204002|NCT00739765|4027414|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204003|NCT00739765|4027415|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204004|NCT00739765|4027412|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4204005|NCT00739765|4027413|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4204006|NCT00739765|4027414|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4204007|NCT00739765|4027415|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4204008|NCT00739765|4027412|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204009|NCT00739765|4027413|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204010|NCT00739765|4027414|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204011|NCT00739765|4027415|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204012|NCT00739765|4027412|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204013|NCT00739765|4027413|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204014|NCT00739765|4027414|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204015|NCT00739765|4027415|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204016|NCT00739765|4027412|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
4204017|NCT00739765|4027413|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4204018|NCT00739765|4027414|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4204019|NCT00739765|4027415|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4204020|NCT00739765|4027412|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4204021|NCT00739765|4027413|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4204022|NCT00739765|4027414|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4204023|NCT00739765|4027415|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4204024|NCT00739765|4027412|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4204025|NCT00739765|4027413|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4204026|NCT00739765|4027414|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4204027|NCT00739765|4027415|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4204028|NCT00739765|4027412|B4||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4204029|NCT00739765|4027413|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4204030|NCT00739765|4027414|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4204031|NCT00739765|4027415|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4204032|NCT00739765|4027412|B4|||Age||Years|Mean|40.10|40.1|Standard Deviation|11.57|11.57|||
4204033|NCT00739765|4027413|B3|||Age||Years|Mean|40.62|40.62|Standard Deviation|11.48|11.48|||
4204034|NCT00739765|4027414|B2|||Age||Years|Mean|41.76|41.76|Standard Deviation|11.99|11.99|||
4204035|NCT00739765|4027415|B1|||Age||Years|Mean|38.12|38.12|Standard Deviation|11.21|11.21|||
4204036|NCT00739752|4027428|B7|United States||Region of Enrollment||Participants|Count of Participants|1747|1747.0||||||
4204037|NCT00739752|4027429|B6|United States||Region of Enrollment||Participants|Count of Participants|293|293.0||||||
4204038|NCT00739752|4027430|B5|United States||Region of Enrollment||Participants|Count of Participants|291|291.0||||||
4204039|NCT00739752|4027431|B4|United States||Region of Enrollment||Participants|Count of Participants|288|288.0||||||
4204040|NCT00739752|4027432|B3|United States||Region of Enrollment||Participants|Count of Participants|292|292.0||||||
4204041|NCT00739752|4027433|B2|United States||Region of Enrollment||Participants|Count of Participants|284|284.0||||||
4204042|NCT00739752|4027434|B1|United States||Region of Enrollment||Participants|Count of Participants|299|299.0||||||
4204043|NCT00739752|4027428|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4204044|NCT00739752|4027429|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4204045|NCT00739752|4027430|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4204046|NCT00739752|4027431|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4204047|NCT00739752|4027432|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4204048|NCT00739752|4027433|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4204049|NCT00739752|4027434|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4204050|NCT00739752|4027428|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4204051|NCT00739752|4027429|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4204052|NCT00739752|4027430|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4204053|NCT00739752|4027431|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4204054|NCT00739752|4027432|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4204055|NCT00739752|4027433|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4204056|NCT00739752|4027434|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4204057|NCT00739752|4027428|B7||White|Race (NIH/OMB)||Participants|Count of Participants|224|224.0||||||
4204058|NCT00739752|4027429|B6||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4204059|NCT00739752|4027430|B5||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4204060|NCT00739752|4027431|B4||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4204061|NCT00739752|4027432|B3||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4204062|NCT00739752|4027433|B2||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4204063|NCT00739752|4027434|B1||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4204064|NCT00739752|4027428|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1426|1426.0||||||
4204065|NCT00739752|4027429|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|233|233.0||||||
4204066|NCT00739752|4027430|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|236|236.0||||||
4204067|NCT00739752|4027431|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|233|233.0||||||
4204068|NCT00739752|4027432|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|239|239.0||||||
4204069|NCT00739752|4027433|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|233|233.0||||||
4204070|NCT00739752|4027434|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|252|252.0||||||
4204071|NCT00739752|4027428|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4204072|NCT00739752|4027429|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204073|NCT00739752|4027430|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204074|NCT00739752|4027431|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4204075|NCT00739752|4027432|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204076|NCT00739752|4027433|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204077|NCT00739752|4027434|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204078|NCT00739752|4027428|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4204079|NCT00739752|4027429|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4204080|NCT00739752|4027430|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4204081|NCT00739752|4027431|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204082|NCT00739752|4027432|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4204083|NCT00739752|4027433|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4204084|NCT00739752|4027434|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204085|NCT00739752|4027428|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4204086|NCT00739752|4027429|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204087|NCT00739752|4027430|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204088|NCT00739752|4027431|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204089|NCT00739752|4027432|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204090|NCT00739752|4027433|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204091|NCT00739752|4027434|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4204092|NCT00739752|4027428|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4204093|NCT00739752|4027429|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4204094|NCT00739752|4027430|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4204095|NCT00739752|4027431|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4204096|NCT00739752|4027432|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4204097|NCT00739752|4027433|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4204098|NCT00739752|4027434|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4204099|NCT00739752|4027428|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1669|1669.0||||||
4204100|NCT00739752|4027429|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|278|278.0||||||
4204101|NCT00739752|4027430|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|282|282.0||||||
4204102|NCT00739752|4027431|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|275|275.0||||||
4204103|NCT00739752|4027432|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|278|278.0||||||
4204104|NCT00739752|4027433|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|272|272.0||||||
4204105|NCT00739752|4027434|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|284|284.0||||||
4204106|NCT00739752|4027428|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4204107|NCT00739752|4027429|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4204108|NCT00739752|4027430|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4204109|NCT00739752|4027431|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4204110|NCT00739752|4027432|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4204111|NCT00739752|4027433|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4204112|NCT00739752|4027434|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4204113|NCT00739752|4027428|B7||Male|Sex: Female, Male||Participants|Count of Participants|693|693.0||||||
4204114|NCT00739752|4027429|B6||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4204115|NCT00739752|4027430|B5||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4204116|NCT00739752|4027431|B4||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4204117|NCT00739752|4027432|B3||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4204118|NCT00739752|4027433|B2||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4204119|NCT00739752|4027434|B1||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4204120|NCT00739752|4027428|B7||Female|Sex: Female, Male||Participants|Count of Participants|1054|1054.0||||||
4204121|NCT00739752|4027429|B6||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4204122|NCT00739752|4027430|B5||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4204123|NCT00739752|4027431|B4||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4204124|NCT00739752|4027432|B3||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4204125|NCT00739752|4027433|B2||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4204126|NCT00739752|4027434|B1||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4204127|NCT00739752|4027428|B7|||Age||Years|Mean|31.7|31.7|Standard Deviation|9.9|9.9|||
4204128|NCT00739752|4027429|B6|||Age||Years|Mean|32.3|32.3|Standard Deviation|10.6|10.6|||
4204129|NCT00739752|4027430|B5|||Age||Years|Mean|32.1|32.1|Standard Deviation|10.1|10.1|||
4204130|NCT00739752|4027431|B4|||Age||Years|Mean|31.7|31.7|Standard Deviation|9.4|9.4|||
4204131|NCT00739752|4027432|B3|||Age||Years|Mean|31.2|31.2|Standard Deviation|9.8|9.8|||
4204132|NCT00739752|4027433|B2|||Age||Years|Mean|31.8|31.8|Standard Deviation|9.8|9.8|||
4204133|NCT00739752|4027434|B1|||Age||Years|Mean|31.2|31.2|Standard Deviation|9.7|9.7|||
4204134|NCT00739674|4027453|B3|||Weight||Kilograms|Mean|87.16|87.16|Standard Deviation|20.13|20.13|||
4204135|NCT00739674|4027454|B2|||Weight||Kilograms|Mean|89.17|89.17|Standard Deviation|20.18|20.18|||
4204136|NCT00739674|4027455|B1|||Weight||Kilograms|Mean|85.41|85.41|Standard Deviation|19.95|19.95|||
4204137|NCT00739674|4027453|B3|||Systolic Blood Pressure||mm Hg|Mean|151.17|151.17|Standard Deviation|11.64|11.64|||
4204138|NCT00739674|4027454|B2|||Systolic Blood Pressure||mm Hg|Mean|151.11|151.11|Standard Deviation|12.55|12.55|||
4204139|NCT00739674|4027455|B1|||Systolic Blood Pressure||mm Hg|Mean|151.23|151.23|Standard Deviation|10.80|10.8|||
4204140|NCT00739674|4027453|B3|||Diastolic Blood Pressure||mm Hg|Mean|91.02|91.02|Standard Deviation|9.57|9.57|||
4204141|NCT00739674|4027454|B2|||Diastolic Blood Pressure||mm Hg|Mean|91.43|91.43|Standard Deviation|9.98|9.98|||
4204142|NCT00739674|4027455|B1|||Diastolic Blood Pressure||mm Hg|Mean|90.67|90.67|Standard Deviation|9.19|9.19|||
4204143|NCT00739674|4027453|B3|Missing||Cardiovascular Risk|Cardiovascular Risk according to Framingham Equation|Participants|Number|8|8.0||||||
4204144|NCT00739674|4027454|B2|Missing||Cardiovascular Risk|Cardiovascular Risk according to Framingham Equation|Participants|Number|4|4.0||||||
4204145|NCT00739674|4027455|B1|Missing||Cardiovascular Risk|Cardiovascular Risk according to Framingham Equation|Participants|Number|4|4.0||||||
4204146|NCT00739674|4027453|B3|Not Available||Cardiovascular Risk|Cardiovascular Risk according to Framingham Equation|Participants|Number|62|62.0||||||
4204147|NCT00739674|4027454|B2|Not Available||Cardiovascular Risk|Cardiovascular Risk according to Framingham Equation|Participants|Number|27|27.0||||||
4204148|NCT00739674|4027455|B1|Not Available||Cardiovascular Risk|Cardiovascular Risk according to Framingham Equation|Participants|Number|35|35.0||||||
4204149|NCT00739674|4027453|B3|Low||Cardiovascular Risk|Cardiovascular Risk according to Framingham Equation|Participants|Number|434|434.0||||||
4204150|NCT00739674|4027454|B2|Low||Cardiovascular Risk|Cardiovascular Risk according to Framingham Equation|Participants|Number|216|216.0||||||
4204151|NCT00739674|4027455|B1|Low||Cardiovascular Risk|Cardiovascular Risk according to Framingham Equation|Participants|Number|218|218.0||||||
4204152|NCT00739674|4027453|B3|Medium||Cardiovascular Risk|Cardiovascular Risk according to Framingham Equation|Participants|Number|155|155.0||||||
4204153|NCT00739674|4027454|B2|Medium||Cardiovascular Risk|Cardiovascular Risk according to Framingham Equation|Participants|Number|61|61.0||||||
4204154|NCT00739674|4027455|B1|Medium||Cardiovascular Risk|Cardiovascular Risk according to Framingham Equation|Participants|Number|94|94.0||||||
4204155|NCT00739674|4027453|B3|High||Cardiovascular Risk|Cardiovascular Risk according to Framingham Equation|Participants|Number|204|204.0||||||
4204156|NCT00739674|4027454|B2|High||Cardiovascular Risk|Cardiovascular Risk according to Framingham Equation|Participants|Number|92|92.0||||||
4204157|NCT00739674|4027455|B1|High||Cardiovascular Risk|Cardiovascular Risk according to Framingham Equation|Participants|Number|112|112.0||||||
4204158|NCT00739674|4027453|B3|Other||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4204159|NCT00739674|4027454|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4204160|NCT00739674|4027455|B1|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4204161|NCT00739674|4027453|B3|Native Indian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4204162|NCT00739674|4027454|B2|Native Indian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4204163|NCT00739674|4027455|B1|Native Indian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4204164|NCT00739674|4027453|B3|Asian||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
4204165|NCT00739674|4027454|B2|Asian||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4204166|NCT00739674|4027455|B1|Asian||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4204167|NCT00739674|4027453|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4204168|NCT00739674|4027454|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4204169|NCT00739674|4027455|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4204170|NCT00739674|4027453|B3|Black||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4204171|NCT00739674|4027454|B2|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4204172|NCT00739674|4027455|B1|Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4204173|NCT00739674|4027453|B3|White||Race/Ethnicity, Customized||participants|Number|773|773.0||||||
4204174|NCT00739674|4027454|B2|White||Race/Ethnicity, Customized||participants|Number|369|369.0||||||
4204175|NCT00739674|4027455|B1|White||Race/Ethnicity, Customized||participants|Number|404|404.0||||||
4204176|NCT00739674|4027453|B3||Male|Sex: Female, Male||Participants|Count of Participants|416|416.0||||||
4204177|NCT00739674|4027454|B2||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4204178|NCT00739674|4027455|B1||Male|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
4204179|NCT00739674|4027453|B3||Female|Sex: Female, Male||Participants|Count of Participants|447|447.0||||||
4204180|NCT00739674|4027454|B2||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4204181|NCT00739674|4027455|B1||Female|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
4204182|NCT00739674|4027453|B3|||Age||years|Mean|55.38|55.38|Standard Deviation|11.76|11.76|||
4204183|NCT00739674|4027454|B2|||Age||years|Mean|54.59|54.59|Standard Deviation|11.98|11.98|||
4204184|NCT00739674|4027455|B1|||Age||years|Mean|56.05|56.05|Standard Deviation|11.54|11.54|||
4204185|NCT00739661|4027482|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4204186|NCT00739661|4027483|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4204187|NCT00739661|4027484|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4204188|NCT00739661|4027482|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4204189|NCT00739661|4027483|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4204190|NCT00739661|4027484|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4204191|NCT00739661|4027482|B3|||Age||years|Mean|57.9|57.9|Standard Deviation|9.6|9.6|||
4204192|NCT00739661|4027483|B2|||Age||years|Mean|58.6|58.6|Standard Deviation|8.9|8.9|||
4204193|NCT00739661|4027484|B1|||Age||years|Mean|57.3|57.3|Standard Deviation|10.2|10.2|||
4204194|NCT00739648|4027495|B3||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4204195|NCT00739648|4027496|B2||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4204196|NCT00739648|4027497|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4204197|NCT00739648|4027495|B3||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4204198|NCT00739648|4027496|B2||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4204199|NCT00739648|4027497|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4204200|NCT00739648|4027495|B3|||Age||years|Mean|63.8|63.8|Standard Deviation|9.10|9.1|||
4204201|NCT00739648|4027496|B2|||Age||years|Mean|64.0|64.0|Standard Deviation|9.14|9.14|||
4204202|NCT00739648|4027497|B1|||Age||years|Mean|63.4|63.4|Standard Deviation|9.06|9.06|||
4204203|NCT00739596|4027510|B3||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4204204|NCT00739596|4027511|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4204205|NCT00739596|4027512|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4204206|NCT00739596|4027510|B3||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4204207|NCT00739596|4027511|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4204208|NCT00739596|4027512|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4204209|NCT00739596|4027510|B3|||Age||years|Mean|52.6|52.6|Standard Deviation|11.41|11.41|||
4204210|NCT00739596|4027511|B2|||Age||years|Mean|53.1|53.1|Standard Deviation|11.56|11.56|||
4204211|NCT00739596|4027512|B1|||Age||years|Mean|52.0|52.0|Standard Deviation|11.27|11.27|||
4204212|NCT00739596|4027510|B3|≥ 65 years||Age, Customized||participants|Number|48|48.0||||||
4204213|NCT00739596|4027511|B2|≥ 65 years||Age, Customized||participants|Number|23|23.0||||||
4204214|NCT00739596|4027512|B1|≥ 65 years||Age, Customized||participants|Number|25|25.0||||||
4204215|NCT00739596|4027510|B3|< 65 years||Age, Customized||participants|Number|284|284.0||||||
4204216|NCT00739596|4027511|B2|< 65 years||Age, Customized||participants|Number|143|143.0||||||
4204217|NCT00739596|4027512|B1|< 65 years||Age, Customized||participants|Number|141|141.0||||||
4204218|NCT00739583|4027527|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4204219|NCT00739583|4027528|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4204220|NCT00739583|4027529|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4204221|NCT00739583|4027527|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4204222|NCT00739583|4027528|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4204223|NCT00739583|4027529|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4204224|NCT00739583|4027527|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4204225|NCT00739583|4027528|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4204226|NCT00739583|4027529|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4204227|NCT00739583|4027527|B3|||Age||years|Mean|72|72.0|Standard Deviation|4.5|4.5|||
4204228|NCT00739583|4027528|B2|||Age||years|Mean|73|73.0|Standard Deviation|4.2|4.2|||
4204229|NCT00739583|4027529|B1|||Age||years|Mean|71|71.0|Standard Deviation|4.6|4.6|||
4204230|NCT00739583|4027527|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4204231|NCT00739583|4027528|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4204232|NCT00739583|4027529|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4204233|NCT00739583|4027527|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4204234|NCT00739583|4027528|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4204235|NCT00739583|4027529|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4204236|NCT00739583|4027527|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4204237|NCT00739583|4027528|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4204238|NCT00739583|4027529|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4204239|NCT00739336|4027540|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
4204240|NCT00739336|4027541|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4204241|NCT00739336|4027542|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4204242|NCT00739336|4027540|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4204243|NCT00739336|4027541|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4204244|NCT00739336|4027542|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4204245|NCT00739336|4027540|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4204246|NCT00739336|4027541|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4204247|NCT00739336|4027542|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4204248|NCT00739336|4027540|B3|||Age||years|Mean|51.2|51.2|Standard Deviation|8.0|8.0|||
4204249|NCT00739336|4027541|B2|||Age||years|Mean|51.2|51.2|Standard Deviation|6.4|6.4|||
4204250|NCT00739336|4027542|B1|||Age||years|Mean|51.1|51.1|Standard Deviation|9.6|9.6|||
4204251|NCT00739310|4027555|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4204252|NCT00739310|4027555|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4204253|NCT00739310|4027555|B1|||Age||years|Mean|9.55|9.55|Standard Deviation|5.57|5.57|||
4204254|NCT00739297|4027560|B1|||FEV1 (Forced Expiratory Volume in One Second)||L (Liter)|Mean|2.44|2.44|Standard Deviation|0.63|0.63|||
4204255|NCT00739297|4027560|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4204256|NCT00739297|4027560|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4204257|NCT00739297|4027560|B1|||Age||years|Mean|39.1|39.1|Standard Deviation|12.6|12.6|||
4204258|NCT00739102|4027594|B1|United States||Region of Enrollment||participants|Number|250|250.0||||||
4204259|NCT00739102|4027594|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4204260|NCT00739102|4027594|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4204261|NCT00739102|4027594|B1|Middle Eastern||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4204262|NCT00739102|4027594|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|214|214.0||||||
4204263|NCT00739102|4027594|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4204264|NCT00739102|4027594|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4204265|NCT00739102|4027594|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4204266|NCT00739102|4027594|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4204267|NCT00739102|4027594|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204268|NCT00739102|4027594|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|240|240.0||||||
4204269|NCT00739102|4027594|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4204270|NCT00739102|4027594|B1||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4204271|NCT00739102|4027594|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4204272|NCT00739102|4027594|B1|||Age||years|Mean|67.71|67.71|Standard Deviation|10.32|10.32|||
4204273|NCT00739102|4027594|B1||>=65 years|Age||Participants|Count of Participants|157|157.0||||||
4204274|NCT00739102|4027594|B1||Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
4204275|NCT00739102|4027594|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4204276|NCT00739063|4027610|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4204277|NCT00739063|4027610|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4204278|NCT00739063|4027610|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4204279|NCT00739063|4027610|B1|||Age||years|Mean|52|52.0|Full Range|||37.0|82.0|
4204280|NCT00739050|4027614|B1|||High Density Lipoprotein Cholesterol (HDL-C)|N=3 (Completed Participants)|mg/dL|Mean|53|53.0|Standard Deviation|10.15|10.15|||
4204281|NCT00739050|4027614|B1|||Low Density Lipoprotein Cholesterol (LDL-C)|N=3 (Completed Participants)|mg/dL|Mean|105|105.0|Standard Deviation|23.64|23.64|||
4204282|NCT00739050|4027614|B1|||Total Cholesterol|N=3 (Completed Participants)|mg/dL|Mean|176.67|176.67|Standard Deviation|28.50|28.5|||
4204283|NCT00739050|4027614|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4204284|NCT00739050|4027614|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4204285|NCT00739050|4027614|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4204286|NCT00739050|4027614|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4204287|NCT00739050|4027614|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4204288|NCT00739024|4027627|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4204289|NCT00739024|4027628|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4204290|NCT00739024|4027629|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4204291|NCT00739024|4027627|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4204292|NCT00739024|4027628|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4204293|NCT00739024|4027629|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4204294|NCT00739024|4027627|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4204295|NCT00739024|4027628|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4204296|NCT00739024|4027629|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4204297|NCT00739024|4027627|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4204298|NCT00739024|4027628|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4204299|NCT00739024|4027629|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4204300|NCT00739024|4027627|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4204301|NCT00739024|4027628|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4204302|NCT00739024|4027629|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4204303|NCT00739024|4027627|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4204304|NCT00739024|4027628|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4204305|NCT00739024|4027629|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4204306|NCT00738972|4027636|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4204307|NCT00738972|4027637|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4204308|NCT00738972|4027638|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4204309|NCT00738972|4027639|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4204310|NCT00738972|4027640|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4204311|NCT00738972|4027636|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4204312|NCT00738972|4027637|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4204313|NCT00738972|4027638|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4204314|NCT00738972|4027639|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4204315|NCT00738972|4027640|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4204316|NCT00738972|4027636|B5|>18 years||Age, Customized||participants|Number|11|11.0||||||
4204317|NCT00738972|4027637|B4|>18 years||Age, Customized||participants|Number|2|2.0||||||
4204318|NCT00738972|4027638|B3|>18 years||Age, Customized||participants|Number|3|3.0||||||
4204319|NCT00738972|4027639|B2|>18 years||Age, Customized||participants|Number|3|3.0||||||
4204320|NCT00738972|4027640|B1|>18 years||Age, Customized||participants|Number|3|3.0||||||
4204321|NCT00738894|4027653|B3|||Atrial septal aneurysm||Participants|Count of Participants|86|86.0||||||
4204322|NCT00738894|4027655|B1|||Atrial septal aneurysm||Participants|Count of Participants|86|86.0||||||
4204323|NCT00738894|4027653|B3||Large (>25 bubbles)|Patent foramen ovale shunt size||Participants|Count of Participants|261|261.0||||||
4204324|NCT00738894|4027654|B2||Large (>25 bubbles)|Patent foramen ovale shunt size||Participants|Count of Participants|79|79.0||||||
4204325|NCT00738894|4027655|B1||Large (>25 bubbles)|Patent foramen ovale shunt size||Participants|Count of Participants|182|182.0||||||
4204326|NCT00738894|4027653|B3||Moderate (6-25 bubbles)|Patent foramen ovale shunt size||Participants|Count of Participants|260|260.0||||||
4204327|NCT00738894|4027654|B2||Moderate (6-25 bubbles)|Patent foramen ovale shunt size||Participants|Count of Participants|94|94.0||||||
4204328|NCT00738894|4027655|B1||Moderate (6-25 bubbles)|Patent foramen ovale shunt size||Participants|Count of Participants|166|166.0||||||
4204329|NCT00738894|4027653|B3||Small (1-5 bubbles)|Patent foramen ovale shunt size||Participants|Count of Participants|120|120.0||||||
4204330|NCT00738894|4027654|B2||Small (1-5 bubbles)|Patent foramen ovale shunt size||Participants|Count of Participants|43|43.0||||||
4204331|NCT00738894|4027655|B1||Small (1-5 bubbles)|Patent foramen ovale shunt size||Participants|Count of Participants|77|77.0||||||
4204332|NCT00738894|4027653|B3||Stroke symptoms <24 hr, w/ imaging confirmation|Index event||Participants|Count of Participants|63|63.0||||||
4204333|NCT00738894|4027654|B2||Stroke symptoms <24 hr, w/ imaging confirmation|Index event||Participants|Count of Participants|24|24.0||||||
4204334|NCT00738894|4027655|B1||Stroke symptoms <24 hr, w/ imaging confirmation|Index event||Participants|Count of Participants|39|39.0||||||
4204335|NCT00738894|4027653|B3||Stroke w/ symptoms >=24 hr|Index event||Participants|Count of Participants|601|601.0||||||
4204336|NCT00738894|4027654|B2||Stroke w/ symptoms >=24 hr|Index event||Participants|Count of Participants|199|199.0||||||
4204337|NCT00738894|4027655|B1||Stroke w/ symptoms >=24 hr|Index event||Participants|Count of Participants|402|402.0||||||
4204338|NCT00738894|4027653|B3|Previous TIA||Stroke or TIA before index event||Participants|Count of Participants|37|37.0||||||
4204339|NCT00738894|4027654|B2|Previous TIA||Stroke or TIA before index event||Participants|Count of Participants|11|11.0||||||
4204340|NCT00738894|4027655|B1|Previous TIA||Stroke or TIA before index event||Participants|Count of Participants|26|26.0||||||
4204341|NCT00738894|4027653|B3|Previous stroke||Stroke or TIA before index event||Participants|Count of Participants|55|55.0||||||
4204342|NCT00738894|4027654|B2|Previous stroke||Stroke or TIA before index event||Participants|Count of Participants|13|13.0||||||
4204343|NCT00738894|4027655|B1|Previous stroke||Stroke or TIA before index event||Participants|Count of Participants|42|42.0||||||
4204489|NCT00738673|4027702|B2|||Height||meters|Mean|1.72|1.72|Standard Deviation|0.05|0.05|||
4204344|NCT00738894|4027653|B3|Previous either||Stroke or TIA before index event||Participants|Count of Participants|85|85.0||||||
4204345|NCT00738894|4027654|B2|Previous either||Stroke or TIA before index event||Participants|Count of Participants|23|23.0||||||
4204346|NCT00738894|4027655|B1|Previous either||Stroke or TIA before index event||Participants|Count of Participants|62|62.0||||||
4204347|NCT00738894|4027653|B3|||Diabetes mellitus||Participants|Count of Participants|28|28.0||||||
4204348|NCT00738894|4027654|B2|||Diabetes mellitus||Participants|Count of Participants|10|10.0||||||
4204349|NCT00738894|4027655|B1|||Diabetes mellitus||Participants|Count of Participants|18|18.0||||||
4204350|NCT00738894|4027653|B3|||Hypertension||Participants|Count of Participants|170|170.0||||||
4204351|NCT00738894|4027654|B2|||Hypertension||Participants|Count of Participants|58|58.0||||||
4204352|NCT00738894|4027655|B1|||Hypertension||Participants|Count of Participants|112|112.0||||||
4204353|NCT00738894|4027653|B3|||Current smoking||Participants|Count of Participants|88|88.0||||||
4204354|NCT00738894|4027654|B2|||Current smoking||Participants|Count of Participants|25|25.0||||||
4204355|NCT00738894|4027655|B1|||Current smoking||Participants|Count of Participants|63|63.0||||||
4204356|NCT00738894|4027653|B3|||Time from qualifying event to randomization||days|Mean|101|101.0|Standard Deviation|53|53.0|||
4204357|NCT00738894|4027654|B2|||Time from qualifying event to randomization||days|Mean|101|101.0|Standard Deviation|53|53.0|||
4204358|NCT00738894|4027655|B1|||Time from qualifying event to randomization||days|Mean|100|100.0|Standard Deviation|52|52.0|||
4204359|NCT00738894|4027653|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
4204360|NCT00738894|4027654|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4204361|NCT00738894|4027655|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4204362|NCT00738894|4027653|B3|Sweden||Region of Enrollment||Participants|Count of Participants|95|95.0||||||
4204363|NCT00738894|4027654|B2|Sweden||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
4204364|NCT00738894|4027655|B1|Sweden||Region of Enrollment||Participants|Count of Participants|64|64.0||||||
4204365|NCT00738894|4027653|B3|Norway||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
4204366|NCT00738894|4027654|B2|Norway||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4204367|NCT00738894|4027655|B1|Norway||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4204368|NCT00738894|4027653|B3|Finland||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
4204369|NCT00738894|4027654|B2|Finland||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4204370|NCT00738894|4027655|B1|Finland||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4204371|NCT00738894|4027653|B3|Denmark||Region of Enrollment||Participants|Count of Participants|117|117.0||||||
4204372|NCT00738894|4027654|B2|Denmark||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
4204373|NCT00738894|4027655|B1|Denmark||Region of Enrollment||Participants|Count of Participants|79|79.0||||||
4204374|NCT00738894|4027653|B3|Canada||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4204375|NCT00738894|4027654|B2|Canada||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4204376|NCT00738894|4027655|B1|Canada||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
4204377|NCT00738894|4027653|B3|United States||Region of Enrollment||Participants|Count of Participants|331|331.0||||||
4204378|NCT00738894|4027654|B2|United States||Region of Enrollment||Participants|Count of Participants|115|115.0||||||
4204379|NCT00738894|4027655|B1|United States||Region of Enrollment||Participants|Count of Participants|216|216.0||||||
4204380|NCT00738894|4027653|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4204381|NCT00738894|4027654|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4204382|NCT00738894|4027655|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4204383|NCT00738894|4027653|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4204384|NCT00738894|4027654|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4204385|NCT00738894|4027655|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4204386|NCT00738894|4027653|B3||White|Race (NIH/OMB)||Participants|Count of Participants|615|615.0||||||
4204387|NCT00738894|4027654|B2||White|Race (NIH/OMB)||Participants|Count of Participants|203|203.0||||||
4204388|NCT00738894|4027655|B1||White|Race (NIH/OMB)||Participants|Count of Participants|412|412.0||||||
4204389|NCT00738894|4027653|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4204390|NCT00738894|4027654|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4204391|NCT00738894|4027655|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4204392|NCT00738894|4027653|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204393|NCT00738894|4027654|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204394|NCT00738894|4027655|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204395|NCT00738894|4027653|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4204396|NCT00738894|4027654|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4204397|NCT00738894|4027655|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204398|NCT00738894|4027653|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4204399|NCT00738894|4027654|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204400|NCT00738894|4027655|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4204401|NCT00738894|4027653|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4204402|NCT00738894|4027654|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4204403|NCT00738894|4027655|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4204404|NCT00738894|4027653|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|626|626.0||||||
4204405|NCT00738894|4027654|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|213|213.0||||||
4204406|NCT00738894|4027655|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|413|413.0||||||
4204407|NCT00738894|4027653|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4204408|NCT00738894|4027654|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4204409|NCT00738894|4027655|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4204410|NCT00738894|4027653|B3||Male|Sex: Female, Male||Participants|Count of Participants|399|399.0||||||
4204411|NCT00738894|4027654|B2||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4204412|NCT00738894|4027655|B1||Male|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
4204413|NCT00738894|4027653|B3||Female|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
4204414|NCT00738894|4027654|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4204415|NCT00738894|4027655|B1||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4204416|NCT00738894|4027653|B3|||Age||years|Mean|45.2|45.2|Standard Deviation|9.4|9.4|||
4204417|NCT00738894|4027654|B2|||Age||years|Mean|44.8|44.8|Standard Deviation|9.6|9.6|||
4204418|NCT00738894|4027655|B1|||Age||years|Mean|45.4|45.4|Standard Deviation|9.3|9.3|||
4204419|NCT00738881|4027667|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4204420|NCT00738881|4027668|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4204421|NCT00738881|4027669|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4204422|NCT00738881|4027667|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4204423|NCT00738881|4027668|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4204424|NCT00738881|4027669|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4204425|NCT00738881|4027667|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4204426|NCT00738881|4027668|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4204427|NCT00738881|4027669|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4204428|NCT00738881|4027667|B3|||Age||years|Median|62|62.0|Full Range|||49.0|76.0|
4204429|NCT00738881|4027668|B2|||Age||years|Median|55|55.0|Full Range|||49.0|75.0|
4204430|NCT00738881|4027669|B1|||Age||years|Median|69|69.0|Full Range|||51.0|76.0|
4204431|NCT00738699|4027682|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4204432|NCT00738699|4027683|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4204433|NCT00738699|4027684|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4204434|NCT00738699|4027682|B3||Female|Sex: Female, Male||Participants|Count of Participants|415|415.0||||||
4204435|NCT00738699|4027683|B2||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4204436|NCT00738699|4027684|B1||Female|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4204437|NCT00738699|4027682|B3|||Age||Years|Geometric Mean|61.0|61.0|Standard Deviation|10.31|10.31|||
4204438|NCT00738699|4027683|B2|||Age||Years|Geometric Mean|61.2|61.2|Standard Deviation|9.44|9.44|||
4204439|NCT00738699|4027684|B1|||Age||Years|Geometric Mean|60.9|60.9|Standard Deviation|10.74|10.74|||
4204440|NCT00738673|4027701|B3|Completely disabled||Eastern Cooporative Oncology Group (ECOG) Performance Status||participants|Number|0|0.0||||||
4204441|NCT00738673|4027702|B2|Completely disabled||Eastern Cooporative Oncology Group (ECOG) Performance Status||participants|Number|0|0.0||||||
4204442|NCT00738673|4027703|B1|Completely disabled||Eastern Cooporative Oncology Group (ECOG) Performance Status||participants|Number|0|0.0||||||
4204443|NCT00738673|4027701|B3|Capable of only limited selfcare||Eastern Cooporative Oncology Group (ECOG) Performance Status||participants|Number|0|0.0||||||
4204444|NCT00738673|4027702|B2|Capable of only limited selfcare||Eastern Cooporative Oncology Group (ECOG) Performance Status||participants|Number|0|0.0||||||
4204445|NCT00738673|4027703|B1|Capable of only limited selfcare||Eastern Cooporative Oncology Group (ECOG) Performance Status||participants|Number|0|0.0||||||
4204446|NCT00738673|4027701|B3|Ambulatory, unable to work||Eastern Cooporative Oncology Group (ECOG) Performance Status||participants|Number|8|8.0||||||
4204447|NCT00738673|4027702|B2|Ambulatory, unable to work||Eastern Cooporative Oncology Group (ECOG) Performance Status||participants|Number|1|1.0||||||
4204448|NCT00738673|4027703|B1|Ambulatory, unable to work||Eastern Cooporative Oncology Group (ECOG) Performance Status||participants|Number|7|7.0||||||
4204449|NCT00738673|4027701|B3|Restricted, but ambulatory||Eastern Cooporative Oncology Group (ECOG) Performance Status||participants|Number|28|28.0||||||
4204450|NCT00738673|4027702|B2|Restricted, but ambulatory||Eastern Cooporative Oncology Group (ECOG) Performance Status||participants|Number|11|11.0||||||
4204451|NCT00738673|4027703|B1|Restricted, but ambulatory||Eastern Cooporative Oncology Group (ECOG) Performance Status||participants|Number|17|17.0||||||
4204452|NCT00738673|4027701|B3|Fully active||Eastern Cooporative Oncology Group (ECOG) Performance Status||participants|Number|0|0.0||||||
4204453|NCT00738673|4027702|B2|Fully active||Eastern Cooporative Oncology Group (ECOG) Performance Status||participants|Number|0|0.0||||||
4204454|NCT00738673|4027703|B1|Fully active||Eastern Cooporative Oncology Group (ECOG) Performance Status||participants|Number|0|0.0||||||
4204490|NCT00738673|4027703|B1|||Height||meters|Mean|1.74|1.74|Standard Deviation|0.06|0.06|||
4204491|NCT00738673|4027701|B3|||Weight||kg|Mean|89.6|89.6|Standard Deviation|15.5|15.5|||
4204455|NCT00738673|4027701|B3|7-10||Gleason Score|The 2005 International Society of Urological Pathologists recommendations for Gleason scoring were used to grade tumors. A primary grade is assigned to the most common tumor pattern (how the cancer cells look under a microscope), and a second grade to the next most common pattern. The two grades are added together to get a Gleason Score with a range of 2-10; 10=worst prognosis.|participants|Number|26|26.0||||||
4204456|NCT00738673|4027702|B2|7-10||Gleason Score|The 2005 International Society of Urological Pathologists recommendations for Gleason scoring were used to grade tumors. A primary grade is assigned to the most common tumor pattern (how the cancer cells look under a microscope), and a second grade to the next most common pattern. The two grades are added together to get a Gleason Score with a range of 2-10; 10=worst prognosis.|participants|Number|7|7.0||||||
4204457|NCT00738673|4027703|B1|7-10||Gleason Score|The 2005 International Society of Urological Pathologists recommendations for Gleason scoring were used to grade tumors. A primary grade is assigned to the most common tumor pattern (how the cancer cells look under a microscope), and a second grade to the next most common pattern. The two grades are added together to get a Gleason Score with a range of 2-10; 10=worst prognosis.|participants|Number|19|19.0||||||
4204458|NCT00738673|4027701|B3|5-6||Gleason Score|The 2005 International Society of Urological Pathologists recommendations for Gleason scoring were used to grade tumors. A primary grade is assigned to the most common tumor pattern (how the cancer cells look under a microscope), and a second grade to the next most common pattern. The two grades are added together to get a Gleason Score with a range of 2-10; 10=worst prognosis.|participants|Number|6|6.0||||||
4204459|NCT00738673|4027702|B2|5-6||Gleason Score|The 2005 International Society of Urological Pathologists recommendations for Gleason scoring were used to grade tumors. A primary grade is assigned to the most common tumor pattern (how the cancer cells look under a microscope), and a second grade to the next most common pattern. The two grades are added together to get a Gleason Score with a range of 2-10; 10=worst prognosis.|participants|Number|2|2.0||||||
4204460|NCT00738673|4027703|B1|5-6||Gleason Score|The 2005 International Society of Urological Pathologists recommendations for Gleason scoring were used to grade tumors. A primary grade is assigned to the most common tumor pattern (how the cancer cells look under a microscope), and a second grade to the next most common pattern. The two grades are added together to get a Gleason Score with a range of 2-10; 10=worst prognosis.|participants|Number|4|4.0||||||
4204461|NCT00738673|4027701|B3|2-4||Gleason Score|The 2005 International Society of Urological Pathologists recommendations for Gleason scoring were used to grade tumors. A primary grade is assigned to the most common tumor pattern (how the cancer cells look under a microscope), and a second grade to the next most common pattern. The two grades are added together to get a Gleason Score with a range of 2-10; 10=worst prognosis.|participants|Number|4|4.0||||||
4204462|NCT00738673|4027702|B2|2-4||Gleason Score|The 2005 International Society of Urological Pathologists recommendations for Gleason scoring were used to grade tumors. A primary grade is assigned to the most common tumor pattern (how the cancer cells look under a microscope), and a second grade to the next most common pattern. The two grades are added together to get a Gleason Score with a range of 2-10; 10=worst prognosis.|participants|Number|3|3.0||||||
4204463|NCT00738673|4027703|B1|2-4||Gleason Score|The 2005 International Society of Urological Pathologists recommendations for Gleason scoring were used to grade tumors. A primary grade is assigned to the most common tumor pattern (how the cancer cells look under a microscope), and a second grade to the next most common pattern. The two grades are added together to get a Gleason Score with a range of 2-10; 10=worst prognosis.|participants|Number|1|1.0||||||
4204464|NCT00738673|4027701|B3|Not classifiable||Stage of Prostate Cancer at Enrolment||participants|Number|12|12.0||||||
4204465|NCT00738673|4027702|B2|Not classifiable||Stage of Prostate Cancer at Enrolment||participants|Number|5|5.0||||||
4204466|NCT00738673|4027703|B1|Not classifiable||Stage of Prostate Cancer at Enrolment||participants|Number|7|7.0||||||
4204467|NCT00738673|4027701|B3|Metastatic||Stage of Prostate Cancer at Enrolment||participants|Number|12|12.0||||||
4204468|NCT00738673|4027702|B2|Metastatic||Stage of Prostate Cancer at Enrolment||participants|Number|5|5.0||||||
4204469|NCT00738673|4027703|B1|Metastatic||Stage of Prostate Cancer at Enrolment||participants|Number|7|7.0||||||
4204470|NCT00738673|4027701|B3|Locally advanced||Stage of Prostate Cancer at Enrolment||participants|Number|9|9.0||||||
4204471|NCT00738673|4027702|B2|Locally advanced||Stage of Prostate Cancer at Enrolment||participants|Number|0|0.0||||||
4204472|NCT00738673|4027703|B1|Locally advanced||Stage of Prostate Cancer at Enrolment||participants|Number|9|9.0||||||
4204473|NCT00738673|4027701|B3|Localized||Stage of Prostate Cancer at Enrolment||participants|Number|3|3.0||||||
4204474|NCT00738673|4027702|B2|Localized||Stage of Prostate Cancer at Enrolment||participants|Number|2|2.0||||||
4204475|NCT00738673|4027703|B1|Localized||Stage of Prostate Cancer at Enrolment||participants|Number|1|1.0||||||
4204476|NCT00738673|4027701|B3|Not classifiable||Stage of Prostate Cancer at Diagnosis||participants|Number|8|8.0||||||
4204477|NCT00738673|4027702|B2|Not classifiable||Stage of Prostate Cancer at Diagnosis||participants|Number|5|5.0||||||
4204478|NCT00738673|4027703|B1|Not classifiable||Stage of Prostate Cancer at Diagnosis||participants|Number|3|3.0||||||
4204479|NCT00738673|4027701|B3|Metastatic||Stage of Prostate Cancer at Diagnosis||participants|Number|8|8.0||||||
4204480|NCT00738673|4027702|B2|Metastatic||Stage of Prostate Cancer at Diagnosis||participants|Number|2|2.0||||||
4204481|NCT00738673|4027703|B1|Metastatic||Stage of Prostate Cancer at Diagnosis||participants|Number|6|6.0||||||
4204482|NCT00738673|4027701|B3|Locally advanced||Stage of Prostate Cancer at Diagnosis||participants|Number|12|12.0||||||
4204483|NCT00738673|4027702|B2|Locally advanced||Stage of Prostate Cancer at Diagnosis||participants|Number|1|1.0||||||
4204484|NCT00738673|4027703|B1|Locally advanced||Stage of Prostate Cancer at Diagnosis||participants|Number|11|11.0||||||
4204485|NCT00738673|4027701|B3|Localized||Stage of Prostate Cancer at Diagnosis||participants|Number|8|8.0||||||
4204486|NCT00738673|4027702|B2|Localized||Stage of Prostate Cancer at Diagnosis||participants|Number|4|4.0||||||
4204487|NCT00738673|4027703|B1|Localized||Stage of Prostate Cancer at Diagnosis||participants|Number|4|4.0||||||
4204488|NCT00738673|4027701|B3|||Height||meters|Mean|1.73|1.73|Standard Deviation|0.06|0.06|||
4204492|NCT00738673|4027702|B2|||Weight||kg|Mean|87.6|87.6|Standard Deviation|11.0|11.0|||
4204493|NCT00738673|4027703|B1|||Weight||kg|Mean|90.5|90.5|Standard Deviation|17.3|17.3|||
4204494|NCT00738673|4027701|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4204495|NCT00738673|4027702|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4204496|NCT00738673|4027703|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4204497|NCT00738673|4027701|B3|White||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4204498|NCT00738673|4027702|B2|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4204499|NCT00738673|4027703|B1|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4204500|NCT00738673|4027701|B3|HIspanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4204501|NCT00738673|4027702|B2|HIspanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4204502|NCT00738673|4027703|B1|HIspanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4204503|NCT00738673|4027701|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4204504|NCT00738673|4027702|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4204505|NCT00738673|4027703|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4204506|NCT00738673|4027701|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4204507|NCT00738673|4027702|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4204508|NCT00738673|4027703|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4204509|NCT00738673|4027701|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4204510|NCT00738673|4027702|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4204511|NCT00738673|4027703|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4204512|NCT00738673|4027701|B3|||Age||years|Mean|73.9|73.9|Standard Deviation|8.08|8.08|||
4204513|NCT00738673|4027702|B2|||Age||years|Mean|76.5|76.5|Standard Deviation|4.68|4.68|||
4204514|NCT00738673|4027703|B1|||Age||years|Mean|72.7|72.7|Standard Deviation|9.11|9.11|||
4204515|NCT00738543|4027732|B1|Mexico||Region of Enrollment||participants|Number|48|48.0||||||
4204516|NCT00738543|4027732|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4204517|NCT00738543|4027732|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4204518|NCT00738543|4027732|B1|||Age||years|Mean|24.4|24.4|Standard Deviation|9.3|9.3|||
4204519|NCT00738543|4027732|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4204520|NCT00738543|4027732|B1||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4204521|NCT00738543|4027732|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4204522|NCT00738530|4027740|B3||Male|Sex: Female, Male||Participants|Count of Participants|457|457.0||||||
4204523|NCT00738530|4027741|B2||Male|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4204524|NCT00738530|4027742|B1||Male|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4204525|NCT00738530|4027740|B3||Female|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4204526|NCT00738530|4027741|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4204527|NCT00738530|4027742|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4204528|NCT00738530|4027740|B3|||Age||years|Mean|59.7|59.7|Standard Deviation|10.51|10.51|||
4204529|NCT00738530|4027741|B2|||Age||years|Mean|59.4|59.4|Standard Deviation|10.89|10.89|||
4204530|NCT00738530|4027742|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|10.12|10.12|||
4204531|NCT00738426|4027767|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4204532|NCT00738426|4027768|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4204533|NCT00738426|4027769|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4204534|NCT00738426|4027767|B3||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
4204535|NCT00738426|4027768|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4204536|NCT00738426|4027769|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4204537|NCT00738426|4027767|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4204538|NCT00738426|4027768|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4204539|NCT00738426|4027769|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4204540|NCT00738426|4027767|B3|United States||Region of Enrollment||participants|Number|67|67.0||||||
4204541|NCT00738426|4027768|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
4204542|NCT00738426|4027769|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4204543|NCT00738426|4027767|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204544|NCT00738426|4027768|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204545|NCT00738426|4027769|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204546|NCT00738426|4027767|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4204547|NCT00738426|4027768|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4204548|NCT00738426|4027769|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4204549|NCT00738426|4027767|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4204550|NCT00738426|4027768|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204551|NCT00738426|4027769|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4204552|NCT00738426|4027767|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4204553|NCT00738426|4027768|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4204554|NCT00738426|4027769|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4204555|NCT00738426|4027767|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4204556|NCT00738426|4027768|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4204557|NCT00738426|4027769|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4204558|NCT00738400|4027776|B3|||BMI (body mass index)|Number of participants analyzed for baseline (visit 2) was safety population.|kg/m^2|Mean|30.4|30.4|Standard Deviation|3.5|3.5|||
4204559|NCT00738400|4027777|B2|||BMI (body mass index)|Number of participants analyzed for baseline (visit 2) was safety population.|kg/m^2|Mean|30.4|30.4|Standard Deviation|3.4|3.4|||
4204560|NCT00738400|4027778|B1|||BMI (body mass index)|Number of participants analyzed for baseline (visit 2) was safety population.|kg/m^2|Mean|30.4|30.4|Standard Deviation|3.6|3.6|||
4204561|NCT00738400|4027776|B3||Male|Sex: Female, Male|Number of participants analyzed for baseline (visit 2) was safety population.|Participants|Count of Participants|147|147.0||||||
4204562|NCT00738400|4027777|B2||Male|Sex: Female, Male|Number of participants analyzed for baseline (visit 2) was safety population.|Participants|Count of Participants|72|72.0||||||
4204563|NCT00738400|4027778|B1||Male|Sex: Female, Male|Number of participants analyzed for baseline (visit 2) was safety population.|Participants|Count of Participants|75|75.0||||||
4204564|NCT00738400|4027776|B3||Female|Sex: Female, Male|Number of participants analyzed for baseline (visit 2) was safety population.|Participants|Count of Participants|0|0.0||||||
4204565|NCT00738400|4027777|B2||Female|Sex: Female, Male|Number of participants analyzed for baseline (visit 2) was safety population.|Participants|Count of Participants|0|0.0||||||
4204566|NCT00738400|4027778|B1||Female|Sex: Female, Male|Number of participants analyzed for baseline (visit 2) was safety population.|Participants|Count of Participants|0|0.0||||||
4204567|NCT00738400|4027776|B3|||Age|Number of participants analyzed for baseline (visit 2) was safety population.|years|Mean|56.0|56.0|Standard Deviation|6.3|6.3|||
4204568|NCT00738400|4027777|B2|||Age|Number of participants analyzed for baseline (visit 2) was safety population.|years|Mean|55.6|55.6|Standard Deviation|6.7|6.7|||
4204569|NCT00738400|4027778|B1|||Age|Number of participants analyzed for baseline (visit 2) was safety population.|years|Mean|56.3|56.3|Standard Deviation|5.9|5.9|||
4204570|NCT00738374|4027797|B4||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4204571|NCT00738374|4027798|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4204572|NCT00738374|4027799|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4204573|NCT00738374|4027800|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4204574|NCT00738374|4027797|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4204575|NCT00738374|4027798|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4204576|NCT00738374|4027799|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4204577|NCT00738374|4027800|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4204578|NCT00738374|4027797|B4|||Age||years|Mean|71.7|71.7|Standard Deviation|6.1|6.1|||
4204579|NCT00738374|4027798|B3|||Age||years|Mean|70.2|70.2|Standard Deviation|5.1|5.1|||
4204580|NCT00738374|4027799|B2|||Age||years|Mean|69.8|69.8|Standard Deviation|5.4|5.4|||
4204581|NCT00738374|4027800|B1|||Age||years|Mean|74.7|74.7|Standard Deviation|6.5|6.5|||
4204582|NCT00738361|4027835|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4204583|NCT00738361|4027835|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204584|NCT00738361|4027835|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204585|NCT00738361|4027835|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4204586|NCT00738361|4027835|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204587|NCT00738361|4027835|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204588|NCT00738361|4027835|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204589|NCT00738361|4027835|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204590|NCT00738361|4027835|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204591|NCT00738361|4027835|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4204592|NCT00738361|4027835|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204593|NCT00738361|4027835|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4204594|NCT00738361|4027835|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4204595|NCT00738361|4027835|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4204596|NCT00738361|4027835|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4204597|NCT00738361|4027835|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4204598|NCT00738283|4027841|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4204599|NCT00738283|4027841|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4204600|NCT00738283|4027841|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4204601|NCT00738283|4027841|B1|||Age||days of life|Mean|44|44.0|Standard Deviation|23|23.0|||
4204602|NCT00738283|4027841|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4204603|NCT00738283|4027841|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4204604|NCT00738283|4027841|B1||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
4204605|NCT00738062|4027845|B4|Other||Primary Clinical Diagnosis||participants|Number|3|3.0||||||
4204606|NCT00738062|4027846|B3|Other||Primary Clinical Diagnosis||participants|Number|1|1.0||||||
4204607|NCT00738062|4027847|B2|Other||Primary Clinical Diagnosis||participants|Number|1|1.0||||||
4204608|NCT00738062|4027848|B1|Other||Primary Clinical Diagnosis||participants|Number|1|1.0||||||
4204609|NCT00738062|4027845|B4|Non-Diabetic Autonomic Neuropathy||Primary Clinical Diagnosis||participants|Number|5|5.0||||||
4204610|NCT00738062|4027846|B3|Non-Diabetic Autonomic Neuropathy||Primary Clinical Diagnosis||participants|Number|2|2.0||||||
4204611|NCT00738062|4027847|B2|Non-Diabetic Autonomic Neuropathy||Primary Clinical Diagnosis||participants|Number|0|0.0||||||
4204612|NCT00738062|4027848|B1|Non-Diabetic Autonomic Neuropathy||Primary Clinical Diagnosis||participants|Number|3|3.0||||||
4204613|NCT00738062|4027845|B4|Dopamine Beta-Hydroxylase Deficiency||Primary Clinical Diagnosis||participants|Number|1|1.0||||||
4204614|NCT00738062|4027846|B3|Dopamine Beta-Hydroxylase Deficiency||Primary Clinical Diagnosis||participants|Number|0|0.0||||||
4204615|NCT00738062|4027847|B2|Dopamine Beta-Hydroxylase Deficiency||Primary Clinical Diagnosis||participants|Number|1|1.0||||||
4204616|NCT00738062|4027848|B1|Dopamine Beta-Hydroxylase Deficiency||Primary Clinical Diagnosis||participants|Number|0|0.0||||||
4204617|NCT00738062|4027845|B4|Pure Autonomic Failure||Primary Clinical Diagnosis||participants|Number|18|18.0||||||
4204618|NCT00738062|4027846|B3|Pure Autonomic Failure||Primary Clinical Diagnosis||participants|Number|7|7.0||||||
4204619|NCT00738062|4027847|B2|Pure Autonomic Failure||Primary Clinical Diagnosis||participants|Number|8|8.0||||||
4204620|NCT00738062|4027848|B1|Pure Autonomic Failure||Primary Clinical Diagnosis||participants|Number|3|3.0||||||
4204621|NCT00738062|4027845|B4|Multiple System Atrophy||Primary Clinical Diagnosis||participants|Number|27|27.0||||||
4204622|NCT00738062|4027846|B3|Multiple System Atrophy||Primary Clinical Diagnosis||participants|Number|9|9.0||||||
4204623|NCT00738062|4027847|B2|Multiple System Atrophy||Primary Clinical Diagnosis||participants|Number|8|8.0||||||
4204624|NCT00738062|4027848|B1|Multiple System Atrophy||Primary Clinical Diagnosis||participants|Number|10|10.0||||||
4204625|NCT00738062|4027845|B4|Parkinson's Disease||Primary Clinical Diagnosis||participants|Number|48|48.0||||||
4204626|NCT00738062|4027846|B3|Parkinson's Disease||Primary Clinical Diagnosis||participants|Number|18|18.0||||||
4204627|NCT00738062|4027847|B2|Parkinson's Disease||Primary Clinical Diagnosis||participants|Number|20|20.0||||||
4204628|NCT00738062|4027848|B1|Parkinson's Disease||Primary Clinical Diagnosis||participants|Number|10|10.0||||||
4204629|NCT00738062|4027845|B4|Poland||Region of Enrollment||participants|Number|16|16.0||||||
4204630|NCT00738062|4027846|B3|Poland||Region of Enrollment||participants|Number|6|6.0||||||
4204631|NCT00738062|4027847|B2|Poland||Region of Enrollment||participants|Number|3|3.0||||||
4204632|NCT00738062|4027848|B1|Poland||Region of Enrollment||participants|Number|7|7.0||||||
4204633|NCT00738062|4027845|B4|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4204634|NCT00738062|4027846|B3|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4204635|NCT00738062|4027847|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4204636|NCT00738062|4027848|B1|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4204637|NCT00738062|4027845|B4|New Zealand||Region of Enrollment||participants|Number|2|2.0||||||
4204638|NCT00738062|4027846|B3|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
4204639|NCT00738062|4027847|B2|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
4204640|NCT00738062|4027848|B1|New Zealand||Region of Enrollment||participants|Number|0|0.0||||||
4204641|NCT00738062|4027845|B4|Australia||Region of Enrollment||participants|Number|6|6.0||||||
4204642|NCT00738062|4027846|B3|Australia||Region of Enrollment||participants|Number|2|2.0||||||
4204643|NCT00738062|4027847|B2|Australia||Region of Enrollment||participants|Number|2|2.0||||||
4204644|NCT00738062|4027848|B1|Australia||Region of Enrollment||participants|Number|2|2.0||||||
4204645|NCT00738062|4027845|B4|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4204646|NCT00738062|4027846|B3|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4204647|NCT00738062|4027847|B2|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4204648|NCT00738062|4027848|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4204649|NCT00738062|4027845|B4|United States||Region of Enrollment||participants|Number|63|63.0||||||
4204650|NCT00738062|4027846|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4204651|NCT00738062|4027847|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4204652|NCT00738062|4027848|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4204653|NCT00738062|4027845|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204654|NCT00738062|4027846|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204655|NCT00738062|4027847|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204656|NCT00738062|4027848|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204657|NCT00738062|4027845|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204658|NCT00738062|4027846|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204659|NCT00738062|4027847|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204660|NCT00738062|4027848|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204661|NCT00738062|4027845|B4||White|Race (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
4204662|NCT00738062|4027846|B3||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4204663|NCT00738062|4027847|B2||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4204664|NCT00738062|4027848|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4204665|NCT00738062|4027845|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204666|NCT00738062|4027846|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204667|NCT00738062|4027847|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204668|NCT00738062|4027848|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204669|NCT00738062|4027845|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204670|NCT00738062|4027846|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204671|NCT00738062|4027847|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204672|NCT00738062|4027848|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204673|NCT00738062|4027845|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4204674|NCT00738062|4027846|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204675|NCT00738062|4027847|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4204676|NCT00738062|4027848|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204677|NCT00738062|4027845|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4204678|NCT00738062|4027846|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4204679|NCT00738062|4027847|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204680|NCT00738062|4027848|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204681|NCT00738062|4027845|B4||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4204682|NCT00738062|4027846|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4204683|NCT00738062|4027847|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4204684|NCT00738062|4027848|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4204685|NCT00738062|4027845|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4204686|NCT00738062|4027846|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4204687|NCT00738062|4027847|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4204688|NCT00738062|4027848|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4204689|NCT00738062|4027845|B4|||Age||years|Mean|65.8|65.8|Standard Deviation|12.31|12.31|||
4204690|NCT00738062|4027846|B3|||Age||years|Mean|66.2|66.2|Standard Deviation|12.09|12.09|||
4204691|NCT00738062|4027847|B2|||Age||years|Mean|68.2|68.2|Standard Deviation|13.03|13.03|||
4204692|NCT00738062|4027848|B1|||Age||years|Mean|61.9|61.9|Standard Deviation|10.95|10.95|||
4204693|NCT00738049|4027875|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4204694|NCT00738049|4027876|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4204695|NCT00738049|4027877|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4204696|NCT00738049|4027875|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4204697|NCT00738049|4027876|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4204698|NCT00738049|4027877|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4204699|NCT00738049|4027875|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4204700|NCT00738049|4027876|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4204701|NCT00738049|4027877|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4204702|NCT00738049|4027875|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4204703|NCT00738049|4027876|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4204704|NCT00738049|4027877|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4204705|NCT00738049|4027875|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4204706|NCT00738049|4027876|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4204707|NCT00738049|4027877|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4204708|NCT00738023|4027890|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4204709|NCT00738023|4027891|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4204710|NCT00738023|4027892|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4204711|NCT00738023|4027890|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4204712|NCT00738023|4027891|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4204713|NCT00738023|4027892|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4204714|NCT00738023|4027890|B3|||Age||years|Mean|41.5|41.5|Standard Deviation|0.7|0.7|||
4204715|NCT00738023|4027891|B2|||Age||years|Mean|42|42.0|Standard Deviation|1|1.0|||
4204716|NCT00738023|4027892|B1|||Age||years|Mean|41|41.0|Standard Deviation|2|2.0|||
4204717|NCT00737737|4027901|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4204718|NCT00737737|4027902|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4204719|NCT00737737|4027903|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4204720|NCT00737737|4027901|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204721|NCT00737737|4027902|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204722|NCT00737737|4027903|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204723|NCT00737737|4027901|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204724|NCT00737737|4027902|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204725|NCT00737737|4027903|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204726|NCT00737737|4027901|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4204727|NCT00737737|4027902|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4204728|NCT00737737|4027903|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4204729|NCT00737737|4027901|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204730|NCT00737737|4027902|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204731|NCT00737737|4027903|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204732|NCT00737737|4027901|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204733|NCT00737737|4027902|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204734|NCT00737737|4027903|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204735|NCT00737737|4027901|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4204736|NCT00737737|4027902|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4204737|NCT00737737|4027903|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204738|NCT00737737|4027901|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204739|NCT00737737|4027902|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204740|NCT00737737|4027903|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204741|NCT00737737|4027901|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4204742|NCT00737737|4027902|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4204743|NCT00737737|4027903|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4204744|NCT00737737|4027901|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4204745|NCT00737737|4027902|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4204746|NCT00737737|4027903|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4204747|NCT00737737|4027901|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4204748|NCT00737737|4027902|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4204749|NCT00737737|4027903|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4204750|NCT00737737|4027901|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4204751|NCT00737737|4027902|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4204752|NCT00737737|4027903|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4204753|NCT00737737|4027901|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4204754|NCT00737737|4027902|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4204755|NCT00737737|4027903|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4204756|NCT00737711|4027912|B1||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4204757|NCT00737711|4027912|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4204758|NCT00737711|4027912|B1|||Age||years|Mean|49.74|49.74|Standard Deviation|14.01|14.01|||
4204759|NCT00737672|4027943|B3|||Total Number of Prior Interventions to the Current Prosthetic Graft or Circuit||Number of Prior Interventions|Mean|2.27|2.27|Standard Deviation|2.82|2.82|||
4204760|NCT00737672|4027944|B2|||Total Number of Prior Interventions to the Current Prosthetic Graft or Circuit||Number of Prior Interventions|Mean|2.26|2.26|Standard Deviation|2.90|2.9|||
4204761|NCT00737672|4027945|B1|||Total Number of Prior Interventions to the Current Prosthetic Graft or Circuit||Number of Prior Interventions|Mean|2.28|2.28|Standard Deviation|2.75|2.75|||
4204762|NCT00737672|4027943|B3|||Total Number of Prior Interventions at the Target Lesions||Number of Prior Interventions|Mean|1.83|1.83|Standard Deviation|2.27|2.27|||
4204763|NCT00737672|4027944|B2|||Total Number of Prior Interventions at the Target Lesions||Number of Prior Interventions|Mean|1.81|1.81|Standard Deviation|2.34|2.34|||
4204764|NCT00737672|4027945|B1|||Total Number of Prior Interventions at the Target Lesions||Number of Prior Interventions|Mean|1.85|1.85|Standard Deviation|2.20|2.2|||
4204765|NCT00737672|4027943|B3|||Age of Vascular Access Graft||Years|Mean|2.11|2.11|Standard Deviation|2.31|2.31|||
4204766|NCT00737672|4027944|B2|||Age of Vascular Access Graft||Years|Mean|2.28|2.28|Standard Deviation|2.64|2.64|||
4204767|NCT00737672|4027945|B1|||Age of Vascular Access Graft||Years|Mean|1.93|1.93|Standard Deviation|1.92|1.92|||
4204768|NCT00737672|4027943|B3|History of Hypertension = NO||History of Hypertension||Participants|Number|6|6.0||||||
4204769|NCT00737672|4027944|B2|History of Hypertension = NO||History of Hypertension||Participants|Number|4|4.0||||||
4204770|NCT00737672|4027945|B1|History of Hypertension = NO||History of Hypertension||Participants|Number|2|2.0||||||
4204771|NCT00737672|4027943|B3|History of Hypertension = YES||History of Hypertension||Participants|Number|287|287.0||||||
4204772|NCT00737672|4027944|B2|History of Hypertension = YES||History of Hypertension||Participants|Number|144|144.0||||||
4204773|NCT00737672|4027945|B1|History of Hypertension = YES||History of Hypertension||Participants|Number|143|143.0||||||
4204774|NCT00737672|4027943|B3|History of Diabetes = NO||History of Diabetes||Participants|Number|101|101.0||||||
4204775|NCT00737672|4027944|B2|History of Diabetes = NO||History of Diabetes||Participants|Number|50|50.0||||||
4204776|NCT00737672|4027945|B1|History of Diabetes = NO||History of Diabetes||Participants|Number|51|51.0||||||
4204777|NCT00737672|4027943|B3|History of Diabetes = YES||History of Diabetes||Participants|Number|192|192.0||||||
4204778|NCT00737672|4027944|B2|History of Diabetes = YES||History of Diabetes||Participants|Number|98|98.0||66.2|66.2|||
4204779|NCT00737672|4027945|B1|History of Diabetes = YES||History of Diabetes||Participants|Number|94|94.0||64.8|64.8|||
4204780|NCT00737672|4027943|B3|||Body Mass Index||Kg/m^2|Mean|29.6|29.6|Standard Deviation|8.8|8.8|||
4204781|NCT00737672|4027944|B2|||Body Mass Index||Kg/m^2|Mean|29.5|29.5|Standard Deviation|8.6|8.6|||
4204782|NCT00737672|4027945|B1|||Body Mass Index||Kg/m^2|Mean|29.7|29.7|Standard Deviation|9.1|9.1|||
4204783|NCT00737672|4027943|B3|United States||Region of Enrollment||Participants|Number|293|293.0||||||
4204784|NCT00737672|4027944|B2|United States||Region of Enrollment||Participants|Number|148|148.0||||||
4204785|NCT00737672|4027945|B1|United States||Region of Enrollment||Participants|Number|145|145.0||||||
4204786|NCT00737672|4027943|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4204787|NCT00737672|4027944|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4204788|NCT00737672|4027945|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204789|NCT00737672|4027943|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204790|NCT00737672|4027944|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204791|NCT00737672|4027945|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204792|NCT00737672|4027943|B3||White|Race (NIH/OMB)||Participants|Count of Participants|117|117.0||||||
4204793|NCT00737672|4027944|B2||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4204794|NCT00737672|4027945|B1||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4204795|NCT00737672|4027943|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|154|154.0||||||
4204796|NCT00737672|4027944|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
4204797|NCT00737672|4027945|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4204798|NCT00737672|4027943|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4204799|NCT00737672|4027944|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204800|NCT00737672|4027945|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4204801|NCT00737672|4027943|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4204802|NCT00737672|4027944|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4204803|NCT00737672|4027945|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4204804|NCT00737672|4027943|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4204805|NCT00737672|4027944|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4204806|NCT00737672|4027945|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4204807|NCT00737672|4027943|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4204808|NCT00737672|4027944|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4204809|NCT00737672|4027945|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4204810|NCT00737672|4027943|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|240|240.0||||||
4204811|NCT00737672|4027944|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|114|114.0||||||
4204812|NCT00737672|4027945|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
4204813|NCT00737672|4027943|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4204814|NCT00737672|4027944|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4204815|NCT00737672|4027945|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4204816|NCT00737672|4027943|B3||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4204817|NCT00737672|4027944|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4204818|NCT00737672|4027945|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4204819|NCT00737672|4027943|B3||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4204820|NCT00737672|4027944|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4204821|NCT00737672|4027945|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4204822|NCT00737672|4027943|B3|||Age||Years|Mean|61.7|61.7|Standard Deviation|14.0|14.0|||
4204823|NCT00737672|4027944|B2|||Age||Years|Mean|61.3|61.3|Standard Deviation|15.0|15.0|||
4204824|NCT00737672|4027945|B1|||Age||Years|Mean|62.2|62.2|Standard Deviation|12.9|12.9|||
4204825|NCT00737633|4027982|B3|United States||Region of Enrollment||participants|Number|101|101.0||||||
4204826|NCT00737633|4027983|B2|United States||Region of Enrollment||participants|Number|57|57.0||||||
4204827|NCT00737633|4027984|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4204828|NCT00737633|4027982|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4204829|NCT00737633|4027983|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4204830|NCT00737633|4027984|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4204831|NCT00737633|4027982|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4204832|NCT00737633|4027983|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4204833|NCT00737633|4027984|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4204834|NCT00737633|4027982|B3|||Age||years|Mean|49.8|49.8|Standard Deviation|7.7|7.7|||
4204835|NCT00737633|4027983|B2|||Age||years|Mean|49.5|49.5|Standard Deviation|7.0|7.0|||
4204836|NCT00737633|4027984|B1|||Age||years|Mean|50.2|50.2|Standard Deviation|8.6|8.6|||
4204837|NCT00737568|4028006|B3|Positive||HBV e Antigen (HBeAg) Status at Baseline||participants|Number|133|133.0||||||
4204838|NCT00737568|4028007|B2|Positive||HBV e Antigen (HBeAg) Status at Baseline||participants|Number|68|68.0||||||
4204839|NCT00737568|4028008|B1|Positive||HBV e Antigen (HBeAg) Status at Baseline||participants|Number|65|65.0||||||
4204840|NCT00737568|4028006|B3|Negative||HBV e Antigen (HBeAg) Status at Baseline||participants|Number|147|147.0||||||
4204841|NCT00737568|4028007|B2|Negative||HBV e Antigen (HBeAg) Status at Baseline||participants|Number|71|71.0||||||
4204842|NCT00737568|4028008|B1|Negative||HBV e Antigen (HBeAg) Status at Baseline||participants|Number|76|76.0||||||
4204843|NCT00737568|4028006|B3|||Hepatitis B Virus (HBV) DNA Level at Baseline||log_10 copies/mL|Mean|6.46|6.46|Standard Deviation|1.896|1.896|||
4204844|NCT00737568|4028007|B2|||Hepatitis B Virus (HBV) DNA Level at Baseline||log_10 copies/mL|Mean|6.53|6.53|Standard Deviation|1.968|1.968|||
4204845|NCT00737568|4028008|B1|||Hepatitis B Virus (HBV) DNA Level at Baseline||log_10 copies/mL|Mean|6.40|6.4|Standard Deviation|1.826|1.826|||
4204846|NCT00737568|4028006|B3|Normal||ALT Normal at Baseline|The ULN was 43 U/L for males and 34 U/L for females aged 18 to < 69, and 35 U/L for males and 32 U/L for females aged ≥ 69.|participants|Number|118|118.0||||||
4204847|NCT00737568|4028007|B2|Normal||ALT Normal at Baseline|The ULN was 43 U/L for males and 34 U/L for females aged 18 to < 69, and 35 U/L for males and 32 U/L for females aged ≥ 69.|participants|Number|56|56.0||||||
4204848|NCT00737568|4028008|B1|Normal||ALT Normal at Baseline|The ULN was 43 U/L for males and 34 U/L for females aged 18 to < 69, and 35 U/L for males and 32 U/L for females aged ≥ 69.|participants|Number|62|62.0||||||
4204849|NCT00737568|4028006|B3|Abnormal||ALT Normal at Baseline|The ULN was 43 U/L for males and 34 U/L for females aged 18 to < 69, and 35 U/L for males and 32 U/L for females aged ≥ 69.|participants|Number|162|162.0||||||
4204850|NCT00737568|4028007|B2|Abnormal||ALT Normal at Baseline|The ULN was 43 U/L for males and 34 U/L for females aged 18 to < 69, and 35 U/L for males and 32 U/L for females aged ≥ 69.|participants|Number|83|83.0||||||
4204851|NCT00737568|4028008|B1|Abnormal||ALT Normal at Baseline|The ULN was 43 U/L for males and 34 U/L for females aged 18 to < 69, and 35 U/L for males and 32 U/L for females aged ≥ 69.|participants|Number|79|79.0||||||
4204852|NCT00737568|4028006|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4204853|NCT00737568|4028007|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4204854|NCT00737568|4028008|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4204855|NCT00737568|4028006|B3|Turkey||Region of Enrollment||participants|Number|28|28.0||||||
4204856|NCT00737568|4028007|B2|Turkey||Region of Enrollment||participants|Number|13|13.0||||||
4204857|NCT00737568|4028008|B1|Turkey||Region of Enrollment||participants|Number|15|15.0||||||
4204858|NCT00737568|4028006|B3|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4204859|NCT00737568|4028007|B2|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4204860|NCT00737568|4028008|B1|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4204861|NCT00737568|4028006|B3|Serbia||Region of Enrollment||participants|Number|36|36.0||||||
4204862|NCT00737568|4028007|B2|Serbia||Region of Enrollment||participants|Number|19|19.0||||||
4204863|NCT00737568|4028008|B1|Serbia||Region of Enrollment||participants|Number|17|17.0||||||
4204864|NCT00737568|4028006|B3|Romania||Region of Enrollment||participants|Number|31|31.0||||||
4204865|NCT00737568|4028007|B2|Romania||Region of Enrollment||participants|Number|14|14.0||||||
4204866|NCT00737568|4028008|B1|Romania||Region of Enrollment||participants|Number|17|17.0||||||
4204867|NCT00737568|4028006|B3|Poland||Region of Enrollment||participants|Number|32|32.0||||||
4204868|NCT00737568|4028007|B2|Poland||Region of Enrollment||participants|Number|19|19.0||||||
4204869|NCT00737568|4028008|B1|Poland||Region of Enrollment||participants|Number|13|13.0||||||
4204870|NCT00737568|4028006|B3|New Zealand||Region of Enrollment||participants|Number|17|17.0||||||
4204871|NCT00737568|4028007|B2|New Zealand||Region of Enrollment||participants|Number|10|10.0||||||
4204872|NCT00737568|4028008|B1|New Zealand||Region of Enrollment||participants|Number|7|7.0||||||
4204873|NCT00737568|4028006|B3|Hungary||Region of Enrollment||participants|Number|7|7.0||||||
4204874|NCT00737568|4028007|B2|Hungary||Region of Enrollment||participants|Number|3|3.0||||||
4204875|NCT00737568|4028008|B1|Hungary||Region of Enrollment||participants|Number|4|4.0||||||
4204876|NCT00737568|4028006|B3|Greece||Region of Enrollment||participants|Number|3|3.0||||||
4204877|NCT00737568|4028007|B2|Greece||Region of Enrollment||participants|Number|1|1.0||||||
4204878|NCT00737568|4028008|B1|Greece||Region of Enrollment||participants|Number|2|2.0||||||
4204879|NCT00737568|4028006|B3|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4204880|NCT00737568|4028007|B2|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4204881|NCT00737568|4028008|B1|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4204882|NCT00737568|4028006|B3|Czech Republic||Region of Enrollment||participants|Number|16|16.0||||||
4204883|NCT00737568|4028007|B2|Czech Republic||Region of Enrollment||participants|Number|7|7.0||||||
4204884|NCT00737568|4028008|B1|Czech Republic||Region of Enrollment||participants|Number|9|9.0||||||
4204885|NCT00737568|4028006|B3|Canada||Region of Enrollment||participants|Number|90|90.0||||||
4204886|NCT00737568|4028007|B2|Canada||Region of Enrollment||participants|Number|43|43.0||||||
4204887|NCT00737568|4028008|B1|Canada||Region of Enrollment||participants|Number|47|47.0||||||
4204888|NCT00737568|4028006|B3|Bulgaria||Region of Enrollment||participants|Number|7|7.0||||||
4204889|NCT00737568|4028007|B2|Bulgaria||Region of Enrollment||participants|Number|5|5.0||||||
4204890|NCT00737568|4028008|B1|Bulgaria||Region of Enrollment||participants|Number|2|2.0||||||
4204891|NCT00737568|4028006|B3|Austria||Region of Enrollment||participants|Number|5|5.0||||||
4204892|NCT00737568|4028007|B2|Austria||Region of Enrollment||participants|Number|3|3.0||||||
4204893|NCT00737568|4028008|B1|Austria||Region of Enrollment||participants|Number|2|2.0||||||
4204894|NCT00737568|4028006|B3|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4204895|NCT00737568|4028007|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4204896|NCT00737568|4028008|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4204897|NCT00737568|4028006|B3|White||Race/Ethnicity, Customized||participants|Number|172|172.0||||||
4204898|NCT00737568|4028007|B2|White||Race/Ethnicity, Customized||participants|Number|89|89.0||||||
4204899|NCT00737568|4028008|B1|White||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
4204900|NCT00737568|4028006|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4204901|NCT00737568|4028007|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4204902|NCT00737568|4028008|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4204903|NCT00737568|4028006|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4204904|NCT00737568|4028007|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4204905|NCT00737568|4028008|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4204906|NCT00737568|4028006|B3|Asian||Race/Ethnicity, Customized||participants|Number|94|94.0||||||
4204907|NCT00737568|4028007|B2|Asian||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4204908|NCT00737568|4028008|B1|Asian||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
4204909|NCT00737568|4028006|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4204910|NCT00737568|4028007|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4204911|NCT00737568|4028008|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4204912|NCT00737568|4028006|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|275|275.0||||||
4204913|NCT00737568|4028007|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|137|137.0||||||
4204914|NCT00737568|4028008|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
4204915|NCT00737568|4028006|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4204916|NCT00737568|4028007|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4204917|NCT00737568|4028008|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4204918|NCT00737568|4028006|B3||Male|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4204919|NCT00737568|4028007|B2||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4204920|NCT00737568|4028008|B1||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4204921|NCT00737568|4028006|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4204922|NCT00737568|4028007|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4204923|NCT00737568|4028008|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4204924|NCT00737568|4028006|B3|||Age||years|Mean|46.7|46.7|Standard Deviation|13.58|13.58|||
4204925|NCT00737568|4028007|B2|||Age||years|Mean|46.3|46.3|Standard Deviation|13.56|13.56|||
4204926|NCT00737568|4028008|B1|||Age||years|Mean|47.1|47.1|Standard Deviation|13.63|13.63|||
4204927|NCT00737529|4028039|B1||Missing|Bulky Disease|Bulky disease is defined as at least one lesion ≥ 7 cm in diameter|Participants|Count of Participants|2|2.0||||||
4204928|NCT00737529|4028039|B1||No|Bulky Disease|Bulky disease is defined as at least one lesion ≥ 7 cm in diameter|Participants|Count of Participants|88|88.0||||||
4204929|NCT00737529|4028039|B1||Yes|Bulky Disease|Bulky disease is defined as at least one lesion ≥ 7 cm in diameter|Participants|Count of Participants|44|44.0||||||
4204930|NCT00737529|4028039|B1||Missing = unable to characterize|Tumor Burden|Defined as at least one lesion that was ≥ 5 cm in diameter or ≥ 3 lesions that were ≥ 3 cm in diameter by central radiology review.|Participants|Count of Participants|2|2.0||||||
4204931|NCT00737529|4028039|B1||Low = < 5cm lesions|Tumor Burden|Defined as at least one lesion that was ≥ 5 cm in diameter or ≥ 3 lesions that were ≥ 3 cm in diameter by central radiology review.|Participants|Count of Participants|54|54.0||||||
4204932|NCT00737529|4028039|B1||High = having 1 lesion ≥ 5 cm or 3 lesions ≥ 3cm|Tumor Burden|Defined as at least one lesion that was ≥ 5 cm in diameter or ≥ 3 lesions that were ≥ 3 cm in diameter by central radiology review.|Participants|Count of Participants|78|78.0||||||
4204933|NCT00737529|4028039|B1||Missing|Prior Bone Marrow Assessment|Baseline assessment of bone marrow involvement was not required per protocol; however, bone marrow biopsy and aspirate data previously conducted were collected if available.|Participants|Count of Participants|19|19.0||||||
4204934|NCT00737529|4028039|B1||Indeterminate|Prior Bone Marrow Assessment|Baseline assessment of bone marrow involvement was not required per protocol; however, bone marrow biopsy and aspirate data previously conducted were collected if available.|Participants|Count of Participants|8|8.0||||||
4204935|NCT00737529|4028039|B1||Negative|Prior Bone Marrow Assessment|Baseline assessment of bone marrow involvement was not required per protocol; however, bone marrow biopsy and aspirate data previously conducted were collected if available.|Participants|Count of Participants|52|52.0||||||
4204936|NCT00737529|4028039|B1||Positive|Prior Bone Marrow Assessment|Baseline assessment of bone marrow involvement was not required per protocol; however, bone marrow biopsy and aspirate data previously conducted were collected if available.|Participants|Count of Participants|55|55.0||||||
4204937|NCT00737529|4028039|B1||Missing|MCL International Prognostic Index (MIPI) Score Group at Enrollment|A prognostic index predictive of the outcome in advanced Mantle Cell Lymphoma|Participants|Count of Participants|5|5.0||||||
4204938|NCT00737529|4028039|B1||High|MCL International Prognostic Index (MIPI) Score Group at Enrollment|A prognostic index predictive of the outcome in advanced Mantle Cell Lymphoma|Participants|Count of Participants|39|39.0||||||
4204939|NCT00737529|4028039|B1||Intermediate|MCL International Prognostic Index (MIPI) Score Group at Enrollment|A prognostic index predictive of the outcome in advanced Mantle Cell Lymphoma|Participants|Count of Participants|51|51.0||||||
4205008|NCT00737204|4028117|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4204940|NCT00737529|4028039|B1||Low|MCL International Prognostic Index (MIPI) Score Group at Enrollment|A prognostic index predictive of the outcome in advanced Mantle Cell Lymphoma|Participants|Count of Participants|39|39.0||||||
4204941|NCT00737529|4028039|B1||Missing|MCL (Ann Arbor) Stage at Diagnosis|Ann Arbor staging is the staging system for lymphomas, both in Hodgkin's lymphoma (previously called Hodgkin's disease) and Non-Hodgkin lymphoma (NHL). Stage I = Involvement of 1 Lymph Node (LN) or extralymphatic region; Stage II = ≥ 2 LN sites on the same side of the diaphragm; Stage III = LN regions on both sides of the diaphragm; may include spleen and 1 extralymphatic organ; Stage IV = involvement of ≥ 1 extralymphatic organs with or without associated LN involvement (diffuse or disseminated).|Participants|Count of Participants|3|3.0||||||
4204942|NCT00737529|4028039|B1||IV|MCL (Ann Arbor) Stage at Diagnosis|Ann Arbor staging is the staging system for lymphomas, both in Hodgkin's lymphoma (previously called Hodgkin's disease) and Non-Hodgkin lymphoma (NHL). Stage I = Involvement of 1 Lymph Node (LN) or extralymphatic region; Stage II = ≥ 2 LN sites on the same side of the diaphragm; Stage III = LN regions on both sides of the diaphragm; may include spleen and 1 extralymphatic organ; Stage IV = involvement of ≥ 1 extralymphatic organs with or without associated LN involvement (diffuse or disseminated).|Participants|Count of Participants|105|105.0||||||
4204943|NCT00737529|4028039|B1||III|MCL (Ann Arbor) Stage at Diagnosis|Ann Arbor staging is the staging system for lymphomas, both in Hodgkin's lymphoma (previously called Hodgkin's disease) and Non-Hodgkin lymphoma (NHL). Stage I = Involvement of 1 Lymph Node (LN) or extralymphatic region; Stage II = ≥ 2 LN sites on the same side of the diaphragm; Stage III = LN regions on both sides of the diaphragm; may include spleen and 1 extralymphatic organ; Stage IV = involvement of ≥ 1 extralymphatic organs with or without associated LN involvement (diffuse or disseminated).|Participants|Count of Participants|19|19.0||||||
4204944|NCT00737529|4028039|B1||II|MCL (Ann Arbor) Stage at Diagnosis|Ann Arbor staging is the staging system for lymphomas, both in Hodgkin's lymphoma (previously called Hodgkin's disease) and Non-Hodgkin lymphoma (NHL). Stage I = Involvement of 1 Lymph Node (LN) or extralymphatic region; Stage II = ≥ 2 LN sites on the same side of the diaphragm; Stage III = LN regions on both sides of the diaphragm; may include spleen and 1 extralymphatic organ; Stage IV = involvement of ≥ 1 extralymphatic organs with or without associated LN involvement (diffuse or disseminated).|Participants|Count of Participants|5|5.0||||||
4204945|NCT00737529|4028039|B1||I|MCL (Ann Arbor) Stage at Diagnosis|Ann Arbor staging is the staging system for lymphomas, both in Hodgkin's lymphoma (previously called Hodgkin's disease) and Non-Hodgkin lymphoma (NHL). Stage I = Involvement of 1 Lymph Node (LN) or extralymphatic region; Stage II = ≥ 2 LN sites on the same side of the diaphragm; Stage III = LN regions on both sides of the diaphragm; may include spleen and 1 extralymphatic organ; Stage IV = involvement of ≥ 1 extralymphatic organs with or without associated LN involvement (diffuse or disseminated).|Participants|Count of Participants|2|2.0||||||
4204946|NCT00737529|4028039|B1|≥ 3 years||Duration of Mantle Cell Lymphoma||years|Number|82|82.0||||||
4204947|NCT00737529|4028039|B1|<3 years||Duration of Mantle Cell Lymphoma||years|Number|52|52.0||||||
4204948|NCT00737529|4028039|B1||Missing|Renal function at baseline|Participants with a Creatinine clearance (as calculated by the Cockcroft-Gault formula, utilizing actual body weight or ideal body weight, whichever was less) of ≥ 60 mL/min received a starting dose of 25 mg once daily. Participants with moderate renal insufficiency (ie, CrCl ≥ 30 mL/min but < 60 mL/min) received a starting dose of 10 mg lenalidomide once daily.|Participants|Count of Participants|6|6.0||||||
4204949|NCT00737529|4028039|B1||Severe Renal Insufficiency (CrCl < 30 mL/min)|Renal function at baseline|Participants with a Creatinine clearance (as calculated by the Cockcroft-Gault formula, utilizing actual body weight or ideal body weight, whichever was less) of ≥ 60 mL/min received a starting dose of 25 mg once daily. Participants with moderate renal insufficiency (ie, CrCl ≥ 30 mL/min but < 60 mL/min) received a starting dose of 10 mg lenalidomide once daily.|Participants|Count of Participants|1|1.0||||||
4204950|NCT00737529|4028039|B1||Moderate Renal Insufficiency (CrCl ≥ 30 and < 60mL|Renal function at baseline|Participants with a Creatinine clearance (as calculated by the Cockcroft-Gault formula, utilizing actual body weight or ideal body weight, whichever was less) of ≥ 60 mL/min received a starting dose of 25 mg once daily. Participants with moderate renal insufficiency (ie, CrCl ≥ 30 mL/min but < 60 mL/min) received a starting dose of 10 mg lenalidomide once daily.|Participants|Count of Participants|28|28.0||||||
4204951|NCT00737529|4028039|B1||Normal (CrCl > = 60 mL/min)|Renal function at baseline|Participants with a Creatinine clearance (as calculated by the Cockcroft-Gault formula, utilizing actual body weight or ideal body weight, whichever was less) of ≥ 60 mL/min received a starting dose of 25 mg once daily. Participants with moderate renal insufficiency (ie, CrCl ≥ 30 mL/min but < 60 mL/min) received a starting dose of 10 mg lenalidomide once daily.|Participants|Count of Participants|99|99.0||||||
4204952|NCT00737529|4028039|B1||4 = (Completely Disabled)|Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|0|0.0||||||
4204953|NCT00737529|4028039|B1||3 = (Limited self care)|Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|1|1.0||||||
4204954|NCT00737529|4028039|B1||2 = (Ambulatory but unable to work)|Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|17|17.0||||||
4204955|NCT00737529|4028039|B1||1 = (Restrictive but ambulatory)|Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|73|73.0||||||
4204956|NCT00737529|4028039|B1||0 = (Fully Active)|Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|Participants|Count of Participants|43|43.0||||||
4204957|NCT00737529|4028039|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4204958|NCT00737529|4028039|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4204959|NCT00737529|4028039|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4204960|NCT00737529|4028039|B1||White or Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|128|128.0||||||
4204961|NCT00737529|4028039|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4204962|NCT00737529|4028039|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4204963|NCT00737529|4028039|B1||≥ 65|Age, Customized||Participants|Count of Participants|85|85.0||||||
4204964|NCT00737529|4028039|B1||<65|Age, Customized||Participants|Count of Participants|49|49.0||||||
4204965|NCT00737529|4028039|B1|||Age||Years|Mean|67.2|67.2|Standard Deviation|8.38|8.38|||
4204966|NCT00737477|4028053|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4204967|NCT00737477|4028053|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4204968|NCT00737477|4028053|B1|||Age||years|Mean|67.9|67.9|Standard Deviation|14.5|14.5|||
4204969|NCT00737464|4028069|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4204970|NCT00737464|4028069|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4204971|NCT00737464|4028069|B1|||Age||years|Mean|52.74|52.74|Standard Deviation|12.40|12.4|||
4204972|NCT00737438|4028090|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4204973|NCT00737438|4028090|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4204974|NCT00737438|4028090|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4204975|NCT00737438|4028090|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4204976|NCT00737438|4028090|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4204977|NCT00737360|4028094|B1|Singapore||Region of Enrollment||participants|Number|5|5.0||||||
4204978|NCT00737360|4028094|B1|Hong Kong||Region of Enrollment||participants|Number|9|9.0||||||
4204979|NCT00737360|4028094|B1|Taiwan||Region of Enrollment||participants|Number|1|1.0||||||
4204980|NCT00737360|4028094|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4204981|NCT00737360|4028094|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4204982|NCT00737360|4028094|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4204983|NCT00737360|4028094|B1|||Age||years|Mean|56|56.0|Standard Deviation|7.96|7.96|||
4204984|NCT00737360|4028094|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4204985|NCT00737360|4028094|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4204986|NCT00737360|4028094|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4204987|NCT00737243|4028109|B1|United States||Region of Enrollment||participants|Number|252|252.0||||||
4204988|NCT00737243|4028109|B1||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4204989|NCT00737243|4028109|B1||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4204990|NCT00737243|4028109|B1|||Age||years|Median|64|64.0|Full Range|||26.0|89.0|
4204991|NCT00737204|4028115|B3|United States||Region of Enrollment||participants|Number|70|70.0||||||
4204992|NCT00737204|4028116|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
4204993|NCT00737204|4028117|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4204994|NCT00737204|4028115|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4204995|NCT00737204|4028116|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4204996|NCT00737204|4028117|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4204997|NCT00737204|4028115|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4204998|NCT00737204|4028116|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4204999|NCT00737204|4028117|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4205000|NCT00737204|4028115|B3|||Age||years|Mean|46|46.0|Standard Deviation|8.4|8.4|||
4205001|NCT00737204|4028116|B2|||Age||years|Mean|46|46.0|Standard Deviation|8.2|8.2|||
4205002|NCT00737204|4028117|B1|||Age||years|Mean|46|46.0|Standard Deviation|8.7|8.7|||
4205003|NCT00737204|4028115|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4205004|NCT00737204|4028116|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4205005|NCT00737204|4028117|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4205006|NCT00737204|4028115|B3||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4205007|NCT00737204|4028116|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4205009|NCT00737204|4028115|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4205010|NCT00737204|4028116|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4205011|NCT00737204|4028117|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4205012|NCT00737178|4028130|B3|United States||Region of Enrollment||participants|Number|156|156.0||||||
4205013|NCT00737178|4028131|B2|United States||Region of Enrollment||participants|Number|85|85.0||||||
4205014|NCT00737178|4028132|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
4205015|NCT00737178|4028130|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4205016|NCT00737178|4028131|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4205017|NCT00737178|4028132|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4205018|NCT00737178|4028130|B3||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4205019|NCT00737178|4028131|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4205020|NCT00737178|4028132|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4205021|NCT00737178|4028130|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4205022|NCT00737178|4028131|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4205023|NCT00737178|4028132|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4205024|NCT00737178|4028130|B3||Between 18 and 65 years|Age||Participants|Count of Participants|156|156.0||||||
4205025|NCT00737178|4028131|B2||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
4205026|NCT00737178|4028132|B1||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4205027|NCT00737178|4028130|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4205028|NCT00737178|4028131|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4205029|NCT00737178|4028132|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4205030|NCT00737100|4028143|B4|Currently smokes||Smoking history||Participants|Number|8|8.0||||||
4205031|NCT00737100|4028144|B3|Currently smokes||Smoking history||Participants|Number|2|2.0||||||
4205032|NCT00737100|4028145|B2|Currently smokes||Smoking history||Participants|Number|4|4.0||||||
4205033|NCT00737100|4028146|B1|Currently smokes||Smoking history||Participants|Number|2|2.0||||||
4205034|NCT00737100|4028143|B4|Ex-smoker||Smoking history||Participants|Number|19|19.0||||||
4205035|NCT00737100|4028144|B3|Ex-smoker||Smoking history||Participants|Number|7|7.0||||||
4205036|NCT00737100|4028145|B2|Ex-smoker||Smoking history||Participants|Number|5|5.0||||||
4205037|NCT00737100|4028146|B1|Ex-smoker||Smoking history||Participants|Number|7|7.0||||||
4205038|NCT00737100|4028143|B4|Never smoked||Smoking history||Participants|Number|483|483.0||||||
4205039|NCT00737100|4028144|B3|Never smoked||Smoking history||Participants|Number|167|167.0||||||
4205040|NCT00737100|4028145|B2|Never smoked||Smoking history||Participants|Number|157|157.0||||||
4205041|NCT00737100|4028146|B1|Never smoked||Smoking history||Participants|Number|159|159.0||||||
4205042|NCT00737100|4028143|B4|Drinks alcohol but could interfere with trial||Alcohol history||Participants|Number|1|1.0||||||
4205043|NCT00737100|4028144|B3|Drinks alcohol but could interfere with trial||Alcohol history||Participants|Number|1|1.0||||||
4205044|NCT00737100|4028145|B2|Drinks alcohol but could interfere with trial||Alcohol history||Participants|Number|0|0.0||||||
4205045|NCT00737100|4028146|B1|Drinks alcohol but could interfere with trial||Alcohol history||Participants|Number|0|0.0||||||
4205046|NCT00737100|4028143|B4|Drinks alcohol but should not interfere with trial||Alcohol history||Participants|Number|135|135.0||||||
4205047|NCT00737100|4028144|B3|Drinks alcohol but should not interfere with trial||Alcohol history||Participants|Number|43|43.0||||||
4205048|NCT00737100|4028145|B2|Drinks alcohol but should not interfere with trial||Alcohol history||Participants|Number|54|54.0||||||
4205049|NCT00737100|4028146|B1|Drinks alcohol but should not interfere with trial||Alcohol history||Participants|Number|38|38.0||||||
4205050|NCT00737100|4028143|B4|Drinks no alcohol||Alcohol history||Participants|Number|374|374.0||||||
4205051|NCT00737100|4028144|B3|Drinks no alcohol||Alcohol history||Participants|Number|132|132.0||||||
4205052|NCT00737100|4028145|B2|Drinks no alcohol||Alcohol history||Participants|Number|112|112.0||||||
4205053|NCT00737100|4028146|B1|Drinks no alcohol||Alcohol history||Participants|Number|130|130.0||||||
4205054|NCT00737100|4028143|B4|||Body Mass Index||kilogram/square meter|Mean|20.1|20.1|Standard Deviation|4.2|4.2|||
4205055|NCT00737100|4028144|B3|||Body Mass Index||kilogram/square meter|Mean|20.0|20.0|Standard Deviation|4.1|4.1|||
4205056|NCT00737100|4028145|B2|||Body Mass Index||kilogram/square meter|Mean|19.9|19.9|Standard Deviation|4.0|4.0|||
4205057|NCT00737100|4028146|B1|||Body Mass Index||kilogram/square meter|Mean|20.3|20.3|Standard Deviation|4.4|4.4|||
4205058|NCT00737100|4028143|B4|||Weight||kilograms|Mean|51.2|51.2|Standard Deviation|18.1|18.1|||
4205059|NCT00737100|4028144|B3|||Weight||kilograms|Mean|50.4|50.4|Standard Deviation|18.2|18.2|||
4205060|NCT00737100|4028145|B2|||Weight||kilograms|Mean|51.0|51.0|Standard Deviation|17.3|17.3|||
4205061|NCT00737100|4028146|B1|||Weight||kilograms|Mean|52.1|52.1|Standard Deviation|19.0|19.0|||
4205062|NCT00737100|4028143|B4|||Height||centimeters|Mean|156.9|156.9|Standard Deviation|17.5|17.5|||
4205063|NCT00737100|4028144|B3|||Height||centimeters|Mean|155.7|155.7|Standard Deviation|18.2|18.2|||
4205064|NCT00737100|4028145|B2|||Height||centimeters|Mean|157.7|157.7|Standard Deviation|17.0|17.0|||
4205065|NCT00737100|4028146|B1|||Height||centimeters|Mean|157.4|157.4|Standard Deviation|17.2|17.2|||
4205066|NCT00737100|4028143|B4|American Indian / Alaskan native||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4205067|NCT00737100|4028144|B3|American Indian / Alaskan native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4205068|NCT00737100|4028145|B2|American Indian / Alaskan native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4205069|NCT00737100|4028146|B1|American Indian / Alaskan native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4205070|NCT00737100|4028143|B4|Missing||Race/Ethnicity, Customized||participants|Number|111|111.0||||||
4205071|NCT00737100|4028144|B3|Missing||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4205072|NCT00737100|4028145|B2|Missing||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4205073|NCT00737100|4028146|B1|Missing||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4205074|NCT00737100|4028143|B4|White||Race/Ethnicity, Customized||participants|Number|383|383.0||||||
4205075|NCT00737100|4028144|B3|White||Race/Ethnicity, Customized||participants|Number|132|132.0||||||
4205076|NCT00737100|4028145|B2|White||Race/Ethnicity, Customized||participants|Number|124|124.0||||||
4205077|NCT00737100|4028146|B1|White||Race/Ethnicity, Customized||participants|Number|127|127.0||||||
4205078|NCT00737100|4028143|B4|Black/African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4205079|NCT00737100|4028144|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4205080|NCT00737100|4028145|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4205081|NCT00737100|4028146|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4205082|NCT00737100|4028143|B4|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4205083|NCT00737100|4028144|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4205084|NCT00737100|4028145|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4205085|NCT00737100|4028146|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4205086|NCT00737100|4028143|B4||Male|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4205087|NCT00737100|4028144|B3||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4205088|NCT00737100|4028145|B2||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4205089|NCT00737100|4028146|B1||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4205090|NCT00737100|4028143|B4||Female|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4205091|NCT00737100|4028144|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4205092|NCT00737100|4028145|B2||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4205093|NCT00737100|4028146|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4205094|NCT00737100|4028143|B4|>= 12 years||Age, Customized||years|Number|372|372.0||||||
4205095|NCT00737100|4028144|B3|>= 12 years||Age, Customized||years|Number|124|124.0||||||
4205096|NCT00737100|4028145|B2|>= 12 years||Age, Customized||years|Number|124|124.0||||||
4205097|NCT00737100|4028146|B1|>= 12 years||Age, Customized||years|Number|124|124.0||||||
4205098|NCT00737100|4028143|B4|<= 11 years||Age, Customized||years|Number|138|138.0||||||
4205099|NCT00737100|4028144|B3|<= 11 years||Age, Customized||years|Number|52|52.0||||||
4205100|NCT00737100|4028145|B2|<= 11 years||Age, Customized||years|Number|42|42.0||||||
4205101|NCT00737100|4028146|B1|<= 11 years||Age, Customized||years|Number|44|44.0||||||
4205102|NCT00737100|4028143|B4|||Age||years|Mean|20.9|20.9|Standard Deviation|11.6|11.6|||
4205103|NCT00737100|4028144|B3|||Age||years|Mean|20.7|20.7|Standard Deviation|11.3|11.3|||
4205104|NCT00737100|4028145|B2|||Age||years|Mean|21.5|21.5|Standard Deviation|12.0|12.0|||
4205105|NCT00737100|4028146|B1|||Age||years|Mean|20.4|20.4|Standard Deviation|11.6|11.6|||
4205106|NCT00737061|4028192|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4205107|NCT00737061|4028192|B1||Female|Sex: Female, Male||Participants|Count of Participants|645|645.0||||||
4205108|NCT00737061|4028192|B1|All Participants||Age||years|Median|31.5|31.5|Full Range|||20.0|45.0|
4205109|NCT00737061|4028192|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4205110|NCT00737061|4028192|B1||Between 18 and 65 years|Age||Participants|Count of Participants|645|645.0||||||
4205111|NCT00737061|4028192|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4205112|NCT00737048|4028206|B4|||Visual Analog Scale (VAS) Score|Pain was assessed by using Visual Analogue Scale (VAS) score ranges from 0 millimeter (mm)=no pain to 100 mm=worst possible pain. An increase in score from Baseline represented disease progression and decrease represented treatment response.|Units on a scale|Mean|61.51|61.51|Standard Deviation|9.04|9.04|||
4205113|NCT00737048|4028207|B3|||Visual Analog Scale (VAS) Score|Pain was assessed by using Visual Analogue Scale (VAS) score ranges from 0 millimeter (mm)=no pain to 100 mm=worst possible pain. An increase in score from Baseline represented disease progression and decrease represented treatment response.|Units on a scale|Mean|61.32|61.32|Standard Deviation|8.81|8.81|||
4205114|NCT00737048|4028208|B2|||Visual Analog Scale (VAS) Score|Pain was assessed by using Visual Analogue Scale (VAS) score ranges from 0 millimeter (mm)=no pain to 100 mm=worst possible pain. An increase in score from Baseline represented disease progression and decrease represented treatment response.|Units on a scale|Mean|60.33|60.33|Standard Deviation|7.63|7.63|||
4205115|NCT00737048|4028209|B1|||Visual Analog Scale (VAS) Score|Pain was assessed by using Visual Analogue Scale (VAS) score ranges from 0 millimeter (mm)=no pain to 100 mm=worst possible pain. An increase in score from Baseline represented disease progression and decrease represented treatment response.|Units on a scale|Mean|62.28|62.28|Standard Deviation|9.85|9.85|||
4205116|NCT00737048|4028206|B4||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4205117|NCT00737048|4028207|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4205118|NCT00737048|4028208|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4205119|NCT00737048|4028209|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4205120|NCT00737048|4028206|B4||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4205121|NCT00737048|4028207|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4205122|NCT00737048|4028208|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4205123|NCT00737048|4028209|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4205124|NCT00737048|4028206|B4|||Age||Years|Mean|27.8|27.8|Standard Deviation|8.3|8.3|||
4205125|NCT00737048|4028207|B3|||Age||Years|Mean|27.5|27.5|Standard Deviation|8.2|8.2|||
4205126|NCT00737048|4028208|B2|||Age||Years|Mean|27.8|27.8|Standard Deviation|8.6|8.6|||
4205127|NCT00737048|4028209|B1|||Age||Years|Mean|28.1|28.1|Standard Deviation|8.3|8.3|||
4205128|NCT00736996|4028252|B4|United States||Region of Enrollment||participants|Number|66|66.0||||||
4205129|NCT00736996|4028253|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4205130|NCT00736996|4028254|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4205131|NCT00736996|4028255|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4205132|NCT00736996|4028252|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205133|NCT00736996|4028253|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205134|NCT00736996|4028254|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205135|NCT00736996|4028255|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205136|NCT00736996|4028252|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205137|NCT00736996|4028253|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205138|NCT00736996|4028254|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205139|NCT00736996|4028255|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205140|NCT00736996|4028252|B4||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4205141|NCT00736996|4028253|B3||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4205142|NCT00736996|4028254|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4205143|NCT00736996|4028255|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4205144|NCT00736996|4028252|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4205145|NCT00736996|4028253|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4205146|NCT00736996|4028254|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4205147|NCT00736996|4028255|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4205148|NCT00736996|4028252|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205149|NCT00736996|4028253|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205150|NCT00736996|4028254|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205151|NCT00736996|4028255|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205152|NCT00736996|4028252|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4205153|NCT00736996|4028253|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205154|NCT00736996|4028254|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4205155|NCT00736996|4028255|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205156|NCT00736996|4028252|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4205157|NCT00736996|4028253|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4205158|NCT00736996|4028254|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205159|NCT00736996|4028255|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4205160|NCT00736996|4028252|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4205161|NCT00736996|4028253|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4205162|NCT00736996|4028254|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205163|NCT00736996|4028255|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205164|NCT00736996|4028252|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4205165|NCT00736996|4028253|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4205166|NCT00736996|4028254|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4205167|NCT00736996|4028255|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4205168|NCT00736996|4028252|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4205169|NCT00736996|4028253|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205170|NCT00736996|4028254|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205171|NCT00736996|4028255|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4205172|NCT00736996|4028252|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4205173|NCT00736996|4028253|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4205174|NCT00736996|4028254|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4205175|NCT00736996|4028255|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4205176|NCT00736996|4028252|B4||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4205177|NCT00736996|4028253|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4205178|NCT00736996|4028254|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4205179|NCT00736996|4028255|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4205180|NCT00736996|4028252|B4|||Age||years|Mean|65|65.0|Standard Deviation|7|7.0|||
4205181|NCT00736996|4028253|B3|||Age||years|Mean|68|68.0|Standard Deviation|7|7.0|||
4205182|NCT00736996|4028254|B2|||Age||years|Mean|64|64.0|Standard Deviation|7|7.0|||
4205183|NCT00736996|4028255|B1|||Age||years|Mean|65|65.0|Standard Deviation|6|6.0|||
4205184|NCT00736957|4028271|B1||Male|Sex: Female, Male|Full analysis set included all participants who met the eligibility criteria, received study medication and had at least one post-treatment efiicacy assessment.|Participants|Count of Participants|84|84.0||||||
4205185|NCT00736957|4028271|B1||Female|Sex: Female, Male|Full analysis set included all participants who met the eligibility criteria, received study medication and had at least one post-treatment efiicacy assessment.|Participants|Count of Participants|106|106.0||||||
4205186|NCT00736957|4028271|B1|||Age|Full analysis set included all participants who met the eligibility criteria, received study medication and had at least one post-treatment efiicacy assessment.|years|Mean|64.3|64.3|Standard Deviation|12.9|12.9|||
4205187|NCT00736944|4028281|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4205188|NCT00736944|4028281|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4205189|NCT00736944|4028281|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4205190|NCT00736944|4028281|B1|||Age||years|Mean|54.5|54.5|Full Range|||39.0|70.0|
4205191|NCT00736944|4028281|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4205192|NCT00736944|4028281|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4205193|NCT00736944|4028281|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4205194|NCT00736879|4028308|B5|||Waist Circumference|Waist was measured in centimeters (cm).|cm|Mean|103.50|103.5|Standard Deviation|12.703|12.703|||
4205195|NCT00736879|4028309|B4|||Waist Circumference|Waist was measured in centimeters (cm).|cm|Mean|103.29|103.29|Standard Deviation|13.745|13.745|||
4205196|NCT00736879|4028310|B3|||Waist Circumference|Waist was measured in centimeters (cm).|cm|Mean|101.48|101.48|Standard Deviation|12.710|12.71|||
4205197|NCT00736879|4028311|B2|||Waist Circumference|Waist was measured in centimeters (cm).|cm|Mean|104.14|104.14|Standard Deviation|11.642|11.642|||
4205198|NCT00736879|4028312|B1|||Waist Circumference|Waist was measured in centimeters (cm).|cm|Mean|105.24|105.24|Standard Deviation|12.653|12.653|||
4205199|NCT00736879|4028308|B5|||Hemoglobin A1c (HbA1c) %||Percent of Hemoglobin|Mean|7.92|7.92|Standard Deviation|1.054|1.054|||
4205200|NCT00736879|4028309|B4|||Hemoglobin A1c (HbA1c) %||Percent of Hemoglobin|Mean|7.94|7.94|Standard Deviation|1.029|1.029|||
4205201|NCT00736879|4028310|B3|||Hemoglobin A1c (HbA1c) %||Percent of Hemoglobin|Mean|8.11|8.11|Standard Deviation|1.072|1.072|||
4205202|NCT00736879|4028311|B2|||Hemoglobin A1c (HbA1c) %||Percent of Hemoglobin|Mean|7.80|7.8|Standard Deviation|0.984|0.984|||
4205203|NCT00736879|4028312|B1|||Hemoglobin A1c (HbA1c) %||Percent of Hemoglobin|Mean|7.80|7.8|Standard Deviation|1.117|1.117|||
4205204|NCT00736879|4028308|B5|>=30 kg/m^2||Body Mass Index in Kg/m^2||participants|Number|171|171.0||||||
4205205|NCT00736879|4028309|B4|>=30 kg/m^2||Body Mass Index in Kg/m^2||participants|Number|37|37.0||||||
4205206|NCT00736879|4028310|B3|>=30 kg/m^2||Body Mass Index in Kg/m^2||participants|Number|45|45.0||||||
4205207|NCT00736879|4028311|B2|>=30 kg/m^2||Body Mass Index in Kg/m^2||participants|Number|48|48.0||||||
4205208|NCT00736879|4028312|B1|>=30 kg/m^2||Body Mass Index in Kg/m^2||participants|Number|41|41.0||||||
4205209|NCT00736879|4028308|B5|>=27 kg/m^2||Body Mass Index in Kg/m^2||participants|Number|219|219.0||||||
4205210|NCT00736879|4028309|B4|>=27 kg/m^2||Body Mass Index in Kg/m^2||participants|Number|48|48.0||||||
4205211|NCT00736879|4028310|B3|>=27 kg/m^2||Body Mass Index in Kg/m^2||participants|Number|54|54.0||||||
4205212|NCT00736879|4028311|B2|>=27 kg/m^2||Body Mass Index in Kg/m^2||participants|Number|57|57.0||||||
4205213|NCT00736879|4028312|B1|>=27 kg/m^2||Body Mass Index in Kg/m^2||participants|Number|60|60.0||||||
4205214|NCT00736879|4028308|B5|>=25 kg/m^2||Body Mass Index in Kg/m^2||participants|Number|256|256.0||||||
4205215|NCT00736879|4028309|B4|>=25 kg/m^2||Body Mass Index in Kg/m^2||participants|Number|61|61.0||||||
4205216|NCT00736879|4028310|B3|>=25 kg/m^2||Body Mass Index in Kg/m^2||participants|Number|64|64.0||||||
4205217|NCT00736879|4028311|B2|>=25 kg/m^2||Body Mass Index in Kg/m^2||participants|Number|66|66.0||||||
4205218|NCT00736879|4028312|B1|>=25 kg/m^2||Body Mass Index in Kg/m^2||participants|Number|65|65.0||||||
4205219|NCT00736879|4028308|B5|< 25 kg/m^2||Body Mass Index in Kg/m^2||participants|Number|26|26.0||||||
4205220|NCT00736879|4028309|B4|< 25 kg/m^2||Body Mass Index in Kg/m^2||participants|Number|7|7.0||||||
4205221|NCT00736879|4028310|B3|< 25 kg/m^2||Body Mass Index in Kg/m^2||participants|Number|10|10.0||||||
4205222|NCT00736879|4028311|B2|< 25 kg/m^2||Body Mass Index in Kg/m^2||participants|Number|6|6.0||||||
4205223|NCT00736879|4028312|B1|< 25 kg/m^2||Body Mass Index in Kg/m^2||participants|Number|3|3.0||||||
4205224|NCT00736879|4028308|B5|Ethnicity Not Reported||Race/Ethnicity, Customized||participants|Number|230|230.0||||||
4205225|NCT00736879|4028309|B4|Ethnicity Not Reported||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
4205226|NCT00736879|4028310|B3|Ethnicity Not Reported||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
4205227|NCT00736879|4028311|B2|Ethnicity Not Reported||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
4205228|NCT00736879|4028312|B1|Ethnicity Not Reported||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
4205229|NCT00736879|4028308|B5|Ethnicity Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4205230|NCT00736879|4028309|B4|Ethnicity Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4205231|NCT00736879|4028310|B3|Ethnicity Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4205232|NCT00736879|4028311|B2|Ethnicity Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4205233|NCT00736879|4028312|B1|Ethnicity Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4205234|NCT00736879|4028308|B5|Ethnicity Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4205235|NCT00736879|4028309|B4|Ethnicity Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4205236|NCT00736879|4028310|B3|Ethnicity Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4205237|NCT00736879|4028311|B2|Ethnicity Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4205238|NCT00736879|4028312|B1|Ethnicity Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4205239|NCT00736879|4028308|B5|Other Race||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4205240|NCT00736879|4028309|B4|Other Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4205241|NCT00736879|4028310|B3|Other Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4205242|NCT00736879|4028311|B2|Other Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4205243|NCT00736879|4028312|B1|Other Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4205244|NCT00736879|4028308|B5|Asian||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4205245|NCT00736879|4028309|B4|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4205246|NCT00736879|4028310|B3|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4205247|NCT00736879|4028311|B2|Asian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4205248|NCT00736879|4028312|B1|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4205249|NCT00736879|4028308|B5|Black/African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4205250|NCT00736879|4028309|B4|Black/African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4205251|NCT00736879|4028310|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4205252|NCT00736879|4028311|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4205253|NCT00736879|4028312|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4205254|NCT00736879|4028308|B5|White||Race/Ethnicity, Customized||participants|Number|229|229.0||||||
4205255|NCT00736879|4028309|B4|White||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
4205256|NCT00736879|4028310|B3|White||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
4205257|NCT00736879|4028311|B2|White||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
4205258|NCT00736879|4028312|B1|White||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
4205259|NCT00736879|4028308|B5||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4205260|NCT00736879|4028309|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4205261|NCT00736879|4028310|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4205262|NCT00736879|4028311|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4205263|NCT00736879|4028312|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4205264|NCT00736879|4028308|B5||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4205265|NCT00736879|4028309|B4||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4205266|NCT00736879|4028310|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4205267|NCT00736879|4028311|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4205268|NCT00736879|4028312|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4205269|NCT00736879|4028308|B5|Female > 50 years||Age, Customized|Female age less than equal to (<=) 50 years and greater than (>) 50 years.|participants|Number|86|86.0||||||
4205270|NCT00736879|4028309|B4|Female > 50 years||Age, Customized|Female age less than equal to (<=) 50 years and greater than (>) 50 years.|participants|Number|14|14.0||||||
4205271|NCT00736879|4028310|B3|Female > 50 years||Age, Customized|Female age less than equal to (<=) 50 years and greater than (>) 50 years.|participants|Number|29|29.0||||||
4205272|NCT00736879|4028311|B2|Female > 50 years||Age, Customized|Female age less than equal to (<=) 50 years and greater than (>) 50 years.|participants|Number|22|22.0||||||
4205273|NCT00736879|4028312|B1|Female > 50 years||Age, Customized|Female age less than equal to (<=) 50 years and greater than (>) 50 years.|participants|Number|21|21.0||||||
4205274|NCT00736879|4028308|B5|Female <= 50 years||Age, Customized|Female age less than equal to (<=) 50 years and greater than (>) 50 years.|participants|Number|55|55.0||||||
4205275|NCT00736879|4028309|B4|Female <= 50 years||Age, Customized|Female age less than equal to (<=) 50 years and greater than (>) 50 years.|participants|Number|22|22.0||||||
4205276|NCT00736879|4028310|B3|Female <= 50 years||Age, Customized|Female age less than equal to (<=) 50 years and greater than (>) 50 years.|participants|Number|11|11.0||||||
4205277|NCT00736879|4028311|B2|Female <= 50 years||Age, Customized|Female age less than equal to (<=) 50 years and greater than (>) 50 years.|participants|Number|12|12.0||||||
4205278|NCT00736879|4028312|B1|Female <= 50 years||Age, Customized|Female age less than equal to (<=) 50 years and greater than (>) 50 years.|participants|Number|10|10.0||||||
4205279|NCT00736879|4028308|B5|Not Reported||Age, Customized||participants|Number|0|0.0||||||
4205280|NCT00736879|4028309|B4|Not Reported||Age, Customized||participants|Number|0|0.0||||||
4205281|NCT00736879|4028310|B3|Not Reported||Age, Customized||participants|Number|0|0.0||||||
4205282|NCT00736879|4028311|B2|Not Reported||Age, Customized||participants|Number|0|0.0||||||
4205283|NCT00736879|4028312|B1|Not Reported||Age, Customized||participants|Number|0|0.0||||||
4205284|NCT00736879|4028308|B5|>= 75 years||Age, Customized||participants|Number|4|4.0||||||
4205285|NCT00736879|4028309|B4|>= 75 years||Age, Customized||participants|Number|1|1.0||||||
4205286|NCT00736879|4028310|B3|>= 75 years||Age, Customized||participants|Number|1|1.0||||||
4205287|NCT00736879|4028311|B2|>= 75 years||Age, Customized||participants|Number|0|0.0||||||
4205288|NCT00736879|4028312|B1|>= 75 years||Age, Customized||participants|Number|2|2.0||||||
4205289|NCT00736879|4028308|B5|Greater than, equal to (>=) 65 and < 75 years||Age, Customized||participants|Number|38|38.0||||||
4205290|NCT00736879|4028309|B4|Greater than, equal to (>=) 65 and < 75 years||Age, Customized||participants|Number|6|6.0||||||
4205291|NCT00736879|4028310|B3|Greater than, equal to (>=) 65 and < 75 years||Age, Customized||participants|Number|12|12.0||||||
4205292|NCT00736879|4028311|B2|Greater than, equal to (>=) 65 and < 75 years||Age, Customized||participants|Number|9|9.0||||||
4205293|NCT00736879|4028312|B1|Greater than, equal to (>=) 65 and < 75 years||Age, Customized||participants|Number|11|11.0||||||
4205294|NCT00736879|4028308|B5|Less than (<) 65 years||Age, Customized||participants|Number|240|240.0||||||
4205295|NCT00736879|4028309|B4|Less than (<) 65 years||Age, Customized||participants|Number|61|61.0||||||
4205296|NCT00736879|4028310|B3|Less than (<) 65 years||Age, Customized||participants|Number|61|61.0||||||
4205297|NCT00736879|4028311|B2|Less than (<) 65 years||Age, Customized||participants|Number|63|63.0||||||
4205298|NCT00736879|4028312|B1|Less than (<) 65 years||Age, Customized||participants|Number|55|55.0||||||
4205299|NCT00736879|4028308|B5|||Age||years|Mean|53.0|53.0|Standard Deviation|10.57|10.57|||
4205300|NCT00736879|4028309|B4|||Age||years|Mean|51.3|51.3|Standard Deviation|11.51|11.51|||
4205301|NCT00736879|4028310|B3|||Age||years|Mean|53.5|53.5|Standard Deviation|10.61|10.61|||
4205302|NCT00736879|4028311|B2|||Age||years|Mean|53.7|53.7|Standard Deviation|9.04|9.04|||
4205303|NCT00736879|4028312|B1|||Age||years|Mean|53.5|53.5|Standard Deviation|11.08|11.08|||
4205304|NCT00736853|4028369|B1||Male|Sex: Female, Male|Efficacy analysis set: Participants who received at least 1 dose of study drug.|Participants|Count of Participants|109|109.0||||||
4205305|NCT00736853|4028369|B1||Female|Sex: Female, Male|Efficacy analysis set: Participants who received at least 1 dose of study drug.|Participants|Count of Participants|168|168.0||||||
4205306|NCT00736853|4028369|B1|||Age|Efficacy analysis set: Participants who received at least 1 dose of study drug.|years|Mean|57.0|57.0|Standard Deviation|17.5|17.5|||
4205307|NCT00736840|4028411|B1|Israel||Region of Enrollment||participants|Number|87|87.0||||||
4205308|NCT00736840|4028411|B1|United States||Region of Enrollment||participants|Number|327|327.0||||||
4205309|NCT00736840|4028411|B1||Male|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
4205310|NCT00736840|4028411|B1||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4205311|NCT00736840|4028411|B1|||Age||years|Mean|51.3|51.3|Standard Deviation|10.9|10.9|||
4205312|NCT00736840|4028411|B1||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4205313|NCT00736840|4028411|B1||Between 18 and 65 years|Age||Participants|Count of Participants|374|374.0||||||
4205314|NCT00736840|4028411|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4205315|NCT00736723|4028416|B3|Germany||Region of Enrollment||participants|Number|44|44.0||||||
4205316|NCT00736723|4028417|B2|Germany||Region of Enrollment||participants|Number|18|18.0||||||
4205317|NCT00736723|4028418|B1|Germany||Region of Enrollment||participants|Number|26|26.0||||||
4205318|NCT00736723|4028416|B3||Male|Gender||Participants|Count of Participants|35|35.0||||||
4205319|NCT00736723|4028417|B2||Male|Gender||Participants|Count of Participants|16|16.0||||||
4205320|NCT00736723|4028418|B1||Male|Gender||Participants|Count of Participants|19|19.0||||||
4205321|NCT00736723|4028416|B3||Female|Gender||Participants|Count of Participants|9|9.0||||||
4205322|NCT00736723|4028417|B2||Female|Gender||Participants|Count of Participants|2|2.0||||||
4205323|NCT00736723|4028418|B1||Female|Gender||Participants|Count of Participants|7|7.0||||||
4205324|NCT00736723|4028416|B3|||Age||years|Median|57|57.0|Full Range|||20.0|88.0|
4205325|NCT00736723|4028417|B2|||Age||years|Median|60|60.0|Full Range|||37.0|88.0|
4205326|NCT00736723|4028418|B1|||Age||years|Median|53|53.0|Full Range|||20.0|80.0|
4205327|NCT00736723|4028416|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4205328|NCT00736723|4028417|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4205329|NCT00736723|4028418|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4205330|NCT00736723|4028416|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4205331|NCT00736723|4028417|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4205332|NCT00736723|4028418|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4205333|NCT00736723|4028416|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4205334|NCT00736723|4028417|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4205335|NCT00736723|4028418|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4205336|NCT00736645|4028425|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205337|NCT00736645|4028426|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205338|NCT00736645|4028427|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205339|NCT00736645|4028428|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205340|NCT00736645|4028429|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205341|NCT00736645|4028425|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205342|NCT00736645|4028426|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205343|NCT00736645|4028427|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205344|NCT00736645|4028428|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205345|NCT00736645|4028429|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205346|NCT00736645|4028425|B5||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4205347|NCT00736645|4028426|B4||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4205348|NCT00736645|4028427|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4205349|NCT00736645|4028428|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4205350|NCT00736645|4028429|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4205351|NCT00736645|4028425|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4205352|NCT00736645|4028426|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205353|NCT00736645|4028427|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4205354|NCT00736645|4028428|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4205355|NCT00736645|4028429|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4205356|NCT00736645|4028425|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205357|NCT00736645|4028426|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205358|NCT00736645|4028427|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205359|NCT00736645|4028428|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205360|NCT00736645|4028429|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205361|NCT00736645|4028425|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205362|NCT00736645|4028426|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205363|NCT00736645|4028427|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205364|NCT00736645|4028428|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205365|NCT00736645|4028429|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205366|NCT00736645|4028425|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205367|NCT00736645|4028426|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205368|NCT00736645|4028427|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205369|NCT00736645|4028428|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205370|NCT00736645|4028429|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205371|NCT00736645|4028425|B5||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4205372|NCT00736645|4028426|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4205373|NCT00736645|4028427|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4205374|NCT00736645|4028428|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4205375|NCT00736645|4028429|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4205376|NCT00736645|4028425|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4205377|NCT00736645|4028426|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4205378|NCT00736645|4028427|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4205379|NCT00736645|4028428|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4205380|NCT00736645|4028429|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4205381|NCT00736645|4028425|B5|||Age||years|Mean|60.8|60.8|Standard Deviation|6.9|6.9|||
4205382|NCT00736645|4028426|B4|||Age||years|Mean|61.9|61.9|Standard Deviation|6.8|6.8|||
4205383|NCT00736645|4028427|B3|||Age||years|Mean|61.2|61.2|Standard Deviation|5.2|5.2|||
4205384|NCT00736645|4028428|B2|||Age||years|Mean|62.0|62.0|Standard Deviation|7.7|7.7|||
4205385|NCT00736645|4028429|B1|||Age||years|Mean|57.9|57.9|Standard Deviation|7.5|7.5|||
4205386|NCT00736580|4028446|B3|United States||Region of Enrollment||participants|Number|240|240.0||||||
4205387|NCT00736580|4028447|B2|United States||Region of Enrollment||participants|Number|123|123.0||||||
4205388|NCT00736580|4028448|B1|United States||Region of Enrollment||participants|Number|117|117.0||||||
4205389|NCT00736580|4028446|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4205390|NCT00736580|4028447|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4205391|NCT00736580|4028448|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4205392|NCT00736580|4028446|B3||Female|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
4205393|NCT00736580|4028447|B2||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4205394|NCT00736580|4028448|B1||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4205395|NCT00736580|4028446|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4205396|NCT00736580|4028447|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4205397|NCT00736580|4028448|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4205398|NCT00736580|4028446|B3||Between 18 and 65 years|Age||Participants|Count of Participants|240|240.0||||||
4205399|NCT00736580|4028447|B2||Between 18 and 65 years|Age||Participants|Count of Participants|123|123.0||||||
4205400|NCT00736580|4028448|B1||Between 18 and 65 years|Age||Participants|Count of Participants|117|117.0||||||
4205401|NCT00736580|4028446|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4205402|NCT00736580|4028447|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4205403|NCT00736580|4028448|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4205404|NCT00736502|4028455|B1||Male|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
4205405|NCT00736502|4028455|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4205406|NCT00736502|4028455|B1|||Age||Years|Mean|38.5|38.5|Standard Deviation|10.3|10.3|||
4205407|NCT00736489|4028461|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4205408|NCT00736489|4028461|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4205409|NCT00736489|4028461|B1|||Age||years|Mean|40.3|40.3|Full Range|||22.0|68.0|
4205410|NCT00736476|4028618|B3||Male|Gender||Participants|Count of Participants|30|30.0||||||
4205411|NCT00736476|4028619|B2||Male|Gender||Participants|Count of Participants|10|10.0||||||
4205412|NCT00736476|4028620|B1||Male|Gender||Participants|Count of Participants|20|20.0||||||
4205413|NCT00736476|4028618|B3||Female|Gender||Participants|Count of Participants|33|33.0||||||
4205414|NCT00736476|4028619|B2||Female|Gender||Participants|Count of Participants|17|17.0||||||
4205415|NCT00736476|4028620|B1||Female|Gender||Participants|Count of Participants|16|16.0||||||
4205416|NCT00736476|4028618|B3|||Age||years|Mean|26.1|26.1|Standard Deviation|5.1|5.1|||
4205417|NCT00736476|4028619|B2|||Age||years|Mean|24.0|24.0|Standard Deviation|3.3|3.3|||
4205418|NCT00736476|4028620|B1|||Age||years|Mean|27.6|27.6|Standard Deviation|5.7|5.7|||
4205419|NCT00736450|4028641|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4205420|NCT00736450|4028641|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4205421|NCT00736450|4028641|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4205422|NCT00736450|4028641|B1|||Age||years|Mean|53|53.0|Full Range|||30.0|75.0|
4205423|NCT00736385|4028647|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4205424|NCT00736385|4028648|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4205425|NCT00736385|4028649|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4205426|NCT00736385|4028647|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205427|NCT00736385|4028648|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205428|NCT00736385|4028649|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205429|NCT00736385|4028647|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205430|NCT00736385|4028648|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205431|NCT00736385|4028649|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205432|NCT00736385|4028647|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4205433|NCT00736385|4028648|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4205434|NCT00736385|4028649|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4205435|NCT00736385|4028647|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205436|NCT00736385|4028648|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205437|NCT00736385|4028649|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205438|NCT00736385|4028647|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205439|NCT00736385|4028648|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205440|NCT00736385|4028649|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205441|NCT00736385|4028647|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205442|NCT00736385|4028648|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205443|NCT00736385|4028649|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205444|NCT00736385|4028647|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205445|NCT00736385|4028648|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205446|NCT00736385|4028649|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205447|NCT00736385|4028647|B3||Male|Gender||Participants|Count of Participants|7|7.0||||||
4205448|NCT00736385|4028648|B2||Male|Gender||Participants|Count of Participants|3|3.0||||||
4205449|NCT00736385|4028649|B1||Male|Gender||Participants|Count of Participants|4|4.0||||||
4205450|NCT00736385|4028647|B3||Female|Gender||Participants|Count of Participants|2|2.0||||||
4205451|NCT00736385|4028648|B2||Female|Gender||Participants|Count of Participants|2|2.0||||||
4205452|NCT00736385|4028649|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
4205453|NCT00736385|4028647|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4205454|NCT00736385|4028648|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4205455|NCT00736385|4028649|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4205456|NCT00736385|4028647|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4205457|NCT00736385|4028648|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4205458|NCT00736385|4028649|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4205459|NCT00736385|4028647|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4205460|NCT00736385|4028648|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4205461|NCT00736385|4028649|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4205462|NCT00736333|4028662|B1||Male|Sex: Female, Male|Gender information was available only for the ITT population.|Participants|Count of Participants|1|1.0||||||
4205463|NCT00736333|4028662|B1||Female|Sex: Female, Male|Gender information was available only for the ITT population.|Participants|Count of Participants|159|159.0||||||
4205464|NCT00736333|4028662|B1|||Age|Age was calculated for the intent-to-treat (ITT) population only (those who received at least one dose of study medication).|years|Mean|62|62.0|Standard Deviation|12|12.0|||
4205465|NCT00736255|4028671|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4205466|NCT00736255|4028672|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4205467|NCT00736255|4028673|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4205468|NCT00736255|4028671|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4205469|NCT00736255|4028672|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4205470|NCT00736255|4028673|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4205471|NCT00736255|4028671|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4205472|NCT00736255|4028672|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4205473|NCT00736255|4028673|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4205474|NCT00736255|4028671|B3|||Age||years|Mean|31|31.0|Standard Deviation|8.5|8.5|||
4205475|NCT00736255|4028672|B2|||Age||years|Mean|33.5|33.5|Standard Deviation|9.1|9.1|||
4205476|NCT00736255|4028673|B1|||Age||years|Mean|29.6|29.6|Standard Deviation|8.4|8.4|||
4205477|NCT00736255|4028671|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4205478|NCT00736255|4028672|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4205479|NCT00736255|4028673|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4205480|NCT00736255|4028671|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4205481|NCT00736255|4028672|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4205482|NCT00736255|4028673|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4205483|NCT00736255|4028671|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4205484|NCT00736255|4028672|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4205485|NCT00736255|4028673|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4205486|NCT00736242|4028692|B1||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4205487|NCT00736242|4028692|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4205488|NCT00736242|4028692|B1|Missing Data||Age, Customized||participants|Number|2|2.0||||||
4205489|NCT00736242|4028692|B1|≥40 years||Age, Customized||participants|Number|119|119.0||||||
4205490|NCT00736242|4028692|B1|≤40 years||Age, Customized||participants|Number|108|108.0||||||
4205491|NCT00736229|4028703|B4|United States||Region of Enrollment||participants|Number|195|195.0||||||
4205492|NCT00736229|4028704|B3|United States||Region of Enrollment||participants|Number|84|84.0||||||
4205493|NCT00736229|4028705|B2|United States||Region of Enrollment||participants|Number|71|71.0||||||
4205494|NCT00736229|4028706|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4205495|NCT00736229|4028703|B4||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4205496|NCT00736229|4028704|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4205497|NCT00736229|4028705|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4205498|NCT00736229|4028706|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4205499|NCT00736229|4028703|B4||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4205500|NCT00736229|4028704|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4205501|NCT00736229|4028705|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4205502|NCT00736229|4028706|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4205503|NCT00736229|4028703|B4|||Age||years|Mean|64.18|64.18|Standard Deviation|12.5|12.5|||
4205504|NCT00736229|4028704|B3|||Age||years|Mean|64|64.0|Standard Deviation|13.7|13.7|||
4205505|NCT00736229|4028705|B2|||Age||years|Mean|64|64.0|Standard Deviation|11.5|11.5|||
4205506|NCT00736229|4028706|B1|||Age||years|Mean|65|65.0|Standard Deviation|11.9|11.9|||
4205507|NCT00736229|4028703|B4||>=65 years|Age||Participants|Count of Participants|88|88.0||||||
4205508|NCT00736229|4028704|B3||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4205509|NCT00736229|4028705|B2||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4205510|NCT00736229|4028706|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4205511|NCT00736229|4028703|B4||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
4205512|NCT00736229|4028704|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4205513|NCT00736229|4028705|B2||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4205514|NCT00736229|4028706|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4205515|NCT00736229|4028703|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4205516|NCT00736229|4028704|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4205517|NCT00736229|4028705|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4205518|NCT00736229|4028706|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4205519|NCT00736190|4028721|B1|Genotype C||HBV genotype|Genotypic analysis was conducted at baseline for all participants.|Participants|Number|47|47.0||||||
4205520|NCT00736190|4028721|B1|Genotype B||HBV genotype|Genotypic analysis was conducted at baseline for all participants.|Participants|Number|43|43.0||||||
4205521|NCT00736190|4028721|B1|<=ULN||ALT|Blood samples were collected for serum chemistry. The ULN for ALT was 34 U/L.|Participants|Number|23|23.0||||||
4205522|NCT00736190|4028721|B1|>ULN||ALT|Blood samples were collected for serum chemistry. The ULN for ALT was 34 U/L.|Participants|Number|67|67.0||||||
4205523|NCT00736190|4028721|B1|||ALT (Multiples of ULN)|Blood samples were collected for serum chemistry. Multiples are based on ULN of 34 U/L.|multiples of ULN|Mean|2.628|2.628|Standard Deviation|3.5698|3.5698|||
4205524|NCT00736190|4028721|B1|||Alanine aminotransferase (ALT); upper limit of normal (ULN) = 34 U/L|Blood samples were collected for serum chemistry.|U/L|Mean|103.5|103.5|Standard Deviation|149.61|149.61|||
4205525|NCT00736190|4028721|B1|||Positive Hepatitis B surface antigen (HBsAg)|Blood samples were collected for HBV serology.|Participants|Number|90|90.0||||||
4205526|NCT00736190|4028721|B1|Unknown||Antibody to HBeAg (Anti-HBe)|Blood samples were collected for HBV serology.|Participants|Number|52|52.0||||||
4205527|NCT00736190|4028721|B1|Positive||Antibody to HBeAg (Anti-HBe)|Blood samples were collected for HBV serology.|Participants|Number|38|38.0||||||
4205528|NCT00736190|4028721|B1|Negative||Hepatitis B e antigen (HBeAg)|Blood samples were collected for HBV serology.|Participants|Number|37|37.0||||||
4205529|NCT00736190|4028721|B1|Positive||Hepatitis B e antigen (HBeAg)|Blood samples were collected for HBV serology.|Participants|Number|53|53.0||||||
4205530|NCT00736190|4028721|B1|||Hepatitis B virus (HBV) deoxyribonucleic acid (DNA)|Plasma HBV DNA was analyzed using polymerase chain reaction (PCR) method.|log10 copies/mL|Mean|7.484|7.484|Standard Deviation|1.7678|1.7678|||
4205531|NCT00736190|4028721|B1|Asian-Cambodian||Ethnicity||Participants|Number|1|1.0||||||
4205532|NCT00736190|4028721|B1|Asian-Vietnamese||Ethnicity||Participants|Number|19|19.0||||||
4205533|NCT00736190|4028721|B1|Asian-Korean||Ethnicity||Participants|Number|12|12.0||||||
4205534|NCT00736190|4028721|B1|Asian-Chinese||Ethnicity||Participants|Number|58|58.0||||||
4205535|NCT00736190|4028721|B1|United States||Region of Enrollment||participants|Number|90|90.0||||||
4205536|NCT00736190|4028721|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205537|NCT00736190|4028721|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205538|NCT00736190|4028721|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205539|NCT00736190|4028721|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205540|NCT00736190|4028721|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205541|NCT00736190|4028721|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4205542|NCT00736190|4028721|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205543|NCT00736190|4028721|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4205544|NCT00736190|4028721|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4205545|NCT00736190|4028721|B1|||Age||years|Mean|36.8|36.8|Standard Deviation|10.49|10.49|||
4205546|NCT00736125|4028734|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4205547|NCT00736125|4028735|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4205548|NCT00736125|4028736|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4205549|NCT00736125|4028734|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4205550|NCT00736125|4028735|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4205551|NCT00736125|4028736|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4205552|NCT00736125|4028734|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4205553|NCT00736125|4028735|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4205554|NCT00736125|4028736|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4205555|NCT00736125|4028734|B3|||Age||years|Mean|63.1|63.1|Standard Deviation|3.5|3.5|||
4205556|NCT00736125|4028735|B2|||Age||years|Mean|63.9|63.9|Standard Deviation|3.7|3.7|||
4205557|NCT00736125|4028736|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|3.3|3.3|||
4205558|NCT00736125|4028734|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4205559|NCT00736125|4028735|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4205560|NCT00736125|4028736|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4205561|NCT00736125|4028734|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4205562|NCT00736125|4028735|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4205563|NCT00736125|4028736|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4205564|NCT00736125|4028734|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4205565|NCT00736125|4028735|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4205566|NCT00736125|4028736|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4205567|NCT00736099|4028745|B3|||Fasting plasma glucose (FPG) at baseline||mg/dL|Mean|155.12|155.12|Standard Deviation|36.34|36.34|||
4205568|NCT00736099|4028746|B2|||Fasting plasma glucose (FPG) at baseline||mg/dL|Mean|164.31|164.31|Standard Deviation|37.36|37.36|||
4205569|NCT00736099|4028747|B1|||Fasting plasma glucose (FPG) at baseline||mg/dL|Mean|151.59|151.59|Standard Deviation|35.32|35.32|||
4205570|NCT00736099|4028745|B3|||Baseline Glycosylated haemoglobin (HbA1c) at baseline||percent|Mean|7.51|7.51|Standard Deviation|0.97|0.97|||
4205571|NCT00736099|4028746|B2|||Baseline Glycosylated haemoglobin (HbA1c) at baseline||percent|Mean|7.87|7.87|Standard Deviation|1.04|1.04|||
4205572|NCT00736099|4028747|B1|||Baseline Glycosylated haemoglobin (HbA1c) at baseline||percent|Mean|7.38|7.38|Standard Deviation|0.90|0.9|||
4205573|NCT00736099|4028745|B3|||Baseline weight||kg|Mean|79.1|79.1|Standard Deviation|16.9|16.9|||
4205574|NCT00736099|4028746|B2|||Baseline weight||kg|Mean|80.1|80.1|Standard Deviation|16.9|16.9|||
4205575|NCT00736099|4028747|B1|||Baseline weight||kg|Mean|78.7|78.7|Standard Deviation|16.9|16.9|||
4205576|NCT00736099|4028745|B3|||Body mass index (BMI) continuous||kg/m^2|Mean|28.95|28.95|Standard Deviation|4.85|4.85|||
4205577|NCT00736099|4028746|B2|||Body mass index (BMI) continuous||kg/m^2|Mean|29.18|29.18|Standard Deviation|4.91|4.91|||
4205578|NCT00736099|4028747|B1|||Body mass index (BMI) continuous||kg/m^2|Mean|28.86|28.86|Standard Deviation|4.82|4.82|||
4205579|NCT00736099|4028745|B3||Male|Sex: Female, Male||Participants|Count of Participants|1099|1099.0||||||
4205580|NCT00736099|4028746|B2||Male|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
4205581|NCT00736099|4028747|B1||Male|Sex: Female, Male||Participants|Count of Participants|789|789.0||||||
4205582|NCT00736099|4028745|B3||Female|Sex: Female, Male||Participants|Count of Participants|1022|1022.0||||||
4205583|NCT00736099|4028746|B2||Female|Sex: Female, Male||Participants|Count of Participants|279|279.0||||||
4205584|NCT00736099|4028747|B1||Female|Sex: Female, Male||Participants|Count of Participants|743|743.0||||||
4205585|NCT00736099|4028745|B3|||Age||years|Mean|57.5|57.5|Standard Deviation|9.9|9.9|||
4205586|NCT00736099|4028746|B2|||Age||years|Mean|56.7|56.7|Standard Deviation|10.0|10.0|||
4205587|NCT00736099|4028747|B1|||Age||years|Mean|57.8|57.8|Standard Deviation|9.8|9.8|||
4205588|NCT00736073|4028844|B3|United States||Region of Enrollment||participants|Number|73|73.0||||||
4205589|NCT00736073|4028845|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
4205590|NCT00736073|4028846|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4205591|NCT00736073|4028844|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4205592|NCT00736073|4028845|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4205593|NCT00736073|4028846|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4205594|NCT00736073|4028844|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4205595|NCT00736073|4028845|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4205596|NCT00736073|4028846|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4205597|NCT00736073|4028844|B3|||Age||years|Mean|48|48.0|Standard Deviation|15|15.0|||
4205598|NCT00736073|4028845|B2|||Age||years|Mean|46|46.0|Standard Deviation|12|12.0|||
4205599|NCT00736073|4028846|B1|||Age||years|Mean|50|50.0|Standard Deviation|17|17.0|||
4205600|NCT00736073|4028844|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4205601|NCT00736073|4028845|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4205602|NCT00736073|4028846|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4205603|NCT00736073|4028844|B3||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4205604|NCT00736073|4028845|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4205605|NCT00736073|4028846|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4205606|NCT00736073|4028844|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4205607|NCT00736073|4028845|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4205608|NCT00736073|4028846|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4205609|NCT00736034|4028857|B1|Israel||Region of Enrollment||participants|Number|18|18.0||||||
4205610|NCT00736034|4028857|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4205611|NCT00736034|4028857|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4205612|NCT00736034|4028857|B1|||Age||years|Mean|75.29|75.29|Standard Deviation|7.09|7.09|||
4205613|NCT00735969|4028861|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4205614|NCT00735969|4028861|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4205615|NCT00735969|4028861|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4205616|NCT00735969|4028861|B1|||Age||years|Mean|55|55.0|Standard Deviation|8|8.0|||
4205617|NCT00735943|4028865|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4205618|NCT00735943|4028865|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4205619|NCT00735943|4028865|B1|||Age||years|Mean|70.4|70.4|Standard Deviation|10.9|10.9|||
4205620|NCT00735917|4028882|B1|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4205621|NCT00735917|4028882|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4205622|NCT00735917|4028882|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4205623|NCT00735917|4028882|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4205624|NCT00735917|4028882|B1|||Age||years|Median|63|63.0|Full Range|||34.0|78.0|
4205625|NCT00735904|4028890|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4205626|NCT00735904|4028890|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4205627|NCT00735904|4028890|B1|||Age||Years|Mean|60.5|60.5|Standard Deviation|7.1|7.1|||
4205628|NCT00735878|4028897|B4|United States||Region of Enrollment||participants|Number|20|20.0||||||
4205629|NCT00735878|4028898|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4205630|NCT00735878|4028899|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4205631|NCT00735878|4028900|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4205632|NCT00735878|4028897|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4205633|NCT00735878|4028898|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4205634|NCT00735878|4028899|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4205635|NCT00735878|4028900|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4205636|NCT00735878|4028897|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4205637|NCT00735878|4028898|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4205638|NCT00735878|4028899|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4205639|NCT00735878|4028900|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4205640|NCT00735878|4028897|B4|||Age||years|Mean|62|62.0|Standard Deviation|8.28|8.28|||
4205641|NCT00735878|4028898|B3|||Age||years|Mean|63|63.0|Standard Deviation|9.28|9.28|||
4205642|NCT00735878|4028899|B2|||Age||years|Mean|62|62.0|Standard Deviation|7.65|7.65|||
4205643|NCT00735878|4028900|B1|||Age||years|Mean|63|63.0|Standard Deviation|||||
4205644|NCT00735878|4028897|B4||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4205645|NCT00735878|4028898|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4205646|NCT00735878|4028899|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4205647|NCT00735878|4028900|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4205648|NCT00735878|4028897|B4||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4205649|NCT00735878|4028898|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4205650|NCT00735878|4028899|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4205651|NCT00735878|4028900|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4205652|NCT00735878|4028897|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4205653|NCT00735878|4028898|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4205654|NCT00735878|4028899|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4205655|NCT00735878|4028900|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4205656|NCT00735839|4028913|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4205657|NCT00735839|4028914|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4205658|NCT00735839|4028915|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4205659|NCT00735839|4028913|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4205660|NCT00735839|4028914|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4205661|NCT00735839|4028915|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4205662|NCT00735839|4028913|B3|>74 years||Age, Customized||participants|Number|0|0.0||||||
4205663|NCT00735839|4028914|B2|>74 years||Age, Customized||participants|Number|0|0.0||||||
4205664|NCT00735839|4028915|B1|>74 years||Age, Customized||participants|Number|0|0.0||||||
4205665|NCT00735839|4028913|B3|20-74 years||Age, Customized||participants|Number|40|40.0||||||
4205666|NCT00735839|4028914|B2|20-74 years||Age, Customized||participants|Number|10|10.0||||||
4205667|NCT00735839|4028915|B1|20-74 years||Age, Customized||participants|Number|30|30.0||||||
4205668|NCT00735839|4028913|B3|<20 years||Age, Customized||participants|Number|0|0.0||||||
4205669|NCT00735839|4028914|B2|<20 years||Age, Customized||participants|Number|0|0.0||||||
4205670|NCT00735839|4028915|B1|<20 years||Age, Customized||participants|Number|0|0.0||||||
4205671|NCT00735826|4028924|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4205672|NCT00735826|4028924|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4205673|NCT00735826|4028924|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4205674|NCT00735826|4028924|B1|||Age||years|Mean|67|67.0|Standard Deviation|17.33|17.33|||
4205675|NCT00735826|4028924|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4205676|NCT00735826|4028924|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4205677|NCT00735826|4028924|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4205678|NCT00735787|4028930|B3|Canada||Region of Enrollment||participants|Number|43|43.0||||||
4205679|NCT00735787|4028931|B2|Canada||Region of Enrollment||participants|Number|29|29.0||||||
4205680|NCT00735787|4028932|B1|Canada||Region of Enrollment||participants|Number|14|14.0||||||
4205681|NCT00735787|4028930|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
4205682|NCT00735787|4028931|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4205683|NCT00735787|4028932|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4205684|NCT00735787|4028930|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4205685|NCT00735787|4028931|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4205686|NCT00735787|4028932|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4205687|NCT00735787|4028930|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4205688|NCT00735787|4028931|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4205689|NCT00735787|4028932|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4205690|NCT00735787|4028930|B3|||Age||years|Mean|50.9|50.9|Standard Deviation|11.65|11.65|||
4205691|NCT00735787|4028931|B2|||Age||years|Mean|49.0|49.0|Standard Deviation|11.41|11.41|||
4205692|NCT00735787|4028932|B1|||Age||years|Mean|54.8|54.8|Standard Deviation|11.40|11.4|||
4205693|NCT00735787|4028930|B3|>= 60 years||Age||subjects|Number|17|17.0||||||
4205694|NCT00735787|4028931|B2|>= 60 years||Age||subjects|Number|9|9.0||||||
4205695|NCT00735787|4028932|B1|>= 60 years||Age||subjects|Number|8|8.0||||||
4205696|NCT00735787|4028930|B3|Between 40 and < 60 years||Age||subjects|Number|43|43.0||||||
4205697|NCT00735787|4028931|B2|Between 40 and < 60 years||Age||subjects|Number|29|29.0||||||
4205698|NCT00735787|4028932|B1|Between 40 and < 60 years||Age||subjects|Number|14|14.0||||||
4205699|NCT00735787|4028930|B3|< 40 years||Age||subjects|Number|12|12.0||||||
4205700|NCT00735787|4028931|B2|< 40 years||Age||subjects|Number|11|11.0||||||
4205701|NCT00735787|4028932|B1|< 40 years||Age||subjects|Number|1|1.0||||||
4205702|NCT00735709|4028977|B5|||Hospital Anxiety and Depression – Depression subscale|The HAD - Depression subscale is completed by the participant and measures depression, focusing on the state of lost interest and diminished pleasure response. The subscale is made up of 7 items that are assessed on a scale from 0 (no depression) to 3 (severe feeling of depression). Participants are required to indicate the response which most accurately reflects the way they have felt over the last few days. The item scores are summed and the total subscore ranges from 0 to 21 (maximal severity).|scores on a scale|Mean|13.7|13.7|Standard Deviation|3.99|3.99|||
4205776|NCT00735709|4028981|B1|||Body Mass Index (BMI)||kg/m^2|Mean|26.36|26.36|Standard Deviation|4.615|4.615|||
4205777|NCT00735709|4028977|B5|||Height||cm|Mean|168.63|168.63|Standard Deviation|9.129|9.129|||
4205778|NCT00735709|4028978|B4|||Height||cm|Mean|168.70|168.7|Standard Deviation|10.209|10.209|||
4205779|NCT00735709|4028979|B3|||Height||cm|Mean|168.56|168.56|Standard Deviation|9.126|9.126|||
4205703|NCT00735709|4028978|B4|||Hospital Anxiety and Depression – Depression subscale|The HAD - Depression subscale is completed by the participant and measures depression, focusing on the state of lost interest and diminished pleasure response. The subscale is made up of 7 items that are assessed on a scale from 0 (no depression) to 3 (severe feeling of depression). Participants are required to indicate the response which most accurately reflects the way they have felt over the last few days. The item scores are summed and the total subscore ranges from 0 to 21 (maximal severity).|scores on a scale|Mean|13.8|13.8|Standard Deviation|3.71|3.71|||
4205704|NCT00735709|4028979|B3|||Hospital Anxiety and Depression – Depression subscale|The HAD - Depression subscale is completed by the participant and measures depression, focusing on the state of lost interest and diminished pleasure response. The subscale is made up of 7 items that are assessed on a scale from 0 (no depression) to 3 (severe feeling of depression). Participants are required to indicate the response which most accurately reflects the way they have felt over the last few days. The item scores are summed and the total subscore ranges from 0 to 21 (maximal severity).|scores on a scale|Mean|13.4|13.4|Standard Deviation|4.02|4.02|||
4205705|NCT00735709|4028980|B2|||Hospital Anxiety and Depression – Depression subscale|The HAD - Depression subscale is completed by the participant and measures depression, focusing on the state of lost interest and diminished pleasure response. The subscale is made up of 7 items that are assessed on a scale from 0 (no depression) to 3 (severe feeling of depression). Participants are required to indicate the response which most accurately reflects the way they have felt over the last few days. The item scores are summed and the total subscore ranges from 0 to 21 (maximal severity).|scores on a scale|Mean|13.8|13.8|Standard Deviation|3.88|3.88|||
4205706|NCT00735709|4028981|B1|||Hospital Anxiety and Depression – Depression subscale|The HAD - Depression subscale is completed by the participant and measures depression, focusing on the state of lost interest and diminished pleasure response. The subscale is made up of 7 items that are assessed on a scale from 0 (no depression) to 3 (severe feeling of depression). Participants are required to indicate the response which most accurately reflects the way they have felt over the last few days. The item scores are summed and the total subscore ranges from 0 to 21 (maximal severity).|scores on a scale|Mean|13.7|13.7|Standard Deviation|4.33|4.33|||
4205707|NCT00735709|4028977|B5|||Hospital Anxiety and Depression (HAD) – Anxiety subscale|The HAD-anxiety subscale is completed by the participant and measures anxiety, including anxious mood, restlessness, anxious thoughts, and panic attacks. The subscale is made up of 7 items that are assessed on a scale from 0 (no anxiety) to 3 (severe feeling of anxiety). Participants are required to indicate the response which most accurately reflects the way they have felt over the last few days. Scores are summed and range from 0 to 21 (maximal severity).|scores on a scale|Mean|11.4|11.4|Standard Deviation|3.95|3.95|||
4205708|NCT00735709|4028978|B4|||Hospital Anxiety and Depression (HAD) – Anxiety subscale|The HAD-anxiety subscale is completed by the participant and measures anxiety, including anxious mood, restlessness, anxious thoughts, and panic attacks. The subscale is made up of 7 items that are assessed on a scale from 0 (no anxiety) to 3 (severe feeling of anxiety). Participants are required to indicate the response which most accurately reflects the way they have felt over the last few days. Scores are summed and range from 0 to 21 (maximal severity).|scores on a scale|Mean|11.7|11.7|Standard Deviation|3.97|3.97|||
4205709|NCT00735709|4028979|B3|||Hospital Anxiety and Depression (HAD) – Anxiety subscale|The HAD-anxiety subscale is completed by the participant and measures anxiety, including anxious mood, restlessness, anxious thoughts, and panic attacks. The subscale is made up of 7 items that are assessed on a scale from 0 (no anxiety) to 3 (severe feeling of anxiety). Participants are required to indicate the response which most accurately reflects the way they have felt over the last few days. Scores are summed and range from 0 to 21 (maximal severity).|scores on a scale|Mean|11.6|11.6|Standard Deviation|4.02|4.02|||
4205710|NCT00735709|4028980|B2|||Hospital Anxiety and Depression (HAD) – Anxiety subscale|The HAD-anxiety subscale is completed by the participant and measures anxiety, including anxious mood, restlessness, anxious thoughts, and panic attacks. The subscale is made up of 7 items that are assessed on a scale from 0 (no anxiety) to 3 (severe feeling of anxiety). Participants are required to indicate the response which most accurately reflects the way they have felt over the last few days. Scores are summed and range from 0 to 21 (maximal severity).|scores on a scale|Mean|11.2|11.2|Standard Deviation|3.83|3.83|||
4205711|NCT00735709|4028981|B1|||Hospital Anxiety and Depression (HAD) – Anxiety subscale|The HAD-anxiety subscale is completed by the participant and measures anxiety, including anxious mood, restlessness, anxious thoughts, and panic attacks. The subscale is made up of 7 items that are assessed on a scale from 0 (no anxiety) to 3 (severe feeling of anxiety). Participants are required to indicate the response which most accurately reflects the way they have felt over the last few days. Scores are summed and range from 0 to 21 (maximal severity).|scores on a scale|Mean|11.2|11.2|Standard Deviation|3.99|3.99|||
4205712|NCT00735709|4028977|B5|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|scores on a scale|Mean|4.8|4.8|Standard Deviation|0.76|0.76|||
4205713|NCT00735709|4028978|B4|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|scores on a scale|Mean|4.9|4.9|Standard Deviation|0.76|0.76|||
4205714|NCT00735709|4028979|B3|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|scores on a scale|Mean|4.8|4.8|Standard Deviation|0.73|0.73|||
4205780|NCT00735709|4028980|B2|||Height||cm|Mean|168.56|168.56|Standard Deviation|8.264|8.264|||
4205781|NCT00735709|4028981|B1|||Height||cm|Mean|168.70|168.7|Standard Deviation|8.907|8.907|||
4205715|NCT00735709|4028980|B2|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|scores on a scale|Mean|4.7|4.7|Standard Deviation|0.73|0.73|||
4205716|NCT00735709|4028981|B1|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|scores on a scale|Mean|4.8|4.8|Standard Deviation|0.80|0.8|||
4205717|NCT00735709|4028977|B5|||Hamilton Anxiety Scale total score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 to 56, where <17 indicates mild severity, 18–24 mild to moderate severity and 25–30 moderate to severe. Total scores above 30 are rare, but indicate very severe anxiety.|scores on a scale|Mean|20.0|20.0|Standard Deviation|6.93|6.93|||
4205718|NCT00735709|4028978|B4|||Hamilton Anxiety Scale total score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 to 56, where <17 indicates mild severity, 18–24 mild to moderate severity and 25–30 moderate to severe. Total scores above 30 are rare, but indicate very severe anxiety.|scores on a scale|Mean|21.1|21.1|Standard Deviation|7.39|7.39|||
4205719|NCT00735709|4028979|B3|||Hamilton Anxiety Scale total score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 to 56, where <17 indicates mild severity, 18–24 mild to moderate severity and 25–30 moderate to severe. Total scores above 30 are rare, but indicate very severe anxiety.|scores on a scale|Mean|19.4|19.4|Standard Deviation|6.77|6.77|||
4205720|NCT00735709|4028980|B2|||Hamilton Anxiety Scale total score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 to 56, where <17 indicates mild severity, 18–24 mild to moderate severity and 25–30 moderate to severe. Total scores above 30 are rare, but indicate very severe anxiety.|scores on a scale|Mean|20.0|20.0|Standard Deviation|6.41|6.41|||
4205721|NCT00735709|4028981|B1|||Hamilton Anxiety Scale total score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 to 56, where <17 indicates mild severity, 18–24 mild to moderate severity and 25–30 moderate to severe. Total scores above 30 are rare, but indicate very severe anxiety.|scores on a scale|Mean|19.7|19.7|Standard Deviation|7.07|7.07|||
4205722|NCT00735709|4028977|B5|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|30.8|30.8|Standard Deviation|3.19|3.19|||
4205723|NCT00735709|4028978|B4|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|31.6|31.6|Standard Deviation|3.83|3.83|||
4205724|NCT00735709|4028979|B3|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|30.6|30.6|Standard Deviation|2.83|2.83|||
4205725|NCT00735709|4028980|B2|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|30.4|30.4|Standard Deviation|3.01|3.01|||
4205726|NCT00735709|4028981|B1|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|30.6|30.6|Standard Deviation|2.89|2.89|||
4205727|NCT00735709|4028977|B5|||24-item Hamilton Depression Scale total score|The 24-item Hamilton Depression Scale (HAM-D24) is a clinician-rated 24-item scale for assessing the severity of depression symptoms. The scores for each item range from 0 to 4 or 0 to 2, where 0 represents no symptoms. The rating is based on the past 7 days prior to the time of assessment. The total score ranges from 0 to 74, where a higher score indicates a greater depressive state.|scores on a scale|Mean|32.6|32.6|Standard Deviation|4.84|4.84|||
4205782|NCT00735709|4028977|B5|||Weight||kg|Mean|75.20|75.2|Standard Deviation|16.099|16.099|||
4205728|NCT00735709|4028978|B4|||24-item Hamilton Depression Scale total score|The 24-item Hamilton Depression Scale (HAM-D24) is a clinician-rated 24-item scale for assessing the severity of depression symptoms. The scores for each item range from 0 to 4 or 0 to 2, where 0 represents no symptoms. The rating is based on the past 7 days prior to the time of assessment. The total score ranges from 0 to 74, where a higher score indicates a greater depressive state.|scores on a scale|Mean|33.1|33.1|Standard Deviation|4.77|4.77|||
4205729|NCT00735709|4028979|B3|||24-item Hamilton Depression Scale total score|The 24-item Hamilton Depression Scale (HAM-D24) is a clinician-rated 24-item scale for assessing the severity of depression symptoms. The scores for each item range from 0 to 4 or 0 to 2, where 0 represents no symptoms. The rating is based on the past 7 days prior to the time of assessment. The total score ranges from 0 to 74, where a higher score indicates a greater depressive state.|scores on a scale|Mean|32.1|32.1|Standard Deviation|5.04|5.04|||
4205730|NCT00735709|4028980|B2|||24-item Hamilton Depression Scale total score|The 24-item Hamilton Depression Scale (HAM-D24) is a clinician-rated 24-item scale for assessing the severity of depression symptoms. The scores for each item range from 0 to 4 or 0 to 2, where 0 represents no symptoms. The rating is based on the past 7 days prior to the time of assessment. The total score ranges from 0 to 74, where a higher score indicates a greater depressive state.|scores on a scale|Mean|32.5|32.5|Standard Deviation|5.13|5.13|||
4205731|NCT00735709|4028981|B1|||24-item Hamilton Depression Scale total score|The 24-item Hamilton Depression Scale (HAM-D24) is a clinician-rated 24-item scale for assessing the severity of depression symptoms. The scores for each item range from 0 to 4 or 0 to 2, where 0 represents no symptoms. The rating is based on the past 7 days prior to the time of assessment. The total score ranges from 0 to 74, where a higher score indicates a greater depressive state.|scores on a scale|Mean|32.7|32.7|Standard Deviation|4.40|4.4|||
4205732|NCT00735709|4028977|B5|Daily||Alcohol Consumption||participants|Number|30|30.0||||||
4205733|NCT00735709|4028978|B4|Daily||Alcohol Consumption||participants|Number|7|7.0||||||
4205734|NCT00735709|4028979|B3|Daily||Alcohol Consumption||participants|Number|9|9.0||||||
4205735|NCT00735709|4028980|B2|Daily||Alcohol Consumption||participants|Number|5|5.0||||||
4205736|NCT00735709|4028981|B1|Daily||Alcohol Consumption||participants|Number|9|9.0||||||
4205737|NCT00735709|4028977|B5|2-to-6 times/week||Alcohol Consumption||participants|Number|35|35.0||||||
4205738|NCT00735709|4028978|B4|2-to-6 times/week||Alcohol Consumption||participants|Number|12|12.0||||||
4205739|NCT00735709|4028979|B3|2-to-6 times/week||Alcohol Consumption||participants|Number|7|7.0||||||
4205740|NCT00735709|4028980|B2|2-to-6 times/week||Alcohol Consumption||participants|Number|11|11.0||||||
4205741|NCT00735709|4028981|B1|2-to-6 times/week||Alcohol Consumption||participants|Number|5|5.0||||||
4205742|NCT00735709|4028977|B5|Once per week||Alcohol Consumption||participants|Number|54|54.0||||||
4205743|NCT00735709|4028978|B4|Once per week||Alcohol Consumption||participants|Number|16|16.0||||||
4205744|NCT00735709|4028979|B3|Once per week||Alcohol Consumption||participants|Number|9|9.0||||||
4205745|NCT00735709|4028980|B2|Once per week||Alcohol Consumption||participants|Number|13|13.0||||||
4205746|NCT00735709|4028981|B1|Once per week||Alcohol Consumption||participants|Number|16|16.0||||||
4205747|NCT00735709|4028977|B5|Once monthly or less often||Alcohol Consumption||participants|Number|227|227.0||||||
4205748|NCT00735709|4028978|B4|Once monthly or less often||Alcohol Consumption||participants|Number|51|51.0||||||
4205749|NCT00735709|4028979|B3|Once monthly or less often||Alcohol Consumption||participants|Number|59|59.0||||||
4205750|NCT00735709|4028980|B2|Once monthly or less often||Alcohol Consumption||participants|Number|60|60.0||||||
4205751|NCT00735709|4028981|B1|Once monthly or less often||Alcohol Consumption||participants|Number|57|57.0||||||
4205752|NCT00735709|4028977|B5|Never||Alcohol Consumption||participants|Number|214|214.0||||||
4205753|NCT00735709|4028978|B4|Never||Alcohol Consumption||participants|Number|54|54.0||||||
4205754|NCT00735709|4028979|B3|Never||Alcohol Consumption||participants|Number|56|56.0||||||
4205755|NCT00735709|4028980|B2|Never||Alcohol Consumption||participants|Number|51|51.0||||||
4205756|NCT00735709|4028981|B1|Never||Alcohol Consumption||participants|Number|53|53.0||||||
4205757|NCT00735709|4028977|B5|Ex-smoker||Smoking Classification||participants|Number|69|69.0||||||
4205758|NCT00735709|4028978|B4|Ex-smoker||Smoking Classification||participants|Number|20|20.0||||||
4205759|NCT00735709|4028979|B3|Ex-smoker||Smoking Classification||participants|Number|19|19.0||||||
4205760|NCT00735709|4028980|B2|Ex-smoker||Smoking Classification||participants|Number|12|12.0||||||
4205761|NCT00735709|4028981|B1|Ex-smoker||Smoking Classification||participants|Number|18|18.0||||||
4205762|NCT00735709|4028977|B5|Current smoker||Smoking Classification||participants|Number|162|162.0||||||
4205763|NCT00735709|4028978|B4|Current smoker||Smoking Classification||participants|Number|41|41.0||||||
4205764|NCT00735709|4028979|B3|Current smoker||Smoking Classification||participants|Number|33|33.0||||||
4205765|NCT00735709|4028980|B2|Current smoker||Smoking Classification||participants|Number|54|54.0||||||
4205766|NCT00735709|4028981|B1|Current smoker||Smoking Classification||participants|Number|34|34.0||||||
4205767|NCT00735709|4028977|B5|Never smoked||Smoking Classification||participants|Number|329|329.0||||||
4205768|NCT00735709|4028978|B4|Never smoked||Smoking Classification||participants|Number|79|79.0||||||
4205769|NCT00735709|4028979|B3|Never smoked||Smoking Classification||participants|Number|88|88.0||||||
4205770|NCT00735709|4028980|B2|Never smoked||Smoking Classification||participants|Number|74|74.0||||||
4205771|NCT00735709|4028981|B1|Never smoked||Smoking Classification||participants|Number|88|88.0||||||
4205772|NCT00735709|4028977|B5|||Body Mass Index (BMI)||kg/m^2|Mean|26.36|26.36|Standard Deviation|4.917|4.917|||
4205773|NCT00735709|4028978|B4|||Body Mass Index (BMI)||kg/m^2|Mean|26.16|26.16|Standard Deviation|4.612|4.612|||
4205774|NCT00735709|4028979|B3|||Body Mass Index (BMI)||kg/m^2|Mean|26.41|26.41|Standard Deviation|5.065|5.065|||
4205775|NCT00735709|4028980|B2|||Body Mass Index (BMI)||kg/m^2|Mean|26.53|26.53|Standard Deviation|5.380|5.38|||
4205783|NCT00735709|4028978|B4|||Weight||kg|Mean|74.58|74.58|Standard Deviation|15.190|15.19|||
4205784|NCT00735709|4028979|B3|||Weight||kg|Mean|75.41|75.41|Standard Deviation|17.022|17.022|||
4205785|NCT00735709|4028980|B2|||Weight||kg|Mean|75.63|75.63|Standard Deviation|17.276|17.276|||
4205786|NCT00735709|4028981|B1|||Weight||kg|Mean|75.18|75.18|Standard Deviation|14.924|14.924|||
4205787|NCT00735709|4028977|B5|Ukraine||Region of Enrollment||participants|Number|47|47.0||||||
4205788|NCT00735709|4028978|B4|Ukraine||Region of Enrollment||participants|Number|11|11.0||||||
4205789|NCT00735709|4028979|B3|Ukraine||Region of Enrollment||participants|Number|11|11.0||||||
4205790|NCT00735709|4028980|B2|Ukraine||Region of Enrollment||participants|Number|15|15.0||||||
4205791|NCT00735709|4028981|B1|Ukraine||Region of Enrollment||participants|Number|10|10.0||||||
4205792|NCT00735709|4028977|B5|Taiwan||Region of Enrollment||participants|Number|4|4.0||||||
4205793|NCT00735709|4028978|B4|Taiwan||Region of Enrollment||participants|Number|3|3.0||||||
4205794|NCT00735709|4028979|B3|Taiwan||Region of Enrollment||participants|Number|1|1.0||||||
4205795|NCT00735709|4028980|B2|Taiwan||Region of Enrollment||participants|Number|0|0.0||||||
4205796|NCT00735709|4028981|B1|Taiwan||Region of Enrollment||participants|Number|0|0.0||||||
4205797|NCT00735709|4028977|B5|South Africa||Region of Enrollment||participants|Number|19|19.0||||||
4205798|NCT00735709|4028978|B4|South Africa||Region of Enrollment||participants|Number|3|3.0||||||
4205799|NCT00735709|4028979|B3|South Africa||Region of Enrollment||participants|Number|5|5.0||||||
4205800|NCT00735709|4028980|B2|South Africa||Region of Enrollment||participants|Number|6|6.0||||||
4205801|NCT00735709|4028981|B1|South Africa||Region of Enrollment||participants|Number|5|5.0||||||
4205802|NCT00735709|4028977|B5|Russia||Region of Enrollment||participants|Number|61|61.0||||||
4205803|NCT00735709|4028978|B4|Russia||Region of Enrollment||participants|Number|20|20.0||||||
4205804|NCT00735709|4028979|B3|Russia||Region of Enrollment||participants|Number|9|9.0||||||
4205805|NCT00735709|4028980|B2|Russia||Region of Enrollment||participants|Number|20|20.0||||||
4205806|NCT00735709|4028981|B1|Russia||Region of Enrollment||participants|Number|12|12.0||||||
4205807|NCT00735709|4028977|B5|Republic of Korea||Region of Enrollment||participants|Number|35|35.0||||||
4205808|NCT00735709|4028978|B4|Republic of Korea||Region of Enrollment||participants|Number|14|14.0||||||
4205809|NCT00735709|4028979|B3|Republic of Korea||Region of Enrollment||participants|Number|9|9.0||||||
4205810|NCT00735709|4028980|B2|Republic of Korea||Region of Enrollment||participants|Number|5|5.0||||||
4205811|NCT00735709|4028981|B1|Republic of Korea||Region of Enrollment||participants|Number|7|7.0||||||
4205812|NCT00735709|4028977|B5|Poland||Region of Enrollment||participants|Number|62|62.0||||||
4205813|NCT00735709|4028978|B4|Poland||Region of Enrollment||participants|Number|11|11.0||||||
4205814|NCT00735709|4028979|B3|Poland||Region of Enrollment||participants|Number|15|15.0||||||
4205815|NCT00735709|4028980|B2|Poland||Region of Enrollment||participants|Number|16|16.0||||||
4205816|NCT00735709|4028981|B1|Poland||Region of Enrollment||participants|Number|20|20.0||||||
4205817|NCT00735709|4028977|B5|Netherlands||Region of Enrollment||participants|Number|7|7.0||||||
4205818|NCT00735709|4028978|B4|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4205819|NCT00735709|4028979|B3|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
4205820|NCT00735709|4028980|B2|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
4205821|NCT00735709|4028981|B1|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4205822|NCT00735709|4028977|B5|Malaysia||Region of Enrollment||participants|Number|22|22.0||||||
4205823|NCT00735709|4028978|B4|Malaysia||Region of Enrollment||participants|Number|6|6.0||||||
4205824|NCT00735709|4028979|B3|Malaysia||Region of Enrollment||participants|Number|6|6.0||||||
4205825|NCT00735709|4028980|B2|Malaysia||Region of Enrollment||participants|Number|3|3.0||||||
4205826|NCT00735709|4028981|B1|Malaysia||Region of Enrollment||participants|Number|7|7.0||||||
4205827|NCT00735709|4028977|B5|Lithuania||Region of Enrollment||participants|Number|13|13.0||||||
4205828|NCT00735709|4028978|B4|Lithuania||Region of Enrollment||participants|Number|3|3.0||||||
4205829|NCT00735709|4028979|B3|Lithuania||Region of Enrollment||participants|Number|2|2.0||||||
4205830|NCT00735709|4028980|B2|Lithuania||Region of Enrollment||participants|Number|4|4.0||||||
4205831|NCT00735709|4028981|B1|Lithuania||Region of Enrollment||participants|Number|4|4.0||||||
4205832|NCT00735709|4028977|B5|Latvia||Region of Enrollment||participants|Number|27|27.0||||||
4205833|NCT00735709|4028978|B4|Latvia||Region of Enrollment||participants|Number|5|5.0||||||
4205834|NCT00735709|4028979|B3|Latvia||Region of Enrollment||participants|Number|9|9.0||||||
4205835|NCT00735709|4028980|B2|Latvia||Region of Enrollment||participants|Number|8|8.0||||||
4205836|NCT00735709|4028981|B1|Latvia||Region of Enrollment||participants|Number|5|5.0||||||
4205837|NCT00735709|4028977|B5|Germany||Region of Enrollment||participants|Number|233|233.0||||||
4205838|NCT00735709|4028978|B4|Germany||Region of Enrollment||participants|Number|56|56.0||||||
4205839|NCT00735709|4028979|B3|Germany||Region of Enrollment||participants|Number|64|64.0||||||
4205840|NCT00735709|4028980|B2|Germany||Region of Enrollment||participants|Number|50|50.0||||||
4205841|NCT00735709|4028981|B1|Germany||Region of Enrollment||participants|Number|63|63.0||||||
4205842|NCT00735709|4028977|B5|France||Region of Enrollment||participants|Number|13|13.0||||||
4205843|NCT00735709|4028978|B4|France||Region of Enrollment||participants|Number|5|5.0||||||
4205844|NCT00735709|4028979|B3|France||Region of Enrollment||participants|Number|1|1.0||||||
4205845|NCT00735709|4028980|B2|France||Region of Enrollment||participants|Number|2|2.0||||||
4205846|NCT00735709|4028981|B1|France||Region of Enrollment||participants|Number|5|5.0||||||
4205847|NCT00735709|4028977|B5|Croatia||Region of Enrollment||participants|Number|13|13.0||||||
4205848|NCT00735709|4028978|B4|Croatia||Region of Enrollment||participants|Number|1|1.0||||||
4205849|NCT00735709|4028979|B3|Croatia||Region of Enrollment||participants|Number|5|5.0||||||
4205850|NCT00735709|4028980|B2|Croatia||Region of Enrollment||participants|Number|5|5.0||||||
4205851|NCT00735709|4028981|B1|Croatia||Region of Enrollment||participants|Number|2|2.0||||||
4205852|NCT00735709|4028977|B5|Australia||Region of Enrollment||participants|Number|4|4.0||||||
4205853|NCT00735709|4028978|B4|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4205854|NCT00735709|4028979|B3|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4205855|NCT00735709|4028980|B2|Australia||Region of Enrollment||participants|Number|3|3.0||||||
4205856|NCT00735709|4028981|B1|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4205857|NCT00735709|4028977|B5|Non-Hispanic/Non-Latino||Race/Ethnicity, Customized||participants|Number|556|556.0||||||
4205858|NCT00735709|4028978|B4|Non-Hispanic/Non-Latino||Race/Ethnicity, Customized||participants|Number|139|139.0||||||
4205859|NCT00735709|4028979|B3|Non-Hispanic/Non-Latino||Race/Ethnicity, Customized||participants|Number|140|140.0||||||
4205860|NCT00735709|4028980|B2|Non-Hispanic/Non-Latino||Race/Ethnicity, Customized||participants|Number|140|140.0||||||
4205861|NCT00735709|4028981|B1|Non-Hispanic/Non-Latino||Race/Ethnicity, Customized||participants|Number|137|137.0||||||
4205862|NCT00735709|4028977|B5|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4205863|NCT00735709|4028978|B4|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4205864|NCT00735709|4028979|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4205865|NCT00735709|4028980|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4205866|NCT00735709|4028981|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4205867|NCT00735709|4028977|B5|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4205868|NCT00735709|4028978|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4205869|NCT00735709|4028979|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4205870|NCT00735709|4028980|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4205871|NCT00735709|4028981|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4205872|NCT00735709|4028977|B5|Asian||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
4205873|NCT00735709|4028978|B4|Asian||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4205874|NCT00735709|4028979|B3|Asian||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4205875|NCT00735709|4028980|B2|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4205876|NCT00735709|4028981|B1|Asian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4205877|NCT00735709|4028977|B5|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4205878|NCT00735709|4028978|B4|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4205879|NCT00735709|4028979|B3|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4205880|NCT00735709|4028980|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4205881|NCT00735709|4028981|B1|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4205882|NCT00735709|4028977|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|483|483.0||||||
4205883|NCT00735709|4028978|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|114|114.0||||||
4205884|NCT00735709|4028979|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|120|120.0||||||
4205885|NCT00735709|4028980|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|129|129.0||||||
4205886|NCT00735709|4028981|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|120|120.0||||||
4205887|NCT00735709|4028977|B5||Male|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4205888|NCT00735709|4028978|B4||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4205889|NCT00735709|4028979|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4205890|NCT00735709|4028980|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4205891|NCT00735709|4028981|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4205892|NCT00735709|4028977|B5||Female|Sex: Female, Male||Participants|Count of Participants|351|351.0||||||
4205893|NCT00735709|4028978|B4||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4205894|NCT00735709|4028979|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4205895|NCT00735709|4028980|B2||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4205896|NCT00735709|4028981|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4205897|NCT00735709|4028977|B5|>55 years||Age, Customized||participants|Number|138|138.0||||||
4205898|NCT00735709|4028978|B4|>55 years||Age, Customized||participants|Number|33|33.0||||||
4205899|NCT00735709|4028979|B3|>55 years||Age, Customized||participants|Number|38|38.0||||||
4205900|NCT00735709|4028980|B2|>55 years||Age, Customized||participants|Number|30|30.0||||||
4205901|NCT00735709|4028981|B1|>55 years||Age, Customized||participants|Number|37|37.0||||||
4205902|NCT00735709|4028977|B5|≤55 years||Age, Customized||participants|Number|422|422.0||||||
4205903|NCT00735709|4028978|B4|≤55 years||Age, Customized||participants|Number|107|107.0||||||
4205904|NCT00735709|4028979|B3|≤55 years||Age, Customized||participants|Number|102|102.0||||||
4205905|NCT00735709|4028980|B2|≤55 years||Age, Customized||participants|Number|110|110.0||||||
4205906|NCT00735709|4028981|B1|≤55 years||Age, Customized||participants|Number|103|103.0||||||
4205907|NCT00735709|4028977|B5|||Age||years|Mean|46.4|46.4|Standard Deviation|12.08|12.08|||
4205908|NCT00735709|4028978|B4|||Age||years|Mean|46.4|46.4|Standard Deviation|12.27|12.27|||
4205909|NCT00735709|4028979|B3|||Age||years|Mean|47.3|47.3|Standard Deviation|11.95|11.95|||
4205910|NCT00735709|4028980|B2|||Age||years|Mean|45.4|45.4|Standard Deviation|11.89|11.89|||
4205911|NCT00735709|4028981|B1|||Age||years|Mean|46.4|46.4|Standard Deviation|12.26|12.26|||
4205912|NCT00735696|4029094|B1|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4205913|NCT00735696|4029094|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4205914|NCT00735696|4029094|B1|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4205915|NCT00735696|4029094|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4205916|NCT00735696|4029094|B1|White||Race/Ethnicity, Customized||Participants|Number|34|34.0||||||
4205917|NCT00735696|4029094|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4205918|NCT00735696|4029094|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4205919|NCT00735696|4029094|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4205920|NCT00735696|4029094|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4205921|NCT00735696|4029094|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4205922|NCT00735696|4029094|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4205923|NCT00735696|4029094|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4205924|NCT00735696|4029094|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4205925|NCT00735670|4029106|B3|Paraplegia||Level of injury||participants|Number|14|14.0||||||
4205926|NCT00735670|4029107|B2|Paraplegia||Level of injury||participants|Number|10|10.0||||||
4205927|NCT00735670|4029108|B1|Paraplegia||Level of injury||participants|Number|4|4.0||||||
4205928|NCT00735670|4029106|B3|Tetraplegia||Level of injury||participants|Number|7|7.0||||||
4205929|NCT00735670|4029107|B2|Tetraplegia||Level of injury||participants|Number|1|1.0||||||
4205930|NCT00735670|4029108|B1|Tetraplegia||Level of injury||participants|Number|6|6.0||||||
4205931|NCT00735670|4029106|B3|||Time since injury||years|Mean|11.9|11.9|Standard Deviation|10.0|10.0|||
4205932|NCT00735670|4029107|B2|||Time since injury||years|Mean|13.64|13.64|Standard Deviation|15.1|15.1|||
4205933|NCT00735670|4029108|B1|||Time since injury||years|Mean|10.01|10.01|Standard Deviation|9.0|9.0|||
4205934|NCT00735670|4029106|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4205935|NCT00735670|4029107|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4205936|NCT00735670|4029108|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4205937|NCT00735670|4029106|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4205938|NCT00735670|4029107|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4205939|NCT00735670|4029108|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4205940|NCT00735670|4029106|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4205941|NCT00735670|4029107|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4205942|NCT00735670|4029108|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4205943|NCT00735670|4029106|B3|||Age||years|Mean|48.7|48.7|Standard Deviation|12.6|12.6|||
4205944|NCT00735670|4029107|B2|||Age||years|Mean|51.7|51.7|Standard Deviation|14.1|14.1|||
4205945|NCT00735670|4029108|B1|||Age||years|Mean|45.4|45.4|Standard Deviation|10.5|10.5|||
4205946|NCT00735670|4029106|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4205947|NCT00735670|4029107|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4205948|NCT00735670|4029108|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4205949|NCT00735670|4029106|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4205950|NCT00735670|4029107|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4205951|NCT00735670|4029108|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4205952|NCT00735670|4029106|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4205953|NCT00735670|4029107|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4205954|NCT00735670|4029108|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4205955|NCT00735644|4029117|B6|Philippines||Region of Enrollment||Participants|Number|709|709.0||||||
4205956|NCT00735644|4029118|B5|Philippines||Region of Enrollment||Participants|Number|60|60.0||||||
4205957|NCT00735644|4029119|B4|Philippines||Region of Enrollment||Participants|Number|117|117.0||||||
4205958|NCT00735644|4029120|B3|Philippines||Region of Enrollment||Participants|Number|175|175.0||||||
4205959|NCT00735644|4029121|B2|Philippines||Region of Enrollment||Participants|Number|177|177.0||||||
4205960|NCT00735644|4029122|B1|Philippines||Region of Enrollment||Participants|Number|180|180.0||||||
4205961|NCT00735644|4029117|B6|Thailand||Region of Enrollment||Participants|Number|490|490.0||||||
4205962|NCT00735644|4029118|B5|Thailand||Region of Enrollment||Participants|Number|42|42.0||||||
4205963|NCT00735644|4029119|B4|Thailand||Region of Enrollment||Participants|Number|82|82.0||||||
4205964|NCT00735644|4029120|B3|Thailand||Region of Enrollment||Participants|Number|121|121.0||||||
4205965|NCT00735644|4029121|B2|Thailand||Region of Enrollment||Participants|Number|122|122.0||||||
4205966|NCT00735644|4029122|B1|Thailand||Region of Enrollment||Participants|Number|123|123.0||||||
4205967|NCT00735644|4029117|B6||Male|Sex: Female, Male||Participants|Count of Participants|624|624.0||||||
4205968|NCT00735644|4029118|B5||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4205969|NCT00735644|4029119|B4||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4205970|NCT00735644|4029120|B3||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4205971|NCT00735644|4029121|B2||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4205972|NCT00735644|4029122|B1||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4205973|NCT00735644|4029117|B6||Female|Sex: Female, Male||Participants|Count of Participants|575|575.0||||||
4205974|NCT00735644|4029118|B5||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4205975|NCT00735644|4029119|B4||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4205976|NCT00735644|4029120|B3||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4205977|NCT00735644|4029121|B2||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4205978|NCT00735644|4029122|B1||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4205979|NCT00735644|4029117|B6|||Age||Months|Mean|14.4|14.4|Standard Deviation|1.87|1.87|||
4205980|NCT00735644|4029118|B5|||Age||Months|Mean|14.3|14.3|Standard Deviation|1.93|1.93|||
4205981|NCT00735644|4029119|B4|||Age||Months|Mean|14.3|14.3|Standard Deviation|1.81|1.81|||
4205982|NCT00735644|4029120|B3|||Age||Months|Mean|14.4|14.4|Standard Deviation|1.88|1.88|||
4205983|NCT00735644|4029121|B2|||Age||Months|Mean|14.5|14.5|Standard Deviation|1.84|1.84|||
4205984|NCT00735644|4029122|B1|||Age||Months|Mean|14.3|14.3|Standard Deviation|1.91|1.91|||
4205985|NCT00735644|4029117|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4205986|NCT00735644|4029118|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4205987|NCT00735644|4029119|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4205988|NCT00735644|4029120|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4205989|NCT00735644|4029121|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4205990|NCT00735644|4029122|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4205991|NCT00735644|4029117|B6||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4205992|NCT00735644|4029118|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4205993|NCT00735644|4029119|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4205994|NCT00735644|4029120|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4205995|NCT00735644|4029121|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4205996|NCT00735644|4029122|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4205997|NCT00735644|4029117|B6||<=18 years|Age||Participants|Count of Participants|1199|1199.0||||||
4205998|NCT00735644|4029118|B5||<=18 years|Age||Participants|Count of Participants|102|102.0||||||
4205999|NCT00735644|4029119|B4||<=18 years|Age||Participants|Count of Participants|199|199.0||||||
4206000|NCT00735644|4029120|B3||<=18 years|Age||Participants|Count of Participants|296|296.0||||||
4206001|NCT00735644|4029121|B2||<=18 years|Age||Participants|Count of Participants|299|299.0||||||
4206002|NCT00735644|4029122|B1||<=18 years|Age||Participants|Count of Participants|303|303.0||||||
4206003|NCT00735618|4029163|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4206004|NCT00735618|4029163|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4206005|NCT00735618|4029163|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4206006|NCT00735618|4029163|B1|||Age||Years|Median|57|57.0|Full Range|||25.0|87.0|
4206007|NCT00735475|4029178|B3|United States||Region of Enrollment||participants|Number|1266|1266.0||||||
4206008|NCT00735475|4029179|B2|United States||Region of Enrollment||participants|Number|636|636.0||||||
4206009|NCT00735475|4029180|B1|United States||Region of Enrollment||participants|Number|630|630.0||||||
4206010|NCT00735475|4029178|B3||Male|Sex: Female, Male||Participants|Count of Participants|540|540.0||||||
4206011|NCT00735475|4029179|B2||Male|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
4206012|NCT00735475|4029180|B1||Male|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
4206013|NCT00735475|4029178|B3||Female|Sex: Female, Male||Participants|Count of Participants|726|726.0||||||
4206014|NCT00735475|4029179|B2||Female|Sex: Female, Male||Participants|Count of Participants|362|362.0||||||
4206015|NCT00735475|4029180|B1||Female|Sex: Female, Male||Participants|Count of Participants|364|364.0||||||
4206016|NCT00735475|4029178|B3|||Age||years|Mean|71.7|71.7|Standard Deviation|5.54|5.54|||
4206017|NCT00735475|4029179|B2|||Age||years|Mean|71.7|71.7|Standard Deviation|5.53|5.53|||
4206018|NCT00735475|4029180|B1|||Age||years|Mean|71.7|71.7|Standard Deviation|5.56|5.56|||
4206019|NCT00735475|4029178|B3||>=65 years|Age|Note: two participants (one in each group) did not provide follow-up safety information. Therefore, they are not included in the Safety Population.|Participants|Count of Participants|1266|1266.0||||||
4206020|NCT00735475|4029179|B2||>=65 years|Age|Note: two participants (one in each group) did not provide follow-up safety information. Therefore, they are not included in the Safety Population.|Participants|Count of Participants|636|636.0||||||
4206021|NCT00735475|4029180|B1||>=65 years|Age|Note: two participants (one in each group) did not provide follow-up safety information. Therefore, they are not included in the Safety Population.|Participants|Count of Participants|630|630.0||||||
4206022|NCT00735475|4029178|B3||Between 18 and 65 years|Age|Note: two participants (one in each group) did not provide follow-up safety information. Therefore, they are not included in the Safety Population.|Participants|Count of Participants|0|0.0||||||
4206023|NCT00735475|4029179|B2||Between 18 and 65 years|Age|Note: two participants (one in each group) did not provide follow-up safety information. Therefore, they are not included in the Safety Population.|Participants|Count of Participants|0|0.0||||||
4206024|NCT00735475|4029180|B1||Between 18 and 65 years|Age|Note: two participants (one in each group) did not provide follow-up safety information. Therefore, they are not included in the Safety Population.|Participants|Count of Participants|0|0.0||||||
4206025|NCT00735475|4029178|B3||<=18 years|Age|Note: two participants (one in each group) did not provide follow-up safety information. Therefore, they are not included in the Safety Population.|Participants|Count of Participants|0|0.0||||||
4206026|NCT00735475|4029179|B2||<=18 years|Age|Note: two participants (one in each group) did not provide follow-up safety information. Therefore, they are not included in the Safety Population.|Participants|Count of Participants|0|0.0||||||
4206027|NCT00735475|4029180|B1||<=18 years|Age|Note: two participants (one in each group) did not provide follow-up safety information. Therefore, they are not included in the Safety Population.|Participants|Count of Participants|0|0.0||||||
4206028|NCT00735462|4029199|B4|United States||Region of Enrollment||participants|Number|511|511.0||||||
4206029|NCT00735462|4029200|B3|United States||Region of Enrollment||participants|Number|105|105.0||||||
4206030|NCT00735462|4029201|B2|United States||Region of Enrollment||participants|Number|204|204.0||||||
4206031|NCT00735462|4029202|B1|United States||Region of Enrollment||participants|Number|202|202.0||||||
4206032|NCT00735462|4029199|B4||Male|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4206033|NCT00735462|4029200|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4206034|NCT00735462|4029201|B2||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4206035|NCT00735462|4029202|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4206036|NCT00735462|4029199|B4||Female|Sex: Female, Male||Participants|Count of Participants|289|289.0||||||
4206037|NCT00735462|4029200|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4206038|NCT00735462|4029201|B2||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4206039|NCT00735462|4029202|B1||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4206040|NCT00735462|4029199|B4|||Age||years|Mean|33.1|33.1|Standard Deviation|10.6|10.6|||
4206041|NCT00735462|4029200|B3|||Age||years|Mean|33.3|33.3|Standard Deviation|10.8|10.8|||
4206042|NCT00735462|4029201|B2|||Age||years|Mean|32.8|32.8|Standard Deviation|11.0|11.0|||
4206043|NCT00735462|4029202|B1|||Age||years|Mean|33.1|33.1|Standard Deviation|10.1|10.1|||
4206044|NCT00735462|4029199|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4206045|NCT00735462|4029200|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4206046|NCT00735462|4029201|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4206047|NCT00735462|4029202|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4206048|NCT00735462|4029199|B4||Between 18 and 65 years|Age||Participants|Count of Participants|506|506.0||||||
4206049|NCT00735462|4029200|B3||Between 18 and 65 years|Age||Participants|Count of Participants|104|104.0||||||
4206050|NCT00735462|4029201|B2||Between 18 and 65 years|Age||Participants|Count of Participants|201|201.0||||||
4206051|NCT00735462|4029202|B1||Between 18 and 65 years|Age||Participants|Count of Participants|201|201.0||||||
4206052|NCT00735462|4029199|B4||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4206053|NCT00735462|4029200|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4206054|NCT00735462|4029201|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4206055|NCT00735462|4029202|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4206056|NCT00735449|4029215|B3||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4206057|NCT00735449|4029216|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4206058|NCT00735449|4029217|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4206059|NCT00735449|4029215|B3||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4206060|NCT00735449|4029216|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4206061|NCT00735449|4029217|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4206062|NCT00735449|4029215|B3|||Age||years|Median|65.4|65.4|Full Range|||29.8|88.9|
4206063|NCT00735449|4029216|B2|||Age||years|Median|65.9|65.9|Full Range|||29.8|88.9|
4206064|NCT00735449|4029217|B1|||Age||years|Median|64.5|64.5|Full Range|||30.1|87.0|
4206065|NCT00735436|4029232|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4206066|NCT00735436|4029232|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4206067|NCT00735436|4029232|B1|||Age||years|Mean|55.3|55.3|Standard Deviation|11.5|11.5|||
4206068|NCT00735397|4029241|B1||Male|Sex: Female, Male||Participants|Count of Participants|611|611.0||||||
4206069|NCT00735397|4029241|B1||Female|Sex: Female, Male||Participants|Count of Participants|607|607.0||||||
4206070|NCT00735397|4029241|B1|||Age||years|Median|33|33.0|Full Range|||12.0|76.0|
4206071|NCT00735371|4029251|B5|United States||Region of Enrollment||participants|Number|314|314.0||||||
4206072|NCT00735371|4029252|B4|United States||Region of Enrollment||participants|Number|79|79.0||||||
4206073|NCT00735371|4029253|B3|United States||Region of Enrollment||participants|Number|78|78.0||||||
4206074|NCT00735371|4029254|B2|United States||Region of Enrollment||participants|Number|79|79.0||||||
4206075|NCT00735371|4029255|B1|United States||Region of Enrollment||participants|Number|78|78.0||||||
4206076|NCT00735371|4029251|B5||Male|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
4206077|NCT00735371|4029252|B4||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4206078|NCT00735371|4029253|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4206079|NCT00735371|4029254|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4206080|NCT00735371|4029255|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4206081|NCT00735371|4029251|B5||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4206082|NCT00735371|4029252|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4206083|NCT00735371|4029253|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4206084|NCT00735371|4029254|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4206085|NCT00735371|4029255|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4206086|NCT00735371|4029251|B5|||Age||years|Mean|14.6|14.6|Standard Deviation|1.31|1.31|||
4206087|NCT00735371|4029252|B4|||Age||years|Mean|14.5|14.5|Standard Deviation|1.25|1.25|||
4206088|NCT00735371|4029253|B3|||Age||years|Mean|14.4|14.4|Standard Deviation|1.30|1.3|||
4206089|NCT00735371|4029254|B2|||Age||years|Mean|14.7|14.7|Standard Deviation|1.29|1.29|||
4206090|NCT00735371|4029255|B1|||Age||years|Mean|14.6|14.6|Standard Deviation|1.39|1.39|||
4206091|NCT00735371|4029251|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4206092|NCT00735371|4029252|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4206093|NCT00735371|4029253|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4206094|NCT00735371|4029254|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4206095|NCT00735371|4029255|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4206096|NCT00735371|4029251|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4206097|NCT00735371|4029252|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4206098|NCT00735371|4029253|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4206099|NCT00735371|4029254|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4206100|NCT00735371|4029255|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4206101|NCT00735371|4029251|B5||<=18 years|Age||Participants|Count of Participants|314|314.0||||||
4206102|NCT00735371|4029252|B4||<=18 years|Age||Participants|Count of Participants|79|79.0||||||
4206103|NCT00735371|4029253|B3||<=18 years|Age||Participants|Count of Participants|78|78.0||||||
4206104|NCT00735371|4029254|B2||<=18 years|Age||Participants|Count of Participants|79|79.0||||||
4206105|NCT00735371|4029255|B1||<=18 years|Age||Participants|Count of Participants|78|78.0||||||
4206106|NCT00735306|4029276|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4206107|NCT00735306|4029276|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206108|NCT00735306|4029276|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206109|NCT00735306|4029276|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4206110|NCT00735306|4029276|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4206111|NCT00735306|4029276|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206112|NCT00735306|4029276|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206113|NCT00735306|4029276|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206114|NCT00735306|4029276|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4206115|NCT00735306|4029276|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4206116|NCT00735306|4029276|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4206117|NCT00735306|4029276|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4206118|NCT00735306|4029276|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4206119|NCT00735072|4029299|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
4206120|NCT00735072|4029300|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4206121|NCT00735072|4029301|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4206122|NCT00735072|4029299|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4206123|NCT00735072|4029300|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4206124|NCT00735072|4029301|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4206125|NCT00735072|4029299|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4206126|NCT00735072|4029300|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4206127|NCT00735072|4029301|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4206128|NCT00735072|4029299|B3|||Age||years|Mean|50|50.0|Standard Deviation|9|9.0|||
4206129|NCT00735072|4029300|B2|||Age||years|Mean|50|50.0|Standard Deviation|10|10.0|||
4206130|NCT00735072|4029301|B1|||Age||years|Mean|50|50.0|Standard Deviation|8|8.0|||
4206131|NCT00735072|4029299|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4206132|NCT00735072|4029300|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4206133|NCT00735072|4029301|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4206134|NCT00735072|4029299|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4206135|NCT00735072|4029300|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4206136|NCT00735072|4029301|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4206137|NCT00735072|4029299|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4206138|NCT00735072|4029300|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4206139|NCT00735072|4029301|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4206140|NCT00735007|4029308|B1|||Multiple Sclerosis Treatment Concern Questionnaire (MSTCQ) Injection Site Reaction Score items 17-20|Intention to treat population. MSTCQ Injection Site Reaction Score items 17-20 has a best possible score of 4 and a worst possible score of 20.|units on a scale|Mean|11.1|11.1|Standard Deviation|3.3|3.3|||
4206141|NCT00735007|4029308|B1|||Multiple Sclerosis Treatment Concern Questionnaire (MSTCQ) Global Side Effects Score items 21-23|Intention to treat population. MSTCQ Global Side Effects Score items 21-23 has a best possible score of 15 and a worst possible score of 3.|units on a scale|Mean|4.8|4.8|Standard Deviation|1.7|1.7|||
4206142|NCT00735007|4029308|B1|||Multiple Sclerosis Treatment Concern Questionnaire (MSTCQ) Flu Like Symptom (FLS) Score items 13-16|Intention to treat population. MSTCQ FLS Score items 13-16 has a best possible score of 4 and a worst possible score of 20.|units on a scale|Mean|9.5|9.5|Standard Deviation|3.7|3.7|||
4206143|NCT00735007|4029308|B1|||Systolic Blood Pressure||mmHg|Mean|118.4|118.4|Standard Deviation|13.1|13.1|||
4206206|NCT00734929|4029351|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4206144|NCT00735007|4029308|B1|||Thyroid Peroxidase antibody||IU/ml|Mean|220|220.0|Standard Deviation|181.9|181.9|||
4206145|NCT00735007|4029308|B1|||Temperature||°C|Mean|36.40|36.4|Standard Deviation|0.43|0.43|||
4206146|NCT00735007|4029308|B1|||Heart rate||beats/min|Mean|74.9|74.9|Standard Deviation|9.0|9.0|||
4206147|NCT00735007|4029308|B1|||Diastolic blood pressure||mmHg|Mean|75.5|75.5|Standard Deviation|10.1|10.1|||
4206148|NCT00735007|4029308|B1|Sweden||Region of Enrollment||participants|Number|5|5.0||||||
4206149|NCT00735007|4029308|B1|Italy||Region of Enrollment||participants|Number|14|14.0||||||
4206150|NCT00735007|4029308|B1|Germany||Region of Enrollment||participants|Number|26|26.0||||||
4206151|NCT00735007|4029308|B1|Spain||Region of Enrollment||participants|Number|24|24.0||||||
4206152|NCT00735007|4029308|B1|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4206153|NCT00735007|4029308|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4206154|NCT00735007|4029308|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4206155|NCT00735007|4029308|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4206156|NCT00735007|4029308|B1|||Age||years|Mean|41.7|41.7|Standard Deviation|9.3|9.3|||
4206157|NCT00735007|4029308|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4206158|NCT00735007|4029308|B1||Between 18 and 65 years|Age||Participants|Count of Participants|106|106.0||||||
4206159|NCT00735007|4029308|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4206160|NCT00734994|4029333|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4206161|NCT00734994|4029333|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206162|NCT00734994|4029333|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206163|NCT00734994|4029333|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4206164|NCT00734994|4029333|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206165|NCT00734994|4029333|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206166|NCT00734994|4029333|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206167|NCT00734994|4029333|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206168|NCT00734994|4029333|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4206169|NCT00734994|4029333|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4206170|NCT00734994|4029333|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4206171|NCT00734994|4029333|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4206172|NCT00734994|4029333|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4206173|NCT00734968|4029338|B3|United States||Region of Enrollment||participants|Number|151|151.0||||||
4206174|NCT00734968|4029339|B2|United States||Region of Enrollment||participants|Number|76|76.0||||||
4206175|NCT00734968|4029340|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
4206176|NCT00734968|4029338|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4206177|NCT00734968|4029339|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4206178|NCT00734968|4029340|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4206179|NCT00734968|4029338|B3|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4206180|NCT00734968|4029339|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4206181|NCT00734968|4029340|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4206182|NCT00734968|4029338|B3|White||Race/Ethnicity, Customized||participants|Number|140|140.0||||||
4206183|NCT00734968|4029339|B2|White||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
4206184|NCT00734968|4029340|B1|White||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
4206185|NCT00734968|4029338|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4206186|NCT00734968|4029339|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4206187|NCT00734968|4029340|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4206188|NCT00734968|4029338|B3||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4206189|NCT00734968|4029339|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4206190|NCT00734968|4029340|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4206191|NCT00734968|4029338|B3|>18 years||Age, Customized||participants|Number|151|151.0||||||
4206192|NCT00734968|4029339|B2|>18 years||Age, Customized||participants|Number|76|76.0||||||
4206193|NCT00734968|4029340|B1|>18 years||Age, Customized||participants|Number|75|75.0||||||
4206194|NCT00734929|4029351|B3|United States||Region of Enrollment||participants|Number|115|115.0||||||
4206195|NCT00734929|4029352|B2|United States||Region of Enrollment||participants|Number|58|58.0||||||
4206196|NCT00734929|4029353|B1|United States||Region of Enrollment||participants|Number|57|57.0||||||
4206197|NCT00734929|4029351|B3|Male||Sex/Gender, Customized||participants|Number|51|51.0||||||
4206198|NCT00734929|4029352|B2|Male||Sex/Gender, Customized||participants|Number|29|29.0||||||
4206199|NCT00734929|4029353|B1|Male||Sex/Gender, Customized||participants|Number|22|22.0||||||
4206200|NCT00734929|4029351|B3|Female||Sex/Gender, Customized||participants|Number|64|64.0||||||
4206201|NCT00734929|4029352|B2|Female||Sex/Gender, Customized||participants|Number|30|30.0||||||
4206202|NCT00734929|4029353|B1|Female||Sex/Gender, Customized||participants|Number|34|34.0||||||
4206203|NCT00734929|4029351|B3|||Age||years|Mean|50|50.0|Standard Deviation|13|13.0|||
4206204|NCT00734929|4029352|B2|||Age||years|Mean|48|48.0|Standard Deviation|13|13.0|||
4206205|NCT00734929|4029353|B1|||Age||years|Mean|51|51.0|Standard Deviation|13|13.0|||
4206207|NCT00734929|4029352|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4206208|NCT00734929|4029353|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4206209|NCT00734929|4029351|B3||Between 18 and 65 years|Age||Participants|Count of Participants|115|115.0||||||
4206210|NCT00734929|4029352|B2||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4206211|NCT00734929|4029353|B1||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4206212|NCT00734929|4029351|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4206213|NCT00734929|4029352|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4206214|NCT00734929|4029353|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4206215|NCT00734903|4029382|B3|United States||Region of Enrollment||Participants|Count of Participants|66|66.0||||||
4206216|NCT00734903|4029383|B2|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
4206217|NCT00734903|4029384|B1|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
4206218|NCT00734903|4029382|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4206219|NCT00734903|4029383|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4206220|NCT00734903|4029384|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4206221|NCT00734903|4029382|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4206222|NCT00734903|4029383|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206223|NCT00734903|4029384|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4206224|NCT00734903|4029382|B3||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4206225|NCT00734903|4029383|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4206226|NCT00734903|4029384|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4206227|NCT00734903|4029382|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4206228|NCT00734903|4029383|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4206229|NCT00734903|4029384|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4206230|NCT00734903|4029382|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206231|NCT00734903|4029383|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206232|NCT00734903|4029384|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206233|NCT00734903|4029382|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206234|NCT00734903|4029383|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206235|NCT00734903|4029384|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206236|NCT00734903|4029382|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4206237|NCT00734903|4029383|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4206238|NCT00734903|4029384|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4206239|NCT00734903|4029382|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4206240|NCT00734903|4029383|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4206241|NCT00734903|4029384|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4206242|NCT00734903|4029382|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4206243|NCT00734903|4029383|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4206244|NCT00734903|4029384|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4206245|NCT00734903|4029382|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4206246|NCT00734903|4029383|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206247|NCT00734903|4029384|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4206248|NCT00734903|4029382|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4206249|NCT00734903|4029383|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4206250|NCT00734903|4029384|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4206251|NCT00734903|4029382|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4206252|NCT00734903|4029383|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4206253|NCT00734903|4029384|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4206254|NCT00734903|4029382|B3|||Age||years|Mean|47.72|47.72|Standard Deviation|9.01|9.01|||
4206255|NCT00734903|4029383|B2|||Age||years|Mean|48.45|48.45|Standard Deviation|8.13|8.13|||
4206256|NCT00734903|4029384|B1|||Age||years|Mean|46.97|46.97|Standard Deviation|9.92|9.92|||
4206257|NCT00734851|4029411|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4206258|NCT00734851|4029411|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4206259|NCT00734851|4029411|B1|||Age||years|Mean|60.76|60.76|Standard Deviation|7.22|7.22|||
4206272|NCT00734799|4029421|B3|||Sleep Quality|Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI), a self-rating scale that yields a quantitative index of general sleep quality/disturbances. The PSQI is composed of 4 open-ended questions and 19 self-rated items (0-3 scale) assessing sleep quality and disturbances over a 1-month interval, and yields aglobal score of sleep quality, ranging from 0 to 21. A PSQI cutoff score of 5 is a sensitive and specific value for predicting both clinical and laboratory assessments of sleep.|units on a scale|Mean|14.24|14.24|Standard Deviation|3.22|3.22|||
4206260|NCT00734799|4029421|B3|||Nightmare Frequency|Nightmare frequency was assessed using an electronic sleep diary. The number and severity of nightmares were obtained using a hand-held computer that was programmed to elicit daily responses from participants and electronically record multiple days of subjective sleep information, in addition to the number and severity of nightmares for the previous night. Nightmare frequency (number of nightmares per night) was one of five variables collected from electronic sleep diaries. The average nightmare frequency per night was calculated over a period of 1 week.|Number of nightmares per night|Mean|0.67|0.67|Standard Deviation|0.53|0.53|||
4206261|NCT00734799|4029422|B2|||Nightmare Frequency|Nightmare frequency was assessed using an electronic sleep diary. The number and severity of nightmares were obtained using a hand-held computer that was programmed to elicit daily responses from participants and electronically record multiple days of subjective sleep information, in addition to the number and severity of nightmares for the previous night. Nightmare frequency (number of nightmares per night) was one of five variables collected from electronic sleep diaries. The average nightmare frequency per night was calculated over a period of 1 week.|Number of nightmares per night|Mean|0.72|0.72|Standard Deviation|0.43|0.43|||
4206262|NCT00734799|4029423|B1|||Nightmare Frequency|Nightmare frequency was assessed using an electronic sleep diary. The number and severity of nightmares were obtained using a hand-held computer that was programmed to elicit daily responses from participants and electronically record multiple days of subjective sleep information, in addition to the number and severity of nightmares for the previous night. Nightmare frequency (number of nightmares per night) was one of five variables collected from electronic sleep diaries. The average nightmare frequency per night was calculated over a period of 1 week.|Number of nightmares per night|Mean|0.59|0.59|Standard Deviation|0.68|0.68|||
4206263|NCT00734799|4029421|B3|||Sleep-Specific PTSD Symptoms|The Pittsburgh Sleep Quality Index Addendum for PTSD (PSQIA) was used to assess PTSD-related sleep quality, and has acceptable psychometric properties. A cut-off score of 4 was found to have excellent sensitivity and specificity for discriminating those without PTSD from those with PTSD. Total scores on the PSQIA range from 0 to 21, with higher scores reflecting poorer PTSD-related sleep quality.|scores on a scale|Mean|10.00|10.0|Standard Deviation|4.50|4.5|||
4206264|NCT00734799|4029422|B2|||Sleep-Specific PTSD Symptoms|The Pittsburgh Sleep Quality Index Addendum for PTSD (PSQIA) was used to assess PTSD-related sleep quality, and has acceptable psychometric properties. A cut-off score of 4 was found to have excellent sensitivity and specificity for discriminating those without PTSD from those with PTSD. Total scores on the PSQIA range from 0 to 21, with higher scores reflecting poorer PTSD-related sleep quality.|scores on a scale|Mean|10.00|10.0|Standard Deviation|4.10|4.1|||
4206265|NCT00734799|4029423|B1|||Sleep-Specific PTSD Symptoms|The Pittsburgh Sleep Quality Index Addendum for PTSD (PSQIA) was used to assess PTSD-related sleep quality, and has acceptable psychometric properties. A cut-off score of 4 was found to have excellent sensitivity and specificity for discriminating those without PTSD from those with PTSD. Total scores on the PSQIA range from 0 to 21, with higher scores reflecting poorer PTSD-related sleep quality.|scores on a scale|Mean|10.00|10.0|Standard Deviation|5.29|5.29|||
4206266|NCT00734799|4029421|B3|||Depression|Depression was assessed using the PHQ-9. The PHQ-2 is a 2-item depression screening instrument that assesses frequency of depressed mood and anhedonia on a scale of 0 (not at all) to 3 (nearly every day). In a primary care population, the PHQ-2 has a sensitivity of 86% and specificity of 78% for detecting major depression, with a score ≥ 2 correctly categorizing the greatest number of those with major depression.|scores on a scale|Mean|3.82|3.82|Standard Deviation|1.84|1.84|||
4206267|NCT00734799|4029422|B2|||Depression|Depression was assessed using the PHQ-9. The PHQ-2 is a 2-item depression screening instrument that assesses frequency of depressed mood and anhedonia on a scale of 0 (not at all) to 3 (nearly every day). In a primary care population, the PHQ-2 has a sensitivity of 86% and specificity of 78% for detecting major depression, with a score ≥ 2 correctly categorizing the greatest number of those with major depression.|scores on a scale|Mean|3.77|3.77|Standard Deviation|1.74|1.74|||
4206268|NCT00734799|4029423|B1|||Depression|Depression was assessed using the PHQ-9. The PHQ-2 is a 2-item depression screening instrument that assesses frequency of depressed mood and anhedonia on a scale of 0 (not at all) to 3 (nearly every day). In a primary care population, the PHQ-2 has a sensitivity of 86% and specificity of 78% for detecting major depression, with a score ≥ 2 correctly categorizing the greatest number of those with major depression.|scores on a scale|Mean|3.88|3.88|Standard Deviation|2.08|2.08|||
4206269|NCT00734799|4029421|B3|||PTSD Symptom Checklist-M|The PCL-M is a 17-item self-report measure reflecting the degree to which veterans were bothered by each of 17 DSM-IV symptoms of PTSD in the past month. It is rated on a 5-point scale ranging from 1 (“not at all”) to 5 (“extremely”). The total score can range from 17 to 85, with higher scores reflecting greater PTSD symptomatology. In Vietnam veterans, a PCL-M score ≥ 50 was found to be highly predictive of PTSD diagnosis using the SCID. The PCL-M was used to assess treatment outcome and as an indicator of clinical significance of study findings.|scores on a scale|Mean|63.23|63.23|Standard Deviation|11.86|11.86|||
4206270|NCT00734799|4029422|B2|||PTSD Symptom Checklist-M|The PCL-M is a 17-item self-report measure reflecting the degree to which veterans were bothered by each of 17 DSM-IV symptoms of PTSD in the past month. It is rated on a 5-point scale ranging from 1 (“not at all”) to 5 (“extremely”). The total score can range from 17 to 85, with higher scores reflecting greater PTSD symptomatology. In Vietnam veterans, a PCL-M score ≥ 50 was found to be highly predictive of PTSD diagnosis using the SCID. The PCL-M was used to assess treatment outcome and as an indicator of clinical significance of study findings.|scores on a scale|Mean|63.08|63.08|Standard Deviation|12.47|12.47|||
4206271|NCT00734799|4029423|B1|||PTSD Symptom Checklist-M|The PCL-M is a 17-item self-report measure reflecting the degree to which veterans were bothered by each of 17 DSM-IV symptoms of PTSD in the past month. It is rated on a 5-point scale ranging from 1 (“not at all”) to 5 (“extremely”). The total score can range from 17 to 85, with higher scores reflecting greater PTSD symptomatology. In Vietnam veterans, a PCL-M score ≥ 50 was found to be highly predictive of PTSD diagnosis using the SCID. The PCL-M was used to assess treatment outcome and as an indicator of clinical significance of study findings.|scores on a scale|Mean|63.44|63.44|Standard Deviation|11.66|11.66|||
4206363|NCT00734604|4029491|B7|No||Prior Vardenafil HCl use||participants|Number|274|274.0||||||
4206364|NCT00734604|4029492|B6|No||Prior Vardenafil HCl use||participants|Number|45|45.0||||||
4206365|NCT00734604|4029493|B5|No||Prior Vardenafil HCl use||participants|Number|44|44.0||||||
4206273|NCT00734799|4029422|B2|||Sleep Quality|Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI), a self-rating scale that yields a quantitative index of general sleep quality/disturbances. The PSQI is composed of 4 open-ended questions and 19 self-rated items (0-3 scale) assessing sleep quality and disturbances over a 1-month interval, and yields aglobal score of sleep quality, ranging from 0 to 21. A PSQI cutoff score of 5 is a sensitive and specific value for predicting both clinical and laboratory assessments of sleep.|units on a scale|Mean|14.17|14.17|Standard Deviation|3.27|3.27|||
4206274|NCT00734799|4029423|B1|||Sleep Quality|Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI), a self-rating scale that yields a quantitative index of general sleep quality/disturbances. The PSQI is composed of 4 open-ended questions and 19 self-rated items (0-3 scale) assessing sleep quality and disturbances over a 1-month interval, and yields aglobal score of sleep quality, ranging from 0 to 21. A PSQI cutoff score of 5 is a sensitive and specific value for predicting both clinical and laboratory assessments of sleep.|units on a scale|Mean|14.33|14.33|Standard Deviation|3.35|3.35|||
4206275|NCT00734799|4029421|B3|||Insomnia Severity|The ISI is a 7-item questionnaire that provides a global measure of perceived insomnia severity. Each item is rated on a 5-point Likert scale, and the total score ranges from 0-28. The following guidelines are recommended for interpreting the total score: 0-7 (no clinical insomnia), 8-14 (subthreshold insomnia), 15-21 (insomnia of moderate severity), and 22-28 (severe insomnia). The ISI was used to determine treatment eligibility, to assess treatment outcome, and to determine clinical significance of study findings.|units on a scale|Mean|22.46|22.46|Standard Deviation|4.25|4.25|||
4206276|NCT00734799|4029422|B2|||Insomnia Severity|The ISI is a 7-item questionnaire that provides a global measure of perceived insomnia severity. Each item is rated on a 5-point Likert scale, and the total score ranges from 0-28. The following guidelines are recommended for interpreting the total score: 0-7 (no clinical insomnia), 8-14 (subthreshold insomnia), 15-21 (insomnia of moderate severity), and 22-28 (severe insomnia). The ISI was used to determine treatment eligibility, to assess treatment outcome, and to determine clinical significance of study findings.|units on a scale|Mean|22.77|22.77|Standard Deviation|4.57|4.57|||
4206277|NCT00734799|4029423|B1|||Insomnia Severity|The ISI is a 7-item questionnaire that provides a global measure of perceived insomnia severity. Each item is rated on a 5-point Likert scale, and the total score ranges from 0-28. The following guidelines are recommended for interpreting the total score: 0-7 (no clinical insomnia), 8-14 (subthreshold insomnia), 15-21 (insomnia of moderate severity), and 22-28 (severe insomnia). The ISI was used to determine treatment eligibility, to assess treatment outcome, and to determine clinical significance of study findings.|units on a scale|Mean|22.00|22.0|Standard Deviation|3.97|3.97|||
4206278|NCT00734799|4029421|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4206279|NCT00734799|4029422|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4206280|NCT00734799|4029423|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4206281|NCT00734799|4029421|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4206282|NCT00734799|4029422|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4206283|NCT00734799|4029423|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4206284|NCT00734799|4029421|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4206285|NCT00734799|4029422|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4206286|NCT00734799|4029423|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4206287|NCT00734799|4029421|B3|||Age||years|Mean|48.61|48.61|Standard Deviation|10.42|10.42|||
4206288|NCT00734799|4029422|B2|||Age||years|Mean|47.00|47.0|Standard Deviation|9.47|9.47|||
4206289|NCT00734799|4029423|B1|||Age||years|Mean|50.22|50.22|Standard Deviation|11.62|11.62|||
4206290|NCT00734799|4029421|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4206291|NCT00734799|4029422|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4206292|NCT00734799|4029423|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4206293|NCT00734799|4029421|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4206294|NCT00734799|4029422|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4206295|NCT00734799|4029423|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4206296|NCT00734799|4029421|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4206297|NCT00734799|4029422|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4206298|NCT00734799|4029423|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4206299|NCT00734747|4029432|B1|No baseline measurement||Hill Grade|Hill Scores indicating the status of the patients' Gastroesophageal Flap Valve (GEFV). A satisfactory flap valve has a Hill Grade of 1 or 2.|participants|Number|7|7.0||||||
4206300|NCT00734747|4029432|B1|Hill Grade >=2||Hill Grade|Hill Scores indicating the status of the patients' Gastroesophageal Flap Valve (GEFV). A satisfactory flap valve has a Hill Grade of 1 or 2.|participants|Number|43|43.0||||||
4206301|NCT00734747|4029432|B1|Hill Grade <= 2||Hill Grade|Hill Scores indicating the status of the patients' Gastroesophageal Flap Valve (GEFV). A satisfactory flap valve has a Hill Grade of 1 or 2.|participants|Number|22|22.0||||||
4206302|NCT00734747|4029432|B1|||% total time pH < 4|Ambulatory, 24 hour esophageal pH measurement; Baseline value calculated for n=66 participants evaluated at 6 months.|% total time|Mean|10.9|10.9|Standard Deviation|10.7|10.7|||
4206303|NCT00734747|4029432|B1|||GERD HRQL off PPI|Gastroesophageal Reflux Disease Health Related Quality of Life (GERD-HRQL) questionnaire, also known as Velanovich score. The questionnaire consists of 10 questions with responses of 0-5. The responses of the 10 questions are totaled (range of 0-50) where a higher total indicates more severe disease than a lower total. This questionnaire was administered while the subjects were not taking proton pump inhibitor (PPI) medication (i.e. off-PPI)|units on a scale|Median|29|29.0|Standard Deviation|6.2|6.2|||
4206366|NCT00734604|4029494|B4|No||Prior Vardenafil HCl use||participants|Number|53|53.0||||||
4206367|NCT00734604|4029495|B3|No||Prior Vardenafil HCl use||participants|Number|46|46.0||||||
4206368|NCT00734604|4029496|B2|No||Prior Vardenafil HCl use||participants|Number|45|45.0||||||
4206304|NCT00734747|4029432|B1|||GERD HRQL on PPI|Gastroesophageal Reflux Disease Health Related Quality of Life (GERD-HRQL) questionnaire, also known as Velanovich score. The questionnaire consists of 10 questions with responses of 0-5. The responses of the 10 questions are totaled (range of 0-50) where a higher total indicates more severe disease than a lower total. This questionnaire was administered while the subjects were taking proton pump inhibitor (PPI) medication.|units on a scale|Median|15|15.0|Standard Deviation|7.5|7.5|||
4206305|NCT00734747|4029432|B1|||BMI|Body Mass Index|kg/m^2|Mean|26.5|26.5|Standard Deviation|4.3|4.3|||
4206306|NCT00734747|4029432|B1|India||Region of Enrollment||participants|Number|13|13.0||||||
4206307|NCT00734747|4029432|B1|Germany||Region of Enrollment||participants|Number|7|7.0||||||
4206308|NCT00734747|4029432|B1|Italy||Region of Enrollment||participants|Number|5|5.0||||||
4206309|NCT00734747|4029432|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4206310|NCT00734747|4029432|B1|Austria||Region of Enrollment||participants|Number|9|9.0||||||
4206311|NCT00734747|4029432|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4206312|NCT00734747|4029432|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4206313|NCT00734747|4029432|B1|||Age||years|Median|47.5|47.5|Full Range|||24.0|74.0|
4206314|NCT00734734|4029439|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4206315|NCT00734734|4029439|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4206316|NCT00734734|4029439|B1|||Age||Years|Mean|73.1|73.1|Standard Deviation|4.8|4.8|||
4206317|NCT00734656|4029446|B1|United States||Region of Enrollment||participants|Number|94|94.0||||||
4206318|NCT00734656|4029446|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4206319|NCT00734656|4029446|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4206320|NCT00734656|4029446|B1|||Age||years|Mean|26.1|26.1|Standard Deviation|6.5|6.5|||
4206321|NCT00734656|4029446|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4206322|NCT00734656|4029446|B1||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
4206323|NCT00734656|4029446|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4206324|NCT00734630|4029471|B3|United States||Region of Enrollment||participants|Number|491|491.0||||||
4206325|NCT00734630|4029472|B2|United States||Region of Enrollment||participants|Number|233|233.0||||||
4206326|NCT00734630|4029473|B1|United States||Region of Enrollment||participants|Number|258|258.0||||||
4206327|NCT00734630|4029471|B3||Male|Sex: Female, Male||Participants|Count of Participants|295|295.0||||||
4206328|NCT00734630|4029472|B2||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4206329|NCT00734630|4029473|B1||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4206330|NCT00734630|4029471|B3||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4206331|NCT00734630|4029472|B2||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4206332|NCT00734630|4029473|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4206333|NCT00734630|4029471|B3|≥65 years||Age, Customized||Participants|Number|61|61.0||||||
4206334|NCT00734630|4029472|B2|≥65 years||Age, Customized||Participants|Number|32|32.0||||||
4206335|NCT00734630|4029473|B1|≥65 years||Age, Customized||Participants|Number|29|29.0||||||
4206336|NCT00734630|4029471|B3|Between 18 and 65 Years||Age, Customized||Participants|Number|430|430.0||||||
4206337|NCT00734630|4029472|B2|Between 18 and 65 Years||Age, Customized||Participants|Number|201|201.0||||||
4206338|NCT00734630|4029473|B1|Between 18 and 65 Years||Age, Customized||Participants|Number|229|229.0||||||
4206339|NCT00734630|4029471|B3|||Age||years|Mean|52.9|52.9|Standard Deviation|9.9|9.9|||
4206340|NCT00734630|4029472|B2|||Age||years|Mean|53.8|53.8|Standard Deviation|9.6|9.6|||
4206341|NCT00734630|4029473|B1|||Age||years|Mean|52.1|52.1|Standard Deviation|10.1|10.1|||
4206342|NCT00734617|4029482|B3|United States||Region of Enrollment||participants|Number|479|479.0||||||
4206343|NCT00734617|4029483|B2|United States||Region of Enrollment||participants|Number|230|230.0||||||
4206344|NCT00734617|4029484|B1|United States||Region of Enrollment||participants|Number|249|249.0||||||
4206345|NCT00734617|4029482|B3||Male|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4206346|NCT00734617|4029483|B2||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4206347|NCT00734617|4029484|B1||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4206348|NCT00734617|4029482|B3||Female|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
4206349|NCT00734617|4029483|B2||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4206350|NCT00734617|4029484|B1||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4206351|NCT00734617|4029482|B3|||Age||years|Mean|43.53|43.53|Standard Deviation|11.12|11.12|||
4206352|NCT00734617|4029483|B2|||Age||years|Mean|44.34|44.34|Standard Deviation|10.92|10.92|||
4206353|NCT00734617|4029484|B1|||Age||years|Mean|42.7|42.7|Standard Deviation|11.4|11.4|||
4206354|NCT00734617|4029482|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4206355|NCT00734617|4029483|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4206356|NCT00734617|4029484|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4206357|NCT00734617|4029482|B3||Between 18 and 65 years|Age||Participants|Count of Participants|479|479.0||||||
4206358|NCT00734617|4029483|B2||Between 18 and 65 years|Age||Participants|Count of Participants|230|230.0||||||
4206359|NCT00734617|4029484|B1||Between 18 and 65 years|Age||Participants|Count of Participants|249|249.0||||||
4206360|NCT00734617|4029482|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4206361|NCT00734617|4029483|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4206362|NCT00734617|4029484|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4206369|NCT00734604|4029497|B1|No||Prior Vardenafil HCl use||participants|Number|41|41.0||||||
4206370|NCT00734604|4029491|B7|Yes||Prior Vardenafil HCl use||participants|Number|104|104.0||||||
4206371|NCT00734604|4029492|B6|Yes||Prior Vardenafil HCl use||participants|Number|19|19.0||||||
4206372|NCT00734604|4029493|B5|Yes||Prior Vardenafil HCl use||participants|Number|19|19.0||||||
4206373|NCT00734604|4029494|B4|Yes||Prior Vardenafil HCl use||participants|Number|10|10.0||||||
4206374|NCT00734604|4029495|B3|Yes||Prior Vardenafil HCl use||participants|Number|17|17.0||||||
4206375|NCT00734604|4029496|B2|Yes||Prior Vardenafil HCl use||participants|Number|18|18.0||||||
4206376|NCT00734604|4029497|B1|Yes||Prior Vardenafil HCl use||participants|Number|21|21.0||||||
4206377|NCT00734604|4029491|B7|No||Prior sildenafil citrate use as needed (PRN)||participants|Number|149|149.0||||||
4206378|NCT00734604|4029492|B6|No||Prior sildenafil citrate use as needed (PRN)||participants|Number|29|29.0||||||
4206379|NCT00734604|4029493|B5|No||Prior sildenafil citrate use as needed (PRN)||participants|Number|24|24.0||||||
4206380|NCT00734604|4029494|B4|No||Prior sildenafil citrate use as needed (PRN)||participants|Number|24|24.0||||||
4206381|NCT00734604|4029495|B3|No||Prior sildenafil citrate use as needed (PRN)||participants|Number|23|23.0||||||
4206382|NCT00734604|4029496|B2|No||Prior sildenafil citrate use as needed (PRN)||participants|Number|23|23.0||||||
4206383|NCT00734604|4029497|B1|No||Prior sildenafil citrate use as needed (PRN)||participants|Number|26|26.0||||||
4206384|NCT00734604|4029491|B7|Yes||Prior sildenafil citrate use as needed (PRN)||participants|Number|229|229.0||||||
4206385|NCT00734604|4029492|B6|Yes||Prior sildenafil citrate use as needed (PRN)||participants|Number|35|35.0||||||
4206386|NCT00734604|4029493|B5|Yes||Prior sildenafil citrate use as needed (PRN)||participants|Number|39|39.0||||||
4206387|NCT00734604|4029494|B4|Yes||Prior sildenafil citrate use as needed (PRN)||participants|Number|39|39.0||||||
4206388|NCT00734604|4029495|B3|Yes||Prior sildenafil citrate use as needed (PRN)||participants|Number|40|40.0||||||
4206389|NCT00734604|4029496|B2|Yes||Prior sildenafil citrate use as needed (PRN)||participants|Number|40|40.0||||||
4206390|NCT00734604|4029497|B1|Yes||Prior sildenafil citrate use as needed (PRN)||participants|Number|36|36.0||||||
4206391|NCT00734604|4029491|B7|Unknown||ED Etiology||participants|Number|35|35.0||||||
4206392|NCT00734604|4029492|B6|Unknown||ED Etiology||participants|Number|4|4.0||||||
4206393|NCT00734604|4029493|B5|Unknown||ED Etiology||participants|Number|9|9.0||||||
4206394|NCT00734604|4029494|B4|Unknown||ED Etiology||participants|Number|2|2.0||||||
4206395|NCT00734604|4029495|B3|Unknown||ED Etiology||participants|Number|4|4.0||||||
4206396|NCT00734604|4029496|B2|Unknown||ED Etiology||participants|Number|6|6.0||||||
4206397|NCT00734604|4029497|B1|Unknown||ED Etiology||participants|Number|10|10.0||||||
4206398|NCT00734604|4029491|B7|Psychogenic||ED Etiology||participants|Number|34|34.0||||||
4206399|NCT00734604|4029492|B6|Psychogenic||ED Etiology||participants|Number|7|7.0||||||
4206400|NCT00734604|4029493|B5|Psychogenic||ED Etiology||participants|Number|1|1.0||||||
4206401|NCT00734604|4029494|B4|Psychogenic||ED Etiology||participants|Number|9|9.0||||||
4206402|NCT00734604|4029495|B3|Psychogenic||ED Etiology||participants|Number|9|9.0||||||
4206403|NCT00734604|4029496|B2|Psychogenic||ED Etiology||participants|Number|3|3.0||||||
4206404|NCT00734604|4029497|B1|Psychogenic||ED Etiology||participants|Number|5|5.0||||||
4206405|NCT00734604|4029491|B7|Organic||ED Etiology||participants|Number|163|163.0||||||
4206406|NCT00734604|4029492|B6|Organic||ED Etiology||participants|Number|25|25.0||||||
4206407|NCT00734604|4029493|B5|Organic||ED Etiology||participants|Number|30|30.0||||||
4206408|NCT00734604|4029494|B4|Organic||ED Etiology||participants|Number|29|29.0||||||
4206409|NCT00734604|4029495|B3|Organic||ED Etiology||participants|Number|29|29.0||||||
4206410|NCT00734604|4029496|B2|Organic||ED Etiology||participants|Number|28|28.0||||||
4206411|NCT00734604|4029497|B1|Organic||ED Etiology||participants|Number|22|22.0||||||
4206412|NCT00734604|4029491|B7|Mixed||ED Etiology||participants|Number|146|146.0||||||
4206413|NCT00734604|4029492|B6|Mixed||ED Etiology||participants|Number|28|28.0||||||
4206414|NCT00734604|4029493|B5|Mixed||ED Etiology||participants|Number|23|23.0||||||
4206415|NCT00734604|4029494|B4|Mixed||ED Etiology||participants|Number|23|23.0||||||
4206416|NCT00734604|4029495|B3|Mixed||ED Etiology||participants|Number|21|21.0||||||
4206417|NCT00734604|4029496|B2|Mixed||ED Etiology||participants|Number|26|26.0||||||
4206418|NCT00734604|4029497|B1|Mixed||ED Etiology||participants|Number|25|25.0||||||
4206419|NCT00734604|4029491|B7|=> than 6 months through <1 year||Erectile Dysfunction (ED) Duration||participants|Number|22|22.0||||||
4206420|NCT00734604|4029492|B6|=> than 6 months through <1 year||Erectile Dysfunction (ED) Duration||participants|Number|5|5.0||||||
4206421|NCT00734604|4029493|B5|=> than 6 months through <1 year||Erectile Dysfunction (ED) Duration||participants|Number|2|2.0||||||
4206422|NCT00734604|4029494|B4|=> than 6 months through <1 year||Erectile Dysfunction (ED) Duration||participants|Number|5|5.0||||||
4206423|NCT00734604|4029495|B3|=> than 6 months through <1 year||Erectile Dysfunction (ED) Duration||participants|Number|5|5.0||||||
4206424|NCT00734604|4029496|B2|=> than 6 months through <1 year||Erectile Dysfunction (ED) Duration||participants|Number|2|2.0||||||
4206425|NCT00734604|4029497|B1|=> than 6 months through <1 year||Erectile Dysfunction (ED) Duration||participants|Number|3|3.0||||||
4206426|NCT00734604|4029491|B7|=> 1 year||Erectile Dysfunction (ED) Duration||participants|Number|356|356.0||||||
4206427|NCT00734604|4029492|B6|=> 1 year||Erectile Dysfunction (ED) Duration||participants|Number|59|59.0||||||
4206428|NCT00734604|4029493|B5|=> 1 year||Erectile Dysfunction (ED) Duration||participants|Number|61|61.0||||||
4206429|NCT00734604|4029494|B4|=> 1 year||Erectile Dysfunction (ED) Duration||participants|Number|58|58.0||||||
4206430|NCT00734604|4029495|B3|=> 1 year||Erectile Dysfunction (ED) Duration||participants|Number|58|58.0||||||
4206431|NCT00734604|4029496|B2|=> 1 year||Erectile Dysfunction (ED) Duration||participants|Number|61|61.0||||||
4206432|NCT00734604|4029497|B1|=> 1 year||Erectile Dysfunction (ED) Duration||participants|Number|59|59.0||||||
4206433|NCT00734604|4029491|B7|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|28.22|28.22|Standard Deviation|3.91|3.91|||
4206434|NCT00734604|4029492|B6|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|29.08|29.08|Standard Deviation|4.26|4.26|||
4206435|NCT00734604|4029493|B5|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|27.80|27.8|Standard Deviation|3.51|3.51|||
4206436|NCT00734604|4029494|B4|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|28.68|28.68|Standard Deviation|4.74|4.74|||
4206437|NCT00734604|4029495|B3|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|27.77|27.77|Standard Deviation|3.71|3.71|||
4206438|NCT00734604|4029496|B2|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|27.62|27.62|Standard Deviation|2.65|2.65|||
4206439|NCT00734604|4029497|B1|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|28.35|28.35|Standard Deviation|4.18|4.18|||
4206440|NCT00734604|4029491|B7|United States||Region of Enrollment||participants|Number|100|100.0||||||
4206441|NCT00734604|4029492|B6|United States||Region of Enrollment||participants|Number|17|17.0||||||
4206442|NCT00734604|4029493|B5|United States||Region of Enrollment||participants|Number|17|17.0||||||
4206443|NCT00734604|4029494|B4|United States||Region of Enrollment||participants|Number|16|16.0||||||
4206444|NCT00734604|4029495|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4206445|NCT00734604|4029496|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4206446|NCT00734604|4029497|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4206447|NCT00734604|4029491|B7|United Kingdom||Region of Enrollment||participants|Number|44|44.0||||||
4206448|NCT00734604|4029492|B6|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
4206449|NCT00734604|4029493|B5|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
4206450|NCT00734604|4029494|B4|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
4206451|NCT00734604|4029495|B3|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
4206452|NCT00734604|4029496|B2|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
4206453|NCT00734604|4029497|B1|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4206454|NCT00734604|4029491|B7|Spain||Region of Enrollment||participants|Number|57|57.0||||||
4206455|NCT00734604|4029492|B6|Spain||Region of Enrollment||participants|Number|9|9.0||||||
4206456|NCT00734604|4029493|B5|Spain||Region of Enrollment||participants|Number|9|9.0||||||
4206457|NCT00734604|4029494|B4|Spain||Region of Enrollment||participants|Number|9|9.0||||||
4206458|NCT00734604|4029495|B3|Spain||Region of Enrollment||participants|Number|10|10.0||||||
4206459|NCT00734604|4029496|B2|Spain||Region of Enrollment||participants|Number|10|10.0||||||
4206460|NCT00734604|4029497|B1|Spain||Region of Enrollment||participants|Number|10|10.0||||||
4206461|NCT00734604|4029491|B7|Mexico||Region of Enrollment||participants|Number|84|84.0||||||
4206462|NCT00734604|4029492|B6|Mexico||Region of Enrollment||participants|Number|14|14.0||||||
4206463|NCT00734604|4029493|B5|Mexico||Region of Enrollment||participants|Number|14|14.0||||||
4206464|NCT00734604|4029494|B4|Mexico||Region of Enrollment||participants|Number|14|14.0||||||
4206465|NCT00734604|4029495|B3|Mexico||Region of Enrollment||participants|Number|14|14.0||||||
4206466|NCT00734604|4029496|B2|Mexico||Region of Enrollment||participants|Number|14|14.0||||||
4206467|NCT00734604|4029497|B1|Mexico||Region of Enrollment||participants|Number|14|14.0||||||
4206468|NCT00734604|4029491|B7|Italy||Region of Enrollment||participants|Number|29|29.0||||||
4206469|NCT00734604|4029492|B6|Italy||Region of Enrollment||participants|Number|5|5.0||||||
4206470|NCT00734604|4029493|B5|Italy||Region of Enrollment||participants|Number|4|4.0||||||
4206471|NCT00734604|4029494|B4|Italy||Region of Enrollment||participants|Number|6|6.0||||||
4206472|NCT00734604|4029495|B3|Italy||Region of Enrollment||participants|Number|4|4.0||||||
4206473|NCT00734604|4029496|B2|Italy||Region of Enrollment||participants|Number|5|5.0||||||
4206474|NCT00734604|4029497|B1|Italy||Region of Enrollment||participants|Number|5|5.0||||||
4206475|NCT00734604|4029491|B7|Germany||Region of Enrollment||participants|Number|40|40.0||||||
4206476|NCT00734604|4029492|B6|Germany||Region of Enrollment||participants|Number|7|7.0||||||
4206477|NCT00734604|4029493|B5|Germany||Region of Enrollment||participants|Number|7|7.0||||||
4206478|NCT00734604|4029494|B4|Germany||Region of Enrollment||participants|Number|7|7.0||||||
4206479|NCT00734604|4029495|B3|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4206480|NCT00734604|4029496|B2|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4206481|NCT00734604|4029497|B1|Germany||Region of Enrollment||participants|Number|7|7.0||||||
4206482|NCT00734604|4029491|B7|Australia||Region of Enrollment||participants|Number|24|24.0||||||
4206483|NCT00734604|4029492|B6|Australia||Region of Enrollment||participants|Number|4|4.0||||||
4206484|NCT00734604|4029493|B5|Australia||Region of Enrollment||participants|Number|4|4.0||||||
4206485|NCT00734604|4029494|B4|Australia||Region of Enrollment||participants|Number|4|4.0||||||
4206486|NCT00734604|4029495|B3|Australia||Region of Enrollment||participants|Number|5|5.0||||||
4206487|NCT00734604|4029496|B2|Australia||Region of Enrollment||participants|Number|4|4.0||||||
4206488|NCT00734604|4029497|B1|Australia||Region of Enrollment||participants|Number|3|3.0||||||
4206489|NCT00734604|4029491|B7|West Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4206490|NCT00734604|4029492|B6|West Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206491|NCT00734604|4029493|B5|West Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206492|NCT00734604|4029494|B4|West Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206493|NCT00734604|4029495|B3|West Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206494|NCT00734604|4029496|B2|West Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4206495|NCT00734604|4029497|B1|West Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206496|NCT00734604|4029491|B7|Native American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4206497|NCT00734604|4029492|B6|Native American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4206498|NCT00734604|4029493|B5|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206499|NCT00734604|4029494|B4|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206500|NCT00734604|4029495|B3|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206501|NCT00734604|4029496|B2|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206502|NCT00734604|4029497|B1|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206503|NCT00734604|4029491|B7|Hispanic||Race/Ethnicity, Customized||participants|Number|105|105.0||||||
4206504|NCT00734604|4029492|B6|Hispanic||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4206505|NCT00734604|4029493|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4206506|NCT00734604|4029494|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4206507|NCT00734604|4029495|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4206508|NCT00734604|4029496|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4206509|NCT00734604|4029497|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4206510|NCT00734604|4029491|B7|East Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4206511|NCT00734604|4029492|B6|East Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4206512|NCT00734604|4029493|B5|East Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206513|NCT00734604|4029494|B4|East Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206514|NCT00734604|4029495|B3|East Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4206515|NCT00734604|4029496|B2|East Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206516|NCT00734604|4029497|B1|East Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4206517|NCT00734604|4029491|B7|Caucasian||Race/Ethnicity, Customized||participants|Number|255|255.0||||||
4206518|NCT00734604|4029492|B6|Caucasian||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4206519|NCT00734604|4029493|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4206520|NCT00734604|4029494|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4206521|NCT00734604|4029495|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4206522|NCT00734604|4029496|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4206523|NCT00734604|4029497|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4206524|NCT00734604|4029491|B7|African||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4206525|NCT00734604|4029492|B6|African||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4206526|NCT00734604|4029493|B5|African||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4206527|NCT00734604|4029494|B4|African||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4206528|NCT00734604|4029495|B3|African||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4206529|NCT00734604|4029496|B2|African||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4206530|NCT00734604|4029497|B1|African||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4206531|NCT00734604|4029491|B7||Male|Sex: Female, Male||Participants|Count of Participants|378|378.0||||||
4206532|NCT00734604|4029492|B6||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4206533|NCT00734604|4029493|B5||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4206534|NCT00734604|4029494|B4||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4206535|NCT00734604|4029495|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4206536|NCT00734604|4029496|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4206537|NCT00734604|4029497|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4206538|NCT00734604|4029491|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4206539|NCT00734604|4029492|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4206540|NCT00734604|4029493|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4206541|NCT00734604|4029494|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4206542|NCT00734604|4029495|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4206543|NCT00734604|4029496|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4206544|NCT00734604|4029497|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4206545|NCT00734604|4029491|B7|||Age||years|Mean|56.21|56.21|Standard Deviation|10.98|10.98|||
4206546|NCT00734604|4029492|B6|||Age||years|Mean|54.36|54.36|Standard Deviation|10.28|10.28|||
4206547|NCT00734604|4029493|B5|||Age||years|Mean|59.04|59.04|Standard Deviation|10.56|10.56|||
4206548|NCT00734604|4029494|B4|||Age||years|Mean|54.87|54.87|Standard Deviation|12.04|12.04|||
4206549|NCT00734604|4029495|B3|||Age||years|Mean|55.40|55.4|Standard Deviation|11.70|11.7|||
4206550|NCT00734604|4029496|B2|||Age||years|Mean|55.12|55.12|Standard Deviation|8.89|8.89|||
4206551|NCT00734604|4029497|B1|||Age||years|Mean|58.53|58.53|Standard Deviation|11.62|11.62|||
4206552|NCT00734591|4029550|B3|Ever-smoker||Smoking status|Reported as number of participants who never smoked (never-smoker) and those who have ever smoked (ever-smoker) includes former smokers and current smokers.|participants|Number|3214|3214.0||||||
4206553|NCT00734591|4029551|B2|Ever-smoker||Smoking status|Reported as number of participants who never smoked (never-smoker) and those who have ever smoked (ever-smoker) includes former smokers and current smokers.|participants|Number|1533|1533.0||||||
4206554|NCT00734591|4029552|B1|Ever-smoker||Smoking status|Reported as number of participants who never smoked (never-smoker) and those who have ever smoked (ever-smoker) includes former smokers and current smokers.|participants|Number|1681|1681.0||||||
4206555|NCT00734591|4029550|B3|Never-smoker||Smoking status|Reported as number of participants who never smoked (never-smoker) and those who have ever smoked (ever-smoker) includes former smokers and current smokers.|participants|Number|4225|4225.0||||||
4206556|NCT00734591|4029551|B2|Never-smoker||Smoking status|Reported as number of participants who never smoked (never-smoker) and those who have ever smoked (ever-smoker) includes former smokers and current smokers.|participants|Number|2031|2031.0||||||
4206557|NCT00734591|4029552|B1|Never-smoker||Smoking status|Reported as number of participants who never smoked (never-smoker) and those who have ever smoked (ever-smoker) includes former smokers and current smokers.|participants|Number|2194|2194.0||||||
4206558|NCT00734591|4029550|B3||Male|Sex: Female, Male||Participants|Count of Participants|4205|4205.0||||||
4206559|NCT00734591|4029551|B2||Male|Sex: Female, Male||Participants|Count of Participants|2007|2007.0||||||
4206560|NCT00734591|4029552|B1||Male|Sex: Female, Male||Participants|Count of Participants|2198|2198.0||||||
4206561|NCT00734591|4029550|B3||Female|Sex: Female, Male||Participants|Count of Participants|3234|3234.0||||||
4206562|NCT00734591|4029551|B2||Female|Sex: Female, Male||Participants|Count of Participants|1557|1557.0||||||
4206563|NCT00734591|4029552|B1||Female|Sex: Female, Male||Participants|Count of Participants|1677|1677.0||||||
4206564|NCT00734591|4029550|B3|||Age|Mean age at original trial|years|Mean|54.8|54.8|Standard Deviation|12.4|12.4|||
4206565|NCT00734591|4029551|B2|||Age|Mean age at original trial|years|Mean|54.7|54.7|Standard Deviation|12.6|12.6|||
4206566|NCT00734591|4029552|B1|||Age|Mean age at original trial|years|Mean|54.8|54.8|Standard Deviation|12.1|12.1|||
4206567|NCT00734578|4029565|B4|United States||Region of Enrollment|The demographics are based on the Safety Population (n = 455) which includes all subjects who received at least 1 dose of study drug.|participants|Number|455|455.0||||||
4206568|NCT00734578|4029566|B3|United States||Region of Enrollment|The demographics are based on the Safety Population (n = 455) which includes all subjects who received at least 1 dose of study drug.|participants|Number|153|153.0||||||
4206569|NCT00734578|4029567|B2|United States||Region of Enrollment|The demographics are based on the Safety Population (n = 455) which includes all subjects who received at least 1 dose of study drug.|participants|Number|152|152.0||||||
4206570|NCT00734578|4029568|B1|United States||Region of Enrollment|The demographics are based on the Safety Population (n = 455) which includes all subjects who received at least 1 dose of study drug.|participants|Number|150|150.0||||||
4206571|NCT00734578|4029565|B4||Male|Sex: Female, Male|The demographics are based on the Safety Population (n = 455) which includes all subjects who received at least 1 dose of study drug.|Participants|Count of Participants|326|326.0||||||
4206572|NCT00734578|4029566|B3||Male|Sex: Female, Male|The demographics are based on the Safety Population (n = 455) which includes all subjects who received at least 1 dose of study drug.|Participants|Count of Participants|112|112.0||||||
4206573|NCT00734578|4029567|B2||Male|Sex: Female, Male|The demographics are based on the Safety Population (n = 455) which includes all subjects who received at least 1 dose of study drug.|Participants|Count of Participants|106|106.0||||||
4206574|NCT00734578|4029568|B1||Male|Sex: Female, Male|The demographics are based on the Safety Population (n = 455) which includes all subjects who received at least 1 dose of study drug.|Participants|Count of Participants|108|108.0||||||
4206575|NCT00734578|4029565|B4||Female|Sex: Female, Male|The demographics are based on the Safety Population (n = 455) which includes all subjects who received at least 1 dose of study drug.|Participants|Count of Participants|129|129.0||||||
4206576|NCT00734578|4029566|B3||Female|Sex: Female, Male|The demographics are based on the Safety Population (n = 455) which includes all subjects who received at least 1 dose of study drug.|Participants|Count of Participants|41|41.0||||||
4206577|NCT00734578|4029567|B2||Female|Sex: Female, Male|The demographics are based on the Safety Population (n = 455) which includes all subjects who received at least 1 dose of study drug.|Participants|Count of Participants|46|46.0||||||
4206578|NCT00734578|4029568|B1||Female|Sex: Female, Male|The demographics are based on the Safety Population (n = 455) which includes all subjects who received at least 1 dose of study drug.|Participants|Count of Participants|42|42.0||||||
4206579|NCT00734578|4029565|B4|6-17 years||Age, Customized|The demographics are based on the Safety Population (n = 455) which includes all subjects who received at least 1 dose of study drug.|participants|Number|455|455.0||||||
4206580|NCT00734578|4029566|B3|6-17 years||Age, Customized|The demographics are based on the Safety Population (n = 455) which includes all subjects who received at least 1 dose of study drug.|participants|Number|153|153.0||||||
4206581|NCT00734578|4029567|B2|6-17 years||Age, Customized|The demographics are based on the Safety Population (n = 455) which includes all subjects who received at least 1 dose of study drug.|participants|Number|152|152.0||||||
4206582|NCT00734578|4029568|B1|6-17 years||Age, Customized|The demographics are based on the Safety Population (n = 455) which includes all subjects who received at least 1 dose of study drug.|participants|Number|150|150.0||||||
4206583|NCT00734578|4029565|B4|||Age|The demographics are based on the Safety Population (n = 455) which includes all subjects who received at least 1 dose of study drug.|years|Mean|10.8|10.8|Standard Deviation|2.4|2.4|||
4206584|NCT00734578|4029566|B3|||Age|The demographics are based on the Safety Population (n = 455) which includes all subjects who received at least 1 dose of study drug.|years|Mean|10.8|10.8|Standard Deviation|2.3|2.3|||
4206626|NCT00734539|4029602|B3||Female|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4206585|NCT00734578|4029567|B2|||Age|The demographics are based on the Safety Population (n = 455) which includes all subjects who received at least 1 dose of study drug.|years|Mean|10.6|10.6|Standard Deviation|2.3|2.3|||
4206586|NCT00734578|4029568|B1|||Age|The demographics are based on the Safety Population (n = 455) which includes all subjects who received at least 1 dose of study drug.|years|Mean|11.0|11.0|Standard Deviation|2.6|2.6|||
4206587|NCT00734539|4029602|B3|||Gestational Age at Birth||weeks|Median|25|25.0|Inter-Quartile Range|||24.0|26.0|
4206588|NCT00734539|4029603|B2|||Gestational Age at Birth||weeks|Median|25|25.0|Inter-Quartile Range|||24.0|26.0|
4206589|NCT00734539|4029604|B1|||Gestational Age at Birth||weeks|Median|25|25.0|Inter-Quartile Range|||24.0|26.0|
4206590|NCT00734539|4029602|B3|||birth weight||grams|Median|650|650.0|Inter-Quartile Range|||570.0|700.0|
4206591|NCT00734539|4029603|B2|||birth weight||grams|Median|640|640.0|Inter-Quartile Range|||573.0|700.0|
4206592|NCT00734539|4029604|B1|||birth weight||grams|Median|653|653.0|Inter-Quartile Range|||570.0|700.0|
4206593|NCT00734539|4029602|B3||Unknown or Not Reported|Race (NIH/OMB)|"2 participants specified a race as other which is not pre-specified in this list of races."|Participants|Count of Participants|2|2.0||||||
4206594|NCT00734539|4029603|B2||Unknown or Not Reported|Race (NIH/OMB)|"2 participants specified a race as other which is not pre-specified in this list of races."|Participants|Count of Participants|2|2.0||||||
4206595|NCT00734539|4029604|B1||Unknown or Not Reported|Race (NIH/OMB)|"2 participants specified a race as other which is not pre-specified in this list of races."|Participants|Count of Participants|0|0.0||||||
4206596|NCT00734539|4029602|B3||More than one race|Race (NIH/OMB)|"2 participants specified a race as other which is not pre-specified in this list of races."|Participants|Count of Participants|0|0.0||||||
4206597|NCT00734539|4029603|B2||More than one race|Race (NIH/OMB)|"2 participants specified a race as other which is not pre-specified in this list of races."|Participants|Count of Participants|0|0.0||||||
4206598|NCT00734539|4029604|B1||More than one race|Race (NIH/OMB)|"2 participants specified a race as other which is not pre-specified in this list of races."|Participants|Count of Participants|0|0.0||||||
4206599|NCT00734539|4029602|B3||White|Race (NIH/OMB)|"2 participants specified a race as other which is not pre-specified in this list of races."|Participants|Count of Participants|143|143.0||||||
4206600|NCT00734539|4029603|B2||White|Race (NIH/OMB)|"2 participants specified a race as other which is not pre-specified in this list of races."|Participants|Count of Participants|70|70.0||||||
4206601|NCT00734539|4029604|B1||White|Race (NIH/OMB)|"2 participants specified a race as other which is not pre-specified in this list of races."|Participants|Count of Participants|73|73.0||||||
4206602|NCT00734539|4029602|B3||Black or African American|Race (NIH/OMB)|"2 participants specified a race as other which is not pre-specified in this list of races."|Participants|Count of Participants|196|196.0||||||
4206603|NCT00734539|4029603|B2||Black or African American|Race (NIH/OMB)|"2 participants specified a race as other which is not pre-specified in this list of races."|Participants|Count of Participants|94|94.0||||||
4206604|NCT00734539|4029604|B1||Black or African American|Race (NIH/OMB)|"2 participants specified a race as other which is not pre-specified in this list of races."|Participants|Count of Participants|102|102.0||||||
4206605|NCT00734539|4029602|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|"2 participants specified a race as other which is not pre-specified in this list of races."|Participants|Count of Participants|0|0.0||||||
4206606|NCT00734539|4029603|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|"2 participants specified a race as other which is not pre-specified in this list of races."|Participants|Count of Participants|0|0.0||||||
4206607|NCT00734539|4029604|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|"2 participants specified a race as other which is not pre-specified in this list of races."|Participants|Count of Participants|0|0.0||||||
4206608|NCT00734539|4029602|B3||Asian|Race (NIH/OMB)|"2 participants specified a race as other which is not pre-specified in this list of races."|Participants|Count of Participants|3|3.0||||||
4206609|NCT00734539|4029603|B2||Asian|Race (NIH/OMB)|"2 participants specified a race as other which is not pre-specified in this list of races."|Participants|Count of Participants|0|0.0||||||
4206610|NCT00734539|4029604|B1||Asian|Race (NIH/OMB)|"2 participants specified a race as other which is not pre-specified in this list of races."|Participants|Count of Participants|3|3.0||||||
4206611|NCT00734539|4029602|B3||American Indian or Alaska Native|Race (NIH/OMB)|"2 participants specified a race as other which is not pre-specified in this list of races."|Participants|Count of Participants|17|17.0||||||
4206612|NCT00734539|4029603|B2||American Indian or Alaska Native|Race (NIH/OMB)|"2 participants specified a race as other which is not pre-specified in this list of races."|Participants|Count of Participants|7|7.0||||||
4206613|NCT00734539|4029604|B1||American Indian or Alaska Native|Race (NIH/OMB)|"2 participants specified a race as other which is not pre-specified in this list of races."|Participants|Count of Participants|10|10.0||||||
4206614|NCT00734539|4029602|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206615|NCT00734539|4029603|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206616|NCT00734539|4029604|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206617|NCT00734539|4029602|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|315|315.0||||||
4206618|NCT00734539|4029603|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|148|148.0||||||
4206619|NCT00734539|4029604|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
4206620|NCT00734539|4029602|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4206621|NCT00734539|4029603|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4206622|NCT00734539|4029604|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4206623|NCT00734539|4029602|B3||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4206624|NCT00734539|4029603|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4206625|NCT00734539|4029604|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4206627|NCT00734539|4029603|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4206628|NCT00734539|4029604|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4206629|NCT00734539|4029602|B3|||Age|Postnatal age at randomization|days|Median|3|3.0|Inter-Quartile Range|||2.0|4.0|
4206630|NCT00734539|4029603|B2|||Age|Postnatal age at randomization|days|Median|3|3.0|Inter-Quartile Range|||2.0|4.0|
4206631|NCT00734539|4029604|B1|||Age|Postnatal age at randomization|days|Median|3|3.0|Inter-Quartile Range|||3.0|4.0|
4206632|NCT00734500|4029633|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4206633|NCT00734500|4029633|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4206634|NCT00734500|4029633|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4206635|NCT00734500|4029633|B1|<=24 months||Age, Customized||participants|Number|15|15.0||||||
4206636|NCT00734500|4029633|B1|||Age||years|Mean|0.22|0.22|Standard Deviation|0.32|0.32|||
4206637|NCT00734474|4029638|B10|||Fasting Plasma Glucose||millimoles per liter (mmol/L)|Mean|NA||Standard Deviation|NA||||Total Mean (SD) were not calculated for this baseline measure.
4206638|NCT00734474|4029639|B9|||Fasting Plasma Glucose||millimoles per liter (mmol/L)|Mean|9.86|9.86|Standard Deviation|3.15|3.15|||
4206639|NCT00734474|4029640|B8|||Fasting Plasma Glucose||millimoles per liter (mmol/L)|Mean|9.56|9.56|Standard Deviation|2.80|2.8|||
4206640|NCT00734474|4029641|B7|||Fasting Plasma Glucose||millimoles per liter (mmol/L)|Mean|NA||Standard Deviation|NA||||Baseline fasting plasma glucose was not summarized for this treatment arm.
4206641|NCT00734474|4029642|B6|||Fasting Plasma Glucose||millimoles per liter (mmol/L)|Mean|NA||Standard Deviation|NA||||Baseline fasting plasma glucose was not summarized for this treatment arm.
4206642|NCT00734474|4029643|B5|||Fasting Plasma Glucose||millimoles per liter (mmol/L)|Mean|9.68|9.68|Standard Deviation|2.94|2.94|||
4206643|NCT00734474|4029644|B4|||Fasting Plasma Glucose||millimoles per liter (mmol/L)|Mean|NA||Standard Deviation|NA||||Baseline fasting plasma glucose was not summarized for this treatment arm.
4206644|NCT00734474|4029645|B3|||Fasting Plasma Glucose||millimoles per liter (mmol/L)|Mean|9.75|9.75|Standard Deviation|3.27|3.27|||
4206645|NCT00734474|4029646|B2|||Fasting Plasma Glucose||millimoles per liter (mmol/L)|Mean|NA||Standard Deviation|NA||||Baseline fasting plasma glucose was not summarized for this treatment arm.
4206646|NCT00734474|4029647|B1|||Fasting Plasma Glucose||millimoles per liter (mmol/L)|Mean|NA||Standard Deviation|NA||||Baseline fasting plasma glucose was not summarized for this treatment arm.
4206647|NCT00734474|4029638|B10|||Duration of Diabetes||years|Mean|7.09|7.09|Standard Deviation|5.12|5.12|||
4206648|NCT00734474|4029639|B9|||Duration of Diabetes||years|Mean|6.96|6.96|Standard Deviation|5.43|5.43|||
4206649|NCT00734474|4029640|B8|||Duration of Diabetes||years|Mean|7.16|7.16|Standard Deviation|4.89|4.89|||
4206650|NCT00734474|4029641|B7|||Duration of Diabetes||years|Mean|6.74|6.74|Standard Deviation|4.20|4.2|||
4206651|NCT00734474|4029642|B6|||Duration of Diabetes||years|Mean|6.75|6.75|Standard Deviation|3.99|3.99|||
4206652|NCT00734474|4029643|B5|||Duration of Diabetes||years|Mean|7.34|7.34|Standard Deviation|4.92|4.92|||
4206653|NCT00734474|4029644|B4|||Duration of Diabetes||years|Mean|7.04|7.04|Standard Deviation|4.57|4.57|||
4206654|NCT00734474|4029645|B3|||Duration of Diabetes||years|Mean|6.95|6.95|Standard Deviation|5.50|5.5|||
4206655|NCT00734474|4029646|B2|||Duration of Diabetes||years|Mean|6.92|6.92|Standard Deviation|5.12|5.12|||
4206656|NCT00734474|4029647|B1|||Duration of Diabetes||years|Mean|6.79|6.79|Standard Deviation|6.34|6.34|||
4206657|NCT00734474|4029638|B10|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|8.13|8.13|Standard Deviation|1.09|1.09|||
4206658|NCT00734474|4029639|B9|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|8.10|8.1|Standard Deviation|1.14|1.14|||
4206659|NCT00734474|4029640|B8|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|8.09|8.09|Standard Deviation|1.09|1.09|||
4206660|NCT00734474|4029641|B7|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|7.82|7.82|Standard Deviation|0.80|0.8|||
4206661|NCT00734474|4029642|B6|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|8.30|8.3|Standard Deviation|1.34|1.34|||
4206662|NCT00734474|4029643|B5|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|8.19|8.19|Standard Deviation|1.11|1.11|||
4206663|NCT00734474|4029644|B4|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|7.87|7.87|Standard Deviation|0.62|0.62|||
4206664|NCT00734474|4029645|B3|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|8.12|8.12|Standard Deviation|1.05|1.05|||
4206665|NCT00734474|4029646|B2|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|8.36|8.36|Standard Deviation|1.04|1.04|||
4206666|NCT00734474|4029647|B1|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|7.95|7.95|Standard Deviation|1.11|1.11|||
4206667|NCT00734474|4029638|B10|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|31.27|31.27|Standard Deviation|4.39|4.39|||
4206668|NCT00734474|4029639|B9|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|31.37|31.37|Standard Deviation|4.25|4.25|||
4206669|NCT00734474|4029640|B8|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|31.02|31.02|Standard Deviation|4.20|4.2|||
4206670|NCT00734474|4029641|B7|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|31.06|31.06|Standard Deviation|3.94|3.94|||
4206671|NCT00734474|4029642|B6|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|32.53|32.53|Standard Deviation|4.61|4.61|||
4206672|NCT00734474|4029643|B5|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|31.15|31.15|Standard Deviation|4.44|4.44|||
4206673|NCT00734474|4029644|B4|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|33.89|33.89|Standard Deviation|4.44|4.44|||
4206674|NCT00734474|4029645|B3|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|31.40|31.4|Standard Deviation|4.57|4.57|||
4206675|NCT00734474|4029646|B2|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|31.45|31.45|Standard Deviation|4.88|4.88|||
4206676|NCT00734474|4029647|B1|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|31.02|31.02|Standard Deviation|4.69|4.69|||
4206677|NCT00734474|4029638|B10|||Body Weight||kilograms|Mean|86.38|86.38|Standard Deviation|17.28|17.28|||
4206678|NCT00734474|4029639|B9|||Body Weight||kilograms|Mean|87.07|87.07|Standard Deviation|16.86|16.86|||
4206679|NCT00734474|4029640|B8|||Body Weight||kilograms|Mean|85.97|85.97|Standard Deviation|16.91|16.91|||
4206680|NCT00734474|4029641|B7|||Body Weight||kilograms|Mean|81.94|81.94|Standard Deviation|17.67|17.67|||
4206681|NCT00734474|4029642|B6|||Body Weight||kilograms|Mean|88.84|88.84|Standard Deviation|14.98|14.98|||
4206682|NCT00734474|4029643|B5|||Body Weight||kilograms|Mean|86.22|86.22|Standard Deviation|17.99|17.99|||
4206683|NCT00734474|4029644|B4|||Body Weight||kilograms|Mean|89.48|89.48|Standard Deviation|18.06|18.06|||
4206684|NCT00734474|4029645|B3|||Body Weight||kilograms|Mean|86.67|86.67|Standard Deviation|17.45|17.45|||
4206685|NCT00734474|4029646|B2|||Body Weight||kilograms|Mean|86.56|86.56|Standard Deviation|18.33|18.33|||
4206686|NCT00734474|4029647|B1|||Body Weight||kilograms|Mean|85.09|85.09|Standard Deviation|14.25|14.25|||
4206687|NCT00734474|4029638|B10|Korea, Republic of||Region of Enrollment||participants|Number|105|105.0||||||
4206688|NCT00734474|4029639|B9|Korea, Republic of||Region of Enrollment||participants|Number|15|15.0||||||
4206689|NCT00734474|4029640|B8|Korea, Republic of||Region of Enrollment||participants|Number|31|31.0||||||
4206690|NCT00734474|4029641|B7|Korea, Republic of||Region of Enrollment||participants|Number|2|2.0||||||
4206691|NCT00734474|4029642|B6|Korea, Republic of||Region of Enrollment||participants|Number|0|0.0||||||
4206692|NCT00734474|4029643|B5|Korea, Republic of||Region of Enrollment||participants|Number|25|25.0||||||
4206693|NCT00734474|4029644|B4|Korea, Republic of||Region of Enrollment||participants|Number|0|0.0||||||
4206694|NCT00734474|4029645|B3|Korea, Republic of||Region of Enrollment||participants|Number|27|27.0||||||
4206695|NCT00734474|4029646|B2|Korea, Republic of||Region of Enrollment||participants|Number|5|5.0||||||
4206696|NCT00734474|4029647|B1|Korea, Republic of||Region of Enrollment||participants|Number|0|0.0||||||
4206697|NCT00734474|4029638|B10|Germany||Region of Enrollment||participants|Number|105|105.0||||||
4206698|NCT00734474|4029639|B9|Germany||Region of Enrollment||participants|Number|15|15.0||||||
4206699|NCT00734474|4029640|B8|Germany||Region of Enrollment||participants|Number|28|28.0||||||
4206700|NCT00734474|4029641|B7|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4206701|NCT00734474|4029642|B6|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4206702|NCT00734474|4029643|B5|Germany||Region of Enrollment||participants|Number|31|31.0||||||
4206703|NCT00734474|4029644|B4|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4206704|NCT00734474|4029645|B3|Germany||Region of Enrollment||participants|Number|31|31.0||||||
4206705|NCT00734474|4029646|B2|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4206706|NCT00734474|4029647|B1|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4206707|NCT00734474|4029638|B10|Romania||Region of Enrollment||participants|Number|32|32.0||||||
4206708|NCT00734474|4029639|B9|Romania||Region of Enrollment||participants|Number|5|5.0||||||
4206709|NCT00734474|4029640|B8|Romania||Region of Enrollment||participants|Number|8|8.0||||||
4206710|NCT00734474|4029641|B7|Romania||Region of Enrollment||participants|Number|4|4.0||||||
4206711|NCT00734474|4029642|B6|Romania||Region of Enrollment||participants|Number|0|0.0||||||
4206712|NCT00734474|4029643|B5|Romania||Region of Enrollment||participants|Number|4|4.0||||||
4206713|NCT00734474|4029644|B4|Romania||Region of Enrollment||participants|Number|1|1.0||||||
4206714|NCT00734474|4029645|B3|Romania||Region of Enrollment||participants|Number|7|7.0||||||
4206715|NCT00734474|4029646|B2|Romania||Region of Enrollment||participants|Number|2|2.0||||||
4206716|NCT00734474|4029647|B1|Romania||Region of Enrollment||participants|Number|1|1.0||||||
4206717|NCT00734474|4029638|B10|Poland||Region of Enrollment||participants|Number|83|83.0||||||
4206718|NCT00734474|4029639|B9|Poland||Region of Enrollment||participants|Number|12|12.0||||||
4206719|NCT00734474|4029640|B8|Poland||Region of Enrollment||participants|Number|23|23.0||||||
4206720|NCT00734474|4029641|B7|Poland||Region of Enrollment||participants|Number|2|2.0||||||
4206721|NCT00734474|4029642|B6|Poland||Region of Enrollment||participants|Number|2|2.0||||||
4206722|NCT00734474|4029643|B5|Poland||Region of Enrollment||participants|Number|23|23.0||||||
4206723|NCT00734474|4029644|B4|Poland||Region of Enrollment||participants|Number|0|0.0||||||
4206724|NCT00734474|4029645|B3|Poland||Region of Enrollment||participants|Number|20|20.0||||||
4206725|NCT00734474|4029646|B2|Poland||Region of Enrollment||participants|Number|0|0.0||||||
4206726|NCT00734474|4029647|B1|Poland||Region of Enrollment||participants|Number|1|1.0||||||
4206727|NCT00734474|4029638|B10|Canada||Region of Enrollment||participants|Number|42|42.0||||||
4206728|NCT00734474|4029639|B9|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4206729|NCT00734474|4029640|B8|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4206730|NCT00734474|4029641|B7|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4206731|NCT00734474|4029642|B6|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4206732|NCT00734474|4029643|B5|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4206733|NCT00734474|4029644|B4|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4206734|NCT00734474|4029645|B3|Canada||Region of Enrollment||participants|Number|13|13.0||||||
4206735|NCT00734474|4029646|B2|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4206736|NCT00734474|4029647|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4206737|NCT00734474|4029638|B10|Puerto Rico||Region of Enrollment||participants|Number|40|40.0||||||
4206738|NCT00734474|4029639|B9|Puerto Rico||Region of Enrollment||participants|Number|7|7.0||||||
4206739|NCT00734474|4029640|B8|Puerto Rico||Region of Enrollment||participants|Number|10|10.0||||||
4206740|NCT00734474|4029641|B7|Puerto Rico||Region of Enrollment||participants|Number|0|0.0||||||
4206741|NCT00734474|4029642|B6|Puerto Rico||Region of Enrollment||participants|Number|3|3.0||||||
4206742|NCT00734474|4029643|B5|Puerto Rico||Region of Enrollment||participants|Number|5|5.0||||||
4206743|NCT00734474|4029644|B4|Puerto Rico||Region of Enrollment||participants|Number|0|0.0||||||
4206744|NCT00734474|4029645|B3|Puerto Rico||Region of Enrollment||participants|Number|12|12.0||||||
4206745|NCT00734474|4029646|B2|Puerto Rico||Region of Enrollment||participants|Number|2|2.0||||||
4206746|NCT00734474|4029647|B1|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
4206747|NCT00734474|4029638|B10|Mexico||Region of Enrollment||participants|Number|151|151.0||||||
4206748|NCT00734474|4029639|B9|Mexico||Region of Enrollment||participants|Number|27|27.0||||||
4206749|NCT00734474|4029640|B8|Mexico||Region of Enrollment||participants|Number|35|35.0||||||
4206750|NCT00734474|4029641|B7|Mexico||Region of Enrollment||participants|Number|6|6.0||||||
4206751|NCT00734474|4029642|B6|Mexico||Region of Enrollment||participants|Number|10|10.0||||||
4206752|NCT00734474|4029643|B5|Mexico||Region of Enrollment||participants|Number|30|30.0||||||
4206753|NCT00734474|4029644|B4|Mexico||Region of Enrollment||participants|Number|5|5.0||||||
4206754|NCT00734474|4029645|B3|Mexico||Region of Enrollment||participants|Number|32|32.0||||||
4206755|NCT00734474|4029646|B2|Mexico||Region of Enrollment||participants|Number|3|3.0||||||
4206756|NCT00734474|4029647|B1|Mexico||Region of Enrollment||participants|Number|3|3.0||||||
4206757|NCT00734474|4029638|B10|France||Region of Enrollment||participants|Number|46|46.0||||||
4206758|NCT00734474|4029639|B9|France||Region of Enrollment||participants|Number|8|8.0||||||
4206759|NCT00734474|4029640|B8|France||Region of Enrollment||participants|Number|12|12.0||||||
4206760|NCT00734474|4029641|B7|France||Region of Enrollment||participants|Number|0|0.0||||||
4206761|NCT00734474|4029642|B6|France||Region of Enrollment||participants|Number|0|0.0||||||
4206762|NCT00734474|4029643|B5|France||Region of Enrollment||participants|Number|14|14.0||||||
4206763|NCT00734474|4029644|B4|France||Region of Enrollment||participants|Number|0|0.0||||||
4206764|NCT00734474|4029645|B3|France||Region of Enrollment||participants|Number|12|12.0||||||
4206765|NCT00734474|4029646|B2|France||Region of Enrollment||participants|Number|0|0.0||||||
4206766|NCT00734474|4029647|B1|France||Region of Enrollment||participants|Number|0|0.0||||||
4206767|NCT00734474|4029638|B10|India||Region of Enrollment||participants|Number|96|96.0||||||
4206768|NCT00734474|4029639|B9|India||Region of Enrollment||participants|Number|12|12.0||||||
4206769|NCT00734474|4029640|B8|India||Region of Enrollment||participants|Number|28|28.0||||||
4206770|NCT00734474|4029641|B7|India||Region of Enrollment||participants|Number|0|0.0||||||
4206771|NCT00734474|4029642|B6|India||Region of Enrollment||participants|Number|0|0.0||||||
4206772|NCT00734474|4029643|B5|India||Region of Enrollment||participants|Number|29|29.0||||||
4206773|NCT00734474|4029644|B4|India||Region of Enrollment||participants|Number|0|0.0||||||
4206774|NCT00734474|4029645|B3|India||Region of Enrollment||participants|Number|27|27.0||||||
4206775|NCT00734474|4029646|B2|India||Region of Enrollment||participants|Number|0|0.0||||||
4206776|NCT00734474|4029647|B1|India||Region of Enrollment||participants|Number|0|0.0||||||
4206777|NCT00734474|4029638|B10|Russian Federation||Region of Enrollment||participants|Number|64|64.0||||||
4206778|NCT00734474|4029639|B9|Russian Federation||Region of Enrollment||participants|Number|8|8.0||||||
4206779|NCT00734474|4029640|B8|Russian Federation||Region of Enrollment||participants|Number|17|17.0||||||
4206780|NCT00734474|4029641|B7|Russian Federation||Region of Enrollment||participants|Number|0|0.0||||||
4206781|NCT00734474|4029642|B6|Russian Federation||Region of Enrollment||participants|Number|0|0.0||||||
4206782|NCT00734474|4029643|B5|Russian Federation||Region of Enrollment||participants|Number|18|18.0||||||
4206783|NCT00734474|4029644|B4|Russian Federation||Region of Enrollment||participants|Number|0|0.0||||||
4206784|NCT00734474|4029645|B3|Russian Federation||Region of Enrollment||participants|Number|21|21.0||||||
4206785|NCT00734474|4029646|B2|Russian Federation||Region of Enrollment||participants|Number|0|0.0||||||
4206786|NCT00734474|4029647|B1|Russian Federation||Region of Enrollment||participants|Number|0|0.0||||||
4206787|NCT00734474|4029638|B10|Spain||Region of Enrollment||participants|Number|36|36.0||||||
4206788|NCT00734474|4029639|B9|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4206789|NCT00734474|4029640|B8|Spain||Region of Enrollment||participants|Number|11|11.0||||||
4206790|NCT00734474|4029641|B7|Spain||Region of Enrollment||participants|Number|0|0.0||||||
4206791|NCT00734474|4029642|B6|Spain||Region of Enrollment||participants|Number|0|0.0||||||
4206792|NCT00734474|4029643|B5|Spain||Region of Enrollment||participants|Number|11|11.0||||||
4206793|NCT00734474|4029644|B4|Spain||Region of Enrollment||participants|Number|0|0.0||||||
4206794|NCT00734474|4029645|B3|Spain||Region of Enrollment||participants|Number|10|10.0||||||
4206795|NCT00734474|4029646|B2|Spain||Region of Enrollment||participants|Number|0|0.0||||||
4206796|NCT00734474|4029647|B1|Spain||Region of Enrollment||participants|Number|0|0.0||||||
4206797|NCT00734474|4029638|B10|Taiwan||Region of Enrollment||participants|Number|73|73.0||||||
4206798|NCT00734474|4029639|B9|Taiwan||Region of Enrollment||participants|Number|12|12.0||||||
4206799|NCT00734474|4029640|B8|Taiwan||Region of Enrollment||participants|Number|20|20.0||||||
4206800|NCT00734474|4029641|B7|Taiwan||Region of Enrollment||participants|Number|3|3.0||||||
4206801|NCT00734474|4029642|B6|Taiwan||Region of Enrollment||participants|Number|0|0.0||||||
4206802|NCT00734474|4029643|B5|Taiwan||Region of Enrollment||participants|Number|18|18.0||||||
4206803|NCT00734474|4029644|B4|Taiwan||Region of Enrollment||participants|Number|0|0.0||||||
4206804|NCT00734474|4029645|B3|Taiwan||Region of Enrollment||participants|Number|19|19.0||||||
4206805|NCT00734474|4029646|B2|Taiwan||Region of Enrollment||participants|Number|1|1.0||||||
4206806|NCT00734474|4029647|B1|Taiwan||Region of Enrollment||participants|Number|0|0.0||||||
4206807|NCT00734474|4029638|B10|United States||Region of Enrollment||participants|Number|329|329.0||||||
4206808|NCT00734474|4029639|B9|United States||Region of Enrollment||participants|Number|46|46.0||||||
4206809|NCT00734474|4029640|B8|United States||Region of Enrollment||participants|Number|80|80.0||||||
4206810|NCT00734474|4029641|B7|United States||Region of Enrollment||participants|Number|7|7.0||||||
4206811|NCT00734474|4029642|B6|United States||Region of Enrollment||participants|Number|10|10.0||||||
4206812|NCT00734474|4029643|B5|United States||Region of Enrollment||participants|Number|83|83.0||||||
4206813|NCT00734474|4029644|B4|United States||Region of Enrollment||participants|Number|4|4.0||||||
4206814|NCT00734474|4029645|B3|United States||Region of Enrollment||participants|Number|73|73.0||||||
4206815|NCT00734474|4029646|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4206816|NCT00734474|4029647|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4206817|NCT00734474|4029638|B10|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4206818|NCT00734474|4029639|B9|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206819|NCT00734474|4029640|B8|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4206820|NCT00734474|4029641|B7|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206821|NCT00734474|4029642|B6|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206822|NCT00734474|4029643|B5|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206823|NCT00734474|4029644|B4|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206824|NCT00734474|4029645|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206825|NCT00734474|4029646|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206826|NCT00734474|4029647|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206827|NCT00734474|4029638|B10|West Asian (Indian sub-continent)||Race/Ethnicity, Customized||participants|Number|97|97.0||||||
4206828|NCT00734474|4029639|B9|West Asian (Indian sub-continent)||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4206829|NCT00734474|4029640|B8|West Asian (Indian sub-continent)||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4206830|NCT00734474|4029641|B7|West Asian (Indian sub-continent)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4206831|NCT00734474|4029642|B6|West Asian (Indian sub-continent)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206832|NCT00734474|4029643|B5|West Asian (Indian sub-continent)||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4206833|NCT00734474|4029644|B4|West Asian (Indian sub-continent)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206834|NCT00734474|4029645|B3|West Asian (Indian sub-continent)||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4206835|NCT00734474|4029646|B2|West Asian (Indian sub-continent)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206836|NCT00734474|4029647|B1|West Asian (Indian sub-continent)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206837|NCT00734474|4029638|B10|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4206838|NCT00734474|4029639|B9|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206839|NCT00734474|4029640|B8|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4206840|NCT00734474|4029641|B7|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206841|NCT00734474|4029642|B6|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206842|NCT00734474|4029643|B5|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206843|NCT00734474|4029644|B4|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206844|NCT00734474|4029645|B3|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206845|NCT00734474|4029646|B2|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206846|NCT00734474|4029647|B1|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206847|NCT00734474|4029638|B10|Hispanic||Race/Ethnicity, Customized||participants|Number|251|251.0||||||
4206848|NCT00734474|4029639|B9|Hispanic||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4206849|NCT00734474|4029640|B8|Hispanic||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
4206850|NCT00734474|4029641|B7|Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4206851|NCT00734474|4029642|B6|Hispanic||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4206852|NCT00734474|4029643|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4206853|NCT00734474|4029644|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4206854|NCT00734474|4029645|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
4206855|NCT00734474|4029646|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4206856|NCT00734474|4029647|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4206857|NCT00734474|4029638|B10|East Asian||Race/Ethnicity, Customized||participants|Number|188|188.0||||||
4206858|NCT00734474|4029639|B9|East Asian||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4206859|NCT00734474|4029640|B8|East Asian||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
4206860|NCT00734474|4029641|B7|East Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4206861|NCT00734474|4029642|B6|East Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206862|NCT00734474|4029643|B5|East Asian||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4206863|NCT00734474|4029644|B4|East Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206864|NCT00734474|4029645|B3|East Asian||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
4206865|NCT00734474|4029646|B2|East Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4206866|NCT00734474|4029647|B1|East Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206867|NCT00734474|4029638|B10|Caucasian||Race/Ethnicity, Customized||participants|Number|613|613.0||||||
4206868|NCT00734474|4029639|B9|Caucasian||Race/Ethnicity, Customized||participants|Number|91|91.0||||||
4206869|NCT00734474|4029640|B8|Caucasian||Race/Ethnicity, Customized||participants|Number|158|158.0||||||
4206870|NCT00734474|4029641|B7|Caucasian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4206871|NCT00734474|4029642|B6|Caucasian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4206872|NCT00734474|4029643|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|162|162.0||||||
4206873|NCT00734474|4029644|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4206874|NCT00734474|4029645|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|157|157.0||||||
4206875|NCT00734474|4029646|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4206876|NCT00734474|4029647|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4206877|NCT00734474|4029638|B10|African||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
4206878|NCT00734474|4029639|B9|African||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4206879|NCT00734474|4029640|B8|African||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4206880|NCT00734474|4029641|B7|African||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206881|NCT00734474|4029642|B6|African||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4206882|NCT00734474|4029643|B5|African||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4206883|NCT00734474|4029644|B4|African||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206884|NCT00734474|4029645|B3|African||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4206885|NCT00734474|4029646|B2|African||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4206886|NCT00734474|4029647|B1|African||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4206887|NCT00734474|4029638|B10|Aboriginal and/or Torres Strait Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4206888|NCT00734474|4029639|B9|Aboriginal and/or Torres Strait Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206889|NCT00734474|4029640|B8|Aboriginal and/or Torres Strait Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4206890|NCT00734474|4029641|B7|Aboriginal and/or Torres Strait Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206891|NCT00734474|4029642|B6|Aboriginal and/or Torres Strait Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206892|NCT00734474|4029643|B5|Aboriginal and/or Torres Strait Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206893|NCT00734474|4029644|B4|Aboriginal and/or Torres Strait Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206894|NCT00734474|4029645|B3|Aboriginal and/or Torres Strait Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206895|NCT00734474|4029646|B2|Aboriginal and/or Torres Strait Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206896|NCT00734474|4029647|B1|Aboriginal and/or Torres Strait Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4206897|NCT00734474|4029638|B10||Male|Sex: Female, Male||Participants|Count of Participants|559|559.0||||||
4206898|NCT00734474|4029639|B9||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4206899|NCT00734474|4029640|B8||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4206900|NCT00734474|4029641|B7||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4206901|NCT00734474|4029642|B6||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4206902|NCT00734474|4029643|B5||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4206903|NCT00734474|4029644|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4206904|NCT00734474|4029645|B3||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4206905|NCT00734474|4029646|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4206906|NCT00734474|4029647|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4206907|NCT00734474|4029638|B10||Female|Sex: Female, Male||Participants|Count of Participants|643|643.0||||||
4206908|NCT00734474|4029639|B9||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4206909|NCT00734474|4029640|B8||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4206910|NCT00734474|4029641|B7||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4206911|NCT00734474|4029642|B6||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4206912|NCT00734474|4029643|B5||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4206913|NCT00734474|4029644|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4206914|NCT00734474|4029645|B3||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4206915|NCT00734474|4029646|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4206916|NCT00734474|4029647|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4206917|NCT00734474|4029638|B10|||Age||years|Mean|54.09|54.09|Standard Deviation|9.85|9.85|||
4206918|NCT00734474|4029639|B9|||Age||years|Mean|54.91|54.91|Standard Deviation|9.05|9.05|||
4206919|NCT00734474|4029640|B8|||Age||years|Mean|53.75|53.75|Standard Deviation|10.27|10.27|||
4206920|NCT00734474|4029641|B7|||Age||years|Mean|56.51|56.51|Standard Deviation|6.56|6.56|||
4206921|NCT00734474|4029642|B6|||Age||years|Mean|54.70|54.7|Standard Deviation|9.72|9.72|||
4206922|NCT00734474|4029643|B5|||Age||years|Mean|54.35|54.35|Standard Deviation|9.81|9.81|||
4206923|NCT00734474|4029644|B4|||Age||years|Mean|55.38|55.38|Standard Deviation|8.71|8.71|||
4206924|NCT00734474|4029645|B3|||Age||years|Mean|53.66|53.66|Standard Deviation|10.02|10.02|||
4206925|NCT00734474|4029646|B2|||Age||years|Mean|52.56|52.56|Standard Deviation|10.95|10.95|||
4206926|NCT00734474|4029647|B1|||Age||years|Mean|52.81|52.81|Standard Deviation|10.66|10.66|||
4206927|NCT00734409|4029822|B3|United States||Region of Enrollment||participants|Number|300|300.0||||||
4206928|NCT00734409|4029823|B2|United States||Region of Enrollment||participants|Number|145|145.0||||||
4206929|NCT00734409|4029824|B1|United States||Region of Enrollment||participants|Number|155|155.0||||||
4206930|NCT00734409|4029822|B3||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4206931|NCT00734409|4029823|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4206932|NCT00734409|4029824|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4206933|NCT00734409|4029822|B3||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4206934|NCT00734409|4029823|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4206935|NCT00734409|4029824|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4206936|NCT00734409|4029822|B3|||Age||years|Mean|55.78|55.78|Standard Deviation|16.91|16.91|||
4206937|NCT00734409|4029823|B2|||Age||years|Mean|57.7|57.7|Standard Deviation|15.30|15.3|||
4206938|NCT00734409|4029824|B1|||Age||years|Mean|53.95|53.95|Standard Deviation|18.15|18.15|||
4206939|NCT00734409|4029822|B3||>=65 years|Age||Participants|Count of Participants|99|99.0||||||
4206940|NCT00734409|4029823|B2||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
4206941|NCT00734409|4029824|B1||>=65 years|Age||Participants|Count of Participants|53|53.0||||||
4206942|NCT00734409|4029822|B3||Between 18 and 65 years|Age||Participants|Count of Participants|201|201.0||||||
4206943|NCT00734409|4029823|B2||Between 18 and 65 years|Age||Participants|Count of Participants|99|99.0||||||
4206944|NCT00734409|4029824|B1||Between 18 and 65 years|Age||Participants|Count of Participants|102|102.0||||||
4206945|NCT00734409|4029822|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4206946|NCT00734409|4029823|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4206947|NCT00734409|4029824|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4206948|NCT00734344|4029835|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4206949|NCT00734344|4029836|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4206950|NCT00734344|4029837|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4206951|NCT00734344|4029835|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206952|NCT00734344|4029836|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206953|NCT00734344|4029837|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206954|NCT00734344|4029835|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206955|NCT00734344|4029836|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206956|NCT00734344|4029837|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206957|NCT00734344|4029835|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4206958|NCT00734344|4029836|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4206959|NCT00734344|4029837|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4206960|NCT00734344|4029835|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4206961|NCT00734344|4029836|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4206962|NCT00734344|4029837|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4206963|NCT00734344|4029835|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206964|NCT00734344|4029836|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206965|NCT00734344|4029837|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206966|NCT00734344|4029835|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206967|NCT00734344|4029836|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206968|NCT00734344|4029837|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206969|NCT00734344|4029835|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206970|NCT00734344|4029836|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206971|NCT00734344|4029837|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206972|NCT00734344|4029835|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4206973|NCT00734344|4029836|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4206974|NCT00734344|4029837|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4206975|NCT00734344|4029835|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4206976|NCT00734344|4029836|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4206977|NCT00734344|4029837|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4206978|NCT00734344|4029835|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4206979|NCT00734344|4029836|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4206980|NCT00734344|4029837|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4206981|NCT00734344|4029835|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4206982|NCT00734344|4029836|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4206983|NCT00734344|4029837|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4206984|NCT00734344|4029835|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4206985|NCT00734344|4029836|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4206986|NCT00734344|4029837|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4206987|NCT00734305|4029906|B3|United States||Region of Enrollment||participants|Number|43|43.0||||||
4206988|NCT00734305|4029907|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4206989|NCT00734305|4029908|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4206990|NCT00734305|4029906|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206991|NCT00734305|4029907|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206992|NCT00734305|4029908|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206993|NCT00734305|4029906|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206994|NCT00734305|4029907|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206995|NCT00734305|4029908|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4206996|NCT00734305|4029906|B3||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4206997|NCT00734305|4029907|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4206998|NCT00734305|4029908|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4206999|NCT00734305|4029906|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4207000|NCT00734305|4029907|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4207001|NCT00734305|4029908|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4207002|NCT00734305|4029906|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207003|NCT00734305|4029907|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207004|NCT00734305|4029908|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207005|NCT00734305|4029906|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207006|NCT00734305|4029907|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207007|NCT00734305|4029908|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207008|NCT00734305|4029906|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207009|NCT00734305|4029907|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207010|NCT00734305|4029908|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207011|NCT00734305|4029906|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207012|NCT00734305|4029907|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207013|NCT00734305|4029908|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207014|NCT00734305|4029906|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4207015|NCT00734305|4029907|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4207016|NCT00734305|4029908|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4207017|NCT00734305|4029906|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4207018|NCT00734305|4029907|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4207019|NCT00734305|4029908|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4207020|NCT00734305|4029906|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4207021|NCT00734305|4029907|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4207022|NCT00734305|4029908|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4207023|NCT00734305|4029906|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4207024|NCT00734305|4029907|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4207025|NCT00734305|4029908|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4207026|NCT00734305|4029906|B3|||Age||years|Mean|59.85|59.85|Standard Deviation|9.45|9.45|||
4207027|NCT00734305|4029907|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|8.08|8.08|||
4207028|NCT00734305|4029908|B1|||Age||years|Mean|61.2|61.2|Standard Deviation|10.82|10.82|||
4207029|NCT00734214|4029943|B3|Canada||Region of Enrollment||participants|Number|258|258.0||||||
4207030|NCT00734214|4029944|B2|Canada||Region of Enrollment||participants|Number|130|130.0||||||
4207031|NCT00734214|4029945|B1|Canada||Region of Enrollment||participants|Number|128|128.0||||||
4207032|NCT00734214|4029943|B3||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4207033|NCT00734214|4029944|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4207034|NCT00734214|4029945|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4207035|NCT00734214|4029943|B3||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4207036|NCT00734214|4029944|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4207037|NCT00734214|4029945|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4207038|NCT00734214|4029943|B3|||Age||years|Mean|9.2|9.2|Standard Deviation|5.6|5.6|||
4207039|NCT00734214|4029944|B2|||Age||years|Mean|9.2|9.2|Standard Deviation|5.7|5.7|||
4207040|NCT00734214|4029945|B1|||Age||years|Mean|9.2|9.2|Standard Deviation|5.5|5.5|||
4207041|NCT00734214|4029943|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4207042|NCT00734214|4029944|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4207043|NCT00734214|4029945|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4207044|NCT00734214|4029943|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4207045|NCT00734214|4029944|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4207046|NCT00734214|4029945|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4207047|NCT00734214|4029943|B3||<=18 years|Age||Participants|Count of Participants|258|258.0||||||
4207048|NCT00734214|4029944|B2||<=18 years|Age||Participants|Count of Participants|130|130.0||||||
4207049|NCT00734214|4029945|B1||<=18 years|Age||Participants|Count of Participants|128|128.0||||||
4207050|NCT00734162|4029952|B5|||HBV DNA level at baseline||Log_10 copies/mL|Mean|8.13|8.13|Standard Deviation|1.403|1.403|||
4207051|NCT00734162|4029953|B4|||HBV DNA level at baseline||Log_10 copies/mL|Mean|8.12|8.12|Standard Deviation|1.451|1.451|||
4207052|NCT00734162|4029954|B3|||HBV DNA level at baseline||Log_10 copies/mL|Mean|8.61|8.61|Standard Deviation|1.166|1.166|||
4207053|NCT00734162|4029955|B2|||HBV DNA level at baseline||Log_10 copies/mL|Mean|7.95|7.95|Standard Deviation|1.421|1.421|||
4207054|NCT00734162|4029956|B1|||HBV DNA level at baseline||Log_10 copies/mL|Mean|8.26|8.26|Standard Deviation|1.455|1.455|||
4207055|NCT00734162|4029952|B5|Positive||Hepatitis B e Antigen (HBeAg) status at baseline||participants|Number|96|96.0||||||
4207056|NCT00734162|4029953|B4|Positive||Hepatitis B e Antigen (HBeAg) status at baseline||participants|Number|35|35.0||||||
4207057|NCT00734162|4029954|B3|Positive||Hepatitis B e Antigen (HBeAg) status at baseline||participants|Number|13|13.0||||||
4207058|NCT00734162|4029955|B2|Positive||Hepatitis B e Antigen (HBeAg) status at baseline||participants|Number|39|39.0||||||
4207059|NCT00734162|4029956|B1|Positive||Hepatitis B e Antigen (HBeAg) status at baseline||participants|Number|9|9.0||||||
4207060|NCT00734162|4029952|B5|Negative||Hepatitis B e Antigen (HBeAg) status at baseline||participants|Number|10|10.0||||||
4207061|NCT00734162|4029953|B4|Negative||Hepatitis B e Antigen (HBeAg) status at baseline||participants|Number|6|6.0||||||
4207062|NCT00734162|4029954|B3|Negative||Hepatitis B e Antigen (HBeAg) status at baseline||participants|Number|0|0.0||||||
4207063|NCT00734162|4029955|B2|Negative||Hepatitis B e Antigen (HBeAg) status at baseline||participants|Number|3|3.0||||||
4207064|NCT00734162|4029956|B1|Negative||Hepatitis B e Antigen (HBeAg) status at baseline||participants|Number|1|1.0||||||
4207065|NCT00734162|4029952|B5|Genotype D||HBV Genotype||participants|Number|33|33.0||||||
4207066|NCT00734162|4029953|B4|Genotype D||HBV Genotype||participants|Number|11|11.0||||||
4207067|NCT00734162|4029954|B3|Genotype D||HBV Genotype||participants|Number|7|7.0||||||
4207068|NCT00734162|4029955|B2|Genotype D||HBV Genotype||participants|Number|10|10.0||||||
4207069|NCT00734162|4029956|B1|Genotype D||HBV Genotype||participants|Number|5|5.0||||||
4207070|NCT00734162|4029952|B5|Genotype C||HBV Genotype||participants|Number|1|1.0||||||
4207071|NCT00734162|4029953|B4|Genotype C||HBV Genotype||participants|Number|0|0.0||||||
4207072|NCT00734162|4029954|B3|Genotype C||HBV Genotype||participants|Number|0|0.0||||||
4207073|NCT00734162|4029955|B2|Genotype C||HBV Genotype||participants|Number|1|1.0||||||
4207074|NCT00734162|4029956|B1|Genotype C||HBV Genotype||participants|Number|0|0.0||||||
4207075|NCT00734162|4029952|B5|Genotype B||HBV Genotype||participants|Number|3|3.0||||||
4207076|NCT00734162|4029953|B4|Genotype B||HBV Genotype||participants|Number|1|1.0||||||
4207077|NCT00734162|4029954|B3|Genotype B||HBV Genotype||participants|Number|1|1.0||||||
4207078|NCT00734162|4029955|B2|Genotype B||HBV Genotype||participants|Number|1|1.0||||||
4207079|NCT00734162|4029956|B1|Genotype B||HBV Genotype||participants|Number|0|0.0||||||
4207080|NCT00734162|4029952|B5|Genotype A||HBV Genotype||participants|Number|69|69.0||||||
4207081|NCT00734162|4029953|B4|Genotype A||HBV Genotype||participants|Number|29|29.0||||||
4207082|NCT00734162|4029954|B3|Genotype A||HBV Genotype||participants|Number|5|5.0||||||
4207083|NCT00734162|4029955|B2|Genotype A||HBV Genotype||participants|Number|30|30.0||||||
4207084|NCT00734162|4029956|B1|Genotype A||HBV Genotype||participants|Number|5|5.0||||||
4207085|NCT00734162|4029952|B5|Abnormal||ALT normal at baseline|The upper limit of normal (ULN) was 43 U/L for males and 34 U/L for females.|participants|Number|77|77.0||||||
4207086|NCT00734162|4029953|B4|Abnormal||ALT normal at baseline|The upper limit of normal (ULN) was 43 U/L for males and 34 U/L for females.|participants|Number|33|33.0||||||
4207087|NCT00734162|4029954|B3|Abnormal||ALT normal at baseline|The upper limit of normal (ULN) was 43 U/L for males and 34 U/L for females.|participants|Number|9|9.0||||||
4207088|NCT00734162|4029955|B2|Abnormal||ALT normal at baseline|The upper limit of normal (ULN) was 43 U/L for males and 34 U/L for females.|participants|Number|28|28.0||||||
4207089|NCT00734162|4029956|B1|Abnormal||ALT normal at baseline|The upper limit of normal (ULN) was 43 U/L for males and 34 U/L for females.|participants|Number|7|7.0||||||
4207090|NCT00734162|4029952|B5|Normal||ALT normal at baseline|The upper limit of normal (ULN) was 43 U/L for males and 34 U/L for females.|participants|Number|29|29.0||||||
4207091|NCT00734162|4029953|B4|Normal||ALT normal at baseline|The upper limit of normal (ULN) was 43 U/L for males and 34 U/L for females.|participants|Number|8|8.0||||||
4207092|NCT00734162|4029954|B3|Normal||ALT normal at baseline|The upper limit of normal (ULN) was 43 U/L for males and 34 U/L for females.|participants|Number|4|4.0||||||
4207093|NCT00734162|4029955|B2|Normal||ALT normal at baseline|The upper limit of normal (ULN) was 43 U/L for males and 34 U/L for females.|participants|Number|14|14.0||||||
4207094|NCT00734162|4029956|B1|Normal||ALT normal at baseline|The upper limit of normal (ULN) was 43 U/L for males and 34 U/L for females.|participants|Number|3|3.0||||||
4207095|NCT00734162|4029952|B5|||Alanine aminotransferase (ALT) level at baseline||U/L|Mean|101|101.0|Standard Deviation|98.5|98.5|||
4207096|NCT00734162|4029953|B4|||Alanine aminotransferase (ALT) level at baseline||U/L|Mean|101|101.0|Standard Deviation|89.5|89.5|||
4207097|NCT00734162|4029954|B3|||Alanine aminotransferase (ALT) level at baseline||U/L|Mean|101|101.0|Standard Deviation|95.4|95.4|||
4207098|NCT00734162|4029955|B2|||Alanine aminotransferase (ALT) level at baseline||U/L|Mean|106|106.0|Standard Deviation|116.4|116.4|||
4207099|NCT00734162|4029956|B1|||Alanine aminotransferase (ALT) level at baseline||U/L|Mean|77|77.0|Standard Deviation|54.8|54.8|||
4207100|NCT00734162|4029952|B5|North America||Region of Enrollment||participants|Number|5|5.0||||||
4207101|NCT00734162|4029953|B4|North America||Region of Enrollment||participants|Number|2|2.0||||||
4207102|NCT00734162|4029954|B3|North America||Region of Enrollment||participants|Number|1|1.0||||||
4207103|NCT00734162|4029955|B2|North America||Region of Enrollment||participants|Number|2|2.0||||||
4207104|NCT00734162|4029956|B1|North America||Region of Enrollment||participants|Number|0|0.0||||||
4207105|NCT00734162|4029952|B5|Europe||Region of Enrollment||participants|Number|101|101.0||||||
4207106|NCT00734162|4029953|B4|Europe||Region of Enrollment||participants|Number|39|39.0||||||
4207107|NCT00734162|4029954|B3|Europe||Region of Enrollment||participants|Number|12|12.0||||||
4207108|NCT00734162|4029955|B2|Europe||Region of Enrollment||participants|Number|40|40.0||||||
4207109|NCT00734162|4029956|B1|Europe||Region of Enrollment||participants|Number|10|10.0||||||
4207110|NCT00734162|4029952|B5|United States||Region of Enrollment||participants|Number|5|5.0||||||
4207111|NCT00734162|4029953|B4|United States||Region of Enrollment||participants|Number|2|2.0||||||
4207112|NCT00734162|4029954|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4207113|NCT00734162|4029955|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4207114|NCT00734162|4029956|B1|United States||Region of Enrollment||participants|Number|0|0.0||||||
4207115|NCT00734162|4029952|B5|Turkey||Region of Enrollment||participants|Number|2|2.0||||||
4207116|NCT00734162|4029953|B4|Turkey||Region of Enrollment||participants|Number|0|0.0||||||
4207117|NCT00734162|4029954|B3|Turkey||Region of Enrollment||participants|Number|1|1.0||||||
4207118|NCT00734162|4029955|B2|Turkey||Region of Enrollment||participants|Number|1|1.0||||||
4207119|NCT00734162|4029956|B1|Turkey||Region of Enrollment||participants|Number|0|0.0||||||
4207120|NCT00734162|4029952|B5|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4207121|NCT00734162|4029953|B4|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4207122|NCT00734162|4029954|B3|Spain||Region of Enrollment||participants|Number|0|0.0||||||
4207123|NCT00734162|4029955|B2|Spain||Region of Enrollment||participants|Number|0|0.0||||||
4207124|NCT00734162|4029956|B1|Spain||Region of Enrollment||participants|Number|0|0.0||||||
4207125|NCT00734162|4029952|B5|Romania||Region of Enrollment||participants|Number|14|14.0||||||
4207126|NCT00734162|4029953|B4|Romania||Region of Enrollment||participants|Number|4|4.0||||||
4207127|NCT00734162|4029954|B3|Romania||Region of Enrollment||participants|Number|2|2.0||||||
4207128|NCT00734162|4029955|B2|Romania||Region of Enrollment||participants|Number|4|4.0||||||
4207129|NCT00734162|4029956|B1|Romania||Region of Enrollment||participants|Number|4|4.0||||||
4207130|NCT00734162|4029952|B5|Poland||Region of Enrollment||participants|Number|74|74.0||||||
4207131|NCT00734162|4029953|B4|Poland||Region of Enrollment||participants|Number|31|31.0||||||
4207132|NCT00734162|4029954|B3|Poland||Region of Enrollment||participants|Number|6|6.0||||||
4207133|NCT00734162|4029955|B2|Poland||Region of Enrollment||participants|Number|31|31.0||||||
4207134|NCT00734162|4029956|B1|Poland||Region of Enrollment||participants|Number|6|6.0||||||
4207135|NCT00734162|4029952|B5|France||Region of Enrollment||participants|Number|2|2.0||||||
4207136|NCT00734162|4029953|B4|France||Region of Enrollment||participants|Number|1|1.0||||||
4207137|NCT00734162|4029954|B3|France||Region of Enrollment||participants|Number|0|0.0||||||
4207138|NCT00734162|4029955|B2|France||Region of Enrollment||participants|Number|1|1.0||||||
4207139|NCT00734162|4029956|B1|France||Region of Enrollment||participants|Number|0|0.0||||||
4207140|NCT00734162|4029952|B5|Bulgaria||Region of Enrollment||participants|Number|7|7.0||||||
4207141|NCT00734162|4029953|B4|Bulgaria||Region of Enrollment||participants|Number|1|1.0||||||
4207142|NCT00734162|4029954|B3|Bulgaria||Region of Enrollment||participants|Number|3|3.0||||||
4207143|NCT00734162|4029955|B2|Bulgaria||Region of Enrollment||participants|Number|3|3.0||||||
4207144|NCT00734162|4029956|B1|Bulgaria||Region of Enrollment||participants|Number|0|0.0||||||
4207145|NCT00734162|4029952|B5|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4207146|NCT00734162|4029953|B4|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4207147|NCT00734162|4029954|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4207148|NCT00734162|4029955|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4207149|NCT00734162|4029956|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4207150|NCT00734162|4029952|B5|White||Race/Ethnicity, Customized||participants|Number|98|98.0||||||
4207151|NCT00734162|4029953|B4|White||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4207152|NCT00734162|4029954|B3|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4207153|NCT00734162|4029955|B2|White||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4207154|NCT00734162|4029956|B1|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4207155|NCT00734162|4029952|B5|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4207156|NCT00734162|4029953|B4|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4207157|NCT00734162|4029954|B3|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4207158|NCT00734162|4029955|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4207159|NCT00734162|4029956|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4207160|NCT00734162|4029952|B5|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4207161|NCT00734162|4029953|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4207162|NCT00734162|4029954|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4207163|NCT00734162|4029955|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4207164|NCT00734162|4029956|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4207165|NCT00734162|4029952|B5||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4207166|NCT00734162|4029953|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4207167|NCT00734162|4029954|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4207168|NCT00734162|4029955|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4207169|NCT00734162|4029956|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4207170|NCT00734162|4029952|B5||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4207171|NCT00734162|4029953|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4207172|NCT00734162|4029954|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4207173|NCT00734162|4029955|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4207174|NCT00734162|4029956|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4207175|NCT00734162|4029952|B5|||Age||years|Mean|15.4|15.4|Standard Deviation|1.38|1.38|||
4207176|NCT00734162|4029953|B4|||Age||years|Mean|15.9|15.9|Standard Deviation|0.82|0.82|||
4207177|NCT00734162|4029954|B3|||Age||years|Mean|13.2|13.2|Standard Deviation|0.69|0.69|||
4207178|NCT00734162|4029955|B2|||Age||years|Mean|16.1|16.1|Standard Deviation|0.75|0.75|||
4207179|NCT00734162|4029956|B1|||Age||years|Mean|13.3|13.3|Standard Deviation|0.82|0.82|||
4207180|NCT00734149|4030183|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4207181|NCT00734149|4030183|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4207182|NCT00734149|4030183|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4207183|NCT00734149|4030183|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4207184|NCT00734149|4030183|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4207185|NCT00734097|4030190|B1||Male|Sex: Female, Male|Gender|Participants|Count of Participants|99|99.0||||||
4207186|NCT00734097|4030190|B1||Female|Sex: Female, Male|Gender|Participants|Count of Participants|212|212.0||||||
4207187|NCT00734097|4030190|B1|||Age|Age at study entry|Years|Mean|42.7|42.7|Standard Deviation|14.3|14.3|||
4207188|NCT00734071|4030205|B3|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|11.96|11.96|Standard Deviation|2.953|2.953|||
4207189|NCT00734071|4030206|B2|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|12.09|12.09|Standard Deviation|2.902|2.902|||
4207190|NCT00734071|4030207|B1|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|11.83|11.83|Standard Deviation|3.007|3.007|||
4207191|NCT00734071|4030205|B3|||Hospital Anxiety and Depression – Depression subscale|Hospital Anxiety and Depression (HAD) Depression sub-scale consists of 7 items that are assessed on a scale from 0 (no depression) to 3 (severe feeling of depression). The depression subscale focuses on the state of lost interest and diminished pleasure response. Scores are summed and range from 0 to 21 (maximal severity). The number of participants with available data were 149 and 151 in each treatment arm respectively.|scores on a scale|Mean|8.3|8.3|Standard Deviation|3.85|3.85|||
4207192|NCT00734071|4030206|B2|||Hospital Anxiety and Depression – Depression subscale|Hospital Anxiety and Depression (HAD) Depression sub-scale consists of 7 items that are assessed on a scale from 0 (no depression) to 3 (severe feeling of depression). The depression subscale focuses on the state of lost interest and diminished pleasure response. Scores are summed and range from 0 to 21 (maximal severity). The number of participants with available data were 149 and 151 in each treatment arm respectively.|scores on a scale|Mean|8.1|8.1|Standard Deviation|3.91|3.91|||
4207193|NCT00734071|4030207|B1|||Hospital Anxiety and Depression – Depression subscale|Hospital Anxiety and Depression (HAD) Depression sub-scale consists of 7 items that are assessed on a scale from 0 (no depression) to 3 (severe feeling of depression). The depression subscale focuses on the state of lost interest and diminished pleasure response. Scores are summed and range from 0 to 21 (maximal severity). The number of participants with available data were 149 and 151 in each treatment arm respectively.|scores on a scale|Mean|8.5|8.5|Standard Deviation|3.79|3.79|||
4207194|NCT00734071|4030205|B3|||Hospital Anxiety and Depression – Anxiety subscale|Hospital Anxiety and Depression (HAD) Anxiety sub-scale consists of 7 items that are assessed on a scale from 0 (no anxiety) to 3 (severe feeling of anxiety). The anxiety subscale determines a state of generalized anxiety including anxious mood, restlessness, anxious thoughts and panic attacks. Scores are summed and range from 0 to 21 (maximal severity). The number of participants with available data were 149 and 151 in each treatment arm respectively.|scores on a scale|Mean|13.7|13.7|Standard Deviation|3.26|3.26|||
4207225|NCT00734071|4030206|B2|Never Smoked||Smoking Classification||participants|Number|76|76.0||||||
4207195|NCT00734071|4030206|B2|||Hospital Anxiety and Depression – Anxiety subscale|Hospital Anxiety and Depression (HAD) Anxiety sub-scale consists of 7 items that are assessed on a scale from 0 (no anxiety) to 3 (severe feeling of anxiety). The anxiety subscale determines a state of generalized anxiety including anxious mood, restlessness, anxious thoughts and panic attacks. Scores are summed and range from 0 to 21 (maximal severity). The number of participants with available data were 149 and 151 in each treatment arm respectively.|scores on a scale|Mean|13.8|13.8|Standard Deviation|3.39|3.39|||
4207196|NCT00734071|4030207|B1|||Hospital Anxiety and Depression – Anxiety subscale|Hospital Anxiety and Depression (HAD) Anxiety sub-scale consists of 7 items that are assessed on a scale from 0 (no anxiety) to 3 (severe feeling of anxiety). The anxiety subscale determines a state of generalized anxiety including anxious mood, restlessness, anxious thoughts and panic attacks. Scores are summed and range from 0 to 21 (maximal severity). The number of participants with available data were 149 and 151 in each treatment arm respectively.|scores on a scale|Mean|13.5|13.5|Standard Deviation|3.14|3.14|||
4207197|NCT00734071|4030205|B3|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill. The number of participants with available data were 151 and 152 in each treatment arm respectively.|scores on a scale|Mean|4.3|4.3|Standard Deviation|0.51|0.51|||
4207198|NCT00734071|4030206|B2|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill. The number of participants with available data were 151 and 152 in each treatment arm respectively.|scores on a scale|Mean|4.3|4.3|Standard Deviation|0.53|0.53|||
4207199|NCT00734071|4030207|B1|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill. The number of participants with available data were 151 and 152 in each treatment arm respectively.|scores on a scale|Mean|4.3|4.3|Standard Deviation|0.49|0.49|||
4207200|NCT00734071|4030205|B3|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 (absent) to 56 (maximum severity).|scores on a scale|Mean|24.7|24.7|Standard Deviation|3.69|3.69|||
4207201|NCT00734071|4030206|B2|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 (absent) to 56 (maximum severity).|scores on a scale|Mean|24.7|24.7|Standard Deviation|3.79|3.79|||
4207202|NCT00734071|4030207|B1|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 (absent) to 56 (maximum severity).|scores on a scale|Mean|24.6|24.6|Standard Deviation|3.60|3.6|||
4207203|NCT00734071|4030205|B3|Daily||Alcohol Consumption||participants|Number|6|6.0||||||
4207204|NCT00734071|4030206|B2|Daily||Alcohol Consumption||participants|Number|3|3.0||||||
4207205|NCT00734071|4030207|B1|Daily||Alcohol Consumption||participants|Number|3|3.0||||||
4207206|NCT00734071|4030205|B3|2 to 6 times per week||Alcohol Consumption||participants|Number|54|54.0||||||
4207207|NCT00734071|4030206|B2|2 to 6 times per week||Alcohol Consumption||participants|Number|27|27.0||||||
4207208|NCT00734071|4030207|B1|2 to 6 times per week||Alcohol Consumption||participants|Number|27|27.0||||||
4207209|NCT00734071|4030205|B3|Once a week||Alcohol Consumption||participants|Number|45|45.0||||||
4207210|NCT00734071|4030206|B2|Once a week||Alcohol Consumption||participants|Number|28|28.0||||||
4207211|NCT00734071|4030207|B1|Once a week||Alcohol Consumption||participants|Number|17|17.0||||||
4207212|NCT00734071|4030205|B3|Once monthly or less often||Alcohol Consumption||participants|Number|112|112.0||||||
4207213|NCT00734071|4030206|B2|Once monthly or less often||Alcohol Consumption||participants|Number|55|55.0||||||
4207214|NCT00734071|4030207|B1|Once monthly or less often||Alcohol Consumption||participants|Number|57|57.0||||||
4207215|NCT00734071|4030205|B3|Never||Alcohol Consumption||participants|Number|87|87.0||||||
4207216|NCT00734071|4030206|B2|Never||Alcohol Consumption||participants|Number|39|39.0||||||
4207217|NCT00734071|4030207|B1|Never||Alcohol Consumption||participants|Number|48|48.0||||||
4207218|NCT00734071|4030205|B3|Ex-smoker||Smoking Classification||participants|Number|69|69.0||||||
4207219|NCT00734071|4030206|B2|Ex-smoker||Smoking Classification||participants|Number|33|33.0||||||
4207220|NCT00734071|4030207|B1|Ex-smoker||Smoking Classification||participants|Number|36|36.0||||||
4207221|NCT00734071|4030205|B3|Current Smoker||Smoking Classification||participants|Number|81|81.0||||||
4207222|NCT00734071|4030206|B2|Current Smoker||Smoking Classification||participants|Number|43|43.0||||||
4207223|NCT00734071|4030207|B1|Current Smoker||Smoking Classification||participants|Number|38|38.0||||||
4207224|NCT00734071|4030205|B3|Never Smoked||Smoking Classification||participants|Number|154|154.0||||||
4207226|NCT00734071|4030207|B1|Never Smoked||Smoking Classification||participants|Number|78|78.0||||||
4207227|NCT00734071|4030205|B3|||Body Mass Index (BMI)||kg/m^2|Mean|29.04|29.04|Standard Deviation|6.789|6.789|||
4207228|NCT00734071|4030206|B2|||Body Mass Index (BMI)||kg/m^2|Mean|28.42|28.42|Standard Deviation|6.680|6.68|||
4207229|NCT00734071|4030207|B1|||Body Mass Index (BMI)||kg/m^2|Mean|29.66|29.66|Standard Deviation|6.861|6.861|||
4207230|NCT00734071|4030205|B3|||Height||cm|Mean|167.73|167.73|Standard Deviation|8.949|8.949|||
4207231|NCT00734071|4030206|B2|||Height||cm|Mean|167.72|167.72|Standard Deviation|9.158|9.158|||
4207232|NCT00734071|4030207|B1|||Height||cm|Mean|167.73|167.73|Standard Deviation|8.765|8.765|||
4207233|NCT00734071|4030205|B3|||Weight||kg|Mean|81.89|81.89|Standard Deviation|20.652|20.652|||
4207234|NCT00734071|4030206|B2|||Weight||kg|Mean|80.10|80.1|Standard Deviation|20.296|20.296|||
4207235|NCT00734071|4030207|B1|||Weight||kg|Mean|83.68|83.68|Standard Deviation|20.916|20.916|||
4207236|NCT00734071|4030205|B3|United States||Region of Enrollment||participants|Number|304|304.0||||||
4207237|NCT00734071|4030206|B2|United States||Region of Enrollment||participants|Number|152|152.0||||||
4207238|NCT00734071|4030207|B1|United States||Region of Enrollment||participants|Number|152|152.0||||||
4207239|NCT00734071|4030205|B3|Non-Hispanic/Non-Latino||Race/Ethnicity, Customized||participants|Number|254|254.0||||||
4207240|NCT00734071|4030206|B2|Non-Hispanic/Non-Latino||Race/Ethnicity, Customized||participants|Number|126|126.0||||||
4207241|NCT00734071|4030207|B1|Non-Hispanic/Non-Latino||Race/Ethnicity, Customized||participants|Number|128|128.0||||||
4207242|NCT00734071|4030205|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
4207243|NCT00734071|4030206|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4207244|NCT00734071|4030207|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4207245|NCT00734071|4030205|B3|Native Hawaiian/ Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4207246|NCT00734071|4030206|B2|Native Hawaiian/ Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4207247|NCT00734071|4030207|B1|Native Hawaiian/ Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4207248|NCT00734071|4030205|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4207249|NCT00734071|4030206|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4207250|NCT00734071|4030207|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4207251|NCT00734071|4030205|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4207252|NCT00734071|4030206|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4207253|NCT00734071|4030207|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4207254|NCT00734071|4030205|B3|Black||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4207255|NCT00734071|4030206|B2|Black||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4207256|NCT00734071|4030207|B1|Black||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4207257|NCT00734071|4030205|B3|Caucasian (White, including Hispanic)||Race/Ethnicity, Customized||participants|Number|254|254.0||||||
4207258|NCT00734071|4030206|B2|Caucasian (White, including Hispanic)||Race/Ethnicity, Customized||participants|Number|123|123.0||||||
4207259|NCT00734071|4030207|B1|Caucasian (White, including Hispanic)||Race/Ethnicity, Customized||participants|Number|131|131.0||||||
4207260|NCT00734071|4030205|B3||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4207261|NCT00734071|4030206|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4207262|NCT00734071|4030207|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4207263|NCT00734071|4030205|B3||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4207264|NCT00734071|4030206|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4207265|NCT00734071|4030207|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4207266|NCT00734071|4030205|B3|>55 years||Age, Customized||participants|Number|47|47.0||||||
4207267|NCT00734071|4030206|B2|>55 years||Age, Customized||participants|Number|23|23.0||||||
4207268|NCT00734071|4030207|B1|>55 years||Age, Customized||participants|Number|24|24.0||||||
4207269|NCT00734071|4030205|B3|≤55 years||Age, Customized||participants|Number|257|257.0||||||
4207270|NCT00734071|4030206|B2|≤55 years||Age, Customized||participants|Number|129|129.0||||||
4207271|NCT00734071|4030207|B1|≤55 years||Age, Customized||participants|Number|128|128.0||||||
4207272|NCT00734071|4030205|B3|||Age||years|Mean|41.2|41.2|Standard Deviation|13.42|13.42|||
4207273|NCT00734071|4030206|B2|||Age||years|Mean|41.0|41.0|Standard Deviation|14.05|14.05|||
4207274|NCT00734071|4030207|B1|||Age||years|Mean|41.4|41.4|Standard Deviation|12.81|12.81|||
4207275|NCT00734032|4030262|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207276|NCT00734032|4030263|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207277|NCT00734032|4030264|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207278|NCT00734032|4030265|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207279|NCT00734032|4030266|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207280|NCT00734032|4030262|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207281|NCT00734032|4030263|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207282|NCT00734032|4030264|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207283|NCT00734032|4030265|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207284|NCT00734032|4030266|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207285|NCT00734032|4030262|B5||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207286|NCT00734032|4030263|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207287|NCT00734032|4030264|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207288|NCT00734032|4030265|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207289|NCT00734032|4030266|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207290|NCT00734032|4030262|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207291|NCT00734032|4030263|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207292|NCT00734032|4030264|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207293|NCT00734032|4030265|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207294|NCT00734032|4030266|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207295|NCT00734032|4030262|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207296|NCT00734032|4030263|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207297|NCT00734032|4030264|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207298|NCT00734032|4030265|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207299|NCT00734032|4030266|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207300|NCT00734032|4030262|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
4207301|NCT00734032|4030263|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4207302|NCT00734032|4030264|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4207303|NCT00734032|4030265|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4207304|NCT00734032|4030266|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4207305|NCT00734032|4030262|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207306|NCT00734032|4030263|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207307|NCT00734032|4030264|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207308|NCT00734032|4030265|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207309|NCT00734032|4030266|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207310|NCT00734032|4030262|B5||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4207311|NCT00734032|4030263|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4207312|NCT00734032|4030264|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4207313|NCT00734032|4030265|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4207314|NCT00734032|4030266|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4207315|NCT00734032|4030262|B5||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4207316|NCT00734032|4030263|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4207317|NCT00734032|4030264|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4207318|NCT00734032|4030265|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4207319|NCT00734032|4030266|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4207320|NCT00734032|4030262|B5|||Age||Years|Mean|59.0|59.0|Standard Deviation|10.34|10.34|||
4207321|NCT00734032|4030263|B4|||Age||Years|Mean|58.3|58.3|Standard Deviation|10.48|10.48|||
4207322|NCT00734032|4030264|B3|||Age||Years|Mean|58.3|58.3|Standard Deviation|9.54|9.54|||
4207323|NCT00734032|4030265|B2|||Age||Years|Mean|59.8|59.8|Standard Deviation|10.17|10.17|||
4207324|NCT00734032|4030266|B1|||Age||Years|Mean|59.5|59.5|Standard Deviation|11.71|11.71|||
4207325|NCT00733993|4030287|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4207326|NCT00733993|4030288|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4207327|NCT00733993|4030289|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4207328|NCT00733993|4030287|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4207329|NCT00733993|4030288|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4207330|NCT00733993|4030289|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4207331|NCT00733993|4030287|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4207332|NCT00733993|4030288|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4207333|NCT00733993|4030289|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4207334|NCT00733993|4030287|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4207335|NCT00733993|4030288|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4207336|NCT00733993|4030289|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4207337|NCT00733993|4030287|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4207338|NCT00733993|4030288|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4207339|NCT00733993|4030289|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4207340|NCT00733993|4030287|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4207341|NCT00733993|4030288|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4207342|NCT00733993|4030289|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4207343|NCT00733980|4030323|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207344|NCT00733980|4030324|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207345|NCT00733980|4030325|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207346|NCT00733980|4030323|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207347|NCT00733980|4030324|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207348|NCT00733980|4030325|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207349|NCT00733980|4030323|B3||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4207350|NCT00733980|4030324|B2||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4207351|NCT00733980|4030325|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4207352|NCT00733980|4030323|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
4207353|NCT00733980|4030324|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4207354|NCT00733980|4030325|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4207355|NCT00733980|4030323|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4207356|NCT00733980|4030324|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207357|NCT00733980|4030325|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4207358|NCT00733980|4030323|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4207359|NCT00733980|4030324|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4207360|NCT00733980|4030325|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207361|NCT00733980|4030323|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4207362|NCT00733980|4030324|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4207363|NCT00733980|4030325|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207364|NCT00733980|4030323|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4207365|NCT00733980|4030324|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4207366|NCT00733980|4030325|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4207367|NCT00733980|4030323|B3||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4207368|NCT00733980|4030324|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4207369|NCT00733980|4030325|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4207370|NCT00733980|4030323|B3|||Age||Years|Mean|39.8|39.8|Standard Deviation|11.76|11.76|||
4207371|NCT00733980|4030324|B2|||Age||Years|Mean|40.8|40.8|Standard Deviation|12.17|12.17|||
4207372|NCT00733980|4030325|B1|||Age||Years|Mean|38.8|38.8|Standard Deviation|11.31|11.31|||
4207373|NCT00733954|4030368|B3||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4207374|NCT00733954|4030369|B2||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4207375|NCT00733954|4030370|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4207376|NCT00733954|4030368|B3||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4207377|NCT00733954|4030369|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4207378|NCT00733954|4030370|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4207379|NCT00733954|4030368|B3|||Age||years|Mean|50.4|50.4|Standard Deviation|13.7|13.7|||
4207380|NCT00733954|4030369|B2|||Age||years|Mean|50.2|50.2|Standard Deviation|13.5|13.5|||
4207381|NCT00733954|4030370|B1|||Age||years|Mean|50.6|50.6|Standard Deviation|14.0|14.0|||
4207382|NCT00733824|4030413|B6|United States||Region of Enrollment||participants|Number|61|61.0||||||
4207383|NCT00733824|4030414|B5|United States||Region of Enrollment||participants|Number|36|36.0||||||
4207384|NCT00733824|4030415|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
4207385|NCT00733824|4030416|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4207386|NCT00733824|4030417|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4207387|NCT00733824|4030418|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4207388|NCT00733824|4030413|B6||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4207389|NCT00733824|4030414|B5||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4207390|NCT00733824|4030415|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4207391|NCT00733824|4030416|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4207392|NCT00733824|4030417|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4207393|NCT00733824|4030418|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4207394|NCT00733824|4030413|B6||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4207395|NCT00733824|4030414|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4207396|NCT00733824|4030415|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4207397|NCT00733824|4030416|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4207398|NCT00733824|4030417|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4207399|NCT00733824|4030418|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4207400|NCT00733824|4030413|B6|||Age||years|Median|53|53.0|Full Range|||23.0|73.0|
4207401|NCT00733824|4030414|B5|||Age||years|Median|60|60.0|Full Range|||23.0|73.0|
4207402|NCT00733824|4030415|B4|||Age||years|Median|47|47.0|Full Range|||25.0|59.0|
4207403|NCT00733824|4030416|B3|||Age||years|Median|50|50.0|Full Range|||25.0|53.0|
4207404|NCT00733824|4030417|B2|||Age||years|Median|48|48.0|Full Range|||30.0|50.0|
4207405|NCT00733824|4030418|B1|||Age||years|Median|49.5|49.5|Full Range|||24.0|69.0|
4207406|NCT00733746|4030441|B1|United States||Region of Enrollment||Participants|Count of Participants|100|100.0||||||
4207407|NCT00733746|4030441|B1|Canada||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4207408|NCT00733746|4030441|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4207409|NCT00733746|4030441|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4207410|NCT00733746|4030441|B1|||Age||years|Median|66|66.0|Full Range|||39.0|88.0|
4207411|NCT00733512|4030449|B1|Male||Sex/Gender, Customized|Gender data received on only 133 subjects|participants|Number|54|54.0||||||
4207412|NCT00733512|4030449|B1|Female||Sex/Gender, Customized|Gender data received on only 133 subjects|participants|Number|79|79.0||||||
4207413|NCT00733512|4030449|B1|>=65 years||Age, Customized|Age data received on only 124 subjects.|participants|Number|59|59.0||||||
4207414|NCT00733512|4030449|B1|Between 18 and 65 years||Age, Customized|Age data received on only 124 subjects.|participants|Number|65|65.0||||||
4207415|NCT00733512|4030449|B1|<=18 years||Age, Customized|Age data received on only 124 subjects.|participants|Number|0|0.0||||||
4207416|NCT00733499|4030454|B3|Ireland||Region of Enrollment||participants|Number|204|204.0||||||
4207417|NCT00733499|4030455|B2|Ireland||Region of Enrollment||participants|Number|102|102.0||||||
4207418|NCT00733499|4030456|B1|Ireland||Region of Enrollment||participants|Number|102|102.0||||||
4207419|NCT00733499|4030454|B3||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4207420|NCT00733499|4030455|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4207421|NCT00733499|4030456|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4207422|NCT00733499|4030454|B3||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4207423|NCT00733499|4030455|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4207424|NCT00733499|4030456|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4207425|NCT00733499|4030454|B3|||Age||years|Mean|70.94|70.94|Standard Deviation|8.96|8.96|||
4207426|NCT00733499|4030455|B2|||Age||years|Mean|70.49|70.49|Standard Deviation|8.97|8.97|||
4207427|NCT00733499|4030456|B1|||Age||years|Mean|71.39|71.39|Standard Deviation|8.98|8.98|||
4207428|NCT00733421|4030463|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4207429|NCT00733421|4030464|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4207430|NCT00733421|4030465|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4207431|NCT00733421|4030463|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4207432|NCT00733421|4030464|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4207433|NCT00733421|4030465|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4207434|NCT00733421|4030463|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4207435|NCT00733421|4030464|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4207436|NCT00733421|4030465|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4207437|NCT00733421|4030463|B3||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4207438|NCT00733421|4030464|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4207439|NCT00733421|4030465|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4207440|NCT00733421|4030463|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4207441|NCT00733421|4030464|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4207442|NCT00733421|4030465|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4207443|NCT00733408|4030488|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4207444|NCT00733408|4030488|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4207445|NCT00733408|4030488|B1||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4207446|NCT00733408|4030488|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4207447|NCT00733408|4030488|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207448|NCT00733408|4030488|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4207449|NCT00733408|4030488|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4207450|NCT00733408|4030488|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4207451|NCT00733408|4030488|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4207452|NCT00733408|4030488|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4207453|NCT00733408|4030488|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4207454|NCT00733408|4030488|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4207455|NCT00733408|4030488|B1|||Age||years|Mean|55.3|55.3|Standard Deviation|12.5|12.5|||
4207456|NCT00733369|4030498|B3|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4207457|NCT00733369|4030499|B2|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4207458|NCT00733369|4030500|B1|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4207459|NCT00733369|4030498|B3|Spain||Region of Enrollment||participants|Number|100|100.0||||||
4207460|NCT00733369|4030499|B2|Spain||Region of Enrollment||participants|Number|52|52.0||||||
4207461|NCT00733369|4030500|B1|Spain||Region of Enrollment||participants|Number|48|48.0||||||
4207462|NCT00733369|4030498|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4207463|NCT00733369|4030499|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4207464|NCT00733369|4030500|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4207465|NCT00733369|4030498|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4207466|NCT00733369|4030499|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4207467|NCT00733369|4030500|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4207468|NCT00733369|4030498|B3|||Age||years|Mean|65.8|65.8|Standard Deviation|6.8|6.8|||
4207469|NCT00733369|4030499|B2|||Age||years|Mean|66.3|66.3|Standard Deviation|6.4|6.4|||
4207470|NCT00733369|4030500|B1|||Age||years|Mean|65.2|65.2|Standard Deviation|7.2|7.2|||
4207471|NCT00733356|4030617|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4207472|NCT00733356|4030617|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4207473|NCT00733356|4030617|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4207474|NCT00733356|4030617|B1|||Age||years|Mean|9.3|9.3|Standard Deviation|1.8|1.8|||
4207475|NCT00733356|4030617|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4207476|NCT00733356|4030617|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4207477|NCT00733356|4030617|B1||<=18 years|Age||Participants|Count of Participants|28|28.0||||||
4207478|NCT00733330|4030621|B3|New Zealand||Region of Enrollment||participants|Number|21|21.0||||||
4207479|NCT00733330|4030622|B2|New Zealand||Region of Enrollment||participants|Number|14|14.0||||||
4207480|NCT00733330|4030623|B1|New Zealand||Region of Enrollment||participants|Number|7|7.0||||||
4207481|NCT00733330|4030621|B3|Australia||Region of Enrollment||participants|Number|21|21.0||||||
4207482|NCT00733330|4030622|B2|Australia||Region of Enrollment||participants|Number|12|12.0||||||
4207483|NCT00733330|4030623|B1|Australia||Region of Enrollment||participants|Number|9|9.0||||||
4207484|NCT00733330|4030621|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4207485|NCT00733330|4030622|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4207486|NCT00733330|4030623|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4207487|NCT00733330|4030621|B3|Male||Gender||participants|Number|34|34.0||||||
4207488|NCT00733330|4030622|B2|Male||Gender||participants|Number|21|21.0||||||
4207489|NCT00733330|4030623|B1|Male||Gender||participants|Number|13|13.0||||||
4207490|NCT00733330|4030621|B3|Female||Gender||participants|Number|49|49.0||||||
4207491|NCT00733330|4030622|B2|Female||Gender||participants|Number|31|31.0||||||
4207492|NCT00733330|4030623|B1|Female||Gender||participants|Number|18|18.0||||||
4207493|NCT00733330|4030621|B3|||Age||years|Mean|65.8|65.8|Standard Deviation|7.9|7.9|||
4207494|NCT00733330|4030622|B2|||Age||years|Mean|65.5|65.5|Standard Deviation|8.8|8.8|||
4207495|NCT00733330|4030623|B1|||Age||years|Mean|66.2|66.2|Standard Deviation|6.3|6.3|||
4207496|NCT00733304|4030706|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207497|NCT00733304|4030707|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207498|NCT00733304|4030708|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207499|NCT00733304|4030709|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207500|NCT00733304|4030706|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207501|NCT00733304|4030707|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207502|NCT00733304|4030708|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207503|NCT00733304|4030709|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207504|NCT00733304|4030706|B4||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4207505|NCT00733304|4030707|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4207506|NCT00733304|4030708|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4207507|NCT00733304|4030709|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4207508|NCT00733304|4030706|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207509|NCT00733304|4030707|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207510|NCT00733304|4030708|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207511|NCT00733304|4030709|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207512|NCT00733304|4030706|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207513|NCT00733304|4030707|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207514|NCT00733304|4030708|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207515|NCT00733304|4030709|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207516|NCT00733304|4030706|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207517|NCT00733304|4030707|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207518|NCT00733304|4030708|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207519|NCT00733304|4030709|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207520|NCT00733304|4030706|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207521|NCT00733304|4030707|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207522|NCT00733304|4030708|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207523|NCT00733304|4030709|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207524|NCT00733304|4030706|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4207525|NCT00733304|4030707|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4207526|NCT00733304|4030708|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4207527|NCT00733304|4030709|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4207528|NCT00733304|4030706|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4207529|NCT00733304|4030707|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4207530|NCT00733304|4030708|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4207531|NCT00733304|4030709|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4207532|NCT00733304|4030706|B4|55 to 88 aged||Age, Customized||Participants|Count of Participants|42|42.0||||||
4207533|NCT00733304|4030707|B3|55 to 88 aged||Age, Customized||Participants|Count of Participants|8|8.0||||||
4207534|NCT00733304|4030708|B2|55 to 88 aged||Age, Customized||Participants|Count of Participants|15|15.0||||||
4207535|NCT00733304|4030709|B1|55 to 88 aged||Age, Customized||Participants|Count of Participants|19|19.0||||||
4207536|NCT00733291|4030791|B3||Male|Sex: Female, Male|This reporting group is based on the number of subjects in the evaluable population.|Participants|Count of Participants|22|22.0||||||
4207537|NCT00733291|4030792|B2||Male|Sex: Female, Male|This reporting group is based on the number of subjects in the evaluable population.|Participants|Count of Participants|9|9.0||||||
4207538|NCT00733291|4030793|B1||Male|Sex: Female, Male|This reporting group is based on the number of subjects in the evaluable population.|Participants|Count of Participants|13|13.0||||||
4207539|NCT00733291|4030791|B3||Female|Sex: Female, Male|This reporting group is based on the number of subjects in the evaluable population.|Participants|Count of Participants|41|41.0||||||
4207540|NCT00733291|4030792|B2||Female|Sex: Female, Male|This reporting group is based on the number of subjects in the evaluable population.|Participants|Count of Participants|25|25.0||||||
4207541|NCT00733291|4030793|B1||Female|Sex: Female, Male|This reporting group is based on the number of subjects in the evaluable population.|Participants|Count of Participants|16|16.0||||||
4207542|NCT00733291|4030791|B3|||Age|This reporting group is based on the number of subjects in the evaluable population.|years|Mean|38.11|38.11|Standard Deviation|13.02|13.02|||
4207543|NCT00733291|4030792|B2|||Age|This reporting group is based on the number of subjects in the evaluable population.|years|Mean|38.56|38.56|Standard Deviation|12.42|12.42|||
4207544|NCT00733291|4030793|B1|||Age|This reporting group is based on the number of subjects in the evaluable population.|years|Mean|37.59|37.59|Standard Deviation|13.90|13.9|||
4207545|NCT00733291|4030791|B3||>=65 years|Age|This reporting group is based on the number of subjects in the evaluable population.|Participants|Count of Participants|2|2.0||||||
4207546|NCT00733291|4030792|B2||>=65 years|Age|This reporting group is based on the number of subjects in the evaluable population.|Participants|Count of Participants|0|0.0||||||
4207547|NCT00733291|4030793|B1||>=65 years|Age|This reporting group is based on the number of subjects in the evaluable population.|Participants|Count of Participants|2|2.0||||||
4207548|NCT00733291|4030791|B3||Between 18 and 65 years|Age|This reporting group is based on the number of subjects in the evaluable population.|Participants|Count of Participants|61|61.0||||||
4207549|NCT00733291|4030792|B2||Between 18 and 65 years|Age|This reporting group is based on the number of subjects in the evaluable population.|Participants|Count of Participants|34|34.0||||||
4207550|NCT00733291|4030793|B1||Between 18 and 65 years|Age|This reporting group is based on the number of subjects in the evaluable population.|Participants|Count of Participants|27|27.0||||||
4207551|NCT00733291|4030791|B3||<=18 years|Age|This reporting group is based on the number of subjects in the evaluable population.|Participants|Count of Participants|0|0.0||||||
4207552|NCT00733291|4030792|B2||<=18 years|Age|This reporting group is based on the number of subjects in the evaluable population.|Participants|Count of Participants|0|0.0||||||
4207553|NCT00733291|4030793|B1||<=18 years|Age|This reporting group is based on the number of subjects in the evaluable population.|Participants|Count of Participants|0|0.0||||||
4207554|NCT00733278|4030818|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4207555|NCT00733278|4030818|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4207556|NCT00733278|4030818|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4207557|NCT00733278|4030818|B1|||Age||years|Mean|NA||Standard Deviation|NA||||Data not relevant to analysis, and, therefore, not collected.
4207558|NCT00733278|4030818|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4207559|NCT00733278|4030818|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4207560|NCT00733278|4030818|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4207561|NCT00733226|4030823|B3|Turkey||Region of Enrollment||participants|Number|80|80.0||||||
4207562|NCT00733226|4030824|B2|Turkey||Region of Enrollment||participants|Number|40|40.0||||||
4207563|NCT00733226|4030825|B1|Turkey||Region of Enrollment||participants|Number|40|40.0||||||
4207564|NCT00733226|4030823|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4207565|NCT00733226|4030824|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4207566|NCT00733226|4030825|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4207567|NCT00733226|4030823|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4207568|NCT00733226|4030824|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4207569|NCT00733226|4030825|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4207570|NCT00733226|4030823|B3|||Age||years|Mean|2.59|2.59|Standard Deviation|0.59|0.59|||
4207571|NCT00733226|4030824|B2|||Age||years|Mean|2.65|2.65|Standard Deviation|1.69|1.69|||
4207572|NCT00733226|4030825|B1|||Age||years|Mean|2.51|2.51|Standard Deviation|1.48|1.48|||
4207573|NCT00733226|4030823|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4207574|NCT00733226|4030824|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4207575|NCT00733226|4030825|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4207576|NCT00733226|4030823|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4207577|NCT00733226|4030824|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4207578|NCT00733226|4030825|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4207579|NCT00733226|4030823|B3||<=18 years|Age||Participants|Count of Participants|80|80.0||||||
4207580|NCT00733226|4030824|B2||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
4207581|NCT00733226|4030825|B1||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
4207582|NCT00733135|4030842|B1|United States||Region of Enrollment||participants|Number|133|133.0||||||
4207583|NCT00733135|4030842|B1||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4207584|NCT00733135|4030842|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4207585|NCT00733135|4030842|B1|||Age||years|Mean|69.7|69.7|Standard Deviation|9.8|9.8|||
4207586|NCT00733135|4030842|B1||>=65 years|Age||Participants|Count of Participants|95|95.0||||||
4207587|NCT00733135|4030842|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4207588|NCT00733135|4030842|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4207589|NCT00733096|4030851|B4|United States||Region of Enrollment||participants|Number|84|84.0||||||
4207590|NCT00733096|4030852|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4207591|NCT00733096|4030853|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4207592|NCT00733096|4030854|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4207593|NCT00733096|4030851|B4||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4207594|NCT00733096|4030852|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4207595|NCT00733096|4030853|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4207596|NCT00733096|4030854|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4207597|NCT00733096|4030851|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4207598|NCT00733096|4030852|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4207599|NCT00733096|4030853|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4207600|NCT00733096|4030854|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4207601|NCT00733096|4030851|B4|||Age||years|Mean|42.29|42.29|Standard Deviation|10.80|10.8|||
4207602|NCT00733096|4030852|B3|||Age||years|Mean|42.3|42.3|Standard Deviation|10.7|10.7|||
4207603|NCT00733096|4030853|B2|||Age||years|Mean|43.2|43.2|Standard Deviation|8.9|8.9|||
4207604|NCT00733096|4030854|B1|||Age||years|Mean|41.4|41.4|Standard Deviation|12.7|12.7|||
4207605|NCT00733005|4030873|B3||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4207606|NCT00733005|4030874|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4207607|NCT00733005|4030875|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4207608|NCT00733005|4030873|B3||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4207609|NCT00733005|4030874|B2||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4207610|NCT00733005|4030875|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4207611|NCT00733005|4030873|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4207612|NCT00733005|4030874|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4207613|NCT00733005|4030875|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4207614|NCT00733005|4030873|B3||Between 18 and 65 years|Age||Participants|Count of Participants|302|302.0||||||
4207615|NCT00733005|4030874|B2||Between 18 and 65 years|Age||Participants|Count of Participants|154|154.0||||||
4207616|NCT00733005|4030875|B1||Between 18 and 65 years|Age||Participants|Count of Participants|148|148.0||||||
4207617|NCT00733005|4030873|B3||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4207618|NCT00733005|4030874|B2||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4207619|NCT00733005|4030875|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4207620|NCT00732992|4030884|B3|Score 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Score 0: Fully active, able to carry on all pre-disease performance without restriction; Score 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, such as light house work and office work.|Participants|Number|6|6.0||||||
4207621|NCT00732992|4030885|B2|Score 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Score 0: Fully active, able to carry on all pre-disease performance without restriction; Score 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, such as light house work and office work.|Participants|Number|2|2.0||||||
4207622|NCT00732992|4030886|B1|Score 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Score 0: Fully active, able to carry on all pre-disease performance without restriction; Score 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, such as light house work and office work.|Participants|Number|4|4.0||||||
4207623|NCT00732992|4030884|B3|Score 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Score 0: Fully active, able to carry on all pre-disease performance without restriction; Score 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, such as light house work and office work.|Participants|Number|6|6.0||||||
4207624|NCT00732992|4030885|B2|Score 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Score 0: Fully active, able to carry on all pre-disease performance without restriction; Score 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, such as light house work and office work.|Participants|Number|4|4.0||||||
4207685|NCT00732875|4030988|B1|||Age||years|Mean|50.1|50.1|Standard Deviation|11.1|11.1|||
4207625|NCT00732992|4030886|B1|Score 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Score 0: Fully active, able to carry on all pre-disease performance without restriction; Score 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, such as light house work and office work.|Participants|Number|2|2.0||||||
4207626|NCT00732992|4030884|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4207627|NCT00732992|4030885|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4207628|NCT00732992|4030886|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4207629|NCT00732992|4030884|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4207630|NCT00732992|4030885|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4207631|NCT00732992|4030886|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4207632|NCT00732992|4030884|B3|>=65 years||Age, Customized||Participants|Number|6|6.0||||||
4207633|NCT00732992|4030885|B2|>=65 years||Age, Customized||Participants|Number|4|4.0||||||
4207634|NCT00732992|4030886|B1|>=65 years||Age, Customized||Participants|Number|2|2.0||||||
4207635|NCT00732992|4030884|B3|45- 64 years||Age, Customized||Participants|Number|6|6.0||||||
4207636|NCT00732992|4030885|B2|45- 64 years||Age, Customized||Participants|Number|2|2.0||||||
4207637|NCT00732992|4030886|B1|45- 64 years||Age, Customized||Participants|Number|4|4.0||||||
4207638|NCT00732992|4030884|B3|20-44 years||Age, Customized||Participants|Number|0|0.0||||||
4207639|NCT00732992|4030885|B2|20-44 years||Age, Customized||Participants|Number|0|0.0||||||
4207640|NCT00732992|4030886|B1|20-44 years||Age, Customized||Participants|Number|0|0.0||||||
4207641|NCT00732940|4030904|B3|Mexico||Region of Enrollment||participants|Number|7|7.0||||||
4207642|NCT00732940|4030905|B2|Mexico||Region of Enrollment||participants|Number|3|3.0||||||
4207643|NCT00732940|4030906|B1|Mexico||Region of Enrollment||participants|Number|4|4.0||||||
4207644|NCT00732940|4030904|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
4207645|NCT00732940|4030905|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4207646|NCT00732940|4030906|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4207647|NCT00732940|4030904|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4207648|NCT00732940|4030905|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4207649|NCT00732940|4030906|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4207650|NCT00732940|4030904|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4207651|NCT00732940|4030905|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4207652|NCT00732940|4030906|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4207653|NCT00732940|4030904|B3|||Age||years|Mean|40.1|40.1|Standard Deviation|12.2|12.2|||
4207654|NCT00732940|4030905|B2|||Age||years|Mean|40.9|40.9|Standard Deviation|13.1|13.1|||
4207655|NCT00732940|4030906|B1|||Age||years|Mean|39.2|39.2|Standard Deviation|11.5|11.5|||
4207656|NCT00732901|4030975|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4207657|NCT00732901|4030976|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4207658|NCT00732901|4030977|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4207659|NCT00732901|4030975|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4207660|NCT00732901|4030976|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4207661|NCT00732901|4030977|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4207662|NCT00732901|4030975|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4207663|NCT00732901|4030976|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4207664|NCT00732901|4030977|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4207665|NCT00732901|4030975|B3|||Age||years|Mean|40.01|40.01|Standard Deviation|7.3|7.3|||
4207666|NCT00732901|4030976|B2|||Age||years|Mean|41.75|41.75|Standard Deviation|6.65|6.65|||
4207667|NCT00732901|4030977|B1|||Age||years|Mean|38.4|38.4|Standard Deviation|7.88|7.88|||
4207668|NCT00732901|4030975|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4207669|NCT00732901|4030976|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4207670|NCT00732901|4030977|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4207671|NCT00732901|4030975|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4207672|NCT00732901|4030976|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4207673|NCT00732901|4030977|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4207674|NCT00732901|4030975|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4207675|NCT00732901|4030976|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4207676|NCT00732901|4030977|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4207677|NCT00732875|4030988|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4207678|NCT00732875|4030988|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4207679|NCT00732875|4030988|B1|>=70 years||Age, Customized||participants|Number|3|3.0||||||
4207680|NCT00732875|4030988|B1|Between 60 and less than 70 years||Age, Customized||participants|Number|15|15.0||||||
4207681|NCT00732875|4030988|B1|Between 50 and less than 60 years||Age, Customized||participants|Number|29|29.0||||||
4207682|NCT00732875|4030988|B1|Between 40 and less than 50 years||Age, Customized||participants|Number|29|29.0||||||
4207683|NCT00732875|4030988|B1|Between 30 and less than 40 years||Age, Customized||participants|Number|14|14.0||||||
4207684|NCT00732875|4030988|B1|<30 years||Age, Customized||participants|Number|2|2.0||||||
4207686|NCT00732758|4030994|B3|25(OH)D>20 ng/mL||Vitamin D-deficient: Defined as serum 25(OH)D <20 ng/mL||participants|Number|70|70.0||||||
4207687|NCT00732758|4030995|B2|25(OH)D>20 ng/mL||Vitamin D-deficient: Defined as serum 25(OH)D <20 ng/mL||participants|Number|34|34.0||||||
4207688|NCT00732758|4030996|B1|25(OH)D>20 ng/mL||Vitamin D-deficient: Defined as serum 25(OH)D <20 ng/mL||participants|Number|36|36.0||||||
4207689|NCT00732758|4030994|B3|25(OH)D<20 ng/mL||Vitamin D-deficient: Defined as serum 25(OH)D <20 ng/mL||participants|Number|87|87.0||||||
4207690|NCT00732758|4030995|B2|25(OH)D<20 ng/mL||Vitamin D-deficient: Defined as serum 25(OH)D <20 ng/mL||participants|Number|45|45.0||||||
4207691|NCT00732758|4030996|B1|25(OH)D<20 ng/mL||Vitamin D-deficient: Defined as serum 25(OH)D <20 ng/mL||participants|Number|42|42.0||||||
4207692|NCT00732758|4030994|B3|Unknown||Skin Type||participants|Number|3|3.0||||||
4207693|NCT00732758|4030995|B2|Unknown||Skin Type||participants|Number|1|1.0||||||
4207694|NCT00732758|4030996|B1|Unknown||Skin Type||participants|Number|2|2.0||||||
4207695|NCT00732758|4030994|B3|V (never burn, marked tan)||Skin Type||participants|Number|23|23.0||||||
4207696|NCT00732758|4030995|B2|V (never burn, marked tan)||Skin Type||participants|Number|16|16.0||||||
4207697|NCT00732758|4030996|B1|V (never burn, marked tan)||Skin Type||participants|Number|7|7.0||||||
4207698|NCT00732758|4030994|B3|IV (no burn, good tan)||Skin Type||participants|Number|63|63.0||||||
4207699|NCT00732758|4030995|B2|IV (no burn, good tan)||Skin Type||participants|Number|27|27.0||||||
4207700|NCT00732758|4030996|B1|IV (no burn, good tan)||Skin Type||participants|Number|36|36.0||||||
4207701|NCT00732758|4030994|B3|III (burn, then tan)||Skin Type||participants|Number|31|31.0||||||
4207702|NCT00732758|4030995|B2|III (burn, then tan)||Skin Type||participants|Number|16|16.0||||||
4207703|NCT00732758|4030996|B1|III (burn, then tan)||Skin Type||participants|Number|15|15.0||||||
4207704|NCT00732758|4030994|B3|II (easy burn, slight tan)||Skin Type||participants|Number|27|27.0||||||
4207705|NCT00732758|4030995|B2|II (easy burn, slight tan)||Skin Type||participants|Number|13|13.0||||||
4207706|NCT00732758|4030996|B1|II (easy burn, slight tan)||Skin Type||participants|Number|14|14.0||||||
4207707|NCT00732758|4030994|B3|I (easy burn, no tan)||Skin Type||participants|Number|10|10.0||||||
4207708|NCT00732758|4030995|B2|I (easy burn, no tan)||Skin Type||participants|Number|6|6.0||||||
4207709|NCT00732758|4030996|B1|I (easy burn, no tan)||Skin Type||participants|Number|4|4.0||||||
4207710|NCT00732758|4030994|B3|||Body Mass Index||kilograms/meters^2|Mean|21.6|21.6|Standard Deviation|5.85|5.85|||
4207711|NCT00732758|4030995|B2|||Body Mass Index||kilograms/meters^2|Mean|21.6|21.6|Standard Deviation|6.2|6.2|||
4207712|NCT00732758|4030996|B1|||Body Mass Index||kilograms/meters^2|Mean|21.6|21.6|Standard Deviation|5.5|5.5|||
4207713|NCT00732758|4030994|B3|United States||Region of Enrollment||participants|Number|157|157.0||||||
4207714|NCT00732758|4030995|B2|United States||Region of Enrollment||participants|Number|79|79.0||||||
4207715|NCT00732758|4030996|B1|United States||Region of Enrollment||participants|Number|78|78.0||||||
4207716|NCT00732758|4030994|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207717|NCT00732758|4030995|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207718|NCT00732758|4030996|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207719|NCT00732758|4030994|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207720|NCT00732758|4030995|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207721|NCT00732758|4030996|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207722|NCT00732758|4030994|B3||White|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
4207723|NCT00732758|4030995|B2||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4207724|NCT00732758|4030996|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4207725|NCT00732758|4030994|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
4207726|NCT00732758|4030995|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4207727|NCT00732758|4030996|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4207728|NCT00732758|4030994|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207729|NCT00732758|4030995|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207730|NCT00732758|4030996|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207731|NCT00732758|4030994|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207732|NCT00732758|4030995|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207733|NCT00732758|4030996|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207734|NCT00732758|4030994|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207735|NCT00732758|4030995|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207736|NCT00732758|4030996|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207737|NCT00732758|4030994|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4207738|NCT00732758|4030995|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4207739|NCT00732758|4030996|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4207740|NCT00732758|4030994|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
4207741|NCT00732758|4030995|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4207742|NCT00732758|4030996|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4207856|NCT00732615|4031057|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4207743|NCT00732758|4030994|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4207744|NCT00732758|4030995|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4207745|NCT00732758|4030996|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4207746|NCT00732758|4030994|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4207747|NCT00732758|4030995|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4207748|NCT00732758|4030996|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4207749|NCT00732758|4030994|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4207750|NCT00732758|4030995|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4207751|NCT00732758|4030996|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4207752|NCT00732758|4030994|B3|||Age||years|Mean|11.3|11.3|Standard Deviation|1.95|1.95|||
4207753|NCT00732758|4030995|B2|||Age||years|Mean|11.4|11.4|Standard Deviation|2.0|2.0|||
4207754|NCT00732758|4030996|B1|||Age||years|Mean|11.2|11.2|Standard Deviation|1.9|1.9|||
4207755|NCT00732680|4031009|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4207756|NCT00732680|4031009|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4207757|NCT00732680|4031009|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4207758|NCT00732680|4031009|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4207759|NCT00732680|4031009|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4207760|NCT00732680|4031009|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4207761|NCT00732654|4031013|B4|||Atopic Dermatitis||Participants|Count of Participants|22|22.0||||||
4207762|NCT00732654|4031014|B3|||Atopic Dermatitis||Participants|Count of Participants|10|10.0||||||
4207763|NCT00732654|4031015|B2|||Atopic Dermatitis||Participants|Count of Participants|6|6.0||||||
4207764|NCT00732654|4031016|B1|||Atopic Dermatitis||Participants|Count of Participants|6|6.0||||||
4207765|NCT00732654|4031013|B4|||Asthma||Participants|Count of Participants|26|26.0||||||
4207766|NCT00732654|4031014|B3|||Asthma||Participants|Count of Participants|8|8.0||||||
4207767|NCT00732654|4031015|B2|||Asthma||Participants|Count of Participants|9|9.0||||||
4207768|NCT00732654|4031016|B1|||Asthma||Participants|Count of Participants|9|9.0||||||
4207769|NCT00732654|4031013|B4|||Other Food Allergies||Participants|Count of Participants|23|23.0||||||
4207770|NCT00732654|4031014|B3|||Other Food Allergies||Participants|Count of Participants|9|9.0||||||
4207771|NCT00732654|4031015|B2|||Other Food Allergies||Participants|Count of Participants|8|8.0||||||
4207772|NCT00732654|4031016|B1|||Other Food Allergies||Participants|Count of Participants|6|6.0||||||
4207773|NCT00732654|4031013|B4|||History of anaphylaxis to Cow's Milk (CM)||Participants|Count of Participants|23|23.0||||||
4207774|NCT00732654|4031014|B3|||History of anaphylaxis to Cow's Milk (CM)||Participants|Count of Participants|8|8.0||||||
4207775|NCT00732654|4031015|B2|||History of anaphylaxis to Cow's Milk (CM)||Participants|Count of Participants|9|9.0||||||
4207776|NCT00732654|4031016|B1|||History of anaphylaxis to Cow's Milk (CM)||Participants|Count of Participants|6|6.0||||||
4207777|NCT00732654|4031013|B4|United States||Region of Enrollment||participants|Number|30|30.0||||||
4207778|NCT00732654|4031014|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4207779|NCT00732654|4031015|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4207780|NCT00732654|4031016|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4207781|NCT00732654|4031013|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4207782|NCT00732654|4031014|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4207783|NCT00732654|4031015|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4207784|NCT00732654|4031016|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4207785|NCT00732654|4031013|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4207786|NCT00732654|4031014|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4207787|NCT00732654|4031015|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4207788|NCT00732654|4031016|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4207789|NCT00732654|4031013|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4207790|NCT00732654|4031014|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4207791|NCT00732654|4031015|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4207792|NCT00732654|4031016|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4207793|NCT00732654|4031013|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4207794|NCT00732654|4031014|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4207795|NCT00732654|4031015|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4207796|NCT00732654|4031016|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4207797|NCT00732654|4031013|B4||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4207798|NCT00732654|4031014|B3||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4207799|NCT00732654|4031015|B2||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4207800|NCT00732654|4031016|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4207801|NCT00732641|4031035|B3|Italy||Region of Enrollment||participants|Number|244|244.0||||||
4207802|NCT00732641|4031036|B2|Italy||Region of Enrollment||participants|Number|121|121.0||||||
4207803|NCT00732641|4031037|B1|Italy||Region of Enrollment||participants|Number|123|123.0||||||
4207857|NCT00732615|4031058|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4207804|NCT00732641|4031035|B3||Male|Sex: Female, Male|Gender was for the intent-to-treat population (those who received at least one dose of study drug)|Participants|Count of Participants|130|130.0||||||
4207805|NCT00732641|4031036|B2||Male|Sex: Female, Male|Gender was for the intent-to-treat population (those who received at least one dose of study drug)|Participants|Count of Participants|61|61.0||||||
4207806|NCT00732641|4031037|B1||Male|Sex: Female, Male|Gender was for the intent-to-treat population (those who received at least one dose of study drug)|Participants|Count of Participants|69|69.0||||||
4207807|NCT00732641|4031035|B3||Female|Sex: Female, Male|Gender was for the intent-to-treat population (those who received at least one dose of study drug)|Participants|Count of Participants|113|113.0||||||
4207808|NCT00732641|4031036|B2||Female|Sex: Female, Male|Gender was for the intent-to-treat population (those who received at least one dose of study drug)|Participants|Count of Participants|60|60.0||||||
4207809|NCT00732641|4031037|B1||Female|Sex: Female, Male|Gender was for the intent-to-treat population (those who received at least one dose of study drug)|Participants|Count of Participants|53|53.0||||||
4207810|NCT00732641|4031035|B3|||Age|Age was for the intent-to-treat population (those who received at least one dose of study drug)|years|Mean|61.7|61.7|Standard Deviation|8.6|8.6|||
4207811|NCT00732641|4031036|B2|||Age|Age was for the intent-to-treat population (those who received at least one dose of study drug)|years|Mean|62.3|62.3|Standard Deviation|8.6|8.6|||
4207812|NCT00732641|4031037|B1|||Age|Age was for the intent-to-treat population (those who received at least one dose of study drug)|years|Mean|61.0|61.0|Standard Deviation|8.5|8.5|||
4207813|NCT00732615|4031056|B3|Hungary||Region of Enrollment||participants|Number|23|23.0||||||
4207814|NCT00732615|4031057|B2|Hungary||Region of Enrollment||participants|Number|16|16.0||||||
4207815|NCT00732615|4031058|B1|Hungary||Region of Enrollment||participants|Number|7|7.0||||||
4207816|NCT00732615|4031056|B3|Europe||Region of Enrollment||participants|Number|37|37.0||||||
4207817|NCT00732615|4031057|B2|Europe||Region of Enrollment||participants|Number|25|25.0||||||
4207818|NCT00732615|4031058|B1|Europe||Region of Enrollment||participants|Number|12|12.0||||||
4207819|NCT00732615|4031056|B3|North America||Region of Enrollment||participants|Number|64|64.0||||||
4207820|NCT00732615|4031057|B2|North America||Region of Enrollment||participants|Number|43|43.0||||||
4207821|NCT00732615|4031058|B1|North America||Region of Enrollment||participants|Number|21|21.0||||||
4207822|NCT00732615|4031056|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4207823|NCT00732615|4031057|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4207824|NCT00732615|4031058|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207825|NCT00732615|4031056|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207826|NCT00732615|4031057|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207827|NCT00732615|4031058|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207828|NCT00732615|4031056|B3||White|Race (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
4207829|NCT00732615|4031057|B2||White|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
4207830|NCT00732615|4031058|B1||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4207831|NCT00732615|4031056|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4207832|NCT00732615|4031057|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4207833|NCT00732615|4031058|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207834|NCT00732615|4031056|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4207835|NCT00732615|4031057|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4207836|NCT00732615|4031058|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207837|NCT00732615|4031056|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4207838|NCT00732615|4031057|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4207839|NCT00732615|4031058|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4207840|NCT00732615|4031056|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207841|NCT00732615|4031057|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207842|NCT00732615|4031058|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207843|NCT00732615|4031056|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207844|NCT00732615|4031057|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207845|NCT00732615|4031058|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207846|NCT00732615|4031056|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
4207847|NCT00732615|4031057|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
4207848|NCT00732615|4031058|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4207849|NCT00732615|4031056|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4207850|NCT00732615|4031057|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4207851|NCT00732615|4031058|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207852|NCT00732615|4031056|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4207853|NCT00732615|4031057|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4207854|NCT00732615|4031058|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4207855|NCT00732615|4031056|B3||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4207858|NCT00732615|4031056|B3|> = 65 years||Age, Customized||participants|Number|8|8.0||||||
4207859|NCT00732615|4031057|B2|> = 65 years||Age, Customized||participants|Number|4|4.0||||||
4207860|NCT00732615|4031058|B1|> = 65 years||Age, Customized||participants|Number|4|4.0||||||
4207861|NCT00732615|4031056|B3|45 to 64 years||Age, Customized||participants|Number|68|68.0||||||
4207862|NCT00732615|4031057|B2|45 to 64 years||Age, Customized||participants|Number|45|45.0||||||
4207863|NCT00732615|4031058|B1|45 to 64 years||Age, Customized||participants|Number|23|23.0||||||
4207864|NCT00732615|4031056|B3|< 45 years||Age, Customized||participants|Number|48|48.0||||||
4207865|NCT00732615|4031057|B2|< 45 years||Age, Customized||participants|Number|35|35.0||||||
4207866|NCT00732615|4031058|B1|< 45 years||Age, Customized||participants|Number|13|13.0||||||
4207867|NCT00732472|4031071|B5|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4207868|NCT00732472|4031072|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4207869|NCT00732472|4031073|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4207870|NCT00732472|4031074|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4207871|NCT00732472|4031075|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4207872|NCT00732472|4031071|B5||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4207873|NCT00732472|4031072|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4207874|NCT00732472|4031073|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4207875|NCT00732472|4031074|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4207876|NCT00732472|4031075|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4207877|NCT00732472|4031071|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4207878|NCT00732472|4031072|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4207879|NCT00732472|4031073|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4207880|NCT00732472|4031074|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4207881|NCT00732472|4031075|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4207882|NCT00732472|4031071|B5|||Age||Years|Mean|64.6|64.6|Standard Deviation|6.72|6.72|||
4207883|NCT00732472|4031072|B4|||Age||Years|Mean|64.2|64.2|Standard Deviation|7.97|7.97|||
4207884|NCT00732472|4031073|B3|||Age||Years|Mean|64.7|64.7|Standard Deviation|6.31|6.31|||
4207885|NCT00732472|4031074|B2|||Age||Years|Mean|63.3|63.3|Standard Deviation|8.21|8.21|||
4207886|NCT00732472|4031075|B1|||Age||Years|Mean|66.2|66.2|Standard Deviation|4.47|4.47|||
4207887|NCT00732381|4031176|B3||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4207888|NCT00732381|4031177|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4207889|NCT00732381|4031178|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4207890|NCT00732381|4031176|B3||Female|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4207891|NCT00732381|4031177|B2||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4207892|NCT00732381|4031178|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4207893|NCT00732381|4031176|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4207894|NCT00732381|4031177|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4207895|NCT00732381|4031178|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4207896|NCT00732381|4031176|B3||Between 18 and 65 years|Age||Participants|Count of Participants|318|318.0||||||
4207897|NCT00732381|4031177|B2||Between 18 and 65 years|Age||Participants|Count of Participants|156|156.0||||||
4207898|NCT00732381|4031178|B1||Between 18 and 65 years|Age||Participants|Count of Participants|162|162.0||||||
4207899|NCT00732381|4031176|B3||<=18 years|Age||Participants|Count of Participants|25|25.0||||||
4207900|NCT00732381|4031177|B2||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4207901|NCT00732381|4031178|B1||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4207902|NCT00732303|4031187|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4207903|NCT00732303|4031187|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4207904|NCT00732303|4031187|B1|||Age||years|Median|68.50|68.5|Full Range|||56.0|75.0|
4207905|NCT00732251|4031193|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4207906|NCT00732251|4031193|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4207907|NCT00732251|4031193|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207908|NCT00732251|4031193|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4207909|NCT00732251|4031193|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4207910|NCT00732251|4031193|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207911|NCT00732251|4031193|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4207912|NCT00732251|4031193|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207913|NCT00732251|4031193|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4207914|NCT00732251|4031193|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207915|NCT00732251|4031193|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4207916|NCT00732251|4031193|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4207917|NCT00732251|4031193|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4207918|NCT00732251|4031193|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4207919|NCT00732251|4031193|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4207920|NCT00732251|4031193|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4207921|NCT00732238|4031197|B3|United States||Region of Enrollment||participants|Number|55|55.0||||||
4207922|NCT00732238|4031198|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4207923|NCT00732238|4031199|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4207924|NCT00732238|4031197|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4207925|NCT00732238|4031198|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4207926|NCT00732238|4031199|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4207927|NCT00732238|4031197|B3|Black||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4207928|NCT00732238|4031198|B2|Black||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4207929|NCT00732238|4031199|B1|Black||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4207930|NCT00732238|4031197|B3|Non-Hispanic White||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4207931|NCT00732238|4031198|B2|Non-Hispanic White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4207932|NCT00732238|4031199|B1|Non-Hispanic White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4207933|NCT00732238|4031197|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4207934|NCT00732238|4031198|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4207935|NCT00732238|4031199|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4207936|NCT00732238|4031197|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4207937|NCT00732238|4031198|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4207938|NCT00732238|4031199|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4207939|NCT00732238|4031197|B3|||Age||years|Mean|59.9|59.9|Standard Deviation|14|14.0|||
4207940|NCT00732238|4031198|B2|||Age||years|Mean|58.3|58.3|Standard Deviation|14.8|14.8|||
4207941|NCT00732238|4031199|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|13|13.0|||
4207942|NCT00732225|4031208|B6|Male||Gender|Gender not available for the following: 2 Discovisc patients, 2 Duovisc patients, 1 Biovisc patient, 2 Amvisc Plus patients.|participants|Number|92|92.0||||||
4207943|NCT00732225|4031209|B5|Male||Gender|Gender not available for the following: 2 Discovisc patients, 2 Duovisc patients, 1 Biovisc patient, 2 Amvisc Plus patients.|participants|Number|23|23.0||||||
4207944|NCT00732225|4031210|B4|Male||Gender|Gender not available for the following: 2 Discovisc patients, 2 Duovisc patients, 1 Biovisc patient, 2 Amvisc Plus patients.|participants|Number|14|14.0||||||
4207945|NCT00732225|4031211|B3|Male||Gender|Gender not available for the following: 2 Discovisc patients, 2 Duovisc patients, 1 Biovisc patient, 2 Amvisc Plus patients.|participants|Number|12|12.0||||||
4207946|NCT00732225|4031212|B2|Male||Gender|Gender not available for the following: 2 Discovisc patients, 2 Duovisc patients, 1 Biovisc patient, 2 Amvisc Plus patients.|participants|Number|16|16.0||||||
4207947|NCT00732225|4031213|B1|Male||Gender|Gender not available for the following: 2 Discovisc patients, 2 Duovisc patients, 1 Biovisc patient, 2 Amvisc Plus patients.|participants|Number|27|27.0||||||
4207948|NCT00732225|4031208|B6|Female||Gender|Gender not available for the following: 2 Discovisc patients, 2 Duovisc patients, 1 Biovisc patient, 2 Amvisc Plus patients.|participants|Number|125|125.0||||||
4207949|NCT00732225|4031209|B5|Female||Gender|Gender not available for the following: 2 Discovisc patients, 2 Duovisc patients, 1 Biovisc patient, 2 Amvisc Plus patients.|participants|Number|29|29.0||||||
4207950|NCT00732225|4031210|B4|Female||Gender|Gender not available for the following: 2 Discovisc patients, 2 Duovisc patients, 1 Biovisc patient, 2 Amvisc Plus patients.|participants|Number|19|19.0||||||
4207951|NCT00732225|4031211|B3|Female||Gender|Gender not available for the following: 2 Discovisc patients, 2 Duovisc patients, 1 Biovisc patient, 2 Amvisc Plus patients.|participants|Number|13|13.0||||||
4207952|NCT00732225|4031212|B2|Female||Gender|Gender not available for the following: 2 Discovisc patients, 2 Duovisc patients, 1 Biovisc patient, 2 Amvisc Plus patients.|participants|Number|22|22.0||||||
4207953|NCT00732225|4031213|B1|Female||Gender|Gender not available for the following: 2 Discovisc patients, 2 Duovisc patients, 1 Biovisc patient, 2 Amvisc Plus patients.|participants|Number|42|42.0||||||
4207954|NCT00732225|4031208|B6|||Age|Age not available for the following: 7 Discovisc patients, 11 Duovisc patients, 3 Biovisc patients, 4 Amvisc Plus patients. Total mean age and standard deviation not calculated.|years|Mean|67.9|67.9|Standard Deviation|10.8|10.8|||
4207955|NCT00732225|4031209|B5|||Age|Age not available for the following: 7 Discovisc patients, 11 Duovisc patients, 3 Biovisc patients, 4 Amvisc Plus patients. Total mean age and standard deviation not calculated.|years|Mean|66.24|66.24|Standard Deviation|10.51|10.51|||
4207956|NCT00732225|4031210|B4|||Age|Age not available for the following: 7 Discovisc patients, 11 Duovisc patients, 3 Biovisc patients, 4 Amvisc Plus patients. Total mean age and standard deviation not calculated.|years|Mean|67.03|67.03|Standard Deviation|12.13|12.13|||
4207957|NCT00732225|4031211|B3|||Age|Age not available for the following: 7 Discovisc patients, 11 Duovisc patients, 3 Biovisc patients, 4 Amvisc Plus patients. Total mean age and standard deviation not calculated.|years|Mean|71.48|71.48|Standard Deviation|8.56|8.56|||
4207958|NCT00732225|4031212|B2|||Age|Age not available for the following: 7 Discovisc patients, 11 Duovisc patients, 3 Biovisc patients, 4 Amvisc Plus patients. Total mean age and standard deviation not calculated.|years|Mean|67.31|67.31|Standard Deviation|12.61|12.61|||
4207959|NCT00732225|4031213|B1|||Age|Age not available for the following: 7 Discovisc patients, 11 Duovisc patients, 3 Biovisc patients, 4 Amvisc Plus patients. Total mean age and standard deviation not calculated.|years|Mean|66.8|66.8|Standard Deviation|9.54|9.54|||
4207960|NCT00732212|4031264|B5|United States||Region of Enrollment||participants|Number|235|235.0||||||
4207961|NCT00732212|4031265|B4|United States||Region of Enrollment||participants|Number|40|40.0||||||
4207962|NCT00732212|4031266|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
4207963|NCT00732212|4031267|B2|United States||Region of Enrollment||participants|Number|72|72.0||||||
4207964|NCT00732212|4031268|B1|United States||Region of Enrollment||participants|Number|76|76.0||||||
4207965|NCT00732212|4031264|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207966|NCT00732212|4031265|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207967|NCT00732212|4031266|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207968|NCT00732212|4031267|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207969|NCT00732212|4031268|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207970|NCT00732212|4031264|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207971|NCT00732212|4031265|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207972|NCT00732212|4031266|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207973|NCT00732212|4031267|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207974|NCT00732212|4031268|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207975|NCT00732212|4031264|B5||White|Race (NIH/OMB)||Participants|Count of Participants|175|175.0||||||
4207976|NCT00732212|4031265|B4||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4207977|NCT00732212|4031266|B3||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4207978|NCT00732212|4031267|B2||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4207979|NCT00732212|4031268|B1||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4207980|NCT00732212|4031264|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4207981|NCT00732212|4031265|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4207982|NCT00732212|4031266|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4207983|NCT00732212|4031267|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4207984|NCT00732212|4031268|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4207985|NCT00732212|4031264|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207986|NCT00732212|4031265|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207987|NCT00732212|4031266|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207988|NCT00732212|4031267|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207989|NCT00732212|4031268|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207990|NCT00732212|4031264|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4207991|NCT00732212|4031265|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4207992|NCT00732212|4031266|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4207993|NCT00732212|4031267|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4207994|NCT00732212|4031268|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4207995|NCT00732212|4031264|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207996|NCT00732212|4031265|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207997|NCT00732212|4031266|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207998|NCT00732212|4031267|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4207999|NCT00732212|4031268|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208000|NCT00732212|4031264|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208001|NCT00732212|4031265|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208002|NCT00732212|4031266|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208003|NCT00732212|4031267|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208004|NCT00732212|4031268|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208005|NCT00732212|4031264|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|194|194.0||||||
4208006|NCT00732212|4031265|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4208007|NCT00732212|4031266|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4208008|NCT00732212|4031267|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4208009|NCT00732212|4031268|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4208010|NCT00732212|4031264|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4208011|NCT00732212|4031265|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4208012|NCT00732212|4031266|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4208013|NCT00732212|4031267|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4208014|NCT00732212|4031268|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4208015|NCT00732212|4031264|B5||Male|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4208016|NCT00732212|4031265|B4||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4208017|NCT00732212|4031266|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4208018|NCT00732212|4031267|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4208019|NCT00732212|4031268|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4208020|NCT00732212|4031264|B5||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4208021|NCT00732212|4031265|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4208022|NCT00732212|4031266|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4208023|NCT00732212|4031267|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4208024|NCT00732212|4031268|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4208025|NCT00732212|4031264|B5|||Age||Years|Mean|60.7|60.7|Standard Deviation|5.6|5.6|||
4208026|NCT00732212|4031265|B4|||Age||Years|Mean|54.7|54.7|Standard Deviation|11.7|11.7|||
4208027|NCT00732212|4031266|B3|||Age||Years|Mean|57.1|57.1|Standard Deviation|9.8|9.8|||
4208028|NCT00732212|4031267|B2|||Age||Years|Mean|65|65.0|Standard Deviation|15.6|15.6|||
4208029|NCT00732212|4031268|B1|||Age||Years|Mean|66|66.0|Standard Deviation|16.1|16.1|||
4208030|NCT00732199|4031299|B3|||Body mass index||kg/m2|Mean|26.8|26.8|Standard Deviation|3.6|3.6|||
4208031|NCT00732199|4031300|B2|||Body mass index||kg/m2|Mean|27.3|27.3|Standard Deviation|3.2|3.2|||
4208032|NCT00732199|4031301|B1|||Body mass index||kg/m2|Mean|26.4|26.4|Standard Deviation|2.4|2.4|||
4208033|NCT00732199|4031299|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
4208034|NCT00732199|4031300|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4208035|NCT00732199|4031301|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4208036|NCT00732199|4031299|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4208037|NCT00732199|4031300|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4208038|NCT00732199|4031301|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4208039|NCT00732199|4031299|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4208040|NCT00732199|4031300|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4208041|NCT00732199|4031301|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4208042|NCT00732199|4031299|B3|Brief Hyperoxia Response Analysis Population|Male|Sex/Gender, Customized||Participants|Count of Participants|10|10.0||||||
4208043|NCT00732199|4031300|B2|Brief Hyperoxia Response Analysis Population|Male|Sex/Gender, Customized||Participants|Count of Participants|4|4.0||||||
4208044|NCT00732199|4031301|B1|Brief Hyperoxia Response Analysis Population|Male|Sex/Gender, Customized||Participants|Count of Participants|6|6.0||||||
4208045|NCT00732199|4031299|B3|Brief Hyperoxia Response Analysis Population|Female|Sex/Gender, Customized||Participants|Count of Participants|9|9.0||||||
4208046|NCT00732199|4031300|B2|Brief Hyperoxia Response Analysis Population|Female|Sex/Gender, Customized||Participants|Count of Participants|6|6.0||||||
4208047|NCT00732199|4031301|B1|Brief Hyperoxia Response Analysis Population|Female|Sex/Gender, Customized||Participants|Count of Participants|3|3.0||||||
4208048|NCT00732199|4031299|B3|Hypoxic Ventilatory Response Analysis Population|Male|Sex/Gender, Customized||Participants|Count of Participants|10|10.0||||||
4208049|NCT00732199|4031300|B2|Hypoxic Ventilatory Response Analysis Population|Male|Sex/Gender, Customized||Participants|Count of Participants|6|6.0||||||
4208050|NCT00732199|4031301|B1|Hypoxic Ventilatory Response Analysis Population|Male|Sex/Gender, Customized||Participants|Count of Participants|4|4.0||||||
4208051|NCT00732199|4031299|B3|Hypoxic Ventilatory Response Analysis Population|Female|Sex/Gender, Customized||Participants|Count of Participants|13|13.0||||||
4208052|NCT00732199|4031300|B2|Hypoxic Ventilatory Response Analysis Population|Female|Sex/Gender, Customized||Participants|Count of Participants|7|7.0||||||
4208053|NCT00732199|4031301|B1|Hypoxic Ventilatory Response Analysis Population|Female|Sex/Gender, Customized||Participants|Count of Participants|6|6.0||||||
4208054|NCT00732199|4031299|B3|LTF and Minute Ventilation Analysis Population|Male|Sex/Gender, Customized||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4208055|NCT00732199|4031300|B2|LTF and Minute Ventilation Analysis Population|Male|Sex/Gender, Customized||Participants|Count of Participants|6|6.0||||||
4208056|NCT00732199|4031301|B1|LTF and Minute Ventilation Analysis Population|Male|Sex/Gender, Customized||Participants|Count of Participants|NA|||||||Long-term Facilitation (LTF) of Ventilation, Minute Ventilation Was Measured in Older Adults Only
4208057|NCT00732199|4031299|B3|LTF and Minute Ventilation Analysis Population|Female|Sex/Gender, Customized||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4208058|NCT00732199|4031300|B2|LTF and Minute Ventilation Analysis Population|Female|Sex/Gender, Customized||Participants|Count of Participants|8|8.0||||||
4208059|NCT00732199|4031301|B1|LTF and Minute Ventilation Analysis Population|Female|Sex/Gender, Customized||Participants|Count of Participants|NA|||||||Long-term Facilitation (LTF) of Ventilation, Minute Ventilation Was Measured in Older Adults Only
4208060|NCT00732199|4031299|B3|Apneic Threshold & CO2 Reserve Analysis Population|Male|Sex/Gender, Customized||Participants|Count of Participants|11|11.0||||||
4208061|NCT00732199|4031300|B2|Apneic Threshold & CO2 Reserve Analysis Population|Male|Sex/Gender, Customized||Participants|Count of Participants|4|4.0||||||
4208062|NCT00732199|4031301|B1|Apneic Threshold & CO2 Reserve Analysis Population|Male|Sex/Gender, Customized||Participants|Count of Participants|7|7.0||||||
4208063|NCT00732199|4031299|B3|Apneic Threshold & CO2 Reserve Analysis Population|Female|Sex/Gender, Customized||Participants|Count of Participants|14|14.0||||||
4208064|NCT00732199|4031300|B2|Apneic Threshold & CO2 Reserve Analysis Population|Female|Sex/Gender, Customized||Participants|Count of Participants|6|6.0||||||
4208065|NCT00732199|4031301|B1|Apneic Threshold & CO2 Reserve Analysis Population|Female|Sex/Gender, Customized||Participants|Count of Participants|8|8.0||||||
4208066|NCT00732199|4031299|B3|||Age||years|Mean|48.3|48.3|Standard Deviation|17.6|17.6|||
4208067|NCT00732199|4031300|B2|||Age||years|Mean|66.9|66.9|Standard Deviation|5.4|5.4|||
4208068|NCT00732199|4031301|B1|||Age||years|Mean|35.9|35.9|Standard Deviation|9.9|9.9|||
4208069|NCT00732160|4031313|B5|||Glucose (mg/dL)||mg/dL|Mean|85.3|85.3|Standard Deviation|7.2|7.2|||
4208070|NCT00732160|4031314|B4|||Glucose (mg/dL)||mg/dL|Mean|85.4|85.4|Standard Deviation|7.2|7.2|||
4208071|NCT00732160|4031315|B3|||Glucose (mg/dL)||mg/dL|Mean|85.3|85.3|Standard Deviation|7.6|7.6|||
4208072|NCT00732160|4031316|B2|||Glucose (mg/dL)||mg/dL|Mean|85.4|85.4|Standard Deviation|7.2|7.2|||
4208073|NCT00732160|4031317|B1|||Glucose (mg/dL)||mg/dL|Mean|85.3|85.3|Standard Deviation|7.6|7.6|||
4208074|NCT00732160|4031313|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4208075|NCT00732160|4031314|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4208076|NCT00732160|4031315|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4208077|NCT00732160|4031316|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4208078|NCT00732160|4031317|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4208079|NCT00732160|4031313|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4208080|NCT00732160|4031314|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4208081|NCT00732160|4031315|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4208082|NCT00732160|4031316|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4208083|NCT00732160|4031317|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4208084|NCT00732160|4031313|B5|||Age||years|Mean|28.4|28.4|Full Range|||20.8|47.5|
4208085|NCT00732160|4031314|B4|||Age||years|Mean|27.2|27.2|Full Range|||20.8|30.8|
4208086|NCT00732160|4031315|B3|||Age||years|Mean|32.5|32.5|Full Range|||20.9|47.5|
4208087|NCT00732160|4031316|B2|||Age||years|Mean|29.2|29.2|Full Range|||24.5|36.5|
4208088|NCT00732160|4031317|B1|||Age||years|Mean|25.1|25.1|Full Range|||21.7|30.1|
4208089|NCT00732069|4031334|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4208090|NCT00732069|4031334|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4208091|NCT00732069|4031334|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4208092|NCT00732069|4031334|B1|||Age||years|Mean|50.5|50.5|Standard Deviation|3.1|3.1|||
4208093|NCT00732069|4031334|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4208094|NCT00732069|4031334|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4208095|NCT00732069|4031334|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4208096|NCT00732030|4031350|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4208097|NCT00732030|4031350|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4208098|NCT00732030|4031350|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4208099|NCT00732030|4031350|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4208100|NCT00732030|4031350|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4208101|NCT00731939|4031357|B1|United Kingdom||Region of Enrollment||participants|Number|26|26.0||||||
4208102|NCT00731939|4031357|B1|Canada||Region of Enrollment||participants|Number|27|27.0||||||
4208103|NCT00731939|4031357|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
4208104|NCT00731939|4031357|B1||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4208105|NCT00731939|4031357|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4208106|NCT00731939|4031357|B1|||Age||years|Mean|61.0|61.0|Standard Deviation|9.1|9.1|||
4208107|NCT00731939|4031357|B1||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4208108|NCT00731939|4031357|B1||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
4208109|NCT00731939|4031357|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4208110|NCT00731874|4031405|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4208111|NCT00731874|4031406|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4208112|NCT00731874|4031407|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4208113|NCT00731874|4031405|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4208114|NCT00731874|4031406|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4208115|NCT00731874|4031407|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4208116|NCT00731874|4031405|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4208117|NCT00731874|4031406|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4208118|NCT00731874|4031407|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4208119|NCT00731874|4031405|B3|||Age||years|Mean|52.7|52.7|Standard Deviation|11.1|11.1|||
4208120|NCT00731874|4031406|B2|||Age||years|Mean|56.1|56.1|Standard Deviation|10.2|10.2|||
4208121|NCT00731874|4031407|B1|||Age||years|Mean|48.4|48.4|Standard Deviation|11.3|11.3|||
4208122|NCT00731874|4031405|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4208123|NCT00731874|4031406|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4208124|NCT00731874|4031407|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4208125|NCT00731874|4031405|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4208126|NCT00731874|4031406|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4208127|NCT00731874|4031407|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4208128|NCT00731874|4031405|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4208129|NCT00731874|4031406|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4208130|NCT00731874|4031407|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4208131|NCT00731822|4031432|B3|White||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
4208132|NCT00731822|4031433|B2|White||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4208133|NCT00731822|4031434|B1|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4208134|NCT00731822|4031432|B3||Male|Gender||Participants|Count of Participants|40|40.0||||||
4208135|NCT00731822|4031433|B2||Male|Gender||Participants|Count of Participants|25|25.0||||||
4208136|NCT00731822|4031434|B1||Male|Gender||Participants|Count of Participants|15|15.0||||||
4208137|NCT00731822|4031432|B3||Female|Gender||Participants|Count of Participants|20|20.0||||||
4208138|NCT00731822|4031433|B2||Female|Gender||Participants|Count of Participants|15|15.0||||||
4208139|NCT00731822|4031434|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
4208140|NCT00731822|4031432|B3|||Age||Years|Mean|63.6|63.6|Standard Deviation|6.71|6.71|||
4208141|NCT00731822|4031433|B2|||Age||Years|Mean|63.5|63.5|Standard Deviation|7.10|7.1|||
4208142|NCT00731822|4031434|B1|||Age||Years|Mean|63.8|63.8|Standard Deviation|6.01|6.01|||
4208143|NCT00731783|4031447|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4208144|NCT00731783|4031448|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4208145|NCT00731783|4031449|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4208146|NCT00731783|4031447|B3||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4208147|NCT00731783|4031448|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4208148|NCT00731783|4031449|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4208149|NCT00731783|4031447|B3|||Age||Years|Mean|6.0|6.0|Standard Deviation|5.8|5.8|||
4208150|NCT00731783|4031448|B2|||Age||Years|Mean|5.7|5.7|Standard Deviation|6.0|6.0|||
4208151|NCT00731783|4031449|B1|||Age||Years|Mean|6.3|6.3|Standard Deviation|5.7|5.7|||
4208152|NCT00731731|4031470|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4208153|NCT00731731|4031471|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4208154|NCT00731731|4031472|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208155|NCT00731731|4031473|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208156|NCT00731731|4031470|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208157|NCT00731731|4031471|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208158|NCT00731731|4031472|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208159|NCT00731731|4031473|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208160|NCT00731731|4031470|B4||White|Race (NIH/OMB)||Participants|Count of Participants|114|114.0||||||
4208161|NCT00731731|4031471|B3||White|Race (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
4208162|NCT00731731|4031472|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4208163|NCT00731731|4031473|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4208164|NCT00731731|4031470|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4208165|NCT00731731|4031471|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4208166|NCT00731731|4031472|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208167|NCT00731731|4031473|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208168|NCT00731731|4031470|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208169|NCT00731731|4031471|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208170|NCT00731731|4031472|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208171|NCT00731731|4031473|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208172|NCT00731731|4031470|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4208173|NCT00731731|4031471|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4208174|NCT00731731|4031472|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208175|NCT00731731|4031473|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208176|NCT00731731|4031470|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208177|NCT00731731|4031471|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208178|NCT00731731|4031472|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208179|NCT00731731|4031473|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208180|NCT00731731|4031470|B4||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4208181|NCT00731731|4031471|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4208182|NCT00731731|4031472|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4208183|NCT00731731|4031473|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4208184|NCT00731731|4031470|B4||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4208185|NCT00731731|4031471|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4208186|NCT00731731|4031472|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4208187|NCT00731731|4031473|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4208188|NCT00731731|4031470|B4|||Age||years|Median|59|59.0|Full Range|||20.0|80.0|
4208189|NCT00731731|4031471|B3|||Age||years|Median|59|59.0|Full Range|||20.0|80.0|
4208190|NCT00731731|4031472|B2|||Age||years|Median|59|59.0|Full Range|||58.0|73.0|
4208191|NCT00731731|4031473|B1|||Age||years|Median|57|57.0|Full Range|||43.0|76.0|
4208192|NCT00731692|4031490|B4||Male|Sex: Female, Male||Participants|Count of Participants|501|501.0||||||
4208193|NCT00731692|4031491|B3||Male|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
4208194|NCT00731692|4031492|B2||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4208195|NCT00731692|4031493|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4208196|NCT00731692|4031490|B4||Female|Sex: Female, Male||Participants|Count of Participants|469|469.0||||||
4208197|NCT00731692|4031491|B3||Female|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4208198|NCT00731692|4031492|B2||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4208199|NCT00731692|4031493|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4208200|NCT00731692|4031490|B4|>50||Age, Customized||Particpants|Number|396|396.0||||||
4208201|NCT00731692|4031491|B3|>50||Age, Customized||Particpants|Number|199|199.0||||||
4208202|NCT00731692|4031492|B2|>50||Age, Customized||Particpants|Number|143|143.0||||||
4208203|NCT00731692|4031493|B1|>50||Age, Customized||Particpants|Number|54|54.0||||||
4208204|NCT00731692|4031490|B4|41 to 50||Age, Customized||Particpants|Number|389|389.0||||||
4208205|NCT00731692|4031491|B3|41 to 50||Age, Customized||Particpants|Number|194|194.0||||||
4208206|NCT00731692|4031492|B2|41 to 50||Age, Customized||Particpants|Number|127|127.0||||||
4208207|NCT00731692|4031493|B1|41 to 50||Age, Customized||Particpants|Number|68|68.0||||||
4208208|NCT00731692|4031490|B4|31 to 40||Age, Customized||Particpants|Number|172|172.0||||||
4208209|NCT00731692|4031491|B3|31 to 40||Age, Customized||Particpants|Number|90|90.0||||||
4208210|NCT00731692|4031492|B2|31 to 40||Age, Customized||Particpants|Number|60|60.0||||||
4208211|NCT00731692|4031493|B1|31 to 40||Age, Customized||Particpants|Number|22|22.0||||||
4208212|NCT00731692|4031490|B4|<=30||Age, Customized||Particpants|Number|13|13.0||||||
4208213|NCT00731692|4031491|B3|<=30||Age, Customized||Particpants|Number|4|4.0||||||
4208214|NCT00731692|4031492|B2|<=30||Age, Customized||Particpants|Number|6|6.0||||||
4208215|NCT00731692|4031493|B1|<=30||Age, Customized||Particpants|Number|3|3.0||||||
4208216|NCT00731692|4031490|B4|||Age||years|Mean|48.5|48.5|Standard Deviation|8.42|8.42|||
4208217|NCT00731692|4031491|B3|||Age||years|Mean|48.5|48.5|Standard Deviation|8.31|8.31|||
4208218|NCT00731692|4031492|B2|||Age||years|Mean|48.5|48.5|Standard Deviation|8.59|8.59|||
4208219|NCT00731692|4031493|B1|||Age||years|Mean|47.8|47.8|Standard Deviation|8.47|8.47|||
4208220|NCT00731679|4031539|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208221|NCT00731679|4031540|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208222|NCT00731679|4031541|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208223|NCT00731679|4031539|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4208224|NCT00731679|4031540|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208225|NCT00731679|4031541|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4208226|NCT00731679|4031539|B3||White|Race (NIH/OMB)||Participants|Count of Participants|561|561.0||||||
4208227|NCT00731679|4031540|B2||White|Race (NIH/OMB)||Participants|Count of Participants|281|281.0||||||
4208228|NCT00731679|4031541|B1||White|Race (NIH/OMB)||Participants|Count of Participants|280|280.0||||||
4208229|NCT00731679|4031539|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4208230|NCT00731679|4031540|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4208231|NCT00731679|4031541|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4208232|NCT00731679|4031539|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4208233|NCT00731679|4031540|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208234|NCT00731679|4031541|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4208235|NCT00731679|4031539|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4208236|NCT00731679|4031540|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4208237|NCT00731679|4031541|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4208238|NCT00731679|4031539|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4208239|NCT00731679|4031540|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4208240|NCT00731679|4031541|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208241|NCT00731679|4031539|B3||Male|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4208242|NCT00731679|4031540|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4208243|NCT00731679|4031541|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4208244|NCT00731679|4031539|B3||Female|Sex: Female, Male||Participants|Count of Participants|457|457.0||||||
4208245|NCT00731679|4031540|B2||Female|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4208246|NCT00731679|4031541|B1||Female|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4208247|NCT00731679|4031539|B3|||Age||years|Mean|45.8|45.8|Standard Deviation|14.8|14.8|||
4208248|NCT00731679|4031540|B2|||Age||years|Mean|46.2|46.2|Standard Deviation|15.0|15.0|||
4208249|NCT00731679|4031541|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|14.6|14.6|||
4208250|NCT00731679|4031539|B3||>=65 years|Age||Participants|Count of Participants|72|72.0||||||
4208251|NCT00731679|4031540|B2||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
4208252|NCT00731679|4031541|B1||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4208253|NCT00731679|4031539|B3||Between 18 and 65 years|Age||Participants|Count of Participants|549|549.0||||||
4208254|NCT00731679|4031540|B2||Between 18 and 65 years|Age||Participants|Count of Participants|274|274.0||||||
4208255|NCT00731679|4031541|B1||Between 18 and 65 years|Age||Participants|Count of Participants|275|275.0||||||
4208256|NCT00731679|4031539|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4208257|NCT00731679|4031540|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4208258|NCT00731679|4031541|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4208259|NCT00731666|4031550|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4208260|NCT00731666|4031550|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4208261|NCT00731666|4031550|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4208262|NCT00731666|4031550|B1|||Age||years|Mean|66.2|66.2|Standard Deviation|11.4|11.4|||
4208263|NCT00731666|4031550|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4208264|NCT00731666|4031550|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4208265|NCT00731666|4031550|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4208266|NCT00731653|4031556|B1|United States||Region of Enrollment||participants|Number|81|81.0||||||
4208267|NCT00731653|4031556|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4208268|NCT00731653|4031556|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4208269|NCT00731653|4031556|B1|||Age||years|Mean|43.7|43.7|Standard Deviation|11.59|11.59|||
4208270|NCT00731653|4031556|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4208271|NCT00731653|4031556|B1||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
4208272|NCT00731653|4031556|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4208273|NCT00731640|4031560|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4208274|NCT00731640|4031561|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4208275|NCT00731640|4031562|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4208276|NCT00731640|4031560|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4208277|NCT00731640|4031561|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4208278|NCT00731640|4031562|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4208279|NCT00731640|4031560|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4208280|NCT00731640|4031561|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4208281|NCT00731640|4031562|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4208282|NCT00731640|4031560|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4208283|NCT00731640|4031561|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4208284|NCT00731640|4031562|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4208285|NCT00731640|4031560|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4208286|NCT00731640|4031561|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4208287|NCT00731640|4031562|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4208288|NCT00731614|4031575|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
4208289|NCT00731614|4031576|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
4208290|NCT00731614|4031577|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4208291|NCT00731614|4031575|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4208292|NCT00731614|4031576|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4208293|NCT00731614|4031577|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4208294|NCT00731614|4031575|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4208295|NCT00731614|4031576|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4208296|NCT00731614|4031577|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4208297|NCT00731614|4031575|B3||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4208298|NCT00731614|4031576|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4208299|NCT00731614|4031577|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4208300|NCT00731614|4031575|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4208301|NCT00731614|4031576|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4208302|NCT00731614|4031577|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4208303|NCT00731614|4031575|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208304|NCT00731614|4031576|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208305|NCT00731614|4031577|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208306|NCT00731614|4031575|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208307|NCT00731614|4031576|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208308|NCT00731614|4031577|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208309|NCT00731614|4031575|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4208310|NCT00731614|4031576|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208311|NCT00731614|4031577|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4208312|NCT00731614|4031575|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4208313|NCT00731614|4031576|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4208314|NCT00731614|4031577|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4208315|NCT00731614|4031575|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4208316|NCT00731614|4031576|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4208317|NCT00731614|4031577|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4208318|NCT00731614|4031575|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4208319|NCT00731614|4031576|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4208320|NCT00731614|4031577|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4208321|NCT00731614|4031575|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4208322|NCT00731614|4031576|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4208323|NCT00731614|4031577|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4208324|NCT00731614|4031575|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4208325|NCT00731614|4031576|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4208326|NCT00731614|4031577|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4208327|NCT00731614|4031575|B3|||Age||years|Mean|57.09|57.09|Standard Deviation|14.99|14.99|||
4208328|NCT00731614|4031576|B2|||Age||years|Mean|54.62|54.62|Standard Deviation|16.32|16.32|||
4208329|NCT00731614|4031577|B1|||Age||years|Mean|60.12|60.12|Standard Deviation|12.85|12.85|||
4208330|NCT00731549|4031584|B1||Male|Sex: Female, Male||Participants|Count of Participants|642|642.0||||||
4208331|NCT00731549|4031584|B1||Female|Sex: Female, Male||Participants|Count of Participants|439|439.0||||||
4208332|NCT00731549|4031584|B1|||Age||Years|Mean|41.2|41.2|Standard Deviation|10.6|10.6|||
4208333|NCT00731484|4031597|B1|United States||Region of Enrollment||participants|Number|233|233.0||||||
4208334|NCT00731484|4031597|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4208335|NCT00731484|4031597|B1||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4208336|NCT00731484|4031597|B1|||Age||years|Mean|47.8|47.8|Standard Deviation|18.0|18.0|||
4208337|NCT00731484|4031597|B1||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
4208338|NCT00731484|4031597|B1||Between 18 and 65 years|Age||Participants|Count of Participants|191|191.0||||||
4208339|NCT00731484|4031597|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4208340|NCT00731341|4031601|B1|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
4208341|NCT00731341|4031601|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4208342|NCT00731341|4031601|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4208343|NCT00731341|4031601|B1|||Age||years|Mean|46.3|46.3|Standard Deviation|1|1.0|||
4208344|NCT00731341|4031601|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4208345|NCT00731341|4031601|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4208346|NCT00731341|4031601|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4208347|NCT00731211|4031610|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4208348|NCT00731211|4031610|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4208349|NCT00731211|4031610|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4208350|NCT00731211|4031610|B1|||Age||years|Median|60|60.0|Full Range|||41.0|82.0|
4208351|NCT00731198|4031615|B3|China||Region of Enrollment||participants|Number|650|650.0||||||
4208352|NCT00731198|4031616|B2|China||Region of Enrollment||participants|Number|325|325.0||||||
4208353|NCT00731198|4031617|B1|China||Region of Enrollment||participants|Number|325|325.0||||||
4208354|NCT00731198|4031615|B3||Male|Sex: Female, Male||Participants|Count of Participants|338|338.0||||||
4208355|NCT00731198|4031616|B2||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4208356|NCT00731198|4031617|B1||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4208357|NCT00731198|4031615|B3||Female|Sex: Female, Male||Participants|Count of Participants|312|312.0||||||
4208358|NCT00731198|4031616|B2||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4208359|NCT00731198|4031617|B1||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4208360|NCT00731198|4031615|B3|||Age||years|Mean|58.09|58.09|Standard Deviation|15.97|15.97|||
4208361|NCT00731198|4031616|B2|||Age||years|Mean|59.20|59.2|Standard Deviation|16.14|16.14|||
4208362|NCT00731198|4031617|B1|||Age||years|Mean|56.98|56.98|Standard Deviation|15.75|15.75|||
4208363|NCT00731198|4031615|B3||>=65 years|Age||Participants|Count of Participants|248|248.0||||||
4208364|NCT00731198|4031616|B2||>=65 years|Age||Participants|Count of Participants|128|128.0||||||
4208365|NCT00731198|4031617|B1||>=65 years|Age||Participants|Count of Participants|120|120.0||||||
4208366|NCT00731198|4031615|B3||Between 18 and 65 years|Age||Participants|Count of Participants|402|402.0||||||
4208367|NCT00731198|4031616|B2||Between 18 and 65 years|Age||Participants|Count of Participants|197|197.0||||||
4208368|NCT00731198|4031617|B1||Between 18 and 65 years|Age||Participants|Count of Participants|205|205.0||||||
4208369|NCT00731198|4031615|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4208370|NCT00731198|4031616|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4208371|NCT00731198|4031617|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4208372|NCT00731133|4031624|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4208373|NCT00731133|4031624|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4208374|NCT00731133|4031624|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4208375|NCT00731133|4031624|B1|||Age||years|Mean|35.93|35.93|Standard Deviation|9.29|9.29|||
4208376|NCT00731133|4031624|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4208377|NCT00731133|4031624|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4208378|NCT00731133|4031624|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4208379|NCT00731120|4031629|B4|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|12.80|12.8|Standard Deviation|2.481|2.481|||
4208380|NCT00731120|4031630|B3|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|13.04|13.04|Standard Deviation|2.521|2.521|||
4208381|NCT00731120|4031631|B2|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|12.64|12.64|Standard Deviation|2.502|2.502|||
4208382|NCT00731120|4031632|B1|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|12.73|12.73|Standard Deviation|2.417|2.417|||
4208383|NCT00731120|4031629|B4|||Hospital Anxiety and Depression – Depression subscale|Hospital Anxiety and Depression (HAD) Depression sub-scale consists of 7 items that are assessed on a scale from 0 (no depression) to 3 (severe feeling of depression). The depression subscale focuses on the state of lost interest and diminished pleasure response. Scores are summed and range from 0 to 21 (maximal severity).|scores on a scale|Mean|8.3|8.3|Standard Deviation|3.70|3.7|||
4208384|NCT00731120|4031630|B3|||Hospital Anxiety and Depression – Depression subscale|Hospital Anxiety and Depression (HAD) Depression sub-scale consists of 7 items that are assessed on a scale from 0 (no depression) to 3 (severe feeling of depression). The depression subscale focuses on the state of lost interest and diminished pleasure response. Scores are summed and range from 0 to 21 (maximal severity).|scores on a scale|Mean|8.0|8.0|Standard Deviation|3.60|3.6|||
4208385|NCT00731120|4031631|B2|||Hospital Anxiety and Depression – Depression subscale|Hospital Anxiety and Depression (HAD) Depression sub-scale consists of 7 items that are assessed on a scale from 0 (no depression) to 3 (severe feeling of depression). The depression subscale focuses on the state of lost interest and diminished pleasure response. Scores are summed and range from 0 to 21 (maximal severity).|scores on a scale|Mean|8.0|8.0|Standard Deviation|3.80|3.8|||
4208386|NCT00731120|4031632|B1|||Hospital Anxiety and Depression – Depression subscale|Hospital Anxiety and Depression (HAD) Depression sub-scale consists of 7 items that are assessed on a scale from 0 (no depression) to 3 (severe feeling of depression). The depression subscale focuses on the state of lost interest and diminished pleasure response. Scores are summed and range from 0 to 21 (maximal severity).|scores on a scale|Mean|8.7|8.7|Standard Deviation|3.67|3.67|||
4208387|NCT00731120|4031629|B4|||Hospital Anxiety and Depression – Anxiety subscale|Hospital Anxiety and Depression (HAD) Anxiety sub-scale consists of 7 items that are assessed on a scale from 0 (no anxiety) to 3 (severe feeling of anxiety). The anxiety subscale determines a state of generalized anxiety including anxious mood, restlessness, anxious thoughts and panic attacks. Scores are summed and range from 0 to 21 (maximal severity).|scores on a scale|Mean|13.4|13.4|Standard Deviation|3.35|3.35|||
4208388|NCT00731120|4031630|B3|||Hospital Anxiety and Depression – Anxiety subscale|Hospital Anxiety and Depression (HAD) Anxiety sub-scale consists of 7 items that are assessed on a scale from 0 (no anxiety) to 3 (severe feeling of anxiety). The anxiety subscale determines a state of generalized anxiety including anxious mood, restlessness, anxious thoughts and panic attacks. Scores are summed and range from 0 to 21 (maximal severity).|scores on a scale|Mean|13.2|13.2|Standard Deviation|3.17|3.17|||
4208389|NCT00731120|4031631|B2|||Hospital Anxiety and Depression – Anxiety subscale|Hospital Anxiety and Depression (HAD) Anxiety sub-scale consists of 7 items that are assessed on a scale from 0 (no anxiety) to 3 (severe feeling of anxiety). The anxiety subscale determines a state of generalized anxiety including anxious mood, restlessness, anxious thoughts and panic attacks. Scores are summed and range from 0 to 21 (maximal severity).|scores on a scale|Mean|13.2|13.2|Standard Deviation|3.56|3.56|||
4208390|NCT00731120|4031632|B1|||Hospital Anxiety and Depression – Anxiety subscale|Hospital Anxiety and Depression (HAD) Anxiety sub-scale consists of 7 items that are assessed on a scale from 0 (no anxiety) to 3 (severe feeling of anxiety). The anxiety subscale determines a state of generalized anxiety including anxious mood, restlessness, anxious thoughts and panic attacks. Scores are summed and range from 0 to 21 (maximal severity).|scores on a scale|Mean|13.9|13.9|Standard Deviation|3.27|3.27|||
4208391|NCT00731120|4031629|B4|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|scores on a scale|Mean|4.3|4.3|Standard Deviation|0.50|0.5|||
4208392|NCT00731120|4031630|B3|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|scores on a scale|Mean|4.3|4.3|Standard Deviation|0.47|0.47|||
4208433|NCT00731120|4031631|B2|||Body Mass Index (BMI)||kg/m^2|Mean|29.69|29.69|Standard Deviation|7.817|7.817|||
4208434|NCT00731120|4031632|B1|||Body Mass Index (BMI)||kg/m^2|Mean|29.10|29.1|Standard Deviation|6.595|6.595|||
4208435|NCT00731120|4031629|B4|||Height||cm|Mean|168.60|168.6|Standard Deviation|9.649|9.649|||
4208393|NCT00731120|4031631|B2|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|scores on a scale|Mean|4.3|4.3|Standard Deviation|0.49|0.49|||
4208394|NCT00731120|4031632|B1|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|scores on a scale|Mean|4.4|4.4|Standard Deviation|0.54|0.54|||
4208395|NCT00731120|4031629|B4|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 (absent) to 56 (maximum severity).|scores on a scale|Mean|24.9|24.9|Standard Deviation|3.73|3.73|||
4208396|NCT00731120|4031630|B3|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 (absent) to 56 (maximum severity).|scores on a scale|Mean|24.5|24.5|Standard Deviation|3.71|3.71|||
4208397|NCT00731120|4031631|B2|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 (absent) to 56 (maximum severity).|scores on a scale|Mean|25.0|25.0|Standard Deviation|3.60|3.6|||
4208398|NCT00731120|4031632|B1|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 (absent) to 56 (maximum severity).|scores on a scale|Mean|25.2|25.2|Standard Deviation|3.86|3.86|||
4208399|NCT00731120|4031629|B4|Daily||Alcohol Consumption||participants|Number|7|7.0||||||
4208400|NCT00731120|4031630|B3|Daily||Alcohol Consumption||participants|Number|1|1.0||||||
4208401|NCT00731120|4031631|B2|Daily||Alcohol Consumption||participants|Number|5|5.0||||||
4208402|NCT00731120|4031632|B1|Daily||Alcohol Consumption||participants|Number|1|1.0||||||
4208403|NCT00731120|4031629|B4|2 to 6 times per week||Alcohol Consumption||participants|Number|62|62.0||||||
4208404|NCT00731120|4031630|B3|2 to 6 times per week||Alcohol Consumption||participants|Number|22|22.0||||||
4208405|NCT00731120|4031631|B2|2 to 6 times per week||Alcohol Consumption||participants|Number|23|23.0||||||
4208406|NCT00731120|4031632|B1|2 to 6 times per week||Alcohol Consumption||participants|Number|17|17.0||||||
4208407|NCT00731120|4031629|B4|Once a week||Alcohol Consumption||participants|Number|90|90.0||||||
4208408|NCT00731120|4031630|B3|Once a week||Alcohol Consumption||participants|Number|29|29.0||||||
4208409|NCT00731120|4031631|B2|Once a week||Alcohol Consumption||participants|Number|28|28.0||||||
4208410|NCT00731120|4031632|B1|Once a week||Alcohol Consumption||participants|Number|33|33.0||||||
4208411|NCT00731120|4031629|B4|Once monthly or less often||Alcohol Consumption||participants|Number|162|162.0||||||
4208412|NCT00731120|4031630|B3|Once monthly or less often||Alcohol Consumption||participants|Number|56|56.0||||||
4208413|NCT00731120|4031631|B2|Once monthly or less often||Alcohol Consumption||participants|Number|54|54.0||||||
4208414|NCT00731120|4031632|B1|Once monthly or less often||Alcohol Consumption||participants|Number|52|52.0||||||
4208415|NCT00731120|4031629|B4|Never||Alcohol Consumption||participants|Number|136|136.0||||||
4208416|NCT00731120|4031630|B3|Never||Alcohol Consumption||participants|Number|44|44.0||||||
4208417|NCT00731120|4031631|B2|Never||Alcohol Consumption||participants|Number|42|42.0||||||
4208418|NCT00731120|4031632|B1|Never||Alcohol Consumption||participants|Number|50|50.0||||||
4208419|NCT00731120|4031629|B4|Ex-smoker||Smoking Classification||participants|Number|73|73.0||||||
4208420|NCT00731120|4031630|B3|Ex-smoker||Smoking Classification||participants|Number|22|22.0||||||
4208421|NCT00731120|4031631|B2|Ex-smoker||Smoking Classification||participants|Number|29|29.0||||||
4208422|NCT00731120|4031632|B1|Ex-smoker||Smoking Classification||participants|Number|22|22.0||||||
4208423|NCT00731120|4031629|B4|Current smoker||Smoking Classification||participants|Number|141|141.0||||||
4208424|NCT00731120|4031630|B3|Current smoker||Smoking Classification||participants|Number|46|46.0||||||
4208425|NCT00731120|4031631|B2|Current smoker||Smoking Classification||participants|Number|51|51.0||||||
4208426|NCT00731120|4031632|B1|Current smoker||Smoking Classification||participants|Number|44|44.0||||||
4208427|NCT00731120|4031629|B4|Never Smoked||Smoking Classification||participants|Number|243|243.0||||||
4208428|NCT00731120|4031630|B3|Never Smoked||Smoking Classification||participants|Number|84|84.0||||||
4208429|NCT00731120|4031631|B2|Never Smoked||Smoking Classification||participants|Number|72|72.0||||||
4208430|NCT00731120|4031632|B1|Never Smoked||Smoking Classification||participants|Number|87|87.0||||||
4208431|NCT00731120|4031629|B4|||Body Mass Index (BMI)||kg/m^2|Mean|29.61|29.61|Standard Deviation|7.415|7.415|||
4208432|NCT00731120|4031630|B3|||Body Mass Index (BMI)||kg/m^2|Mean|30.04|30.04|Standard Deviation|7.792|7.792|||
4208436|NCT00731120|4031630|B3|||Height||cm|Mean|168.86|168.86|Standard Deviation|10.032|10.032|||
4208437|NCT00731120|4031631|B2|||Height||cm|Mean|168.63|168.63|Standard Deviation|8.932|8.932|||
4208438|NCT00731120|4031632|B1|||Height||cm|Mean|168.31|168.31|Standard Deviation|9.994|9.994|||
4208439|NCT00731120|4031629|B4|||Weight||kg|Mean|84.27|84.27|Standard Deviation|22.245|22.245|||
4208440|NCT00731120|4031630|B3|||Weight||kg|Mean|85.67|85.67|Standard Deviation|23.249|23.249|||
4208441|NCT00731120|4031631|B2|||Weight||kg|Mean|84.48|84.48|Standard Deviation|22.727|22.727|||
4208442|NCT00731120|4031632|B1|||Weight||kg|Mean|82.66|82.66|Standard Deviation|20.731|20.731|||
4208443|NCT00731120|4031629|B4|United States||Region of Enrollment||participants|Number|457|457.0||||||
4208444|NCT00731120|4031630|B3|United States||Region of Enrollment||participants|Number|152|152.0||||||
4208445|NCT00731120|4031631|B2|United States||Region of Enrollment||participants|Number|152|152.0||||||
4208446|NCT00731120|4031632|B1|United States||Region of Enrollment||participants|Number|153|153.0||||||
4208447|NCT00731120|4031629|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4208448|NCT00731120|4031630|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4208449|NCT00731120|4031631|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4208450|NCT00731120|4031632|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4208451|NCT00731120|4031629|B4|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4208452|NCT00731120|4031630|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4208453|NCT00731120|4031631|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4208454|NCT00731120|4031632|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4208455|NCT00731120|4031629|B4|Black||Race/Ethnicity, Customized||participants|Number|122|122.0||||||
4208456|NCT00731120|4031630|B3|Black||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4208457|NCT00731120|4031631|B2|Black||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4208458|NCT00731120|4031632|B1|Black||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4208459|NCT00731120|4031629|B4|Caucasian (White, including Hispanic)||Race/Ethnicity, Customized||participants|Number|327|327.0||||||
4208460|NCT00731120|4031630|B3|Caucasian (White, including Hispanic)||Race/Ethnicity, Customized||participants|Number|112|112.0||||||
4208461|NCT00731120|4031631|B2|Caucasian (White, including Hispanic)||Race/Ethnicity, Customized||participants|Number|110|110.0||||||
4208462|NCT00731120|4031632|B1|Caucasian (White, including Hispanic)||Race/Ethnicity, Customized||participants|Number|105|105.0||||||
4208463|NCT00731120|4031629|B4|Non-Hispanic/Non-Latino||Race/Ethnicity, Customized||participants|Number|411|411.0||||||
4208464|NCT00731120|4031630|B3|Non-Hispanic/Non-Latino||Race/Ethnicity, Customized||participants|Number|137|137.0||||||
4208465|NCT00731120|4031631|B2|Non-Hispanic/Non-Latino||Race/Ethnicity, Customized||participants|Number|134|134.0||||||
4208466|NCT00731120|4031632|B1|Non-Hispanic/Non-Latino||Race/Ethnicity, Customized||participants|Number|140|140.0||||||
4208467|NCT00731120|4031629|B4|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4208468|NCT00731120|4031630|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4208469|NCT00731120|4031631|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4208470|NCT00731120|4031632|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4208471|NCT00731120|4031629|B4||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4208472|NCT00731120|4031630|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4208473|NCT00731120|4031631|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4208474|NCT00731120|4031632|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4208475|NCT00731120|4031629|B4||Female|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
4208476|NCT00731120|4031630|B3||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4208477|NCT00731120|4031631|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4208478|NCT00731120|4031632|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4208479|NCT00731120|4031629|B4|>55 years||Age, Customized||participants|Number|74|74.0||||||
4208480|NCT00731120|4031630|B3|>55 years||Age, Customized||participants|Number|32|32.0||||||
4208481|NCT00731120|4031631|B2|>55 years||Age, Customized||participants|Number|25|25.0||||||
4208482|NCT00731120|4031632|B1|>55 years||Age, Customized||participants|Number|17|17.0||||||
4208483|NCT00731120|4031629|B4|≤55 years||Age, Customized||participants|Number|383|383.0||||||
4208484|NCT00731120|4031630|B3|≤55 years||Age, Customized||participants|Number|120|120.0||||||
4208485|NCT00731120|4031631|B2|≤55 years||Age, Customized||participants|Number|127|127.0||||||
4208486|NCT00731120|4031632|B1|≤55 years||Age, Customized||participants|Number|136|136.0||||||
4208487|NCT00731120|4031629|B4|||Age||years|Mean|41.2|41.2|Standard Deviation|14.15|14.15|||
4208488|NCT00731120|4031630|B3|||Age||years|Mean|43.3|43.3|Standard Deviation|14.99|14.99|||
4208489|NCT00731120|4031631|B2|||Age||years|Mean|40.8|40.8|Standard Deviation|13.81|13.81|||
4208490|NCT00731120|4031632|B1|||Age||years|Mean|39.5|39.5|Standard Deviation|13.45|13.45|||
4208491|NCT00731094|4031669|B3|||Body Mass Index (BMI)||kg/m2|Mean|31.6|31.6|Standard Deviation|4.9|4.9|||
4208492|NCT00731094|4031670|B2|||Body Mass Index (BMI)||kg/m2|Mean|32.2|32.2|Standard Deviation|5.0|5.0|||
4208493|NCT00731094|4031671|B1|||Body Mass Index (BMI)||kg/m2|Mean|31.1|31.1|Standard Deviation|4.7|4.7|||
4208494|NCT00731094|4031669|B3|United States||Region of Enrollment||participants|Number|232|232.0||||||
4208495|NCT00731094|4031670|B2|United States||Region of Enrollment||participants|Number|116|116.0||||||
4208496|NCT00731094|4031671|B1|United States||Region of Enrollment||participants|Number|116|116.0||||||
4208497|NCT00731094|4031669|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4208498|NCT00731094|4031670|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4208499|NCT00731094|4031671|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4208500|NCT00731094|4031669|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4208501|NCT00731094|4031670|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4208502|NCT00731094|4031671|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4208503|NCT00731094|4031669|B3||White|Race (NIH/OMB)||Participants|Count of Participants|173|173.0||||||
4208504|NCT00731094|4031670|B2||White|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
4208505|NCT00731094|4031671|B1||White|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4208506|NCT00731094|4031669|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4208507|NCT00731094|4031670|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4208508|NCT00731094|4031671|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4208509|NCT00731094|4031669|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208510|NCT00731094|4031670|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208511|NCT00731094|4031671|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208512|NCT00731094|4031669|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208513|NCT00731094|4031670|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208514|NCT00731094|4031671|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208515|NCT00731094|4031669|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208516|NCT00731094|4031670|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208517|NCT00731094|4031671|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208518|NCT00731094|4031669|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4208519|NCT00731094|4031670|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208520|NCT00731094|4031671|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4208521|NCT00731094|4031669|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|224|224.0||||||
4208522|NCT00731094|4031670|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
4208523|NCT00731094|4031671|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
4208524|NCT00731094|4031669|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4208525|NCT00731094|4031670|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4208526|NCT00731094|4031671|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4208527|NCT00731094|4031669|B3||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4208528|NCT00731094|4031670|B2||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4208529|NCT00731094|4031671|B1||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4208530|NCT00731094|4031669|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4208531|NCT00731094|4031670|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4208532|NCT00731094|4031671|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4208533|NCT00731094|4031669|B3|||Age||years|Mean|63.2|63.2|Standard Deviation|12.8|12.8|||
4208534|NCT00731094|4031670|B2|||Age||years|Mean|62.6|62.6|Standard Deviation|13.2|13.2|||
4208535|NCT00731094|4031671|B1|||Age||years|Mean|63.7|63.7|Standard Deviation|12.5|12.5|||
4208536|NCT00731055|4031742|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4208537|NCT00731055|4031742|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208538|NCT00731055|4031742|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208539|NCT00731055|4031742|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4208540|NCT00731055|4031742|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4208541|NCT00731055|4031742|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208542|NCT00731055|4031742|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208543|NCT00731055|4031742|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208544|NCT00731055|4031742|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4208545|NCT00731055|4031742|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4208546|NCT00731055|4031742|B1|||Age||years|Mean|36.5|36.5|Full Range|||23.0|44.0|
4208547|NCT00731042|4031749|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4208548|NCT00731042|4031750|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4208549|NCT00731042|4031751|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4208550|NCT00731042|4031749|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4208551|NCT00731042|4031750|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4208552|NCT00731042|4031751|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4208553|NCT00731042|4031749|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4208554|NCT00731042|4031750|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4208555|NCT00731042|4031751|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4208556|NCT00731042|4031749|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4208557|NCT00731042|4031750|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4208558|NCT00731042|4031751|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4208559|NCT00731042|4031749|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4208560|NCT00731042|4031750|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4208561|NCT00731042|4031751|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4208562|NCT00730964|4031758|B1|United States||Region of Enrollment||participants|Number|1039|1039.0||||||
4208563|NCT00730964|4031758|B1||Male|Sex: Female, Male||Participants|Count of Participants|648|648.0||||||
4208564|NCT00730964|4031758|B1||Female|Sex: Female, Male||Participants|Count of Participants|391|391.0||||||
4208565|NCT00730964|4031758|B1|>=75 years||Age, Customized||participants|Number|141|141.0||||||
4208566|NCT00730964|4031758|B1|Between 65 and 75 years||Age, Customized||participants|Number|227|227.0||||||
4208567|NCT00730964|4031758|B1|<=65 years||Age, Customized||participants|Number|671|671.0||||||
4208568|NCT00730964|4031758|B1|||Age||years|Mean|59.9|59.9|Standard Deviation|12.99|12.99|||
4208569|NCT00730925|4031763|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4208570|NCT00730925|4031763|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4208571|NCT00730925|4031763|B1|||Age||years|Mean|60.7|60.7|Standard Deviation|13.4|13.4|||
4208572|NCT00730912|4031770|B4||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4208573|NCT00730912|4031771|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4208574|NCT00730912|4031772|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4208575|NCT00730912|4031773|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4208576|NCT00730912|4031770|B4||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4208577|NCT00730912|4031771|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4208578|NCT00730912|4031772|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4208579|NCT00730912|4031773|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4208580|NCT00730912|4031770|B4|Between 16 - 64 years||Age, Customized||participants|Number|104|104.0||||||
4208581|NCT00730912|4031771|B3|Between 16 - 64 years||Age, Customized||participants|Number|104|104.0||||||
4208582|NCT00730912|4031772|B2|Between 16 - 64 years||Age, Customized||participants|Number|0|0.0||||||
4208583|NCT00730912|4031773|B1|Between 16 - 64 years||Age, Customized||participants|Number|0|0.0||||||
4208584|NCT00730912|4031770|B4|Between 7 and 15 years||Age, Customized||participants|Number|104|104.0||||||
4208585|NCT00730912|4031771|B3|Between 7 and 15 years||Age, Customized||participants|Number|0|0.0||||||
4208586|NCT00730912|4031772|B2|Between 7 and 15 years||Age, Customized||participants|Number|104|104.0||||||
4208587|NCT00730912|4031773|B1|Between 7 and 15 years||Age, Customized||participants|Number|0|0.0||||||
4208588|NCT00730912|4031770|B4|Between 3-6 years||Age, Customized||participants|Number|53|53.0||||||
4208589|NCT00730912|4031771|B3|Between 3-6 years||Age, Customized||participants|Number|0|0.0||||||
4208590|NCT00730912|4031772|B2|Between 3-6 years||Age, Customized||participants|Number|0|0.0||||||
4208591|NCT00730912|4031773|B1|Between 3-6 years||Age, Customized||participants|Number|53|53.0||||||
4208592|NCT00730886|4031786|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208593|NCT00730886|4031788|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208594|NCT00730886|4031786|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208595|NCT00730886|4031788|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208596|NCT00730886|4031786|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4208597|NCT00730886|4031788|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4208598|NCT00730886|4031786|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208599|NCT00730886|4031788|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208600|NCT00730886|4031786|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208601|NCT00730886|4031788|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208602|NCT00730886|4031786|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4208603|NCT00730886|4031788|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4208604|NCT00730886|4031786|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208605|NCT00730886|4031788|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208606|NCT00730886|4031786|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4208607|NCT00730886|4031788|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4208608|NCT00730886|4031786|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4208609|NCT00730886|4031788|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4208610|NCT00730886|4031786|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4208611|NCT00730886|4031788|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4208612|NCT00730886|4031786|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4208613|NCT00730886|4031788|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4208614|NCT00730886|4031786|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4208615|NCT00730886|4031788|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4208616|NCT00730847|4031813|B1|Not specified||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4208617|NCT00730847|4031813|B1|Chinese||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4208618|NCT00730847|4031813|B1|South Asian||Race/Ethnicity, Customized||Participants|Count of Participants|594|594.0||||||
4208619|NCT00730847|4031813|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4208620|NCT00730847|4031813|B1||Female|Sex: Female, Male||Participants|Count of Participants|596|596.0||||||
4208621|NCT00730847|4031813|B1|||Age||Years|Mean|32.8|32.8|Standard Deviation|10.27|10.27|||
4208622|NCT00730756|4031820|B3|PM Reflective TOSS||Total Nasal (TNSS) and Total Ocular (TOSS) Symptom Scores|Total Symptom Scores (scale of 0-9; sum of the three individual nasal or ocular scores) based on 3 nasal symptoms (rhinorrhea, nasal congestion, and post-nasal drip) and 3 ocular symptoms (eye itching/burning, eye tearing/watering, and eye redness). Symptoms were evaluated on a scale of 0 (none), 1 (mild), 2 (moderate), or 3 (severe).|points on a scale|Mean|2.8|2.8|Standard Deviation|2.34|2.34|||
4208623|NCT00730756|4031821|B2|PM Reflective TOSS||Total Nasal (TNSS) and Total Ocular (TOSS) Symptom Scores|Total Symptom Scores (scale of 0-9; sum of the three individual nasal or ocular scores) based on 3 nasal symptoms (rhinorrhea, nasal congestion, and post-nasal drip) and 3 ocular symptoms (eye itching/burning, eye tearing/watering, and eye redness). Symptoms were evaluated on a scale of 0 (none), 1 (mild), 2 (moderate), or 3 (severe).|points on a scale|Mean|3.2|3.2|Standard Deviation|2.42|2.42|||
4208624|NCT00730756|4031822|B1|PM Reflective TOSS||Total Nasal (TNSS) and Total Ocular (TOSS) Symptom Scores|Total Symptom Scores (scale of 0-9; sum of the three individual nasal or ocular scores) based on 3 nasal symptoms (rhinorrhea, nasal congestion, and post-nasal drip) and 3 ocular symptoms (eye itching/burning, eye tearing/watering, and eye redness). Symptoms were evaluated on a scale of 0 (none), 1 (mild), 2 (moderate), or 3 (severe).|points on a scale|Mean|2.4|2.4|Standard Deviation|2.19|2.19|||
4208625|NCT00730756|4031820|B3|AM Reflective TOSS||Total Nasal (TNSS) and Total Ocular (TOSS) Symptom Scores|Total Symptom Scores (scale of 0-9; sum of the three individual nasal or ocular scores) based on 3 nasal symptoms (rhinorrhea, nasal congestion, and post-nasal drip) and 3 ocular symptoms (eye itching/burning, eye tearing/watering, and eye redness). Symptoms were evaluated on a scale of 0 (none), 1 (mild), 2 (moderate), or 3 (severe).|points on a scale|Mean|2.7|2.7|Standard Deviation|2.19|2.19|||
4208626|NCT00730756|4031821|B2|AM Reflective TOSS||Total Nasal (TNSS) and Total Ocular (TOSS) Symptom Scores|Total Symptom Scores (scale of 0-9; sum of the three individual nasal or ocular scores) based on 3 nasal symptoms (rhinorrhea, nasal congestion, and post-nasal drip) and 3 ocular symptoms (eye itching/burning, eye tearing/watering, and eye redness). Symptoms were evaluated on a scale of 0 (none), 1 (mild), 2 (moderate), or 3 (severe).|points on a scale|Mean|3.0|3.0|Standard Deviation|2.16|2.16|||
4208627|NCT00730756|4031822|B1|AM Reflective TOSS||Total Nasal (TNSS) and Total Ocular (TOSS) Symptom Scores|Total Symptom Scores (scale of 0-9; sum of the three individual nasal or ocular scores) based on 3 nasal symptoms (rhinorrhea, nasal congestion, and post-nasal drip) and 3 ocular symptoms (eye itching/burning, eye tearing/watering, and eye redness). Symptoms were evaluated on a scale of 0 (none), 1 (mild), 2 (moderate), or 3 (severe).|points on a scale|Mean|2.4|2.4|Standard Deviation|2.20|2.2|||
4208628|NCT00730756|4031820|B3|AM pre-dose iTOSS||Total Nasal (TNSS) and Total Ocular (TOSS) Symptom Scores|Total Symptom Scores (scale of 0-9; sum of the three individual nasal or ocular scores) based on 3 nasal symptoms (rhinorrhea, nasal congestion, and post-nasal drip) and 3 ocular symptoms (eye itching/burning, eye tearing/watering, and eye redness). Symptoms were evaluated on a scale of 0 (none), 1 (mild), 2 (moderate), or 3 (severe).|points on a scale|Mean|2.8|2.8|Standard Deviation|2.22|2.22|||
4208629|NCT00730756|4031821|B2|AM pre-dose iTOSS||Total Nasal (TNSS) and Total Ocular (TOSS) Symptom Scores|Total Symptom Scores (scale of 0-9; sum of the three individual nasal or ocular scores) based on 3 nasal symptoms (rhinorrhea, nasal congestion, and post-nasal drip) and 3 ocular symptoms (eye itching/burning, eye tearing/watering, and eye redness). Symptoms were evaluated on a scale of 0 (none), 1 (mild), 2 (moderate), or 3 (severe).|points on a scale|Mean|3.1|3.1|Standard Deviation|2.17|2.17|||
4208630|NCT00730756|4031822|B1|AM pre-dose iTOSS||Total Nasal (TNSS) and Total Ocular (TOSS) Symptom Scores|Total Symptom Scores (scale of 0-9; sum of the three individual nasal or ocular scores) based on 3 nasal symptoms (rhinorrhea, nasal congestion, and post-nasal drip) and 3 ocular symptoms (eye itching/burning, eye tearing/watering, and eye redness). Symptoms were evaluated on a scale of 0 (none), 1 (mild), 2 (moderate), or 3 (severe).|points on a scale|Mean|2.4|2.4|Standard Deviation|2.24|2.24|||
4208631|NCT00730756|4031820|B3|Daily Reflective TOSS||Total Nasal (TNSS) and Total Ocular (TOSS) Symptom Scores|Total Symptom Scores (scale of 0-9; sum of the three individual nasal or ocular scores) based on 3 nasal symptoms (rhinorrhea, nasal congestion, and post-nasal drip) and 3 ocular symptoms (eye itching/burning, eye tearing/watering, and eye redness). Symptoms were evaluated on a scale of 0 (none), 1 (mild), 2 (moderate), or 3 (severe).|points on a scale|Mean|2.8|2.8|Standard Deviation|2.24|2.24|||
4208632|NCT00730756|4031821|B2|Daily Reflective TOSS||Total Nasal (TNSS) and Total Ocular (TOSS) Symptom Scores|Total Symptom Scores (scale of 0-9; sum of the three individual nasal or ocular scores) based on 3 nasal symptoms (rhinorrhea, nasal congestion, and post-nasal drip) and 3 ocular symptoms (eye itching/burning, eye tearing/watering, and eye redness). Symptoms were evaluated on a scale of 0 (none), 1 (mild), 2 (moderate), or 3 (severe).|points on a scale|Mean|3.1|3.1|Standard Deviation|2.27|2.27|||
4208633|NCT00730756|4031822|B1|Daily Reflective TOSS||Total Nasal (TNSS) and Total Ocular (TOSS) Symptom Scores|Total Symptom Scores (scale of 0-9; sum of the three individual nasal or ocular scores) based on 3 nasal symptoms (rhinorrhea, nasal congestion, and post-nasal drip) and 3 ocular symptoms (eye itching/burning, eye tearing/watering, and eye redness). Symptoms were evaluated on a scale of 0 (none), 1 (mild), 2 (moderate), or 3 (severe).|points on a scale|Mean|2.4|2.4|Standard Deviation|2.17|2.17|||
4208656|NCT00730756|4031821|B2|||Age|Participants must have been 12 years of age or older.|years|Mean|37.1|37.1|Standard Deviation|12.78|12.78|||
4208657|NCT00730756|4031822|B1|||Age|Participants must have been 12 years of age or older.|years|Mean|35.9|35.9|Standard Deviation|10.89|10.89|||
4208658|NCT00730730|4031845|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4208634|NCT00730756|4031820|B3|Evening (PM) Reflective TNSS||Total Nasal (TNSS) and Total Ocular (TOSS) Symptom Scores|Total Symptom Scores (scale of 0-9; sum of the three individual nasal or ocular scores) based on 3 nasal symptoms (rhinorrhea, nasal congestion, and post-nasal drip) and 3 ocular symptoms (eye itching/burning, eye tearing/watering, and eye redness). Symptoms were evaluated on a scale of 0 (none), 1 (mild), 2 (moderate), or 3 (severe).|points on a scale|Mean|6.5|6.5|Standard Deviation|1.32|1.32|||
4208635|NCT00730756|4031821|B2|Evening (PM) Reflective TNSS||Total Nasal (TNSS) and Total Ocular (TOSS) Symptom Scores|Total Symptom Scores (scale of 0-9; sum of the three individual nasal or ocular scores) based on 3 nasal symptoms (rhinorrhea, nasal congestion, and post-nasal drip) and 3 ocular symptoms (eye itching/burning, eye tearing/watering, and eye redness). Symptoms were evaluated on a scale of 0 (none), 1 (mild), 2 (moderate), or 3 (severe).|points on a scale|Mean|6.7|6.7|Standard Deviation|1.32|1.32|||
4208636|NCT00730756|4031822|B1|Evening (PM) Reflective TNSS||Total Nasal (TNSS) and Total Ocular (TOSS) Symptom Scores|Total Symptom Scores (scale of 0-9; sum of the three individual nasal or ocular scores) based on 3 nasal symptoms (rhinorrhea, nasal congestion, and post-nasal drip) and 3 ocular symptoms (eye itching/burning, eye tearing/watering, and eye redness). Symptoms were evaluated on a scale of 0 (none), 1 (mild), 2 (moderate), or 3 (severe).|points on a scale|Mean|6.3|6.3|Standard Deviation|1.31|1.31|||
4208637|NCT00730756|4031820|B3|AM Reflective TNSS||Total Nasal (TNSS) and Total Ocular (TOSS) Symptom Scores|Total Symptom Scores (scale of 0-9; sum of the three individual nasal or ocular scores) based on 3 nasal symptoms (rhinorrhea, nasal congestion, and post-nasal drip) and 3 ocular symptoms (eye itching/burning, eye tearing/watering, and eye redness). Symptoms were evaluated on a scale of 0 (none), 1 (mild), 2 (moderate), or 3 (severe).|points on a scale|Mean|6.5|6.5|Standard Deviation|1.30|1.3|||
4208638|NCT00730756|4031821|B2|AM Reflective TNSS||Total Nasal (TNSS) and Total Ocular (TOSS) Symptom Scores|Total Symptom Scores (scale of 0-9; sum of the three individual nasal or ocular scores) based on 3 nasal symptoms (rhinorrhea, nasal congestion, and post-nasal drip) and 3 ocular symptoms (eye itching/burning, eye tearing/watering, and eye redness). Symptoms were evaluated on a scale of 0 (none), 1 (mild), 2 (moderate), or 3 (severe).|points on a scale|Mean|6.7|6.7|Standard Deviation|1.36|1.36|||
4208639|NCT00730756|4031822|B1|AM Reflective TNSS||Total Nasal (TNSS) and Total Ocular (TOSS) Symptom Scores|Total Symptom Scores (scale of 0-9; sum of the three individual nasal or ocular scores) based on 3 nasal symptoms (rhinorrhea, nasal congestion, and post-nasal drip) and 3 ocular symptoms (eye itching/burning, eye tearing/watering, and eye redness). Symptoms were evaluated on a scale of 0 (none), 1 (mild), 2 (moderate), or 3 (severe).|points on a scale|Mean|6.4|6.4|Standard Deviation|1.24|1.24|||
4208640|NCT00730756|4031820|B3|Morning (AM) pre-dose instantaneous (i) TNSS||Total Nasal (TNSS) and Total Ocular (TOSS) Symptom Scores|Total Symptom Scores (scale of 0-9; sum of the three individual nasal or ocular scores) based on 3 nasal symptoms (rhinorrhea, nasal congestion, and post-nasal drip) and 3 ocular symptoms (eye itching/burning, eye tearing/watering, and eye redness). Symptoms were evaluated on a scale of 0 (none), 1 (mild), 2 (moderate), or 3 (severe).|points on a scale|Mean|6.4|6.4|Standard Deviation|1.53|1.53|||
4208641|NCT00730756|4031821|B2|Morning (AM) pre-dose instantaneous (i) TNSS||Total Nasal (TNSS) and Total Ocular (TOSS) Symptom Scores|Total Symptom Scores (scale of 0-9; sum of the three individual nasal or ocular scores) based on 3 nasal symptoms (rhinorrhea, nasal congestion, and post-nasal drip) and 3 ocular symptoms (eye itching/burning, eye tearing/watering, and eye redness). Symptoms were evaluated on a scale of 0 (none), 1 (mild), 2 (moderate), or 3 (severe).|points on a scale|Mean|6.5|6.5|Standard Deviation|1.57|1.57|||
4208642|NCT00730756|4031822|B1|Morning (AM) pre-dose instantaneous (i) TNSS||Total Nasal (TNSS) and Total Ocular (TOSS) Symptom Scores|Total Symptom Scores (scale of 0-9; sum of the three individual nasal or ocular scores) based on 3 nasal symptoms (rhinorrhea, nasal congestion, and post-nasal drip) and 3 ocular symptoms (eye itching/burning, eye tearing/watering, and eye redness). Symptoms were evaluated on a scale of 0 (none), 1 (mild), 2 (moderate), or 3 (severe).|points on a scale|Mean|6.3|6.3|Standard Deviation|1.50|1.5|||
4208643|NCT00730756|4031820|B3|Daily Reflective TNSS||Total Nasal (TNSS) and Total Ocular (TOSS) Symptom Scores|Total Symptom Scores (scale of 0-9; sum of the three individual nasal or ocular scores) based on 3 nasal symptoms (rhinorrhea, nasal congestion, and post-nasal drip) and 3 ocular symptoms (eye itching/burning, eye tearing/watering, and eye redness). Symptoms were evaluated on a scale of 0 (none), 1 (mild), 2 (moderate), or 3 (severe).|points on a scale|Mean|6.5|6.5|Standard Deviation|1.22|1.22|||
4208644|NCT00730756|4031821|B2|Daily Reflective TNSS||Total Nasal (TNSS) and Total Ocular (TOSS) Symptom Scores|Total Symptom Scores (scale of 0-9; sum of the three individual nasal or ocular scores) based on 3 nasal symptoms (rhinorrhea, nasal congestion, and post-nasal drip) and 3 ocular symptoms (eye itching/burning, eye tearing/watering, and eye redness). Symptoms were evaluated on a scale of 0 (none), 1 (mild), 2 (moderate), or 3 (severe).|points on a scale|Mean|6.7|6.7|Standard Deviation|1.25|1.25|||
4208645|NCT00730756|4031822|B1|Daily Reflective TNSS||Total Nasal (TNSS) and Total Ocular (TOSS) Symptom Scores|Total Symptom Scores (scale of 0-9; sum of the three individual nasal or ocular scores) based on 3 nasal symptoms (rhinorrhea, nasal congestion, and post-nasal drip) and 3 ocular symptoms (eye itching/burning, eye tearing/watering, and eye redness). Symptoms were evaluated on a scale of 0 (none), 1 (mild), 2 (moderate), or 3 (severe).|points on a scale|Mean|6.4|6.4|Standard Deviation|1.16|1.16|||
4208646|NCT00730756|4031820|B3|Asian||Race/Ethnicity, Customized||participants|Number|102|102.0||||||
4208647|NCT00730756|4031821|B2|Asian||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
4208648|NCT00730756|4031822|B1|Asian||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4208649|NCT00730756|4031820|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4208650|NCT00730756|4031821|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4208651|NCT00730756|4031822|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4208652|NCT00730756|4031820|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4208653|NCT00730756|4031821|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4208654|NCT00730756|4031822|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4208655|NCT00730756|4031820|B3|||Age|Participants must have been 12 years of age or older.|years|Mean|36.6|36.6|Standard Deviation|11.87|11.87|||
4208659|NCT00730730|4031845|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4208660|NCT00730730|4031845|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4208661|NCT00730730|4031845|B1|||Age||years|Mean|66|66.0|Standard Deviation|12|12.0|||
4208662|NCT00730691|4031852|B6|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|12.16|12.16|Standard Deviation|2.989|2.989|||
4208663|NCT00730691|4031853|B5|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|11.99|11.99|Standard Deviation|3.087|3.087|||
4208664|NCT00730691|4031854|B4|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|12.47|12.47|Standard Deviation|2.868|2.868|||
4208665|NCT00730691|4031855|B3|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|12.24|12.24|Standard Deviation|2.895|2.895|||
4208666|NCT00730691|4031856|B2|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|12.24|12.24|Standard Deviation|3.279|3.279|||
4208667|NCT00730691|4031857|B1|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|11.83|11.83|Standard Deviation|2.787|2.787|||
4208668|NCT00730691|4031852|B6|||Hospital Anxiety and Depression – Depression subscale|Hospital Anxiety and Depression (HAD) Depression sub-scale consists of 7 items that are assessed on a scale from 0 (no depression) to 3 (severe feeling of depression). The depression subscale focuses on the state of lost interest and diminished pleasure response. Scores are summed and range from 0 to 21 (maximal severity).|scores on a scale|Mean|8.2|8.2|Standard Deviation|3.89|3.89|||
4208669|NCT00730691|4031853|B5|||Hospital Anxiety and Depression – Depression subscale|Hospital Anxiety and Depression (HAD) Depression sub-scale consists of 7 items that are assessed on a scale from 0 (no depression) to 3 (severe feeling of depression). The depression subscale focuses on the state of lost interest and diminished pleasure response. Scores are summed and range from 0 to 21 (maximal severity).|scores on a scale|Mean|8.2|8.2|Standard Deviation|4.00|4.0|||
4208670|NCT00730691|4031854|B4|||Hospital Anxiety and Depression – Depression subscale|Hospital Anxiety and Depression (HAD) Depression sub-scale consists of 7 items that are assessed on a scale from 0 (no depression) to 3 (severe feeling of depression). The depression subscale focuses on the state of lost interest and diminished pleasure response. Scores are summed and range from 0 to 21 (maximal severity).|scores on a scale|Mean|8.5|8.5|Standard Deviation|3.59|3.59|||
4208671|NCT00730691|4031855|B3|||Hospital Anxiety and Depression – Depression subscale|Hospital Anxiety and Depression (HAD) Depression sub-scale consists of 7 items that are assessed on a scale from 0 (no depression) to 3 (severe feeling of depression). The depression subscale focuses on the state of lost interest and diminished pleasure response. Scores are summed and range from 0 to 21 (maximal severity).|scores on a scale|Mean|8.2|8.2|Standard Deviation|3.94|3.94|||
4208672|NCT00730691|4031856|B2|||Hospital Anxiety and Depression – Depression subscale|Hospital Anxiety and Depression (HAD) Depression sub-scale consists of 7 items that are assessed on a scale from 0 (no depression) to 3 (severe feeling of depression). The depression subscale focuses on the state of lost interest and diminished pleasure response. Scores are summed and range from 0 to 21 (maximal severity).|scores on a scale|Mean|8.2|8.2|Standard Deviation|3.83|3.83|||
4208673|NCT00730691|4031857|B1|||Hospital Anxiety and Depression – Depression subscale|Hospital Anxiety and Depression (HAD) Depression sub-scale consists of 7 items that are assessed on a scale from 0 (no depression) to 3 (severe feeling of depression). The depression subscale focuses on the state of lost interest and diminished pleasure response. Scores are summed and range from 0 to 21 (maximal severity).|scores on a scale|Mean|8.2|8.2|Standard Deviation|4.12|4.12|||
4208674|NCT00730691|4031852|B6|||Hospital Anxiety and Depression – Anxiety subscale|Hospital Anxiety and Depression (HAD) Anxiety sub-scale consists of 7 items that are assessed on a scale from 0 (no anxiety) to 3 (severe feeling of anxiety). The anxiety subscale determines a state of generalized anxiety including anxious mood, restlessness, anxious thoughts and panic attacks. Scores are summed and range from 0 to 21 (maximal severity).|scores on a scale|Mean|13.8|13.8|Standard Deviation|3.41|3.41|||
4208675|NCT00730691|4031853|B5|||Hospital Anxiety and Depression – Anxiety subscale|Hospital Anxiety and Depression (HAD) Anxiety sub-scale consists of 7 items that are assessed on a scale from 0 (no anxiety) to 3 (severe feeling of anxiety). The anxiety subscale determines a state of generalized anxiety including anxious mood, restlessness, anxious thoughts and panic attacks. Scores are summed and range from 0 to 21 (maximal severity).|scores on a scale|Mean|13.4|13.4|Standard Deviation|3.70|3.7|||
4208676|NCT00730691|4031854|B4|||Hospital Anxiety and Depression – Anxiety subscale|Hospital Anxiety and Depression (HAD) Anxiety sub-scale consists of 7 items that are assessed on a scale from 0 (no anxiety) to 3 (severe feeling of anxiety). The anxiety subscale determines a state of generalized anxiety including anxious mood, restlessness, anxious thoughts and panic attacks. Scores are summed and range from 0 to 21 (maximal severity).|scores on a scale|Mean|14.0|14.0|Standard Deviation|3.02|3.02|||
4208725|NCT00730691|4031855|B3|Ex-smoker||Smoking Classification|Smoking classification data available for 156 participants in the placebo arm.|participants|Number|31|31.0||||||
4208825|NCT00730639|4031949|B5|NSCLC of Unspecified Histology||Tumor Type||participants|Number|1|1.0||||||
4208677|NCT00730691|4031855|B3|||Hospital Anxiety and Depression – Anxiety subscale|Hospital Anxiety and Depression (HAD) Anxiety sub-scale consists of 7 items that are assessed on a scale from 0 (no anxiety) to 3 (severe feeling of anxiety). The anxiety subscale determines a state of generalized anxiety including anxious mood, restlessness, anxious thoughts and panic attacks. Scores are summed and range from 0 to 21 (maximal severity).|scores on a scale|Mean|13.8|13.8|Standard Deviation|3.70|3.7|||
4208678|NCT00730691|4031856|B2|||Hospital Anxiety and Depression – Anxiety subscale|Hospital Anxiety and Depression (HAD) Anxiety sub-scale consists of 7 items that are assessed on a scale from 0 (no anxiety) to 3 (severe feeling of anxiety). The anxiety subscale determines a state of generalized anxiety including anxious mood, restlessness, anxious thoughts and panic attacks. Scores are summed and range from 0 to 21 (maximal severity).|scores on a scale|Mean|13.8|13.8|Standard Deviation|3.40|3.4|||
4208679|NCT00730691|4031857|B1|||Hospital Anxiety and Depression – Anxiety subscale|Hospital Anxiety and Depression (HAD) Anxiety sub-scale consists of 7 items that are assessed on a scale from 0 (no anxiety) to 3 (severe feeling of anxiety). The anxiety subscale determines a state of generalized anxiety including anxious mood, restlessness, anxious thoughts and panic attacks. Scores are summed and range from 0 to 21 (maximal severity).|scores on a scale|Mean|13.9|13.9|Standard Deviation|3.23|3.23|||
4208680|NCT00730691|4031852|B6|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|scores on a scale|Mean|4.4|4.4|Standard Deviation|0.60|0.6|||
4208681|NCT00730691|4031853|B5|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|scores on a scale|Mean|4.4|4.4|Standard Deviation|0.62|0.62|||
4208682|NCT00730691|4031854|B4|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|scores on a scale|Mean|4.4|4.4|Standard Deviation|0.59|0.59|||
4208683|NCT00730691|4031855|B3|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|scores on a scale|Mean|4.4|4.4|Standard Deviation|0.59|0.59|||
4208684|NCT00730691|4031856|B2|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|scores on a scale|Mean|4.4|4.4|Standard Deviation|0.63|0.63|||
4208685|NCT00730691|4031857|B1|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|scores on a scale|Mean|4.3|4.3|Standard Deviation|0.56|0.56|||
4208686|NCT00730691|4031852|B6|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 (absent) to 56 (maximum severity).|scores on a scale|Mean|25.0|25.0|Standard Deviation|3.90|3.9|||
4208687|NCT00730691|4031853|B5|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 (absent) to 56 (maximum severity).|scores on a scale|Mean|25.0|25.0|Standard Deviation|3.94|3.94|||
4208688|NCT00730691|4031854|B4|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 (absent) to 56 (maximum severity).|scores on a scale|Mean|25.3|25.3|Standard Deviation|3.96|3.96|||
4208689|NCT00730691|4031855|B3|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 (absent) to 56 (maximum severity).|scores on a scale|Mean|25.0|25.0|Standard Deviation|3.57|3.57|||
4208726|NCT00730691|4031856|B2|Ex-smoker||Smoking Classification|Smoking classification data available for 156 participants in the placebo arm.|participants|Number|28|28.0||||||
4208727|NCT00730691|4031857|B1|Ex-smoker||Smoking Classification|Smoking classification data available for 156 participants in the placebo arm.|participants|Number|23|23.0||||||
4208690|NCT00730691|4031856|B2|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 (absent) to 56 (maximum severity).|scores on a scale|Mean|25.3|25.3|Standard Deviation|4.25|4.25|||
4208691|NCT00730691|4031857|B1|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 (absent) to 56 (maximum severity).|scores on a scale|Mean|24.4|24.4|Standard Deviation|3.73|3.73|||
4208692|NCT00730691|4031852|B6|Daily||Alcohol Consumption|Alcohol consumption data available for 156 participants in the placebo arm.|participants|Number|15|15.0||||||
4208693|NCT00730691|4031853|B5|Daily||Alcohol Consumption|Alcohol consumption data available for 156 participants in the placebo arm.|participants|Number|7|7.0||||||
4208694|NCT00730691|4031854|B4|Daily||Alcohol Consumption|Alcohol consumption data available for 156 participants in the placebo arm.|participants|Number|3|3.0||||||
4208695|NCT00730691|4031855|B3|Daily||Alcohol Consumption|Alcohol consumption data available for 156 participants in the placebo arm.|participants|Number|2|2.0||||||
4208696|NCT00730691|4031856|B2|Daily||Alcohol Consumption|Alcohol consumption data available for 156 participants in the placebo arm.|participants|Number|2|2.0||||||
4208697|NCT00730691|4031857|B1|Daily||Alcohol Consumption|Alcohol consumption data available for 156 participants in the placebo arm.|participants|Number|1|1.0||||||
4208698|NCT00730691|4031852|B6|2 to 6 times per week||Alcohol Consumption|Alcohol consumption data available for 156 participants in the placebo arm.|participants|Number|108|108.0||||||
4208699|NCT00730691|4031853|B5|2 to 6 times per week||Alcohol Consumption|Alcohol consumption data available for 156 participants in the placebo arm.|participants|Number|22|22.0||||||
4208700|NCT00730691|4031854|B4|2 to 6 times per week||Alcohol Consumption|Alcohol consumption data available for 156 participants in the placebo arm.|participants|Number|22|22.0||||||
4208701|NCT00730691|4031855|B3|2 to 6 times per week||Alcohol Consumption|Alcohol consumption data available for 156 participants in the placebo arm.|participants|Number|17|17.0||||||
4208702|NCT00730691|4031856|B2|2 to 6 times per week||Alcohol Consumption|Alcohol consumption data available for 156 participants in the placebo arm.|participants|Number|30|30.0||||||
4208703|NCT00730691|4031857|B1|2 to 6 times per week||Alcohol Consumption|Alcohol consumption data available for 156 participants in the placebo arm.|participants|Number|17|17.0||||||
4208704|NCT00730691|4031852|B6|Once a week||Alcohol Consumption|Alcohol consumption data available for 156 participants in the placebo arm.|participants|Number|131|131.0||||||
4208705|NCT00730691|4031853|B5|Once a week||Alcohol Consumption|Alcohol consumption data available for 156 participants in the placebo arm.|participants|Number|19|19.0||||||
4208706|NCT00730691|4031854|B4|Once a week||Alcohol Consumption|Alcohol consumption data available for 156 participants in the placebo arm.|participants|Number|29|29.0||||||
4208707|NCT00730691|4031855|B3|Once a week||Alcohol Consumption|Alcohol consumption data available for 156 participants in the placebo arm.|participants|Number|31|31.0||||||
4208708|NCT00730691|4031856|B2|Once a week||Alcohol Consumption|Alcohol consumption data available for 156 participants in the placebo arm.|participants|Number|25|25.0||||||
4208709|NCT00730691|4031857|B1|Once a week||Alcohol Consumption|Alcohol consumption data available for 156 participants in the placebo arm.|participants|Number|27|27.0||||||
4208710|NCT00730691|4031852|B6|Once monthly or less often||Alcohol Consumption|Alcohol consumption data available for 156 participants in the placebo arm.|participants|Number|300|300.0||||||
4208711|NCT00730691|4031853|B5|Once monthly or less often||Alcohol Consumption|Alcohol consumption data available for 156 participants in the placebo arm.|participants|Number|64|64.0||||||
4208712|NCT00730691|4031854|B4|Once monthly or less often||Alcohol Consumption|Alcohol consumption data available for 156 participants in the placebo arm.|participants|Number|49|49.0||||||
4208713|NCT00730691|4031855|B3|Once monthly or less often||Alcohol Consumption|Alcohol consumption data available for 156 participants in the placebo arm.|participants|Number|66|66.0||||||
4208714|NCT00730691|4031856|B2|Once monthly or less often||Alcohol Consumption|Alcohol consumption data available for 156 participants in the placebo arm.|participants|Number|50|50.0||||||
4208715|NCT00730691|4031857|B1|Once monthly or less often||Alcohol Consumption|Alcohol consumption data available for 156 participants in the placebo arm.|participants|Number|71|71.0||||||
4208716|NCT00730691|4031852|B6|Never||Alcohol Consumption|Alcohol consumption data available for 156 participants in the placebo arm.|participants|Number|226|226.0||||||
4208717|NCT00730691|4031853|B5|Never||Alcohol Consumption|Alcohol consumption data available for 156 participants in the placebo arm.|participants|Number|44|44.0||||||
4208718|NCT00730691|4031854|B4|Never||Alcohol Consumption|Alcohol consumption data available for 156 participants in the placebo arm.|participants|Number|53|53.0||||||
4208719|NCT00730691|4031855|B3|Never||Alcohol Consumption|Alcohol consumption data available for 156 participants in the placebo arm.|participants|Number|40|40.0||||||
4208720|NCT00730691|4031856|B2|Never||Alcohol Consumption|Alcohol consumption data available for 156 participants in the placebo arm.|participants|Number|49|49.0||||||
4208721|NCT00730691|4031857|B1|Never||Alcohol Consumption|Alcohol consumption data available for 156 participants in the placebo arm.|participants|Number|40|40.0||||||
4208722|NCT00730691|4031852|B6|Ex-smoker||Smoking Classification|Smoking classification data available for 156 participants in the placebo arm.|participants|Number|141|141.0||||||
4208723|NCT00730691|4031853|B5|Ex-smoker||Smoking Classification|Smoking classification data available for 156 participants in the placebo arm.|participants|Number|31|31.0||||||
4208724|NCT00730691|4031854|B4|Ex-smoker||Smoking Classification|Smoking classification data available for 156 participants in the placebo arm.|participants|Number|28|28.0||||||
4208824|NCT00730639|4031948|B6|NSCLC of Unspecified Histology||Tumor Type||participants|Number|1|1.0||||||
4208728|NCT00730691|4031852|B6|Current Smoker||Smoking Classification|Smoking classification data available for 156 participants in the placebo arm.|participants|Number|214|214.0||||||
4208729|NCT00730691|4031853|B5|Current Smoker||Smoking Classification|Smoking classification data available for 156 participants in the placebo arm.|participants|Number|43|43.0||||||
4208730|NCT00730691|4031854|B4|Current Smoker||Smoking Classification|Smoking classification data available for 156 participants in the placebo arm.|participants|Number|43|43.0||||||
4208731|NCT00730691|4031855|B3|Current Smoker||Smoking Classification|Smoking classification data available for 156 participants in the placebo arm.|participants|Number|44|44.0||||||
4208732|NCT00730691|4031856|B2|Current Smoker||Smoking Classification|Smoking classification data available for 156 participants in the placebo arm.|participants|Number|43|43.0||||||
4208733|NCT00730691|4031857|B1|Current Smoker||Smoking Classification|Smoking classification data available for 156 participants in the placebo arm.|participants|Number|41|41.0||||||
4208734|NCT00730691|4031852|B6|Never Smoked||Smoking Classification|Smoking classification data available for 156 participants in the placebo arm.|participants|Number|425|425.0||||||
4208735|NCT00730691|4031853|B5|Never Smoked||Smoking Classification|Smoking classification data available for 156 participants in the placebo arm.|participants|Number|82|82.0||||||
4208736|NCT00730691|4031854|B4|Never Smoked||Smoking Classification|Smoking classification data available for 156 participants in the placebo arm.|participants|Number|85|85.0||||||
4208737|NCT00730691|4031855|B3|Never Smoked||Smoking Classification|Smoking classification data available for 156 participants in the placebo arm.|participants|Number|81|81.0||||||
4208738|NCT00730691|4031856|B2|Never Smoked||Smoking Classification|Smoking classification data available for 156 participants in the placebo arm.|participants|Number|85|85.0||||||
4208739|NCT00730691|4031857|B1|Never Smoked||Smoking Classification|Smoking classification data available for 156 participants in the placebo arm.|participants|Number|92|92.0||||||
4208740|NCT00730691|4031852|B6|||Body Mass Index (BMI)||kg/m^2|Mean|28.51|28.51|Standard Deviation|7.064|7.064|||
4208741|NCT00730691|4031853|B5|||Body Mass Index (BMI)||kg/m^2|Mean|28.10|28.1|Standard Deviation|6.325|6.325|||
4208742|NCT00730691|4031854|B4|||Body Mass Index (BMI)||kg/m^2|Mean|28.49|28.49|Standard Deviation|7.058|7.058|||
4208743|NCT00730691|4031855|B3|||Body Mass Index (BMI)||kg/m^2|Mean|28.24|28.24|Standard Deviation|6.589|6.589|||
4208744|NCT00730691|4031856|B2|||Body Mass Index (BMI)||kg/m^2|Mean|28.19|28.19|Standard Deviation|6.651|6.651|||
4208745|NCT00730691|4031857|B1|||Body Mass Index (BMI)||kg/m^2|Mean|29.54|29.54|Standard Deviation|8.478|8.478|||
4208746|NCT00730691|4031852|B6|||Height||cm|Mean|168.28|168.28|Standard Deviation|9.147|9.147|||
4208747|NCT00730691|4031853|B5|||Height||cm|Mean|167.94|167.94|Standard Deviation|9.300|9.3|||
4208748|NCT00730691|4031854|B4|||Height||cm|Mean|167.61|167.61|Standard Deviation|8.378|8.378|||
4208749|NCT00730691|4031855|B3|||Height||cm|Mean|169.25|169.25|Standard Deviation|9.282|9.282|||
4208750|NCT00730691|4031856|B2|||Height||cm|Mean|167.87|167.87|Standard Deviation|9.139|9.139|||
4208751|NCT00730691|4031857|B1|||Height||cm|Mean|168.74|168.74|Standard Deviation|9.605|9.605|||
4208752|NCT00730691|4031852|B6|||Weight||kg|Mean|80.91|80.91|Standard Deviation|21.558|21.558|||
4208753|NCT00730691|4031853|B5|||Weight||kg|Mean|79.51|79.51|Standard Deviation|20.090|20.09|||
4208754|NCT00730691|4031854|B4|||Weight||kg|Mean|80.17|80.17|Standard Deviation|21.420|21.42|||
4208755|NCT00730691|4031855|B3|||Weight||kg|Mean|80.98|80.98|Standard Deviation|20.312|20.312|||
4208756|NCT00730691|4031856|B2|||Weight||kg|Mean|79.47|79.47|Standard Deviation|19.893|19.893|||
4208757|NCT00730691|4031857|B1|||Weight||kg|Mean|84.40|84.4|Standard Deviation|25.426|25.426|||
4208758|NCT00730691|4031852|B6|United States||Region of Enrollment||participants|Number|781|781.0||||||
4208759|NCT00730691|4031853|B5|United States||Region of Enrollment||participants|Number|156|156.0||||||
4208760|NCT00730691|4031854|B4|United States||Region of Enrollment||participants|Number|156|156.0||||||
4208761|NCT00730691|4031855|B3|United States||Region of Enrollment||participants|Number|156|156.0||||||
4208762|NCT00730691|4031856|B2|United States||Region of Enrollment||participants|Number|156|156.0||||||
4208763|NCT00730691|4031857|B1|United States||Region of Enrollment||participants|Number|157|157.0||||||
4208764|NCT00730691|4031852|B6|Native Hawaiian/ Other Pacific Islander||Race/Ethnicity, Customized|Race data only available for 154 participants in the vortioxetine 2.5 mg arm.|participants|Number|2|2.0||||||
4208765|NCT00730691|4031853|B5|Native Hawaiian/ Other Pacific Islander||Race/Ethnicity, Customized|Race data only available for 154 participants in the vortioxetine 2.5 mg arm.|participants|Number|0|0.0||||||
4208766|NCT00730691|4031854|B4|Native Hawaiian/ Other Pacific Islander||Race/Ethnicity, Customized|Race data only available for 154 participants in the vortioxetine 2.5 mg arm.|participants|Number|1|1.0||||||
4208767|NCT00730691|4031855|B3|Native Hawaiian/ Other Pacific Islander||Race/Ethnicity, Customized|Race data only available for 154 participants in the vortioxetine 2.5 mg arm.|participants|Number|0|0.0||||||
4208768|NCT00730691|4031856|B2|Native Hawaiian/ Other Pacific Islander||Race/Ethnicity, Customized|Race data only available for 154 participants in the vortioxetine 2.5 mg arm.|participants|Number|1|1.0||||||
4208769|NCT00730691|4031857|B1|Native Hawaiian/ Other Pacific Islander||Race/Ethnicity, Customized|Race data only available for 154 participants in the vortioxetine 2.5 mg arm.|participants|Number|0|0.0||||||
4208770|NCT00730691|4031852|B6|American Indian or Alaska Native||Race/Ethnicity, Customized|Race data only available for 154 participants in the vortioxetine 2.5 mg arm.|participants|Number|3|3.0||||||
4208771|NCT00730691|4031853|B5|American Indian or Alaska Native||Race/Ethnicity, Customized|Race data only available for 154 participants in the vortioxetine 2.5 mg arm.|participants|Number|0|0.0||||||
4208772|NCT00730691|4031854|B4|American Indian or Alaska Native||Race/Ethnicity, Customized|Race data only available for 154 participants in the vortioxetine 2.5 mg arm.|participants|Number|2|2.0||||||
4208773|NCT00730691|4031855|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|Race data only available for 154 participants in the vortioxetine 2.5 mg arm.|participants|Number|0|0.0||||||
4208774|NCT00730691|4031856|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|Race data only available for 154 participants in the vortioxetine 2.5 mg arm.|participants|Number|1|1.0||||||
4208775|NCT00730691|4031857|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Race data only available for 154 participants in the vortioxetine 2.5 mg arm.|participants|Number|0|0.0||||||
4208776|NCT00730691|4031852|B6|Asian||Race/Ethnicity, Customized|Race data only available for 154 participants in the vortioxetine 2.5 mg arm.|participants|Number|14|14.0||||||
4208777|NCT00730691|4031853|B5|Asian||Race/Ethnicity, Customized|Race data only available for 154 participants in the vortioxetine 2.5 mg arm.|participants|Number|4|4.0||||||
4208778|NCT00730691|4031854|B4|Asian||Race/Ethnicity, Customized|Race data only available for 154 participants in the vortioxetine 2.5 mg arm.|participants|Number|0|0.0||||||
4208779|NCT00730691|4031855|B3|Asian||Race/Ethnicity, Customized|Race data only available for 154 participants in the vortioxetine 2.5 mg arm.|participants|Number|6|6.0||||||
4208780|NCT00730691|4031856|B2|Asian||Race/Ethnicity, Customized|Race data only available for 154 participants in the vortioxetine 2.5 mg arm.|participants|Number|0|0.0||||||
4208781|NCT00730691|4031857|B1|Asian||Race/Ethnicity, Customized|Race data only available for 154 participants in the vortioxetine 2.5 mg arm.|participants|Number|4|4.0||||||
4208782|NCT00730691|4031852|B6|Black||Race/Ethnicity, Customized|Race data only available for 154 participants in the vortioxetine 2.5 mg arm.|participants|Number|156|156.0||||||
4208783|NCT00730691|4031853|B5|Black||Race/Ethnicity, Customized|Race data only available for 154 participants in the vortioxetine 2.5 mg arm.|participants|Number|31|31.0||||||
4208784|NCT00730691|4031854|B4|Black||Race/Ethnicity, Customized|Race data only available for 154 participants in the vortioxetine 2.5 mg arm.|participants|Number|33|33.0||||||
4208785|NCT00730691|4031855|B3|Black||Race/Ethnicity, Customized|Race data only available for 154 participants in the vortioxetine 2.5 mg arm.|participants|Number|26|26.0||||||
4208786|NCT00730691|4031856|B2|Black||Race/Ethnicity, Customized|Race data only available for 154 participants in the vortioxetine 2.5 mg arm.|participants|Number|31|31.0||||||
4208787|NCT00730691|4031857|B1|Black||Race/Ethnicity, Customized|Race data only available for 154 participants in the vortioxetine 2.5 mg arm.|participants|Number|35|35.0||||||
4208788|NCT00730691|4031852|B6|Caucasian (White, including Hispanic)||Race/Ethnicity, Customized|Race data only available for 154 participants in the vortioxetine 2.5 mg arm.|participants|Number|604|604.0||||||
4208789|NCT00730691|4031853|B5|Caucasian (White, including Hispanic)||Race/Ethnicity, Customized|Race data only available for 154 participants in the vortioxetine 2.5 mg arm.|participants|Number|121|121.0||||||
4208790|NCT00730691|4031854|B4|Caucasian (White, including Hispanic)||Race/Ethnicity, Customized|Race data only available for 154 participants in the vortioxetine 2.5 mg arm.|participants|Number|120|120.0||||||
4208791|NCT00730691|4031855|B3|Caucasian (White, including Hispanic)||Race/Ethnicity, Customized|Race data only available for 154 participants in the vortioxetine 2.5 mg arm.|participants|Number|124|124.0||||||
4208792|NCT00730691|4031856|B2|Caucasian (White, including Hispanic)||Race/Ethnicity, Customized|Race data only available for 154 participants in the vortioxetine 2.5 mg arm.|participants|Number|121|121.0||||||
4208793|NCT00730691|4031857|B1|Caucasian (White, including Hispanic)||Race/Ethnicity, Customized|Race data only available for 154 participants in the vortioxetine 2.5 mg arm.|participants|Number|118|118.0||||||
4208794|NCT00730691|4031852|B6||Male|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
4208795|NCT00730691|4031853|B5||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4208796|NCT00730691|4031854|B4||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4208797|NCT00730691|4031855|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4208798|NCT00730691|4031856|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4208799|NCT00730691|4031857|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4208800|NCT00730691|4031852|B6||Female|Sex: Female, Male||Participants|Count of Participants|529|529.0||||||
4208801|NCT00730691|4031853|B5||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4208802|NCT00730691|4031854|B4||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4208803|NCT00730691|4031855|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4208804|NCT00730691|4031856|B2||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4208805|NCT00730691|4031857|B1||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4208806|NCT00730691|4031852|B6|>55 years||Age, Customized||participants|Number|77|77.0||||||
4208807|NCT00730691|4031853|B5|>55 years||Age, Customized||participants|Number|19|19.0||||||
4208808|NCT00730691|4031854|B4|>55 years||Age, Customized||participants|Number|19|19.0||||||
4208809|NCT00730691|4031855|B3|>55 years||Age, Customized||participants|Number|9|9.0||||||
4208810|NCT00730691|4031856|B2|>55 years||Age, Customized||participants|Number|16|16.0||||||
4208811|NCT00730691|4031857|B1|>55 years||Age, Customized||participants|Number|14|14.0||||||
4208812|NCT00730691|4031852|B6|≤55 years||Age, Customized||participants|Number|704|704.0||||||
4208813|NCT00730691|4031853|B5|≤55 years||Age, Customized||participants|Number|137|137.0||||||
4208814|NCT00730691|4031854|B4|≤55 years||Age, Customized||participants|Number|137|137.0||||||
4208815|NCT00730691|4031855|B3|≤55 years||Age, Customized||participants|Number|147|147.0||||||
4208816|NCT00730691|4031856|B2|≤55 years||Age, Customized||participants|Number|140|140.0||||||
4208817|NCT00730691|4031857|B1|≤55 years||Age, Customized||participants|Number|143|143.0||||||
4208818|NCT00730691|4031852|B6|||Age||years|Mean|38.6|38.6|Standard Deviation|12.14|12.14|||
4208819|NCT00730691|4031853|B5|||Age||years|Mean|39.5|39.5|Standard Deviation|12.28|12.28|||
4208820|NCT00730691|4031854|B4|||Age||years|Mean|39.8|39.8|Standard Deviation|12.33|12.33|||
4208821|NCT00730691|4031855|B3|||Age||years|Mean|37.7|37.7|Standard Deviation|11.96|11.96|||
4208822|NCT00730691|4031856|B2|||Age||years|Mean|39.2|39.2|Standard Deviation|11.90|11.9|||
4208823|NCT00730691|4031857|B1|||Age||years|Mean|36.8|36.8|Standard Deviation|12.12|12.12|||
4208826|NCT00730639|4031950|B4|NSCLC of Unspecified Histology||Tumor Type||participants|Number|0|0.0||||||
4208827|NCT00730639|4031951|B3|NSCLC of Unspecified Histology||Tumor Type||participants|Number|0|0.0||||||
4208828|NCT00730639|4031952|B2|NSCLC of Unspecified Histology||Tumor Type||participants|Number|0|0.0||||||
4208829|NCT00730639|4031953|B1|NSCLC of Unspecified Histology||Tumor Type||participants|Number|0|0.0||||||
4208830|NCT00730639|4031948|B6|MCRPC||Tumor Type||participants|Number|17|17.0||||||
4208831|NCT00730639|4031949|B5|MCRPC||Tumor Type||participants|Number|17|17.0||||||
4208832|NCT00730639|4031950|B4|MCRPC||Tumor Type||participants|Number|0|0.0||||||
4208833|NCT00730639|4031951|B3|MCRPC||Tumor Type||participants|Number|0|0.0||||||
4208834|NCT00730639|4031952|B2|MCRPC||Tumor Type||participants|Number|0|0.0||||||
4208835|NCT00730639|4031953|B1|MCRPC||Tumor Type||participants|Number|0|0.0||||||
4208836|NCT00730639|4031948|B6|Castrate-Resistant Prostate Cancer (CRC)||Tumor Type||participants|Number|19|19.0||||||
4208837|NCT00730639|4031949|B5|Castrate-Resistant Prostate Cancer (CRC)||Tumor Type||participants|Number|19|19.0||||||
4208838|NCT00730639|4031950|B4|Castrate-Resistant Prostate Cancer (CRC)||Tumor Type||participants|Number|0|0.0||||||
4208839|NCT00730639|4031951|B3|Castrate-Resistant Prostate Cancer (CRC)||Tumor Type||participants|Number|0|0.0||||||
4208840|NCT00730639|4031952|B2|Castrate-Resistant Prostate Cancer (CRC)||Tumor Type||participants|Number|0|0.0||||||
4208841|NCT00730639|4031953|B1|Castrate-Resistant Prostate Cancer (CRC)||Tumor Type||participants|Number|0|0.0||||||
4208842|NCT00730639|4031948|B6|Renal Cell Carcinoma (RCC)||Tumor Type||participants|Number|34|34.0||||||
4208843|NCT00730639|4031949|B5|Renal Cell Carcinoma (RCC)||Tumor Type||participants|Number|16|16.0||||||
4208844|NCT00730639|4031950|B4|Renal Cell Carcinoma (RCC)||Tumor Type||participants|Number|0|0.0||||||
4208845|NCT00730639|4031951|B3|Renal Cell Carcinoma (RCC)||Tumor Type||participants|Number|18|18.0||||||
4208846|NCT00730639|4031952|B2|Renal Cell Carcinoma (RCC)||Tumor Type||participants|Number|0|0.0||||||
4208847|NCT00730639|4031953|B1|Renal Cell Carcinoma (RCC)||Tumor Type||participants|Number|0|0.0||||||
4208848|NCT00730639|4031948|B6|Melanoma||Tumor Type||participants|Number|107|107.0||||||
4208849|NCT00730639|4031949|B5|Melanoma||Tumor Type||participants|Number|20|20.0||||||
4208850|NCT00730639|4031950|B4|Melanoma||Tumor Type||participants|Number|17|17.0||||||
4208851|NCT00730639|4031951|B3|Melanoma||Tumor Type||participants|Number|35|35.0||||||
4208852|NCT00730639|4031952|B2|Melanoma||Tumor Type||participants|Number|18|18.0||||||
4208853|NCT00730639|4031953|B1|Melanoma||Tumor Type||participants|Number|17|17.0||||||
4208854|NCT00730639|4031948|B6|Non-Squamous NSCLC (NSQ NSCLC)||Tumor Type||participants|Number|74|74.0||||||
4208855|NCT00730639|4031949|B5|Non-Squamous NSCLC (NSQ NSCLC)||Tumor Type||participants|Number|37|37.0||||||
4208856|NCT00730639|4031950|B4|Non-Squamous NSCLC (NSQ NSCLC)||Tumor Type||participants|Number|19|19.0||||||
4208857|NCT00730639|4031951|B3|Non-Squamous NSCLC (NSQ NSCLC)||Tumor Type||participants|Number|18|18.0||||||
4208858|NCT00730639|4031952|B2|Non-Squamous NSCLC (NSQ NSCLC)||Tumor Type||participants|Number|0|0.0||||||
4208859|NCT00730639|4031953|B1|Non-Squamous NSCLC (NSQ NSCLC)||Tumor Type||participants|Number|0|0.0||||||
4208860|NCT00730639|4031948|B6|Squamous Non-Small Cell Lung Cancer (SQ NSCLC)||Tumor Type||participants|Number|54|54.0||||||
4208861|NCT00730639|4031949|B5|Squamous Non-Small Cell Lung Cancer (SQ NSCLC)||Tumor Type||participants|Number|21|21.0||||||
4208862|NCT00730639|4031950|B4|Squamous Non-Small Cell Lung Cancer (SQ NSCLC)||Tumor Type||participants|Number|18|18.0||||||
4208863|NCT00730639|4031951|B3|Squamous Non-Small Cell Lung Cancer (SQ NSCLC)||Tumor Type||participants|Number|15|15.0||||||
4208864|NCT00730639|4031952|B2|Squamous Non-Small Cell Lung Cancer (SQ NSCLC)||Tumor Type||participants|Number|0|0.0||||||
4208865|NCT00730639|4031953|B1|Squamous Non-Small Cell Lung Cancer (SQ NSCLC)||Tumor Type||participants|Number|0|0.0||||||
4208866|NCT00730639|4031948|B6||Male|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4208867|NCT00730639|4031949|B5||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4208868|NCT00730639|4031950|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4208869|NCT00730639|4031951|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4208870|NCT00730639|4031952|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4208871|NCT00730639|4031953|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4208872|NCT00730639|4031948|B6||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4208873|NCT00730639|4031949|B5||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4208874|NCT00730639|4031950|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4208875|NCT00730639|4031951|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4208876|NCT00730639|4031952|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4208877|NCT00730639|4031953|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4208878|NCT00730639|4031948|B6|Greater than or equal to (>)= 65 years||Age, Customized||participants|Number|138|138.0||||||
4208879|NCT00730639|4031949|B5|Greater than or equal to (>)= 65 years||Age, Customized||participants|Number|64|64.0||||||
4208880|NCT00730639|4031950|B4|Greater than or equal to (>)= 65 years||Age, Customized||participants|Number|24|24.0||||||
4208881|NCT00730639|4031951|B3|Greater than or equal to (>)= 65 years||Age, Customized||participants|Number|37|37.0||||||
4208882|NCT00730639|4031952|B2|Greater than or equal to (>)= 65 years||Age, Customized||participants|Number|9|9.0||||||
4208883|NCT00730639|4031953|B1|Greater than or equal to (>)= 65 years||Age, Customized||participants|Number|4|4.0||||||
4208884|NCT00730639|4031948|B6|Less than (<) 65 years||Age, Customized||participants|Number|168|168.0||||||
4208885|NCT00730639|4031949|B5|Less than (<) 65 years||Age, Customized||participants|Number|67|67.0||||||
4208886|NCT00730639|4031950|B4|Less than (<) 65 years||Age, Customized||participants|Number|30|30.0||||||
4208887|NCT00730639|4031951|B3|Less than (<) 65 years||Age, Customized||participants|Number|49|49.0||||||
4208888|NCT00730639|4031952|B2|Less than (<) 65 years||Age, Customized||participants|Number|9|9.0||||||
4208889|NCT00730639|4031953|B1|Less than (<) 65 years||Age, Customized||participants|Number|13|13.0||||||
4208890|NCT00730639|4031948|B6|||Age||years|Mean|62.2|62.2|Full Range|||29.0|85.0|
4208891|NCT00730639|4031949|B5|||Age||years|Mean|63.1|63.1|Full Range|||30.0|85.0|
4208892|NCT00730639|4031950|B4|||Age||years|Mean|62.7|62.7|Full Range|||32.0|81.0|
4208893|NCT00730639|4031951|B3|||Age||years|Mean|61.8|61.8|Full Range|||37.0|83.0|
4208894|NCT00730639|4031952|B2|||Age||years|Mean|60.8|60.8|Full Range|||29.0|85.0|
4208895|NCT00730639|4031953|B1|||Age||years|Mean|57.5|57.5|Full Range|||33.0|79.0|
4208896|NCT00730483|4032021|B1|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4208897|NCT00730483|4032021|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4208898|NCT00730483|4032021|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4208899|NCT00730483|4032021|B1|||Age||years|Mean|64|64.0|Full Range|||47.0|80.0|
4208900|NCT00730405|4032029|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4208901|NCT00730405|4032030|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4208902|NCT00730405|4032031|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4208903|NCT00730405|4032032|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4208904|NCT00730405|4032033|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4208905|NCT00730405|4032034|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4208906|NCT00730405|4032029|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208907|NCT00730405|4032030|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208908|NCT00730405|4032031|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208909|NCT00730405|4032032|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208910|NCT00730405|4032033|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208911|NCT00730405|4032034|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208912|NCT00730405|4032029|B6||White|Race (NIH/OMB)||Participants|Count of Participants|481|481.0||||||
4208913|NCT00730405|4032030|B5||White|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4208914|NCT00730405|4032031|B4||White|Race (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
4208915|NCT00730405|4032032|B3||White|Race (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
4208916|NCT00730405|4032033|B2||White|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
4208917|NCT00730405|4032034|B1||White|Race (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
4208918|NCT00730405|4032029|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4208919|NCT00730405|4032030|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4208920|NCT00730405|4032031|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4208921|NCT00730405|4032032|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4208922|NCT00730405|4032033|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4208923|NCT00730405|4032034|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4208924|NCT00730405|4032029|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4208925|NCT00730405|4032030|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4208926|NCT00730405|4032031|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208927|NCT00730405|4032032|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208928|NCT00730405|4032033|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4208929|NCT00730405|4032034|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208930|NCT00730405|4032029|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4208931|NCT00730405|4032030|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208932|NCT00730405|4032031|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4208933|NCT00730405|4032032|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4208934|NCT00730405|4032033|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4208935|NCT00730405|4032034|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4208936|NCT00730405|4032029|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4208937|NCT00730405|4032030|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208938|NCT00730405|4032031|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4208939|NCT00730405|4032032|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4208940|NCT00730405|4032033|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4208941|NCT00730405|4032034|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4208942|NCT00730405|4032029|B6||Male|Sex: Female, Male||Participants|Count of Participants|441|441.0||||||
4208943|NCT00730405|4032030|B5||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4208944|NCT00730405|4032031|B4||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4208945|NCT00730405|4032032|B3||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4208946|NCT00730405|4032033|B2||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4208947|NCT00730405|4032034|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4208948|NCT00730405|4032029|B6||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4208949|NCT00730405|4032030|B5||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4208950|NCT00730405|4032031|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4208951|NCT00730405|4032032|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4208952|NCT00730405|4032033|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4208953|NCT00730405|4032034|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4208954|NCT00730405|4032029|B6|||Age||Years|Mean|48.6|48.6|Standard Deviation|11.9|11.9|||
4208955|NCT00730405|4032030|B5|||Age||Years|Mean|48.5|48.5|Standard Deviation|12.3|12.3|||
4208956|NCT00730405|4032031|B4|||Age||Years|Mean|46.8|46.8|Standard Deviation|12.3|12.3|||
4208957|NCT00730405|4032032|B3|||Age||Years|Mean|49.0|49.0|Standard Deviation|11.0|11.0|||
4208958|NCT00730405|4032033|B2|||Age||Years|Mean|49.2|49.2|Standard Deviation|12.4|12.4|||
4208959|NCT00730405|4032034|B1|||Age||Years|Mean|49.3|49.3|Standard Deviation|11.4|11.4|||
4208960|NCT00730353|4032075|B1|No||Prior Treatment||participants|Number|17|17.0||||||
4208961|NCT00730353|4032075|B1|Yes||Prior Treatment||participants|Number|11|11.0||||||
4208962|NCT00730353|4032075|B1|Squamous cell carcinoma||Histology||participants|Number|2|2.0||||||
4208963|NCT00730353|4032075|B1|Adenocarcinoma||Histology||participants|Number|26|26.0||||||
4208964|NCT00730353|4032075|B1|Gastroesophageal Junction||Tumor Site||participants|Number|6|6.0||||||
4208965|NCT00730353|4032075|B1|Esophagus||Tumor Site||participants|Number|22|22.0||||||
4208966|NCT00730353|4032075|B1|ECOG PS 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0-5 that describes a patient's level of functioning where 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Dead:|Participants|Number|2|2.0||||||
4208967|NCT00730353|4032075|B1|ECOG PS 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0-5 that describes a patient's level of functioning where 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Dead:|Participants|Number|11|11.0||||||
4208968|NCT00730353|4032075|B1|ECOG PS 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0-5 that describes a patient's level of functioning where 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Dead:|Participants|Number|15|15.0||||||
4208969|NCT00730353|4032075|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4208970|NCT00730353|4032075|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4208971|NCT00730353|4032075|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4208972|NCT00730353|4032075|B1|||Age||years|Median|59.5|59.5|Full Range|||40.0|84.0|
4208973|NCT00730327|4032083|B3|Unknown||Number of Years Obese||participants|Number|5|5.0||||||
4208974|NCT00730327|4032084|B2|Unknown||Number of Years Obese||participants|Number|2|2.0||||||
4208975|NCT00730327|4032085|B1|Unknown||Number of Years Obese||participants|Number|3|3.0||||||
4208976|NCT00730327|4032083|B3|50 years obese & over||Number of Years Obese||participants|Number|0|0.0||||||
4208977|NCT00730327|4032084|B2|50 years obese & over||Number of Years Obese||participants|Number|0|0.0||||||
4208978|NCT00730327|4032085|B1|50 years obese & over||Number of Years Obese||participants|Number|0|0.0||||||
4208979|NCT00730327|4032083|B3|40-49 years obese||Number of Years Obese||participants|Number|5|5.0||||||
4208980|NCT00730327|4032084|B2|40-49 years obese||Number of Years Obese||participants|Number|4|4.0||||||
4208981|NCT00730327|4032085|B1|40-49 years obese||Number of Years Obese||participants|Number|1|1.0||||||
4208982|NCT00730327|4032083|B3|30-39 years obese||Number of Years Obese||participants|Number|16|16.0||||||
4208983|NCT00730327|4032084|B2|30-39 years obese||Number of Years Obese||participants|Number|6|6.0||||||
4208984|NCT00730327|4032085|B1|30-39 years obese||Number of Years Obese||participants|Number|10|10.0||||||
4208985|NCT00730327|4032083|B3|20-29 years obese||Number of Years Obese||participants|Number|37|37.0||||||
4208986|NCT00730327|4032084|B2|20-29 years obese||Number of Years Obese||participants|Number|19|19.0||||||
4208987|NCT00730327|4032085|B1|20-29 years obese||Number of Years Obese||participants|Number|18|18.0||||||
4208988|NCT00730327|4032083|B3|10-19 years obese||Number of Years Obese||participants|Number|89|89.0||||||
4208989|NCT00730327|4032084|B2|10-19 years obese||Number of Years Obese||participants|Number|51|51.0||||||
4208990|NCT00730327|4032085|B1|10-19 years obese||Number of Years Obese||participants|Number|38|38.0||||||
4208991|NCT00730327|4032083|B3|5-9 years obese||Number of Years Obese||participants|Number|61|61.0||||||
4208992|NCT00730327|4032084|B2|5-9 years obese||Number of Years Obese||participants|Number|26|26.0||||||
4208993|NCT00730327|4032085|B1|5-9 years obese||Number of Years Obese||participants|Number|35|35.0||||||
4208994|NCT00730327|4032083|B3|< 5 years obese||Number of Years Obese||participants|Number|42|42.0||||||
4208995|NCT00730327|4032084|B2|< 5 years obese||Number of Years Obese||participants|Number|22|22.0||||||
4208996|NCT00730327|4032085|B1|< 5 years obese||Number of Years Obese||participants|Number|20|20.0||||||
4208997|NCT00730327|4032083|B3|BMI >40||BMI|Subject BMI (kg/m²) was calculated using their baseline weight at screening. Subjects with BMI<30 or >40 were major protocol deviations|participants|Number|6|6.0||||||
4208998|NCT00730327|4032084|B2|BMI >40||BMI|Subject BMI (kg/m²) was calculated using their baseline weight at screening. Subjects with BMI<30 or >40 were major protocol deviations|participants|Number|2|2.0||||||
4209052|NCT00730275|4032111|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4208999|NCT00730327|4032085|B1|BMI >40||BMI|Subject BMI (kg/m²) was calculated using their baseline weight at screening. Subjects with BMI<30 or >40 were major protocol deviations|participants|Number|4|4.0||||||
4209000|NCT00730327|4032083|B3|BMI ≥35 and ≤40||BMI|Subject BMI (kg/m²) was calculated using their baseline weight at screening. Subjects with BMI<30 or >40 were major protocol deviations|participants|Number|126|126.0||||||
4209001|NCT00730327|4032084|B2|BMI ≥35 and ≤40||BMI|Subject BMI (kg/m²) was calculated using their baseline weight at screening. Subjects with BMI<30 or >40 were major protocol deviations|participants|Number|70|70.0||||||
4209002|NCT00730327|4032085|B1|BMI ≥35 and ≤40||BMI|Subject BMI (kg/m²) was calculated using their baseline weight at screening. Subjects with BMI<30 or >40 were major protocol deviations|participants|Number|56|56.0||||||
4209003|NCT00730327|4032083|B3|BMI ≥30 and <35||BMI|Subject BMI (kg/m²) was calculated using their baseline weight at screening. Subjects with BMI<30 or >40 were major protocol deviations|participants|Number|120|120.0||||||
4209004|NCT00730327|4032084|B2|BMI ≥30 and <35||BMI|Subject BMI (kg/m²) was calculated using their baseline weight at screening. Subjects with BMI<30 or >40 were major protocol deviations|participants|Number|57|57.0||||||
4209005|NCT00730327|4032085|B1|BMI ≥30 and <35||BMI|Subject BMI (kg/m²) was calculated using their baseline weight at screening. Subjects with BMI<30 or >40 were major protocol deviations|participants|Number|63|63.0||||||
4209006|NCT00730327|4032083|B3|BMI <30||BMI|Subject BMI (kg/m²) was calculated using their baseline weight at screening. Subjects with BMI<30 or >40 were major protocol deviations|participants|Number|3|3.0||||||
4209007|NCT00730327|4032084|B2|BMI <30||BMI|Subject BMI (kg/m²) was calculated using their baseline weight at screening. Subjects with BMI<30 or >40 were major protocol deviations|participants|Number|1|1.0||||||
4209008|NCT00730327|4032085|B1|BMI <30||BMI|Subject BMI (kg/m²) was calculated using their baseline weight at screening. Subjects with BMI<30 or >40 were major protocol deviations|participants|Number|2|2.0||||||
4209009|NCT00730327|4032083|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4209010|NCT00730327|4032084|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4209011|NCT00730327|4032085|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4209012|NCT00730327|4032083|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4209013|NCT00730327|4032084|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4209014|NCT00730327|4032085|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4209015|NCT00730327|4032083|B3|Black (not of Hispanic origin)||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4209016|NCT00730327|4032084|B2|Black (not of Hispanic origin)||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4209017|NCT00730327|4032085|B1|Black (not of Hispanic origin)||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4209018|NCT00730327|4032083|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4209019|NCT00730327|4032084|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4209020|NCT00730327|4032085|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4209021|NCT00730327|4032083|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|207|207.0||||||
4209022|NCT00730327|4032084|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|106|106.0||||||
4209023|NCT00730327|4032085|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|101|101.0||||||
4209024|NCT00730327|4032083|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4209025|NCT00730327|4032084|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4209026|NCT00730327|4032085|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4209027|NCT00730327|4032083|B3||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4209028|NCT00730327|4032084|B2||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4209029|NCT00730327|4032085|B1||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4209030|NCT00730327|4032083|B3|60 years & over||Age, Customized||participants|Number|6|6.0||||||
4209031|NCT00730327|4032084|B2|60 years & over||Age, Customized||participants|Number|5|5.0||||||
4209032|NCT00730327|4032085|B1|60 years & over||Age, Customized||participants|Number|1|1.0||||||
4209033|NCT00730327|4032083|B3|50-59 years||Age, Customized||participants|Number|38|38.0||||||
4209034|NCT00730327|4032084|B2|50-59 years||Age, Customized||participants|Number|16|16.0||||||
4209035|NCT00730327|4032085|B1|50-59 years||Age, Customized||participants|Number|22|22.0||||||
4209036|NCT00730327|4032083|B3|40-49 years||Age, Customized||participants|Number|85|85.0||||||
4209037|NCT00730327|4032084|B2|40-49 years||Age, Customized||participants|Number|54|54.0||||||
4209038|NCT00730327|4032085|B1|40-49 years||Age, Customized||participants|Number|31|31.0||||||
4209039|NCT00730327|4032083|B3|30-39 years||Age, Customized||participants|Number|86|86.0||||||
4209040|NCT00730327|4032084|B2|30-39 years||Age, Customized||participants|Number|37|37.0||||||
4209041|NCT00730327|4032085|B1|30-39 years||Age, Customized||participants|Number|49|49.0||||||
4209042|NCT00730327|4032083|B3|20-29 years||Age, Customized||participants|Number|39|39.0||||||
4209043|NCT00730327|4032084|B2|20-29 years||Age, Customized||participants|Number|18|18.0||||||
4209044|NCT00730327|4032085|B1|20-29 years||Age, Customized||participants|Number|21|21.0||||||
4209045|NCT00730327|4032083|B3|18-19 years||Age, Customized||participants|Number|1|1.0||||||
4209046|NCT00730327|4032084|B2|18-19 years||Age, Customized||participants|Number|0|0.0||||||
4209047|NCT00730327|4032085|B1|18-19 years||Age, Customized||participants|Number|1|1.0||||||
4209048|NCT00730275|4032107|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4209049|NCT00730275|4032108|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4209050|NCT00730275|4032109|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4209051|NCT00730275|4032110|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4209053|NCT00730275|4032107|B5||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4209054|NCT00730275|4032108|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4209055|NCT00730275|4032109|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4209056|NCT00730275|4032110|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4209057|NCT00730275|4032111|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4209058|NCT00730275|4032107|B5|||Age||years|Mean|14.3|14.3|Standard Deviation|1.98|1.98|||
4209059|NCT00730275|4032108|B4|||Age||years|Mean|14.1|14.1|Standard Deviation|2.26|2.26|||
4209060|NCT00730275|4032109|B3|||Age||years|Mean|14.8|14.8|Standard Deviation|1.75|1.75|||
4209061|NCT00730275|4032110|B2|||Age||years|Mean|14.3|14.3|Standard Deviation|1.41|1.41|||
4209062|NCT00730275|4032111|B1|||Age||years|Mean|13.9|13.9|Standard Deviation|2.52|2.52|||
4209063|NCT00730236|4032140|B1|Italy||Region of Enrollment||participants|Number|6|6.0||||||
4209064|NCT00730236|4032140|B1|South Africa||Region of Enrollment||participants|Number|11|11.0||||||
4209065|NCT00730236|4032140|B1|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4209066|NCT00730236|4032140|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4209067|NCT00730236|4032140|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4209068|NCT00730236|4032140|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209069|NCT00730236|4032140|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4209070|NCT00730236|4032140|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4209071|NCT00730236|4032140|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209072|NCT00730236|4032140|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4209073|NCT00730236|4032140|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209074|NCT00730236|4032140|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4209075|NCT00730236|4032140|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4209076|NCT00730236|4032140|B1|||Age||years|Mean|30.7|30.7|Standard Deviation|10.64|10.64|||
4209077|NCT00730171|4032155|B1||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4209078|NCT00730171|4032155|B1||Female|Sex: Female, Male||Participants|Count of Participants|1532|1532.0||||||
4209079|NCT00730171|4032155|B1|||Age||years|Mean|47.1|47.1|Standard Deviation|13.5|13.5|||
4209080|NCT00730132|4032163|B1|Russian Federation||Region of Enrollment||participants|Number|712|712.0||||||
4209081|NCT00730132|4032163|B1|Not Reported||Sex/Gender, Customized||participants|Number|2|2.0||||||
4209082|NCT00730132|4032163|B1|Male||Sex/Gender, Customized||participants|Number|386|386.0||||||
4209083|NCT00730132|4032163|B1|Female||Sex/Gender, Customized||participants|Number|324|324.0||||||
4209084|NCT00730132|4032163|B1|||Age||years|Mean|59.57|59.57|Standard Deviation|9.367|9.367|||
4209085|NCT00730041|4032179|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
4209086|NCT00730041|4032180|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4209087|NCT00730041|4032181|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4209088|NCT00730041|4032179|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4209089|NCT00730041|4032180|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4209090|NCT00730041|4032181|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4209091|NCT00730041|4032179|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4209092|NCT00730041|4032180|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4209093|NCT00730041|4032181|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4209094|NCT00730041|4032179|B3|||Age||years|Mean|51.7|51.7|Standard Deviation|9.6|9.6|||
4209095|NCT00730041|4032180|B2|||Age||years|Mean|51.1|51.1|Standard Deviation|9.0|9.0|||
4209096|NCT00730041|4032181|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|10.3|10.3|||
4209097|NCT00730041|4032179|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4209098|NCT00730041|4032180|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4209099|NCT00730041|4032181|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4209100|NCT00730041|4032179|B3||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4209101|NCT00730041|4032180|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4209102|NCT00730041|4032181|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4209103|NCT00730041|4032179|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4209104|NCT00730041|4032180|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4209105|NCT00730041|4032181|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4209106|NCT00730028|4032200|B6|United States||Region of Enrollment||participants|Number|1310|1310.0||||||
4209107|NCT00730028|4032201|B5|United States||Region of Enrollment||participants|Number|257|257.0||||||
4209108|NCT00730028|4032202|B4|United States||Region of Enrollment||participants|Number|263|263.0||||||
4209109|NCT00730028|4032203|B3|United States||Region of Enrollment||participants|Number|266|266.0||||||
4209110|NCT00730028|4032204|B2|United States||Region of Enrollment||participants|Number|260|260.0||||||
4209111|NCT00730028|4032205|B1|United States||Region of Enrollment||participants|Number|264|264.0||||||
4209112|NCT00730028|4032200|B6||Male|Sex: Female, Male||Participants|Count of Participants|722|722.0||||||
4209113|NCT00730028|4032201|B5||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4209114|NCT00730028|4032202|B4||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4209115|NCT00730028|4032203|B3||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4209116|NCT00730028|4032204|B2||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4209117|NCT00730028|4032205|B1||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4209118|NCT00730028|4032200|B6||Female|Sex: Female, Male||Participants|Count of Participants|588|588.0||||||
4209119|NCT00730028|4032201|B5||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4209120|NCT00730028|4032202|B4||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4209121|NCT00730028|4032203|B3||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4209122|NCT00730028|4032204|B2||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4209123|NCT00730028|4032205|B1||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4209124|NCT00730028|4032200|B6|||Age||years|Mean|27.1|27.1|Standard Deviation|17.0|17.0|||
4209125|NCT00730028|4032201|B5|||Age||years|Mean|26.2|26.2|Standard Deviation|18.7|18.7|||
4209126|NCT00730028|4032202|B4|||Age||years|Mean|25.6|25.6|Standard Deviation|18.1|18.1|||
4209127|NCT00730028|4032203|B3|||Age||years|Mean|24.8|24.8|Standard Deviation|17.8|17.8|||
4209128|NCT00730028|4032204|B2|||Age||years|Mean|27.5|27.5|Standard Deviation|16.9|16.9|||
4209129|NCT00730028|4032205|B1|||Age||years|Mean|26.8|26.8|Standard Deviation|17.2|17.2|||
4209130|NCT00730028|4032200|B6||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4209131|NCT00730028|4032201|B5||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4209132|NCT00730028|4032202|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4209133|NCT00730028|4032203|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4209134|NCT00730028|4032204|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4209135|NCT00730028|4032205|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4209136|NCT00730028|4032200|B6||Between 18 and 65 years|Age||Participants|Count of Participants|864|864.0||||||
4209137|NCT00730028|4032201|B5||Between 18 and 65 years|Age||Participants|Count of Participants|166|166.0||||||
4209138|NCT00730028|4032202|B4||Between 18 and 65 years|Age||Participants|Count of Participants|169|169.0||||||
4209139|NCT00730028|4032203|B3||Between 18 and 65 years|Age||Participants|Count of Participants|164|164.0||||||
4209140|NCT00730028|4032204|B2||Between 18 and 65 years|Age||Participants|Count of Participants|184|184.0||||||
4209141|NCT00730028|4032205|B1||Between 18 and 65 years|Age||Participants|Count of Participants|181|181.0||||||
4209142|NCT00730028|4032200|B6||<=18 years|Age||Participants|Count of Participants|436|436.0||||||
4209143|NCT00730028|4032201|B5||<=18 years|Age||Participants|Count of Participants|89|89.0||||||
4209144|NCT00730028|4032202|B4||<=18 years|Age||Participants|Count of Participants|91|91.0||||||
4209145|NCT00730028|4032203|B3||<=18 years|Age||Participants|Count of Participants|101|101.0||||||
4209146|NCT00730028|4032204|B2||<=18 years|Age||Participants|Count of Participants|74|74.0||||||
4209147|NCT00730028|4032205|B1||<=18 years|Age||Participants|Count of Participants|81|81.0||||||
4209148|NCT00730015|4032256|B4|United States||Region of Enrollment||participants|Number|643|643.0||||||
4209149|NCT00730015|4032257|B3|United States||Region of Enrollment||participants|Number|209|209.0||||||
4209150|NCT00730015|4032258|B2|United States||Region of Enrollment||participants|Number|217|217.0||||||
4209151|NCT00730015|4032259|B1|United States||Region of Enrollment||participants|Number|217|217.0||||||
4209152|NCT00730015|4032256|B4||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4209153|NCT00730015|4032257|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4209154|NCT00730015|4032258|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4209155|NCT00730015|4032259|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4209156|NCT00730015|4032256|B4||Female|Sex: Female, Male||Participants|Count of Participants|562|562.0||||||
4209157|NCT00730015|4032257|B3||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4209158|NCT00730015|4032258|B2||Female|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4209159|NCT00730015|4032259|B1||Female|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4209160|NCT00730015|4032256|B4|65 years and older||Age, Customized||Participants|Number|82|82.0||||||
4209161|NCT00730015|4032257|B3|65 years and older||Age, Customized||Participants|Number|28|28.0||||||
4209162|NCT00730015|4032258|B2|65 years and older||Age, Customized||Participants|Number|27|27.0||||||
4209163|NCT00730015|4032259|B1|65 years and older||Age, Customized||Participants|Number|27|27.0||||||
4209164|NCT00730015|4032256|B4|18 years to 64 years||Age, Customized||Participants|Number|561|561.0||||||
4209165|NCT00730015|4032257|B3|18 years to 64 years||Age, Customized||Participants|Number|181|181.0||||||
4209166|NCT00730015|4032258|B2|18 years to 64 years||Age, Customized||Participants|Number|190|190.0||||||
4209167|NCT00730015|4032259|B1|18 years to 64 years||Age, Customized||Participants|Number|190|190.0||||||
4209168|NCT00730015|4032256|B4|||Age||years|Mean|48.0|48.0|Standard Deviation|14.3|14.3|||
4209169|NCT00730015|4032257|B3|||Age||years|Mean|49.3|49.3|Standard Deviation|14.3|14.3|||
4209170|NCT00730015|4032258|B2|||Age||years|Mean|47.7|47.7|Standard Deviation|14.2|14.2|||
4209171|NCT00730015|4032259|B1|||Age||years|Mean|47.1|47.1|Standard Deviation|14.2|14.2|||
4209172|NCT00729937|4032295|B7|United States||Region of Enrollment||participants|Number|1869|1869.0||||||
4209173|NCT00729937|4032296|B6|United States||Region of Enrollment||participants|Number|193|193.0||||||
4209174|NCT00729937|4032297|B5|United States||Region of Enrollment||participants|Number|218|218.0||||||
4209175|NCT00729937|4032298|B4|United States||Region of Enrollment||participants|Number|203|203.0||||||
4209176|NCT00729937|4032299|B3|United States||Region of Enrollment||participants|Number|198|198.0||||||
4209177|NCT00729937|4032300|B2|United States||Region of Enrollment||participants|Number|524|524.0||||||
4209178|NCT00729937|4032301|B1|United States||Region of Enrollment||participants|Number|533|533.0||||||
4209179|NCT00729937|4032295|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4209180|NCT00729937|4032296|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209181|NCT00729937|4032297|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209182|NCT00729937|4032298|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209183|NCT00729937|4032299|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4209184|NCT00729937|4032300|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209185|NCT00729937|4032301|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209186|NCT00729937|4032295|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1240|1240.0||||||
4209187|NCT00729937|4032296|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|133|133.0||||||
4209188|NCT00729937|4032297|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|143|143.0||||||
4209189|NCT00729937|4032298|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
4209190|NCT00729937|4032299|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
4209191|NCT00729937|4032300|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|346|346.0||||||
4209192|NCT00729937|4032301|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|353|353.0||||||
4209193|NCT00729937|4032295|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|628|628.0||||||
4209194|NCT00729937|4032296|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4209195|NCT00729937|4032297|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4209196|NCT00729937|4032298|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4209197|NCT00729937|4032299|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4209198|NCT00729937|4032300|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|178|178.0||||||
4209199|NCT00729937|4032301|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|180|180.0||||||
4209200|NCT00729937|4032295|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4209201|NCT00729937|4032296|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4209202|NCT00729937|4032297|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4209203|NCT00729937|4032298|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4209204|NCT00729937|4032299|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4209205|NCT00729937|4032300|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4209206|NCT00729937|4032301|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4209207|NCT00729937|4032295|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
4209208|NCT00729937|4032296|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4209209|NCT00729937|4032297|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4209210|NCT00729937|4032298|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4209211|NCT00729937|4032299|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4209212|NCT00729937|4032300|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4209213|NCT00729937|4032301|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4209214|NCT00729937|4032295|B7||White|Race (NIH/OMB)||Participants|Count of Participants|962|962.0||||||
4209215|NCT00729937|4032296|B6||White|Race (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
4209216|NCT00729937|4032297|B5||White|Race (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
4209217|NCT00729937|4032298|B4||White|Race (NIH/OMB)||Participants|Count of Participants|117|117.0||||||
4209218|NCT00729937|4032299|B3||White|Race (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
4209219|NCT00729937|4032300|B2||White|Race (NIH/OMB)||Participants|Count of Participants|244|244.0||||||
4209220|NCT00729937|4032301|B1||White|Race (NIH/OMB)||Participants|Count of Participants|252|252.0||||||
4209221|NCT00729937|4032295|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|752|752.0||||||
4209222|NCT00729937|4032296|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4209223|NCT00729937|4032297|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4209224|NCT00729937|4032298|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
4209225|NCT00729937|4032299|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
4209226|NCT00729937|4032300|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|232|232.0||||||
4209227|NCT00729937|4032301|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|233|233.0||||||
4209228|NCT00729937|4032295|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4209229|NCT00729937|4032296|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209230|NCT00729937|4032297|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209231|NCT00729937|4032298|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209232|NCT00729937|4032299|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209233|NCT00729937|4032300|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209234|NCT00729937|4032301|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4209235|NCT00729937|4032295|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4209236|NCT00729937|4032296|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4209237|NCT00729937|4032297|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4209238|NCT00729937|4032298|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209239|NCT00729937|4032299|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209240|NCT00729937|4032300|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4209241|NCT00729937|4032301|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4209242|NCT00729937|4032295|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4209243|NCT00729937|4032296|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209244|NCT00729937|4032297|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4209245|NCT00729937|4032298|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4209246|NCT00729937|4032299|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209247|NCT00729937|4032300|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4209248|NCT00729937|4032301|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4209249|NCT00729937|4032295|B7||Male|Sex: Female, Male||Participants|Count of Participants|1106|1106.0||||||
4209250|NCT00729937|4032296|B6||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4209251|NCT00729937|4032297|B5||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4209252|NCT00729937|4032298|B4||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4209253|NCT00729937|4032299|B3||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4209254|NCT00729937|4032300|B2||Male|Sex: Female, Male||Participants|Count of Participants|303|303.0||||||
4209255|NCT00729937|4032301|B1||Male|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
4209256|NCT00729937|4032295|B7||Female|Sex: Female, Male||Participants|Count of Participants|763|763.0||||||
4209257|NCT00729937|4032296|B6||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4209258|NCT00729937|4032297|B5||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4209259|NCT00729937|4032298|B4||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4209260|NCT00729937|4032299|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4209261|NCT00729937|4032300|B2||Female|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
4209262|NCT00729937|4032301|B1||Female|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
4209263|NCT00729937|4032295|B7||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4209264|NCT00729937|4032296|B6||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4209265|NCT00729937|4032297|B5||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4209266|NCT00729937|4032298|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4209267|NCT00729937|4032299|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4209268|NCT00729937|4032300|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4209269|NCT00729937|4032301|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4209270|NCT00729937|4032295|B7||Between 18 and 65 years|Age||Participants|Count of Participants|1803|1803.0||||||
4209271|NCT00729937|4032296|B6||Between 18 and 65 years|Age||Participants|Count of Participants|187|187.0||||||
4209272|NCT00729937|4032297|B5||Between 18 and 65 years|Age||Participants|Count of Participants|206|206.0||||||
4209273|NCT00729937|4032298|B4||Between 18 and 65 years|Age||Participants|Count of Participants|195|195.0||||||
4209274|NCT00729937|4032299|B3||Between 18 and 65 years|Age||Participants|Count of Participants|191|191.0||||||
4209275|NCT00729937|4032300|B2||Between 18 and 65 years|Age||Participants|Count of Participants|511|511.0||||||
4209276|NCT00729937|4032301|B1||Between 18 and 65 years|Age||Participants|Count of Participants|513|513.0||||||
4209277|NCT00729937|4032295|B7||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
4209278|NCT00729937|4032296|B6||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4209279|NCT00729937|4032297|B5||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4209280|NCT00729937|4032298|B4||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4209281|NCT00729937|4032299|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4209282|NCT00729937|4032300|B2||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4209283|NCT00729937|4032301|B1||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
4209284|NCT00729937|4032295|B7|||Age||years|Mean|38.0|38.0|Standard Deviation|12.9|12.9|||
4209285|NCT00729937|4032296|B6|||Age||years|Mean|39.4|39.4|Standard Deviation|13.2|13.2|||
4209286|NCT00729937|4032297|B5|||Age||years|Mean|39.7|39.7|Standard Deviation|13.3|13.3|||
4209287|NCT00729937|4032298|B4|||Age||years|Mean|38.0|38.0|Standard Deviation|13.3|13.3|||
4209288|NCT00729937|4032299|B3|||Age||years|Mean|40.4|40.4|Standard Deviation|13.1|13.1|||
4209289|NCT00729937|4032300|B2|||Age||years|Mean|37.0|37.0|Standard Deviation|12.6|12.6|||
4209290|NCT00729937|4032301|B1|||Age||years|Mean|36.8|36.8|Standard Deviation|12.3|12.3|||
4209291|NCT00729924|4032500|B1|T/T Genotype||ABCB1 Genotype|ABCB1 (rs1045642) C/C or T/T Genotype|participants|Number|20|20.0||||||
4209292|NCT00729924|4032500|B1|C/C Genotype||ABCB1 Genotype|ABCB1 (rs1045642) C/C or T/T Genotype|participants|Number|20|20.0||||||
4209293|NCT00729924|4032500|B1|||Body Mass Index||kilgrams/(meter squared)|Median|24.0|24.0|Inter-Quartile Range|||22.2|25.6|
4209294|NCT00729924|4032500|B1|||Weight||kilograms|Median|74.6|74.6|Inter-Quartile Range|||62.6|80.5|
4209295|NCT00729924|4032500|B1|||Cerebrospinal Fluid Protein||mg/dL|Median|33|33.0|Inter-Quartile Range|||24.0|43.0|
4209296|NCT00729924|4032500|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4209297|NCT00729924|4032500|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209298|NCT00729924|4032500|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209299|NCT00729924|4032500|B1||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4209300|NCT00729924|4032500|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209301|NCT00729924|4032500|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209302|NCT00729924|4032500|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209303|NCT00729924|4032500|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209304|NCT00729924|4032500|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4209305|NCT00729924|4032500|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4209306|NCT00729924|4032500|B1|||Age||years|Median|34.5|34.5|Inter-Quartile Range|||26.8|45.0|
4209307|NCT00729859|4032507|B4|||Body Mass Index (BMI)||kg/m^2|Mean|25.5|25.5|Standard Deviation|3.0|3.0|||
4209308|NCT00729859|4032508|B3|||Body Mass Index (BMI)||kg/m^2|Mean|23.7|23.7|Standard Deviation|2.1|2.1|||
4209309|NCT00729859|4032509|B2|||Body Mass Index (BMI)||kg/m^2|Mean|27.1|27.1|Standard Deviation|3.8|3.8|||
4209310|NCT00729859|4032510|B1|||Body Mass Index (BMI)||kg/m^2|Mean|26.2|26.2|Standard Deviation|2.5|2.5|||
4209311|NCT00729859|4032507|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209312|NCT00729859|4032508|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209313|NCT00729859|4032509|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209314|NCT00729859|4032510|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209315|NCT00729859|4032507|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209316|NCT00729859|4032508|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209317|NCT00729859|4032509|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209318|NCT00729859|4032510|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209319|NCT00729859|4032507|B4||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4209320|NCT00729859|4032508|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4209321|NCT00729859|4032509|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4209322|NCT00729859|4032510|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4209323|NCT00729859|4032507|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4209324|NCT00729859|4032508|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4209325|NCT00729859|4032509|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4209326|NCT00729859|4032510|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209327|NCT00729859|4032507|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209328|NCT00729859|4032508|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209329|NCT00729859|4032509|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209330|NCT00729859|4032510|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209331|NCT00729859|4032507|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209332|NCT00729859|4032508|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209333|NCT00729859|4032509|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209334|NCT00729859|4032510|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209335|NCT00729859|4032507|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209336|NCT00729859|4032508|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209337|NCT00729859|4032509|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209338|NCT00729859|4032510|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209339|NCT00729859|4032507|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209340|NCT00729859|4032508|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209341|NCT00729859|4032509|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209342|NCT00729859|4032510|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209343|NCT00729859|4032507|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4209344|NCT00729859|4032508|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4209345|NCT00729859|4032509|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4209346|NCT00729859|4032510|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4209347|NCT00729859|4032507|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4209348|NCT00729859|4032508|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4209349|NCT00729859|4032509|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4209350|NCT00729859|4032510|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209351|NCT00729859|4032507|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4209352|NCT00729859|4032508|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4209353|NCT00729859|4032509|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4209354|NCT00729859|4032510|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4209355|NCT00729859|4032507|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4209356|NCT00729859|4032508|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4209357|NCT00729859|4032509|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4209358|NCT00729859|4032510|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4209359|NCT00729859|4032507|B4|||Age||years|Mean|30.0|30.0|Standard Deviation|10.5|10.5|||
4209360|NCT00729859|4032508|B3|||Age||years|Mean|25.8|25.8|Standard Deviation|8.4|8.4|||
4209361|NCT00729859|4032509|B2|||Age||years|Mean|24.3|24.3|Standard Deviation|4.0|4.0|||
4209362|NCT00729859|4032510|B1|||Age||years|Mean|38.5|38.5|Standard Deviation|10.6|10.6|||
4209363|NCT00729859|4032507|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4209364|NCT00729859|4032508|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4209365|NCT00729859|4032509|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4209366|NCT00729859|4032510|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4209367|NCT00729859|4032507|B4||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4209368|NCT00729859|4032508|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4209369|NCT00729859|4032509|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4209370|NCT00729859|4032510|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4209371|NCT00729859|4032507|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4209372|NCT00729859|4032508|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4209373|NCT00729859|4032509|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4209374|NCT00729859|4032510|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4209375|NCT00729846|4032547|B3|||visual acuity||ETDRS letters|Mean|57.34|57.34|Standard Deviation|10.8|10.8|||
4209376|NCT00729846|4032548|B2|||visual acuity||ETDRS letters|Mean|60.5|60.5|Standard Deviation|7.9|7.9|||
4209377|NCT00729846|4032549|B1|||visual acuity||ETDRS letters|Mean|54.18|54.18|Standard Deviation|13.7|13.7|||
4209378|NCT00729846|4032547|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4209379|NCT00729846|4032548|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4209380|NCT00729846|4032549|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4209381|NCT00729846|4032547|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4209382|NCT00729846|4032548|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4209383|NCT00729846|4032549|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4209384|NCT00729846|4032547|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4209385|NCT00729846|4032548|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4209386|NCT00729846|4032549|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4209387|NCT00729846|4032547|B3|||Age||years|Mean|81.4|81.4|Full Range|||73.0|94.0|
4209388|NCT00729846|4032548|B2|||Age||years|Mean|83.8|83.8|Full Range|||75.0|94.0|
4209389|NCT00729846|4032549|B1|||Age||years|Mean|79.0|79.0|Full Range|||73.0|84.0|
4209390|NCT00729833|4032556|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4209391|NCT00729833|4032556|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4209392|NCT00729833|4032556|B1|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|12|12.0||||||
4209393|NCT00729833|4032556|B1|45 to 64 years||Age, Customized||participants|Number|22|22.0||||||
4209394|NCT00729833|4032556|B1|18 to 44 years||Age, Customized||participants|Number|11|11.0||||||
4209395|NCT00729807|4032598|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4209396|NCT00729807|4032598|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4209397|NCT00729807|4032598|B1|||Age||years|Mean|63|63.0|Full Range|||43.0|80.0|
4209398|NCT00729781|4032602|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4209399|NCT00729781|4032602|B1|White||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4209400|NCT00729781|4032602|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4209401|NCT00729781|4032602|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4209402|NCT00729781|4032602|B1|All subjects||Age||years|Mean|45.0|45.0|Standard Deviation|12.2|12.2|||
4209403|NCT00729690|4032608|B4|United States||Region of Enrollment||participants|Number|48|48.0||||||
4209404|NCT00729690|4032609|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4209405|NCT00729690|4032610|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4209406|NCT00729690|4032611|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4209407|NCT00729690|4032608|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4209408|NCT00729690|4032609|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4209409|NCT00729690|4032610|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4209410|NCT00729690|4032611|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4209411|NCT00729690|4032608|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4209412|NCT00729690|4032609|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4209413|NCT00729690|4032610|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4209414|NCT00729690|4032611|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4209415|NCT00729690|4032608|B4|||Age||years|Mean|66.1|66.1|Standard Deviation|5.2|5.2|||
4209416|NCT00729690|4032609|B3|||Age||years|Mean|66.4|66.4|Standard Deviation|4.5|4.5|||
4209417|NCT00729690|4032610|B2|||Age||years|Mean|64.8|64.8|Standard Deviation|4.4|4.4|||
4209418|NCT00729690|4032611|B1|||Age||years|Mean|66.9|66.9|Standard Deviation|6.4|6.4|||
4209419|NCT00729677|4032630|B1|United States||Region of Enrollment||participants|Number|64|64.0||||||
4209420|NCT00729677|4032630|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4209421|NCT00729677|4032630|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4209422|NCT00729677|4032630|B1||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4209423|NCT00729677|4032630|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4209424|NCT00729677|4032630|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4209425|NCT00729651|4032641|B3|||serum 25 OHD (Serum 25-hydroxyvitamin D)||ng/ml|Mean|18.77|18.77|Standard Deviation|6.35|6.35|||
4209426|NCT00729651|4032642|B2|||serum 25 OHD (Serum 25-hydroxyvitamin D)||ng/ml|Mean|18.71|18.71|Standard Deviation|6.25|6.25|||
4209427|NCT00729651|4032643|B1|||serum 25 OHD (Serum 25-hydroxyvitamin D)||ng/ml|Mean|18.82|18.82|Standard Deviation|6.46|6.46|||
4209428|NCT00729651|4032641|B3|||Weight|1 Participant from the Fosamax plus D group is missing data for this Measure, 2 Participants from the Fosamax group are missing data for this Measure|Kilograms|Mean|54.32|54.32|Standard Deviation|6.97|6.97|||
4209429|NCT00729651|4032642|B2|||Weight|1 Participant from the Fosamax plus D group is missing data for this Measure, 2 Participants from the Fosamax group are missing data for this Measure|Kilograms|Mean|54.8|54.8|Standard Deviation|7.03|7.03|||
4209430|NCT00729651|4032643|B1|||Weight|1 Participant from the Fosamax plus D group is missing data for this Measure, 2 Participants from the Fosamax group are missing data for this Measure|Kilograms|Mean|53.84|53.84|Standard Deviation|6.89|6.89|||
4209431|NCT00729651|4032641|B3|||Systolic Blood Pressure|1 Participant from the Fosamax group is missing data for this Measure|mm Hg|Mean|123.45|123.45|Standard Deviation|15.17|15.17|||
4209432|NCT00729651|4032642|B2|||Systolic Blood Pressure|1 Participant from the Fosamax group is missing data for this Measure|mm Hg|Mean|124.08|124.08|Standard Deviation|14.52|14.52|||
4209433|NCT00729651|4032643|B1|||Systolic Blood Pressure|1 Participant from the Fosamax group is missing data for this Measure|mm Hg|Mean|122.83|122.83|Standard Deviation|15.8|15.8|||
4209434|NCT00729651|4032641|B3|||Spine (average of spine Lumbar 1, Lumbar 2, Lumbar 3, Lumbar 4 ) T-score ≤ -2.5|The analyzable number of patients with Spine (average of spine Lumbar 1, Lumbar 2, Lumbar 3, Lumbar 4) are 144 in Fosamax Plus D Group and 132 in Fosamax Group.|T-score|Mean|-3.01|-3.01|Standard Deviation|0.45|0.45|||
4209435|NCT00729651|4032642|B2|||Spine (average of spine Lumbar 1, Lumbar 2, Lumbar 3, Lumbar 4 ) T-score ≤ -2.5|The analyzable number of patients with Spine (average of spine Lumbar 1, Lumbar 2, Lumbar 3, Lumbar 4) are 144 in Fosamax Plus D Group and 132 in Fosamax Group.|T-score|Mean|-3.06|-3.06|Standard Deviation|0.50|0.5|||
4209436|NCT00729651|4032643|B1|||Spine (average of spine Lumbar 1, Lumbar 2, Lumbar 3, Lumbar 4 ) T-score ≤ -2.5|The analyzable number of patients with Spine (average of spine Lumbar 1, Lumbar 2, Lumbar 3, Lumbar 4) are 144 in Fosamax Plus D Group and 132 in Fosamax Group.|T-score|Mean|-2.96|-2.96|Standard Deviation|0.40|0.4|||
4209437|NCT00729651|4032641|B3|||Serum PTH (Parathyroid hormone)||pg/ml|Mean|24.38|24.38|Standard Deviation|11.45|11.45|||
4209438|NCT00729651|4032642|B2|||Serum PTH (Parathyroid hormone)||pg/ml|Mean|23.47|23.47|Standard Deviation|11.85|11.85|||
4209439|NCT00729651|4032643|B1|||Serum PTH (Parathyroid hormone)||pg/ml|Mean|25.27|25.27|Standard Deviation|11.01|11.01|||
4209440|NCT00729651|4032641|B3|||Height|2 Participants from the Fosamax group are missing data for this Measure|Centimeters|Mean|152.29|152.29|Standard Deviation|5.73|5.73|||
4209441|NCT00729651|4032642|B2|||Height|2 Participants from the Fosamax group are missing data for this Measure|Centimeters|Mean|152.47|152.47|Standard Deviation|5.59|5.59|||
4209442|NCT00729651|4032643|B1|||Height|2 Participants from the Fosamax group are missing data for this Measure|Centimeters|Mean|152.11|152.11|Standard Deviation|5.88|5.88|||
4209443|NCT00729651|4032641|B3|||Femoral total T-score ≤ -2.5|The analyzable number of patients with Femoral total T-score ≤ -2.5 are 20 in Fosamax Plus D Group and 25 in Fosamax Group.|T-score|Mean|-3.00|-3.0|Standard Deviation|0.46|0.46|||
4209444|NCT00729651|4032642|B2|||Femoral total T-score ≤ -2.5|The analyzable number of patients with Femoral total T-score ≤ -2.5 are 20 in Fosamax Plus D Group and 25 in Fosamax Group.|T-score|Mean|-3.00|-3.0|Standard Deviation|0.41|0.41|||
4209445|NCT00729651|4032643|B1|||Femoral total T-score ≤ -2.5|The analyzable number of patients with Femoral total T-score ≤ -2.5 are 20 in Fosamax Plus D Group and 25 in Fosamax Group.|T-score|Mean|-3.00|-3.0|Standard Deviation|0.52|0.52|||
4209446|NCT00729651|4032641|B3|||Femoral neck T-score ≤ -2.5|The analyzable number of patients with Femoral neck T-score ≤ -2.5 are 43 in Fosamax Plus D Group and 58 in Fosamax Group.|T-score|Mean|-2.94|-2.94|Standard Deviation|0.45|0.45|||
4209447|NCT00729651|4032642|B2|||Femoral neck T-score ≤ -2.5|The analyzable number of patients with Femoral neck T-score ≤ -2.5 are 43 in Fosamax Plus D Group and 58 in Fosamax Group.|T-score|Mean|-2.94|-2.94|Standard Deviation|0.42|0.42|||
4209448|NCT00729651|4032643|B1|||Femoral neck T-score ≤ -2.5|The analyzable number of patients with Femoral neck T-score ≤ -2.5 are 43 in Fosamax Plus D Group and 58 in Fosamax Group.|T-score|Mean|-2.95|-2.95|Standard Deviation|0.48|0.48|||
4209449|NCT00729651|4032641|B3|||Diastolic Blood Pressure|1 Participant from the Fosamax group is missing data for this Measure|mm Hg|Mean|73.15|73.15|Standard Deviation|8.86|8.86|||
4209547|NCT00729586|4032664|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4209450|NCT00729651|4032642|B2|||Diastolic Blood Pressure|1 Participant from the Fosamax group is missing data for this Measure|mm Hg|Mean|73.82|73.82|Standard Deviation|8.85|8.85|||
4209451|NCT00729651|4032643|B1|||Diastolic Blood Pressure|1 Participant from the Fosamax group is missing data for this Measure|mm Hg|Mean|72.5|72.5|Standard Deviation|8.84|8.84|||
4209452|NCT00729651|4032641|B3|||A fracture in spine Lumbar 1, Lumbar 2, Lumbar 3, Lumbar 4 and T-score ≤-2.0|The analyzable number of patients with A fracture in spine Lumbar 1, Lumbar 2, Lumbar 3, Lumbar 4 and T-score ≤ -2.0 are 9 in Fosamax Plus D Group and 5 in Fosamax Group.|T-score|Mean|-2.40|-2.4|Standard Deviation|0.59|0.59|||
4209453|NCT00729651|4032642|B2|||A fracture in spine Lumbar 1, Lumbar 2, Lumbar 3, Lumbar 4 and T-score ≤-2.0|The analyzable number of patients with A fracture in spine Lumbar 1, Lumbar 2, Lumbar 3, Lumbar 4 and T-score ≤ -2.0 are 9 in Fosamax Plus D Group and 5 in Fosamax Group.|T-score|Mean|-2.34|-2.34|Standard Deviation|0.3|0.3|||
4209454|NCT00729651|4032643|B1|||A fracture in spine Lumbar 1, Lumbar 2, Lumbar 3, Lumbar 4 and T-score ≤-2.0|The analyzable number of patients with A fracture in spine Lumbar 1, Lumbar 2, Lumbar 3, Lumbar 4 and T-score ≤ -2.0 are 9 in Fosamax Plus D Group and 5 in Fosamax Group.|T-score|Mean|-2.44|-2.44|Standard Deviation|0.71|0.71|||
4209455|NCT00729651|4032641|B3|Not Applicable||Two or more fractures in spine (Lumbar 1-4)||Participants|Number|336|336.0||||||
4209456|NCT00729651|4032642|B2|Not Applicable||Two or more fractures in spine (Lumbar 1-4)||Participants|Number|166|166.0||||||
4209457|NCT00729651|4032643|B1|Not Applicable||Two or more fractures in spine (Lumbar 1-4)||Participants|Number|170|170.0||||||
4209458|NCT00729651|4032641|B3|Two or more fractures in spine(Lumbar 1-4)||Two or more fractures in spine (Lumbar 1-4)||Participants|Number|7|7.0||||||
4209459|NCT00729651|4032642|B2|Two or more fractures in spine(Lumbar 1-4)||Two or more fractures in spine (Lumbar 1-4)||Participants|Number|4|4.0||||||
4209460|NCT00729651|4032643|B1|Two or more fractures in spine(Lumbar 1-4)||Two or more fractures in spine (Lumbar 1-4)||Participants|Number|3|3.0||||||
4209461|NCT00729651|4032641|B3|Not Applicable||T-score classification by inclusion criteria: Spine (average of spine Lumbar 1-4 ) T-score ≤-2.5|T-score: a measurement expressed in standard deviation units from a given mean used in assessment of osteoporosis, equal to a patient's bone mineral density measurement by DEXA minus the value in a young healthy person, divided by the standard deviation of the measurement in the population.|Participants|Number|67|67.0||||||
4209462|NCT00729651|4032642|B2|Not Applicable||T-score classification by inclusion criteria: Spine (average of spine Lumbar 1-4 ) T-score ≤-2.5|T-score: a measurement expressed in standard deviation units from a given mean used in assessment of osteoporosis, equal to a patient's bone mineral density measurement by DEXA minus the value in a young healthy person, divided by the standard deviation of the measurement in the population.|Participants|Number|38|38.0||||||
4209463|NCT00729651|4032643|B1|Not Applicable||T-score classification by inclusion criteria: Spine (average of spine Lumbar 1-4 ) T-score ≤-2.5|T-score: a measurement expressed in standard deviation units from a given mean used in assessment of osteoporosis, equal to a patient's bone mineral density measurement by DEXA minus the value in a young healthy person, divided by the standard deviation of the measurement in the population.|Participants|Number|29|29.0||||||
4209464|NCT00729651|4032641|B3|Spine (average of spine Lumbar 1-4 ) T-score ≤-2.5||T-score classification by inclusion criteria: Spine (average of spine Lumbar 1-4 ) T-score ≤-2.5|T-score: a measurement expressed in standard deviation units from a given mean used in assessment of osteoporosis, equal to a patient's bone mineral density measurement by DEXA minus the value in a young healthy person, divided by the standard deviation of the measurement in the population.|Participants|Number|276|276.0||||||
4209465|NCT00729651|4032642|B2|Spine (average of spine Lumbar 1-4 ) T-score ≤-2.5||T-score classification by inclusion criteria: Spine (average of spine Lumbar 1-4 ) T-score ≤-2.5|T-score: a measurement expressed in standard deviation units from a given mean used in assessment of osteoporosis, equal to a patient's bone mineral density measurement by DEXA minus the value in a young healthy person, divided by the standard deviation of the measurement in the population.|Participants|Number|132|132.0||||||
4209466|NCT00729651|4032643|B1|Spine (average of spine Lumbar 1-4 ) T-score ≤-2.5||T-score classification by inclusion criteria: Spine (average of spine Lumbar 1-4 ) T-score ≤-2.5|T-score: a measurement expressed in standard deviation units from a given mean used in assessment of osteoporosis, equal to a patient's bone mineral density measurement by DEXA minus the value in a young healthy person, divided by the standard deviation of the measurement in the population.|Participants|Number|144|144.0||||||
4209467|NCT00729651|4032641|B3|Not Applicable||T-score classification by inclusion criteria: Femoral total T-score ≤ -2.5|T-score: a measurement expressed in standard deviation units from a given mean used in assessment of osteoporosis, equal to a patient's bone mineral density measurement by DEXA minus the value in a young healthy person, divided by the standard deviation of the measurement in the population.|Participants|Number|298|298.0||||||
4209468|NCT00729651|4032642|B2|Not Applicable||T-score classification by inclusion criteria: Femoral total T-score ≤ -2.5|T-score: a measurement expressed in standard deviation units from a given mean used in assessment of osteoporosis, equal to a patient's bone mineral density measurement by DEXA minus the value in a young healthy person, divided by the standard deviation of the measurement in the population.|Participants|Number|145|145.0||||||
4209469|NCT00729651|4032643|B1|Not Applicable||T-score classification by inclusion criteria: Femoral total T-score ≤ -2.5|T-score: a measurement expressed in standard deviation units from a given mean used in assessment of osteoporosis, equal to a patient's bone mineral density measurement by DEXA minus the value in a young healthy person, divided by the standard deviation of the measurement in the population.|Participants|Number|153|153.0||||||
4209470|NCT00729651|4032641|B3|Femoral total T-score ≤ -2.5||T-score classification by inclusion criteria: Femoral total T-score ≤ -2.5|T-score: a measurement expressed in standard deviation units from a given mean used in assessment of osteoporosis, equal to a patient's bone mineral density measurement by DEXA minus the value in a young healthy person, divided by the standard deviation of the measurement in the population.|Participants|Number|45|45.0||||||
4209471|NCT00729651|4032642|B2|Femoral total T-score ≤ -2.5||T-score classification by inclusion criteria: Femoral total T-score ≤ -2.5|T-score: a measurement expressed in standard deviation units from a given mean used in assessment of osteoporosis, equal to a patient's bone mineral density measurement by DEXA minus the value in a young healthy person, divided by the standard deviation of the measurement in the population.|Participants|Number|25|25.0||||||
4209472|NCT00729651|4032643|B1|Femoral total T-score ≤ -2.5||T-score classification by inclusion criteria: Femoral total T-score ≤ -2.5|T-score: a measurement expressed in standard deviation units from a given mean used in assessment of osteoporosis, equal to a patient's bone mineral density measurement by DEXA minus the value in a young healthy person, divided by the standard deviation of the measurement in the population.|Participants|Number|20|20.0||||||
4209473|NCT00729651|4032641|B3|Not Applicable||T-score classification by inclusion criteria: Femoral neck T-score ≤ -2.5|T-score: a measurement expressed in standard deviation units from a given mean used in assessment of osteoporosis, equal to a patient's bone mineral density measurement by DEXA minus the value in a young healthy person, divided by the standard deviation of the measurement in the population.|Participants|Number|242|242.0||||||
4209474|NCT00729651|4032642|B2|Not Applicable||T-score classification by inclusion criteria: Femoral neck T-score ≤ -2.5|T-score: a measurement expressed in standard deviation units from a given mean used in assessment of osteoporosis, equal to a patient's bone mineral density measurement by DEXA minus the value in a young healthy person, divided by the standard deviation of the measurement in the population.|Participants|Number|112|112.0||||||
4209475|NCT00729651|4032643|B1|Not Applicable||T-score classification by inclusion criteria: Femoral neck T-score ≤ -2.5|T-score: a measurement expressed in standard deviation units from a given mean used in assessment of osteoporosis, equal to a patient's bone mineral density measurement by DEXA minus the value in a young healthy person, divided by the standard deviation of the measurement in the population.|Participants|Number|130|130.0||||||
4209476|NCT00729651|4032641|B3|Femoral neck T-score ≤ -2.5||T-score classification by inclusion criteria: Femoral neck T-score ≤ -2.5|T-score: a measurement expressed in standard deviation units from a given mean used in assessment of osteoporosis, equal to a patient's bone mineral density measurement by DEXA minus the value in a young healthy person, divided by the standard deviation of the measurement in the population.|Participants|Number|101|101.0||||||
4209477|NCT00729651|4032642|B2|Femoral neck T-score ≤ -2.5||T-score classification by inclusion criteria: Femoral neck T-score ≤ -2.5|T-score: a measurement expressed in standard deviation units from a given mean used in assessment of osteoporosis, equal to a patient's bone mineral density measurement by DEXA minus the value in a young healthy person, divided by the standard deviation of the measurement in the population.|Participants|Number|58|58.0||||||
4209478|NCT00729651|4032643|B1|Femoral neck T-score ≤ -2.5||T-score classification by inclusion criteria: Femoral neck T-score ≤ -2.5|T-score: a measurement expressed in standard deviation units from a given mean used in assessment of osteoporosis, equal to a patient's bone mineral density measurement by DEXA minus the value in a young healthy person, divided by the standard deviation of the measurement in the population.|Participants|Number|43|43.0||||||
4209479|NCT00729651|4032641|B3|Not Applicable||T-score classification by inclusion criteria: A fracture in spine Lumbar 1-4 and T-score ≤ -2.0]|T-score: a measurement expressed in standard deviation units from a given mean used in assessment of osteoporosis, equal to a patient's bone mineral density measurement by Dual Energy X-ray Absorptiometry (DEXA) minus the value in a young healthy person, divided by the standard deviation of the measurement in the population.|Participants|Number|329|329.0||||||
4209480|NCT00729651|4032642|B2|Not Applicable||T-score classification by inclusion criteria: A fracture in spine Lumbar 1-4 and T-score ≤ -2.0]|T-score: a measurement expressed in standard deviation units from a given mean used in assessment of osteoporosis, equal to a patient's bone mineral density measurement by Dual Energy X-ray Absorptiometry (DEXA) minus the value in a young healthy person, divided by the standard deviation of the measurement in the population.|Participants|Number|165|165.0||||||
4209481|NCT00729651|4032643|B1|Not Applicable||T-score classification by inclusion criteria: A fracture in spine Lumbar 1-4 and T-score ≤ -2.0]|T-score: a measurement expressed in standard deviation units from a given mean used in assessment of osteoporosis, equal to a patient's bone mineral density measurement by Dual Energy X-ray Absorptiometry (DEXA) minus the value in a young healthy person, divided by the standard deviation of the measurement in the population.|Participants|Number|164|164.0||||||
4209482|NCT00729651|4032641|B3|A fracture in spine Lumbar 1-4 and T-score ≤ -2.0||T-score classification by inclusion criteria: A fracture in spine Lumbar 1-4 and T-score ≤ -2.0]|T-score: a measurement expressed in standard deviation units from a given mean used in assessment of osteoporosis, equal to a patient's bone mineral density measurement by Dual Energy X-ray Absorptiometry (DEXA) minus the value in a young healthy person, divided by the standard deviation of the measurement in the population.|Participants|Number|14|14.0||||||
4209483|NCT00729651|4032642|B2|A fracture in spine Lumbar 1-4 and T-score ≤ -2.0||T-score classification by inclusion criteria: A fracture in spine Lumbar 1-4 and T-score ≤ -2.0]|T-score: a measurement expressed in standard deviation units from a given mean used in assessment of osteoporosis, equal to a patient's bone mineral density measurement by Dual Energy X-ray Absorptiometry (DEXA) minus the value in a young healthy person, divided by the standard deviation of the measurement in the population.|Participants|Number|5|5.0||||||
4209484|NCT00729651|4032643|B1|A fracture in spine Lumbar 1-4 and T-score ≤ -2.0||T-score classification by inclusion criteria: A fracture in spine Lumbar 1-4 and T-score ≤ -2.0]|T-score: a measurement expressed in standard deviation units from a given mean used in assessment of osteoporosis, equal to a patient's bone mineral density measurement by Dual Energy X-ray Absorptiometry (DEXA) minus the value in a young healthy person, divided by the standard deviation of the measurement in the population.|Participants|Number|9|9.0||||||
4209485|NCT00729651|4032641|B3|Without Vitamin D deficiency at baseline||Patients with/without Vitamin D deficiency|Vitamin D deficiency means serum 25 OHD (hydroxyvitamin D) below the deficiency level (less than 15 ng/ml) in this study.|participants|Number|230|230.0||||||
4209486|NCT00729651|4032642|B2|Without Vitamin D deficiency at baseline||Patients with/without Vitamin D deficiency|Vitamin D deficiency means serum 25 OHD (hydroxyvitamin D) below the deficiency level (less than 15 ng/ml) in this study.|participants|Number|114|114.0||||||
4209487|NCT00729651|4032643|B1|Without Vitamin D deficiency at baseline||Patients with/without Vitamin D deficiency|Vitamin D deficiency means serum 25 OHD (hydroxyvitamin D) below the deficiency level (less than 15 ng/ml) in this study.|participants|Number|116|116.0||||||
4209488|NCT00729651|4032641|B3|With Vitamin D deficiency at baseline||Patients with/without Vitamin D deficiency|Vitamin D deficiency means serum 25 OHD (hydroxyvitamin D) below the deficiency level (less than 15 ng/ml) in this study.|participants|Number|113|113.0||||||
4209548|NCT00729586|4032665|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4209489|NCT00729651|4032642|B2|With Vitamin D deficiency at baseline||Patients with/without Vitamin D deficiency|Vitamin D deficiency means serum 25 OHD (hydroxyvitamin D) below the deficiency level (less than 15 ng/ml) in this study.|participants|Number|56|56.0||||||
4209490|NCT00729651|4032643|B1|With Vitamin D deficiency at baseline||Patients with/without Vitamin D deficiency|Vitamin D deficiency means serum 25 OHD (hydroxyvitamin D) below the deficiency level (less than 15 ng/ml) in this study.|participants|Number|57|57.0||||||
4209491|NCT00729651|4032641|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4209492|NCT00729651|4032642|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4209493|NCT00729651|4032643|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4209494|NCT00729651|4032641|B3||Female|Sex: Female, Male||Participants|Count of Participants|343|343.0||||||
4209495|NCT00729651|4032642|B2||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4209496|NCT00729651|4032643|B1||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4209497|NCT00729651|4032641|B3|>=80 years of age||Age, Customized||participants|Number|6|6.0||||||
4209498|NCT00729651|4032642|B2|>=80 years of age||Age, Customized||participants|Number|3|3.0||||||
4209499|NCT00729651|4032643|B1|>=80 years of age||Age, Customized||participants|Number|3|3.0||||||
4209500|NCT00729651|4032641|B3|70-79 years of age||Age, Customized||participants|Number|88|88.0||||||
4209501|NCT00729651|4032642|B2|70-79 years of age||Age, Customized||participants|Number|51|51.0||||||
4209502|NCT00729651|4032643|B1|70-79 years of age||Age, Customized||participants|Number|37|37.0||||||
4209503|NCT00729651|4032641|B3|60-69 years of age||Age, Customized||participants|Number|158|158.0||||||
4209504|NCT00729651|4032642|B2|60-69 years of age||Age, Customized||participants|Number|73|73.0||||||
4209505|NCT00729651|4032643|B1|60-69 years of age||Age, Customized||participants|Number|85|85.0||||||
4209506|NCT00729651|4032641|B3|50-59 years of age||Age, Customized||participants|Number|90|90.0||||||
4209507|NCT00729651|4032642|B2|50-59 years of age||Age, Customized||participants|Number|43|43.0||||||
4209508|NCT00729651|4032643|B1|50-59 years of age||Age, Customized||participants|Number|47|47.0||||||
4209509|NCT00729651|4032641|B3|45-49 years of age||Age, Customized||participants|Number|1|1.0||||||
4209510|NCT00729651|4032642|B2|45-49 years of age||Age, Customized||participants|Number|0|0.0||||||
4209511|NCT00729651|4032643|B1|45-49 years of age||Age, Customized||participants|Number|1|1.0||||||
4209512|NCT00729651|4032641|B3|<=44 years of age||Age, Customized||participants|Number|0|0.0||||||
4209513|NCT00729651|4032642|B2|<=44 years of age||Age, Customized||participants|Number|0|0.0||||||
4209514|NCT00729651|4032643|B1|<=44 years of age||Age, Customized||participants|Number|0|0.0||||||
4209515|NCT00729651|4032641|B3|||Age||years|Mean|64.94|64.94|Standard Deviation|7.36|7.36|||
4209516|NCT00729651|4032642|B2|||Age||years|Mean|65.31|65.31|Standard Deviation|7.62|7.62|||
4209517|NCT00729651|4032643|B1|||Age||years|Mean|64.59|64.59|Standard Deviation|7.09|7.09|||
4209518|NCT00729612|4032656|B1|United States||Region of Enrollment||patients|Number|63|63.0||||||
4209519|NCT00729612|4032656|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4209520|NCT00729612|4032656|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4209521|NCT00729612|4032656|B1|||Age||years|Median|63.3|63.3|Full Range|||36.0|82.0|
4209522|NCT00729586|4032663|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209523|NCT00729586|4032664|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209524|NCT00729586|4032665|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209525|NCT00729586|4032663|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209526|NCT00729586|4032664|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209527|NCT00729586|4032665|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209528|NCT00729586|4032663|B3||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4209529|NCT00729586|4032664|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4209530|NCT00729586|4032665|B1||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4209531|NCT00729586|4032663|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4209532|NCT00729586|4032664|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4209533|NCT00729586|4032665|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4209534|NCT00729586|4032663|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209535|NCT00729586|4032664|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209536|NCT00729586|4032665|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209537|NCT00729586|4032663|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209538|NCT00729586|4032664|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209539|NCT00729586|4032665|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209540|NCT00729586|4032663|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209541|NCT00729586|4032664|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209542|NCT00729586|4032665|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209543|NCT00729586|4032663|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4209544|NCT00729586|4032664|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4209545|NCT00729586|4032665|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4209546|NCT00729586|4032663|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4209549|NCT00729586|4032663|B3|>=80 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
4209550|NCT00729586|4032664|B2|>=80 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
4209551|NCT00729586|4032665|B1|>=80 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
4209552|NCT00729586|4032663|B3|70-79 years||Age, Customized||Participants|Count of Participants|11|11.0||||||
4209553|NCT00729586|4032664|B2|70-79 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
4209554|NCT00729586|4032665|B1|70-79 years||Age, Customized||Participants|Count of Participants|8|8.0||||||
4209555|NCT00729586|4032663|B3|60-69 years||Age, Customized||Participants|Count of Participants|36|36.0||||||
4209556|NCT00729586|4032664|B2|60-69 years||Age, Customized||Participants|Count of Participants|10|10.0||||||
4209557|NCT00729586|4032665|B1|60-69 years||Age, Customized||Participants|Count of Participants|26|26.0||||||
4209558|NCT00729586|4032663|B3|50-59 years||Age, Customized||Participants|Count of Participants|15|15.0||||||
4209559|NCT00729586|4032664|B2|50-59 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
4209560|NCT00729586|4032665|B1|50-59 years||Age, Customized||Participants|Count of Participants|9|9.0||||||
4209561|NCT00729586|4032663|B3|40-49 years||Age, Customized||Participants|Count of Participants|4|4.0||||||
4209562|NCT00729586|4032664|B2|40-49 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4209563|NCT00729586|4032665|B1|40-49 years||Age, Customized||Participants|Count of Participants|4|4.0||||||
4209564|NCT00729560|4032679|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4209565|NCT00729560|4032679|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4209566|NCT00729560|4032679|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209567|NCT00729560|4032679|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209568|NCT00729560|4032679|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209569|NCT00729560|4032679|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209570|NCT00729560|4032679|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209571|NCT00729560|4032679|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209572|NCT00729560|4032679|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4209573|NCT00729560|4032679|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4209574|NCT00729560|4032679|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4209575|NCT00729560|4032679|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4209576|NCT00729560|4032679|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4209577|NCT00729521|4032683|B4|Not collected||Sex/Gender, Customized||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4209578|NCT00729521|4032684|B3|Not collected||Sex/Gender, Customized||participants|Number|NA|||||||Study looked at all older adults over age 65 years and not specifically at male and females
4209579|NCT00729521|4032685|B2|Not collected||Sex/Gender, Customized||participants|Number|NA|||||||Study looked at all older adults over age 65 years and not specifically at male and females
4209580|NCT00729521|4032686|B1|Not collected||Sex/Gender, Customized||participants|Number|NA|||||||Study looked at all older adults over age 65 years and not specifically at male and females
4209581|NCT00729521|4032683|B4||>=65 years|Age|Adults age 65 years.|Participants|Count of Participants|35037|35037.0||||||
4209582|NCT00729521|4032684|B3||>=65 years|Age|Adults age 65 years.|Participants|Count of Participants|7701|7701.0||||||
4209583|NCT00729521|4032685|B2||>=65 years|Age|Adults age 65 years.|Participants|Count of Participants|14842|14842.0||||||
4209584|NCT00729521|4032686|B1||>=65 years|Age|Adults age 65 years.|Participants|Count of Participants|12494|12494.0||||||
4209585|NCT00729521|4032683|B4||Between 18 and 65 years|Age|Adults age 65 years.|Participants|Count of Participants|0|0.0||||||
4209586|NCT00729521|4032684|B3||Between 18 and 65 years|Age|Adults age 65 years.|Participants|Count of Participants|0|0.0||||||
4209587|NCT00729521|4032685|B2||Between 18 and 65 years|Age|Adults age 65 years.|Participants|Count of Participants|0|0.0||||||
4209588|NCT00729521|4032686|B1||Between 18 and 65 years|Age|Adults age 65 years.|Participants|Count of Participants|0|0.0||||||
4209589|NCT00729521|4032683|B4||<=18 years|Age|Adults age 65 years.|Participants|Count of Participants|0|0.0||||||
4209590|NCT00729521|4032684|B3||<=18 years|Age|Adults age 65 years.|Participants|Count of Participants|0|0.0||||||
4209591|NCT00729521|4032685|B2||<=18 years|Age|Adults age 65 years.|Participants|Count of Participants|0|0.0||||||
4209592|NCT00729521|4032686|B1||<=18 years|Age|Adults age 65 years.|Participants|Count of Participants|0|0.0||||||
4209593|NCT00729482|4032696|B1|Korea, Republic of||Region of Enrollment||participants|Number|54|54.0||||||
4209594|NCT00729482|4032696|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4209595|NCT00729482|4032696|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4209596|NCT00729482|4032696|B1|||Age, Customized||years|Median|57.5|57.5|Full Range|||27.0|72.0|
4209597|NCT00729469|4032703|B3|||BMI||kg/m^2|Mean|26.18|26.18|Standard Deviation|4.31|4.31|||
4209598|NCT00729469|4032704|B2|||BMI||kg/m^2|Mean|26.16|26.16|Standard Deviation|4.31|4.31|||
4209599|NCT00729469|4032705|B1|||BMI||kg/m^2|Mean|26.21|26.21|Standard Deviation|4.32|4.32|||
4209600|NCT00729469|4032703|B3|||Weight||kg|Mean|69.18|69.18|Standard Deviation|12.37|12.37|||
4209601|NCT00729469|4032704|B2|||Weight||kg|Mean|68.98|68.98|Standard Deviation|12.38|12.38|||
4209602|NCT00729469|4032705|B1|||Weight||kg|Mean|69.38|69.38|Standard Deviation|12.38|12.38|||
4209603|NCT00729469|4032703|B3|||Height||cm|Mean|162.5|162.5|Standard Deviation|6.36|6.36|||
4209604|NCT00729469|4032704|B2|||Height||cm|Mean|162.3|162.3|Standard Deviation|6.34|6.34|||
4209605|NCT00729469|4032705|B1|||Height||cm|Mean|162.6|162.6|Standard Deviation|6.39|6.39|||
4209606|NCT00729469|4032703|B3|Other||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4209607|NCT00729469|4032704|B2|Other||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4209608|NCT00729469|4032705|B1|Other||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4209609|NCT00729469|4032703|B3|Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4209610|NCT00729469|4032704|B2|Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4209611|NCT00729469|4032705|B1|Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4209612|NCT00729469|4032703|B3|Asian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4209613|NCT00729469|4032704|B2|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4209614|NCT00729469|4032705|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4209615|NCT00729469|4032703|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
4209616|NCT00729469|4032704|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4209617|NCT00729469|4032705|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4209618|NCT00729469|4032703|B3|White||Race/Ethnicity, Customized||participants|Number|805|805.0||||||
4209619|NCT00729469|4032704|B2|White||Race/Ethnicity, Customized||participants|Number|409|409.0||||||
4209620|NCT00729469|4032705|B1|White||Race/Ethnicity, Customized||participants|Number|396|396.0||||||
4209621|NCT00729469|4032703|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4209622|NCT00729469|4032704|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4209623|NCT00729469|4032705|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4209624|NCT00729469|4032703|B3||Female|Sex: Female, Male||Participants|Count of Participants|919|919.0||||||
4209625|NCT00729469|4032704|B2||Female|Sex: Female, Male||Participants|Count of Participants|463|463.0||||||
4209626|NCT00729469|4032705|B1||Female|Sex: Female, Male||Participants|Count of Participants|456|456.0||||||
4209627|NCT00729469|4032703|B3|>=65||Age, Customized||participants|Number|159|159.0||||||
4209628|NCT00729469|4032704|B2|>=65||Age, Customized||participants|Number|82|82.0||||||
4209629|NCT00729469|4032705|B1|>=65||Age, Customized||participants|Number|77|77.0||||||
4209630|NCT00729469|4032703|B3|55-64||Age, Customized||participants|Number|526|526.0||||||
4209631|NCT00729469|4032704|B2|55-64||Age, Customized||participants|Number|260|260.0||||||
4209632|NCT00729469|4032705|B1|55-64||Age, Customized||participants|Number|266|266.0||||||
4209633|NCT00729469|4032703|B3|45-54||Age, Customized||participants|Number|219|219.0||||||
4209634|NCT00729469|4032704|B2|45-54||Age, Customized||participants|Number|113|113.0||||||
4209635|NCT00729469|4032705|B1|45-54||Age, Customized||participants|Number|106|106.0||||||
4209636|NCT00729469|4032703|B3|<45||Age, Customized||participants|Number|15|15.0||||||
4209637|NCT00729469|4032704|B2|<45||Age, Customized||participants|Number|8|8.0||||||
4209638|NCT00729469|4032705|B1|<45||Age, Customized||participants|Number|7|7.0||||||
4209639|NCT00729469|4032703|B3|||Age||Years|Mean|58.6|58.6|Standard Deviation|6.47|6.47|||
4209640|NCT00729469|4032704|B2|||Age||Years|Mean|58.7|58.7|Standard Deviation|6.56|6.56|||
4209641|NCT00729469|4032705|B1|||Age||Years|Mean|58.5|58.5|Standard Deviation|6.39|6.39|||
4209642|NCT00729430|4032742|B3|United States||Region of Enrollment||Participants|Count of Participants|358|358.0||||||
4209643|NCT00729430|4032743|B2|United States||Region of Enrollment||Participants|Count of Participants|178|178.0||||||
4209644|NCT00729430|4032744|B1|United States||Region of Enrollment||Participants|Count of Participants|180|180.0||||||
4209645|NCT00729430|4032742|B3||Male|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
4209646|NCT00729430|4032743|B2||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4209647|NCT00729430|4032744|B1||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4209648|NCT00729430|4032742|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4209649|NCT00729430|4032743|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4209650|NCT00729430|4032744|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4209651|NCT00729430|4032742|B3|||Age||years|Mean|59|59.0|Standard Deviation|10|10.0|||
4209652|NCT00729430|4032743|B2|||Age||years|Mean|58|58.0|Standard Deviation|10|10.0|||
4209653|NCT00729430|4032744|B1|||Age||years|Mean|60|60.0|Standard Deviation|10|10.0|||
4209654|NCT00729378|4032757|B3|United States||Region of Enrollment||Participants|Count of Participants|509|509.0||||||
4209655|NCT00729378|4032758|B2|United States||Region of Enrollment||Participants|Count of Participants|217|217.0||||||
4209656|NCT00729378|4032759|B1|United States||Region of Enrollment||Participants|Count of Participants|292|292.0||||||
4209657|NCT00729378|4032757|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4209658|NCT00729378|4032758|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4209659|NCT00729378|4032759|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4209660|NCT00729378|4032757|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4209661|NCT00729378|4032758|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209662|NCT00729378|4032759|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4209663|NCT00729378|4032757|B3||White|Race (NIH/OMB)||Participants|Count of Participants|450|450.0||||||
4209664|NCT00729378|4032758|B2||White|Race (NIH/OMB)||Participants|Count of Participants|196|196.0||||||
4209665|NCT00729378|4032759|B1||White|Race (NIH/OMB)||Participants|Count of Participants|254|254.0||||||
4209666|NCT00729378|4032757|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4209667|NCT00729378|4032758|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4209668|NCT00729378|4032759|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4209669|NCT00729378|4032757|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4209670|NCT00729378|4032758|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4209671|NCT00729378|4032759|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4209672|NCT00729378|4032757|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4209673|NCT00729378|4032758|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4209674|NCT00729378|4032759|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4209675|NCT00729378|4032757|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4209676|NCT00729378|4032758|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4209677|NCT00729378|4032759|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4209678|NCT00729378|4032757|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209679|NCT00729378|4032758|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209680|NCT00729378|4032759|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209681|NCT00729378|4032757|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|392|392.0||||||
4209682|NCT00729378|4032758|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
4209683|NCT00729378|4032759|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|225|225.0||||||
4209684|NCT00729378|4032757|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|117|117.0||||||
4209685|NCT00729378|4032758|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4209686|NCT00729378|4032759|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4209687|NCT00729378|4032757|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4209688|NCT00729378|4032758|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4209689|NCT00729378|4032759|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4209690|NCT00729378|4032757|B3||Female|Sex: Female, Male||Participants|Count of Participants|509|509.0||||||
4209691|NCT00729378|4032758|B2||Female|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
4209692|NCT00729378|4032759|B1||Female|Sex: Female, Male||Participants|Count of Participants|292|292.0||||||
4209693|NCT00729378|4032757|B3|||Age||years|Mean|10.7|10.7|Standard Deviation|1.1|1.1|||
4209694|NCT00729378|4032758|B2|||Age||years|Mean|10.7|10.7|Standard Deviation|1.0|1.0|||
4209695|NCT00729378|4032759|B1|||Age||years|Mean|10.6|10.6|Standard Deviation|1.1|1.1|||
4209696|NCT00729365|4032956|B4|United States||Region of Enrollment||participants|Number|46|46.0||||||
4209697|NCT00729365|4032957|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4209698|NCT00729365|4032958|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4209699|NCT00729365|4032959|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4209700|NCT00729365|4032956|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4209701|NCT00729365|4032957|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209702|NCT00729365|4032958|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209703|NCT00729365|4032959|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4209704|NCT00729365|4032956|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209705|NCT00729365|4032957|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209706|NCT00729365|4032958|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209707|NCT00729365|4032959|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209708|NCT00729365|4032956|B4||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4209709|NCT00729365|4032957|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4209710|NCT00729365|4032958|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4209711|NCT00729365|4032959|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4209712|NCT00729365|4032956|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4209713|NCT00729365|4032957|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209714|NCT00729365|4032958|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4209715|NCT00729365|4032959|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4209716|NCT00729365|4032956|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209717|NCT00729365|4032957|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209718|NCT00729365|4032958|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209719|NCT00729365|4032959|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209720|NCT00729365|4032956|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209721|NCT00729365|4032957|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209722|NCT00729365|4032958|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209723|NCT00729365|4032959|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209724|NCT00729365|4032956|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209725|NCT00729365|4032957|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209726|NCT00729365|4032958|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209727|NCT00729365|4032959|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209728|NCT00729365|4032956|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209729|NCT00729365|4032957|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209730|NCT00729365|4032958|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209731|NCT00729365|4032959|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209732|NCT00729365|4032956|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4209733|NCT00729365|4032957|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4209734|NCT00729365|4032958|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4209735|NCT00729365|4032959|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4209736|NCT00729365|4032956|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209737|NCT00729365|4032957|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209738|NCT00729365|4032958|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209739|NCT00729365|4032959|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209740|NCT00729365|4032956|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4209741|NCT00729365|4032957|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4209742|NCT00729365|4032958|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4209743|NCT00729365|4032959|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4209744|NCT00729365|4032956|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4209745|NCT00729365|4032957|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4209746|NCT00729365|4032958|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4209747|NCT00729365|4032959|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4209748|NCT00729365|4032956|B4|||Age||years|Median|29.5|29.5|Full Range|||13.0|49.0|
4209749|NCT00729365|4032957|B3|||Age||years|Median|30.0|30.0|Full Range|||23.0|47.0|
4209750|NCT00729365|4032958|B2|||Age||years|Median|27.5|27.5|Full Range|||17.0|44.0|
4209751|NCT00729365|4032959|B1|||Age||years|Median|30.0|30.0|Full Range|||13.0|49.0|
4209752|NCT00729365|4032956|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4209753|NCT00729365|4032957|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4209754|NCT00729365|4032958|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4209755|NCT00729365|4032959|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4209756|NCT00729365|4032956|B4||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4209757|NCT00729365|4032957|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4209758|NCT00729365|4032958|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4209759|NCT00729365|4032959|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4209760|NCT00729365|4032956|B4||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4209761|NCT00729365|4032957|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4209762|NCT00729365|4032958|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4209763|NCT00729365|4032959|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4209764|NCT00729326|4032972|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4209765|NCT00729326|4032973|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4209766|NCT00729326|4032974|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4209767|NCT00729326|4032972|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4209768|NCT00729326|4032973|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4209769|NCT00729326|4032974|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4209770|NCT00729326|4032972|B3|||Age||years|Mean|54.1|54.1|Standard Deviation|9.75|9.75|||
4209771|NCT00729326|4032973|B2|||Age||years|Mean|53.5|53.5|Standard Deviation|9.49|9.49|||
4209772|NCT00729326|4032974|B1|||Age||years|Mean|54.7|54.7|Standard Deviation|10.10|10.1|||
4209773|NCT00729326|4032972|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4209774|NCT00729326|4032973|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4209775|NCT00729326|4032974|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4209776|NCT00729326|4032972|B3||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4209777|NCT00729326|4032973|B2||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4209778|NCT00729326|4032974|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4209779|NCT00729326|4032972|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4209780|NCT00729326|4032973|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4209781|NCT00729326|4032974|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4209782|NCT00729248|4033017|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4209783|NCT00729248|4033017|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4209784|NCT00729248|4033017|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4209785|NCT00729248|4033017|B1|||Age||years|Mean|47.08|47.08|Standard Deviation|10.5|10.5|||
4209786|NCT00729248|4033017|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4209787|NCT00729248|4033017|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4209788|NCT00729248|4033017|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4209789|NCT00729183|4033022|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4209790|NCT00729183|4033023|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4209791|NCT00729183|4033024|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4209792|NCT00729183|4033022|B3||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4209793|NCT00729183|4033023|B2||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4209794|NCT00729183|4033024|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4209795|NCT00729183|4033022|B3|||Age||years|Mean|64.0|64.0|Standard Deviation|6.8|6.8|||
4209796|NCT00729183|4033023|B2|||Age||years|Mean|64.0|64.0|Standard Deviation|6.2|6.2|||
4209797|NCT00729183|4033024|B1|||Age||years|Mean|63.9|63.9|Standard Deviation|7.3|7.3|||
4209798|NCT00729157|4033057|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4209799|NCT00729157|4033057|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4209800|NCT00729157|4033057|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4209801|NCT00729157|4033057|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4209802|NCT00729157|4033057|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4209803|NCT00729157|4033057|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4209804|NCT00729053|4033065|B5||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4209805|NCT00729053|4033066|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4209806|NCT00729053|4033067|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4209807|NCT00729053|4033068|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4209808|NCT00729053|4033069|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4209809|NCT00729053|4033065|B5||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4209810|NCT00729053|4033066|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4209811|NCT00729053|4033067|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4209812|NCT00729053|4033068|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4209813|NCT00729053|4033069|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4209814|NCT00729053|4033065|B5|||Age|Age in years at the time of screening.|Years|Mean|61.4|61.4|Standard Deviation|10.7|10.7|||
4209815|NCT00729053|4033066|B4|||Age|Age in years at the time of screening.|Years|Mean|60.6|60.6|Standard Deviation|12.0|12.0|||
4209816|NCT00729053|4033067|B3|||Age|Age in years at the time of screening.|Years|Mean|65.6|65.6|Standard Deviation|9.4|9.4|||
4209817|NCT00729053|4033068|B2|||Age|Age in years at the time of screening.|Years|Mean|59.2|59.2|Standard Deviation|10.3|10.3|||
4209818|NCT00729053|4033069|B1|||Age|Age in years at the time of screening.|Years|Mean|60.1|60.1|Standard Deviation|10.6|10.6|||
4209819|NCT00728988|4033098|B3||Male|Sex: Female, Male||Participants|Count of Participants|341|341.0||||||
4209820|NCT00728988|4033099|B2||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4209821|NCT00728988|4033100|B1||Male|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4209822|NCT00728988|4033098|B3||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4209823|NCT00728988|4033099|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4209824|NCT00728988|4033100|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4209825|NCT00728988|4033098|B3|>= 65 years||Age, Customized||participants|Number|177|177.0||||||
4209826|NCT00728988|4033099|B2|>= 65 years||Age, Customized||participants|Number|87|87.0||||||
4209827|NCT00728988|4033100|B1|>= 65 years||Age, Customized||participants|Number|90|90.0||||||
4209828|NCT00728988|4033098|B3|45 to 64 years||Age, Customized||participants|Number|290|290.0||||||
4209829|NCT00728988|4033099|B2|45 to 64 years||Age, Customized||participants|Number|156|156.0||||||
4209830|NCT00728988|4033100|B1|45 to 64 years||Age, Customized||participants|Number|134|134.0||||||
4209831|NCT00728988|4033098|B3|18 to 44 years||Age, Customized||participants|Number|32|32.0||||||
4209832|NCT00728988|4033099|B2|18 to 44 years||Age, Customized||participants|Number|9|9.0||||||
4209833|NCT00728988|4033100|B1|18 to 44 years||Age, Customized||participants|Number|23|23.0||||||
4209834|NCT00728962|4033119|B1|Germany||Region of Enrollment||participants|Number|13|13.0||||||
4209835|NCT00728962|4033119|B1|France||Region of Enrollment||participants|Number|16|16.0||||||
4209836|NCT00728962|4033119|B1|Netherlands||Region of Enrollment||participants|Number|7|7.0||||||
4209837|NCT00728962|4033119|B1|Italy||Region of Enrollment||participants|Number|17|17.0||||||
4209838|NCT00728962|4033119|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4209839|NCT00728962|4033119|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4209840|NCT00728962|4033119|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4209841|NCT00728962|4033119|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4209842|NCT00728962|4033119|B1||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4209843|NCT00728962|4033119|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4209844|NCT00728949|4033123|B3|United States||Region of Enrollment||Participants|Count of Participants|93|93.0||||||
4209845|NCT00728949|4033124|B2|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
4209846|NCT00728949|4033125|B1|United States||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
4209847|NCT00728949|4033123|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209848|NCT00728949|4033124|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209849|NCT00728949|4033125|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209850|NCT00728949|4033123|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4209851|NCT00728949|4033124|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4209852|NCT00728949|4033125|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4209853|NCT00728949|4033123|B3||White|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
4209854|NCT00728949|4033124|B2||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4209855|NCT00728949|4033125|B1||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4209856|NCT00728949|4033123|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4209857|NCT00728949|4033124|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4209858|NCT00728949|4033125|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4209859|NCT00728949|4033123|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209860|NCT00728949|4033124|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209861|NCT00728949|4033125|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209862|NCT00728949|4033123|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209863|NCT00728949|4033124|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209864|NCT00728949|4033125|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209865|NCT00728949|4033123|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209866|NCT00728949|4033124|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209867|NCT00728949|4033125|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209868|NCT00728949|4033123|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209869|NCT00728949|4033124|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209870|NCT00728949|4033125|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209871|NCT00728949|4033123|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
4209872|NCT00728949|4033124|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4209873|NCT00728949|4033125|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4209874|NCT00728949|4033123|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4209875|NCT00728949|4033124|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4209876|NCT00728949|4033125|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4209877|NCT00728949|4033123|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4209878|NCT00728949|4033124|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4209879|NCT00728949|4033125|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4209880|NCT00728949|4033123|B3||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4209881|NCT00728949|4033124|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4209882|NCT00728949|4033125|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4209883|NCT00728949|4033123|B3||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4209884|NCT00728949|4033124|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4209885|NCT00728949|4033125|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4209886|NCT00728949|4033123|B3||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4209887|NCT00728949|4033124|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4209888|NCT00728949|4033125|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4209889|NCT00728949|4033123|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4209890|NCT00728949|4033124|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4209891|NCT00728949|4033125|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4209892|NCT00728923|4033144|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4209893|NCT00728923|4033144|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4209894|NCT00728923|4033144|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4209895|NCT00728923|4033144|B1|||Age||years|Mean|37|37.0|Standard Deviation|15|15.0|||
4209896|NCT00728923|4033144|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4209897|NCT00728923|4033144|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4209898|NCT00728923|4033144|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4209899|NCT00728910|4033149|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4209900|NCT00728910|4033149|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4209901|NCT00728910|4033149|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4209902|NCT00728910|4033149|B1|||Age||years|Mean|47|47.0|Standard Deviation|10.74|10.74|||
4209903|NCT00728910|4033149|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4209904|NCT00728910|4033149|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4209905|NCT00728910|4033149|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4209906|NCT00728884|4033161|B1|Sweden||Region of Enrollment||participants|Number|20|20.0||||||
4209907|NCT00728884|4033161|B1|France||Region of Enrollment||participants|Number|9|9.0||||||
4209908|NCT00728884|4033161|B1|Italy||Region of Enrollment||participants|Number|52|52.0||||||
4209909|NCT00728884|4033161|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4209910|NCT00728884|4033161|B1|Ireland||Region of Enrollment||participants|Number|14|14.0||||||
4209911|NCT00728884|4033161|B1|Australia||Region of Enrollment||participants|Number|10|10.0||||||
4209912|NCT00728884|4033161|B1|Austria||Region of Enrollment||participants|Number|26|26.0||||||
4209913|NCT00728884|4033161|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4209914|NCT00728884|4033161|B1||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4209915|NCT00728884|4033161|B1||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4209916|NCT00728884|4033161|B1||Between 18 and 65 years|Age||Participants|Count of Participants|135|135.0||||||
4209917|NCT00728884|4033161|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4209918|NCT00728845|4033165|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4209919|NCT00728845|4033167|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4209920|NCT00728845|4033165|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4209921|NCT00728845|4033167|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4209922|NCT00728845|4033165|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4209923|NCT00728845|4033167|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4209924|NCT00728845|4033165|B3|||Age||years|Mean|63.3|63.3|Standard Deviation|8.4|8.4|||
4209925|NCT00728845|4033167|B1|||Age||years|Mean|63.3|63.3|Standard Deviation|8.4|8.4|||
4209926|NCT00728845|4033165|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4209927|NCT00728845|4033167|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4209928|NCT00728845|4033165|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4209929|NCT00728845|4033167|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4209930|NCT00728845|4033165|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4209931|NCT00728845|4033167|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4209932|NCT00728819|4033182|B3|United States||Region of Enrollment||Participants|Count of Participants|339|339.0||||||
4209933|NCT00728819|4033183|B2|United States||Region of Enrollment||Participants|Count of Participants|168|168.0||||||
4209934|NCT00728819|4033184|B1|United States||Region of Enrollment||Participants|Count of Participants|171|171.0||||||
4209935|NCT00728819|4033182|B3||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4209936|NCT00728819|4033183|B2||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4209937|NCT00728819|4033184|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4209938|NCT00728819|4033182|B3||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4209939|NCT00728819|4033183|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4209940|NCT00728819|4033184|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4209941|NCT00728819|4033182|B3|18-90 yo||Age, Customized||Participants|Count of Participants|339|339.0||||||
4209942|NCT00728819|4033183|B2|18-90 yo||Age, Customized||Participants|Count of Participants|168|168.0||||||
4209943|NCT00728819|4033184|B1|18-90 yo||Age, Customized||Participants|Count of Participants|171|171.0||||||
4209944|NCT00728754|4033195|B3|Australia||Region of Enrollment||participants|Number|8|8.0||||||
4209945|NCT00728754|4033196|B2|Australia||Region of Enrollment||participants|Number|5|5.0||||||
4209946|NCT00728754|4033197|B1|Australia||Region of Enrollment||participants|Number|3|3.0||||||
4209947|NCT00728754|4033195|B3|Sweden||Region of Enrollment||participants|Number|9|9.0||||||
4209948|NCT00728754|4033196|B2|Sweden||Region of Enrollment||participants|Number|4|4.0||||||
4209949|NCT00728754|4033197|B1|Sweden||Region of Enrollment||participants|Number|5|5.0||||||
4209950|NCT00728754|4033195|B3|Italy||Region of Enrollment||participants|Number|30|30.0||||||
4209951|NCT00728754|4033196|B2|Italy||Region of Enrollment||participants|Number|15|15.0||||||
4209952|NCT00728754|4033197|B1|Italy||Region of Enrollment||participants|Number|15|15.0||||||
4209953|NCT00728754|4033195|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4209954|NCT00728754|4033196|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4209955|NCT00728754|4033197|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4209956|NCT00728754|4033195|B3|Male||Sex/Gender, Customized||participants|Number|32|32.0||||||
4209957|NCT00728754|4033196|B2|Male||Sex/Gender, Customized||participants|Number|17|17.0||||||
4209958|NCT00728754|4033197|B1|Male||Sex/Gender, Customized||participants|Number|15|15.0||||||
4209959|NCT00728754|4033195|B3|Female||Sex/Gender, Customized||participants|Number|29|29.0||||||
4209960|NCT00728754|4033196|B2|Female||Sex/Gender, Customized||participants|Number|15|15.0||||||
4209961|NCT00728754|4033197|B1|Female||Sex/Gender, Customized||participants|Number|14|14.0||||||
4209962|NCT00728754|4033195|B3|>=65 years||Age, Customized||participants|Number|22|22.0||||||
4209963|NCT00728754|4033196|B2|>=65 years||Age, Customized||participants|Number|11|11.0||||||
4209964|NCT00728754|4033197|B1|>=65 years||Age, Customized||participants|Number|11|11.0||||||
4209965|NCT00728754|4033195|B3|Between 18 and 65 years||Age, Customized||participants|Number|39|39.0||||||
4209966|NCT00728754|4033196|B2|Between 18 and 65 years||Age, Customized||participants|Number|21|21.0||||||
4209967|NCT00728754|4033197|B1|Between 18 and 65 years||Age, Customized||participants|Number|18|18.0||||||
4209968|NCT00728754|4033195|B3|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4209969|NCT00728754|4033196|B2|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4209970|NCT00728754|4033197|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4209971|NCT00728728|4033204|B3|United States||Region of Enrollment||participants|Number|88|88.0||||||
4209972|NCT00728728|4033205|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
4209973|NCT00728728|4033206|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4209974|NCT00728728|4033204|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209975|NCT00728728|4033205|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209976|NCT00728728|4033206|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209977|NCT00728728|4033204|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4209978|NCT00728728|4033205|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4209979|NCT00728728|4033206|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4209980|NCT00728728|4033204|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4209981|NCT00728728|4033205|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4209982|NCT00728728|4033206|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4209983|NCT00728728|4033204|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4209984|NCT00728728|4033205|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4209985|NCT00728728|4033206|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4209986|NCT00728728|4033204|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209987|NCT00728728|4033205|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209988|NCT00728728|4033206|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209989|NCT00728728|4033204|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209990|NCT00728728|4033205|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209991|NCT00728728|4033206|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209992|NCT00728728|4033204|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209993|NCT00728728|4033205|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209994|NCT00728728|4033206|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4209995|NCT00728728|4033204|B3||Male|Gender||Participants|Count of Participants|75|75.0||||||
4209996|NCT00728728|4033205|B2||Male|Gender||Participants|Count of Participants|39|39.0||||||
4209997|NCT00728728|4033206|B1||Male|Gender||Participants|Count of Participants|36|36.0||||||
4209998|NCT00728728|4033204|B3||Female|Gender||Participants|Count of Participants|13|13.0||||||
4209999|NCT00728728|4033205|B2||Female|Gender||Participants|Count of Participants|7|7.0||||||
4210000|NCT00728728|4033206|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
4210001|NCT00728728|4033204|B3|||Age||years|Mean|51.7|51.7|Standard Deviation|8.4|8.4|||
4210002|NCT00728728|4033205|B2|||Age||years|Mean|51.6|51.6|Standard Deviation|8.4|8.4|||
4210003|NCT00728728|4033206|B1|||Age||years|Mean|51.9|51.9|Standard Deviation|8.5|8.5|||
4210004|NCT00728689|4033225|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4210005|NCT00728689|4033226|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4210006|NCT00728689|4033227|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4210007|NCT00728689|4033225|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4210008|NCT00728689|4033226|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4210009|NCT00728689|4033227|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4210010|NCT00728689|4033225|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4210011|NCT00728689|4033226|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4210012|NCT00728689|4033227|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4210013|NCT00728689|4033225|B3|||Age||years|Mean|34.8|34.8|Standard Deviation|8.3|8.3|||
4210014|NCT00728689|4033226|B2|||Age||years|Mean|34.8|34.8|Standard Deviation|9.4|9.4|||
4210015|NCT00728689|4033227|B1|||Age||years|Mean|34.7|34.7|Standard Deviation|8|8.0|||
4210016|NCT00728689|4033225|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4210017|NCT00728689|4033226|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4210018|NCT00728689|4033227|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4210019|NCT00728689|4033225|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4210020|NCT00728689|4033226|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4210021|NCT00728689|4033227|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4210022|NCT00728689|4033225|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4210023|NCT00728689|4033226|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4210024|NCT00728689|4033227|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4210025|NCT00728507|4033244|B3|Brazil||Region of Enrollment||participants|Number|121|121.0||||||
4210026|NCT00728507|4033245|B2|Brazil||Region of Enrollment||participants|Number|59|59.0||||||
4210027|NCT00728507|4033246|B1|Brazil||Region of Enrollment||participants|Number|62|62.0||||||
4210028|NCT00728507|4033244|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4210029|NCT00728507|4033245|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4210030|NCT00728507|4033246|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4210031|NCT00728507|4033244|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4210032|NCT00728507|4033245|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4210033|NCT00728507|4033246|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4210034|NCT00728507|4033244|B3|||Age||years|Median|32|32.0|Inter-Quartile Range|||24.0|47.0|
4210035|NCT00728507|4033245|B2|||Age||years|Median|30|30.0|Inter-Quartile Range|||24.0|45.0|
4210036|NCT00728507|4033246|B1|||Age||years|Median|33|33.0|Inter-Quartile Range|||25.0|48.0|
4210037|NCT00728494|4033255|B3|Poland||Region of Enrollment||participants|Number|99|99.0||||||
4210038|NCT00728494|4033256|B2|Poland||Region of Enrollment||participants|Number|39|39.0||||||
4210039|NCT00728494|4033257|B1|Poland||Region of Enrollment||participants|Number|60|60.0||||||
4210040|NCT00728494|4033255|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4210041|NCT00728494|4033256|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4210042|NCT00728494|4033257|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4210043|NCT00728494|4033255|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4210044|NCT00728494|4033256|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4210045|NCT00728494|4033257|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4210046|NCT00728494|4033255|B3|||Age||years|Mean|45|45.0|Standard Deviation|13|13.0|||
4210047|NCT00728494|4033256|B2|||Age||years|Mean|42|42.0|Standard Deviation|14|14.0|||
4210048|NCT00728494|4033257|B1|||Age||years|Mean|47|47.0|Standard Deviation|12|12.0|||
4210049|NCT00728481|4033274|B3|No symptoms||Number of participants with frequent GERD/dysphagia symptoms|"The GERD portion of the Mayo Dysphagia Questionnaire-30 day (MDQ-30) was used to evaluate the frequency of GERD symptoms. The Mayo Dysphagia Questionnaire is a validated 28 item instrument; 0 = no dysphagia, higher levels indicate greater dysphagia severity.~Note: 18 of the 19 participants with GERD completed the questionnaire."|participants|Number|15|15.0||||||
4210050|NCT00728481|4033275|B2|No symptoms||Number of participants with frequent GERD/dysphagia symptoms|"The GERD portion of the Mayo Dysphagia Questionnaire-30 day (MDQ-30) was used to evaluate the frequency of GERD symptoms. The Mayo Dysphagia Questionnaire is a validated 28 item instrument; 0 = no dysphagia, higher levels indicate greater dysphagia severity.~Note: 18 of the 19 participants with GERD completed the questionnaire."|participants|Number|15|15.0||||||
4210051|NCT00728481|4033276|B1|No symptoms||Number of participants with frequent GERD/dysphagia symptoms|"The GERD portion of the Mayo Dysphagia Questionnaire-30 day (MDQ-30) was used to evaluate the frequency of GERD symptoms. The Mayo Dysphagia Questionnaire is a validated 28 item instrument; 0 = no dysphagia, higher levels indicate greater dysphagia severity.~Note: 18 of the 19 participants with GERD completed the questionnaire."|participants|Number|0|0.0||||||
4210052|NCT00728481|4033274|B3|No or infrequent symptoms||Number of participants with frequent GERD/dysphagia symptoms|"The GERD portion of the Mayo Dysphagia Questionnaire-30 day (MDQ-30) was used to evaluate the frequency of GERD symptoms. The Mayo Dysphagia Questionnaire is a validated 28 item instrument; 0 = no dysphagia, higher levels indicate greater dysphagia severity.~Note: 18 of the 19 participants with GERD completed the questionnaire."|participants|Number|20|20.0||||||
4210053|NCT00728481|4033275|B2|No or infrequent symptoms||Number of participants with frequent GERD/dysphagia symptoms|"The GERD portion of the Mayo Dysphagia Questionnaire-30 day (MDQ-30) was used to evaluate the frequency of GERD symptoms. The Mayo Dysphagia Questionnaire is a validated 28 item instrument; 0 = no dysphagia, higher levels indicate greater dysphagia severity.~Note: 18 of the 19 participants with GERD completed the questionnaire."|participants|Number|17|17.0||||||
4210054|NCT00728481|4033276|B1|No or infrequent symptoms||Number of participants with frequent GERD/dysphagia symptoms|"The GERD portion of the Mayo Dysphagia Questionnaire-30 day (MDQ-30) was used to evaluate the frequency of GERD symptoms. The Mayo Dysphagia Questionnaire is a validated 28 item instrument; 0 = no dysphagia, higher levels indicate greater dysphagia severity.~Note: 18 of the 19 participants with GERD completed the questionnaire."|participants|Number|3|3.0||||||
4210055|NCT00728481|4033274|B3|Frequent symptoms||Number of participants with frequent GERD/dysphagia symptoms|"The GERD portion of the Mayo Dysphagia Questionnaire-30 day (MDQ-30) was used to evaluate the frequency of GERD symptoms. The Mayo Dysphagia Questionnaire is a validated 28 item instrument; 0 = no dysphagia, higher levels indicate greater dysphagia severity.~Note: 18 of the 19 participants with GERD completed the questionnaire."|participants|Number|15|15.0||||||
4210056|NCT00728481|4033275|B2|Frequent symptoms||Number of participants with frequent GERD/dysphagia symptoms|"The GERD portion of the Mayo Dysphagia Questionnaire-30 day (MDQ-30) was used to evaluate the frequency of GERD symptoms. The Mayo Dysphagia Questionnaire is a validated 28 item instrument; 0 = no dysphagia, higher levels indicate greater dysphagia severity.~Note: 18 of the 19 participants with GERD completed the questionnaire."|participants|Number|0|0.0||||||
4210057|NCT00728481|4033276|B1|Frequent symptoms||Number of participants with frequent GERD/dysphagia symptoms|"The GERD portion of the Mayo Dysphagia Questionnaire-30 day (MDQ-30) was used to evaluate the frequency of GERD symptoms. The Mayo Dysphagia Questionnaire is a validated 28 item instrument; 0 = no dysphagia, higher levels indicate greater dysphagia severity.~Note: 18 of the 19 participants with GERD completed the questionnaire."|participants|Number|15|15.0||||||
4210058|NCT00728481|4033274|B3|Erosive esophagitis||Endoscopic evidence of GERD|Participants could have had more than one symptom of GERD, or no symptoms of GERD.|Participants|Number|9|9.0||||||
4210059|NCT00728481|4033275|B2|Erosive esophagitis||Endoscopic evidence of GERD|Participants could have had more than one symptom of GERD, or no symptoms of GERD.|Participants|Number|2|2.0||||||
4210060|NCT00728481|4033276|B1|Erosive esophagitis||Endoscopic evidence of GERD|Participants could have had more than one symptom of GERD, or no symptoms of GERD.|Participants|Number|7|7.0||||||
4210061|NCT00728481|4033274|B3|Hiatal hernia||Endoscopic evidence of GERD|Participants could have had more than one symptom of GERD, or no symptoms of GERD.|Participants|Number|25|25.0||||||
4210062|NCT00728481|4033275|B2|Hiatal hernia||Endoscopic evidence of GERD|Participants could have had more than one symptom of GERD, or no symptoms of GERD.|Participants|Number|10|10.0||||||
4210063|NCT00728481|4033276|B1|Hiatal hernia||Endoscopic evidence of GERD|Participants could have had more than one symptom of GERD, or no symptoms of GERD.|Participants|Number|15|15.0||||||
4210064|NCT00728481|4033274|B3|Multiple rings (felinization or corrugations)||Endoscopic evidence of GERD|Participants could have had more than one symptom of GERD, or no symptoms of GERD.|Participants|Number|32|32.0||||||
4210065|NCT00728481|4033275|B2|Multiple rings (felinization or corrugations)||Endoscopic evidence of GERD|Participants could have had more than one symptom of GERD, or no symptoms of GERD.|Participants|Number|18|18.0||||||
4210066|NCT00728481|4033276|B1|Multiple rings (felinization or corrugations)||Endoscopic evidence of GERD|Participants could have had more than one symptom of GERD, or no symptoms of GERD.|Participants|Number|14|14.0||||||
4210067|NCT00728481|4033274|B3|||Mean number of eosinophils per high powered field in esophagus|Mean eosinophilic density per high power field [eos/hpf] (at 400 x magnification) of four esophageal biopsies each taken from the proximal & distal esophagus at some point 18 months or less prior to study enrollment.|eos/hpf|Mean|41.2|41.2|Standard Deviation|27.7|27.7|||
4210068|NCT00728481|4033275|B2|||Mean number of eosinophils per high powered field in esophagus|Mean eosinophilic density per high power field [eos/hpf] (at 400 x magnification) of four esophageal biopsies each taken from the proximal & distal esophagus at some point 18 months or less prior to study enrollment.|eos/hpf|Mean|46.7|46.7|Standard Deviation|26.5|26.5|||
4210069|NCT00728481|4033276|B1|||Mean number of eosinophils per high powered field in esophagus|Mean eosinophilic density per high power field [eos/hpf] (at 400 x magnification) of four esophageal biopsies each taken from the proximal & distal esophagus at some point 18 months or less prior to study enrollment.|eos/hpf|Mean|35.6|35.6|Standard Deviation|24.7|24.7|||
4210070|NCT00728481|4033274|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
4210071|NCT00728481|4033275|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
4210072|NCT00728481|4033276|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4210073|NCT00728481|4033274|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4210074|NCT00728481|4033275|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4210075|NCT00728481|4033276|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4210076|NCT00728481|4033274|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4210077|NCT00728481|4033275|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4210078|NCT00728481|4033276|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4210079|NCT00728481|4033274|B3|||Age||years|Mean|39|39.0|Standard Deviation|13.9|13.9|||
4210080|NCT00728481|4033275|B2|||Age||years|Mean|33.7|33.7|Standard Deviation|10.4|10.4|||
4210081|NCT00728481|4033276|B1|||Age||years|Mean|47.5|47.5|Standard Deviation|14.9|14.9|||
4210082|NCT00728468|4033293|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4210083|NCT00728468|4033293|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4210084|NCT00728468|4033293|B1|||Age||Years|Mean|57.1|57.1|Standard Deviation|12.0|12.0|||
4210085|NCT00728416|4033315|B3||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4210086|NCT00728416|4033316|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4210087|NCT00728416|4033317|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4210088|NCT00728416|4033315|B3||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4210089|NCT00728416|4033316|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4210090|NCT00728416|4033317|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4210091|NCT00728416|4033315|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4210092|NCT00728416|4033316|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4210093|NCT00728416|4033317|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4210094|NCT00728416|4033315|B3||Between 18 and 65 years|Age||Participants|Count of Participants|294|294.0||||||
4210095|NCT00728416|4033316|B2||Between 18 and 65 years|Age||Participants|Count of Participants|146|146.0||||||
4210096|NCT00728416|4033317|B1||Between 18 and 65 years|Age||Participants|Count of Participants|148|148.0||||||
4210097|NCT00728416|4033315|B3||<=18 years|Age||Participants|Count of Participants|28|28.0||||||
4210098|NCT00728416|4033316|B2||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4210099|NCT00728416|4033317|B1||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4210100|NCT00728260|4033326|B1|Not Available||Indication for Vaccination|Based on automated subject data. Participants may be included in more than 1 category|Participants|Number|987|987.0||||||
4210101|NCT00728260|4033326|B1|Travel-Related||Indication for Vaccination|Based on automated subject data. Participants may be included in more than 1 category|Participants|Number|364|364.0||||||
4210102|NCT00728260|4033326|B1|Human Immunodeficiency Virus Infection||Indication for Vaccination|Based on automated subject data. Participants may be included in more than 1 category|Participants|Number|1|1.0||||||
4210103|NCT00728260|4033326|B1|Other Hemoglobinopathy||Indication for Vaccination|Based on automated subject data. Participants may be included in more than 1 category|Participants|Number|9|9.0||||||
4210104|NCT00728260|4033326|B1|Thalassemias||Indication for Vaccination|Based on automated subject data. Participants may be included in more than 1 category|Participants|Number|22|22.0||||||
4210105|NCT00728260|4033326|B1|Sickle Cell Disease||Indication for Vaccination|Based on automated subject data. Participants may be included in more than 1 category|Participants|Number|44|44.0||||||
4210106|NCT00728260|4033326|B1|Hereditary Spherocytosis||Indication for Vaccination|Based on automated subject data. Participants may be included in more than 1 category|Participants|Number|8|8.0||||||
4210107|NCT00728260|4033326|B1|Hereditary Elliptocytosis||Indication for Vaccination|Based on automated subject data. Participants may be included in more than 1 category|Participants|Number|1|1.0||||||
4210108|NCT00728260|4033326|B1|Complement Deficiency||Indication for Vaccination|Based on automated subject data. Participants may be included in more than 1 category|Participants|Number|2|2.0||||||
4210109|NCT00728260|4033326|B1|Asplenia (Surgical or Congenital)||Indication for Vaccination|Based on automated subject data. Participants may be included in more than 1 category|Participants|Number|17|17.0||||||
4210110|NCT00728260|4033326|B1|September - November||Seasonality|Data represent participants receiving vaccine during each time period shown. One participant had received more than one dose of Menactra vaccine; each dose is counted in the seasonality section.|Participants|Number|294|294.0||||||
4210111|NCT00728260|4033326|B1|June - August||Seasonality|Data represent participants receiving vaccine during each time period shown. One participant had received more than one dose of Menactra vaccine; each dose is counted in the seasonality section.|Participants|Number|593|593.0||||||
4210112|NCT00728260|4033326|B1|March - May||Seasonality|Data represent participants receiving vaccine during each time period shown. One participant had received more than one dose of Menactra vaccine; each dose is counted in the seasonality section.|Participants|Number|372|372.0||||||
4210113|NCT00728260|4033326|B1|December - February||Seasonality|Data represent participants receiving vaccine during each time period shown. One participant had received more than one dose of Menactra vaccine; each dose is counted in the seasonality section.|Participants|Number|163|163.0||||||
4210114|NCT00728260|4033326|B1|United States||Region of Enrollment||participants|Number|1421|1421.0||||||
4210115|NCT00728260|4033326|B1||Male|Sex: Female, Male||Participants|Count of Participants|712|712.0||||||
4210116|NCT00728260|4033326|B1||Female|Sex: Female, Male||Participants|Count of Participants|709|709.0||||||
4210117|NCT00728260|4033326|B1|||Age||Years|Mean|8.36|8.36|Standard Deviation|2.55|2.55|||
4210118|NCT00728260|4033326|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4210119|NCT00728260|4033326|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4210120|NCT00728260|4033326|B1||<=18 years|Age||Participants|Count of Participants|1421|1421.0||||||
4210121|NCT00728182|4033332|B3|Canada||Region of Enrollment||participants|Number|158|158.0||||||
4210122|NCT00728182|4033333|B2|Canada||Region of Enrollment||participants|Number|78|78.0||||||
4210123|NCT00728182|4033334|B1|Canada||Region of Enrollment||participants|Number|80|80.0||||||
4210124|NCT00728182|4033332|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
4210125|NCT00728182|4033333|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4210126|NCT00728182|4033334|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4210127|NCT00728182|4033332|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4210128|NCT00728182|4033333|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4210129|NCT00728182|4033334|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4210130|NCT00728182|4033332|B3||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4210131|NCT00728182|4033333|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4210132|NCT00728182|4033334|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4210133|NCT00728182|4033332|B3|||Age||years|Mean|56.88|56.88|Standard Deviation|10.5|10.5|||
4210134|NCT00728182|4033333|B2|||Age||years|Mean|56.05|56.05|Standard Deviation|10.3|10.3|||
4210135|NCT00728182|4033334|B1|||Age||years|Mean|57.72|57.72|Standard Deviation|10.6|10.6|||
4210136|NCT00728182|4033332|B3||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
4210137|NCT00728182|4033333|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4210138|NCT00728182|4033334|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4210139|NCT00728182|4033332|B3||Between 18 and 65 years|Age||Participants|Count of Participants|148|148.0||||||
4210140|NCT00728182|4033333|B2||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
4210141|NCT00728182|4033334|B1||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4210142|NCT00728182|4033332|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4210143|NCT00728182|4033333|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4210144|NCT00728182|4033334|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4210145|NCT00728130|4033363|B1|Not completed||surgical bed inspection||participants|Number|3|3.0||||||
4210146|NCT00728130|4033363|B1|Surgery||surgical bed inspection||participants|Number|19|19.0||||||
4210147|NCT00728130|4033363|B1|Not completed||sublevel IB dissection||participants|Number|3|3.0||||||
4210148|NCT00728130|4033363|B1|Surgery||sublevel IB dissection||participants|Number|19|19.0||||||
4210149|NCT00728130|4033363|B1|Not completed||submandibular gland excision||participants|Number|3|3.0||||||
4210150|NCT00728130|4033363|B1|Surgery||submandibular gland excision||participants|Number|19|19.0||||||
4210151|NCT00728130|4033363|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4210152|NCT00728130|4033363|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4210153|NCT00728130|4033363|B1|>=80 years||Age, Customized||participants|Number|0|0.0||||||
4210154|NCT00728130|4033363|B1|Between 18 and 79 years||Age, Customized||participants|Number|22|22.0||||||
4210155|NCT00728130|4033363|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4210156|NCT00728130|4033363|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|10.8|10.8|||
4210157|NCT00727961|4033368|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4210158|NCT00727961|4033368|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4210159|NCT00727961|4033368|B1|||Age, Customized||participants|Number|58|58.0||||||
4210160|NCT00727909|4033378|B1|United States||Region of Enrollment||participants|Number|290|290.0||||||
4210161|NCT00727909|4033378|B1||Male|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
4210162|NCT00727909|4033378|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4210163|NCT00727909|4033378|B1|||Age||years|Mean|67.9|67.9|Standard Deviation|9.4|9.4|||
4210164|NCT00727909|4033378|B1||>=65 years|Age||Participants|Count of Participants|184|184.0||||||
4210165|NCT00727909|4033378|B1||Between 18 and 65 years|Age||Participants|Count of Participants|106|106.0||||||
4210166|NCT00727909|4033378|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4210167|NCT00727857|4033385|B4|||Body Mass Index||kg/m²|Mean|30.94|30.94|Standard Deviation|5.63|5.63|||
4210168|NCT00727857|4033386|B3|||Body Mass Index||kg/m²|Mean|30.83|30.83|Standard Deviation|5.66|5.66|||
4210169|NCT00727857|4033387|B2|||Body Mass Index||kg/m²|Mean|31.18|31.18|Standard Deviation|5.50|5.5|||
4210170|NCT00727857|4033388|B1|||Body Mass Index||kg/m²|Mean|30.84|30.84|Standard Deviation|5.74|5.74|||
4210171|NCT00727857|4033385|B4|Multiracial||Race/Ethnicity, Customized||participants|Number|178|178.0||||||
4210172|NCT00727857|4033386|B3|Multiracial||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
4210173|NCT00727857|4033387|B2|Multiracial||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
4210174|NCT00727857|4033388|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
4210175|NCT00727857|4033385|B4|White||Race/Ethnicity, Customized||participants|Number|356|356.0||||||
4210176|NCT00727857|4033386|B3|White||Race/Ethnicity, Customized||participants|Number|124|124.0||||||
4210177|NCT00727857|4033387|B2|White||Race/Ethnicity, Customized||participants|Number|109|109.0||||||
4210178|NCT00727857|4033388|B1|White||Race/Ethnicity, Customized||participants|Number|123|123.0||||||
4210179|NCT00727857|4033385|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4210180|NCT00727857|4033386|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4210181|NCT00727857|4033387|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4210182|NCT00727857|4033388|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4210183|NCT00727857|4033385|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4210184|NCT00727857|4033386|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4210185|NCT00727857|4033387|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4210186|NCT00727857|4033388|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4210187|NCT00727857|4033385|B4|Asian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4210188|NCT00727857|4033386|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4210189|NCT00727857|4033387|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4210190|NCT00727857|4033388|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4210191|NCT00727857|4033385|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4210192|NCT00727857|4033386|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4210193|NCT00727857|4033387|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4210194|NCT00727857|4033388|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4210195|NCT00727857|4033385|B4||Male|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
4210196|NCT00727857|4033386|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4210197|NCT00727857|4033387|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4210198|NCT00727857|4033388|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4210199|NCT00727857|4033385|B4||Female|Sex: Female, Male||Participants|Count of Participants|346|346.0||||||
4210200|NCT00727857|4033386|B3||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4210201|NCT00727857|4033387|B2||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4210202|NCT00727857|4033388|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4210203|NCT00727857|4033385|B4|||Age||years|Mean|54.1|54.1|Standard Deviation|12.09|12.09|||
4210204|NCT00727857|4033386|B3|||Age||years|Mean|53.7|53.7|Standard Deviation|12.00|12.0|||
4210205|NCT00727857|4033387|B2|||Age||years|Mean|54.0|54.0|Standard Deviation|12.08|12.08|||
4210206|NCT00727857|4033388|B1|||Age||years|Mean|54.7|54.7|Standard Deviation|12.23|12.23|||
4210207|NCT00727844|4033476|B3|Korea, Republic of||Region of Enrollment||participants|Number|39|39.0||||||
4210208|NCT00727844|4033477|B2|Korea, Republic of||Region of Enrollment||participants|Number|20|20.0||||||
4210209|NCT00727844|4033478|B1|Korea, Republic of||Region of Enrollment||participants|Number|19|19.0||||||
4210210|NCT00727844|4033476|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4210211|NCT00727844|4033477|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4210212|NCT00727844|4033478|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4210213|NCT00727844|4033476|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4210214|NCT00727844|4033477|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4210215|NCT00727844|4033478|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4210216|NCT00727844|4033476|B3|||Age||years|Mean|41.2|41.2|Standard Deviation|10.4|10.4|||
4210217|NCT00727844|4033477|B2|||Age||years|Mean|40.4|40.4|Standard Deviation|9.8|9.8|||
4210218|NCT00727844|4033478|B1|||Age||years|Mean|42.1|42.1|Standard Deviation|11.2|11.2|||
4210219|NCT00727844|4033476|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4210220|NCT00727844|4033477|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4210221|NCT00727844|4033478|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4210222|NCT00727844|4033476|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4210223|NCT00727844|4033477|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4210224|NCT00727844|4033478|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4210225|NCT00727844|4033476|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4210226|NCT00727844|4033477|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4210227|NCT00727844|4033478|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4210228|NCT00727740|4033486|B3||Male|Gender||Participants|Count of Participants|71|71.0||||||
4210229|NCT00727740|4033487|B2||Male|Gender||Participants|Count of Participants|37|37.0||||||
4210230|NCT00727740|4033488|B1||Male|Gender||Participants|Count of Participants|34|34.0||||||
4210231|NCT00727740|4033486|B3||Female|Gender||Participants|Count of Participants|46|46.0||||||
4210232|NCT00727740|4033487|B2||Female|Gender||Participants|Count of Participants|24|24.0||||||
4210233|NCT00727740|4033488|B1||Female|Gender||Participants|Count of Participants|22|22.0||||||
4210234|NCT00727740|4033486|B3|||Age||years|Mean|55.4|55.4|Standard Deviation|16.1|16.1|||
4210235|NCT00727740|4033487|B2|||Age||years|Mean|56.6|56.6|Standard Deviation|13.5|13.5|||
4210236|NCT00727740|4033488|B1|||Age||years|Mean|54.2|54.2|Standard Deviation|18.3|18.3|||
4210237|NCT00727714|4033495|B1|IL-10||Inflammatory markers in blood||ng/litre|Median|1.12|1.12|Full Range|||0.18|10.78|
4210238|NCT00727714|4033495|B1|IL-1B||Inflammatory markers in blood||ng/litre|Median|0.25|0.25|Full Range|||0.09|7.0|
4210239|NCT00727714|4033495|B1|||Fraction of exhaled nitric oxide (FeNO)||parts per billion|Median|14|14.0|Full Range|||0.0|96.0|
4210240|NCT00727714|4033495|B1|FEV1||Spirometry||Litres|Mean|3.92|3.92|Standard Deviation|0.81|0.81|||
4210241|NCT00727714|4033495|B1|FVC||Spirometry||Litres|Mean|5.02|5.02|Standard Deviation|0.91|0.91|||
4210242|NCT00727714|4033495|B1|||duration of exposure||years|Mean|16|16.0|Standard Deviation|13|13.0|||
4210243|NCT00727714|4033495|B1|Smokers||Smoking||participants|Number|39|39.0||||||
4210244|NCT00727714|4033495|B1|Ex-smokers||Smoking||participants|Number|22|22.0||||||
4210245|NCT00727714|4033495|B1|Never-smokers||Smoking||participants|Number|34|34.0||||||
4210246|NCT00727714|4033495|B1|||BMI||kg/m^2|Mean|28|28.0|Standard Deviation|4|4.0|||
4210247|NCT00727714|4033495|B1|||height||cm|Mean|179|179.0|Standard Deviation|7|7.0|||
4210248|NCT00727714|4033495|B1|Norway||Region of Enrollment||participants|Number|95|95.0||||||
4210249|NCT00727714|4033495|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4210250|NCT00727714|4033495|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4210251|NCT00727714|4033495|B1|||Age||years|Mean|41|41.0|Standard Deviation|13|13.0|||
4210252|NCT00727649|4033503|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
4210253|NCT00727649|4033504|B2|United States||Region of Enrollment||participants|Number|43|43.0||||||
4210254|NCT00727649|4033505|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4210255|NCT00727649|4033503|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4210256|NCT00727649|4033504|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4210257|NCT00727649|4033505|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4210258|NCT00727649|4033503|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4210259|NCT00727649|4033504|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4210260|NCT00727649|4033505|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4210261|NCT00727649|4033503|B3|||Age||years|Mean|60.8|60.8|Standard Deviation|10.1|10.1|||
4210262|NCT00727649|4033504|B2|||Age||years|Mean|59.2|59.2|Standard Deviation|9.2|9.2|||
4210263|NCT00727649|4033505|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|10.9|10.9|||
4210264|NCT00727649|4033503|B3||>=65 years|Age||Participants|Count of Participants|47|47.0||||||
4210265|NCT00727649|4033504|B2||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4210266|NCT00727649|4033505|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4210267|NCT00727649|4033503|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4210268|NCT00727649|4033504|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4210269|NCT00727649|4033505|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4210270|NCT00727649|4033503|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4210271|NCT00727649|4033504|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4210272|NCT00727649|4033505|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4210273|NCT00727636|4033518|B3|United States||Region of Enrollment||participants|Number|52|52.0||||||
4210274|NCT00727636|4033519|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4210275|NCT00727636|4033520|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4210276|NCT00727636|4033518|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4210277|NCT00727636|4033519|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4210278|NCT00727636|4033520|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4210279|NCT00727636|4033518|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4210280|NCT00727636|4033519|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4210281|NCT00727636|4033520|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4210282|NCT00727636|4033518|B3|||Age||years|Mean|16.1|16.1|Standard Deviation|3.6|3.6|||
4210283|NCT00727636|4033519|B2|||Age||years|Mean|18.9|18.9|Standard Deviation|3.5|3.5|||
4210284|NCT00727636|4033520|B1|||Age||years|Mean|14.9|14.9|Standard Deviation|3.1|3.1|||
4210285|NCT00727636|4033518|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4210286|NCT00727636|4033519|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4210287|NCT00727636|4033520|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4210288|NCT00727636|4033518|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4210289|NCT00727636|4033519|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4210290|NCT00727636|4033520|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4210291|NCT00727636|4033518|B3||<=18 years|Age||Participants|Count of Participants|39|39.0||||||
4210292|NCT00727636|4033519|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4210293|NCT00727636|4033520|B1||<=18 years|Age||Participants|Count of Participants|33|33.0||||||
4210294|NCT00727597|4033533|B3|United States||Region of Enrollment||participants|Number|101|101.0||||||
4210295|NCT00727597|4033534|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
4210296|NCT00727597|4033535|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4210297|NCT00727597|4033533|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4210298|NCT00727597|4033534|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4210299|NCT00727597|4033535|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4210300|NCT00727597|4033533|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4210301|NCT00727597|4033534|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4210302|NCT00727597|4033535|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4210303|NCT00727597|4033533|B3|||Age||years|Mean|34|34.0|Standard Deviation|2|2.0|||
4210304|NCT00727597|4033534|B2|||Age||years|Mean|34|34.0|Standard Deviation|2|2.0|||
4210305|NCT00727597|4033535|B1|||Age||years|Mean|33.5|33.5|Standard Deviation|2|2.0|||
4210306|NCT00727597|4033533|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4210307|NCT00727597|4033534|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4210308|NCT00727597|4033535|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4210309|NCT00727597|4033533|B3||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4210310|NCT00727597|4033534|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4210311|NCT00727597|4033535|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4210312|NCT00727597|4033533|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4210313|NCT00727597|4033534|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4210314|NCT00727597|4033535|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4210315|NCT00727571|4033544|B5||Male|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
4210316|NCT00727571|4033545|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4210317|NCT00727571|4033546|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4210318|NCT00727571|4033547|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4210319|NCT00727571|4033548|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4210320|NCT00727571|4033544|B5||Female|Sex: Female, Male||Participants|Count of Participants|558|558.0||||||
4210321|NCT00727571|4033545|B4||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4210322|NCT00727571|4033546|B3||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4210323|NCT00727571|4033547|B2||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4210324|NCT00727571|4033548|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4210325|NCT00727571|4033544|B5|||Age||Years|Mean|83.1|83.1|Standard Deviation|8.3|8.3|||
4210326|NCT00727571|4033545|B4|||Age||Years|Mean|83.8|83.8|Standard Deviation|8.4|8.4|||
4210327|NCT00727571|4033546|B3|||Age||Years|Mean|84.6|84.6|Standard Deviation|8.1|8.1|||
4210328|NCT00727571|4033547|B2|||Age||Years|Mean|81.6|81.6|Standard Deviation|8.2|8.2|||
4210329|NCT00727571|4033548|B1|||Age||Years|Mean|82.6|82.6|Standard Deviation|8.3|8.3|||
4210330|NCT00727558|4033576|B3|United Kingdom||Region of Enrollment|Includes completed subjects only|participants|Number|243|243.0||||||
4210331|NCT00727558|4033577|B2|United Kingdom||Region of Enrollment|Includes completed subjects only|participants|Number|118|118.0||||||
4210332|NCT00727558|4033578|B1|United Kingdom||Region of Enrollment|Includes completed subjects only|participants|Number|125|125.0||||||
4210333|NCT00727558|4033576|B3||Male|Sex: Female, Male|Includes completed subjects only|Participants|Count of Participants|61|61.0||||||
4210334|NCT00727558|4033577|B2||Male|Sex: Female, Male|Includes completed subjects only|Participants|Count of Participants|26|26.0||||||
4210335|NCT00727558|4033578|B1||Male|Sex: Female, Male|Includes completed subjects only|Participants|Count of Participants|35|35.0||||||
4210336|NCT00727558|4033576|B3||Female|Sex: Female, Male|Includes completed subjects only|Participants|Count of Participants|182|182.0||||||
4210337|NCT00727558|4033577|B2||Female|Sex: Female, Male|Includes completed subjects only|Participants|Count of Participants|92|92.0||||||
4210338|NCT00727558|4033578|B1||Female|Sex: Female, Male|Includes completed subjects only|Participants|Count of Participants|90|90.0||||||
4210339|NCT00727558|4033576|B3|||Age|Includes completed subjects only|years|Mean|33.0|33.0|Standard Deviation|10.0|10.0|||
4210340|NCT00727558|4033577|B2|||Age|Includes completed subjects only|years|Mean|32.9|32.9|Standard Deviation|10.6|10.6|||
4210341|NCT00727558|4033578|B1|||Age|Includes completed subjects only|years|Mean|33.0|33.0|Standard Deviation|9.5|9.5|||
4210342|NCT00727506|4033597|B7|100||Karnofsky performance score|The scale range is from 100 (Normal no complaints) to 0 (dead). This score was used in Phase II randomization stratification and in some efficacy analyses.|Number of participants|Number|19|19.0||||||
4210372|NCT00727506|4033599|B5|White||Race/Ethnicity, Customized||Number of participants|Number|40|40.0||||||
4210343|NCT00727506|4033598|B6|100||Karnofsky performance score|The scale range is from 100 (Normal no complaints) to 0 (dead). This score was used in Phase II randomization stratification and in some efficacy analyses.|Number of participants|Number|3|3.0||||||
4210344|NCT00727506|4033599|B5|100||Karnofsky performance score|The scale range is from 100 (Normal no complaints) to 0 (dead). This score was used in Phase II randomization stratification and in some efficacy analyses.|Number of participants|Number|3|3.0||||||
4210345|NCT00727506|4033600|B4|100||Karnofsky performance score|The scale range is from 100 (Normal no complaints) to 0 (dead). This score was used in Phase II randomization stratification and in some efficacy analyses.|Number of participants|Number|5|5.0||||||
4210346|NCT00727506|4033601|B3|100||Karnofsky performance score|The scale range is from 100 (Normal no complaints) to 0 (dead). This score was used in Phase II randomization stratification and in some efficacy analyses.|Number of participants|Number|4|4.0||||||
4210347|NCT00727506|4033602|B2|100||Karnofsky performance score|The scale range is from 100 (Normal no complaints) to 0 (dead). This score was used in Phase II randomization stratification and in some efficacy analyses.|Number of participants|Number|2|2.0||||||
4210348|NCT00727506|4033603|B1|100||Karnofsky performance score|The scale range is from 100 (Normal no complaints) to 0 (dead). This score was used in Phase II randomization stratification and in some efficacy analyses.|Number of participants|Number|2|2.0||||||
4210349|NCT00727506|4033597|B7|90||Karnofsky performance score|The scale range is from 100 (Normal no complaints) to 0 (dead). This score was used in Phase II randomization stratification and in some efficacy analyses.|Number of participants|Number|61|61.0||||||
4210350|NCT00727506|4033598|B6|90||Karnofsky performance score|The scale range is from 100 (Normal no complaints) to 0 (dead). This score was used in Phase II randomization stratification and in some efficacy analyses.|Number of participants|Number|15|15.0||||||
4210351|NCT00727506|4033599|B5|90||Karnofsky performance score|The scale range is from 100 (Normal no complaints) to 0 (dead). This score was used in Phase II randomization stratification and in some efficacy analyses.|Number of participants|Number|17|17.0||||||
4210352|NCT00727506|4033600|B4|90||Karnofsky performance score|The scale range is from 100 (Normal no complaints) to 0 (dead). This score was used in Phase II randomization stratification and in some efficacy analyses.|Number of participants|Number|12|12.0||||||
4210353|NCT00727506|4033601|B3|90||Karnofsky performance score|The scale range is from 100 (Normal no complaints) to 0 (dead). This score was used in Phase II randomization stratification and in some efficacy analyses.|Number of participants|Number|11|11.0||||||
4210354|NCT00727506|4033602|B2|90||Karnofsky performance score|The scale range is from 100 (Normal no complaints) to 0 (dead). This score was used in Phase II randomization stratification and in some efficacy analyses.|Number of participants|Number|4|4.0||||||
4210355|NCT00727506|4033603|B1|90||Karnofsky performance score|The scale range is from 100 (Normal no complaints) to 0 (dead). This score was used in Phase II randomization stratification and in some efficacy analyses.|Number of participants|Number|2|2.0||||||
4210356|NCT00727506|4033597|B7|80||Karnofsky performance score|The scale range is from 100 (Normal no complaints) to 0 (dead). This score was used in Phase II randomization stratification and in some efficacy analyses.|Number of participants|Number|38|38.0||||||
4210357|NCT00727506|4033598|B6|80||Karnofsky performance score|The scale range is from 100 (Normal no complaints) to 0 (dead). This score was used in Phase II randomization stratification and in some efficacy analyses.|Number of participants|Number|9|9.0||||||
4210358|NCT00727506|4033599|B5|80||Karnofsky performance score|The scale range is from 100 (Normal no complaints) to 0 (dead). This score was used in Phase II randomization stratification and in some efficacy analyses.|Number of participants|Number|12|12.0||||||
4210359|NCT00727506|4033600|B4|80||Karnofsky performance score|The scale range is from 100 (Normal no complaints) to 0 (dead). This score was used in Phase II randomization stratification and in some efficacy analyses.|Number of participants|Number|13|13.0||||||
4210360|NCT00727506|4033601|B3|80||Karnofsky performance score|The scale range is from 100 (Normal no complaints) to 0 (dead). This score was used in Phase II randomization stratification and in some efficacy analyses.|Number of participants|Number|2|2.0||||||
4210361|NCT00727506|4033602|B2|80||Karnofsky performance score|The scale range is from 100 (Normal no complaints) to 0 (dead). This score was used in Phase II randomization stratification and in some efficacy analyses.|Number of participants|Number|1|1.0||||||
4210362|NCT00727506|4033603|B1|80||Karnofsky performance score|The scale range is from 100 (Normal no complaints) to 0 (dead). This score was used in Phase II randomization stratification and in some efficacy analyses.|Number of participants|Number|1|1.0||||||
4210363|NCT00727506|4033597|B7|70||Karnofsky performance score|The scale range is from 100 (Normal no complaints) to 0 (dead). This score was used in Phase II randomization stratification and in some efficacy analyses.|Number of participants|Number|33|33.0||||||
4210364|NCT00727506|4033598|B6|70||Karnofsky performance score|The scale range is from 100 (Normal no complaints) to 0 (dead). This score was used in Phase II randomization stratification and in some efficacy analyses.|Number of participants|Number|12|12.0||||||
4210365|NCT00727506|4033599|B5|70||Karnofsky performance score|The scale range is from 100 (Normal no complaints) to 0 (dead). This score was used in Phase II randomization stratification and in some efficacy analyses.|Number of participants|Number|9|9.0||||||
4210366|NCT00727506|4033600|B4|70||Karnofsky performance score|The scale range is from 100 (Normal no complaints) to 0 (dead). This score was used in Phase II randomization stratification and in some efficacy analyses.|Number of participants|Number|9|9.0||||||
4210367|NCT00727506|4033601|B3|70||Karnofsky performance score|The scale range is from 100 (Normal no complaints) to 0 (dead). This score was used in Phase II randomization stratification and in some efficacy analyses.|Number of participants|Number|1|1.0||||||
4210368|NCT00727506|4033602|B2|70||Karnofsky performance score|The scale range is from 100 (Normal no complaints) to 0 (dead). This score was used in Phase II randomization stratification and in some efficacy analyses.|Number of participants|Number|1|1.0||||||
4210369|NCT00727506|4033603|B1|70||Karnofsky performance score|The scale range is from 100 (Normal no complaints) to 0 (dead). This score was used in Phase II randomization stratification and in some efficacy analyses.|Number of participants|Number|1|1.0||||||
4210370|NCT00727506|4033597|B7|White||Race/Ethnicity, Customized||Number of participants|Number|141|141.0||||||
4210371|NCT00727506|4033598|B6|White||Race/Ethnicity, Customized||Number of participants|Number|35|35.0||||||
4210373|NCT00727506|4033600|B4|White||Race/Ethnicity, Customized||Number of participants|Number|37|37.0||||||
4210374|NCT00727506|4033601|B3|White||Race/Ethnicity, Customized||Number of participants|Number|16|16.0||||||
4210375|NCT00727506|4033602|B2|White||Race/Ethnicity, Customized||Number of participants|Number|7|7.0||||||
4210376|NCT00727506|4033603|B1|White||Race/Ethnicity, Customized||Number of participants|Number|6|6.0||||||
4210377|NCT00727506|4033597|B7|Hawaiian/Pacific Isle||Race/Ethnicity, Customized||Number of participants|Number|1|1.0||||||
4210378|NCT00727506|4033598|B6|Hawaiian/Pacific Isle||Race/Ethnicity, Customized||Number of participants|Number|1|1.0||||||
4210379|NCT00727506|4033599|B5|Hawaiian/Pacific Isle||Race/Ethnicity, Customized||Number of participants|Number|0|0.0||||||
4210380|NCT00727506|4033600|B4|Hawaiian/Pacific Isle||Race/Ethnicity, Customized||Number of participants|Number|0|0.0||||||
4210381|NCT00727506|4033601|B3|Hawaiian/Pacific Isle||Race/Ethnicity, Customized||Number of participants|Number|0|0.0||||||
4210382|NCT00727506|4033602|B2|Hawaiian/Pacific Isle||Race/Ethnicity, Customized||Number of participants|Number|0|0.0||||||
4210383|NCT00727506|4033603|B1|Hawaiian/Pacific Isle||Race/Ethnicity, Customized||Number of participants|Number|0|0.0||||||
4210384|NCT00727506|4033597|B7|Black/African American||Race/Ethnicity, Customized||Number of participants|Number|6|6.0||||||
4210385|NCT00727506|4033598|B6|Black/African American||Race/Ethnicity, Customized||Number of participants|Number|2|2.0||||||
4210386|NCT00727506|4033599|B5|Black/African American||Race/Ethnicity, Customized||Number of participants|Number|0|0.0||||||
4210387|NCT00727506|4033600|B4|Black/African American||Race/Ethnicity, Customized||Number of participants|Number|2|2.0||||||
4210388|NCT00727506|4033601|B3|Black/African American||Race/Ethnicity, Customized||Number of participants|Number|2|2.0||||||
4210389|NCT00727506|4033602|B2|Black/African American||Race/Ethnicity, Customized||Number of participants|Number|0|0.0||||||
4210390|NCT00727506|4033603|B1|Black/African American||Race/Ethnicity, Customized||Number of participants|Number|0|0.0||||||
4210391|NCT00727506|4033597|B7|Asian||Race/Ethnicity, Customized||Number of participants|Number|3|3.0||||||
4210392|NCT00727506|4033598|B6|Asian||Race/Ethnicity, Customized||Number of participants|Number|1|1.0||||||
4210393|NCT00727506|4033599|B5|Asian||Race/Ethnicity, Customized||Number of participants|Number|1|1.0||||||
4210394|NCT00727506|4033600|B4|Asian||Race/Ethnicity, Customized||Number of participants|Number|0|0.0||||||
4210395|NCT00727506|4033601|B3|Asian||Race/Ethnicity, Customized||Number of participants|Number|0|0.0||||||
4210396|NCT00727506|4033602|B2|Asian||Race/Ethnicity, Customized||Number of participants|Number|1|1.0||||||
4210397|NCT00727506|4033603|B1|Asian||Race/Ethnicity, Customized||Number of participants|Number|0|0.0||||||
4210398|NCT00727506|4033597|B7||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4210399|NCT00727506|4033598|B6||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4210400|NCT00727506|4033599|B5||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4210401|NCT00727506|4033600|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4210402|NCT00727506|4033601|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4210403|NCT00727506|4033602|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4210404|NCT00727506|4033603|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4210405|NCT00727506|4033597|B7||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4210406|NCT00727506|4033598|B6||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4210407|NCT00727506|4033599|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4210408|NCT00727506|4033600|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4210409|NCT00727506|4033601|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4210410|NCT00727506|4033602|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4210411|NCT00727506|4033603|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4210412|NCT00727506|4033597|B7|||Age||years|Mean|56.3|56.3|Standard Deviation|10.3|10.3|||
4210413|NCT00727506|4033598|B6|||Age||years|Mean|55.4|55.4|Standard Deviation|11.02|11.02|||
4210414|NCT00727506|4033599|B5|||Age||years|Mean|56.6|56.6|Standard Deviation|9.44|9.44|||
4210415|NCT00727506|4033600|B4|||Age||years|Mean|56.9|56.9|Standard Deviation|10.62|10.62|||
4210416|NCT00727506|4033601|B3|||Age||years|Mean|51.0|51.0|Standard Deviation|9.4|9.4|||
4210417|NCT00727506|4033602|B2|||Age||years|Mean|51.6|51.6|Standard Deviation|14.2|14.2|||
4210418|NCT00727506|4033603|B1|||Age||years|Mean|51.7|51.7|Standard Deviation|12.4|12.4|||
4210419|NCT00727402|4033701|B1|United States||Region of Enrollment||participants|Number|205|205.0||||||
4210420|NCT00727402|4033701|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4210421|NCT00727402|4033701|B1||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4210422|NCT00727402|4033701|B1|>50 years||Age, Customized||participants|Number|16|16.0||||||
4210423|NCT00727402|4033701|B1|Between 21 and 50 years||Age, Customized||participants|Number|163|163.0||||||
4210424|NCT00727402|4033701|B1|<=21 years||Age, Customized||participants|Number|26|26.0||||||
4210425|NCT00727402|4033701|B1|||Age||years|Mean|32.8|32.8|Standard Deviation|5|5.0|||
4210426|NCT00727337|4033705|B5|United States||Region of Enrollment||Participants|Count of Participants|279|279.0||||||
4210427|NCT00727337|4033706|B4|United States||Region of Enrollment||Participants|Count of Participants|73|73.0||||||
4210428|NCT00727337|4033707|B3|United States||Region of Enrollment||Participants|Count of Participants|73|73.0||||||
4210429|NCT00727337|4033708|B2|United States||Region of Enrollment||Participants|Count of Participants|65|65.0||||||
4210430|NCT00727337|4033709|B1|United States||Region of Enrollment||Participants|Count of Participants|68|68.0||||||
4210431|NCT00727337|4033705|B5||Male|Sex: Female, Male||Participants|Count of Participants|279|279.0||||||
4210432|NCT00727337|4033706|B4||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4210433|NCT00727337|4033707|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4210434|NCT00727337|4033708|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4210435|NCT00727337|4033709|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4210436|NCT00727337|4033705|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4210437|NCT00727337|4033706|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4210438|NCT00727337|4033707|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4210439|NCT00727337|4033708|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4210440|NCT00727337|4033709|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4210441|NCT00727337|4033705|B5|||Age||years|Mean|68.6|68.6|Standard Deviation|7.7|7.7|||
4210442|NCT00727337|4033706|B4|||Age||years|Mean|70|70.0|Standard Deviation|7.3|7.3|||
4210443|NCT00727337|4033707|B3|||Age||years|Mean|67.1|67.1|Standard Deviation|7.7|7.7|||
4210444|NCT00727337|4033708|B2|||Age||years|Mean|69|69.0|Standard Deviation|7.8|7.8|||
4210445|NCT00727337|4033709|B1|||Age||years|Mean|68.2|68.2|Standard Deviation|7.7|7.7|||
4210446|NCT00727337|4033705|B5||>=65 years|Age||Participants|Count of Participants|170|170.0||||||
4210447|NCT00727337|4033706|B4||>=65 years|Age||Participants|Count of Participants|52|52.0||||||
4210448|NCT00727337|4033707|B3||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4210449|NCT00727337|4033708|B2||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
4210450|NCT00727337|4033709|B1||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
4210451|NCT00727337|4033705|B5||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
4210452|NCT00727337|4033706|B4||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4210453|NCT00727337|4033707|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4210454|NCT00727337|4033708|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4210455|NCT00727337|4033709|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4210456|NCT00727337|4033705|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4210457|NCT00727337|4033706|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4210458|NCT00727337|4033707|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4210459|NCT00727337|4033708|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4210460|NCT00727337|4033709|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4210461|NCT00727311|4033730|B1|Germany||Region of Enrollment||participants|Number|2302|2302.0||||||
4210462|NCT00727311|4033730|B1|Gender information not captured||Sex/Gender, Customized||participants|Number|367|367.0||||||
4210463|NCT00727311|4033730|B1|Female||Sex/Gender, Customized||participants|Number|766|766.0||||||
4210464|NCT00727311|4033730|B1|Male||Sex/Gender, Customized||participants|Number|1169|1169.0||||||
4210465|NCT00727311|4033730|B1|||Age|Mean age was for the evaluable population of 1986 participants.|years|Mean|42.1|42.1|Standard Deviation|11.7|11.7|||
4210466|NCT00727298|4033737|B1|Not Specified||Sex/Gender, Customized||participants|Number|83|83.0||||||
4210467|NCT00727298|4033737|B1|Male||Sex/Gender, Customized||participants|Number|1554|1554.0||||||
4210468|NCT00727298|4033737|B1|Female||Sex/Gender, Customized||participants|Number|1591|1591.0||||||
4210469|NCT00727298|4033737|B1|||Age||years|Mean|46.3|46.3|Standard Deviation|13.9|13.9|||
4210470|NCT00727272|4033743|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4210471|NCT00727272|4033743|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4210472|NCT00727272|4033743|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4210473|NCT00727272|4033743|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4210474|NCT00727272|4033743|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4210475|NCT00727272|4033743|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4210476|NCT00727272|4033743|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4210477|NCT00727272|4033743|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4210478|NCT00727272|4033743|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4210479|NCT00727272|4033743|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4210480|NCT00727272|4033743|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4210481|NCT00727272|4033743|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4210482|NCT00727272|4033743|B1|||Age||years|Mean|24.11|24.11|Standard Deviation|8.87|8.87|||
4210483|NCT00727272|4033743|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4210484|NCT00727272|4033743|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4210485|NCT00727272|4033743|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4210486|NCT00727259|4033762|B1|France||Region of Enrollment||Participants|Number|940|940.0||||||
4210487|NCT00727259|4033762|B1|Missing data||Sex/Gender, Customized||Participants|Number|1|1.0||||||
4210488|NCT00727259|4033762|B1|Male||Sex/Gender, Customized||Participants|Number|616|616.0||||||
4210489|NCT00727259|4033762|B1|Female||Sex/Gender, Customized||Participants|Number|323|323.0||||||
4210490|NCT00727259|4033762|B1|||Age||years|Mean|47.50|47.5|Standard Deviation|12.34|12.34|||
4210491|NCT00727246|4033767|B5|United States||Region of Enrollment||participants|Number|15|15.0||||||
4210492|NCT00727246|4033768|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
4210493|NCT00727246|4033769|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4210494|NCT00727246|4033770|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4210495|NCT00727246|4033771|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4210496|NCT00727246|4033767|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4210497|NCT00727246|4033768|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4210498|NCT00727246|4033769|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4210499|NCT00727246|4033770|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4210500|NCT00727246|4033771|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4210501|NCT00727246|4033767|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4210502|NCT00727246|4033768|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4210503|NCT00727246|4033769|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4210504|NCT00727246|4033770|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4210505|NCT00727246|4033771|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4210506|NCT00727246|4033767|B5|||Age||years|Mean|29.8|29.8|Standard Deviation|8.98|8.98|||
4210507|NCT00727246|4033768|B4|||Age||years|Mean|34|34.0|Standard Deviation|13|13.0|||
4210508|NCT00727246|4033769|B3|||Age||years|Mean|29|29.0|Standard Deviation|7.90|7.9|||
4210509|NCT00727246|4033770|B2|||Age||years|Mean|25|25.0|Standard Deviation|1.41|1.41|||
4210510|NCT00727246|4033771|B1|||Age||years|Mean|30.66|30.66|Standard Deviation|12.42|12.42|||
4210511|NCT00727220|4033788|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4210512|NCT00727220|4033789|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4210513|NCT00727220|4033790|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4210514|NCT00727220|4033788|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4210515|NCT00727220|4033789|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4210516|NCT00727220|4033790|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4210517|NCT00727220|4033788|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4210518|NCT00727220|4033789|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4210519|NCT00727220|4033790|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4210520|NCT00727220|4033788|B3|||Age||years|Mean|3.8|3.8|Standard Deviation|0.8|0.8|||
4210521|NCT00727220|4033789|B2|||Age||years|Mean|3.7|3.7|Standard Deviation|0.7|0.7|||
4210522|NCT00727220|4033790|B1|||Age||years|Mean|3.8|3.8|Standard Deviation|0.8|0.8|||
4210523|NCT00727220|4033788|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4210524|NCT00727220|4033789|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4210525|NCT00727220|4033790|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4210526|NCT00727220|4033788|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4210527|NCT00727220|4033789|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4210528|NCT00727220|4033790|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4210529|NCT00727220|4033788|B3||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
4210530|NCT00727220|4033789|B2||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
4210531|NCT00727220|4033790|B1||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
4210532|NCT00727194|4033797|B1|||Myasthenia Gravis-Activity of Daily Living (MG-ADL)|The MG-ADL is a questionnaire that focuses on relevant symptoms and functional performance of activities of daily living in MG patients. The MG-ADL consists of 8 items: ocular (2 items), bulbar (3 items), respiratory (1 item) and gross motor or limb (2 items). Each response is graded 0 (normal) to 3 (most severe). The range of total MG-ADL score is 0 (normal) to 24 (most severe).|units on a scale|Mean|8.2|8.2|Full Range|||3.0|14.0|
4210533|NCT00727194|4033797|B1|||Quantitative Myasthenia Gravis (QMG) at Screening|The QMG scoring system is considered to be an objective evaluation of therapy for MG and is based on quantitative testing of muscle strength and endurance/fatigue of sentinel muscle groups. The QMG consists of 13 items: ocular (2 items), facial (1 item), bulbar (2 items), gross motor (6 items), axial (1 item) and respiratory (1 item); each graded 0 to 3, with 3 being the most severe. The range of total QMG score is 0 – 39.|QMG score|Mean|19|19.0|Standard Deviation|6|6.0|||
4210534|NCT00727194|4033797|B1|No||Cholinesterase inhibitor use at Screening||participants|Number|2|2.0||||||
4210535|NCT00727194|4033797|B1|Yes||Cholinesterase inhibitor use at Screening||participants|Number|12|12.0||||||
4210536|NCT00727194|4033797|B1|No||Immunosuppression therapy other than prednisone at Screening|An inclusion criterion was that patients must have failed treatment or failed to achieve significant clinical benefit with at least 2 immunomodulators after 1 year of treatment.|participants|Number|7|7.0||||||
4210537|NCT00727194|4033797|B1|Yes||Immunosuppression therapy other than prednisone at Screening|An inclusion criterion was that patients must have failed treatment or failed to achieve significant clinical benefit with at least 2 immunomodulators after 1 year of treatment.|participants|Number|7|7.0||||||
4210538|NCT00727194|4033797|B1|No prednisone use||Prednisone use at Screening|An inclusion criterion was that patients must have failed treatment or failed to achieve significant clinical benefit with at least 2 immunomodulators after 1 year of treatment.|participants|Number|7|7.0||||||
4210539|NCT00727194|4033797|B1|Prednisone use||Prednisone use at Screening|An inclusion criterion was that patients must have failed treatment or failed to achieve significant clinical benefit with at least 2 immunomodulators after 1 year of treatment.|participants|Number|7|7.0||||||
4210540|NCT00727194|4033797|B1|||Number of MG crisis/exacerbation prior to Screening|The number of a MG crisis/exacerbation prior to Screening provides pertinent information about disease morbidity and severity.|Events|Mean|5|5.0|Standard Deviation|6|6.0|||
4210541|NCT00727194|4033797|B1|IVa||Myasthenia Gravis Foundation of America (MGFA) classification at Screening|"MGFA Classification identifies the subgroup patients with MG who share distinct clinical features or severity of disease: Class I (ocular MG), classes II, III and IV generalized MG with mild, moderate and severe disease, respectively; Class V MG crisis. Separate subclasses under classes II, III and IV are designed: “a” if the predominant weakness is affecting limb/axial weakness or both; subclass b if the predominant weakness is affecting oropharyngeal or respiratory muscles or both."|participants|Number|2|2.0||||||
4210542|NCT00727194|4033797|B1|IIIa||Myasthenia Gravis Foundation of America (MGFA) classification at Screening|"MGFA Classification identifies the subgroup patients with MG who share distinct clinical features or severity of disease: Class I (ocular MG), classes II, III and IV generalized MG with mild, moderate and severe disease, respectively; Class V MG crisis. Separate subclasses under classes II, III and IV are designed: “a” if the predominant weakness is affecting limb/axial weakness or both; subclass b if the predominant weakness is affecting oropharyngeal or respiratory muscles or both."|participants|Number|8|8.0||||||
4210543|NCT00727194|4033797|B1|IIb||Myasthenia Gravis Foundation of America (MGFA) classification at Screening|"MGFA Classification identifies the subgroup patients with MG who share distinct clinical features or severity of disease: Class I (ocular MG), classes II, III and IV generalized MG with mild, moderate and severe disease, respectively; Class V MG crisis. Separate subclasses under classes II, III and IV are designed: “a” if the predominant weakness is affecting limb/axial weakness or both; subclass b if the predominant weakness is affecting oropharyngeal or respiratory muscles or both."|participants|Number|2|2.0||||||
4210544|NCT00727194|4033797|B1|IIa||Myasthenia Gravis Foundation of America (MGFA) classification at Screening|"MGFA Classification identifies the subgroup patients with MG who share distinct clinical features or severity of disease: Class I (ocular MG), classes II, III and IV generalized MG with mild, moderate and severe disease, respectively; Class V MG crisis. Separate subclasses under classes II, III and IV are designed: “a” if the predominant weakness is affecting limb/axial weakness or both; subclass b if the predominant weakness is affecting oropharyngeal or respiratory muscles or both."|participants|Number|2|2.0||||||
4210545|NCT00727194|4033797|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4210546|NCT00727194|4033797|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4210547|NCT00727194|4033797|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4210548|NCT00727194|4033797|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4210549|NCT00727194|4033797|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4210550|NCT00727194|4033797|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4210551|NCT00727194|4033797|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
4210552|NCT00727194|4033797|B1||Female|Gender||Participants|Count of Participants|8|8.0||||||
4210553|NCT00727194|4033797|B1|||Age||years|Mean|49|49.0|Standard Deviation|14|14.0|||
4210554|NCT00727090|4033833|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4210555|NCT00727090|4033834|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4210556|NCT00727090|4033835|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4210557|NCT00727090|4033833|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4210558|NCT00727090|4033834|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4210559|NCT00727090|4033835|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4210560|NCT00727090|4033833|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4210561|NCT00727090|4033834|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4210562|NCT00727090|4033835|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4210563|NCT00727090|4033833|B3|>70 years||Age, Customized||participants|Number|0|0.0||||||
4210564|NCT00727090|4033834|B2|>70 years||Age, Customized||participants|Number|0|0.0||||||
4210565|NCT00727090|4033835|B1|>70 years||Age, Customized||participants|Number|0|0.0||||||
4210566|NCT00727090|4033833|B3|Between 18 and 70 years||Age, Customized||participants|Number|6|6.0||||||
4210567|NCT00727090|4033834|B2|Between 18 and 70 years||Age, Customized||participants|Number|3|3.0||||||
4210568|NCT00727090|4033835|B1|Between 18 and 70 years||Age, Customized||participants|Number|3|3.0||||||
4210569|NCT00727090|4033833|B3|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4210570|NCT00727090|4033834|B2|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4210571|NCT00727090|4033835|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4210572|NCT00727090|4033833|B3|||Age||years|Mean|55|55.0|Standard Deviation|19.2|19.2|||
4210573|NCT00727090|4033834|B2|||Age||years|Mean|67|67.0|Standard Deviation|2|2.0|||
4210574|NCT00727090|4033835|B1|||Age||years|Mean|43|43.0|Standard Deviation|22.0|22.0|||
4210575|NCT00727064|4033852|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4210576|NCT00727064|4033853|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4210577|NCT00727064|4033854|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4210578|NCT00727064|4033852|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4210579|NCT00727064|4033853|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4210580|NCT00727064|4033854|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4210581|NCT00727064|4033852|B3|||Age||years|Mean|29.21|29.21|Standard Deviation|9.33|9.33|||
4210582|NCT00727064|4033853|B2|||Age||years|Mean|28.29|28.29|Standard Deviation|8.90|8.9|||
4210583|NCT00727064|4033854|B1|||Age||years|Mean|30.14|30.14|Standard Deviation|10.37|10.37|||
4210584|NCT00727025|4033871|B1|United States||Region of Enrollment||participants|Number|74|74.0||||||
4210585|NCT00727025|4033871|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4210586|NCT00727025|4033871|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4210587|NCT00727025|4033871|B1|||Age||years|Mean|47|47.0|Standard Deviation|5.6|5.6|||
4210588|NCT00727025|4033871|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4210589|NCT00727025|4033871|B1||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
4210590|NCT00727025|4033871|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4210591|NCT00726999|4033881|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4210592|NCT00726999|4033882|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4210593|NCT00726999|4033883|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4210594|NCT00726999|4033881|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4210595|NCT00726999|4033882|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4210596|NCT00726999|4033883|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4210597|NCT00726999|4033881|B3|||Age||years|Mean|14.5|14.5|Standard Deviation|2.0|2.0|||
4210598|NCT00726999|4033882|B2|||Age||years|Mean|14.2|14.2|Standard Deviation|1.8|1.8|||
4210599|NCT00726999|4033883|B1|||Age||years|Mean|14.8|14.8|Standard Deviation|2.1|2.1|||
4210600|NCT00726999|4033881|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4210601|NCT00726999|4033882|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4210602|NCT00726999|4033883|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4210603|NCT00726999|4033881|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4210604|NCT00726999|4033882|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4210605|NCT00726999|4033883|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4210606|NCT00726999|4033881|B3||<=18 years|Age||Participants|Count of Participants|63|63.0||||||
4210607|NCT00726999|4033882|B2||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
4210608|NCT00726999|4033883|B1||<=18 years|Age||Participants|Count of Participants|32|32.0||||||
4210609|NCT00726986|4033894|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4210610|NCT00726986|4033894|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4210611|NCT00726986|4033894|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4210612|NCT00726986|4033894|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4210613|NCT00726986|4033894|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4210614|NCT00726986|4033894|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4210615|NCT00726986|4033894|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4210616|NCT00726986|4033894|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4210617|NCT00726986|4033894|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4210618|NCT00726986|4033894|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4210619|NCT00726986|4033894|B1|||Age||years|Median|63|63.0|Full Range|||45.0|82.0|
4210620|NCT00726895|4033901|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4210621|NCT00726895|4033901|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4210622|NCT00726895|4033901|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4210623|NCT00726895|4033901|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4210624|NCT00726895|4033901|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4210625|NCT00726895|4033901|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4210626|NCT00726895|4033901|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4210627|NCT00726895|4033901|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4210628|NCT00726895|4033901|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4210629|NCT00726895|4033901|B1|||Age||years|Mean|33|33.0|Standard Deviation|13.9|13.9|||
4210630|NCT00726895|4033901|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4210631|NCT00726895|4033901|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4210632|NCT00726895|4033901|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4210633|NCT00726882|4033915|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4210634|NCT00726882|4033915|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4210635|NCT00726882|4033915|B1|||Age||years|Mean|45.3|45.3|Standard Deviation|11.12|11.12|||
4210636|NCT00726830|4033921|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4210637|NCT00726830|4033923|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4210638|NCT00726830|4033921|B3|Male||Gender||participants|Number|0|0.0||||||
4210639|NCT00726830|4033923|B1|Male||Gender||participants|Number|0|0.0||||||
4210640|NCT00726830|4033921|B3|Female||Gender||participants|Number|1|1.0||||||
4210641|NCT00726830|4033923|B1|Female||Gender||participants|Number|1|1.0||||||
4210642|NCT00726830|4033921|B3|>=65 years||Age||years|Number|0|0.0||||||
4210643|NCT00726830|4033923|B1|>=65 years||Age||years|Number|0|0.0||||||
4210644|NCT00726830|4033921|B3|Between 18 and 65 years||Age||years|Number|1|1.0||||||
4210645|NCT00726830|4033923|B1|Between 18 and 65 years||Age||years|Number|1|1.0||||||
4210646|NCT00726830|4033921|B3|<=18 years||Age||years|Number|0|0.0||||||
4210647|NCT00726830|4033923|B1|<=18 years||Age||years|Number|0|0.0||||||
4210648|NCT00726752|4033930|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4210649|NCT00726752|4033930|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4210650|NCT00726752|4033930|B1|||Age||years|Mean|53.8|53.8|Standard Deviation|15.8|15.8|||
4210651|NCT00726739|4033944|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4210652|NCT00726739|4033945|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4210653|NCT00726739|4033946|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4210654|NCT00726739|4033944|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4210655|NCT00726739|4033945|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4210656|NCT00726739|4033946|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4210657|NCT00726739|4033944|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4210658|NCT00726739|4033945|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4210659|NCT00726739|4033946|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4210660|NCT00726739|4033944|B3|||Age||years|Mean|63.9|63.9|Standard Deviation|12.8|12.8|||
4210661|NCT00726739|4033945|B2|||Age||years|Mean|64.0|64.0|Standard Deviation|14.9|14.9|||
4210662|NCT00726739|4033946|B1|||Age||years|Mean|63.8|63.8|Standard Deviation|11.4|11.4|||
4210663|NCT00726739|4033944|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4210664|NCT00726739|4033945|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4210665|NCT00726739|4033946|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4210666|NCT00726739|4033944|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4210667|NCT00726739|4033945|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4210668|NCT00726739|4033946|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4210669|NCT00726739|4033944|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4210670|NCT00726739|4033945|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4210671|NCT00726739|4033946|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4210672|NCT00726713|4033961|B3||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4210673|NCT00726713|4033962|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4210674|NCT00726713|4033963|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4210675|NCT00726713|4033961|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4210676|NCT00726713|4033962|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4210677|NCT00726713|4033963|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4210678|NCT00726713|4033961|B3|||Age||years|Mean|62.6|62.6|Standard Deviation|8.9|8.9|||
4210679|NCT00726713|4033962|B2|||Age||years|Mean|62.95|62.95|Standard Deviation|9.17|9.17|||
4210680|NCT00726713|4033963|B1|||Age||years|Mean|62.29|62.29|Standard Deviation|8.54|8.54|||
4210681|NCT00726661|4033990|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4210682|NCT00726661|4033991|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4210683|NCT00726661|4033992|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4210684|NCT00726661|4033990|B3||Female|Sex: Female, Male||Participants|Count of Participants|1260|1260.0||||||
4210685|NCT00726661|4033991|B2||Female|Sex: Female, Male||Participants|Count of Participants|434|434.0||||||
4210686|NCT00726661|4033992|B1||Female|Sex: Female, Male||Participants|Count of Participants|826|826.0||||||
4210687|NCT00726661|4033990|B3|||Age||years|Mean|59.66|59.66|Standard Deviation|12.58|12.58|||
4210688|NCT00726661|4033991|B2|||Age||years|Mean|63.99|63.99|Standard Deviation|12.57|12.57|||
4210689|NCT00726661|4033992|B1|||Age||years|Mean|57.40|57.4|Standard Deviation|11.98|11.98|||
4210690|NCT00726622|4034008|B3|United States||Region of Enrollment||participants|Number|481|481.0||||||
4210691|NCT00726622|4034009|B2|United States||Region of Enrollment||participants|Number|242|242.0||||||
4210692|NCT00726622|4034010|B1|United States||Region of Enrollment||participants|Number|239|239.0||||||
4210693|NCT00726622|4034008|B3||Male|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
4210694|NCT00726622|4034009|B2||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4210695|NCT00726622|4034010|B1||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4210696|NCT00726622|4034008|B3||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4210697|NCT00726622|4034009|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4210698|NCT00726622|4034010|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4210699|NCT00726622|4034008|B3|||Age||years|Mean|57.4|57.4|Standard Deviation|11.8|11.8|||
4210700|NCT00726622|4034009|B2|||Age||years|Mean|57.7|57.7|Standard Deviation|11.5|11.5|||
4210701|NCT00726622|4034010|B1|||Age||years|Mean|57.2|57.2|Standard Deviation|12.1|12.1|||
4210702|NCT00726609|4034029|B1|Germany||Region of Enrollment||participants|Number|214|214.0||||||
4210703|NCT00726609|4034029|B1||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4210704|NCT00726609|4034029|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4210705|NCT00726609|4034029|B1|||Age||years|Mean|55.6|55.6|Standard Deviation|12.77|12.77|||
4210706|NCT00726557|4034033|B1|Germany||Region of Enrollment||participants|Number|246|246.0||||||
4210707|NCT00726557|4034033|B1|Unavailable||Sex/Gender, Customized||participants|Number|128|128.0||||||
4210708|NCT00726557|4034033|B1|Male||Sex/Gender, Customized||participants|Number|83|83.0||||||
4210709|NCT00726557|4034033|B1|Female||Sex/Gender, Customized||participants|Number|35|35.0||||||
4210710|NCT00726557|4034033|B1|||Age||years|Mean|36.64|36.64|Standard Deviation|8.39|8.39|||
4210711|NCT00726453|4034038|B3|United States||Region of Enrollment||participants|Number|1516|1516.0||||||
4210712|NCT00726453|4034039|B2|United States||Region of Enrollment||participants|Number|114|114.0||||||
4210713|NCT00726453|4034040|B1|United States||Region of Enrollment||participants|Number|1402|1402.0||||||
4210714|NCT00726453|4034038|B3||Male|Sex: Female, Male||Participants|Count of Participants|1042|1042.0||||||
4210715|NCT00726453|4034039|B2||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4210716|NCT00726453|4034040|B1||Male|Sex: Female, Male||Participants|Count of Participants|958|958.0||||||
4210717|NCT00726453|4034038|B3||Female|Sex: Female, Male||Participants|Count of Participants|474|474.0||||||
4210718|NCT00726453|4034039|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4210719|NCT00726453|4034040|B1||Female|Sex: Female, Male||Participants|Count of Participants|444|444.0||||||
4210720|NCT00726453|4034038|B3|||Age||years|Mean|64.5|64.5|Standard Deviation|10.2|10.2|||
4210721|NCT00726453|4034039|B2|||Age||years|Mean|64.8|64.8|Standard Deviation|9.7|9.7|||
4210722|NCT00726453|4034040|B1|||Age||years|Mean|64.1|64.1|Standard Deviation|10.7|10.7|||
4210723|NCT00726414|4034051|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4210724|NCT00726414|4034051|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4210725|NCT00726414|4034051|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4210726|NCT00726414|4034051|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4210727|NCT00726414|4034051|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4210728|NCT00726414|4034051|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4210729|NCT00726414|4034051|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4210730|NCT00726414|4034051|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4210731|NCT00726414|4034051|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4210732|NCT00726414|4034051|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4210733|NCT00726414|4034051|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4210734|NCT00726414|4034051|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4210735|NCT00726414|4034051|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4210736|NCT00726414|4034051|B1|||Age||years|Mean|20.6|20.6|Standard Deviation|3.4|3.4|||
4210737|NCT00726414|4034051|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4210738|NCT00726414|4034051|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4210739|NCT00726414|4034051|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4210740|NCT00726375|4034062|B1|Recipient and donor negative||CMV Status|Cytomegalovirus (CMV) status at baseline. R represents recipient status and D represents donor status.|participants|Number|10|10.0||||||
4210741|NCT00726375|4034062|B1|R-, D+||CMV Status|Cytomegalovirus (CMV) status at baseline. R represents recipient status and D represents donor status.|participants|Number|3|3.0||||||
4210742|NCT00726375|4034062|B1|R+, D-||CMV Status|Cytomegalovirus (CMV) status at baseline. R represents recipient status and D represents donor status.|participants|Number|12|12.0||||||
4210743|NCT00726375|4034062|B1|R+, D+||CMV Status|Cytomegalovirus (CMV) status at baseline. R represents recipient status and D represents donor status.|participants|Number|9|9.0||||||
4210744|NCT00726375|4034062|B1|Mismatched unrelated||Donor||participants|Number|6|6.0||||||
4210745|NCT00726375|4034062|B1|Mismatched related||Donor||participants|Number|0|0.0||||||
4210746|NCT00726375|4034062|B1|Matched unrelated||Donor||participants|Number|16|16.0||||||
4210747|NCT00726375|4034062|B1|Matched related||Donor||participants|Number|12|12.0||||||
4210748|NCT00726375|4034062|B1|High||Disease Risk Status||participants|Number|16|16.0||||||
4210749|NCT00726375|4034062|B1|Intermediate||Disease Risk Status||participants|Number|5|5.0||||||
4210750|NCT00726375|4034062|B1|Low||Disease Risk Status||participants|Number|13|13.0||||||
4210751|NCT00726375|4034062|B1|Nonmalignant disease||Diagnosis|Cancer diagnosis.|participants|Number|2|2.0||||||
4210752|NCT00726375|4034062|B1|Chronic myelogenous leukemia||Diagnosis|Cancer diagnosis.|participants|Number|0|0.0||||||
4210753|NCT00726375|4034062|B1|Chronic lymphocytic leukemia||Diagnosis|Cancer diagnosis.|participants|Number|1|1.0||||||
4210754|NCT00726375|4034062|B1|Myelofibrosis||Diagnosis|Cancer diagnosis.|participants|Number|2|2.0||||||
4210755|NCT00726375|4034062|B1|Non-Hodgkin’s lymphoma||Diagnosis|Cancer diagnosis.|participants|Number|2|2.0||||||
4210756|NCT00726375|4034062|B1|Myelodysplastic syndrome||Diagnosis|Cancer diagnosis.|participants|Number|4|4.0||||||
4210757|NCT00726375|4034062|B1|Multiple myeloma||Diagnosis|Cancer diagnosis.|participants|Number|4|4.0||||||
4210758|NCT00726375|4034062|B1|Acute lymphoblastic leukemia||Diagnosis|Cancer diagnosis.|participants|Number|6|6.0||||||
4210759|NCT00726375|4034062|B1|Acute myelogenous leukemia||Diagnosis|Cancer diagnosis.|participants|Number|13|13.0||||||
4210760|NCT00726375|4034062|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4210761|NCT00726375|4034062|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4210762|NCT00726375|4034062|B1|White||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4210763|NCT00726375|4034062|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4210764|NCT00726375|4034062|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4210765|NCT00726375|4034062|B1|||Age||years|Median|51|51.0|Full Range|||10.0|67.0|
4210766|NCT00726323|4034067|B3|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4210767|NCT00726323|4034068|B2|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4210768|NCT00726323|4034069|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4210769|NCT00726323|4034067|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4210770|NCT00726323|4034068|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4210771|NCT00726323|4034069|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4210772|NCT00726323|4034067|B3|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4210773|NCT00726323|4034068|B2|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4210774|NCT00726323|4034069|B1|Multiple||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4210775|NCT00726323|4034067|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|64|64.0||||||
4210776|NCT00726323|4034068|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
4210777|NCT00726323|4034069|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
4210778|NCT00726323|4034067|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4210779|NCT00726323|4034068|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4210780|NCT00726323|4034069|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4210781|NCT00726323|4034067|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4210782|NCT00726323|4034068|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4210783|NCT00726323|4034069|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4210784|NCT00726323|4034067|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4210785|NCT00726323|4034068|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4210786|NCT00726323|4034069|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4210787|NCT00726323|4034067|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4210788|NCT00726323|4034068|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4210789|NCT00726323|4034069|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4210790|NCT00726323|4034067|B3|||Age||Years|Mean|55.6|55.6|Standard Deviation|13.06|13.06|||
4210791|NCT00726323|4034068|B2|||Age||Years|Mean|56.2|56.2|Standard Deviation|14.32|14.32|||
4210792|NCT00726323|4034069|B1|||Age||Years|Mean|55.1|55.1|Standard Deviation|11.84|11.84|||
4210793|NCT00726232|4034094|B7|< 10 x 10^9 per liter||White blood cell count||participants|Number|37|37.0||||||
4210794|NCT00726232|4034095|B6|< 10 x 10^9 per liter||White blood cell count||participants|Number|7|7.0||||||
4210795|NCT00726232|4034096|B5|< 10 x 10^9 per liter||White blood cell count||participants|Number|15|15.0||||||
4210796|NCT00726232|4034097|B4|< 10 x 10^9 per liter||White blood cell count||participants|Number|6|6.0||||||
4210797|NCT00726232|4034098|B3|< 10 x 10^9 per liter||White blood cell count||participants|Number|1|1.0||||||
4210798|NCT00726232|4034099|B2|< 10 x 10^9 per liter||White blood cell count||participants|Number|1|1.0||||||
4210799|NCT00726232|4034100|B1|< 10 x 10^9 per liter||White blood cell count||participants|Number|7|7.0||||||
4210800|NCT00726232|4034094|B7|≥ 10 x 10^9 per liter||White blood cell count||participants|Number|36|36.0||||||
4210801|NCT00726232|4034095|B6|≥ 10 x 10^9 per liter||White blood cell count||participants|Number|2|2.0||||||
4210802|NCT00726232|4034096|B5|≥ 10 x 10^9 per liter||White blood cell count||participants|Number|7|7.0||||||
4210803|NCT00726232|4034097|B4|≥ 10 x 10^9 per liter||White blood cell count||participants|Number|2|2.0||||||
4210804|NCT00726232|4034098|B3|≥ 10 x 10^9 per liter||White blood cell count||participants|Number|6|6.0||||||
4210805|NCT00726232|4034099|B2|≥ 10 x 10^9 per liter||White blood cell count||participants|Number|7|7.0||||||
4210806|NCT00726232|4034100|B1|≥ 10 x 10^9 per liter||White blood cell count||participants|Number|12|12.0||||||
4210807|NCT00726232|4034094|B7|< 400 x 10^9 per liter||Platelet count||participants|Number|12|12.0||||||
4210808|NCT00726232|4034095|B6|< 400 x 10^9 per liter||Platelet count||participants|Number|0|0.0||||||
4210809|NCT00726232|4034096|B5|< 400 x 10^9 per liter||Platelet count||participants|Number|0|0.0||||||
4210810|NCT00726232|4034097|B4|< 400 x 10^9 per liter||Platelet count||participants|Number|1|1.0||||||
4210811|NCT00726232|4034098|B3|< 400 x 10^9 per liter||Platelet count||participants|Number|1|1.0||||||
4210812|NCT00726232|4034099|B2|< 400 x 10^9 per liter||Platelet count||participants|Number|4|4.0||||||
4210813|NCT00726232|4034100|B1|< 400 x 10^9 per liter||Platelet count||participants|Number|6|6.0||||||
4210814|NCT00726232|4034094|B7|≥400 x 10^9 per liter||Platelet count||participants|Number|61|61.0||||||
4210815|NCT00726232|4034095|B6|≥400 x 10^9 per liter||Platelet count||participants|Number|9|9.0||||||
4210816|NCT00726232|4034096|B5|≥400 x 10^9 per liter||Platelet count||participants|Number|22|22.0||||||
4210817|NCT00726232|4034097|B4|≥400 x 10^9 per liter||Platelet count||participants|Number|7|7.0||||||
4210818|NCT00726232|4034098|B3|≥400 x 10^9 per liter||Platelet count||participants|Number|6|6.0||||||
4210819|NCT00726232|4034099|B2|≥400 x 10^9 per liter||Platelet count||participants|Number|4|4.0||||||
4210820|NCT00726232|4034100|B1|≥400 x 10^9 per liter||Platelet count||participants|Number|13|13.0||||||
4210821|NCT00726232|4034094|B7|Hematocrit < 45%||Hematocrit||participants|Number|45|45.0||||||
4210822|NCT00726232|4034095|B6|Hematocrit < 45%||Hematocrit||participants|Number|9|9.0||||||
4210823|NCT00726232|4034096|B5|Hematocrit < 45%||Hematocrit||participants|Number|18|18.0||||||
4210824|NCT00726232|4034097|B4|Hematocrit < 45%||Hematocrit||participants|Number|7|7.0||||||
4210825|NCT00726232|4034098|B3|Hematocrit < 45%||Hematocrit||participants|Number|1|1.0||||||
4210826|NCT00726232|4034099|B2|Hematocrit < 45%||Hematocrit||participants|Number|1|1.0||||||
4210827|NCT00726232|4034100|B1|Hematocrit < 45%||Hematocrit||participants|Number|9|9.0||||||
4210828|NCT00726232|4034094|B7|Hematocrit ≥ 45%||Hematocrit||participants|Number|28|28.0||||||
4210829|NCT00726232|4034095|B6|Hematocrit ≥ 45%||Hematocrit||participants|Number|0|0.0||||||
4210830|NCT00726232|4034096|B5|Hematocrit ≥ 45%||Hematocrit||participants|Number|4|4.0||||||
4210831|NCT00726232|4034097|B4|Hematocrit ≥ 45%||Hematocrit||participants|Number|1|1.0||||||
4210832|NCT00726232|4034098|B3|Hematocrit ≥ 45%||Hematocrit||participants|Number|6|6.0||||||
4210833|NCT00726232|4034099|B2|Hematocrit ≥ 45%||Hematocrit||participants|Number|7|7.0||||||
4210834|NCT00726232|4034100|B1|Hematocrit ≥ 45%||Hematocrit||participants|Number|10|10.0||||||
4210835|NCT00726232|4034094|B7||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4210836|NCT00726232|4034095|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4210837|NCT00726232|4034096|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4210838|NCT00726232|4034097|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4210839|NCT00726232|4034098|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4210840|NCT00726232|4034099|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4210841|NCT00726232|4034100|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4210842|NCT00726232|4034094|B7||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4210843|NCT00726232|4034095|B6||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4210844|NCT00726232|4034096|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4210845|NCT00726232|4034097|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4210846|NCT00726232|4034098|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4210847|NCT00726232|4034099|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4210848|NCT00726232|4034100|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4210849|NCT00726232|4034094|B7|< 65||Age, Customized||participants|Number|56|56.0||||||
4210850|NCT00726232|4034095|B6|< 65||Age, Customized||participants|Number|6|6.0||||||
4210851|NCT00726232|4034096|B5|< 65||Age, Customized||participants|Number|19|19.0||||||
4210852|NCT00726232|4034097|B4|< 65||Age, Customized||participants|Number|7|7.0||||||
4210853|NCT00726232|4034098|B3|< 65||Age, Customized||participants|Number|5|5.0||||||
4210854|NCT00726232|4034099|B2|< 65||Age, Customized||participants|Number|5|5.0||||||
4210855|NCT00726232|4034100|B1|< 65||Age, Customized||participants|Number|14|14.0||||||
4210856|NCT00726232|4034094|B7|>= 65||Age, Customized||participants|Number|17|17.0||||||
4210857|NCT00726232|4034095|B6|>= 65||Age, Customized||participants|Number|3|3.0||||||
4210858|NCT00726232|4034096|B5|>= 65||Age, Customized||participants|Number|3|3.0||||||
4210859|NCT00726232|4034097|B4|>= 65||Age, Customized||participants|Number|1|1.0||||||
4210860|NCT00726232|4034098|B3|>= 65||Age, Customized||participants|Number|2|2.0||||||
4210861|NCT00726232|4034099|B2|>= 65||Age, Customized||participants|Number|3|3.0||||||
4210862|NCT00726232|4034100|B1|>= 65||Age, Customized||participants|Number|5|5.0||||||
4210863|NCT00726232|4034094|B7|Essential thrombocythemia group||Age||years|Mean|52.9|52.9|Standard Deviation|13.19|13.19|||
4210864|NCT00726232|4034095|B6|Essential thrombocythemia group||Age||years|Mean|52.8|52.8|Standard Deviation|13.48|13.48|||
4210865|NCT00726232|4034096|B5|Essential thrombocythemia group||Age||years|Mean|54.1|54.1|Standard Deviation|11.55|11.55|||
4210866|NCT00726232|4034097|B4|Essential thrombocythemia group||Age||years|Mean|49.6|49.6|Standard Deviation|17.89|17.89|||
4210867|NCT00726232|4034098|B3|Essential thrombocythemia group||Age||years|Mean|NA||Standard Deviation|NA||||Age demographic data for the essential thrombocythemia group.
4210868|NCT00726232|4034099|B2|Essential thrombocythemia group||Age||years|Mean|NA||Standard Deviation|NA||||Age demographic data for the essential thrombocythemia group.
4210869|NCT00726232|4034100|B1|Essential thrombocythemia group||Age||years|Mean|NA||Standard Deviation|NA||||Age demographic data for the essential thrombocythemia group.
4210870|NCT00726232|4034094|B7|Polycythemia vera group||Age||years|Mean|55.4|55.4|Standard Deviation|13.20|13.2|||
4210871|NCT00726232|4034095|B6|Polycythemia vera group||Age||years|Mean|NA||Standard Deviation|NA||||Age demographic data for the polycythemia vera group.
4210872|NCT00726232|4034096|B5|Polycythemia vera group||Age||years|Mean|NA||Standard Deviation|NA||||Age demographic data for the polycythemia vera group.
4210873|NCT00726232|4034097|B4|Polycythemia vera group||Age||years|Mean|NA||Standard Deviation|NA||||Age demographic data for the polycythemia vera group.
4210874|NCT00726232|4034098|B3|Polycythemia vera group||Age||years|Mean|51.0|51.0|Standard Deviation|20.49|20.49|||
4210875|NCT00726232|4034099|B2|Polycythemia vera group||Age||years|Mean|57.0|57.0|Standard Deviation|11.26|11.26|||
4210876|NCT00726232|4034100|B1|Polycythemia vera group||Age||years|Mean|56.3|56.3|Standard Deviation|10.98|10.98|||
4210877|NCT00726180|4034149|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4210878|NCT00726180|4034149|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4210879|NCT00726180|4034149|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4210880|NCT00726180|4034149|B1|||Age||years|Mean|32|32.0|Standard Deviation|||||
4210881|NCT00726180|4034149|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4210882|NCT00726180|4034149|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4210883|NCT00726180|4034149|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4210884|NCT00726063|4034153|B3||Male|Sex: Female, Male|Overall number baseline implants Nanotite= 239 Overall number baseline implants Osseotite = 246 Nanotite implants in Females = 116 Nanotite implants in Males = 123 Osseotite implants in Females = 120 Osseotite implants in Males = 126|Participants|Count of Participants|116|116.0||||||
4210885|NCT00726063|4034154|B2||Male|Sex: Female, Male|Overall number baseline implants Nanotite= 239 Overall number baseline implants Osseotite = 246 Nanotite implants in Females = 116 Nanotite implants in Males = 123 Osseotite implants in Females = 120 Osseotite implants in Males = 126|Participants|Count of Participants|55|55.0||||||
4210965|NCT00725920|4034216|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4210966|NCT00725920|4034217|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4210886|NCT00726063|4034155|B1||Male|Sex: Female, Male|Overall number baseline implants Nanotite= 239 Overall number baseline implants Osseotite = 246 Nanotite implants in Females = 116 Nanotite implants in Males = 123 Osseotite implants in Females = 120 Osseotite implants in Males = 126|Participants|Count of Participants|61|61.0||||||
4210887|NCT00726063|4034153|B3||Female|Sex: Female, Male|Overall number baseline implants Nanotite= 239 Overall number baseline implants Osseotite = 246 Nanotite implants in Females = 116 Nanotite implants in Males = 123 Osseotite implants in Females = 120 Osseotite implants in Males = 126|Participants|Count of Participants|125|125.0||||||
4210888|NCT00726063|4034154|B2||Female|Sex: Female, Male|Overall number baseline implants Nanotite= 239 Overall number baseline implants Osseotite = 246 Nanotite implants in Females = 116 Nanotite implants in Males = 123 Osseotite implants in Females = 120 Osseotite implants in Males = 126|Participants|Count of Participants|64|64.0||||||
4210889|NCT00726063|4034155|B1||Female|Sex: Female, Male|Overall number baseline implants Nanotite= 239 Overall number baseline implants Osseotite = 246 Nanotite implants in Females = 116 Nanotite implants in Males = 123 Osseotite implants in Females = 120 Osseotite implants in Males = 126|Participants|Count of Participants|61|61.0||||||
4210890|NCT00726063|4034153|B3||>=65 years|Age|Overall number of Nanotite implants = 239 Overall number of Osseotite implants = 246 Nanotite implants in <18 yrs = 1 Nanotite implants in 18-65 = 163 Nanotite implants in >65 = 75 Osseotite implants in <18 yrs = 0 Osseotite implants in 18-65 = 173 Osseotite implants in >65 = 73|Participants|Count of Participants|116|116.0||||||
4210891|NCT00726063|4034154|B2||>=65 years|Age|Overall number of Nanotite implants = 239 Overall number of Osseotite implants = 246 Nanotite implants in <18 yrs = 1 Nanotite implants in 18-65 = 163 Nanotite implants in >65 = 75 Osseotite implants in <18 yrs = 0 Osseotite implants in 18-65 = 173 Osseotite implants in >65 = 73|Participants|Count of Participants|56|56.0||||||
4210892|NCT00726063|4034155|B1||>=65 years|Age|Overall number of Nanotite implants = 239 Overall number of Osseotite implants = 246 Nanotite implants in <18 yrs = 1 Nanotite implants in 18-65 = 163 Nanotite implants in >65 = 75 Osseotite implants in <18 yrs = 0 Osseotite implants in 18-65 = 173 Osseotite implants in >65 = 73|Participants|Count of Participants|60|60.0||||||
4210893|NCT00726063|4034153|B3||Between 18 and 65 years|Age|Overall number of Nanotite implants = 239 Overall number of Osseotite implants = 246 Nanotite implants in <18 yrs = 1 Nanotite implants in 18-65 = 163 Nanotite implants in >65 = 75 Osseotite implants in <18 yrs = 0 Osseotite implants in 18-65 = 173 Osseotite implants in >65 = 73|Participants|Count of Participants|124|124.0||||||
4210894|NCT00726063|4034154|B2||Between 18 and 65 years|Age|Overall number of Nanotite implants = 239 Overall number of Osseotite implants = 246 Nanotite implants in <18 yrs = 1 Nanotite implants in 18-65 = 163 Nanotite implants in >65 = 75 Osseotite implants in <18 yrs = 0 Osseotite implants in 18-65 = 173 Osseotite implants in >65 = 73|Participants|Count of Participants|63|63.0||||||
4210895|NCT00726063|4034155|B1||Between 18 and 65 years|Age|Overall number of Nanotite implants = 239 Overall number of Osseotite implants = 246 Nanotite implants in <18 yrs = 1 Nanotite implants in 18-65 = 163 Nanotite implants in >65 = 75 Osseotite implants in <18 yrs = 0 Osseotite implants in 18-65 = 173 Osseotite implants in >65 = 73|Participants|Count of Participants|61|61.0||||||
4210896|NCT00726063|4034153|B3||<=18 years|Age|Overall number of Nanotite implants = 239 Overall number of Osseotite implants = 246 Nanotite implants in <18 yrs = 1 Nanotite implants in 18-65 = 163 Nanotite implants in >65 = 75 Osseotite implants in <18 yrs = 0 Osseotite implants in 18-65 = 173 Osseotite implants in >65 = 73|Participants|Count of Participants|1|1.0||||||
4210897|NCT00726063|4034154|B2||<=18 years|Age|Overall number of Nanotite implants = 239 Overall number of Osseotite implants = 246 Nanotite implants in <18 yrs = 1 Nanotite implants in 18-65 = 163 Nanotite implants in >65 = 75 Osseotite implants in <18 yrs = 0 Osseotite implants in 18-65 = 173 Osseotite implants in >65 = 73|Participants|Count of Participants|0|0.0||||||
4210898|NCT00726063|4034155|B1||<=18 years|Age|Overall number of Nanotite implants = 239 Overall number of Osseotite implants = 246 Nanotite implants in <18 yrs = 1 Nanotite implants in 18-65 = 163 Nanotite implants in >65 = 75 Osseotite implants in <18 yrs = 0 Osseotite implants in 18-65 = 173 Osseotite implants in >65 = 73|Participants|Count of Participants|1|1.0||||||
4210899|NCT00726037|4034162|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4210900|NCT00726037|4034162|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4210901|NCT00726037|4034162|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4210902|NCT00726037|4034162|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4210903|NCT00726037|4034162|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4210904|NCT00726037|4034162|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4210905|NCT00725985|4034167|B4|||Number of T1 Hypointense Lesions||lesions|Mean|7.4|7.4|Standard Deviation|10.9|10.9|||
4210906|NCT00725985|4034168|B3|||Number of T1 Hypointense Lesions||lesions|Mean|7.0|7.0|Standard Deviation|8.6|8.6|||
4210907|NCT00725985|4034169|B2|||Number of T1 Hypointense Lesions||lesions|Mean|7.3|7.3|Standard Deviation|12.2|12.2|||
4210908|NCT00725985|4034170|B1|||Number of T1 Hypointense Lesions||lesions|Mean|8.0|8.0|Standard Deviation|11.7|11.7|||
4210909|NCT00725985|4034167|B4|||Number of Time constant 2 (T2) Lesions||lesions|Mean|27.6|27.6|Standard Deviation|28.4|28.4|||
4210910|NCT00725985|4034168|B3|||Number of Time constant 2 (T2) Lesions||lesions|Mean|26.3|26.3|Standard Deviation|27.4|27.4|||
4210911|NCT00725985|4034169|B2|||Number of Time constant 2 (T2) Lesions||lesions|Mean|26.8|26.8|Standard Deviation|28.3|28.3|||
4210912|NCT00725985|4034170|B1|||Number of Time constant 2 (T2) Lesions||lesions|Mean|29.7|29.7|Standard Deviation|29.6|29.6|||
4210913|NCT00725985|4034167|B4|||Number of Time Constant 1 (T1) Gadolinium Enhanced (Gd+) Lesions||lesions|Mean|1.4|1.4|Standard Deviation|4.5|4.5|||
4210914|NCT00725985|4034168|B3|||Number of Time Constant 1 (T1) Gadolinium Enhanced (Gd+) Lesions||lesions|Mean|0.9|0.9|Standard Deviation|2.5|2.5|||
4210915|NCT00725985|4034169|B2|||Number of Time Constant 1 (T1) Gadolinium Enhanced (Gd+) Lesions||lesions|Mean|1.5|1.5|Standard Deviation|4.5|4.5|||
4210916|NCT00725985|4034170|B1|||Number of Time Constant 1 (T1) Gadolinium Enhanced (Gd+) Lesions||lesions|Mean|1.8|1.8|Standard Deviation|5.8|5.8|||
4210967|NCT00725920|4034218|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4210917|NCT00725985|4034167|B4|||Expanded disability status scale (EDSS) score|Expanded disability status scale (EDSS) assesses disability in 8 functional systems. An overall score ranging from 0 (normal) to 10 (death due to MS) was calculated.|units on scale|Mean|1.6|1.6|Standard Deviation|0.9|0.9|||
4210918|NCT00725985|4034168|B3|||Expanded disability status scale (EDSS) score|Expanded disability status scale (EDSS) assesses disability in 8 functional systems. An overall score ranging from 0 (normal) to 10 (death due to MS) was calculated.|units on scale|Mean|1.7|1.7|Standard Deviation|0.9|0.9|||
4210919|NCT00725985|4034169|B2|||Expanded disability status scale (EDSS) score|Expanded disability status scale (EDSS) assesses disability in 8 functional systems. An overall score ranging from 0 (normal) to 10 (death due to MS) was calculated.|units on scale|Mean|1.6|1.6|Standard Deviation|0.9|0.9|||
4210920|NCT00725985|4034170|B1|||Expanded disability status scale (EDSS) score|Expanded disability status scale (EDSS) assesses disability in 8 functional systems. An overall score ranging from 0 (normal) to 10 (death due to MS) was calculated.|units on scale|Mean|1.6|1.6|Standard Deviation|0.9|0.9|||
4210921|NCT00725985|4034167|B4||Male|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4210922|NCT00725985|4034168|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4210923|NCT00725985|4034169|B2||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4210924|NCT00725985|4034170|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4210925|NCT00725985|4034167|B4||Female|Sex: Female, Male||Participants|Count of Participants|400|400.0||||||
4210926|NCT00725985|4034168|B3||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4210927|NCT00725985|4034169|B2||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4210928|NCT00725985|4034170|B1||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4210929|NCT00725985|4034167|B4|Less than 30 years||Age, Customized||participants|Number|282|282.0||||||
4210930|NCT00725985|4034168|B3|Less than 30 years||Age, Customized||participants|Number|93|93.0||||||
4210931|NCT00725985|4034169|B2|Less than 30 years||Age, Customized||participants|Number|96|96.0||||||
4210932|NCT00725985|4034170|B1|Less than 30 years||Age, Customized||participants|Number|93|93.0||||||
4210933|NCT00725985|4034167|B4|Greater than or equal to 30 years||Age, Customized||participants|Number|334|334.0||||||
4210934|NCT00725985|4034168|B3|Greater than or equal to 30 years||Age, Customized||participants|Number|113|113.0||||||
4210935|NCT00725985|4034169|B2|Greater than or equal to 30 years||Age, Customized||participants|Number|110|110.0||||||
4210936|NCT00725985|4034170|B1|Greater than or equal to 30 years||Age, Customized||participants|Number|111|111.0||||||
4210937|NCT00725985|4034167|B4|||Age||years|Mean|31.9|31.9|Standard Deviation|8.7|8.7|||
4210938|NCT00725985|4034168|B3|||Age||years|Mean|32.2|32.2|Standard Deviation|8.2|8.2|||
4210939|NCT00725985|4034169|B2|||Age||years|Mean|31.7|31.7|Standard Deviation|9.1|9.1|||
4210940|NCT00725985|4034170|B1|||Age||years|Mean|31.9|31.9|Standard Deviation|8.8|8.8|||
4210941|NCT00725959|4034207|B3||Male|Sex: Female, Male||Participants|Count of Participants|666|666.0||||||
4210942|NCT00725959|4034208|B2||Male|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4210943|NCT00725959|4034209|B1||Male|Sex: Female, Male||Participants|Count of Participants|421|421.0||||||
4210944|NCT00725959|4034207|B3||Female|Sex: Female, Male||Participants|Count of Participants|912|912.0||||||
4210945|NCT00725959|4034208|B2||Female|Sex: Female, Male||Participants|Count of Participants|391|391.0||||||
4210946|NCT00725959|4034209|B1||Female|Sex: Female, Male||Participants|Count of Participants|521|521.0||||||
4210947|NCT00725959|4034207|B3|||Age|Years of age|years|Mean|19.8|19.8|Standard Deviation|2.1|2.1|||
4210948|NCT00725959|4034208|B2|||Age|Years of age|years|Mean|20.2|20.2|Standard Deviation|2.4|2.4|||
4210949|NCT00725959|4034209|B1|||Age|Years of age|years|Mean|19.7|19.7|Standard Deviation|2.0|2.0|||
4210950|NCT00725920|4034216|B3|Total CAPS||Clinician Administered Posttraumatic Scale (CAPS)||scores on a scale|Mean|72.43|72.43|Standard Deviation|16.73|16.73|||
4210951|NCT00725920|4034217|B2|Total CAPS||Clinician Administered Posttraumatic Scale (CAPS)||scores on a scale|Mean|64.33|64.33|Standard Deviation|22|22.0|||
4210952|NCT00725920|4034218|B1|Total CAPS||Clinician Administered Posttraumatic Scale (CAPS)||scores on a scale|Mean|79.64|79.64|Standard Deviation|12.03|12.03|||
4210953|NCT00725920|4034216|B3|Hyperarousal symptoms (CAPS-D)||Clinician Administered Posttraumatic Scale (CAPS)||scores on a scale|Mean|22.03|22.03|Standard Deviation|3.8|3.8|||
4210954|NCT00725920|4034217|B2|Hyperarousal symptoms (CAPS-D)||Clinician Administered Posttraumatic Scale (CAPS)||scores on a scale|Mean|20.14|20.14|Standard Deviation|8.29|8.29|||
4210955|NCT00725920|4034218|B1|Hyperarousal symptoms (CAPS-D)||Clinician Administered Posttraumatic Scale (CAPS)||scores on a scale|Mean|24.11|24.11|Standard Deviation|5.69|5.69|||
4210956|NCT00725920|4034216|B3|Avoidance/numbing symptoms (CAPS-C)||Clinician Administered Posttraumatic Scale (CAPS)||scores on a scale|Mean|28.6|28.6|Standard Deviation|4.79|4.79|||
4210957|NCT00725920|4034217|B2|Avoidance/numbing symptoms (CAPS-C)||Clinician Administered Posttraumatic Scale (CAPS)||scores on a scale|Mean|24.78|24.78|Standard Deviation|11.30|11.3|||
4210958|NCT00725920|4034218|B1|Avoidance/numbing symptoms (CAPS-C)||Clinician Administered Posttraumatic Scale (CAPS)||scores on a scale|Mean|31.58|31.58|Standard Deviation|7.13|7.13|||
4210959|NCT00725920|4034216|B3|Reexperiencing symptoms (CAPS-B)||Clinician Administered Posttraumatic Scale (CAPS)||scores on a scale|Mean|22.84|22.84|Standard Deviation|3.85|3.85|||
4210960|NCT00725920|4034217|B2|Reexperiencing symptoms (CAPS-B)||Clinician Administered Posttraumatic Scale (CAPS)||scores on a scale|Mean|21.21|21.21|Standard Deviation|7.15|7.15|||
4210961|NCT00725920|4034218|B1|Reexperiencing symptoms (CAPS-B)||Clinician Administered Posttraumatic Scale (CAPS)||scores on a scale|Mean|23.05|23.05|Standard Deviation|5.88|5.88|||
4210962|NCT00725920|4034216|B3|Brazil||Region of Enrollment||participants|Number|35|35.0||||||
4210963|NCT00725920|4034217|B2|Brazil||Region of Enrollment||participants|Number|18|18.0||||||
4210964|NCT00725920|4034218|B1|Brazil||Region of Enrollment||participants|Number|17|17.0||||||
4210968|NCT00725920|4034216|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4210969|NCT00725920|4034217|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4210970|NCT00725920|4034218|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4210971|NCT00725920|4034216|B3|||Age||years|Mean|37.54|37.54|Standard Deviation|12.08|12.08|||
4210972|NCT00725920|4034217|B2|||Age||years|Mean|36.5|36.5|Standard Deviation|7.97|7.97|||
4210973|NCT00725920|4034218|B1|||Age||years|Mean|43.7|43.7|Standard Deviation|13.44|13.44|||
4210974|NCT00725920|4034216|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4210975|NCT00725920|4034217|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4210976|NCT00725920|4034218|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4210977|NCT00725920|4034216|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4210978|NCT00725920|4034217|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4210979|NCT00725920|4034218|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4210980|NCT00725920|4034216|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4210981|NCT00725920|4034217|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4210982|NCT00725920|4034218|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4210983|NCT00725842|4034225|B1||Male|Sex: Female, Male|Gender data unavailable for the 7 participants excluded from analysis.|Participants|Count of Participants|65|65.0||||||
4210984|NCT00725842|4034225|B1||Female|Sex: Female, Male|Gender data unavailable for the 7 participants excluded from analysis.|Participants|Count of Participants|25|25.0||||||
4210985|NCT00725842|4034225|B1|||Age|Age data unavailable for the 7 participants excluded from analysis.|years|Mean|46.0|46.0|Standard Deviation|12.5|12.5|||
4210986|NCT00725764|4034232|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4210987|NCT00725764|4034232|B1|White||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4210988|NCT00725764|4034232|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4210989|NCT00725764|4034232|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4210990|NCT00725764|4034232|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4210991|NCT00725764|4034232|B1|||Age||Years|Mean|59.6|59.6|Standard Deviation|8.50|8.5|||
4210992|NCT00725751|4034250|B3|Austria||Region of Enrollment||participants|Number|348|348.0||||||
4210993|NCT00725751|4034251|B2|Austria||Region of Enrollment||participants|Number|258|258.0||||||
4210994|NCT00725751|4034252|B1|Austria||Region of Enrollment||participants|Number|90|90.0||||||
4210995|NCT00725751|4034250|B3||Male|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4210996|NCT00725751|4034251|B2||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4210997|NCT00725751|4034252|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4210998|NCT00725751|4034250|B3||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4210999|NCT00725751|4034251|B2||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4211000|NCT00725751|4034252|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4211001|NCT00725751|4034250|B3|||Age||years|Mean|39.71|39.71|Standard Deviation|12.64|12.64|||
4211002|NCT00725751|4034251|B2|||Age||years|Mean|42.26|42.26|Standard Deviation|12.62|12.62|||
4211003|NCT00725751|4034252|B1|||Age||years|Mean|32.38|32.38|Standard Deviation|9.51|9.51|||
4211004|NCT00725725|4034262|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4211005|NCT00725725|4034263|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4211006|NCT00725725|4034264|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4211007|NCT00725725|4034265|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4211008|NCT00725725|4034262|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4211009|NCT00725725|4034263|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4211010|NCT00725725|4034264|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4211011|NCT00725725|4034265|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4211012|NCT00725725|4034262|B4|||Age||years|Mean|34.1|34.1|Standard Deviation|9.9|9.9|||
4211013|NCT00725725|4034263|B3|||Age||years|Mean|32.8|32.8|Standard Deviation|10.8|10.8|||
4211014|NCT00725725|4034264|B2|||Age||years|Mean|36.4|36.4|Standard Deviation|8.9|8.9|||
4211015|NCT00725725|4034265|B1|||Age||years|Mean|33.1|33.1|Standard Deviation|9.9|9.9|||
4211016|NCT00725712|4034308|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4211017|NCT00725712|4034309|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4211018|NCT00725712|4034310|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4211019|NCT00725712|4034308|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4211020|NCT00725712|4034309|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211021|NCT00725712|4034310|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4211022|NCT00725712|4034308|B3||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4211023|NCT00725712|4034309|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4211024|NCT00725712|4034310|B1||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4211025|NCT00725712|4034308|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4211026|NCT00725712|4034309|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4211027|NCT00725712|4034310|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4211028|NCT00725712|4034308|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211029|NCT00725712|4034309|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211030|NCT00725712|4034310|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211031|NCT00725712|4034308|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4211032|NCT00725712|4034309|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4211033|NCT00725712|4034310|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4211034|NCT00725712|4034308|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4211035|NCT00725712|4034309|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4211036|NCT00725712|4034310|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211037|NCT00725712|4034308|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4211038|NCT00725712|4034309|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4211039|NCT00725712|4034310|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4211040|NCT00725712|4034308|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4211041|NCT00725712|4034309|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4211042|NCT00725712|4034310|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4211043|NCT00725712|4034308|B3|||Age||Years|Mean|59.3|59.3|Standard Deviation|13.57|13.57|||
4211044|NCT00725712|4034309|B2|||Age||Years|Mean|59.5|59.5|Standard Deviation|15.35|15.35|||
4211045|NCT00725712|4034310|B1|||Age||Years|Mean|59.1|59.1|Standard Deviation|12.68|12.68|||
4211046|NCT00725621|4034347|B1||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4211047|NCT00725621|4034347|B1||Female|Sex: Female, Male||Participants|Count of Participants|398|398.0||||||
4211048|NCT00725621|4034347|B1|||Age||years|Mean|55.43|55.43|Standard Deviation|13.52|13.52|||
4211049|NCT00725608|4034370|B1|Austria||Region of Enrollment||participants|Number|307|307.0||||||
4211050|NCT00725608|4034370|B1||Male|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
4211051|NCT00725608|4034370|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4211052|NCT00725608|4034370|B1|||Age||Years|Mean|30.3|30.3|Standard Deviation|7.3|7.3|||
4211053|NCT00725543|4034376|B1||Male|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
4211054|NCT00725543|4034376|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4211055|NCT00725543|4034376|B1|||Age||years|Mean|42.08|42.08|Standard Deviation|11.81|11.81|||
4211056|NCT00725530|4034385|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4211057|NCT00725530|4034385|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4211058|NCT00725530|4034385|B1|||Age||years|Mean|32.35|32.35|Standard Deviation|12.71|12.71|||
4211059|NCT00725504|4034392|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
4211060|NCT00725504|4034392|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4211061|NCT00725504|4034392|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4211062|NCT00725504|4034392|B1|||Age||years|Mean|47|47.0|Full Range|||17.0|82.0|
4211063|NCT00725504|4034392|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4211064|NCT00725504|4034392|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4211065|NCT00725504|4034392|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4211066|NCT00725491|4034399|B3|China||Region of Enrollment|Intention to treat population|participants|Number|233|233.0||||||
4211067|NCT00725491|4034400|B2|China||Region of Enrollment|Intention to treat population|participants|Number|120|120.0||||||
4211068|NCT00725491|4034401|B1|China||Region of Enrollment|Intention to treat population|participants|Number|113|113.0||||||
4211069|NCT00725491|4034399|B3||Male|Sex: Female, Male|Intention to treat population|Participants|Count of Participants|0|0.0||||||
4211070|NCT00725491|4034400|B2||Male|Sex: Female, Male|Intention to treat population|Participants|Count of Participants|0|0.0||||||
4211071|NCT00725491|4034401|B1||Male|Sex: Female, Male|Intention to treat population|Participants|Count of Participants|0|0.0||||||
4211072|NCT00725491|4034399|B3||Female|Sex: Female, Male|Intention to treat population|Participants|Count of Participants|233|233.0||||||
4211073|NCT00725491|4034400|B2||Female|Sex: Female, Male|Intention to treat population|Participants|Count of Participants|120|120.0||||||
4211074|NCT00725491|4034401|B1||Female|Sex: Female, Male|Intention to treat population|Participants|Count of Participants|113|113.0||||||
4211075|NCT00725491|4034399|B3|||Age|Intention to treat population|years|Mean|29.2|29.2|Standard Deviation|2.9|2.9|||
4211076|NCT00725491|4034400|B2|||Age|Intention to treat population|years|Mean|29.1|29.1|Standard Deviation|3.0|3.0|||
4211077|NCT00725491|4034401|B1|||Age|Intention to treat population|years|Mean|29.3|29.3|Standard Deviation|2.8|2.8|||
4211078|NCT00725452|4034408|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4211079|NCT00725452|4034408|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4211080|NCT00725452|4034408|B1|||Age||years|Mean|46.23|46.23|Standard Deviation|10.17|10.17|||
4211081|NCT00725361|4034417|B1|||Mean diameter of baseline digital ulcers||mm|Mean|3.3|3.3|Standard Deviation|1.6|1.6|||
4211082|NCT00725361|4034417|B1|||Mean number of total baseline digital ulcers||digital ulcers|Mean|3.1|3.1|Standard Deviation|2.1|2.1|||
4211083|NCT00725361|4034417|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4211084|NCT00725361|4034417|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4211085|NCT00725361|4034417|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4211086|NCT00725361|4034417|B1|||Age||years|Mean|49.3|49.3|Standard Deviation|13.8|13.8|||
4211087|NCT00725322|4034425|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
4211088|NCT00725322|4034426|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4211089|NCT00725322|4034427|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4211090|NCT00725322|4034425|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4211091|NCT00725322|4034426|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4211092|NCT00725322|4034427|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4211093|NCT00725322|4034425|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4211094|NCT00725322|4034426|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4211095|NCT00725322|4034427|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4211096|NCT00725322|4034425|B3|||Age||Years|Mean|48.44|48.44|Standard Deviation|13.54|13.54|||
4211097|NCT00725322|4034426|B2|||Age||Years|Mean|50.14|50.14|Standard Deviation|12.48|12.48|||
4211098|NCT00725322|4034427|B1|||Age||Years|Mean|46.62|46.62|Standard Deviation|14.87|14.87|||
4211099|NCT00725322|4034425|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4211100|NCT00725322|4034426|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4211101|NCT00725322|4034427|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4211102|NCT00725322|4034425|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4211103|NCT00725322|4034426|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4211104|NCT00725322|4034427|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4211105|NCT00725322|4034425|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4211106|NCT00725322|4034426|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4211107|NCT00725322|4034427|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4211108|NCT00725296|4034436|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4211109|NCT00725296|4034436|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4211110|NCT00725296|4034436|B1|||Age|Mean age of participants was assessed in 163 out of 178 enrolled participants. A total of 163 participants received at least one dose of Infliximab.|years|Mean|47.96|47.96|Standard Deviation|13.22|13.22|||
4211111|NCT00725283|4034445|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4211112|NCT00725283|4034445|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4211113|NCT00725283|4034445|B1|||Age||Years|Mean|60.1|60.1|Standard Deviation|12.3|12.3|||
4211114|NCT00725270|4034455|B3|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4211115|NCT00725270|4034456|B2|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4211116|NCT00725270|4034457|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4211117|NCT00725270|4034455|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211118|NCT00725270|4034456|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211119|NCT00725270|4034457|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211120|NCT00725270|4034455|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4211121|NCT00725270|4034456|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211122|NCT00725270|4034457|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4211123|NCT00725270|4034455|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4211124|NCT00725270|4034456|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4211125|NCT00725270|4034457|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4211126|NCT00725270|4034455|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4211127|NCT00725270|4034456|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211128|NCT00725270|4034457|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4211129|NCT00725270|4034455|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211130|NCT00725270|4034456|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211131|NCT00725270|4034457|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211132|NCT00725270|4034455|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4211133|NCT00725270|4034456|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211134|NCT00725270|4034457|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4211135|NCT00725270|4034455|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211136|NCT00725270|4034456|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211137|NCT00725270|4034457|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211138|NCT00725270|4034455|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4211139|NCT00725270|4034456|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4211140|NCT00725270|4034457|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4211141|NCT00725270|4034455|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4211142|NCT00725270|4034456|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4211143|NCT00725270|4034457|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4211144|NCT00725270|4034455|B3|||Age||years|Mean|31.08|31.08|Standard Deviation|12.4|12.4|||
4211145|NCT00725270|4034456|B2|||Age||years|Mean|27.29|27.29|Standard Deviation|8.6|8.6|||
4211146|NCT00725270|4034457|B1|||Age||years|Mean|36.4|36.4|Standard Deviation|15.9|15.9|||
4211147|NCT00725205|4034466|B1||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4211148|NCT00725205|4034466|B1||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4211149|NCT00725205|4034466|B1|||Age||years|Mean|46.7|46.7|Standard Deviation|10.8|10.8|||
4211150|NCT00725153|4034472|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4211151|NCT00725153|4034472|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4211152|NCT00725153|4034472|B1|||Age||years|Mean|31.95|31.95|Standard Deviation|12.03|12.03|||
4211153|NCT00725101|4034479|B1|Other||Main Reasons for Discontinuing Medications Before Starting Fibromyalgia (FM) Treatment at Baseline|Physicians reported the single, main reason for a participant to discontinue a medication during the Baseline visit. The number of participants included those who discontinued medication before starting fibromyalgia treatment at Baseline.|participants|Number|59|59.0||||||
4211154|NCT00725101|4034479|B1|Too costly||Main Reasons for Discontinuing Medications Before Starting Fibromyalgia (FM) Treatment at Baseline|Physicians reported the single, main reason for a participant to discontinue a medication during the Baseline visit. The number of participants included those who discontinued medication before starting fibromyalgia treatment at Baseline.|participants|Number|14|14.0||||||
4211155|NCT00725101|4034479|B1|Adverse events||Main Reasons for Discontinuing Medications Before Starting Fibromyalgia (FM) Treatment at Baseline|Physicians reported the single, main reason for a participant to discontinue a medication during the Baseline visit. The number of participants included those who discontinued medication before starting fibromyalgia treatment at Baseline.|participants|Number|81|81.0||||||
4211156|NCT00725101|4034479|B1|Did not help||Main Reasons for Discontinuing Medications Before Starting Fibromyalgia (FM) Treatment at Baseline|Physicians reported the single, main reason for a participant to discontinue a medication during the Baseline visit. The number of participants included those who discontinued medication before starting fibromyalgia treatment at Baseline.|participants|Number|332|332.0||||||
4211157|NCT00725101|4034479|B1|Felt better||Main Reasons for Discontinuing Medications Before Starting Fibromyalgia (FM) Treatment at Baseline|Physicians reported the single, main reason for a participant to discontinue a medication during the Baseline visit. The number of participants included those who discontinued medication before starting fibromyalgia treatment at Baseline.|participants|Number|6|6.0||||||
4211158|NCT00725101|4034479|B1|Yes||Nonsteroidal Anti-Inflammatory Drug (NSAID) Use||participants|Number|455|455.0||||||
4211159|NCT00725101|4034479|B1|No||Nonsteroidal Anti-Inflammatory Drug (NSAID) Use||participants|Number|1245|1245.0||||||
4211160|NCT00725101|4034479|B1|Yes||Opioid Use||participants|Number|412|412.0||||||
4211161|NCT00725101|4034479|B1|No||Opioid Use||participants|Number|1288|1288.0||||||
4211162|NCT00725101|4034479|B1|||Sheehan Disability Scale (SDS) Total Score|SDS is a self-rated measurement of disability across 3 domains: work/school, social life, and family life/home responsibilities. Participant marks along the line from 0 (not at all) to 10 (extremely disrupted), the number that best represents how much each area is disrupted by fibromyalgia symptoms.|units on a scale|Mean|18.3|18.3|Standard Deviation|7.6|7.6|||
4211163|NCT00725101|4034479|B1|||Fibromyalgia Impact Questionnaire (FIQ)|FIQ measures self-reported fibromyalgia (FM) status, progress, and outcomes over past week. FIQ has 20 items: Items 1-11 measure physical functioning (each rated on 4-point Likert-type scale); Items 12 + 13 measure number (no.) of days participant felt well and no. of days participant felt unable to work due to FM symptoms. Items 14-20 are numerical, 11-point Likert-type scales (marked in 10-millimeter [mm] increments) rating work difficulty, pain intensity, fatigue, morning tiredness, stiffness, anxiety, and depression. Total scores range from 0 to 80; Higher score=greater negative impact.|units on a scale|Mean|54.4|54.4|Standard Deviation|13.7|13.7|||
4211164|NCT00725101|4034479|B1|||Brief Pain Inventory-Interference (BPI-I) Average Subscale Score|Average BPI-I measures self-reported degree of pain interference on function. Interference scores range from 0 (does not interfere) to 10 (completely interferes) for each question assessing interference of pain within the past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. Average interference = average of non-missing scores of individual interference items.|units on a scale|Mean|6.1|6.1|Standard Deviation|2.2|2.2|||
4211165|NCT00725101|4034479|B1|||Brief Pain Inventory-Severity (BPI-S) Average Subscale Score|BPI-S measures self-reported severity of pain. Severity scores range from 0 (no pain) to 10 (pain as bad as you can imagine) for each question assessing worst pain, least pain, and average pain in the past 24 hours, and current pain.|units on a scale|Mean|5.5|5.5|Standard Deviation|1.8|1.8|||
4211166|NCT00725101|4034479|B1|||Mean Number of Concurrent Baseline Medications Taken for Fibromyalgia (FM)||concurrent baseline medications|Mean|2.6|2.6|Standard Deviation|1.2|1.2|||
4211167|NCT00725101|4034479|B1|||Number of Unique Baseline Medications Taken for Fibromyalgia (FM; Newly-Initiated and Continuing)||unique baseline medications|Number|181|181.0||||||
4211168|NCT00725101|4034479|B1|Puerto Rico||Region of Enrollment||participants|Number|161|161.0||||||
4211169|NCT00725101|4034479|B1|United States||Region of Enrollment||participants|Number|1539|1539.0||||||
4211170|NCT00725101|4034479|B1|Other||Race/Ethnicity, Customized||participants|Number|100|100.0||||||
4211171|NCT00725101|4034479|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|209|209.0||||||
4211172|NCT00725101|4034479|B1|White||Race/Ethnicity, Customized||participants|Number|1391|1391.0||||||
4211173|NCT00725101|4034479|B1||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4211174|NCT00725101|4034479|B1||Female|Sex: Female, Male||Participants|Count of Participants|1601|1601.0||||||
4211175|NCT00725101|4034479|B1|||Age||years|Mean|50.4|50.4|Standard Deviation|11.9|11.9|||
4211176|NCT00725075|4034499|B4||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4211177|NCT00725075|4034500|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4211178|NCT00725075|4034501|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4211179|NCT00725075|4034502|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4211180|NCT00725075|4034499|B4||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4211181|NCT00725075|4034500|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4211182|NCT00725075|4034501|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4211183|NCT00725075|4034502|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4211184|NCT00725075|4034499|B4|||Age||Years|Mean|38.3|38.3|Standard Deviation|10.5|10.5|||
4211185|NCT00725075|4034500|B3|||Age||Years|Mean|38.1|38.1|Standard Deviation|10.5|10.5|||
4211186|NCT00725075|4034501|B2|||Age||Years|Mean|38.8|38.8|Standard Deviation|11.0|11.0|||
4211187|NCT00725075|4034502|B1|||Age||Years|Mean|37.8|37.8|Standard Deviation|10.1|10.1|||
4211188|NCT00725049|4034548|B3|Italy||Region of Enrollment||participants|Number|19|19.0||||||
4211189|NCT00725049|4034549|B2|Italy||Region of Enrollment||participants|Number|10|10.0||||||
4211190|NCT00725049|4034550|B1|Italy||Region of Enrollment||participants|Number|9|9.0||||||
4211191|NCT00725049|4034548|B3|Greece||Region of Enrollment||participants|Number|9|9.0||||||
4211192|NCT00725049|4034549|B2|Greece||Region of Enrollment||participants|Number|6|6.0||||||
4211193|NCT00725049|4034550|B1|Greece||Region of Enrollment||participants|Number|3|3.0||||||
4211194|NCT00725049|4034548|B3|Spain||Region of Enrollment||participants|Number|9|9.0||||||
4211195|NCT00725049|4034549|B2|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4211196|NCT00725049|4034550|B1|Spain||Region of Enrollment||participants|Number|5|5.0||||||
4211197|NCT00725049|4034548|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4211198|NCT00725049|4034549|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4211199|NCT00725049|4034550|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4211200|NCT00725049|4034548|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4211201|NCT00725049|4034549|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4211202|NCT00725049|4034550|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4211203|NCT00725049|4034548|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4211204|NCT00725049|4034549|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4211205|NCT00725049|4034550|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4211206|NCT00725049|4034548|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4211207|NCT00725049|4034549|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4211208|NCT00725049|4034550|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4211209|NCT00725049|4034548|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4211210|NCT00725049|4034549|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4211211|NCT00725049|4034550|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4211212|NCT00725010|4034557|B1|Austria||Region of Enrollment||participants|Number|50|50.0||||||
4211213|NCT00725010|4034557|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4211214|NCT00725010|4034557|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4211215|NCT00725010|4034557|B1|||Age||years|Mean|57|57.0|Standard Deviation|12.06|12.06|||
4211216|NCT00724984|4034565|B7|United States||Region of Enrollment||participants|Number|55|55.0||||||
4211217|NCT00724984|4034566|B6|United States||Region of Enrollment||participants|Number|14|14.0||||||
4211218|NCT00724984|4034567|B5|United States||Region of Enrollment||participants|Number|16|16.0||||||
4211219|NCT00724984|4034568|B4|United States||Region of Enrollment||participants|Number|9|9.0||||||
4211220|NCT00724984|4034569|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4211221|NCT00724984|4034570|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4211222|NCT00724984|4034571|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4211223|NCT00724984|4034565|B7||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4211224|NCT00724984|4034566|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4211225|NCT00724984|4034567|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4211226|NCT00724984|4034568|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4211227|NCT00724984|4034569|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4211228|NCT00724984|4034570|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4211229|NCT00724984|4034571|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4211230|NCT00724984|4034565|B7||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4211231|NCT00724984|4034566|B6||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4211232|NCT00724984|4034567|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4211233|NCT00724984|4034568|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4211234|NCT00724984|4034569|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4211235|NCT00724984|4034570|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4211236|NCT00724984|4034571|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4211237|NCT00724984|4034565|B7|||Age||years|Median|66|66.0|Full Range|||32.0|81.0|
4211238|NCT00724984|4034566|B6|||Age||years|Median|67|67.0|Full Range|||59.0|77.0|
4211239|NCT00724984|4034567|B5|||Age||years|Median|62|62.0|Full Range|||36.0|81.0|
4211240|NCT00724984|4034568|B4|||Age||years|Median|66|66.0|Full Range|||44.0|76.0|
4211241|NCT00724984|4034569|B3|||Age||years|Median|62|62.0|Full Range|||32.0|79.0|
4211242|NCT00724984|4034570|B2|||Age||years|Median|67|67.0|Full Range|||47.0|76.0|
4211243|NCT00724984|4034571|B1|||Age||years|Median|68|68.0|Full Range|||40.0|75.0|
4211244|NCT00724958|4034590|B1|Austria||Region of Enrollment||participants|Number|343|343.0||||||
4211245|NCT00724958|4034590|B1||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4211246|NCT00724958|4034590|B1||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4211247|NCT00724958|4034590|B1|||Age||years|Mean|38.68|38.68|Standard Deviation|12.30|12.3|||
4211248|NCT00724945|4034599|B1|United States||Region of Enrollment||participants|Number|103|103.0||||||
4211249|NCT00724945|4034599|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4211250|NCT00724945|4034599|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4211251|NCT00724945|4034599|B1|||Age||years|Mean|49.2|49.2|Standard Deviation|5.9|5.9|||
4211252|NCT00724932|4034610|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4211253|NCT00724932|4034611|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4211254|NCT00724932|4034612|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4211255|NCT00724932|4034610|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4211256|NCT00724932|4034611|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4211257|NCT00724932|4034612|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4211258|NCT00724932|4034610|B3|||Age||years|Mean|51|51.0|Standard Deviation|15|15.0|||
4211259|NCT00724932|4034611|B2|||Age||years|Mean|51|51.0|Standard Deviation|14|14.0|||
4211260|NCT00724932|4034612|B1|||Age||years|Mean|51|51.0|Standard Deviation|16|16.0|||
4211261|NCT00724893|4034682|B3||Male|Sex: Female, Male||Participants|Count of Participants|1652|1652.0||||||
4211262|NCT00724893|4034683|B2||Male|Sex: Female, Male||Participants|Count of Participants|782|782.0||||||
4211263|NCT00724893|4034684|B1||Male|Sex: Female, Male||Participants|Count of Participants|870|870.0||||||
4211264|NCT00724893|4034682|B3||Female|Sex: Female, Male||Participants|Count of Participants|778|778.0||||||
4211265|NCT00724893|4034683|B2||Female|Sex: Female, Male||Participants|Count of Participants|346|346.0||||||
4211266|NCT00724893|4034684|B1||Female|Sex: Female, Male||Participants|Count of Participants|432|432.0||||||
4211267|NCT00724893|4034682|B3|>55 years||Age, Customized||Participants|Number|449|449.0||||||
4211268|NCT00724893|4034683|B2|>55 years||Age, Customized||Participants|Number|228|228.0||||||
4211269|NCT00724893|4034684|B1|>55 years||Age, Customized||Participants|Number|221|221.0||||||
4211270|NCT00724893|4034682|B3|40 to < 55 yeats||Age, Customized||Participants|Number|1454|1454.0||||||
4211271|NCT00724893|4034683|B2|40 to < 55 yeats||Age, Customized||Participants|Number|671|671.0||||||
4211272|NCT00724893|4034684|B1|40 to < 55 yeats||Age, Customized||Participants|Number|783|783.0||||||
4211273|NCT00724893|4034682|B3|24 to < 40 years||Age, Customized||Participants|Number|492|492.0||||||
4211274|NCT00724893|4034683|B2|24 to < 40 years||Age, Customized||Participants|Number|217|217.0||||||
4211275|NCT00724893|4034684|B1|24 to < 40 years||Age, Customized||Participants|Number|275|275.0||||||
4211276|NCT00724893|4034682|B3|<25 years||Age, Customized||Participants|Number|35|35.0||||||
4211277|NCT00724893|4034683|B2|<25 years||Age, Customized||Participants|Number|12|12.0||||||
4211278|NCT00724893|4034684|B1|<25 years||Age, Customized||Participants|Number|23|23.0||||||
4211279|NCT00724867|4034753|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4211280|NCT00724867|4034753|B1|White: White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|183|183.0||||||
4211281|NCT00724867|4034753|B1|White: Middle East/North African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4211282|NCT00724867|4034753|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4211283|NCT00724867|4034753|B1|Asian: Southeast Asian Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4211284|NCT00724867|4034753|B1|Asian: South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4211285|NCT00724867|4034753|B1|Asian: Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4211286|NCT00724867|4034753|B1|Asian: East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4211287|NCT00724867|4034753|B1|Asian: Central Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4211288|NCT00724867|4034753|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4211289|NCT00724867|4034753|B1|Black or African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|57|57.0||||||
4211290|NCT00724867|4034753|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4211291|NCT00724867|4034753|B1||Female|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
4211292|NCT00724867|4034753|B1|||Age||Years|Mean|42.8|42.8|Standard Deviation|11.33|11.33|||
4211293|NCT00724854|4034791|B3|Brazil||Region of Enrollment||participants|Number|1082|1082.0||||||
4211294|NCT00724854|4034792|B2|Brazil||Region of Enrollment||participants|Number|72|72.0||||||
4211295|NCT00724854|4034793|B1|Brazil||Region of Enrollment||participants|Number|1010|1010.0||||||
4211296|NCT00724854|4034791|B3||Male|Sex: Female, Male||Participants|Count of Participants|615|615.0||||||
4211297|NCT00724854|4034792|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4211298|NCT00724854|4034793|B1||Male|Sex: Female, Male||Participants|Count of Participants|566|566.0||||||
4211299|NCT00724854|4034791|B3||Female|Sex: Female, Male||Participants|Count of Participants|467|467.0||||||
4211300|NCT00724854|4034792|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4211301|NCT00724854|4034793|B1||Female|Sex: Female, Male||Participants|Count of Participants|444|444.0||||||
4211302|NCT00724854|4034791|B3|>40 years||Age, Customized||Participants|Number|853|853.0||||||
4211303|NCT00724854|4034792|B2|>40 years||Age, Customized||Participants|Number|36|36.0||||||
4211304|NCT00724854|4034793|B1|>40 years||Age, Customized||Participants|Number|817|817.0||||||
4211305|NCT00724854|4034791|B3|<=40 years||Age, Customized||Participants|Number|229|229.0||||||
4211306|NCT00724854|4034792|B2|<=40 years||Age, Customized||Participants|Number|36|36.0||||||
4211307|NCT00724854|4034793|B1|<=40 years||Age, Customized||Participants|Number|193|193.0||||||
4211308|NCT00724815|4034809|B3|United States||Region of Enrollment||participants|Number|469|469.0||||||
4211309|NCT00724815|4034810|B2|United States||Region of Enrollment||participants|Number|235|235.0||||||
4211310|NCT00724815|4034811|B1|United States||Region of Enrollment||participants|Number|234|234.0||||||
4211311|NCT00724815|4034809|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4211312|NCT00724815|4034810|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4211313|NCT00724815|4034811|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4211314|NCT00724815|4034809|B3||Female|Sex: Female, Male||Participants|Count of Participants|398|398.0||||||
4211315|NCT00724815|4034810|B2||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4211316|NCT00724815|4034811|B1||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4211317|NCT00724815|4034809|B3|||Age||years|Mean|40.8|40.8|Standard Deviation|11.12|11.12|||
4211318|NCT00724815|4034810|B2|||Age||years|Mean|41.2|41.2|Standard Deviation|11.06|11.06|||
4211319|NCT00724815|4034811|B1|||Age||years|Mean|40.5|40.5|Standard Deviation|11.20|11.2|||
4211320|NCT00724815|4034809|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4211321|NCT00724815|4034810|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4211322|NCT00724815|4034811|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4211323|NCT00724815|4034809|B3||Between 18 and 65 years|Age||Participants|Count of Participants|468|468.0||||||
4211324|NCT00724815|4034810|B2||Between 18 and 65 years|Age||Participants|Count of Participants|235|235.0||||||
4211325|NCT00724815|4034811|B1||Between 18 and 65 years|Age||Participants|Count of Participants|233|233.0||||||
4211326|NCT00724815|4034809|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4211327|NCT00724815|4034810|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4211328|NCT00724815|4034811|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4211329|NCT00724750|4034824|B3|United States||Region of Enrollment||participants|Number|87|87.0||||||
4211330|NCT00724750|4034825|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
4211331|NCT00724750|4034826|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4211332|NCT00724750|4034824|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4211333|NCT00724750|4034825|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4211334|NCT00724750|4034826|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4211335|NCT00724750|4034824|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4211336|NCT00724750|4034825|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4211337|NCT00724750|4034826|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4211338|NCT00724750|4034824|B3|||Age||years|Mean|53|53.0|Full Range|||19.0|82.0|
4211339|NCT00724750|4034825|B2|||Age||years|Mean|54|54.0|Full Range|||19.0|82.0|
4211340|NCT00724750|4034826|B1|||Age||years|Mean|53|53.0|Full Range|||23.0|80.0|
4211341|NCT00724711|4034843|B3|||Body Mass Index (BMI)||kg/m^2|Mean|27.3|27.3|Standard Deviation|5.46|5.46|||
4211342|NCT00724711|4034844|B2|||Body Mass Index (BMI)||kg/m^2|Mean|27.2|27.2|Standard Deviation|4.93|4.93|||
4211343|NCT00724711|4034845|B1|||Body Mass Index (BMI)||kg/m^2|Mean|27.3|27.3|Standard Deviation|5.96|5.96|||
4211344|NCT00724711|4034843|B3|||Height||cm|Mean|173.9|173.9|Standard Deviation|9.52|9.52|||
4211345|NCT00724711|4034844|B2|||Height||cm|Mean|174.1|174.1|Standard Deviation|9.55|9.55|||
4211346|NCT00724711|4034845|B1|||Height||cm|Mean|173.8|173.8|Standard Deviation|9.52|9.52|||
4211347|NCT00724711|4034843|B3|||Weight||kg|Mean|82.3|82.3|Standard Deviation|16.52|16.52|||
4211348|NCT00724711|4034844|B2|||Weight||kg|Mean|82.5|82.5|Standard Deviation|15.65|15.65|||
4211349|NCT00724711|4034845|B1|||Weight||kg|Mean|82.2|82.2|Standard Deviation|17.40|17.4|||
4211350|NCT00724711|4034843|B3|Canada||Region of Enrollment||participants|Number|14|14.0||||||
4211351|NCT00724711|4034844|B2|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4211352|NCT00724711|4034845|B1|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4211353|NCT00724711|4034843|B3|Puerto Rico||Region of Enrollment||participants|Number|9|9.0||||||
4211354|NCT00724711|4034844|B2|Puerto Rico||Region of Enrollment||participants|Number|5|5.0||||||
4211355|NCT00724711|4034845|B1|Puerto Rico||Region of Enrollment||participants|Number|4|4.0||||||
4211356|NCT00724711|4034843|B3|United States||Region of Enrollment||participants|Number|288|288.0||||||
4211357|NCT00724711|4034844|B2|United States||Region of Enrollment||participants|Number|142|142.0||||||
4211358|NCT00724711|4034845|B1|United States||Region of Enrollment||participants|Number|146|146.0||||||
4211359|NCT00724711|4034843|B3|Non-Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|237|237.0||||||
4211360|NCT00724711|4034844|B2|Non-Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|120|120.0||||||
4211361|NCT00724711|4034845|B1|Non-Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|117|117.0||||||
4211362|NCT00724711|4034843|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
4211363|NCT00724711|4034844|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4211364|NCT00724711|4034845|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4211365|NCT00724711|4034843|B3|Other||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4211366|NCT00724711|4034844|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4211367|NCT00724711|4034845|B1|Other||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4211368|NCT00724711|4034843|B3|White||Race/Ethnicity, Customized||participants|Number|202|202.0||||||
4211369|NCT00724711|4034844|B2|White||Race/Ethnicity, Customized||participants|Number|106|106.0||||||
4211370|NCT00724711|4034845|B1|White||Race/Ethnicity, Customized||participants|Number|96|96.0||||||
4211371|NCT00724711|4034843|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|87|87.0||||||
4211372|NCT00724711|4034844|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4211373|NCT00724711|4034845|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4211374|NCT00724711|4034843|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4211375|NCT00724711|4034844|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4211376|NCT00724711|4034845|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4211377|NCT00724711|4034843|B3|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4211378|NCT00724711|4034844|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4211379|NCT00724711|4034845|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4211380|NCT00724711|4034843|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4211381|NCT00724711|4034844|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4211382|NCT00724711|4034845|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4211383|NCT00724711|4034843|B3||Male|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
4211384|NCT00724711|4034844|B2||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4211385|NCT00724711|4034845|B1||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4211386|NCT00724711|4034843|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4211387|NCT00724711|4034844|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4211388|NCT00724711|4034845|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4211389|NCT00724711|4034843|B3|||Age||years|Mean|46|46.0|Standard Deviation|9.3|9.3|||
4211390|NCT00724711|4034844|B2|||Age||years|Mean|47|47.0|Standard Deviation|9.7|9.7|||
4211391|NCT00724711|4034845|B1|||Age||years|Mean|46|46.0|Standard Deviation|9.0|9.0|||
4211392|NCT00724698|4034878|B1||Male|Sex: Female, Male||Participants|Count of Participants|1223|1223.0||||||
4211393|NCT00724698|4034878|B1||Female|Sex: Female, Male||Participants|Count of Participants|1788|1788.0||||||
4211394|NCT00724698|4034878|B1||>=65 years|Age||Participants|Count of Participants|230|230.0||||||
4211395|NCT00724698|4034878|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2542|2542.0||||||
4211396|NCT00724698|4034878|B1||<=18 years|Age||Participants|Count of Participants|239|239.0||||||
4211397|NCT00724594|4034881|B5|United States||Region of Enrollment||participants|Number|46|46.0||||||
4211398|NCT00724594|4034882|B4|United States||Region of Enrollment||participants|Number|11|11.0||||||
4211399|NCT00724594|4034883|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4211400|NCT00724594|4034884|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4211401|NCT00724594|4034885|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4211402|NCT00724594|4034881|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211403|NCT00724594|4034882|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211404|NCT00724594|4034883|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211405|NCT00724594|4034884|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211406|NCT00724594|4034885|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211407|NCT00724594|4034881|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211408|NCT00724594|4034882|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211409|NCT00724594|4034883|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211410|NCT00724594|4034884|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211411|NCT00724594|4034885|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211412|NCT00724594|4034881|B5||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4211413|NCT00724594|4034882|B4||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4211414|NCT00724594|4034883|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4211415|NCT00724594|4034884|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4211416|NCT00724594|4034885|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4211417|NCT00724594|4034881|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4211418|NCT00724594|4034882|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4211419|NCT00724594|4034883|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4211420|NCT00724594|4034884|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4211421|NCT00724594|4034885|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4211422|NCT00724594|4034881|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211423|NCT00724594|4034882|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211483|NCT00724373|4034951|B1|Male||Sex/Gender, Customized||participants|Number|296|296.0||||||
4211424|NCT00724594|4034883|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211425|NCT00724594|4034884|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211426|NCT00724594|4034885|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211427|NCT00724594|4034881|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211428|NCT00724594|4034882|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211429|NCT00724594|4034883|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211430|NCT00724594|4034884|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211431|NCT00724594|4034885|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211432|NCT00724594|4034881|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211433|NCT00724594|4034882|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211434|NCT00724594|4034883|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211435|NCT00724594|4034884|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211436|NCT00724594|4034885|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211437|NCT00724594|4034881|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4211438|NCT00724594|4034882|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4211439|NCT00724594|4034883|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4211440|NCT00724594|4034884|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4211441|NCT00724594|4034885|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4211442|NCT00724594|4034881|B5||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4211443|NCT00724594|4034882|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4211444|NCT00724594|4034883|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4211445|NCT00724594|4034884|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4211446|NCT00724594|4034885|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4211447|NCT00724594|4034881|B5|Mothers aged 18-45years||Age, Customized||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4211448|NCT00724594|4034882|B4|Mothers aged 18-45years||Age, Customized||participants|Number|11|11.0||||||
4211449|NCT00724594|4034883|B3|Mothers aged 18-45years||Age, Customized||participants|Number|11|11.0||||||
4211450|NCT00724594|4034884|B2|Mothers aged 18-45years||Age, Customized||participants|Number|NA|||||||Only applicable to mothers
4211451|NCT00724594|4034885|B1|Mothers aged 18-45years||Age, Customized||participants|Number|NA|||||||Only applicable to mothers
4211452|NCT00724594|4034881|B5|Term Infants||Age, Customized||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4211453|NCT00724594|4034882|B4|Term Infants||Age, Customized||participants|Number|NA|||||||Only applicable to infants
4211454|NCT00724594|4034883|B3|Term Infants||Age, Customized||participants|Number|NA|||||||Only applicable to infants
4211455|NCT00724594|4034884|B2|Term Infants||Age, Customized||participants|Number|5|5.0||||||
4211456|NCT00724594|4034885|B1|Term Infants||Age, Customized||participants|Number|5|5.0||||||
4211457|NCT00724594|4034881|B5|Preterm Infants||Age, Customized||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4211458|NCT00724594|4034882|B4|Preterm Infants||Age, Customized||participants|Number|NA|||||||Only applicable to infants
4211459|NCT00724594|4034883|B3|Preterm Infants||Age, Customized||participants|Number|NA|||||||Only applicable to infants
4211460|NCT00724594|4034884|B2|Preterm Infants||Age, Customized||participants|Number|7|7.0||||||
4211461|NCT00724594|4034885|B1|Preterm Infants||Age, Customized||participants|Number|7|7.0||||||
4211462|NCT00724568|4034923|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4211463|NCT00724568|4034923|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4211464|NCT00724568|4034923|B1|||Age||years|Median|59|59.0|Full Range|||29.0|77.0|
4211465|NCT00724477|4034929|B1|France||Region of Enrollment||participants|Number|1663|1663.0||||||
4211466|NCT00724477|4034929|B1||Male|Sex: Female, Male||Participants|Count of Participants|1078|1078.0||||||
4211467|NCT00724477|4034929|B1||Female|Sex: Female, Male||Participants|Count of Participants|585|585.0||||||
4211468|NCT00724477|4034929|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|10.4|10.4|||
4211469|NCT00724464|4034933|B1||Male|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4211470|NCT00724464|4034933|B1||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4211471|NCT00724464|4034933|B1|||Age||years|Mean|39.9|39.9|Standard Deviation|11.8|11.8|||
4211472|NCT00724451|4034945|B1||Male|Sex: Female, Male||Participants|Count of Participants|577|577.0||||||
4211473|NCT00724451|4034945|B1||Female|Sex: Female, Male||Participants|Count of Participants|541|541.0||||||
4211474|NCT00724451|4034945|B1|≥80 years||Age, Customized||participants|Number|20|20.0||||||
4211475|NCT00724451|4034945|B1|70-79 years||Age, Customized||participants|Number|210|210.0||||||
4211476|NCT00724451|4034945|B1|60-69 years||Age, Customized||participants|Number|263|263.0||||||
4211477|NCT00724451|4034945|B1|50-59 years||Age, Customized||participants|Number|211|211.0||||||
4211478|NCT00724451|4034945|B1|40-49 years||Age, Customized||participants|Number|244|244.0||||||
4211479|NCT00724451|4034945|B1|30-39 years||Age, Customized||participants|Number|119|119.0||||||
4211480|NCT00724451|4034945|B1|18-29 years||Age, Customized||participants|Number|51|51.0||||||
4211481|NCT00724373|4034951|B1|United Kingdom||Region of Enrollment||participants|Number|442|442.0||||||
4211482|NCT00724373|4034951|B1|Gender information missing||Sex/Gender, Customized||participants|Number|3|3.0||||||
4211484|NCT00724373|4034951|B1|Female||Sex/Gender, Customized||participants|Number|143|143.0||||||
4211485|NCT00724373|4034951|B1|||Age, Customized|Mean age was calculated for 441 of the 442 participants. Age was missing for one participant.|Years|Mean|43|43.0|Standard Deviation|10.13|10.13|||
4211486|NCT00724347|4034955|B1|Thresholds 6000 Hz||Audiometry|Pure tone audiometric thresholds measured in dB HL (i.e., relative to normal hearing listeners) from 250 to 8000 Hz in each ear.|Sound intensity dB HL|Mean|71.25|71.25|Standard Deviation|12.58|12.58|||
4211487|NCT00724347|4034955|B1|Thresholds 4000 Hz||Audiometry|Pure tone audiometric thresholds measured in dB HL (i.e., relative to normal hearing listeners) from 250 to 8000 Hz in each ear.|Sound intensity dB HL|Mean|66.88|66.88|Standard Deviation|9.46|9.46|||
4211488|NCT00724347|4034955|B1|Thresholds 2000 Hz||Audiometry|Pure tone audiometric thresholds measured in dB HL (i.e., relative to normal hearing listeners) from 250 to 8000 Hz in each ear.|Sound intensity dB HL|Mean|43.13|43.13|Standard Deviation|15.15|15.15|||
4211489|NCT00724347|4034955|B1|Thresholds 1000 Hz||Audiometry|Pure tone audiometric thresholds measured in dB HL (i.e., relative to normal hearing listeners) from 250 to 8000 Hz in each ear.|Sound intensity dB HL|Mean|29.38|29.38|Standard Deviation|16.42|16.42|||
4211490|NCT00724347|4034955|B1|Thresholds 500 Hz||Audiometry|Pure tone audiometric thresholds measured in dB HL (i.e., relative to normal hearing listeners) from 250 to 8000 Hz in each ear.|Sound intensity dB HL|Mean|19.69|19.69|Standard Deviation|13.35|13.35|||
4211491|NCT00724347|4034955|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4211492|NCT00724347|4034955|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4211493|NCT00724347|4034955|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4211494|NCT00724347|4034955|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4211495|NCT00724347|4034955|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4211496|NCT00724347|4034955|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4211497|NCT00724347|4034955|B1|||Age||years|Mean|65.67|65.67|Standard Deviation|6.51|6.51|||
4211498|NCT00724308|4034959|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4211499|NCT00724308|4034960|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4211500|NCT00724308|4034961|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4211501|NCT00724308|4034959|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4211502|NCT00724308|4034960|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4211503|NCT00724308|4034961|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4211504|NCT00724308|4034959|B3||White|Race (NIH/OMB)||Participants|Count of Participants|320|320.0||||||
4211505|NCT00724308|4034960|B2||White|Race (NIH/OMB)||Participants|Count of Participants|169|169.0||||||
4211506|NCT00724308|4034961|B1||White|Race (NIH/OMB)||Participants|Count of Participants|151|151.0||||||
4211507|NCT00724308|4034959|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|206|206.0||||||
4211508|NCT00724308|4034960|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|114|114.0||||||
4211509|NCT00724308|4034961|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
4211510|NCT00724308|4034959|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211511|NCT00724308|4034960|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211512|NCT00724308|4034961|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211513|NCT00724308|4034959|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4211514|NCT00724308|4034960|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4211515|NCT00724308|4034961|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4211516|NCT00724308|4034959|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4211517|NCT00724308|4034960|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4211518|NCT00724308|4034961|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4211519|NCT00724308|4034959|B3||Male|Sex: Female, Male||Participants|Count of Participants|534|534.0||||||
4211520|NCT00724308|4034960|B2||Male|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
4211521|NCT00724308|4034961|B1||Male|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
4211522|NCT00724308|4034959|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4211523|NCT00724308|4034960|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4211524|NCT00724308|4034961|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4211525|NCT00724308|4034959|B3|||Age||years|Mean|54|54.0|Standard Deviation|12|12.0|||
4211526|NCT00724308|4034960|B2|||Age||years|Mean|54|54.0|Standard Deviation|12|12.0|||
4211527|NCT00724308|4034961|B1|||Age||years|Mean|54|54.0|Standard Deviation|12|12.0|||
4211528|NCT00724282|4034968|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4211529|NCT00724282|4034968|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211530|NCT00724282|4034968|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211531|NCT00724282|4034968|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4211532|NCT00724282|4034968|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4211533|NCT00724282|4034968|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211534|NCT00724282|4034968|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4211535|NCT00724282|4034968|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211536|NCT00724282|4034968|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4211537|NCT00724282|4034968|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4211538|NCT00724282|4034968|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4211539|NCT00724282|4034968|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4211540|NCT00724282|4034968|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4211541|NCT00724243|4034972|B1|Slovakia||Region of Enrollment||participants|Number|33|33.0||||||
4211542|NCT00724243|4034972|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4211543|NCT00724243|4034972|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4211544|NCT00724243|4034972|B1|||Age||years|Mean|43.38|43.38|Standard Deviation|10.74|10.74|||
4211545|NCT00724152|4034977|B6|||Tinnitus Handicap Inventory|The THI score ranges from 0 to 100, with 100 indicating the most severe tinnitus and 0 is the least severe tinnitus.|units on a scale|Mean|49.1|49.1|Standard Deviation|18.1|18.1|||
4211546|NCT00724152|4034978|B5|||Tinnitus Handicap Inventory|The THI score ranges from 0 to 100, with 100 indicating the most severe tinnitus and 0 is the least severe tinnitus.|units on a scale|Mean|30.0|30.0|Standard Deviation|0|0.0|||
4211547|NCT00724152|4034980|B3|||Tinnitus Handicap Inventory|The THI score ranges from 0 to 100, with 100 indicating the most severe tinnitus and 0 is the least severe tinnitus.|units on a scale|Mean|40.7|40.7|Standard Deviation|19.6|19.6|||
4211548|NCT00724152|4034981|B2|||Tinnitus Handicap Inventory|The THI score ranges from 0 to 100, with 100 indicating the most severe tinnitus and 0 is the least severe tinnitus.|units on a scale|Mean|55.1|55.1|Standard Deviation|13.9|13.9|||
4211549|NCT00724152|4034982|B1|||Tinnitus Handicap Inventory|The THI score ranges from 0 to 100, with 100 indicating the most severe tinnitus and 0 is the least severe tinnitus.|units on a scale|Mean|44.1|44.1|Standard Deviation|20.2|20.2|||
4211550|NCT00724152|4034977|B6|Mixed||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4211551|NCT00724152|4034978|B5|Mixed||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4211552|NCT00724152|4034980|B3|Mixed||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4211553|NCT00724152|4034981|B2|Mixed||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4211554|NCT00724152|4034982|B1|Mixed||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4211555|NCT00724152|4034977|B6|Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4211556|NCT00724152|4034978|B5|Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4211557|NCT00724152|4034980|B3|Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4211558|NCT00724152|4034981|B2|Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4211559|NCT00724152|4034982|B1|Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4211560|NCT00724152|4034977|B6|African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4211561|NCT00724152|4034978|B5|African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4211562|NCT00724152|4034980|B3|African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4211563|NCT00724152|4034981|B2|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4211564|NCT00724152|4034982|B1|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4211565|NCT00724152|4034977|B6|Caucasian||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4211566|NCT00724152|4034978|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4211567|NCT00724152|4034980|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4211568|NCT00724152|4034981|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4211569|NCT00724152|4034982|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4211570|NCT00724152|4034977|B6|Male||Gender||participants|Number|24|24.0||||||
4211571|NCT00724152|4034978|B5|Male||Gender||participants|Number|1|1.0||||||
4211572|NCT00724152|4034980|B3|Male||Gender||participants|Number|3|3.0||||||
4211573|NCT00724152|4034981|B2|Male||Gender||participants|Number|9|9.0||||||
4211574|NCT00724152|4034982|B1|Male||Gender||participants|Number|11|11.0||||||
4211575|NCT00724152|4034977|B6|Female||Gender||participants|Number|0|0.0||||||
4211576|NCT00724152|4034978|B5|Female||Gender||participants|Number|0|0.0||||||
4211577|NCT00724152|4034980|B3|Female||Gender||participants|Number|0|0.0||||||
4211578|NCT00724152|4034981|B2|Female||Gender||participants|Number|0|0.0||||||
4211579|NCT00724152|4034982|B1|Female||Gender||participants|Number|0|0.0||||||
4211580|NCT00724152|4034977|B6|||Age||years|Mean|64|64.0|Standard Deviation|9.7|9.7|||
4211581|NCT00724152|4034978|B5|||Age||years|Mean|60|60.0|Standard Deviation|0|0.0|||
4211582|NCT00724152|4034980|B3|||Age||years|Mean|63|63.0|Standard Deviation|19.5|19.5|||
4211583|NCT00724152|4034981|B2|||Age||years|Mean|66.4|66.4|Standard Deviation|9.5|9.5|||
4211584|NCT00724152|4034982|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|9.6|9.6|||
4211585|NCT00724126|4034999|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211586|NCT00724126|4035000|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211587|NCT00724126|4035001|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211588|NCT00724126|4034999|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4211589|NCT00724126|4035000|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4211590|NCT00724126|4035001|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211591|NCT00724126|4034999|B3||White|Race (NIH/OMB)||Participants|Count of Participants|584|584.0||||||
4211592|NCT00724126|4035000|B2||White|Race (NIH/OMB)||Participants|Count of Participants|282|282.0||||||
4211593|NCT00724126|4035001|B1||White|Race (NIH/OMB)||Participants|Count of Participants|302|302.0||||||
4211594|NCT00724126|4034999|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4211595|NCT00724126|4035000|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4211596|NCT00724126|4035001|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4211597|NCT00724126|4034999|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4211598|NCT00724126|4035000|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4211599|NCT00724126|4035001|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211600|NCT00724126|4034999|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4211601|NCT00724126|4035000|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4211602|NCT00724126|4035001|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4211603|NCT00724126|4034999|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4211604|NCT00724126|4035000|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4211605|NCT00724126|4035001|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4211606|NCT00724126|4034999|B3||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4211607|NCT00724126|4035000|B2||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4211608|NCT00724126|4035001|B1||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4211609|NCT00724126|4034999|B3||Female|Sex: Female, Male||Participants|Count of Participants|452|452.0||||||
4211610|NCT00724126|4035000|B2||Female|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
4211611|NCT00724126|4035001|B1||Female|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
4211612|NCT00724126|4034999|B3|||Age||years|Mean|46.1|46.1|Standard Deviation|14.2|14.2|||
4211613|NCT00724126|4035000|B2|||Age||years|Mean|45.9|45.9|Standard Deviation|13.9|13.9|||
4211614|NCT00724126|4035001|B1|||Age||years|Mean|46.3|46.3|Standard Deviation|14.6|14.6|||
4211615|NCT00724126|4034999|B3||>=65 years|Age||Participants|Count of Participants|67|67.0||||||
4211616|NCT00724126|4035000|B2||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4211617|NCT00724126|4035001|B1||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
4211618|NCT00724126|4034999|B3||Between 18 and 65 years|Age||Participants|Count of Participants|567|567.0||||||
4211619|NCT00724126|4035000|B2||Between 18 and 65 years|Age||Participants|Count of Participants|285|285.0||||||
4211620|NCT00724126|4035001|B1||Between 18 and 65 years|Age||Participants|Count of Participants|282|282.0||||||
4211621|NCT00724126|4034999|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4211622|NCT00724126|4035000|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4211623|NCT00724126|4035001|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4211624|NCT00724061|4035010|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4211625|NCT00724061|4035010|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4211626|NCT00724061|4035010|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4211627|NCT00724061|4035010|B1|80-89||Age, Customized||participants|Number|0|0.0||||||
4211628|NCT00724061|4035010|B1|70-79||Age, Customized||participants|Number|2|2.0||||||
4211629|NCT00724061|4035010|B1|60-69||Age, Customized||participants|Number|0|0.0||||||
4211630|NCT00724061|4035010|B1|50-59||Age, Customized||participants|Number|2|2.0||||||
4211631|NCT00724061|4035010|B1|40-49||Age, Customized||participants|Number|2|2.0||||||
4211632|NCT00724061|4035010|B1|30-39||Age, Customized||participants|Number|1|1.0||||||
4211633|NCT00724009|4035017|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4211634|NCT00724009|4035017|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4211635|NCT00724009|4035017|B1|||Age||years|Median|51|51.0|Full Range|||23.0|69.0|
4211636|NCT00723957|4035028|B3|βIII tubulin-negative tumors||Number of participants with βIII-tubulin positive and negative tumors||Participants|Number|93|93.0||||||
4211637|NCT00723957|4035029|B2|βIII tubulin-negative tumors||Number of participants with βIII-tubulin positive and negative tumors||Participants|Number|48|48.0||||||
4211638|NCT00723957|4035030|B1|βIII tubulin-negative tumors||Number of participants with βIII-tubulin positive and negative tumors||Participants|Number|45|45.0||||||
4211639|NCT00723957|4035028|B3|βIII tubulin-positive tumors||Number of participants with βIII-tubulin positive and negative tumors||Participants|Number|104|104.0||||||
4211640|NCT00723957|4035029|B2|βIII tubulin-positive tumors||Number of participants with βIII-tubulin positive and negative tumors||Participants|Number|51|51.0||||||
4211641|NCT00723957|4035030|B1|βIII tubulin-positive tumors||Number of participants with βIII-tubulin positive and negative tumors||Participants|Number|53|53.0||||||
4211642|NCT00723957|4035028|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4211643|NCT00723957|4035029|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4211644|NCT00723957|4035030|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4211645|NCT00723957|4035028|B3|White||Race/Ethnicity, Customized||participants|Number|144|144.0||||||
4211646|NCT00723957|4035029|B2|White||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
4211647|NCT00723957|4035030|B1|White||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
4211648|NCT00723957|4035028|B3|Asian||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
4211649|NCT00723957|4035029|B2|Asian||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4211650|NCT00723957|4035030|B1|Asian||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4211651|NCT00723957|4035028|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4211652|NCT00723957|4035029|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4211653|NCT00723957|4035030|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4211654|NCT00723957|4035028|B3||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4211655|NCT00723957|4035029|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4211656|NCT00723957|4035030|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4211657|NCT00723957|4035028|B3|βIII-tubulin negative tumors (N=45, 48)||Age, Customized|Participants with beta III (βIII)-tubulin positive tumors|Years|Median|60.0|60.0|Full Range|||34.0|85.0|
4211658|NCT00723957|4035029|B2|βIII-tubulin negative tumors (N=45, 48)||Age, Customized|Participants with beta III (βIII)-tubulin positive tumors|Years|Median|60.5|60.5|Full Range|||34.0|85.0|
4211659|NCT00723957|4035030|B1|βIII-tubulin negative tumors (N=45, 48)||Age, Customized|Participants with beta III (βIII)-tubulin positive tumors|Years|Median|60.0|60.0|Full Range|||35.0|78.0|
4211660|NCT00723957|4035028|B3|Beta III (βIII)-tubulin positive tumors (n=53, 51)||Age, Customized|Participants with beta III (βIII)-tubulin positive tumors|Years|Median|60.0|60.0|Full Range|||29.0|80.0|
4211661|NCT00723957|4035029|B2|Beta III (βIII)-tubulin positive tumors (n=53, 51)||Age, Customized|Participants with beta III (βIII)-tubulin positive tumors|Years|Median|60.0|60.0|Full Range|||43.0|80.0|
4211662|NCT00723957|4035030|B1|Beta III (βIII)-tubulin positive tumors (n=53, 51)||Age, Customized|Participants with beta III (βIII)-tubulin positive tumors|Years|Median|60.0|60.0|Full Range|||29.0|80.0|
4211663|NCT00723944|4035053|B3|Sweden||Region of Enrollment||participants|Number|9|9.0||||||
4211664|NCT00723944|4035054|B2|Sweden||Region of Enrollment||participants|Number|4|4.0||||||
4211665|NCT00723944|4035055|B1|Sweden||Region of Enrollment||participants|Number|5|5.0||||||
4211666|NCT00723944|4035053|B3|Germany||Region of Enrollment||participants|Number|16|16.0||||||
4211667|NCT00723944|4035054|B2|Germany||Region of Enrollment||participants|Number|8|8.0||||||
4211668|NCT00723944|4035055|B1|Germany||Region of Enrollment||participants|Number|8|8.0||||||
4211669|NCT00723944|4035053|B3|France||Region of Enrollment||participants|Number|11|11.0||||||
4211670|NCT00723944|4035054|B2|France||Region of Enrollment||participants|Number|5|5.0||||||
4211671|NCT00723944|4035055|B1|France||Region of Enrollment||participants|Number|6|6.0||||||
4211672|NCT00723944|4035053|B3|Italy||Region of Enrollment||participants|Number|36|36.0||||||
4211673|NCT00723944|4035054|B2|Italy||Region of Enrollment||participants|Number|17|17.0||||||
4211674|NCT00723944|4035055|B1|Italy||Region of Enrollment||participants|Number|19|19.0||||||
4211675|NCT00723944|4035053|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4211676|NCT00723944|4035054|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4211677|NCT00723944|4035055|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4211678|NCT00723944|4035053|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4211679|NCT00723944|4035054|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4211680|NCT00723944|4035055|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4211681|NCT00723944|4035053|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4211682|NCT00723944|4035054|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4211683|NCT00723944|4035055|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4211684|NCT00723944|4035053|B3||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4211685|NCT00723944|4035054|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4211686|NCT00723944|4035055|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4211687|NCT00723944|4035053|B3||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
4211688|NCT00723944|4035054|B2||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4211689|NCT00723944|4035055|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4211690|NCT00723944|4035053|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4211691|NCT00723944|4035054|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4211692|NCT00723944|4035055|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4211693|NCT00723931|4035062|B1||Male|Sex: Female, Male||Participants|Count of Participants|682|682.0||||||
4211694|NCT00723931|4035062|B1||Female|Sex: Female, Male||Participants|Count of Participants|585|585.0||||||
4211695|NCT00723931|4035062|B1|Between 16 and 80 years||Age, Customized||participants|Number|1267|1267.0||||||
4211696|NCT00723892|4035067|B3|France||Region of Enrollment|Participants foreseen to complete treatment, consulted and assigned to treatment were analyzed.|participants|Number|568|568.0||||||
4211697|NCT00723892|4035068|B2|France||Region of Enrollment|Participants foreseen to complete treatment, consulted and assigned to treatment were analyzed.|participants|Number|255|255.0||||||
4211698|NCT00723892|4035069|B1|France||Region of Enrollment|Participants foreseen to complete treatment, consulted and assigned to treatment were analyzed.|participants|Number|313|313.0||||||
4211699|NCT00723892|4035067|B3|Unavailable (missing data)||Sex/Gender, Customized|Participants foreseen to complete treatment, consulted and assigned to treatment were analyzed.|participants|Number|1|1.0||||||
4211700|NCT00723892|4035068|B2|Unavailable (missing data)||Sex/Gender, Customized|Participants foreseen to complete treatment, consulted and assigned to treatment were analyzed.|participants|Number|0|0.0||||||
4211701|NCT00723892|4035069|B1|Unavailable (missing data)||Sex/Gender, Customized|Participants foreseen to complete treatment, consulted and assigned to treatment were analyzed.|participants|Number|1|1.0||||||
4211702|NCT00723892|4035067|B3|Male||Sex/Gender, Customized|Participants foreseen to complete treatment, consulted and assigned to treatment were analyzed.|participants|Number|370|370.0||||||
4211703|NCT00723892|4035068|B2|Male||Sex/Gender, Customized|Participants foreseen to complete treatment, consulted and assigned to treatment were analyzed.|participants|Number|175|175.0||||||
4211740|NCT00723788|4035107|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4211704|NCT00723892|4035069|B1|Male||Sex/Gender, Customized|Participants foreseen to complete treatment, consulted and assigned to treatment were analyzed.|participants|Number|195|195.0||||||
4211705|NCT00723892|4035067|B3|Female||Sex/Gender, Customized|Participants foreseen to complete treatment, consulted and assigned to treatment were analyzed.|participants|Number|197|197.0||||||
4211706|NCT00723892|4035068|B2|Female||Sex/Gender, Customized|Participants foreseen to complete treatment, consulted and assigned to treatment were analyzed.|participants|Number|80|80.0||||||
4211707|NCT00723892|4035069|B1|Female||Sex/Gender, Customized|Participants foreseen to complete treatment, consulted and assigned to treatment were analyzed.|participants|Number|117|117.0||||||
4211708|NCT00723892|4035067|B3|||Age|Participants foreseen to complete treatment, consulted and assigned to treatment were analyzed.|years|Mean|46.8|46.8|Standard Deviation|11.3|11.3|||
4211709|NCT00723892|4035068|B2|||Age|Participants foreseen to complete treatment, consulted and assigned to treatment were analyzed.|years|Mean|48.5|48.5|Standard Deviation|11.8|11.8|||
4211710|NCT00723892|4035069|B1|||Age|Participants foreseen to complete treatment, consulted and assigned to treatment were analyzed.|years|Mean|45.5|45.5|Standard Deviation|10.7|10.7|||
4211711|NCT00723840|4035077|B1|Italy||Region of Enrollment||participants|Number|162|162.0||||||
4211712|NCT00723840|4035077|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4211713|NCT00723840|4035077|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4211714|NCT00723840|4035077|B1|>=65 years||Age, Customized|Baseline characteristics for participants included in the pharmacoeconomic analysis. Of the enrolled population, a total of 82 subjects interrupted the study prematurely. In addition, for one participant, the age and sex were not available. These participants were not included in the pharmacoeconomic analysis. Therefore, the number of participants analyzed for this study is 162.|participants|Number|12|12.0||||||
4211715|NCT00723840|4035077|B1|Between 45 and 64 years||Age, Customized|Baseline characteristics for participants included in the pharmacoeconomic analysis. Of the enrolled population, a total of 82 subjects interrupted the study prematurely. In addition, for one participant, the age and sex were not available. These participants were not included in the pharmacoeconomic analysis. Therefore, the number of participants analyzed for this study is 162.|participants|Number|61|61.0||||||
4211716|NCT00723840|4035077|B1|Between 35 and 44 years||Age, Customized|Baseline characteristics for participants included in the pharmacoeconomic analysis. Of the enrolled population, a total of 82 subjects interrupted the study prematurely. In addition, for one participant, the age and sex were not available. These participants were not included in the pharmacoeconomic analysis. Therefore, the number of participants analyzed for this study is 162.|participants|Number|43|43.0||||||
4211717|NCT00723840|4035077|B1|Between 18 and 34 years||Age, Customized|Baseline characteristics for participants included in the pharmacoeconomic analysis. Of the enrolled population, a total of 82 subjects interrupted the study prematurely. In addition, for one participant, the age and sex were not available. These participants were not included in the pharmacoeconomic analysis. Therefore, the number of participants analyzed for this study is 162.|participants|Number|46|46.0||||||
4211718|NCT00723840|4035077|B1|<18 years||Age, Customized|Baseline characteristics for participants included in the pharmacoeconomic analysis. Of the enrolled population, a total of 82 subjects interrupted the study prematurely. In addition, for one participant, the age and sex were not available. These participants were not included in the pharmacoeconomic analysis. Therefore, the number of participants analyzed for this study is 162.|participants|Number|0|0.0||||||
4211719|NCT00723827|4035088|B1|Korea, Republic Of||Region of Enrollment||participants|Number|682|682.0||||||
4211720|NCT00723827|4035088|B1||Male|Sex: Female, Male||Participants|Count of Participants|385|385.0||||||
4211721|NCT00723827|4035088|B1||Female|Sex: Female, Male||Participants|Count of Participants|297|297.0||||||
4211722|NCT00723827|4035088|B1|||Age||years|Mean|53.57|53.57|Standard Deviation|13.86|13.86|||
4211723|NCT00723801|4035096|B3|||Ejection Fraction|Ejection Fraction is a measurement of how much blood volume is ejected from the left ventricle with each contraction. It is a measure of how effectively the heart is pumping blood.|%|Mean|61|61.0|Standard Deviation|5|5.0|||
4211724|NCT00723801|4035097|B2|||Ejection Fraction|Ejection Fraction is a measurement of how much blood volume is ejected from the left ventricle with each contraction. It is a measure of how effectively the heart is pumping blood.|%|Mean|62|62.0|Standard Deviation|6|6.0|||
4211725|NCT00723801|4035098|B1|||Ejection Fraction|Ejection Fraction is a measurement of how much blood volume is ejected from the left ventricle with each contraction. It is a measure of how effectively the heart is pumping blood.|%|Mean|60|60.0|Standard Deviation|4|4.0|||
4211726|NCT00723801|4035096|B3|||Pulse wave velocity|Pulse Wave Velocity is a measure of arterial stiffness that is a well-characterized indicator of cardiovascular risk.|meters/second|Mean|7.55|7.55|Standard Deviation|2.0|2.0|||
4211727|NCT00723801|4035097|B2|||Pulse wave velocity|Pulse Wave Velocity is a measure of arterial stiffness that is a well-characterized indicator of cardiovascular risk.|meters/second|Mean|7.6|7.6|Standard Deviation|2.4|2.4|||
4211728|NCT00723801|4035098|B1|||Pulse wave velocity|Pulse Wave Velocity is a measure of arterial stiffness that is a well-characterized indicator of cardiovascular risk.|meters/second|Mean|7.5|7.5|Standard Deviation|1.6|1.6|||
4211729|NCT00723801|4035096|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4211730|NCT00723801|4035097|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4211731|NCT00723801|4035098|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4211732|NCT00723801|4035096|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4211733|NCT00723801|4035097|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4211734|NCT00723801|4035098|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4211735|NCT00723801|4035096|B3|||Age||years|Median|35|35.0|Inter-Quartile Range|||27.0|45.0|
4211736|NCT00723801|4035097|B2|||Age||years|Median|36|36.0|Inter-Quartile Range|||31.0|44.0|
4211737|NCT00723801|4035098|B1|||Age||years|Median|34|34.0|Inter-Quartile Range|||25.0|45.0|
4211738|NCT00723788|4035107|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4211739|NCT00723788|4035107|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4211741|NCT00723788|4035107|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4211742|NCT00723788|4035107|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4211743|NCT00723788|4035107|B1||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
4211744|NCT00723749|4035113|B1|Germany||Region of Enrollment||participants|Number|345|345.0||||||
4211745|NCT00723749|4035113|B1||Male|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
4211746|NCT00723749|4035113|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4211747|NCT00723749|4035113|B1|||Age||years|Mean|35.2|35.2|Standard Deviation|8.9|8.9|||
4211748|NCT00723736|4035120|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4211749|NCT00723736|4035120|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4211750|NCT00723736|4035120|B1|||Age||years|Mean|3.1|3.1|Standard Deviation|1.2|1.2|||
4211751|NCT00723710|4035124|B1||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4211752|NCT00723710|4035124|B1||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4211753|NCT00723710|4035124|B1|||Age||years|Median|52|52.0|Full Range|||19.0|78.0|
4211754|NCT00723697|4035128|B1||Male|Sex: Female, Male|A total of 880 patients returned a Day 1 self-questionnaire; 879 patients had identified gender.|Participants|Count of Participants|687|687.0||||||
4211755|NCT00723697|4035128|B1||Female|Sex: Female, Male|A total of 880 patients returned a Day 1 self-questionnaire; 879 patients had identified gender.|Participants|Count of Participants|192|192.0||||||
4211756|NCT00723697|4035128|B1|||Age|A total of 880 patients returned a Day 1 self-questionnaire; only 824 patients had identifiable ages.|years|Mean|34.70|34.7|Full Range|||14.0|70.0|
4211757|NCT00723645|4035136|B1||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4211758|NCT00723645|4035136|B1||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4211759|NCT00723645|4035136|B1|||Age||years|Mean|45.72|45.72|Standard Deviation|9.94|9.94|||
4211760|NCT00723632|4035141|B1||Male|Sex: Female, Male|Gender is reported for participants in the analysis population|Participants|Count of Participants|398|398.0||||||
4211761|NCT00723632|4035141|B1||Female|Sex: Female, Male|Gender is reported for participants in the analysis population|Participants|Count of Participants|300|300.0||||||
4211762|NCT00723632|4035141|B1|||Age|Age is reported for participants in the analysis population|years|Mean|38|38.0|Full Range|||18.0|80.0|
4211763|NCT00723606|4035147|B3||Male|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4211764|NCT00723606|4035148|B2||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4211765|NCT00723606|4035149|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4211766|NCT00723606|4035147|B3||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4211767|NCT00723606|4035148|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4211768|NCT00723606|4035149|B1||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4211769|NCT00723606|4035147|B3|> = 65 years||Age, Customized||participants|Number|0|0.0||||||
4211770|NCT00723606|4035148|B2|> = 65 years||Age, Customized||participants|Number|0|0.0||||||
4211771|NCT00723606|4035149|B1|> = 65 years||Age, Customized||participants|Number|0|0.0||||||
4211772|NCT00723606|4035147|B3|45 to 64 years||Age, Customized||participants|Number|56|56.0||||||
4211773|NCT00723606|4035148|B2|45 to 64 years||Age, Customized||participants|Number|28|28.0||||||
4211774|NCT00723606|4035149|B1|45 to 64 years||Age, Customized||participants|Number|28|28.0||||||
4211775|NCT00723606|4035147|B3|18 to 44 years||Age, Customized||participants|Number|318|318.0||||||
4211776|NCT00723606|4035148|B2|18 to 44 years||Age, Customized||participants|Number|157|157.0||||||
4211777|NCT00723606|4035149|B1|18 to 44 years||Age, Customized||participants|Number|161|161.0||||||
4211778|NCT00723606|4035147|B3|< 18 years||Age, Customized||participants|Number|2|2.0||||||
4211779|NCT00723606|4035148|B2|< 18 years||Age, Customized||participants|Number|2|2.0||||||
4211780|NCT00723606|4035149|B1|< 18 years||Age, Customized||participants|Number|0|0.0||||||
4211781|NCT00723580|4035166|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4211782|NCT00723580|4035166|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4211783|NCT00723580|4035166|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4211784|NCT00723580|4035166|B1|||Age||years|Mean|6|6.0|Standard Deviation|0|0.0|||
4211785|NCT00723580|4035166|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4211786|NCT00723580|4035166|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4211787|NCT00723580|4035166|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4211788|NCT00723554|4035170|B1|United States||Region of Enrollment||participants|Number|63|63.0||||||
4211789|NCT00723554|4035170|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4211790|NCT00723554|4035170|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4211791|NCT00723554|4035170|B1|||Age||years|Mean|59.9|59.9|Standard Deviation|12.91|12.91|||
4211792|NCT00723554|4035170|B1||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4211793|NCT00723554|4035170|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4211794|NCT00723554|4035170|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4211795|NCT00723528|4035217|B4||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4211796|NCT00723528|4035218|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4211797|NCT00723528|4035219|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4211798|NCT00723528|4035220|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4211799|NCT00723528|4035217|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4211800|NCT00723528|4035218|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4211801|NCT00723528|4035219|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4211802|NCT00723528|4035220|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4211803|NCT00723528|4035217|B4|||Age||Years|Mean|47.0|47.0|Standard Deviation|12.6|12.6|||
4211804|NCT00723528|4035218|B3|||Age||Years|Mean|46.8|46.8|Standard Deviation|12.8|12.8|||
4211805|NCT00723528|4035219|B2|||Age||Years|Mean|46.6|46.6|Standard Deviation|12.5|12.5|||
4211806|NCT00723528|4035220|B1|||Age||Years|Mean|48.5|48.5|Standard Deviation|12.7|12.7|||
4211807|NCT00723489|4035284|B5|||Percent Eosinophils in Blood|Eosinophils are a type of immune cell that has granules (small particles) with enzymes that are released during infections, allergic reactions, and asthma. An eosinophil is a type of white blood cell. Normal Reference Range: 0.0% – 7.0%.|Percent Eosinophils|Mean|3.1|3.1|Standard Deviation|2.4|2.4|||
4211808|NCT00723489|4035285|B4|||Percent Eosinophils in Blood|Eosinophils are a type of immune cell that has granules (small particles) with enzymes that are released during infections, allergic reactions, and asthma. An eosinophil is a type of white blood cell. Normal Reference Range: 0.0% – 7.0%.|Percent Eosinophils|Mean|3.8|3.8|Standard Deviation|3.2|3.2|||
4211809|NCT00723489|4035286|B3|||Percent Eosinophils in Blood|Eosinophils are a type of immune cell that has granules (small particles) with enzymes that are released during infections, allergic reactions, and asthma. An eosinophil is a type of white blood cell. Normal Reference Range: 0.0% – 7.0%.|Percent Eosinophils|Mean|2.4|2.4|Standard Deviation|2.0|2.0|||
4211810|NCT00723489|4035287|B2|||Percent Eosinophils in Blood|Eosinophils are a type of immune cell that has granules (small particles) with enzymes that are released during infections, allergic reactions, and asthma. An eosinophil is a type of white blood cell. Normal Reference Range: 0.0% – 7.0%.|Percent Eosinophils|Mean|3.7|3.7|Standard Deviation|2.1|2.1|||
4211811|NCT00723489|4035288|B1|||Percent Eosinophils in Blood|Eosinophils are a type of immune cell that has granules (small particles) with enzymes that are released during infections, allergic reactions, and asthma. An eosinophil is a type of white blood cell. Normal Reference Range: 0.0% – 7.0%.|Percent Eosinophils|Mean|2.6|2.6|Standard Deviation|1.9|1.9|||
4211812|NCT00723489|4035284|B5|||Total Serum Immunoglobulin E (IgE; kU/L)|Total amount of IgE in the blood, which is a measurement of allergen sensitization. Higher IgE is indicative of greater allergen sensitization. There is no “normal” level for total serum IgE since a wide overlap exists between the total serum IgE in healthy non-allergic and allergic individuals.|kU/L|Mean|1006.0|1006.0|Standard Deviation|4646.1|4646.1|||
4211813|NCT00723489|4035285|B4|||Total Serum Immunoglobulin E (IgE; kU/L)|Total amount of IgE in the blood, which is a measurement of allergen sensitization. Higher IgE is indicative of greater allergen sensitization. There is no “normal” level for total serum IgE since a wide overlap exists between the total serum IgE in healthy non-allergic and allergic individuals.|kU/L|Mean|2742.1|2742.1|Standard Deviation|8262.5|8262.5|||
4211814|NCT00723489|4035286|B3|||Total Serum Immunoglobulin E (IgE; kU/L)|Total amount of IgE in the blood, which is a measurement of allergen sensitization. Higher IgE is indicative of greater allergen sensitization. There is no “normal” level for total serum IgE since a wide overlap exists between the total serum IgE in healthy non-allergic and allergic individuals.|kU/L|Mean|73.6|73.6|Standard Deviation|115.7|115.7|||
4211815|NCT00723489|4035287|B2|||Total Serum Immunoglobulin E (IgE; kU/L)|Total amount of IgE in the blood, which is a measurement of allergen sensitization. Higher IgE is indicative of greater allergen sensitization. There is no “normal” level for total serum IgE since a wide overlap exists between the total serum IgE in healthy non-allergic and allergic individuals.|kU/L|Mean|1166.4|1166.4|Standard Deviation|3609.5|3609.5|||
4211816|NCT00723489|4035288|B1|||Total Serum Immunoglobulin E (IgE; kU/L)|Total amount of IgE in the blood, which is a measurement of allergen sensitization. Higher IgE is indicative of greater allergen sensitization. There is no “normal” level for total serum IgE since a wide overlap exists between the total serum IgE in healthy non-allergic and allergic individuals.|kU/L|Mean|35.4|35.4|Standard Deviation|40.3|40.3|||
4211817|NCT00723489|4035284|B5|United States||Region of Enrollment||participants|Number|74|74.0||||||
4211818|NCT00723489|4035285|B4|United States||Region of Enrollment||participants|Number|20|20.0||||||
4211819|NCT00723489|4035286|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4211820|NCT00723489|4035287|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4211821|NCT00723489|4035288|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4211822|NCT00723489|4035284|B5||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4211823|NCT00723489|4035285|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4211824|NCT00723489|4035286|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4211825|NCT00723489|4035287|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4211826|NCT00723489|4035288|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4211827|NCT00723489|4035284|B5||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4211828|NCT00723489|4035285|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4211829|NCT00723489|4035286|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4211830|NCT00723489|4035287|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4211831|NCT00723489|4035288|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4211832|NCT00723489|4035284|B5|||Age||years|Mean|33.3|33.3|Standard Deviation|4.9|4.9|||
4211833|NCT00723489|4035285|B4|||Age||years|Mean|32.8|32.8|Standard Deviation|4.3|4.3|||
4211834|NCT00723489|4035286|B3|||Age||years|Mean|33.9|33.9|Standard Deviation|4.7|4.7|||
4211835|NCT00723489|4035287|B2|||Age||years|Mean|34.7|34.7|Standard Deviation|6.2|6.2|||
4211836|NCT00723489|4035288|B1|||Age||years|Mean|32.0|32.0|Standard Deviation|4.5|4.5|||
4211837|NCT00723450|4035317|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4211838|NCT00723450|4035318|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4211839|NCT00723450|4035319|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4211840|NCT00723450|4035317|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|142|142.0||||||
4211841|NCT00723450|4035318|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|71|71.0||||||
4211842|NCT00723450|4035319|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|71|71.0||||||
4211843|NCT00723450|4035317|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4211844|NCT00723450|4035318|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4211845|NCT00723450|4035319|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4211846|NCT00723450|4035317|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4211847|NCT00723450|4035318|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4211848|NCT00723450|4035319|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4211849|NCT00723450|4035317|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4211850|NCT00723450|4035318|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4211851|NCT00723450|4035319|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4211852|NCT00723450|4035317|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4211853|NCT00723450|4035318|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4211854|NCT00723450|4035319|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4211855|NCT00723450|4035317|B3||Male|Gender||Participants|Count of Participants|101|101.0||||||
4211856|NCT00723450|4035318|B2||Male|Gender||Participants|Count of Participants|54|54.0||||||
4211857|NCT00723450|4035319|B1||Male|Gender||Participants|Count of Participants|47|47.0||||||
4211858|NCT00723450|4035317|B3||Female|Gender||Participants|Count of Participants|72|72.0||||||
4211859|NCT00723450|4035318|B2||Female|Gender||Participants|Count of Participants|33|33.0||||||
4211860|NCT00723450|4035319|B1||Female|Gender||Participants|Count of Participants|39|39.0||||||
4211861|NCT00723450|4035317|B3|||Age||Years|Mean|13.5|13.5|Standard Deviation|2.27|2.27|||
4211862|NCT00723450|4035318|B2|||Age||Years|Mean|13.4|13.4|Standard Deviation|2.33|2.33|||
4211863|NCT00723450|4035319|B1|||Age||Years|Mean|13.5|13.5|Standard Deviation|2.22|2.22|||
4211864|NCT00723398|4035362|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211865|NCT00723398|4035363|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211866|NCT00723398|4035364|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211867|NCT00723398|4035365|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211868|NCT00723398|4035366|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211869|NCT00723398|4035367|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211870|NCT00723398|4035362|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211871|NCT00723398|4035363|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211872|NCT00723398|4035364|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211873|NCT00723398|4035365|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211874|NCT00723398|4035366|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211875|NCT00723398|4035367|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211876|NCT00723398|4035362|B6||White|Race (NIH/OMB)||Participants|Count of Participants|259|259.0||||||
4211877|NCT00723398|4035363|B5||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4211878|NCT00723398|4035364|B4||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4211879|NCT00723398|4035365|B3||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4211880|NCT00723398|4035366|B2||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4211881|NCT00723398|4035367|B1||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4211882|NCT00723398|4035362|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4211883|NCT00723398|4035363|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211884|NCT00723398|4035364|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4211885|NCT00723398|4035365|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4211886|NCT00723398|4035366|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4211887|NCT00723398|4035367|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4211888|NCT00723398|4035362|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4211889|NCT00723398|4035363|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211890|NCT00723398|4035364|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4211891|NCT00723398|4035365|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211892|NCT00723398|4035366|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211893|NCT00723398|4035367|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211894|NCT00723398|4035362|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4211895|NCT00723398|4035363|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211896|NCT00723398|4035364|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4211897|NCT00723398|4035365|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211898|NCT00723398|4035366|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211899|NCT00723398|4035367|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4211900|NCT00723398|4035362|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211901|NCT00723398|4035363|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211902|NCT00723398|4035364|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211903|NCT00723398|4035365|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211904|NCT00723398|4035366|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211905|NCT00723398|4035367|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211906|NCT00723398|4035362|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211907|NCT00723398|4035363|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211908|NCT00723398|4035364|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211909|NCT00723398|4035365|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211910|NCT00723398|4035366|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211911|NCT00723398|4035367|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211912|NCT00723398|4035362|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|264|264.0||||||
4211913|NCT00723398|4035363|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4211914|NCT00723398|4035364|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4211915|NCT00723398|4035365|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4211916|NCT00723398|4035366|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4211917|NCT00723398|4035367|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4211918|NCT00723398|4035362|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4211919|NCT00723398|4035363|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211920|NCT00723398|4035364|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4211921|NCT00723398|4035365|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211922|NCT00723398|4035366|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211923|NCT00723398|4035367|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4211924|NCT00723398|4035362|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4211925|NCT00723398|4035363|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4211926|NCT00723398|4035364|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4211927|NCT00723398|4035365|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4211928|NCT00723398|4035366|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4211929|NCT00723398|4035367|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4211930|NCT00723398|4035362|B6||Female|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
4211931|NCT00723398|4035363|B5||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4211932|NCT00723398|4035364|B4||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4211933|NCT00723398|4035365|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4211934|NCT00723398|4035366|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4211935|NCT00723398|4035367|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4211936|NCT00723398|4035362|B6||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
4211937|NCT00723398|4035363|B5||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4211938|NCT00723398|4035364|B4||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4211939|NCT00723398|4035365|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4211940|NCT00723398|4035366|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4211941|NCT00723398|4035367|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4211942|NCT00723398|4035362|B6||Between 18 and 65 years|Age||Participants|Count of Participants|231|231.0||||||
4211943|NCT00723398|4035363|B5||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4211944|NCT00723398|4035364|B4||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4211945|NCT00723398|4035365|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4211946|NCT00723398|4035366|B2||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4211947|NCT00723398|4035367|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4211948|NCT00723398|4035362|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4211949|NCT00723398|4035363|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4211950|NCT00723398|4035364|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4211951|NCT00723398|4035365|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4211952|NCT00723398|4035366|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4211953|NCT00723398|4035367|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4211954|NCT00723294|4035433|B1|United States||Region of Enrollment||participants|Number|86|86.0||||||
4211955|NCT00723294|4035433|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4211956|NCT00723294|4035433|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4211957|NCT00723294|4035433|B1|||Age||years|Median|62|62.0|Full Range|||42.0|81.0|
4211958|NCT00723255|4035438|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4211959|NCT00723255|4035438|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4211960|NCT00723255|4035438|B1|80-89 years||Age, Customized||participants|Number|1|1.0||||||
4211961|NCT00723255|4035438|B1|70-79 years||Age, Customized||participants|Number|11|11.0||||||
4211962|NCT00723255|4035438|B1|60-69 years||Age, Customized||participants|Number|21|21.0||||||
4211963|NCT00723255|4035438|B1|50-59 years||Age, Customized||participants|Number|11|11.0||||||
4211964|NCT00723255|4035438|B1|40-49 years||Age, Customized||participants|Number|4|4.0||||||
4211965|NCT00723255|4035438|B1|30-39 years||Age, Customized||participants|Number|1|1.0||||||
4211966|NCT00723255|4035438|B1|20-29 years||Age, Customized||participants|Number|0|0.0||||||
4211967|NCT00723229|4035463|B3|HIV seronegative||HIV serostatus||Participants|Number|32|32.0||||||
4211968|NCT00723229|4035464|B2|HIV seronegative||HIV serostatus||Participants|Number|16|16.0||||||
4211969|NCT00723229|4035465|B1|HIV seronegative||HIV serostatus||Participants|Number|16|16.0||||||
4211970|NCT00723229|4035463|B3|HIV seropositive||HIV serostatus||Participants|Number|16|16.0||||||
4211971|NCT00723229|4035464|B2|HIV seropositive||HIV serostatus||Participants|Number|7|7.0||||||
4211972|NCT00723229|4035465|B1|HIV seropositive||HIV serostatus||Participants|Number|9|9.0||||||
4211973|NCT00723229|4035463|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211974|NCT00723229|4035464|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211975|NCT00723229|4035465|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211976|NCT00723229|4035463|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4211977|NCT00723229|4035464|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4211978|NCT00723229|4035465|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4211979|NCT00723229|4035463|B3||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4211980|NCT00723229|4035464|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4211981|NCT00723229|4035465|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4211982|NCT00723229|4035463|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4211983|NCT00723229|4035464|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4211984|NCT00723229|4035465|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4211985|NCT00723229|4035463|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211986|NCT00723229|4035464|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211987|NCT00723229|4035465|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211988|NCT00723229|4035463|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211989|NCT00723229|4035464|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211990|NCT00723229|4035465|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211991|NCT00723229|4035463|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211992|NCT00723229|4035464|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211993|NCT00723229|4035465|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4211994|NCT00723229|4035463|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4211995|NCT00723229|4035464|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4211996|NCT00723229|4035465|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4211997|NCT00723229|4035463|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4211998|NCT00723229|4035464|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4211999|NCT00723229|4035465|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4212000|NCT00723229|4035463|B3|||Age||years|Mean|44.4|44.4|Standard Deviation|12.7|12.7|||
4212001|NCT00723229|4035464|B2|||Age||years|Mean|42.1|42.1|Standard Deviation|13.1|13.1|||
4212002|NCT00723229|4035465|B1|||Age||years|Mean|46.6|46.6|Standard Deviation|12.3|12.3|||
4212003|NCT00723203|4035478|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4212004|NCT00723203|4035478|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4212005|NCT00723203|4035478|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4212006|NCT00723203|4035478|B1|||Age||years|Median|57|57.0|Full Range|||19.0|81.0|
4212007|NCT00723190|4035482|B1|||Weight|Data collected from 291 participants|Kilograms|Median|38.1|38.1|Full Range|||19.6|131.0|
4212008|NCT00723190|4035482|B1|||Weight|Data collected from 291 participants|Kilograms|Mean|42.3|42.3|Standard Deviation|18.94|18.94|||
4212009|NCT00723190|4035482|B1|Other||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
4212010|NCT00723190|4035482|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
4212011|NCT00723190|4035482|B1|Black/African American||Race/Ethnicity, Customized||Participants|Number|69|69.0||||||
4212012|NCT00723190|4035482|B1|White||Race/Ethnicity, Customized||Participants|Number|186|186.0||||||
4212072|NCT00723073|4035527|B2|Hematopoietic stem cell transplantation||hematopoietic stem cell transplantation status||participants|Number|108|108.0||||||
4212013|NCT00723190|4035482|B1||Male|Sex: Female, Male|Baseline characteristics are presented for the subjects in the safety population (total 301 participants)|Participants|Count of Participants|221|221.0||||||
4212014|NCT00723190|4035482|B1||Female|Sex: Female, Male|Baseline characteristics are presented for the subjects in the safety population (total 301 participants)|Participants|Count of Participants|80|80.0||||||
4212015|NCT00723190|4035482|B1|> 12-17 Years||Age, Customized||Participants|Number|62|62.0||||||
4212016|NCT00723190|4035482|B1|6-12 Years||Age, Customized||Participants|Number|239|239.0||||||
4212017|NCT00723190|4035482|B1|||Age||Years|Median|10.0|10.0|Full Range|||6.0|17.0|
4212018|NCT00723190|4035482|B1|||Age||Years|Mean|10.1|10.1|Standard Deviation|2.75|2.75|||
4212019|NCT00723177|4035497|B4|United States||Region of Enrollment||participants|Number|44|44.0||||||
4212020|NCT00723177|4035498|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4212021|NCT00723177|4035499|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4212022|NCT00723177|4035500|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4212023|NCT00723177|4035497|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4212024|NCT00723177|4035498|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4212025|NCT00723177|4035499|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4212026|NCT00723177|4035500|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4212027|NCT00723177|4035497|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4212028|NCT00723177|4035498|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4212029|NCT00723177|4035499|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4212030|NCT00723177|4035500|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4212031|NCT00723177|4035497|B4|||Age||Year|Mean|38|38.0|Standard Deviation|4.8|4.8|||
4212032|NCT00723177|4035498|B3|||Age||Year|Mean|38|38.0|Standard Deviation|4.3|4.3|||
4212033|NCT00723177|4035499|B2|||Age||Year|Mean|38|38.0|Standard Deviation|5.3|5.3|||
4212034|NCT00723177|4035500|B1|||Age||Year|Mean|39|39.0|Standard Deviation|4.5|4.5|||
4212035|NCT00723177|4035497|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4212036|NCT00723177|4035498|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4212037|NCT00723177|4035499|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4212038|NCT00723177|4035500|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4212039|NCT00723177|4035497|B4||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4212040|NCT00723177|4035498|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4212041|NCT00723177|4035499|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4212042|NCT00723177|4035500|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4212043|NCT00723177|4035497|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212044|NCT00723177|4035498|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212045|NCT00723177|4035499|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212046|NCT00723177|4035500|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212047|NCT00723125|4035513|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4212048|NCT00723125|4035514|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4212049|NCT00723125|4035515|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4212050|NCT00723125|4035513|B3|Female||Sex/Gender, Customized||participants|Number|60|60.0||||||
4212051|NCT00723125|4035514|B2|Female||Sex/Gender, Customized||participants|Number|27|27.0||||||
4212052|NCT00723125|4035515|B1|Female||Sex/Gender, Customized||participants|Number|33|33.0||||||
4212053|NCT00723125|4035513|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4212054|NCT00723125|4035514|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4212055|NCT00723125|4035515|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4212056|NCT00723125|4035513|B3||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4212057|NCT00723125|4035514|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4212058|NCT00723125|4035515|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4212059|NCT00723125|4035513|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212060|NCT00723125|4035514|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212061|NCT00723125|4035515|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212062|NCT00723125|4035513|B3|||Age||years|Mean|46.8|46.8|Full Range|||25.0|68.0|
4212063|NCT00723125|4035514|B2|||Age||years|Mean|45.8|45.8|Full Range|||28.0|63.0|
4212064|NCT00723125|4035515|B1|||Age||years|Mean|47.6|47.6|Full Range|||25.0|68.0|
4212065|NCT00723073|4035526|B3|||Patient Weight, kg||kilograms|Median|80|80.0|Inter-Quartile Range|||65.0|95.0|
4212066|NCT00723073|4035527|B2|||Patient Weight, kg||kilograms|Median|80|80.0|Inter-Quartile Range|||65.0|95.0|
4212067|NCT00723073|4035528|B1|||Patient Weight, kg||kilograms|Median|80|80.0|Inter-Quartile Range|||67.0|89.0|
4212068|NCT00723073|4035526|B3|No - Hematopoietic stem cell transplantation||hematopoietic stem cell transplantation status||participants|Number|134|134.0||||||
4212069|NCT00723073|4035527|B2|No - Hematopoietic stem cell transplantation||hematopoietic stem cell transplantation status||participants|Number|66|66.0||||||
4212070|NCT00723073|4035528|B1|No - Hematopoietic stem cell transplantation||hematopoietic stem cell transplantation status||participants|Number|68|68.0||||||
4212071|NCT00723073|4035526|B3|Hematopoietic stem cell transplantation||hematopoietic stem cell transplantation status||participants|Number|189|189.0||||||
4212126|NCT00723008|4035611|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4212073|NCT00723073|4035528|B1|Hematopoietic stem cell transplantation||hematopoietic stem cell transplantation status||participants|Number|81|81.0||||||
4212074|NCT00723073|4035526|B3|other onocological diagnosis||Primary Underlying Disease|primary oncological diagnosis|participants|Number|15|15.0||||||
4212075|NCT00723073|4035527|B2|other onocological diagnosis||Primary Underlying Disease|primary oncological diagnosis|participants|Number|7|7.0||||||
4212076|NCT00723073|4035528|B1|other onocological diagnosis||Primary Underlying Disease|primary oncological diagnosis|participants|Number|8|8.0||||||
4212077|NCT00723073|4035526|B3|Aplastic anemia||Primary Underlying Disease|primary oncological diagnosis|participants|Number|8|8.0||||||
4212078|NCT00723073|4035527|B2|Aplastic anemia||Primary Underlying Disease|primary oncological diagnosis|participants|Number|5|5.0||||||
4212079|NCT00723073|4035528|B1|Aplastic anemia||Primary Underlying Disease|primary oncological diagnosis|participants|Number|3|3.0||||||
4212080|NCT00723073|4035526|B3|Myelodysplastic syndrome||Primary Underlying Disease|primary oncological diagnosis|participants|Number|12|12.0||||||
4212081|NCT00723073|4035527|B2|Myelodysplastic syndrome||Primary Underlying Disease|primary oncological diagnosis|participants|Number|7|7.0||||||
4212082|NCT00723073|4035528|B1|Myelodysplastic syndrome||Primary Underlying Disease|primary oncological diagnosis|participants|Number|5|5.0||||||
4212083|NCT00723073|4035526|B3|Multiple myeloma||Primary Underlying Disease|primary oncological diagnosis|participants|Number|14|14.0||||||
4212084|NCT00723073|4035527|B2|Multiple myeloma||Primary Underlying Disease|primary oncological diagnosis|participants|Number|8|8.0||||||
4212085|NCT00723073|4035528|B1|Multiple myeloma||Primary Underlying Disease|primary oncological diagnosis|participants|Number|6|6.0||||||
4212086|NCT00723073|4035526|B3|Chronic myelogenous leukemia||Primary Underlying Disease|primary oncological diagnosis|participants|Number|14|14.0||||||
4212087|NCT00723073|4035527|B2|Chronic myelogenous leukemia||Primary Underlying Disease|primary oncological diagnosis|participants|Number|8|8.0||||||
4212088|NCT00723073|4035528|B1|Chronic myelogenous leukemia||Primary Underlying Disease|primary oncological diagnosis|participants|Number|6|6.0||||||
4212089|NCT00723073|4035526|B3|Hodgkin's lymphoma||Primary Underlying Disease|primary oncological diagnosis|participants|Number|20|20.0||||||
4212090|NCT00723073|4035527|B2|Hodgkin's lymphoma||Primary Underlying Disease|primary oncological diagnosis|participants|Number|12|12.0||||||
4212091|NCT00723073|4035528|B1|Hodgkin's lymphoma||Primary Underlying Disease|primary oncological diagnosis|participants|Number|8|8.0||||||
4212092|NCT00723073|4035526|B3|Acute lymphoblastic leukemia||Primary Underlying Disease|primary oncological diagnosis|participants|Number|29|29.0||||||
4212093|NCT00723073|4035527|B2|Acute lymphoblastic leukemia||Primary Underlying Disease|primary oncological diagnosis|participants|Number|20|20.0||||||
4212094|NCT00723073|4035528|B1|Acute lymphoblastic leukemia||Primary Underlying Disease|primary oncological diagnosis|participants|Number|9|9.0||||||
4212095|NCT00723073|4035526|B3|Non-Hodgkin's lymphoma||Primary Underlying Disease|primary oncological diagnosis|participants|Number|53|53.0||||||
4212096|NCT00723073|4035527|B2|Non-Hodgkin's lymphoma||Primary Underlying Disease|primary oncological diagnosis|participants|Number|25|25.0||||||
4212097|NCT00723073|4035528|B1|Non-Hodgkin's lymphoma||Primary Underlying Disease|primary oncological diagnosis|participants|Number|28|28.0||||||
4212098|NCT00723073|4035526|B3|Acute myelogenous leukemia||Primary Underlying Disease|primary oncological diagnosis|participants|Number|158|158.0||||||
4212099|NCT00723073|4035527|B2|Acute myelogenous leukemia||Primary Underlying Disease|primary oncological diagnosis|participants|Number|82|82.0||||||
4212100|NCT00723073|4035528|B1|Acute myelogenous leukemia||Primary Underlying Disease|primary oncological diagnosis|participants|Number|76|76.0||||||
4212101|NCT00723073|4035526|B3||Male|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4212102|NCT00723073|4035527|B2||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4212103|NCT00723073|4035528|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4212104|NCT00723073|4035526|B3||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4212105|NCT00723073|4035527|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4212106|NCT00723073|4035528|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4212107|NCT00723073|4035526|B3|||Age||years|Median|49|49.0|Inter-Quartile Range|||39.0|58.0|
4212108|NCT00723073|4035527|B2|||Age||years|Median|49|49.0|Inter-Quartile Range|||40.0|58.0|
4212109|NCT00723073|4035528|B1|||Age||years|Median|49|49.0|Inter-Quartile Range|||39.0|58.0|
4212110|NCT00723021|4035553|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4212111|NCT00723021|4035553|B1|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4212112|NCT00723021|4035553|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4212113|NCT00723021|4035553|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4212114|NCT00723021|4035553|B1|||Age||years|Mean|33.5|33.5|Standard Deviation|9.7|9.7|||
4212115|NCT00723008|4035609|B3|Other, not specified||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4212116|NCT00723008|4035610|B2|Other, not specified||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4212117|NCT00723008|4035611|B1|Other, not specified||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4212118|NCT00723008|4035609|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4212119|NCT00723008|4035610|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4212120|NCT00723008|4035611|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4212121|NCT00723008|4035609|B3|African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4212122|NCT00723008|4035610|B2|African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4212123|NCT00723008|4035611|B1|African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4212124|NCT00723008|4035609|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4212125|NCT00723008|4035610|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4212127|NCT00723008|4035609|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4212128|NCT00723008|4035610|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4212129|NCT00723008|4035611|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4212130|NCT00723008|4035609|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4212131|NCT00723008|4035610|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4212132|NCT00723008|4035611|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4212133|NCT00723008|4035609|B3|||Age||years|Mean|26.8|26.8|Standard Deviation|4.8|4.8|||
4212134|NCT00723008|4035610|B2|||Age||years|Mean|27.3|27.3|Standard Deviation|4.9|4.9|||
4212135|NCT00723008|4035611|B1|||Age||years|Mean|26.3|26.3|Standard Deviation|4.9|4.9|||
4212136|NCT00722865|4035634|B1|5||International Prognostic Scoring System (IPSS)|Risk score: 0-1= very low, 2 = low, 3 = intermediate, 4-5=high|Participants|Count of Participants|3|3.0||||||
4212137|NCT00722865|4035634|B1|4||International Prognostic Scoring System (IPSS)|Risk score: 0-1= very low, 2 = low, 3 = intermediate, 4-5=high|Participants|Count of Participants|7|7.0||||||
4212138|NCT00722865|4035634|B1|3||International Prognostic Scoring System (IPSS)|Risk score: 0-1= very low, 2 = low, 3 = intermediate, 4-5=high|Participants|Count of Participants|4|4.0||||||
4212139|NCT00722865|4035634|B1|2||International Prognostic Scoring System (IPSS)|Risk score: 0-1= very low, 2 = low, 3 = intermediate, 4-5=high|Participants|Count of Participants|5|5.0||||||
4212140|NCT00722865|4035634|B1|1||International Prognostic Scoring System (IPSS)|Risk score: 0-1= very low, 2 = low, 3 = intermediate, 4-5=high|Participants|Count of Participants|5|5.0||||||
4212141|NCT00722865|4035634|B1|0||International Prognostic Scoring System (IPSS)|Risk score: 0-1= very low, 2 = low, 3 = intermediate, 4-5=high|Participants|Count of Participants|1|1.0||||||
4212142|NCT00722865|4035634|B1|No||B symptoms|B symptoms refer to systemic symptoms of fever, night sweats, and weight loss which can be associated with both Hodgkin's lymphoma and non-Hodgkin's lymphoma. The presence or absence of B symptoms has prognostic significance and is reflected in the staging of these lymphomas.|Participants|Count of Participants|10|10.0||||||
4212143|NCT00722865|4035634|B1|Yes||B symptoms|B symptoms refer to systemic symptoms of fever, night sweats, and weight loss which can be associated with both Hodgkin's lymphoma and non-Hodgkin's lymphoma. The presence or absence of B symptoms has prognostic significance and is reflected in the staging of these lymphomas.|Participants|Count of Participants|15|15.0||||||
4212144|NCT00722865|4035634|B1|>=4.0 g/dL||Albumin||Participants|Count of Participants|8|8.0||||||
4212145|NCT00722865|4035634|B1|<4.0 g/dL||Albumin||Participants|Count of Participants|17|17.0||||||
4212146|NCT00722865|4035634|B1|>=600/uL||Absolute lymphocyte count||Participants|Count of Participants|21|21.0||||||
4212147|NCT00722865|4035634|B1|<600/uL||Absolute lymphocyte count||Participants|Count of Participants|4|4.0||||||
4212148|NCT00722865|4035634|B1|<=15,000/uL||Leukocytosis||Participants|Count of Participants|20|20.0||||||
4212149|NCT00722865|4035634|B1|>15,000/uL||Leukocytosis||Participants|Count of Participants|5|5.0||||||
4212150|NCT00722865|4035634|B1|>=10.5 g/dL||Hemoglobin||Participants|Count of Participants|18|18.0||||||
4212151|NCT00722865|4035634|B1|<10.5 g/dL||Hemoglobin||Participants|Count of Participants|7|7.0||||||
4212152|NCT00722865|4035634|B1|Stage IV||Stage of Cancer||Participants|Count of Participants|15|15.0||||||
4212153|NCT00722865|4035634|B1|Stage III||Stage of Cancer||Participants|Count of Participants|10|10.0||||||
4212154|NCT00722865|4035634|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4212155|NCT00722865|4035634|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4212156|NCT00722865|4035634|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4212157|NCT00722865|4035634|B1|||Age||years|Median|29|29.0|Full Range|||18.0|51.0|
4212158|NCT00722800|4035642|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4212159|NCT00722800|4035643|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4212160|NCT00722800|4035644|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4212161|NCT00722800|4035642|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4212162|NCT00722800|4035643|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4212163|NCT00722800|4035644|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4212164|NCT00722800|4035642|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4212165|NCT00722800|4035643|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4212166|NCT00722800|4035644|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4212167|NCT00722800|4035642|B3|||Age||years|Mean|34.75|34.75|Standard Deviation|11.33|11.33|||
4212168|NCT00722800|4035643|B2|||Age||years|Mean|35.5|35.5|Standard Deviation|14.85|14.85|||
4212169|NCT00722800|4035644|B1|||Age||years|Mean|34|34.0|Standard Deviation|12.73|12.73|||
4212170|NCT00722800|4035642|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4212171|NCT00722800|4035643|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4212172|NCT00722800|4035644|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4212173|NCT00722800|4035642|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4212174|NCT00722800|4035643|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4212175|NCT00722800|4035644|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4212176|NCT00722800|4035642|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212177|NCT00722800|4035643|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212178|NCT00722800|4035644|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212179|NCT00722761|4035655|B3|||BMI||kg/m2|Mean|23.4|23.4|Standard Deviation|2.9|2.9|||
4212180|NCT00722761|4035656|B2|||BMI||kg/m2|Mean|23.6|23.6|Standard Deviation|2.6|2.6|||
4212181|NCT00722761|4035657|B1|||BMI||kg/m2|Mean|23.2|23.2|Standard Deviation|2.2|2.2|||
4212182|NCT00722761|4035655|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4212183|NCT00722761|4035656|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4212184|NCT00722761|4035657|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4212185|NCT00722761|4035655|B3|African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4212186|NCT00722761|4035656|B2|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4212187|NCT00722761|4035657|B1|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4212188|NCT00722761|4035655|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4212189|NCT00722761|4035656|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4212190|NCT00722761|4035657|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4212191|NCT00722761|4035655|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4212192|NCT00722761|4035656|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4212193|NCT00722761|4035657|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4212194|NCT00722761|4035655|B3|Female||Sex/Gender, Customized||participants|Number|30|30.0||||||
4212195|NCT00722761|4035656|B2|Female||Sex/Gender, Customized||participants|Number|14|14.0||||||
4212196|NCT00722761|4035657|B1|Female||Sex/Gender, Customized||participants|Number|16|16.0||||||
4212197|NCT00722761|4035655|B3|||Age||years|Mean|24|24.0|Standard Deviation|4.5|4.5|||
4212198|NCT00722761|4035656|B2|||Age||years|Mean|24|24.0|Standard Deviation|3.7|3.7|||
4212199|NCT00722761|4035657|B1|||Age||years|Mean|23|23.0|Standard Deviation|5.1|5.1|||
4212200|NCT00722722|4035666|B4|United States||Region of Enrollment||participants|Number|18|18.0||||||
4212201|NCT00722722|4035667|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4212202|NCT00722722|4035668|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4212203|NCT00722722|4035669|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4212204|NCT00722722|4035666|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4212205|NCT00722722|4035667|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4212206|NCT00722722|4035668|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4212207|NCT00722722|4035669|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4212208|NCT00722722|4035666|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4212209|NCT00722722|4035667|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4212210|NCT00722722|4035668|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4212211|NCT00722722|4035669|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4212212|NCT00722722|4035666|B4|||Age||years|Mean|39.1|39.1|Standard Deviation|7.6|7.6|||
4212213|NCT00722722|4035667|B3|||Age||years|Mean|39.5|39.5|Standard Deviation|6.6|6.6|||
4212214|NCT00722722|4035668|B2|||Age||years|Mean|40.4|40.4|Standard Deviation|11.4|11.4|||
4212215|NCT00722722|4035669|B1|||Age||years|Mean|35.3|35.3|Standard Deviation|3.5|3.5|||
4212216|NCT00722566|4035679|B3|India||Region of Enrollment||participants|Number|6|6.0||||||
4212217|NCT00722566|4035680|B2|India||Region of Enrollment||participants|Number|3|3.0||||||
4212218|NCT00722566|4035681|B1|India||Region of Enrollment||participants|Number|3|3.0||||||
4212219|NCT00722566|4035679|B3|Argentina||Region of Enrollment||participants|Number|13|13.0||||||
4212220|NCT00722566|4035680|B2|Argentina||Region of Enrollment||participants|Number|8|8.0||||||
4212221|NCT00722566|4035681|B1|Argentina||Region of Enrollment||participants|Number|5|5.0||||||
4212222|NCT00722566|4035679|B3|Poland||Region of Enrollment||participants|Number|27|27.0||||||
4212223|NCT00722566|4035680|B2|Poland||Region of Enrollment||participants|Number|7|7.0||||||
4212224|NCT00722566|4035681|B1|Poland||Region of Enrollment||participants|Number|20|20.0||||||
4212225|NCT00722566|4035679|B3|Russian Federation||Region of Enrollment||participants|Number|35|35.0||||||
4212226|NCT00722566|4035680|B2|Russian Federation||Region of Enrollment||participants|Number|9|9.0||||||
4212227|NCT00722566|4035681|B1|Russian Federation||Region of Enrollment||participants|Number|26|26.0||||||
4212228|NCT00722566|4035679|B3|Ukraine||Region of Enrollment||participants|Number|68|68.0||||||
4212229|NCT00722566|4035680|B2|Ukraine||Region of Enrollment||participants|Number|17|17.0||||||
4212230|NCT00722566|4035681|B1|Ukraine||Region of Enrollment||participants|Number|51|51.0||||||
4212231|NCT00722566|4035679|B3|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
4212232|NCT00722566|4035680|B2|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4212233|NCT00722566|4035681|B1|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4212234|NCT00722566|4035679|B3|Netherlands||Region of Enrollment||participants|Number|10|10.0||||||
4212235|NCT00722566|4035680|B2|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
4212236|NCT00722566|4035681|B1|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
4212237|NCT00722566|4035679|B3|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4212238|NCT00722566|4035680|B2|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4212239|NCT00722566|4035681|B1|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4212240|NCT00722566|4035679|B3|Belgium||Region of Enrollment||participants|Number|12|12.0||||||
4212241|NCT00722566|4035680|B2|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
4212242|NCT00722566|4035681|B1|Belgium||Region of Enrollment||participants|Number|7|7.0||||||
4212243|NCT00722566|4035679|B3|France||Region of Enrollment||participants|Number|36|36.0||||||
4212244|NCT00722566|4035680|B2|France||Region of Enrollment||participants|Number|14|14.0||||||
4212245|NCT00722566|4035681|B1|France||Region of Enrollment||participants|Number|22|22.0||||||
4212246|NCT00722566|4035679|B3||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4212247|NCT00722566|4035680|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4212248|NCT00722566|4035681|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4212249|NCT00722566|4035679|B3||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4212250|NCT00722566|4035680|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4212251|NCT00722566|4035681|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4212252|NCT00722566|4035679|B3|||Age||years|Mean|64.2|64.2|Standard Deviation|10.09|10.09|||
4212253|NCT00722566|4035680|B2|||Age||years|Mean|64.0|64.0|Standard Deviation|12.11|12.11|||
4212254|NCT00722566|4035681|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|8.96|8.96|||
4212255|NCT00722566|4035679|B3||>=65 years|Age||Participants|Count of Participants|111|111.0||||||
4212256|NCT00722566|4035680|B2||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
4212257|NCT00722566|4035681|B1||>=65 years|Age||Participants|Count of Participants|74|74.0||||||
4212258|NCT00722566|4035679|B3||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
4212259|NCT00722566|4035680|B2||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4212260|NCT00722566|4035681|B1||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
4212261|NCT00722566|4035679|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212262|NCT00722566|4035680|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212263|NCT00722566|4035681|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212264|NCT00722553|4035690|B1|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4212265|NCT00722553|4035690|B1|Spain||Region of Enrollment||participants|Number|10|10.0||||||
4212266|NCT00722553|4035690|B1|Argentina||Region of Enrollment||participants|Number|1|1.0||||||
4212267|NCT00722553|4035690|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4212268|NCT00722553|4035690|B1|France||Region of Enrollment||participants|Number|14|14.0||||||
4212269|NCT00722553|4035690|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4212270|NCT00722553|4035690|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4212271|NCT00722553|4035690|B1|||Age||years|Mean|65.8|65.8|Standard Deviation|9|9.0|||
4212272|NCT00722553|4035690|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4212273|NCT00722553|4035690|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4212274|NCT00722553|4035690|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212275|NCT00722436|4035698|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4212276|NCT00722436|4035699|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4212277|NCT00722436|4035700|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4212278|NCT00722436|4035698|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4212279|NCT00722436|4035699|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4212280|NCT00722436|4035700|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4212281|NCT00722436|4035698|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4212282|NCT00722436|4035699|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4212283|NCT00722436|4035700|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4212284|NCT00722436|4035698|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4212285|NCT00722436|4035699|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4212286|NCT00722436|4035700|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4212287|NCT00722436|4035698|B3||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
4212288|NCT00722436|4035699|B2||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4212289|NCT00722436|4035700|B1||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4212290|NCT00722423|4035713|B3|United States||Region of Enrollment||participants|Number|363|363.0||||||
4212291|NCT00722423|4035714|B2|United States||Region of Enrollment||participants|Number|181|181.0||||||
4212292|NCT00722423|4035715|B1|United States||Region of Enrollment||participants|Number|182|182.0||||||
4212293|NCT00722423|4035713|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
4212294|NCT00722423|4035714|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4212295|NCT00722423|4035715|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
4212296|NCT00722423|4035713|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
4212297|NCT00722423|4035714|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4212298|NCT00722423|4035715|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
4212299|NCT00722423|4035713|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4212300|NCT00722423|4035714|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4212301|NCT00722423|4035715|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4212302|NCT00722423|4035713|B3||Male|Sex: Female, Male||Participants|Count of Participants|355|355.0||||||
4212303|NCT00722423|4035714|B2||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4212304|NCT00722423|4035715|B1||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4212305|NCT00722423|4035713|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4212306|NCT00722423|4035714|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4212307|NCT00722423|4035715|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4212308|NCT00722423|4035713|B3|||Age||years|Mean|55.4|55.4|Standard Deviation|5.65|5.65|||
4212309|NCT00722423|4035714|B2|||Age||years|Mean|55.5|55.5|Standard Deviation|5.79|5.79|||
4212310|NCT00722423|4035715|B1|||Age||years|Mean|55.3|55.3|Standard Deviation|5.51|5.51|||
4212311|NCT00722423|4035713|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4212312|NCT00722423|4035714|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4212313|NCT00722423|4035715|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4212314|NCT00722423|4035713|B3||Between 18 and 65 years|Age||Participants|Count of Participants|363|363.0||||||
4212315|NCT00722423|4035714|B2||Between 18 and 65 years|Age||Participants|Count of Participants|181|181.0||||||
4212316|NCT00722423|4035715|B1||Between 18 and 65 years|Age||Participants|Count of Participants|182|182.0||||||
4212317|NCT00722423|4035713|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212318|NCT00722423|4035714|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212319|NCT00722423|4035715|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212320|NCT00722371|4035724|B8||Male|Sex: Female, Male||Participants|Count of Participants|912|912.0||||||
4212321|NCT00722371|4035725|B7||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4212322|NCT00722371|4035726|B6||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4212323|NCT00722371|4035727|B5||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4212324|NCT00722371|4035728|B4||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4212325|NCT00722371|4035729|B3||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4212326|NCT00722371|4035730|B2||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4212327|NCT00722371|4035731|B1||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4212328|NCT00722371|4035724|B8||Female|Sex: Female, Male||Participants|Count of Participants|703|703.0||||||
4212329|NCT00722371|4035725|B7||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4212330|NCT00722371|4035726|B6||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4212331|NCT00722371|4035727|B5||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4212332|NCT00722371|4035728|B4||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4212333|NCT00722371|4035729|B3||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4212334|NCT00722371|4035730|B2||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4212335|NCT00722371|4035731|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4212336|NCT00722371|4035724|B8|>70 years||Age, Customized||Participants|Number|54|54.0||||||
4212337|NCT00722371|4035725|B7|>70 years||Age, Customized||Participants|Number|5|5.0||||||
4212338|NCT00722371|4035726|B6|>70 years||Age, Customized||Participants|Number|5|5.0||||||
4212339|NCT00722371|4035727|B5|>70 years||Age, Customized||Participants|Number|11|11.0||||||
4212340|NCT00722371|4035728|B4|>70 years||Age, Customized||Participants|Number|6|6.0||||||
4212341|NCT00722371|4035729|B3|>70 years||Age, Customized||Participants|Number|5|5.0||||||
4212342|NCT00722371|4035730|B2|>70 years||Age, Customized||Participants|Number|11|11.0||||||
4212343|NCT00722371|4035731|B1|>70 years||Age, Customized||Participants|Number|11|11.0||||||
4212344|NCT00722371|4035724|B8|61 to 70 years||Age, Customized||Participants|Number|307|307.0||||||
4212345|NCT00722371|4035725|B7|61 to 70 years||Age, Customized||Participants|Number|51|51.0||||||
4212346|NCT00722371|4035726|B6|61 to 70 years||Age, Customized||Participants|Number|49|49.0||||||
4212347|NCT00722371|4035727|B5|61 to 70 years||Age, Customized||Participants|Number|44|44.0||||||
4212348|NCT00722371|4035728|B4|61 to 70 years||Age, Customized||Participants|Number|53|53.0||||||
4212349|NCT00722371|4035729|B3|61 to 70 years||Age, Customized||Participants|Number|45|45.0||||||
4212350|NCT00722371|4035730|B2|61 to 70 years||Age, Customized||Participants|Number|34|34.0||||||
4212351|NCT00722371|4035731|B1|61 to 70 years||Age, Customized||Participants|Number|31|31.0||||||
4212352|NCT00722371|4035724|B8|51 to 60 years||Age, Customized||Participants|Number|556|556.0||||||
4212353|NCT00722371|4035725|B7|51 to 60 years||Age, Customized||Participants|Number|87|87.0||||||
4212354|NCT00722371|4035726|B6|51 to 60 years||Age, Customized||Participants|Number|75|75.0||||||
4212355|NCT00722371|4035727|B5|51 to 60 years||Age, Customized||Participants|Number|80|80.0||||||
4212356|NCT00722371|4035728|B4|51 to 60 years||Age, Customized||Participants|Number|76|76.0||||||
4212357|NCT00722371|4035729|B3|51 to 60 years||Age, Customized||Participants|Number|88|88.0||||||
4212358|NCT00722371|4035730|B2|51 to 60 years||Age, Customized||Participants|Number|67|67.0||||||
4212359|NCT00722371|4035731|B1|51 to 60 years||Age, Customized||Participants|Number|83|83.0||||||
4212360|NCT00722371|4035724|B8|41 to 50 years||Age, Customized||Participants|Number|468|468.0||||||
4212361|NCT00722371|4035725|B7|41 to 50 years||Age, Customized||Participants|Number|68|68.0||||||
4212362|NCT00722371|4035726|B6|41 to 50 years||Age, Customized||Participants|Number|60|60.0||||||
4212363|NCT00722371|4035727|B5|41 to 50 years||Age, Customized||Participants|Number|73|73.0||||||
4212364|NCT00722371|4035728|B4|41 to 50 years||Age, Customized||Participants|Number|70|70.0||||||
4212365|NCT00722371|4035729|B3|41 to 50 years||Age, Customized||Participants|Number|60|60.0||||||
4212366|NCT00722371|4035730|B2|41 to 50 years||Age, Customized||Participants|Number|73|73.0||||||
4212367|NCT00722371|4035731|B1|41 to 50 years||Age, Customized||Participants|Number|64|64.0||||||
4212368|NCT00722371|4035724|B8|31 to 40 years||Age, Customized||Participants|Number|195|195.0||||||
4212369|NCT00722371|4035725|B7|31 to 40 years||Age, Customized||Participants|Number|15|15.0||||||
4212370|NCT00722371|4035726|B6|31 to 40 years||Age, Customized||Participants|Number|34|34.0||||||
4212371|NCT00722371|4035727|B5|31 to 40 years||Age, Customized||Participants|Number|17|17.0||||||
4212372|NCT00722371|4035728|B4|31 to 40 years||Age, Customized||Participants|Number|20|20.0||||||
4212373|NCT00722371|4035729|B3|31 to 40 years||Age, Customized||Participants|Number|33|33.0||||||
4212374|NCT00722371|4035730|B2|31 to 40 years||Age, Customized||Participants|Number|39|39.0||||||
4212375|NCT00722371|4035731|B1|31 to 40 years||Age, Customized||Participants|Number|37|37.0||||||
4212376|NCT00722371|4035724|B8|21 to 30 years||Age, Customized||Participants|Number|35|35.0||||||
4212377|NCT00722371|4035725|B7|21 to 30 years||Age, Customized||Participants|Number|4|4.0||||||
4212378|NCT00722371|4035726|B6|21 to 30 years||Age, Customized||Participants|Number|8|8.0||||||
4212379|NCT00722371|4035727|B5|21 to 30 years||Age, Customized||Participants|Number|5|5.0||||||
4212380|NCT00722371|4035728|B4|21 to 30 years||Age, Customized||Participants|Number|5|5.0||||||
4212381|NCT00722371|4035729|B3|21 to 30 years||Age, Customized||Participants|Number|2|2.0||||||
4212382|NCT00722371|4035730|B2|21 to 30 years||Age, Customized||Participants|Number|6|6.0||||||
4212383|NCT00722371|4035731|B1|21 to 30 years||Age, Customized||Participants|Number|5|5.0||||||
4212384|NCT00722371|4035724|B8|<=20 years||Age, Customized||Participants|Number|0|0.0||||||
4212385|NCT00722371|4035725|B7|<=20 years||Age, Customized||Participants|Number|0|0.0||||||
4212386|NCT00722371|4035726|B6|<=20 years||Age, Customized||Participants|Number|0|0.0||||||
4212387|NCT00722371|4035727|B5|<=20 years||Age, Customized||Participants|Number|0|0.0||||||
4212388|NCT00722371|4035728|B4|<=20 years||Age, Customized||Participants|Number|0|0.0||||||
4212389|NCT00722371|4035729|B3|<=20 years||Age, Customized||Participants|Number|0|0.0||||||
4212390|NCT00722371|4035730|B2|<=20 years||Age, Customized||Participants|Number|0|0.0||||||
4212391|NCT00722371|4035731|B1|<=20 years||Age, Customized||Participants|Number|0|0.0||||||
4212392|NCT00722137|4035788|B3|Taiwan, Province Of China||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4212393|NCT00722137|4035789|B2|Taiwan, Province Of China||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4212394|NCT00722137|4035790|B1|Taiwan, Province Of China||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4212395|NCT00722137|4035788|B3|Singapore||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4212396|NCT00722137|4035789|B2|Singapore||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4212397|NCT00722137|4035790|B1|Singapore||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4212398|NCT00722137|4035788|B3|Chile||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4212399|NCT00722137|4035789|B2|Chile||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4212400|NCT00722137|4035790|B1|Chile||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4212401|NCT00722137|4035788|B3|Korea, Republic Of||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4212402|NCT00722137|4035789|B2|Korea, Republic Of||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4212403|NCT00722137|4035790|B1|Korea, Republic Of||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4212404|NCT00722137|4035788|B3|Colombia||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4212405|NCT00722137|4035789|B2|Colombia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4212406|NCT00722137|4035790|B1|Colombia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4212407|NCT00722137|4035788|B3|Turkey||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4212408|NCT00722137|4035789|B2|Turkey||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4212409|NCT00722137|4035790|B1|Turkey||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4212410|NCT00722137|4035788|B3|Tunisia||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4212411|NCT00722137|4035789|B2|Tunisia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4212412|NCT00722137|4035790|B1|Tunisia||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4212413|NCT00722137|4035788|B3|Israel||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4212414|NCT00722137|4035789|B2|Israel||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4212415|NCT00722137|4035790|B1|Israel||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4212416|NCT00722137|4035788|B3|India||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4212417|NCT00722137|4035789|B2|India||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4212418|NCT00722137|4035790|B1|India||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4212419|NCT00722137|4035788|B3|Japan||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4212420|NCT00722137|4035789|B2|Japan||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4212421|NCT00722137|4035790|B1|Japan||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4212422|NCT00722137|4035788|B3|Thailand||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4212423|NCT00722137|4035789|B2|Thailand||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4212424|NCT00722137|4035790|B1|Thailand||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4212425|NCT00722137|4035788|B3|Brazil||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4212426|NCT00722137|4035789|B2|Brazil||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4212427|NCT00722137|4035790|B1|Brazil||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4212428|NCT00722137|4035788|B3|Ukraine||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
4212429|NCT00722137|4035789|B2|Ukraine||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4212430|NCT00722137|4035790|B1|Ukraine||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4212431|NCT00722137|4035788|B3|China||Region of Enrollment||Participants|Count of Participants|95|95.0||||||
4212432|NCT00722137|4035789|B2|China||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
4212433|NCT00722137|4035790|B1|China||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
4212434|NCT00722137|4035788|B3|Russia||Region of Enrollment||Participants|Count of Participants|99|99.0||||||
4212435|NCT00722137|4035789|B2|Russia||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
4212436|NCT00722137|4035790|B1|Russia||Region of Enrollment||Participants|Count of Participants|57|57.0||||||
4212437|NCT00722137|4035788|B3|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4212438|NCT00722137|4035789|B2|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4212439|NCT00722137|4035790|B1|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4212440|NCT00722137|4035788|B3|Canada||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4212441|NCT00722137|4035789|B2|Canada||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4212442|NCT00722137|4035790|B1|Canada||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4212443|NCT00722137|4035788|B3|France||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4212444|NCT00722137|4035789|B2|France||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4212445|NCT00722137|4035790|B1|France||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4212446|NCT00722137|4035788|B3|Portugal||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4212447|NCT00722137|4035789|B2|Portugal||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4212448|NCT00722137|4035790|B1|Portugal||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4212449|NCT00722137|4035788|B3|Germany||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4212450|NCT00722137|4035789|B2|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4212451|NCT00722137|4035790|B1|Germany||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4212452|NCT00722137|4035788|B3|Italy||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4212453|NCT00722137|4035789|B2|Italy||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4212454|NCT00722137|4035790|B1|Italy||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4212455|NCT00722137|4035788|B3|Austria||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4212456|NCT00722137|4035789|B2|Austria||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4212457|NCT00722137|4035790|B1|Austria||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4212458|NCT00722137|4035788|B3|Romania||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4212459|NCT00722137|4035789|B2|Romania||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4212460|NCT00722137|4035790|B1|Romania||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4212461|NCT00722137|4035788|B3|Hungary||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4212462|NCT00722137|4035789|B2|Hungary||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4212463|NCT00722137|4035790|B1|Hungary||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4212464|NCT00722137|4035788|B3|Spain||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4212465|NCT00722137|4035789|B2|Spain||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4212466|NCT00722137|4035790|B1|Spain||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4212467|NCT00722137|4035788|B3|Czech Republic||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4212468|NCT00722137|4035789|B2|Czech Republic||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4212469|NCT00722137|4035790|B1|Czech Republic||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4212470|NCT00722137|4035788|B3|Poland||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4212471|NCT00722137|4035789|B2|Poland||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4212472|NCT00722137|4035790|B1|Poland||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4212473|NCT00722137|4035788|B3|Belgium||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
4212474|NCT00722137|4035789|B2|Belgium||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4212475|NCT00722137|4035790|B1|Belgium||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4212476|NCT00722137|4035788|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212477|NCT00722137|4035789|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212478|NCT00722137|4035790|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212479|NCT00722137|4035788|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4212480|NCT00722137|4035789|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4212481|NCT00722137|4035790|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4212482|NCT00722137|4035788|B3||White|Race (NIH/OMB)||Participants|Count of Participants|323|323.0||||||
4212483|NCT00722137|4035789|B2||White|Race (NIH/OMB)||Participants|Count of Participants|151|151.0||||||
4212484|NCT00722137|4035790|B1||White|Race (NIH/OMB)||Participants|Count of Participants|172|172.0||||||
4212485|NCT00722137|4035788|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4212486|NCT00722137|4035789|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4212487|NCT00722137|4035790|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212488|NCT00722137|4035788|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212489|NCT00722137|4035789|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212490|NCT00722137|4035790|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212491|NCT00722137|4035788|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|156|156.0||||||
4212492|NCT00722137|4035789|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
4212493|NCT00722137|4035790|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4212494|NCT00722137|4035788|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212495|NCT00722137|4035789|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212496|NCT00722137|4035790|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212497|NCT00722137|4035788|B3||Male|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
4212498|NCT00722137|4035789|B2||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4212499|NCT00722137|4035790|B1||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4212500|NCT00722137|4035788|B3||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4212501|NCT00722137|4035789|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4212502|NCT00722137|4035790|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4212503|NCT00722137|4035788|B3|||Age||Years|Mean|64.3|64.3|Standard Deviation|9.23|9.23|||
4212504|NCT00722137|4035789|B2|||Age||Years|Mean|64.2|64.2|Standard Deviation|9.68|9.68|||
4212505|NCT00722137|4035790|B1|||Age||Years|Mean|64.4|64.4|Standard Deviation|8.78|8.78|||
4212506|NCT00722124|4035817|B4|||baseline smoking rate|Average cigarettes per day at study entry|cigarettes per day|Mean|19.6|19.6|Standard Deviation|8.5|8.5|||
4212507|NCT00722124|4035818|B3|||baseline smoking rate|Average cigarettes per day at study entry|cigarettes per day|Mean|19.5|19.5|Standard Deviation|8.0|8.0|||
4212508|NCT00722124|4035819|B2|||baseline smoking rate|Average cigarettes per day at study entry|cigarettes per day|Mean|19.9|19.9|Standard Deviation|8.4|8.4|||
4212509|NCT00722124|4035820|B1|||baseline smoking rate|Average cigarettes per day at study entry|cigarettes per day|Mean|19.5|19.5|Standard Deviation|9.3|9.3|||
4212510|NCT00722124|4035817|B4||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4212511|NCT00722124|4035818|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4212512|NCT00722124|4035819|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4212513|NCT00722124|4035820|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4212514|NCT00722124|4035817|B4||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4212515|NCT00722124|4035818|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4212516|NCT00722124|4035819|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4212517|NCT00722124|4035820|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4212518|NCT00722124|4035817|B4|||Age||years|Mean|39.9|39.9|Standard Deviation|14.1|14.1|||
4212519|NCT00722124|4035818|B3|||Age||years|Mean|37.0|37.0|Standard Deviation|13.6|13.6|||
4212520|NCT00722124|4035819|B2|||Age||years|Mean|40.8|40.8|Standard Deviation|12.3|12.3|||
4212521|NCT00722124|4035820|B1|||Age||years|Mean|42.1|42.1|Standard Deviation|16.0|16.0|||
4212522|NCT00722124|4035817|B4||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4212523|NCT00722124|4035818|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4212524|NCT00722124|4035819|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4212525|NCT00722124|4035820|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4212526|NCT00722124|4035817|B4||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
4212527|NCT00722124|4035818|B3||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4212528|NCT00722124|4035819|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4212529|NCT00722124|4035820|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4212530|NCT00722124|4035817|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212531|NCT00722124|4035818|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212532|NCT00722124|4035819|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212533|NCT00722124|4035820|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212534|NCT00722072|4035840|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4212535|NCT00722072|4035840|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4212536|NCT00722072|4035840|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4212537|NCT00722072|4035840|B1|||Age||years|Mean|57.166|57.166|Standard Deviation|9.0235|9.0235|||
4212538|NCT00722072|4035840|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4212539|NCT00722072|4035840|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4212540|NCT00722072|4035840|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212541|NCT00722020|4035848|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4212542|NCT00722020|4035849|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4212543|NCT00722020|4035850|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4212544|NCT00722020|4035848|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4212545|NCT00722020|4035849|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4212546|NCT00722020|4035850|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4212547|NCT00722020|4035848|B3|||Age||years|Mean|8.2|8.2|Standard Deviation|1.5|1.5|||
4212548|NCT00722020|4035849|B2|||Age||years|Mean|8.2|8.2|Standard Deviation|2.0|2.0|||
4212549|NCT00722020|4035850|B1|||Age||years|Mean|8.0|8.0|Standard Deviation|2.3|2.3|||
4212550|NCT00721968|4035859|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
4212551|NCT00721968|4035860|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4212552|NCT00721968|4035861|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4212553|NCT00721968|4035859|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4212554|NCT00721968|4035860|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4212555|NCT00721968|4035861|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4212556|NCT00721968|4035859|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4212557|NCT00721968|4035860|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4212558|NCT00721968|4035861|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4212559|NCT00721968|4035859|B3||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
4212560|NCT00721968|4035860|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4212561|NCT00721968|4035861|B1||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4212562|NCT00721968|4035859|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4212563|NCT00721968|4035860|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4212564|NCT00721968|4035861|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4212565|NCT00721968|4035859|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212566|NCT00721968|4035860|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212567|NCT00721968|4035861|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212568|NCT00721955|4035870|B4|United States||Region of Enrollment||participants|Number|314|314.0||||||
4212569|NCT00721955|4035871|B3|United States||Region of Enrollment||participants|Number|105|105.0||||||
4212570|NCT00721955|4035872|B2|United States||Region of Enrollment||participants|Number|104|104.0||||||
4212571|NCT00721955|4035873|B1|United States||Region of Enrollment||participants|Number|105|105.0||||||
4212572|NCT00721955|4035870|B4||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4212573|NCT00721955|4035871|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4212574|NCT00721955|4035872|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4212575|NCT00721955|4035873|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4212576|NCT00721955|4035870|B4||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4212577|NCT00721955|4035871|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4212578|NCT00721955|4035872|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4212579|NCT00721955|4035873|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4212580|NCT00721955|4035870|B4|||Age||years|Mean|40.7|40.7|Standard Deviation|9.72|9.72|||
4212581|NCT00721955|4035871|B3|||Age||years|Mean|40.5|40.5|Standard Deviation|9.80|9.8|||
4212582|NCT00721955|4035872|B2|||Age||years|Mean|41.2|41.2|Standard Deviation|9.63|9.63|||
4212583|NCT00721955|4035873|B1|||Age||years|Mean|40.6|40.6|Standard Deviation|9.82|9.82|||
4212584|NCT00721955|4035870|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4212585|NCT00721955|4035871|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4212586|NCT00721955|4035872|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4212587|NCT00721955|4035873|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4212588|NCT00721955|4035870|B4||Between 18 and 65 years|Age||Participants|Count of Participants|314|314.0||||||
4212589|NCT00721955|4035871|B3||Between 18 and 65 years|Age||Participants|Count of Participants|105|105.0||||||
4212590|NCT00721955|4035872|B2||Between 18 and 65 years|Age||Participants|Count of Participants|104|104.0||||||
4212591|NCT00721955|4035873|B1||Between 18 and 65 years|Age||Participants|Count of Participants|105|105.0||||||
4212592|NCT00721955|4035870|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212593|NCT00721955|4035871|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212594|NCT00721955|4035872|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212595|NCT00721955|4035873|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212596|NCT00721799|4035889|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4212597|NCT00721799|4035889|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4212598|NCT00721799|4035889|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212599|NCT00721799|4035889|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4212600|NCT00721799|4035889|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212601|NCT00721799|4035889|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212602|NCT00721799|4035889|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212603|NCT00721799|4035889|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212604|NCT00721799|4035889|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4212605|NCT00721799|4035889|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4212606|NCT00721799|4035889|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212607|NCT00721799|4035889|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4212608|NCT00721799|4035889|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4212609|NCT00721799|4035889|B1|||Age||years|Mean|57.8|57.8|Standard Deviation|10.0|10.0|||
4212610|NCT00721799|4035889|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4212611|NCT00721799|4035889|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4212612|NCT00721799|4035889|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212613|NCT00721734|4035924|B6|2 (Ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|10|10.0||||||
4212614|NCT00721734|4035925|B5|2 (Ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|3|3.0||||||
4212615|NCT00721734|4035926|B4|2 (Ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|5|5.0||||||
4212616|NCT00721734|4035927|B3|2 (Ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|1|1.0||||||
4212617|NCT00721734|4035928|B2|2 (Ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|1|1.0||||||
4212618|NCT00721734|4035929|B1|2 (Ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4212619|NCT00721734|4035924|B6|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|32|32.0||||||
4212620|NCT00721734|4035925|B5|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|5|5.0||||||
4212621|NCT00721734|4035926|B4|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|1|1.0||||||
4212622|NCT00721734|4035927|B3|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|9|9.0||||||
4212623|NCT00721734|4035928|B2|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|9|9.0||||||
4212624|NCT00721734|4035929|B1|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|8|8.0||||||
4212625|NCT00721734|4035924|B6|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|8|8.0||||||
4212626|NCT00721734|4035925|B5|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4212627|NCT00721734|4035926|B4|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|2|2.0||||||
4212628|NCT00721734|4035927|B3|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4212629|NCT00721734|4035928|B2|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|2|2.0||||||
4212630|NCT00721734|4035929|B1|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Dead.|participants|Number|4|4.0||||||
4212631|NCT00721734|4035924|B6|Caucasian||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4212632|NCT00721734|4035925|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4212633|NCT00721734|4035926|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4212634|NCT00721734|4035927|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4212635|NCT00721734|4035928|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4212636|NCT00721734|4035929|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4212637|NCT00721734|4035924|B6|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4212638|NCT00721734|4035925|B5|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4212639|NCT00721734|4035926|B4|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4212640|NCT00721734|4035927|B3|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4212641|NCT00721734|4035928|B2|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4212642|NCT00721734|4035929|B1|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4212643|NCT00721734|4035924|B6|African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4212644|NCT00721734|4035925|B5|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4212645|NCT00721734|4035926|B4|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4212646|NCT00721734|4035927|B3|African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4212647|NCT00721734|4035928|B2|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4212648|NCT00721734|4035929|B1|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4212649|NCT00721734|4035924|B6||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4212650|NCT00721734|4035925|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4212651|NCT00721734|4035926|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4212652|NCT00721734|4035927|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4212653|NCT00721734|4035928|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4212654|NCT00721734|4035929|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4212655|NCT00721734|4035924|B6||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4212656|NCT00721734|4035925|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4212657|NCT00721734|4035926|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4212658|NCT00721734|4035927|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4212659|NCT00721734|4035928|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4212660|NCT00721734|4035929|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4212661|NCT00721734|4035924|B6|||Age||years|Mean|64.6|64.6|Standard Deviation|9.01|9.01|||
4212662|NCT00721734|4035925|B5|||Age||years|Mean|56.0|56.0|Standard Deviation|7.91|7.91|||
4212663|NCT00721734|4035926|B4|||Age||years|Mean|73.0|73.0|Standard Deviation|8.23|8.23|||
4212664|NCT00721734|4035927|B3|||Age||years|Mean|66.2|66.2|Standard Deviation|9.65|9.65|||
4212665|NCT00721734|4035928|B2|||Age||years|Mean|63.5|63.5|Standard Deviation|7.85|7.85|||
4212666|NCT00721734|4035929|B1|||Age||years|Mean|64.5|64.5|Standard Deviation|5.70|5.7|||
4212667|NCT00721734|4035924|B6||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4212668|NCT00721734|4035925|B5||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4212669|NCT00721734|4035926|B4||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4212670|NCT00721734|4035927|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4212671|NCT00721734|4035928|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4212672|NCT00721734|4035929|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4212673|NCT00721734|4035924|B6||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4212674|NCT00721734|4035925|B5||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4212675|NCT00721734|4035926|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4212676|NCT00721734|4035927|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4212677|NCT00721734|4035928|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4212678|NCT00721734|4035929|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4212679|NCT00721734|4035924|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212680|NCT00721734|4035925|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212681|NCT00721734|4035926|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212682|NCT00721734|4035927|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212683|NCT00721734|4035928|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212684|NCT00721734|4035929|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212685|NCT00721630|4036045|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4212686|NCT00721630|4036045|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212687|NCT00721630|4036045|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212688|NCT00721630|4036045|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4212689|NCT00721630|4036045|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4212690|NCT00721630|4036045|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212691|NCT00721630|4036045|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212692|NCT00721630|4036045|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212693|NCT00721630|4036045|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212694|NCT00721630|4036045|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4212695|NCT00721630|4036045|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4212696|NCT00721630|4036045|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4212697|NCT00721630|4036045|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4212698|NCT00721630|4036045|B1|||Age||years|Median|54|54.0|Full Range|||34.0|72.0|
4212699|NCT00721617|4036050|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4212700|NCT00721617|4036050|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4212701|NCT00721617|4036050|B1|||Age||years|Mean|41|41.0|Standard Deviation|7|7.0|||
4212702|NCT00721578|4036074|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4212703|NCT00721578|4036074|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4212704|NCT00721578|4036074|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4212705|NCT00721578|4036074|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4212706|NCT00721578|4036074|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212707|NCT00721539|4036087|B1|United States||Region of Enrollment|Adult patients from a tertiary referral academic center|participants|Number|9|9.0||||||
4212708|NCT00721539|4036087|B1||Male|Gender||Participants|Count of Participants|7|7.0||||||
4212709|NCT00721539|4036087|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
4212710|NCT00721539|4036087|B1|||Age||Years|Mean|41.5|41.5|Full Range|||18.0|65.0|
4212711|NCT00721539|4036087|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4212712|NCT00721539|4036087|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4212713|NCT00721539|4036087|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4212714|NCT00721500|4036094|B1|United Kingdom||Region of Enrollment||participants|Number|25|25.0||||||
4212715|NCT00721500|4036094|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4212716|NCT00721500|4036094|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4212717|NCT00721500|4036094|B1|||Age||years|Mean|44.9|44.9|Standard Deviation|11.9|11.9|||
4212718|NCT00721409|4036115|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4212719|NCT00721409|4036116|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4212720|NCT00721409|4036117|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4212721|NCT00721409|4036118|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4212722|NCT00721409|4036115|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212723|NCT00721409|4036116|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212724|NCT00721409|4036117|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212725|NCT00721409|4036118|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212726|NCT00721409|4036115|B4||White|Race (NIH/OMB)||Participants|Count of Participants|159|159.0||||||
4212727|NCT00721409|4036116|B3||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4212728|NCT00721409|4036117|B2||White|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
4212729|NCT00721409|4036118|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4212730|NCT00721409|4036115|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4212731|NCT00721409|4036116|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4212732|NCT00721409|4036117|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4212733|NCT00721409|4036118|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212734|NCT00721409|4036115|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212735|NCT00721409|4036116|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212736|NCT00721409|4036117|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212737|NCT00721409|4036118|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212738|NCT00721409|4036115|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4212739|NCT00721409|4036116|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4212740|NCT00721409|4036117|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4212741|NCT00721409|4036118|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212742|NCT00721409|4036115|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212743|NCT00721409|4036116|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212744|NCT00721409|4036117|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212745|NCT00721409|4036118|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212746|NCT00721409|4036115|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4212747|NCT00721409|4036116|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4212748|NCT00721409|4036117|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4212749|NCT00721409|4036118|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4212750|NCT00721409|4036115|B4||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4212751|NCT00721409|4036116|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4212752|NCT00721409|4036117|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4212753|NCT00721409|4036118|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4212754|NCT00721409|4036115|B4|>= 65 Years||Age, Customized||Participants|Count of Participants|81|81.0||||||
4212755|NCT00721409|4036116|B3|>= 65 Years||Age, Customized||Participants|Count of Participants|39|39.0||||||
4212756|NCT00721409|4036117|B2|>= 65 Years||Age, Customized||Participants|Count of Participants|37|37.0||||||
4212757|NCT00721409|4036118|B1|>= 65 Years||Age, Customized||Participants|Count of Participants|5|5.0||||||
4212758|NCT00721409|4036115|B4|45-64 Years||Age, Customized||Participants|Count of Participants|89|89.0||||||
4212759|NCT00721409|4036116|B3|45-64 Years||Age, Customized||Participants|Count of Participants|38|38.0||||||
4212760|NCT00721409|4036117|B2|45-64 Years||Age, Customized||Participants|Count of Participants|45|45.0||||||
4212761|NCT00721409|4036118|B1|45-64 Years||Age, Customized||Participants|Count of Participants|6|6.0||||||
4212762|NCT00721409|4036115|B4|18-44 Years||Age, Customized||Participants|Count of Participants|7|7.0||||||
4212763|NCT00721409|4036116|B3|18-44 Years||Age, Customized||Participants|Count of Participants|4|4.0||||||
4212764|NCT00721409|4036117|B2|18-44 Years||Age, Customized||Participants|Count of Participants|2|2.0||||||
4212765|NCT00721409|4036118|B1|18-44 Years||Age, Customized||Participants|Count of Participants|1|1.0||||||
4212766|NCT00721409|4036115|B4|<18 Years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4212767|NCT00721409|4036116|B3|<18 Years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4212768|NCT00721409|4036117|B2|<18 Years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4212769|NCT00721409|4036118|B1|<18 Years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4212770|NCT00721396|4036243|B5||Male|Sex: Female, Male||Participants|Count of Participants|958|958.0||||||
4212771|NCT00721396|4036244|B4||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4212772|NCT00721396|4036245|B3||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4212773|NCT00721396|4036246|B2||Male|Sex: Female, Male||Participants|Count of Participants|316|316.0||||||
4212774|NCT00721396|4036247|B1||Male|Sex: Female, Male||Participants|Count of Participants|335|335.0||||||
4212775|NCT00721396|4036243|B5||Female|Sex: Female, Male||Participants|Count of Participants|927|927.0||||||
4212776|NCT00721396|4036244|B4||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4212777|NCT00721396|4036245|B3||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4212778|NCT00721396|4036246|B2||Female|Sex: Female, Male||Participants|Count of Participants|312|312.0||||||
4212779|NCT00721396|4036247|B1||Female|Sex: Female, Male||Participants|Count of Participants|292|292.0||||||
4212780|NCT00721396|4036243|B5|||Age||days|Mean|68.7|68.7|Standard Deviation|9.1|9.1|||
4212781|NCT00721396|4036244|B4|||Age||days|Mean|68.1|68.1|Standard Deviation|9.0|9.0|||
4212782|NCT00721396|4036245|B3|||Age||days|Mean|68.8|68.8|Standard Deviation|9.1|9.1|||
4212783|NCT00721396|4036246|B2|||Age||days|Mean|68.8|68.8|Standard Deviation|9.4|9.4|||
4212784|NCT00721396|4036247|B1|||Age||days|Mean|68.7|68.7|Standard Deviation|8.9|8.9|||
4212785|NCT00721357|4036286|B3|||muscle mechanical energy expenditure|This is a calculation of how much work is done by each joint (i.e. ankle, knee and hip) of each leag during walking.|Joules per kg|Mean|309|309.0|Standard Deviation|112|112.0|||
4212786|NCT00721357|4036287|B2|||muscle mechanical energy expenditure|This is a calculation of how much work is done by each joint (i.e. ankle, knee and hip) of each leag during walking.|Joules per kg|Mean|242|242.0|Standard Deviation|66|66.0|||
4212787|NCT00721357|4036288|B1|||muscle mechanical energy expenditure|This is a calculation of how much work is done by each joint (i.e. ankle, knee and hip) of each leag during walking.|Joules per kg|Mean|374|374.0|Standard Deviation|161|161.0|||
4212788|NCT00721357|4036286|B3|||muscle oxidative capacity|This measures specific compounds in leg muscles to estimate how well they would perform repeated physical tasks (e.g. walking).|millimolar inorganic phosphate|Mean|4.2|4.2|Standard Deviation|0.72|0.72|||
4212789|NCT00721357|4036287|B2|||muscle oxidative capacity|This measures specific compounds in leg muscles to estimate how well they would perform repeated physical tasks (e.g. walking).|millimolar inorganic phosphate|Mean|3.2|3.2|Standard Deviation|0.56|0.56|||
4212790|NCT00721357|4036288|B1|||muscle oxidative capacity|This measures specific compounds in leg muscles to estimate how well they would perform repeated physical tasks (e.g. walking).|millimolar inorganic phosphate|Mean|5.1|5.1|Standard Deviation|0.87|0.87|||
4212791|NCT00721357|4036286|B3|||walking speed|"The overground speed the individuals walk when instructed to walk at you normal comfortable speed."|meters per second|Mean|0.87|0.87|Standard Deviation|0.20|0.2|||
4212792|NCT00721357|4036287|B2|||walking speed|"The overground speed the individuals walk when instructed to walk at you normal comfortable speed."|meters per second|Mean|1.17|1.17|Standard Deviation|0.15|0.15|||
4212793|NCT00721357|4036288|B1|||walking speed|"The overground speed the individuals walk when instructed to walk at you normal comfortable speed."|meters per second|Mean|0.57|0.57|Standard Deviation|0.23|0.23|||
4212794|NCT00721357|4036286|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4212795|NCT00721357|4036287|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4212796|NCT00721357|4036288|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4212797|NCT00721357|4036286|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4212798|NCT00721357|4036287|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4212799|NCT00721357|4036288|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4212800|NCT00721357|4036286|B3|||Age||years|Mean|57.3|57.3|Standard Deviation|9.2|9.2|||
4212801|NCT00721357|4036287|B2|||Age||years|Mean|54.2|54.2|Standard Deviation|5.1|5.1|||
4212802|NCT00721357|4036288|B1|||Age||years|Mean|57.3|57.3|Standard Deviation|9.2|9.2|||
4212803|NCT00721279|4036295|B3|missing||Sex/Gender, Customized||participants|Number|12|12.0||||||
4212804|NCT00721279|4036296|B2|missing||Sex/Gender, Customized||participants|Number|8|8.0||||||
4212805|NCT00721279|4036297|B1|missing||Sex/Gender, Customized||participants|Number|4|4.0||||||
4212806|NCT00721279|4036295|B3|Male||Sex/Gender, Customized||participants|Number|154|154.0||||||
4212807|NCT00721279|4036296|B2|Male||Sex/Gender, Customized||participants|Number|23|23.0||||||
4212808|NCT00721279|4036297|B1|Male||Sex/Gender, Customized||participants|Number|131|131.0||||||
4212809|NCT00721279|4036295|B3|Female||Sex/Gender, Customized||participants|Number|383|383.0||||||
4212810|NCT00721279|4036296|B2|Female||Sex/Gender, Customized||participants|Number|66|66.0||||||
4212811|NCT00721279|4036297|B1|Female||Sex/Gender, Customized||participants|Number|317|317.0||||||
4212812|NCT00721279|4036295|B3|||Age|N= 432 - De-novo, 85 - Pre-treated, 517- Total|years|Mean|66.69|66.69|Standard Deviation|12.82|12.82|||
4212813|NCT00721279|4036296|B2|||Age|N= 432 - De-novo, 85 - Pre-treated, 517- Total|years|Mean|67.81|67.81|Standard Deviation|12.61|12.61|||
4212814|NCT00721279|4036297|B1|||Age|N= 432 - De-novo, 85 - Pre-treated, 517- Total|years|Mean|66.48|66.48|Standard Deviation|12.87|12.87|||
4212815|NCT00721253|4036310|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4212816|NCT00721253|4036311|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4212817|NCT00721253|4036312|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4212818|NCT00721253|4036310|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4212819|NCT00721253|4036311|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4212820|NCT00721253|4036312|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4212821|NCT00721253|4036310|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4212822|NCT00721253|4036311|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4212823|NCT00721253|4036312|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4212824|NCT00721253|4036310|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4212825|NCT00721253|4036311|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4212826|NCT00721253|4036312|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4212827|NCT00721253|4036310|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212828|NCT00721253|4036311|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212829|NCT00721253|4036312|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212830|NCT00721227|4036324|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4212831|NCT00721227|4036325|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4212832|NCT00721227|4036326|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4212833|NCT00721227|4036324|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4212834|NCT00721227|4036325|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4212835|NCT00721227|4036326|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4212836|NCT00721227|4036324|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4212837|NCT00721227|4036325|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4212838|NCT00721227|4036326|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4212839|NCT00721227|4036324|B3|||Age||years|Mean|41.7|41.7|Standard Deviation|10.19|10.19|||
4212840|NCT00721227|4036325|B2|||Age||years|Mean|36.8|36.8|Standard Deviation|8.42|8.42|||
4212841|NCT00721227|4036326|B1|||Age||years|Mean|45.0|45.0|Standard Deviation|10.37|10.37|||
4212842|NCT00721227|4036324|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4212843|NCT00721227|4036325|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4212844|NCT00721227|4036326|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4212845|NCT00721227|4036324|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4212846|NCT00721227|4036325|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4212847|NCT00721227|4036326|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4212848|NCT00721227|4036324|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212849|NCT00721227|4036325|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212850|NCT00721227|4036326|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212851|NCT00721214|4036337|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4212852|NCT00721214|4036337|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4212853|NCT00721214|4036337|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4212854|NCT00721214|4036337|B1|||Age||years|Mean|54|54.0|Standard Deviation|9.9|9.9|||
4212855|NCT00721214|4036337|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4212856|NCT00721214|4036337|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4212857|NCT00721214|4036337|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212858|NCT00721188|4036348|B1|Mexico||Region of Enrollment||participants|Number|11|11.0||||||
4212859|NCT00721188|4036348|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4212860|NCT00721188|4036348|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4212861|NCT00721188|4036348|B1|||Age||years|Mean|13.5|13.5|Standard Deviation|1.51|1.51|||
4212862|NCT00721188|4036348|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4212863|NCT00721188|4036348|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4212864|NCT00721188|4036348|B1||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4212865|NCT00721175|4036363|B3|Thailand||Region of Enrollment||participants|Number|108|108.0||||||
4212866|NCT00721175|4036364|B2|Thailand||Region of Enrollment||participants|Number|54|54.0||||||
4212867|NCT00721175|4036365|B1|Thailand||Region of Enrollment||participants|Number|54|54.0||||||
4212868|NCT00721175|4036363|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4212869|NCT00721175|4036364|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4212870|NCT00721175|4036365|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4212871|NCT00721175|4036363|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4212872|NCT00721175|4036364|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4212873|NCT00721175|4036365|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4212874|NCT00721175|4036363|B3|||Age||years|Mean|60.0|60.0|Standard Deviation|11.3|11.3|||
4212875|NCT00721175|4036364|B2|||Age||years|Mean|57.3|57.3|Standard Deviation|11.7|11.7|||
4212876|NCT00721175|4036365|B1|||Age||years|Mean|62.7|62.7|Standard Deviation|10.3|10.3|||
4212877|NCT00721175|4036363|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4212878|NCT00721175|4036364|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4212879|NCT00721175|4036365|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4212880|NCT00721175|4036363|B3||Between 18 and 65 years|Age||Participants|Count of Participants|98|98.0||||||
4212881|NCT00721175|4036364|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4212882|NCT00721175|4036365|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4212883|NCT00721175|4036363|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212884|NCT00721175|4036364|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212885|NCT00721175|4036365|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212886|NCT00721162|4036378|B1|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4212887|NCT00721162|4036378|B1|United States||Region of Enrollment||participants|Number|56|56.0||||||
4212888|NCT00721162|4036378|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4212889|NCT00721162|4036378|B1|White||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
4212890|NCT00721162|4036378|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4212891|NCT00721162|4036378|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212892|NCT00721162|4036378|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4212893|NCT00721162|4036378|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4212894|NCT00721162|4036378|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4212895|NCT00721162|4036378|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4212896|NCT00721162|4036378|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4212897|NCT00721162|4036378|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4212898|NCT00721162|4036378|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212899|NCT00721149|4036387|B1|Without Atrial Flutter||Atrial Flutter Condition||Participants|Number|8|8.0||||||
4212900|NCT00721149|4036387|B1|With Atrial Flutter||Atrial Flutter Condition||Participants|Number|2|2.0||||||
4212901|NCT00721149|4036387|B1|Without Hypertension||Hypertension Condition||Participants|Number|7|7.0||||||
4212902|NCT00721149|4036387|B1|With Hypertension||Hypertension Condition||Participants|Number|3|3.0||||||
4212903|NCT00721149|4036387|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4212904|NCT00721149|4036387|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212905|NCT00721149|4036387|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212906|NCT00721149|4036387|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4212907|NCT00721149|4036387|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212908|NCT00721149|4036387|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212909|NCT00721149|4036387|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212910|NCT00721149|4036387|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4212911|NCT00721149|4036387|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4212912|NCT00721149|4036387|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4212913|NCT00721149|4036387|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|13.2|13.2|||
4212914|NCT00721136|4036396|B5|United States||Region of Enrollment||participants|Number|100|100.0||||||
4212915|NCT00721136|4036397|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
4212916|NCT00721136|4036398|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4212917|NCT00721136|4036399|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
4212918|NCT00721136|4036400|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4212919|NCT00721136|4036396|B5||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4212920|NCT00721136|4036397|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4212921|NCT00721136|4036398|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4212922|NCT00721136|4036399|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4212923|NCT00721136|4036400|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4212924|NCT00721136|4036396|B5||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4212925|NCT00721136|4036397|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4212926|NCT00721136|4036398|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4212927|NCT00721136|4036399|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4212928|NCT00721136|4036400|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4212929|NCT00721136|4036396|B5|||Age||years|Mean|71.5|71.5|Standard Deviation|11.6|11.6|||
4212930|NCT00721136|4036397|B4|||Age||years|Mean|68.8|68.8|Standard Deviation|11.7|11.7|||
4212931|NCT00721136|4036398|B3|||Age||years|Mean|72.9|72.9|Standard Deviation|11.4|11.4|||
4212932|NCT00721136|4036399|B2|||Age||years|Mean|68.8|68.8|Standard Deviation|11.7|11.7|||
4212933|NCT00721136|4036400|B1|||Age||years|Mean|72.9|72.9|Standard Deviation|11.4|11.4|||
4212934|NCT00721136|4036396|B5||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
4212935|NCT00721136|4036397|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4212936|NCT00721136|4036398|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4212937|NCT00721136|4036399|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4212938|NCT00721136|4036400|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4212939|NCT00721136|4036396|B5||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4212940|NCT00721136|4036397|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4212941|NCT00721136|4036398|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4212942|NCT00721136|4036399|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4212943|NCT00721136|4036400|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4212944|NCT00721136|4036396|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212945|NCT00721136|4036397|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212946|NCT00721136|4036398|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212947|NCT00721136|4036399|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212948|NCT00721136|4036400|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4212949|NCT00721123|4036421|B1||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4212950|NCT00721123|4036421|B1||Female|Sex: Female, Male||Participants|Count of Participants|443|443.0||||||
4212951|NCT00721123|4036421|B1|||Age||years|Mean|50.8|50.8|Standard Deviation|12.03|12.03|||
4212952|NCT00721110|4036495|B5|||Preoperative 6-MWD||m|Mean|320|320.0|Standard Deviation|47|47.0|||
4212953|NCT00721110|4036496|B4|||Preoperative 6-MWD||m|Mean|338|338.0|Standard Deviation|52|52.0|||
4212954|NCT00721110|4036497|B3|||Preoperative 6-MWD||m|Mean|304|304.0|Standard Deviation|41|41.0|||
4212955|NCT00721110|4036498|B2|||Preoperative 6-MWD||m|Mean|320|320.0|Standard Deviation|44|44.0|||
4212956|NCT00721110|4036499|B1|||Preoperative 6-MWD||m|Mean|318|318.0|Standard Deviation|47|47.0|||
4212957|NCT00721110|4036495|B5|||Body Mass Index||kg per meters squared|Mean|29|29.0|Standard Deviation|7|7.0|||
4212958|NCT00721110|4036496|B4|||Body Mass Index||kg per meters squared|Mean|28|28.0|Standard Deviation|6|6.0|||
4212959|NCT00721110|4036497|B3|||Body Mass Index||kg per meters squared|Mean|29|29.0|Standard Deviation|10|10.0|||
4212960|NCT00721110|4036498|B2|||Body Mass Index||kg per meters squared|Mean|29|29.0|Standard Deviation|6|6.0|||
4212961|NCT00721110|4036499|B1|||Body Mass Index||kg per meters squared|Mean|28|28.0|Standard Deviation|6|6.0|||
4212962|NCT00721110|4036495|B5|A patient with severe systemic disease||American Society of Anesthesiologists Physical Status|"American Society of Anesthesiologists Physical Status applied to each patient ranging from I to VI. The scale is defined as follows:~I: A normal healthy patient II: A patient with mild systemic disease III: A patient with severe systemic disease IV: A patient with severe systemic disease that is a constant threat to life V: A moribund patient who is not expected to survive without the operation VI: A declared brain-dead patient whose organs are being removed for donor purposes"|participants|Number|8|8.0||||||
4212963|NCT00721110|4036496|B4|A patient with severe systemic disease||American Society of Anesthesiologists Physical Status|"American Society of Anesthesiologists Physical Status applied to each patient ranging from I to VI. The scale is defined as follows:~I: A normal healthy patient II: A patient with mild systemic disease III: A patient with severe systemic disease IV: A patient with severe systemic disease that is a constant threat to life V: A moribund patient who is not expected to survive without the operation VI: A declared brain-dead patient whose organs are being removed for donor purposes"|participants|Number|1|1.0||||||
4212964|NCT00721110|4036497|B3|A patient with severe systemic disease||American Society of Anesthesiologists Physical Status|"American Society of Anesthesiologists Physical Status applied to each patient ranging from I to VI. The scale is defined as follows:~I: A normal healthy patient II: A patient with mild systemic disease III: A patient with severe systemic disease IV: A patient with severe systemic disease that is a constant threat to life V: A moribund patient who is not expected to survive without the operation VI: A declared brain-dead patient whose organs are being removed for donor purposes"|participants|Number|3|3.0||||||
4212965|NCT00721110|4036498|B2|A patient with severe systemic disease||American Society of Anesthesiologists Physical Status|"American Society of Anesthesiologists Physical Status applied to each patient ranging from I to VI. The scale is defined as follows:~I: A normal healthy patient II: A patient with mild systemic disease III: A patient with severe systemic disease IV: A patient with severe systemic disease that is a constant threat to life V: A moribund patient who is not expected to survive without the operation VI: A declared brain-dead patient whose organs are being removed for donor purposes"|participants|Number|3|3.0||||||
4212966|NCT00721110|4036499|B1|A patient with severe systemic disease||American Society of Anesthesiologists Physical Status|"American Society of Anesthesiologists Physical Status applied to each patient ranging from I to VI. The scale is defined as follows:~I: A normal healthy patient II: A patient with mild systemic disease III: A patient with severe systemic disease IV: A patient with severe systemic disease that is a constant threat to life V: A moribund patient who is not expected to survive without the operation VI: A declared brain-dead patient whose organs are being removed for donor purposes"|participants|Number|1|1.0||||||
4212967|NCT00721110|4036495|B5|A patient with mild systemic disease||American Society of Anesthesiologists Physical Status|"American Society of Anesthesiologists Physical Status applied to each patient ranging from I to VI. The scale is defined as follows:~I: A normal healthy patient II: A patient with mild systemic disease III: A patient with severe systemic disease IV: A patient with severe systemic disease that is a constant threat to life V: A moribund patient who is not expected to survive without the operation VI: A declared brain-dead patient whose organs are being removed for donor purposes"|participants|Number|52|52.0||||||
4212968|NCT00721110|4036496|B4|A patient with mild systemic disease||American Society of Anesthesiologists Physical Status|"American Society of Anesthesiologists Physical Status applied to each patient ranging from I to VI. The scale is defined as follows:~I: A normal healthy patient II: A patient with mild systemic disease III: A patient with severe systemic disease IV: A patient with severe systemic disease that is a constant threat to life V: A moribund patient who is not expected to survive without the operation VI: A declared brain-dead patient whose organs are being removed for donor purposes"|participants|Number|15|15.0||||||
4212969|NCT00721110|4036497|B3|A patient with mild systemic disease||American Society of Anesthesiologists Physical Status|"American Society of Anesthesiologists Physical Status applied to each patient ranging from I to VI. The scale is defined as follows:~I: A normal healthy patient II: A patient with mild systemic disease III: A patient with severe systemic disease IV: A patient with severe systemic disease that is a constant threat to life V: A moribund patient who is not expected to survive without the operation VI: A declared brain-dead patient whose organs are being removed for donor purposes"|participants|Number|10|10.0||||||
4212970|NCT00721110|4036498|B2|A patient with mild systemic disease||American Society of Anesthesiologists Physical Status|"American Society of Anesthesiologists Physical Status applied to each patient ranging from I to VI. The scale is defined as follows:~I: A normal healthy patient II: A patient with mild systemic disease III: A patient with severe systemic disease IV: A patient with severe systemic disease that is a constant threat to life V: A moribund patient who is not expected to survive without the operation VI: A declared brain-dead patient whose organs are being removed for donor purposes"|participants|Number|13|13.0||||||
4213008|NCT00720941|4036529|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4213009|NCT00720941|4036530|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4213010|NCT00720941|4036528|B3||Male|Sex: Female, Male||Participants|Count of Participants|813|813.0||||||
4213011|NCT00720941|4036529|B2||Male|Sex: Female, Male||Participants|Count of Participants|415|415.0||||||
4212971|NCT00721110|4036499|B1|A patient with mild systemic disease||American Society of Anesthesiologists Physical Status|"American Society of Anesthesiologists Physical Status applied to each patient ranging from I to VI. The scale is defined as follows:~I: A normal healthy patient II: A patient with mild systemic disease III: A patient with severe systemic disease IV: A patient with severe systemic disease that is a constant threat to life V: A moribund patient who is not expected to survive without the operation VI: A declared brain-dead patient whose organs are being removed for donor purposes"|participants|Number|14|14.0||||||
4212972|NCT00721110|4036495|B5|A normal healthy patient||American Society of Anesthesiologists Physical Status|"American Society of Anesthesiologists Physical Status applied to each patient ranging from I to VI. The scale is defined as follows:~I: A normal healthy patient II: A patient with mild systemic disease III: A patient with severe systemic disease IV: A patient with severe systemic disease that is a constant threat to life V: A moribund patient who is not expected to survive without the operation VI: A declared brain-dead patient whose organs are being removed for donor purposes"|participants|Number|2|2.0||||||
4212973|NCT00721110|4036496|B4|A normal healthy patient||American Society of Anesthesiologists Physical Status|"American Society of Anesthesiologists Physical Status applied to each patient ranging from I to VI. The scale is defined as follows:~I: A normal healthy patient II: A patient with mild systemic disease III: A patient with severe systemic disease IV: A patient with severe systemic disease that is a constant threat to life V: A moribund patient who is not expected to survive without the operation VI: A declared brain-dead patient whose organs are being removed for donor purposes"|participants|Number|0|0.0||||||
4212974|NCT00721110|4036497|B3|A normal healthy patient||American Society of Anesthesiologists Physical Status|"American Society of Anesthesiologists Physical Status applied to each patient ranging from I to VI. The scale is defined as follows:~I: A normal healthy patient II: A patient with mild systemic disease III: A patient with severe systemic disease IV: A patient with severe systemic disease that is a constant threat to life V: A moribund patient who is not expected to survive without the operation VI: A declared brain-dead patient whose organs are being removed for donor purposes"|participants|Number|2|2.0||||||
4212975|NCT00721110|4036498|B2|A normal healthy patient||American Society of Anesthesiologists Physical Status|"American Society of Anesthesiologists Physical Status applied to each patient ranging from I to VI. The scale is defined as follows:~I: A normal healthy patient II: A patient with mild systemic disease III: A patient with severe systemic disease IV: A patient with severe systemic disease that is a constant threat to life V: A moribund patient who is not expected to survive without the operation VI: A declared brain-dead patient whose organs are being removed for donor purposes"|participants|Number|0|0.0||||||
4212976|NCT00721110|4036499|B1|A normal healthy patient||American Society of Anesthesiologists Physical Status|"American Society of Anesthesiologists Physical Status applied to each patient ranging from I to VI. The scale is defined as follows:~I: A normal healthy patient II: A patient with mild systemic disease III: A patient with severe systemic disease IV: A patient with severe systemic disease that is a constant threat to life V: A moribund patient who is not expected to survive without the operation VI: A declared brain-dead patient whose organs are being removed for donor purposes"|participants|Number|0|0.0||||||
4212977|NCT00721110|4036495|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4212978|NCT00721110|4036496|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4212979|NCT00721110|4036497|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4212980|NCT00721110|4036498|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4212981|NCT00721110|4036499|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4212982|NCT00721110|4036495|B5||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4212983|NCT00721110|4036496|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4212984|NCT00721110|4036497|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4212985|NCT00721110|4036498|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4212986|NCT00721110|4036499|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4212987|NCT00721110|4036495|B5|||Age||years|Mean|46|46.0|Standard Deviation|8|8.0|||
4212988|NCT00721110|4036496|B4|||Age||years|Mean|47|47.0|Standard Deviation|8|8.0|||
4212989|NCT00721110|4036497|B3|||Age||years|Mean|46|46.0|Standard Deviation|9|9.0|||
4212990|NCT00721110|4036498|B2|||Age||years|Mean|46|46.0|Standard Deviation|7|7.0|||
4212991|NCT00721110|4036499|B1|||Age||years|Mean|46|46.0|Standard Deviation|7|7.0|||
4212992|NCT00720941|4036528|B3|Unknown||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4212993|NCT00720941|4036529|B2|Unknown||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4212994|NCT00720941|4036530|B1|Unknown||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4212995|NCT00720941|4036528|B3|American Indian or Alaska Native & White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4212996|NCT00720941|4036529|B2|American Indian or Alaska Native & White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4212997|NCT00720941|4036530|B1|American Indian or Alaska Native & White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4212998|NCT00720941|4036528|B3|White||Race/Ethnicity, Customized||Participants|Number|707|707.0||||||
4212999|NCT00720941|4036529|B2|White||Race/Ethnicity, Customized||Participants|Number|358|358.0||||||
4213000|NCT00720941|4036530|B1|White||Race/Ethnicity, Customized||Participants|Number|349|349.0||||||
4213001|NCT00720941|4036528|B3|Asian||Race/Ethnicity, Customized||Participants|Number|382|382.0||||||
4213002|NCT00720941|4036529|B2|Asian||Race/Ethnicity, Customized||Participants|Number|188|188.0||||||
4213003|NCT00720941|4036530|B1|Asian||Race/Ethnicity, Customized||Participants|Number|194|194.0||||||
4213004|NCT00720941|4036528|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4213005|NCT00720941|4036529|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4213006|NCT00720941|4036530|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4213007|NCT00720941|4036528|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4213012|NCT00720941|4036530|B1||Male|Sex: Female, Male||Participants|Count of Participants|398|398.0||||||
4213013|NCT00720941|4036528|B3||Female|Sex: Female, Male||Participants|Count of Participants|297|297.0||||||
4213014|NCT00720941|4036529|B2||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4213015|NCT00720941|4036530|B1||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4213016|NCT00720941|4036528|B3|||Age||Years|Mean|61.1|61.1|Standard Deviation|10.93|10.93|||
4213017|NCT00720941|4036529|B2|||Age||Years|Mean|61.2|61.2|Standard Deviation|10.98|10.98|||
4213018|NCT00720941|4036530|B1|||Age||Years|Mean|60.9|60.9|Standard Deviation|10.89|10.89|||
4213019|NCT00720876|4036571|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4213020|NCT00720876|4036571|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213021|NCT00720876|4036571|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213022|NCT00720876|4036571|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4213023|NCT00720876|4036571|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213024|NCT00720876|4036571|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213025|NCT00720876|4036571|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4213026|NCT00720876|4036571|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213027|NCT00720876|4036571|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4213028|NCT00720876|4036571|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4213029|NCT00720876|4036571|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4213030|NCT00720876|4036571|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4213031|NCT00720876|4036571|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4213032|NCT00720876|4036571|B1|||Age||years|Median|62|62.0|Full Range|||44.0|85.0|
4213033|NCT00720798|4036577|B1||Male|Sex: Female, Male||Participants|Count of Participants|378|378.0||||||
4213034|NCT00720798|4036577|B1||Female|Sex: Female, Male||Participants|Count of Participants|1689|1689.0||||||
4213035|NCT00720798|4036577|B1|||Age||years|Mean|52.2|52.2|Standard Deviation|12.60|12.6|||
4213036|NCT00720759|4036596|B5|United States||Region of Enrollment||participants|Number|24|24.0||||||
4213037|NCT00720759|4036597|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
4213038|NCT00720759|4036598|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4213039|NCT00720759|4036599|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4213040|NCT00720759|4036600|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4213041|NCT00720759|4036596|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4213042|NCT00720759|4036597|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4213043|NCT00720759|4036598|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4213044|NCT00720759|4036599|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4213045|NCT00720759|4036600|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4213046|NCT00720759|4036596|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4213047|NCT00720759|4036597|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4213048|NCT00720759|4036598|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4213049|NCT00720759|4036599|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4213050|NCT00720759|4036600|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4213051|NCT00720759|4036596|B5|||Age||years|Mean|58.2|58.2|Standard Deviation|8.9|8.9|||
4213052|NCT00720759|4036597|B4|||Age||years|Mean|58.17|58.17|Standard Deviation|11.63|11.63|||
4213053|NCT00720759|4036598|B3|||Age||years|Mean|56.50|56.5|Standard Deviation|12.31|12.31|||
4213054|NCT00720759|4036599|B2|||Age||years|Mean|57.83|57.83|Standard Deviation|4.40|4.4|||
4213055|NCT00720759|4036600|B1|||Age||years|Mean|60.33|60.33|Standard Deviation|6.71|6.71|||
4213056|NCT00720759|4036596|B5||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4213057|NCT00720759|4036597|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4213058|NCT00720759|4036598|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4213059|NCT00720759|4036599|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4213060|NCT00720759|4036600|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4213061|NCT00720759|4036596|B5||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4213062|NCT00720759|4036597|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4213063|NCT00720759|4036598|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4213064|NCT00720759|4036599|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4213065|NCT00720759|4036600|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4213066|NCT00720759|4036596|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4213067|NCT00720759|4036597|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4213068|NCT00720759|4036598|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4213069|NCT00720759|4036599|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4213070|NCT00720759|4036600|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4213071|NCT00720629|4036613|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4213072|NCT00720629|4036613|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4213073|NCT00720629|4036613|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4213074|NCT00720629|4036613|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4213075|NCT00720629|4036613|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4213076|NCT00720629|4036613|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4213077|NCT00720629|4036613|B1|||Age||years|Median|36.5|36.5|Full Range|||23.0|50.0|
4213078|NCT00720499|4036623|B1||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4213079|NCT00720499|4036623|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4213080|NCT00720499|4036623|B1|||Age||years|Mean|63.67|63.67|Standard Deviation|8.19|8.19|||
4213081|NCT00720473|4036686|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
4213082|NCT00720473|4036687|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4213083|NCT00720473|4036688|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4213084|NCT00720473|4036686|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4213085|NCT00720473|4036687|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4213086|NCT00720473|4036688|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4213087|NCT00720473|4036686|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4213088|NCT00720473|4036687|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4213089|NCT00720473|4036688|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4213090|NCT00720473|4036686|B3|||Age||years|Mean|64.6|64.6|Standard Deviation|7.4|7.4|||
4213091|NCT00720473|4036687|B2|||Age||years|Mean|67.5|67.5|Standard Deviation|8.8|8.8|||
4213092|NCT00720473|4036688|B1|||Age||years|Mean|62.0|62.0|Standard Deviation|5.9|5.9|||
4213093|NCT00720473|4036686|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4213094|NCT00720473|4036687|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4213095|NCT00720473|4036688|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4213096|NCT00720473|4036686|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4213097|NCT00720473|4036687|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4213098|NCT00720473|4036688|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4213099|NCT00720473|4036686|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4213100|NCT00720473|4036687|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4213101|NCT00720473|4036688|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4213102|NCT00720434|4036713|B5||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4213103|NCT00720434|4036714|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4213104|NCT00720434|4036715|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4213105|NCT00720434|4036716|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4213106|NCT00720434|4036717|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4213107|NCT00720434|4036713|B5||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4213108|NCT00720434|4036714|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4213109|NCT00720434|4036715|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4213110|NCT00720434|4036716|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4213111|NCT00720434|4036717|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4213112|NCT00720434|4036713|B5|45 to 64 years||Age, Customized||participants|Number|23|23.0||||||
4213113|NCT00720434|4036714|B4|45 to 64 years||Age, Customized||participants|Number|7|7.0||||||
4213114|NCT00720434|4036715|B3|45 to 64 years||Age, Customized||participants|Number|5|5.0||||||
4213115|NCT00720434|4036716|B2|45 to 64 years||Age, Customized||participants|Number|6|6.0||||||
4213116|NCT00720434|4036717|B1|45 to 64 years||Age, Customized||participants|Number|5|5.0||||||
4213117|NCT00720434|4036713|B5|18 to 44 years||Age, Customized||participants|Number|12|12.0||||||
4213118|NCT00720434|4036714|B4|18 to 44 years||Age, Customized||participants|Number|1|1.0||||||
4213119|NCT00720434|4036715|B3|18 to 44 years||Age, Customized||participants|Number|3|3.0||||||
4213120|NCT00720434|4036716|B2|18 to 44 years||Age, Customized||participants|Number|3|3.0||||||
4213121|NCT00720434|4036717|B1|18 to 44 years||Age, Customized||participants|Number|5|5.0||||||
4213122|NCT00720382|4036742|B3|United States||Region of Enrollment||participants|Number|703|703.0||||||
4213123|NCT00720382|4036743|B2|United States||Region of Enrollment||participants|Number|237|237.0||||||
4213124|NCT00720382|4036744|B1|United States||Region of Enrollment||participants|Number|466|466.0||||||
4213125|NCT00720382|4036742|B3||Male|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4213126|NCT00720382|4036743|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4213127|NCT00720382|4036744|B1||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4213128|NCT00720382|4036742|B3||Female|Sex: Female, Male||Participants|Count of Participants|485|485.0||||||
4213129|NCT00720382|4036743|B2||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4213130|NCT00720382|4036744|B1||Female|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
4213131|NCT00720382|4036742|B3|||Age||years|Mean|39.2|39.2|Standard Deviation|14.55|14.55|||
4213132|NCT00720382|4036743|B2|||Age||years|Mean|39.1|39.1|Standard Deviation|14.61|14.61|||
4213133|NCT00720382|4036744|B1|||Age||years|Mean|39.3|39.3|Standard Deviation|14.54|14.54|||
4213134|NCT00720382|4036742|B3||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4213135|NCT00720382|4036743|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4213136|NCT00720382|4036744|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4213137|NCT00720382|4036742|B3||Between 18 and 65 years|Age||Participants|Count of Participants|621|621.0||||||
4213138|NCT00720382|4036743|B2||Between 18 and 65 years|Age||Participants|Count of Participants|211|211.0||||||
4213139|NCT00720382|4036744|B1||Between 18 and 65 years|Age||Participants|Count of Participants|410|410.0||||||
4213140|NCT00720382|4036742|B3||<=18 years|Age||Participants|Count of Participants|55|55.0||||||
4213141|NCT00720382|4036743|B2||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
4213142|NCT00720382|4036744|B1||<=18 years|Age||Participants|Count of Participants|37|37.0||||||
4213143|NCT00720369|4036753|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4213144|NCT00720369|4036754|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4213145|NCT00720369|4036755|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4213146|NCT00720369|4036753|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4213147|NCT00720369|4036754|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4213148|NCT00720369|4036755|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4213149|NCT00720369|4036753|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4213150|NCT00720369|4036754|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4213151|NCT00720369|4036755|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4213152|NCT00720369|4036753|B3|||Age||years|Mean|64.6|64.6|Standard Deviation|8.3|8.3|||
4213153|NCT00720369|4036754|B2|||Age||years|Mean|66.4|66.4|Standard Deviation|9.5|9.5|||
4213154|NCT00720369|4036755|B1|||Age||years|Mean|63.4|63.4|Standard Deviation|7.5|7.5|||
4213155|NCT00720369|4036753|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4213156|NCT00720369|4036754|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4213157|NCT00720369|4036755|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4213158|NCT00720369|4036753|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4213159|NCT00720369|4036754|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4213160|NCT00720369|4036755|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4213161|NCT00720369|4036753|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4213162|NCT00720369|4036754|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4213163|NCT00720369|4036755|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4213164|NCT00720356|4036764|B1||Unmethylated MGMT promoter|Methylated/unmethylated MGMT promoter|After registration step 1 was completed, patients tissue was sent out for methylation MGMT determination. Only patients with unmethylated MGMT promoters were eligible for the study and completed registration step 2.|Participants|Count of Participants|48|48.0||||||
4213165|NCT00720356|4036764|B1||Methylated MGMT promoter|Methylated/unmethylated MGMT promoter|After registration step 1 was completed, patients tissue was sent out for methylation MGMT determination. Only patients with unmethylated MGMT promoters were eligible for the study and completed registration step 2.|Participants|Count of Participants|67|67.0||||||
4213166|NCT00720356|4036764|B1|United States||Region of Enrollment||participants|Number|115|115.0||||||
4213167|NCT00720356|4036764|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4213168|NCT00720356|4036764|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213169|NCT00720356|4036764|B1||White|Race (NIH/OMB)||Participants|Count of Participants|109|109.0||||||
4213170|NCT00720356|4036764|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4213171|NCT00720356|4036764|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213172|NCT00720356|4036764|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213173|NCT00720356|4036764|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213174|NCT00720356|4036764|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4213175|NCT00720356|4036764|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4213176|NCT00720356|4036764|B1||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
4213177|NCT00720356|4036764|B1||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
4213178|NCT00720356|4036764|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4213179|NCT00720343|4036778|B1|United States||Region of Enrollment||participants|Number|54|54.0||||||
4213180|NCT00720343|4036778|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4213181|NCT00720343|4036778|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4213182|NCT00720343|4036778|B1|18 to 60 years||Age, Customized||participants|Number|54|54.0||||||
4213183|NCT00720330|4036784|B4|||Height||cm|Mean|179|179.0|Standard Deviation|7|7.0|||
4213184|NCT00720330|4036785|B3|||Height||cm|Mean|179|179.0|Standard Deviation|13|13.0|||
4213185|NCT00720330|4036786|B2|||Height||cm|Mean|183|183.0|Standard Deviation|5|5.0|||
4213186|NCT00720330|4036787|B1|||Height||cm|Mean|176|176.0|Standard Deviation|10|10.0|||
4213187|NCT00720330|4036784|B4|||Weight||kg|Mean|88|88.0|Standard Deviation|15|15.0|||
4213188|NCT00720330|4036785|B3|||Weight||kg|Mean|101|101.0|Standard Deviation|13|13.0|||
4213189|NCT00720330|4036786|B2|||Weight||kg|Mean|77|77.0|Standard Deviation|14|14.0|||
4213190|NCT00720330|4036787|B1|||Weight||kg|Mean|90|90.0|Standard Deviation|13|13.0|||
4213191|NCT00720330|4036784|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213192|NCT00720330|4036785|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213193|NCT00720330|4036786|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213194|NCT00720330|4036787|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213195|NCT00720330|4036784|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213196|NCT00720330|4036785|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213197|NCT00720330|4036786|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213198|NCT00720330|4036787|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213199|NCT00720330|4036784|B4||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4213200|NCT00720330|4036785|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4213201|NCT00720330|4036786|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4213202|NCT00720330|4036787|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4213203|NCT00720330|4036784|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4213204|NCT00720330|4036785|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4213205|NCT00720330|4036786|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213206|NCT00720330|4036787|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213207|NCT00720330|4036784|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213208|NCT00720330|4036785|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213209|NCT00720330|4036786|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213210|NCT00720330|4036787|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213211|NCT00720330|4036784|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213212|NCT00720330|4036785|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213213|NCT00720330|4036786|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213214|NCT00720330|4036787|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213215|NCT00720330|4036784|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213216|NCT00720330|4036785|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213217|NCT00720330|4036786|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213218|NCT00720330|4036787|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213219|NCT00720330|4036784|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4213220|NCT00720330|4036785|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4213221|NCT00720330|4036786|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4213222|NCT00720330|4036787|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4213223|NCT00720330|4036784|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4213224|NCT00720330|4036785|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4213225|NCT00720330|4036786|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4213226|NCT00720330|4036787|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4213227|NCT00720330|4036784|B4|||Age||years|Mean|50|50.0|Standard Deviation|11|11.0|||
4213228|NCT00720330|4036785|B3|||Age||years|Mean|53|53.0|Standard Deviation|13|13.0|||
4213229|NCT00720330|4036786|B2|||Age||years|Mean|52|52.0|Standard Deviation|10|10.0|||
4213230|NCT00720330|4036787|B1|||Age||years|Mean|48|48.0|Standard Deviation|12|12.0|||
4213231|NCT00720278|4036809|B4|United States||Region of Enrollment|Number of participants based on ITT population|participants|Number|523|523.0||||||
4213232|NCT00720278|4036810|B3|United States||Region of Enrollment|Number of participants based on ITT population|participants|Number|177|177.0||||||
4213233|NCT00720278|4036811|B2|United States||Region of Enrollment|Number of participants based on ITT population|participants|Number|169|169.0||||||
4213234|NCT00720278|4036812|B1|United States||Region of Enrollment|Number of participants based on ITT population|participants|Number|177|177.0||||||
4213235|NCT00720278|4036809|B4||Male|Sex: Female, Male|Number of participants based on ITT population|Participants|Count of Participants|189|189.0||||||
4213236|NCT00720278|4036810|B3||Male|Sex: Female, Male|Number of participants based on ITT population|Participants|Count of Participants|70|70.0||||||
4213237|NCT00720278|4036811|B2||Male|Sex: Female, Male|Number of participants based on ITT population|Participants|Count of Participants|58|58.0||||||
4213238|NCT00720278|4036812|B1||Male|Sex: Female, Male|Number of participants based on ITT population|Participants|Count of Participants|61|61.0||||||
4213239|NCT00720278|4036809|B4||Female|Sex: Female, Male|Number of participants based on ITT population|Participants|Count of Participants|334|334.0||||||
4213240|NCT00720278|4036810|B3||Female|Sex: Female, Male|Number of participants based on ITT population|Participants|Count of Participants|107|107.0||||||
4213241|NCT00720278|4036811|B2||Female|Sex: Female, Male|Number of participants based on ITT population|Participants|Count of Participants|111|111.0||||||
4213242|NCT00720278|4036812|B1||Female|Sex: Female, Male|Number of participants based on ITT population|Participants|Count of Participants|116|116.0||||||
4213243|NCT00720278|4036809|B4|||Age|Number of participants based on ITT population|years|Mean|36.7|36.7|Standard Deviation|14.23|14.23|||
4213244|NCT00720278|4036810|B3|||Age|Number of participants based on ITT population|years|Mean|37.7|37.7|Standard Deviation|14.64|14.64|||
4213245|NCT00720278|4036811|B2|||Age|Number of participants based on ITT population|years|Mean|35.4|35.4|Standard Deviation|13.74|13.74|||
4213246|NCT00720278|4036812|B1|||Age|Number of participants based on ITT population|years|Mean|36.9|36.9|Standard Deviation|14.27|14.27|||
4213247|NCT00720278|4036809|B4||>=65 years|Age|Number of participants based on ITT population|Participants|Count of Participants|12|12.0||||||
4213248|NCT00720278|4036810|B3||>=65 years|Age|Number of participants based on ITT population|Participants|Count of Participants|5|5.0||||||
4213249|NCT00720278|4036811|B2||>=65 years|Age|Number of participants based on ITT population|Participants|Count of Participants|2|2.0||||||
4213250|NCT00720278|4036812|B1||>=65 years|Age|Number of participants based on ITT population|Participants|Count of Participants|5|5.0||||||
4213251|NCT00720278|4036809|B4||Between 18 and 65 years|Age|Number of participants based on ITT population|Participants|Count of Participants|455|455.0||||||
4213252|NCT00720278|4036810|B3||Between 18 and 65 years|Age|Number of participants based on ITT population|Participants|Count of Participants|156|156.0||||||
4213253|NCT00720278|4036811|B2||Between 18 and 65 years|Age|Number of participants based on ITT population|Participants|Count of Participants|151|151.0||||||
4213254|NCT00720278|4036812|B1||Between 18 and 65 years|Age|Number of participants based on ITT population|Participants|Count of Participants|148|148.0||||||
4213255|NCT00720278|4036809|B4||<=18 years|Age|Number of participants based on ITT population|Participants|Count of Participants|56|56.0||||||
4213256|NCT00720278|4036810|B3||<=18 years|Age|Number of participants based on ITT population|Participants|Count of Participants|16|16.0||||||
4213257|NCT00720278|4036811|B2||<=18 years|Age|Number of participants based on ITT population|Participants|Count of Participants|16|16.0||||||
4213258|NCT00720278|4036812|B1||<=18 years|Age|Number of participants based on ITT population|Participants|Count of Participants|24|24.0||||||
4213259|NCT00720226|4036834|B3|||Emphysema on HRCT|Emphysema was measured as percent of lung voxels with Hounsfield units (HU) less than -950 HU. Participants with 5-35% of lung parenchyma with HU < -950 were considered to have radiographic emphysema.|Participants|Count of Participants|45|45.0||||||
4213260|NCT00720226|4036835|B2|||Emphysema on HRCT|Emphysema was measured as percent of lung voxels with Hounsfield units (HU) less than -950 HU. Participants with 5-35% of lung parenchyma with HU < -950 were considered to have radiographic emphysema.|Participants|Count of Participants|21|21.0||||||
4213261|NCT00720226|4036836|B1|||Emphysema on HRCT|Emphysema was measured as percent of lung voxels with Hounsfield units (HU) less than -950 HU. Participants with 5-35% of lung parenchyma with HU < -950 were considered to have radiographic emphysema.|Participants|Count of Participants|24|24.0||||||
4213262|NCT00720226|4036834|B3|Former Smoker||Smoking Status||participants|Number|34|34.0||||||
4213263|NCT00720226|4036835|B2|Former Smoker||Smoking Status||participants|Number|16|16.0||||||
4213264|NCT00720226|4036836|B1|Former Smoker||Smoking Status||participants|Number|18|18.0||||||
4213265|NCT00720226|4036834|B3|Current Smoker||Smoking Status||participants|Number|72|72.0||||||
4213266|NCT00720226|4036835|B2|Current Smoker||Smoking Status||participants|Number|36|36.0||||||
4213267|NCT00720226|4036836|B1|Current Smoker||Smoking Status||participants|Number|36|36.0||||||
4213268|NCT00720226|4036834|B3|||FEV1/FVC (%)|Ratio of Forced Expiratory Volume in 1 second (FEV1) divided by Forced Vital Capacity (FVC) and then multiplied by 100 to give the ratio in percent.|percent|Mean|51.4|51.4|Standard Deviation|15.4|15.4|||
4213269|NCT00720226|4036835|B2|||FEV1/FVC (%)|Ratio of Forced Expiratory Volume in 1 second (FEV1) divided by Forced Vital Capacity (FVC) and then multiplied by 100 to give the ratio in percent.|percent|Mean|49.9|49.9|Standard Deviation|11.3|11.3|||
4213270|NCT00720226|4036836|B1|||FEV1/FVC (%)|Ratio of Forced Expiratory Volume in 1 second (FEV1) divided by Forced Vital Capacity (FVC) and then multiplied by 100 to give the ratio in percent.|percent|Mean|52.9|52.9|Standard Deviation|10.5|10.5|||
4213271|NCT00720226|4036834|B3|||FEV1 (L)||L (BTPS)|Mean|1.49|1.49|Standard Deviation|0.69|0.69|||
4213272|NCT00720226|4036835|B2|||FEV1 (L)||L (BTPS)|Mean|1.42|1.42|Standard Deviation|.46|0.46|||
4213273|NCT00720226|4036836|B1|||FEV1 (L)||L (BTPS)|Mean|1.57|1.57|Standard Deviation|0.52|0.52|||
4213274|NCT00720226|4036834|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213275|NCT00720226|4036835|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213276|NCT00720226|4036836|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213277|NCT00720226|4036834|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213278|NCT00720226|4036835|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213279|NCT00720226|4036836|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213280|NCT00720226|4036834|B3||White|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
4213281|NCT00720226|4036835|B2||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4213282|NCT00720226|4036836|B1||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4213283|NCT00720226|4036834|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4213284|NCT00720226|4036835|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4213285|NCT00720226|4036836|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4213286|NCT00720226|4036834|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213287|NCT00720226|4036835|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213288|NCT00720226|4036836|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213289|NCT00720226|4036834|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213290|NCT00720226|4036835|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213291|NCT00720226|4036836|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213292|NCT00720226|4036834|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213293|NCT00720226|4036835|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213294|NCT00720226|4036836|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213295|NCT00720226|4036834|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4213296|NCT00720226|4036835|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4213297|NCT00720226|4036836|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4213298|NCT00720226|4036834|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4213299|NCT00720226|4036835|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4213300|NCT00720226|4036836|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4213301|NCT00720226|4036834|B3|||Age||Years|Mean|58.8|58.8|Standard Deviation|14.0|14.0|||
4213302|NCT00720226|4036835|B2|||Age||Years|Mean|59.3|59.3|Standard Deviation|9.8|9.8|||
4213303|NCT00720226|4036836|B1|||Age||Years|Mean|58.3|58.3|Standard Deviation|10.0|10.0|||
4213304|NCT00720122|4036845|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4213305|NCT00720122|4036845|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4213306|NCT00720122|4036845|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4213307|NCT00720122|4036845|B1|||Age||years|Mean|20.142857|20.142857|Standard Deviation|3.6180032|3.6180032|||
4213308|NCT00720122|4036845|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4213309|NCT00720122|4036845|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4213310|NCT00720122|4036845|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4213311|NCT00720109|4036849|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213312|NCT00720109|4036849|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4213313|NCT00720109|4036849|B1||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4213314|NCT00720109|4036849|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4213315|NCT00720109|4036849|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4213316|NCT00720109|4036849|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4213317|NCT00720109|4036849|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4213318|NCT00720109|4036849|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4213319|NCT00720109|4036849|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4213320|NCT00720109|4036849|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4213321|NCT00720109|4036849|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4213322|NCT00720109|4036849|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4213323|NCT00720109|4036849|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4213324|NCT00720109|4036849|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4213325|NCT00720109|4036849|B1||<=18 years|Age||Participants|Count of Participants|56|56.0||||||
4213326|NCT00720096|4036869|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4213327|NCT00720096|4036870|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4213328|NCT00720096|4036871|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4213329|NCT00720096|4036869|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4213330|NCT00720096|4036870|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4213331|NCT00720096|4036871|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4213332|NCT00720096|4036869|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4213333|NCT00720096|4036870|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4213334|NCT00720096|4036871|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4213335|NCT00720096|4036869|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4213336|NCT00720096|4036870|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4213337|NCT00720096|4036871|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4213338|NCT00720096|4036869|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4213339|NCT00720096|4036870|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4213340|NCT00720096|4036871|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4213341|NCT00720096|4036869|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4213342|NCT00720096|4036870|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4213343|NCT00720096|4036871|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4213344|NCT00720083|4036882|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4213345|NCT00720083|4036883|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4213346|NCT00720083|4036884|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4213347|NCT00720083|4036882|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4213348|NCT00720083|4036883|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4213349|NCT00720083|4036884|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4213350|NCT00720083|4036882|B3|||Age||years|Median|57|57.0|Full Range|||39.0|76.0|
4213351|NCT00720083|4036883|B2|||Age||years|Median|53|53.0|Full Range|||39.0|76.0|
4213352|NCT00720083|4036884|B1|||Age||years|Median|57|57.0|Full Range|||40.0|74.0|
4213353|NCT00720057|4036891|B3|||Baseline Pain Intensity by Visual Analog Scale|Visual Analog Scale 0-100 mm: 0 is no pain and 100 is worse possible pain.|scores on a scale|Mean|72.4|72.4|Standard Deviation|12.51|12.51|||
4213354|NCT00720057|4036892|B2|||Baseline Pain Intensity by Visual Analog Scale|Visual Analog Scale 0-100 mm: 0 is no pain and 100 is worse possible pain.|scores on a scale|Mean|72.6|72.6|Standard Deviation|11.91|11.91|||
4213355|NCT00720057|4036893|B1|||Baseline Pain Intensity by Visual Analog Scale|Visual Analog Scale 0-100 mm: 0 is no pain and 100 is worse possible pain.|scores on a scale|Mean|72.3|72.3|Standard Deviation|13.13|13.13|||
4213356|NCT00720057|4036891|B3|Severe||Baseline Pain Intensity by Categorical Scale|Categorical scale: No Pain (0), Mild Pain (1), Moderate Pain (2), Severe Pain (3).|participants|Number|110|110.0||||||
4213357|NCT00720057|4036892|B2|Severe||Baseline Pain Intensity by Categorical Scale|Categorical scale: No Pain (0), Mild Pain (1), Moderate Pain (2), Severe Pain (3).|participants|Number|56|56.0||||||
4213358|NCT00720057|4036893|B1|Severe||Baseline Pain Intensity by Categorical Scale|Categorical scale: No Pain (0), Mild Pain (1), Moderate Pain (2), Severe Pain (3).|participants|Number|54|54.0||||||
4213359|NCT00720057|4036891|B3|Moderate||Baseline Pain Intensity by Categorical Scale|Categorical scale: No Pain (0), Mild Pain (1), Moderate Pain (2), Severe Pain (3).|participants|Number|202|202.0||||||
4213360|NCT00720057|4036892|B2|Moderate||Baseline Pain Intensity by Categorical Scale|Categorical scale: No Pain (0), Mild Pain (1), Moderate Pain (2), Severe Pain (3).|participants|Number|103|103.0||||||
4213361|NCT00720057|4036893|B1|Moderate||Baseline Pain Intensity by Categorical Scale|Categorical scale: No Pain (0), Mild Pain (1), Moderate Pain (2), Severe Pain (3).|participants|Number|99|99.0||||||
4213362|NCT00720057|4036891|B3||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4213363|NCT00720057|4036892|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4213364|NCT00720057|4036893|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4213365|NCT00720057|4036891|B3||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4213366|NCT00720057|4036892|B2||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4213367|NCT00720057|4036893|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4213368|NCT00720057|4036891|B3|||Age||years|Mean|20.6|20.6|Standard Deviation|4.17|4.17|||
4213369|NCT00720057|4036892|B2|||Age||years|Mean|20.4|20.4|Standard Deviation|4.31|4.31|||
4213370|NCT00720057|4036893|B1|||Age||years|Mean|20.8|20.8|Standard Deviation|4.03|4.03|||
4213371|NCT00719953|4036910|B1|Israel||Region of Enrollment||participants|Number|30|30.0||||||
4213372|NCT00719953|4036910|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4213373|NCT00719953|4036910|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4213374|NCT00719953|4036910|B1|||Age||years|Mean|72.97|72.97|Standard Deviation|6.16|6.16|||
4213375|NCT00719914|4036914|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4213376|NCT00719914|4036915|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4213377|NCT00719914|4036916|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4213378|NCT00719914|4036914|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4213379|NCT00719914|4036915|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4213380|NCT00719914|4036916|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4213381|NCT00719914|4036914|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4213382|NCT00719914|4036915|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4213383|NCT00719914|4036916|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4213384|NCT00719914|4036914|B3|>=75 years||Age, Customized||participants|Number|2|2.0||||||
4213385|NCT00719914|4036915|B2|>=75 years||Age, Customized||participants|Number|1|1.0||||||
4213386|NCT00719914|4036916|B1|>=75 years||Age, Customized||participants|Number|1|1.0||||||
4213387|NCT00719914|4036914|B3|Between 18 and 75 years||Age, Customized||participants|Number|15|15.0||||||
4213388|NCT00719914|4036915|B2|Between 18 and 75 years||Age, Customized||participants|Number|6|6.0||||||
4213389|NCT00719914|4036916|B1|Between 18 and 75 years||Age, Customized||participants|Number|9|9.0||||||
4213390|NCT00719914|4036914|B3|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4213391|NCT00719914|4036915|B2|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4213392|NCT00719914|4036916|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4213393|NCT00719914|4036914|B3|||Age||years|Mean|61.6|61.6|Standard Deviation|10.7|10.7|||
4213394|NCT00719914|4036915|B2|||Age||years|Mean|67|67.0|Standard Deviation|9.5|9.5|||
4213395|NCT00719914|4036916|B1|||Age||years|Mean|57.9|57.9|Standard Deviation|10.2|10.2|||
4213396|NCT00719901|4036923|B1|Obatoclax mesylate IV 40 mg/m^2||Dose Level||participants|Number|3|3.0||||||
4213397|NCT00719901|4036923|B1|Obatoclax mesylate IV 30 mg/m^2||Dose Level||participants|Number|4|4.0||||||
4213398|NCT00719901|4036923|B1|Obatoclax mesylate IV 14 mg/m^2||Dose Level||participants|Number|3|3.0||||||
4213399|NCT00719901|4036923|B1|1=Restricted in physically strenuous activity||Performance Status||participants|Number|9|9.0||||||
4213400|NCT00719901|4036923|B1|0=Fully active||Performance Status||participants|Number|1|1.0||||||
4213401|NCT00719901|4036923|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4213402|NCT00719901|4036923|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4213403|NCT00719901|4036923|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4213404|NCT00719901|4036923|B1|||Age||years|Mean|62.1|62.1|Standard Deviation|10.4|10.4|||
4213405|NCT00719862|4036933|B3|United States||Region of Enrollment|Participants are based on ITT population|participants|Number|480|480.0||||||
4213406|NCT00719862|4036934|B2|United States||Region of Enrollment|Participants are based on ITT population|participants|Number|238|238.0||||||
4213407|NCT00719862|4036935|B1|United States||Region of Enrollment|Participants are based on ITT population|participants|Number|242|242.0||||||
4213408|NCT00719862|4036933|B3||Male|Sex: Female, Male|Number of participants is based on ITT population|Participants|Count of Participants|164|164.0||||||
4213409|NCT00719862|4036934|B2||Male|Sex: Female, Male|Number of participants is based on ITT population|Participants|Count of Participants|84|84.0||||||
4213410|NCT00719862|4036935|B1||Male|Sex: Female, Male|Number of participants is based on ITT population|Participants|Count of Participants|80|80.0||||||
4213411|NCT00719862|4036933|B3||Female|Sex: Female, Male|Number of participants is based on ITT population|Participants|Count of Participants|316|316.0||||||
4213412|NCT00719862|4036934|B2||Female|Sex: Female, Male|Number of participants is based on ITT population|Participants|Count of Participants|154|154.0||||||
4213413|NCT00719862|4036935|B1||Female|Sex: Female, Male|Number of participants is based on ITT population|Participants|Count of Participants|162|162.0||||||
4213414|NCT00719862|4036933|B3|||Age|Number of participants based on ITT population|years|Mean|35.4|35.4|Standard Deviation|13.71|13.71|||
4213415|NCT00719862|4036934|B2|||Age|Number of participants based on ITT population|years|Mean|35.5|35.5|Standard Deviation|13.53|13.53|||
4213416|NCT00719862|4036935|B1|||Age|Number of participants based on ITT population|years|Mean|35.3|35.3|Standard Deviation|13.91|13.91|||
4213417|NCT00719862|4036933|B3||>=65 years|Age|Number of participants based on ITT population|Participants|Count of Participants|11|11.0||||||
4213418|NCT00719862|4036934|B2||>=65 years|Age|Number of participants based on ITT population|Participants|Count of Participants|3|3.0||||||
4213419|NCT00719862|4036935|B1||>=65 years|Age|Number of participants based on ITT population|Participants|Count of Participants|8|8.0||||||
4213420|NCT00719862|4036933|B3||Between 18 and 65 years|Age|Number of participants based on ITT population|Participants|Count of Participants|418|418.0||||||
4213421|NCT00719862|4036934|B2||Between 18 and 65 years|Age|Number of participants based on ITT population|Participants|Count of Participants|213|213.0||||||
4213422|NCT00719862|4036935|B1||Between 18 and 65 years|Age|Number of participants based on ITT population|Participants|Count of Participants|205|205.0||||||
4213423|NCT00719862|4036933|B3||<=18 years|Age|Number of participants based on ITT population|Participants|Count of Participants|51|51.0||||||
4213424|NCT00719862|4036934|B2||<=18 years|Age|Number of participants based on ITT population|Participants|Count of Participants|22|22.0||||||
4213425|NCT00719862|4036935|B1||<=18 years|Age|Number of participants based on ITT population|Participants|Count of Participants|29|29.0||||||
4213426|NCT00719849|4036952|B3||MDS (Myelodysplastic Syndromes)|Disease Diagnosis||Participants|Count of Participants|2|2.0||||||
4213427|NCT00719849|4036953|B2||MDS (Myelodysplastic Syndromes)|Disease Diagnosis||Participants|Count of Participants|2|2.0||||||
4213428|NCT00719849|4036954|B1||MDS (Myelodysplastic Syndromes)|Disease Diagnosis||Participants|Count of Participants|0|0.0||||||
4213429|NCT00719849|4036952|B3||NHL (Non-Hodgkin's Lymphoma)|Disease Diagnosis||Participants|Count of Participants|1|1.0||||||
4213430|NCT00719849|4036953|B2||NHL (Non-Hodgkin's Lymphoma)|Disease Diagnosis||Participants|Count of Participants|1|1.0||||||
4213431|NCT00719849|4036954|B1||NHL (Non-Hodgkin's Lymphoma)|Disease Diagnosis||Participants|Count of Participants|0|0.0||||||
4213432|NCT00719849|4036952|B3||CML (Chronic Myeloid Leukemia)|Disease Diagnosis||Participants|Count of Participants|1|1.0||||||
4213433|NCT00719849|4036953|B2||CML (Chronic Myeloid Leukemia)|Disease Diagnosis||Participants|Count of Participants|1|1.0||||||
4213434|NCT00719849|4036954|B1||CML (Chronic Myeloid Leukemia)|Disease Diagnosis||Participants|Count of Participants|0|0.0||||||
4213435|NCT00719849|4036952|B3||AML (Acute Myeloid Leukemia)|Disease Diagnosis||Participants|Count of Participants|9|9.0||||||
4213436|NCT00719849|4036953|B2||AML (Acute Myeloid Leukemia)|Disease Diagnosis||Participants|Count of Participants|5|5.0||||||
4213437|NCT00719849|4036954|B1||AML (Acute Myeloid Leukemia)|Disease Diagnosis||Participants|Count of Participants|4|4.0||||||
4213438|NCT00719849|4036952|B3|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4213439|NCT00719849|4036953|B2|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4213440|NCT00719849|4036954|B1|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4213441|NCT00719849|4036952|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213442|NCT00719849|4036953|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213443|NCT00719849|4036954|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213444|NCT00719849|4036952|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213445|NCT00719849|4036953|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213446|NCT00719849|4036954|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213447|NCT00719849|4036952|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4213448|NCT00719849|4036953|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4213449|NCT00719849|4036954|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4213450|NCT00719849|4036952|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4213451|NCT00719849|4036953|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4213452|NCT00719849|4036954|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213453|NCT00719849|4036952|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213454|NCT00719849|4036953|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213455|NCT00719849|4036954|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213456|NCT00719849|4036952|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213457|NCT00719849|4036953|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213458|NCT00719849|4036954|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213459|NCT00719849|4036952|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213460|NCT00719849|4036953|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213521|NCT00719615|4037049|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4213461|NCT00719849|4036954|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213462|NCT00719849|4036952|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4213463|NCT00719849|4036953|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4213464|NCT00719849|4036954|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4213465|NCT00719849|4036952|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4213466|NCT00719849|4036953|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4213467|NCT00719849|4036954|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4213468|NCT00719849|4036952|B3|||Age||years|Mean|53.6|53.6|Full Range|||24.0|68.0|
4213469|NCT00719849|4036953|B2|||Age||years|Mean|55.1|55.1|Full Range|||37.0|68.0|
4213470|NCT00719849|4036954|B1|||Age||years|Mean|52.5|52.5|Full Range|||24.0|67.0|
4213471|NCT00719810|4036991|B4||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4213472|NCT00719810|4036992|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4213473|NCT00719810|4036993|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4213474|NCT00719810|4036994|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4213475|NCT00719810|4036991|B4||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4213476|NCT00719810|4036992|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4213477|NCT00719810|4036993|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4213478|NCT00719810|4036994|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4213479|NCT00719810|4036991|B4|||Age||years|Mean|40.1|40.1|Standard Deviation|14.51|14.51|||
4213480|NCT00719810|4036992|B3|||Age||years|Mean|40.4|40.4|Standard Deviation|13.83|13.83|||
4213481|NCT00719810|4036993|B2|||Age||years|Mean|37.2|37.2|Standard Deviation|14.35|14.35|||
4213482|NCT00719810|4036994|B1|||Age||years|Mean|42.7|42.7|Standard Deviation|15.10|15.1|||
4213483|NCT00719732|4037007|B1|Male||Gender|Gender not received for 212 of 218 subjects, therefore, gender missing for 6 subjects.|participants|Number|124|124.0||||||
4213484|NCT00719732|4037007|B1|Female||Gender|Gender not received for 212 of 218 subjects, therefore, gender missing for 6 subjects.|participants|Number|88|88.0||||||
4213485|NCT00719732|4037007|B1|>=65 years||Age|Date of birth received for 207 of 218 subjects; therefore, age data not available for 11 subjects.|participants|Number|64|64.0||||||
4213486|NCT00719732|4037007|B1|Between 18 and 65 years||Age|Date of birth received for 207 of 218 subjects; therefore, age data not available for 11 subjects.|participants|Number|143|143.0||||||
4213487|NCT00719732|4037007|B1|<=18 years||Age|Date of birth received for 207 of 218 subjects; therefore, age data not available for 11 subjects.|participants|Number|0|0.0||||||
4213488|NCT00719706|4037011|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4213489|NCT00719706|4037012|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4213490|NCT00719706|4037013|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4213491|NCT00719706|4037011|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4213492|NCT00719706|4037012|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4213493|NCT00719706|4037013|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4213494|NCT00719706|4037011|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4213495|NCT00719706|4037012|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4213496|NCT00719706|4037013|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4213497|NCT00719706|4037011|B3|||Age||years|Mean|45.45|45.45|Standard Deviation|11.1|11.1|||
4213498|NCT00719706|4037012|B2|||Age||years|Mean|44.9|44.9|Standard Deviation|11.9|11.9|||
4213499|NCT00719706|4037013|B1|||Age||years|Mean|46|46.0|Standard Deviation|10.3|10.3|||
4213500|NCT00719706|4037011|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4213501|NCT00719706|4037012|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4213502|NCT00719706|4037013|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4213503|NCT00719706|4037011|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4213504|NCT00719706|4037012|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4213505|NCT00719706|4037013|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4213506|NCT00719706|4037011|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4213507|NCT00719706|4037012|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4213508|NCT00719706|4037013|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4213509|NCT00719680|4037028|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4213510|NCT00719680|4037028|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4213511|NCT00719680|4037028|B1|>= 65 years||Age, Customized||participants|Number|3|3.0||||||
4213512|NCT00719680|4037028|B1|>= 16 to < 65 years||Age, Customized||participants|Number|16|16.0||||||
4213513|NCT00719680|4037028|B1|>= 12 to < 16 years||Age, Customized||participants|Number|1|1.0||||||
4213514|NCT00719680|4037028|B1|>= 2 to < 12 years||Age, Customized||participants|Number|1|1.0||||||
4213515|NCT00719680|4037028|B1|||Age||years|Mean|42.4|42.4|Standard Deviation|18.53|18.53|||
4213516|NCT00719615|4037048|B4|United States||Region of Enrollment||participants|Number|111|111.0||||||
4213517|NCT00719615|4037049|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4213518|NCT00719615|4037050|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
4213519|NCT00719615|4037051|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4213520|NCT00719615|4037048|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4213522|NCT00719615|4037050|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4213523|NCT00719615|4037051|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4213524|NCT00719615|4037048|B4||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4213525|NCT00719615|4037049|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4213526|NCT00719615|4037050|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4213527|NCT00719615|4037051|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4213528|NCT00719615|4037048|B4||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4213529|NCT00719615|4037049|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4213530|NCT00719615|4037050|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4213531|NCT00719615|4037051|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4213532|NCT00719615|4037048|B4||Between 18 and 65 years|Age||Participants|Count of Participants|106|106.0||||||
4213533|NCT00719615|4037049|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4213534|NCT00719615|4037050|B2||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4213535|NCT00719615|4037051|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4213536|NCT00719615|4037048|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4213537|NCT00719615|4037049|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4213538|NCT00719615|4037050|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4213539|NCT00719615|4037051|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4213540|NCT00719576|4037061|B3|France||Region of Enrollment||participants|Number|18|18.0||||||
4213541|NCT00719576|4037062|B2|France||Region of Enrollment||participants|Number|9|9.0||||||
4213542|NCT00719576|4037063|B1|France||Region of Enrollment||participants|Number|9|9.0||||||
4213543|NCT00719576|4037061|B3|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
4213544|NCT00719576|4037062|B2|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4213545|NCT00719576|4037063|B1|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4213546|NCT00719576|4037061|B3|Poland||Region of Enrollment||participants|Number|28|28.0||||||
4213547|NCT00719576|4037062|B2|Poland||Region of Enrollment||participants|Number|14|14.0||||||
4213548|NCT00719576|4037063|B1|Poland||Region of Enrollment||participants|Number|14|14.0||||||
4213549|NCT00719576|4037061|B3|Norway||Region of Enrollment||participants|Number|6|6.0||||||
4213550|NCT00719576|4037062|B2|Norway||Region of Enrollment||participants|Number|3|3.0||||||
4213551|NCT00719576|4037063|B1|Norway||Region of Enrollment||participants|Number|3|3.0||||||
4213552|NCT00719576|4037061|B3|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
4213553|NCT00719576|4037062|B2|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
4213554|NCT00719576|4037063|B1|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
4213555|NCT00719576|4037061|B3|Netherlands||Region of Enrollment||participants|Number|58|58.0||||||
4213556|NCT00719576|4037062|B2|Netherlands||Region of Enrollment||participants|Number|30|30.0||||||
4213557|NCT00719576|4037063|B1|Netherlands||Region of Enrollment||participants|Number|28|28.0||||||
4213558|NCT00719576|4037061|B3|Czech Republic||Region of Enrollment||participants|Number|24|24.0||||||
4213559|NCT00719576|4037062|B2|Czech Republic||Region of Enrollment||participants|Number|11|11.0||||||
4213560|NCT00719576|4037063|B1|Czech Republic||Region of Enrollment||participants|Number|13|13.0||||||
4213561|NCT00719576|4037061|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4213562|NCT00719576|4037062|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4213563|NCT00719576|4037063|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4213564|NCT00719576|4037061|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4213565|NCT00719576|4037062|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4213566|NCT00719576|4037063|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4213567|NCT00719576|4037061|B3|||Age||years|Mean|33.8|33.8|Standard Deviation|9.00|9.0|||
4213568|NCT00719576|4037062|B2|||Age||years|Mean|32.9|32.9|Standard Deviation|8.78|8.78|||
4213569|NCT00719576|4037063|B1|||Age||years|Mean|34.8|34.8|Standard Deviation|9.16|9.16|||
4213570|NCT00719563|4037082|B3|Missing||Exercising regularly||participants|Number|6|6.0||||||
4213571|NCT00719563|4037083|B2|Missing||Exercising regularly||participants|Number|4|4.0||||||
4213572|NCT00719563|4037084|B1|Missing||Exercising regularly||participants|Number|2|2.0||||||
4213573|NCT00719563|4037082|B3|No||Exercising regularly||participants|Number|196|196.0||||||
4213574|NCT00719563|4037083|B2|No||Exercising regularly||participants|Number|98|98.0||||||
4213575|NCT00719563|4037084|B1|No||Exercising regularly||participants|Number|98|98.0||||||
4213576|NCT00719563|4037082|B3|Yes||Exercising regularly||participants|Number|139|139.0||||||
4213577|NCT00719563|4037083|B2|Yes||Exercising regularly||participants|Number|68|68.0||||||
4213578|NCT00719563|4037084|B1|Yes||Exercising regularly||participants|Number|71|71.0||||||
4213579|NCT00719563|4037082|B3|Not taking sleep aids||If taking sleep aids, how frequent?||participants|Number|269|269.0||||||
4213580|NCT00719563|4037083|B2|Not taking sleep aids||If taking sleep aids, how frequent?||participants|Number|141|141.0||||||
4213581|NCT00719563|4037084|B1|Not taking sleep aids||If taking sleep aids, how frequent?||participants|Number|128|128.0||||||
4213582|NCT00719563|4037082|B3|Intermittent||If taking sleep aids, how frequent?||participants|Number|38|38.0||||||
4213583|NCT00719563|4037083|B2|Intermittent||If taking sleep aids, how frequent?||participants|Number|13|13.0||||||
4213584|NCT00719563|4037084|B1|Intermittent||If taking sleep aids, how frequent?||participants|Number|25|25.0||||||
4213585|NCT00719563|4037082|B3|Daily||If taking sleep aids, how frequent?||participants|Number|34|34.0||||||
4213586|NCT00719563|4037083|B2|Daily||If taking sleep aids, how frequent?||participants|Number|16|16.0||||||
4213587|NCT00719563|4037084|B1|Daily||If taking sleep aids, how frequent?||participants|Number|18|18.0||||||
4213588|NCT00719563|4037082|B3|No||Sleep aids||participants|Number|269|269.0||||||
4213589|NCT00719563|4037083|B2|No||Sleep aids||participants|Number|141|141.0||||||
4213590|NCT00719563|4037084|B1|No||Sleep aids||participants|Number|128|128.0||||||
4213591|NCT00719563|4037082|B3|Yes||Sleep aids||participants|Number|72|72.0||||||
4213592|NCT00719563|4037083|B2|Yes||Sleep aids||participants|Number|29|29.0||||||
4213593|NCT00719563|4037084|B1|Yes||Sleep aids||participants|Number|43|43.0||||||
4213594|NCT00719563|4037082|B3|None||Current endocrine therapy||participants|Number|219|219.0||||||
4213595|NCT00719563|4037083|B2|None||Current endocrine therapy||participants|Number|107|107.0||||||
4213596|NCT00719563|4037084|B1|None||Current endocrine therapy||participants|Number|112|112.0||||||
4213597|NCT00719563|4037082|B3|Other||Current endocrine therapy||participants|Number|10|10.0||||||
4213598|NCT00719563|4037083|B2|Other||Current endocrine therapy||participants|Number|3|3.0||||||
4213599|NCT00719563|4037084|B1|Other||Current endocrine therapy||participants|Number|7|7.0||||||
4213600|NCT00719563|4037082|B3|Antiandrogen||Current endocrine therapy||participants|Number|7|7.0||||||
4213601|NCT00719563|4037083|B2|Antiandrogen||Current endocrine therapy||participants|Number|5|5.0||||||
4213602|NCT00719563|4037084|B1|Antiandrogen||Current endocrine therapy||participants|Number|2|2.0||||||
4213603|NCT00719563|4037082|B3|Aromatase inhibitor||Current endocrine therapy||participants|Number|60|60.0||||||
4213604|NCT00719563|4037083|B2|Aromatase inhibitor||Current endocrine therapy||participants|Number|33|33.0||||||
4213605|NCT00719563|4037084|B1|Aromatase inhibitor||Current endocrine therapy||participants|Number|27|27.0||||||
4213606|NCT00719563|4037082|B3|Tamoxifen||Current endocrine therapy||participants|Number|45|45.0||||||
4213607|NCT00719563|4037083|B2|Tamoxifen||Current endocrine therapy||participants|Number|22|22.0||||||
4213608|NCT00719563|4037084|B1|Tamoxifen||Current endocrine therapy||participants|Number|23|23.0||||||
4213609|NCT00719563|4037082|B3|No||Currently receiving treatment||participants|Number|175|175.0||||||
4213610|NCT00719563|4037083|B2|No||Currently receiving treatment||participants|Number|87|87.0||||||
4213611|NCT00719563|4037084|B1|No||Currently receiving treatment||participants|Number|88|88.0||||||
4213612|NCT00719563|4037082|B3|Yes||Currently receiving treatment||participants|Number|166|166.0||||||
4213613|NCT00719563|4037083|B2|Yes||Currently receiving treatment||participants|Number|83|83.0||||||
4213614|NCT00719563|4037084|B1|Yes||Currently receiving treatment||participants|Number|83|83.0||||||
4213615|NCT00719563|4037082|B3|Combination/unknown/other||Type of cancer||participants|Number|55|55.0||||||
4213616|NCT00719563|4037083|B2|Combination/unknown/other||Type of cancer||participants|Number|33|33.0||||||
4213617|NCT00719563|4037084|B1|Combination/unknown/other||Type of cancer||participants|Number|22|22.0||||||
4213618|NCT00719563|4037082|B3|Gynecologic||Type of cancer||participants|Number|12|12.0||||||
4213619|NCT00719563|4037083|B2|Gynecologic||Type of cancer||participants|Number|7|7.0||||||
4213620|NCT00719563|4037084|B1|Gynecologic||Type of cancer||participants|Number|5|5.0||||||
4213621|NCT00719563|4037082|B3|Hematologic||Type of cancer||participants|Number|17|17.0||||||
4213622|NCT00719563|4037083|B2|Hematologic||Type of cancer||participants|Number|9|9.0||||||
4213623|NCT00719563|4037084|B1|Hematologic||Type of cancer||participants|Number|8|8.0||||||
4213624|NCT00719563|4037082|B3|Prostate||Type of cancer||participants|Number|14|14.0||||||
4213625|NCT00719563|4037083|B2|Prostate||Type of cancer||participants|Number|8|8.0||||||
4213626|NCT00719563|4037084|B1|Prostate||Type of cancer||participants|Number|6|6.0||||||
4213627|NCT00719563|4037082|B3|Colon||Type of cancer||participants|Number|37|37.0||||||
4213628|NCT00719563|4037083|B2|Colon||Type of cancer||participants|Number|17|17.0||||||
4213629|NCT00719563|4037084|B1|Colon||Type of cancer||participants|Number|20|20.0||||||
4213630|NCT00719563|4037082|B3|Breast||Type of cancer||participants|Number|206|206.0||||||
4213631|NCT00719563|4037083|B2|Breast||Type of cancer||participants|Number|96|96.0||||||
4213632|NCT00719563|4037084|B1|Breast||Type of cancer||participants|Number|110|110.0||||||
4213633|NCT00719563|4037082|B3|No||More than one primary cancer||participants|Number|265|265.0||||||
4213634|NCT00719563|4037083|B2|No||More than one primary cancer||participants|Number|134|134.0||||||
4213635|NCT00719563|4037084|B1|No||More than one primary cancer||participants|Number|131|131.0||||||
4213636|NCT00719563|4037082|B3|Yes||More than one primary cancer||participants|Number|76|76.0||||||
4213637|NCT00719563|4037083|B2|Yes||More than one primary cancer||participants|Number|36|36.0||||||
4213638|NCT00719563|4037084|B1|Yes||More than one primary cancer||participants|Number|40|40.0||||||
4213639|NCT00719563|4037082|B3|>360 days||Time since current cancer diagnosis||participants|Number|125|125.0||||||
4213640|NCT00719563|4037083|B2|>360 days||Time since current cancer diagnosis||participants|Number|64|64.0||||||
4213641|NCT00719563|4037084|B1|>360 days||Time since current cancer diagnosis||participants|Number|61|61.0||||||
4213642|NCT00719563|4037082|B3|180-360 days||Time since current cancer diagnosis||participants|Number|89|89.0||||||
4213643|NCT00719563|4037083|B2|180-360 days||Time since current cancer diagnosis||participants|Number|42|42.0||||||
4213644|NCT00719563|4037084|B1|180-360 days||Time since current cancer diagnosis||participants|Number|47|47.0||||||
4213645|NCT00719563|4037082|B3|<180 days||Time since current cancer diagnosis||participants|Number|127|127.0||||||
4213646|NCT00719563|4037083|B2|<180 days||Time since current cancer diagnosis||participants|Number|64|64.0||||||
4213647|NCT00719563|4037084|B1|<180 days||Time since current cancer diagnosis||participants|Number|63|63.0||||||
4213648|NCT00719563|4037082|B3|Unknown||Menopausal status||participants|Number|13|13.0||||||
4213649|NCT00719563|4037083|B2|Unknown||Menopausal status||participants|Number|7|7.0||||||
4213650|NCT00719563|4037084|B1|Unknown||Menopausal status||participants|Number|6|6.0||||||
4213651|NCT00719563|4037082|B3|Not applicable (Male)||Menopausal status||participants|Number|75|75.0||||||
4213652|NCT00719563|4037083|B2|Not applicable (Male)||Menopausal status||participants|Number|42|42.0||||||
4213653|NCT00719563|4037084|B1|Not applicable (Male)||Menopausal status||participants|Number|33|33.0||||||
4213654|NCT00719563|4037082|B3|Post/natural-surgical||Menopausal status||participants|Number|185|185.0||||||
4213655|NCT00719563|4037083|B2|Post/natural-surgical||Menopausal status||participants|Number|90|90.0||||||
4213656|NCT00719563|4037084|B1|Post/natural-surgical||Menopausal status||participants|Number|95|95.0||||||
4213657|NCT00719563|4037082|B3|Pre||Menopausal status||participants|Number|68|68.0||||||
4213658|NCT00719563|4037083|B2|Pre||Menopausal status||participants|Number|31|31.0||||||
4213659|NCT00719563|4037084|B1|Pre||Menopausal status||participants|Number|37|37.0||||||
4213660|NCT00719563|4037082|B3|United States||Region of Enrollment||participants|Number|341|341.0||||||
4213661|NCT00719563|4037083|B2|United States||Region of Enrollment||participants|Number|170|170.0||||||
4213662|NCT00719563|4037084|B1|United States||Region of Enrollment||participants|Number|171|171.0||||||
4213663|NCT00719563|4037082|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4213664|NCT00719563|4037083|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213665|NCT00719563|4037084|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4213666|NCT00719563|4037082|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213667|NCT00719563|4037083|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213668|NCT00719563|4037084|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213669|NCT00719563|4037082|B3||White|Race (NIH/OMB)||Participants|Count of Participants|312|312.0||||||
4213670|NCT00719563|4037083|B2||White|Race (NIH/OMB)||Participants|Count of Participants|157|157.0||||||
4213671|NCT00719563|4037084|B1||White|Race (NIH/OMB)||Participants|Count of Participants|155|155.0||||||
4213672|NCT00719563|4037082|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4213673|NCT00719563|4037083|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4213674|NCT00719563|4037084|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4213675|NCT00719563|4037082|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4213676|NCT00719563|4037083|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213677|NCT00719563|4037084|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4213678|NCT00719563|4037082|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4213679|NCT00719563|4037083|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4213680|NCT00719563|4037084|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4213681|NCT00719563|4037082|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4213682|NCT00719563|4037083|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4213683|NCT00719563|4037084|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4213684|NCT00719563|4037082|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4213685|NCT00719563|4037083|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4213686|NCT00719563|4037084|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4213687|NCT00719563|4037082|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|330|330.0||||||
4213688|NCT00719563|4037083|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|166|166.0||||||
4213689|NCT00719563|4037084|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|164|164.0||||||
4213690|NCT00719563|4037082|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4213691|NCT00719563|4037083|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4213692|NCT00719563|4037084|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4213693|NCT00719563|4037082|B3||Male|Gender||Participants|Count of Participants|75|75.0||||||
4213694|NCT00719563|4037083|B2||Male|Gender||Participants|Count of Participants|42|42.0||||||
4213695|NCT00719563|4037084|B1||Male|Gender||Participants|Count of Participants|33|33.0||||||
4213696|NCT00719563|4037082|B3||Female|Gender||Participants|Count of Participants|266|266.0||||||
4213697|NCT00719563|4037083|B2||Female|Gender||Participants|Count of Participants|128|128.0||||||
4213698|NCT00719563|4037084|B1||Female|Gender||Participants|Count of Participants|138|138.0||||||
4213699|NCT00719563|4037082|B3|||Age||years|Mean|55.6|55.6|Standard Deviation|12.2|12.2|||
4213700|NCT00719563|4037083|B2|||Age||years|Mean|55.9|55.9|Standard Deviation|11.8|11.8|||
4213701|NCT00719563|4037084|B1|||Age||years|Mean|55.3|55.3|Standard Deviation|12.7|12.7|||
4213702|NCT00719537|4037115|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4213703|NCT00719537|4037116|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4213704|NCT00719537|4037117|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4213705|NCT00719537|4037115|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4213706|NCT00719537|4037116|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4213707|NCT00719537|4037117|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4213708|NCT00719537|4037115|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4213709|NCT00719537|4037116|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4213710|NCT00719537|4037117|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4213711|NCT00719537|4037115|B3||>=65 years|Age|18-50 years, female|Participants|Count of Participants|0|0.0||||||
4213712|NCT00719537|4037116|B2||>=65 years|Age|18-50 years, female|Participants|Count of Participants|0|0.0||||||
4213713|NCT00719537|4037117|B1||>=65 years|Age|18-50 years, female|Participants|Count of Participants|0|0.0||||||
4213714|NCT00719537|4037115|B3||Between 18 and 65 years|Age|18-50 years, female|Participants|Count of Participants|3|3.0||||||
4213715|NCT00719537|4037116|B2||Between 18 and 65 years|Age|18-50 years, female|Participants|Count of Participants|1|1.0||||||
4213716|NCT00719537|4037117|B1||Between 18 and 65 years|Age|18-50 years, female|Participants|Count of Participants|2|2.0||||||
4213717|NCT00719537|4037115|B3||<=18 years|Age|18-50 years, female|Participants|Count of Participants|0|0.0||||||
4213718|NCT00719537|4037116|B2||<=18 years|Age|18-50 years, female|Participants|Count of Participants|0|0.0||||||
4213719|NCT00719537|4037117|B1||<=18 years|Age|18-50 years, female|Participants|Count of Participants|0|0.0||||||
4213720|NCT00719472|4037124|B1||Male|Sex: Female, Male|Demographic data are reported for the intent-to-treat (ITT) population which included all patients who received at least 1 dose of rituximab regardless of infusion rate. Of the 451 enrolled patients, 26 withdrew before receiving treatment and were not included in the ITT population.|Participants|Count of Participants|234|234.0||||||
4213721|NCT00719472|4037124|B1||Female|Sex: Female, Male|Demographic data are reported for the intent-to-treat (ITT) population which included all patients who received at least 1 dose of rituximab regardless of infusion rate. Of the 451 enrolled patients, 26 withdrew before receiving treatment and were not included in the ITT population.|Participants|Count of Participants|191|191.0||||||
4213722|NCT00719472|4037124|B1|||Age|Demographic data are reported for the intent-to-treat (ITT) population which included all patients who received at least 1 dose of rituximab regardless of infusion rate. Of the 451 enrolled patients, 26 withdrew before receiving treatment and were not included in the ITT population.|years|Mean|62.7|62.7|Standard Deviation|13.4|13.4|||
4213723|NCT00719355|4037133|B3|United States||Region of Enrollment||participants|Number|103|103.0||||||
4213724|NCT00719355|4037134|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
4213725|NCT00719355|4037135|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4213726|NCT00719355|4037133|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4213727|NCT00719355|4037134|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4213728|NCT00719355|4037135|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4213729|NCT00719355|4037133|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4213730|NCT00719355|4037134|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4213731|NCT00719355|4037135|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4213732|NCT00719355|4037133|B3|||Age||years|Mean|69.7|69.7|Standard Deviation|8.9|8.9|||
4213733|NCT00719355|4037134|B2|||Age||years|Mean|68.0|68.0|Standard Deviation|8.5|8.5|||
4213734|NCT00719355|4037135|B1|||Age||years|Mean|71.4|71.4|Standard Deviation|9.1|9.1|||
4213735|NCT00719355|4037133|B3||>=65 years|Age||Participants|Count of Participants|64|64.0||||||
4213736|NCT00719355|4037134|B2||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4213737|NCT00719355|4037135|B1||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
4213738|NCT00719355|4037133|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4213739|NCT00719355|4037134|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4213740|NCT00719355|4037135|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4213741|NCT00719355|4037133|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4213742|NCT00719355|4037134|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4213743|NCT00719355|4037135|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4213744|NCT00719329|4037144|B4||Male|Sex: Female, Male||Participants|Count of Participants|976|976.0||||||
4213745|NCT00719329|4037145|B3||Male|Sex: Female, Male||Participants|Count of Participants|331|331.0||||||
4213746|NCT00719329|4037146|B2||Male|Sex: Female, Male||Participants|Count of Participants|279|279.0||||||
4213747|NCT00719329|4037147|B1||Male|Sex: Female, Male||Participants|Count of Participants|366|366.0||||||
4213748|NCT00719329|4037144|B4||Female|Sex: Female, Male||Participants|Count of Participants|947|947.0||||||
4213749|NCT00719329|4037145|B3||Female|Sex: Female, Male||Participants|Count of Participants|316|316.0||||||
4213750|NCT00719329|4037146|B2||Female|Sex: Female, Male||Participants|Count of Participants|292|292.0||||||
4213751|NCT00719329|4037147|B1||Female|Sex: Female, Male||Participants|Count of Participants|339|339.0||||||
4213752|NCT00719329|4037144|B4|>=24 Hours||Age, Customized||Participants|Number|118|118.0||||||
4213753|NCT00719329|4037145|B3|>=24 Hours||Age, Customized||Participants|Number|30|30.0||||||
4213754|NCT00719329|4037146|B2|>=24 Hours||Age, Customized||Participants|Number|45|45.0||||||
4213755|NCT00719329|4037147|B1|>=24 Hours||Age, Customized||Participants|Number|43|43.0||||||
4213756|NCT00719329|4037144|B4|[12, 24) Hours||Age, Customized||Participants|Number|242|242.0||||||
4213757|NCT00719329|4037145|B3|[12, 24) Hours||Age, Customized||Participants|Number|86|86.0||||||
4213758|NCT00719329|4037146|B2|[12, 24) Hours||Age, Customized||Participants|Number|72|72.0||||||
4213759|NCT00719329|4037147|B1|[12, 24) Hours||Age, Customized||Participants|Number|84|84.0||||||
4213760|NCT00719329|4037144|B4|[6, 12) Hours||Age, Customized||Participants|Number|324|324.0||||||
4213761|NCT00719329|4037145|B3|[6, 12) Hours||Age, Customized||Participants|Number|106|106.0||||||
4213762|NCT00719329|4037146|B2|[6, 12) Hours||Age, Customized||Participants|Number|104|104.0||||||
4213763|NCT00719329|4037147|B1|[6, 12) Hours||Age, Customized||Participants|Number|114|114.0||||||
4213764|NCT00719329|4037144|B4|[0, 6) Hours||Age, Customized||Participants|Number|1239|1239.0||||||
4213765|NCT00719329|4037145|B3|[0, 6) Hours||Age, Customized||Participants|Number|425|425.0||||||
4213766|NCT00719329|4037146|B2|[0, 6) Hours||Age, Customized||Participants|Number|350|350.0||||||
4213767|NCT00719329|4037147|B1|[0, 6) Hours||Age, Customized||Participants|Number|464|464.0||||||
4213768|NCT00719264|4037163|B3||Male|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
4213769|NCT00719264|4037164|B2||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4213770|NCT00719264|4037165|B1||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4213771|NCT00719264|4037163|B3||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4213772|NCT00719264|4037164|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4213773|NCT00719264|4037165|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4213774|NCT00719264|4037163|B3|||Age||Years|Mean|60.32|60.32|Standard Deviation|10.422|10.422|||
4213775|NCT00719264|4037164|B2|||Age||Years|Mean|59.93|59.93|Standard Deviation|10.272|10.272|||
4213776|NCT00719264|4037165|B1|||Age||Years|Mean|60.71|60.71|Standard Deviation|10.584|10.584|||
4213777|NCT00719212|4037185|B1|5 therapies||Number of prior therapies|Prior anti-tumor treatment characteristics|participants|Number|2|2.0||||||
4213778|NCT00719212|4037185|B1|4 therapies||Number of prior therapies|Prior anti-tumor treatment characteristics|participants|Number|3|3.0||||||
4213779|NCT00719212|4037185|B1|3 therapies||Number of prior therapies|Prior anti-tumor treatment characteristics|participants|Number|16|16.0||||||
4213780|NCT00719212|4037185|B1|2 therapies||Number of prior therapies|Prior anti-tumor treatment characteristics|participants|Number|38|38.0||||||
4213781|NCT00719212|4037185|B1|1 therapy||Number of prior therapies|Prior anti-tumor treatment characteristics|participants|Number|2|2.0||||||
4213782|NCT00719212|4037185|B1|With CA125normal+target lesions+/-nontargetlesions||CA 125 status|CA 125 level measurement from a blood sample|participants|Number|8|8.0||||||
4213783|NCT00719212|4037185|B1|With elevatCA125+target lesions+/-nontargetlesions||CA 125 status|CA 125 level measurement from a blood sample|participants|Number|37|37.0||||||
4213784|NCT00719212|4037185|B1|With elevated CA 125 + Non target lesion(s) only||CA 125 status|CA 125 level measurement from a blood sample|participants|Number|11|11.0||||||
4213785|NCT00719212|4037185|B1|With elevated CA 125 only||CA 125 status|CA 125 level measurement from a blood sample|participants|Number|5|5.0||||||
4213786|NCT00719212|4037185|B1|Not done||Histologic Grade (G)|Cancer cells compared with normal cells|participants|Number|9|9.0||||||
4213787|NCT00719212|4037185|B1|G3 (poorly differentiated)||Histologic Grade (G)|Cancer cells compared with normal cells|participants|Number|45|45.0||||||
4213788|NCT00719212|4037185|B1|G2 (moderately differentiated)||Histologic Grade (G)|Cancer cells compared with normal cells|participants|Number|6|6.0||||||
4213789|NCT00719212|4037185|B1|G1 (well differentiated)||Histologic Grade (G)|Cancer cells compared with normal cells|participants|Number|1|1.0||||||
4213790|NCT00719212|4037185|B1|Other||Histopathologic Type||participants|Number|6|6.0||||||
4213791|NCT00719212|4037185|B1|Mixed||Histopathologic Type||participants|Number|2|2.0||||||
4213792|NCT00719212|4037185|B1|Clear cell||Histopathologic Type||participants|Number|4|4.0||||||
4213793|NCT00719212|4037185|B1|Endometroid||Histopathologic Type||participants|Number|5|5.0||||||
4213794|NCT00719212|4037185|B1|Mucinous||Histopathologic Type||participants|Number|2|2.0||||||
4213795|NCT00719212|4037185|B1|Papillary serous||Histopathologic Type||participants|Number|42|42.0||||||
4213796|NCT00719212|4037185|B1|IV||Stage at First Diagnosis (International Federation of Gynecology and Obstetrics (FIGO) )|5-point ordinal scale to assess the extent of the disease (0 ->IV). Roman numeral staging from the less to the most advanced cancer. Individual stage (I to III) is broken down in substage: IA, IB, IC,...|participants|Number|5|5.0||||||
4213797|NCT00719212|4037185|B1|IIIC||Stage at First Diagnosis (International Federation of Gynecology and Obstetrics (FIGO) )|5-point ordinal scale to assess the extent of the disease (0 ->IV). Roman numeral staging from the less to the most advanced cancer. Individual stage (I to III) is broken down in substage: IA, IB, IC,...|participants|Number|44|44.0||||||
4213798|NCT00719212|4037185|B1|IIIB||Stage at First Diagnosis (International Federation of Gynecology and Obstetrics (FIGO) )|5-point ordinal scale to assess the extent of the disease (0 ->IV). Roman numeral staging from the less to the most advanced cancer. Individual stage (I to III) is broken down in substage: IA, IB, IC,...|participants|Number|3|3.0||||||
4213799|NCT00719212|4037185|B1|IIIA||Stage at First Diagnosis (International Federation of Gynecology and Obstetrics (FIGO) )|5-point ordinal scale to assess the extent of the disease (0 ->IV). Roman numeral staging from the less to the most advanced cancer. Individual stage (I to III) is broken down in substage: IA, IB, IC,...|participants|Number|1|1.0||||||
4213800|NCT00719212|4037185|B1|IIC||Stage at First Diagnosis (International Federation of Gynecology and Obstetrics (FIGO) )|5-point ordinal scale to assess the extent of the disease (0 ->IV). Roman numeral staging from the less to the most advanced cancer. Individual stage (I to III) is broken down in substage: IA, IB, IC,...|participants|Number|2|2.0||||||
4213801|NCT00719212|4037185|B1|IIB||Stage at First Diagnosis (International Federation of Gynecology and Obstetrics (FIGO) )|5-point ordinal scale to assess the extent of the disease (0 ->IV). Roman numeral staging from the less to the most advanced cancer. Individual stage (I to III) is broken down in substage: IA, IB, IC,...|participants|Number|2|2.0||||||
4213802|NCT00719212|4037185|B1|IIA||Stage at First Diagnosis (International Federation of Gynecology and Obstetrics (FIGO) )|5-point ordinal scale to assess the extent of the disease (0 ->IV). Roman numeral staging from the less to the most advanced cancer. Individual stage (I to III) is broken down in substage: IA, IB, IC,...|participants|Number|1|1.0||||||
4213803|NCT00719212|4037185|B1|IC||Stage at First Diagnosis (International Federation of Gynecology and Obstetrics (FIGO) )|5-point ordinal scale to assess the extent of the disease (0 ->IV). Roman numeral staging from the less to the most advanced cancer. Individual stage (I to III) is broken down in substage: IA, IB, IC,...|participants|Number|3|3.0||||||
4213804|NCT00719212|4037185|B1|Ovarian + Fallopian Tube||Origin of tumor||participants|Number|4|4.0||||||
4213805|NCT00719212|4037185|B1|Ovarian + Primary Peritoneal||Origin of tumor||participants|Number|3|3.0||||||
4213806|NCT00719212|4037185|B1|Ovarian||Origin of tumor||participants|Number|46|46.0||||||
4213807|NCT00719212|4037185|B1|Fallopian Tube||Origin of tumor||participants|Number|3|3.0||||||
4213808|NCT00719212|4037185|B1|Primary Peritoneal||Origin of tumor||participants|Number|5|5.0||||||
4213809|NCT00719212|4037185|B1|||Time from initial diagnosis to registration||Months|Mean|20.4|20.4|Standard Deviation|6.2|6.2|||
4213810|NCT00719212|4037185|B1|PS 1 (restricted in physically strenuous activity)||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|6-point (0 to 5) ordinal scale to assess how the disease affects the daily living abilities of the patient and determine apporpriate treatment and prognosis|participants|Number|20|20.0||||||
4213811|NCT00719212|4037185|B1|PS 0 (fully active)||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|6-point (0 to 5) ordinal scale to assess how the disease affects the daily living abilities of the patient and determine apporpriate treatment and prognosis|participants|Number|41|41.0||||||
4213812|NCT00719212|4037185|B1|Israel||Region of Enrollment||participants|Number|1|1.0||||||
4213813|NCT00719212|4037185|B1|Ireland||Region of Enrollment||participants|Number|7|7.0||||||
4213814|NCT00719212|4037185|B1|France||Region of Enrollment||participants|Number|24|24.0||||||
4213815|NCT00719212|4037185|B1|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4213816|NCT00719212|4037185|B1|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4213817|NCT00719212|4037185|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4213818|NCT00719212|4037185|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4213819|NCT00719212|4037185|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4213820|NCT00719212|4037185|B1|||Age||years|Mean|61.8|61.8|Standard Deviation|10.4|10.4|||
4213821|NCT00719212|4037185|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4213822|NCT00719212|4037185|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4213823|NCT00719212|4037185|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4213824|NCT00719186|4037195|B3|United States||Region of Enrollment||Participants|Count of Participants|750|750.0||||||
4213825|NCT00719186|4037196|B2|United States||Region of Enrollment||Participants|Count of Participants|374|374.0||||||
4213826|NCT00719186|4037197|B1|United States||Region of Enrollment||Participants|Count of Participants|376|376.0||||||
4213827|NCT00719186|4037195|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4213828|NCT00719186|4037196|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4213829|NCT00719186|4037197|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4213830|NCT00719186|4037195|B3||Female|Sex: Female, Male||Participants|Count of Participants|750|750.0||||||
4213831|NCT00719186|4037196|B2||Female|Sex: Female, Male||Participants|Count of Participants|374|374.0||||||
4213832|NCT00719186|4037197|B1||Female|Sex: Female, Male||Participants|Count of Participants|376|376.0||||||
4213833|NCT00719186|4037195|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4213834|NCT00719186|4037196|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4213835|NCT00719186|4037197|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4213836|NCT00719186|4037195|B3||Between 18 and 65 years|Age||Participants|Count of Participants|750|750.0||||||
4213837|NCT00719186|4037196|B2||Between 18 and 65 years|Age||Participants|Count of Participants|374|374.0||||||
4213838|NCT00719186|4037197|B1||Between 18 and 65 years|Age||Participants|Count of Participants|376|376.0||||||
4213839|NCT00719186|4037195|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4213840|NCT00719186|4037196|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4213841|NCT00719186|4037197|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4213842|NCT00719186|4037195|B3|||Age||years|Mean|28.9|28.9|Standard Deviation|4.3|4.3|||
4213843|NCT00719186|4037196|B2|||Age||years|Mean|28.9|28.9|Standard Deviation|4.5|4.5|||
4213844|NCT00719186|4037197|B1|||Age||years|Mean|28.2|28.2|Standard Deviation|4.0|4.0|||
4213845|NCT00719160|4037212|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4213846|NCT00719160|4037212|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4213847|NCT00719160|4037212|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4213848|NCT00719160|4037212|B1|||Age||years|Mean|30.9|30.9|Standard Deviation|8.3|8.3|||
4213849|NCT00719160|4037212|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4213850|NCT00719160|4037212|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4213851|NCT00719160|4037212|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4213852|NCT00719134|4037220|B1|||Headache intensity|pain score at 30 minutes after onset of migraine as measured on a visual analog scale that ranges from 0 (no pain) to 10 (worst pain imaginable).|units on a scale|Mean|4.6|4.6|Standard Deviation|1.8|1.8|||
4213853|NCT00719134|4037220|B1|United States||Region of Enrollment||participants|Number|76|76.0||||||
4213854|NCT00719134|4037220|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4213855|NCT00719134|4037220|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4213856|NCT00719134|4037220|B1|||Age||years|Mean|40.6|40.6|Standard Deviation|12.7|12.7|||
4213857|NCT00719043|4037226|B8||Male|Sex: Female, Male||Participants|Count of Participants|336|336.0||||||
4213858|NCT00719043|4037227|B7||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4213859|NCT00719043|4037228|B6||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4213860|NCT00719043|4037229|B5||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4213861|NCT00719043|4037230|B4||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4213862|NCT00719043|4037231|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4213863|NCT00719043|4037232|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4213864|NCT00719043|4037233|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4213865|NCT00719043|4037226|B8||Female|Sex: Female, Male||Participants|Count of Participants|505|505.0||||||
4213866|NCT00719043|4037227|B7||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4213867|NCT00719043|4037228|B6||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4213868|NCT00719043|4037229|B5||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4213869|NCT00719043|4037230|B4||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4213870|NCT00719043|4037231|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4213871|NCT00719043|4037232|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4213872|NCT00719043|4037233|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4213873|NCT00719043|4037226|B8|||Age||Years|Mean|49.95|49.95|Standard Deviation|17.99|17.99|||
4213874|NCT00719043|4037227|B7|||Age||Years|Mean|50.0|50.0|Standard Deviation|18.03|18.03|||
4213875|NCT00719043|4037228|B6|||Age||Years|Mean|50.1|50.1|Standard Deviation|18.92|18.92|||
4213876|NCT00719043|4037229|B5|||Age||Years|Mean|50.3|50.3|Standard Deviation|17.77|17.77|||
4213877|NCT00719043|4037230|B4|||Age||Years|Mean|49.2|49.2|Standard Deviation|17.75|17.75|||
4213878|NCT00719043|4037231|B3|||Age||Years|Mean|50.7|50.7|Standard Deviation|17.67|17.67|||
4213879|NCT00719043|4037232|B2|||Age||Years|Mean|49.6|49.6|Standard Deviation|17.93|17.93|||
4213880|NCT00719043|4037233|B1|||Age||Years|Mean|49.8|49.8|Standard Deviation|18.01|18.01|||
4213881|NCT00718887|4037361|B3|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4213882|NCT00718887|4037362|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4213883|NCT00718887|4037363|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4213884|NCT00718887|4037361|B3|Asian||Race/Ethnicity, Customized||Participants|Number|166|166.0||||||
4213885|NCT00718887|4037362|B2|Asian||Race/Ethnicity, Customized||Participants|Number|77|77.0||||||
4213886|NCT00718887|4037363|B1|Asian||Race/Ethnicity, Customized||Participants|Number|89|89.0||||||
4213887|NCT00718887|4037361|B3||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4213888|NCT00718887|4037362|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4213889|NCT00718887|4037363|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4213890|NCT00718887|4037361|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4213891|NCT00718887|4037362|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4213892|NCT00718887|4037363|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4213893|NCT00718887|4037361|B3|||Age||Years|Median|33.4|33.4|Full Range|||16.9|63.1|
4213894|NCT00718887|4037362|B2|||Age||Years|Median|34.1|34.1|Full Range|||18.9|63.1|
4213895|NCT00718887|4037363|B1|||Age||Years|Median|32.6|32.6|Full Range|||16.9|62.4|
4213896|NCT00718861|4037386|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4213897|NCT00718861|4037387|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4213898|NCT00718861|4037388|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4213899|NCT00718861|4037386|B3||Female|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4213900|NCT00718861|4037387|B2||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4213901|NCT00718861|4037388|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4213902|NCT00718861|4037386|B3|||Age||Years|Mean|78.1|78.1|Standard Deviation|4.77|4.77|||
4213903|NCT00718861|4037387|B2|||Age||Years|Mean|78.1|78.1|Standard Deviation|4.85|4.85|||
4213904|NCT00718861|4037388|B1|||Age||Years|Mean|78|78.0|Standard Deviation|4.71|4.71|||
4213905|NCT00718809|4037415|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4213906|NCT00718809|4037416|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213907|NCT00718809|4037417|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4213908|NCT00718809|4037415|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213909|NCT00718809|4037416|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213910|NCT00718809|4037417|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213911|NCT00718809|4037415|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4213912|NCT00718809|4037416|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4213913|NCT00718809|4037417|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4213914|NCT00718809|4037415|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4213915|NCT00718809|4037416|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213916|NCT00718809|4037417|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4213917|NCT00718809|4037415|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213918|NCT00718809|4037416|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213919|NCT00718809|4037417|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213920|NCT00718809|4037415|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4213921|NCT00718809|4037416|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4213922|NCT00718809|4037417|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4213923|NCT00718809|4037415|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213924|NCT00718809|4037416|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213925|NCT00718809|4037417|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213926|NCT00718809|4037415|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213927|NCT00718809|4037416|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213928|NCT00718809|4037417|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213929|NCT00718809|4037415|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4213930|NCT00718809|4037416|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4213931|NCT00718809|4037417|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4213932|NCT00718809|4037415|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4213933|NCT00718809|4037416|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4213934|NCT00718809|4037417|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4213935|NCT00718809|4037415|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4213936|NCT00718809|4037416|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4213937|NCT00718809|4037417|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4213938|NCT00718809|4037415|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4213939|NCT00718809|4037416|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4213940|NCT00718809|4037417|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4213941|NCT00718809|4037415|B3|||Age||years|Mean|51.3|51.3|Standard Deviation|14.76|14.76|||
4213942|NCT00718809|4037416|B2|||Age||years|Mean|54.2|54.2|Standard Deviation|17.94|17.94|||
4213943|NCT00718809|4037417|B1|||Age||years|Mean|49.2|49.2|Standard Deviation|12.25|12.25|||
4213944|NCT00718809|4037415|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4213945|NCT00718809|4037416|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4213946|NCT00718809|4037417|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4213947|NCT00718809|4037415|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4213948|NCT00718809|4037416|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4213949|NCT00718809|4037417|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4213950|NCT00718809|4037415|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4213951|NCT00718809|4037416|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4213952|NCT00718809|4037417|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4213953|NCT00718770|4037432|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4213954|NCT00718770|4037432|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4213955|NCT00718770|4037432|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4213956|NCT00718770|4037432|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|8.5|8.5|||
4213957|NCT00718770|4037432|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4213958|NCT00718770|4037432|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4213959|NCT00718770|4037432|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4213960|NCT00718718|4037436|B8|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4213961|NCT00718718|4037437|B7|United States||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4213962|NCT00718718|4037438|B6|United States||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4213963|NCT00718718|4037439|B5|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4213964|NCT00718718|4037440|B4|United States||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4213965|NCT00718718|4037441|B3|United States||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4213966|NCT00718718|4037442|B2|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4213967|NCT00718718|4037443|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4213968|NCT00718718|4037436|B8|Russian Federation||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
4213969|NCT00718718|4037437|B7|Russian Federation||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4213970|NCT00718718|4037438|B6|Russian Federation||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4213971|NCT00718718|4037439|B5|Russian Federation||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4213972|NCT00718718|4037440|B4|Russian Federation||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4213973|NCT00718718|4037441|B3|Russian Federation||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4213974|NCT00718718|4037442|B2|Russian Federation||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4213975|NCT00718718|4037443|B1|Russian Federation||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4213976|NCT00718718|4037436|B8|Republic of Korea||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4213977|NCT00718718|4037437|B7|Republic of Korea||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4213978|NCT00718718|4037438|B6|Republic of Korea||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4213979|NCT00718718|4037439|B5|Republic of Korea||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4213980|NCT00718718|4037440|B4|Republic of Korea||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4213981|NCT00718718|4037441|B3|Republic of Korea||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4213982|NCT00718718|4037442|B2|Republic of Korea||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4213983|NCT00718718|4037443|B1|Republic of Korea||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4213984|NCT00718718|4037436|B8|Poland||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
4213985|NCT00718718|4037437|B7|Poland||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4213986|NCT00718718|4037438|B6|Poland||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4213987|NCT00718718|4037439|B5|Poland||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4213988|NCT00718718|4037440|B4|Poland||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4213989|NCT00718718|4037441|B3|Poland||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4213990|NCT00718718|4037442|B2|Poland||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4213991|NCT00718718|4037443|B1|Poland||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4213992|NCT00718718|4037436|B8|Mexico||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4213993|NCT00718718|4037437|B7|Mexico||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4213994|NCT00718718|4037438|B6|Mexico||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4213995|NCT00718718|4037439|B5|Mexico||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4213996|NCT00718718|4037440|B4|Mexico||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4213997|NCT00718718|4037441|B3|Mexico||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4213998|NCT00718718|4037442|B2|Mexico||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4213999|NCT00718718|4037443|B1|Mexico||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4214000|NCT00718718|4037436|B8|Japan||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
4214001|NCT00718718|4037437|B7|Japan||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4214002|NCT00718718|4037438|B6|Japan||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4214003|NCT00718718|4037439|B5|Japan||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4214004|NCT00718718|4037440|B4|Japan||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4214005|NCT00718718|4037441|B3|Japan||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4214006|NCT00718718|4037442|B2|Japan||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4214007|NCT00718718|4037443|B1|Japan||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4214008|NCT00718718|4037436|B8|Hungary||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
4214009|NCT00718718|4037437|B7|Hungary||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4214010|NCT00718718|4037438|B6|Hungary||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4214011|NCT00718718|4037439|B5|Hungary||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4214012|NCT00718718|4037440|B4|Hungary||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4214013|NCT00718718|4037441|B3|Hungary||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4214014|NCT00718718|4037442|B2|Hungary||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4214015|NCT00718718|4037443|B1|Hungary||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4214016|NCT00718718|4037436|B8||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4214017|NCT00718718|4037437|B7||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4214018|NCT00718718|4037438|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4214019|NCT00718718|4037439|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4214020|NCT00718718|4037440|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4214021|NCT00718718|4037441|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4214022|NCT00718718|4037442|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4214023|NCT00718718|4037443|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4214024|NCT00718718|4037436|B8||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4214025|NCT00718718|4037437|B7||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4214026|NCT00718718|4037438|B6||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4214027|NCT00718718|4037439|B5||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4214028|NCT00718718|4037440|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4214029|NCT00718718|4037441|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4214030|NCT00718718|4037442|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4214031|NCT00718718|4037443|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4214032|NCT00718718|4037436|B8|||Age||years|Mean|51.8|51.8|Standard Deviation|11.26|11.26|||
4214033|NCT00718718|4037437|B7|||Age||years|Mean|52.8|52.8|Standard Deviation|9.41|9.41|||
4214034|NCT00718718|4037438|B6|||Age||years|Mean|50.9|50.9|Standard Deviation|10.29|10.29|||
4214035|NCT00718718|4037439|B5|||Age||years|Mean|52|52.0|Standard Deviation|11|11.0|||
4214036|NCT00718718|4037440|B4|||Age||years|Mean|53.8|53.8|Standard Deviation|13.02|13.02|||
4214037|NCT00718718|4037441|B3|||Age||years|Mean|54.1|54.1|Standard Deviation|12.72|12.72|||
4214038|NCT00718718|4037442|B2|||Age||years|Mean|50.1|50.1|Standard Deviation|10.72|10.72|||
4214039|NCT00718718|4037443|B1|||Age||years|Mean|46.2|46.2|Standard Deviation|10.24|10.24|||
4214040|NCT00718666|4037492|B4|Geographic ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|55|55.0||||||
4214041|NCT00718666|4037493|B3|Geographic ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4214042|NCT00718666|4037494|B2|Geographic ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
4214043|NCT00718666|4037495|B1|Geographic ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
4214044|NCT00718666|4037492|B4|Geographic ancestry|White-Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|185|185.0||||||
4214045|NCT00718666|4037493|B3|Geographic ancestry|White-Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
4214046|NCT00718666|4037494|B2|Geographic ancestry|White-Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|67|67.0||||||
4214047|NCT00718666|4037495|B1|Geographic ancestry|White-Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|72|72.0||||||
4214048|NCT00718666|4037492|B4|Geographic ancestry|White-Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4214049|NCT00718666|4037493|B3|Geographic ancestry|White-Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4214050|NCT00718666|4037494|B2|Geographic ancestry|White-Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4214051|NCT00718666|4037495|B1|Geographic ancestry|White-Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4214052|NCT00718666|4037492|B4|Geographic ancestry|Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4214053|NCT00718666|4037493|B3|Geographic ancestry|Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4214054|NCT00718666|4037494|B2|Geographic ancestry|Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4214055|NCT00718666|4037495|B1|Geographic ancestry|Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4214056|NCT00718666|4037492|B4|Geographic ancestry|Asian-South East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
4214057|NCT00718666|4037493|B3|Geographic ancestry|Asian-South East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4214058|NCT00718666|4037494|B2|Geographic ancestry|Asian-South East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4214059|NCT00718666|4037495|B1|Geographic ancestry|Asian-South East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4214060|NCT00718666|4037492|B4|Geographic ancestry|Asian-East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4214061|NCT00718666|4037493|B3|Geographic ancestry|Asian-East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4214062|NCT00718666|4037494|B2|Geographic ancestry|Asian-East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4214063|NCT00718666|4037495|B1|Geographic ancestry|Asian-East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4214064|NCT00718666|4037492|B4|Geographic ancestry|Asian-Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4214065|NCT00718666|4037493|B3|Geographic ancestry|Asian-Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4214066|NCT00718666|4037494|B2|Geographic ancestry|Asian-Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4214067|NCT00718666|4037495|B1|Geographic ancestry|Asian-Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4214068|NCT00718666|4037492|B4|Geographic ancestry|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
4214069|NCT00718666|4037493|B3|Geographic ancestry|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4214070|NCT00718666|4037494|B2|Geographic ancestry|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
4214071|NCT00718666|4037495|B1|Geographic ancestry|American Indian or Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4214072|NCT00718666|4037492|B4|Geographic ancestry|African heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
4214073|NCT00718666|4037493|B3|Geographic ancestry|African heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
4214074|NCT00718666|4037494|B2|Geographic ancestry|African heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4214075|NCT00718666|4037495|B1|Geographic ancestry|African heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4214076|NCT00718666|4037492|B4|Male||Sex/Gender, Customized||Participants|Count of Participants|182|182.0||||||
4214077|NCT00718666|4037493|B3|Male||Sex/Gender, Customized||Participants|Count of Participants|56|56.0||||||
4214078|NCT00718666|4037494|B2|Male||Sex/Gender, Customized||Participants|Count of Participants|64|64.0||||||
4214079|NCT00718666|4037495|B1|Male||Sex/Gender, Customized||Participants|Count of Participants|62|62.0||||||
4214080|NCT00718666|4037492|B4|Female||Sex/Gender, Customized||Participants|Count of Participants|166|166.0||||||
4214081|NCT00718666|4037493|B3|Female||Sex/Gender, Customized||Participants|Count of Participants|44|44.0||||||
4214082|NCT00718666|4037494|B2|Female||Sex/Gender, Customized||Participants|Count of Participants|66|66.0||||||
4214083|NCT00718666|4037495|B1|Female||Sex/Gender, Customized||Participants|Count of Participants|56|56.0||||||
4214084|NCT00718666|4037492|B4|||Age||Months|Mean|37.38|37.38|Standard Deviation|20.56|20.56|||
4214085|NCT00718666|4037493|B3|||Age||Months|Mean|69.2|69.2|Standard Deviation|6.6|6.6|||
4214086|NCT00718666|4037494|B2|||Age||Months|Mean|24.6|24.6|Standard Deviation|1.00|1.0|||
4214087|NCT00718666|4037495|B1|||Age||Months|Mean|24.5|24.5|Standard Deviation|0.97|0.97|||
4214088|NCT00718640|4037581|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4214089|NCT00718640|4037581|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4214090|NCT00718640|4037581|B1|>=75||Age, Customized||participants|Number|4|4.0||||||
4214091|NCT00718640|4037581|B1|Between 70-74||Age, Customized||participants|Number|4|4.0||||||
4214092|NCT00718640|4037581|B1|Between 65-69||Age, Customized||participants|Number|1|1.0||||||
4214093|NCT00718640|4037581|B1|< 65||Age, Customized||participants|Number|1|1.0||||||
4214094|NCT00718549|4037593|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4214095|NCT00718549|4037593|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4214096|NCT00718549|4037593|B1|||Age||years|Mean|57.5|57.5|Standard Deviation|8.3|8.3|||
4214097|NCT00718523|4037618|B3|missing||CA 125 status||participants|Number|1|1.0||||||
4214098|NCT00718523|4037619|B2|missing||CA 125 status||participants|Number|1|1.0||||||
4214099|NCT00718523|4037620|B1|missing||CA 125 status||participants|Number|0|0.0||||||
4214100|NCT00718523|4037618|B3|with CA 125 in the normal range||CA 125 status||participants|Number|32|32.0||||||
4214101|NCT00718523|4037619|B2|with CA 125 in the normal range||CA 125 status||participants|Number|15|15.0||||||
4214102|NCT00718523|4037620|B1|with CA 125 in the normal range||CA 125 status||participants|Number|17|17.0||||||
4214103|NCT00718523|4037618|B3|with elevated CA 125||CA 125 status||participants|Number|137|137.0||||||
4214104|NCT00718523|4037619|B2|with elevated CA 125||CA 125 status||participants|Number|70|70.0||||||
4214105|NCT00718523|4037620|B1|with elevated CA 125||CA 125 status||participants|Number|67|67.0||||||
4214106|NCT00718523|4037618|B3|2 therapies||Number of prior therapies|Prior anti-tumor treatment characteristics|participants|Number|12|12.0||||||
4214107|NCT00718523|4037619|B2|2 therapies||Number of prior therapies|Prior anti-tumor treatment characteristics|participants|Number|8|8.0||||||
4214108|NCT00718523|4037620|B1|2 therapies||Number of prior therapies|Prior anti-tumor treatment characteristics|participants|Number|4|4.0||||||
4214109|NCT00718523|4037618|B3|1 therapy||Number of prior therapies|Prior anti-tumor treatment characteristics|participants|Number|158|158.0||||||
4214110|NCT00718523|4037619|B2|1 therapy||Number of prior therapies|Prior anti-tumor treatment characteristics|participants|Number|78|78.0||||||
4214111|NCT00718523|4037620|B1|1 therapy||Number of prior therapies|Prior anti-tumor treatment characteristics|participants|Number|80|80.0||||||
4214112|NCT00718523|4037618|B3|Not done||Histologic Grade|Cancer cells compared with normal cells|participants|Number|9|9.0||||||
4214113|NCT00718523|4037619|B2|Not done||Histologic Grade|Cancer cells compared with normal cells|participants|Number|6|6.0||||||
4214114|NCT00718523|4037620|B1|Not done||Histologic Grade|Cancer cells compared with normal cells|participants|Number|3|3.0||||||
4214115|NCT00718523|4037618|B3|G3 (poorly differentiated)||Histologic Grade|Cancer cells compared with normal cells|participants|Number|122|122.0||||||
4214116|NCT00718523|4037619|B2|G3 (poorly differentiated)||Histologic Grade|Cancer cells compared with normal cells|participants|Number|57|57.0||||||
4214117|NCT00718523|4037620|B1|G3 (poorly differentiated)||Histologic Grade|Cancer cells compared with normal cells|participants|Number|65|65.0||||||
4214118|NCT00718523|4037618|B3|G2 (moderately differentiated)||Histologic Grade|Cancer cells compared with normal cells|participants|Number|33|33.0||||||
4214119|NCT00718523|4037619|B2|G2 (moderately differentiated)||Histologic Grade|Cancer cells compared with normal cells|participants|Number|18|18.0||||||
4214120|NCT00718523|4037620|B1|G2 (moderately differentiated)||Histologic Grade|Cancer cells compared with normal cells|participants|Number|15|15.0||||||
4214121|NCT00718523|4037618|B3|G1 (well differentiated)||Histologic Grade|Cancer cells compared with normal cells|participants|Number|6|6.0||||||
4214122|NCT00718523|4037619|B2|G1 (well differentiated)||Histologic Grade|Cancer cells compared with normal cells|participants|Number|5|5.0||||||
4214123|NCT00718523|4037620|B1|G1 (well differentiated)||Histologic Grade|Cancer cells compared with normal cells|participants|Number|1|1.0||||||
4214124|NCT00718523|4037618|B3|other||Histopathologic type||participants|Number|7|7.0||||||
4214125|NCT00718523|4037619|B2|other||Histopathologic type||participants|Number|3|3.0||||||
4214126|NCT00718523|4037620|B1|other||Histopathologic type||participants|Number|4|4.0||||||
4214127|NCT00718523|4037618|B3|mixed||Histopathologic type||participants|Number|8|8.0||||||
4214128|NCT00718523|4037619|B2|mixed||Histopathologic type||participants|Number|3|3.0||||||
4214129|NCT00718523|4037620|B1|mixed||Histopathologic type||participants|Number|5|5.0||||||
4214130|NCT00718523|4037618|B3|clear cell||Histopathologic type||participants|Number|4|4.0||||||
4214131|NCT00718523|4037619|B2|clear cell||Histopathologic type||participants|Number|2|2.0||||||
4214132|NCT00718523|4037620|B1|clear cell||Histopathologic type||participants|Number|2|2.0||||||
4214133|NCT00718523|4037618|B3|endometroid||Histopathologic type||participants|Number|9|9.0||||||
4214134|NCT00718523|4037619|B2|endometroid||Histopathologic type||participants|Number|5|5.0||||||
4214135|NCT00718523|4037620|B1|endometroid||Histopathologic type||participants|Number|4|4.0||||||
4214136|NCT00718523|4037618|B3|mucinous||Histopathologic type||participants|Number|1|1.0||||||
4214137|NCT00718523|4037619|B2|mucinous||Histopathologic type||participants|Number|1|1.0||||||
4214138|NCT00718523|4037620|B1|mucinous||Histopathologic type||participants|Number|0|0.0||||||
4214139|NCT00718523|4037618|B3|papillary serous||Histopathologic type||participants|Number|141|141.0||||||
4214140|NCT00718523|4037619|B2|papillary serous||Histopathologic type||participants|Number|72|72.0||||||
4214141|NCT00718523|4037620|B1|papillary serous||Histopathologic type||participants|Number|69|69.0||||||
4214142|NCT00718523|4037618|B3|IV||Stage at first diagnosis (International Federation of Gynecology and Obstetrics (FIGO))|5-point ordinal scale to assess the extent of the disease (0->IV). Roman numeral staging from the less to the most advanced cancer. Individual stage (I to III) is broken down in substage: IA, IB, IC,...|participants|Number|12|12.0||||||
4214143|NCT00718523|4037619|B2|IV||Stage at first diagnosis (International Federation of Gynecology and Obstetrics (FIGO))|5-point ordinal scale to assess the extent of the disease (0->IV). Roman numeral staging from the less to the most advanced cancer. Individual stage (I to III) is broken down in substage: IA, IB, IC,...|participants|Number|6|6.0||||||
4214144|NCT00718523|4037620|B1|IV||Stage at first diagnosis (International Federation of Gynecology and Obstetrics (FIGO))|5-point ordinal scale to assess the extent of the disease (0->IV). Roman numeral staging from the less to the most advanced cancer. Individual stage (I to III) is broken down in substage: IA, IB, IC,...|participants|Number|6|6.0||||||
4214145|NCT00718523|4037618|B3|IIIC||Stage at first diagnosis (International Federation of Gynecology and Obstetrics (FIGO))|5-point ordinal scale to assess the extent of the disease (0->IV). Roman numeral staging from the less to the most advanced cancer. Individual stage (I to III) is broken down in substage: IA, IB, IC,...|participants|Number|137|137.0||||||
4214146|NCT00718523|4037619|B2|IIIC||Stage at first diagnosis (International Federation of Gynecology and Obstetrics (FIGO))|5-point ordinal scale to assess the extent of the disease (0->IV). Roman numeral staging from the less to the most advanced cancer. Individual stage (I to III) is broken down in substage: IA, IB, IC,...|participants|Number|72|72.0||||||
4214147|NCT00718523|4037620|B1|IIIC||Stage at first diagnosis (International Federation of Gynecology and Obstetrics (FIGO))|5-point ordinal scale to assess the extent of the disease (0->IV). Roman numeral staging from the less to the most advanced cancer. Individual stage (I to III) is broken down in substage: IA, IB, IC,...|participants|Number|65|65.0||||||
4214148|NCT00718523|4037618|B3|IIIB||Stage at first diagnosis (International Federation of Gynecology and Obstetrics (FIGO))|5-point ordinal scale to assess the extent of the disease (0->IV). Roman numeral staging from the less to the most advanced cancer. Individual stage (I to III) is broken down in substage: IA, IB, IC,...|participants|Number|16|16.0||||||
4214149|NCT00718523|4037619|B2|IIIB||Stage at first diagnosis (International Federation of Gynecology and Obstetrics (FIGO))|5-point ordinal scale to assess the extent of the disease (0->IV). Roman numeral staging from the less to the most advanced cancer. Individual stage (I to III) is broken down in substage: IA, IB, IC,...|participants|Number|6|6.0||||||
4214150|NCT00718523|4037620|B1|IIIB||Stage at first diagnosis (International Federation of Gynecology and Obstetrics (FIGO))|5-point ordinal scale to assess the extent of the disease (0->IV). Roman numeral staging from the less to the most advanced cancer. Individual stage (I to III) is broken down in substage: IA, IB, IC,...|participants|Number|10|10.0||||||
4214151|NCT00718523|4037618|B3|IIIA||Stage at first diagnosis (International Federation of Gynecology and Obstetrics (FIGO))|5-point ordinal scale to assess the extent of the disease (0->IV). Roman numeral staging from the less to the most advanced cancer. Individual stage (I to III) is broken down in substage: IA, IB, IC,...|participants|Number|5|5.0||||||
4214152|NCT00718523|4037619|B2|IIIA||Stage at first diagnosis (International Federation of Gynecology and Obstetrics (FIGO))|5-point ordinal scale to assess the extent of the disease (0->IV). Roman numeral staging from the less to the most advanced cancer. Individual stage (I to III) is broken down in substage: IA, IB, IC,...|participants|Number|2|2.0||||||
4214153|NCT00718523|4037620|B1|IIIA||Stage at first diagnosis (International Federation of Gynecology and Obstetrics (FIGO))|5-point ordinal scale to assess the extent of the disease (0->IV). Roman numeral staging from the less to the most advanced cancer. Individual stage (I to III) is broken down in substage: IA, IB, IC,...|participants|Number|3|3.0||||||
4214154|NCT00718523|4037618|B3|Missing||Origin of tumor||participants|Number|1|1.0||||||
4214155|NCT00718523|4037619|B2|Missing||Origin of tumor||participants|Number|0|0.0||||||
4214156|NCT00718523|4037620|B1|Missing||Origin of tumor||participants|Number|1|1.0||||||
4214157|NCT00718523|4037618|B3|Ovarian + Fallopian tube||Origin of tumor||participants|Number|2|2.0||||||
4214158|NCT00718523|4037619|B2|Ovarian + Fallopian tube||Origin of tumor||participants|Number|0|0.0||||||
4214159|NCT00718523|4037620|B1|Ovarian + Fallopian tube||Origin of tumor||participants|Number|2|2.0||||||
4214160|NCT00718523|4037618|B3|Ovarian + Primary peritoneal||Origin of tumor||participants|Number|1|1.0||||||
4214161|NCT00718523|4037619|B2|Ovarian + Primary peritoneal||Origin of tumor||participants|Number|1|1.0||||||
4214162|NCT00718523|4037620|B1|Ovarian + Primary peritoneal||Origin of tumor||participants|Number|0|0.0||||||
4214163|NCT00718523|4037618|B3|Ovarian||Origin of tumor||participants|Number|146|146.0||||||
4214164|NCT00718523|4037619|B2|Ovarian||Origin of tumor||participants|Number|77|77.0||||||
4214165|NCT00718523|4037620|B1|Ovarian||Origin of tumor||participants|Number|69|69.0||||||
4214166|NCT00718523|4037618|B3|Fallopian tube||Origin of tumor||participants|Number|8|8.0||||||
4214167|NCT00718523|4037619|B2|Fallopian tube||Origin of tumor||participants|Number|4|4.0||||||
4214168|NCT00718523|4037620|B1|Fallopian tube||Origin of tumor||participants|Number|4|4.0||||||
4214169|NCT00718523|4037618|B3|Primary peritoneal||Origin of tumor||participants|Number|12|12.0||||||
4214170|NCT00718523|4037619|B2|Primary peritoneal||Origin of tumor||participants|Number|4|4.0||||||
4214171|NCT00718523|4037620|B1|Primary peritoneal||Origin of tumor||participants|Number|8|8.0||||||
4214172|NCT00718523|4037618|B3|||Time from diagnosis to randomization||weeks|Mean|5.3|5.3|Standard Deviation|2.9|2.9|||
4214173|NCT00718523|4037619|B2|||Time from diagnosis to randomization||weeks|Mean|5.4|5.4|Standard Deviation|3.4|3.4|||
4214174|NCT00718523|4037620|B1|||Time from diagnosis to randomization||weeks|Mean|5.2|5.2|Standard Deviation|2.3|2.3|||
4214175|NCT00718523|4037618|B3|||Time from Surgery to first treatment dose||weeks|Mean|5.1|5.1|Standard Deviation|1.3|1.3|||
4214176|NCT00718523|4037619|B2|||Time from Surgery to first treatment dose||weeks|Mean|5.1|5.1|Standard Deviation|1.4|1.4|||
4214177|NCT00718523|4037620|B1|||Time from Surgery to first treatment dose||weeks|Mean|5.1|5.1|Standard Deviation|1.2|1.2|||
4214178|NCT00718523|4037618|B3|Missing||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|6-point (0 to 5) ordinal scale to assess how the disease affects the daily living abilities of the patients and determine appropriate treatment and prognosis|participants|Number|2|2.0||||||
4214223|NCT00718523|4037618|B3||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
4214179|NCT00718523|4037619|B2|Missing||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|6-point (0 to 5) ordinal scale to assess how the disease affects the daily living abilities of the patients and determine appropriate treatment and prognosis|participants|Number|2|2.0||||||
4214180|NCT00718523|4037620|B1|Missing||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|6-point (0 to 5) ordinal scale to assess how the disease affects the daily living abilities of the patients and determine appropriate treatment and prognosis|participants|Number|0|0.0||||||
4214181|NCT00718523|4037618|B3|PS2(ambulatory and capable of all selfcare)||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|6-point (0 to 5) ordinal scale to assess how the disease affects the daily living abilities of the patients and determine appropriate treatment and prognosis|participants|Number|11|11.0||||||
4214182|NCT00718523|4037619|B2|PS2(ambulatory and capable of all selfcare)||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|6-point (0 to 5) ordinal scale to assess how the disease affects the daily living abilities of the patients and determine appropriate treatment and prognosis|participants|Number|6|6.0||||||
4214183|NCT00718523|4037620|B1|PS2(ambulatory and capable of all selfcare)||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|6-point (0 to 5) ordinal scale to assess how the disease affects the daily living abilities of the patients and determine appropriate treatment and prognosis|participants|Number|5|5.0||||||
4214184|NCT00718523|4037618|B3|PS 1 (restricted in physically strenuous activity)||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|6-point (0 to 5) ordinal scale to assess how the disease affects the daily living abilities of the patients and determine appropriate treatment and prognosis|participants|Number|89|89.0||||||
4214185|NCT00718523|4037619|B2|PS 1 (restricted in physically strenuous activity)||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|6-point (0 to 5) ordinal scale to assess how the disease affects the daily living abilities of the patients and determine appropriate treatment and prognosis|participants|Number|46|46.0||||||
4214186|NCT00718523|4037620|B1|PS 1 (restricted in physically strenuous activity)||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|6-point (0 to 5) ordinal scale to assess how the disease affects the daily living abilities of the patients and determine appropriate treatment and prognosis|participants|Number|43|43.0||||||
4214187|NCT00718523|4037618|B3|PS 0 (fully active)||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|6-point (0 to 5) ordinal scale to assess how the disease affects the daily living abilities of the patients and determine appropriate treatment and prognosis|participants|Number|68|68.0||||||
4214188|NCT00718523|4037619|B2|PS 0 (fully active)||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|6-point (0 to 5) ordinal scale to assess how the disease affects the daily living abilities of the patients and determine appropriate treatment and prognosis|participants|Number|32|32.0||||||
4214189|NCT00718523|4037620|B1|PS 0 (fully active)||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|6-point (0 to 5) ordinal scale to assess how the disease affects the daily living abilities of the patients and determine appropriate treatment and prognosis|participants|Number|36|36.0||||||
4214190|NCT00718523|4037618|B3|Germany||Region of Enrollment||participants|Number|82|82.0||||||
4214191|NCT00718523|4037619|B2|Germany||Region of Enrollment||participants|Number|38|38.0||||||
4214192|NCT00718523|4037620|B1|Germany||Region of Enrollment||participants|Number|44|44.0||||||
4214193|NCT00718523|4037618|B3|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4214194|NCT00718523|4037619|B2|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4214195|NCT00718523|4037620|B1|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4214196|NCT00718523|4037618|B3|Israel||Region of Enrollment||participants|Number|4|4.0||||||
4214197|NCT00718523|4037619|B2|Israel||Region of Enrollment||participants|Number|2|2.0||||||
4214198|NCT00718523|4037620|B1|Israel||Region of Enrollment||participants|Number|2|2.0||||||
4214199|NCT00718523|4037618|B3|France||Region of Enrollment||participants|Number|10|10.0||||||
4214200|NCT00718523|4037619|B2|France||Region of Enrollment||participants|Number|3|3.0||||||
4214201|NCT00718523|4037620|B1|France||Region of Enrollment||participants|Number|7|7.0||||||
4214202|NCT00718523|4037618|B3|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4214203|NCT00718523|4037619|B2|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4214204|NCT00718523|4037620|B1|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4214205|NCT00718523|4037618|B3|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4214206|NCT00718523|4037619|B2|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4214207|NCT00718523|4037620|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4214208|NCT00718523|4037618|B3|United States||Region of Enrollment||participants|Number|59|59.0||||||
4214209|NCT00718523|4037619|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
4214210|NCT00718523|4037620|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4214211|NCT00718523|4037618|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4214212|NCT00718523|4037619|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4214213|NCT00718523|4037620|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4214214|NCT00718523|4037618|B3||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4214215|NCT00718523|4037619|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4214216|NCT00718523|4037620|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4214217|NCT00718523|4037618|B3|||Age||years|Mean|57.6|57.6|Standard Deviation|11.2|11.2|||
4214218|NCT00718523|4037619|B2|||Age||years|Mean|57.2|57.2|Standard Deviation|12.3|12.3|||
4214219|NCT00718523|4037620|B1|||Age||years|Mean|58.1|58.1|Standard Deviation|10.0|10.0|||
4214220|NCT00718523|4037618|B3||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
4214221|NCT00718523|4037619|B2||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4214222|NCT00718523|4037620|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4214224|NCT00718523|4037619|B2||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4214225|NCT00718523|4037620|B1||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4214226|NCT00718523|4037618|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4214227|NCT00718523|4037619|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4214228|NCT00718523|4037620|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4214229|NCT00718510|4037631|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4214230|NCT00718510|4037632|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4214231|NCT00718510|4037633|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4214232|NCT00718510|4037631|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4214233|NCT00718510|4037632|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4214234|NCT00718510|4037633|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4214235|NCT00718510|4037631|B3|||Age||years|Mean|36|36.0|Standard Deviation|11.5|11.5|||
4214236|NCT00718510|4037632|B2|||Age||years|Mean|37.8|37.8|Standard Deviation|8.1|8.1|||
4214237|NCT00718510|4037633|B1|||Age||years|Mean|33.8|33.8|Standard Deviation|15.1|15.1|||
4214238|NCT00718328|4037644|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4214239|NCT00718328|4037646|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4214240|NCT00718328|4037644|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4214241|NCT00718328|4037646|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4214242|NCT00718328|4037644|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4214243|NCT00718328|4037646|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4214244|NCT00718328|4037644|B3|||Age||years|Mean|62|62.0|Full Range|||62.0|62.0|
4214245|NCT00718328|4037646|B1|||Age||years|Mean|62|62.0|Full Range|||62.0|62.0|
4214246|NCT00718328|4037644|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4214247|NCT00718328|4037645|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4214248|NCT00718328|4037646|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4214249|NCT00718328|4037644|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4214250|NCT00718328|4037645|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4214251|NCT00718328|4037646|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4214252|NCT00718328|4037644|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4214253|NCT00718328|4037645|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4214254|NCT00718328|4037646|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4214255|NCT00718315|4037653|B4||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4214256|NCT00718315|4037654|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4214257|NCT00718315|4037655|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4214258|NCT00718315|4037656|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4214259|NCT00718315|4037653|B4||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4214260|NCT00718315|4037654|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4214261|NCT00718315|4037655|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4214262|NCT00718315|4037656|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4214263|NCT00718315|4037653|B4|||Age||years|Mean|64.7|64.7|Standard Deviation|12.2|12.2|||
4214264|NCT00718315|4037654|B3|||Age||years|Mean|64.6|64.6|Standard Deviation|14.0|14.0|||
4214265|NCT00718315|4037655|B2|||Age||years|Mean|63.6|63.6|Standard Deviation|11.0|11.0|||
4214266|NCT00718315|4037656|B1|||Age||years|Mean|65.3|65.3|Standard Deviation|11.1|11.1|||
4214267|NCT00718302|4037690|B3||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4214268|NCT00718302|4037691|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4214269|NCT00718302|4037692|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4214270|NCT00718302|4037690|B3||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4214271|NCT00718302|4037691|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4214272|NCT00718302|4037692|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4214273|NCT00718302|4037690|B3||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4214274|NCT00718302|4037691|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4214275|NCT00718302|4037692|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4214276|NCT00718302|4037690|B3||Between 18 and 65 years|Age||Participants|Count of Participants|213|213.0||||||
4214277|NCT00718302|4037691|B2||Between 18 and 65 years|Age||Participants|Count of Participants|106|106.0||||||
4214278|NCT00718302|4037692|B1||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
4214279|NCT00718302|4037690|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4214280|NCT00718302|4037691|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4214281|NCT00718302|4037692|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4214282|NCT00718237|4037707|B3||Male|Sex: Female, Male||Participants|Count of Participants|407|407.0||||||
4214283|NCT00718237|4037708|B2||Male|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4214284|NCT00718237|4037709|B1||Male|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4214285|NCT00718237|4037707|B3||Female|Sex: Female, Male||Participants|Count of Participants|355|355.0||||||
4214286|NCT00718237|4037708|B2||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4214287|NCT00718237|4037709|B1||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4214288|NCT00718237|4037707|B3|6 to 12 Weeks of age||Age, Customized||participants|Number|762|762.0||||||
4214289|NCT00718237|4037708|B2|6 to 12 Weeks of age||Age, Customized||participants|Number|381|381.0||||||
4214290|NCT00718237|4037709|B1|6 to 12 Weeks of age||Age, Customized||participants|Number|381|381.0||||||
4214291|NCT00718237|4037707|B3|||Age||Weeks|Mean|7.5|7.5|Standard Deviation|1.6|1.6|||
4214292|NCT00718237|4037708|B2|||Age||Weeks|Mean|7.5|7.5|Standard Deviation|1.6|1.6|||
4214293|NCT00718237|4037709|B1|||Age||Weeks|Mean|7.6|7.6|Standard Deviation|1.7|1.7|||
4214294|NCT00718159|4037720|B8|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4214295|NCT00718159|4037721|B7|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4214296|NCT00718159|4037722|B6|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4214297|NCT00718159|4037723|B5|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4214298|NCT00718159|4037724|B4|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4214299|NCT00718159|4037725|B3|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4214300|NCT00718159|4037726|B2|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4214301|NCT00718159|4037727|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4214302|NCT00718159|4037720|B8|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4214303|NCT00718159|4037721|B7|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4214304|NCT00718159|4037722|B6|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4214305|NCT00718159|4037723|B5|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4214306|NCT00718159|4037724|B4|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4214307|NCT00718159|4037725|B3|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4214308|NCT00718159|4037726|B2|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4214309|NCT00718159|4037727|B1|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4214310|NCT00718159|4037720|B8|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4214311|NCT00718159|4037721|B7|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4214312|NCT00718159|4037722|B6|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4214313|NCT00718159|4037723|B5|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4214314|NCT00718159|4037724|B4|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4214315|NCT00718159|4037725|B3|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4214316|NCT00718159|4037726|B2|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4214317|NCT00718159|4037727|B1|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4214318|NCT00718159|4037720|B8|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
4214319|NCT00718159|4037721|B7|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4214320|NCT00718159|4037722|B6|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4214321|NCT00718159|4037723|B5|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4214322|NCT00718159|4037724|B4|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4214323|NCT00718159|4037725|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4214324|NCT00718159|4037726|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4214325|NCT00718159|4037727|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4214326|NCT00718159|4037720|B8|African||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4214327|NCT00718159|4037721|B7|African||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4214328|NCT00718159|4037722|B6|African||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4214329|NCT00718159|4037723|B5|African||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4214330|NCT00718159|4037724|B4|African||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4214331|NCT00718159|4037725|B3|African||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4214332|NCT00718159|4037726|B2|African||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4214333|NCT00718159|4037727|B1|African||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4214334|NCT00718159|4037720|B8||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4214335|NCT00718159|4037721|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4214336|NCT00718159|4037722|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4214337|NCT00718159|4037723|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4214338|NCT00718159|4037724|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4214339|NCT00718159|4037725|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4214340|NCT00718159|4037726|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4214341|NCT00718159|4037727|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4214342|NCT00718159|4037720|B8||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4214343|NCT00718159|4037721|B7||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4214344|NCT00718159|4037722|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4214345|NCT00718159|4037723|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4214346|NCT00718159|4037724|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4214347|NCT00718159|4037725|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4214348|NCT00718159|4037726|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4214349|NCT00718159|4037727|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4214350|NCT00718159|4037720|B8|||Age||years|Median|56.86|56.86|Full Range|||24.16|82.19|
4214351|NCT00718159|4037721|B7|||Age||years|Median|65.09|65.09|Full Range|||0.0|0.0|Only one participant, therefore range is not calculable.
4214352|NCT00718159|4037722|B6|||Age||years|Median|81.19|81.19|Full Range|||0.0|0.0|Only one participant, therefore range is not calculable.
4214353|NCT00718159|4037723|B5|||Age||years|Median|58.57|58.57|Full Range|||24.16|82.19|
4214354|NCT00718159|4037724|B4|||Age||years|Median|55.46|55.46|Full Range|||50.14|64.83|
4214355|NCT00718159|4037725|B3|||Age||years|Median|66.62|66.62|Full Range|||54.69|75.7|
4214356|NCT00718159|4037726|B2|||Age||years|Median|52.48|52.48|Full Range|||49.4|58.36|
4214357|NCT00718159|4037727|B1|||Age||years|Median|55.22|55.22|Full Range|||55.16|76.21|
4214358|NCT00718120|4037757|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4214359|NCT00718120|4037758|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4214360|NCT00718120|4037759|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4214361|NCT00718120|4037757|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4214362|NCT00718120|4037758|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4214363|NCT00718120|4037759|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4214364|NCT00718120|4037757|B3|||Age||years|Mean|53.2|53.2|Standard Deviation|16.08|16.08|||
4214365|NCT00718120|4037758|B2|||Age||years|Mean|66.4|66.4|Standard Deviation|4.61|4.61|||
4214366|NCT00718120|4037759|B1|||Age||years|Mean|40.1|40.1|Standard Deviation|12.16|12.16|||
4214367|NCT00718094|4037778|B3|||Ulcerative colitis (UC) disease activity index|"This is a standard method of measuring disease activity. The index assesses four variables, which include stool frequency, severity of bleeding, colonic mucosal appearance, and the physician's overall assessment of disease activity.~Each variable is scored from 0–3 so that the total index score ranges from 0–12; 0–2: remission; 3–6: mild; 7–10: moderate; >10: severe UC."|units on a scale|Mean|7.0|7.0|Standard Deviation|1.7|1.7|||
4214368|NCT00718094|4037779|B2|||Ulcerative colitis (UC) disease activity index|"This is a standard method of measuring disease activity. The index assesses four variables, which include stool frequency, severity of bleeding, colonic mucosal appearance, and the physician's overall assessment of disease activity.~Each variable is scored from 0–3 so that the total index score ranges from 0–12; 0–2: remission; 3–6: mild; 7–10: moderate; >10: severe UC."|units on a scale|Mean|7.3|7.3|Standard Deviation|1.7|1.7|||
4214369|NCT00718094|4037780|B1|||Ulcerative colitis (UC) disease activity index|"This is a standard method of measuring disease activity. The index assesses four variables, which include stool frequency, severity of bleeding, colonic mucosal appearance, and the physician's overall assessment of disease activity.~Each variable is scored from 0–3 so that the total index score ranges from 0–12; 0–2: remission; 3–6: mild; 7–10: moderate; >10: severe UC."|units on a scale|Mean|6.5|6.5|Standard Deviation|1.7|1.7|||
4214370|NCT00718094|4037778|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4214371|NCT00718094|4037779|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4214372|NCT00718094|4037780|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4214373|NCT00718094|4037778|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4214374|NCT00718094|4037779|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4214375|NCT00718094|4037780|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4214376|NCT00718094|4037778|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4214377|NCT00718094|4037779|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4214378|NCT00718094|4037780|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4214379|NCT00718094|4037778|B3|||Age||years|Mean|40|40.0|Standard Deviation|15|15.0|||
4214380|NCT00718094|4037779|B2|||Age||years|Mean|30.7|30.7|Standard Deviation|14.4|14.4|||
4214381|NCT00718094|4037780|B1|||Age||years|Mean|44.9|44.9|Standard Deviation|15|15.0|||
4214382|NCT00718081|4037787|B4|United States||Region of Enrollment||participants|Number|88|88.0||||||
4214383|NCT00718081|4037788|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4214384|NCT00718081|4037789|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4214385|NCT00718081|4037790|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4214386|NCT00718081|4037787|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4214387|NCT00718081|4037788|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4214388|NCT00718081|4037789|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4214389|NCT00718081|4037790|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4214390|NCT00718081|4037787|B4||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4214391|NCT00718081|4037788|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4214392|NCT00718081|4037789|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4214393|NCT00718081|4037790|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4214394|NCT00718081|4037787|B4|||Age||years|Mean|46.2|46.2|Standard Deviation|10.3|10.3|||
4214395|NCT00718081|4037788|B3|||Age||years|Mean|46.8|46.8|Standard Deviation|10.1|10.1|||
4214396|NCT00718081|4037789|B2|||Age||years|Mean|45.3|45.3|Standard Deviation|11.3|11.3|||
4214397|NCT00718081|4037790|B1|||Age||years|Mean|46.4|46.4|Standard Deviation|9.7|9.7|||
4214398|NCT00718081|4037787|B4||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4214399|NCT00718081|4037788|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4214400|NCT00718081|4037789|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4214401|NCT00718081|4037790|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4214402|NCT00718081|4037787|B4||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4214403|NCT00718081|4037788|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4214404|NCT00718081|4037789|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4214405|NCT00718081|4037790|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4214406|NCT00718081|4037787|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4214407|NCT00718081|4037788|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4214408|NCT00718081|4037789|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4214409|NCT00718081|4037790|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4214410|NCT00718042|4037803|B7|Bolivia||Region of Enrollment||participants|Number|22|22.0||||||
4214411|NCT00718042|4037804|B6|Bolivia||Region of Enrollment||participants|Number|0|0.0||||||
4214412|NCT00718042|4037805|B5|Bolivia||Region of Enrollment||participants|Number|22|22.0||||||
4214413|NCT00718042|4037806|B4|Bolivia||Region of Enrollment||participants|Number|0|0.0||||||
4214414|NCT00718042|4037807|B3|Bolivia||Region of Enrollment||participants|Number|0|0.0||||||
4214415|NCT00718042|4037808|B2|Bolivia||Region of Enrollment||participants|Number|0|0.0||||||
4214416|NCT00718042|4037809|B1|Bolivia||Region of Enrollment||participants|Number|0|0.0||||||
4214417|NCT00718042|4037803|B7|Peru||Region of Enrollment||participants|Number|105|105.0||||||
4214418|NCT00718042|4037804|B6|Peru||Region of Enrollment||participants|Number|0|0.0||||||
4214419|NCT00718042|4037805|B5|Peru||Region of Enrollment||participants|Number|5|5.0||||||
4214420|NCT00718042|4037806|B4|Peru||Region of Enrollment||participants|Number|0|0.0||||||
4214421|NCT00718042|4037807|B3|Peru||Region of Enrollment||participants|Number|100|100.0||||||
4214422|NCT00718042|4037808|B2|Peru||Region of Enrollment||participants|Number|0|0.0||||||
4214423|NCT00718042|4037809|B1|Peru||Region of Enrollment||participants|Number|0|0.0||||||
4214424|NCT00718042|4037803|B7|Panama||Region of Enrollment||participants|Number|50|50.0||||||
4214425|NCT00718042|4037804|B6|Panama||Region of Enrollment||participants|Number|0|0.0||||||
4214426|NCT00718042|4037805|B5|Panama||Region of Enrollment||participants|Number|0|0.0||||||
4214427|NCT00718042|4037806|B4|Panama||Region of Enrollment||participants|Number|0|0.0||||||
4214428|NCT00718042|4037807|B3|Panama||Region of Enrollment||participants|Number|50|50.0||||||
4214429|NCT00718042|4037808|B2|Panama||Region of Enrollment||participants|Number|0|0.0||||||
4214430|NCT00718042|4037809|B1|Panama||Region of Enrollment||participants|Number|0|0.0||||||
4214431|NCT00718042|4037803|B7|Guatemala||Region of Enrollment||participants|Number|149|149.0||||||
4214432|NCT00718042|4037804|B6|Guatemala||Region of Enrollment||participants|Number|0|0.0||||||
4214433|NCT00718042|4037805|B5|Guatemala||Region of Enrollment||participants|Number|0|0.0||||||
4214434|NCT00718042|4037806|B4|Guatemala||Region of Enrollment||participants|Number|0|0.0||||||
4214435|NCT00718042|4037807|B3|Guatemala||Region of Enrollment||participants|Number|149|149.0||||||
4214436|NCT00718042|4037808|B2|Guatemala||Region of Enrollment||participants|Number|0|0.0||||||
4214437|NCT00718042|4037809|B1|Guatemala||Region of Enrollment||participants|Number|0|0.0||||||
4214438|NCT00718042|4037803|B7|Brazil||Region of Enrollment||participants|Number|57|57.0||||||
4214439|NCT00718042|4037804|B6|Brazil||Region of Enrollment||participants|Number|0|0.0||||||
4214440|NCT00718042|4037805|B5|Brazil||Region of Enrollment||participants|Number|7|7.0||||||
4214441|NCT00718042|4037806|B4|Brazil||Region of Enrollment||participants|Number|0|0.0||||||
4214442|NCT00718042|4037807|B3|Brazil||Region of Enrollment||participants|Number|50|50.0||||||
4214443|NCT00718042|4037808|B2|Brazil||Region of Enrollment||participants|Number|0|0.0||||||
4214444|NCT00718042|4037809|B1|Brazil||Region of Enrollment||participants|Number|0|0.0||||||
4214445|NCT00718042|4037803|B7|Argentina||Region of Enrollment||participants|Number|337|337.0||||||
4214446|NCT00718042|4037804|B6|Argentina||Region of Enrollment||participants|Number|0|0.0||||||
4214447|NCT00718042|4037805|B5|Argentina||Region of Enrollment||participants|Number|76|76.0||||||
4214448|NCT00718042|4037806|B4|Argentina||Region of Enrollment||participants|Number|0|0.0||||||
4214449|NCT00718042|4037807|B3|Argentina||Region of Enrollment||participants|Number|176|176.0||||||
4214450|NCT00718042|4037808|B2|Argentina||Region of Enrollment||participants|Number|85|85.0||||||
4214451|NCT00718042|4037809|B1|Argentina||Region of Enrollment||participants|Number|0|0.0||||||
4214452|NCT00718042|4037803|B7|United States||Region of Enrollment||participants|Number|42396|42396.0||||||
4214453|NCT00718042|4037804|B6|United States||Region of Enrollment||participants|Number|25549|25549.0||||||
4214454|NCT00718042|4037805|B5|United States||Region of Enrollment||participants|Number|0|0.0||||||
4214455|NCT00718042|4037806|B4|United States||Region of Enrollment||participants|Number|330|330.0||||||
4214456|NCT00718042|4037807|B3|United States||Region of Enrollment||participants|Number|0|0.0||||||
4214457|NCT00718042|4037808|B2|United States||Region of Enrollment||participants|Number|204|204.0||||||
4214458|NCT00718042|4037809|B1|United States||Region of Enrollment||participants|Number|16313|16313.0||||||
4214459|NCT00718042|4037803|B7|Not Collected||Sex/Gender, Customized|Gender was not collected for all study populations.|Participant|Number|42396|42396.0||||||
4214460|NCT00718042|4037804|B6|Not Collected||Sex/Gender, Customized|Gender was not collected for all study populations.|Participant|Number|25549|25549.0||||||
4214461|NCT00718042|4037805|B5|Not Collected||Sex/Gender, Customized|Gender was not collected for all study populations.|Participant|Number|0|0.0||||||
4214462|NCT00718042|4037806|B4|Not Collected||Sex/Gender, Customized|Gender was not collected for all study populations.|Participant|Number|330|330.0||||||
4214463|NCT00718042|4037807|B3|Not Collected||Sex/Gender, Customized|Gender was not collected for all study populations.|Participant|Number|0|0.0||||||
4214464|NCT00718042|4037808|B2|Not Collected||Sex/Gender, Customized|Gender was not collected for all study populations.|Participant|Number|204|204.0||||||
4214465|NCT00718042|4037809|B1|Not Collected||Sex/Gender, Customized|Gender was not collected for all study populations.|Participant|Number|16313|16313.0||||||
4214466|NCT00718042|4037803|B7|Male||Sex/Gender, Customized|Gender was not collected for all study populations.|Participant|Number|287|287.0||||||
4214467|NCT00718042|4037804|B6|Male||Sex/Gender, Customized|Gender was not collected for all study populations.|Participant|Number|0|0.0||||||
4214468|NCT00718042|4037805|B5|Male||Sex/Gender, Customized|Gender was not collected for all study populations.|Participant|Number|57|57.0||||||
4214469|NCT00718042|4037806|B4|Male||Sex/Gender, Customized|Gender was not collected for all study populations.|Participant|Number|0|0.0||||||
4214470|NCT00718042|4037807|B3|Male||Sex/Gender, Customized|Gender was not collected for all study populations.|Participant|Number|189|189.0||||||
4214471|NCT00718042|4037808|B2|Male||Sex/Gender, Customized|Gender was not collected for all study populations.|Participant|Number|41|41.0||||||
4214472|NCT00718042|4037809|B1|Male||Sex/Gender, Customized|Gender was not collected for all study populations.|Participant|Number|0|0.0||||||
4214473|NCT00718042|4037803|B7|Female||Sex/Gender, Customized|Gender was not collected for all study populations.|Participant|Number|433|433.0||||||
4214474|NCT00718042|4037804|B6|Female||Sex/Gender, Customized|Gender was not collected for all study populations.|Participant|Number|0|0.0||||||
4214475|NCT00718042|4037805|B5|Female||Sex/Gender, Customized|Gender was not collected for all study populations.|Participant|Number|53|53.0||||||
4214476|NCT00718042|4037806|B4|Female||Sex/Gender, Customized|Gender was not collected for all study populations.|Participant|Number|0|0.0||||||
4214477|NCT00718042|4037807|B3|Female||Sex/Gender, Customized|Gender was not collected for all study populations.|Participant|Number|336|336.0||||||
4214478|NCT00718042|4037808|B2|Female||Sex/Gender, Customized|Gender was not collected for all study populations.|Participant|Number|44|44.0||||||
4214479|NCT00718042|4037809|B1|Female||Sex/Gender, Customized|Gender was not collected for all study populations.|Participant|Number|0|0.0||||||
4214480|NCT00718042|4037803|B7|Not Collected||Age, Customized|Age was not collected for this study.|Participants|Number|204|204.0||||||
4214481|NCT00718042|4037804|B6|Not Collected||Age, Customized|Age was not collected for this study.|Participants|Number|0|0.0||||||
4214482|NCT00718042|4037805|B5|Not Collected||Age, Customized|Age was not collected for this study.|Participants|Number|0|0.0||||||
4214483|NCT00718042|4037806|B4|Not Collected||Age, Customized|Age was not collected for this study.|Participants|Number|0|0.0||||||
4214484|NCT00718042|4037807|B3|Not Collected||Age, Customized|Age was not collected for this study.|Participants|Number|0|0.0||||||
4214485|NCT00718042|4037808|B2|Not Collected||Age, Customized|Age was not collected for this study.|Participants|Number|204|204.0||||||
4214486|NCT00718042|4037809|B1|Not Collected||Age, Customized|Age was not collected for this study.|Participants|Number|0|0.0||||||
4214487|NCT00718042|4037803|B7|>= 18 years||Age, Customized|Age was not collected for this study.|Participants|Number|42912|42912.0||||||
4214488|NCT00718042|4037804|B6|>= 18 years||Age, Customized|Age was not collected for this study.|Participants|Number|25549|25549.0||||||
4214489|NCT00718042|4037805|B5|>= 18 years||Age, Customized|Age was not collected for this study.|Participants|Number|110|110.0||||||
4214490|NCT00718042|4037806|B4|>= 18 years||Age, Customized|Age was not collected for this study.|Participants|Number|330|330.0||||||
4214491|NCT00718042|4037807|B3|>= 18 years||Age, Customized|Age was not collected for this study.|Participants|Number|525|525.0||||||
4214492|NCT00718042|4037808|B2|>= 18 years||Age, Customized|Age was not collected for this study.|Participants|Number|85|85.0||||||
4214493|NCT00718042|4037809|B1|>= 18 years||Age, Customized|Age was not collected for this study.|Participants|Number|16313|16313.0||||||
4214494|NCT00717977|4037826|B1|>=45 years||Hemoglobin A1c||Percent|Mean|5.5|5.5|Standard Deviation|0.3|0.3|||
4214495|NCT00717977|4037826|B1|25-<45 years||Hemoglobin A1c||Percent|Mean|5.2|5.2|Standard Deviation|0.3|0.3|||
4214496|NCT00717977|4037826|B1|15-<25 years||Hemoglobin A1c||Percent|Mean|5.2|5.2|Standard Deviation|0.2|0.2|||
4214497|NCT00717977|4037826|B1|8-<15 years||Hemoglobin A1c||Percent|Mean|5.3|5.3|Standard Deviation|0.2|0.2|||
4214498|NCT00717977|4037826|B1|All||Hemoglobin A1c||Percent|Mean|5.3|5.3|Standard Deviation|0.3|0.3|||
4214499|NCT00717977|4037826|B1|||Fasting Glucose||mg/dL|Mean|86|86.0|Standard Deviation|8|8.0|||
4214500|NCT00717977|4037826|B1|||2-hour post-oral glucose tolerance test (OGTT)|Fasting blood glucose measurement taken 2 hours following the OGTT.|mg/dL|Mean|96|96.0|Standard Deviation|22|22.0|||
4214501|NCT00717977|4037826|B1|Other Race/Ethnicities||Race/Ethnicity, Customized||Participant|Number|5|5.0||||||
4214502|NCT00717977|4037826|B1|African American||Race/Ethnicity, Customized||Participant|Number|1|1.0||||||
4214503|NCT00717977|4037826|B1|Hispanic||Race/Ethnicity, Customized||Participant|Number|13|13.0||||||
4214504|NCT00717977|4037826|B1|Non-Hispanic, Caucasian||Race/Ethnicity, Customized||Participant|Number|55|55.0||||||
4214505|NCT00717977|4037826|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4214506|NCT00717977|4037826|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4214507|NCT00717977|4037826|B1|>=45 years||Age, Customized||Participants|Number|17|17.0||||||
4214508|NCT00717977|4037826|B1|25-<45 years||Age, Customized||Participants|Number|20|20.0||||||
4214509|NCT00717977|4037826|B1|15-<25 years||Age, Customized||Participants|Number|17|17.0||||||
4214510|NCT00717977|4037826|B1|8-<15 years||Age, Customized||Participants|Number|20|20.0||||||
4214511|NCT00717912|4037854|B1|France||Region of Enrollment||participants|Number|6|6.0||||||
4214512|NCT00717912|4037854|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4214513|NCT00717912|4037854|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4214514|NCT00717912|4037854|B1|||Age||years|Mean|23.7|23.7|Standard Deviation|4.9|4.9|||
4214515|NCT00717912|4037854|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4214516|NCT00717912|4037854|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4214517|NCT00717912|4037854|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4214518|NCT00717886|4037870|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4214519|NCT00717886|4037870|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4214520|NCT00717886|4037870|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4214521|NCT00717886|4037870|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4214522|NCT00717886|4037870|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4214523|NCT00717873|4037874|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4214524|NCT00717873|4037875|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4214525|NCT00717873|4037876|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4214526|NCT00717873|4037874|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4214527|NCT00717873|4037875|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4214528|NCT00717873|4037876|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4214529|NCT00717873|4037874|B3|||Age||years|Mean|44|44.0|Standard Deviation|18|18.0|||
4214530|NCT00717873|4037875|B2|||Age||years|Mean|45|45.0|Standard Deviation|18|18.0|||
4214531|NCT00717873|4037876|B1|||Age||years|Mean|42|42.0|Standard Deviation|18|18.0|||
4214532|NCT00717860|4037883|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4214533|NCT00717860|4037884|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4214534|NCT00717860|4037885|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4214535|NCT00717860|4037883|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4214536|NCT00717860|4037884|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4214537|NCT00717860|4037885|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4214538|NCT00717860|4037883|B3|||Age||years|Mean|69.1|69.1|Standard Deviation|10.1|10.1|||
4214539|NCT00717860|4037884|B2|||Age||years|Mean|69.3|69.3|Standard Deviation|9.0|9.0|||
4214540|NCT00717860|4037885|B1|||Age||years|Mean|68.9|68.9|Standard Deviation|11.2|11.2|||
4214541|NCT00717756|4037896|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4214542|NCT00717756|4037896|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4214543|NCT00717756|4037896|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4214544|NCT00717756|4037896|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4214545|NCT00717756|4037896|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4214546|NCT00717756|4037896|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4214547|NCT00717756|4037896|B1|||Age||years|Median|60.5|60.5|Full Range|||17.0|88.0|
4214548|NCT00717574|4037900|B3|||Body Mass Index (BMI)||kg/m^2|Mean|31.5|31.5|Standard Deviation|8|8.0|||
4214549|NCT00717574|4037901|B2|||Body Mass Index (BMI)||kg/m^2|Mean|32|32.0|Standard Deviation|10|10.0|||
4214550|NCT00717574|4037902|B1|||Body Mass Index (BMI)||kg/m^2|Mean|31|31.0|Standard Deviation|6|6.0|||
4214551|NCT00717574|4037900|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
4214552|NCT00717574|4037901|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4214553|NCT00717574|4037902|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4214554|NCT00717574|4037900|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4214555|NCT00717574|4037901|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4214556|NCT00717574|4037902|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4214557|NCT00717574|4037900|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4214558|NCT00717574|4037901|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4214559|NCT00717574|4037902|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4214560|NCT00717574|4037900|B3||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4214561|NCT00717574|4037901|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4214562|NCT00717574|4037902|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4214563|NCT00717574|4037900|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4214564|NCT00717574|4037901|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4214565|NCT00717574|4037902|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4214566|NCT00717574|4037900|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4214567|NCT00717574|4037901|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4214568|NCT00717574|4037902|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4214569|NCT00717574|4037900|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4214570|NCT00717574|4037901|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4214571|NCT00717574|4037902|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4214572|NCT00717574|4037900|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4214573|NCT00717574|4037901|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4214574|NCT00717574|4037902|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4214575|NCT00717574|4037900|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4214576|NCT00717574|4037901|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4214577|NCT00717574|4037902|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4214578|NCT00717574|4037900|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4214579|NCT00717574|4037901|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4214580|NCT00717574|4037902|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4214581|NCT00717574|4037900|B3|||Age||years|Mean|38.7|38.7|Standard Deviation|9.7|9.7|||
4214582|NCT00717574|4037901|B2|||Age||years|Mean|38|38.0|Standard Deviation|9.6|9.6|||
4214583|NCT00717574|4037902|B1|||Age||years|Mean|39|39.0|Standard Deviation|10|10.0|||
4214584|NCT00717522|4037909|B1|Non-white||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4214585|NCT00717522|4037909|B1|White||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4214586|NCT00717522|4037909|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4214587|NCT00717522|4037909|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4214588|NCT00717522|4037909|B1|||Age||years|Mean|58.9|58.9|Standard Deviation|13.52|13.52|||
4214589|NCT00717418|4037914|B5||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4214590|NCT00717418|4037915|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4214591|NCT00717418|4037916|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4214592|NCT00717418|4037917|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4214593|NCT00717418|4037918|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4214594|NCT00717418|4037914|B5||Female|Sex: Female, Male||Participants|Count of Participants|627|627.0||||||
4214595|NCT00717418|4037915|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4214596|NCT00717418|4037916|B3||Female|Sex: Female, Male||Participants|Count of Participants|425|425.0||||||
4214597|NCT00717418|4037917|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4214598|NCT00717418|4037918|B1||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4214599|NCT00717418|4037914|B5|||Age||years|Median|60.0|60.0|Full Range|||18.0|96.0|
4214600|NCT00717418|4037915|B4|||Age||years|Median|61.0|61.0|Full Range|||26.0|87.0|
4214601|NCT00717418|4037916|B3|||Age||years|Median|60.0|60.0|Full Range|||18.0|96.0|
4214602|NCT00717418|4037917|B2|||Age||years|Median|64.5|64.5|Full Range|||28.0|87.0|
4214603|NCT00717418|4037918|B1|||Age||years|Median|55.0|55.0|Full Range|||19.0|91.0|
4214604|NCT00717405|4037926|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4214605|NCT00717405|4037926|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4214606|NCT00717405|4037926|B1|||Age||years|Mean|51.48|51.48|Standard Deviation|9.78|9.78|||
4214607|NCT00717366|4037943|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4214608|NCT00717366|4037944|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4214609|NCT00717366|4037945|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4214610|NCT00717366|4037943|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4214611|NCT00717366|4037944|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4214612|NCT00717366|4037945|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4214613|NCT00717366|4037943|B3|||Age||years|Mean|12.6|12.6|Standard Deviation|3.17|3.17|||
4214614|NCT00717366|4037944|B2|||Age||years|Mean|13.0|13.0|Standard Deviation|3.06|3.06|||
4214615|NCT00717366|4037945|B1|||Age||years|Mean|11.3|11.3|Standard Deviation|3.24|3.24|||
4214616|NCT00717314|4037968|B3||Male|Sex: Female, Male|PP population included all participants completing study treatment, n= 37 and 34 participants in the MMF, 50% CNI Reduction and MMF, ≥75% CNI Reduction groups, respectively.|Participants|Count of Participants|63|63.0||||||
4214617|NCT00717314|4037969|B2||Male|Sex: Female, Male|PP population included all participants completing study treatment, n= 37 and 34 participants in the MMF, 50% CNI Reduction and MMF, ≥75% CNI Reduction groups, respectively.|Participants|Count of Participants|30|30.0||||||
4214618|NCT00717314|4037970|B1||Male|Sex: Female, Male|PP population included all participants completing study treatment, n= 37 and 34 participants in the MMF, 50% CNI Reduction and MMF, ≥75% CNI Reduction groups, respectively.|Participants|Count of Participants|33|33.0||||||
4214619|NCT00717314|4037968|B3||Female|Sex: Female, Male|PP population included all participants completing study treatment, n= 37 and 34 participants in the MMF, 50% CNI Reduction and MMF, ≥75% CNI Reduction groups, respectively.|Participants|Count of Participants|8|8.0||||||
4214620|NCT00717314|4037969|B2||Female|Sex: Female, Male|PP population included all participants completing study treatment, n= 37 and 34 participants in the MMF, 50% CNI Reduction and MMF, ≥75% CNI Reduction groups, respectively.|Participants|Count of Participants|4|4.0||||||
4214621|NCT00717314|4037970|B1||Female|Sex: Female, Male|PP population included all participants completing study treatment, n= 37 and 34 participants in the MMF, 50% CNI Reduction and MMF, ≥75% CNI Reduction groups, respectively.|Participants|Count of Participants|4|4.0||||||
4214622|NCT00717314|4037968|B3|||Age||years|Mean|52.6|52.6|Standard Deviation|9.9|9.9|||
4214623|NCT00717314|4037969|B2|||Age||years|Mean|52.4|52.4|Standard Deviation|11.1|11.1|||
4214624|NCT00717314|4037970|B1|||Age||years|Mean|52.8|52.8|Standard Deviation|8.7|8.7|||
4214625|NCT00717288|4037989|B4|United States||Region of Enrollment||participants|Number|82|82.0||||||
4214626|NCT00717288|4037990|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4214627|NCT00717288|4037991|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4214628|NCT00717288|4037992|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4214629|NCT00717288|4037989|B4||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4214630|NCT00717288|4037990|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4214631|NCT00717288|4037991|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4214632|NCT00717288|4037992|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4214633|NCT00717288|4037989|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4214634|NCT00717288|4037990|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4214635|NCT00717288|4037991|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4214636|NCT00717288|4037992|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4214637|NCT00717288|4037989|B4|||Age||years|Mean|58.7|58.7|Standard Deviation|8.4|8.4|||
4214638|NCT00717288|4037990|B3|||Age||years|Mean|61|61.0|Standard Deviation|7.6|7.6|||
4214639|NCT00717288|4037991|B2|||Age||years|Mean|57|57.0|Standard Deviation|9.1|9.1|||
4214640|NCT00717288|4037992|B1|||Age||years|Mean|58|58.0|Standard Deviation|8.0|8.0|||
4214641|NCT00717288|4037989|B4||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4214642|NCT00717288|4037990|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4214643|NCT00717288|4037991|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4214644|NCT00717288|4037992|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4214645|NCT00717288|4037989|B4||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4214646|NCT00717288|4037990|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4214647|NCT00717288|4037991|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4214648|NCT00717288|4037992|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4214649|NCT00717288|4037989|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4214650|NCT00717288|4037990|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4214651|NCT00717288|4037991|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4214652|NCT00717288|4037992|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4214653|NCT00717275|4038008|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4214654|NCT00717275|4038008|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4214655|NCT00717275|4038008|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4214656|NCT00717275|4038008|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4214657|NCT00717275|4038008|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4214658|NCT00717275|4038008|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4214659|NCT00717249|4038012|B3|United States||Region of Enrollment||participants|Number|491|491.0||||||
4214660|NCT00717249|4038013|B2|United States||Region of Enrollment||participants|Number|165|165.0||||||
4214661|NCT00717249|4038014|B1|United States||Region of Enrollment||participants|Number|326|326.0||||||
4214662|NCT00717249|4038012|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4214663|NCT00717249|4038013|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4214664|NCT00717249|4038014|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4214665|NCT00717249|4038012|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4214666|NCT00717249|4038013|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4214667|NCT00717249|4038014|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4214668|NCT00717249|4038012|B3|Asian - Indian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4214669|NCT00717249|4038013|B2|Asian - Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4214670|NCT00717249|4038014|B1|Asian - Indian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4214671|NCT00717249|4038012|B3|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4214672|NCT00717249|4038013|B2|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4214673|NCT00717249|4038014|B1|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4214674|NCT00717249|4038012|B3|African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4214675|NCT00717249|4038013|B2|African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4214676|NCT00717249|4038014|B1|African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4214677|NCT00717249|4038012|B3|White||Race/Ethnicity, Customized||participants|Number|451|451.0||||||
4214678|NCT00717249|4038013|B2|White||Race/Ethnicity, Customized||participants|Number|147|147.0||||||
4214679|NCT00717249|4038014|B1|White||Race/Ethnicity, Customized||participants|Number|304|304.0||||||
4214680|NCT00717249|4038012|B3|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4214681|NCT00717249|4038013|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4214682|NCT00717249|4038014|B1|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4214683|NCT00717249|4038012|B3||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4214684|NCT00717249|4038013|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4214685|NCT00717249|4038014|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4214686|NCT00717249|4038012|B3||Female|Sex: Female, Male||Participants|Count of Participants|324|324.0||||||
4214687|NCT00717249|4038013|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4214688|NCT00717249|4038014|B1||Female|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
4214689|NCT00717249|4038012|B3|||Age||years|Mean|30.9|30.9|Full Range|||18.0|60.0|
4214690|NCT00717249|4038013|B2|||Age||years|Mean|29.8|29.8|Full Range|||18.0|51.0|
4214691|NCT00717249|4038014|B1|||Age||years|Mean|31.9|31.9|Full Range|||18.0|60.0|
4214692|NCT00717236|4038027|B3|Italy||Region of Enrollment||participants|Number|15|15.0||||||
4214693|NCT00717236|4038028|B2|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4214694|NCT00717236|4038029|B1|Italy||Region of Enrollment||participants|Number|13|13.0||||||
4214695|NCT00717236|4038027|B3|Germany||Region of Enrollment||participants|Number|198|198.0||||||
4214696|NCT00717236|4038028|B2|Germany||Region of Enrollment||participants|Number|44|44.0||||||
4214697|NCT00717236|4038029|B1|Germany||Region of Enrollment||participants|Number|154|154.0||||||
4214698|NCT00717236|4038027|B3|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
4214699|NCT00717236|4038028|B2|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4214700|NCT00717236|4038029|B1|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
4214701|NCT00717236|4038027|B3|Spain||Region of Enrollment||participants|Number|34|34.0||||||
4214702|NCT00717236|4038028|B2|Spain||Region of Enrollment||participants|Number|8|8.0||||||
4214703|NCT00717236|4038029|B1|Spain||Region of Enrollment||participants|Number|26|26.0||||||
4214704|NCT00717236|4038027|B3|Canada||Region of Enrollment||participants|Number|82|82.0||||||
4214705|NCT00717236|4038028|B2|Canada||Region of Enrollment||participants|Number|17|17.0||||||
4214706|NCT00717236|4038029|B1|Canada||Region of Enrollment||participants|Number|65|65.0||||||
4214707|NCT00717236|4038027|B3|United States||Region of Enrollment||participants|Number|716|716.0||||||
4214708|NCT00717236|4038028|B2|United States||Region of Enrollment||participants|Number|141|141.0||||||
4214709|NCT00717236|4038029|B1|United States||Region of Enrollment||participants|Number|575|575.0||||||
4214710|NCT00717236|4038027|B3|France||Region of Enrollment||participants|Number|14|14.0||||||
4214711|NCT00717236|4038028|B2|France||Region of Enrollment||participants|Number|0|0.0||||||
4214712|NCT00717236|4038029|B1|France||Region of Enrollment||participants|Number|14|14.0||||||
4214713|NCT00717236|4038027|B3||Male|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
4214714|NCT00717236|4038028|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4214715|NCT00717236|4038029|B1||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4214716|NCT00717236|4038027|B3||Female|Sex: Female, Male||Participants|Count of Participants|829|829.0||||||
4214717|NCT00717236|4038028|B2||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4214718|NCT00717236|4038029|B1||Female|Sex: Female, Male||Participants|Count of Participants|660|660.0||||||
4214719|NCT00717236|4038027|B3|||Age||years|Mean|55.1|55.1|Standard Deviation|12.49|12.49|||
4214720|NCT00717236|4038028|B2|||Age||years|Mean|53.9|53.9|Standard Deviation|12.66|12.66|||
4214721|NCT00717236|4038029|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|12.43|12.43|||
4214722|NCT00717236|4038027|B3||>=65 years|Age||Participants|Count of Participants|255|255.0||||||
4214723|NCT00717236|4038028|B2||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4214724|NCT00717236|4038029|B1||>=65 years|Age||Participants|Count of Participants|207|207.0||||||
4214725|NCT00717236|4038027|B3||Between 18 and 65 years|Age||Participants|Count of Participants|808|808.0||||||
4214726|NCT00717236|4038028|B2||Between 18 and 65 years|Age||Participants|Count of Participants|164|164.0||||||
4214727|NCT00717236|4038029|B1||Between 18 and 65 years|Age||Participants|Count of Participants|644|644.0||||||
4214728|NCT00717236|4038027|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4214729|NCT00717236|4038028|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4214730|NCT00717236|4038029|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4214731|NCT00717197|4038099|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4214732|NCT00717197|4038099|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4214733|NCT00717197|4038099|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4214734|NCT00717197|4038099|B1|||Age||years|Mean|51.5|51.5|Standard Deviation|12.6|12.6|||
4214735|NCT00717197|4038099|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4214736|NCT00717197|4038099|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4214737|NCT00717197|4038099|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4214738|NCT00717093|4038103|B3||Male|Sex: Female, Male||Participants|Count of Participants|385|385.0||||||
4214739|NCT00717093|4038104|B2||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4214740|NCT00717093|4038105|B1||Male|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4214741|NCT00717093|4038103|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4214742|NCT00717093|4038104|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4214743|NCT00717093|4038105|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4214744|NCT00717093|4038103|B3|>= 65 years||Age, Customized||participants|Number|18|18.0||||||
4214745|NCT00717093|4038104|B2|>= 65 years||Age, Customized||participants|Number|10|10.0||||||
4214746|NCT00717093|4038105|B1|>= 65 years||Age, Customized||participants|Number|8|8.0||||||
4214747|NCT00717093|4038103|B3|45 - 64 years||Age, Customized||participants|Number|181|181.0||||||
4214748|NCT00717093|4038104|B2|45 - 64 years||Age, Customized||participants|Number|93|93.0||||||
4214749|NCT00717093|4038105|B1|45 - 64 years||Age, Customized||participants|Number|88|88.0||||||
4214750|NCT00717093|4038103|B3|18 - 44 years||Age, Customized||participants|Number|232|232.0||||||
4214751|NCT00717093|4038104|B2|18 - 44 years||Age, Customized||participants|Number|115|115.0||||||
4214752|NCT00717093|4038105|B1|18 - 44 years||Age, Customized||participants|Number|117|117.0||||||
4214753|NCT00717067|4038118|B6||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4214754|NCT00717067|4038119|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4214755|NCT00717067|4038120|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4214756|NCT00717067|4038121|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4214757|NCT00717067|4038122|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4214758|NCT00717067|4038123|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4214759|NCT00717067|4038118|B6||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4214760|NCT00717067|4038119|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4214761|NCT00717067|4038120|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4214762|NCT00717067|4038121|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4214763|NCT00717067|4038122|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4214764|NCT00717067|4038123|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4214765|NCT00717067|4038118|B6|>= 65 years||Age, Customized||years|Number|12|12.0||||||
4214766|NCT00717067|4038119|B5|>= 65 years||Age, Customized||years|Number|1|1.0||||||
4214767|NCT00717067|4038120|B4|>= 65 years||Age, Customized||years|Number|3|3.0||||||
4214768|NCT00717067|4038121|B3|>= 65 years||Age, Customized||years|Number|5|5.0||||||
4214769|NCT00717067|4038122|B2|>= 65 years||Age, Customized||years|Number|2|2.0||||||
4214770|NCT00717067|4038123|B1|>= 65 years||Age, Customized||years|Number|1|1.0||||||
4214771|NCT00717067|4038118|B6|45 - 64 years||Age, Customized||years|Number|15|15.0||||||
4214772|NCT00717067|4038119|B5|45 - 64 years||Age, Customized||years|Number|4|4.0||||||
4214773|NCT00717067|4038120|B4|45 - 64 years||Age, Customized||years|Number|2|2.0||||||
4214774|NCT00717067|4038121|B3|45 - 64 years||Age, Customized||years|Number|0|0.0||||||
4214775|NCT00717067|4038122|B2|45 - 64 years||Age, Customized||years|Number|4|4.0||||||
4214776|NCT00717067|4038123|B1|45 - 64 years||Age, Customized||years|Number|5|5.0||||||
4214777|NCT00717067|4038118|B6|18 - 44 years||Age, Customized||years|Number|3|3.0||||||
4214778|NCT00717067|4038119|B5|18 - 44 years||Age, Customized||years|Number|1|1.0||||||
4214779|NCT00717067|4038120|B4|18 - 44 years||Age, Customized||years|Number|1|1.0||||||
4214780|NCT00717067|4038121|B3|18 - 44 years||Age, Customized||years|Number|1|1.0||||||
4214781|NCT00717067|4038122|B2|18 - 44 years||Age, Customized||years|Number|0|0.0||||||
4214782|NCT00717067|4038123|B1|18 - 44 years||Age, Customized||years|Number|0|0.0||||||
4214783|NCT00717054|4038209|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4214784|NCT00717054|4038210|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4214785|NCT00717054|4038211|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4214786|NCT00717054|4038209|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4214787|NCT00717054|4038210|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4214788|NCT00717054|4038211|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4214789|NCT00717054|4038209|B3|||Age||years|Mean|46.8|46.8|Standard Deviation|11.17|11.17|||
4214790|NCT00717054|4038210|B2|||Age||years|Mean|47.2|47.2|Standard Deviation|11.27|11.27|||
4214791|NCT00717054|4038211|B1|||Age||years|Mean|46.3|46.3|Standard Deviation|11.06|11.06|||
4214792|NCT00717041|4038224|B1|||Cognitive Impairment (>2 on SIS)|Number of participants with Six Item Screener testing with greater than 2 errors (more errors, worse cognition).|participants|Number|106|106.0||||||
4214793|NCT00717041|4038224|B1|||Depression (>=10 on PHQ9)|Number of participants with the Patient Health Questionnaire - 9 (Depression) >= 10 (more depression).|participants|Number|177|177.0||||||
4214794|NCT00717041|4038224|B1|||Anxiety (>=10 on GAD7)|The number of participants with Generalized Anxiety Disorder - 7 scores greater than or equal to 10 (more anxiety).|participants|Number|119|119.0||||||
4214795|NCT00717041|4038224|B1|United States||Region of Enrollment||participants|Number|1206|1206.0||||||
4214796|NCT00717041|4038224|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4214797|NCT00717041|4038224|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4214798|NCT00717041|4038224|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1000|1000.0||||||
4214799|NCT00717041|4038224|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|178|178.0||||||
4214800|NCT00717041|4038224|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4214801|NCT00717041|4038224|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4214802|NCT00717041|4038224|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4214803|NCT00717041|4038224|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4214804|NCT00717041|4038224|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1184|1184.0||||||
4214805|NCT00717041|4038224|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4214806|NCT00717041|4038224|B1||Male|Sex: Female, Male||Participants|Count of Participants|572|572.0||||||
4214807|NCT00717041|4038224|B1||Female|Sex: Female, Male||Participants|Count of Participants|634|634.0||||||
4214808|NCT00717041|4038224|B1|||Age||years|Median|71|71.0|Inter-Quartile Range|||65.0|80.0|
4214809|NCT00716976|4038232|B3|United States||Region of Enrollment|1 patient of unknown origin in STS arm|participants|Number|118|118.0||||||
4214810|NCT00716976|4038233|B2|United States||Region of Enrollment|1 patient of unknown origin in STS arm|participants|Number|62|62.0||||||
4214811|NCT00716976|4038234|B1|United States||Region of Enrollment|1 patient of unknown origin in STS arm|participants|Number|56|56.0||||||
4214870|NCT00716859|4038275|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4214812|NCT00716976|4038232|B3|Canada||Region of Enrollment|1 patient of unknown origin in STS arm|participants|Number|12|12.0||||||
4214813|NCT00716976|4038233|B2|Canada||Region of Enrollment|1 patient of unknown origin in STS arm|participants|Number|4|4.0||||||
4214814|NCT00716976|4038234|B1|Canada||Region of Enrollment|1 patient of unknown origin in STS arm|participants|Number|8|8.0||||||
4214815|NCT00716976|4038232|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4214816|NCT00716976|4038233|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4214817|NCT00716976|4038234|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4214818|NCT00716976|4038232|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4214819|NCT00716976|4038233|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4214820|NCT00716976|4038234|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4214821|NCT00716976|4038232|B3||White|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
4214822|NCT00716976|4038233|B2||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4214823|NCT00716976|4038234|B1||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4214824|NCT00716976|4038232|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4214825|NCT00716976|4038233|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4214826|NCT00716976|4038234|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4214827|NCT00716976|4038232|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4214828|NCT00716976|4038233|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4214829|NCT00716976|4038234|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4214830|NCT00716976|4038232|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4214831|NCT00716976|4038233|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4214832|NCT00716976|4038234|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4214833|NCT00716976|4038232|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4214834|NCT00716976|4038233|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4214835|NCT00716976|4038234|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4214836|NCT00716976|4038232|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4214837|NCT00716976|4038233|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4214838|NCT00716976|4038234|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4214839|NCT00716976|4038232|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
4214840|NCT00716976|4038233|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4214841|NCT00716976|4038234|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4214842|NCT00716976|4038232|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4214843|NCT00716976|4038233|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4214844|NCT00716976|4038234|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4214845|NCT00716976|4038232|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4214846|NCT00716976|4038233|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4214847|NCT00716976|4038234|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4214848|NCT00716976|4038232|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4214849|NCT00716976|4038233|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4214850|NCT00716976|4038234|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4214851|NCT00716976|4038232|B3|||Age||Years|Mean|8.68|8.68|Standard Deviation|5.89|5.89|||
4214852|NCT00716976|4038233|B2|||Age||Years|Mean|8.39|8.39|Standard Deviation|5.88|5.88|||
4214853|NCT00716976|4038234|B1|||Age||Years|Mean|8.97|8.97|Standard Deviation|5.93|5.93|||
4214854|NCT00716976|4038232|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4214855|NCT00716976|4038233|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4214856|NCT00716976|4038234|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4214857|NCT00716976|4038232|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4214858|NCT00716976|4038233|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4214859|NCT00716976|4038234|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4214860|NCT00716976|4038232|B3||<=18 years|Age||Participants|Count of Participants|131|131.0||||||
4214861|NCT00716976|4038233|B2||<=18 years|Age||Participants|Count of Participants|66|66.0||||||
4214862|NCT00716976|4038234|B1||<=18 years|Age||Participants|Count of Participants|65|65.0||||||
4214863|NCT00716963|4038257|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4214864|NCT00716963|4038257|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4214865|NCT00716963|4038257|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4214866|NCT00716963|4038257|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4214867|NCT00716963|4038257|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4214868|NCT00716859|4038273|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4214869|NCT00716859|4038274|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4214871|NCT00716859|4038273|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4214872|NCT00716859|4038274|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4214873|NCT00716859|4038275|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4214874|NCT00716859|4038273|B3|0 to < 3 years||Age, Customized||Participants|Number|34|34.0||||||
4214875|NCT00716859|4038274|B2|0 to < 3 years||Age, Customized||Participants|Number|17|17.0||||||
4214876|NCT00716859|4038275|B1|0 to < 3 years||Age, Customized||Participants|Number|17|17.0||||||
4214877|NCT00716859|4038273|B3|3 to less than (<) 12 years||Age, Customized||Participants|Number|55|55.0||||||
4214878|NCT00716859|4038274|B2|3 to less than (<) 12 years||Age, Customized||Participants|Number|26|26.0||||||
4214879|NCT00716859|4038275|B1|3 to less than (<) 12 years||Age, Customized||Participants|Number|29|29.0||||||
4214880|NCT00716859|4038273|B3|12 to 18 years||Age, Customized||Participants|Number|48|48.0||||||
4214881|NCT00716859|4038274|B2|12 to 18 years||Age, Customized||Participants|Number|25|25.0||||||
4214882|NCT00716859|4038275|B1|12 to 18 years||Age, Customized||Participants|Number|23|23.0||||||
4214883|NCT00716820|4038300|B1||Male|Sex: Female, Male||Participants|Count of Participants|297|297.0||||||
4214884|NCT00716820|4038300|B1||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4214885|NCT00716820|4038300|B1|Unknown||Age, Customized||Participants|Number|7|7.0||||||
4214886|NCT00716820|4038300|B1|˃=65 years||Age, Customized||Participants|Number|227|227.0||||||
4214887|NCT00716820|4038300|B1|>=15 and <65 years||Age, Customized||Participants|Number|238|238.0||||||
4214888|NCT00716820|4038300|B1|<15 years||Age, Customized||Participants|Number|0|0.0||||||
4214889|NCT00716807|4038331|B5|United States||Region of Enrollment||participants|Number|46|46.0||||||
4214890|NCT00716807|4038332|B4|United States||Region of Enrollment||participants|Number|15|15.0||||||
4214891|NCT00716807|4038333|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4214892|NCT00716807|4038334|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4214893|NCT00716807|4038335|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4214894|NCT00716807|4038331|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4214895|NCT00716807|4038332|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4214896|NCT00716807|4038333|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4214897|NCT00716807|4038334|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4214898|NCT00716807|4038335|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4214899|NCT00716807|4038331|B5||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4214900|NCT00716807|4038332|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4214901|NCT00716807|4038333|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4214902|NCT00716807|4038334|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4214903|NCT00716807|4038335|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4214904|NCT00716807|4038331|B5|Unknown||Age, Customized||Participants|Number|46|46.0||||||
4214905|NCT00716807|4038332|B4|Unknown||Age, Customized||Participants|Number|15|15.0||||||
4214906|NCT00716807|4038333|B3|Unknown||Age, Customized||Participants|Number|18|18.0||||||
4214907|NCT00716807|4038334|B2|Unknown||Age, Customized||Participants|Number|5|5.0||||||
4214908|NCT00716807|4038335|B1|Unknown||Age, Customized||Participants|Number|8|8.0||||||
4214909|NCT00716742|4038348|B4||Male|Sex: Female, Male||Participants|Count of Participants|482|482.0||||||
4214910|NCT00716742|4038349|B3||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4214911|NCT00716742|4038350|B2||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4214912|NCT00716742|4038351|B1||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4214913|NCT00716742|4038348|B4||Female|Sex: Female, Male||Participants|Count of Participants|617|617.0||||||
4214914|NCT00716742|4038349|B3||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4214915|NCT00716742|4038350|B2||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
4214916|NCT00716742|4038351|B1||Female|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4214917|NCT00716742|4038348|B4|||Age||years|Median|67.0|67.0|Full Range|||21.0|98.0|
4214918|NCT00716742|4038349|B3|||Age||years|Median|67.0|67.0|Full Range|||23.0|95.0|
4214919|NCT00716742|4038350|B2|||Age||years|Median|67.0|67.0|Full Range|||32.0|98.0|
4214920|NCT00716742|4038351|B1|||Age||years|Median|65.5|65.5|Full Range|||21.0|97.0|
4214921|NCT00716625|4038361|B1||Male|Gender||Participants|Count of Participants|1252|1252.0||||||
4214922|NCT00716625|4038361|B1||Female|Gender||Participants|Count of Participants|421|421.0||||||
4214923|NCT00716625|4038361|B1|Unknown||Age, Customized||Participants|Number|20|20.0||||||
4214924|NCT00716625|4038361|B1|˃=65 years||Age, Customized||Participants|Number|712|712.0||||||
4214925|NCT00716625|4038361|B1|>=15 and <65 years||Age, Customized||Participants|Number|940|940.0||||||
4214926|NCT00716625|4038361|B1|<15 years||Age, Customized||Participants|Number|1|1.0||||||
4214927|NCT00716482|4038386|B1|United Kingdom||Region of Enrollment||participants|Number|175|175.0||||||
4214928|NCT00716482|4038386|B1|Italy||Region of Enrollment||participants|Number|89|89.0||||||
4214929|NCT00716482|4038386|B1|Germany||Region of Enrollment||participants|Number|529|529.0||||||
4214930|NCT00716482|4038386|B1|United States||Region of Enrollment||participants|Number|566|566.0||||||
4214931|NCT00716482|4038386|B1|France||Region of Enrollment||participants|Number|322|322.0||||||
4214932|NCT00716482|4038386|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4214933|NCT00716482|4038386|B1||Female|Sex: Female, Male||Participants|Count of Participants|1681|1681.0||||||
4215171|NCT00716079|4038707|B2|Chile||Region of Enrollment||participants|Number|12|12.0||||||
4214934|NCT00716482|4038386|B1|||Age|mean age is based on 1681 participants|years|Mean|51.8|51.8|Standard Deviation|14.5|14.5|||
4214935|NCT00716456|4038396|B4|United States||Region of Enrollment||participants|Number|21|21.0||||||
4214936|NCT00716456|4038397|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4214937|NCT00716456|4038398|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4214938|NCT00716456|4038399|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4214939|NCT00716456|4038396|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4214940|NCT00716456|4038397|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4214941|NCT00716456|4038398|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4214942|NCT00716456|4038399|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4214943|NCT00716456|4038396|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4214944|NCT00716456|4038397|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4214945|NCT00716456|4038398|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4214946|NCT00716456|4038399|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4214947|NCT00716456|4038396|B4||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4214948|NCT00716456|4038397|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4214949|NCT00716456|4038398|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4214950|NCT00716456|4038399|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4214951|NCT00716456|4038396|B4||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4214952|NCT00716456|4038397|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4214953|NCT00716456|4038398|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4214954|NCT00716456|4038399|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4214955|NCT00716456|4038396|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4214956|NCT00716456|4038397|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4214957|NCT00716456|4038398|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4214958|NCT00716456|4038399|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4214959|NCT00716443|4038409|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4214960|NCT00716443|4038409|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4214961|NCT00716443|4038409|B1|||Age||years|Mean|47.8|47.8|Standard Deviation|8.34|8.34|||
4214962|NCT00716417|4038442|B11||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4214963|NCT00716417|4038443|B10||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4214964|NCT00716417|4038444|B9||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4214965|NCT00716417|4038445|B8||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4214966|NCT00716417|4038446|B7||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4214967|NCT00716417|4038447|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4214968|NCT00716417|4038448|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4214969|NCT00716417|4038449|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4214970|NCT00716417|4038450|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4214971|NCT00716417|4038451|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4214972|NCT00716417|4038452|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4214973|NCT00716417|4038442|B11||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4214974|NCT00716417|4038443|B10||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4214975|NCT00716417|4038444|B9||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4214976|NCT00716417|4038445|B8||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4214977|NCT00716417|4038446|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4214978|NCT00716417|4038447|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4214979|NCT00716417|4038448|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4214980|NCT00716417|4038449|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4214981|NCT00716417|4038450|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4214982|NCT00716417|4038451|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4214983|NCT00716417|4038452|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4214984|NCT00716417|4038442|B11|||Age||years|Mean|58.58|58.58|Standard Deviation|11.3|11.3|||
4214985|NCT00716417|4038443|B10|||Age||years|Mean|63.7|63.7|Standard Deviation|9.3|9.3|||
4214986|NCT00716417|4038444|B9|||Age||years|Mean|59.2|59.2|Standard Deviation|14.4|14.4|||
4214987|NCT00716417|4038445|B8|||Age||years|Mean|65.0|65.0|Standard Deviation|8.5|8.5|||
4214988|NCT00716417|4038446|B7|||Age||years|Mean|53.1|53.1|Standard Deviation|16.1|16.1|||
4214989|NCT00716417|4038447|B6|||Age||years|Mean|52.7|52.7|Standard Deviation|9.7|9.7|||
4214990|NCT00716417|4038448|B5|||Age||years|Mean|54.0|54.0|Standard Deviation|NA||||only one patient in this group
4214991|NCT00716417|4038449|B4|||Age||years|Mean|58.1|58.1|Standard Deviation|7.8|7.8|||
4214992|NCT00716417|4038450|B3|||Age||years|Mean|61.8|61.8|Standard Deviation|5.9|5.9|||
4214993|NCT00716417|4038451|B2|||Age||years|Mean|61.8|61.8|Standard Deviation|15.6|15.6|||
4214994|NCT00716417|4038452|B1|||Age||years|Mean|56.7|56.7|Standard Deviation|14.0|14.0|||
4214995|NCT00716274|4038505|B4|United States||Region of Enrollment||Participants|Count of Participants|110|110.0||||||
4214996|NCT00716274|4038506|B3|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
4214997|NCT00716274|4038507|B2|United States||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
4214998|NCT00716274|4038508|B1|United States||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
4214999|NCT00716274|4038505|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4215000|NCT00716274|4038506|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4215001|NCT00716274|4038507|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4215002|NCT00716274|4038508|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4215003|NCT00716274|4038505|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215004|NCT00716274|4038506|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215005|NCT00716274|4038507|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215006|NCT00716274|4038508|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215007|NCT00716274|4038505|B4||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4215008|NCT00716274|4038506|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4215009|NCT00716274|4038507|B2||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4215010|NCT00716274|4038508|B1||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4215011|NCT00716274|4038505|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4215012|NCT00716274|4038506|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4215013|NCT00716274|4038507|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4215014|NCT00716274|4038508|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4215015|NCT00716274|4038505|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215016|NCT00716274|4038506|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215017|NCT00716274|4038507|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215018|NCT00716274|4038508|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215019|NCT00716274|4038505|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4215020|NCT00716274|4038506|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215021|NCT00716274|4038507|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215022|NCT00716274|4038508|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4215023|NCT00716274|4038505|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215024|NCT00716274|4038506|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215025|NCT00716274|4038507|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215026|NCT00716274|4038508|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215027|NCT00716274|4038505|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215028|NCT00716274|4038506|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215029|NCT00716274|4038507|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215030|NCT00716274|4038508|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215031|NCT00716274|4038505|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
4215032|NCT00716274|4038506|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4215033|NCT00716274|4038507|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4215034|NCT00716274|4038508|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4215035|NCT00716274|4038505|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4215036|NCT00716274|4038506|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4215037|NCT00716274|4038507|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4215038|NCT00716274|4038508|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4215039|NCT00716274|4038505|B4||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4215040|NCT00716274|4038506|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4215041|NCT00716274|4038507|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4215042|NCT00716274|4038508|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4215043|NCT00716274|4038505|B4||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4215044|NCT00716274|4038506|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4215045|NCT00716274|4038507|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4215046|NCT00716274|4038508|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4215047|NCT00716274|4038505|B4|||Age||years|Mean|12.20|12.2|Standard Deviation|1.92|1.92|||
4215048|NCT00716274|4038506|B3|||Age||years|Mean|12.4|12.4|Standard Deviation|2.05|2.05|||
4215049|NCT00716274|4038507|B2|||Age||years|Mean|12.1|12.1|Standard Deviation|1.90|1.9|||
4215050|NCT00716274|4038508|B1|||Age||years|Mean|12.2|12.2|Standard Deviation|1.89|1.89|||
4215051|NCT00716144|4038643|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215052|NCT00716144|4038644|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215053|NCT00716144|4038645|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215054|NCT00716144|4038646|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215055|NCT00716144|4038647|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215056|NCT00716144|4038643|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215057|NCT00716144|4038644|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215058|NCT00716144|4038645|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215059|NCT00716144|4038646|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215060|NCT00716144|4038647|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215061|NCT00716144|4038643|B5||White|Race (NIH/OMB)||Participants|Count of Participants|174|174.0||||||
4215062|NCT00716144|4038644|B4||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4215063|NCT00716144|4038645|B3||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4215064|NCT00716144|4038646|B2||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4215065|NCT00716144|4038647|B1||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4215066|NCT00716144|4038643|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215067|NCT00716144|4038644|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215068|NCT00716144|4038645|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215069|NCT00716144|4038646|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215070|NCT00716144|4038647|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215071|NCT00716144|4038643|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215072|NCT00716144|4038644|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215073|NCT00716144|4038645|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215074|NCT00716144|4038646|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215075|NCT00716144|4038647|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215076|NCT00716144|4038643|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4215077|NCT00716144|4038644|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215078|NCT00716144|4038645|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4215079|NCT00716144|4038646|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215080|NCT00716144|4038647|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4215081|NCT00716144|4038643|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215082|NCT00716144|4038644|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215083|NCT00716144|4038645|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215084|NCT00716144|4038646|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215085|NCT00716144|4038647|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215086|NCT00716144|4038643|B5||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4215087|NCT00716144|4038644|B4||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4215088|NCT00716144|4038645|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4215089|NCT00716144|4038646|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4215090|NCT00716144|4038647|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4215091|NCT00716144|4038643|B5||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4215092|NCT00716144|4038644|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4215093|NCT00716144|4038645|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4215094|NCT00716144|4038646|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4215095|NCT00716144|4038647|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4215096|NCT00716144|4038643|B5|||Age||Years|Mean|NA||Standard Deviation|NA||||Age totals (mean and SD) were not provided in CSR. The raw data for this study is no longer available in any of our statistical systems, despite a thorough search. We are unable to supply this total data as typically required.
4215097|NCT00716144|4038644|B4|||Age||Years|Mean|48.2|48.2|Standard Deviation|12.4|12.4|||
4215098|NCT00716144|4038645|B3|||Age||Years|Mean|47.3|47.3|Standard Deviation|11.5|11.5|||
4215099|NCT00716144|4038646|B2|||Age||Years|Mean|42.3|42.3|Standard Deviation|13.3|13.3|||
4215100|NCT00716144|4038647|B1|||Age||Years|Mean|45.9|45.9|Standard Deviation|12.3|12.3|||
4215101|NCT00716092|4038672|B4|||Fasting plasma glucose (FPG) continuous||mg/dL|Mean|166.6|166.6|Standard Deviation|27.55|27.55|||
4215102|NCT00716092|4038673|B3|||Fasting plasma glucose (FPG) continuous||mg/dL|Mean|160.3|160.3|Standard Deviation|25.35|25.35|||
4215103|NCT00716092|4038674|B2|||Fasting plasma glucose (FPG) continuous||mg/dL|Mean|166.9|166.9|Standard Deviation|27.65|27.65|||
4215104|NCT00716092|4038675|B1|||Fasting plasma glucose (FPG) continuous||mg/dL|Mean|172.8|172.8|Standard Deviation|28.81|28.81|||
4215105|NCT00716092|4038672|B4|||Glycosylated Hemoglobin A1 (HbA1C) continuous||Percent|Mean|7.32|7.32|Standard Deviation|0.53|0.53|||
4215106|NCT00716092|4038673|B3|||Glycosylated Hemoglobin A1 (HbA1C) continuous||Percent|Mean|7.17|7.17|Standard Deviation|0.44|0.44|||
4215107|NCT00716092|4038674|B2|||Glycosylated Hemoglobin A1 (HbA1C) continuous||Percent|Mean|7.32|7.32|Standard Deviation|0.59|0.59|||
4215108|NCT00716092|4038675|B1|||Glycosylated Hemoglobin A1 (HbA1C) continuous||Percent|Mean|7.47|7.47|Standard Deviation|0.53|0.53|||
4215109|NCT00716092|4038672|B4|||Body Mass Index (BMI) continuous||kg/m^2|Mean|30.8|30.8|Standard Deviation|4.29|4.29|||
4215110|NCT00716092|4038673|B3|||Body Mass Index (BMI) continuous||kg/m^2|Mean|30.7|30.7|Standard Deviation|4.56|4.56|||
4215111|NCT00716092|4038674|B2|||Body Mass Index (BMI) continuous||kg/m^2|Mean|31.4|31.4|Standard Deviation|4.48|4.48|||
4215112|NCT00716092|4038675|B1|||Body Mass Index (BMI) continuous||kg/m^2|Mean|30.3|30.3|Standard Deviation|3.83|3.83|||
4215113|NCT00716092|4038672|B4||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4215114|NCT00716092|4038673|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4215115|NCT00716092|4038674|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4215116|NCT00716092|4038675|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4215117|NCT00716092|4038672|B4||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4215118|NCT00716092|4038673|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4215119|NCT00716092|4038674|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4215120|NCT00716092|4038675|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4215121|NCT00716092|4038672|B4|||Age||Years|Mean|61.1|61.1|Standard Deviation|9.14|9.14|||
4215122|NCT00716092|4038673|B3|||Age||Years|Mean|62.0|62.0|Standard Deviation|7.85|7.85|||
4215123|NCT00716092|4038674|B2|||Age||Years|Mean|60.7|60.7|Standard Deviation|10.11|10.11|||
4215124|NCT00716092|4038675|B1|||Age||Years|Mean|60.5|60.5|Standard Deviation|9.5|9.5|||
4215125|NCT00716079|4038706|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4215126|NCT00716079|4038707|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4215127|NCT00716079|4038708|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4215128|NCT00716079|4038706|B3|United Kingdom||Region of Enrollment||participants|Number|70|70.0||||||
4215129|NCT00716079|4038707|B2|United Kingdom||Region of Enrollment||participants|Number|35|35.0||||||
4215130|NCT00716079|4038708|B1|United Kingdom||Region of Enrollment||participants|Number|35|35.0||||||
4215131|NCT00716079|4038706|B3|Switzerland||Region of Enrollment||participants|Number|3|3.0||||||
4215132|NCT00716079|4038707|B2|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4215133|NCT00716079|4038708|B1|Switzerland||Region of Enrollment||participants|Number|2|2.0||||||
4215134|NCT00716079|4038706|B3|Spain||Region of Enrollment||participants|Number|50|50.0||||||
4215135|NCT00716079|4038707|B2|Spain||Region of Enrollment||participants|Number|25|25.0||||||
4215136|NCT00716079|4038708|B1|Spain||Region of Enrollment||participants|Number|25|25.0||||||
4215137|NCT00716079|4038706|B3|Portugal||Region of Enrollment||participants|Number|22|22.0||||||
4215138|NCT00716079|4038707|B2|Portugal||Region of Enrollment||participants|Number|10|10.0||||||
4215139|NCT00716079|4038708|B1|Portugal||Region of Enrollment||participants|Number|12|12.0||||||
4215140|NCT00716079|4038706|B3|Pakistan||Region of Enrollment||participants|Number|9|9.0||||||
4215141|NCT00716079|4038707|B2|Pakistan||Region of Enrollment||participants|Number|4|4.0||||||
4215142|NCT00716079|4038708|B1|Pakistan||Region of Enrollment||participants|Number|5|5.0||||||
4215143|NCT00716079|4038706|B3|Norway||Region of Enrollment||participants|Number|5|5.0||||||
4215144|NCT00716079|4038707|B2|Norway||Region of Enrollment||participants|Number|3|3.0||||||
4215145|NCT00716079|4038708|B1|Norway||Region of Enrollment||participants|Number|2|2.0||||||
4215146|NCT00716079|4038706|B3|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
4215147|NCT00716079|4038707|B2|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4215148|NCT00716079|4038708|B1|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4215149|NCT00716079|4038706|B3|Italy||Region of Enrollment||participants|Number|47|47.0||||||
4215150|NCT00716079|4038707|B2|Italy||Region of Enrollment||participants|Number|28|28.0||||||
4215151|NCT00716079|4038708|B1|Italy||Region of Enrollment||participants|Number|19|19.0||||||
4215152|NCT00716079|4038706|B3|India||Region of Enrollment||participants|Number|97|97.0||||||
4215153|NCT00716079|4038707|B2|India||Region of Enrollment||participants|Number|49|49.0||||||
4215154|NCT00716079|4038708|B1|India||Region of Enrollment||participants|Number|48|48.0||||||
4215155|NCT00716079|4038706|B3|Hong Kong||Region of Enrollment||participants|Number|1|1.0||||||
4215156|NCT00716079|4038707|B2|Hong Kong||Region of Enrollment||participants|Number|1|1.0||||||
4215157|NCT00716079|4038708|B1|Hong Kong||Region of Enrollment||participants|Number|0|0.0||||||
4215158|NCT00716079|4038706|B3|Germany||Region of Enrollment||participants|Number|141|141.0||||||
4215159|NCT00716079|4038707|B2|Germany||Region of Enrollment||participants|Number|71|71.0||||||
4215160|NCT00716079|4038708|B1|Germany||Region of Enrollment||participants|Number|70|70.0||||||
4215161|NCT00716079|4038706|B3|France||Region of Enrollment||participants|Number|221|221.0||||||
4215162|NCT00716079|4038707|B2|France||Region of Enrollment||participants|Number|112|112.0||||||
4215163|NCT00716079|4038708|B1|France||Region of Enrollment||participants|Number|109|109.0||||||
4215164|NCT00716079|4038706|B3|Finland||Region of Enrollment||participants|Number|36|36.0||||||
4215165|NCT00716079|4038707|B2|Finland||Region of Enrollment||participants|Number|17|17.0||||||
4215166|NCT00716079|4038708|B1|Finland||Region of Enrollment||participants|Number|19|19.0||||||
4215167|NCT00716079|4038706|B3|China||Region of Enrollment||participants|Number|1926|1926.0||||||
4215168|NCT00716079|4038707|B2|China||Region of Enrollment||participants|Number|976|976.0||||||
4215169|NCT00716079|4038708|B1|China||Region of Enrollment||participants|Number|950|950.0||||||
4215170|NCT00716079|4038706|B3|Chile||Region of Enrollment||participants|Number|29|29.0||||||
4215172|NCT00716079|4038708|B1|Chile||Region of Enrollment||participants|Number|17|17.0||||||
4215173|NCT00716079|4038706|B3|Brazil||Region of Enrollment||participants|Number|17|17.0||||||
4215174|NCT00716079|4038707|B2|Brazil||Region of Enrollment||participants|Number|9|9.0||||||
4215175|NCT00716079|4038708|B1|Brazil||Region of Enrollment||participants|Number|8|8.0||||||
4215176|NCT00716079|4038706|B3|Belgium||Region of Enrollment||participants|Number|12|12.0||||||
4215177|NCT00716079|4038707|B2|Belgium||Region of Enrollment||participants|Number|6|6.0||||||
4215178|NCT00716079|4038708|B1|Belgium||Region of Enrollment||participants|Number|6|6.0||||||
4215179|NCT00716079|4038706|B3|Austria||Region of Enrollment||participants|Number|63|63.0||||||
4215180|NCT00716079|4038707|B2|Austria||Region of Enrollment||participants|Number|28|28.0||||||
4215181|NCT00716079|4038708|B1|Austria||Region of Enrollment||participants|Number|35|35.0||||||
4215182|NCT00716079|4038706|B3|Australia||Region of Enrollment||participants|Number|73|73.0||||||
4215183|NCT00716079|4038707|B2|Australia||Region of Enrollment||participants|Number|40|40.0||||||
4215184|NCT00716079|4038708|B1|Australia||Region of Enrollment||participants|Number|33|33.0||||||
4215185|NCT00716079|4038706|B3|Argentina||Region of Enrollment||participants|Number|4|4.0||||||
4215186|NCT00716079|4038707|B2|Argentina||Region of Enrollment||participants|Number|2|2.0||||||
4215187|NCT00716079|4038708|B1|Argentina||Region of Enrollment||participants|Number|2|2.0||||||
4215188|NCT00716079|4038706|B3||Male|Sex: Female, Male||Participants|Count of Participants|1780|1780.0||||||
4215189|NCT00716079|4038707|B2||Male|Sex: Female, Male||Participants|Count of Participants|882|882.0||||||
4215190|NCT00716079|4038708|B1||Male|Sex: Female, Male||Participants|Count of Participants|898|898.0||||||
4215191|NCT00716079|4038706|B3||Female|Sex: Female, Male||Participants|Count of Participants|1059|1059.0||||||
4215192|NCT00716079|4038707|B2||Female|Sex: Female, Male||Participants|Count of Participants|554|554.0||||||
4215193|NCT00716079|4038708|B1||Female|Sex: Female, Male||Participants|Count of Participants|505|505.0||||||
4215194|NCT00716079|4038706|B3|||Age||years|Mean|63.5|63.5|Standard Deviation|12.9|12.9|||
4215195|NCT00716079|4038707|B2|||Age||years|Mean|64.1|64.1|Standard Deviation|12.6|12.6|||
4215196|NCT00716079|4038708|B1|||Age||years|Mean|63.0|63.0|Standard Deviation|13.1|13.1|||
4215197|NCT00716079|4038706|B3||>=65 years|Age||Participants|Count of Participants|1272|1272.0||||||
4215198|NCT00716079|4038707|B2||>=65 years|Age||Participants|Count of Participants|666|666.0||||||
4215199|NCT00716079|4038708|B1||>=65 years|Age||Participants|Count of Participants|606|606.0||||||
4215200|NCT00716079|4038706|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1567|1567.0||||||
4215201|NCT00716079|4038707|B2||Between 18 and 65 years|Age||Participants|Count of Participants|770|770.0||||||
4215202|NCT00716079|4038708|B1||Between 18 and 65 years|Age||Participants|Count of Participants|797|797.0||||||
4215203|NCT00716079|4038706|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4215204|NCT00716079|4038707|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4215205|NCT00716079|4038708|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4215206|NCT00715962|4038717|B3|||Geriatric Depression Scale (GDS)|"The Geriatric Depression Scale-short form is a 15-item questionnaire to screen for the presence of depression. Answers to the 15 yes or no questions are summed with scores of 6 or greater being identified as a positive screen for depression."|units on a scale|Mean|4.8|4.8|Standard Deviation|3.1|3.1|||
4215207|NCT00715962|4038718|B2|||Geriatric Depression Scale (GDS)|"The Geriatric Depression Scale-short form is a 15-item questionnaire to screen for the presence of depression. Answers to the 15 yes or no questions are summed with scores of 6 or greater being identified as a positive screen for depression."|units on a scale|Mean|5.0|5.0|Standard Deviation|3.0|3.0|||
4215208|NCT00715962|4038719|B1|||Geriatric Depression Scale (GDS)|"The Geriatric Depression Scale-short form is a 15-item questionnaire to screen for the presence of depression. Answers to the 15 yes or no questions are summed with scores of 6 or greater being identified as a positive screen for depression."|units on a scale|Mean|4.7|4.7|Standard Deviation|3.2|3.2|||
4215209|NCT00715962|4038717|B3|||Gait speed|If able to walk a short distance, patients were asked to perform a timed 10-foot (3 meter) walk. Two walks were done with the faster of the two times being utilized for analysis. Gait speeds of > or = to 1.0 meters/sec are considered normal; slower gait speeds are associated with increased risk of adverse outcomes including falls, ADL decline, nursing home placement and death.|meters per second|Mean|0.51|0.51|Standard Deviation|0.26|0.26|||
4215210|NCT00715962|4038718|B2|||Gait speed|If able to walk a short distance, patients were asked to perform a timed 10-foot (3 meter) walk. Two walks were done with the faster of the two times being utilized for analysis. Gait speeds of > or = to 1.0 meters/sec are considered normal; slower gait speeds are associated with increased risk of adverse outcomes including falls, ADL decline, nursing home placement and death.|meters per second|Mean|0.51|0.51|Standard Deviation|0.26|0.26|||
4215211|NCT00715962|4038719|B1|||Gait speed|If able to walk a short distance, patients were asked to perform a timed 10-foot (3 meter) walk. Two walks were done with the faster of the two times being utilized for analysis. Gait speeds of > or = to 1.0 meters/sec are considered normal; slower gait speeds are associated with increased risk of adverse outcomes including falls, ADL decline, nursing home placement and death.|meters per second|Mean|0.50|0.5|Standard Deviation|0.26|0.26|||
4215212|NCT00715962|4038717|B3|||Short Nutritional Assessment Questionnaire (SNAQ) score|This 4-item questionnaire is used to determine risk of weight loss. Each question is scored from 1-5 and the questions are summed to give a SNAQ score. Scores range from 4 - 20 and SNAQ scores of ≤14 indicate significant risk of at least 5 % weight loss within six months.|units on a scale|Mean|13.6|13.6|Standard Deviation|3.3|3.3|||
4215213|NCT00715962|4038718|B2|||Short Nutritional Assessment Questionnaire (SNAQ) score|This 4-item questionnaire is used to determine risk of weight loss. Each question is scored from 1-5 and the questions are summed to give a SNAQ score. Scores range from 4 - 20 and SNAQ scores of ≤14 indicate significant risk of at least 5 % weight loss within six months.|units on a scale|Mean|13.5|13.5|Standard Deviation|3.3|3.3|||
4215214|NCT00715962|4038719|B1|||Short Nutritional Assessment Questionnaire (SNAQ) score|This 4-item questionnaire is used to determine risk of weight loss. Each question is scored from 1-5 and the questions are summed to give a SNAQ score. Scores range from 4 - 20 and SNAQ scores of ≤14 indicate significant risk of at least 5 % weight loss within six months.|units on a scale|Mean|13.7|13.7|Standard Deviation|3.4|3.4|||
4215215|NCT00715962|4038717|B3|||Mini-Nutritional Assessment score|"The Mini-Nutritional Assessment (MNA) is a 6-item screening test of risk for malnutrition. Responses to the questions are summed to provide a score, with a range from 0-14.~12-14 points: Normal nutritional status 8-11 points: At risk of malnutrition 0-7 points: Malnourished"|units on a scale|Mean|9.2|9.2|Standard Deviation|2.4|2.4|||
4215216|NCT00715962|4038718|B2|||Mini-Nutritional Assessment score|"The Mini-Nutritional Assessment (MNA) is a 6-item screening test of risk for malnutrition. Responses to the questions are summed to provide a score, with a range from 0-14.~12-14 points: Normal nutritional status 8-11 points: At risk of malnutrition 0-7 points: Malnourished"|units on a scale|Mean|9.0|9.0|Standard Deviation|2.3|2.3|||
4215217|NCT00715962|4038719|B1|||Mini-Nutritional Assessment score|"The Mini-Nutritional Assessment (MNA) is a 6-item screening test of risk for malnutrition. Responses to the questions are summed to provide a score, with a range from 0-14.~12-14 points: Normal nutritional status 8-11 points: At risk of malnutrition 0-7 points: Malnourished"|units on a scale|Mean|9.4|9.4|Standard Deviation|2.6|2.6|||
4215218|NCT00715962|4038717|B3|||Life-Space Assessment score|The UAB Study of Aging Life-Space Assessment (LSA) is a validated tool that measures mobility and function based on the distance which a person reports moving during the four weeks preceding the assessment. Scores range from 0 - 120 with higher scores reflecting higher levels of community mobility.|units on a scale|Mean|52.7|52.7|Standard Deviation|25.5|25.5|||
4215219|NCT00715962|4038718|B2|||Life-Space Assessment score|The UAB Study of Aging Life-Space Assessment (LSA) is a validated tool that measures mobility and function based on the distance which a person reports moving during the four weeks preceding the assessment. Scores range from 0 - 120 with higher scores reflecting higher levels of community mobility.|units on a scale|Mean|51.5|51.5|Standard Deviation|21.1|21.1|||
4215220|NCT00715962|4038719|B1|||Life-Space Assessment score|The UAB Study of Aging Life-Space Assessment (LSA) is a validated tool that measures mobility and function based on the distance which a person reports moving during the four weeks preceding the assessment. Scores range from 0 - 120 with higher scores reflecting higher levels of community mobility.|units on a scale|Mean|53.9|53.9|Standard Deviation|29.4|29.4|||
4215221|NCT00715962|4038717|B3|||ADL on Admission|At baseline, patients were asked to rate their current level of independence with six activities of daily living (feeding, bathing, dressing, toileting, transferring, and walking). They were asked if they were independent (score =1), needed some assistance (score = 2) or required total assistance with the activity (score = 3). Scores for each of the 6 ADLs were summed; scores ranged from 6-18 with higher scores indicating less independence with ADLs.|units on a scale|Mean|8.9|8.9|Standard Deviation|2.8|2.8|||
4215222|NCT00715962|4038718|B2|||ADL on Admission|At baseline, patients were asked to rate their current level of independence with six activities of daily living (feeding, bathing, dressing, toileting, transferring, and walking). They were asked if they were independent (score =1), needed some assistance (score = 2) or required total assistance with the activity (score = 3). Scores for each of the 6 ADLs were summed; scores ranged from 6-18 with higher scores indicating less independence with ADLs.|units on a scale|Mean|9.1|9.1|Standard Deviation|2.9|2.9|||
4215223|NCT00715962|4038719|B1|||ADL on Admission|At baseline, patients were asked to rate their current level of independence with six activities of daily living (feeding, bathing, dressing, toileting, transferring, and walking). They were asked if they were independent (score =1), needed some assistance (score = 2) or required total assistance with the activity (score = 3). Scores for each of the 6 ADLs were summed; scores ranged from 6-18 with higher scores indicating less independence with ADLs.|units on a scale|Mean|8.8|8.8|Standard Deviation|2.7|2.7|||
4215224|NCT00715962|4038717|B3|||Activities of Daily Living (ADL) 2 Weeks prior to admission|At baseline, patients were asked to rate their level of independence with 6 activities of daily living (feeding, bathing, dressing, toileting, transferring, and walking) in the two weeks prior to their hospital admission. They were asked if they were independent (score =1), needed some assistance (score = 2) or required total assistance with the activity (score = 3). Scores for all 6 ADLs were summed with a range of 6-18 with higher scores indicating less independence with ADLs.|units on a scale|Mean|8.0|8.0|Standard Deviation|1.6|1.6|||
4215225|NCT00715962|4038718|B2|||Activities of Daily Living (ADL) 2 Weeks prior to admission|At baseline, patients were asked to rate their level of independence with 6 activities of daily living (feeding, bathing, dressing, toileting, transferring, and walking) in the two weeks prior to their hospital admission. They were asked if they were independent (score =1), needed some assistance (score = 2) or required total assistance with the activity (score = 3). Scores for all 6 ADLs were summed with a range of 6-18 with higher scores indicating less independence with ADLs.|units on a scale|Mean|8.0|8.0|Standard Deviation|1.8|1.8|||
4215226|NCT00715962|4038719|B1|||Activities of Daily Living (ADL) 2 Weeks prior to admission|At baseline, patients were asked to rate their level of independence with 6 activities of daily living (feeding, bathing, dressing, toileting, transferring, and walking) in the two weeks prior to their hospital admission. They were asked if they were independent (score =1), needed some assistance (score = 2) or required total assistance with the activity (score = 3). Scores for all 6 ADLs were summed with a range of 6-18 with higher scores indicating less independence with ADLs.|units on a scale|Mean|7.96|7.96|Standard Deviation|1.5|1.5|||
4215227|NCT00715962|4038717|B3|||Falls Self-Efficacy|"The participant was asked On a scale from 1 to 10, with 1 being very confident and 10 being not confident at all, how confident are you that you can do the following activities without falling?. Each item is scored from 1 to 10, and the responses are summed for all 10 questions. The Falls Self-efficacy scale scores range from 10 - 100 with higher scores indicating lower confidence in ability to perform 10 different activities without falling."|units on a scale|Mean|15.8|15.8|Standard Deviation|6.3|6.3|||
4215277|NCT00715949|4038730|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4215278|NCT00715949|4038730|B1||<=18 years|Age||Participants|Count of Participants|116|116.0||||||
4215279|NCT00715910|4038734|B5||Male|Sex: Female, Male||Participants|Count of Participants|352|352.0||||||
4215280|NCT00715910|4038735|B4||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4215228|NCT00715962|4038718|B2|||Falls Self-Efficacy|"The participant was asked On a scale from 1 to 10, with 1 being very confident and 10 being not confident at all, how confident are you that you can do the following activities without falling?. Each item is scored from 1 to 10, and the responses are summed for all 10 questions. The Falls Self-efficacy scale scores range from 10 - 100 with higher scores indicating lower confidence in ability to perform 10 different activities without falling."|units on a scale|Mean|15.8|15.8|Standard Deviation|6.2|6.2|||
4215229|NCT00715962|4038719|B1|||Falls Self-Efficacy|"The participant was asked On a scale from 1 to 10, with 1 being very confident and 10 being not confident at all, how confident are you that you can do the following activities without falling?. Each item is scored from 1 to 10, and the responses are summed for all 10 questions. The Falls Self-efficacy scale scores range from 10 - 100 with higher scores indicating lower confidence in ability to perform 10 different activities without falling."|units on a scale|Mean|15.8|15.8|Standard Deviation|6.5|6.5|||
4215230|NCT00715962|4038717|B3|||Mobility Knowledge PreTest Score|Scale range 0-5 with higher scores indicating higher knowledge regarding importance of mobility during hospitalization.|units on a scale|Mean|2.5|2.5|Standard Deviation|1.1|1.1|||
4215231|NCT00715962|4038718|B2|||Mobility Knowledge PreTest Score|Scale range 0-5 with higher scores indicating higher knowledge regarding importance of mobility during hospitalization.|units on a scale|Mean|2.6|2.6|Standard Deviation|1.1|1.1|||
4215232|NCT00715962|4038719|B1|||Mobility Knowledge PreTest Score|Scale range 0-5 with higher scores indicating higher knowledge regarding importance of mobility during hospitalization.|units on a scale|Mean|2.4|2.4|Standard Deviation|1.1|1.1|||
4215233|NCT00715962|4038717|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
4215234|NCT00715962|4038718|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
4215235|NCT00715962|4038719|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4215236|NCT00715962|4038717|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215237|NCT00715962|4038718|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215238|NCT00715962|4038719|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215239|NCT00715962|4038717|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215240|NCT00715962|4038718|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215241|NCT00715962|4038719|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215242|NCT00715962|4038717|B3||White|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
4215243|NCT00715962|4038718|B2||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4215244|NCT00715962|4038719|B1||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4215245|NCT00715962|4038717|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4215246|NCT00715962|4038718|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4215247|NCT00715962|4038719|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4215248|NCT00715962|4038717|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215249|NCT00715962|4038718|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215250|NCT00715962|4038719|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215251|NCT00715962|4038717|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215252|NCT00715962|4038718|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215253|NCT00715962|4038719|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215254|NCT00715962|4038717|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215255|NCT00715962|4038718|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215256|NCT00715962|4038719|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215257|NCT00715962|4038717|B3||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4215258|NCT00715962|4038718|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4215259|NCT00715962|4038719|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4215260|NCT00715962|4038717|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4215261|NCT00715962|4038718|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4215262|NCT00715962|4038719|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4215263|NCT00715962|4038717|B3||>=65 years|Age||Participants|Count of Participants|100|100.0||||||
4215264|NCT00715962|4038718|B2||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
4215265|NCT00715962|4038719|B1||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
4215266|NCT00715962|4038717|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4215267|NCT00715962|4038718|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4215268|NCT00715962|4038719|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4215269|NCT00715962|4038717|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4215270|NCT00715962|4038718|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4215271|NCT00715962|4038719|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4215272|NCT00715949|4038730|B1|United States||Region of Enrollment||participants|Number|116|116.0||||||
4215273|NCT00715949|4038730|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4215274|NCT00715949|4038730|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4215275|NCT00715949|4038730|B1|||Age||years|Mean|14.1|14.1|Standard Deviation|1.8|1.8|||
4215276|NCT00715949|4038730|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4215281|NCT00715910|4038736|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4215282|NCT00715910|4038737|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4215283|NCT00715910|4038738|B1||Male|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
4215284|NCT00715910|4038734|B5||Female|Sex: Female, Male||Participants|Count of Participants|397|397.0||||||
4215285|NCT00715910|4038735|B4||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4215286|NCT00715910|4038736|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4215287|NCT00715910|4038737|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4215288|NCT00715910|4038738|B1||Female|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
4215289|NCT00715910|4038734|B5|||Age||Years|Mean|16.5|16.5|Standard Deviation|4.26|4.26|||
4215290|NCT00715910|4038735|B4|||Age||Years|Mean|23.3|23.3|Standard Deviation|4.74|4.74|||
4215291|NCT00715910|4038736|B3|||Age||Years|Mean|11.2|11.2|Standard Deviation|0.42|0.42|||
4215292|NCT00715910|4038737|B2|||Age||Years|Mean|16.0|16.0|Standard Deviation|2.83|2.83|||
4215293|NCT00715910|4038738|B1|||Age||Years|Mean|15.9|15.9|Standard Deviation|2.79|2.79|||
4215294|NCT00715884|4038817|B3|Without History of Diabetes Mellitus||Patients with History of Diabetes Mellitus||participants|Number|465|465.0||||||
4215295|NCT00715884|4038818|B2|Without History of Diabetes Mellitus||Patients with History of Diabetes Mellitus||participants|Number|157|157.0||||||
4215296|NCT00715884|4038819|B1|Without History of Diabetes Mellitus||Patients with History of Diabetes Mellitus||participants|Number|308|308.0||||||
4215297|NCT00715884|4038817|B3|History of Diabetes Mellitus||Patients with History of Diabetes Mellitus||participants|Number|213|213.0||||||
4215298|NCT00715884|4038818|B2|History of Diabetes Mellitus||Patients with History of Diabetes Mellitus||participants|Number|69|69.0||||||
4215299|NCT00715884|4038819|B1|History of Diabetes Mellitus||Patients with History of Diabetes Mellitus||participants|Number|144|144.0||||||
4215300|NCT00715884|4038817|B3|Without History of Hypertension||Patients with History of Hypertension||participants|Number|140|140.0||||||
4215301|NCT00715884|4038818|B2|Without History of Hypertension||Patients with History of Hypertension||participants|Number|48|48.0||||||
4215302|NCT00715884|4038819|B1|Without History of Hypertension||Patients with History of Hypertension||participants|Number|92|92.0||||||
4215303|NCT00715884|4038817|B3|History of Hypertension||Patients with History of Hypertension||participants|Number|538|538.0||||||
4215304|NCT00715884|4038818|B2|History of Hypertension||Patients with History of Hypertension||participants|Number|178|178.0||||||
4215305|NCT00715884|4038819|B1|History of Hypertension||Patients with History of Hypertension||participants|Number|360|360.0||||||
4215306|NCT00715884|4038817|B3|Without History of Hyperlipidemia||Patients with History of Hyperlipidemia||participants|Number|102|102.0||||||
4215307|NCT00715884|4038818|B2|Without History of Hyperlipidemia||Patients with History of Hyperlipidemia||participants|Number|38|38.0||||||
4215308|NCT00715884|4038819|B1|Without History of Hyperlipidemia||Patients with History of Hyperlipidemia||participants|Number|64|64.0||||||
4215309|NCT00715884|4038817|B3|History of Hyperlipidemia||Patients with History of Hyperlipidemia||participants|Number|576|576.0||||||
4215310|NCT00715884|4038818|B2|History of Hyperlipidemia||Patients with History of Hyperlipidemia||participants|Number|188|188.0||||||
4215311|NCT00715884|4038819|B1|History of Hyperlipidemia||Patients with History of Hyperlipidemia||participants|Number|388|388.0||||||
4215312|NCT00715884|4038817|B3|Without Family History of Coronary Artery (CAD)||Patients with Family History of Coronary Artery (CAD)||participants|Number|286|286.0||||||
4215313|NCT00715884|4038818|B2|Without Family History of Coronary Artery (CAD)||Patients with Family History of Coronary Artery (CAD)||participants|Number|89|89.0||||||
4215314|NCT00715884|4038819|B1|Without Family History of Coronary Artery (CAD)||Patients with Family History of Coronary Artery (CAD)||participants|Number|197|197.0||||||
4215315|NCT00715884|4038817|B3|Family History of Coronary Artery (CAD)||Patients with Family History of Coronary Artery (CAD)||participants|Number|392|392.0||||||
4215316|NCT00715884|4038818|B2|Family History of Coronary Artery (CAD)||Patients with Family History of Coronary Artery (CAD)||participants|Number|137|137.0||||||
4215317|NCT00715884|4038819|B1|Family History of Coronary Artery (CAD)||Patients with Family History of Coronary Artery (CAD)||participants|Number|255|255.0||||||
4215318|NCT00715884|4038817|B3|Without History of Previous CABG||Patients with History of Previous Coronary Artery Bypass Graft (CABG)||participants|Number|609|609.0||||||
4215319|NCT00715884|4038818|B2|Without History of Previous CABG||Patients with History of Previous Coronary Artery Bypass Graft (CABG)||participants|Number|205|205.0||||||
4215320|NCT00715884|4038819|B1|Without History of Previous CABG||Patients with History of Previous Coronary Artery Bypass Graft (CABG)||participants|Number|404|404.0||||||
4215321|NCT00715884|4038817|B3|History of Previous CABG||Patients with History of Previous Coronary Artery Bypass Graft (CABG)||participants|Number|69|69.0||||||
4215322|NCT00715884|4038818|B2|History of Previous CABG||Patients with History of Previous Coronary Artery Bypass Graft (CABG)||participants|Number|21|21.0||||||
4215323|NCT00715884|4038819|B1|History of Previous CABG||Patients with History of Previous Coronary Artery Bypass Graft (CABG)||participants|Number|48|48.0||||||
4215324|NCT00715884|4038817|B3|Without History of Previous PCI||Patients with History of Previous Percutaneous Coronary Intervention (PCI)||participants|Number|464|464.0||||||
4215325|NCT00715884|4038818|B2|Without History of Previous PCI||Patients with History of Previous Percutaneous Coronary Intervention (PCI)||participants|Number|157|157.0||||||
4215326|NCT00715884|4038819|B1|Without History of Previous PCI||Patients with History of Previous Percutaneous Coronary Intervention (PCI)||participants|Number|307|307.0||||||
4215327|NCT00715884|4038817|B3|History of Previous PCI||Patients with History of Previous Percutaneous Coronary Intervention (PCI)||participants|Number|214|214.0||||||
4215328|NCT00715884|4038818|B2|History of Previous PCI||Patients with History of Previous Percutaneous Coronary Intervention (PCI)||participants|Number|69|69.0||||||
4215329|NCT00715884|4038819|B1|History of Previous PCI||Patients with History of Previous Percutaneous Coronary Intervention (PCI)||participants|Number|145|145.0||||||
4215330|NCT00715884|4038817|B3|Other||Race||participants|Number|3|3.0||||||
4215331|NCT00715884|4038818|B2|Other||Race||participants|Number|0|0.0||||||
4215332|NCT00715884|4038819|B1|Other||Race||participants|Number|3|3.0||||||
4215333|NCT00715884|4038817|B3|White||Race||participants|Number|606|606.0||||||
4215334|NCT00715884|4038818|B2|White||Race||participants|Number|203|203.0||||||
4215335|NCT00715884|4038819|B1|White||Race||participants|Number|403|403.0||||||
4215336|NCT00715884|4038817|B3|Black or African American||Race||participants|Number|53|53.0||||||
4215337|NCT00715884|4038818|B2|Black or African American||Race||participants|Number|20|20.0||||||
4215338|NCT00715884|4038819|B1|Black or African American||Race||participants|Number|33|33.0||||||
4215339|NCT00715884|4038817|B3|Native Hawaiian or Other Pacific Islander||Race||participants|Number|0|0.0||||||
4215340|NCT00715884|4038818|B2|Native Hawaiian or Other Pacific Islander||Race||participants|Number|0|0.0||||||
4215341|NCT00715884|4038819|B1|Native Hawaiian or Other Pacific Islander||Race||participants|Number|0|0.0||||||
4215342|NCT00715884|4038817|B3|Asian||Race||participants|Number|14|14.0||||||
4215343|NCT00715884|4038818|B2|Asian||Race||participants|Number|3|3.0||||||
4215344|NCT00715884|4038819|B1|Asian||Race||participants|Number|11|11.0||||||
4215345|NCT00715884|4038817|B3|American Indian or Alaska Native||Race||participants|Number|2|2.0||||||
4215346|NCT00715884|4038818|B2|American Indian or Alaska Native||Race||participants|Number|0|0.0||||||
4215347|NCT00715884|4038819|B1|American Indian or Alaska Native||Race||participants|Number|2|2.0||||||
4215348|NCT00715884|4038817|B3|United States||Region of Enrollment||participants|Number|678|678.0||||||
4215349|NCT00715884|4038818|B2|United States||Region of Enrollment||participants|Number|226|226.0||||||
4215350|NCT00715884|4038819|B1|United States||Region of Enrollment||participants|Number|452|452.0||||||
4215351|NCT00715884|4038817|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4215352|NCT00715884|4038818|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4215353|NCT00715884|4038819|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4215354|NCT00715884|4038817|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|639|639.0||||||
4215355|NCT00715884|4038818|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|218|218.0||||||
4215356|NCT00715884|4038819|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|421|421.0||||||
4215357|NCT00715884|4038817|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4215358|NCT00715884|4038818|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4215359|NCT00715884|4038819|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4215360|NCT00715884|4038817|B3||Male|Sex: Female, Male||Participants|Count of Participants|466|466.0||||||
4215361|NCT00715884|4038818|B2||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4215362|NCT00715884|4038819|B1||Male|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
4215363|NCT00715884|4038817|B3||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4215364|NCT00715884|4038818|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4215365|NCT00715884|4038819|B1||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4215366|NCT00715884|4038817|B3|||Age||years|Mean|62.8|62.8|Standard Deviation|10.5|10.5|||
4215367|NCT00715884|4038818|B2|||Age||years|Mean|62.2|62.2|Standard Deviation|10.5|10.5|||
4215368|NCT00715884|4038819|B1|||Age||years|Mean|63.1|63.1|Standard Deviation|10.5|10.5|||
4215369|NCT00715884|4038817|B3||>=65 years|Age||Participants|Count of Participants|289|289.0||||||
4215370|NCT00715884|4038818|B2||>=65 years|Age||Participants|Count of Participants|89|89.0||||||
4215371|NCT00715884|4038819|B1||>=65 years|Age||Participants|Count of Participants|200|200.0||||||
4215372|NCT00715884|4038817|B3||Between 18 and 65 years|Age||Participants|Count of Participants|389|389.0||||||
4215373|NCT00715884|4038818|B2||Between 18 and 65 years|Age||Participants|Count of Participants|137|137.0||||||
4215374|NCT00715884|4038819|B1||Between 18 and 65 years|Age||Participants|Count of Participants|252|252.0||||||
4215375|NCT00715884|4038817|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4215376|NCT00715884|4038818|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4215377|NCT00715884|4038819|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4215378|NCT00715793|4038862|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4215379|NCT00715793|4038862|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4215380|NCT00715793|4038862|B1|||Age||years|Median|63.3|63.3|Full Range|||36.2|77.4|
4215381|NCT00715754|4038875|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4215382|NCT00715754|4038875|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4215383|NCT00715754|4038875|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4215384|NCT00715754|4038875|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4215385|NCT00715754|4038875|B1||<=18 years|Age||Participants|Count of Participants|47|47.0||||||
4215386|NCT00715741|4038881|B5|United States||Region of Enrollment||participants|Number|100|100.0||||||
4215387|NCT00715741|4038882|B4|United States||Region of Enrollment||participants|Number|25|25.0||||||
4215388|NCT00715741|4038883|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4215389|NCT00715741|4038884|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4215390|NCT00715741|4038885|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4215391|NCT00715741|4038881|B5||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4215392|NCT00715741|4038882|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4215393|NCT00715741|4038883|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4215394|NCT00715741|4038884|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4215395|NCT00715741|4038885|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4215396|NCT00715741|4038881|B5||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4215397|NCT00715741|4038882|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4215398|NCT00715741|4038883|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4215399|NCT00715741|4038884|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4215400|NCT00715741|4038885|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4215401|NCT00715741|4038881|B5|||Age||years|Mean|46|46.0|Standard Deviation|13|13.0|||
4215402|NCT00715741|4038882|B4|||Age||years|Mean|46|46.0|Standard Deviation|13|13.0|||
4215403|NCT00715741|4038883|B3|||Age||years|Mean|46|46.0|Standard Deviation|15|15.0|||
4215404|NCT00715741|4038884|B2|||Age||years|Mean|45|45.0|Standard Deviation|12|12.0|||
4215405|NCT00715741|4038885|B1|||Age||years|Mean|47|47.0|Standard Deviation|13|13.0|||
4215406|NCT00715741|4038881|B5|>=65 years||Age, Customized||participants|Number|6|6.0||||||
4215407|NCT00715741|4038882|B4|>=65 years||Age, Customized||participants|Number|2|2.0||||||
4215408|NCT00715741|4038883|B3|>=65 years||Age, Customized||participants|Number|1|1.0||||||
4215409|NCT00715741|4038884|B2|>=65 years||Age, Customized||participants|Number|1|1.0||||||
4215410|NCT00715741|4038885|B1|>=65 years||Age, Customized||participants|Number|2|2.0||||||
4215411|NCT00715741|4038881|B5|Between 18 and 65 years||Age, Customized||participants|Number|94|94.0||||||
4215412|NCT00715741|4038882|B4|Between 18 and 65 years||Age, Customized||participants|Number|23|23.0||||||
4215413|NCT00715741|4038883|B3|Between 18 and 65 years||Age, Customized||participants|Number|24|24.0||||||
4215414|NCT00715741|4038884|B2|Between 18 and 65 years||Age, Customized||participants|Number|24|24.0||||||
4215415|NCT00715741|4038885|B1|Between 18 and 65 years||Age, Customized||participants|Number|23|23.0||||||
4215416|NCT00715741|4038881|B5|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4215417|NCT00715741|4038882|B4|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4215418|NCT00715741|4038883|B3|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4215419|NCT00715741|4038884|B2|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4215420|NCT00715741|4038885|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4215421|NCT00715728|4038910|B3|Austria||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
4215422|NCT00715728|4038911|B2|Austria||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4215423|NCT00715728|4038912|B1|Austria||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4215424|NCT00715728|4038910|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4215425|NCT00715728|4038911|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4215426|NCT00715728|4038912|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4215427|NCT00715728|4038910|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4215428|NCT00715728|4038911|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4215429|NCT00715728|4038912|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4215430|NCT00715728|4038910|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4215431|NCT00715728|4038911|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4215432|NCT00715728|4038912|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4215433|NCT00715728|4038910|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4215434|NCT00715728|4038911|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4215435|NCT00715728|4038912|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4215436|NCT00715728|4038910|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4215437|NCT00715728|4038911|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4215438|NCT00715728|4038912|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4215439|NCT00715676|4038921|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4215440|NCT00715676|4038922|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4215441|NCT00715676|4038923|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4215442|NCT00715676|4038924|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4215443|NCT00715676|4038921|B4||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4215444|NCT00715676|4038922|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4215445|NCT00715676|4038923|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4215446|NCT00715676|4038924|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4215447|NCT00715676|4038921|B4|||Age||years|Mean|61.5|61.5|Standard Deviation|5.8|5.8|||
4215448|NCT00715676|4038922|B3|||Age||years|Mean|61.9|61.9|Standard Deviation|5.3|5.3|||
4215449|NCT00715676|4038923|B2|||Age||years|Mean|61.6|61.6|Standard Deviation|5.5|5.5|||
4215450|NCT00715676|4038924|B1|||Age||years|Mean|61.1|61.1|Standard Deviation|6.5|6.5|||
4215451|NCT00715650|4038952|B3|Would rather turn down job than lose benefits||"Attitudes and beliefs: If a person is receiving VA benefits and starts working for pay ..."|Veterans were asked to rate their agreement with three statements asserting a relationship between work and receipt of disability payments. Agreement was rated on a 4-point, forced-choice Likert scale anchored by strongly disagree (1), somewhat disagree (2), somewhat agree (3), and strongly agree (4).|Likert scale|Mean|3.45|3.45|Standard Deviation|1|1.0|||
4215452|NCT00715650|4038953|B2|Would rather turn down job than lose benefits||"Attitudes and beliefs: If a person is receiving VA benefits and starts working for pay ..."|Veterans were asked to rate their agreement with three statements asserting a relationship between work and receipt of disability payments. Agreement was rated on a 4-point, forced-choice Likert scale anchored by strongly disagree (1), somewhat disagree (2), somewhat agree (3), and strongly agree (4).|Likert scale|Mean|3.6|3.6|Standard Deviation|1.0|1.0|||
4215453|NCT00715650|4038954|B1|Would rather turn down job than lose benefits||"Attitudes and beliefs: If a person is receiving VA benefits and starts working for pay ..."|Veterans were asked to rate their agreement with three statements asserting a relationship between work and receipt of disability payments. Agreement was rated on a 4-point, forced-choice Likert scale anchored by strongly disagree (1), somewhat disagree (2), somewhat agree (3), and strongly agree (4).|Likert scale|Mean|3.3|3.3|Standard Deviation|1.0|1.0|||
4215454|NCT00715650|4038952|B3|Medical benefits will remain the same||"Attitudes and beliefs: If a person is receiving VA benefits and starts working for pay ..."|Veterans were asked to rate their agreement with three statements asserting a relationship between work and receipt of disability payments. Agreement was rated on a 4-point, forced-choice Likert scale anchored by strongly disagree (1), somewhat disagree (2), somewhat agree (3), and strongly agree (4).|Likert scale|Mean|2.95|2.95|Standard Deviation|1.4|1.4|||
4215455|NCT00715650|4038953|B2|Medical benefits will remain the same||"Attitudes and beliefs: If a person is receiving VA benefits and starts working for pay ..."|Veterans were asked to rate their agreement with three statements asserting a relationship between work and receipt of disability payments. Agreement was rated on a 4-point, forced-choice Likert scale anchored by strongly disagree (1), somewhat disagree (2), somewhat agree (3), and strongly agree (4).|Likert scale|Mean|2.8|2.8|Standard Deviation|1.3|1.3|||
4215456|NCT00715650|4038954|B1|Medical benefits will remain the same||"Attitudes and beliefs: If a person is receiving VA benefits and starts working for pay ..."|Veterans were asked to rate their agreement with three statements asserting a relationship between work and receipt of disability payments. Agreement was rated on a 4-point, forced-choice Likert scale anchored by strongly disagree (1), somewhat disagree (2), somewhat agree (3), and strongly agree (4).|Likert scale|Mean|3.1|3.1|Standard Deviation|1.4|1.4|||
4215457|NCT00715650|4038952|B3|Income benefits will be reduced or stopped||"Attitudes and beliefs: If a person is receiving VA benefits and starts working for pay ..."|Veterans were asked to rate their agreement with three statements asserting a relationship between work and receipt of disability payments. Agreement was rated on a 4-point, forced-choice Likert scale anchored by strongly disagree (1), somewhat disagree (2), somewhat agree (3), and strongly agree (4).|Likert scale|Mean|3.45|3.45|Standard Deviation|1.4|1.4|||
4215458|NCT00715650|4038953|B2|Income benefits will be reduced or stopped||"Attitudes and beliefs: If a person is receiving VA benefits and starts working for pay ..."|Veterans were asked to rate their agreement with three statements asserting a relationship between work and receipt of disability payments. Agreement was rated on a 4-point, forced-choice Likert scale anchored by strongly disagree (1), somewhat disagree (2), somewhat agree (3), and strongly agree (4).|Likert scale|Mean|3.5|3.5|Standard Deviation|1.2|1.2|||
4215459|NCT00715650|4038954|B1|Income benefits will be reduced or stopped||"Attitudes and beliefs: If a person is receiving VA benefits and starts working for pay ..."|Veterans were asked to rate their agreement with three statements asserting a relationship between work and receipt of disability payments. Agreement was rated on a 4-point, forced-choice Likert scale anchored by strongly disagree (1), somewhat disagree (2), somewhat agree (3), and strongly agree (4).|Likert scale|Mean|3.4|3.4|Standard Deviation|1.4|1.4|||
4215460|NCT00715650|4038952|B3|Substance abuse||Psychiatric diagnosis||participants|Number|17|17.0||||||
4215461|NCT00715650|4038953|B2|Substance abuse||Psychiatric diagnosis||participants|Number|6|6.0||||||
4215462|NCT00715650|4038954|B1|Substance abuse||Psychiatric diagnosis||participants|Number|11|11.0||||||
4215463|NCT00715650|4038952|B3|Schizophrenia type/Bipolar||Psychiatric diagnosis||participants|Number|5|5.0||||||
4215464|NCT00715650|4038953|B2|Schizophrenia type/Bipolar||Psychiatric diagnosis||participants|Number|2|2.0||||||
4215465|NCT00715650|4038954|B1|Schizophrenia type/Bipolar||Psychiatric diagnosis||participants|Number|3|3.0||||||
4215466|NCT00715650|4038952|B3|TBI||Psychiatric diagnosis||participants|Number|4|4.0||||||
4215467|NCT00715650|4038953|B2|TBI||Psychiatric diagnosis||participants|Number|3|3.0||||||
4215468|NCT00715650|4038954|B1|TBI||Psychiatric diagnosis||participants|Number|1|1.0||||||
4215469|NCT00715650|4038952|B3|PTSD||Psychiatric diagnosis||participants|Number|24|24.0||||||
4215470|NCT00715650|4038953|B2|PTSD||Psychiatric diagnosis||participants|Number|15|15.0||||||
4215471|NCT00715650|4038954|B1|PTSD||Psychiatric diagnosis||participants|Number|9|9.0||||||
4215472|NCT00715650|4038952|B3|Major depression||Psychiatric diagnosis||participants|Number|25|25.0||||||
4215473|NCT00715650|4038953|B2|Major depression||Psychiatric diagnosis||participants|Number|10|10.0||||||
4215474|NCT00715650|4038954|B1|Major depression||Psychiatric diagnosis||participants|Number|15|15.0||||||
4215475|NCT00715650|4038952|B3|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4215476|NCT00715650|4038953|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4215477|NCT00715650|4038954|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4215478|NCT00715650|4038952|B3|Latino||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4215479|NCT00715650|4038953|B2|Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4215480|NCT00715650|4038954|B1|Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4215481|NCT00715650|4038952|B3|African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4215482|NCT00715650|4038953|B2|African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4215483|NCT00715650|4038954|B1|African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4215484|NCT00715650|4038952|B3|White||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
4215485|NCT00715650|4038953|B2|White||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4215486|NCT00715650|4038954|B1|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4215487|NCT00715650|4038952|B3||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4215488|NCT00715650|4038953|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4215489|NCT00715650|4038954|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4215490|NCT00715650|4038952|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4215491|NCT00715650|4038953|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4215492|NCT00715650|4038954|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4215493|NCT00715650|4038952|B3|||Age||years|Mean|38.5|38.5|Standard Deviation|14|14.0|||
4215494|NCT00715650|4038953|B2|||Age||years|Mean|40|40.0|Standard Deviation|14|14.0|||
4215495|NCT00715650|4038954|B1|||Age||years|Mean|37|37.0|Standard Deviation|4|4.0|||
4215496|NCT00715624|4038967|B3|||Metformin Daily Dose|Here, number of patients analyzed = 131 and 261 for Placebo and Lixisenatide treatment arm, respectively as only these participants received metformin.|milligram (mg) per day|Mean|1976.72|1976.72|Standard Deviation|453.38|453.38|||
4215497|NCT00715624|4038968|B2|||Metformin Daily Dose|Here, number of patients analyzed = 131 and 261 for Placebo and Lixisenatide treatment arm, respectively as only these participants received metformin.|milligram (mg) per day|Mean|1961.02|1961.02|Standard Deviation|459.07|459.07|||
4215498|NCT00715624|4038969|B1|||Metformin Daily Dose|Here, number of patients analyzed = 131 and 261 for Placebo and Lixisenatide treatment arm, respectively as only these participants received metformin.|milligram (mg) per day|Mean|2008.02|2008.02|Standard Deviation|441.88|441.88|||
4215499|NCT00715624|4038967|B3|No||Number of Patients With Metformin use at Baseline||participants|Number|103|103.0||||||
4215500|NCT00715624|4038968|B2|No||Number of Patients With Metformin use at Baseline||participants|Number|67|67.0||||||
4215501|NCT00715624|4038969|B1|No||Number of Patients With Metformin use at Baseline||participants|Number|36|36.0||||||
4215502|NCT00715624|4038967|B3|Yes||Number of Patients With Metformin use at Baseline||participants|Number|392|392.0||||||
4215503|NCT00715624|4038968|B2|Yes||Number of Patients With Metformin use at Baseline||participants|Number|261|261.0||||||
4215504|NCT00715624|4038969|B1|Yes||Number of Patients With Metformin use at Baseline||participants|Number|131|131.0||||||
4215505|NCT00715624|4038967|B3|Premix (Mixed Insulin)||Number of Patients With Insulin Therapy at Baseline|NPH included isophane insulin and insulin human injection, isophane. Premix insulin included Novolin 70/30 mix and Humalog 75/25 mix.|participants|Number|8|8.0||||||
4215506|NCT00715624|4038968|B2|Premix (Mixed Insulin)||Number of Patients With Insulin Therapy at Baseline|NPH included isophane insulin and insulin human injection, isophane. Premix insulin included Novolin 70/30 mix and Humalog 75/25 mix.|participants|Number|5|5.0||||||
4215507|NCT00715624|4038969|B1|Premix (Mixed Insulin)||Number of Patients With Insulin Therapy at Baseline|NPH included isophane insulin and insulin human injection, isophane. Premix insulin included Novolin 70/30 mix and Humalog 75/25 mix.|participants|Number|3|3.0||||||
4215508|NCT00715624|4038967|B3|Neutral protamine hagedorn (NPH)||Number of Patients With Insulin Therapy at Baseline|NPH included isophane insulin and insulin human injection, isophane. Premix insulin included Novolin 70/30 mix and Humalog 75/25 mix.|participants|Number|198|198.0||||||
4215509|NCT00715624|4038968|B2|Neutral protamine hagedorn (NPH)||Number of Patients With Insulin Therapy at Baseline|NPH included isophane insulin and insulin human injection, isophane. Premix insulin included Novolin 70/30 mix and Humalog 75/25 mix.|participants|Number|134|134.0||||||
4215510|NCT00715624|4038969|B1|Neutral protamine hagedorn (NPH)||Number of Patients With Insulin Therapy at Baseline|NPH included isophane insulin and insulin human injection, isophane. Premix insulin included Novolin 70/30 mix and Humalog 75/25 mix.|participants|Number|64|64.0||||||
4215511|NCT00715624|4038967|B3|Detemir||Number of Patients With Insulin Therapy at Baseline|NPH included isophane insulin and insulin human injection, isophane. Premix insulin included Novolin 70/30 mix and Humalog 75/25 mix.|participants|Number|43|43.0||||||
4215512|NCT00715624|4038968|B2|Detemir||Number of Patients With Insulin Therapy at Baseline|NPH included isophane insulin and insulin human injection, isophane. Premix insulin included Novolin 70/30 mix and Humalog 75/25 mix.|participants|Number|24|24.0||||||
4215513|NCT00715624|4038969|B1|Detemir||Number of Patients With Insulin Therapy at Baseline|NPH included isophane insulin and insulin human injection, isophane. Premix insulin included Novolin 70/30 mix and Humalog 75/25 mix.|participants|Number|19|19.0||||||
4215514|NCT00715624|4038967|B3|Glargine||Number of Patients With Insulin Therapy at Baseline|NPH included isophane insulin and insulin human injection, isophane. Premix insulin included Novolin 70/30 mix and Humalog 75/25 mix.|participants|Number|248|248.0||||||
4215515|NCT00715624|4038968|B2|Glargine||Number of Patients With Insulin Therapy at Baseline|NPH included isophane insulin and insulin human injection, isophane. Premix insulin included Novolin 70/30 mix and Humalog 75/25 mix.|participants|Number|165|165.0||||||
4215516|NCT00715624|4038969|B1|Glargine||Number of Patients With Insulin Therapy at Baseline|NPH included isophane insulin and insulin human injection, isophane. Premix insulin included Novolin 70/30 mix and Humalog 75/25 mix.|participants|Number|83|83.0||||||
4215517|NCT00715624|4038967|B3|||Basal Insulin Treatment Duration||years|Mean|3.11|3.11|Standard Deviation|3.57|3.57|||
4215518|NCT00715624|4038968|B2|||Basal Insulin Treatment Duration||years|Mean|3.06|3.06|Standard Deviation|3.37|3.37|||
4215519|NCT00715624|4038969|B1|||Basal Insulin Treatment Duration||years|Mean|3.20|3.2|Standard Deviation|3.96|3.96|||
4215520|NCT00715624|4038967|B3|||Body Mass Index (BMI)|BMI was calculated by dividing body weight by the height squared.|kilogram per square meter (kg/m^2)|Mean|32.13|32.13|Standard Deviation|6.22|6.22|||
4215521|NCT00715624|4038968|B2|||Body Mass Index (BMI)|BMI was calculated by dividing body weight by the height squared.|kilogram per square meter (kg/m^2)|Mean|31.91|31.91|Standard Deviation|6.17|6.17|||
4215522|NCT00715624|4038969|B1|||Body Mass Index (BMI)|BMI was calculated by dividing body weight by the height squared.|kilogram per square meter (kg/m^2)|Mean|32.56|32.56|Standard Deviation|6.32|6.32|||
4215523|NCT00715624|4038967|B3|||Duration of Diabetes||years|Mean|12.46|12.46|Standard Deviation|6.80|6.8|||
4215524|NCT00715624|4038968|B2|||Duration of Diabetes||years|Mean|12.48|12.48|Standard Deviation|7.04|7.04|||
4215525|NCT00715624|4038969|B1|||Duration of Diabetes||years|Mean|12.43|12.43|Standard Deviation|6.33|6.33|||
4215526|NCT00715624|4038967|B3|||Glucose Excursion|Glucose excursion = 2-hour PPG minus plasma glucose 30 minutes prior to the meal test, before study drug administration. Number of patients analyzed = 153 and 301 for Placebo and Lixisenatide treatment arms, respectively.|mmol/L|Mean|7.50|7.5|Standard Deviation|3.54|3.54|||
4215527|NCT00715624|4038968|B2|||Glucose Excursion|Glucose excursion = 2-hour PPG minus plasma glucose 30 minutes prior to the meal test, before study drug administration. Number of patients analyzed = 153 and 301 for Placebo and Lixisenatide treatment arms, respectively.|mmol/L|Mean|7.59|7.59|Standard Deviation|3.60|3.6|||
4215528|NCT00715624|4038969|B1|||Glucose Excursion|Glucose excursion = 2-hour PPG minus plasma glucose 30 minutes prior to the meal test, before study drug administration. Number of patients analyzed = 153 and 301 for Placebo and Lixisenatide treatment arms, respectively.|mmol/L|Mean|7.32|7.32|Standard Deviation|3.43|3.43|||
4215529|NCT00715624|4038967|B3|||Total Insulin Dose||units per day|Mean|54.88|54.88|Standard Deviation|34.14|34.14|||
4215530|NCT00715624|4038968|B2|||Total Insulin Dose||units per day|Mean|53.43|53.43|Standard Deviation|33.89|33.89|||
4215531|NCT00715624|4038969|B1|||Total Insulin Dose||units per day|Mean|57.73|57.73|Standard Deviation|34.54|34.54|||
4215532|NCT00715624|4038967|B3|||Body Weight||kilogram (kg)|Mean|87.72|87.72|Standard Deviation|20.29|20.29|||
4215533|NCT00715624|4038968|B2|||Body Weight||kilogram (kg)|Mean|87.10|87.1|Standard Deviation|20.01|20.01|||
4215534|NCT00715624|4038969|B1|||Body Weight||kilogram (kg)|Mean|88.94|88.94|Standard Deviation|20.84|20.84|||
4215535|NCT00715624|4038967|B3|||Fasting Plasma Glucose (FPG)||millimole per liter (mmol/L)|Mean|8.10|8.1|Standard Deviation|2.76|2.76|||
4215536|NCT00715624|4038968|B2|||Fasting Plasma Glucose (FPG)||millimole per liter (mmol/L)|Mean|8.13|8.13|Standard Deviation|2.83|2.83|||
4215537|NCT00715624|4038969|B1|||Fasting Plasma Glucose (FPG)||millimole per liter (mmol/L)|Mean|8.05|8.05|Standard Deviation|2.65|2.65|||
4215538|NCT00715624|4038967|B3|||Average 7-Point Self Monitored Plasma Glucose (SMPG)|Patients recorded a 7-point plasma glucose profile before and 2 hours after each meal and at bedtime once in a week and the average value for the 7-time points was calculated. Number of patients analyzed = 155 and 301 for Placebo and Lixisenatide treatment arms, respectively.|mmol/L|Mean|10.70|10.7|Standard Deviation|2.64|2.64|||
4215539|NCT00715624|4038968|B2|||Average 7-Point Self Monitored Plasma Glucose (SMPG)|Patients recorded a 7-point plasma glucose profile before and 2 hours after each meal and at bedtime once in a week and the average value for the 7-time points was calculated. Number of patients analyzed = 155 and 301 for Placebo and Lixisenatide treatment arms, respectively.|mmol/L|Mean|10.76|10.76|Standard Deviation|2.61|2.61|||
4215540|NCT00715624|4038969|B1|||Average 7-Point Self Monitored Plasma Glucose (SMPG)|Patients recorded a 7-point plasma glucose profile before and 2 hours after each meal and at bedtime once in a week and the average value for the 7-time points was calculated. Number of patients analyzed = 155 and 301 for Placebo and Lixisenatide treatment arms, respectively.|mmol/L|Mean|10.58|10.58|Standard Deviation|2.69|2.69|||
4215541|NCT00715624|4038967|B3|||2-Hour Postprandial Plasma Glucose (PPG)|The 2-hour PPG test measured blood glucose 2 hours after eating a standardized meal. Number of patients analyzed = 153 and 302 for Placebo and Lixisenatide treatment arms, respectively.|mmol/L|Mean|16.35|16.35|Standard Deviation|4.15|4.15|||
4215542|NCT00715624|4038968|B2|||2-Hour Postprandial Plasma Glucose (PPG)|The 2-hour PPG test measured blood glucose 2 hours after eating a standardized meal. Number of patients analyzed = 153 and 302 for Placebo and Lixisenatide treatment arms, respectively.|mmol/L|Mean|16.47|16.47|Standard Deviation|4.30|4.3|||
4215543|NCT00715624|4038969|B1|||2-Hour Postprandial Plasma Glucose (PPG)|The 2-hour PPG test measured blood glucose 2 hours after eating a standardized meal. Number of patients analyzed = 153 and 302 for Placebo and Lixisenatide treatment arms, respectively.|mmol/L|Mean|16.11|16.11|Standard Deviation|3.86|3.86|||
4215544|NCT00715624|4038967|B3|||Glycosylated Hemoglobin (HbA1c)||percentage of hemoglobin|Mean|8.40|8.4|Standard Deviation|0.87|0.87|||
4215545|NCT00715624|4038968|B2|||Glycosylated Hemoglobin (HbA1c)||percentage of hemoglobin|Mean|8.42|8.42|Standard Deviation|0.88|0.88|||
4215546|NCT00715624|4038969|B1|||Glycosylated Hemoglobin (HbA1c)||percentage of hemoglobin|Mean|8.37|8.37|Standard Deviation|0.84|0.84|||
4215547|NCT00715624|4038967|B3|Ethnicity: Non Hispanic||Race/Ethnicity, Customized||participants|Number|361|361.0||||||
4215548|NCT00715624|4038968|B2|Ethnicity: Non Hispanic||Race/Ethnicity, Customized||participants|Number|234|234.0||||||
4215549|NCT00715624|4038969|B1|Ethnicity: Non Hispanic||Race/Ethnicity, Customized||participants|Number|127|127.0||||||
4215550|NCT00715624|4038967|B3|Ethnicity: Hispanic||Race/Ethnicity, Customized||participants|Number|134|134.0||||||
4215551|NCT00715624|4038968|B2|Ethnicity: Hispanic||Race/Ethnicity, Customized||participants|Number|94|94.0||||||
4215552|NCT00715624|4038969|B1|Ethnicity: Hispanic||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4215553|NCT00715624|4038967|B3|Race: Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4215554|NCT00715624|4038968|B2|Race: Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4215555|NCT00715624|4038969|B1|Race: Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4215556|NCT00715624|4038967|B3|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
4215557|NCT00715624|4038968|B2|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
4215558|NCT00715624|4038969|B1|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4215559|NCT00715624|4038967|B3|Race: Black||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4215560|NCT00715624|4038968|B2|Race: Black||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4215561|NCT00715624|4038969|B1|Race: Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4215562|NCT00715624|4038967|B3|Race: Caucasian/White||Race/Ethnicity, Customized||participants|Number|384|384.0||||||
4215563|NCT00715624|4038968|B2|Race: Caucasian/White||Race/Ethnicity, Customized||participants|Number|254|254.0||||||
4215564|NCT00715624|4038969|B1|Race: Caucasian/White||Race/Ethnicity, Customized||participants|Number|130|130.0||||||
4215565|NCT00715624|4038967|B3||Male|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
4215566|NCT00715624|4038968|B2||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4215567|NCT00715624|4038969|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4215568|NCT00715624|4038967|B3||Female|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
4215569|NCT00715624|4038968|B2||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4215570|NCT00715624|4038969|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4215571|NCT00715624|4038967|B3|||Age||years|Mean|57.2|57.2|Standard Deviation|9.6|9.6|||
4215572|NCT00715624|4038968|B2|||Age||years|Mean|57.4|57.4|Standard Deviation|9.5|9.5|||
4215573|NCT00715624|4038969|B1|||Age||years|Mean|56.9|56.9|Standard Deviation|9.8|9.8|||
4215574|NCT00715559|4038998|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4215575|NCT00715559|4038998|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4215576|NCT00715559|4038998|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4215577|NCT00715559|4038998|B1|||Age||years|Mean|47|47.0|Standard Deviation|15.6|15.6|||
4215578|NCT00715559|4038998|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4215579|NCT00715559|4038998|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4215580|NCT00715559|4038998|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4215581|NCT00715520|4039005|B4|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4215582|NCT00715520|4039006|B3|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4215583|NCT00715520|4039007|B2|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4215584|NCT00715520|4039008|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4215585|NCT00715520|4039005|B4|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4215586|NCT00715520|4039005|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4215587|NCT00715520|4039006|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4215588|NCT00715520|4039007|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4215589|NCT00715520|4039008|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4215590|NCT00715520|4039005|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4215591|NCT00715520|4039006|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4215592|NCT00715520|4039007|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4215593|NCT00715520|4039008|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4215594|NCT00715520|4039005|B4||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4215595|NCT00715520|4039006|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4215596|NCT00715520|4039007|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4215597|NCT00715520|4039008|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4215598|NCT00715520|4039005|B4||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4215599|NCT00715520|4039006|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4215600|NCT00715520|4039007|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4215601|NCT00715520|4039008|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4215602|NCT00715520|4039005|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4215603|NCT00715520|4039006|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4215604|NCT00715520|4039007|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4215605|NCT00715520|4039008|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4215606|NCT00715403|4039023|B8||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4215607|NCT00715403|4039024|B7||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4215608|NCT00715403|4039025|B6||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4215609|NCT00715403|4039026|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4215610|NCT00715403|4039027|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4215611|NCT00715403|4039028|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4215612|NCT00715403|4039029|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4215613|NCT00715403|4039030|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4215614|NCT00715403|4039023|B8||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4215615|NCT00715403|4039024|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4215616|NCT00715403|4039025|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4215617|NCT00715403|4039026|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4215618|NCT00715403|4039027|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4215619|NCT00715403|4039028|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4215620|NCT00715403|4039029|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4215621|NCT00715403|4039030|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4215622|NCT00715403|4039023|B8|||Age||years|Median|66.0|66.0|Full Range|||41.0|80.0|
4215623|NCT00715403|4039024|B7|||Age||years|Median|67.0|67.0|Full Range|||67.0|67.0|
4215624|NCT00715403|4039025|B6|||Age||years|Median|66.0|66.0|Full Range|||41.0|80.0|
4215625|NCT00715403|4039026|B5|||Age||years|Median|63.5|63.5|Full Range|||45.0|74.0|
4215626|NCT00715403|4039027|B4|||Age||years|Median|66.0|66.0|Full Range|||52.0|78.0|
4215627|NCT00715403|4039028|B3|||Age||years|Median|65.5|65.5|Full Range|||52.0|75.0|
4215628|NCT00715403|4039029|B2|||Age||years|Median|47.0|47.0|Full Range|||47.0|47.0|
4215629|NCT00715403|4039030|B1|||Age||years|Median|75.0|75.0|Full Range|||75.0|75.0|
4215630|NCT00715390|4039171|B1|||Children with potential intraoperative dysrhythmias|Subjects were identified by flagging charts that included the administration of anti-arrhythmic drugs, significant variation in heart rate or pulse rate, and identification of certain keywords known to be associated with the development of an arrhythmia.|participants|Number|234|234.0||||||
4215631|NCT00715390|4039171|B1|United States||Region of Enrollment||participants|Number|234|234.0||||||
4215632|NCT00715390|4039171|B1||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4215633|NCT00715390|4039171|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4215634|NCT00715390|4039171|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4215635|NCT00715390|4039171|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4215636|NCT00715390|4039171|B1||<=18 years|Age||Participants|Count of Participants|234|234.0||||||
4215637|NCT00715299|4039175|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4215638|NCT00715299|4039175|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4215639|NCT00715299|4039175|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4215640|NCT00715299|4039175|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|13.0|13.0|||
4215641|NCT00715299|4039175|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4215642|NCT00715299|4039175|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4215643|NCT00715299|4039175|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4215644|NCT00715208|4039179|B3|United States||Region of Enrollment||participants|Number|55|55.0||||||
4215645|NCT00715208|4039180|B2|United States||Region of Enrollment||participants|Number|48|48.0||||||
4215646|NCT00715208|4039181|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4215647|NCT00715208|4039179|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4215648|NCT00715208|4039180|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4215649|NCT00715208|4039181|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4215650|NCT00715208|4039179|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4215651|NCT00715208|4039180|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4215652|NCT00715208|4039181|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4215653|NCT00715208|4039179|B3|||Age||years|Mean|62.3|62.3|Standard Deviation|10.98|10.98|||
4215654|NCT00715208|4039180|B2|||Age||years|Mean|62.3|62.3|Standard Deviation|11.39|11.39|||
4215655|NCT00715208|4039181|B1|||Age||years|Mean|62.9|62.9|Standard Deviation|8.30|8.3|||
4215656|NCT00715208|4039179|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4215657|NCT00715208|4039180|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4215658|NCT00715208|4039181|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4215659|NCT00715208|4039179|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4215660|NCT00715208|4039180|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4215661|NCT00715208|4039181|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4215662|NCT00715208|4039179|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4215663|NCT00715208|4039180|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4215664|NCT00715208|4039181|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4215665|NCT00715117|4039196|B3|||Pediatric Crohn's Disease Activity Index (PCDAI) score|"The PCDAI score is a number unit that is calculated from symptoms scores by the subject over a 7-day period prior to the visit, laboratory values, height & weight, and physical exam findings. A score of 10 and under denotes remission. Mild disease (score of 11-30); moderate disease (score of 31-45), a severe disease (scores greater than 45. A decline of 10 points or more is considered response to therapy. The score can range from 0 to >60 Patient must have a PCDAI score of equal or greater than 30 to qualify for this study (i.e., moderate to severe disease)."|score|Mean|41.7|41.7|Full Range|||30.0|57.0|
4215666|NCT00715117|4039197|B2|||Pediatric Crohn's Disease Activity Index (PCDAI) score|"The PCDAI score is a number unit that is calculated from symptoms scores by the subject over a 7-day period prior to the visit, laboratory values, height & weight, and physical exam findings. A score of 10 and under denotes remission. Mild disease (score of 11-30); moderate disease (score of 31-45), a severe disease (scores greater than 45. A decline of 10 points or more is considered response to therapy. The score can range from 0 to >60 Patient must have a PCDAI score of equal or greater than 30 to qualify for this study (i.e., moderate to severe disease)."|score|Mean|38.3|38.3|Full Range|||30.0|57.0|
4215667|NCT00715117|4039198|B1|||Pediatric Crohn's Disease Activity Index (PCDAI) score|"The PCDAI score is a number unit that is calculated from symptoms scores by the subject over a 7-day period prior to the visit, laboratory values, height & weight, and physical exam findings. A score of 10 and under denotes remission. Mild disease (score of 11-30); moderate disease (score of 31-45), a severe disease (scores greater than 45. A decline of 10 points or more is considered response to therapy. The score can range from 0 to >60 Patient must have a PCDAI score of equal or greater than 30 to qualify for this study (i.e., moderate to severe disease)."|score|Mean|45|45.0|Full Range|||35.0|52.5|
4215668|NCT00715117|4039196|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4215669|NCT00715117|4039197|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4215670|NCT00715117|4039198|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4215671|NCT00715117|4039196|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4215672|NCT00715117|4039197|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4215673|NCT00715117|4039198|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4215674|NCT00715117|4039196|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4215675|NCT00715117|4039197|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4215676|NCT00715117|4039198|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4215677|NCT00715117|4039196|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4215678|NCT00715117|4039197|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4215679|NCT00715117|4039198|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4215680|NCT00715117|4039196|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4215681|NCT00715117|4039197|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4215682|NCT00715117|4039198|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4215683|NCT00715117|4039196|B3|||Age||years|Mean|12.5|12.5|Standard Deviation|3.2|3.2|||
4215684|NCT00715117|4039197|B2|||Age||years|Mean|13|13.0|Standard Deviation|3.22|3.22|||
4215685|NCT00715117|4039198|B1|||Age||years|Mean|12.2|12.2|Standard Deviation|3.31|3.31|||
4215686|NCT00715117|4039196|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4215687|NCT00715117|4039197|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4215688|NCT00715117|4039198|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4215689|NCT00715117|4039196|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4215690|NCT00715117|4039197|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4215691|NCT00715117|4039198|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4215692|NCT00715117|4039196|B3||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4215693|NCT00715117|4039197|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4215694|NCT00715117|4039198|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4215695|NCT00715104|4039210|B4|United States||Region of Enrollment||participants|Number|42|42.0||||||
4215696|NCT00715104|4039211|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4215697|NCT00715104|4039212|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4215698|NCT00715104|4039213|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4215699|NCT00715104|4039210|B4||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4215700|NCT00715104|4039211|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4215701|NCT00715104|4039212|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4215702|NCT00715104|4039213|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4215703|NCT00715104|4039210|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4215704|NCT00715104|4039211|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4215705|NCT00715104|4039212|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4215706|NCT00715104|4039213|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4215707|NCT00715104|4039210|B4|||Age||years|Mean|61.1|61.1|Standard Deviation|5.4|5.4|||
4215708|NCT00715104|4039211|B3|||Age||years|Mean|62.1|62.1|Standard Deviation|5.7|5.7|||
4215709|NCT00715104|4039212|B2|||Age||years|Mean|61.4|61.4|Standard Deviation|5.3|5.3|||
4215710|NCT00715104|4039213|B1|||Age||years|Mean|60.5|60.5|Standard Deviation|5.6|5.6|||
4215711|NCT00715104|4039210|B4||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4215712|NCT00715104|4039211|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4215713|NCT00715104|4039212|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4215714|NCT00715104|4039213|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4215715|NCT00715104|4039210|B4||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4215716|NCT00715104|4039211|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4215717|NCT00715104|4039212|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4215718|NCT00715104|4039213|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4215719|NCT00715104|4039210|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4215720|NCT00715104|4039211|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4215721|NCT00715104|4039212|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4215722|NCT00715104|4039213|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4215723|NCT00715078|4039264|B4|Missing information||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|1|1.0||||||
4215724|NCT00715078|4039265|B3|Missing information||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|0|0.0||||||
4215793|NCT00715078|4039266|B2||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4215794|NCT00715078|4039267|B1||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4215725|NCT00715078|4039266|B2|Missing information||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|1|1.0||||||
4215726|NCT00715078|4039267|B1|Missing information||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|0|0.0||||||
4215727|NCT00715078|4039264|B4|Gleason Score ≥ 8||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|61|61.0||||||
4215728|NCT00715078|4039265|B3|Gleason Score ≥ 8||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|23|23.0||||||
4215729|NCT00715078|4039266|B2|Gleason Score ≥ 8||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|16|16.0||||||
4215730|NCT00715078|4039267|B1|Gleason Score ≥ 8||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|22|22.0||||||
4215731|NCT00715078|4039264|B4|Gleason Score =7||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|41|41.0||||||
4215732|NCT00715078|4039265|B3|Gleason Score =7||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|14|14.0||||||
4215733|NCT00715078|4039266|B2|Gleason Score =7||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|15|15.0||||||
4215734|NCT00715078|4039267|B1|Gleason Score =7||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|12|12.0||||||
4215795|NCT00715078|4039264|B4||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4215796|NCT00715078|4039265|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4215797|NCT00715078|4039266|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4215798|NCT00715078|4039267|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4215799|NCT00715078|4039264|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4215735|NCT00715078|4039264|B4|Gleason Score ≤ 6||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|19|19.0||||||
4215736|NCT00715078|4039265|B3|Gleason Score ≤ 6||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|4|4.0||||||
4215737|NCT00715078|4039266|B2|Gleason Score ≤ 6||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|8|8.0||||||
4215738|NCT00715078|4039267|B1|Gleason Score ≤ 6||Gleason Score|Gleason score= prostate cancer grading system based on how tissue looks under a microscope. Scores range 2-10 and indicates how likely it is that a tumor will spread. A low score means the cancer tissue is similar to normal tissue and the tumor is less likely to spread. Gleason Score ≤ 6=the tumor is well differentiated, less aggressive and likely to grow more slowly;7=the tumor is moderately differentiated, moderately aggressive, and likely to grow but may not spread quickly;≥8=the tumor is poorly differentiated or undifferentiated, highly aggressive, and likely to grow faster and spread.|Participants|Count of Participants|7|7.0||||||
4215739|NCT00715078|4039264|B4|ECOG 1= Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|42|42.0||||||
4215740|NCT00715078|4039265|B3|ECOG 1= Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|14|14.0||||||
4215741|NCT00715078|4039266|B2|ECOG 1= Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|16|16.0||||||
4215742|NCT00715078|4039267|B1|ECOG 1= Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|12|12.0||||||
4215743|NCT00715078|4039264|B4|ECOG 0=Fully Active; No restrictions||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|80|80.0||||||
4215744|NCT00715078|4039265|B3|ECOG 0=Fully Active; No restrictions||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|27|27.0||||||
4215800|NCT00715078|4039265|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4215801|NCT00715078|4039266|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4215745|NCT00715078|4039266|B2|ECOG 0=Fully Active; No restrictions||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|24|24.0||||||
4215746|NCT00715078|4039267|B1|ECOG 0=Fully Active; No restrictions||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about >50% of waking hour; 3=Capable of limited self-care, confined to bed or chair >50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead|Participants|Count of Participants|29|29.0||||||
4215747|NCT00715078|4039264|B4|United States||Region of Enrollment||Participants|Count of Participants|122|122.0||||||
4215748|NCT00715078|4039265|B3|United States||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
4215749|NCT00715078|4039266|B2|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
4215750|NCT00715078|4039267|B1|United States||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
4215751|NCT00715078|4039264|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215752|NCT00715078|4039265|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215753|NCT00715078|4039266|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215754|NCT00715078|4039267|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215755|NCT00715078|4039264|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215756|NCT00715078|4039265|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215757|NCT00715078|4039266|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215758|NCT00715078|4039267|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215759|NCT00715078|4039264|B4||White|Race (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
4215760|NCT00715078|4039265|B3||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4215761|NCT00715078|4039266|B2||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4215762|NCT00715078|4039267|B1||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4215763|NCT00715078|4039264|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4215764|NCT00715078|4039265|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4215765|NCT00715078|4039266|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215766|NCT00715078|4039267|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4215767|NCT00715078|4039264|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215768|NCT00715078|4039265|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215769|NCT00715078|4039266|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215770|NCT00715078|4039267|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215771|NCT00715078|4039264|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4215772|NCT00715078|4039265|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215773|NCT00715078|4039266|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4215774|NCT00715078|4039267|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215775|NCT00715078|4039264|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215776|NCT00715078|4039265|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215777|NCT00715078|4039266|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215778|NCT00715078|4039267|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4215779|NCT00715078|4039264|B4||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4215780|NCT00715078|4039265|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4215781|NCT00715078|4039266|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4215782|NCT00715078|4039267|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4215783|NCT00715078|4039264|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4215784|NCT00715078|4039265|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4215785|NCT00715078|4039266|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4215786|NCT00715078|4039267|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4215787|NCT00715078|4039264|B4|||Age||years|Mean|70.5|70.5|Standard Deviation|8.07|8.07|||
4215788|NCT00715078|4039265|B3|||Age||years|Mean|68.6|68.6|Standard Deviation|7.5|7.5|||
4215789|NCT00715078|4039266|B2|||Age||years|Mean|71.8|71.8|Standard Deviation|8.29|8.29|||
4215790|NCT00715078|4039267|B1|||Age||years|Mean|71.0|71.0|Standard Deviation|8.25|8.25|||
4215791|NCT00715078|4039264|B4||>=65 years|Age||Participants|Count of Participants|91|91.0||||||
4215792|NCT00715078|4039265|B3||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4215802|NCT00715078|4039267|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4215803|NCT00715026|4039277|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4215804|NCT00715026|4039277|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4215805|NCT00715026|4039277|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4215806|NCT00715026|4039277|B1|||Age||Years|Median|58|58.0|Standard Deviation|14|14.0|||
4215807|NCT00714948|4039282|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4215808|NCT00714948|4039282|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4215809|NCT00714948|4039282|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4215810|NCT00714948|4039282|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4215811|NCT00714948|4039282|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4215812|NCT00714948|4039282|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4215813|NCT00714870|4039286|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
4215814|NCT00714870|4039287|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4215815|NCT00714870|4039288|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4215816|NCT00714870|4039286|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4215817|NCT00714870|4039287|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4215818|NCT00714870|4039288|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4215819|NCT00714870|4039286|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4215820|NCT00714870|4039287|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4215821|NCT00714870|4039288|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4215822|NCT00714870|4039286|B3|||Age||years|Mean|11.8|11.8|Standard Deviation|2.2|2.2|||
4215823|NCT00714870|4039287|B2|||Age||years|Mean|12|12.0|Standard Deviation|2.3|2.3|||
4215824|NCT00714870|4039288|B1|||Age||years|Mean|11.6|11.6|Standard Deviation|2.1|2.1|||
4215825|NCT00714870|4039286|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4215826|NCT00714870|4039287|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4215827|NCT00714870|4039288|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4215828|NCT00714870|4039286|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4215829|NCT00714870|4039287|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4215830|NCT00714870|4039288|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4215831|NCT00714870|4039286|B3||<=18 years|Age||Participants|Count of Participants|43|43.0||||||
4215832|NCT00714870|4039287|B2||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
4215833|NCT00714870|4039288|B1||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
4215834|NCT00714792|4039295|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4215835|NCT00714792|4039296|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4215836|NCT00714792|4039297|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4215837|NCT00714792|4039295|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4215838|NCT00714792|4039296|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4215839|NCT00714792|4039297|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4215840|NCT00714792|4039295|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4215841|NCT00714792|4039296|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4215842|NCT00714792|4039297|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4215843|NCT00714792|4039295|B3|||Age||years|Mean|60|60.0|Standard Deviation|13.5|13.5|||
4215844|NCT00714792|4039296|B2|||Age||years|Mean|54|54.0|Standard Deviation|12.4|12.4|||
4215845|NCT00714792|4039297|B1|||Age||years|Mean|66|66.0|Standard Deviation|14.3|14.3|||
4215846|NCT00714792|4039295|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4215847|NCT00714792|4039296|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4215848|NCT00714792|4039297|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4215849|NCT00714792|4039295|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4215850|NCT00714792|4039296|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4215851|NCT00714792|4039297|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4215852|NCT00714792|4039295|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4215853|NCT00714792|4039296|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4215854|NCT00714792|4039297|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4215855|NCT00714753|4039304|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4215856|NCT00714753|4039304|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4215857|NCT00714753|4039304|B1|||Age||years|Median|69.0|69.0|Inter-Quartile Range|||65.0|72.0|
4215858|NCT00714714|4039313|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4215859|NCT00714714|4039313|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4215860|NCT00714714|4039313|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4215861|NCT00714714|4039313|B1|||Age||years|Mean|30.36|30.36|Standard Deviation|6.6|6.6|||
4215862|NCT00714714|4039313|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4215863|NCT00714714|4039313|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4215864|NCT00714714|4039313|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4215865|NCT00714688|4039319|B4||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4215866|NCT00714688|4039320|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4215867|NCT00714688|4039321|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4215868|NCT00714688|4039322|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4215869|NCT00714688|4039319|B4||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4215870|NCT00714688|4039320|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4215871|NCT00714688|4039321|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4215872|NCT00714688|4039322|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4215873|NCT00714688|4039319|B4|||Age||years|Mean|35.7|35.7|Standard Deviation|10.20|10.2|||
4215874|NCT00714688|4039320|B3|||Age||years|Mean|35.8|35.8|Standard Deviation|10.08|10.08|||
4215875|NCT00714688|4039321|B2|||Age||years|Mean|35.8|35.8|Standard Deviation|11.71|11.71|||
4215876|NCT00714688|4039322|B1|||Age||years|Mean|35.5|35.5|Standard Deviation|8.81|8.81|||
4215877|NCT00714688|4039319|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4215878|NCT00714688|4039320|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4215879|NCT00714688|4039321|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4215880|NCT00714688|4039322|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4215881|NCT00714688|4039319|B4||Between 18 and 65 years|Age||Participants|Count of Participants|275|275.0||||||
4215882|NCT00714688|4039320|B3||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
4215883|NCT00714688|4039321|B2||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
4215884|NCT00714688|4039322|B1||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
4215885|NCT00714688|4039319|B4||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4215886|NCT00714688|4039320|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4215887|NCT00714688|4039321|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4215888|NCT00714688|4039322|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4215889|NCT00714571|4039341|B7|United States||Region of Enrollment||participants|Number|79|79.0||||||
4215890|NCT00714571|4039342|B6|United States||Region of Enrollment||participants|Number|15|15.0||||||
4215891|NCT00714571|4039343|B5|United States||Region of Enrollment||participants|Number|15|15.0||||||
4215892|NCT00714571|4039344|B4|United States||Region of Enrollment||participants|Number|14|14.0||||||
4215893|NCT00714571|4039345|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4215894|NCT00714571|4039346|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4215895|NCT00714571|4039347|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4215896|NCT00714571|4039341|B7||Male|Gender||Participants|Count of Participants|28|28.0||||||
4215897|NCT00714571|4039342|B6||Male|Gender||Participants|Count of Participants|2|2.0||||||
4215898|NCT00714571|4039343|B5||Male|Gender||Participants|Count of Participants|2|2.0||||||
4215899|NCT00714571|4039344|B4||Male|Gender||Participants|Count of Participants|6|6.0||||||
4215900|NCT00714571|4039345|B3||Male|Gender||Participants|Count of Participants|4|4.0||||||
4215901|NCT00714571|4039346|B2||Male|Gender||Participants|Count of Participants|10|10.0||||||
4215902|NCT00714571|4039347|B1||Male|Gender||Participants|Count of Participants|4|4.0||||||
4215903|NCT00714571|4039341|B7||Female|Gender||Participants|Count of Participants|51|51.0||||||
4215904|NCT00714571|4039342|B6||Female|Gender||Participants|Count of Participants|13|13.0||||||
4215905|NCT00714571|4039343|B5||Female|Gender||Participants|Count of Participants|13|13.0||||||
4215906|NCT00714571|4039344|B4||Female|Gender||Participants|Count of Participants|8|8.0||||||
4215907|NCT00714571|4039345|B3||Female|Gender||Participants|Count of Participants|6|6.0||||||
4215908|NCT00714571|4039346|B2||Female|Gender||Participants|Count of Participants|4|4.0||||||
4215909|NCT00714571|4039347|B1||Female|Gender||Participants|Count of Participants|7|7.0||||||
4215910|NCT00714571|4039341|B7|||Age||years|Mean|71.3|71.3|Standard Deviation|7.9|7.9|||
4215911|NCT00714571|4039342|B6|||Age||years|Mean|72.0|72.0|Standard Deviation|7.6|7.6|||
4215912|NCT00714571|4039343|B5|||Age||years|Mean|67.1|67.1|Standard Deviation|7.9|7.9|||
4215913|NCT00714571|4039344|B4|||Age||years|Mean|70.5|70.5|Standard Deviation|5.8|5.8|||
4215914|NCT00714571|4039345|B3|||Age||years|Mean|72.5|72.5|Standard Deviation|6.8|6.8|||
4215915|NCT00714571|4039346|B2|||Age||years|Mean|73.5|73.5|Standard Deviation|10.1|10.1|||
4215916|NCT00714571|4039347|B1|||Age||years|Mean|73.2|73.2|Standard Deviation|7.7|7.7|||
4215917|NCT00714493|4039366|B1|North America||Region of Enrollment||participants|Number|160|160.0||||||
4215918|NCT00714493|4039366|B1|Europe||Region of Enrollment||participants|Number|43|43.0||||||
4215919|NCT00714493|4039366|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4215920|NCT00714493|4039366|B1||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4215921|NCT00714493|4039366|B1|||Age||years|Mean|54|54.0|Standard Deviation|12.07|12.07|||
4215922|NCT00714493|4039366|B1||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4215923|NCT00714493|4039366|B1||Between 18 and 65 years|Age||Participants|Count of Participants|171|171.0||||||
4215924|NCT00714493|4039366|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4215925|NCT00714415|4039376|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4215926|NCT00714415|4039377|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4215927|NCT00714415|4039378|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4215928|NCT00714415|4039376|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4215929|NCT00714415|4039377|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4215930|NCT00714415|4039378|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4215931|NCT00714415|4039376|B3|||Age||years|Mean|17.3|17.3|Standard Deviation|14.6|14.6|||
4215932|NCT00714415|4039377|B2|||Age||years|Mean|16.0|16.0|Standard Deviation|12.2|12.2|||
4215933|NCT00714415|4039378|B1|||Age||years|Mean|20.2|20.2|Standard Deviation|18.8|18.8|||
4215934|NCT00714389|4039411|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4215935|NCT00714389|4039411|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4215936|NCT00714389|4039411|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4215937|NCT00714389|4039411|B1|||Age||years|Mean|50|50.0|Standard Deviation|10|10.0|||
4215938|NCT00714389|4039411|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4215939|NCT00714389|4039411|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4215940|NCT00714389|4039411|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4215941|NCT00714311|4039416|B3|Germany||Region of Enrollment||participants|Number|64|64.0||||||
4215942|NCT00714311|4039417|B2|Germany||Region of Enrollment||participants|Number|32|32.0||||||
4215943|NCT00714311|4039418|B1|Germany||Region of Enrollment||participants|Number|32|32.0||||||
4215944|NCT00714311|4039416|B3|Austria||Region of Enrollment||participants|Number|40|40.0||||||
4215945|NCT00714311|4039417|B2|Austria||Region of Enrollment||participants|Number|20|20.0||||||
4215946|NCT00714311|4039418|B1|Austria||Region of Enrollment||participants|Number|20|20.0||||||
4215947|NCT00714311|4039416|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4215948|NCT00714311|4039417|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4215949|NCT00714311|4039418|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4215950|NCT00714311|4039416|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4215951|NCT00714311|4039417|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4215952|NCT00714311|4039418|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4215953|NCT00714311|4039416|B3|||Age||years|Mean|27.33|27.33|Standard Deviation|7.11|7.11|||
4215954|NCT00714311|4039417|B2|||Age||years|Mean|27.19|27.19|Standard Deviation|7.5|7.5|||
4215955|NCT00714311|4039418|B1|||Age||years|Mean|27.46|27.46|Standard Deviation|6.8|6.8|||
4215956|NCT00714311|4039416|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4215957|NCT00714311|4039417|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4215958|NCT00714311|4039418|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4215959|NCT00714311|4039416|B3||Between 18 and 65 years|Age||Participants|Count of Participants|104|104.0||||||
4215960|NCT00714311|4039417|B2||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4215961|NCT00714311|4039418|B1||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4215962|NCT00714311|4039416|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4215963|NCT00714311|4039417|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4215964|NCT00714311|4039418|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4215965|NCT00714285|4039425|B5||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4215966|NCT00714285|4039426|B4||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4215967|NCT00714285|4039427|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4215968|NCT00714285|4039428|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4215969|NCT00714285|4039429|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4215970|NCT00714285|4039425|B5||Female|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4215971|NCT00714285|4039426|B4||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4215972|NCT00714285|4039427|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4215973|NCT00714285|4039428|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4215974|NCT00714285|4039429|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4215975|NCT00714285|4039425|B5|||Age||Years|Mean|37.5|37.5|Standard Deviation|12.36|12.36|||
4215976|NCT00714285|4039426|B4|||Age||Years|Mean|37.4|37.4|Standard Deviation|12.51|12.51|||
4215977|NCT00714285|4039427|B3|||Age||Years|Mean|36.6|36.6|Standard Deviation|12.87|12.87|||
4215978|NCT00714285|4039428|B2|||Age||Years|Mean|37.6|37.6|Standard Deviation|12.30|12.3|||
4215979|NCT00714285|4039429|B1|||Age||Years|Mean|38.5|38.5|Standard Deviation|11.85|11.85|||
4215980|NCT00714259|4039482|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4215981|NCT00714259|4039482|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4215982|NCT00714259|4039482|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4215983|NCT00714259|4039482|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4215984|NCT00714259|4039482|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4215985|NCT00714233|4039492|B5|United States||Region of Enrollment||participants|Number|42|42.0||||||
4215986|NCT00714233|4039493|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
4215987|NCT00714233|4039494|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4215988|NCT00714233|4039495|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4215989|NCT00714233|4039496|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4215990|NCT00714233|4039492|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4215991|NCT00714233|4039493|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4215992|NCT00714233|4039494|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4215993|NCT00714233|4039495|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4215994|NCT00714233|4039496|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4215995|NCT00714233|4039492|B5||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4215996|NCT00714233|4039493|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4215997|NCT00714233|4039494|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4215998|NCT00714233|4039495|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4215999|NCT00714233|4039496|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4216000|NCT00714233|4039492|B5|||Age||years|Mean|15.6|15.6|Standard Deviation|1.4|1.4|||
4216001|NCT00714233|4039493|B4|||Age||years|Mean|15.4|15.4|Standard Deviation|1.7|1.7|||
4216002|NCT00714233|4039494|B3|||Age||years|Mean|15.4|15.4|Standard Deviation|1.2|1.2|||
4216003|NCT00714233|4039495|B2|||Age||years|Mean|15.4|15.4|Standard Deviation|1.4|1.4|||
4216004|NCT00714233|4039496|B1|||Age||years|Mean|16|16.0|Standard Deviation|1.7|1.7|||
4216005|NCT00714233|4039492|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4216006|NCT00714233|4039493|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4216007|NCT00714233|4039494|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4216008|NCT00714233|4039495|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4216009|NCT00714233|4039496|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4216010|NCT00714233|4039492|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4216011|NCT00714233|4039493|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4216012|NCT00714233|4039494|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4216013|NCT00714233|4039495|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4216014|NCT00714233|4039496|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4216015|NCT00714233|4039492|B5||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
4216016|NCT00714233|4039493|B4||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4216017|NCT00714233|4039494|B3||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4216018|NCT00714233|4039495|B2||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4216019|NCT00714233|4039496|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4216020|NCT00714168|4039526|B3|United States||Region of Enrollment||participants|Number|363|363.0||||||
4216021|NCT00714168|4039527|B2|United States||Region of Enrollment||participants|Number|198|198.0||||||
4216022|NCT00714168|4039528|B1|United States||Region of Enrollment||participants|Number|165|165.0||||||
4216023|NCT00714168|4039526|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4216024|NCT00714168|4039527|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4216025|NCT00714168|4039528|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4216026|NCT00714168|4039526|B3||Female|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
4216027|NCT00714168|4039527|B2||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4216028|NCT00714168|4039528|B1||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4216029|NCT00714168|4039526|B3|||Age||years|Mean|42.20|42.2|Standard Deviation|9.03|9.03|||
4216030|NCT00714168|4039527|B2|||Age||years|Mean|42.04|42.04|Standard Deviation|8.89|8.89|||
4216031|NCT00714168|4039528|B1|||Age||years|Mean|42.39|42.39|Standard Deviation|9.22|9.22|||
4216032|NCT00714168|4039526|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4216033|NCT00714168|4039527|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4216034|NCT00714168|4039528|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4216035|NCT00714168|4039526|B3||Between 18 and 65 years|Age||Participants|Count of Participants|363|363.0||||||
4216036|NCT00714168|4039527|B2||Between 18 and 65 years|Age||Participants|Count of Participants|198|198.0||||||
4216037|NCT00714168|4039528|B1||Between 18 and 65 years|Age||Participants|Count of Participants|165|165.0||||||
4216038|NCT00714168|4039526|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4216039|NCT00714168|4039527|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4216040|NCT00714168|4039528|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4216041|NCT00714051|4039543|B3|||Quadriceps strength||foot pounds|Mean|89.5|89.5|Standard Deviation|22.8|22.8|||
4216042|NCT00714051|4039544|B2|||Quadriceps strength||foot pounds|Mean|89.5|89.5|Standard Deviation|20.4|20.4|||
4216043|NCT00714051|4039545|B1|||Quadriceps strength||foot pounds|Mean|89.5|89.5|Standard Deviation|25.6|25.6|||
4216044|NCT00714051|4039543|B3|||Sit and reach flexibility||Centimeters|Mean|15.8|15.8|Standard Deviation|11.1|11.1|||
4216045|NCT00714051|4039544|B2|||Sit and reach flexibility||Centimeters|Mean|16.2|16.2|Standard Deviation|9.4|9.4|||
4216046|NCT00714051|4039545|B1|||Sit and reach flexibility||Centimeters|Mean|15.4|15.4|Standard Deviation|12.8|12.8|||
4216047|NCT00714051|4039543|B3|||Modified Falls Efficacy Scale|The Modified Falls Efficacy scale measures self-perceived fear of falling during the completion of 14 common activities. A score of 0=not confident at all and a score of 10=completely confident. The items are summed to form a total score. The higher score is the better score. The range of scores is 0-140.|units on a scale|Mean|136.4|136.4|Standard Deviation|10.1|10.1|||
4216101|NCT00713830|4039552|B3|||2-hour postprandial proinsulin-to-insulin ratio|Number of patients analyzed = 130 and 253 for Placebo and Lixisenatide treatment arm, respectively.|ratio|Mean|0.31|0.31|Standard Deviation|0.23|0.23|||
4216048|NCT00714051|4039544|B2|||Modified Falls Efficacy Scale|The Modified Falls Efficacy scale measures self-perceived fear of falling during the completion of 14 common activities. A score of 0=not confident at all and a score of 10=completely confident. The items are summed to form a total score. The higher score is the better score. The range of scores is 0-140.|units on a scale|Mean|136.3|136.3|Standard Deviation|10.5|10.5|||
4216049|NCT00714051|4039545|B1|||Modified Falls Efficacy Scale|The Modified Falls Efficacy scale measures self-perceived fear of falling during the completion of 14 common activities. A score of 0=not confident at all and a score of 10=completely confident. The items are summed to form a total score. The higher score is the better score. The range of scores is 0-140.|units on a scale|Mean|136.5|136.5|Standard Deviation|9.9|9.9|||
4216050|NCT00714051|4039543|B3|||Six minute walk||meters|Mean|545|545.0|Standard Deviation|96|96.0|||
4216051|NCT00714051|4039544|B2|||Six minute walk||meters|Mean|545|545.0|Standard Deviation|102|102.0|||
4216052|NCT00714051|4039545|B1|||Six minute walk||meters|Mean|546|546.0|Standard Deviation|90|90.0|||
4216053|NCT00714051|4039543|B3|||Bone mineral density||gm/cm2|Mean|0.92|0.92|Standard Deviation|0.11|0.11|||
4216054|NCT00714051|4039544|B2|||Bone mineral density||gm/cm2|Mean|0.90|0.9|Standard Deviation|0.11|0.11|||
4216055|NCT00714051|4039545|B1|||Bone mineral density||gm/cm2|Mean|0.94|0.94|Standard Deviation|0.1|0.1|||
4216056|NCT00714051|4039543|B3|||Co-morbidities||co-morbidities|Mean|2.9|2.9|Standard Deviation|1.9|1.9|||
4216057|NCT00714051|4039544|B2|||Co-morbidities||co-morbidities|Mean|3.1|3.1|Standard Deviation|2.2|2.2|||
4216058|NCT00714051|4039545|B1|||Co-morbidities||co-morbidities|Mean|2.6|2.6|Standard Deviation|1.6|1.6|||
4216059|NCT00714051|4039543|B3|United States||Region of Enrollment||participants|Number|55|55.0||||||
4216060|NCT00714051|4039544|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4216061|NCT00714051|4039545|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4216062|NCT00714051|4039543|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4216063|NCT00714051|4039544|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4216064|NCT00714051|4039545|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4216065|NCT00714051|4039543|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4216066|NCT00714051|4039544|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4216067|NCT00714051|4039545|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4216068|NCT00714051|4039543|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4216069|NCT00714051|4039544|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4216070|NCT00714051|4039545|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4216071|NCT00714051|4039543|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4216072|NCT00714051|4039544|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4216073|NCT00714051|4039545|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4216074|NCT00714051|4039543|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4216075|NCT00714051|4039544|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4216076|NCT00714051|4039545|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4216077|NCT00714051|4039543|B3||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4216078|NCT00714051|4039544|B2||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4216079|NCT00714051|4039545|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4216080|NCT00714051|4039543|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4216081|NCT00714051|4039544|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4216082|NCT00714051|4039545|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4216083|NCT00714051|4039543|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4216084|NCT00714051|4039544|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4216085|NCT00714051|4039545|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4216086|NCT00714051|4039543|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4216087|NCT00714051|4039544|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4216088|NCT00714051|4039545|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4216089|NCT00714051|4039543|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4216090|NCT00714051|4039544|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4216091|NCT00714051|4039545|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4216092|NCT00714051|4039543|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4216093|NCT00714051|4039544|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4216094|NCT00714051|4039545|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4216095|NCT00714051|4039543|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4216096|NCT00714051|4039544|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4216097|NCT00714051|4039545|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4216098|NCT00714051|4039543|B3|||Age||years|Mean|71.9|71.9|Standard Deviation|4.3|4.3|||
4216099|NCT00714051|4039544|B2|||Age||years|Mean|70.9|70.9|Standard Deviation|4.3|4.3|||
4216100|NCT00714051|4039545|B1|||Age||years|Mean|73.0|73.0|Standard Deviation|4.2|4.2|||
4216102|NCT00713830|4039553|B2|||2-hour postprandial proinsulin-to-insulin ratio|Number of patients analyzed = 130 and 253 for Placebo and Lixisenatide treatment arm, respectively.|ratio|Mean|0.32|0.32|Standard Deviation|0.24|0.24|||
4216103|NCT00713830|4039554|B1|||2-hour postprandial proinsulin-to-insulin ratio|Number of patients analyzed = 130 and 253 for Placebo and Lixisenatide treatment arm, respectively.|ratio|Mean|0.30|0.3|Standard Deviation|0.22|0.22|||
4216104|NCT00713830|4039552|B3|||Fasting proinsulin-to-insulin ratio|Number of patients analyzed = 137 and 285 for Placebo and Lixisenatide treatment arm, respectively.|ratio|Mean|0.67|0.67|Standard Deviation|0.51|0.51|||
4216105|NCT00713830|4039553|B2|||Fasting proinsulin-to-insulin ratio|Number of patients analyzed = 137 and 285 for Placebo and Lixisenatide treatment arm, respectively.|ratio|Mean|0.70|0.7|Standard Deviation|0.57|0.57|||
4216106|NCT00713830|4039554|B1|||Fasting proinsulin-to-insulin ratio|Number of patients analyzed = 137 and 285 for Placebo and Lixisenatide treatment arm, respectively.|ratio|Mean|0.62|0.62|Standard Deviation|0.36|0.36|||
4216107|NCT00713830|4039552|B3|||Glucose Excursion|Glucose excursion = 2-hour PPG minus plasma glucose 30 minutes prior to the meal test, before study drug administration. Number of patients analyzed = 154 and 309 for Placebo and Lixisenatide treatment arms, respectively.|mmol/L|Mean|6.94|6.94|Standard Deviation|3.73|3.73|||
4216108|NCT00713830|4039553|B2|||Glucose Excursion|Glucose excursion = 2-hour PPG minus plasma glucose 30 minutes prior to the meal test, before study drug administration. Number of patients analyzed = 154 and 309 for Placebo and Lixisenatide treatment arms, respectively.|mmol/L|Mean|6.99|6.99|Standard Deviation|3.71|3.71|||
4216109|NCT00713830|4039554|B1|||Glucose Excursion|Glucose excursion = 2-hour PPG minus plasma glucose 30 minutes prior to the meal test, before study drug administration. Number of patients analyzed = 154 and 309 for Placebo and Lixisenatide treatment arms, respectively.|mmol/L|Mean|6.84|6.84|Standard Deviation|3.78|3.78|||
4216110|NCT00713830|4039552|B3|||2-hour postprandial C-peptide|Number of patients analyzed = 152 and 308 for Placebo and Lixisenatide treatment arm, respectively.|mmol/L|Mean|2.03|2.03|Standard Deviation|0.95|0.95|||
4216111|NCT00713830|4039553|B2|||2-hour postprandial C-peptide|Number of patients analyzed = 152 and 308 for Placebo and Lixisenatide treatment arm, respectively.|mmol/L|Mean|1.99|1.99|Standard Deviation|0.90|0.9|||
4216112|NCT00713830|4039554|B1|||2-hour postprandial C-peptide|Number of patients analyzed = 152 and 308 for Placebo and Lixisenatide treatment arm, respectively.|mmol/L|Mean|2.12|2.12|Standard Deviation|1.05|1.05|||
4216113|NCT00713830|4039552|B3|||Fasting C-peptide|Number of patients analyzed = 152 and 309 for Placebo and Lixisenatide treatment arm, respectively.|mmol/L|Mean|0.85|0.85|Standard Deviation|0.47|0.47|||
4216114|NCT00713830|4039553|B2|||Fasting C-peptide|Number of patients analyzed = 152 and 309 for Placebo and Lixisenatide treatment arm, respectively.|mmol/L|Mean|0.83|0.83|Standard Deviation|0.43|0.43|||
4216115|NCT00713830|4039554|B1|||Fasting C-peptide|Number of patients analyzed = 152 and 309 for Placebo and Lixisenatide treatment arm, respectively.|mmol/L|Mean|0.89|0.89|Standard Deviation|0.55|0.55|||
4216116|NCT00713830|4039552|B3|||2-hour postprandial proinsulin|Number of patients analyzed = 130 and 257 for Placebo and Lixisenatide treatment arm, respectively.|pmol/L|Mean|61.99|61.99|Standard Deviation|45.31|45.31|||
4216117|NCT00713830|4039553|B2|||2-hour postprandial proinsulin|Number of patients analyzed = 130 and 257 for Placebo and Lixisenatide treatment arm, respectively.|pmol/L|Mean|62.12|62.12|Standard Deviation|44.80|44.8|||
4216118|NCT00713830|4039554|B1|||2-hour postprandial proinsulin|Number of patients analyzed = 130 and 257 for Placebo and Lixisenatide treatment arm, respectively.|pmol/L|Mean|61.73|61.73|Standard Deviation|46.48|46.48|||
4216119|NCT00713830|4039552|B3|||Fasting proinsulin|Number of patients analyzed = 138 and 290 for Placebo and Lixisenatide treatment arm, respectively.|pmol/L|Mean|33.69|33.69|Standard Deviation|29.17|29.17|||
4216120|NCT00713830|4039553|B2|||Fasting proinsulin|Number of patients analyzed = 138 and 290 for Placebo and Lixisenatide treatment arm, respectively.|pmol/L|Mean|33.35|33.35|Standard Deviation|27.43|27.43|||
4216121|NCT00713830|4039554|B1|||Fasting proinsulin|Number of patients analyzed = 138 and 290 for Placebo and Lixisenatide treatment arm, respectively.|pmol/L|Mean|34.39|34.39|Standard Deviation|32.61|32.61|||
4216122|NCT00713830|4039552|B3|||2-hour postprandial plasma insulin|Number of patients analyzed = 154 and 305 for Placebo and Lixisenatide treatment arm, respectively.|pmol/L|Mean|266.76|266.76|Standard Deviation|205.09|205.09|||
4216123|NCT00713830|4039553|B2|||2-hour postprandial plasma insulin|Number of patients analyzed = 154 and 305 for Placebo and Lixisenatide treatment arm, respectively.|pmol/L|Mean|259.44|259.44|Standard Deviation|182.64|182.64|||
4216124|NCT00713830|4039554|B1|||2-hour postprandial plasma insulin|Number of patients analyzed = 154 and 305 for Placebo and Lixisenatide treatment arm, respectively.|pmol/L|Mean|281.26|281.26|Standard Deviation|243.56|243.56|||
4216125|NCT00713830|4039552|B3|||Fasting plasma insulin (FPI)|Number of patients analyzed = 152 and 306 for Placebo and Lixisenatide treatment arm, respectively.|picomole per liter (pmol/L)|Mean|63.18|63.18|Standard Deviation|56.61|56.61|||
4216126|NCT00713830|4039553|B2|||Fasting plasma insulin (FPI)|Number of patients analyzed = 152 and 306 for Placebo and Lixisenatide treatment arm, respectively.|picomole per liter (pmol/L)|Mean|61.34|61.34|Standard Deviation|52.63|52.63|||
4216127|NCT00713830|4039554|B1|||Fasting plasma insulin (FPI)|Number of patients analyzed = 152 and 306 for Placebo and Lixisenatide treatment arm, respectively.|picomole per liter (pmol/L)|Mean|66.89|66.89|Standard Deviation|63.92|63.92|||
4216128|NCT00713830|4039552|B3|||2-hour postprandial glucagon|Number of patients analyzed = 149 and 300 for Placebo and Lixisenatide treatment arm, respectively.|ng/L|Mean|99.31|99.31|Standard Deviation|34.60|34.6|||
4216129|NCT00713830|4039553|B2|||2-hour postprandial glucagon|Number of patients analyzed = 149 and 300 for Placebo and Lixisenatide treatment arm, respectively.|ng/L|Mean|97.83|97.83|Standard Deviation|31.94|31.94|||
4216130|NCT00713830|4039554|B1|||2-hour postprandial glucagon|Number of patients analyzed = 149 and 300 for Placebo and Lixisenatide treatment arm, respectively.|ng/L|Mean|102.27|102.27|Standard Deviation|39.37|39.37|||
4216131|NCT00713830|4039552|B3|||Fasting glucagon|Number of patients analyzed = 152 and 309 for Placebo and Lixisenatide treatment arm, respectively.|nanogram per liter (ng/L)|Mean|0.85|0.85|Standard Deviation|0.47|0.47|||
4216174|NCT00713817|4039592|B2|Czech Republic||Region of Enrollment||participants|Number|7|7.0||||||
4216132|NCT00713830|4039553|B2|||Fasting glucagon|Number of patients analyzed = 152 and 309 for Placebo and Lixisenatide treatment arm, respectively.|nanogram per liter (ng/L)|Mean|0.83|0.83|Standard Deviation|0.43|0.43|||
4216133|NCT00713830|4039554|B1|||Fasting glucagon|Number of patients analyzed = 152 and 309 for Placebo and Lixisenatide treatment arm, respectively.|nanogram per liter (ng/L)|Mean|0.89|0.89|Standard Deviation|0.55|0.55|||
4216134|NCT00713830|4039552|B3|||Homeostasis Model Assessment for Beta-cell Function (HOMA-beta)|Beta cell function was assessed by HOMA-beta. HOMA-beta (percentage [%] of normal beta cells function) = (20 multiplied by fasting plasma insulin [micro unit per milliliter]) divided by (FPG [mmol/L] minus 3.5). Number of patients analyzed = 152 and 306 for Placebo and Lixisenatide treatment arms, respectively.|percentage of normal beta cells function|Mean|34.99|34.99|Standard Deviation|61.39|61.39|||
4216135|NCT00713830|4039553|B2|||Homeostasis Model Assessment for Beta-cell Function (HOMA-beta)|Beta cell function was assessed by HOMA-beta. HOMA-beta (percentage [%] of normal beta cells function) = (20 multiplied by fasting plasma insulin [micro unit per milliliter]) divided by (FPG [mmol/L] minus 3.5). Number of patients analyzed = 152 and 306 for Placebo and Lixisenatide treatment arms, respectively.|percentage of normal beta cells function|Mean|34.28|34.28|Standard Deviation|69.82|69.82|||
4216136|NCT00713830|4039554|B1|||Homeostasis Model Assessment for Beta-cell Function (HOMA-beta)|Beta cell function was assessed by HOMA-beta. HOMA-beta (percentage [%] of normal beta cells function) = (20 multiplied by fasting plasma insulin [micro unit per milliliter]) divided by (FPG [mmol/L] minus 3.5). Number of patients analyzed = 152 and 306 for Placebo and Lixisenatide treatment arms, respectively.|percentage of normal beta cells function|Mean|36.43|36.43|Standard Deviation|39.43|39.43|||
4216137|NCT00713830|4039552|B3|||Body Weight||kilogram (kg)|Mean|83.00|83.0|Standard Deviation|22.13|22.13|||
4216138|NCT00713830|4039553|B2|||Body Weight||kilogram (kg)|Mean|82.30|82.3|Standard Deviation|21.76|21.76|||
4216139|NCT00713830|4039554|B1|||Body Weight||kilogram (kg)|Mean|84.42|84.42|Standard Deviation|22.83|22.83|||
4216140|NCT00713830|4039552|B3|||Fasting Plasma Glucose (FPG)||mmol/L|Mean|9.55|9.55|Standard Deviation|2.29|2.29|||
4216141|NCT00713830|4039553|B2|||Fasting Plasma Glucose (FPG)||mmol/L|Mean|9.67|9.67|Standard Deviation|2.24|2.24|||
4216142|NCT00713830|4039554|B1|||Fasting Plasma Glucose (FPG)||mmol/L|Mean|9.29|9.29|Standard Deviation|2.37|2.37|||
4216143|NCT00713830|4039552|B3|||2-Hour Postprandial Plasma Glucose (PPG)|The 2-hour PPG test measured blood glucose 2 hours after eating a standardized meal. Number of patients analyzed = 154 and 309 for Placebo and Lixisenatide treatment arms, respectively.|millimole per liter (mmol/L)|Mean|16.60|16.6|Standard Deviation|3.92|3.92|||
4216144|NCT00713830|4039553|B2|||2-Hour Postprandial Plasma Glucose (PPG)|The 2-hour PPG test measured blood glucose 2 hours after eating a standardized meal. Number of patients analyzed = 154 and 309 for Placebo and Lixisenatide treatment arms, respectively.|millimole per liter (mmol/L)|Mean|16.69|16.69|Standard Deviation|4.02|4.02|||
4216145|NCT00713830|4039554|B1|||2-Hour Postprandial Plasma Glucose (PPG)|The 2-hour PPG test measured blood glucose 2 hours after eating a standardized meal. Number of patients analyzed = 154 and 309 for Placebo and Lixisenatide treatment arms, respectively.|millimole per liter (mmol/L)|Mean|16.44|16.44|Standard Deviation|3.74|3.74|||
4216146|NCT00713830|4039552|B3|||Glycosylated Hemoglobin (HbA1c)||percentage of hemoglobin|Mean|8.25|8.25|Standard Deviation|0.85|0.85|||
4216147|NCT00713830|4039553|B2|||Glycosylated Hemoglobin (HbA1c)||percentage of hemoglobin|Mean|8.28|8.28|Standard Deviation|0.86|0.86|||
4216148|NCT00713830|4039554|B1|||Glycosylated Hemoglobin (HbA1c)||percentage of hemoglobin|Mean|8.21|8.21|Standard Deviation|0.84|0.84|||
4216149|NCT00713830|4039552|B3|Ethnicity: Non Hispanic||Race/Ethnicity, Customized||participants|Number|836|836.0||||||
4216150|NCT00713830|4039553|B2|Ethnicity: Non Hispanic||Race/Ethnicity, Customized||participants|Number|556|556.0||||||
4216151|NCT00713830|4039554|B1|Ethnicity: Non Hispanic||Race/Ethnicity, Customized||participants|Number|280|280.0||||||
4216152|NCT00713830|4039552|B3|Ethnicity: Hispanic||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4216153|NCT00713830|4039553|B2|Ethnicity: Hispanic||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4216154|NCT00713830|4039554|B1|Ethnicity: Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4216155|NCT00713830|4039552|B3|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|385|385.0||||||
4216156|NCT00713830|4039553|B2|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|260|260.0||||||
4216157|NCT00713830|4039554|B1|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|125|125.0||||||
4216158|NCT00713830|4039552|B3|Race: Black||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4216159|NCT00713830|4039553|B2|Race: Black||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4216160|NCT00713830|4039554|B1|Race: Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4216161|NCT00713830|4039552|B3|Race: Caucasian/White||Race/Ethnicity, Customized||participants|Number|448|448.0||||||
4216162|NCT00713830|4039553|B2|Race: Caucasian/White||Race/Ethnicity, Customized||participants|Number|297|297.0||||||
4216163|NCT00713830|4039554|B1|Race: Caucasian/White||Race/Ethnicity, Customized||participants|Number|151|151.0||||||
4216164|NCT00713830|4039552|B3||Male|Sex: Female, Male||Participants|Count of Participants|434|434.0||||||
4216165|NCT00713830|4039553|B2||Male|Sex: Female, Male||Participants|Count of Participants|284|284.0||||||
4216166|NCT00713830|4039554|B1||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4216167|NCT00713830|4039552|B3||Female|Sex: Female, Male||Participants|Count of Participants|425|425.0||||||
4216168|NCT00713830|4039553|B2||Female|Sex: Female, Male||Participants|Count of Participants|290|290.0||||||
4216169|NCT00713830|4039554|B1||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4216170|NCT00713830|4039552|B3|||Age||years|Mean|57.2|57.2|Standard Deviation|9.9|9.9|||
4216171|NCT00713830|4039553|B2|||Age||years|Mean|57.0|57.0|Standard Deviation|9.8|9.8|||
4216172|NCT00713830|4039554|B1|||Age||years|Mean|57.8|57.8|Standard Deviation|10.1|10.1|||
4216173|NCT00713817|4039591|B3|Czech Republic||Region of Enrollment||participants|Number|15|15.0||||||
4216175|NCT00713817|4039593|B1|Czech Republic||Region of Enrollment||participants|Number|8|8.0||||||
4216176|NCT00713817|4039591|B3|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4216177|NCT00713817|4039592|B2|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4216178|NCT00713817|4039593|B1|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4216179|NCT00713817|4039591|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4216180|NCT00713817|4039592|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4216181|NCT00713817|4039593|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4216182|NCT00713817|4039591|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4216183|NCT00713817|4039592|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4216184|NCT00713817|4039593|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4216185|NCT00713817|4039591|B3|||Age||years|Mean|53.8|53.8|Standard Deviation|7.98|7.98|||
4216186|NCT00713817|4039592|B2|||Age||years|Mean|56.1|56.1|Standard Deviation|10.33|10.33|||
4216187|NCT00713817|4039593|B1|||Age||years|Mean|51.7|51.7|Standard Deviation|4.69|4.69|||
4216188|NCT00713817|4039591|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4216189|NCT00713817|4039592|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4216190|NCT00713817|4039593|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4216191|NCT00713817|4039591|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4216192|NCT00713817|4039592|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4216193|NCT00713817|4039593|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4216194|NCT00713817|4039591|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4216195|NCT00713817|4039592|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4216196|NCT00713817|4039593|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4216197|NCT00713700|4039612|B1|United States||Region of Enrollment||participants|Number|192|192.0||||||
4216198|NCT00713700|4039612|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4216199|NCT00713700|4039612|B1||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4216200|NCT00713700|4039612|B1|||Age||years|Mean|4.4|4.4|Standard Deviation|4.2|4.2|||
4216201|NCT00713700|4039612|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4216202|NCT00713700|4039612|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4216203|NCT00713700|4039612|B1||<=18 years|Age||Participants|Count of Participants|192|192.0||||||
4216204|NCT00713661|4039617|B5||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4216205|NCT00713661|4039618|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4216206|NCT00713661|4039619|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4216207|NCT00713661|4039620|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4216208|NCT00713661|4039621|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4216209|NCT00713661|4039617|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4216210|NCT00713661|4039618|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4216211|NCT00713661|4039619|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4216212|NCT00713661|4039620|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4216213|NCT00713661|4039621|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4216214|NCT00713661|4039617|B5|||Age||years|Mean|65.1|65.1|Standard Deviation|10.6|10.6|||
4216215|NCT00713661|4039618|B4|||Age||years|Mean|65.2|65.2|Standard Deviation|12.0|12.0|||
4216216|NCT00713661|4039619|B3|||Age||years|Mean|68.5|68.5|Standard Deviation|9.9|9.9|||
4216217|NCT00713661|4039620|B2|||Age||years|Mean|64.6|64.6|Standard Deviation|12.8|12.8|||
4216218|NCT00713661|4039621|B1|||Age||years|Mean|63.7|63.7|Standard Deviation|8.5|8.5|||
4216219|NCT00713648|4039638|B1|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4216220|NCT00713648|4039638|B1|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4216221|NCT00713648|4039638|B1|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4216222|NCT00713648|4039638|B1|White||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4216223|NCT00713648|4039638|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4216224|NCT00713648|4039638|B1||Male|Gender||Participants|Count of Participants|23|23.0||||||
4216225|NCT00713648|4039638|B1||Female|Gender||Participants|Count of Participants|18|18.0||||||
4216226|NCT00713648|4039638|B1|||Age||years|Mean|26.4|26.4|Standard Deviation|15.9|15.9|||
4216227|NCT00713609|4039645|B7|White||Race/Ethnicity, Customized||Participants|Number|384|384.0||||||
4216228|NCT00713609|4039646|B6|White||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
4216229|NCT00713609|4039647|B5|White||Race/Ethnicity, Customized||Participants|Number|74|74.0||||||
4216230|NCT00713609|4039648|B4|White||Race/Ethnicity, Customized||Participants|Number|79|79.0||||||
4216231|NCT00713609|4039649|B3|White||Race/Ethnicity, Customized||Participants|Number|68|68.0||||||
4216232|NCT00713609|4039650|B2|White||Race/Ethnicity, Customized||Participants|Number|63|63.0||||||
4216233|NCT00713609|4039651|B1|White||Race/Ethnicity, Customized||Participants|Number|63|63.0||||||
4216234|NCT00713609|4039645|B7|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4216235|NCT00713609|4039646|B6|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4216236|NCT00713609|4039647|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4216237|NCT00713609|4039648|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4216238|NCT00713609|4039649|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4216239|NCT00713609|4039650|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4216240|NCT00713609|4039651|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4216241|NCT00713609|4039645|B7|Multiracial||Race/Ethnicity, Customized||Participants|Number|51|51.0||||||
4216242|NCT00713609|4039646|B6|Multiracial||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4216243|NCT00713609|4039647|B5|Multiracial||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4216244|NCT00713609|4039648|B4|Multiracial||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4216245|NCT00713609|4039649|B3|Multiracial||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4216246|NCT00713609|4039650|B2|Multiracial||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4216247|NCT00713609|4039651|B1|Multiracial||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4216248|NCT00713609|4039645|B7|Black||Race/Ethnicity, Customized||Participants|Number|100|100.0||||||
4216249|NCT00713609|4039646|B6|Black||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4216250|NCT00713609|4039647|B5|Black||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4216251|NCT00713609|4039648|B4|Black||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4216252|NCT00713609|4039649|B3|Black||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
4216253|NCT00713609|4039650|B2|Black||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4216254|NCT00713609|4039651|B1|Black||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
4216255|NCT00713609|4039645|B7|Asian||Race/Ethnicity, Customized||Participants|Number|47|47.0||||||
4216256|NCT00713609|4039646|B6|Asian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4216257|NCT00713609|4039647|B5|Asian||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4216258|NCT00713609|4039648|B4|Asian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4216259|NCT00713609|4039649|B3|Asian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4216260|NCT00713609|4039650|B2|Asian||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4216261|NCT00713609|4039651|B1|Asian||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4216262|NCT00713609|4039645|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4216263|NCT00713609|4039646|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4216264|NCT00713609|4039647|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4216265|NCT00713609|4039648|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4216266|NCT00713609|4039649|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4216267|NCT00713609|4039650|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4216268|NCT00713609|4039651|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4216269|NCT00713609|4039645|B7||Male|Gender||Participants|Count of Participants|253|253.0||||||
4216270|NCT00713609|4039646|B6||Male|Gender||Participants|Count of Participants|20|20.0||||||
4216271|NCT00713609|4039647|B5||Male|Gender||Participants|Count of Participants|41|41.0||||||
4216272|NCT00713609|4039648|B4||Male|Gender||Participants|Count of Participants|48|48.0||||||
4216273|NCT00713609|4039649|B3||Male|Gender||Participants|Count of Participants|47|47.0||||||
4216274|NCT00713609|4039650|B2||Male|Gender||Participants|Count of Participants|49|49.0||||||
4216275|NCT00713609|4039651|B1||Male|Gender||Participants|Count of Participants|48|48.0||||||
4216276|NCT00713609|4039645|B7||Female|Gender||Participants|Count of Participants|334|334.0||||||
4216277|NCT00713609|4039646|B6||Female|Gender||Participants|Count of Participants|35|35.0||||||
4216278|NCT00713609|4039647|B5||Female|Gender||Participants|Count of Participants|65|65.0||||||
4216279|NCT00713609|4039648|B4||Female|Gender||Participants|Count of Participants|60|60.0||||||
4216280|NCT00713609|4039649|B3||Female|Gender||Participants|Count of Participants|60|60.0||||||
4216281|NCT00713609|4039650|B2||Female|Gender||Participants|Count of Participants|56|56.0||||||
4216282|NCT00713609|4039651|B1||Female|Gender||Participants|Count of Participants|58|58.0||||||
4216283|NCT00713609|4039645|B7|||Age||Years|Mean|20.1|20.1|Standard Deviation|7.1|7.1|||
4216284|NCT00713609|4039646|B6|||Age||Years|Mean|19.8|19.8|Standard Deviation|6.6|6.6|||
4216285|NCT00713609|4039647|B5|||Age||Years|Mean|21.7|21.7|Standard Deviation|8.4|8.4|||
4216286|NCT00713609|4039648|B4|||Age||Years|Mean|19.2|19.2|Standard Deviation|6.2|6.2|||
4216287|NCT00713609|4039649|B3|||Age||Years|Mean|20.2|20.2|Standard Deviation|7.3|7.3|||
4216288|NCT00713609|4039650|B2|||Age||Years|Mean|19.7|19.7|Standard Deviation|6.9|6.9|||
4216289|NCT00713609|4039651|B1|||Age||Years|Mean|19.7|19.7|Standard Deviation|6.6|6.6|||
4216290|NCT00713596|4039688|B4|United States||Region of Enrollment||participants|Number|25|25.0||||||
4216291|NCT00713596|4039689|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4216292|NCT00713596|4039690|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4216293|NCT00713596|4039691|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4216294|NCT00713596|4039688|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4216295|NCT00713596|4039689|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4216296|NCT00713596|4039690|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4216297|NCT00713596|4039691|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4216298|NCT00713596|4039688|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4216299|NCT00713596|4039689|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4216300|NCT00713596|4039690|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4216301|NCT00713596|4039691|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4216302|NCT00713596|4039688|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4216303|NCT00713596|4039689|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4216304|NCT00713596|4039690|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4216305|NCT00713596|4039691|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4216306|NCT00713596|4039688|B4||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4216307|NCT00713596|4039689|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4216308|NCT00713596|4039690|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4216309|NCT00713596|4039691|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4216310|NCT00713596|4039688|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4216311|NCT00713596|4039689|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4216312|NCT00713596|4039690|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4216313|NCT00713596|4039691|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4216314|NCT00713583|4039704|B3|United States||Region of Enrollment||Participants|Count of Participants|85|85.0||||||
4216315|NCT00713583|4039705|B2|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
4216316|NCT00713583|4039706|B1|United States||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
4216317|NCT00713583|4039704|B3||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4216318|NCT00713583|4039705|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4216319|NCT00713583|4039706|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4216320|NCT00713583|4039704|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4216321|NCT00713583|4039705|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4216322|NCT00713583|4039706|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4216323|NCT00713583|4039704|B3|||Age||years|Mean|46|46.0|Standard Deviation|8.5|8.5|||
4216324|NCT00713583|4039705|B2|||Age||years|Mean|45|45.0|Standard Deviation|9.2|9.2|||
4216325|NCT00713583|4039706|B1|||Age||years|Mean|46|46.0|Standard Deviation|7.9|7.9|||
4216326|NCT00713544|4039713|B7|||Disease Activity Score (based on 28 joint counts) (DAS28)|Change from baseline in the DAS28 composite score (a measure of RA symptoms including: joint swelling and tenderness; patient’s assessment of disease activity; and ESR) after 12 Weeks’ treatment. A change of zero indicates no effect of treatment and a negative change of 1.2 indicates a clinically important improvement in symptoms. The DAS scale runs from 0 to 10, with the higher scores indicating worse RA symptoms.|Units on a scale|Mean|6.5|6.5|Standard Deviation|0.79|0.79|||
4216327|NCT00713544|4039714|B6|||Disease Activity Score (based on 28 joint counts) (DAS28)|Change from baseline in the DAS28 composite score (a measure of RA symptoms including: joint swelling and tenderness; patient’s assessment of disease activity; and ESR) after 12 Weeks’ treatment. A change of zero indicates no effect of treatment and a negative change of 1.2 indicates a clinically important improvement in symptoms. The DAS scale runs from 0 to 10, with the higher scores indicating worse RA symptoms.|Units on a scale|Mean|6.7|6.7|Standard Deviation|0.80|0.8|||
4216328|NCT00713544|4039715|B5|||Disease Activity Score (based on 28 joint counts) (DAS28)|Change from baseline in the DAS28 composite score (a measure of RA symptoms including: joint swelling and tenderness; patient’s assessment of disease activity; and ESR) after 12 Weeks’ treatment. A change of zero indicates no effect of treatment and a negative change of 1.2 indicates a clinically important improvement in symptoms. The DAS scale runs from 0 to 10, with the higher scores indicating worse RA symptoms.|Units on a scale|Mean|6.6|6.6|Standard Deviation|0.74|0.74|||
4216329|NCT00713544|4039716|B4|||Disease Activity Score (based on 28 joint counts) (DAS28)|Change from baseline in the DAS28 composite score (a measure of RA symptoms including: joint swelling and tenderness; patient’s assessment of disease activity; and ESR) after 12 Weeks’ treatment. A change of zero indicates no effect of treatment and a negative change of 1.2 indicates a clinically important improvement in symptoms. The DAS scale runs from 0 to 10, with the higher scores indicating worse RA symptoms.|Units on a scale|Mean|6.3|6.3|Standard Deviation|0.79|0.79|||
4216330|NCT00713544|4039717|B3|||Disease Activity Score (based on 28 joint counts) (DAS28)|Change from baseline in the DAS28 composite score (a measure of RA symptoms including: joint swelling and tenderness; patient’s assessment of disease activity; and ESR) after 12 Weeks’ treatment. A change of zero indicates no effect of treatment and a negative change of 1.2 indicates a clinically important improvement in symptoms. The DAS scale runs from 0 to 10, with the higher scores indicating worse RA symptoms.|Units on a scale|Mean|6.4|6.4|Standard Deviation|0.72|0.72|||
4216331|NCT00713544|4039718|B2|||Disease Activity Score (based on 28 joint counts) (DAS28)|Change from baseline in the DAS28 composite score (a measure of RA symptoms including: joint swelling and tenderness; patient’s assessment of disease activity; and ESR) after 12 Weeks’ treatment. A change of zero indicates no effect of treatment and a negative change of 1.2 indicates a clinically important improvement in symptoms. The DAS scale runs from 0 to 10, with the higher scores indicating worse RA symptoms.|Units on a scale|Mean|6.5|6.5|Standard Deviation|0.87|0.87|||
4216332|NCT00713544|4039719|B1|||Disease Activity Score (based on 28 joint counts) (DAS28)|Change from baseline in the DAS28 composite score (a measure of RA symptoms including: joint swelling and tenderness; patient’s assessment of disease activity; and ESR) after 12 Weeks’ treatment. A change of zero indicates no effect of treatment and a negative change of 1.2 indicates a clinically important improvement in symptoms. The DAS scale runs from 0 to 10, with the higher scores indicating worse RA symptoms.|Units on a scale|Mean|6.6|6.6|Standard Deviation|0.80|0.8|||
4216333|NCT00713544|4039713|B7|Duration of rheumatoid arthritis <= 5years||Duration of rheumatoid arthritis||participants|Number|170|170.0||||||
4216334|NCT00713544|4039714|B6|Duration of rheumatoid arthritis <= 5years||Duration of rheumatoid arthritis||participants|Number|27|27.0||||||
4216335|NCT00713544|4039715|B5|Duration of rheumatoid arthritis <= 5years||Duration of rheumatoid arthritis||participants|Number|29|29.0||||||
4216336|NCT00713544|4039716|B4|Duration of rheumatoid arthritis <= 5years||Duration of rheumatoid arthritis||participants|Number|37|37.0||||||
4216337|NCT00713544|4039717|B3|Duration of rheumatoid arthritis <= 5years||Duration of rheumatoid arthritis||participants|Number|26|26.0||||||
4216338|NCT00713544|4039718|B2|Duration of rheumatoid arthritis <= 5years||Duration of rheumatoid arthritis||participants|Number|22|22.0||||||
4216339|NCT00713544|4039719|B1|Duration of rheumatoid arthritis <= 5years||Duration of rheumatoid arthritis||participants|Number|29|29.0||||||
4216340|NCT00713544|4039713|B7|Duration of rheumatoid arthritis > 5 years||Duration of rheumatoid arthritis||participants|Number|201|201.0||||0.0|0.0|
4216341|NCT00713544|4039714|B6|Duration of rheumatoid arthritis > 5 years||Duration of rheumatoid arthritis||participants|Number|48|48.0||||||
4216342|NCT00713544|4039715|B5|Duration of rheumatoid arthritis > 5 years||Duration of rheumatoid arthritis||participants|Number|36|36.0||||||
4216343|NCT00713544|4039716|B4|Duration of rheumatoid arthritis > 5 years||Duration of rheumatoid arthritis||participants|Number|39|39.0||||||
4216344|NCT00713544|4039717|B3|Duration of rheumatoid arthritis > 5 years||Duration of rheumatoid arthritis||participants|Number|25|25.0||||||
4216345|NCT00713544|4039718|B2|Duration of rheumatoid arthritis > 5 years||Duration of rheumatoid arthritis||participants|Number|30|30.0||||||
4216346|NCT00713544|4039719|B1|Duration of rheumatoid arthritis > 5 years||Duration of rheumatoid arthritis||participants|Number|23|23.0||||29.0||
4216347|NCT00713544|4039713|B7||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4216348|NCT00713544|4039714|B6||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4216349|NCT00713544|4039715|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4216350|NCT00713544|4039716|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4216351|NCT00713544|4039717|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4216352|NCT00713544|4039718|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4216353|NCT00713544|4039719|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4216354|NCT00713544|4039713|B7||Female|Sex: Female, Male||Participants|Count of Participants|322|322.0||||||
4216355|NCT00713544|4039714|B6||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4216356|NCT00713544|4039715|B5||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4216357|NCT00713544|4039716|B4||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4216358|NCT00713544|4039717|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4216359|NCT00713544|4039718|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4216360|NCT00713544|4039719|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4216361|NCT00713544|4039713|B7|||Age||Year|Mean|53|53.0|Standard Deviation|10.8|10.8|||
4216362|NCT00713544|4039714|B6|||Age||Year|Mean|54|54.0|Standard Deviation|9.6|9.6|||
4216363|NCT00713544|4039715|B5|||Age||Year|Mean|53|53.0|Standard Deviation|10.6|10.6|||
4216364|NCT00713544|4039716|B4|||Age||Year|Mean|53|53.0|Standard Deviation|10.2|10.2|||
4216365|NCT00713544|4039717|B3|||Age||Year|Mean|54|54.0|Standard Deviation|10.8|10.8|||
4216366|NCT00713544|4039718|B2|||Age||Year|Mean|53|53.0|Standard Deviation|12|12.0|||
4216367|NCT00713544|4039719|B1|||Age||Year|Mean|53|53.0|Standard Deviation|12.7|12.7|||
4216368|NCT00713479|4039762|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4216369|NCT00713479|4039762|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4216370|NCT00713479|4039762|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4216371|NCT00713479|4039762|B1|||Age|This value is for subjects completing both arms of the trial (n=8)|years|Mean|39.3|39.3|Standard Deviation|2.1|2.1|||
4216372|NCT00713479|4039762|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4216373|NCT00713479|4039762|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4216374|NCT00713479|4039762|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4216375|NCT00713349|4039775|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4216376|NCT00713349|4039775|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4216377|NCT00713349|4039775|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4216378|NCT00713349|4039775|B1|||Age||years|Mean|43|43.0|Standard Deviation|12.1|12.1|||
4216379|NCT00713349|4039775|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4216380|NCT00713349|4039775|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4216381|NCT00713349|4039775|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4216382|NCT00713323|4039781|B1|Czech Republic||Region of Enrollment||participants|Number|94|94.0||||||
4216383|NCT00713323|4039781|B1|Romania||Region of Enrollment||participants|Number|50|50.0||||||
4216384|NCT00713323|4039781|B1|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4216385|NCT00713323|4039781|B1|Belgium||Region of Enrollment||participants|Number|9|9.0||||||
4216386|NCT00713323|4039781|B1|United Kingdom||Region of Enrollment||participants|Number|222|222.0||||||
4216387|NCT00713323|4039781|B1||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4216388|NCT00713323|4039781|B1||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4216389|NCT00713323|4039781|B1|||Age||years|Mean|57.8|57.8|Standard Deviation|12.03|12.03|||
4216390|NCT00713323|4039781|B1||>=65 years|Age||Participants|Count of Participants|93|93.0||||||
4216391|NCT00713323|4039781|B1||Between 18 and 65 years|Age||Participants|Count of Participants|287|287.0||||||
4216392|NCT00713323|4039781|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4216393|NCT00713310|4039792|B3|Croatia||Region of Enrollment||participants|Number|6|6.0||||||
4216394|NCT00713310|4039793|B2|Croatia||Region of Enrollment||participants|Number|2|2.0||||||
4216395|NCT00713310|4039794|B1|Croatia||Region of Enrollment||participants|Number|4|4.0||||||
4216396|NCT00713310|4039792|B3|Romania||Region of Enrollment||participants|Number|5|5.0||||||
4216397|NCT00713310|4039793|B2|Romania||Region of Enrollment||participants|Number|3|3.0||||||
4216398|NCT00713310|4039794|B1|Romania||Region of Enrollment||participants|Number|2|2.0||||||
4216399|NCT00713310|4039792|B3|Poland||Region of Enrollment||participants|Number|19|19.0||||||
4216400|NCT00713310|4039793|B2|Poland||Region of Enrollment||participants|Number|10|10.0||||||
4216401|NCT00713310|4039794|B1|Poland||Region of Enrollment||participants|Number|9|9.0||||||
4216402|NCT00713310|4039792|B3|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4216403|NCT00713310|4039793|B2|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4216404|NCT00713310|4039794|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4216405|NCT00713310|4039792|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
4216406|NCT00713310|4039793|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4216407|NCT00713310|4039794|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4216408|NCT00713310|4039792|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4216409|NCT00713310|4039793|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4216410|NCT00713310|4039794|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4216411|NCT00713310|4039792|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4216412|NCT00713310|4039793|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4216413|NCT00713310|4039794|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4216414|NCT00713310|4039792|B3|9-17 years||Age, Customized||participants|Number|75|75.0||||||
4216415|NCT00713310|4039793|B2|9-17 years||Age, Customized||participants|Number|38|38.0||||||
4216416|NCT00713310|4039794|B1|9-17 years||Age, Customized||participants|Number|37|37.0||||||
4216417|NCT00713310|4039792|B3|5-8 years||Age, Customized||participants|Number|8|8.0||||||
4216418|NCT00713310|4039793|B2|5-8 years||Age, Customized||participants|Number|4|4.0||||||
4216419|NCT00713310|4039794|B1|5-8 years||Age, Customized||participants|Number|4|4.0||||||
4216420|NCT00713310|4039792|B3|||Age|mITT Population|years|Mean|12.9|12.9|Standard Deviation|3.1|3.1|||
4216421|NCT00713310|4039793|B2|||Age|mITT Population|years|Mean|12.8|12.8|Standard Deviation|3.0|3.0|||
4216422|NCT00713310|4039794|B1|||Age|mITT Population|years|Mean|13.0|13.0|Standard Deviation|3.2|3.2|||
4216423|NCT00713258|4039803|B3|||Mean NRS score|NRS = 11-point numerical rating scale to assess the pain. The NRS score ranges from 0 to 10, with lower scores meaning less pain.|scores on a scale|Mean|6.49|6.49|Standard Deviation|1.56|1.56|||
4216424|NCT00713258|4039804|B2|||Mean NRS score|NRS = 11-point numerical rating scale to assess the pain. The NRS score ranges from 0 to 10, with lower scores meaning less pain.|scores on a scale|Mean|6.36|6.36|Standard Deviation|1.70|1.7|||
4216425|NCT00713258|4039805|B1|||Mean NRS score|NRS = 11-point numerical rating scale to assess the pain. The NRS score ranges from 0 to 10, with lower scores meaning less pain.|scores on a scale|Mean|6.60|6.6|Standard Deviation|1.45|1.45|||
4216426|NCT00713258|4039803|B3|||Age at onset of menopause||years|Mean|48.5|48.5|Standard Deviation|4.43|4.43|||
4216427|NCT00713258|4039804|B2|||Age at onset of menopause||years|Mean|48.6|48.6|Standard Deviation|5.25|5.25|||
4216428|NCT00713258|4039805|B1|||Age at onset of menopause||years|Mean|48.5|48.5|Standard Deviation|3.68|3.68|||
4216429|NCT00713258|4039803|B3|||Family history of osteoporosis|A family history of osteoporosis was reported by 22 subjects, which differs from the overall number of baseline participants.|patients|Number|22|22.0||||||
4216430|NCT00713258|4039804|B2|||Family history of osteoporosis|A family history of osteoporosis was reported by 22 subjects, which differs from the overall number of baseline participants.|patients|Number|9|9.0||||||
4216431|NCT00713258|4039805|B1|||Family history of osteoporosis|A family history of osteoporosis was reported by 22 subjects, which differs from the overall number of baseline participants.|patients|Number|13|13.0||||||
4216432|NCT00713258|4039803|B3|||Vertebral Fracture at Baseline|The baseline measure is shown as average number per patient.|vertebral fractures per patient|Mean|3.21|3.21|Standard Deviation|2.27|2.27|||
4216433|NCT00713258|4039804|B2|||Vertebral Fracture at Baseline|The baseline measure is shown as average number per patient.|vertebral fractures per patient|Mean|2.94|2.94|Standard Deviation|1.97|1.97|||
4216434|NCT00713258|4039805|B1|||Vertebral Fracture at Baseline|The baseline measure is shown as average number per patient.|vertebral fractures per patient|Mean|3.44|3.44|Standard Deviation|2.49|2.49|||
4216435|NCT00713258|4039803|B3|Female||Sex/Gender, Customized||participants|Number|75|75.0||||||
4216436|NCT00713258|4039804|B2|Female||Sex/Gender, Customized||participants|Number|34|34.0||||||
4216437|NCT00713258|4039805|B1|Female||Sex/Gender, Customized||participants|Number|41|41.0||||||
4216438|NCT00713258|4039803|B3|||Age||years|Mean|70.3|70.3|Standard Deviation|8.53|8.53|||
4216439|NCT00713258|4039804|B2|||Age||years|Mean|69.8|69.8|Standard Deviation|7.84|7.84|||
4216440|NCT00713258|4039805|B1|||Age||years|Mean|70.7|70.7|Standard Deviation|9.14|9.14|||
4216441|NCT00713219|4039814|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4216442|NCT00713219|4039814|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4216443|NCT00713219|4039814|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4216444|NCT00713219|4039814|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4216445|NCT00713219|4039814|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4216446|NCT00713206|4039818|B3|Portugal||Region of Enrollment||participants|Number|15|15.0||||||
4216447|NCT00713206|4039819|B2|Portugal||Region of Enrollment||participants|Number|6|6.0||||||
4216448|NCT00713206|4039820|B1|Portugal||Region of Enrollment||participants|Number|9|9.0||||||
4216449|NCT00713206|4039818|B3|Spain||Region of Enrollment||participants|Number|14|14.0||||||
4216450|NCT00713206|4039819|B2|Spain||Region of Enrollment||participants|Number|5|5.0||||||
4216451|NCT00713206|4039820|B1|Spain||Region of Enrollment||participants|Number|9|9.0||||||
4216452|NCT00713206|4039818|B3|Italy||Region of Enrollment||participants|Number|63|63.0||||||
4216453|NCT00713206|4039819|B2|Italy||Region of Enrollment||participants|Number|19|19.0||||||
4216454|NCT00713206|4039820|B1|Italy||Region of Enrollment||participants|Number|44|44.0||||||
4216455|NCT00713206|4039818|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4216456|NCT00713206|4039819|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4216457|NCT00713206|4039820|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4216458|NCT00713206|4039818|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4216459|NCT00713206|4039819|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4216460|NCT00713206|4039820|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4216461|NCT00713206|4039818|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4216462|NCT00713206|4039819|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4216463|NCT00713206|4039820|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4216464|NCT00713206|4039818|B3||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
4216465|NCT00713206|4039819|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4216466|NCT00713206|4039820|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4216467|NCT00713206|4039818|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4216468|NCT00713206|4039819|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4216469|NCT00713206|4039820|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4216470|NCT00712985|4039827|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4216471|NCT00712985|4039827|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4216472|NCT00712985|4039827|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4216473|NCT00712985|4039827|B1|||Age||years|Mean|56|56.0|Standard Deviation|9.89|9.89|||
4216474|NCT00712985|4039827|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4216475|NCT00712985|4039827|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4216476|NCT00712985|4039827|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4216477|NCT00712959|4039831|B3|Canada||Region of Enrollment||participants|Number|768|768.0||||||
4216478|NCT00712959|4039832|B2|Canada||Region of Enrollment||participants|Number|407|407.0||||||
4216479|NCT00712959|4039833|B1|Canada||Region of Enrollment||participants|Number|361|361.0||||||
4216480|NCT00712959|4039831|B3||Male|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
4216481|NCT00712959|4039832|B2||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4216482|NCT00712959|4039833|B1||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4216483|NCT00712959|4039831|B3||Female|Sex: Female, Male||Participants|Count of Participants|458|458.0||||||
4216484|NCT00712959|4039832|B2||Female|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
4216485|NCT00712959|4039833|B1||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4216486|NCT00712959|4039831|B3|||Age||Years|Mean|33.0|33.0|Standard Deviation|13.4|13.4|||
4216487|NCT00712959|4039832|B2|||Age||Years|Mean|34.6|34.6|Standard Deviation|12.5|12.5|||
4216488|NCT00712959|4039833|B1|||Age||Years|Mean|31.2|31.2|Standard Deviation|14.0|14.0|||
4216489|NCT00712959|4039831|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4216490|NCT00712959|4039832|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4216491|NCT00712959|4039833|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4216492|NCT00712959|4039831|B3||Between 18 and 65 years|Age||Participants|Count of Participants|758|758.0||||||
4216493|NCT00712959|4039832|B2||Between 18 and 65 years|Age||Participants|Count of Participants|402|402.0||||||
4216494|NCT00712959|4039833|B1||Between 18 and 65 years|Age||Participants|Count of Participants|356|356.0||||||
4216495|NCT00712959|4039831|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4216496|NCT00712959|4039832|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4216497|NCT00712959|4039833|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4216498|NCT00712933|4039852|B1|White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|256|256.0||||||
4216499|NCT00712933|4039852|B1|Middle East/North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
4216500|NCT00712933|4039852|B1|Southeast Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|58|58.0||||||
4216501|NCT00712933|4039852|B1|South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
4216502|NCT00712933|4039852|B1|East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|118|118.0||||||
4216503|NCT00712933|4039852|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|225|225.0||||||
4216504|NCT00712933|4039852|B1|Black or African American/African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
4216505|NCT00712933|4039852|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4216506|NCT00712933|4039852|B1||Female|Sex: Female, Male||Participants|Count of Participants|695|695.0||||||
4216507|NCT00712933|4039852|B1|||Age||Years|Mean|37.2|37.2|Standard Deviation|11.17|11.17|||
4216508|NCT00712920|4039879|B4|United States||Region of Enrollment|Number of participants based on ITT population|participants|Number|578|578.0||||||
4216509|NCT00712920|4039880|B3|United States||Region of Enrollment|Number of participants based on ITT population|participants|Number|192|192.0||||||
4216510|NCT00712920|4039881|B2|United States||Region of Enrollment|Number of participants based on ITT population|participants|Number|194|194.0||||||
4216511|NCT00712920|4039882|B1|United States||Region of Enrollment|Number of participants based on ITT population|participants|Number|192|192.0||||||
4216512|NCT00712920|4039879|B4||Male|Sex: Female, Male|Number of participants based on ITT population|Participants|Count of Participants|185|185.0||||||
4216513|NCT00712920|4039880|B3||Male|Sex: Female, Male|Number of participants based on ITT population|Participants|Count of Participants|65|65.0||||||
4216514|NCT00712920|4039881|B2||Male|Sex: Female, Male|Number of participants based on ITT population|Participants|Count of Participants|58|58.0||||||
4216515|NCT00712920|4039882|B1||Male|Sex: Female, Male|Number of participants based on ITT population|Participants|Count of Participants|62|62.0||||||
4216516|NCT00712920|4039879|B4||Female|Sex: Female, Male|Number of participants based on ITT population|Participants|Count of Participants|393|393.0||||||
4216517|NCT00712920|4039880|B3||Female|Sex: Female, Male|Number of participants based on ITT population|Participants|Count of Participants|127|127.0||||||
4216518|NCT00712920|4039881|B2||Female|Sex: Female, Male|Number of participants based on ITT population|Participants|Count of Participants|136|136.0||||||
4216519|NCT00712920|4039882|B1||Female|Sex: Female, Male|Number of participants based on ITT population|Participants|Count of Participants|130|130.0||||||
4216520|NCT00712920|4039879|B4|||Age|Number of participants based on ITT population|years|Mean|36.9|36.9|Standard Deviation|13.97|13.97|||
4216521|NCT00712920|4039880|B3|||Age|Number of participants based on ITT population|years|Mean|35.6|35.6|Standard Deviation|13.31|13.31|||
4216522|NCT00712920|4039881|B2|||Age|Number of participants based on ITT population|years|Mean|36.9|36.9|Standard Deviation|13.09|13.09|||
4216523|NCT00712920|4039882|B1|||Age|Number of participants based on ITT population|years|Mean|38.1|38.1|Standard Deviation|15.37|15.37|||
4216524|NCT00712920|4039879|B4||>=65 years|Age|Number of participants based on ITT population|Participants|Count of Participants|14|14.0||||||
4216525|NCT00712920|4039880|B3||>=65 years|Age|Number of participants based on ITT population|Participants|Count of Participants|4|4.0||||||
4216526|NCT00712920|4039881|B2||>=65 years|Age|Number of participants based on ITT population|Participants|Count of Participants|0|0.0||||||
4216527|NCT00712920|4039882|B1||>=65 years|Age|Number of participants based on ITT population|Participants|Count of Participants|10|10.0||||||
4216528|NCT00712920|4039879|B4||Between 18 and 65 years|Age|Number of participants based on ITT population|Participants|Count of Participants|514|514.0||||||
4216529|NCT00712920|4039880|B3||Between 18 and 65 years|Age|Number of participants based on ITT population|Participants|Count of Participants|170|170.0||||||
4216530|NCT00712920|4039881|B2||Between 18 and 65 years|Age|Number of participants based on ITT population|Participants|Count of Participants|183|183.0||||||
4216531|NCT00712920|4039882|B1||Between 18 and 65 years|Age|Number of participants based on ITT population|Participants|Count of Participants|161|161.0||||||
4216532|NCT00712920|4039879|B4||<=18 years|Age|Number of participants based on ITT population|Participants|Count of Participants|50|50.0||||||
4216533|NCT00712920|4039880|B3||<=18 years|Age|Number of participants based on ITT population|Participants|Count of Participants|18|18.0||||||
4216534|NCT00712920|4039881|B2||<=18 years|Age|Number of participants based on ITT population|Participants|Count of Participants|11|11.0||||||
4216535|NCT00712920|4039882|B1||<=18 years|Age|Number of participants based on ITT population|Participants|Count of Participants|21|21.0||||||
4216536|NCT00712725|4039904|B9|Ex-United States||Study Region||Participants|Number|277|277.0||||||
4216537|NCT00712725|4039905|B8|Ex-United States||Study Region||Participants|Number|43|43.0||||||
4216538|NCT00712725|4039906|B7|Ex-United States||Study Region||Participants|Number|28|28.0||||||
4216539|NCT00712725|4039907|B6|Ex-United States||Study Region||Participants|Number|23|23.0||||||
4216540|NCT00712725|4039908|B5|Ex-United States||Study Region||Participants|Number|28|28.0||||||
4216541|NCT00712725|4039909|B4|Ex-United States||Study Region||Participants|Number|37|37.0||||||
4216542|NCT00712725|4039910|B3|Ex-United States||Study Region||Participants|Number|25|25.0||||||
4216543|NCT00712725|4039911|B2|Ex-United States||Study Region||Participants|Number|19|19.0||||||
4216544|NCT00712725|4039912|B1|Ex-United States||Study Region||Participants|Number|74|74.0||||||
4216545|NCT00712725|4039904|B9|United States||Study Region||Participants|Number|270|270.0||||||
4216546|NCT00712725|4039905|B8|United States||Study Region||Participants|Number|20|20.0||||||
4216547|NCT00712725|4039906|B7|United States||Study Region||Participants|Number|34|34.0||||||
4216548|NCT00712725|4039907|B6|United States||Study Region||Participants|Number|45|45.0||||||
4216549|NCT00712725|4039908|B5|United States||Study Region||Participants|Number|39|39.0||||||
4216550|NCT00712725|4039909|B4|United States||Study Region||Participants|Number|30|30.0||||||
4216551|NCT00712725|4039910|B3|United States||Study Region||Participants|Number|22|22.0||||||
4216552|NCT00712725|4039911|B2|United States||Study Region||Participants|Number|14|14.0||||||
4216553|NCT00712725|4039912|B1|United States||Study Region||Participants|Number|66|66.0||||||
4216554|NCT00712725|4039904|B9|Multi-Racial||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4216555|NCT00712725|4039905|B8|Multi-Racial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4216556|NCT00712725|4039906|B7|Multi-Racial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4216557|NCT00712725|4039907|B6|Multi-Racial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4216558|NCT00712725|4039908|B5|Multi-Racial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4216559|NCT00712725|4039909|B4|Multi-Racial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4216560|NCT00712725|4039910|B3|Multi-Racial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4216561|NCT00712725|4039911|B2|Multi-Racial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4216562|NCT00712725|4039912|B1|Multi-Racial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4216563|NCT00712725|4039904|B9|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4216564|NCT00712725|4039905|B8|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4216565|NCT00712725|4039906|B7|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4216566|NCT00712725|4039907|B6|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4216567|NCT00712725|4039908|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4216568|NCT00712725|4039909|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4216569|NCT00712725|4039910|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4216570|NCT00712725|4039911|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4216571|NCT00712725|4039912|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4216572|NCT00712725|4039904|B9|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4216573|NCT00712725|4039905|B8|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4216574|NCT00712725|4039906|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4216575|NCT00712725|4039907|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4216576|NCT00712725|4039908|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4216577|NCT00712725|4039909|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4216578|NCT00712725|4039910|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4216579|NCT00712725|4039911|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4216580|NCT00712725|4039912|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4216581|NCT00712725|4039904|B9|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4216582|NCT00712725|4039905|B8|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4216583|NCT00712725|4039906|B7|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4216584|NCT00712725|4039907|B6|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4216585|NCT00712725|4039908|B5|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4216586|NCT00712725|4039909|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4216587|NCT00712725|4039910|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4216588|NCT00712725|4039911|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4216589|NCT00712725|4039912|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4216590|NCT00712725|4039904|B9|Black||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4216591|NCT00712725|4039905|B8|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4216592|NCT00712725|4039906|B7|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4216593|NCT00712725|4039907|B6|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4216594|NCT00712725|4039908|B5|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4216595|NCT00712725|4039909|B4|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4216596|NCT00712725|4039910|B3|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4216597|NCT00712725|4039911|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4216598|NCT00712725|4039912|B1|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4216599|NCT00712725|4039904|B9|White||Race/Ethnicity, Customized||participants|Number|517|517.0||||||
4216600|NCT00712725|4039905|B8|White||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
4216601|NCT00712725|4039906|B7|White||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
4216602|NCT00712725|4039907|B6|White||Race/Ethnicity, Customized||participants|Number|64|64.0||||||
4216603|NCT00712725|4039908|B5|White||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
4216604|NCT00712725|4039909|B4|White||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
4216605|NCT00712725|4039910|B3|White||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4216606|NCT00712725|4039911|B2|White||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4216607|NCT00712725|4039912|B1|White||Race/Ethnicity, Customized||participants|Number|132|132.0||||||
4216608|NCT00712725|4039904|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4216609|NCT00712725|4039905|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4216610|NCT00712725|4039906|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4216611|NCT00712725|4039907|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4216612|NCT00712725|4039908|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4216613|NCT00712725|4039909|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4216614|NCT00712725|4039910|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4216615|NCT00712725|4039911|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4216616|NCT00712725|4039912|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4216617|NCT00712725|4039904|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|478|478.0||||||
4216618|NCT00712725|4039905|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4216619|NCT00712725|4039906|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4216620|NCT00712725|4039907|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4216621|NCT00712725|4039908|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4216622|NCT00712725|4039909|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4216623|NCT00712725|4039910|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4216624|NCT00712725|4039911|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4216625|NCT00712725|4039912|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
4216626|NCT00712725|4039904|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
4216627|NCT00712725|4039905|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4216628|NCT00712725|4039906|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4216629|NCT00712725|4039907|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4216630|NCT00712725|4039908|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4216631|NCT00712725|4039909|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4216632|NCT00712725|4039910|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4216633|NCT00712725|4039911|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4216634|NCT00712725|4039912|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4216635|NCT00712725|4039904|B9||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4216636|NCT00712725|4039905|B8||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4216637|NCT00712725|4039906|B7||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4216638|NCT00712725|4039907|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4216639|NCT00712725|4039908|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4216640|NCT00712725|4039909|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4216641|NCT00712725|4039910|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4216642|NCT00712725|4039911|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4216643|NCT00712725|4039912|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4216644|NCT00712725|4039904|B9||Female|Sex: Female, Male||Participants|Count of Participants|476|476.0||||||
4216645|NCT00712725|4039905|B8||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4216646|NCT00712725|4039906|B7||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4216647|NCT00712725|4039907|B6||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4216648|NCT00712725|4039908|B5||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4216649|NCT00712725|4039909|B4||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4216650|NCT00712725|4039910|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4216651|NCT00712725|4039911|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4216652|NCT00712725|4039912|B1||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4216653|NCT00712725|4039904|B9|||Age||years|Mean|42.7|42.7|Standard Deviation|10.9|10.9|||
4216654|NCT00712725|4039905|B8|||Age||years|Mean|40.5|40.5|Standard Deviation|10.7|10.7|||
4216655|NCT00712725|4039906|B7|||Age||years|Mean|42.2|42.2|Standard Deviation|10.9|10.9|||
4216656|NCT00712725|4039907|B6|||Age||years|Mean|42.2|42.2|Standard Deviation|10.8|10.8|||
4216657|NCT00712725|4039908|B5|||Age||years|Mean|44.1|44.1|Standard Deviation|11.3|11.3|||
4216658|NCT00712725|4039909|B4|||Age||years|Mean|44.1|44.1|Standard Deviation|10.0|10.0|||
4216659|NCT00712725|4039910|B3|||Age||years|Mean|43.4|43.4|Standard Deviation|11.1|11.1|||
4216660|NCT00712725|4039911|B2|||Age||years|Mean|43.3|43.3|Standard Deviation|10.5|10.5|||
4216661|NCT00712725|4039912|B1|||Age||years|Mean|42.1|42.1|Standard Deviation|11.2|11.2|||
4216662|NCT00712673|4039977|B4|||Metformin Daily Dose||milligram (mg)|Mean|1967.10|1967.1|Standard Deviation|430.22|430.22|||
4216663|NCT00712673|4039978|B3|||Metformin Daily Dose||milligram (mg)|Mean|1942.65|1942.65|Standard Deviation|406.17|406.17|||
4216664|NCT00712673|4039979|B2|||Metformin Daily Dose||milligram (mg)|Mean|1968.82|1968.82|Standard Deviation|446.99|446.99|||
4216665|NCT00712673|4039980|B1|||Metformin Daily Dose||milligram (mg)|Mean|2001.18|2001.18|Standard Deviation|439.70|439.7|||
4216666|NCT00712673|4039977|B4|||Duration of Metformin Treatment||years|Mean|3.61|3.61|Standard Deviation|3.59|3.59|||
4216667|NCT00712673|4039978|B3|||Duration of Metformin Treatment||years|Mean|3.68|3.68|Standard Deviation|3.90|3.9|||
4216668|NCT00712673|4039979|B2|||Duration of Metformin Treatment||years|Mean|3.73|3.73|Standard Deviation|3.34|3.34|||
4216669|NCT00712673|4039980|B1|||Duration of Metformin Treatment||years|Mean|3.34|3.34|Standard Deviation|3.45|3.45|||
4216670|NCT00712673|4039977|B4|||Duration of Diabetes||years|Mean|6.11|6.11|Standard Deviation|5.17|5.17|0.8|52.1|
4216671|NCT00712673|4039978|B3|||Duration of Diabetes||years|Mean|6.21|6.21|Standard Deviation|5.40|5.4|||
4216672|NCT00712673|4039979|B2|||Duration of Diabetes||years|Mean|6.18|6.18|Standard Deviation|5.25|5.25|||
4216673|NCT00712673|4039980|B1|||Duration of Diabetes||years|Mean|5.87|5.87|Standard Deviation|4.72|4.72|||
4216674|NCT00712673|4039977|B4|||Body Mass Index (BMI)|BMI was calculated by dividing body weight by the height squared.|kilogram per square meter (kg/m^2)|Mean|32.91|32.91|Standard Deviation|6.36|6.36|||
4216675|NCT00712673|4039978|B3|||Body Mass Index (BMI)|BMI was calculated by dividing body weight by the height squared.|kilogram per square meter (kg/m^2)|Mean|32.47|32.47|Standard Deviation|5.77|5.77|||
4216676|NCT00712673|4039979|B2|||Body Mass Index (BMI)|BMI was calculated by dividing body weight by the height squared.|kilogram per square meter (kg/m^2)|Mean|33.22|33.22|Standard Deviation|6.85|6.85|||
4216677|NCT00712673|4039980|B1|||Body Mass Index (BMI)|BMI was calculated by dividing body weight by the height squared.|kilogram per square meter (kg/m^2)|Mean|33.12|33.12|Standard Deviation|6.45|6.45|||
4216678|NCT00712673|4039977|B4|||Glucose Excursion|Number of patients analyzed = 168, 252 and 252 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|mmol/L|Mean|5.87|5.87|Standard Deviation|3.04|3.04|||
4216679|NCT00712673|4039978|B3|||Glucose Excursion|Number of patients analyzed = 168, 252 and 252 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|mmol/L|Mean|5.80|5.8|Standard Deviation|3.13|3.13|||
4216680|NCT00712673|4039979|B2|||Glucose Excursion|Number of patients analyzed = 168, 252 and 252 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|mmol/L|Mean|6.09|6.09|Standard Deviation|3.09|3.09|||
4216681|NCT00712673|4039980|B1|||Glucose Excursion|Number of patients analyzed = 168, 252 and 252 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|mmol/L|Mean|5.64|5.64|Standard Deviation|2.81|2.81|||
4216682|NCT00712673|4039977|B4|||2-hour Postprandial Proinsulin|Number of patients analyzed = 139, 204 and 213 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|pmol/L|Mean|81.15|81.15|Standard Deviation|55.05|55.05|||
4216683|NCT00712673|4039978|B3|||2-hour Postprandial Proinsulin|Number of patients analyzed = 139, 204 and 213 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|pmol/L|Mean|77.19|77.19|Standard Deviation|53.44|53.44|||
4216684|NCT00712673|4039979|B2|||2-hour Postprandial Proinsulin|Number of patients analyzed = 139, 204 and 213 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|pmol/L|Mean|83.71|83.71|Standard Deviation|54.65|54.65|||
4216685|NCT00712673|4039980|B1|||2-hour Postprandial Proinsulin|Number of patients analyzed = 139, 204 and 213 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|pmol/L|Mean|83.48|83.48|Standard Deviation|58.02|58.02|||
4216686|NCT00712673|4039977|B4|||Fasting Proinsulin|Number of patients analyzed = 142, 223 and 226 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|pmol/L|Mean|33.16|33.16|Standard Deviation|21.16|21.16|||
4216687|NCT00712673|4039978|B3|||Fasting Proinsulin|Number of patients analyzed = 142, 223 and 226 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|pmol/L|Mean|32.35|32.35|Standard Deviation|18.45|18.45|||
4216688|NCT00712673|4039979|B2|||Fasting Proinsulin|Number of patients analyzed = 142, 223 and 226 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|pmol/L|Mean|34.93|34.93|Standard Deviation|24.14|24.14|||
4216689|NCT00712673|4039980|B1|||Fasting Proinsulin|Number of patients analyzed = 142, 223 and 226 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|pmol/L|Mean|31.68|31.68|Standard Deviation|20.10|20.1|||
4216690|NCT00712673|4039977|B4|||2-hour Postprandial Glucagon|Number of patients analyzed = 163, 241 and 248 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|ng/L|Mean|101.21|101.21|Standard Deviation|34.17|34.17|||
4216691|NCT00712673|4039978|B3|||2-hour Postprandial Glucagon|Number of patients analyzed = 163, 241 and 248 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|ng/L|Mean|100.90|100.9|Standard Deviation|34.12|34.12|||
4216692|NCT00712673|4039979|B2|||2-hour Postprandial Glucagon|Number of patients analyzed = 163, 241 and 248 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|ng/L|Mean|101.46|101.46|Standard Deviation|34.54|34.54|||
4216693|NCT00712673|4039980|B1|||2-hour Postprandial Glucagon|Number of patients analyzed = 163, 241 and 248 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|ng/L|Mean|101.30|101.3|Standard Deviation|33.88|33.88|||
4216694|NCT00712673|4039977|B4|||Fasting Glucagon|Number of patients analyzed = 162, 242 and 247 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|nanogram per liter (ng/L)|Mean|88.51|88.51|Standard Deviation|29.88|29.88|||
4216695|NCT00712673|4039978|B3|||Fasting Glucagon|Number of patients analyzed = 162, 242 and 247 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|nanogram per liter (ng/L)|Mean|88.53|88.53|Standard Deviation|27.30|27.3|||
4216696|NCT00712673|4039979|B2|||Fasting Glucagon|Number of patients analyzed = 162, 242 and 247 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|nanogram per liter (ng/L)|Mean|88.89|88.89|Standard Deviation|32.90|32.9|||
4216697|NCT00712673|4039980|B1|||Fasting Glucagon|Number of patients analyzed = 162, 242 and 247 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|nanogram per liter (ng/L)|Mean|87.92|87.92|Standard Deviation|29.05|29.05|||
4216698|NCT00712673|4039977|B4|||2-hour Postprandial C-peptide|Number of patients analyzed = 166, 251 and 249 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|nmol/L|Mean|2.48|2.48|Standard Deviation|1.12|1.12|||
4216699|NCT00712673|4039978|B3|||2-hour Postprandial C-peptide|Number of patients analyzed = 166, 251 and 249 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|nmol/L|Mean|2.42|2.42|Standard Deviation|1.16|1.16|||
4216700|NCT00712673|4039979|B2|||2-hour Postprandial C-peptide|Number of patients analyzed = 166, 251 and 249 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|nmol/L|Mean|2.56|2.56|Standard Deviation|1.11|1.11|||
4216769|NCT00712673|4039980|B1||Female|Gender||Participants|Count of Participants|89|89.0||||||
4216770|NCT00712673|4039977|B4|||Age||years|Mean|54.7|54.7|Standard Deviation|9.7|9.7|||
4216701|NCT00712673|4039980|B1|||2-hour Postprandial C-peptide|Number of patients analyzed = 166, 251 and 249 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|nmol/L|Mean|2.46|2.46|Standard Deviation|1.08|1.08|||
4216702|NCT00712673|4039977|B4|||Fasting C-peptide|Number of patients analyzed = 164, 252 and 249 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|nanomole per liter (nmol/L)|Mean|0.94|0.94|Standard Deviation|0.41|0.41|||
4216703|NCT00712673|4039978|B3|||Fasting C-peptide|Number of patients analyzed = 164, 252 and 249 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|nanomole per liter (nmol/L)|Mean|0.94|0.94|Standard Deviation|0.43|0.43|||
4216704|NCT00712673|4039979|B2|||Fasting C-peptide|Number of patients analyzed = 164, 252 and 249 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|nanomole per liter (nmol/L)|Mean|0.97|0.97|Standard Deviation|0.43|0.43|||
4216705|NCT00712673|4039980|B1|||Fasting C-peptide|Number of patients analyzed = 164, 252 and 249 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|nanomole per liter (nmol/L)|Mean|0.90|0.9|Standard Deviation|0.36|0.36|||
4216706|NCT00712673|4039977|B4|||2-hour Postprandial Plasma Insulin (PPI)|Number of patients analyzed = 151, 232 and 240 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|pmol/L|Mean|378.30|378.3|Standard Deviation|289.51|289.51|||
4216707|NCT00712673|4039978|B3|||2-hour Postprandial Plasma Insulin (PPI)|Number of patients analyzed = 151, 232 and 240 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|pmol/L|Mean|378.67|378.67|Standard Deviation|328.19|328.19|||
4216708|NCT00712673|4039979|B2|||2-hour Postprandial Plasma Insulin (PPI)|Number of patients analyzed = 151, 232 and 240 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|pmol/L|Mean|380.53|380.53|Standard Deviation|260.96|260.96|||
4216709|NCT00712673|4039980|B1|||2-hour Postprandial Plasma Insulin (PPI)|Number of patients analyzed = 151, 232 and 240 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|pmol/L|Mean|374.28|374.28|Standard Deviation|266.55|266.55|||
4216710|NCT00712673|4039977|B4|||Fasting Plasma Insulin (FPI)|Number of patients analyzed = 168, 251 and 253 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|picomole per liter (pmol/L)|Mean|79.53|79.53|Standard Deviation|60.84|60.84|||
4216711|NCT00712673|4039978|B3|||Fasting Plasma Insulin (FPI)|Number of patients analyzed = 168, 251 and 253 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|picomole per liter (pmol/L)|Mean|77.90|77.9|Standard Deviation|65.46|65.46|||
4216712|NCT00712673|4039979|B2|||Fasting Plasma Insulin (FPI)|Number of patients analyzed = 168, 251 and 253 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|picomole per liter (pmol/L)|Mean|83.68|83.68|Standard Deviation|63.60|63.6|||
4216713|NCT00712673|4039980|B1|||Fasting Plasma Insulin (FPI)|Number of patients analyzed = 168, 251 and 253 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|picomole per liter (pmol/L)|Mean|75.79|75.79|Standard Deviation|48.02|48.02|||
4216714|NCT00712673|4039977|B4|||Adiponectin|Number of patients analyzed = 164, 248 and 248 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|microgram per milliliter (mcg/mL)|Mean|5.34|5.34|Standard Deviation|3.01|3.01|||
4216715|NCT00712673|4039978|B3|||Adiponectin|Number of patients analyzed = 164, 248 and 248 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|microgram per milliliter (mcg/mL)|Mean|5.25|5.25|Standard Deviation|2.93|2.93|||
4216716|NCT00712673|4039979|B2|||Adiponectin|Number of patients analyzed = 164, 248 and 248 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|microgram per milliliter (mcg/mL)|Mean|5.25|5.25|Standard Deviation|2.90|2.9|||
4216717|NCT00712673|4039980|B1|||Adiponectin|Number of patients analyzed = 164, 248 and 248 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|microgram per milliliter (mcg/mL)|Mean|5.61|5.61|Standard Deviation|3.26|3.26|||
4216718|NCT00712673|4039977|B4|||Homeostasis Model Assessment for Beta-cell Function (HOMA-beta)|Beta cell function was assessed by HOMA-beta. HOMA-beta (% of normal beta cells function) = (20 multiplied by fasting plasma insulin [micro unit per milliliter]) divided by (fasting plasma glucose [mmol/L] minus 3.5). Number of patients analyzed = 168, 251 and 252 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|percentage of normal beta cells function|Mean|43.38|43.38|Standard Deviation|40.38|40.38|||
4216719|NCT00712673|4039978|B3|||Homeostasis Model Assessment for Beta-cell Function (HOMA-beta)|Beta cell function was assessed by HOMA-beta. HOMA-beta (% of normal beta cells function) = (20 multiplied by fasting plasma insulin [micro unit per milliliter]) divided by (fasting plasma glucose [mmol/L] minus 3.5). Number of patients analyzed = 168, 251 and 252 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|percentage of normal beta cells function|Mean|45.21|45.21|Standard Deviation|46.09|46.09|||
4216720|NCT00712673|4039979|B2|||Homeostasis Model Assessment for Beta-cell Function (HOMA-beta)|Beta cell function was assessed by HOMA-beta. HOMA-beta (% of normal beta cells function) = (20 multiplied by fasting plasma insulin [micro unit per milliliter]) divided by (fasting plasma glucose [mmol/L] minus 3.5). Number of patients analyzed = 168, 251 and 252 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|percentage of normal beta cells function|Mean|42.82|42.82|Standard Deviation|32.33|32.33|||
4216771|NCT00712673|4039978|B3|||Age||years|Mean|54.8|54.8|Standard Deviation|10.4|10.4|||
4216772|NCT00712673|4039979|B2|||Age||years|Mean|54.5|54.5|Standard Deviation|9.2|9.2|||
4216773|NCT00712673|4039980|B1|||Age||years|Mean|55.0|55.0|Standard Deviation|9.4|9.4|||
4216774|NCT00712543|4040045|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4216721|NCT00712673|4039980|B1|||Homeostasis Model Assessment for Beta-cell Function (HOMA-beta)|Beta cell function was assessed by HOMA-beta. HOMA-beta (% of normal beta cells function) = (20 multiplied by fasting plasma insulin [micro unit per milliliter]) divided by (fasting plasma glucose [mmol/L] minus 3.5). Number of patients analyzed = 168, 251 and 252 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|percentage of normal beta cells function|Mean|41.48|41.48|Standard Deviation|42.12|42.12|||
4216722|NCT00712673|4039977|B4|||Body Weight||kilogram (kg)|Mean|89.71|89.71|Standard Deviation|20.70|20.7|||
4216723|NCT00712673|4039978|B3|||Body Weight||kilogram (kg)|Mean|89.05|89.05|Standard Deviation|20.74|20.74|||
4216724|NCT00712673|4039979|B2|||Body Weight||kilogram (kg)|Mean|90.09|90.09|Standard Deviation|21.10|21.1|||
4216725|NCT00712673|4039980|B1|||Body Weight||kilogram (kg)|Mean|90.15|90.15|Standard Deviation|20.14|20.14|||
4216726|NCT00712673|4039977|B4|||2-hour Postprandial Plasma Glucose (PPG)|Number of patients analyzed = 169, 253 and 252 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|mmol/L|Mean|15.53|15.53|Standard Deviation|3.86|3.86|||
4216727|NCT00712673|4039978|B3|||2-hour Postprandial Plasma Glucose (PPG)|Number of patients analyzed = 169, 253 and 252 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|mmol/L|Mean|15.46|15.46|Standard Deviation|4.03|4.03|||
4216728|NCT00712673|4039979|B2|||2-hour Postprandial Plasma Glucose (PPG)|Number of patients analyzed = 169, 253 and 252 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|mmol/L|Mean|15.62|15.62|Standard Deviation|3.97|3.97|||
4216729|NCT00712673|4039980|B1|||2-hour Postprandial Plasma Glucose (PPG)|Number of patients analyzed = 169, 253 and 252 for Placebo (Combined), Lixisenatide (Morning Injection) and Lixisenatide (Evening Injection) treatment arms, respectively.|mmol/L|Mean|15.51|15.51|Standard Deviation|3.43|3.43|||
4216730|NCT00712673|4039977|B4|||Fasting Plasma Glucose (FPG)||millimole per liter (mmol/L)|Mean|9.40|9.4|Standard Deviation|2.22|2.22|||
4216731|NCT00712673|4039978|B3|||Fasting Plasma Glucose (FPG)||millimole per liter (mmol/L)|Mean|9.31|9.31|Standard Deviation|2.25|2.25|||
4216732|NCT00712673|4039979|B2|||Fasting Plasma Glucose (FPG)||millimole per liter (mmol/L)|Mean|9.43|9.43|Standard Deviation|2.15|2.15|||
4216733|NCT00712673|4039980|B1|||Fasting Plasma Glucose (FPG)||millimole per liter (mmol/L)|Mean|9.51|9.51|Standard Deviation|2.28|2.28|||
4216734|NCT00712673|4039977|B4|||Glycosylated Hemoglobin (HbA1c)||percentage of hemoglobin|Mean|8.06|8.06|Standard Deviation|0.89|0.89|||
4216735|NCT00712673|4039978|B3|||Glycosylated Hemoglobin (HbA1c)||percentage of hemoglobin|Mean|8.09|8.09|Standard Deviation|0.91|0.91|||
4216736|NCT00712673|4039979|B2|||Glycosylated Hemoglobin (HbA1c)||percentage of hemoglobin|Mean|8.04|8.04|Standard Deviation|0.86|0.86|||
4216737|NCT00712673|4039980|B1|||Glycosylated Hemoglobin (HbA1c)||percentage of hemoglobin|Mean|8.06|8.06|Standard Deviation|0.90|0.9|||
4216738|NCT00712673|4039977|B4|Ethnicity: Non Hispanic||Race/Ethnicity, Customized||participants|Number|437|437.0||||||
4216739|NCT00712673|4039978|B3|Ethnicity: Non Hispanic||Race/Ethnicity, Customized||participants|Number|157|157.0||||||
4216740|NCT00712673|4039979|B2|Ethnicity: Non Hispanic||Race/Ethnicity, Customized||participants|Number|159|159.0||||||
4216741|NCT00712673|4039980|B1|Ethnicity: Non Hispanic||Race/Ethnicity, Customized||participants|Number|121|121.0||||||
4216742|NCT00712673|4039977|B4|Ethnicity: Hispanic||Race/Ethnicity, Customized||participants|Number|243|243.0||||||
4216743|NCT00712673|4039978|B3|Ethnicity: Hispanic||Race/Ethnicity, Customized||participants|Number|98|98.0||||||
4216744|NCT00712673|4039979|B2|Ethnicity: Hispanic||Race/Ethnicity, Customized||participants|Number|96|96.0||||||
4216745|NCT00712673|4039980|B1|Ethnicity: Hispanic||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4216746|NCT00712673|4039977|B4|Race: Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4216747|NCT00712673|4039978|B3|Race: Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4216748|NCT00712673|4039979|B2|Race: Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4216749|NCT00712673|4039980|B1|Race: Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4216750|NCT00712673|4039977|B4|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
4216751|NCT00712673|4039978|B3|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4216752|NCT00712673|4039979|B2|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4216753|NCT00712673|4039980|B1|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4216754|NCT00712673|4039977|B4|Race: Black||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4216755|NCT00712673|4039978|B3|Race: Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4216756|NCT00712673|4039979|B2|Race: Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4216757|NCT00712673|4039980|B1|Race: Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4216758|NCT00712673|4039977|B4|Race: Caucasian/White||Race/Ethnicity, Customized||participants|Number|604|604.0||||||
4216759|NCT00712673|4039978|B3|Race: Caucasian/White||Race/Ethnicity, Customized||participants|Number|228|228.0||||||
4216760|NCT00712673|4039979|B2|Race: Caucasian/White||Race/Ethnicity, Customized||participants|Number|221|221.0||||||
4216761|NCT00712673|4039980|B1|Race: Caucasian/White||Race/Ethnicity, Customized||participants|Number|155|155.0||||||
4216762|NCT00712673|4039977|B4||Male|Gender||Participants|Count of Participants|293|293.0||||||
4216763|NCT00712673|4039978|B3||Male|Gender||Participants|Count of Participants|114|114.0||||||
4216764|NCT00712673|4039979|B2||Male|Gender||Participants|Count of Participants|98|98.0||||||
4216765|NCT00712673|4039980|B1||Male|Gender||Participants|Count of Participants|81|81.0||||||
4216766|NCT00712673|4039977|B4||Female|Gender||Participants|Count of Participants|387|387.0||||||
4216767|NCT00712673|4039978|B3||Female|Gender||Participants|Count of Participants|141|141.0||||||
4216768|NCT00712673|4039979|B2||Female|Gender||Participants|Count of Participants|157|157.0||||||
4216775|NCT00712543|4040046|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4216776|NCT00712543|4040047|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4216777|NCT00712543|4040045|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4216778|NCT00712543|4040046|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4216779|NCT00712543|4040047|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4216780|NCT00712543|4040045|B3|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4216781|NCT00712543|4040046|B2|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4216782|NCT00712543|4040047|B1|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4216783|NCT00712543|4040045|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4216784|NCT00712543|4040046|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4216785|NCT00712543|4040047|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4216786|NCT00712543|4040045|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4216787|NCT00712543|4040046|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4216788|NCT00712543|4040047|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4216789|NCT00712543|4040045|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4216790|NCT00712543|4040046|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4216791|NCT00712543|4040047|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4216792|NCT00712543|4040045|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4216793|NCT00712543|4040046|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4216794|NCT00712543|4040047|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4216795|NCT00712543|4040045|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4216796|NCT00712543|4040046|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4216797|NCT00712543|4040047|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4216798|NCT00712543|4040045|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4216799|NCT00712543|4040046|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4216800|NCT00712543|4040047|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4216801|NCT00712543|4040045|B3|||Age, Customized||years|Mean|48.61|48.61|Standard Deviation|14.95|14.95|||
4216802|NCT00712543|4040046|B2|||Age, Customized||years|Mean|52.37|52.37|Standard Deviation|15.71|15.71|||
4216803|NCT00712543|4040047|B1|||Age, Customized||years|Mean|44.02|44.02|Standard Deviation|13.37|13.37|||
4216804|NCT00712530|4040054|B4|Hungary||Region of Enrollment||participants|Number|9|9.0||||||
4216805|NCT00712530|4040055|B3|Hungary||Region of Enrollment||participants|Number|3|3.0||||||
4216806|NCT00712530|4040056|B2|Hungary||Region of Enrollment||participants|Number|3|3.0||||||
4216807|NCT00712530|4040057|B1|Hungary||Region of Enrollment||participants|Number|3|3.0||||||
4216808|NCT00712530|4040054|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4216809|NCT00712530|4040055|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4216810|NCT00712530|4040056|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4216811|NCT00712530|4040057|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4216812|NCT00712530|4040054|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4216813|NCT00712530|4040055|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4216814|NCT00712530|4040056|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4216815|NCT00712530|4040057|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4216816|NCT00712530|4040054|B4|||Age||years|Mean|38|38.0|Standard Deviation|7.4|7.4|||
4216817|NCT00712530|4040055|B3|||Age||years|Mean|36|36.0|Standard Deviation|9.0|9.0|||
4216818|NCT00712530|4040056|B2|||Age||years|Mean|34|34.0|Standard Deviation|4.0|4.0|||
4216819|NCT00712530|4040057|B1|||Age||years|Mean|45|45.0|Standard Deviation|4.3|4.3|||
4216820|NCT00712530|4040054|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4216821|NCT00712530|4040055|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4216822|NCT00712530|4040056|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4216823|NCT00712530|4040057|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4216824|NCT00712530|4040054|B4||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4216825|NCT00712530|4040055|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4216826|NCT00712530|4040056|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4216827|NCT00712530|4040057|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4216828|NCT00712530|4040054|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4216829|NCT00712530|4040055|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4216830|NCT00712530|4040056|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4216831|NCT00712530|4040057|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4216832|NCT00712348|4040082|B1|UNREPORTED||Religion||participants|Number|2|2.0||||||
4216833|NCT00712348|4040082|B1|NON JEWISH||Religion||participants|Number|15|15.0||||||
4216834|NCT00712348|4040082|B1|JEWISH - NONASHKENAZI||Religion||participants|Number|0|0.0||||||
4216835|NCT00712348|4040082|B1|JEWISH - ASHKENAZI||Religion||participants|Number|14|14.0||||||
4216836|NCT00712348|4040082|B1|Singapore||Region of Enrollment||participants|Number|1|1.0||||||
4216837|NCT00712348|4040082|B1|Serbia||Region of Enrollment||participants|Number|4|4.0||||||
4216838|NCT00712348|4040082|B1|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4216839|NCT00712348|4040082|B1|Israel||Region of Enrollment||participants|Number|9|9.0||||||
4216840|NCT00712348|4040082|B1|Australia||Region of Enrollment||participants|Number|3|3.0||||||
4216841|NCT00712348|4040082|B1|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4216842|NCT00712348|4040082|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4216843|NCT00712348|4040082|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4216844|NCT00712348|4040082|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4216845|NCT00712348|4040082|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4216846|NCT00712348|4040082|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4216847|NCT00712348|4040082|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4216848|NCT00712348|4040082|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4216849|NCT00712348|4040082|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4216850|NCT00712348|4040082|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4216851|NCT00712348|4040082|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4216852|NCT00712348|4040082|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4216853|NCT00712348|4040082|B1|||Age||years|Mean|41.6|41.6|Standard Deviation|17.4|17.4|||
4216854|NCT00712348|4040082|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4216855|NCT00712348|4040082|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4216856|NCT00712348|4040082|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4216857|NCT00712335|4040089|B6|Korea, Republic of||Region of Enrollment||participants|Number|105|105.0||||||
4216858|NCT00712335|4040090|B5|Korea, Republic of||Region of Enrollment||participants|Number|30|30.0||||||
4216859|NCT00712335|4040091|B4|Korea, Republic of||Region of Enrollment||participants|Number|24|24.0||||||
4216860|NCT00712335|4040092|B3|Korea, Republic of||Region of Enrollment||participants|Number|11|11.0||||||
4216861|NCT00712335|4040093|B2|Korea, Republic of||Region of Enrollment||participants|Number|32|32.0||||||
4216862|NCT00712335|4040094|B1|Korea, Republic of||Region of Enrollment||participants|Number|8|8.0||||||
4216863|NCT00712335|4040089|B6||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4216864|NCT00712335|4040090|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4216865|NCT00712335|4040091|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4216866|NCT00712335|4040092|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4216867|NCT00712335|4040093|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4216868|NCT00712335|4040094|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4216869|NCT00712335|4040089|B6||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4216870|NCT00712335|4040090|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4216871|NCT00712335|4040091|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4216872|NCT00712335|4040092|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4216873|NCT00712335|4040093|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4216874|NCT00712335|4040094|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4216875|NCT00712335|4040089|B6|||Age||years|Mean|40.09|40.09|Standard Deviation|4.24|4.24|||
4216876|NCT00712335|4040090|B5|||Age||years|Mean|40.55|40.55|Standard Deviation|11.35|11.35|||
4216877|NCT00712335|4040091|B4|||Age||years|Mean|39.00|39.0|Standard Deviation|14.79|14.79|||
4216878|NCT00712335|4040092|B3|||Age||years|Mean|45.64|45.64|Standard Deviation|17.46|17.46|||
4216879|NCT00712335|4040093|B2|||Age||years|Mean|36.03|36.03|Standard Deviation|8.52|8.52|||
4216880|NCT00712335|4040094|B1|||Age||years|Mean|51.38|51.38|Standard Deviation|11.41|11.41|||
4216881|NCT00712335|4040089|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4216882|NCT00712335|4040090|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4216883|NCT00712335|4040091|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4216884|NCT00712335|4040092|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4216885|NCT00712335|4040093|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4216886|NCT00712335|4040094|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4216887|NCT00712335|4040089|B6||Between 18 and 65 years|Age||Participants|Count of Participants|105|105.0||||||
4216888|NCT00712335|4040090|B5||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4216889|NCT00712335|4040091|B4||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4216890|NCT00712335|4040092|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4216891|NCT00712335|4040093|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4216892|NCT00712335|4040094|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4216893|NCT00712335|4040089|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4216894|NCT00712335|4040090|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4216895|NCT00712335|4040091|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4216896|NCT00712335|4040092|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4216897|NCT00712335|4040093|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4216898|NCT00712335|4040094|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4216899|NCT00712244|4040152|B5|Male||Gender|Gender not available for 2 DisCoVisc subjects, 1 Duovisc subject, and 1 AmVisc Plus subject.|participants|Number|40|40.0||||||
4216900|NCT00712244|4040153|B4|Male||Gender|Gender not available for 2 DisCoVisc subjects, 1 Duovisc subject, and 1 AmVisc Plus subject.|participants|Number|7|7.0||||||
4216901|NCT00712244|4040154|B3|Male||Gender|Gender not available for 2 DisCoVisc subjects, 1 Duovisc subject, and 1 AmVisc Plus subject.|participants|Number|11|11.0||||||
4216902|NCT00712244|4040155|B2|Male||Gender|Gender not available for 2 DisCoVisc subjects, 1 Duovisc subject, and 1 AmVisc Plus subject.|participants|Number|12|12.0||||||
4216903|NCT00712244|4040156|B1|Male||Gender|Gender not available for 2 DisCoVisc subjects, 1 Duovisc subject, and 1 AmVisc Plus subject.|participants|Number|10|10.0||||||
4216904|NCT00712244|4040152|B5|Female||Gender|Gender not available for 2 DisCoVisc subjects, 1 Duovisc subject, and 1 AmVisc Plus subject.|participants|Number|68|68.0||||||
4216905|NCT00712244|4040153|B4|Female||Gender|Gender not available for 2 DisCoVisc subjects, 1 Duovisc subject, and 1 AmVisc Plus subject.|participants|Number|19|19.0||||||
4216906|NCT00712244|4040154|B3|Female||Gender|Gender not available for 2 DisCoVisc subjects, 1 Duovisc subject, and 1 AmVisc Plus subject.|participants|Number|16|16.0||||||
4216907|NCT00712244|4040155|B2|Female||Gender|Gender not available for 2 DisCoVisc subjects, 1 Duovisc subject, and 1 AmVisc Plus subject.|participants|Number|15|15.0||||||
4216908|NCT00712244|4040156|B1|Female||Gender|Gender not available for 2 DisCoVisc subjects, 1 Duovisc subject, and 1 AmVisc Plus subject.|participants|Number|18|18.0||||||
4216909|NCT00712244|4040152|B5|>=65 years||Age|Age data not available for 2 DisCoVisc subjects, 2 Duovisc subjects, and 1 AmVisc Plus subject.|participants|Number|67|67.0||||||
4216910|NCT00712244|4040153|B4|>=65 years||Age|Age data not available for 2 DisCoVisc subjects, 2 Duovisc subjects, and 1 AmVisc Plus subject.|participants|Number|18|18.0||||||
4216911|NCT00712244|4040154|B3|>=65 years||Age|Age data not available for 2 DisCoVisc subjects, 2 Duovisc subjects, and 1 AmVisc Plus subject.|participants|Number|18|18.0||||||
4216912|NCT00712244|4040155|B2|>=65 years||Age|Age data not available for 2 DisCoVisc subjects, 2 Duovisc subjects, and 1 AmVisc Plus subject.|participants|Number|15|15.0||||||
4216913|NCT00712244|4040156|B1|>=65 years||Age|Age data not available for 2 DisCoVisc subjects, 2 Duovisc subjects, and 1 AmVisc Plus subject.|participants|Number|16|16.0||||||
4216914|NCT00712244|4040152|B5|Between 18 and 65 years||Age|Age data not available for 2 DisCoVisc subjects, 2 Duovisc subjects, and 1 AmVisc Plus subject.|participants|Number|41|41.0||||||
4216915|NCT00712244|4040153|B4|Between 18 and 65 years||Age|Age data not available for 2 DisCoVisc subjects, 2 Duovisc subjects, and 1 AmVisc Plus subject.|participants|Number|8|8.0||||||
4216916|NCT00712244|4040154|B3|Between 18 and 65 years||Age|Age data not available for 2 DisCoVisc subjects, 2 Duovisc subjects, and 1 AmVisc Plus subject.|participants|Number|9|9.0||||||
4216917|NCT00712244|4040155|B2|Between 18 and 65 years||Age|Age data not available for 2 DisCoVisc subjects, 2 Duovisc subjects, and 1 AmVisc Plus subject.|participants|Number|12|12.0||||||
4216918|NCT00712244|4040156|B1|Between 18 and 65 years||Age|Age data not available for 2 DisCoVisc subjects, 2 Duovisc subjects, and 1 AmVisc Plus subject.|participants|Number|12|12.0||||||
4216919|NCT00712244|4040152|B5|<=18 years||Age|Age data not available for 2 DisCoVisc subjects, 2 Duovisc subjects, and 1 AmVisc Plus subject.|participants|Number|0|0.0||||||
4216920|NCT00712244|4040153|B4|<=18 years||Age|Age data not available for 2 DisCoVisc subjects, 2 Duovisc subjects, and 1 AmVisc Plus subject.|participants|Number|0|0.0||||||
4216921|NCT00712244|4040154|B3|<=18 years||Age|Age data not available for 2 DisCoVisc subjects, 2 Duovisc subjects, and 1 AmVisc Plus subject.|participants|Number|0|0.0||||||
4216922|NCT00712244|4040155|B2|<=18 years||Age|Age data not available for 2 DisCoVisc subjects, 2 Duovisc subjects, and 1 AmVisc Plus subject.|participants|Number|0|0.0||||||
4216923|NCT00712244|4040156|B1|<=18 years||Age|Age data not available for 2 DisCoVisc subjects, 2 Duovisc subjects, and 1 AmVisc Plus subject.|participants|Number|0|0.0||||||
4216924|NCT00712179|4040201|B1|||Baseline walking speed||meters per second|Mean|0.59|0.59|Standard Deviation|0.23|0.23|||
4216925|NCT00712179|4040201|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
4216926|NCT00712179|4040201|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4216927|NCT00712179|4040201|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4216928|NCT00712179|4040201|B1|||Age||years|Mean|61.1|61.1|Standard Deviation|11.5|11.5|||
4216929|NCT00712179|4040201|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4216930|NCT00712179|4040201|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4216931|NCT00712179|4040201|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4216932|NCT00712166|4040205|B3|Australia||Region of Enrollment||participants|Number|10|10.0||||||
4216933|NCT00712166|4040206|B2|Australia||Region of Enrollment||participants|Number|4|4.0||||||
4216934|NCT00712166|4040207|B1|Australia||Region of Enrollment||participants|Number|6|6.0||||||
4216935|NCT00712166|4040205|B3|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4216936|NCT00712166|4040206|B2|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4216937|NCT00712166|4040207|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4216938|NCT00712166|4040205|B3|United States||Region of Enrollment||participants|Number|145|145.0||||||
4216939|NCT00712166|4040206|B2|United States||Region of Enrollment||participants|Number|72|72.0||||||
4216940|NCT00712166|4040207|B1|United States||Region of Enrollment||participants|Number|73|73.0||||||
4216941|NCT00712166|4040205|B3||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4216942|NCT00712166|4040206|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4216943|NCT00712166|4040207|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4216944|NCT00712166|4040205|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4216945|NCT00712166|4040206|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4216946|NCT00712166|4040207|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4216947|NCT00712166|4040205|B3|||Age||years|Mean|19.2|19.2|Standard Deviation|9.07|9.07|||
4216948|NCT00712166|4040206|B2|||Age||years|Mean|19.5|19.5|Standard Deviation|9.07|9.07|||
4216949|NCT00712166|4040207|B1|||Age||years|Mean|18.9|18.9|Standard Deviation|9.11|9.11|||
4216950|NCT00712166|4040205|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4216951|NCT00712166|4040206|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4216952|NCT00712166|4040207|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4216953|NCT00712166|4040205|B3||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
4216954|NCT00712166|4040206|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4216955|NCT00712166|4040207|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4216956|NCT00712166|4040205|B3||<=18 years|Age||Participants|Count of Participants|89|89.0||||||
4216957|NCT00712166|4040206|B2||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
4216958|NCT00712166|4040207|B1||<=18 years|Age||Participants|Count of Participants|47|47.0||||||
4216959|NCT00712075|4040232|B4|United States||Region of Enrollment||participants|Number|57|57.0||||||
4216960|NCT00712075|4040233|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4216961|NCT00712075|4040234|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4216962|NCT00712075|4040235|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4216963|NCT00712075|4040232|B4||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4216964|NCT00712075|4040233|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4216965|NCT00712075|4040234|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4216966|NCT00712075|4040235|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4216967|NCT00712075|4040232|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4216968|NCT00712075|4040233|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4216969|NCT00712075|4040234|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4216970|NCT00712075|4040235|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4216971|NCT00712075|4040232|B4|Age 45 and older||Age, Customized||participants|Number|57|57.0||||||
4216972|NCT00712075|4040233|B3|Age 45 and older||Age, Customized||participants|Number|14|14.0||||||
4216973|NCT00712075|4040234|B2|Age 45 and older||Age, Customized||participants|Number|26|26.0||||||
4216974|NCT00712075|4040235|B1|Age 45 and older||Age, Customized||participants|Number|17|17.0||||||
4216975|NCT00712010|4040251|B1|||Body Mass Index (BMI)|BMI is obtained by dividing the weight (kg) by the square height (m2)|kg/m2|Mean|23.5|23.5|Standard Deviation|0.3|0.3|||
4216976|NCT00712010|4040251|B1|||Body weight||kg|Mean|74.2|74.2|Standard Deviation|1.3|1.3|||
4216977|NCT00712010|4040251|B1|Switzerland||Region of Enrollment||participants|Number|25|25.0||||||
4216978|NCT00712010|4040251|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4216979|NCT00712010|4040251|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4216980|NCT00712010|4040251|B1|>=50 years||Age, Customized||participants|Number|0|0.0||||||
4216981|NCT00712010|4040251|B1|Between 20 and 50 years||Age, Customized||participants|Number|25|25.0||||||
4216982|NCT00712010|4040251|B1|<=20 years||Age, Customized||participants|Number|0|0.0||||||
4216983|NCT00712010|4040251|B1|||Age||Years|Mean|28.3|28.3|Standard Deviation|1.5|1.5|||
4216984|NCT00711997|4040274|B3|Israel||Region of Enrollment||participants|Number|8|8.0||||||
4216985|NCT00711997|4040275|B2|Israel||Region of Enrollment||participants|Number|5|5.0||||||
4216986|NCT00711997|4040276|B1|Israel||Region of Enrollment||participants|Number|3|3.0||||||
4216987|NCT00711997|4040274|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4216988|NCT00711997|4040275|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4216989|NCT00711997|4040276|B1|United States||Region of Enrollment||participants|Number|0|0.0||||||
4216990|NCT00711997|4040274|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4216991|NCT00711997|4040275|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4216992|NCT00711997|4040276|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4216993|NCT00711997|4040274|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4216994|NCT00711997|4040275|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4216995|NCT00711997|4040276|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4216996|NCT00711997|4040274|B3|||Age||years|Mean|62|62.0|Standard Deviation|12.3|12.3|||
4216997|NCT00711997|4040275|B2|||Age||years|Mean|60|60.0|Standard Deviation|10|10.0|||
4216998|NCT00711997|4040276|B1|||Age||years|Mean|64|64.0|Standard Deviation|18.3|18.3|||
4216999|NCT00711997|4040274|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4217000|NCT00711997|4040275|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4217001|NCT00711997|4040276|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4217002|NCT00711997|4040274|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4217003|NCT00711997|4040275|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4217004|NCT00711997|4040276|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4217005|NCT00711997|4040274|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217006|NCT00711997|4040275|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217007|NCT00711997|4040276|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217049|NCT00711971|4040288|B3|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4217008|NCT00711971|4040287|B4|||EPDS Screen (Edinburgh Prenatal Depression Scale)|The EPDS Screen is self-administered and subsequently scored by researchers on a 0 - 30 point range with 0 as no depression and 30 as most severe.|units on a scale|Mean|7.80|7.8|Standard Deviation|4.51|4.51|||
4217009|NCT00711971|4040288|B3|||EPDS Screen (Edinburgh Prenatal Depression Scale)|The EPDS Screen is self-administered and subsequently scored by researchers on a 0 - 30 point range with 0 as no depression and 30 as most severe.|units on a scale|Mean|7.34|7.34|Standard Deviation|4.40|4.4|||
4217010|NCT00711971|4040289|B2|||EPDS Screen (Edinburgh Prenatal Depression Scale)|The EPDS Screen is self-administered and subsequently scored by researchers on a 0 - 30 point range with 0 as no depression and 30 as most severe.|units on a scale|Mean|7.56|7.56|Standard Deviation|4.49|4.49|||
4217011|NCT00711971|4040290|B1|||EPDS Screen (Edinburgh Prenatal Depression Scale)|The EPDS Screen is self-administered and subsequently scored by researchers on a 0 - 30 point range with 0 as no depression and 30 as most severe.|units on a scale|Mean|7.93|7.93|Standard Deviation|4.63|4.63|||
4217012|NCT00711971|4040287|B4|||BDI (Beck Depression Inventory) score|Beck Depression Inventory contains self-reported answers to questions concerning depression symptoms. It has been validated for use with pregnant women. Minimum score is 0 with 0 as no depression and maximum score is 63 representing the most severe depression.|units on a scale|Mean|7.72|7.72|Standard Deviation|5.38|5.38|||
4217013|NCT00711971|4040288|B3|||BDI (Beck Depression Inventory) score|Beck Depression Inventory contains self-reported answers to questions concerning depression symptoms. It has been validated for use with pregnant women. Minimum score is 0 with 0 as no depression and maximum score is 63 representing the most severe depression.|units on a scale|Mean|7.15|7.15|Standard Deviation|5.21|5.21|||
4217014|NCT00711971|4040289|B2|||BDI (Beck Depression Inventory) score|Beck Depression Inventory contains self-reported answers to questions concerning depression symptoms. It has been validated for use with pregnant women. Minimum score is 0 with 0 as no depression and maximum score is 63 representing the most severe depression.|units on a scale|Mean|7.79|7.79|Standard Deviation|5.29|5.29|||
4217015|NCT00711971|4040290|B1|||BDI (Beck Depression Inventory) score|Beck Depression Inventory contains self-reported answers to questions concerning depression symptoms. It has been validated for use with pregnant women. Minimum score is 0 with 0 as no depression and maximum score is 63 representing the most severe depression.|units on a scale|Mean|8.41|8.41|Standard Deviation|5.65|5.65|||
4217016|NCT00711971|4040287|B4|||Past history of depression(self reported)||participants|Number|95|95.0||||||
4217017|NCT00711971|4040288|B3|||Past history of depression(self reported)||participants|Number|33|33.0||||||
4217018|NCT00711971|4040289|B2|||Past history of depression(self reported)||participants|Number|30|30.0||||||
4217019|NCT00711971|4040290|B1|||Past history of depression(self reported)||participants|Number|32|32.0||||||
4217020|NCT00711971|4040287|B4|||Parity||number of previous deliveries|Mean|0.93|0.93|Standard Deviation|1.01|1.01|||
4217021|NCT00711971|4040288|B3|||Parity||number of previous deliveries|Mean|0.85|0.85|Standard Deviation|1.20|1.2|||
4217022|NCT00711971|4040289|B2|||Parity||number of previous deliveries|Mean|1.08|1.08|Standard Deviation|0.94|0.94|||
4217023|NCT00711971|4040290|B1|||Parity||number of previous deliveries|Mean|0.87|0.87|Standard Deviation|0.83|0.83|||
4217024|NCT00711971|4040287|B4|||Gestational age at enrollment||weeks|Mean|16.36|16.36|Standard Deviation|2.4|2.4|||
4217025|NCT00711971|4040288|B3|||Gestational age at enrollment||weeks|Mean|16.2|16.2|Standard Deviation|2.3|2.3|||
4217026|NCT00711971|4040289|B2|||Gestational age at enrollment||weeks|Mean|17|17.0|Standard Deviation|2.3|2.3|||
4217027|NCT00711971|4040290|B1|||Gestational age at enrollment||weeks|Mean|15.9|15.9|Standard Deviation|2.6|2.6|||
4217028|NCT00711971|4040287|B4|United States||Region of Enrollment||Participants|Count of Participants|118|118.0||||||
4217029|NCT00711971|4040288|B3|United States||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
4217030|NCT00711971|4040289|B2|United States||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
4217031|NCT00711971|4040290|B1|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
4217032|NCT00711971|4040287|B4|Native Hawaiian or other Pacific ethnicity||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4217033|NCT00711971|4040288|B3|Native Hawaiian or other Pacific ethnicity||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4217034|NCT00711971|4040289|B2|Native Hawaiian or other Pacific ethnicity||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4217035|NCT00711971|4040290|B1|Native Hawaiian or other Pacific ethnicity||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4217036|NCT00711971|4040287|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4217037|NCT00711971|4040288|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4217038|NCT00711971|4040289|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4217039|NCT00711971|4040290|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4217040|NCT00711971|4040287|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4217041|NCT00711971|4040288|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4217042|NCT00711971|4040289|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4217043|NCT00711971|4040290|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4217044|NCT00711971|4040287|B4|Hispanic-Latina||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4217045|NCT00711971|4040288|B3|Hispanic-Latina||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4217046|NCT00711971|4040289|B2|Hispanic-Latina||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4217047|NCT00711971|4040290|B1|Hispanic-Latina||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4217048|NCT00711971|4040287|B4|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4217050|NCT00711971|4040289|B2|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4217051|NCT00711971|4040290|B1|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4217052|NCT00711971|4040287|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|96|96.0||||||
4217053|NCT00711971|4040288|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
4217054|NCT00711971|4040289|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
4217055|NCT00711971|4040290|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
4217056|NCT00711971|4040287|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4217057|NCT00711971|4040288|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4217058|NCT00711971|4040289|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4217059|NCT00711971|4040290|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4217060|NCT00711971|4040287|B4||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4217061|NCT00711971|4040288|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4217062|NCT00711971|4040289|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4217063|NCT00711971|4040290|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4217064|NCT00711971|4040287|B4|||Age||years|Mean|30.3|30.3|Standard Deviation|5.18|5.18|||
4217065|NCT00711971|4040288|B3|||Age||years|Mean|30.4|30.4|Standard Deviation|5.9|5.9|||
4217066|NCT00711971|4040289|B2|||Age||years|Mean|30.6|30.6|Standard Deviation|4.5|4.5|||
4217067|NCT00711971|4040290|B1|||Age||years|Mean|29.9|29.9|Standard Deviation|5.0|5.0|||
4217068|NCT00711958|4040324|B3||other|most frequent site of primary malignancy||Participants|Count of Participants|43|43.0||||||
4217069|NCT00711958|4040325|B2||other|most frequent site of primary malignancy||Participants|Count of Participants|16|16.0||||||
4217070|NCT00711958|4040326|B1||other|most frequent site of primary malignancy||Participants|Count of Participants|27|27.0||||||
4217071|NCT00711958|4040324|B3||breast|most frequent site of primary malignancy||Participants|Count of Participants|11|11.0||||||
4217072|NCT00711958|4040325|B2||breast|most frequent site of primary malignancy||Participants|Count of Participants|3|3.0||||||
4217073|NCT00711958|4040326|B1||breast|most frequent site of primary malignancy||Participants|Count of Participants|8|8.0||||||
4217074|NCT00711958|4040324|B3||stomach|most frequent site of primary malignancy||Participants|Count of Participants|8|8.0||||||
4217075|NCT00711958|4040325|B2||stomach|most frequent site of primary malignancy||Participants|Count of Participants|4|4.0||||||
4217076|NCT00711958|4040326|B1||stomach|most frequent site of primary malignancy||Participants|Count of Participants|4|4.0||||||
4217077|NCT00711958|4040324|B3||pancreas|most frequent site of primary malignancy||Participants|Count of Participants|9|9.0||||||
4217078|NCT00711958|4040325|B2||pancreas|most frequent site of primary malignancy||Participants|Count of Participants|4|4.0||||||
4217079|NCT00711958|4040326|B1||pancreas|most frequent site of primary malignancy||Participants|Count of Participants|5|5.0||||||
4217080|NCT00711958|4040324|B3||lung|most frequent site of primary malignancy||Participants|Count of Participants|19|19.0||||||
4217081|NCT00711958|4040325|B2||lung|most frequent site of primary malignancy||Participants|Count of Participants|6|6.0||||||
4217082|NCT00711958|4040326|B1||lung|most frequent site of primary malignancy||Participants|Count of Participants|13|13.0||||||
4217083|NCT00711958|4040324|B3||ovary|most frequent site of primary malignancy||Participants|Count of Participants|24|24.0||||||
4217084|NCT00711958|4040325|B2||ovary|most frequent site of primary malignancy||Participants|Count of Participants|7|7.0||||||
4217085|NCT00711958|4040326|B1||ovary|most frequent site of primary malignancy||Participants|Count of Participants|17|17.0||||||
4217086|NCT00711958|4040324|B3|Germany||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
4217087|NCT00711958|4040325|B2|Germany||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4217088|NCT00711958|4040326|B1|Germany||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
4217089|NCT00711958|4040324|B3|Romania||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
4217090|NCT00711958|4040325|B2|Romania||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4217091|NCT00711958|4040326|B1|Romania||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
4217092|NCT00711958|4040324|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4217093|NCT00711958|4040325|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4217094|NCT00711958|4040326|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4217095|NCT00711958|4040324|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4217096|NCT00711958|4040325|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4217097|NCT00711958|4040326|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4217098|NCT00711958|4040324|B3|≥65 years||Age, Customized||Participants|Count of Participants|47|47.0||||||
4217099|NCT00711958|4040325|B2|≥65 years||Age, Customized||Participants|Count of Participants|19|19.0||||||
4217100|NCT00711958|4040326|B1|≥65 years||Age, Customized||Participants|Count of Participants|28|28.0||||||
4217101|NCT00711958|4040324|B3|40-64 years||Age, Customized||Participants|Count of Participants|61|61.0||||||
4217102|NCT00711958|4040325|B2|40-64 years||Age, Customized||Participants|Count of Participants|18|18.0||||||
4217103|NCT00711958|4040326|B1|40-64 years||Age, Customized||Participants|Count of Participants|43|43.0||||||
4217104|NCT00711958|4040324|B3|18-39 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
4217105|NCT00711958|4040325|B2|18-39 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
4217106|NCT00711958|4040326|B1|18-39 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
4217107|NCT00711880|4040333|B3|Belgium||Region of Enrollment||participants|Number|24|24.0||||||
4217108|NCT00711880|4040334|B2|Belgium||Region of Enrollment||participants|Number|12|12.0||||||
4217109|NCT00711880|4040335|B1|Belgium||Region of Enrollment||participants|Number|12|12.0||||||
4217110|NCT00711880|4040333|B3|United Kingdom||Region of Enrollment||participants|Number|101|101.0||||||
4217111|NCT00711880|4040334|B2|United Kingdom||Region of Enrollment||participants|Number|50|50.0||||||
4217112|NCT00711880|4040335|B1|United Kingdom||Region of Enrollment||participants|Number|51|51.0||||||
4217113|NCT00711880|4040333|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4217114|NCT00711880|4040334|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4217115|NCT00711880|4040335|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4217116|NCT00711880|4040333|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4217117|NCT00711880|4040334|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4217118|NCT00711880|4040335|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4217119|NCT00711880|4040333|B3|||Age||years|Mean|53.4|53.4|Standard Deviation|15.4|15.4|||
4217120|NCT00711880|4040334|B2|||Age||years|Mean|54.3|54.3|Standard Deviation|15.2|15.2|||
4217121|NCT00711880|4040335|B1|||Age||years|Mean|52.4|52.4|Standard Deviation|15.8|15.8|||
4217122|NCT00711880|4040333|B3||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4217123|NCT00711880|4040334|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4217124|NCT00711880|4040335|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4217125|NCT00711880|4040333|B3||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4217126|NCT00711880|4040334|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4217127|NCT00711880|4040335|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4217128|NCT00711880|4040333|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217129|NCT00711880|4040334|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217130|NCT00711880|4040335|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217131|NCT00711867|4040372|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4217132|NCT00711867|4040373|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4217133|NCT00711867|4040374|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4217134|NCT00711867|4040372|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4217135|NCT00711867|4040373|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4217136|NCT00711867|4040374|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4217137|NCT00711867|4040372|B3|||Age||years|Mean|68.0|68.0|Standard Deviation|10.5|10.5|||
4217138|NCT00711867|4040373|B2|||Age||years|Mean|67.0|67.0|Standard Deviation|9.4|9.4|||
4217139|NCT00711867|4040374|B1|||Age||years|Mean|68.9|68.9|Standard Deviation|11.4|11.4|||
4217140|NCT00711828|4040381|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4217141|NCT00711828|4040381|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4217142|NCT00711828|4040381|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4217143|NCT00711828|4040381|B1|||Age||years|Median|69|69.0|Full Range|||51.0|80.0|
4217144|NCT00711802|4040390|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4217145|NCT00711802|4040391|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4217146|NCT00711802|4040392|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217147|NCT00711802|4040393|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217148|NCT00711802|4040394|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4217149|NCT00711802|4040395|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217150|NCT00711802|4040396|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4217151|NCT00711802|4040397|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4217152|NCT00711802|4040398|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217153|NCT00711802|4040390|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4217154|NCT00711802|4040391|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217155|NCT00711802|4040392|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217156|NCT00711802|4040393|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4217157|NCT00711802|4040394|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217158|NCT00711802|4040395|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4217159|NCT00711802|4040396|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217160|NCT00711802|4040397|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217161|NCT00711802|4040398|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217162|NCT00711802|4040390|B9||White|Race (NIH/OMB)||Participants|Count of Participants|165|165.0||||||
4217163|NCT00711802|4040391|B8||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4217164|NCT00711802|4040392|B7||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4217165|NCT00711802|4040393|B6||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4217166|NCT00711802|4040394|B5||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4217167|NCT00711802|4040395|B4||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4217168|NCT00711802|4040396|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4217169|NCT00711802|4040397|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4217170|NCT00711802|4040398|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4217171|NCT00711802|4040390|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4217172|NCT00711802|4040391|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4217173|NCT00711802|4040392|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4217174|NCT00711802|4040393|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4217175|NCT00711802|4040394|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4217176|NCT00711802|4040395|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4217177|NCT00711802|4040396|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4217178|NCT00711802|4040397|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4217179|NCT00711802|4040398|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4217180|NCT00711802|4040390|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217181|NCT00711802|4040391|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217182|NCT00711802|4040392|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217183|NCT00711802|4040393|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217184|NCT00711802|4040394|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217185|NCT00711802|4040395|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217186|NCT00711802|4040396|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217187|NCT00711802|4040397|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217188|NCT00711802|4040398|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217189|NCT00711802|4040390|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
4217190|NCT00711802|4040391|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4217191|NCT00711802|4040392|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217192|NCT00711802|4040393|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217193|NCT00711802|4040394|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4217194|NCT00711802|4040395|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4217195|NCT00711802|4040396|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4217196|NCT00711802|4040397|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4217197|NCT00711802|4040398|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4217198|NCT00711802|4040390|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217199|NCT00711802|4040391|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217200|NCT00711802|4040392|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217201|NCT00711802|4040393|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217202|NCT00711802|4040394|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217203|NCT00711802|4040395|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217204|NCT00711802|4040396|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217205|NCT00711802|4040397|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217206|NCT00711802|4040398|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217207|NCT00711802|4040390|B9||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4217208|NCT00711802|4040391|B8||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4217209|NCT00711802|4040392|B7||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4217210|NCT00711802|4040393|B6||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4217211|NCT00711802|4040394|B5||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4217212|NCT00711802|4040395|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4217213|NCT00711802|4040396|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4217214|NCT00711802|4040397|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4217215|NCT00711802|4040398|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4217216|NCT00711802|4040390|B9||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4217217|NCT00711802|4040391|B8||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4217218|NCT00711802|4040392|B7||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4217219|NCT00711802|4040393|B6||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4217220|NCT00711802|4040394|B5||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4217221|NCT00711802|4040395|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4217222|NCT00711802|4040396|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4217223|NCT00711802|4040397|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4217224|NCT00711802|4040398|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4217225|NCT00711802|4040390|B9|||Age||years|Mean|8.21|8.21|Standard Deviation|5.134|5.134|||
4217226|NCT00711802|4040391|B8|||Age||years|Mean|1.43|1.43|Standard Deviation|0.299|0.299|||
4217227|NCT00711802|4040392|B7|||Age||years|Mean|1.46|1.46|Standard Deviation|0.299|0.299|||
4217228|NCT00711802|4040393|B6|||Age||years|Mean|3.86|3.86|Standard Deviation|1.555|1.555|||
4217229|NCT00711802|4040394|B5|||Age||years|Mean|3.92|3.92|Standard Deviation|1.556|1.556|||
4217230|NCT00711802|4040395|B4|||Age||years|Mean|8.98|8.98|Standard Deviation|1.305|1.305|||
4217231|NCT00711802|4040396|B3|||Age||years|Mean|9.05|9.05|Standard Deviation|1.443|1.443|||
4217232|NCT00711802|4040397|B2|||Age||years|Mean|14.84|14.84|Standard Deviation|1.735|1.735|||
4217233|NCT00711802|4040398|B1|||Age||years|Mean|15.02|15.02|Standard Deviation|1.584|1.584|||
4217234|NCT00711646|4040435|B3|Romania||Region of Enrollment||participants|Number|25|25.0||||||
4217235|NCT00711646|4040436|B2|Romania||Region of Enrollment||participants|Number|9|9.0||||||
4217236|NCT00711646|4040437|B1|Romania||Region of Enrollment||participants|Number|16|16.0||||||
4217237|NCT00711646|4040435|B3|United Kingdom||Region of Enrollment||participants|Number|164|164.0||||||
4217238|NCT00711646|4040436|B2|United Kingdom||Region of Enrollment||participants|Number|56|56.0||||||
4217239|NCT00711646|4040437|B1|United Kingdom||Region of Enrollment||participants|Number|108|108.0||||||
4217240|NCT00711646|4040435|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4217241|NCT00711646|4040436|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4217242|NCT00711646|4040437|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4217243|NCT00711646|4040435|B3||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4217244|NCT00711646|4040436|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4217245|NCT00711646|4040437|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4217246|NCT00711646|4040435|B3|||Age||years|Mean|49.1|49.1|Standard Deviation|9.9|9.9|||
4217247|NCT00711646|4040436|B2|||Age||years|Mean|47.8|47.8|Standard Deviation|9.5|9.5|||
4217248|NCT00711646|4040437|B1|||Age||years|Mean|49.7|49.7|Standard Deviation|10.2|10.2|||
4217249|NCT00711646|4040435|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4217250|NCT00711646|4040436|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4217251|NCT00711646|4040437|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4217252|NCT00711646|4040435|B3||Between 18 and 65 years|Age||Participants|Count of Participants|183|183.0||||||
4217253|NCT00711646|4040436|B2||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4217254|NCT00711646|4040437|B1||Between 18 and 65 years|Age||Participants|Count of Participants|118|118.0||||||
4217255|NCT00711646|4040435|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217256|NCT00711646|4040436|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217257|NCT00711646|4040437|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217258|NCT00711594|4040456|B5||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4217259|NCT00711594|4040457|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4217260|NCT00711594|4040458|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4217261|NCT00711594|4040459|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4217262|NCT00711594|4040460|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4217263|NCT00711594|4040456|B5||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4217264|NCT00711594|4040457|B4||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4217265|NCT00711594|4040458|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4217266|NCT00711594|4040459|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4217267|NCT00711594|4040460|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4217268|NCT00711594|4040456|B5|||Age|BIBW 20mg, 40mg, 50mg (Phase I)|years|Median|65.0|65.0|Full Range|||33.0|84.0|
4217269|NCT00711594|4040457|B4|||Age|BIBW 20mg, 40mg, 50mg (Phase I)|years|Median|65.0|65.0|Full Range|||33.0|84.0|
4217270|NCT00711594|4040458|B3|||Age|BIBW 20mg, 40mg, 50mg (Phase I)|years|Median|63.0|63.0|Full Range|||39.0|67.0|
4217271|NCT00711594|4040459|B2|||Age|BIBW 20mg, 40mg, 50mg (Phase I)|years|Median|56.0|56.0|Full Range|||46.0|57.0|
4217272|NCT00711594|4040460|B1|||Age|BIBW 20mg, 40mg, 50mg (Phase I)|years|Median|65.0|65.0|Full Range|||64.0|67.0|
4217273|NCT00711555|4040500|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4217274|NCT00711555|4040500|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4217275|NCT00711555|4040500|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4217276|NCT00711555|4040500|B1|||Age||years|Mean|42|42.0|Standard Deviation|15|15.0|||
4217277|NCT00711555|4040500|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4217278|NCT00711555|4040500|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4217279|NCT00711555|4040500|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217280|NCT00711529|4040507|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4217281|NCT00711529|4040508|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4217282|NCT00711529|4040509|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4217283|NCT00711529|4040507|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4217284|NCT00711529|4040508|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4217285|NCT00711529|4040509|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4217286|NCT00711529|4040507|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4217287|NCT00711529|4040508|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4217288|NCT00711529|4040509|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4217289|NCT00711529|4040507|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4217290|NCT00711529|4040508|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4217291|NCT00711529|4040509|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4217292|NCT00711529|4040507|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217293|NCT00711529|4040508|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217294|NCT00711529|4040509|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217295|NCT00711516|4040532|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4217296|NCT00711516|4040533|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4217297|NCT00711516|4040534|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4217298|NCT00711516|4040532|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4217299|NCT00711516|4040533|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4217300|NCT00711516|4040534|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4217301|NCT00711516|4040532|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4217302|NCT00711516|4040533|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4217303|NCT00711516|4040534|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4217304|NCT00711516|4040532|B3|||Age||years|Mean|50.3|50.3|Standard Deviation|8.41|8.41|||
4217305|NCT00711516|4040533|B2|||Age||years|Mean|50.7|50.7|Standard Deviation|7.95|7.95|||
4217306|NCT00711516|4040534|B1|||Age||years|Mean|49.9|49.9|Standard Deviation|8.98|8.98|||
4217307|NCT00711516|4040532|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4217308|NCT00711516|4040533|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4217309|NCT00711516|4040534|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4217310|NCT00711516|4040532|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4217311|NCT00711516|4040533|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4217312|NCT00711516|4040534|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4217313|NCT00711516|4040532|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217314|NCT00711516|4040533|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217315|NCT00711516|4040534|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217316|NCT00711490|4040629|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4217317|NCT00711490|4040629|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4217318|NCT00711490|4040629|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4217319|NCT00711490|4040629|B1|||Age||years|Mean|67.2|67.2|Standard Deviation|4.76|4.76|||
4217320|NCT00711490|4040629|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4217321|NCT00711490|4040629|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4217322|NCT00711490|4040629|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217323|NCT00711477|4040640|B3|||BMI||kg/m^2|Mean|32.38|32.38|Standard Deviation|3.75|3.75|||
4217324|NCT00711477|4040641|B2|||BMI||kg/m^2|Mean|31.80|31.8|Standard Deviation|3.10|3.1|||
4217325|NCT00711477|4040642|B1|||BMI||kg/m^2|Mean|32.96|32.96|Standard Deviation|4.30|4.3|||
4217326|NCT00711477|4040640|B3|||Weight||kg|Mean|88.64|88.64|Standard Deviation|14.50|14.5|||
4217327|NCT00711477|4040641|B2|||Weight||kg|Mean|89.59|89.59|Standard Deviation|13.34|13.34|||
4217328|NCT00711477|4040642|B1|||Weight||kg|Mean|87.70|87.7|Standard Deviation|15.83|15.83|||
4217329|NCT00711477|4040640|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4217330|NCT00711477|4040641|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4217331|NCT00711477|4040642|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4217332|NCT00711477|4040640|B3|Other||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4217333|NCT00711477|4040641|B2|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4217334|NCT00711477|4040642|B1|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4217335|NCT00711477|4040640|B3|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4217336|NCT00711477|4040641|B2|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4217337|NCT00711477|4040642|B1|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4217338|NCT00711477|4040640|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4217339|NCT00711477|4040641|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4217340|NCT00711477|4040642|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4217341|NCT00711477|4040640|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4217342|NCT00711477|4040641|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4217343|NCT00711477|4040642|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4217344|NCT00711477|4040640|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4217345|NCT00711477|4040641|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4217346|NCT00711477|4040642|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4217347|NCT00711477|4040640|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4217348|NCT00711477|4040641|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4217349|NCT00711477|4040642|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4217350|NCT00711477|4040640|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4217351|NCT00711477|4040641|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4217352|NCT00711477|4040642|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4217353|NCT00711477|4040640|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4217354|NCT00711477|4040641|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4217355|NCT00711477|4040642|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4217356|NCT00711477|4040640|B3|||Age||years|Mean|30.67|30.67|Standard Deviation|7.99|7.99|||
4217357|NCT00711477|4040641|B2|||Age||years|Mean|30.39|30.39|Standard Deviation|8.46|8.46|||
4217358|NCT00711477|4040642|B1|||Age||years|Mean|30.96|30.96|Standard Deviation|7.68|7.68|||
4217359|NCT00711464|4040671|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4217360|NCT00711464|4040671|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217361|NCT00711464|4040671|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217362|NCT00711464|4040671|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4217363|NCT00711464|4040671|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4217364|NCT00711464|4040671|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217365|NCT00711464|4040671|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4217366|NCT00711464|4040671|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217367|NCT00711464|4040671|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217368|NCT00711464|4040671|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4217369|NCT00711464|4040671|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4217370|NCT00711464|4040671|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4217371|NCT00711464|4040671|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4217372|NCT00711464|4040671|B1|||Age||years|Mean|31|31.0|Standard Deviation|9|9.0|||
4217373|NCT00711425|4040689|B1|Germany||Region of Enrollment||participants|Number|15|15.0||||||
4217374|NCT00711425|4040689|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4217375|NCT00711425|4040689|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4217376|NCT00711425|4040689|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4217377|NCT00711425|4040689|B1|||Age||years|Mean|57|57.0|Standard Deviation|10|10.0|||
4217378|NCT00711412|4040695|B1|United States||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
4217379|NCT00711412|4040695|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217380|NCT00711412|4040695|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217381|NCT00711412|4040695|B1||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4217382|NCT00711412|4040695|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4217383|NCT00711412|4040695|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217384|NCT00711412|4040695|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4217385|NCT00711412|4040695|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217386|NCT00711412|4040695|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217387|NCT00711412|4040695|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4217388|NCT00711412|4040695|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4217389|NCT00711412|4040695|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4217390|NCT00711412|4040695|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4217391|NCT00711412|4040695|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4217392|NCT00711412|4040695|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4217393|NCT00711412|4040695|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217394|NCT00711347|4040707|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4217395|NCT00711347|4040708|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4217396|NCT00711347|4040709|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4217397|NCT00711347|4040707|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4217398|NCT00711347|4040708|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4217399|NCT00711347|4040709|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4217400|NCT00711347|4040707|B3||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4217401|NCT00711347|4040708|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4217402|NCT00711347|4040709|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4217403|NCT00711347|4040707|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4217404|NCT00711347|4040708|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4217405|NCT00711347|4040709|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4217406|NCT00711347|4040707|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217407|NCT00711347|4040708|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217408|NCT00711347|4040709|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217409|NCT00711269|4040726|B5|Korea, Republic of||Region of Enrollment||participants|Number|101|101.0||||||
4217410|NCT00711269|4040727|B4|Korea, Republic of||Region of Enrollment||participants|Number|15|15.0||||||
4217411|NCT00711269|4040728|B3|Korea, Republic of||Region of Enrollment||participants|Number|30|30.0||||||
4217412|NCT00711269|4040729|B2|Korea, Republic of||Region of Enrollment||participants|Number|28|28.0||||||
4217413|NCT00711269|4040730|B1|Korea, Republic of||Region of Enrollment||participants|Number|28|28.0||||||
4217414|NCT00711269|4040726|B5|Taiwan||Region of Enrollment||participants|Number|125|125.0||||||
4217415|NCT00711269|4040727|B4|Taiwan||Region of Enrollment||participants|Number|16|16.0||||||
4217416|NCT00711269|4040728|B3|Taiwan||Region of Enrollment||participants|Number|38|38.0||||||
4217417|NCT00711269|4040729|B2|Taiwan||Region of Enrollment||participants|Number|37|37.0||||||
4217418|NCT00711269|4040730|B1|Taiwan||Region of Enrollment||participants|Number|34|34.0||||||
4217419|NCT00711269|4040726|B5|Japan||Region of Enrollment||participants|Number|221|221.0||||||
4217420|NCT00711269|4040727|B4|Japan||Region of Enrollment||participants|Number|33|33.0||||||
4217421|NCT00711269|4040728|B3|Japan||Region of Enrollment||participants|Number|61|61.0||||||
4217422|NCT00711269|4040729|B2|Japan||Region of Enrollment||participants|Number|64|64.0||||||
4217423|NCT00711269|4040730|B1|Japan||Region of Enrollment||participants|Number|63|63.0||||||
4217424|NCT00711269|4040726|B5||Male|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
4217425|NCT00711269|4040727|B4||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4217426|NCT00711269|4040728|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4217427|NCT00711269|4040729|B2||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4217428|NCT00711269|4040730|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4217429|NCT00711269|4040726|B5||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4217430|NCT00711269|4040727|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4217431|NCT00711269|4040728|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4217432|NCT00711269|4040729|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4217433|NCT00711269|4040730|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4217434|NCT00711269|4040726|B5|||Age||years|Mean|45.6|45.6|Standard Deviation|13.44|13.44|||
4217435|NCT00711269|4040727|B4|||Age||years|Mean|44.8|44.8|Standard Deviation|12.59|12.59|||
4217436|NCT00711269|4040728|B3|||Age||years|Mean|46.0|46.0|Standard Deviation|12.85|12.85|||
4217437|NCT00711269|4040729|B2|||Age||years|Mean|45.7|45.7|Standard Deviation|13.51|13.51|||
4217438|NCT00711269|4040730|B1|||Age||years|Mean|45.6|45.6|Standard Deviation|14.48|14.48|||
4217439|NCT00711243|4040767|B7|United States||Region of Enrollment||Participants|Count of Participants|59|59.0||||||
4217440|NCT00711243|4040768|B6|United States||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
4217441|NCT00711243|4040769|B5|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4217442|NCT00711243|4040770|B4|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4217443|NCT00711243|4040771|B3|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4217444|NCT00711243|4040772|B2|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4217445|NCT00711243|4040773|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4217446|NCT00711243|4040767|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4217447|NCT00711243|4040768|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217448|NCT00711243|4040769|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217449|NCT00711243|4040770|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217450|NCT00711243|4040771|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4217451|NCT00711243|4040772|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217452|NCT00711243|4040773|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217453|NCT00711243|4040767|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217454|NCT00711243|4040768|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217455|NCT00711243|4040769|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217456|NCT00711243|4040770|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217457|NCT00711243|4040771|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217458|NCT00711243|4040772|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217459|NCT00711243|4040773|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217460|NCT00711243|4040767|B7||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4217461|NCT00711243|4040768|B6||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4217462|NCT00711243|4040769|B5||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4217463|NCT00711243|4040770|B4||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4217464|NCT00711243|4040771|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4217465|NCT00711243|4040772|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4217466|NCT00711243|4040773|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4217522|NCT00711243|4040773|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4217467|NCT00711243|4040767|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4217468|NCT00711243|4040768|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4217469|NCT00711243|4040769|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217470|NCT00711243|4040770|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217471|NCT00711243|4040771|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217472|NCT00711243|4040772|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4217473|NCT00711243|4040773|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4217474|NCT00711243|4040767|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217475|NCT00711243|4040768|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217476|NCT00711243|4040769|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217477|NCT00711243|4040770|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217478|NCT00711243|4040771|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217479|NCT00711243|4040772|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217480|NCT00711243|4040773|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217481|NCT00711243|4040767|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4217482|NCT00711243|4040768|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4217483|NCT00711243|4040769|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217484|NCT00711243|4040770|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217485|NCT00711243|4040771|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217486|NCT00711243|4040772|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217487|NCT00711243|4040773|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217488|NCT00711243|4040767|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217489|NCT00711243|4040768|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217490|NCT00711243|4040769|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217491|NCT00711243|4040770|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217492|NCT00711243|4040771|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217493|NCT00711243|4040772|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217494|NCT00711243|4040773|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217495|NCT00711243|4040767|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4217496|NCT00711243|4040768|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4217497|NCT00711243|4040769|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217498|NCT00711243|4040770|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217499|NCT00711243|4040771|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4217500|NCT00711243|4040772|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217501|NCT00711243|4040773|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217502|NCT00711243|4040767|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4217503|NCT00711243|4040768|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4217504|NCT00711243|4040769|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4217505|NCT00711243|4040770|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4217506|NCT00711243|4040771|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4217507|NCT00711243|4040772|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4217508|NCT00711243|4040773|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4217509|NCT00711243|4040767|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4217510|NCT00711243|4040768|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4217511|NCT00711243|4040769|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217512|NCT00711243|4040770|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217513|NCT00711243|4040771|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217514|NCT00711243|4040772|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4217515|NCT00711243|4040773|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217516|NCT00711243|4040767|B7||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4217517|NCT00711243|4040768|B6||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4217518|NCT00711243|4040769|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4217519|NCT00711243|4040770|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4217520|NCT00711243|4040771|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4217521|NCT00711243|4040772|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4217523|NCT00711243|4040767|B7||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4217524|NCT00711243|4040768|B6||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4217525|NCT00711243|4040769|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4217526|NCT00711243|4040770|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4217527|NCT00711243|4040771|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4217528|NCT00711243|4040772|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4217529|NCT00711243|4040773|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4217530|NCT00711243|4040767|B7||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4217531|NCT00711243|4040768|B6||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4217532|NCT00711243|4040769|B5||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4217533|NCT00711243|4040770|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4217534|NCT00711243|4040771|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4217535|NCT00711243|4040772|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4217536|NCT00711243|4040773|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4217537|NCT00711243|4040767|B7||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4217538|NCT00711243|4040768|B6||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4217539|NCT00711243|4040769|B5||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4217540|NCT00711243|4040770|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4217541|NCT00711243|4040771|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4217542|NCT00711243|4040772|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4217543|NCT00711243|4040773|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4217544|NCT00711243|4040767|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217545|NCT00711243|4040768|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217546|NCT00711243|4040769|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217547|NCT00711243|4040770|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217548|NCT00711243|4040771|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217549|NCT00711243|4040772|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217550|NCT00711243|4040773|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217551|NCT00711191|4040798|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4217552|NCT00711191|4040799|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4217553|NCT00711191|4040800|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4217554|NCT00711191|4040801|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4217555|NCT00711191|4040798|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4217556|NCT00711191|4040799|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4217557|NCT00711191|4040800|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4217558|NCT00711191|4040801|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4217559|NCT00711191|4040798|B4|||Age||years|Mean|59.9|59.9|Standard Deviation|9.8|9.8|||
4217560|NCT00711191|4040799|B3|||Age||years|Mean|57.4|57.4|Standard Deviation|8.1|8.1|||
4217561|NCT00711191|4040800|B2|||Age||years|Mean|62.3|62.3|Standard Deviation|13.3|13.3|||
4217562|NCT00711191|4040801|B1|||Age||years|Mean|65.7|65.7|Standard Deviation|7.8|7.8|||
4217563|NCT00711113|4040840|B1|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4217564|NCT00711113|4040840|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4217565|NCT00711113|4040840|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4217566|NCT00711113|4040840|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4217567|NCT00711113|4040840|B1|||Age||years|Mean|59|59.0|Standard Deviation|11|11.0|||
4217568|NCT00711100|4040846|B1|United States||Region of Enrollment||participants|Number|104|104.0||||||
4217569|NCT00711100|4040846|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4217570|NCT00711100|4040846|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4217571|NCT00711100|4040846|B1|||Age||years|Mean|40.1|40.1|Standard Deviation|13.2|13.2|||
4217572|NCT00711100|4040846|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4217573|NCT00711100|4040846|B1||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
4217574|NCT00711100|4040846|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4217575|NCT00711087|4040862|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4217576|NCT00711087|4040864|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4217577|NCT00711087|4040862|B3|Male||Gender||participants|Number|1|1.0||||||
4217578|NCT00711087|4040864|B1|Male||Gender||participants|Number|1|1.0||||||
4217579|NCT00711087|4040862|B3|Female||Gender||participants|Number|0|0.0||||||
4217580|NCT00711087|4040864|B1|Female||Gender||participants|Number|0|0.0||||||
4217581|NCT00711087|4040862|B3|||Age||years|Mean|36|36.0|Full Range|||36.0|36.0|
4217582|NCT00711087|4040864|B1|||Age||years|Mean|36|36.0|Full Range|||36.0|36.0|
4217583|NCT00711022|4040871|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4217584|NCT00711022|4040871|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4217585|NCT00711022|4040871|B1|||Age||years|Mean|65.8|65.8|Standard Deviation|10|10.0|||
4217700|NCT00710866|4041097|B3|Canada||Region of Enrollment||participants|Number|252|252.0||||||
4217586|NCT00711009|4040875|B3|||CD4+ T-Cell Counts||cells/microliter|Mean|293.5|293.5|Standard Deviation|157.93|157.93|||
4217587|NCT00711009|4040876|B2|||CD4+ T-Cell Counts||cells/microliter|Mean|289.3|289.3|Standard Deviation|149.03|149.03|||
4217588|NCT00711009|4040877|B1|||CD4+ T-Cell Counts||cells/microliter|Mean|297.6|297.6|Standard Deviation|166.66|166.66|||
4217589|NCT00711009|4040875|B3|||Plasma Human Immunodeficiency Virus Type 1 (HIV-1) Ribonucleic Acid (RNA) Level||log10 copies/milliliter|Mean|4.2|4.2|Standard Deviation|0.79|0.79|||
4217590|NCT00711009|4040876|B2|||Plasma Human Immunodeficiency Virus Type 1 (HIV-1) Ribonucleic Acid (RNA) Level||log10 copies/milliliter|Mean|4.2|4.2|Standard Deviation|0.83|0.83|||
4217591|NCT00711009|4040877|B1|||Plasma Human Immunodeficiency Virus Type 1 (HIV-1) Ribonucleic Acid (RNA) Level||log10 copies/milliliter|Mean|4.3|4.3|Standard Deviation|0.76|0.76|||
4217592|NCT00711009|4040875|B3|Europe||Region of Enrollment||participants|Number|86|86.0||||||
4217593|NCT00711009|4040876|B2|Europe||Region of Enrollment||participants|Number|42|42.0||||||
4217594|NCT00711009|4040877|B1|Europe||Region of Enrollment||participants|Number|44|44.0||||||
4217595|NCT00711009|4040875|B3|North America||Region of Enrollment||participants|Number|120|120.0||||||
4217596|NCT00711009|4040876|B2|North America||Region of Enrollment||participants|Number|59|59.0||||||
4217597|NCT00711009|4040877|B1|North America||Region of Enrollment||participants|Number|61|61.0||||||
4217598|NCT00711009|4040875|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4217599|NCT00711009|4040876|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4217600|NCT00711009|4040877|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4217601|NCT00711009|4040875|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4217602|NCT00711009|4040876|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4217603|NCT00711009|4040877|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4217604|NCT00711009|4040875|B3|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4217605|NCT00711009|4040876|B2|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4217606|NCT00711009|4040877|B1|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4217607|NCT00711009|4040875|B3|White||Race/Ethnicity, Customized||participants|Number|155|155.0||||||
4217608|NCT00711009|4040876|B2|White||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
4217609|NCT00711009|4040877|B1|White||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
4217610|NCT00711009|4040875|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4217611|NCT00711009|4040876|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4217612|NCT00711009|4040877|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4217613|NCT00711009|4040875|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4217614|NCT00711009|4040876|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4217615|NCT00711009|4040877|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4217616|NCT00711009|4040875|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4217617|NCT00711009|4040876|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4217618|NCT00711009|4040877|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4217619|NCT00711009|4040875|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4217620|NCT00711009|4040876|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4217621|NCT00711009|4040877|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4217622|NCT00711009|4040875|B3||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4217623|NCT00711009|4040876|B2||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4217624|NCT00711009|4040877|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4217625|NCT00711009|4040875|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4217626|NCT00711009|4040876|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4217627|NCT00711009|4040877|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4217628|NCT00711009|4040875|B3|||Age||years|Mean|39.6|39.6|Standard Deviation|10.60|10.6|||
4217629|NCT00711009|4040876|B2|||Age||years|Mean|39.8|39.8|Standard Deviation|9.94|9.94|||
4217630|NCT00711009|4040877|B1|||Age||years|Mean|39.4|39.4|Standard Deviation|11.24|11.24|||
4217631|NCT00710996|4041046|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4217632|NCT00710996|4041047|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4217633|NCT00710996|4041048|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4217634|NCT00710996|4041049|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4217635|NCT00710996|4041046|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4217636|NCT00710996|4041047|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4217637|NCT00710996|4041048|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4217638|NCT00710996|4041049|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4217639|NCT00710996|4041046|B4||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
4217640|NCT00710996|4041047|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4217641|NCT00710996|4041048|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4217642|NCT00710996|4041049|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4217643|NCT00710996|4041046|B4||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4217644|NCT00710996|4041047|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4217645|NCT00710996|4041048|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4217646|NCT00710996|4041049|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4217647|NCT00710996|4041046|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217648|NCT00710996|4041047|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217649|NCT00710996|4041048|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217650|NCT00710996|4041049|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217651|NCT00710970|4041059|B1|Italy||Region of Enrollment||participants|Number|7|7.0||||||
4217652|NCT00710970|4041059|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4217653|NCT00710970|4041059|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4217654|NCT00710970|4041059|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4217655|NCT00710970|4041059|B1|||Age||years|Mean|69|69.0|Standard Deviation|10.844|10.844|||
4217656|NCT00710970|4041059|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4217657|NCT00710970|4041059|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4217658|NCT00710970|4041059|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217659|NCT00710944|4041063|B4||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4217660|NCT00710944|4041064|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4217661|NCT00710944|4041065|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4217662|NCT00710944|4041066|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4217663|NCT00710944|4041063|B4||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4217664|NCT00710944|4041064|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4217665|NCT00710944|4041065|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4217666|NCT00710944|4041066|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4217667|NCT00710944|4041063|B4|||Age||years|Mean|42|42.0|Standard Deviation|17|17.0|||
4217668|NCT00710944|4041064|B3|||Age||years|Mean|40|40.0|Standard Deviation|17|17.0|||
4217669|NCT00710944|4041065|B2|||Age||years|Mean|42|42.0|Standard Deviation|15|15.0|||
4217670|NCT00710944|4041066|B1|||Age||years|Mean|45|45.0|Standard Deviation|14|14.0|||
4217671|NCT00710931|4041076|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4217672|NCT00710931|4041076|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4217673|NCT00710931|4041076|B1|||Age||years|Median|74.5|74.5|Standard Deviation|6.44|6.44|||
4217674|NCT00710905|4041080|B1|Male||Gender|Gender information was not collected for one subject.|participants|Number|25|25.0||||||
4217675|NCT00710905|4041080|B1|Female||Gender|Gender information was not collected for one subject.|participants|Number|24|24.0||||||
4217676|NCT00710905|4041080|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4217677|NCT00710905|4041080|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4217678|NCT00710905|4041080|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217679|NCT00710879|4041084|B3|4 Grandparents||Participants with Grandparents Born in Japan|Participants with Grandparents Born in Japan|Participants|Number|131|131.0||||||
4217680|NCT00710879|4041085|B2|4 Grandparents||Participants with Grandparents Born in Japan|Participants with Grandparents Born in Japan|Participants|Number|82|82.0||||||
4217681|NCT00710879|4041086|B1|4 Grandparents||Participants with Grandparents Born in Japan|Participants with Grandparents Born in Japan|Participants|Number|49|49.0||||||
4217682|NCT00710879|4041084|B3|3 Grandparents||Participants with Grandparents Born in Japan|Participants with Grandparents Born in Japan|Participants|Number|10|10.0||||||
4217683|NCT00710879|4041085|B2|3 Grandparents||Participants with Grandparents Born in Japan|Participants with Grandparents Born in Japan|Participants|Number|6|6.0||||||
4217684|NCT00710879|4041086|B1|3 Grandparents||Participants with Grandparents Born in Japan|Participants with Grandparents Born in Japan|Participants|Number|4|4.0||||||
4217685|NCT00710879|4041084|B3|2 Grandparents||Participants with Grandparents Born in Japan|Participants with Grandparents Born in Japan|Participants|Number|25|25.0||||||
4217686|NCT00710879|4041085|B2|2 Grandparents||Participants with Grandparents Born in Japan|Participants with Grandparents Born in Japan|Participants|Number|18|18.0||||||
4217687|NCT00710879|4041086|B1|2 Grandparents||Participants with Grandparents Born in Japan|Participants with Grandparents Born in Japan|Participants|Number|7|7.0||||||
4217688|NCT00710879|4041084|B3|1 Grandparent||Participants with Grandparents Born in Japan|Participants with Grandparents Born in Japan|Participants|Number|11|11.0||||||
4217689|NCT00710879|4041085|B2|1 Grandparent||Participants with Grandparents Born in Japan|Participants with Grandparents Born in Japan|Participants|Number|11|11.0||||||
4217690|NCT00710879|4041086|B1|1 Grandparent||Participants with Grandparents Born in Japan|Participants with Grandparents Born in Japan|Participants|Number|0|0.0||||||
4217691|NCT00710879|4041084|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4217692|NCT00710879|4041085|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4217693|NCT00710879|4041086|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4217694|NCT00710879|4041084|B3||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4217695|NCT00710879|4041085|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4217696|NCT00710879|4041086|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4217697|NCT00710879|4041084|B3|Aged 18-64||Age, Customized||Participants|Number|177|177.0||||||
4217698|NCT00710879|4041085|B2|Aged 18-64||Age, Customized||Participants|Number|117|117.0||10.3|10.3|||
4217699|NCT00710879|4041086|B1|Aged 18-64||Age, Customized||Participants|Number|60|60.0||11.0|11.0|||
4217701|NCT00710866|4041098|B2|Canada||Region of Enrollment||participants|Number|128|128.0||||||
4217702|NCT00710866|4041099|B1|Canada||Region of Enrollment||participants|Number|124|124.0||||||
4217703|NCT00710866|4041097|B3||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4217704|NCT00710866|4041098|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4217705|NCT00710866|4041099|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4217706|NCT00710866|4041097|B3||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4217707|NCT00710866|4041098|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4217708|NCT00710866|4041099|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4217709|NCT00710866|4041097|B3|||Age||years|Mean|1.1|1.1|Standard Deviation|0.4|0.4|||
4217710|NCT00710866|4041098|B2|||Age||years|Mean|1.1|1.1|Standard Deviation|0.4|0.4|||
4217711|NCT00710866|4041099|B1|||Age||years|Mean|1.1|1.1|Standard Deviation|0.4|0.4|||
4217712|NCT00710866|4041097|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4217713|NCT00710866|4041098|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4217714|NCT00710866|4041099|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4217715|NCT00710866|4041097|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4217716|NCT00710866|4041098|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4217717|NCT00710866|4041099|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4217718|NCT00710866|4041097|B3||<=18 years|Age||Participants|Count of Participants|252|252.0||||||
4217719|NCT00710866|4041098|B2||<=18 years|Age||Participants|Count of Participants|128|128.0||||||
4217720|NCT00710866|4041099|B1||<=18 years|Age||Participants|Count of Participants|124|124.0||||||
4217721|NCT00710840|4041120|B3|||BMI||kg\m^2|Mean|30.9|30.9|Standard Deviation|5.4|5.4|||
4217722|NCT00710840|4041121|B2|||BMI||kg\m^2|Mean|31.3|31.3|Standard Deviation|5.1|5.1|||
4217723|NCT00710840|4041122|B1|||BMI||kg\m^2|Mean|30.5|30.5|Standard Deviation|5.6|5.6|||
4217724|NCT00710840|4041120|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
4217725|NCT00710840|4041121|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4217726|NCT00710840|4041122|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4217727|NCT00710840|4041120|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4217728|NCT00710840|4041121|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4217729|NCT00710840|4041122|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4217730|NCT00710840|4041120|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4217731|NCT00710840|4041121|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4217732|NCT00710840|4041122|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4217733|NCT00710840|4041120|B3|||Age||years|Mean|64.3|64.3|Standard Deviation|8.4|8.4|||
4217734|NCT00710840|4041121|B2|||Age||years|Mean|64.0|64.0|Standard Deviation|8.4|8.4|||
4217735|NCT00710840|4041122|B1|||Age||years|Mean|64.6|64.6|Standard Deviation|8.5|8.5|||
4217736|NCT00710814|4041135|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4217737|NCT00710814|4041136|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4217738|NCT00710814|4041137|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4217739|NCT00710814|4041135|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4217740|NCT00710814|4041136|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4217741|NCT00710814|4041137|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4217742|NCT00710814|4041135|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4217743|NCT00710814|4041136|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4217744|NCT00710814|4041137|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4217745|NCT00710814|4041135|B3|||Age||Years|Mean|47|47.0|Full Range|||29.0|61.0|
4217746|NCT00710814|4041136|B2|||Age||Years|Mean|42.76|42.76|Full Range|||29.0|56.0|
4217747|NCT00710814|4041137|B1|||Age||Years|Mean|50.93|50.93|Full Range|||42.0|61.0|
4217748|NCT00710814|4041135|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4217749|NCT00710814|4041136|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4217750|NCT00710814|4041137|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4217751|NCT00710814|4041135|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4217752|NCT00710814|4041136|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4217753|NCT00710814|4041137|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4217754|NCT00710814|4041135|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217755|NCT00710814|4041136|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217756|NCT00710814|4041137|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217757|NCT00710762|4041144|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4217758|NCT00710762|4041145|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4217759|NCT00710762|4041146|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4217760|NCT00710762|4041144|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4217761|NCT00710762|4041145|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4217762|NCT00710762|4041146|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4217763|NCT00710762|4041144|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|9.3|9.3|||
4217764|NCT00710762|4041145|B2|||Age||years|Mean|61.3|61.3|Standard Deviation|9.1|9.1|||
4217765|NCT00710762|4041146|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|9.5|9.5|||
4217766|NCT00710749|4041163|B1|United Kingdom||Region of Enrollment||participants|Number|29|29.0||||||
4217767|NCT00710749|4041163|B1|Netherlands||Region of Enrollment||participants|Number|13|13.0||||||
4217768|NCT00710749|4041163|B1|Poland||Region of Enrollment||participants|Number|16|16.0||||||
4217769|NCT00710749|4041163|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4217770|NCT00710749|4041163|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4217771|NCT00710749|4041163|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4217772|NCT00710749|4041163|B1|||Age||years|Mean|66|66.0|Standard Deviation|9.8|9.8|||
4217773|NCT00710684|4041172|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4217774|NCT00710684|4041173|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4217775|NCT00710684|4041174|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217776|NCT00710684|4041175|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217777|NCT00710684|4041172|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217778|NCT00710684|4041173|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217779|NCT00710684|4041174|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217780|NCT00710684|4041175|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217781|NCT00710684|4041172|B4||White|Race (NIH/OMB)||Participants|Count of Participants|671|671.0||||||
4217782|NCT00710684|4041173|B3||White|Race (NIH/OMB)||Participants|Count of Participants|233|233.0||||||
4217783|NCT00710684|4041174|B2||White|Race (NIH/OMB)||Participants|Count of Participants|215|215.0||||||
4217784|NCT00710684|4041175|B1||White|Race (NIH/OMB)||Participants|Count of Participants|223|223.0||||||
4217785|NCT00710684|4041172|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4217786|NCT00710684|4041173|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4217787|NCT00710684|4041174|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4217788|NCT00710684|4041175|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217789|NCT00710684|4041172|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217790|NCT00710684|4041173|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217791|NCT00710684|4041174|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217792|NCT00710684|4041175|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217793|NCT00710684|4041172|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217794|NCT00710684|4041173|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217795|NCT00710684|4041174|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217796|NCT00710684|4041175|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217797|NCT00710684|4041172|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217798|NCT00710684|4041173|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217799|NCT00710684|4041174|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217800|NCT00710684|4041175|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4217801|NCT00710684|4041172|B4||Male|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
4217802|NCT00710684|4041173|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4217803|NCT00710684|4041174|B2||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4217804|NCT00710684|4041175|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4217805|NCT00710684|4041172|B4||Female|Sex: Female, Male||Participants|Count of Participants|395|395.0||||||
4217806|NCT00710684|4041173|B3||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4217807|NCT00710684|4041174|B2||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4217808|NCT00710684|4041175|B1||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4217809|NCT00710684|4041172|B4|||Age||years|Mean|73.7|73.7|Standard Deviation|7.09|7.09|||
4217810|NCT00710684|4041173|B3|||Age||years|Mean|73.8|73.8|Standard Deviation|6.92|6.92|||
4217811|NCT00710684|4041174|B2|||Age||years|Mean|74.2|74.2|Standard Deviation|6.82|6.82|||
4217812|NCT00710684|4041175|B1|||Age||years|Mean|73.1|73.1|Standard Deviation|7.49|7.49|||
4217813|NCT00710606|4041232|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4217814|NCT00710606|4041233|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4217815|NCT00710606|4041234|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4217816|NCT00710606|4041232|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4217817|NCT00710606|4041233|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4217818|NCT00710606|4041234|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4217819|NCT00710606|4041232|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4217820|NCT00710606|4041233|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4217821|NCT00710606|4041234|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4217822|NCT00710606|4041232|B3|||Age||years|Mean|25.8|25.8|Standard Deviation|3.7|3.7|||
4217823|NCT00710606|4041233|B2|||Age||years|Mean|26.0|26.0|Standard Deviation|3.6|3.6|||
4217824|NCT00710606|4041234|B1|||Age||years|Mean|24.5|24.5|Standard Deviation|3.2|3.2|||
4217825|NCT00710606|4041232|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4217826|NCT00710606|4041233|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4217827|NCT00710606|4041234|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4217828|NCT00710606|4041232|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4217829|NCT00710606|4041233|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4217830|NCT00710606|4041234|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4217831|NCT00710606|4041232|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217832|NCT00710606|4041233|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217833|NCT00710606|4041234|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217834|NCT00710593|4041245|B3|Puerto Rico||Region of Enrollment||participants|Number|7|7.0||||||
4217835|NCT00710593|4041246|B2|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
4217836|NCT00710593|4041247|B1|Puerto Rico||Region of Enrollment||participants|Number|6|6.0||||||
4217837|NCT00710593|4041245|B3|United States||Region of Enrollment||participants|Number|92|92.0||||||
4217838|NCT00710593|4041246|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4217839|NCT00710593|4041247|B1|United States||Region of Enrollment||participants|Number|63|63.0||||||
4217840|NCT00710593|4041245|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4217841|NCT00710593|4041246|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4217842|NCT00710593|4041247|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4217843|NCT00710593|4041245|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4217844|NCT00710593|4041246|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4217845|NCT00710593|4041247|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4217846|NCT00710593|4041245|B3|> = 20 years||Age, Customized||Participants|Number|77|77.0||||||
4217847|NCT00710593|4041246|B2|> = 20 years||Age, Customized||Participants|Number|24|24.0||||||
4217848|NCT00710593|4041247|B1|> = 20 years||Age, Customized||Participants|Number|53|53.0||||||
4217849|NCT00710593|4041245|B3|< 20 years||Age, Customized||Participants|Number|22|22.0||||||
4217850|NCT00710593|4041246|B2|< 20 years||Age, Customized||Participants|Number|6|6.0||||||
4217851|NCT00710593|4041247|B1|< 20 years||Age, Customized||Participants|Number|16|16.0||||||
4217852|NCT00710554|4041289|B3|Romania||Region of Enrollment||participants|Number|13|13.0||||||
4217853|NCT00710554|4041290|B2|Romania||Region of Enrollment||participants|Number|5|5.0||||||
4217854|NCT00710554|4041291|B1|Romania||Region of Enrollment||participants|Number|8|8.0||||||
4217855|NCT00710554|4041289|B3|Czech Republic||Region of Enrollment||participants|Number|67|67.0||||||
4217856|NCT00710554|4041290|B2|Czech Republic||Region of Enrollment||participants|Number|32|32.0||||||
4217857|NCT00710554|4041291|B1|Czech Republic||Region of Enrollment||participants|Number|35|35.0||||||
4217858|NCT00710554|4041289|B3|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4217859|NCT00710554|4041290|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4217860|NCT00710554|4041291|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4217861|NCT00710554|4041289|B3|Belgium||Region of Enrollment||participants|Number|15|15.0||||||
4217862|NCT00710554|4041290|B2|Belgium||Region of Enrollment||participants|Number|7|7.0||||||
4217863|NCT00710554|4041291|B1|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
4217864|NCT00710554|4041289|B3|United Kingdom||Region of Enrollment||participants|Number|146|146.0||||||
4217865|NCT00710554|4041290|B2|United Kingdom||Region of Enrollment||participants|Number|72|72.0||||||
4217866|NCT00710554|4041291|B1|United Kingdom||Region of Enrollment||participants|Number|74|74.0||||||
4217867|NCT00710554|4041289|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4217868|NCT00710554|4041290|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4217869|NCT00710554|4041291|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4217870|NCT00710554|4041289|B3||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4217871|NCT00710554|4041290|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4217872|NCT00710554|4041291|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4217873|NCT00710554|4041289|B3|||Age||years|Mean|57.3|57.3|Standard Deviation|14.21|14.21|||
4217874|NCT00710554|4041290|B2|||Age||years|Mean|57|57.0|Standard Deviation|14.07|14.07|||
4217875|NCT00710554|4041291|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|14.38|14.38|||
4217876|NCT00710554|4041289|B3||>=65 years|Age||Participants|Count of Participants|67|67.0||||||
4217877|NCT00710554|4041290|B2||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4217878|NCT00710554|4041291|B1||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
4217879|NCT00710554|4041289|B3||Between 18 and 65 years|Age||Participants|Count of Participants|179|179.0||||||
4217880|NCT00710554|4041290|B2||Between 18 and 65 years|Age||Participants|Count of Participants|88|88.0||||||
4217881|NCT00710554|4041291|B1||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
4217882|NCT00710554|4041289|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217883|NCT00710554|4041290|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217884|NCT00710554|4041291|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217885|NCT00710424|4041318|B3|Romania||Region of Enrollment||participants|Number|49|49.0||||||
4217886|NCT00710424|4041319|B2|Romania||Region of Enrollment||participants|Number|25|25.0||||||
4217887|NCT00710424|4041320|B1|Romania||Region of Enrollment||participants|Number|24|24.0||||||
4217888|NCT00710424|4041318|B3|Czech Republic||Region of Enrollment||participants|Number|71|71.0||||||
4217889|NCT00710424|4041319|B2|Czech Republic||Region of Enrollment||participants|Number|37|37.0||||||
4217890|NCT00710424|4041320|B1|Czech Republic||Region of Enrollment||participants|Number|34|34.0||||||
4217891|NCT00710424|4041318|B3|United Kingdom||Region of Enrollment||participants|Number|177|177.0||||||
4217892|NCT00710424|4041319|B2|United Kingdom||Region of Enrollment||participants|Number|86|86.0||||||
4217893|NCT00710424|4041320|B1|United Kingdom||Region of Enrollment||participants|Number|91|91.0||||||
4217894|NCT00710424|4041318|B3||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4217895|NCT00710424|4041319|B2||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4217896|NCT00710424|4041320|B1||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4217897|NCT00710424|4041318|B3||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4217898|NCT00710424|4041319|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4217899|NCT00710424|4041320|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4217900|NCT00710424|4041318|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|10.54|10.54|||
4217901|NCT00710424|4041319|B2|||Age||years|Mean|58.2|58.2|Standard Deviation|10.57|10.57|||
4217902|NCT00710424|4041320|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|10.38|10.38|||
4217903|NCT00710424|4041318|B3||>=65 years|Age||Participants|Count of Participants|81|81.0||||||
4217904|NCT00710424|4041319|B2||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4217905|NCT00710424|4041320|B1||>=65 years|Age||Participants|Count of Participants|52|52.0||||||
4217906|NCT00710424|4041318|B3||Between 18 and 65 years|Age||Participants|Count of Participants|216|216.0||||||
4217907|NCT00710424|4041319|B2||Between 18 and 65 years|Age||Participants|Count of Participants|119|119.0||||||
4217908|NCT00710424|4041320|B1||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
4217909|NCT00710424|4041318|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217910|NCT00710424|4041319|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217911|NCT00710424|4041320|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217912|NCT00710385|4041345|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4217913|NCT00710385|4041345|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4217914|NCT00710385|4041345|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4217915|NCT00710385|4041345|B1|||Age||years|Mean|36.2|36.2|Standard Deviation|6.2|6.2|||
4217916|NCT00710385|4041345|B1||>=65 years|Age|verbal report verified by ID|Participants|Count of Participants|0|0.0||||||
4217917|NCT00710385|4041345|B1||Between 18 and 65 years|Age|verbal report verified by ID|Participants|Count of Participants|12|12.0||||||
4217918|NCT00710385|4041345|B1||<=18 years|Age|verbal report verified by ID|Participants|Count of Participants|0|0.0||||||
4217919|NCT00710203|4041362|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4217920|NCT00710203|4041362|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4217921|NCT00710203|4041362|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4217922|NCT00710203|4041362|B1|||Age||years|Mean|51.60|51.6|Standard Deviation|12.62|12.62|||
4217923|NCT00710203|4041362|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4217924|NCT00710203|4041362|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4217925|NCT00710203|4041362|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217926|NCT00710034|4041388|B3|United States||Region of Enrollment||participants|Number|391|391.0||||||
4217927|NCT00710034|4041389|B2|United States||Region of Enrollment||participants|Number|196|196.0||||||
4217928|NCT00710034|4041390|B1|United States||Region of Enrollment||participants|Number|195|195.0||||||
4217929|NCT00710034|4041388|B3||Male|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4217930|NCT00710034|4041389|B2||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4217931|NCT00710034|4041390|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4217932|NCT00710034|4041388|B3||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4217933|NCT00710034|4041389|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4217934|NCT00710034|4041390|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4217935|NCT00710034|4041388|B3|||Age||years|Mean|43.9|43.9|Standard Deviation|12.5|12.5|||
4217936|NCT00710034|4041389|B2|||Age||years|Mean|43.2|43.2|Standard Deviation|12.5|12.5|||
4217937|NCT00710034|4041390|B1|||Age||years|Mean|43.9|43.9|Standard Deviation|12.5|12.5|||
4217938|NCT00710034|4041388|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4217939|NCT00710034|4041389|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4217940|NCT00710034|4041390|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4217941|NCT00710034|4041388|B3||Between 18 and 65 years|Age||Participants|Count of Participants|391|391.0||||||
4217942|NCT00710034|4041389|B2||Between 18 and 65 years|Age||Participants|Count of Participants|196|196.0||||||
4217943|NCT00710034|4041390|B1||Between 18 and 65 years|Age||Participants|Count of Participants|195|195.0||||||
4217944|NCT00710034|4041388|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217945|NCT00710034|4041389|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217946|NCT00710034|4041390|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4217966|NCT00710021|4041408|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4217947|NCT00710021|4041405|B4|||Modified SELENA-SLEDAI Score|The modified Safety of Estrogens in Lupus Erythematosus National Assessment SLE Disease Activity Index (SELENA-SLEDAI) is calculated from 24 individual descriptors; scores may range from 0 (indicates inactive disease) to 105 (the maximum theoretical score). The SELENA-SLEDAI assesses disease activity for 10 days prior to and including the day of assessment. For this study, the SELENA-SLEDAI score was modified to include proteinuria defined by dipstick rather than 24 hour urine. A SELENA-SLEDAI score of 4 or less, indicative of stable disease, was a requirement to enter this study.|score|Mean|2.7|2.7|Standard Deviation|1.1|1.1|||
4217948|NCT00710021|4041406|B3|||Modified SELENA-SLEDAI Score|The modified Safety of Estrogens in Lupus Erythematosus National Assessment SLE Disease Activity Index (SELENA-SLEDAI) is calculated from 24 individual descriptors; scores may range from 0 (indicates inactive disease) to 105 (the maximum theoretical score). The SELENA-SLEDAI assesses disease activity for 10 days prior to and including the day of assessment. For this study, the SELENA-SLEDAI score was modified to include proteinuria defined by dipstick rather than 24 hour urine. A SELENA-SLEDAI score of 4 or less, indicative of stable disease, was a requirement to enter this study.|score|Mean|2.6|2.6|Standard Deviation|1.0|1.0|||
4217949|NCT00710021|4041407|B2|||Modified SELENA-SLEDAI Score|The modified Safety of Estrogens in Lupus Erythematosus National Assessment SLE Disease Activity Index (SELENA-SLEDAI) is calculated from 24 individual descriptors; scores may range from 0 (indicates inactive disease) to 105 (the maximum theoretical score). The SELENA-SLEDAI assesses disease activity for 10 days prior to and including the day of assessment. For this study, the SELENA-SLEDAI score was modified to include proteinuria defined by dipstick rather than 24 hour urine. A SELENA-SLEDAI score of 4 or less, indicative of stable disease, was a requirement to enter this study.|score|Mean|2.7|2.7|Standard Deviation|1.2|1.2|||
4217950|NCT00710021|4041408|B1|||Modified SELENA-SLEDAI Score|The modified Safety of Estrogens in Lupus Erythematosus National Assessment SLE Disease Activity Index (SELENA-SLEDAI) is calculated from 24 individual descriptors; scores may range from 0 (indicates inactive disease) to 105 (the maximum theoretical score). The SELENA-SLEDAI assesses disease activity for 10 days prior to and including the day of assessment. For this study, the SELENA-SLEDAI score was modified to include proteinuria defined by dipstick rather than 24 hour urine. A SELENA-SLEDAI score of 4 or less, indicative of stable disease, was a requirement to enter this study.|score|Mean|2.9|2.9|Standard Deviation|1.2|1.2|||
4217951|NCT00710021|4041405|B4|||Number of American College of Rheumatology (ACR) Criteria met at Screening|The diagnosis of SLE is made using the American College of Rheumatology (ACR) criteria. The presence of 4 or more of the following 11 ACR criteria is diagnostic for lupus and was required to participate in this trial: malar rash, discoid rash, photosensitive skin rash, oral ulcers, nonerosive arthritis, pleuritis/pericarditis, renal disorder, neurologic disorder, hematologic disorder, immunologic disorder, and a positive antinuclear antibody (ANA) test. Reference: Arthritis Rheum 1997; 40(9): 1725.|number of criteria met|Mean|5.6|5.6|Standard Deviation|1.2|1.2|||
4217952|NCT00710021|4041406|B3|||Number of American College of Rheumatology (ACR) Criteria met at Screening|The diagnosis of SLE is made using the American College of Rheumatology (ACR) criteria. The presence of 4 or more of the following 11 ACR criteria is diagnostic for lupus and was required to participate in this trial: malar rash, discoid rash, photosensitive skin rash, oral ulcers, nonerosive arthritis, pleuritis/pericarditis, renal disorder, neurologic disorder, hematologic disorder, immunologic disorder, and a positive antinuclear antibody (ANA) test. Reference: Arthritis Rheum 1997; 40(9): 1725.|number of criteria met|Mean|5.8|5.8|Standard Deviation|1.3|1.3|||
4217953|NCT00710021|4041407|B2|||Number of American College of Rheumatology (ACR) Criteria met at Screening|The diagnosis of SLE is made using the American College of Rheumatology (ACR) criteria. The presence of 4 or more of the following 11 ACR criteria is diagnostic for lupus and was required to participate in this trial: malar rash, discoid rash, photosensitive skin rash, oral ulcers, nonerosive arthritis, pleuritis/pericarditis, renal disorder, neurologic disorder, hematologic disorder, immunologic disorder, and a positive antinuclear antibody (ANA) test. Reference: Arthritis Rheum 1997; 40(9): 1725.|number of criteria met|Mean|5.5|5.5|Standard Deviation|1.1|1.1|||
4217954|NCT00710021|4041408|B1|||Number of American College of Rheumatology (ACR) Criteria met at Screening|The diagnosis of SLE is made using the American College of Rheumatology (ACR) criteria. The presence of 4 or more of the following 11 ACR criteria is diagnostic for lupus and was required to participate in this trial: malar rash, discoid rash, photosensitive skin rash, oral ulcers, nonerosive arthritis, pleuritis/pericarditis, renal disorder, neurologic disorder, hematologic disorder, immunologic disorder, and a positive antinuclear antibody (ANA) test. Reference: Arthritis Rheum 1997; 40(9): 1725.|number of criteria met|Mean|5.4|5.4|Standard Deviation|1.3|1.3|||
4217955|NCT00710021|4041405|B4|||Years with Systemic Lupus Erythematosus (SLE) at Baseline|Years since systemic lupus erythematosus was diagnosed by a physician. This information was obtained by medical history during the Baseline visit.|years|Mean|9.9|9.9|Standard Deviation|7.1|7.1|||
4217956|NCT00710021|4041406|B3|||Years with Systemic Lupus Erythematosus (SLE) at Baseline|Years since systemic lupus erythematosus was diagnosed by a physician. This information was obtained by medical history during the Baseline visit.|years|Mean|8.7|8.7|Standard Deviation|6.0|6.0|||
4217957|NCT00710021|4041407|B2|||Years with Systemic Lupus Erythematosus (SLE) at Baseline|Years since systemic lupus erythematosus was diagnosed by a physician. This information was obtained by medical history during the Baseline visit.|years|Mean|10.0|10.0|Standard Deviation|7.8|7.8|||
4217958|NCT00710021|4041408|B1|||Years with Systemic Lupus Erythematosus (SLE) at Baseline|Years since systemic lupus erythematosus was diagnosed by a physician. This information was obtained by medical history during the Baseline visit.|years|Mean|10.9|10.9|Standard Deviation|7.8|7.8|||
4217959|NCT00710021|4041405|B4|United States||Region of Enrollment||participants|Number|54|54.0||||||
4217960|NCT00710021|4041406|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4217961|NCT00710021|4041407|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4217962|NCT00710021|4041408|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4217963|NCT00710021|4041405|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4217964|NCT00710021|4041406|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4217965|NCT00710021|4041407|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4217967|NCT00710021|4041405|B4||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4217968|NCT00710021|4041406|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4217969|NCT00710021|4041407|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4217970|NCT00710021|4041408|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4217971|NCT00710021|4041405|B4|||Age||years|Mean|37.9|37.9|Standard Deviation|11.9|11.9|||
4217972|NCT00710021|4041406|B3|||Age||years|Mean|38.3|38.3|Standard Deviation|12.9|12.9|||
4217973|NCT00710021|4041407|B2|||Age||years|Mean|36.5|36.5|Standard Deviation|10.9|10.9|||
4217974|NCT00710021|4041408|B1|||Age||years|Mean|38.7|38.7|Standard Deviation|12.3|12.3|||
4217975|NCT00709956|4041523|B3|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4217976|NCT00709956|4041524|B2|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4217977|NCT00709956|4041525|B1|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4217978|NCT00709956|4041523|B3|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4217979|NCT00709956|4041524|B2|Austria||Region of Enrollment||participants|Number|2|2.0||||||
4217980|NCT00709956|4041525|B1|Austria||Region of Enrollment||participants|Number|2|2.0||||||
4217981|NCT00709956|4041523|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
4217982|NCT00709956|4041524|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4217983|NCT00709956|4041525|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4217984|NCT00709956|4041523|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4217985|NCT00709956|4041524|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4217986|NCT00709956|4041525|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4217987|NCT00709956|4041523|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4217988|NCT00709956|4041524|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4217989|NCT00709956|4041525|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4217990|NCT00709956|4041523|B3|||Age||years|Mean|55.7|55.7|Standard Deviation|14.98|14.98|||
4217991|NCT00709956|4041524|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|16.40|16.4|||
4217992|NCT00709956|4041525|B1|||Age||years|Mean|55.5|55.5|Standard Deviation|13.57|13.57|||
4217993|NCT00709956|4041523|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4217994|NCT00709956|4041524|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4217995|NCT00709956|4041525|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4217996|NCT00709956|4041523|B3||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4217997|NCT00709956|4041524|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4217998|NCT00709956|4041525|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4217999|NCT00709956|4041523|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4218000|NCT00709956|4041524|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4218001|NCT00709956|4041525|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4218002|NCT00709891|4041534|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4218003|NCT00709891|4041534|B1||Female|Sex: Female, Male||Participants|Count of Participants|46887|46887.0||||||
4218004|NCT00709891|4041534|B1|||Age||years|Mean|39.8|39.8|Standard Deviation|12.3|12.3|||
4218005|NCT00709878|4041539|B5|United States||Region of Enrollment||participants|Number|32|32.0||||||
4218006|NCT00709878|4041540|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
4218007|NCT00709878|4041541|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4218008|NCT00709878|4041542|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4218009|NCT00709878|4041543|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4218010|NCT00709878|4041539|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4218011|NCT00709878|4041540|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4218012|NCT00709878|4041541|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4218013|NCT00709878|4041542|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4218014|NCT00709878|4041543|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4218015|NCT00709878|4041539|B5||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4218016|NCT00709878|4041540|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4218017|NCT00709878|4041541|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4218018|NCT00709878|4041542|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4218019|NCT00709878|4041543|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4218020|NCT00709878|4041539|B5|||Age||years|Mean|60.35|60.35|Full Range|||17.0|81.0|
4218021|NCT00709878|4041540|B4|||Age||years|Mean|66.7|66.7|Full Range|||46.0|81.0|
4218022|NCT00709878|4041541|B3|||Age||years|Mean|65|65.0|Full Range|||39.0|81.0|
4218023|NCT00709878|4041542|B2|||Age||years|Mean|54.5|54.5|Full Range|||34.0|72.0|
4218024|NCT00709878|4041543|B1|||Age||years|Mean|55.7|55.7|Full Range|||17.0|62.0|
4218025|NCT00709852|4041556|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4218026|NCT00709852|4041556|B1|Asian||Race/Ethnicity, Customized||participants|Number|112|112.0||||||
4218027|NCT00709852|4041556|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4218028|NCT00709852|4041556|B1|Black||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4218029|NCT00709852|4041556|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|235|235.0||||||
4218030|NCT00709852|4041556|B1||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4218031|NCT00709852|4041556|B1||Female|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
4218032|NCT00709852|4041556|B1|≥ 65 years||Age, Customized||participants|Number|94|94.0||||||
4218033|NCT00709852|4041556|B1|45-64 years||Age, Customized||participants|Number|164|164.0||||||
4218034|NCT00709852|4041556|B1|< 45 years||Age, Customized||participants|Number|144|144.0||||||
4218035|NCT00709826|4041710|B3|United States||Region of Enrollment||participants|Number|109|109.0||||||
4218036|NCT00709826|4041711|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
4218037|NCT00709826|4041712|B1|United States||Region of Enrollment||participants|Number|70|70.0||||||
4218038|NCT00709826|4041710|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4218039|NCT00709826|4041711|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4218040|NCT00709826|4041712|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4218041|NCT00709826|4041710|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4218042|NCT00709826|4041711|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4218043|NCT00709826|4041712|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4218044|NCT00709826|4041710|B3|||Age||years|Mean|64|64.0|Standard Deviation|64.8|64.8|||
4218045|NCT00709826|4041711|B2|||Age||years|Mean|67|67.0|Standard Deviation|66|66.0|||
4218046|NCT00709826|4041712|B1|||Age||years|Mean|63|63.0|Standard Deviation|64.2|64.2|||
4218047|NCT00709826|4041710|B3||>=65 years|Age||Participants|Count of Participants|54|54.0||||||
4218048|NCT00709826|4041711|B2||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4218049|NCT00709826|4041712|B1||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4218050|NCT00709826|4041710|B3||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4218051|NCT00709826|4041711|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4218052|NCT00709826|4041712|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4218053|NCT00709826|4041710|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4218054|NCT00709826|4041711|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4218055|NCT00709826|4041712|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4218056|NCT00709761|4041721|B1|American Indian of Alaska Native and White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4218057|NCT00709761|4041721|B1|Native Hawaiian of other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4218058|NCT00709761|4041721|B1|Japanese/East Asian Her./South East Asian Her.||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4218059|NCT00709761|4041721|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4218060|NCT00709761|4041721|B1|African American/African Heritage (Her.)||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4218061|NCT00709761|4041721|B1|White||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
4218062|NCT00709761|4041721|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4218063|NCT00709761|4041721|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4218064|NCT00709761|4041721|B1|||Age||Years|Mean|56.7|56.7|Standard Deviation|12.78|12.78|||
4218065|NCT00709735|4041730|B3|||Clinician-Administered PTSD Scale (CAPS) Score|The clinician evaluated the overall frequency and intensity/severity of the participant’s PTSD symptoms using the CAPS. 17 Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) PTSD symptoms were assessed using a 5-point scale for intensity where 0=none to 4=extreme and a 5-point scale for frequency where 0=never to 4=most or all of the time. The intensity score and the frequency scores were added together for a total possible score of 0 (best) to 136 (worst).|score on a scale|Mean|60.9|60.9|Standard Deviation|14.2|14.2|||
4218066|NCT00709735|4041731|B2|||Clinician-Administered PTSD Scale (CAPS) Score|The clinician evaluated the overall frequency and intensity/severity of the participant’s PTSD symptoms using the CAPS. 17 Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) PTSD symptoms were assessed using a 5-point scale for intensity where 0=none to 4=extreme and a 5-point scale for frequency where 0=never to 4=most or all of the time. The intensity score and the frequency scores were added together for a total possible score of 0 (best) to 136 (worst).|score on a scale|Mean|62.7|62.7|Standard Deviation|13.7|13.7|||
4218067|NCT00709735|4041732|B1|||Clinician-Administered PTSD Scale (CAPS) Score|The clinician evaluated the overall frequency and intensity/severity of the participant’s PTSD symptoms using the CAPS. 17 Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) PTSD symptoms were assessed using a 5-point scale for intensity where 0=none to 4=extreme and a 5-point scale for frequency where 0=never to 4=most or all of the time. The intensity score and the frequency scores were added together for a total possible score of 0 (best) to 136 (worst).|score on a scale|Mean|58.6|58.6|Standard Deviation|14.8|14.8|||
4218068|NCT00709735|4041730|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4218069|NCT00709735|4041731|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4218070|NCT00709735|4041732|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4218071|NCT00709735|4041730|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4218072|NCT00709735|4041731|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4218073|NCT00709735|4041732|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4218074|NCT00709735|4041730|B3|||Age||years|Mean|36.1|36.1|Standard Deviation|13.3|13.3|||
4218075|NCT00709735|4041731|B2|||Age||years|Mean|38.7|38.7|Standard Deviation|14.9|14.9|||
4218076|NCT00709735|4041732|B1|||Age||years|Mean|33.3|33.3|Standard Deviation|11.5|11.5|||
4218077|NCT00709722|4041741|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218078|NCT00709722|4041741|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218079|NCT00709722|4041741|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4218080|NCT00709722|4041741|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218081|NCT00709722|4041741|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218082|NCT00709722|4041741|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218083|NCT00709722|4041741|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218084|NCT00709722|4041741|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
4218085|NCT00709722|4041741|B1||Female|Gender||Participants|Count of Participants|17|17.0||||||
4218086|NCT00709722|4041741|B1|||Age||Years|Mean|31.3|31.3|Full Range|||19.0|46.0|
4218087|NCT00709722|4041741|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4218088|NCT00709722|4041741|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4218089|NCT00709722|4041741|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4218090|NCT00709696|4041747|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4218091|NCT00709696|4041748|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4218092|NCT00709696|4041749|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4218093|NCT00709696|4041747|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4218094|NCT00709696|4041748|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4218095|NCT00709696|4041749|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4218096|NCT00709696|4041747|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4218097|NCT00709696|4041748|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4218098|NCT00709696|4041749|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4218099|NCT00709696|4041747|B3|||Age||years|Mean|32.0|32.0|Standard Deviation|9.1|9.1|||
4218100|NCT00709696|4041748|B2|||Age||years|Mean|38.3|38.3|Standard Deviation|9.7|9.7|||
4218101|NCT00709696|4041749|B1|||Age||years|Mean|27.3|27.3|Standard Deviation|5.69|5.69|||
4218102|NCT00709696|4041747|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4218103|NCT00709696|4041748|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4218104|NCT00709696|4041749|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4218105|NCT00709696|4041747|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4218106|NCT00709696|4041748|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4218107|NCT00709696|4041749|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4218108|NCT00709696|4041747|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4218109|NCT00709696|4041748|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4218110|NCT00709696|4041749|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4218111|NCT00709618|4041756|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4218112|NCT00709618|4041756|B1|White||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4218113|NCT00709618|4041756|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4218114|NCT00709618|4041756|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4218115|NCT00709618|4041756|B1|||Age||Years|Mean|56.2|56.2|Standard Deviation|12.49|12.49|||
4218116|NCT00709592|4041766|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4218117|NCT00709592|4041767|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4218118|NCT00709592|4041768|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4218119|NCT00709592|4041766|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4218120|NCT00709592|4041767|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4218121|NCT00709592|4041768|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4218122|NCT00709592|4041766|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4218123|NCT00709592|4041767|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4218124|NCT00709592|4041768|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4218125|NCT00709592|4041766|B3|||Age||years|Median|57|57.0|Full Range|||40.0|69.0|
4218126|NCT00709592|4041767|B2|||Age||years|Median|57|57.0|Full Range|||40.0|68.0|
4218127|NCT00709592|4041768|B1|||Age||years|Median|57|57.0|Full Range|||44.0|69.0|
4218128|NCT00709319|4041791|B1|No||Surgery characteristic: Scatter laser over peripheral schisis or barrier laser used||Participants|Number|83|83.0||||||
4218129|NCT00709319|4041791|B1|Yes||Surgery characteristic: Scatter laser over peripheral schisis or barrier laser used||Participants|Number|4|4.0||||||
4218130|NCT00709319|4041791|B1|No||Surgery characteristic: Laser used with indirect ophthalmoscope||Participants|Number|80|80.0||||||
4218131|NCT00709319|4041791|B1|Yes||Surgery characteristic: Laser used with indirect ophthalmoscope||Participants|Number|7|7.0||||||
4218132|NCT00709319|4041791|B1|No||Surgery characteristic: Laser used with endoprobe||Participants|Number|66|66.0||||||
4218133|NCT00709319|4041791|B1|Yes||Surgery characteristic: Laser used with endoprobe||Participants|Number|21|21.0||||||
4218134|NCT00709319|4041791|B1|No||Surgery characteristic: Panretinal photocoagulation, with none used prior||Participants|Number|68|68.0||||||
4218135|NCT00709319|4041791|B1|Yes||Surgery characteristic: Panretinal photocoagulation, with none used prior||Participants|Number|19|19.0||||||
4218136|NCT00709319|4041791|B1|No||Trypan blue used to improve visualization||Participants|Number|85|85.0||||||
4218137|NCT00709319|4041791|B1|Yes||Trypan blue used to improve visualization||Participants|Number|2|2.0||||||
4218138|NCT00709319|4041791|B1|No||Reasons for Vitrectomy: Unresponsive to other therapies||Participants|Number|60|60.0||||||
4218139|NCT00709319|4041791|B1|Yes||Reasons for Vitrectomy: Unresponsive to other therapies||Participants|Number|27|27.0||||||
4218140|NCT00709319|4041791|B1|||Retinal Volume||mm3|Median|9.2|9.2|Inter-Quartile Range|||8.5|11.8|
4218141|NCT00709319|4041791|B1|||Hemoglobin A1c||Percent|Median|7.1|7.1|Inter-Quartile Range|||6.7|7.9|
4218142|NCT00709319|4041791|B1|||Electronic-Early Treatment Diabetic Retinopathy Study Visual Acuity Letter Score|Visual Acuity Letter Score Scale: 100 being the best and 0 the worst|Number on a Scale|Median|52|52.0|Inter-Quartile Range|||41.0|58.0|
4218143|NCT00709319|4041791|B1|||Duration of Diabetes||Years|Median|20|20.0|Inter-Quartile Range|||12.0|25.0|
4218144|NCT00709319|4041791|B1|||Central Subfield Thickness||Microns|Median|491|491.0|Inter-Quartile Range|||356.0|586.0|
4218145|NCT00709319|4041791|B1|No||Surgical Charachteristic:Epiretinal membrane peeled||Participants|Number|34|34.0||||||
4218146|NCT00709319|4041791|B1|Yes||Surgical Charachteristic:Epiretinal membrane peeled||Participants|Number|53|53.0||||||
4218147|NCT00709319|4041791|B1|23 gauge||Surgical Characteristic: Vitrectomy System||Participants|Number|9|9.0||||||
4218148|NCT00709319|4041791|B1|25 gauge||Surgical Characteristic: Vitrectomy System||Participants|Number|43|43.0||||||
4218149|NCT00709319|4041791|B1|19/20 gauge||Surgical Characteristic: Vitrectomy System||Participants|Number|35|35.0||||||
4218150|NCT00709319|4041791|B1|No||Surgical Characteristic: Focal to grid breaks Laser Used||Participants|Number|73|73.0||||||
4218151|NCT00709319|4041791|B1|Yes||Surgical Characteristic: Focal to grid breaks Laser Used||Participants|Number|14|14.0||||||
4218152|NCT00709319|4041791|B1|No||Surgical Characteristic: Internal Limiting Membrane Removed||Participants|Number|40|40.0||||||
4218153|NCT00709319|4041791|B1|Yes||Surgical Characteristic: Internal Limiting Membrane Removed||Participants|Number|47|47.0||||||
4218154|NCT00709319|4041791|B1|No||Triamcinolone acetonide used to improve visualization|Same subjects could be listed for multiple categories|Participants|Number|57|57.0||||||
4218155|NCT00709319|4041791|B1|Yes||Triamcinolone acetonide used to improve visualization|Same subjects could be listed for multiple categories|Participants|Number|30|30.0||||||
4218156|NCT00709319|4041791|B1|Uncertain||Status of the Vitreous|Status determined from investigators observations at enrollment.|Participants|Number|5|5.0||||||
4218157|NCT00709319|4041791|B1|Detached||Status of the Vitreous|Status determined from investigators observations at enrollment.|Participants|Number|5|5.0||||||
4218158|NCT00709319|4041791|B1|Partially Attached||Status of the Vitreous|Status determined from investigators observations at enrollment.|Participants|Number|28|28.0||||||
4218159|NCT00709319|4041791|B1|Attached||Status of the Vitreous|Status determined from investigators observations at enrollment.|Participants|Number|49|49.0||||||
4218160|NCT00709319|4041791|B1|Retinal volume not obtained||Retinopathy Severity||Participants|Number|11|11.0||||||
4218161|NCT00709319|4041791|B1|Proliferative diabetic retinopathy||Retinopathy Severity||Participants|Number|51|51.0||||||
4218162|NCT00709319|4041791|B1|Severe nonproliferative diabetic retinopathy||Retinopathy Severity||Participants|Number|4|4.0||||||
4218163|NCT00709319|4041791|B1|Moderate/severe nonproliferative diabetic retinopa||Retinopathy Severity||Participants|Number|14|14.0||||||
4218164|NCT00709319|4041791|B1|Mild/moderate nonproliferative diabetic retinopath||Retinopathy Severity||Participants|Number|6|6.0||||||
4218165|NCT00709319|4041791|B1|Microaneurysms only||Retinopathy Severity||Participants|Number|1|1.0||||||
4218166|NCT00709319|4041791|B1|||Reasons for Vitrectomy: Vitreomacular interface abnormality||Participants|Number|87|87.0||||||
4218167|NCT00709319|4041791|B1|No||Prior Treatment for Diabetic Macular Edema||Participants|Number|36|36.0||||||
4218168|NCT00709319|4041791|B1|Yes||Prior Treatment for Diabetic Macular Edema||Participants|Number|51|51.0||||||
4218169|NCT00709319|4041791|B1|No||Prior Scatter Photocoagulation||Participants|Number|48|48.0||||||
4218170|NCT00709319|4041791|B1|Yes||Prior Scatter Photocoagulation||Participants|Number|39|39.0||||||
4218171|NCT00709319|4041791|B1|Pseudophakic/aphakic||Lens Status||Participants|Number|50|50.0||||||
4218172|NCT00709319|4041791|B1|Phakic||Lens Status||Participants|Number|37|37.0||||||
4218173|NCT00709319|4041791|B1|Can not deterimine||Epiretinal Membranes Present|Assessment based on investigators assessment at enrollment.|Participants|Number|4|4.0||||||
4218174|NCT00709319|4041791|B1|Definite||Epiretinal Membranes Present|Assessment based on investigators assessment at enrollment.|Participants|Number|43|43.0||||||
4218175|NCT00709319|4041791|B1|Probable||Epiretinal Membranes Present|Assessment based on investigators assessment at enrollment.|Participants|Number|19|19.0||||||
4218176|NCT00709319|4041791|B1|No||Epiretinal Membranes Present|Assessment based on investigators assessment at enrollment.|Participants|Number|21|21.0||||||
4218177|NCT00709319|4041791|B1|Type 2||Diabetes Type||Participants|Number|73|73.0||||||
4218178|NCT00709319|4041791|B1|Type 1||Diabetes Type||Participants|Number|14|14.0||||||
4218179|NCT00709319|4041791|B1|No||Indocyanine green used to improve visualization||Participants|Number|63|63.0||||||
4218180|NCT00709319|4041791|B1|Yes||Indocyanine green used to improve visualization||Participants|Number|24|24.0||||||
4218181|NCT00709319|4041791|B1|No||Surgery characteristic: Panretinal photocoagulation, history of prior use||Participants|Number|71|71.0||||||
4218182|NCT00709319|4041791|B1|Yes||Surgery characteristic: Panretinal photocoagulation, history of prior use||Participants|Number|16|16.0||||||
4218183|NCT00709319|4041791|B1|No||Surgery characteristic: Focal/grid laser to diabetic macular edema used||Participants|Number|83|83.0||||||
4218184|NCT00709319|4041791|B1|Yes||Surgery characteristic: Focal/grid laser to diabetic macular edema used||Participants|Number|4|4.0||||||
4218185|NCT00709319|4041791|B1|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4218186|NCT00709319|4041791|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4218187|NCT00709319|4041791|B1|African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4218188|NCT00709319|4041791|B1|White||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
4218189|NCT00709319|4041791|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4218190|NCT00709319|4041791|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4218191|NCT00709319|4041791|B1|||Age, Customized||Years|Median|66|66.0|Inter-Quartile Range|||60.0|72.0|
4218192|NCT00709306|4041799|B5||data missing|Stage of Change Scale|The Sun Stage of Change (SOC) Scale has 4 items asking participants whether they have been protecting their skin for the past year (maintenance), if they protect their skin now (action), whether they intend to protect their skin in the next 30 days (preparation), whether they intend to protect their skin in the next year (contemplation), or none of the above (pre-contemplation).|Participants|Count of Participants|3|3.0||||||
4218193|NCT00709306|4041800|B4||data missing|Stage of Change Scale|The Sun Stage of Change (SOC) Scale has 4 items asking participants whether they have been protecting their skin for the past year (maintenance), if they protect their skin now (action), whether they intend to protect their skin in the next 30 days (preparation), whether they intend to protect their skin in the next year (contemplation), or none of the above (pre-contemplation).|Participants|Count of Participants|2|2.0||||||
4218194|NCT00709306|4041801|B3||data missing|Stage of Change Scale|The Sun Stage of Change (SOC) Scale has 4 items asking participants whether they have been protecting their skin for the past year (maintenance), if they protect their skin now (action), whether they intend to protect their skin in the next 30 days (preparation), whether they intend to protect their skin in the next year (contemplation), or none of the above (pre-contemplation).|Participants|Count of Participants|1|1.0||||||
4218195|NCT00709306|4041802|B2||data missing|Stage of Change Scale|The Sun Stage of Change (SOC) Scale has 4 items asking participants whether they have been protecting their skin for the past year (maintenance), if they protect their skin now (action), whether they intend to protect their skin in the next 30 days (preparation), whether they intend to protect their skin in the next year (contemplation), or none of the above (pre-contemplation).|Participants|Count of Participants|0|0.0||||||
4218196|NCT00709306|4041803|B1||data missing|Stage of Change Scale|The Sun Stage of Change (SOC) Scale has 4 items asking participants whether they have been protecting their skin for the past year (maintenance), if they protect their skin now (action), whether they intend to protect their skin in the next 30 days (preparation), whether they intend to protect their skin in the next year (contemplation), or none of the above (pre-contemplation).|Participants|Count of Participants|0|0.0||||||
4218197|NCT00709306|4041799|B5||Maintenance|Stage of Change Scale|The Sun Stage of Change (SOC) Scale has 4 items asking participants whether they have been protecting their skin for the past year (maintenance), if they protect their skin now (action), whether they intend to protect their skin in the next 30 days (preparation), whether they intend to protect their skin in the next year (contemplation), or none of the above (pre-contemplation).|Participants|Count of Participants|42|42.0||||||
4218198|NCT00709306|4041800|B4||Maintenance|Stage of Change Scale|The Sun Stage of Change (SOC) Scale has 4 items asking participants whether they have been protecting their skin for the past year (maintenance), if they protect their skin now (action), whether they intend to protect their skin in the next 30 days (preparation), whether they intend to protect their skin in the next year (contemplation), or none of the above (pre-contemplation).|Participants|Count of Participants|10|10.0||||||
4218199|NCT00709306|4041801|B3||Maintenance|Stage of Change Scale|The Sun Stage of Change (SOC) Scale has 4 items asking participants whether they have been protecting their skin for the past year (maintenance), if they protect their skin now (action), whether they intend to protect their skin in the next 30 days (preparation), whether they intend to protect their skin in the next year (contemplation), or none of the above (pre-contemplation).|Participants|Count of Participants|9|9.0||||||
4218200|NCT00709306|4041802|B2||Maintenance|Stage of Change Scale|The Sun Stage of Change (SOC) Scale has 4 items asking participants whether they have been protecting their skin for the past year (maintenance), if they protect their skin now (action), whether they intend to protect their skin in the next 30 days (preparation), whether they intend to protect their skin in the next year (contemplation), or none of the above (pre-contemplation).|Participants|Count of Participants|10|10.0||||||
4218201|NCT00709306|4041803|B1||Maintenance|Stage of Change Scale|The Sun Stage of Change (SOC) Scale has 4 items asking participants whether they have been protecting their skin for the past year (maintenance), if they protect their skin now (action), whether they intend to protect their skin in the next 30 days (preparation), whether they intend to protect their skin in the next year (contemplation), or none of the above (pre-contemplation).|Participants|Count of Participants|13|13.0||||||
4218202|NCT00709306|4041799|B5||Action|Stage of Change Scale|The Sun Stage of Change (SOC) Scale has 4 items asking participants whether they have been protecting their skin for the past year (maintenance), if they protect their skin now (action), whether they intend to protect their skin in the next 30 days (preparation), whether they intend to protect their skin in the next year (contemplation), or none of the above (pre-contemplation).|Participants|Count of Participants|16|16.0||||||
4218203|NCT00709306|4041800|B4||Action|Stage of Change Scale|The Sun Stage of Change (SOC) Scale has 4 items asking participants whether they have been protecting their skin for the past year (maintenance), if they protect their skin now (action), whether they intend to protect their skin in the next 30 days (preparation), whether they intend to protect their skin in the next year (contemplation), or none of the above (pre-contemplation).|Participants|Count of Participants|2|2.0||||||
4218204|NCT00709306|4041801|B3||Action|Stage of Change Scale|The Sun Stage of Change (SOC) Scale has 4 items asking participants whether they have been protecting their skin for the past year (maintenance), if they protect their skin now (action), whether they intend to protect their skin in the next 30 days (preparation), whether they intend to protect their skin in the next year (contemplation), or none of the above (pre-contemplation).|Participants|Count of Participants|6|6.0||||||
4218205|NCT00709306|4041802|B2||Action|Stage of Change Scale|The Sun Stage of Change (SOC) Scale has 4 items asking participants whether they have been protecting their skin for the past year (maintenance), if they protect their skin now (action), whether they intend to protect their skin in the next 30 days (preparation), whether they intend to protect their skin in the next year (contemplation), or none of the above (pre-contemplation).|Participants|Count of Participants|3|3.0||||||
4218206|NCT00709306|4041803|B1||Action|Stage of Change Scale|The Sun Stage of Change (SOC) Scale has 4 items asking participants whether they have been protecting their skin for the past year (maintenance), if they protect their skin now (action), whether they intend to protect their skin in the next 30 days (preparation), whether they intend to protect their skin in the next year (contemplation), or none of the above (pre-contemplation).|Participants|Count of Participants|5|5.0||||||
4218207|NCT00709306|4041799|B5||Preparation|Stage of Change Scale|The Sun Stage of Change (SOC) Scale has 4 items asking participants whether they have been protecting their skin for the past year (maintenance), if they protect their skin now (action), whether they intend to protect their skin in the next 30 days (preparation), whether they intend to protect their skin in the next year (contemplation), or none of the above (pre-contemplation).|Participants|Count of Participants|48|48.0||||||
4218208|NCT00709306|4041800|B4||Preparation|Stage of Change Scale|The Sun Stage of Change (SOC) Scale has 4 items asking participants whether they have been protecting their skin for the past year (maintenance), if they protect their skin now (action), whether they intend to protect their skin in the next 30 days (preparation), whether they intend to protect their skin in the next year (contemplation), or none of the above (pre-contemplation).|Participants|Count of Participants|14|14.0||||||
4218209|NCT00709306|4041801|B3||Preparation|Stage of Change Scale|The Sun Stage of Change (SOC) Scale has 4 items asking participants whether they have been protecting their skin for the past year (maintenance), if they protect their skin now (action), whether they intend to protect their skin in the next 30 days (preparation), whether they intend to protect their skin in the next year (contemplation), or none of the above (pre-contemplation).|Participants|Count of Participants|14|14.0||||||
4218210|NCT00709306|4041802|B2||Preparation|Stage of Change Scale|The Sun Stage of Change (SOC) Scale has 4 items asking participants whether they have been protecting their skin for the past year (maintenance), if they protect their skin now (action), whether they intend to protect their skin in the next 30 days (preparation), whether they intend to protect their skin in the next year (contemplation), or none of the above (pre-contemplation).|Participants|Count of Participants|12|12.0||||||
4218211|NCT00709306|4041803|B1||Preparation|Stage of Change Scale|The Sun Stage of Change (SOC) Scale has 4 items asking participants whether they have been protecting their skin for the past year (maintenance), if they protect their skin now (action), whether they intend to protect their skin in the next 30 days (preparation), whether they intend to protect their skin in the next year (contemplation), or none of the above (pre-contemplation).|Participants|Count of Participants|8|8.0||||||
4218212|NCT00709306|4041799|B5||Contemplation|Stage of Change Scale|The Sun Stage of Change (SOC) Scale has 4 items asking participants whether they have been protecting their skin for the past year (maintenance), if they protect their skin now (action), whether they intend to protect their skin in the next 30 days (preparation), whether they intend to protect their skin in the next year (contemplation), or none of the above (pre-contemplation).|Participants|Count of Participants|17|17.0||||||
4218213|NCT00709306|4041800|B4||Contemplation|Stage of Change Scale|The Sun Stage of Change (SOC) Scale has 4 items asking participants whether they have been protecting their skin for the past year (maintenance), if they protect their skin now (action), whether they intend to protect their skin in the next 30 days (preparation), whether they intend to protect their skin in the next year (contemplation), or none of the above (pre-contemplation).|Participants|Count of Participants|4|4.0||||||
4218214|NCT00709306|4041801|B3||Contemplation|Stage of Change Scale|The Sun Stage of Change (SOC) Scale has 4 items asking participants whether they have been protecting their skin for the past year (maintenance), if they protect their skin now (action), whether they intend to protect their skin in the next 30 days (preparation), whether they intend to protect their skin in the next year (contemplation), or none of the above (pre-contemplation).|Participants|Count of Participants|4|4.0||||||
4218215|NCT00709306|4041802|B2||Contemplation|Stage of Change Scale|The Sun Stage of Change (SOC) Scale has 4 items asking participants whether they have been protecting their skin for the past year (maintenance), if they protect their skin now (action), whether they intend to protect their skin in the next 30 days (preparation), whether they intend to protect their skin in the next year (contemplation), or none of the above (pre-contemplation).|Participants|Count of Participants|4|4.0||||||
4218216|NCT00709306|4041803|B1||Contemplation|Stage of Change Scale|The Sun Stage of Change (SOC) Scale has 4 items asking participants whether they have been protecting their skin for the past year (maintenance), if they protect their skin now (action), whether they intend to protect their skin in the next 30 days (preparation), whether they intend to protect their skin in the next year (contemplation), or none of the above (pre-contemplation).|Participants|Count of Participants|5|5.0||||||
4218217|NCT00709306|4041799|B5||Precontemplation|Stage of Change Scale|The Sun Stage of Change (SOC) Scale has 4 items asking participants whether they have been protecting their skin for the past year (maintenance), if they protect their skin now (action), whether they intend to protect their skin in the next 30 days (preparation), whether they intend to protect their skin in the next year (contemplation), or none of the above (pre-contemplation).|Participants|Count of Participants|71|71.0||||||
4218218|NCT00709306|4041800|B4||Precontemplation|Stage of Change Scale|The Sun Stage of Change (SOC) Scale has 4 items asking participants whether they have been protecting their skin for the past year (maintenance), if they protect their skin now (action), whether they intend to protect their skin in the next 30 days (preparation), whether they intend to protect their skin in the next year (contemplation), or none of the above (pre-contemplation).|Participants|Count of Participants|15|15.0||||||
4218219|NCT00709306|4041801|B3||Precontemplation|Stage of Change Scale|The Sun Stage of Change (SOC) Scale has 4 items asking participants whether they have been protecting their skin for the past year (maintenance), if they protect their skin now (action), whether they intend to protect their skin in the next 30 days (preparation), whether they intend to protect their skin in the next year (contemplation), or none of the above (pre-contemplation).|Participants|Count of Participants|24|24.0||||||
4218220|NCT00709306|4041802|B2||Precontemplation|Stage of Change Scale|The Sun Stage of Change (SOC) Scale has 4 items asking participants whether they have been protecting their skin for the past year (maintenance), if they protect their skin now (action), whether they intend to protect their skin in the next 30 days (preparation), whether they intend to protect their skin in the next year (contemplation), or none of the above (pre-contemplation).|Participants|Count of Participants|15|15.0||||||
4218221|NCT00709306|4041803|B1||Precontemplation|Stage of Change Scale|The Sun Stage of Change (SOC) Scale has 4 items asking participants whether they have been protecting their skin for the past year (maintenance), if they protect their skin now (action), whether they intend to protect their skin in the next 30 days (preparation), whether they intend to protect their skin in the next year (contemplation), or none of the above (pre-contemplation).|Participants|Count of Participants|17|17.0||||||
4218222|NCT00709306|4041799|B5|Other/Mixed||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
4218223|NCT00709306|4041800|B4|Other/Mixed||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4218224|NCT00709306|4041801|B3|Other/Mixed||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4218225|NCT00709306|4041802|B2|Other/Mixed||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4218226|NCT00709306|4041803|B1|Other/Mixed||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4218227|NCT00709306|4041799|B5|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4218228|NCT00709306|4041800|B4|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4218229|NCT00709306|4041801|B3|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4218230|NCT00709306|4041802|B2|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4218231|NCT00709306|4041803|B1|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4218232|NCT00709306|4041799|B5|Caucasian/White||Race/Ethnicity, Customized||Participants|Count of Participants|146|146.0||||||
4218233|NCT00709306|4041800|B4|Caucasian/White||Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
4218234|NCT00709306|4041801|B3|Caucasian/White||Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
4218235|NCT00709306|4041802|B2|Caucasian/White||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
4218236|NCT00709306|4041803|B1|Caucasian/White||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
4218237|NCT00709306|4041799|B5|Asian-American/Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
4218238|NCT00709306|4041800|B4|Asian-American/Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4218239|NCT00709306|4041801|B3|Asian-American/Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4218240|NCT00709306|4041802|B2|Asian-American/Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4218241|NCT00709306|4041803|B1|Asian-American/Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4218242|NCT00709306|4041799|B5|African American/Black||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4218243|NCT00709306|4041800|B4|African American/Black||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4218244|NCT00709306|4041801|B3|African American/Black||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4218245|NCT00709306|4041802|B2|African American/Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4218246|NCT00709306|4041803|B1|African American/Black||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4218247|NCT00709306|4041799|B5||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4218248|NCT00709306|4041800|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4218249|NCT00709306|4041801|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4218250|NCT00709306|4041802|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4218251|NCT00709306|4041803|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4218252|NCT00709306|4041799|B5||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4218253|NCT00709306|4041800|B4||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4218254|NCT00709306|4041801|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4218255|NCT00709306|4041802|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4218256|NCT00709306|4041803|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4218257|NCT00709306|4041799|B5|||Age||years|Mean|20.47|20.47|Standard Deviation|1.56|1.56|||
4218258|NCT00709306|4041800|B4|||Age||years|Mean|20.85|20.85|Standard Deviation|1.67|1.67|||
4218259|NCT00709306|4041801|B3|||Age||years|Mean|20.43|20.43|Standard Deviation|1.49|1.49|||
4218260|NCT00709306|4041802|B2|||Age||years|Mean|20.32|20.32|Standard Deviation|1.41|1.41|||
4218261|NCT00709306|4041803|B1|||Age||years|Mean|20.29|20.29|Standard Deviation|1.68|1.68|||
4218262|NCT00709306|4041799|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4218263|NCT00709306|4041800|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4218264|NCT00709306|4041801|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4218265|NCT00709306|4041802|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4218266|NCT00709306|4041803|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4218267|NCT00709306|4041799|B5||Between 18 and 65 years|Age||Participants|Count of Participants|197|197.0||||||
4218268|NCT00709306|4041800|B4||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4218269|NCT00709306|4041801|B3||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4218270|NCT00709306|4041802|B2||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4218271|NCT00709306|4041803|B1||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4218272|NCT00709306|4041799|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4218273|NCT00709306|4041800|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4218274|NCT00709306|4041801|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4218275|NCT00709306|4041802|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4218276|NCT00709306|4041803|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4218277|NCT00709228|4041820|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4218278|NCT00709228|4041820|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4218279|NCT00709228|4041820|B1|||Age||years|Mean|37.8|37.8|Standard Deviation|10.4|10.4|||
4218280|NCT00709124|4041824|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
4218281|NCT00709124|4041825|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4218282|NCT00709124|4041826|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4218283|NCT00709124|4041824|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4218284|NCT00709124|4041825|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4218285|NCT00709124|4041826|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4218286|NCT00709124|4041824|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4218287|NCT00709124|4041825|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4218288|NCT00709124|4041826|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4218289|NCT00709124|4041824|B3|||Age||years|Mean|55|55.0|Standard Deviation|16|16.0|||
4218290|NCT00709124|4041825|B2|||Age||years|Mean|56|56.0|Standard Deviation|18|18.0|||
4218291|NCT00709124|4041826|B1|||Age||years|Mean|54|54.0|Standard Deviation|16|16.0|||
4218292|NCT00709111|4041861|B1|||Time with suppressed HIV-1 RNA prior to study entry|Four (4) participants had no documentation or recall of the date when they became suppressed (HIV-1 RNA <400 copies/ml)|years|Median|3.0|3.0|Inter-Quartile Range|||1.8|4.5|
4218293|NCT00709111|4041861|B1|||Baseline CD8+ T-cell count|Baseline CD8+ T-cell count is the average (mean) of the pre-entry and entry values|cells/mm^3|Median|559|559.0|Inter-Quartile Range|||416.0|872.0|
4218294|NCT00709111|4041861|B1|||Baseline CD4 percentage|Baseline CD4 percentage is the average (mean) of the pre-entry and entry values|% of total lymphocytes|Median|13|13.0|Inter-Quartile Range|||10.0|17.0|
4218295|NCT00709111|4041861|B1|||Baseline CD4+ T-cell count|Baseline CD4+ T-cell count is the average (mean) of the pre-entry and entry values|cells/mm^3|Median|153|153.0|Inter-Quartile Range|||119.0|203.0|
4218296|NCT00709111|4041861|B1|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4218297|NCT00709111|4041861|B1|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4218298|NCT00709111|4041861|B1|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4218299|NCT00709111|4041861|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4218300|NCT00709111|4041861|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4218301|NCT00709111|4041861|B1|||Age||years|Median|50|50.0|Inter-Quartile Range|||47.0|55.0|
4218302|NCT00709098|4041899|B4|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4218303|NCT00709098|4041901|B2|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4218304|NCT00709098|4041902|B1|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4218305|NCT00709098|4041899|B4|United States||Region of Enrollment||participants|Number|45|45.0||||||
4218306|NCT00709098|4041901|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4218307|NCT00709098|4041902|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4218308|NCT00709098|4041899|B4|Male||Gender||participants|Number|11|11.0||||||
4218309|NCT00709098|4041901|B2|Male||Gender||participants|Number|5|5.0||||||
4218310|NCT00709098|4041902|B1|Male||Gender||participants|Number|6|6.0||||||
4218311|NCT00709098|4041899|B4|Female||Gender||participants|Number|38|38.0||||||
4218312|NCT00709098|4041901|B2|Female||Gender||participants|Number|19|19.0||||||
4218313|NCT00709098|4041902|B1|Female||Gender||participants|Number|19|19.0||||||
4218314|NCT00709098|4041899|B4|||Age||years|Mean|56.9|56.9|Full Range|15.21|15.21|25.0|87.0|
4218315|NCT00709098|4041901|B2|||Age||years|Mean|55.4|55.4|Full Range|13.96|13.96|29.0|79.0|
4218316|NCT00709098|4041902|B1|||Age||years|Mean|58.3|58.3|Full Range|16.49|16.49|25.0|87.0|
4218317|NCT00709059|4041923|B1|Gender not available||Sex/Gender, Customized||Participants|Number|33|33.0||||||
4218318|NCT00709059|4041923|B1|Male||Sex/Gender, Customized||Participants|Number|302|302.0||||||
4218319|NCT00709059|4041923|B1|Female||Sex/Gender, Customized||Participants|Number|203|203.0||||||
4218320|NCT00709059|4041923|B1|age not available||Age, Customized||Participants|Number|33|33.0||||||
4218321|NCT00709059|4041923|B1|>=50 years||Age, Customized||Participants|Number|204|204.0||||||
4218322|NCT00709059|4041923|B1|<50 years||Age, Customized||Participants|Number|301|301.0||||||
4218323|NCT00708942|4041927|B6|Germany||Region of Enrollment||participants|Number|60|60.0||||||
4218324|NCT00708942|4041928|B5|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4218325|NCT00708942|4041929|B4|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4218326|NCT00708942|4041930|B3|Germany||Region of Enrollment||participants|Number|10|10.0||||||
4218327|NCT00708942|4041931|B2|Germany||Region of Enrollment||participants|Number|10|10.0||||||
4218328|NCT00708942|4041932|B1|Germany||Region of Enrollment||participants|Number|40|40.0||||||
4218329|NCT00708942|4041927|B6|Norway||Region of Enrollment||participants|Number|13|13.0||||||
4218330|NCT00708942|4041928|B5|Norway||Region of Enrollment||participants|Number|3|3.0||||||
4218331|NCT00708942|4041929|B4|Norway||Region of Enrollment||participants|Number|9|9.0||||||
4218332|NCT00708942|4041930|B3|Norway||Region of Enrollment||participants|Number|0|0.0||||||
4218333|NCT00708942|4041931|B2|Norway||Region of Enrollment||participants|Number|1|1.0||||||
4218334|NCT00708942|4041932|B1|Norway||Region of Enrollment||participants|Number|0|0.0||||||
4218335|NCT00708942|4041927|B6|France||Region of Enrollment||participants|Number|10|10.0||||||
4218336|NCT00708942|4041928|B5|France||Region of Enrollment||participants|Number|0|0.0||||||
4218337|NCT00708942|4041929|B4|France||Region of Enrollment||participants|Number|1|1.0||||||
4218338|NCT00708942|4041930|B3|France||Region of Enrollment||participants|Number|1|1.0||||||
4218339|NCT00708942|4041931|B2|France||Region of Enrollment||participants|Number|1|1.0||||||
4218340|NCT00708942|4041932|B1|France||Region of Enrollment||participants|Number|7|7.0||||||
4218341|NCT00708942|4041927|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4218342|NCT00708942|4041928|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4218343|NCT00708942|4041929|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4218344|NCT00708942|4041930|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4218345|NCT00708942|4041931|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4218346|NCT00708942|4041932|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4218347|NCT00708942|4041927|B6||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4218348|NCT00708942|4041928|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4218349|NCT00708942|4041929|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4218350|NCT00708942|4041930|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4218351|NCT00708942|4041931|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4218352|NCT00708942|4041932|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4218353|NCT00708942|4041927|B6|||Age||years|Mean|31.4|31.4|Standard Deviation|7.1|7.1|||
4218354|NCT00708942|4041928|B5|||Age||years|Mean|31.0|31.0|Standard Deviation|4.0|4.0|||
4218355|NCT00708942|4041929|B4|||Age||years|Mean|38.8|38.8|Standard Deviation|9.4|9.4|||
4218356|NCT00708942|4041930|B3|||Age||years|Mean|32.5|32.5|Standard Deviation|8.4|8.4|||
4218357|NCT00708942|4041931|B2|||Age||years|Mean|29.1|29.1|Standard Deviation|4.7|4.7|||
4218358|NCT00708942|4041932|B1|||Age||years|Mean|30.2|30.2|Standard Deviation|6.9|6.9|||
4218359|NCT00708942|4041927|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4218360|NCT00708942|4041928|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4218361|NCT00708942|4041929|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4218362|NCT00708942|4041930|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4218363|NCT00708942|4041931|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4218364|NCT00708942|4041932|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4218365|NCT00708942|4041927|B6||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
4218366|NCT00708942|4041928|B5||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4218367|NCT00708942|4041929|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4218368|NCT00708942|4041930|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4218369|NCT00708942|4041931|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4218370|NCT00708942|4041932|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4218371|NCT00708942|4041927|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4218372|NCT00708942|4041928|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4218373|NCT00708942|4041929|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4218374|NCT00708942|4041930|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4218375|NCT00708942|4041931|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4218376|NCT00708942|4041932|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4218377|NCT00708877|4041958|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4218378|NCT00708877|4041958|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4218379|NCT00708877|4041958|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4218380|NCT00708877|4041958|B1|||Age||years|Mean|44.8|44.8|Standard Deviation|19.92|19.92|||
4218381|NCT00708877|4041958|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4218382|NCT00708877|4041958|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4218383|NCT00708877|4041958|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4218384|NCT00708851|4041962|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4218385|NCT00708851|4041962|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4218386|NCT00708851|4041962|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4218387|NCT00708851|4041962|B1|||Age||years|Mean|44.41|44.41|Full Range|||25.0|67.0|
4218388|NCT00708851|4041962|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4218389|NCT00708851|4041962|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4218390|NCT00708851|4041962|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4218391|NCT00708734|4041970|B1||Male|Sex: Female, Male|Gender of participants in the study|Participants|Count of Participants|9|9.0||||||
4218392|NCT00708734|4041970|B1||Female|Sex: Female, Male|Gender of participants in the study|Participants|Count of Participants|1|1.0||||||
4218393|NCT00708734|4041970|B1|||Age|Age criteria for participants in the study was age 50 and older.|years|Mean|66.5|66.5|Full Range|||50.0|77.0|
4218394|NCT00708721|4041974|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4218395|NCT00708721|4041974|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4218396|NCT00708721|4041974|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4218397|NCT00708721|4041974|B1|||Age||years|Mean|68.3|68.3|Full Range|||59.0|81.0|
4218398|NCT00708721|4041974|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4218399|NCT00708721|4041974|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4218400|NCT00708721|4041974|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4218401|NCT00708708|4041990|B1|Missing values||Sex/Gender, Customized||participants|Number|4|4.0||||||
4218402|NCT00708708|4041990|B1|Male||Sex/Gender, Customized||participants|Number|583|583.0||||||
4218403|NCT00708708|4041990|B1|Female||Sex/Gender, Customized||participants|Number|339|339.0||||||
4218404|NCT00708708|4041990|B1|||Age|Only 915 participants had data available for age.|years|Mean|47.4|47.4|Standard Deviation|12.9|12.9|||
4218405|NCT00708682|4042038|B1||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4218406|NCT00708682|4042038|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4218407|NCT00708682|4042038|B1|||Age||months|Mean|2.1|2.1|Standard Deviation|0.5|0.5|||
4218408|NCT00708643|4042057|B3|Canada||Region of Enrollment|Includes all subjects that completed the study.|participants|Number|79|79.0||||||
4218409|NCT00708643|4042058|B2|Canada||Region of Enrollment|Includes all subjects that completed the study.|participants|Number|39|39.0||||||
4218410|NCT00708643|4042059|B1|Canada||Region of Enrollment|Includes all subjects that completed the study.|participants|Number|40|40.0||||||
4218411|NCT00708643|4042057|B3|Male||Gender|Includes all subjects that completed the study.|participants|Number|14|14.0||||||
4218412|NCT00708643|4042058|B2|Male||Gender|Includes all subjects that completed the study.|participants|Number|6|6.0||||||
4218413|NCT00708643|4042059|B1|Male||Gender|Includes all subjects that completed the study.|participants|Number|8|8.0||||||
4218414|NCT00708643|4042057|B3|Female||Gender|Includes all subjects that completed the study.|participants|Number|65|65.0||||||
4218415|NCT00708643|4042058|B2|Female||Gender|Includes all subjects that completed the study.|participants|Number|33|33.0||||||
4218416|NCT00708643|4042059|B1|Female||Gender|Includes all subjects that completed the study.|participants|Number|32|32.0||||||
4218417|NCT00708643|4042057|B3|||Age|Includes all subjects that completed the study.|years|Mean|27.2|27.2|Standard Deviation|9.6|9.6|||
4218418|NCT00708643|4042058|B2|||Age|Includes all subjects that completed the study.|years|Mean|25.8|25.8|Standard Deviation|8.7|8.7|||
4218419|NCT00708643|4042059|B1|||Age|Includes all subjects that completed the study.|years|Mean|28.3|28.3|Standard Deviation|9.9|9.9|||
4218420|NCT00708552|4042076|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218421|NCT00708552|4042077|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218422|NCT00708552|4042078|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218423|NCT00708552|4042079|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218424|NCT00708552|4042080|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218425|NCT00708552|4042076|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218426|NCT00708552|4042077|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218427|NCT00708552|4042078|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218428|NCT00708552|4042079|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218429|NCT00708552|4042080|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218430|NCT00708552|4042076|B5||White|Race (NIH/OMB)||Participants|Count of Participants|502|502.0||||||
4218431|NCT00708552|4042077|B4||White|Race (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
4218432|NCT00708552|4042078|B3||White|Race (NIH/OMB)||Participants|Count of Participants|118|118.0||||||
4218433|NCT00708552|4042079|B2||White|Race (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
4218434|NCT00708552|4042080|B1||White|Race (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
4218435|NCT00708552|4042076|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4218436|NCT00708552|4042077|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4218437|NCT00708552|4042078|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4218438|NCT00708552|4042079|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218439|NCT00708552|4042080|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218440|NCT00708552|4042076|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218441|NCT00708552|4042077|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218442|NCT00708552|4042078|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218443|NCT00708552|4042079|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218444|NCT00708552|4042080|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218445|NCT00708552|4042076|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4218446|NCT00708552|4042077|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4218447|NCT00708552|4042078|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4218448|NCT00708552|4042079|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4218449|NCT00708552|4042080|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4218450|NCT00708552|4042076|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4218451|NCT00708552|4042077|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4218452|NCT00708552|4042078|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4218453|NCT00708552|4042079|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4218454|NCT00708552|4042080|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4218455|NCT00708552|4042076|B5||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4218456|NCT00708552|4042077|B4||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4218457|NCT00708552|4042078|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4218458|NCT00708552|4042079|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4218459|NCT00708552|4042080|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4218460|NCT00708552|4042076|B5||Female|Sex: Female, Male||Participants|Count of Participants|353|353.0||||||
4218461|NCT00708552|4042077|B4||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4218462|NCT00708552|4042078|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4218463|NCT00708552|4042079|B2||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4218464|NCT00708552|4042080|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4218465|NCT00708552|4042076|B5|||Age||Years|Mean|72.3|72.3|Standard Deviation|7.49|7.49|||
4218466|NCT00708552|4042077|B4|||Age||Years|Mean|71.1|71.1|Standard Deviation|7.49|7.49|||
4218467|NCT00708552|4042078|B3|||Age||Years|Mean|72.5|72.5|Standard Deviation|7.38|7.38|||
4218468|NCT00708552|4042079|B2|||Age||Years|Mean|72.4|72.4|Standard Deviation|8.12|8.12|||
4218469|NCT00708552|4042080|B1|||Age||Years|Mean|73.3|73.3|Standard Deviation|6.80|6.8|||
4218470|NCT00708526|4042231|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4218471|NCT00708526|4042232|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4218472|NCT00708526|4042233|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4218473|NCT00708526|4042231|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4218474|NCT00708526|4042232|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4218475|NCT00708526|4042233|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4218476|NCT00708526|4042231|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4218477|NCT00708526|4042232|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4218478|NCT00708526|4042233|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4218479|NCT00708526|4042231|B3|Age||Age||years|Mean|42.1|42.1|Standard Deviation|15.1|15.1|||
4218480|NCT00708526|4042232|B2|Age||Age||years|Mean|40.4|40.4|Standard Deviation|15|15.0|||
4218481|NCT00708526|4042233|B1|Age||Age||years|Mean|43.7|43.7|Standard Deviation|15.1|15.1|||
4218482|NCT00708500|4042242|B4||Male|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
4218483|NCT00708500|4042243|B3||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4218484|NCT00708500|4042244|B2||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4218485|NCT00708500|4042245|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4218486|NCT00708500|4042242|B4||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4218487|NCT00708500|4042243|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4218488|NCT00708500|4042244|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4218489|NCT00708500|4042245|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4218490|NCT00708500|4042242|B4|||Age||years|Mean|52.7|52.7|Standard Deviation|7.7|7.7|||
4218491|NCT00708500|4042243|B3|||Age||years|Mean|52.3|52.3|Standard Deviation|7.7|7.7|||
4218492|NCT00708500|4042244|B2|||Age||years|Mean|52.9|52.9|Standard Deviation|7.4|7.4|||
4218493|NCT00708500|4042245|B1|||Age||years|Mean|52.9|52.9|Standard Deviation|8.1|8.1|||
4218494|NCT00708461|4042264|B3|United States||Region of Enrollment||participants|Number|1747|1747.0||||||
4218495|NCT00708461|4042265|B2|United States||Region of Enrollment||participants|Number|995|995.0||||||
4218496|NCT00708461|4042266|B1|United States||Region of Enrollment||participants|Number|752|752.0||||||
4218497|NCT00708461|4042264|B3||Male|Sex: Female, Male||Participants|Count of Participants|661|661.0||||||
4218498|NCT00708461|4042265|B2||Male|Sex: Female, Male||Participants|Count of Participants|387|387.0||||||
4218499|NCT00708461|4042266|B1||Male|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
4218500|NCT00708461|4042264|B3||Female|Sex: Female, Male||Participants|Count of Participants|1086|1086.0||||||
4218501|NCT00708461|4042265|B2||Female|Sex: Female, Male||Participants|Count of Participants|608|608.0||||||
4218502|NCT00708461|4042266|B1||Female|Sex: Female, Male||Participants|Count of Participants|478|478.0||||||
4218503|NCT00708461|4042264|B3|||Age||years|Mean|42.9|42.9|Standard Deviation|10.7|10.7|||
4218504|NCT00708461|4042265|B2|||Age||years|Mean|43.1|43.1|Standard Deviation|10.6|10.6|||
4218505|NCT00708461|4042266|B1|||Age||years|Mean|42.7|42.7|Standard Deviation|10.8|10.8|||
4218506|NCT00708461|4042264|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4218507|NCT00708461|4042265|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4218508|NCT00708461|4042266|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4218509|NCT00708461|4042264|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1683|1683.0||||||
4218510|NCT00708461|4042265|B2||Between 18 and 65 years|Age||Participants|Count of Participants|954|954.0||||||
4218511|NCT00708461|4042266|B1||Between 18 and 65 years|Age||Participants|Count of Participants|729|729.0||||||
4218512|NCT00708461|4042264|B3||<=18 years|Age||Participants|Count of Participants|49|49.0||||||
4218513|NCT00708461|4042265|B2||<=18 years|Age||Participants|Count of Participants|32|32.0||||||
4218514|NCT00708461|4042266|B1||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
4218515|NCT00708435|4042273|B3||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4218516|NCT00708435|4042274|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4218517|NCT00708435|4042275|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4218518|NCT00708435|4042273|B3||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4218519|NCT00708435|4042274|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4218520|NCT00708435|4042275|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4218521|NCT00708435|4042273|B3|≥ 75 years||Age, Customized||Participants|Number|91|91.0||||||
4218522|NCT00708435|4042274|B2|≥ 75 years||Age, Customized||Participants|Number|48|48.0||||||
4218523|NCT00708435|4042275|B1|≥ 75 years||Age, Customized||Participants|Number|43|43.0||||||
4218524|NCT00708435|4042273|B3|≥ 65 to < 75 years||Age, Customized||Participants|Number|57|57.0||||||
4218525|NCT00708435|4042274|B2|≥ 65 to < 75 years||Age, Customized||Participants|Number|29|29.0||||||
4218526|NCT00708435|4042275|B1|≥ 65 to < 75 years||Age, Customized||Participants|Number|28|28.0||||||
4218527|NCT00708435|4042273|B3|< 65 years||Age, Customized||Participants|Number|68|68.0||||||
4218528|NCT00708435|4042274|B2|< 65 years||Age, Customized||Participants|Number|32|32.0||||||
4218529|NCT00708435|4042275|B1|< 65 years||Age, Customized||Participants|Number|36|36.0||||||
4218530|NCT00708422|4042301|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4218531|NCT00708422|4042302|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4218532|NCT00708422|4042303|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4218533|NCT00708422|4042301|B3||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4218534|NCT00708422|4042302|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4218535|NCT00708422|4042303|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4218536|NCT00708422|4042301|B3||>=65 years|Age||Participants|Count of Participants|148|148.0||||||
4218537|NCT00708422|4042302|B2||>=65 years|Age||Participants|Count of Participants|70|70.0||||||
4218538|NCT00708422|4042303|B1||>=65 years|Age||Participants|Count of Participants|78|78.0||||||
4218539|NCT00708422|4042301|B3||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
4218540|NCT00708422|4042302|B2||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4218541|NCT00708422|4042303|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4218542|NCT00708422|4042301|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4218543|NCT00708422|4042302|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4218544|NCT00708422|4042303|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4218545|NCT00708305|4042312|B1|United States||Region of Enrollment||participants|Number|65|65.0||||||
4218546|NCT00708305|4042312|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4218547|NCT00708305|4042312|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4218548|NCT00708305|4042312|B1|||Age||years|Mean|26.4|26.4|Standard Deviation|6.97|6.97|||
4218549|NCT00708227|4042347|B5|||ADRB2 Genotype at Codon 16||Participants|Count of Participants|88|88.0||||||
4218550|NCT00708227|4042348|B4|||ADRB2 Genotype at Codon 16||Participants|Count of Participants|25|25.0||||||
4218551|NCT00708227|4042349|B3|||ADRB2 Genotype at Codon 16||Participants|Count of Participants|18|18.0||||||
4218552|NCT00708227|4042350|B2|||ADRB2 Genotype at Codon 16||Participants|Count of Participants|26|26.0||||||
4218553|NCT00708227|4042351|B1|||ADRB2 Genotype at Codon 16||Participants|Count of Participants|19|19.0||||||
4218554|NCT00708227|4042347|B5|United States||Region of Enrollment||Participants|Count of Participants|88|88.0||||||
4218555|NCT00708227|4042348|B4|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4218556|NCT00708227|4042349|B3|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4218557|NCT00708227|4042350|B2|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
4218558|NCT00708227|4042351|B1|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4218559|NCT00708227|4042347|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218560|NCT00708227|4042348|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218561|NCT00708227|4042349|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218562|NCT00708227|4042350|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218563|NCT00708227|4042351|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218564|NCT00708227|4042347|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218565|NCT00708227|4042348|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218566|NCT00708227|4042349|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218567|NCT00708227|4042350|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218568|NCT00708227|4042351|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218569|NCT00708227|4042347|B5||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4218570|NCT00708227|4042348|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218571|NCT00708227|4042349|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218572|NCT00708227|4042350|B2||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4218573|NCT00708227|4042351|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4218574|NCT00708227|4042347|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4218575|NCT00708227|4042348|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4218576|NCT00708227|4042349|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4218577|NCT00708227|4042350|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218578|NCT00708227|4042351|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218579|NCT00708227|4042347|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218580|NCT00708227|4042348|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218581|NCT00708227|4042349|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218582|NCT00708227|4042350|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218583|NCT00708227|4042351|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218584|NCT00708227|4042347|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218585|NCT00708227|4042348|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218586|NCT00708227|4042349|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218587|NCT00708227|4042350|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218588|NCT00708227|4042351|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218589|NCT00708227|4042347|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218590|NCT00708227|4042348|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218591|NCT00708227|4042349|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218592|NCT00708227|4042350|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218593|NCT00708227|4042351|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218594|NCT00708227|4042347|B5||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4218595|NCT00708227|4042348|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4218596|NCT00708227|4042349|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4218597|NCT00708227|4042350|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4218598|NCT00708227|4042351|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4218599|NCT00708227|4042347|B5||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4218600|NCT00708227|4042348|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4218601|NCT00708227|4042349|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4218602|NCT00708227|4042350|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4218603|NCT00708227|4042351|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4218604|NCT00708227|4042347|B5|||Age||years|Mean|32|32.0|Standard Deviation|19|19.0|||
4218605|NCT00708227|4042348|B4|||Age||years|Mean|28|28.0|Standard Deviation|17|17.0|||
4218606|NCT00708227|4042349|B3|||Age||years|Mean|27|27.0|Standard Deviation|21|21.0|||
4218607|NCT00708227|4042350|B2|||Age||years|Mean|37|37.0|Standard Deviation|20|20.0|||
4218608|NCT00708227|4042351|B1|||Age||years|Mean|34|34.0|Standard Deviation|19|19.0|||
4218609|NCT00708227|4042347|B5||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4218610|NCT00708227|4042348|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4218611|NCT00708227|4042349|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4218612|NCT00708227|4042350|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4218613|NCT00708227|4042351|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4218614|NCT00708227|4042347|B5||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4218615|NCT00708227|4042348|B4||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4218616|NCT00708227|4042349|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4218617|NCT00708227|4042350|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4218618|NCT00708227|4042351|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4218619|NCT00708227|4042347|B5||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4218620|NCT00708227|4042348|B4||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4218621|NCT00708227|4042349|B3||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4218622|NCT00708227|4042350|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4218623|NCT00708227|4042351|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4218624|NCT00708214|4042384|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4218625|NCT00708214|4042385|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4218626|NCT00708214|4042386|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4218627|NCT00708214|4042387|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4218628|NCT00708214|4042384|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4218629|NCT00708214|4042385|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4218630|NCT00708214|4042386|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4218631|NCT00708214|4042387|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4218632|NCT00708214|4042384|B4|||Age||years|Mean|62.5|62.5|Standard Deviation|10.0|10.0|||
4218633|NCT00708214|4042385|B3|||Age||years|Mean|58.5|58.5|Standard Deviation|9.0|9.0|||
4218634|NCT00708214|4042386|B2|||Age||years|Mean|64.8|64.8|Standard Deviation|7.2|7.2|||
4218635|NCT00708214|4042387|B1|||Age||years|Mean|63.0|63.0|Standard Deviation|14.7|14.7|||
4218636|NCT00708201|4042430|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218637|NCT00708201|4042431|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218638|NCT00708201|4042432|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218639|NCT00708201|4042430|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218699|NCT00708175|4042455|B3|Non Hispanic or Latino||Ethnicity||participants|Number|84|84.0||||||
4218640|NCT00708201|4042431|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218641|NCT00708201|4042432|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218642|NCT00708201|4042430|B3||White|Race (NIH/OMB)||Participants|Count of Participants|269|269.0||||||
4218643|NCT00708201|4042431|B2||White|Race (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
4218644|NCT00708201|4042432|B1||White|Race (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
4218645|NCT00708201|4042430|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4218646|NCT00708201|4042431|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4218647|NCT00708201|4042432|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4218648|NCT00708201|4042430|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4218649|NCT00708201|4042431|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4218650|NCT00708201|4042432|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218651|NCT00708201|4042430|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218652|NCT00708201|4042431|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218653|NCT00708201|4042432|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218654|NCT00708201|4042430|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218655|NCT00708201|4042431|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218656|NCT00708201|4042432|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218657|NCT00708201|4042430|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218658|NCT00708201|4042431|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218659|NCT00708201|4042432|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4218660|NCT00708201|4042430|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|276|276.0||||||
4218661|NCT00708201|4042431|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|142|142.0||||||
4218662|NCT00708201|4042432|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
4218663|NCT00708201|4042430|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4218664|NCT00708201|4042431|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4218665|NCT00708201|4042432|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4218666|NCT00708201|4042430|B3||Male|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4218667|NCT00708201|4042431|B2||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4218668|NCT00708201|4042432|B1||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4218669|NCT00708201|4042430|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4218670|NCT00708201|4042431|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4218671|NCT00708201|4042432|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4218672|NCT00708201|4042430|B3|||Age||Years|Mean|65.1|65.1|Standard Deviation|10.39|10.39|||
4218673|NCT00708201|4042431|B2|||Age||Years|Mean|66.3|66.3|Standard Deviation|10.93|10.93|||
4218674|NCT00708201|4042432|B1|||Age||Years|Mean|63.9|63.9|Standard Deviation|9.84|9.84|||
4218675|NCT00708175|4042455|B3|No||History of hip fracture?||participants|Number|148|148.0||||||
4218676|NCT00708175|4042456|B2|No||History of hip fracture?||participants|Number|75|75.0||||||
4218677|NCT00708175|4042457|B1|No||History of hip fracture?||participants|Number|73|73.0||||||
4218678|NCT00708175|4042455|B3|Yes||History of hip fracture?||participants|Number|8|8.0||||||
4218679|NCT00708175|4042456|B2|Yes||History of hip fracture?||participants|Number|3|3.0||||||
4218680|NCT00708175|4042457|B1|Yes||History of hip fracture?||participants|Number|5|5.0||||||
4218681|NCT00708175|4042455|B3|Ex-smoker||Smoking Classification||participants|Number|33|33.0||||||
4218682|NCT00708175|4042456|B2|Ex-smoker||Smoking Classification||participants|Number|14|14.0||||||
4218683|NCT00708175|4042457|B1|Ex-smoker||Smoking Classification||participants|Number|19|19.0||||||
4218684|NCT00708175|4042455|B3|Current smoker||Smoking Classification||participants|Number|16|16.0||||||
4218685|NCT00708175|4042456|B2|Current smoker||Smoking Classification||participants|Number|9|9.0||||||
4218686|NCT00708175|4042457|B1|Current smoker||Smoking Classification||participants|Number|7|7.0||||||
4218687|NCT00708175|4042455|B3|Never smoked||Smoking Classification||participants|Number|107|107.0||||||
4218688|NCT00708175|4042456|B2|Never smoked||Smoking Classification||participants|Number|55|55.0||||||
4218689|NCT00708175|4042457|B1|Never smoked||Smoking Classification||participants|Number|52|52.0||||||
4218690|NCT00708175|4042455|B3|||Body Mass Index (BMI)||kg/m2|Mean|29.95|29.95|Standard Deviation|4.960|4.96|||
4218691|NCT00708175|4042456|B2|||Body Mass Index (BMI)||kg/m2|Mean|30.29|30.29|Standard Deviation|4.872|4.872|||
4218692|NCT00708175|4042457|B1|||Body Mass Index (BMI)||kg/m2|Mean|29.61|29.61|Standard Deviation|5.055|5.055|||
4218693|NCT00708175|4042455|B3|||Weight||kg|Mean|77.53|77.53|Standard Deviation|14.964|14.964|||
4218694|NCT00708175|4042456|B2|||Weight||kg|Mean|79.02|79.02|Standard Deviation|16.326|16.326|||
4218695|NCT00708175|4042457|B1|||Weight||kg|Mean|76.03|76.03|Standard Deviation|13.406|13.406|||
4218696|NCT00708175|4042455|B3|||Height||cm|Mean|160.7|160.7|Standard Deviation|7.28|7.28|||
4218697|NCT00708175|4042456|B2|||Height||cm|Mean|161.1|161.1|Standard Deviation|7.70|7.7|||
4218698|NCT00708175|4042457|B1|||Height||cm|Mean|160.3|160.3|Standard Deviation|6.85|6.85|||
4218700|NCT00708175|4042456|B2|Non Hispanic or Latino||Ethnicity||participants|Number|44|44.0||||||
4218701|NCT00708175|4042457|B1|Non Hispanic or Latino||Ethnicity||participants|Number|40|40.0||||||
4218702|NCT00708175|4042455|B3|Hispanic or Latino||Ethnicity||participants|Number|72|72.0||||||
4218703|NCT00708175|4042456|B2|Hispanic or Latino||Ethnicity||participants|Number|34|34.0||||||
4218704|NCT00708175|4042457|B1|Hispanic or Latino||Ethnicity||participants|Number|38|38.0||||||
4218705|NCT00708175|4042455|B3|United States||Region of Enrollment||participants|Number|156|156.0||||||
4218706|NCT00708175|4042456|B2|United States||Region of Enrollment||participants|Number|78|78.0||||||
4218707|NCT00708175|4042457|B1|United States||Region of Enrollment||participants|Number|78|78.0||||||
4218708|NCT00708175|4042455|B3|Unknown or Not Reported||Race (NIH/OMB)|For race, a participant may choose more than one category for race. Participants who indicated more than one race category are included in each category indicated and they are also included in the Multiracial category. Thus the total number and percentage of participants does not necessarily add up to the total number of randomized participants.|participants|Number|0|0.0||||||
4218709|NCT00708175|4042456|B2|Unknown or Not Reported||Race (NIH/OMB)|For race, a participant may choose more than one category for race. Participants who indicated more than one race category are included in each category indicated and they are also included in the Multiracial category. Thus the total number and percentage of participants does not necessarily add up to the total number of randomized participants.|participants|Number|0|0.0||||||
4218710|NCT00708175|4042457|B1|Unknown or Not Reported||Race (NIH/OMB)|For race, a participant may choose more than one category for race. Participants who indicated more than one race category are included in each category indicated and they are also included in the Multiracial category. Thus the total number and percentage of participants does not necessarily add up to the total number of randomized participants.|participants|Number|0|0.0||||||
4218711|NCT00708175|4042455|B3|More than one race||Race (NIH/OMB)|For race, a participant may choose more than one category for race. Participants who indicated more than one race category are included in each category indicated and they are also included in the Multiracial category. Thus the total number and percentage of participants does not necessarily add up to the total number of randomized participants.|participants|Number|1|1.0||||||
4218712|NCT00708175|4042456|B2|More than one race||Race (NIH/OMB)|For race, a participant may choose more than one category for race. Participants who indicated more than one race category are included in each category indicated and they are also included in the Multiracial category. Thus the total number and percentage of participants does not necessarily add up to the total number of randomized participants.|participants|Number|0|0.0||||||
4218713|NCT00708175|4042457|B1|More than one race||Race (NIH/OMB)|For race, a participant may choose more than one category for race. Participants who indicated more than one race category are included in each category indicated and they are also included in the Multiracial category. Thus the total number and percentage of participants does not necessarily add up to the total number of randomized participants.|participants|Number|1|1.0||||||
4218714|NCT00708175|4042455|B3|White||Race (NIH/OMB)|For race, a participant may choose more than one category for race. Participants who indicated more than one race category are included in each category indicated and they are also included in the Multiracial category. Thus the total number and percentage of participants does not necessarily add up to the total number of randomized participants.|participants|Number|138|138.0||||||
4218715|NCT00708175|4042456|B2|White||Race (NIH/OMB)|For race, a participant may choose more than one category for race. Participants who indicated more than one race category are included in each category indicated and they are also included in the Multiracial category. Thus the total number and percentage of participants does not necessarily add up to the total number of randomized participants.|participants|Number|68|68.0||||||
4218716|NCT00708175|4042457|B1|White||Race (NIH/OMB)|For race, a participant may choose more than one category for race. Participants who indicated more than one race category are included in each category indicated and they are also included in the Multiracial category. Thus the total number and percentage of participants does not necessarily add up to the total number of randomized participants.|participants|Number|70|70.0||||||
4218717|NCT00708175|4042455|B3|Black or African American||Race (NIH/OMB)|For race, a participant may choose more than one category for race. Participants who indicated more than one race category are included in each category indicated and they are also included in the Multiracial category. Thus the total number and percentage of participants does not necessarily add up to the total number of randomized participants.|participants|Number|12|12.0||||||
4218718|NCT00708175|4042456|B2|Black or African American||Race (NIH/OMB)|For race, a participant may choose more than one category for race. Participants who indicated more than one race category are included in each category indicated and they are also included in the Multiracial category. Thus the total number and percentage of participants does not necessarily add up to the total number of randomized participants.|participants|Number|6|6.0||||||
4218719|NCT00708175|4042457|B1|Black or African American||Race (NIH/OMB)|For race, a participant may choose more than one category for race. Participants who indicated more than one race category are included in each category indicated and they are also included in the Multiracial category. Thus the total number and percentage of participants does not necessarily add up to the total number of randomized participants.|participants|Number|6|6.0||||||
4218720|NCT00708175|4042455|B3|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|For race, a participant may choose more than one category for race. Participants who indicated more than one race category are included in each category indicated and they are also included in the Multiracial category. Thus the total number and percentage of participants does not necessarily add up to the total number of randomized participants.|participants|Number|0|0.0||||||
4218721|NCT00708175|4042456|B2|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|For race, a participant may choose more than one category for race. Participants who indicated more than one race category are included in each category indicated and they are also included in the Multiracial category. Thus the total number and percentage of participants does not necessarily add up to the total number of randomized participants.|participants|Number|0|0.0||||||
4218763|NCT00708162|4042473|B2|Positive||Chronic Hepatitis B (HBV) Infection Status||participants|Number|13|13.0||||||
4218764|NCT00708162|4042474|B1|Positive||Chronic Hepatitis B (HBV) Infection Status||participants|Number|17|17.0||||||
4218722|NCT00708175|4042457|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|For race, a participant may choose more than one category for race. Participants who indicated more than one race category are included in each category indicated and they are also included in the Multiracial category. Thus the total number and percentage of participants does not necessarily add up to the total number of randomized participants.|participants|Number|0|0.0||||||
4218723|NCT00708175|4042455|B3|Asian||Race (NIH/OMB)|For race, a participant may choose more than one category for race. Participants who indicated more than one race category are included in each category indicated and they are also included in the Multiracial category. Thus the total number and percentage of participants does not necessarily add up to the total number of randomized participants.|participants|Number|6|6.0||||||
4218724|NCT00708175|4042456|B2|Asian||Race (NIH/OMB)|For race, a participant may choose more than one category for race. Participants who indicated more than one race category are included in each category indicated and they are also included in the Multiracial category. Thus the total number and percentage of participants does not necessarily add up to the total number of randomized participants.|participants|Number|4|4.0||||||
4218725|NCT00708175|4042457|B1|Asian||Race (NIH/OMB)|For race, a participant may choose more than one category for race. Participants who indicated more than one race category are included in each category indicated and they are also included in the Multiracial category. Thus the total number and percentage of participants does not necessarily add up to the total number of randomized participants.|participants|Number|2|2.0||||||
4218726|NCT00708175|4042455|B3|American Indian or Alaska Native||Race (NIH/OMB)|For race, a participant may choose more than one category for race. Participants who indicated more than one race category are included in each category indicated and they are also included in the Multiracial category. Thus the total number and percentage of participants does not necessarily add up to the total number of randomized participants.|participants|Number|1|1.0||||||
4218727|NCT00708175|4042456|B2|American Indian or Alaska Native||Race (NIH/OMB)|For race, a participant may choose more than one category for race. Participants who indicated more than one race category are included in each category indicated and they are also included in the Multiracial category. Thus the total number and percentage of participants does not necessarily add up to the total number of randomized participants.|participants|Number|0|0.0||||||
4218728|NCT00708175|4042457|B1|American Indian or Alaska Native||Race (NIH/OMB)|For race, a participant may choose more than one category for race. Participants who indicated more than one race category are included in each category indicated and they are also included in the Multiracial category. Thus the total number and percentage of participants does not necessarily add up to the total number of randomized participants.|participants|Number|1|1.0||||||
4218729|NCT00708175|4042455|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4218730|NCT00708175|4042456|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4218731|NCT00708175|4042457|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4218732|NCT00708175|4042455|B3||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4218733|NCT00708175|4042456|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4218734|NCT00708175|4042457|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4218735|NCT00708175|4042455|B3|≥65 years||Age, Customized||participants|Number|35|35.0||||||
4218736|NCT00708175|4042456|B2|≥65 years||Age, Customized||participants|Number|23|23.0||||||
4218737|NCT00708175|4042457|B1|≥65 years||Age, Customized||participants|Number|12|12.0||||||
4218738|NCT00708175|4042455|B3|Between 45 and 64 years||Age, Customized||participants|Number|120|120.0||||||
4218739|NCT00708175|4042456|B2|Between 45 and 64 years||Age, Customized||participants|Number|54|54.0||||||
4218740|NCT00708175|4042457|B1|Between 45 and 64 years||Age, Customized||participants|Number|66|66.0||||||
4218741|NCT00708175|4042455|B3|<45 years||Age, Customized||participants|Number|1|1.0||||||
4218742|NCT00708175|4042456|B2|<45 years||Age, Customized||participants|Number|1|1.0||||||
4218743|NCT00708175|4042457|B1|<45 years||Age, Customized||participants|Number|0|0.0||||||
4218744|NCT00708175|4042455|B3|||Age||years|Mean|59.6|59.6|Standard Deviation|5.65|5.65|||
4218745|NCT00708175|4042456|B2|||Age||years|Mean|60.2|60.2|Standard Deviation|6.17|6.17|||
4218746|NCT00708175|4042457|B1|||Age||years|Mean|59.0|59.0|Standard Deviation|5.04|5.04|||
4218747|NCT00708162|4042472|B3|No baseline HCV measurement||Chronic Hepatitis C (HCV) Infection Status||participants|Number|6|6.0||||||
4218748|NCT00708162|4042473|B2|No baseline HCV measurement||Chronic Hepatitis C (HCV) Infection Status||participants|Number|3|3.0||||||
4218749|NCT00708162|4042474|B1|No baseline HCV measurement||Chronic Hepatitis C (HCV) Infection Status||participants|Number|3|3.0||||||
4218750|NCT00708162|4042472|B3|Positive||Chronic Hepatitis C (HCV) Infection Status||participants|Number|99|99.0||||||
4218751|NCT00708162|4042473|B2|Positive||Chronic Hepatitis C (HCV) Infection Status||participants|Number|55|55.0||||||
4218752|NCT00708162|4042474|B1|Positive||Chronic Hepatitis C (HCV) Infection Status||participants|Number|44|44.0||||||
4218753|NCT00708162|4042472|B3|Negative||Chronic Hepatitis C (HCV) Infection Status||participants|Number|603|603.0||||||
4218754|NCT00708162|4042473|B2|Negative||Chronic Hepatitis C (HCV) Infection Status||participants|Number|298|298.0||||||
4218755|NCT00708162|4042474|B1|Negative||Chronic Hepatitis C (HCV) Infection Status||participants|Number|305|305.0||||||
4218756|NCT00708162|4042472|B3|Indeterminant||Chronic Hepatitis C (HCV) Infection Status||participants|Number|4|4.0||||||
4218757|NCT00708162|4042473|B2|Indeterminant||Chronic Hepatitis C (HCV) Infection Status||participants|Number|2|2.0||||||
4218758|NCT00708162|4042474|B1|Indeterminant||Chronic Hepatitis C (HCV) Infection Status||participants|Number|2|2.0||||||
4218759|NCT00708162|4042472|B3|No baseline HBV measurement||Chronic Hepatitis B (HBV) Infection Status||participants|Number|6|6.0||||||
4218760|NCT00708162|4042473|B2|No baseline HBV measurement||Chronic Hepatitis B (HBV) Infection Status||participants|Number|3|3.0||||||
4218761|NCT00708162|4042474|B1|No baseline HBV measurement||Chronic Hepatitis B (HBV) Infection Status||participants|Number|3|3.0||||||
4218762|NCT00708162|4042472|B3|Positive||Chronic Hepatitis B (HBV) Infection Status||participants|Number|30|30.0||||||
4218765|NCT00708162|4042472|B3|Negative||Chronic Hepatitis B (HBV) Infection Status||participants|Number|675|675.0||||||
4218766|NCT00708162|4042473|B2|Negative||Chronic Hepatitis B (HBV) Infection Status||participants|Number|342|342.0||||||
4218767|NCT00708162|4042474|B1|Negative||Chronic Hepatitis B (HBV) Infection Status||participants|Number|333|333.0||||||
4218768|NCT00708162|4042472|B3|Indeterminant||Chronic Hepatitis B (HBV) Infection Status||participants|Number|1|1.0||||||
4218769|NCT00708162|4042473|B2|Indeterminant||Chronic Hepatitis B (HBV) Infection Status||participants|Number|0|0.0||||||
4218770|NCT00708162|4042474|B1|Indeterminant||Chronic Hepatitis B (HBV) Infection Status||participants|Number|1|1.0||||||
4218771|NCT00708162|4042472|B3|No baseline PSS score||Phenotypic Sensitivity Score|Phenotypic sensitivity score (PSS) was calculated by summing up drug susceptibility values (1=sensitive; 0.5=partially sensitive; 0=resistance or reduced susceptibility) on all drugs in the baseline background regimen. For subjects naive to enfuvirtide (or maraviroc), a score of 1 was assigned for enfuvirtide (or maraviroc). Higher scores correspond to increased sensitivity.|participants|Number|2|2.0||||||
4218772|NCT00708162|4042473|B2|No baseline PSS score||Phenotypic Sensitivity Score|Phenotypic sensitivity score (PSS) was calculated by summing up drug susceptibility values (1=sensitive; 0.5=partially sensitive; 0=resistance or reduced susceptibility) on all drugs in the baseline background regimen. For subjects naive to enfuvirtide (or maraviroc), a score of 1 was assigned for enfuvirtide (or maraviroc). Higher scores correspond to increased sensitivity.|participants|Number|1|1.0||||||
4218773|NCT00708162|4042474|B1|No baseline PSS score||Phenotypic Sensitivity Score|Phenotypic sensitivity score (PSS) was calculated by summing up drug susceptibility values (1=sensitive; 0.5=partially sensitive; 0=resistance or reduced susceptibility) on all drugs in the baseline background regimen. For subjects naive to enfuvirtide (or maraviroc), a score of 1 was assigned for enfuvirtide (or maraviroc). Higher scores correspond to increased sensitivity.|participants|Number|1|1.0||||||
4218774|NCT00708162|4042472|B3|3.5||Phenotypic Sensitivity Score|Phenotypic sensitivity score (PSS) was calculated by summing up drug susceptibility values (1=sensitive; 0.5=partially sensitive; 0=resistance or reduced susceptibility) on all drugs in the baseline background regimen. For subjects naive to enfuvirtide (or maraviroc), a score of 1 was assigned for enfuvirtide (or maraviroc). Higher scores correspond to increased sensitivity.|participants|Number|1|1.0||||||
4218775|NCT00708162|4042473|B2|3.5||Phenotypic Sensitivity Score|Phenotypic sensitivity score (PSS) was calculated by summing up drug susceptibility values (1=sensitive; 0.5=partially sensitive; 0=resistance or reduced susceptibility) on all drugs in the baseline background regimen. For subjects naive to enfuvirtide (or maraviroc), a score of 1 was assigned for enfuvirtide (or maraviroc). Higher scores correspond to increased sensitivity.|participants|Number|1|1.0||||||
4218776|NCT00708162|4042474|B1|3.5||Phenotypic Sensitivity Score|Phenotypic sensitivity score (PSS) was calculated by summing up drug susceptibility values (1=sensitive; 0.5=partially sensitive; 0=resistance or reduced susceptibility) on all drugs in the baseline background regimen. For subjects naive to enfuvirtide (or maraviroc), a score of 1 was assigned for enfuvirtide (or maraviroc). Higher scores correspond to increased sensitivity.|participants|Number|0|0.0||||||
4218777|NCT00708162|4042472|B3|3.0||Phenotypic Sensitivity Score|Phenotypic sensitivity score (PSS) was calculated by summing up drug susceptibility values (1=sensitive; 0.5=partially sensitive; 0=resistance or reduced susceptibility) on all drugs in the baseline background regimen. For subjects naive to enfuvirtide (or maraviroc), a score of 1 was assigned for enfuvirtide (or maraviroc). Higher scores correspond to increased sensitivity.|participants|Number|24|24.0||||||
4218778|NCT00708162|4042473|B2|3.0||Phenotypic Sensitivity Score|Phenotypic sensitivity score (PSS) was calculated by summing up drug susceptibility values (1=sensitive; 0.5=partially sensitive; 0=resistance or reduced susceptibility) on all drugs in the baseline background regimen. For subjects naive to enfuvirtide (or maraviroc), a score of 1 was assigned for enfuvirtide (or maraviroc). Higher scores correspond to increased sensitivity.|participants|Number|10|10.0||||||
4218779|NCT00708162|4042474|B1|3.0||Phenotypic Sensitivity Score|Phenotypic sensitivity score (PSS) was calculated by summing up drug susceptibility values (1=sensitive; 0.5=partially sensitive; 0=resistance or reduced susceptibility) on all drugs in the baseline background regimen. For subjects naive to enfuvirtide (or maraviroc), a score of 1 was assigned for enfuvirtide (or maraviroc). Higher scores correspond to increased sensitivity.|participants|Number|14|14.0||||||
4218780|NCT00708162|4042472|B3|2.5||Phenotypic Sensitivity Score|Phenotypic sensitivity score (PSS) was calculated by summing up drug susceptibility values (1=sensitive; 0.5=partially sensitive; 0=resistance or reduced susceptibility) on all drugs in the baseline background regimen. For subjects naive to enfuvirtide (or maraviroc), a score of 1 was assigned for enfuvirtide (or maraviroc). Higher scores correspond to increased sensitivity.|participants|Number|3|3.0||||||
4218781|NCT00708162|4042473|B2|2.5||Phenotypic Sensitivity Score|Phenotypic sensitivity score (PSS) was calculated by summing up drug susceptibility values (1=sensitive; 0.5=partially sensitive; 0=resistance or reduced susceptibility) on all drugs in the baseline background regimen. For subjects naive to enfuvirtide (or maraviroc), a score of 1 was assigned for enfuvirtide (or maraviroc). Higher scores correspond to increased sensitivity.|participants|Number|1|1.0||||||
4218782|NCT00708162|4042474|B1|2.5||Phenotypic Sensitivity Score|Phenotypic sensitivity score (PSS) was calculated by summing up drug susceptibility values (1=sensitive; 0.5=partially sensitive; 0=resistance or reduced susceptibility) on all drugs in the baseline background regimen. For subjects naive to enfuvirtide (or maraviroc), a score of 1 was assigned for enfuvirtide (or maraviroc). Higher scores correspond to increased sensitivity.|participants|Number|2|2.0||||||
4218783|NCT00708162|4042472|B3|2.0||Phenotypic Sensitivity Score|Phenotypic sensitivity score (PSS) was calculated by summing up drug susceptibility values (1=sensitive; 0.5=partially sensitive; 0=resistance or reduced susceptibility) on all drugs in the baseline background regimen. For subjects naive to enfuvirtide (or maraviroc), a score of 1 was assigned for enfuvirtide (or maraviroc). Higher scores correspond to increased sensitivity.|participants|Number|622|622.0||||||
4218784|NCT00708162|4042473|B2|2.0||Phenotypic Sensitivity Score|Phenotypic sensitivity score (PSS) was calculated by summing up drug susceptibility values (1=sensitive; 0.5=partially sensitive; 0=resistance or reduced susceptibility) on all drugs in the baseline background regimen. For subjects naive to enfuvirtide (or maraviroc), a score of 1 was assigned for enfuvirtide (or maraviroc). Higher scores correspond to increased sensitivity.|participants|Number|313|313.0||||||
4218785|NCT00708162|4042474|B1|2.0||Phenotypic Sensitivity Score|Phenotypic sensitivity score (PSS) was calculated by summing up drug susceptibility values (1=sensitive; 0.5=partially sensitive; 0=resistance or reduced susceptibility) on all drugs in the baseline background regimen. For subjects naive to enfuvirtide (or maraviroc), a score of 1 was assigned for enfuvirtide (or maraviroc). Higher scores correspond to increased sensitivity.|participants|Number|309|309.0||||||
4218786|NCT00708162|4042472|B3|1.5||Phenotypic Sensitivity Score|Phenotypic sensitivity score (PSS) was calculated by summing up drug susceptibility values (1=sensitive; 0.5=partially sensitive; 0=resistance or reduced susceptibility) on all drugs in the baseline background regimen. For subjects naive to enfuvirtide (or maraviroc), a score of 1 was assigned for enfuvirtide (or maraviroc). Higher scores correspond to increased sensitivity.|participants|Number|51|51.0||||||
4218787|NCT00708162|4042473|B2|1.5||Phenotypic Sensitivity Score|Phenotypic sensitivity score (PSS) was calculated by summing up drug susceptibility values (1=sensitive; 0.5=partially sensitive; 0=resistance or reduced susceptibility) on all drugs in the baseline background regimen. For subjects naive to enfuvirtide (or maraviroc), a score of 1 was assigned for enfuvirtide (or maraviroc). Higher scores correspond to increased sensitivity.|participants|Number|28|28.0||||||
4218788|NCT00708162|4042474|B1|1.5||Phenotypic Sensitivity Score|Phenotypic sensitivity score (PSS) was calculated by summing up drug susceptibility values (1=sensitive; 0.5=partially sensitive; 0=resistance or reduced susceptibility) on all drugs in the baseline background regimen. For subjects naive to enfuvirtide (or maraviroc), a score of 1 was assigned for enfuvirtide (or maraviroc). Higher scores correspond to increased sensitivity.|participants|Number|23|23.0||||||
4218789|NCT00708162|4042472|B3|1.0||Phenotypic Sensitivity Score|Phenotypic sensitivity score (PSS) was calculated by summing up drug susceptibility values (1=sensitive; 0.5=partially sensitive; 0=resistance or reduced susceptibility) on all drugs in the baseline background regimen. For subjects naive to enfuvirtide (or maraviroc), a score of 1 was assigned for enfuvirtide (or maraviroc). Higher scores correspond to increased sensitivity.|participants|Number|9|9.0||||||
4218790|NCT00708162|4042473|B2|1.0||Phenotypic Sensitivity Score|Phenotypic sensitivity score (PSS) was calculated by summing up drug susceptibility values (1=sensitive; 0.5=partially sensitive; 0=resistance or reduced susceptibility) on all drugs in the baseline background regimen. For subjects naive to enfuvirtide (or maraviroc), a score of 1 was assigned for enfuvirtide (or maraviroc). Higher scores correspond to increased sensitivity.|participants|Number|4|4.0||||||
4218791|NCT00708162|4042474|B1|1.0||Phenotypic Sensitivity Score|Phenotypic sensitivity score (PSS) was calculated by summing up drug susceptibility values (1=sensitive; 0.5=partially sensitive; 0=resistance or reduced susceptibility) on all drugs in the baseline background regimen. For subjects naive to enfuvirtide (or maraviroc), a score of 1 was assigned for enfuvirtide (or maraviroc). Higher scores correspond to increased sensitivity.|participants|Number|5|5.0||||||
4218792|NCT00708162|4042472|B3|Yes||Maraviroc in background regimen||participants|Number|42|42.0||||||
4218793|NCT00708162|4042473|B2|Yes||Maraviroc in background regimen||participants|Number|18|18.0||||||
4218794|NCT00708162|4042474|B1|Yes||Maraviroc in background regimen||participants|Number|24|24.0||||||
4218795|NCT00708162|4042472|B3|No||Maraviroc in background regimen||participants|Number|670|670.0||||||
4218796|NCT00708162|4042473|B2|No||Maraviroc in background regimen||participants|Number|340|340.0||||||
4218797|NCT00708162|4042474|B1|No||Maraviroc in background regimen||participants|Number|330|330.0||||||
4218798|NCT00708162|4042472|B3|Yes||Etravirine in background regimen||participants|Number|100|100.0||||||
4218799|NCT00708162|4042473|B2|Yes||Etravirine in background regimen||participants|Number|55|55.0||||||
4218800|NCT00708162|4042474|B1|Yes||Etravirine in background regimen||participants|Number|45|45.0||||||
4218801|NCT00708162|4042472|B3|No||Etravirine in background regimen||participants|Number|612|612.0||||||
4218802|NCT00708162|4042473|B2|No||Etravirine in background regimen||participants|Number|303|303.0||||||
4218803|NCT00708162|4042474|B1|No||Etravirine in background regimen||participants|Number|309|309.0||||||
4218804|NCT00708162|4042472|B3|Yes||Enfuvirtide (T-20) in background regimen||participants|Number|3|3.0||||||
4218805|NCT00708162|4042473|B2|Yes||Enfuvirtide (T-20) in background regimen||participants|Number|1|1.0||||||
4218806|NCT00708162|4042474|B1|Yes||Enfuvirtide (T-20) in background regimen||participants|Number|2|2.0||||||
4218807|NCT00708162|4042472|B3|No||Enfuvirtide (T-20) in background regimen||participants|Number|709|709.0||||||
4218808|NCT00708162|4042473|B2|No||Enfuvirtide (T-20) in background regimen||participants|Number|357|357.0||||||
4218809|NCT00708162|4042474|B1|No||Enfuvirtide (T-20) in background regimen||participants|Number|352|352.0||||||
4218810|NCT00708162|4042472|B3|no NRTI in background regimen||Type of NRTI in Background Regimen||participants|Number|129|129.0||||||
4218811|NCT00708162|4042473|B2|no NRTI in background regimen||Type of NRTI in Background Regimen||participants|Number|64|64.0||||||
4218812|NCT00708162|4042474|B1|no NRTI in background regimen||Type of NRTI in Background Regimen||participants|Number|65|65.0||||||
4218813|NCT00708162|4042472|B3|emtricitabine||Type of NRTI in Background Regimen||participants|Number|5|5.0||||||
4218814|NCT00708162|4042473|B2|emtricitabine||Type of NRTI in Background Regimen||participants|Number|3|3.0||||||
4218815|NCT00708162|4042474|B1|emtricitabine||Type of NRTI in Background Regimen||participants|Number|2|2.0||||||
4218816|NCT00708162|4042472|B3|didanosine||Type of NRTI in Background Regimen||participants|Number|8|8.0||||||
4218817|NCT00708162|4042473|B2|didanosine||Type of NRTI in Background Regimen||participants|Number|7|7.0||||||
4218818|NCT00708162|4042474|B1|didanosine||Type of NRTI in Background Regimen||participants|Number|1|1.0||||||
4218819|NCT00708162|4042472|B3|zidovudine||Type of NRTI in Background Regimen||participants|Number|9|9.0||||||
4218820|NCT00708162|4042473|B2|zidovudine||Type of NRTI in Background Regimen||participants|Number|6|6.0||||||
4218821|NCT00708162|4042474|B1|zidovudine||Type of NRTI in Background Regimen||participants|Number|3|3.0||||||
4218822|NCT00708162|4042472|B3|lamivudine/zidovudine||Type of NRTI in Background Regimen||participants|Number|11|11.0||||||
4218823|NCT00708162|4042473|B2|lamivudine/zidovudine||Type of NRTI in Background Regimen||participants|Number|5|5.0||||||
4218824|NCT00708162|4042474|B1|lamivudine/zidovudine||Type of NRTI in Background Regimen||participants|Number|6|6.0||||||
4218825|NCT00708162|4042472|B3|abacavir/lamivudine||Type of NRTI in Background Regimen||participants|Number|12|12.0||||||
4218826|NCT00708162|4042473|B2|abacavir/lamivudine||Type of NRTI in Background Regimen||participants|Number|8|8.0||||||
4218827|NCT00708162|4042474|B1|abacavir/lamivudine||Type of NRTI in Background Regimen||participants|Number|4|4.0||||||
4218828|NCT00708162|4042472|B3|abacavir||Type of NRTI in Background Regimen||participants|Number|21|21.0||||||
4218829|NCT00708162|4042473|B2|abacavir||Type of NRTI in Background Regimen||participants|Number|15|15.0||||||
4218830|NCT00708162|4042474|B1|abacavir||Type of NRTI in Background Regimen||participants|Number|6|6.0||||||
4218831|NCT00708162|4042472|B3|lamivudine||Type of NRTI in Background Regimen||participants|Number|26|26.0||||||
4218832|NCT00708162|4042473|B2|lamivudine||Type of NRTI in Background Regimen||participants|Number|13|13.0||||||
4218833|NCT00708162|4042474|B1|lamivudine||Type of NRTI in Background Regimen||participants|Number|13|13.0||||||
4218834|NCT00708162|4042472|B3|emtricitabine/tenofovir disoproxil fumarate||Type of NRTI in Background Regimen||participants|Number|157|157.0||||||
4218835|NCT00708162|4042473|B2|emtricitabine/tenofovir disoproxil fumarate||Type of NRTI in Background Regimen||participants|Number|66|66.0||||||
4218836|NCT00708162|4042474|B1|emtricitabine/tenofovir disoproxil fumarate||Type of NRTI in Background Regimen||participants|Number|91|91.0||||||
4218837|NCT00708162|4042472|B3|tenofovir disoproxil fumarate||Type of NRTI in Background Regimen||participants|Number|334|334.0||||||
4218838|NCT00708162|4042473|B2|tenofovir disoproxil fumarate||Type of NRTI in Background Regimen||participants|Number|171|171.0||||||
4218839|NCT00708162|4042474|B1|tenofovir disoproxil fumarate||Type of NRTI in Background Regimen||participants|Number|163|163.0||||||
4218840|NCT00708162|4042472|B3|tipranavir||Type of PI in Background Regimen (Excluding Ritonavir)|One participant in the Raltegravir group switched from darunavir to fosamprenavir at Day 5, and is counted only in the number receiving darunavir at baseline.|participants|Number|13|13.0||||||
4218841|NCT00708162|4042473|B2|tipranavir||Type of PI in Background Regimen (Excluding Ritonavir)|One participant in the Raltegravir group switched from darunavir to fosamprenavir at Day 5, and is counted only in the number receiving darunavir at baseline.|participants|Number|7|7.0||||||
4218842|NCT00708162|4042474|B1|tipranavir||Type of PI in Background Regimen (Excluding Ritonavir)|One participant in the Raltegravir group switched from darunavir to fosamprenavir at Day 5, and is counted only in the number receiving darunavir at baseline.|participants|Number|6|6.0||||||
4218843|NCT00708162|4042472|B3|lopinavir||Type of PI in Background Regimen (Excluding Ritonavir)|One participant in the Raltegravir group switched from darunavir to fosamprenavir at Day 5, and is counted only in the number receiving darunavir at baseline.|participants|Number|140|140.0||||||
4218844|NCT00708162|4042473|B2|lopinavir||Type of PI in Background Regimen (Excluding Ritonavir)|One participant in the Raltegravir group switched from darunavir to fosamprenavir at Day 5, and is counted only in the number receiving darunavir at baseline.|participants|Number|72|72.0||||||
4218845|NCT00708162|4042474|B1|lopinavir||Type of PI in Background Regimen (Excluding Ritonavir)|One participant in the Raltegravir group switched from darunavir to fosamprenavir at Day 5, and is counted only in the number receiving darunavir at baseline.|participants|Number|68|68.0||||||
4218846|NCT00708162|4042472|B3|fosamprenavir||Type of PI in Background Regimen (Excluding Ritonavir)|One participant in the Raltegravir group switched from darunavir to fosamprenavir at Day 5, and is counted only in the number receiving darunavir at baseline.|participants|Number|34|34.0||||||
4218847|NCT00708162|4042473|B2|fosamprenavir||Type of PI in Background Regimen (Excluding Ritonavir)|One participant in the Raltegravir group switched from darunavir to fosamprenavir at Day 5, and is counted only in the number receiving darunavir at baseline.|participants|Number|20|20.0||||||
4218848|NCT00708162|4042474|B1|fosamprenavir||Type of PI in Background Regimen (Excluding Ritonavir)|One participant in the Raltegravir group switched from darunavir to fosamprenavir at Day 5, and is counted only in the number receiving darunavir at baseline.|participants|Number|14|14.0||||||
4218849|NCT00708162|4042472|B3|darunavir||Type of PI in Background Regimen (Excluding Ritonavir)|One participant in the Raltegravir group switched from darunavir to fosamprenavir at Day 5, and is counted only in the number receiving darunavir at baseline.|participants|Number|408|408.0||||||
4218850|NCT00708162|4042473|B2|darunavir||Type of PI in Background Regimen (Excluding Ritonavir)|One participant in the Raltegravir group switched from darunavir to fosamprenavir at Day 5, and is counted only in the number receiving darunavir at baseline.|participants|Number|206|206.0||||||
4218851|NCT00708162|4042474|B1|darunavir||Type of PI in Background Regimen (Excluding Ritonavir)|One participant in the Raltegravir group switched from darunavir to fosamprenavir at Day 5, and is counted only in the number receiving darunavir at baseline.|participants|Number|202|202.0||||||
4218852|NCT00708162|4042472|B3|atazanavir||Type of PI in Background Regimen (Excluding Ritonavir)|One participant in the Raltegravir group switched from darunavir to fosamprenavir at Day 5, and is counted only in the number receiving darunavir at baseline.|participants|Number|117|117.0||||||
4218853|NCT00708162|4042473|B2|atazanavir||Type of PI in Background Regimen (Excluding Ritonavir)|One participant in the Raltegravir group switched from darunavir to fosamprenavir at Day 5, and is counted only in the number receiving darunavir at baseline.|participants|Number|53|53.0||||||
4218854|NCT00708162|4042474|B1|atazanavir||Type of PI in Background Regimen (Excluding Ritonavir)|One participant in the Raltegravir group switched from darunavir to fosamprenavir at Day 5, and is counted only in the number receiving darunavir at baseline.|participants|Number|64|64.0||||||
4218855|NCT00708162|4042472|B3|Unknown||HIV Disease Status||participants|Number|8|8.0||||||
4218856|NCT00708162|4042473|B2|Unknown||HIV Disease Status||participants|Number|4|4.0||||||
4218857|NCT00708162|4042474|B1|Unknown||HIV Disease Status||participants|Number|4|4.0||||||
4218858|NCT00708162|4042472|B3|AIDS||HIV Disease Status||participants|Number|251|251.0||||||
4218859|NCT00708162|4042473|B2|AIDS||HIV Disease Status||participants|Number|125|125.0||||||
4218860|NCT00708162|4042474|B1|AIDS||HIV Disease Status||participants|Number|126|126.0||||||
4218861|NCT00708162|4042472|B3|Symptomatic HIV Infections||HIV Disease Status||participants|Number|106|106.0||||||
4218862|NCT00708162|4042473|B2|Symptomatic HIV Infections||HIV Disease Status||participants|Number|54|54.0||||||
4218863|NCT00708162|4042474|B1|Symptomatic HIV Infections||HIV Disease Status||participants|Number|52|52.0||||||
4218864|NCT00708162|4042472|B3|Asymptomatic||HIV Disease Status||participants|Number|347|347.0||||||
4218865|NCT00708162|4042473|B2|Asymptomatic||HIV Disease Status||participants|Number|175|175.0||||||
4218866|NCT00708162|4042474|B1|Asymptomatic||HIV Disease Status||participants|Number|172|172.0||||||
4218867|NCT00708162|4042472|B3|||Cluster of differentiation (CD4) Cell Count||cells/mm^3|Mean|261.6|261.6|Standard Deviation|205.57|205.57|||
4218868|NCT00708162|4042473|B2|||Cluster of differentiation (CD4) Cell Count||cells/mm^3|Mean|265.3|265.3|Standard Deviation|207.04|207.04|||
4218869|NCT00708162|4042474|B1|||Cluster of differentiation (CD4) Cell Count||cells/mm^3|Mean|257.9|257.9|Standard Deviation|204.31|204.31|||
4218870|NCT00708162|4042472|B3|> 100,000 copies/mL||HIV-1 RNA category||participants|Number|182|182.0||||||
4218871|NCT00708162|4042473|B2|> 100,000 copies/mL||HIV-1 RNA category||participants|Number|91|91.0||||||
4218872|NCT00708162|4042474|B1|> 100,000 copies/mL||HIV-1 RNA category||participants|Number|91|91.0||||||
4218873|NCT00708162|4042472|B3|≤ 100,000 copies/mL||HIV-1 RNA category||participants|Number|530|530.0||||||
4218874|NCT00708162|4042473|B2|≤ 100,000 copies/mL||HIV-1 RNA category||participants|Number|267|267.0||||||
4218875|NCT00708162|4042474|B1|≤ 100,000 copies/mL||HIV-1 RNA category||participants|Number|263|263.0||||||
4218876|NCT00708162|4042472|B3|||HIV-1 RNA||log10 copies/mL|Mean|4.26|4.26|Standard Deviation|0.955|0.955|||
4218877|NCT00708162|4042473|B2|||HIV-1 RNA||log10 copies/mL|Mean|4.27|4.27|Standard Deviation|0.943|0.943|||
4218878|NCT00708162|4042474|B1|||HIV-1 RNA||log10 copies/mL|Mean|4.26|4.26|Standard Deviation|0.969|0.969|||
4218879|NCT00708162|4042472|B3|Netherlands||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (elvitegravir arm: n = 361; raltegravir arm: n = 363)|participants|Number|2|2.0||||||
4218880|NCT00708162|4042473|B2|Netherlands||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (elvitegravir arm: n = 361; raltegravir arm: n = 363)|participants|Number|2|2.0||||||
4218881|NCT00708162|4042474|B1|Netherlands||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (elvitegravir arm: n = 361; raltegravir arm: n = 363)|participants|Number|0|0.0||||||
4218882|NCT00708162|4042472|B3|Germany||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (elvitegravir arm: n = 361; raltegravir arm: n = 363)|participants|Number|14|14.0||||||
4218883|NCT00708162|4042473|B2|Germany||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (elvitegravir arm: n = 361; raltegravir arm: n = 363)|participants|Number|8|8.0||||||
4218884|NCT00708162|4042474|B1|Germany||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (elvitegravir arm: n = 361; raltegravir arm: n = 363)|participants|Number|6|6.0||||||
4218885|NCT00708162|4042472|B3|Australia||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (elvitegravir arm: n = 361; raltegravir arm: n = 363)|participants|Number|29|29.0||||||
4218886|NCT00708162|4042473|B2|Australia||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (elvitegravir arm: n = 361; raltegravir arm: n = 363)|participants|Number|12|12.0||||||
4218887|NCT00708162|4042474|B1|Australia||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (elvitegravir arm: n = 361; raltegravir arm: n = 363)|participants|Number|17|17.0||||||
4218888|NCT00708162|4042472|B3|Belgium||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (elvitegravir arm: n = 361; raltegravir arm: n = 363)|participants|Number|11|11.0||||||
4218889|NCT00708162|4042473|B2|Belgium||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (elvitegravir arm: n = 361; raltegravir arm: n = 363)|participants|Number|6|6.0||||||
4218890|NCT00708162|4042474|B1|Belgium||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (elvitegravir arm: n = 361; raltegravir arm: n = 363)|participants|Number|5|5.0||||||
4218891|NCT00708162|4042472|B3|Puerto Rico||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (elvitegravir arm: n = 361; raltegravir arm: n = 363)|participants|Number|22|22.0||||||
4218892|NCT00708162|4042473|B2|Puerto Rico||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (elvitegravir arm: n = 361; raltegravir arm: n = 363)|participants|Number|14|14.0||||||
4218893|NCT00708162|4042474|B1|Puerto Rico||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (elvitegravir arm: n = 361; raltegravir arm: n = 363)|participants|Number|8|8.0||||||
4218894|NCT00708162|4042472|B3|Canada||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (elvitegravir arm: n = 361; raltegravir arm: n = 363)|participants|Number|34|34.0||||||
4218895|NCT00708162|4042473|B2|Canada||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (elvitegravir arm: n = 361; raltegravir arm: n = 363)|participants|Number|18|18.0||||||
4218896|NCT00708162|4042474|B1|Canada||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (elvitegravir arm: n = 361; raltegravir arm: n = 363)|participants|Number|16|16.0||||||
4218897|NCT00708162|4042472|B3|Mexico||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (elvitegravir arm: n = 361; raltegravir arm: n = 363)|participants|Number|51|51.0||||||
4218898|NCT00708162|4042473|B2|Mexico||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (elvitegravir arm: n = 361; raltegravir arm: n = 363)|participants|Number|25|25.0||||||
4218899|NCT00708162|4042474|B1|Mexico||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (elvitegravir arm: n = 361; raltegravir arm: n = 363)|participants|Number|26|26.0||||||
4218900|NCT00708162|4042472|B3|France||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (elvitegravir arm: n = 361; raltegravir arm: n = 363)|participants|Number|25|25.0||||||
4218901|NCT00708162|4042473|B2|France||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (elvitegravir arm: n = 361; raltegravir arm: n = 363)|participants|Number|9|9.0||||||
4218902|NCT00708162|4042474|B1|France||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (elvitegravir arm: n = 361; raltegravir arm: n = 363)|participants|Number|16|16.0||||||
4218903|NCT00708162|4042472|B3|Italy||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (elvitegravir arm: n = 361; raltegravir arm: n = 363)|participants|Number|17|17.0||||||
4218904|NCT00708162|4042473|B2|Italy||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (elvitegravir arm: n = 361; raltegravir arm: n = 363)|participants|Number|10|10.0||||||
4218905|NCT00708162|4042474|B1|Italy||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (elvitegravir arm: n = 361; raltegravir arm: n = 363)|participants|Number|7|7.0||||||
4218906|NCT00708162|4042472|B3|United Kingdom||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (elvitegravir arm: n = 361; raltegravir arm: n = 363)|participants|Number|11|11.0||||||
4218907|NCT00708162|4042473|B2|United Kingdom||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (elvitegravir arm: n = 361; raltegravir arm: n = 363)|participants|Number|5|5.0||||||
4218908|NCT00708162|4042474|B1|United Kingdom||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (elvitegravir arm: n = 361; raltegravir arm: n = 363)|participants|Number|6|6.0||||||
4218909|NCT00708162|4042472|B3|Spain||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (elvitegravir arm: n = 361; raltegravir arm: n = 363)|participants|Number|34|34.0||||||
4218910|NCT00708162|4042473|B2|Spain||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (elvitegravir arm: n = 361; raltegravir arm: n = 363)|participants|Number|20|20.0||||||
4218911|NCT00708162|4042474|B1|Spain||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (elvitegravir arm: n = 361; raltegravir arm: n = 363)|participants|Number|14|14.0||||||
4218912|NCT00708162|4042472|B3|Portugal||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (elvitegravir arm: n = 361; raltegravir arm: n = 363)|participants|Number|21|21.0||||||
4218913|NCT00708162|4042473|B2|Portugal||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (elvitegravir arm: n = 361; raltegravir arm: n = 363)|participants|Number|11|11.0||||||
4218914|NCT00708162|4042474|B1|Portugal||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (elvitegravir arm: n = 361; raltegravir arm: n = 363)|participants|Number|10|10.0||||||
4218915|NCT00708162|4042472|B3|United States||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (elvitegravir arm: n = 361; raltegravir arm: n = 363)|participants|Number|453|453.0||||||
4218916|NCT00708162|4042473|B2|United States||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (elvitegravir arm: n = 361; raltegravir arm: n = 363)|participants|Number|223|223.0||||||
4218917|NCT00708162|4042474|B1|United States||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment (elvitegravir arm: n = 361; raltegravir arm: n = 363)|participants|Number|230|230.0||||||
4218918|NCT00708162|4042472|B3|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4218919|NCT00708162|4042473|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4218920|NCT00708162|4042474|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4218921|NCT00708162|4042472|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4218922|NCT00708162|4042473|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4218923|NCT00708162|4042474|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4218924|NCT00708162|4042472|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4218925|NCT00708162|4042473|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4218926|NCT00708162|4042474|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4218927|NCT00708162|4042472|B3|Asian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4218928|NCT00708162|4042473|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4218929|NCT00708162|4042474|B1|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4218930|NCT00708162|4042472|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|247|247.0||||||
4218931|NCT00708162|4042473|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|119|119.0||||||
4218932|NCT00708162|4042474|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|128|128.0||||||
4218933|NCT00708162|4042472|B3|White||Race/Ethnicity, Customized||participants|Number|437|437.0||||||
4218934|NCT00708162|4042473|B2|White||Race/Ethnicity, Customized||participants|Number|227|227.0||||||
4218935|NCT00708162|4042474|B1|White||Race/Ethnicity, Customized||participants|Number|210|210.0||||||
4218936|NCT00708162|4042472|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4218937|NCT00708162|4042473|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4218938|NCT00708162|4042474|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4218939|NCT00708162|4042472|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|555|555.0||||||
4218940|NCT00708162|4042473|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|283|283.0||||||
4218941|NCT00708162|4042474|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|272|272.0||||||
4218942|NCT00708162|4042472|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|155|155.0||||||
4218943|NCT00708162|4042473|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4218944|NCT00708162|4042474|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
4218945|NCT00708162|4042472|B3||Male|Sex: Female, Male||Participants|Count of Participants|585|585.0||||||
4218946|NCT00708162|4042473|B2||Male|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
4218947|NCT00708162|4042474|B1||Male|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
4218948|NCT00708162|4042472|B3||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4218949|NCT00708162|4042473|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4218950|NCT00708162|4042474|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4218951|NCT00708162|4042472|B3|||Age||years|Mean|45|45.0|Standard Deviation|9.1|9.1|||
4218952|NCT00708162|4042473|B2|||Age||years|Mean|45|45.0|Standard Deviation|9.1|9.1|||
4218953|NCT00708162|4042474|B1|||Age||years|Mean|44|44.0|Standard Deviation|9.0|9.0|||
4218954|NCT00708123|4042516|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4218955|NCT00708123|4042516|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4218956|NCT00708123|4042516|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4218957|NCT00708123|4042516|B1|||Age||years|Mean|67.31|67.31|Standard Deviation|9.166|9.166|||
4218958|NCT00708110|4042540|B5|White – White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4218959|NCT00708110|4042541|B4|White – White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4218960|NCT00708110|4042542|B3|White – White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4218961|NCT00708110|4042543|B2|White – White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4218962|NCT00708110|4042544|B1|White – White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4218963|NCT00708110|4042540|B5|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4218964|NCT00708110|4042541|B4|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4218965|NCT00708110|4042542|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4218966|NCT00708110|4042543|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4218967|NCT00708110|4042544|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4218968|NCT00708110|4042540|B5||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4218969|NCT00708110|4042541|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4218970|NCT00708110|4042542|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4218971|NCT00708110|4042543|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4218972|NCT00708110|4042544|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4218973|NCT00708110|4042540|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4218974|NCT00708110|4042541|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4218975|NCT00708110|4042542|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4218976|NCT00708110|4042543|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4218977|NCT00708110|4042544|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4218978|NCT00708110|4042540|B5|||Age||Years|Mean|38.4|38.4|Standard Deviation|9.38|9.38|||
4218979|NCT00708110|4042541|B4|||Age||Years|Mean|33.7|33.7|Standard Deviation|10.45|10.45|||
4218980|NCT00708110|4042542|B3|||Age||Years|Mean|39.9|39.9|Standard Deviation|4.14|4.14|||
4218981|NCT00708110|4042543|B2|||Age||Years|Mean|41.1|41.1|Standard Deviation|10.47|10.47|||
4218982|NCT00708110|4042544|B1|||Age||Years|Mean|39.6|39.6|Standard Deviation|10.64|10.64|||
4218983|NCT00708097|4042653|B1|United States||Region of Enrollment||participants|Number|57|57.0||||||
4218984|NCT00708097|4042653|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4218985|NCT00708097|4042653|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4218986|NCT00708097|4042653|B1|||Age||years|Mean|65.5|65.5|Standard Deviation|10.32|10.32|||
4218987|NCT00708071|4042687|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4218988|NCT00708071|4042687|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4218989|NCT00708071|4042687|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4218990|NCT00708071|4042687|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|6.9|6.9|||
4218991|NCT00708032|4042765|B3|United Kingdom||Region of Enrollment||participants|Number|74|74.0||||||
4218992|NCT00708032|4042766|B2|United Kingdom||Region of Enrollment||participants|Number|38|38.0||||||
4218993|NCT00708032|4042767|B1|United Kingdom||Region of Enrollment||participants|Number|36|36.0||||||
4218994|NCT00708032|4042765|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4218995|NCT00708032|4042766|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4218996|NCT00708032|4042767|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4218997|NCT00708032|4042765|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4218998|NCT00708032|4042766|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4218999|NCT00708032|4042767|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4219000|NCT00708032|4042765|B3|||Age||years|Mean|26.5|26.5|Standard Deviation|7.7|7.7|||
4219001|NCT00708032|4042766|B2|||Age||years|Mean|26.5|26.5|Standard Deviation|7.4|7.4|||
4219002|NCT00708032|4042767|B1|||Age||years|Mean|26.5|26.5|Standard Deviation|8.1|8.1|||
4219003|NCT00708019|4042782|B3|United States||Region of Enrollment||participants|Number|185|185.0||||||
4219004|NCT00708019|4042783|B2|United States||Region of Enrollment||participants|Number|93|93.0||||||
4219005|NCT00708019|4042784|B1|United States||Region of Enrollment||participants|Number|92|92.0||||||
4219006|NCT00708019|4042782|B3||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4219007|NCT00708019|4042783|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4219008|NCT00708019|4042784|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4219009|NCT00708019|4042782|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4219010|NCT00708019|4042783|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4219011|NCT00708019|4042784|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4219012|NCT00708019|4042782|B3|||Age||years|Mean|59.15|59.15|Standard Deviation|11.90|11.9|||
4219013|NCT00708019|4042783|B2|||Age||years|Mean|59.29|59.29|Standard Deviation|1.29|1.29|||
4219014|NCT00708019|4042784|B1|||Age||years|Mean|59.01|59.01|Standard Deviation|1.19|1.19|||
4219015|NCT00707993|4042793|B3|Ex-smoker||Smoking history||participants|Number|86|86.0||||||
4219016|NCT00707993|4042794|B2|Ex-smoker||Smoking history||participants|Number|40|40.0||||||
4219017|NCT00707993|4042795|B1|Ex-smoker||Smoking history||participants|Number|46|46.0||||||
4219018|NCT00707993|4042793|B3|Current smoker||Smoking history||participants|Number|27|27.0||||||
4219019|NCT00707993|4042794|B2|Current smoker||Smoking history||participants|Number|11|11.0||||||
4219020|NCT00707993|4042795|B1|Current smoker||Smoking history||participants|Number|16|16.0||||||
4219021|NCT00707993|4042793|B3|Never smoked||Smoking history||participants|Number|328|328.0||||||
4219022|NCT00707993|4042794|B2|Never smoked||Smoking history||participants|Number|168|168.0||||||
4219023|NCT00707993|4042795|B1|Never smoked||Smoking history||participants|Number|160|160.0||||||
4219024|NCT00707993|4042793|B3|||Glomerular Filtration Rate (GFR)|Using the Modification of Diet in Renal Disease method.|mL/min/1.73 m2|Mean|73.26|73.26|Standard Deviation|15.133|15.133|||
4219025|NCT00707993|4042794|B2|||Glomerular Filtration Rate (GFR)|Using the Modification of Diet in Renal Disease method.|mL/min/1.73 m2|Mean|72.89|72.89|Standard Deviation|15.524|15.524|||
4219026|NCT00707993|4042795|B1|||Glomerular Filtration Rate (GFR)|Using the Modification of Diet in Renal Disease method.|mL/min/1.73 m2|Mean|73.62|73.62|Standard Deviation|14.762|14.762|||
4219027|NCT00707993|4042793|B3|||Diabetes duration||years|Mean|6.10|6.1|Standard Deviation|6.275|6.275|||
4219028|NCT00707993|4042794|B2|||Diabetes duration||years|Mean|5.94|5.94|Standard Deviation|6.276|6.276|||
4219029|NCT00707993|4042795|B1|||Diabetes duration||years|Mean|6.25|6.25|Standard Deviation|6.285|6.285|||
4219030|NCT00707993|4042793|B3|||Body Mass Index (BMI)||kg/m2|Mean|29.79|29.79|Standard Deviation|4.404|4.404|||
4219031|NCT00707993|4042794|B2|||Body Mass Index (BMI)||kg/m2|Mean|30.02|30.02|Standard Deviation|4.459|4.459|||
4219032|NCT00707993|4042795|B1|||Body Mass Index (BMI)||kg/m2|Mean|29.58|29.58|Standard Deviation|4.348|4.348|||
4219033|NCT00707993|4042793|B3|||Weight||kg|Mean|78.70|78.7|Standard Deviation|15.024|15.024|||
4219034|NCT00707993|4042794|B2|||Weight||kg|Mean|78.81|78.81|Standard Deviation|15.239|15.239|||
4219035|NCT00707993|4042795|B1|||Weight||kg|Mean|78.60|78.6|Standard Deviation|14.842|14.842|||
4219036|NCT00707993|4042793|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219037|NCT00707993|4042794|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219038|NCT00707993|4042795|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219039|NCT00707993|4042793|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4219040|NCT00707993|4042794|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4219041|NCT00707993|4042795|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4219042|NCT00707993|4042793|B3||White|Race (NIH/OMB)||Participants|Count of Participants|323|323.0||||||
4219043|NCT00707993|4042794|B2||White|Race (NIH/OMB)||Participants|Count of Participants|154|154.0||||||
4219044|NCT00707993|4042795|B1||White|Race (NIH/OMB)||Participants|Count of Participants|169|169.0||||||
4219045|NCT00707993|4042793|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4219046|NCT00707993|4042794|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4219047|NCT00707993|4042795|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4219048|NCT00707993|4042793|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219049|NCT00707993|4042794|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219050|NCT00707993|4042795|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219051|NCT00707993|4042793|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4219052|NCT00707993|4042794|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4219053|NCT00707993|4042795|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4219054|NCT00707993|4042793|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4219055|NCT00707993|4042794|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4219056|NCT00707993|4042795|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4219057|NCT00707993|4042793|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219058|NCT00707993|4042794|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219059|NCT00707993|4042795|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219060|NCT00707993|4042793|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|292|292.0||||||
4219061|NCT00707993|4042794|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|149|149.0||||||
4219062|NCT00707993|4042795|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|143|143.0||||||
4219063|NCT00707993|4042793|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|149|149.0||||||
4219064|NCT00707993|4042794|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4219065|NCT00707993|4042795|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
4219066|NCT00707993|4042793|B3||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4219067|NCT00707993|4042794|B2||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4219068|NCT00707993|4042795|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4219069|NCT00707993|4042793|B3||Female|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
4219070|NCT00707993|4042794|B2||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4219071|NCT00707993|4042795|B1||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4219072|NCT00707993|4042793|B3|≥75 years||Age, Customized||participants|Number|62|62.0||||||
4219073|NCT00707993|4042794|B2|≥75 years||Age, Customized||participants|Number|26|26.0||||||
4219074|NCT00707993|4042795|B1|≥75 years||Age, Customized||participants|Number|36|36.0||||||
4219075|NCT00707993|4042793|B3|<75 years||Age, Customized||participants|Number|379|379.0||||||
4219076|NCT00707993|4042794|B2|<75 years||Age, Customized||participants|Number|193|193.0||||||
4219077|NCT00707993|4042795|B1|<75 years||Age, Customized||participants|Number|186|186.0||||||
4219078|NCT00707993|4042793|B3|||Age||years|Mean|69.9|69.9|Standard Deviation|4.24|4.24|||
4219079|NCT00707993|4042794|B2|||Age||years|Mean|69.8|69.8|Standard Deviation|4.07|4.07|||
4219080|NCT00707993|4042795|B1|||Age||years|Mean|70.1|70.1|Standard Deviation|4.42|4.42|||
4219081|NCT00707980|4042838|B1|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|scores on a scale|Mean|3.2|3.2|Standard Deviation|1.26|1.26|||
4219082|NCT00707980|4042838|B1|||Hamilton Anxiety Scale total score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 to 56, where <17 indicates mild severity, 18–24 mild to moderate severity and 25–30 moderate to severe. Total scores above 30 are rare, but indicate very severe anxiety.|scores on a scale|Mean|12.1|12.1|Standard Deviation|7.17|7.17|||
4219083|NCT00707980|4042838|B1|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|16.6|16.6|Standard Deviation|9.24|9.24|||
4219084|NCT00707980|4042838|B1|||24-item Hamilton Depression Scale total score|The 24-item Hamilton Depression Scale (HAM-D24) is a clinician-rated 24-item scale for assessing the severity of depression symptoms. The scores for each item range from 0 to 4 or 0 to 2, where 0 represents no symptoms. The rating is based on the past 7 days prior to the time of assessment. The total score ranges from 0 to 74, where a higher score indicates a greater depressive state.|scores on a scale|Mean|17.6|17.6|Standard Deviation|9.40|9.4|||
4219085|NCT00707980|4042838|B1|||Body Mass Index (BMI)||kg/m^2|Mean|28.41|28.41|Standard Deviation|7.074|7.074|||
4219086|NCT00707980|4042838|B1|||Height||cm|Mean|169.00|169.0|Standard Deviation|9.777|9.777|||
4219087|NCT00707980|4042838|B1|||Weight||kg|Mean|81.16|81.16|Standard Deviation|20.829|20.829|||
4219088|NCT00707980|4042838|B1|United States||Region of Enrollment||Participants|Number|387|387.0||||||
4219089|NCT00707980|4042838|B1|Ukraine||Region of Enrollment||Participants|Number|37|37.0||||||
4219090|NCT00707980|4042838|B1|Taiwan||Region of Enrollment||Participants|Number|3|3.0||||||
4219091|NCT00707980|4042838|B1|Russia||Region of Enrollment||Participants|Number|40|40.0||||||
4219092|NCT00707980|4042838|B1|Poland||Region of Enrollment||Participants|Number|57|57.0||||||
4219093|NCT00707980|4042838|B1|Netherlands||Region of Enrollment||Participants|Number|7|7.0||||||
4219094|NCT00707980|4042838|B1|Malaysia||Region of Enrollment||Participants|Number|17|17.0||||||
4219095|NCT00707980|4042838|B1|Latvia||Region of Enrollment||Participants|Number|20|20.0||||||
4219096|NCT00707980|4042838|B1|Lithuania||Region of Enrollment||Participants|Number|10|10.0||||||
4219097|NCT00707980|4042838|B1|Republic of Korea||Region of Enrollment||Participants|Number|25|25.0||||||
4219098|NCT00707980|4042838|B1|Croatia||Region of Enrollment||Participants|Number|11|11.0||||||
4219099|NCT00707980|4042838|B1|France||Region of Enrollment||Participants|Number|11|11.0||||||
4219100|NCT00707980|4042838|B1|Germany||Region of Enrollment||Participants|Number|207|207.0||||||
4219101|NCT00707980|4042838|B1|Australia||Region of Enrollment||Participants|Number|4|4.0||||||
4219102|NCT00707980|4042838|B1|Missing||Race/Ethnicity, Customized|Race data available for 836 participants.|Participants|Number|1|1.0||||||
4219103|NCT00707980|4042838|B1|Non-Hispanic/Non-Latino||Race/Ethnicity, Customized|Race data available for 836 participants.|Participants|Number|782|782.0||||||
4219104|NCT00707980|4042838|B1|Hispanic/Latino||Race/Ethnicity, Customized|Race data available for 836 participants.|Participants|Number|53|53.0||||||
4219105|NCT00707980|4042838|B1|Native Hawaiian/ Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4219106|NCT00707980|4042838|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4219107|NCT00707980|4042838|B1|Asian||Race/Ethnicity, Customized||Participants|Number|54|54.0||||||
4219108|NCT00707980|4042838|B1|Black||Race/Ethnicity, Customized||Participants|Number|86|86.0||||||
4219109|NCT00707980|4042838|B1|Caucasian (White, including Hispanic)||Race/Ethnicity, Customized||Participants|Number|693|693.0||||||
4219110|NCT00707980|4042838|B1||Male|Sex: Female, Male|Note: Baseline refers to the open-label extension study baseline throughout these results.|Participants|Count of Participants|310|310.0||||||
4219111|NCT00707980|4042838|B1||Female|Sex: Female, Male|Note: Baseline refers to the open-label extension study baseline throughout these results.|Participants|Count of Participants|526|526.0||||||
4219112|NCT00707980|4042838|B1|>55 years||Age, Customized||Participants|Number|200|200.0||||||
4219113|NCT00707980|4042838|B1|≤55 years||Age, Customized||Participants|Number|636|636.0||||||
4219114|NCT00707980|4042838|B1|||Age||Years|Mean|45.5|45.5|Standard Deviation|12.78|12.78|||
4219115|NCT00707967|4042853|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4219116|NCT00707967|4042854|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4219117|NCT00707967|4042855|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4219118|NCT00707967|4042856|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4219119|NCT00707967|4042853|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4219120|NCT00707967|4042854|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4219121|NCT00707967|4042855|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4219122|NCT00707967|4042856|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4219123|NCT00707967|4042853|B4|||Age||Years|Mean|40.12|40.12|Standard Deviation|6.54|6.54|||
4219124|NCT00707967|4042854|B3|||Age||Years|Mean|41.9|41.9|Standard Deviation|4.67|4.67|||
4219125|NCT00707967|4042855|B2|||Age||Years|Mean|40.0|40.0|Standard Deviation|5.61|5.61|||
4219126|NCT00707967|4042856|B1|||Age||Years|Mean|39.6|39.6|Standard Deviation|7.43|7.43|||
4219127|NCT00707954|4042917|B6||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4219128|NCT00707954|4042918|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4219129|NCT00707954|4042919|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4219130|NCT00707954|4042920|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4219131|NCT00707954|4042921|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4219132|NCT00707954|4042922|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4219133|NCT00707954|4042917|B6||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4219134|NCT00707954|4042918|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4219135|NCT00707954|4042919|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4219136|NCT00707954|4042920|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4219137|NCT00707954|4042921|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4219138|NCT00707954|4042922|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4219139|NCT00707954|4042917|B6|||Age||years|Mean|54.3|54.3|Standard Deviation|8.8|8.8|||
4219140|NCT00707954|4042918|B5|||Age||years|Mean|57.6|57.6|Standard Deviation|6.3|6.3|||
4219141|NCT00707954|4042919|B4|||Age||years|Mean|56.5|56.5|Standard Deviation|8.2|8.2|||
4219142|NCT00707954|4042920|B3|||Age||years|Mean|56.2|56.2|Standard Deviation|8.6|8.6|||
4219143|NCT00707954|4042921|B2|||Age||years|Mean|52.1|52.1|Standard Deviation|7.6|7.6|||
4219144|NCT00707954|4042922|B1|||Age||years|Mean|49|49.0|Standard Deviation|10.6|10.6|||
4219145|NCT00707915|4042938|B1|Japan||Region of Enrollment||participants|Number|30|30.0||||||
4219146|NCT00707915|4042938|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4219147|NCT00707915|4042938|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4219148|NCT00707915|4042938|B1|||Age||years|Mean|79.1|79.1|Standard Deviation|8.9|8.9|||
4219149|NCT00707915|4042938|B1||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4219150|NCT00707915|4042938|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4219151|NCT00707915|4042938|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4219152|NCT00707863|4042947|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4219153|NCT00707863|4042948|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4219154|NCT00707863|4042949|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4219155|NCT00707863|4042947|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4219156|NCT00707863|4042948|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4219157|NCT00707863|4042949|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4219158|NCT00707863|4042947|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4219159|NCT00707863|4042948|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4219160|NCT00707863|4042949|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4219161|NCT00707863|4042947|B3|||Age||years|Mean|30|30.0|Standard Deviation|7|7.0|||
4219162|NCT00707863|4042948|B2|||Age||years|Mean|34|34.0|Standard Deviation|6|6.0|||
4219163|NCT00707863|4042949|B1|||Age||years|Mean|22|22.0|Standard Deviation|1|1.0|||
4219164|NCT00707863|4042947|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4219165|NCT00707863|4042948|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4219166|NCT00707863|4042949|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4219167|NCT00707863|4042947|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4219168|NCT00707863|4042948|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4219169|NCT00707863|4042949|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4219170|NCT00707863|4042947|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4219171|NCT00707863|4042948|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4219172|NCT00707863|4042949|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4219173|NCT00707759|4042956|B3|||Height Z-score||units on a scale|Mean|-2.3|-2.3|Standard Deviation|1.1|1.1|||
4219174|NCT00707759|4042957|B2|||Height Z-score||units on a scale|Mean|-2.0|-2.0|Standard Deviation|1.2|1.2|||
4219175|NCT00707759|4042958|B1|||Height Z-score||units on a scale|Mean|-2.5|-2.5|Standard Deviation|1.0|1.0|||
4219176|NCT00707759|4042956|B3|Chile||Region of Enrollment||participants|Number|24|24.0||||||
4219177|NCT00707759|4042957|B2|Chile||Region of Enrollment||participants|Number|12|12.0||||||
4219178|NCT00707759|4042958|B1|Chile||Region of Enrollment||participants|Number|12|12.0||||||
4219179|NCT00707759|4042956|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4219180|NCT00707759|4042957|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4219181|NCT00707759|4042958|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4219182|NCT00707759|4042956|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4219183|NCT00707759|4042957|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4219184|NCT00707759|4042958|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4219185|NCT00707759|4042956|B3|||Age||years|Mean|6.5|6.5|Standard Deviation|3.6|3.6|||
4219186|NCT00707759|4042957|B2|||Age||years|Mean|6.9|6.9|Standard Deviation|3.9|3.9|||
4219187|NCT00707759|4042958|B1|||Age||years|Mean|6.0|6.0|Standard Deviation|3.3|3.3|||
4219188|NCT00707746|4042965|B3|Never||Alcohol use||participants|Number|4|4.0||||||
4219189|NCT00707746|4042966|B2|Never||Alcohol use||participants|Number|2|2.0||||||
4219190|NCT00707746|4042967|B1|Never||Alcohol use||participants|Number|2|2.0||||||
4219191|NCT00707746|4042965|B3|Non-current||Alcohol use||participants|Number|5|5.0||||||
4219192|NCT00707746|4042966|B2|Non-current||Alcohol use||participants|Number|3|3.0||||||
4219193|NCT00707746|4042967|B1|Non-current||Alcohol use||participants|Number|2|2.0||||||
4219194|NCT00707746|4042965|B3|Current||Alcohol use||participants|Number|24|24.0||||||
4219195|NCT00707746|4042966|B2|Current||Alcohol use||participants|Number|16|16.0||||||
4219196|NCT00707746|4042967|B1|Current||Alcohol use||participants|Number|8|8.0||||||
4219197|NCT00707746|4042965|B3|Never||Tobacco Use||participants|Number|11|11.0||||||
4219198|NCT00707746|4042966|B2|Never||Tobacco Use||participants|Number|6|6.0||||||
4219199|NCT00707746|4042967|B1|Never||Tobacco Use||participants|Number|5|5.0||||||
4219200|NCT00707746|4042965|B3|Non-current||Tobacco Use||participants|Number|14|14.0||||||
4219201|NCT00707746|4042966|B2|Non-current||Tobacco Use||participants|Number|9|9.0||||||
4219202|NCT00707746|4042967|B1|Non-current||Tobacco Use||participants|Number|5|5.0||||||
4219203|NCT00707746|4042965|B3|Current||Tobacco Use||participants|Number|8|8.0||||||
4219204|NCT00707746|4042966|B2|Current||Tobacco Use||participants|Number|6|6.0||||||
4219205|NCT00707746|4042967|B1|Current||Tobacco Use||participants|Number|2|2.0||||||
4219206|NCT00707746|4042965|B3|Yes||Metabolic syndrome|"A participant was classified as having metabolic syndrome if any 3 of the following risk factors existed: 1) Waist circumference ≥102 cm (men) or ≥88 cm (women); 2) Triglycerides ≥150 mg/dl *; 3) High density lipoprotein cholesterol <40 mg/dl (men) or <50 mg/dl (women)*; 4) Systolic blood pressure ≥130 or diastolic ≥85 mmHg *; 5) Fasting glucose ≥100 mg/dl *.~* = or on medication for the specified risk factor."|participants|Number|17|17.0||||||
4219207|NCT00707746|4042966|B2|Yes||Metabolic syndrome|"A participant was classified as having metabolic syndrome if any 3 of the following risk factors existed: 1) Waist circumference ≥102 cm (men) or ≥88 cm (women); 2) Triglycerides ≥150 mg/dl *; 3) High density lipoprotein cholesterol <40 mg/dl (men) or <50 mg/dl (women)*; 4) Systolic blood pressure ≥130 or diastolic ≥85 mmHg *; 5) Fasting glucose ≥100 mg/dl *.~* = or on medication for the specified risk factor."|participants|Number|9|9.0||||||
4219208|NCT00707746|4042967|B1|Yes||Metabolic syndrome|"A participant was classified as having metabolic syndrome if any 3 of the following risk factors existed: 1) Waist circumference ≥102 cm (men) or ≥88 cm (women); 2) Triglycerides ≥150 mg/dl *; 3) High density lipoprotein cholesterol <40 mg/dl (men) or <50 mg/dl (women)*; 4) Systolic blood pressure ≥130 or diastolic ≥85 mmHg *; 5) Fasting glucose ≥100 mg/dl *.~* = or on medication for the specified risk factor."|participants|Number|8|8.0||||||
4219209|NCT00707746|4042965|B3|No||Metabolic syndrome|"A participant was classified as having metabolic syndrome if any 3 of the following risk factors existed: 1) Waist circumference ≥102 cm (men) or ≥88 cm (women); 2) Triglycerides ≥150 mg/dl *; 3) High density lipoprotein cholesterol <40 mg/dl (men) or <50 mg/dl (women)*; 4) Systolic blood pressure ≥130 or diastolic ≥85 mmHg *; 5) Fasting glucose ≥100 mg/dl *.~* = or on medication for the specified risk factor."|participants|Number|16|16.0||||||
4219210|NCT00707746|4042966|B2|No||Metabolic syndrome|"A participant was classified as having metabolic syndrome if any 3 of the following risk factors existed: 1) Waist circumference ≥102 cm (men) or ≥88 cm (women); 2) Triglycerides ≥150 mg/dl *; 3) High density lipoprotein cholesterol <40 mg/dl (men) or <50 mg/dl (women)*; 4) Systolic blood pressure ≥130 or diastolic ≥85 mmHg *; 5) Fasting glucose ≥100 mg/dl *.~* = or on medication for the specified risk factor."|participants|Number|12|12.0||||||
4219211|NCT00707746|4042967|B1|No||Metabolic syndrome|"A participant was classified as having metabolic syndrome if any 3 of the following risk factors existed: 1) Waist circumference ≥102 cm (men) or ≥88 cm (women); 2) Triglycerides ≥150 mg/dl *; 3) High density lipoprotein cholesterol <40 mg/dl (men) or <50 mg/dl (women)*; 4) Systolic blood pressure ≥130 or diastolic ≥85 mmHg *; 5) Fasting glucose ≥100 mg/dl *.~* = or on medication for the specified risk factor."|participants|Number|4|4.0||||||
4219212|NCT00707746|4042965|B3|||Waist/hip Ratio||ratio|Mean|0.93|0.93|Standard Deviation|0.08|0.08|||
4219213|NCT00707746|4042966|B2|||Waist/hip Ratio||ratio|Mean|0.93|0.93|Standard Deviation|0.08|0.08|||
4219214|NCT00707746|4042967|B1|||Waist/hip Ratio||ratio|Mean|0.92|0.92|Standard Deviation|0.09|0.09|||
4219215|NCT00707746|4042965|B3|||Body Mass Index (BMI)||kg/m^2|Mean|26.31|26.31|Standard Deviation|2.96|2.96|||
4219216|NCT00707746|4042966|B2|||Body Mass Index (BMI)||kg/m^2|Mean|26.46|26.46|Standard Deviation|3.25|3.25|||
4219217|NCT00707746|4042967|B1|||Body Mass Index (BMI)||kg/m^2|Mean|26.06|26.06|Standard Deviation|2.49|2.49|||
4219218|NCT00707746|4042965|B3|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4219219|NCT00707746|4042966|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4219220|NCT00707746|4042967|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4219221|NCT00707746|4042965|B3|White||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4219222|NCT00707746|4042966|B2|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4219223|NCT00707746|4042967|B1|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4219224|NCT00707746|4042965|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219225|NCT00707746|4042966|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219226|NCT00707746|4042967|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219227|NCT00707746|4042965|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4219228|NCT00707746|4042966|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4219229|NCT00707746|4042967|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4219230|NCT00707746|4042965|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219231|NCT00707746|4042966|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219232|NCT00707746|4042967|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219233|NCT00707746|4042965|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4219234|NCT00707746|4042966|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4219235|NCT00707746|4042967|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4219236|NCT00707746|4042965|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4219237|NCT00707746|4042966|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4219238|NCT00707746|4042967|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4219239|NCT00707746|4042965|B3|||Age||years|Mean|54.2|54.2|Standard Deviation|7.6|7.6|||
4219240|NCT00707746|4042966|B2|||Age||years|Mean|55.6|55.6|Standard Deviation|6.8|6.8|||
4219241|NCT00707746|4042967|B1|||Age||years|Mean|51.7|51.7|Standard Deviation|8.7|8.7|||
4219242|NCT00707655|4043014|B3|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4219243|NCT00707655|4043015|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4219244|NCT00707655|4043016|B1|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4219245|NCT00707655|4043014|B3|France||Region of Enrollment||participants|Number|4|4.0||||||
4219246|NCT00707655|4043015|B2|France||Region of Enrollment||participants|Number|4|4.0||||||
4219247|NCT00707655|4043016|B1|France||Region of Enrollment||participants|Number|0|0.0||||||
4219248|NCT00707655|4043014|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4219249|NCT00707655|4043015|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4219250|NCT00707655|4043016|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4219251|NCT00707655|4043014|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4219252|NCT00707655|4043015|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4219253|NCT00707655|4043016|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4219254|NCT00707655|4043014|B3|||Age||years|Median|72|72.0|Full Range|||43.0|81.0|
4219255|NCT00707655|4043015|B2|||Age||years|Median|70|70.0|Full Range|||43.0|81.0|
4219256|NCT00707655|4043016|B1|||Age||years|Median|73|73.0|Full Range|||72.0|77.0|
4219257|NCT00707655|4043014|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4219258|NCT00707655|4043015|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4219259|NCT00707655|4043016|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4219260|NCT00707655|4043014|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4219261|NCT00707655|4043015|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4219262|NCT00707655|4043016|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4219263|NCT00707655|4043014|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4219264|NCT00707655|4043015|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4219265|NCT00707655|4043016|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4219266|NCT00707577|4043027|B3|||Amount of physical activity/week||hours|Median|3.0|3.0|Inter-Quartile Range|||1.0|6.0|
4219267|NCT00707577|4043028|B2|||Amount of physical activity/week||hours|Median|3.5|3.5|Inter-Quartile Range|||1.0|5.8|
4219268|NCT00707577|4043029|B1|||Amount of physical activity/week||hours|Median|2.6|2.6|Inter-Quartile Range|||1.0|6.0|
4219269|NCT00707577|4043027|B3|||Current smoking||Participants|Count of Participants|15|15.0||||||
4219270|NCT00707577|4043028|B2|||Current smoking||Participants|Count of Participants|6|6.0||||||
4219271|NCT00707577|4043029|B1|||Current smoking||Participants|Count of Participants|9|9.0||||||
4219272|NCT00707577|4043027|B3|||BMI greater than 25||Participants|Count of Participants|210|210.0||||||
4219273|NCT00707577|4043028|B2|||BMI greater than 25||Participants|Count of Participants|95|95.0||||||
4219274|NCT00707577|4043029|B1|||BMI greater than 25||Participants|Count of Participants|115|115.0||||||
4219275|NCT00707577|4043027|B3|||Employment at MGH > 5 years||Participants|Count of Participants|158|158.0||||||
4219276|NCT00707577|4043028|B2|||Employment at MGH > 5 years||Participants|Count of Participants|69|69.0||||||
4219277|NCT00707577|4043029|B1|||Employment at MGH > 5 years||Participants|Count of Participants|89|89.0||||||
4219278|NCT00707577|4043027|B3|||Married or living with significant other||Participants|Count of Participants|193|193.0||||||
4219279|NCT00707577|4043028|B2|||Married or living with significant other||Participants|Count of Participants|83|83.0||||||
4219280|NCT00707577|4043029|B1|||Married or living with significant other||Participants|Count of Participants|110|110.0||||||
4219281|NCT00707577|4043027|B3|United States||Region of Enrollment||participants|Number|330|330.0||||||
4219282|NCT00707577|4043028|B2|United States||Region of Enrollment||participants|Number|156|156.0||||||
4219283|NCT00707577|4043029|B1|United States||Region of Enrollment||participants|Number|174|174.0||||||
4219284|NCT00707577|4043027|B3|Non-white||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
4219285|NCT00707577|4043028|B2|Non-white||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4219286|NCT00707577|4043029|B1|Non-white||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4219287|NCT00707577|4043027|B3|White||Race/Ethnicity, Customized||participants|Number|272|272.0||||||
4219288|NCT00707577|4043028|B2|White||Race/Ethnicity, Customized||participants|Number|124|124.0||||||
4219289|NCT00707577|4043029|B1|White||Race/Ethnicity, Customized||participants|Number|148|148.0||||||
4219290|NCT00707577|4043027|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4219291|NCT00707577|4043028|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4219292|NCT00707577|4043029|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4219293|NCT00707577|4043027|B3||Female|Sex: Female, Male||Participants|Count of Participants|280|280.0||||||
4219294|NCT00707577|4043028|B2||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4219295|NCT00707577|4043029|B1||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4219296|NCT00707577|4043027|B3|||Age||years|Mean|42.9|42.9|Standard Deviation|12.7|12.7|||
4219297|NCT00707577|4043028|B2|||Age||years|Mean|41.6|41.6|Standard Deviation|13.6|13.6|||
4219298|NCT00707577|4043029|B1|||Age||years|Mean|44.2|44.2|Standard Deviation|11.8|11.8|||
4219299|NCT00707486|4043036|B1|||Systolic Blood Pressure||mmHg|Mean|128.1|128.1|Standard Deviation|15.13|15.13|||
4219300|NCT00707486|4043036|B1|||Diastolic Blood Pressure||mmHg|Mean|73.3|73.3|Standard Deviation|8.36|8.36|||
4219301|NCT00707486|4043036|B1|United States||Region of Enrollment||participants|Number|72|72.0||||||
4219302|NCT00707486|4043036|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4219303|NCT00707486|4043036|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4219304|NCT00707486|4043036|B1|||Age||years|Mean|19.1|19.1|Standard Deviation|3.95|3.95|||
4219305|NCT00707486|4043036|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4219306|NCT00707486|4043036|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4219307|NCT00707486|4043036|B1||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4219308|NCT00707447|4043045|B3|Germany||Region of Enrollment||participants|Number|182|182.0||||||
4219309|NCT00707447|4043046|B2|Germany||Region of Enrollment||participants|Number|93|93.0||||||
4219310|NCT00707447|4043047|B1|Germany||Region of Enrollment||participants|Number|89|89.0||||||
4219311|NCT00707447|4043045|B3||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4219312|NCT00707447|4043046|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4219313|NCT00707447|4043047|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4219314|NCT00707447|4043045|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4219315|NCT00707447|4043046|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4219316|NCT00707447|4043047|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4219317|NCT00707447|4043045|B3|||Age||years|Mean|56.2|56.2|Standard Deviation|10.1|10.1|||
4219318|NCT00707447|4043046|B2|||Age||years|Mean|56.6|56.6|Standard Deviation|9.6|9.6|||
4219319|NCT00707447|4043047|B1|||Age||years|Mean|55.9|55.9|Standard Deviation|10.7|10.7|||
4219320|NCT00707447|4043045|B3||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4219321|NCT00707447|4043046|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4219322|NCT00707447|4043047|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4219323|NCT00707447|4043045|B3||Between 18 and 65 years|Age||Participants|Count of Participants|152|152.0||||||
4219324|NCT00707447|4043046|B2||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4219325|NCT00707447|4043047|B1||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
4219326|NCT00707447|4043045|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4219327|NCT00707447|4043046|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4219328|NCT00707447|4043047|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4219329|NCT00707343|4043072|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4219330|NCT00707343|4043072|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4219331|NCT00707343|4043072|B1|||Age||years|Median|47|47.0|Full Range|||22.0|75.0|
4219332|NCT00707239|4043076|B4||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4219333|NCT00707239|4043077|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4219334|NCT00707239|4043078|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4219335|NCT00707239|4043079|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4219336|NCT00707239|4043076|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4219337|NCT00707239|4043077|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4219338|NCT00707239|4043078|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4219339|NCT00707239|4043079|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4219340|NCT00707239|4043076|B4|||Age||years|Mean|62.16|62.16|Standard Deviation|15.37|15.37|||
4219341|NCT00707239|4043077|B3|||Age||years|Mean|64.85|64.85|Standard Deviation|15.33|15.33|||
4219342|NCT00707239|4043078|B2|||Age||years|Mean|61.46|61.46|Standard Deviation|16.05|16.05|||
4219343|NCT00707239|4043079|B1|||Age||years|Mean|60.31|60.31|Standard Deviation|14.82|14.82|||
4219344|NCT00707174|4043127|B3|United States||Region of Enrollment||participants|Number|90|90.0||||||
4219345|NCT00707174|4043128|B2|United States||Region of Enrollment||participants|Number|44|44.0||||||
4219346|NCT00707174|4043129|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4219347|NCT00707174|4043127|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4219348|NCT00707174|4043128|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4219349|NCT00707174|4043129|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4219350|NCT00707174|4043127|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4219351|NCT00707174|4043128|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4219352|NCT00707174|4043129|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4219353|NCT00707174|4043127|B3|||Age||years|Mean|67.64|67.64|Standard Deviation|12.49655|12.49655|||
4219354|NCT00707174|4043128|B2|||Age||years|Mean|67.40909|67.40909|Standard Deviation|11.99286|11.99286|||
4219355|NCT00707174|4043129|B1|||Age||years|Mean|67.87234|67.87234|Standard Deviation|13.07606|13.07606|||
4219356|NCT00707174|4043127|B3||>=65 years|Age||Participants|Count of Participants|53|53.0||||||
4219357|NCT00707174|4043128|B2||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4219358|NCT00707174|4043129|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4219359|NCT00707174|4043127|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4219360|NCT00707174|4043128|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4219361|NCT00707174|4043129|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4219362|NCT00707174|4043127|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4219363|NCT00707174|4043128|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4219364|NCT00707174|4043129|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4219365|NCT00707161|4043136|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4219366|NCT00707161|4043136|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4219367|NCT00707161|4043136|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4219368|NCT00707161|4043136|B1|||Age||years|Mean|67.6|67.6|Standard Deviation|7.8|7.8|||
4219369|NCT00707161|4043136|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4219370|NCT00707161|4043136|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4219371|NCT00707161|4043136|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4219372|NCT00707057|4043140|B3|United States||Region of Enrollment||participants|Number|256|256.0||||||
4219373|NCT00707057|4043141|B2|United States||Region of Enrollment||participants|Number|87|87.0||||||
4219374|NCT00707057|4043142|B1|United States||Region of Enrollment||participants|Number|169|169.0||||||
4219375|NCT00707057|4043140|B3||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4219376|NCT00707057|4043141|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4219377|NCT00707057|4043142|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4219378|NCT00707057|4043140|B3||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4219379|NCT00707057|4043141|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4219380|NCT00707057|4043142|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4219381|NCT00707057|4043140|B3|||Age||years|Mean|18.9|18.9|Standard Deviation|3.22|3.22|||
4219382|NCT00707057|4043141|B2|||Age||years|Mean|18.8|18.8|Standard Deviation|3.25|3.25|||
4219383|NCT00707057|4043142|B1|||Age||years|Mean|18.9|18.9|Standard Deviation|3.22|3.22|||
4219384|NCT00707057|4043140|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4219385|NCT00707057|4043141|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4219386|NCT00707057|4043142|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4219387|NCT00707057|4043140|B3||Between 18 and 65 years|Age||Participants|Count of Participants|157|157.0||||||
4219388|NCT00707057|4043141|B2||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4219389|NCT00707057|4043142|B1||Between 18 and 65 years|Age||Participants|Count of Participants|105|105.0||||||
4219390|NCT00707057|4043140|B3||<=18 years|Age||Participants|Count of Participants|99|99.0||||||
4219391|NCT00707057|4043141|B2||<=18 years|Age||Participants|Count of Participants|35|35.0||||||
4219392|NCT00707057|4043142|B1||<=18 years|Age||Participants|Count of Participants|64|64.0||||||
4219393|NCT00707031|4043175|B3|||Daily Metformin Dose||milligram (mg)|Mean|2039.24|2039.24|Standard Deviation|456.38|456.38|||
4219394|NCT00707031|4043176|B2|||Daily Metformin Dose||milligram (mg)|Mean|2058.39|2058.39|Standard Deviation|453.23|453.23|||
4219395|NCT00707031|4043177|B1|||Daily Metformin Dose||milligram (mg)|Mean|2020.20|2020.2|Standard Deviation|459.41|459.41|||
4219396|NCT00707031|4043175|B3|||Duration of Diabetes||years|Mean|6.76|6.76|Standard Deviation|5.21|5.21|||
4219397|NCT00707031|4043176|B2|||Duration of Diabetes||years|Mean|6.75|6.75|Standard Deviation|4.87|4.87|||
4219398|NCT00707031|4043177|B1|||Duration of Diabetes||years|Mean|6.78|6.78|Standard Deviation|5.54|5.54|||
4219399|NCT00707031|4043175|B3|||Body Mass Index (BMI)|BMI was calculated by dividing body weight by the height squared.|kilogram per square meter (kg/m^2)|Mean|33.60|33.6|Standard Deviation|6.40|6.4|||
4219400|NCT00707031|4043176|B2|||Body Mass Index (BMI)|BMI was calculated by dividing body weight by the height squared.|kilogram per square meter (kg/m^2)|Mean|33.51|33.51|Standard Deviation|6.54|6.54|||
4219401|NCT00707031|4043177|B1|||Body Mass Index (BMI)|BMI was calculated by dividing body weight by the height squared.|kilogram per square meter (kg/m^2)|Mean|33.68|33.68|Standard Deviation|6.27|6.27|||
4219402|NCT00707031|4043175|B3|||Patient Assessment of Upper Gastrointestinal Disorders-Quality of Life (PAGI-QOL) Total Score|A 30-item self-administered questionnaire to measure health related quality of life (QOL) of patients with upper gastrointestinal disorders during past 2 weeks; consisted of 5 dimensions (subscales). Each item rated on a 0-5 point Likert scale, where 0=none of the time and 5=all the time. Subscale score was calculated by dividing sum of all items of subscale by number of items in subscale. Total score was calculated by taking the mean of subscale scores. Subscale score and total score range from 0 to 5 with lower scores indicating better quality of life.|units on a scale|Mean|0.58|0.58|Standard Deviation|0.7|0.7|||
4219403|NCT00707031|4043176|B2|||Patient Assessment of Upper Gastrointestinal Disorders-Quality of Life (PAGI-QOL) Total Score|A 30-item self-administered questionnaire to measure health related quality of life (QOL) of patients with upper gastrointestinal disorders during past 2 weeks; consisted of 5 dimensions (subscales). Each item rated on a 0-5 point Likert scale, where 0=none of the time and 5=all the time. Subscale score was calculated by dividing sum of all items of subscale by number of items in subscale. Total score was calculated by taking the mean of subscale scores. Subscale score and total score range from 0 to 5 with lower scores indicating better quality of life.|units on a scale|Mean|0.56|0.56|Standard Deviation|0.7|0.7|||
4219404|NCT00707031|4043177|B1|||Patient Assessment of Upper Gastrointestinal Disorders-Quality of Life (PAGI-QOL) Total Score|A 30-item self-administered questionnaire to measure health related quality of life (QOL) of patients with upper gastrointestinal disorders during past 2 weeks; consisted of 5 dimensions (subscales). Each item rated on a 0-5 point Likert scale, where 0=none of the time and 5=all the time. Subscale score was calculated by dividing sum of all items of subscale by number of items in subscale. Total score was calculated by taking the mean of subscale scores. Subscale score and total score range from 0 to 5 with lower scores indicating better quality of life.|units on a scale|Mean|0.59|0.59|Standard Deviation|0.7|0.7|||
4219405|NCT00707031|4043175|B3|||Body Weight||kilogram (kg)|Mean|95.0|95.0|Standard Deviation|21.13|21.13|||
4219406|NCT00707031|4043176|B2|||Body Weight||kilogram (kg)|Mean|96.1|96.1|Standard Deviation|22.5|22.5|||
4219407|NCT00707031|4043177|B1|||Body Weight||kilogram (kg)|Mean|94.0|94.0|Standard Deviation|19.6|19.6|||
4219408|NCT00707031|4043175|B3|||Fasting Plasma Glucose (FPG)||millimole per liter (mmol/L)|Mean|9.7|9.7|Standard Deviation|2.1|2.1|||
4219409|NCT00707031|4043176|B2|||Fasting Plasma Glucose (FPG)||millimole per liter (mmol/L)|Mean|9.7|9.7|Standard Deviation|2.3|2.3|||
4219410|NCT00707031|4043177|B1|||Fasting Plasma Glucose (FPG)||millimole per liter (mmol/L)|Mean|9.7|9.7|Standard Deviation|2.0|2.0|||
4219411|NCT00707031|4043175|B3|||Glycosylated Hemoglobin (HbA1c)||percentage of hemoglobin|Mean|7.96|7.96|Standard Deviation|0.80|0.8|||
4219412|NCT00707031|4043176|B2|||Glycosylated Hemoglobin (HbA1c)||percentage of hemoglobin|Mean|7.97|7.97|Standard Deviation|0.78|0.78|||
4219413|NCT00707031|4043177|B1|||Glycosylated Hemoglobin (HbA1c)||percentage of hemoglobin|Mean|7.95|7.95|Standard Deviation|0.81|0.81|||
4219414|NCT00707031|4043175|B3|Ethnicity: Non Hispanic||Race/Ethnicity, Customized||participants|Number|464|464.0||||||
4219415|NCT00707031|4043176|B2|Ethnicity: Non Hispanic||Race/Ethnicity, Customized||participants|Number|233|233.0||||||
4219416|NCT00707031|4043177|B1|Ethnicity: Non Hispanic||Race/Ethnicity, Customized||participants|Number|231|231.0||||||
4219417|NCT00707031|4043175|B3|Ethnicity: Hispanic||Race/Ethnicity, Customized||participants|Number|170|170.0||||||
4219418|NCT00707031|4043176|B2|Ethnicity: Hispanic||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
4219419|NCT00707031|4043177|B1|Ethnicity: Hispanic||Race/Ethnicity, Customized||participants|Number|87|87.0||||||
4219420|NCT00707031|4043175|B3|Race: Other||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4219421|NCT00707031|4043176|B2|Race: Other||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4219422|NCT00707031|4043177|B1|Race: Other||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4219423|NCT00707031|4043175|B3|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4219424|NCT00707031|4043176|B2|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4219425|NCT00707031|4043177|B1|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4219426|NCT00707031|4043175|B3|Race: Black||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4219427|NCT00707031|4043176|B2|Race: Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4219428|NCT00707031|4043177|B1|Race: Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4219429|NCT00707031|4043175|B3|Race: Caucasian/White||Race/Ethnicity, Customized||participants|Number|588|588.0||||||
4219430|NCT00707031|4043176|B2|Race: Caucasian/White||Race/Ethnicity, Customized||participants|Number|292|292.0||||||
4219431|NCT00707031|4043177|B1|Race: Caucasian/White||Race/Ethnicity, Customized||participants|Number|296|296.0||||||
4219432|NCT00707031|4043175|B3||Male|Sex: Female, Male||Participants|Count of Participants|338|338.0||||||
4219433|NCT00707031|4043176|B2||Male|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4219434|NCT00707031|4043177|B1||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4219435|NCT00707031|4043175|B3||Female|Sex: Female, Male||Participants|Count of Participants|296|296.0||||||
4219436|NCT00707031|4043176|B2||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4219437|NCT00707031|4043177|B1||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4219438|NCT00707031|4043175|B3|||Age||years|Mean|57.4|57.4|Standard Deviation|9.9|9.9|||
4219439|NCT00707031|4043176|B2|||Age||years|Mean|57.6|57.6|Standard Deviation|10.7|10.7|||
4219440|NCT00707031|4043177|B1|||Age||years|Mean|57.3|57.3|Standard Deviation|9.2|9.2|||
4219441|NCT00706992|4043200|B8|United States||Region of Enrollment||participants|Number|50|50.0||||||
4219442|NCT00706992|4043201|B7|United States||Region of Enrollment||participants|Number|6|6.0||||||
4219443|NCT00706992|4043202|B6|United States||Region of Enrollment||participants|Number|5|5.0||||||
4219444|NCT00706992|4043203|B5|United States||Region of Enrollment||participants|Number|6|6.0||||||
4219445|NCT00706992|4043204|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
4219446|NCT00706992|4043205|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4219447|NCT00706992|4043206|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4219448|NCT00706992|4043207|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4219449|NCT00706992|4043200|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219450|NCT00706992|4043201|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219451|NCT00706992|4043202|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219452|NCT00706992|4043203|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219453|NCT00706992|4043204|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219454|NCT00706992|4043205|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219455|NCT00706992|4043206|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219456|NCT00706992|4043207|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219457|NCT00706992|4043200|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4219458|NCT00706992|4043201|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219459|NCT00706992|4043202|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219460|NCT00706992|4043203|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219461|NCT00706992|4043204|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219462|NCT00706992|4043205|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219463|NCT00706992|4043206|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4219464|NCT00706992|4043207|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219465|NCT00706992|4043200|B8||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4219466|NCT00706992|4043201|B7||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4219467|NCT00706992|4043202|B6||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4219468|NCT00706992|4043203|B5||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4219469|NCT00706992|4043204|B4||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4219470|NCT00706992|4043205|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4219471|NCT00706992|4043206|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4219472|NCT00706992|4043207|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4219473|NCT00706992|4043200|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4219474|NCT00706992|4043201|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219475|NCT00706992|4043202|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219476|NCT00706992|4043203|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219477|NCT00706992|4043204|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219478|NCT00706992|4043205|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4219479|NCT00706992|4043206|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219480|NCT00706992|4043207|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219481|NCT00706992|4043200|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219482|NCT00706992|4043201|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219483|NCT00706992|4043202|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219484|NCT00706992|4043203|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219485|NCT00706992|4043204|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219486|NCT00706992|4043205|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219487|NCT00706992|4043206|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219488|NCT00706992|4043207|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219489|NCT00706992|4043200|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219490|NCT00706992|4043201|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219491|NCT00706992|4043202|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219492|NCT00706992|4043203|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219493|NCT00706992|4043204|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219494|NCT00706992|4043205|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219495|NCT00706992|4043206|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219496|NCT00706992|4043207|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219497|NCT00706992|4043200|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219498|NCT00706992|4043201|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219499|NCT00706992|4043202|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219500|NCT00706992|4043203|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219501|NCT00706992|4043204|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219502|NCT00706992|4043205|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219503|NCT00706992|4043206|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219504|NCT00706992|4043207|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219505|NCT00706992|4043200|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219506|NCT00706992|4043201|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219507|NCT00706992|4043202|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219508|NCT00706992|4043203|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219509|NCT00706992|4043204|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219510|NCT00706992|4043205|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219511|NCT00706992|4043206|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219512|NCT00706992|4043207|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219513|NCT00706992|4043200|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4219514|NCT00706992|4043201|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4219515|NCT00706992|4043202|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4219516|NCT00706992|4043203|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4219517|NCT00706992|4043204|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4219518|NCT00706992|4043205|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4219519|NCT00706992|4043206|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4219520|NCT00706992|4043207|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4219521|NCT00706992|4043200|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4219522|NCT00706992|4043201|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219523|NCT00706992|4043202|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219524|NCT00706992|4043203|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219525|NCT00706992|4043204|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219526|NCT00706992|4043205|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219527|NCT00706992|4043206|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4219528|NCT00706992|4043207|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219529|NCT00706992|4043200|B8||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4219530|NCT00706992|4043201|B7||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4219531|NCT00706992|4043202|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4219532|NCT00706992|4043203|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4219533|NCT00706992|4043204|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4219534|NCT00706992|4043205|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4219535|NCT00706992|4043206|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4219536|NCT00706992|4043207|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4219537|NCT00706992|4043200|B8||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4219538|NCT00706992|4043201|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4219539|NCT00706992|4043202|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4219540|NCT00706992|4043203|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4219541|NCT00706992|4043204|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4219542|NCT00706992|4043205|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4219543|NCT00706992|4043206|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4219544|NCT00706992|4043207|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4219545|NCT00706992|4043200|B8|||Age||years|Mean|47.2|47.2|Standard Deviation|10.4|10.4|||
4219546|NCT00706992|4043201|B7|||Age||years|Mean|39.2|39.2|Standard Deviation|5.7|5.7|||
4219547|NCT00706992|4043202|B6|||Age||years|Mean|49.0|49.0|Standard Deviation|11.2|11.2|||
4219548|NCT00706992|4043203|B5|||Age||years|Mean|49.2|49.2|Standard Deviation|8.3|8.3|||
4219549|NCT00706992|4043204|B4|||Age||years|Mean|51.4|51.4|Standard Deviation|9.7|9.7|||
4219550|NCT00706992|4043205|B3|||Age||years|Mean|43.1|43.1|Standard Deviation|11.4|11.4|||
4219551|NCT00706992|4043206|B2|||Age||years|Mean|47.4|47.4|Standard Deviation|8.9|8.9|||
4219552|NCT00706992|4043207|B1|||Age||years|Mean|51.0|51.0|Standard Deviation|12.9|12.9|||
4219553|NCT00706992|4043200|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4219554|NCT00706992|4043201|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4219555|NCT00706992|4043202|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4219556|NCT00706992|4043203|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4219557|NCT00706992|4043204|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4219558|NCT00706992|4043205|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4219559|NCT00706992|4043206|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4219560|NCT00706992|4043207|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4219561|NCT00706992|4043200|B8||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4219562|NCT00706992|4043201|B7||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4219563|NCT00706992|4043202|B6||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4219564|NCT00706992|4043203|B5||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4219565|NCT00706992|4043204|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4219566|NCT00706992|4043205|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4219567|NCT00706992|4043206|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4219568|NCT00706992|4043207|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4219569|NCT00706992|4043200|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4219570|NCT00706992|4043201|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4219571|NCT00706992|4043202|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4219572|NCT00706992|4043203|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4219573|NCT00706992|4043204|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4219574|NCT00706992|4043205|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4219575|NCT00706992|4043206|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4219576|NCT00706992|4043207|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4219577|NCT00706979|4043230|B3|United States||Region of Enrollment||participants|Number|849|849.0||||||
4219578|NCT00706979|4043231|B2|United States||Region of Enrollment||participants|Number|423|423.0||||||
4219579|NCT00706979|4043232|B1|United States||Region of Enrollment||participants|Number|426|426.0||||||
4219580|NCT00706979|4043230|B3||Male|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
4219581|NCT00706979|4043231|B2||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4219582|NCT00706979|4043232|B1||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4219583|NCT00706979|4043230|B3||Female|Sex: Female, Male||Participants|Count of Participants|545|545.0||||||
4219584|NCT00706979|4043231|B2||Female|Sex: Female, Male||Participants|Count of Participants|279|279.0||||||
4219585|NCT00706979|4043232|B1||Female|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
4219586|NCT00706979|4043230|B3|||Age||years|Mean|50.6|50.6|Standard Deviation|11.6|11.6|||
4219587|NCT00706979|4043231|B2|||Age||years|Mean|50.7|50.7|Standard Deviation|11.4|11.4|||
4219588|NCT00706979|4043232|B1|||Age||years|Mean|50.5|50.5|Standard Deviation|11.8|11.8|||
4219589|NCT00706979|4043230|B3||>=65 years|Age||Participants|Count of Participants|78|78.0||||||
4219590|NCT00706979|4043231|B2||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
4219591|NCT00706979|4043232|B1||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
4219592|NCT00706979|4043230|B3||Between 18 and 65 years|Age||Participants|Count of Participants|771|771.0||||||
4219593|NCT00706979|4043231|B2||Between 18 and 65 years|Age||Participants|Count of Participants|389|389.0||||||
4219594|NCT00706979|4043232|B1||Between 18 and 65 years|Age||Participants|Count of Participants|382|382.0||||||
4219595|NCT00706979|4043230|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4219596|NCT00706979|4043231|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4219597|NCT00706979|4043232|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4219598|NCT00706966|4043245|B1|||Prostate volume|To assess prostate volume, regions of interest were manually drawn around the prostate across its full three-dimensional extent on the T2-weighted MR images; at subsequent timepoints, prostate volume was assessed as a percentage of the baseline value.|mL|Mean|47.3|47.3|Full Range|||22.0|75.2|
4219599|NCT00706966|4043245|B1|||Total PSA|The prostate-specific antigen (PSA) test measures the blood level of PSA, a protein that is produced by the prostate gland.|ng/mL|Median|5.05|5.05|Full Range|||2.14|11.74|
4219600|NCT00706966|4043245|B1|T2a||Clinical Stage|In the TNM system, T refers to the primary prostate tumor, N refers to the status of the lymph nodes near to the prostate, and M refers to the degree to which prostate cancer has traveled out of the immediate area of the prostate to other organs of the body (metastases). T1c = a positive prostate specific antigen (PSA) test but no other clinical sign of the disease (i.e., no abnormality felt on digital rectal examination or visible on any form of imaging test). T2a = tumor is palpable or visible on imaging (ultrasound or MRI) in not more than half of one side (one lobe) of the prostate.|Participants|Number|3|3.0||||||
4219601|NCT00706966|4043245|B1|T1c||Clinical Stage|In the TNM system, T refers to the primary prostate tumor, N refers to the status of the lymph nodes near to the prostate, and M refers to the degree to which prostate cancer has traveled out of the immediate area of the prostate to other organs of the body (metastases). T1c = a positive prostate specific antigen (PSA) test but no other clinical sign of the disease (i.e., no abnormality felt on digital rectal examination or visible on any form of imaging test). T2a = tumor is palpable or visible on imaging (ultrasound or MRI) in not more than half of one side (one lobe) of the prostate.|Participants|Number|7|7.0||||||
4219602|NCT00706966|4043245|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4219603|NCT00706966|4043245|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4219604|NCT00706966|4043245|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4219605|NCT00706966|4043245|B1|||Age||years|Mean|65|65.0|Full Range|||57.0|78.0|
4219606|NCT00706914|4043278|B4||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4219607|NCT00706914|4043279|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4219608|NCT00706914|4043280|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4219609|NCT00706914|4043281|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4219610|NCT00706914|4043278|B4||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4219611|NCT00706914|4043279|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4219612|NCT00706914|4043280|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4219613|NCT00706914|4043281|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4219614|NCT00706914|4043278|B4|||Age||Years|Mean|63.2|63.2|Standard Deviation|8.5|8.5|||
4219615|NCT00706914|4043279|B3|||Age||Years|Mean|62.2|62.2|Standard Deviation|10.1|10.1|||
4219616|NCT00706914|4043280|B2|||Age||Years|Mean|63.9|63.9|Standard Deviation|9.0|9.0|||
4219617|NCT00706914|4043281|B1|||Age||Years|Mean|63.0|63.0|Standard Deviation|7.2|7.2|||
4219618|NCT00706901|4043303|B4|United States||Region of Enrollment||participants|Number|180|180.0||||||
4219619|NCT00706901|4043304|B3|United States||Region of Enrollment||participants|Number|59|59.0||||||
4219620|NCT00706901|4043305|B2|United States||Region of Enrollment||participants|Number|62|62.0||||||
4219621|NCT00706901|4043306|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
4219622|NCT00706901|4043303|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4219623|NCT00706901|4043304|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4219624|NCT00706901|4043305|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4219625|NCT00706901|4043306|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219626|NCT00706901|4043303|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219627|NCT00706901|4043304|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219628|NCT00706901|4043305|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219629|NCT00706901|4043306|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219630|NCT00706901|4043303|B4||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4219631|NCT00706901|4043304|B3||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4219632|NCT00706901|4043305|B2||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4219633|NCT00706901|4043306|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4219634|NCT00706901|4043303|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
4219635|NCT00706901|4043304|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4219636|NCT00706901|4043305|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4219637|NCT00706901|4043306|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4219638|NCT00706901|4043303|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219639|NCT00706901|4043304|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219640|NCT00706901|4043305|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219641|NCT00706901|4043306|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219642|NCT00706901|4043303|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219643|NCT00706901|4043304|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219644|NCT00706901|4043305|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219645|NCT00706901|4043306|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219646|NCT00706901|4043303|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219647|NCT00706901|4043304|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219648|NCT00706901|4043305|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219649|NCT00706901|4043306|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4219650|NCT00706901|4043303|B4||Male|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4219651|NCT00706901|4043304|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4219652|NCT00706901|4043305|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4219653|NCT00706901|4043306|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4219654|NCT00706901|4043303|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4219655|NCT00706901|4043304|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4219656|NCT00706901|4043305|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4219657|NCT00706901|4043306|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4219658|NCT00706901|4043303|B4|||Age||years|Mean|52.1|52.1|Standard Deviation|9.9|9.9|||
4219659|NCT00706901|4043304|B3|||Age||years|Mean|51.1|51.1|Standard Deviation|10.6|10.6|||
4219660|NCT00706901|4043305|B2|||Age||years|Mean|52.3|52.3|Standard Deviation|10.3|10.3|||
4219661|NCT00706901|4043306|B1|||Age||years|Mean|52.9|52.9|Standard Deviation|8.8|8.8|||
4219662|NCT00706849|4043331|B3|Never||Alcohol use||participants|Number|12|12.0||||||
4219663|NCT00706849|4043332|B2|Never||Alcohol use||participants|Number|9|9.0||||||
4219664|NCT00706849|4043333|B1|Never||Alcohol use||participants|Number|3|3.0||||||
4219665|NCT00706849|4043331|B3|Non-current||Alcohol use||participants|Number|17|17.0||||||
4219666|NCT00706849|4043332|B2|Non-current||Alcohol use||participants|Number|10|10.0||||||
4219667|NCT00706849|4043333|B1|Non-current||Alcohol use||participants|Number|7|7.0||||||
4219668|NCT00706849|4043331|B3|Current||Alcohol use||participants|Number|95|95.0||||||
4219669|NCT00706849|4043332|B2|Current||Alcohol use||participants|Number|64|64.0||||||
4219670|NCT00706849|4043333|B1|Current||Alcohol use||participants|Number|31|31.0||||||
4219671|NCT00706849|4043331|B3|Never||Tobacco use||participants|Number|58|58.0||||||
4219672|NCT00706849|4043332|B2|Never||Tobacco use||participants|Number|38|38.0||||||
4219673|NCT00706849|4043333|B1|Never||Tobacco use||participants|Number|20|20.0||||||
4219674|NCT00706849|4043331|B3|non-current||Tobacco use||participants|Number|49|49.0||||||
4219675|NCT00706849|4043332|B2|non-current||Tobacco use||participants|Number|32|32.0||||||
4219676|NCT00706849|4043333|B1|non-current||Tobacco use||participants|Number|17|17.0||||||
4219677|NCT00706849|4043331|B3|Current||Tobacco use||participants|Number|17|17.0||||||
4219678|NCT00706849|4043332|B2|Current||Tobacco use||participants|Number|13|13.0||||||
4219679|NCT00706849|4043333|B1|Current||Tobacco use||participants|Number|4|4.0||||||
4219680|NCT00706849|4043331|B3|Yes||Metabolic syndrome|"A patient was classified as having metabolic syndrome if any 3 of the following risk factors existed: 1) Waist circumference ≥102 cm (men) or ≥88 cm (women); 2) Triglycerides ≥150 mg/dl *; 3) High density lipoprotein cholesterol <40 mg/dl (men) or <50 mg/dl (women)*; 4) Systolic blood pressure ≥130 or diastolic ≥85 mmHg *; 5) Fasting glucose ≥100 mg/dl *.~* = or on medication for the specified risk factor."|participants|Number|46|46.0||||||
4219681|NCT00706849|4043332|B2|Yes||Metabolic syndrome|"A patient was classified as having metabolic syndrome if any 3 of the following risk factors existed: 1) Waist circumference ≥102 cm (men) or ≥88 cm (women); 2) Triglycerides ≥150 mg/dl *; 3) High density lipoprotein cholesterol <40 mg/dl (men) or <50 mg/dl (women)*; 4) Systolic blood pressure ≥130 or diastolic ≥85 mmHg *; 5) Fasting glucose ≥100 mg/dl *.~* = or on medication for the specified risk factor."|participants|Number|35|35.0||||||
4219682|NCT00706849|4043333|B1|Yes||Metabolic syndrome|"A patient was classified as having metabolic syndrome if any 3 of the following risk factors existed: 1) Waist circumference ≥102 cm (men) or ≥88 cm (women); 2) Triglycerides ≥150 mg/dl *; 3) High density lipoprotein cholesterol <40 mg/dl (men) or <50 mg/dl (women)*; 4) Systolic blood pressure ≥130 or diastolic ≥85 mmHg *; 5) Fasting glucose ≥100 mg/dl *.~* = or on medication for the specified risk factor."|participants|Number|11|11.0||||||
4219683|NCT00706849|4043331|B3|No||Metabolic syndrome|"A patient was classified as having metabolic syndrome if any 3 of the following risk factors existed: 1) Waist circumference ≥102 cm (men) or ≥88 cm (women); 2) Triglycerides ≥150 mg/dl *; 3) High density lipoprotein cholesterol <40 mg/dl (men) or <50 mg/dl (women)*; 4) Systolic blood pressure ≥130 or diastolic ≥85 mmHg *; 5) Fasting glucose ≥100 mg/dl *.~* = or on medication for the specified risk factor."|participants|Number|78|78.0||||||
4219684|NCT00706849|4043332|B2|No||Metabolic syndrome|"A patient was classified as having metabolic syndrome if any 3 of the following risk factors existed: 1) Waist circumference ≥102 cm (men) or ≥88 cm (women); 2) Triglycerides ≥150 mg/dl *; 3) High density lipoprotein cholesterol <40 mg/dl (men) or <50 mg/dl (women)*; 4) Systolic blood pressure ≥130 or diastolic ≥85 mmHg *; 5) Fasting glucose ≥100 mg/dl *.~* = or on medication for the specified risk factor."|participants|Number|48|48.0||||||
4219685|NCT00706849|4043333|B1|No||Metabolic syndrome|"A patient was classified as having metabolic syndrome if any 3 of the following risk factors existed: 1) Waist circumference ≥102 cm (men) or ≥88 cm (women); 2) Triglycerides ≥150 mg/dl *; 3) High density lipoprotein cholesterol <40 mg/dl (men) or <50 mg/dl (women)*; 4) Systolic blood pressure ≥130 or diastolic ≥85 mmHg *; 5) Fasting glucose ≥100 mg/dl *.~* = or on medication for the specified risk factor."|participants|Number|30|30.0||||||
4219686|NCT00706849|4043331|B3|||Waist/hip ratio||ratio|Mean|0.93|0.93|Standard Deviation|0.08|0.08|||
4219687|NCT00706849|4043332|B2|||Waist/hip ratio||ratio|Mean|0.93|0.93|Standard Deviation|0.08|0.08|||
4219688|NCT00706849|4043333|B1|||Waist/hip ratio||ratio|Mean|0.95|0.95|Standard Deviation|0.07|0.07|||
4219689|NCT00706849|4043331|B3|||Body Mass Index (BMI)||kg/m^2|Mean|29.18|29.18|Standard Deviation|4.14|4.14|||
4219690|NCT00706849|4043332|B2|||Body Mass Index (BMI)||kg/m^2|Mean|28.66|28.66|Standard Deviation|4.23|4.23|||
4219691|NCT00706849|4043333|B1|||Body Mass Index (BMI)||kg/m^2|Mean|30.25|30.25|Standard Deviation|3.79|3.79|||
4219692|NCT00706849|4043331|B3|Other race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4219693|NCT00706849|4043332|B2|Other race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4219694|NCT00706849|4043333|B1|Other race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4219695|NCT00706849|4043331|B3|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4219696|NCT00706849|4043332|B2|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4219697|NCT00706849|4043333|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4219698|NCT00706849|4043331|B3|White||Race/Ethnicity, Customized||participants|Number|119|119.0||||||
4219699|NCT00706849|4043332|B2|White||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
4219700|NCT00706849|4043333|B1|White||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4219701|NCT00706849|4043331|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|120|120.0||||||
4219702|NCT00706849|4043332|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
4219703|NCT00706849|4043333|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4219704|NCT00706849|4043331|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4219705|NCT00706849|4043332|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4219706|NCT00706849|4043333|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4219707|NCT00706849|4043331|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4219708|NCT00706849|4043332|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4219709|NCT00706849|4043333|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4219710|NCT00706849|4043331|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4219711|NCT00706849|4043332|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4219712|NCT00706849|4043333|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4219713|NCT00706849|4043331|B3|||Age||years|Mean|56.1|56.1|Standard Deviation|9.5|9.5|||
4219714|NCT00706849|4043332|B2|||Age||years|Mean|56.2|56.2|Standard Deviation|9.7|9.7|||
4219715|NCT00706849|4043333|B1|||Age||years|Mean|55.9|55.9|Standard Deviation|9.3|9.3|||
4219716|NCT00706836|4043378|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4219717|NCT00706836|4043378|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4219718|NCT00706836|4043378|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4219719|NCT00706836|4043378|B1|||Age||years|Mean|23.2|23.2|Standard Deviation|2.6|2.6|||
4219720|NCT00706823|4043386|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4219721|NCT00706823|4043387|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4219722|NCT00706823|4043388|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4219723|NCT00706823|4043386|B3||Male|Gender||Participants|Count of Participants|35|35.0||||||
4219724|NCT00706823|4043387|B2||Male|Gender||Participants|Count of Participants|19|19.0||||||
4219725|NCT00706823|4043388|B1||Male|Gender||Participants|Count of Participants|16|16.0||||||
4219726|NCT00706823|4043386|B3||Female|Gender||Participants|Count of Participants|15|15.0||||||
4219727|NCT00706823|4043387|B2||Female|Gender||Participants|Count of Participants|6|6.0||||||
4219728|NCT00706823|4043388|B1||Female|Gender||Participants|Count of Participants|9|9.0||||||
4219729|NCT00706823|4043386|B3|||Age||years|Mean|37.28|37.28|Standard Deviation|13.8|13.8|||
4219730|NCT00706823|4043387|B2|||Age||years|Mean|35.3|35.3|Standard Deviation|16.6|16.6|||
4219731|NCT00706823|4043388|B1|||Age||years|Mean|38.2|38.2|Standard Deviation|10.5|10.5|||
4219732|NCT00706823|4043386|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4219733|NCT00706823|4043387|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4219734|NCT00706823|4043388|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4219735|NCT00706823|4043386|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4219736|NCT00706823|4043387|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4219737|NCT00706823|4043388|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4219738|NCT00706823|4043386|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4219739|NCT00706823|4043387|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4219740|NCT00706823|4043388|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4219741|NCT00706810|4043405|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4219742|NCT00706810|4043405|B1|Male||Sex/Gender, Customized||participants|Number|1|1.0||||||
4219743|NCT00706810|4043405|B1|Female||Sex/Gender, Customized||participants|Number|6|6.0||||||
4219744|NCT00706810|4043405|B1|||Age||years|Mean|50|50.0|Full Range|||25.0|76.0|
4219745|NCT00706810|4043405|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4219746|NCT00706810|4043405|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4219747|NCT00706810|4043405|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4219748|NCT00706797|4043410|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4219749|NCT00706797|4043411|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4219750|NCT00706797|4043412|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4219751|NCT00706797|4043410|B3||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4219752|NCT00706797|4043411|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4219753|NCT00706797|4043412|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4219754|NCT00706797|4043410|B3|||Age||years|Mean|55.5|55.5|Standard Deviation|12.7|12.7|||
4219755|NCT00706797|4043411|B2|||Age||years|Mean|53.8|53.8|Standard Deviation|13.1|13.1|||
4219756|NCT00706797|4043412|B1|||Age||years|Mean|57.3|57.3|Standard Deviation|12.1|12.1|||
4219757|NCT00706784|4043453|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4219758|NCT00706784|4043454|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4219759|NCT00706784|4043455|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4219760|NCT00706784|4043453|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4219761|NCT00706784|4043454|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4219762|NCT00706784|4043455|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4219763|NCT00706784|4043453|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4219764|NCT00706784|4043454|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4219765|NCT00706784|4043455|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4219766|NCT00706784|4043453|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4219767|NCT00706784|4043454|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4219768|NCT00706784|4043455|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4219769|NCT00706784|4043453|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4219770|NCT00706784|4043454|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4219771|NCT00706784|4043455|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4219772|NCT00706719|4043462|B4|United States||Region of Enrollment||participants|Number|17|17.0||||||
4219773|NCT00706719|4043463|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4219774|NCT00706719|4043464|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4219775|NCT00706719|4043465|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4219776|NCT00706719|4043462|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4219777|NCT00706719|4043463|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4219778|NCT00706719|4043464|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4219779|NCT00706719|4043465|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4219780|NCT00706719|4043462|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4219781|NCT00706719|4043463|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4219782|NCT00706719|4043464|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4219783|NCT00706719|4043465|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4219784|NCT00706719|4043462|B4|||Age||years|Mean|52.7|52.7|Standard Deviation|7.72|7.72|||
4219785|NCT00706719|4043463|B3|||Age||years|Mean|56.4|56.4|Standard Deviation|23.8|23.8|||
4219786|NCT00706719|4043464|B2|||Age||years|Mean|48.9|48.9|Standard Deviation|8.99|8.99|||
4219787|NCT00706719|4043465|B1|||Age||years|Mean|54.4|54.4|Standard Deviation|4.88|4.88|||
4219788|NCT00706719|4043462|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4219789|NCT00706719|4043463|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4219790|NCT00706719|4043464|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4219791|NCT00706719|4043465|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4219792|NCT00706719|4043462|B4||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4219793|NCT00706719|4043463|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4219794|NCT00706719|4043464|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4219795|NCT00706719|4043465|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4219796|NCT00706719|4043462|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4219797|NCT00706719|4043463|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4219798|NCT00706719|4043464|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4219799|NCT00706719|4043465|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4219800|NCT00706706|4043482|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4219801|NCT00706706|4043482|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4219802|NCT00706706|4043482|B1|||Age||Years|Mean|54.6|54.6|Standard Deviation|12.9|12.9|||
4219803|NCT00706654|4043489|B4||Male|Sex: Female, Male||Participants|Count of Participants|406|406.0||||||
4219804|NCT00706654|4043490|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4219805|NCT00706654|4043491|B2||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4219806|NCT00706654|4043492|B1||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4219807|NCT00706654|4043489|B4||Female|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
4219808|NCT00706654|4043490|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4219809|NCT00706654|4043491|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4219810|NCT00706654|4043492|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4219811|NCT00706654|4043489|B4|||Age||years|Mean|40.7|40.7|Standard Deviation|10.4|10.4|||
4219812|NCT00706654|4043490|B3|||Age||years|Mean|40.2|40.2|Standard Deviation|9.6|9.6|||
4219813|NCT00706654|4043491|B2|||Age||years|Mean|41.2|41.2|Standard Deviation|10.8|10.8|||
4219814|NCT00706654|4043492|B1|||Age||years|Mean|41.7|41.7|Standard Deviation|10.4|10.4|||
4219815|NCT00706641|4043514|B1|T4a||T-Stage at Study Entry|"Tumor Node Metastasis (TNM) Staging. This system classifies tumors by size and extent of the primary tumor (T), involvement of regional lymph nodes (N), and the presence or absence of distant metastases (M)~T0=No evidence of primary tumor, Tis=Carcinoma in situ, and T1, T2, T3, T4=Increasing size and/or local extension of the primary tumor, TX=Not assessed N0=No Regional lymph node metastases, N1, N2, N3=Increasing number or extent of regional lymph node involvement, NX=not assessed M0=No distant metastases, M1=Distant metastases present"|participants|Number|0|0.0||||||
4219816|NCT00706641|4043514|B1|T3||T-Stage at Study Entry|"Tumor Node Metastasis (TNM) Staging. This system classifies tumors by size and extent of the primary tumor (T), involvement of regional lymph nodes (N), and the presence or absence of distant metastases (M)~T0=No evidence of primary tumor, Tis=Carcinoma in situ, and T1, T2, T3, T4=Increasing size and/or local extension of the primary tumor, TX=Not assessed N0=No Regional lymph node metastases, N1, N2, N3=Increasing number or extent of regional lymph node involvement, NX=not assessed M0=No distant metastases, M1=Distant metastases present"|participants|Number|7|7.0||||||
4219817|NCT00706641|4043514|B1|T2||T-Stage at Study Entry|"Tumor Node Metastasis (TNM) Staging. This system classifies tumors by size and extent of the primary tumor (T), involvement of regional lymph nodes (N), and the presence or absence of distant metastases (M)~T0=No evidence of primary tumor, Tis=Carcinoma in situ, and T1, T2, T3, T4=Increasing size and/or local extension of the primary tumor, TX=Not assessed N0=No Regional lymph node metastases, N1, N2, N3=Increasing number or extent of regional lymph node involvement, NX=not assessed M0=No distant metastases, M1=Distant metastases present"|participants|Number|17|17.0||||||
4219818|NCT00706641|4043514|B1|ECOG PS 1||ECOG PS|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0-5 that describes a patient's level of functioning where 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Dead|participants|Number|6|6.0||||||
4219819|NCT00706641|4043514|B1|ECOG PS 0||ECOG PS|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0-5 that describes a patient's level of functioning where 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Dead|participants|Number|19|19.0||||||
4219820|NCT00706641|4043514|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4219821|NCT00706641|4043514|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4219822|NCT00706641|4043514|B1|||Age||years|Median|62|62.0|Full Range|||47.0|83.0|
4219823|NCT00706628|4043524|B5||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4219824|NCT00706628|4043525|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4219825|NCT00706628|4043526|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4219826|NCT00706628|4043527|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4219827|NCT00706628|4043528|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4219828|NCT00706628|4043524|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4219829|NCT00706628|4043525|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4219830|NCT00706628|4043526|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4219831|NCT00706628|4043527|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4219832|NCT00706628|4043528|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4219833|NCT00706628|4043524|B5|||Age||years|Mean|68.4|68.4|Standard Deviation|7.4|7.4|||
4219834|NCT00706628|4043525|B4|||Age||years|Mean|68.3|68.3|Standard Deviation|0.6|0.6|||
4219835|NCT00706628|4043526|B3|||Age||years|Mean|70.4|70.4|Standard Deviation|8.1|8.1|||
4219836|NCT00706628|4043527|B2|||Age||years|Mean|68.4|68.4|Standard Deviation|5.4|5.4|||
4219837|NCT00706628|4043528|B1|||Age||years|Mean|67.7|67.7|Standard Deviation|8.1|8.1|||
4219838|NCT00706589|4043579|B3|Korea, Republic of||Region of Enrollment||participants|Number|61|61.0||||||
4219839|NCT00706589|4043580|B2|Korea, Republic of||Region of Enrollment||participants|Number|29|29.0||||||
4219840|NCT00706589|4043581|B1|Korea, Republic of||Region of Enrollment||participants|Number|32|32.0||||||
4219841|NCT00706589|4043579|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4219842|NCT00706589|4043580|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4219843|NCT00706589|4043581|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4219844|NCT00706589|4043579|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4219845|NCT00706589|4043580|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4219846|NCT00706589|4043581|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4219847|NCT00706589|4043579|B3|||Age||years|Mean|10.95|10.95|Standard Deviation|2.72|2.72|||
4219848|NCT00706589|4043580|B2|||Age||years|Mean|10.93|10.93|Standard Deviation|3.00|3.0|||
4219849|NCT00706589|4043581|B1|||Age||years|Mean|10.97|10.97|Standard Deviation|2.49|2.49|||
4219850|NCT00706589|4043579|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4219851|NCT00706589|4043580|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4219852|NCT00706589|4043581|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4219853|NCT00706589|4043579|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4219854|NCT00706589|4043580|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4219855|NCT00706589|4043581|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4219856|NCT00706589|4043579|B3||<=18 years|Age||Participants|Count of Participants|61|61.0||||||
4219857|NCT00706589|4043580|B2||<=18 years|Age||Participants|Count of Participants|29|29.0||||||
4219858|NCT00706589|4043581|B1||<=18 years|Age||Participants|Count of Participants|32|32.0||||||
4219859|NCT00706563|4043588|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4219860|NCT00706563|4043589|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4219861|NCT00706563|4043590|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4219862|NCT00706563|4043588|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4219863|NCT00706563|4043589|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4219864|NCT00706563|4043590|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4219865|NCT00706563|4043588|B3|||Age||years|Mean|53.7|53.7|Standard Deviation|18.01|18.01|||
4219866|NCT00706563|4043589|B2|||Age||years|Mean|68.8|68.8|Standard Deviation|5.25|5.25|||
4219867|NCT00706563|4043590|B1|||Age||years|Mean|39.1|39.1|Standard Deviation|13.26|13.26|||
4219868|NCT00706550|4043613|B3|United States||Region of Enrollment||participants|Number|107|107.0||||||
4219869|NCT00706550|4043614|B2|United States||Region of Enrollment||participants|Number|64|64.0||||||
4219870|NCT00706550|4043615|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4219871|NCT00706550|4043613|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4219872|NCT00706550|4043614|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4219873|NCT00706550|4043615|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4219874|NCT00706550|4043613|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4219875|NCT00706550|4043614|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4219876|NCT00706550|4043615|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4219877|NCT00706550|4043613|B3|||Age||years|Mean|41.8|41.8|Standard Deviation|12.1|12.1|||
4219878|NCT00706550|4043614|B2|||Age||years|Mean|40.8|40.8|Standard Deviation|11.6|11.6|||
4219879|NCT00706550|4043615|B1|||Age||years|Mean|43.4|43.4|Standard Deviation|12.9|12.9|||
4219880|NCT00706550|4043613|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4219881|NCT00706550|4043614|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4219882|NCT00706550|4043615|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4219883|NCT00706550|4043613|B3||Between 18 and 65 years|Age||Participants|Count of Participants|105|105.0||||||
4219884|NCT00706550|4043614|B2||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4219885|NCT00706550|4043615|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4219886|NCT00706550|4043613|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4219887|NCT00706550|4043614|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4219888|NCT00706550|4043615|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4219889|NCT00706485|4043632|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4219890|NCT00706485|4043632|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4219891|NCT00706485|4043632|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4219892|NCT00706485|4043632|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4219893|NCT00706485|4043632|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4219894|NCT00706446|4043638|B7|United States||Region of Enrollment||Participants|Count of Participants|255|255.0||||||
4219895|NCT00706446|4043639|B6|United States||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
4219896|NCT00706446|4043640|B5|United States||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
4219897|NCT00706446|4043641|B4|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
4219898|NCT00706446|4043642|B3|United States||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
4219899|NCT00706446|4043643|B2|United States||Region of Enrollment||Participants|Count of Participants|57|57.0||||||
4219900|NCT00706446|4043644|B1|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
4219901|NCT00706446|4043638|B7||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4219902|NCT00706446|4043639|B6||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4219903|NCT00706446|4043640|B5||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4219904|NCT00706446|4043641|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4219905|NCT00706446|4043642|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4219906|NCT00706446|4043643|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4219907|NCT00706446|4043644|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4219908|NCT00706446|4043638|B7||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4219909|NCT00706446|4043639|B6||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4219910|NCT00706446|4043640|B5||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4219911|NCT00706446|4043641|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4219912|NCT00706446|4043642|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4219913|NCT00706446|4043643|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4219914|NCT00706446|4043644|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4219915|NCT00706446|4043638|B7|||Age||years|Mean|47.85|47.85|Standard Deviation|14.58|14.58|||
4219916|NCT00706446|4043639|B6|||Age||years|Mean|50.5|50.5|Standard Deviation|13.6|13.6|||
4219917|NCT00706446|4043640|B5|||Age||years|Mean|50.3|50.3|Standard Deviation|14.7|14.7|||
4219918|NCT00706446|4043641|B4|||Age||years|Mean|46.6|46.6|Standard Deviation|14.2|14.2|||
4219919|NCT00706446|4043642|B3|||Age||years|Mean|46.0|46.0|Standard Deviation|16.3|16.3|||
4219920|NCT00706446|4043643|B2|||Age||years|Mean|45.7|45.7|Standard Deviation|13.2|13.2|||
4219921|NCT00706446|4043644|B1|||Age||years|Mean|47.3|47.3|Standard Deviation|15.9|15.9|||
4219922|NCT00706433|4043687|B5|||Number of Inflammatory Lesions||lesions|Median|44.5|44.5|Standard Deviation|31.4|31.4|||
4219923|NCT00706433|4043688|B4|||Number of Inflammatory Lesions||lesions|Median|41.5|41.5|Standard Deviation|26.6|26.6|||
4219924|NCT00706433|4043689|B3|||Number of Inflammatory Lesions||lesions|Median|49.0|49.0|Standard Deviation|34.8|34.8|||
4219925|NCT00706433|4043690|B2|||Number of Inflammatory Lesions||lesions|Median|44.0|44.0|Standard Deviation|27.0|27.0|||
4219926|NCT00706433|4043691|B1|||Number of Inflammatory Lesions||lesions|Median|50.0|50.0|Standard Deviation|35.8|35.8|||
4219927|NCT00706433|4043687|B5|Grade 1 (minimal)||Stinging/Burning||participant|Number|10|10.0||||||
4219928|NCT00706433|4043688|B4|Grade 1 (minimal)||Stinging/Burning||participant|Number|3|3.0||||||
4219929|NCT00706433|4043689|B3|Grade 1 (minimal)||Stinging/Burning||participant|Number|1|1.0||||||
4219930|NCT00706433|4043690|B2|Grade 1 (minimal)||Stinging/Burning||participant|Number|2|2.0||||||
4219931|NCT00706433|4043691|B1|Grade 1 (minimal)||Stinging/Burning||participant|Number|4|4.0||||||
4219932|NCT00706433|4043687|B5|Grade 0 (none)||Stinging/Burning||participant|Number|256|256.0||||||
4219933|NCT00706433|4043688|B4|Grade 0 (none)||Stinging/Burning||participant|Number|63|63.0||||||
4219934|NCT00706433|4043689|B3|Grade 0 (none)||Stinging/Burning||participant|Number|66|66.0||||||
4219935|NCT00706433|4043690|B2|Grade 0 (none)||Stinging/Burning||participant|Number|63|63.0||||||
4219936|NCT00706433|4043691|B1|Grade 0 (none)||Stinging/Burning||participant|Number|64|64.0||||||
4219937|NCT00706433|4043687|B5|Grade 4 (severe)||Scaling and Dryness||participants|Number|1|1.0||||||
4219938|NCT00706433|4043688|B4|Grade 4 (severe)||Scaling and Dryness||participants|Number|0|0.0||||||
4219939|NCT00706433|4043689|B3|Grade 4 (severe)||Scaling and Dryness||participants|Number|1|1.0||||||
4219940|NCT00706433|4043690|B2|Grade 4 (severe)||Scaling and Dryness||participants|Number|0|0.0||||||
4219941|NCT00706433|4043691|B1|Grade 4 (severe)||Scaling and Dryness||participants|Number|0|0.0||||||
4219942|NCT00706433|4043687|B5|Grade 3 (moderate)||Scaling and Dryness||participants|Number|2|2.0||||||
4219943|NCT00706433|4043688|B4|Grade 3 (moderate)||Scaling and Dryness||participants|Number|1|1.0||||||
4219944|NCT00706433|4043689|B3|Grade 3 (moderate)||Scaling and Dryness||participants|Number|0|0.0||||||
4219945|NCT00706433|4043690|B2|Grade 3 (moderate)||Scaling and Dryness||participants|Number|1|1.0||||||
4219946|NCT00706433|4043691|B1|Grade 3 (moderate)||Scaling and Dryness||participants|Number|0|0.0||||||
4219947|NCT00706433|4043687|B5|Grade 2 (mild)||Scaling and Dryness||participants|Number|9|9.0||||||
4219948|NCT00706433|4043688|B4|Grade 2 (mild)||Scaling and Dryness||participants|Number|2|2.0||||||
4219949|NCT00706433|4043689|B3|Grade 2 (mild)||Scaling and Dryness||participants|Number|2|2.0||||||
4219950|NCT00706433|4043690|B2|Grade 2 (mild)||Scaling and Dryness||participants|Number|3|3.0||||||
4219951|NCT00706433|4043691|B1|Grade 2 (mild)||Scaling and Dryness||participants|Number|2|2.0||||||
4219952|NCT00706433|4043687|B5|Grade 1 (minimal)||Scaling and Dryness||participants|Number|64|64.0||||||
4219953|NCT00706433|4043688|B4|Grade 1 (minimal)||Scaling and Dryness||participants|Number|17|17.0||||||
4219954|NCT00706433|4043689|B3|Grade 1 (minimal)||Scaling and Dryness||participants|Number|20|20.0||||||
4219955|NCT00706433|4043690|B2|Grade 1 (minimal)||Scaling and Dryness||participants|Number|14|14.0||||||
4219956|NCT00706433|4043691|B1|Grade 1 (minimal)||Scaling and Dryness||participants|Number|13|13.0||||||
4219957|NCT00706433|4043687|B5|Grade 0 (none)||Scaling and Dryness||participants|Number|190|190.0||||||
4219958|NCT00706433|4043688|B4|Grade 0 (none)||Scaling and Dryness||participants|Number|46|46.0||||||
4219959|NCT00706433|4043689|B3|Grade 0 (none)||Scaling and Dryness||participants|Number|44|44.0||||||
4219960|NCT00706433|4043690|B2|Grade 0 (none)||Scaling and Dryness||participants|Number|47|47.0||||||
4219961|NCT00706433|4043691|B1|Grade 0 (none)||Scaling and Dryness||participants|Number|53|53.0||||||
4219962|NCT00706433|4043687|B5|Grade 2 (mild)||Oozing/vesiculation.crusting||participants|Number|6|6.0||||||
4219963|NCT00706433|4043688|B4|Grade 2 (mild)||Oozing/vesiculation.crusting||participants|Number|0|0.0||||||
4219964|NCT00706433|4043689|B3|Grade 2 (mild)||Oozing/vesiculation.crusting||participants|Number|3|3.0||||||
4219965|NCT00706433|4043690|B2|Grade 2 (mild)||Oozing/vesiculation.crusting||participants|Number|0|0.0||||||
4219966|NCT00706433|4043691|B1|Grade 2 (mild)||Oozing/vesiculation.crusting||participants|Number|3|3.0||||||
4219967|NCT00706433|4043687|B5|Grade 1 (minimal)||Oozing/vesiculation.crusting||participants|Number|9|9.0||||||
4219968|NCT00706433|4043688|B4|Grade 1 (minimal)||Oozing/vesiculation.crusting||participants|Number|2|2.0||||||
4219969|NCT00706433|4043689|B3|Grade 1 (minimal)||Oozing/vesiculation.crusting||participants|Number|1|1.0||||||
4219970|NCT00706433|4043690|B2|Grade 1 (minimal)||Oozing/vesiculation.crusting||participants|Number|3|3.0||||||
4219971|NCT00706433|4043691|B1|Grade 1 (minimal)||Oozing/vesiculation.crusting||participants|Number|3|3.0||||||
4219972|NCT00706433|4043687|B5|Grade 0 (none)||Oozing/vesiculation.crusting||participants|Number|251|251.0||||||
4219973|NCT00706433|4043688|B4|Grade 0 (none)||Oozing/vesiculation.crusting||participants|Number|64|64.0||||||
4219974|NCT00706433|4043689|B3|Grade 0 (none)||Oozing/vesiculation.crusting||participants|Number|63|63.0||||||
4219975|NCT00706433|4043690|B2|Grade 0 (none)||Oozing/vesiculation.crusting||participants|Number|62|62.0||||||
4219976|NCT00706433|4043691|B1|Grade 0 (none)||Oozing/vesiculation.crusting||participants|Number|62|62.0||||||
4219977|NCT00706433|4043687|B5|Grade 4 (severe)||Investigator Global Assessment of Acne Severity|Scale consists of Grade 0 (clear skin) to Grade 4 (severe: up to many non-inflammatory and inflammatory lesions, but no more than a few nodular lesions)|participants|Number|139|139.0||||||
4219978|NCT00706433|4043688|B4|Grade 4 (severe)||Investigator Global Assessment of Acne Severity|Scale consists of Grade 0 (clear skin) to Grade 4 (severe: up to many non-inflammatory and inflammatory lesions, but no more than a few nodular lesions)|participants|Number|35|35.0||||||
4219979|NCT00706433|4043689|B3|Grade 4 (severe)||Investigator Global Assessment of Acne Severity|Scale consists of Grade 0 (clear skin) to Grade 4 (severe: up to many non-inflammatory and inflammatory lesions, but no more than a few nodular lesions)|participants|Number|36|36.0||||||
4219980|NCT00706433|4043690|B2|Grade 4 (severe)||Investigator Global Assessment of Acne Severity|Scale consists of Grade 0 (clear skin) to Grade 4 (severe: up to many non-inflammatory and inflammatory lesions, but no more than a few nodular lesions)|participants|Number|28|28.0||||||
4219981|NCT00706433|4043691|B1|Grade 4 (severe)||Investigator Global Assessment of Acne Severity|Scale consists of Grade 0 (clear skin) to Grade 4 (severe: up to many non-inflammatory and inflammatory lesions, but no more than a few nodular lesions)|participants|Number|40|40.0||||||
4219982|NCT00706433|4043687|B5|Grade 3 (moderate severity)||Investigator Global Assessment of Acne Severity|Scale consists of Grade 0 (clear skin) to Grade 4 (severe: up to many non-inflammatory and inflammatory lesions, but no more than a few nodular lesions)|participants|Number|127|127.0||||||
4219983|NCT00706433|4043688|B4|Grade 3 (moderate severity)||Investigator Global Assessment of Acne Severity|Scale consists of Grade 0 (clear skin) to Grade 4 (severe: up to many non-inflammatory and inflammatory lesions, but no more than a few nodular lesions)|participants|Number|31|31.0||||||
4219984|NCT00706433|4043689|B3|Grade 3 (moderate severity)||Investigator Global Assessment of Acne Severity|Scale consists of Grade 0 (clear skin) to Grade 4 (severe: up to many non-inflammatory and inflammatory lesions, but no more than a few nodular lesions)|participants|Number|31|31.0||||||
4219985|NCT00706433|4043690|B2|Grade 3 (moderate severity)||Investigator Global Assessment of Acne Severity|Scale consists of Grade 0 (clear skin) to Grade 4 (severe: up to many non-inflammatory and inflammatory lesions, but no more than a few nodular lesions)|participants|Number|37|37.0||||||
4219986|NCT00706433|4043691|B1|Grade 3 (moderate severity)||Investigator Global Assessment of Acne Severity|Scale consists of Grade 0 (clear skin) to Grade 4 (severe: up to many non-inflammatory and inflammatory lesions, but no more than a few nodular lesions)|participants|Number|28|28.0||||||
4219987|NCT00706433|4043687|B5|Grade 1 (light)||Hypopigmentation||participants|Number|5|5.0||||||
4219988|NCT00706433|4043688|B4|Grade 1 (light)||Hypopigmentation||participants|Number|2|2.0||||||
4219989|NCT00706433|4043689|B3|Grade 1 (light)||Hypopigmentation||participants|Number|0|0.0||||||
4219990|NCT00706433|4043690|B2|Grade 1 (light)||Hypopigmentation||participants|Number|0|0.0||||||
4219991|NCT00706433|4043691|B1|Grade 1 (light)||Hypopigmentation||participants|Number|3|3.0||||||
4219992|NCT00706433|4043687|B5|Grade 0 (none)||Hypopigmentation||participants|Number|261|261.0||||||
4219993|NCT00706433|4043688|B4|Grade 0 (none)||Hypopigmentation||participants|Number|64|64.0||||||
4219994|NCT00706433|4043689|B3|Grade 0 (none)||Hypopigmentation||participants|Number|67|67.0||||||
4219995|NCT00706433|4043690|B2|Grade 0 (none)||Hypopigmentation||participants|Number|65|65.0||||||
4219996|NCT00706433|4043691|B1|Grade 0 (none)||Hypopigmentation||participants|Number|65|65.0||||||
4219997|NCT00706433|4043687|B5|Grade 3 (moderate - moderate)||Hyperpigmentation||participants|Number|4|4.0||||||
4219998|NCT00706433|4043688|B4|Grade 3 (moderate - moderate)||Hyperpigmentation||participants|Number|3|3.0||||||
4219999|NCT00706433|4043689|B3|Grade 3 (moderate - moderate)||Hyperpigmentation||participants|Number|0|0.0||||||
4220000|NCT00706433|4043690|B2|Grade 3 (moderate - moderate)||Hyperpigmentation||participants|Number|0|0.0||||||
4220001|NCT00706433|4043691|B1|Grade 3 (moderate - moderate)||Hyperpigmentation||participants|Number|1|1.0||||||
4220002|NCT00706433|4043687|B5|Grade 2 (moderate - small)||Hyperpigmentation||participants|Number|16|16.0||||||
4220003|NCT00706433|4043688|B4|Grade 2 (moderate - small)||Hyperpigmentation||participants|Number|4|4.0||||||
4220004|NCT00706433|4043689|B3|Grade 2 (moderate - small)||Hyperpigmentation||participants|Number|6|6.0||||||
4220005|NCT00706433|4043690|B2|Grade 2 (moderate - small)||Hyperpigmentation||participants|Number|1|1.0||||||
4220006|NCT00706433|4043691|B1|Grade 2 (moderate - small)||Hyperpigmentation||participants|Number|5|5.0||||||
4220007|NCT00706433|4043687|B5|Grade 1 (light)||Hyperpigmentation||participants|Number|46|46.0||||||
4220008|NCT00706433|4043688|B4|Grade 1 (light)||Hyperpigmentation||participants|Number|6|6.0||||||
4220009|NCT00706433|4043689|B3|Grade 1 (light)||Hyperpigmentation||participants|Number|12|12.0||||||
4220010|NCT00706433|4043690|B2|Grade 1 (light)||Hyperpigmentation||participants|Number|16|16.0||||||
4220011|NCT00706433|4043691|B1|Grade 1 (light)||Hyperpigmentation||participants|Number|12|12.0||||||
4220012|NCT00706433|4043687|B5|Grade 0 (none)||Hyperpigmentation||participants|Number|200|200.0||||||
4220013|NCT00706433|4043688|B4|Grade 0 (none)||Hyperpigmentation||participants|Number|53|53.0||||||
4220014|NCT00706433|4043689|B3|Grade 0 (none)||Hyperpigmentation||participants|Number|49|49.0||||||
4220015|NCT00706433|4043690|B2|Grade 0 (none)||Hyperpigmentation||participants|Number|48|48.0||||||
4220016|NCT00706433|4043691|B1|Grade 0 (none)||Hyperpigmentation||participants|Number|50|50.0||||||
4220017|NCT00706433|4043687|B5|Type VI - deeply pigmented (insensitive)||Fitzpatrick Skin Type||participant|Number|19|19.0||||||
4220018|NCT00706433|4043688|B4|Type VI - deeply pigmented (insensitive)||Fitzpatrick Skin Type||participant|Number|3|3.0||||||
4220019|NCT00706433|4043689|B3|Type VI - deeply pigmented (insensitive)||Fitzpatrick Skin Type||participant|Number|6|6.0||||||
4220020|NCT00706433|4043690|B2|Type VI - deeply pigmented (insensitive)||Fitzpatrick Skin Type||participant|Number|6|6.0||||||
4220021|NCT00706433|4043691|B1|Type VI - deeply pigmented (insensitive)||Fitzpatrick Skin Type||participant|Number|4|4.0||||||
4220022|NCT00706433|4043687|B5|Type V - tans profusely (dark brown)||Fitzpatrick Skin Type||participant|Number|27|27.0||||||
4220023|NCT00706433|4043688|B4|Type V - tans profusely (dark brown)||Fitzpatrick Skin Type||participant|Number|10|10.0||||||
4220024|NCT00706433|4043689|B3|Type V - tans profusely (dark brown)||Fitzpatrick Skin Type||participant|Number|6|6.0||||||
4220025|NCT00706433|4043690|B2|Type V - tans profusely (dark brown)||Fitzpatrick Skin Type||participant|Number|4|4.0||||||
4220026|NCT00706433|4043691|B1|Type V - tans profusely (dark brown)||Fitzpatrick Skin Type||participant|Number|7|7.0||||||
4220027|NCT00706433|4043687|B5|Type IV - always tans well (moderate brown)||Fitzpatrick Skin Type||participant|Number|63|63.0||||||
4220028|NCT00706433|4043688|B4|Type IV - always tans well (moderate brown)||Fitzpatrick Skin Type||participant|Number|16|16.0||||||
4220029|NCT00706433|4043689|B3|Type IV - always tans well (moderate brown)||Fitzpatrick Skin Type||participant|Number|15|15.0||||||
4220030|NCT00706433|4043690|B2|Type IV - always tans well (moderate brown)||Fitzpatrick Skin Type||participant|Number|15|15.0||||||
4220031|NCT00706433|4043691|B1|Type IV - always tans well (moderate brown)||Fitzpatrick Skin Type||participant|Number|17|17.0||||||
4220032|NCT00706433|4043687|B5|Type III - tans gradually (light brown)(normal)||Fitzpatrick Skin Type||participant|Number|87|87.0||||||
4220033|NCT00706433|4043688|B4|Type III - tans gradually (light brown)(normal)||Fitzpatrick Skin Type||participant|Number|15|15.0||||||
4220034|NCT00706433|4043689|B3|Type III - tans gradually (light brown)(normal)||Fitzpatrick Skin Type||participant|Number|24|24.0||||||
4220035|NCT00706433|4043690|B2|Type III - tans gradually (light brown)(normal)||Fitzpatrick Skin Type||participant|Number|24|24.0||||||
4220036|NCT00706433|4043691|B1|Type III - tans gradually (light brown)(normal)||Fitzpatrick Skin Type||participant|Number|24|24.0||||||
4220037|NCT00706433|4043687|B5|Type II - tans minimally (sensitive)||Fitzpatrick Skin Type||participant|Number|62|62.0||||||
4220038|NCT00706433|4043688|B4|Type II - tans minimally (sensitive)||Fitzpatrick Skin Type||participant|Number|19|19.0||||||
4220039|NCT00706433|4043689|B3|Type II - tans minimally (sensitive)||Fitzpatrick Skin Type||participant|Number|14|14.0||||||
4220040|NCT00706433|4043690|B2|Type II - tans minimally (sensitive)||Fitzpatrick Skin Type||participant|Number|13|13.0||||||
4220041|NCT00706433|4043691|B1|Type II - tans minimally (sensitive)||Fitzpatrick Skin Type||participant|Number|16|16.0||||||
4220042|NCT00706433|4043687|B5|Type I - never tans (sensitive)||Fitzpatrick Skin Type||participant|Number|8|8.0||||||
4220043|NCT00706433|4043688|B4|Type I - never tans (sensitive)||Fitzpatrick Skin Type||participant|Number|3|3.0||||||
4220044|NCT00706433|4043689|B3|Type I - never tans (sensitive)||Fitzpatrick Skin Type||participant|Number|2|2.0||||||
4220045|NCT00706433|4043690|B2|Type I - never tans (sensitive)||Fitzpatrick Skin Type||participant|Number|3|3.0||||||
4220046|NCT00706433|4043691|B1|Type I - never tans (sensitive)||Fitzpatrick Skin Type||participant|Number|0|0.0||||||
4220047|NCT00706433|4043687|B5|Grade 3 (moderate)||Erythema||participants|Number|3|3.0||||||
4220048|NCT00706433|4043688|B4|Grade 3 (moderate)||Erythema||participants|Number|1|1.0||||||
4220049|NCT00706433|4043689|B3|Grade 3 (moderate)||Erythema||participants|Number|1|1.0||||||
4220050|NCT00706433|4043690|B2|Grade 3 (moderate)||Erythema||participants|Number|0|0.0||||||
4220051|NCT00706433|4043691|B1|Grade 3 (moderate)||Erythema||participants|Number|1|1.0||||||
4220052|NCT00706433|4043687|B5|Grade 2 (mild)||Erythema||participants|Number|34|34.0||||||
4220053|NCT00706433|4043688|B4|Grade 2 (mild)||Erythema||participants|Number|8|8.0||||||
4220054|NCT00706433|4043689|B3|Grade 2 (mild)||Erythema||participants|Number|9|9.0||||||
4220055|NCT00706433|4043690|B2|Grade 2 (mild)||Erythema||participants|Number|11|11.0||||||
4220056|NCT00706433|4043691|B1|Grade 2 (mild)||Erythema||participants|Number|6|6.0||||||
4220057|NCT00706433|4043687|B5|Grade 1 (minimal)||Erythema||participants|Number|81|81.0||||||
4220058|NCT00706433|4043688|B4|Grade 1 (minimal)||Erythema||participants|Number|21|21.0||||||
4220059|NCT00706433|4043689|B3|Grade 1 (minimal)||Erythema||participants|Number|16|16.0||||||
4220060|NCT00706433|4043690|B2|Grade 1 (minimal)||Erythema||participants|Number|20|20.0||||||
4220061|NCT00706433|4043691|B1|Grade 1 (minimal)||Erythema||participants|Number|24|24.0||||||
4220062|NCT00706433|4043687|B5|Grade 0 (none)||Erythema||participants|Number|148|148.0||||||
4220063|NCT00706433|4043688|B4|Grade 0 (none)||Erythema||participants|Number|36|36.0||||||
4220064|NCT00706433|4043689|B3|Grade 0 (none)||Erythema||participants|Number|41|41.0||||||
4220065|NCT00706433|4043690|B2|Grade 0 (none)||Erythema||participants|Number|34|34.0||||||
4220066|NCT00706433|4043691|B1|Grade 0 (none)||Erythema||participants|Number|37|37.0||||||
4220067|NCT00706433|4043687|B5|Grade 1 (minimal)||Edema||participants|Number|7|7.0||||||
4220068|NCT00706433|4043688|B4|Grade 1 (minimal)||Edema||participants|Number|1|1.0||||||
4220069|NCT00706433|4043689|B3|Grade 1 (minimal)||Edema||participants|Number|2|2.0||||||
4220070|NCT00706433|4043690|B2|Grade 1 (minimal)||Edema||participants|Number|1|1.0||||||
4220071|NCT00706433|4043691|B1|Grade 1 (minimal)||Edema||participants|Number|3|3.0||||||
4220072|NCT00706433|4043687|B5|Grade 0 (none)||Edema||participants|Number|259|259.0||||||
4220073|NCT00706433|4043688|B4|Grade 0 (none)||Edema||participants|Number|65|65.0||||||
4220074|NCT00706433|4043689|B3|Grade 0 (none)||Edema||participants|Number|65|65.0||||||
4220075|NCT00706433|4043690|B2|Grade 0 (none)||Edema||participants|Number|64|64.0||||||
4220076|NCT00706433|4043691|B1|Grade 0 (none)||Edema||participants|Number|65|65.0||||||
4220077|NCT00706433|4043687|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220078|NCT00706433|4043688|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220079|NCT00706433|4043689|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220080|NCT00706433|4043690|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220081|NCT00706433|4043691|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220082|NCT00706433|4043687|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|227|227.0||||||
4220083|NCT00706433|4043688|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4220084|NCT00706433|4043689|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4220085|NCT00706433|4043690|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4220086|NCT00706433|4043691|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4220087|NCT00706433|4043687|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4220088|NCT00706433|4043688|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4220089|NCT00706433|4043689|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4220090|NCT00706433|4043690|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4220091|NCT00706433|4043691|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4220092|NCT00706433|4043687|B5||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4220093|NCT00706433|4043688|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4220094|NCT00706433|4043689|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4220095|NCT00706433|4043690|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4220096|NCT00706433|4043691|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4220097|NCT00706433|4043687|B5||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4220098|NCT00706433|4043688|B4||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4220099|NCT00706433|4043689|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4220100|NCT00706433|4043690|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4220101|NCT00706433|4043691|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4220102|NCT00706433|4043687|B5|||Age||years|Mean|20.1|20.1|Standard Deviation|6.3|6.3|||
4220103|NCT00706433|4043688|B4|||Age||years|Mean|19.8|19.8|Standard Deviation|5.31|5.31|||
4220104|NCT00706433|4043689|B3|||Age||years|Mean|21.3|21.3|Standard Deviation|6.77|6.77|||
4220105|NCT00706433|4043690|B2|||Age||years|Mean|19.4|19.4|Standard Deviation|6.82|6.82|||
4220106|NCT00706433|4043691|B1|||Age||years|Mean|20.0|20.0|Standard Deviation|6.15|6.15|||
4220107|NCT00706433|4043687|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4220108|NCT00706433|4043688|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4220109|NCT00706433|4043689|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4220110|NCT00706433|4043690|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4220111|NCT00706433|4043691|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4220112|NCT00706433|4043687|B5||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
4220113|NCT00706433|4043688|B4||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4220114|NCT00706433|4043689|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4220115|NCT00706433|4043690|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4220116|NCT00706433|4043691|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4220117|NCT00706433|4043687|B5||<=18 years|Age||Participants|Count of Participants|155|155.0||||||
4220118|NCT00706433|4043688|B4||<=18 years|Age||Participants|Count of Participants|37|37.0||||||
4220119|NCT00706433|4043689|B3||<=18 years|Age||Participants|Count of Participants|33|33.0||||||
4220120|NCT00706433|4043690|B2||<=18 years|Age||Participants|Count of Participants|44|44.0||||||
4220121|NCT00706433|4043691|B1||<=18 years|Age||Participants|Count of Participants|41|41.0||||||
4220122|NCT00706407|4044008|B3|||Bladder Outlet Obstruction (BOO) Index (Pressure flow study)|BOOI is a mathematical index of out-let resistance used to help in the diagnosis of men with Benign Prostatic Hyperplasia. Higher values represent an increased amount of bladder outlet obstruction.|units on a scale|Mean|64|64.0|Standard Deviation|36|36.0|||
4220123|NCT00706407|4044009|B2|||Bladder Outlet Obstruction (BOO) Index (Pressure flow study)|BOOI is a mathematical index of out-let resistance used to help in the diagnosis of men with Benign Prostatic Hyperplasia. Higher values represent an increased amount of bladder outlet obstruction.|units on a scale|Mean|16|16.0|Standard Deviation|10|10.0|||
4220124|NCT00706407|4044010|B1|||Bladder Outlet Obstruction (BOO) Index (Pressure flow study)|BOOI is a mathematical index of out-let resistance used to help in the diagnosis of men with Benign Prostatic Hyperplasia. Higher values represent an increased amount of bladder outlet obstruction.|units on a scale|Mean|78|78.0|Standard Deviation|28|28.0|||
4220125|NCT00706407|4044008|B3|||Max Detrusor pressure (Pdet) (Pressure flow study)|Detrusor pressure (Pdet) -- is that component of vesical pressure that is created by forces in the bladder wall (passive and active).|cm H2O|Mean|80|80.0|Standard Deviation|32|32.0|||
4220126|NCT00706407|4044009|B2|||Max Detrusor pressure (Pdet) (Pressure flow study)|Detrusor pressure (Pdet) -- is that component of vesical pressure that is created by forces in the bladder wall (passive and active).|cm H2O|Mean|43|43.0|Standard Deviation|12|12.0|||
4220127|NCT00706407|4044010|B1|||Max Detrusor pressure (Pdet) (Pressure flow study)|Detrusor pressure (Pdet) -- is that component of vesical pressure that is created by forces in the bladder wall (passive and active).|cm H2O|Mean|90|90.0|Standard Deviation|29|29.0|||
4220128|NCT00706407|4044008|B3|||Pdet at Qmax (Pressure flow study)|Pdet is detrusor pressure at maximum flow rate (Qmax)|cm H2O|Mean|72|72.0|Standard Deviation|31|31.0|||
4220129|NCT00706407|4044009|B2|||Pdet at Qmax (Pressure flow study)|Pdet is detrusor pressure at maximum flow rate (Qmax)|cm H2O|Mean|33|33.0|Standard Deviation|13|13.0|||
4220130|NCT00706407|4044010|B1|||Pdet at Qmax (Pressure flow study)|Pdet is detrusor pressure at maximum flow rate (Qmax)|cm H2O|Mean|83|83.0|Standard Deviation|24|24.0|||
4220131|NCT00706407|4044008|B3|||Postvoid Residual Volume (PVR) (Pressure flow study)|Measure Description: Postvoid residual volume (PVR) is the volume of fluid remaining in the bladder immediately after the completion of micturition.|ml|Mean|287|287.0|Standard Deviation|209|209.0|||
4220132|NCT00706407|4044009|B2|||Postvoid Residual Volume (PVR) (Pressure flow study)|Measure Description: Postvoid residual volume (PVR) is the volume of fluid remaining in the bladder immediately after the completion of micturition.|ml|Mean|270|270.0|Standard Deviation|209|209.0|||
4220133|NCT00706407|4044010|B1|||Postvoid Residual Volume (PVR) (Pressure flow study)|Measure Description: Postvoid residual volume (PVR) is the volume of fluid remaining in the bladder immediately after the completion of micturition.|ml|Mean|292|292.0|Standard Deviation|213|213.0|||
4220134|NCT00706407|4044008|B3|||Voided Volume (Pressure flow study)||ml|Mean|179|179.0|Standard Deviation|131|131.0|||
4220135|NCT00706407|4044009|B2|||Voided Volume (Pressure flow study)||ml|Mean|283|283.0|Standard Deviation|171|171.0|||
4220136|NCT00706407|4044010|B1|||Voided Volume (Pressure flow study)||ml|Mean|150|150.0|Standard Deviation|104|104.0|||
4220137|NCT00706407|4044008|B3|||Qmax (Pressure flow study)||ml/sec|Mean|6.7|6.7|Standard Deviation|4.4|4.4|||
4220138|NCT00706407|4044009|B2|||Qmax (Pressure flow study)||ml/sec|Mean|10.4|10.4|Standard Deviation|5.0|5.0|||
4220139|NCT00706407|4044010|B1|||Qmax (Pressure flow study)||ml/sec|Mean|5.7|5.7|Standard Deviation|3.7|3.7|||
4220140|NCT00706407|4044008|B3|||Postvoid residual volume (PVR) (Free Flow Study)|Postvoid residual volume (PVR) is the volume of fluid remaining in the bladder immediately after the completion of micturition.|ml|Mean|161|161.0|Standard Deviation|188|188.0|||
4220141|NCT00706407|4044009|B2|||Postvoid residual volume (PVR) (Free Flow Study)|Postvoid residual volume (PVR) is the volume of fluid remaining in the bladder immediately after the completion of micturition.|ml|Mean|157|157.0|Standard Deviation|113|113.0|||
4220142|NCT00706407|4044010|B1|||Postvoid residual volume (PVR) (Free Flow Study)|Postvoid residual volume (PVR) is the volume of fluid remaining in the bladder immediately after the completion of micturition.|ml|Mean|162|162.0|Standard Deviation|206|206.0|||
4220143|NCT00706407|4044008|B3|||Voided Volume (Free Flow Study)||ml|Mean|197|197.0|Standard Deviation|134|134.0|||
4220144|NCT00706407|4044009|B2|||Voided Volume (Free Flow Study)||ml|Mean|299|299.0|Standard Deviation|230|230.0|||
4220145|NCT00706407|4044010|B1|||Voided Volume (Free Flow Study)||ml|Mean|173|173.0|Standard Deviation|92|92.0|||
4220146|NCT00706407|4044008|B3|||Qmax (Free Flow Study)|Maximum flow rate (Qmax) is the the maximum recorded flow rate|ml/sec|Mean|10.0|10.0|Standard Deviation|5.5|5.5|||
4220147|NCT00706407|4044009|B2|||Qmax (Free Flow Study)|Maximum flow rate (Qmax) is the the maximum recorded flow rate|ml/sec|Mean|12.4|12.4|Standard Deviation|6.6|6.6|||
4220148|NCT00706407|4044010|B1|||Qmax (Free Flow Study)|Maximum flow rate (Qmax) is the the maximum recorded flow rate|ml/sec|Mean|9.3|9.3|Standard Deviation|5.2|5.2|||
4220149|NCT00706407|4044008|B3|||Prostate Specific Antigen (PSA)|Prostate Specific Antigen (PSA) is a protein that is produced by the cells in the prostate. A PSA test measures these levels in a man's blood.|ng/ml|Mean|2.0|2.0|Standard Deviation|2.3|2.3|||
4220150|NCT00706407|4044009|B2|||Prostate Specific Antigen (PSA)|Prostate Specific Antigen (PSA) is a protein that is produced by the cells in the prostate. A PSA test measures these levels in a man's blood.|ng/ml|Mean|0.6|0.6|Standard Deviation|0.8|0.8|||
4220151|NCT00706407|4044010|B1|||Prostate Specific Antigen (PSA)|Prostate Specific Antigen (PSA) is a protein that is produced by the cells in the prostate. A PSA test measures these levels in a man's blood.|ng/ml|Mean|2.3|2.3|Standard Deviation|2.4|2.4|||
4220152|NCT00706407|4044008|B3|||Prostate Volume||ml|Mean|48|48.0|Standard Deviation|39|39.0|||
4220153|NCT00706407|4044009|B2|||Prostate Volume||ml|Mean|28|28.0|Standard Deviation|23|23.0|||
4220154|NCT00706407|4044010|B1|||Prostate Volume||ml|Mean|53|53.0|Standard Deviation|42|42.0|||
4220155|NCT00706407|4044008|B3|||Quality of Life (QoL)|Quality of Life (QoL) is a one point scale used to assess how their symptoms affect their quality of life on the IPSS. A score ranges from 1 to 6, with 6 being the worse outcome.|units on a scale|Mean|4|4.0|Standard Deviation|1|1.0|||
4220156|NCT00706407|4044009|B2|||Quality of Life (QoL)|Quality of Life (QoL) is a one point scale used to assess how their symptoms affect their quality of life on the IPSS. A score ranges from 1 to 6, with 6 being the worse outcome.|units on a scale|Mean|4|4.0|Standard Deviation|1|1.0|||
4220157|NCT00706407|4044010|B1|||Quality of Life (QoL)|Quality of Life (QoL) is a one point scale used to assess how their symptoms affect their quality of life on the IPSS. A score ranges from 1 to 6, with 6 being the worse outcome.|units on a scale|Mean|5|5.0|Standard Deviation|1|1.0|||
4220158|NCT00706407|4044008|B3|||International Prostate Symptom Score (IPSS)|International Prostate Symptom Score (IPSS) is a 7 point scale used to screen, track and manage symptoms associated with BPH. The symptoms questions include feeling of incomplete bladder emptying, frequency, intermittency, urgency, weak stream, straining and nocturia. Scores range from 1 to 5 for a total of maximum 35 points (0-7 Mildly symptomatic, 8-19 Moderately symptomatic, 20-35 Severely symptomatic)|units on a scale|Mean|19|19.0|Standard Deviation|7|7.0|||
4220159|NCT00706407|4044009|B2|||International Prostate Symptom Score (IPSS)|International Prostate Symptom Score (IPSS) is a 7 point scale used to screen, track and manage symptoms associated with BPH. The symptoms questions include feeling of incomplete bladder emptying, frequency, intermittency, urgency, weak stream, straining and nocturia. Scores range from 1 to 5 for a total of maximum 35 points (0-7 Mildly symptomatic, 8-19 Moderately symptomatic, 20-35 Severely symptomatic)|units on a scale|Mean|18|18.0|Standard Deviation|7|7.0|||
4220160|NCT00706407|4044010|B1|||International Prostate Symptom Score (IPSS)|International Prostate Symptom Score (IPSS) is a 7 point scale used to screen, track and manage symptoms associated with BPH. The symptoms questions include feeling of incomplete bladder emptying, frequency, intermittency, urgency, weak stream, straining and nocturia. Scores range from 1 to 5 for a total of maximum 35 points (0-7 Mildly symptomatic, 8-19 Moderately symptomatic, 20-35 Severely symptomatic)|units on a scale|Mean|19|19.0|Standard Deviation|7|7.0|||
4220161|NCT00706407|4044008|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
4220162|NCT00706407|4044009|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4220163|NCT00706407|4044010|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4220164|NCT00706407|4044008|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4220165|NCT00706407|4044009|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4220166|NCT00706407|4044010|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4220167|NCT00706407|4044008|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4220168|NCT00706407|4044009|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4220169|NCT00706407|4044010|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4220170|NCT00706407|4044008|B3|||Age||years|Mean|67|67.0|Standard Deviation|14|14.0|||
4220171|NCT00706407|4044009|B2|||Age||years|Mean|NA||Standard Deviation|NA||||Raw data regarding the age of participants in the unobstructed group was pooled and not coded. Thus age was not able to be calculated individually, but was reported for the total.
4220172|NCT00706407|4044010|B1|||Age||years|Mean|NA||Standard Deviation|NA||||Raw data regarding the age of participants in the obstructed group was pooled and not coded. Thus age was not able to be calculated individually, but was reported for the total.
4220173|NCT00706355|4044017|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4220174|NCT00706355|4044018|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4220175|NCT00706355|4044019|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4220176|NCT00706355|4044020|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4220177|NCT00706355|4044021|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4220178|NCT00706355|4044017|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4220179|NCT00706355|4044018|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4220180|NCT00706355|4044019|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4220181|NCT00706355|4044020|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4220182|NCT00706355|4044021|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4220183|NCT00706355|4044017|B5|||Age||Years|Mean|57.3|57.3|Standard Deviation|13.8|13.8|||
4220184|NCT00706355|4044018|B4|||Age||Years|Mean|54.0|54.0|Standard Deviation|13.9|13.9|||
4220185|NCT00706355|4044019|B3|||Age||Years|Mean|66.0|66.0|Standard Deviation|18.4|18.4|||
4220186|NCT00706355|4044020|B2|||Age||Years|Mean|50.6|50.6|Standard Deviation|10.8|10.8|||
4220187|NCT00706355|4044021|B1|||Age||Years|Mean|71.3|71.3|Standard Deviation|8.6|8.6|||
4220188|NCT00706342|4044076|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4220189|NCT00706342|4044076|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4220190|NCT00706342|4044076|B1|Median (Range)||Age||years|Median|65|65.0|Full Range|||30.0|81.0|
4220191|NCT00706342|4044076|B1|||Age||years|Mean|61.9|61.9|Standard Deviation|15.63|15.63|||
4220192|NCT00706134|4044089|B5||Male|Sex: Female, Male||Participants|Count of Participants|339|339.0||||||
4220193|NCT00706134|4044090|B4||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4220194|NCT00706134|4044091|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4220195|NCT00706134|4044092|B2||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4220196|NCT00706134|4044093|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4220197|NCT00706134|4044089|B5||Female|Sex: Female, Male||Participants|Count of Participants|417|417.0||||||
4220198|NCT00706134|4044090|B4||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4220199|NCT00706134|4044091|B3||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4220200|NCT00706134|4044092|B2||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4220201|NCT00706134|4044093|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4220202|NCT00706134|4044089|B5|≥ 75 years of age||Age, Customized||Participants|Number|239|239.0||||||
4220203|NCT00706134|4044090|B4|≥ 75 years of age||Age, Customized||Participants|Number|57|57.0||||||
4220204|NCT00706134|4044091|B3|≥ 75 years of age||Age, Customized||Participants|Number|60|60.0||||||
4220205|NCT00706134|4044092|B2|≥ 75 years of age||Age, Customized||Participants|Number|61|61.0||||||
4220206|NCT00706134|4044093|B1|≥ 75 years of age||Age, Customized||Participants|Number|61|61.0||||||
4220207|NCT00706134|4044089|B5|≥ 65 and < 75 years of age||Age, Customized||Participants|Number|517|517.0||||||
4220208|NCT00706134|4044090|B4|≥ 65 and < 75 years of age||Age, Customized||Participants|Number|129|129.0||||||
4220209|NCT00706134|4044091|B3|≥ 65 and < 75 years of age||Age, Customized||Participants|Number|129|129.0||||||
4220210|NCT00706134|4044092|B2|≥ 65 and < 75 years of age||Age, Customized||Participants|Number|131|131.0||||||
4220211|NCT00706134|4044093|B1|≥ 65 and < 75 years of age||Age, Customized||Participants|Number|128|128.0||||||
4220212|NCT00706121|4044126|B5|||Medication Use -- Statins||Participants|Count of Participants|1144|1144.0||||||
4220213|NCT00706121|4044127|B4|||Medication Use -- Statins||Participants|Count of Participants|284|284.0||||||
4220214|NCT00706121|4044128|B3|||Medication Use -- Statins||Participants|Count of Participants|283|283.0||||||
4220215|NCT00706121|4044129|B2|||Medication Use -- Statins||Participants|Count of Participants|297|297.0||||||
4220216|NCT00706121|4044130|B1|||Medication Use -- Statins||Participants|Count of Participants|280|280.0||||||
4220217|NCT00706121|4044126|B5|||Medication Use -- Other NSAIDs||Participants|Count of Participants|680|680.0||||||
4220218|NCT00706121|4044127|B4|||Medication Use -- Other NSAIDs||Participants|Count of Participants|168|168.0||||||
4220219|NCT00706121|4044128|B3|||Medication Use -- Other NSAIDs||Participants|Count of Participants|164|164.0||||||
4220220|NCT00706121|4044129|B2|||Medication Use -- Other NSAIDs||Participants|Count of Participants|175|175.0||||||
4220221|NCT00706121|4044130|B1|||Medication Use -- Other NSAIDs||Participants|Count of Participants|173|173.0||||||
4220222|NCT00706121|4044126|B5|||Medication Use -- Cox II Inhibitors||Participants|Count of Participants|345|345.0||||||
4220223|NCT00706121|4044127|B4|||Medication Use -- Cox II Inhibitors||Participants|Count of Participants|77|77.0||||||
4220224|NCT00706121|4044128|B3|||Medication Use -- Cox II Inhibitors||Participants|Count of Participants|92|92.0||||||
4220225|NCT00706121|4044129|B2|||Medication Use -- Cox II Inhibitors||Participants|Count of Participants|85|85.0||||||
4220226|NCT00706121|4044130|B1|||Medication Use -- Cox II Inhibitors||Participants|Count of Participants|91|91.0||||||
4220227|NCT00706121|4044126|B5|||Medication Use -- Aspirin||Participants|Count of Participants|3036|3036.0||||||
4220228|NCT00706121|4044127|B4|||Medication Use -- Aspirin||Participants|Count of Participants|736|736.0||||||
4220229|NCT00706121|4044128|B3|||Medication Use -- Aspirin||Participants|Count of Participants|775|775.0||||||
4220230|NCT00706121|4044129|B2|||Medication Use -- Aspirin||Participants|Count of Participants|769|769.0||||||
4220231|NCT00706121|4044130|B1|||Medication Use -- Aspirin||Participants|Count of Participants|756|756.0||||||
4220232|NCT00706121|4044126|B5||2 or more|Number of First Degree Relatives with Colorectal Cancer||Participants|Count of Participants|103|103.0||||||
4220233|NCT00706121|4044127|B4||2 or more|Number of First Degree Relatives with Colorectal Cancer||Participants|Count of Participants|26|26.0||||||
4220234|NCT00706121|4044128|B3||2 or more|Number of First Degree Relatives with Colorectal Cancer||Participants|Count of Participants|23|23.0||||||
4220235|NCT00706121|4044129|B2||2 or more|Number of First Degree Relatives with Colorectal Cancer||Participants|Count of Participants|26|26.0||||||
4220236|NCT00706121|4044130|B1||2 or more|Number of First Degree Relatives with Colorectal Cancer||Participants|Count of Participants|28|28.0||||||
4220237|NCT00706121|4044126|B5||1|Number of First Degree Relatives with Colorectal Cancer||Participants|Count of Participants|760|760.0||||||
4220238|NCT00706121|4044127|B4||1|Number of First Degree Relatives with Colorectal Cancer||Participants|Count of Participants|196|196.0||||||
4220239|NCT00706121|4044128|B3||1|Number of First Degree Relatives with Colorectal Cancer||Participants|Count of Participants|181|181.0||||||
4220240|NCT00706121|4044129|B2||1|Number of First Degree Relatives with Colorectal Cancer||Participants|Count of Participants|198|198.0||||||
4220241|NCT00706121|4044130|B1||1|Number of First Degree Relatives with Colorectal Cancer||Participants|Count of Participants|185|185.0||||||
4220242|NCT00706121|4044126|B5||0|Number of First Degree Relatives with Colorectal Cancer||Participants|Count of Participants|5369|5369.0||||||
4220243|NCT00706121|4044127|B4||0|Number of First Degree Relatives with Colorectal Cancer||Participants|Count of Participants|1279|1279.0||||||
4220244|NCT00706121|4044128|B3||0|Number of First Degree Relatives with Colorectal Cancer||Participants|Count of Participants|1350|1350.0||||||
4220245|NCT00706121|4044129|B2||0|Number of First Degree Relatives with Colorectal Cancer||Participants|Count of Participants|1393|1393.0||||||
4220246|NCT00706121|4044130|B1||0|Number of First Degree Relatives with Colorectal Cancer||Participants|Count of Participants|1347|1347.0||||||
4220247|NCT00706121|4044126|B5|||History of Diabetes||Participants|Count of Participants|538|538.0||||||
4220248|NCT00706121|4044127|B4|||History of Diabetes||Participants|Count of Participants|148|148.0||||||
4220249|NCT00706121|4044128|B3|||History of Diabetes||Participants|Count of Participants|126|126.0||||||
4220250|NCT00706121|4044129|B2|||History of Diabetes||Participants|Count of Participants|126|126.0||||||
4220251|NCT00706121|4044130|B1|||History of Diabetes||Participants|Count of Participants|138|138.0||||||
4220252|NCT00706121|4044126|B5|||History of Diverticulitis||Participants|Count of Participants|462|462.0||||||
4220253|NCT00706121|4044127|B4|||History of Diverticulitis||Participants|Count of Participants|110|110.0||||||
4220254|NCT00706121|4044128|B3|||History of Diverticulitis||Participants|Count of Participants|121|121.0||||||
4220255|NCT00706121|4044129|B2|||History of Diverticulitis||Participants|Count of Participants|103|103.0||||||
4220256|NCT00706121|4044130|B1|||History of Diverticulitis||Participants|Count of Participants|128|128.0||||||
4220257|NCT00706121|4044126|B5|||History of Colon Polyps||Participants|Count of Participants|1396|1396.0||||||
4220258|NCT00706121|4044127|B4|||History of Colon Polyps||Participants|Count of Participants|355|355.0||||||
4220259|NCT00706121|4044128|B3|||History of Colon Polyps||Participants|Count of Participants|339|339.0||||||
4220260|NCT00706121|4044129|B2|||History of Colon Polyps||Participants|Count of Participants|347|347.0||||||
4220261|NCT00706121|4044130|B1|||History of Colon Polyps||Participants|Count of Participants|355|355.0||||||
4220262|NCT00706121|4044126|B5|||History of Colorectal Cancer||Participants|Count of Participants|26|26.0||||||
4220263|NCT00706121|4044127|B4|||History of Colorectal Cancer||Participants|Count of Participants|5|5.0||||||
4220264|NCT00706121|4044128|B3|||History of Colorectal Cancer||Participants|Count of Participants|7|7.0||||||
4220265|NCT00706121|4044129|B2|||History of Colorectal Cancer||Participants|Count of Participants|7|7.0||||||
4220266|NCT00706121|4044130|B1|||History of Colorectal Cancer||Participants|Count of Participants|7|7.0||||||
4220267|NCT00706121|4044126|B5|||History of Cancer||Participants|Count of Participants|135|135.0||||||
4220268|NCT00706121|4044127|B4|||History of Cancer||Participants|Count of Participants|30|30.0||||||
4220269|NCT00706121|4044128|B3|||History of Cancer||Participants|Count of Participants|35|35.0||||||
4220270|NCT00706121|4044129|B2|||History of Cancer||Participants|Count of Participants|32|32.0||||||
4220271|NCT00706121|4044130|B1|||History of Cancer||Participants|Count of Participants|38|38.0||||||
4220272|NCT00706121|4044126|B5|||BMI, Continuous||kg/m^2|Median|27.9|27.9|Inter-Quartile Range|||25.7|30.9|
4220273|NCT00706121|4044127|B4|||BMI, Continuous||kg/m^2|Median|28.0|28.0|Inter-Quartile Range|||25.4|30.8|
4220274|NCT00706121|4044128|B3|||BMI, Continuous||kg/m^2|Median|27.8|27.8|Inter-Quartile Range|||25.6|30.9|
4220275|NCT00706121|4044129|B2|||BMI, Continuous||kg/m^2|Median|28.0|28.0|Inter-Quartile Range|||25.4|30.9|
4220276|NCT00706121|4044130|B1|||BMI, Continuous||kg/m^2|Median|27.8|27.8|Inter-Quartile Range|||25.7|31.2|
4220277|NCT00706121|4044126|B5||Obese (>30)|BMI, Categorical||Participants|Count of Participants|2049|2049.0||||||
4220278|NCT00706121|4044127|B4||Obese (>30)|BMI, Categorical||Participants|Count of Participants|484|484.0||||||
4220279|NCT00706121|4044128|B3||Obese (>30)|BMI, Categorical||Participants|Count of Participants|492|492.0||||||
4220280|NCT00706121|4044129|B2||Obese (>30)|BMI, Categorical||Participants|Count of Participants|545|545.0||||||
4220281|NCT00706121|4044130|B1||Obese (>30)|BMI, Categorical||Participants|Count of Participants|528|528.0||||||
4220282|NCT00706121|4044126|B5||Overweight (>25 to 30)|BMI, Categorical||Participants|Count of Participants|3177|3177.0||||||
4220283|NCT00706121|4044127|B4||Overweight (>25 to 30)|BMI, Categorical||Participants|Count of Participants|764|764.0||||||
4220284|NCT00706121|4044128|B3||Overweight (>25 to 30)|BMI, Categorical||Participants|Count of Participants|800|800.0||||||
4220285|NCT00706121|4044129|B2||Overweight (>25 to 30)|BMI, Categorical||Participants|Count of Participants|795|795.0||||||
4220286|NCT00706121|4044130|B1||Overweight (>25 to 30)|BMI, Categorical||Participants|Count of Participants|818|818.0||||||
4220287|NCT00706121|4044126|B5||Normal or underweight (<=25)|BMI, Categorical||Participants|Count of Participants|1299|1299.0||||||
4220288|NCT00706121|4044127|B4||Normal or underweight (<=25)|BMI, Categorical||Participants|Count of Participants|324|324.0||||||
4220289|NCT00706121|4044128|B3||Normal or underweight (<=25)|BMI, Categorical||Participants|Count of Participants|327|327.0||||||
4220290|NCT00706121|4044129|B2||Normal or underweight (<=25)|BMI, Categorical||Participants|Count of Participants|355|355.0||||||
4220291|NCT00706121|4044130|B1||Normal or underweight (<=25)|BMI, Categorical||Participants|Count of Participants|293|293.0||||||
4220292|NCT00706121|4044126|B5||Former|Smoking Status||Participants|Count of Participants|3208|3208.0||||||
4220293|NCT00706121|4044127|B4||Former|Smoking Status||Participants|Count of Participants|767|767.0||||||
4220294|NCT00706121|4044128|B3||Former|Smoking Status||Participants|Count of Participants|800|800.0||||||
4220295|NCT00706121|4044129|B2||Former|Smoking Status||Participants|Count of Participants|815|815.0||||||
4220296|NCT00706121|4044130|B1||Former|Smoking Status||Participants|Count of Participants|826|826.0||||||
4220297|NCT00706121|4044126|B5||Current|Smoking Status||Participants|Count of Participants|381|381.0||||||
4220298|NCT00706121|4044127|B4||Current|Smoking Status||Participants|Count of Participants|97|97.0||||||
4220299|NCT00706121|4044128|B3||Current|Smoking Status||Participants|Count of Participants|99|99.0||||||
4220300|NCT00706121|4044129|B2||Current|Smoking Status||Participants|Count of Participants|98|98.0||||||
4220301|NCT00706121|4044130|B1||Current|Smoking Status||Participants|Count of Participants|87|87.0||||||
4220302|NCT00706121|4044126|B5||Never|Smoking Status||Participants|Count of Participants|2951|2951.0||||||
4220303|NCT00706121|4044127|B4||Never|Smoking Status||Participants|Count of Participants|711|711.0||||||
4220304|NCT00706121|4044128|B3||Never|Smoking Status||Participants|Count of Participants|726|726.0||||||
4220305|NCT00706121|4044129|B2||Never|Smoking Status||Participants|Count of Participants|785|785.0||||||
4220306|NCT00706121|4044130|B1||Never|Smoking Status||Participants|Count of Participants|729|729.0||||||
4220307|NCT00706121|4044126|B5|>=College graduate||Education||Participants|Count of Participants|3847|3847.0||||||
4220359|NCT00706121|4044128|B3||Male|Sex: Female, Male||Participants|Count of Participants|1626|1626.0||||||
4220308|NCT00706121|4044127|B4|>=College graduate||Education||Participants|Count of Participants|931|931.0||||||
4220309|NCT00706121|4044128|B3|>=College graduate||Education||Participants|Count of Participants|992|992.0||||||
4220310|NCT00706121|4044129|B2|>=College graduate||Education||Participants|Count of Participants|980|980.0||||||
4220311|NCT00706121|4044130|B1|>=College graduate||Education||Participants|Count of Participants|944|944.0||||||
4220312|NCT00706121|4044126|B5|Some college/vocational||Education||Participants|Count of Participants|1654|1654.0||||||
4220313|NCT00706121|4044127|B4|Some college/vocational||Education||Participants|Count of Participants|378|378.0||||||
4220314|NCT00706121|4044128|B3|Some college/vocational||Education||Participants|Count of Participants|397|397.0||||||
4220315|NCT00706121|4044129|B2|Some college/vocational||Education||Participants|Count of Participants|447|447.0||||||
4220316|NCT00706121|4044130|B1|Some college/vocational||Education||Participants|Count of Participants|432|432.0||||||
4220317|NCT00706121|4044126|B5|<=High school/GED||Education||Participants|Count of Participants|1016|1016.0||||||
4220318|NCT00706121|4044127|B4|<=High school/GED||Education||Participants|Count of Participants|263|263.0||||||
4220319|NCT00706121|4044128|B3|<=High school/GED||Education||Participants|Count of Participants|226|226.0||||||
4220320|NCT00706121|4044129|B2|<=High school/GED||Education||Participants|Count of Participants|264|264.0||||||
4220321|NCT00706121|4044130|B1|<=High school/GED||Education||Participants|Count of Participants|263|263.0||||||
4220322|NCT00706121|4044126|B5|Race/ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
4220323|NCT00706121|4044127|B4|Race/ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4220324|NCT00706121|4044128|B3|Race/ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4220325|NCT00706121|4044129|B2|Race/ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4220326|NCT00706121|4044130|B1|Race/ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4220327|NCT00706121|4044126|B5|Race/ethnicity|Asian/Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|54|54.0||||||
4220328|NCT00706121|4044127|B4|Race/ethnicity|Asian/Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4220329|NCT00706121|4044128|B3|Race/ethnicity|Asian/Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4220330|NCT00706121|4044129|B2|Race/ethnicity|Asian/Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
4220331|NCT00706121|4044130|B1|Race/ethnicity|Asian/Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4220332|NCT00706121|4044126|B5|Race/ethnicity|Aboriginal|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
4220333|NCT00706121|4044127|B4|Race/ethnicity|Aboriginal|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4220334|NCT00706121|4044128|B3|Race/ethnicity|Aboriginal|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4220335|NCT00706121|4044129|B2|Race/ethnicity|Aboriginal|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4220336|NCT00706121|4044130|B1|Race/ethnicity|Aboriginal|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4220337|NCT00706121|4044126|B5|Race/ethnicity|Hispanic, African American|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4220338|NCT00706121|4044127|B4|Race/ethnicity|Hispanic, African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4220339|NCT00706121|4044128|B3|Race/ethnicity|Hispanic, African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4220340|NCT00706121|4044129|B2|Race/ethnicity|Hispanic, African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4220341|NCT00706121|4044130|B1|Race/ethnicity|Hispanic, African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4220342|NCT00706121|4044126|B5|Race/ethnicity|Hispanic, not African American|Race/Ethnicity, Customized||Participants|Count of Participants|117|117.0||||||
4220343|NCT00706121|4044127|B4|Race/ethnicity|Hispanic, not African American|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
4220344|NCT00706121|4044128|B3|Race/ethnicity|Hispanic, not African American|Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
4220345|NCT00706121|4044129|B2|Race/ethnicity|Hispanic, not African American|Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
4220346|NCT00706121|4044130|B1|Race/ethnicity|Hispanic, not African American|Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
4220347|NCT00706121|4044126|B5|Race/ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|695|695.0||||||
4220348|NCT00706121|4044127|B4|Race/ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|160|160.0||||||
4220349|NCT00706121|4044128|B3|Race/ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|167|167.0||||||
4220350|NCT00706121|4044129|B2|Race/ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|187|187.0||||||
4220351|NCT00706121|4044130|B1|Race/ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|181|181.0||||||
4220352|NCT00706121|4044126|B5|Race/ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|5642|5642.0||||||
4220353|NCT00706121|4044127|B4|Race/ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|1374|1374.0||||||
4220354|NCT00706121|4044128|B3|Race/ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|1412|1412.0||||||
4220355|NCT00706121|4044129|B2|Race/ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|1445|1445.0||||||
4220356|NCT00706121|4044130|B1|Race/ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|1411|1411.0||||||
4220357|NCT00706121|4044126|B5||Male|Sex: Female, Male||Participants|Count of Participants|6546|6546.0||||||
4220358|NCT00706121|4044127|B4||Male|Sex: Female, Male||Participants|Count of Participants|1577|1577.0||||||
4220360|NCT00706121|4044129|B2||Male|Sex: Female, Male||Participants|Count of Participants|1700|1700.0||||||
4220361|NCT00706121|4044130|B1||Male|Sex: Female, Male||Participants|Count of Participants|1643|1643.0||||||
4220362|NCT00706121|4044126|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4220363|NCT00706121|4044127|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4220364|NCT00706121|4044128|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4220365|NCT00706121|4044129|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4220366|NCT00706121|4044130|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4220367|NCT00706121|4044126|B5|Age, Categorical|>= 75|Age, Customized||Participants|Count of Participants|249|249.0||||||
4220368|NCT00706121|4044127|B4|Age, Categorical|>= 75|Age, Customized||Participants|Count of Participants|68|68.0||||||
4220369|NCT00706121|4044128|B3|Age, Categorical|>= 75|Age, Customized||Participants|Count of Participants|59|59.0||||||
4220370|NCT00706121|4044129|B2|Age, Categorical|>= 75|Age, Customized||Participants|Count of Participants|58|58.0||||||
4220371|NCT00706121|4044130|B1|Age, Categorical|>= 75|Age, Customized||Participants|Count of Participants|64|64.0||||||
4220372|NCT00706121|4044126|B5|Age, Categorical|65-74|Age, Customized||Participants|Count of Participants|2072|2072.0||||||
4220373|NCT00706121|4044127|B4|Age, Categorical|65-74|Age, Customized||Participants|Count of Participants|524|524.0||||||
4220374|NCT00706121|4044128|B3|Age, Categorical|65-74|Age, Customized||Participants|Count of Participants|516|516.0||||||
4220375|NCT00706121|4044129|B2|Age, Categorical|65-74|Age, Customized||Participants|Count of Participants|538|538.0||||||
4220376|NCT00706121|4044130|B1|Age, Categorical|65-74|Age, Customized||Participants|Count of Participants|494|494.0||||||
4220377|NCT00706121|4044126|B5|Age, Categorical|55-64|Age, Customized||Participants|Count of Participants|4005|4005.0||||||
4220378|NCT00706121|4044127|B4|Age, Categorical|55-64|Age, Customized||Participants|Count of Participants|933|933.0||||||
4220379|NCT00706121|4044128|B3|Age, Categorical|55-64|Age, Customized||Participants|Count of Participants|1002|1002.0||||||
4220380|NCT00706121|4044129|B2|Age, Categorical|55-64|Age, Customized||Participants|Count of Participants|1045|1045.0||||||
4220381|NCT00706121|4044130|B1|Age, Categorical|55-64|Age, Customized||Participants|Count of Participants|1025|1025.0||||||
4220382|NCT00706121|4044126|B5|Age, Categorical|50-54|Age, Customized||Participants|Count of Participants|220|220.0||||||
4220383|NCT00706121|4044127|B4|Age, Categorical|50-54|Age, Customized||Participants|Count of Participants|52|52.0||||||
4220384|NCT00706121|4044128|B3|Age, Categorical|50-54|Age, Customized||Participants|Count of Participants|49|49.0||||||
4220385|NCT00706121|4044129|B2|Age, Categorical|50-54|Age, Customized||Participants|Count of Participants|59|59.0||||||
4220386|NCT00706121|4044130|B1|Age, Categorical|50-54|Age, Customized||Participants|Count of Participants|60|60.0||||||
4220387|NCT00706121|4044126|B5|||Age||years|Median|62.0|62.0|Inter-Quartile Range|||58.0|66.0|
4220388|NCT00706121|4044127|B4|||Age||years|Median|62.0|62.0|Inter-Quartile Range|||58.0|67.0|
4220389|NCT00706121|4044128|B3|||Age||years|Median|62.0|62.0|Inter-Quartile Range|||58.0|67.0|
4220390|NCT00706121|4044129|B2|||Age||years|Median|62.0|62.0|Inter-Quartile Range|||58.0|66.0|
4220391|NCT00706121|4044130|B1|||Age||years|Median|61.0|61.0|Inter-Quartile Range|||58.0|66.0|
4220392|NCT00706095|4044159|B4|White||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4220393|NCT00706095|4044160|B3|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4220394|NCT00706095|4044161|B2|White||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4220395|NCT00706095|4044162|B1|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4220396|NCT00706095|4044159|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4220397|NCT00706095|4044160|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4220398|NCT00706095|4044161|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4220399|NCT00706095|4044162|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4220400|NCT00706095|4044159|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4220401|NCT00706095|4044160|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4220402|NCT00706095|4044161|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4220403|NCT00706095|4044162|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4220404|NCT00706095|4044159|B4|||Age||years|Mean|61.4|61.4|Standard Deviation|5.14|5.14|||
4220405|NCT00706095|4044160|B3|||Age||years|Mean|65.2|65.2|Standard Deviation|2.68|2.68|||
4220406|NCT00706095|4044161|B2|||Age||years|Mean|59.9|59.9|Standard Deviation|4.88|4.88|||
4220407|NCT00706095|4044162|B1|||Age||years|Mean|60.2|60.2|Standard Deviation|5.98|5.98|||
4220408|NCT00706030|4044178|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4220409|NCT00706030|4044179|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220410|NCT00706030|4044180|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4220411|NCT00706030|4044181|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220412|NCT00706030|4044182|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4220413|NCT00706030|4044178|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220414|NCT00706030|4044179|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220415|NCT00706030|4044180|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220416|NCT00706030|4044181|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220417|NCT00706030|4044182|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220418|NCT00706030|4044178|B5||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4220419|NCT00706030|4044179|B4||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4220420|NCT00706030|4044180|B3||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4220421|NCT00706030|4044181|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4220422|NCT00706030|4044182|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4220423|NCT00706030|4044178|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4220424|NCT00706030|4044179|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220425|NCT00706030|4044180|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4220426|NCT00706030|4044181|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4220427|NCT00706030|4044182|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220428|NCT00706030|4044178|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220429|NCT00706030|4044179|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220430|NCT00706030|4044180|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220431|NCT00706030|4044181|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220432|NCT00706030|4044182|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220433|NCT00706030|4044178|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4220434|NCT00706030|4044179|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4220435|NCT00706030|4044180|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4220436|NCT00706030|4044181|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220437|NCT00706030|4044182|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220438|NCT00706030|4044178|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220439|NCT00706030|4044179|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220440|NCT00706030|4044180|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220441|NCT00706030|4044181|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220442|NCT00706030|4044182|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220443|NCT00706030|4044178|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4220444|NCT00706030|4044179|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4220445|NCT00706030|4044180|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4220446|NCT00706030|4044181|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4220447|NCT00706030|4044182|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4220448|NCT00706030|4044178|B5||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4220449|NCT00706030|4044179|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4220450|NCT00706030|4044180|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4220451|NCT00706030|4044181|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4220452|NCT00706030|4044182|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4220453|NCT00706030|4044178|B5|||Age||years|Mean|51.6|51.6|Standard Deviation|10.8|10.8|||
4220454|NCT00706030|4044179|B4|||Age||years|Mean|52.1|52.1|Standard Deviation|9.8|9.8|||
4220455|NCT00706030|4044180|B3|||Age||years|Mean|51.1|51.1|Standard Deviation|10.6|10.6|||
4220456|NCT00706030|4044181|B2|||Age||years|Mean|54.3|54.3|Standard Deviation|13.9|13.9|||
4220457|NCT00706030|4044182|B1|||Age||years|Mean|53.2|53.2|Standard Deviation|14.8|14.8|||
4220458|NCT00706004|4044200|B1|United States||Region of Enrollment|The number of subjects analyzed here is 7 as only 7 completed this pilot study.|participants|Number|7|7.0||||||
4220459|NCT00706004|4044200|B1||Male|Sex: Female, Male|The number of subjects analyzed here is 7 as only 7 completed this pilot study.|Participants|Count of Participants|3|3.0||||||
4220460|NCT00706004|4044200|B1||Female|Sex: Female, Male|The number of subjects analyzed here is 7 as only 7 completed this pilot study.|Participants|Count of Participants|4|4.0||||||
4220461|NCT00706004|4044200|B1|||Age|The number of subjects analyzed here is 7 as only 7 completed this pilot study.|years|Mean|26|26.0|Standard Deviation|5.4|5.4|||
4220462|NCT00706004|4044200|B1||>=65 years|Age|The number of subjects analyzed here is 7 as only 7 completed this pilot study.|Participants|Count of Participants|0|0.0||||||
4220463|NCT00706004|4044200|B1||Between 18 and 65 years|Age|The number of subjects analyzed here is 7 as only 7 completed this pilot study.|Participants|Count of Participants|7|7.0||||||
4220464|NCT00706004|4044200|B1||<=18 years|Age|The number of subjects analyzed here is 7 as only 7 completed this pilot study.|Participants|Count of Participants|0|0.0||||||
4220465|NCT00705939|4044225|B4|Mexico||Region of Enrollment||participants|Number|5|5.0||||||
4220466|NCT00705939|4044226|B3|Mexico||Region of Enrollment||participants|Number|0|0.0||||||
4220467|NCT00705939|4044227|B2|Mexico||Region of Enrollment||participants|Number|2|2.0||||||
4220468|NCT00705939|4044228|B1|Mexico||Region of Enrollment||participants|Number|3|3.0||||||
4220469|NCT00705939|4044225|B4|Serbia||Region of Enrollment||participants|Number|6|6.0||||||
4220470|NCT00705939|4044226|B3|Serbia||Region of Enrollment||participants|Number|2|2.0||||||
4220471|NCT00705939|4044227|B2|Serbia||Region of Enrollment||participants|Number|2|2.0||||||
4220472|NCT00705939|4044228|B1|Serbia||Region of Enrollment||participants|Number|2|2.0||||||
4220473|NCT00705939|4044225|B4|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4220474|NCT00705939|4044226|B3|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4220475|NCT00705939|4044227|B2|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4220476|NCT00705939|4044228|B1|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4220477|NCT00705939|4044225|B4|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4220478|NCT00705939|4044226|B3|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4220479|NCT00705939|4044227|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4220480|NCT00705939|4044228|B1|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4220481|NCT00705939|4044225|B4|Israel||Region of Enrollment||participants|Number|13|13.0||||||
4220482|NCT00705939|4044226|B3|Israel||Region of Enrollment||participants|Number|6|6.0||||||
4220483|NCT00705939|4044227|B2|Israel||Region of Enrollment||participants|Number|4|4.0||||||
4220484|NCT00705939|4044228|B1|Israel||Region of Enrollment||participants|Number|3|3.0||||||
4220485|NCT00705939|4044225|B4|South Africa||Region of Enrollment||participants|Number|2|2.0||||||
4220486|NCT00705939|4044226|B3|South Africa||Region of Enrollment||participants|Number|0|0.0||||||
4220487|NCT00705939|4044227|B2|South Africa||Region of Enrollment||participants|Number|1|1.0||||||
4220488|NCT00705939|4044228|B1|South Africa||Region of Enrollment||participants|Number|1|1.0||||||
4220489|NCT00705939|4044225|B4|Chile||Region of Enrollment||participants|Number|2|2.0||||||
4220490|NCT00705939|4044226|B3|Chile||Region of Enrollment||participants|Number|0|0.0||||||
4220491|NCT00705939|4044227|B2|Chile||Region of Enrollment||participants|Number|1|1.0||||||
4220492|NCT00705939|4044228|B1|Chile||Region of Enrollment||participants|Number|1|1.0||||||
4220493|NCT00705939|4044225|B4|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4220494|NCT00705939|4044226|B3|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4220495|NCT00705939|4044227|B2|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4220496|NCT00705939|4044228|B1|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4220497|NCT00705939|4044225|B4|Spain||Region of Enrollment||participants|Number|3|3.0||||||
4220498|NCT00705939|4044226|B3|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4220499|NCT00705939|4044227|B2|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4220500|NCT00705939|4044228|B1|Spain||Region of Enrollment||participants|Number|0|0.0||||||
4220501|NCT00705939|4044225|B4|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4220502|NCT00705939|4044226|B3|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4220503|NCT00705939|4044227|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4220504|NCT00705939|4044228|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4220505|NCT00705939|4044225|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
4220506|NCT00705939|4044226|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4220507|NCT00705939|4044227|B2|United States||Region of Enrollment||participants|Number|0|0.0||||||
4220508|NCT00705939|4044228|B1|United States||Region of Enrollment||participants|Number|0|0.0||||||
4220509|NCT00705939|4044225|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4220510|NCT00705939|4044226|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220511|NCT00705939|4044227|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4220512|NCT00705939|4044228|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220513|NCT00705939|4044225|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220514|NCT00705939|4044226|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220515|NCT00705939|4044227|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220516|NCT00705939|4044228|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220517|NCT00705939|4044225|B4||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4220518|NCT00705939|4044226|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4220519|NCT00705939|4044227|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4220520|NCT00705939|4044228|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4220521|NCT00705939|4044225|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220522|NCT00705939|4044226|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220523|NCT00705939|4044227|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220524|NCT00705939|4044228|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220525|NCT00705939|4044225|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220526|NCT00705939|4044226|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220527|NCT00705939|4044227|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220528|NCT00705939|4044228|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220529|NCT00705939|4044225|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220530|NCT00705939|4044226|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220531|NCT00705939|4044227|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220532|NCT00705939|4044228|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220533|NCT00705939|4044225|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220534|NCT00705939|4044226|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220535|NCT00705939|4044227|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220536|NCT00705939|4044228|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220537|NCT00705939|4044225|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4220538|NCT00705939|4044226|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4220539|NCT00705939|4044227|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4220540|NCT00705939|4044228|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4220541|NCT00705939|4044225|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4220542|NCT00705939|4044226|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4220543|NCT00705939|4044227|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4220544|NCT00705939|4044228|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4220545|NCT00705939|4044225|B4|||Age||years|Mean|41.6|41.6|Standard Deviation|13.0|13.0|||
4220546|NCT00705939|4044226|B3|||Age||years|Mean|46.5|46.5|Standard Deviation|13.7|13.7|||
4220547|NCT00705939|4044227|B2|||Age||years|Mean|36.6|36.6|Standard Deviation|12.0|12.0|||
4220548|NCT00705939|4044228|B1|||Age||years|Mean|39.7|39.7|Standard Deviation|11.8|11.8|||
4220549|NCT00705874|4044253|B8|United States||Region of Enrollment||participants|Number|172|172.0||||||
4220550|NCT00705874|4044254|B7|United States||Region of Enrollment||participants|Number|3|3.0||||||
4220551|NCT00705874|4044255|B6|United States||Region of Enrollment||participants|Number|32|32.0||||||
4220552|NCT00705874|4044256|B5|United States||Region of Enrollment||participants|Number|48|48.0||||||
4220553|NCT00705874|4044257|B4|United States||Region of Enrollment||participants|Number|34|34.0||||||
4220554|NCT00705874|4044258|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
4220555|NCT00705874|4044259|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4220556|NCT00705874|4044260|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4220557|NCT00705874|4044253|B8||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4220558|NCT00705874|4044254|B7||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4220559|NCT00705874|4044255|B6||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4220560|NCT00705874|4044256|B5||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4220561|NCT00705874|4044257|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4220562|NCT00705874|4044258|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4220563|NCT00705874|4044259|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4220564|NCT00705874|4044260|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4220565|NCT00705874|4044253|B8||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4220566|NCT00705874|4044254|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4220567|NCT00705874|4044255|B6||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4220568|NCT00705874|4044256|B5||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4220569|NCT00705874|4044257|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4220570|NCT00705874|4044258|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4220571|NCT00705874|4044259|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4220572|NCT00705874|4044260|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4220573|NCT00705874|4044253|B8|||Age||years|Mean|59.8|59.8|Standard Deviation|11.7|11.7|||
4220574|NCT00705874|4044254|B7|||Age||years|Mean|60.0|60.0|Standard Deviation|24.4|24.4|||
4220575|NCT00705874|4044255|B6|||Age||years|Mean|60.2|60.2|Standard Deviation|12.2|12.2|||
4220576|NCT00705874|4044256|B5|||Age||years|Mean|59.8|59.8|Standard Deviation|10.1|10.1|||
4220577|NCT00705874|4044257|B4|||Age||years|Mean|62.8|62.8|Standard Deviation|11.0|11.0|||
4220578|NCT00705874|4044258|B3|||Age||years|Mean|56.3|56.3|Standard Deviation|12.8|12.8|||
4220579|NCT00705874|4044259|B2|||Age||years|Mean|63.2|63.2|Standard Deviation|13.1|13.1|||
4220580|NCT00705874|4044260|B1|||Age||years|Mean|58.3|58.3|Standard Deviation|10.8|10.8|||
4220581|NCT00705874|4044253|B8||>=65 years|Age||Participants|Count of Participants|62|62.0||||||
4220582|NCT00705874|4044254|B7||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4220583|NCT00705874|4044255|B6||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4220584|NCT00705874|4044256|B5||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4220585|NCT00705874|4044257|B4||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4220586|NCT00705874|4044258|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4220587|NCT00705874|4044259|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4220588|NCT00705874|4044260|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4220589|NCT00705874|4044253|B8||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
4220590|NCT00705874|4044254|B7||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4220591|NCT00705874|4044255|B6||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4220592|NCT00705874|4044256|B5||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4220593|NCT00705874|4044257|B4||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4220594|NCT00705874|4044258|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4220595|NCT00705874|4044259|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4220596|NCT00705874|4044260|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4220597|NCT00705874|4044253|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4220598|NCT00705874|4044254|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4220599|NCT00705874|4044255|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4220600|NCT00705874|4044256|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4220601|NCT00705874|4044257|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4220602|NCT00705874|4044258|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4220603|NCT00705874|4044259|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4220604|NCT00705874|4044260|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4220605|NCT00705783|4044282|B3||Male|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
4220606|NCT00705783|4044283|B2||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4220607|NCT00705783|4044284|B1||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4220608|NCT00705783|4044282|B3||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4220609|NCT00705783|4044283|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4220610|NCT00705783|4044284|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4220611|NCT00705783|4044282|B3|||Age||years|Mean|40.6|40.6|Standard Deviation|10.8|10.8|||
4220612|NCT00705783|4044283|B2|||Age||years|Mean|41.7|41.7|Standard Deviation|10.5|10.5|||
4220613|NCT00705783|4044284|B1|||Age||years|Mean|40.1|40.1|Standard Deviation|11.0|11.0|||
4220614|NCT00705757|4044313|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220615|NCT00705757|4044314|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220616|NCT00705757|4044315|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220617|NCT00705757|4044316|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220618|NCT00705757|4044313|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220619|NCT00705757|4044314|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220620|NCT00705757|4044315|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220621|NCT00705757|4044316|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220622|NCT00705757|4044313|B4||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4220623|NCT00705757|4044314|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4220624|NCT00705757|4044315|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4220625|NCT00705757|4044316|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4220626|NCT00705757|4044313|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4220627|NCT00705757|4044314|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4220628|NCT00705757|4044315|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4220629|NCT00705757|4044316|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4220630|NCT00705757|4044313|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220631|NCT00705757|4044314|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220632|NCT00705757|4044315|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220633|NCT00705757|4044316|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220634|NCT00705757|4044313|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220635|NCT00705757|4044314|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220636|NCT00705757|4044315|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220637|NCT00705757|4044316|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220638|NCT00705757|4044313|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220639|NCT00705757|4044314|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220640|NCT00705757|4044315|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220641|NCT00705757|4044316|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4220642|NCT00705757|4044313|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4220643|NCT00705757|4044314|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4220644|NCT00705757|4044315|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4220645|NCT00705757|4044316|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4220646|NCT00705757|4044313|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4220647|NCT00705757|4044314|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4220648|NCT00705757|4044315|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4220649|NCT00705757|4044316|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4220650|NCT00705757|4044313|B4|||Age||years|Mean|60.4|60.4|Full Range|||30.0|81.0|
4220651|NCT00705757|4044314|B3|||Age||years|Mean|60.5|60.5|Full Range|||39.0|73.0|
4220652|NCT00705757|4044315|B2|||Age||years|Mean|59.2|59.2|Full Range|||30.0|81.0|
4220653|NCT00705757|4044316|B1|||Age||years|Mean|61.5|61.5|Full Range|||41.0|78.0|
4220654|NCT00705718|4044326|B3|Tabacco use in the last 10 years||Baseline Medical History|The Overall Number of Baseline Participants number may differ from the number within each baseline measure category. The Category number indicates the number of Participants with the baseline measure within that category.|participants|Number|95|95.0||||||
4221164|NCT00705536|4044463|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4220655|NCT00705718|4044327|B2|Tabacco use in the last 10 years||Baseline Medical History|The Overall Number of Baseline Participants number may differ from the number within each baseline measure category. The Category number indicates the number of Participants with the baseline measure within that category.|participants|Number|66|66.0||||||
4220656|NCT00705718|4044328|B1|Tabacco use in the last 10 years||Baseline Medical History|The Overall Number of Baseline Participants number may differ from the number within each baseline measure category. The Category number indicates the number of Participants with the baseline measure within that category.|participants|Number|29|29.0||||||
4220657|NCT00705718|4044326|B3|Diabetes||Baseline Medical History|The Overall Number of Baseline Participants number may differ from the number within each baseline measure category. The Category number indicates the number of Participants with the baseline measure within that category.|participants|Number|51|51.0||||||
4220658|NCT00705718|4044327|B2|Diabetes||Baseline Medical History|The Overall Number of Baseline Participants number may differ from the number within each baseline measure category. The Category number indicates the number of Participants with the baseline measure within that category.|participants|Number|40|40.0||||||
4220659|NCT00705718|4044328|B1|Diabetes||Baseline Medical History|The Overall Number of Baseline Participants number may differ from the number within each baseline measure category. The Category number indicates the number of Participants with the baseline measure within that category.|participants|Number|11|11.0||||||
4220660|NCT00705718|4044326|B3|Chronic obstructive pulmonary disorder||Baseline Medical History|The Overall Number of Baseline Participants number may differ from the number within each baseline measure category. The Category number indicates the number of Participants with the baseline measure within that category.|participants|Number|79|79.0||||||
4220661|NCT00705718|4044327|B2|Chronic obstructive pulmonary disorder||Baseline Medical History|The Overall Number of Baseline Participants number may differ from the number within each baseline measure category. The Category number indicates the number of Participants with the baseline measure within that category.|participants|Number|53|53.0||||||
4220662|NCT00705718|4044328|B1|Chronic obstructive pulmonary disorder||Baseline Medical History|The Overall Number of Baseline Participants number may differ from the number within each baseline measure category. The Category number indicates the number of Participants with the baseline measure within that category.|participants|Number|26|26.0||||||
4220663|NCT00705718|4044326|B3|Abnormal renal function||Baseline Medical History|The Overall Number of Baseline Participants number may differ from the number within each baseline measure category. The Category number indicates the number of Participants with the baseline measure within that category.|participants|Number|57|57.0||||||
4220664|NCT00705718|4044327|B2|Abnormal renal function||Baseline Medical History|The Overall Number of Baseline Participants number may differ from the number within each baseline measure category. The Category number indicates the number of Participants with the baseline measure within that category.|participants|Number|43|43.0||||||
4220665|NCT00705718|4044328|B1|Abnormal renal function||Baseline Medical History|The Overall Number of Baseline Participants number may differ from the number within each baseline measure category. The Category number indicates the number of Participants with the baseline measure within that category.|participants|Number|14|14.0||||||
4220666|NCT00705718|4044326|B3|Peripheral vascular disease||Baseline Medical History|The Overall Number of Baseline Participants number may differ from the number within each baseline measure category. The Category number indicates the number of Participants with the baseline measure within that category.|participants|Number|67|67.0||||||
4220667|NCT00705718|4044327|B2|Peripheral vascular disease||Baseline Medical History|The Overall Number of Baseline Participants number may differ from the number within each baseline measure category. The Category number indicates the number of Participants with the baseline measure within that category.|participants|Number|34|34.0||||||
4220668|NCT00705718|4044328|B1|Peripheral vascular disease||Baseline Medical History|The Overall Number of Baseline Participants number may differ from the number within each baseline measure category. The Category number indicates the number of Participants with the baseline measure within that category.|participants|Number|33|33.0||||||
4220669|NCT00705718|4044326|B3|Myocardial Infarction||Baseline Medical History|The Overall Number of Baseline Participants number may differ from the number within each baseline measure category. The Category number indicates the number of Participants with the baseline measure within that category.|participants|Number|59|59.0||||||
4220670|NCT00705718|4044327|B2|Myocardial Infarction||Baseline Medical History|The Overall Number of Baseline Participants number may differ from the number within each baseline measure category. The Category number indicates the number of Participants with the baseline measure within that category.|participants|Number|45|45.0||||||
4220671|NCT00705718|4044328|B1|Myocardial Infarction||Baseline Medical History|The Overall Number of Baseline Participants number may differ from the number within each baseline measure category. The Category number indicates the number of Participants with the baseline measure within that category.|participants|Number|14|14.0||||||
4220672|NCT00705718|4044326|B3|Hypertension||Baseline Medical History|The Overall Number of Baseline Participants number may differ from the number within each baseline measure category. The Category number indicates the number of Participants with the baseline measure within that category.|participants|Number|168|168.0||||||
4220673|NCT00705718|4044327|B2|Hypertension||Baseline Medical History|The Overall Number of Baseline Participants number may differ from the number within each baseline measure category. The Category number indicates the number of Participants with the baseline measure within that category.|participants|Number|130|130.0||||||
4220674|NCT00705718|4044328|B1|Hypertension||Baseline Medical History|The Overall Number of Baseline Participants number may differ from the number within each baseline measure category. The Category number indicates the number of Participants with the baseline measure within that category.|participants|Number|38|38.0||||||
4220675|NCT00705718|4044326|B3|Congestive Heart Failure||Baseline Medical History|The Overall Number of Baseline Participants number may differ from the number within each baseline measure category. The Category number indicates the number of Participants with the baseline measure within that category.|participants|Number|31|31.0||||||
4220676|NCT00705718|4044327|B2|Congestive Heart Failure||Baseline Medical History|The Overall Number of Baseline Participants number may differ from the number within each baseline measure category. The Category number indicates the number of Participants with the baseline measure within that category.|participants|Number|24|24.0||||||
4220677|NCT00705718|4044328|B1|Congestive Heart Failure||Baseline Medical History|The Overall Number of Baseline Participants number may differ from the number within each baseline measure category. The Category number indicates the number of Participants with the baseline measure within that category.|participants|Number|7|7.0||||||
4220678|NCT00705718|4044326|B3|Arrhythmia||Baseline Medical History|The Overall Number of Baseline Participants number may differ from the number within each baseline measure category. The Category number indicates the number of Participants with the baseline measure within that category.|participants|Number|74|74.0||||||
4220679|NCT00705718|4044327|B2|Arrhythmia||Baseline Medical History|The Overall Number of Baseline Participants number may differ from the number within each baseline measure category. The Category number indicates the number of Participants with the baseline measure within that category.|participants|Number|59|59.0||||||
4220680|NCT00705718|4044328|B1|Arrhythmia||Baseline Medical History|The Overall Number of Baseline Participants number may differ from the number within each baseline measure category. The Category number indicates the number of Participants with the baseline measure within that category.|participants|Number|15|15.0||||||
4220681|NCT00705718|4044326|B3|Angina||Baseline Medical History|The Overall Number of Baseline Participants number may differ from the number within each baseline measure category. The Category number indicates the number of Participants with the baseline measure within that category.|participants|Number|38|38.0||||||
4220682|NCT00705718|4044327|B2|Angina||Baseline Medical History|The Overall Number of Baseline Participants number may differ from the number within each baseline measure category. The Category number indicates the number of Participants with the baseline measure within that category.|participants|Number|27|27.0||||||
4220683|NCT00705718|4044328|B1|Angina||Baseline Medical History|The Overall Number of Baseline Participants number may differ from the number within each baseline measure category. The Category number indicates the number of Participants with the baseline measure within that category.|participants|Number|11|11.0||||||
4220684|NCT00705718|4044326|B3|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4220685|NCT00705718|4044327|B2|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4220686|NCT00705718|4044328|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4220687|NCT00705718|4044326|B3|United States||Region of Enrollment||participants|Number|191|191.0||||||
4220688|NCT00705718|4044327|B2|United States||Region of Enrollment||participants|Number|150|150.0||||||
4220689|NCT00705718|4044328|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4220690|NCT00705718|4044326|B3||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4220691|NCT00705718|4044327|B2||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4220692|NCT00705718|4044328|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4220693|NCT00705718|4044326|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4220694|NCT00705718|4044327|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4220695|NCT00705718|4044328|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4220696|NCT00705718|4044326|B3|||Age||years|Mean|73.3|73.3|Standard Deviation|7.9|7.9|||
4220697|NCT00705718|4044327|B2|||Age||years|Mean|73.1|73.1|Standard Deviation|8.0|8.0|||
4220698|NCT00705718|4044328|B1|||Age||years|Mean|73.8|73.8|Standard Deviation|7.6|7.6|||
4220699|NCT00705679|4044345|B6|Missing||Bacterial vaginosis infection|Bacterial vaginosis was determined by the Nugent score on Gram's staining of vaginal fluid (Nugent score 7-10).|participants|Number|19|19.0||||||
4220700|NCT00705679|4044346|B5|Missing||Bacterial vaginosis infection|Bacterial vaginosis was determined by the Nugent score on Gram's staining of vaginal fluid (Nugent score 7-10).|participants|Number|6|6.0||||||
4220701|NCT00705679|4044347|B4|Missing||Bacterial vaginosis infection|Bacterial vaginosis was determined by the Nugent score on Gram's staining of vaginal fluid (Nugent score 7-10).|participants|Number|4|4.0||||||
4220702|NCT00705679|4044348|B3|Missing||Bacterial vaginosis infection|Bacterial vaginosis was determined by the Nugent score on Gram's staining of vaginal fluid (Nugent score 7-10).|participants|Number|1|1.0||||||
4220703|NCT00705679|4044349|B2|Missing||Bacterial vaginosis infection|Bacterial vaginosis was determined by the Nugent score on Gram's staining of vaginal fluid (Nugent score 7-10).|participants|Number|1|1.0||||||
4220704|NCT00705679|4044350|B1|Missing||Bacterial vaginosis infection|Bacterial vaginosis was determined by the Nugent score on Gram's staining of vaginal fluid (Nugent score 7-10).|participants|Number|7|7.0||||||
4220705|NCT00705679|4044345|B6|No||Bacterial vaginosis infection|Bacterial vaginosis was determined by the Nugent score on Gram's staining of vaginal fluid (Nugent score 7-10).|participants|Number|2987|2987.0||||||
4220706|NCT00705679|4044346|B5|No||Bacterial vaginosis infection|Bacterial vaginosis was determined by the Nugent score on Gram's staining of vaginal fluid (Nugent score 7-10).|participants|Number|604|604.0||||||
4220707|NCT00705679|4044347|B4|No||Bacterial vaginosis infection|Bacterial vaginosis was determined by the Nugent score on Gram's staining of vaginal fluid (Nugent score 7-10).|participants|Number|606|606.0||||||
4220708|NCT00705679|4044348|B3|No||Bacterial vaginosis infection|Bacterial vaginosis was determined by the Nugent score on Gram's staining of vaginal fluid (Nugent score 7-10).|participants|Number|607|607.0||||||
4220709|NCT00705679|4044349|B2|No||Bacterial vaginosis infection|Bacterial vaginosis was determined by the Nugent score on Gram's staining of vaginal fluid (Nugent score 7-10).|participants|Number|592|592.0||||||
4220710|NCT00705679|4044350|B1|No||Bacterial vaginosis infection|Bacterial vaginosis was determined by the Nugent score on Gram's staining of vaginal fluid (Nugent score 7-10).|participants|Number|578|578.0||||||
4220711|NCT00705679|4044345|B6|Yes||Bacterial vaginosis infection|Bacterial vaginosis was determined by the Nugent score on Gram's staining of vaginal fluid (Nugent score 7-10).|participants|Number|2023|2023.0||||||
4220712|NCT00705679|4044346|B5|Yes||Bacterial vaginosis infection|Bacterial vaginosis was determined by the Nugent score on Gram's staining of vaginal fluid (Nugent score 7-10).|participants|Number|393|393.0||||||
4220713|NCT00705679|4044347|B4|Yes||Bacterial vaginosis infection|Bacterial vaginosis was determined by the Nugent score on Gram's staining of vaginal fluid (Nugent score 7-10).|participants|Number|397|397.0||||||
4221165|NCT00705536|4044464|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4220714|NCT00705679|4044348|B3|Yes||Bacterial vaginosis infection|Bacterial vaginosis was determined by the Nugent score on Gram's staining of vaginal fluid (Nugent score 7-10).|participants|Number|401|401.0||||||
4220715|NCT00705679|4044349|B2|Yes||Bacterial vaginosis infection|Bacterial vaginosis was determined by the Nugent score on Gram's staining of vaginal fluid (Nugent score 7-10).|participants|Number|410|410.0||||||
4220716|NCT00705679|4044350|B1|Yes||Bacterial vaginosis infection|Bacterial vaginosis was determined by the Nugent score on Gram's staining of vaginal fluid (Nugent score 7-10).|participants|Number|422|422.0||||||
4220717|NCT00705679|4044345|B6|Missing||HSV-2 infection|HSV-2 seropositivity was determined with the use of the HerpeSelect 2 enzyme immunoassay at the time of enrollment; an index value of 3.5 or greater was considered to be a positive result.|participants|Number|24|24.0||||||
4220718|NCT00705679|4044346|B5|Missing||HSV-2 infection|HSV-2 seropositivity was determined with the use of the HerpeSelect 2 enzyme immunoassay at the time of enrollment; an index value of 3.5 or greater was considered to be a positive result.|participants|Number|7|7.0||||||
4220719|NCT00705679|4044347|B4|Missing||HSV-2 infection|HSV-2 seropositivity was determined with the use of the HerpeSelect 2 enzyme immunoassay at the time of enrollment; an index value of 3.5 or greater was considered to be a positive result.|participants|Number|3|3.0||||||
4220720|NCT00705679|4044348|B3|Missing||HSV-2 infection|HSV-2 seropositivity was determined with the use of the HerpeSelect 2 enzyme immunoassay at the time of enrollment; an index value of 3.5 or greater was considered to be a positive result.|participants|Number|3|3.0||||||
4220721|NCT00705679|4044349|B2|Missing||HSV-2 infection|HSV-2 seropositivity was determined with the use of the HerpeSelect 2 enzyme immunoassay at the time of enrollment; an index value of 3.5 or greater was considered to be a positive result.|participants|Number|6|6.0||||||
4220722|NCT00705679|4044350|B1|Missing||HSV-2 infection|HSV-2 seropositivity was determined with the use of the HerpeSelect 2 enzyme immunoassay at the time of enrollment; an index value of 3.5 or greater was considered to be a positive result.|participants|Number|5|5.0||||||
4220723|NCT00705679|4044345|B6|No||HSV-2 infection|HSV-2 seropositivity was determined with the use of the HerpeSelect 2 enzyme immunoassay at the time of enrollment; an index value of 3.5 or greater was considered to be a positive result.|participants|Number|2716|2716.0||||||
4220724|NCT00705679|4044346|B5|No||HSV-2 infection|HSV-2 seropositivity was determined with the use of the HerpeSelect 2 enzyme immunoassay at the time of enrollment; an index value of 3.5 or greater was considered to be a positive result.|participants|Number|531|531.0||||||
4220725|NCT00705679|4044347|B4|No||HSV-2 infection|HSV-2 seropositivity was determined with the use of the HerpeSelect 2 enzyme immunoassay at the time of enrollment; an index value of 3.5 or greater was considered to be a positive result.|participants|Number|566|566.0||||||
4220726|NCT00705679|4044348|B3|No||HSV-2 infection|HSV-2 seropositivity was determined with the use of the HerpeSelect 2 enzyme immunoassay at the time of enrollment; an index value of 3.5 or greater was considered to be a positive result.|participants|Number|551|551.0||||||
4220727|NCT00705679|4044349|B2|No||HSV-2 infection|HSV-2 seropositivity was determined with the use of the HerpeSelect 2 enzyme immunoassay at the time of enrollment; an index value of 3.5 or greater was considered to be a positive result.|participants|Number|548|548.0||||||
4220728|NCT00705679|4044350|B1|No||HSV-2 infection|HSV-2 seropositivity was determined with the use of the HerpeSelect 2 enzyme immunoassay at the time of enrollment; an index value of 3.5 or greater was considered to be a positive result.|participants|Number|520|520.0||||||
4220729|NCT00705679|4044345|B6|Yes||HSV-2 infection|HSV-2 seropositivity was determined with the use of the HerpeSelect 2 enzyme immunoassay at the time of enrollment; an index value of 3.5 or greater was considered to be a positive result.|participants|Number|2289|2289.0||||||
4220730|NCT00705679|4044346|B5|Yes||HSV-2 infection|HSV-2 seropositivity was determined with the use of the HerpeSelect 2 enzyme immunoassay at the time of enrollment; an index value of 3.5 or greater was considered to be a positive result.|participants|Number|465|465.0||||||
4220731|NCT00705679|4044347|B4|Yes||HSV-2 infection|HSV-2 seropositivity was determined with the use of the HerpeSelect 2 enzyme immunoassay at the time of enrollment; an index value of 3.5 or greater was considered to be a positive result.|participants|Number|438|438.0||||||
4220732|NCT00705679|4044348|B3|Yes||HSV-2 infection|HSV-2 seropositivity was determined with the use of the HerpeSelect 2 enzyme immunoassay at the time of enrollment; an index value of 3.5 or greater was considered to be a positive result.|participants|Number|455|455.0||||||
4220733|NCT00705679|4044349|B2|Yes||HSV-2 infection|HSV-2 seropositivity was determined with the use of the HerpeSelect 2 enzyme immunoassay at the time of enrollment; an index value of 3.5 or greater was considered to be a positive result.|participants|Number|449|449.0||||||
4220734|NCT00705679|4044350|B1|Yes||HSV-2 infection|HSV-2 seropositivity was determined with the use of the HerpeSelect 2 enzyme immunoassay at the time of enrollment; an index value of 3.5 or greater was considered to be a positive result.|participants|Number|482|482.0||||||
4220735|NCT00705679|4044345|B6|Missing||Syphilis infection|Testing was performed with the use of a rapid plasma reagin screening test followed by a confirmatory microhemagglutinin assay|participants|Number|1|1.0||||||
4220736|NCT00705679|4044346|B5|Missing||Syphilis infection|Testing was performed with the use of a rapid plasma reagin screening test followed by a confirmatory microhemagglutinin assay|participants|Number|0|0.0||||||
4220737|NCT00705679|4044347|B4|Missing||Syphilis infection|Testing was performed with the use of a rapid plasma reagin screening test followed by a confirmatory microhemagglutinin assay|participants|Number|0|0.0||||||
4220738|NCT00705679|4044348|B3|Missing||Syphilis infection|Testing was performed with the use of a rapid plasma reagin screening test followed by a confirmatory microhemagglutinin assay|participants|Number|0|0.0||||||
4220739|NCT00705679|4044349|B2|Missing||Syphilis infection|Testing was performed with the use of a rapid plasma reagin screening test followed by a confirmatory microhemagglutinin assay|participants|Number|0|0.0||||||
4220740|NCT00705679|4044350|B1|Missing||Syphilis infection|Testing was performed with the use of a rapid plasma reagin screening test followed by a confirmatory microhemagglutinin assay|participants|Number|1|1.0||||||
4220741|NCT00705679|4044345|B6|No||Syphilis infection|Testing was performed with the use of a rapid plasma reagin screening test followed by a confirmatory microhemagglutinin assay|participants|Number|4960|4960.0||||||
4221166|NCT00705536|4044465|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4220742|NCT00705679|4044346|B5|No||Syphilis infection|Testing was performed with the use of a rapid plasma reagin screening test followed by a confirmatory microhemagglutinin assay|participants|Number|992|992.0||||||
4220743|NCT00705679|4044347|B4|No||Syphilis infection|Testing was performed with the use of a rapid plasma reagin screening test followed by a confirmatory microhemagglutinin assay|participants|Number|993|993.0||||||
4220744|NCT00705679|4044348|B3|No||Syphilis infection|Testing was performed with the use of a rapid plasma reagin screening test followed by a confirmatory microhemagglutinin assay|participants|Number|993|993.0||||||
4220745|NCT00705679|4044349|B2|No||Syphilis infection|Testing was performed with the use of a rapid plasma reagin screening test followed by a confirmatory microhemagglutinin assay|participants|Number|988|988.0||||||
4220746|NCT00705679|4044350|B1|No||Syphilis infection|Testing was performed with the use of a rapid plasma reagin screening test followed by a confirmatory microhemagglutinin assay|participants|Number|994|994.0||||||
4220747|NCT00705679|4044345|B6|Yes||Syphilis infection|Testing was performed with the use of a rapid plasma reagin screening test followed by a confirmatory microhemagglutinin assay|participants|Number|68|68.0||||||
4220748|NCT00705679|4044346|B5|Yes||Syphilis infection|Testing was performed with the use of a rapid plasma reagin screening test followed by a confirmatory microhemagglutinin assay|participants|Number|11|11.0||||||
4220749|NCT00705679|4044347|B4|Yes||Syphilis infection|Testing was performed with the use of a rapid plasma reagin screening test followed by a confirmatory microhemagglutinin assay|participants|Number|14|14.0||||||
4220750|NCT00705679|4044348|B3|Yes||Syphilis infection|Testing was performed with the use of a rapid plasma reagin screening test followed by a confirmatory microhemagglutinin assay|participants|Number|16|16.0||||||
4220751|NCT00705679|4044349|B2|Yes||Syphilis infection|Testing was performed with the use of a rapid plasma reagin screening test followed by a confirmatory microhemagglutinin assay|participants|Number|15|15.0||||||
4220752|NCT00705679|4044350|B1|Yes||Syphilis infection|Testing was performed with the use of a rapid plasma reagin screening test followed by a confirmatory microhemagglutinin assay|participants|Number|12|12.0||||||
4220753|NCT00705679|4044345|B6|Missing||Infection by Trichomonas vaginalis|Testing was performed with the use of the OSOM Trichomonas Rapid Test|participants|Number|6|6.0||||||
4220754|NCT00705679|4044346|B5|Missing||Infection by Trichomonas vaginalis|Testing was performed with the use of the OSOM Trichomonas Rapid Test|participants|Number|3|3.0||||||
4220755|NCT00705679|4044347|B4|Missing||Infection by Trichomonas vaginalis|Testing was performed with the use of the OSOM Trichomonas Rapid Test|participants|Number|2|2.0||||||
4220756|NCT00705679|4044348|B3|Missing||Infection by Trichomonas vaginalis|Testing was performed with the use of the OSOM Trichomonas Rapid Test|participants|Number|0|0.0||||||
4220757|NCT00705679|4044349|B2|Missing||Infection by Trichomonas vaginalis|Testing was performed with the use of the OSOM Trichomonas Rapid Test|participants|Number|1|1.0||||||
4220758|NCT00705679|4044350|B1|Missing||Infection by Trichomonas vaginalis|Testing was performed with the use of the OSOM Trichomonas Rapid Test|participants|Number|0|0.0||||||
4220759|NCT00705679|4044345|B6|No||Infection by Trichomonas vaginalis|Testing was performed with the use of the OSOM Trichomonas Rapid Test|participants|Number|4722|4722.0||||||
4220760|NCT00705679|4044346|B5|No||Infection by Trichomonas vaginalis|Testing was performed with the use of the OSOM Trichomonas Rapid Test|participants|Number|949|949.0||||||
4220761|NCT00705679|4044347|B4|No||Infection by Trichomonas vaginalis|Testing was performed with the use of the OSOM Trichomonas Rapid Test|participants|Number|943|943.0||||||
4220762|NCT00705679|4044348|B3|No||Infection by Trichomonas vaginalis|Testing was performed with the use of the OSOM Trichomonas Rapid Test|participants|Number|943|943.0||||||
4220763|NCT00705679|4044349|B2|No||Infection by Trichomonas vaginalis|Testing was performed with the use of the OSOM Trichomonas Rapid Test|participants|Number|948|948.0||||||
4220764|NCT00705679|4044350|B1|No||Infection by Trichomonas vaginalis|Testing was performed with the use of the OSOM Trichomonas Rapid Test|participants|Number|939|939.0||||||
4220765|NCT00705679|4044345|B6|Yes||Infection by Trichomonas vaginalis|Testing was performed with the use of the OSOM Trichomonas Rapid Test|participants|Number|301|301.0||||||
4220766|NCT00705679|4044346|B5|Yes||Infection by Trichomonas vaginalis|Testing was performed with the use of the OSOM Trichomonas Rapid Test|participants|Number|51|51.0||||||
4220767|NCT00705679|4044347|B4|Yes||Infection by Trichomonas vaginalis|Testing was performed with the use of the OSOM Trichomonas Rapid Test|participants|Number|62|62.0||||||
4220768|NCT00705679|4044348|B3|Yes||Infection by Trichomonas vaginalis|Testing was performed with the use of the OSOM Trichomonas Rapid Test|participants|Number|66|66.0||||||
4220769|NCT00705679|4044349|B2|Yes||Infection by Trichomonas vaginalis|Testing was performed with the use of the OSOM Trichomonas Rapid Test|participants|Number|54|54.0||||||
4220770|NCT00705679|4044350|B1|Yes||Infection by Trichomonas vaginalis|Testing was performed with the use of the OSOM Trichomonas Rapid Test|participants|Number|68|68.0||||||
4220771|NCT00705679|4044345|B6|Missing||Infection by Neisseria gonorrhoeae|Testing was performed with the use of a strand-displacement amplification assay|participants|Number|1|1.0||||||
4220772|NCT00705679|4044346|B5|Missing||Infection by Neisseria gonorrhoeae|Testing was performed with the use of a strand-displacement amplification assay|participants|Number|0|0.0||||||
4220773|NCT00705679|4044347|B4|Missing||Infection by Neisseria gonorrhoeae|Testing was performed with the use of a strand-displacement amplification assay|participants|Number|0|0.0||||||
4220774|NCT00705679|4044348|B3|Missing||Infection by Neisseria gonorrhoeae|Testing was performed with the use of a strand-displacement amplification assay|participants|Number|0|0.0||||||
4220775|NCT00705679|4044349|B2|Missing||Infection by Neisseria gonorrhoeae|Testing was performed with the use of a strand-displacement amplification assay|participants|Number|0|0.0||||||
4220776|NCT00705679|4044350|B1|Missing||Infection by Neisseria gonorrhoeae|Testing was performed with the use of a strand-displacement amplification assay|participants|Number|1|1.0||||||
4220777|NCT00705679|4044345|B6|No||Infection by Neisseria gonorrhoeae|Testing was performed with the use of a strand-displacement amplification assay|participants|Number|4865|4865.0||||||
4220778|NCT00705679|4044346|B5|No||Infection by Neisseria gonorrhoeae|Testing was performed with the use of a strand-displacement amplification assay|participants|Number|967|967.0||||||
4220779|NCT00705679|4044347|B4|No||Infection by Neisseria gonorrhoeae|Testing was performed with the use of a strand-displacement amplification assay|participants|Number|983|983.0||||||
4220780|NCT00705679|4044348|B3|No||Infection by Neisseria gonorrhoeae|Testing was performed with the use of a strand-displacement amplification assay|participants|Number|975|975.0||||||
4220781|NCT00705679|4044349|B2|No||Infection by Neisseria gonorrhoeae|Testing was performed with the use of a strand-displacement amplification assay|participants|Number|976|976.0||||||
4220782|NCT00705679|4044350|B1|No||Infection by Neisseria gonorrhoeae|Testing was performed with the use of a strand-displacement amplification assay|participants|Number|964|964.0||||||
4220783|NCT00705679|4044345|B6|Yes||Infection by Neisseria gonorrhoeae|Testing was performed with the use of a strand-displacement amplification assay|participants|Number|163|163.0||||||
4220784|NCT00705679|4044346|B5|Yes||Infection by Neisseria gonorrhoeae|Testing was performed with the use of a strand-displacement amplification assay|participants|Number|36|36.0||||||
4220785|NCT00705679|4044347|B4|Yes||Infection by Neisseria gonorrhoeae|Testing was performed with the use of a strand-displacement amplification assay|participants|Number|24|24.0||||||
4220786|NCT00705679|4044348|B3|Yes||Infection by Neisseria gonorrhoeae|Testing was performed with the use of a strand-displacement amplification assay|participants|Number|34|34.0||||||
4220787|NCT00705679|4044349|B2|Yes||Infection by Neisseria gonorrhoeae|Testing was performed with the use of a strand-displacement amplification assay|participants|Number|27|27.0||||||
4220788|NCT00705679|4044350|B1|Yes||Infection by Neisseria gonorrhoeae|Testing was performed with the use of a strand-displacement amplification assay|participants|Number|42|42.0||||||
4220789|NCT00705679|4044345|B6|Missing||Infection by Chlamydia trachomatis|Testing was performed with the use of a strand-displacement amplification assay|participants|Number|1|1.0||||||
4220790|NCT00705679|4044346|B5|Missing||Infection by Chlamydia trachomatis|Testing was performed with the use of a strand-displacement amplification assay|participants|Number|0|0.0||||||
4220791|NCT00705679|4044347|B4|Missing||Infection by Chlamydia trachomatis|Testing was performed with the use of a strand-displacement amplification assay|participants|Number|0|0.0||||||
4220792|NCT00705679|4044348|B3|Missing||Infection by Chlamydia trachomatis|Testing was performed with the use of a strand-displacement amplification assay|participants|Number|0|0.0||||||
4220793|NCT00705679|4044349|B2|Missing||Infection by Chlamydia trachomatis|Testing was performed with the use of a strand-displacement amplification assay|participants|Number|0|0.0||||||
4220794|NCT00705679|4044350|B1|Missing||Infection by Chlamydia trachomatis|Testing was performed with the use of a strand-displacement amplification assay|participants|Number|1|1.0||||||
4220795|NCT00705679|4044345|B6|No||Infection by Chlamydia trachomatis|Testing was performed with the use of a strand-displacement amplification assay|participants|Number|4417|4417.0||||||
4220796|NCT00705679|4044346|B5|No||Infection by Chlamydia trachomatis|Testing was performed with the use of a strand-displacement amplification assay|participants|Number|874|874.0||||||
4220797|NCT00705679|4044347|B4|No||Infection by Chlamydia trachomatis|Testing was performed with the use of a strand-displacement amplification assay|participants|Number|891|891.0||||||
4220798|NCT00705679|4044348|B3|No||Infection by Chlamydia trachomatis|Testing was performed with the use of a strand-displacement amplification assay|participants|Number|882|882.0||||||
4220799|NCT00705679|4044349|B2|No||Infection by Chlamydia trachomatis|Testing was performed with the use of a strand-displacement amplification assay|participants|Number|886|886.0||||||
4220800|NCT00705679|4044350|B1|No||Infection by Chlamydia trachomatis|Testing was performed with the use of a strand-displacement amplification assay|participants|Number|884|884.0||||||
4220801|NCT00705679|4044345|B6|Yes||Infection by Chlamydia trachomatis|Testing was performed with the use of a strand-displacement amplification assay|participants|Number|611|611.0||||||
4220802|NCT00705679|4044346|B5|Yes||Infection by Chlamydia trachomatis|Testing was performed with the use of a strand-displacement amplification assay|participants|Number|129|129.0||||||
4220803|NCT00705679|4044347|B4|Yes||Infection by Chlamydia trachomatis|Testing was performed with the use of a strand-displacement amplification assay|participants|Number|116|116.0||||||
4220804|NCT00705679|4044348|B3|Yes||Infection by Chlamydia trachomatis|Testing was performed with the use of a strand-displacement amplification assay|participants|Number|127|127.0||||||
4220805|NCT00705679|4044349|B2|Yes||Infection by Chlamydia trachomatis|Testing was performed with the use of a strand-displacement amplification assay|participants|Number|117|117.0||||||
4220806|NCT00705679|4044350|B1|Yes||Infection by Chlamydia trachomatis|Testing was performed with the use of a strand-displacement amplification assay|participants|Number|122|122.0||||||
4220807|NCT00705679|4044345|B6|No||Oral pills contraception|Response to question: What method(s) of contraception/family planning is the participant currently using? (Participant could indicate more than one method.)|participants|Number|3889|3889.0||||||
4220808|NCT00705679|4044346|B5|No||Oral pills contraception|Response to question: What method(s) of contraception/family planning is the participant currently using? (Participant could indicate more than one method.)|participants|Number|788|788.0||||||
4220809|NCT00705679|4044347|B4|No||Oral pills contraception|Response to question: What method(s) of contraception/family planning is the participant currently using? (Participant could indicate more than one method.)|participants|Number|769|769.0||||||
4220810|NCT00705679|4044348|B3|No||Oral pills contraception|Response to question: What method(s) of contraception/family planning is the participant currently using? (Participant could indicate more than one method.)|participants|Number|771|771.0||||||
4220811|NCT00705679|4044349|B2|No||Oral pills contraception|Response to question: What method(s) of contraception/family planning is the participant currently using? (Participant could indicate more than one method.)|participants|Number|780|780.0||||||
4220812|NCT00705679|4044350|B1|No||Oral pills contraception|Response to question: What method(s) of contraception/family planning is the participant currently using? (Participant could indicate more than one method.)|participants|Number|781|781.0||||||
4220813|NCT00705679|4044345|B6|Yes||Oral pills contraception|Response to question: What method(s) of contraception/family planning is the participant currently using? (Participant could indicate more than one method.)|participants|Number|1140|1140.0||||||
4220927|NCT00705679|4044345|B6|Missing||Some secondary school education or higher|Response to question: What is your highest level of education?|participants|Number|4|4.0||||||
4220814|NCT00705679|4044346|B5|Yes||Oral pills contraception|Response to question: What method(s) of contraception/family planning is the participant currently using? (Participant could indicate more than one method.)|participants|Number|215|215.0||||||
4220815|NCT00705679|4044347|B4|Yes||Oral pills contraception|Response to question: What method(s) of contraception/family planning is the participant currently using? (Participant could indicate more than one method.)|participants|Number|238|238.0||||||
4220816|NCT00705679|4044348|B3|Yes||Oral pills contraception|Response to question: What method(s) of contraception/family planning is the participant currently using? (Participant could indicate more than one method.)|participants|Number|238|238.0||||||
4220817|NCT00705679|4044349|B2|Yes||Oral pills contraception|Response to question: What method(s) of contraception/family planning is the participant currently using? (Participant could indicate more than one method.)|participants|Number|223|223.0||||||
4220818|NCT00705679|4044350|B1|Yes||Oral pills contraception|Response to question: What method(s) of contraception/family planning is the participant currently using? (Participant could indicate more than one method.)|participants|Number|226|226.0||||||
4220819|NCT00705679|4044345|B6|No||Injectable contraception use|Response to question: What method(s) of contraception/family planning is the participant currently using? (Participant could indicate more than one method.)|participants|Number|1464|1464.0||||||
4220820|NCT00705679|4044346|B5|No||Injectable contraception use|Response to question: What method(s) of contraception/family planning is the participant currently using? (Participant could indicate more than one method.)|participants|Number|277|277.0||||||
4220821|NCT00705679|4044347|B4|No||Injectable contraception use|Response to question: What method(s) of contraception/family planning is the participant currently using? (Participant could indicate more than one method.)|participants|Number|300|300.0||||||
4220822|NCT00705679|4044348|B3|No||Injectable contraception use|Response to question: What method(s) of contraception/family planning is the participant currently using? (Participant could indicate more than one method.)|participants|Number|309|309.0||||||
4220823|NCT00705679|4044349|B2|No||Injectable contraception use|Response to question: What method(s) of contraception/family planning is the participant currently using? (Participant could indicate more than one method.)|participants|Number|280|280.0||||||
4220824|NCT00705679|4044350|B1|No||Injectable contraception use|Response to question: What method(s) of contraception/family planning is the participant currently using? (Participant could indicate more than one method.)|participants|Number|298|298.0||||||
4220825|NCT00705679|4044345|B6|Yes||Injectable contraception use|Response to question: What method(s) of contraception/family planning is the participant currently using? (Participant could indicate more than one method.)|participants|Number|3565|3565.0||||||
4220826|NCT00705679|4044346|B5|Yes||Injectable contraception use|Response to question: What method(s) of contraception/family planning is the participant currently using? (Participant could indicate more than one method.)|participants|Number|726|726.0||||||
4220827|NCT00705679|4044347|B4|Yes||Injectable contraception use|Response to question: What method(s) of contraception/family planning is the participant currently using? (Participant could indicate more than one method.)|participants|Number|707|707.0||||||
4220828|NCT00705679|4044348|B3|Yes||Injectable contraception use|Response to question: What method(s) of contraception/family planning is the participant currently using? (Participant could indicate more than one method.)|participants|Number|700|700.0||||||
4220829|NCT00705679|4044349|B2|Yes||Injectable contraception use|Response to question: What method(s) of contraception/family planning is the participant currently using? (Participant could indicate more than one method.)|participants|Number|723|723.0||||||
4220830|NCT00705679|4044350|B1|Yes||Injectable contraception use|Response to question: What method(s) of contraception/family planning is the participant currently using? (Participant could indicate more than one method.)|participants|Number|709|709.0||||||
4220831|NCT00705679|4044345|B6|Missing||Anal sex in the previous 3 months|A response of 1 or more to the question: In the past 3 months how many times have you had anal sex?|participants|Number|75|75.0||||||
4220832|NCT00705679|4044346|B5|Missing||Anal sex in the previous 3 months|A response of 1 or more to the question: In the past 3 months how many times have you had anal sex?|participants|Number|17|17.0||||||
4220833|NCT00705679|4044347|B4|Missing||Anal sex in the previous 3 months|A response of 1 or more to the question: In the past 3 months how many times have you had anal sex?|participants|Number|14|14.0||||||
4220834|NCT00705679|4044348|B3|Missing||Anal sex in the previous 3 months|A response of 1 or more to the question: In the past 3 months how many times have you had anal sex?|participants|Number|12|12.0||||||
4220835|NCT00705679|4044349|B2|Missing||Anal sex in the previous 3 months|A response of 1 or more to the question: In the past 3 months how many times have you had anal sex?|participants|Number|16|16.0||||||
4220836|NCT00705679|4044350|B1|Missing||Anal sex in the previous 3 months|A response of 1 or more to the question: In the past 3 months how many times have you had anal sex?|participants|Number|16|16.0||||||
4220837|NCT00705679|4044345|B6|No||Anal sex in the previous 3 months|A response of 1 or more to the question: In the past 3 months how many times have you had anal sex?|participants|Number|4086|4086.0||||||
4220838|NCT00705679|4044346|B5|No||Anal sex in the previous 3 months|A response of 1 or more to the question: In the past 3 months how many times have you had anal sex?|participants|Number|810|810.0||||||
4220839|NCT00705679|4044347|B4|No||Anal sex in the previous 3 months|A response of 1 or more to the question: In the past 3 months how many times have you had anal sex?|participants|Number|814|814.0||||||
4220840|NCT00705679|4044348|B3|No||Anal sex in the previous 3 months|A response of 1 or more to the question: In the past 3 months how many times have you had anal sex?|participants|Number|823|823.0||||||
4220841|NCT00705679|4044349|B2|No||Anal sex in the previous 3 months|A response of 1 or more to the question: In the past 3 months how many times have you had anal sex?|participants|Number|812|812.0||||||
4220842|NCT00705679|4044350|B1|No||Anal sex in the previous 3 months|A response of 1 or more to the question: In the past 3 months how many times have you had anal sex?|participants|Number|827|827.0||||||
4220843|NCT00705679|4044345|B6|Yes||Anal sex in the previous 3 months|A response of 1 or more to the question: In the past 3 months how many times have you had anal sex?|participants|Number|868|868.0||||||
4220844|NCT00705679|4044346|B5|Yes||Anal sex in the previous 3 months|A response of 1 or more to the question: In the past 3 months how many times have you had anal sex?|participants|Number|176|176.0||||||
4220845|NCT00705679|4044347|B4|Yes||Anal sex in the previous 3 months|A response of 1 or more to the question: In the past 3 months how many times have you had anal sex?|participants|Number|179|179.0||||||
4220846|NCT00705679|4044348|B3|Yes||Anal sex in the previous 3 months|A response of 1 or more to the question: In the past 3 months how many times have you had anal sex?|participants|Number|174|174.0||||||
4220847|NCT00705679|4044349|B2|Yes||Anal sex in the previous 3 months|A response of 1 or more to the question: In the past 3 months how many times have you had anal sex?|participants|Number|175|175.0||||||
4220848|NCT00705679|4044350|B1|Yes||Anal sex in the previous 3 months|A response of 1 or more to the question: In the past 3 months how many times have you had anal sex?|participants|Number|164|164.0||||||
4220849|NCT00705679|4044345|B6|Missing||Condom use during last vaginal intercourse||participants|Number|12|12.0||||||
4220850|NCT00705679|4044346|B5|Missing||Condom use during last vaginal intercourse||participants|Number|2|2.0||||||
4220851|NCT00705679|4044347|B4|Missing||Condom use during last vaginal intercourse||participants|Number|0|0.0||||||
4220852|NCT00705679|4044348|B3|Missing||Condom use during last vaginal intercourse||participants|Number|4|4.0||||||
4220853|NCT00705679|4044349|B2|Missing||Condom use during last vaginal intercourse||participants|Number|4|4.0||||||
4220854|NCT00705679|4044350|B1|Missing||Condom use during last vaginal intercourse||participants|Number|2|2.0||||||
4220855|NCT00705679|4044345|B6|No||Condom use during last vaginal intercourse||participants|Number|1251|1251.0||||||
4220856|NCT00705679|4044346|B5|No||Condom use during last vaginal intercourse||participants|Number|268|268.0||||||
4220857|NCT00705679|4044347|B4|No||Condom use during last vaginal intercourse||participants|Number|239|239.0||||||
4220858|NCT00705679|4044348|B3|No||Condom use during last vaginal intercourse||participants|Number|263|263.0||||||
4220859|NCT00705679|4044349|B2|No||Condom use during last vaginal intercourse||participants|Number|239|239.0||||||
4220860|NCT00705679|4044350|B1|No||Condom use during last vaginal intercourse||participants|Number|242|242.0||||||
4220861|NCT00705679|4044345|B6|Yes||Condom use during last vaginal intercourse||participants|Number|3766|3766.0||||||
4220862|NCT00705679|4044346|B5|Yes||Condom use during last vaginal intercourse||participants|Number|733|733.0||||||
4220863|NCT00705679|4044347|B4|Yes||Condom use during last vaginal intercourse||participants|Number|768|768.0||||||
4220864|NCT00705679|4044348|B3|Yes||Condom use during last vaginal intercourse||participants|Number|742|742.0||||||
4220865|NCT00705679|4044349|B2|Yes||Condom use during last vaginal intercourse||participants|Number|760|760.0||||||
4220866|NCT00705679|4044350|B1|Yes||Condom use during last vaginal intercourse||participants|Number|763|763.0||||||
4220867|NCT00705679|4044345|B6|||Episodes of vaginal intercourse in the past 7 days||episodes|Mean|2.5|2.5|Standard Deviation|3.1|3.1|||
4220868|NCT00705679|4044346|B5|||Episodes of vaginal intercourse in the past 7 days||episodes|Mean|2.6|2.6|Standard Deviation|2.9|2.9|||
4220869|NCT00705679|4044347|B4|||Episodes of vaginal intercourse in the past 7 days||episodes|Mean|2.6|2.6|Standard Deviation|3.6|3.6|||
4220870|NCT00705679|4044348|B3|||Episodes of vaginal intercourse in the past 7 days||episodes|Mean|2.5|2.5|Standard Deviation|2.6|2.6|||
4220871|NCT00705679|4044349|B2|||Episodes of vaginal intercourse in the past 7 days||episodes|Mean|2.5|2.5|Standard Deviation|3.4|3.4|||
4220872|NCT00705679|4044350|B1|||Episodes of vaginal intercourse in the past 7 days||episodes|Mean|2.5|2.5|Standard Deviation|2.8|2.8|||
4220873|NCT00705679|4044345|B6|No response||At least 2 male sex partners in the past 3 months|Includes primary partner and at least 1 other male partner with which the participant has had vaginal sex in the past 3 months|participants|Number|56|56.0||||||
4220874|NCT00705679|4044346|B5|No response||At least 2 male sex partners in the past 3 months|Includes primary partner and at least 1 other male partner with which the participant has had vaginal sex in the past 3 months|participants|Number|11|11.0||||||
4220875|NCT00705679|4044347|B4|No response||At least 2 male sex partners in the past 3 months|Includes primary partner and at least 1 other male partner with which the participant has had vaginal sex in the past 3 months|participants|Number|11|11.0||||||
4220876|NCT00705679|4044348|B3|No response||At least 2 male sex partners in the past 3 months|Includes primary partner and at least 1 other male partner with which the participant has had vaginal sex in the past 3 months|participants|Number|11|11.0||||||
4220877|NCT00705679|4044349|B2|No response||At least 2 male sex partners in the past 3 months|Includes primary partner and at least 1 other male partner with which the participant has had vaginal sex in the past 3 months|participants|Number|13|13.0||||||
4220878|NCT00705679|4044350|B1|No response||At least 2 male sex partners in the past 3 months|Includes primary partner and at least 1 other male partner with which the participant has had vaginal sex in the past 3 months|participants|Number|10|10.0||||||
4220879|NCT00705679|4044345|B6|No||At least 2 male sex partners in the past 3 months|Includes primary partner and at least 1 other male partner with which the participant has had vaginal sex in the past 3 months|participants|Number|3869|3869.0||||||
4220880|NCT00705679|4044346|B5|No||At least 2 male sex partners in the past 3 months|Includes primary partner and at least 1 other male partner with which the participant has had vaginal sex in the past 3 months|participants|Number|793|793.0||||||
4220881|NCT00705679|4044347|B4|No||At least 2 male sex partners in the past 3 months|Includes primary partner and at least 1 other male partner with which the participant has had vaginal sex in the past 3 months|participants|Number|779|779.0||||||
4220882|NCT00705679|4044348|B3|No||At least 2 male sex partners in the past 3 months|Includes primary partner and at least 1 other male partner with which the participant has had vaginal sex in the past 3 months|participants|Number|754|754.0||||||
4220883|NCT00705679|4044349|B2|No||At least 2 male sex partners in the past 3 months|Includes primary partner and at least 1 other male partner with which the participant has had vaginal sex in the past 3 months|participants|Number|782|782.0||||||
4220884|NCT00705679|4044350|B1|No||At least 2 male sex partners in the past 3 months|Includes primary partner and at least 1 other male partner with which the participant has had vaginal sex in the past 3 months|participants|Number|761|761.0||||||
4220928|NCT00705679|4044346|B5|Missing||Some secondary school education or higher|Response to question: What is your highest level of education?|participants|Number|1|1.0||||||
4220885|NCT00705679|4044345|B6|Yes||At least 2 male sex partners in the past 3 months|Includes primary partner and at least 1 other male partner with which the participant has had vaginal sex in the past 3 months|participants|Number|1104|1104.0||||||
4220886|NCT00705679|4044346|B5|Yes||At least 2 male sex partners in the past 3 months|Includes primary partner and at least 1 other male partner with which the participant has had vaginal sex in the past 3 months|participants|Number|199|199.0||||||
4220887|NCT00705679|4044347|B4|Yes||At least 2 male sex partners in the past 3 months|Includes primary partner and at least 1 other male partner with which the participant has had vaginal sex in the past 3 months|participants|Number|217|217.0||||||
4220888|NCT00705679|4044348|B3|Yes||At least 2 male sex partners in the past 3 months|Includes primary partner and at least 1 other male partner with which the participant has had vaginal sex in the past 3 months|participants|Number|244|244.0||||||
4220889|NCT00705679|4044349|B2|Yes||At least 2 male sex partners in the past 3 months|Includes primary partner and at least 1 other male partner with which the participant has had vaginal sex in the past 3 months|participants|Number|208|208.0||||||
4220890|NCT00705679|4044350|B1|Yes||At least 2 male sex partners in the past 3 months|Includes primary partner and at least 1 other male partner with which the participant has had vaginal sex in the past 3 months|participants|Number|236|236.0||||||
4220891|NCT00705679|4044345|B6|No||Currently married|Response to question: Are you currently married?|participants|Number|3977|3977.0||||||
4220892|NCT00705679|4044346|B5|No||Currently married|Response to question: Are you currently married?|participants|Number|788|788.0||||||
4220893|NCT00705679|4044347|B4|No||Currently married|Response to question: Are you currently married?|participants|Number|797|797.0||||||
4220894|NCT00705679|4044348|B3|No||Currently married|Response to question: Are you currently married?|participants|Number|798|798.0||||||
4220895|NCT00705679|4044349|B2|No||Currently married|Response to question: Are you currently married?|participants|Number|794|794.0||||||
4220896|NCT00705679|4044350|B1|No||Currently married|Response to question: Are you currently married?|participants|Number|800|800.0||||||
4220897|NCT00705679|4044345|B6|Yes||Currently married|Response to question: Are you currently married?|participants|Number|1052|1052.0||||||
4220898|NCT00705679|4044346|B5|Yes||Currently married|Response to question: Are you currently married?|participants|Number|215|215.0||||||
4220899|NCT00705679|4044347|B4|Yes||Currently married|Response to question: Are you currently married?|participants|Number|210|210.0||||||
4220900|NCT00705679|4044348|B3|Yes||Currently married|Response to question: Are you currently married?|participants|Number|211|211.0||||||
4220901|NCT00705679|4044349|B2|Yes||Currently married|Response to question: Are you currently married?|participants|Number|209|209.0||||||
4220902|NCT00705679|4044350|B1|Yes||Currently married|Response to question: Are you currently married?|participants|Number|207|207.0||||||
4220903|NCT00705679|4044345|B6|||Live births|Response to question: How many children have you given birth to who were alive at birth?|children|Mean|1.5|1.5|Standard Deviation|1.1|1.1|||
4220904|NCT00705679|4044346|B5|||Live births|Response to question: How many children have you given birth to who were alive at birth?|children|Mean|1.5|1.5|Standard Deviation|1.2|1.2|||
4220905|NCT00705679|4044347|B4|||Live births|Response to question: How many children have you given birth to who were alive at birth?|children|Mean|1.5|1.5|Standard Deviation|1.1|1.1|||
4220906|NCT00705679|4044348|B3|||Live births|Response to question: How many children have you given birth to who were alive at birth?|children|Mean|1.5|1.5|Standard Deviation|1.2|1.2|||
4220907|NCT00705679|4044349|B2|||Live births|Response to question: How many children have you given birth to who were alive at birth?|children|Mean|1.5|1.5|Standard Deviation|1.1|1.1|||
4220908|NCT00705679|4044350|B1|||Live births|Response to question: How many children have you given birth to who were alive at birth?|children|Mean|1.6|1.6|Standard Deviation|1.1|1.1|||
4220909|NCT00705679|4044345|B6|Missing||Earns own income|Response to question: Do you earn an income of your own?|participants|Number|1|1.0||||||
4220910|NCT00705679|4044346|B5|Missing||Earns own income|Response to question: Do you earn an income of your own?|participants|Number|1|1.0||||||
4220911|NCT00705679|4044347|B4|Missing||Earns own income|Response to question: Do you earn an income of your own?|participants|Number|0|0.0||||||
4220912|NCT00705679|4044348|B3|Missing||Earns own income|Response to question: Do you earn an income of your own?|participants|Number|0|0.0||||||
4220913|NCT00705679|4044349|B2|Missing||Earns own income|Response to question: Do you earn an income of your own?|participants|Number|0|0.0||||||
4220914|NCT00705679|4044350|B1|Missing||Earns own income|Response to question: Do you earn an income of your own?|participants|Number|0|0.0||||||
4220915|NCT00705679|4044345|B6|No||Earns own income|Response to question: Do you earn an income of your own?|participants|Number|2147|2147.0||||||
4220916|NCT00705679|4044346|B5|No||Earns own income|Response to question: Do you earn an income of your own?|participants|Number|432|432.0||||||
4220917|NCT00705679|4044347|B4|No||Earns own income|Response to question: Do you earn an income of your own?|participants|Number|420|420.0||||||
4220918|NCT00705679|4044348|B3|No||Earns own income|Response to question: Do you earn an income of your own?|participants|Number|423|423.0||||||
4220919|NCT00705679|4044349|B2|No||Earns own income|Response to question: Do you earn an income of your own?|participants|Number|434|434.0||||||
4220920|NCT00705679|4044350|B1|No||Earns own income|Response to question: Do you earn an income of your own?|participants|Number|438|438.0||||||
4220921|NCT00705679|4044345|B6|Yes||Earns own income|Response to question: Do you earn an income of your own?|participants|Number|2881|2881.0||||||
4220922|NCT00705679|4044346|B5|Yes||Earns own income|Response to question: Do you earn an income of your own?|participants|Number|570|570.0||||||
4220923|NCT00705679|4044347|B4|Yes||Earns own income|Response to question: Do you earn an income of your own?|participants|Number|587|587.0||||||
4220924|NCT00705679|4044348|B3|Yes||Earns own income|Response to question: Do you earn an income of your own?|participants|Number|586|586.0||||||
4220925|NCT00705679|4044349|B2|Yes||Earns own income|Response to question: Do you earn an income of your own?|participants|Number|569|569.0||||||
4220926|NCT00705679|4044350|B1|Yes||Earns own income|Response to question: Do you earn an income of your own?|participants|Number|569|569.0||||||
4220929|NCT00705679|4044347|B4|Missing||Some secondary school education or higher|Response to question: What is your highest level of education?|participants|Number|2|2.0||||||
4220930|NCT00705679|4044348|B3|Missing||Some secondary school education or higher|Response to question: What is your highest level of education?|participants|Number|0|0.0||||||
4220931|NCT00705679|4044349|B2|Missing||Some secondary school education or higher|Response to question: What is your highest level of education?|participants|Number|0|0.0||||||
4220932|NCT00705679|4044350|B1|Missing||Some secondary school education or higher|Response to question: What is your highest level of education?|participants|Number|1|1.0||||||
4220933|NCT00705679|4044345|B6|Complete primary school education or lower||Some secondary school education or higher|Response to question: What is your highest level of education?|participants|Number|403|403.0||||||
4220934|NCT00705679|4044346|B5|Complete primary school education or lower||Some secondary school education or higher|Response to question: What is your highest level of education?|participants|Number|79|79.0||||||
4220935|NCT00705679|4044347|B4|Complete primary school education or lower||Some secondary school education or higher|Response to question: What is your highest level of education?|participants|Number|85|85.0||||||
4220936|NCT00705679|4044348|B3|Complete primary school education or lower||Some secondary school education or higher|Response to question: What is your highest level of education?|participants|Number|83|83.0||||||
4220937|NCT00705679|4044349|B2|Complete primary school education or lower||Some secondary school education or higher|Response to question: What is your highest level of education?|participants|Number|74|74.0||||||
4220938|NCT00705679|4044350|B1|Complete primary school education or lower||Some secondary school education or higher|Response to question: What is your highest level of education?|participants|Number|82|82.0||||||
4220939|NCT00705679|4044345|B6|Some secondary school education or higher||Some secondary school education or higher|Response to question: What is your highest level of education?|participants|Number|4622|4622.0||||||
4220940|NCT00705679|4044346|B5|Some secondary school education or higher||Some secondary school education or higher|Response to question: What is your highest level of education?|participants|Number|923|923.0||||||
4220941|NCT00705679|4044347|B4|Some secondary school education or higher||Some secondary school education or higher|Response to question: What is your highest level of education?|participants|Number|920|920.0||||||
4220942|NCT00705679|4044348|B3|Some secondary school education or higher||Some secondary school education or higher|Response to question: What is your highest level of education?|participants|Number|926|926.0||||||
4220943|NCT00705679|4044349|B2|Some secondary school education or higher||Some secondary school education or higher|Response to question: What is your highest level of education?|participants|Number|929|929.0||||||
4220944|NCT00705679|4044350|B1|Some secondary school education or higher||Some secondary school education or higher|Response to question: What is your highest level of education?|participants|Number|924|924.0||||||
4220945|NCT00705679|4044345|B6|Zimbabwe||Region of Enrollment|Country at time of enrollment|participants|Number|630|630.0||||||
4220946|NCT00705679|4044346|B5|Zimbabwe||Region of Enrollment|Country at time of enrollment|participants|Number|123|123.0||||||
4220947|NCT00705679|4044347|B4|Zimbabwe||Region of Enrollment|Country at time of enrollment|participants|Number|124|124.0||||||
4220948|NCT00705679|4044348|B3|Zimbabwe||Region of Enrollment|Country at time of enrollment|participants|Number|129|129.0||||||
4220949|NCT00705679|4044349|B2|Zimbabwe||Region of Enrollment|Country at time of enrollment|participants|Number|127|127.0||||||
4220950|NCT00705679|4044350|B1|Zimbabwe||Region of Enrollment|Country at time of enrollment|participants|Number|127|127.0||||||
4220951|NCT00705679|4044345|B6|Uganda||Region of Enrollment|Country at time of enrollment|participants|Number|322|322.0||||||
4220952|NCT00705679|4044346|B5|Uganda||Region of Enrollment|Country at time of enrollment|participants|Number|64|64.0||||||
4220953|NCT00705679|4044347|B4|Uganda||Region of Enrollment|Country at time of enrollment|participants|Number|65|65.0||||||
4220954|NCT00705679|4044348|B3|Uganda||Region of Enrollment|Country at time of enrollment|participants|Number|65|65.0||||||
4220955|NCT00705679|4044349|B2|Uganda||Region of Enrollment|Country at time of enrollment|participants|Number|64|64.0||||||
4220956|NCT00705679|4044350|B1|Uganda||Region of Enrollment|Country at time of enrollment|participants|Number|64|64.0||||||
4220957|NCT00705679|4044345|B6|South Africa||Region of Enrollment|Country at time of enrollment|participants|Number|4077|4077.0||||||
4220958|NCT00705679|4044346|B5|South Africa||Region of Enrollment|Country at time of enrollment|participants|Number|816|816.0||||||
4220959|NCT00705679|4044347|B4|South Africa||Region of Enrollment|Country at time of enrollment|participants|Number|818|818.0||||||
4220960|NCT00705679|4044348|B3|South Africa||Region of Enrollment|Country at time of enrollment|participants|Number|815|815.0||||||
4220961|NCT00705679|4044349|B2|South Africa||Region of Enrollment|Country at time of enrollment|participants|Number|812|812.0||||||
4220962|NCT00705679|4044350|B1|South Africa||Region of Enrollment|Country at time of enrollment|participants|Number|816|816.0||||||
4220963|NCT00705679|4044345|B6|Other||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|120|120.0||||||
4220964|NCT00705679|4044346|B5|Other||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|25|25.0||||||
4220965|NCT00705679|4044347|B4|Other||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|24|24.0||||||
4220966|NCT00705679|4044348|B3|Other||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|30|30.0||||||
4220967|NCT00705679|4044349|B2|Other||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|24|24.0||||||
4220968|NCT00705679|4044350|B1|Other||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|17|17.0||||||
4220969|NCT00705679|4044345|B6|Ndebele||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|106|106.0||||||
4220970|NCT00705679|4044346|B5|Ndebele||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|22|22.0||||||
4221162|NCT00705536|4044464|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4220971|NCT00705679|4044347|B4|Ndebele||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|25|25.0||||||
4220972|NCT00705679|4044348|B3|Ndebele||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|18|18.0||||||
4220973|NCT00705679|4044349|B2|Ndebele||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|27|27.0||||||
4220974|NCT00705679|4044350|B1|Ndebele||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|14|14.0||||||
4220975|NCT00705679|4044345|B6|Shona||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|570|570.0||||||
4220976|NCT00705679|4044346|B5|Shona||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|117|117.0||||||
4220977|NCT00705679|4044347|B4|Shona||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|111|111.0||||||
4220978|NCT00705679|4044348|B3|Shona||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|111|111.0||||||
4220979|NCT00705679|4044349|B2|Shona||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|108|108.0||||||
4220980|NCT00705679|4044350|B1|Shona||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|123|123.0||||||
4220981|NCT00705679|4044345|B6|Lozi||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|0|0.0||||||
4220982|NCT00705679|4044346|B5|Lozi||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|0|0.0||||||
4220983|NCT00705679|4044347|B4|Lozi||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|0|0.0||||||
4220984|NCT00705679|4044348|B3|Lozi||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|0|0.0||||||
4220985|NCT00705679|4044349|B2|Lozi||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|0|0.0||||||
4220986|NCT00705679|4044350|B1|Lozi||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|0|0.0||||||
4220987|NCT00705679|4044345|B6|Tonga||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|0|0.0||||||
4220988|NCT00705679|4044346|B5|Tonga||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|0|0.0||||||
4220989|NCT00705679|4044347|B4|Tonga||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|0|0.0||||||
4220990|NCT00705679|4044348|B3|Tonga||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|0|0.0||||||
4220991|NCT00705679|4044349|B2|Tonga||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|0|0.0||||||
4220992|NCT00705679|4044350|B1|Tonga||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|0|0.0||||||
4220993|NCT00705679|4044345|B6|Chewa||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|2|2.0||||||
4220994|NCT00705679|4044346|B5|Chewa||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|0|0.0||||||
4220995|NCT00705679|4044347|B4|Chewa||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|0|0.0||||||
4220996|NCT00705679|4044348|B3|Chewa||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|0|0.0||||||
4220997|NCT00705679|4044349|B2|Chewa||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|1|1.0||||||
4220998|NCT00705679|4044350|B1|Chewa||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|1|1.0||||||
4220999|NCT00705679|4044345|B6|Bemba||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|0|0.0||||||
4221000|NCT00705679|4044346|B5|Bemba||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|0|0.0||||||
4221001|NCT00705679|4044347|B4|Bemba||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|0|0.0||||||
4221002|NCT00705679|4044348|B3|Bemba||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|0|0.0||||||
4221003|NCT00705679|4044349|B2|Bemba||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|0|0.0||||||
4221004|NCT00705679|4044350|B1|Bemba||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|0|0.0||||||
4221005|NCT00705679|4044345|B6|Black||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|322|322.0||||||
4221006|NCT00705679|4044346|B5|Black||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|64|64.0||||||
4221007|NCT00705679|4044347|B4|Black||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|65|65.0||||||
4221008|NCT00705679|4044348|B3|Black||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|65|65.0||||||
4221009|NCT00705679|4044349|B2|Black||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|64|64.0||||||
4221010|NCT00705679|4044350|B1|Black||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|64|64.0||||||
4221011|NCT00705679|4044345|B6|Colored||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|11|11.0||||||
4221012|NCT00705679|4044346|B5|Colored||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|1|1.0||||||
4221013|NCT00705679|4044347|B4|Colored||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|4|4.0||||||
4221014|NCT00705679|4044348|B3|Colored||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|3|3.0||||||
4221015|NCT00705679|4044349|B2|Colored||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|3|3.0||||||
4221016|NCT00705679|4044350|B1|Colored||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|0|0.0||||||
4221017|NCT00705679|4044345|B6|Indian||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|115|115.0||||||
4221018|NCT00705679|4044346|B5|Indian||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|22|22.0||||||
4221019|NCT00705679|4044347|B4|Indian||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|22|22.0||||||
4221020|NCT00705679|4044348|B3|Indian||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|22|22.0||||||
4221021|NCT00705679|4044349|B2|Indian||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|28|28.0||||||
4221022|NCT00705679|4044350|B1|Indian||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|21|21.0||||||
4221023|NCT00705679|4044345|B6|Xhosa||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|398|398.0||||||
4221024|NCT00705679|4044346|B5|Xhosa||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|92|92.0||||||
4221025|NCT00705679|4044347|B4|Xhosa||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|72|72.0||||||
4221026|NCT00705679|4044348|B3|Xhosa||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|74|74.0||||||
4221027|NCT00705679|4044349|B2|Xhosa||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|75|75.0||||||
4221028|NCT00705679|4044350|B1|Xhosa||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|85|85.0||||||
4221029|NCT00705679|4044345|B6|Zulu||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|2939|2939.0||||||
4221030|NCT00705679|4044346|B5|Zulu||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|571|571.0||||||
4221031|NCT00705679|4044347|B4|Zulu||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|585|585.0||||||
4221032|NCT00705679|4044348|B3|Zulu||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|595|595.0||||||
4221033|NCT00705679|4044349|B2|Zulu||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|587|587.0||||||
4221034|NCT00705679|4044350|B1|Zulu||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|601|601.0||||||
4221035|NCT00705679|4044345|B6|White||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|0|0.0||||||
4221036|NCT00705679|4044346|B5|White||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|0|0.0||||||
4221037|NCT00705679|4044347|B4|White||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|0|0.0||||||
4221038|NCT00705679|4044348|B3|White||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|0|0.0||||||
4221039|NCT00705679|4044349|B2|White||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|0|0.0||||||
4221040|NCT00705679|4044350|B1|White||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|0|0.0||||||
4221041|NCT00705679|4044345|B6|Other African tribe||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|410|410.0||||||
4221042|NCT00705679|4044346|B5|Other African tribe||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|84|84.0||||||
4221043|NCT00705679|4044347|B4|Other African tribe||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|92|92.0||||||
4221044|NCT00705679|4044348|B3|Other African tribe||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|83|83.0||||||
4221045|NCT00705679|4044349|B2|Other African tribe||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|75|75.0||||||
4221046|NCT00705679|4044350|B1|Other African tribe||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|76|76.0||||||
4221047|NCT00705679|4044345|B6|Tumbuka||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|3|3.0||||||
4221048|NCT00705679|4044346|B5|Tumbuka||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|1|1.0||||||
4221049|NCT00705679|4044347|B4|Tumbuka||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|0|0.0||||||
4221050|NCT00705679|4044348|B3|Tumbuka||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|1|1.0||||||
4221051|NCT00705679|4044349|B2|Tumbuka||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|1|1.0||||||
4221052|NCT00705679|4044350|B1|Tumbuka||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|0|0.0||||||
4221053|NCT00705679|4044345|B6|Yao||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|2|2.0||||||
4221054|NCT00705679|4044346|B5|Yao||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|1|1.0||||||
4221055|NCT00705679|4044347|B4|Yao||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|0|0.0||||||
4221056|NCT00705679|4044348|B3|Yao||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|0|0.0||||||
4221057|NCT00705679|4044349|B2|Yao||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|0|0.0||||||
4221058|NCT00705679|4044350|B1|Yao||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|1|1.0||||||
4221059|NCT00705679|4044345|B6|Lombwe||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|1|1.0||||||
4221060|NCT00705679|4044346|B5|Lombwe||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|1|1.0||||||
4221061|NCT00705679|4044347|B4|Lombwe||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|0|0.0||||||
4221062|NCT00705679|4044348|B3|Lombwe||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|0|0.0||||||
4221063|NCT00705679|4044349|B2|Lombwe||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|0|0.0||||||
4221064|NCT00705679|4044350|B1|Lombwe||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|0|0.0||||||
4221065|NCT00705679|4044345|B6|Chichewa||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|30|30.0||||||
4221066|NCT00705679|4044346|B5|Chichewa||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|2|2.0||||||
4221067|NCT00705679|4044347|B4|Chichewa||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|7|7.0||||||
4221068|NCT00705679|4044348|B3|Chichewa||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|7|7.0||||||
4221069|NCT00705679|4044349|B2|Chichewa||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|10|10.0||||||
4221070|NCT00705679|4044350|B1|Chichewa||Race/Ethnicity, Customized|Response to the question: What is your ethnic group or tribe?|participants|Number|4|4.0||||||
4221071|NCT00705679|4044345|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4221072|NCT00705679|4044346|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4221073|NCT00705679|4044347|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4221074|NCT00705679|4044348|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4221075|NCT00705679|4044349|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4221076|NCT00705679|4044350|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4221077|NCT00705679|4044345|B6||Female|Sex: Female, Male||Participants|Count of Participants|5029|5029.0||||||
4221078|NCT00705679|4044346|B5||Female|Sex: Female, Male||Participants|Count of Participants|1003|1003.0||||||
4221079|NCT00705679|4044347|B4||Female|Sex: Female, Male||Participants|Count of Participants|1007|1007.0||||||
4221080|NCT00705679|4044348|B3||Female|Sex: Female, Male||Participants|Count of Participants|1009|1009.0||||||
4221081|NCT00705679|4044349|B2||Female|Sex: Female, Male||Participants|Count of Participants|1003|1003.0||||||
4221082|NCT00705679|4044350|B1||Female|Sex: Female, Male||Participants|Count of Participants|1007|1007.0||||||
4221083|NCT00705679|4044345|B6|||Age||years|Mean|25.3|25.3|Standard Deviation|5.2|5.2|||
4221084|NCT00705679|4044346|B5|||Age||years|Mean|25.3|25.3|Standard Deviation|5.1|5.1|||
4221085|NCT00705679|4044347|B4|||Age||years|Mean|25.3|25.3|Standard Deviation|5.2|5.2|||
4221086|NCT00705679|4044348|B3|||Age||years|Mean|25.3|25.3|Standard Deviation|5.2|5.2|||
4221087|NCT00705679|4044349|B2|||Age||years|Mean|25.2|25.2|Standard Deviation|5.2|5.2|||
4221088|NCT00705679|4044350|B1|||Age||years|Mean|25.5|25.5|Standard Deviation|5.1|5.1|||
4221089|NCT00705666|4044389|B1|France||Region of Enrollment||participants|Number|789|789.0||||||
4221090|NCT00705666|4044389|B1|Unavailable||Sex/Gender, Customized|Gender is provided for the patients that were included in the analysis (781); gender is unknown for the eight (8) participants that were not included in the analysis.|participants|Number|8|8.0||||||
4221091|NCT00705666|4044389|B1|Male||Sex/Gender, Customized|Gender is provided for the patients that were included in the analysis (781); gender is unknown for the eight (8) participants that were not included in the analysis.|participants|Number|485|485.0||||||
4221092|NCT00705666|4044389|B1|Female||Sex/Gender, Customized|Gender is provided for the patients that were included in the analysis (781); gender is unknown for the eight (8) participants that were not included in the analysis.|participants|Number|296|296.0||||||
4221093|NCT00705666|4044389|B1|||Age, Customized||years|Mean|49|49.0|Standard Deviation|12.1|12.1|||
4221094|NCT00705653|4044393|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4221095|NCT00705653|4044393|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4221096|NCT00705653|4044393|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4221097|NCT00705653|4044393|B1|||Age||years|Mean|61.2|61.2|Standard Deviation|11.0|11.0|||
4221098|NCT00705653|4044393|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4221099|NCT00705653|4044393|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4221100|NCT00705653|4044393|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4221101|NCT00705614|4044398|B3|Male (Switched to Remicade)||Sex/Gender, Customized||Participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4221102|NCT00705614|4044399|B2|Male (Switched to Remicade)||Sex/Gender, Customized||Participants|Number|107|107.0||||||
4221103|NCT00705614|4044400|B1|Male (Switched to Remicade)||Sex/Gender, Customized||Participants|Number|NA|||||||Not available (N/A) because there are no participants in this group.
4221104|NCT00705614|4044398|B3|Female (Switched to Remicade)||Sex/Gender, Customized||Participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4221105|NCT00705614|4044399|B2|Female (Switched to Remicade)||Sex/Gender, Customized||Participants|Number|191|191.0||||||
4221163|NCT00705536|4044465|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4221106|NCT00705614|4044400|B1|Female (Switched to Remicade)||Sex/Gender, Customized||Participants|Number|NA|||||||Not available (N/A) because there are no participants in this group.
4221107|NCT00705614|4044398|B3|Male (All Participants)||Sex/Gender, Customized||Participants|Number|1050|1050.0||||||
4221108|NCT00705614|4044399|B2|Male (All Participants)||Sex/Gender, Customized||Participants|Number|444|444.0||||||
4221109|NCT00705614|4044400|B1|Male (All Participants)||Sex/Gender, Customized||Participants|Number|606|606.0||||||
4221110|NCT00705614|4044398|B3|Female (All Participants)||Sex/Gender, Customized||Participants|Number|1612|1612.0||||||
4221111|NCT00705614|4044399|B2|Female (All Participants)||Sex/Gender, Customized||Participants|Number|677|677.0||||||
4221112|NCT00705614|4044400|B1|Female (All Participants)||Sex/Gender, Customized||Participants|Number|935|935.0||||||
4221113|NCT00705614|4044398|B3|Switched to Remicade||Age||Years|Mean|36.7|36.7|Standard Deviation|12.3|12.3|||
4221114|NCT00705614|4044399|B2|Switched to Remicade||Age||Years|Mean|36.7|36.7|Standard Deviation|12.3|12.3|||
4221115|NCT00705614|4044400|B1|Switched to Remicade||Age||Years|Mean|NA||Standard Deviation|NA||||Not available (N/A) because there are no participants in this group.
4221116|NCT00705614|4044398|B3|All Participants||Age||Years|Mean|36.7|36.7|Standard Deviation|12.90|12.9|||
4221117|NCT00705614|4044399|B2|All Participants||Age||Years|Mean|37.5|37.5|Standard Deviation|12.86|12.86|||
4221118|NCT00705614|4044400|B1|All Participants||Age||Years|Mean|36.1|36.1|Standard Deviation|12.90|12.9|||
4221119|NCT00705575|4044448|B3||Male|Sex: Female, Male||Participants|Count of Participants|347|347.0||||||
4221120|NCT00705575|4044449|B2||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4221121|NCT00705575|4044450|B1||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4221122|NCT00705575|4044448|B3||Female|Sex: Female, Male||Participants|Count of Participants|341|341.0||||||
4221123|NCT00705575|4044449|B2||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4221124|NCT00705575|4044450|B1||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4221125|NCT00705575|4044448|B3|||Age||years|Mean|56.9|56.9|Standard Deviation|10.53|10.53|||
4221126|NCT00705575|4044449|B2|||Age||years|Mean|56.4|56.4|Standard Deviation|10.73|10.73|||
4221127|NCT00705575|4044450|B1|||Age||years|Mean|57.4|57.4|Standard Deviation|10.33|10.33|||
4221128|NCT00705536|4044463|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4221129|NCT00705536|4044464|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4221130|NCT00705536|4044465|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4221131|NCT00705536|4044463|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221132|NCT00705536|4044464|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221133|NCT00705536|4044465|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221134|NCT00705536|4044463|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221135|NCT00705536|4044464|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221136|NCT00705536|4044465|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221137|NCT00705536|4044463|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4221138|NCT00705536|4044464|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4221139|NCT00705536|4044465|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4221140|NCT00705536|4044463|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4221141|NCT00705536|4044464|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4221142|NCT00705536|4044465|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4221143|NCT00705536|4044463|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221144|NCT00705536|4044464|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221145|NCT00705536|4044465|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221146|NCT00705536|4044463|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221147|NCT00705536|4044464|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221148|NCT00705536|4044465|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221149|NCT00705536|4044463|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4221150|NCT00705536|4044464|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221151|NCT00705536|4044465|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4221152|NCT00705536|4044463|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221153|NCT00705536|4044464|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221154|NCT00705536|4044465|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221155|NCT00705536|4044463|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4221156|NCT00705536|4044464|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4221157|NCT00705536|4044465|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4221158|NCT00705536|4044463|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4221159|NCT00705536|4044464|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4221160|NCT00705536|4044465|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4221161|NCT00705536|4044463|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4221167|NCT00705536|4044463|B3|||Age||years|Mean|37.2|37.2|Standard Deviation|8.3|8.3|||
4221168|NCT00705536|4044464|B2|||Age||years|Mean|36.7|36.7|Standard Deviation|8.9|8.9|||
4221169|NCT00705536|4044465|B1|||Age||years|Mean|37.7|37.7|Standard Deviation|7.8|7.8|||
4221170|NCT00705523|4044527|B3|||Days of Alcohol Use in Past 30 Days||Drinking Days|Mean|18.0|18.0|Standard Deviation|8.95|8.95|||
4221171|NCT00705523|4044528|B2|||Days of Alcohol Use in Past 30 Days||Drinking Days|Mean|17.6|17.6|Standard Deviation|9.1|9.1|||
4221172|NCT00705523|4044529|B1|||Days of Alcohol Use in Past 30 Days||Drinking Days|Mean|18.4|18.4|Standard Deviation|8.8|8.8|||
4221173|NCT00705523|4044527|B3|||ASI Alcohol Composite Score, Baseline|The Addiction Severity Index (ASI) is a semistructured interview that measures the severity of addiction in 25 questions concerning seven problem areas: medical problems, employment problems, drug use, alcohol use, family and social problems, criminality, and psychiatric problems. We used the ASI to obtain background information and to assess the severity of participants' abuse problems.|Alcohol Composite Score|Mean|0.61|0.61|Standard Deviation|0.16|0.16|||
4221174|NCT00705523|4044528|B2|||ASI Alcohol Composite Score, Baseline|The Addiction Severity Index (ASI) is a semistructured interview that measures the severity of addiction in 25 questions concerning seven problem areas: medical problems, employment problems, drug use, alcohol use, family and social problems, criminality, and psychiatric problems. We used the ASI to obtain background information and to assess the severity of participants' abuse problems.|Alcohol Composite Score|Mean|0.60|0.6|Standard Deviation|0.15|0.15|||
4221175|NCT00705523|4044529|B1|||ASI Alcohol Composite Score, Baseline|The Addiction Severity Index (ASI) is a semistructured interview that measures the severity of addiction in 25 questions concerning seven problem areas: medical problems, employment problems, drug use, alcohol use, family and social problems, criminality, and psychiatric problems. We used the ASI to obtain background information and to assess the severity of participants' abuse problems.|Alcohol Composite Score|Mean|0.61|0.61|Standard Deviation|0.16|0.16|||
4221176|NCT00705523|4044527|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4221177|NCT00705523|4044528|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4221178|NCT00705523|4044529|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4221179|NCT00705523|4044527|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4221180|NCT00705523|4044528|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4221181|NCT00705523|4044529|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4221182|NCT00705523|4044527|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4221183|NCT00705523|4044528|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4221184|NCT00705523|4044529|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4221185|NCT00705523|4044527|B3|||Age||years|Mean|46.5|46.5|Standard Deviation|11.7|11.7|||
4221186|NCT00705523|4044528|B2|||Age||years|Mean|48.1|48.1|Standard Deviation|10.5|10.5|||
4221187|NCT00705523|4044529|B1|||Age||years|Mean|44.8|44.8|Standard Deviation|12.3|12.3|||
4221188|NCT00705523|4044527|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4221189|NCT00705523|4044528|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4221190|NCT00705523|4044529|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4221191|NCT00705523|4044527|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4221192|NCT00705523|4044528|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4221193|NCT00705523|4044529|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4221194|NCT00705523|4044527|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4221195|NCT00705523|4044528|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4221196|NCT00705523|4044529|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4221197|NCT00705484|4044538|B3||Male|Sex: Female, Male||Participants|Count of Participants|1234|1234.0||||||
4221198|NCT00705484|4044539|B2||Male|Sex: Female, Male||Participants|Count of Participants|639|639.0||||||
4221199|NCT00705484|4044540|B1||Male|Sex: Female, Male||Participants|Count of Participants|595|595.0||||||
4221200|NCT00705484|4044538|B3||Female|Sex: Female, Male||Participants|Count of Participants|1005|1005.0||||||
4221201|NCT00705484|4044539|B2||Female|Sex: Female, Male||Participants|Count of Participants|541|541.0||||||
4221202|NCT00705484|4044540|B1||Female|Sex: Female, Male||Participants|Count of Participants|464|464.0||||||
4221203|NCT00705484|4044538|B3|||Age||Years|Mean|41.2|41.2|Standard Deviation|14.91|14.91|||
4221204|NCT00705484|4044539|B2|||Age||Years|Mean|42.0|42.0|Standard Deviation|15.44|15.44|||
4221205|NCT00705484|4044540|B1|||Age||Years|Mean|40.3|40.3|Standard Deviation|14.24|14.24|||
4221206|NCT00705432|4044549|B7||Male|Sex: Female, Male||Participants|Count of Participants|656|656.0||||||
4221207|NCT00705432|4044550|B6||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4221208|NCT00705432|4044551|B5||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4221209|NCT00705432|4044552|B4||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4221210|NCT00705432|4044553|B3||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4221211|NCT00705432|4044554|B2||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4221212|NCT00705432|4044555|B1||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4221213|NCT00705432|4044549|B7||Female|Sex: Female, Male||Participants|Count of Participants|441|441.0||||||
4221214|NCT00705432|4044550|B6||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4221215|NCT00705432|4044551|B5||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4221216|NCT00705432|4044552|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4221217|NCT00705432|4044553|B3||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4221218|NCT00705432|4044554|B2||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4221219|NCT00705432|4044555|B1||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4221220|NCT00705432|4044549|B7|>=65 years||Age, Customized||participants|Number|34|34.0||||||
4221221|NCT00705432|4044550|B6|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4221222|NCT00705432|4044551|B5|>=65 years||Age, Customized||participants|Number|2|2.0||||||
4221223|NCT00705432|4044552|B4|>=65 years||Age, Customized||participants|Number|1|1.0||||||
4221224|NCT00705432|4044553|B3|>=65 years||Age, Customized||participants|Number|7|7.0||||||
4221225|NCT00705432|4044554|B2|>=65 years||Age, Customized||participants|Number|10|10.0||||||
4221226|NCT00705432|4044555|B1|>=65 years||Age, Customized||participants|Number|14|14.0||||||
4221227|NCT00705432|4044549|B7|>= 40 and <65 years||Age, Customized||participants|Number|905|905.0||||||
4221228|NCT00705432|4044550|B6|>= 40 and <65 years||Age, Customized||participants|Number|51|51.0||||||
4221229|NCT00705432|4044551|B5|>= 40 and <65 years||Age, Customized||participants|Number|47|47.0||||||
4221230|NCT00705432|4044552|B4|>= 40 and <65 years||Age, Customized||participants|Number|45|45.0||||||
4221231|NCT00705432|4044553|B3|>= 40 and <65 years||Age, Customized||participants|Number|255|255.0||||||
4221232|NCT00705432|4044554|B2|>= 40 and <65 years||Age, Customized||participants|Number|261|261.0||||||
4221233|NCT00705432|4044555|B1|>= 40 and <65 years||Age, Customized||participants|Number|246|246.0||||||
4221234|NCT00705432|4044549|B7|<40 years||Age, Customized||participants|Number|158|158.0||||||
4221235|NCT00705432|4044550|B6|<40 years||Age, Customized||participants|Number|4|4.0||||||
4221236|NCT00705432|4044551|B5|<40 years||Age, Customized||participants|Number|3|3.0||||||
4221237|NCT00705432|4044552|B4|<40 years||Age, Customized||participants|Number|6|6.0||||||
4221238|NCT00705432|4044553|B3|<40 years||Age, Customized||participants|Number|49|49.0||||||
4221239|NCT00705432|4044554|B2|<40 years||Age, Customized||participants|Number|45|45.0||||||
4221240|NCT00705432|4044555|B1|<40 years||Age, Customized||participants|Number|51|51.0||||||
4221241|NCT00705406|4044595|B3|Nonsmoker||Current Smoking Behavior||participants|Number|331|331.0||||||
4221242|NCT00705406|4044596|B2|Nonsmoker||Current Smoking Behavior||participants|Number|165|165.0||||||
4221243|NCT00705406|4044597|B1|Nonsmoker||Current Smoking Behavior||participants|Number|166|166.0||||||
4221244|NCT00705406|4044595|B3|Smoker||Current Smoking Behavior||participants|Number|74|74.0||||||
4221245|NCT00705406|4044596|B2|Smoker||Current Smoking Behavior||participants|Number|37|37.0||||||
4221246|NCT00705406|4044597|B1|Smoker||Current Smoking Behavior||participants|Number|37|37.0||||||
4221247|NCT00705406|4044595|B3|No Result/Sample||Confirmed Influenza Infection Result||participants|Number|3|3.0||||||
4221248|NCT00705406|4044596|B2|No Result/Sample||Confirmed Influenza Infection Result||participants|Number|2|2.0||||||
4221249|NCT00705406|4044597|B1|No Result/Sample||Confirmed Influenza Infection Result||participants|Number|1|1.0||||||
4221250|NCT00705406|4044595|B3|Negative by PCR and Viral Culture||Confirmed Influenza Infection Result||participants|Number|68|68.0||||||
4221251|NCT00705406|4044596|B2|Negative by PCR and Viral Culture||Confirmed Influenza Infection Result||participants|Number|40|40.0||||||
4221252|NCT00705406|4044597|B1|Negative by PCR and Viral Culture||Confirmed Influenza Infection Result||participants|Number|28|28.0||||||
4221253|NCT00705406|4044595|B3|Positive by PCR and Viral Culture||Confirmed Influenza Infection Result||participants|Number|269|269.0||||||
4221254|NCT00705406|4044596|B2|Positive by PCR and Viral Culture||Confirmed Influenza Infection Result||participants|Number|122|122.0||||||
4221255|NCT00705406|4044597|B1|Positive by PCR and Viral Culture||Confirmed Influenza Infection Result||participants|Number|147|147.0||||||
4221256|NCT00705406|4044595|B3|Positive by Viral Culture Only||Confirmed Influenza Infection Result||participants|Number|0|0.0||||||
4221257|NCT00705406|4044596|B2|Positive by Viral Culture Only||Confirmed Influenza Infection Result||participants|Number|0|0.0||||||
4221258|NCT00705406|4044597|B1|Positive by Viral Culture Only||Confirmed Influenza Infection Result||participants|Number|0|0.0||||||
4221259|NCT00705406|4044595|B3|Positive by PCR Only||Confirmed Influenza Infection Result||participants|Number|65|65.0||||||
4221260|NCT00705406|4044596|B2|Positive by PCR Only||Confirmed Influenza Infection Result||participants|Number|38|38.0||||||
4221261|NCT00705406|4044597|B1|Positive by PCR Only||Confirmed Influenza Infection Result||participants|Number|27|27.0||||||
4221262|NCT00705406|4044595|B3|No data reported||Rapid Antigen Test (RAT) Results|Positive influenza infection confirmed by PCR or virus culture.|participants|Number|3|3.0||||||
4221263|NCT00705406|4044596|B2|No data reported||Rapid Antigen Test (RAT) Results|Positive influenza infection confirmed by PCR or virus culture.|participants|Number|2|2.0||||||
4221264|NCT00705406|4044597|B1|No data reported||Rapid Antigen Test (RAT) Results|Positive influenza infection confirmed by PCR or virus culture.|participants|Number|1|1.0||||||
4221265|NCT00705406|4044595|B3|Positive||Rapid Antigen Test (RAT) Results|Positive influenza infection confirmed by PCR or virus culture.|participants|Number|402|402.0||||||
4221266|NCT00705406|4044596|B2|Positive||Rapid Antigen Test (RAT) Results|Positive influenza infection confirmed by PCR or virus culture.|participants|Number|200|200.0||||||
4221267|NCT00705406|4044597|B1|Positive||Rapid Antigen Test (RAT) Results|Positive influenza infection confirmed by PCR or virus culture.|participants|Number|202|202.0||||||
4221268|NCT00705406|4044595|B3|||Initial Composite Symptom Score|Initial Composite Symptom Score is defined as the sum of the 7 symptoms of influenza initially recorded by the subject in the diary (cough; sore throat; nasal congestion; myalgia [aches and pains]; headache; feverishness; and fatigue), each graded on a 4-point severity scale [0, absent; 1, mild; 2, moderate; 3, severe]); for the composite score, individual scores were summed, with a range from 0 to 21.|units on a scale|Mean|14|14.0|Standard Deviation|4.1|4.1|||
4221304|NCT00705406|4044595|B3||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
4221305|NCT00705406|4044596|B2||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4221306|NCT00705406|4044597|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4221269|NCT00705406|4044596|B2|||Initial Composite Symptom Score|Initial Composite Symptom Score is defined as the sum of the 7 symptoms of influenza initially recorded by the subject in the diary (cough; sore throat; nasal congestion; myalgia [aches and pains]; headache; feverishness; and fatigue), each graded on a 4-point severity scale [0, absent; 1, mild; 2, moderate; 3, severe]); for the composite score, individual scores were summed, with a range from 0 to 21.|units on a scale|Mean|14|14.0|Standard Deviation|3.9|3.9|||
4221270|NCT00705406|4044597|B1|||Initial Composite Symptom Score|Initial Composite Symptom Score is defined as the sum of the 7 symptoms of influenza initially recorded by the subject in the diary (cough; sore throat; nasal congestion; myalgia [aches and pains]; headache; feverishness; and fatigue), each graded on a 4-point severity scale [0, absent; 1, mild; 2, moderate; 3, severe]); for the composite score, individual scores were summed, with a range from 0 to 21.|units on a scale|Mean|14|14.0|Standard Deviation|4.3|4.3|||
4221271|NCT00705406|4044595|B3|Data Missing||Estimated Time of Onset of Symptoms at Screening||participants|Number|1|1.0||||||
4221272|NCT00705406|4044596|B2|Data Missing||Estimated Time of Onset of Symptoms at Screening||participants|Number|1|1.0||||||
4221273|NCT00705406|4044597|B1|Data Missing||Estimated Time of Onset of Symptoms at Screening||participants|Number|0|0.0||||||
4221274|NCT00705406|4044595|B3|24-36 h Ago||Estimated Time of Onset of Symptoms at Screening||participants|Number|203|203.0||||||
4221275|NCT00705406|4044596|B2|24-36 h Ago||Estimated Time of Onset of Symptoms at Screening||participants|Number|104|104.0||||||
4221276|NCT00705406|4044597|B1|24-36 h Ago||Estimated Time of Onset of Symptoms at Screening||participants|Number|99|99.0||||||
4221277|NCT00705406|4044595|B3|12-24 h Ago||Estimated Time of Onset of Symptoms at Screening||participants|Number|172|172.0||||||
4221278|NCT00705406|4044596|B2|12-24 h Ago||Estimated Time of Onset of Symptoms at Screening||participants|Number|81|81.0||||||
4221279|NCT00705406|4044597|B1|12-24 h Ago||Estimated Time of Onset of Symptoms at Screening||participants|Number|91|91.0||||||
4221280|NCT00705406|4044595|B3|0-12 h Ago||Estimated Time of Onset of Symptoms at Screening||participants|Number|29|29.0||||||
4221281|NCT00705406|4044596|B2|0-12 h Ago||Estimated Time of Onset of Symptoms at Screening||participants|Number|16|16.0||||||
4221282|NCT00705406|4044597|B1|0-12 h Ago||Estimated Time of Onset of Symptoms at Screening||participants|Number|13|13.0||||||
4221283|NCT00705406|4044595|B3|||Body Mass Index (BMI)||kg/m^2|Mean|27.4|27.4|Standard Deviation|6.43|6.43|||
4221284|NCT00705406|4044596|B2|||Body Mass Index (BMI)||kg/m^2|Mean|27.2|27.2|Standard Deviation|6.12|6.12|||
4221285|NCT00705406|4044597|B1|||Body Mass Index (BMI)||kg/m^2|Mean|27.5|27.5|Standard Deviation|6.73|6.73|||
4221286|NCT00705406|4044595|B3|Other||Race/Ethnicity, Customized|Participants may have been counted in more than 1 category; therefore, numbers may add up to more than the total number of participants.|participants|Number|31|31.0||||||
4221287|NCT00705406|4044596|B2|Other||Race/Ethnicity, Customized|Participants may have been counted in more than 1 category; therefore, numbers may add up to more than the total number of participants.|participants|Number|17|17.0||||||
4221288|NCT00705406|4044597|B1|Other||Race/Ethnicity, Customized|Participants may have been counted in more than 1 category; therefore, numbers may add up to more than the total number of participants.|participants|Number|14|14.0||||||
4221289|NCT00705406|4044595|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|Participants may have been counted in more than 1 category; therefore, numbers may add up to more than the total number of participants.|participants|Number|8|8.0||||||
4221290|NCT00705406|4044596|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|Participants may have been counted in more than 1 category; therefore, numbers may add up to more than the total number of participants.|participants|Number|3|3.0||||||
4221291|NCT00705406|4044597|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Participants may have been counted in more than 1 category; therefore, numbers may add up to more than the total number of participants.|participants|Number|5|5.0||||||
4221292|NCT00705406|4044595|B3|Asian||Race/Ethnicity, Customized|Participants may have been counted in more than 1 category; therefore, numbers may add up to more than the total number of participants.|participants|Number|30|30.0||||||
4221293|NCT00705406|4044596|B2|Asian||Race/Ethnicity, Customized|Participants may have been counted in more than 1 category; therefore, numbers may add up to more than the total number of participants.|participants|Number|15|15.0||||||
4221294|NCT00705406|4044597|B1|Asian||Race/Ethnicity, Customized|Participants may have been counted in more than 1 category; therefore, numbers may add up to more than the total number of participants.|participants|Number|15|15.0||||||
4221295|NCT00705406|4044595|B3|Black or African American||Race/Ethnicity, Customized|Participants may have been counted in more than 1 category; therefore, numbers may add up to more than the total number of participants.|participants|Number|129|129.0||||||
4221296|NCT00705406|4044596|B2|Black or African American||Race/Ethnicity, Customized|Participants may have been counted in more than 1 category; therefore, numbers may add up to more than the total number of participants.|participants|Number|61|61.0||||||
4221297|NCT00705406|4044597|B1|Black or African American||Race/Ethnicity, Customized|Participants may have been counted in more than 1 category; therefore, numbers may add up to more than the total number of participants.|participants|Number|68|68.0||||||
4221298|NCT00705406|4044595|B3|White or Caucasian||Race/Ethnicity, Customized|Participants may have been counted in more than 1 category; therefore, numbers may add up to more than the total number of participants.|participants|Number|207|207.0||||||
4221299|NCT00705406|4044596|B2|White or Caucasian||Race/Ethnicity, Customized|Participants may have been counted in more than 1 category; therefore, numbers may add up to more than the total number of participants.|participants|Number|106|106.0||||||
4221300|NCT00705406|4044597|B1|White or Caucasian||Race/Ethnicity, Customized|Participants may have been counted in more than 1 category; therefore, numbers may add up to more than the total number of participants.|participants|Number|101|101.0||||||
4221301|NCT00705406|4044595|B3||Male|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4221302|NCT00705406|4044596|B2||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4221303|NCT00705406|4044597|B1||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4221307|NCT00705406|4044595|B3|||Age||years|Mean|35|35.0|Standard Deviation|11.7|11.7|||
4221308|NCT00705406|4044596|B2|||Age||years|Mean|35|35.0|Standard Deviation|12.1|12.1|||
4221309|NCT00705406|4044597|B1|||Age||years|Mean|35|35.0|Standard Deviation|11.3|11.3|||
4221310|NCT00705367|4044620|B3|||Weight||kg|Mean|60.44|60.44|Standard Deviation|8.79|8.79|||
4221311|NCT00705367|4044621|B2|||Weight||kg|Mean|63.67|63.67|Standard Deviation|4.04|4.04|||
4221312|NCT00705367|4044622|B1|||Weight||kg|Mean|58.83|58.83|Standard Deviation|10.38|10.38|||
4221313|NCT00705367|4044620|B3|||Duration of Systemic Lupus Erythematosus (SLE)||years|Mean|8.50|8.5|Standard Deviation|4.73|4.73|||
4221314|NCT00705367|4044621|B2|||Duration of Systemic Lupus Erythematosus (SLE)||years|Mean|11.11|11.11|Standard Deviation|3.18|3.18|||
4221315|NCT00705367|4044622|B1|||Duration of Systemic Lupus Erythematosus (SLE)||years|Mean|7.20|7.2|Standard Deviation|5.06|5.06|||
4221316|NCT00705367|4044620|B3|||Duration of Lupus Nephritis||months|Mean|55.90|55.9|Standard Deviation|47.10|47.1|||
4221317|NCT00705367|4044621|B2|||Duration of Lupus Nephritis||months|Mean|85.26|85.26|Standard Deviation|65.03|65.03|||
4221318|NCT00705367|4044622|B1|||Duration of Lupus Nephritis||months|Mean|41.23|41.23|Standard Deviation|32.90|32.9|||
4221319|NCT00705367|4044620|B3|China||Region of Enrollment||participants|Number|9|9.0||||||
4221320|NCT00705367|4044621|B2|China||Region of Enrollment||participants|Number|3|3.0||||||
4221321|NCT00705367|4044622|B1|China||Region of Enrollment||participants|Number|6|6.0||||||
4221322|NCT00705367|4044620|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4221323|NCT00705367|4044621|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4221324|NCT00705367|4044622|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4221325|NCT00705367|4044620|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4221326|NCT00705367|4044621|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4221327|NCT00705367|4044622|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4221328|NCT00705367|4044620|B3|||Age||years|Mean|35.44|35.44|Standard Deviation|9.21|9.21|||
4221329|NCT00705367|4044621|B2|||Age||years|Mean|41.33|41.33|Standard Deviation|8.33|8.33|||
4221330|NCT00705367|4044622|B1|||Age||years|Mean|32.50|32.5|Standard Deviation|8.76|8.76|||
4221331|NCT00705341|4044648|B3|United States||Region of Enrollment||participants|Number|219|219.0||||||
4221332|NCT00705341|4044649|B2|United States||Region of Enrollment||participants|Number|126|126.0||||||
4221333|NCT00705341|4044650|B1|United States||Region of Enrollment||participants|Number|93|93.0||||||
4221334|NCT00705341|4044648|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4221335|NCT00705341|4044649|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4221336|NCT00705341|4044650|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4221337|NCT00705341|4044648|B3||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4221338|NCT00705341|4044649|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4221339|NCT00705341|4044650|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4221340|NCT00705341|4044648|B3|||Age||years|Mean|35|35.0|Standard Deviation|14|14.0|||
4221341|NCT00705341|4044649|B2|||Age||years|Mean|38|38.0|Standard Deviation|15|15.0|||
4221342|NCT00705341|4044650|B1|||Age||years|Mean|33|33.0|Standard Deviation|13|13.0|||
4221343|NCT00705341|4044648|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4221344|NCT00705341|4044649|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4221345|NCT00705341|4044650|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4221346|NCT00705341|4044648|B3||Between 18 and 65 years|Age||Participants|Count of Participants|219|219.0||||||
4221347|NCT00705341|4044649|B2||Between 18 and 65 years|Age||Participants|Count of Participants|126|126.0||||||
4221348|NCT00705341|4044650|B1||Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
4221349|NCT00705341|4044648|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4221350|NCT00705341|4044649|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4221351|NCT00705341|4044650|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4221352|NCT00705289|4044661|B1|||Time since diagnosis|Data available for 703 participants.|years|Mean|9.0|9.0|Standard Deviation|8.99|8.99|||
4221353|NCT00705289|4044661|B1||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4221354|NCT00705289|4044661|B1||Female|Sex: Female, Male||Participants|Count of Participants|571|571.0||||||
4221355|NCT00705289|4044661|B1|||Age||years|Mean|54.1|54.1|Standard Deviation|13.08|13.08|||
4221356|NCT00705263|4044685|B1|Slovenia||Region of Enrollment||participants|Number|110|110.0||||||
4221357|NCT00705263|4044685|B1|Not provided||Sex/Gender, Customized||participants|Number|5|5.0||||||
4221358|NCT00705263|4044685|B1|Male||Sex/Gender, Customized||participants|Number|68|68.0||||||
4221359|NCT00705263|4044685|B1|Female||Sex/Gender, Customized||participants|Number|37|37.0||||||
4221360|NCT00705263|4044685|B1|||Age||years|Mean|40.25|40.25|Standard Deviation|12.71|12.71|||
4221361|NCT00705250|4044689|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4221362|NCT00705250|4044689|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4221363|NCT00705250|4044689|B1|||Age||years|Median|34|34.0|Full Range|||21.0|75.0|
4221364|NCT00705224|4044693|B1||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4221365|NCT00705224|4044693|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4221366|NCT00705224|4044693|B1|||Age||years|Mean|36.0|36.0|Standard Deviation|9.78|9.78|||
4221367|NCT00705159|4044705|B5|United States||Region of Enrollment||participants|Number|137|137.0||||||
4221368|NCT00705159|4044706|B4|United States||Region of Enrollment||participants|Number|34|34.0||||||
4221369|NCT00705159|4044707|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
4221370|NCT00705159|4044708|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
4221371|NCT00705159|4044709|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4221372|NCT00705159|4044705|B5||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4221373|NCT00705159|4044706|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4221374|NCT00705159|4044707|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4221375|NCT00705159|4044708|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4221376|NCT00705159|4044709|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4221377|NCT00705159|4044705|B5||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4221378|NCT00705159|4044706|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4221379|NCT00705159|4044707|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4221380|NCT00705159|4044708|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4221381|NCT00705159|4044709|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4221382|NCT00705159|4044705|B5|0-6 years||Age, Customized||participants|Number|137|137.0||||||
4221383|NCT00705159|4044706|B4|0-6 years||Age, Customized||participants|Number|34|34.0||||||
4221384|NCT00705159|4044707|B3|0-6 years||Age, Customized||participants|Number|34|34.0||||||
4221385|NCT00705159|4044708|B2|0-6 years||Age, Customized||participants|Number|35|35.0||||||
4221386|NCT00705159|4044709|B1|0-6 years||Age, Customized||participants|Number|34|34.0||||||
4221387|NCT00705146|4044730|B3|Canada||Region of Enrollment||participants|Number|56|56.0||||||
4221388|NCT00705146|4044731|B2|Canada||Region of Enrollment||participants|Number|24|24.0||||||
4221389|NCT00705146|4044732|B1|Canada||Region of Enrollment||participants|Number|32|32.0||||||
4221390|NCT00705146|4044730|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4221391|NCT00705146|4044731|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4221392|NCT00705146|4044732|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4221393|NCT00705146|4044730|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4221394|NCT00705146|4044731|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4221395|NCT00705146|4044732|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4221396|NCT00705146|4044730|B3|||Age||years|Mean|64.05|64.05|Standard Deviation|8.61|8.61|||
4221397|NCT00705146|4044731|B2|||Age||years|Mean|65.67|65.67|Standard Deviation|8.64|8.64|||
4221398|NCT00705146|4044732|B1|||Age||years|Mean|62.84|62.84|Standard Deviation|8.48|8.48|||
4221399|NCT00705146|4044730|B3||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4221400|NCT00705146|4044731|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4221401|NCT00705146|4044732|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4221402|NCT00705146|4044730|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4221403|NCT00705146|4044731|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4221404|NCT00705146|4044732|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4221405|NCT00705146|4044730|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4221406|NCT00705146|4044731|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4221407|NCT00705146|4044732|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4221408|NCT00705107|4044741|B1|Romania||Region of Enrollment||participants|Number|267|267.0||||||
4221409|NCT00705107|4044741|B1|Missing||Sex/Gender, Customized||participants|Number|1|1.0||||||
4221410|NCT00705107|4044741|B1|Male||Sex/Gender, Customized||participants|Number|98|98.0||||||
4221411|NCT00705107|4044741|B1|Female||Sex/Gender, Customized||participants|Number|168|168.0||||||
4221412|NCT00705107|4044741|B1|||Age||years|Mean|51.35|51.35|Standard Deviation|10.11|10.11|||
4221413|NCT00705081|4044746|B3|Indonesia||Region of Enrollment||participants|Number|453|453.0||||||
4221414|NCT00705081|4044747|B2|Indonesia||Region of Enrollment||participants|Number|198|198.0||||||
4221415|NCT00705081|4044748|B1|Indonesia||Region of Enrollment||participants|Number|255|255.0||||||
4221416|NCT00705081|4044746|B3||Male|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
4221417|NCT00705081|4044747|B2||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4221418|NCT00705081|4044748|B1||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4221419|NCT00705081|4044746|B3||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4221420|NCT00705081|4044747|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4221421|NCT00705081|4044748|B1||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4221422|NCT00705081|4044746|B3|>61 years||Age, Customized||participants|Number|103|103.0||||||
4221423|NCT00705081|4044747|B2|>61 years||Age, Customized||participants|Number|50|50.0||||||
4221424|NCT00705081|4044748|B1|>61 years||Age, Customized||participants|Number|53|53.0||||||
4221425|NCT00705081|4044746|B3|51-60 years||Age, Customized||participants|Number|189|189.0||||||
4221426|NCT00705081|4044747|B2|51-60 years||Age, Customized||participants|Number|81|81.0||||||
4221427|NCT00705081|4044748|B1|51-60 years||Age, Customized||participants|Number|108|108.0||||||
4221428|NCT00705081|4044746|B3|41-50 years||Age, Customized||participants|Number|126|126.0||||||
4221429|NCT00705081|4044747|B2|41-50 years||Age, Customized||participants|Number|57|57.0||||||
4221430|NCT00705081|4044748|B1|41-50 years||Age, Customized||participants|Number|69|69.0||||||
4221431|NCT00705081|4044746|B3|31-40 years||Age, Customized||participants|Number|30|30.0||||||
4221432|NCT00705081|4044747|B2|31-40 years||Age, Customized||participants|Number|9|9.0||||||
4221433|NCT00705081|4044748|B1|31-40 years||Age, Customized||participants|Number|21|21.0||||||
4221434|NCT00705081|4044746|B3|20-30 years||Age, Customized||participants|Number|5|5.0||||||
4221435|NCT00705081|4044747|B2|20-30 years||Age, Customized||participants|Number|1|1.0||||||
4221436|NCT00705081|4044748|B1|20-30 years||Age, Customized||participants|Number|4|4.0||||||
4221437|NCT00705016|4044759|B4|Other, including non-classifiable||Site of origin of tumor||participants|Number|7|7.0||||||
4221438|NCT00705016|4044760|B3|Other, including non-classifiable||Site of origin of tumor||participants|Number|3|3.0||||||
4221439|NCT00705016|4044761|B2|Other, including non-classifiable||Site of origin of tumor||participants|Number|2|2.0||||||
4221440|NCT00705016|4044762|B1|Other, including non-classifiable||Site of origin of tumor||participants|Number|2|2.0||||||
4221441|NCT00705016|4044759|B4|Oral cavity||Site of origin of tumor||participants|Number|28|28.0||||||
4221442|NCT00705016|4044760|B3|Oral cavity||Site of origin of tumor||participants|Number|11|11.0||||||
4221443|NCT00705016|4044761|B2|Oral cavity||Site of origin of tumor||participants|Number|6|6.0||||||
4221444|NCT00705016|4044762|B1|Oral cavity||Site of origin of tumor||participants|Number|11|11.0||||||
4221445|NCT00705016|4044759|B4|Larynx||Site of origin of tumor||participants|Number|42|42.0||||||
4221446|NCT00705016|4044760|B3|Larynx||Site of origin of tumor||participants|Number|13|13.0||||||
4221447|NCT00705016|4044761|B2|Larynx||Site of origin of tumor||participants|Number|15|15.0||||||
4221448|NCT00705016|4044762|B1|Larynx||Site of origin of tumor||participants|Number|14|14.0||||||
4221449|NCT00705016|4044759|B4|Hypopharynx||Site of origin of tumor||participants|Number|38|38.0||||||
4221450|NCT00705016|4044760|B3|Hypopharynx||Site of origin of tumor||participants|Number|14|14.0||||||
4221451|NCT00705016|4044761|B2|Hypopharynx||Site of origin of tumor||participants|Number|14|14.0||||||
4221452|NCT00705016|4044762|B1|Hypopharynx||Site of origin of tumor||participants|Number|10|10.0||||||
4221453|NCT00705016|4044759|B4|Oropharynx||Site of origin of tumor||participants|Number|69|69.0||||||
4221454|NCT00705016|4044760|B3|Oropharynx||Site of origin of tumor||participants|Number|21|21.0||||||
4221455|NCT00705016|4044761|B2|Oropharynx||Site of origin of tumor||participants|Number|23|23.0||||||
4221456|NCT00705016|4044762|B1|Oropharynx||Site of origin of tumor||participants|Number|25|25.0||||||
4221457|NCT00705016|4044759|B4|Poorly differentiated||Tumor Grade|Out of a total of 62 participants in Cilengitide 2000 mg once weekly + Cetuximab + 5-FU + Cisplatin group, 60 participants in Cilengitide 2000 mg twice weekly + Cetuximab + 5-FU + Cisplatin group, and 62 participants in Cetuximab + 5-FU + Cisplatin group, data for baseline measure (Tumor grade) was available for 57, 58 and 57 participants only, respectively. Tumor grades were divided in to well or moderately differentiated and poorly differentiated.|participants|Number|52|52.0||||||
4221458|NCT00705016|4044760|B3|Poorly differentiated||Tumor Grade|Out of a total of 62 participants in Cilengitide 2000 mg once weekly + Cetuximab + 5-FU + Cisplatin group, 60 participants in Cilengitide 2000 mg twice weekly + Cetuximab + 5-FU + Cisplatin group, and 62 participants in Cetuximab + 5-FU + Cisplatin group, data for baseline measure (Tumor grade) was available for 57, 58 and 57 participants only, respectively. Tumor grades were divided in to well or moderately differentiated and poorly differentiated.|participants|Number|22|22.0||||||
4221459|NCT00705016|4044761|B2|Poorly differentiated||Tumor Grade|Out of a total of 62 participants in Cilengitide 2000 mg once weekly + Cetuximab + 5-FU + Cisplatin group, 60 participants in Cilengitide 2000 mg twice weekly + Cetuximab + 5-FU + Cisplatin group, and 62 participants in Cetuximab + 5-FU + Cisplatin group, data for baseline measure (Tumor grade) was available for 57, 58 and 57 participants only, respectively. Tumor grades were divided in to well or moderately differentiated and poorly differentiated.|participants|Number|19|19.0||||||
4221460|NCT00705016|4044762|B1|Poorly differentiated||Tumor Grade|Out of a total of 62 participants in Cilengitide 2000 mg once weekly + Cetuximab + 5-FU + Cisplatin group, 60 participants in Cilengitide 2000 mg twice weekly + Cetuximab + 5-FU + Cisplatin group, and 62 participants in Cetuximab + 5-FU + Cisplatin group, data for baseline measure (Tumor grade) was available for 57, 58 and 57 participants only, respectively. Tumor grades were divided in to well or moderately differentiated and poorly differentiated.|participants|Number|11|11.0||||||
4221461|NCT00705016|4044759|B4|Well or moderately differentiated||Tumor Grade|Out of a total of 62 participants in Cilengitide 2000 mg once weekly + Cetuximab + 5-FU + Cisplatin group, 60 participants in Cilengitide 2000 mg twice weekly + Cetuximab + 5-FU + Cisplatin group, and 62 participants in Cetuximab + 5-FU + Cisplatin group, data for baseline measure (Tumor grade) was available for 57, 58 and 57 participants only, respectively. Tumor grades were divided in to well or moderately differentiated and poorly differentiated.|participants|Number|120|120.0||||||
4221462|NCT00705016|4044760|B3|Well or moderately differentiated||Tumor Grade|Out of a total of 62 participants in Cilengitide 2000 mg once weekly + Cetuximab + 5-FU + Cisplatin group, 60 participants in Cilengitide 2000 mg twice weekly + Cetuximab + 5-FU + Cisplatin group, and 62 participants in Cetuximab + 5-FU + Cisplatin group, data for baseline measure (Tumor grade) was available for 57, 58 and 57 participants only, respectively. Tumor grades were divided in to well or moderately differentiated and poorly differentiated.|participants|Number|35|35.0||||||
4221463|NCT00705016|4044761|B2|Well or moderately differentiated||Tumor Grade|Out of a total of 62 participants in Cilengitide 2000 mg once weekly + Cetuximab + 5-FU + Cisplatin group, 60 participants in Cilengitide 2000 mg twice weekly + Cetuximab + 5-FU + Cisplatin group, and 62 participants in Cetuximab + 5-FU + Cisplatin group, data for baseline measure (Tumor grade) was available for 57, 58 and 57 participants only, respectively. Tumor grades were divided in to well or moderately differentiated and poorly differentiated.|participants|Number|39|39.0||||||
4221464|NCT00705016|4044762|B1|Well or moderately differentiated||Tumor Grade|Out of a total of 62 participants in Cilengitide 2000 mg once weekly + Cetuximab + 5-FU + Cisplatin group, 60 participants in Cilengitide 2000 mg twice weekly + Cetuximab + 5-FU + Cisplatin group, and 62 participants in Cetuximab + 5-FU + Cisplatin group, data for baseline measure (Tumor grade) was available for 57, 58 and 57 participants only, respectively. Tumor grades were divided in to well or moderately differentiated and poorly differentiated.|participants|Number|46|46.0||||||
4221488|NCT00705016|4044762|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4221465|NCT00705016|4044759|B4|Distant Metastasis||Extent of disease at study entry||participants|Number|91|91.0||||||
4221466|NCT00705016|4044760|B3|Distant Metastasis||Extent of disease at study entry||participants|Number|31|31.0||||||
4221467|NCT00705016|4044761|B2|Distant Metastasis||Extent of disease at study entry||participants|Number|28|28.0||||||
4221468|NCT00705016|4044762|B1|Distant Metastasis||Extent of disease at study entry||participants|Number|32|32.0||||||
4221469|NCT00705016|4044759|B4|Recurrence||Extent of disease at study entry||participants|Number|93|93.0||||||
4221470|NCT00705016|4044760|B3|Recurrence||Extent of disease at study entry||participants|Number|31|31.0||||||
4221471|NCT00705016|4044761|B2|Recurrence||Extent of disease at study entry||participants|Number|32|32.0||||||
4221472|NCT00705016|4044762|B1|Recurrence||Extent of disease at study entry||participants|Number|30|30.0||||||
4221473|NCT00705016|4044759|B4|>= 80 (Karnofsky Score)||Karnofsky Performance Status|Karnofsky performance status score ranged from 100 to 0; 100: Normal; 90: Able to Carry on normal Activity; 80: Normal Activity with Effort; Some Signs or Symptoms of Disease; 70: Cares for Self, Unable to Carry on Normal Activity or to Do Active Work; 60: Requires Occasional Assistance but is Able to Care for Most of Needs; 50: Requires Considerable Assistance and Frequent Medical Care; 40: Disabled, Requires Special Care and Assistance; 30: Severely Disabled; Hospitalization Indicated Although Death is Not Imminent; 20: Very Sick; 10: Moribund, Fatal Processes Progressing Rapidly; 0: Death.|participants|Number|166|166.0||||||
4221474|NCT00705016|4044760|B3|>= 80 (Karnofsky Score)||Karnofsky Performance Status|Karnofsky performance status score ranged from 100 to 0; 100: Normal; 90: Able to Carry on normal Activity; 80: Normal Activity with Effort; Some Signs or Symptoms of Disease; 70: Cares for Self, Unable to Carry on Normal Activity or to Do Active Work; 60: Requires Occasional Assistance but is Able to Care for Most of Needs; 50: Requires Considerable Assistance and Frequent Medical Care; 40: Disabled, Requires Special Care and Assistance; 30: Severely Disabled; Hospitalization Indicated Although Death is Not Imminent; 20: Very Sick; 10: Moribund, Fatal Processes Progressing Rapidly; 0: Death.|participants|Number|57|57.0||||||
4221475|NCT00705016|4044761|B2|>= 80 (Karnofsky Score)||Karnofsky Performance Status|Karnofsky performance status score ranged from 100 to 0; 100: Normal; 90: Able to Carry on normal Activity; 80: Normal Activity with Effort; Some Signs or Symptoms of Disease; 70: Cares for Self, Unable to Carry on Normal Activity or to Do Active Work; 60: Requires Occasional Assistance but is Able to Care for Most of Needs; 50: Requires Considerable Assistance and Frequent Medical Care; 40: Disabled, Requires Special Care and Assistance; 30: Severely Disabled; Hospitalization Indicated Although Death is Not Imminent; 20: Very Sick; 10: Moribund, Fatal Processes Progressing Rapidly; 0: Death.|participants|Number|54|54.0||||||
4221476|NCT00705016|4044762|B1|>= 80 (Karnofsky Score)||Karnofsky Performance Status|Karnofsky performance status score ranged from 100 to 0; 100: Normal; 90: Able to Carry on normal Activity; 80: Normal Activity with Effort; Some Signs or Symptoms of Disease; 70: Cares for Self, Unable to Carry on Normal Activity or to Do Active Work; 60: Requires Occasional Assistance but is Able to Care for Most of Needs; 50: Requires Considerable Assistance and Frequent Medical Care; 40: Disabled, Requires Special Care and Assistance; 30: Severely Disabled; Hospitalization Indicated Although Death is Not Imminent; 20: Very Sick; 10: Moribund, Fatal Processes Progressing Rapidly; 0: Death.|participants|Number|55|55.0||||||
4221477|NCT00705016|4044759|B4|< 80 (Karnofsky Score)||Karnofsky Performance Status|Karnofsky performance status score ranged from 100 to 0; 100: Normal; 90: Able to Carry on normal Activity; 80: Normal Activity with Effort; Some Signs or Symptoms of Disease; 70: Cares for Self, Unable to Carry on Normal Activity or to Do Active Work; 60: Requires Occasional Assistance but is Able to Care for Most of Needs; 50: Requires Considerable Assistance and Frequent Medical Care; 40: Disabled, Requires Special Care and Assistance; 30: Severely Disabled; Hospitalization Indicated Although Death is Not Imminent; 20: Very Sick; 10: Moribund, Fatal Processes Progressing Rapidly; 0: Death.|participants|Number|18|18.0||||||
4221478|NCT00705016|4044760|B3|< 80 (Karnofsky Score)||Karnofsky Performance Status|Karnofsky performance status score ranged from 100 to 0; 100: Normal; 90: Able to Carry on normal Activity; 80: Normal Activity with Effort; Some Signs or Symptoms of Disease; 70: Cares for Self, Unable to Carry on Normal Activity or to Do Active Work; 60: Requires Occasional Assistance but is Able to Care for Most of Needs; 50: Requires Considerable Assistance and Frequent Medical Care; 40: Disabled, Requires Special Care and Assistance; 30: Severely Disabled; Hospitalization Indicated Although Death is Not Imminent; 20: Very Sick; 10: Moribund, Fatal Processes Progressing Rapidly; 0: Death.|participants|Number|5|5.0||||||
4221479|NCT00705016|4044761|B2|< 80 (Karnofsky Score)||Karnofsky Performance Status|Karnofsky performance status score ranged from 100 to 0; 100: Normal; 90: Able to Carry on normal Activity; 80: Normal Activity with Effort; Some Signs or Symptoms of Disease; 70: Cares for Self, Unable to Carry on Normal Activity or to Do Active Work; 60: Requires Occasional Assistance but is Able to Care for Most of Needs; 50: Requires Considerable Assistance and Frequent Medical Care; 40: Disabled, Requires Special Care and Assistance; 30: Severely Disabled; Hospitalization Indicated Although Death is Not Imminent; 20: Very Sick; 10: Moribund, Fatal Processes Progressing Rapidly; 0: Death.|participants|Number|6|6.0||||||
4221480|NCT00705016|4044762|B1|< 80 (Karnofsky Score)||Karnofsky Performance Status|Karnofsky performance status score ranged from 100 to 0; 100: Normal; 90: Able to Carry on normal Activity; 80: Normal Activity with Effort; Some Signs or Symptoms of Disease; 70: Cares for Self, Unable to Carry on Normal Activity or to Do Active Work; 60: Requires Occasional Assistance but is Able to Care for Most of Needs; 50: Requires Considerable Assistance and Frequent Medical Care; 40: Disabled, Requires Special Care and Assistance; 30: Severely Disabled; Hospitalization Indicated Although Death is Not Imminent; 20: Very Sick; 10: Moribund, Fatal Processes Progressing Rapidly; 0: Death.|participants|Number|7|7.0||||||
4221481|NCT00705016|4044759|B4||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4221482|NCT00705016|4044760|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4221483|NCT00705016|4044761|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4221484|NCT00705016|4044762|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4221485|NCT00705016|4044759|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4221486|NCT00705016|4044760|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4221487|NCT00705016|4044761|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4221489|NCT00705016|4044759|B4|Greater than or equal to (>=) 65 years||Age, Customized|Out of a total of 62 participants in Cetuximab + 5-FU + Cisplatin group, data for baseline measure (age) was available for 61 participants only.|participants|Number|42|42.0||||||
4221490|NCT00705016|4044760|B3|Greater than or equal to (>=) 65 years||Age, Customized|Out of a total of 62 participants in Cetuximab + 5-FU + Cisplatin group, data for baseline measure (age) was available for 61 participants only.|participants|Number|15|15.0||||||
4221491|NCT00705016|4044761|B2|Greater than or equal to (>=) 65 years||Age, Customized|Out of a total of 62 participants in Cetuximab + 5-FU + Cisplatin group, data for baseline measure (age) was available for 61 participants only.|participants|Number|12|12.0||||||
4221492|NCT00705016|4044762|B1|Greater than or equal to (>=) 65 years||Age, Customized|Out of a total of 62 participants in Cetuximab + 5-FU + Cisplatin group, data for baseline measure (age) was available for 61 participants only.|participants|Number|15|15.0||||||
4221493|NCT00705016|4044759|B4|Less than (<) 65 years||Age, Customized|Out of a total of 62 participants in Cetuximab + 5-FU + Cisplatin group, data for baseline measure (age) was available for 61 participants only.|participants|Number|141|141.0||||||
4221494|NCT00705016|4044760|B3|Less than (<) 65 years||Age, Customized|Out of a total of 62 participants in Cetuximab + 5-FU + Cisplatin group, data for baseline measure (age) was available for 61 participants only.|participants|Number|46|46.0||||||
4221495|NCT00705016|4044761|B2|Less than (<) 65 years||Age, Customized|Out of a total of 62 participants in Cetuximab + 5-FU + Cisplatin group, data for baseline measure (age) was available for 61 participants only.|participants|Number|48|48.0||||||
4221496|NCT00705016|4044762|B1|Less than (<) 65 years||Age, Customized|Out of a total of 62 participants in Cetuximab + 5-FU + Cisplatin group, data for baseline measure (age) was available for 61 participants only.|participants|Number|47|47.0||||||
4221497|NCT00705016|4044759|B4|||Age|Out of a total of 62 participants in Cetuximab + 5-FU + Cisplatin group, data for baseline measure (age) was available for 61 participants only.|years|Mean|58.2|58.2|Standard Deviation|7.8|7.8|||
4221498|NCT00705016|4044760|B3|||Age|Out of a total of 62 participants in Cetuximab + 5-FU + Cisplatin group, data for baseline measure (age) was available for 61 participants only.|years|Mean|58.6|58.6|Standard Deviation|8.1|8.1|||
4221499|NCT00705016|4044761|B2|||Age|Out of a total of 62 participants in Cetuximab + 5-FU + Cisplatin group, data for baseline measure (age) was available for 61 participants only.|years|Mean|56.8|56.8|Standard Deviation|7.9|7.9|||
4221500|NCT00705016|4044762|B1|||Age|Out of a total of 62 participants in Cetuximab + 5-FU + Cisplatin group, data for baseline measure (age) was available for 61 participants only.|years|Mean|59.1|59.1|Standard Deviation|7.4|7.4|||
4221501|NCT00705003|4044790|B4|United States||Region of Enrollment||participants|Number|134|134.0||||||
4221502|NCT00705003|4044791|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
4221503|NCT00705003|4044792|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
4221504|NCT00705003|4044793|B1|United States||Region of Enrollment||participants|Number|67|67.0||||||
4221505|NCT00705003|4044790|B4||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4221506|NCT00705003|4044791|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4221507|NCT00705003|4044792|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4221508|NCT00705003|4044793|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4221509|NCT00705003|4044790|B4||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4221510|NCT00705003|4044791|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4221511|NCT00705003|4044792|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4221512|NCT00705003|4044793|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4221513|NCT00705003|4044790|B4|||Age||years|Mean|42.4|42.4|Standard Deviation|12.03|12.03|||
4221514|NCT00705003|4044791|B3|||Age||years|Mean|42.7|42.7|Standard Deviation|11.62|11.62|||
4221515|NCT00705003|4044792|B2|||Age||years|Mean|40.8|40.8|Standard Deviation|12.55|12.55|||
4221516|NCT00705003|4044793|B1|||Age||years|Mean|43.1|43.1|Standard Deviation|12.06|12.06|||
4221517|NCT00705003|4044790|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4221518|NCT00705003|4044791|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4221519|NCT00705003|4044792|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4221520|NCT00705003|4044793|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4221521|NCT00705003|4044790|B4||Between 18 and 65 years|Age||Participants|Count of Participants|134|134.0||||||
4221522|NCT00705003|4044791|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4221523|NCT00705003|4044792|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4221524|NCT00705003|4044793|B1||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
4221525|NCT00705003|4044790|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4221526|NCT00705003|4044791|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4221527|NCT00705003|4044792|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4221528|NCT00705003|4044793|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4221529|NCT00704964|4044815|B1|Germany||Region of Enrollment||participants|Number|746|746.0||||||
4221530|NCT00704964|4044815|B1||Male|Sex: Female, Male||Participants|Count of Participants|449|449.0||||||
4221531|NCT00704964|4044815|B1||Female|Sex: Female, Male||Participants|Count of Participants|297|297.0||||||
4221532|NCT00704964|4044815|B1|||Age||years|Mean|42.3|42.3|Standard Deviation|11.44|11.44|||
4221533|NCT00704938|4044820|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4221534|NCT00704938|4044821|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4221535|NCT00704938|4044822|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4221536|NCT00704938|4044820|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221537|NCT00704938|4044821|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221538|NCT00704938|4044822|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221539|NCT00704938|4044820|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221540|NCT00704938|4044821|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221541|NCT00704938|4044822|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221542|NCT00704938|4044820|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4221543|NCT00704938|4044821|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4221544|NCT00704938|4044822|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4221545|NCT00704938|4044820|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221546|NCT00704938|4044821|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221547|NCT00704938|4044822|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221548|NCT00704938|4044820|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221549|NCT00704938|4044821|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221550|NCT00704938|4044822|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221551|NCT00704938|4044820|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221552|NCT00704938|4044821|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221553|NCT00704938|4044822|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221554|NCT00704938|4044820|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221555|NCT00704938|4044821|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221556|NCT00704938|4044822|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221557|NCT00704938|4044820|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221558|NCT00704938|4044821|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221559|NCT00704938|4044822|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221560|NCT00704938|4044820|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4221561|NCT00704938|4044821|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4221562|NCT00704938|4044822|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4221563|NCT00704938|4044820|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221564|NCT00704938|4044821|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221565|NCT00704938|4044822|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221566|NCT00704938|4044820|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4221567|NCT00704938|4044821|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4221568|NCT00704938|4044822|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4221569|NCT00704938|4044820|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4221570|NCT00704938|4044821|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4221571|NCT00704938|4044822|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4221572|NCT00704938|4044820|B3|||Age||years|Mean|47.25|47.25|Standard Deviation|6.7|6.7|||
4221573|NCT00704938|4044821|B2|||Age||years|Mean|58.0|58.0|Standard Deviation|||||
4221574|NCT00704938|4044822|B1|||Age||years|Mean|36.5|36.5|Standard Deviation|13.4|13.4|||
4221575|NCT00704938|4044820|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4221576|NCT00704938|4044821|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4221577|NCT00704938|4044822|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4221578|NCT00704938|4044820|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4221579|NCT00704938|4044821|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4221580|NCT00704938|4044822|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4221581|NCT00704938|4044820|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4221582|NCT00704938|4044821|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4221583|NCT00704938|4044822|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4221584|NCT00704912|4044831|B4|Unknown||Metabolic Syndrome||participants|Number|2|2.0||||||
4221585|NCT00704912|4044832|B3|Unknown||Metabolic Syndrome||participants|Number|0|0.0||||||
4221586|NCT00704912|4044833|B2|Unknown||Metabolic Syndrome||participants|Number|1|1.0||||||
4221587|NCT00704912|4044834|B1|Unknown||Metabolic Syndrome||participants|Number|1|1.0||||||
4221588|NCT00704912|4044831|B4|No||Metabolic Syndrome||participants|Number|94|94.0||||||
4221589|NCT00704912|4044832|B3|No||Metabolic Syndrome||participants|Number|29|29.0||||||
4221590|NCT00704912|4044833|B2|No||Metabolic Syndrome||participants|Number|34|34.0||||||
4221591|NCT00704912|4044834|B1|No||Metabolic Syndrome||participants|Number|31|31.0||||||
4221592|NCT00704912|4044831|B4|Yes||Metabolic Syndrome||participants|Number|53|53.0||||||
4221593|NCT00704912|4044832|B3|Yes||Metabolic Syndrome||participants|Number|21|21.0||||||
4221594|NCT00704912|4044833|B2|Yes||Metabolic Syndrome||participants|Number|14|14.0||||||
4221595|NCT00704912|4044834|B1|Yes||Metabolic Syndrome||participants|Number|18|18.0||||||
4221596|NCT00704912|4044831|B4|||Body Mass Index (BMI)||kg/m2|Mean|35.2|35.2|Standard Deviation|4.4|4.4|||
4221597|NCT00704912|4044832|B3|||Body Mass Index (BMI)||kg/m2|Mean|35.5|35.5|Standard Deviation|4.4|4.4|||
4221598|NCT00704912|4044833|B2|||Body Mass Index (BMI)||kg/m2|Mean|35.1|35.1|Standard Deviation|4.2|4.2|||
4221599|NCT00704912|4044834|B1|||Body Mass Index (BMI)||kg/m2|Mean|35.1|35.1|Standard Deviation|4.6|4.6|||
4221600|NCT00704912|4044831|B4|||Weight||kg|Mean|95.3|95.3|Standard Deviation|14.8|14.8|||
4221601|NCT00704912|4044832|B3|||Weight||kg|Mean|95.2|95.2|Standard Deviation|14.5|14.5|||
4221602|NCT00704912|4044833|B2|||Weight||kg|Mean|94.6|94.6|Standard Deviation|14.4|14.4|||
4221603|NCT00704912|4044834|B1|||Weight||kg|Mean|96.0|96.0|Standard Deviation|15.8|15.8|||
4221604|NCT00704912|4044831|B4|>0 births||Parity||participants|Number|25|25.0||||||
4221605|NCT00704912|4044832|B3|>0 births||Parity||participants|Number|5|5.0||||||
4221606|NCT00704912|4044833|B2|>0 births||Parity||participants|Number|11|11.0||||||
4221607|NCT00704912|4044834|B1|>0 births||Parity||participants|Number|9|9.0||||||
4221608|NCT00704912|4044831|B4|0 births||Parity||participants|Number|124|124.0||||||
4221609|NCT00704912|4044832|B3|0 births||Parity||participants|Number|45|45.0||||||
4221610|NCT00704912|4044833|B2|0 births||Parity||participants|Number|38|38.0||||||
4221611|NCT00704912|4044834|B1|0 births||Parity||participants|Number|41|41.0||||||
4221612|NCT00704912|4044831|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4221613|NCT00704912|4044832|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221614|NCT00704912|4044833|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221615|NCT00704912|4044834|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4221616|NCT00704912|4044831|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4221617|NCT00704912|4044832|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4221618|NCT00704912|4044833|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4221619|NCT00704912|4044834|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4221620|NCT00704912|4044831|B4||White|Race (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
4221621|NCT00704912|4044832|B3||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4221622|NCT00704912|4044833|B2||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4221623|NCT00704912|4044834|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4221624|NCT00704912|4044831|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4221625|NCT00704912|4044832|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4221626|NCT00704912|4044833|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4221627|NCT00704912|4044834|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4221628|NCT00704912|4044831|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221629|NCT00704912|4044832|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221630|NCT00704912|4044833|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221631|NCT00704912|4044834|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221632|NCT00704912|4044831|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4221633|NCT00704912|4044832|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4221634|NCT00704912|4044833|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221635|NCT00704912|4044834|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4221636|NCT00704912|4044831|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221637|NCT00704912|4044832|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221638|NCT00704912|4044833|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221639|NCT00704912|4044834|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221640|NCT00704912|4044831|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221641|NCT00704912|4044832|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221642|NCT00704912|4044833|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221643|NCT00704912|4044834|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4221644|NCT00704912|4044831|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
4221645|NCT00704912|4044832|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4221646|NCT00704912|4044833|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4221647|NCT00704912|4044834|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4221648|NCT00704912|4044831|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4221649|NCT00704912|4044832|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4221650|NCT00704912|4044833|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4221651|NCT00704912|4044834|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4221652|NCT00704912|4044831|B4||Male|Gender||Participants|Count of Participants|0|0.0||||||
4221653|NCT00704912|4044832|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
4221654|NCT00704912|4044833|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
4221655|NCT00704912|4044834|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4221656|NCT00704912|4044831|B4||Female|Gender||Participants|Count of Participants|149|149.0||||||
4221657|NCT00704912|4044832|B3||Female|Gender||Participants|Count of Participants|50|50.0||||||
4221658|NCT00704912|4044833|B2||Female|Gender||Participants|Count of Participants|49|49.0||||||
4221659|NCT00704912|4044834|B1||Female|Gender||Participants|Count of Participants|50|50.0||||||
4221660|NCT00704912|4044831|B4|||Age||years|Mean|29.0|29.0|Standard Deviation|3.8|3.8|||
4221661|NCT00704912|4044832|B3|||Age||years|Mean|28.7|28.7|Standard Deviation|4.2|4.2|||
4221662|NCT00704912|4044833|B2|||Age||years|Mean|29.8|29.8|Standard Deviation|3.7|3.7|||
4221663|NCT00704912|4044834|B1|||Age||years|Mean|28.6|28.6|Standard Deviation|3.4|3.4|||
4221664|NCT00704847|4044853|B3|United Kingdom||Region of Enrollment||participants|Number|51|51.0||||||
4221665|NCT00704847|4044854|B2|United Kingdom||Region of Enrollment||participants|Number|25|25.0||||||
4221666|NCT00704847|4044855|B1|United Kingdom||Region of Enrollment||participants|Number|26|26.0||||||
4221667|NCT00704847|4044853|B3|Denmark||Region of Enrollment||participants|Number|527|527.0||||||
4221668|NCT00704847|4044854|B2|Denmark||Region of Enrollment||participants|Number|264|264.0||||||
4221669|NCT00704847|4044855|B1|Denmark||Region of Enrollment||participants|Number|263|263.0||||||
4221670|NCT00704847|4044853|B3|Romania||Region of Enrollment||participants|Number|18|18.0||||||
4221671|NCT00704847|4044854|B2|Romania||Region of Enrollment||participants|Number|9|9.0||||||
4221672|NCT00704847|4044855|B1|Romania||Region of Enrollment||participants|Number|9|9.0||||||
4221673|NCT00704847|4044853|B3|Poland||Region of Enrollment||participants|Number|133|133.0||||||
4221674|NCT00704847|4044854|B2|Poland||Region of Enrollment||participants|Number|66|66.0||||||
4221675|NCT00704847|4044855|B1|Poland||Region of Enrollment||participants|Number|67|67.0||||||
4221676|NCT00704847|4044853|B3|Belgium||Region of Enrollment||participants|Number|14|14.0||||||
4221677|NCT00704847|4044854|B2|Belgium||Region of Enrollment||participants|Number|7|7.0||||||
4221678|NCT00704847|4044855|B1|Belgium||Region of Enrollment||participants|Number|7|7.0||||||
4221679|NCT00704847|4044853|B3|Spain||Region of Enrollment||participants|Number|6|6.0||||||
4221680|NCT00704847|4044854|B2|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4221681|NCT00704847|4044855|B1|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4221682|NCT00704847|4044853|B3|Canada||Region of Enrollment||participants|Number|19|19.0||||||
4221683|NCT00704847|4044854|B2|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4221684|NCT00704847|4044855|B1|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4221685|NCT00704847|4044853|B3|Czech Republic||Region of Enrollment||participants|Number|71|71.0||||||
4221686|NCT00704847|4044854|B2|Czech Republic||Region of Enrollment||participants|Number|35|35.0||||||
4221687|NCT00704847|4044855|B1|Czech Republic||Region of Enrollment||participants|Number|36|36.0||||||
4221688|NCT00704847|4044853|B3|Hong Kong||Region of Enrollment||participants|Number|144|144.0||||||
4221689|NCT00704847|4044854|B2|Hong Kong||Region of Enrollment||participants|Number|72|72.0||||||
4221690|NCT00704847|4044855|B1|Hong Kong||Region of Enrollment||participants|Number|72|72.0||||||
4221691|NCT00704847|4044853|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
4221692|NCT00704847|4044854|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4221693|NCT00704847|4044855|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4221694|NCT00704847|4044853|B3||Male|Sex: Female, Male||Participants|Count of Participants|404|404.0||||||
4221695|NCT00704847|4044854|B2||Male|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4221696|NCT00704847|4044855|B1||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4221697|NCT00704847|4044853|B3||Female|Sex: Female, Male||Participants|Count of Participants|626|626.0||||||
4221698|NCT00704847|4044854|B2||Female|Sex: Female, Male||Participants|Count of Participants|305|305.0||||||
4221699|NCT00704847|4044855|B1||Female|Sex: Female, Male||Participants|Count of Participants|321|321.0||||||
4221700|NCT00704847|4044853|B3|||Age||years|Mean|64.3|64.3|Standard Deviation|6.9|6.9|||
4221701|NCT00704847|4044854|B2|||Age||years|Mean|64.2|64.2|Standard Deviation|6.8|6.8|||
4221702|NCT00704847|4044855|B1|||Age||years|Mean|64.4|64.4|Standard Deviation|7.0|7.0|||
4221703|NCT00704847|4044853|B3||>=65 years|Age||Participants|Count of Participants|450|450.0||||||
4221704|NCT00704847|4044854|B2||>=65 years|Age||Participants|Count of Participants|221|221.0||||||
4221705|NCT00704847|4044855|B1||>=65 years|Age||Participants|Count of Participants|229|229.0||||||
4221706|NCT00704847|4044853|B3||Between 18 and 65 years|Age||Participants|Count of Participants|580|580.0||||||
4221707|NCT00704847|4044854|B2||Between 18 and 65 years|Age||Participants|Count of Participants|288|288.0||||||
4221708|NCT00704847|4044855|B1||Between 18 and 65 years|Age||Participants|Count of Participants|292|292.0||||||
4221709|NCT00704847|4044853|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4221710|NCT00704847|4044854|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4221711|NCT00704847|4044855|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4221712|NCT00704808|4044864|B1|Germany||Region of Enrollment||participants|Number|180|180.0||||||
4221713|NCT00704808|4044864|B1|Unavailable||Sex/Gender, Customized|Gender information only available for the Intent-to-Treat population of 166 participants.|participants|Number|14|14.0||||||
4221714|NCT00704808|4044864|B1|Male||Sex/Gender, Customized|Gender information only available for the Intent-to-Treat population of 166 participants.|participants|Number|101|101.0||||||
4221715|NCT00704808|4044864|B1|Female||Sex/Gender, Customized|Gender information only available for the Intent-to-Treat population of 166 participants.|participants|Number|65|65.0||||||
4221716|NCT00704808|4044864|B1|||Age|Mean age data based on 165 participants (one less than the Intent-to-treat (ITT) population of 166) due to missing data for 1 participant.|years|Mean|57.65|57.65|Standard Deviation|11.52|11.52|||
4221717|NCT00704769|4044868|B1|Indonesia||Region of Enrollment||participants|Number|591|591.0||||||
4221718|NCT00704769|4044868|B1|Missing Information for sex||Sex/Gender, Customized||participants|Number|8|8.0||||||
4221719|NCT00704769|4044868|B1|Male||Sex/Gender, Customized||participants|Number|345|345.0||||||
4221720|NCT00704769|4044868|B1|Female||Sex/Gender, Customized||participants|Number|238|238.0||||||
4221721|NCT00704769|4044868|B1|||Age||years|Mean|5.28|5.28|Standard Deviation|2.92|2.92|||
4221722|NCT00704769|4044868|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4221723|NCT00704769|4044868|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4221724|NCT00704769|4044868|B1||<=18 years|Age||Participants|Count of Participants|591|591.0||||||
4221725|NCT00704730|4044873|B3|United States||Region of Enrollment||participants|Number|94|94.0||||||
4221726|NCT00704730|4044874|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
4221727|NCT00704730|4044875|B1|United States||Region of Enrollment||participants|Number|63|63.0||||||
4221728|NCT00704730|4044873|B3|United Kingdom||Region of Enrollment||participants|Number|19|19.0||||||
4221729|NCT00704730|4044874|B2|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
4221730|NCT00704730|4044875|B1|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
4221731|NCT00704730|4044873|B3|Sweden||Region of Enrollment||participants|Number|10|10.0||||||
4221732|NCT00704730|4044874|B2|Sweden||Region of Enrollment||participants|Number|4|4.0||||||
4221733|NCT00704730|4044875|B1|Sweden||Region of Enrollment||participants|Number|6|6.0||||||
4221734|NCT00704730|4044873|B3|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4221735|NCT00704730|4044874|B2|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
4221736|NCT00704730|4044875|B1|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4221737|NCT00704730|4044873|B3|Spain||Region of Enrollment||participants|Number|8|8.0||||||
4221738|NCT00704730|4044874|B2|Spain||Region of Enrollment||participants|Number|3|3.0||||||
4221739|NCT00704730|4044875|B1|Spain||Region of Enrollment||participants|Number|5|5.0||||||
4221740|NCT00704730|4044873|B3|Russian Federation||Region of Enrollment||participants|Number|13|13.0||||||
4221741|NCT00704730|4044874|B2|Russian Federation||Region of Enrollment||participants|Number|5|5.0||||||
4221742|NCT00704730|4044875|B1|Russian Federation||Region of Enrollment||participants|Number|8|8.0||||||
4221743|NCT00704730|4044873|B3|Poland||Region of Enrollment||participants|Number|15|15.0||||||
4221744|NCT00704730|4044874|B2|Poland||Region of Enrollment||participants|Number|3|3.0||||||
4221745|NCT00704730|4044875|B1|Poland||Region of Enrollment||participants|Number|12|12.0||||||
4221746|NCT00704730|4044873|B3|Peru||Region of Enrollment||participants|Number|1|1.0||||||
4221747|NCT00704730|4044874|B2|Peru||Region of Enrollment||participants|Number|0|0.0||||||
4221748|NCT00704730|4044875|B1|Peru||Region of Enrollment||participants|Number|1|1.0||||||
4221749|NCT00704730|4044873|B3|Netherlands||Region of Enrollment||participants|Number|8|8.0||||||
4221750|NCT00704730|4044874|B2|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
4221751|NCT00704730|4044875|B1|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
4221752|NCT00704730|4044873|B3|Korea, Republic of||Region of Enrollment||participants|Number|7|7.0||||||
4221753|NCT00704730|4044874|B2|Korea, Republic of||Region of Enrollment||participants|Number|4|4.0||||||
4221754|NCT00704730|4044875|B1|Korea, Republic of||Region of Enrollment||participants|Number|3|3.0||||||
4221755|NCT00704730|4044873|B3|Italy||Region of Enrollment||participants|Number|42|42.0||||||
4221756|NCT00704730|4044874|B2|Italy||Region of Enrollment||participants|Number|14|14.0||||||
4221757|NCT00704730|4044875|B1|Italy||Region of Enrollment||participants|Number|28|28.0||||||
4221758|NCT00704730|4044873|B3|Israel||Region of Enrollment||participants|Number|9|9.0||||||
4221759|NCT00704730|4044874|B2|Israel||Region of Enrollment||participants|Number|4|4.0||||||
4221760|NCT00704730|4044875|B1|Israel||Region of Enrollment||participants|Number|5|5.0||||||
4221761|NCT00704730|4044873|B3|India||Region of Enrollment||participants|Number|6|6.0||||||
4221762|NCT00704730|4044874|B2|India||Region of Enrollment||participants|Number|1|1.0||||||
4221763|NCT00704730|4044875|B1|India||Region of Enrollment||participants|Number|5|5.0||||||
4221764|NCT00704730|4044873|B3|Portugal||Region of Enrollment||participants|Number|1|1.0||||||
4221765|NCT00704730|4044874|B2|Portugal||Region of Enrollment||participants|Number|1|1.0||||||
4221766|NCT00704730|4044875|B1|Portugal||Region of Enrollment||participants|Number|0|0.0||||||
4221767|NCT00704730|4044873|B3|Greece||Region of Enrollment||participants|Number|3|3.0||||||
4221768|NCT00704730|4044874|B2|Greece||Region of Enrollment||participants|Number|2|2.0||||||
4221769|NCT00704730|4044875|B1|Greece||Region of Enrollment||participants|Number|1|1.0||||||
4221770|NCT00704730|4044873|B3|Germany||Region of Enrollment||participants|Number|25|25.0||||||
4221771|NCT00704730|4044874|B2|Germany||Region of Enrollment||participants|Number|10|10.0||||||
4221772|NCT00704730|4044875|B1|Germany||Region of Enrollment||participants|Number|15|15.0||||||
4221773|NCT00704730|4044873|B3|France||Region of Enrollment||participants|Number|30|30.0||||||
4221774|NCT00704730|4044874|B2|France||Region of Enrollment||participants|Number|5|5.0||||||
4221775|NCT00704730|4044875|B1|France||Region of Enrollment||participants|Number|25|25.0||||||
4221776|NCT00704730|4044873|B3|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
4221777|NCT00704730|4044874|B2|Denmark||Region of Enrollment||participants|Number|0|0.0||||||
4221778|NCT00704730|4044875|B1|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
4221779|NCT00704730|4044873|B3|Chile||Region of Enrollment||participants|Number|1|1.0||||||
4221780|NCT00704730|4044874|B2|Chile||Region of Enrollment||participants|Number|1|1.0||||||
4221781|NCT00704730|4044875|B1|Chile||Region of Enrollment||participants|Number|0|0.0||||||
4221782|NCT00704730|4044873|B3|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4221783|NCT00704730|4044874|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4221784|NCT00704730|4044875|B1|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4221785|NCT00704730|4044873|B3|Brazil||Region of Enrollment||participants|Number|7|7.0||||||
4221786|NCT00704730|4044874|B2|Brazil||Region of Enrollment||participants|Number|3|3.0||||||
4221787|NCT00704730|4044875|B1|Brazil||Region of Enrollment||participants|Number|4|4.0||||||
4221788|NCT00704730|4044873|B3|Belgium||Region of Enrollment||participants|Number|12|12.0||||||
4221789|NCT00704730|4044874|B2|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
4221790|NCT00704730|4044875|B1|Belgium||Region of Enrollment||participants|Number|7|7.0||||||
4221791|NCT00704730|4044873|B3|Austria||Region of Enrollment||participants|Number|9|9.0||||||
4221792|NCT00704730|4044874|B2|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4221793|NCT00704730|4044875|B1|Austria||Region of Enrollment||participants|Number|8|8.0||||||
4221794|NCT00704730|4044873|B3||Male|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
4221795|NCT00704730|4044874|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4221796|NCT00704730|4044875|B1||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4221797|NCT00704730|4044873|B3||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4221798|NCT00704730|4044874|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4221799|NCT00704730|4044875|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4221800|NCT00704730|4044873|B3|||Age||years|Mean|54.2|54.2|Standard Deviation|13.33|13.33|||
4221801|NCT00704730|4044874|B2|||Age||years|Mean|53.8|53.8|Standard Deviation|13.39|13.39|||
4221802|NCT00704730|4044875|B1|||Age||years|Mean|54.4|54.4|Standard Deviation|13.33|13.33|||
4221803|NCT00704730|4044873|B3||>=65 years|Age||Participants|Count of Participants|72|72.0||||||
4221804|NCT00704730|4044874|B2||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4221805|NCT00704730|4044875|B1||>=65 years|Age||Participants|Count of Participants|47|47.0||||||
4221806|NCT00704730|4044873|B3||Between 18 and 65 years|Age||Participants|Count of Participants|258|258.0||||||
4221807|NCT00704730|4044874|B2||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
4221808|NCT00704730|4044875|B1||Between 18 and 65 years|Age||Participants|Count of Participants|172|172.0||||||
4221809|NCT00704730|4044873|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4221810|NCT00704730|4044874|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4221811|NCT00704730|4044875|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4221812|NCT00704717|4044892|B1|Romania||Region of Enrollment||participants|Number|185|185.0||||||
4221813|NCT00704717|4044892|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4221814|NCT00704717|4044892|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4221815|NCT00704717|4044892|B1|||Age||years|Mean|49.18|49.18|Standard Deviation|9.94|9.94|||
4221816|NCT00704535|4044896|B1|Male||Sex/Gender, Customized|Gender was not reported for 13 subjects|participants|Number|1930|1930.0||||||
4221817|NCT00704535|4044896|B1|Female||Sex/Gender, Customized|Gender was not reported for 13 subjects|participants|Number|2175|2175.0||||||
4221818|NCT00704535|4044896|B1|||Age|Age was not reported for 10 subjects|years|Mean|54.62|54.62|Standard Deviation|11.60|11.6|||
4221819|NCT00704522|4044907|B3|Austria||Region of Enrollment||participants|Number|601|601.0||||||
4221820|NCT00704522|4044908|B2|Austria||Region of Enrollment||participants|Number|120|120.0||||||
4221821|NCT00704522|4044909|B1|Austria||Region of Enrollment||participants|Number|481|481.0||||||
4221822|NCT00704522|4044907|B3||Male|Sex: Female, Male||Participants|Count of Participants|384|384.0||||||
4221823|NCT00704522|4044908|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4221824|NCT00704522|4044909|B1||Male|Sex: Female, Male||Participants|Count of Participants|306|306.0||||||
4221825|NCT00704522|4044907|B3||Female|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
4221826|NCT00704522|4044908|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4221827|NCT00704522|4044909|B1||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4221828|NCT00704522|4044907|B3|||Age||years|Mean|41.76|41.76|Standard Deviation|12.77|12.77|||
4221829|NCT00704522|4044908|B2|||Age||years|Mean|41.38|41.38|Standard Deviation|11.96|11.96|||
4221830|NCT00704522|4044909|B1|||Age||years|Mean|41.85|41.85|Standard Deviation|12.98|12.98|||
4221831|NCT00704418|4044928|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4221832|NCT00704418|4044929|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4221833|NCT00704418|4044930|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4221834|NCT00704418|4044928|B3||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4221835|NCT00704418|4044929|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4221836|NCT00704418|4044930|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4221837|NCT00704418|4044928|B3|||Age||years|Mean|68.4|68.4|Full Range|||27.0|90.0|
4221838|NCT00704418|4044929|B2|||Age||years|Mean|68.0|68.0|Full Range|||43.0|86.0|
4221839|NCT00704418|4044930|B1|||Age||years|Mean|68.7|68.7|Full Range|||27.0|90.0|
4221840|NCT00704405|4044939|B6||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4221841|NCT00704405|4044940|B5||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4221842|NCT00704405|4044941|B4||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4221843|NCT00704405|4044942|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4221844|NCT00704405|4044943|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4221845|NCT00704405|4044944|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4221846|NCT00704405|4044939|B6||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4221847|NCT00704405|4044940|B5||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4221848|NCT00704405|4044941|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4221849|NCT00704405|4044942|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4221850|NCT00704405|4044943|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4221851|NCT00704405|4044944|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4221852|NCT00704405|4044939|B6|||Age||Years|Mean|50.8|50.8|Standard Deviation|8.1|8.1|||
4221853|NCT00704405|4044940|B5|||Age||Years|Mean|49.9|49.9|Standard Deviation|7.8|7.8|||
4221854|NCT00704405|4044941|B4|||Age||Years|Mean|52.1|52.1|Standard Deviation|8.7|8.7|||
4221855|NCT00704405|4044942|B3|||Age||Years|Mean|50.6|50.6|Standard Deviation|7.5|7.5|||
4221856|NCT00704405|4044943|B2|||Age||Years|Mean|51.6|51.6|Standard Deviation|8.1|8.1|||
4221857|NCT00704405|4044944|B1|||Age||Years|Mean|50.0|50.0|Standard Deviation|8.4|8.4|||
4221858|NCT00704379|4044976|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4221859|NCT00704379|4044977|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4221860|NCT00704379|4044978|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4221861|NCT00704379|4044976|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4221862|NCT00704379|4044977|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4221863|NCT00704379|4044978|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4221864|NCT00704379|4044976|B3|||Age||years|Mean|52.39|52.39|Standard Deviation|19.24|19.24|||
4221865|NCT00704379|4044977|B2|||Age||years|Mean|49.98|49.98|Standard Deviation|20.05|20.05|||
4221866|NCT00704379|4044978|B1|||Age||years|Mean|54.91|54.91|Standard Deviation|18.24|18.24|||
4221867|NCT00704353|4044995|B3|United States||Region of Enrollment||participants|Number|735|735.0||||||
4221868|NCT00704353|4044996|B2|United States||Region of Enrollment||participants|Number|369|369.0||||||
4221869|NCT00704353|4044997|B1|United States||Region of Enrollment||participants|Number|366|366.0||||||
4221870|NCT00704353|4044995|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4221871|NCT00704353|4044996|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4221872|NCT00704353|4044997|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4221873|NCT00704353|4044995|B3||Female|Sex: Female, Male||Participants|Count of Participants|637|637.0||||||
4221874|NCT00704353|4044996|B2||Female|Sex: Female, Male||Participants|Count of Participants|315|315.0||||||
4221875|NCT00704353|4044997|B1||Female|Sex: Female, Male||Participants|Count of Participants|322|322.0||||||
4221876|NCT00704353|4044995|B3|||Age||years|Mean|49.4|49.4|Standard Deviation|19.91|19.91|||
4221877|NCT00704353|4044996|B2|||Age||years|Mean|49.6|49.6|Standard Deviation|19.88|19.88|||
4221878|NCT00704353|4044997|B1|||Age||years|Mean|49.2|49.2|Standard Deviation|19.94|19.94|||
4221879|NCT00704353|4044995|B3||>=65 years|Age||Participants|Count of Participants|195|195.0||||||
4221880|NCT00704353|4044996|B2||>=65 years|Age||Participants|Count of Participants|98|98.0||||||
4221881|NCT00704353|4044997|B1||>=65 years|Age||Participants|Count of Participants|97|97.0||||||
4221882|NCT00704353|4044995|B3||Between 18 and 65 years|Age||Participants|Count of Participants|531|531.0||||||
4221883|NCT00704353|4044996|B2||Between 18 and 65 years|Age||Participants|Count of Participants|265|265.0||||||
4221884|NCT00704353|4044997|B1||Between 18 and 65 years|Age||Participants|Count of Participants|266|266.0||||||
4221885|NCT00704353|4044995|B3||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4221886|NCT00704353|4044996|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4221887|NCT00704353|4044997|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4221888|NCT00704340|4045004|B3|United States||Region of Enrollment||participants|Number|237|237.0||||||
4221889|NCT00704340|4045005|B2|United States||Region of Enrollment||participants|Number|117|117.0||||||
4221890|NCT00704340|4045006|B1|United States||Region of Enrollment||participants|Number|120|120.0||||||
4221891|NCT00704340|4045004|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4221892|NCT00704340|4045005|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4221893|NCT00704340|4045006|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4221894|NCT00704340|4045004|B3||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4221895|NCT00704340|4045005|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4221896|NCT00704340|4045006|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4221897|NCT00704340|4045004|B3|||Age||years|Mean|48.9|48.9|Standard Deviation|13.8|13.8|||
4221898|NCT00704340|4045005|B2|||Age||years|Mean|48.2|48.2|Standard Deviation|13.5|13.5|||
4221899|NCT00704340|4045006|B1|||Age||years|Mean|49.6|49.6|Standard Deviation|14.1|14.1|||
4221900|NCT00704340|4045004|B3||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4221901|NCT00704340|4045005|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4221902|NCT00704340|4045006|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4221903|NCT00704340|4045004|B3||Between 18 and 65 years|Age||Participants|Count of Participants|210|210.0||||||
4221904|NCT00704340|4045005|B2||Between 18 and 65 years|Age||Participants|Count of Participants|102|102.0||||||
4221905|NCT00704340|4045006|B1||Between 18 and 65 years|Age||Participants|Count of Participants|108|108.0||||||
4221906|NCT00704340|4045004|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4221907|NCT00704340|4045005|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4221908|NCT00704340|4045006|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4221909|NCT00704184|4045017|B6||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4221910|NCT00704184|4045018|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4221911|NCT00704184|4045019|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4221912|NCT00704184|4045020|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4221913|NCT00704184|4045021|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4221914|NCT00704184|4045022|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4221915|NCT00704184|4045017|B6||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4221916|NCT00704184|4045018|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4221917|NCT00704184|4045019|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4221918|NCT00704184|4045020|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4221919|NCT00704184|4045021|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4221920|NCT00704184|4045022|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4221921|NCT00704184|4045017|B6|||Age||Years|Mean|46.2|46.2|Standard Deviation|10.5|10.5|||
4221922|NCT00704184|4045018|B5|||Age||Years|Mean|45.1|45.1|Standard Deviation|12.0|12.0|||
4221923|NCT00704184|4045019|B4|||Age||Years|Mean|50.1|50.1|Standard Deviation|8.4|8.4|||
4221924|NCT00704184|4045020|B3|||Age||Years|Mean|42.0|42.0|Standard Deviation|10.7|10.7|||
4221925|NCT00704184|4045021|B2|||Age||Years|Mean|46.7|46.7|Standard Deviation|10.2|10.2|||
4221926|NCT00704184|4045022|B1|||Age||Years|Mean|47.8|47.8|Standard Deviation|10.1|10.1|||
4221927|NCT00704171|4045063|B3|||Weight||kg|Mean|75.00|75.0|Standard Deviation|14.64|14.64|||
4221928|NCT00704171|4045064|B2|||Weight||kg|Mean|75.57|75.57|Standard Deviation|13.96|13.96|||
4221929|NCT00704171|4045065|B1|||Weight||kg|Mean|74.46|74.46|Standard Deviation|15.35|15.35|||
4221930|NCT00704171|4045063|B3|||Height||cm|Mean|169.4|169.4|Standard Deviation|9.1|9.1|||
4221931|NCT00704171|4045064|B2|||Height||cm|Mean|169.4|169.4|Standard Deviation|9.6|9.6|||
4221932|NCT00704171|4045065|B1|||Height||cm|Mean|169.5|169.5|Standard Deviation|8.8|8.8|||
4221933|NCT00704171|4045063|B3|||Body Mass Index||kg/m^2|Mean|26.10|26.1|Standard Deviation|4.63|4.63|||
4221934|NCT00704171|4045064|B2|||Body Mass Index||kg/m^2|Mean|26.35|26.35|Standard Deviation|4.55|4.55|||
4221935|NCT00704171|4045065|B1|||Body Mass Index||kg/m^2|Mean|25.86|25.86|Standard Deviation|4.73|4.73|||
4221936|NCT00704171|4045063|B3|Never||Nicotine Use||participants|Number|17|17.0||||||
4221937|NCT00704171|4045064|B2|Never||Nicotine Use||participants|Number|8|8.0||||||
4221938|NCT00704171|4045065|B1|Never||Nicotine Use||participants|Number|9|9.0||||||
4221939|NCT00704171|4045063|B3|Current||Nicotine Use||participants|Number|39|39.0||||||
4221940|NCT00704171|4045064|B2|Current||Nicotine Use||participants|Number|17|17.0||||||
4221941|NCT00704171|4045065|B1|Current||Nicotine Use||participants|Number|22|22.0||||||
4221942|NCT00704171|4045063|B3|History||Nicotine Use||participants|Number|65|65.0||||||
4221943|NCT00704171|4045064|B2|History||Nicotine Use||participants|Number|34|34.0||||||
4221944|NCT00704171|4045065|B1|History||Nicotine Use||participants|Number|31|31.0||||||
4221945|NCT00704171|4045063|B3|Switzerland||Region of Enrollment||participants|Number|6|6.0||||||
4221946|NCT00704171|4045064|B2|Switzerland||Region of Enrollment||participants|Number|5|5.0||||||
4221947|NCT00704171|4045065|B1|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4221948|NCT00704171|4045063|B3|Austria||Region of Enrollment||participants|Number|62|62.0||||||
4221949|NCT00704171|4045064|B2|Austria||Region of Enrollment||participants|Number|30|30.0||||||
4221950|NCT00704171|4045065|B1|Austria||Region of Enrollment||participants|Number|32|32.0||||||
4221951|NCT00704171|4045063|B3|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
4221952|NCT00704171|4045064|B2|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4221953|NCT00704171|4045065|B1|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4221954|NCT00704171|4045063|B3|Belgium||Region of Enrollment||participants|Number|28|28.0||||||
4221955|NCT00704171|4045064|B2|Belgium||Region of Enrollment||participants|Number|14|14.0||||||
4221956|NCT00704171|4045065|B1|Belgium||Region of Enrollment||participants|Number|14|14.0||||||
4221957|NCT00704171|4045063|B3|Netherlands||Region of Enrollment||participants|Number|15|15.0||||||
4221958|NCT00704171|4045064|B2|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
4221959|NCT00704171|4045065|B1|Netherlands||Region of Enrollment||participants|Number|9|9.0||||||
4221960|NCT00704171|4045063|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4221961|NCT00704171|4045064|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4221962|NCT00704171|4045065|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4221963|NCT00704171|4045063|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4221964|NCT00704171|4045064|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4221965|NCT00704171|4045065|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4221966|NCT00704171|4045063|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4221967|NCT00704171|4045064|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4221968|NCT00704171|4045065|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4221969|NCT00704171|4045063|B3|African||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4221970|NCT00704171|4045064|B2|African||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4221971|NCT00704171|4045065|B1|African||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4221972|NCT00704171|4045063|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|116|116.0||||||
4221973|NCT00704171|4045064|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
4221974|NCT00704171|4045065|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
4221975|NCT00704171|4045063|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4221976|NCT00704171|4045064|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4221977|NCT00704171|4045065|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4221978|NCT00704171|4045063|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4221979|NCT00704171|4045064|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4221980|NCT00704171|4045065|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4221981|NCT00704171|4045063|B3|||Age||years|Mean|62.1|62.1|Standard Deviation|9.9|9.9|||
4221982|NCT00704171|4045064|B2|||Age||years|Mean|62.8|62.8|Standard Deviation|10.8|10.8|||
4221983|NCT00704171|4045065|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|9.1|9.1|||
4221984|NCT00704132|4045082|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4221985|NCT00704132|4045083|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4221986|NCT00704132|4045084|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4221987|NCT00704132|4045082|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4221988|NCT00704132|4045083|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4221989|NCT00704132|4045084|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4221990|NCT00704132|4045082|B3|||Age, Customized||participants|Number|50|50.0||||||
4221991|NCT00704132|4045083|B2|||Age, Customized||participants|Number|24|24.0||||||
4221992|NCT00704132|4045084|B1|||Age, Customized||participants|Number|26|26.0||||||
4221993|NCT00704028|4045091|B3|United States||Region of Enrollment||participants|Number|160|160.0||||||
4221994|NCT00704028|4045092|B2|United States||Region of Enrollment||participants|Number|78|78.0||||||
4221995|NCT00704028|4045093|B1|United States||Region of Enrollment||participants|Number|82|82.0||||||
4221996|NCT00704028|4045091|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4221997|NCT00704028|4045092|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4221998|NCT00704028|4045093|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4221999|NCT00704028|4045091|B3||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4222000|NCT00704028|4045092|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4222001|NCT00704028|4045093|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4222002|NCT00704028|4045091|B3|||Age||years|Mean|47.2|47.2|Standard Deviation|15.84|15.84|||
4222003|NCT00704028|4045092|B2|||Age||years|Mean|48.2|48.2|Standard Deviation|17.10|17.1|||
4222004|NCT00704028|4045093|B1|||Age||years|Mean|46.2|46.2|Standard Deviation|14.64|14.64|||
4222005|NCT00704028|4045091|B3||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4222006|NCT00704028|4045092|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4222007|NCT00704028|4045093|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4222008|NCT00704028|4045091|B3||Between 18 and 65 years|Age||Participants|Count of Participants|134|134.0||||||
4222009|NCT00704028|4045092|B2||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4222010|NCT00704028|4045093|B1||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
4222011|NCT00704028|4045091|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4222012|NCT00704028|4045092|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4222013|NCT00704028|4045093|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4222014|NCT00703976|4045100|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4222015|NCT00703976|4045101|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4222016|NCT00703976|4045102|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4222017|NCT00703976|4045100|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4222018|NCT00703976|4045101|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4222019|NCT00703976|4045102|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4222020|NCT00703976|4045100|B3|||Age||years|Median|56|56.0|Full Range|||35.0|76.0|
4222021|NCT00703976|4045101|B2|||Age||years|Median|56|56.0|Full Range|||35.0|76.0|
4222022|NCT00703976|4045102|B1|||Age||years|Median|57|57.0|Full Range|||39.0|69.0|
4222023|NCT00703963|4045111|B3|United States||Region of Enrollment||participants|Number|200|200.0||||||
4222024|NCT00703963|4045112|B2|United States||Region of Enrollment||participants|Number|100|100.0||||||
4222025|NCT00703963|4045113|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
4222026|NCT00703963|4045111|B3||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4222027|NCT00703963|4045112|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4222028|NCT00703963|4045113|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4222029|NCT00703963|4045111|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4222030|NCT00703963|4045112|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4222031|NCT00703963|4045113|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4222032|NCT00703963|4045111|B3|||Age||years|Median|54|54.0|Full Range|||18.0|84.0|
4222033|NCT00703963|4045112|B2|||Age||years|Median|55|55.0|Full Range|||18.0|79.0|
4222034|NCT00703963|4045113|B1|||Age||years|Median|53|53.0|Full Range|||19.0|84.0|
4222035|NCT00703937|4045124|B3|United States||Region of Enrollment||participants|Number|703|703.0||||||
4222036|NCT00703937|4045125|B2|United States||Region of Enrollment||participants|Number|360|360.0||||||
4222037|NCT00703937|4045126|B1|United States||Region of Enrollment||participants|Number|343|343.0||||||
4222038|NCT00703937|4045124|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4222039|NCT00703937|4045125|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4222040|NCT00703937|4045126|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4222041|NCT00703937|4045124|B3||Female|Sex: Female, Male||Participants|Count of Participants|610|610.0||||||
4222042|NCT00703937|4045125|B2||Female|Sex: Female, Male||Participants|Count of Participants|318|318.0||||||
4222043|NCT00703937|4045126|B1||Female|Sex: Female, Male||Participants|Count of Participants|292|292.0||||||
4222044|NCT00703937|4045124|B3|||Age||years|Mean|48.5|48.5|Standard Deviation|18.05|18.05|||
4222045|NCT00703937|4045125|B2|||Age||years|Mean|47.7|47.7|Standard Deviation|17.62|17.62|||
4222046|NCT00703937|4045126|B1|||Age||years|Mean|49.3|49.3|Standard Deviation|18.48|18.48|||
4222047|NCT00703937|4045124|B3||>=65 years|Age||Participants|Count of Participants|145|145.0||||||
4222048|NCT00703937|4045125|B2||>=65 years|Age||Participants|Count of Participants|70|70.0||||||
4222049|NCT00703937|4045126|B1||>=65 years|Age||Participants|Count of Participants|75|75.0||||||
4222050|NCT00703937|4045124|B3||Between 18 and 65 years|Age||Participants|Count of Participants|554|554.0||||||
4222051|NCT00703937|4045125|B2||Between 18 and 65 years|Age||Participants|Count of Participants|287|287.0||||||
4222052|NCT00703937|4045126|B1||Between 18 and 65 years|Age||Participants|Count of Participants|267|267.0||||||
4222053|NCT00703937|4045124|B3||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4222054|NCT00703937|4045125|B2||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4222055|NCT00703937|4045126|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4222056|NCT00703924|4045133|B3|Tunisia||Region of Enrollment||participants|Number|82|82.0||||||
4222057|NCT00703924|4045134|B2|Tunisia||Region of Enrollment||participants|Number|37|37.0||||||
4222058|NCT00703924|4045135|B1|Tunisia||Region of Enrollment||participants|Number|45|45.0||||||
4222059|NCT00703924|4045133|B3|France||Region of Enrollment||participants|Number|10|10.0||||||
4222060|NCT00703924|4045134|B2|France||Region of Enrollment||participants|Number|5|5.0||||||
4222061|NCT00703924|4045135|B1|France||Region of Enrollment||participants|Number|5|5.0||||||
4222062|NCT00703924|4045133|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4222063|NCT00703924|4045134|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4222064|NCT00703924|4045135|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4222065|NCT00703924|4045133|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4222066|NCT00703924|4045134|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4222067|NCT00703924|4045135|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4222068|NCT00703924|4045133|B3|>18 years||Age, Customized||years|Number|12|12.0||||||
4222069|NCT00703924|4045134|B2|>18 years||Age, Customized||years|Number|9|9.0||||||
4222070|NCT00703924|4045135|B1|>18 years||Age, Customized||years|Number|3|3.0||||||
4222071|NCT00703924|4045133|B3|<18 years||Age, Customized||years|Number|80|80.0||||||
4222072|NCT00703924|4045134|B2|<18 years||Age, Customized||years|Number|33|33.0||||||
4222073|NCT00703924|4045135|B1|<18 years||Age, Customized||years|Number|47|47.0||||||
4222074|NCT00703911|4045152|B1|Other bypassing agent (e.g., FEIBA)||Primary treatment type and dose for the 6 months preceding enrolment in registry||participants|Number|13|13.0||||||
4222075|NCT00703911|4045152|B1|Other dose regimen NovoSeven®||Primary treatment type and dose for the 6 months preceding enrolment in registry||participants|Number|17|17.0||||||
4222076|NCT00703911|4045152|B1|Single dose 270 mcg/kg NovoSeven®||Primary treatment type and dose for the 6 months preceding enrolment in registry||participants|Number|28|28.0||||||
4222077|NCT00703911|4045152|B1|Multiple dose 90 mcg/kg NovoSeven®||Primary treatment type and dose for the 6 months preceding enrolment in registry||participants|Number|44|44.0||||||
4222078|NCT00703911|4045152|B1|Data missing||Primary treatment pattern for the 6 months preceding enrolment in registry||participants|Number|1|1.0||||||
4222079|NCT00703911|4045152|B1|Prophylaxis||Primary treatment pattern for the 6 months preceding enrolment in registry||participants|Number|13|13.0||||||
4222080|NCT00703911|4045152|B1|On-demand||Primary treatment pattern for the 6 months preceding enrolment in registry||participants|Number|88|88.0||||||
4222081|NCT00703911|4045152|B1|Data missing||Estimated number of bleeds for the 6 months preceding enrolment in registry||participants|Number|1|1.0||||||
4222082|NCT00703911|4045152|B1|18 (more than 3 per month)||Estimated number of bleeds for the 6 months preceding enrolment in registry||participants|Number|2|2.0||||||
4222083|NCT00703911|4045152|B1|12 - 18 (2 - 3 per month)||Estimated number of bleeds for the 6 months preceding enrolment in registry||participants|Number|12|12.0||||||
4222084|NCT00703911|4045152|B1|6 - 12 (1 - 2 per month)||Estimated number of bleeds for the 6 months preceding enrolment in registry||participants|Number|13|13.0||||||
4222085|NCT00703911|4045152|B1|1 - 6 (1 or less per month)||Estimated number of bleeds for the 6 months preceding enrolment in registry||participants|Number|65|65.0||||||
4222086|NCT00703911|4045152|B1|None||Estimated number of bleeds for the 6 months preceding enrolment in registry||participants|Number|9|9.0||||||
4222087|NCT00703911|4045152|B1|Ongoing ITI||Outcome of immune tolerance induction (ITI) treatment||participants|Number|11|11.0||||||
4222088|NCT00703911|4045152|B1|Successful, with inhibitor recurrence||Outcome of immune tolerance induction (ITI) treatment||participants|Number|5|5.0||||||
4222089|NCT00703911|4045152|B1|Unsuccessful||Outcome of immune tolerance induction (ITI) treatment||participants|Number|20|20.0||||||
4222090|NCT00703911|4045152|B1|None||Outcome of immune tolerance induction (ITI) treatment||participants|Number|66|66.0||||||
4222091|NCT00703911|4045152|B1|Less than 5 Bethesda Units||Peak inhibitor titre||participants|Number|11|11.0||||||
4222092|NCT00703911|4045152|B1|At least 5 Bethesda Units||Peak inhibitor titre||participants|Number|91|91.0||||||
4222093|NCT00703911|4045152|B1|Venezuela||Region of Enrollment||participants|Number|6|6.0||||||
4222094|NCT00703911|4045152|B1|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
4222095|NCT00703911|4045152|B1|Turkey||Region of Enrollment||participants|Number|6|6.0||||||
4222096|NCT00703911|4045152|B1|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
4222097|NCT00703911|4045152|B1|South Africa||Region of Enrollment||participants|Number|8|8.0||||||
4222098|NCT00703911|4045152|B1|Saudi Arabia||Region of Enrollment||participants|Number|2|2.0||||||
4222099|NCT00703911|4045152|B1|Portugal||Region of Enrollment||participants|Number|1|1.0||||||
4222100|NCT00703911|4045152|B1|Poland||Region of Enrollment||participants|Number|9|9.0||||||
4222101|NCT00703911|4045152|B1|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4222102|NCT00703911|4045152|B1|Italy||Region of Enrollment||participants|Number|16|16.0||||||
4222103|NCT00703911|4045152|B1|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4222104|NCT00703911|4045152|B1|France||Region of Enrollment||participants|Number|16|16.0||||||
4222105|NCT00703911|4045152|B1|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
4222106|NCT00703911|4045152|B1|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
4222107|NCT00703911|4045152|B1|Austria||Region of Enrollment||participants|Number|3|3.0||||||
4222108|NCT00703911|4045152|B1|Algeria||Region of Enrollment||participants|Number|17|17.0||||||
4222109|NCT00703911|4045152|B1||Male|Gender||Participants|Count of Participants|102|102.0||||||
4222110|NCT00703911|4045152|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
4222111|NCT00703911|4045152|B1|18 years or above||Age, Customized||participants|Number|53|53.0||||||
4222112|NCT00703911|4045152|B1|above 12 - 17 years||Age, Customized||participants|Number|14|14.0||||||
4222113|NCT00703911|4045152|B1|2 - 12 years||Age, Customized||participants|Number|35|35.0||||||
4222114|NCT00703911|4045152|B1|||Age||years|Mean|23.3|23.3|Standard Deviation|16.37|16.37|||
4222115|NCT00703885|4045180|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4222116|NCT00703885|4045180|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4222117|NCT00703885|4045180|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4222118|NCT00703885|4045180|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4222119|NCT00703885|4045180|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4222120|NCT00703885|4045180|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4222121|NCT00703846|4045185|B1|White||Race/Ethnicity, Customized||participants|Number|346|346.0||||||
4222122|NCT00703846|4045185|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4222123|NCT00703846|4045185|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4222124|NCT00703846|4045185|B1|Black||Race/Ethnicity, Customized||participants|Number|108|108.0||||||
4222125|NCT00703846|4045185|B1|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4222126|NCT00703846|4045185|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4222127|NCT00703846|4045185|B1||Male|Gender||Participants|Count of Participants|259|259.0||||||
4222128|NCT00703846|4045185|B1||Female|Gender||Participants|Count of Participants|239|239.0||||||
4222129|NCT00703846|4045185|B1|||Age|Baseline Characteristics were collected in the Safety Analysis Set Population, comprised of all participants who were randomized and received at least one dose of study drug. Two participants did not receive any study treatment and are thus not included in this population.|Years|Mean|47.2|47.2|Standard Deviation|17.4|17.4|||
4222130|NCT00703820|4045199|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4222131|NCT00703820|4045200|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4222132|NCT00703820|4045201|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4222133|NCT00703820|4045199|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4222134|NCT00703820|4045200|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4222135|NCT00703820|4045201|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4222136|NCT00703820|4045199|B3||White|Race (NIH/OMB)||Participants|Count of Participants|181|181.0||||||
4222137|NCT00703820|4045200|B2||White|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
4222138|NCT00703820|4045201|B1||White|Race (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
4222139|NCT00703820|4045199|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4222140|NCT00703820|4045200|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4222141|NCT00703820|4045201|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4222142|NCT00703820|4045199|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4222143|NCT00703820|4045200|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4222144|NCT00703820|4045201|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4222145|NCT00703820|4045199|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4222146|NCT00703820|4045200|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4222147|NCT00703820|4045201|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4222148|NCT00703820|4045199|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222149|NCT00703820|4045200|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222150|NCT00703820|4045201|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222151|NCT00703820|4045199|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4222152|NCT00703820|4045200|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4222153|NCT00703820|4045201|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4222154|NCT00703820|4045199|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|209|209.0||||||
4222155|NCT00703820|4045200|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
4222156|NCT00703820|4045201|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
4222157|NCT00703820|4045199|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4222158|NCT00703820|4045200|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4222159|NCT00703820|4045201|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4222160|NCT00703820|4045199|B3||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4222161|NCT00703820|4045200|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4222162|NCT00703820|4045201|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4222163|NCT00703820|4045199|B3||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4222164|NCT00703820|4045200|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4222165|NCT00703820|4045201|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4222166|NCT00703820|4045199|B3|||Age||years|Mean|9.31|9.31|Standard Deviation|6.18|6.18|||
4222167|NCT00703820|4045200|B2|||Age||years|Mean|9.05|9.05|Standard Deviation|6.40|6.4|||
4222168|NCT00703820|4045201|B1|||Age||years|Mean|9.57|9.57|Standard Deviation|6.00|6.0|||
4222169|NCT00703781|4045209|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4222170|NCT00703781|4045210|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4222171|NCT00703781|4045211|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4222172|NCT00703781|4045209|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4222173|NCT00703781|4045210|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4222174|NCT00703781|4045211|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4222175|NCT00703781|4045209|B3|||Age||years|Mean|67.9|67.9|Full Range|9.8|9.8|41.0|87.0|
4222176|NCT00703781|4045210|B2|||Age||years|Mean|68.6|68.6|Full Range|8.6|8.6|51.0|87.0|
4222177|NCT00703781|4045211|B1|||Age||years|Mean|67.1|67.1|Full Range|10.8|10.8|41.0|86.0|
4222178|NCT00703729|4045220|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4222179|NCT00703729|4045221|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4222180|NCT00703729|4045222|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4222181|NCT00703729|4045220|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4222182|NCT00703729|4045221|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4222183|NCT00703729|4045222|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4222184|NCT00703729|4045220|B3|||Age||years|Mean|55.6|55.6|Standard Deviation|10.8|10.8|||
4222185|NCT00703729|4045221|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|11.2|11.2|||
4222186|NCT00703729|4045222|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|10.6|10.6|||
4222187|NCT00703677|4045257|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4222188|NCT00703677|4045257|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4222189|NCT00703677|4045257|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4222190|NCT00703677|4045257|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4222191|NCT00703677|4045257|B1|70 - 79 years||Age, Customized|Age at enrollment|participants|Number|6|6.0||||||
4222192|NCT00703677|4045257|B1|60 - 69 years||Age, Customized|Age at enrollment|participants|Number|9|9.0||||||
4222193|NCT00703677|4045257|B1|50 - 59 years||Age, Customized|Age at enrollment|participants|Number|2|2.0||||||
4222194|NCT00703677|4045257|B1|40 - 49 years||Age, Customized|Age at enrollment|participants|Number|0|0.0||||||
4222195|NCT00703664|4045270|B4|Status: 2||Eastern Cooperative Oncology Group (ECOG) Status|ECOG Status 0: Normal activity. Fully active, able to carry on all pre-disease performance without restriction. ECOG Status 1: Symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work). ECOG Status 2: In bed < 50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hours.|Participants|Count of Participants|9|9.0||||||
4222196|NCT00703664|4045271|B3|Status: 2||Eastern Cooperative Oncology Group (ECOG) Status|ECOG Status 0: Normal activity. Fully active, able to carry on all pre-disease performance without restriction. ECOG Status 1: Symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work). ECOG Status 2: In bed < 50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hours.|Participants|Count of Participants|9|9.0||||||
4222218|NCT00703664|4045273|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222219|NCT00703664|4045270|B4||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4222220|NCT00703664|4045271|B3||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4222221|NCT00703664|4045272|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4222197|NCT00703664|4045272|B2|Status: 2||Eastern Cooperative Oncology Group (ECOG) Status|ECOG Status 0: Normal activity. Fully active, able to carry on all pre-disease performance without restriction. ECOG Status 1: Symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work). ECOG Status 2: In bed < 50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hours.|Participants|Count of Participants|0|0.0||||||
4222198|NCT00703664|4045273|B1|Status: 2||Eastern Cooperative Oncology Group (ECOG) Status|ECOG Status 0: Normal activity. Fully active, able to carry on all pre-disease performance without restriction. ECOG Status 1: Symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work). ECOG Status 2: In bed < 50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hours.|Participants|Count of Participants|0|0.0||||||
4222199|NCT00703664|4045270|B4|Status: 1||Eastern Cooperative Oncology Group (ECOG) Status|ECOG Status 0: Normal activity. Fully active, able to carry on all pre-disease performance without restriction. ECOG Status 1: Symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work). ECOG Status 2: In bed < 50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hours.|Participants|Count of Participants|29|29.0||||||
4222200|NCT00703664|4045271|B3|Status: 1||Eastern Cooperative Oncology Group (ECOG) Status|ECOG Status 0: Normal activity. Fully active, able to carry on all pre-disease performance without restriction. ECOG Status 1: Symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work). ECOG Status 2: In bed < 50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hours.|Participants|Count of Participants|19|19.0||||||
4222201|NCT00703664|4045272|B2|Status: 1||Eastern Cooperative Oncology Group (ECOG) Status|ECOG Status 0: Normal activity. Fully active, able to carry on all pre-disease performance without restriction. ECOG Status 1: Symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work). ECOG Status 2: In bed < 50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hours.|Participants|Count of Participants|1|1.0||||||
4222202|NCT00703664|4045273|B1|Status: 1||Eastern Cooperative Oncology Group (ECOG) Status|ECOG Status 0: Normal activity. Fully active, able to carry on all pre-disease performance without restriction. ECOG Status 1: Symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work). ECOG Status 2: In bed < 50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hours.|Participants|Count of Participants|9|9.0||||||
4222203|NCT00703664|4045270|B4|Status: 0||Eastern Cooperative Oncology Group (ECOG) Status|ECOG Status 0: Normal activity. Fully active, able to carry on all pre-disease performance without restriction. ECOG Status 1: Symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work). ECOG Status 2: In bed < 50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hours.|Participants|Count of Participants|27|27.0||||||
4222204|NCT00703664|4045271|B3|Status: 0||Eastern Cooperative Oncology Group (ECOG) Status|ECOG Status 0: Normal activity. Fully active, able to carry on all pre-disease performance without restriction. ECOG Status 1: Symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work). ECOG Status 2: In bed < 50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hours.|Participants|Count of Participants|11|11.0||||||
4222205|NCT00703664|4045272|B2|Status: 0||Eastern Cooperative Oncology Group (ECOG) Status|ECOG Status 0: Normal activity. Fully active, able to carry on all pre-disease performance without restriction. ECOG Status 1: Symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work). ECOG Status 2: In bed < 50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hours.|Participants|Count of Participants|3|3.0||||||
4222206|NCT00703664|4045273|B1|Status: 0||Eastern Cooperative Oncology Group (ECOG) Status|ECOG Status 0: Normal activity. Fully active, able to carry on all pre-disease performance without restriction. ECOG Status 1: Symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work). ECOG Status 2: In bed < 50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Up and about more than 50% of waking hours.|Participants|Count of Participants|13|13.0||||||
4222207|NCT00703664|4045270|B4|United States||Region of Enrollment||Participants|Count of Participants|65|65.0||||||
4222208|NCT00703664|4045271|B3|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
4222209|NCT00703664|4045272|B2|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4222210|NCT00703664|4045273|B1|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4222211|NCT00703664|4045270|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4222212|NCT00703664|4045271|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4222213|NCT00703664|4045272|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222214|NCT00703664|4045273|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4222215|NCT00703664|4045270|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222216|NCT00703664|4045271|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222217|NCT00703664|4045272|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222222|NCT00703664|4045273|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4222223|NCT00703664|4045270|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4222224|NCT00703664|4045271|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4222225|NCT00703664|4045272|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222226|NCT00703664|4045273|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4222227|NCT00703664|4045270|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222228|NCT00703664|4045271|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222229|NCT00703664|4045272|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222230|NCT00703664|4045273|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222231|NCT00703664|4045270|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222232|NCT00703664|4045271|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222233|NCT00703664|4045272|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222234|NCT00703664|4045273|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222235|NCT00703664|4045270|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222236|NCT00703664|4045271|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222237|NCT00703664|4045272|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222238|NCT00703664|4045273|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222239|NCT00703664|4045270|B4||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4222240|NCT00703664|4045271|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4222241|NCT00703664|4045272|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4222242|NCT00703664|4045273|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4222243|NCT00703664|4045270|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4222244|NCT00703664|4045271|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4222245|NCT00703664|4045272|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4222246|NCT00703664|4045273|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4222247|NCT00703664|4045270|B4|||Age||years|Median|60|60.0|Full Range|||29.0|89.0|
4222248|NCT00703664|4045271|B3|||Age||years|Median|57|57.0|Full Range|||29.0|89.0|
4222249|NCT00703664|4045272|B2|||Age||years|Median|63|63.0|Full Range|||58.0|78.0|
4222250|NCT00703664|4045273|B1|||Age||years|Median|64|64.0|Full Range|||48.0|72.0|
4222251|NCT00703534|4045295|B3||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4222252|NCT00703534|4045296|B2||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4222253|NCT00703534|4045297|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4222254|NCT00703534|4045295|B3||Female|Sex: Female, Male||Participants|Count of Participants|280|280.0||||||
4222255|NCT00703534|4045296|B2||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4222256|NCT00703534|4045297|B1||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4222257|NCT00703534|4045295|B3|||Age||Years|Mean|48.7|48.7|Standard Deviation|11.2|11.2|||
4222258|NCT00703534|4045296|B2|||Age||Years|Mean|47.8|47.8|Standard Deviation|11.5|11.5|||
4222259|NCT00703534|4045297|B1|||Age||Years|Mean|49.7|49.7|Standard Deviation|10.09|10.09|||
4222260|NCT00703508|4045304|B1|||BMI||kg/m^2|Mean|35.0|35.0|Standard Deviation|7.6|7.6|||
4222261|NCT00703508|4045304|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4222262|NCT00703508|4045304|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4222263|NCT00703508|4045304|B1|||Age||years|Mean|27.9|27.9|Standard Deviation|4.2|4.2|||
4222264|NCT00703391|4045316|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4222265|NCT00703391|4045317|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4222266|NCT00703391|4045318|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4222267|NCT00703391|4045316|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4222268|NCT00703391|4045317|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4222269|NCT00703391|4045318|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4222270|NCT00703391|4045316|B3|||Age||Years|Mean|56|56.0|Full Range|||42.0|70.0|
4222271|NCT00703391|4045317|B2|||Age||Years|Mean|52.8|52.8|Full Range|||44.0|65.0|
4222272|NCT00703391|4045318|B1|||Age||Years|Mean|57.6|57.6|Full Range|||42.0|70.0|
4222273|NCT00703339|4045363|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4222274|NCT00703339|4045363|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4222275|NCT00703339|4045363|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4222276|NCT00703339|4045363|B1|||Age||years|Mean|62|62.0|Standard Deviation|||||
4222277|NCT00703339|4045363|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4222278|NCT00703339|4045363|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4222279|NCT00703339|4045363|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4222280|NCT00703326|4045368|B3|Other||Race||participants|Number|31|31.0||||||
4222281|NCT00703326|4045369|B2|Other||Race||participants|Number|9|9.0||||||
4222282|NCT00703326|4045370|B1|Other||Race||participants|Number|22|22.0||||||
4222283|NCT00703326|4045368|B3|White||Race||participants|Number|1017|1017.0||||||
4222284|NCT00703326|4045369|B2|White||Race||participants|Number|341|341.0||||||
4222285|NCT00703326|4045370|B1|White||Race||participants|Number|676|676.0||||||
4222286|NCT00703326|4045368|B3|Black or African American||Race||participants|Number|41|41.0||||||
4222287|NCT00703326|4045369|B2|Black or African American||Race||participants|Number|14|14.0||||||
4222288|NCT00703326|4045370|B1|Black or African American||Race||participants|Number|27|27.0||||||
4222289|NCT00703326|4045368|B3|Native Hawaiian or Other Pacific Islander||Race||participants|Number|2|2.0||||||
4222290|NCT00703326|4045369|B2|Native Hawaiian or Other Pacific Islander||Race||participants|Number|0|0.0||||||
4222291|NCT00703326|4045370|B1|Native Hawaiian or Other Pacific Islander||Race||participants|Number|2|2.0||||||
4222292|NCT00703326|4045368|B3|Asian||Race||participants|Number|51|51.0||||||
4222293|NCT00703326|4045369|B2|Asian||Race||participants|Number|20|20.0||||||
4222294|NCT00703326|4045370|B1|Asian||Race||participants|Number|31|31.0||||||
4222295|NCT00703326|4045368|B3|American Indian or Alaska Native||Race||participants|Number|2|2.0||||||
4222296|NCT00703326|4045369|B2|American Indian or Alaska Native||Race||participants|Number|1|1.0||||||
4222297|NCT00703326|4045370|B1|American Indian or Alaska Native||Race||participants|Number|1|1.0||||||
4222298|NCT00703326|4045368|B3|Korea, Republic of||Region of Enrollment||participants|Number|21|21.0||||||
4222299|NCT00703326|4045369|B2|Korea, Republic of||Region of Enrollment||participants|Number|7|7.0||||||
4222300|NCT00703326|4045370|B1|Korea, Republic of||Region of Enrollment||participants|Number|14|14.0||||||
4222301|NCT00703326|4045368|B3|New Zealand||Region of Enrollment||participants|Number|11|11.0||||||
4222302|NCT00703326|4045369|B2|New Zealand||Region of Enrollment||participants|Number|6|6.0||||||
4222303|NCT00703326|4045370|B1|New Zealand||Region of Enrollment||participants|Number|5|5.0||||||
4222304|NCT00703326|4045368|B3|Germany||Region of Enrollment||participants|Number|17|17.0||||||
4222305|NCT00703326|4045369|B2|Germany||Region of Enrollment||participants|Number|5|5.0||||||
4222306|NCT00703326|4045370|B1|Germany||Region of Enrollment||participants|Number|12|12.0||||||
4222307|NCT00703326|4045368|B3|South Africa||Region of Enrollment||participants|Number|63|63.0||||||
4222308|NCT00703326|4045369|B2|South Africa||Region of Enrollment||participants|Number|22|22.0||||||
4222309|NCT00703326|4045370|B1|South Africa||Region of Enrollment||participants|Number|41|41.0||||||
4222310|NCT00703326|4045368|B3|Australia||Region of Enrollment||participants|Number|49|49.0||||||
4222311|NCT00703326|4045369|B2|Australia||Region of Enrollment||participants|Number|21|21.0||||||
4222312|NCT00703326|4045370|B1|Australia||Region of Enrollment||participants|Number|28|28.0||||||
4222313|NCT00703326|4045368|B3|Peru||Region of Enrollment||participants|Number|16|16.0||||||
4222314|NCT00703326|4045369|B2|Peru||Region of Enrollment||participants|Number|4|4.0||||||
4222315|NCT00703326|4045370|B1|Peru||Region of Enrollment||participants|Number|12|12.0||||||
4222316|NCT00703326|4045368|B3|Brazil||Region of Enrollment||participants|Number|50|50.0||||||
4222317|NCT00703326|4045369|B2|Brazil||Region of Enrollment||participants|Number|20|20.0||||||
4222318|NCT00703326|4045370|B1|Brazil||Region of Enrollment||participants|Number|30|30.0||||||
4222319|NCT00703326|4045368|B3|Belgium||Region of Enrollment||participants|Number|68|68.0||||||
4222320|NCT00703326|4045369|B2|Belgium||Region of Enrollment||participants|Number|20|20.0||||||
4222321|NCT00703326|4045370|B1|Belgium||Region of Enrollment||participants|Number|48|48.0||||||
4222322|NCT00703326|4045368|B3|Poland||Region of Enrollment||participants|Number|17|17.0||||||
4222323|NCT00703326|4045369|B2|Poland||Region of Enrollment||participants|Number|5|5.0||||||
4222324|NCT00703326|4045370|B1|Poland||Region of Enrollment||participants|Number|12|12.0||||||
4222325|NCT00703326|4045368|B3|Canada||Region of Enrollment||participants|Number|129|129.0||||||
4222326|NCT00703326|4045369|B2|Canada||Region of Enrollment||participants|Number|46|46.0||||||
4222327|NCT00703326|4045370|B1|Canada||Region of Enrollment||participants|Number|83|83.0||||||
4222328|NCT00703326|4045368|B3|Czech Republic||Region of Enrollment||participants|Number|7|7.0||||||
4222329|NCT00703326|4045369|B2|Czech Republic||Region of Enrollment||participants|Number|3|3.0||||||
4222330|NCT00703326|4045370|B1|Czech Republic||Region of Enrollment||participants|Number|4|4.0||||||
4222331|NCT00703326|4045368|B3|Egypt||Region of Enrollment||participants|Number|12|12.0||||||
4222332|NCT00703326|4045369|B2|Egypt||Region of Enrollment||participants|Number|3|3.0||||||
4222333|NCT00703326|4045370|B1|Egypt||Region of Enrollment||participants|Number|9|9.0||||||
4222334|NCT00703326|4045368|B3|United Kingdom||Region of Enrollment||participants|Number|31|31.0||||||
4222335|NCT00703326|4045369|B2|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
4222336|NCT00703326|4045370|B1|United Kingdom||Region of Enrollment||participants|Number|21|21.0||||||
4222337|NCT00703326|4045368|B3|Israel||Region of Enrollment||participants|Number|23|23.0||||||
4222338|NCT00703326|4045369|B2|Israel||Region of Enrollment||participants|Number|7|7.0||||||
4222339|NCT00703326|4045370|B1|Israel||Region of Enrollment||participants|Number|16|16.0||||||
4222340|NCT00703326|4045368|B3|Russian Federation||Region of Enrollment||participants|Number|309|309.0||||||
4222341|NCT00703326|4045369|B2|Russian Federation||Region of Enrollment||participants|Number|99|99.0||||||
4222342|NCT00703326|4045370|B1|Russian Federation||Region of Enrollment||participants|Number|210|210.0||||||
4222343|NCT00703326|4045368|B3|Ireland||Region of Enrollment||participants|Number|10|10.0||||||
4222344|NCT00703326|4045369|B2|Ireland||Region of Enrollment||participants|Number|2|2.0||||||
4222345|NCT00703326|4045370|B1|Ireland||Region of Enrollment||participants|Number|8|8.0||||||
4222346|NCT00703326|4045368|B3|Lebanon||Region of Enrollment||participants|Number|38|38.0||||||
4222347|NCT00703326|4045369|B2|Lebanon||Region of Enrollment||participants|Number|14|14.0||||||
4222348|NCT00703326|4045370|B1|Lebanon||Region of Enrollment||participants|Number|24|24.0||||||
4222349|NCT00703326|4045368|B3|Spain||Region of Enrollment||participants|Number|182|182.0||||||
4222350|NCT00703326|4045369|B2|Spain||Region of Enrollment||participants|Number|64|64.0||||||
4222351|NCT00703326|4045370|B1|Spain||Region of Enrollment||participants|Number|118|118.0||||||
4222352|NCT00703326|4045368|B3|Slovakia||Region of Enrollment||participants|Number|4|4.0||||||
4222353|NCT00703326|4045369|B2|Slovakia||Region of Enrollment||participants|Number|2|2.0||||||
4222354|NCT00703326|4045370|B1|Slovakia||Region of Enrollment||participants|Number|2|2.0||||||
4222355|NCT00703326|4045368|B3|Taiwan||Region of Enrollment||participants|Number|6|6.0||||||
4222356|NCT00703326|4045369|B2|Taiwan||Region of Enrollment||participants|Number|2|2.0||||||
4222357|NCT00703326|4045370|B1|Taiwan||Region of Enrollment||participants|Number|4|4.0||||||
4222358|NCT00703326|4045368|B3|United States||Region of Enrollment||participants|Number|79|79.0||||||
4222359|NCT00703326|4045369|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4222360|NCT00703326|4045370|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
4222361|NCT00703326|4045368|B3|Serbia||Region of Enrollment||participants|Number|2|2.0||||||
4222362|NCT00703326|4045369|B2|Serbia||Region of Enrollment||participants|Number|2|2.0||||||
4222363|NCT00703326|4045370|B1|Serbia||Region of Enrollment||participants|Number|0|0.0||||||
4222364|NCT00703326|4045368|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222365|NCT00703326|4045369|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222366|NCT00703326|4045370|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222367|NCT00703326|4045368|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1033|1033.0||||||
4222368|NCT00703326|4045369|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|343|343.0||||||
4222369|NCT00703326|4045370|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|690|690.0||||||
4222370|NCT00703326|4045368|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
4222371|NCT00703326|4045369|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4222372|NCT00703326|4045370|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
4222373|NCT00703326|4045368|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4222374|NCT00703326|4045369|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4222375|NCT00703326|4045370|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4222376|NCT00703326|4045368|B3||Female|Sex: Female, Male||Participants|Count of Participants|1144|1144.0||||||
4222377|NCT00703326|4045369|B2||Female|Sex: Female, Male||Participants|Count of Participants|385|385.0||||||
4222378|NCT00703326|4045370|B1||Female|Sex: Female, Male||Participants|Count of Participants|759|759.0||||||
4222379|NCT00703326|4045368|B3|||Age||years|Mean|54.0|54.0|Standard Deviation|10.4|10.4|||
4222380|NCT00703326|4045369|B2|||Age||years|Mean|54.2|54.2|Standard Deviation|10.0|10.0|||
4222381|NCT00703326|4045370|B1|||Age||years|Mean|53.9|53.9|Standard Deviation|10.5|10.5|||
4222382|NCT00703326|4045368|B3||>=65 years|Age||Participants|Count of Participants|190|190.0||||||
4222383|NCT00703326|4045369|B2||>=65 years|Age||Participants|Count of Participants|60|60.0||||||
4222384|NCT00703326|4045370|B1||>=65 years|Age||Participants|Count of Participants|130|130.0||||||
4222385|NCT00703326|4045368|B3||Between 18 and 65 years|Age||Participants|Count of Participants|954|954.0||||||
4222386|NCT00703326|4045369|B2||Between 18 and 65 years|Age||Participants|Count of Participants|325|325.0||||||
4222387|NCT00703326|4045370|B1||Between 18 and 65 years|Age||Participants|Count of Participants|629|629.0||||||
4222388|NCT00703326|4045368|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4222389|NCT00703326|4045369|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4222390|NCT00703326|4045370|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4222391|NCT00703261|4045391|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4222392|NCT00703261|4045392|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4222393|NCT00703261|4045393|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4222394|NCT00703261|4045391|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4222395|NCT00703261|4045392|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4222396|NCT00703261|4045393|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4222397|NCT00703261|4045391|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|9.40|9.4|||
4222398|NCT00703261|4045392|B2|||Age||years|Mean|59.1|59.1|Standard Deviation|9.24|9.24|||
4222399|NCT00703261|4045393|B1|||Age||years|Mean|60.0|60.0|Standard Deviation|9.63|9.63|||
4222400|NCT00703157|4045401|B3|II||NYHA Class|"The New York Heart Association (NYHA) Functional Classification places patients in one of four categories based on their limitations during physical activity.The limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina.~Class I: No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea (shortness of breath).~Class II: Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath)."|Participants|Count of Participants|4|4.0||||||
4222401|NCT00703157|4045402|B2|II||NYHA Class|"The New York Heart Association (NYHA) Functional Classification places patients in one of four categories based on their limitations during physical activity.The limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina.~Class I: No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea (shortness of breath).~Class II: Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath)."|Participants|Count of Participants|3|3.0||||||
4222402|NCT00703157|4045403|B1|II||NYHA Class|"The New York Heart Association (NYHA) Functional Classification places patients in one of four categories based on their limitations during physical activity.The limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina.~Class I: No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea (shortness of breath).~Class II: Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath)."|Participants|Count of Participants|1|1.0||||||
4222403|NCT00703157|4045401|B3|I||NYHA Class|"The New York Heart Association (NYHA) Functional Classification places patients in one of four categories based on their limitations during physical activity.The limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina.~Class I: No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea (shortness of breath).~Class II: Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath)."|Participants|Count of Participants|48|48.0||||||
4222404|NCT00703157|4045402|B2|I||NYHA Class|"The New York Heart Association (NYHA) Functional Classification places patients in one of four categories based on their limitations during physical activity.The limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina.~Class I: No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea (shortness of breath).~Class II: Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath)."|Participants|Count of Participants|23|23.0||||||
4222405|NCT00703157|4045403|B1|I||NYHA Class|"The New York Heart Association (NYHA) Functional Classification places patients in one of four categories based on their limitations during physical activity.The limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina.~Class I: No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea (shortness of breath).~Class II: Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath)."|Participants|Count of Participants|25|25.0||||||
4222406|NCT00703157|4045401|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4222407|NCT00703157|4045402|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4222408|NCT00703157|4045403|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4222409|NCT00703157|4045401|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4222410|NCT00703157|4045402|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4222411|NCT00703157|4045403|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4222412|NCT00703157|4045401|B3|||Age||years|Mean|58|58.0|Standard Deviation|9|9.0|||
4222413|NCT00703157|4045402|B2|||Age||years|Mean|55|55.0|Standard Deviation|9|9.0|||
4222414|NCT00703157|4045403|B1|||Age||years|Mean|61|61.0|Standard Deviation|7|7.0|||
4222415|NCT00703118|4045435|B4|>= 65 years||AgeCategoricalOther||participants|Number|20|20.0||||||
4222416|NCT00703118|4045436|B3|>= 65 years||AgeCategoricalOther||participants|Number|7|7.0||||||
4222417|NCT00703118|4045437|B2|>= 65 years||AgeCategoricalOther||participants|Number|8|8.0||||||
4222418|NCT00703118|4045438|B1|>= 65 years||AgeCategoricalOther||participants|Number|5|5.0||||||
4222419|NCT00703118|4045435|B4|Between 45 and 65 years||AgeCategoricalOther||participants|Number|483|483.0||||||
4222420|NCT00703118|4045436|B3|Between 45 and 65 years||AgeCategoricalOther||participants|Number|85|85.0||||||
4222421|NCT00703118|4045437|B2|Between 45 and 65 years||AgeCategoricalOther||participants|Number|201|201.0||||||
4222422|NCT00703118|4045438|B1|Between 45 and 65 years||AgeCategoricalOther||participants|Number|197|197.0||||||
4222423|NCT00703118|4045435|B4|>= 45 years||AgeCategoricalOther||participants|Number|159|159.0||||||
4222424|NCT00703118|4045436|B3|>= 45 years||AgeCategoricalOther||participants|Number|40|40.0||||||
4222425|NCT00703118|4045437|B2|>= 45 years||AgeCategoricalOther||participants|Number|55|55.0||||||
4222426|NCT00703118|4045438|B1|>= 45 years||AgeCategoricalOther||participants|Number|64|64.0||||||
4222427|NCT00703118|4045435|B4|Other||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4222428|NCT00703118|4045436|B3|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4222429|NCT00703118|4045437|B2|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4222430|NCT00703118|4045438|B1|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4222431|NCT00703118|4045435|B4|White||Race/Ethnicity, Customized||Participants|Number|615|615.0||||||
4222432|NCT00703118|4045436|B3|White||Race/Ethnicity, Customized||Participants|Number|117|117.0||||||
4222433|NCT00703118|4045437|B2|White||Race/Ethnicity, Customized||Participants|Number|252|252.0||||||
4222434|NCT00703118|4045438|B1|White||Race/Ethnicity, Customized||Participants|Number|246|246.0||||||
4222435|NCT00703118|4045435|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
4222436|NCT00703118|4045436|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4222437|NCT00703118|4045437|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4222438|NCT00703118|4045438|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4222439|NCT00703118|4045435|B4|Asian||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4222440|NCT00703118|4045436|B3|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4222441|NCT00703118|4045437|B2|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4222442|NCT00703118|4045438|B1|Asian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4222443|NCT00703118|4045435|B4||Male|Sex: Female, Male||Participants|Count of Participants|460|460.0||||||
4222444|NCT00703118|4045436|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4222445|NCT00703118|4045437|B2||Male|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4222446|NCT00703118|4045438|B1||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4222447|NCT00703118|4045435|B4||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4222448|NCT00703118|4045436|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4222449|NCT00703118|4045437|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4222450|NCT00703118|4045438|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4222451|NCT00703118|4045435|B4|||Age||years|Mean|50.6|50.6|Standard Deviation|8.66|8.66|||
4222452|NCT00703118|4045436|B3|||Age||years|Mean|49.9|49.9|Standard Deviation|9.74|9.74|||
4222453|NCT00703118|4045437|B2|||Age||years|Mean|51|51.0|Standard Deviation|8.24|8.24|||
4222454|NCT00703118|4045438|B1|||Age||years|Mean|50.7|50.7|Standard Deviation|8.51|8.51|||
4222455|NCT00703092|4045471|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4222456|NCT00703092|4045471|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4222457|NCT00703092|4045471|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4222458|NCT00703092|4045471|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4222459|NCT00703092|4045471|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4222460|NCT00703092|4045471|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4222461|NCT00703053|4045476|B10|United States||Region of Enrollment||participants|Number|505|505.0||||||
4222462|NCT00703053|4045477|B9|United States||Region of Enrollment||participants|Number|103|103.0||||||
4222463|NCT00703053|4045478|B8|United States||Region of Enrollment||participants|Number|97|97.0||||||
4222464|NCT00703053|4045479|B7|United States||Region of Enrollment||participants|Number|52|52.0||||||
4222465|NCT00703053|4045480|B6|United States||Region of Enrollment||participants|Number|49|49.0||||||
4222466|NCT00703053|4045481|B5|United States||Region of Enrollment||participants|Number|51|51.0||||||
4222467|NCT00703053|4045482|B4|United States||Region of Enrollment||participants|Number|49|49.0||||||
4222468|NCT00703053|4045483|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
4222469|NCT00703053|4045484|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4222470|NCT00703053|4045485|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4222471|NCT00703053|4045476|B10||Male|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4222472|NCT00703053|4045477|B9||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4222473|NCT00703053|4045478|B8||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4222474|NCT00703053|4045479|B7||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4222475|NCT00703053|4045480|B6||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4222476|NCT00703053|4045481|B5||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4222477|NCT00703053|4045482|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4222478|NCT00703053|4045483|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4222479|NCT00703053|4045484|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4222480|NCT00703053|4045485|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4222481|NCT00703053|4045476|B10||Female|Sex: Female, Male||Participants|Count of Participants|296|296.0||||||
4222482|NCT00703053|4045477|B9||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4222483|NCT00703053|4045478|B8||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4222484|NCT00703053|4045479|B7||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4222485|NCT00703053|4045480|B6||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4222486|NCT00703053|4045481|B5||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4222487|NCT00703053|4045482|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4222488|NCT00703053|4045483|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4222489|NCT00703053|4045484|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4222490|NCT00703053|4045485|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4222491|NCT00703053|4045476|B10|||Age||years|Mean|34.3|34.3|Standard Deviation|9.0|9.0|||
4222492|NCT00703053|4045477|B9|||Age||years|Mean|35.2|35.2|Standard Deviation|8.4|8.4|||
4222493|NCT00703053|4045478|B8|||Age||years|Mean|34.3|34.3|Standard Deviation|9.4|9.4|||
4222494|NCT00703053|4045479|B7|||Age||years|Mean|33.5|33.5|Standard Deviation|9.6|9.6|||
4222495|NCT00703053|4045480|B6|||Age||years|Mean|33.8|33.8|Standard Deviation|9.3|9.3|||
4222496|NCT00703053|4045481|B5|||Age||years|Mean|31.9|31.9|Standard Deviation|8.8|8.8|||
4222497|NCT00703053|4045482|B4|||Age||years|Mean|33.6|33.6|Standard Deviation|7.9|7.9|||
4222498|NCT00703053|4045483|B3|||Age||years|Mean|37.0|37.0|Standard Deviation|9.2|9.2|||
4222499|NCT00703053|4045484|B2|||Age||years|Mean|34.0|34.0|Standard Deviation|9.5|9.5|||
4222500|NCT00703053|4045485|B1|||Age||years|Mean|34.6|34.6|Standard Deviation|9.6|9.6|||
4222501|NCT00703053|4045476|B10||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4222502|NCT00703053|4045477|B9||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4222503|NCT00703053|4045478|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4222504|NCT00703053|4045479|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4222505|NCT00703053|4045480|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4222506|NCT00703053|4045481|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4222507|NCT00703053|4045482|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4222508|NCT00703053|4045483|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4222509|NCT00703053|4045484|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4222510|NCT00703053|4045485|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4222511|NCT00703053|4045476|B10||Between 18 and 65 years|Age||Participants|Count of Participants|505|505.0||||||
4222512|NCT00703053|4045477|B9||Between 18 and 65 years|Age||Participants|Count of Participants|103|103.0||||||
4222513|NCT00703053|4045478|B8||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
4222514|NCT00703053|4045479|B7||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4222515|NCT00703053|4045480|B6||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4222516|NCT00703053|4045481|B5||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4222517|NCT00703053|4045482|B4||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4222518|NCT00703053|4045483|B3||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4222519|NCT00703053|4045484|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4222520|NCT00703053|4045485|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4222521|NCT00703053|4045476|B10||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4222522|NCT00703053|4045477|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4222523|NCT00703053|4045478|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4222524|NCT00703053|4045479|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4222525|NCT00703053|4045480|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4222526|NCT00703053|4045481|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4222527|NCT00703053|4045482|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4222528|NCT00703053|4045483|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4222529|NCT00703053|4045484|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4222530|NCT00703053|4045485|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4222531|NCT00703014|4045677|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4222532|NCT00703014|4045678|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4222533|NCT00703014|4045679|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4222534|NCT00703014|4045677|B3||Female|Sex: Female, Male||Participants|Count of Participants|541|541.0||||||
4222535|NCT00703014|4045678|B2||Female|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
4222536|NCT00703014|4045679|B1||Female|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
4222537|NCT00703014|4045677|B3|||Age||Years|Mean|31.3|31.3|Standard Deviation|3.3|3.3|||
4222538|NCT00703014|4045678|B2|||Age||Years|Mean|31.3|31.3|Standard Deviation|3.5|3.5|||
4222539|NCT00703014|4045679|B1|||Age||Years|Mean|31.4|31.4|Standard Deviation|3.2|3.2|||
4222540|NCT00702962|4045700|B3|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4222541|NCT00702962|4045701|B2|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4222542|NCT00702962|4045702|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4222543|NCT00702962|4045700|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4222544|NCT00702962|4045701|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4222545|NCT00702962|4045702|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4222546|NCT00702962|4045700|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4222547|NCT00702962|4045701|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4222548|NCT00702962|4045702|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4222549|NCT00702962|4045700|B3|||Age||years|Mean|65.8|65.8|Standard Deviation|9.7|9.7|||
4222550|NCT00702962|4045701|B2|||Age||years|Mean|70|70.0|Standard Deviation|0|0.0|||
4222551|NCT00702962|4045702|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|10.8|10.8|||
4222552|NCT00702962|4045700|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4222553|NCT00702962|4045701|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4222554|NCT00702962|4045702|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4222555|NCT00702962|4045700|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4222556|NCT00702962|4045701|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4222557|NCT00702962|4045702|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4222558|NCT00702962|4045700|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4222559|NCT00702962|4045701|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4222560|NCT00702962|4045702|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4222561|NCT00702949|4045711|B4|United States||Region of Enrollment||participants|Number|191|191.0||||||
4222562|NCT00702949|4045712|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
4222563|NCT00702949|4045713|B2|United States||Region of Enrollment||participants|Number|66|66.0||||||
4222564|NCT00702949|4045714|B1|United States||Region of Enrollment||participants|Number|63|63.0||||||
4222565|NCT00702949|4045711|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4222566|NCT00702949|4045712|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4222567|NCT00702949|4045713|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4222568|NCT00702949|4045714|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4222569|NCT00702949|4045711|B4||Female|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4222570|NCT00702949|4045712|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4222571|NCT00702949|4045713|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4222572|NCT00702949|4045714|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4222573|NCT00702949|4045711|B4|||Age||years|Mean|60.3|60.3|Standard Deviation|8.9|8.9|||
4222574|NCT00702949|4045712|B3|||Age||years|Mean|56.6|56.6|Standard Deviation|6.4|6.4|||
4222575|NCT00702949|4045713|B2|||Age||years|Mean|60.6|60.6|Standard Deviation|9.5|9.5|||
4222576|NCT00702949|4045714|B1|||Age||years|Mean|64.5|64.5|Standard Deviation|10.6|10.6|||
4222577|NCT00702923|4045741|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4222578|NCT00702923|4045741|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4222579|NCT00702923|4045741|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4222580|NCT00702923|4045741|B1|||Age||years|Mean|64.7|64.7|Standard Deviation|5.2|5.2|||
4222581|NCT00702923|4045741|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4222582|NCT00702923|4045741|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4222583|NCT00702923|4045741|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4222584|NCT00702884|4045750|B1|United States||Region of Enrollment||patients|Number|25|25.0||||||
4222585|NCT00702884|4045750|B1|Black||Race/Ethnicity, Customized||patients|Number|2|2.0||||||
4222586|NCT00702884|4045750|B1|White||Race/Ethnicity, Customized||patients|Number|23|23.0||||||
4222587|NCT00702884|4045750|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4222588|NCT00702884|4045750|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4222589|NCT00702884|4045750|B1|||Age, Customized||years|Median|61|61.0|Full Range|||38.0|74.0|
4222590|NCT00702845|4045762|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4222591|NCT00702845|4045763|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4222592|NCT00702845|4045764|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4222593|NCT00702845|4045762|B3||Female|Sex: Female, Male||Participants|Count of Participants|396|396.0||||||
4222594|NCT00702845|4045763|B2||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4222595|NCT00702845|4045764|B1||Female|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
4222596|NCT00702845|4045762|B3|||Age||Years|Mean|31.0|31.0|Standard Deviation|3.1|3.1|||
4222597|NCT00702845|4045763|B2|||Age||Years|Mean|31.1|31.1|Standard Deviation|3.0|3.0|||
4222598|NCT00702845|4045764|B1|||Age||Years|Mean|30.9|30.9|Standard Deviation|3.2|3.2|||
4222599|NCT00702780|4045803|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4222600|NCT00702780|4045804|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4222601|NCT00702780|4045805|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4222602|NCT00702780|4045803|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4222603|NCT00702780|4045804|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4222604|NCT00702780|4045805|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4222605|NCT00702780|4045803|B3|||Age||years|Mean|74.58|74.58|Standard Deviation|8.17|8.17|||
4222606|NCT00702780|4045804|B2|||Age||years|Mean|74.82|74.82|Standard Deviation|9.19|9.19|||
4222607|NCT00702780|4045805|B1|||Age||years|Mean|74.33|74.33|Standard Deviation|7.12|7.12|||
4222608|NCT00702754|4045814|B1|North America||Region of Enrollment||participants|Number|502|502.0||||||
4222609|NCT00702754|4045814|B1||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4222610|NCT00702754|4045814|B1||Female|Sex: Female, Male||Participants|Count of Participants|341|341.0||||||
4222611|NCT00702754|4045814|B1|||Age||years|Mean|54|54.0|Standard Deviation|11|11.0|||
4222612|NCT00702754|4045814|B1||>=65 years|Age||Participants|Count of Participants|83|83.0||||||
4222613|NCT00702754|4045814|B1||Between 18 and 65 years|Age||Participants|Count of Participants|419|419.0||||||
4222614|NCT00702754|4045814|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4222615|NCT00702715|4045825|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4222616|NCT00702715|4045826|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4222617|NCT00702715|4045827|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4222618|NCT00702715|4045825|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4222619|NCT00702715|4045826|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4222620|NCT00702715|4045827|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4222621|NCT00702715|4045825|B3|||Age||years|Mean|51|51.0|Standard Deviation|16|16.0|||
4222622|NCT00702715|4045826|B2|||Age||years|Mean|45|45.0|Standard Deviation|15|15.0|||
4222623|NCT00702715|4045827|B1|||Age||years|Mean|57|57.0|Standard Deviation|16|16.0|||
4222624|NCT00702689|4045849|B1|Patient 20||Baseline Range of Motion (ROM) Percent (of Predicted)|This table lists the percentage of ROM present at baseline compared to expected ROM at a given joint. No measure of dispersion was performed because this is baseline data.|ROM Percent of Predicted|Number|-5|-5.0||||||
4222625|NCT00702689|4045849|B1|Patient 19||Baseline Range of Motion (ROM) Percent (of Predicted)|This table lists the percentage of ROM present at baseline compared to expected ROM at a given joint. No measure of dispersion was performed because this is baseline data.|ROM Percent of Predicted|Number|33|33.0||||||
4222626|NCT00702689|4045849|B1|Patient 18||Baseline Range of Motion (ROM) Percent (of Predicted)|This table lists the percentage of ROM present at baseline compared to expected ROM at a given joint. No measure of dispersion was performed because this is baseline data.|ROM Percent of Predicted|Number|54|54.0||||||
4222627|NCT00702689|4045849|B1|Patient 17||Baseline Range of Motion (ROM) Percent (of Predicted)|This table lists the percentage of ROM present at baseline compared to expected ROM at a given joint. No measure of dispersion was performed because this is baseline data.|ROM Percent of Predicted|Number|64|64.0||||||
4222628|NCT00702689|4045849|B1|Patient 16||Baseline Range of Motion (ROM) Percent (of Predicted)|This table lists the percentage of ROM present at baseline compared to expected ROM at a given joint. No measure of dispersion was performed because this is baseline data.|ROM Percent of Predicted|Number|71|71.0||||||
4222629|NCT00702689|4045849|B1|Patient 15||Baseline Range of Motion (ROM) Percent (of Predicted)|This table lists the percentage of ROM present at baseline compared to expected ROM at a given joint. No measure of dispersion was performed because this is baseline data.|ROM Percent of Predicted|Number|22|22.0||||||
4222630|NCT00702689|4045849|B1|Patient 14||Baseline Range of Motion (ROM) Percent (of Predicted)|This table lists the percentage of ROM present at baseline compared to expected ROM at a given joint. No measure of dispersion was performed because this is baseline data.|ROM Percent of Predicted|Number|32|32.0||||||
4222631|NCT00702689|4045849|B1|Patient 13||Baseline Range of Motion (ROM) Percent (of Predicted)|This table lists the percentage of ROM present at baseline compared to expected ROM at a given joint. No measure of dispersion was performed because this is baseline data.|ROM Percent of Predicted|Number|27|27.0||||||
4222632|NCT00702689|4045849|B1|Patient 12||Baseline Range of Motion (ROM) Percent (of Predicted)|This table lists the percentage of ROM present at baseline compared to expected ROM at a given joint. No measure of dispersion was performed because this is baseline data.|ROM Percent of Predicted|Number|37|37.0||||||
4222633|NCT00702689|4045849|B1|Patient 11||Baseline Range of Motion (ROM) Percent (of Predicted)|This table lists the percentage of ROM present at baseline compared to expected ROM at a given joint. No measure of dispersion was performed because this is baseline data.|ROM Percent of Predicted|Number|56|56.0||||||
4222634|NCT00702689|4045849|B1|Patient 10||Baseline Range of Motion (ROM) Percent (of Predicted)|This table lists the percentage of ROM present at baseline compared to expected ROM at a given joint. No measure of dispersion was performed because this is baseline data.|ROM Percent of Predicted|Number|-7|-7.0||||||
4222635|NCT00702689|4045849|B1|Patient 9||Baseline Range of Motion (ROM) Percent (of Predicted)|This table lists the percentage of ROM present at baseline compared to expected ROM at a given joint. No measure of dispersion was performed because this is baseline data.|ROM Percent of Predicted|Number|42|42.0||||||
4222636|NCT00702689|4045849|B1|Patient 8||Baseline Range of Motion (ROM) Percent (of Predicted)|This table lists the percentage of ROM present at baseline compared to expected ROM at a given joint. No measure of dispersion was performed because this is baseline data.|ROM Percent of Predicted|Number|35|35.0||||||
4222637|NCT00702689|4045849|B1|Patient 7||Baseline Range of Motion (ROM) Percent (of Predicted)|This table lists the percentage of ROM present at baseline compared to expected ROM at a given joint. No measure of dispersion was performed because this is baseline data.|ROM Percent of Predicted|Number|61|61.0||||||
4222638|NCT00702689|4045849|B1|Patient 6||Baseline Range of Motion (ROM) Percent (of Predicted)|This table lists the percentage of ROM present at baseline compared to expected ROM at a given joint. No measure of dispersion was performed because this is baseline data.|ROM Percent of Predicted|Number|47|47.0||||||
4222639|NCT00702689|4045849|B1|Patient 5||Baseline Range of Motion (ROM) Percent (of Predicted)|This table lists the percentage of ROM present at baseline compared to expected ROM at a given joint. No measure of dispersion was performed because this is baseline data.|ROM Percent of Predicted|Number|34|34.0||||||
4222640|NCT00702689|4045849|B1|Patient 4||Baseline Range of Motion (ROM) Percent (of Predicted)|This table lists the percentage of ROM present at baseline compared to expected ROM at a given joint. No measure of dispersion was performed because this is baseline data.|ROM Percent of Predicted|Number|7|7.0||||||
4222641|NCT00702689|4045849|B1|Patient 3||Baseline Range of Motion (ROM) Percent (of Predicted)|This table lists the percentage of ROM present at baseline compared to expected ROM at a given joint. No measure of dispersion was performed because this is baseline data.|ROM Percent of Predicted|Number|73|73.0||||||
4222642|NCT00702689|4045849|B1|Patient 2||Baseline Range of Motion (ROM) Percent (of Predicted)|This table lists the percentage of ROM present at baseline compared to expected ROM at a given joint. No measure of dispersion was performed because this is baseline data.|ROM Percent of Predicted|Number|56|56.0||||||
4222643|NCT00702689|4045849|B1|Patient 1||Baseline Range of Motion (ROM) Percent (of Predicted)|This table lists the percentage of ROM present at baseline compared to expected ROM at a given joint. No measure of dispersion was performed because this is baseline data.|ROM Percent of Predicted|Number|37|37.0||||||
4222644|NCT00702689|4045849|B1|Patient 20||Percent Body Surface Area (BSA) Nonmoveable Sclerosis at Baseline|Non-moveable sclerosis is also known as non-hidebound thickened skin. Skin thickening that is full thickness and/or fixed to underlying bone and fascia.|Percent BSA nonmoveable sclerosis|Number|23.4|23.4||||||
4222645|NCT00702689|4045849|B1|Patient 19||Percent Body Surface Area (BSA) Nonmoveable Sclerosis at Baseline|Non-moveable sclerosis is also known as non-hidebound thickened skin. Skin thickening that is full thickness and/or fixed to underlying bone and fascia.|Percent BSA nonmoveable sclerosis|Number|11.7|11.7||||||
4222646|NCT00702689|4045849|B1|Patient 18||Percent Body Surface Area (BSA) Nonmoveable Sclerosis at Baseline|Non-moveable sclerosis is also known as non-hidebound thickened skin. Skin thickening that is full thickness and/or fixed to underlying bone and fascia.|Percent BSA nonmoveable sclerosis|Number|4.5|4.5||||||
4222647|NCT00702689|4045849|B1|Patient 17||Percent Body Surface Area (BSA) Nonmoveable Sclerosis at Baseline|Non-moveable sclerosis is also known as non-hidebound thickened skin. Skin thickening that is full thickness and/or fixed to underlying bone and fascia.|Percent BSA nonmoveable sclerosis|Number|0|0.0||||||
4222648|NCT00702689|4045849|B1|Patient 16||Percent Body Surface Area (BSA) Nonmoveable Sclerosis at Baseline|Non-moveable sclerosis is also known as non-hidebound thickened skin. Skin thickening that is full thickness and/or fixed to underlying bone and fascia.|Percent BSA nonmoveable sclerosis|Number|9.54|9.54||||||
4222649|NCT00702689|4045849|B1|Patient 15||Percent Body Surface Area (BSA) Nonmoveable Sclerosis at Baseline|Non-moveable sclerosis is also known as non-hidebound thickened skin. Skin thickening that is full thickness and/or fixed to underlying bone and fascia.|Percent BSA nonmoveable sclerosis|Number|10.8|10.8||||||
4222650|NCT00702689|4045849|B1|Patient 14||Percent Body Surface Area (BSA) Nonmoveable Sclerosis at Baseline|Non-moveable sclerosis is also known as non-hidebound thickened skin. Skin thickening that is full thickness and/or fixed to underlying bone and fascia.|Percent BSA nonmoveable sclerosis|Number|31.5|31.5||||||
4222651|NCT00702689|4045849|B1|Patient 13||Percent Body Surface Area (BSA) Nonmoveable Sclerosis at Baseline|Non-moveable sclerosis is also known as non-hidebound thickened skin. Skin thickening that is full thickness and/or fixed to underlying bone and fascia.|Percent BSA nonmoveable sclerosis|Number|71.1|71.1||||||
4222652|NCT00702689|4045849|B1|Patient 12||Percent Body Surface Area (BSA) Nonmoveable Sclerosis at Baseline|Non-moveable sclerosis is also known as non-hidebound thickened skin. Skin thickening that is full thickness and/or fixed to underlying bone and fascia.|Percent BSA nonmoveable sclerosis|Number|8.64|8.64||||||
4222653|NCT00702689|4045849|B1|Patient 11||Percent Body Surface Area (BSA) Nonmoveable Sclerosis at Baseline|Non-moveable sclerosis is also known as non-hidebound thickened skin. Skin thickening that is full thickness and/or fixed to underlying bone and fascia.|Percent BSA nonmoveable sclerosis|Number|0|0.0||||||
4222654|NCT00702689|4045849|B1|Patient 10||Percent Body Surface Area (BSA) Nonmoveable Sclerosis at Baseline|Non-moveable sclerosis is also known as non-hidebound thickened skin. Skin thickening that is full thickness and/or fixed to underlying bone and fascia.|Percent BSA nonmoveable sclerosis|Number|8.28|8.28||||||
4222655|NCT00702689|4045849|B1|Patient 9||Percent Body Surface Area (BSA) Nonmoveable Sclerosis at Baseline|Non-moveable sclerosis is also known as non-hidebound thickened skin. Skin thickening that is full thickness and/or fixed to underlying bone and fascia.|Percent BSA nonmoveable sclerosis|Number|9|9.0||||||
4222656|NCT00702689|4045849|B1|Patient 8||Percent Body Surface Area (BSA) Nonmoveable Sclerosis at Baseline|Non-moveable sclerosis is also known as non-hidebound thickened skin. Skin thickening that is full thickness and/or fixed to underlying bone and fascia.|Percent BSA nonmoveable sclerosis|Number|36.9|36.9||||||
4222657|NCT00702689|4045849|B1|Patient 7||Percent Body Surface Area (BSA) Nonmoveable Sclerosis at Baseline|Non-moveable sclerosis is also known as non-hidebound thickened skin. Skin thickening that is full thickness and/or fixed to underlying bone and fascia.|Percent BSA nonmoveable sclerosis|Number|32.4|32.4||||||
4222658|NCT00702689|4045849|B1|Patient 6||Percent Body Surface Area (BSA) Nonmoveable Sclerosis at Baseline|Non-moveable sclerosis is also known as non-hidebound thickened skin. Skin thickening that is full thickness and/or fixed to underlying bone and fascia.|Percent BSA nonmoveable sclerosis|Number|0|0.0||||||
4222659|NCT00702689|4045849|B1|Patient 5||Percent Body Surface Area (BSA) Nonmoveable Sclerosis at Baseline|Non-moveable sclerosis is also known as non-hidebound thickened skin. Skin thickening that is full thickness and/or fixed to underlying bone and fascia.|Percent BSA nonmoveable sclerosis|Number|77.94|77.94||||||
4222660|NCT00702689|4045849|B1|Patient 4||Percent Body Surface Area (BSA) Nonmoveable Sclerosis at Baseline|Non-moveable sclerosis is also known as non-hidebound thickened skin. Skin thickening that is full thickness and/or fixed to underlying bone and fascia.|Percent BSA nonmoveable sclerosis|Number|19.98|19.98||||||
4222661|NCT00702689|4045849|B1|Patient 3||Percent Body Surface Area (BSA) Nonmoveable Sclerosis at Baseline|Non-moveable sclerosis is also known as non-hidebound thickened skin. Skin thickening that is full thickness and/or fixed to underlying bone and fascia.|Percent BSA nonmoveable sclerosis|Number|36.9|36.9||||||
4222662|NCT00702689|4045849|B1|Patient 2||Percent Body Surface Area (BSA) Nonmoveable Sclerosis at Baseline|Non-moveable sclerosis is also known as non-hidebound thickened skin. Skin thickening that is full thickness and/or fixed to underlying bone and fascia.|Percent BSA nonmoveable sclerosis|Number|56.7|56.7||||||
4222663|NCT00702689|4045849|B1|Patient 1||Percent Body Surface Area (BSA) Nonmoveable Sclerosis at Baseline|Non-moveable sclerosis is also known as non-hidebound thickened skin. Skin thickening that is full thickness and/or fixed to underlying bone and fascia.|Percent BSA nonmoveable sclerosis|Number|7.56|7.56||||||
4222664|NCT00702689|4045849|B1|Patient 20||Percent Body Surface Area (BSA) Moveable Sclerosis at Baseline|Moveable sclerosis is also known as Morphea-like skin. Skin thickening that is full thickness and/or fixed to underlying bone and fascia.|Percent BSA moveable sclerosis|Number|0|0.0||||||
4222665|NCT00702689|4045849|B1|Patient 19||Percent Body Surface Area (BSA) Moveable Sclerosis at Baseline|Moveable sclerosis is also known as Morphea-like skin. Skin thickening that is full thickness and/or fixed to underlying bone and fascia.|Percent BSA moveable sclerosis|Number|9.45|9.45||||||
4222666|NCT00702689|4045849|B1|Patient 18||Percent Body Surface Area (BSA) Moveable Sclerosis at Baseline|Moveable sclerosis is also known as Morphea-like skin. Skin thickening that is full thickness and/or fixed to underlying bone and fascia.|Percent BSA moveable sclerosis|Number|15.84|15.84||||||
4222667|NCT00702689|4045849|B1|Patient 17||Percent Body Surface Area (BSA) Moveable Sclerosis at Baseline|Moveable sclerosis is also known as Morphea-like skin. Skin thickening that is full thickness and/or fixed to underlying bone and fascia.|Percent BSA moveable sclerosis|Number|84.24|84.24||||||
4222668|NCT00702689|4045849|B1|Patient 16||Percent Body Surface Area (BSA) Moveable Sclerosis at Baseline|Moveable sclerosis is also known as Morphea-like skin. Skin thickening that is full thickness and/or fixed to underlying bone and fascia.|Percent BSA moveable sclerosis|Number|0|0.0||||||
4222669|NCT00702689|4045849|B1|Patient 15||Percent Body Surface Area (BSA) Moveable Sclerosis at Baseline|Moveable sclerosis is also known as Morphea-like skin. Skin thickening that is full thickness and/or fixed to underlying bone and fascia.|Percent BSA moveable sclerosis|Number|49.77|49.77||||||
4222670|NCT00702689|4045849|B1|Patient 14||Percent Body Surface Area (BSA) Moveable Sclerosis at Baseline|Moveable sclerosis is also known as Morphea-like skin. Skin thickening that is full thickness and/or fixed to underlying bone and fascia.|Percent BSA moveable sclerosis|Number|5.4|5.4||||||
4222671|NCT00702689|4045849|B1|Patient 13||Percent Body Surface Area (BSA) Moveable Sclerosis at Baseline|Moveable sclerosis is also known as Morphea-like skin. Skin thickening that is full thickness and/or fixed to underlying bone and fascia.|Percent BSA moveable sclerosis|Number|1.8|1.8||||||
4222672|NCT00702689|4045849|B1|Patient 12||Percent Body Surface Area (BSA) Moveable Sclerosis at Baseline|Moveable sclerosis is also known as Morphea-like skin. Skin thickening that is full thickness and/or fixed to underlying bone and fascia.|Percent BSA moveable sclerosis|Number|12.6|12.6||||||
4222673|NCT00702689|4045849|B1|Patient 11||Percent Body Surface Area (BSA) Moveable Sclerosis at Baseline|Moveable sclerosis is also known as Morphea-like skin. Skin thickening that is full thickness and/or fixed to underlying bone and fascia.|Percent BSA moveable sclerosis|Number|82.08|82.08||||||
4222674|NCT00702689|4045849|B1|Patient 10||Percent Body Surface Area (BSA) Moveable Sclerosis at Baseline|Moveable sclerosis is also known as Morphea-like skin. Skin thickening that is full thickness and/or fixed to underlying bone and fascia.|Percent BSA moveable sclerosis|Number|0|0.0||||||
4222675|NCT00702689|4045849|B1|Patient 9||Percent Body Surface Area (BSA) Moveable Sclerosis at Baseline|Moveable sclerosis is also known as Morphea-like skin. Skin thickening that is full thickness and/or fixed to underlying bone and fascia.|Percent BSA moveable sclerosis|Number|3.33|3.33||||||
4222676|NCT00702689|4045849|B1|Patient 8||Percent Body Surface Area (BSA) Moveable Sclerosis at Baseline|Moveable sclerosis is also known as Morphea-like skin. Skin thickening that is full thickness and/or fixed to underlying bone and fascia.|Percent BSA moveable sclerosis|Number|15.3|15.3||||||
4222677|NCT00702689|4045849|B1|Patient 7||Percent Body Surface Area (BSA) Moveable Sclerosis at Baseline|Moveable sclerosis is also known as Morphea-like skin. Skin thickening that is full thickness and/or fixed to underlying bone and fascia.|Percent BSA moveable sclerosis|Number|29.7|29.7||||||
4222678|NCT00702689|4045849|B1|Patient 6||Percent Body Surface Area (BSA) Moveable Sclerosis at Baseline|Moveable sclerosis is also known as Morphea-like skin. Skin thickening that is full thickness and/or fixed to underlying bone and fascia.|Percent BSA moveable sclerosis|Number|59.4|59.4||||||
4222679|NCT00702689|4045849|B1|Patient 5||Percent Body Surface Area (BSA) Moveable Sclerosis at Baseline|Moveable sclerosis is also known as Morphea-like skin. Skin thickening that is full thickness and/or fixed to underlying bone and fascia.|Percent BSA moveable sclerosis|Number|8.1|8.1||||||
4222680|NCT00702689|4045849|B1|Patient 4||Percent Body Surface Area (BSA) Moveable Sclerosis at Baseline|Moveable sclerosis is also known as Morphea-like skin. Skin thickening that is full thickness and/or fixed to underlying bone and fascia.|Percent BSA moveable sclerosis|Number|0.18|0.18||||||
4222681|NCT00702689|4045849|B1|Patient 3||Percent Body Surface Area (BSA) Moveable Sclerosis at Baseline|Moveable sclerosis is also known as Morphea-like skin. Skin thickening that is full thickness and/or fixed to underlying bone and fascia.|Percent BSA moveable sclerosis|Number|6.3|6.3||||||
4222682|NCT00702689|4045849|B1|Patient 2||Percent Body Surface Area (BSA) Moveable Sclerosis at Baseline|Moveable sclerosis is also known as Morphea-like skin. Skin thickening that is full thickness and/or fixed to underlying bone and fascia.|Percent BSA moveable sclerosis|Number|2.7|2.7||||||
4222683|NCT00702689|4045849|B1|Patient 1||Percent Body Surface Area (BSA) Moveable Sclerosis at Baseline|Moveable sclerosis is also known as Morphea-like skin. Skin thickening that is full thickness and/or fixed to underlying bone and fascia.|Percent BSA moveable sclerosis|Number|57.15|57.15||||||
4222684|NCT00702689|4045849|B1|Patient 20||Measure of Number of Organs with Graft Versus Host Disease (GVHD)||affected organs|Number|7|7.0||||||
4222685|NCT00702689|4045849|B1|Patient 19||Measure of Number of Organs with Graft Versus Host Disease (GVHD)||affected organs|Number|4|4.0||||||
4222686|NCT00702689|4045849|B1|Patient 18||Measure of Number of Organs with Graft Versus Host Disease (GVHD)||affected organs|Number|4|4.0||||||
4222687|NCT00702689|4045849|B1|Patient 17||Measure of Number of Organs with Graft Versus Host Disease (GVHD)||affected organs|Number|4|4.0||||||
4222688|NCT00702689|4045849|B1|Patient 16||Measure of Number of Organs with Graft Versus Host Disease (GVHD)||affected organs|Number|2|2.0||||||
4222689|NCT00702689|4045849|B1|Patient 15||Measure of Number of Organs with Graft Versus Host Disease (GVHD)||affected organs|Number|6|6.0||||||
4222690|NCT00702689|4045849|B1|Patient 14||Measure of Number of Organs with Graft Versus Host Disease (GVHD)||affected organs|Number|5|5.0||||||
4222691|NCT00702689|4045849|B1|Patient 13||Measure of Number of Organs with Graft Versus Host Disease (GVHD)||affected organs|Number|6|6.0||||||
4222692|NCT00702689|4045849|B1|Patient 12||Measure of Number of Organs with Graft Versus Host Disease (GVHD)||affected organs|Number|6|6.0||||||
4222693|NCT00702689|4045849|B1|Patient 11||Measure of Number of Organs with Graft Versus Host Disease (GVHD)||affected organs|Number|7|7.0||||||
4222694|NCT00702689|4045849|B1|Patient 10||Measure of Number of Organs with Graft Versus Host Disease (GVHD)||affected organs|Number|5|5.0||||||
4222695|NCT00702689|4045849|B1|Patient 9||Measure of Number of Organs with Graft Versus Host Disease (GVHD)||affected organs|Number|7|7.0||||||
4222696|NCT00702689|4045849|B1|Patient 8||Measure of Number of Organs with Graft Versus Host Disease (GVHD)||affected organs|Number|6|6.0||||||
4222697|NCT00702689|4045849|B1|Patient 7||Measure of Number of Organs with Graft Versus Host Disease (GVHD)||affected organs|Number|7|7.0||||||
4222698|NCT00702689|4045849|B1|Patient 6||Measure of Number of Organs with Graft Versus Host Disease (GVHD)||affected organs|Number|7|7.0||||||
4222699|NCT00702689|4045849|B1|Patient 5||Measure of Number of Organs with Graft Versus Host Disease (GVHD)||affected organs|Number|6|6.0||||||
4222700|NCT00702689|4045849|B1|Patient 4||Measure of Number of Organs with Graft Versus Host Disease (GVHD)||affected organs|Number|4|4.0||||||
4222701|NCT00702689|4045849|B1|Patient 3||Measure of Number of Organs with Graft Versus Host Disease (GVHD)||affected organs|Number|3|3.0||||||
4222702|NCT00702689|4045849|B1|Patient 2||Measure of Number of Organs with Graft Versus Host Disease (GVHD)||affected organs|Number|4|4.0||||||
4222703|NCT00702689|4045849|B1|Patient 1||Measure of Number of Organs with Graft Versus Host Disease (GVHD)||affected organs|Number|5|5.0||||||
4222704|NCT00702689|4045849|B1|Patient 20||Average National Institutes of Health Chronic Graft Versus Host Disease (cGVHD) Score at Baseline|The scores are the average scores for each patient based on the sum of individual organ involvement (0-3) for 7 organs (males) and 8 organs (females) divided by 7 or 8, respectively. This is demographic data and no measure of dispersion was performed. An organ score of zero is none, and 3 is severely affected.|scores on a scale|Number|2.00|2.0||||||
4222705|NCT00702689|4045849|B1|Patient 19||Average National Institutes of Health Chronic Graft Versus Host Disease (cGVHD) Score at Baseline|The scores are the average scores for each patient based on the sum of individual organ involvement (0-3) for 7 organs (males) and 8 organs (females) divided by 7 or 8, respectively. This is demographic data and no measure of dispersion was performed. An organ score of zero is none, and 3 is severely affected.|scores on a scale|Number|1.14|1.14||||||
4222706|NCT00702689|4045849|B1|Patient 18||Average National Institutes of Health Chronic Graft Versus Host Disease (cGVHD) Score at Baseline|The scores are the average scores for each patient based on the sum of individual organ involvement (0-3) for 7 organs (males) and 8 organs (females) divided by 7 or 8, respectively. This is demographic data and no measure of dispersion was performed. An organ score of zero is none, and 3 is severely affected.|scores on a scale|Number|1.57|1.57||||||
4222888|NCT00702377|4045988|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4222707|NCT00702689|4045849|B1|Patient 17||Average National Institutes of Health Chronic Graft Versus Host Disease (cGVHD) Score at Baseline|The scores are the average scores for each patient based on the sum of individual organ involvement (0-3) for 7 organs (males) and 8 organs (females) divided by 7 or 8, respectively. This is demographic data and no measure of dispersion was performed. An organ score of zero is none, and 3 is severely affected.|scores on a scale|Number|1.13|1.13||||||
4222708|NCT00702689|4045849|B1|Patient 16||Average National Institutes of Health Chronic Graft Versus Host Disease (cGVHD) Score at Baseline|The scores are the average scores for each patient based on the sum of individual organ involvement (0-3) for 7 organs (males) and 8 organs (females) divided by 7 or 8, respectively. This is demographic data and no measure of dispersion was performed. An organ score of zero is none, and 3 is severely affected.|scores on a scale|Number|.86|0.86||||||
4222709|NCT00702689|4045849|B1|Patient 15||Average National Institutes of Health Chronic Graft Versus Host Disease (cGVHD) Score at Baseline|The scores are the average scores for each patient based on the sum of individual organ involvement (0-3) for 7 organs (males) and 8 organs (females) divided by 7 or 8, respectively. This is demographic data and no measure of dispersion was performed. An organ score of zero is none, and 3 is severely affected.|scores on a scale|Number|1.43|1.43||||||
4222710|NCT00702689|4045849|B1|Patient 14||Average National Institutes of Health Chronic Graft Versus Host Disease (cGVHD) Score at Baseline|The scores are the average scores for each patient based on the sum of individual organ involvement (0-3) for 7 organs (males) and 8 organs (females) divided by 7 or 8, respectively. This is demographic data and no measure of dispersion was performed. An organ score of zero is none, and 3 is severely affected.|scores on a scale|Number|1.29|1.29||||||
4222711|NCT00702689|4045849|B1|Patient 13||Average National Institutes of Health Chronic Graft Versus Host Disease (cGVHD) Score at Baseline|The scores are the average scores for each patient based on the sum of individual organ involvement (0-3) for 7 organs (males) and 8 organs (females) divided by 7 or 8, respectively. This is demographic data and no measure of dispersion was performed. An organ score of zero is none, and 3 is severely affected.|scores on a scale|Number|1.38|1.38||||||
4222712|NCT00702689|4045849|B1|Patient 12||Average National Institutes of Health Chronic Graft Versus Host Disease (cGVHD) Score at Baseline|The scores are the average scores for each patient based on the sum of individual organ involvement (0-3) for 7 organs (males) and 8 organs (females) divided by 7 or 8, respectively. This is demographic data and no measure of dispersion was performed. An organ score of zero is none, and 3 is severely affected.|scores on a scale|Number|1.43|1.43||||||
4222713|NCT00702689|4045849|B1|Patient 11||Average National Institutes of Health Chronic Graft Versus Host Disease (cGVHD) Score at Baseline|The scores are the average scores for each patient based on the sum of individual organ involvement (0-3) for 7 organs (males) and 8 organs (females) divided by 7 or 8, respectively. This is demographic data and no measure of dispersion was performed. An organ score of zero is none, and 3 is severely affected.|scores on a scale|Number|1.75|1.75||||||
4222714|NCT00702689|4045849|B1|Patient 10||Average National Institutes of Health Chronic Graft Versus Host Disease (cGVHD) Score at Baseline|The scores are the average scores for each patient based on the sum of individual organ involvement (0-3) for 7 organs (males) and 8 organs (females) divided by 7 or 8, respectively. This is demographic data and no measure of dispersion was performed. An organ score of zero is none, and 3 is severely affected.|scores on a scale|Number|1.43|1.43||||||
4222715|NCT00702689|4045849|B1|Patient 9||Average National Institutes of Health Chronic Graft Versus Host Disease (cGVHD) Score at Baseline|The scores are the average scores for each patient based on the sum of individual organ involvement (0-3) for 7 organs (males) and 8 organs (females) divided by 7 or 8, respectively. This is demographic data and no measure of dispersion was performed. An organ score of zero is none, and 3 is severely affected.|scores on a scale|Number|1.71|1.71||||||
4222716|NCT00702689|4045849|B1|Patient 8||Average National Institutes of Health Chronic Graft Versus Host Disease (cGVHD) Score at Baseline|The scores are the average scores for each patient based on the sum of individual organ involvement (0-3) for 7 organs (males) and 8 organs (females) divided by 7 or 8, respectively. This is demographic data and no measure of dispersion was performed. An organ score of zero is none, and 3 is severely affected.|scores on a scale|Number|1.57|1.57||||||
4222717|NCT00702689|4045849|B1|Patient 7||Average National Institutes of Health Chronic Graft Versus Host Disease (cGVHD) Score at Baseline|The scores are the average scores for each patient based on the sum of individual organ involvement (0-3) for 7 organs (males) and 8 organs (females) divided by 7 or 8, respectively. This is demographic data and no measure of dispersion was performed. An organ score of zero is none, and 3 is severely affected.|scores on a scale|Number|1.90|1.9||||||
4222718|NCT00702689|4045849|B1|Patient 6||Average National Institutes of Health Chronic Graft Versus Host Disease (cGVHD) Score at Baseline|The scores are the average scores for each patient based on the sum of individual organ involvement (0-3) for 7 organs (males) and 8 organs (females) divided by 7 or 8, respectively. This is demographic data and no measure of dispersion was performed. An organ score of zero is none, and 3 is severely affected.|scores on a scale|Number|1.86|1.86||||||
4222719|NCT00702689|4045849|B1|Patient 5||Average National Institutes of Health Chronic Graft Versus Host Disease (cGVHD) Score at Baseline|The scores are the average scores for each patient based on the sum of individual organ involvement (0-3) for 7 organs (males) and 8 organs (females) divided by 7 or 8, respectively. This is demographic data and no measure of dispersion was performed. An organ score of zero is none, and 3 is severely affected.|scores on a scale|Number|1.48|1.48||||||
4222720|NCT00702689|4045849|B1|Patient 4||Average National Institutes of Health Chronic Graft Versus Host Disease (cGVHD) Score at Baseline|The scores are the average scores for each patient based on the sum of individual organ involvement (0-3) for 7 organs (males) and 8 organs (females) divided by 7 or 8, respectively. This is demographic data and no measure of dispersion was performed. An organ score of zero is none, and 3 is severely affected.|scores on a scale|Number|1.0|1.0||||||
4222721|NCT00702689|4045849|B1|Patient 3||Average National Institutes of Health Chronic Graft Versus Host Disease (cGVHD) Score at Baseline|The scores are the average scores for each patient based on the sum of individual organ involvement (0-3) for 7 organs (males) and 8 organs (females) divided by 7 or 8, respectively. This is demographic data and no measure of dispersion was performed. An organ score of zero is none, and 3 is severely affected.|scores on a scale|Number|.75|0.75||||||
4222778|NCT00702689|4045849|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4222722|NCT00702689|4045849|B1|Patient 2||Average National Institutes of Health Chronic Graft Versus Host Disease (cGVHD) Score at Baseline|The scores are the average scores for each patient based on the sum of individual organ involvement (0-3) for 7 organs (males) and 8 organs (females) divided by 7 or 8, respectively. This is demographic data and no measure of dispersion was performed. An organ score of zero is none, and 3 is severely affected.|scores on a scale|Number|1.14|1.14||||||
4222723|NCT00702689|4045849|B1|Patient 1||Average National Institutes of Health Chronic Graft Versus Host Disease (cGVHD) Score at Baseline|The scores are the average scores for each patient based on the sum of individual organ involvement (0-3) for 7 organs (males) and 8 organs (females) divided by 7 or 8, respectively. This is demographic data and no measure of dispersion was performed. An organ score of zero is none, and 3 is severely affected.|scores on a scale|Number|1.28|1.28||||||
4222724|NCT00702689|4045849|B1|Patient 20||Assessable Joints at Baseline|*Patient 13 started with 3 measurable joints at enrollment on study. Patient experienced an episode of acute shoulder pain while on study, and evaluation revealed avascular necrosis of that shoulder. Therefore, only 2 joints were used in the final analysis.|joints|Number|3|3.0||||||
4222725|NCT00702689|4045849|B1|Patient 19||Assessable Joints at Baseline|*Patient 13 started with 3 measurable joints at enrollment on study. Patient experienced an episode of acute shoulder pain while on study, and evaluation revealed avascular necrosis of that shoulder. Therefore, only 2 joints were used in the final analysis.|joints|Number|3|3.0||||||
4222726|NCT00702689|4045849|B1|Patient 18||Assessable Joints at Baseline|*Patient 13 started with 3 measurable joints at enrollment on study. Patient experienced an episode of acute shoulder pain while on study, and evaluation revealed avascular necrosis of that shoulder. Therefore, only 2 joints were used in the final analysis.|joints|Number|3|3.0||||||
4222727|NCT00702689|4045849|B1|Patient 17||Assessable Joints at Baseline|*Patient 13 started with 3 measurable joints at enrollment on study. Patient experienced an episode of acute shoulder pain while on study, and evaluation revealed avascular necrosis of that shoulder. Therefore, only 2 joints were used in the final analysis.|joints|Number|3|3.0||||||
4222728|NCT00702689|4045849|B1|Patient 16||Assessable Joints at Baseline|*Patient 13 started with 3 measurable joints at enrollment on study. Patient experienced an episode of acute shoulder pain while on study, and evaluation revealed avascular necrosis of that shoulder. Therefore, only 2 joints were used in the final analysis.|joints|Number|1|1.0||||||
4222729|NCT00702689|4045849|B1|Patient 15||Assessable Joints at Baseline|*Patient 13 started with 3 measurable joints at enrollment on study. Patient experienced an episode of acute shoulder pain while on study, and evaluation revealed avascular necrosis of that shoulder. Therefore, only 2 joints were used in the final analysis.|joints|Number|3|3.0||||||
4222730|NCT00702689|4045849|B1|Patient 14||Assessable Joints at Baseline|*Patient 13 started with 3 measurable joints at enrollment on study. Patient experienced an episode of acute shoulder pain while on study, and evaluation revealed avascular necrosis of that shoulder. Therefore, only 2 joints were used in the final analysis.|joints|Number|3|3.0||||||
4222731|NCT00702689|4045849|B1|*Patient 13||Assessable Joints at Baseline|*Patient 13 started with 3 measurable joints at enrollment on study. Patient experienced an episode of acute shoulder pain while on study, and evaluation revealed avascular necrosis of that shoulder. Therefore, only 2 joints were used in the final analysis.|joints|Number|3|3.0||||||
4222732|NCT00702689|4045849|B1|Patient 12||Assessable Joints at Baseline|*Patient 13 started with 3 measurable joints at enrollment on study. Patient experienced an episode of acute shoulder pain while on study, and evaluation revealed avascular necrosis of that shoulder. Therefore, only 2 joints were used in the final analysis.|joints|Number|3|3.0||||||
4222733|NCT00702689|4045849|B1|Patient 11||Assessable Joints at Baseline|*Patient 13 started with 3 measurable joints at enrollment on study. Patient experienced an episode of acute shoulder pain while on study, and evaluation revealed avascular necrosis of that shoulder. Therefore, only 2 joints were used in the final analysis.|joints|Number|3|3.0||||||
4222734|NCT00702689|4045849|B1|Patient 10||Assessable Joints at Baseline|*Patient 13 started with 3 measurable joints at enrollment on study. Patient experienced an episode of acute shoulder pain while on study, and evaluation revealed avascular necrosis of that shoulder. Therefore, only 2 joints were used in the final analysis.|joints|Number|3|3.0||||||
4222735|NCT00702689|4045849|B1|Patient 9||Assessable Joints at Baseline|*Patient 13 started with 3 measurable joints at enrollment on study. Patient experienced an episode of acute shoulder pain while on study, and evaluation revealed avascular necrosis of that shoulder. Therefore, only 2 joints were used in the final analysis.|joints|Number|3|3.0||||||
4222736|NCT00702689|4045849|B1|Patient 8||Assessable Joints at Baseline|*Patient 13 started with 3 measurable joints at enrollment on study. Patient experienced an episode of acute shoulder pain while on study, and evaluation revealed avascular necrosis of that shoulder. Therefore, only 2 joints were used in the final analysis.|joints|Number|3|3.0||||||
4222737|NCT00702689|4045849|B1|Patient 7||Assessable Joints at Baseline|*Patient 13 started with 3 measurable joints at enrollment on study. Patient experienced an episode of acute shoulder pain while on study, and evaluation revealed avascular necrosis of that shoulder. Therefore, only 2 joints were used in the final analysis.|joints|Number|3|3.0||||||
4222738|NCT00702689|4045849|B1|Patient 6||Assessable Joints at Baseline|*Patient 13 started with 3 measurable joints at enrollment on study. Patient experienced an episode of acute shoulder pain while on study, and evaluation revealed avascular necrosis of that shoulder. Therefore, only 2 joints were used in the final analysis.|joints|Number|3|3.0||||||
4222739|NCT00702689|4045849|B1|Patient 5||Assessable Joints at Baseline|*Patient 13 started with 3 measurable joints at enrollment on study. Patient experienced an episode of acute shoulder pain while on study, and evaluation revealed avascular necrosis of that shoulder. Therefore, only 2 joints were used in the final analysis.|joints|Number|3|3.0||||||
4222740|NCT00702689|4045849|B1|Patient 4||Assessable Joints at Baseline|*Patient 13 started with 3 measurable joints at enrollment on study. Patient experienced an episode of acute shoulder pain while on study, and evaluation revealed avascular necrosis of that shoulder. Therefore, only 2 joints were used in the final analysis.|joints|Number|3|3.0||||||
4222741|NCT00702689|4045849|B1|Patient 3||Assessable Joints at Baseline|*Patient 13 started with 3 measurable joints at enrollment on study. Patient experienced an episode of acute shoulder pain while on study, and evaluation revealed avascular necrosis of that shoulder. Therefore, only 2 joints were used in the final analysis.|joints|Number|2|2.0||||||
4222887|NCT00702377|4045987|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4222742|NCT00702689|4045849|B1|Patient 2||Assessable Joints at Baseline|*Patient 13 started with 3 measurable joints at enrollment on study. Patient experienced an episode of acute shoulder pain while on study, and evaluation revealed avascular necrosis of that shoulder. Therefore, only 2 joints were used in the final analysis.|joints|Number|3|3.0||||||
4222743|NCT00702689|4045849|B1|Patient 1||Assessable Joints at Baseline|*Patient 13 started with 3 measurable joints at enrollment on study. Patient experienced an episode of acute shoulder pain while on study, and evaluation revealed avascular necrosis of that shoulder. Therefore, only 2 joints were used in the final analysis.|joints|Number|3|3.0||||||
4222744|NCT00702689|4045849|B1|None||Concomitant Immunosuppressive Medication (ISM)|Pred:prednisone; tacro:tacrolimus; MPred:methylprednisolone; MTX:methotrexate; siro:sirolimus; and MMF:mycophenolate mofetil|Participants|Count of Participants|1|1.0||||||
4222745|NCT00702689|4045849|B1|Siro||Concomitant Immunosuppressive Medication (ISM)|Pred:prednisone; tacro:tacrolimus; MPred:methylprednisolone; MTX:methotrexate; siro:sirolimus; and MMF:mycophenolate mofetil|Participants|Count of Participants|1|1.0||||||
4222746|NCT00702689|4045849|B1|MPred/tacro/MMF||Concomitant Immunosuppressive Medication (ISM)|Pred:prednisone; tacro:tacrolimus; MPred:methylprednisolone; MTX:methotrexate; siro:sirolimus; and MMF:mycophenolate mofetil|Participants|Count of Participants|1|1.0||||||
4222747|NCT00702689|4045849|B1|Siro/MMF||Concomitant Immunosuppressive Medication (ISM)|Pred:prednisone; tacro:tacrolimus; MPred:methylprednisolone; MTX:methotrexate; siro:sirolimus; and MMF:mycophenolate mofetil|Participants|Count of Participants|1|1.0||||||
4222748|NCT00702689|4045849|B1|Pred/MMF||Concomitant Immunosuppressive Medication (ISM)|Pred:prednisone; tacro:tacrolimus; MPred:methylprednisolone; MTX:methotrexate; siro:sirolimus; and MMF:mycophenolate mofetil|Participants|Count of Participants|1|1.0||||||
4222749|NCT00702689|4045849|B1|Tacro/MMF||Concomitant Immunosuppressive Medication (ISM)|Pred:prednisone; tacro:tacrolimus; MPred:methylprednisolone; MTX:methotrexate; siro:sirolimus; and MMF:mycophenolate mofetil|Participants|Count of Participants|3|3.0||||||
4222750|NCT00702689|4045849|B1|Pred/tacro/siro||Concomitant Immunosuppressive Medication (ISM)|Pred:prednisone; tacro:tacrolimus; MPred:methylprednisolone; MTX:methotrexate; siro:sirolimus; and MMF:mycophenolate mofetil|Participants|Count of Participants|1|1.0||||||
4222751|NCT00702689|4045849|B1|Tacro||Concomitant Immunosuppressive Medication (ISM)|Pred:prednisone; tacro:tacrolimus; MPred:methylprednisolone; MTX:methotrexate; siro:sirolimus; and MMF:mycophenolate mofetil|Participants|Count of Participants|1|1.0||||||
4222752|NCT00702689|4045849|B1|Pred/siro/MMF||Concomitant Immunosuppressive Medication (ISM)|Pred:prednisone; tacro:tacrolimus; MPred:methylprednisolone; MTX:methotrexate; siro:sirolimus; and MMF:mycophenolate mofetil|Participants|Count of Participants|2|2.0||||||
4222753|NCT00702689|4045849|B1|MPred/tacro/siro/MMF||Concomitant Immunosuppressive Medication (ISM)|Pred:prednisone; tacro:tacrolimus; MPred:methylprednisolone; MTX:methotrexate; siro:sirolimus; and MMF:mycophenolate mofetil|Participants|Count of Participants|1|1.0||||||
4222754|NCT00702689|4045849|B1|Pred/siro/tacro||Concomitant Immunosuppressive Medication (ISM)|Pred:prednisone; tacro:tacrolimus; MPred:methylprednisolone; MTX:methotrexate; siro:sirolimus; and MMF:mycophenolate mofetil|Participants|Count of Participants|1|1.0||||||
4222755|NCT00702689|4045849|B1|Pred/siro||Concomitant Immunosuppressive Medication (ISM)|Pred:prednisone; tacro:tacrolimus; MPred:methylprednisolone; MTX:methotrexate; siro:sirolimus; and MMF:mycophenolate mofetil|Participants|Count of Participants|2|2.0||||||
4222756|NCT00702689|4045849|B1|MPred/MTX||Concomitant Immunosuppressive Medication (ISM)|Pred:prednisone; tacro:tacrolimus; MPred:methylprednisolone; MTX:methotrexate; siro:sirolimus; and MMF:mycophenolate mofetil|Participants|Count of Participants|1|1.0||||||
4222757|NCT00702689|4045849|B1|Pred||Concomitant Immunosuppressive Medication (ISM)|Pred:prednisone; tacro:tacrolimus; MPred:methylprednisolone; MTX:methotrexate; siro:sirolimus; and MMF:mycophenolate mofetil|Participants|Count of Participants|1|1.0||||||
4222758|NCT00702689|4045849|B1|Pred/tacro||Concomitant Immunosuppressive Medication (ISM)|Pred:prednisone; tacro:tacrolimus; MPred:methylprednisolone; MTX:methotrexate; siro:sirolimus; and MMF:mycophenolate mofetil|Participants|Count of Participants|2|2.0||||||
4222759|NCT00702689|4045849|B1|||Months from transplant||Months|Median|55.4|55.4|Full Range|||12.7|121.0|
4222760|NCT00702689|4045849|B1|||Months from Chronic Graft Versus Host Disease (cGVHD) diagnosis||Months|Median|39.85|39.85|Full Range|||4.8|112.0|
4222761|NCT00702689|4045849|B1|||Donor Match (6/6)||Percentage of participants|Number|90|90.0||||||
4222762|NCT00702689|4045849|B1|Cord||Donor Source||Percentage of participants|Number|0|0.0||||||
4222763|NCT00702689|4045849|B1|Peripheral blood||Donor Source||Percentage of participants|Number|90|90.0||||||
4222764|NCT00702689|4045849|B1|Bone marrow||Donor Source||Percentage of participants|Number|10|10.0||||||
4222765|NCT00702689|4045849|B1|Severe (3)||Global National Institutes of Health Graft Versus Host Disease (GVHD) score||Percentage of participants|Number|100|100.0||||||
4222766|NCT00702689|4045849|B1|Moderate (2)||Global National Institutes of Health Graft Versus Host Disease (GVHD) score||Percentage of participants|Number|0|0.0||||||
4222767|NCT00702689|4045849|B1|Mild (1)||Global National Institutes of Health Graft Versus Host Disease (GVHD) score||Percentage of participants|Number|0|0.0||||||
4222768|NCT00702689|4045849|B1|Progressive||Chronic Graft Versus Host Disease presentation||Percentage of participants|Number|50|50.0||||||
4222769|NCT00702689|4045849|B1|Quiescent||Chronic Graft Versus Host Disease presentation||Percentage of participants|Number|20|20.0||||||
4222770|NCT00702689|4045849|B1|De novo||Chronic Graft Versus Host Disease presentation||Percentage of participants|Number|30|30.0||||||
4222771|NCT00702689|4045849|B1|Late acute||Chronic Graft Versus Host Disease (cGVHD) category||percentage of participants|Number|0|0.0||||||
4222772|NCT00702689|4045849|B1|Classic||Chronic Graft Versus Host Disease (cGVHD) category||percentage of participants|Number|95|95.0||||||
4222773|NCT00702689|4045849|B1|Overlap||Chronic Graft Versus Host Disease (cGVHD) category||percentage of participants|Number|5|5.0||||||
4222774|NCT00702689|4045849|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4222775|NCT00702689|4045849|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4222776|NCT00702689|4045849|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222777|NCT00702689|4045849|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4222779|NCT00702689|4045849|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222780|NCT00702689|4045849|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222781|NCT00702689|4045849|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222782|NCT00702689|4045849|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222783|NCT00702689|4045849|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4222784|NCT00702689|4045849|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4222785|NCT00702689|4045849|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4222786|NCT00702689|4045849|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4222787|NCT00702689|4045849|B1|||Age||years|Mean|42.59|42.59|Standard Deviation|17.49|17.49|||
4222788|NCT00702689|4045849|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4222789|NCT00702689|4045849|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4222790|NCT00702689|4045849|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4222791|NCT00702650|4045860|B1|||Baseline Total Testosterone Level||nanograms per deciliter (ng/dL)|Mean|196.73|196.73|Standard Deviation|91.04|91.04|||
4222792|NCT00702650|4045860|B1|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|29.53|29.53|Standard Deviation|3.60|3.6|||
4222793|NCT00702650|4045860|B1|Sweden||Region of Enrollment||participants|Number|11|11.0||||||
4222794|NCT00702650|4045860|B1|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
4222795|NCT00702650|4045860|B1|Germany||Region of Enrollment||participants|Number|9|9.0||||||
4222796|NCT00702650|4045860|B1|Australia||Region of Enrollment||participants|Number|10|10.0||||||
4222797|NCT00702650|4045860|B1|United States||Region of Enrollment||participants|Number|104|104.0||||||
4222798|NCT00702650|4045860|B1|France||Region of Enrollment||participants|Number|11|11.0||||||
4222799|NCT00702650|4045860|B1|Missing||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4222800|NCT00702650|4045860|B1|Other - Not Specified||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4222801|NCT00702650|4045860|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4222802|NCT00702650|4045860|B1|African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4222803|NCT00702650|4045860|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|122|122.0||||||
4222804|NCT00702650|4045860|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4222805|NCT00702650|4045860|B1||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4222806|NCT00702650|4045860|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4222807|NCT00702650|4045860|B1|||Age||years|Mean|51.5|51.5|Standard Deviation|12.7|12.7|||
4222808|NCT00702624|4045878|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4222809|NCT00702624|4045879|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4222810|NCT00702624|4045880|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4222811|NCT00702624|4045878|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4222812|NCT00702624|4045879|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4222813|NCT00702624|4045880|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4222814|NCT00702624|4045878|B3|||Age||Years|Mean|30.8|30.8|Standard Deviation|3.2|3.2|||
4222815|NCT00702624|4045879|B2|||Age||Years|Mean|31.3|31.3|Standard Deviation|3.1|3.1|||
4222816|NCT00702624|4045880|B1|||Age||Years|Mean|30.5|30.5|Standard Deviation|3.3|3.3|||
4222817|NCT00702546|4045899|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4222818|NCT00702546|4045900|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4222819|NCT00702546|4045901|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4222820|NCT00702546|4045899|B3||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4222821|NCT00702546|4045900|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4222822|NCT00702546|4045901|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4222823|NCT00702546|4045899|B3|||Age||Years|Mean|31.2|31.2|Standard Deviation|2.9|2.9|||
4222824|NCT00702546|4045900|B2|||Age||Years|Mean|31.2|31.2|Standard Deviation|2.8|2.8|||
4222825|NCT00702546|4045901|B1|||Age||Years|Mean|31.2|31.2|Standard Deviation|3.0|3.0|||
4222826|NCT00702520|4045920|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4222827|NCT00702520|4045921|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4222828|NCT00702520|4045922|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4222829|NCT00702520|4045920|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4222830|NCT00702520|4045921|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4222831|NCT00702520|4045922|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4222832|NCT00702520|4045920|B3|||Age||Years|Mean|30.7|30.7|Standard Deviation|3.3|3.3|||
4222833|NCT00702520|4045921|B2|||Age||Years|Mean|31.3|31.3|Standard Deviation|4.2|4.2|||
4222834|NCT00702520|4045922|B1|||Age||Years|Mean|30.1|30.1|Standard Deviation|2.0|2.0|||
4222835|NCT00702507|4045941|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4222836|NCT00702507|4045941|B1|White/Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4222837|NCT00702507|4045941|B1|Hispanic/White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4222838|NCT00702507|4045941|B1|Hispanic/Persian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4222839|NCT00702507|4045941|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|121|121.0||||||
4222840|NCT00702507|4045941|B1|Black||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4222841|NCT00702507|4045941|B1|White||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4222842|NCT00702507|4045941|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4222843|NCT00702507|4045941|B1||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4222844|NCT00702507|4045941|B1|||Age||Months|Mean|6.6|6.6|Standard Deviation|3.80|3.8|||
4222845|NCT00702468|4045953|B3|||Baseline Spasticity Numerical Rating Scale (NRS) Score|"Spasticity NRS was completed daily by answering the following question:~“On a scale of ‘0 to 10’ please indicate the average level of your spasticity over the last 24 hours” with the anchors: 0 = ‘no spasticity’ and 10 = ‘worst possible spasticity’."|Score on scale|Mean|3.87|3.87|Standard Deviation|1.96|1.96|||
4222846|NCT00702468|4045954|B2|||Baseline Spasticity Numerical Rating Scale (NRS) Score|"Spasticity NRS was completed daily by answering the following question:~“On a scale of ‘0 to 10’ please indicate the average level of your spasticity over the last 24 hours” with the anchors: 0 = ‘no spasticity’ and 10 = ‘worst possible spasticity’."|Score on scale|Mean|4.13|4.13|Standard Deviation|2.23|2.23|||
4222847|NCT00702468|4045955|B1|||Baseline Spasticity Numerical Rating Scale (NRS) Score|"Spasticity NRS was completed daily by answering the following question:~“On a scale of ‘0 to 10’ please indicate the average level of your spasticity over the last 24 hours” with the anchors: 0 = ‘no spasticity’ and 10 = ‘worst possible spasticity’."|Score on scale|Mean|3.60|3.6|Standard Deviation|1.67|1.67|||
4222848|NCT00702468|4045953|B3|||Expanded Disability Status Scale (EDSS) Score|The EDSS is an ordinal clinical rating scale ranging from 0 (normal neurologic examination) to 10 (death due to MS) in half-point increments.|Score on scale|Median|7.0|7.0|Full Range|1.96|1.96|4.0|8.5|
4222849|NCT00702468|4045954|B2|||Expanded Disability Status Scale (EDSS) Score|The EDSS is an ordinal clinical rating scale ranging from 0 (normal neurologic examination) to 10 (death due to MS) in half-point increments.|Score on scale|Median|7.0|7.0|Full Range|2.23|2.23|5.5|8.5|
4222850|NCT00702468|4045955|B1|||Expanded Disability Status Scale (EDSS) Score|The EDSS is an ordinal clinical rating scale ranging from 0 (normal neurologic examination) to 10 (death due to MS) in half-point increments.|Score on scale|Median|7.0|7.0|Full Range|1.67|1.67|4.0|8.5|
4222851|NCT00702468|4045953|B3|||Duration of Spasticity||years|Mean|12.69|12.69|Standard Deviation|9.14|9.14|||
4222852|NCT00702468|4045954|B2|||Duration of Spasticity||years|Mean|11.01|11.01|Standard Deviation|8.25|8.25|||
4222853|NCT00702468|4045955|B1|||Duration of Spasticity||years|Mean|14.38|14.38|Standard Deviation|9.90|9.9|||
4222854|NCT00702468|4045953|B3|||Duration of Multiple Sclerosis (MS)||years|Mean|16.44|16.44|Standard Deviation|9.29|9.29|||
4222855|NCT00702468|4045954|B2|||Duration of Multiple Sclerosis (MS)||years|Mean|15.05|15.05|Standard Deviation|10.07|10.07|||
4222856|NCT00702468|4045955|B1|||Duration of Multiple Sclerosis (MS)||years|Mean|17.84|17.84|Standard Deviation|8.48|8.48|||
4222857|NCT00702468|4045953|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4222858|NCT00702468|4045954|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4222859|NCT00702468|4045955|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4222860|NCT00702468|4045953|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4222861|NCT00702468|4045954|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4222862|NCT00702468|4045955|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4222863|NCT00702468|4045953|B3|||Age||years|Mean|57.1|57.1|Standard Deviation|9.94|9.94|||
4222864|NCT00702468|4045954|B2|||Age||years|Mean|54.4|54.4|Standard Deviation|10.42|10.42|||
4222865|NCT00702468|4045955|B1|||Age||years|Mean|59.7|59.7|Standard Deviation|8.97|8.97|||
4222866|NCT00702403|4045978|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4222867|NCT00702403|4045978|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4222868|NCT00702403|4045978|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4222869|NCT00702403|4045978|B1||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4222870|NCT00702403|4045978|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222871|NCT00702403|4045978|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4222872|NCT00702403|4045978|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4222873|NCT00702403|4045978|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4222874|NCT00702403|4045978|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222875|NCT00702403|4045978|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4222876|NCT00702403|4045978|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4222877|NCT00702403|4045978|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4222878|NCT00702403|4045978|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4222879|NCT00702403|4045978|B1|||Age||years|Median|42.5|42.5|Full Range|||11.0|65.0|
4222880|NCT00702377|4045986|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4222881|NCT00702377|4045987|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4222882|NCT00702377|4045988|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4222883|NCT00702377|4045986|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4222884|NCT00702377|4045987|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4222885|NCT00702377|4045988|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4222886|NCT00702377|4045986|B3||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4222889|NCT00702377|4045986|B3||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
4222890|NCT00702377|4045987|B2||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4222891|NCT00702377|4045988|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4222892|NCT00702377|4045986|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4222893|NCT00702377|4045987|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4222894|NCT00702377|4045988|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4222895|NCT00702364|4045999|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4222896|NCT00702364|4046000|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4222897|NCT00702364|4046001|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4222898|NCT00702364|4045999|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4222899|NCT00702364|4046000|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4222900|NCT00702364|4046001|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4222901|NCT00702364|4045999|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4222902|NCT00702364|4046000|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4222903|NCT00702364|4046001|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4222904|NCT00702364|4045999|B3||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4222905|NCT00702364|4046000|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4222906|NCT00702364|4046001|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4222907|NCT00702364|4045999|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4222908|NCT00702364|4046000|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4222909|NCT00702364|4046001|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4222910|NCT00702338|4046014|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4222911|NCT00702338|4046014|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4222912|NCT00702338|4046014|B1|||Age||years|Mean|31|31.0|Standard Deviation|0|0.0|||
4222913|NCT00702325|4046030|B3||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4222914|NCT00702325|4046031|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4222915|NCT00702325|4046032|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4222916|NCT00702325|4046030|B3||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4222917|NCT00702325|4046031|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4222918|NCT00702325|4046032|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4222919|NCT00702325|4046030|B3|||Age||Years|Mean|39.2|39.2|Standard Deviation|14.6|14.6|||
4222920|NCT00702325|4046031|B2|||Age||Years|Mean|39.8|39.8|Standard Deviation|15.4|15.4|||
4222921|NCT00702325|4046032|B1|||Age||Years|Mean|38.6|38.6|Standard Deviation|13.8|13.8|||
4222922|NCT00702299|4046085|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4222923|NCT00702299|4046085|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4222924|NCT00702299|4046085|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4222925|NCT00702299|4046085|B1|||Age||years|Mean|61.73|61.73|Standard Deviation|9.76|9.76|||
4222926|NCT00702299|4046085|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4222927|NCT00702299|4046085|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4222928|NCT00702299|4046085|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4222929|NCT00702273|4046096|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4222930|NCT00702273|4046097|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4222931|NCT00702273|4046098|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4222932|NCT00702273|4046096|B3||Female|Sex: Female, Male||Participants|Count of Participants|344|344.0||||||
4222933|NCT00702273|4046097|B2||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4222934|NCT00702273|4046098|B1||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4222935|NCT00702273|4046096|B3|||Age||Years|Mean|31.2|31.2|Standard Deviation|3.4|3.4|||
4222936|NCT00702273|4046097|B2|||Age||Years|Mean|31.3|31.3|Standard Deviation|3.0|3.0|||
4222937|NCT00702273|4046098|B1|||Age||Years|Mean|31.1|31.1|Standard Deviation|3.8|3.8|||
4222938|NCT00702234|4046117|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4222939|NCT00702234|4046117|B1||Female|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
4222940|NCT00702234|4046117|B1|||Age||years|Mean|32.8|32.8|Standard Deviation|3.3|3.3|||
4222941|NCT00702221|4046127|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4222942|NCT00702221|4046128|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4222943|NCT00702221|4046129|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222944|NCT00702221|4046127|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222945|NCT00702221|4046128|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222946|NCT00702221|4046129|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222947|NCT00702221|4046127|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4222948|NCT00702221|4046128|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4222949|NCT00702221|4046129|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4222950|NCT00702221|4046127|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4222951|NCT00702221|4046128|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4222952|NCT00702221|4046129|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222953|NCT00702221|4046127|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222954|NCT00702221|4046128|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222955|NCT00702221|4046129|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222956|NCT00702221|4046127|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222957|NCT00702221|4046128|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222958|NCT00702221|4046129|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222959|NCT00702221|4046127|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222960|NCT00702221|4046128|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222961|NCT00702221|4046129|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4222962|NCT00702221|4046127|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4222963|NCT00702221|4046128|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4222964|NCT00702221|4046129|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4222965|NCT00702221|4046127|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4222966|NCT00702221|4046128|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4222967|NCT00702221|4046129|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4222968|NCT00702221|4046127|B3|||Age||years|Mean|52.8|52.8|Standard Deviation|6.56|6.56|||
4222969|NCT00702221|4046128|B2|||Age||years|Mean|53.7|53.7|Standard Deviation|6.63|6.63|||
4222970|NCT00702221|4046129|B1|||Age||years|Mean|51.8|51.8|Standard Deviation|6.94|6.94|||
4222971|NCT00702208|4046136|B1|United States||Region of Enrollment||participants|Number|198|198.0||||||
4222972|NCT00702208|4046136|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4222973|NCT00702208|4046136|B1||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4222974|NCT00702208|4046136|B1|||Age||years|Mean|34.6|34.6|Standard Deviation|13.0|13.0|||
4222975|NCT00702208|4046136|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4222976|NCT00702208|4046136|B1||Between 18 and 65 years|Age||Participants|Count of Participants|195|195.0||||||
4222977|NCT00702208|4046136|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4222978|NCT00702143|4046142|B4|United States||Region of Enrollment||participants|Number|184|184.0||||||
4222979|NCT00702143|4046143|B3|United States||Region of Enrollment||participants|Number|79|79.0||||||
4222980|NCT00702143|4046144|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
4222981|NCT00702143|4046145|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4222982|NCT00702143|4046142|B4||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4222983|NCT00702143|4046143|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4222984|NCT00702143|4046144|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4222985|NCT00702143|4046145|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4222986|NCT00702143|4046142|B4||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4222987|NCT00702143|4046143|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4222988|NCT00702143|4046144|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4222989|NCT00702143|4046145|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4222990|NCT00702143|4046142|B4|||Age||years|Mean|71.6|71.6|Standard Deviation|10.57|10.57|||
4222991|NCT00702143|4046143|B3|||Age||years|Mean|69.4|69.4|Standard Deviation|11.04|11.04|||
4222992|NCT00702143|4046144|B2|||Age||years|Mean|71.7|71.7|Standard Deviation|10.23|10.23|||
4222993|NCT00702143|4046145|B1|||Age||years|Mean|75.4|75.4|Standard Deviation|9.21|9.21|||
4222994|NCT00701935|4046159|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4222995|NCT00701935|4046160|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4222996|NCT00701935|4046161|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4222997|NCT00701935|4046159|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4222998|NCT00701935|4046160|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4222999|NCT00701935|4046161|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4223000|NCT00701935|4046159|B3|||Age||years|Mean|58.1|58.1|Standard Deviation|11.6|11.6|||
4223001|NCT00701935|4046160|B2|||Age||years|Mean|57.9|57.9|Standard Deviation|11.0|11.0|||
4223002|NCT00701935|4046161|B1|||Age||years|Mean|58.2|58.2|Standard Deviation|12.2|12.2|||
4223003|NCT00701805|4046192|B5|Japan||Region of Enrollment||participants|Number|104|104.0||||||
4223004|NCT00701805|4046193|B4|Japan||Region of Enrollment||participants|Number|26|26.0||||||
4223005|NCT00701805|4046194|B3|Japan||Region of Enrollment||participants|Number|23|23.0||||||
4223006|NCT00701805|4046195|B2|Japan||Region of Enrollment||participants|Number|29|29.0||||||
4223007|NCT00701805|4046196|B1|Japan||Region of Enrollment||participants|Number|26|26.0||||||
4223008|NCT00701805|4046192|B5||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4223009|NCT00701805|4046193|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4223010|NCT00701805|4046194|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4223011|NCT00701805|4046195|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4223012|NCT00701805|4046196|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4223013|NCT00701805|4046192|B5||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4223014|NCT00701805|4046193|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4223015|NCT00701805|4046194|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4223016|NCT00701805|4046195|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4223017|NCT00701805|4046196|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4223018|NCT00701805|4046192|B5|||Age||years|Mean|60.6|60.6|Standard Deviation|11.90|11.9|||
4223019|NCT00701805|4046193|B4|||Age||years|Mean|61.1|61.1|Standard Deviation|11.91|11.91|||
4223020|NCT00701805|4046194|B3|||Age||years|Mean|58.6|58.6|Standard Deviation|12.14|12.14|||
4223021|NCT00701805|4046195|B2|||Age||years|Mean|60.3|60.3|Standard Deviation|12.06|12.06|||
4223022|NCT00701805|4046196|B1|||Age||years|Mean|62.4|62.4|Standard Deviation|11.89|11.89|||
4223023|NCT00701805|4046192|B5||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
4223024|NCT00701805|4046193|B4||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4223025|NCT00701805|4046194|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4223026|NCT00701805|4046195|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4223027|NCT00701805|4046196|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4223028|NCT00701805|4046192|B5||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4223029|NCT00701805|4046193|B4||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4223030|NCT00701805|4046194|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4223031|NCT00701805|4046195|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4223032|NCT00701805|4046196|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4223033|NCT00701805|4046192|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223034|NCT00701805|4046193|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223035|NCT00701805|4046194|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223036|NCT00701805|4046195|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223037|NCT00701805|4046196|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223038|NCT00701779|4046249|B1|||Benign Prostatic Hyperplasia Impact Index (BII)|"Benign Prostatic Hyperplasia Impact Index asked the following:~Over the past month, how much physical discomfort did any urinary problems cause you? (0-3)~Over the past month, how much did you worry about yoru health because of any urinary problems? (0-3)~Overall, how bothersome has any trouble with urination been during the past month? (0-3)~Over the past month, how much of the time has any urinary problem kept you from doing the kinds of things you usually do? (0-4) 0 indicates no symptoms, high values indicate high frequency of symptoms.~Total symptom score range 0-13."|units on a scale|Mean|6.31|6.31|Standard Deviation|3.11|3.11|||
4223039|NCT00701779|4046249|B1|||Post-Void Residual Volume||ml|Mean|82.33|82.33|Standard Deviation|58.36|58.36|||
4223040|NCT00701779|4046249|B1|||Prostate Volume||cc|Mean|57.61|57.61|Standard Deviation|22.83|22.83|||
4223041|NCT00701779|4046249|B1|||Prostate Specific Antigen||ng/mL|Mean|4.70|4.7|Standard Deviation|3.01|3.01|||
4223042|NCT00701779|4046249|B1|||Peak Flow Rate||ml/sec|Mean|10.14|10.14|Standard Deviation|2.64|2.64|||
4223043|NCT00701779|4046249|B1|||International Prostate Symptom Score (IPSS)|"Questionnaire consisting of seven symptom scores: incomplete emptying, frequency, intermittency, urgency, weak stream, straining, and nocturia. Symptoms are scored on a 5 point scale with 0 representing absence of symptoms and 5 representing the most severe presentation of a symptom.~Total range is from 0-35. The scores are evaluated as such:~0-7: Mild 8-19: Moderate 20-35: Severe"|units on a scale|Mean|19.80|19.8|Standard Deviation|5.86|5.86|||
4223044|NCT00701779|4046249|B1|Male||Sex/Gender, Customized||participants|Number|54|54.0||||||
4223045|NCT00701779|4046249|B1|||Age, Customized||years|Mean|66.63|66.63|Standard Deviation|8.50|8.5|||
4223046|NCT00701727|4046261|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4223047|NCT00701727|4046261|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4223048|NCT00701727|4046261|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4223049|NCT00701727|4046261|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4223050|NCT00701727|4046261|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4223051|NCT00701727|4046261|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223052|NCT00701714|4046280|B3|India||Region of Enrollment||participants|Number|12|12.0||||||
4223053|NCT00701714|4046281|B2|India||Region of Enrollment||participants|Number|6|6.0||||||
4223054|NCT00701714|4046282|B1|India||Region of Enrollment||participants|Number|6|6.0||||||
4223055|NCT00701714|4046280|B3|Germany||Region of Enrollment||participants|Number|84|84.0||||||
4223056|NCT00701714|4046281|B2|Germany||Region of Enrollment||participants|Number|39|39.0||||||
4223057|NCT00701714|4046282|B1|Germany||Region of Enrollment||participants|Number|45|45.0||||||
4223058|NCT00701714|4046280|B3|France||Region of Enrollment||participants|Number|1|1.0||||||
4223059|NCT00701714|4046281|B2|France||Region of Enrollment||participants|Number|1|1.0||||||
4223060|NCT00701714|4046282|B1|France||Region of Enrollment||participants|Number|0|0.0||||||
4223061|NCT00701714|4046280|B3|Bulgaria||Region of Enrollment||participants|Number|8|8.0||||||
4223062|NCT00701714|4046281|B2|Bulgaria||Region of Enrollment||participants|Number|4|4.0||||||
4223063|NCT00701714|4046282|B1|Bulgaria||Region of Enrollment||participants|Number|4|4.0||||||
4223064|NCT00701714|4046280|B3|Slovakia||Region of Enrollment||participants|Number|7|7.0||||||
4223065|NCT00701714|4046281|B2|Slovakia||Region of Enrollment||participants|Number|3|3.0||||||
4223066|NCT00701714|4046282|B1|Slovakia||Region of Enrollment||participants|Number|4|4.0||||||
4223067|NCT00701714|4046280|B3|Poland||Region of Enrollment||participants|Number|27|27.0||||||
4223068|NCT00701714|4046281|B2|Poland||Region of Enrollment||participants|Number|14|14.0||||||
4223069|NCT00701714|4046282|B1|Poland||Region of Enrollment||participants|Number|13|13.0||||||
4223070|NCT00701714|4046280|B3|Romania||Region of Enrollment||participants|Number|99|99.0||||||
4223071|NCT00701714|4046281|B2|Romania||Region of Enrollment||participants|Number|52|52.0||||||
4223072|NCT00701714|4046282|B1|Romania||Region of Enrollment||participants|Number|47|47.0||||||
4223073|NCT00701714|4046280|B3|Russian Federation||Region of Enrollment||participants|Number|53|53.0||||||
4223074|NCT00701714|4046281|B2|Russian Federation||Region of Enrollment||participants|Number|24|24.0||||||
4223075|NCT00701714|4046282|B1|Russian Federation||Region of Enrollment||participants|Number|29|29.0||||||
4223076|NCT00701714|4046280|B3|Czech Republic||Region of Enrollment||participants|Number|41|41.0||||||
4223077|NCT00701714|4046281|B2|Czech Republic||Region of Enrollment||participants|Number|19|19.0||||||
4223078|NCT00701714|4046282|B1|Czech Republic||Region of Enrollment||participants|Number|22|22.0||||||
4223079|NCT00701714|4046280|B3|Austria||Region of Enrollment||participants|Number|5|5.0||||||
4223080|NCT00701714|4046281|B2|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4223081|NCT00701714|4046282|B1|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4223082|NCT00701714|4046280|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4223083|NCT00701714|4046281|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4223084|NCT00701714|4046282|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4223085|NCT00701714|4046280|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4223086|NCT00701714|4046281|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4223087|NCT00701714|4046282|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4223088|NCT00701714|4046280|B3||White|Race (NIH/OMB)||Participants|Count of Participants|322|322.0||||||
4223089|NCT00701714|4046281|B2||White|Race (NIH/OMB)||Participants|Count of Participants|155|155.0||||||
4223090|NCT00701714|4046282|B1||White|Race (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
4223091|NCT00701714|4046280|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4223092|NCT00701714|4046281|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4223093|NCT00701714|4046282|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4223094|NCT00701714|4046280|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4223095|NCT00701714|4046281|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4223096|NCT00701714|4046282|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4223097|NCT00701714|4046280|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4223098|NCT00701714|4046281|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4223099|NCT00701714|4046282|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4223100|NCT00701714|4046280|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4223101|NCT00701714|4046281|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4223102|NCT00701714|4046282|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4223103|NCT00701714|4046280|B3||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4223104|NCT00701714|4046281|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4223105|NCT00701714|4046282|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4223106|NCT00701714|4046280|B3||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4223107|NCT00701714|4046281|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4223108|NCT00701714|4046282|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4223109|NCT00701714|4046280|B3|||Age||years|Mean|64.5|64.5|Standard Deviation|14.7|14.7|||
4223110|NCT00701714|4046281|B2|||Age||years|Mean|64.9|64.9|Standard Deviation|15|15.0|||
4223111|NCT00701714|4046282|B1|||Age||years|Mean|64.1|64.1|Standard Deviation|14.4|14.4|||
4223112|NCT00701675|4046295|B4|United States||Region of Enrollment||participants|Number|42|42.0||||||
4223113|NCT00701675|4046296|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4223114|NCT00701675|4046297|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4223115|NCT00701675|4046298|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4223116|NCT00701675|4046295|B4||Male|Gender||Participants|Count of Participants|41|41.0||||||
4223117|NCT00701675|4046296|B3||Male|Gender||Participants|Count of Participants|14|14.0||||||
4223118|NCT00701675|4046297|B2||Male|Gender||Participants|Count of Participants|14|14.0||||||
4223119|NCT00701675|4046298|B1||Male|Gender||Participants|Count of Participants|13|13.0||||||
4223120|NCT00701675|4046295|B4||Female|Gender||Participants|Count of Participants|1|1.0||||||
4223121|NCT00701675|4046296|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
4223122|NCT00701675|4046297|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
4223123|NCT00701675|4046298|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
4223124|NCT00701675|4046295|B4||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4223125|NCT00701675|4046296|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4223126|NCT00701675|4046297|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4223127|NCT00701675|4046298|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4223128|NCT00701675|4046295|B4||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4223129|NCT00701675|4046296|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4223130|NCT00701675|4046297|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4223131|NCT00701675|4046298|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4223132|NCT00701675|4046295|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223133|NCT00701675|4046296|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223134|NCT00701675|4046297|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223135|NCT00701675|4046298|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223136|NCT00701662|4046308|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4223137|NCT00701662|4046308|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4223138|NCT00701662|4046308|B1|>= 65 years||Age, Customized||participants|Number|3|3.0||||||
4223139|NCT00701662|4046308|B1|> 18 to < 65 years||Age, Customized||participants|Number|5|5.0||||||
4223140|NCT00701662|4046308|B1|||Age||years|Mean|57.3|57.3|Standard Deviation|8.78|8.78|||
4223141|NCT00701636|4046325|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4223142|NCT00701636|4046326|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4223143|NCT00701636|4046327|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4223144|NCT00701636|4046325|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4223145|NCT00701636|4046326|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4223146|NCT00701636|4046327|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4223147|NCT00701636|4046325|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4223148|NCT00701636|4046326|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4223149|NCT00701636|4046327|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4223150|NCT00701636|4046325|B3|||Age||years|Mean|56|56.0|Standard Deviation|7.4|7.4|||
4223151|NCT00701636|4046326|B2|||Age||years|Mean|57|57.0|Standard Deviation|8.7|8.7|||
4223152|NCT00701636|4046327|B1|||Age||years|Mean|56|56.0|Standard Deviation|8.0|8.0|||
4223153|NCT00701636|4046325|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4223154|NCT00701636|4046326|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4223155|NCT00701636|4046327|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4223156|NCT00701636|4046325|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4223157|NCT00701636|4046326|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4223158|NCT00701636|4046327|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4223159|NCT00701636|4046325|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223160|NCT00701636|4046326|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223161|NCT00701636|4046327|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223162|NCT00701558|4046333|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4223163|NCT00701558|4046333|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4223164|NCT00701558|4046333|B1|||Age||years|Mean|62.47|62.47|Standard Deviation|9.67|9.67|||
4223165|NCT00701441|4046339|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4223166|NCT00701441|4046340|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4223167|NCT00701441|4046341|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4223168|NCT00701441|4046339|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4223169|NCT00701441|4046340|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4223170|NCT00701441|4046341|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4223171|NCT00701441|4046339|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4223172|NCT00701441|4046340|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4223173|NCT00701441|4046341|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4223174|NCT00701441|4046339|B3|||Age||years|Mean|39.5|39.5|Standard Deviation|11.3|11.3|||
4223175|NCT00701441|4046340|B2|||Age||years|Mean|43.6|43.6|Standard Deviation|11.2|11.2|||
4223176|NCT00701441|4046341|B1|||Age||years|Mean|32.2|32.2|Standard Deviation|7.4|7.4|||
4223177|NCT00701441|4046339|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4223178|NCT00701441|4046340|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4223179|NCT00701441|4046341|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4223180|NCT00701441|4046339|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4223181|NCT00701441|4046340|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4223182|NCT00701441|4046341|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4223183|NCT00701441|4046339|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223184|NCT00701441|4046340|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223185|NCT00701441|4046341|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223186|NCT00701415|4046352|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4223187|NCT00701415|4046353|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4223188|NCT00701415|4046354|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4223189|NCT00701415|4046352|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4223190|NCT00701415|4046353|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4223191|NCT00701415|4046354|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4223192|NCT00701415|4046352|B3|||Age||years|Mean|11.5|11.5|Standard Deviation|4.2|4.2|||
4223193|NCT00701415|4046353|B2|||Age||years|Mean|11.9|11.9|Standard Deviation|4.5|4.5|||
4223194|NCT00701415|4046354|B1|||Age||years|Mean|11.2|11.2|Standard Deviation|4|4.0|||
4223195|NCT00701389|4046365|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4223196|NCT00701389|4046365|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4223197|NCT00701389|4046365|B1|||Age||years|Mean|35.0|35.0|Full Range|||21.0|56.0|
4223198|NCT00701363|4046386|B5|||Body Mass Index (BMI)||kg/m^2|Mean|28.8|28.8|Standard Deviation|5.6|5.6|||
4223199|NCT00701363|4046387|B4|||Body Mass Index (BMI)||kg/m^2|Mean|27.0|27.0|Standard Deviation|4.3|4.3|||
4223200|NCT00701363|4046388|B3|||Body Mass Index (BMI)||kg/m^2|Mean|29.5|29.5|Standard Deviation|6.5|6.5|||
4223201|NCT00701363|4046389|B2|||Body Mass Index (BMI)||kg/m^2|Mean|29.2|29.2|Standard Deviation|4.1|4.1|||
4223202|NCT00701363|4046390|B1|||Body Mass Index (BMI)||kg/m^2|Mean|28.4|28.4|Standard Deviation|2.9|2.9|||
4223203|NCT00701363|4046386|B5|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4223204|NCT00701363|4046387|B4|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4223205|NCT00701363|4046388|B3|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4223206|NCT00701363|4046389|B2|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4223207|NCT00701363|4046390|B1|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4223208|NCT00701363|4046386|B5|Romania||Region of Enrollment||participants|Number|1|1.0||||||
4223209|NCT00701363|4046387|B4|Romania||Region of Enrollment||participants|Number|0|0.0||||||
4223210|NCT00701363|4046388|B3|Romania||Region of Enrollment||participants|Number|1|1.0||||||
4223211|NCT00701363|4046389|B2|Romania||Region of Enrollment||participants|Number|0|0.0||||||
4223212|NCT00701363|4046390|B1|Romania||Region of Enrollment||participants|Number|0|0.0||||||
4223213|NCT00701363|4046386|B5|Norway||Region of Enrollment||participants|Number|1|1.0||||||
4223214|NCT00701363|4046387|B4|Norway||Region of Enrollment||participants|Number|0|0.0||||||
4223215|NCT00701363|4046388|B3|Norway||Region of Enrollment||participants|Number|0|0.0||||||
4223216|NCT00701363|4046389|B2|Norway||Region of Enrollment||participants|Number|0|0.0||||||
4223217|NCT00701363|4046390|B1|Norway||Region of Enrollment||participants|Number|1|1.0||||||
4223218|NCT00701363|4046386|B5|Denmark||Region of Enrollment||participants|Number|2|2.0||||||
4223219|NCT00701363|4046387|B4|Denmark||Region of Enrollment||participants|Number|2|2.0||||||
4223220|NCT00701363|4046388|B3|Denmark||Region of Enrollment||participants|Number|0|0.0||||||
4223221|NCT00701363|4046389|B2|Denmark||Region of Enrollment||participants|Number|0|0.0||||||
4223222|NCT00701363|4046390|B1|Denmark||Region of Enrollment||participants|Number|0|0.0||||||
4223223|NCT00701363|4046386|B5|Finland||Region of Enrollment||participants|Number|3|3.0||||||
4223224|NCT00701363|4046387|B4|Finland||Region of Enrollment||participants|Number|1|1.0||||||
4223225|NCT00701363|4046388|B3|Finland||Region of Enrollment||participants|Number|0|0.0||||||
4223226|NCT00701363|4046389|B2|Finland||Region of Enrollment||participants|Number|1|1.0||||||
4223227|NCT00701363|4046390|B1|Finland||Region of Enrollment||participants|Number|1|1.0||||||
4223228|NCT00701363|4046386|B5|Sweden||Region of Enrollment||participants|Number|4|4.0||||||
4223229|NCT00701363|4046387|B4|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
4223230|NCT00701363|4046388|B3|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
4223231|NCT00701363|4046389|B2|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
4223232|NCT00701363|4046390|B1|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
4223233|NCT00701363|4046386|B5|Greece||Region of Enrollment||participants|Number|9|9.0||||||
4223234|NCT00701363|4046387|B4|Greece||Region of Enrollment||participants|Number|4|4.0||||||
4223235|NCT00701363|4046388|B3|Greece||Region of Enrollment||participants|Number|3|3.0||||||
4223236|NCT00701363|4046389|B2|Greece||Region of Enrollment||participants|Number|0|0.0||||||
4223237|NCT00701363|4046390|B1|Greece||Region of Enrollment||participants|Number|2|2.0||||||
4223238|NCT00701363|4046386|B5|Latvia||Region of Enrollment||participants|Number|10|10.0||||||
4223239|NCT00701363|4046387|B4|Latvia||Region of Enrollment||participants|Number|2|2.0||||||
4223240|NCT00701363|4046388|B3|Latvia||Region of Enrollment||participants|Number|7|7.0||||||
4223241|NCT00701363|4046389|B2|Latvia||Region of Enrollment||participants|Number|0|0.0||||||
4223242|NCT00701363|4046390|B1|Latvia||Region of Enrollment||participants|Number|1|1.0||||||
4223243|NCT00701363|4046386|B5|Poland||Region of Enrollment||participants|Number|12|12.0||||||
4223244|NCT00701363|4046387|B4|Poland||Region of Enrollment||participants|Number|2|2.0||||||
4223245|NCT00701363|4046388|B3|Poland||Region of Enrollment||participants|Number|8|8.0||||||
4223246|NCT00701363|4046389|B2|Poland||Region of Enrollment||participants|Number|1|1.0||||||
4223247|NCT00701363|4046390|B1|Poland||Region of Enrollment||participants|Number|1|1.0||||||
4223248|NCT00701363|4046386|B5|France||Region of Enrollment||participants|Number|14|14.0||||||
4223249|NCT00701363|4046387|B4|France||Region of Enrollment||participants|Number|4|4.0||||||
4223250|NCT00701363|4046388|B3|France||Region of Enrollment||participants|Number|9|9.0||||||
4223251|NCT00701363|4046389|B2|France||Region of Enrollment||participants|Number|0|0.0||||||
4223252|NCT00701363|4046390|B1|France||Region of Enrollment||participants|Number|1|1.0||||||
4223253|NCT00701363|4046386|B5|Serbia||Region of Enrollment||participants|Number|15|15.0||||||
4223254|NCT00701363|4046387|B4|Serbia||Region of Enrollment||participants|Number|2|2.0||||||
4223255|NCT00701363|4046388|B3|Serbia||Region of Enrollment||participants|Number|8|8.0||||||
4223256|NCT00701363|4046389|B2|Serbia||Region of Enrollment||participants|Number|3|3.0||||||
4223257|NCT00701363|4046390|B1|Serbia||Region of Enrollment||participants|Number|2|2.0||||||
4223258|NCT00701363|4046386|B5|Brazil||Region of Enrollment||participants|Number|15|15.0||||||
4223259|NCT00701363|4046387|B4|Brazil||Region of Enrollment||participants|Number|1|1.0||||||
4223260|NCT00701363|4046388|B3|Brazil||Region of Enrollment||participants|Number|12|12.0||||||
4223261|NCT00701363|4046389|B2|Brazil||Region of Enrollment||participants|Number|0|0.0||||||
4223262|NCT00701363|4046390|B1|Brazil||Region of Enrollment||participants|Number|2|2.0||||||
4223263|NCT00701363|4046386|B5|Korea, Republic of||Region of Enrollment||participants|Number|17|17.0||||||
4223264|NCT00701363|4046387|B4|Korea, Republic of||Region of Enrollment||participants|Number|4|4.0||||||
4223265|NCT00701363|4046388|B3|Korea, Republic of||Region of Enrollment||participants|Number|7|7.0||||||
4223266|NCT00701363|4046389|B2|Korea, Republic of||Region of Enrollment||participants|Number|4|4.0||||||
4223267|NCT00701363|4046390|B1|Korea, Republic of||Region of Enrollment||participants|Number|2|2.0||||||
4223268|NCT00701363|4046386|B5|Russian Federation||Region of Enrollment||participants|Number|20|20.0||||||
4223269|NCT00701363|4046387|B4|Russian Federation||Region of Enrollment||participants|Number|4|4.0||||||
4223270|NCT00701363|4046388|B3|Russian Federation||Region of Enrollment||participants|Number|12|12.0||||||
4223271|NCT00701363|4046389|B2|Russian Federation||Region of Enrollment||participants|Number|3|3.0||||||
4223272|NCT00701363|4046390|B1|Russian Federation||Region of Enrollment||participants|Number|1|1.0||||||
4223273|NCT00701363|4046386|B5||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4223274|NCT00701363|4046387|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4223275|NCT00701363|4046388|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4223276|NCT00701363|4046389|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4223277|NCT00701363|4046390|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4223278|NCT00701363|4046386|B5||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4223279|NCT00701363|4046387|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4223280|NCT00701363|4046388|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4223281|NCT00701363|4046389|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4223282|NCT00701363|4046390|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4223283|NCT00701363|4046386|B5|||Age||years|Mean|55.4|55.4|Standard Deviation|10.9|10.9|||
4223284|NCT00701363|4046387|B4|||Age||years|Mean|57.0|57.0|Standard Deviation|9.8|9.8|||
4223285|NCT00701363|4046388|B3|||Age||years|Mean|53.2|53.2|Standard Deviation|10.4|10.4|||
4223286|NCT00701363|4046389|B2|||Age||years|Mean|55.0|55.0|Standard Deviation|10.1|10.1|||
4223287|NCT00701363|4046390|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|15.3|15.3|||
4223288|NCT00701311|4046433|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4223289|NCT00701311|4046433|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4223290|NCT00701311|4046433|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4223291|NCT00701311|4046433|B1|||Age||years|Mean|48.2|48.2|Standard Deviation|10|10.0|||
4223292|NCT00701311|4046433|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4223293|NCT00701311|4046433|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4223294|NCT00701311|4046433|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223295|NCT00701129|4046437|B1|Caregiver Assistance: Social Function Score (n=2)||Disability Index Assessed by the Pompe Pediatric Evaluation of Disability Inventory (Pompe PEDI)|It consists of all items of original PEDI (197 functional skill items in 3 domains:self-care;mobility;social function) and additional items in functional skills,mobility,self-care domains to reflect functional skills for children with Pompe. Each domain consists of 2 subdomains: functional skill performance, caregiver assistance scale. Norm-based scoring was developed for additional items, and scoring for PEDI have been adjusted to reflect additional normative data collected for Pompe PEDI. Total score range for each domain (mean of subdomains) and subdomain=0-100;higher score=high capability.|units on a scale|Median|0|0.0|Full Range|||0.0|0.0|
4223296|NCT00701129|4046437|B1|Caregiver Assistance: Self-Care Score (n=2)||Disability Index Assessed by the Pompe Pediatric Evaluation of Disability Inventory (Pompe PEDI)|It consists of all items of original PEDI (197 functional skill items in 3 domains:self-care;mobility;social function) and additional items in functional skills,mobility,self-care domains to reflect functional skills for children with Pompe. Each domain consists of 2 subdomains: functional skill performance, caregiver assistance scale. Norm-based scoring was developed for additional items, and scoring for PEDI have been adjusted to reflect additional normative data collected for Pompe PEDI. Total score range for each domain (mean of subdomains) and subdomain=0-100;higher score=high capability.|units on a scale|Median|0|0.0|Full Range|||0.0|0.0|
4223297|NCT00701129|4046437|B1|Caregiver Assistance: Mobility Score (n=2)||Disability Index Assessed by the Pompe Pediatric Evaluation of Disability Inventory (Pompe PEDI)|It consists of all items of original PEDI (197 functional skill items in 3 domains:self-care;mobility;social function) and additional items in functional skills,mobility,self-care domains to reflect functional skills for children with Pompe. Each domain consists of 2 subdomains: functional skill performance, caregiver assistance scale. Norm-based scoring was developed for additional items, and scoring for PEDI have been adjusted to reflect additional normative data collected for Pompe PEDI. Total score range for each domain (mean of subdomains) and subdomain=0-100;higher score=high capability.|units on a scale|Median|0|0.0|Full Range|||0.0|0.0|
4223310|NCT00701129|4046437|B1|Negative||Number of Patients With Anti-Recombinant Human Acid Alfa-glucosidase (Anti-rhGAA) Immunoglobulin G|As all patients were treatment naïve, it was expected that no patient would be Anti-rhGAA immunoglobulin G (IgG) antibody positive at baseline.|participants|Number|4|4.0||||||
4223298|NCT00701129|4046437|B1|Functional Skills: Social Function Score (n=1)||Disability Index Assessed by the Pompe Pediatric Evaluation of Disability Inventory (Pompe PEDI)|It consists of all items of original PEDI (197 functional skill items in 3 domains:self-care;mobility;social function) and additional items in functional skills,mobility,self-care domains to reflect functional skills for children with Pompe. Each domain consists of 2 subdomains: functional skill performance, caregiver assistance scale. Norm-based scoring was developed for additional items, and scoring for PEDI have been adjusted to reflect additional normative data collected for Pompe PEDI. Total score range for each domain (mean of subdomains) and subdomain=0-100;higher score=high capability.|units on a scale|Median|10.5|10.5|Full Range|||10.5|10.5|
4223299|NCT00701129|4046437|B1|Functional Skills: Self-Care Score (n=4)||Disability Index Assessed by the Pompe Pediatric Evaluation of Disability Inventory (Pompe PEDI)|It consists of all items of original PEDI (197 functional skill items in 3 domains:self-care;mobility;social function) and additional items in functional skills,mobility,self-care domains to reflect functional skills for children with Pompe. Each domain consists of 2 subdomains: functional skill performance, caregiver assistance scale. Norm-based scoring was developed for additional items, and scoring for PEDI have been adjusted to reflect additional normative data collected for Pompe PEDI. Total score range for each domain (mean of subdomains) and subdomain=0-100;higher score=high capability.|units on a scale|Median|14.4|14.4|Full Range|||4.9|16.1|
4223300|NCT00701129|4046437|B1|Functional Skills: Mobility Score (n=4)||Disability Index Assessed by the Pompe Pediatric Evaluation of Disability Inventory (Pompe PEDI)|It consists of all items of original PEDI (197 functional skill items in 3 domains:self-care;mobility;social function) and additional items in functional skills,mobility,self-care domains to reflect functional skills for children with Pompe. Each domain consists of 2 subdomains: functional skill performance, caregiver assistance scale. Norm-based scoring was developed for additional items, and scoring for PEDI have been adjusted to reflect additional normative data collected for Pompe PEDI. Total score range for each domain (mean of subdomains) and subdomain=0-100;higher score=high capability.|units on a scale|Median|4.5|4.5|Full Range|||0.0|18.4|
4223301|NCT00701129|4046437|B1|||Motor Development Status Assessed by Alberta Infantile Motor Scale (AIMS)|AIMS:58-item in 4 subscales: prone; supine; sitting; and standing. Each item is scored as observed/not observed. Item in observed range create a motor window. Subscale scores are calculated by giving child 1 point for observed items within motor window in addition to being given 1 point for all less mature items before motor window. AIMS total score=sum of scores for 58 items, range: 0-58,higher score=more mature motor development. Score was then compared with age-equivalent peers from normative sample and equivalence level age (in months) is reported. Here, number of patients analyzed = 3.|months|Median|0|0.0|Full Range|||0.0|1.37|
4223302|NCT00701129|4046437|B1|||Gross Motor Disability Assessed by Gross Motor Function Measure-88 (GMFM-88)|GMFM-88:an 88-item measure to detect gross motor function; consists of 5 categories: lying and rolling; sitting; crawling and kneeling; standing; walking, running and jumping. Each item is scored on a 4-point Likert scale(0=cannot do; 1=initiates [<10% of the task]; 2=partially completes [10% to <100% of the task]; 3=task completion). Score for each dimension is expressed as a percentage of maximum score for that dimension. Total score=sum of percentage scores for each dimension divided by number of dimensions. Total score range: 0% to 100%, where higher scores indicate better motor functions.|percentage of maximum total score|Median|5.10|5.1|Full Range|||0.39|7.49|
4223303|NCT00701129|4046437|B1|No||Number of Patients With Ventilator Use||participants|Number|1|1.0||||||
4223304|NCT00701129|4046437|B1|Yes||Number of Patients With Ventilator Use||participants|Number|3|3.0||||||
4223305|NCT00701129|4046437|B1|LVM index: Abnormal||Number of Patients With Normal/Abnormal Left Ventricular Mass (LVM) Z-Score and LVM Index|LVM Z-Score and LVM Index were assessed by echocardiography (ECHO). LVM Z-Score: an indicator of degree of standard deviations from mean in a normal distribution. Negative values indicate a smaller LVM than mean and values higher than 0 indicate a larger LVM than mean. Normal range is -2 to 2; values <-2 or >2 indicate abnormal score. LVM index: an index value derived by normalizing LVM by body surface area. LVM index provides evidence of cardiomyopathy. LVM index values <65 gram per square meter (g/m^2) were considered as normal and LVM index values >=65 g/m^2 were considered as abnormal.|participants|Number|4|4.0||||||
4223306|NCT00701129|4046437|B1|LVM index: Normal||Number of Patients With Normal/Abnormal Left Ventricular Mass (LVM) Z-Score and LVM Index|LVM Z-Score and LVM Index were assessed by echocardiography (ECHO). LVM Z-Score: an indicator of degree of standard deviations from mean in a normal distribution. Negative values indicate a smaller LVM than mean and values higher than 0 indicate a larger LVM than mean. Normal range is -2 to 2; values <-2 or >2 indicate abnormal score. LVM index: an index value derived by normalizing LVM by body surface area. LVM index provides evidence of cardiomyopathy. LVM index values <65 gram per square meter (g/m^2) were considered as normal and LVM index values >=65 g/m^2 were considered as abnormal.|participants|Number|0|0.0||||||
4223307|NCT00701129|4046437|B1|LVM Z-score: Abnormal||Number of Patients With Normal/Abnormal Left Ventricular Mass (LVM) Z-Score and LVM Index|LVM Z-Score and LVM Index were assessed by echocardiography (ECHO). LVM Z-Score: an indicator of degree of standard deviations from mean in a normal distribution. Negative values indicate a smaller LVM than mean and values higher than 0 indicate a larger LVM than mean. Normal range is -2 to 2; values <-2 or >2 indicate abnormal score. LVM index: an index value derived by normalizing LVM by body surface area. LVM index provides evidence of cardiomyopathy. LVM index values <65 gram per square meter (g/m^2) were considered as normal and LVM index values >=65 g/m^2 were considered as abnormal.|participants|Number|4|4.0||||||
4223308|NCT00701129|4046437|B1|LVM Z-score: Normal||Number of Patients With Normal/Abnormal Left Ventricular Mass (LVM) Z-Score and LVM Index|LVM Z-Score and LVM Index were assessed by echocardiography (ECHO). LVM Z-Score: an indicator of degree of standard deviations from mean in a normal distribution. Negative values indicate a smaller LVM than mean and values higher than 0 indicate a larger LVM than mean. Normal range is -2 to 2; values <-2 or >2 indicate abnormal score. LVM index: an index value derived by normalizing LVM by body surface area. LVM index provides evidence of cardiomyopathy. LVM index values <65 gram per square meter (g/m^2) were considered as normal and LVM index values >=65 g/m^2 were considered as abnormal.|participants|Number|0|0.0||||||
4223309|NCT00701129|4046437|B1|Positive||Number of Patients With Anti-Recombinant Human Acid Alfa-glucosidase (Anti-rhGAA) Immunoglobulin G|As all patients were treatment naïve, it was expected that no patient would be Anti-rhGAA immunoglobulin G (IgG) antibody positive at baseline.|participants|Number|0|0.0||||||
4223311|NCT00701129|4046437|B1|Ethnicity: Non Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4223312|NCT00701129|4046437|B1|Ethnicity: Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4223313|NCT00701129|4046437|B1|Race: White, Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4223314|NCT00701129|4046437|B1|Race: White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4223315|NCT00701129|4046437|B1|Race: Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4223316|NCT00701129|4046437|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4223317|NCT00701129|4046437|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4223318|NCT00701129|4046437|B1|Greater Than (>) 6 Months||Age, Customized||participants|Number|2|2.0||||||
4223319|NCT00701129|4046437|B1|Less Than or Equal to (=<) 6 Months||Age, Customized||participants|Number|2|2.0||||||
4223320|NCT00701103|4046448|B12||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4223321|NCT00701103|4046449|B11||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4223322|NCT00701103|4046450|B10||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4223323|NCT00701103|4046451|B9||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4223324|NCT00701103|4046452|B8||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4223325|NCT00701103|4046453|B7||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4223326|NCT00701103|4046454|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4223327|NCT00701103|4046455|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4223328|NCT00701103|4046456|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4223329|NCT00701103|4046457|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4223330|NCT00701103|4046458|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4223331|NCT00701103|4046459|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4223332|NCT00701103|4046448|B12||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4223333|NCT00701103|4046449|B11||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4223334|NCT00701103|4046450|B10||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4223335|NCT00701103|4046451|B9||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4223336|NCT00701103|4046452|B8||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4223337|NCT00701103|4046453|B7||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4223338|NCT00701103|4046454|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4223339|NCT00701103|4046455|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4223340|NCT00701103|4046456|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4223341|NCT00701103|4046457|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4223342|NCT00701103|4046458|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4223343|NCT00701103|4046459|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4223344|NCT00701103|4046448|B12|||Age||Years|Mean|55|55.0|Standard Deviation|16|16.0|19.0|81.0|
4223345|NCT00701103|4046449|B11|||Age||Years|Mean|52|52.0|Standard Deviation|15|15.0|19.0|73.0|
4223346|NCT00701103|4046450|B10|||Age||Years|Mean|55|55.0|Standard Deviation|17|17.0|23.0|77.0|
4223347|NCT00701103|4046451|B9|||Age||Years|Mean|52|52.0|Standard Deviation|18|18.0|22.0|69.0|
4223348|NCT00701103|4046452|B8|||Age||Years|Mean|46|46.0|Standard Deviation|13|13.0|27.0|78.0|
4223349|NCT00701103|4046453|B7|||Age||Years|Mean|54|54.0|Standard Deviation|18|18.0|29.0|64.0|
4223350|NCT00701103|4046454|B6|||Age||Years|Mean|49|49.0|Standard Deviation|22|22.0|23.0|70.0|
4223351|NCT00701103|4046455|B5|||Age||Years|Mean|53|53.0|Standard Deviation|17|17.0|26.0|70.0|
4223352|NCT00701103|4046456|B4|||Age||Years|Mean|56|56.0|Standard Deviation|10|10.0|40.0|68.0|
4223353|NCT00701103|4046457|B3|||Age||Years|Mean|68|68.0|Standard Deviation|9|9.0|51.0|80.0|
4223354|NCT00701103|4046458|B2|||Age||Years|Mean|60|60.0|Standard Deviation|9|9.0|50.0|68.0|
4223355|NCT00701103|4046459|B1|||Age||Years|Mean|69|69.0|Standard Deviation|9|9.0|59.0|81.0|
4223356|NCT00701090|4046573|B3|||A1C (Hemoglobin A1c)||Percent|Mean|7.50|7.5|Standard Deviation|0.73|0.73|||
4223357|NCT00701090|4046574|B2|||A1C (Hemoglobin A1c)||Percent|Mean|7.51|7.51|Standard Deviation|0.76|0.76|||
4223358|NCT00701090|4046575|B1|||A1C (Hemoglobin A1c)||Percent|Mean|7.50|7.5|Standard Deviation|0.70|0.7|||
4223359|NCT00701090|4046573|B3|Other||Race/Ethnicity, Customized||participants|Number|157|157.0||||||
4223360|NCT00701090|4046574|B2|Other||Race/Ethnicity, Customized||participants|Number|78|78.0||||||
4223361|NCT00701090|4046575|B1|Other||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
4223362|NCT00701090|4046573|B3|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4223363|NCT00701090|4046574|B2|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4223364|NCT00701090|4046575|B1|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4223365|NCT00701090|4046573|B3|Asian||Race/Ethnicity, Customized||participants|Number|220|220.0||||||
4223366|NCT00701090|4046574|B2|Asian||Race/Ethnicity, Customized||participants|Number|111|111.0||||||
4223367|NCT00701090|4046575|B1|Asian||Race/Ethnicity, Customized||participants|Number|109|109.0||||||
4223368|NCT00701090|4046573|B3|Black||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4223369|NCT00701090|4046574|B2|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4223370|NCT00701090|4046575|B1|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4223371|NCT00701090|4046573|B3|White||Race/Ethnicity, Customized||participants|Number|595|595.0||||||
4223372|NCT00701090|4046574|B2|White||Race/Ethnicity, Customized||participants|Number|298|298.0||||||
4223373|NCT00701090|4046575|B1|White||Race/Ethnicity, Customized||participants|Number|297|297.0||||||
4223374|NCT00701090|4046573|B3||Male|Sex: Female, Male||Participants|Count of Participants|563|563.0||||||
4223375|NCT00701090|4046574|B2||Male|Sex: Female, Male||Participants|Count of Participants|279|279.0||||||
4223376|NCT00701090|4046575|B1||Male|Sex: Female, Male||Participants|Count of Participants|284|284.0||||||
4223377|NCT00701090|4046573|B3||Female|Sex: Female, Male||Participants|Count of Participants|472|472.0||||||
4223378|NCT00701090|4046574|B2||Female|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
4223379|NCT00701090|4046575|B1||Female|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
4223380|NCT00701090|4046573|B3|||Age||years|Mean|56.3|56.3|Standard Deviation|9.9|9.9|||
4223381|NCT00701090|4046574|B2|||Age||years|Mean|56.2|56.2|Standard Deviation|10.1|10.1|||
4223382|NCT00701090|4046575|B1|||Age||years|Mean|56.3|56.3|Standard Deviation|9.7|9.7|||
4223383|NCT00701064|4046592|B3|||Pittsburgh Sleep Quality Inventory|A common instrument that assesses sleep quality over the previous month. The PSQI range is 0-21 with higher scores indicating worse sleep. Scores of > 5 have been considered indicative of a sleep problem.|units on a scale|Mean|10.4|10.4|Standard Deviation|3.8|3.8|||
4223384|NCT00701064|4046593|B2|||Pittsburgh Sleep Quality Inventory|A common instrument that assesses sleep quality over the previous month. The PSQI range is 0-21 with higher scores indicating worse sleep. Scores of > 5 have been considered indicative of a sleep problem.|units on a scale|Mean|10.4|10.4|Standard Deviation|4.2|4.2|||
4223385|NCT00701064|4046594|B1|||Pittsburgh Sleep Quality Inventory|A common instrument that assesses sleep quality over the previous month. The PSQI range is 0-21 with higher scores indicating worse sleep. Scores of > 5 have been considered indicative of a sleep problem.|units on a scale|Mean|10.3|10.3|Standard Deviation|3.4|3.4|||
4223386|NCT00701064|4046592|B3|||PTSD Checklist (PCL)|A 17-item self-rated PTSD scale ranging from 17-105, with higher levels indicating more severe PTSD. The PCL correlates highly with the CAPS-2.|units on a scale|Mean|46.3|46.3|Standard Deviation|12.9|12.9|||
4223387|NCT00701064|4046593|B2|||PTSD Checklist (PCL)|A 17-item self-rated PTSD scale ranging from 17-105, with higher levels indicating more severe PTSD. The PCL correlates highly with the CAPS-2.|units on a scale|Mean|47.2|47.2|Standard Deviation|15.2|15.2|||
4223388|NCT00701064|4046594|B1|||PTSD Checklist (PCL)|A 17-item self-rated PTSD scale ranging from 17-105, with higher levels indicating more severe PTSD. The PCL correlates highly with the CAPS-2.|units on a scale|Mean|45.3|45.3|Standard Deviation|10.1|10.1|||
4223389|NCT00701064|4046592|B3|||Clinical Global Impression Scale (CGI)|Clinical judgement of the severity of one's condition at baseline (7 point scale: 1=normal; 4=moderately ill; 7= among the most severely ill)|units on a scale|Mean|4.3|4.3|Standard Deviation|1.3|1.3|||
4223390|NCT00701064|4046593|B2|||Clinical Global Impression Scale (CGI)|Clinical judgement of the severity of one's condition at baseline (7 point scale: 1=normal; 4=moderately ill; 7= among the most severely ill)|units on a scale|Mean|4.2|4.2|Standard Deviation|1.6|1.6|||
4223391|NCT00701064|4046594|B1|||Clinical Global Impression Scale (CGI)|Clinical judgement of the severity of one's condition at baseline (7 point scale: 1=normal; 4=moderately ill; 7= among the most severely ill)|units on a scale|Mean|4.3|4.3|Standard Deviation|0.9|0.9|||
4223392|NCT00701064|4046592|B3|||Clinician Administered PTSD Scale (CAPS2)|PTSD assessed by a skilled clinician, the CAPS2 is the most common clinical and experimental measure of PTSD severity. It is designed to assess changes in PTSD severity over time, the scale ranges from 0-136. Higher levels indicate greater severity of PTSD. Scores of 30 or more or 40 or more have been considered indicated of moderate severity PTSD.|units on a scale|Mean|62.6|62.6|Standard Deviation|23.5|23.5|||
4223393|NCT00701064|4046593|B2|||Clinician Administered PTSD Scale (CAPS2)|PTSD assessed by a skilled clinician, the CAPS2 is the most common clinical and experimental measure of PTSD severity. It is designed to assess changes in PTSD severity over time, the scale ranges from 0-136. Higher levels indicate greater severity of PTSD. Scores of 30 or more or 40 or more have been considered indicated of moderate severity PTSD.|units on a scale|Mean|62.3|62.3|Standard Deviation|26.6|26.6|||
4223394|NCT00701064|4046594|B1|||Clinician Administered PTSD Scale (CAPS2)|PTSD assessed by a skilled clinician, the CAPS2 is the most common clinical and experimental measure of PTSD severity. It is designed to assess changes in PTSD severity over time, the scale ranges from 0-136. Higher levels indicate greater severity of PTSD. Scores of 30 or more or 40 or more have been considered indicated of moderate severity PTSD.|units on a scale|Mean|63.0|63.0|Standard Deviation|20.2|20.2|||
4223395|NCT00701064|4046592|B3|United States||Region of Enrollment||Participants|Count of Participants|71|71.0||||||
4223396|NCT00701064|4046593|B2|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
4223397|NCT00701064|4046594|B1|United States||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
4223398|NCT00701064|4046592|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4223399|NCT00701064|4046593|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4223400|NCT00701064|4046594|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4223401|NCT00701064|4046592|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4223402|NCT00701064|4046593|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4223403|NCT00701064|4046594|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4223404|NCT00701064|4046592|B3||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4223405|NCT00701064|4046593|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4223406|NCT00701064|4046594|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4223407|NCT00701064|4046592|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4223408|NCT00701064|4046593|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4223409|NCT00701064|4046594|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4223410|NCT00701064|4046592|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4223411|NCT00701064|4046593|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4223412|NCT00701064|4046594|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4223413|NCT00701064|4046592|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4223414|NCT00701064|4046593|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4223415|NCT00701064|4046594|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4223416|NCT00701064|4046592|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4223417|NCT00701064|4046593|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4223418|NCT00701064|4046594|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4223419|NCT00701064|4046592|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4223420|NCT00701064|4046593|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4223421|NCT00701064|4046594|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4223422|NCT00701064|4046592|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4223423|NCT00701064|4046593|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4223424|NCT00701064|4046594|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4223425|NCT00701064|4046592|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4223426|NCT00701064|4046593|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4223427|NCT00701064|4046594|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4223428|NCT00701064|4046592|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4223429|NCT00701064|4046593|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4223430|NCT00701064|4046594|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4223431|NCT00701064|4046592|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4223432|NCT00701064|4046593|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4223433|NCT00701064|4046594|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4223434|NCT00701064|4046592|B3|||Age||years|Mean|36.7|36.7|Standard Deviation|8.6|8.6|||
4223435|NCT00701064|4046593|B2|||Age||years|Mean|36.0|36.0|Standard Deviation|8.0|8.0|||
4223436|NCT00701064|4046594|B1|||Age||years|Mean|37.5|37.5|Standard Deviation|9.3|9.3|||
4223437|NCT00701064|4046592|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4223438|NCT00701064|4046593|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4223439|NCT00701064|4046594|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4223440|NCT00701064|4046592|B3||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4223441|NCT00701064|4046593|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4223442|NCT00701064|4046594|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4223443|NCT00701064|4046592|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223444|NCT00701064|4046593|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223445|NCT00701064|4046594|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223446|NCT00701051|4046605|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4223447|NCT00701051|4046606|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4223448|NCT00701051|4046607|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4223449|NCT00701051|4046605|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4223450|NCT00701051|4046606|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4223451|NCT00701051|4046607|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4223452|NCT00701051|4046605|B3|||Age||years|Mean|60|60.0|Standard Deviation|7|7.0|||
4223453|NCT00701051|4046606|B2|||Age||years|Mean|60|60.0|Standard Deviation|8|8.0|||
4223454|NCT00701051|4046607|B1|||Age||years|Mean|60|60.0|Standard Deviation|7|7.0|||
4223455|NCT00701038|4046625|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
4223456|NCT00701038|4046626|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4223457|NCT00701038|4046627|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4223458|NCT00701038|4046625|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4223459|NCT00701038|4046626|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4223460|NCT00701038|4046627|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4223461|NCT00701038|4046625|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4223462|NCT00701038|4046626|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4223463|NCT00701038|4046627|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4223464|NCT00701038|4046625|B3|||Age||years|Mean|56|56.0|Standard Deviation|14|14.0|||
4223465|NCT00701038|4046626|B2|||Age||years|Mean|51|51.0|Standard Deviation|12|12.0|||
4223466|NCT00701038|4046627|B1|||Age||years|Mean|62|62.0|Standard Deviation|14|14.0|||
4223467|NCT00701038|4046625|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4223468|NCT00701038|4046626|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4223469|NCT00701038|4046627|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4223470|NCT00701038|4046625|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4223471|NCT00701038|4046626|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4223472|NCT00701038|4046627|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4223473|NCT00701038|4046625|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223474|NCT00701038|4046626|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223475|NCT00701038|4046627|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223476|NCT00700999|4046634|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
4223477|NCT00700999|4046635|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4223478|NCT00700999|4046636|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4223479|NCT00700999|4046634|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4223480|NCT00700999|4046635|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4223481|NCT00700999|4046636|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4223482|NCT00700999|4046634|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4223483|NCT00700999|4046635|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4223484|NCT00700999|4046636|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4223485|NCT00700999|4046634|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4223486|NCT00700999|4046635|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4223487|NCT00700999|4046636|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4223488|NCT00700999|4046634|B3||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4223489|NCT00700999|4046635|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4223490|NCT00700999|4046636|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4223491|NCT00700999|4046634|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223492|NCT00700999|4046635|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223493|NCT00700999|4046636|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223494|NCT00700973|4046643|B3|United States||Region of Enrollment||participants|Number|141|141.0||||||
4223495|NCT00700973|4046644|B2|United States||Region of Enrollment||participants|Number|70|70.0||||||
4223496|NCT00700973|4046645|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
4223497|NCT00700973|4046643|B3|Non-White||Race/Ethnicity, Customized||participants|Number|73|73.0||||||
4223498|NCT00700973|4046644|B2|Non-White||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4223499|NCT00700973|4046645|B1|Non-White||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4223500|NCT00700973|4046643|B3|White||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
4223501|NCT00700973|4046644|B2|White||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4223502|NCT00700973|4046645|B1|White||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4223503|NCT00700973|4046643|B3||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4223504|NCT00700973|4046644|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4223505|NCT00700973|4046645|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4223506|NCT00700973|4046643|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4223507|NCT00700973|4046644|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4223508|NCT00700973|4046645|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4223509|NCT00700973|4046643|B3|||Age||years|Mean|52|52.0|Standard Deviation|8|8.0|||
4223510|NCT00700973|4046644|B2|||Age||years|Mean|51|51.0|Standard Deviation|8|8.0|||
4223511|NCT00700973|4046645|B1|||Age||years|Mean|52|52.0|Standard Deviation|8|8.0|||
4223512|NCT00700817|4046652|B6|||Glycosylated Haemoglobin A1c (HbA1c) at Randomisation||Percentage point of total HbA1c|Mean|8.4|8.4|Standard Deviation|0.8|0.8|||
4223513|NCT00700817|4046655|B3|||Glycosylated Haemoglobin A1c (HbA1c) at Randomisation||Percentage point of total HbA1c|Mean|8.5|8.5|Standard Deviation|0.7|0.7|||
4223514|NCT00700817|4046656|B2|||Glycosylated Haemoglobin A1c (HbA1c) at Randomisation||Percentage point of total HbA1c|Mean|8.4|8.4|Standard Deviation|0.7|0.7|||
4223515|NCT00700817|4046657|B1|||Glycosylated Haemoglobin A1c (HbA1c) at Randomisation||Percentage point of total HbA1c|Mean|8.4|8.4|Standard Deviation|0.8|0.8|||
4223516|NCT00700817|4046652|B6|||Fasting Plasma Glucose (FPG) at Randomisation||mmol/L|Mean|10.0|10.0|Standard Deviation|2.3|2.3|||
4223517|NCT00700817|4046655|B3|||Fasting Plasma Glucose (FPG) at Randomisation||mmol/L|Mean|10.0|10.0|Standard Deviation|2.0|2.0|||
4223518|NCT00700817|4046656|B2|||Fasting Plasma Glucose (FPG) at Randomisation||mmol/L|Mean|9.9|9.9|Standard Deviation|2.4|2.4|||
4223519|NCT00700817|4046657|B1|||Fasting Plasma Glucose (FPG) at Randomisation||mmol/L|Mean|10.1|10.1|Standard Deviation|2.4|2.4|||
4223520|NCT00700817|4046652|B6|||Duration of Diabetes|The time (in years) the patient had been diagnosed with diabetes when screened for the trial|years|Mean|6.2|6.2|Standard Deviation|5.1|5.1|||
4223521|NCT00700817|4046655|B3|||Duration of Diabetes|The time (in years) the patient had been diagnosed with diabetes when screened for the trial|years|Mean|6.3|6.3|Standard Deviation|5.4|5.4|||
4223522|NCT00700817|4046656|B2|||Duration of Diabetes|The time (in years) the patient had been diagnosed with diabetes when screened for the trial|years|Mean|6.4|6.4|Standard Deviation|5.4|5.4|||
4223523|NCT00700817|4046657|B1|||Duration of Diabetes|The time (in years) the patient had been diagnosed with diabetes when screened for the trial|years|Mean|6.0|6.0|Standard Deviation|4.5|4.5|||
4223524|NCT00700817|4046652|B6|||Body Mass Index (BMI) at Screening||kg/m^2|Mean|32.8|32.8|Standard Deviation|5.2|5.2|||
4223525|NCT00700817|4046655|B3|||Body Mass Index (BMI) at Screening||kg/m^2|Mean|32.6|32.6|Standard Deviation|5.4|5.4|||
4223526|NCT00700817|4046656|B2|||Body Mass Index (BMI) at Screening||kg/m^2|Mean|33.1|33.1|Standard Deviation|5.1|5.1|||
4223527|NCT00700817|4046657|B1|||Body Mass Index (BMI) at Screening||kg/m^2|Mean|32.6|32.6|Standard Deviation|5.2|5.2|||
4223528|NCT00700817|4046652|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4223529|NCT00700817|4046655|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4223530|NCT00700817|4046656|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4223531|NCT00700817|4046657|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4223532|NCT00700817|4046652|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4223533|NCT00700817|4046655|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4223534|NCT00700817|4046656|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4223535|NCT00700817|4046657|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4223536|NCT00700817|4046652|B6||White|Race (NIH/OMB)||Participants|Count of Participants|576|576.0||||||
4223537|NCT00700817|4046655|B3||White|Race (NIH/OMB)||Participants|Count of Participants|199|199.0||||||
4223538|NCT00700817|4046656|B2||White|Race (NIH/OMB)||Participants|Count of Participants|193|193.0||||||
4223539|NCT00700817|4046657|B1||White|Race (NIH/OMB)||Participants|Count of Participants|184|184.0||||||
4223540|NCT00700817|4046652|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4223541|NCT00700817|4046655|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4223542|NCT00700817|4046656|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4223543|NCT00700817|4046657|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4223544|NCT00700817|4046652|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4223545|NCT00700817|4046655|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4223546|NCT00700817|4046656|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4223547|NCT00700817|4046657|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4223548|NCT00700817|4046652|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4223549|NCT00700817|4046655|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4223550|NCT00700817|4046656|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4223551|NCT00700817|4046657|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4223552|NCT00700817|4046652|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4223553|NCT00700817|4046655|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4223554|NCT00700817|4046656|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4223555|NCT00700817|4046657|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4223556|NCT00700817|4046652|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4223557|NCT00700817|4046655|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4223558|NCT00700817|4046656|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4223559|NCT00700817|4046657|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4223560|NCT00700817|4046652|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|557|557.0||||||
4223561|NCT00700817|4046655|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|184|184.0||||||
4223562|NCT00700817|4046656|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|187|187.0||||||
4223563|NCT00700817|4046657|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|186|186.0||||||
4223564|NCT00700817|4046652|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
4223565|NCT00700817|4046655|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4223566|NCT00700817|4046656|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4223567|NCT00700817|4046657|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4223568|NCT00700817|4046652|B6||Male|Sex: Female, Male||Participants|Count of Participants|352|352.0||||||
4223569|NCT00700817|4046655|B3||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4223570|NCT00700817|4046656|B2||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4223571|NCT00700817|4046657|B1||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4223572|NCT00700817|4046652|B6||Female|Sex: Female, Male||Participants|Count of Participants|313|313.0||||||
4223573|NCT00700817|4046655|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4223574|NCT00700817|4046656|B2||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4223575|NCT00700817|4046657|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4223576|NCT00700817|4046652|B6|||Age||years|Mean|55.3|55.3|Standard Deviation|9.2|9.2|||
4223577|NCT00700817|4046655|B3|||Age||years|Mean|55.0|55.0|Standard Deviation|9.0|9.0|||
4223578|NCT00700817|4046656|B2|||Age||years|Mean|55.0|55.0|Standard Deviation|9.1|9.1|||
4223579|NCT00700817|4046657|B1|||Age||years|Mean|55.9|55.9|Standard Deviation|9.6|9.6|||
4223580|NCT00700804|4047041|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4223581|NCT00700804|4047042|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4223582|NCT00700804|4047043|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4223583|NCT00700804|4047041|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4223584|NCT00700804|4047042|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4223585|NCT00700804|4047043|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4223586|NCT00700804|4047041|B3|||Age||years|Mean|57|57.0|Standard Deviation|5|5.0|||
4223587|NCT00700804|4047042|B2|||Age||years|Mean|58|58.0|Standard Deviation|6|6.0|||
4223588|NCT00700804|4047043|B1|||Age||years|Mean|57|57.0|Standard Deviation|5|5.0|||
4223589|NCT00700804|4047041|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4223590|NCT00700804|4047042|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4223591|NCT00700804|4047043|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4223592|NCT00700804|4047041|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4223593|NCT00700804|4047042|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4223594|NCT00700804|4047043|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4223595|NCT00700804|4047041|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223596|NCT00700804|4047042|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223597|NCT00700804|4047043|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223598|NCT00700752|4047052|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4223599|NCT00700752|4047052|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4223600|NCT00700752|4047052|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4223601|NCT00700752|4047052|B1|||Age||years|Mean|24.4|24.4|Standard Deviation|3.4|3.4|||
4223602|NCT00700739|4047059|B3|United Kingdom||Region of Enrollment||participants|Number|34|34.0||||||
4223603|NCT00700739|4047060|B2|United Kingdom||Region of Enrollment||participants|Number|14|14.0||||||
4223604|NCT00700739|4047061|B1|United Kingdom||Region of Enrollment||participants|Number|20|20.0||||||
4223605|NCT00700739|4047059|B3|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4223606|NCT00700739|4047060|B2|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4223607|NCT00700739|4047061|B1|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4223608|NCT00700739|4047059|B3|Spain||Region of Enrollment||participants|Number|3|3.0||||||
4223609|NCT00700739|4047060|B2|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4223610|NCT00700739|4047061|B1|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4223611|NCT00700739|4047059|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4223612|NCT00700739|4047060|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4223613|NCT00700739|4047061|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4223614|NCT00700739|4047059|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4223615|NCT00700739|4047060|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4223616|NCT00700739|4047061|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4223617|NCT00700739|4047059|B3|||Age||years|Mean|46.2|46.2|Standard Deviation|8.65|8.65|||
4223618|NCT00700739|4047060|B2|||Age||years|Mean|47.5|47.5|Standard Deviation|8.17|8.17|||
4223619|NCT00700739|4047061|B1|||Age||years|Mean|45.3|45.3|Standard Deviation|8.87|8.87|||
4223620|NCT00700713|4047098|B4|United States||Region of Enrollment||Participants|Number|181|181.0||||||
4223621|NCT00700713|4047099|B3|United States||Region of Enrollment||Participants|Number|67|67.0||||||
4223622|NCT00700713|4047100|B2|United States||Region of Enrollment||Participants|Number|66|66.0||||||
4223623|NCT00700713|4047101|B1|United States||Region of Enrollment||Participants|Number|48|48.0||||||
4223624|NCT00700713|4047098|B4||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4223625|NCT00700713|4047099|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4223626|NCT00700713|4047100|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4223627|NCT00700713|4047101|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4223628|NCT00700713|4047098|B4||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4223629|NCT00700713|4047099|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4223630|NCT00700713|4047100|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4223631|NCT00700713|4047101|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4223632|NCT00700713|4047098|B4|||Age||Months|Mean|53.4|53.4|Standard Deviation|7.75|7.75|||
4223633|NCT00700713|4047099|B3|||Age||Months|Mean|52.5|52.5|Standard Deviation|11.8|11.8|||
4223634|NCT00700713|4047100|B2|||Age||Months|Mean|51.6|51.6|Standard Deviation|1.96|1.96|||
4223635|NCT00700713|4047101|B1|||Age||Months|Mean|57.4|57.4|Standard Deviation|2.89|2.89|||
4223636|NCT00700713|4047098|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4223637|NCT00700713|4047099|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4223638|NCT00700713|4047100|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4223639|NCT00700713|4047101|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4223640|NCT00700713|4047098|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4223641|NCT00700713|4047099|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4223642|NCT00700713|4047100|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4223643|NCT00700713|4047101|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4223644|NCT00700713|4047098|B4||<=18 years|Age||Participants|Count of Participants|181|181.0||||||
4223645|NCT00700713|4047099|B3||<=18 years|Age||Participants|Count of Participants|67|67.0||||||
4223646|NCT00700713|4047100|B2||<=18 years|Age||Participants|Count of Participants|66|66.0||||||
4223647|NCT00700713|4047101|B1||<=18 years|Age||Participants|Count of Participants|48|48.0||||||
4223648|NCT00700635|4047117|B4|United States||Region of Enrollment||participants|Number|333|333.0||||||
4223649|NCT00700635|4047118|B3|United States||Region of Enrollment||participants|Number|111|111.0||||||
4223650|NCT00700635|4047119|B2|United States||Region of Enrollment||participants|Number|111|111.0||||||
4223651|NCT00700635|4047120|B1|United States||Region of Enrollment||participants|Number|111|111.0||||||
4223652|NCT00700635|4047117|B4||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4223653|NCT00700635|4047118|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4223654|NCT00700635|4047119|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4223655|NCT00700635|4047120|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4223656|NCT00700635|4047117|B4||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4223657|NCT00700635|4047118|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4223658|NCT00700635|4047119|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4223659|NCT00700635|4047120|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4223660|NCT00700635|4047117|B4|Age Continuous||Age||Years|Mean|4.99|4.99|Standard Deviation|2.47|2.47|||
4223661|NCT00700635|4047118|B3|Age Continuous||Age||Years|Mean|8.05|8.05|Standard Deviation|1.31|1.31|||
4223662|NCT00700635|4047119|B2|Age Continuous||Age||Years|Mean|4.46|4.46|Standard Deviation|0.5|0.5|||
4223663|NCT00700635|4047120|B1|Age Continuous||Age||Years|Mean|2.46|2.46|Standard Deviation|0.5|0.5|||
4223664|NCT00700635|4047117|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4223665|NCT00700635|4047118|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4223666|NCT00700635|4047119|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4223667|NCT00700635|4047120|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4223668|NCT00700635|4047117|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4223669|NCT00700635|4047118|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4223670|NCT00700635|4047119|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4223671|NCT00700635|4047120|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4223672|NCT00700635|4047117|B4||<=18 years|Age||Participants|Count of Participants|333|333.0||||||
4223673|NCT00700635|4047118|B3||<=18 years|Age||Participants|Count of Participants|111|111.0||||||
4223674|NCT00700635|4047119|B2||<=18 years|Age||Participants|Count of Participants|111|111.0||||||
4223675|NCT00700635|4047120|B1||<=18 years|Age||Participants|Count of Participants|111|111.0||||||
4223676|NCT00700622|4047142|B3|Other||Race||participants|Number|2|2.0||||||
4223677|NCT00700622|4047143|B2|Other||Race||participants|Number|1|1.0||||||
4223678|NCT00700622|4047144|B1|Other||Race||participants|Number|1|1.0||||||
4223679|NCT00700622|4047142|B3|Hispanic||Race||participants|Number|10|10.0||||||
4223680|NCT00700622|4047143|B2|Hispanic||Race||participants|Number|5|5.0||||||
4223681|NCT00700622|4047144|B1|Hispanic||Race||participants|Number|5|5.0||||||
4223682|NCT00700622|4047142|B3|Black||Race||participants|Number|3|3.0||||||
4223683|NCT00700622|4047143|B2|Black||Race||participants|Number|0|0.0||||||
4223684|NCT00700622|4047144|B1|Black||Race||participants|Number|3|3.0||||||
4223685|NCT00700622|4047142|B3|Caucasian||Race||participants|Number|115|115.0||||||
4223686|NCT00700622|4047143|B2|Caucasian||Race||participants|Number|59|59.0||||||
4223687|NCT00700622|4047144|B1|Caucasian||Race||participants|Number|56|56.0||||||
4223688|NCT00700622|4047142|B3|||Fasting Blood Glucose||mg/dL|Mean|177.15|177.15|Standard Deviation|72.084|72.084|||
4223689|NCT00700622|4047143|B2|||Fasting Blood Glucose||mg/dL|Mean|176.20|176.2|Standard Deviation|67.268|67.268|||
4223690|NCT00700622|4047144|B1|||Fasting Blood Glucose||mg/dL|Mean|178.06|178.06|Standard Deviation|76.916|76.916|||
4223691|NCT00700622|4047142|B3|||Waist Circumference||cm|Mean|86.78|86.78|Standard Deviation|10.530|10.53|||
4223692|NCT00700622|4047143|B2|||Waist Circumference||cm|Mean|87.31|87.31|Standard Deviation|10.669|10.669|||
4223693|NCT00700622|4047144|B1|||Waist Circumference||cm|Mean|86.26|86.26|Standard Deviation|10.445|10.445|||
4223694|NCT00700622|4047142|B3|||HbA1c||%|Mean|7.69|7.69|Standard Deviation|0.579|0.579|||
4223695|NCT00700622|4047143|B2|||HbA1c||%|Mean|7.62|7.62|Standard Deviation|0.602|0.602|||
4223696|NCT00700622|4047144|B1|||HbA1c||%|Mean|7.76|7.76|Standard Deviation|0.550|0.55|||
4223697|NCT00700622|4047142|B3|||Body Mass Index||kg/m^2|Mean|25.3|25.3|Standard Deviation|3.454|3.454|||
4223698|NCT00700622|4047143|B2|||Body Mass Index||kg/m^2|Mean|25.63|25.63|Standard Deviation|3.141|3.141|||
4223699|NCT00700622|4047144|B1|||Body Mass Index||kg/m^2|Mean|25.07|25.07|Standard Deviation|3.744|3.744|||
4223700|NCT00700622|4047142|B3|||Height||cm|Mean|170.9|170.9|Standard Deviation|9.579|9.579|||
4223701|NCT00700622|4047143|B2|||Height||cm|Mean|169.61|169.61|Standard Deviation|9.807|9.807|||
4223702|NCT00700622|4047144|B1|||Height||cm|Mean|172.22|172.22|Standard Deviation|9.238|9.238|||
4223703|NCT00700622|4047142|B3|||Weight||kg|Mean|74.3|74.3|Standard Deviation|13.53|13.53|||
4223704|NCT00700622|4047143|B2|||Weight||kg|Mean|74.18|74.18|Standard Deviation|13.894|13.894|||
4223705|NCT00700622|4047144|B1|||Weight||kg|Mean|74.49|74.49|Standard Deviation|13.270|13.27|||
4223706|NCT00700622|4047142|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4223707|NCT00700622|4047143|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4223708|NCT00700622|4047144|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4223709|NCT00700622|4047142|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4223710|NCT00700622|4047143|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4223711|NCT00700622|4047144|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4223712|NCT00700622|4047142|B3|||Age||years|Mean|39.0|39.0|Standard Deviation|11.60|11.6|||
4223713|NCT00700622|4047143|B2|||Age||years|Mean|39.4|39.4|Standard Deviation|11.46|11.46|||
4223714|NCT00700622|4047144|B1|||Age||years|Mean|38.6|38.6|Standard Deviation|11.82|11.82|||
4223715|NCT00700570|4047151|B3||Male|Gender||Participants|Count of Participants|27|27.0||||||
4223716|NCT00700570|4047152|B2||Male|Gender||Participants|Count of Participants|14|14.0||||||
4223717|NCT00700570|4047153|B1||Male|Gender||Participants|Count of Participants|13|13.0||||||
4223718|NCT00700570|4047151|B3||Female|Gender||Participants|Count of Participants|18|18.0||||||
4223719|NCT00700570|4047152|B2||Female|Gender||Participants|Count of Participants|12|12.0||||||
4223720|NCT00700570|4047153|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
4223721|NCT00700570|4047151|B3|||Age||years|Mean|55.08|55.08|Standard Deviation|11.2|11.2|||
4223722|NCT00700570|4047152|B2|||Age||years|Mean|55.1|55.1|Standard Deviation|10.4|10.4|||
4223723|NCT00700570|4047153|B1|||Age||years|Mean|55.0|55.0|Standard Deviation|11.6|11.6|||
4223724|NCT00700440|4047166|B1|China||Region of Enrollment||participants|Number|100|100.0||||||
4223725|NCT00700440|4047166|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4223726|NCT00700440|4047166|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4223727|NCT00700440|4047166|B1|||Age||Years|Median|43|43.0|Full Range|||18.0|65.0|
4223728|NCT00700440|4047166|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4223729|NCT00700440|4047166|B1||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4223730|NCT00700440|4047166|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223731|NCT00700427|4047170|B1|United States||Region of Enrollment||participants|Number|602|602.0||||||
4223732|NCT00700427|4047170|B1|United Kingdom||Region of Enrollment||participants|Number|27|27.0||||||
4223733|NCT00700427|4047170|B1|Switzerland||Region of Enrollment||participants|Number|7|7.0||||||
4223734|NCT00700427|4047170|B1|Sweden||Region of Enrollment||participants|Number|112|112.0||||||
4223735|NCT00700427|4047170|B1|Spain||Region of Enrollment||participants|Number|153|153.0||||||
4223736|NCT00700427|4047170|B1|Russian Federation||Region of Enrollment||participants|Number|6|6.0||||||
4223737|NCT00700427|4047170|B1|Puerto Rico||Region of Enrollment||participants|Number|52|52.0||||||
4223738|NCT00700427|4047170|B1|Portugal||Region of Enrollment||participants|Number|3|3.0||||||
4223739|NCT00700427|4047170|B1|Netherlands||Region of Enrollment||participants|Number|71|71.0||||||
4223740|NCT00700427|4047170|B1|Mexico||Region of Enrollment||participants|Number|53|53.0||||||
4223741|NCT00700427|4047170|B1|Italy||Region of Enrollment||participants|Number|32|32.0||||||
4223742|NCT00700427|4047170|B1|Germany||Region of Enrollment||participants|Number|434|434.0||||||
4223743|NCT00700427|4047170|B1|France||Region of Enrollment||participants|Number|65|65.0||||||
4223744|NCT00700427|4047170|B1|Finland||Region of Enrollment||participants|Number|52|52.0||||||
4223745|NCT00700427|4047170|B1|Denmark||Region of Enrollment||participants|Number|15|15.0||||||
4223746|NCT00700427|4047170|B1|Canada||Region of Enrollment||participants|Number|60|60.0||||||
4223747|NCT00700427|4047170|B1|Belgium||Region of Enrollment||participants|Number|137|137.0||||||
4223748|NCT00700427|4047170|B1|Austria||Region of Enrollment||participants|Number|109|109.0||||||
4223749|NCT00700427|4047170|B1|Argentina||Region of Enrollment||participants|Number|27|27.0||||||
4223750|NCT00700427|4047170|B1|Missing||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4223751|NCT00700427|4047170|B1|West Asian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4223752|NCT00700427|4047170|B1|East Asian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4223753|NCT00700427|4047170|B1|Native American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4223754|NCT00700427|4047170|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|159|159.0||||||
4223755|NCT00700427|4047170|B1|African||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
4223756|NCT00700427|4047170|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|1765|1765.0||||||
4223757|NCT00700427|4047170|B1||Male|Sex: Female, Male||Participants|Count of Participants|1184|1184.0||||||
4223758|NCT00700427|4047170|B1||Female|Sex: Female, Male||Participants|Count of Participants|833|833.0||||||
4223759|NCT00700427|4047170|B1|||Age||years|Mean|33.15|33.15|Standard Deviation|9.09|9.09|||
4223760|NCT00700401|4047196|B1||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4223761|NCT00700401|4047196|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4223762|NCT00700401|4047196|B1|||Age||Years|Mean|49.7|49.7|Standard Deviation|9.9|9.9|||
4223763|NCT00700375|4047207|B3|Japan||Region of Enrollment||participants|Number|59|59.0||||||
4223764|NCT00700375|4047208|B2|Japan||Region of Enrollment||participants|Number|29|29.0||||||
4223765|NCT00700375|4047209|B1|Japan||Region of Enrollment||participants|Number|30|30.0||||||
4223766|NCT00700375|4047207|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4223767|NCT00700375|4047208|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4223768|NCT00700375|4047209|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4223769|NCT00700375|4047207|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4223770|NCT00700375|4047208|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4223771|NCT00700375|4047209|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4223772|NCT00700375|4047207|B3|||Age||years|Mean|75|75.0|Standard Deviation|9.8|9.8|||
4223773|NCT00700375|4047208|B2|||Age||years|Mean|75|75.0|Standard Deviation|10.3|10.3|||
4223774|NCT00700375|4047209|B1|||Age||years|Mean|76|76.0|Standard Deviation|9.3|9.3|||
4223775|NCT00700375|4047207|B3||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4223776|NCT00700375|4047208|B2||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4223777|NCT00700375|4047209|B1||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4223778|NCT00700375|4047207|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4223779|NCT00700375|4047208|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4223780|NCT00700375|4047209|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4223781|NCT00700375|4047207|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223782|NCT00700375|4047208|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223783|NCT00700375|4047209|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223784|NCT00700310|4047216|B5|Other||Race/Ethnicity, Customized|Race|Participants|Number|3|3.0||||||
4223785|NCT00700310|4047217|B4|Other||Race/Ethnicity, Customized|Race|Participants|Number|0|0.0||||||
4223786|NCT00700310|4047218|B3|Other||Race/Ethnicity, Customized|Race|Participants|Number|1|1.0||||||
4223787|NCT00700310|4047219|B2|Other||Race/Ethnicity, Customized|Race|Participants|Number|1|1.0||||||
4223788|NCT00700310|4047220|B1|Other||Race/Ethnicity, Customized|Race|Participants|Number|1|1.0||||||
4223789|NCT00700310|4047216|B5|Chinese||Race/Ethnicity, Customized|Race|Participants|Number|110|110.0||||||
4223790|NCT00700310|4047217|B4|Chinese||Race/Ethnicity, Customized|Race|Participants|Number|25|25.0||||||
4223791|NCT00700310|4047218|B3|Chinese||Race/Ethnicity, Customized|Race|Participants|Number|29|29.0||||||
4223792|NCT00700310|4047219|B2|Chinese||Race/Ethnicity, Customized|Race|Participants|Number|25|25.0||||||
4223793|NCT00700310|4047220|B1|Chinese||Race/Ethnicity, Customized|Race|Participants|Number|31|31.0||||||
4223794|NCT00700310|4047216|B5|Asian||Race/Ethnicity, Customized|Race|Participants|Number|134|134.0||||||
4223795|NCT00700310|4047217|B4|Asian||Race/Ethnicity, Customized|Race|Participants|Number|28|28.0||||||
4223796|NCT00700310|4047218|B3|Asian||Race/Ethnicity, Customized|Race|Participants|Number|37|37.0||||||
4223797|NCT00700310|4047219|B2|Asian||Race/Ethnicity, Customized|Race|Participants|Number|35|35.0||||||
4223798|NCT00700310|4047220|B1|Asian||Race/Ethnicity, Customized|Race|Participants|Number|34|34.0||||||
4223799|NCT00700310|4047216|B5|White||Race/Ethnicity, Customized|Race|Participants|Number|459|459.0||||||
4223800|NCT00700310|4047217|B4|White||Race/Ethnicity, Customized|Race|Participants|Number|116|116.0||||||
4223801|NCT00700310|4047218|B3|White||Race/Ethnicity, Customized|Race|Participants|Number|105|105.0||||||
4223802|NCT00700310|4047219|B2|White||Race/Ethnicity, Customized|Race|Participants|Number|119|119.0||||||
4223803|NCT00700310|4047220|B1|White||Race/Ethnicity, Customized|Race|Participants|Number|119|119.0||||||
4223804|NCT00700310|4047216|B5||Male|Sex: Female, Male|The number of participants started is not consistant with the number of Baseline Participants due to 6 participants who were randomized in the study, but not treated with study drug.|Participants|Count of Participants|345|345.0||||||
4223805|NCT00700310|4047217|B4||Male|Sex: Female, Male|The number of participants started is not consistant with the number of Baseline Participants due to 6 participants who were randomized in the study, but not treated with study drug.|Participants|Count of Participants|77|77.0||||||
4223806|NCT00700310|4047218|B3||Male|Sex: Female, Male|The number of participants started is not consistant with the number of Baseline Participants due to 6 participants who were randomized in the study, but not treated with study drug.|Participants|Count of Participants|88|88.0||||||
4223807|NCT00700310|4047219|B2||Male|Sex: Female, Male|The number of participants started is not consistant with the number of Baseline Participants due to 6 participants who were randomized in the study, but not treated with study drug.|Participants|Count of Participants|85|85.0||||||
4223808|NCT00700310|4047220|B1||Male|Sex: Female, Male|The number of participants started is not consistant with the number of Baseline Participants due to 6 participants who were randomized in the study, but not treated with study drug.|Participants|Count of Participants|95|95.0||||||
4223809|NCT00700310|4047216|B5||Female|Sex: Female, Male|The number of participants started is not consistant with the number of Baseline Participants due to 6 participants who were randomized in the study, but not treated with study drug.|Participants|Count of Participants|361|361.0||||||
4223810|NCT00700310|4047217|B4||Female|Sex: Female, Male|The number of participants started is not consistant with the number of Baseline Participants due to 6 participants who were randomized in the study, but not treated with study drug.|Participants|Count of Participants|92|92.0||||||
4223811|NCT00700310|4047218|B3||Female|Sex: Female, Male|The number of participants started is not consistant with the number of Baseline Participants due to 6 participants who were randomized in the study, but not treated with study drug.|Participants|Count of Participants|84|84.0||||||
4223812|NCT00700310|4047219|B2||Female|Sex: Female, Male|The number of participants started is not consistant with the number of Baseline Participants due to 6 participants who were randomized in the study, but not treated with study drug.|Participants|Count of Participants|95|95.0||||||
4223813|NCT00700310|4047220|B1||Female|Sex: Female, Male|The number of participants started is not consistant with the number of Baseline Participants due to 6 participants who were randomized in the study, but not treated with study drug.|Participants|Count of Participants|90|90.0||||||
4223814|NCT00700310|4047216|B5|>64 Years||Age, Customized||Participants|Number|10|10.0||||||
4223815|NCT00700310|4047217|B4|>64 Years||Age, Customized||Participants|Number|4|4.0||||||
4223816|NCT00700310|4047218|B3|>64 Years||Age, Customized||Participants|Number|1|1.0||||||
4223817|NCT00700310|4047219|B2|>64 Years||Age, Customized||Participants|Number|3|3.0||||||
4223818|NCT00700310|4047220|B1|>64 Years||Age, Customized||Participants|Number|2|2.0||||||
4223819|NCT00700310|4047216|B5|18-64 Years||Age, Customized||Participants|Number|636|636.0||||||
4223820|NCT00700310|4047217|B4|18-64 Years||Age, Customized||Participants|Number|153|153.0||||||
4223821|NCT00700310|4047218|B3|18-64 Years||Age, Customized||Participants|Number|158|158.0||||||
4223822|NCT00700310|4047219|B2|18-64 Years||Age, Customized||Participants|Number|156|156.0||||||
4223823|NCT00700310|4047220|B1|18-64 Years||Age, Customized||Participants|Number|169|169.0||||||
4223824|NCT00700310|4047216|B5|<18 Years||Age, Customized||Participants|Number|60|60.0||||||
4223825|NCT00700310|4047217|B4|<18 Years||Age, Customized||Participants|Number|12|12.0||||||
4223826|NCT00700310|4047218|B3|<18 Years||Age, Customized||Participants|Number|13|13.0||||||
4223827|NCT00700310|4047219|B2|<18 Years||Age, Customized||Participants|Number|21|21.0||||||
4223828|NCT00700310|4047220|B1|<18 Years||Age, Customized||Participants|Number|14|14.0||||||
4223829|NCT00700271|4047241|B3||Male|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
4223830|NCT00700271|4047242|B2||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4223831|NCT00700271|4047243|B1||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4223832|NCT00700271|4047241|B3||Female|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
4223833|NCT00700271|4047242|B2||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4223834|NCT00700271|4047243|B1||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4223835|NCT00700271|4047241|B3|||Age|Demographic data is provided for the Intent-to-Treat population, which included all the patients randomized and treated in the study and for whom two ABPM evaluations were available.|years|Mean|56.0|56.0|Standard Deviation|9.74|9.74|||
4223836|NCT00700271|4047242|B2|||Age|Demographic data is provided for the Intent-to-Treat population, which included all the patients randomized and treated in the study and for whom two ABPM evaluations were available.|years|Mean|56.2|56.2|Standard Deviation|9.59|9.59|||
4223837|NCT00700271|4047243|B1|||Age|Demographic data is provided for the Intent-to-Treat population, which included all the patients randomized and treated in the study and for whom two ABPM evaluations were available.|years|Mean|55.8|55.8|Standard Deviation|9.89|9.89|||
4223838|NCT00700180|4047270|B3||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4223839|NCT00700180|4047271|B2||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4223840|NCT00700180|4047272|B1||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4223841|NCT00700180|4047270|B3||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4223842|NCT00700180|4047271|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4223843|NCT00700180|4047272|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4223844|NCT00700180|4047270|B3|||Age||years|Mean|59.2|59.2|Standard Deviation|10.66|10.66|||
4223845|NCT00700180|4047271|B2|||Age||years|Mean|58.8|58.8|Standard Deviation|11.20|11.2|||
4223846|NCT00700180|4047272|B1|||Age||years|Mean|59.7|59.7|Standard Deviation|10.13|10.13|||
4223847|NCT00700141|4047295|B1|TE||Type of surgery|"Enuc = Enucleation in one or both sides of the thyroid gland~1-ST = Subtotal or near-total resection of one side of the thyroid gland~HT = Total resection of one side of the thyroid gland= hemithyroidectomy~2-ST = Subtotal or near-total resection of both sides of the thyroid gland~HT+ST = Total resection of one side=hemithyroidectomy and subtotal or neartotal resection of the contralateral side~TE = Total resection of both lobes of the thyroid gland=thyroidectomy"|participants|Number|217|217.0||||||
4223848|NCT00700141|4047295|B1|HT+ST||Type of surgery|"Enuc = Enucleation in one or both sides of the thyroid gland~1-ST = Subtotal or near-total resection of one side of the thyroid gland~HT = Total resection of one side of the thyroid gland= hemithyroidectomy~2-ST = Subtotal or near-total resection of both sides of the thyroid gland~HT+ST = Total resection of one side=hemithyroidectomy and subtotal or neartotal resection of the contralateral side~TE = Total resection of both lobes of the thyroid gland=thyroidectomy"|participants|Number|70|70.0||||||
4223849|NCT00700141|4047295|B1|2-ST||Type of surgery|"Enuc = Enucleation in one or both sides of the thyroid gland~1-ST = Subtotal or near-total resection of one side of the thyroid gland~HT = Total resection of one side of the thyroid gland= hemithyroidectomy~2-ST = Subtotal or near-total resection of both sides of the thyroid gland~HT+ST = Total resection of one side=hemithyroidectomy and subtotal or neartotal resection of the contralateral side~TE = Total resection of both lobes of the thyroid gland=thyroidectomy"|participants|Number|82|82.0||||||
4223850|NCT00700141|4047295|B1|HT||Type of surgery|"Enuc = Enucleation in one or both sides of the thyroid gland~1-ST = Subtotal or near-total resection of one side of the thyroid gland~HT = Total resection of one side of the thyroid gland= hemithyroidectomy~2-ST = Subtotal or near-total resection of both sides of the thyroid gland~HT+ST = Total resection of one side=hemithyroidectomy and subtotal or neartotal resection of the contralateral side~TE = Total resection of both lobes of the thyroid gland=thyroidectomy"|participants|Number|83|83.0||||||
4223851|NCT00700141|4047295|B1|1-ST||Type of surgery|"Enuc = Enucleation in one or both sides of the thyroid gland~1-ST = Subtotal or near-total resection of one side of the thyroid gland~HT = Total resection of one side of the thyroid gland= hemithyroidectomy~2-ST = Subtotal or near-total resection of both sides of the thyroid gland~HT+ST = Total resection of one side=hemithyroidectomy and subtotal or neartotal resection of the contralateral side~TE = Total resection of both lobes of the thyroid gland=thyroidectomy"|participants|Number|25|25.0||||||
4223852|NCT00700141|4047295|B1|Enuc||Type of surgery|"Enuc = Enucleation in one or both sides of the thyroid gland~1-ST = Subtotal or near-total resection of one side of the thyroid gland~HT = Total resection of one side of the thyroid gland= hemithyroidectomy~2-ST = Subtotal or near-total resection of both sides of the thyroid gland~HT+ST = Total resection of one side=hemithyroidectomy and subtotal or neartotal resection of the contralateral side~TE = Total resection of both lobes of the thyroid gland=thyroidectomy"|participants|Number|5|5.0||||||
4223853|NCT00700141|4047295|B1|Hyperparathyroidism||Number of Participants with the Indicated Hemorrhagic Risk Present|Multiple risks are possible for 184 participants (out of a total of 482 participants) who are affected by preoperative hemorrhagic risk according to surgeon assessment|participants|Number|80|80.0||||||
4223854|NCT00700141|4047295|B1|Other risks (M.Basedow, thyroiditis, tumor)||Number of Participants with the Indicated Hemorrhagic Risk Present|Multiple risks are possible for 184 participants (out of a total of 482 participants) who are affected by preoperative hemorrhagic risk according to surgeon assessment|participants|Number|47|47.0||||||
4223909|NCT00700063|4047338|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4223910|NCT00700063|4047330|B9||Male|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
4223855|NCT00700141|4047295|B1|Disturbance of the thrombocyte hemostasis||Number of Participants with the Indicated Hemorrhagic Risk Present|Multiple risks are possible for 184 participants (out of a total of 482 participants) who are affected by preoperative hemorrhagic risk according to surgeon assessment|participants|Number|9|9.0||||||
4223856|NCT00700141|4047295|B1|Liver function disorders||Number of Participants with the Indicated Hemorrhagic Risk Present|Multiple risks are possible for 184 participants (out of a total of 482 participants) who are affected by preoperative hemorrhagic risk according to surgeon assessment|participants|Number|3|3.0||||||
4223857|NCT00700141|4047295|B1|Hereditary coagulation disorders||Number of Participants with the Indicated Hemorrhagic Risk Present|Multiple risks are possible for 184 participants (out of a total of 482 participants) who are affected by preoperative hemorrhagic risk according to surgeon assessment|participants|Number|4|4.0||||||
4223858|NCT00700141|4047295|B1|Application of medicines affecting coagulation||Number of Participants with the Indicated Hemorrhagic Risk Present|Multiple risks are possible for 184 participants (out of a total of 482 participants) who are affected by preoperative hemorrhagic risk according to surgeon assessment|participants|Number|96|96.0||||||
4223859|NCT00700141|4047295|B1||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4223860|NCT00700141|4047295|B1||Female|Sex: Female, Male||Participants|Count of Participants|343|343.0||||||
4223861|NCT00700141|4047295|B1|between 15 and 91 years||Age|The measured value is related to the number of 465 subjects. This number differs from the overall number of baseline participants due to non-availability of this information for 17 subjects.|years|Mean|53.33|53.33|Standard Deviation|14.39|14.39|||
4223862|NCT00700115|4047300|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4223863|NCT00700115|4047301|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4223864|NCT00700115|4047302|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4223865|NCT00700115|4047300|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4223866|NCT00700115|4047301|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4223867|NCT00700115|4047302|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4223868|NCT00700115|4047300|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4223869|NCT00700115|4047301|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4223870|NCT00700115|4047302|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4223871|NCT00700115|4047300|B3|||Age||years|Mean|47|47.0|Standard Deviation|10|10.0|||
4223872|NCT00700115|4047301|B2|||Age||years|Mean|48|48.0|Standard Deviation|12|12.0|||
4223873|NCT00700115|4047302|B1|||Age||years|Mean|46|46.0|Standard Deviation|9|9.0|||
4223874|NCT00700115|4047300|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4223875|NCT00700115|4047301|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4223876|NCT00700115|4047302|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4223877|NCT00700115|4047300|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4223878|NCT00700115|4047301|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4223879|NCT00700115|4047302|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4223880|NCT00700115|4047300|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223881|NCT00700115|4047301|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223882|NCT00700115|4047302|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223883|NCT00700102|4047311|B3||Male|Sex: Female, Male||Participants|Count of Participants|526|526.0||||||
4223884|NCT00700102|4047312|B2||Male|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
4223885|NCT00700102|4047313|B1||Male|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
4223886|NCT00700102|4047311|B3||Female|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
4223887|NCT00700102|4047312|B2||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4223888|NCT00700102|4047313|B1||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4223889|NCT00700102|4047311|B3|||Age||years|Mean|62.0|62.0|Standard Deviation|9.66|9.66|||
4223890|NCT00700102|4047312|B2|||Age||years|Mean|62.1|62.1|Standard Deviation|9.78|9.78|||
4223891|NCT00700102|4047313|B1|||Age||years|Mean|61.9|61.9|Standard Deviation|9.55|9.55|||
4223892|NCT00700063|4047330|B9|Australia||Region of Enrollment||participants|Number|33|33.0||||||
4223893|NCT00700063|4047331|B8|Australia||Region of Enrollment||participants|Number|5|5.0||||||
4223894|NCT00700063|4047332|B7|Australia||Region of Enrollment||participants|Number|7|7.0||||||
4223895|NCT00700063|4047333|B6|Australia||Region of Enrollment||participants|Number|3|3.0||||||
4223896|NCT00700063|4047334|B5|Australia||Region of Enrollment||participants|Number|4|4.0||||||
4223897|NCT00700063|4047335|B4|Australia||Region of Enrollment||participants|Number|4|4.0||||||
4223898|NCT00700063|4047336|B3|Australia||Region of Enrollment||participants|Number|2|2.0||||||
4223899|NCT00700063|4047337|B2|Australia||Region of Enrollment||participants|Number|5|5.0||||||
4223900|NCT00700063|4047338|B1|Australia||Region of Enrollment||participants|Number|3|3.0||||||
4223901|NCT00700063|4047330|B9|United States||Region of Enrollment||participants|Number|232|232.0||||||
4223902|NCT00700063|4047331|B8|United States||Region of Enrollment||participants|Number|28|28.0||||||
4223903|NCT00700063|4047332|B7|United States||Region of Enrollment||participants|Number|25|25.0||||||
4223904|NCT00700063|4047333|B6|United States||Region of Enrollment||participants|Number|31|31.0||||||
4223905|NCT00700063|4047334|B5|United States||Region of Enrollment||participants|Number|29|29.0||||||
4223906|NCT00700063|4047335|B4|United States||Region of Enrollment||participants|Number|29|29.0||||||
4223907|NCT00700063|4047336|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4223908|NCT00700063|4047337|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4223911|NCT00700063|4047331|B8||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4223912|NCT00700063|4047332|B7||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4223913|NCT00700063|4047333|B6||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4223914|NCT00700063|4047334|B5||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4223915|NCT00700063|4047335|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4223916|NCT00700063|4047336|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4223917|NCT00700063|4047337|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4223918|NCT00700063|4047338|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4223919|NCT00700063|4047330|B9||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4223920|NCT00700063|4047331|B8||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4223921|NCT00700063|4047332|B7||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4223922|NCT00700063|4047333|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4223923|NCT00700063|4047334|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4223924|NCT00700063|4047335|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4223925|NCT00700063|4047336|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4223926|NCT00700063|4047337|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4223927|NCT00700063|4047338|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4223928|NCT00700063|4047330|B9|||Age||years|Mean|67.4|67.4|Standard Deviation|9.8|9.8|||
4223929|NCT00700063|4047331|B8|||Age||years|Mean|69.3|69.3|Standard Deviation|10.7|10.7|||
4223930|NCT00700063|4047332|B7|||Age||years|Mean|67.2|67.2|Standard Deviation|10.1|10.1|||
4223931|NCT00700063|4047333|B6|||Age||years|Mean|67.7|67.7|Standard Deviation|9.0|9.0|||
4223932|NCT00700063|4047334|B5|||Age||years|Mean|68.7|68.7|Standard Deviation|11.0|11.0|||
4223933|NCT00700063|4047335|B4|||Age||years|Mean|65.2|65.2|Standard Deviation|9.7|9.7|||
4223934|NCT00700063|4047336|B3|||Age||years|Mean|67.8|67.8|Standard Deviation|7.0|7.0|||
4223935|NCT00700063|4047337|B2|||Age||years|Mean|67.5|67.5|Standard Deviation|10.5|10.5|||
4223936|NCT00700063|4047338|B1|||Age||years|Mean|66.2|66.2|Standard Deviation|10.2|10.2|||
4223937|NCT00700063|4047330|B9||>=65 years|Age||Participants|Count of Participants|153|153.0||||||
4223938|NCT00700063|4047331|B8||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4223939|NCT00700063|4047332|B7||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4223940|NCT00700063|4047333|B6||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4223941|NCT00700063|4047334|B5||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4223942|NCT00700063|4047335|B4||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4223943|NCT00700063|4047336|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4223944|NCT00700063|4047337|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4223945|NCT00700063|4047338|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4223946|NCT00700063|4047330|B9||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
4223947|NCT00700063|4047331|B8||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4223948|NCT00700063|4047332|B7||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4223949|NCT00700063|4047333|B6||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4223950|NCT00700063|4047334|B5||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4223951|NCT00700063|4047335|B4||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4223952|NCT00700063|4047336|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4223953|NCT00700063|4047337|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4223954|NCT00700063|4047338|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4223955|NCT00700063|4047330|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223956|NCT00700063|4047331|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223957|NCT00700063|4047332|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223958|NCT00700063|4047333|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223959|NCT00700063|4047334|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223960|NCT00700063|4047335|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223961|NCT00700063|4047336|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223962|NCT00700063|4047337|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223963|NCT00700063|4047338|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223964|NCT00700011|4047451|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4223965|NCT00700011|4047452|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4223966|NCT00700011|4047453|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4223967|NCT00700011|4047451|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4223968|NCT00700011|4047452|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4223969|NCT00700011|4047453|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4223970|NCT00700011|4047451|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4223971|NCT00700011|4047452|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4223972|NCT00700011|4047453|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4223973|NCT00700011|4047451|B3|||Age||years|Mean|74.2|74.2|Standard Deviation|4.022|4.022|||
4223974|NCT00700011|4047452|B2|||Age||years|Mean|77.5|77.5|Standard Deviation|0.707|0.707|||
4223975|NCT00700011|4047453|B1|||Age||years|Mean|73.38|73.38|Standard Deviation|4.10357|4.10357|||
4223976|NCT00700011|4047451|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4223977|NCT00700011|4047452|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4223978|NCT00700011|4047453|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4223979|NCT00700011|4047451|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4223980|NCT00700011|4047452|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4223981|NCT00700011|4047453|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4223982|NCT00700011|4047451|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223983|NCT00700011|4047452|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223984|NCT00700011|4047453|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4223985|NCT00699998|4047466|B5|Unknown/Did not meet criteria||Clinical Presentation of UA or NSTEMI|Clinical Presentation of unstable angina (UA) or non-ST-segment elevation myocardial infarction (NSTEMI)|participants|Number|504|504.0||||||
4223986|NCT00699998|4047467|B4|Unknown/Did not meet criteria||Clinical Presentation of UA or NSTEMI|Clinical Presentation of unstable angina (UA) or non-ST-segment elevation myocardial infarction (NSTEMI)|participants|Number|44|44.0||||||
4223987|NCT00699998|4047468|B3|Unknown/Did not meet criteria||Clinical Presentation of UA or NSTEMI|Clinical Presentation of unstable angina (UA) or non-ST-segment elevation myocardial infarction (NSTEMI)|participants|Number|208|208.0||||||
4223988|NCT00699998|4047469|B2|Unknown/Did not meet criteria||Clinical Presentation of UA or NSTEMI|Clinical Presentation of unstable angina (UA) or non-ST-segment elevation myocardial infarction (NSTEMI)|participants|Number|48|48.0||||||
4223989|NCT00699998|4047470|B1|Unknown/Did not meet criteria||Clinical Presentation of UA or NSTEMI|Clinical Presentation of unstable angina (UA) or non-ST-segment elevation myocardial infarction (NSTEMI)|participants|Number|204|204.0||||||
4223990|NCT00699998|4047466|B5|Non-ST-segment Elevation Myocardial Infarction||Clinical Presentation of UA or NSTEMI|Clinical Presentation of unstable angina (UA) or non-ST-segment elevation myocardial infarction (NSTEMI)|participants|Number|6520|6520.0||||||
4223991|NCT00699998|4047467|B4|Non-ST-segment Elevation Myocardial Infarction||Clinical Presentation of UA or NSTEMI|Clinical Presentation of unstable angina (UA) or non-ST-segment elevation myocardial infarction (NSTEMI)|participants|Number|804|804.0||||||
4223992|NCT00699998|4047468|B3|Non-ST-segment Elevation Myocardial Infarction||Clinical Presentation of UA or NSTEMI|Clinical Presentation of unstable angina (UA) or non-ST-segment elevation myocardial infarction (NSTEMI)|participants|Number|2434|2434.0||||||
4223993|NCT00699998|4047469|B2|Non-ST-segment Elevation Myocardial Infarction||Clinical Presentation of UA or NSTEMI|Clinical Presentation of unstable angina (UA) or non-ST-segment elevation myocardial infarction (NSTEMI)|participants|Number|829|829.0||||||
4223994|NCT00699998|4047470|B1|Non-ST-segment Elevation Myocardial Infarction||Clinical Presentation of UA or NSTEMI|Clinical Presentation of unstable angina (UA) or non-ST-segment elevation myocardial infarction (NSTEMI)|participants|Number|2453|2453.0||||||
4223995|NCT00699998|4047466|B5|Unstable Angina||Clinical Presentation of UA or NSTEMI|Clinical Presentation of unstable angina (UA) or non-ST-segment elevation myocardial infarction (NSTEMI)|participants|Number|2302|2302.0||||||
4223996|NCT00699998|4047467|B4|Unstable Angina||Clinical Presentation of UA or NSTEMI|Clinical Presentation of unstable angina (UA) or non-ST-segment elevation myocardial infarction (NSTEMI)|participants|Number|192|192.0||||||
4223997|NCT00699998|4047468|B3|Unstable Angina||Clinical Presentation of UA or NSTEMI|Clinical Presentation of unstable angina (UA) or non-ST-segment elevation myocardial infarction (NSTEMI)|participants|Number|981|981.0||||||
4223998|NCT00699998|4047469|B2|Unstable Angina||Clinical Presentation of UA or NSTEMI|Clinical Presentation of unstable angina (UA) or non-ST-segment elevation myocardial infarction (NSTEMI)|participants|Number|166|166.0||||||
4223999|NCT00699998|4047470|B1|Unstable Angina||Clinical Presentation of UA or NSTEMI|Clinical Presentation of unstable angina (UA) or non-ST-segment elevation myocardial infarction (NSTEMI)|participants|Number|963|963.0||||||
4224000|NCT00699998|4047466|B5|Unknown||History of Coronary Revascularization (PCI or CABG)|History of Coronary Revascularization due to percutaneous coronary intervention (PCI) or coronary artery bypass graft surgery (CABG)|participants|Number|45|45.0||||||
4224001|NCT00699998|4047467|B4|Unknown||History of Coronary Revascularization (PCI or CABG)|History of Coronary Revascularization due to percutaneous coronary intervention (PCI) or coronary artery bypass graft surgery (CABG)|participants|Number|7|7.0||||||
4224002|NCT00699998|4047468|B3|Unknown||History of Coronary Revascularization (PCI or CABG)|History of Coronary Revascularization due to percutaneous coronary intervention (PCI) or coronary artery bypass graft surgery (CABG)|participants|Number|19|19.0||||||
4224003|NCT00699998|4047469|B2|Unknown||History of Coronary Revascularization (PCI or CABG)|History of Coronary Revascularization due to percutaneous coronary intervention (PCI) or coronary artery bypass graft surgery (CABG)|participants|Number|10|10.0||||||
4224004|NCT00699998|4047470|B1|Unknown||History of Coronary Revascularization (PCI or CABG)|History of Coronary Revascularization due to percutaneous coronary intervention (PCI) or coronary artery bypass graft surgery (CABG)|participants|Number|9|9.0||||||
4224005|NCT00699998|4047466|B5|No||History of Coronary Revascularization (PCI or CABG)|History of Coronary Revascularization due to percutaneous coronary intervention (PCI) or coronary artery bypass graft surgery (CABG)|participants|Number|6008|6008.0||||||
4224006|NCT00699998|4047467|B4|No||History of Coronary Revascularization (PCI or CABG)|History of Coronary Revascularization due to percutaneous coronary intervention (PCI) or coronary artery bypass graft surgery (CABG)|participants|Number|734|734.0||||||
4224007|NCT00699998|4047468|B3|No||History of Coronary Revascularization (PCI or CABG)|History of Coronary Revascularization due to percutaneous coronary intervention (PCI) or coronary artery bypass graft surgery (CABG)|participants|Number|2239|2239.0||||||
4224008|NCT00699998|4047469|B2|No||History of Coronary Revascularization (PCI or CABG)|History of Coronary Revascularization due to percutaneous coronary intervention (PCI) or coronary artery bypass graft surgery (CABG)|participants|Number|703|703.0||||||
4224065|NCT00699998|4047466|B5|Belgium||Region of Enrollment||participants|Number|29|29.0||||||
4224009|NCT00699998|4047470|B1|No||History of Coronary Revascularization (PCI or CABG)|History of Coronary Revascularization due to percutaneous coronary intervention (PCI) or coronary artery bypass graft surgery (CABG)|participants|Number|2332|2332.0||||||
4224010|NCT00699998|4047466|B5|Yes||History of Coronary Revascularization (PCI or CABG)|History of Coronary Revascularization due to percutaneous coronary intervention (PCI) or coronary artery bypass graft surgery (CABG)|participants|Number|3273|3273.0||||||
4224011|NCT00699998|4047467|B4|Yes||History of Coronary Revascularization (PCI or CABG)|History of Coronary Revascularization due to percutaneous coronary intervention (PCI) or coronary artery bypass graft surgery (CABG)|participants|Number|299|299.0||||||
4224012|NCT00699998|4047468|B3|Yes||History of Coronary Revascularization (PCI or CABG)|History of Coronary Revascularization due to percutaneous coronary intervention (PCI) or coronary artery bypass graft surgery (CABG)|participants|Number|1365|1365.0||||||
4224013|NCT00699998|4047469|B2|Yes||History of Coronary Revascularization (PCI or CABG)|History of Coronary Revascularization due to percutaneous coronary intervention (PCI) or coronary artery bypass graft surgery (CABG)|participants|Number|330|330.0||||||
4224014|NCT00699998|4047470|B1|Yes||History of Coronary Revascularization (PCI or CABG)|History of Coronary Revascularization due to percutaneous coronary intervention (PCI) or coronary artery bypass graft surgery (CABG)|participants|Number|1279|1279.0||||||
4224015|NCT00699998|4047466|B5|Unknown||History of Myocardial Infarction (MI)||participants|Number|80|80.0||||||
4224016|NCT00699998|4047467|B4|Unknown||History of Myocardial Infarction (MI)||participants|Number|14|14.0||||||
4224017|NCT00699998|4047468|B3|Unknown||History of Myocardial Infarction (MI)||participants|Number|23|23.0||||||
4224018|NCT00699998|4047469|B2|Unknown||History of Myocardial Infarction (MI)||participants|Number|14|14.0||||||
4224019|NCT00699998|4047470|B1|Unknown||History of Myocardial Infarction (MI)||participants|Number|29|29.0||||||
4224020|NCT00699998|4047466|B5|No||History of Myocardial Infarction (MI)||participants|Number|5259|5259.0||||||
4224021|NCT00699998|4047467|B4|No||History of Myocardial Infarction (MI)||participants|Number|633|633.0||||||
4224022|NCT00699998|4047468|B3|No||History of Myocardial Infarction (MI)||participants|Number|1988|1988.0||||||
4224023|NCT00699998|4047469|B2|No||History of Myocardial Infarction (MI)||participants|Number|603|603.0||||||
4224024|NCT00699998|4047470|B1|No||History of Myocardial Infarction (MI)||participants|Number|2035|2035.0||||||
4224025|NCT00699998|4047466|B5|Yes||History of Myocardial Infarction (MI)||participants|Number|3987|3987.0||||||
4224026|NCT00699998|4047467|B4|Yes||History of Myocardial Infarction (MI)||participants|Number|393|393.0||||||
4224027|NCT00699998|4047468|B3|Yes||History of Myocardial Infarction (MI)||participants|Number|1612|1612.0||||||
4224028|NCT00699998|4047469|B2|Yes||History of Myocardial Infarction (MI)||participants|Number|426|426.0||||||
4224029|NCT00699998|4047470|B1|Yes||History of Myocardial Infarction (MI)||participants|Number|1556|1556.0||||||
4224030|NCT00699998|4047466|B5|Unknown||History of Diabetes||participants|Number|20|20.0||||||
4224031|NCT00699998|4047467|B4|Unknown||History of Diabetes||participants|Number|0|0.0||||||
4224032|NCT00699998|4047468|B3|Unknown||History of Diabetes||participants|Number|12|12.0||||||
4224033|NCT00699998|4047469|B2|Unknown||History of Diabetes||participants|Number|2|2.0||||||
4224034|NCT00699998|4047470|B1|Unknown||History of Diabetes||participants|Number|6|6.0||||||
4224035|NCT00699998|4047466|B5|No||History of Diabetes||participants|Number|5767|5767.0||||||
4224036|NCT00699998|4047467|B4|No||History of Diabetes||participants|Number|675|675.0||||||
4224037|NCT00699998|4047468|B3|No||History of Diabetes||participants|Number|2193|2193.0||||||
4224038|NCT00699998|4047469|B2|No||History of Diabetes||participants|Number|678|678.0||||||
4224039|NCT00699998|4047470|B1|No||History of Diabetes||participants|Number|2221|2221.0||||||
4224040|NCT00699998|4047466|B5|Yes||History of Diabetes||participants|Number|3539|3539.0||||||
4224041|NCT00699998|4047467|B4|Yes||History of Diabetes||participants|Number|365|365.0||||||
4224042|NCT00699998|4047468|B3|Yes||History of Diabetes||participants|Number|1418|1418.0||||||
4224043|NCT00699998|4047469|B2|Yes||History of Diabetes||participants|Number|363|363.0||||||
4224044|NCT00699998|4047470|B1|Yes||History of Diabetes||participants|Number|1393|1393.0||||||
4224045|NCT00699998|4047466|B5|New Zealand||Region of Enrollment||participants|Number|26|26.0||||||
4224046|NCT00699998|4047467|B4|New Zealand||Region of Enrollment||participants|Number|3|3.0||||||
4224047|NCT00699998|4047468|B3|New Zealand||Region of Enrollment||participants|Number|10|10.0||||||
4224048|NCT00699998|4047469|B2|New Zealand||Region of Enrollment||participants|Number|3|3.0||||||
4224049|NCT00699998|4047470|B1|New Zealand||Region of Enrollment||participants|Number|10|10.0||||||
4224050|NCT00699998|4047466|B5|Germany||Region of Enrollment||participants|Number|133|133.0||||||
4224051|NCT00699998|4047467|B4|Germany||Region of Enrollment||participants|Number|21|21.0||||||
4224052|NCT00699998|4047468|B3|Germany||Region of Enrollment||participants|Number|46|46.0||||||
4224053|NCT00699998|4047469|B2|Germany||Region of Enrollment||participants|Number|20|20.0||||||
4224054|NCT00699998|4047470|B1|Germany||Region of Enrollment||participants|Number|46|46.0||||||
4224055|NCT00699998|4047466|B5|Bulgaria||Region of Enrollment||participants|Number|528|528.0||||||
4224056|NCT00699998|4047467|B4|Bulgaria||Region of Enrollment||participants|Number|55|55.0||||||
4224057|NCT00699998|4047468|B3|Bulgaria||Region of Enrollment||participants|Number|209|209.0||||||
4224058|NCT00699998|4047469|B2|Bulgaria||Region of Enrollment||participants|Number|48|48.0||||||
4224059|NCT00699998|4047470|B1|Bulgaria||Region of Enrollment||participants|Number|216|216.0||||||
4224060|NCT00699998|4047466|B5|Singapore||Region of Enrollment||participants|Number|13|13.0||||||
4224061|NCT00699998|4047467|B4|Singapore||Region of Enrollment||participants|Number|1|1.0||||||
4224062|NCT00699998|4047468|B3|Singapore||Region of Enrollment||participants|Number|5|5.0||||||
4224063|NCT00699998|4047469|B2|Singapore||Region of Enrollment||participants|Number|5|5.0||||||
4224064|NCT00699998|4047470|B1|Singapore||Region of Enrollment||participants|Number|2|2.0||||||
4224066|NCT00699998|4047467|B4|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
4224067|NCT00699998|4047468|B3|Belgium||Region of Enrollment||participants|Number|7|7.0||||||
4224068|NCT00699998|4047469|B2|Belgium||Region of Enrollment||participants|Number|7|7.0||||||
4224069|NCT00699998|4047470|B1|Belgium||Region of Enrollment||participants|Number|7|7.0||||||
4224070|NCT00699998|4047466|B5|Poland||Region of Enrollment||participants|Number|393|393.0||||||
4224071|NCT00699998|4047467|B4|Poland||Region of Enrollment||participants|Number|68|68.0||||||
4224072|NCT00699998|4047468|B3|Poland||Region of Enrollment||participants|Number|129|129.0||||||
4224073|NCT00699998|4047469|B2|Poland||Region of Enrollment||participants|Number|59|59.0||||||
4224074|NCT00699998|4047470|B1|Poland||Region of Enrollment||participants|Number|137|137.0||||||
4224075|NCT00699998|4047466|B5|Argentina||Region of Enrollment||participants|Number|357|357.0||||||
4224076|NCT00699998|4047467|B4|Argentina||Region of Enrollment||participants|Number|41|41.0||||||
4224077|NCT00699998|4047468|B3|Argentina||Region of Enrollment||participants|Number|138|138.0||||||
4224078|NCT00699998|4047469|B2|Argentina||Region of Enrollment||participants|Number|58|58.0||||||
4224079|NCT00699998|4047470|B1|Argentina||Region of Enrollment||participants|Number|120|120.0||||||
4224080|NCT00699998|4047466|B5|Hungary||Region of Enrollment||participants|Number|260|260.0||||||
4224081|NCT00699998|4047467|B4|Hungary||Region of Enrollment||participants|Number|44|44.0||||||
4224082|NCT00699998|4047468|B3|Hungary||Region of Enrollment||participants|Number|87|87.0||||||
4224083|NCT00699998|4047469|B2|Hungary||Region of Enrollment||participants|Number|43|43.0||||||
4224084|NCT00699998|4047470|B1|Hungary||Region of Enrollment||participants|Number|86|86.0||||||
4224085|NCT00699998|4047466|B5|Egypt||Region of Enrollment||participants|Number|132|132.0||||||
4224086|NCT00699998|4047467|B4|Egypt||Region of Enrollment||participants|Number|4|4.0||||||
4224087|NCT00699998|4047468|B3|Egypt||Region of Enrollment||participants|Number|62|62.0||||||
4224088|NCT00699998|4047469|B2|Egypt||Region of Enrollment||participants|Number|1|1.0||||||
4224089|NCT00699998|4047470|B1|Egypt||Region of Enrollment||participants|Number|65|65.0||||||
4224090|NCT00699998|4047466|B5|United Kingdom||Region of Enrollment||participants|Number|106|106.0||||||
4224091|NCT00699998|4047467|B4|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
4224092|NCT00699998|4047468|B3|United Kingdom||Region of Enrollment||participants|Number|40|40.0||||||
4224093|NCT00699998|4047469|B2|United Kingdom||Region of Enrollment||participants|Number|21|21.0||||||
4224094|NCT00699998|4047470|B1|United Kingdom||Region of Enrollment||participants|Number|33|33.0||||||
4224095|NCT00699998|4047466|B5|Malta||Region of Enrollment||participants|Number|22|22.0||||||
4224096|NCT00699998|4047467|B4|Malta||Region of Enrollment||participants|Number|2|2.0||||||
4224097|NCT00699998|4047468|B3|Malta||Region of Enrollment||participants|Number|10|10.0||||||
4224098|NCT00699998|4047469|B2|Malta||Region of Enrollment||participants|Number|1|1.0||||||
4224099|NCT00699998|4047470|B1|Malta||Region of Enrollment||participants|Number|9|9.0||||||
4224100|NCT00699998|4047466|B5|Austria||Region of Enrollment||participants|Number|23|23.0||||||
4224101|NCT00699998|4047467|B4|Austria||Region of Enrollment||participants|Number|5|5.0||||||
4224102|NCT00699998|4047468|B3|Austria||Region of Enrollment||participants|Number|6|6.0||||||
4224103|NCT00699998|4047469|B2|Austria||Region of Enrollment||participants|Number|6|6.0||||||
4224104|NCT00699998|4047470|B1|Austria||Region of Enrollment||participants|Number|6|6.0||||||
4224105|NCT00699998|4047466|B5|Lithuania||Region of Enrollment||participants|Number|73|73.0||||||
4224106|NCT00699998|4047467|B4|Lithuania||Region of Enrollment||participants|Number|4|4.0||||||
4224107|NCT00699998|4047468|B3|Lithuania||Region of Enrollment||participants|Number|32|32.0||||||
4224108|NCT00699998|4047469|B2|Lithuania||Region of Enrollment||participants|Number|8|8.0||||||
4224109|NCT00699998|4047470|B1|Lithuania||Region of Enrollment||participants|Number|29|29.0||||||
4224110|NCT00699998|4047466|B5|Finland||Region of Enrollment||participants|Number|13|13.0||||||
4224111|NCT00699998|4047467|B4|Finland||Region of Enrollment||participants|Number|2|2.0||||||
4224112|NCT00699998|4047468|B3|Finland||Region of Enrollment||participants|Number|5|5.0||||||
4224113|NCT00699998|4047469|B2|Finland||Region of Enrollment||participants|Number|3|3.0||||||
4224114|NCT00699998|4047470|B1|Finland||Region of Enrollment||participants|Number|3|3.0||||||
4224115|NCT00699998|4047466|B5|China||Region of Enrollment||participants|Number|328|328.0||||||
4224116|NCT00699998|4047467|B4|China||Region of Enrollment||participants|Number|44|44.0||||||
4224117|NCT00699998|4047468|B3|China||Region of Enrollment||participants|Number|120|120.0||||||
4224118|NCT00699998|4047469|B2|China||Region of Enrollment||participants|Number|38|38.0||||||
4224119|NCT00699998|4047470|B1|China||Region of Enrollment||participants|Number|126|126.0||||||
4224120|NCT00699998|4047466|B5|Tunisia||Region of Enrollment||participants|Number|47|47.0||||||
4224121|NCT00699998|4047467|B4|Tunisia||Region of Enrollment||participants|Number|4|4.0||||||
4224122|NCT00699998|4047468|B3|Tunisia||Region of Enrollment||participants|Number|20|20.0||||||
4224123|NCT00699998|4047469|B2|Tunisia||Region of Enrollment||participants|Number|3|3.0||||||
4224124|NCT00699998|4047470|B1|Tunisia||Region of Enrollment||participants|Number|20|20.0||||||
4224125|NCT00699998|4047466|B5|Netherlands||Region of Enrollment||participants|Number|155|155.0||||||
4224126|NCT00699998|4047467|B4|Netherlands||Region of Enrollment||participants|Number|24|24.0||||||
4224127|NCT00699998|4047468|B3|Netherlands||Region of Enrollment||participants|Number|53|53.0||||||
4224128|NCT00699998|4047469|B2|Netherlands||Region of Enrollment||participants|Number|23|23.0||||||
4224129|NCT00699998|4047470|B1|Netherlands||Region of Enrollment||participants|Number|55|55.0||||||
4224130|NCT00699998|4047466|B5|South Africa||Region of Enrollment||participants|Number|77|77.0||||||
4224131|NCT00699998|4047467|B4|South Africa||Region of Enrollment||participants|Number|12|12.0||||||
4224132|NCT00699998|4047468|B3|South Africa||Region of Enrollment||participants|Number|27|27.0||||||
4224133|NCT00699998|4047469|B2|South Africa||Region of Enrollment||participants|Number|11|11.0||||||
4224134|NCT00699998|4047470|B1|South Africa||Region of Enrollment||participants|Number|27|27.0||||||
4224135|NCT00699998|4047466|B5|Australia||Region of Enrollment||participants|Number|41|41.0||||||
4224136|NCT00699998|4047467|B4|Australia||Region of Enrollment||participants|Number|7|7.0||||||
4224137|NCT00699998|4047468|B3|Australia||Region of Enrollment||participants|Number|15|15.0||||||
4224138|NCT00699998|4047469|B2|Australia||Region of Enrollment||participants|Number|6|6.0||||||
4224139|NCT00699998|4047470|B1|Australia||Region of Enrollment||participants|Number|13|13.0||||||
4224140|NCT00699998|4047466|B5|Peru||Region of Enrollment||participants|Number|156|156.0||||||
4224141|NCT00699998|4047467|B4|Peru||Region of Enrollment||participants|Number|12|12.0||||||
4224142|NCT00699998|4047468|B3|Peru||Region of Enrollment||participants|Number|67|67.0||||||
4224143|NCT00699998|4047469|B2|Peru||Region of Enrollment||participants|Number|19|19.0||||||
4224144|NCT00699998|4047470|B1|Peru||Region of Enrollment||participants|Number|58|58.0||||||
4224145|NCT00699998|4047466|B5|Malaysia||Region of Enrollment||participants|Number|84|84.0||||||
4224146|NCT00699998|4047467|B4|Malaysia||Region of Enrollment||participants|Number|9|9.0||||||
4224147|NCT00699998|4047468|B3|Malaysia||Region of Enrollment||participants|Number|33|33.0||||||
4224148|NCT00699998|4047469|B2|Malaysia||Region of Enrollment||participants|Number|7|7.0||||||
4224149|NCT00699998|4047470|B1|Malaysia||Region of Enrollment||participants|Number|35|35.0||||||
4224150|NCT00699998|4047466|B5|Switzerland||Region of Enrollment||participants|Number|20|20.0||||||
4224151|NCT00699998|4047467|B4|Switzerland||Region of Enrollment||participants|Number|6|6.0||||||
4224152|NCT00699998|4047468|B3|Switzerland||Region of Enrollment||participants|Number|4|4.0||||||
4224153|NCT00699998|4047469|B2|Switzerland||Region of Enrollment||participants|Number|4|4.0||||||
4224154|NCT00699998|4047470|B1|Switzerland||Region of Enrollment||participants|Number|6|6.0||||||
4224155|NCT00699998|4047466|B5|Colombia||Region of Enrollment||participants|Number|123|123.0||||||
4224156|NCT00699998|4047467|B4|Colombia||Region of Enrollment||participants|Number|17|17.0||||||
4224157|NCT00699998|4047468|B3|Colombia||Region of Enrollment||participants|Number|45|45.0||||||
4224158|NCT00699998|4047469|B2|Colombia||Region of Enrollment||participants|Number|21|21.0||||||
4224159|NCT00699998|4047470|B1|Colombia||Region of Enrollment||participants|Number|40|40.0||||||
4224160|NCT00699998|4047466|B5|Russian Federation||Region of Enrollment||participants|Number|299|299.0||||||
4224161|NCT00699998|4047467|B4|Russian Federation||Region of Enrollment||participants|Number|14|14.0||||||
4224162|NCT00699998|4047468|B3|Russian Federation||Region of Enrollment||participants|Number|135|135.0||||||
4224163|NCT00699998|4047469|B2|Russian Federation||Region of Enrollment||participants|Number|22|22.0||||||
4224164|NCT00699998|4047470|B1|Russian Federation||Region of Enrollment||participants|Number|128|128.0||||||
4224165|NCT00699998|4047466|B5|Israel||Region of Enrollment||participants|Number|214|214.0||||||
4224166|NCT00699998|4047467|B4|Israel||Region of Enrollment||participants|Number|21|21.0||||||
4224167|NCT00699998|4047468|B3|Israel||Region of Enrollment||participants|Number|85|85.0||||||
4224168|NCT00699998|4047469|B2|Israel||Region of Enrollment||participants|Number|33|33.0||||||
4224169|NCT00699998|4047470|B1|Israel||Region of Enrollment||participants|Number|75|75.0||||||
4224170|NCT00699998|4047466|B5|Ireland||Region of Enrollment||participants|Number|18|18.0||||||
4224171|NCT00699998|4047467|B4|Ireland||Region of Enrollment||participants|Number|3|3.0||||||
4224172|NCT00699998|4047468|B3|Ireland||Region of Enrollment||participants|Number|6|6.0||||||
4224173|NCT00699998|4047469|B2|Ireland||Region of Enrollment||participants|Number|4|4.0||||||
4224174|NCT00699998|4047470|B1|Ireland||Region of Enrollment||participants|Number|5|5.0||||||
4224175|NCT00699998|4047466|B5|Spain||Region of Enrollment||participants|Number|43|43.0||||||
4224176|NCT00699998|4047467|B4|Spain||Region of Enrollment||participants|Number|12|12.0||||||
4224177|NCT00699998|4047468|B3|Spain||Region of Enrollment||participants|Number|10|10.0||||||
4224178|NCT00699998|4047469|B2|Spain||Region of Enrollment||participants|Number|8|8.0||||||
4224179|NCT00699998|4047470|B1|Spain||Region of Enrollment||participants|Number|13|13.0||||||
4224180|NCT00699998|4047466|B5|Serbia||Region of Enrollment||participants|Number|91|91.0||||||
4224181|NCT00699998|4047467|B4|Serbia||Region of Enrollment||participants|Number|5|5.0||||||
4224182|NCT00699998|4047468|B3|Serbia||Region of Enrollment||participants|Number|40|40.0||||||
4224183|NCT00699998|4047469|B2|Serbia||Region of Enrollment||participants|Number|4|4.0||||||
4224184|NCT00699998|4047470|B1|Serbia||Region of Enrollment||participants|Number|42|42.0||||||
4224185|NCT00699998|4047466|B5|United States||Region of Enrollment||participants|Number|1125|1125.0||||||
4224186|NCT00699998|4047467|B4|United States||Region of Enrollment||participants|Number|116|116.0||||||
4224187|NCT00699998|4047468|B3|United States||Region of Enrollment||participants|Number|446|446.0||||||
4224188|NCT00699998|4047469|B2|United States||Region of Enrollment||participants|Number|133|133.0||||||
4224189|NCT00699998|4047470|B1|United States||Region of Enrollment||participants|Number|430|430.0||||||
4224190|NCT00699998|4047466|B5|Sweden||Region of Enrollment||participants|Number|14|14.0||||||
4224191|NCT00699998|4047467|B4|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
4224192|NCT00699998|4047468|B3|Sweden||Region of Enrollment||participants|Number|6|6.0||||||
4224193|NCT00699998|4047469|B2|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
4224194|NCT00699998|4047470|B1|Sweden||Region of Enrollment||participants|Number|4|4.0||||||
4224195|NCT00699998|4047466|B5|Croatia||Region of Enrollment||participants|Number|182|182.0||||||
4224196|NCT00699998|4047467|B4|Croatia||Region of Enrollment||participants|Number|31|31.0||||||
4224197|NCT00699998|4047468|B3|Croatia||Region of Enrollment||participants|Number|60|60.0||||||
4224198|NCT00699998|4047469|B2|Croatia||Region of Enrollment||participants|Number|28|28.0||||||
4224199|NCT00699998|4047470|B1|Croatia||Region of Enrollment||participants|Number|63|63.0||||||
4224200|NCT00699998|4047466|B5|Romania||Region of Enrollment||participants|Number|257|257.0||||||
4224201|NCT00699998|4047467|B4|Romania||Region of Enrollment||participants|Number|23|23.0||||||
4224202|NCT00699998|4047468|B3|Romania||Region of Enrollment||participants|Number|105|105.0||||||
4224203|NCT00699998|4047469|B2|Romania||Region of Enrollment||participants|Number|26|26.0||||||
4224204|NCT00699998|4047470|B1|Romania||Region of Enrollment||participants|Number|103|103.0||||||
4224205|NCT00699998|4047466|B5|Brazil||Region of Enrollment||participants|Number|362|362.0||||||
4224206|NCT00699998|4047467|B4|Brazil||Region of Enrollment||participants|Number|34|34.0||||||
4224207|NCT00699998|4047468|B3|Brazil||Region of Enrollment||participants|Number|147|147.0||||||
4224208|NCT00699998|4047469|B2|Brazil||Region of Enrollment||participants|Number|27|27.0||||||
4224209|NCT00699998|4047470|B1|Brazil||Region of Enrollment||participants|Number|154|154.0||||||
4224210|NCT00699998|4047466|B5|Canada||Region of Enrollment||participants|Number|146|146.0||||||
4224211|NCT00699998|4047467|B4|Canada||Region of Enrollment||participants|Number|13|13.0||||||
4224212|NCT00699998|4047468|B3|Canada||Region of Enrollment||participants|Number|61|61.0||||||
4224213|NCT00699998|4047469|B2|Canada||Region of Enrollment||participants|Number|14|14.0||||||
4224214|NCT00699998|4047470|B1|Canada||Region of Enrollment||participants|Number|58|58.0||||||
4224215|NCT00699998|4047466|B5|Mexico||Region of Enrollment||participants|Number|109|109.0||||||
4224216|NCT00699998|4047467|B4|Mexico||Region of Enrollment||participants|Number|16|16.0||||||
4224217|NCT00699998|4047468|B3|Mexico||Region of Enrollment||participants|Number|40|40.0||||||
4224218|NCT00699998|4047469|B2|Mexico||Region of Enrollment||participants|Number|15|15.0||||||
4224219|NCT00699998|4047470|B1|Mexico||Region of Enrollment||participants|Number|38|38.0||||||
4224220|NCT00699998|4047466|B5|Czech Republic||Region of Enrollment||participants|Number|138|138.0||||||
4224221|NCT00699998|4047467|B4|Czech Republic||Region of Enrollment||participants|Number|38|38.0||||||
4224222|NCT00699998|4047468|B3|Czech Republic||Region of Enrollment||participants|Number|32|32.0||||||
4224223|NCT00699998|4047469|B2|Czech Republic||Region of Enrollment||participants|Number|31|31.0||||||
4224224|NCT00699998|4047470|B1|Czech Republic||Region of Enrollment||participants|Number|37|37.0||||||
4224225|NCT00699998|4047466|B5|Turkey||Region of Enrollment||participants|Number|200|200.0||||||
4224226|NCT00699998|4047467|B4|Turkey||Region of Enrollment||participants|Number|19|19.0||||||
4224227|NCT00699998|4047468|B3|Turkey||Region of Enrollment||participants|Number|81|81.0||||||
4224228|NCT00699998|4047469|B2|Turkey||Region of Enrollment||participants|Number|24|24.0||||||
4224229|NCT00699998|4047470|B1|Turkey||Region of Enrollment||participants|Number|76|76.0||||||
4224230|NCT00699998|4047466|B5|Panama||Region of Enrollment||participants|Number|70|70.0||||||
4224231|NCT00699998|4047467|B4|Panama||Region of Enrollment||participants|Number|10|10.0||||||
4224232|NCT00699998|4047468|B3|Panama||Region of Enrollment||participants|Number|24|24.0||||||
4224233|NCT00699998|4047469|B2|Panama||Region of Enrollment||participants|Number|7|7.0||||||
4224234|NCT00699998|4047470|B1|Panama||Region of Enrollment||participants|Number|29|29.0||||||
4224235|NCT00699998|4047466|B5|Korea, Republic of||Region of Enrollment||participants|Number|82|82.0||||||
4224236|NCT00699998|4047467|B4|Korea, Republic of||Region of Enrollment||participants|Number|7|7.0||||||
4224237|NCT00699998|4047468|B3|Korea, Republic of||Region of Enrollment||participants|Number|33|33.0||||||
4224238|NCT00699998|4047469|B2|Korea, Republic of||Region of Enrollment||participants|Number|7|7.0||||||
4224239|NCT00699998|4047470|B1|Korea, Republic of||Region of Enrollment||participants|Number|35|35.0||||||
4224240|NCT00699998|4047466|B5|Denmark||Region of Enrollment||participants|Number|55|55.0||||||
4224241|NCT00699998|4047467|B4|Denmark||Region of Enrollment||participants|Number|10|10.0||||||
4224242|NCT00699998|4047468|B3|Denmark||Region of Enrollment||participants|Number|17|17.0||||||
4224243|NCT00699998|4047469|B2|Denmark||Region of Enrollment||participants|Number|7|7.0||||||
4224244|NCT00699998|4047470|B1|Denmark||Region of Enrollment||participants|Number|21|21.0||||||
4224245|NCT00699998|4047466|B5|France||Region of Enrollment||participants|Number|99|99.0||||||
4224246|NCT00699998|4047467|B4|France||Region of Enrollment||participants|Number|19|19.0||||||
4224247|NCT00699998|4047468|B3|France||Region of Enrollment||participants|Number|29|29.0||||||
4224248|NCT00699998|4047469|B2|France||Region of Enrollment||participants|Number|22|22.0||||||
4224249|NCT00699998|4047470|B1|France||Region of Enrollment||participants|Number|29|29.0||||||
4224250|NCT00699998|4047466|B5|India||Region of Enrollment||participants|Number|1141|1141.0||||||
4224251|NCT00699998|4047467|B4|India||Region of Enrollment||participants|Number|64|64.0||||||
4224252|NCT00699998|4047468|B3|India||Region of Enrollment||participants|Number|508|508.0||||||
4224253|NCT00699998|4047469|B2|India||Region of Enrollment||participants|Number|56|56.0||||||
4224254|NCT00699998|4047470|B1|India||Region of Enrollment||participants|Number|513|513.0||||||
4224255|NCT00699998|4047466|B5|Italy||Region of Enrollment||participants|Number|232|232.0||||||
4224256|NCT00699998|4047467|B4|Italy||Region of Enrollment||participants|Number|47|47.0||||||
4224257|NCT00699998|4047468|B3|Italy||Region of Enrollment||participants|Number|70|70.0||||||
4224258|NCT00699998|4047469|B2|Italy||Region of Enrollment||participants|Number|44|44.0||||||
4224259|NCT00699998|4047470|B1|Italy||Region of Enrollment||participants|Number|71|71.0||||||
4224260|NCT00699998|4047466|B5|Chile||Region of Enrollment||participants|Number|89|89.0||||||
4224261|NCT00699998|4047467|B4|Chile||Region of Enrollment||participants|Number|13|13.0||||||
4224262|NCT00699998|4047468|B3|Chile||Region of Enrollment||participants|Number|33|33.0||||||
4224263|NCT00699998|4047469|B2|Chile||Region of Enrollment||participants|Number|15|15.0||||||
4224264|NCT00699998|4047470|B1|Chile||Region of Enrollment||participants|Number|28|28.0||||||
4224265|NCT00699998|4047466|B5|Ukraine||Region of Enrollment||participants|Number|707|707.0||||||
4224266|NCT00699998|4047467|B4|Ukraine||Region of Enrollment||participants|Number|42|42.0||||||
4224267|NCT00699998|4047468|B3|Ukraine||Region of Enrollment||participants|Number|311|311.0||||||
4224268|NCT00699998|4047469|B2|Ukraine||Region of Enrollment||participants|Number|28|28.0||||||
4224269|NCT00699998|4047470|B1|Ukraine||Region of Enrollment||participants|Number|326|326.0||||||
4224270|NCT00699998|4047466|B5|Thailand||Region of Enrollment||participants|Number|93|93.0||||||
4224271|NCT00699998|4047467|B4|Thailand||Region of Enrollment||participants|Number|10|10.0||||||
4224272|NCT00699998|4047468|B3|Thailand||Region of Enrollment||participants|Number|36|36.0||||||
4224273|NCT00699998|4047469|B2|Thailand||Region of Enrollment||participants|Number|17|17.0||||||
4224274|NCT00699998|4047470|B1|Thailand||Region of Enrollment||participants|Number|30|30.0||||||
4224275|NCT00699998|4047466|B5|Costa Rica||Region of Enrollment||participants|Number|10|10.0||||||
4224276|NCT00699998|4047467|B4|Costa Rica||Region of Enrollment||participants|Number|2|2.0||||||
4224277|NCT00699998|4047468|B3|Costa Rica||Region of Enrollment||participants|Number|2|2.0||||||
4224278|NCT00699998|4047469|B2|Costa Rica||Region of Enrollment||participants|Number|1|1.0||||||
4224279|NCT00699998|4047470|B1|Costa Rica||Region of Enrollment||participants|Number|5|5.0||||||
4224280|NCT00699998|4047466|B5|Greece||Region of Enrollment||participants|Number|43|43.0||||||
4224281|NCT00699998|4047467|B4|Greece||Region of Enrollment||participants|Number|11|11.0||||||
4224282|NCT00699998|4047468|B3|Greece||Region of Enrollment||participants|Number|10|10.0||||||
4224283|NCT00699998|4047469|B2|Greece||Region of Enrollment||participants|Number|8|8.0||||||
4224284|NCT00699998|4047470|B1|Greece||Region of Enrollment||participants|Number|14|14.0||||||
4224285|NCT00699998|4047466|B5|Slovakia||Region of Enrollment||participants|Number|162|162.0||||||
4224286|NCT00699998|4047467|B4|Slovakia||Region of Enrollment||participants|Number|20|20.0||||||
4224287|NCT00699998|4047468|B3|Slovakia||Region of Enrollment||participants|Number|60|60.0||||||
4224288|NCT00699998|4047469|B2|Slovakia||Region of Enrollment||participants|Number|20|20.0||||||
4224289|NCT00699998|4047470|B1|Slovakia||Region of Enrollment||participants|Number|62|62.0||||||
4224290|NCT00699998|4047466|B5|Taiwan||Region of Enrollment||participants|Number|25|25.0||||||
4224291|NCT00699998|4047467|B4|Taiwan||Region of Enrollment||participants|Number|9|9.0||||||
4224292|NCT00699998|4047468|B3|Taiwan||Region of Enrollment||participants|Number|4|4.0||||||
4224293|NCT00699998|4047469|B2|Taiwan||Region of Enrollment||participants|Number|6|6.0||||||
4224294|NCT00699998|4047470|B1|Taiwan||Region of Enrollment||participants|Number|6|6.0||||||
4224295|NCT00699998|4047466|B5|Philippines||Region of Enrollment||participants|Number|127|127.0||||||
4224296|NCT00699998|4047467|B4|Philippines||Region of Enrollment||participants|Number|14|14.0||||||
4224297|NCT00699998|4047468|B3|Philippines||Region of Enrollment||participants|Number|48|48.0||||||
4224298|NCT00699998|4047469|B2|Philippines||Region of Enrollment||participants|Number|7|7.0||||||
4224299|NCT00699998|4047470|B1|Philippines||Region of Enrollment||participants|Number|58|58.0||||||
4224300|NCT00699998|4047466|B5|Portugal||Region of Enrollment||participants|Number|54|54.0||||||
4224301|NCT00699998|4047467|B4|Portugal||Region of Enrollment||participants|Number|11|11.0||||||
4224302|NCT00699998|4047468|B3|Portugal||Region of Enrollment||participants|Number|14|14.0||||||
4224303|NCT00699998|4047469|B2|Portugal||Region of Enrollment||participants|Number|11|11.0||||||
4224304|NCT00699998|4047470|B1|Portugal||Region of Enrollment||participants|Number|18|18.0||||||
4224305|NCT00699998|4047466|B5|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4224306|NCT00699998|4047467|B4|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4224307|NCT00699998|4047468|B3|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4224308|NCT00699998|4047469|B2|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4224309|NCT00699998|4047470|B1|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4224310|NCT00699998|4047466|B5|Other||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
4224311|NCT00699998|4047467|B4|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4224312|NCT00699998|4047468|B3|Other||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4224313|NCT00699998|4047469|B2|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4224314|NCT00699998|4047470|B1|Other||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4224315|NCT00699998|4047466|B5|Asian||Race/Ethnicity, Customized||participants|Number|1932|1932.0||||||
4224316|NCT00699998|4047467|B4|Asian||Race/Ethnicity, Customized||participants|Number|164|164.0||||||
4224317|NCT00699998|4047468|B3|Asian||Race/Ethnicity, Customized||participants|Number|800|800.0||||||
4224318|NCT00699998|4047469|B2|Asian||Race/Ethnicity, Customized||participants|Number|147|147.0||||||
4224319|NCT00699998|4047470|B1|Asian||Race/Ethnicity, Customized||participants|Number|821|821.0||||||
4224320|NCT00699998|4047466|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|862|862.0||||||
4224321|NCT00699998|4047467|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|86|86.0||||||
4224322|NCT00699998|4047468|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|346|346.0||||||
4224323|NCT00699998|4047469|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|109|109.0||||||
4224324|NCT00699998|4047470|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|321|321.0||||||
4224325|NCT00699998|4047466|B5|African||Race/Ethnicity, Customized||participants|Number|185|185.0||||||
4224326|NCT00699998|4047467|B4|African||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4224327|NCT00699998|4047468|B3|African||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
4224328|NCT00699998|4047469|B2|African||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4224329|NCT00699998|4047470|B1|African||Race/Ethnicity, Customized||participants|Number|87|87.0||||||
4224330|NCT00699998|4047466|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|6276|6276.0||||||
4224331|NCT00699998|4047467|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|773|773.0||||||
4224332|NCT00699998|4047468|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|2374|2374.0||||||
4224333|NCT00699998|4047469|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|767|767.0||||||
4224334|NCT00699998|4047470|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|2362|2362.0||||||
4224335|NCT00699998|4047466|B5||Male|Sex: Female, Male||Participants|Count of Participants|5676|5676.0||||||
4224336|NCT00699998|4047467|B4||Male|Sex: Female, Male||Participants|Count of Participants|509|509.0||||||
4224337|NCT00699998|4047468|B3||Male|Sex: Female, Male||Participants|Count of Participants|2333|2333.0||||||
4224338|NCT00699998|4047469|B2||Male|Sex: Female, Male||Participants|Count of Participants|523|523.0||||||
4224339|NCT00699998|4047470|B1||Male|Sex: Female, Male||Participants|Count of Participants|2311|2311.0||||||
4224340|NCT00699998|4047466|B5||Female|Sex: Female, Male||Participants|Count of Participants|3650|3650.0||||||
4224341|NCT00699998|4047467|B4||Female|Sex: Female, Male||Participants|Count of Participants|531|531.0||||||
4224342|NCT00699998|4047468|B3||Female|Sex: Female, Male||Participants|Count of Participants|1290|1290.0||||||
4224343|NCT00699998|4047469|B2||Female|Sex: Female, Male||Participants|Count of Participants|520|520.0||||||
4224344|NCT00699998|4047470|B1||Female|Sex: Female, Male||Participants|Count of Participants|1309|1309.0||||||
4224345|NCT00699998|4047466|B5|||Age||years|Mean|65.7|65.7|Standard Deviation|11.02|11.02|||
4224346|NCT00699998|4047467|B4|||Age||years|Mean|80.3|80.3|Standard Deviation|4.39|4.39|||
4224347|NCT00699998|4047468|B3|||Age||years|Mean|61.5|61.5|Standard Deviation|8.38|8.38|||
4224348|NCT00699998|4047469|B2|||Age||years|Mean|80.3|80.3|Standard Deviation|4.29|4.29|||
4224349|NCT00699998|4047470|B1|||Age||years|Mean|61.4|61.4|Standard Deviation|8.55|8.55|||
4224350|NCT00699972|4047515|B4|Other||Race/Ethnicity, Customized|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|participants|Number|17|17.0||||||
4224351|NCT00699972|4047516|B3|Other||Race/Ethnicity, Customized|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|participants|Number|6|6.0||||||
4224352|NCT00699972|4047517|B2|Other||Race/Ethnicity, Customized|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|participants|Number|6|6.0||||||
4224353|NCT00699972|4047518|B1|Other||Race/Ethnicity, Customized|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|participants|Number|5|5.0||||||
4224354|NCT00699972|4047515|B4|American Indian or Alaska Native||Race/Ethnicity, Customized|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|participants|Number|6|6.0||||||
4224355|NCT00699972|4047516|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|participants|Number|2|2.0||||||
4224356|NCT00699972|4047517|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|participants|Number|4|4.0||||||
4224357|NCT00699972|4047518|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|participants|Number|0|0.0||||||
4224358|NCT00699972|4047515|B4|Chinese||Race/Ethnicity, Customized|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|participants|Number|2|2.0||||||
4224359|NCT00699972|4047516|B3|Chinese||Race/Ethnicity, Customized|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|participants|Number|1|1.0||||||
4224360|NCT00699972|4047517|B2|Chinese||Race/Ethnicity, Customized|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|participants|Number|1|1.0||||||
4224361|NCT00699972|4047518|B1|Chinese||Race/Ethnicity, Customized|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|participants|Number|0|0.0||||||
4224362|NCT00699972|4047515|B4|Asian||Race/Ethnicity, Customized|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|participants|Number|2|2.0||||||
4224363|NCT00699972|4047516|B3|Asian||Race/Ethnicity, Customized|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|participants|Number|1|1.0||||||
4224364|NCT00699972|4047517|B2|Asian||Race/Ethnicity, Customized|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|participants|Number|1|1.0||||||
4224365|NCT00699972|4047518|B1|Asian||Race/Ethnicity, Customized|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|participants|Number|0|0.0||||||
4224366|NCT00699972|4047515|B4|Black or African American||Race/Ethnicity, Customized|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|participants|Number|27|27.0||||||
4224367|NCT00699972|4047516|B3|Black or African American||Race/Ethnicity, Customized|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|participants|Number|8|8.0||||||
4224368|NCT00699972|4047517|B2|Black or African American||Race/Ethnicity, Customized|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|participants|Number|6|6.0||||||
4224369|NCT00699972|4047518|B1|Black or African American||Race/Ethnicity, Customized|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|participants|Number|13|13.0||||||
4224370|NCT00699972|4047515|B4|White||Race/Ethnicity, Customized|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|participants|Number|334|334.0||||||
4224371|NCT00699972|4047516|B3|White||Race/Ethnicity, Customized|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|participants|Number|116|116.0||||||
4224372|NCT00699972|4047517|B2|White||Race/Ethnicity, Customized|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|participants|Number|115|115.0||||||
4224373|NCT00699972|4047518|B1|White||Race/Ethnicity, Customized|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|participants|Number|103|103.0||||||
4224374|NCT00699972|4047515|B4||Male|Sex: Female, Male|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|Participants|Count of Participants|188|188.0||||||
4224375|NCT00699972|4047516|B3||Male|Sex: Female, Male|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|Participants|Count of Participants|69|69.0||||||
4224376|NCT00699972|4047517|B2||Male|Sex: Female, Male|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|Participants|Count of Participants|65|65.0||||||
4224377|NCT00699972|4047518|B1||Male|Sex: Female, Male|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|Participants|Count of Participants|54|54.0||||||
4224378|NCT00699972|4047515|B4||Female|Sex: Female, Male|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|Participants|Count of Participants|200|200.0||||||
4224379|NCT00699972|4047516|B3||Female|Sex: Female, Male|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|Participants|Count of Participants|65|65.0||||||
4224380|NCT00699972|4047517|B2||Female|Sex: Female, Male|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|Participants|Count of Participants|68|68.0||||||
4224381|NCT00699972|4047518|B1||Female|Sex: Female, Male|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|Participants|Count of Participants|67|67.0||||||
4224382|NCT00699972|4047515|B4|>64 years||Age, Customized|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|participants|Number|12|12.0||||||
4224383|NCT00699972|4047516|B3|>64 years||Age, Customized|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|participants|Number|5|5.0||||||
4224384|NCT00699972|4047517|B2|>64 years||Age, Customized|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|participants|Number|2|2.0||||||
4224385|NCT00699972|4047518|B1|>64 years||Age, Customized|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|participants|Number|5|5.0||||||
4224386|NCT00699972|4047515|B4|18-64 years||Age, Customized|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|participants|Number|337|337.0||||||
4224387|NCT00699972|4047516|B3|18-64 years||Age, Customized|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|participants|Number|119|119.0||||||
4224388|NCT00699972|4047517|B2|18-64 years||Age, Customized|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|participants|Number|116|116.0||||||
4224389|NCT00699972|4047518|B1|18-64 years||Age, Customized|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|participants|Number|102|102.0||||||
4224390|NCT00699972|4047515|B4|<18 years||Age, Customized|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|participants|Number|39|39.0||||||
4224391|NCT00699972|4047516|B3|<18 years||Age, Customized|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|participants|Number|10|10.0||||||
4224392|NCT00699972|4047517|B2|<18 years||Age, Customized|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|participants|Number|15|15.0||||||
4224393|NCT00699972|4047518|B1|<18 years||Age, Customized|Safety Population used. One subject in Arm 1 and one subject in Arm 3 were randomized, but not treated.|participants|Number|14|14.0||||||
4224394|NCT00699907|4047534|B4|United States||Region of Enrollment||participants|Number|107|107.0||||||
4224395|NCT00699907|4047535|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
4224396|NCT00699907|4047536|B2|United States||Region of Enrollment||participants|Number|47|47.0||||||
4224397|NCT00699907|4047537|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4224398|NCT00699907|4047534|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4224399|NCT00699907|4047535|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4224400|NCT00699907|4047536|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4224401|NCT00699907|4047537|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4224402|NCT00699907|4047534|B4||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4224403|NCT00699907|4047535|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4224404|NCT00699907|4047536|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4224405|NCT00699907|4047537|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4224406|NCT00699907|4047534|B4|||Age||years|Mean|48.9|48.9|Full Range|||21.0|81.0|
4224407|NCT00699907|4047535|B3|||Age||years|Mean|51.7|51.7|Full Range|||21.0|81.0|
4224408|NCT00699907|4047536|B2|||Age||years|Mean|46.9|46.9|Full Range|||27.0|66.0|
4224409|NCT00699907|4047537|B1|||Age||years|Mean|45.2|45.2|Full Range|||36.0|58.0|
4224410|NCT00699842|4047571|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
4224411|NCT00699842|4047573|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4224412|NCT00699842|4047574|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4224413|NCT00699842|4047571|B4|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|5|5.0||||||
4224414|NCT00699842|4047573|B2|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|3|3.0||||||
4224415|NCT00699842|4047574|B1|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|2|2.0||||||
4224416|NCT00699842|4047571|B4|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|3|3.0||||||
4224417|NCT00699842|4047573|B2|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|2|2.0||||||
4224418|NCT00699842|4047574|B1|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|1|1.0||||||
4224419|NCT00699842|4047571|B4|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
4224420|NCT00699842|4047573|B2|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
4224421|NCT00699842|4047574|B1|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
4224422|NCT00699842|4047571|B4|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4224423|NCT00699842|4047573|B2|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4224424|NCT00699842|4047574|B1|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4224425|NCT00699842|4047571|B4|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4224426|NCT00699842|4047573|B2|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4224427|NCT00699842|4047574|B1|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4224428|NCT00699842|4047571|B4|White||Race (NIH/OMB)||participants|Number|7|7.0||||||
4224429|NCT00699842|4047573|B2|White||Race (NIH/OMB)||participants|Number|4|4.0||||||
4224430|NCT00699842|4047574|B1|White||Race (NIH/OMB)||participants|Number|3|3.0||||||
4224431|NCT00699842|4047571|B4|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
4224432|NCT00699842|4047573|B2|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
4224433|NCT00699842|4047574|B1|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
4224434|NCT00699842|4047571|B4|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4224435|NCT00699842|4047573|B2|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4224436|NCT00699842|4047574|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4224437|NCT00699842|4047571|B4|Asian||Race (NIH/OMB)||participants|Number|1|1.0||||||
4224438|NCT00699842|4047573|B2|Asian||Race (NIH/OMB)||participants|Number|1|1.0||||||
4224439|NCT00699842|4047574|B1|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
4224440|NCT00699842|4047571|B4|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
4224441|NCT00699842|4047573|B2|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
4224442|NCT00699842|4047574|B1|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
4224443|NCT00699842|4047571|B4|Male||Gender||participants|Number|6|6.0||||||
4224444|NCT00699842|4047573|B2|Male||Gender||participants|Number|3|3.0||||||
4224445|NCT00699842|4047574|B1|Male||Gender||participants|Number|3|3.0||||||
4224446|NCT00699842|4047571|B4|Female||Gender||participants|Number|2|2.0||||||
4224447|NCT00699842|4047573|B2|Female||Gender||participants|Number|2|2.0||||||
4224448|NCT00699842|4047574|B1|Female||Gender||participants|Number|0|0.0||||||
4224449|NCT00699842|4047571|B4|>=65 years||Age||participants|Number|3|3.0||||||
4224450|NCT00699842|4047573|B2|>=65 years||Age||participants|Number|2|2.0||||||
4224451|NCT00699842|4047574|B1|>=65 years||Age||participants|Number|1|1.0||||||
4224452|NCT00699842|4047571|B4|Between 18 and 65 years||Age||participants|Number|5|5.0||||||
4224453|NCT00699842|4047573|B2|Between 18 and 65 years||Age||participants|Number|3|3.0||||||
4224454|NCT00699842|4047574|B1|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
4224455|NCT00699842|4047571|B4|<=18 years||Age||participants|Number|0|0.0||||||
4224456|NCT00699842|4047573|B2|<=18 years||Age||participants|Number|0|0.0||||||
4224457|NCT00699842|4047574|B1|<=18 years||Age||participants|Number|0|0.0||||||
4224458|NCT00699842|4047571|B4|||Age||years|Mean|62.76|62.76|Standard Deviation|14.29|14.29|||
4224459|NCT00699842|4047573|B2|||Age||years|Mean|65.98|65.98|Standard Deviation|11.02|11.02|||
4224460|NCT00699842|4047574|B1|||Age||years|Mean|57.38|57.38|Standard Deviation|20.06|20.06|||
4224461|NCT00699816|4047587|B3|||Platelet||x 10^3/mm^3|Median|128.6|128.6|Inter-Quartile Range|||100.0|157.2|
4224462|NCT00699816|4047588|B2|||Platelet||x 10^3/mm^3|Median|141.0|141.0|Inter-Quartile Range|||117.5|166.3|
4224463|NCT00699816|4047589|B1|||Platelet||x 10^3/mm^3|Median|116.5|116.5|Inter-Quartile Range|||92.3|158.0|
4224464|NCT00699816|4047587|B3|||Creatinine level||mg/dL|Median|0.9|0.9|Inter-Quartile Range|||0.8|1.0|
4224465|NCT00699816|4047588|B2|||Creatinine level||mg/dL|Median|0.9|0.9|Inter-Quartile Range|||0.7|1.0|
4224466|NCT00699816|4047589|B1|||Creatinine level||mg/dL|Median|0.9|0.9|Inter-Quartile Range|||0.8|1.0|
4224467|NCT00699816|4047587|B3|||Prothrombin time||seconds|Median|13.8|13.8|Inter-Quartile Range|||13.2|14.6|
4224468|NCT00699816|4047588|B2|||Prothrombin time||seconds|Median|13.9|13.9|Inter-Quartile Range|||13.2|14.4|
4224469|NCT00699816|4047589|B1|||Prothrombin time||seconds|Median|13.7|13.7|Inter-Quartile Range|||13.1|14.7|
4224470|NCT00699816|4047587|B3|||Total bilirubin level||mg/dL|Median|0.8|0.8|Inter-Quartile Range|||0.6|1.0|
4224471|NCT00699816|4047588|B2|||Total bilirubin level||mg/dL|Median|0.8|0.8|Inter-Quartile Range|||0.6|1.0|
4224472|NCT00699816|4047589|B1|||Total bilirubin level||mg/dL|Median|0.8|0.8|Inter-Quartile Range|||0.6|1.0|
4224473|NCT00699816|4047587|B3|||Albumin level||g/dL|Median|4.1|4.1|Inter-Quartile Range|||3.9|4.3|
4224474|NCT00699816|4047588|B2|||Albumin level||g/dL|Median|4.1|4.1|Inter-Quartile Range|||3.9|4.3|
4224475|NCT00699816|4047589|B1|||Albumin level||g/dL|Median|4.1|4.1|Inter-Quartile Range|||3.9|4.3|
4224476|NCT00699816|4047587|B3|||Alkaline phosphatase level||IU/L|Median|82.3|82.3|Inter-Quartile Range|||67.0|100.3|
4224477|NCT00699816|4047588|B2|||Alkaline phosphatase level||IU/L|Median|82.0|82.0|Inter-Quartile Range|||65.0|100.0|
4224478|NCT00699816|4047589|B1|||Alkaline phosphatase level||IU/L|Median|82.5|82.5|Inter-Quartile Range|||70.0|101.5|
4224479|NCT00699816|4047587|B3|||Alanine aminotransferase level||IU/L|Median|33.0|33.0|Inter-Quartile Range|||24.0|46.7|
4224480|NCT00699816|4047588|B2|||Alanine aminotransferase level||IU/L|Median|33.0|33.0|Inter-Quartile Range|||23.0|47.5|
4224481|NCT00699816|4047589|B1|||Alanine aminotransferase level||IU/L|Median|33.0|33.0|Inter-Quartile Range|||25.0|45.8|
4224482|NCT00699816|4047587|B3|||Aspartate aminotransferase level||IU/L|Median|33.5|33.5|Inter-Quartile Range|||26.9|43.8|
4224483|NCT00699816|4047588|B2|||Aspartate aminotransferase level||IU/L|Median|34.0|34.0|Inter-Quartile Range|||26.8|44.0|
4224484|NCT00699816|4047589|B1|||Aspartate aminotransferase level||IU/L|Median|33.0|33.0|Inter-Quartile Range|||27.0|43.5|
4224485|NCT00699816|4047587|B3|||PIVKA-II||mAU/mL|Median|18.5|18.5|Inter-Quartile Range|||14.0|24.4|
4224486|NCT00699816|4047588|B2|||PIVKA-II||mAU/mL|Median|18.0|18.0|Inter-Quartile Range|||14.0|24.0|
4224487|NCT00699816|4047589|B1|||PIVKA-II||mAU/mL|Median|19.0|19.0|Inter-Quartile Range|||14.0|24.8|
4224488|NCT00699816|4047587|B3|||Alpha fetoprotein level||ng/mL|Median|5.3|5.3|Inter-Quartile Range|||3.0|11.4|
4224489|NCT00699816|4047588|B2|||Alpha fetoprotein level||ng/mL|Median|5.4|5.4|Inter-Quartile Range|||3.0|13.0|
4224490|NCT00699816|4047589|B1|||Alpha fetoprotein level||ng/mL|Median|5.2|5.2|Inter-Quartile Range|||3.1|9.9|
4224491|NCT00699816|4047587|B3|Co-infection (Cirrhosis)||Cause of liver disease||participants|Number|146|146.0||||||
4224492|NCT00699816|4047588|B2|Co-infection (Cirrhosis)||Cause of liver disease||participants|Number|70|70.0||||||
4224493|NCT00699816|4047589|B1|Co-infection (Cirrhosis)||Cause of liver disease||participants|Number|76|76.0||||||
4224494|NCT00699816|4047587|B3|Co-infection (Others)||Cause of liver disease||participants|Number|17|17.0||||||
4224495|NCT00699816|4047588|B2|Co-infection (Others)||Cause of liver disease||participants|Number|10|10.0||||||
4224496|NCT00699816|4047589|B1|Co-infection (Others)||Cause of liver disease||participants|Number|7|7.0||||||
4224497|NCT00699816|4047587|B3|HBV and HCV||Cause of liver disease||participants|Number|4|4.0||||||
4224498|NCT00699816|4047588|B2|HBV and HCV||Cause of liver disease||participants|Number|2|2.0||||||
4224499|NCT00699816|4047589|B1|HBV and HCV||Cause of liver disease||participants|Number|2|2.0||||||
4224500|NCT00699816|4047587|B3|HCV infection only||Cause of liver disease||participants|Number|19|19.0||||||
4224501|NCT00699816|4047588|B2|HCV infection only||Cause of liver disease||participants|Number|10|10.0||||||
4224502|NCT00699816|4047589|B1|HCV infection only||Cause of liver disease||participants|Number|9|9.0||||||
4224503|NCT00699816|4047587|B3|HBV infection only||Cause of liver disease||participants|Number|186|186.0||||||
4224504|NCT00699816|4047588|B2|HBV infection only||Cause of liver disease||participants|Number|90|90.0||||||
4224505|NCT00699816|4047589|B1|HBV infection only||Cause of liver disease||participants|Number|96|96.0||||||
4224506|NCT00699816|4047587|B3|1||ECOG performance status|ECOG (Eastern Cooperative Oncology Group) performance status assesses the daily living abilities of the patient, on a scale ranging from 0(fully active) to 5(dead).|participants|Number|64|64.0||||||
4224507|NCT00699816|4047588|B2|1||ECOG performance status|ECOG (Eastern Cooperative Oncology Group) performance status assesses the daily living abilities of the patient, on a scale ranging from 0(fully active) to 5(dead).|participants|Number|31|31.0||||||
4224508|NCT00699816|4047589|B1|1||ECOG performance status|ECOG (Eastern Cooperative Oncology Group) performance status assesses the daily living abilities of the patient, on a scale ranging from 0(fully active) to 5(dead).|participants|Number|33|33.0||||||
4224509|NCT00699816|4047587|B3|0||ECOG performance status|ECOG (Eastern Cooperative Oncology Group) performance status assesses the daily living abilities of the patient, on a scale ranging from 0(fully active) to 5(dead).|participants|Number|162|162.0||||||
4224510|NCT00699816|4047588|B2|0||ECOG performance status|ECOG (Eastern Cooperative Oncology Group) performance status assesses the daily living abilities of the patient, on a scale ranging from 0(fully active) to 5(dead).|participants|Number|81|81.0||||||
4224511|NCT00699816|4047589|B1|0||ECOG performance status|ECOG (Eastern Cooperative Oncology Group) performance status assesses the daily living abilities of the patient, on a scale ranging from 0(fully active) to 5(dead).|participants|Number|81|81.0||||||
4224512|NCT00699816|4047587|B3|||Size of HCC|Tumor assessments were performed using dynamic computed tomography or magnetic resonance imaging. All scans were reviewed by 2 independent radiologists at each site(hospital) with more than 5 years' experience, who were unaware of the group assignment. In cases of discordance, an additional third independent experienced radiologist reviewed images and consensus was achieved among the 3 radiologists.|centimeter|Median|2.0|2.0|Inter-Quartile Range|||1.4|2.7|
4224513|NCT00699816|4047588|B2|||Size of HCC|Tumor assessments were performed using dynamic computed tomography or magnetic resonance imaging. All scans were reviewed by 2 independent radiologists at each site(hospital) with more than 5 years' experience, who were unaware of the group assignment. In cases of discordance, an additional third independent experienced radiologist reviewed images and consensus was achieved among the 3 radiologists.|centimeter|Median|2.3|2.3|Inter-Quartile Range|||1.5|3.1|
4224514|NCT00699816|4047589|B1|||Size of HCC|Tumor assessments were performed using dynamic computed tomography or magnetic resonance imaging. All scans were reviewed by 2 independent radiologists at each site(hospital) with more than 5 years' experience, who were unaware of the group assignment. In cases of discordance, an additional third independent experienced radiologist reviewed images and consensus was achieved among the 3 radiologists.|centimeter|Median|1.8|1.8|Inter-Quartile Range|||1.4|2.3|
4224515|NCT00699816|4047587|B3|<3||Number of HCC|Tumor assessments were performed using dynamic computed tomography or magnetic resonance imaging. All scans were reviewed by 2 independent radiologists at each site(hospital) with more than 5 years' experience, who were unaware of the group assignment. In cases of discordance, an additional third independent experienced radiologist reviewed images and consensus was achieved among the 3 radiologists.|participants|Number|222|222.0||||||
4224516|NCT00699816|4047588|B2|<3||Number of HCC|Tumor assessments were performed using dynamic computed tomography or magnetic resonance imaging. All scans were reviewed by 2 independent radiologists at each site(hospital) with more than 5 years' experience, who were unaware of the group assignment. In cases of discordance, an additional third independent experienced radiologist reviewed images and consensus was achieved among the 3 radiologists.|participants|Number|110|110.0||||||
4224517|NCT00699816|4047589|B1|<3||Number of HCC|Tumor assessments were performed using dynamic computed tomography or magnetic resonance imaging. All scans were reviewed by 2 independent radiologists at each site(hospital) with more than 5 years' experience, who were unaware of the group assignment. In cases of discordance, an additional third independent experienced radiologist reviewed images and consensus was achieved among the 3 radiologists.|participants|Number|112|112.0||||||
4224518|NCT00699816|4047587|B3|>3 or =3||Number of HCC|Tumor assessments were performed using dynamic computed tomography or magnetic resonance imaging. All scans were reviewed by 2 independent radiologists at each site(hospital) with more than 5 years' experience, who were unaware of the group assignment. In cases of discordance, an additional third independent experienced radiologist reviewed images and consensus was achieved among the 3 radiologists.|participants|Number|4|4.0||||||
4224519|NCT00699816|4047588|B2|>3 or =3||Number of HCC|Tumor assessments were performed using dynamic computed tomography or magnetic resonance imaging. All scans were reviewed by 2 independent radiologists at each site(hospital) with more than 5 years' experience, who were unaware of the group assignment. In cases of discordance, an additional third independent experienced radiologist reviewed images and consensus was achieved among the 3 radiologists.|participants|Number|2|2.0||||||
4224520|NCT00699816|4047589|B1|>3 or =3||Number of HCC|Tumor assessments were performed using dynamic computed tomography or magnetic resonance imaging. All scans were reviewed by 2 independent radiologists at each site(hospital) with more than 5 years' experience, who were unaware of the group assignment. In cases of discordance, an additional third independent experienced radiologist reviewed images and consensus was achieved among the 3 radiologists.|participants|Number|2|2.0||||||
4224521|NCT00699816|4047587|B3|Stage II||HCC stage|"HCC staging criteria is AJCC staging system(6th edition) developed by the American Joint Committee on Cancer for describing the extent of disease progression in cancer patients. It utilizes in part the TNM scoring system: Tumor size, Lymph Nodes affected, Metastases.~The TNM Staging System is based on the extent of the tumor (T), the extent of spread to the lymph nodes (N), and the presence of metastasis (M). Once the T, N, and M are determined, they are combined, and an overall Stage of I, II, III, IV is assigned. Higher stage cancers are more advanced."|participants|Number|34|34.0||||||
4224522|NCT00699816|4047588|B2|Stage II||HCC stage|"HCC staging criteria is AJCC staging system(6th edition) developed by the American Joint Committee on Cancer for describing the extent of disease progression in cancer patients. It utilizes in part the TNM scoring system: Tumor size, Lymph Nodes affected, Metastases.~The TNM Staging System is based on the extent of the tumor (T), the extent of spread to the lymph nodes (N), and the presence of metastasis (M). Once the T, N, and M are determined, they are combined, and an overall Stage of I, II, III, IV is assigned. Higher stage cancers are more advanced."|participants|Number|18|18.0||||||
4224523|NCT00699816|4047589|B1|Stage II||HCC stage|"HCC staging criteria is AJCC staging system(6th edition) developed by the American Joint Committee on Cancer for describing the extent of disease progression in cancer patients. It utilizes in part the TNM scoring system: Tumor size, Lymph Nodes affected, Metastases.~The TNM Staging System is based on the extent of the tumor (T), the extent of spread to the lymph nodes (N), and the presence of metastasis (M). Once the T, N, and M are determined, they are combined, and an overall Stage of I, II, III, IV is assigned. Higher stage cancers are more advanced."|participants|Number|16|16.0||||||
4224524|NCT00699816|4047587|B3|Stage I||HCC stage|"HCC staging criteria is AJCC staging system(6th edition) developed by the American Joint Committee on Cancer for describing the extent of disease progression in cancer patients. It utilizes in part the TNM scoring system: Tumor size, Lymph Nodes affected, Metastases.~The TNM Staging System is based on the extent of the tumor (T), the extent of spread to the lymph nodes (N), and the presence of metastasis (M). Once the T, N, and M are determined, they are combined, and an overall Stage of I, II, III, IV is assigned. Higher stage cancers are more advanced."|participants|Number|192|192.0||||||
4224525|NCT00699816|4047588|B2|Stage I||HCC stage|"HCC staging criteria is AJCC staging system(6th edition) developed by the American Joint Committee on Cancer for describing the extent of disease progression in cancer patients. It utilizes in part the TNM scoring system: Tumor size, Lymph Nodes affected, Metastases.~The TNM Staging System is based on the extent of the tumor (T), the extent of spread to the lymph nodes (N), and the presence of metastasis (M). Once the T, N, and M are determined, they are combined, and an overall Stage of I, II, III, IV is assigned. Higher stage cancers are more advanced."|participants|Number|94|94.0||||||
4224526|NCT00699816|4047589|B1|Stage I||HCC stage|"HCC staging criteria is AJCC staging system(6th edition) developed by the American Joint Committee on Cancer for describing the extent of disease progression in cancer patients. It utilizes in part the TNM scoring system: Tumor size, Lymph Nodes affected, Metastases.~The TNM Staging System is based on the extent of the tumor (T), the extent of spread to the lymph nodes (N), and the presence of metastasis (M). Once the T, N, and M are determined, they are combined, and an overall Stage of I, II, III, IV is assigned. Higher stage cancers are more advanced."|participants|Number|98|98.0||||||
4224527|NCT00699816|4047587|B3|Surgical resection||Treatment modality||participants|Number|70|70.0||||||
4224528|NCT00699816|4047588|B2|Surgical resection||Treatment modality||participants|Number|38|38.0||||||
4224529|NCT00699816|4047589|B1|Surgical resection||Treatment modality||participants|Number|32|32.0||||||
4224530|NCT00699816|4047587|B3|Radiofrequency ablation||Treatment modality||participants|Number|139|139.0||||||
4224531|NCT00699816|4047588|B2|Radiofrequency ablation||Treatment modality||participants|Number|70|70.0||||||
4224532|NCT00699816|4047589|B1|Radiofrequency ablation||Treatment modality||participants|Number|69|69.0||||||
4224533|NCT00699816|4047587|B3|Percutaneous ethanol injection||Treatment modality||participants|Number|17|17.0||||||
4224534|NCT00699816|4047588|B2|Percutaneous ethanol injection||Treatment modality||participants|Number|4|4.0||||||
4224535|NCT00699816|4047589|B1|Percutaneous ethanol injection||Treatment modality||participants|Number|13|13.0||||||
4224536|NCT00699816|4047587|B3|Korea, Republic of||Region of Enrollment||participants|Number|226|226.0||||||
4224537|NCT00699816|4047588|B2|Korea, Republic of||Region of Enrollment||participants|Number|112|112.0||||||
4224538|NCT00699816|4047589|B1|Korea, Republic of||Region of Enrollment||participants|Number|114|114.0||||||
4224539|NCT00699816|4047587|B3||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4224540|NCT00699816|4047588|B2||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4224541|NCT00699816|4047589|B1||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4224542|NCT00699816|4047587|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4224543|NCT00699816|4047588|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4224544|NCT00699816|4047589|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4224545|NCT00699816|4047587|B3|Age||Age, Customized||years|Mean|55.9|55.9|Standard Deviation|9.4|9.4|||
4224546|NCT00699816|4047588|B2|Age||Age, Customized||years|Mean|56.4|56.4|Standard Deviation|10.6|10.6|||
4224547|NCT00699816|4047589|B1|Age||Age, Customized||years|Mean|55.4|55.4|Standard Deviation|8.2|8.2|||
4224548|NCT00699751|4047606|B3|No||Any prior use of docetaxel||Participants|Number|395|395.0||||||
4224549|NCT00699751|4047607|B2|No||Any prior use of docetaxel||Participants|Number|133|133.0||||||
4224550|NCT00699751|4047608|B1|No||Any prior use of docetaxel||Participants|Number|262|262.0||||||
4224551|NCT00699751|4047606|B3|Yes||Any prior use of docetaxel||Participants|Number|526|526.0||||||
4224552|NCT00699751|4047607|B2|Yes||Any prior use of docetaxel||Participants|Number|174|174.0||||||
4224553|NCT00699751|4047608|B1|Yes||Any prior use of docetaxel||Participants|Number|352|352.0||||||
4224554|NCT00699751|4047606|B3|No||Current use of bisphosphonates|Subjects may have been on bisphosphonate therapy during the study.|Participants|Number|547|547.0||||||
4224555|NCT00699751|4047607|B2|No||Current use of bisphosphonates|Subjects may have been on bisphosphonate therapy during the study.|Participants|Number|183|183.0||||||
4224556|NCT00699751|4047608|B1|No||Current use of bisphosphonates|Subjects may have been on bisphosphonate therapy during the study.|Participants|Number|364|364.0||||||
4224557|NCT00699751|4047606|B3|Yes||Current use of bisphosphonates|Subjects may have been on bisphosphonate therapy during the study.|Participants|Number|374|374.0||||||
4224558|NCT00699751|4047607|B2|Yes||Current use of bisphosphonates|Subjects may have been on bisphosphonate therapy during the study.|Participants|Number|124|124.0||||||
4224559|NCT00699751|4047608|B1|Yes||Current use of bisphosphonates|Subjects may have been on bisphosphonate therapy during the study.|Participants|Number|250|250.0||||||
4224560|NCT00699751|4047606|B3|≥ 220 U/L||Total Alkaline Phosphatase (ALP)|The total amount of ALP in the blood was determined at baseline.|Participants|Number|404|404.0||||||
4224561|NCT00699751|4047607|B2|≥ 220 U/L||Total Alkaline Phosphatase (ALP)|The total amount of ALP in the blood was determined at baseline.|Participants|Number|138|138.0||||||
4224562|NCT00699751|4047608|B1|≥ 220 U/L||Total Alkaline Phosphatase (ALP)|The total amount of ALP in the blood was determined at baseline.|Participants|Number|266|266.0||||||
4224563|NCT00699751|4047606|B3|< 220 U/L||Total Alkaline Phosphatase (ALP)|The total amount of ALP in the blood was determined at baseline.|Participants|Number|517|517.0||||||
4224564|NCT00699751|4047607|B2|< 220 U/L||Total Alkaline Phosphatase (ALP)|The total amount of ALP in the blood was determined at baseline.|Participants|Number|169|169.0||||||
4224565|NCT00699751|4047608|B1|< 220 U/L||Total Alkaline Phosphatase (ALP)|The total amount of ALP in the blood was determined at baseline.|Participants|Number|348|348.0||||||
4224566|NCT00699751|4047606|B3||Male|Sex: Female, Male||Participants|Count of Participants|921|921.0||||||
4224567|NCT00699751|4047607|B2||Male|Sex: Female, Male||Participants|Count of Participants|307|307.0||||||
4224568|NCT00699751|4047608|B1||Male|Sex: Female, Male||Participants|Count of Participants|614|614.0||||||
4224569|NCT00699751|4047606|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4224570|NCT00699751|4047607|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4224571|NCT00699751|4047608|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4224572|NCT00699751|4047606|B3|||Age||Years|Mean|70.4|70.4|Standard Deviation|8.03|8.03|||
4224573|NCT00699751|4047607|B2|||Age||Years|Mean|70.8|70.8|Standard Deviation|7.87|7.87|||
4224574|NCT00699751|4047608|B1|||Age||Years|Mean|70.2|70.2|Standard Deviation|8.10|8.1|||
4224575|NCT00699699|4047694|B1||Male|Sex: Female, Male||Participants|Count of Participants|780|780.0||||||
4224576|NCT00699699|4047694|B1||Female|Sex: Female, Male||Participants|Count of Participants|500|500.0||||||
4224577|NCT00699699|4047694|B1|||Age||Years|Mean|65.5|65.5|Standard Deviation|10.6|10.6|||
4224578|NCT00699660|4047701|B3|Other/Missing||Marital Status||participants|Number|14|14.0||||||
4224579|NCT00699660|4047702|B2|Other/Missing||Marital Status||participants|Number|6|6.0||||||
4224580|NCT00699660|4047703|B1|Other/Missing||Marital Status||participants|Number|8|8.0||||||
4224581|NCT00699660|4047701|B3|Separated||Marital Status||participants|Number|69|69.0||||||
4224582|NCT00699660|4047702|B2|Separated||Marital Status||participants|Number|37|37.0||||||
4224583|NCT00699660|4047703|B1|Separated||Marital Status||participants|Number|32|32.0||||||
4224584|NCT00699660|4047701|B3|Single||Marital Status||participants|Number|63|63.0||||||
4224585|NCT00699660|4047702|B2|Single||Marital Status||participants|Number|35|35.0||||||
4224586|NCT00699660|4047703|B1|Single||Marital Status||participants|Number|28|28.0||||||
4224587|NCT00699660|4047701|B3|Married||Marital Status||participants|Number|238|238.0||||||
4224588|NCT00699660|4047702|B2|Married||Marital Status||participants|Number|130|130.0||||||
4224589|NCT00699660|4047703|B1|Married||Marital Status||participants|Number|108|108.0||||||
4224590|NCT00699660|4047701|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4224591|NCT00699660|4047702|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4224592|NCT00699660|4047703|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4224703|NCT00699413|4047830|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4224593|NCT00699660|4047701|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4224594|NCT00699660|4047702|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4224595|NCT00699660|4047703|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4224596|NCT00699660|4047701|B3||White|Race (NIH/OMB)||Participants|Count of Participants|227|227.0||||||
4224597|NCT00699660|4047702|B2||White|Race (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
4224598|NCT00699660|4047703|B1||White|Race (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
4224599|NCT00699660|4047701|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
4224600|NCT00699660|4047702|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4224601|NCT00699660|4047703|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4224602|NCT00699660|4047701|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4224603|NCT00699660|4047702|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4224604|NCT00699660|4047703|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4224605|NCT00699660|4047701|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4224606|NCT00699660|4047702|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4224607|NCT00699660|4047703|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4224608|NCT00699660|4047701|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4224609|NCT00699660|4047702|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4224610|NCT00699660|4047703|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4224611|NCT00699660|4047701|B3||Male|Sex: Female, Male||Participants|Count of Participants|365|365.0||||||
4224612|NCT00699660|4047702|B2||Male|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4224613|NCT00699660|4047703|B1||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4224614|NCT00699660|4047701|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4224615|NCT00699660|4047702|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4224616|NCT00699660|4047703|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4224617|NCT00699660|4047701|B3|||Age||years|Median|59|59.0|Inter-Quartile Range|||41.0|62.0|
4224618|NCT00699660|4047702|B2|||Age||years|Median|59|59.0|Inter-Quartile Range|||41.0|62.0|
4224619|NCT00699660|4047703|B1|||Age||years|Median|60|60.0|Inter-Quartile Range|||41.0|63.0|
4224620|NCT00699608|4047716|B1|Asian-East Asian Heritage||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4224621|NCT00699608|4047716|B1|Asian-South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4224622|NCT00699608|4047716|B1|Asian-Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4224623|NCT00699608|4047716|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4224624|NCT00699608|4047716|B1|White||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
4224625|NCT00699608|4047716|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4224626|NCT00699608|4047716|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4224627|NCT00699608|4047716|B1|||Age||years|Mean|29.8|29.8|Standard Deviation|3.87|3.87|||
4224628|NCT00699582|4047771|B4|Other||Race/Ethnicity, Customized|Race|participants|Number|17|17.0||||||
4224629|NCT00699582|4047772|B3|Other||Race/Ethnicity, Customized|Race|participants|Number|4|4.0||||||
4224630|NCT00699582|4047773|B2|Other||Race/Ethnicity, Customized|Race|participants|Number|6|6.0||||||
4224631|NCT00699582|4047774|B1|Other||Race/Ethnicity, Customized|Race|participants|Number|7|7.0||||||
4224632|NCT00699582|4047771|B4|American Indian or Alaska Native||Race/Ethnicity, Customized|Race|participants|Number|1|1.0||||||
4224633|NCT00699582|4047772|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|Race|participants|Number|0|0.0||||||
4224634|NCT00699582|4047773|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|Race|participants|Number|0|0.0||||||
4224635|NCT00699582|4047774|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Race|participants|Number|1|1.0||||||
4224636|NCT00699582|4047771|B4|Asian||Race/Ethnicity, Customized|Race|participants|Number|42|42.0||||||
4224637|NCT00699582|4047772|B3|Asian||Race/Ethnicity, Customized|Race|participants|Number|16|16.0||||||
4224638|NCT00699582|4047773|B2|Asian||Race/Ethnicity, Customized|Race|participants|Number|14|14.0||||||
4224639|NCT00699582|4047774|B1|Asian||Race/Ethnicity, Customized|Race|participants|Number|12|12.0||||||
4224640|NCT00699582|4047771|B4|Black or African American||Race/Ethnicity, Customized|Race|participants|Number|4|4.0||||||
4224641|NCT00699582|4047772|B3|Black or African American||Race/Ethnicity, Customized|Race|participants|Number|1|1.0||||||
4224642|NCT00699582|4047773|B2|Black or African American||Race/Ethnicity, Customized|Race|participants|Number|2|2.0||||||
4224643|NCT00699582|4047774|B1|Black or African American||Race/Ethnicity, Customized|Race|participants|Number|1|1.0||||||
4224644|NCT00699582|4047771|B4|White||Race/Ethnicity, Customized|Race|participants|Number|325|325.0||||||
4224645|NCT00699582|4047772|B3|White||Race/Ethnicity, Customized|Race|participants|Number|100|100.0||||||
4224646|NCT00699582|4047773|B2|White||Race/Ethnicity, Customized|Race|participants|Number|108|108.0||||||
4224647|NCT00699582|4047774|B1|White||Race/Ethnicity, Customized|Race|participants|Number|117|117.0||||||
4224648|NCT00699582|4047771|B4||Male|Sex: Female, Male|For the placebo arm, there were 2 subjects who were randomized, but not treated. For the perampanel 8mg arm, there was 1 subject who was randomized, but not treated.|Participants|Count of Participants|188|188.0||||||
4224704|NCT00699413|4047831|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4224649|NCT00699582|4047772|B3||Male|Sex: Female, Male|For the placebo arm, there were 2 subjects who were randomized, but not treated. For the perampanel 8mg arm, there was 1 subject who was randomized, but not treated.|Participants|Count of Participants|50|50.0||||||
4224650|NCT00699582|4047773|B2||Male|Sex: Female, Male|For the placebo arm, there were 2 subjects who were randomized, but not treated. For the perampanel 8mg arm, there was 1 subject who was randomized, but not treated.|Participants|Count of Participants|66|66.0||||||
4224651|NCT00699582|4047774|B1||Male|Sex: Female, Male|For the placebo arm, there were 2 subjects who were randomized, but not treated. For the perampanel 8mg arm, there was 1 subject who was randomized, but not treated.|Participants|Count of Participants|72|72.0||||||
4224652|NCT00699582|4047771|B4||Female|Sex: Female, Male|For the placebo arm, there were 2 subjects who were randomized, but not treated. For the perampanel 8mg arm, there was 1 subject who was randomized, but not treated.|Participants|Count of Participants|201|201.0||||||
4224653|NCT00699582|4047772|B3||Female|Sex: Female, Male|For the placebo arm, there were 2 subjects who were randomized, but not treated. For the perampanel 8mg arm, there was 1 subject who was randomized, but not treated.|Participants|Count of Participants|71|71.0||||||
4224654|NCT00699582|4047773|B2||Female|Sex: Female, Male|For the placebo arm, there were 2 subjects who were randomized, but not treated. For the perampanel 8mg arm, there was 1 subject who was randomized, but not treated.|Participants|Count of Participants|64|64.0||||||
4224655|NCT00699582|4047774|B1||Female|Sex: Female, Male|For the placebo arm, there were 2 subjects who were randomized, but not treated. For the perampanel 8mg arm, there was 1 subject who was randomized, but not treated.|Participants|Count of Participants|66|66.0||||||
4224656|NCT00699582|4047771|B4|>64 years||Age, Customized||participants|Number|6|6.0||||||
4224657|NCT00699582|4047772|B3|>64 years||Age, Customized||participants|Number|2|2.0||||||
4224658|NCT00699582|4047773|B2|>64 years||Age, Customized||participants|Number|3|3.0||||||
4224659|NCT00699582|4047774|B1|>64 years||Age, Customized||participants|Number|1|1.0||||||
4224660|NCT00699582|4047771|B4|18-64 years||Age, Customized||participants|Number|339|339.0||||||
4224661|NCT00699582|4047772|B3|18-64 years||Age, Customized||participants|Number|109|109.0||||||
4224662|NCT00699582|4047773|B2|18-64 years||Age, Customized||participants|Number|110|110.0||||||
4224663|NCT00699582|4047774|B1|18-64 years||Age, Customized||participants|Number|120|120.0||||||
4224664|NCT00699582|4047771|B4|<18 years||Age, Customized||participants|Number|44|44.0||||||
4224665|NCT00699582|4047772|B3|<18 years||Age, Customized||participants|Number|10|10.0||||||
4224666|NCT00699582|4047773|B2|<18 years||Age, Customized||participants|Number|17|17.0||||||
4224667|NCT00699582|4047774|B1|<18 years||Age, Customized||participants|Number|17|17.0||||||
4224668|NCT00699556|4047790|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4224669|NCT00699556|4047790|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4224670|NCT00699556|4047790|B1|||Age||years|Mean|37.1|37.1|Standard Deviation|10.2|10.2|||
4224671|NCT00699491|4047799|B7|United States||Region of Enrollment||participants|Number|48|48.0||||||
4224672|NCT00699491|4047800|B6|United States||Region of Enrollment||participants|Number|22|22.0||||||
4224673|NCT00699491|4047801|B5|United States||Region of Enrollment||participants|Number|8|8.0||||||
4224674|NCT00699491|4047802|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
4224675|NCT00699491|4047803|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4224676|NCT00699491|4047804|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4224677|NCT00699491|4047805|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4224678|NCT00699491|4047799|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4224679|NCT00699491|4047800|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4224680|NCT00699491|4047801|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4224681|NCT00699491|4047802|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4224682|NCT00699491|4047803|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4224683|NCT00699491|4047804|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4224684|NCT00699491|4047805|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4224685|NCT00699491|4047799|B7||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4224686|NCT00699491|4047800|B6||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4224687|NCT00699491|4047801|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4224688|NCT00699491|4047802|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4224689|NCT00699491|4047803|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4224690|NCT00699491|4047804|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4224691|NCT00699491|4047805|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4224692|NCT00699491|4047799|B7|||Age||years|Median|48.5|48.5|Full Range|||34.0|80.0|
4224693|NCT00699491|4047800|B6|||Age||years|Median|57|57.0|Full Range|||35.0|82.0|
4224694|NCT00699491|4047801|B5|||Age||years|Median|48.5|48.5|Full Range|||35.0|72.0|
4224695|NCT00699491|4047802|B4|||Age||years|Median|53|53.0|Full Range|||43.0|63.0|
4224696|NCT00699491|4047803|B3|||Age||years|Median|49|49.0|Full Range|||36.0|65.0|
4224697|NCT00699491|4047804|B2|||Age||years|Median|68|68.0|Full Range|||56.0|80.0|
4224698|NCT00699491|4047805|B1|||Age||years|Median|35|35.0|Full Range|||34.0|40.0|
4224699|NCT00699413|4047829|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4224700|NCT00699413|4047830|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4224701|NCT00699413|4047831|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4224702|NCT00699413|4047829|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4224705|NCT00699413|4047829|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4224706|NCT00699413|4047830|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4224707|NCT00699413|4047831|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4224708|NCT00699413|4047829|B3|||Age||years|Mean|14.6|14.6|Standard Deviation|1.37|1.37|||
4224709|NCT00699413|4047830|B2|||Age||years|Mean|14|14.0|Standard Deviation|1|1.0|||
4224710|NCT00699413|4047831|B1|||Age||years|Mean|15|15.0|Standard Deviation|1.41|1.41|||
4224711|NCT00699413|4047829|B3|<=18 years||Age, Customized||participants|Number|6|6.0||||||
4224712|NCT00699413|4047830|B2|<=18 years||Age, Customized||participants|Number|2|2.0||||||
4224713|NCT00699413|4047831|B1|<=18 years||Age, Customized||participants|Number|4|4.0||||||
4224714|NCT00699400|4047838|B4|||Donor Age||Years|Mean|25.7|25.7|Standard Deviation|2.8|2.8|||
4224715|NCT00699400|4047839|B3|||Donor Age||Years|Mean|NA||Standard Deviation|NA||||Values not available for Pre-freeze Discontinuation Arm. These participants withdrew before oocyte retrieval or the oocyte retrieval procedure failed (had no oocytes to freeze from themselves or from donors).
4224716|NCT00699400|4047840|B2|||Donor Age||Years|Mean|26.0|26.0|Standard Deviation|2.8|2.8|||
4224717|NCT00699400|4047841|B1|||Donor Age||Years|Mean|25.1|25.1|Standard Deviation|2.7|2.7|||
4224718|NCT00699400|4047838|B4|||BMI||Kg/m^2|Mean|23.7|23.7|Standard Deviation|4.1|4.1|||
4224719|NCT00699400|4047839|B3|||BMI||Kg/m^2|Mean|19.7|19.7|Standard Deviation|0|0.0|||
4224720|NCT00699400|4047840|B2|||BMI||Kg/m^2|Mean|23.4|23.4|Standard Deviation|3.6|3.6|||
4224721|NCT00699400|4047841|B1|||BMI||Kg/m^2|Mean|24.6|24.6|Standard Deviation|5.2|5.2|||
4224722|NCT00699400|4047838|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4224723|NCT00699400|4047839|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4224724|NCT00699400|4047840|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4224725|NCT00699400|4047841|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4224726|NCT00699400|4047838|B4||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4224727|NCT00699400|4047839|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4224728|NCT00699400|4047840|B2||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4224729|NCT00699400|4047841|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4224730|NCT00699400|4047838|B4|> 44 years||Age, Customized|"Four subjects underwent cryopreservation cycles for both slow-freezing and vitrification~11 Participants who enrolled in the study but withdrew before oocyte retrieval or for whom oocyte retrieval failed (had no oocytes to freeze) are captured in the Pre-Freeze Discontinuation Arm."|Participants|Number|30|30.0||||||
4224731|NCT00699400|4047839|B3|> 44 years||Age, Customized|"Four subjects underwent cryopreservation cycles for both slow-freezing and vitrification~11 Participants who enrolled in the study but withdrew before oocyte retrieval or for whom oocyte retrieval failed (had no oocytes to freeze) are captured in the Pre-Freeze Discontinuation Arm."|Participants|Number|1|1.0||||||
4224732|NCT00699400|4047840|B2|> 44 years||Age, Customized|"Four subjects underwent cryopreservation cycles for both slow-freezing and vitrification~11 Participants who enrolled in the study but withdrew before oocyte retrieval or for whom oocyte retrieval failed (had no oocytes to freeze) are captured in the Pre-Freeze Discontinuation Arm."|Participants|Number|19|19.0||||||
4224733|NCT00699400|4047841|B1|> 44 years||Age, Customized|"Four subjects underwent cryopreservation cycles for both slow-freezing and vitrification~11 Participants who enrolled in the study but withdrew before oocyte retrieval or for whom oocyte retrieval failed (had no oocytes to freeze) are captured in the Pre-Freeze Discontinuation Arm."|Participants|Number|10|10.0||||||
4224734|NCT00699400|4047838|B4|43-44 years||Age, Customized|"Four subjects underwent cryopreservation cycles for both slow-freezing and vitrification~11 Participants who enrolled in the study but withdrew before oocyte retrieval or for whom oocyte retrieval failed (had no oocytes to freeze) are captured in the Pre-Freeze Discontinuation Arm."|Participants|Number|29|29.0||||||
4224735|NCT00699400|4047839|B3|43-44 years||Age, Customized|"Four subjects underwent cryopreservation cycles for both slow-freezing and vitrification~11 Participants who enrolled in the study but withdrew before oocyte retrieval or for whom oocyte retrieval failed (had no oocytes to freeze) are captured in the Pre-Freeze Discontinuation Arm."|Participants|Number|1|1.0||||||
4224736|NCT00699400|4047840|B2|43-44 years||Age, Customized|"Four subjects underwent cryopreservation cycles for both slow-freezing and vitrification~11 Participants who enrolled in the study but withdrew before oocyte retrieval or for whom oocyte retrieval failed (had no oocytes to freeze) are captured in the Pre-Freeze Discontinuation Arm."|Participants|Number|15|15.0||||||
4224737|NCT00699400|4047841|B1|43-44 years||Age, Customized|"Four subjects underwent cryopreservation cycles for both slow-freezing and vitrification~11 Participants who enrolled in the study but withdrew before oocyte retrieval or for whom oocyte retrieval failed (had no oocytes to freeze) are captured in the Pre-Freeze Discontinuation Arm."|Participants|Number|13|13.0||||||
4224738|NCT00699400|4047838|B4|41-42 years||Age, Customized|"Four subjects underwent cryopreservation cycles for both slow-freezing and vitrification~11 Participants who enrolled in the study but withdrew before oocyte retrieval or for whom oocyte retrieval failed (had no oocytes to freeze) are captured in the Pre-Freeze Discontinuation Arm."|Participants|Number|30|30.0||||||
4224739|NCT00699400|4047839|B3|41-42 years||Age, Customized|"Four subjects underwent cryopreservation cycles for both slow-freezing and vitrification~11 Participants who enrolled in the study but withdrew before oocyte retrieval or for whom oocyte retrieval failed (had no oocytes to freeze) are captured in the Pre-Freeze Discontinuation Arm."|Participants|Number|0|0.0||||||
4224740|NCT00699400|4047840|B2|41-42 years||Age, Customized|"Four subjects underwent cryopreservation cycles for both slow-freezing and vitrification~11 Participants who enrolled in the study but withdrew before oocyte retrieval or for whom oocyte retrieval failed (had no oocytes to freeze) are captured in the Pre-Freeze Discontinuation Arm."|Participants|Number|26|26.0||||||
4224772|NCT00699335|4047902|B1|Missing data||Type of pain|Multiple types of pain possible. One participant can have more than one type of pain.|participants|Number|7|7.0||||||
4224890|NCT00698932|4048007|B3|||Age||Years|Mean|51.4|51.4|Standard Deviation|10.18|10.18|||
4224741|NCT00699400|4047841|B1|41-42 years||Age, Customized|"Four subjects underwent cryopreservation cycles for both slow-freezing and vitrification~11 Participants who enrolled in the study but withdrew before oocyte retrieval or for whom oocyte retrieval failed (had no oocytes to freeze) are captured in the Pre-Freeze Discontinuation Arm."|Participants|Number|4|4.0||||||
4224742|NCT00699400|4047838|B4|38-40 years||Age, Customized|"Four subjects underwent cryopreservation cycles for both slow-freezing and vitrification~11 Participants who enrolled in the study but withdrew before oocyte retrieval or for whom oocyte retrieval failed (had no oocytes to freeze) are captured in the Pre-Freeze Discontinuation Arm."|Participants|Number|47|47.0||||||
4224743|NCT00699400|4047839|B3|38-40 years||Age, Customized|"Four subjects underwent cryopreservation cycles for both slow-freezing and vitrification~11 Participants who enrolled in the study but withdrew before oocyte retrieval or for whom oocyte retrieval failed (had no oocytes to freeze) are captured in the Pre-Freeze Discontinuation Arm."|Participants|Number|2|2.0||||||
4224744|NCT00699400|4047840|B2|38-40 years||Age, Customized|"Four subjects underwent cryopreservation cycles for both slow-freezing and vitrification~11 Participants who enrolled in the study but withdrew before oocyte retrieval or for whom oocyte retrieval failed (had no oocytes to freeze) are captured in the Pre-Freeze Discontinuation Arm."|Participants|Number|30|30.0||||||
4224745|NCT00699400|4047841|B1|38-40 years||Age, Customized|"Four subjects underwent cryopreservation cycles for both slow-freezing and vitrification~11 Participants who enrolled in the study but withdrew before oocyte retrieval or for whom oocyte retrieval failed (had no oocytes to freeze) are captured in the Pre-Freeze Discontinuation Arm."|Participants|Number|15|15.0||||||
4224746|NCT00699400|4047838|B4|35-37 years||Age, Customized|"Four subjects underwent cryopreservation cycles for both slow-freezing and vitrification~11 Participants who enrolled in the study but withdrew before oocyte retrieval or for whom oocyte retrieval failed (had no oocytes to freeze) are captured in the Pre-Freeze Discontinuation Arm."|Participants|Number|29|29.0||||||
4224747|NCT00699400|4047839|B3|35-37 years||Age, Customized|"Four subjects underwent cryopreservation cycles for both slow-freezing and vitrification~11 Participants who enrolled in the study but withdrew before oocyte retrieval or for whom oocyte retrieval failed (had no oocytes to freeze) are captured in the Pre-Freeze Discontinuation Arm."|Participants|Number|2|2.0||||||
4224748|NCT00699400|4047840|B2|35-37 years||Age, Customized|"Four subjects underwent cryopreservation cycles for both slow-freezing and vitrification~11 Participants who enrolled in the study but withdrew before oocyte retrieval or for whom oocyte retrieval failed (had no oocytes to freeze) are captured in the Pre-Freeze Discontinuation Arm."|Participants|Number|24|24.0||||||
4224749|NCT00699400|4047841|B1|35-37 years||Age, Customized|"Four subjects underwent cryopreservation cycles for both slow-freezing and vitrification~11 Participants who enrolled in the study but withdrew before oocyte retrieval or for whom oocyte retrieval failed (had no oocytes to freeze) are captured in the Pre-Freeze Discontinuation Arm."|Participants|Number|3|3.0||||||
4224750|NCT00699400|4047838|B4|<35 years||Age, Customized|"Four subjects underwent cryopreservation cycles for both slow-freezing and vitrification~11 Participants who enrolled in the study but withdrew before oocyte retrieval or for whom oocyte retrieval failed (had no oocytes to freeze) are captured in the Pre-Freeze Discontinuation Arm."|Participants|Number|43|43.0||||||
4224751|NCT00699400|4047839|B3|<35 years||Age, Customized|"Four subjects underwent cryopreservation cycles for both slow-freezing and vitrification~11 Participants who enrolled in the study but withdrew before oocyte retrieval or for whom oocyte retrieval failed (had no oocytes to freeze) are captured in the Pre-Freeze Discontinuation Arm."|Participants|Number|5|5.0||||||
4224752|NCT00699400|4047840|B2|<35 years||Age, Customized|"Four subjects underwent cryopreservation cycles for both slow-freezing and vitrification~11 Participants who enrolled in the study but withdrew before oocyte retrieval or for whom oocyte retrieval failed (had no oocytes to freeze) are captured in the Pre-Freeze Discontinuation Arm."|Participants|Number|34|34.0||||||
4224753|NCT00699400|4047841|B1|<35 years||Age, Customized|"Four subjects underwent cryopreservation cycles for both slow-freezing and vitrification~11 Participants who enrolled in the study but withdrew before oocyte retrieval or for whom oocyte retrieval failed (had no oocytes to freeze) are captured in the Pre-Freeze Discontinuation Arm."|Participants|Number|4|4.0||||||
4224754|NCT00699374|4047878|B3||Male|Sex: Female, Male||Participants|Count of Participants|895|895.0||||||
4224755|NCT00699374|4047879|B2||Male|Sex: Female, Male||Participants|Count of Participants|459|459.0||||||
4224756|NCT00699374|4047880|B1||Male|Sex: Female, Male||Participants|Count of Participants|436|436.0||||||
4224757|NCT00699374|4047878|B3||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4224758|NCT00699374|4047879|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4224759|NCT00699374|4047880|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4224760|NCT00699374|4047878|B3|||Age||Years|Mean|58.3|58.3|Standard Deviation|12.89|12.89|||
4224761|NCT00699374|4047879|B2|||Age||Years|Mean|58.5|58.5|Standard Deviation|12.93|12.93|||
4224762|NCT00699374|4047880|B1|||Age||Years|Mean|58.1|58.1|Standard Deviation|12.86|12.86|||
4224763|NCT00699348|4047893|B1||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4224764|NCT00699348|4047893|B1||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4224765|NCT00699348|4047893|B1|||Age||years|Mean|65.7|65.7|Standard Deviation|13.32|13.32|||
4224766|NCT00699335|4047902|B1|Missing data||Underlying disease|Multiple diseases possible. One participant can have more than one underlying disease.|Participants|Number|371|371.0||||||
4224767|NCT00699335|4047902|B1|Underlying disease NOS||Underlying disease|Multiple diseases possible. One participant can have more than one underlying disease.|Participants|Number|210|210.0||||||
4224768|NCT00699335|4047902|B1|Dermatological disorders||Underlying disease|Multiple diseases possible. One participant can have more than one underlying disease.|Participants|Number|51|51.0||||||
4224769|NCT00699335|4047902|B1|Neurological disorders||Underlying disease|Multiple diseases possible. One participant can have more than one underlying disease.|Participants|Number|514|514.0||||||
4224770|NCT00699335|4047902|B1|Tumor||Underlying disease|Multiple diseases possible. One participant can have more than one underlying disease.|Participants|Number|1416|1416.0||||||
4224771|NCT00699335|4047902|B1|Musculoskeletal disorders||Underlying disease|Multiple diseases possible. One participant can have more than one underlying disease.|Participants|Number|3396|3396.0||||||
4224773|NCT00699335|4047902|B1|Other type of pain||Type of pain|Multiple types of pain possible. One participant can have more than one type of pain.|participants|Number|877|877.0||||||
4224774|NCT00699335|4047902|B1|Pain caused by a tumor||Type of pain|Multiple types of pain possible. One participant can have more than one type of pain.|participants|Number|1359|1359.0||||||
4224775|NCT00699335|4047902|B1|Severe pain when moving||Type of pain|Multiple types of pain possible. One participant can have more than one type of pain.|participants|Number|3751|3751.0||||||
4224776|NCT00699335|4047902|B1|Male||Gender|The reported values are related to the number of 5305 subjects. This number differs from the overall number of baseline participants due to missing data for 3 subjects.|participants|Number|1971|1971.0||||||
4224777|NCT00699335|4047902|B1|Female||Gender|The reported values are related to the number of 5305 subjects. This number differs from the overall number of baseline participants due to missing data for 3 subjects.|participants|Number|3334|3334.0||||||
4224778|NCT00699335|4047902|B1|||Age|The reported values are related to the number of 5174 subjects. This number differs from the overall number of baseline participants due to missing data for 134 subjects.|years|Mean|70.3|70.3|Standard Deviation|13.2|13.2|||
4224779|NCT00699283|4047933|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4224780|NCT00699283|4047934|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4224781|NCT00699283|4047935|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4224782|NCT00699283|4047933|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4224783|NCT00699283|4047934|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4224784|NCT00699283|4047935|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4224785|NCT00699283|4047933|B3|||Age||years|Mean|40.3|40.3|Standard Deviation|14.4|14.4|||
4224786|NCT00699283|4047934|B2|||Age||years|Mean|44.3|44.3|Standard Deviation|15.9|15.9|||
4224787|NCT00699283|4047935|B1|||Age||years|Mean|39.0|39.0|Standard Deviation|13.8|13.8|||
4224788|NCT00699283|4047933|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4224789|NCT00699283|4047934|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4224790|NCT00699283|4047935|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4224791|NCT00699283|4047933|B3||Between 18 and 65 Years|Age||Participants|Count of Participants|59|59.0||||||
4224792|NCT00699283|4047934|B2||Between 18 and 65 Years|Age||Participants|Count of Participants|14|14.0||||||
4224793|NCT00699283|4047935|B1||Between 18 and 65 Years|Age||Participants|Count of Participants|45|45.0||||||
4224794|NCT00699283|4047933|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4224795|NCT00699283|4047934|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4224796|NCT00699283|4047935|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4224797|NCT00699218|4047941|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4224798|NCT00699218|4047941|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4224799|NCT00699218|4047941|B1|||Age||years|Mean|50|50.0|Full Range|||19.0|68.0|
4224800|NCT00699218|4047941|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4224801|NCT00699218|4047941|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4224802|NCT00699218|4047941|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4224803|NCT00699192|4047946|B4||Male|Sex: Female, Male||Participants|Count of Participants|387|387.0||||||
4224804|NCT00699192|4047947|B3||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4224805|NCT00699192|4047948|B2||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4224806|NCT00699192|4047949|B1||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4224807|NCT00699192|4047946|B4||Female|Sex: Female, Male||Participants|Count of Participants|432|432.0||||||
4224808|NCT00699192|4047947|B3||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4224809|NCT00699192|4047948|B2||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4224810|NCT00699192|4047949|B1||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4224811|NCT00699192|4047946|B4|||Age||years|Mean|71.6|71.6|Standard Deviation|5.27|5.27|||
4224812|NCT00699192|4047947|B3|||Age||years|Mean|71.4|71.4|Standard Deviation|5.44|5.44|||
4224813|NCT00699192|4047948|B2|||Age||years|Mean|71.6|71.6|Standard Deviation|5.38|5.38|||
4224814|NCT00699192|4047949|B1|||Age||years|Mean|71.8|71.8|Standard Deviation|5.01|5.01|||
4224815|NCT00699153|4047971|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4224816|NCT00699153|4047972|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4224817|NCT00699153|4047973|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4224818|NCT00699153|4047971|B3|Native Hawiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4224819|NCT00699153|4047972|B2|Native Hawiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4224820|NCT00699153|4047973|B1|Native Hawiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4224821|NCT00699153|4047971|B3|Asian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4224822|NCT00699153|4047972|B2|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4224823|NCT00699153|4047973|B1|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4224824|NCT00699153|4047971|B3|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4224825|NCT00699153|4047972|B2|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4224826|NCT00699153|4047973|B1|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4224827|NCT00699153|4047971|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4224828|NCT00699153|4047972|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4224829|NCT00699153|4047973|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4224830|NCT00699153|4047971|B3|White||Race/Ethnicity, Customized||participants|Number|360|360.0||||||
4224831|NCT00699153|4047972|B2|White||Race/Ethnicity, Customized||participants|Number|178|178.0||||||
4224832|NCT00699153|4047973|B1|White||Race/Ethnicity, Customized||participants|Number|182|182.0||||||
4224833|NCT00699153|4047971|B3||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4224834|NCT00699153|4047972|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4224835|NCT00699153|4047973|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4224836|NCT00699153|4047971|B3||Female|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4224837|NCT00699153|4047972|B2||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4224838|NCT00699153|4047973|B1||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4224839|NCT00699153|4047971|B3|||Age||years|Mean|68.8|68.8|Standard Deviation|9.24|9.24|||
4224840|NCT00699153|4047972|B2|||Age||years|Mean|69.2|69.2|Standard Deviation|9.36|9.36|||
4224841|NCT00699153|4047973|B1|||Age||years|Mean|68.3|68.3|Standard Deviation|9.13|9.13|||
4224842|NCT00699140|4047986|B1|||Platelet count||platelets x 10^-9/L|Median|8.5|8.5|Full Range|||3.0|36.0|
4224843|NCT00699140|4047986|B1|No||Subjects with haemorrhagic history||participants|Number|5|5.0||||||
4224844|NCT00699140|4047986|B1|Yes||Subjects with haemorrhagic history||participants|Number|13|13.0||||||
4224845|NCT00699140|4047986|B1|No||Subjects with medical history of splenectomy||participants|Number|9|9.0||||||
4224846|NCT00699140|4047986|B1|Yes||Subjects with medical history of splenectomy||participants|Number|9|9.0||||||
4224847|NCT00699140|4047986|B1|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4224848|NCT00699140|4047986|B1|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4224849|NCT00699140|4047986|B1|Russian Federation||Region of Enrollment||participants|Number|12|12.0||||||
4224850|NCT00699140|4047986|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4224851|NCT00699140|4047986|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4224852|NCT00699140|4047986|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4224853|NCT00699140|4047986|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4224854|NCT00699140|4047986|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4224855|NCT00699140|4047986|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4224856|NCT00699140|4047986|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4224857|NCT00699140|4047986|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4224858|NCT00699140|4047986|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4224859|NCT00699140|4047986|B1|||Age||years|Median|43|43.0|Full Range|||20.0|77.0|
4224860|NCT00699140|4047986|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4224861|NCT00699140|4047986|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4224862|NCT00699140|4047986|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4224863|NCT00699010|4047998|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
4224864|NCT00699010|4047999|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4224865|NCT00699010|4048000|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4224866|NCT00699010|4047998|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4224867|NCT00699010|4047999|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4224868|NCT00699010|4048000|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4224869|NCT00699010|4047998|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4224870|NCT00699010|4047999|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4224871|NCT00699010|4048000|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4224872|NCT00699010|4047998|B3|||Age||years|Mean|44.7|44.7|Standard Deviation|5.5|5.5|||
4224873|NCT00699010|4047999|B2|||Age||years|Mean|44.7|44.7|Standard Deviation|5.5|5.5|||
4224874|NCT00699010|4048000|B1|||Age||years|Mean|44.7|44.7|Standard Deviation|5.5|5.5|||
4224875|NCT00699010|4047998|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4224876|NCT00699010|4047999|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4224877|NCT00699010|4048000|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4224878|NCT00699010|4047998|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4224879|NCT00699010|4047999|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4224880|NCT00699010|4048000|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4224881|NCT00699010|4047998|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4224882|NCT00699010|4047999|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4224883|NCT00699010|4048000|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4224884|NCT00698932|4048007|B3||Male|Sex: Female, Male||Participants|Count of Participants|315|315.0||||||
4224885|NCT00698932|4048008|B2||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4224886|NCT00698932|4048009|B1||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4224887|NCT00698932|4048007|B3||Female|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
4224888|NCT00698932|4048008|B2||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4224889|NCT00698932|4048009|B1||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4224891|NCT00698932|4048008|B2|||Age||Years|Mean|51.57|51.57|Standard Deviation|10.34|10.34|||
4224892|NCT00698932|4048009|B1|||Age||Years|Mean|51.23|51.23|Standard Deviation|10.04|10.04|||
4224893|NCT00698867|4048026|B1|Revision Surgery||Primary Diagnosis||elbows|Number|1|1.0||||||
4224894|NCT00698867|4048026|B1|Recurrent Dislocation/Stability||Primary Diagnosis||elbows|Number|5|5.0||||||
4224895|NCT00698867|4048026|B1|Ulnar Fracture||Primary Diagnosis||elbows|Number|2|2.0||||||
4224896|NCT00698867|4048026|B1|Traumatic Arthritis||Primary Diagnosis||elbows|Number|15|15.0||||||
4224897|NCT00698867|4048026|B1|Rheumatoid Arthritis||Primary Diagnosis||elbows|Number|52|52.0||||||
4224898|NCT00698867|4048026|B1|Other Inflammatory Arthroses||Primary Diagnosis||elbows|Number|1|1.0||||||
4224899|NCT00698867|4048026|B1|Other||Primary Diagnosis||elbows|Number|13|13.0||||||
4224900|NCT00698867|4048026|B1|Osteoarthritis||Primary Diagnosis||elbows|Number|8|8.0||||||
4224901|NCT00698867|4048026|B1|Humeral Fracture||Primary Diagnosis||elbows|Number|20|20.0||||||
4224902|NCT00698867|4048026|B1|Functional Deformity||Primary Diagnosis||elbows|Number|1|1.0||||||
4224903|NCT00698867|4048026|B1|Right||Hand Dominance||elbows|Number|111|111.0||||||
4224904|NCT00698867|4048026|B1|Left||Hand Dominance||elbows|Number|5|5.0||||||
4224905|NCT00698867|4048026|B1|Ambidextrous||Hand Dominance||elbows|Number|2|2.0||||||
4224906|NCT00698867|4048026|B1|United States||Region of Enrollment||elbows|Number|118|118.0||||||
4224907|NCT00698867|4048026|B1|Male||Sex/Gender, Customized||elbows|Number|28|28.0||||||
4224908|NCT00698867|4048026|B1|Female||Sex/Gender, Customized||elbows|Number|90|90.0||||||
4224909|NCT00698867|4048026|B1|90-99||Age, Customized||Elbows|Number|2|2.0||||||
4224910|NCT00698867|4048026|B1|80-89||Age, Customized||Elbows|Number|11|11.0||||||
4224911|NCT00698867|4048026|B1|70-79||Age, Customized||Elbows|Number|22|22.0||||||
4224912|NCT00698867|4048026|B1|60-69||Age, Customized||Elbows|Number|41|41.0||||||
4224913|NCT00698867|4048026|B1|50-59||Age, Customized||Elbows|Number|24|24.0||||||
4224914|NCT00698867|4048026|B1|40-49||Age, Customized||Elbows|Number|10|10.0||||||
4224915|NCT00698867|4048026|B1|30-39||Age, Customized||Elbows|Number|7|7.0||||||
4224916|NCT00698867|4048026|B1|20-29||Age, Customized||Elbows|Number|1|1.0||||||
4224917|NCT00698867|4048026|B1|Less than 20||Age, Customized||Elbows|Number|0|0.0||||||
4224918|NCT00698841|4048036|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4224919|NCT00698841|4048036|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4224920|NCT00698841|4048036|B1||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4224921|NCT00698841|4048036|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4224922|NCT00698841|4048036|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4224923|NCT00698841|4048036|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4224924|NCT00698841|4048036|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4224925|NCT00698841|4048036|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4224926|NCT00698841|4048036|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4224927|NCT00698841|4048036|B1|||Age||years|Mean|61|61.0|Standard Deviation|12|12.0|||
4224928|NCT00698815|4048047|B4|IV||Stage (TMN)|"The TNM staging system is based on the size and/or extent (reach) of the primary tumor (T), whether cancer cells have spread to nearby (regional) lymph nodes (N), and whether metastasis (M), or the spread of the cancer to other parts of the body, has occurred~Stage IIIB: Extensive disease: Larger tumor size and/or spread of the cancer beyond the organ in which it first developed to nearby lymph nodes and/or tissues or organs adjacent to the location of the primary tumor Stage IV (worst): Cancer has spread to distant tissues or organs"|participants|Number|114|114.0||||||
4224929|NCT00698815|4048048|B3|IV||Stage (TMN)|"The TNM staging system is based on the size and/or extent (reach) of the primary tumor (T), whether cancer cells have spread to nearby (regional) lymph nodes (N), and whether metastasis (M), or the spread of the cancer to other parts of the body, has occurred~Stage IIIB: Extensive disease: Larger tumor size and/or spread of the cancer beyond the organ in which it first developed to nearby lymph nodes and/or tissues or organs adjacent to the location of the primary tumor Stage IV (worst): Cancer has spread to distant tissues or organs"|participants|Number|38|38.0||||||
4224930|NCT00698815|4048049|B2|IV||Stage (TMN)|"The TNM staging system is based on the size and/or extent (reach) of the primary tumor (T), whether cancer cells have spread to nearby (regional) lymph nodes (N), and whether metastasis (M), or the spread of the cancer to other parts of the body, has occurred~Stage IIIB: Extensive disease: Larger tumor size and/or spread of the cancer beyond the organ in which it first developed to nearby lymph nodes and/or tissues or organs adjacent to the location of the primary tumor Stage IV (worst): Cancer has spread to distant tissues or organs"|participants|Number|39|39.0||||||
4224931|NCT00698815|4048050|B1|IV||Stage (TMN)|"The TNM staging system is based on the size and/or extent (reach) of the primary tumor (T), whether cancer cells have spread to nearby (regional) lymph nodes (N), and whether metastasis (M), or the spread of the cancer to other parts of the body, has occurred~Stage IIIB: Extensive disease: Larger tumor size and/or spread of the cancer beyond the organ in which it first developed to nearby lymph nodes and/or tissues or organs adjacent to the location of the primary tumor Stage IV (worst): Cancer has spread to distant tissues or organs"|participants|Number|37|37.0||||||
4224932|NCT00698815|4048047|B4|IIIB||Stage (TMN)|"The TNM staging system is based on the size and/or extent (reach) of the primary tumor (T), whether cancer cells have spread to nearby (regional) lymph nodes (N), and whether metastasis (M), or the spread of the cancer to other parts of the body, has occurred~Stage IIIB: Extensive disease: Larger tumor size and/or spread of the cancer beyond the organ in which it first developed to nearby lymph nodes and/or tissues or organs adjacent to the location of the primary tumor Stage IV (worst): Cancer has spread to distant tissues or organs"|participants|Number|16|16.0||||||
4224947|NCT00698815|4048050|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4224948|NCT00698815|4048047|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4224933|NCT00698815|4048048|B3|IIIB||Stage (TMN)|"The TNM staging system is based on the size and/or extent (reach) of the primary tumor (T), whether cancer cells have spread to nearby (regional) lymph nodes (N), and whether metastasis (M), or the spread of the cancer to other parts of the body, has occurred~Stage IIIB: Extensive disease: Larger tumor size and/or spread of the cancer beyond the organ in which it first developed to nearby lymph nodes and/or tissues or organs adjacent to the location of the primary tumor Stage IV (worst): Cancer has spread to distant tissues or organs"|participants|Number|3|3.0||||||
4224934|NCT00698815|4048049|B2|IIIB||Stage (TMN)|"The TNM staging system is based on the size and/or extent (reach) of the primary tumor (T), whether cancer cells have spread to nearby (regional) lymph nodes (N), and whether metastasis (M), or the spread of the cancer to other parts of the body, has occurred~Stage IIIB: Extensive disease: Larger tumor size and/or spread of the cancer beyond the organ in which it first developed to nearby lymph nodes and/or tissues or organs adjacent to the location of the primary tumor Stage IV (worst): Cancer has spread to distant tissues or organs"|participants|Number|8|8.0||||||
4224935|NCT00698815|4048050|B1|IIIB||Stage (TMN)|"The TNM staging system is based on the size and/or extent (reach) of the primary tumor (T), whether cancer cells have spread to nearby (regional) lymph nodes (N), and whether metastasis (M), or the spread of the cancer to other parts of the body, has occurred~Stage IIIB: Extensive disease: Larger tumor size and/or spread of the cancer beyond the organ in which it first developed to nearby lymph nodes and/or tissues or organs adjacent to the location of the primary tumor Stage IV (worst): Cancer has spread to distant tissues or organs"|participants|Number|5|5.0||||||
4224936|NCT00698815|4048047|B4|1||ECOG Performance Status|ECOG (Eastern Cooperative Oncology Group) Performance Status is a functional impairment classification, 0: Fully active, able to carry on all pre-disease performance without restriction; 1: Restricted in strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2: Ambulatory and capable of all self-care but unable to carry out work activities. Up and about > 50% of waking hours; 3: Capable of limited self-care, confined to bed/chair > 50% of waking hours; 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; or 5: Dead|participants|Number|86|86.0||||||
4224937|NCT00698815|4048048|B3|1||ECOG Performance Status|ECOG (Eastern Cooperative Oncology Group) Performance Status is a functional impairment classification, 0: Fully active, able to carry on all pre-disease performance without restriction; 1: Restricted in strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2: Ambulatory and capable of all self-care but unable to carry out work activities. Up and about > 50% of waking hours; 3: Capable of limited self-care, confined to bed/chair > 50% of waking hours; 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; or 5: Dead|participants|Number|27|27.0||||||
4224938|NCT00698815|4048049|B2|1||ECOG Performance Status|ECOG (Eastern Cooperative Oncology Group) Performance Status is a functional impairment classification, 0: Fully active, able to carry on all pre-disease performance without restriction; 1: Restricted in strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2: Ambulatory and capable of all self-care but unable to carry out work activities. Up and about > 50% of waking hours; 3: Capable of limited self-care, confined to bed/chair > 50% of waking hours; 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; or 5: Dead|participants|Number|30|30.0||||||
4224939|NCT00698815|4048050|B1|1||ECOG Performance Status|ECOG (Eastern Cooperative Oncology Group) Performance Status is a functional impairment classification, 0: Fully active, able to carry on all pre-disease performance without restriction; 1: Restricted in strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2: Ambulatory and capable of all self-care but unable to carry out work activities. Up and about > 50% of waking hours; 3: Capable of limited self-care, confined to bed/chair > 50% of waking hours; 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; or 5: Dead|participants|Number|29|29.0||||||
4224940|NCT00698815|4048047|B4|0||ECOG Performance Status|ECOG (Eastern Cooperative Oncology Group) Performance Status is a functional impairment classification, 0: Fully active, able to carry on all pre-disease performance without restriction; 1: Restricted in strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2: Ambulatory and capable of all self-care but unable to carry out work activities. Up and about > 50% of waking hours; 3: Capable of limited self-care, confined to bed/chair > 50% of waking hours; 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; or 5: Dead|participants|Number|44|44.0||||||
4224941|NCT00698815|4048048|B3|0||ECOG Performance Status|ECOG (Eastern Cooperative Oncology Group) Performance Status is a functional impairment classification, 0: Fully active, able to carry on all pre-disease performance without restriction; 1: Restricted in strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2: Ambulatory and capable of all self-care but unable to carry out work activities. Up and about > 50% of waking hours; 3: Capable of limited self-care, confined to bed/chair > 50% of waking hours; 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; or 5: Dead|participants|Number|14|14.0||||||
4224942|NCT00698815|4048049|B2|0||ECOG Performance Status|ECOG (Eastern Cooperative Oncology Group) Performance Status is a functional impairment classification, 0: Fully active, able to carry on all pre-disease performance without restriction; 1: Restricted in strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2: Ambulatory and capable of all self-care but unable to carry out work activities. Up and about > 50% of waking hours; 3: Capable of limited self-care, confined to bed/chair > 50% of waking hours; 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; or 5: Dead|participants|Number|17|17.0||||||
4224943|NCT00698815|4048050|B1|0||ECOG Performance Status|ECOG (Eastern Cooperative Oncology Group) Performance Status is a functional impairment classification, 0: Fully active, able to carry on all pre-disease performance without restriction; 1: Restricted in strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2: Ambulatory and capable of all self-care but unable to carry out work activities. Up and about > 50% of waking hours; 3: Capable of limited self-care, confined to bed/chair > 50% of waking hours; 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; or 5: Dead|participants|Number|13|13.0||||||
4224944|NCT00698815|4048047|B4|United States||Region of Enrollment||participants|Number|130|130.0||||||
4224945|NCT00698815|4048048|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
4224946|NCT00698815|4048049|B2|United States||Region of Enrollment||participants|Number|47|47.0||||||
4224949|NCT00698815|4048048|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4224950|NCT00698815|4048049|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4224951|NCT00698815|4048050|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4224952|NCT00698815|4048047|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4224953|NCT00698815|4048048|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4224954|NCT00698815|4048049|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4224955|NCT00698815|4048050|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4224956|NCT00698815|4048047|B4||White|Race (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
4224957|NCT00698815|4048048|B3||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4224958|NCT00698815|4048049|B2||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4224959|NCT00698815|4048050|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4224960|NCT00698815|4048047|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4224961|NCT00698815|4048048|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4224962|NCT00698815|4048049|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4224963|NCT00698815|4048050|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4224964|NCT00698815|4048047|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4224965|NCT00698815|4048048|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4224966|NCT00698815|4048049|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4224967|NCT00698815|4048050|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4224968|NCT00698815|4048047|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4224969|NCT00698815|4048048|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4224970|NCT00698815|4048049|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4224971|NCT00698815|4048050|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4224972|NCT00698815|4048047|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4224973|NCT00698815|4048048|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4224974|NCT00698815|4048049|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4224975|NCT00698815|4048050|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4224976|NCT00698815|4048047|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4224977|NCT00698815|4048048|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4224978|NCT00698815|4048049|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4224979|NCT00698815|4048050|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4224980|NCT00698815|4048047|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
4224981|NCT00698815|4048048|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4224982|NCT00698815|4048049|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4224983|NCT00698815|4048050|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4224984|NCT00698815|4048047|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4224985|NCT00698815|4048048|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4224986|NCT00698815|4048049|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4224987|NCT00698815|4048050|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4224988|NCT00698815|4048047|B4||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4224989|NCT00698815|4048048|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4224990|NCT00698815|4048049|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4224991|NCT00698815|4048050|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4224992|NCT00698815|4048047|B4||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4224993|NCT00698815|4048048|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4224994|NCT00698815|4048049|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4224995|NCT00698815|4048050|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4224996|NCT00698815|4048047|B4|>=70 years||Age, Customized||participants|Number|32|32.0||||||
4224997|NCT00698815|4048048|B3|>=70 years||Age, Customized||participants|Number|13|13.0||||||
4224998|NCT00698815|4048049|B2|>=70 years||Age, Customized||participants|Number|8|8.0||||||
4224999|NCT00698815|4048050|B1|>=70 years||Age, Customized||participants|Number|11|11.0||||||
4225000|NCT00698815|4048047|B4|60-69 years||Age, Customized||participants|Number|52|52.0||||||
4225001|NCT00698815|4048048|B3|60-69 years||Age, Customized||participants|Number|13|13.0||||||
4225002|NCT00698815|4048049|B2|60-69 years||Age, Customized||participants|Number|24|24.0||||||
4225003|NCT00698815|4048050|B1|60-69 years||Age, Customized||participants|Number|15|15.0||||||
4225004|NCT00698815|4048047|B4|<60 years||Age, Customized||participants|Number|46|46.0||||||
4225005|NCT00698815|4048048|B3|<60 years||Age, Customized||participants|Number|15|15.0||||||
4225006|NCT00698815|4048049|B2|<60 years||Age, Customized||participants|Number|15|15.0||||||
4225007|NCT00698815|4048050|B1|<60 years||Age, Customized||participants|Number|16|16.0||||||
4225008|NCT00698685|4048069|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4225009|NCT00698685|4048069|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4225010|NCT00698685|4048069|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4225011|NCT00698685|4048069|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4225012|NCT00698685|4048069|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4225013|NCT00698685|4048069|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4225014|NCT00698646|4048074|B4||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4225015|NCT00698646|4048075|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4225016|NCT00698646|4048076|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4225017|NCT00698646|4048077|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4225018|NCT00698646|4048074|B4||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4225019|NCT00698646|4048075|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4225020|NCT00698646|4048076|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4225021|NCT00698646|4048077|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4225022|NCT00698646|4048074|B4|>80 years||Age, Customized||participants|Number|77|77.0||||||
4225023|NCT00698646|4048075|B3|>80 years||Age, Customized||participants|Number|19|19.0||||||
4225024|NCT00698646|4048076|B2|>80 years||Age, Customized||participants|Number|31|31.0||||||
4225025|NCT00698646|4048077|B1|>80 years||Age, Customized||participants|Number|27|27.0||||||
4225026|NCT00698646|4048074|B4|76-80 years||Age, Customized||participants|Number|181|181.0||||||
4225027|NCT00698646|4048075|B3|76-80 years||Age, Customized||participants|Number|65|65.0||||||
4225028|NCT00698646|4048076|B2|76-80 years||Age, Customized||participants|Number|56|56.0||||||
4225029|NCT00698646|4048077|B1|76-80 years||Age, Customized||participants|Number|60|60.0||||||
4225030|NCT00698646|4048074|B4|70-75 years||Age, Customized||participants|Number|126|126.0||||||
4225031|NCT00698646|4048075|B3|70-75 years||Age, Customized||participants|Number|44|44.0||||||
4225032|NCT00698646|4048076|B2|70-75 years||Age, Customized||participants|Number|41|41.0||||||
4225033|NCT00698646|4048077|B1|70-75 years||Age, Customized||participants|Number|41|41.0||||||
4225034|NCT00698646|4048074|B4|||Age||years|Mean|77.5|77.5|Standard Deviation|4.34|4.34|||
4225035|NCT00698646|4048075|B3|||Age||years|Mean|77.2|77.2|Standard Deviation|3.99|3.99|||
4225036|NCT00698646|4048076|B2|||Age||years|Mean|77.7|77.7|Standard Deviation|4.80|4.8|||
4225037|NCT00698646|4048077|B1|||Age||years|Mean|77.7|77.7|Standard Deviation|4.22|4.22|||
4225038|NCT00698581|4048102|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4225039|NCT00698581|4048103|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4225040|NCT00698581|4048104|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4225041|NCT00698581|4048102|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4225042|NCT00698581|4048103|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4225043|NCT00698581|4048104|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4225044|NCT00698581|4048102|B3|>= 65 years||Age, Customized||participants|Number|3|3.0||||||
4225045|NCT00698581|4048103|B2|>= 65 years||Age, Customized||participants|Number|1|1.0||||||
4225046|NCT00698581|4048104|B1|>= 65 years||Age, Customized||participants|Number|2|2.0||||||
4225047|NCT00698581|4048102|B3|< 65 years||Age, Customized||participants|Number|85|85.0||||||
4225048|NCT00698581|4048103|B2|< 65 years||Age, Customized||participants|Number|19|19.0||||||
4225049|NCT00698581|4048104|B1|< 65 years||Age, Customized||participants|Number|66|66.0||||||
4225050|NCT00698581|4048102|B3|||Age||years|Mean|39.0|39.0|Standard Deviation|12.2|12.2|||
4225051|NCT00698581|4048103|B2|||Age||years|Mean|43.6|43.6|Standard Deviation|13.2|13.2|||
4225052|NCT00698581|4048104|B1|||Age||years|Mean|37.7|37.7|Standard Deviation|11.7|11.7|||
4225053|NCT00698516|4048116|B1|White and Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4225054|NCT00698516|4048116|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4225055|NCT00698516|4048116|B1|White||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4225056|NCT00698516|4048116|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4225057|NCT00698516|4048116|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4225058|NCT00698516|4048116|B1|||Age||Years|Mean|60.8|60.8|Standard Deviation|10.75|10.75|||
4225059|NCT00698451|4048134|B1|United States||Region of Enrollment||participants|Number|54|54.0||||||
4225060|NCT00698451|4048134|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225061|NCT00698451|4048134|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4225062|NCT00698451|4048134|B1|||Age||years|Mean|62.1|62.1|Standard Deviation|9.00|9.0|||
4225063|NCT00698451|4048134|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4225064|NCT00698451|4048134|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4225065|NCT00698451|4048134|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4225066|NCT00698204|4048139|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225067|NCT00698204|4048140|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225068|NCT00698204|4048141|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225069|NCT00698204|4048139|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4225070|NCT00698204|4048140|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4225071|NCT00698204|4048141|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4225072|NCT00698204|4048139|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4225073|NCT00698204|4048140|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4225074|NCT00698204|4048141|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225075|NCT00698204|4048139|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225076|NCT00698204|4048140|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225077|NCT00698204|4048141|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225078|NCT00698204|4048139|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225079|NCT00698204|4048140|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225080|NCT00698204|4048141|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225081|NCT00698204|4048139|B3||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4225082|NCT00698204|4048140|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4225083|NCT00698204|4048141|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4225084|NCT00698204|4048139|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4225085|NCT00698204|4048140|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4225086|NCT00698204|4048141|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225087|NCT00698204|4048139|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225088|NCT00698204|4048140|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225089|NCT00698204|4048141|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225090|NCT00698204|4048139|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225091|NCT00698204|4048140|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225092|NCT00698204|4048141|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225093|NCT00698204|4048139|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225094|NCT00698204|4048140|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225095|NCT00698204|4048141|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225096|NCT00698204|4048139|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4225097|NCT00698204|4048140|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4225098|NCT00698204|4048141|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4225099|NCT00698204|4048139|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4225100|NCT00698204|4048140|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4225101|NCT00698204|4048141|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4225102|NCT00698204|4048139|B3|||Age||years|Mean|54.58|54.58|Full Range|||34.0|71.0|
4225103|NCT00698204|4048140|B2|||Age||years|Mean|56.00|56.0|Full Range|||36.0|69.0|
4225104|NCT00698204|4048141|B1|||Age||years|Mean|53.15|53.15|Full Range|||34.0|71.0|
4225105|NCT00698139|4048150|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225106|NCT00698139|4048151|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225107|NCT00698139|4048152|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225108|NCT00698139|4048153|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225109|NCT00698139|4048150|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4225110|NCT00698139|4048151|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4225111|NCT00698139|4048152|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4225112|NCT00698139|4048153|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4225113|NCT00698139|4048150|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4225114|NCT00698139|4048151|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4225115|NCT00698139|4048152|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4225116|NCT00698139|4048153|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4225117|NCT00698139|4048150|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4225118|NCT00698139|4048151|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4225119|NCT00698139|4048152|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4225120|NCT00698139|4048153|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4225121|NCT00698139|4048150|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4225122|NCT00698139|4048151|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4225123|NCT00698139|4048152|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4225124|NCT00698139|4048153|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4225125|NCT00698139|4048150|B4|||Age||years|Mean|69|69.0|Standard Deviation|27|27.0|||
4225126|NCT00698139|4048151|B3|||Age||years|Mean|84|84.0|Standard Deviation|0|0.0|||
4225127|NCT00698139|4048152|B2|||Age||years|Mean|85|85.0|Standard Deviation|0|0.0|||
4225128|NCT00698139|4048153|B1|||Age||years|Mean|48|48.0|Standard Deviation|0|0.0|||
4225129|NCT00698035|4048169|B3|United States||Region of Enrollment||participants|Number|75|75.0||||||
4225130|NCT00698035|4048170|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
4225131|NCT00698035|4048171|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4225132|NCT00698035|4048169|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225133|NCT00698035|4048170|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225134|NCT00698035|4048171|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225135|NCT00698035|4048169|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4225136|NCT00698035|4048170|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4225137|NCT00698035|4048171|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4225138|NCT00698035|4048169|B3|||Age||years|Mean|56|56.0|Full Range|||37.0|78.0|
4225139|NCT00698035|4048170|B2|||Age||years|Mean|57|57.0|Full Range|||38.0|74.0|
4225140|NCT00698035|4048171|B1|||Age||years|Mean|56|56.0|Full Range|||37.0|78.0|
4225141|NCT00698022|4048189|B4|India||Region of Enrollment||participants|Number|76|76.0||||||
4225142|NCT00698022|4048190|B3|India||Region of Enrollment||participants|Number|16|16.0||||||
4225143|NCT00698022|4048191|B2|India||Region of Enrollment||participants|Number|30|30.0||||||
4225144|NCT00698022|4048192|B1|India||Region of Enrollment||participants|Number|30|30.0||||||
4225145|NCT00698022|4048189|B4||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4225146|NCT00698022|4048190|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4225147|NCT00698022|4048191|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4225148|NCT00698022|4048192|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4225149|NCT00698022|4048189|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225150|NCT00698022|4048190|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225151|NCT00698022|4048191|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225152|NCT00698022|4048192|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225153|NCT00698022|4048189|B4|||Age||years|Mean|25|25.0|Standard Deviation|3.9|3.9|||
4225154|NCT00698022|4048190|B3|||Age||years|Mean|24.9|24.9|Standard Deviation|4.6|4.6|||
4225155|NCT00698022|4048191|B2|||Age||years|Mean|25.6|25.6|Standard Deviation|3.6|3.6|||
4225156|NCT00698022|4048192|B1|||Age||years|Mean|24.6|24.6|Standard Deviation|3.9|3.9|||
4225157|NCT00698022|4048189|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4225158|NCT00698022|4048190|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4225159|NCT00698022|4048191|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4225160|NCT00698022|4048192|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4225161|NCT00698022|4048189|B4||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
4225162|NCT00698022|4048190|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4225163|NCT00698022|4048191|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4225164|NCT00698022|4048192|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4225165|NCT00698022|4048189|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4225166|NCT00698022|4048190|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4225167|NCT00698022|4048191|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4225168|NCT00698022|4048192|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4225169|NCT00698009|4048202|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4225170|NCT00698009|4048202|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4225171|NCT00698009|4048202|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225172|NCT00698009|4048202|B1|||Age||years|Median|10|10.0|Standard Deviation|||||
4225173|NCT00697827|4048206|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
4225174|NCT00697827|4048207|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4225175|NCT00697827|4048208|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4225176|NCT00697827|4048206|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4225177|NCT00697827|4048207|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4225178|NCT00697827|4048208|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4225179|NCT00697827|4048206|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4225180|NCT00697827|4048207|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4225181|NCT00697827|4048208|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4225182|NCT00697827|4048206|B3|||Age||years|Mean|64.0|64.0|Standard Deviation|7.23|7.23|||
4225183|NCT00697827|4048207|B2|||Age||years|Mean|64.8|64.8|Standard Deviation|6.69|6.69|||
4225184|NCT00697827|4048208|B1|||Age||years|Mean|63.1|63.1|Standard Deviation|7.88|7.88|||
4225185|NCT00697827|4048206|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4225186|NCT00697827|4048207|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4225187|NCT00697827|4048208|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4225188|NCT00697827|4048206|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4225189|NCT00697827|4048207|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4225190|NCT00697827|4048208|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4225191|NCT00697827|4048206|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4225192|NCT00697827|4048207|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4225193|NCT00697827|4048208|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4225194|NCT00697801|4048217|B4||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4225195|NCT00697801|4048218|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4225196|NCT00697801|4048219|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4225197|NCT00697801|4048220|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4225198|NCT00697801|4048217|B4||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4225199|NCT00697801|4048218|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4225200|NCT00697801|4048219|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4225201|NCT00697801|4048220|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4225202|NCT00697801|4048217|B4|||Age||years|Mean|10.3|10.3|Standard Deviation|4.68|4.68|||
4225203|NCT00697801|4048218|B3|||Age||years|Mean|10.2|10.2|Standard Deviation|4.52|4.52|||
4225204|NCT00697801|4048219|B2|||Age||years|Mean|10.5|10.5|Standard Deviation|4.75|4.75|||
4225205|NCT00697801|4048220|B1|||Age||years|Mean|10.2|10.2|Standard Deviation|4.76|4.76|||
4225206|NCT00697788|4048236|B1|||Fluid intake-Fluid output||ml/kg/24 hours|Mean|88.7|88.7|Standard Deviation|71.8|71.8|||
4225207|NCT00697788|4048236|B1|||Time after injury in days||days|Mean|19.7|19.7|Standard Deviation|10.3|10.3|||
4225208|NCT00697788|4048236|B1|||Central Venous Pressure||millimeters of mercury (mm Hg)|Mean|10.4|10.4|Standard Deviation|4|4.0|||
4225209|NCT00697788|4048236|B1|||Weight||kilograms|Mean|33.5|33.5|Standard Deviation|23.5|23.5|||
4225210|NCT00697788|4048236|B1|||Total Body Surface Area Burned||percentage of surface|Mean|58.3|58.3|Standard Deviation|15.2|15.2|||
4225211|NCT00697788|4048236|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4225212|NCT00697788|4048236|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225213|NCT00697788|4048236|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4225214|NCT00697788|4048236|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4225215|NCT00697788|4048236|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4225216|NCT00697788|4048236|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225217|NCT00697788|4048236|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225218|NCT00697788|4048236|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225219|NCT00697788|4048236|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225220|NCT00697788|4048236|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4225221|NCT00697788|4048236|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4225222|NCT00697788|4048236|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4225223|NCT00697788|4048236|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4225224|NCT00697788|4048236|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4225225|NCT00697788|4048236|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4225226|NCT00697788|4048236|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4225227|NCT00697697|4048285|B3||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4225228|NCT00697697|4048286|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4225229|NCT00697697|4048287|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4225230|NCT00697697|4048285|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4225231|NCT00697697|4048286|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4225232|NCT00697697|4048287|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4225233|NCT00697697|4048285|B3|||Age||years|Median|5.0|5.0|Full Range|||1.0|9.0|
4225234|NCT00697697|4048286|B2|||Age||years|Median|5.0|5.0|Full Range|||1.0|8.0|
4225235|NCT00697697|4048287|B1|||Age||years|Median|5.0|5.0|Full Range|||1.0|9.0|
4225236|NCT00697697|4048285|B3|||Age||years|Mean|4.8|4.8|Standard Deviation|2.27|2.27|||
4225237|NCT00697697|4048286|B2|||Age||years|Mean|4.9|4.9|Standard Deviation|2.03|2.03|||
4225238|NCT00697697|4048287|B1|||Age||years|Mean|4.6|4.6|Standard Deviation|2.50|2.5|||
4225239|NCT00697619|4048296|B3|China||Region of Enrollment||participants|Number|60|60.0||||||
4225240|NCT00697619|4048297|B2|China||Region of Enrollment||participants|Number|30|30.0||||||
4225241|NCT00697619|4048298|B1|China||Region of Enrollment||participants|Number|30|30.0||||||
4225242|NCT00697619|4048296|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4225243|NCT00697619|4048297|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4225244|NCT00697619|4048298|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4225245|NCT00697619|4048296|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4225246|NCT00697619|4048297|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4225247|NCT00697619|4048298|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4225248|NCT00697619|4048296|B3|||Age||years|Mean|44|44.0|Standard Deviation|11|11.0|||
4225249|NCT00697619|4048297|B2|||Age||years|Mean|41|41.0|Standard Deviation|11|11.0|||
4225250|NCT00697619|4048298|B1|||Age||years|Mean|46|46.0|Standard Deviation|10|10.0|||
4225251|NCT00697619|4048296|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4225252|NCT00697619|4048297|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4225253|NCT00697619|4048298|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4225254|NCT00697619|4048296|B3||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4225255|NCT00697619|4048297|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4225256|NCT00697619|4048298|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4225257|NCT00697619|4048296|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4225258|NCT00697619|4048297|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4225259|NCT00697619|4048298|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4225260|NCT00697593|4048305|B1|||Urinalysis - pH||pH units|Mean|5.84|5.84|Standard Deviation|0.49|0.49|||
4225261|NCT00697593|4048305|B1|Present||Urinalysis - Blood|Number of participants with or without blood detected in urine|participants|Number|4|4.0||||||
4225262|NCT00697593|4048305|B1|Negative||Urinalysis - Blood|Number of participants with or without blood detected in urine|participants|Number|66|66.0||||||
4225263|NCT00697593|4048305|B1|Present||Urinalysis - Values - Protein||participants|Number|11|11.0||||||
4225264|NCT00697593|4048305|B1|Negative||Urinalysis - Values - Protein||participants|Number|59|59.0||||||
4225265|NCT00697593|4048305|B1|Present||Urinalysis - Leukocytes Esterase|Number of participants with or without leukocytes esterase detected in urine|participants|Number|10|10.0||||||
4225266|NCT00697593|4048305|B1|Negative||Urinalysis - Leukocytes Esterase|Number of participants with or without leukocytes esterase detected in urine|participants|Number|60|60.0||||||
4225267|NCT00697593|4048305|B1|Positive||Urinalysis - Values - Nitrite|Number of participants with or without nitrite detected in urine|participants|Number|1|1.0||||||
4225268|NCT00697593|4048305|B1|Negative||Urinalysis - Values - Nitrite|Number of participants with or without nitrite detected in urine|participants|Number|69|69.0||||||
4225269|NCT00697593|4048305|B1|Present||Urinalysis - Ketones|Number of participants with or without ketones detected in urine|participants|Number|3|3.0||||||
4225270|NCT00697593|4048305|B1|Negative||Urinalysis - Ketones|Number of participants with or without ketones detected in urine|participants|Number|67|67.0||||||
4225271|NCT00697593|4048305|B1|Present||Urinalysis - Glucose|Number of participants with or without glucose detected in urine|participants|Number|4|4.0||||||
4225272|NCT00697593|4048305|B1|Negative||Urinalysis - Glucose|Number of participants with or without glucose detected in urine|participants|Number|66|66.0||||||
4225273|NCT00697593|4048305|B1|||Hematology - Platelet Count||x10^9/L|Mean|256.0|256.0|Standard Deviation|54.7|54.7|||
4225274|NCT00697593|4048305|B1|||Hematology - Neutrophils||x10^9/L|Mean|4.533|4.533|Standard Deviation|1.582|1.582|||
4225275|NCT00697593|4048305|B1|||Hematology - Monocytes||x10^9/L|Mean|0.462|0.462|Standard Deviation|0.188|0.188|||
4225276|NCT00697593|4048305|B1|||Hematology - Lymphocytes||x10^9/L|Mean|1.911|1.911|Standard Deviation|0.670|0.67|||
4225277|NCT00697593|4048305|B1|||Hematology - Eosinophils||x10^9/L|Mean|0.177|0.177|Standard Deviation|0.135|0.135|||
4225278|NCT00697593|4048305|B1|||Hematology - Basophils||x10^9/L|Mean|0.032|0.032|Standard Deviation|0.033|0.033|||
4225279|NCT00697593|4048305|B1|||Hematology - White Blood Cell Count||x10^9/L|Mean|7.11|7.11|Standard Deviation|1.95|1.95|||
4225280|NCT00697593|4048305|B1|||Hematology - Red Blood Cell Count||x10^12/L|Mean|4.69|4.69|Standard Deviation|0.52|0.52|||
4225281|NCT00697593|4048305|B1|||Hematology - Hemoglobin||g/L|Mean|145.0|145.0|Standard Deviation|13.7|13.7|||
4225282|NCT00697593|4048305|B1|||Hematology - Hematocrit||packed cell volume|Mean|0.430|0.43|Standard Deviation|0.040|0.04|||
4225283|NCT00697593|4048305|B1|||Biochemistry - Urea||mmol/L|Mean|5.677|5.677|Standard Deviation|1.633|1.633|||
4225284|NCT00697593|4048305|B1|||Biochemistry - Total Bilirubin||μmol/L|Mean|8.0|8.0|Standard Deviation|4.7|4.7|||
4225285|NCT00697593|4048305|B1|||Biochemistry - Values: Sodium||mmol/L|Mean|139.5|139.5|Standard Deviation|1.9|1.9|||
4225286|NCT00697593|4048305|B1|||Biochemistry - Potassium||mmol/L|Mean|4.19|4.19|Standard Deviation|0.36|0.36|||
4225287|NCT00697593|4048305|B1|||Biochemistry - Glutamyl Transferase||IU/L|Mean|25.9|25.9|Standard Deviation|15.3|15.3|||
4225288|NCT00697593|4048305|B1|||Biochemistry - Creatinine||μmol/L|Mean|82.9|82.9|Standard Deviation|18.9|18.9|||
4225289|NCT00697593|4048305|B1|||Biochemistry - Aspartate Transaminase (AST)||IU/L|Mean|23.0|23.0|Standard Deviation|7.8|7.8|||
4225290|NCT00697593|4048305|B1|||Biochemistry - Alkaline Phosphatase||IU/L|Mean|76.6|76.6|Standard Deviation|19.0|19.0|||
4225291|NCT00697593|4048305|B1|||Biochemistry - Alanine Transaminase (ALT)||IU/L|Mean|27.8|27.8|Standard Deviation|12.2|12.2|||
4225292|NCT00697593|4048305|B1|Participants with >6 mg/L||Biochemistry - C-Reactive Protein (CRP)|Numbers of participants with CRP values <3 mg/L, 3-6 mg/L, and >6 mg/L|participants|Number|15|15.0||||||
4225293|NCT00697593|4048305|B1|Participants with 3 mg/L-6mg/L||Biochemistry - C-Reactive Protein (CRP)|Numbers of participants with CRP values <3 mg/L, 3-6 mg/L, and >6 mg/L|participants|Number|19|19.0||||||
4225294|NCT00697593|4048305|B1|Participants with <3 mg/L||Biochemistry - C-Reactive Protein (CRP)|Numbers of participants with CRP values <3 mg/L, 3-6 mg/L, and >6 mg/L|participants|Number|36|36.0||||||
4225295|NCT00697593|4048305|B1|Very Severe||static Physician's Global Assessment (sPGA)|Numbers of participants with sPGA ratings of clear; minimal; mild; moderate; severe; or very severe|participants|Number|1|1.0||||||
4225296|NCT00697593|4048305|B1|Severe||static Physician's Global Assessment (sPGA)|Numbers of participants with sPGA ratings of clear; minimal; mild; moderate; severe; or very severe|participants|Number|21|21.0||||||
4225297|NCT00697593|4048305|B1|Moderate||static Physician's Global Assessment (sPGA)|Numbers of participants with sPGA ratings of clear; minimal; mild; moderate; severe; or very severe|participants|Number|38|38.0||||||
4225298|NCT00697593|4048305|B1|Mild||static Physician's Global Assessment (sPGA)|Numbers of participants with sPGA ratings of clear; minimal; mild; moderate; severe; or very severe|participants|Number|6|6.0||||||
4225299|NCT00697593|4048305|B1|Minimal||static Physician's Global Assessment (sPGA)|Numbers of participants with sPGA ratings of clear; minimal; mild; moderate; severe; or very severe|participants|Number|4|4.0||||||
4225362|NCT00697073|4048460|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4225300|NCT00697593|4048305|B1|Clear||static Physician's Global Assessment (sPGA)|Numbers of participants with sPGA ratings of clear; minimal; mild; moderate; severe; or very severe|participants|Number|0|0.0||||||
4225301|NCT00697593|4048305|B1|Netherlands||Region of Enrollment||participants|Number|10|10.0||||||
4225302|NCT00697593|4048305|B1|Canada||Region of Enrollment||participants|Number|60|60.0||||||
4225303|NCT00697593|4048305|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4225304|NCT00697593|4048305|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4225305|NCT00697593|4048305|B1|>64 years||Age, Customized||participants|Number|8|8.0||||||
4225306|NCT00697593|4048305|B1|41 to 64 years||Age, Customized||participants|Number|36|36.0||||||
4225307|NCT00697593|4048305|B1|18 - 40 years||Age, Customized||participants|Number|26|26.0||||||
4225308|NCT00697593|4048305|B1|||Age||years|Mean|46.9|46.9|Standard Deviation|14.7|14.7|||
4225309|NCT00697541|4048336|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4225310|NCT00697541|4048337|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4225311|NCT00697541|4048338|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4225312|NCT00697541|4048336|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225313|NCT00697541|4048337|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225314|NCT00697541|4048338|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225315|NCT00697541|4048336|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4225316|NCT00697541|4048337|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4225317|NCT00697541|4048338|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4225318|NCT00697541|4048336|B3|||Age||years|Mean|45.1|45.1|Standard Deviation|7.8|7.8|||
4225319|NCT00697541|4048337|B2|||Age||years|Mean|47.1|47.1|Standard Deviation|6.7|6.7|||
4225320|NCT00697541|4048338|B1|||Age||years|Mean|43.0|43.0|Standard Deviation|8.5|8.5|||
4225321|NCT00697541|4048336|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4225322|NCT00697541|4048337|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4225323|NCT00697541|4048338|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4225324|NCT00697541|4048336|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4225325|NCT00697541|4048337|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4225326|NCT00697541|4048338|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4225327|NCT00697541|4048336|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4225328|NCT00697541|4048337|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4225329|NCT00697541|4048338|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4225330|NCT00697515|4048349|B1|United States||Region of Enrollment||participants|Number|142|142.0||||||
4225331|NCT00697515|4048349|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4225332|NCT00697515|4048349|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4225333|NCT00697515|4048349|B1|||Age||years|Mean|30.5|30.5|Standard Deviation|10.7|10.7|||
4225334|NCT00697515|4048349|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4225335|NCT00697515|4048349|B1||Between 18 and 65 years|Age||Participants|Count of Participants|142|142.0||||||
4225336|NCT00697515|4048349|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4225337|NCT00697463|4048378|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4225338|NCT00697463|4048378|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225339|NCT00697463|4048378|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4225340|NCT00697463|4048378|B1|||Age||years|Mean|39.6|39.6|Standard Deviation|5.4|5.4|||
4225341|NCT00697463|4048378|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4225342|NCT00697463|4048378|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4225343|NCT00697463|4048378|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4225344|NCT00697255|4048382|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225345|NCT00697255|4048383|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225346|NCT00697255|4048384|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225347|NCT00697255|4048382|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4225348|NCT00697255|4048383|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4225349|NCT00697255|4048384|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4225350|NCT00697255|4048382|B3|||Age||years|Mean|30.0|30.0|Standard Deviation|4.8|4.8|||
4225351|NCT00697255|4048383|B2|||Age||years|Mean|28.7|28.7|Standard Deviation|2.5|2.5|||
4225352|NCT00697255|4048384|B1|||Age||years|Mean|30.8|30.8|Standard Deviation|5.9|5.9|||
4225353|NCT00697190|4048401|B1|United Kingdom||Region of Enrollment||participants|Number|38|38.0||||||
4225354|NCT00697190|4048401|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4225355|NCT00697190|4048401|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4225356|NCT00697190|4048401|B1|||Age||years|Mean|31.4|31.4|Standard Deviation|12.5|12.5|||
4225357|NCT00697112|4048436|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4225358|NCT00697112|4048436|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4225359|NCT00697112|4048436|B1|||Age||years|Mean|48.7|48.7|Standard Deviation|14.9|14.9|||
4225360|NCT00697073|4048460|B1|United States||Region of Enrollment||participants|Number|68|68.0||||||
4225361|NCT00697073|4048460|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4225363|NCT00697073|4048460|B1|||Age||years|Mean|14.0|14.0|Standard Deviation|2.72|2.72|||
4225364|NCT00697073|4048460|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4225365|NCT00697073|4048460|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4225366|NCT00697073|4048460|B1||<=18 years|Age||Participants|Count of Participants|68|68.0||||||
4225367|NCT00696878|4048464|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225368|NCT00696878|4048464|B1||Female|Sex: Female, Male||Participants|Count of Participants|682|682.0||||||
4225369|NCT00696878|4048464|B1|||Age||years|Mean|32.9|32.9|Standard Deviation|3.6|3.6|||
4225370|NCT00696800|4048536|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225371|NCT00696800|4048537|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225372|NCT00696800|4048538|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225373|NCT00696800|4048536|B3||Female|Sex: Female, Male||Participants|Count of Participants|1506|1506.0||||||
4225374|NCT00696800|4048537|B2||Female|Sex: Female, Male||Participants|Count of Participants|750|750.0||||||
4225375|NCT00696800|4048538|B1||Female|Sex: Female, Male||Participants|Count of Participants|756|756.0||||||
4225376|NCT00696800|4048536|B3|||Age||Years|Mean|31.5|31.5|Standard Deviation|3.3|3.3|||
4225377|NCT00696800|4048537|B2|||Age||Years|Mean|31.5|31.5|Standard Deviation|3.2|3.2|||
4225378|NCT00696800|4048538|B1|||Age||Years|Mean|31.5|31.5|Standard Deviation|3.3|3.3|||
4225379|NCT00696787|4048589|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225380|NCT00696787|4048590|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225381|NCT00696787|4048591|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225382|NCT00696787|4048592|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225383|NCT00696787|4048589|B4||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4225384|NCT00696787|4048590|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4225385|NCT00696787|4048591|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4225386|NCT00696787|4048592|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4225387|NCT00696787|4048589|B4|||Age||years|Mean|46.70|46.7|Standard Deviation|11.74|11.74|||
4225388|NCT00696787|4048590|B3|||Age||years|Mean|45.42|45.42|Standard Deviation|12.11|12.11|||
4225389|NCT00696787|4048591|B2|||Age||years|Mean|47.83|47.83|Standard Deviation|10.53|10.53|||
4225390|NCT00696787|4048592|B1|||Age||years|Mean|46.90|46.9|Standard Deviation|12.65|12.65|||
4225391|NCT00696774|4048605|B4|||Treatment Satisfaction Questionnaire for Medication (TSQM)|The TSQM is a participant-reported measure that best describes how the study medication makes them feel since the last study visit, assessing perceived effectiveness, severity of side effects, and convenience. Convenience, Effectiveness, Side-Effects, and Global Satisfaction scale scores range from 0 (extremely dissatisfied) to 100 (extremely satisfied).|Units on a scale|Mean|43.7|43.7|Standard Deviation|18.3|18.3|||
4225392|NCT00696774|4048606|B3|||Treatment Satisfaction Questionnaire for Medication (TSQM)|The TSQM is a participant-reported measure that best describes how the study medication makes them feel since the last study visit, assessing perceived effectiveness, severity of side effects, and convenience. Convenience, Effectiveness, Side-Effects, and Global Satisfaction scale scores range from 0 (extremely dissatisfied) to 100 (extremely satisfied).|Units on a scale|Mean|47.2|47.2|Standard Deviation|20.8|20.8|||
4225393|NCT00696774|4048607|B2|||Treatment Satisfaction Questionnaire for Medication (TSQM)|The TSQM is a participant-reported measure that best describes how the study medication makes them feel since the last study visit, assessing perceived effectiveness, severity of side effects, and convenience. Convenience, Effectiveness, Side-Effects, and Global Satisfaction scale scores range from 0 (extremely dissatisfied) to 100 (extremely satisfied).|Units on a scale|Mean|41.6|41.6|Standard Deviation|18.2|18.2|||
4225394|NCT00696774|4048608|B1|||Treatment Satisfaction Questionnaire for Medication (TSQM)|The TSQM is a participant-reported measure that best describes how the study medication makes them feel since the last study visit, assessing perceived effectiveness, severity of side effects, and convenience. Convenience, Effectiveness, Side-Effects, and Global Satisfaction scale scores range from 0 (extremely dissatisfied) to 100 (extremely satisfied).|Units on a scale|Mean|44.2|44.2|Standard Deviation|17.6|17.6|||
4225395|NCT00696774|4048605|B4|||Sheehan Disability Scale (SDS)|The SDS is completed by the patient and is used to assess the effect of the patient's symptoms on their work/social/family life. Total scores range from 0 to 30 with higher values indicating greater disruption in the patient's work/social/family life.|Units on a scale|Mean|5.7|5.7|Standard Deviation|3.0|3.0|||
4225396|NCT00696774|4048606|B3|||Sheehan Disability Scale (SDS)|The SDS is completed by the patient and is used to assess the effect of the patient's symptoms on their work/social/family life. Total scores range from 0 to 30 with higher values indicating greater disruption in the patient's work/social/family life.|Units on a scale|Mean|5.5|5.5|Standard Deviation|3.0|3.0|||
4225397|NCT00696774|4048607|B2|||Sheehan Disability Scale (SDS)|The SDS is completed by the patient and is used to assess the effect of the patient's symptoms on their work/social/family life. Total scores range from 0 to 30 with higher values indicating greater disruption in the patient's work/social/family life.|Units on a scale|Mean|6.3|6.3|Standard Deviation|3.0|3.0|||
4225398|NCT00696774|4048608|B1|||Sheehan Disability Scale (SDS)|The SDS is completed by the patient and is used to assess the effect of the patient's symptoms on their work/social/family life. Total scores range from 0 to 30 with higher values indicating greater disruption in the patient's work/social/family life.|Units on a scale|Mean|5.4|5.4|Standard Deviation|2.9|2.9|||
4225399|NCT00696774|4048605|B4|||Number of Previous MDD Episodes in the Past 24 Months||MDD episodes|Mean|1.6|1.6|Standard Deviation|0.9|0.9|||
4225400|NCT00696774|4048606|B3|||Number of Previous MDD Episodes in the Past 24 Months||MDD episodes|Mean|1.8|1.8|Standard Deviation|1.5|1.5|||
4225401|NCT00696774|4048607|B2|||Number of Previous MDD Episodes in the Past 24 Months||MDD episodes|Mean|1.5|1.5|Standard Deviation|0.7|0.7|||
4225474|NCT00696774|4048608|B1|No||Had at Least One Historical Illness||participants|Number|71|71.0||||||
4225402|NCT00696774|4048608|B1|||Number of Previous MDD Episodes in the Past 24 Months||MDD episodes|Mean|1.6|1.6|Standard Deviation|0.8|0.8|||
4225403|NCT00696774|4048605|B4|||Number of MDD Hospitalizations in the Past 24 Months||hospitalizations|Mean|1.0|1.0|Standard Deviation|0.0|0.0|||
4225404|NCT00696774|4048606|B3|||Number of MDD Hospitalizations in the Past 24 Months||hospitalizations|Mean|1.0|1.0|Standard Deviation|0.0|0.0|||
4225405|NCT00696774|4048607|B2|||Number of MDD Hospitalizations in the Past 24 Months||hospitalizations|Mean|1.0|1.0|Standard Deviation|0.0|0.0|||
4225406|NCT00696774|4048608|B1|||Number of MDD Hospitalizations in the Past 24 Months||hospitalizations|Mean|1.0|1.0|Standard Deviation|0.0|0.0|||
4225407|NCT00696774|4048605|B4|||Hamilton Anxiety Rating Scale (HAMA) Total Score|The HAMA scale measures anxiety symptoms accompanying major depressive disorder (MDD). Each item of the 14-item HAMA was scored from 0 (not present) to 4 (very severe), with a resulting maximum total score of 56.|Units on a scale|Mean|19.2|19.2|Standard Deviation|7.1|7.1|||
4225408|NCT00696774|4048606|B3|||Hamilton Anxiety Rating Scale (HAMA) Total Score|The HAMA scale measures anxiety symptoms accompanying major depressive disorder (MDD). Each item of the 14-item HAMA was scored from 0 (not present) to 4 (very severe), with a resulting maximum total score of 56.|Units on a scale|Mean|17.9|17.9|Standard Deviation|7.6|7.6|||
4225409|NCT00696774|4048607|B2|||Hamilton Anxiety Rating Scale (HAMA) Total Score|The HAMA scale measures anxiety symptoms accompanying major depressive disorder (MDD). Each item of the 14-item HAMA was scored from 0 (not present) to 4 (very severe), with a resulting maximum total score of 56.|Units on a scale|Mean|21.4|21.4|Standard Deviation|6.8|6.8|||
4225410|NCT00696774|4048608|B1|||Hamilton Anxiety Rating Scale (HAMA) Total Score|The HAMA scale measures anxiety symptoms accompanying major depressive disorder (MDD). Each item of the 14-item HAMA was scored from 0 (not present) to 4 (very severe), with a resulting maximum total score of 56.|Units on a scale|Mean|17.9|17.9|Standard Deviation|6.8|6.8|||
4225411|NCT00696774|4048605|B4|||Duration of the Current Episode||days|Mean|247.3|247.3|Standard Deviation|333.3|333.3|||
4225412|NCT00696774|4048606|B3|||Duration of the Current Episode||days|Mean|194.1|194.1|Standard Deviation|182.6|182.6|||
4225413|NCT00696774|4048607|B2|||Duration of the Current Episode||days|Mean|264.5|264.5|Standard Deviation|318.1|318.1|||
4225414|NCT00696774|4048608|B1|||Duration of the Current Episode||days|Mean|249.4|249.4|Standard Deviation|378.3|378.3|||
4225415|NCT00696774|4048605|B4|||Clinical Global Impressions - Severity (CGI-Severity) Score|Measures severity of illness at the time of assessment compared with start of treatment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|Units on a scale|Mean|4.3|4.3|Standard Deviation|0.6|0.6|||
4225416|NCT00696774|4048606|B3|||Clinical Global Impressions - Severity (CGI-Severity) Score|Measures severity of illness at the time of assessment compared with start of treatment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|Units on a scale|Mean|4.3|4.3|Standard Deviation|0.7|0.7|||
4225417|NCT00696774|4048607|B2|||Clinical Global Impressions - Severity (CGI-Severity) Score|Measures severity of illness at the time of assessment compared with start of treatment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|Units on a scale|Mean|4.4|4.4|Standard Deviation|0.6|0.6|||
4225418|NCT00696774|4048608|B1|||Clinical Global Impressions - Severity (CGI-Severity) Score|Measures severity of illness at the time of assessment compared with start of treatment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|Units on a scale|Mean|4.2|4.2|Standard Deviation|0.6|0.6|||
4225419|NCT00696774|4048605|B4|||Changes in Sexual Function Questionnaire (CSFQ)|A 14-item patient-rated scale designed to assess medication-related changes in sexual activity/functioning. Items are rated from 1 (never, low enjoyment or pleasure) to 5 (every day/great enjoyment or pleasure). CSFQ measures 5 dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; orgasm. CSFQ total score is obtained across all 5 dimensions. Lower scores are associated with sexual dysfunction/diminished sexual functioning. Total scores <=47 (men) and <=41 (women) indicate global sexual dysfunction, with all phases of the sexual response cycle being affected.|Units on a scale|Mean|35.1|35.1|Standard Deviation|10.0|10.0|||
4225420|NCT00696774|4048606|B3|||Changes in Sexual Function Questionnaire (CSFQ)|A 14-item patient-rated scale designed to assess medication-related changes in sexual activity/functioning. Items are rated from 1 (never, low enjoyment or pleasure) to 5 (every day/great enjoyment or pleasure). CSFQ measures 5 dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; orgasm. CSFQ total score is obtained across all 5 dimensions. Lower scores are associated with sexual dysfunction/diminished sexual functioning. Total scores <=47 (men) and <=41 (women) indicate global sexual dysfunction, with all phases of the sexual response cycle being affected.|Units on a scale|Mean|33.8|33.8|Standard Deviation|9.4|9.4|||
4225421|NCT00696774|4048607|B2|||Changes in Sexual Function Questionnaire (CSFQ)|A 14-item patient-rated scale designed to assess medication-related changes in sexual activity/functioning. Items are rated from 1 (never, low enjoyment or pleasure) to 5 (every day/great enjoyment or pleasure). CSFQ measures 5 dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; orgasm. CSFQ total score is obtained across all 5 dimensions. Lower scores are associated with sexual dysfunction/diminished sexual functioning. Total scores <=47 (men) and <=41 (women) indicate global sexual dysfunction, with all phases of the sexual response cycle being affected.|Units on a scale|Mean|35.4|35.4|Standard Deviation|9.8|9.8|||
4225422|NCT00696774|4048608|B1|||Changes in Sexual Function Questionnaire (CSFQ)|A 14-item patient-rated scale designed to assess medication-related changes in sexual activity/functioning. Items are rated from 1 (never, low enjoyment or pleasure) to 5 (every day/great enjoyment or pleasure). CSFQ measures 5 dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; orgasm. CSFQ total score is obtained across all 5 dimensions. Lower scores are associated with sexual dysfunction/diminished sexual functioning. Total scores <=47 (men) and <=41 (women) indicate global sexual dysfunction, with all phases of the sexual response cycle being affected.|Units on a scale|Mean|35.3|35.3|Standard Deviation|10.3|10.3|||
4225445|NCT00696774|4048607|B2|||17-Item Hamilton Depression Rating Scale (HAMD-17) Retardation Score|The Retardation Subscale (Items 1,7,8,14) evaluates dysfunction in mood, work, and sexual activity, as well as overall motor retardation. Total subscale scores range from 0 (normal) to 14 (severe).|units on a scale|Mean|8.2|8.2|Standard Deviation|1.9|1.9|||
4225423|NCT00696774|4048605|B4|||Brief Pain Inventory - Short Form Interference Score|The BPI-SF interference score asks about the degree to which pain interferes with mood, walking and other physical activity, work, social activity, relations with others, and sleep. BPI-SF interference score ranges from 0 (no interference) to 10 (interferes completely).|Units on a scale|Mean|5.5|5.5|Standard Deviation|1.8|1.8|||
4225424|NCT00696774|4048606|B3|||Brief Pain Inventory - Short Form Interference Score|The BPI-SF interference score asks about the degree to which pain interferes with mood, walking and other physical activity, work, social activity, relations with others, and sleep. BPI-SF interference score ranges from 0 (no interference) to 10 (interferes completely).|Units on a scale|Mean|5.2|5.2|Standard Deviation|1.9|1.9|||
4225425|NCT00696774|4048607|B2|||Brief Pain Inventory - Short Form Interference Score|The BPI-SF interference score asks about the degree to which pain interferes with mood, walking and other physical activity, work, social activity, relations with others, and sleep. BPI-SF interference score ranges from 0 (no interference) to 10 (interferes completely).|Units on a scale|Mean|5.9|5.9|Standard Deviation|1.8|1.8|||
4225426|NCT00696774|4048608|B1|||Brief Pain Inventory - Short Form Interference Score|The BPI-SF interference score asks about the degree to which pain interferes with mood, walking and other physical activity, work, social activity, relations with others, and sleep. BPI-SF interference score ranges from 0 (no interference) to 10 (interferes completely).|Units on a scale|Mean|5.2|5.2|Standard Deviation|1.6|1.6|||
4225427|NCT00696774|4048605|B4|||Brief Pain Inventory - Short Form (BPI-SF) Average Pain Score|A self-reported scale that measures the severity of pain based on the average pain experienced over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|Units on a scale|Mean|4.8|4.8|Standard Deviation|2.0|2.0|||
4225428|NCT00696774|4048606|B3|||Brief Pain Inventory - Short Form (BPI-SF) Average Pain Score|A self-reported scale that measures the severity of pain based on the average pain experienced over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|Units on a scale|Mean|4.4|4.4|Standard Deviation|2.2|2.2|||
4225429|NCT00696774|4048607|B2|||Brief Pain Inventory - Short Form (BPI-SF) Average Pain Score|A self-reported scale that measures the severity of pain based on the average pain experienced over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|Units on a scale|Mean|5.0|5.0|Standard Deviation|2.0|2.0|||
4225430|NCT00696774|4048608|B1|||Brief Pain Inventory - Short Form (BPI-SF) Average Pain Score|A self-reported scale that measures the severity of pain based on the average pain experienced over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|Units on a scale|Mean|4.7|4.7|Standard Deviation|1.9|1.9|||
4225431|NCT00696774|4048605|B4|||Age of First Episode of MDD||years|Mean|34.8|34.8|Standard Deviation|12.6|12.6|||
4225432|NCT00696774|4048606|B3|||Age of First Episode of MDD||years|Mean|36.9|36.9|Standard Deviation|12.8|12.8|||
4225433|NCT00696774|4048607|B2|||Age of First Episode of MDD||years|Mean|33.5|33.5|Standard Deviation|13.6|13.6|||
4225434|NCT00696774|4048608|B1|||Age of First Episode of MDD||years|Mean|35.2|35.2|Standard Deviation|11.7|11.7|||
4225435|NCT00696774|4048605|B4|||17-Item Hamilton Depression Rating Scale (HAMD-17) Total Score|The HAMD-17 measures depression severity. Each item was evaluated and scored using either a 5-point scale (e.g. absent, mild, moderate, severe, very severe) or a 3-point scale (e.g. absent, mild, marked). The total score of HAMD-17 may range from 0 (normal) to 52 (severe).|units on a scale|Mean|21.9|21.9|Standard Deviation|4.6|4.6|||
4225436|NCT00696774|4048606|B3|||17-Item Hamilton Depression Rating Scale (HAMD-17) Total Score|The HAMD-17 measures depression severity. Each item was evaluated and scored using either a 5-point scale (e.g. absent, mild, moderate, severe, very severe) or a 3-point scale (e.g. absent, mild, marked). The total score of HAMD-17 may range from 0 (normal) to 52 (severe).|units on a scale|Mean|20.7|20.7|Standard Deviation|4.5|4.5|||
4225437|NCT00696774|4048607|B2|||17-Item Hamilton Depression Rating Scale (HAMD-17) Total Score|The HAMD-17 measures depression severity. Each item was evaluated and scored using either a 5-point scale (e.g. absent, mild, moderate, severe, very severe) or a 3-point scale (e.g. absent, mild, marked). The total score of HAMD-17 may range from 0 (normal) to 52 (severe).|units on a scale|Mean|23.3|23.3|Standard Deviation|4.5|4.5|||
4225438|NCT00696774|4048608|B1|||17-Item Hamilton Depression Rating Scale (HAMD-17) Total Score|The HAMD-17 measures depression severity. Each item was evaluated and scored using either a 5-point scale (e.g. absent, mild, moderate, severe, very severe) or a 3-point scale (e.g. absent, mild, marked). The total score of HAMD-17 may range from 0 (normal) to 52 (severe).|units on a scale|Mean|21.3|21.3|Standard Deviation|4.5|4.5|||
4225439|NCT00696774|4048605|B4|||17-Item Hamilton Depression Rating Scale (HAMD-17) Sleep Score|The Sleep Subscale (Items 4,5,6) evaluates initial, middle, and late insomnia. Total subscale scores range from 0 (no difficulty) to 6 (difficulty).|units on a scale|Mean|3.2|3.2|Standard Deviation|1.5|1.5|||
4225440|NCT00696774|4048606|B3|||17-Item Hamilton Depression Rating Scale (HAMD-17) Sleep Score|The Sleep Subscale (Items 4,5,6) evaluates initial, middle, and late insomnia. Total subscale scores range from 0 (no difficulty) to 6 (difficulty).|units on a scale|Mean|3.2|3.2|Standard Deviation|1.7|1.7|||
4225441|NCT00696774|4048607|B2|||17-Item Hamilton Depression Rating Scale (HAMD-17) Sleep Score|The Sleep Subscale (Items 4,5,6) evaluates initial, middle, and late insomnia. Total subscale scores range from 0 (no difficulty) to 6 (difficulty).|units on a scale|Mean|3.4|3.4|Standard Deviation|1.4|1.4|||
4225442|NCT00696774|4048608|B1|||17-Item Hamilton Depression Rating Scale (HAMD-17) Sleep Score|The Sleep Subscale (Items 4,5,6) evaluates initial, middle, and late insomnia. Total subscale scores range from 0 (no difficulty) to 6 (difficulty).|units on a scale|Mean|3.1|3.1|Standard Deviation|1.6|1.6|||
4225443|NCT00696774|4048605|B4|||17-Item Hamilton Depression Rating Scale (HAMD-17) Retardation Score|The Retardation Subscale (Items 1,7,8,14) evaluates dysfunction in mood, work, and sexual activity, as well as overall motor retardation. Total subscale scores range from 0 (normal) to 14 (severe).|units on a scale|Mean|7.5|7.5|Standard Deviation|2.1|2.1|||
4225444|NCT00696774|4048606|B3|||17-Item Hamilton Depression Rating Scale (HAMD-17) Retardation Score|The Retardation Subscale (Items 1,7,8,14) evaluates dysfunction in mood, work, and sexual activity, as well as overall motor retardation. Total subscale scores range from 0 (normal) to 14 (severe).|units on a scale|Mean|7.2|7.2|Standard Deviation|2.4|2.4|||
4225446|NCT00696774|4048608|B1|||17-Item Hamilton Depression Rating Scale (HAMD-17) Retardation Score|The Retardation Subscale (Items 1,7,8,14) evaluates dysfunction in mood, work, and sexual activity, as well as overall motor retardation. Total subscale scores range from 0 (normal) to 14 (severe).|units on a scale|Mean|7.1|7.1|Standard Deviation|2.1|2.1|||
4225447|NCT00696774|4048605|B4|||17-Item Hamilton Depression Rating Scale (HAMD-17) Maier Score|"The Maier subscale (Items 1,2,7,8,9,10) represents the core symptoms of depression. Total subscale scores range from 0 (normal) to 24 (severe)."|units on a scale|Mean|11.0|11.0|Standard Deviation|2.7|2.7|||
4225448|NCT00696774|4048606|B3|||17-Item Hamilton Depression Rating Scale (HAMD-17) Maier Score|"The Maier subscale (Items 1,2,7,8,9,10) represents the core symptoms of depression. Total subscale scores range from 0 (normal) to 24 (severe)."|units on a scale|Mean|10.0|10.0|Standard Deviation|2.7|2.7|||
4225449|NCT00696774|4048607|B2|||17-Item Hamilton Depression Rating Scale (HAMD-17) Maier Score|"The Maier subscale (Items 1,2,7,8,9,10) represents the core symptoms of depression. Total subscale scores range from 0 (normal) to 24 (severe)."|units on a scale|Mean|11.7|11.7|Standard Deviation|2.6|2.6|||
4225450|NCT00696774|4048608|B1|||17-Item Hamilton Depression Rating Scale (HAMD-17) Maier Score|"The Maier subscale (Items 1,2,7,8,9,10) represents the core symptoms of depression. Total subscale scores range from 0 (normal) to 24 (severe)."|units on a scale|Mean|10.7|10.7|Standard Deviation|2.6|2.6|||
4225451|NCT00696774|4048605|B4|||17-Item Hamilton Depression Rating Scale (HAMD-17) Core Score|"The Core subscale (Items 1,2,3,7,8) evaluates core symptoms of depression. Total subscale scores range from 0 (normal) to 20 (severe)."|units on a scale|Mean|8.4|8.4|Standard Deviation|2.7|2.7|||
4225452|NCT00696774|4048606|B3|||17-Item Hamilton Depression Rating Scale (HAMD-17) Core Score|"The Core subscale (Items 1,2,3,7,8) evaluates core symptoms of depression. Total subscale scores range from 0 (normal) to 20 (severe)."|units on a scale|Mean|7.9|7.9|Standard Deviation|2.8|2.8|||
4225453|NCT00696774|4048607|B2|||17-Item Hamilton Depression Rating Scale (HAMD-17) Core Score|"The Core subscale (Items 1,2,3,7,8) evaluates core symptoms of depression. Total subscale scores range from 0 (normal) to 20 (severe)."|units on a scale|Mean|9.0|9.0|Standard Deviation|2.6|2.6|||
4225454|NCT00696774|4048608|B1|||17-Item Hamilton Depression Rating Scale (HAMD-17) Core Score|"The Core subscale (Items 1,2,3,7,8) evaluates core symptoms of depression. Total subscale scores range from 0 (normal) to 20 (severe)."|units on a scale|Mean|8.1|8.1|Standard Deviation|2.6|2.6|||
4225455|NCT00696774|4048605|B4|||17-Item Hamilton Depression Rating Scale (HAMD-17) Anxiety/Somatization Score|The Anxiety/Somatization Subscale (Items 10-13, 15, 17) evaluates severity of psychic and somatic manifestations of anxiety as well as agitation. Total subscale scores range from 0 (normal) to 18 (severe).|units on a scale|Mean|7.8|7.8|Standard Deviation|2.0|2.0|||
4225456|NCT00696774|4048606|B3|||17-Item Hamilton Depression Rating Scale (HAMD-17) Anxiety/Somatization Score|The Anxiety/Somatization Subscale (Items 10-13, 15, 17) evaluates severity of psychic and somatic manifestations of anxiety as well as agitation. Total subscale scores range from 0 (normal) to 18 (severe).|units on a scale|Mean|7.4|7.4|Standard Deviation|1.7|1.7|||
4225457|NCT00696774|4048607|B2|||17-Item Hamilton Depression Rating Scale (HAMD-17) Anxiety/Somatization Score|The Anxiety/Somatization Subscale (Items 10-13, 15, 17) evaluates severity of psychic and somatic manifestations of anxiety as well as agitation. Total subscale scores range from 0 (normal) to 18 (severe).|units on a scale|Mean|8.0|8.0|Standard Deviation|2.0|2.0|||
4225458|NCT00696774|4048608|B1|||17-Item Hamilton Depression Rating Scale (HAMD-17) Anxiety/Somatization Score|The Anxiety/Somatization Subscale (Items 10-13, 15, 17) evaluates severity of psychic and somatic manifestations of anxiety as well as agitation. Total subscale scores range from 0 (normal) to 18 (severe).|units on a scale|Mean|7.7|7.7|Standard Deviation|2.1|2.1|||
4225459|NCT00696774|4048605|B4|Missing or Unknown||Previous Treatment|Previous selective serotonin reuptake inhibitor (SSRI) or serotonin norepinephrine reuptake inhibitor (SNRI) treatment.|participants|Number|4|4.0||||||
4225460|NCT00696774|4048606|B3|Missing or Unknown||Previous Treatment|Previous selective serotonin reuptake inhibitor (SSRI) or serotonin norepinephrine reuptake inhibitor (SNRI) treatment.|participants|Number|2|2.0||||||
4225461|NCT00696774|4048607|B2|Missing or Unknown||Previous Treatment|Previous selective serotonin reuptake inhibitor (SSRI) or serotonin norepinephrine reuptake inhibitor (SNRI) treatment.|participants|Number|1|1.0||||||
4225462|NCT00696774|4048608|B1|Missing or Unknown||Previous Treatment|Previous selective serotonin reuptake inhibitor (SSRI) or serotonin norepinephrine reuptake inhibitor (SNRI) treatment.|participants|Number|1|1.0||||||
4225463|NCT00696774|4048605|B4|SNRI||Previous Treatment|Previous selective serotonin reuptake inhibitor (SSRI) or serotonin norepinephrine reuptake inhibitor (SNRI) treatment.|participants|Number|61|61.0||||||
4225464|NCT00696774|4048606|B3|SNRI||Previous Treatment|Previous selective serotonin reuptake inhibitor (SSRI) or serotonin norepinephrine reuptake inhibitor (SNRI) treatment.|participants|Number|9|9.0||||||
4225465|NCT00696774|4048607|B2|SNRI||Previous Treatment|Previous selective serotonin reuptake inhibitor (SSRI) or serotonin norepinephrine reuptake inhibitor (SNRI) treatment.|participants|Number|21|21.0||||||
4225466|NCT00696774|4048608|B1|SNRI||Previous Treatment|Previous selective serotonin reuptake inhibitor (SSRI) or serotonin norepinephrine reuptake inhibitor (SNRI) treatment.|participants|Number|31|31.0||||||
4225467|NCT00696774|4048605|B4|SSRI||Previous Treatment|Previous selective serotonin reuptake inhibitor (SSRI) or serotonin norepinephrine reuptake inhibitor (SNRI) treatment.|participants|Number|177|177.0||||||
4225468|NCT00696774|4048606|B3|SSRI||Previous Treatment|Previous selective serotonin reuptake inhibitor (SSRI) or serotonin norepinephrine reuptake inhibitor (SNRI) treatment.|participants|Number|25|25.0||||||
4225469|NCT00696774|4048607|B2|SSRI||Previous Treatment|Previous selective serotonin reuptake inhibitor (SSRI) or serotonin norepinephrine reuptake inhibitor (SNRI) treatment.|participants|Number|69|69.0||||||
4225470|NCT00696774|4048608|B1|SSRI||Previous Treatment|Previous selective serotonin reuptake inhibitor (SSRI) or serotonin norepinephrine reuptake inhibitor (SNRI) treatment.|participants|Number|83|83.0||||||
4225471|NCT00696774|4048605|B4|No||Had at Least One Historical Illness||participants|Number|151|151.0||||||
4225472|NCT00696774|4048606|B3|No||Had at Least One Historical Illness||participants|Number|21|21.0||||||
4225473|NCT00696774|4048607|B2|No||Had at Least One Historical Illness||participants|Number|59|59.0||||||
4225475|NCT00696774|4048605|B4|Yes||Had at Least One Historical Illness||participants|Number|91|91.0||||||
4225476|NCT00696774|4048606|B3|Yes||Had at Least One Historical Illness||participants|Number|15|15.0||||||
4225477|NCT00696774|4048607|B2|Yes||Had at Least One Historical Illness||participants|Number|32|32.0||||||
4225478|NCT00696774|4048608|B1|Yes||Had at Least One Historical Illness||participants|Number|44|44.0||||||
4225479|NCT00696774|4048605|B4|No||Had Previous MDD in the Past 24 Months||participants|Number|85|85.0||||||
4225480|NCT00696774|4048606|B3|No||Had Previous MDD in the Past 24 Months||participants|Number|12|12.0||||||
4225481|NCT00696774|4048607|B2|No||Had Previous MDD in the Past 24 Months||participants|Number|37|37.0||||||
4225482|NCT00696774|4048608|B1|No||Had Previous MDD in the Past 24 Months||participants|Number|36|36.0||||||
4225483|NCT00696774|4048605|B4|Yes||Had Previous MDD in the Past 24 Months||participants|Number|157|157.0||||||
4225484|NCT00696774|4048606|B3|Yes||Had Previous MDD in the Past 24 Months||participants|Number|24|24.0||||||
4225485|NCT00696774|4048607|B2|Yes||Had Previous MDD in the Past 24 Months||participants|Number|54|54.0||||||
4225486|NCT00696774|4048608|B1|Yes||Had Previous MDD in the Past 24 Months||participants|Number|79|79.0||||||
4225487|NCT00696774|4048605|B4|No||Had Major Depressive Disorder (MDD) Hospitalizations in the Past 24 Months||participants|Number|227|227.0||||||
4225488|NCT00696774|4048606|B3|No||Had Major Depressive Disorder (MDD) Hospitalizations in the Past 24 Months||participants|Number|34|34.0||||||
4225489|NCT00696774|4048607|B2|No||Had Major Depressive Disorder (MDD) Hospitalizations in the Past 24 Months||participants|Number|86|86.0||||||
4225490|NCT00696774|4048608|B1|No||Had Major Depressive Disorder (MDD) Hospitalizations in the Past 24 Months||participants|Number|107|107.0||||||
4225491|NCT00696774|4048605|B4|Yes||Had Major Depressive Disorder (MDD) Hospitalizations in the Past 24 Months||participants|Number|15|15.0||||||
4225492|NCT00696774|4048606|B3|Yes||Had Major Depressive Disorder (MDD) Hospitalizations in the Past 24 Months||participants|Number|2|2.0||||||
4225493|NCT00696774|4048607|B2|Yes||Had Major Depressive Disorder (MDD) Hospitalizations in the Past 24 Months||participants|Number|5|5.0||||||
4225494|NCT00696774|4048608|B1|Yes||Had Major Depressive Disorder (MDD) Hospitalizations in the Past 24 Months||participants|Number|8|8.0||||||
4225495|NCT00696774|4048605|B4|Canada||Region of Enrollment||participants|Number|130|130.0||||||
4225496|NCT00696774|4048606|B3|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4225497|NCT00696774|4048607|B2|Canada||Region of Enrollment||participants|Number|56|56.0||||||
4225498|NCT00696774|4048608|B1|Canada||Region of Enrollment||participants|Number|63|63.0||||||
4225499|NCT00696774|4048605|B4|China||Region of Enrollment||participants|Number|41|41.0||||||
4225500|NCT00696774|4048606|B3|China||Region of Enrollment||participants|Number|3|3.0||||||
4225501|NCT00696774|4048607|B2|China||Region of Enrollment||participants|Number|13|13.0||||||
4225502|NCT00696774|4048608|B1|China||Region of Enrollment||participants|Number|25|25.0||||||
4225503|NCT00696774|4048605|B4|Brazil||Region of Enrollment||participants|Number|33|33.0||||||
4225504|NCT00696774|4048606|B3|Brazil||Region of Enrollment||participants|Number|13|13.0||||||
4225505|NCT00696774|4048607|B2|Brazil||Region of Enrollment||participants|Number|11|11.0||||||
4225506|NCT00696774|4048608|B1|Brazil||Region of Enrollment||participants|Number|9|9.0||||||
4225507|NCT00696774|4048605|B4|Korea, Republic of||Region of Enrollment||participants|Number|38|38.0||||||
4225508|NCT00696774|4048606|B3|Korea, Republic of||Region of Enrollment||participants|Number|9|9.0||||||
4225509|NCT00696774|4048607|B2|Korea, Republic of||Region of Enrollment||participants|Number|11|11.0||||||
4225510|NCT00696774|4048608|B1|Korea, Republic of||Region of Enrollment||participants|Number|18|18.0||||||
4225511|NCT00696774|4048605|B4|West Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4225512|NCT00696774|4048606|B3|West Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4225513|NCT00696774|4048607|B2|West Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4225514|NCT00696774|4048608|B1|West Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4225515|NCT00696774|4048605|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4225516|NCT00696774|4048606|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4225517|NCT00696774|4048607|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4225518|NCT00696774|4048608|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4225519|NCT00696774|4048605|B4|African||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4225520|NCT00696774|4048606|B3|African||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4225521|NCT00696774|4048607|B2|African||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4225522|NCT00696774|4048608|B1|African||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4225523|NCT00696774|4048605|B4|East Asian||Race/Ethnicity, Customized||participants|Number|78|78.0||||||
4225524|NCT00696774|4048606|B3|East Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4225525|NCT00696774|4048607|B2|East Asian||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4225526|NCT00696774|4048608|B1|East Asian||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4225527|NCT00696774|4048605|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|150|150.0||||||
4225528|NCT00696774|4048606|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4225529|NCT00696774|4048607|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
4225530|NCT00696774|4048608|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
4225531|NCT00696774|4048605|B4||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4225532|NCT00696774|4048606|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4225533|NCT00696774|4048607|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4225534|NCT00696774|4048608|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4225535|NCT00696774|4048605|B4||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4225536|NCT00696774|4048606|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4225537|NCT00696774|4048607|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4225538|NCT00696774|4048608|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4225539|NCT00696774|4048605|B4|||Age||years|Mean|44.9|44.9|Standard Deviation|12.5|12.5|||
4225540|NCT00696774|4048606|B3|||Age||years|Mean|47.4|47.4|Standard Deviation|10.6|10.6|||
4225541|NCT00696774|4048607|B2|||Age||years|Mean|45.6|45.6|Standard Deviation|12.5|12.5|||
4225542|NCT00696774|4048608|B1|||Age||years|Mean|43.5|43.5|Standard Deviation|12.9|12.9|||
4225543|NCT00696761|4048644|B5|||international prostate symptom score|higher values represent a worse outcome total score range (form 0 to 35)|scores|Mean|19.5|19.5|Standard Deviation|6.95|6.95|||
4225544|NCT00696761|4048645|B4|||international prostate symptom score|higher values represent a worse outcome total score range (form 0 to 35)|scores|Mean|21.0|21.0|Standard Deviation|6.5|6.5|||
4225545|NCT00696761|4048646|B3|||international prostate symptom score|higher values represent a worse outcome total score range (form 0 to 35)|scores|Mean|19.4|19.4|Standard Deviation|6.9|6.9|||
4225546|NCT00696761|4048647|B2|||international prostate symptom score|higher values represent a worse outcome total score range (form 0 to 35)|scores|Mean|18.8|18.8|Standard Deviation|6.8|6.8|||
4225547|NCT00696761|4048648|B1|||international prostate symptom score|higher values represent a worse outcome total score range (form 0 to 35)|scores|Mean|18.9|18.9|Standard Deviation|7.6|7.6|||
4225548|NCT00696761|4048644|B5|Korea, Republic of||Region of Enrollment||participants|Number|232|232.0||||||
4225549|NCT00696761|4048645|B4|Korea, Republic of||Region of Enrollment||participants|Number|76|76.0||||||
4225550|NCT00696761|4048646|B3|Korea, Republic of||Region of Enrollment||participants|Number|61|61.0||||||
4225551|NCT00696761|4048647|B2|Korea, Republic of||Region of Enrollment||participants|Number|54|54.0||||||
4225552|NCT00696761|4048648|B1|Korea, Republic of||Region of Enrollment||participants|Number|41|41.0||||||
4225553|NCT00696761|4048644|B5||Male|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
4225554|NCT00696761|4048645|B4||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4225555|NCT00696761|4048646|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4225556|NCT00696761|4048647|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4225557|NCT00696761|4048648|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4225558|NCT00696761|4048644|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225559|NCT00696761|4048645|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225560|NCT00696761|4048646|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225561|NCT00696761|4048647|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225562|NCT00696761|4048648|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225563|NCT00696761|4048644|B5|||Age||years|Mean|65.7|65.7|Standard Deviation|7.3|7.3|||
4225564|NCT00696761|4048645|B4|||Age||years|Mean|63.1|63.1|Standard Deviation|5|5.0|||
4225565|NCT00696761|4048646|B3|||Age||years|Mean|66.0|66.0|Standard Deviation|1.2|1.2|||
4225566|NCT00696761|4048647|B2|||Age||years|Mean|67.4|67.4|Standard Deviation|0|0.0|||
4225567|NCT00696761|4048648|B1|||Age||years|Mean|67.0|67.0|Standard Deviation|2.0|2.0|||
4225568|NCT00696761|4048644|B5||>=65 years|Age||Participants|Count of Participants|192|192.0||||||
4225569|NCT00696761|4048645|B4||>=65 years|Age||Participants|Count of Participants|66|66.0||||||
4225570|NCT00696761|4048646|B3||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
4225571|NCT00696761|4048647|B2||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
4225572|NCT00696761|4048648|B1||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4225573|NCT00696761|4048644|B5||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4225574|NCT00696761|4048645|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4225575|NCT00696761|4048646|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4225576|NCT00696761|4048647|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4225577|NCT00696761|4048648|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4225578|NCT00696761|4048644|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4225579|NCT00696761|4048645|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4225580|NCT00696761|4048646|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4225581|NCT00696761|4048647|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4225582|NCT00696761|4048648|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4225583|NCT00696696|4048665|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4225584|NCT00696696|4048665|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4225585|NCT00696696|4048665|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4225586|NCT00696696|4048665|B1|||Age||years|Median|64|64.0|Full Range|9|9.0|45.0|84.0|
4225587|NCT00696696|4048665|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4225588|NCT00696696|4048665|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4225589|NCT00696696|4048665|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4225590|NCT00696657|4048671|B10|||Pulse||Beats/min|Mean|73.5|73.5|Standard Deviation|9.2|9.2|||
4225591|NCT00696657|4048672|B9|||Pulse||Beats/min|Mean|74.6|74.6|Standard Deviation|10.8|10.8|||
4225592|NCT00696657|4048673|B8|||Pulse||Beats/min|Mean|72.3|72.3|Standard Deviation|7.5|7.5|||
4225593|NCT00696657|4048674|B7|||Pulse||Beats/min|Mean|73.9|73.9|Standard Deviation|9.7|9.7|||
4225594|NCT00696657|4048675|B6|||Pulse||Beats/min|Mean|74.2|74.2|Standard Deviation|10.2|10.2|||
4225595|NCT00696657|4048676|B5|||Pulse||Beats/min|Mean|74.7|74.7|Standard Deviation|8.7|8.7|||
4225596|NCT00696657|4048677|B4|||Pulse||Beats/min|Mean|74.3|74.3|Standard Deviation|9.2|9.2|||
4225597|NCT00696657|4048678|B3|||Pulse||Beats/min|Mean|72.8|72.8|Standard Deviation|9.0|9.0|||
4225598|NCT00696657|4048679|B2|||Pulse||Beats/min|Mean|74.2|74.2|Standard Deviation|8.0|8.0|||
4225599|NCT00696657|4048680|B1|||Pulse||Beats/min|Mean|70.4|70.4|Standard Deviation|9.2|9.2|||
4225600|NCT00696657|4048671|B10|||Diastolic blood pressure (DBP)||mmHg|Mean|79.9|79.9|Standard Deviation|8.1|8.1|||
4225601|NCT00696657|4048672|B9|||Diastolic blood pressure (DBP)||mmHg|Mean|78.9|78.9|Standard Deviation|7.7|7.7|||
4225602|NCT00696657|4048673|B8|||Diastolic blood pressure (DBP)||mmHg|Mean|80.0|80.0|Standard Deviation|9.2|9.2|||
4225603|NCT00696657|4048674|B7|||Diastolic blood pressure (DBP)||mmHg|Mean|80.9|80.9|Standard Deviation|8.9|8.9|||
4225604|NCT00696657|4048675|B6|||Diastolic blood pressure (DBP)||mmHg|Mean|79.4|79.4|Standard Deviation|9.3|9.3|||
4225605|NCT00696657|4048676|B5|||Diastolic blood pressure (DBP)||mmHg|Mean|80.8|80.8|Standard Deviation|7.9|7.9|||
4225606|NCT00696657|4048677|B4|||Diastolic blood pressure (DBP)||mmHg|Mean|81.9|81.9|Standard Deviation|7.5|7.5|||
4225607|NCT00696657|4048678|B3|||Diastolic blood pressure (DBP)||mmHg|Mean|79.3|79.3|Standard Deviation|7.6|7.6|||
4225608|NCT00696657|4048679|B2|||Diastolic blood pressure (DBP)||mmHg|Mean|79.1|79.1|Standard Deviation|6.5|6.5|||
4225609|NCT00696657|4048680|B1|||Diastolic blood pressure (DBP)||mmHg|Mean|79.1|79.1|Standard Deviation|8.3|8.3|||
4225610|NCT00696657|4048671|B10|||Systolic blood pressure (SBP)||mmHg|Mean|130.7|130.7|Standard Deviation|12.5|12.5|||
4225611|NCT00696657|4048672|B9|||Systolic blood pressure (SBP)||mmHg|Mean|130.4|130.4|Standard Deviation|13.9|13.9|||
4225612|NCT00696657|4048673|B8|||Systolic blood pressure (SBP)||mmHg|Mean|128.0|128.0|Standard Deviation|10.2|10.2|||
4225613|NCT00696657|4048674|B7|||Systolic blood pressure (SBP)||mmHg|Mean|131.1|131.1|Standard Deviation|10.7|10.7|||
4225614|NCT00696657|4048675|B6|||Systolic blood pressure (SBP)||mmHg|Mean|130.3|130.3|Standard Deviation|13.0|13.0|||
4225615|NCT00696657|4048676|B5|||Systolic blood pressure (SBP)||mmHg|Mean|132.6|132.6|Standard Deviation|13.3|13.3|||
4225616|NCT00696657|4048677|B4|||Systolic blood pressure (SBP)||mmHg|Mean|134.0|134.0|Standard Deviation|12.9|12.9|||
4225617|NCT00696657|4048678|B3|||Systolic blood pressure (SBP)||mmHg|Mean|129.3|129.3|Standard Deviation|13.4|13.4|||
4225618|NCT00696657|4048679|B2|||Systolic blood pressure (SBP)||mmHg|Mean|129.4|129.4|Standard Deviation|11.6|11.6|||
4225619|NCT00696657|4048680|B1|||Systolic blood pressure (SBP)||mmHg|Mean|130.9|130.9|Standard Deviation|13.1|13.1|||
4225620|NCT00696657|4048671|B10|||Glycosylated haemoglobin (HbA1c)||Percentage (%) of HbA1c|Mean|8.1|8.1|Standard Deviation|0.8|0.8|||
4225621|NCT00696657|4048672|B9|||Glycosylated haemoglobin (HbA1c)||Percentage (%) of HbA1c|Mean|8.1|8.1|Standard Deviation|0.7|0.7|||
4225622|NCT00696657|4048673|B8|||Glycosylated haemoglobin (HbA1c)||Percentage (%) of HbA1c|Mean|8.0|8.0|Standard Deviation|0.8|0.8|||
4225623|NCT00696657|4048674|B7|||Glycosylated haemoglobin (HbA1c)||Percentage (%) of HbA1c|Mean|8.0|8.0|Standard Deviation|0.7|0.7|||
4225624|NCT00696657|4048675|B6|||Glycosylated haemoglobin (HbA1c)||Percentage (%) of HbA1c|Mean|8.0|8.0|Standard Deviation|0.8|0.8|||
4225625|NCT00696657|4048676|B5|||Glycosylated haemoglobin (HbA1c)||Percentage (%) of HbA1c|Mean|8.2|8.2|Standard Deviation|0.9|0.9|||
4225626|NCT00696657|4048677|B4|||Glycosylated haemoglobin (HbA1c)||Percentage (%) of HbA1c|Mean|8.1|8.1|Standard Deviation|0.9|0.9|||
4225627|NCT00696657|4048678|B3|||Glycosylated haemoglobin (HbA1c)||Percentage (%) of HbA1c|Mean|8.2|8.2|Standard Deviation|0.9|0.9|||
4225628|NCT00696657|4048679|B2|||Glycosylated haemoglobin (HbA1c)||Percentage (%) of HbA1c|Mean|8.2|8.2|Standard Deviation|0.9|0.9|||
4225629|NCT00696657|4048680|B1|||Glycosylated haemoglobin (HbA1c)||Percentage (%) of HbA1c|Mean|8.1|8.1|Standard Deviation|0.8|0.8|||
4225630|NCT00696657|4048671|B10||Male|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
4225631|NCT00696657|4048672|B9||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4225632|NCT00696657|4048673|B8||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4225633|NCT00696657|4048674|B7||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4225634|NCT00696657|4048675|B6||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4225635|NCT00696657|4048676|B5||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4225636|NCT00696657|4048677|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4225637|NCT00696657|4048678|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4225638|NCT00696657|4048679|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4225639|NCT00696657|4048680|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4225640|NCT00696657|4048671|B10||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4225641|NCT00696657|4048672|B9||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4225642|NCT00696657|4048673|B8||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4225643|NCT00696657|4048674|B7||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4225644|NCT00696657|4048675|B6||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4225645|NCT00696657|4048676|B5||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4225646|NCT00696657|4048677|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4225647|NCT00696657|4048678|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4225648|NCT00696657|4048679|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4225649|NCT00696657|4048680|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4225650|NCT00696657|4048671|B10|||Age||Years|Mean|55.0|55.0|Standard Deviation|9.8|9.8|||
4225651|NCT00696657|4048672|B9|||Age||Years|Mean|54.3|54.3|Standard Deviation|10.1|10.1|||
4225652|NCT00696657|4048673|B8|||Age||Years|Mean|54.8|54.8|Standard Deviation|9.2|9.2|||
4225653|NCT00696657|4048674|B7|||Age||Years|Mean|56.4|56.4|Standard Deviation|10.5|10.5|||
4225654|NCT00696657|4048675|B6|||Age||Years|Mean|55.9|55.9|Standard Deviation|7.9|7.9|||
4225655|NCT00696657|4048676|B5|||Age||Years|Mean|55.0|55.0|Standard Deviation|9.7|9.7|||
4225656|NCT00696657|4048677|B4|||Age||Years|Mean|53.8|53.8|Standard Deviation|10.2|10.2|||
4225657|NCT00696657|4048678|B3|||Age||Years|Mean|54.7|54.7|Standard Deviation|10.0|10.0|||
4225658|NCT00696657|4048679|B2|||Age||Years|Mean|55.2|55.2|Standard Deviation|10.1|10.1|||
4225659|NCT00696657|4048680|B1|||Age||Years|Mean|55.3|55.3|Standard Deviation|10.6|10.6|||
4225660|NCT00696618|4049012|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4225661|NCT00696618|4049013|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4225662|NCT00696618|4049014|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4225663|NCT00696618|4049015|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4225664|NCT00696618|4049012|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225665|NCT00696618|4049013|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225666|NCT00696618|4049014|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225667|NCT00696618|4049015|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225668|NCT00696618|4049012|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4225669|NCT00696618|4049013|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4225670|NCT00696618|4049014|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4225671|NCT00696618|4049015|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4225672|NCT00696618|4049012|B4||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4225673|NCT00696618|4049013|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4225674|NCT00696618|4049014|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4225675|NCT00696618|4049015|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4225676|NCT00696618|4049012|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4225677|NCT00696618|4049013|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4225678|NCT00696618|4049014|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4225679|NCT00696618|4049015|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4225680|NCT00696488|4049031|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4225681|NCT00696488|4049031|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4225682|NCT00696488|4049031|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4225683|NCT00696488|4049031|B1|||Age||years|Mean|67|67.0|Full Range|||51.0|91.0|
4225684|NCT00696449|4049035|B5|United States||Region of Enrollment||participants|Number|61|61.0||||||
4225685|NCT00696449|4049036|B4|United States||Region of Enrollment||participants|Number|16|16.0||||||
4225686|NCT00696449|4049037|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4225687|NCT00696449|4049038|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4225688|NCT00696449|4049039|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4225689|NCT00696449|4049035|B5||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4225690|NCT00696449|4049036|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4225691|NCT00696449|4049037|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4225692|NCT00696449|4049038|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4225693|NCT00696449|4049039|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4225694|NCT00696449|4049035|B5||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4225695|NCT00696449|4049036|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4225696|NCT00696449|4049037|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4225697|NCT00696449|4049038|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4225698|NCT00696449|4049039|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4225699|NCT00696449|4049035|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4225700|NCT00696449|4049036|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4225701|NCT00696449|4049037|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4225702|NCT00696449|4049038|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4225703|NCT00696449|4049039|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4225704|NCT00696449|4049035|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4225705|NCT00696449|4049036|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4225706|NCT00696449|4049037|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4225707|NCT00696449|4049038|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4225708|NCT00696449|4049039|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4225709|NCT00696449|4049035|B5||<=18 years|Age||Participants|Count of Participants|61|61.0||||||
4225710|NCT00696449|4049036|B4||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4225711|NCT00696449|4049037|B3||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4225712|NCT00696449|4049038|B2||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4225713|NCT00696449|4049039|B1||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4225714|NCT00696436|4049052|B6||Male|Sex: Female, Male||Participants|Count of Participants|699|699.0||||||
4225715|NCT00696436|4049053|B5||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4225716|NCT00696436|4049054|B4||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4225717|NCT00696436|4049055|B3||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4225718|NCT00696436|4049056|B2||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4225719|NCT00696436|4049057|B1||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4225720|NCT00696436|4049052|B6||Female|Sex: Female, Male||Participants|Count of Participants|592|592.0||||||
4225721|NCT00696436|4049053|B5||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4225722|NCT00696436|4049054|B4||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4225723|NCT00696436|4049055|B3||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4225724|NCT00696436|4049056|B2||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4225725|NCT00696436|4049057|B1||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4225726|NCT00696436|4049052|B6|≥65 years||Age||participants|Number|282|282.0||||||
4225727|NCT00696436|4049053|B5|≥65 years||Age||participants|Number|36|36.0||||||
4225728|NCT00696436|4049054|B4|≥65 years||Age||participants|Number|66|66.0||||||
4225729|NCT00696436|4049055|B3|≥65 years||Age||participants|Number|48|48.0||||||
4225730|NCT00696436|4049056|B2|≥65 years||Age||participants|Number|63|63.0||||||
4225731|NCT00696436|4049057|B1|≥65 years||Age||participants|Number|69|69.0||||||
4225732|NCT00696436|4049052|B6|Between 45 and 64 years||Age||participants|Number|815|815.0||||||
4225733|NCT00696436|4049053|B5|Between 45 and 64 years||Age||participants|Number|98|98.0||||||
4225734|NCT00696436|4049054|B4|Between 45 and 64 years||Age||participants|Number|185|185.0||||||
4225735|NCT00696436|4049055|B3|Between 45 and 64 years||Age||participants|Number|178|178.0||||||
4225736|NCT00696436|4049056|B2|Between 45 and 64 years||Age||participants|Number|184|184.0||||||
4225737|NCT00696436|4049057|B1|Between 45 and 64 years||Age||participants|Number|170|170.0||||||
4225738|NCT00696436|4049052|B6|<45 years||Age||participants|Number|194|194.0||||||
4225739|NCT00696436|4049053|B5|<45 years||Age||participants|Number|20|20.0||||||
4225740|NCT00696436|4049054|B4|<45 years||Age||participants|Number|39|39.0||||||
4225741|NCT00696436|4049055|B3|<45 years||Age||participants|Number|56|56.0||||||
4225742|NCT00696436|4049056|B2|<45 years||Age||participants|Number|38|38.0||||||
4225743|NCT00696436|4049057|B1|<45 years||Age||participants|Number|41|41.0||||||
4225744|NCT00696423|4049143|B3||Male|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
4225745|NCT00696423|4049144|B2||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4225746|NCT00696423|4049145|B1||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4225747|NCT00696423|4049143|B3||Female|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
4225748|NCT00696423|4049144|B2||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4225749|NCT00696423|4049145|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4225750|NCT00696423|4049143|B3|||Age||months|Mean|19.2|19.2|Standard Deviation|0.77|0.77|||
4225751|NCT00696423|4049144|B2|||Age||months|Mean|19.2|19.2|Standard Deviation|0.75|0.75|||
4225752|NCT00696423|4049145|B1|||Age||months|Mean|19.2|19.2|Standard Deviation|0.79|0.79|||
4225753|NCT00696410|4049176|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
4225754|NCT00696410|4049177|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4225755|NCT00696410|4049178|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4225756|NCT00696410|4049176|B3|Male||Sex/Gender, Customized||participants|Number|22|22.0||||||
4225757|NCT00696410|4049177|B2|Male||Sex/Gender, Customized||participants|Number|4|4.0||||||
4225758|NCT00696410|4049178|B1|Male||Sex/Gender, Customized||participants|Number|18|18.0||||||
4225759|NCT00696410|4049176|B3|Female||Sex/Gender, Customized||participants|Number|16|16.0||||||
4225760|NCT00696410|4049177|B2|Female||Sex/Gender, Customized||participants|Number|6|6.0||||||
4225761|NCT00696410|4049178|B1|Female||Sex/Gender, Customized||participants|Number|10|10.0||||||
4225762|NCT00696410|4049176|B3|>=65 years||Age, Customized||participants|Number|9|9.0||||||
4225763|NCT00696410|4049177|B2|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4225764|NCT00696410|4049178|B1|>=65 years||Age, Customized||participants|Number|9|9.0||||||
4225765|NCT00696410|4049176|B3|Between 18 and 64 years||Age, Customized||participants|Number|39|39.0||||||
4225766|NCT00696410|4049177|B2|Between 18 and 64 years||Age, Customized||participants|Number|10|10.0||||||
4225767|NCT00696410|4049178|B1|Between 18 and 64 years||Age, Customized||participants|Number|29|29.0||||||
4225768|NCT00696410|4049176|B3|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4225769|NCT00696410|4049177|B2|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4225770|NCT00696410|4049178|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4225771|NCT00696410|4049176|B3|||Age||years|Mean|55|55.0|Standard Deviation|11|11.0|||
4225772|NCT00696410|4049177|B2|||Age||years|Mean|52|52.0|Standard Deviation|8|8.0|||
4225773|NCT00696410|4049178|B1|||Age||years|Mean|56|56.0|Standard Deviation|11|11.0|||
4225774|NCT00696384|4049193|B1|Male||Sex/Gender, Customized||participants|Number|208|208.0||||||
4225775|NCT00696384|4049193|B1|Female||Sex/Gender, Customized||participants|Number|210|210.0||||||
4225776|NCT00696384|4049193|B1|≥ 65 years||Age, Customized||percentage of participants|Number|10.0|10.0||||||
4225777|NCT00696384|4049193|B1|Between 45 and 64 years||Age, Customized||percentage of participants|Number|68.7|68.7||||||
4225778|NCT00696384|4049193|B1|<45 years||Age, Customized||percentage of participants|Number|21.3|21.3||||||
4225779|NCT00696384|4049193|B1|≥ 65 years||Age, Customized||participants|Number|42|42.0||||||
4225780|NCT00696384|4049193|B1|Between 45 and 64 years||Age, Customized||participants|Number|287|287.0||||||
4225781|NCT00696384|4049193|B1|<45 years||Age, Customized||participants|Number|89|89.0||||||
4225782|NCT00696293|4049209|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4225783|NCT00696293|4049209|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4225784|NCT00696293|4049209|B1|||Age||years|Mean|71.4|71.4|Standard Deviation|7.61|7.61|||
4225785|NCT00696241|4049214|B6||Male|Sex: Female, Male||Participants|Count of Participants|640|640.0||||||
4225786|NCT00696241|4049215|B5||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4225787|NCT00696241|4049216|B4||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4225788|NCT00696241|4049217|B3||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4225789|NCT00696241|4049218|B2||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4225790|NCT00696241|4049219|B1||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4225791|NCT00696241|4049214|B6||Female|Sex: Female, Male||Participants|Count of Participants|635|635.0||||||
4225792|NCT00696241|4049215|B5||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4225793|NCT00696241|4049216|B4||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4225794|NCT00696241|4049217|B3||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4225795|NCT00696241|4049218|B2||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4225796|NCT00696241|4049219|B1||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4225797|NCT00696241|4049214|B6|≥65 years||Age||participants|Number|376|376.0||||||
4225798|NCT00696241|4049215|B5|≥65 years||Age||participants|Number|47|47.0||||||
4225799|NCT00696241|4049216|B4|≥65 years||Age||participants|Number|97|97.0||||||
4225800|NCT00696241|4049217|B3|≥65 years||Age||participants|Number|87|87.0||||||
4225801|NCT00696241|4049218|B2|≥65 years||Age||participants|Number|67|67.0||||||
4225802|NCT00696241|4049219|B1|≥65 years||Age||participants|Number|78|78.0||||||
4225803|NCT00696241|4049214|B6|Between 45 and 64 years||Age||participants|Number|758|758.0||||||
4225804|NCT00696241|4049215|B5|Between 45 and 64 years||Age||participants|Number|84|84.0||||||
4225805|NCT00696241|4049216|B4|Between 45 and 64 years||Age||participants|Number|153|153.0||||||
4225806|NCT00696241|4049217|B3|Between 45 and 64 years||Age||participants|Number|161|161.0||||||
4225807|NCT00696241|4049218|B2|Between 45 and 64 years||Age||participants|Number|187|187.0||||||
4225808|NCT00696241|4049219|B1|Between 45 and 64 years||Age||participants|Number|173|173.0||||||
4225809|NCT00696241|4049214|B6|<45 years||Age||participants|Number|141|141.0||||||
4225810|NCT00696241|4049215|B5|<45 years||Age||participants|Number|11|11.0||||||
4225811|NCT00696241|4049216|B4|<45 years||Age||participants|Number|32|32.0||||||
4225812|NCT00696241|4049217|B3|<45 years||Age||participants|Number|37|37.0||||||
4225813|NCT00696241|4049218|B2|<45 years||Age||participants|Number|29|29.0||||||
4225814|NCT00696241|4049219|B1|<45 years||Age||participants|Number|32|32.0||||||
4225815|NCT00696137|4049305|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225816|NCT00696137|4049305|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225817|NCT00696137|4049305|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4225818|NCT00696137|4049305|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225819|NCT00696137|4049305|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225820|NCT00696137|4049305|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225821|NCT00696137|4049305|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225822|NCT00696137|4049305|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225823|NCT00696137|4049305|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4225824|NCT00696137|4049305|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4225825|NCT00696137|4049305|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4225826|NCT00696137|4049305|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4225827|NCT00696072|4049309|B3|United States||Region of Enrollment||participants|Number|120|120.0||||||
4225828|NCT00696072|4049310|B2|United States||Region of Enrollment||participants|Number|63|63.0||||||
4225829|NCT00696072|4049311|B1|United States||Region of Enrollment||participants|Number|57|57.0||||||
4225830|NCT00696072|4049309|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225831|NCT00696072|4049310|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225832|NCT00696072|4049311|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225833|NCT00696072|4049309|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4225834|NCT00696072|4049310|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4225835|NCT00696072|4049311|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4225836|NCT00696072|4049309|B3|Greater than or equal to 65 years||Age, Customized||participants|Number|53|53.0||||||
4225837|NCT00696072|4049310|B2|Greater than or equal to 65 years||Age, Customized||participants|Number|29|29.0||||||
4225838|NCT00696072|4049311|B1|Greater than or equal to 65 years||Age, Customized||participants|Number|24|24.0||||||
4225839|NCT00696072|4049309|B3|Less than 65 years||Age, Customized||participants|Number|67|67.0||||||
4225840|NCT00696072|4049310|B2|Less than 65 years||Age, Customized||participants|Number|34|34.0||||||
4225841|NCT00696072|4049311|B1|Less than 65 years||Age, Customized||participants|Number|33|33.0||||||
4225842|NCT00696020|4049329|B5||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4225843|NCT00696020|4049330|B4||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4225844|NCT00696020|4049331|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4225845|NCT00696020|4049332|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4225846|NCT00696020|4049333|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4225847|NCT00696020|4049329|B5||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4225848|NCT00696020|4049330|B4||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4225849|NCT00696020|4049331|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4225850|NCT00696020|4049332|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4225851|NCT00696020|4049333|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4225852|NCT00696020|4049329|B5|||Age||years|Mean|63.30|63.3|Standard Deviation|9.07|9.07|||
4225853|NCT00696020|4049330|B4|||Age||years|Mean|62.66|62.66|Standard Deviation|8.86|8.86|||
4225854|NCT00696020|4049331|B3|||Age||years|Mean|64.19|64.19|Standard Deviation|9.59|9.59|||
4225855|NCT00696020|4049332|B2|||Age||years|Mean|64.44|64.44|Standard Deviation|9.18|9.18|||
4225856|NCT00696020|4049333|B1|||Age||years|Mean|61.87|61.87|Standard Deviation|8.50|8.5|||
4225857|NCT00695955|4049444|B1|Male (Cohort 2)||Sex/Gender, Customized||participants|Number|163|163.0||||||
4225858|NCT00695955|4049444|B1|Female (Cohort 2)||Sex/Gender, Customized||participants|Number|144|144.0||||||
4225859|NCT00695955|4049444|B1|Male (Cohort 1)||Sex/Gender, Customized||participants|Number|189|189.0||||||
4225860|NCT00695955|4049444|B1|Female (Cohort 1)||Sex/Gender, Customized||participants|Number|173|173.0||||||
4225861|NCT00695955|4049444|B1|≥65 years (Cohort 2)||Age, Customized||participants|Number|24|24.0||||||
4225862|NCT00695955|4049444|B1|Between 45 and 64 years (Cohort 2)||Age, Customized||participants|Number|193|193.0||||||
4225863|NCT00695955|4049444|B1|<45 years (Cohort 2)||Age, Customized||participants|Number|90|90.0||||||
4225864|NCT00695955|4049444|B1|≥65 years (Cohort 1)||Age, Customized||participants|Number|48|48.0||||||
4225865|NCT00695955|4049444|B1|Between 45 and 64 years (Cohort 1)||Age, Customized||participants|Number|233|233.0||||||
4225866|NCT00695955|4049444|B1|<45 years (Cohort 1)||Age, Customized||participants|Number|81|81.0||||||
4225867|NCT00695903|4049454|B3||Male|Sex: Female, Male|Safety Population. Two patients in the high-dose vancomycin arm were randomized but not treated and therefore not included in the safety population.|Participants|Count of Participants|26|26.0||||||
4225868|NCT00695903|4049455|B2||Male|Sex: Female, Male|Safety Population. Two patients in the high-dose vancomycin arm were randomized but not treated and therefore not included in the safety population.|Participants|Count of Participants|13|13.0||||||
4225869|NCT00695903|4049456|B1||Male|Sex: Female, Male|Safety Population. Two patients in the high-dose vancomycin arm were randomized but not treated and therefore not included in the safety population.|Participants|Count of Participants|13|13.0||||||
4225870|NCT00695903|4049454|B3||Female|Sex: Female, Male|Safety Population. Two patients in the high-dose vancomycin arm were randomized but not treated and therefore not included in the safety population.|Participants|Count of Participants|10|10.0||||||
4225871|NCT00695903|4049455|B2||Female|Sex: Female, Male|Safety Population. Two patients in the high-dose vancomycin arm were randomized but not treated and therefore not included in the safety population.|Participants|Count of Participants|4|4.0||||||
4225872|NCT00695903|4049456|B1||Female|Sex: Female, Male|Safety Population. Two patients in the high-dose vancomycin arm were randomized but not treated and therefore not included in the safety population.|Participants|Count of Participants|6|6.0||||||
4225873|NCT00695903|4049454|B3||>=65 years|Age|Safety Population. Two patients in the high-dose vancomycin arm were randomized but not treated and therefore not included in the safety population.|Participants|Count of Participants|5|5.0||||||
4225874|NCT00695903|4049455|B2||>=65 years|Age|Safety Population. Two patients in the high-dose vancomycin arm were randomized but not treated and therefore not included in the safety population.|Participants|Count of Participants|2|2.0||||||
4225875|NCT00695903|4049456|B1||>=65 years|Age|Safety Population. Two patients in the high-dose vancomycin arm were randomized but not treated and therefore not included in the safety population.|Participants|Count of Participants|3|3.0||||||
4225876|NCT00695903|4049454|B3||Between 18 and 65 years|Age|Safety Population. Two patients in the high-dose vancomycin arm were randomized but not treated and therefore not included in the safety population.|Participants|Count of Participants|31|31.0||||||
4225877|NCT00695903|4049455|B2||Between 18 and 65 years|Age|Safety Population. Two patients in the high-dose vancomycin arm were randomized but not treated and therefore not included in the safety population.|Participants|Count of Participants|15|15.0||||||
4225878|NCT00695903|4049456|B1||Between 18 and 65 years|Age|Safety Population. Two patients in the high-dose vancomycin arm were randomized but not treated and therefore not included in the safety population.|Participants|Count of Participants|16|16.0||||||
4225879|NCT00695903|4049454|B3||<=18 years|Age|Safety Population. Two patients in the high-dose vancomycin arm were randomized but not treated and therefore not included in the safety population.|Participants|Count of Participants|0|0.0||||||
4225880|NCT00695903|4049455|B2||<=18 years|Age|Safety Population. Two patients in the high-dose vancomycin arm were randomized but not treated and therefore not included in the safety population.|Participants|Count of Participants|0|0.0||||||
4225881|NCT00695903|4049456|B1||<=18 years|Age|Safety Population. Two patients in the high-dose vancomycin arm were randomized but not treated and therefore not included in the safety population.|Participants|Count of Participants|0|0.0||||||
4225882|NCT00695864|4049469|B1|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4225883|NCT00695864|4049469|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4225884|NCT00695864|4049469|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4225885|NCT00695864|4049469|B1|||Age||years|Mean|42.8|42.8|Full Range|||27.0|55.0|
4225886|NCT00695669|4049475|B5||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4225887|NCT00695669|4049476|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4225888|NCT00695669|4049477|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4225889|NCT00695669|4049478|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4225890|NCT00695669|4049479|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4225891|NCT00695669|4049475|B5||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4225892|NCT00695669|4049476|B4||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4225893|NCT00695669|4049477|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4225894|NCT00695669|4049478|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4225895|NCT00695669|4049479|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4225896|NCT00695669|4049475|B5|||Age||Years|Mean|40.3|40.3|Standard Deviation|13.64|13.64|||
4225897|NCT00695669|4049476|B4|||Age||Years|Mean|40.7|40.7|Standard Deviation|13.22|13.22|||
4225898|NCT00695669|4049477|B3|||Age||Years|Mean|40.8|40.8|Standard Deviation|13.87|13.87|||
4225899|NCT00695669|4049478|B2|||Age||Years|Mean|39.7|39.7|Standard Deviation|13.81|13.81|||
4225900|NCT00695669|4049479|B1|||Age||Years|Mean|40.2|40.2|Standard Deviation|13.88|13.88|||
4225901|NCT00695578|4049556|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4225902|NCT00695578|4049557|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4225903|NCT00695578|4049558|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4225904|NCT00695578|4049556|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225905|NCT00695578|4049557|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225906|NCT00695578|4049558|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225907|NCT00695578|4049556|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225908|NCT00695578|4049557|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225909|NCT00695578|4049558|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225910|NCT00695578|4049556|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4225911|NCT00695578|4049557|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4225912|NCT00695578|4049558|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4225913|NCT00695578|4049556|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225914|NCT00695578|4049557|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225915|NCT00695578|4049558|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225916|NCT00695578|4049556|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225917|NCT00695578|4049557|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225918|NCT00695578|4049558|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225919|NCT00695578|4049556|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225920|NCT00695578|4049557|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225921|NCT00695578|4049558|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225922|NCT00695578|4049556|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225923|NCT00695578|4049557|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225924|NCT00695578|4049558|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225925|NCT00695578|4049556|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4225926|NCT00695578|4049557|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4225927|NCT00695578|4049558|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4225928|NCT00695578|4049556|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4225929|NCT00695578|4049557|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4225930|NCT00695578|4049558|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4225931|NCT00695578|4049556|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4225932|NCT00695578|4049557|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4225933|NCT00695578|4049558|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4225934|NCT00695578|4049556|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4225935|NCT00695578|4049557|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4225936|NCT00695578|4049558|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4225937|NCT00695578|4049556|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4225938|NCT00695578|4049557|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4225939|NCT00695578|4049558|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4225940|NCT00695565|4049565|B3|United States||Region of Enrollment||participants|Number|180|180.0||||||
4225941|NCT00695565|4049566|B2|United States||Region of Enrollment||participants|Number|90|90.0||||||
4225942|NCT00695565|4049567|B1|United States||Region of Enrollment||participants|Number|90|90.0||||||
4225943|NCT00695565|4049565|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4225944|NCT00695565|4049566|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4225945|NCT00695565|4049567|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4225946|NCT00695565|4049565|B3||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4225947|NCT00695565|4049566|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4225948|NCT00695565|4049567|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4225949|NCT00695565|4049565|B3|||Age||years|Mean|58.5|58.5|Standard Deviation|9.7|9.7|||
4225950|NCT00695565|4049566|B2|||Age||years|Mean|59.4|59.4|Standard Deviation|9.9|9.9|||
4225951|NCT00695565|4049567|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|9.5|9.5|||
4225952|NCT00695500|4049600|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225953|NCT00695500|4049601|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225954|NCT00695500|4049602|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225955|NCT00695500|4049600|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4225956|NCT00695500|4049601|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4225957|NCT00695500|4049602|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225958|NCT00695500|4049600|B3||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4225959|NCT00695500|4049601|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4225960|NCT00695500|4049602|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4225961|NCT00695500|4049600|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4225962|NCT00695500|4049601|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4225963|NCT00695500|4049602|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4225964|NCT00695500|4049600|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225965|NCT00695500|4049601|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225966|NCT00695500|4049602|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225967|NCT00695500|4049600|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4225968|NCT00695500|4049601|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225969|NCT00695500|4049602|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4225970|NCT00695500|4049600|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225971|NCT00695500|4049601|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225972|NCT00695500|4049602|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225973|NCT00695500|4049600|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225974|NCT00695500|4049601|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225975|NCT00695500|4049602|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4225976|NCT00695500|4049600|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4225977|NCT00695500|4049601|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4225978|NCT00695500|4049602|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4225979|NCT00695500|4049600|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4225980|NCT00695500|4049601|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4225981|NCT00695500|4049602|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4225982|NCT00695500|4049600|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4225983|NCT00695500|4049601|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4225984|NCT00695500|4049602|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4225985|NCT00695500|4049600|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4225986|NCT00695500|4049601|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4225987|NCT00695500|4049602|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4225988|NCT00695500|4049600|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4225989|NCT00695500|4049601|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4225990|NCT00695500|4049602|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4225991|NCT00695500|4049600|B3||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4225992|NCT00695500|4049601|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4225993|NCT00695500|4049602|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4225994|NCT00695500|4049600|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4225995|NCT00695500|4049601|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4225996|NCT00695500|4049602|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4225997|NCT00695435|4049613|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4225998|NCT00695435|4049613|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4225999|NCT00695435|4049613|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4226000|NCT00695435|4049613|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4226001|NCT00695435|4049613|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226002|NCT00695409|4049626|B1|United States||Region of Enrollment||Participants|Count of Participants|122|122.0||||||
4226003|NCT00695409|4049626|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4226004|NCT00695409|4049626|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4226005|NCT00695409|4049626|B1||White|Race (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
4226006|NCT00695409|4049626|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4226007|NCT00695409|4049626|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4226008|NCT00695409|4049626|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4226009|NCT00695409|4049626|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4226010|NCT00695409|4049626|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4226011|NCT00695409|4049626|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
4226012|NCT00695409|4049626|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4226013|NCT00695409|4049626|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4226014|NCT00695409|4049626|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4226015|NCT00695409|4049626|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4226016|NCT00695409|4049626|B1||Between 18 and 65 years|Age||Participants|Count of Participants|103|103.0||||||
4226017|NCT00695409|4049626|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226018|NCT00695396|4049638|B4|USA||Region of Enrollment||participants|Number|17|17.0||||||
4226019|NCT00695396|4049639|B3|USA||Region of Enrollment||participants|Number|5|5.0||||||
4226020|NCT00695396|4049640|B2|USA||Region of Enrollment||participants|Number|7|7.0||||||
4226021|NCT00695396|4049641|B1|USA||Region of Enrollment||participants|Number|5|5.0||||||
4226022|NCT00695396|4049638|B4|RUSSIA||Region of Enrollment||participants|Number|6|6.0||||||
4226023|NCT00695396|4049639|B3|RUSSIA||Region of Enrollment||participants|Number|4|4.0||||||
4226024|NCT00695396|4049640|B2|RUSSIA||Region of Enrollment||participants|Number|0|0.0||||||
4226025|NCT00695396|4049641|B1|RUSSIA||Region of Enrollment||participants|Number|2|2.0||||||
4226026|NCT00695396|4049638|B4|ITALY||Region of Enrollment||participants|Number|1|1.0||||||
4226027|NCT00695396|4049639|B3|ITALY||Region of Enrollment||participants|Number|0|0.0||||||
4226028|NCT00695396|4049640|B2|ITALY||Region of Enrollment||participants|Number|1|1.0||||||
4226029|NCT00695396|4049641|B1|ITALY||Region of Enrollment||participants|Number|0|0.0||||||
4226030|NCT00695396|4049638|B4|CANADA||Region of Enrollment||participants|Number|1|1.0||||||
4226031|NCT00695396|4049639|B3|CANADA||Region of Enrollment||participants|Number|0|0.0||||||
4226032|NCT00695396|4049640|B2|CANADA||Region of Enrollment||participants|Number|0|0.0||||||
4226033|NCT00695396|4049641|B1|CANADA||Region of Enrollment||participants|Number|1|1.0||||||
4226034|NCT00695396|4049638|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4226035|NCT00695396|4049639|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4226036|NCT00695396|4049640|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4226037|NCT00695396|4049641|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4226038|NCT00695396|4049638|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4226039|NCT00695396|4049639|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4226040|NCT00695396|4049640|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4226041|NCT00695396|4049641|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4226042|NCT00695396|4049638|B4|||Age||years|Mean|72.4|72.4|Standard Deviation|10.44|10.44|||
4226043|NCT00695396|4049639|B3|||Age||years|Mean|67.7|67.7|Standard Deviation|9.89|9.89|||
4226044|NCT00695396|4049640|B2|||Age||years|Mean|77.3|77.3|Standard Deviation|9.78|9.78|||
4226045|NCT00695396|4049641|B1|||Age||years|Mean|73|73.0|Standard Deviation|10.52|10.52|||
4226046|NCT00695396|4049638|B4||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4226047|NCT00695396|4049639|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4226048|NCT00695396|4049640|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4226049|NCT00695396|4049641|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4226050|NCT00695396|4049638|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4226051|NCT00695396|4049639|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4226052|NCT00695396|4049640|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4226053|NCT00695396|4049641|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4226054|NCT00695396|4049638|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226055|NCT00695396|4049639|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226056|NCT00695396|4049640|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226057|NCT00695396|4049641|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226058|NCT00695318|4049657|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4226059|NCT00695318|4049658|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4226060|NCT00695318|4049659|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4226061|NCT00695318|4049657|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4226062|NCT00695318|4049658|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4226063|NCT00695318|4049659|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4226064|NCT00695318|4049657|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4226065|NCT00695318|4049658|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4226066|NCT00695318|4049659|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4226067|NCT00695318|4049657|B3|≥85 years||Age, Customized||participants|Number|7|7.0||||||
4226068|NCT00695318|4049658|B2|≥85 years||Age, Customized||participants|Number|4|4.0||||||
4226069|NCT00695318|4049659|B1|≥85 years||Age, Customized||participants|Number|3|3.0||||||
4226070|NCT00695318|4049657|B3|75-84 years||Age, Customized||participants|Number|7|7.0||||||
4226071|NCT00695318|4049658|B2|75-84 years||Age, Customized||participants|Number|2|2.0||||||
4226072|NCT00695318|4049659|B1|75-84 years||Age, Customized||participants|Number|5|5.0||||||
4226073|NCT00695318|4049657|B3|65-74 years||Age, Customized||participants|Number|2|2.0||||||
4226074|NCT00695318|4049658|B2|65-74 years||Age, Customized||participants|Number|1|1.0||||||
4226075|NCT00695318|4049659|B1|65-74 years||Age, Customized||participants|Number|1|1.0||||||
4226076|NCT00695318|4049657|B3|55-64 years||Age, Customized||participants|Number|1|1.0||||||
4226077|NCT00695318|4049658|B2|55-64 years||Age, Customized||participants|Number|0|0.0||||||
4226078|NCT00695318|4049659|B1|55-64 years||Age, Customized||participants|Number|1|1.0||||||
4226079|NCT00695318|4049657|B3|45-54 years||Age, Customized||participants|Number|0|0.0||||||
4226080|NCT00695318|4049658|B2|45-54 years||Age, Customized||participants|Number|0|0.0||||||
4226081|NCT00695318|4049659|B1|45-54 years||Age, Customized||participants|Number|0|0.0||||||
4226082|NCT00695318|4049657|B3|35-44 years||Age, Customized||participants|Number|0|0.0||||||
4226083|NCT00695318|4049658|B2|35-44 years||Age, Customized||participants|Number|0|0.0||||||
4226084|NCT00695318|4049659|B1|35-44 years||Age, Customized||participants|Number|0|0.0||||||
4226085|NCT00695318|4049657|B3|<35 years||Age, Customized||participants|Number|0|0.0||||||
4226086|NCT00695318|4049658|B2|<35 years||Age, Customized||participants|Number|0|0.0||||||
4226087|NCT00695318|4049659|B1|<35 years||Age, Customized||participants|Number|0|0.0||||||
4226088|NCT00695318|4049657|B3|||Age||years|Mean|81.02|81.02|Standard Deviation|7.799|7.799|||
4226089|NCT00695318|4049658|B2|||Age||years|Mean|82.55|82.55|Standard Deviation|6.056|6.056|||
4226090|NCT00695318|4049659|B1|||Age||years|Mean|79.95|79.95|Standard Deviation|8.976|8.976|||
4226091|NCT00695292|4049671|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4226092|NCT00695292|4049671|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4226093|NCT00695292|4049671|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4226094|NCT00695292|4049671|B1|||Age||years|Mean|64|64.0|Standard Deviation|9.9|9.9|||
4226095|NCT00695292|4049671|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4226096|NCT00695292|4049671|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4226097|NCT00695292|4049671|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226098|NCT00695188|4049676|B3|Austria||Region of Enrollment||participants|Number|19|19.0||||||
4226099|NCT00695188|4049677|B2|Austria||Region of Enrollment||participants|Number|9|9.0||||||
4226100|NCT00695188|4049678|B1|Austria||Region of Enrollment||participants|Number|10|10.0||||||
4226101|NCT00695188|4049676|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4226102|NCT00695188|4049677|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4226103|NCT00695188|4049678|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4226104|NCT00695188|4049676|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4226105|NCT00695188|4049677|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4226106|NCT00695188|4049678|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4226107|NCT00695188|4049676|B3|||Age||years|Mean|56|56.0|Standard Deviation|13|13.0|||
4226108|NCT00695188|4049677|B2|||Age||years|Mean|62|62.0|Standard Deviation|7|7.0|||
4226109|NCT00695188|4049678|B1|||Age||years|Mean|51|51.0|Standard Deviation|15|15.0|||
4226110|NCT00695188|4049676|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4226111|NCT00695188|4049677|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4226112|NCT00695188|4049678|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4226113|NCT00695188|4049676|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4226114|NCT00695188|4049677|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4226115|NCT00695188|4049678|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4226116|NCT00695188|4049676|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226117|NCT00695188|4049677|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226118|NCT00695188|4049678|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226119|NCT00695136|4049685|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4226120|NCT00695136|4049685|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4226121|NCT00695136|4049685|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4226122|NCT00695136|4049685|B1|||Age||years|Mean|5.08|5.08|Standard Deviation|1.62|1.62|||
4226123|NCT00695136|4049685|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4226124|NCT00695136|4049685|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4226125|NCT00695136|4049685|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4226126|NCT00695097|4049689|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4226127|NCT00695097|4049690|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4226128|NCT00695097|4049691|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4226129|NCT00695097|4049689|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4226130|NCT00695097|4049690|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4226131|NCT00695097|4049691|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4226132|NCT00695097|4049689|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4226133|NCT00695097|4049690|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4226134|NCT00695097|4049691|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4226135|NCT00695097|4049689|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4226136|NCT00695097|4049690|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4226137|NCT00695097|4049691|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4226138|NCT00695097|4049689|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4226139|NCT00695097|4049690|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4226140|NCT00695097|4049691|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4226141|NCT00695097|4049689|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226142|NCT00695097|4049690|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226143|NCT00695097|4049691|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226144|NCT00695019|4049698|B4|Taiwan||Region of Enrollment||participants|Number|169|169.0||||||
4226145|NCT00695019|4049699|B3|Taiwan||Region of Enrollment||participants|Number|57|57.0||||||
4226146|NCT00695019|4049700|B2|Taiwan||Region of Enrollment||participants|Number|53|53.0||||||
4226147|NCT00695019|4049701|B1|Taiwan||Region of Enrollment||participants|Number|59|59.0||||||
4226148|NCT00695019|4049698|B4||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4226149|NCT00695019|4049699|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4226150|NCT00695019|4049700|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4226151|NCT00695019|4049701|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4226152|NCT00695019|4049698|B4||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4226153|NCT00695019|4049699|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4226154|NCT00695019|4049700|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4226155|NCT00695019|4049701|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4226156|NCT00695019|4049698|B4|||Age||years|Mean|55.8|55.8|Standard Deviation|10.8|10.8|||
4226157|NCT00695019|4049699|B3|||Age||years|Mean|56.8|56.8|Standard Deviation|9.5|9.5|||
4226158|NCT00695019|4049700|B2|||Age||years|Mean|55.7|55.7|Standard Deviation|10.8|10.8|||
4226159|NCT00695019|4049701|B1|||Age||years|Mean|54.9|54.9|Standard Deviation|11.9|11.9|||
4226160|NCT00695019|4049698|B4||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4226161|NCT00695019|4049699|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4226162|NCT00695019|4049700|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4226163|NCT00695019|4049701|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4226164|NCT00695019|4049698|B4||Between 18 and 65 years|Age||Participants|Count of Participants|138|138.0||||||
4226165|NCT00695019|4049699|B3||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4226166|NCT00695019|4049700|B2||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4226167|NCT00695019|4049701|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4226168|NCT00695019|4049698|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226169|NCT00695019|4049699|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226170|NCT00695019|4049700|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226171|NCT00695019|4049701|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226172|NCT00694603|4049732|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4226173|NCT00694603|4049732|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4226174|NCT00694603|4049732|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4226175|NCT00694603|4049732|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4226176|NCT00694603|4049732|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4226177|NCT00694603|4049732|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226178|NCT00694564|4049737|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4226179|NCT00694564|4049737|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4226180|NCT00694564|4049737|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4226181|NCT00694564|4049737|B1|||Age||years|Mean|14|14.0|Standard Deviation|2|2.0|||
4226182|NCT00694564|4049737|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4226183|NCT00694564|4049737|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4226184|NCT00694564|4049737|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4226185|NCT00694551|4049741|B4|United States||Region of Enrollment||participants|Number|29|29.0||||||
4226186|NCT00694551|4049742|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4226187|NCT00694551|4049743|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4226188|NCT00694551|4049744|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4226189|NCT00694551|4049741|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4226190|NCT00694551|4049742|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4226191|NCT00694551|4049743|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4226192|NCT00694551|4049744|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4226193|NCT00694551|4049741|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4226194|NCT00694551|4049742|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4226195|NCT00694551|4049743|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4226196|NCT00694551|4049744|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4226197|NCT00694551|4049741|B4||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4226198|NCT00694551|4049742|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4226199|NCT00694551|4049743|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4226200|NCT00694551|4049744|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4226201|NCT00694551|4049741|B4||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4226202|NCT00694551|4049742|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4226203|NCT00694551|4049743|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4226204|NCT00694551|4049744|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4226205|NCT00694551|4049741|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226206|NCT00694551|4049742|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226207|NCT00694551|4049743|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226208|NCT00694551|4049744|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226209|NCT00694551|4049741|B4|||Age||years|Median|69.5|69.5|Full Range|||56.0|83.0|
4226210|NCT00694551|4049742|B3|||Age||years|Median|69|69.0|Full Range|||58.0|80.0|
4226211|NCT00694551|4049743|B2|||Age||years|Median|69.5|69.5|Full Range|||56.0|83.0|
4226212|NCT00694551|4049744|B1|||Age||years|Median|69|69.0|Full Range|||56.0|82.0|
4226213|NCT00694473|4049760|B1|United States||Region of Enrollment||Participants|Count of Participants|69|69.0||||||
4226214|NCT00694473|4049760|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4226215|NCT00694473|4049760|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4226216|NCT00694473|4049760|B1|||Age||years|Mean|59|59.0|Standard Deviation|15.2|15.2|||
4226217|NCT00694473|4049760|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4226218|NCT00694473|4049760|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4226219|NCT00694473|4049760|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226220|NCT00694369|4049770|B6|||Number of Teeth Removed||Teeth|Mean|2.05|2.05|Standard Deviation|0.26|0.26|||
4226221|NCT00694369|4049771|B5|||Number of Teeth Removed||Teeth|Mean|2.03|2.03|Standard Deviation|0.18|0.18|||
4226222|NCT00694369|4049772|B4|||Number of Teeth Removed||Teeth|Mean|2.02|2.02|Standard Deviation|0.12|0.12|||
4226223|NCT00694369|4049773|B3|||Number of Teeth Removed||Teeth|Mean|2.10|2.1|Standard Deviation|0.39|0.39|||
4226224|NCT00694369|4049774|B2|||Number of Teeth Removed||Teeth|Mean|2.06|2.06|Standard Deviation|0.27|0.27|||
4226225|NCT00694369|4049775|B1|||Number of Teeth Removed||Teeth|Mean|2.04|2.04|Standard Deviation|0.29|0.29|||
4226226|NCT00694369|4049770|B6|||Number of Hours from End of Surgery to Dosing||Hours|Mean|2.96|2.96|Standard Deviation|0.79|0.79|||
4226227|NCT00694369|4049771|B5|||Number of Hours from End of Surgery to Dosing||Hours|Mean|2.97|2.97|Standard Deviation|0.78|0.78|||
4226228|NCT00694369|4049772|B4|||Number of Hours from End of Surgery to Dosing||Hours|Mean|3.01|3.01|Standard Deviation|0.84|0.84|||
4226229|NCT00694369|4049773|B3|||Number of Hours from End of Surgery to Dosing||Hours|Mean|2.84|2.84|Standard Deviation|0.75|0.75|||
4226230|NCT00694369|4049774|B2|||Number of Hours from End of Surgery to Dosing||Hours|Mean|2.94|2.94|Standard Deviation|0.77|0.77|||
4226231|NCT00694369|4049775|B1|||Number of Hours from End of Surgery to Dosing||Hours|Mean|3.06|3.06|Standard Deviation|0.79|0.79|||
4226232|NCT00694369|4049770|B6|||Mean Impaction Score|"Impaction Score (Soft Tissue =1, Partial Embedded= 2,~Embedded = 3)"|Units on a Scale|Mean|2.45|2.45|Standard Deviation|0.50|0.5|||
4226233|NCT00694369|4049771|B5|||Mean Impaction Score|"Impaction Score (Soft Tissue =1, Partial Embedded= 2,~Embedded = 3)"|Units on a Scale|Mean|2.40|2.4|Standard Deviation|0.51|0.51|||
4226234|NCT00694369|4049772|B4|||Mean Impaction Score|"Impaction Score (Soft Tissue =1, Partial Embedded= 2,~Embedded = 3)"|Units on a Scale|Mean|2.50|2.5|Standard Deviation|0.48|0.48|||
4226235|NCT00694369|4049773|B3|||Mean Impaction Score|"Impaction Score (Soft Tissue =1, Partial Embedded= 2,~Embedded = 3)"|Units on a Scale|Mean|2.40|2.4|Standard Deviation|0.52|0.52|||
4226236|NCT00694369|4049774|B2|||Mean Impaction Score|"Impaction Score (Soft Tissue =1, Partial Embedded= 2,~Embedded = 3)"|Units on a Scale|Mean|2.44|2.44|Standard Deviation|0.50|0.5|||
4226237|NCT00694369|4049775|B1|||Mean Impaction Score|"Impaction Score (Soft Tissue =1, Partial Embedded= 2,~Embedded = 3)"|Units on a Scale|Mean|2.41|2.41|Standard Deviation|0.51|0.51|||
4226238|NCT00694369|4049770|B6|||Height||Centimeters|Mean|168.56|168.56|Standard Deviation|9.59|9.59|||
4226239|NCT00694369|4049771|B5|||Height||Centimeters|Mean|168.38|168.38|Standard Deviation|9.86|9.86|||
4226240|NCT00694369|4049772|B4|||Height||Centimeters|Mean|168.50|168.5|Standard Deviation|9.05|9.05|||
4226241|NCT00694369|4049773|B3|||Height||Centimeters|Mean|167.92|167.92|Standard Deviation|10.07|10.07|||
4226242|NCT00694369|4049774|B2|||Height||Centimeters|Mean|168.39|168.39|Standard Deviation|9.95|9.95|||
4226243|NCT00694369|4049775|B1|||Height||Centimeters|Mean|171.03|171.03|Standard Deviation|8.91|8.91|||
4226244|NCT00694369|4049770|B6|||Duration of Surgery||Hours|Mean|0.14|0.14|Standard Deviation|0.06|0.06|||
4226245|NCT00694369|4049771|B5|||Duration of Surgery||Hours|Mean|0.13|0.13|Standard Deviation|0.06|0.06|||
4226246|NCT00694369|4049772|B4|||Duration of Surgery||Hours|Mean|0.14|0.14|Standard Deviation|0.06|0.06|||
4226247|NCT00694369|4049773|B3|||Duration of Surgery||Hours|Mean|0.15|0.15|Standard Deviation|0.08|0.08|||
4226248|NCT00694369|4049774|B2|||Duration of Surgery||Hours|Mean|0.13|0.13|Standard Deviation|0.06|0.06|||
4226249|NCT00694369|4049775|B1|||Duration of Surgery||Hours|Mean|0.14|0.14|Standard Deviation|0.06|0.06|||
4226250|NCT00694369|4049770|B6|||Body Weight||Kilograms|Mean|71.76|71.76|Standard Deviation|16.29|16.29|||
4226251|NCT00694369|4049771|B5|||Body Weight||Kilograms|Mean|69.43|69.43|Standard Deviation|13.99|13.99|||
4226252|NCT00694369|4049772|B4|||Body Weight||Kilograms|Mean|72.24|72.24|Standard Deviation|16.81|16.81|||
4226253|NCT00694369|4049773|B3|||Body Weight||Kilograms|Mean|71.02|71.02|Standard Deviation|15.96|15.96|||
4226254|NCT00694369|4049774|B2|||Body Weight||Kilograms|Mean|72.53|72.53|Standard Deviation|16.68|16.68|||
4226255|NCT00694369|4049775|B1|||Body Weight||Kilograms|Mean|71.21|71.21|Standard Deviation|16.33|16.33|||
4226256|NCT00694369|4049770|B6|Severe||Baseline Pain Intensity|"The level of pain at baseline (before dosing) is indicated by the patient on the patient diary by placing a check mark next to the appropriate response to the following question (My starting pain is: None, Slight, Moderate, Severe). Patients who indicated moderate to severe pain at baseline were eligible to be~randomized into the study."|Participants|Number|284|284.0||||||
4226257|NCT00694369|4049771|B5|Severe||Baseline Pain Intensity|"The level of pain at baseline (before dosing) is indicated by the patient on the patient diary by placing a check mark next to the appropriate response to the following question (My starting pain is: None, Slight, Moderate, Severe). Patients who indicated moderate to severe pain at baseline were eligible to be~randomized into the study."|Participants|Number|32|32.0||||||
4226258|NCT00694369|4049772|B4|Severe||Baseline Pain Intensity|"The level of pain at baseline (before dosing) is indicated by the patient on the patient diary by placing a check mark next to the appropriate response to the following question (My starting pain is: None, Slight, Moderate, Severe). Patients who indicated moderate to severe pain at baseline were eligible to be~randomized into the study."|Participants|Number|86|86.0||||||
4226259|NCT00694369|4049773|B3|Severe||Baseline Pain Intensity|"The level of pain at baseline (before dosing) is indicated by the patient on the patient diary by placing a check mark next to the appropriate response to the following question (My starting pain is: None, Slight, Moderate, Severe). Patients who indicated moderate to severe pain at baseline were eligible to be~randomized into the study."|Participants|Number|48|48.0||||||
4226260|NCT00694369|4049774|B2|Severe||Baseline Pain Intensity|"The level of pain at baseline (before dosing) is indicated by the patient on the patient diary by placing a check mark next to the appropriate response to the following question (My starting pain is: None, Slight, Moderate, Severe). Patients who indicated moderate to severe pain at baseline were eligible to be~randomized into the study."|Participants|Number|93|93.0||||||
4226261|NCT00694369|4049775|B1|Severe||Baseline Pain Intensity|"The level of pain at baseline (before dosing) is indicated by the patient on the patient diary by placing a check mark next to the appropriate response to the following question (My starting pain is: None, Slight, Moderate, Severe). Patients who indicated moderate to severe pain at baseline were eligible to be~randomized into the study."|Participants|Number|25|25.0||||||
4226262|NCT00694369|4049770|B6|Moderate||Baseline Pain Intensity|"The level of pain at baseline (before dosing) is indicated by the patient on the patient diary by placing a check mark next to the appropriate response to the following question (My starting pain is: None, Slight, Moderate, Severe). Patients who indicated moderate to severe pain at baseline were eligible to be~randomized into the study."|Participants|Number|304|304.0||||||
4226263|NCT00694369|4049771|B5|Moderate||Baseline Pain Intensity|"The level of pain at baseline (before dosing) is indicated by the patient on the patient diary by placing a check mark next to the appropriate response to the following question (My starting pain is: None, Slight, Moderate, Severe). Patients who indicated moderate to severe pain at baseline were eligible to be~randomized into the study."|Participants|Number|30|30.0||||||
4226264|NCT00694369|4049772|B4|Moderate||Baseline Pain Intensity|"The level of pain at baseline (before dosing) is indicated by the patient on the patient diary by placing a check mark next to the appropriate response to the following question (My starting pain is: None, Slight, Moderate, Severe). Patients who indicated moderate to severe pain at baseline were eligible to be~randomized into the study."|Participants|Number|106|106.0||||||
4226265|NCT00694369|4049773|B3|Moderate||Baseline Pain Intensity|"The level of pain at baseline (before dosing) is indicated by the patient on the patient diary by placing a check mark next to the appropriate response to the following question (My starting pain is: None, Slight, Moderate, Severe). Patients who indicated moderate to severe pain at baseline were eligible to be~randomized into the study."|Participants|Number|49|49.0||||||
4226266|NCT00694369|4049774|B2|Moderate||Baseline Pain Intensity|"The level of pain at baseline (before dosing) is indicated by the patient on the patient diary by placing a check mark next to the appropriate response to the following question (My starting pain is: None, Slight, Moderate, Severe). Patients who indicated moderate to severe pain at baseline were eligible to be~randomized into the study."|Participants|Number|98|98.0||||||
4226267|NCT00694369|4049775|B1|Moderate||Baseline Pain Intensity|"The level of pain at baseline (before dosing) is indicated by the patient on the patient diary by placing a check mark next to the appropriate response to the following question (My starting pain is: None, Slight, Moderate, Severe). Patients who indicated moderate to severe pain at baseline were eligible to be~randomized into the study."|Participants|Number|21|21.0||||||
4226268|NCT00694369|4049770|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4226269|NCT00694369|4049771|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4226270|NCT00694369|4049772|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4226271|NCT00694369|4049773|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4226272|NCT00694369|4049774|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4226273|NCT00694369|4049775|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4226274|NCT00694369|4049770|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4226275|NCT00694369|4049771|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4226276|NCT00694369|4049772|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4226277|NCT00694369|4049773|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4226278|NCT00694369|4049774|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4226279|NCT00694369|4049775|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4226280|NCT00694369|4049770|B6||White|Race (NIH/OMB)||Participants|Count of Participants|532|532.0||||||
4226281|NCT00694369|4049771|B5||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4226282|NCT00694369|4049772|B4||White|Race (NIH/OMB)||Participants|Count of Participants|173|173.0||||||
4226283|NCT00694369|4049773|B3||White|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4226284|NCT00694369|4049774|B2||White|Race (NIH/OMB)||Participants|Count of Participants|174|174.0||||||
4226285|NCT00694369|4049775|B1||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4226286|NCT00694369|4049770|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4226287|NCT00694369|4049771|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4226288|NCT00694369|4049772|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4226289|NCT00694369|4049773|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4226290|NCT00694369|4049774|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4226291|NCT00694369|4049775|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4226292|NCT00694369|4049770|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4226293|NCT00694369|4049771|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4226294|NCT00694369|4049772|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4226295|NCT00694369|4049773|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4226296|NCT00694369|4049774|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4226297|NCT00694369|4049775|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4226298|NCT00694369|4049770|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4226299|NCT00694369|4049771|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4226300|NCT00694369|4049772|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4226301|NCT00694369|4049773|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4226302|NCT00694369|4049774|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4226303|NCT00694369|4049775|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4226304|NCT00694369|4049770|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4226305|NCT00694369|4049771|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4226306|NCT00694369|4049772|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4226307|NCT00694369|4049773|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4226308|NCT00694369|4049774|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4226309|NCT00694369|4049775|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4226310|NCT00694369|4049770|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4226311|NCT00694369|4049771|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4226312|NCT00694369|4049772|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4226313|NCT00694369|4049773|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4226314|NCT00694369|4049774|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4226315|NCT00694369|4049775|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4226316|NCT00694369|4049770|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|432|432.0||||||
4226317|NCT00694369|4049771|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4226318|NCT00694369|4049772|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|142|142.0||||||
4226319|NCT00694369|4049773|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4226320|NCT00694369|4049774|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|139|139.0||||||
4226321|NCT00694369|4049775|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4226322|NCT00694369|4049770|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|155|155.0||||||
4226323|NCT00694369|4049771|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4226324|NCT00694369|4049772|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4226325|NCT00694369|4049773|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4226326|NCT00694369|4049774|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4226327|NCT00694369|4049775|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4226328|NCT00694369|4049770|B6||Male|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
4226329|NCT00694369|4049771|B5||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4226330|NCT00694369|4049772|B4||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4226331|NCT00694369|4049773|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4226332|NCT00694369|4049774|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4226333|NCT00694369|4049775|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4226334|NCT00694369|4049770|B6||Female|Sex: Female, Male||Participants|Count of Participants|340|340.0||||||
4226335|NCT00694369|4049771|B5||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4226336|NCT00694369|4049772|B4||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4226337|NCT00694369|4049773|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4226338|NCT00694369|4049774|B2||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4226339|NCT00694369|4049775|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4226340|NCT00694369|4049770|B6|||Age||years|Mean|21.5|21.5|Standard Deviation|3.5|3.5|||
4226341|NCT00694369|4049771|B5|||Age||years|Mean|20.5|20.5|Standard Deviation|2.8|2.8|||
4226342|NCT00694369|4049772|B4|||Age||years|Mean|21.6|21.6|Standard Deviation|3.8|3.8|||
4226343|NCT00694369|4049773|B3|||Age||years|Mean|21.8|21.8|Standard Deviation|3.5|3.5|||
4226344|NCT00694369|4049774|B2|||Age||years|Mean|21.8|21.8|Standard Deviation|3.6|3.6|||
4226345|NCT00694369|4049775|B1|||Age||years|Mean|21.0|21.0|Standard Deviation|3.0|3.0|||
4226346|NCT00694356|4049796|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4226347|NCT00694356|4049797|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4226348|NCT00694356|4049798|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4226349|NCT00694356|4049799|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4226350|NCT00694356|4049796|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4226351|NCT00694356|4049797|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4226352|NCT00694356|4049798|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4226353|NCT00694356|4049799|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4226354|NCT00694356|4049796|B4|||Age||Years|Mean|62.3|62.3|Standard Deviation|9.3|9.3|||
4226355|NCT00694356|4049797|B3|||Age||Years|Mean|59.2|59.2|Standard Deviation|14.2|14.2|||
4226356|NCT00694356|4049798|B2|||Age||Years|Mean|63.5|63.5|Standard Deviation|3.9|3.9|||
4226357|NCT00694356|4049799|B1|||Age||Years|Mean|66.3|66.3|Standard Deviation|1.5|1.5|||
4226358|NCT00694304|4049836|B1|||SDS|The Sheehan Disability Scale (SDS) comprises self-rated items designed to measure impairment. The patient rates the extent to which his or her (1) work, (2) social life or leisure activities and (3) home life or family responsibilities are impaired on a 10-point visual analogue scales, on which 0 = normal functioning and 10 = severe functional impairment. The three items may be summed into a single dimensional measure of global functional impairment that ranges from 0 (unimpaired) to 30 (highly impaired). The higher the score, the more severe.|units on a scale|Mean|12.42|12.42|Standard Deviation|8.13|8.13|||
4226359|NCT00694304|4049836|B1|||CGI-S|The Clinical Global Impression - Severity of Illness (CGI-S) is a 7-point scale rated from 1 (normal, not at all ill) to 7 (among the most extremely ill patients). The investigator should use his/her total clinical experience with this patient population to judge how mentally ill the patient is at the time of rating.|units on a scale|Mean|2.7|2.7|Standard Deviation|1.2|1.2|||
4226360|NCT00694304|4049836|B1|||HAM-A|The Hamilton Anxiety Rating Scale (HAM-A) consists of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behaviour at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic, and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total score from 0 to 56. The higher the score, the more severe.|units on a scale|Mean|11.0|11.0|Standard Deviation|7.2|7.2|||
4226361|NCT00694304|4049836|B1|||HAM-D-24|The Hamilton Depression Scale - 24 Items (HAM-D-24) measures depression severity. Items are rated on a scale from 0 (symptoms not present) to a maximum of 2 to 4 (symptom extremely severe) for a total score range of 0 to 76. The higher the score, the more severe.|units on a scale|Mean|13.4|13.4|Standard Deviation|8.7|8.7|||
4226362|NCT00694304|4049836|B1|||MADRS|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 (no symptom) to 6 (severe symptom). The 10 items represent the core symptoms of depressive illness. The rating should be based on a clinical interview with the patient, moving from broadly phrased questions about symptoms to more detailed ones, which allow a precise rating of severity, covering the last 7 days. Total score from 0 to 60. The higher the score, the more severe.|units on a scale|Mean|13.5|13.5|Standard Deviation|8.7|8.7|||
4226363|NCT00694304|4049836|B1||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4226364|NCT00694304|4049836|B1||Female|Sex: Female, Male||Participants|Count of Participants|366|366.0||||||
4226365|NCT00694304|4049836|B1|||Age||years|Mean|45.7|45.7|Standard Deviation|12.3|12.3|||
4226366|NCT00694161|4049849|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4226367|NCT00694161|4049849|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4226368|NCT00694161|4049849|B1|||Age||Years|Mean|76.4|76.4|Standard Deviation|4.7|4.7|||
4226369|NCT00694122|4049888|B1|Regular||Fast Acting Insulin||participants|Number|1|1.0||||||
4226370|NCT00694122|4049888|B1|Novolog||Fast Acting Insulin||participants|Number|6|6.0||||||
4226371|NCT00694122|4049888|B1|Humalog||Fast Acting Insulin||participants|Number|8|8.0||||||
4226372|NCT00694122|4049888|B1|NPH||Type of Insulin at First Overnight Visit|Participants entered the study on either Lantus or NPH. .|participants|Number|5|5.0||||||
4226373|NCT00694122|4049888|B1|Lantus (glargine)||Type of Insulin at First Overnight Visit|Participants entered the study on either Lantus or NPH. .|participants|Number|10|10.0||||||
4226374|NCT00694122|4049888|B1|||Diabetes duration|Self reported duration of type 1 diabetes.|years|Mean|22.8|22.8|Standard Deviation|10.2|10.2|||
4226375|NCT00694122|4049888|B1|||C-peptide|Fasting blood was drawn. C-peptide (nmole/L) was determined.|nmole/L|Mean|0.1|0.1|Standard Deviation|0|0.0|||
4226432|NCT00693992|4049950|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4226376|NCT00694122|4049888|B1|||Body Mass Index (BMI)|BMI (kg/m2) was calculated from measured height and weight. Height was obtained using a wall mounted stadiometer and weight was performed using a digital scale.|kg/m2|Mean|25.8|25.8|Standard Deviation|3.3|3.3|||
4226377|NCT00694122|4049888|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4226378|NCT00694122|4049888|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4226379|NCT00694122|4049888|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4226380|NCT00694122|4049888|B1|||Age||years|Mean|46.5|46.5|Standard Deviation|12.5|12.5|||
4226381|NCT00694122|4049888|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4226382|NCT00694122|4049888|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4226383|NCT00694122|4049888|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226384|NCT00694109|4049905|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4226385|NCT00694109|4049905|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4226386|NCT00694109|4049905|B1|||Age||years|Mean|49.3|49.3|Standard Deviation|15.3|15.3|||
4226387|NCT00694096|4049929|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4226388|NCT00694096|4049929|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4226389|NCT00694096|4049929|B1|||Age||years|Median|67|67.0|Full Range|||50.0|86.0|
4226390|NCT00694070|4049935|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4226391|NCT00694070|4049935|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4226392|NCT00694070|4049935|B1|||Age||years|Median|53|53.0|Full Range|||18.0|82.0|
4226393|NCT00694018|4049941|B3|||Daily step counts||steps|Mean|4404.8|4404.8|Standard Deviation|2517.0|2517.0|||
4226394|NCT00694018|4049942|B2|||Daily step counts||steps|Mean|4492.9|4492.9|Standard Deviation|2749.9|2749.9|||
4226395|NCT00694018|4049943|B1|||Daily step counts||steps|Mean|4321.9|4321.9|Standard Deviation|2285.4|2285.4|||
4226396|NCT00694018|4049941|B3|||Roland Morris Disability Questionnaire (RDQ) Score|The Roland Morris Disability Questionnaire score ranges from 0-24, with higher scores indicating greater disability.|units on a scale|Mean|9.5|9.5|Standard Deviation|5.8|5.8|||
4226397|NCT00694018|4049942|B2|||Roland Morris Disability Questionnaire (RDQ) Score|The Roland Morris Disability Questionnaire score ranges from 0-24, with higher scores indicating greater disability.|units on a scale|Mean|9.1|9.1|Standard Deviation|6.0|6.0|||
4226398|NCT00694018|4049943|B1|||Roland Morris Disability Questionnaire (RDQ) Score|The Roland Morris Disability Questionnaire score ranges from 0-24, with higher scores indicating greater disability.|units on a scale|Mean|9.8|9.8|Standard Deviation|5.7|5.7|||
4226399|NCT00694018|4049941|B3|United States||Region of Enrollment||participants|Number|229|229.0||||||
4226400|NCT00694018|4049942|B2|United States||Region of Enrollment||participants|Number|111|111.0||||||
4226401|NCT00694018|4049943|B1|United States||Region of Enrollment||participants|Number|118|118.0||||||
4226402|NCT00694018|4049941|B3|Other or prefer not to answer||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4226403|NCT00694018|4049942|B2|Other or prefer not to answer||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4226404|NCT00694018|4049943|B1|Other or prefer not to answer||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4226405|NCT00694018|4049941|B3|Black||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4226406|NCT00694018|4049942|B2|Black||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4226407|NCT00694018|4049943|B1|Black||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4226408|NCT00694018|4049941|B3|White||Race/Ethnicity, Customized||participants|Number|183|183.0||||||
4226409|NCT00694018|4049942|B2|White||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
4226410|NCT00694018|4049943|B1|White||Race/Ethnicity, Customized||participants|Number|101|101.0||||||
4226411|NCT00694018|4049941|B3||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4226412|NCT00694018|4049942|B2||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4226413|NCT00694018|4049943|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4226414|NCT00694018|4049941|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4226415|NCT00694018|4049942|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4226416|NCT00694018|4049943|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4226417|NCT00694018|4049941|B3|||Age||years|Mean|51.5|51.5|Standard Deviation|12.6|12.6|||
4226418|NCT00694018|4049942|B2|||Age||years|Mean|51.2|51.2|Standard Deviation|12.5|12.5|||
4226419|NCT00694018|4049943|B1|||Age||years|Mean|51.9|51.9|Standard Deviation|12.8|12.8|||
4226420|NCT00693992|4049950|B3|United States||Region of Enrollment||participants|Number|210|210.0||||||
4226421|NCT00693992|4049951|B2|United States||Region of Enrollment||participants|Number|104|104.0||||||
4226422|NCT00693992|4049952|B1|United States||Region of Enrollment||participants|Number|106|106.0||||||
4226423|NCT00693992|4049950|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4226424|NCT00693992|4049951|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4226425|NCT00693992|4049952|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4226426|NCT00693992|4049950|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4226427|NCT00693992|4049951|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4226428|NCT00693992|4049952|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4226429|NCT00693992|4049950|B3||White|Race (NIH/OMB)||Participants|Count of Participants|172|172.0||||||
4226430|NCT00693992|4049951|B2||White|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
4226431|NCT00693992|4049952|B1||White|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
4226433|NCT00693992|4049951|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4226434|NCT00693992|4049952|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4226435|NCT00693992|4049950|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4226436|NCT00693992|4049951|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4226437|NCT00693992|4049952|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4226438|NCT00693992|4049950|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4226439|NCT00693992|4049951|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4226440|NCT00693992|4049952|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4226441|NCT00693992|4049950|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4226442|NCT00693992|4049951|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4226443|NCT00693992|4049952|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4226444|NCT00693992|4049950|B3||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4226445|NCT00693992|4049951|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4226446|NCT00693992|4049952|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4226447|NCT00693992|4049950|B3||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4226448|NCT00693992|4049951|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4226449|NCT00693992|4049952|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4226450|NCT00693992|4049950|B3|||Age||years|Median|66|66.0|Full Range|||25.0|89.0|
4226451|NCT00693992|4049951|B2|||Age||years|Median|67|67.0|Full Range|||44.0|89.0|
4226452|NCT00693992|4049952|B1|||Age||years|Median|65|65.0|Full Range|||25.0|84.0|
4226453|NCT00693784|4049969|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4226454|NCT00693784|4049969|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4226455|NCT00693784|4049969|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4226456|NCT00693784|4049969|B1|||Age||years|Mean|43.9|43.9|Standard Deviation|10.7|10.7|||
4226457|NCT00693784|4049969|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4226458|NCT00693784|4049969|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4226459|NCT00693784|4049969|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4226460|NCT00693719|4049975|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4226461|NCT00693719|4049975|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4226462|NCT00693719|4049975|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4226463|NCT00693719|4049975|B1|||Age||years|Mean|54.68|54.68|Standard Deviation|11.33|11.33|||
4226464|NCT00693719|4049975|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4226465|NCT00693719|4049975|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4226466|NCT00693719|4049975|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226467|NCT00693706|4049980|B3||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4226468|NCT00693706|4049981|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4226469|NCT00693706|4049982|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4226470|NCT00693706|4049980|B3||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4226471|NCT00693706|4049981|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4226472|NCT00693706|4049982|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4226473|NCT00693706|4049980|B3|||Age||Years|Mean|32.4|32.4|Standard Deviation|10.0|10.0|||
4226474|NCT00693706|4049981|B2|||Age||Years|Mean|31.6|31.6|Standard Deviation|9.77|9.77|||
4226475|NCT00693706|4049982|B1|||Age||Years|Mean|33.1|33.1|Standard Deviation|10.24|10.24|||
4226476|NCT00693693|4050007|B4|United States||Region of Enrollment||participants|Number|21|21.0||||||
4226477|NCT00693693|4050008|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4226478|NCT00693693|4050009|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4226479|NCT00693693|4050010|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4226480|NCT00693693|4050007|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4226481|NCT00693693|4050008|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4226482|NCT00693693|4050009|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4226483|NCT00693693|4050010|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4226484|NCT00693693|4050007|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4226485|NCT00693693|4050008|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4226486|NCT00693693|4050009|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4226487|NCT00693693|4050010|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4226488|NCT00693693|4050007|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4226489|NCT00693693|4050008|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4226490|NCT00693693|4050009|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4226491|NCT00693693|4050010|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4226492|NCT00693693|4050007|B4||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4226493|NCT00693693|4050008|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4226494|NCT00693693|4050009|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4226495|NCT00693693|4050010|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4226496|NCT00693693|4050007|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226497|NCT00693693|4050008|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226498|NCT00693693|4050009|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226499|NCT00693693|4050010|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226500|NCT00693654|4050020|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
4226501|NCT00693654|4050021|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4226502|NCT00693654|4050022|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4226503|NCT00693654|4050020|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4226504|NCT00693654|4050021|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4226505|NCT00693654|4050022|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4226506|NCT00693654|4050020|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4226507|NCT00693654|4050021|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4226508|NCT00693654|4050022|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4226509|NCT00693654|4050020|B3|||Age||years|Mean|53.5|53.5|Standard Deviation|7.54|7.54|||
4226510|NCT00693654|4050021|B2|||Age||years|Mean|58.0|58.0|Standard Deviation|7.54|7.54|||
4226511|NCT00693654|4050022|B1|||Age||years|Mean|48.9|48.9|Standard Deviation|13.6|13.6|||
4226512|NCT00693654|4050020|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4226513|NCT00693654|4050021|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4226514|NCT00693654|4050022|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4226515|NCT00693654|4050020|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4226516|NCT00693654|4050021|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4226517|NCT00693654|4050022|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4226518|NCT00693654|4050020|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226519|NCT00693654|4050021|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226520|NCT00693654|4050022|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226521|NCT00693628|4050031|B3||>=65 years|Age||||0|0.0||||||
4226522|NCT00693628|4050031|B3||Between 18 and 65 years|Age||||0|0.0||||||
4226523|NCT00693628|4050031|B3||<=18 years|Age||||0|0.0||||||
4226524|NCT00693498|4050040|B3||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4226525|NCT00693498|4050041|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4226526|NCT00693498|4050042|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4226527|NCT00693498|4050040|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4226528|NCT00693498|4050041|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4226529|NCT00693498|4050042|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4226530|NCT00693498|4050040|B3|Age||Age||days|Median|1|1.0|Full Range|||1.0|17.0|
4226531|NCT00693498|4050041|B2|Age||Age||days|Median|1|1.0|Full Range|||1.0|17.0|
4226532|NCT00693498|4050042|B1|Age||Age||days|Median|1|1.0|Full Range|NA||1.0|17.0|
4226533|NCT00693498|4050040|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4226534|NCT00693498|4050041|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4226535|NCT00693498|4050042|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4226536|NCT00693498|4050040|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4226537|NCT00693498|4050041|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4226538|NCT00693498|4050042|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4226539|NCT00693498|4050040|B3||<=18 years|Age||Participants|Count of Participants|162|162.0||||||
4226540|NCT00693498|4050041|B2||<=18 years|Age||Participants|Count of Participants|81|81.0||||||
4226541|NCT00693498|4050042|B1||<=18 years|Age||Participants|Count of Participants|81|81.0||||||
4226542|NCT00693485|4050051|B4|||Mean Deviation from Normal Visual Field Using the HFA 24-2|Mean deviation is the difference between the expected normal visual field compared to the patient's visual field.|Decibels (db)|Mean|-16.0|-16.0|Full Range|||-30.9|-6.4|
4226543|NCT00693485|4050052|B3|||Mean Deviation from Normal Visual Field Using the HFA 24-2|Mean deviation is the difference between the expected normal visual field compared to the patient's visual field.|Decibels (db)|Mean|-17.9|-17.9|Full Range|5.09|5.09|-30.9|-9.4|
4226544|NCT00693485|4050053|B2|||Mean Deviation from Normal Visual Field Using the HFA 24-2|Mean deviation is the difference between the expected normal visual field compared to the patient's visual field.|Decibels (db)|Mean|-14.6|-14.6|Full Range|3.67|3.67|-24.3|-10.1|
4226545|NCT00693485|4050054|B1|||Mean Deviation from Normal Visual Field Using the HFA 24-2|Mean deviation is the difference between the expected normal visual field compared to the patient's visual field.|Decibels (db)|Mean|-15.5|-15.5|Full Range|5.26|5.26|-28.2|-6.4|
4226546|NCT00693485|4050051|B4||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4226547|NCT00693485|4050052|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4226548|NCT00693485|4050053|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4226549|NCT00693485|4050054|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4226550|NCT00693485|4050051|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4226551|NCT00693485|4050052|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4226552|NCT00693485|4050053|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4226553|NCT00693485|4050054|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4226554|NCT00693485|4050051|B4|>65 years||Age, Customized||Participants|Number|37|37.0||||||
4226555|NCT00693485|4050052|B3|>65 years||Age, Customized||Participants|Number|11|11.0||||||
4226556|NCT00693485|4050053|B2|>65 years||Age, Customized||Participants|Number|10|10.0||||||
4226557|NCT00693485|4050054|B1|>65 years||Age, Customized||Participants|Number|16|16.0||||||
4226558|NCT00693485|4050051|B4|Between 45 and 65 years||Age, Customized||Participants|Number|32|32.0||||||
4226559|NCT00693485|4050052|B3|Between 45 and 65 years||Age, Customized||Participants|Number|12|12.0||||||
4226560|NCT00693485|4050053|B2|Between 45 and 65 years||Age, Customized||Participants|Number|11|11.0||||||
4226561|NCT00693485|4050054|B1|Between 45 and 65 years||Age, Customized||Participants|Number|9|9.0||||||
4226562|NCT00693485|4050051|B4|<45 years||Age, Customized||Participants|Number|1|1.0||||||
4226563|NCT00693485|4050052|B3|<45 years||Age, Customized||Participants|Number|1|1.0||||||
4226564|NCT00693485|4050053|B2|<45 years||Age, Customized||Participants|Number|0|0.0||||||
4226565|NCT00693485|4050054|B1|<45 years||Age, Customized||Participants|Number|0|0.0||||||
4226566|NCT00693472|4050067|B5||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4226567|NCT00693472|4050068|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4226568|NCT00693472|4050069|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4226569|NCT00693472|4050070|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4226570|NCT00693472|4050071|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4226571|NCT00693472|4050067|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4226572|NCT00693472|4050068|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4226573|NCT00693472|4050069|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4226574|NCT00693472|4050070|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4226575|NCT00693472|4050071|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4226576|NCT00693472|4050067|B5|>=65 years||Age, Customized||Participants|Number|0|0.0||||||
4226577|NCT00693472|4050068|B4|>=65 years||Age, Customized||Participants|Number|0|0.0||||||
4226578|NCT00693472|4050069|B3|>=65 years||Age, Customized||Participants|Number|0|0.0||||||
4226579|NCT00693472|4050070|B2|>=65 years||Age, Customized||Participants|Number|0|0.0||||||
4226580|NCT00693472|4050071|B1|>=65 years||Age, Customized||Participants|Number|0|0.0||||||
4226581|NCT00693472|4050067|B5|Between 18 and <65 years||Age, Customized||Participants|Number|46|46.0||||||
4226582|NCT00693472|4050068|B4|Between 18 and <65 years||Age, Customized||Participants|Number|6|6.0||||||
4226583|NCT00693472|4050069|B3|Between 18 and <65 years||Age, Customized||Participants|Number|8|8.0||||||
4226584|NCT00693472|4050070|B2|Between 18 and <65 years||Age, Customized||Participants|Number|13|13.0||||||
4226585|NCT00693472|4050071|B1|Between 18 and <65 years||Age, Customized||Participants|Number|19|19.0||||||
4226586|NCT00693472|4050067|B5|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4226587|NCT00693472|4050068|B4|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4226588|NCT00693472|4050069|B3|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4226589|NCT00693472|4050070|B2|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4226590|NCT00693472|4050071|B1|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4226591|NCT00693420|4050092|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4226592|NCT00693420|4050093|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4226593|NCT00693420|4050094|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4226594|NCT00693420|4050092|B3||Female|Sex: Female, Male||Participants|Count of Participants|270|270.0||||||
4226595|NCT00693420|4050093|B2||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4226596|NCT00693420|4050094|B1||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4226597|NCT00693420|4050092|B3|>65 years||Age, Customized||participants|Number|21|21.0||||||
4226598|NCT00693420|4050093|B2|>65 years||Age, Customized||participants|Number|10|10.0||||||
4226599|NCT00693420|4050094|B1|>65 years||Age, Customized||participants|Number|11|11.0||||||
4226600|NCT00693420|4050092|B3|Between 45 and 65 years||Age, Customized||participants|Number|170|170.0||||||
4226601|NCT00693420|4050093|B2|Between 45 and 65 years||Age, Customized||participants|Number|88|88.0||||||
4226602|NCT00693420|4050094|B1|Between 45 and 65 years||Age, Customized||participants|Number|82|82.0||||||
4226603|NCT00693420|4050092|B3|<45 years||Age, Customized||participants|Number|87|87.0||||||
4226604|NCT00693420|4050093|B2|<45 years||Age, Customized||participants|Number|43|43.0||||||
4226605|NCT00693420|4050094|B1|<45 years||Age, Customized||participants|Number|44|44.0||||||
4226606|NCT00693303|4050119|B1|||Evaluation Tool of Children's Handwriting|This criterion-referenced tool measures legibility and speed in grades one through six. The ETCH asks the child to write letters and words in lower-case and upper-case, write numerals, perform near point and far point copying, write to dictation, and compose original sentences.|Mean percent of legible letters, & words|Mean|95|95.0|Standard Deviation|9.9|9.9|||
4226607|NCT00693303|4050119|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4226608|NCT00693303|4050119|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4226609|NCT00693303|4050119|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4226610|NCT00693303|4050119|B1|||Age||years|Mean|9|9.0|Standard Deviation|1.5|1.5|||
4226611|NCT00693303|4050119|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4226612|NCT00693303|4050119|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4226613|NCT00693303|4050119|B1||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
4226614|NCT00693238|4050123|B3|United States||Region of Enrollment||participants|Number|228|228.0||||||
4226615|NCT00693238|4050124|B2|United States||Region of Enrollment||participants|Number|106|106.0||||||
4226616|NCT00693238|4050125|B1|United States||Region of Enrollment||participants|Number|122|122.0||||||
4226617|NCT00693238|4050123|B3||Male|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
4226618|NCT00693238|4050124|B2||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4226619|NCT00693238|4050125|B1||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4226620|NCT00693238|4050123|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4226621|NCT00693238|4050124|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4226622|NCT00693238|4050125|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4226623|NCT00693238|4050123|B3|||Age||years|Mean|64.7|64.7|Standard Deviation|7.2|7.2|||
4226624|NCT00693238|4050124|B2|||Age||years|Mean|64.1|64.1|Standard Deviation|6.9|6.9|||
4226625|NCT00693238|4050125|B1|||Age||years|Mean|65.3|65.3|Standard Deviation|7.5|7.5|||
4226626|NCT00693238|4050123|B3||>=65 years|Age||Participants|Count of Participants|124|124.0||||||
4226627|NCT00693238|4050124|B2||>=65 years|Age||Participants|Count of Participants|62|62.0||||||
4226628|NCT00693238|4050125|B1||>=65 years|Age||Participants|Count of Participants|62|62.0||||||
4226629|NCT00693238|4050123|B3||Between 18 and 65 years|Age||Participants|Count of Participants|104|104.0||||||
4226630|NCT00693238|4050124|B2||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4226631|NCT00693238|4050125|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4226632|NCT00693238|4050123|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226633|NCT00693238|4050124|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226634|NCT00693238|4050125|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226635|NCT00693225|4050132|B3|LA grade D (severe esophagitis)||Esophagitis Severity|Esophagitis Severity was measured in Los Angeles (LA) Classification system, which quantifies erosive esophagitis and is graded on an A-D scale with increasing severity of injury.|participants|Number|32|32.0||||||
4226636|NCT00693225|4050133|B2|LA grade D (severe esophagitis)||Esophagitis Severity|Esophagitis Severity was measured in Los Angeles (LA) Classification system, which quantifies erosive esophagitis and is graded on an A-D scale with increasing severity of injury.|participants|Number|15|15.0||||||
4226637|NCT00693225|4050134|B1|LA grade D (severe esophagitis)||Esophagitis Severity|Esophagitis Severity was measured in Los Angeles (LA) Classification system, which quantifies erosive esophagitis and is graded on an A-D scale with increasing severity of injury.|participants|Number|17|17.0||||||
4226638|NCT00693225|4050132|B3|LA grade C (moderate esophagitis)||Esophagitis Severity|Esophagitis Severity was measured in Los Angeles (LA) Classification system, which quantifies erosive esophagitis and is graded on an A-D scale with increasing severity of injury.|participants|Number|59|59.0||||||
4226639|NCT00693225|4050133|B2|LA grade C (moderate esophagitis)||Esophagitis Severity|Esophagitis Severity was measured in Los Angeles (LA) Classification system, which quantifies erosive esophagitis and is graded on an A-D scale with increasing severity of injury.|participants|Number|33|33.0||||||
4226640|NCT00693225|4050134|B1|LA grade C (moderate esophagitis)||Esophagitis Severity|Esophagitis Severity was measured in Los Angeles (LA) Classification system, which quantifies erosive esophagitis and is graded on an A-D scale with increasing severity of injury.|participants|Number|26|26.0||||||
4226641|NCT00693225|4050132|B3|||Body Mass Index (BMI)||kg/m^2|Mean|31.1|31.1|Full Range|||21.2|51.0|
4226642|NCT00693225|4050133|B2|||Body Mass Index (BMI)||kg/m^2|Mean|31.1|31.1|Full Range|||21.2|46.8|
4226643|NCT00693225|4050134|B1|||Body Mass Index (BMI)||kg/m^2|Mean|31.1|31.1|Full Range|||24.5|51.0|
4226644|NCT00693225|4050132|B3|United States||Region of Enrollment||participants|Number|91|91.0||||||
4226645|NCT00693225|4050133|B2|United States||Region of Enrollment||participants|Number|48|48.0||||||
4226646|NCT00693225|4050134|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4226647|NCT00693225|4050132|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4226648|NCT00693225|4050133|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4226649|NCT00693225|4050134|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4226650|NCT00693225|4050132|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4226651|NCT00693225|4050133|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4226652|NCT00693225|4050134|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4226653|NCT00693225|4050132|B3|||Age||years|Mean|58|58.0|Full Range|||19.0|86.0|
4226654|NCT00693225|4050133|B2|||Age||years|Mean|59|59.0|Full Range|||30.0|86.0|
4226655|NCT00693225|4050134|B1|||Age||years|Mean|58|58.0|Full Range|||19.0|86.0|
4226656|NCT00693160|4050145|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4226657|NCT00693160|4050146|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4226658|NCT00693160|4050147|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4226659|NCT00693160|4050145|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4226660|NCT00693160|4050146|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4226661|NCT00693160|4050147|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4226662|NCT00693160|4050145|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4226663|NCT00693160|4050146|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4226664|NCT00693160|4050147|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4226665|NCT00693160|4050145|B3|||Age||years|Mean|31.93|31.93|Standard Deviation|9.86|9.86|||
4226666|NCT00693160|4050146|B2|||Age||years|Mean|32.06|32.06|Standard Deviation|8.52|8.52|||
4226667|NCT00693160|4050147|B1|||Age||years|Mean|31.78|31.78|Standard Deviation|11.52|11.52|||
4226668|NCT00693160|4050145|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4226669|NCT00693160|4050146|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4226670|NCT00693160|4050147|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4226671|NCT00693160|4050145|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4226672|NCT00693160|4050146|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4226673|NCT00693160|4050147|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4226674|NCT00693160|4050145|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226675|NCT00693160|4050146|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226676|NCT00693160|4050147|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226677|NCT00693017|4050156|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4226678|NCT00693017|4050157|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4226679|NCT00693017|4050158|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4226680|NCT00693017|4050156|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4226681|NCT00693017|4050157|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4226682|NCT00693017|4050158|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4226683|NCT00693017|4050156|B3|||Age||years|Mean|28.8|28.8|Standard Deviation|17.54|17.54|||
4226684|NCT00693017|4050157|B2|||Age||years|Mean|33.5|33.5|Standard Deviation|23.33|23.33|||
4226685|NCT00693017|4050158|B1|||Age||years|Mean|24.0|24.0|Standard Deviation|16.97|16.97|||
4226686|NCT00692913|4050167|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4226687|NCT00692913|4050168|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4226688|NCT00692913|4050169|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4226689|NCT00692913|4050167|B3||Female|Sex: Female, Male||Participants|Count of Participants|515|515.0||||||
4226690|NCT00692913|4050168|B2||Female|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
4226691|NCT00692913|4050169|B1||Female|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
4226692|NCT00692913|4050167|B3|||Age||years|Mean|72.9|72.9|Standard Deviation|5.6|5.6|||
4226693|NCT00692913|4050168|B2|||Age||years|Mean|72.9|72.9|Standard Deviation|5.9|5.9|||
4226694|NCT00692913|4050169|B1|||Age||years|Mean|72.9|72.9|Standard Deviation|5.3|5.3|||
4226695|NCT00692770|4050190|B3||Male|Sex: Female, Male||Participants|Count of Participants|912|912.0||||||
4226696|NCT00692770|4050191|B2||Male|Sex: Female, Male||Participants|Count of Participants|461|461.0||||||
4226697|NCT00692770|4050192|B1||Male|Sex: Female, Male||Participants|Count of Participants|451|451.0||||||
4226698|NCT00692770|4050190|B3||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4226699|NCT00692770|4050191|B2||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4226700|NCT00692770|4050192|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4226701|NCT00692770|4050190|B3||>=65 years|Age, Customized||Participants|Count of Participants|370|370.0||||||
4226702|NCT00692770|4050191|B2||>=65 years|Age, Customized||Participants|Count of Participants|197|197.0||||||
4226703|NCT00692770|4050192|B1||>=65 years|Age, Customized||Participants|Count of Participants|173|173.0||||||
4226704|NCT00692770|4050190|B3||Between 18 and 65 years|Age, Customized||Participants|Count of Participants|744|744.0||||||
4226705|NCT00692770|4050191|B2||Between 18 and 65 years|Age, Customized||Participants|Count of Participants|361|361.0||||||
4226706|NCT00692770|4050192|B1||Between 18 and 65 years|Age, Customized||Participants|Count of Participants|383|383.0||||||
4226707|NCT00692770|4050190|B3||<18 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
4226708|NCT00692770|4050191|B2||<18 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
4226709|NCT00692770|4050192|B1||<18 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
4226710|NCT00692770|4050190|B3|||Age||Years|Mean|58.4|58.4|Standard Deviation|12.0|12.0|||
4226711|NCT00692770|4050191|B2|||Age||Years|Mean|58.7|58.7|Standard Deviation|12.2|12.2|||
4226712|NCT00692770|4050192|B1|||Age||Years|Mean|58.1|58.1|Standard Deviation|11.7|11.7|||
4226713|NCT00692692|4050217|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4226714|NCT00692692|4050217|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4226715|NCT00692692|4050217|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4226716|NCT00692692|4050217|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4226717|NCT00692692|4050217|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4226718|NCT00692692|4050217|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226719|NCT00692419|4050226|B3||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4226720|NCT00692419|4050227|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4226721|NCT00692419|4050228|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4226722|NCT00692419|4050226|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4226723|NCT00692419|4050227|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4226724|NCT00692419|4050228|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4226725|NCT00692419|4050226|B3|||Age||years|Mean|63.2|63.2|Standard Deviation|13.5|13.5|||
4226726|NCT00692419|4050227|B2|||Age||years|Mean|63.9|63.9|Standard Deviation|12.0|12.0|||
4226727|NCT00692419|4050228|B1|||Age||years|Mean|62.6|62.6|Standard Deviation|14.3|14.3|||
4226728|NCT00692406|4050239|B1|United States||Region of Enrollment||participants|Number|80|80.0||0|0.0|||
4226729|NCT00692406|4050239|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4226730|NCT00692406|4050239|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4226731|NCT00692406|4050239|B1|||Age||years|Mean|31.4|31.4|Standard Deviation|8.2|8.2|||
4226732|NCT00692406|4050239|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4226733|NCT00692406|4050239|B1||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4226734|NCT00692406|4050239|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226735|NCT00692341|4050250|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4226736|NCT00692341|4050251|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4226737|NCT00692341|4050252|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4226738|NCT00692341|4050253|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4226739|NCT00692341|4050250|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4226740|NCT00692341|4050251|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4226741|NCT00692341|4050252|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4226742|NCT00692341|4050253|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4226743|NCT00692341|4050250|B4|||Age||years|Mean|51.4|51.4|Standard Deviation|5.8|5.8|||
4226744|NCT00692341|4050251|B3|||Age||years|Mean|54.3|54.3|Standard Deviation|4.7|4.7|||
4226745|NCT00692341|4050252|B2|||Age||years|Mean|52.5|52.5|Standard Deviation|5.6|5.6|||
4226746|NCT00692341|4050253|B1|||Age||years|Mean|47.4|47.4|Standard Deviation|5.2|5.2|||
4226747|NCT00692237|4050299|B3|Italy||Region of Enrollment||participants|Number|59|59.0||||||
4226748|NCT00692237|4050300|B2|Italy||Region of Enrollment||participants|Number|29|29.0||||||
4226749|NCT00692237|4050301|B1|Italy||Region of Enrollment||participants|Number|30|30.0||||||
4226750|NCT00692237|4050299|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4226751|NCT00692237|4050300|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4226752|NCT00692237|4050301|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4226753|NCT00692237|4050299|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4226754|NCT00692237|4050300|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4226755|NCT00692237|4050301|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4226756|NCT00692237|4050299|B3|||Age||years|Mean|60|60.0|Standard Deviation|7|7.0|||
4226757|NCT00692237|4050300|B2|||Age||years|Mean|59|59.0|Standard Deviation|7|7.0|||
4226758|NCT00692237|4050301|B1|||Age||years|Mean|61|61.0|Standard Deviation|7|7.0|||
4226759|NCT00692237|4050299|B3||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4226760|NCT00692237|4050300|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4226761|NCT00692237|4050301|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4226762|NCT00692237|4050299|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4226763|NCT00692237|4050300|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4226764|NCT00692237|4050301|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4226765|NCT00692237|4050299|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226766|NCT00692237|4050300|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226767|NCT00692237|4050301|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226768|NCT00692211|4050310|B3|United States||Region of Enrollment||participants|Number|404|404.0||||||
4226769|NCT00692211|4050311|B2|United States||Region of Enrollment||participants|Number|202|202.0||||||
4226770|NCT00692211|4050312|B1|United States||Region of Enrollment||participants|Number|202|202.0||||||
4226771|NCT00692211|4050310|B3||Male|Sex: Female, Male||Participants|Count of Participants|392|392.0||||||
4226772|NCT00692211|4050311|B2||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4226773|NCT00692211|4050312|B1||Male|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4226774|NCT00692211|4050310|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4226775|NCT00692211|4050311|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4226776|NCT00692211|4050312|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4226777|NCT00692211|4050310|B3|||Age||years|Mean|63.9|63.9|Standard Deviation|7.7|7.7|||
4226778|NCT00692211|4050311|B2|||Age||years|Mean|63.9|63.9|Standard Deviation|8.1|8.1|||
4226779|NCT00692211|4050312|B1|||Age||years|Mean|63.9|63.9|Standard Deviation|7.3|7.3|||
4226780|NCT00692211|4050310|B3||>=65 years|Age||Participants|Count of Participants|145|145.0||||||
4226781|NCT00692211|4050311|B2||>=65 years|Age||Participants|Count of Participants|71|71.0||||||
4226782|NCT00692211|4050312|B1||>=65 years|Age||Participants|Count of Participants|74|74.0||||||
4226783|NCT00692211|4050310|B3||Between 18 and 65 years|Age||Participants|Count of Participants|259|259.0||||||
4226784|NCT00692211|4050311|B2||Between 18 and 65 years|Age||Participants|Count of Participants|131|131.0||||||
4226785|NCT00692211|4050312|B1||Between 18 and 65 years|Age||Participants|Count of Participants|128|128.0||||||
4226786|NCT00692211|4050310|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226787|NCT00692211|4050311|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226788|NCT00692211|4050312|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226789|NCT00692198|4050319|B3||Unknown|Nadir SpO2 during 6-min walk while breathing ambient air||Participants|Count of Participants|156|156.0||||||
4226889|NCT00691938|4050376|B7|United States||Region of Enrollment||participants|Number|14|14.0||||||
4226790|NCT00692198|4050320|B2||Unknown|Nadir SpO2 during 6-min walk while breathing ambient air||Participants|Count of Participants|80|80.0||||||
4226791|NCT00692198|4050321|B1||Unknown|Nadir SpO2 during 6-min walk while breathing ambient air||Participants|Count of Participants|76|76.0||||||
4226792|NCT00692198|4050319|B3||Greater than 88%|Nadir SpO2 during 6-min walk while breathing ambient air||Participants|Count of Participants|203|203.0||||||
4226793|NCT00692198|4050320|B2||Greater than 88%|Nadir SpO2 during 6-min walk while breathing ambient air||Participants|Count of Participants|102|102.0||||||
4226794|NCT00692198|4050321|B1||Greater than 88%|Nadir SpO2 during 6-min walk while breathing ambient air||Participants|Count of Participants|101|101.0||||||
4226795|NCT00692198|4050319|B3||86% through 88%|Nadir SpO2 during 6-min walk while breathing ambient air||Participants|Count of Participants|208|208.0||||||
4226796|NCT00692198|4050320|B2||86% through 88%|Nadir SpO2 during 6-min walk while breathing ambient air||Participants|Count of Participants|103|103.0||||||
4226797|NCT00692198|4050321|B1||86% through 88%|Nadir SpO2 during 6-min walk while breathing ambient air||Participants|Count of Participants|105|105.0||||||
4226798|NCT00692198|4050319|B3||Less than 86%|Nadir SpO2 during 6-min walk while breathing ambient air||Participants|Count of Participants|171|171.0||||||
4226799|NCT00692198|4050320|B2||Less than 86%|Nadir SpO2 during 6-min walk while breathing ambient air||Participants|Count of Participants|85|85.0||||||
4226800|NCT00692198|4050321|B1||Less than 86%|Nadir SpO2 during 6-min walk while breathing ambient air||Participants|Count of Participants|86|86.0||||||
4226801|NCT00692198|4050319|B3|||SpO2 at rest while breathing ambient air||SpO2 (percent saturation)|Mean|93.4|93.4|Standard Deviation|2.0|2.0|||
4226802|NCT00692198|4050320|B2|||SpO2 at rest while breathing ambient air||SpO2 (percent saturation)|Mean|93.5|93.5|Standard Deviation|1.9|1.9|||
4226803|NCT00692198|4050321|B1|||SpO2 at rest while breathing ambient air||SpO2 (percent saturation)|Mean|93.3|93.3|Standard Deviation|2.1|2.1|||
4226804|NCT00692198|4050319|B3||Resting and exercise|Oxygen desaturation type qualifying patient for enrollment||Participants|Count of Participants|286|286.0||||||
4226805|NCT00692198|4050320|B2||Resting and exercise|Oxygen desaturation type qualifying patient for enrollment||Participants|Count of Participants|139|139.0||||||
4226806|NCT00692198|4050321|B1||Resting and exercise|Oxygen desaturation type qualifying patient for enrollment||Participants|Count of Participants|147|147.0||||||
4226807|NCT00692198|4050319|B3||Exercise desaturation only|Oxygen desaturation type qualifying patient for enrollment||Participants|Count of Participants|319|319.0||||||
4226808|NCT00692198|4050320|B2||Exercise desaturation only|Oxygen desaturation type qualifying patient for enrollment||Participants|Count of Participants|171|171.0||||||
4226809|NCT00692198|4050321|B1||Exercise desaturation only|Oxygen desaturation type qualifying patient for enrollment||Participants|Count of Participants|148|148.0||||||
4226810|NCT00692198|4050319|B3||Resting desaturation only|Oxygen desaturation type qualifying patient for enrollment||Participants|Count of Participants|133|133.0||||||
4226811|NCT00692198|4050320|B2||Resting desaturation only|Oxygen desaturation type qualifying patient for enrollment||Participants|Count of Participants|60|60.0||||||
4226812|NCT00692198|4050321|B1||Resting desaturation only|Oxygen desaturation type qualifying patient for enrollment||Participants|Count of Participants|73|73.0||||||
4226813|NCT00692198|4050319|B3|||St George's Respiratory Questionnaire total score|The St George's Respiratory Questionnaire measures the impact of chest disease on daily life and well-being and is comprised of 51 items. The total score ranges from 0 to 100 with lower scores indicating better functioning.|units on a scale|Mean|50.0|50.0|Standard Deviation|17.9|17.9|||
4226814|NCT00692198|4050320|B2|||St George's Respiratory Questionnaire total score|The St George's Respiratory Questionnaire measures the impact of chest disease on daily life and well-being and is comprised of 51 items. The total score ranges from 0 to 100 with lower scores indicating better functioning.|units on a scale|Mean|50.2|50.2|Standard Deviation|17.1|17.1|||
4226815|NCT00692198|4050321|B1|||St George's Respiratory Questionnaire total score|The St George's Respiratory Questionnaire measures the impact of chest disease on daily life and well-being and is comprised of 51 items. The total score ranges from 0 to 100 with lower scores indicating better functioning.|units on a scale|Mean|49.8|49.8|Standard Deviation|18.7|18.7|||
4226816|NCT00692198|4050319|B3|||Quality of Well-Being Scale mean daily score|The Quality of Well Being questionnaire measures health related quality of life and is comprised of of 79 self reported items. The total daily score ranges from 0 to 1, with higher score indicating higher quality of life.|units on a scale|Mean|0.56|0.56|Standard Deviation|0.13|0.13|||
4226817|NCT00692198|4050320|B2|||Quality of Well-Being Scale mean daily score|The Quality of Well Being questionnaire measures health related quality of life and is comprised of of 79 self reported items. The total daily score ranges from 0 to 1, with higher score indicating higher quality of life.|units on a scale|Mean|0.56|0.56|Standard Deviation|0.13|0.13|||
4226818|NCT00692198|4050321|B1|||Quality of Well-Being Scale mean daily score|The Quality of Well Being questionnaire measures health related quality of life and is comprised of of 79 self reported items. The total daily score ranges from 0 to 1, with higher score indicating higher quality of life.|units on a scale|Mean|0.56|0.56|Standard Deviation|0.13|0.13|||
4226819|NCT00692198|4050319|B3|||Current tobacco-cigarette smoker||Participants|Count of Participants|202|202.0||||||
4226820|NCT00692198|4050320|B2|||Current tobacco-cigarette smoker||Participants|Count of Participants|92|92.0||||||
4226821|NCT00692198|4050321|B1|||Current tobacco-cigarette smoker||Participants|Count of Participants|110|110.0||||||
4226822|NCT00692198|4050319|B3|||Medicare coverage||Participants|Count of Participants|541|541.0||||||
4226823|NCT00692198|4050320|B2|||Medicare coverage||Participants|Count of Participants|273|273.0||||||
4226824|NCT00692198|4050321|B1|||Medicare coverage||Participants|Count of Participants|268|268.0||||||
4226825|NCT00692198|4050319|B3|United States||Region of Enrollment||participants|Number|738|738.0||||||
4226826|NCT00692198|4050320|B2|United States||Region of Enrollment||participants|Number|370|370.0||||||
4226827|NCT00692198|4050321|B1|United States||Region of Enrollment||participants|Number|368|368.0||||||
4226828|NCT00692198|4050319|B3|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
4226829|NCT00692198|4050320|B2|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4226830|NCT00692198|4050321|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
4226831|NCT00692198|4050319|B3|Race|Caucasian only|Race/Ethnicity, Customized||Participants|Count of Participants|621|621.0||||||
4226832|NCT00692198|4050320|B2|Race|Caucasian only|Race/Ethnicity, Customized||Participants|Count of Participants|322|322.0||||||
4226833|NCT00692198|4050321|B1|Race|Caucasian only|Race/Ethnicity, Customized||Participants|Count of Participants|299|299.0||||||
4226834|NCT00692198|4050319|B3|Race|African American only|Race/Ethnicity, Customized||Participants|Count of Participants|80|80.0||||||
4226835|NCT00692198|4050320|B2|Race|African American only|Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
4226836|NCT00692198|4050321|B1|Race|African American only|Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
4226837|NCT00692198|4050319|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4226838|NCT00692198|4050320|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4226839|NCT00692198|4050321|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4226840|NCT00692198|4050319|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|724|724.0||||||
4226841|NCT00692198|4050320|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|366|366.0||||||
4226842|NCT00692198|4050321|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|358|358.0||||||
4226843|NCT00692198|4050319|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4226844|NCT00692198|4050320|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4226845|NCT00692198|4050321|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4226846|NCT00692198|4050319|B3||Male|Sex: Female, Male||Participants|Count of Participants|542|542.0||||||
4226847|NCT00692198|4050320|B2||Male|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
4226848|NCT00692198|4050321|B1||Male|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
4226849|NCT00692198|4050319|B3||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4226850|NCT00692198|4050320|B2||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4226851|NCT00692198|4050321|B1||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4226852|NCT00692198|4050319|B3|||Age||years|Mean|68.8|68.8|Standard Deviation|7.5|7.5|||
4226853|NCT00692198|4050320|B2|||Age||years|Mean|69.3|69.3|Standard Deviation|7.4|7.4|||
4226854|NCT00692198|4050321|B1|||Age||years|Mean|68.3|68.3|Standard Deviation|7.5|7.5|||
4226855|NCT00692185|4050355|B3|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4226856|NCT00692185|4050356|B2|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4226857|NCT00692185|4050357|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4226858|NCT00692185|4050355|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4226859|NCT00692185|4050356|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4226860|NCT00692185|4050357|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4226861|NCT00692185|4050355|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4226862|NCT00692185|4050356|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4226863|NCT00692185|4050357|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4226864|NCT00692185|4050355|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4226865|NCT00692185|4050356|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4226866|NCT00692185|4050357|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4226867|NCT00692185|4050355|B3|||Age||years|Mean|27.7|27.7|Standard Deviation|9.1|9.1|||
4226868|NCT00692185|4050356|B2|||Age||years|Mean|26.9|26.9|Standard Deviation|8.7|8.7|||
4226869|NCT00692185|4050357|B1|||Age||years|Mean|28.6|28.6|Standard Deviation|9.9|9.9|||
4226870|NCT00692185|4050355|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4226871|NCT00692185|4050356|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4226872|NCT00692185|4050357|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4226873|NCT00692185|4050355|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4226874|NCT00692185|4050356|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4226875|NCT00692185|4050357|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4226876|NCT00692185|4050355|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226877|NCT00692185|4050356|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226878|NCT00692185|4050357|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226879|NCT00692003|4050364|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4226880|NCT00692003|4050365|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4226881|NCT00692003|4050366|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4226882|NCT00692003|4050364|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4226883|NCT00692003|4050365|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4226884|NCT00692003|4050366|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4226885|NCT00692003|4050364|B3|||Age||years|Mean|36.5|36.5|Standard Deviation|17.33|17.33|||
4226886|NCT00692003|4050365|B2|||Age||years|Mean|27.0|27.0|Standard Deviation|NA||||N=1
4226887|NCT00692003|4050366|B1|||Age||years|Mean|38.4|38.4|Standard Deviation|18.66|18.66|||
4226888|NCT00691938|4050375|B8|United States||Region of Enrollment||participants|Number|52|52.0||||||
4226890|NCT00691938|4050377|B6|United States||Region of Enrollment||participants|Number|6|6.0||||||
4226891|NCT00691938|4050378|B5|United States||Region of Enrollment||participants|Number|10|10.0||||||
4226892|NCT00691938|4050379|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
4226893|NCT00691938|4050380|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4226894|NCT00691938|4050381|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4226895|NCT00691938|4050382|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4226896|NCT00691938|4050375|B8||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4226897|NCT00691938|4050376|B7||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4226898|NCT00691938|4050377|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4226899|NCT00691938|4050378|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4226900|NCT00691938|4050379|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4226901|NCT00691938|4050380|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4226902|NCT00691938|4050381|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4226903|NCT00691938|4050382|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4226904|NCT00691938|4050375|B8||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4226905|NCT00691938|4050376|B7||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4226906|NCT00691938|4050377|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4226907|NCT00691938|4050378|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4226908|NCT00691938|4050379|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4226909|NCT00691938|4050380|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4226910|NCT00691938|4050381|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4226911|NCT00691938|4050382|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4226912|NCT00691938|4050375|B8|||Age||years|Median|70|70.0|Full Range|||61.0|87.0|
4226913|NCT00691938|4050376|B7|||Age||years|Median|66|66.0|Full Range|||61.0|78.0|
4226914|NCT00691938|4050377|B6|||Age||years|Median|71|71.0|Full Range|||63.0|80.0|
4226915|NCT00691938|4050378|B5|||Age||years|Median|73|73.0|Full Range|||64.0|87.0|
4226916|NCT00691938|4050379|B4|||Age||years|Median|72|72.0|Full Range|||61.0|86.0|
4226917|NCT00691938|4050380|B3|||Age||years|Median|68|68.0|Full Range|||62.0|75.0|
4226918|NCT00691938|4050381|B2|||Age||years|Median|69|69.0|Full Range|||67.0|83.0|
4226919|NCT00691938|4050382|B1|||Age||years|Median|69|69.0|Full Range|||62.0|74.0|
4226920|NCT00691808|4050409|B4|White||Race/Ethnicity, Customized||Participants|Number|101|101.0||||||
4226921|NCT00691808|4050410|B3|White||Race/Ethnicity, Customized||Participants|Number|31|31.0||||||
4226922|NCT00691808|4050411|B2|White||Race/Ethnicity, Customized||Participants|Number|36|36.0||||||
4226923|NCT00691808|4050412|B1|White||Race/Ethnicity, Customized||Participants|Number|34|34.0||||||
4226924|NCT00691808|4050409|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4226925|NCT00691808|4050410|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4226926|NCT00691808|4050411|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4226927|NCT00691808|4050412|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4226928|NCT00691808|4050409|B4|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4226929|NCT00691808|4050410|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4226930|NCT00691808|4050411|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4226931|NCT00691808|4050412|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4226932|NCT00691808|4050409|B4||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4226933|NCT00691808|4050410|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4226934|NCT00691808|4050411|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4226935|NCT00691808|4050412|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4226936|NCT00691808|4050409|B4||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4226937|NCT00691808|4050410|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4226938|NCT00691808|4050411|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4226939|NCT00691808|4050412|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4226940|NCT00691808|4050409|B4|||Age||years|Mean|67.05|67.05|Standard Deviation|4.30|4.3|||
4226941|NCT00691808|4050410|B3|||Age||years|Mean|67.37|67.37|Standard Deviation|4.41|4.41|||
4226942|NCT00691808|4050411|B2|||Age||years|Mean|67.81|67.81|Standard Deviation|4.79|4.79|||
4226943|NCT00691808|4050412|B1|||Age||years|Mean|65.97|65.97|Standard Deviation|3.48|3.48|||
4226944|NCT00691704|4050455|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4226945|NCT00691704|4050455|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4226946|NCT00691704|4050455|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4226947|NCT00691704|4050455|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4226948|NCT00691704|4050455|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4226949|NCT00691704|4050455|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4226950|NCT00691704|4050455|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4226951|NCT00691704|4050455|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4226952|NCT00691704|4050455|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4226953|NCT00691704|4050455|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4226954|NCT00691704|4050455|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4226955|NCT00691704|4050455|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4226956|NCT00691704|4050455|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4226957|NCT00691704|4050455|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4226958|NCT00691704|4050455|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4226959|NCT00691704|4050455|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226960|NCT00691665|4050463|B3|Male||Gender|Gender information was not collected for 3 patients at baseline.|participants|Number|63|63.0||||||
4226961|NCT00691665|4050464|B2|Male||Gender|Gender information was not collected for 3 patients at baseline.|participants|Number|33|33.0||||||
4226962|NCT00691665|4050465|B1|Male||Gender|Gender information was not collected for 3 patients at baseline.|participants|Number|30|30.0||||||
4226963|NCT00691665|4050463|B3|Female||Gender|Gender information was not collected for 3 patients at baseline.|participants|Number|64|64.0||||||
4226964|NCT00691665|4050464|B2|Female||Gender|Gender information was not collected for 3 patients at baseline.|participants|Number|30|30.0||||||
4226965|NCT00691665|4050465|B1|Female||Gender|Gender information was not collected for 3 patients at baseline.|participants|Number|34|34.0||||||
4226966|NCT00691665|4050463|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4226967|NCT00691665|4050464|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4226968|NCT00691665|4050465|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4226969|NCT00691665|4050463|B3||Between 18 and 65 years|Age||Participants|Count of Participants|118|118.0||||||
4226970|NCT00691665|4050464|B2||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4226971|NCT00691665|4050465|B1||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4226972|NCT00691665|4050463|B3||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4226973|NCT00691665|4050464|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4226974|NCT00691665|4050465|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4226975|NCT00691652|4050478|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4226976|NCT00691652|4050478|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4226977|NCT00691652|4050478|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4226978|NCT00691652|4050478|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|4.949|4.949|||
4226979|NCT00691652|4050478|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4226980|NCT00691652|4050478|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4226981|NCT00691652|4050478|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4226982|NCT00691483|4050482|B3||Male|Sex: Female, Male||Participants|Count of Participants|392|392.0||||||
4226983|NCT00691483|4050483|B2||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4226984|NCT00691483|4050484|B1||Male|Sex: Female, Male||Participants|Count of Participants|293|293.0||||||
4226985|NCT00691483|4050482|B3||Female|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
4226986|NCT00691483|4050483|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4226987|NCT00691483|4050484|B1||Female|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4226988|NCT00691483|4050482|B3|>= 65 years||Age, Customized||Participants|Number|37|37.0||||||
4226989|NCT00691483|4050483|B2|>= 65 years||Age, Customized||Participants|Number|8|8.0||||||
4226990|NCT00691483|4050484|B1|>= 65 years||Age, Customized||Participants|Number|29|29.0||||||
4226991|NCT00691483|4050482|B3|Between 45 and 64 years||Age, Customized||Participants|Number|273|273.0||||||
4226992|NCT00691483|4050483|B2|Between 45 and 64 years||Age, Customized||Participants|Number|64|64.0||||||
4226993|NCT00691483|4050484|B1|Between 45 and 64 years||Age, Customized||Participants|Number|209|209.0||||||
4226994|NCT00691483|4050482|B3|Between 18 and 44 years||Age, Customized||Participants|Number|341|341.0||||||
4226995|NCT00691483|4050483|B2|Between 18 and 44 years||Age, Customized||Participants|Number|93|93.0||||||
4226996|NCT00691483|4050484|B1|Between 18 and 44 years||Age, Customized||Participants|Number|248|248.0||||||
4226997|NCT00691327|4050501|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4226998|NCT00691327|4050502|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4226999|NCT00691327|4050503|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4227000|NCT00691327|4050501|B3||Female|Sex: Female, Male||Participants|Count of Participants|84329|84329.0||||||
4227001|NCT00691327|4050502|B2||Female|Sex: Female, Male||Participants|Count of Participants|39274|39274.0||||||
4227002|NCT00691327|4050503|B1||Female|Sex: Female, Male||Participants|Count of Participants|45055|45055.0||||||
4227003|NCT00691327|4050501|B3|Not provided||Age, Customized||participants|Number|1190|1190.0||||||
4227004|NCT00691327|4050502|B2|Not provided||Age, Customized||participants|Number|619|619.0||||||
4227005|NCT00691327|4050503|B1|Not provided||Age, Customized||participants|Number|571|571.0||||||
4227006|NCT00691327|4050501|B3|>=70 years||Age, Customized||participants|Number|2104|2104.0||||||
4227007|NCT00691327|4050502|B2|>=70 years||Age, Customized||participants|Number|1039|1039.0||||||
4227008|NCT00691327|4050503|B1|>=70 years||Age, Customized||participants|Number|1065|1065.0||||||
4227009|NCT00691327|4050501|B3|Between 18 and 69 years||Age, Customized||participants|Number|80916|80916.0||||||
4227010|NCT00691327|4050502|B2|Between 18 and 69 years||Age, Customized||participants|Number|37612|37612.0||||||
4227011|NCT00691327|4050503|B1|Between 18 and 69 years||Age, Customized||participants|Number|43304|43304.0||||||
4227012|NCT00691327|4050501|B3|<=17 years||Age, Customized||participants|Number|119|119.0||||||
4227013|NCT00691327|4050502|B2|<=17 years||Age, Customized||participants|Number|4|4.0||||||
4227014|NCT00691327|4050503|B1|<=17 years||Age, Customized||participants|Number|115|115.0||||||
4227015|NCT00691301|4050512|B1|United States||Region of Enrollment||participants|Number|54|54.0||||||
4227016|NCT00691301|4050512|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4227017|NCT00691301|4050512|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227018|NCT00691301|4050512|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4227019|NCT00691301|4050512|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4227020|NCT00691301|4050512|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227021|NCT00691301|4050512|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4227022|NCT00691301|4050512|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4227023|NCT00691301|4050512|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227024|NCT00691301|4050512|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4227025|NCT00691301|4050512|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4227026|NCT00691301|4050512|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4227027|NCT00691301|4050512|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4227028|NCT00691301|4050512|B1|>60 years||Age, Customized||participants|Number|3|3.0||||||
4227029|NCT00691301|4050512|B1|50-59 years||Age, Customized||participants|Number|15|15.0||||||
4227030|NCT00691301|4050512|B1|40-49 years||Age, Customized||participants|Number|23|23.0||||||
4227031|NCT00691301|4050512|B1|30-39 years||Age, Customized||participants|Number|10|10.0||||||
4227032|NCT00691301|4050512|B1|20-29 years||Age, Customized||participants|Number|3|3.0||||||
4227033|NCT00691210|4050524|B9|Male||Gender||participants|Number|23|23.0||||||
4227034|NCT00691210|4050526|B7|Male||Gender||participants|Number|4|4.0||||||
4227035|NCT00691210|4050527|B6|Male||Gender||participants|Number|5|5.0||||||
4227036|NCT00691210|4050528|B5|Male||Gender||participants|Number|3|3.0||||||
4227037|NCT00691210|4050529|B4|Male||Gender||participants|Number|5|5.0||||||
4227038|NCT00691210|4050530|B3|Male||Gender||participants|Number|2|2.0||||||
4227039|NCT00691210|4050531|B2|Male||Gender||participants|Number|3|3.0||||||
4227040|NCT00691210|4050532|B1|Male||Gender||participants|Number|1|1.0||||||
4227041|NCT00691210|4050524|B9|Female||Gender||participants|Number|15|15.0||||||
4227042|NCT00691210|4050526|B7|Female||Gender||participants|Number|2|2.0||||||
4227043|NCT00691210|4050527|B6|Female||Gender||participants|Number|2|2.0||||||
4227044|NCT00691210|4050528|B5|Female||Gender||participants|Number|2|2.0||||||
4227045|NCT00691210|4050529|B4|Female||Gender||participants|Number|4|4.0||||||
4227046|NCT00691210|4050530|B3|Female||Gender||participants|Number|1|1.0||||||
4227047|NCT00691210|4050531|B2|Female||Gender||participants|Number|2|2.0||||||
4227048|NCT00691210|4050532|B1|Female||Gender||participants|Number|2|2.0||||||
4227049|NCT00691210|4050524|B9|>=65 years||Age||participants|Number|8|8.0||||||
4227050|NCT00691210|4050526|B7|>=65 years||Age||participants|Number|2|2.0||||||
4227051|NCT00691210|4050527|B6|>=65 years||Age||participants|Number|1|1.0||||||
4227052|NCT00691210|4050528|B5|>=65 years||Age||participants|Number|2|2.0||||||
4227053|NCT00691210|4050529|B4|>=65 years||Age||participants|Number|2|2.0||||||
4227054|NCT00691210|4050530|B3|>=65 years||Age||participants|Number|0|0.0||||||
4227055|NCT00691210|4050531|B2|>=65 years||Age||participants|Number|0|0.0||||||
4227056|NCT00691210|4050532|B1|>=65 years||Age||participants|Number|1|1.0||||||
4227057|NCT00691210|4050524|B9|Between 18 and 65 years||Age||participants|Number|30|30.0||||||
4227058|NCT00691210|4050526|B7|Between 18 and 65 years||Age||participants|Number|4|4.0||||||
4227059|NCT00691210|4050527|B6|Between 18 and 65 years||Age||participants|Number|6|6.0||||||
4227060|NCT00691210|4050528|B5|Between 18 and 65 years||Age||participants|Number|3|3.0||||||
4227061|NCT00691210|4050529|B4|Between 18 and 65 years||Age||participants|Number|7|7.0||||||
4227062|NCT00691210|4050530|B3|Between 18 and 65 years||Age||participants|Number|3|3.0||||||
4227063|NCT00691210|4050531|B2|Between 18 and 65 years||Age||participants|Number|5|5.0||||||
4227064|NCT00691210|4050532|B1|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
4227065|NCT00691210|4050524|B9|<=18 years||Age||participants|Number|0|0.0||||||
4227066|NCT00691210|4050526|B7|<=18 years||Age||participants|Number|0|0.0||||||
4227067|NCT00691210|4050527|B6|<=18 years||Age||participants|Number|0|0.0||||||
4227068|NCT00691210|4050528|B5|<=18 years||Age||participants|Number|0|0.0||||||
4227069|NCT00691210|4050529|B4|<=18 years||Age||participants|Number|0|0.0||||||
4227070|NCT00691210|4050530|B3|<=18 years||Age||participants|Number|0|0.0||||||
4227071|NCT00691210|4050531|B2|<=18 years||Age||participants|Number|0|0.0||||||
4227072|NCT00691210|4050532|B1|<=18 years||Age||participants|Number|0|0.0||||||
4227073|NCT00691197|4050557|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4227074|NCT00691197|4050558|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4227075|NCT00691197|4050559|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4227076|NCT00691197|4050557|B3||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4227077|NCT00691197|4050558|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4227078|NCT00691197|4050559|B1||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4227079|NCT00691197|4050557|B3|||Age||Years|Mean|37.4|37.4|Standard Deviation|11.80|11.8|||
4227080|NCT00691197|4050558|B2|||Age||Years|Mean|36.8|36.8|Standard Deviation|11.54|11.54|||
4227081|NCT00691197|4050559|B1|||Age||Years|Mean|37.6|37.6|Standard Deviation|11.94|11.94|||
4227082|NCT00691132|4050572|B3|Both null||GSTM1 & GSTT1 genotypes||participants|Number|12|12.0||||||
4227083|NCT00691132|4050573|B2|Both null||GSTM1 & GSTT1 genotypes||participants|Number|8|8.0||||||
4227084|NCT00691132|4050574|B1|Both null||GSTM1 & GSTT1 genotypes||participants|Number|4|4.0||||||
4227085|NCT00691132|4050572|B3|Null/present||GSTM1 & GSTT1 genotypes||participants|Number|25|25.0||||||
4227086|NCT00691132|4050573|B2|Null/present||GSTM1 & GSTT1 genotypes||participants|Number|11|11.0||||||
4227087|NCT00691132|4050574|B1|Null/present||GSTM1 & GSTT1 genotypes||participants|Number|14|14.0||||||
4227088|NCT00691132|4050572|B3|Present/null||GSTM1 & GSTT1 genotypes||participants|Number|7|7.0||||||
4227089|NCT00691132|4050573|B2|Present/null||GSTM1 & GSTT1 genotypes||participants|Number|4|4.0||||||
4227090|NCT00691132|4050574|B1|Present/null||GSTM1 & GSTT1 genotypes||participants|Number|3|3.0||||||
4227091|NCT00691132|4050572|B3|Both present||GSTM1 & GSTT1 genotypes||participants|Number|38|38.0||||||
4227092|NCT00691132|4050573|B2|Both present||GSTM1 & GSTT1 genotypes||participants|Number|18|18.0||||||
4227093|NCT00691132|4050574|B1|Both present||GSTM1 & GSTT1 genotypes||participants|Number|20|20.0||||||
4227094|NCT00691132|4050572|B3|Greater than monthly||Alcohol drinking||participants|Number|23|23.0||||||
4227095|NCT00691132|4050573|B2|Greater than monthly||Alcohol drinking||participants|Number|11|11.0||||||
4227096|NCT00691132|4050574|B1|Greater than monthly||Alcohol drinking||participants|Number|12|12.0||||||
4227097|NCT00691132|4050572|B3|Monthly or less||Alcohol drinking||participants|Number|26|26.0||||||
4227098|NCT00691132|4050573|B2|Monthly or less||Alcohol drinking||participants|Number|12|12.0||||||
4227099|NCT00691132|4050574|B1|Monthly or less||Alcohol drinking||participants|Number|14|14.0||||||
4227100|NCT00691132|4050572|B3|Never||Alcohol drinking||participants|Number|31|31.0||||||
4227101|NCT00691132|4050573|B2|Never||Alcohol drinking||participants|Number|17|17.0||||||
4227102|NCT00691132|4050574|B1|Never||Alcohol drinking||participants|Number|14|14.0||||||
4227103|NCT00691132|4050572|B3|Age became regular smokers||Cigarette smoking history||years|Mean|18.1|18.1|Standard Deviation|6.2|6.2|||
4227104|NCT00691132|4050573|B2|Age became regular smokers||Cigarette smoking history||years|Mean|17.7|17.7|Standard Deviation|5.2|5.2|||
4227105|NCT00691132|4050574|B1|Age became regular smokers||Cigarette smoking history||years|Mean|18.6|18.6|Standard Deviation|7.1|7.1|||
4227106|NCT00691132|4050572|B3|Age at starting smoking||Cigarette smoking history||years|Mean|15.1|15.1|Standard Deviation|4.7|4.7|||
4227107|NCT00691132|4050573|B2|Age at starting smoking||Cigarette smoking history||years|Mean|15.1|15.1|Standard Deviation|4.6|4.6|||
4227108|NCT00691132|4050574|B1|Age at starting smoking||Cigarette smoking history||years|Mean|15.2|15.2|Standard Deviation|4.9|4.9|||
4227109|NCT00691132|4050572|B3|Years of smoking||Cigarette smoking history||years|Mean|16.3|16.3|Standard Deviation|9.8|9.8|||
4227110|NCT00691132|4050573|B2|Years of smoking||Cigarette smoking history||years|Mean|17.9|17.9|Standard Deviation|9.4|9.4|||
4227111|NCT00691132|4050574|B1|Years of smoking||Cigarette smoking history||years|Mean|14.7|14.7|Standard Deviation|10.3|10.3|||
4227112|NCT00691132|4050572|B3|||Current smoking rate||cigarettes/day|Mean|19.1|19.1|Standard Deviation|6.6|6.6|||
4227113|NCT00691132|4050573|B2|||Current smoking rate||cigarettes/day|Mean|19.0|19.0|Standard Deviation|6.7|6.7|||
4227114|NCT00691132|4050574|B1|||Current smoking rate||cigarettes/day|Mean|19.3|19.3|Standard Deviation|6.6|6.6|||
4227115|NCT00691132|4050572|B3|College or higher||Level of Education||participants|Number|48|48.0||||||
4227116|NCT00691132|4050573|B2|College or higher||Level of Education||participants|Number|21|21.0||||||
4227117|NCT00691132|4050574|B1|College or higher||Level of Education||participants|Number|27|27.0||||||
4227118|NCT00691132|4050572|B3|High school or lower||Level of Education||participants|Number|34|34.0||||||
4227119|NCT00691132|4050573|B2|High school or lower||Level of Education||participants|Number|20|20.0||||||
4227120|NCT00691132|4050574|B1|High school or lower||Level of Education||participants|Number|14|14.0||||||
4227121|NCT00691132|4050572|B3|||Body Mass Index||kg/m^2|Mean|28.0|28.0|Standard Deviation|5.6|5.6|||
4227122|NCT00691132|4050573|B2|||Body Mass Index||kg/m^2|Mean|28.0|28.0|Standard Deviation|6.3|6.3|||
4227123|NCT00691132|4050574|B1|||Body Mass Index||kg/m^2|Mean|28.0|28.0|Standard Deviation|4.8|4.8|||
4227124|NCT00691132|4050572|B3|United States||Region of Enrollment||participants|Number|82|82.0||||||
4227125|NCT00691132|4050573|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
4227126|NCT00691132|4050574|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4227127|NCT00691132|4050572|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4227128|NCT00691132|4050573|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4227129|NCT00691132|4050574|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4227130|NCT00691132|4050572|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227131|NCT00691132|4050573|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227132|NCT00691132|4050574|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227133|NCT00691132|4050572|B3||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4227134|NCT00691132|4050573|B2||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4227135|NCT00691132|4050574|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4227136|NCT00691132|4050572|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4227137|NCT00691132|4050573|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4227138|NCT00691132|4050574|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4227139|NCT00691132|4050572|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227140|NCT00691132|4050573|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227141|NCT00691132|4050574|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227142|NCT00691132|4050572|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227143|NCT00691132|4050573|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227144|NCT00691132|4050574|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227145|NCT00691132|4050572|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227146|NCT00691132|4050573|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227147|NCT00691132|4050574|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227148|NCT00691132|4050572|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4227149|NCT00691132|4050573|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4227150|NCT00691132|4050574|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4227151|NCT00691132|4050572|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4227152|NCT00691132|4050573|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4227153|NCT00691132|4050574|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4227154|NCT00691132|4050572|B3|||Age||years|Mean|41.0|41.0|Standard Deviation|10.1|10.1|||
4227155|NCT00691132|4050573|B2|||Age||years|Mean|41.1|41.1|Standard Deviation|9.6|9.6|||
4227156|NCT00691132|4050574|B1|||Age||years|Mean|40.9|40.9|Standard Deviation|10.6|10.6|||
4227157|NCT00691132|4050572|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4227158|NCT00691132|4050573|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4227159|NCT00691132|4050574|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4227160|NCT00691132|4050572|B3||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
4227161|NCT00691132|4050573|B2||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4227162|NCT00691132|4050574|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4227163|NCT00691132|4050572|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4227164|NCT00691132|4050573|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4227165|NCT00691132|4050574|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4227166|NCT00691093|4050594|B1||Male|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
4227167|NCT00691093|4050594|B1||Female|Sex: Female, Male||Participants|Count of Participants|574|574.0||||||
4227168|NCT00691093|4050594|B1|>=65 years||Age, Customized||participants|Number|213|213.0||||||
4227169|NCT00691093|4050594|B1|44-64||Age, Customized||participants|Number|497|497.0||||||
4227170|NCT00691093|4050594|B1|18-44 years||Age, Customized||participants|Number|102|102.0||||||
4227171|NCT00691093|4050594|B1|<18 years||Age, Customized||participants|Number|11|11.0||||||
4227172|NCT00691054|4050628|B1|||Stage-IV Disease|Number of participants with stage IV disease at enrollment|participants|Number|18|18.0||||||
4227173|NCT00691054|4050628|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4227174|NCT00691054|4050628|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4227175|NCT00691054|4050628|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4227176|NCT00691054|4050628|B1|||Age||years|Median|61|61.0|Full Range|||24.0|80.0|
4227177|NCT00691054|4050628|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4227178|NCT00691054|4050628|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4227179|NCT00691054|4050628|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4227180|NCT00691028|4050637|B4||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4227181|NCT00691028|4050638|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4227182|NCT00691028|4050639|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4227183|NCT00691028|4050640|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4227184|NCT00691028|4050637|B4||Female|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
4227185|NCT00691028|4050638|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4227186|NCT00691028|4050639|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4227187|NCT00691028|4050640|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4227188|NCT00691028|4050637|B4|||Age||years|Mean|49.6|49.6|Standard Deviation|12.0|12.0|||
4227189|NCT00691028|4050638|B3|||Age||years|Mean|50.4|50.4|Standard Deviation|12.5|12.5|||
4227190|NCT00691028|4050639|B2|||Age||years|Mean|48.8|48.8|Standard Deviation|11.8|11.8|||
4227191|NCT00691028|4050640|B1|||Age||years|Mean|49.7|49.7|Standard Deviation|11.7|11.7|||
4227192|NCT00691028|4050637|B4||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4227193|NCT00691028|4050638|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4227194|NCT00691028|4050639|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4227195|NCT00691028|4050640|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4227196|NCT00691028|4050637|B4||Between 18 and 65 years|Age||Participants|Count of Participants|277|277.0||||||
4227197|NCT00691028|4050638|B3||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
4227198|NCT00691028|4050639|B2||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
4227199|NCT00691028|4050640|B1||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
4227200|NCT00691028|4050637|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4227201|NCT00691028|4050638|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4227202|NCT00691028|4050639|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4227203|NCT00691028|4050640|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4227204|NCT00691015|4050676|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
4227205|NCT00691015|4050676|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4227206|NCT00691015|4050676|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4227207|NCT00691015|4050676|B1|||Age||years|Median|53|53.0|Full Range|||20.0|70.0|
4227208|NCT00690924|4050687|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227209|NCT00690924|4050687|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227210|NCT00690924|4050687|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4227211|NCT00690924|4050687|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227212|NCT00690924|4050687|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227213|NCT00690924|4050687|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227214|NCT00690924|4050687|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227215|NCT00690924|4050687|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4227216|NCT00690924|4050687|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4227217|NCT00690924|4050687|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|8.6|8.6|||
4227218|NCT00690924|4050687|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4227219|NCT00690924|4050687|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4227220|NCT00690924|4050687|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4227221|NCT00690898|4050691|B1|||Global AcroQoL score|Acromegaly Quality of Life Assessment (AcroQoL) questionnaire response scores range from 0 to 100. Higher scores indicate best possible Quality of Life. AcroQoL not assessed in patients from Turkey and Finland.|score on a scale|Mean|56.4|56.4|Standard Deviation|16.1|16.1|||
4227222|NCT00690898|4050691|B1|||Prolactin level||mcg/L|Mean|19.0|19.0|Standard Deviation|20.2|20.2|||
4227223|NCT00690898|4050691|B1|||Insulin-like Growth Factor 1 (IGF-1) level||mcg/L|Mean|810|810.0|Standard Deviation|300|300.0|||
4227224|NCT00690898|4050691|B1|||Growth Hormone (GH) level||mcg/L|Mean|15.0|15.0|Standard Deviation|18.8|18.8|||
4227225|NCT00690898|4050691|B1|||Pituitary gland MRI volume (V1)||mm^3|Mean|2739.3|2739.3|Standard Deviation|3262.7|3262.7|||
4227226|NCT00690898|4050691|B1|||Time since acromegaly diagnosis||days|Mean|121.2|121.2|Standard Deviation|149.9|149.9|||
4227227|NCT00690898|4050691|B1|Arthralgia||Acromegaly Symptoms|Acromegaly symptoms assessed on a scale of 0 to 8 (0- no symptoms to 8-severe/incapacitating).|score on a scale|Mean|3.5|3.5|Standard Deviation|2.6|2.6|||
4227228|NCT00690898|4050691|B1|Soft tissue swelling||Acromegaly Symptoms|Acromegaly symptoms assessed on a scale of 0 to 8 (0- no symptoms to 8-severe/incapacitating).|score on a scale|Mean|4.1|4.1|Standard Deviation|2.4|2.4|||
4227229|NCT00690898|4050691|B1|Fatigue||Acromegaly Symptoms|Acromegaly symptoms assessed on a scale of 0 to 8 (0- no symptoms to 8-severe/incapacitating).|score on a scale|Mean|4.2|4.2|Standard Deviation|2.5|2.5|||
4227230|NCT00690898|4050691|B1|Excessive perspiration||Acromegaly Symptoms|Acromegaly symptoms assessed on a scale of 0 to 8 (0- no symptoms to 8-severe/incapacitating).|score on a scale|Mean|4.1|4.1|Standard Deviation|2.4|2.4|||
4227231|NCT00690898|4050691|B1|Headache||Acromegaly Symptoms|Acromegaly symptoms assessed on a scale of 0 to 8 (0- no symptoms to 8-severe/incapacitating).|score on a scale|Mean|2.8|2.8|Standard Deviation|2.6|2.6|||
4227232|NCT00690898|4050691|B1|||Maximum pituitary adenoma diameter (V1)||mm|Mean|19.0|19.0|Standard Deviation|7.1|7.1|||
4227233|NCT00690898|4050691|B1|Turkey||Region of Enrollment||participants|Number|2|2.0||||||
4227234|NCT00690898|4050691|B1|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
4227235|NCT00690898|4050691|B1|Finland||Region of Enrollment||participants|Number|3|3.0||||||
4227236|NCT00690898|4050691|B1|Czech Republic||Region of Enrollment||participants|Number|3|3.0||||||
4227237|NCT00690898|4050691|B1|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
4227238|NCT00690898|4050691|B1|Italy||Region of Enrollment||participants|Number|7|7.0||||||
4227239|NCT00690898|4050691|B1|Germany||Region of Enrollment||participants|Number|10|10.0||||||
4227240|NCT00690898|4050691|B1|United Kingdom||Region of Enrollment||participants|Number|17|17.0||||||
4227241|NCT00690898|4050691|B1|France||Region of Enrollment||participants|Number|42|42.0||||||
4227242|NCT00690898|4050691|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4227243|NCT00690898|4050691|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4227244|NCT00690898|4050691|B1|||Age||years|Mean|49.5|49.5|Standard Deviation|12.4|12.4|||
4227245|NCT00690833|4050705|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4227246|NCT00690833|4050705|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4227247|NCT00690833|4050705|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4227248|NCT00690833|4050705|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4227249|NCT00690833|4050705|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4227250|NCT00690833|4050705|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227251|NCT00690833|4050705|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4227252|NCT00690833|4050705|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227253|NCT00690833|4050705|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4227254|NCT00690833|4050705|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4227255|NCT00690833|4050705|B1|||Age||years|Median|13|13.0|Full Range|||1.0|70.0|
4227256|NCT00690820|4050709|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4227257|NCT00690820|4050710|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4227258|NCT00690820|4050711|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4227259|NCT00690820|4050709|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4227260|NCT00690820|4050710|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4227261|NCT00690820|4050711|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4227262|NCT00690820|4050709|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4227263|NCT00690820|4050710|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4227264|NCT00690820|4050711|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4227265|NCT00690820|4050709|B3|||Age||years|Mean|8.8|8.8|Standard Deviation|1.3|1.3|||
4227266|NCT00690820|4050710|B2|||Age||years|Mean|8.7|8.7|Standard Deviation|1.4|1.4|||
4227267|NCT00690820|4050711|B1|||Age||years|Mean|8.9|8.9|Standard Deviation|1.1|1.1|||
4227268|NCT00690794|4050732|B3||Male|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
4227269|NCT00690794|4050733|B2||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4227270|NCT00690794|4050734|B1||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4227271|NCT00690794|4050732|B3||Female|Sex: Female, Male||Participants|Count of Participants|441|441.0||||||
4227272|NCT00690794|4050733|B2||Female|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4227273|NCT00690794|4050734|B1||Female|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4227274|NCT00690794|4050732|B3|||Age||years|Mean|67.5|67.5|Standard Deviation|10.9|10.9|||
4227275|NCT00690794|4050733|B2|||Age||years|Mean|67.8|67.8|Standard Deviation|10.8|10.8|||
4227276|NCT00690794|4050734|B1|||Age||years|Mean|67.1|67.1|Standard Deviation|11.0|11.0|||
4227277|NCT00690755|4050743|B8|United States||Region of Enrollment||participants|Number|100|100.0||||||
4227278|NCT00690755|4050745|B6|United States||Region of Enrollment||participants|Number|6|6.0||||||
4227279|NCT00690755|4050747|B4|United States||Region of Enrollment||participants|Number|15|15.0||||||
4227280|NCT00690755|4050748|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
4227281|NCT00690755|4050750|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4227282|NCT00690755|4050743|B8|Male||Gender||participants|Number|63|63.0||||||
4227283|NCT00690755|4050745|B6|Male||Gender||participants|Number|3|3.0||||||
4227284|NCT00690755|4050747|B4|Male||Gender||participants|Number|5|5.0||||||
4227285|NCT00690755|4050748|B3|Male||Gender||participants|Number|33|33.0||||||
4227286|NCT00690755|4050750|B1|Male||Gender||participants|Number|22|22.0||||||
4227287|NCT00690755|4050743|B8|Female||Gender||participants|Number|37|37.0||||||
4227288|NCT00690755|4050745|B6|Female||Gender||participants|Number|3|3.0||||||
4227289|NCT00690755|4050747|B4|Female||Gender||participants|Number|10|10.0||||||
4227290|NCT00690755|4050748|B3|Female||Gender||participants|Number|18|18.0||||||
4227291|NCT00690755|4050750|B1|Female||Gender||participants|Number|6|6.0||||||
4227292|NCT00690755|4050743|B8|||Age||years|Mean|47|47.0|Standard Deviation|4|4.0|||
4227293|NCT00690755|4050745|B6|||Age||years|Mean|43|43.0|Standard Deviation|3|3.0|||
4227294|NCT00690755|4050747|B4|||Age||years|Mean|51|51.0|Standard Deviation|3|3.0|||
4227295|NCT00690755|4050748|B3|||Age||years|Mean|47|47.0|Standard Deviation|3|3.0|||
4227296|NCT00690755|4050750|B1|||Age||years|Mean|51|51.0|Standard Deviation|1|1.0|||
4227297|NCT00690612|4050772|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4227298|NCT00690612|4050772|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4227299|NCT00690612|4050772|B1|<=11 years||Age||Years|Mean|4.4|4.4|Standard Deviation|1.6|1.6|||
4227300|NCT00690573|4050777|B1|Japan||Region of Enrollment||participants|Number|25|25.0||||||
4227301|NCT00690573|4050777|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4227302|NCT00690573|4050777|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4227303|NCT00690573|4050777|B1|||Age||years|Mean|13.0|13.0|Standard Deviation|3.38|3.38|||
4227304|NCT00690573|4050777|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4227305|NCT00690573|4050777|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4227306|NCT00690573|4050777|B1||<=18 years|Age||Participants|Count of Participants|25|25.0||||||
4227307|NCT00690495|4050785|B3|Germany||Region of Enrollment||participants|Number|100|100.0||||||
4227308|NCT00690495|4050786|B2|Germany||Region of Enrollment||participants|Number|50|50.0||||||
4227309|NCT00690495|4050787|B1|Germany||Region of Enrollment||participants|Number|50|50.0||||||
4227310|NCT00690495|4050785|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4227311|NCT00690495|4050786|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4227312|NCT00690495|4050787|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4227313|NCT00690495|4050785|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4227314|NCT00690495|4050786|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4227315|NCT00690495|4050787|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4227316|NCT00690495|4050785|B3|||Age||years|Mean|54.8|54.8|Standard Deviation|14.2|14.2|||
4227317|NCT00690495|4050786|B2|||Age||years|Mean|55.2|55.2|Standard Deviation|13.9|13.9|||
4227318|NCT00690495|4050787|B1|||Age||years|Mean|54.4|54.4|Standard Deviation|14.6|14.6|||
4227319|NCT00690495|4050785|B3||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4227320|NCT00690495|4050786|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4227321|NCT00690495|4050787|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4227322|NCT00690495|4050785|B3||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
4227323|NCT00690495|4050786|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4227324|NCT00690495|4050787|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4227325|NCT00690495|4050785|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4227326|NCT00690495|4050786|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4227327|NCT00690495|4050787|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4227328|NCT00690482|4050794|B3||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4227329|NCT00690482|4050795|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4227330|NCT00690482|4050796|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4227331|NCT00690482|4050794|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4227332|NCT00690482|4050795|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4227333|NCT00690482|4050796|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4227334|NCT00690482|4050794|B3|||Age||Years|Mean|62.4|62.4|Full Range|||43.0|83.0|
4227335|NCT00690482|4050795|B2|||Age||Years|Mean|62.4|62.4|Full Range|||43.0|83.0|
4227336|NCT00690482|4050796|B1|||Age||Years|Mean|64.1|64.1|Full Range|||47.0|78.0|
4227337|NCT00690443|4050829|B3|United States||Region of Enrollment||Participants|Number|44|44.0||||||
4227338|NCT00690443|4050830|B2|United States||Region of Enrollment||Participants|Number|21|21.0||||||
4227339|NCT00690443|4050831|B1|United States||Region of Enrollment||Participants|Number|23|23.0||||||
4227340|NCT00690443|4050829|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227341|NCT00690443|4050830|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227342|NCT00690443|4050831|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227343|NCT00690443|4050829|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227344|NCT00690443|4050830|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227345|NCT00690443|4050831|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227346|NCT00690443|4050829|B3||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4227347|NCT00690443|4050830|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4227348|NCT00690443|4050831|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4227349|NCT00690443|4050829|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4227350|NCT00690443|4050830|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4227351|NCT00690443|4050831|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227352|NCT00690443|4050829|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227353|NCT00690443|4050830|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227354|NCT00690443|4050831|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227355|NCT00690443|4050829|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4227356|NCT00690443|4050830|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227357|NCT00690443|4050831|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4227358|NCT00690443|4050829|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227359|NCT00690443|4050830|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227360|NCT00690443|4050831|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227361|NCT00690443|4050829|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227362|NCT00690443|4050830|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227363|NCT00690443|4050831|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227364|NCT00690443|4050829|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4227365|NCT00690443|4050830|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4227366|NCT00690443|4050831|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4227367|NCT00690443|4050829|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4227368|NCT00690443|4050830|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4227369|NCT00690443|4050831|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4227370|NCT00690443|4050829|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4227371|NCT00690443|4050830|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4227372|NCT00690443|4050831|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4227373|NCT00690443|4050829|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4227374|NCT00690443|4050830|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4227375|NCT00690443|4050831|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4227376|NCT00690443|4050829|B3|||Age||Years|Mean|58.3|58.3|Standard Deviation|7.09|7.09|||
4227377|NCT00690443|4050830|B2|||Age||Years|Mean|57.8|57.8|Standard Deviation|8.06|8.06|||
4227378|NCT00690443|4050831|B1|||Age||Years|Mean|58.8|58.8|Standard Deviation|6.22|6.22|||
4227379|NCT00690430|4050840|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4227380|NCT00690430|4050841|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4227381|NCT00690430|4050842|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4227382|NCT00690430|4050840|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4227383|NCT00690430|4050841|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4227384|NCT00690430|4050842|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4227385|NCT00690430|4050840|B3|||Age||Years|Mean|62|62.0|Standard Deviation|10.67|10.67|||
4227386|NCT00690430|4050841|B2|||Age||Years|Mean|62.8|62.8|Standard Deviation|11.91|11.91|||
4227387|NCT00690430|4050842|B1|||Age||Years|Mean|61.2|61.2|Standard Deviation|9.21|9.21|||
4227388|NCT00690378|4050871|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4227389|NCT00690378|4050872|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4227390|NCT00690378|4050873|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4227391|NCT00690378|4050871|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4227392|NCT00690378|4050872|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4227393|NCT00690378|4050873|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4227394|NCT00690378|4050871|B3|||Age||Years|Mean|48.15|48.15|Standard Deviation|18.34|18.34|||
4227395|NCT00690378|4050872|B2|||Age||Years|Mean|49.9|49.9|Standard Deviation|18.44|18.44|||
4227396|NCT00690378|4050873|B1|||Age||Years|Mean|46.4|46.4|Standard Deviation|18.24|18.24|||
4227397|NCT00690339|4050918|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4227398|NCT00690339|4050919|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4227399|NCT00690339|4050920|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4227400|NCT00690339|4050921|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4227401|NCT00690339|4050922|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4227402|NCT00690339|4050918|B5||Female|Sex: Female, Male||Participants|Count of Participants|941|941.0||||||
4227403|NCT00690339|4050919|B4||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4227404|NCT00690339|4050920|B3||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4227405|NCT00690339|4050921|B2||Female|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
4227406|NCT00690339|4050922|B1||Female|Sex: Female, Male||Participants|Count of Participants|492|492.0||||||
4227407|NCT00690339|4050918|B5||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4227408|NCT00690339|4050919|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4227409|NCT00690339|4050920|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4227410|NCT00690339|4050921|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4227411|NCT00690339|4050922|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4227412|NCT00690339|4050918|B5||Between 18 and 65 years|Age||Participants|Count of Participants|931|931.0||||||
4227413|NCT00690339|4050919|B4||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4227414|NCT00690339|4050920|B3||Between 18 and 65 years|Age||Participants|Count of Participants|156|156.0||||||
4227415|NCT00690339|4050921|B2||Between 18 and 65 years|Age||Participants|Count of Participants|218|218.0||||||
4227416|NCT00690339|4050922|B1||Between 18 and 65 years|Age||Participants|Count of Participants|492|492.0||||||
4227417|NCT00690339|4050918|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4227418|NCT00690339|4050919|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4227419|NCT00690339|4050920|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4227420|NCT00690339|4050921|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4227421|NCT00690339|4050922|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4227422|NCT00690235|4050939|B3|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
4227423|NCT00690235|4050940|B2|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4227424|NCT00690235|4050941|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4227425|NCT00690235|4050939|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227426|NCT00690235|4050940|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227427|NCT00690235|4050941|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227428|NCT00690235|4050939|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227429|NCT00690235|4050940|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227430|NCT00690235|4050941|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227431|NCT00690235|4050939|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4227432|NCT00690235|4050940|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4227433|NCT00690235|4050941|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4227434|NCT00690235|4050939|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4227435|NCT00690235|4050940|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4227436|NCT00690235|4050941|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4227437|NCT00690235|4050939|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227438|NCT00690235|4050940|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227439|NCT00690235|4050941|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227440|NCT00690235|4050939|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227441|NCT00690235|4050940|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227442|NCT00690235|4050941|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227443|NCT00690235|4050939|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227444|NCT00690235|4050940|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227445|NCT00690235|4050941|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227446|NCT00690235|4050939|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227447|NCT00690235|4050940|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227448|NCT00690235|4050941|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227449|NCT00690235|4050939|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4227450|NCT00690235|4050940|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4227451|NCT00690235|4050941|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4227452|NCT00690235|4050939|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4227453|NCT00690235|4050940|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4227454|NCT00690235|4050941|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4227455|NCT00690235|4050939|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4227456|NCT00690235|4050940|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4227457|NCT00690235|4050941|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4227458|NCT00690235|4050939|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4227459|NCT00690235|4050940|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4227460|NCT00690235|4050941|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4227461|NCT00690235|4050939|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4227462|NCT00690235|4050940|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4227463|NCT00690235|4050941|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4227464|NCT00690235|4050939|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4227465|NCT00690235|4050940|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4227466|NCT00690235|4050941|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4227467|NCT00690235|4050939|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4227468|NCT00690235|4050940|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4227469|NCT00690235|4050941|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4227470|NCT00690040|4050948|B3|Israel||Region of Enrollment||participants|Number|293|293.0||||||
4227471|NCT00690040|4050949|B2|Israel||Region of Enrollment||participants|Number|148|148.0||||||
4227472|NCT00690040|4050950|B1|Israel||Region of Enrollment||participants|Number|145|145.0||||||
4227473|NCT00690040|4050948|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4227474|NCT00690040|4050949|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4227475|NCT00690040|4050950|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4227476|NCT00690040|4050948|B3||Female|Sex: Female, Male||Participants|Count of Participants|293|293.0||||||
4227477|NCT00690040|4050949|B2||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4227478|NCT00690040|4050950|B1||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4227479|NCT00690040|4050948|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4227480|NCT00690040|4050949|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4227481|NCT00690040|4050950|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4227482|NCT00690040|4050948|B3||Between 18 and 65 years|Age||Participants|Count of Participants|293|293.0||||||
4227483|NCT00690040|4050949|B2||Between 18 and 65 years|Age||Participants|Count of Participants|148|148.0||||||
4227484|NCT00690040|4050950|B1||Between 18 and 65 years|Age||Participants|Count of Participants|145|145.0||||||
4227485|NCT00690040|4050948|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4227486|NCT00690040|4050949|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4227487|NCT00690040|4050950|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4227488|NCT00689936|4050957|B4|Missing||Cytogenetic Risk|Cytogenetic risk categories are mutually exclusive. Definitions: Adverse risk category: t(4:14), t(14:16), del (13q) or monosomy 13, del (17p), 1q gain; Non-adverse risk categories include favorable hyperdiploidy: t(11:14), gains of 5/9/15; normal: a normal result, gains other than 5/9/15, IgH deletion, and uncertain risk: probes used for analysis cannot place participant in any risk categories. Not evaluable: no specimen received, test failure or insufficient number of cells available for analysis.|Participants|Number|95|95.0||||||
4227489|NCT00689936|4050958|B3|Missing||Cytogenetic Risk|Cytogenetic risk categories are mutually exclusive. Definitions: Adverse risk category: t(4:14), t(14:16), del (13q) or monosomy 13, del (17p), 1q gain; Non-adverse risk categories include favorable hyperdiploidy: t(11:14), gains of 5/9/15; normal: a normal result, gains other than 5/9/15, IgH deletion, and uncertain risk: probes used for analysis cannot place participant in any risk categories. Not evaluable: no specimen received, test failure or insufficient number of cells available for analysis.|Participants|Number|31|31.0||||||
4227490|NCT00689936|4050959|B2|Missing||Cytogenetic Risk|Cytogenetic risk categories are mutually exclusive. Definitions: Adverse risk category: t(4:14), t(14:16), del (13q) or monosomy 13, del (17p), 1q gain; Non-adverse risk categories include favorable hyperdiploidy: t(11:14), gains of 5/9/15; normal: a normal result, gains other than 5/9/15, IgH deletion, and uncertain risk: probes used for analysis cannot place participant in any risk categories. Not evaluable: no specimen received, test failure or insufficient number of cells available for analysis.|Participants|Number|31|31.0||||||
4227491|NCT00689936|4050960|B1|Missing||Cytogenetic Risk|Cytogenetic risk categories are mutually exclusive. Definitions: Adverse risk category: t(4:14), t(14:16), del (13q) or monosomy 13, del (17p), 1q gain; Non-adverse risk categories include favorable hyperdiploidy: t(11:14), gains of 5/9/15; normal: a normal result, gains other than 5/9/15, IgH deletion, and uncertain risk: probes used for analysis cannot place participant in any risk categories. Not evaluable: no specimen received, test failure or insufficient number of cells available for analysis.|Participants|Number|33|33.0||||||
4227492|NCT00689936|4050957|B4|Not evaluable||Cytogenetic Risk|Cytogenetic risk categories are mutually exclusive. Definitions: Adverse risk category: t(4:14), t(14:16), del (13q) or monosomy 13, del (17p), 1q gain; Non-adverse risk categories include favorable hyperdiploidy: t(11:14), gains of 5/9/15; normal: a normal result, gains other than 5/9/15, IgH deletion, and uncertain risk: probes used for analysis cannot place participant in any risk categories. Not evaluable: no specimen received, test failure or insufficient number of cells available for analysis.|Participants|Number|113|113.0||||||
4227493|NCT00689936|4050958|B3|Not evaluable||Cytogenetic Risk|Cytogenetic risk categories are mutually exclusive. Definitions: Adverse risk category: t(4:14), t(14:16), del (13q) or monosomy 13, del (17p), 1q gain; Non-adverse risk categories include favorable hyperdiploidy: t(11:14), gains of 5/9/15; normal: a normal result, gains other than 5/9/15, IgH deletion, and uncertain risk: probes used for analysis cannot place participant in any risk categories. Not evaluable: no specimen received, test failure or insufficient number of cells available for analysis.|Participants|Number|44|44.0||||||
4227494|NCT00689936|4050959|B2|Not evaluable||Cytogenetic Risk|Cytogenetic risk categories are mutually exclusive. Definitions: Adverse risk category: t(4:14), t(14:16), del (13q) or monosomy 13, del (17p), 1q gain; Non-adverse risk categories include favorable hyperdiploidy: t(11:14), gains of 5/9/15; normal: a normal result, gains other than 5/9/15, IgH deletion, and uncertain risk: probes used for analysis cannot place participant in any risk categories. Not evaluable: no specimen received, test failure or insufficient number of cells available for analysis.|Participants|Number|35|35.0||||||
4227495|NCT00689936|4050960|B1|Not evaluable||Cytogenetic Risk|Cytogenetic risk categories are mutually exclusive. Definitions: Adverse risk category: t(4:14), t(14:16), del (13q) or monosomy 13, del (17p), 1q gain; Non-adverse risk categories include favorable hyperdiploidy: t(11:14), gains of 5/9/15; normal: a normal result, gains other than 5/9/15, IgH deletion, and uncertain risk: probes used for analysis cannot place participant in any risk categories. Not evaluable: no specimen received, test failure or insufficient number of cells available for analysis.|Participants|Number|34|34.0||||||
4227496|NCT00689936|4050957|B4|Uncertain Risk||Cytogenetic Risk|Cytogenetic risk categories are mutually exclusive. Definitions: Adverse risk category: t(4:14), t(14:16), del (13q) or monosomy 13, del (17p), 1q gain; Non-adverse risk categories include favorable hyperdiploidy: t(11:14), gains of 5/9/15; normal: a normal result, gains other than 5/9/15, IgH deletion, and uncertain risk: probes used for analysis cannot place participant in any risk categories. Not evaluable: no specimen received, test failure or insufficient number of cells available for analysis.|Participants|Number|134|134.0||||||
4227497|NCT00689936|4050958|B3|Uncertain Risk||Cytogenetic Risk|Cytogenetic risk categories are mutually exclusive. Definitions: Adverse risk category: t(4:14), t(14:16), del (13q) or monosomy 13, del (17p), 1q gain; Non-adverse risk categories include favorable hyperdiploidy: t(11:14), gains of 5/9/15; normal: a normal result, gains other than 5/9/15, IgH deletion, and uncertain risk: probes used for analysis cannot place participant in any risk categories. Not evaluable: no specimen received, test failure or insufficient number of cells available for analysis.|Participants|Number|40|40.0||||||
4227498|NCT00689936|4050959|B2|Uncertain Risk||Cytogenetic Risk|Cytogenetic risk categories are mutually exclusive. Definitions: Adverse risk category: t(4:14), t(14:16), del (13q) or monosomy 13, del (17p), 1q gain; Non-adverse risk categories include favorable hyperdiploidy: t(11:14), gains of 5/9/15; normal: a normal result, gains other than 5/9/15, IgH deletion, and uncertain risk: probes used for analysis cannot place participant in any risk categories. Not evaluable: no specimen received, test failure or insufficient number of cells available for analysis.|Participants|Number|56|56.0||||||
4227499|NCT00689936|4050960|B1|Uncertain Risk||Cytogenetic Risk|Cytogenetic risk categories are mutually exclusive. Definitions: Adverse risk category: t(4:14), t(14:16), del (13q) or monosomy 13, del (17p), 1q gain; Non-adverse risk categories include favorable hyperdiploidy: t(11:14), gains of 5/9/15; normal: a normal result, gains other than 5/9/15, IgH deletion, and uncertain risk: probes used for analysis cannot place participant in any risk categories. Not evaluable: no specimen received, test failure or insufficient number of cells available for analysis.|Participants|Number|38|38.0||||||
4227500|NCT00689936|4050957|B4|Normal||Cytogenetic Risk|Cytogenetic risk categories are mutually exclusive. Definitions: Adverse risk category: t(4:14), t(14:16), del (13q) or monosomy 13, del (17p), 1q gain; Non-adverse risk categories include favorable hyperdiploidy: t(11:14), gains of 5/9/15; normal: a normal result, gains other than 5/9/15, IgH deletion, and uncertain risk: probes used for analysis cannot place participant in any risk categories. Not evaluable: no specimen received, test failure or insufficient number of cells available for analysis.|Participants|Number|420|420.0||||||
4227501|NCT00689936|4050958|B3|Normal||Cytogenetic Risk|Cytogenetic risk categories are mutually exclusive. Definitions: Adverse risk category: t(4:14), t(14:16), del (13q) or monosomy 13, del (17p), 1q gain; Non-adverse risk categories include favorable hyperdiploidy: t(11:14), gains of 5/9/15; normal: a normal result, gains other than 5/9/15, IgH deletion, and uncertain risk: probes used for analysis cannot place participant in any risk categories. Not evaluable: no specimen received, test failure or insufficient number of cells available for analysis.|Participants|Number|141|141.0||||||
4227524|NCT00689936|4050957|B4|Immunoglobulin D||Multiple Myeloma Subtype||Participants|Number|15|15.0||||||
4227525|NCT00689936|4050958|B3|Immunoglobulin D||Multiple Myeloma Subtype||Participants|Number|4|4.0||||||
4227526|NCT00689936|4050959|B2|Immunoglobulin D||Multiple Myeloma Subtype||Participants|Number|7|7.0||||||
4227527|NCT00689936|4050960|B1|Immunoglobulin D||Multiple Myeloma Subtype||Participants|Number|4|4.0||||||
4227502|NCT00689936|4050959|B2|Normal||Cytogenetic Risk|Cytogenetic risk categories are mutually exclusive. Definitions: Adverse risk category: t(4:14), t(14:16), del (13q) or monosomy 13, del (17p), 1q gain; Non-adverse risk categories include favorable hyperdiploidy: t(11:14), gains of 5/9/15; normal: a normal result, gains other than 5/9/15, IgH deletion, and uncertain risk: probes used for analysis cannot place participant in any risk categories. Not evaluable: no specimen received, test failure or insufficient number of cells available for analysis.|Participants|Number|131|131.0||||||
4227503|NCT00689936|4050960|B1|Normal||Cytogenetic Risk|Cytogenetic risk categories are mutually exclusive. Definitions: Adverse risk category: t(4:14), t(14:16), del (13q) or monosomy 13, del (17p), 1q gain; Non-adverse risk categories include favorable hyperdiploidy: t(11:14), gains of 5/9/15; normal: a normal result, gains other than 5/9/15, IgH deletion, and uncertain risk: probes used for analysis cannot place participant in any risk categories. Not evaluable: no specimen received, test failure or insufficient number of cells available for analysis.|Participants|Number|148|148.0||||||
4227504|NCT00689936|4050957|B4|Favorable Hyperdiploidy||Cytogenetic Risk|Cytogenetic risk categories are mutually exclusive. Definitions: Adverse risk category: t(4:14), t(14:16), del (13q) or monosomy 13, del (17p), 1q gain; Non-adverse risk categories include favorable hyperdiploidy: t(11:14), gains of 5/9/15; normal: a normal result, gains other than 5/9/15, IgH deletion, and uncertain risk: probes used for analysis cannot place participant in any risk categories. Not evaluable: no specimen received, test failure or insufficient number of cells available for analysis.|Participants|Number|317|317.0||||||
4227505|NCT00689936|4050958|B3|Favorable Hyperdiploidy||Cytogenetic Risk|Cytogenetic risk categories are mutually exclusive. Definitions: Adverse risk category: t(4:14), t(14:16), del (13q) or monosomy 13, del (17p), 1q gain; Non-adverse risk categories include favorable hyperdiploidy: t(11:14), gains of 5/9/15; normal: a normal result, gains other than 5/9/15, IgH deletion, and uncertain risk: probes used for analysis cannot place participant in any risk categories. Not evaluable: no specimen received, test failure or insufficient number of cells available for analysis.|Participants|Number|102|102.0||||||
4227506|NCT00689936|4050959|B2|Favorable Hyperdiploidy||Cytogenetic Risk|Cytogenetic risk categories are mutually exclusive. Definitions: Adverse risk category: t(4:14), t(14:16), del (13q) or monosomy 13, del (17p), 1q gain; Non-adverse risk categories include favorable hyperdiploidy: t(11:14), gains of 5/9/15; normal: a normal result, gains other than 5/9/15, IgH deletion, and uncertain risk: probes used for analysis cannot place participant in any risk categories. Not evaluable: no specimen received, test failure or insufficient number of cells available for analysis.|Participants|Number|103|103.0||||||
4227507|NCT00689936|4050960|B1|Favorable Hyperdiploidy||Cytogenetic Risk|Cytogenetic risk categories are mutually exclusive. Definitions: Adverse risk category: t(4:14), t(14:16), del (13q) or monosomy 13, del (17p), 1q gain; Non-adverse risk categories include favorable hyperdiploidy: t(11:14), gains of 5/9/15; normal: a normal result, gains other than 5/9/15, IgH deletion, and uncertain risk: probes used for analysis cannot place participant in any risk categories. Not evaluable: no specimen received, test failure or insufficient number of cells available for analysis.|Participants|Number|112|112.0||||||
4227508|NCT00689936|4050957|B4|Adverse Risk||Cytogenetic Risk|Cytogenetic risk categories are mutually exclusive. Definitions: Adverse risk category: t(4:14), t(14:16), del (13q) or monosomy 13, del (17p), 1q gain; Non-adverse risk categories include favorable hyperdiploidy: t(11:14), gains of 5/9/15; normal: a normal result, gains other than 5/9/15, IgH deletion, and uncertain risk: probes used for analysis cannot place participant in any risk categories. Not evaluable: no specimen received, test failure or insufficient number of cells available for analysis.|Participants|Number|544|544.0||||||
4227509|NCT00689936|4050958|B3|Adverse Risk||Cytogenetic Risk|Cytogenetic risk categories are mutually exclusive. Definitions: Adverse risk category: t(4:14), t(14:16), del (13q) or monosomy 13, del (17p), 1q gain; Non-adverse risk categories include favorable hyperdiploidy: t(11:14), gains of 5/9/15; normal: a normal result, gains other than 5/9/15, IgH deletion, and uncertain risk: probes used for analysis cannot place participant in any risk categories. Not evaluable: no specimen received, test failure or insufficient number of cells available for analysis.|Participants|Number|189|189.0||||||
4227510|NCT00689936|4050959|B2|Adverse Risk||Cytogenetic Risk|Cytogenetic risk categories are mutually exclusive. Definitions: Adverse risk category: t(4:14), t(14:16), del (13q) or monosomy 13, del (17p), 1q gain; Non-adverse risk categories include favorable hyperdiploidy: t(11:14), gains of 5/9/15; normal: a normal result, gains other than 5/9/15, IgH deletion, and uncertain risk: probes used for analysis cannot place participant in any risk categories. Not evaluable: no specimen received, test failure or insufficient number of cells available for analysis.|Participants|Number|185|185.0||||||
4227511|NCT00689936|4050960|B1|Adverse Risk||Cytogenetic Risk|Cytogenetic risk categories are mutually exclusive. Definitions: Adverse risk category: t(4:14), t(14:16), del (13q) or monosomy 13, del (17p), 1q gain; Non-adverse risk categories include favorable hyperdiploidy: t(11:14), gains of 5/9/15; normal: a normal result, gains other than 5/9/15, IgH deletion, and uncertain risk: probes used for analysis cannot place participant in any risk categories. Not evaluable: no specimen received, test failure or insufficient number of cells available for analysis.|Participants|Number|170|170.0||||||
4227512|NCT00689936|4050957|B4|Not available (includes light-chain disease)||Multiple Myeloma Subtype||Participants|Number|163|163.0||||||
4227513|NCT00689936|4050958|B3|Not available (includes light-chain disease)||Multiple Myeloma Subtype||Participants|Number|60|60.0||||||
4227514|NCT00689936|4050959|B2|Not available (includes light-chain disease)||Multiple Myeloma Subtype||Participants|Number|54|54.0||||||
4227515|NCT00689936|4050960|B1|Not available (includes light-chain disease)||Multiple Myeloma Subtype||Participants|Number|49|49.0||||||
4227516|NCT00689936|4050957|B4|Immunoglobulin M||Multiple Myeloma Subtype||Participants|Number|5|5.0||||||
4227517|NCT00689936|4050958|B3|Immunoglobulin M||Multiple Myeloma Subtype||Participants|Number|1|1.0||||||
4227518|NCT00689936|4050959|B2|Immunoglobulin M||Multiple Myeloma Subtype||Participants|Number|1|1.0||||||
4227519|NCT00689936|4050960|B1|Immunoglobulin M||Multiple Myeloma Subtype||Participants|Number|3|3.0||||||
4227520|NCT00689936|4050957|B4|Immunoglobulin G||Multiple Myeloma Subtype||Participants|Number|1015|1015.0||||||
4227521|NCT00689936|4050958|B3|Immunoglobulin G||Multiple Myeloma Subtype||Participants|Number|350|350.0||||||
4227522|NCT00689936|4050959|B2|Immunoglobulin G||Multiple Myeloma Subtype||Participants|Number|331|331.0||||||
4227523|NCT00689936|4050960|B1|Immunoglobulin G||Multiple Myeloma Subtype||Participants|Number|334|334.0||||||
4227528|NCT00689936|4050957|B4|Immunoglobulin A and Immunoglobulin M||Multiple Myeloma Subtype||Participants|Number|1|1.0||||||
4227529|NCT00689936|4050958|B3|Immunoglobulin A and Immunoglobulin M||Multiple Myeloma Subtype||Participants|Number|1|1.0||||||
4227530|NCT00689936|4050959|B2|Immunoglobulin A and Immunoglobulin M||Multiple Myeloma Subtype||Participants|Number|0|0.0||||||
4227531|NCT00689936|4050960|B1|Immunoglobulin A and Immunoglobulin M||Multiple Myeloma Subtype||Participants|Number|0|0.0||||||
4227532|NCT00689936|4050957|B4|Immunoglobulin A and Immunoglobulin G||Multiple Myeloma Subtype||Participants|Number|21|21.0||||||
4227533|NCT00689936|4050958|B3|Immunoglobulin A and Immunoglobulin G||Multiple Myeloma Subtype||Participants|Number|8|8.0||||||
4227534|NCT00689936|4050959|B2|Immunoglobulin A and Immunoglobulin G||Multiple Myeloma Subtype||Participants|Number|6|6.0||||||
4227535|NCT00689936|4050960|B1|Immunoglobulin A and Immunoglobulin G||Multiple Myeloma Subtype||Participants|Number|7|7.0||||||
4227536|NCT00689936|4050957|B4|Immunoglobulin A||Multiple Myeloma Subtype||Participants|Number|403|403.0||||||
4227537|NCT00689936|4050958|B3|Immunoglobulin A||Multiple Myeloma Subtype||Participants|Number|123|123.0||||||
4227538|NCT00689936|4050959|B2|Immunoglobulin A||Multiple Myeloma Subtype||Participants|Number|142|142.0||||||
4227539|NCT00689936|4050960|B1|Immunoglobulin A||Multiple Myeloma Subtype||Participants|Number|138|138.0||||||
4227540|NCT00689936|4050957|B4|Missing||Lactic Dehydrogenase||Participants|Number|2|2.0||||||
4227541|NCT00689936|4050958|B3|Missing||Lactic Dehydrogenase||Participants|Number|1|1.0||||||
4227542|NCT00689936|4050959|B2|Missing||Lactic Dehydrogenase||Participants|Number|0|0.0||||||
4227543|NCT00689936|4050960|B1|Missing||Lactic Dehydrogenase||Participants|Number|1|1.0||||||
4227544|NCT00689936|4050957|B4|>=200 U/L||Lactic Dehydrogenase||Participants|Number|297|297.0||||||
4227545|NCT00689936|4050958|B3|>=200 U/L||Lactic Dehydrogenase||Participants|Number|112|112.0||||||
4227546|NCT00689936|4050959|B2|>=200 U/L||Lactic Dehydrogenase||Participants|Number|99|99.0||||||
4227547|NCT00689936|4050960|B1|>=200 U/L||Lactic Dehydrogenase||Participants|Number|86|86.0||||||
4227548|NCT00689936|4050957|B4|<200 U/L||Lactic Dehydrogenase||Participants|Number|1324|1324.0||||||
4227549|NCT00689936|4050958|B3|<200 U/L||Lactic Dehydrogenase||Participants|Number|434|434.0||||||
4227550|NCT00689936|4050959|B2|<200 U/L||Lactic Dehydrogenase||Participants|Number|442|442.0||||||
4227551|NCT00689936|4050960|B1|<200 U/L||Lactic Dehydrogenase||Participants|Number|448|448.0||||||
4227552|NCT00689936|4050957|B4|Missing||Albumin||Participants|Number|1|1.0||||||
4227553|NCT00689936|4050958|B3|Missing||Albumin||Participants|Number|0|0.0||||||
4227554|NCT00689936|4050959|B2|Missing||Albumin||Participants|Number|1|1.0||||||
4227555|NCT00689936|4050960|B1|Missing||Albumin||Participants|Number|0|0.0||||||
4227556|NCT00689936|4050957|B4|> 35 g/L||Albumin||Participants|Number|998|998.0||||||
4227557|NCT00689936|4050958|B3|> 35 g/L||Albumin||Participants|Number|324|324.0||||||
4227558|NCT00689936|4050959|B2|> 35 g/L||Albumin||Participants|Number|331|331.0||||||
4227559|NCT00689936|4050960|B1|> 35 g/L||Albumin||Participants|Number|343|343.0||||||
4227560|NCT00689936|4050957|B4|<=35 g/L||Albumin||Participants|Number|624|624.0||||||
4227561|NCT00689936|4050958|B3|<=35 g/L||Albumin||Participants|Number|223|223.0||||||
4227562|NCT00689936|4050959|B2|<=35 g/L||Albumin||Participants|Number|209|209.0||||||
4227563|NCT00689936|4050960|B1|<=35 g/L||Albumin||Participants|Number|192|192.0||||||
4227564|NCT00689936|4050957|B4|Missing||Beta2 Microglobulin||Participants|Number|4|4.0||||||
4227565|NCT00689936|4050958|B3|Missing||Beta2 Microglobulin||Participants|Number|1|1.0||||||
4227566|NCT00689936|4050959|B2|Missing||Beta2 Microglobulin||Participants|Number|1|1.0||||||
4227567|NCT00689936|4050960|B1|Missing||Beta2 Microglobulin||Participants|Number|2|2.0||||||
4227568|NCT00689936|4050957|B4|<=5.5 mg/L||Beta2 Microglobulin||Participants|Number|937|937.0||||||
4227569|NCT00689936|4050958|B3|<=5.5 mg/L||Beta2 Microglobulin||Participants|Number|312|312.0||||||
4227570|NCT00689936|4050959|B2|<=5.5 mg/L||Beta2 Microglobulin||Participants|Number|316|316.0||||||
4227571|NCT00689936|4050960|B1|<=5.5 mg/L||Beta2 Microglobulin||Participants|Number|309|309.0||||||
4227572|NCT00689936|4050957|B4|>5.5 mg/L||Beta2 Microglobulin||Participants|Number|682|682.0||||||
4227573|NCT00689936|4050958|B3|>5.5 mg/L||Beta2 Microglobulin||Participants|Number|234|234.0||||||
4227574|NCT00689936|4050959|B2|>5.5 mg/L||Beta2 Microglobulin||Participants|Number|224|224.0||||||
4227575|NCT00689936|4050960|B1|>5.5 mg/L||Beta2 Microglobulin||Participants|Number|224|224.0||||||
4227576|NCT00689936|4050957|B4|Missing||Creatinine clearance||Participants|Number|1|1.0||||||
4227577|NCT00689936|4050958|B3|Missing||Creatinine clearance||Participants|Number|1|1.0||||||
4227578|NCT00689936|4050959|B2|Missing||Creatinine clearance||Participants|Number|0|0.0||||||
4227579|NCT00689936|4050960|B1|Missing||Creatinine clearance||Participants|Number|0|0.0||||||
4227580|NCT00689936|4050957|B4|<60 ml/min||Creatinine clearance||Participants|Number|788|788.0||||||
4227581|NCT00689936|4050958|B3|<60 ml/min||Creatinine clearance||Participants|Number|261|261.0||||||
4227582|NCT00689936|4050959|B2|<60 ml/min||Creatinine clearance||Participants|Number|261|261.0||||||
4227583|NCT00689936|4050960|B1|<60 ml/min||Creatinine clearance||Participants|Number|266|266.0||||||
4227584|NCT00689936|4050957|B4|>=60 ml/min||Creatinine clearance||Participants|Number|834|834.0||||||
4227585|NCT00689936|4050958|B3|>=60 ml/min||Creatinine clearance||Participants|Number|285|285.0||||||
4227586|NCT00689936|4050959|B2|>=60 ml/min||Creatinine clearance||Participants|Number|280|280.0||||||
4227587|NCT00689936|4050960|B1|>=60 ml/min||Creatinine clearance||Participants|Number|269|269.0||||||
4227588|NCT00689936|4050957|B4|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|5|5.0||||||
4227589|NCT00689936|4050958|B3|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|3|3.0||||||
4227590|NCT00689936|4050959|B2|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|0|0.0||||||
4227591|NCT00689936|4050960|B1|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|2|2.0||||||
4227592|NCT00689936|4050957|B4|3-4 (limited self-care, completely disabled)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|6|6.0||||||
4227593|NCT00689936|4050958|B3|3-4 (limited self-care, completely disabled)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|2|2.0||||||
4227594|NCT00689936|4050959|B2|3-4 (limited self-care, completely disabled)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|2|2.0||||||
4227595|NCT00689936|4050960|B1|3-4 (limited self-care, completely disabled)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|2|2.0||||||
4227596|NCT00689936|4050957|B4|2 (ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|343|343.0||||||
4227597|NCT00689936|4050958|B3|2 (ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|111|111.0||||||
4227598|NCT00689936|4050959|B2|2 (ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|113|113.0||||||
4227599|NCT00689936|4050960|B1|2 (ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|119|119.0||||||
4227600|NCT00689936|4050957|B4|1 (restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|795|795.0||||||
4227601|NCT00689936|4050958|B3|1 (restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|275|275.0||||||
4227602|NCT00689936|4050959|B2|1 (restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|263|263.0||||||
4227603|NCT00689936|4050960|B1|1 (restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|257|257.0||||||
4227604|NCT00689936|4050957|B4|0 (fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|474|474.0||||||
4227605|NCT00689936|4050958|B3|0 (fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|156|156.0||||||
4227606|NCT00689936|4050959|B2|0 (fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|163|163.0||||||
4227607|NCT00689936|4050960|B1|0 (fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|Participants|Number|155|155.0||||||
4227707|NCT00689819|4051129|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4227608|NCT00689936|4050957|B4|Stage III||International Staging System (ISS)|International Staging System (ISS) is used as a staging system for multiple myeloma and divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels. Higher stages represent more advanced disease.|Participants|Number|627|627.0||||||
4227609|NCT00689936|4050958|B3|Stage III||International Staging System (ISS)|International Staging System (ISS) is used as a staging system for multiple myeloma and divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels. Higher stages represent more advanced disease.|Participants|Number|219|219.0||||||
4227610|NCT00689936|4050959|B2|Stage III||International Staging System (ISS)|International Staging System (ISS) is used as a staging system for multiple myeloma and divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels. Higher stages represent more advanced disease.|Participants|Number|206|206.0||||||
4227611|NCT00689936|4050960|B1|Stage III||International Staging System (ISS)|International Staging System (ISS) is used as a staging system for multiple myeloma and divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels. Higher stages represent more advanced disease.|Participants|Number|202|202.0||||||
4227612|NCT00689936|4050957|B4|Stage II||International Staging System (ISS)|International Staging System (ISS) is used as a staging system for multiple myeloma and divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels. Higher stages represent more advanced disease.|Participants|Number|681|681.0||||||
4227613|NCT00689936|4050958|B3|Stage II||International Staging System (ISS)|International Staging System (ISS) is used as a staging system for multiple myeloma and divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels. Higher stages represent more advanced disease.|Participants|Number|225|225.0||||||
4227614|NCT00689936|4050959|B2|Stage II||International Staging System (ISS)|International Staging System (ISS) is used as a staging system for multiple myeloma and divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels. Higher stages represent more advanced disease.|Participants|Number|229|229.0||||||
4227615|NCT00689936|4050960|B1|Stage II||International Staging System (ISS)|International Staging System (ISS) is used as a staging system for multiple myeloma and divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels. Higher stages represent more advanced disease.|Participants|Number|227|227.0||||||
4227616|NCT00689936|4050957|B4|Stage I||International Staging System (ISS)|International Staging System (ISS) is used as a staging system for multiple myeloma and divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels. Higher stages represent more advanced disease.|Participants|Number|315|315.0||||||
4227617|NCT00689936|4050958|B3|Stage I||International Staging System (ISS)|International Staging System (ISS) is used as a staging system for multiple myeloma and divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels. Higher stages represent more advanced disease.|Participants|Number|103|103.0||||||
4227618|NCT00689936|4050959|B2|Stage I||International Staging System (ISS)|International Staging System (ISS) is used as a staging system for multiple myeloma and divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels. Higher stages represent more advanced disease.|Participants|Number|106|106.0||||||
4227619|NCT00689936|4050960|B1|Stage I||International Staging System (ISS)|International Staging System (ISS) is used as a staging system for multiple myeloma and divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels. Higher stages represent more advanced disease.|Participants|Number|106|106.0||||||
4227620|NCT00689936|4050957|B4|Undisclosed||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4227621|NCT00689936|4050958|B3|Undisclosed||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4227622|NCT00689936|4050959|B2|Undisclosed||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4227623|NCT00689936|4050960|B1|Undisclosed||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4227624|NCT00689936|4050957|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|1506|1506.0||||||
4227625|NCT00689936|4050958|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|508|508.0||||||
4227626|NCT00689936|4050959|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|505|505.0||||||
4227627|NCT00689936|4050960|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|493|493.0||||||
4227628|NCT00689936|4050957|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|106|106.0||||||
4227629|NCT00689936|4050958|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|36|36.0||||||
4227630|NCT00689936|4050959|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|33|33.0||||||
4227631|NCT00689936|4050960|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
4227632|NCT00689936|4050957|B4|Undisclosed||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4227633|NCT00689936|4050958|B3|Undisclosed||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4227634|NCT00689936|4050959|B2|Undisclosed||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4227635|NCT00689936|4050960|B1|Undisclosed||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4227636|NCT00689936|4050957|B4|Other, Miscellaneous||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
4227637|NCT00689936|4050958|B3|Other, Miscellaneous||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4227638|NCT00689936|4050959|B2|Other, Miscellaneous||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4227639|NCT00689936|4050960|B1|Other, Miscellaneous||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4227640|NCT00689936|4050957|B4|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|1445|1445.0||||||
4227641|NCT00689936|4050958|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|491|491.0||||||
4227642|NCT00689936|4050959|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|480|480.0||||||
4227643|NCT00689936|4050960|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|474|474.0||||||
4227644|NCT00689936|4050957|B4|Native Hawaiian or other Pacific Islanders||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4227645|NCT00689936|4050958|B3|Native Hawaiian or other Pacific Islanders||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4227646|NCT00689936|4050959|B2|Native Hawaiian or other Pacific Islanders||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4227647|NCT00689936|4050960|B1|Native Hawaiian or other Pacific Islanders||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4227648|NCT00689936|4050957|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
4227649|NCT00689936|4050958|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4227650|NCT00689936|4050959|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4227651|NCT00689936|4050960|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4227652|NCT00689936|4050957|B4|Asian||Race/Ethnicity, Customized||Participants|Number|127|127.0||||||
4227653|NCT00689936|4050958|B3|Asian||Race/Ethnicity, Customized||Participants|Number|44|44.0||||||
4227654|NCT00689936|4050959|B2|Asian||Race/Ethnicity, Customized||Participants|Number|43|43.0||||||
4227655|NCT00689936|4050960|B1|Asian||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
4227656|NCT00689936|4050957|B4||Male|Sex: Female, Male||Participants|Count of Participants|854|854.0||||||
4227657|NCT00689936|4050958|B3||Male|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
4227658|NCT00689936|4050959|B2||Male|Sex: Female, Male||Participants|Count of Participants|273|273.0||||||
4227659|NCT00689936|4050960|B1||Male|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
4227660|NCT00689936|4050957|B4||Female|Sex: Female, Male||Participants|Count of Participants|769|769.0||||||
4227661|NCT00689936|4050958|B3||Female|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
4227662|NCT00689936|4050959|B2||Female|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
4227663|NCT00689936|4050960|B1||Female|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
4227664|NCT00689936|4050957|B4|||Age||years|Mean|73.1|73.1|Standard Deviation|6.46|6.46|||
4227665|NCT00689936|4050958|B3|||Age||years|Mean|73.1|73.1|Standard Deviation|6.32|6.32|||
4227666|NCT00689936|4050959|B2|||Age||years|Mean|72.9|72.9|Standard Deviation|6.50|6.5|||
4227667|NCT00689936|4050960|B1|||Age||years|Mean|73.2|73.2|Standard Deviation|6.57|6.57|||
4227668|NCT00689884|4051102|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4227669|NCT00689884|4051102|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4227670|NCT00689884|4051102|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4227671|NCT00689884|4051102|B1|||Age||years|Mean|60|60.0|Standard Deviation|22|22.0|||
4227672|NCT00689884|4051102|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4227673|NCT00689884|4051102|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4227674|NCT00689884|4051102|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4227675|NCT00689871|4051107|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4227676|NCT00689871|4051108|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4227677|NCT00689871|4051109|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4227678|NCT00689871|4051110|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4227679|NCT00689871|4051111|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4227680|NCT00689871|4051107|B5||Female|Sex: Female, Male||Participants|Count of Participants|715|715.0||||||
4227681|NCT00689871|4051108|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4227682|NCT00689871|4051109|B3||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4227683|NCT00689871|4051110|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4227684|NCT00689871|4051111|B1||Female|Sex: Female, Male||Participants|Count of Participants|455|455.0||||||
4227685|NCT00689871|4051107|B5|>=60 years||Age, Customized||participants|Number|23|23.0||||||
4227686|NCT00689871|4051108|B4|>=60 years||Age, Customized||participants|Number|6|6.0||||||
4227687|NCT00689871|4051109|B3|>=60 years||Age, Customized||participants|Number|2|2.0||||||
4227688|NCT00689871|4051110|B2|>=60 years||Age, Customized||participants|Number|15|15.0||||||
4227689|NCT00689871|4051111|B1|>=60 years||Age, Customized||participants|Number|0|0.0||||||
4227690|NCT00689871|4051107|B5|Between 40 and 60 years||Age, Customized||participants|Number|302|302.0||||||
4227691|NCT00689871|4051108|B4|Between 40 and 60 years||Age, Customized||participants|Number|9|9.0||||||
4227692|NCT00689871|4051109|B3|Between 40 and 60 years||Age, Customized||participants|Number|84|84.0||||||
4227693|NCT00689871|4051110|B2|Between 40 and 60 years||Age, Customized||participants|Number|73|73.0||||||
4227694|NCT00689871|4051111|B1|Between 40 and 60 years||Age, Customized||participants|Number|136|136.0||||||
4227695|NCT00689871|4051107|B5|<=40 years||Age, Customized||participants|Number|390|390.0||||||
4227696|NCT00689871|4051108|B4|<=40 years||Age, Customized||participants|Number|0|0.0||||||
4227697|NCT00689871|4051109|B3|<=40 years||Age, Customized||participants|Number|61|61.0||||||
4227698|NCT00689871|4051110|B2|<=40 years||Age, Customized||participants|Number|10|10.0||||||
4227699|NCT00689871|4051111|B1|<=40 years||Age, Customized||participants|Number|319|319.0||||||
4227700|NCT00689819|4051128|B3|United States||Region of Enrollment||participants|Number|123|123.0||||||
4227701|NCT00689819|4051129|B2|United States||Region of Enrollment||participants|Number|58|58.0||||||
4227702|NCT00689819|4051130|B1|United States||Region of Enrollment||participants|Number|65|65.0||||||
4227703|NCT00689819|4051128|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4227704|NCT00689819|4051129|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4227705|NCT00689819|4051130|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4227706|NCT00689819|4051128|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4227708|NCT00689819|4051130|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4227709|NCT00689819|4051128|B3|||Age||years|Mean|49.4|49.4|Standard Deviation|7.8|7.8|||
4227710|NCT00689819|4051129|B2|||Age||years|Mean|49.6|49.6|Standard Deviation|8.3|8.3|||
4227711|NCT00689819|4051130|B1|||Age||years|Mean|49.3|49.3|Standard Deviation|8.1|8.1|||
4227712|NCT00689819|4051128|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4227713|NCT00689819|4051129|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4227714|NCT00689819|4051130|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4227715|NCT00689819|4051128|B3||Between 18 and 65 years|Age||Participants|Count of Participants|123|123.0||||||
4227716|NCT00689819|4051129|B2||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4227717|NCT00689819|4051130|B1||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4227718|NCT00689819|4051128|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4227719|NCT00689819|4051129|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4227720|NCT00689819|4051130|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4227721|NCT00689793|4051139|B3|Switzerland||Region of Enrollment||participants|Number|154|154.0||||||
4227722|NCT00689793|4051140|B2|Switzerland||Region of Enrollment||participants|Number|76|76.0||||||
4227723|NCT00689793|4051141|B1|Switzerland||Region of Enrollment||participants|Number|78|78.0||||||
4227724|NCT00689793|4051139|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4227725|NCT00689793|4051140|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4227726|NCT00689793|4051141|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4227727|NCT00689793|4051139|B3||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4227728|NCT00689793|4051140|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4227729|NCT00689793|4051141|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4227730|NCT00689793|4051139|B3|||Age||years|Mean|31.6|31.6|Standard Deviation|8.7|8.7|||
4227731|NCT00689793|4051140|B2|||Age||years|Mean|30.7|30.7|Standard Deviation|8.8|8.8|||
4227732|NCT00689793|4051141|B1|||Age||years|Mean|32.9|32.9|Standard Deviation|8.4|8.4|||
4227733|NCT00689793|4051139|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4227734|NCT00689793|4051140|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4227735|NCT00689793|4051141|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4227736|NCT00689793|4051139|B3||Between 18 and 65 years|Age||Participants|Count of Participants|154|154.0||||||
4227737|NCT00689793|4051140|B2||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
4227738|NCT00689793|4051141|B1||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
4227739|NCT00689793|4051139|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4227740|NCT00689793|4051140|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4227741|NCT00689793|4051141|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4227742|NCT00689728|4051158|B4|Germany||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4227743|NCT00689728|4051159|B3|Germany||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4227744|NCT00689728|4051160|B2|Germany||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4227745|NCT00689728|4051161|B1|Germany||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4227746|NCT00689728|4051158|B4|Austria||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4227747|NCT00689728|4051159|B3|Austria||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4227748|NCT00689728|4051160|B2|Austria||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4227749|NCT00689728|4051161|B1|Austria||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4227750|NCT00689728|4051158|B4|Brazil||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4227751|NCT00689728|4051159|B3|Brazil||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4227752|NCT00689728|4051160|B2|Brazil||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4227753|NCT00689728|4051161|B1|Brazil||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4227754|NCT00689728|4051158|B4|Belgium||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4227755|NCT00689728|4051159|B3|Belgium||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4227756|NCT00689728|4051160|B2|Belgium||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4227757|NCT00689728|4051161|B1|Belgium||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4227758|NCT00689728|4051158|B4|Poland||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4227759|NCT00689728|4051159|B3|Poland||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4227760|NCT00689728|4051160|B2|Poland||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4227761|NCT00689728|4051161|B1|Poland||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4227762|NCT00689728|4051158|B4|Argentina||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4227763|NCT00689728|4051159|B3|Argentina||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4227764|NCT00689728|4051160|B2|Argentina||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4227765|NCT00689728|4051161|B1|Argentina||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4227766|NCT00689728|4051158|B4|Canada||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4227767|NCT00689728|4051159|B3|Canada||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4227768|NCT00689728|4051160|B2|Canada||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4227769|NCT00689728|4051161|B1|Canada||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4227770|NCT00689728|4051158|B4|Puerto Rico||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4227771|NCT00689728|4051159|B3|Puerto Rico||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4227772|NCT00689728|4051160|B2|Puerto Rico||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4227773|NCT00689728|4051161|B1|Puerto Rico||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4227774|NCT00689728|4051158|B4|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
4227775|NCT00689728|4051159|B3|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4227776|NCT00689728|4051160|B2|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4227777|NCT00689728|4051161|B1|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4227778|NCT00689728|4051158|B4||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
4227779|NCT00689728|4051159|B3||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4227780|NCT00689728|4051160|B2||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4227781|NCT00689728|4051161|B1||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4227782|NCT00689728|4051158|B4||African|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4227783|NCT00689728|4051159|B3||African|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4227784|NCT00689728|4051160|B2||African|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4227785|NCT00689728|4051161|B1||African|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4227786|NCT00689728|4051158|B4||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|67|67.0||||||
4227787|NCT00689728|4051159|B3||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
4227788|NCT00689728|4051160|B2||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
4227789|NCT00689728|4051161|B1||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
4227790|NCT00689728|4051158|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4227791|NCT00689728|4051159|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4227792|NCT00689728|4051160|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4227793|NCT00689728|4051161|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4227794|NCT00689728|4051158|B4||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4227795|NCT00689728|4051159|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4227796|NCT00689728|4051160|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4227797|NCT00689728|4051161|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4227798|NCT00689728|4051158|B4|||Age||Years|Mean|52.4|52.4|Standard Deviation|12.70|12.7|||
4227799|NCT00689728|4051159|B3|||Age||Years|Mean|52.2|52.2|Standard Deviation|11.46|11.46|||
4227800|NCT00689728|4051160|B2|||Age||Years|Mean|52.7|52.7|Standard Deviation|14.05|14.05|||
4227801|NCT00689728|4051161|B1|||Age||Years|Mean|52.4|52.4|Standard Deviation|13.03|13.03|||
4227802|NCT00689611|4051244|B3|||Coronary artery bypass graft during index admission||participants|Number|25|25.0||||||
4227803|NCT00689611|4051245|B2|||Coronary artery bypass graft during index admission||participants|Number|10|10.0||||||
4227804|NCT00689611|4051246|B1|||Coronary artery bypass graft during index admission||participants|Number|15|15.0||||||
4227805|NCT00689611|4051244|B3|||Percutaneous coronary intervention during index admission||participants|Number|197|197.0||||||
4227806|NCT00689611|4051245|B2|||Percutaneous coronary intervention during index admission||participants|Number|93|93.0||||||
4227807|NCT00689611|4051246|B1|||Percutaneous coronary intervention during index admission||participants|Number|104|104.0||||||
4227808|NCT00689611|4051244|B3|||Cardiac catheterization during index admission||participants|Number|264|264.0||||||
4227809|NCT00689611|4051245|B2|||Cardiac catheterization during index admission||participants|Number|128|128.0||||||
4227810|NCT00689611|4051246|B1|||Cardiac catheterization during index admission||participants|Number|136|136.0||||||
4227811|NCT00689611|4051244|B3|||Index admission was for ST-segment elevation myocardial infarction [STEMI]||participants|Number|254|254.0||||||
4227812|NCT00689611|4051245|B2|||Index admission was for ST-segment elevation myocardial infarction [STEMI]||participants|Number|121|121.0||||||
4227813|NCT00689611|4051246|B1|||Index admission was for ST-segment elevation myocardial infarction [STEMI]||participants|Number|133|133.0||||||
4227814|NCT00689611|4051244|B3|||No. of cigarettes/day (past year)||cigarettes/day|Mean|23.2|23.2|Standard Deviation|10.6|10.6|||
4227815|NCT00689611|4051245|B2|||No. of cigarettes/day (past year)||cigarettes/day|Mean|23.2|23.2|Standard Deviation|10.8|10.8|||
4227816|NCT00689611|4051246|B1|||No. of cigarettes/day (past year)||cigarettes/day|Mean|23.2|23.2|Standard Deviation|10.4|10.4|||
4227817|NCT00689611|4051244|B3|||No. of years smoked||years|Mean|32.9|32.9|Standard Deviation|12.4|12.4|||
4227818|NCT00689611|4051245|B2|||No. of years smoked||years|Mean|33.2|33.2|Standard Deviation|13.0|13.0|||
4227819|NCT00689611|4051246|B1|||No. of years smoked||years|Mean|32.6|32.6|Standard Deviation|11.9|11.9|||
4227820|NCT00689611|4051244|B3|India||Region of Enrollment||participants|Number|19|19.0||||||
4227821|NCT00689611|4051245|B2|India||Region of Enrollment||participants|Number|10|10.0||||||
4227822|NCT00689611|4051246|B1|India||Region of Enrollment||participants|Number|9|9.0||||||
4227823|NCT00689611|4051244|B3|Tunisia||Region of Enrollment||participants|Number|10|10.0||||||
4227824|NCT00689611|4051245|B2|Tunisia||Region of Enrollment||participants|Number|4|4.0||||||
4227825|NCT00689611|4051246|B1|Tunisia||Region of Enrollment||participants|Number|6|6.0||||||
4227826|NCT00689611|4051244|B3|Iran, Islamic Republic of||Region of Enrollment||participants|Number|62|62.0||||||
4227827|NCT00689611|4051245|B2|Iran, Islamic Republic of||Region of Enrollment||participants|Number|31|31.0||||||
4227828|NCT00689611|4051246|B1|Iran, Islamic Republic of||Region of Enrollment||participants|Number|31|31.0||||||
4227829|NCT00689611|4051244|B3|Canada||Region of Enrollment||participants|Number|197|197.0||||||
4227830|NCT00689611|4051245|B2|Canada||Region of Enrollment||participants|Number|96|96.0||||||
4227831|NCT00689611|4051246|B1|Canada||Region of Enrollment||participants|Number|101|101.0||||||
4227832|NCT00689611|4051244|B3|Pakistan||Region of Enrollment||participants|Number|36|36.0||||||
4227833|NCT00689611|4051245|B2|Pakistan||Region of Enrollment||participants|Number|18|18.0||||||
4227834|NCT00689611|4051246|B1|Pakistan||Region of Enrollment||participants|Number|18|18.0||||||
4227835|NCT00689611|4051244|B3|United States||Region of Enrollment||participants|Number|68|68.0||||||
4227836|NCT00689611|4051245|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4227837|NCT00689611|4051246|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4227838|NCT00689611|4051244|B3||Male|Sex: Female, Male||Participants|Count of Participants|327|327.0||||||
4227839|NCT00689611|4051245|B2||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4227840|NCT00689611|4051246|B1||Male|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4227841|NCT00689611|4051244|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4227842|NCT00689611|4051245|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4227843|NCT00689611|4051246|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4227844|NCT00689611|4051244|B3|||Age||years|Mean|53.9|53.9|Standard Deviation|10.3|10.3|||
4227845|NCT00689611|4051245|B2|||Age||years|Mean|54.5|54.5|Standard Deviation|10.4|10.4|||
4227846|NCT00689611|4051246|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|10.3|10.3|||
4227847|NCT00689481|4051255|B3|||Disease Characteristic - Percent BSA (extent of psoriasis)|Disease characteristics of Percent of BSA (extent of psoriasis) at baseline|percentage|Mean|6.4|6.4|Standard Deviation|4.9|4.9|||
4227848|NCT00689481|4051256|B2|||Disease Characteristic - Percent BSA (extent of psoriasis)|Disease characteristics of Percent of BSA (extent of psoriasis) at baseline|percentage|Mean|6.4|6.4|Standard Deviation|5.2|5.2|||
4227849|NCT00689481|4051257|B1|||Disease Characteristic - Percent BSA (extent of psoriasis)|Disease characteristics of Percent of BSA (extent of psoriasis) at baseline|percentage|Mean|6.3|6.3|Standard Deviation|4.7|4.7|||
4227850|NCT00689481|4051255|B3|Severe||Disease Characteristic - Subject's Global Assessment|Disease characteristics of Subject's Global Assessment at baseline|participants|Number|53|53.0||||||
4227851|NCT00689481|4051256|B2|Severe||Disease Characteristic - Subject's Global Assessment|Disease characteristics of Subject's Global Assessment at baseline|participants|Number|17|17.0||||||
4227852|NCT00689481|4051257|B1|Severe||Disease Characteristic - Subject's Global Assessment|Disease characteristics of Subject's Global Assessment at baseline|participants|Number|36|36.0||||||
4227853|NCT00689481|4051255|B3|Very noticeable||Disease Characteristic - Subject's Global Assessment|Disease characteristics of Subject's Global Assessment at baseline|participants|Number|151|151.0||||||
4227854|NCT00689481|4051256|B2|Very noticeable||Disease Characteristic - Subject's Global Assessment|Disease characteristics of Subject's Global Assessment at baseline|participants|Number|55|55.0||||||
4227855|NCT00689481|4051257|B1|Very noticeable||Disease Characteristic - Subject's Global Assessment|Disease characteristics of Subject's Global Assessment at baseline|participants|Number|96|96.0||||||
4227856|NCT00689481|4051255|B3|Moderate||Disease Characteristic - Subject's Global Assessment|Disease characteristics of Subject's Global Assessment at baseline|participants|Number|88|88.0||||||
4227857|NCT00689481|4051256|B2|Moderate||Disease Characteristic - Subject's Global Assessment|Disease characteristics of Subject's Global Assessment at baseline|participants|Number|26|26.0||||||
4227858|NCT00689481|4051257|B1|Moderate||Disease Characteristic - Subject's Global Assessment|Disease characteristics of Subject's Global Assessment at baseline|participants|Number|62|62.0||||||
4227859|NCT00689481|4051255|B3|Mild||Disease Characteristic - Subject's Global Assessment|Disease characteristics of Subject's Global Assessment at baseline|participants|Number|27|27.0||||||
4227860|NCT00689481|4051256|B2|Mild||Disease Characteristic - Subject's Global Assessment|Disease characteristics of Subject's Global Assessment at baseline|participants|Number|9|9.0||||||
4227861|NCT00689481|4051257|B1|Mild||Disease Characteristic - Subject's Global Assessment|Disease characteristics of Subject's Global Assessment at baseline|participants|Number|18|18.0||||||
4227862|NCT00689481|4051255|B3|Almost clear||Disease Characteristic - Subject's Global Assessment|Disease characteristics of Subject's Global Assessment at baseline|participants|Number|4|4.0||||||
4227863|NCT00689481|4051256|B2|Almost clear||Disease Characteristic - Subject's Global Assessment|Disease characteristics of Subject's Global Assessment at baseline|participants|Number|2|2.0||||||
4227864|NCT00689481|4051257|B1|Almost clear||Disease Characteristic - Subject's Global Assessment|Disease characteristics of Subject's Global Assessment at baseline|participants|Number|2|2.0||||||
4227865|NCT00689481|4051255|B3|Moderate||Disease Characteristic - Investigator Static Global Assesssment (ISGA)|Disease characteristics of ISGA at baseline|participants|Number|236|236.0||||||
4227866|NCT00689481|4051256|B2|Moderate||Disease Characteristic - Investigator Static Global Assesssment (ISGA)|Disease characteristics of ISGA at baseline|participants|Number|78|78.0||||||
4227867|NCT00689481|4051257|B1|Moderate||Disease Characteristic - Investigator Static Global Assesssment (ISGA)|Disease characteristics of ISGA at baseline|participants|Number|158|158.0||||||
4227868|NCT00689481|4051255|B3|Mild||Disease Characteristic - Investigator Static Global Assesssment (ISGA)|Disease characteristics of ISGA at baseline|participants|Number|87|87.0||||||
4227869|NCT00689481|4051256|B2|Mild||Disease Characteristic - Investigator Static Global Assesssment (ISGA)|Disease characteristics of ISGA at baseline|participants|Number|31|31.0||||||
4227870|NCT00689481|4051257|B1|Mild||Disease Characteristic - Investigator Static Global Assesssment (ISGA)|Disease characteristics of ISGA at baseline|participants|Number|56|56.0||||||
4227871|NCT00689481|4051255|B3|Trunk||Disease Characteristic - Target Lesion Location|Disease characteristics of Target Lesion Location at baseline|participants|Number|59|59.0||||||
4227872|NCT00689481|4051256|B2|Trunk||Disease Characteristic - Target Lesion Location|Disease characteristics of Target Lesion Location at baseline|participants|Number|27|27.0||||||
4227873|NCT00689481|4051257|B1|Trunk||Disease Characteristic - Target Lesion Location|Disease characteristics of Target Lesion Location at baseline|participants|Number|32|32.0||||||
4227874|NCT00689481|4051255|B3|Leg||Disease Characteristic - Target Lesion Location|Disease characteristics of Target Lesion Location at baseline|participants|Number|184|184.0||||||
4227875|NCT00689481|4051256|B2|Leg||Disease Characteristic - Target Lesion Location|Disease characteristics of Target Lesion Location at baseline|participants|Number|55|55.0||||||
4227876|NCT00689481|4051257|B1|Leg||Disease Characteristic - Target Lesion Location|Disease characteristics of Target Lesion Location at baseline|participants|Number|129|129.0||||||
4227877|NCT00689481|4051255|B3|Arm||Disease Characteristic - Target Lesion Location|Disease characteristics of Target Lesion Location at baseline|participants|Number|80|80.0||||||
4227878|NCT00689481|4051256|B2|Arm||Disease Characteristic - Target Lesion Location|Disease characteristics of Target Lesion Location at baseline|participants|Number|27|27.0||||||
4227879|NCT00689481|4051257|B1|Arm||Disease Characteristic - Target Lesion Location|Disease characteristics of Target Lesion Location at baseline|participants|Number|53|53.0||||||
4227880|NCT00689481|4051255|B3|Very marked elevation||Disease Characteristic - Plaque Thickness|Disease characteristics of Plaque Thickness at baseline|participants|Number|1|1.0||||||
4227881|NCT00689481|4051256|B2|Very marked elevation||Disease Characteristic - Plaque Thickness|Disease characteristics of Plaque Thickness at baseline|participants|Number|0|0.0||||||
4227882|NCT00689481|4051257|B1|Very marked elevation||Disease Characteristic - Plaque Thickness|Disease characteristics of Plaque Thickness at baseline|participants|Number|1|1.0||||||
4227883|NCT00689481|4051255|B3|Marked elevation||Disease Characteristic - Plaque Thickness|Disease characteristics of Plaque Thickness at baseline|participants|Number|3|3.0||||||
4227884|NCT00689481|4051256|B2|Marked elevation||Disease Characteristic - Plaque Thickness|Disease characteristics of Plaque Thickness at baseline|participants|Number|1|1.0||||||
4227885|NCT00689481|4051257|B1|Marked elevation||Disease Characteristic - Plaque Thickness|Disease characteristics of Plaque Thickness at baseline|participants|Number|2|2.0||||||
4227886|NCT00689481|4051255|B3|Moderate elevation||Disease Characteristic - Plaque Thickness|Disease characteristics of Plaque Thickness at baseline|participants|Number|210|210.0||||||
4227887|NCT00689481|4051256|B2|Moderate elevation||Disease Characteristic - Plaque Thickness|Disease characteristics of Plaque Thickness at baseline|participants|Number|66|66.0||||||
4227888|NCT00689481|4051257|B1|Moderate elevation||Disease Characteristic - Plaque Thickness|Disease characteristics of Plaque Thickness at baseline|participants|Number|144|144.0||||||
4227889|NCT00689481|4051255|B3|Slight but definite elevation||Disease Characteristic - Plaque Thickness|Disease characteristics of Plaque Thickness at baseline|participants|Number|107|107.0||||||
4227890|NCT00689481|4051256|B2|Slight but definite elevation||Disease Characteristic - Plaque Thickness|Disease characteristics of Plaque Thickness at baseline|participants|Number|41|41.0||||||
4227891|NCT00689481|4051257|B1|Slight but definite elevation||Disease Characteristic - Plaque Thickness|Disease characteristics of Plaque Thickness at baseline|participants|Number|66|66.0||||||
4227892|NCT00689481|4051255|B3|Possible but difficult to ascertain||Disease Characteristic - Plaque Thickness|Disease characteristics of Plaque Thickness at baseline|participants|Number|2|2.0||||||
4227893|NCT00689481|4051256|B2|Possible but difficult to ascertain||Disease Characteristic - Plaque Thickness|Disease characteristics of Plaque Thickness at baseline|participants|Number|1|1.0||||||
4227894|NCT00689481|4051257|B1|Possible but difficult to ascertain||Disease Characteristic - Plaque Thickness|Disease characteristics of Plaque Thickness at baseline|participants|Number|1|1.0||||||
4227895|NCT00689481|4051255|B3|Severe||Disease Characteristic - Scaling|Disease characteristics of Scaling at baseline|participants|Number|1|1.0||||||
4227896|NCT00689481|4051256|B2|Severe||Disease Characteristic - Scaling|Disease characteristics of Scaling at baseline|participants|Number|0|0.0||||||
4227897|NCT00689481|4051257|B1|Severe||Disease Characteristic - Scaling|Disease characteristics of Scaling at baseline|participants|Number|1|1.0||||||
4227898|NCT00689481|4051255|B3|Marked||Disease Characteristic - Scaling|Disease characteristics of Scaling at baseline|participants|Number|2|2.0||||||
4227899|NCT00689481|4051256|B2|Marked||Disease Characteristic - Scaling|Disease characteristics of Scaling at baseline|participants|Number|0|0.0||||||
4227900|NCT00689481|4051257|B1|Marked||Disease Characteristic - Scaling|Disease characteristics of Scaling at baseline|participants|Number|2|2.0||||||
4227901|NCT00689481|4051255|B3|Moderate||Disease Characteristic - Scaling|Disease characteristics of Scaling at baseline|participants|Number|221|221.0||||||
4227902|NCT00689481|4051256|B2|Moderate||Disease Characteristic - Scaling|Disease characteristics of Scaling at baseline|participants|Number|76|76.0||||||
4227903|NCT00689481|4051257|B1|Moderate||Disease Characteristic - Scaling|Disease characteristics of Scaling at baseline|participants|Number|145|145.0||||||
4227904|NCT00689481|4051255|B3|Mild||Disease Characteristic - Scaling|Disease characteristics of Scaling at baseline|participants|Number|98|98.0||||||
4227905|NCT00689481|4051256|B2|Mild||Disease Characteristic - Scaling|Disease characteristics of Scaling at baseline|participants|Number|33|33.0||||||
4227906|NCT00689481|4051257|B1|Mild||Disease Characteristic - Scaling|Disease characteristics of Scaling at baseline|participants|Number|65|65.0||||||
4227907|NCT00689481|4051255|B3|Minimal||Disease Characteristic - Scaling|Disease characteristics of Scaling at baseline|participants|Number|1|1.0||||||
4227908|NCT00689481|4051256|B2|Minimal||Disease Characteristic - Scaling|Disease characteristics of Scaling at baseline|participants|Number|0|0.0||||||
4227909|NCT00689481|4051257|B1|Minimal||Disease Characteristic - Scaling|Disease characteristics of Scaling at baseline|participants|Number|1|1.0||||||
4227910|NCT00689481|4051255|B3|Bright red coloration||Disease Characteristic - Erythema|Disease characteristics of Erythema at baseline|participants|Number|7|7.0||||||
4227969|NCT00689390|4051276|B1|<40 years||Age, Customized||participants|Number|173|173.0||||||
4227911|NCT00689481|4051256|B2|Bright red coloration||Disease Characteristic - Erythema|Disease characteristics of Erythema at baseline|participants|Number|3|3.0||||||
4227912|NCT00689481|4051257|B1|Bright red coloration||Disease Characteristic - Erythema|Disease characteristics of Erythema at baseline|participants|Number|4|4.0||||||
4227913|NCT00689481|4051255|B3|Moderate red coloration||Disease Characteristic - Erythema|Disease characteristics of Erythema at baseline|participants|Number|234|234.0||||||
4227914|NCT00689481|4051256|B2|Moderate red coloration||Disease Characteristic - Erythema|Disease characteristics of Erythema at baseline|participants|Number|76|76.0||||||
4227915|NCT00689481|4051257|B1|Moderate red coloration||Disease Characteristic - Erythema|Disease characteristics of Erythema at baseline|participants|Number|158|158.0||||||
4227916|NCT00689481|4051255|B3|Light red coloration||Disease Characteristic - Erythema|Disease characteristics of Erythema at baseline|participants|Number|82|82.0||||||
4227917|NCT00689481|4051256|B2|Light red coloration||Disease Characteristic - Erythema|Disease characteristics of Erythema at baseline|participants|Number|30|30.0||||||
4227918|NCT00689481|4051257|B1|Light red coloration||Disease Characteristic - Erythema|Disease characteristics of Erythema at baseline|participants|Number|52|52.0||||||
4227919|NCT00689481|4051255|B3|White||Race/Ethnicity, Customized||participants|Number|293|293.0||||||
4227920|NCT00689481|4051256|B2|White||Race/Ethnicity, Customized||participants|Number|99|99.0||||||
4227921|NCT00689481|4051257|B1|White||Race/Ethnicity, Customized||participants|Number|194|194.0||||||
4227922|NCT00689481|4051255|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4227923|NCT00689481|4051256|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4227924|NCT00689481|4051257|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4227925|NCT00689481|4051255|B3|Mulitracial||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4227926|NCT00689481|4051256|B2|Mulitracial||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4227927|NCT00689481|4051257|B1|Mulitracial||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4227928|NCT00689481|4051255|B3|Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4227929|NCT00689481|4051256|B2|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4227930|NCT00689481|4051257|B1|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4227931|NCT00689481|4051255|B3|Asian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4227932|NCT00689481|4051256|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4227933|NCT00689481|4051257|B1|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4227934|NCT00689481|4051255|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4227935|NCT00689481|4051256|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4227936|NCT00689481|4051257|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4227937|NCT00689481|4051255|B3||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4227938|NCT00689481|4051256|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4227939|NCT00689481|4051257|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4227940|NCT00689481|4051255|B3||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4227941|NCT00689481|4051256|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4227942|NCT00689481|4051257|B1||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4227943|NCT00689481|4051255|B3|> 65 years||Age, Customized||participants|Number|45|45.0||||||
4227944|NCT00689481|4051256|B2|> 65 years||Age, Customized||participants|Number|18|18.0||||||
4227945|NCT00689481|4051257|B1|> 65 years||Age, Customized||participants|Number|27|27.0||||||
4227946|NCT00689481|4051255|B3|18 to < 65 years||Age, Customized||participants|Number|273|273.0||||||
4227947|NCT00689481|4051256|B2|18 to < 65 years||Age, Customized||participants|Number|88|88.0||||||
4227948|NCT00689481|4051257|B1|18 to < 65 years||Age, Customized||participants|Number|185|185.0||||||
4227949|NCT00689481|4051255|B3|12 to < 18 years||Age, Customized||participants|Number|5|5.0||||||
4227950|NCT00689481|4051256|B2|12 to < 18 years||Age, Customized||participants|Number|3|3.0||||||
4227951|NCT00689481|4051257|B1|12 to < 18 years||Age, Customized||participants|Number|2|2.0||||||
4227952|NCT00689481|4051255|B3|||Age||years|Mean|47.8|47.8|Standard Deviation|15.2|15.2|||
4227953|NCT00689481|4051256|B2|||Age||years|Mean|47.5|47.5|Standard Deviation|16.9|16.9|||
4227954|NCT00689481|4051257|B1|||Age||years|Mean|47.9|47.9|Standard Deviation|14.2|14.2|||
4227955|NCT00689390|4051274|B3||Male|Sex: Female, Male||Participants|Count of Participants|1150|1150.0||||||
4227956|NCT00689390|4051275|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4227957|NCT00689390|4051276|B1||Male|Sex: Female, Male||Participants|Count of Participants|1122|1122.0||||||
4227958|NCT00689390|4051274|B3||Female|Sex: Female, Male||Participants|Count of Participants|804|804.0||||||
4227959|NCT00689390|4051275|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4227960|NCT00689390|4051276|B1||Female|Sex: Female, Male||Participants|Count of Participants|785|785.0||||||
4227961|NCT00689390|4051274|B3|≥65 years||Age, Customized||participants|Number|83|83.0||||||
4227962|NCT00689390|4051275|B2|≥65 years||Age, Customized||participants|Number|0|0.0||||||
4227963|NCT00689390|4051276|B1|≥65 years||Age, Customized||participants|Number|83|83.0||||||
4227964|NCT00689390|4051274|B3|40 to <65 years||Age, Customized||participants|Number|1693|1693.0||||||
4227965|NCT00689390|4051275|B2|40 to <65 years||Age, Customized||participants|Number|42|42.0||||||
4227966|NCT00689390|4051276|B1|40 to <65 years||Age, Customized||participants|Number|1651|1651.0||||||
4227967|NCT00689390|4051274|B3|<40 years||Age, Customized||participants|Number|178|178.0||||||
4227968|NCT00689390|4051275|B2|<40 years||Age, Customized||participants|Number|5|5.0||||||
4227970|NCT00689351|4051293|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4227971|NCT00689351|4051294|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4227972|NCT00689351|4051295|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4227973|NCT00689351|4051293|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4227974|NCT00689351|4051294|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4227975|NCT00689351|4051295|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4227976|NCT00689351|4051293|B3|||Age||months|Mean|2.1|2.1|Standard Deviation|0.2|0.2|||
4227977|NCT00689351|4051294|B2|||Age||months|Mean|2.1|2.1|Standard Deviation|0.2|0.2|||
4227978|NCT00689351|4051295|B1|||Age||months|Mean|2.1|2.1|Standard Deviation|0.3|0.3|||
4227979|NCT00689338|4051328|B1||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4227980|NCT00689338|4051328|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4227981|NCT00689338|4051328|B1|≥ 65 years||Age, Customized||participants|Number|100|100.0||||||
4227982|NCT00689338|4051328|B1|45 to 64 years||Age, Customized||participants|Number|89|89.0||||||
4227983|NCT00689338|4051328|B1|18 to 44 years||Age, Customized||participants|Number|27|27.0||||||
4227984|NCT00689338|4051328|B1|<18 years||Age, Customized||participants|Number|0|0.0||||||
4227985|NCT00689299|4051338|B4|United States||Region of Enrollment||participants|Number|169|169.0||||||
4227986|NCT00689299|4051339|B3|United States||Region of Enrollment||participants|Number|57|57.0||||||
4227987|NCT00689299|4051340|B2|United States||Region of Enrollment||participants|Number|54|54.0||||||
4227988|NCT00689299|4051341|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
4227989|NCT00689299|4051338|B4||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4227990|NCT00689299|4051339|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4227991|NCT00689299|4051340|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4227992|NCT00689299|4051341|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4227993|NCT00689299|4051338|B4||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4227994|NCT00689299|4051339|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4227995|NCT00689299|4051340|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4227996|NCT00689299|4051341|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4227997|NCT00689299|4051338|B4|||Age||years|Mean|34.5|34.5|Standard Deviation|9|9.0|||
4227998|NCT00689299|4051339|B3|||Age||years|Mean|33|33.0|Standard Deviation|9|9.0|||
4227999|NCT00689299|4051340|B2|||Age||years|Mean|36|36.0|Standard Deviation|8|8.0|||
4228000|NCT00689299|4051341|B1|||Age||years|Mean|34|34.0|Standard Deviation|9|9.0|||
4228001|NCT00689299|4051338|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4228002|NCT00689299|4051339|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4228003|NCT00689299|4051340|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4228004|NCT00689299|4051341|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4228005|NCT00689299|4051338|B4||Between 18 and 65 years|Age||Participants|Count of Participants|169|169.0||||||
4228006|NCT00689299|4051339|B3||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4228007|NCT00689299|4051340|B2||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4228008|NCT00689299|4051341|B1||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4228009|NCT00689299|4051338|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4228010|NCT00689299|4051339|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4228011|NCT00689299|4051340|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4228012|NCT00689299|4051341|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4228013|NCT00689260|4051351|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4228014|NCT00689260|4051352|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4228015|NCT00689260|4051353|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4228016|NCT00689260|4051351|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4228017|NCT00689260|4051352|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4228018|NCT00689260|4051353|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4228019|NCT00689260|4051351|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4228020|NCT00689260|4051352|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4228021|NCT00689260|4051353|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4228022|NCT00689260|4051351|B3|||Age||years|Mean|12.7|12.7|Standard Deviation|2.10|2.1|||
4228023|NCT00689260|4051352|B2|||Age||years|Mean|13.0|13.0|Standard Deviation|2.56|2.56|||
4228024|NCT00689260|4051353|B1|||Age||years|Mean|12.4|12.4|Standard Deviation|1.50|1.5|||
4228025|NCT00689260|4051351|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4228026|NCT00689260|4051352|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4228027|NCT00689260|4051353|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4228028|NCT00689260|4051351|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4228029|NCT00689260|4051352|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4228030|NCT00689260|4051353|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4228031|NCT00689260|4051351|B3||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
4228032|NCT00689260|4051352|B2||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
4228033|NCT00689260|4051353|B1||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
4228034|NCT00689221|4051370|B3||Male|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
4228035|NCT00689221|4051371|B2||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4228036|NCT00689221|4051372|B1||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4228037|NCT00689221|4051370|B3||Female|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
4228038|NCT00689221|4051371|B2||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4228039|NCT00689221|4051372|B1||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4228040|NCT00689221|4051370|B3|||Age||years|Mean|56.4|56.4|Standard Deviation|10.98|10.98|||
4228041|NCT00689221|4051371|B2|||Age||years|Mean|56.0|56.0|Standard Deviation|10.97|10.97|||
4228042|NCT00689221|4051372|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|11.00|11.0|||
4228043|NCT00689117|4051398|B5|Missing||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4228044|NCT00689117|4051399|B4|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4228045|NCT00689117|4051400|B3|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4228046|NCT00689117|4051401|B2|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4228047|NCT00689117|4051402|B1|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4228048|NCT00689117|4051398|B5|White||Race/Ethnicity, Customized||participants|Number|1207|1207.0||||||
4228049|NCT00689117|4051399|B4|White||Race/Ethnicity, Customized||participants|Number|176|176.0||||||
4228050|NCT00689117|4051400|B3|White||Race/Ethnicity, Customized||participants|Number|324|324.0||||||
4228051|NCT00689117|4051401|B2|White||Race/Ethnicity, Customized||participants|Number|349|349.0||||||
4228052|NCT00689117|4051402|B1|White||Race/Ethnicity, Customized||participants|Number|358|358.0||||||
4228053|NCT00689117|4051398|B5|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4228054|NCT00689117|4051399|B4|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4228055|NCT00689117|4051400|B3|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4228056|NCT00689117|4051401|B2|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4228057|NCT00689117|4051402|B1|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4228058|NCT00689117|4051398|B5|Multiracial||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
4228059|NCT00689117|4051399|B4|Multiracial||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4228060|NCT00689117|4051400|B3|Multiracial||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4228061|NCT00689117|4051401|B2|Multiracial||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4228062|NCT00689117|4051402|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4228063|NCT00689117|4051398|B5|Black||Race/Ethnicity, Customized||participants|Number|333|333.0||||||
4228064|NCT00689117|4051399|B4|Black||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4228065|NCT00689117|4051400|B3|Black||Race/Ethnicity, Customized||participants|Number|103|103.0||||||
4228066|NCT00689117|4051401|B2|Black||Race/Ethnicity, Customized||participants|Number|85|85.0||||||
4228067|NCT00689117|4051402|B1|Black||Race/Ethnicity, Customized||participants|Number|94|94.0||||||
4228068|NCT00689117|4051398|B5|Asian||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4228069|NCT00689117|4051399|B4|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4228070|NCT00689117|4051400|B3|Asian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4228071|NCT00689117|4051401|B2|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4228072|NCT00689117|4051402|B1|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4228073|NCT00689117|4051398|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4228074|NCT00689117|4051399|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4228075|NCT00689117|4051400|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4228076|NCT00689117|4051401|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4228077|NCT00689117|4051402|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4228078|NCT00689117|4051398|B5||Male|Sex: Female, Male||Participants|Count of Participants|697|697.0||||||
4228079|NCT00689117|4051399|B4||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4228080|NCT00689117|4051400|B3||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4228081|NCT00689117|4051401|B2||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4228082|NCT00689117|4051402|B1||Male|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4228083|NCT00689117|4051398|B5||Female|Sex: Female, Male||Participants|Count of Participants|952|952.0||||||
4228084|NCT00689117|4051399|B4||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4228085|NCT00689117|4051400|B3||Female|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
4228086|NCT00689117|4051401|B2||Female|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
4228087|NCT00689117|4051402|B1||Female|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
4228088|NCT00689117|4051398|B5|||Age||years|Mean|20.4|20.4|Standard Deviation|8.1|8.1|||
4228089|NCT00689117|4051399|B4|||Age||years|Mean|20.6|20.6|Standard Deviation|8.4|8.4|||
4228090|NCT00689117|4051400|B3|||Age||years|Mean|20.2|20.2|Standard Deviation|7.7|7.7|||
4228091|NCT00689117|4051401|B2|||Age||years|Mean|20.2|20.2|Standard Deviation|8.1|8.1|||
4228092|NCT00689117|4051402|B1|||Age||years|Mean|20.8|20.8|Standard Deviation|8.5|8.5|||
4228212|NCT00689026|4051676|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4228093|NCT00689104|4051431|B5|||Mean number of pads used per 24 hours|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|pads|Mean|1.13|1.13|Standard Deviation|1.884|1.884|||
4228094|NCT00689104|4051432|B4|||Mean number of pads used per 24 hours|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|pads|Mean|1.04|1.04|Standard Deviation|1.752|1.752|||
4228095|NCT00689104|4051433|B3|||Mean number of pads used per 24 hours|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|pads|Mean|1.25|1.25|Standard Deviation|2.020|2.02|||
4228096|NCT00689104|4051434|B2|||Mean number of pads used per 24 hours|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|pads|Mean|1.12|1.12|Standard Deviation|1.941|1.941|||
4228097|NCT00689104|4051435|B1|||Mean number of pads used per 24 hours|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|pads|Mean|1.12|1.12|Standard Deviation|1.812|1.812|||
4228098|NCT00689104|4051431|B5|||Mean number of nocturia episodes per 24 hours|The average number of times a patient waked at night to urinate (excluding incontinence only episodes) recorded for 3 days prior to the Baseline visit in the patient micturition diary.|nocturia episodes|Mean|1.92|1.92|Standard Deviation|1.373|1.373|||
4228099|NCT00689104|4051432|B4|||Mean number of nocturia episodes per 24 hours|The average number of times a patient waked at night to urinate (excluding incontinence only episodes) recorded for 3 days prior to the Baseline visit in the patient micturition diary.|nocturia episodes|Mean|1.93|1.93|Standard Deviation|1.417|1.417|||
4228100|NCT00689104|4051433|B3|||Mean number of nocturia episodes per 24 hours|The average number of times a patient waked at night to urinate (excluding incontinence only episodes) recorded for 3 days prior to the Baseline visit in the patient micturition diary.|nocturia episodes|Mean|1.91|1.91|Standard Deviation|1.374|1.374|||
4228101|NCT00689104|4051434|B2|||Mean number of nocturia episodes per 24 hours|The average number of times a patient waked at night to urinate (excluding incontinence only episodes) recorded for 3 days prior to the Baseline visit in the patient micturition diary.|nocturia episodes|Mean|1.87|1.87|Standard Deviation|1.294|1.294|||
4228102|NCT00689104|4051435|B1|||Mean number of nocturia episodes per 24 hours|The average number of times a patient waked at night to urinate (excluding incontinence only episodes) recorded for 3 days prior to the Baseline visit in the patient micturition diary.|nocturia episodes|Mean|1.98|1.98|Standard Deviation|1.405|1.405|||
4228103|NCT00689104|4051431|B5|||Mean level of urgency|Average of patients’ ratings on the degree of urgency associated with each micturition and/or incontinence episode recorded in a 3-day micturition diary according to the following 5-point categorical scale (Patient Perception of Intensity of Urgency Scale): 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet.|scores on a scale|Mean|2.41|2.41|Standard Deviation|0.551|0.551|||
4228104|NCT00689104|4051432|B4|||Mean level of urgency|Average of patients’ ratings on the degree of urgency associated with each micturition and/or incontinence episode recorded in a 3-day micturition diary according to the following 5-point categorical scale (Patient Perception of Intensity of Urgency Scale): 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet.|scores on a scale|Mean|2.41|2.41|Standard Deviation|0.561|0.561|||
4228105|NCT00689104|4051433|B3|||Mean level of urgency|Average of patients’ ratings on the degree of urgency associated with each micturition and/or incontinence episode recorded in a 3-day micturition diary according to the following 5-point categorical scale (Patient Perception of Intensity of Urgency Scale): 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet.|scores on a scale|Mean|2.46|2.46|Standard Deviation|0.528|0.528|||
4228106|NCT00689104|4051434|B2|||Mean level of urgency|Average of patients’ ratings on the degree of urgency associated with each micturition and/or incontinence episode recorded in a 3-day micturition diary according to the following 5-point categorical scale (Patient Perception of Intensity of Urgency Scale): 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet.|scores on a scale|Mean|2.40|2.4|Standard Deviation|0.547|0.547|||
4228107|NCT00689104|4051435|B1|||Mean level of urgency|Average of patients’ ratings on the degree of urgency associated with each micturition and/or incontinence episode recorded in a 3-day micturition diary according to the following 5-point categorical scale (Patient Perception of Intensity of Urgency Scale): 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet.|scores on a scale|Mean|2.36|2.36|Standard Deviation|0.563|0.563|||
4228108|NCT00689104|4051431|B5|||Mean number of urgency episodes (grade 3 or 4) per 24 hours|Urgency episodes were those classified by the patient in a 3-day micturition diary as 3 or 4 on the following 5-point categorical scale (Patient Perception of Intensity of Urgency Scale): 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet.|urgency episodes|Mean|5.79|5.79|Standard Deviation|3.713|3.713|||
4228109|NCT00689104|4051432|B4|||Mean number of urgency episodes (grade 3 or 4) per 24 hours|Urgency episodes were those classified by the patient in a 3-day micturition diary as 3 or 4 on the following 5-point categorical scale (Patient Perception of Intensity of Urgency Scale): 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet.|urgency episodes|Mean|5.79|5.79|Standard Deviation|3.494|3.494|||
4228110|NCT00689104|4051433|B3|||Mean number of urgency episodes (grade 3 or 4) per 24 hours|Urgency episodes were those classified by the patient in a 3-day micturition diary as 3 or 4 on the following 5-point categorical scale (Patient Perception of Intensity of Urgency Scale): 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet.|urgency episodes|Mean|5.95|5.95|Standard Deviation|3.699|3.699|||
4228154|NCT00689104|4051432|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4228155|NCT00689104|4051433|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4228111|NCT00689104|4051434|B2|||Mean number of urgency episodes (grade 3 or 4) per 24 hours|Urgency episodes were those classified by the patient in a 3-day micturition diary as 3 or 4 on the following 5-point categorical scale (Patient Perception of Intensity of Urgency Scale): 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet.|urgency episodes|Mean|5.68|5.68|Standard Deviation|3.679|3.679|||
4228112|NCT00689104|4051435|B1|||Mean number of urgency episodes (grade 3 or 4) per 24 hours|Urgency episodes were those classified by the patient in a 3-day micturition diary as 3 or 4 on the following 5-point categorical scale (Patient Perception of Intensity of Urgency Scale): 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet.|urgency episodes|Mean|5.72|5.72|Standard Deviation|3.972|3.972|||
4228113|NCT00689104|4051431|B5|||Mean volume voided per micturition|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|mL|Mean|158.3|158.3|Standard Deviation|54.69|54.69|||
4228114|NCT00689104|4051432|B4|||Mean volume voided per micturition|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|mL|Mean|157.4|157.4|Standard Deviation|54.23|54.23|||
4228115|NCT00689104|4051433|B3|||Mean volume voided per micturition|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|mL|Mean|158.9|158.9|Standard Deviation|53.95|53.95|||
4228116|NCT00689104|4051434|B2|||Mean volume voided per micturition|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|mL|Mean|160.3|160.3|Standard Deviation|57.85|57.85|||
4228117|NCT00689104|4051435|B1|||Mean volume voided per micturition|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|mL|Mean|156.8|156.8|Standard Deviation|52.73|52.73|||
4228118|NCT00689104|4051431|B5|||Mean number of micturitions per 24 Hours|The average number of micturitions (urinations) recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|micturitions|Mean|11.59|11.59|Standard Deviation|2.899|2.899|||
4228119|NCT00689104|4051432|B4|||Mean number of micturitions per 24 Hours|The average number of micturitions (urinations) recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|micturitions|Mean|11.53|11.53|Standard Deviation|2.773|2.773|||
4228120|NCT00689104|4051433|B3|||Mean number of micturitions per 24 Hours|The average number of micturitions (urinations) recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|micturitions|Mean|11.49|11.49|Standard Deviation|2.720|2.72|||
4228121|NCT00689104|4051434|B2|||Mean number of micturitions per 24 Hours|The average number of micturitions (urinations) recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|micturitions|Mean|11.64|11.64|Standard Deviation|2.967|2.967|||
4228122|NCT00689104|4051435|B1|||Mean number of micturitions per 24 Hours|The average number of micturitions (urinations) recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|micturitions|Mean|11.72|11.72|Standard Deviation|3.122|3.122|||
4228123|NCT00689104|4051431|B5|||Duration of OAB symptoms||months|Mean|79.0|79.0|Standard Deviation|91.25|91.25|||
4228124|NCT00689104|4051432|B4|||Duration of OAB symptoms||months|Mean|75.5|75.5|Standard Deviation|92.20|92.2|||
4228125|NCT00689104|4051433|B3|||Duration of OAB symptoms||months|Mean|84.8|84.8|Standard Deviation|94.12|94.12|||
4228126|NCT00689104|4051434|B2|||Duration of OAB symptoms||months|Mean|79.6|79.6|Standard Deviation|87.14|87.14|||
4228127|NCT00689104|4051435|B1|||Duration of OAB symptoms||months|Mean|76.0|76.0|Standard Deviation|91.38|91.38|||
4228128|NCT00689104|4051431|B5|Frequency||Type of overactive bladder (OAB)||participants|Number|747|747.0||||||
4228129|NCT00689104|4051432|B4|Frequency||Type of overactive bladder (OAB)||participants|Number|194|194.0||||||
4228130|NCT00689104|4051433|B3|Frequency||Type of overactive bladder (OAB)||participants|Number|189|189.0||||||
4228131|NCT00689104|4051434|B2|Frequency||Type of overactive bladder (OAB)||participants|Number|180|180.0||||||
4228132|NCT00689104|4051435|B1|Frequency||Type of overactive bladder (OAB)||participants|Number|184|184.0||||||
4228133|NCT00689104|4051431|B5|Mixed||Type of overactive bladder (OAB)||participants|Number|449|449.0||||||
4228134|NCT00689104|4051432|B4|Mixed||Type of overactive bladder (OAB)||participants|Number|111|111.0||||||
4228135|NCT00689104|4051433|B3|Mixed||Type of overactive bladder (OAB)||participants|Number|119|119.0||||||
4228136|NCT00689104|4051434|B2|Mixed||Type of overactive bladder (OAB)||participants|Number|113|113.0||||||
4228137|NCT00689104|4051435|B1|Mixed||Type of overactive bladder (OAB)||participants|Number|106|106.0||||||
4228138|NCT00689104|4051431|B5|Urge Incontinence||Type of overactive bladder (OAB)||participants|Number|782|782.0||||||
4228139|NCT00689104|4051432|B4|Urge Incontinence||Type of overactive bladder (OAB)||participants|Number|190|190.0||||||
4228140|NCT00689104|4051433|B3|Urge Incontinence||Type of overactive bladder (OAB)||participants|Number|188|188.0||||||
4228141|NCT00689104|4051434|B2|Urge Incontinence||Type of overactive bladder (OAB)||participants|Number|200|200.0||||||
4228142|NCT00689104|4051435|B1|Urge Incontinence||Type of overactive bladder (OAB)||participants|Number|204|204.0||||||
4228143|NCT00689104|4051431|B5|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4228144|NCT00689104|4051432|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4228145|NCT00689104|4051433|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4228146|NCT00689104|4051434|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4228147|NCT00689104|4051435|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4228148|NCT00689104|4051431|B5|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4228149|NCT00689104|4051432|B4|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4228150|NCT00689104|4051433|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4228151|NCT00689104|4051434|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4228152|NCT00689104|4051435|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4228153|NCT00689104|4051431|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4228156|NCT00689104|4051434|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4228157|NCT00689104|4051435|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4228158|NCT00689104|4051431|B5|White||Race/Ethnicity, Customized||participants|Number|1960|1960.0||||||
4228159|NCT00689104|4051432|B4|White||Race/Ethnicity, Customized||participants|Number|490|490.0||||||
4228160|NCT00689104|4051433|B3|White||Race/Ethnicity, Customized||participants|Number|492|492.0||||||
4228161|NCT00689104|4051434|B2|White||Race/Ethnicity, Customized||participants|Number|488|488.0||||||
4228162|NCT00689104|4051435|B1|White||Race/Ethnicity, Customized||participants|Number|490|490.0||||||
4228163|NCT00689104|4051431|B5||Male|Sex: Female, Male||Participants|Count of Participants|549|549.0||||||
4228164|NCT00689104|4051432|B4||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4228165|NCT00689104|4051433|B3||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4228166|NCT00689104|4051434|B2||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4228167|NCT00689104|4051435|B1||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4228168|NCT00689104|4051431|B5||Female|Sex: Female, Male||Participants|Count of Participants|1429|1429.0||||||
4228169|NCT00689104|4051432|B4||Female|Sex: Female, Male||Participants|Count of Participants|361|361.0||||||
4228170|NCT00689104|4051433|B3||Female|Sex: Female, Male||Participants|Count of Participants|355|355.0||||||
4228171|NCT00689104|4051434|B2||Female|Sex: Female, Male||Participants|Count of Participants|357|357.0||||||
4228172|NCT00689104|4051435|B1||Female|Sex: Female, Male||Participants|Count of Participants|356|356.0||||||
4228173|NCT00689104|4051431|B5|||Age|Baseline Measure data are provided for all randomized patients who took at least 1 dose of double-blind study drug (Safety Analysis Set).|years|Mean|59.1|59.1|Standard Deviation|12.56|12.56|||
4228174|NCT00689104|4051432|B4|||Age|Baseline Measure data are provided for all randomized patients who took at least 1 dose of double-blind study drug (Safety Analysis Set).|years|Mean|59.1|59.1|Standard Deviation|12.89|12.89|||
4228175|NCT00689104|4051433|B3|||Age|Baseline Measure data are provided for all randomized patients who took at least 1 dose of double-blind study drug (Safety Analysis Set).|years|Mean|59.0|59.0|Standard Deviation|12.71|12.71|||
4228176|NCT00689104|4051434|B2|||Age|Baseline Measure data are provided for all randomized patients who took at least 1 dose of double-blind study drug (Safety Analysis Set).|years|Mean|59.1|59.1|Standard Deviation|12.36|12.36|||
4228177|NCT00689104|4051435|B1|||Age|Baseline Measure data are provided for all randomized patients who took at least 1 dose of double-blind study drug (Safety Analysis Set).|years|Mean|59.2|59.2|Standard Deviation|12.30|12.3|||
4228178|NCT00689091|4051568|B3||Male|Sex: Female, Male||Participants|Count of Participants|8438|8438.0||||||
4228179|NCT00689091|4051569|B2||Male|Sex: Female, Male||Participants|Count of Participants|4,201|4.0||||||
4228180|NCT00689091|4051570|B1||Male|Sex: Female, Male||Participants|Count of Participants|4,237|4.0||||||
4228181|NCT00689091|4051568|B3||Female|Sex: Female, Male||Participants|Count of Participants|10398|10398.0||||||
4228182|NCT00689091|4051569|B2||Female|Sex: Female, Male||Participants|Count of Participants|5,175|5.0||||||
4228183|NCT00689091|4051570|B1||Female|Sex: Female, Male||Participants|Count of Participants|5,223|5.0||||||
4228184|NCT00689091|4051568|B3|||Age||years|Median|53|53.0|Inter-Quartile Range|||41.0|64.0|
4228185|NCT00689091|4051569|B2|||Age||years|Median|53|53.0|Inter-Quartile Range|||41.0|64.0|
4228186|NCT00689091|4051570|B1|||Age||years|Median|53|53.0|Inter-Quartile Range|||41.0|64.0|
4228187|NCT00689078|4051589|B5||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4228188|NCT00689078|4051590|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4228189|NCT00689078|4051591|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4228190|NCT00689078|4051592|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4228191|NCT00689078|4051593|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4228192|NCT00689078|4051589|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4228193|NCT00689078|4051590|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4228194|NCT00689078|4051591|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4228195|NCT00689078|4051592|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4228196|NCT00689078|4051593|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4228197|NCT00689078|4051589|B5|||Age||years|Mean|43.67|43.67|Standard Deviation|13.14|13.14|||
4228198|NCT00689078|4051590|B4|||Age||years|Mean|45.78|45.78|Standard Deviation|14.71|14.71|||
4228199|NCT00689078|4051591|B3|||Age||years|Mean|44.67|44.67|Standard Deviation|18.65|18.65|||
4228200|NCT00689078|4051592|B2|||Age||years|Mean|44.11|44.11|Standard Deviation|11.53|11.53|||
4228201|NCT00689078|4051593|B1|||Age||years|Mean|40.11|40.11|Standard Deviation|6.15|6.15|||
4228202|NCT00689052|4051642|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4228203|NCT00689052|4051643|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4228204|NCT00689052|4051644|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4228205|NCT00689052|4051642|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4228206|NCT00689052|4051643|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4228207|NCT00689052|4051644|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4228208|NCT00689052|4051642|B3|||Age||years|Mean|51.5|51.5|Standard Deviation|9.9|9.9|||
4228209|NCT00689052|4051643|B2|||Age||years|Mean|50.7|50.7|Standard Deviation|9.7|9.7|||
4228210|NCT00689052|4051644|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|10.3|10.3|||
4228211|NCT00689026|4051675|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4228213|NCT00689026|4051677|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4228214|NCT00689026|4051675|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4228215|NCT00689026|4051676|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4228216|NCT00689026|4051677|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4228217|NCT00689026|4051675|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4228218|NCT00689026|4051676|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4228219|NCT00689026|4051677|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4228220|NCT00689026|4051675|B3|||Age||years|Mean|58.5|58.5|Standard Deviation|8|8.0|||
4228221|NCT00689026|4051676|B2|||Age||years|Mean|62|62.0|Standard Deviation|8|8.0|||
4228222|NCT00689026|4051677|B1|||Age||years|Mean|55|55.0|Standard Deviation|7|7.0|||
4228223|NCT00689026|4051675|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4228224|NCT00689026|4051676|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4228225|NCT00689026|4051677|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4228226|NCT00689026|4051675|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4228227|NCT00689026|4051676|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4228228|NCT00689026|4051677|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4228229|NCT00689026|4051675|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4228230|NCT00689026|4051676|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4228231|NCT00689026|4051677|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4228232|NCT00688870|4051684|B3|Taiwan||Region of Enrollment||participants|Number|168|168.0||||||
4228233|NCT00688870|4051685|B2|Taiwan||Region of Enrollment||participants|Number|84|84.0||||||
4228234|NCT00688870|4051686|B1|Taiwan||Region of Enrollment||participants|Number|84|84.0||||||
4228235|NCT00688870|4051684|B3||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4228236|NCT00688870|4051685|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4228237|NCT00688870|4051686|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4228238|NCT00688870|4051684|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4228239|NCT00688870|4051685|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4228240|NCT00688870|4051686|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4228241|NCT00688870|4051684|B3|||Age||months|Mean|2.2|2.2|Standard Deviation|0.3|0.3|||
4228242|NCT00688870|4051685|B2|||Age||months|Mean|2.3|2.3|Standard Deviation|0.3|0.3|||
4228243|NCT00688870|4051686|B1|||Age||months|Mean|2.2|2.2|Standard Deviation|0.3|0.3|||
4228244|NCT00688844|4051719|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
4228245|NCT00688844|4051719|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4228246|NCT00688844|4051719|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4228247|NCT00688844|4051719|B1|||Age||years|Mean|17|17.0|Standard Deviation|11|11.0|||
4228248|NCT00688844|4051719|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4228249|NCT00688844|4051719|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4228250|NCT00688844|4051719|B1||<=18 years|Age||Participants|Count of Participants|38|38.0||||||
4228251|NCT00688753|4051729|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4228252|NCT00688753|4051729|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4228253|NCT00688753|4051729|B1|||Age||years|Mean|59.9|59.9|Standard Deviation|14.9|14.9|||
4228254|NCT00688753|4051729|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4228255|NCT00688753|4051729|B1||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
4228256|NCT00688753|4051729|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4228257|NCT00688740|4051738|B3|4 or More Positive Nodes||Number of Positive Nodes||participants|Number|565|565.0||||||
4228258|NCT00688740|4051739|B2|4 or More Positive Nodes||Number of Positive Nodes||participants|Number|287|287.0||||||
4228259|NCT00688740|4051740|B1|4 or More Positive Nodes||Number of Positive Nodes||participants|Number|278|278.0||||||
4228260|NCT00688740|4051738|B3|1-3 Positive Nodes||Number of Positive Nodes||participants|Number|926|926.0||||||
4228261|NCT00688740|4051739|B2|1-3 Positive Nodes||Number of Positive Nodes||participants|Number|459|459.0||||||
4228262|NCT00688740|4051740|B1|1-3 Positive Nodes||Number of Positive Nodes||participants|Number|467|467.0||||||
4228263|NCT00688740|4051738|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4228264|NCT00688740|4051739|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4228265|NCT00688740|4051740|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4228266|NCT00688740|4051738|B3||Female|Sex: Female, Male||Participants|Count of Participants|1491|1491.0||||||
4228267|NCT00688740|4051739|B2||Female|Sex: Female, Male||Participants|Count of Participants|746|746.0||||||
4228268|NCT00688740|4051740|B1||Female|Sex: Female, Male||Participants|Count of Participants|745|745.0||||||
4228269|NCT00688740|4051738|B3||>=65 years|Age||Participants|Count of Participants|89|89.0||||||
4228270|NCT00688740|4051739|B2||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
4228271|NCT00688740|4051740|B1||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4228272|NCT00688740|4051738|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1402|1402.0||||||
4228273|NCT00688740|4051739|B2||Between 18 and 65 years|Age||Participants|Count of Participants|705|705.0||||||
4228274|NCT00688740|4051740|B1||Between 18 and 65 years|Age||Participants|Count of Participants|697|697.0||||||
4228275|NCT00688701|4051751|B4|||Body Mass Index (BMI)|BMI was calculated by dividing body weight by the height squared.|kilogram per square meter (kg/m^2)|Mean|31.91|31.91|Standard Deviation|6.66|6.66|||
4228276|NCT00688701|4051752|B3|||Body Mass Index (BMI)|BMI was calculated by dividing body weight by the height squared.|kilogram per square meter (kg/m^2)|Mean|31.65|31.65|Standard Deviation|6.62|6.62|||
4228277|NCT00688701|4051753|B2|||Body Mass Index (BMI)|BMI was calculated by dividing body weight by the height squared.|kilogram per square meter (kg/m^2)|Mean|32.34|32.34|Standard Deviation|6.72|6.72|||
4228278|NCT00688701|4051754|B1|||Body Mass Index (BMI)|BMI was calculated by dividing body weight by the height squared.|kilogram per square meter (kg/m^2)|Mean|31.76|31.76|Standard Deviation|6.69|6.69|||
4228279|NCT00688701|4051751|B4|||Duration of Diabetes||years|Median|1.33|1.33|Full Range|||0.2|23.9|
4228280|NCT00688701|4051752|B3|||Duration of Diabetes||years|Median|1.11|1.11|Full Range|||0.2|23.9|
4228281|NCT00688701|4051753|B2|||Duration of Diabetes||years|Median|1.42|1.42|Full Range|||0.2|21.5|
4228282|NCT00688701|4051754|B1|||Duration of Diabetes||years|Median|1.37|1.37|Full Range|||0.2|12.5|
4228283|NCT00688701|4051751|B4|||Glucose Excursion|Glucose excursion = 2-hour PPG minus plasma glucose 30 minutes prior to the meal test, before study drug administration. Number of patients analyzed = 60, 59 and 65 for Placebo (Combined), Lixisenatide (Two-Step Titration) and Lixisenatide (One-Step Titration) treatment arms, respectively, as meal challenge test was performed at selected sites only.|mmol/L|Mean|5.27|5.27|Standard Deviation|3.25|3.25|||
4228284|NCT00688701|4051752|B3|||Glucose Excursion|Glucose excursion = 2-hour PPG minus plasma glucose 30 minutes prior to the meal test, before study drug administration. Number of patients analyzed = 60, 59 and 65 for Placebo (Combined), Lixisenatide (Two-Step Titration) and Lixisenatide (One-Step Titration) treatment arms, respectively, as meal challenge test was performed at selected sites only.|mmol/L|Mean|5.34|5.34|Standard Deviation|2.96|2.96|||
4228285|NCT00688701|4051753|B2|||Glucose Excursion|Glucose excursion = 2-hour PPG minus plasma glucose 30 minutes prior to the meal test, before study drug administration. Number of patients analyzed = 60, 59 and 65 for Placebo (Combined), Lixisenatide (Two-Step Titration) and Lixisenatide (One-Step Titration) treatment arms, respectively, as meal challenge test was performed at selected sites only.|mmol/L|Mean|5.67|5.67|Standard Deviation|3.05|3.05|||
4228286|NCT00688701|4051754|B1|||Glucose Excursion|Glucose excursion = 2-hour PPG minus plasma glucose 30 minutes prior to the meal test, before study drug administration. Number of patients analyzed = 60, 59 and 65 for Placebo (Combined), Lixisenatide (Two-Step Titration) and Lixisenatide (One-Step Titration) treatment arms, respectively, as meal challenge test was performed at selected sites only.|mmol/L|Mean|4.82|4.82|Standard Deviation|3.69|3.69|||
4228287|NCT00688701|4051751|B4|||Fasting Plasma Glucose (FPG)||millimole per liter (mmol/L)|Mean|9.03|9.03|Standard Deviation|2.04|2.04|||
4228288|NCT00688701|4051752|B3|||Fasting Plasma Glucose (FPG)||millimole per liter (mmol/L)|Mean|9.04|9.04|Standard Deviation|1.97|1.97|||
4228289|NCT00688701|4051753|B2|||Fasting Plasma Glucose (FPG)||millimole per liter (mmol/L)|Mean|9.15|9.15|Standard Deviation|1.99|1.99|||
4228290|NCT00688701|4051754|B1|||Fasting Plasma Glucose (FPG)||millimole per liter (mmol/L)|Mean|8.90|8.9|Standard Deviation|2.16|2.16|||
4228291|NCT00688701|4051751|B4|||Body Weight||kilogram (kg)|Mean|87.20|87.2|Standard Deviation|21.78|21.78|||
4228292|NCT00688701|4051752|B3|||Body Weight||kilogram (kg)|Mean|86.50|86.5|Standard Deviation|21.00|21.0|||
4228293|NCT00688701|4051753|B2|||Body Weight||kilogram (kg)|Mean|89.04|89.04|Standard Deviation|22.16|22.16|||
4228294|NCT00688701|4051754|B1|||Body Weight||kilogram (kg)|Mean|86.08|86.08|Standard Deviation|22.21|22.21|||
4228295|NCT00688701|4051751|B4|||2-Hour Postprandial Plasma Glucose (PPG)|The 2-hour PPG test measured blood glucose 2 hours after eating a standardized meal. Number of patients analyzed = 60, 59 and 65 for Placebo (Combined), Lixisenatide (Two-Step Titration) and Lixisenatide (One-Step Titration) treatment arms, respectively, as meal challenge test was performed at selected sites only.|mmol/L|Mean|14.57|14.57|Standard Deviation|4.05|4.05|||
4228296|NCT00688701|4051752|B3|||2-Hour Postprandial Plasma Glucose (PPG)|The 2-hour PPG test measured blood glucose 2 hours after eating a standardized meal. Number of patients analyzed = 60, 59 and 65 for Placebo (Combined), Lixisenatide (Two-Step Titration) and Lixisenatide (One-Step Titration) treatment arms, respectively, as meal challenge test was performed at selected sites only.|mmol/L|Mean|14.62|14.62|Standard Deviation|3.41|3.41|||
4228297|NCT00688701|4051753|B2|||2-Hour Postprandial Plasma Glucose (PPG)|The 2-hour PPG test measured blood glucose 2 hours after eating a standardized meal. Number of patients analyzed = 60, 59 and 65 for Placebo (Combined), Lixisenatide (Two-Step Titration) and Lixisenatide (One-Step Titration) treatment arms, respectively, as meal challenge test was performed at selected sites only.|mmol/L|Mean|14.81|14.81|Standard Deviation|3.87|3.87|||
4228298|NCT00688701|4051754|B1|||2-Hour Postprandial Plasma Glucose (PPG)|The 2-hour PPG test measured blood glucose 2 hours after eating a standardized meal. Number of patients analyzed = 60, 59 and 65 for Placebo (Combined), Lixisenatide (Two-Step Titration) and Lixisenatide (One-Step Titration) treatment arms, respectively, as meal challenge test was performed at selected sites only.|mmol/L|Mean|14.27|14.27|Standard Deviation|4.84|4.84|||
4228299|NCT00688701|4051751|B4|||Glycosylated Hemoglobin (HbA1c)||percentage of hemoglobin|Mean|8.04|8.04|Standard Deviation|0.90|0.9|||
4228300|NCT00688701|4051752|B3|||Glycosylated Hemoglobin (HbA1c)||percentage of hemoglobin|Mean|8.07|8.07|Standard Deviation|0.87|0.87|||
4228301|NCT00688701|4051753|B2|||Glycosylated Hemoglobin (HbA1c)||percentage of hemoglobin|Mean|7.98|7.98|Standard Deviation|0.92|0.92|||
4228302|NCT00688701|4051754|B1|||Glycosylated Hemoglobin (HbA1c)||percentage of hemoglobin|Mean|8.07|8.07|Standard Deviation|0.91|0.91|||
4228303|NCT00688701|4051751|B4|Ethnicity: Non Hispanic||Race/Ethnicity, Customized||participants|Number|283|283.0||||||
4228304|NCT00688701|4051752|B3|Ethnicity: Non Hispanic||Race/Ethnicity, Customized||participants|Number|97|97.0||||||
4228305|NCT00688701|4051753|B2|Ethnicity: Non Hispanic||Race/Ethnicity, Customized||participants|Number|95|95.0||||||
4228306|NCT00688701|4051754|B1|Ethnicity: Non Hispanic||Race/Ethnicity, Customized||participants|Number|91|91.0||||||
4228307|NCT00688701|4051751|B4|Ethnicity: Hispanic||Race/Ethnicity, Customized||participants|Number|78|78.0||||||
4228308|NCT00688701|4051752|B3|Ethnicity: Hispanic||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4228309|NCT00688701|4051753|B2|Ethnicity: Hispanic||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4228310|NCT00688701|4051754|B1|Ethnicity: Hispanic||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4228311|NCT00688701|4051751|B4|Race: Other||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4228312|NCT00688701|4051752|B3|Race: Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4228313|NCT00688701|4051753|B2|Race: Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4228314|NCT00688701|4051754|B1|Race: Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4228315|NCT00688701|4051751|B4|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|80|80.0||||||
4228316|NCT00688701|4051752|B3|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4228317|NCT00688701|4051753|B2|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4228318|NCT00688701|4051754|B1|Race: Asian/Oriental||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4228319|NCT00688701|4051751|B4|Race: Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4228320|NCT00688701|4051752|B3|Race: Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4228321|NCT00688701|4051753|B2|Race: Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4228322|NCT00688701|4051754|B1|Race: Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4228323|NCT00688701|4051751|B4|Race: Caucasian/White||Race/Ethnicity, Customized||participants|Number|263|263.0||||||
4228324|NCT00688701|4051752|B3|Race: Caucasian/White||Race/Ethnicity, Customized||participants|Number|85|85.0||||||
4228325|NCT00688701|4051753|B2|Race: Caucasian/White||Race/Ethnicity, Customized||participants|Number|88|88.0||||||
4228326|NCT00688701|4051754|B1|Race: Caucasian/White||Race/Ethnicity, Customized||participants|Number|90|90.0||||||
4228327|NCT00688701|4051751|B4||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4228328|NCT00688701|4051752|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4228329|NCT00688701|4051753|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4228330|NCT00688701|4051754|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4228331|NCT00688701|4051751|B4||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4228332|NCT00688701|4051752|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4228333|NCT00688701|4051753|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4228334|NCT00688701|4051754|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4228335|NCT00688701|4051751|B4|||Age||years|Mean|53.7|53.7|Standard Deviation|10.5|10.5|||
4228336|NCT00688701|4051752|B3|||Age||years|Mean|53.8|53.8|Standard Deviation|10.9|10.9|||
4228337|NCT00688701|4051753|B2|||Age||years|Mean|53.3|53.3|Standard Deviation|9.7|9.7|||
4228338|NCT00688701|4051754|B1|||Age||years|Mean|54.1|54.1|Standard Deviation|11.0|11.0|||
4228339|NCT00688688|4051795|B4|||Mean number of pads used per 24 hours|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|pads|Mean|1.01|1.01|Standard Deviation|1.800|1.8|||
4228340|NCT00688688|4051796|B3|||Mean number of pads used per 24 hours|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|pads|Mean|0.98|0.98|Standard Deviation|1.759|1.759|||
4228341|NCT00688688|4051797|B2|||Mean number of pads used per 24 hours|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|pads|Mean|0.98|0.98|Standard Deviation|1.769|1.769|||
4228342|NCT00688688|4051798|B1|||Mean number of pads used per 24 hours|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|pads|Mean|1.06|1.06|Standard Deviation|1.872|1.872|||
4228343|NCT00688688|4051795|B4|||Mean number of nocturia episodes per 24 hours|The average number of times a patient woke at night to urinate (excluding incontinence only episodes) recorded for 3 days prior to the Baseline visit in the patient micturition diary.|nocturia episodes|Mean|1.82|1.82|Standard Deviation|1.384|1.384|||
4228344|NCT00688688|4051796|B3|||Mean number of nocturia episodes per 24 hours|The average number of times a patient woke at night to urinate (excluding incontinence only episodes) recorded for 3 days prior to the Baseline visit in the patient micturition diary.|nocturia episodes|Mean|1.77|1.77|Standard Deviation|1.388|1.388|||
4228345|NCT00688688|4051797|B2|||Mean number of nocturia episodes per 24 hours|The average number of times a patient woke at night to urinate (excluding incontinence only episodes) recorded for 3 days prior to the Baseline visit in the patient micturition diary.|nocturia episodes|Mean|1.85|1.85|Standard Deviation|1.404|1.404|||
4228346|NCT00688688|4051798|B1|||Mean number of nocturia episodes per 24 hours|The average number of times a patient woke at night to urinate (excluding incontinence only episodes) recorded for 3 days prior to the Baseline visit in the patient micturition diary.|nocturia episodes|Mean|1.83|1.83|Standard Deviation|1.361|1.361|||
4228347|NCT00688688|4051795|B4|||Mean level of urgency|Average of patients’ ratings on the degree of associated urgency for each micturition and/or incontinence episode recorded in a 3-day micturition diary according to the following 5-point categorical scale (Patient Perception of Intensity of Urgency Scale): 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet.|scores on a scale|Mean|2.44|2.44|Standard Deviation|0.529|0.529|||
4228348|NCT00688688|4051796|B3|||Mean level of urgency|Average of patients’ ratings on the degree of associated urgency for each micturition and/or incontinence episode recorded in a 3-day micturition diary according to the following 5-point categorical scale (Patient Perception of Intensity of Urgency Scale): 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet.|scores on a scale|Mean|2.43|2.43|Standard Deviation|0.519|0.519|||
4228381|NCT00688688|4051797|B2|Placebo||Summary of previous treatment||participants|Number|174|174.0||||||
4228382|NCT00688688|4051798|B1|Placebo||Summary of previous treatment||participants|Number|190|190.0||||||
4228349|NCT00688688|4051797|B2|||Mean level of urgency|Average of patients’ ratings on the degree of associated urgency for each micturition and/or incontinence episode recorded in a 3-day micturition diary according to the following 5-point categorical scale (Patient Perception of Intensity of Urgency Scale): 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet.|scores on a scale|Mean|2.44|2.44|Standard Deviation|0.525|0.525|||
4228350|NCT00688688|4051798|B1|||Mean level of urgency|Average of patients’ ratings on the degree of associated urgency for each micturition and/or incontinence episode recorded in a 3-day micturition diary according to the following 5-point categorical scale (Patient Perception of Intensity of Urgency Scale): 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet.|scores on a scale|Mean|2.45|2.45|Standard Deviation|0.544|0.544|||
4228351|NCT00688688|4051795|B4|||Mean number of urgency episodes (grade 3 or 4) per 24 hours|Urgency episodes were those classified by the patient in a 3-day micturition diary as 3 or 4 on the Patient Perception of Intensity of Urgency (PPIUS) scale: 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet.|urgency episodes|Mean|5.57|5.57|Standard Deviation|3.594|3.594|||
4228352|NCT00688688|4051796|B3|||Mean number of urgency episodes (grade 3 or 4) per 24 hours|Urgency episodes were those classified by the patient in a 3-day micturition diary as 3 or 4 on the Patient Perception of Intensity of Urgency (PPIUS) scale: 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet.|urgency episodes|Mean|5.44|5.44|Standard Deviation|3.453|3.453|||
4228353|NCT00688688|4051797|B2|||Mean number of urgency episodes (grade 3 or 4) per 24 hours|Urgency episodes were those classified by the patient in a 3-day micturition diary as 3 or 4 on the Patient Perception of Intensity of Urgency (PPIUS) scale: 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet.|urgency episodes|Mean|5.61|5.61|Standard Deviation|3.722|3.722|||
4228354|NCT00688688|4051798|B1|||Mean number of urgency episodes (grade 3 or 4) per 24 hours|Urgency episodes were those classified by the patient in a 3-day micturition diary as 3 or 4 on the Patient Perception of Intensity of Urgency (PPIUS) scale: 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet.|urgency episodes|Mean|5.66|5.66|Standard Deviation|3.601|3.601|||
4228355|NCT00688688|4051795|B4|||Mean volume voided per micturition|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|mL|Mean|162.0|162.0|Standard Deviation|58.15|58.15|||
4228356|NCT00688688|4051796|B3|||Mean volume voided per micturition|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|mL|Mean|160.8|160.8|Standard Deviation|56.98|56.98|||
4228357|NCT00688688|4051797|B2|||Mean volume voided per micturition|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|mL|Mean|164.6|164.6|Standard Deviation|58.62|58.62|||
4228358|NCT00688688|4051798|B1|||Mean volume voided per micturition|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|mL|Mean|160.4|160.4|Standard Deviation|58.80|58.8|||
4228359|NCT00688688|4051795|B4|||Mean number of micturitions per 24 Hours|The average number of micturitions (urinations) per 24 hours recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|micturitions|Mean|11.08|11.08|Standard Deviation|2.801|2.801|||
4228360|NCT00688688|4051796|B3|||Mean number of micturitions per 24 Hours|The average number of micturitions (urinations) per 24 hours recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|micturitions|Mean|10.94|10.94|Standard Deviation|2.668|2.668|||
4228361|NCT00688688|4051797|B2|||Mean number of micturitions per 24 Hours|The average number of micturitions (urinations) per 24 hours recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|micturitions|Mean|11.16|11.16|Standard Deviation|2.917|2.917|||
4228362|NCT00688688|4051798|B1|||Mean number of micturitions per 24 Hours|The average number of micturitions (urinations) per 24 hours recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|micturitions|Mean|11.12|11.12|Standard Deviation|2.809|2.809|||
4228363|NCT00688688|4051795|B4|Naive||Summary of previous treatment||participants|Number|456|456.0||||||
4228364|NCT00688688|4051796|B3|Naive||Summary of previous treatment||participants|Number|156|156.0||||||
4228365|NCT00688688|4051797|B2|Naive||Summary of previous treatment||participants|Number|161|161.0||||||
4228366|NCT00688688|4051798|B1|Naive||Summary of previous treatment||participants|Number|139|139.0||||||
4228367|NCT00688688|4051795|B4|Tolterodine ER 4 mg||Summary of previous treatment||participants|Number|345|345.0||||||
4228368|NCT00688688|4051796|B3|Tolterodine ER 4 mg||Summary of previous treatment||participants|Number|108|108.0||||||
4228369|NCT00688688|4051797|B2|Tolterodine ER 4 mg||Summary of previous treatment||participants|Number|107|107.0||||||
4228370|NCT00688688|4051798|B1|Tolterodine ER 4 mg||Summary of previous treatment||participants|Number|130|130.0||||||
4228371|NCT00688688|4051795|B4|Mirabegron 100 mg||Summary of previous treatment||participants|Number|578|578.0||||||
4228372|NCT00688688|4051796|B3|Mirabegron 100 mg||Summary of previous treatment||participants|Number|197|197.0||||||
4228373|NCT00688688|4051797|B2|Mirabegron 100 mg||Summary of previous treatment||participants|Number|198|198.0||||||
4228374|NCT00688688|4051798|B1|Mirabegron 100 mg||Summary of previous treatment||participants|Number|183|183.0||||||
4228375|NCT00688688|4051795|B4|Mirabegron 50 mg||Summary of previous treatment||participants|Number|521|521.0||||||
4228376|NCT00688688|4051796|B3|Mirabegron 50 mg||Summary of previous treatment||participants|Number|171|171.0||||||
4228377|NCT00688688|4051797|B2|Mirabegron 50 mg||Summary of previous treatment||participants|Number|180|180.0||||||
4228378|NCT00688688|4051798|B1|Mirabegron 50 mg||Summary of previous treatment||participants|Number|170|170.0||||||
4228379|NCT00688688|4051795|B4|Placebo||Summary of previous treatment||participants|Number|544|544.0||||||
4228380|NCT00688688|4051796|B3|Placebo||Summary of previous treatment||participants|Number|180|180.0||||||
4228383|NCT00688688|4051795|B4|||Duration of OAB symptoms||months|Mean|86.4|86.4|Standard Deviation|91.77|91.77|||
4228384|NCT00688688|4051796|B3|||Duration of OAB symptoms||months|Mean|83.8|83.8|Standard Deviation|87.34|87.34|||
4228385|NCT00688688|4051797|B2|||Duration of OAB symptoms||months|Mean|87.9|87.9|Standard Deviation|91.52|91.52|||
4228386|NCT00688688|4051798|B1|||Duration of OAB symptoms||months|Mean|87.4|87.4|Standard Deviation|96.28|96.28|||
4228387|NCT00688688|4051795|B4|Frequency||Type of overactive bladder (OAB)||participants|Number|856|856.0||||||
4228388|NCT00688688|4051796|B3|Frequency||Type of overactive bladder (OAB)||participants|Number|285|285.0||||||
4228389|NCT00688688|4051797|B2|Frequency||Type of overactive bladder (OAB)||participants|Number|287|287.0||||||
4228390|NCT00688688|4051798|B1|Frequency||Type of overactive bladder (OAB)||participants|Number|284|284.0||||||
4228391|NCT00688688|4051795|B4|Mixed||Type of overactive bladder (OAB)||participants|Number|670|670.0||||||
4228392|NCT00688688|4051796|B3|Mixed||Type of overactive bladder (OAB)||participants|Number|210|210.0||||||
4228393|NCT00688688|4051797|B2|Mixed||Type of overactive bladder (OAB)||participants|Number|228|228.0||||||
4228394|NCT00688688|4051798|B1|Mixed||Type of overactive bladder (OAB)||participants|Number|232|232.0||||||
4228395|NCT00688688|4051795|B4|Urge incontinence||Type of overactive bladder (OAB)||participants|Number|918|918.0||||||
4228396|NCT00688688|4051796|B3|Urge incontinence||Type of overactive bladder (OAB)||participants|Number|317|317.0||||||
4228397|NCT00688688|4051797|B2|Urge incontinence||Type of overactive bladder (OAB)||participants|Number|305|305.0||||||
4228398|NCT00688688|4051798|B1|Urge incontinence||Type of overactive bladder (OAB)||participants|Number|296|296.0||||||
4228399|NCT00688688|4051795|B4||Male|Sex: Female, Male||Participants|Count of Participants|634|634.0||||||
4228400|NCT00688688|4051796|B3||Male|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4228401|NCT00688688|4051797|B2||Male|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4228402|NCT00688688|4051798|B1||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4228403|NCT00688688|4051795|B4||Female|Sex: Female, Male||Participants|Count of Participants|1810|1810.0||||||
4228404|NCT00688688|4051796|B3||Female|Sex: Female, Male||Participants|Count of Participants|600|600.0||||||
4228405|NCT00688688|4051797|B2||Female|Sex: Female, Male||Participants|Count of Participants|608|608.0||||||
4228406|NCT00688688|4051798|B1||Female|Sex: Female, Male||Participants|Count of Participants|602|602.0||||||
4228407|NCT00688688|4051795|B4|||Age|Baseline Measure data are provided for all randomized patients who took at least 1 dose of double-blind study drug (Safety Analysis Set).|years|Mean|59.6|59.6|Standard Deviation|12.32|12.32|||
4228408|NCT00688688|4051796|B3|||Age|Baseline Measure data are provided for all randomized patients who took at least 1 dose of double-blind study drug (Safety Analysis Set).|years|Mean|59.6|59.6|Standard Deviation|12.47|12.47|||
4228409|NCT00688688|4051797|B2|||Age|Baseline Measure data are provided for all randomized patients who took at least 1 dose of double-blind study drug (Safety Analysis Set).|years|Mean|60.1|60.1|Standard Deviation|11.92|11.92|||
4228410|NCT00688688|4051798|B1|||Age|Baseline Measure data are provided for all randomized patients who took at least 1 dose of double-blind study drug (Safety Analysis Set).|years|Mean|59.2|59.2|Standard Deviation|12.56|12.56|||
4228411|NCT00688662|4051889|B3|United States||Region of Enrollment||participants|Number|214|214.0||||||
4228412|NCT00688662|4051890|B2|United States||Region of Enrollment||participants|Number|73|73.0||||||
4228413|NCT00688662|4051891|B1|United States||Region of Enrollment||participants|Number|141|141.0||||||
4228414|NCT00688662|4051889|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4228415|NCT00688662|4051890|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4228416|NCT00688662|4051891|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4228417|NCT00688662|4051889|B3||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4228418|NCT00688662|4051890|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4228419|NCT00688662|4051891|B1||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4228420|NCT00688662|4051889|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4228421|NCT00688662|4051890|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4228422|NCT00688662|4051891|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4228423|NCT00688662|4051889|B3||Between 18 and 65 years|Age||Participants|Count of Participants|214|214.0||||||
4228424|NCT00688662|4051890|B2||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4228425|NCT00688662|4051891|B1||Between 18 and 65 years|Age||Participants|Count of Participants|141|141.0||||||
4228426|NCT00688662|4051889|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4228427|NCT00688662|4051890|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4228428|NCT00688662|4051891|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4228429|NCT00688636|4051900|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4228430|NCT00688636|4051901|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4228431|NCT00688636|4051902|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4228432|NCT00688636|4051900|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4228433|NCT00688636|4051901|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4228434|NCT00688636|4051902|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4228435|NCT00688636|4051900|B3|||Age||years|Median|38.0|38.0|Inter-Quartile Range|||27.0|47.0|
4228436|NCT00688636|4051901|B2|||Age||years|Median|32.0|32.0|Inter-Quartile Range|||26.0|45.0|
4228437|NCT00688636|4051902|B1|||Age||years|Median|43.0|43.0|Inter-Quartile Range|||28.0|49.0|
4228438|NCT00688597|4051917|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4228439|NCT00688597|4051920|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4228440|NCT00688597|4051917|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4228441|NCT00688597|4051920|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4228442|NCT00688597|4051917|B4|||Age||years|Mean|49.07|49.07|Standard Deviation|11.02|11.02|||
4228443|NCT00688597|4051920|B1|||Age||years|Mean|49.07|49.07|Standard Deviation|11.02|11.02|||
4228444|NCT00688545|4051933|B3|Height||Weight and Height percentiles overall|Percentile category based on WHO 2000 Centers for Disease Control growth charts|Percentile|Mean|49.08|49.08|Standard Deviation|30.63|30.63|||
4228445|NCT00688545|4051934|B2|Height||Weight and Height percentiles overall|Percentile category based on WHO 2000 Centers for Disease Control growth charts|Percentile|Mean|50.70|50.7|Standard Deviation|30.76|30.76|||
4228446|NCT00688545|4051935|B1|Height||Weight and Height percentiles overall|Percentile category based on WHO 2000 Centers for Disease Control growth charts|Percentile|Mean|42.77|42.77|Standard Deviation|29.59|29.59|||
4228447|NCT00688545|4051933|B3|Weight||Weight and Height percentiles overall|Percentile category based on WHO 2000 Centers for Disease Control growth charts|Percentile|Mean|54.76|54.76|Standard Deviation|30.94|30.94|||
4228448|NCT00688545|4051934|B2|Weight||Weight and Height percentiles overall|Percentile category based on WHO 2000 Centers for Disease Control growth charts|Percentile|Mean|56.68|56.68|Standard Deviation|30.96|30.96|||
4228449|NCT00688545|4051935|B1|Weight||Weight and Height percentiles overall|Percentile category based on WHO 2000 Centers for Disease Control growth charts|Percentile|Mean|47.22|47.22|Standard Deviation|29.95|29.95|||
4228450|NCT00688545|4051933|B3|||Body Mass Index (BMI)|Based on World Health Organization (WHO) 2000 Centers for Disease Control growth charts. BMI = Weight in Kilograms divided by (/) (Height in Meters multipled by [*] Height in Meters).|kilograms per meter squared (kg/m^2)|Median|17.55|17.55|Full Range|||7.4|45.1|
4228451|NCT00688545|4051934|B2|||Body Mass Index (BMI)|Based on World Health Organization (WHO) 2000 Centers for Disease Control growth charts. BMI = Weight in Kilograms divided by (/) (Height in Meters multipled by [*] Height in Meters).|kilograms per meter squared (kg/m^2)|Median|17.31|17.31|Full Range|||12.5|45.1|
4228452|NCT00688545|4051935|B1|||Body Mass Index (BMI)|Based on World Health Organization (WHO) 2000 Centers for Disease Control growth charts. BMI = Weight in Kilograms divided by (/) (Height in Meters multipled by [*] Height in Meters).|kilograms per meter squared (kg/m^2)|Median|17.70|17.7|Full Range|||7.4|28.6|
4228453|NCT00688545|4051933|B3|||Height||centimeters (cm)|Median|132.00|132.0|Full Range|||77.5|179.0|
4228454|NCT00688545|4051934|B2|||Height||centimeters (cm)|Median|130.10|130.1|Full Range|||77.5|179.0|
4228455|NCT00688545|4051935|B1|||Height||centimeters (cm)|Median|141.30|141.3|Full Range|||81.2|174.5|
4228456|NCT00688545|4051933|B3|||Body weight||kilogram (kg)|Median|30.90|30.9|Full Range|||8.7|99.5|
4228457|NCT00688545|4051934|B2|||Body weight||kilogram (kg)|Median|30.20|30.2|Full Range|||8.7|99.5|
4228458|NCT00688545|4051935|B1|||Body weight||kilogram (kg)|Median|33.60|33.6|Full Range|||10.7|67.4|
4228459|NCT00688545|4051933|B3|||GISSK - severity of stomach problems|GISSK is a validated measure of GI symptom severity and types of GI problems, if any. For severity of stomach problems, participant or caregiver reported severity of participant's stomach problems during the last week using VAS, where scores ranged from 0 (no trouble at all) to 100 (severe stomach problems).|Units on a scale|Mean|14.0|14.0|Standard Deviation|21.47|21.47|||
4228460|NCT00688545|4051934|B2|||GISSK - severity of stomach problems|GISSK is a validated measure of GI symptom severity and types of GI problems, if any. For severity of stomach problems, participant or caregiver reported severity of participant's stomach problems during the last week using VAS, where scores ranged from 0 (no trouble at all) to 100 (severe stomach problems).|Units on a scale|Mean|12.0|12.0|Standard Deviation|19.84|19.84|||
4228461|NCT00688545|4051935|B1|||GISSK - severity of stomach problems|GISSK is a validated measure of GI symptom severity and types of GI problems, if any. For severity of stomach problems, participant or caregiver reported severity of participant's stomach problems during the last week using VAS, where scores ranged from 0 (no trouble at all) to 100 (severe stomach problems).|Units on a scale|Mean|21.9|21.9|Standard Deviation|25.75|25.75|||
4228462|NCT00688545|4051933|B3|||Number of joints with active arthritis|Active arthritis defined as swelling or limitation of motion of the joint accompanied by heat, pain, or tenderness. A total of 36 joints and spine (cervical, thoracic, and lumbar) checked.|Joints|Mean|3.0|3.0|Standard Deviation|4.42|4.42|||
4228463|NCT00688545|4051934|B2|||Number of joints with active arthritis|Active arthritis defined as swelling or limitation of motion of the joint accompanied by heat, pain, or tenderness. A total of 36 joints and spine (cervical, thoracic, and lumbar) checked.|Joints|Mean|2.9|2.9|Standard Deviation|4.14|4.14|||
4228464|NCT00688545|4051935|B1|||Number of joints with active arthritis|Active arthritis defined as swelling or limitation of motion of the joint accompanied by heat, pain, or tenderness. A total of 36 joints and spine (cervical, thoracic, and lumbar) checked.|Joints|Mean|3.4|3.4|Standard Deviation|5.39|5.39|||
4228465|NCT00688545|4051933|B3|||CHAQ - functioning|Daily functioning included questions on level of difficulty child had with 8 categories of daily living. Responses ranged from 'without any difficulty' (0) to 'unable to do' (3). Functioning score = sum of highest score in each category divided by number of categories answered; scores ranged from 0 to 3; higher scores indicated more impairment.|Units on a scale|Mean|0.52|0.52|Standard Deviation|0.57|0.57|||
4228466|NCT00688545|4051934|B2|||CHAQ - functioning|Daily functioning included questions on level of difficulty child had with 8 categories of daily living. Responses ranged from 'without any difficulty' (0) to 'unable to do' (3). Functioning score = sum of highest score in each category divided by number of categories answered; scores ranged from 0 to 3; higher scores indicated more impairment.|Units on a scale|Mean|0.48|0.48|Standard Deviation|0.54|0.54|||
4228467|NCT00688545|4051935|B1|||CHAQ - functioning|Daily functioning included questions on level of difficulty child had with 8 categories of daily living. Responses ranged from 'without any difficulty' (0) to 'unable to do' (3). Functioning score = sum of highest score in each category divided by number of categories answered; scores ranged from 0 to 3; higher scores indicated more impairment.|Units on a scale|Mean|0.65|0.65|Standard Deviation|0.68|0.68|||
4228578|NCT00688545|4051935|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4228468|NCT00688545|4051933|B3|||CHAQ - pain|CHAQ: validated parent or legal guardian assessed instrument of child's activities of daily living, pain, and global assessment. Pain rated on a VAS from 0 (no pain) to 100 (severe pain). Scores converted to 0, 1, 2, or 3 where 0 = no pain and 3 = severe pain.|Units on a scale|Mean|0.75|0.75|Standard Deviation|0.75|0.75|||
4228469|NCT00688545|4051934|B2|||CHAQ - pain|CHAQ: validated parent or legal guardian assessed instrument of child's activities of daily living, pain, and global assessment. Pain rated on a VAS from 0 (no pain) to 100 (severe pain). Scores converted to 0, 1, 2, or 3 where 0 = no pain and 3 = severe pain.|Units on a scale|Mean|0.71|0.71|Standard Deviation|0.72|0.72|||
4228470|NCT00688545|4051935|B1|||CHAQ - pain|CHAQ: validated parent or legal guardian assessed instrument of child's activities of daily living, pain, and global assessment. Pain rated on a VAS from 0 (no pain) to 100 (severe pain). Scores converted to 0, 1, 2, or 3 where 0 = no pain and 3 = severe pain.|Units on a scale|Mean|0.92|0.92|Standard Deviation|0.85|0.85|||
4228471|NCT00688545|4051933|B3|||Child Health Questionnaire (CHAQ) - global evaluation|CHAQ: validated parent or legal guardian assessed instrument of child's activities of daily living, pain, and global assessment. Global evaluation rated on a visual analog scale (VAS) from 0 (very well) to 100 (very poor) where higher scores indicated a worse evaluation.|Units on a scale|Mean|21.96|21.96|Standard Deviation|23.56|23.56|||
4228472|NCT00688545|4051934|B2|||Child Health Questionnaire (CHAQ) - global evaluation|CHAQ: validated parent or legal guardian assessed instrument of child's activities of daily living, pain, and global assessment. Global evaluation rated on a visual analog scale (VAS) from 0 (very well) to 100 (very poor) where higher scores indicated a worse evaluation.|Units on a scale|Mean|20.15|20.15|Standard Deviation|21.58|21.58|||
4228473|NCT00688545|4051935|B1|||Child Health Questionnaire (CHAQ) - global evaluation|CHAQ: validated parent or legal guardian assessed instrument of child's activities of daily living, pain, and global assessment. Global evaluation rated on a visual analog scale (VAS) from 0 (very well) to 100 (very poor) where higher scores indicated a worse evaluation.|Units on a scale|Mean|29.11|29.11|Standard Deviation|29.34|29.34|||
4228474|NCT00688545|4051933|B3|||Participant or caregiver's assessment of participant's overall well-being|Overall well being measured on a scale from 0 (very well) to 10 (very poor).|Units on a scale|Mean|2.9|2.9|Standard Deviation|2.52|2.52|||
4228475|NCT00688545|4051934|B2|||Participant or caregiver's assessment of participant's overall well-being|Overall well being measured on a scale from 0 (very well) to 10 (very poor).|Units on a scale|Mean|2.8|2.8|Standard Deviation|2.50|2.5|||
4228476|NCT00688545|4051935|B1|||Participant or caregiver's assessment of participant's overall well-being|Overall well being measured on a scale from 0 (very well) to 10 (very poor).|Units on a scale|Mean|3.2|3.2|Standard Deviation|2.58|2.58|||
4228477|NCT00688545|4051933|B3|||Physician Global Assessment (PGA) of Disease Activity|PGA measured on a scale from 0 (not active) to 10 (very active) where higher scores indicated more disease activity.|Units on a scale|Mean|2.8|2.8|Standard Deviation|2.22|2.22|||
4228478|NCT00688545|4051934|B2|||Physician Global Assessment (PGA) of Disease Activity|PGA measured on a scale from 0 (not active) to 10 (very active) where higher scores indicated more disease activity.|Units on a scale|Mean|2.9|2.9|Standard Deviation|2.19|2.19|||
4228479|NCT00688545|4051935|B1|||Physician Global Assessment (PGA) of Disease Activity|PGA measured on a scale from 0 (not active) to 10 (very active) where higher scores indicated more disease activity.|Units on a scale|Mean|2.6|2.6|Standard Deviation|2.36|2.36|||
4228480|NCT00688545|4051933|B3|||Number of participants with abnormal physical exam results|Abnormal findings in physical examination as determined by physician|Participants|Number|80|80.0||||||
4228481|NCT00688545|4051934|B2|||Number of participants with abnormal physical exam results|Abnormal findings in physical examination as determined by physician|Participants|Number|63|63.0||||||
4228482|NCT00688545|4051935|B1|||Number of participants with abnormal physical exam results|Abnormal findings in physical examination as determined by physician|Participants|Number|17|17.0||||||
4228483|NCT00688545|4051933|B3|Analgesics (Acetaminophen, Opioids, Other)||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|27|27.0||||||
4228484|NCT00688545|4051934|B2|Analgesics (Acetaminophen, Opioids, Other)||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|18|18.0||||||
4228485|NCT00688545|4051935|B1|Analgesics (Acetaminophen, Opioids, Other)||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|9|9.0||||||
4228486|NCT00688545|4051933|B3|Corticosteroids (Other)||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|5|5.0||||||
4228487|NCT00688545|4051934|B2|Corticosteroids (Other)||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|3|3.0||||||
4228488|NCT00688545|4051935|B1|Corticosteroids (Other)||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|2|2.0||||||
4228579|NCT00688545|4051933|B3|16-18 years||Age, Customized||Participants|Number|19|19.0||||||
4228489|NCT00688545|4051933|B3|Corticosteroids (Oral, IV, Intra-Articular)||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|24|24.0||||||
4228490|NCT00688545|4051934|B2|Corticosteroids (Oral, IV, Intra-Articular)||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|19|19.0||||||
4228491|NCT00688545|4051935|B1|Corticosteroids (Oral, IV, Intra-Articular)||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|5|5.0||||||
4228492|NCT00688545|4051933|B3|NSAIDs (Other)||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|5|5.0||||||
4228493|NCT00688545|4051934|B2|NSAIDs (Other)||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|5|5.0||||||
4228494|NCT00688545|4051935|B1|NSAIDs (Other)||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|0|0.0||||||
4228495|NCT00688545|4051933|B3|NSAIDs (Naproxen)||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|16|16.0||||||
4228496|NCT00688545|4051934|B2|NSAIDs (Naproxen)||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|16|16.0||||||
4228497|NCT00688545|4051935|B1|NSAIDs (Naproxen)||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|0|0.0||||||
4228498|NCT00688545|4051933|B3|NSAIDs (Meloxicam)||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|6|6.0||||||
4228499|NCT00688545|4051934|B2|NSAIDs (Meloxicam)||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|6|6.0||||||
4228500|NCT00688545|4051935|B1|NSAIDs (Meloxicam)||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|0|0.0||||||
4228501|NCT00688545|4051933|B3|NSAIDs (Ibuprofen)||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|9|9.0||||||
4228502|NCT00688545|4051934|B2|NSAIDs (Ibuprofen)||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|7|7.0||||||
4228503|NCT00688545|4051935|B1|NSAIDs (Ibuprofen)||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|2|2.0||||||
4228504|NCT00688545|4051933|B3|NSAIDs (Diclofenac)||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|0|0.0||||||
4228580|NCT00688545|4051934|B2|16-18 years||Age, Customized||Participants|Number|11|11.0||||||
4228581|NCT00688545|4051935|B1|16-18 years||Age, Customized||Participants|Number|8|8.0||||||
4228582|NCT00688545|4051933|B3|13-15 years||Age, Customized||Participants|Number|42|42.0||||||
4228505|NCT00688545|4051934|B2|NSAIDs (Diclofenac)||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|0|0.0||||||
4228506|NCT00688545|4051935|B1|NSAIDs (Diclofenac)||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|0|0.0||||||
4228507|NCT00688545|4051933|B3|NSAIDs (Celecoxib)||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|8|8.0||||||
4228508|NCT00688545|4051934|B2|NSAIDs (Celecoxib)||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|0|0.0||||||
4228509|NCT00688545|4051935|B1|NSAIDs (Celecoxib)||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|8|8.0||||||
4228510|NCT00688545|4051933|B3|Antihypertensives||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|5|5.0||||||
4228511|NCT00688545|4051934|B2|Antihypertensives||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|4|4.0||||||
4228512|NCT00688545|4051935|B1|Antihypertensives||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|1|1.0||||||
4228513|NCT00688545|4051933|B3|Biologics||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|36|36.0||||||
4228514|NCT00688545|4051934|B2|Biologics||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|28|28.0||||||
4228515|NCT00688545|4051935|B1|Biologics||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|8|8.0||||||
4228516|NCT00688545|4051933|B3|Disease-modifying antirheumatic drugs (DMARDs)||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|104|104.0||||||
4228517|NCT00688545|4051934|B2|Disease-modifying antirheumatic drugs (DMARDs)||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|83|83.0||||||
4228518|NCT00688545|4051935|B1|Disease-modifying antirheumatic drugs (DMARDs)||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|21|21.0||||||
4228519|NCT00688545|4051933|B3|Other GI||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|8|8.0||||||
4228520|NCT00688545|4051934|B2|Other GI||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|4|4.0||||||
4228583|NCT00688545|4051934|B2|13-15 years||Age, Customized||Participants|Number|35|35.0||||||
4228584|NCT00688545|4051935|B1|13-15 years||Age, Customized||Participants|Number|7|7.0||||||
4228585|NCT00688545|4051933|B3|10-12 years||Age, Customized||Participants|Number|59|59.0||||||
4228521|NCT00688545|4051935|B1|Other GI||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|4|4.0||||||
4228522|NCT00688545|4051933|B3|Gastrointestinal (GI) protective agents||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|66|66.0||||||
4228523|NCT00688545|4051934|B2|Gastrointestinal (GI) protective agents||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|48|48.0||||||
4228524|NCT00688545|4051935|B1|Gastrointestinal (GI) protective agents||JIA medications|JIA medications by class: GI protective agents (eg, proton-pump inhibitors), other GI, DMARDs, biologics, antihypertensives, NSAIDs (Celecoxib, Diclofenac, Ibuprofen, Meloxicam, Naproxen, other), corticosteroids (oral, intravenous [IV], intra-articular, other forms), analgesics (eg, Acetaminophen). Participants could receive more than 1 medication.|Participants|Number|18|18.0||||||
4228525|NCT00688545|4051933|B3|Missing||Gastrointestinal Symptom Scale for Kids (GISSK) - Type of stomach problems|Participant or caregiver reported severity of participant's stomach problems during the last week using visual analogue scale (VAS), scores ranged from 0 (no trouble at all) to 100 (severe stomach problems). Also identified types of participant's stomach problems, if any, during the last week by selecting one or more check boxes.|Participants|Number|4|4.0||||||
4228526|NCT00688545|4051934|B2|Missing||Gastrointestinal Symptom Scale for Kids (GISSK) - Type of stomach problems|Participant or caregiver reported severity of participant's stomach problems during the last week using visual analogue scale (VAS), scores ranged from 0 (no trouble at all) to 100 (severe stomach problems). Also identified types of participant's stomach problems, if any, during the last week by selecting one or more check boxes.|Participants|Number|3|3.0||||||
4228527|NCT00688545|4051935|B1|Missing||Gastrointestinal Symptom Scale for Kids (GISSK) - Type of stomach problems|Participant or caregiver reported severity of participant's stomach problems during the last week using visual analogue scale (VAS), scores ranged from 0 (no trouble at all) to 100 (severe stomach problems). Also identified types of participant's stomach problems, if any, during the last week by selecting one or more check boxes.|Participants|Number|1|1.0||||||
4228528|NCT00688545|4051933|B3|No problems||Gastrointestinal Symptom Scale for Kids (GISSK) - Type of stomach problems|Participant or caregiver reported severity of participant's stomach problems during the last week using visual analogue scale (VAS), scores ranged from 0 (no trouble at all) to 100 (severe stomach problems). Also identified types of participant's stomach problems, if any, during the last week by selecting one or more check boxes.|Participants|Number|155|155.0||||||
4228529|NCT00688545|4051934|B2|No problems||Gastrointestinal Symptom Scale for Kids (GISSK) - Type of stomach problems|Participant or caregiver reported severity of participant's stomach problems during the last week using visual analogue scale (VAS), scores ranged from 0 (no trouble at all) to 100 (severe stomach problems). Also identified types of participant's stomach problems, if any, during the last week by selecting one or more check boxes.|Participants|Number|132|132.0||||||
4228530|NCT00688545|4051935|B1|No problems||Gastrointestinal Symptom Scale for Kids (GISSK) - Type of stomach problems|Participant or caregiver reported severity of participant's stomach problems during the last week using visual analogue scale (VAS), scores ranged from 0 (no trouble at all) to 100 (severe stomach problems). Also identified types of participant's stomach problems, if any, during the last week by selecting one or more check boxes.|Participants|Number|23|23.0||||||
4228531|NCT00688545|4051933|B3|Poor appetite||Gastrointestinal Symptom Scale for Kids (GISSK) - Type of stomach problems|Participant or caregiver reported severity of participant's stomach problems during the last week using visual analogue scale (VAS), scores ranged from 0 (no trouble at all) to 100 (severe stomach problems). Also identified types of participant's stomach problems, if any, during the last week by selecting one or more check boxes.|Participants|Number|20|20.0||||||
4228532|NCT00688545|4051934|B2|Poor appetite||Gastrointestinal Symptom Scale for Kids (GISSK) - Type of stomach problems|Participant or caregiver reported severity of participant's stomach problems during the last week using visual analogue scale (VAS), scores ranged from 0 (no trouble at all) to 100 (severe stomach problems). Also identified types of participant's stomach problems, if any, during the last week by selecting one or more check boxes.|Participants|Number|13|13.0||||||
4228533|NCT00688545|4051935|B1|Poor appetite||Gastrointestinal Symptom Scale for Kids (GISSK) - Type of stomach problems|Participant or caregiver reported severity of participant's stomach problems during the last week using visual analogue scale (VAS), scores ranged from 0 (no trouble at all) to 100 (severe stomach problems). Also identified types of participant's stomach problems, if any, during the last week by selecting one or more check boxes.|Participants|Number|7|7.0||||||
4228534|NCT00688545|4051933|B3|Vomiting||Gastrointestinal Symptom Scale for Kids (GISSK) - Type of stomach problems|Participant or caregiver reported severity of participant's stomach problems during the last week using visual analogue scale (VAS), scores ranged from 0 (no trouble at all) to 100 (severe stomach problems). Also identified types of participant's stomach problems, if any, during the last week by selecting one or more check boxes.|Participants|Number|10|10.0||||||
4228535|NCT00688545|4051934|B2|Vomiting||Gastrointestinal Symptom Scale for Kids (GISSK) - Type of stomach problems|Participant or caregiver reported severity of participant's stomach problems during the last week using visual analogue scale (VAS), scores ranged from 0 (no trouble at all) to 100 (severe stomach problems). Also identified types of participant's stomach problems, if any, during the last week by selecting one or more check boxes.|Participants|Number|8|8.0||||||
4228536|NCT00688545|4051935|B1|Vomiting||Gastrointestinal Symptom Scale for Kids (GISSK) - Type of stomach problems|Participant or caregiver reported severity of participant's stomach problems during the last week using visual analogue scale (VAS), scores ranged from 0 (no trouble at all) to 100 (severe stomach problems). Also identified types of participant's stomach problems, if any, during the last week by selecting one or more check boxes.|Participants|Number|2|2.0||||||
4228537|NCT00688545|4051933|B3|Constipation||Gastrointestinal Symptom Scale for Kids (GISSK) - Type of stomach problems|Participant or caregiver reported severity of participant's stomach problems during the last week using visual analogue scale (VAS), scores ranged from 0 (no trouble at all) to 100 (severe stomach problems). Also identified types of participant's stomach problems, if any, during the last week by selecting one or more check boxes.|Participants|Number|21|21.0||||||
4228538|NCT00688545|4051934|B2|Constipation||Gastrointestinal Symptom Scale for Kids (GISSK) - Type of stomach problems|Participant or caregiver reported severity of participant's stomach problems during the last week using visual analogue scale (VAS), scores ranged from 0 (no trouble at all) to 100 (severe stomach problems). Also identified types of participant's stomach problems, if any, during the last week by selecting one or more check boxes.|Participants|Number|16|16.0||||||
4228539|NCT00688545|4051935|B1|Constipation||Gastrointestinal Symptom Scale for Kids (GISSK) - Type of stomach problems|Participant or caregiver reported severity of participant's stomach problems during the last week using visual analogue scale (VAS), scores ranged from 0 (no trouble at all) to 100 (severe stomach problems). Also identified types of participant's stomach problems, if any, during the last week by selecting one or more check boxes.|Participants|Number|5|5.0||||||
4228540|NCT00688545|4051933|B3|Diarrhea||Gastrointestinal Symptom Scale for Kids (GISSK) - Type of stomach problems|Participant or caregiver reported severity of participant's stomach problems during the last week using visual analogue scale (VAS), scores ranged from 0 (no trouble at all) to 100 (severe stomach problems). Also identified types of participant's stomach problems, if any, during the last week by selecting one or more check boxes.|Participants|Number|23|23.0||||||
4228541|NCT00688545|4051934|B2|Diarrhea||Gastrointestinal Symptom Scale for Kids (GISSK) - Type of stomach problems|Participant or caregiver reported severity of participant's stomach problems during the last week using visual analogue scale (VAS), scores ranged from 0 (no trouble at all) to 100 (severe stomach problems). Also identified types of participant's stomach problems, if any, during the last week by selecting one or more check boxes.|Participants|Number|18|18.0||||||
4228542|NCT00688545|4051935|B1|Diarrhea||Gastrointestinal Symptom Scale for Kids (GISSK) - Type of stomach problems|Participant or caregiver reported severity of participant's stomach problems during the last week using visual analogue scale (VAS), scores ranged from 0 (no trouble at all) to 100 (severe stomach problems). Also identified types of participant's stomach problems, if any, during the last week by selecting one or more check boxes.|Participants|Number|5|5.0||||||
4228543|NCT00688545|4051933|B3|Nausea||Gastrointestinal Symptom Scale for Kids (GISSK) - Type of stomach problems|Participant or caregiver reported severity of participant's stomach problems during the last week using visual analogue scale (VAS), scores ranged from 0 (no trouble at all) to 100 (severe stomach problems). Also identified types of participant's stomach problems, if any, during the last week by selecting one or more check boxes.|Participants|Number|46|46.0||||||
4228544|NCT00688545|4051934|B2|Nausea||Gastrointestinal Symptom Scale for Kids (GISSK) - Type of stomach problems|Participant or caregiver reported severity of participant's stomach problems during the last week using visual analogue scale (VAS), scores ranged from 0 (no trouble at all) to 100 (severe stomach problems). Also identified types of participant's stomach problems, if any, during the last week by selecting one or more check boxes.|Participants|Number|32|32.0||||||
4228545|NCT00688545|4051935|B1|Nausea||Gastrointestinal Symptom Scale for Kids (GISSK) - Type of stomach problems|Participant or caregiver reported severity of participant's stomach problems during the last week using visual analogue scale (VAS), scores ranged from 0 (no trouble at all) to 100 (severe stomach problems). Also identified types of participant's stomach problems, if any, during the last week by selecting one or more check boxes.|Participants|Number|14|14.0||||||
4228546|NCT00688545|4051933|B3|Lower stomach pain||Gastrointestinal Symptom Scale for Kids (GISSK) - Type of stomach problems|Participant or caregiver reported severity of participant's stomach problems during the last week using visual analogue scale (VAS), scores ranged from 0 (no trouble at all) to 100 (severe stomach problems). Also identified types of participant's stomach problems, if any, during the last week by selecting one or more check boxes.|Participants|Number|50|50.0||||||
4228547|NCT00688545|4051934|B2|Lower stomach pain||Gastrointestinal Symptom Scale for Kids (GISSK) - Type of stomach problems|Participant or caregiver reported severity of participant's stomach problems during the last week using visual analogue scale (VAS), scores ranged from 0 (no trouble at all) to 100 (severe stomach problems). Also identified types of participant's stomach problems, if any, during the last week by selecting one or more check boxes.|Participants|Number|34|34.0||||||
4228548|NCT00688545|4051935|B1|Lower stomach pain||Gastrointestinal Symptom Scale for Kids (GISSK) - Type of stomach problems|Participant or caregiver reported severity of participant's stomach problems during the last week using visual analogue scale (VAS), scores ranged from 0 (no trouble at all) to 100 (severe stomach problems). Also identified types of participant's stomach problems, if any, during the last week by selecting one or more check boxes.|Participants|Number|16|16.0||||||
4228549|NCT00688545|4051933|B3|Upper stomach pain||Gastrointestinal Symptom Scale for Kids (GISSK) - Type of stomach problems|Participant or caregiver reported severity of participant's stomach problems during the last week using visual analogue scale (VAS), scores ranged from 0 (no trouble at all) to 100 (severe stomach problems). Also identified types of participant's stomach problems, if any, during the last week by selecting one or more check boxes.|Participants|Number|26|26.0||||||
4228550|NCT00688545|4051934|B2|Upper stomach pain||Gastrointestinal Symptom Scale for Kids (GISSK) - Type of stomach problems|Participant or caregiver reported severity of participant's stomach problems during the last week using visual analogue scale (VAS), scores ranged from 0 (no trouble at all) to 100 (severe stomach problems). Also identified types of participant's stomach problems, if any, during the last week by selecting one or more check boxes.|Participants|Number|18|18.0||||||
4228551|NCT00688545|4051935|B1|Upper stomach pain||Gastrointestinal Symptom Scale for Kids (GISSK) - Type of stomach problems|Participant or caregiver reported severity of participant's stomach problems during the last week using visual analogue scale (VAS), scores ranged from 0 (no trouble at all) to 100 (severe stomach problems). Also identified types of participant's stomach problems, if any, during the last week by selecting one or more check boxes.|Participants|Number|8|8.0||||||
4228586|NCT00688545|4051934|B2|10-12 years||Age, Customized||Participants|Number|44|44.0||||||
4228587|NCT00688545|4051935|B1|10-12 years||Age, Customized||Participants|Number|15|15.0||||||
4228588|NCT00688545|4051933|B3|6-9 years||Age, Customized||Participants|Number|69|69.0||||||
4228552|NCT00688545|4051933|B3|Heartburn||Gastrointestinal Symptom Scale for Kids (GISSK) - Type of stomach problems|Participant or caregiver reported severity of participant's stomach problems during the last week using visual analogue scale (VAS), scores ranged from 0 (no trouble at all) to 100 (severe stomach problems). Also identified types of participant's stomach problems, if any, during the last week by selecting one or more check boxes.|Participants|Number|30|30.0||||||
4228553|NCT00688545|4051934|B2|Heartburn||Gastrointestinal Symptom Scale for Kids (GISSK) - Type of stomach problems|Participant or caregiver reported severity of participant's stomach problems during the last week using visual analogue scale (VAS), scores ranged from 0 (no trouble at all) to 100 (severe stomach problems). Also identified types of participant's stomach problems, if any, during the last week by selecting one or more check boxes.|Participants|Number|21|21.0||||||
4228554|NCT00688545|4051935|B1|Heartburn||Gastrointestinal Symptom Scale for Kids (GISSK) - Type of stomach problems|Participant or caregiver reported severity of participant's stomach problems during the last week using visual analogue scale (VAS), scores ranged from 0 (no trouble at all) to 100 (severe stomach problems). Also identified types of participant's stomach problems, if any, during the last week by selecting one or more check boxes.|Participants|Number|9|9.0||||||
4228555|NCT00688545|4051933|B3|Missing||Juvenile Idiopathic Arthritis (JIA)|Number of participants with JIA by subtype: systemic persistent oligoarticular, extended oligoarticular, polyarticular rheumatoid factor negative (Poly RF-) and positive (Poly RF+).|Participants|Number|1|1.0||||||
4228556|NCT00688545|4051934|B2|Missing||Juvenile Idiopathic Arthritis (JIA)|Number of participants with JIA by subtype: systemic persistent oligoarticular, extended oligoarticular, polyarticular rheumatoid factor negative (Poly RF-) and positive (Poly RF+).|Participants|Number|1|1.0||||||
4228557|NCT00688545|4051935|B1|Missing||Juvenile Idiopathic Arthritis (JIA)|Number of participants with JIA by subtype: systemic persistent oligoarticular, extended oligoarticular, polyarticular rheumatoid factor negative (Poly RF-) and positive (Poly RF+).|Participants|Number|0|0.0||||||
4228558|NCT00688545|4051933|B3|Poly RF+||Juvenile Idiopathic Arthritis (JIA)|Number of participants with JIA by subtype: systemic persistent oligoarticular, extended oligoarticular, polyarticular rheumatoid factor negative (Poly RF-) and positive (Poly RF+).|Participants|Number|17|17.0||||||
4228559|NCT00688545|4051934|B2|Poly RF+||Juvenile Idiopathic Arthritis (JIA)|Number of participants with JIA by subtype: systemic persistent oligoarticular, extended oligoarticular, polyarticular rheumatoid factor negative (Poly RF-) and positive (Poly RF+).|Participants|Number|14|14.0||||||
4228560|NCT00688545|4051935|B1|Poly RF+||Juvenile Idiopathic Arthritis (JIA)|Number of participants with JIA by subtype: systemic persistent oligoarticular, extended oligoarticular, polyarticular rheumatoid factor negative (Poly RF-) and positive (Poly RF+).|Participants|Number|3|3.0||||||
4228561|NCT00688545|4051933|B3|Poly RF-||Juvenile Idiopathic Arthritis (JIA)|Number of participants with JIA by subtype: systemic persistent oligoarticular, extended oligoarticular, polyarticular rheumatoid factor negative (Poly RF-) and positive (Poly RF+).|Participants|Number|93|93.0||||||
4228562|NCT00688545|4051934|B2|Poly RF-||Juvenile Idiopathic Arthritis (JIA)|Number of participants with JIA by subtype: systemic persistent oligoarticular, extended oligoarticular, polyarticular rheumatoid factor negative (Poly RF-) and positive (Poly RF+).|Participants|Number|70|70.0||||||
4228563|NCT00688545|4051935|B1|Poly RF-||Juvenile Idiopathic Arthritis (JIA)|Number of participants with JIA by subtype: systemic persistent oligoarticular, extended oligoarticular, polyarticular rheumatoid factor negative (Poly RF-) and positive (Poly RF+).|Participants|Number|23|23.0||||||
4228564|NCT00688545|4051933|B3|Extended Oligoarticular||Juvenile Idiopathic Arthritis (JIA)|Number of participants with JIA by subtype: systemic persistent oligoarticular, extended oligoarticular, polyarticular rheumatoid factor negative (Poly RF-) and positive (Poly RF+).|Participants|Number|14|14.0||||||
4228565|NCT00688545|4051934|B2|Extended Oligoarticular||Juvenile Idiopathic Arthritis (JIA)|Number of participants with JIA by subtype: systemic persistent oligoarticular, extended oligoarticular, polyarticular rheumatoid factor negative (Poly RF-) and positive (Poly RF+).|Participants|Number|12|12.0||||||
4228566|NCT00688545|4051935|B1|Extended Oligoarticular||Juvenile Idiopathic Arthritis (JIA)|Number of participants with JIA by subtype: systemic persistent oligoarticular, extended oligoarticular, polyarticular rheumatoid factor negative (Poly RF-) and positive (Poly RF+).|Participants|Number|2|2.0||||||
4228567|NCT00688545|4051933|B3|Persistent Oligoarticular||Juvenile Idiopathic Arthritis (JIA)|Number of participants with JIA by subtype: systemic persistent oligoarticular, extended oligoarticular, polyarticular rheumatoid factor negative (Poly RF-) and positive (Poly RF+).|Participants|Number|146|146.0||||||
4228568|NCT00688545|4051934|B2|Persistent Oligoarticular||Juvenile Idiopathic Arthritis (JIA)|Number of participants with JIA by subtype: systemic persistent oligoarticular, extended oligoarticular, polyarticular rheumatoid factor negative (Poly RF-) and positive (Poly RF+).|Participants|Number|119|119.0||||||
4228569|NCT00688545|4051935|B1|Persistent Oligoarticular||Juvenile Idiopathic Arthritis (JIA)|Number of participants with JIA by subtype: systemic persistent oligoarticular, extended oligoarticular, polyarticular rheumatoid factor negative (Poly RF-) and positive (Poly RF+).|Participants|Number|27|27.0||||||
4228570|NCT00688545|4051933|B3|Systemic||Juvenile Idiopathic Arthritis (JIA)|Number of participants with JIA by subtype: systemic persistent oligoarticular, extended oligoarticular, polyarticular rheumatoid factor negative (Poly RF-) and positive (Poly RF+).|Participants|Number|3|3.0||||||
4228571|NCT00688545|4051934|B2|Systemic||Juvenile Idiopathic Arthritis (JIA)|Number of participants with JIA by subtype: systemic persistent oligoarticular, extended oligoarticular, polyarticular rheumatoid factor negative (Poly RF-) and positive (Poly RF+).|Participants|Number|3|3.0||||||
4228572|NCT00688545|4051935|B1|Systemic||Juvenile Idiopathic Arthritis (JIA)|Number of participants with JIA by subtype: systemic persistent oligoarticular, extended oligoarticular, polyarticular rheumatoid factor negative (Poly RF-) and positive (Poly RF+).|Participants|Number|0|0.0||||||
4228573|NCT00688545|4051933|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4228574|NCT00688545|4051934|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4228575|NCT00688545|4051935|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4228576|NCT00688545|4051933|B3||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4228577|NCT00688545|4051934|B2||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4228589|NCT00688545|4051934|B2|6-9 years||Age, Customized||Participants|Number|52|52.0||||||
4228590|NCT00688545|4051935|B1|6-9 years||Age, Customized||Participants|Number|17|17.0||||||
4228591|NCT00688545|4051933|B3|2-5 years||Age, Customized||Participants|Number|85|85.0||||||
4228592|NCT00688545|4051934|B2|2-5 years||Age, Customized||Participants|Number|77|77.0||||||
4228593|NCT00688545|4051935|B1|2-5 years||Age, Customized||Participants|Number|8|8.0||||||
4228594|NCT00688519|4051944|B3|||Disease Characteristic - Percent BSA (extent of psoriasis)|Disease characteristics of BSA (extent of psoriasis) at baseline|percent of body surface|Mean|6.2|6.2|Standard Deviation|4.8|4.8|||
4228595|NCT00688519|4051945|B2|||Disease Characteristic - Percent BSA (extent of psoriasis)|Disease characteristics of BSA (extent of psoriasis) at baseline|percent of body surface|Mean|5.8|5.8|Standard Deviation|4.7|4.7|||
4228596|NCT00688519|4051946|B1|||Disease Characteristic - Percent BSA (extent of psoriasis)|Disease characteristics of BSA (extent of psoriasis) at baseline|percent of body surface|Mean|6.4|6.4|Standard Deviation|4.8|4.8|||
4228597|NCT00688519|4051944|B3|Severe||Disease Characteristic - Subject's Global Assessment|Disease characteristics of Subject's Global Assessment at baseline|participants|Number|46|46.0||||||
4228598|NCT00688519|4051945|B2|Severe||Disease Characteristic - Subject's Global Assessment|Disease characteristics of Subject's Global Assessment at baseline|participants|Number|13|13.0||||||
4228599|NCT00688519|4051946|B1|Severe||Disease Characteristic - Subject's Global Assessment|Disease characteristics of Subject's Global Assessment at baseline|participants|Number|33|33.0||||||
4228600|NCT00688519|4051944|B3|Very Noticeable||Disease Characteristic - Subject's Global Assessment|Disease characteristics of Subject's Global Assessment at baseline|participants|Number|172|172.0||||||
4228601|NCT00688519|4051945|B2|Very Noticeable||Disease Characteristic - Subject's Global Assessment|Disease characteristics of Subject's Global Assessment at baseline|participants|Number|63|63.0||||||
4228602|NCT00688519|4051946|B1|Very Noticeable||Disease Characteristic - Subject's Global Assessment|Disease characteristics of Subject's Global Assessment at baseline|participants|Number|109|109.0||||||
4228603|NCT00688519|4051944|B3|Moderate||Disease Characteristic - Subject's Global Assessment|Disease characteristics of Subject's Global Assessment at baseline|participants|Number|90|90.0||||||
4228604|NCT00688519|4051945|B2|Moderate||Disease Characteristic - Subject's Global Assessment|Disease characteristics of Subject's Global Assessment at baseline|participants|Number|24|24.0||||||
4228605|NCT00688519|4051946|B1|Moderate||Disease Characteristic - Subject's Global Assessment|Disease characteristics of Subject's Global Assessment at baseline|participants|Number|66|66.0||||||
4228606|NCT00688519|4051944|B3|Mild||Disease Characteristic - Subject's Global Assessment|Disease characteristics of Subject's Global Assessment at baseline|participants|Number|26|26.0||||||
4228607|NCT00688519|4051945|B2|Mild||Disease Characteristic - Subject's Global Assessment|Disease characteristics of Subject's Global Assessment at baseline|participants|Number|12|12.0||||||
4228608|NCT00688519|4051946|B1|Mild||Disease Characteristic - Subject's Global Assessment|Disease characteristics of Subject's Global Assessment at baseline|participants|Number|14|14.0||||||
4228609|NCT00688519|4051944|B3|Almost Clear||Disease Characteristic - Subject's Global Assessment|Disease characteristics of Subject's Global Assessment at baseline|participants|Number|1|1.0||||||
4228610|NCT00688519|4051945|B2|Almost Clear||Disease Characteristic - Subject's Global Assessment|Disease characteristics of Subject's Global Assessment at baseline|participants|Number|1|1.0||||||
4228611|NCT00688519|4051946|B1|Almost Clear||Disease Characteristic - Subject's Global Assessment|Disease characteristics of Subject's Global Assessment at baseline|participants|Number|0|0.0||||||
4228612|NCT00688519|4051944|B3|Clear||Disease Characteristic - Subject's Global Assessment|Disease characteristics of Subject's Global Assessment at baseline|participants|Number|1|1.0||||||
4228613|NCT00688519|4051945|B2|Clear||Disease Characteristic - Subject's Global Assessment|Disease characteristics of Subject's Global Assessment at baseline|participants|Number|0|0.0||||||
4228614|NCT00688519|4051946|B1|Clear||Disease Characteristic - Subject's Global Assessment|Disease characteristics of Subject's Global Assessment at baseline|participants|Number|1|1.0||||||
4228615|NCT00688519|4051944|B3|Moderate||Disease Characteristic - Investigator's Static Global Assessment|Disease characteristics of Investigator's Static Global Assessment at baseline|participants|Number|229|229.0||||||
4228616|NCT00688519|4051945|B2|Moderate||Disease Characteristic - Investigator's Static Global Assessment|Disease characteristics of Investigator's Static Global Assessment at baseline|participants|Number|79|79.0||||||
4228617|NCT00688519|4051946|B1|Moderate||Disease Characteristic - Investigator's Static Global Assessment|Disease characteristics of Investigator's Static Global Assessment at baseline|participants|Number|150|150.0||||||
4228618|NCT00688519|4051944|B3|Mild||Disease Characteristic - Investigator's Static Global Assessment|Disease characteristics of Investigator's Static Global Assessment at baseline|participants|Number|107|107.0||||||
4228619|NCT00688519|4051945|B2|Mild||Disease Characteristic - Investigator's Static Global Assessment|Disease characteristics of Investigator's Static Global Assessment at baseline|participants|Number|34|34.0||||||
4228620|NCT00688519|4051946|B1|Mild||Disease Characteristic - Investigator's Static Global Assessment|Disease characteristics of Investigator's Static Global Assessment at baseline|participants|Number|73|73.0||||||
4228621|NCT00688519|4051944|B3|Trunk||Disease Characteristic- Target Lesion Location|Disease characteristics of Target Lesion Location at baseline|participants|Number|62|62.0||||||
4228622|NCT00688519|4051945|B2|Trunk||Disease Characteristic- Target Lesion Location|Disease characteristics of Target Lesion Location at baseline|participants|Number|22|22.0||||||
4228623|NCT00688519|4051946|B1|Trunk||Disease Characteristic- Target Lesion Location|Disease characteristics of Target Lesion Location at baseline|participants|Number|40|40.0||||||
4228624|NCT00688519|4051944|B3|Leg||Disease Characteristic- Target Lesion Location|Disease characteristics of Target Lesion Location at baseline|participants|Number|182|182.0||||||
4228625|NCT00688519|4051945|B2|Leg||Disease Characteristic- Target Lesion Location|Disease characteristics of Target Lesion Location at baseline|participants|Number|59|59.0||||||
4228626|NCT00688519|4051946|B1|Leg||Disease Characteristic- Target Lesion Location|Disease characteristics of Target Lesion Location at baseline|participants|Number|123|123.0||||||
4228627|NCT00688519|4051944|B3|Arm||Disease Characteristic- Target Lesion Location|Disease characteristics of Target Lesion Location at baseline|participants|Number|92|92.0||||||
4228628|NCT00688519|4051945|B2|Arm||Disease Characteristic- Target Lesion Location|Disease characteristics of Target Lesion Location at baseline|participants|Number|32|32.0||||||
4228629|NCT00688519|4051946|B1|Arm||Disease Characteristic- Target Lesion Location|Disease characteristics of Target Lesion Location at baseline|participants|Number|60|60.0||||||
4228630|NCT00688519|4051944|B3|Moderate elevation||Disease Characteristic - Plaque Thickness|Disease characteristics of Plaque Thickness at baseline|participants|Number|186|186.0||||||
4228631|NCT00688519|4051945|B2|Moderate elevation||Disease Characteristic - Plaque Thickness|Disease characteristics of Plaque Thickness at baseline|participants|Number|64|64.0||||||
4228632|NCT00688519|4051946|B1|Moderate elevation||Disease Characteristic - Plaque Thickness|Disease characteristics of Plaque Thickness at baseline|participants|Number|122|122.0||||||
4228633|NCT00688519|4051944|B3|Slight but definite elevation||Disease Characteristic - Plaque Thickness|Disease characteristics of Plaque Thickness at baseline|participants|Number|150|150.0||||||
4228634|NCT00688519|4051945|B2|Slight but definite elevation||Disease Characteristic - Plaque Thickness|Disease characteristics of Plaque Thickness at baseline|participants|Number|49|49.0||||||
4228635|NCT00688519|4051946|B1|Slight but definite elevation||Disease Characteristic - Plaque Thickness|Disease characteristics of Plaque Thickness at baseline|participants|Number|101|101.0||||||
4228636|NCT00688519|4051944|B3|Marked||Disease Characteristic - Scaling|Disease characteristics of Scaling at baseline|participants|Number|2|2.0||||||
4228637|NCT00688519|4051945|B2|Marked||Disease Characteristic - Scaling|Disease characteristics of Scaling at baseline|participants|Number|1|1.0||||||
4228638|NCT00688519|4051946|B1|Marked||Disease Characteristic - Scaling|Disease characteristics of Scaling at baseline|participants|Number|1|1.0||||||
4228639|NCT00688519|4051944|B3|Moderate||Disease Characteristic - Scaling|Disease characteristics of Scaling at baseline|participants|Number|192|192.0||||||
4228640|NCT00688519|4051945|B2|Moderate||Disease Characteristic - Scaling|Disease characteristics of Scaling at baseline|participants|Number|61|61.0||||||
4228641|NCT00688519|4051946|B1|Moderate||Disease Characteristic - Scaling|Disease characteristics of Scaling at baseline|participants|Number|131|131.0||||||
4228642|NCT00688519|4051944|B3|Mild||Disease Characteristic - Scaling|Disease characteristics of Scaling at baseline|participants|Number|142|142.0||||||
4228643|NCT00688519|4051945|B2|Mild||Disease Characteristic - Scaling|Disease characteristics of Scaling at baseline|participants|Number|51|51.0||||||
4228644|NCT00688519|4051946|B1|Mild||Disease Characteristic - Scaling|Disease characteristics of Scaling at baseline|participants|Number|91|91.0||||||
4228645|NCT00688519|4051944|B3|Bright red coloration||Disease Characteristic - Erythema|Disease characteristics of Erythema at baseline|participants|Number|1|1.0||||||
4228646|NCT00688519|4051945|B2|Bright red coloration||Disease Characteristic - Erythema|Disease characteristics of Erythema at baseline|participants|Number|1|1.0||||||
4228647|NCT00688519|4051946|B1|Bright red coloration||Disease Characteristic - Erythema|Disease characteristics of Erythema at baseline|participants|Number|0|0.0||||||
4228648|NCT00688519|4051944|B3|Moderate red coloration||Disease Characteristic - Erythema|Disease characteristics of Erythema at baseline|participants|Number|224|224.0||||||
4228649|NCT00688519|4051945|B2|Moderate red coloration||Disease Characteristic - Erythema|Disease characteristics of Erythema at baseline|participants|Number|75|75.0||||||
4228650|NCT00688519|4051946|B1|Moderate red coloration||Disease Characteristic - Erythema|Disease characteristics of Erythema at baseline|participants|Number|149|149.0||||||
4228651|NCT00688519|4051944|B3|Light red coloration||Disease Characteristic - Erythema|Disease characteristics of Erythema at baseline|participants|Number|111|111.0||||||
4228652|NCT00688519|4051945|B2|Light red coloration||Disease Characteristic - Erythema|Disease characteristics of Erythema at baseline|participants|Number|37|37.0||||||
4228653|NCT00688519|4051946|B1|Light red coloration||Disease Characteristic - Erythema|Disease characteristics of Erythema at baseline|participants|Number|74|74.0||||||
4228654|NCT00688519|4051944|B3|Missing||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4228655|NCT00688519|4051945|B2|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4228656|NCT00688519|4051946|B1|Missing||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4228657|NCT00688519|4051944|B3|White||Race/Ethnicity, Customized||participants|Number|289|289.0||||||
4228658|NCT00688519|4051945|B2|White||Race/Ethnicity, Customized||participants|Number|101|101.0||||||
4228659|NCT00688519|4051946|B1|White||Race/Ethnicity, Customized||participants|Number|188|188.0||||||
4228660|NCT00688519|4051944|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4228661|NCT00688519|4051945|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4228662|NCT00688519|4051946|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4228663|NCT00688519|4051944|B3|Multiracial||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4228664|NCT00688519|4051945|B2|Multiracial||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4228665|NCT00688519|4051946|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4228666|NCT00688519|4051944|B3|Black||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4228667|NCT00688519|4051945|B2|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4228668|NCT00688519|4051946|B1|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4228669|NCT00688519|4051944|B3|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4228670|NCT00688519|4051945|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4228671|NCT00688519|4051946|B1|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4228672|NCT00688519|4051944|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4228673|NCT00688519|4051945|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4228771|NCT00688155|4052058|B5||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4228674|NCT00688519|4051946|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4228675|NCT00688519|4051944|B3||Male|Gender||Participants|Count of Participants|203|203.0||||||
4228676|NCT00688519|4051945|B2||Male|Gender||Participants|Count of Participants|71|71.0||||||
4228677|NCT00688519|4051946|B1||Male|Gender||Participants|Count of Participants|132|132.0||||||
4228678|NCT00688519|4051944|B3||Female|Gender||Participants|Count of Participants|133|133.0||||||
4228679|NCT00688519|4051945|B2||Female|Gender||Participants|Count of Participants|42|42.0||||||
4228680|NCT00688519|4051946|B1||Female|Gender||Participants|Count of Participants|91|91.0||||||
4228681|NCT00688519|4051944|B3|> 65 years||Age, Customized||participants|Number|45|45.0||||||
4228682|NCT00688519|4051945|B2|> 65 years||Age, Customized||participants|Number|17|17.0||||||
4228683|NCT00688519|4051946|B1|> 65 years||Age, Customized||participants|Number|28|28.0||||||
4228684|NCT00688519|4051944|B3|18 to <65 years||Age, Customized||participants|Number|286|286.0||||||
4228685|NCT00688519|4051945|B2|18 to <65 years||Age, Customized||participants|Number|95|95.0||||||
4228686|NCT00688519|4051946|B1|18 to <65 years||Age, Customized||participants|Number|191|191.0||||||
4228687|NCT00688519|4051944|B3|12 to <18 years||Age, Customized||participants|Number|5|5.0||||||
4228688|NCT00688519|4051945|B2|12 to <18 years||Age, Customized||participants|Number|1|1.0||||||
4228689|NCT00688519|4051946|B1|12 to <18 years||Age, Customized||participants|Number|4|4.0||||||
4228690|NCT00688519|4051944|B3|||Age||years|Mean|48.7|48.7|Standard Deviation|14.4|14.4|||
4228691|NCT00688519|4051945|B2|||Age||years|Mean|49.2|49.2|Standard Deviation|13.9|13.9|||
4228692|NCT00688519|4051946|B1|||Age||years|Mean|48.4|48.4|Standard Deviation|14.7|14.7|||
4228693|NCT00688467|4051963|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4228694|NCT00688467|4051964|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4228695|NCT00688467|4051965|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4228696|NCT00688467|4051963|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4228697|NCT00688467|4051964|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4228698|NCT00688467|4051965|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4228699|NCT00688467|4051963|B3|||Age||Years|Mean|29.4|29.4|Standard Deviation|9.8|9.8|||
4228700|NCT00688467|4051964|B2|||Age||Years|Mean|24.9|24.9|Standard Deviation|4.0|4.0|||
4228701|NCT00688467|4051965|B1|||Age||Years|Mean|34.3|34.3|Standard Deviation|12.0|12.0|||
4228702|NCT00688324|4051996|B1|Missing||Alcohol Abuse History||participants|Number|2|2.0||||||
4228703|NCT00688324|4051996|B1|Absent||Alcohol Abuse History||participants|Number|18|18.0||||||
4228704|NCT00688324|4051996|B1|Present||Alcohol Abuse History||participants|Number|16|16.0||||||
4228705|NCT00688324|4051996|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4228706|NCT00688324|4051996|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4228707|NCT00688324|4051996|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4228708|NCT00688324|4051996|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4228709|NCT00688324|4051996|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4228710|NCT00688324|4051996|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4228711|NCT00688324|4051996|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4228712|NCT00688324|4051996|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4228713|NCT00688324|4051996|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4228714|NCT00688324|4051996|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4228715|NCT00688324|4051996|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4228716|NCT00688324|4051996|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4228717|NCT00688324|4051996|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4228718|NCT00688324|4051996|B1|||Age||years|Mean|44|44.0|Standard Deviation|9.2|9.2|||
4228719|NCT00688324|4051996|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4228720|NCT00688324|4051996|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4228721|NCT00688324|4051996|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4228722|NCT00688259|4052039|B3|||Number of years since first began experiencing symptoms (self-report)||years|Mean|24.06|24.06|Standard Deviation|10.99|10.99|||
4228723|NCT00688259|4052040|B2|||Number of years since first began experiencing symptoms (self-report)||years|Mean|23.22|23.22|Standard Deviation|11.65|11.65|||
4228724|NCT00688259|4052041|B1|||Number of years since first began experiencing symptoms (self-report)||years|Mean|24.89|24.89|Standard Deviation|10.30|10.3|||
4228725|NCT00688259|4052039|B3|Latino/Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4228726|NCT00688259|4052040|B2|Latino/Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4228727|NCT00688259|4052041|B1|Latino/Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4228728|NCT00688259|4052039|B3|Asian/Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4228729|NCT00688259|4052040|B2|Asian/Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4228730|NCT00688259|4052041|B1|Asian/Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4228731|NCT00688259|4052039|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
4228732|NCT00688259|4052040|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
4228733|NCT00688259|4052041|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4228734|NCT00688259|4052039|B3|African- American||Race/Ethnicity, Customized||Participants|Count of Participants|49|49.0||||||
4228735|NCT00688259|4052040|B2|African- American||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
4228736|NCT00688259|4052041|B1|African- American||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
4228737|NCT00688259|4052039|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4228738|NCT00688259|4052040|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4228739|NCT00688259|4052041|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4228740|NCT00688259|4052039|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4228741|NCT00688259|4052040|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4228742|NCT00688259|4052041|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4228743|NCT00688259|4052039|B3|||Age||years|Mean|49.66|49.66|Standard Deviation|9.47|9.47|||
4228744|NCT00688259|4052040|B2|||Age||years|Mean|49.07|49.07|Standard Deviation|9.63|9.63|||
4228745|NCT00688259|4052041|B1|||Age||years|Mean|50.25|50.25|Standard Deviation|9.31|9.31|||
4228746|NCT00688155|4052058|B5|||Modified MiniMental State Exam Score|The Modified Mini Mental State Exam (3MS) Memory Functioning questionnaire asks the participant to rate on a scale of 1 (always) to 7 (never) how often remembering something presents a problem. In order to participate, subjects had to score at least an 88 or greater if their education level is greater than 8 years and if education level was 0-8 years, scores had to be at least an 80 or higher. The possible scores (units on a scale) range from 0 to 100, with higher scores reflecting better global cognitive functioning.|Units on a scale|Mean|94.8|94.8|Standard Deviation|3.5|3.5|||
4228747|NCT00688155|4052059|B4|||Modified MiniMental State Exam Score|The Modified Mini Mental State Exam (3MS) Memory Functioning questionnaire asks the participant to rate on a scale of 1 (always) to 7 (never) how often remembering something presents a problem. In order to participate, subjects had to score at least an 88 or greater if their education level is greater than 8 years and if education level was 0-8 years, scores had to be at least an 80 or higher. The possible scores (units on a scale) range from 0 to 100, with higher scores reflecting better global cognitive functioning.|Units on a scale|Mean|94.3|94.3|Standard Deviation|2.4|2.4|||
4228748|NCT00688155|4052060|B3|||Modified MiniMental State Exam Score|The Modified Mini Mental State Exam (3MS) Memory Functioning questionnaire asks the participant to rate on a scale of 1 (always) to 7 (never) how often remembering something presents a problem. In order to participate, subjects had to score at least an 88 or greater if their education level is greater than 8 years and if education level was 0-8 years, scores had to be at least an 80 or higher. The possible scores (units on a scale) range from 0 to 100, with higher scores reflecting better global cognitive functioning.|Units on a scale|Mean|94.6|94.6|Standard Deviation|4.3|4.3|||
4228749|NCT00688155|4052061|B2|||Modified MiniMental State Exam Score|The Modified Mini Mental State Exam (3MS) Memory Functioning questionnaire asks the participant to rate on a scale of 1 (always) to 7 (never) how often remembering something presents a problem. In order to participate, subjects had to score at least an 88 or greater if their education level is greater than 8 years and if education level was 0-8 years, scores had to be at least an 80 or higher. The possible scores (units on a scale) range from 0 to 100, with higher scores reflecting better global cognitive functioning.|Units on a scale|Mean|95.6|95.6|Standard Deviation|3.4|3.4|||
4228750|NCT00688155|4052062|B1|||Modified MiniMental State Exam Score|The Modified Mini Mental State Exam (3MS) Memory Functioning questionnaire asks the participant to rate on a scale of 1 (always) to 7 (never) how often remembering something presents a problem. In order to participate, subjects had to score at least an 88 or greater if their education level is greater than 8 years and if education level was 0-8 years, scores had to be at least an 80 or higher. The possible scores (units on a scale) range from 0 to 100, with higher scores reflecting better global cognitive functioning.|Units on a scale|Mean|94.6|94.6|Standard Deviation|3.9|3.9|||
4228751|NCT00688155|4052058|B5|||400 meter walk time||Seconds|Mean|342|342.0|Standard Deviation|55|55.0|||
4228752|NCT00688155|4052059|B4|||400 meter walk time||Seconds|Mean|331|331.0|Standard Deviation|66|66.0|||
4228753|NCT00688155|4052060|B3|||400 meter walk time||Seconds|Mean|347|347.0|Standard Deviation|56|56.0|||
4228754|NCT00688155|4052061|B2|||400 meter walk time||Seconds|Mean|331|331.0|Standard Deviation|50|50.0|||
4228755|NCT00688155|4052062|B1|||400 meter walk time||Seconds|Mean|360|360.0|Standard Deviation|48|48.0|||
4228756|NCT00688155|4052058|B5|United States||Region of Enrollment||Participants|Count of Participants|73|73.0||||||
4228757|NCT00688155|4052059|B4|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4228758|NCT00688155|4052060|B3|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4228759|NCT00688155|4052061|B2|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4228760|NCT00688155|4052062|B1|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4228761|NCT00688155|4052058|B5|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|66|66.0||||||
4228762|NCT00688155|4052059|B4|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4228763|NCT00688155|4052060|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
4228764|NCT00688155|4052061|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4228765|NCT00688155|4052062|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4228766|NCT00688155|4052058|B5|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4228767|NCT00688155|4052059|B4|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4228768|NCT00688155|4052060|B3|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4228769|NCT00688155|4052061|B2|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4228770|NCT00688155|4052062|B1|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4228772|NCT00688155|4052059|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4228773|NCT00688155|4052060|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4228774|NCT00688155|4052061|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4228775|NCT00688155|4052062|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4228776|NCT00688155|4052058|B5||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4228777|NCT00688155|4052059|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4228778|NCT00688155|4052060|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4228779|NCT00688155|4052061|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4228780|NCT00688155|4052062|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4228781|NCT00688155|4052058|B5|||Age||years|Mean|76.4|76.4|Standard Deviation|4.7|4.7|||
4228782|NCT00688155|4052059|B4|||Age||years|Mean|75.4|75.4|Standard Deviation|4.8|4.8|||
4228783|NCT00688155|4052060|B3|||Age||years|Mean|76.9|76.9|Standard Deviation|4.0|4.0|||
4228784|NCT00688155|4052061|B2|||Age||years|Mean|76.0|76.0|Standard Deviation|5.2|5.2|||
4228785|NCT00688155|4052062|B1|||Age||years|Mean|77.5|77.5|Standard Deviation|4.8|4.8|||
4228786|NCT00688103|4052083|B3|Japan||Region of Enrollment||participants|Number|151|151.0||||||
4228787|NCT00688103|4052084|B2|Japan||Region of Enrollment||participants|Number|77|77.0||||||
4228788|NCT00688103|4052085|B1|Japan||Region of Enrollment||participants|Number|74|74.0||||||
4228789|NCT00688103|4052083|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4228790|NCT00688103|4052084|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4228791|NCT00688103|4052085|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4228792|NCT00688103|4052083|B3||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4228793|NCT00688103|4052084|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4228794|NCT00688103|4052085|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4228795|NCT00688103|4052083|B3|||Age||years|Mean|57.3|57.3|Standard Deviation|10.2|10.2|||
4228796|NCT00688103|4052084|B2|||Age||years|Mean|56.6|56.6|Standard Deviation|11.1|11.1|||
4228797|NCT00688103|4052085|B1|||Age||years|Mean|58.1|58.1|Standard Deviation|12.6|12.6|||
4228798|NCT00688103|4052083|B3||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4228799|NCT00688103|4052084|B2||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4228800|NCT00688103|4052085|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4228801|NCT00688103|4052083|B3||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
4228802|NCT00688103|4052084|B2||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4228803|NCT00688103|4052085|B1||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4228804|NCT00688103|4052083|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4228805|NCT00688103|4052084|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4228806|NCT00688103|4052085|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4228807|NCT00688064|4052096|B3|Canada||Region of Enrollment||participants|Number|89|89.0||||||
4228808|NCT00688064|4052097|B2|Canada||Region of Enrollment||participants|Number|45|45.0||||||
4228809|NCT00688064|4052098|B1|Canada||Region of Enrollment||participants|Number|44|44.0||||||
4228810|NCT00688064|4052096|B3|Puerto Rico||Region of Enrollment||participants|Number|36|36.0||||||
4228811|NCT00688064|4052097|B2|Puerto Rico||Region of Enrollment||participants|Number|18|18.0||||||
4228812|NCT00688064|4052098|B1|Puerto Rico||Region of Enrollment||participants|Number|18|18.0||||||
4228813|NCT00688064|4052096|B3|United States||Region of Enrollment||participants|Number|334|334.0||||||
4228814|NCT00688064|4052097|B2|United States||Region of Enrollment||participants|Number|164|164.0||||||
4228815|NCT00688064|4052098|B1|United States||Region of Enrollment||participants|Number|170|170.0||||||
4228816|NCT00688064|4052096|B3||Male|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
4228817|NCT00688064|4052097|B2||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4228818|NCT00688064|4052098|B1||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4228819|NCT00688064|4052096|B3||Female|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4228820|NCT00688064|4052097|B2||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4228821|NCT00688064|4052098|B1||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4228822|NCT00688064|4052096|B3|||Age||years|Mean|18.4|18.4|Standard Deviation|5.41|5.41|||
4228823|NCT00688064|4052097|B2|||Age||years|Mean|18.1|18.1|Standard Deviation|4.92|4.92|||
4228824|NCT00688064|4052098|B1|||Age||years|Mean|18.6|18.6|Standard Deviation|5.84|5.84|||
4228825|NCT00688064|4052096|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4228826|NCT00688064|4052097|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4228827|NCT00688064|4052098|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4228828|NCT00688064|4052096|B3||Between 18 and 65 years|Age||Participants|Count of Participants|151|151.0||||||
4228829|NCT00688064|4052097|B2||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4228830|NCT00688064|4052098|B1||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4228831|NCT00688064|4052096|B3||<=18 years|Age||Participants|Count of Participants|308|308.0||||||
4228832|NCT00688064|4052097|B2||<=18 years|Age||Participants|Count of Participants|156|156.0||||||
4228833|NCT00688064|4052098|B1||<=18 years|Age||Participants|Count of Participants|152|152.0||||||
4228834|NCT00687973|4052113|B3|France||Region of Enrollment||participants|Number|393|393.0||||||
4228835|NCT00687973|4052114|B2|France||Region of Enrollment||participants|Number|200|200.0||||||
4228836|NCT00687973|4052115|B1|France||Region of Enrollment||participants|Number|193|193.0||||||
4228837|NCT00687973|4052113|B3||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4228838|NCT00687973|4052114|B2||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4228839|NCT00687973|4052115|B1||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4228840|NCT00687973|4052113|B3||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4228841|NCT00687973|4052114|B2||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4228842|NCT00687973|4052115|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4228843|NCT00687973|4052113|B3|||Age||years|Mean|56.9|56.9|Standard Deviation|10.55|10.55|||
4228844|NCT00687973|4052114|B2|||Age||years|Mean|56.2|56.2|Standard Deviation|11.09|11.09|||
4228845|NCT00687973|4052115|B1|||Age||years|Mean|57.5|57.5|Standard Deviation|9.94|9.94|||
4228846|NCT00687908|4052143|B3|Canada||Region of Enrollment||participants|Number|54|54.0||||||
4228847|NCT00687908|4052144|B2|Canada||Region of Enrollment||participants|Number|28|28.0||||||
4228848|NCT00687908|4052145|B1|Canada||Region of Enrollment||participants|Number|26|26.0||||||
4228849|NCT00687908|4052143|B3|Puerto Rico||Region of Enrollment||participants|Number|26|26.0||||||
4228850|NCT00687908|4052144|B2|Puerto Rico||Region of Enrollment||participants|Number|13|13.0||||||
4228851|NCT00687908|4052145|B1|Puerto Rico||Region of Enrollment||participants|Number|13|13.0||||||
4228852|NCT00687908|4052143|B3|United States||Region of Enrollment||participants|Number|163|163.0||||||
4228853|NCT00687908|4052144|B2|United States||Region of Enrollment||participants|Number|79|79.0||||||
4228854|NCT00687908|4052145|B1|United States||Region of Enrollment||participants|Number|84|84.0||||||
4228855|NCT00687908|4052143|B3||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4228856|NCT00687908|4052144|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4228857|NCT00687908|4052145|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4228858|NCT00687908|4052143|B3||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4228859|NCT00687908|4052144|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4228860|NCT00687908|4052145|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4228861|NCT00687908|4052143|B3|||Age||years|Mean|18.6|18.6|Standard Deviation|5.58|5.58|||
4228862|NCT00687908|4052144|B2|||Age||years|Mean|18.2|18.2|Standard Deviation|5.23|5.23|||
4228863|NCT00687908|4052145|B1|||Age||years|Mean|19.1|19.1|Standard Deviation|5.89|5.89|||
4228864|NCT00687908|4052143|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4228865|NCT00687908|4052144|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4228866|NCT00687908|4052145|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4228867|NCT00687908|4052143|B3||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
4228868|NCT00687908|4052144|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4228869|NCT00687908|4052145|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4228870|NCT00687908|4052143|B3||<=18 years|Age||Participants|Count of Participants|160|160.0||||||
4228871|NCT00687908|4052144|B2||<=18 years|Age||Participants|Count of Participants|84|84.0||||||
4228872|NCT00687908|4052145|B1||<=18 years|Age||Participants|Count of Participants|76|76.0||||||
4228873|NCT00687856|4052160|B1|United States||Region of Enrollment||participants|Number|211|211.0||||||
4228874|NCT00687856|4052160|B1||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4228875|NCT00687856|4052160|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4228876|NCT00687856|4052160|B1|||Age||years|Mean|48|48.0|Standard Deviation|23|23.0|||
4228877|NCT00687856|4052160|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4228878|NCT00687856|4052160|B1||Between 18 and 65 years|Age||Participants|Count of Participants|211|211.0||||||
4228879|NCT00687856|4052160|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4228880|NCT00687830|4052164|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4228881|NCT00687830|4052165|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4228882|NCT00687830|4052166|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4228883|NCT00687830|4052164|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4228884|NCT00687830|4052165|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4228885|NCT00687830|4052166|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4228886|NCT00687830|4052164|B3|||Age||years|Mean|51.8|51.8|Standard Deviation|10.8|10.8|||
4228887|NCT00687830|4052165|B2|||Age||years|Mean|51.4|51.4|Standard Deviation|10.2|10.2|||
4228888|NCT00687830|4052166|B1|||Age||years|Mean|52.2|52.2|Standard Deviation|11.5|11.5|||
4228889|NCT00687804|4052175|B4||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4228890|NCT00687804|4052176|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4228891|NCT00687804|4052177|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4228892|NCT00687804|4052178|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4228893|NCT00687804|4052175|B4||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4228894|NCT00687804|4052176|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4228895|NCT00687804|4052177|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4228896|NCT00687804|4052178|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4228897|NCT00687804|4052175|B4|>=75 years||Age, Customized||Participants|Number|34|34.0||||||
4228898|NCT00687804|4052176|B3|>=75 years||Age, Customized||Participants|Number|14|14.0||||||
4228899|NCT00687804|4052177|B2|>=75 years||Age, Customized||Participants|Number|9|9.0||||||
4228900|NCT00687804|4052178|B1|>=75 years||Age, Customized||Participants|Number|11|11.0||||||
4228901|NCT00687804|4052175|B4|65 - <75 years||Age, Customized||Participants|Number|124|124.0||||||
4228902|NCT00687804|4052176|B3|65 - <75 years||Age, Customized||Participants|Number|31|31.0||||||
4228903|NCT00687804|4052177|B2|65 - <75 years||Age, Customized||Participants|Number|53|53.0||||||
4228904|NCT00687804|4052178|B1|65 - <75 years||Age, Customized||Participants|Number|40|40.0||||||
4228905|NCT00687804|4052175|B4|55 - <65 years||Age, Customized||Participants|Number|136|136.0||||||
4228906|NCT00687804|4052176|B3|55 - <65 years||Age, Customized||Participants|Number|53|53.0||||||
4228907|NCT00687804|4052177|B2|55 - <65 years||Age, Customized||Participants|Number|42|42.0||||||
4228908|NCT00687804|4052178|B1|55 - <65 years||Age, Customized||Participants|Number|41|41.0||||||
4228909|NCT00687804|4052175|B4|< 55 years||Age, Customized||Participants|Number|51|51.0||||||
4228910|NCT00687804|4052176|B3|< 55 years||Age, Customized||Participants|Number|13|13.0||||||
4228911|NCT00687804|4052177|B2|< 55 years||Age, Customized||Participants|Number|14|14.0||||||
4228912|NCT00687804|4052178|B1|< 55 years||Age, Customized||Participants|Number|24|24.0||||||
4228913|NCT00687804|4052175|B4|||Age||years|Mean|63.5|63.5|Standard Deviation|8.75|8.75|||
4228914|NCT00687804|4052176|B3|||Age||years|Mean|63.5|63.5|Standard Deviation|8.81|8.81|||
4228915|NCT00687804|4052177|B2|||Age||years|Mean|64.0|64.0|Standard Deviation|8.15|8.15|||
4228916|NCT00687804|4052178|B1|||Age||years|Mean|62.9|62.9|Standard Deviation|9.29|9.29|||
4228917|NCT00687713|4052223|B3|United States||Region of Enrollment||participants|Number|205|205.0||||||
4228918|NCT00687713|4052224|B2|United States||Region of Enrollment||participants|Number|105|105.0||||||
4228919|NCT00687713|4052225|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
4228920|NCT00687713|4052223|B3||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4228921|NCT00687713|4052224|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4228922|NCT00687713|4052225|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4228923|NCT00687713|4052223|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4228924|NCT00687713|4052224|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4228925|NCT00687713|4052225|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4228926|NCT00687713|4052223|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4228927|NCT00687713|4052224|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4228928|NCT00687713|4052225|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4228929|NCT00687713|4052223|B3||Between 18 and 65 years|Age||Participants|Count of Participants|204|204.0||||||
4228930|NCT00687713|4052224|B2||Between 18 and 65 years|Age||Participants|Count of Participants|104|104.0||||||
4228931|NCT00687713|4052225|B1||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4228932|NCT00687713|4052223|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4228933|NCT00687713|4052224|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4228934|NCT00687713|4052225|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4228935|NCT00687674|4052234|B1|No||Prior Transplant||participants|Number|1|1.0||||||
4228936|NCT00687674|4052234|B1|Yes||Prior Transplant||participants|Number|12|12.0||||||
4228937|NCT00687674|4052234|B1|No||Prior Lenalidomide||participants|Number|11|11.0||||||
4228938|NCT00687674|4052234|B1|Yes||Prior Lenalidomide||participants|Number|2|2.0||||||
4228939|NCT00687674|4052234|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4228940|NCT00687674|4052234|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4228941|NCT00687674|4052234|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4228942|NCT00687674|4052234|B1|||Age||years|Median|62|62.0|Full Range|||42.0|77.0|
4228943|NCT00687609|4052241|B1|Actual Attempt||Columbia Suicide Rating Scale (C-SSRS) Suicidal Behavior|Solicits suicide-related information with structured questioning. Scale consists of 28 items in 4 sections: suicidal behavior, actual attempts, suicidal ideation, intensity of ideation. Suicidal behavior consists of 7 yes/no items: actual attempt, non-suicidal self-injurious behavior, interrupted attempt, aborted attempt, preparatory acts or behavior, presence of suicidal behavior, completed suicide. Only items with yes responses are listed.|Participants|Number|1|1.0||||||
4228944|NCT00687609|4052241|B1|Presence of Suicidal Behavior||Columbia Suicide Rating Scale (C-SSRS) Suicidal Behavior|Solicits suicide-related information with structured questioning. Scale consists of 28 items in 4 sections: suicidal behavior, actual attempts, suicidal ideation, intensity of ideation. Suicidal behavior consists of 7 yes/no items: actual attempt, non-suicidal self-injurious behavior, interrupted attempt, aborted attempt, preparatory acts or behavior, presence of suicidal behavior, completed suicide. Only items with yes responses are listed.|Participants|Number|1|1.0||||||
4228945|NCT00687609|4052241|B1|Non-Suicidal Self Injurious Behavior||Columbia Suicide Rating Scale (C-SSRS) Suicidal Behavior|Solicits suicide-related information with structured questioning. Scale consists of 28 items in 4 sections: suicidal behavior, actual attempts, suicidal ideation, intensity of ideation. Suicidal behavior consists of 7 yes/no items: actual attempt, non-suicidal self-injurious behavior, interrupted attempt, aborted attempt, preparatory acts or behavior, presence of suicidal behavior, completed suicide. Only items with yes responses are listed.|Participants|Number|2|2.0||||||
4229002|NCT00687453|4052279|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229003|NCT00687453|4052280|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229004|NCT00687453|4052278|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4229005|NCT00687453|4052279|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4228946|NCT00687609|4052241|B1|Aborted Attempt||Columbia Suicide Rating Scale (C-SSRS) Suicidal Behavior|Solicits suicide-related information with structured questioning. Scale consists of 28 items in 4 sections: suicidal behavior, actual attempts, suicidal ideation, intensity of ideation. Suicidal behavior consists of 7 yes/no items: actual attempt, non-suicidal self-injurious behavior, interrupted attempt, aborted attempt, preparatory acts or behavior, presence of suicidal behavior, completed suicide. Only items with yes responses are listed.|Participants|Number|1|1.0||||||
4228947|NCT00687609|4052241|B1|Netherlands||Region of Enrollment||participants|Number|7|7.0||||||
4228948|NCT00687609|4052241|B1|West Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4228949|NCT00687609|4052241|B1|East Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4228950|NCT00687609|4052241|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4228951|NCT00687609|4052241|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4228952|NCT00687609|4052241|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4228953|NCT00687609|4052241|B1|||Age||Years|Mean|16.3|16.3|Standard Deviation|0.95|0.95|||
4228954|NCT00687544|4052255|B1|Indonesia||Region of Enrollment||participants|Number|11|11.0||||||
4228955|NCT00687544|4052255|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4228956|NCT00687544|4052255|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4228957|NCT00687544|4052255|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4228958|NCT00687544|4052255|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4228959|NCT00687544|4052255|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4228960|NCT00687531|4052264|B1|Not Available to Report||Sex/Gender, Customized||participants|Number|1|1.0||||||
4228961|NCT00687531|4052264|B1|Male||Sex/Gender, Customized||participants|Number|81|81.0||||||
4228962|NCT00687531|4052264|B1|Female||Sex/Gender, Customized||participants|Number|199|199.0||||||
4228963|NCT00687531|4052264|B1|Not Available to Report||Age, Customized||participants|Number|3|3.0||||||
4228964|NCT00687531|4052264|B1|Between 81 and 90 years||Age, Customized||participants|Number|6|6.0||||||
4228965|NCT00687531|4052264|B1|Between 71 and 80 years||Age, Customized||participants|Number|17|17.0||||||
4228966|NCT00687531|4052264|B1|Between 61 and 70 years||Age, Customized||participants|Number|39|39.0||||||
4228967|NCT00687531|4052264|B1|Between 51 and 60 years||Age, Customized||participants|Number|64|64.0||||||
4228968|NCT00687531|4052264|B1|Between 41 and 50 years||Age, Customized||participants|Number|58|58.0||||||
4228969|NCT00687531|4052264|B1|Between 31 and 40 years||Age, Customized||participants|Number|40|40.0||||||
4228970|NCT00687531|4052264|B1|Between 21 and 30 years||Age, Customized||participants|Number|54|54.0||||||
4228971|NCT00687453|4052278|B3|||Body Mass Index||kg/m^2|Mean|31.8|31.8|Standard Deviation|5.8|5.8|||
4228972|NCT00687453|4052279|B2|||Body Mass Index||kg/m^2|Mean|33.5|33.5|Standard Deviation|6.6|6.6|||
4228973|NCT00687453|4052280|B1|||Body Mass Index||kg/m^2|Mean|29.9|29.9|Standard Deviation|4.1|4.1|||
4228974|NCT00687453|4052278|B3|||Diabetes Duration||Years|Mean|10.6|10.6|Standard Deviation|3.8|3.8|||
4228975|NCT00687453|4052279|B2|||Diabetes Duration||Years|Mean|11.5|11.5|Standard Deviation|4.0|4.0|||
4228976|NCT00687453|4052280|B1|||Diabetes Duration||Years|Mean|9.4|9.4|Standard Deviation|3.5|3.5|||
4228977|NCT00687453|4052278|B3|||Fasting Plasma Glucose||mg/dL|Mean|146|146.0|Standard Deviation|56|56.0|||
4228978|NCT00687453|4052279|B2|||Fasting Plasma Glucose||mg/dL|Mean|145|145.0|Standard Deviation|34|34.0|||
4228979|NCT00687453|4052280|B1|||Fasting Plasma Glucose||mg/dL|Mean|146|146.0|Standard Deviation|75|75.0|||
4228980|NCT00687453|4052278|B3|||Hemoglobin A1c||Percent|Mean|9.3|9.3|Standard Deviation|1.3|1.3|||
4228981|NCT00687453|4052279|B2|||Hemoglobin A1c||Percent|Mean|9.5|9.5|Standard Deviation|1.2|1.2|||
4228982|NCT00687453|4052280|B1|||Hemoglobin A1c||Percent|Mean|9.1|9.1|Standard Deviation|1.4|1.4|||
4228983|NCT00687453|4052278|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4228984|NCT00687453|4052279|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4228985|NCT00687453|4052280|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4228986|NCT00687453|4052278|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4228987|NCT00687453|4052279|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4228988|NCT00687453|4052280|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4228989|NCT00687453|4052278|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4228990|NCT00687453|4052279|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4228991|NCT00687453|4052280|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4228992|NCT00687453|4052278|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4228993|NCT00687453|4052279|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4228994|NCT00687453|4052280|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4228995|NCT00687453|4052278|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4228996|NCT00687453|4052279|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4228997|NCT00687453|4052280|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4228998|NCT00687453|4052278|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4228999|NCT00687453|4052279|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229000|NCT00687453|4052280|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229001|NCT00687453|4052278|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229006|NCT00687453|4052280|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4229007|NCT00687453|4052278|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4229008|NCT00687453|4052279|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4229009|NCT00687453|4052280|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4229010|NCT00687453|4052278|B3|||Age||years|Mean|55.0|55.0|Standard Deviation|7.2|7.2|||
4229011|NCT00687453|4052279|B2|||Age||years|Mean|54.6|54.6|Standard Deviation|7.6|7.6|||
4229012|NCT00687453|4052280|B1|||Age||years|Mean|55.6|55.6|Standard Deviation|7.0|7.0|||
4229013|NCT00687440|4052287|B1|Italy||Region of Enrollment||participants|Number|27|27.0||||||
4229014|NCT00687440|4052287|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4229015|NCT00687440|4052287|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4229016|NCT00687440|4052287|B1|||Age, Customized||years|Number|27|27.0||||||
4229017|NCT00687401|4052291|B1||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4229018|NCT00687401|4052291|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4229019|NCT00687401|4052291|B1|||Age||years|Mean|44.15|44.15|Standard Deviation|12.80|12.8|||
4229020|NCT00687362|4052296|B1|Middle East||Region of Enrollment||participants|Number|22|22.0||||||
4229021|NCT00687362|4052296|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4229022|NCT00687362|4052296|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4229023|NCT00687362|4052296|B1|||Age||years|Mean|37.05|37.05|Standard Deviation|13.15|13.15|||
4229024|NCT00687323|4052300|B1|Canada||Region of Enrollment|Number of participants who received treatment|participants|Number|47|47.0||||||
4229025|NCT00687323|4052300|B1||Male|Sex: Female, Male|Number of participants who received treatment|Participants|Count of Participants|29|29.0||||||
4229026|NCT00687323|4052300|B1||Female|Sex: Female, Male|Number of participants who received treatment|Participants|Count of Participants|18|18.0||||||
4229027|NCT00687323|4052300|B1|||Age|Number of participants who received treatment|years|Mean|75|75.0|Full Range|||52.0|89.0|
4229028|NCT00687297|4052314|B3|United States||Region of Enrollment||participants|Number|162|162.0||||||
4229029|NCT00687297|4052315|B2|United States||Region of Enrollment||participants|Number|82|82.0||||||
4229030|NCT00687297|4052316|B1|United States||Region of Enrollment||participants|Number|80|80.0||||||
4229031|NCT00687297|4052314|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4229032|NCT00687297|4052315|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4229033|NCT00687297|4052316|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4229034|NCT00687297|4052314|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4229035|NCT00687297|4052315|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4229036|NCT00687297|4052316|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4229037|NCT00687297|4052314|B3|||Age||years|Median|63|63.0|Full Range|||36.0|84.0|
4229038|NCT00687297|4052315|B2|||Age||years|Median|63|63.0|Full Range|||36.0|82.0|
4229039|NCT00687297|4052316|B1|||Age||years|Median|63.5|63.5|Full Range|||38.0|84.0|
4229040|NCT00687271|4052327|B5||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4229041|NCT00687271|4052328|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4229042|NCT00687271|4052329|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4229043|NCT00687271|4052330|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4229044|NCT00687271|4052331|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4229045|NCT00687271|4052327|B5||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4229046|NCT00687271|4052328|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4229047|NCT00687271|4052329|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4229048|NCT00687271|4052330|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4229049|NCT00687271|4052331|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4229050|NCT00687271|4052327|B5|||Age||Years|Mean|54.3|54.3|Standard Deviation|10.5|10.5|||
4229051|NCT00687271|4052328|B4|||Age||Years|Mean|54.7|54.7|Standard Deviation|10.7|10.7|||
4229052|NCT00687271|4052329|B3|||Age||Years|Mean|56.2|56.2|Standard Deviation|10.0|10.0|||
4229053|NCT00687271|4052330|B2|||Age||Years|Mean|53.6|53.6|Standard Deviation|10.2|10.2|||
4229054|NCT00687271|4052331|B1|||Age||Years|Mean|52.9|52.9|Standard Deviation|10.9|10.9|||
4229055|NCT00687219|4052372|B1|Japan||Region of Enrollment||Participants|Number|102|102.0||||||
4229056|NCT00687219|4052372|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4229057|NCT00687219|4052372|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4229058|NCT00687219|4052372|B1|||Age||Years|Mean|58.6|58.6|Standard Deviation|8.1|8.1|||
4229059|NCT00687193|4052378|B7||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4229060|NCT00687193|4052379|B6||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4229061|NCT00687193|4052380|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4229062|NCT00687193|4052381|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4229063|NCT00687193|4052382|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4229064|NCT00687193|4052383|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4229065|NCT00687193|4052384|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4229066|NCT00687193|4052378|B7||Female|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
4229067|NCT00687193|4052379|B6||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4229068|NCT00687193|4052380|B5||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4229069|NCT00687193|4052381|B4||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4229070|NCT00687193|4052382|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4229071|NCT00687193|4052383|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4229072|NCT00687193|4052384|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4229073|NCT00687193|4052378|B7|>= 65 years||Age, Customized||Participants|Number|56|56.0||||||
4229074|NCT00687193|4052379|B6|>= 65 years||Age, Customized||Participants|Number|9|9.0||||||
4229075|NCT00687193|4052380|B5|>= 65 years||Age, Customized||Participants|Number|12|12.0||||||
4229076|NCT00687193|4052381|B4|>= 65 years||Age, Customized||Participants|Number|12|12.0||||||
4229077|NCT00687193|4052382|B3|>= 65 years||Age, Customized||Participants|Number|8|8.0||||||
4229078|NCT00687193|4052383|B2|>= 65 years||Age, Customized||Participants|Number|9|9.0||||||
4229079|NCT00687193|4052384|B1|>= 65 years||Age, Customized||Participants|Number|6|6.0||||||
4229080|NCT00687193|4052378|B7|Between 45 and 64 years||Age, Customized||Participants|Number|194|194.0||||||
4229081|NCT00687193|4052379|B6|Between 45 and 64 years||Age, Customized||Participants|Number|29|29.0||||||
4229082|NCT00687193|4052380|B5|Between 45 and 64 years||Age, Customized||Participants|Number|30|30.0||||||
4229083|NCT00687193|4052381|B4|Between 45 and 64 years||Age, Customized||Participants|Number|32|32.0||||||
4229084|NCT00687193|4052382|B3|Between 45 and 64 years||Age, Customized||Participants|Number|31|31.0||||||
4229085|NCT00687193|4052383|B2|Between 45 and 64 years||Age, Customized||Participants|Number|33|33.0||||||
4229086|NCT00687193|4052384|B1|Between 45 and 64 years||Age, Customized||Participants|Number|39|39.0||||||
4229087|NCT00687193|4052378|B7|Between 18 and 44 years||Age, Customized||Participants|Number|67|67.0||||||
4229088|NCT00687193|4052379|B6|Between 18 and 44 years||Age, Customized||Participants|Number|14|14.0||||||
4229089|NCT00687193|4052380|B5|Between 18 and 44 years||Age, Customized||Participants|Number|12|12.0||||||
4229090|NCT00687193|4052381|B4|Between 18 and 44 years||Age, Customized||Participants|Number|9|9.0||||||
4229091|NCT00687193|4052382|B3|Between 18 and 44 years||Age, Customized||Participants|Number|13|13.0||||||
4229092|NCT00687193|4052383|B2|Between 18 and 44 years||Age, Customized||Participants|Number|11|11.0||||||
4229093|NCT00687193|4052384|B1|Between 18 and 44 years||Age, Customized||Participants|Number|8|8.0||||||
4229094|NCT00687193|4052378|B7|< 18 years||Age, Customized||Participants|Number|0|0.0||||||
4229095|NCT00687193|4052379|B6|< 18 years||Age, Customized||Participants|Number|0|0.0||||||
4229096|NCT00687193|4052380|B5|< 18 years||Age, Customized||Participants|Number|0|0.0||||||
4229097|NCT00687193|4052381|B4|< 18 years||Age, Customized||Participants|Number|0|0.0||||||
4229098|NCT00687193|4052382|B3|< 18 years||Age, Customized||Participants|Number|0|0.0||||||
4229099|NCT00687193|4052383|B2|< 18 years||Age, Customized||Participants|Number|0|0.0||||||
4229100|NCT00687193|4052384|B1|< 18 years||Age, Customized||Participants|Number|0|0.0||||||
4229101|NCT00687167|4052553|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229102|NCT00687167|4052553|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229103|NCT00687167|4052553|B1||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4229104|NCT00687167|4052553|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229105|NCT00687167|4052553|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229106|NCT00687167|4052553|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229107|NCT00687167|4052553|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229108|NCT00687167|4052553|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4229109|NCT00687167|4052553|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4229110|NCT00687167|4052553|B1|||Age||years|Mean|27.7|27.7|Standard Deviation|10|10.0|||
4229111|NCT00687167|4052553|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4229112|NCT00687167|4052553|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4229113|NCT00687167|4052553|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4229114|NCT00687102|4052562|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
4229115|NCT00687102|4052563|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4229116|NCT00687102|4052564|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4229117|NCT00687102|4052562|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229118|NCT00687102|4052563|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229119|NCT00687102|4052564|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229120|NCT00687102|4052562|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1400|1400.0||||||
4229121|NCT00687102|4052563|B2||White|Race (NIH/OMB)||Participants|Count of Participants|715|715.0||||||
4229122|NCT00687102|4052564|B1||White|Race (NIH/OMB)||Participants|Count of Participants|685|685.0||||||
4229123|NCT00687102|4052562|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229124|NCT00687102|4052563|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229125|NCT00687102|4052564|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229126|NCT00687102|4052562|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229127|NCT00687102|4052563|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229185|NCT00686998|4052598|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4229128|NCT00687102|4052564|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229129|NCT00687102|4052562|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229130|NCT00687102|4052563|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229131|NCT00687102|4052564|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229132|NCT00687102|4052562|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229133|NCT00687102|4052563|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229134|NCT00687102|4052564|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229135|NCT00687102|4052562|B3||Male|Sex: Female, Male|This study was designed to recruit female participants only.|Participants|Count of Participants|0|0.0||||||
4229136|NCT00687102|4052563|B2||Male|Sex: Female, Male|This study was designed to recruit female participants only.|Participants|Count of Participants|0|0.0||||||
4229137|NCT00687102|4052564|B1||Male|Sex: Female, Male|This study was designed to recruit female participants only.|Participants|Count of Participants|0|0.0||||||
4229138|NCT00687102|4052562|B3||Female|Sex: Female, Male|This study was designed to recruit female participants only.|Participants|Count of Participants|1498|1498.0||||||
4229139|NCT00687102|4052563|B2||Female|Sex: Female, Male|This study was designed to recruit female participants only.|Participants|Count of Participants|765|765.0||||||
4229140|NCT00687102|4052564|B1||Female|Sex: Female, Male|This study was designed to recruit female participants only.|Participants|Count of Participants|733|733.0||||||
4229141|NCT00687102|4052562|B3||>=65 years|Age||Participants|Count of Participants|1498|1498.0||||||
4229142|NCT00687102|4052563|B2||>=65 years|Age||Participants|Count of Participants|765|765.0||||||
4229143|NCT00687102|4052564|B1||>=65 years|Age||Participants|Count of Participants|733|733.0||||||
4229144|NCT00687102|4052562|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4229145|NCT00687102|4052563|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4229146|NCT00687102|4052564|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4229147|NCT00687102|4052562|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4229148|NCT00687102|4052563|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4229149|NCT00687102|4052564|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4229150|NCT00687076|4052585|B3|United States||Region of Enrollment||participants|Number|95|95.0||||||
4229151|NCT00687076|4052586|B2|United States||Region of Enrollment||participants|Number|48|48.0||||||
4229152|NCT00687076|4052587|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
4229153|NCT00687076|4052585|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229154|NCT00687076|4052586|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229155|NCT00687076|4052587|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229156|NCT00687076|4052585|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229157|NCT00687076|4052586|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229158|NCT00687076|4052587|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229159|NCT00687076|4052585|B3||White|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
4229160|NCT00687076|4052586|B2||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4229161|NCT00687076|4052587|B1||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4229162|NCT00687076|4052585|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4229163|NCT00687076|4052586|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4229164|NCT00687076|4052587|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4229165|NCT00687076|4052585|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229166|NCT00687076|4052586|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229167|NCT00687076|4052587|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229168|NCT00687076|4052585|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229169|NCT00687076|4052586|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229170|NCT00687076|4052587|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229171|NCT00687076|4052585|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4229172|NCT00687076|4052586|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229173|NCT00687076|4052587|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4229174|NCT00687076|4052585|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4229175|NCT00687076|4052586|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4229176|NCT00687076|4052587|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4229177|NCT00687076|4052585|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4229178|NCT00687076|4052586|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4229179|NCT00687076|4052587|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4229180|NCT00687076|4052585|B3|||Age||years|Mean|63.0|63.0|Standard Deviation|7.5|7.5|||
4229181|NCT00687076|4052586|B2|||Age||years|Mean|63.9|63.9|Standard Deviation|7.1|7.1|||
4229182|NCT00687076|4052587|B1|||Age||years|Mean|62.1|62.1|Standard Deviation|7.8|7.8|||
4229183|NCT00686998|4052596|B4||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4229184|NCT00686998|4052597|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4229186|NCT00686998|4052599|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4229187|NCT00686998|4052596|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4229188|NCT00686998|4052597|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4229189|NCT00686998|4052598|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4229190|NCT00686998|4052599|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4229191|NCT00686998|4052596|B4|||Age||Year|Mean|39.2|39.2|Standard Deviation|11.3|11.3|||
4229192|NCT00686998|4052597|B3|||Age||Year|Mean|35.3|35.3|Standard Deviation|8.7|8.7|||
4229193|NCT00686998|4052598|B2|||Age||Year|Mean|40.2|40.2|Standard Deviation|11.6|11.6|||
4229194|NCT00686998|4052599|B1|||Age||Year|Mean|40.1|40.1|Standard Deviation|12|12.0|||
4229195|NCT00686972|4052609|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4229196|NCT00686972|4052609|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4229197|NCT00686972|4052609|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4229198|NCT00686972|4052609|B1|>=21 and <=65||Age, Customized||participants|Number|51|51.0||||||
4229199|NCT00686959|4052613|B3|No||Baseline PET scan|Participant had a baseline Positron Emission Tomography (PET) scan for staging|participants|Number|107|107.0||||||
4229200|NCT00686959|4052614|B2|No||Baseline PET scan|Participant had a baseline Positron Emission Tomography (PET) scan for staging|participants|Number|56|56.0||||||
4229201|NCT00686959|4052615|B1|No||Baseline PET scan|Participant had a baseline Positron Emission Tomography (PET) scan for staging|participants|Number|51|51.0||||||
4229202|NCT00686959|4052613|B3|Yes||Baseline PET scan|Participant had a baseline Positron Emission Tomography (PET) scan for staging|participants|Number|491|491.0||||||
4229203|NCT00686959|4052614|B2|Yes||Baseline PET scan|Participant had a baseline Positron Emission Tomography (PET) scan for staging|participants|Number|241|241.0||||||
4229204|NCT00686959|4052615|B1|Yes||Baseline PET scan|Participant had a baseline Positron Emission Tomography (PET) scan for staging|participants|Number|250|250.0||||||
4229205|NCT00686959|4052613|B3|Missing||Smoking status||participants|Number|37|37.0||||||
4229206|NCT00686959|4052614|B2|Missing||Smoking status||participants|Number|18|18.0||||||
4229207|NCT00686959|4052615|B1|Missing||Smoking status||participants|Number|19|19.0||||||
4229208|NCT00686959|4052613|B3|Heavy smoker||Smoking status||participants|Number|373|373.0||||||
4229209|NCT00686959|4052614|B2|Heavy smoker||Smoking status||participants|Number|183|183.0||||||
4229210|NCT00686959|4052615|B1|Heavy smoker||Smoking status||participants|Number|190|190.0||||||
4229211|NCT00686959|4052613|B3|Moderate smoker||Smoking status||participants|Number|80|80.0||||||
4229212|NCT00686959|4052614|B2|Moderate smoker||Smoking status||participants|Number|38|38.0||||||
4229213|NCT00686959|4052615|B1|Moderate smoker||Smoking status||participants|Number|42|42.0||||||
4229214|NCT00686959|4052613|B3|Never smoked||Smoking status||participants|Number|108|108.0||||||
4229215|NCT00686959|4052614|B2|Never smoked||Smoking status||participants|Number|58|58.0||||||
4229216|NCT00686959|4052615|B1|Never smoked||Smoking status||participants|Number|50|50.0||||||
4229217|NCT00686959|4052613|B3|Missing||Histology||participants|Number|2|2.0||||||
4229218|NCT00686959|4052614|B2|Missing||Histology||participants|Number|2|2.0||||||
4229219|NCT00686959|4052615|B1|Missing||Histology||participants|Number|0|0.0||||||
4229220|NCT00686959|4052613|B3|Other||Histology||participants|Number|107|107.0||||||
4229221|NCT00686959|4052614|B2|Other||Histology||participants|Number|48|48.0||||||
4229222|NCT00686959|4052615|B1|Other||Histology||participants|Number|59|59.0||||||
4229223|NCT00686959|4052613|B3|Large cell carcinoma||Histology||participants|Number|37|37.0||||||
4229224|NCT00686959|4052614|B2|Large cell carcinoma||Histology||participants|Number|21|21.0||||||
4229225|NCT00686959|4052615|B1|Large cell carcinoma||Histology||participants|Number|16|16.0||||||
4229226|NCT00686959|4052613|B3|Adenocarcinoma||Histology||participants|Number|452|452.0||||||
4229227|NCT00686959|4052614|B2|Adenocarcinoma||Histology||participants|Number|226|226.0||||||
4229228|NCT00686959|4052615|B1|Adenocarcinoma||Histology||participants|Number|226|226.0||||||
4229229|NCT00686959|4052613|B3|Missing||Disease stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIA - the cancer has spread to nearby tissue or spread to far away lymph nodes; Stage IIIB - cancer spread to opposite side of chest, more than one tumor within same lobe of lung.|participants|Number|3|3.0||||||
4229230|NCT00686959|4052614|B2|Missing||Disease stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIA - the cancer has spread to nearby tissue or spread to far away lymph nodes; Stage IIIB - cancer spread to opposite side of chest, more than one tumor within same lobe of lung.|participants|Number|3|3.0||||||
4229231|NCT00686959|4052615|B1|Missing||Disease stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIA - the cancer has spread to nearby tissue or spread to far away lymph nodes; Stage IIIB - cancer spread to opposite side of chest, more than one tumor within same lobe of lung.|participants|Number|0|0.0||||||
4229232|NCT00686959|4052613|B3|Stage IIIB||Disease stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIA - the cancer has spread to nearby tissue or spread to far away lymph nodes; Stage IIIB - cancer spread to opposite side of chest, more than one tumor within same lobe of lung.|participants|Number|313|313.0||||||
4229233|NCT00686959|4052614|B2|Stage IIIB||Disease stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIA - the cancer has spread to nearby tissue or spread to far away lymph nodes; Stage IIIB - cancer spread to opposite side of chest, more than one tumor within same lobe of lung.|participants|Number|152|152.0||||||
4229267|NCT00686959|4052615|B1|Taiwan||Region of Enrollment||participants|Number|11|11.0||||||
4229268|NCT00686959|4052613|B3|China||Region of Enrollment||participants|Number|61|61.0||||||
4229234|NCT00686959|4052615|B1|Stage IIIB||Disease stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIA - the cancer has spread to nearby tissue or spread to far away lymph nodes; Stage IIIB - cancer spread to opposite side of chest, more than one tumor within same lobe of lung.|participants|Number|161|161.0||||||
4229235|NCT00686959|4052613|B3|Stage IIIA||Disease stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIA - the cancer has spread to nearby tissue or spread to far away lymph nodes; Stage IIIB - cancer spread to opposite side of chest, more than one tumor within same lobe of lung.|participants|Number|282|282.0||||||
4229236|NCT00686959|4052614|B2|Stage IIIA||Disease stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIA - the cancer has spread to nearby tissue or spread to far away lymph nodes; Stage IIIB - cancer spread to opposite side of chest, more than one tumor within same lobe of lung.|participants|Number|142|142.0||||||
4229237|NCT00686959|4052615|B1|Stage IIIA||Disease stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIA - the cancer has spread to nearby tissue or spread to far away lymph nodes; Stage IIIB - cancer spread to opposite side of chest, more than one tumor within same lobe of lung.|participants|Number|140|140.0||||||
4229238|NCT00686959|4052613|B3|Missing||ECOG performance status|"Eastern Cooperative Oncology Group (ECOG) performance status:~0=Fully active, able to carry on all pre-disease performance without restriction~1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, such as, light housework, office work"|participants|Number|4|4.0||||||
4229239|NCT00686959|4052614|B2|Missing||ECOG performance status|"Eastern Cooperative Oncology Group (ECOG) performance status:~0=Fully active, able to carry on all pre-disease performance without restriction~1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, such as, light housework, office work"|participants|Number|3|3.0||||||
4229240|NCT00686959|4052615|B1|Missing||ECOG performance status|"Eastern Cooperative Oncology Group (ECOG) performance status:~0=Fully active, able to carry on all pre-disease performance without restriction~1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, such as, light housework, office work"|participants|Number|1|1.0||||||
4229241|NCT00686959|4052613|B3|1||ECOG performance status|"Eastern Cooperative Oncology Group (ECOG) performance status:~0=Fully active, able to carry on all pre-disease performance without restriction~1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, such as, light housework, office work"|participants|Number|301|301.0||||||
4229242|NCT00686959|4052614|B2|1||ECOG performance status|"Eastern Cooperative Oncology Group (ECOG) performance status:~0=Fully active, able to carry on all pre-disease performance without restriction~1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, such as, light housework, office work"|participants|Number|149|149.0||||||
4229243|NCT00686959|4052615|B1|1||ECOG performance status|"Eastern Cooperative Oncology Group (ECOG) performance status:~0=Fully active, able to carry on all pre-disease performance without restriction~1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, such as, light housework, office work"|participants|Number|152|152.0||||||
4229244|NCT00686959|4052613|B3|0||ECOG performance status|"Eastern Cooperative Oncology Group (ECOG) performance status:~0=Fully active, able to carry on all pre-disease performance without restriction~1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, such as, light housework, office work"|participants|Number|293|293.0||||||
4229245|NCT00686959|4052614|B2|0||ECOG performance status|"Eastern Cooperative Oncology Group (ECOG) performance status:~0=Fully active, able to carry on all pre-disease performance without restriction~1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, such as, light housework, office work"|participants|Number|145|145.0||||||
4229246|NCT00686959|4052615|B1|0||ECOG performance status|"Eastern Cooperative Oncology Group (ECOG) performance status:~0=Fully active, able to carry on all pre-disease performance without restriction~1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, such as, light housework, office work"|participants|Number|148|148.0||||||
4229247|NCT00686959|4052613|B3|Mexico||Region of Enrollment||participants|Number|2|2.0||||||
4229248|NCT00686959|4052614|B2|Mexico||Region of Enrollment||participants|Number|0|0.0||||||
4229249|NCT00686959|4052615|B1|Mexico||Region of Enrollment||participants|Number|2|2.0||||||
4229250|NCT00686959|4052613|B3|Germany||Region of Enrollment||participants|Number|37|37.0||||||
4229251|NCT00686959|4052614|B2|Germany||Region of Enrollment||participants|Number|22|22.0||||||
4229252|NCT00686959|4052615|B1|Germany||Region of Enrollment||participants|Number|15|15.0||||||
4229253|NCT00686959|4052613|B3|France||Region of Enrollment||participants|Number|22|22.0||||||
4229254|NCT00686959|4052614|B2|France||Region of Enrollment||participants|Number|9|9.0||||||
4229255|NCT00686959|4052615|B1|France||Region of Enrollment||participants|Number|13|13.0||||||
4229256|NCT00686959|4052613|B3|Australia||Region of Enrollment||participants|Number|17|17.0||||||
4229257|NCT00686959|4052614|B2|Australia||Region of Enrollment||participants|Number|10|10.0||||||
4229258|NCT00686959|4052615|B1|Australia||Region of Enrollment||participants|Number|7|7.0||||||
4229259|NCT00686959|4052613|B3|Korea, Republic of||Region of Enrollment||participants|Number|11|11.0||||||
4229260|NCT00686959|4052614|B2|Korea, Republic of||Region of Enrollment||participants|Number|5|5.0||||||
4229261|NCT00686959|4052615|B1|Korea, Republic of||Region of Enrollment||participants|Number|6|6.0||||||
4229262|NCT00686959|4052613|B3|Brazil||Region of Enrollment||participants|Number|16|16.0||||||
4229263|NCT00686959|4052614|B2|Brazil||Region of Enrollment||participants|Number|9|9.0||||||
4229264|NCT00686959|4052615|B1|Brazil||Region of Enrollment||participants|Number|7|7.0||||||
4229265|NCT00686959|4052613|B3|Taiwan||Region of Enrollment||participants|Number|25|25.0||||||
4229266|NCT00686959|4052614|B2|Taiwan||Region of Enrollment||participants|Number|14|14.0||||||
4229269|NCT00686959|4052614|B2|China||Region of Enrollment||participants|Number|34|34.0||||||
4229270|NCT00686959|4052615|B1|China||Region of Enrollment||participants|Number|27|27.0||||||
4229271|NCT00686959|4052613|B3|Ireland||Region of Enrollment||participants|Number|1|1.0||||||
4229272|NCT00686959|4052614|B2|Ireland||Region of Enrollment||participants|Number|0|0.0||||||
4229273|NCT00686959|4052615|B1|Ireland||Region of Enrollment||participants|Number|1|1.0||||||
4229274|NCT00686959|4052613|B3|Belgium||Region of Enrollment||participants|Number|44|44.0||||||
4229275|NCT00686959|4052614|B2|Belgium||Region of Enrollment||participants|Number|23|23.0||||||
4229276|NCT00686959|4052615|B1|Belgium||Region of Enrollment||participants|Number|21|21.0||||||
4229277|NCT00686959|4052613|B3|Turkey||Region of Enrollment||participants|Number|7|7.0||||||
4229278|NCT00686959|4052614|B2|Turkey||Region of Enrollment||participants|Number|4|4.0||||||
4229279|NCT00686959|4052615|B1|Turkey||Region of Enrollment||participants|Number|3|3.0||||||
4229280|NCT00686959|4052613|B3|Netherlands||Region of Enrollment||participants|Number|46|46.0||||||
4229281|NCT00686959|4052614|B2|Netherlands||Region of Enrollment||participants|Number|20|20.0||||||
4229282|NCT00686959|4052615|B1|Netherlands||Region of Enrollment||participants|Number|26|26.0||||||
4229283|NCT00686959|4052613|B3|Canada||Region of Enrollment||participants|Number|26|26.0||||||
4229284|NCT00686959|4052614|B2|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4229285|NCT00686959|4052615|B1|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4229286|NCT00686959|4052613|B3|Greece||Region of Enrollment||participants|Number|16|16.0||||||
4229287|NCT00686959|4052614|B2|Greece||Region of Enrollment||participants|Number|3|3.0||||||
4229288|NCT00686959|4052615|B1|Greece||Region of Enrollment||participants|Number|13|13.0||||||
4229289|NCT00686959|4052613|B3|India||Region of Enrollment||participants|Number|28|28.0||||||
4229290|NCT00686959|4052614|B2|India||Region of Enrollment||participants|Number|14|14.0||||||
4229291|NCT00686959|4052615|B1|India||Region of Enrollment||participants|Number|14|14.0||||||
4229292|NCT00686959|4052613|B3|Spain||Region of Enrollment||participants|Number|65|65.0||||||
4229293|NCT00686959|4052614|B2|Spain||Region of Enrollment||participants|Number|27|27.0||||||
4229294|NCT00686959|4052615|B1|Spain||Region of Enrollment||participants|Number|38|38.0||||||
4229295|NCT00686959|4052613|B3|Portugal||Region of Enrollment||participants|Number|18|18.0||||||
4229296|NCT00686959|4052614|B2|Portugal||Region of Enrollment||participants|Number|11|11.0||||||
4229297|NCT00686959|4052615|B1|Portugal||Region of Enrollment||participants|Number|7|7.0||||||
4229298|NCT00686959|4052613|B3|United Kingdom||Region of Enrollment||participants|Number|19|19.0||||||
4229299|NCT00686959|4052614|B2|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4229300|NCT00686959|4052615|B1|United Kingdom||Region of Enrollment||participants|Number|14|14.0||||||
4229301|NCT00686959|4052613|B3|United States||Region of Enrollment||participants|Number|134|134.0||||||
4229302|NCT00686959|4052614|B2|United States||Region of Enrollment||participants|Number|76|76.0||||||
4229303|NCT00686959|4052615|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
4229304|NCT00686959|4052613|B3|Argentina||Region of Enrollment||participants|Number|3|3.0||||||
4229305|NCT00686959|4052614|B2|Argentina||Region of Enrollment||participants|Number|1|1.0||||||
4229306|NCT00686959|4052615|B1|Argentina||Region of Enrollment||participants|Number|2|2.0||||||
4229307|NCT00686959|4052613|B3|Missing (unknown)||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4229308|NCT00686959|4052614|B2|Missing (unknown)||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4229309|NCT00686959|4052615|B1|Missing (unknown)||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4229310|NCT00686959|4052613|B3|West Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4229311|NCT00686959|4052614|B2|West Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4229312|NCT00686959|4052615|B1|West Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4229313|NCT00686959|4052613|B3|Native American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4229314|NCT00686959|4052614|B2|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4229315|NCT00686959|4052615|B1|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4229316|NCT00686959|4052613|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4229317|NCT00686959|4052614|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4229318|NCT00686959|4052615|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4229319|NCT00686959|4052613|B3|East Asian||Race/Ethnicity, Customized||participants|Number|122|122.0||||||
4229320|NCT00686959|4052614|B2|East Asian||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
4229321|NCT00686959|4052615|B1|East Asian||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
4229322|NCT00686959|4052613|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|421|421.0||||||
4229323|NCT00686959|4052614|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|204|204.0||||||
4229324|NCT00686959|4052615|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|217|217.0||||||
4229325|NCT00686959|4052613|B3|African||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4229326|NCT00686959|4052614|B2|African||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4229327|NCT00686959|4052615|B1|African||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4229328|NCT00686959|4052613|B3||Male|Sex: Female, Male||Participants|Count of Participants|355|355.0||||||
4229329|NCT00686959|4052614|B2||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4229330|NCT00686959|4052615|B1||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4229331|NCT00686959|4052613|B3||Female|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
4229332|NCT00686959|4052614|B2||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4229333|NCT00686959|4052615|B1||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4229334|NCT00686959|4052613|B3|||Age||years|Mean|58.8|58.8|Standard Deviation|9.5|9.5|||
4229335|NCT00686959|4052614|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|9.4|9.4|||
4229336|NCT00686959|4052615|B1|||Age||years|Mean|59.1|59.1|Standard Deviation|9.6|9.6|||
4229337|NCT00686894|4052634|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4229338|NCT00686894|4052634|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4229339|NCT00686894|4052634|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4229340|NCT00686894|4052634|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4229341|NCT00686894|4052634|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4229342|NCT00686881|4052638|B3|Japan||Region of Enrollment|Of the 261 randomized participants, 253 received study drug; 1 of these participants in the SNMC Arm had no data available after initial treatment and is excluded from study analyses.|participants|Number|252|252.0||||||
4229343|NCT00686881|4052639|B2|Japan||Region of Enrollment|Of the 261 randomized participants, 253 received study drug; 1 of these participants in the SNMC Arm had no data available after initial treatment and is excluded from study analyses.|participants|Number|127|127.0||||||
4229344|NCT00686881|4052640|B1|Japan||Region of Enrollment|Of the 261 randomized participants, 253 received study drug; 1 of these participants in the SNMC Arm had no data available after initial treatment and is excluded from study analyses.|participants|Number|125|125.0||||||
4229345|NCT00686881|4052638|B3||Male|Sex: Female, Male|Of the 261 randomized participants, 253 received study drug; 1 of these participants in the SNMC Arm had no data available after initial treatment and is excluded from study analyses.|Participants|Count of Participants|127|127.0||||||
4229346|NCT00686881|4052639|B2||Male|Sex: Female, Male|Of the 261 randomized participants, 253 received study drug; 1 of these participants in the SNMC Arm had no data available after initial treatment and is excluded from study analyses.|Participants|Count of Participants|62|62.0||||||
4229347|NCT00686881|4052640|B1||Male|Sex: Female, Male|Of the 261 randomized participants, 253 received study drug; 1 of these participants in the SNMC Arm had no data available after initial treatment and is excluded from study analyses.|Participants|Count of Participants|65|65.0||||||
4229348|NCT00686881|4052638|B3||Female|Sex: Female, Male|Of the 261 randomized participants, 253 received study drug; 1 of these participants in the SNMC Arm had no data available after initial treatment and is excluded from study analyses.|Participants|Count of Participants|125|125.0||||||
4229349|NCT00686881|4052639|B2||Female|Sex: Female, Male|Of the 261 randomized participants, 253 received study drug; 1 of these participants in the SNMC Arm had no data available after initial treatment and is excluded from study analyses.|Participants|Count of Participants|65|65.0||||||
4229350|NCT00686881|4052640|B1||Female|Sex: Female, Male|Of the 261 randomized participants, 253 received study drug; 1 of these participants in the SNMC Arm had no data available after initial treatment and is excluded from study analyses.|Participants|Count of Participants|60|60.0||||||
4229351|NCT00686881|4052638|B3|||Age|Of the 261 randomized participants, 253 received study drug; 1 of these participants in the SNMC Arm had no data available after initial treatment and is excluded from study analyses.|years|Mean|60.3|60.3|Standard Deviation|9.2|9.2|||
4229352|NCT00686881|4052639|B2|||Age|Of the 261 randomized participants, 253 received study drug; 1 of these participants in the SNMC Arm had no data available after initial treatment and is excluded from study analyses.|years|Mean|60.7|60.7|Standard Deviation|8.9|8.9|||
4229353|NCT00686881|4052640|B1|||Age|Of the 261 randomized participants, 253 received study drug; 1 of these participants in the SNMC Arm had no data available after initial treatment and is excluded from study analyses.|years|Mean|59.8|59.8|Standard Deviation|9.5|9.5|||
4229354|NCT00686855|4052651|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
4229355|NCT00686855|4052652|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4229356|NCT00686855|4052653|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4229357|NCT00686855|4052651|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4229358|NCT00686855|4052652|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4229359|NCT00686855|4052653|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4229360|NCT00686855|4052651|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4229361|NCT00686855|4052652|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4229362|NCT00686855|4052653|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4229363|NCT00686855|4052651|B3|||Age||years|Mean|54.2|54.2|Standard Deviation|13|13.0|||
4229364|NCT00686855|4052652|B2|||Age||years|Mean|54.9|54.9|Standard Deviation|15.3|15.3|||
4229365|NCT00686855|4052653|B1|||Age||years|Mean|53.8|53.8|Standard Deviation|11.5|11.5|||
4229366|NCT00686855|4052651|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4229367|NCT00686855|4052652|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4229368|NCT00686855|4052653|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4229369|NCT00686855|4052651|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4229370|NCT00686855|4052652|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4229371|NCT00686855|4052653|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4229372|NCT00686855|4052651|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4229373|NCT00686855|4052652|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4229374|NCT00686855|4052653|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4229375|NCT00686842|4052660|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4229376|NCT00686842|4052660|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4229377|NCT00686842|4052660|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4229378|NCT00686842|4052660|B1|||Age||years|Mean|44.7|44.7|Standard Deviation|6.5|6.5|||
4229379|NCT00686842|4052660|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4229380|NCT00686842|4052660|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4229381|NCT00686842|4052660|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4229382|NCT00686803|4052664|B4|United States||Region of Enrollment||participants|Number|21|21.0||||||
4229383|NCT00686803|4052665|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4229384|NCT00686803|4052666|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4229385|NCT00686803|4052667|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4229386|NCT00686803|4052664|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4229387|NCT00686803|4052665|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4229388|NCT00686803|4052666|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4229389|NCT00686803|4052667|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4229390|NCT00686803|4052664|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4229391|NCT00686803|4052665|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4229392|NCT00686803|4052666|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4229393|NCT00686803|4052667|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4229394|NCT00686803|4052664|B4|||Age||years|Mean|53.3|53.3|Standard Deviation|5.72|5.72|||
4229395|NCT00686803|4052665|B3|||Age||years|Mean|59.3|59.3|Standard Deviation|5.13|5.13|||
4229396|NCT00686803|4052666|B2|||Age||years|Mean|51.7|51.7|Standard Deviation|5.42|5.42|||
4229397|NCT00686803|4052667|B1|||Age||years|Mean|53.5|53.5|Standard Deviation|5.24|5.24|||
4229398|NCT00686803|4052664|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4229399|NCT00686803|4052665|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4229400|NCT00686803|4052666|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4229401|NCT00686803|4052667|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4229402|NCT00686803|4052664|B4||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4229403|NCT00686803|4052665|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4229404|NCT00686803|4052666|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4229405|NCT00686803|4052667|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4229406|NCT00686803|4052664|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4229407|NCT00686803|4052665|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4229408|NCT00686803|4052666|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4229409|NCT00686803|4052667|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4229410|NCT00686790|4052680|B1|Romania||Region of Enrollment||Participants|Number|48|48.0||||||
4229411|NCT00686790|4052680|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4229412|NCT00686790|4052680|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4229413|NCT00686790|4052680|B1|||Age|ITT Population|years|Mean|37.55|37.55|Standard Deviation|12.48|12.48|||
4229414|NCT00686777|4052688|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4229415|NCT00686777|4052688|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4229416|NCT00686777|4052688|B1|≥ 65 yrs||Age, Customized||participants|Number|11|11.0||||||
4229417|NCT00686777|4052688|B1|< 65 yrs||Age, Customized||participants|Number|64|64.0||||||
4229418|NCT00686777|4052688|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|9.7|9.7|||
4229419|NCT00686725|4052694|B3|China||Region of Enrollment||participants|Number|99|99.0||||||
4229420|NCT00686725|4052695|B2|China||Region of Enrollment||participants|Number|52|52.0||||||
4229421|NCT00686725|4052696|B1|China||Region of Enrollment||participants|Number|47|47.0||||||
4229422|NCT00686725|4052694|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4229423|NCT00686725|4052695|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4229424|NCT00686725|4052696|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4229425|NCT00686725|4052694|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4229426|NCT00686725|4052695|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4229427|NCT00686725|4052696|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4229428|NCT00686725|4052694|B3|||Age||years|Mean|50.2|50.2|Standard Deviation|11.82|11.82|||
4229429|NCT00686725|4052695|B2|||Age||years|Mean|48.5|48.5|Standard Deviation|13.04|13.04|||
4229430|NCT00686725|4052696|B1|||Age||years|Mean|52.1|52.1|Standard Deviation|10.12|10.12|||
4229431|NCT00686712|4052719|B4|||Body Mass Index||kg/m^2|Mean|31.6|31.6|Standard Deviation|5.4|5.4|||
4229432|NCT00686712|4052720|B3|||Body Mass Index||kg/m^2|Mean|32.1|32.1|Standard Deviation|6.0|6.0|||
4229433|NCT00686712|4052721|B2|||Body Mass Index||kg/m^2|Mean|31.1|31.1|Standard Deviation|5.2|5.2|||
4229434|NCT00686712|4052722|B1|||Body Mass Index||kg/m^2|Mean|31.6|31.6|Standard Deviation|5.0|5.0|||
4229435|NCT00686712|4052719|B4|||Diabetes Duration||Years|Mean|8.7|8.7|Standard Deviation|5.1|5.1|||
4229436|NCT00686712|4052720|B3|||Diabetes Duration||Years|Mean|7.8|7.8|Standard Deviation|4.2|4.2|||
4229437|NCT00686712|4052721|B2|||Diabetes Duration||Years|Mean|9.5|9.5|Standard Deviation|5.2|5.2|||
4229438|NCT00686712|4052722|B1|||Diabetes Duration||Years|Mean|9.0|9.0|Standard Deviation|5.9|5.9|||
4229439|NCT00686712|4052719|B4|||Hemoglobin A1c||Percent|Mean|9.3|9.3|Standard Deviation|1.4|1.4|||
4229440|NCT00686712|4052720|B3|||Hemoglobin A1c||Percent|Mean|9.3|9.3|Standard Deviation|1.6|1.6|||
4229441|NCT00686712|4052721|B2|||Hemoglobin A1c||Percent|Mean|9.6|9.6|Standard Deviation|1.2|1.2|||
4229442|NCT00686712|4052722|B1|||Hemoglobin A1c||Percent|Mean|9.2|9.2|Standard Deviation|1.3|1.3|||
4229443|NCT00686712|4052719|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4229444|NCT00686712|4052720|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4229445|NCT00686712|4052721|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4229446|NCT00686712|4052722|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4229447|NCT00686712|4052719|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
4229448|NCT00686712|4052720|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4229449|NCT00686712|4052721|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4229450|NCT00686712|4052722|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4229451|NCT00686712|4052719|B4||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4229452|NCT00686712|4052720|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4229453|NCT00686712|4052721|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4229454|NCT00686712|4052722|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4229455|NCT00686712|4052719|B4||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4229456|NCT00686712|4052720|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4229457|NCT00686712|4052721|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4229458|NCT00686712|4052722|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4229459|NCT00686712|4052719|B4|||Age||years|Mean|52.1|52.1|Standard Deviation|9.3|9.3|||
4229460|NCT00686712|4052720|B3|||Age||years|Mean|53.2|53.2|Standard Deviation|7.7|7.7|||
4229461|NCT00686712|4052721|B2|||Age||years|Mean|53.0|53.0|Standard Deviation|8.6|8.6|||
4229462|NCT00686712|4052722|B1|||Age||years|Mean|50.3|50.3|Standard Deviation|11.2|11.2|||
4229463|NCT00686699|4052750|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4229464|NCT00686699|4052751|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4229465|NCT00686699|4052752|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4229466|NCT00686699|4052750|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4229467|NCT00686699|4052751|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4229468|NCT00686699|4052752|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4229469|NCT00686699|4052750|B3|||Age||Years|Mean|41.5|41.5|Standard Deviation|12.8|12.8|||
4229470|NCT00686699|4052751|B2|||Age||Years|Mean|46.0|46.0|Standard Deviation|13.2|13.2|||
4229471|NCT00686699|4052752|B1|||Age||Years|Mean|33.8|33.8|Standard Deviation|8.5|8.5|||
4229472|NCT00686686|4052777|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4229473|NCT00686686|4052777|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4229474|NCT00686686|4052777|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|11.9|11.9|||
4229475|NCT00686647|4052785|B1|United States||Region of Enrollment||participants|Number|93|93.0||||||
4229476|NCT00686647|4052785|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4229477|NCT00686647|4052785|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4229478|NCT00686647|4052785|B1|||Age||years|Mean|61.54|61.54|Standard Deviation|11.6|11.6|||
4229479|NCT00686647|4052785|B1||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4229480|NCT00686647|4052785|B1||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4229481|NCT00686647|4052785|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4229482|NCT00686634|4052791|B1|United States||Region of Enrollment||participants|Number|108|108.0||||||
4229483|NCT00686634|4052791|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4229484|NCT00686634|4052791|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4229485|NCT00686634|4052791|B1|||Age||years|Mean|50.7|50.7|Standard Deviation|9.8|9.8|||
4229486|NCT00686634|4052791|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4229487|NCT00686634|4052791|B1||Between 18 and 65 years|Age||Participants|Count of Participants|104|104.0||||||
4229488|NCT00686634|4052791|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4229489|NCT00686595|4052798|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4229490|NCT00686595|4052798|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4229491|NCT00686595|4052798|B1|||Age||years|Mean|46.54|46.54|Standard Deviation|9.70|9.7|||
4229492|NCT00686543|4052823|B5||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4229493|NCT00686543|4052824|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4229494|NCT00686543|4052825|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4229495|NCT00686543|4052826|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4229496|NCT00686543|4052827|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4229497|NCT00686543|4052823|B5||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4229498|NCT00686543|4052824|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4229499|NCT00686543|4052825|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4229500|NCT00686543|4052826|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4229501|NCT00686543|4052827|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4229502|NCT00686543|4052823|B5||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4229503|NCT00686543|4052824|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4229504|NCT00686543|4052825|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4229505|NCT00686543|4052826|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4229506|NCT00686543|4052827|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4229507|NCT00686543|4052823|B5||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4229508|NCT00686543|4052824|B4||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4229509|NCT00686543|4052825|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4229510|NCT00686543|4052826|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4229511|NCT00686543|4052827|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4229512|NCT00686543|4052823|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4229513|NCT00686543|4052824|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4229514|NCT00686543|4052825|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4229515|NCT00686543|4052826|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4229516|NCT00686543|4052827|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4229517|NCT00686517|4052848|B4|Italy||Region of Enrollment||participants|Number|130|130.0||||||
4229518|NCT00686517|4052849|B3|Italy||Region of Enrollment||participants|Number|43|43.0||||||
4229519|NCT00686517|4052850|B2|Italy||Region of Enrollment||participants|Number|43|43.0||||||
4229520|NCT00686517|4052851|B1|Italy||Region of Enrollment||participants|Number|44|44.0||||||
4229521|NCT00686517|4052848|B4||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4229522|NCT00686517|4052849|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4229523|NCT00686517|4052850|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4229524|NCT00686517|4052851|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4229525|NCT00686517|4052848|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4229526|NCT00686517|4052849|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4229527|NCT00686517|4052850|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4229528|NCT00686517|4052851|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4229529|NCT00686517|4052848|B4|||Age||years|Mean|37.79|37.79|Standard Deviation|13.37|13.37|||
4229530|NCT00686517|4052849|B3|||Age||years|Mean|38.52|38.52|Standard Deviation|12.48|12.48|||
4229531|NCT00686517|4052850|B2|||Age||years|Mean|38.32|38.32|Standard Deviation|13.95|13.95|||
4229532|NCT00686517|4052851|B1|||Age||years|Mean|36.55|36.55|Standard Deviation|13.86|13.86|||
4229533|NCT00686374|4052876|B1||≥ 40 kg|Body weight at Study M06-806 Baseline||Participants|Count of Participants|62|62.0||||||
4229534|NCT00686374|4052876|B1||< 40 kg|Body weight at Study M06-806 Baseline||Participants|Count of Participants|38|38.0||||||
4229535|NCT00686374|4052876|B1|Multi-race||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4229536|NCT00686374|4052876|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4229537|NCT00686374|4052876|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4229538|NCT00686374|4052876|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|93|93.0||||||
4229539|NCT00686374|4052876|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4229540|NCT00686374|4052876|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4229541|NCT00686374|4052876|B1|||Age|Age at Study M06-806 Baseline|years|Mean|13.5|13.5|Standard Deviation|2.5|2.5|||
4229542|NCT00686335|4052887|B1|France||Region of Enrollment||participants|Number|12|12.0||||||
4229543|NCT00686335|4052887|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4229544|NCT00686335|4052887|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4229545|NCT00686335|4052887|B1|||Age||years|Mean|48.9|48.9|Standard Deviation|14.40|14.4|||
4229546|NCT00686335|4052887|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4229547|NCT00686335|4052887|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4229548|NCT00686335|4052887|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4229549|NCT00686257|4052893|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4229550|NCT00686257|4052894|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
4229551|NCT00686257|4052895|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4229552|NCT00686257|4052893|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4229553|NCT00686257|4052894|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4229554|NCT00686257|4052895|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4229555|NCT00686257|4052893|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4229556|NCT00686257|4052894|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4229557|NCT00686257|4052895|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4229558|NCT00686257|4052893|B3|||Age||years|Mean|62.9|62.9|Standard Deviation|9|9.0|||
4229559|NCT00686257|4052894|B2|||Age||years|Mean|62.6|62.6|Standard Deviation|17|17.0|||
4229560|NCT00686257|4052895|B1|||Age||years|Mean|63.4|63.4|Standard Deviation|15|15.0|||
4229561|NCT00686231|4052916|B4|United States||Region of Enrollment||participants|Number|57|57.0||||||
4229562|NCT00686231|4052917|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4229563|NCT00686231|4052918|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4229564|NCT00686231|4052919|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4229565|NCT00686231|4052916|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4229566|NCT00686231|4052917|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4229567|NCT00686231|4052918|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4229568|NCT00686231|4052919|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4229569|NCT00686231|4052916|B4||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4229570|NCT00686231|4052917|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4229571|NCT00686231|4052918|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4229572|NCT00686231|4052919|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4229573|NCT00686231|4052916|B4|||Age||years|Mean|29|29.0|Standard Deviation|4|4.0|||
4229574|NCT00686231|4052917|B3|||Age||years|Mean|29|29.0|Standard Deviation|4|4.0|||
4229575|NCT00686231|4052918|B2|||Age||years|Mean|29|29.0|Standard Deviation|4|4.0|||
4229576|NCT00686231|4052919|B1|||Age||years|Mean|29|29.0|Standard Deviation|4|4.0|||
4229577|NCT00686231|4052916|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4229578|NCT00686231|4052917|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4229579|NCT00686231|4052918|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4229580|NCT00686231|4052919|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4229581|NCT00686231|4052916|B4||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4229582|NCT00686231|4052917|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4229583|NCT00686231|4052918|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4229584|NCT00686231|4052919|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4229585|NCT00686231|4052916|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4229586|NCT00686231|4052917|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4229587|NCT00686231|4052918|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4229588|NCT00686231|4052919|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4229589|NCT00686205|4052929|B3|Cameroon||Region of Enrollment||participants|Number|51|51.0||||||
4229590|NCT00686205|4052930|B2|Cameroon||Region of Enrollment||participants|Number|51|51.0||||||
4229591|NCT00686205|4052931|B1|Cameroon||Region of Enrollment||participants|Number|0|0.0||||||
4229592|NCT00686205|4052929|B3|Côte D'Ivoire||Region of Enrollment||participants|Number|840|840.0||||||
4229593|NCT00686205|4052930|B2|Côte D'Ivoire||Region of Enrollment||participants|Number|840|840.0||||||
4229594|NCT00686205|4052931|B1|Côte D'Ivoire||Region of Enrollment||participants|Number|0|0.0||||||
4229595|NCT00686205|4052929|B3|United States||Region of Enrollment||participants|Number|23220|23220.0||||||
4229596|NCT00686205|4052930|B2|United States||Region of Enrollment||participants|Number|1614|1614.0||||||
4229597|NCT00686205|4052931|B1|United States||Region of Enrollment||participants|Number|21606|21606.0||||||
4229598|NCT00686205|4052929|B3|Not Collected||Sex/Gender, Customized||Participants|Number|21987|21987.0||||||
4229599|NCT00686205|4052930|B2|Not Collected||Sex/Gender, Customized||Participants|Number|381|381.0||||||
4229600|NCT00686205|4052931|B1|Not Collected||Sex/Gender, Customized||Participants|Number|21606|21606.0||||||
4229601|NCT00686205|4052929|B3|Female||Sex/Gender, Customized||Participants|Number|441|441.0||||||
4229602|NCT00686205|4052930|B2|Female||Sex/Gender, Customized||Participants|Number|441|441.0||||||
4229603|NCT00686205|4052931|B1|Female||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4229604|NCT00686205|4052929|B3|Male||Sex/Gender, Customized||Participants|Number|1683|1683.0||||||
4229605|NCT00686205|4052930|B2|Male||Sex/Gender, Customized||Participants|Number|1683|1683.0||||||
4229606|NCT00686205|4052931|B1|Male||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4229607|NCT00686205|4052929|B3|not collected||Age, Customized||Participants|Number|51|51.0||||||
4229608|NCT00686205|4052930|B2|not collected||Age, Customized||Participants|Number|51|51.0||||||
4229609|NCT00686205|4052931|B1|not collected||Age, Customized||Participants|Number|0|0.0||||||
4229610|NCT00686205|4052929|B3|>= 17 years||Age, Customized||Participants|Number|24060|24060.0||||||
4229611|NCT00686205|4052930|B2|>= 17 years||Age, Customized||Participants|Number|2454|2454.0||||||
4229612|NCT00686205|4052931|B1|>= 17 years||Age, Customized||Participants|Number|21606|21606.0||||||
4229613|NCT00686166|4052938|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4229614|NCT00686166|4052938|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229615|NCT00686166|4052938|B1||White|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4229616|NCT00686166|4052938|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4229617|NCT00686166|4052938|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229618|NCT00686166|4052938|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4229619|NCT00686166|4052938|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4229620|NCT00686166|4052938|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4229621|NCT00686166|4052938|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4229622|NCT00686166|4052938|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4229623|NCT00686166|4052938|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4229624|NCT00686166|4052938|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4229625|NCT00686166|4052938|B1|||Age||years|Median|56.4|56.4|Full Range|||25.5|77.6|
4229626|NCT00686127|4052948|B3|||Worst pain intensity|Patients scored their pain intensity in the breast and/or ipsilateral arm at enrollment using a 0 to 10 numeric rating scale, ranging from no pain (0) to worst pain imaginable (10)|units on a scale|Mean|7.1|7.1|Standard Deviation|3.3|3.3|||
4229627|NCT00686127|4052949|B2|||Worst pain intensity|Patients scored their pain intensity in the breast and/or ipsilateral arm at enrollment using a 0 to 10 numeric rating scale, ranging from no pain (0) to worst pain imaginable (10)|units on a scale|Mean|6.4|6.4|Standard Deviation|4.8|4.8|||
4229628|NCT00686127|4052950|B1|||Worst pain intensity|Patients scored their pain intensity in the breast and/or ipsilateral arm at enrollment using a 0 to 10 numeric rating scale, ranging from no pain (0) to worst pain imaginable (10)|units on a scale|Mean|7.8|7.8|Standard Deviation|1.5|1.5|||
4229629|NCT00686127|4052948|B3|||Average pain intensity|Patients scored their pain intensity in the breast and/or ipsilateral arm at enrollment using a 0 to 10 numeric rating scale, ranging from no pain (0) to worst pain imaginable (10)|units on a scale|Mean|4.8|4.8|Standard Deviation|1.9|1.9|||
4229630|NCT00686127|4052949|B2|||Average pain intensity|Patients scored their pain intensity in the breast and/or ipsilateral arm at enrollment using a 0 to 10 numeric rating scale, ranging from no pain (0) to worst pain imaginable (10)|units on a scale|Mean|4.2|4.2|Standard Deviation|1.1|1.1|||
4229631|NCT00686127|4052950|B1|||Average pain intensity|Patients scored their pain intensity in the breast and/or ipsilateral arm at enrollment using a 0 to 10 numeric rating scale, ranging from no pain (0) to worst pain imaginable (10)|units on a scale|Mean|5.3|5.3|Standard Deviation|2.3|2.3|||
4229632|NCT00686127|4052948|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4229633|NCT00686127|4052949|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4229634|NCT00686127|4052950|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4229635|NCT00686127|4052948|B3|Hispanic or Mixed Ethnic Background||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4229636|NCT00686127|4052949|B2|Hispanic or Mixed Ethnic Background||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4229637|NCT00686127|4052950|B1|Hispanic or Mixed Ethnic Background||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4229638|NCT00686127|4052948|B3|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4229639|NCT00686127|4052949|B2|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4229640|NCT00686127|4052950|B1|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4229641|NCT00686127|4052948|B3|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4229642|NCT00686127|4052949|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4229643|NCT00686127|4052950|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4229644|NCT00686127|4052948|B3|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4229645|NCT00686127|4052949|B2|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4229646|NCT00686127|4052950|B1|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4229647|NCT00686127|4052948|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4229648|NCT00686127|4052949|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4229649|NCT00686127|4052950|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4229650|NCT00686127|4052948|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4229651|NCT00686127|4052949|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4229652|NCT00686127|4052950|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4229653|NCT00686127|4052948|B3|||Age||years|Mean|49.5|49.5|Standard Deviation|11.4|11.4|||
4229654|NCT00686127|4052949|B2|||Age||years|Mean|46.1|46.1|Standard Deviation|13.5|13.5|||
4229655|NCT00686127|4052950|B1|||Age||years|Mean|51.2|51.2|Standard Deviation|10.3|10.3|||
4229656|NCT00686075|4052957|B11||Male|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
4229657|NCT00686075|4052958|B10||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4229658|NCT00686075|4052959|B9||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4229659|NCT00686075|4052960|B8||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4229660|NCT00686075|4052961|B7||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4229661|NCT00686075|4052962|B6||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4229662|NCT00686075|4052963|B5||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4229663|NCT00686075|4052964|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4229664|NCT00686075|4052965|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4229665|NCT00686075|4052966|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4229666|NCT00686075|4052967|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4229667|NCT00686075|4052957|B11||Female|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
4229668|NCT00686075|4052958|B10||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4229669|NCT00686075|4052959|B9||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4229670|NCT00686075|4052960|B8||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4229671|NCT00686075|4052961|B7||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4229672|NCT00686075|4052962|B6||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4229673|NCT00686075|4052963|B5||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4229674|NCT00686075|4052964|B4||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4229675|NCT00686075|4052965|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4229676|NCT00686075|4052966|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4229677|NCT00686075|4052967|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4229678|NCT00686075|4052957|B11|6 to <24 months||Age, Customized||participants|Number|320|320.0||||||
4229679|NCT00686075|4052958|B10|6 to <24 months||Age, Customized||participants|Number|0|0.0||||||
4229680|NCT00686075|4052959|B9|6 to <24 months||Age, Customized||participants|Number|0|0.0||||||
4229681|NCT00686075|4052960|B8|6 to <24 months||Age, Customized||participants|Number|0|0.0||||||
4229682|NCT00686075|4052961|B7|6 to <24 months||Age, Customized||participants|Number|0|0.0||||||
4229683|NCT00686075|4052962|B6|6 to <24 months||Age, Customized||participants|Number|0|0.0||||||
4229684|NCT00686075|4052963|B5|6 to <24 months||Age, Customized||participants|Number|0|0.0||||||
4229685|NCT00686075|4052964|B4|6 to <24 months||Age, Customized||participants|Number|80|80.0||||||
4229686|NCT00686075|4052965|B3|6 to <24 months||Age, Customized||participants|Number|80|80.0||||||
4229687|NCT00686075|4052966|B2|6 to <24 months||Age, Customized||participants|Number|81|81.0||||||
4229688|NCT00686075|4052967|B1|6 to <24 months||Age, Customized||participants|Number|79|79.0||||||
4229689|NCT00686075|4052957|B11|Less than (<) 6 months||Age, Customized||participants|Number|400|400.0||||||
4229690|NCT00686075|4052958|B10|Less than (<) 6 months||Age, Customized||participants|Number|79|79.0||||||
4229691|NCT00686075|4052959|B9|Less than (<) 6 months||Age, Customized||participants|Number|81|81.0||||||
4229692|NCT00686075|4052960|B8|Less than (<) 6 months||Age, Customized||participants|Number|78|78.0||||||
4229693|NCT00686075|4052961|B7|Less than (<) 6 months||Age, Customized||participants|Number|82|82.0||||||
4229694|NCT00686075|4052962|B6|Less than (<) 6 months||Age, Customized||participants|Number|40|40.0||||||
4229695|NCT00686075|4052963|B5|Less than (<) 6 months||Age, Customized||participants|Number|40|40.0||||||
4229696|NCT00686075|4052964|B4|Less than (<) 6 months||Age, Customized||participants|Number|0|0.0||||||
4229697|NCT00686075|4052965|B3|Less than (<) 6 months||Age, Customized||participants|Number|0|0.0||||||
4229698|NCT00686075|4052966|B2|Less than (<) 6 months||Age, Customized||participants|Number|0|0.0||||||
4229699|NCT00686075|4052967|B1|Less than (<) 6 months||Age, Customized||participants|Number|0|0.0||||||
4229700|NCT00686036|4053168|B3|White||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4229701|NCT00686036|4053169|B2|White||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4229702|NCT00686036|4053170|B1|White||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4229703|NCT00686036|4053168|B3|Male||Sex/Gender, Customized||Participants|Number|17|17.0||||||
4229704|NCT00686036|4053169|B2|Male||Sex/Gender, Customized||Participants|Number|8|8.0||||||
4229705|NCT00686036|4053170|B1|Male||Sex/Gender, Customized||Participants|Number|9|9.0||||||
4229706|NCT00686036|4053168|B3|||Age||Years|Mean|71.5|71.5|Standard Deviation|7.489|7.489|||
4229707|NCT00686036|4053169|B2|||Age||Years|Mean|71.5|71.5|Standard Deviation|7.709|7.709|||
4229708|NCT00686036|4053170|B1|||Age||Years|Mean|72|72.0|Standard Deviation|7.263|7.263|||
4229709|NCT00685945|4053183|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4229710|NCT00685945|4053183|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4229711|NCT00685945|4053183|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4229712|NCT00685945|4053183|B1|||Age||years|Mean|31.71|31.71|Standard Deviation|6.51|6.51|||
4229713|NCT00685945|4053183|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4229714|NCT00685945|4053183|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4229715|NCT00685945|4053183|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4229716|NCT00685932|4053198|B3|United States||Region of Enrollment||participants|Number|154|154.0||||||
4229717|NCT00685932|4053199|B2|United States||Region of Enrollment||participants|Number|78|78.0||||||
4229718|NCT00685932|4053200|B1|United States||Region of Enrollment||participants|Number|76|76.0||||||
4229719|NCT00685932|4053198|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4229720|NCT00685932|4053199|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4229721|NCT00685932|4053200|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4229722|NCT00685932|4053198|B3||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4229723|NCT00685932|4053199|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4229724|NCT00685932|4053200|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4229725|NCT00685932|4053198|B3|||Age||years|Mean|30.7|30.7|Standard Deviation|5.5|5.5|||
4229726|NCT00685932|4053199|B2|||Age||years|Mean|30.3|30.3|Standard Deviation|5.3|5.3|||
4229727|NCT00685932|4053200|B1|||Age||years|Mean|31.1|31.1|Standard Deviation|5.7|5.7|||
4229728|NCT00685932|4053198|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4229729|NCT00685932|4053199|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4229730|NCT00685932|4053200|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4229731|NCT00685932|4053198|B3||Between 18 and 65 years|Age||Participants|Count of Participants|154|154.0||||||
4229732|NCT00685932|4053199|B2||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
4229733|NCT00685932|4053200|B1||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
4229734|NCT00685932|4053198|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4229735|NCT00685932|4053199|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4229736|NCT00685932|4053200|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4229737|NCT00685880|4053209|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4229738|NCT00685880|4053210|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4229739|NCT00685880|4053209|B3|Male||Gender||participants|Number|0|0.0||||||
4229740|NCT00685880|4053210|B2|Male||Gender||participants|Number|0|0.0||||||
4229741|NCT00685880|4053209|B3|Female||Gender||participants|Number|2|2.0||||||
4229742|NCT00685880|4053210|B2|Female||Gender||participants|Number|2|2.0||||||
4229743|NCT00685880|4053209|B3|>=65 years||Age||participants|Number|2|2.0||||||
4229744|NCT00685880|4053210|B2|>=65 years||Age||participants|Number|2|2.0||||||
4229745|NCT00685880|4053209|B3|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
4229746|NCT00685880|4053210|B2|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
4229747|NCT00685880|4053209|B3|<=18 years||Age||participants|Number|0|0.0||||||
4229748|NCT00685880|4053210|B2|<=18 years||Age||participants|Number|0|0.0||||||
4229749|NCT00685802|4053218|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229750|NCT00685802|4053218|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229751|NCT00685802|4053218|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4229752|NCT00685802|4053218|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4229753|NCT00685802|4053218|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229754|NCT00685802|4053218|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4229755|NCT00685802|4053218|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229756|NCT00685802|4053218|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4229757|NCT00685802|4053218|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4229758|NCT00685802|4053218|B1|||Age||years|Mean|32.25|32.25|Standard Deviation|11.98|11.98|||
4229759|NCT00685802|4053218|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4229760|NCT00685802|4053218|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4229761|NCT00685802|4053218|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4229762|NCT00685763|4053229|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4229763|NCT00685763|4053229|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4229764|NCT00685763|4053229|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4229765|NCT00685763|4053229|B1|||Age||Years|Median|68|68.0|Full Range|||51.0|86.0|
4229766|NCT00685763|4053229|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4229767|NCT00685763|4053229|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4229768|NCT00685763|4053229|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4229769|NCT00685698|4053233|B1|||Time Since Diabetes Diagnosis|The patient population included some newly diagnosed individuals.|years|Median|6.0|6.0|Full Range|||0.0|23.0|
4229770|NCT00685698|4053233|B1|Insulin||Current treatment for Diabetes|Most patients (75.8%) received oral agent(s) for their treatment of diabetes, and nearly half the patients were on insulin.|participants|Number|16|16.0||||||
4229771|NCT00685698|4053233|B1|Oral Agent||Current treatment for Diabetes|Most patients (75.8%) received oral agent(s) for their treatment of diabetes, and nearly half the patients were on insulin.|participants|Number|25|25.0||||||
4229772|NCT00685698|4053233|B1|Diet and Exercise||Current treatment for Diabetes|Most patients (75.8%) received oral agent(s) for their treatment of diabetes, and nearly half the patients were on insulin.|participants|Number|20|20.0||||||
4229773|NCT00685698|4053233|B1|>= 12.0%||HbA1c % Result at Visit 1|Central Laboratory Data if available. Local Laboratory Data if not available. Most patients (54.5%) had a baseline HbA1c value between 7.0 and 9.0%, and 24.2% (8/33) appeared to be well controlled with values below 7.0%.|participants|Number|1|1.0||||||
4229774|NCT00685698|4053233|B1|>= 11.0% and < 12.0%||HbA1c % Result at Visit 1|Central Laboratory Data if available. Local Laboratory Data if not available. Most patients (54.5%) had a baseline HbA1c value between 7.0 and 9.0%, and 24.2% (8/33) appeared to be well controlled with values below 7.0%.|participants|Number|2|2.0||||||
4229775|NCT00685698|4053233|B1|>= 10.0% and < 11.0%||HbA1c % Result at Visit 1|Central Laboratory Data if available. Local Laboratory Data if not available. Most patients (54.5%) had a baseline HbA1c value between 7.0 and 9.0%, and 24.2% (8/33) appeared to be well controlled with values below 7.0%.|participants|Number|1|1.0||||||
4229776|NCT00685698|4053233|B1|>= 9.0% and < 10.0%||HbA1c % Result at Visit 1|Central Laboratory Data if available. Local Laboratory Data if not available. Most patients (54.5%) had a baseline HbA1c value between 7.0 and 9.0%, and 24.2% (8/33) appeared to be well controlled with values below 7.0%.|participants|Number|3|3.0||||||
4229777|NCT00685698|4053233|B1|>= 7.0% and < 9.0%||HbA1c % Result at Visit 1|Central Laboratory Data if available. Local Laboratory Data if not available. Most patients (54.5%) had a baseline HbA1c value between 7.0 and 9.0%, and 24.2% (8/33) appeared to be well controlled with values below 7.0%.|participants|Number|18|18.0||||||
4229778|NCT00685698|4053233|B1|>= 6.5% and < 7.0%||HbA1c % Result at Visit 1|Central Laboratory Data if available. Local Laboratory Data if not available. Most patients (54.5%) had a baseline HbA1c value between 7.0 and 9.0%, and 24.2% (8/33) appeared to be well controlled with values below 7.0%.|participants|Number|2|2.0||||||
4229779|NCT00685698|4053233|B1|< 6.5%||HbA1c % Result at Visit 1|Central Laboratory Data if available. Local Laboratory Data if not available. Most patients (54.5%) had a baseline HbA1c value between 7.0 and 9.0%, and 24.2% (8/33) appeared to be well controlled with values below 7.0%.|participants|Number|6|6.0||||||
4229780|NCT00685698|4053233|B1|Missing||Most Recent HbA1c % Result|Performed within 6 Months prior to Visit 1.|participants|Number|12|12.0||||||
4229781|NCT00685698|4053233|B1|>= 12.0%||Most Recent HbA1c % Result|Performed within 6 Months prior to Visit 1.|participants|Number|0|0.0||||||
4229782|NCT00685698|4053233|B1|>= 11.0% and < 12.0%||Most Recent HbA1c % Result|Performed within 6 Months prior to Visit 1.|participants|Number|1|1.0||||||
4229783|NCT00685698|4053233|B1|>= 10.0% and < 11.0%||Most Recent HbA1c % Result|Performed within 6 Months prior to Visit 1.|participants|Number|2|2.0||||||
4229784|NCT00685698|4053233|B1|>= 9.0% and < 10.0%||Most Recent HbA1c % Result|Performed within 6 Months prior to Visit 1.|participants|Number|3|3.0||||||
4229840|NCT00685659|4053282|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229785|NCT00685698|4053233|B1|>= 7.0% and < 9.0%||Most Recent HbA1c % Result|Performed within 6 Months prior to Visit 1.|participants|Number|10|10.0||||||
4229786|NCT00685698|4053233|B1|>= 6.5% and < 7.0%||Most Recent HbA1c % Result|Performed within 6 Months prior to Visit 1.|participants|Number|3|3.0||||||
4229787|NCT00685698|4053233|B1|< 6.5%||Most Recent HbA1c % Result|Performed within 6 Months prior to Visit 1.|participants|Number|2|2.0||||||
4229788|NCT00685698|4053233|B1|Missing||Distribution of Time Since Diabetes Diagnosis||participants|Number|2|2.0||||||
4229789|NCT00685698|4053233|B1|>= 40 years||Distribution of Time Since Diabetes Diagnosis||participants|Number|0|0.0||||||
4229790|NCT00685698|4053233|B1|>= 30 and < 40 years||Distribution of Time Since Diabetes Diagnosis||participants|Number|0|0.0||||||
4229791|NCT00685698|4053233|B1|>= 20 and < 30 years||Distribution of Time Since Diabetes Diagnosis||participants|Number|2|2.0||||||
4229792|NCT00685698|4053233|B1|>= 10 and < 20 years||Distribution of Time Since Diabetes Diagnosis||participants|Number|9|9.0||||||
4229793|NCT00685698|4053233|B1|>= 5 and < 10 years||Distribution of Time Since Diabetes Diagnosis||participants|Number|8|8.0||||||
4229794|NCT00685698|4053233|B1|< 5 years||Distribution of Time Since Diabetes Diagnosis||participants|Number|12|12.0||||||
4229795|NCT00685698|4053233|B1|||Time Since Diabetes Diagnosis||years|Mean|8.0|8.0|Standard Deviation|6.49|6.49|||
4229796|NCT00685698|4053233|B1|Type 2 (Adult Onset)||Type of Diabetes|Most patients (90.9%) were type 2 diabetes.|participants|Number|30|30.0||||||
4229797|NCT00685698|4053233|B1|Type 1 (Juvenile Onset)||Type of Diabetes|Most patients (90.9%) were type 2 diabetes.|participants|Number|3|3.0||||||
4229798|NCT00685698|4053233|B1|Other||Race/Ethnicity, Customized|Most patients (45.5%) were white.|participants|Number|6|6.0||||||
4229799|NCT00685698|4053233|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Most patients (45.5%) were white.|participants|Number|0|0.0||||||
4229800|NCT00685698|4053233|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Most patients (45.5%) were white.|participants|Number|0|0.0||||||
4229801|NCT00685698|4053233|B1|Asian||Race/Ethnicity, Customized|Most patients (45.5%) were white.|participants|Number|5|5.0||||||
4229802|NCT00685698|4053233|B1|Black||Race/Ethnicity, Customized|Most patients (45.5%) were white.|participants|Number|7|7.0||||||
4229803|NCT00685698|4053233|B1|White||Race/Ethnicity, Customized|Most patients (45.5%) were white.|participants|Number|15|15.0||||||
4229804|NCT00685698|4053233|B1||Male|Sex: Female, Male|Most patients (66.7%) were male.|Participants|Count of Participants|22|22.0||||||
4229805|NCT00685698|4053233|B1||Female|Sex: Female, Male|Most patients (66.7%) were male.|Participants|Count of Participants|11|11.0||||||
4229806|NCT00685698|4053233|B1|>= 80 years||Age, Customized||participants|Number|1|1.0||||||
4229807|NCT00685698|4053233|B1|>= 70 and < 80 years||Age, Customized||participants|Number|9|9.0||||||
4229808|NCT00685698|4053233|B1|>= 60 and < 70 years||Age, Customized||participants|Number|3|3.0||||||
4229809|NCT00685698|4053233|B1|>= 50 and < 60 years||Age, Customized||participants|Number|11|11.0||||||
4229810|NCT00685698|4053233|B1|>= 40 and < 50 years||Age, Customized||participants|Number|8|8.0||||||
4229811|NCT00685698|4053233|B1|>= 30 and < 40 years||Age, Customized||participants|Number|1|1.0||||||
4229812|NCT00685698|4053233|B1|>= 20 and < 30 years||Age, Customized||participants|Number|0|0.0||||||
4229813|NCT00685698|4053233|B1|< 20 years||Age, Customized||participants|Number|0|0.0||||||
4229814|NCT00685698|4053233|B1|||Age||years|Median|57.0|57.0|Full Range|||39.0|87.0|
4229815|NCT00685698|4053233|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|11.87|11.87|||
4229816|NCT00685685|4053268|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229817|NCT00685685|4053268|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229818|NCT00685685|4053268|B1||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4229819|NCT00685685|4053268|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4229820|NCT00685685|4053268|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229821|NCT00685685|4053268|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229822|NCT00685685|4053268|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229823|NCT00685685|4053268|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4229824|NCT00685685|4053268|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4229825|NCT00685685|4053268|B1|||Age||years|Mean|40.4|40.4|Standard Deviation|12.57|12.57|||
4229826|NCT00685685|4053268|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4229827|NCT00685685|4053268|B1||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4229828|NCT00685685|4053268|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4229829|NCT00685659|4053279|B4|United States||Region of Enrollment||participants|Number|321|321.0||||||
4229830|NCT00685659|4053280|B3|United States||Region of Enrollment||participants|Number|107|107.0||||||
4229831|NCT00685659|4053281|B2|United States||Region of Enrollment||participants|Number|106|106.0||||||
4229832|NCT00685659|4053282|B1|United States||Region of Enrollment||participants|Number|108|108.0||||||
4229833|NCT00685659|4053279|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4229834|NCT00685659|4053280|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4229835|NCT00685659|4053281|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4229836|NCT00685659|4053282|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4229837|NCT00685659|4053279|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229838|NCT00685659|4053280|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229839|NCT00685659|4053281|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229841|NCT00685659|4053279|B4||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4229842|NCT00685659|4053280|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4229843|NCT00685659|4053281|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4229844|NCT00685659|4053282|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4229845|NCT00685659|4053279|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|284|284.0||||||
4229846|NCT00685659|4053280|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
4229847|NCT00685659|4053281|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
4229848|NCT00685659|4053282|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
4229849|NCT00685659|4053279|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229850|NCT00685659|4053280|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229851|NCT00685659|4053281|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229852|NCT00685659|4053282|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229853|NCT00685659|4053279|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229854|NCT00685659|4053280|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229855|NCT00685659|4053281|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229856|NCT00685659|4053282|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229857|NCT00685659|4053279|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229858|NCT00685659|4053280|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229859|NCT00685659|4053281|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229860|NCT00685659|4053282|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229861|NCT00685659|4053279|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4229862|NCT00685659|4053280|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229863|NCT00685659|4053281|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229864|NCT00685659|4053282|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4229865|NCT00685659|4053279|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|308|308.0||||||
4229866|NCT00685659|4053280|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
4229867|NCT00685659|4053281|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
4229868|NCT00685659|4053282|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
4229869|NCT00685659|4053279|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4229870|NCT00685659|4053280|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4229871|NCT00685659|4053281|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4229872|NCT00685659|4053282|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4229873|NCT00685659|4053279|B4||Male|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4229874|NCT00685659|4053280|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4229875|NCT00685659|4053281|B2||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4229876|NCT00685659|4053282|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4229877|NCT00685659|4053279|B4||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4229878|NCT00685659|4053280|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4229879|NCT00685659|4053281|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4229880|NCT00685659|4053282|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4229881|NCT00685659|4053279|B4|||Age||years|Mean|43.2|43.2|Standard Deviation|7.43|7.43|||
4229882|NCT00685659|4053280|B3|||Age||years|Mean|43.4|43.4|Standard Deviation|6.48|6.48|||
4229883|NCT00685659|4053281|B2|||Age||years|Mean|43.3|43.3|Standard Deviation|7.8|7.8|||
4229884|NCT00685659|4053282|B1|||Age||years|Mean|42.9|42.9|Standard Deviation|8.0|8.0|||
4229885|NCT00685516|4053379|B4|||Serum prostate-specific antigen (PSA)||ng/mL|Mean|9.6|9.6|Standard Deviation|6|6.0|||
4229886|NCT00685516|4053380|B3|||Serum prostate-specific antigen (PSA)||ng/mL|Mean|9.2|9.2|Standard Deviation|4.3|4.3|||
4229887|NCT00685516|4053381|B2|||Serum prostate-specific antigen (PSA)||ng/mL|Mean|9.9|9.9|Standard Deviation|8.5|8.5|||
4229888|NCT00685516|4053382|B1|||Serum prostate-specific antigen (PSA)||ng/mL|Mean|9.6|9.6|Standard Deviation|5.2|5.2|||
4229889|NCT00685516|4053379|B4|greater than or equal to 8||Biopsy Gleason Score (percent)|Gleason Score: a system of grading prostate cancer tissue based on how it looks under a microscope. Gleason scores range from 2 to 10 and indicate how likely it is that a tumor will spread. A low Gleason score means the cancer tissue is similar to normal prostate tissue and the tumor is less likely to spread; a high Gleason score means the cancer tissue is very different from normal and the tumor is more likely to spread. A score of Gleason 7 (3 + 4) is considered significantly better and the cancer less likely to spread then a Gleason score of 7 (4 + 3).|participants|Number|10|10.0||||||
4229944|NCT00685516|4053382|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4229945|NCT00685516|4053379|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229946|NCT00685516|4053380|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229890|NCT00685516|4053380|B3|greater than or equal to 8||Biopsy Gleason Score (percent)|Gleason Score: a system of grading prostate cancer tissue based on how it looks under a microscope. Gleason scores range from 2 to 10 and indicate how likely it is that a tumor will spread. A low Gleason score means the cancer tissue is similar to normal prostate tissue and the tumor is less likely to spread; a high Gleason score means the cancer tissue is very different from normal and the tumor is more likely to spread. A score of Gleason 7 (3 + 4) is considered significantly better and the cancer less likely to spread then a Gleason score of 7 (4 + 3).|participants|Number|3|3.0||||||
4229891|NCT00685516|4053381|B2|greater than or equal to 8||Biopsy Gleason Score (percent)|Gleason Score: a system of grading prostate cancer tissue based on how it looks under a microscope. Gleason scores range from 2 to 10 and indicate how likely it is that a tumor will spread. A low Gleason score means the cancer tissue is similar to normal prostate tissue and the tumor is less likely to spread; a high Gleason score means the cancer tissue is very different from normal and the tumor is more likely to spread. A score of Gleason 7 (3 + 4) is considered significantly better and the cancer less likely to spread then a Gleason score of 7 (4 + 3).|participants|Number|3|3.0||||||
4229892|NCT00685516|4053382|B1|greater than or equal to 8||Biopsy Gleason Score (percent)|Gleason Score: a system of grading prostate cancer tissue based on how it looks under a microscope. Gleason scores range from 2 to 10 and indicate how likely it is that a tumor will spread. A low Gleason score means the cancer tissue is similar to normal prostate tissue and the tumor is less likely to spread; a high Gleason score means the cancer tissue is very different from normal and the tumor is more likely to spread. A score of Gleason 7 (3 + 4) is considered significantly better and the cancer less likely to spread then a Gleason score of 7 (4 + 3).|participants|Number|4|4.0||||||
4229893|NCT00685516|4053379|B4|7 (4+3)||Biopsy Gleason Score (percent)|Gleason Score: a system of grading prostate cancer tissue based on how it looks under a microscope. Gleason scores range from 2 to 10 and indicate how likely it is that a tumor will spread. A low Gleason score means the cancer tissue is similar to normal prostate tissue and the tumor is less likely to spread; a high Gleason score means the cancer tissue is very different from normal and the tumor is more likely to spread. A score of Gleason 7 (3 + 4) is considered significantly better and the cancer less likely to spread then a Gleason score of 7 (4 + 3).|participants|Number|9|9.0||||||
4229894|NCT00685516|4053380|B3|7 (4+3)||Biopsy Gleason Score (percent)|Gleason Score: a system of grading prostate cancer tissue based on how it looks under a microscope. Gleason scores range from 2 to 10 and indicate how likely it is that a tumor will spread. A low Gleason score means the cancer tissue is similar to normal prostate tissue and the tumor is less likely to spread; a high Gleason score means the cancer tissue is very different from normal and the tumor is more likely to spread. A score of Gleason 7 (3 + 4) is considered significantly better and the cancer less likely to spread then a Gleason score of 7 (4 + 3).|participants|Number|3|3.0||||||
4229895|NCT00685516|4053381|B2|7 (4+3)||Biopsy Gleason Score (percent)|Gleason Score: a system of grading prostate cancer tissue based on how it looks under a microscope. Gleason scores range from 2 to 10 and indicate how likely it is that a tumor will spread. A low Gleason score means the cancer tissue is similar to normal prostate tissue and the tumor is less likely to spread; a high Gleason score means the cancer tissue is very different from normal and the tumor is more likely to spread. A score of Gleason 7 (3 + 4) is considered significantly better and the cancer less likely to spread then a Gleason score of 7 (4 + 3).|participants|Number|3|3.0||||||
4229896|NCT00685516|4053382|B1|7 (4+3)||Biopsy Gleason Score (percent)|Gleason Score: a system of grading prostate cancer tissue based on how it looks under a microscope. Gleason scores range from 2 to 10 and indicate how likely it is that a tumor will spread. A low Gleason score means the cancer tissue is similar to normal prostate tissue and the tumor is less likely to spread; a high Gleason score means the cancer tissue is very different from normal and the tumor is more likely to spread. A score of Gleason 7 (3 + 4) is considered significantly better and the cancer less likely to spread then a Gleason score of 7 (4 + 3).|participants|Number|3|3.0||||||
4229897|NCT00685516|4053379|B4|7 (3+4)||Biopsy Gleason Score (percent)|Gleason Score: a system of grading prostate cancer tissue based on how it looks under a microscope. Gleason scores range from 2 to 10 and indicate how likely it is that a tumor will spread. A low Gleason score means the cancer tissue is similar to normal prostate tissue and the tumor is less likely to spread; a high Gleason score means the cancer tissue is very different from normal and the tumor is more likely to spread. A score of Gleason 7 (3 + 4) is considered significantly better and the cancer less likely to spread then a Gleason score of 7 (4 + 3).|participants|Number|33|33.0||||||
4229898|NCT00685516|4053380|B3|7 (3+4)||Biopsy Gleason Score (percent)|Gleason Score: a system of grading prostate cancer tissue based on how it looks under a microscope. Gleason scores range from 2 to 10 and indicate how likely it is that a tumor will spread. A low Gleason score means the cancer tissue is similar to normal prostate tissue and the tumor is less likely to spread; a high Gleason score means the cancer tissue is very different from normal and the tumor is more likely to spread. A score of Gleason 7 (3 + 4) is considered significantly better and the cancer less likely to spread then a Gleason score of 7 (4 + 3).|participants|Number|9|9.0||||||
4229899|NCT00685516|4053381|B2|7 (3+4)||Biopsy Gleason Score (percent)|Gleason Score: a system of grading prostate cancer tissue based on how it looks under a microscope. Gleason scores range from 2 to 10 and indicate how likely it is that a tumor will spread. A low Gleason score means the cancer tissue is similar to normal prostate tissue and the tumor is less likely to spread; a high Gleason score means the cancer tissue is very different from normal and the tumor is more likely to spread. A score of Gleason 7 (3 + 4) is considered significantly better and the cancer less likely to spread then a Gleason score of 7 (4 + 3).|participants|Number|15|15.0||||||
4229900|NCT00685516|4053382|B1|7 (3+4)||Biopsy Gleason Score (percent)|Gleason Score: a system of grading prostate cancer tissue based on how it looks under a microscope. Gleason scores range from 2 to 10 and indicate how likely it is that a tumor will spread. A low Gleason score means the cancer tissue is similar to normal prostate tissue and the tumor is less likely to spread; a high Gleason score means the cancer tissue is very different from normal and the tumor is more likely to spread. A score of Gleason 7 (3 + 4) is considered significantly better and the cancer less likely to spread then a Gleason score of 7 (4 + 3).|participants|Number|9|9.0||||||
4229947|NCT00685516|4053381|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229948|NCT00685516|4053382|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229901|NCT00685516|4053379|B4|6||Biopsy Gleason Score (percent)|Gleason Score: a system of grading prostate cancer tissue based on how it looks under a microscope. Gleason scores range from 2 to 10 and indicate how likely it is that a tumor will spread. A low Gleason score means the cancer tissue is similar to normal prostate tissue and the tumor is less likely to spread; a high Gleason score means the cancer tissue is very different from normal and the tumor is more likely to spread. A score of Gleason 7 (3 + 4) is considered significantly better and the cancer less likely to spread then a Gleason score of 7 (4 + 3).|participants|Number|41|41.0||||||
4229902|NCT00685516|4053380|B3|6||Biopsy Gleason Score (percent)|Gleason Score: a system of grading prostate cancer tissue based on how it looks under a microscope. Gleason scores range from 2 to 10 and indicate how likely it is that a tumor will spread. A low Gleason score means the cancer tissue is similar to normal prostate tissue and the tumor is less likely to spread; a high Gleason score means the cancer tissue is very different from normal and the tumor is more likely to spread. A score of Gleason 7 (3 + 4) is considered significantly better and the cancer less likely to spread then a Gleason score of 7 (4 + 3).|participants|Number|11|11.0||||||
4229903|NCT00685516|4053381|B2|6||Biopsy Gleason Score (percent)|Gleason Score: a system of grading prostate cancer tissue based on how it looks under a microscope. Gleason scores range from 2 to 10 and indicate how likely it is that a tumor will spread. A low Gleason score means the cancer tissue is similar to normal prostate tissue and the tumor is less likely to spread; a high Gleason score means the cancer tissue is very different from normal and the tumor is more likely to spread. A score of Gleason 7 (3 + 4) is considered significantly better and the cancer less likely to spread then a Gleason score of 7 (4 + 3).|participants|Number|12|12.0||||||
4229904|NCT00685516|4053382|B1|6||Biopsy Gleason Score (percent)|Gleason Score: a system of grading prostate cancer tissue based on how it looks under a microscope. Gleason scores range from 2 to 10 and indicate how likely it is that a tumor will spread. A low Gleason score means the cancer tissue is similar to normal prostate tissue and the tumor is less likely to spread; a high Gleason score means the cancer tissue is very different from normal and the tumor is more likely to spread. A score of Gleason 7 (3 + 4) is considered significantly better and the cancer less likely to spread then a Gleason score of 7 (4 + 3).|participants|Number|18|18.0||||||
4229905|NCT00685516|4053379|B4|||BMI (kg/m^2)||kg/m^2|Mean|27.3|27.3|Standard Deviation|4|4.0|||
4229906|NCT00685516|4053380|B3|||BMI (kg/m^2)||kg/m^2|Mean|27.4|27.4|Standard Deviation|3.6|3.6|||
4229907|NCT00685516|4053381|B2|||BMI (kg/m^2)||kg/m^2|Mean|27.4|27.4|Standard Deviation|4.9|4.9|||
4229908|NCT00685516|4053382|B1|||BMI (kg/m^2)||kg/m^2|Mean|27.2|27.2|Standard Deviation|3.8|3.8|||
4229909|NCT00685516|4053379|B4|||Height (cm)||cm|Mean|175.3|175.3|Standard Deviation|22|22.0|||
4229910|NCT00685516|4053380|B3|||Height (cm)||cm|Mean|175|175.0|Standard Deviation|22|22.0|||
4229911|NCT00685516|4053381|B2|||Height (cm)||cm|Mean|175|175.0|Standard Deviation|22|22.0|||
4229912|NCT00685516|4053382|B1|||Height (cm)||cm|Mean|176|176.0|Standard Deviation|21|21.0|||
4229913|NCT00685516|4053379|B4|||Weight (KG)||kg|Mean|87.6|87.6|Standard Deviation|14|14.0|||
4229914|NCT00685516|4053380|B3|||Weight (KG)||kg|Mean|89.9|89.9|Standard Deviation|13.4|13.4|||
4229915|NCT00685516|4053381|B2|||Weight (KG)||kg|Mean|86.6|86.6|Standard Deviation|14.3|14.3|||
4229916|NCT00685516|4053382|B1|||Weight (KG)||kg|Mean|85.7|85.7|Standard Deviation|12.2|12.2|||
4229917|NCT00685516|4053379|B4|United States||Region of Enrollment||participants|Number|93|93.0||||||
4229918|NCT00685516|4053380|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4229919|NCT00685516|4053381|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4229920|NCT00685516|4053382|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4229921|NCT00685516|4053379|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229922|NCT00685516|4053380|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229923|NCT00685516|4053381|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229924|NCT00685516|4053382|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229925|NCT00685516|4053379|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4229926|NCT00685516|4053380|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4229927|NCT00685516|4053381|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4229928|NCT00685516|4053382|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4229929|NCT00685516|4053379|B4||White|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4229930|NCT00685516|4053380|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4229931|NCT00685516|4053381|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4229932|NCT00685516|4053382|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4229933|NCT00685516|4053379|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4229934|NCT00685516|4053380|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4229935|NCT00685516|4053381|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4229936|NCT00685516|4053382|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4229937|NCT00685516|4053379|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229938|NCT00685516|4053380|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229939|NCT00685516|4053381|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229940|NCT00685516|4053382|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229941|NCT00685516|4053379|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4229942|NCT00685516|4053380|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4229943|NCT00685516|4053381|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229949|NCT00685516|4053379|B4||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4229950|NCT00685516|4053380|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4229951|NCT00685516|4053381|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4229952|NCT00685516|4053382|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4229953|NCT00685516|4053379|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4229954|NCT00685516|4053380|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4229955|NCT00685516|4053381|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4229956|NCT00685516|4053382|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4229957|NCT00685516|4053379|B4|||Age||years|Mean|61.8|61.8|Standard Deviation|6.8|6.8|||
4229958|NCT00685516|4053380|B3|||Age||years|Mean|61.4|61.4|Standard Deviation|7.4|7.4|||
4229959|NCT00685516|4053381|B2|||Age||years|Mean|61.8|61.8|Standard Deviation|6.2|6.2|||
4229960|NCT00685516|4053382|B1|||Age||years|Mean|62.1|62.1|Standard Deviation|6.9|6.9|||
4229961|NCT00685477|4053401|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4229962|NCT00685477|4053401|B1||Male|Gender||Participants|Count of Participants|28|28.0||||||
4229963|NCT00685477|4053401|B1||Female|Gender||Participants|Count of Participants|32|32.0||||||
4229964|NCT00685477|4053401|B1|||Age||years|Mean|38|38.0|Standard Deviation|12|12.0|||
4229965|NCT00685399|4053415|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4229966|NCT00685399|4053416|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4229967|NCT00685399|4053417|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4229968|NCT00685399|4053418|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4229969|NCT00685399|4053419|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4229970|NCT00685399|4053420|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4229971|NCT00685399|4053421|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4229972|NCT00685399|4053422|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4229973|NCT00685399|4053415|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229974|NCT00685399|4053416|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229975|NCT00685399|4053417|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229976|NCT00685399|4053418|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229977|NCT00685399|4053419|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229978|NCT00685399|4053420|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229979|NCT00685399|4053421|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229980|NCT00685399|4053422|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229981|NCT00685399|4053415|B8||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4229982|NCT00685399|4053416|B7||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4229983|NCT00685399|4053417|B6||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4229984|NCT00685399|4053418|B5||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4229985|NCT00685399|4053419|B4||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4229986|NCT00685399|4053420|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4229987|NCT00685399|4053421|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4229988|NCT00685399|4053422|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4229989|NCT00685399|4053415|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4229990|NCT00685399|4053416|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4229991|NCT00685399|4053417|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4229992|NCT00685399|4053418|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4229993|NCT00685399|4053419|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229994|NCT00685399|4053420|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229995|NCT00685399|4053421|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4229996|NCT00685399|4053422|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4229997|NCT00685399|4053415|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229998|NCT00685399|4053416|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4229999|NCT00685399|4053417|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230000|NCT00685399|4053418|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230001|NCT00685399|4053419|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230002|NCT00685399|4053420|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230003|NCT00685399|4053421|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230004|NCT00685399|4053422|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230005|NCT00685399|4053415|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4230006|NCT00685399|4053416|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230007|NCT00685399|4053417|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230008|NCT00685399|4053418|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230009|NCT00685399|4053419|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4230010|NCT00685399|4053420|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230011|NCT00685399|4053421|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230012|NCT00685399|4053422|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4230013|NCT00685399|4053415|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230014|NCT00685399|4053416|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230015|NCT00685399|4053417|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230016|NCT00685399|4053418|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230017|NCT00685399|4053419|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230018|NCT00685399|4053420|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230019|NCT00685399|4053421|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230020|NCT00685399|4053422|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230021|NCT00685399|4053415|B8||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4230022|NCT00685399|4053416|B7||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4230023|NCT00685399|4053417|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4230024|NCT00685399|4053418|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4230025|NCT00685399|4053419|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4230026|NCT00685399|4053420|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4230027|NCT00685399|4053421|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4230028|NCT00685399|4053422|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4230029|NCT00685399|4053415|B8||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4230030|NCT00685399|4053416|B7||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4230031|NCT00685399|4053417|B6||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4230032|NCT00685399|4053418|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4230033|NCT00685399|4053419|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4230034|NCT00685399|4053420|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4230035|NCT00685399|4053421|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4230036|NCT00685399|4053422|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4230037|NCT00685399|4053415|B8||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4230038|NCT00685399|4053416|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230039|NCT00685399|4053417|B6||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4230040|NCT00685399|4053418|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230041|NCT00685399|4053419|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230042|NCT00685399|4053420|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230043|NCT00685399|4053421|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4230044|NCT00685399|4053422|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4230045|NCT00685399|4053415|B8||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
4230046|NCT00685399|4053416|B7||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4230047|NCT00685399|4053417|B6||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4230048|NCT00685399|4053418|B5||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4230049|NCT00685399|4053419|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4230050|NCT00685399|4053420|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4230051|NCT00685399|4053421|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4230052|NCT00685399|4053422|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4230053|NCT00685399|4053415|B8||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4230054|NCT00685399|4053416|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230055|NCT00685399|4053417|B6||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4230056|NCT00685399|4053418|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230057|NCT00685399|4053419|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230058|NCT00685399|4053420|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230059|NCT00685399|4053421|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230060|NCT00685399|4053422|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230061|NCT00685373|4053462|B1|Information Missing||Disease Characteristics||participants|Number|1|1.0||||||
4230062|NCT00685373|4053462|B1|Neonatal Onset Multi-System Inflammatory Syndrome||Disease Characteristics||participants|Number|32|32.0||||||
4230063|NCT00685373|4053462|B1|Familial Cold Autoinflammatory Syndrome||Disease Characteristics||participants|Number|30|30.0||||||
4230064|NCT00685373|4053462|B1|Muckle-Wells Syndrome||Disease Characteristics||participants|Number|103|103.0||||||
4230065|NCT00685373|4053462|B1||Male|Gender||Participants|Count of Participants|69|69.0||||||
4230066|NCT00685373|4053462|B1||Female|Gender||Participants|Count of Participants|97|97.0||||||
4230067|NCT00685373|4053462|B1|>= 75 years||Age, Customized||participants|Number|2|2.0||||||
4230068|NCT00685373|4053462|B1|>= 41 to < 75 years||Age, Customized||participants|Number|52|52.0||||||
4230069|NCT00685373|4053462|B1|>= 18 to < 41 years||Age, Customized||participants|Number|65|65.0||||||
4230070|NCT00685373|4053462|B1|>= 3 to < 18 years||Age, Customized||participants|Number|47|47.0||||||
4230071|NCT00685334|4053469|B3|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4230072|NCT00685334|4053470|B2|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4230073|NCT00685334|4053471|B1|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4230074|NCT00685334|4053469|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4230075|NCT00685334|4053470|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4230076|NCT00685334|4053471|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4230077|NCT00685334|4053469|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4230078|NCT00685334|4053470|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4230079|NCT00685334|4053471|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4230080|NCT00685334|4053469|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4230081|NCT00685334|4053470|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4230082|NCT00685334|4053471|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4230083|NCT00685334|4053469|B3|||Age||years|Mean|29.1|29.1|Standard Deviation|9.3|9.3|||
4230084|NCT00685334|4053470|B2|||Age||years|Mean|30.7|30.7|Standard Deviation|11.6|11.6|||
4230085|NCT00685334|4053471|B1|||Age||years|Mean|27.7|27.7|Standard Deviation|7.2|7.2|||
4230086|NCT00685334|4053469|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230087|NCT00685334|4053470|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230088|NCT00685334|4053471|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230089|NCT00685334|4053469|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4230090|NCT00685334|4053470|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4230091|NCT00685334|4053471|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4230092|NCT00685334|4053469|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230093|NCT00685334|4053470|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230094|NCT00685334|4053471|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230095|NCT00685295|4053480|B3|United States||Region of Enrollment||participants|Number|60.0|60.0||||||
4230096|NCT00685295|4053481|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4230097|NCT00685295|4053482|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4230098|NCT00685295|4053480|B3||Male|Gender||Participants|Count of Participants|38|38.0||||||
4230099|NCT00685295|4053481|B2||Male|Gender||Participants|Count of Participants|18|18.0||||||
4230100|NCT00685295|4053482|B1||Male|Gender||Participants|Count of Participants|20|20.0||||||
4230101|NCT00685295|4053480|B3||Female|Gender||Participants|Count of Participants|22|22.0||||||
4230102|NCT00685295|4053481|B2||Female|Gender||Participants|Count of Participants|12|12.0||||||
4230103|NCT00685295|4053482|B1||Female|Gender||Participants|Count of Participants|10|10.0||||||
4230104|NCT00685295|4053480|B3|||Age||years|Mean|30|30.0|Standard Deviation|10|10.0|||
4230105|NCT00685295|4053481|B2|||Age||years|Mean|30|30.0|Standard Deviation|12|12.0|||
4230106|NCT00685295|4053482|B1|||Age||years|Mean|29|29.0|Standard Deviation|8|8.0|||
4230107|NCT00685295|4053480|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230108|NCT00685295|4053481|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230109|NCT00685295|4053482|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230110|NCT00685295|4053480|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4230111|NCT00685295|4053481|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4230112|NCT00685295|4053482|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4230113|NCT00685295|4053480|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230114|NCT00685295|4053481|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230115|NCT00685295|4053482|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230116|NCT00685178|4053493|B5|United States||Region of Enrollment||participants|Number|171|171.0||||||
4230117|NCT00685178|4053494|B4|United States||Region of Enrollment||participants|Number|47|47.0||||||
4230118|NCT00685178|4053495|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
4230119|NCT00685178|4053496|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
4230120|NCT00685178|4053497|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4230121|NCT00685178|4053493|B5||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4230122|NCT00685178|4053494|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4230123|NCT00685178|4053495|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4230124|NCT00685178|4053496|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4230125|NCT00685178|4053497|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4230126|NCT00685178|4053493|B5||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4230127|NCT00685178|4053494|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4230128|NCT00685178|4053495|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4230129|NCT00685178|4053496|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4230130|NCT00685178|4053497|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4230131|NCT00685178|4053493|B5|||Age||years|Mean|42|42.0|Standard Deviation|7|7.0|||
4230132|NCT00685178|4053494|B4|||Age||years|Mean|42|42.0|Standard Deviation|7|7.0|||
4230133|NCT00685178|4053495|B3|||Age||years|Mean|40|40.0|Standard Deviation|8|8.0|||
4230134|NCT00685178|4053496|B2|||Age||years|Mean|41|41.0|Standard Deviation|7|7.0|||
4230135|NCT00685178|4053497|B1|||Age||years|Mean|43|43.0|Standard Deviation|7|7.0|||
4230136|NCT00685178|4053493|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230137|NCT00685178|4053494|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230138|NCT00685178|4053495|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230139|NCT00685178|4053496|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230140|NCT00685178|4053497|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230141|NCT00685178|4053493|B5||Between 18 and 65 years|Age||Participants|Count of Participants|171|171.0||||||
4230142|NCT00685178|4053494|B4||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4230143|NCT00685178|4053495|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4230144|NCT00685178|4053496|B2||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4230145|NCT00685178|4053497|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4230146|NCT00685178|4053493|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230147|NCT00685178|4053494|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230148|NCT00685178|4053495|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230149|NCT00685178|4053496|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230150|NCT00685178|4053497|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230151|NCT00685165|4053514|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4230152|NCT00685165|4053514|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230153|NCT00685165|4053514|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4230154|NCT00685165|4053514|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4230155|NCT00685165|4053514|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230156|NCT00685165|4053514|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230157|NCT00685165|4053514|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230158|NCT00685165|4053514|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230159|NCT00685165|4053514|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4230160|NCT00685165|4053514|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4230161|NCT00685165|4053514|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4230162|NCT00685165|4053514|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4230163|NCT00685165|4053514|B1|||Age||years|Mean|31.76|31.76|Standard Deviation|12.10|12.1|||
4230164|NCT00685165|4053514|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230165|NCT00685165|4053514|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4230166|NCT00685165|4053514|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230167|NCT00685139|4053525|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4230168|NCT00685139|4053525|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230169|NCT00685139|4053525|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4230170|NCT00685139|4053525|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4230171|NCT00685139|4053525|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230172|NCT00685139|4053525|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4230173|NCT00685139|4053525|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230174|NCT00685139|4053525|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4230175|NCT00685139|4053525|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4230176|NCT00685139|4053525|B1|||Age||years|Mean|33.6|33.6|Standard Deviation|15|15.0|||
4230177|NCT00685139|4053525|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4230178|NCT00685139|4053525|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4230179|NCT00685139|4053525|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230180|NCT00685035|4053534|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4230181|NCT00685035|4053534|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4230182|NCT00685035|4053534|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4230183|NCT00685035|4053534|B1|||Age||years|Mean|33.3|33.3|Standard Deviation|7.3|7.3|||
4230184|NCT00685035|4053534|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230185|NCT00685035|4053534|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4230186|NCT00685035|4053534|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230187|NCT00684996|4053559|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230188|NCT00684996|4053559|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230189|NCT00684996|4053559|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4230190|NCT00684996|4053559|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230191|NCT00684996|4053559|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230192|NCT00684996|4053559|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230193|NCT00684996|4053559|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230194|NCT00684996|4053559|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4230195|NCT00684996|4053559|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4230196|NCT00684996|4053559|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230197|NCT00684996|4053559|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4230198|NCT00684996|4053559|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4230199|NCT00684996|4053559|B1|||Age||years|Median|61.5|61.5|Full Range|||45.3|80.8|
4230200|NCT00684983|4053572|B3|United States||Region of Enrollment||participants|Number|64|64.0||||||
4230201|NCT00684983|4053573|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
4230202|NCT00684983|4053574|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4230203|NCT00684983|4053572|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4230204|NCT00684983|4053573|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4230205|NCT00684983|4053574|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4230206|NCT00684983|4053572|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4230207|NCT00684983|4053573|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4230208|NCT00684983|4053574|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4230209|NCT00684983|4053572|B3|||Age||years|Mean|53.5|53.5|Full Range|||29.0|78.0|
4230210|NCT00684983|4053573|B2|||Age||years|Mean|53|53.0|Full Range|||29.0|78.0|
4230211|NCT00684983|4053574|B1|||Age||years|Mean|57|57.0|Full Range|||35.0|75.0|
4230212|NCT00684814|4053591|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4230213|NCT00684814|4053591|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230214|NCT00684814|4053591|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230215|NCT00684814|4053591|B1||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4230216|NCT00684814|4053591|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4230217|NCT00684814|4053591|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230218|NCT00684814|4053591|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230219|NCT00684814|4053591|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230220|NCT00684814|4053591|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4230221|NCT00684814|4053591|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4230222|NCT00684814|4053591|B1|||Age||years|Mean|28.92|28.92|Standard Deviation|8.64|8.64|||
4230223|NCT00684814|4053591|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230224|NCT00684814|4053591|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4230225|NCT00684814|4053591|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230226|NCT00684788|4053602|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
4230227|NCT00684788|4053603|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4230228|NCT00684788|4053604|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4230229|NCT00684788|4053602|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4230230|NCT00684788|4053603|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4230231|NCT00684788|4053604|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4230232|NCT00684788|4053602|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4230233|NCT00684788|4053603|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4230234|NCT00684788|4053604|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4230235|NCT00684788|4053602|B3|||Age||years|Mean|42|42.0|Standard Deviation|6|6.0|||
4230236|NCT00684788|4053603|B2|||Age||years|Mean|43|43.0|Standard Deviation|7|7.0|||
4230237|NCT00684788|4053604|B1|||Age||years|Mean|42|42.0|Standard Deviation|6|6.0|||
4230238|NCT00684775|4053623|B3|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4230239|NCT00684775|4053624|B2|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4230240|NCT00684775|4053625|B1|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4230241|NCT00684775|4053623|B3|Black||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4230242|NCT00684775|4053624|B2|Black||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4230243|NCT00684775|4053625|B1|Black||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4230244|NCT00684775|4053623|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4230245|NCT00684775|4053624|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4230246|NCT00684775|4053625|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4230247|NCT00684775|4053623|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4230248|NCT00684775|4053624|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4230249|NCT00684775|4053625|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4230250|NCT00684775|4053623|B3|||Age||years|Mean|44|44.0|Standard Deviation|9|9.0|||
4230251|NCT00684775|4053624|B2|||Age||years|Mean|45|45.0|Standard Deviation|8|8.0|||
4230252|NCT00684775|4053625|B1|||Age||years|Mean|42|42.0|Standard Deviation|10|10.0|||
4230253|NCT00684762|4053644|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4230254|NCT00684762|4053644|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230255|NCT00684762|4053644|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4230256|NCT00684762|4053644|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4230257|NCT00684762|4053644|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230258|NCT00684762|4053644|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4230259|NCT00684762|4053644|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230260|NCT00684762|4053644|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4230261|NCT00684762|4053644|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4230262|NCT00684762|4053644|B1|||Age||years|Mean|36.09|36.09|Standard Deviation|11.63|11.63|||
4230263|NCT00684762|4053644|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230264|NCT00684762|4053644|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4230265|NCT00684762|4053644|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230266|NCT00684749|4053655|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4230267|NCT00684749|4053655|B1||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4230268|NCT00684749|4053655|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230269|NCT00684749|4053655|B1||Between 18 and 65 years|Age||Participants|Count of Participants|142|142.0||||||
4230270|NCT00684749|4053655|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230271|NCT00684723|4053659|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230272|NCT00684723|4053659|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230273|NCT00684723|4053659|B1||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4230274|NCT00684723|4053659|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4230275|NCT00684723|4053659|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230276|NCT00684723|4053659|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4230277|NCT00684723|4053659|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4230278|NCT00684723|4053659|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4230279|NCT00684723|4053659|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4230280|NCT00684723|4053659|B1|||Age||years|Mean|42|42.0|Standard Deviation|10|10.0|||
4230281|NCT00684723|4053659|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230282|NCT00684723|4053659|B1||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4230283|NCT00684723|4053659|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230284|NCT00684671|4053670|B4||Male|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
4230285|NCT00684671|4053671|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4230286|NCT00684671|4053672|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4230287|NCT00684671|4053673|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4230288|NCT00684671|4053670|B4||Female|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
4230289|NCT00684671|4053671|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4230290|NCT00684671|4053672|B2||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4230291|NCT00684671|4053673|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4230292|NCT00684671|4053670|B4|||Age||years|Mean|59.0|59.0|Standard Deviation|9.36|9.36|||
4230293|NCT00684671|4053671|B3|||Age||years|Mean|59.1|59.1|Standard Deviation|9.16|9.16|||
4230294|NCT00684671|4053672|B2|||Age||years|Mean|59.5|59.5|Standard Deviation|10.18|10.18|||
4230295|NCT00684671|4053673|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|8.70|8.7|||
4230296|NCT00684645|4053704|B1|Hypertension absent||Prevalence of Hypertension|Hypertension was defined as blood pressure >140/90 millimeters of Mercury (mm Hg). At baseline, presence/absence of hypertension was recorded. If either the presence/absence of hypertension question or the blood pressure at Baseline indicated that the participant currently had hypertension, then the participant was considered to have hypertension at baseline. At subsequent visits, hypertension status was determined in terms of the blood pressure recorded at that visit.|participants|Number|67|67.0||||||
4230297|NCT00684645|4053704|B1|Hypertension present||Prevalence of Hypertension|Hypertension was defined as blood pressure >140/90 millimeters of Mercury (mm Hg). At baseline, presence/absence of hypertension was recorded. If either the presence/absence of hypertension question or the blood pressure at Baseline indicated that the participant currently had hypertension, then the participant was considered to have hypertension at baseline. At subsequent visits, hypertension status was determined in terms of the blood pressure recorded at that visit.|participants|Number|119|119.0||||||
4230298|NCT00684645|4053704|B1|Hypothyroidism absent||Prevalence of hypothyroidism|At baseline, participants were considered hypothyroid if the investigator indicated they had hypothyroidism (yes/no) on the case report form (CRF). At subsequent visits, thyroid-stimulating hormone (TSH) and free thyroxine (FT4) levels were measured and hypothyroidism was defined as a TSH level greater than (>)5.0 milli-International Units per liter (mIU/L) at that visit.|participants|Number|171|171.0||||||
4230299|NCT00684645|4053704|B1|Hypothyroidism present||Prevalence of hypothyroidism|At baseline, participants were considered hypothyroid if the investigator indicated they had hypothyroidism (yes/no) on the case report form (CRF). At subsequent visits, thyroid-stimulating hormone (TSH) and free thyroxine (FT4) levels were measured and hypothyroidism was defined as a TSH level greater than (>)5.0 milli-International Units per liter (mIU/L) at that visit.|participants|Number|15|15.0||||||
4230300|NCT00684645|4053704|B1|Spleen||Frequency of Involved Disease Sites|The sum of participants may not be equal to the number of participants beginning the study. A participant may be included in more than one category, or a participant may not be included in any category.|participants|Number|1|1.0||||||
4230301|NCT00684645|4053704|B1|Skin||Frequency of Involved Disease Sites|The sum of participants may not be equal to the number of participants beginning the study. A participant may be included in more than one category, or a participant may not be included in any category.|participants|Number|1|1.0||||||
4230302|NCT00684645|4053704|B1|Pleura||Frequency of Involved Disease Sites|The sum of participants may not be equal to the number of participants beginning the study. A participant may be included in more than one category, or a participant may not be included in any category.|participants|Number|1|1.0||||||
4230303|NCT00684645|4053704|B1|Peritoneum||Frequency of Involved Disease Sites|The sum of participants may not be equal to the number of participants beginning the study. A participant may be included in more than one category, or a participant may not be included in any category.|participants|Number|7|7.0||||||
4230304|NCT00684645|4053704|B1|Pelvis||Frequency of Involved Disease Sites|The sum of participants may not be equal to the number of participants beginning the study. A participant may be included in more than one category, or a participant may not be included in any category.|participants|Number|1|1.0||||||
4230305|NCT00684645|4053704|B1|Pancreas||Frequency of Involved Disease Sites|The sum of participants may not be equal to the number of participants beginning the study. A participant may be included in more than one category, or a participant may not be included in any category.|participants|Number|4|4.0||||||
4230306|NCT00684645|4053704|B1|Other||Frequency of Involved Disease Sites|The sum of participants may not be equal to the number of participants beginning the study. A participant may be included in more than one category, or a participant may not be included in any category.|participants|Number|13|13.0||||||
4230307|NCT00684645|4053704|B1|Mediastinum||Frequency of Involved Disease Sites|The sum of participants may not be equal to the number of participants beginning the study. A participant may be included in more than one category, or a participant may not be included in any category.|participants|Number|3|3.0||||||
4230308|NCT00684645|4053704|B1|Lymph node - Regional||Frequency of Involved Disease Sites|The sum of participants may not be equal to the number of participants beginning the study. A participant may be included in more than one category, or a participant may not be included in any category.|participants|Number|2|2.0||||||
4230309|NCT00684645|4053704|B1|Lymph node - Supraclavicular||Frequency of Involved Disease Sites|The sum of participants may not be equal to the number of participants beginning the study. A participant may be included in more than one category, or a participant may not be included in any category.|participants|Number|2|2.0||||||
4230310|NCT00684645|4053704|B1|Lymph node - Retroperitoneal||Frequency of Involved Disease Sites|The sum of participants may not be equal to the number of participants beginning the study. A participant may be included in more than one category, or a participant may not be included in any category.|participants|Number|12|12.0||||||
4230311|NCT00684645|4053704|B1|Lymph node - Other||Frequency of Involved Disease Sites|The sum of participants may not be equal to the number of participants beginning the study. A participant may be included in more than one category, or a participant may not be included in any category.|participants|Number|4|4.0||||||
4230312|NCT00684645|4053704|B1|Lymph node - Mediastinum||Frequency of Involved Disease Sites|The sum of participants may not be equal to the number of participants beginning the study. A participant may be included in more than one category, or a participant may not be included in any category.|participants|Number|13|13.0||||||
4230313|NCT00684645|4053704|B1|Lymph node||Frequency of Involved Disease Sites|The sum of participants may not be equal to the number of participants beginning the study. A participant may be included in more than one category, or a participant may not be included in any category.|participants|Number|7|7.0||||||
4230314|NCT00684645|4053704|B1|Lung||Frequency of Involved Disease Sites|The sum of participants may not be equal to the number of participants beginning the study. A participant may be included in more than one category, or a participant may not be included in any category.|participants|Number|88|88.0||||||
4230315|NCT00684645|4053704|B1|Liver||Frequency of Involved Disease Sites|The sum of participants may not be equal to the number of participants beginning the study. A participant may be included in more than one category, or a participant may not be included in any category.|participants|Number|20|20.0||||||
4230316|NCT00684645|4053704|B1|Kidney||Frequency of Involved Disease Sites|The sum of participants may not be equal to the number of participants beginning the study. A participant may be included in more than one category, or a participant may not be included in any category.|participants|Number|26|26.0||||||
4230317|NCT00684645|4053704|B1|Chest wall||Frequency of Involved Disease Sites|The sum of participants may not be equal to the number of participants beginning the study. A participant may be included in more than one category, or a participant may not be included in any category.|participants|Number|1|1.0||||||
4230318|NCT00684645|4053704|B1|Bone||Frequency of Involved Disease Sites|The sum of participants may not be equal to the number of participants beginning the study. A participant may be included in more than one category, or a participant may not be included in any category.|participants|Number|32|32.0||||||
4230319|NCT00684645|4053704|B1|Adrenal||Frequency of Involved Disease Sites|The sum of participants may not be equal to the number of participants beginning the study. A participant may be included in more than one category, or a participant may not be included in any category.|participants|Number|5|5.0||||||
4230320|NCT00684645|4053704|B1|ECOG Performance Status 5||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead.|percentage of participants|Number|0|0.0||||||
4230321|NCT00684645|4053704|B1|ECOG Performance Status 4||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead.|percentage of participants|Number|0|0.0||||||
4230415|NCT00684424|4053795|B1|45 - 65 years||Age, Customized||participants|Number|60|60.0||||||
4230322|NCT00684645|4053704|B1|ECOG Performance Status 3||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead.|percentage of participants|Number|0|0.0||||||
4230323|NCT00684645|4053704|B1|ECOG Performance Status 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead.|percentage of participants|Number|5|5.0||||||
4230324|NCT00684645|4053704|B1|ECOG Performance Status 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead.|percentage of participants|Number|72|72.0||||||
4230325|NCT00684645|4053704|B1|ECOG Performance Status 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead.|percentage of participants|Number|23|23.0||||||
4230326|NCT00684645|4053704|B1|Prior Cancer Surgeries||Previous Anti-Tumor Therapy|The sum of participants may not be equal to the number of participants beginning the study. A participant may be included in more than one category, or a participant may not be included in any category.|participants|Number|8|8.0||||||
4230327|NCT00684645|4053704|B1|Prior Immunotherapy||Previous Anti-Tumor Therapy|The sum of participants may not be equal to the number of participants beginning the study. A participant may be included in more than one category, or a participant may not be included in any category.|participants|Number|35|35.0||||||
4230328|NCT00684645|4053704|B1|Prior Hormonal Therapy||Previous Anti-Tumor Therapy|The sum of participants may not be equal to the number of participants beginning the study. A participant may be included in more than one category, or a participant may not be included in any category.|participants|Number|180|180.0||||||
4230329|NCT00684645|4053704|B1|Prior Chemotherapy||Previous Anti-Tumor Therapy|The sum of participants may not be equal to the number of participants beginning the study. A participant may be included in more than one category, or a participant may not be included in any category.|participants|Number|173|173.0||||||
4230330|NCT00684645|4053704|B1|Prior Radiotherapy||Previous Anti-Tumor Therapy|The sum of participants may not be equal to the number of participants beginning the study. A participant may be included in more than one category, or a participant may not be included in any category.|participants|Number|152|152.0||||||
4230331|NCT00684645|4053704|B1|Paracaval||Involvement of Regional Lymph Nodes|The sum of participants may not be equal to the number of participants beginning the study. A participant may be included in more than one category, or a participant may not be included in any category.|participants|Number|6|6.0||||||
4230332|NCT00684645|4053704|B1|Paraaortal||Involvement of Regional Lymph Nodes|The sum of participants may not be equal to the number of participants beginning the study. A participant may be included in more than one category, or a participant may not be included in any category.|participants|Number|25|25.0||||||
4230333|NCT00684645|4053704|B1|Iliac||Involvement of Regional Lymph Nodes|The sum of participants may not be equal to the number of participants beginning the study. A participant may be included in more than one category, or a participant may not be included in any category.|participants|Number|31|31.0||||||
4230334|NCT00684645|4053704|B1||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4230335|NCT00684645|4053704|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4230336|NCT00684645|4053704|B1|65 years or more||Age, Customized||participants|Number|77|77.0||||||
4230337|NCT00684645|4053704|B1|45 to 64 years||Age, Customized||participants|Number|99|99.0||||||
4230338|NCT00684645|4053704|B1|18 to 44 years||Age, Customized||participants|Number|10|10.0||||||
4230339|NCT00684593|4053722|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4230340|NCT00684593|4053723|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4230341|NCT00684593|4053724|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4230342|NCT00684593|4053722|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4230343|NCT00684593|4053723|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4230344|NCT00684593|4053724|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4230345|NCT00684593|4053722|B3|||Age||Years|Mean|47.7|47.7|Standard Deviation|11.6|11.6|||
4230346|NCT00684593|4053723|B2|||Age||Years|Mean|43.9|43.9|Standard Deviation|13.4|13.4|||
4230347|NCT00684593|4053724|B1|||Age||Years|Mean|49.5|49.5|Standard Deviation|10.5|10.5|||
4230348|NCT00684567|4053737|B1|Biopsy||Type of Surgery||Participants|Number|2|2.0||||||
4230349|NCT00684567|4053737|B1|Partial Extraction||Type of Surgery||Participants|Number|21|21.0||||||
4230350|NCT00684567|4053737|B1|Radical Extraction||Type of Surgery||Participants|Number|7|7.0||||||
4230351|NCT00684567|4053737|B1|5||Eastern Cooperative Oncology Group (ECOG) Performance Status|6-point, ordinal scale specifying patient's ability to perform activities from 0 (fully active) to 5 (dead).|Participants|Number|0|0.0||||||
4230352|NCT00684567|4053737|B1|4||Eastern Cooperative Oncology Group (ECOG) Performance Status|6-point, ordinal scale specifying patient's ability to perform activities from 0 (fully active) to 5 (dead).|Participants|Number|0|0.0||||||
4230353|NCT00684567|4053737|B1|3||Eastern Cooperative Oncology Group (ECOG) Performance Status|6-point, ordinal scale specifying patient's ability to perform activities from 0 (fully active) to 5 (dead).|Participants|Number|0|0.0||||||
4230354|NCT00684567|4053737|B1|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|6-point, ordinal scale specifying patient's ability to perform activities from 0 (fully active) to 5 (dead).|Participants|Number|5|5.0||||||
4230416|NCT00684424|4053795|B1|18 - 44 years||Age, Customized||participants|Number|104|104.0||||||
4230355|NCT00684567|4053737|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|6-point, ordinal scale specifying patient's ability to perform activities from 0 (fully active) to 5 (dead).|Participants|Number|11|11.0||||||
4230356|NCT00684567|4053737|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|6-point, ordinal scale specifying patient's ability to perform activities from 0 (fully active) to 5 (dead).|Participants|Number|14|14.0||||||
4230357|NCT00684567|4053737|B1|Gliosarcoma||Centralized Pathologic Diagnosis||Participants|Number|1|1.0||||||
4230358|NCT00684567|4053737|B1|Anaplastic Astrocytoma||Centralized Pathologic Diagnosis||Participants|Number|1|1.0||||||
4230359|NCT00684567|4053737|B1|Glioblastoma Multiforme||Centralized Pathologic Diagnosis||Participants|Number|27|27.0||||||
4230360|NCT00684567|4053737|B1|High Grade Astrocytoma||Centralized Pathologic Diagnosis||Participants|Number|1|1.0||||||
4230361|NCT00684567|4053737|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4230362|NCT00684567|4053737|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4230363|NCT00684567|4053737|B1|||Age||years|Mean|54.2|54.2|Standard Deviation|9.4|9.4|||
4230364|NCT00684554|4053745|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4230365|NCT00684554|4053746|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4230366|NCT00684554|4053747|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4230367|NCT00684554|4053745|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4230368|NCT00684554|4053746|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4230369|NCT00684554|4053747|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4230370|NCT00684554|4053745|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4230371|NCT00684554|4053746|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4230372|NCT00684554|4053747|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4230373|NCT00684554|4053745|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230374|NCT00684554|4053746|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230375|NCT00684554|4053747|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230376|NCT00684554|4053745|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4230377|NCT00684554|4053746|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4230378|NCT00684554|4053747|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4230379|NCT00684554|4053745|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230380|NCT00684554|4053746|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230381|NCT00684554|4053747|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230382|NCT00684541|4053756|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
4230383|NCT00684541|4053757|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4230384|NCT00684541|4053758|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4230385|NCT00684541|4053756|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4230386|NCT00684541|4053757|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4230387|NCT00684541|4053758|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4230388|NCT00684541|4053756|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4230389|NCT00684541|4053757|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4230390|NCT00684541|4053758|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4230391|NCT00684541|4053756|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230392|NCT00684541|4053757|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230393|NCT00684541|4053758|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230394|NCT00684541|4053756|B3||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4230395|NCT00684541|4053757|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4230396|NCT00684541|4053758|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4230397|NCT00684541|4053756|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230398|NCT00684541|4053757|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230399|NCT00684541|4053758|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230400|NCT00684515|4053767|B4||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4230401|NCT00684515|4053768|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4230402|NCT00684515|4053769|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4230403|NCT00684515|4053770|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4230404|NCT00684515|4053767|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4230405|NCT00684515|4053768|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4230406|NCT00684515|4053769|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4230407|NCT00684515|4053770|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4230408|NCT00684515|4053767|B4|||Age||Years|Mean|64.3|64.3|Standard Deviation|10.8|10.8|||
4230409|NCT00684515|4053768|B3|||Age||Years|Mean|63.7|63.7|Standard Deviation|8.9|8.9|||
4230410|NCT00684515|4053769|B2|||Age||Years|Mean|65.8|65.8|Standard Deviation|11.6|11.6|||
4230411|NCT00684515|4053770|B1|||Age||Years|Mean|63.0|63.0|Standard Deviation|10.0|10.0|||
4230412|NCT00684424|4053795|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4230413|NCT00684424|4053795|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4230414|NCT00684424|4053795|B1|>= 65 years||Age, Customized||participants|Number|33|33.0||||||
4230417|NCT00684424|4053795|B1|<=18 years||Age, Customized||participants|Number|2|2.0||||||
4230418|NCT00684411|4053810|B1|High||International Prognostic Index (IPI)|Low risk: 0 – 1 points, low-intermediate risk: 2 points, high-intermediate risk: 3 points, high risk: 4 – 5 points based on risk factors of >60 years of age; stage III or IV disease; elevated serum LDH; ECOG performance status 2, 3 or 4; and >1 extranodal site.|participants|Number|1|1.0||||||
4230419|NCT00684411|4053810|B1|High-Intermediate||International Prognostic Index (IPI)|Low risk: 0 – 1 points, low-intermediate risk: 2 points, high-intermediate risk: 3 points, high risk: 4 – 5 points based on risk factors of >60 years of age; stage III or IV disease; elevated serum LDH; ECOG performance status 2, 3 or 4; and >1 extranodal site.|participants|Number|3|3.0||||||
4230420|NCT00684411|4053810|B1|Low-Intermediate||International Prognostic Index (IPI)|Low risk: 0 – 1 points, low-intermediate risk: 2 points, high-intermediate risk: 3 points, high risk: 4 – 5 points based on risk factors of >60 years of age; stage III or IV disease; elevated serum LDH; ECOG performance status 2, 3 or 4; and >1 extranodal site.|participants|Number|5|5.0||||||
4230421|NCT00684411|4053810|B1|Low||International Prognostic Index (IPI)|Low risk: 0 – 1 points, low-intermediate risk: 2 points, high-intermediate risk: 3 points, high risk: 4 – 5 points based on risk factors of >60 years of age; stage III or IV disease; elevated serum LDH; ECOG performance status 2, 3 or 4; and >1 extranodal site.|participants|Number|3|3.0||||||
4230422|NCT00684411|4053810|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4230423|NCT00684411|4053810|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
4230424|NCT00684411|4053810|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
4230425|NCT00684411|4053810|B1|||Age||years|Median|70.7|70.7|Full Range|||40.0|82.0|
4230426|NCT00684320|4053816|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
4230427|NCT00684320|4053817|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4230428|NCT00684320|4053818|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4230429|NCT00684320|4053816|B3|unreported||Sex/Gender, Customized||participants|Number|2|2.0||||||
4230430|NCT00684320|4053817|B2|unreported||Sex/Gender, Customized||participants|Number|0|0.0||||||
4230431|NCT00684320|4053818|B1|unreported||Sex/Gender, Customized||participants|Number|2|2.0||||||
4230432|NCT00684320|4053816|B3|female||Sex/Gender, Customized||participants|Number|27|27.0||||||
4230433|NCT00684320|4053817|B2|female||Sex/Gender, Customized||participants|Number|14|14.0||||||
4230434|NCT00684320|4053818|B1|female||Sex/Gender, Customized||participants|Number|13|13.0||||||
4230435|NCT00684320|4053816|B3|male||Sex/Gender, Customized||participants|Number|19|19.0||||||
4230436|NCT00684320|4053817|B2|male||Sex/Gender, Customized||participants|Number|8|8.0||||||
4230437|NCT00684320|4053818|B1|male||Sex/Gender, Customized||participants|Number|11|11.0||||||
4230438|NCT00684320|4053816|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230439|NCT00684320|4053817|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230440|NCT00684320|4053818|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230441|NCT00684320|4053816|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4230442|NCT00684320|4053817|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4230443|NCT00684320|4053818|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4230444|NCT00684320|4053816|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230445|NCT00684320|4053817|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230446|NCT00684320|4053818|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230447|NCT00684307|4053827|B6||Male|Sex: Female, Male||Participants|Count of Participants|650|650.0||||||
4230448|NCT00684307|4053828|B5||Male|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
4230449|NCT00684307|4053829|B4||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4230450|NCT00684307|4053830|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4230451|NCT00684307|4053831|B2||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4230452|NCT00684307|4053832|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4230453|NCT00684307|4053827|B6||Female|Sex: Female, Male||Participants|Count of Participants|299|299.0||||||
4230454|NCT00684307|4053828|B5||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4230455|NCT00684307|4053829|B4||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4230456|NCT00684307|4053830|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4230457|NCT00684307|4053831|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4230458|NCT00684307|4053832|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4230459|NCT00684307|4053827|B6|||Age||Years|Mean|9.18|9.18|Standard Deviation|69.02|69.02|||
4230460|NCT00684307|4053828|B5|||Age||Years|Mean|9.1|9.1|Standard Deviation|68.3|68.3|||
4230461|NCT00684307|4053829|B4|||Age||Years|Mean|9.4|9.4|Standard Deviation|67.8|67.8|||
4230462|NCT00684307|4053830|B3|||Age||Years|Mean|9.4|9.4|Standard Deviation|69.3|69.3|||
4230463|NCT00684307|4053831|B2|||Age||Years|Mean|9.0|9.0|Standard Deviation|69.8|69.8|||
4230464|NCT00684307|4053832|B1|||Age||Years|Mean|9.0|9.0|Standard Deviation|69.9|69.9|||
4230465|NCT00684255|4053903|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4230466|NCT00684255|4053903|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4230467|NCT00684255|4053903|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4230468|NCT00684255|4053903|B1||>=65 years|Age|Subjects 7-17yrs will be enrolled|Participants|Count of Participants|0|0.0||||||
4230469|NCT00684255|4053903|B1||Between 18 and 65 years|Age|Subjects 7-17yrs will be enrolled|Participants|Count of Participants|0|0.0||||||
4230470|NCT00684255|4053903|B1||<=18 years|Age|Subjects 7-17yrs will be enrolled|Participants|Count of Participants|1|1.0||||||
4230471|NCT00684242|4053908|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4230472|NCT00684242|4053908|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4230473|NCT00684242|4053908|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4230474|NCT00684242|4053908|B1|||Age||years|Median|64|64.0|Full Range|||44.0|72.0|
4230475|NCT00684203|4053912|B7||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4230476|NCT00684203|4053913|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4230477|NCT00684203|4053914|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4230478|NCT00684203|4053915|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4230479|NCT00684203|4053916|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4230480|NCT00684203|4053917|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4230481|NCT00684203|4053918|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4230482|NCT00684203|4053912|B7||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4230483|NCT00684203|4053913|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4230484|NCT00684203|4053914|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4230485|NCT00684203|4053915|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4230486|NCT00684203|4053916|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4230487|NCT00684203|4053917|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4230488|NCT00684203|4053918|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4230489|NCT00684203|4053912|B7|||Age||Years|Mean|64.2|64.2|Standard Deviation|10.3|10.3|||
4230490|NCT00684203|4053913|B6|||Age||Years|Mean|66.5|66.5|Standard Deviation|3.5|3.5|||
4230491|NCT00684203|4053914|B5|||Age||Years|Mean|64.1|64.1|Standard Deviation|13.6|13.6|||
4230492|NCT00684203|4053915|B4|||Age||Years|Mean|59.0|59.0|Standard Deviation|14.3|14.3|||
4230493|NCT00684203|4053916|B3|||Age||Years|Mean|65.0|65.0|Standard Deviation|10.8|10.8|||
4230494|NCT00684203|4053917|B2|||Age||Years|Mean|64.5|64.5|Standard Deviation|9.0|9.0|||
4230495|NCT00684203|4053918|B1|||Age||Years|Mean|64.3|64.3|Standard Deviation|9.2|9.2|||
4230496|NCT00684177|4053982|B3|Mixed Race||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4230497|NCT00684177|4053983|B2|Mixed Race||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4230498|NCT00684177|4053984|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4230499|NCT00684177|4053982|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|193|193.0||||||
4230500|NCT00684177|4053983|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
4230501|NCT00684177|4053984|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|132|132.0||||||
4230502|NCT00684177|4053982|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4230503|NCT00684177|4053983|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4230504|NCT00684177|4053984|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4230505|NCT00684177|4053982|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4230506|NCT00684177|4053983|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4230507|NCT00684177|4053984|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4230508|NCT00684177|4053982|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
4230509|NCT00684177|4053983|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4230510|NCT00684177|4053984|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4230511|NCT00684177|4053982|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4230512|NCT00684177|4053983|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4230513|NCT00684177|4053984|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4230514|NCT00684177|4053982|B3|Asian - Central / South Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4230515|NCT00684177|4053983|B2|Asian - Central / South Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4230516|NCT00684177|4053984|B1|Asian - Central / South Asian Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4230517|NCT00684177|4053982|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4230518|NCT00684177|4053983|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4230519|NCT00684177|4053984|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4230520|NCT00684177|4053982|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|215|215.0||||||
4230521|NCT00684177|4053983|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|71|71.0||||||
4230522|NCT00684177|4053984|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|144|144.0||||||
4230523|NCT00684177|4053982|B3||Male|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
4230524|NCT00684177|4053983|B2||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4230525|NCT00684177|4053984|B1||Male|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4230526|NCT00684177|4053982|B3||Female|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4230527|NCT00684177|4053983|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4230528|NCT00684177|4053984|B1||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4230529|NCT00684177|4053982|B3|||Age||years|Mean|31.3|31.3|Standard Deviation|18.70|18.7|||
4230530|NCT00684177|4053983|B2|||Age||years|Mean|28.6|28.6|Standard Deviation|18.32|18.32|||
4230531|NCT00684177|4053984|B1|||Age||years|Mean|32.6|32.6|Standard Deviation|18.77|18.77|||
4230532|NCT00684138|4054001|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4230533|NCT00684138|4054002|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4230534|NCT00684138|4054003|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4230535|NCT00684138|4054001|B3||Female|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4230536|NCT00684138|4054002|B2||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4230537|NCT00684138|4054003|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4230538|NCT00684138|4054001|B3||>=65 years|Age||Participants|Count of Participants|189|189.0||||||
4230539|NCT00684138|4054002|B2||>=65 years|Age||Participants|Count of Participants|99|99.0||||||
4230540|NCT00684138|4054003|B1||>=65 years|Age||Participants|Count of Participants|90|90.0||||||
4230541|NCT00684138|4054001|B3||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
4230542|NCT00684138|4054002|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4230543|NCT00684138|4054003|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4230544|NCT00684138|4054001|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230545|NCT00684138|4054002|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230546|NCT00684138|4054003|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230547|NCT00684073|4054020|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4230548|NCT00684073|4054020|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4230549|NCT00684073|4054020|B1|||Age||years|Mean|38.9|38.9|Standard Deviation|8.6|8.6|||
4230550|NCT00684060|4054028|B3|United States||Region of Enrollment||participants|Number|87|87.0||||||
4230551|NCT00684060|4054029|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4230552|NCT00684060|4054030|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
4230553|NCT00684060|4054028|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4230554|NCT00684060|4054029|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4230555|NCT00684060|4054030|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4230556|NCT00684060|4054028|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4230557|NCT00684060|4054029|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4230558|NCT00684060|4054030|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4230559|NCT00684060|4054028|B3|||Age||years|Mean|57|57.0|Standard Deviation|11|11.0|||
4230560|NCT00684060|4054029|B2|||Age||years|Mean|54.6|54.6|Standard Deviation|11|11.0|||
4230561|NCT00684060|4054030|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|11|11.0|||
4230562|NCT00684047|4054051|B4||Male|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4230563|NCT00684047|4054052|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4230564|NCT00684047|4054053|B2||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4230565|NCT00684047|4054054|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4230566|NCT00684047|4054051|B4||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4230567|NCT00684047|4054052|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4230568|NCT00684047|4054053|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4230569|NCT00684047|4054054|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4230570|NCT00684047|4054051|B4|||Age||years|Mean|68.0|68.0|Standard Deviation|9.23|9.23|||
4230571|NCT00684047|4054052|B3|||Age||years|Mean|67.0|67.0|Standard Deviation|10.28|10.28|||
4230572|NCT00684047|4054053|B2|||Age||years|Mean|68.4|68.4|Standard Deviation|8.90|8.9|||
4230573|NCT00684047|4054054|B1|||Age||years|Mean|68.2|68.2|Standard Deviation|8.91|8.91|||
4230574|NCT00684021|4054066|B5|United States||Region of Enrollment||participants|Number|120|120.0||||||
4230575|NCT00684021|4054067|B4|United States||Region of Enrollment||participants|Number|17|17.0||||||
4230576|NCT00684021|4054068|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4230577|NCT00684021|4054069|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4230578|NCT00684021|4054070|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4230579|NCT00684021|4054066|B5||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4230580|NCT00684021|4054067|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4230581|NCT00684021|4054068|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4230582|NCT00684021|4054069|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4230583|NCT00684021|4054070|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4230584|NCT00684021|4054066|B5||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4230585|NCT00684021|4054067|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4230586|NCT00684021|4054068|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4230587|NCT00684021|4054069|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4230588|NCT00684021|4054070|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4230589|NCT00684021|4054066|B5|||Age||years|Mean|56.9|56.9|Standard Deviation|10.9|10.9|||
4230590|NCT00684021|4054067|B4|||Age||years|Mean|57.0|57.0|Standard Deviation|8.0|8.0|||
4230591|NCT00684021|4054068|B3|||Age||years|Mean|58.2|58.2|Standard Deviation|11.3|11.3|||
4230592|NCT00684021|4054069|B2|||Age||years|Mean|57.0|57.0|Standard Deviation|12.4|12.4|||
4230593|NCT00684021|4054070|B1|||Age||years|Mean|55.6|55.6|Standard Deviation|10.8|10.8|||
4230594|NCT00683930|4054111|B4||Male|Sex: Female, Male|Intent-to-treat population|Participants|Count of Participants|38|38.0||||||
4230595|NCT00683930|4054112|B3||Male|Sex: Female, Male|Intent-to-treat population|Participants|Count of Participants|19|19.0||||||
4230596|NCT00683930|4054113|B2||Male|Sex: Female, Male|Intent-to-treat population|Participants|Count of Participants|7|7.0||||||
4230597|NCT00683930|4054114|B1||Male|Sex: Female, Male|Intent-to-treat population|Participants|Count of Participants|12|12.0||||||
4230598|NCT00683930|4054111|B4||Female|Sex: Female, Male|Intent-to-treat population|Participants|Count of Participants|56|56.0||||||
4230599|NCT00683930|4054112|B3||Female|Sex: Female, Male|Intent-to-treat population|Participants|Count of Participants|18|18.0||||||
4230600|NCT00683930|4054113|B2||Female|Sex: Female, Male|Intent-to-treat population|Participants|Count of Participants|14|14.0||||||
4230601|NCT00683930|4054114|B1||Female|Sex: Female, Male|Intent-to-treat population|Participants|Count of Participants|24|24.0||||||
4230602|NCT00683930|4054111|B4|||Age|Intent-to-treat population|years|Mean|44.33|44.33|Standard Deviation|13.45|13.45|||
4230603|NCT00683930|4054112|B3|||Age|Intent-to-treat population|years|Mean|44.8|44.8|Standard Deviation|13.47|13.47|||
4230604|NCT00683930|4054113|B2|||Age|Intent-to-treat population|years|Mean|41.0|41.0|Standard Deviation|15.59|15.59|||
4230605|NCT00683930|4054114|B1|||Age|Intent-to-treat population|years|Mean|45.8|45.8|Standard Deviation|12.18|12.18|||
4230606|NCT00683904|4054142|B3|Japanese||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4230607|NCT00683904|4054143|B2|Japanese||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4230608|NCT00683904|4054144|B1|Japanese||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4230609|NCT00683904|4054142|B3|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4230610|NCT00683904|4054143|B2|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4230611|NCT00683904|4054144|B1|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4230612|NCT00683904|4054142|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4230613|NCT00683904|4054143|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4230614|NCT00683904|4054144|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4230615|NCT00683904|4054142|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4230616|NCT00683904|4054143|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4230617|NCT00683904|4054144|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4230618|NCT00683904|4054142|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4230619|NCT00683904|4054143|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4230620|NCT00683904|4054144|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4230621|NCT00683904|4054142|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4230622|NCT00683904|4054143|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4230623|NCT00683904|4054144|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4230624|NCT00683904|4054142|B3|||Age||years|Mean|54.4|54.4|Standard Deviation|9.62|9.62|||
4230625|NCT00683904|4054143|B2|||Age||years|Mean|57.7|57.7|Standard Deviation|10.5|10.5|||
4230626|NCT00683904|4054144|B1|||Age||years|Mean|51.2|51.2|Standard Deviation|8.30|8.3|||
4230627|NCT00683904|4054142|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4230628|NCT00683904|4054143|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4230629|NCT00683904|4054144|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230630|NCT00683904|4054142|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4230631|NCT00683904|4054143|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4230632|NCT00683904|4054144|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4230633|NCT00683904|4054142|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230634|NCT00683904|4054143|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230635|NCT00683904|4054144|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230636|NCT00683878|4054178|B4|Other||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4230637|NCT00683878|4054179|B3|Other||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4230638|NCT00683878|4054180|B2|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4230639|NCT00683878|4054181|B1|Other||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4230640|NCT00683878|4054178|B4|White||Race/Ethnicity, Customized||Participants|Number|305|305.0||||||
4230641|NCT00683878|4054179|B3|White||Race/Ethnicity, Customized||Participants|Number|101|101.0||||||
4230642|NCT00683878|4054180|B2|White||Race/Ethnicity, Customized||Participants|Number|102|102.0||||||
4230643|NCT00683878|4054181|B1|White||Race/Ethnicity, Customized||Participants|Number|102|102.0||||||
4230644|NCT00683878|4054178|B4|Black/African American||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4230645|NCT00683878|4054179|B3|Black/African American||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4230646|NCT00683878|4054180|B2|Black/African American||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4230647|NCT00683878|4054181|B1|Black/African American||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4230648|NCT00683878|4054178|B4|Asian||Race/Ethnicity, Customized||Participants|Number|71|71.0||||||
4230649|NCT00683878|4054179|B3|Asian||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
4230650|NCT00683878|4054180|B2|Asian||Race/Ethnicity, Customized||Participants|Number|26|26.0||||||
4230651|NCT00683878|4054181|B1|Asian||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
4230652|NCT00683878|4054178|B4||Male|Gender||Participants|Count of Participants|208|208.0||||||
4230653|NCT00683878|4054179|B3||Male|Gender||Participants|Count of Participants|59|59.0||||||
4230654|NCT00683878|4054180|B2||Male|Gender||Participants|Count of Participants|78|78.0||||||
4230655|NCT00683878|4054181|B1||Male|Gender||Participants|Count of Participants|71|71.0||||||
4230656|NCT00683878|4054178|B4||Female|Gender||Participants|Count of Participants|212|212.0||||||
4230657|NCT00683878|4054179|B3||Female|Gender||Participants|Count of Participants|81|81.0||||||
4230658|NCT00683878|4054180|B2||Female|Gender||Participants|Count of Participants|63|63.0||||||
4230659|NCT00683878|4054181|B1||Female|Gender||Participants|Count of Participants|68|68.0||||||
4230660|NCT00683878|4054178|B4|75 years and older||Age, Customized||Participants|Number|10|10.0||||||
4230661|NCT00683878|4054179|B3|75 years and older||Age, Customized||Participants|Number|2|2.0||||||
4230662|NCT00683878|4054180|B2|75 years and older||Age, Customized||Participants|Number|5|5.0||||||
4230663|NCT00683878|4054181|B1|75 years and older||Age, Customized||Participants|Number|3|3.0||||||
4230664|NCT00683878|4054178|B4|65 to younger than 75 years||Age, Customized||Participants|Number|57|57.0||||||
4230665|NCT00683878|4054179|B3|65 to younger than 75 years||Age, Customized||Participants|Number|20|20.0||||||
4230666|NCT00683878|4054180|B2|65 to younger than 75 years||Age, Customized||Participants|Number|16|16.0||||||
4230667|NCT00683878|4054181|B1|65 to younger than 75 years||Age, Customized||Participants|Number|21|21.0||||||
4230668|NCT00683878|4054178|B4|Yonger than 65 years||Age, Customized||Participants|Number|353|353.0||||||
4230669|NCT00683878|4054179|B3|Yonger than 65 years||Age, Customized||Participants|Number|118|118.0||||||
4230670|NCT00683878|4054180|B2|Yonger than 65 years||Age, Customized||Participants|Number|120|120.0||||||
4230671|NCT00683878|4054181|B1|Yonger than 65 years||Age, Customized||Participants|Number|115|115.0||||||
4230672|NCT00683878|4054178|B4|||Age||Years|Mean|53.5|53.5|Standard Deviation|10.86|10.86|||
4230673|NCT00683878|4054179|B3|||Age||Years|Mean|53.8|53.8|Standard Deviation|10.35|10.35|||
4230674|NCT00683878|4054180|B2|||Age||Years|Mean|53.2|53.2|Standard Deviation|10.90|10.9|||
4230675|NCT00683878|4054181|B1|||Age||Years|Mean|53.5|53.5|Standard Deviation|11.38|11.38|||
4230676|NCT00683852|4054209|B3|United States||Region of Enrollment||participants|Number|225|225.0||||||
4230677|NCT00683852|4054210|B2|United States||Region of Enrollment||participants|Number|169|169.0||||||
4230678|NCT00683852|4054211|B1|United States||Region of Enrollment||participants|Number|56|56.0||||||
4230679|NCT00683852|4054209|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4230680|NCT00683852|4054210|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4230681|NCT00683852|4054211|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4230682|NCT00683852|4054209|B3||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4230683|NCT00683852|4054210|B2||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4230684|NCT00683852|4054211|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4230685|NCT00683852|4054209|B3|||Age||years|Mean|45.16|45.16|Standard Deviation|10.85|10.85|||
4230686|NCT00683852|4054210|B2|||Age||years|Mean|45.06|45.06|Standard Deviation|11.34|11.34|||
4230687|NCT00683852|4054211|B1|||Age||years|Mean|45.36|45.36|Standard Deviation|10.35|10.35|||
4230688|NCT00683852|4054209|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230689|NCT00683852|4054210|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230690|NCT00683852|4054211|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230691|NCT00683852|4054209|B3||Between 18 and 65 years|Age||Participants|Count of Participants|225|225.0||||||
4230692|NCT00683852|4054210|B2||Between 18 and 65 years|Age||Participants|Count of Participants|169|169.0||||||
4230693|NCT00683852|4054211|B1||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4230694|NCT00683852|4054209|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230695|NCT00683852|4054210|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230696|NCT00683852|4054211|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230697|NCT00683826|4054244|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
4230698|NCT00683826|4054245|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4230699|NCT00683826|4054246|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4230700|NCT00683826|4054247|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4230701|NCT00683826|4054244|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4230702|NCT00683826|4054245|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4230703|NCT00683826|4054246|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4230704|NCT00683826|4054247|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4230705|NCT00683826|4054244|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4230706|NCT00683826|4054245|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4230707|NCT00683826|4054246|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4230708|NCT00683826|4054247|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4230709|NCT00683826|4054244|B4|||Age||years|Mean|40|40.0|Standard Deviation|7|7.0|||
4230710|NCT00683826|4054245|B3|||Age||years|Mean|45|45.0|Standard Deviation|7|7.0|||
4230711|NCT00683826|4054246|B2|||Age||years|Mean|40|40.0|Standard Deviation|7|7.0|||
4230712|NCT00683826|4054247|B1|||Age||years|Mean|35|35.0|Standard Deviation|7|7.0|||
4230713|NCT00683826|4054244|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230714|NCT00683826|4054245|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230715|NCT00683826|4054246|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230716|NCT00683826|4054247|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230717|NCT00683826|4054244|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4230718|NCT00683826|4054245|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4230719|NCT00683826|4054246|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4230720|NCT00683826|4054247|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4230721|NCT00683826|4054244|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230722|NCT00683826|4054245|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230723|NCT00683826|4054246|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230724|NCT00683826|4054247|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230725|NCT00683800|4054255|B3|||Daily severity score of hot flushes|Severity: mild (sensation of heat without sweating); moderate (sensation of heat with sweating; able to continue activity) to severe (sensation of heat with sweating; causing cessation of activity). Average daily severity of hot flushes for each time period was calculated as (1*Number of mild+2*Number of moderate+3*Number of severe)/(Total number of hot flushes). For days with no hot flushes, severity score was set as 0. As this was derived from count data, there was no maximum; minimum score was 0; the higher values showed worse outcomes. n=184 (DVS SR 100 mg group); n=181 (placebo group).|Units on a scale|Mean|2.37|2.37|Standard Deviation|0.34|0.34|||
4230726|NCT00683800|4054256|B2|||Daily severity score of hot flushes|Severity: mild (sensation of heat without sweating); moderate (sensation of heat with sweating; able to continue activity) to severe (sensation of heat with sweating; causing cessation of activity). Average daily severity of hot flushes for each time period was calculated as (1*Number of mild+2*Number of moderate+3*Number of severe)/(Total number of hot flushes). For days with no hot flushes, severity score was set as 0. As this was derived from count data, there was no maximum; minimum score was 0; the higher values showed worse outcomes. n=184 (DVS SR 100 mg group); n=181 (placebo group).|Units on a scale|Mean|2.39|2.39|Standard Deviation|0.35|0.35|||
4230727|NCT00683800|4054257|B1|||Daily severity score of hot flushes|Severity: mild (sensation of heat without sweating); moderate (sensation of heat with sweating; able to continue activity) to severe (sensation of heat with sweating; causing cessation of activity). Average daily severity of hot flushes for each time period was calculated as (1*Number of mild+2*Number of moderate+3*Number of severe)/(Total number of hot flushes). For days with no hot flushes, severity score was set as 0. As this was derived from count data, there was no maximum; minimum score was 0; the higher values showed worse outcomes. n=184 (DVS SR 100 mg group); n=181 (placebo group).|Units on a scale|Mean|2.36|2.36|Standard Deviation|0.34|0.34|||
4230728|NCT00683800|4054255|B3|||Daily number of moderate and severe hot flushes|Average daily number of moderate and severe hot flushes was calculated as the sum of number of moderate and severe hot flushes on each day divided by number of days with data. Moderate: sensation of heat with sweating; able to continue activity; and severe: sensation of heat with sweating; causing cessation of activity. Participants analysed were 184 and 181 for DVS SR 100 mg group and placebo group, respectively.|Hot Flushes|Mean|11.79|11.79|Standard Deviation|5.66|5.66|||
4230729|NCT00683800|4054256|B2|||Daily number of moderate and severe hot flushes|Average daily number of moderate and severe hot flushes was calculated as the sum of number of moderate and severe hot flushes on each day divided by number of days with data. Moderate: sensation of heat with sweating; able to continue activity; and severe: sensation of heat with sweating; causing cessation of activity. Participants analysed were 184 and 181 for DVS SR 100 mg group and placebo group, respectively.|Hot Flushes|Mean|11.91|11.91|Standard Deviation|5.71|5.71|||
4230730|NCT00683800|4054257|B1|||Daily number of moderate and severe hot flushes|Average daily number of moderate and severe hot flushes was calculated as the sum of number of moderate and severe hot flushes on each day divided by number of days with data. Moderate: sensation of heat with sweating; able to continue activity; and severe: sensation of heat with sweating; causing cessation of activity. Participants analysed were 184 and 181 for DVS SR 100 mg group and placebo group, respectively.|Hot Flushes|Mean|11.67|11.67|Standard Deviation|5.62|5.62|||
4230731|NCT00683800|4054255|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4230732|NCT00683800|4054256|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4230733|NCT00683800|4054257|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4230734|NCT00683800|4054255|B3||Female|Sex: Female, Male||Participants|Count of Participants|2118|2118.0||||||
4230735|NCT00683800|4054256|B2||Female|Sex: Female, Male||Participants|Count of Participants|1052|1052.0||||||
4230736|NCT00683800|4054257|B1||Female|Sex: Female, Male||Participants|Count of Participants|1066|1066.0||||||
4230737|NCT00683800|4054255|B3|||Age||Years|Mean|53.77|53.77|Standard Deviation|4.90|4.9|||
4230738|NCT00683800|4054256|B2|||Age||Years|Mean|53.59|53.59|Standard Deviation|4.91|4.91|||
4230739|NCT00683800|4054257|B1|||Age||Years|Mean|53.95|53.95|Standard Deviation|4.90|4.9|||
4230740|NCT00683787|4054322|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4230741|NCT00683787|4054323|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4230742|NCT00683787|4054324|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4230743|NCT00683787|4054325|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4230744|NCT00683787|4054322|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4230745|NCT00683787|4054323|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4230746|NCT00683787|4054324|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4230747|NCT00683787|4054325|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4230748|NCT00683787|4054322|B4|||Age||years|Mean|61.38|61.38|Standard Deviation|7.37|7.37|||
4230749|NCT00683787|4054323|B3|||Age||years|Mean|60|60.0|Standard Deviation|8.49|8.49|||
4230750|NCT00683787|4054324|B2|||Age||years|Mean|67|67.0|Standard Deviation|3.61|3.61|||
4230751|NCT00683787|4054325|B1|||Age||years|Mean|56.67|56.67|Standard Deviation|7.64|7.64|||
4230752|NCT00683774|4054344|B3|||uCI MYO (ml/min)||ml/min|Mean|2.17|2.17|Full Range|||1.3|3.49|
4230753|NCT00683774|4054345|B2|||uCI MYO (ml/min)||ml/min|Mean|2.43|2.43|Full Range|||1.69|3.49|
4230754|NCT00683774|4054346|B1|||uCI MYO (ml/min)||ml/min|Mean|1.91|1.91|Full Range|||1.3|2.81|
4230755|NCT00683774|4054344|B3|||24-h urinary MYO (nmol/day)||nmol/day|Mean|65888|65888.0|Full Range|||32681.0|124184.0|
4230756|NCT00683774|4054345|B2|||24-h urinary MYO (nmol/day)||nmol/day|Mean|78909|78909.0|Full Range|||50140.0|124184.0|
4230757|NCT00683774|4054346|B1|||24-h urinary MYO (nmol/day)||nmol/day|Mean|52866|52866.0|Full Range|||32681.0|85519.0|
4230758|NCT00683774|4054344|B3|||Plasma myo-Inositol (MYO) (nmol/mL)||nmol/mL|Mean|21.4|21.4|Full Range|||15.9|27.3|
4230759|NCT00683774|4054345|B2|||Plasma myo-Inositol (MYO) (nmol/mL)||nmol/mL|Mean|23.1|23.1|Full Range|||18.9|27.3|
4230760|NCT00683774|4054346|B1|||Plasma myo-Inositol (MYO) (nmol/mL)||nmol/mL|Mean|19.7|19.7|Full Range|||15.9|23.4|
4230761|NCT00683774|4054344|B3|||Urinary clearance (uCl) DCI (ml/min)||ml/min|Mean|3.24|3.24|Full Range|||1.38|7.92|
4230762|NCT00683774|4054345|B2|||Urinary clearance (uCl) DCI (ml/min)||ml/min|Mean|3.02|3.02|Full Range|||1.38|6.59|
4230763|NCT00683774|4054346|B1|||Urinary clearance (uCl) DCI (ml/min)||ml/min|Mean|3.46|3.46|Full Range|||1.51|7.92|
4230764|NCT00683774|4054344|B3|||24-h urinary D-chiroinositol (DCI) (nmol/day)||nmol/day|Mean|1628|1628.0|Full Range|||771.0|3527.0|
4230765|NCT00683774|4054345|B2|||24-h urinary D-chiroinositol (DCI) (nmol/day)||nmol/day|Mean|1448|1448.0|Full Range|||771.0|2719.0|
4230766|NCT00683774|4054346|B1|||24-h urinary D-chiroinositol (DCI) (nmol/day)||nmol/day|Mean|1808|1808.0|Full Range|||927.0|3527.0|
4230767|NCT00683774|4054344|B3|||Plasma DCI (nmol/mL)||nmol/mL|Mean|0.35|0.35|Full Range|||0.18|0.72|
4230768|NCT00683774|4054345|B2|||Plasma DCI (nmol/mL)||nmol/mL|Mean|0.33|0.33|Full Range|||0.18|0.63|
4230769|NCT00683774|4054346|B1|||Plasma DCI (nmol/mL)||nmol/mL|Mean|0.36|0.36|Full Range|||0.18|0.72|
4230770|NCT00683774|4054344|B3|||Whole Body Insulin Sensitivity Index||units on a scale|Mean|5.83|5.83|Full Range|||2.4|8.93|
4230771|NCT00683774|4054345|B2|||Whole Body Insulin Sensitivity Index||units on a scale|Mean|6.90|6.9|Full Range|||4.87|8.93|
4230772|NCT00683774|4054346|B1|||Whole Body Insulin Sensitivity Index||units on a scale|Mean|4.76|4.76|Full Range|||2.4|7.11|
4230773|NCT00683774|4054344|B3|||AUC insulin (mg*min/ml)||mg*min/ml|Mean|6818|6818.0|Full Range|||3127.0|14568.0|
4230774|NCT00683774|4054345|B2|||AUC insulin (mg*min/ml)||mg*min/ml|Mean|5284|5284.0|Full Range|||3127.0|8929.0|
4230775|NCT00683774|4054346|B1|||AUC insulin (mg*min/ml)||mg*min/ml|Mean|8351|8351.0|Full Range|||4788.0|14568.0|
4230776|NCT00683774|4054344|B3|||Area under the curve (AUC) glucose (mg*min/dL)||mg*min/dL|Mean|14808|14808.0|Full Range|||12209.0|17504.0|
4230777|NCT00683774|4054345|B2|||Area under the curve (AUC) glucose (mg*min/dL)||mg*min/dL|Mean|13168|13168.0|Full Range|||12209.0|14127.0|
4230778|NCT00683774|4054346|B1|||Area under the curve (AUC) glucose (mg*min/dL)||mg*min/dL|Mean|16447|16447.0|Full Range|||15390.0|17504.0|
4230779|NCT00683774|4054344|B3|||Fasting insulin (ulU/mL)||ulU/mL|Mean|8.1|8.1|Full Range|||5.0|13.1|
4230780|NCT00683774|4054345|B2|||Fasting insulin (ulU/mL)||ulU/mL|Mean|6.8|6.8|Full Range|||5.0|9.4|
4230781|NCT00683774|4054346|B1|||Fasting insulin (ulU/mL)||ulU/mL|Mean|9.4|9.4|Full Range|||6.7|13.1|
4230782|NCT00683774|4054344|B3|||Fasting glucose (mg/dl)||mg/dl|Mean|84.8|84.8|Full Range|||77.9|90.5|
4230783|NCT00683774|4054345|B2|||Fasting glucose (mg/dl)||mg/dl|Mean|84.2|84.2|Full Range|||77.9|90.5|
4230784|NCT00683774|4054346|B1|||Fasting glucose (mg/dl)||mg/dl|Mean|85.3|85.3|Full Range|||80.7|89.9|
4230785|NCT00683774|4054344|B3|||Free testosterone (pmol/L)||pmol/L|Mean|101|101.0|Full Range|||30.4|285.1|
4230786|NCT00683774|4054345|B2|||Free testosterone (pmol/L)||pmol/L|Mean|57.7|57.7|Full Range|||30.4|109.6|
4230787|NCT00683774|4054346|B1|||Free testosterone (pmol/L)||pmol/L|Mean|144.3|144.3|Full Range|||73.1|285.1|
4230788|NCT00683774|4054344|B3|||Total testosterone (ng/mL)||ng/mL|Mean|1.7|1.7|Full Range|||0.6|3.8|
4230789|NCT00683774|4054345|B2|||Total testosterone (ng/mL)||ng/mL|Mean|1.1|1.1|Full Range|||0.6|1.8|
4230790|NCT00683774|4054346|B1|||Total testosterone (ng/mL)||ng/mL|Mean|2.2|2.2|Full Range|||1.2|3.8|
4230791|NCT00683774|4054344|B3|||Sex hormone binding globulin (SHBG) (nmol/L)||nmol/L|Mean|38.9|38.9|Full Range|||23.3|61.7|
4230792|NCT00683774|4054345|B2|||Sex hormone binding globulin (SHBG) (nmol/L)||nmol/L|Mean|45.6|45.6|Full Range|||33.7|61.7|
4230793|NCT00683774|4054346|B1|||Sex hormone binding globulin (SHBG) (nmol/L)||nmol/L|Mean|32.1|32.1|Full Range|||23.3|44.2|
4230794|NCT00683774|4054344|B3|||Waist-to-hip ratio (WHR)||unitless|Mean|0.81|0.81|Full Range|||0.72|0.88|
4230795|NCT00683774|4054345|B2|||Waist-to-hip ratio (WHR)||unitless|Mean|0.78|0.78|Full Range|||0.72|0.84|
4230796|NCT00683774|4054346|B1|||Waist-to-hip ratio (WHR)||unitless|Mean|0.84|0.84|Full Range|||0.81|0.88|
4230797|NCT00683774|4054344|B3|||BMI (Body Mass Index)||kg/m^2|Mean|39.7|39.7|Full Range|||32.7|49.2|
4230798|NCT00683774|4054345|B2|||BMI (Body Mass Index)||kg/m^2|Mean|38.4|38.4|Full Range|||33.3|43.4|
4230799|NCT00683774|4054346|B1|||BMI (Body Mass Index)||kg/m^2|Mean|41.0|41.0|Full Range|||32.7|49.2|
4230800|NCT00683774|4054344|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4230801|NCT00683774|4054345|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4230802|NCT00683774|4054346|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4230803|NCT00683774|4054344|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4230804|NCT00683774|4054345|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4230805|NCT00683774|4054346|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4230806|NCT00683774|4054344|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4230807|NCT00683774|4054345|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4230808|NCT00683774|4054346|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4230809|NCT00683774|4054344|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230810|NCT00683774|4054345|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230811|NCT00683774|4054346|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4230812|NCT00683774|4054344|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4230813|NCT00683774|4054345|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4230814|NCT00683774|4054346|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4230815|NCT00683774|4054344|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230816|NCT00683774|4054345|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230817|NCT00683774|4054346|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4230818|NCT00683696|4054355|B3|Netherlands||Region of Enrollment||participants|Number|20|20.0||||||
4230819|NCT00683696|4054356|B2|Netherlands||Region of Enrollment||participants|Number|10|10.0||||||
4230820|NCT00683696|4054357|B1|Netherlands||Region of Enrollment||participants|Number|10|10.0||||||
4230821|NCT00683696|4054355|B3|Germany||Region of Enrollment||participants|Number|82|82.0||||||
4230822|NCT00683696|4054356|B2|Germany||Region of Enrollment||participants|Number|41|41.0||||||
4230823|NCT00683696|4054357|B1|Germany||Region of Enrollment||participants|Number|41|41.0||||||
4230824|NCT00683696|4054355|B3|Denmark||Region of Enrollment||participants|Number|47|47.0||||||
4230825|NCT00683696|4054356|B2|Denmark||Region of Enrollment||participants|Number|23|23.0||||||
4230826|NCT00683696|4054357|B1|Denmark||Region of Enrollment||participants|Number|24|24.0||||||
4230827|NCT00683696|4054355|B3|Australia||Region of Enrollment||participants|Number|23|23.0||||||
4230828|NCT00683696|4054356|B2|Australia||Region of Enrollment||participants|Number|11|11.0||||||
4230829|NCT00683696|4054357|B1|Australia||Region of Enrollment||participants|Number|12|12.0||||||
4230830|NCT00683696|4054355|B3|Belgium||Region of Enrollment||participants|Number|12|12.0||||||
4230831|NCT00683696|4054356|B2|Belgium||Region of Enrollment||participants|Number|6|6.0||||||
4230832|NCT00683696|4054357|B1|Belgium||Region of Enrollment||participants|Number|6|6.0||||||
4230833|NCT00683696|4054355|B3|Poland||Region of Enrollment||participants|Number|2|2.0||||||
4230834|NCT00683696|4054356|B2|Poland||Region of Enrollment||participants|Number|2|2.0||||||
4230835|NCT00683696|4054357|B1|Poland||Region of Enrollment||participants|Number|0|0.0||||||
4230836|NCT00683696|4054355|B3|Canada||Region of Enrollment||participants|Number|27|27.0||||||
4230837|NCT00683696|4054356|B2|Canada||Region of Enrollment||participants|Number|14|14.0||||||
4230838|NCT00683696|4054357|B1|Canada||Region of Enrollment||participants|Number|13|13.0||||||
4230839|NCT00683696|4054355|B3|Czech Republic||Region of Enrollment||participants|Number|23|23.0||||||
4230840|NCT00683696|4054356|B2|Czech Republic||Region of Enrollment||participants|Number|11|11.0||||||
4230841|NCT00683696|4054357|B1|Czech Republic||Region of Enrollment||participants|Number|12|12.0||||||
4230842|NCT00683696|4054355|B3|France||Region of Enrollment||participants|Number|21|21.0||||||
4230843|NCT00683696|4054356|B2|France||Region of Enrollment||participants|Number|11|11.0||||||
4230844|NCT00683696|4054357|B1|France||Region of Enrollment||participants|Number|10|10.0||||||
4230845|NCT00683696|4054355|B3|Italy||Region of Enrollment||participants|Number|8|8.0||||||
4230846|NCT00683696|4054356|B2|Italy||Region of Enrollment||participants|Number|4|4.0||||||
4230847|NCT00683696|4054357|B1|Italy||Region of Enrollment||participants|Number|4|4.0||||||
4230848|NCT00683696|4054355|B3|Switzerland||Region of Enrollment||participants|Number|22|22.0||||||
4230849|NCT00683696|4054356|B2|Switzerland||Region of Enrollment||participants|Number|11|11.0||||||
4230850|NCT00683696|4054357|B1|Switzerland||Region of Enrollment||participants|Number|11|11.0||||||
4230851|NCT00683696|4054355|B3|United Kingdom||Region of Enrollment||participants|Number|37|37.0||||||
4230852|NCT00683696|4054356|B2|United Kingdom||Region of Enrollment||participants|Number|18|18.0||||||
4230853|NCT00683696|4054357|B1|United Kingdom||Region of Enrollment||participants|Number|19|19.0||||||
4230854|NCT00683696|4054355|B3|Israel||Region of Enrollment||participants|Number|34|34.0||||||
4230855|NCT00683696|4054356|B2|Israel||Region of Enrollment||participants|Number|16|16.0||||||
4230856|NCT00683696|4054357|B1|Israel||Region of Enrollment||participants|Number|18|18.0||||||
4230857|NCT00683696|4054355|B3|Austria||Region of Enrollment||participants|Number|14|14.0||||||
4230858|NCT00683696|4054356|B2|Austria||Region of Enrollment||participants|Number|8|8.0||||||
4230859|NCT00683696|4054357|B1|Austria||Region of Enrollment||participants|Number|6|6.0||||||
4230860|NCT00683696|4054355|B3|Spain||Region of Enrollment||participants|Number|36|36.0||||||
4230861|NCT00683696|4054356|B2|Spain||Region of Enrollment||participants|Number|18|18.0||||||
4230862|NCT00683696|4054357|B1|Spain||Region of Enrollment||participants|Number|18|18.0||||||
4230863|NCT00683696|4054355|B3|United States||Region of Enrollment||participants|Number|394|394.0||||||
4230864|NCT00683696|4054356|B2|United States||Region of Enrollment||participants|Number|198|198.0||||||
4230865|NCT00683696|4054357|B1|United States||Region of Enrollment||participants|Number|196|196.0||||||
4230866|NCT00683696|4054355|B3|Portugal||Region of Enrollment||participants|Number|7|7.0||||||
4230867|NCT00683696|4054356|B2|Portugal||Region of Enrollment||participants|Number|3|3.0||||||
4230868|NCT00683696|4054357|B1|Portugal||Region of Enrollment||participants|Number|4|4.0||||||
4230869|NCT00683696|4054355|B3||Male|Sex: Female, Male||Participants|Count of Participants|585|585.0||||||
4230870|NCT00683696|4054356|B2||Male|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
4230871|NCT00683696|4054357|B1||Male|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
4230872|NCT00683696|4054355|B3||Female|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
4230873|NCT00683696|4054356|B2||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4230874|NCT00683696|4054357|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4230875|NCT00683696|4054355|B3|||Age||years|Mean|58.0|58.0|Standard Deviation|12.7|12.7|||
4230876|NCT00683696|4054356|B2|||Age||years|Mean|58.3|58.3|Standard Deviation|12.6|12.6|||
4230877|NCT00683696|4054357|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|12.9|12.9|||
4230878|NCT00683657|4054375|B3|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4230879|NCT00683657|4054376|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4230880|NCT00683657|4054377|B1|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4230881|NCT00683657|4054375|B3|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4230882|NCT00683657|4054376|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4230883|NCT00683657|4054377|B1|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4230884|NCT00683657|4054375|B3|Black/African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4230885|NCT00683657|4054376|B2|Black/African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4230886|NCT00683657|4054377|B1|Black/African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4230887|NCT00683657|4054375|B3|White||Race/Ethnicity, Customized||Participants|Number|82|82.0||||||
4230888|NCT00683657|4054376|B2|White||Race/Ethnicity, Customized||Participants|Number|43|43.0||||||
4230889|NCT00683657|4054377|B1|White||Race/Ethnicity, Customized||Participants|Number|39|39.0||||||
4230890|NCT00683657|4054375|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4230891|NCT00683657|4054376|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4230892|NCT00683657|4054377|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4230893|NCT00683657|4054375|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4230894|NCT00683657|4054376|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4230895|NCT00683657|4054377|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4230896|NCT00683657|4054375|B3|>= 75 years||Age, Customized||participants|Number|1|1.0||||||
4230897|NCT00683657|4054376|B2|>= 75 years||Age, Customized||participants|Number|1|1.0||||||
4230898|NCT00683657|4054377|B1|>= 75 years||Age, Customized||participants|Number|0|0.0||||||
4230899|NCT00683657|4054375|B3|>= 65 years to <75 years||Age, Customized||participants|Number|14|14.0||||||
4230900|NCT00683657|4054376|B2|>= 65 years to <75 years||Age, Customized||participants|Number|8|8.0||||||
4230901|NCT00683657|4054377|B1|>= 65 years to <75 years||Age, Customized||participants|Number|6|6.0||||||
4230902|NCT00683657|4054375|B3|<65 years||Age, Customized||participants|Number|78|78.0||||||
4230903|NCT00683657|4054376|B2|<65 years||Age, Customized||participants|Number|38|38.0||||||
4230904|NCT00683657|4054377|B1|<65 years||Age, Customized||participants|Number|40|40.0||||||
4230905|NCT00683657|4054375|B3|||Age||years|Mean|55.14|55.14|Standard Deviation|9.14|9.14|||
4230906|NCT00683657|4054376|B2|||Age||years|Mean|55.77|55.77|Standard Deviation|9.14|9.14|||
4230907|NCT00683657|4054377|B1|||Age||years|Mean|54.50|54.5|Standard Deviation|9.20|9.2|||
4230908|NCT00683644|4054392|B3|||Tinnitus Loudness Rating Scale|Tinnitus loudness rate on a scale of 0 (no perception of tinnitus) to 100 (highest degree of tinnitus perception)|units on a scale|Mean|67.3|67.3|Standard Deviation|15.6|15.6|||
4230909|NCT00683644|4054393|B2|||Tinnitus Loudness Rating Scale|Tinnitus loudness rate on a scale of 0 (no perception of tinnitus) to 100 (highest degree of tinnitus perception)|units on a scale|Mean|67.5|67.5|Standard Deviation|15.1|15.1|||
4230910|NCT00683644|4054394|B1|||Tinnitus Loudness Rating Scale|Tinnitus loudness rate on a scale of 0 (no perception of tinnitus) to 100 (highest degree of tinnitus perception)|units on a scale|Mean|66.7|66.7|Standard Deviation|16.2|16.2|||
4230911|NCT00683644|4054392|B3|||Tinnitus Annoyance Rating Scale|Tinnitus annoyance rate on a scale of 0 (no annoyance) to 100 (maximum degree of annoyance)|units on a scale|Mean|63|63.0|Standard Deviation|23.1|23.1|||
4230912|NCT00683644|4054393|B2|||Tinnitus Annoyance Rating Scale|Tinnitus annoyance rate on a scale of 0 (no annoyance) to 100 (maximum degree of annoyance)|units on a scale|Mean|65.8|65.8|Standard Deviation|23|23.0|||
4230913|NCT00683644|4054394|B1|||Tinnitus Annoyance Rating Scale|Tinnitus annoyance rate on a scale of 0 (no annoyance) to 100 (maximum degree of annoyance)|units on a scale|Mean|60|60.0|Standard Deviation|22.7|22.7|||
4230914|NCT00683644|4054392|B3|||Tinnitus Handicap Questionaire||units on a scale|Mean|27.9|27.9|Standard Deviation|19.8|19.8|||
4230915|NCT00683644|4054393|B2|||Tinnitus Handicap Questionaire||units on a scale|Mean|27.4|27.4|Standard Deviation|19.2|19.2|||
4230916|NCT00683644|4054394|B1|||Tinnitus Handicap Questionaire||units on a scale|Mean|28.4|28.4|Standard Deviation|20.3|20.3|||
4230917|NCT00683644|4054392|B3|United States||Region of Enrollment||participants|Number|109|109.0||||||
4230918|NCT00683644|4054393|B2|United States||Region of Enrollment||participants|Number|58|58.0||||||
4230919|NCT00683644|4054394|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
4230920|NCT00683644|4054392|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4230921|NCT00683644|4054393|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4230922|NCT00683644|4054394|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4230923|NCT00683644|4054392|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4230924|NCT00683644|4054393|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4230925|NCT00683644|4054394|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4230926|NCT00683644|4054392|B3|||Age||years|Mean|67.8|67.8|Standard Deviation|5.6|5.6|||
4230927|NCT00683644|4054393|B2|||Age||years|Mean|67.8|67.8|Standard Deviation|5.8|5.8|||
4230928|NCT00683644|4054394|B1|||Age||years|Mean|67.5|67.5|Standard Deviation|5.5|5.5|||
4230929|NCT00683618|4054405|B4|||triglyceride (TG) level||mmol/L|Mean|1.991|1.991|Standard Deviation|0.8494|0.8494|||
4230930|NCT00683618|4054406|B3|||triglyceride (TG) level||mmol/L|Mean|2.061|2.061|Standard Deviation|0.8971|0.8971|||
4230931|NCT00683618|4054407|B2|||triglyceride (TG) level||mmol/L|Mean|2.042|2.042|Standard Deviation|0.9164|0.9164|||
4230932|NCT00683618|4054408|B1|||triglyceride (TG) level||mmol/L|Mean|1.921|1.921|Standard Deviation|0.7825|0.7825|||
4230933|NCT00683618|4054405|B4|||Low density lipoprotein cholesterol (LDL-C level)||mmol/L|Mean|4.186|4.186|Standard Deviation|0.6717|0.6717|||
4230934|NCT00683618|4054406|B3|||Low density lipoprotein cholesterol (LDL-C level)||mmol/L|Mean|4.213|4.213|Standard Deviation|0.6617|0.6617|||
4230935|NCT00683618|4054407|B2|||Low density lipoprotein cholesterol (LDL-C level)||mmol/L|Mean|4.131|4.131|Standard Deviation|0.6818|0.6818|||
4230936|NCT00683618|4054408|B1|||Low density lipoprotein cholesterol (LDL-C level)||mmol/L|Mean|4.242|4.242|Standard Deviation|0.6769|0.6769|||
4230937|NCT00683618|4054405|B4|Nativ Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4230938|NCT00683618|4054406|B3|Nativ Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4230939|NCT00683618|4054407|B2|Nativ Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4230940|NCT00683618|4054408|B1|Nativ Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4230941|NCT00683618|4054405|B4|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4230942|NCT00683618|4054406|B3|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4230943|NCT00683618|4054407|B2|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4230944|NCT00683618|4054408|B1|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4230945|NCT00683618|4054405|B4|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4230946|NCT00683618|4054406|B3|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4230947|NCT00683618|4054407|B2|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4230948|NCT00683618|4054408|B1|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4230949|NCT00683618|4054405|B4|White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4230950|NCT00683618|4054406|B3|White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4230951|NCT00683618|4054407|B2|White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4230952|NCT00683618|4054408|B1|White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4230953|NCT00683618|4054405|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4230954|NCT00683618|4054406|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4230955|NCT00683618|4054407|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4230956|NCT00683618|4054408|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4230957|NCT00683618|4054405|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4230958|NCT00683618|4054406|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4230959|NCT00683618|4054407|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4230960|NCT00683618|4054408|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4230961|NCT00683618|4054405|B4|Asian||Race/Ethnicity, Customized||Participants|Number|414|414.0||||||
4230962|NCT00683618|4054406|B3|Asian||Race/Ethnicity, Customized||Participants|Number|139|139.0||||||
4230963|NCT00683618|4054407|B2|Asian||Race/Ethnicity, Customized||Participants|Number|139|139.0||||||
4230964|NCT00683618|4054408|B1|Asian||Race/Ethnicity, Customized||Participants|Number|136|136.0||||||
4230965|NCT00683618|4054405|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4230966|NCT00683618|4054406|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4230967|NCT00683618|4054407|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4230968|NCT00683618|4054408|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4230969|NCT00683618|4054405|B4||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4230970|NCT00683618|4054406|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4230971|NCT00683618|4054407|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4230972|NCT00683618|4054408|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4230973|NCT00683618|4054405|B4||Female|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
4230974|NCT00683618|4054406|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4230975|NCT00683618|4054407|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4230976|NCT00683618|4054408|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4230977|NCT00683618|4054405|B4|||Age||Years|Mean|59.5|59.5|Standard Deviation|9.51|9.51|||
4230978|NCT00683618|4054406|B3|||Age||Years|Mean|58.4|58.4|Standard Deviation|9.29|9.29|||
4230979|NCT00683618|4054407|B2|||Age||Years|Mean|59.7|59.7|Standard Deviation|10.57|10.57|||
4230980|NCT00683618|4054408|B1|||Age||Years|Mean|60.4|60.4|Standard Deviation|8.51|8.51|||
4230981|NCT00683592|4054458|B3|United States||Region of Enrollment||participants|Number|463|463.0||||||
4230982|NCT00683592|4054459|B2|United States||Region of Enrollment||participants|Number|232|232.0||||||
4230983|NCT00683592|4054460|B1|United States||Region of Enrollment||participants|Number|231|231.0||||||
4230984|NCT00683592|4054458|B3||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4230985|NCT00683592|4054459|B2||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4230986|NCT00683592|4054460|B1||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4230987|NCT00683592|4054458|B3||Female|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
4230988|NCT00683592|4054459|B2||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4230989|NCT00683592|4054460|B1||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4230990|NCT00683592|4054458|B3|||Age||years|Mean|41.7|41.7|Standard Deviation|12.36|12.36|||
4230991|NCT00683592|4054459|B2|||Age||years|Mean|42.4|42.4|Standard Deviation|12.49|12.49|||
4230992|NCT00683592|4054460|B1|||Age||years|Mean|41.1|41.1|Standard Deviation|12.22|12.22|||
4230993|NCT00683475|4054477|B3|United States||Region of Enrollment||participants|Number|132|132.0||||||
4230994|NCT00683475|4054478|B2|United States||Region of Enrollment||participants|Number|66|66.0||||||
4230995|NCT00683475|4054479|B1|United States||Region of Enrollment||participants|Number|66|66.0||||||
4230996|NCT00683475|4054477|B3|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4230997|NCT00683475|4054478|B2|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4230998|NCT00683475|4054479|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4230999|NCT00683475|4054477|B3|Black Or African American||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4231000|NCT00683475|4054478|B2|Black Or African American||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4231001|NCT00683475|4054479|B1|Black Or African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4231002|NCT00683475|4054477|B3|White||Race/Ethnicity, Customized||Participants|Number|119|119.0||||||
4231003|NCT00683475|4054478|B2|White||Race/Ethnicity, Customized||Participants|Number|58|58.0||||||
4231004|NCT00683475|4054479|B1|White||Race/Ethnicity, Customized||Participants|Number|61|61.0||||||
4231005|NCT00683475|4054477|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4231006|NCT00683475|4054478|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4231007|NCT00683475|4054479|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4231008|NCT00683475|4054477|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
4231009|NCT00683475|4054478|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4231010|NCT00683475|4054479|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4231011|NCT00683475|4054477|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4231012|NCT00683475|4054478|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4231013|NCT00683475|4054479|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4231014|NCT00683475|4054477|B3||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4231015|NCT00683475|4054478|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4231016|NCT00683475|4054479|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4231017|NCT00683475|4054477|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4231018|NCT00683475|4054478|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4231019|NCT00683475|4054479|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4231020|NCT00683475|4054477|B3||>=65 years|Age||Participants|Count of Participants|81|81.0||||||
4231021|NCT00683475|4054478|B2||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
4231022|NCT00683475|4054479|B1||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4231023|NCT00683475|4054477|B3||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4231024|NCT00683475|4054478|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4231025|NCT00683475|4054479|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4231026|NCT00683475|4054477|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231027|NCT00683475|4054478|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231028|NCT00683475|4054479|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231029|NCT00683449|4054510|B6|United States||Region of Enrollment||participants|Number|29|29.0||||||
4231030|NCT00683449|4054511|B5|United States||Region of Enrollment||participants|Number|2|2.0||||||
4231031|NCT00683449|4054512|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
4231032|NCT00683449|4054513|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4231033|NCT00683449|4054514|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4231034|NCT00683449|4054515|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4231035|NCT00683449|4054510|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4231036|NCT00683449|4054511|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4231037|NCT00683449|4054512|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4231038|NCT00683449|4054513|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4231039|NCT00683449|4054514|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4231040|NCT00683449|4054515|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4231041|NCT00683449|4054510|B6||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4231042|NCT00683449|4054511|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4231043|NCT00683449|4054512|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4231044|NCT00683449|4054513|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4231045|NCT00683449|4054514|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4231046|NCT00683449|4054515|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4231047|NCT00683449|4054510|B6|||Age||years|Mean|37.83|37.83|Standard Deviation|11.31|11.31|||
4231048|NCT00683449|4054511|B5|||Age||years|Mean|45|45.0|Standard Deviation|0.0|0.0|||
4231049|NCT00683449|4054512|B4|||Age||years|Mean|39.2|39.2|Standard Deviation|9.77|9.77|||
4231050|NCT00683449|4054513|B3|||Age||years|Mean|22.3|22.3|Standard Deviation|3.21|3.21|||
4231051|NCT00683449|4054514|B2|||Age||years|Mean|42.6|42.6|Standard Deviation|9.7|9.7|||
4231052|NCT00683449|4054515|B1|||Age||years|Mean|30.2|30.2|Standard Deviation|11.56|11.56|||
4231053|NCT00683449|4054510|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4231054|NCT00683449|4054511|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4231055|NCT00683449|4054512|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4231056|NCT00683449|4054513|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4231057|NCT00683449|4054514|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4231058|NCT00683449|4054515|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4231059|NCT00683449|4054510|B6||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4231060|NCT00683449|4054511|B5||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4231061|NCT00683449|4054512|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4231062|NCT00683449|4054513|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4231063|NCT00683449|4054514|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4231064|NCT00683449|4054515|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4231065|NCT00683449|4054510|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231066|NCT00683449|4054511|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231067|NCT00683449|4054512|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231068|NCT00683449|4054513|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231069|NCT00683449|4054514|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231070|NCT00683449|4054515|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231071|NCT00683410|4054541|B1||Male|Sex: Female, Male||Participants|Count of Participants|1790|1790.0||||||
4231072|NCT00683410|4054541|B1||Female|Sex: Female, Male||Participants|Count of Participants|1576|1576.0||||||
4231073|NCT00683410|4054541|B1|||Age||weeks|Mean|43.6|43.6|Standard Deviation|50.9|50.9|||
4231074|NCT00683384|4054545|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4231075|NCT00683384|4054545|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4231076|NCT00683384|4054545|B1|||Age||years|Mean|41.8|41.8|Standard Deviation|18.7|18.7|||
4231077|NCT00683332|4054549|B1||Male|Sex: Female, Male||Participants|Count of Participants|367|367.0||||||
4231078|NCT00683332|4054549|B1||Female|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
4231079|NCT00683332|4054549|B1|||Age||Years|Mean|55.7|55.7|Standard Deviation|17.4|17.4|||
4231080|NCT00683293|4054553|B3|Switzerland||Region of Enrollment||participants|Number|100|100.0||||||
4231081|NCT00683293|4054554|B2|Switzerland||Region of Enrollment||participants|Number|50|50.0||||||
4231082|NCT00683293|4054555|B1|Switzerland||Region of Enrollment||participants|Number|50|50.0||||||
4231083|NCT00683293|4054553|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4231084|NCT00683293|4054554|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4231085|NCT00683293|4054555|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4231086|NCT00683293|4054553|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4231087|NCT00683293|4054554|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4231088|NCT00683293|4054555|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4231089|NCT00683293|4054553|B3|||Age||years|Mean|46|46.0|Standard Deviation|5.1|5.1|||
4231090|NCT00683293|4054554|B2|||Age||years|Mean|46.3|46.3|Standard Deviation|4.2|4.2|||
4231091|NCT00683293|4054555|B1|||Age||years|Mean|45.8|45.8|Standard Deviation|6|6.0|||
4231092|NCT00683293|4054553|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4231093|NCT00683293|4054554|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4231094|NCT00683293|4054555|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4231095|NCT00683293|4054553|B3||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4231096|NCT00683293|4054554|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4231097|NCT00683293|4054555|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4231098|NCT00683293|4054553|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231099|NCT00683293|4054554|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231100|NCT00683293|4054555|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231101|NCT00683163|4054564|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
4231102|NCT00683163|4054565|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4231103|NCT00683163|4054566|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4231104|NCT00683163|4054564|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4231105|NCT00683163|4054565|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4231106|NCT00683163|4054566|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4231107|NCT00683163|4054564|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4231108|NCT00683163|4054565|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4231109|NCT00683163|4054566|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4231110|NCT00683163|4054564|B3|||Age||years|Mean|61.9|61.9|Standard Deviation|4.1|4.1|||
4231111|NCT00683163|4054565|B2|||Age||years|Mean|61.2|61.2|Standard Deviation|4.1|4.1|||
4231112|NCT00683163|4054566|B1|||Age||years|Mean|62.7|62.7|Standard Deviation|4.1|4.1|||
4231113|NCT00683163|4054564|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4231114|NCT00683163|4054565|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4231115|NCT00683163|4054566|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4231116|NCT00683163|4054564|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4231117|NCT00683163|4054565|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4231118|NCT00683163|4054566|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4231119|NCT00683163|4054564|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231120|NCT00683163|4054565|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231121|NCT00683163|4054566|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231122|NCT00683085|4054575|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4231123|NCT00683085|4054575|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4231124|NCT00683085|4054575|B1|||Age||years|Mean|55|55.0|Standard Deviation|7.07|7.07|||
4231125|NCT00683085|4054575|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4231126|NCT00683085|4054575|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4231127|NCT00683085|4054575|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231128|NCT00683046|4054580|B1||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4231129|NCT00683046|4054580|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4231130|NCT00683046|4054580|B1|||Age||years|Mean|51.0|51.0|Standard Deviation|12.0|12.0|||
4231131|NCT00683020|4054585|B3|||Low-density Lipoprotein||mg/dL|Mean|93.1|93.1|Standard Deviation|30.8|30.8|||
4231132|NCT00683020|4054586|B2|||Low-density Lipoprotein||mg/dL|Mean|93.5|93.5|Standard Deviation|31.5|31.5|||
4231133|NCT00683020|4054587|B1|||Low-density Lipoprotein||mg/dL|Mean|92.7|92.7|Standard Deviation|30.3|30.3|||
4231134|NCT00683020|4054585|B3|||Diastolic Blood Pressure||mm Hg|Mean|74.5|74.5|Standard Deviation|9.7|9.7|||
4231135|NCT00683020|4054586|B2|||Diastolic Blood Pressure||mm Hg|Mean|76.1|76.1|Standard Deviation|9.9|9.9|||
4231136|NCT00683020|4054587|B1|||Diastolic Blood Pressure||mm Hg|Mean|72.9|72.9|Standard Deviation|9.3|9.3|||
4231137|NCT00683020|4054585|B3|||Systolic Blood Pressure||mm Hg|Mean|127.7|127.7|Standard Deviation|17.7|17.7|||
4231138|NCT00683020|4054586|B2|||Systolic Blood Pressure||mm Hg|Mean|128.1|128.1|Standard Deviation|18.2|18.2|||
4231139|NCT00683020|4054587|B1|||Systolic Blood Pressure||mm Hg|Mean|127.3|127.3|Standard Deviation|17.3|17.3|||
4231140|NCT00683020|4054585|B3|||Hemoglobin A1c|Data is based on the 252 participants with both baseline and 6-month follow-up measures and with Hemoglobin A1c data.|%|Mean|7.7|7.7|Standard Deviation|1.5|1.5|||
4231141|NCT00683020|4054586|B2|||Hemoglobin A1c|Data is based on the 252 participants with both baseline and 6-month follow-up measures and with Hemoglobin A1c data.|%|Mean|7.5|7.5|Standard Deviation|1.3|1.3|||
4231142|NCT00683020|4054587|B1|||Hemoglobin A1c|Data is based on the 252 participants with both baseline and 6-month follow-up measures and with Hemoglobin A1c data.|%|Mean|7.8|7.8|Standard Deviation|1.6|1.6|||
4231143|NCT00683020|4054585|B3|≤ 8.0%||Hemoglobin A1c|Data is based on the 252 participants with both baseline and 6-month follow-up measures and with Hemoglobin A1c data.|Participants|Number|177|177.0||||||
4231144|NCT00683020|4054586|B2|≤ 8.0%||Hemoglobin A1c|Data is based on the 252 participants with both baseline and 6-month follow-up measures and with Hemoglobin A1c data.|Participants|Number|90|90.0||||||
4231145|NCT00683020|4054587|B1|≤ 8.0%||Hemoglobin A1c|Data is based on the 252 participants with both baseline and 6-month follow-up measures and with Hemoglobin A1c data.|Participants|Number|87|87.0||||||
4231146|NCT00683020|4054585|B3|> 8.0%||Hemoglobin A1c|Data is based on the 252 participants with both baseline and 6-month follow-up measures and with Hemoglobin A1c data.|Participants|Number|66|66.0||||||
4231147|NCT00683020|4054586|B2|> 8.0%||Hemoglobin A1c|Data is based on the 252 participants with both baseline and 6-month follow-up measures and with Hemoglobin A1c data.|Participants|Number|29|29.0||||||
4231148|NCT00683020|4054587|B1|> 8.0%||Hemoglobin A1c|Data is based on the 252 participants with both baseline and 6-month follow-up measures and with Hemoglobin A1c data.|Participants|Number|37|37.0||||||
4231149|NCT00683020|4054585|B3|No||Insulin Treatment||Participants|Number|209|209.0||||||
4231150|NCT00683020|4054586|B2|No||Insulin Treatment||Participants|Number|107|107.0||||||
4231151|NCT00683020|4054587|B1|No||Insulin Treatment||Participants|Number|102|102.0||||||
4231152|NCT00683020|4054585|B3|Yes||Insulin Treatment||Participants|Number|43|43.0||||||
4231153|NCT00683020|4054586|B2|Yes||Insulin Treatment||Participants|Number|18|18.0||||||
4231154|NCT00683020|4054587|B1|Yes||Insulin Treatment||Participants|Number|25|25.0||||||
4231155|NCT00683020|4054585|B3|||Diabetes Duration||Years|Mean|7.0|7.0|Standard Deviation|5.7|5.7|||
4231156|NCT00683020|4054586|B2|||Diabetes Duration||Years|Mean|7.2|7.2|Standard Deviation|5.4|5.4|||
4231157|NCT00683020|4054587|B1|||Diabetes Duration||Years|Mean|6.9|6.9|Standard Deviation|5.9|5.9|||
4231243|NCT00683020|4054586|B2|Black / African-American||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4231158|NCT00683020|4054585|B3|Healthy Worker / Healthy San Francisco||Financial Class - Insurance Type|Data is based on the 252 participants with both baseline and 6-month follow-up measures and with financial class information.|Participants|Number|187|187.0||||||
4231159|NCT00683020|4054586|B2|Healthy Worker / Healthy San Francisco||Financial Class - Insurance Type|Data is based on the 252 participants with both baseline and 6-month follow-up measures and with financial class information.|Participants|Number|94|94.0||||||
4231160|NCT00683020|4054587|B1|Healthy Worker / Healthy San Francisco||Financial Class - Insurance Type|Data is based on the 252 participants with both baseline and 6-month follow-up measures and with financial class information.|Participants|Number|93|93.0||||||
4231161|NCT00683020|4054585|B3|Uninsured / Commercial||Financial Class - Insurance Type|Data is based on the 252 participants with both baseline and 6-month follow-up measures and with financial class information.|Participants|Number|3|3.0||||||
4231162|NCT00683020|4054586|B2|Uninsured / Commercial||Financial Class - Insurance Type|Data is based on the 252 participants with both baseline and 6-month follow-up measures and with financial class information.|Participants|Number|2|2.0||||||
4231163|NCT00683020|4054587|B1|Uninsured / Commercial||Financial Class - Insurance Type|Data is based on the 252 participants with both baseline and 6-month follow-up measures and with financial class information.|Participants|Number|1|1.0||||||
4231164|NCT00683020|4054585|B3|Medicare||Financial Class - Insurance Type|Data is based on the 252 participants with both baseline and 6-month follow-up measures and with financial class information.|Participants|Number|11|11.0||||||
4231165|NCT00683020|4054586|B2|Medicare||Financial Class - Insurance Type|Data is based on the 252 participants with both baseline and 6-month follow-up measures and with financial class information.|Participants|Number|7|7.0||||||
4231166|NCT00683020|4054587|B1|Medicare||Financial Class - Insurance Type|Data is based on the 252 participants with both baseline and 6-month follow-up measures and with financial class information.|Participants|Number|4|4.0||||||
4231167|NCT00683020|4054585|B3|Medicaid||Financial Class - Insurance Type|Data is based on the 252 participants with both baseline and 6-month follow-up measures and with financial class information.|Participants|Number|50|50.0||||||
4231168|NCT00683020|4054586|B2|Medicaid||Financial Class - Insurance Type|Data is based on the 252 participants with both baseline and 6-month follow-up measures and with financial class information.|Participants|Number|22|22.0||||||
4231169|NCT00683020|4054587|B1|Medicaid||Financial Class - Insurance Type|Data is based on the 252 participants with both baseline and 6-month follow-up measures and with financial class information.|Participants|Number|28|28.0||||||
4231170|NCT00683020|4054585|B3|>$30,000||Annual Household Income|Data is based on the 252 participants with both baseline and 6-month follow-up measures and with answer to the question on annual household income.|Participants|Number|38|38.0||||||
4231171|NCT00683020|4054586|B2|>$30,000||Annual Household Income|Data is based on the 252 participants with both baseline and 6-month follow-up measures and with answer to the question on annual household income.|Participants|Number|19|19.0||||||
4231172|NCT00683020|4054587|B1|>$30,000||Annual Household Income|Data is based on the 252 participants with both baseline and 6-month follow-up measures and with answer to the question on annual household income.|Participants|Number|19|19.0||||||
4231173|NCT00683020|4054585|B3|$20,001 - $30,000||Annual Household Income|Data is based on the 252 participants with both baseline and 6-month follow-up measures and with answer to the question on annual household income.|Participants|Number|49|49.0||||||
4231174|NCT00683020|4054586|B2|$20,001 - $30,000||Annual Household Income|Data is based on the 252 participants with both baseline and 6-month follow-up measures and with answer to the question on annual household income.|Participants|Number|25|25.0||||||
4231175|NCT00683020|4054587|B1|$20,001 - $30,000||Annual Household Income|Data is based on the 252 participants with both baseline and 6-month follow-up measures and with answer to the question on annual household income.|Participants|Number|24|24.0||||||
4231176|NCT00683020|4054585|B3|≤ $20,000||Annual Household Income|Data is based on the 252 participants with both baseline and 6-month follow-up measures and with answer to the question on annual household income.|Participants|Number|148|148.0||||||
4231177|NCT00683020|4054586|B2|≤ $20,000||Annual Household Income|Data is based on the 252 participants with both baseline and 6-month follow-up measures and with answer to the question on annual household income.|Participants|Number|75|75.0||||||
4231178|NCT00683020|4054587|B1|≤ $20,000||Annual Household Income|Data is based on the 252 participants with both baseline and 6-month follow-up measures and with answer to the question on annual household income.|Participants|Number|73|73.0||||||
4231179|NCT00683020|4054585|B3|Homemaker / Retired / Other||Employment Status||Participants|Number|30|30.0||||||
4231180|NCT00683020|4054586|B2|Homemaker / Retired / Other||Employment Status||Participants|Number|13|13.0||||||
4231181|NCT00683020|4054587|B1|Homemaker / Retired / Other||Employment Status||Participants|Number|17|17.0||||||
4231182|NCT00683020|4054585|B3|Disabled||Employment Status||Participants|Number|20|20.0||||||
4231183|NCT00683020|4054586|B2|Disabled||Employment Status||Participants|Number|13|13.0||||||
4231184|NCT00683020|4054587|B1|Disabled||Employment Status||Participants|Number|7|7.0||||||
4231185|NCT00683020|4054585|B3|Unemployed||Employment Status||Participants|Number|27|27.0||||||
4231186|NCT00683020|4054586|B2|Unemployed||Employment Status||Participants|Number|15|15.0||||||
4231187|NCT00683020|4054587|B1|Unemployed||Employment Status||Participants|Number|12|12.0||||||
4231188|NCT00683020|4054585|B3|Part-time||Employment Status||Participants|Number|121|121.0||||||
4231189|NCT00683020|4054586|B2|Part-time||Employment Status||Participants|Number|58|58.0||||||
4231190|NCT00683020|4054587|B1|Part-time||Employment Status||Participants|Number|63|63.0||||||
4231191|NCT00683020|4054585|B3|Employed full-time||Employment Status||Participants|Number|54|54.0||||||
4231192|NCT00683020|4054586|B2|Employed full-time||Employment Status||Participants|Number|26|26.0||||||
4231193|NCT00683020|4054587|B1|Employed full-time||Employment Status||Participants|Number|28|28.0||||||
4231194|NCT00683020|4054585|B3|Adequate||Health Literacy|Data is based on the 252 participants with both baseline and 6-month follow-up measures and with answers to all health literacy questions.|Participants|Number|143|143.0||||||
4231195|NCT00683020|4054586|B2|Adequate||Health Literacy|Data is based on the 252 participants with both baseline and 6-month follow-up measures and with answers to all health literacy questions.|Participants|Number|75|75.0||||||
4231196|NCT00683020|4054587|B1|Adequate||Health Literacy|Data is based on the 252 participants with both baseline and 6-month follow-up measures and with answers to all health literacy questions.|Participants|Number|68|68.0||||||
4231197|NCT00683020|4054585|B3|Limited||Health Literacy|Data is based on the 252 participants with both baseline and 6-month follow-up measures and with answers to all health literacy questions.|Participants|Number|108|108.0||||||
4231198|NCT00683020|4054586|B2|Limited||Health Literacy|Data is based on the 252 participants with both baseline and 6-month follow-up measures and with answers to all health literacy questions.|Participants|Number|50|50.0||||||
4231199|NCT00683020|4054587|B1|Limited||Health Literacy|Data is based on the 252 participants with both baseline and 6-month follow-up measures and with answers to all health literacy questions.|Participants|Number|58|58.0||||||
4231200|NCT00683020|4054585|B3|College graduate or above||Educational Attainment||Participants|Number|64|64.0||||||
4231201|NCT00683020|4054586|B2|College graduate or above||Educational Attainment||Participants|Number|33|33.0||||||
4231202|NCT00683020|4054587|B1|College graduate or above||Educational Attainment||Participants|Number|31|31.0||||||
4231203|NCT00683020|4054585|B3|High school graduate or GED||Educational Attainment||Participants|Number|55|55.0||||||
4231204|NCT00683020|4054586|B2|High school graduate or GED||Educational Attainment||Participants|Number|22|22.0||||||
4231205|NCT00683020|4054587|B1|High school graduate or GED||Educational Attainment||Participants|Number|33|33.0||||||
4231206|NCT00683020|4054585|B3|Some high school||Educational Attainment||Participants|Number|25|25.0||||||
4231207|NCT00683020|4054586|B2|Some high school||Educational Attainment||Participants|Number|12|12.0||||||
4231208|NCT00683020|4054587|B1|Some high school||Educational Attainment||Participants|Number|13|13.0||||||
4231209|NCT00683020|4054585|B3|8th grade education or less||Educational Attainment||Participants|Number|108|108.0||||||
4231210|NCT00683020|4054586|B2|8th grade education or less||Educational Attainment||Participants|Number|58|58.0||||||
4231211|NCT00683020|4054587|B1|8th grade education or less||Educational Attainment||Participants|Number|50|50.0||||||
4231212|NCT00683020|4054585|B3|Discordant||Language Concordance with Primary Care Provider|Data is based on the 252 participants with baseline and 6-month follow-up measures, Cantonese- or Spanish-speaking, and with a regular primary care provider.|Participants|Number|119|119.0||||||
4231213|NCT00683020|4054586|B2|Discordant||Language Concordance with Primary Care Provider|Data is based on the 252 participants with baseline and 6-month follow-up measures, Cantonese- or Spanish-speaking, and with a regular primary care provider.|Participants|Number|62|62.0||||||
4231214|NCT00683020|4054587|B1|Discordant||Language Concordance with Primary Care Provider|Data is based on the 252 participants with baseline and 6-month follow-up measures, Cantonese- or Spanish-speaking, and with a regular primary care provider.|Participants|Number|57|57.0||||||
4231215|NCT00683020|4054585|B3|Concordant||Language Concordance with Primary Care Provider|Data is based on the 252 participants with baseline and 6-month follow-up measures, Cantonese- or Spanish-speaking, and with a regular primary care provider.|Participants|Number|59|59.0||||||
4231216|NCT00683020|4054586|B2|Concordant||Language Concordance with Primary Care Provider|Data is based on the 252 participants with baseline and 6-month follow-up measures, Cantonese- or Spanish-speaking, and with a regular primary care provider.|Participants|Number|26|26.0||||||
4231217|NCT00683020|4054587|B1|Concordant||Language Concordance with Primary Care Provider|Data is based on the 252 participants with baseline and 6-month follow-up measures, Cantonese- or Spanish-speaking, and with a regular primary care provider.|Participants|Number|33|33.0||||||
4231218|NCT00683020|4054585|B3|English||Language||Participants|Number|66|66.0||||||
4231219|NCT00683020|4054586|B2|English||Language||Participants|Number|33|33.0||||||
4231220|NCT00683020|4054587|B1|English||Language||Participants|Number|33|33.0||||||
4231221|NCT00683020|4054585|B3|Spanish||Language||Participants|Number|48|48.0||||||
4231222|NCT00683020|4054586|B2|Spanish||Language||Participants|Number|23|23.0||||||
4231223|NCT00683020|4054587|B1|Spanish||Language||Participants|Number|25|25.0||||||
4231224|NCT00683020|4054585|B3|Cantonese||Language||Participants|Number|138|138.0||||||
4231225|NCT00683020|4054586|B2|Cantonese||Language||Participants|Number|69|69.0||||||
4231226|NCT00683020|4054587|B1|Cantonese||Language||Participants|Number|69|69.0||||||
4231227|NCT00683020|4054585|B3|Inside U.S.||Birth Place||Participants|Number|36|36.0||||||
4231228|NCT00683020|4054586|B2|Inside U.S.||Birth Place||Participants|Number|19|19.0||||||
4231229|NCT00683020|4054587|B1|Inside U.S.||Birth Place||Participants|Number|17|17.0||||||
4231230|NCT00683020|4054585|B3|Outside U.S.||Birth Place||Participants|Number|216|216.0||||||
4231231|NCT00683020|4054586|B2|Outside U.S.||Birth Place||Participants|Number|106|106.0||||||
4231232|NCT00683020|4054587|B1|Outside U.S.||Birth Place||Participants|Number|110|110.0||||||
4231233|NCT00683020|4054585|B3|Multi-Ethnic / Other||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4231234|NCT00683020|4054586|B2|Multi-Ethnic / Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4231235|NCT00683020|4054587|B1|Multi-Ethnic / Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4231236|NCT00683020|4054585|B3|White / Caucasian||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4231237|NCT00683020|4054586|B2|White / Caucasian||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4231238|NCT00683020|4054587|B1|White / Caucasian||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4231239|NCT00683020|4054585|B3|Asian / Pacific Islander||Race/Ethnicity, Customized||Participants|Number|155|155.0||||||
4231240|NCT00683020|4054586|B2|Asian / Pacific Islander||Race/Ethnicity, Customized||Participants|Number|78|78.0||||||
4231241|NCT00683020|4054587|B1|Asian / Pacific Islander||Race/Ethnicity, Customized||Participants|Number|77|77.0||||||
4231242|NCT00683020|4054585|B3|Black / African-American||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4231244|NCT00683020|4054587|B1|Black / African-American||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4231245|NCT00683020|4054585|B3|Latino||Race/Ethnicity, Customized||Participants|Number|57|57.0||||||
4231246|NCT00683020|4054586|B2|Latino||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
4231247|NCT00683020|4054587|B1|Latino||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
4231248|NCT00683020|4054585|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4231249|NCT00683020|4054586|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4231250|NCT00683020|4054587|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4231251|NCT00683020|4054585|B3||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4231252|NCT00683020|4054586|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4231253|NCT00683020|4054587|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4231254|NCT00683020|4054585|B3|||Age||years|Mean|55.7|55.7|Standard Deviation|8.2|8.2|||
4231255|NCT00683020|4054586|B2|||Age||years|Mean|55.0|55.0|Standard Deviation|8.6|8.6|||
4231256|NCT00683020|4054587|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|7.9|7.9|||
4231257|NCT00682929|4054616|B4|United States||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
4231258|NCT00682929|4054617|B3|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4231259|NCT00682929|4054618|B2|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4231260|NCT00682929|4054619|B1|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4231261|NCT00682929|4054616|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4231262|NCT00682929|4054617|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4231263|NCT00682929|4054618|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4231264|NCT00682929|4054619|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4231265|NCT00682929|4054616|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4231266|NCT00682929|4054617|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4231267|NCT00682929|4054618|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4231268|NCT00682929|4054619|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4231269|NCT00682929|4054616|B4||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4231270|NCT00682929|4054617|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4231271|NCT00682929|4054618|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4231272|NCT00682929|4054619|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4231273|NCT00682929|4054616|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4231274|NCT00682929|4054617|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4231275|NCT00682929|4054618|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4231276|NCT00682929|4054619|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4231277|NCT00682929|4054616|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4231278|NCT00682929|4054617|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4231279|NCT00682929|4054618|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4231280|NCT00682929|4054619|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4231281|NCT00682929|4054616|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4231282|NCT00682929|4054617|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4231283|NCT00682929|4054618|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4231284|NCT00682929|4054619|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4231285|NCT00682929|4054616|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4231286|NCT00682929|4054617|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4231287|NCT00682929|4054618|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4231288|NCT00682929|4054619|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4231289|NCT00682929|4054616|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4231290|NCT00682929|4054617|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4231291|NCT00682929|4054618|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4231292|NCT00682929|4054619|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4231293|NCT00682929|4054616|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4231294|NCT00682929|4054617|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4231295|NCT00682929|4054618|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4231296|NCT00682929|4054619|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4231297|NCT00682929|4054616|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4231298|NCT00682929|4054617|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4231299|NCT00682929|4054618|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4231300|NCT00682929|4054619|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4231301|NCT00682929|4054616|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4231302|NCT00682929|4054617|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4231303|NCT00682929|4054618|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4231304|NCT00682929|4054619|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4231305|NCT00682929|4054616|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4231306|NCT00682929|4054617|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4231307|NCT00682929|4054618|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4231308|NCT00682929|4054619|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4231309|NCT00682929|4054616|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4231310|NCT00682929|4054617|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4231311|NCT00682929|4054618|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4231312|NCT00682929|4054619|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4231313|NCT00682929|4054616|B4||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4231314|NCT00682929|4054617|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4231315|NCT00682929|4054618|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4231316|NCT00682929|4054619|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4231317|NCT00682929|4054616|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231318|NCT00682929|4054617|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231319|NCT00682929|4054618|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231320|NCT00682929|4054619|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231321|NCT00682890|4054788|B3|||Body Mass Index (BMI)||kg/m2|Mean|34.4|34.4|Standard Deviation|2.4|2.4|||
4231322|NCT00682890|4054789|B2|||Body Mass Index (BMI)||kg/m2|Mean|36.2|36.2|Standard Deviation|2.5|2.5|||
4231323|NCT00682890|4054790|B1|||Body Mass Index (BMI)||kg/m2|Mean|32.6|32.6|Standard Deviation|2.3|2.3|||
4231324|NCT00682890|4054788|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4231325|NCT00682890|4054789|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4231326|NCT00682890|4054790|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4231327|NCT00682890|4054788|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4231328|NCT00682890|4054789|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4231329|NCT00682890|4054790|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4231330|NCT00682890|4054788|B3|||Age||years|Mean|25.5|25.5|Standard Deviation|1.4|1.4|||
4231331|NCT00682890|4054789|B2|||Age||years|Mean|26.6|26.6|Standard Deviation|1.4|1.4|||
4231332|NCT00682890|4054790|B1|||Age||years|Mean|24.3|24.3|Standard Deviation|1.3|1.3|||
4231333|NCT00682851|4054799|B3|United States||Region of Enrollment||participants|Number|519|519.0||||||
4231334|NCT00682851|4054800|B2|United States||Region of Enrollment||participants|Number|268|268.0||||||
4231335|NCT00682851|4054801|B1|United States||Region of Enrollment||participants|Number|251|251.0||||||
4231336|NCT00682851|4054799|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4231337|NCT00682851|4054800|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4231338|NCT00682851|4054801|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4231339|NCT00682851|4054799|B3||Female|Sex: Female, Male||Participants|Count of Participants|519|519.0||||||
4231340|NCT00682851|4054800|B2||Female|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
4231341|NCT00682851|4054801|B1||Female|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4231342|NCT00682851|4054799|B3|||Age||years|Mean|27.6|27.6|Standard Deviation|8.6|8.6|||
4231343|NCT00682851|4054800|B2|||Age||years|Mean|27.0|27.0|Standard Deviation|8.7|8.7|||
4231344|NCT00682851|4054801|B1|||Age||years|Mean|28.3|28.3|Standard Deviation|8.2|8.2|||
4231345|NCT00682851|4054799|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4231346|NCT00682851|4054800|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4231347|NCT00682851|4054801|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4231348|NCT00682851|4054799|B3||Between 18 and 65 years|Age||Participants|Count of Participants|491|491.0||||||
4231349|NCT00682851|4054800|B2||Between 18 and 65 years|Age||Participants|Count of Participants|252|252.0||||||
4231350|NCT00682851|4054801|B1||Between 18 and 65 years|Age||Participants|Count of Participants|239|239.0||||||
4231351|NCT00682851|4054799|B3||<=18 years|Age||Participants|Count of Participants|28|28.0||||||
4231352|NCT00682851|4054800|B2||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4231353|NCT00682851|4054801|B1||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4231354|NCT00682838|4054814|B5|United States||Region of Enrollment||participants|Number|280|280.0||||||
4231355|NCT00682838|4054815|B4|United States||Region of Enrollment||participants|Number|73|73.0||||||
4231356|NCT00682838|4054816|B3|United States||Region of Enrollment||participants|Number|75|75.0||||||
4231357|NCT00682838|4054817|B2|United States||Region of Enrollment||participants|Number|67|67.0||||||
4231358|NCT00682838|4054818|B1|United States||Region of Enrollment||participants|Number|65|65.0||||||
4231359|NCT00682838|4054814|B5||Male|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
4231360|NCT00682838|4054815|B4||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4231361|NCT00682838|4054816|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4231362|NCT00682838|4054817|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4231363|NCT00682838|4054818|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4231364|NCT00682838|4054814|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4231365|NCT00682838|4054815|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4231366|NCT00682838|4054816|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4231367|NCT00682838|4054817|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4231368|NCT00682838|4054818|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4231369|NCT00682838|4054814|B5||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4231370|NCT00682838|4054815|B4||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4231371|NCT00682838|4054816|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4231372|NCT00682838|4054817|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4231373|NCT00682838|4054818|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4231374|NCT00682838|4054814|B5||Between 18 and 65 years|Age||Participants|Count of Participants|241|241.0||||||
4231375|NCT00682838|4054815|B4||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4231376|NCT00682838|4054816|B3||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4231377|NCT00682838|4054817|B2||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4231378|NCT00682838|4054818|B1||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4231379|NCT00682838|4054814|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231380|NCT00682838|4054815|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231381|NCT00682838|4054816|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231382|NCT00682838|4054817|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231383|NCT00682838|4054818|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231384|NCT00682786|4054831|B3|Not reported||Tumor grade||participants|Number|6|6.0||||||
4231385|NCT00682786|4054832|B2|Not reported||Tumor grade||participants|Number|1|1.0||||||
4231386|NCT00682786|4054833|B1|Not reported||Tumor grade||participants|Number|5|5.0||||||
4231387|NCT00682786|4054831|B3|Poorly differentiated||Tumor grade||participants|Number|24|24.0||||||
4231388|NCT00682786|4054832|B2|Poorly differentiated||Tumor grade||participants|Number|7|7.0||||||
4231389|NCT00682786|4054833|B1|Poorly differentiated||Tumor grade||participants|Number|17|17.0||||||
4231390|NCT00682786|4054831|B3|Moderately differentiated||Tumor grade||participants|Number|93|93.0||||||
4231391|NCT00682786|4054832|B2|Moderately differentiated||Tumor grade||participants|Number|25|25.0||||||
4231392|NCT00682786|4054833|B1|Moderately differentiated||Tumor grade||participants|Number|68|68.0||||||
4231393|NCT00682786|4054831|B3|Well differentiated||Tumor grade||participants|Number|12|12.0||||||
4231394|NCT00682786|4054832|B2|Well differentiated||Tumor grade||participants|Number|4|4.0||||||
4231395|NCT00682786|4054833|B1|Well differentiated||Tumor grade||participants|Number|8|8.0||||||
4231396|NCT00682786|4054831|B3|>10||Tumor distance from anal verge (cm)||participants|Number|12|12.0||||||
4231397|NCT00682786|4054832|B2|>10||Tumor distance from anal verge (cm)||participants|Number|4|4.0||||||
4231398|NCT00682786|4054833|B1|>10||Tumor distance from anal verge (cm)||participants|Number|8|8.0||||||
4231399|NCT00682786|4054831|B3|5-10||Tumor distance from anal verge (cm)||participants|Number|78|78.0||||||
4231400|NCT00682786|4054832|B2|5-10||Tumor distance from anal verge (cm)||participants|Number|21|21.0||||||
4231401|NCT00682786|4054833|B1|5-10||Tumor distance from anal verge (cm)||participants|Number|57|57.0||||||
4231402|NCT00682786|4054831|B3|<5||Tumor distance from anal verge (cm)||participants|Number|45|45.0||||||
4231403|NCT00682786|4054832|B2|<5||Tumor distance from anal verge (cm)||participants|Number|12|12.0||||||
4231404|NCT00682786|4054833|B1|<5||Tumor distance from anal verge (cm)||participants|Number|33|33.0||||||
4231405|NCT00682786|4054831|B3|MRI||Clinical staging modality||participants|Number|26|26.0||||||
4231406|NCT00682786|4054832|B2|MRI||Clinical staging modality||participants|Number|10|10.0||||||
4231407|NCT00682786|4054833|B1|MRI||Clinical staging modality||participants|Number|16|16.0||||||
4231408|NCT00682786|4054831|B3|CT Scan +/- PET Scan||Clinical staging modality||participants|Number|28|28.0||||||
4231409|NCT00682786|4054832|B2|CT Scan +/- PET Scan||Clinical staging modality||participants|Number|6|6.0||||||
4231410|NCT00682786|4054833|B1|CT Scan +/- PET Scan||Clinical staging modality||participants|Number|22|22.0||||||
4231411|NCT00682786|4054831|B3|Endoscopic ultrasound||Clinical staging modality||participants|Number|81|81.0||||||
4231412|NCT00682786|4054832|B2|Endoscopic ultrasound||Clinical staging modality||participants|Number|21|21.0||||||
4231413|NCT00682786|4054833|B1|Endoscopic ultrasound||Clinical staging modality||participants|Number|60|60.0||||||
4231414|NCT00682786|4054831|B3|M1||Baseline clinical M stage||participants|Number|19|19.0||||||
4231415|NCT00682786|4054832|B2|M1||Baseline clinical M stage||participants|Number|5|5.0||||||
4231416|NCT00682786|4054833|B1|M1||Baseline clinical M stage||participants|Number|14|14.0||||||
4231417|NCT00682786|4054831|B3|M0||Baseline clinical M stage||participants|Number|116|116.0||||||
4231418|NCT00682786|4054832|B2|M0||Baseline clinical M stage||participants|Number|32|32.0||||||
4231419|NCT00682786|4054833|B1|M0||Baseline clinical M stage||participants|Number|84|84.0||||||
4231420|NCT00682786|4054831|B3|N2||Baseline clinical N stage||participants|Number|8|8.0||||||
4231421|NCT00682786|4054832|B2|N2||Baseline clinical N stage||participants|Number|4|4.0||||||
4231422|NCT00682786|4054833|B1|N2||Baseline clinical N stage||participants|Number|4|4.0||||||
4231423|NCT00682786|4054831|B3|N1||Baseline clinical N stage||participants|Number|86|86.0||||||
4231424|NCT00682786|4054832|B2|N1||Baseline clinical N stage||participants|Number|22|22.0||||||
4231425|NCT00682786|4054833|B1|N1||Baseline clinical N stage||participants|Number|64|64.0||||||
4231426|NCT00682786|4054831|B3|N0||Baseline clinical N stage||participants|Number|41|41.0||||||
4231427|NCT00682786|4054832|B2|N0||Baseline clinical N stage||participants|Number|11|11.0||||||
4231428|NCT00682786|4054833|B1|N0||Baseline clinical N stage||participants|Number|30|30.0||||||
4231429|NCT00682786|4054831|B3|T4||Baseline clinical T stage||participants|Number|24|24.0||||||
4231430|NCT00682786|4054832|B2|T4||Baseline clinical T stage||participants|Number|5|5.0||||||
4231431|NCT00682786|4054833|B1|T4||Baseline clinical T stage||participants|Number|19|19.0||||||
4231432|NCT00682786|4054831|B3|T3||Baseline clinical T stage||participants|Number|109|109.0||||||
4231433|NCT00682786|4054832|B2|T3||Baseline clinical T stage||participants|Number|32|32.0||||||
4231434|NCT00682786|4054833|B1|T3||Baseline clinical T stage||participants|Number|77|77.0||||||
4231435|NCT00682786|4054831|B3|T1-2||Baseline clinical T stage||participants|Number|2|2.0||||||
4231436|NCT00682786|4054832|B2|T1-2||Baseline clinical T stage||participants|Number|0|0.0||||||
4231437|NCT00682786|4054833|B1|T1-2||Baseline clinical T stage||participants|Number|2|2.0||||||
4231438|NCT00682786|4054831|B3|Stage IV (T-any, N-any, M1)||Baseline Stage|"T describes how far the primary tumor has grown into the wall of the intestine and whether it has grown into nearby areas.~N describes the extent of spread to nearby lymph nodes.~M indicates whether the cancer has spread to other organs of the body.~Numbers or letters appear after T, N, and M to provide more details about each of these factors. The numbers 0 through 4 indicate increasing severity. The letter X means cannot be assessed because the information is not available."|participants|Number|19|19.0||||||
4231439|NCT00682786|4054832|B2|Stage IV (T-any, N-any, M1)||Baseline Stage|"T describes how far the primary tumor has grown into the wall of the intestine and whether it has grown into nearby areas.~N describes the extent of spread to nearby lymph nodes.~M indicates whether the cancer has spread to other organs of the body.~Numbers or letters appear after T, N, and M to provide more details about each of these factors. The numbers 0 through 4 indicate increasing severity. The letter X means cannot be assessed because the information is not available."|participants|Number|5|5.0||||||
4231440|NCT00682786|4054833|B1|Stage IV (T-any, N-any, M1)||Baseline Stage|"T describes how far the primary tumor has grown into the wall of the intestine and whether it has grown into nearby areas.~N describes the extent of spread to nearby lymph nodes.~M indicates whether the cancer has spread to other organs of the body.~Numbers or letters appear after T, N, and M to provide more details about each of these factors. The numbers 0 through 4 indicate increasing severity. The letter X means cannot be assessed because the information is not available."|participants|Number|14|14.0||||||
4231441|NCT00682786|4054831|B3|Stage IIIC (T-any, N2, M0)||Baseline Stage|"T describes how far the primary tumor has grown into the wall of the intestine and whether it has grown into nearby areas.~N describes the extent of spread to nearby lymph nodes.~M indicates whether the cancer has spread to other organs of the body.~Numbers or letters appear after T, N, and M to provide more details about each of these factors. The numbers 0 through 4 indicate increasing severity. The letter X means cannot be assessed because the information is not available."|participants|Number|6|6.0||||||
4231442|NCT00682786|4054832|B2|Stage IIIC (T-any, N2, M0)||Baseline Stage|"T describes how far the primary tumor has grown into the wall of the intestine and whether it has grown into nearby areas.~N describes the extent of spread to nearby lymph nodes.~M indicates whether the cancer has spread to other organs of the body.~Numbers or letters appear after T, N, and M to provide more details about each of these factors. The numbers 0 through 4 indicate increasing severity. The letter X means cannot be assessed because the information is not available."|participants|Number|3|3.0||||||
4231443|NCT00682786|4054833|B1|Stage IIIC (T-any, N2, M0)||Baseline Stage|"T describes how far the primary tumor has grown into the wall of the intestine and whether it has grown into nearby areas.~N describes the extent of spread to nearby lymph nodes.~M indicates whether the cancer has spread to other organs of the body.~Numbers or letters appear after T, N, and M to provide more details about each of these factors. The numbers 0 through 4 indicate increasing severity. The letter X means cannot be assessed because the information is not available."|participants|Number|3|3.0||||||
4231444|NCT00682786|4054831|B3|Stage IIIB (T3-4, N1, M0)||Baseline Stage|"T describes how far the primary tumor has grown into the wall of the intestine and whether it has grown into nearby areas.~N describes the extent of spread to nearby lymph nodes.~M indicates whether the cancer has spread to other organs of the body.~Numbers or letters appear after T, N, and M to provide more details about each of these factors. The numbers 0 through 4 indicate increasing severity. The letter X means cannot be assessed because the information is not available."|participants|Number|72|72.0||||||
4231445|NCT00682786|4054832|B2|Stage IIIB (T3-4, N1, M0)||Baseline Stage|"T describes how far the primary tumor has grown into the wall of the intestine and whether it has grown into nearby areas.~N describes the extent of spread to nearby lymph nodes.~M indicates whether the cancer has spread to other organs of the body.~Numbers or letters appear after T, N, and M to provide more details about each of these factors. The numbers 0 through 4 indicate increasing severity. The letter X means cannot be assessed because the information is not available."|participants|Number|19|19.0||||||
4231446|NCT00682786|4054833|B1|Stage IIIB (T3-4, N1, M0)||Baseline Stage|"T describes how far the primary tumor has grown into the wall of the intestine and whether it has grown into nearby areas.~N describes the extent of spread to nearby lymph nodes.~M indicates whether the cancer has spread to other organs of the body.~Numbers or letters appear after T, N, and M to provide more details about each of these factors. The numbers 0 through 4 indicate increasing severity. The letter X means cannot be assessed because the information is not available."|participants|Number|53|53.0||||||
4231447|NCT00682786|4054831|B3|Stage IIIA (T1-2, N1, M0)||Baseline Stage|"T describes how far the primary tumor has grown into the wall of the intestine and whether it has grown into nearby areas.~N describes the extent of spread to nearby lymph nodes.~M indicates whether the cancer has spread to other organs of the body.~Numbers or letters appear after T, N, and M to provide more details about each of these factors. The numbers 0 through 4 indicate increasing severity. The letter X means cannot be assessed because the information is not available."|participants|Number|1|1.0||||||
4231498|NCT00682786|4054831|B3||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4231499|NCT00682786|4054832|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4231500|NCT00682786|4054833|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4231448|NCT00682786|4054832|B2|Stage IIIA (T1-2, N1, M0)||Baseline Stage|"T describes how far the primary tumor has grown into the wall of the intestine and whether it has grown into nearby areas.~N describes the extent of spread to nearby lymph nodes.~M indicates whether the cancer has spread to other organs of the body.~Numbers or letters appear after T, N, and M to provide more details about each of these factors. The numbers 0 through 4 indicate increasing severity. The letter X means cannot be assessed because the information is not available."|participants|Number|0|0.0||||||
4231449|NCT00682786|4054833|B1|Stage IIIA (T1-2, N1, M0)||Baseline Stage|"T describes how far the primary tumor has grown into the wall of the intestine and whether it has grown into nearby areas.~N describes the extent of spread to nearby lymph nodes.~M indicates whether the cancer has spread to other organs of the body.~Numbers or letters appear after T, N, and M to provide more details about each of these factors. The numbers 0 through 4 indicate increasing severity. The letter X means cannot be assessed because the information is not available."|participants|Number|1|1.0||||||
4231450|NCT00682786|4054831|B3|Stage IIB (T4, N0, M0)||Baseline Stage|"T describes how far the primary tumor has grown into the wall of the intestine and whether it has grown into nearby areas.~N describes the extent of spread to nearby lymph nodes.~M indicates whether the cancer has spread to other organs of the body.~Numbers or letters appear after T, N, and M to provide more details about each of these factors. The numbers 0 through 4 indicate increasing severity. The letter X means cannot be assessed because the information is not available."|participants|Number|3|3.0||||||
4231451|NCT00682786|4054832|B2|Stage IIB (T4, N0, M0)||Baseline Stage|"T describes how far the primary tumor has grown into the wall of the intestine and whether it has grown into nearby areas.~N describes the extent of spread to nearby lymph nodes.~M indicates whether the cancer has spread to other organs of the body.~Numbers or letters appear after T, N, and M to provide more details about each of these factors. The numbers 0 through 4 indicate increasing severity. The letter X means cannot be assessed because the information is not available."|participants|Number|0|0.0||||||
4231452|NCT00682786|4054833|B1|Stage IIB (T4, N0, M0)||Baseline Stage|"T describes how far the primary tumor has grown into the wall of the intestine and whether it has grown into nearby areas.~N describes the extent of spread to nearby lymph nodes.~M indicates whether the cancer has spread to other organs of the body.~Numbers or letters appear after T, N, and M to provide more details about each of these factors. The numbers 0 through 4 indicate increasing severity. The letter X means cannot be assessed because the information is not available."|participants|Number|3|3.0||||||
4231453|NCT00682786|4054831|B3|Stage IIA (T3, N0, M0)||Baseline Stage|"T describes how far the primary tumor has grown into the wall of the intestine and whether it has grown into nearby areas.~N describes the extent of spread to nearby lymph nodes.~M indicates whether the cancer has spread to other organs of the body.~Numbers or letters appear after T, N, and M to provide more details about each of these factors. The numbers 0 through 4 indicate increasing severity. The letter X means cannot be assessed because the information is not available."|participants|Number|34|34.0||||||
4231454|NCT00682786|4054832|B2|Stage IIA (T3, N0, M0)||Baseline Stage|"T describes how far the primary tumor has grown into the wall of the intestine and whether it has grown into nearby areas.~N describes the extent of spread to nearby lymph nodes.~M indicates whether the cancer has spread to other organs of the body.~Numbers or letters appear after T, N, and M to provide more details about each of these factors. The numbers 0 through 4 indicate increasing severity. The letter X means cannot be assessed because the information is not available."|participants|Number|10|10.0||||||
4231455|NCT00682786|4054833|B1|Stage IIA (T3, N0, M0)||Baseline Stage|"T describes how far the primary tumor has grown into the wall of the intestine and whether it has grown into nearby areas.~N describes the extent of spread to nearby lymph nodes.~M indicates whether the cancer has spread to other organs of the body.~Numbers or letters appear after T, N, and M to provide more details about each of these factors. The numbers 0 through 4 indicate increasing severity. The letter X means cannot be assessed because the information is not available."|participants|Number|24|24.0||||||
4231456|NCT00682786|4054831|B3|2||Performance status|"Eastern Cooperative Oncology Group (ECOG) Performance Status Grade 0 Fully active able to carry on all predisease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (light house work/office work)~Ambulatory, capable of all selfcare but unable to carry out any work activities. Up & about more than 50% of waking hours~Capable of limited selfcare, confined to bed/chair more than 50% of waking hours~Completely disabled. Cannot carry on selfcare. Totally confined to bed/chair~Dead"|participants|Number|1|1.0||||||
4231457|NCT00682786|4054832|B2|2||Performance status|"Eastern Cooperative Oncology Group (ECOG) Performance Status Grade 0 Fully active able to carry on all predisease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (light house work/office work)~Ambulatory, capable of all selfcare but unable to carry out any work activities. Up & about more than 50% of waking hours~Capable of limited selfcare, confined to bed/chair more than 50% of waking hours~Completely disabled. Cannot carry on selfcare. Totally confined to bed/chair~Dead"|participants|Number|0|0.0||||||
4231458|NCT00682786|4054833|B1|2||Performance status|"Eastern Cooperative Oncology Group (ECOG) Performance Status Grade 0 Fully active able to carry on all predisease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (light house work/office work)~Ambulatory, capable of all selfcare but unable to carry out any work activities. Up & about more than 50% of waking hours~Capable of limited selfcare, confined to bed/chair more than 50% of waking hours~Completely disabled. Cannot carry on selfcare. Totally confined to bed/chair~Dead"|participants|Number|1|1.0||||||
4231459|NCT00682786|4054831|B3|1||Performance status|"Eastern Cooperative Oncology Group (ECOG) Performance Status Grade 0 Fully active able to carry on all predisease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (light house work/office work)~Ambulatory, capable of all selfcare but unable to carry out any work activities. Up & about more than 50% of waking hours~Capable of limited selfcare, confined to bed/chair more than 50% of waking hours~Completely disabled. Cannot carry on selfcare. Totally confined to bed/chair~Dead"|participants|Number|45|45.0||||||
4231501|NCT00682786|4054831|B3|||Age||years|Median|56|56.0|Full Range|||26.0|85.0|
4231502|NCT00682786|4054832|B2|||Age||years|Median|59|59.0|Full Range|||26.0|77.0|
4231503|NCT00682786|4054833|B1|||Age||years|Median|55|55.0|Full Range|||32.0|85.0|
4231460|NCT00682786|4054832|B2|1||Performance status|"Eastern Cooperative Oncology Group (ECOG) Performance Status Grade 0 Fully active able to carry on all predisease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (light house work/office work)~Ambulatory, capable of all selfcare but unable to carry out any work activities. Up & about more than 50% of waking hours~Capable of limited selfcare, confined to bed/chair more than 50% of waking hours~Completely disabled. Cannot carry on selfcare. Totally confined to bed/chair~Dead"|participants|Number|11|11.0||||||
4231461|NCT00682786|4054833|B1|1||Performance status|"Eastern Cooperative Oncology Group (ECOG) Performance Status Grade 0 Fully active able to carry on all predisease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (light house work/office work)~Ambulatory, capable of all selfcare but unable to carry out any work activities. Up & about more than 50% of waking hours~Capable of limited selfcare, confined to bed/chair more than 50% of waking hours~Completely disabled. Cannot carry on selfcare. Totally confined to bed/chair~Dead"|participants|Number|34|34.0||||||
4231462|NCT00682786|4054831|B3|0||Performance status|"Eastern Cooperative Oncology Group (ECOG) Performance Status Grade 0 Fully active able to carry on all predisease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (light house work/office work)~Ambulatory, capable of all selfcare but unable to carry out any work activities. Up & about more than 50% of waking hours~Capable of limited selfcare, confined to bed/chair more than 50% of waking hours~Completely disabled. Cannot carry on selfcare. Totally confined to bed/chair~Dead"|participants|Number|89|89.0||||||
4231463|NCT00682786|4054832|B2|0||Performance status|"Eastern Cooperative Oncology Group (ECOG) Performance Status Grade 0 Fully active able to carry on all predisease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (light house work/office work)~Ambulatory, capable of all selfcare but unable to carry out any work activities. Up & about more than 50% of waking hours~Capable of limited selfcare, confined to bed/chair more than 50% of waking hours~Completely disabled. Cannot carry on selfcare. Totally confined to bed/chair~Dead"|participants|Number|26|26.0||||||
4231464|NCT00682786|4054833|B1|0||Performance status|"Eastern Cooperative Oncology Group (ECOG) Performance Status Grade 0 Fully active able to carry on all predisease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (light house work/office work)~Ambulatory, capable of all selfcare but unable to carry out any work activities. Up & about more than 50% of waking hours~Capable of limited selfcare, confined to bed/chair more than 50% of waking hours~Completely disabled. Cannot carry on selfcare. Totally confined to bed/chair~Dead"|participants|Number|63|63.0||||||
4231465|NCT00682786|4054831|B3|*3/*4||Thymidylate Synthase Enhancer Region (TSER) genotype||participants|Number|2|2.0||||||
4231466|NCT00682786|4054832|B2|*3/*4||Thymidylate Synthase Enhancer Region (TSER) genotype||participants|Number|2|2.0||||||
4231467|NCT00682786|4054833|B1|*3/*4||Thymidylate Synthase Enhancer Region (TSER) genotype||participants|Number|0|0.0||||||
4231468|NCT00682786|4054831|B3|*3/*3||Thymidylate Synthase Enhancer Region (TSER) genotype||participants|Number|35|35.0||||||
4231469|NCT00682786|4054832|B2|*3/*3||Thymidylate Synthase Enhancer Region (TSER) genotype||participants|Number|35|35.0||||||
4231470|NCT00682786|4054833|B1|*3/*3||Thymidylate Synthase Enhancer Region (TSER) genotype||participants|Number|0|0.0||||||
4231471|NCT00682786|4054831|B3|*2/*4||Thymidylate Synthase Enhancer Region (TSER) genotype||participants|Number|1|1.0||||||
4231472|NCT00682786|4054832|B2|*2/*4||Thymidylate Synthase Enhancer Region (TSER) genotype||participants|Number|0|0.0||||||
4231473|NCT00682786|4054833|B1|*2/*4||Thymidylate Synthase Enhancer Region (TSER) genotype||participants|Number|1|1.0||||||
4231474|NCT00682786|4054831|B3|*2/*3||Thymidylate Synthase Enhancer Region (TSER) genotype||participants|Number|71|71.0||||||
4231475|NCT00682786|4054832|B2|*2/*3||Thymidylate Synthase Enhancer Region (TSER) genotype||participants|Number|0|0.0||||||
4231476|NCT00682786|4054833|B1|*2/*3||Thymidylate Synthase Enhancer Region (TSER) genotype||participants|Number|71|71.0||||||
4231477|NCT00682786|4054831|B3|*2/*2||Thymidylate Synthase Enhancer Region (TSER) genotype||participants|Number|26|26.0||||||
4231478|NCT00682786|4054832|B2|*2/*2||Thymidylate Synthase Enhancer Region (TSER) genotype||participants|Number|0|0.0||||||
4231479|NCT00682786|4054833|B1|*2/*2||Thymidylate Synthase Enhancer Region (TSER) genotype||participants|Number|26|26.0||||||
4231480|NCT00682786|4054831|B3|United States||Region of Enrollment||participants|Number|135|135.0||||||
4231481|NCT00682786|4054832|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4231482|NCT00682786|4054833|B1|United States||Region of Enrollment||participants|Number|98|98.0||||||
4231483|NCT00682786|4054831|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4231484|NCT00682786|4054832|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4231485|NCT00682786|4054833|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4231486|NCT00682786|4054831|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4231487|NCT00682786|4054832|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4231488|NCT00682786|4054833|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4231489|NCT00682786|4054831|B3|African American||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4231490|NCT00682786|4054832|B2|African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4231491|NCT00682786|4054833|B1|African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4231492|NCT00682786|4054831|B3|White||Race/Ethnicity, Customized||participants|Number|115|115.0||||||
4231493|NCT00682786|4054832|B2|White||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4231494|NCT00682786|4054833|B1|White||Race/Ethnicity, Customized||participants|Number|86|86.0||||||
4231495|NCT00682786|4054831|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4231496|NCT00682786|4054832|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4231497|NCT00682786|4054833|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4231504|NCT00682734|4054868|B4||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4231505|NCT00682734|4054869|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4231506|NCT00682734|4054870|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4231507|NCT00682734|4054871|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4231508|NCT00682734|4054868|B4||Female|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
4231509|NCT00682734|4054869|B3||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4231510|NCT00682734|4054870|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4231511|NCT00682734|4054871|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4231512|NCT00682734|4054868|B4|Adults||Age||years|Mean|38.2|38.2|Standard Deviation|11.1|11.1|||
4231513|NCT00682734|4054869|B3|Adults||Age||years|Mean|38.4|38.4|Standard Deviation|12.0|12.0|||
4231514|NCT00682734|4054870|B2|Adults||Age||years|Mean|37.5|37.5|Standard Deviation|9.9|9.9|||
4231515|NCT00682734|4054871|B1|Adults||Age||years|Mean|38.7|38.7|Standard Deviation|11.5|11.5|||
4231516|NCT00682643|4054881|B3|African American/African Heritage & White||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized and received at least one dose of double-blind study drug. One participant in the placebo group and one participant in the FF 110 mcg QD group did not receive any study drug and were thus not included in the ITT Population.|participants|Number|1|1.0||||||
4231517|NCT00682643|4054882|B2|African American/African Heritage & White||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized and received at least one dose of double-blind study drug. One participant in the placebo group and one participant in the FF 110 mcg QD group did not receive any study drug and were thus not included in the ITT Population.|participants|Number|0|0.0||||||
4231518|NCT00682643|4054883|B1|African American/African Heritage & White||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized and received at least one dose of double-blind study drug. One participant in the placebo group and one participant in the FF 110 mcg QD group did not receive any study drug and were thus not included in the ITT Population.|participants|Number|1|1.0||||||
4231519|NCT00682643|4054881|B3|White||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized and received at least one dose of double-blind study drug. One participant in the placebo group and one participant in the FF 110 mcg QD group did not receive any study drug and were thus not included in the ITT Population.|participants|Number|449|449.0||||||
4231520|NCT00682643|4054882|B2|White||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized and received at least one dose of double-blind study drug. One participant in the placebo group and one participant in the FF 110 mcg QD group did not receive any study drug and were thus not included in the ITT Population.|participants|Number|303|303.0||||||
4231521|NCT00682643|4054883|B1|White||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized and received at least one dose of double-blind study drug. One participant in the placebo group and one participant in the FF 110 mcg QD group did not receive any study drug and were thus not included in the ITT Population.|participants|Number|146|146.0||||||
4231522|NCT00682643|4054881|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized and received at least one dose of double-blind study drug. One participant in the placebo group and one participant in the FF 110 mcg QD group did not receive any study drug and were thus not included in the ITT Population.|participants|Number|4|4.0||||||
4231523|NCT00682643|4054882|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized and received at least one dose of double-blind study drug. One participant in the placebo group and one participant in the FF 110 mcg QD group did not receive any study drug and were thus not included in the ITT Population.|participants|Number|2|2.0||||||
4231524|NCT00682643|4054883|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized and received at least one dose of double-blind study drug. One participant in the placebo group and one participant in the FF 110 mcg QD group did not receive any study drug and were thus not included in the ITT Population.|participants|Number|2|2.0||||||
4231525|NCT00682643|4054881|B3|Mixed Asian Heritage||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized and received at least one dose of double-blind study drug. One participant in the placebo group and one participant in the FF 110 mcg QD group did not receive any study drug and were thus not included in the ITT Population.|participants|Number|1|1.0||||||
4231526|NCT00682643|4054882|B2|Mixed Asian Heritage||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized and received at least one dose of double-blind study drug. One participant in the placebo group and one participant in the FF 110 mcg QD group did not receive any study drug and were thus not included in the ITT Population.|participants|Number|1|1.0||||||
4231527|NCT00682643|4054883|B1|Mixed Asian Heritage||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized and received at least one dose of double-blind study drug. One participant in the placebo group and one participant in the FF 110 mcg QD group did not receive any study drug and were thus not included in the ITT Population.|participants|Number|0|0.0||||||
4231589|NCT00682539|4054942|B4||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4231590|NCT00682539|4054943|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4231528|NCT00682643|4054881|B3|Japanese/East Asian/South East Asian Heritage||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized and received at least one dose of double-blind study drug. One participant in the placebo group and one participant in the FF 110 mcg QD group did not receive any study drug and were thus not included in the ITT Population.|participants|Number|8|8.0||||||
4231529|NCT00682643|4054882|B2|Japanese/East Asian/South East Asian Heritage||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized and received at least one dose of double-blind study drug. One participant in the placebo group and one participant in the FF 110 mcg QD group did not receive any study drug and were thus not included in the ITT Population.|participants|Number|6|6.0||||||
4231530|NCT00682643|4054883|B1|Japanese/East Asian/South East Asian Heritage||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized and received at least one dose of double-blind study drug. One participant in the placebo group and one participant in the FF 110 mcg QD group did not receive any study drug and were thus not included in the ITT Population.|participants|Number|2|2.0||||||
4231531|NCT00682643|4054881|B3|Central/South Asian Heritage||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized and received at least one dose of double-blind study drug. One participant in the placebo group and one participant in the FF 110 mcg QD group did not receive any study drug and were thus not included in the ITT Population.|participants|Number|1|1.0||||||
4231532|NCT00682643|4054882|B2|Central/South Asian Heritage||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized and received at least one dose of double-blind study drug. One participant in the placebo group and one participant in the FF 110 mcg QD group did not receive any study drug and were thus not included in the ITT Population.|participants|Number|1|1.0||||||
4231533|NCT00682643|4054883|B1|Central/South Asian Heritage||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized and received at least one dose of double-blind study drug. One participant in the placebo group and one participant in the FF 110 mcg QD group did not receive any study drug and were thus not included in the ITT Population.|participants|Number|0|0.0||||||
4231534|NCT00682643|4054881|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized and received at least one dose of double-blind study drug. One participant in the placebo group and one participant in the FF 110 mcg QD group did not receive any study drug and were thus not included in the ITT Population.|participants|Number|5|5.0||||||
4231535|NCT00682643|4054882|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized and received at least one dose of double-blind study drug. One participant in the placebo group and one participant in the FF 110 mcg QD group did not receive any study drug and were thus not included in the ITT Population.|participants|Number|4|4.0||||||
4231536|NCT00682643|4054883|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized and received at least one dose of double-blind study drug. One participant in the placebo group and one participant in the FF 110 mcg QD group did not receive any study drug and were thus not included in the ITT Population.|participants|Number|1|1.0||||||
4231537|NCT00682643|4054881|B3|African American/African Heritage||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized and received at least one dose of double-blind study drug. One participant in the placebo group and one participant in the FF 110 mcg QD group did not receive any study drug and were thus not included in the ITT Population.|participants|Number|79|79.0||||||
4231538|NCT00682643|4054882|B2|African American/African Heritage||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized and received at least one dose of double-blind study drug. One participant in the placebo group and one participant in the FF 110 mcg QD group did not receive any study drug and were thus not included in the ITT Population.|participants|Number|50|50.0||||||
4231539|NCT00682643|4054883|B1|African American/African Heritage||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized and received at least one dose of double-blind study drug. One participant in the placebo group and one participant in the FF 110 mcg QD group did not receive any study drug and were thus not included in the ITT Population.|participants|Number|29|29.0||||||
4231540|NCT00682643|4054881|B3||Male|Gender|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized and received at least one dose of double-blind study drug. One participant in the placebo group and one participant in the FF 110 mcg QD group did not receive any study drug and were thus not included in the ITT Population.|Participants|Count of Participants|177|177.0||||||
4231541|NCT00682643|4054882|B2||Male|Gender|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized and received at least one dose of double-blind study drug. One participant in the placebo group and one participant in the FF 110 mcg QD group did not receive any study drug and were thus not included in the ITT Population.|Participants|Count of Participants|112|112.0||||||
4231542|NCT00682643|4054883|B1||Male|Gender|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized and received at least one dose of double-blind study drug. One participant in the placebo group and one participant in the FF 110 mcg QD group did not receive any study drug and were thus not included in the ITT Population.|Participants|Count of Participants|65|65.0||||||
4231591|NCT00682539|4054944|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4231592|NCT00682539|4054945|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4231650|NCT00682357|4054984|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231543|NCT00682643|4054881|B3||Female|Gender|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized and received at least one dose of double-blind study drug. One participant in the placebo group and one participant in the FF 110 mcg QD group did not receive any study drug and were thus not included in the ITT Population.|Participants|Count of Participants|371|371.0||||||
4231544|NCT00682643|4054882|B2||Female|Gender|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized and received at least one dose of double-blind study drug. One participant in the placebo group and one participant in the FF 110 mcg QD group did not receive any study drug and were thus not included in the ITT Population.|Participants|Count of Participants|255|255.0||||||
4231545|NCT00682643|4054883|B1||Female|Gender|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized and received at least one dose of double-blind study drug. One participant in the placebo group and one participant in the FF 110 mcg QD group did not receive any study drug and were thus not included in the ITT Population.|Participants|Count of Participants|116|116.0||||||
4231546|NCT00682643|4054881|B3|||Age|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized and received at least one dose of double-blind study drug. One participant in the placebo group and one participant in the FF 110 mcg QD group did not receive any study drug and were thus not included in the ITT Population.|Years|Mean|37.4|37.4|Standard Deviation|13.43|13.43|||
4231547|NCT00682643|4054882|B2|||Age|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized and received at least one dose of double-blind study drug. One participant in the placebo group and one participant in the FF 110 mcg QD group did not receive any study drug and were thus not included in the ITT Population.|Years|Mean|37.0|37.0|Standard Deviation|13.48|13.48|||
4231548|NCT00682643|4054883|B1|||Age|Baseline Characteristics were collected in members of the Intent-to-Treat (ITT) Population, comprised of all participants who were randomized and received at least one dose of double-blind study drug. One participant in the placebo group and one participant in the FF 110 mcg QD group did not receive any study drug and were thus not included in the ITT Population.|Years|Mean|38.0|38.0|Standard Deviation|13.34|13.34|||
4231549|NCT00682565|4054916|B4|Georgia||Region of Enrollment||participants|Number|73|73.0||||||
4231550|NCT00682565|4054917|B3|Georgia||Region of Enrollment||participants|Number|22|22.0||||||
4231551|NCT00682565|4054918|B2|Georgia||Region of Enrollment||participants|Number|20|20.0||||||
4231552|NCT00682565|4054919|B1|Georgia||Region of Enrollment||participants|Number|31|31.0||||||
4231553|NCT00682565|4054916|B4|Russian Federation||Region of Enrollment||participants|Number|21|21.0||||||
4231554|NCT00682565|4054917|B3|Russian Federation||Region of Enrollment||participants|Number|7|7.0||||||
4231555|NCT00682565|4054918|B2|Russian Federation||Region of Enrollment||participants|Number|14|14.0||||||
4231556|NCT00682565|4054919|B1|Russian Federation||Region of Enrollment||participants|Number|0|0.0||||||
4231557|NCT00682565|4054916|B4||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4231558|NCT00682565|4054917|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4231559|NCT00682565|4054918|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4231560|NCT00682565|4054919|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4231561|NCT00682565|4054916|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4231562|NCT00682565|4054917|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4231563|NCT00682565|4054918|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4231564|NCT00682565|4054919|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4231565|NCT00682565|4054916|B4|||Age||years|Mean|63.4|63.4|Standard Deviation|9.3|9.3|||
4231566|NCT00682565|4054917|B3|||Age||years|Mean|62.3|62.3|Standard Deviation|9.8|9.8|||
4231567|NCT00682565|4054918|B2|||Age||years|Mean|62.6|62.6|Standard Deviation|8.1|8.1|||
4231568|NCT00682565|4054919|B1|||Age||years|Mean|65.2|65.2|Standard Deviation|10.0|10.0|||
4231569|NCT00682565|4054916|B4||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
4231570|NCT00682565|4054917|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4231571|NCT00682565|4054918|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4231572|NCT00682565|4054919|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4231573|NCT00682565|4054916|B4||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4231574|NCT00682565|4054917|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4231575|NCT00682565|4054918|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4231576|NCT00682565|4054919|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4231577|NCT00682565|4054916|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231578|NCT00682565|4054917|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231579|NCT00682565|4054918|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231580|NCT00682565|4054919|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231581|NCT00682539|4054942|B4||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4231582|NCT00682539|4054943|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4231583|NCT00682539|4054944|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4231584|NCT00682539|4054945|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4231585|NCT00682539|4054942|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4231586|NCT00682539|4054943|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4231587|NCT00682539|4054944|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4231588|NCT00682539|4054945|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4231593|NCT00682539|4054942|B4||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4231594|NCT00682539|4054943|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4231595|NCT00682539|4054944|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4231596|NCT00682539|4054945|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4231597|NCT00682539|4054942|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231598|NCT00682539|4054943|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231599|NCT00682539|4054944|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231600|NCT00682539|4054945|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231601|NCT00682461|4054958|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4231602|NCT00682461|4054959|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4231603|NCT00682461|4054960|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4231604|NCT00682461|4054958|B3||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4231605|NCT00682461|4054959|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4231606|NCT00682461|4054960|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4231607|NCT00682461|4054958|B3|||Age||Years|Mean|42.58|42.58|Standard Deviation|12.042|12.042|||
4231608|NCT00682461|4054959|B2|||Age||Years|Mean|42.84|42.84|Standard Deviation|12.34|12.34|||
4231609|NCT00682461|4054960|B1|||Age||Years|Mean|42.32|42.32|Standard Deviation|11.79|11.79|||
4231610|NCT00682435|4054975|B1|No||Number of participants experiencing Nausea or Vomiting before baseline||Participants|Count of Participants|138|138.0||||||
4231611|NCT00682435|4054975|B1|Yes||Number of participants experiencing Nausea or Vomiting before baseline||Participants|Count of Participants|85|85.0||||||
4231612|NCT00682435|4054975|B1|10||Pain intensity|Pain intensity is measured on the numerical rating scale (NRS), from 0 (no pain) to 10 (worst pain imaginable)|Participants|Count of Participants|119|119.0||||||
4231613|NCT00682435|4054975|B1|9||Pain intensity|Pain intensity is measured on the numerical rating scale (NRS), from 0 (no pain) to 10 (worst pain imaginable)|Participants|Count of Participants|36|36.0||||||
4231614|NCT00682435|4054975|B1|8||Pain intensity|Pain intensity is measured on the numerical rating scale (NRS), from 0 (no pain) to 10 (worst pain imaginable)|Participants|Count of Participants|39|39.0||||||
4231615|NCT00682435|4054975|B1|7||Pain intensity|Pain intensity is measured on the numerical rating scale (NRS), from 0 (no pain) to 10 (worst pain imaginable)|Participants|Count of Participants|17|17.0||||||
4231616|NCT00682435|4054975|B1|4-6||Pain intensity|Pain intensity is measured on the numerical rating scale (NRS), from 0 (no pain) to 10 (worst pain imaginable)|Participants|Count of Participants|12|12.0||||||
4231617|NCT00682435|4054975|B1|Other||Location of pain||Participants|Count of Participants|74|74.0||||||
4231618|NCT00682435|4054975|B1|Abdomen||Location of pain||Participants|Count of Participants|149|149.0||||||
4231619|NCT00682435|4054975|B1|||Weight||lbs|Median|179|179.0|Inter-Quartile Range|||147.0|200.0|
4231620|NCT00682435|4054975|B1|United States||Region of Enrollment||Participants|Count of Participants|223|223.0||||||
4231621|NCT00682435|4054975|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4231622|NCT00682435|4054975|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
4231623|NCT00682435|4054975|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|65|65.0||||||
4231624|NCT00682435|4054975|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|134|134.0||||||
4231625|NCT00682435|4054975|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4231626|NCT00682435|4054975|B1||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4231627|NCT00682435|4054975|B1|||Age||years|Median|40|40.0|Inter-Quartile Range|||30.0|50.0|
4231628|NCT00682357|4054982|B4|United States||Region of Enrollment||participants|Number|25|25.0||||||
4231629|NCT00682357|4054983|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4231630|NCT00682357|4054984|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4231631|NCT00682357|4054985|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4231632|NCT00682357|4054982|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4231633|NCT00682357|4054983|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4231634|NCT00682357|4054984|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4231635|NCT00682357|4054985|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4231636|NCT00682357|4054982|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4231637|NCT00682357|4054983|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4231638|NCT00682357|4054984|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4231639|NCT00682357|4054985|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4231640|NCT00682357|4054982|B4||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4231641|NCT00682357|4054983|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4231642|NCT00682357|4054984|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4231643|NCT00682357|4054985|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4231644|NCT00682357|4054982|B4||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4231645|NCT00682357|4054983|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4231646|NCT00682357|4054984|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4231647|NCT00682357|4054985|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4231648|NCT00682357|4054982|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231649|NCT00682357|4054983|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231651|NCT00682357|4054985|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231652|NCT00681889|4055004|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4231653|NCT00681889|4055004|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4231654|NCT00681889|4055004|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4231655|NCT00681889|4055004|B1|||Age||years|Mean|57.3|57.3|Standard Deviation|14.5|14.5|||
4231656|NCT00681889|4055004|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4231657|NCT00681889|4055004|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4231658|NCT00681889|4055004|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231659|NCT00681863|4055008|B1|Received pramipexole||Treatment received in previous trial (NCT00558467)||Participants|Number|31|31.0||||||
4231660|NCT00681863|4055008|B1|Received placebo||Treatment received in previous trial (NCT00558467)||Participants|Number|14|14.0||||||
4231661|NCT00681863|4055008|B1|Negative||Attention Deficit Hyperactive Disorder|Diagnosis of disorder was performed using National Institute of Mental Health Diagnostic Interview Schedule for Children (NIMH DISC-IV)|participants|Number|22|22.0||||||
4231662|NCT00681863|4055008|B1|Intermediate||Attention Deficit Hyperactive Disorder|Diagnosis of disorder was performed using National Institute of Mental Health Diagnostic Interview Schedule for Children (NIMH DISC-IV)|participants|Number|6|6.0||||||
4231663|NCT00681863|4055008|B1|Positive||Attention Deficit Hyperactive Disorder|Diagnosis of disorder was performed using National Institute of Mental Health Diagnostic Interview Schedule for Children (NIMH DISC-IV)|participants|Number|17|17.0||||||
4231664|NCT00681863|4055008|B1|Negative||Obsessive Compulsive Disorder|Diagnosis of disorder was performed using National Institute of Mental Health Diagnostic Interview Schedule for Children (NIMH DISC-IV)|Participants|Number|37|37.0||||||
4231665|NCT00681863|4055008|B1|Intermediate||Obsessive Compulsive Disorder|Diagnosis of disorder was performed using National Institute of Mental Health Diagnostic Interview Schedule for Children (NIMH DISC-IV)|Participants|Number|4|4.0||||||
4231666|NCT00681863|4055008|B1|Positive||Obsessive Compulsive Disorder|Diagnosis of disorder was performed using National Institute of Mental Health Diagnostic Interview Schedule for Children (NIMH DISC-IV)|Participants|Number|4|4.0||||||
4231667|NCT00681863|4055008|B1|||Respiration||breaths/minute|Mean|17.4|17.4|Standard Deviation|2.0|2.0|||
4231668|NCT00681863|4055008|B1|||Body temperature||Degrees centigrade|Mean|36.752|36.752|Standard Deviation|0.718|0.718|||
4231669|NCT00681863|4055008|B1|||Body mass index||kilograms/square meter|Mean|22.064|22.064|Standard Deviation|5.930|5.93|||
4231670|NCT00681863|4055008|B1|||Weight||kilograms|Mean|53.01|53.01|Standard Deviation|21.58|21.58|||
4231671|NCT00681863|4055008|B1|||Height||centimeters|Mean|152.6|152.6|Standard Deviation|19.4|19.4|||
4231672|NCT00681863|4055008|B1|1 to 5 years||Duration of Tourettes Syndrome||Participants|Number|20|20.0||||||
4231673|NCT00681863|4055008|B1|Less than 1 year||Duration of Tourettes Syndrome||Participants|Number|15|15.0||||||
4231674|NCT00681863|4055008|B1|More than 5 years||Duration of Tourettes Syndrome||Participants|Number|10|10.0||||||
4231675|NCT00681863|4055008|B1|White||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4231676|NCT00681863|4055008|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4231677|NCT00681863|4055008|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4231678|NCT00681863|4055008|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4231679|NCT00681863|4055008|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4231680|NCT00681863|4055008|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4231681|NCT00681863|4055008|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4231682|NCT00681863|4055008|B1|||Age||Years|Mean|11.8|11.8|Standard Deviation|2.8|2.8|||
4231683|NCT00681824|4055053|B4|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4231684|NCT00681824|4055054|B3|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4231685|NCT00681824|4055055|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4231686|NCT00681824|4055056|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4231687|NCT00681824|4055053|B4|United States||Region of Enrollment||participants|Number|67|67.0||||||
4231688|NCT00681824|4055054|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4231689|NCT00681824|4055055|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4231690|NCT00681824|4055056|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4231691|NCT00681824|4055053|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4231692|NCT00681824|4055054|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4231693|NCT00681824|4055055|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4231694|NCT00681824|4055056|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4231695|NCT00681824|4055053|B4||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4231696|NCT00681824|4055054|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4231697|NCT00681824|4055055|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4231698|NCT00681824|4055056|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4231699|NCT00681824|4055053|B4|||Age||years|Mean|37.5|37.5|Standard Deviation|19.6|19.6|||
4231700|NCT00681824|4055054|B3|||Age||years|Mean|33.3|33.3|Standard Deviation|19.01|19.01|||
4231701|NCT00681824|4055055|B2|||Age||years|Mean|42.9|42.9|Standard Deviation|20.34|20.34|||
4231702|NCT00681824|4055056|B1|||Age||years|Mean|40.2|40.2|Standard Deviation|19.7|19.7|||
4231703|NCT00681811|4055074|B3|Denmark||Region of Enrollment||participants|Number|11|11.0||||||
4231704|NCT00681811|4055075|B2|Denmark||Region of Enrollment||participants|Number|5|5.0||||||
4231705|NCT00681811|4055076|B1|Denmark||Region of Enrollment||participants|Number|6|6.0||||||
4231706|NCT00681811|4055074|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4231707|NCT00681811|4055075|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4231708|NCT00681811|4055076|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4231709|NCT00681811|4055074|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4231710|NCT00681811|4055075|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4231711|NCT00681811|4055076|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4231712|NCT00681811|4055074|B3|||Age|Age at Week 54 or Week 56 in HGT-MLD-049 (NCT00681811)|months|Mean|51.71|51.71|Standard Deviation|9.420|9.42|||
4231713|NCT00681811|4055075|B2|||Age|Age at Week 54 or Week 56 in HGT-MLD-049 (NCT00681811)|months|Mean|49.99|49.99|Standard Deviation|8.752|8.752|||
4231714|NCT00681811|4055076|B1|||Age|Age at Week 54 or Week 56 in HGT-MLD-049 (NCT00681811)|months|Mean|53.14|53.14|Standard Deviation|10.526|10.526|||
4231715|NCT00681811|4055074|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4231716|NCT00681811|4055075|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4231717|NCT00681811|4055076|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4231718|NCT00681811|4055074|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4231719|NCT00681811|4055075|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4231720|NCT00681811|4055076|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4231721|NCT00681811|4055074|B3||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4231722|NCT00681811|4055075|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4231723|NCT00681811|4055076|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4231724|NCT00681668|4055105|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4231725|NCT00681668|4055105|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4231726|NCT00681668|4055105|B1|>= 65 years||Age, Customized||Participants|Number|0|0.0||||||
4231727|NCT00681668|4055105|B1|Between 18 and 65 years||Age, Customized||Participants|Number|0|0.0||||||
4231728|NCT00681668|4055105|B1|18 to < 40 years||Age, Customized||Participants|Number|5|5.0||||||
4231729|NCT00681629|4055112|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4231730|NCT00681629|4055113|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4231731|NCT00681629|4055114|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4231732|NCT00681629|4055112|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4231733|NCT00681629|4055113|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4231734|NCT00681629|4055114|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4231735|NCT00681629|4055112|B3|18-65 years||Age, Customized||Participants|Number|7|7.0||||||
4231736|NCT00681629|4055113|B2|18-65 years||Age, Customized||Participants|Number|2|2.0||||||
4231737|NCT00681629|4055114|B1|18-65 years||Age, Customized||Participants|Number|5|5.0||||||
4231738|NCT00681590|4055159|B3||Male|Gender||Participants|Count of Participants|18|18.0||||||
4231739|NCT00681590|4055160|B2||Male|Gender||Participants|Count of Participants|12|12.0||||||
4231740|NCT00681590|4055161|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
4231741|NCT00681590|4055159|B3||Female|Gender||Participants|Count of Participants|87|87.0||||||
4231742|NCT00681590|4055160|B2||Female|Gender||Participants|Count of Participants|59|59.0||||||
4231743|NCT00681590|4055161|B1||Female|Gender||Participants|Count of Participants|28|28.0||||||
4231744|NCT00681590|4055159|B3|||Age||years|Mean|73.5|73.5|Standard Deviation|6.5|6.5|||
4231745|NCT00681590|4055160|B2|||Age||years|Mean|73.9|73.9|Standard Deviation|6.7|6.7|||
4231746|NCT00681590|4055161|B1|||Age||years|Mean|72.8|72.8|Standard Deviation|5.9|5.9|||
4231747|NCT00681564|4055170|B3|||Serum C-reactive protein (CRP)|"Fasting plasma hs-CRP concentrations were determined using a solid-phase, chemiluminescent immunometric assay (Immulite 1000, Siemens). Baseline serum samples were not collected for one patient randomized into the periodontal prophylaxis group because of inaccessible veins.~Number of patients analyzed:~Periodontal intervention (n=47); Periodontal prophylaxis (n=54); Total (n=101)."|mg/L|Mean|3.6|3.6|Standard Deviation|5.4|5.4|||
4231748|NCT00681564|4055171|B2|||Serum C-reactive protein (CRP)|"Fasting plasma hs-CRP concentrations were determined using a solid-phase, chemiluminescent immunometric assay (Immulite 1000, Siemens). Baseline serum samples were not collected for one patient randomized into the periodontal prophylaxis group because of inaccessible veins.~Number of patients analyzed:~Periodontal intervention (n=47); Periodontal prophylaxis (n=54); Total (n=101)."|mg/L|Mean|3.1|3.1|Standard Deviation|3.6|3.6|||
4231749|NCT00681564|4055172|B1|||Serum C-reactive protein (CRP)|"Fasting plasma hs-CRP concentrations were determined using a solid-phase, chemiluminescent immunometric assay (Immulite 1000, Siemens). Baseline serum samples were not collected for one patient randomized into the periodontal prophylaxis group because of inaccessible veins.~Number of patients analyzed:~Periodontal intervention (n=47); Periodontal prophylaxis (n=54); Total (n=101)."|mg/L|Mean|4|4.0|Standard Deviation|7|7.0|||
4231750|NCT00681564|4055170|B3|||Endothelium-dependent brachial artery flow-mediated dilatation|"Assessments of vascular function were performed in the morning, in a temperature controlled room, with participants required to fast for at least 8 hours.~Flow-mediated endothelium dependent vasodilatation of the brachial artery (FMD) was determined using the technique previously described by Celermajer et al. (doi: 10.1016/0140-6736(92)93147-F.) and Coretti et al. ( doi: 10.1111/j.1399-302X.1996.tb00183.x.).~FMD was calculated as the percentage of change in the diameter of brachial artery measured 45-60 s after cuff release in relation to the baseline measure."|Percentage of dilation|Mean|9.9|9.9|Standard Deviation|7.9|7.9|||
4231790|NCT00681564|4055171|B2|Currently smoking||Smoking status||participants|Number|14|14.0||||||
4231791|NCT00681564|4055172|B1|Currently smoking||Smoking status||participants|Number|12|12.0||||||
4231751|NCT00681564|4055171|B2|||Endothelium-dependent brachial artery flow-mediated dilatation|"Assessments of vascular function were performed in the morning, in a temperature controlled room, with participants required to fast for at least 8 hours.~Flow-mediated endothelium dependent vasodilatation of the brachial artery (FMD) was determined using the technique previously described by Celermajer et al. (doi: 10.1016/0140-6736(92)93147-F.) and Coretti et al. ( doi: 10.1111/j.1399-302X.1996.tb00183.x.).~FMD was calculated as the percentage of change in the diameter of brachial artery measured 45-60 s after cuff release in relation to the baseline measure."|Percentage of dilation|Mean|9.9|9.9|Standard Deviation|8.5|8.5|||
4231752|NCT00681564|4055172|B1|||Endothelium-dependent brachial artery flow-mediated dilatation|"Assessments of vascular function were performed in the morning, in a temperature controlled room, with participants required to fast for at least 8 hours.~Flow-mediated endothelium dependent vasodilatation of the brachial artery (FMD) was determined using the technique previously described by Celermajer et al. (doi: 10.1016/0140-6736(92)93147-F.) and Coretti et al. ( doi: 10.1111/j.1399-302X.1996.tb00183.x.).~FMD was calculated as the percentage of change in the diameter of brachial artery measured 45-60 s after cuff release in relation to the baseline measure."|Percentage of dilation|Mean|9.9|9.9|Standard Deviation|7.4|7.4|||
4231753|NCT00681564|4055170|B3|Prepaid medicine plan||Medical insurance||participants|Number|2|2.0||||||
4231754|NCT00681564|4055171|B2|Prepaid medicine plan||Medical insurance||participants|Number|1|1.0||||||
4231755|NCT00681564|4055172|B1|Prepaid medicine plan||Medical insurance||participants|Number|1|1.0||||||
4231756|NCT00681564|4055170|B3|Contributory regime (private insurance)||Medical insurance||participants|Number|26|26.0||||||
4231757|NCT00681564|4055171|B2|Contributory regime (private insurance)||Medical insurance||participants|Number|15|15.0||||||
4231758|NCT00681564|4055172|B1|Contributory regime (private insurance)||Medical insurance||participants|Number|11|11.0||||||
4231759|NCT00681564|4055170|B3|State-subsidized healthcare||Medical insurance||participants|Number|64|64.0||||||
4231760|NCT00681564|4055171|B2|State-subsidized healthcare||Medical insurance||participants|Number|34|34.0||||||
4231761|NCT00681564|4055172|B1|State-subsidized healthcare||Medical insurance||participants|Number|30|30.0||||||
4231762|NCT00681564|4055170|B3|None||Medical insurance||participants|Number|10|10.0||||||
4231763|NCT00681564|4055171|B2|None||Medical insurance||participants|Number|5|5.0||||||
4231764|NCT00681564|4055172|B1|None||Medical insurance||participants|Number|5|5.0||||||
4231765|NCT00681564|4055170|B3|More than $600 USD||Family monthly income|Economic incomes are presented in United States Dollars (USD). Exchange rate used in this study for the conversion of Colombian Pesos (COP) to USD: 2000 COP = 1 USD.|participants|Number|14|14.0||||||
4231766|NCT00681564|4055171|B2|More than $600 USD||Family monthly income|Economic incomes are presented in United States Dollars (USD). Exchange rate used in this study for the conversion of Colombian Pesos (COP) to USD: 2000 COP = 1 USD.|participants|Number|10|10.0||||||
4231767|NCT00681564|4055172|B1|More than $600 USD||Family monthly income|Economic incomes are presented in United States Dollars (USD). Exchange rate used in this study for the conversion of Colombian Pesos (COP) to USD: 2000 COP = 1 USD.|participants|Number|4|4.0||||||
4231768|NCT00681564|4055170|B3|≥ $300 and ≤ $600 USD||Family monthly income|Economic incomes are presented in United States Dollars (USD). Exchange rate used in this study for the conversion of Colombian Pesos (COP) to USD: 2000 COP = 1 USD.|participants|Number|46|46.0||||||
4231769|NCT00681564|4055171|B2|≥ $300 and ≤ $600 USD||Family monthly income|Economic incomes are presented in United States Dollars (USD). Exchange rate used in this study for the conversion of Colombian Pesos (COP) to USD: 2000 COP = 1 USD.|participants|Number|22|22.0||||||
4231770|NCT00681564|4055172|B1|≥ $300 and ≤ $600 USD||Family monthly income|Economic incomes are presented in United States Dollars (USD). Exchange rate used in this study for the conversion of Colombian Pesos (COP) to USD: 2000 COP = 1 USD.|participants|Number|24|24.0||||||
4231771|NCT00681564|4055170|B3|Less than $300 USD||Family monthly income|Economic incomes are presented in United States Dollars (USD). Exchange rate used in this study for the conversion of Colombian Pesos (COP) to USD: 2000 COP = 1 USD.|participants|Number|42|42.0||||||
4231772|NCT00681564|4055171|B2|Less than $300 USD||Family monthly income|Economic incomes are presented in United States Dollars (USD). Exchange rate used in this study for the conversion of Colombian Pesos (COP) to USD: 2000 COP = 1 USD.|participants|Number|23|23.0||||||
4231773|NCT00681564|4055172|B1|Less than $300 USD||Family monthly income|Economic incomes are presented in United States Dollars (USD). Exchange rate used in this study for the conversion of Colombian Pesos (COP) to USD: 2000 COP = 1 USD.|participants|Number|19|19.0||||||
4231774|NCT00681564|4055170|B3|Higher education (12 or more years)||Formal education||participants|Number|24|24.0||||||
4231775|NCT00681564|4055171|B2|Higher education (12 or more years)||Formal education||participants|Number|13|13.0||||||
4231776|NCT00681564|4055172|B1|Higher education (12 or more years)||Formal education||participants|Number|11|11.0||||||
4231777|NCT00681564|4055170|B3|Secondary education (6 to 11 years)||Formal education||participants|Number|47|47.0||||||
4231778|NCT00681564|4055171|B2|Secondary education (6 to 11 years)||Formal education||participants|Number|25|25.0||||||
4231779|NCT00681564|4055172|B1|Secondary education (6 to 11 years)||Formal education||participants|Number|22|22.0||||||
4231780|NCT00681564|4055170|B3|Elementary education (1 to 5 years)||Formal education||participants|Number|31|31.0||||||
4231781|NCT00681564|4055171|B2|Elementary education (1 to 5 years)||Formal education||participants|Number|17|17.0||||||
4231782|NCT00681564|4055172|B1|Elementary education (1 to 5 years)||Formal education||participants|Number|14|14.0||||||
4231783|NCT00681564|4055170|B3|Former smoker||Smoking status||participants|Number|24|24.0||||||
4231784|NCT00681564|4055171|B2|Former smoker||Smoking status||participants|Number|13|13.0||||||
4231785|NCT00681564|4055172|B1|Former smoker||Smoking status||participants|Number|11|11.0||||||
4231786|NCT00681564|4055170|B3|Never smoker||Smoking status||participants|Number|52|52.0||||||
4231787|NCT00681564|4055171|B2|Never smoker||Smoking status||participants|Number|28|28.0||||||
4231788|NCT00681564|4055172|B1|Never smoker||Smoking status||participants|Number|24|24.0||||||
4231789|NCT00681564|4055170|B3|Currently smoking||Smoking status||participants|Number|26|26.0||||||
4231792|NCT00681564|4055170|B3|Mixed ethnicity||Race/Ethnicity, Customized|Ethnicity self reported by the participant of this clinical trial.|participants|Number|78|78.0||||||
4231793|NCT00681564|4055171|B2|Mixed ethnicity||Race/Ethnicity, Customized|Ethnicity self reported by the participant of this clinical trial.|participants|Number|42|42.0||||||
4231794|NCT00681564|4055172|B1|Mixed ethnicity||Race/Ethnicity, Customized|Ethnicity self reported by the participant of this clinical trial.|participants|Number|36|36.0||||||
4231795|NCT00681564|4055170|B3|Indian||Race/Ethnicity, Customized|Ethnicity self reported by the participant of this clinical trial.|participants|Number|3|3.0||||||
4231796|NCT00681564|4055171|B2|Indian||Race/Ethnicity, Customized|Ethnicity self reported by the participant of this clinical trial.|participants|Number|3|3.0||||||
4231797|NCT00681564|4055172|B1|Indian||Race/Ethnicity, Customized|Ethnicity self reported by the participant of this clinical trial.|participants|Number|0|0.0||||||
4231798|NCT00681564|4055170|B3|Black||Race/Ethnicity, Customized|Ethnicity self reported by the participant of this clinical trial.|participants|Number|10|10.0||||||
4231799|NCT00681564|4055171|B2|Black||Race/Ethnicity, Customized|Ethnicity self reported by the participant of this clinical trial.|participants|Number|5|5.0||||||
4231800|NCT00681564|4055172|B1|Black||Race/Ethnicity, Customized|Ethnicity self reported by the participant of this clinical trial.|participants|Number|5|5.0||||||
4231801|NCT00681564|4055170|B3|White||Race/Ethnicity, Customized|Ethnicity self reported by the participant of this clinical trial.|participants|Number|11|11.0||||||
4231802|NCT00681564|4055171|B2|White||Race/Ethnicity, Customized|Ethnicity self reported by the participant of this clinical trial.|participants|Number|5|5.0||||||
4231803|NCT00681564|4055172|B1|White||Race/Ethnicity, Customized|Ethnicity self reported by the participant of this clinical trial.|participants|Number|6|6.0||||||
4231804|NCT00681564|4055170|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4231805|NCT00681564|4055171|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4231806|NCT00681564|4055172|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4231807|NCT00681564|4055170|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4231808|NCT00681564|4055171|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4231809|NCT00681564|4055172|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4231810|NCT00681564|4055170|B3|||Age||years|Mean|45.5|45.5|Standard Deviation|6.9|6.9|||
4231811|NCT00681564|4055171|B2|||Age||years|Mean|45.5|45.5|Standard Deviation|8.1|8.1|||
4231812|NCT00681564|4055172|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|9.4|9.4|||
4231813|NCT00681538|4055201|B3|||Baseline Spasticity numerical rating scale (NRS) Score Phase B|"Of the 572 subjects who entered Phase A, 241 entered Phase B; 124 randomised to Sativex and 117 to placebo.~Subjects were asked “On a scale of ‘0 to 10’ please indicate the average level of your spasticity over the last 24 hours” with the anchors: 0 = ‘no spasticity’ and 10 = ‘worst possible spasticity’. They were asked to relate ‘no spasticity’ to the time prior to the onset of their spasticity."|Score|Mean|3.90|3.9|Standard Deviation|1.51|1.51|||
4231814|NCT00681538|4055202|B2|||Baseline Spasticity numerical rating scale (NRS) Score Phase B|"Of the 572 subjects who entered Phase A, 241 entered Phase B; 124 randomised to Sativex and 117 to placebo.~Subjects were asked “On a scale of ‘0 to 10’ please indicate the average level of your spasticity over the last 24 hours” with the anchors: 0 = ‘no spasticity’ and 10 = ‘worst possible spasticity’. They were asked to relate ‘no spasticity’ to the time prior to the onset of their spasticity."|Score|Mean|3.92|3.92|Standard Deviation|1.55|1.55|||
4231815|NCT00681538|4055203|B1|||Baseline Spasticity numerical rating scale (NRS) Score Phase B|"Of the 572 subjects who entered Phase A, 241 entered Phase B; 124 randomised to Sativex and 117 to placebo.~Subjects were asked “On a scale of ‘0 to 10’ please indicate the average level of your spasticity over the last 24 hours” with the anchors: 0 = ‘no spasticity’ and 10 = ‘worst possible spasticity’. They were asked to relate ‘no spasticity’ to the time prior to the onset of their spasticity."|Score|Mean|3.87|3.87|Standard Deviation|1.49|1.49|||
4231816|NCT00681538|4055201|B3|||Expanded Disability Status Scale (EDSS)- Phase B|241 entered Phase B; 124 randomised to Sativex and 117 to placebo. EDSS is a method of quantifying disability in multiple sclerosis.The EDSS quantifies disability in eight Functional Systems (FS) and allows neurologists to assign a Functional System Score in each of these. EDSS steps 1.0 to 4.5 refer to people with MS who are fully ambulatory. EDSS steps 5.0 to 9.5 are defined by the impairment to ambulation. Each score is given a definition and thus can identify for the subject their score depending on their condition e.g. score of 1.0: No disability, minimal signs on 1 FS.|Score|Mean|6.0|6.0|Standard Deviation|1.45|1.45|||
4231817|NCT00681538|4055202|B2|||Expanded Disability Status Scale (EDSS)- Phase B|241 entered Phase B; 124 randomised to Sativex and 117 to placebo. EDSS is a method of quantifying disability in multiple sclerosis.The EDSS quantifies disability in eight Functional Systems (FS) and allows neurologists to assign a Functional System Score in each of these. EDSS steps 1.0 to 4.5 refer to people with MS who are fully ambulatory. EDSS steps 5.0 to 9.5 are defined by the impairment to ambulation. Each score is given a definition and thus can identify for the subject their score depending on their condition e.g. score of 1.0: No disability, minimal signs on 1 FS.|Score|Mean|6.0|6.0|Standard Deviation|1.44|1.44|||
4231818|NCT00681538|4055203|B1|||Expanded Disability Status Scale (EDSS)- Phase B|241 entered Phase B; 124 randomised to Sativex and 117 to placebo. EDSS is a method of quantifying disability in multiple sclerosis.The EDSS quantifies disability in eight Functional Systems (FS) and allows neurologists to assign a Functional System Score in each of these. EDSS steps 1.0 to 4.5 refer to people with MS who are fully ambulatory. EDSS steps 5.0 to 9.5 are defined by the impairment to ambulation. Each score is given a definition and thus can identify for the subject their score depending on their condition e.g. score of 1.0: No disability, minimal signs on 1 FS.|Score|Mean|6.5|6.5|Standard Deviation|1.46|1.46|||
4231819|NCT00681538|4055201|B3|||Duration of Spasticity Phase B|Of the 572 subjects who entered Phase A, 241 entered Phase B; 124 randomised to Sativex and 117 to placebo.|years|Mean|7.7|7.7|Standard Deviation|6.27|6.27|||
4231820|NCT00681538|4055202|B2|||Duration of Spasticity Phase B|Of the 572 subjects who entered Phase A, 241 entered Phase B; 124 randomised to Sativex and 117 to placebo.|years|Mean|6.7|6.7|Standard Deviation|5.40|5.4|||
4231821|NCT00681538|4055203|B1|||Duration of Spasticity Phase B|Of the 572 subjects who entered Phase A, 241 entered Phase B; 124 randomised to Sativex and 117 to placebo.|years|Mean|8.6|8.6|Standard Deviation|6.89|6.89|||
4231822|NCT00681538|4055201|B3|||Duration of Multiple Sclerosis Phase B|Of the 572 subjects who entered Phase A, 241 entered Phase B; 124 randomised to Sativex and 117 to placebo.|years|Mean|12.6|12.6|Standard Deviation|7.88|7.88|||
4231823|NCT00681538|4055202|B2|||Duration of Multiple Sclerosis Phase B|Of the 572 subjects who entered Phase A, 241 entered Phase B; 124 randomised to Sativex and 117 to placebo.|years|Mean|11.8|11.8|Standard Deviation|7.38|7.38|||
4231824|NCT00681538|4055203|B1|||Duration of Multiple Sclerosis Phase B|Of the 572 subjects who entered Phase A, 241 entered Phase B; 124 randomised to Sativex and 117 to placebo.|years|Mean|13.3|13.3|Standard Deviation|8.29|8.29|||
4231825|NCT00681538|4055201|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4231826|NCT00681538|4055202|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4231827|NCT00681538|4055203|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4231828|NCT00681538|4055201|B3||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4231829|NCT00681538|4055202|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4231830|NCT00681538|4055203|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4231831|NCT00681538|4055201|B3|||Age|Of the 572 subjects who entered Phase A, 241 entered Phase B; 124 randomised to Sativex and 117 to placebo. The data below details that for Phase B.|Years|Mean|48.6|48.6|Standard Deviation|9.33|9.33|||
4231832|NCT00681538|4055202|B2|||Age|Of the 572 subjects who entered Phase A, 241 entered Phase B; 124 randomised to Sativex and 117 to placebo. The data below details that for Phase B.|Years|Mean|48.1|48.1|Standard Deviation|9.59|9.59|||
4231833|NCT00681538|4055203|B1|||Age|Of the 572 subjects who entered Phase A, 241 entered Phase B; 124 randomised to Sativex and 117 to placebo. The data below details that for Phase B.|Years|Mean|49.1|49.1|Standard Deviation|9.09|9.09|||
4231834|NCT00681473|4055234|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4231835|NCT00681473|4055234|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4231836|NCT00681473|4055234|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4231837|NCT00681473|4055234|B1|||Age||years|Median|37.5|37.5|Full Range|||22.0|56.0|
4231838|NCT00681291|4055240|B3|United States||Region of Enrollment||participants|Number|172|172.0||||||
4231839|NCT00681291|4055241|B2|United States||Region of Enrollment||participants|Number|84|84.0||||||
4231840|NCT00681291|4055242|B1|United States||Region of Enrollment||participants|Number|88|88.0||||||
4231841|NCT00681291|4055240|B3||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4231842|NCT00681291|4055241|B2||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4231843|NCT00681291|4055242|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4231844|NCT00681291|4055240|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4231845|NCT00681291|4055241|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4231846|NCT00681291|4055242|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4231847|NCT00681291|4055240|B3|||Age||years|Mean|55.8|55.8|Standard Deviation|14.12|14.12|||
4231848|NCT00681291|4055241|B2|||Age||years|Mean|55.2|55.2|Standard Deviation|14.53|14.53|||
4231849|NCT00681291|4055242|B1|||Age||years|Mean|56.3|56.3|Standard Deviation|13.78|13.78|||
4231850|NCT00681265|4055255|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4231851|NCT00681265|4055255|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4231852|NCT00681265|4055255|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4231853|NCT00681265|4055255|B1|||Age||years|Mean|44.5|44.5|Standard Deviation|10.8|10.8|||
4231854|NCT00681265|4055255|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4231855|NCT00681265|4055255|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4231856|NCT00681265|4055255|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231857|NCT00681187|4055263|B3|Sweden||Region of Enrollment||participants|Number|15|15.0||||||
4231858|NCT00681187|4055264|B2|Sweden||Region of Enrollment||participants|Number|8|8.0||||||
4231859|NCT00681187|4055265|B1|Sweden||Region of Enrollment||participants|Number|7|7.0||||||
4231860|NCT00681187|4055263|B3|Norway||Region of Enrollment||participants|Number|4|4.0||||||
4231861|NCT00681187|4055264|B2|Norway||Region of Enrollment||participants|Number|3|3.0||||||
4231862|NCT00681187|4055265|B1|Norway||Region of Enrollment||participants|Number|1|1.0||||||
4231863|NCT00681187|4055263|B3|Denmark||Region of Enrollment||participants|Number|7|7.0||||||
4231864|NCT00681187|4055264|B2|Denmark||Region of Enrollment||participants|Number|4|4.0||||||
4231865|NCT00681187|4055265|B1|Denmark||Region of Enrollment||participants|Number|3|3.0||||||
4231866|NCT00681187|4055263|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4231867|NCT00681187|4055264|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4231868|NCT00681187|4055265|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4231869|NCT00681187|4055263|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4231870|NCT00681187|4055264|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4231871|NCT00681187|4055265|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4231872|NCT00681187|4055263|B3|||Age||years|Mean|61.4|61.4|Standard Deviation|10.5|10.5|||
4231873|NCT00681187|4055264|B2|||Age||years|Mean|60.0|60.0|Standard Deviation|12.7|12.7|||
4231874|NCT00681187|4055265|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|6.5|6.5|||
4231875|NCT00681187|4055263|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4231876|NCT00681187|4055264|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4231877|NCT00681187|4055265|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4231878|NCT00681187|4055263|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4231879|NCT00681187|4055264|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4231880|NCT00681187|4055265|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4231881|NCT00681187|4055263|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231882|NCT00681187|4055264|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231883|NCT00681187|4055265|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231884|NCT00681109|4055298|B4|||Ocular Surface Disease Index (OSDI)|The Ocular Surface Disease Index (OSDI) is a 12-item questionnaire designed to provide a rapid assessment of the symptoms of ocular irritation consistent with dry eye disease and their impact on vision-related functioning. OSDI is scored on a scale of 0 to 100, with higher scores representing greater disability.|units on a scale|Mean|46.1|46.1|Standard Deviation|20.4|20.4|||
4231885|NCT00681109|4055299|B3|||Ocular Surface Disease Index (OSDI)|The Ocular Surface Disease Index (OSDI) is a 12-item questionnaire designed to provide a rapid assessment of the symptoms of ocular irritation consistent with dry eye disease and their impact on vision-related functioning. OSDI is scored on a scale of 0 to 100, with higher scores representing greater disability.|units on a scale|Mean|48.5|48.5|Standard Deviation|21.0|21.0|||
4231886|NCT00681109|4055300|B2|||Ocular Surface Disease Index (OSDI)|The Ocular Surface Disease Index (OSDI) is a 12-item questionnaire designed to provide a rapid assessment of the symptoms of ocular irritation consistent with dry eye disease and their impact on vision-related functioning. OSDI is scored on a scale of 0 to 100, with higher scores representing greater disability.|units on a scale|Mean|45.6|45.6|Standard Deviation|21.1|21.1|||
4231887|NCT00681109|4055301|B1|||Ocular Surface Disease Index (OSDI)|The Ocular Surface Disease Index (OSDI) is a 12-item questionnaire designed to provide a rapid assessment of the symptoms of ocular irritation consistent with dry eye disease and their impact on vision-related functioning. OSDI is scored on a scale of 0 to 100, with higher scores representing greater disability.|units on a scale|Mean|44.2|44.2|Standard Deviation|20.4|20.4|||
4231888|NCT00681109|4055298|B4|||Corneal Fluorescein Staining Score|CFS is used to assess the level of corneal epitheliopathy that is related to dry eye disease. The CFS scale ranges from 0 to 15 scale, with 0 representing the minimum level of corneal epitheliopathy and 15 representing the maximum level of epitheliopathy.|units on a scale|Mean|1.7|1.7|Standard Deviation|1.0|1.0|||
4231889|NCT00681109|4055299|B3|||Corneal Fluorescein Staining Score|CFS is used to assess the level of corneal epitheliopathy that is related to dry eye disease. The CFS scale ranges from 0 to 15 scale, with 0 representing the minimum level of corneal epitheliopathy and 15 representing the maximum level of epitheliopathy.|units on a scale|Mean|1.7|1.7|Standard Deviation|0.9|0.9|||
4231890|NCT00681109|4055300|B2|||Corneal Fluorescein Staining Score|CFS is used to assess the level of corneal epitheliopathy that is related to dry eye disease. The CFS scale ranges from 0 to 15 scale, with 0 representing the minimum level of corneal epitheliopathy and 15 representing the maximum level of epitheliopathy.|units on a scale|Mean|1.7|1.7|Standard Deviation|1.2|1.2|||
4231891|NCT00681109|4055301|B1|||Corneal Fluorescein Staining Score|CFS is used to assess the level of corneal epitheliopathy that is related to dry eye disease. The CFS scale ranges from 0 to 15 scale, with 0 representing the minimum level of corneal epitheliopathy and 15 representing the maximum level of epitheliopathy.|units on a scale|Mean|1.6|1.6|Standard Deviation|0.9|0.9|||
4231892|NCT00681109|4055298|B4|||Tear Film Break-Up Time (TBUT)|TBUT measures the amount of time, in seconds, that the tear film completely coats the ocular surface after each blink. The longer the time the tear film completely coats the ocular surface is considered to be better than a shorter amount of time.|Seconds|Mean|3.7|3.7|Standard Deviation|2.5|2.5|||
4231893|NCT00681109|4055299|B3|||Tear Film Break-Up Time (TBUT)|TBUT measures the amount of time, in seconds, that the tear film completely coats the ocular surface after each blink. The longer the time the tear film completely coats the ocular surface is considered to be better than a shorter amount of time.|Seconds|Mean|3.5|3.5|Standard Deviation|2.2|2.2|||
4231894|NCT00681109|4055300|B2|||Tear Film Break-Up Time (TBUT)|TBUT measures the amount of time, in seconds, that the tear film completely coats the ocular surface after each blink. The longer the time the tear film completely coats the ocular surface is considered to be better than a shorter amount of time.|Seconds|Mean|3.8|3.8|Standard Deviation|2.1|2.1|||
4231895|NCT00681109|4055301|B1|||Tear Film Break-Up Time (TBUT)|TBUT measures the amount of time, in seconds, that the tear film completely coats the ocular surface after each blink. The longer the time the tear film completely coats the ocular surface is considered to be better than a shorter amount of time.|Seconds|Mean|3.8|3.8|Standard Deviation|2.8|2.8|||
4231896|NCT00681109|4055298|B4|||Meibomian Gland Secretion Quality|Meibomian Gland Secretion Quality has a range of 0 (normal secretion quality) to 3 (abnormal secretion quality)|units on a scale|Mean|1.9|1.9|Standard Deviation|0.5|0.5|||
4231897|NCT00681109|4055299|B3|||Meibomian Gland Secretion Quality|Meibomian Gland Secretion Quality has a range of 0 (normal secretion quality) to 3 (abnormal secretion quality)|units on a scale|Mean|1.9|1.9|Standard Deviation|0.5|0.5|||
4231898|NCT00681109|4055300|B2|||Meibomian Gland Secretion Quality|Meibomian Gland Secretion Quality has a range of 0 (normal secretion quality) to 3 (abnormal secretion quality)|units on a scale|Mean|1.8|1.8|Standard Deviation|0.5|0.5|||
4231899|NCT00681109|4055301|B1|||Meibomian Gland Secretion Quality|Meibomian Gland Secretion Quality has a range of 0 (normal secretion quality) to 3 (abnormal secretion quality)|units on a scale|Mean|1.9|1.9|Standard Deviation|0.4|0.4|||
4231900|NCT00681109|4055298|B4|United States||Region of Enrollment||participants|Number|75|75.0||||||
4231901|NCT00681109|4055299|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4231902|NCT00681109|4055300|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4231903|NCT00681109|4055301|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4231904|NCT00681109|4055298|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4231905|NCT00681109|4055299|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4231906|NCT00681109|4055300|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4231907|NCT00681109|4055301|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4231908|NCT00681109|4055298|B4||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4231909|NCT00681109|4055299|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4231910|NCT00681109|4055300|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4231911|NCT00681109|4055301|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4231912|NCT00681109|4055298|B4|||Age||years|Mean|52|52.0|Standard Deviation|14|14.0|||
4231913|NCT00681109|4055299|B3|||Age||years|Mean|58|58.0|Standard Deviation|16|16.0|||
4231914|NCT00681109|4055300|B2|||Age||years|Mean|53|53.0|Standard Deviation|12|12.0|||
4231915|NCT00681109|4055301|B1|||Age||years|Mean|49|49.0|Standard Deviation|14|14.0|||
4231916|NCT00681044|4055320|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4231917|NCT00681044|4055320|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4231918|NCT00681044|4055320|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4231919|NCT00681044|4055320|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4231920|NCT00681044|4055320|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4231921|NCT00681044|4055320|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4231922|NCT00681044|4055320|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4231923|NCT00681044|4055320|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4231924|NCT00681044|4055320|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4231925|NCT00681044|4055320|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4231926|NCT00681044|4055320|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4231927|NCT00681044|4055320|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4231928|NCT00681044|4055320|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4231929|NCT00681044|4055320|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4231930|NCT00681044|4055320|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231931|NCT00681031|4055328|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4231932|NCT00681031|4055328|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4231933|NCT00681031|4055328|B1|||Age||years|Mean|62.2|62.2|Standard Deviation|8.4|8.4|||
4231934|NCT00680992|4055332|B4|Recurrent unresectable||GCTB Disease Type||Participants|Number|185|185.0||||||
4231935|NCT00680992|4055333|B3|Recurrent unresectable||GCTB Disease Type||Participants|Number|10|10.0||||||
4231936|NCT00680992|4055334|B2|Recurrent unresectable||GCTB Disease Type||Participants|Number|0|0.0||||||
4231937|NCT00680992|4055335|B1|Recurrent unresectable||GCTB Disease Type||Participants|Number|175|175.0||||||
4231938|NCT00680992|4055332|B4|Recurrent resectable||GCTB Disease Type||Participants|Number|85|85.0||||||
4231939|NCT00680992|4055333|B3|Recurrent resectable||GCTB Disease Type||Participants|Number|0|0.0||||||
4231940|NCT00680992|4055334|B2|Recurrent resectable||GCTB Disease Type||Participants|Number|85|85.0||||||
4231941|NCT00680992|4055335|B1|Recurrent resectable||GCTB Disease Type||Participants|Number|0|0.0||||||
4231942|NCT00680992|4055332|B4|Primary unresectable||GCTB Disease Type||Participants|Number|95|95.0||||||
4231943|NCT00680992|4055333|B3|Primary unresectable||GCTB Disease Type||Participants|Number|2|2.0||||||
4231944|NCT00680992|4055334|B2|Primary unresectable||GCTB Disease Type||Participants|Number|0|0.0||||||
4231945|NCT00680992|4055335|B1|Primary unresectable||GCTB Disease Type||Participants|Number|93|93.0||||||
4231946|NCT00680992|4055332|B4|Primary resectable||GCTB Disease Type||Participants|Number|167|167.0||||||
4231947|NCT00680992|4055333|B3|Primary resectable||GCTB Disease Type||Participants|Number|0|0.0||||||
4231948|NCT00680992|4055334|B2|Primary resectable||GCTB Disease Type||Participants|Number|167|167.0||||||
4231949|NCT00680992|4055335|B1|Primary resectable||GCTB Disease Type||Participants|Number|0|0.0||||||
4231950|NCT00680992|4055332|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4231951|NCT00680992|4055333|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4231952|NCT00680992|4055334|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4231953|NCT00680992|4055335|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4231954|NCT00680992|4055332|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4231955|NCT00680992|4055333|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4231956|NCT00680992|4055334|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4231957|NCT00680992|4055335|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4231958|NCT00680992|4055332|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
4231959|NCT00680992|4055333|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4231960|NCT00680992|4055334|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4231961|NCT00680992|4055335|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4231962|NCT00680992|4055332|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
4231963|NCT00680992|4055333|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4232022|NCT00680914|4055370|B2|East Asia||Region of Enrollment||participants|Number|129|129.0||||||
4231964|NCT00680992|4055334|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4231965|NCT00680992|4055335|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4231966|NCT00680992|4055332|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
4231967|NCT00680992|4055333|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4231968|NCT00680992|4055334|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4231969|NCT00680992|4055335|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
4231970|NCT00680992|4055332|B4|White or Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|440|440.0||||||
4231971|NCT00680992|4055333|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4231972|NCT00680992|4055334|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|208|208.0||||||
4231973|NCT00680992|4055335|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|221|221.0||||||
4231974|NCT00680992|4055332|B4||Male|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
4231975|NCT00680992|4055333|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4231976|NCT00680992|4055334|B2||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4231977|NCT00680992|4055335|B1||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4231978|NCT00680992|4055332|B4||Female|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
4231979|NCT00680992|4055333|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4231980|NCT00680992|4055334|B2||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4231981|NCT00680992|4055335|B1||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4231982|NCT00680992|4055332|B4|||Age||Years|Mean|35.8|35.8|Standard Deviation|14.1|14.1|||
4231983|NCT00680992|4055333|B3|||Age||Years|Mean|36.1|36.1|Standard Deviation|14.9|14.9|||
4231984|NCT00680992|4055334|B2|||Age||Years|Mean|35.1|35.1|Standard Deviation|13.5|13.5|||
4231985|NCT00680992|4055335|B1|||Age||Years|Mean|36.4|36.4|Standard Deviation|14.6|14.6|||
4231986|NCT00680992|4055332|B4||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4231987|NCT00680992|4055333|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4231988|NCT00680992|4055334|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4231989|NCT00680992|4055335|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4231990|NCT00680992|4055332|B4||Between 18 and 65 years|Age||Participants|Count of Participants|481|481.0||||||
4231991|NCT00680992|4055333|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4231992|NCT00680992|4055334|B2||Between 18 and 65 years|Age||Participants|Count of Participants|231|231.0||||||
4231993|NCT00680992|4055335|B1||Between 18 and 65 years|Age||Participants|Count of Participants|238|238.0||||||
4231994|NCT00680992|4055332|B4||<=18 years|Age||Participants|Count of Participants|28|28.0||||||
4231995|NCT00680992|4055333|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4231996|NCT00680992|4055334|B2||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4231997|NCT00680992|4055335|B1||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4231998|NCT00680953|4055350|B4|||the number of participants with vertebral fractures|the number of participants with vertebral fractures|Participants|Number|1174|1174.0||||||
4231999|NCT00680953|4055351|B3|||the number of participants with vertebral fractures|the number of participants with vertebral fractures|Participants|Number|237|237.0||||||
4232000|NCT00680953|4055352|B2|||the number of participants with vertebral fractures|the number of participants with vertebral fractures|Participants|Number|471|471.0||||||
4232001|NCT00680953|4055353|B1|||the number of participants with vertebral fractures|the number of participants with vertebral fractures|Participants|Number|466|466.0||||||
4232002|NCT00680953|4055350|B4|Japan||Region of Enrollment||participants|Number|1194|1194.0||||||
4232003|NCT00680953|4055351|B3|Japan||Region of Enrollment||participants|Number|242|242.0||||||
4232004|NCT00680953|4055352|B2|Japan||Region of Enrollment||participants|Number|480|480.0||||||
4232005|NCT00680953|4055353|B1|Japan||Region of Enrollment||participants|Number|472|472.0||||||
4232006|NCT00680953|4055350|B4||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4232007|NCT00680953|4055351|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4232008|NCT00680953|4055352|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4232009|NCT00680953|4055353|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4232010|NCT00680953|4055350|B4||Female|Sex: Female, Male||Participants|Count of Participants|1135|1135.0||||||
4232011|NCT00680953|4055351|B3||Female|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4232012|NCT00680953|4055352|B2||Female|Sex: Female, Male||Participants|Count of Participants|456|456.0||||||
4232013|NCT00680953|4055353|B1||Female|Sex: Female, Male||Participants|Count of Participants|449|449.0||||||
4232014|NCT00680953|4055350|B4|||Age||years|Mean|69.6|69.6|Standard Deviation|7.49|7.49|||
4232015|NCT00680953|4055351|B3|||Age||years|Mean|70.2|70.2|Standard Deviation|7.31|7.31|||
4232016|NCT00680953|4055352|B2|||Age||years|Mean|69.0|69.0|Standard Deviation|7.67|7.67|||
4232017|NCT00680953|4055353|B1|||Age||years|Mean|69.9|69.9|Standard Deviation|7.36|7.36|||
4232018|NCT00680914|4055369|B3|Southeast Asia||Region of Enrollment||participants|Number|1|1.0||0|0.0|0.0|0.0|
4232019|NCT00680914|4055370|B2|Southeast Asia||Region of Enrollment||participants|Number|0|0.0||||||
4232020|NCT00680914|4055371|B1|Southeast Asia||Region of Enrollment||participants|Number|1|1.0||||||
4232021|NCT00680914|4055369|B3|East Asia||Region of Enrollment||participants|Number|502|502.0||0|0.0|0.0|0.0|
4232023|NCT00680914|4055371|B1|East Asia||Region of Enrollment||participants|Number|373|373.0||||||
4232024|NCT00680914|4055369|B3||Male|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
4232025|NCT00680914|4055370|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4232026|NCT00680914|4055371|B1||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4232027|NCT00680914|4055369|B3||Female|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
4232028|NCT00680914|4055370|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4232029|NCT00680914|4055371|B1||Female|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4232030|NCT00680914|4055369|B3|||Age||years|Mean|9.5|9.5|Standard Deviation|1.47|1.47|||
4232031|NCT00680914|4055370|B2|||Age||years|Mean|9.5|9.5|Standard Deviation|1.43|1.43|||
4232032|NCT00680914|4055371|B1|||Age||years|Mean|9.5|9.5|Standard Deviation|1.49|1.49|||
4232033|NCT00680901|4055404|B3|White||Race/Ethnicity, Customized||Participants|Number|294|294.0||||||
4232034|NCT00680901|4055405|B2|White||Race/Ethnicity, Customized||Participants|Number|150|150.0||||||
4232035|NCT00680901|4055406|B1|White||Race/Ethnicity, Customized||Participants|Number|144|144.0||||||
4232036|NCT00680901|4055404|B3|Japanese/East Asian Hrtg/South East Asian Hrtg||Race/Ethnicity, Customized||Participants|Number|226|226.0||||||
4232037|NCT00680901|4055405|B2|Japanese/East Asian Hrtg/South East Asian Hrtg||Race/Ethnicity, Customized||Participants|Number|114|114.0||||||
4232038|NCT00680901|4055406|B1|Japanese/East Asian Hrtg/South East Asian Hrtg||Race/Ethnicity, Customized||Participants|Number|112|112.0||||||
4232039|NCT00680901|4055404|B3|Central/South Asian Hrtg||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4232040|NCT00680901|4055405|B2|Central/South Asian Hrtg||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4232041|NCT00680901|4055406|B1|Central/South Asian Hrtg||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4232042|NCT00680901|4055404|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4232043|NCT00680901|4055405|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4232044|NCT00680901|4055406|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4232045|NCT00680901|4055404|B3|African American/African Heritage (Hrtg)||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4232046|NCT00680901|4055405|B2|African American/African Heritage (Hrtg)||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4232047|NCT00680901|4055406|B1|African American/African Heritage (Hrtg)||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4232048|NCT00680901|4055404|B3||Male|Sex: Female, Male||Participants|Count of Participants|406|406.0||||||
4232049|NCT00680901|4055405|B2||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4232050|NCT00680901|4055406|B1||Male|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
4232051|NCT00680901|4055404|B3||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4232052|NCT00680901|4055405|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4232053|NCT00680901|4055406|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4232054|NCT00680901|4055404|B3|||Age||Years|Mean|58.9|58.9|Standard Deviation|11.21|11.21|||
4232055|NCT00680901|4055405|B2|||Age||Years|Mean|58.5|58.5|Standard Deviation|11.23|11.23|||
4232056|NCT00680901|4055406|B1|||Age||Years|Mean|59.4|59.4|Standard Deviation|11.20|11.2|||
4232057|NCT00680862|4055439|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4232058|NCT00680862|4055439|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4232059|NCT00680862|4055439|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4232060|NCT00680862|4055439|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4232061|NCT00680862|4055439|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4232062|NCT00680862|4055439|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232063|NCT00680862|4055439|B1|||Age||years|Mean|36|36.0|Standard Deviation|2|2.0|||
4232064|NCT00680836|4055443|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
4232065|NCT00680836|4055444|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4232066|NCT00680836|4055445|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4232067|NCT00680836|4055443|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4232068|NCT00680836|4055444|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4232069|NCT00680836|4055445|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4232070|NCT00680836|4055443|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4232071|NCT00680836|4055444|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4232072|NCT00680836|4055445|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4232073|NCT00680836|4055443|B3|||Age, Customized||years|Mean|52|52.0|Full Range|||33.0|77.0|
4232074|NCT00680836|4055444|B2|||Age, Customized||years|Mean|56|56.0|Full Range|||33.0|77.0|
4232075|NCT00680836|4055445|B1|||Age, Customized||years|Mean|52|52.0|Full Range|||41.0|67.0|
4232076|NCT00680823|4055462|B4|United States||Region of Enrollment||participants|Number|150|150.0||||||
4232077|NCT00680823|4055463|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4232078|NCT00680823|4055464|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
4232079|NCT00680823|4055465|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4232080|NCT00680823|4055462|B4||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4232081|NCT00680823|4055463|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4232082|NCT00680823|4055464|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4232083|NCT00680823|4055465|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4232084|NCT00680823|4055462|B4||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4232085|NCT00680823|4055463|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4232086|NCT00680823|4055464|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4232087|NCT00680823|4055465|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4232088|NCT00680823|4055462|B4|||Age||years|Mean|14|14.0|Standard Deviation|2|2.0|||
4232089|NCT00680823|4055463|B3|||Age||years|Mean|15|15.0|Standard Deviation|2|2.0|||
4232090|NCT00680823|4055464|B2|||Age||years|Mean|14|14.0|Standard Deviation|2|2.0|||
4232091|NCT00680823|4055465|B1|||Age||years|Mean|14|14.0|Standard Deviation|2|2.0|||
4232092|NCT00680823|4055462|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4232093|NCT00680823|4055463|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4232094|NCT00680823|4055464|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4232095|NCT00680823|4055465|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4232096|NCT00680823|4055462|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4232097|NCT00680823|4055463|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4232098|NCT00680823|4055464|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4232099|NCT00680823|4055465|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4232100|NCT00680823|4055462|B4||<=18 years|Age||Participants|Count of Participants|150|150.0||||||
4232101|NCT00680823|4055463|B3||<=18 years|Age||Participants|Count of Participants|50|50.0||||||
4232102|NCT00680823|4055464|B2||<=18 years|Age||Participants|Count of Participants|50|50.0||||||
4232103|NCT00680823|4055465|B1||<=18 years|Age||Participants|Count of Participants|50|50.0||||||
4232104|NCT00680797|4055481|B5|||Total testosterone||nanogram/deciliter|Mean|467.7|467.7|Standard Deviation|242|242.0|||
4232105|NCT00680797|4055482|B4|||Total testosterone||nanogram/deciliter|Mean|558.3|558.3|Standard Deviation|362.9|362.9|||
4232106|NCT00680797|4055483|B3|||Total testosterone||nanogram/deciliter|Mean|480.0|480.0|Standard Deviation|231.7|231.7|||
4232107|NCT00680797|4055484|B2|||Total testosterone||nanogram/deciliter|Mean|418.9|418.9|Standard Deviation|207.7|207.7|||
4232108|NCT00680797|4055485|B1|||Total testosterone||nanogram/deciliter|Mean|419.6|419.6|Standard Deviation|146.5|146.5|||
4232109|NCT00680797|4055481|B5|||Body-Mass-Index||kilogram/meter squared|Mean|28.2|28.2|Standard Deviation|4|4.0|||
4232110|NCT00680797|4055482|B4|||Body-Mass-Index||kilogram/meter squared|Mean|29.0|29.0|Standard Deviation|2.9|2.9|||
4232111|NCT00680797|4055483|B3|||Body-Mass-Index||kilogram/meter squared|Mean|28.2|28.2|Standard Deviation|4.1|4.1|||
4232112|NCT00680797|4055484|B2|||Body-Mass-Index||kilogram/meter squared|Mean|28.6|28.6|Standard Deviation|4.3|4.3|||
4232113|NCT00680797|4055485|B1|||Body-Mass-Index||kilogram/meter squared|Mean|27.1|27.1|Standard Deviation|4.9|4.9|||
4232114|NCT00680797|4055481|B5|United States||Region of Enrollment||participants|Number|33|33.0||||||
4232115|NCT00680797|4055482|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
4232116|NCT00680797|4055483|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4232117|NCT00680797|4055484|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4232118|NCT00680797|4055485|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4232119|NCT00680797|4055481|B5|Male||Sex/Gender, Customized||participants|Number|33|33.0||||||
4232120|NCT00680797|4055482|B4|Male||Sex/Gender, Customized||participants|Number|8|8.0||||||
4232121|NCT00680797|4055483|B3|Male||Sex/Gender, Customized||participants|Number|8|8.0||||||
4232122|NCT00680797|4055484|B2|Male||Sex/Gender, Customized||participants|Number|8|8.0||||||
4232123|NCT00680797|4055485|B1|Male||Sex/Gender, Customized||participants|Number|9|9.0||||||
4232124|NCT00680797|4055481|B5|||Age||years|Mean|66|66.0|Standard Deviation|6|6.0|||
4232125|NCT00680797|4055482|B4|||Age||years|Mean|63|63.0|Standard Deviation|3|3.0|||
4232126|NCT00680797|4055483|B3|||Age||years|Mean|69|69.0|Standard Deviation|6|6.0|||
4232127|NCT00680797|4055484|B2|||Age||years|Mean|66|66.0|Standard Deviation|5|5.0|||
4232128|NCT00680797|4055485|B1|||Age||years|Mean|67|67.0|Standard Deviation|8|8.0|||
4232129|NCT00680797|4055481|B5||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4232130|NCT00680797|4055482|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4232131|NCT00680797|4055483|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4232132|NCT00680797|4055484|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4232133|NCT00680797|4055485|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4232134|NCT00680797|4055481|B5||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4232135|NCT00680797|4055482|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4232136|NCT00680797|4055483|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4232137|NCT00680797|4055484|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4232138|NCT00680797|4055485|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4232139|NCT00680797|4055481|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232140|NCT00680797|4055482|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232141|NCT00680797|4055483|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232142|NCT00680797|4055484|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232143|NCT00680797|4055485|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232144|NCT00680771|4055498|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4232145|NCT00680771|4055499|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4232146|NCT00680771|4055500|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4232147|NCT00680771|4055498|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4232148|NCT00680771|4055499|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4232149|NCT00680771|4055500|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4232150|NCT00680771|4055498|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4232151|NCT00680771|4055499|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4232152|NCT00680771|4055500|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4232153|NCT00680771|4055498|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4232154|NCT00680771|4055499|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4232155|NCT00680771|4055500|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4232156|NCT00680771|4055498|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232157|NCT00680771|4055499|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232158|NCT00680771|4055500|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232159|NCT00680745|4055507|B5|||HbA1c||Percent|Mean|8.11|8.11|Standard Deviation|0.763|0.763|||
4232160|NCT00680745|4055508|B4|||HbA1c||Percent|Mean|8.15|8.15|Standard Deviation|0.736|0.736|||
4232161|NCT00680745|4055509|B3|||HbA1c||Percent|Mean|8.07|8.07|Standard Deviation|0.790|0.79|||
4232162|NCT00680745|4055510|B2|||HbA1c||Percent|Mean|8.12|8.12|Standard Deviation|0.781|0.781|||
4232163|NCT00680745|4055511|B1|||HbA1c||Percent|Mean|8.11|8.11|Standard Deviation|0.749|0.749|||
4232164|NCT00680745|4055507|B5|||BMI||kg/m2|Mean|29.84|29.84|Standard Deviation|5.135|5.135|||
4232165|NCT00680745|4055508|B4|||BMI||kg/m2|Mean|29.74|29.74|Standard Deviation|4.569|4.569|||
4232166|NCT00680745|4055509|B3|||BMI||kg/m2|Mean|29.75|29.75|Standard Deviation|5.641|5.641|||
4232167|NCT00680745|4055510|B2|||BMI||kg/m2|Mean|29.84|29.84|Standard Deviation|5.182|5.182|||
4232168|NCT00680745|4055511|B1|||BMI||kg/m2|Mean|30.01|30.01|Standard Deviation|5.120|5.12|||
4232169|NCT00680745|4055507|B5|Asian||Race/Ethnicity, Customized||Participants|Number|181|181.0||||||
4232170|NCT00680745|4055508|B4|Asian||Race/Ethnicity, Customized||Participants|Number|44|44.0||||||
4232171|NCT00680745|4055509|B3|Asian||Race/Ethnicity, Customized||Participants|Number|45|45.0||||||
4232172|NCT00680745|4055510|B2|Asian||Race/Ethnicity, Customized||Participants|Number|46|46.0||||||
4232173|NCT00680745|4055511|B1|Asian||Race/Ethnicity, Customized||Participants|Number|46|46.0||||||
4232174|NCT00680745|4055507|B5|White||Race/Ethnicity, Customized||Participants|Number|411|411.0||||||
4232175|NCT00680745|4055508|B4|White||Race/Ethnicity, Customized||Participants|Number|101|101.0||||||
4232176|NCT00680745|4055509|B3|White||Race/Ethnicity, Customized||Participants|Number|106|106.0||||||
4232177|NCT00680745|4055510|B2|White||Race/Ethnicity, Customized||Participants|Number|96|96.0||||||
4232178|NCT00680745|4055511|B1|White||Race/Ethnicity, Customized||Participants|Number|108|108.0||||||
4232179|NCT00680745|4055507|B5||Male|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
4232180|NCT00680745|4055508|B4||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4232181|NCT00680745|4055509|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4232182|NCT00680745|4055510|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4232183|NCT00680745|4055511|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4232184|NCT00680745|4055507|B5||Female|Sex: Female, Male||Participants|Count of Participants|307|307.0||||||
4232185|NCT00680745|4055508|B4||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4232186|NCT00680745|4055509|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4232187|NCT00680745|4055510|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4232188|NCT00680745|4055511|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4232189|NCT00680745|4055507|B5|||Age||years|Mean|59.8|59.8|Standard Deviation|9.60|9.6|||
4232190|NCT00680745|4055508|B4|||Age||years|Mean|60.3|60.3|Standard Deviation|10.16|10.16|||
4232191|NCT00680745|4055509|B3|||Age||years|Mean|58.9|58.9|Standard Deviation|8.32|8.32|||
4232192|NCT00680745|4055510|B2|||Age||years|Mean|60.2|60.2|Standard Deviation|9.73|9.73|||
4232193|NCT00680745|4055511|B1|||Age||years|Mean|59.9|59.9|Standard Deviation|10.14|10.14|||
4232194|NCT00680706|4055544|B3|Unknown||Sex/Gender, Customized||participants|Number|3|3.0||||||
4232195|NCT00680706|4055545|B2|Unknown||Sex/Gender, Customized||participants|Number|0|0.0||||||
4232196|NCT00680706|4055546|B1|Unknown||Sex/Gender, Customized||participants|Number|3|3.0||||||
4232197|NCT00680706|4055544|B3|Female||Sex/Gender, Customized||participants|Number|60|60.0||||||
4232198|NCT00680706|4055545|B2|Female||Sex/Gender, Customized||participants|Number|27|27.0||||||
4232199|NCT00680706|4055546|B1|Female||Sex/Gender, Customized||participants|Number|33|33.0||||||
4232200|NCT00680706|4055544|B3|Male||Sex/Gender, Customized||participants|Number|67|67.0||||||
4232201|NCT00680706|4055545|B2|Male||Sex/Gender, Customized||participants|Number|33|33.0||||||
4232202|NCT00680706|4055546|B1|Male||Sex/Gender, Customized||participants|Number|34|34.0||||||
4232203|NCT00680706|4055544|B3|||Age||years|Mean|73|73.0|Standard Deviation|13|13.0|||
4232204|NCT00680706|4055545|B2|||Age||years|Mean|73|73.0|Standard Deviation|13|13.0|||
4232205|NCT00680706|4055546|B1|||Age||years|Mean|73|73.0|Standard Deviation|13|13.0|||
4232206|NCT00680628|4055555|B3|United States||Region of Enrollment||participants|Number|83|83.0||||||
4232207|NCT00680628|4055556|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4232208|NCT00680628|4055557|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4232209|NCT00680628|4055555|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4232210|NCT00680628|4055556|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4232211|NCT00680628|4055557|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4232212|NCT00680628|4055555|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4232213|NCT00680628|4055556|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4232214|NCT00680628|4055557|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4232215|NCT00680628|4055555|B3|||Age||years|Mean|55|55.0|Standard Deviation|14|14.0|||
4232216|NCT00680628|4055556|B2|||Age||years|Mean|57|57.0|Standard Deviation|14|14.0|||
4232217|NCT00680628|4055557|B1|||Age||years|Mean|54|54.0|Standard Deviation|14|14.0|||
4232218|NCT00680628|4055555|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4232219|NCT00680628|4055556|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4232220|NCT00680628|4055557|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4232221|NCT00680628|4055555|B3||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4232222|NCT00680628|4055556|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4232223|NCT00680628|4055557|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4232224|NCT00680628|4055555|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232225|NCT00680628|4055556|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232226|NCT00680628|4055557|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232227|NCT00680524|4055568|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4232228|NCT00680524|4055568|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4232229|NCT00680524|4055568|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4232230|NCT00680524|4055568|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4232231|NCT00680524|4055568|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232232|NCT00680459|4055572|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4232233|NCT00680459|4055573|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4232234|NCT00680459|4055574|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4232235|NCT00680459|4055572|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4232236|NCT00680459|4055573|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4232237|NCT00680459|4055574|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4232238|NCT00680459|4055572|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4232239|NCT00680459|4055573|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4232240|NCT00680459|4055574|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4232241|NCT00680459|4055572|B3|||Age||years|Mean|6.9|6.9|Standard Deviation|4.4|4.4|||
4232242|NCT00680459|4055573|B2|||Age||years|Mean|6.33|6.33|Standard Deviation|4.0|4.0|||
4232243|NCT00680459|4055574|B1|||Age||years|Mean|7.4|7.4|Standard Deviation|4.96|4.96|||
4232244|NCT00680459|4055572|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4232245|NCT00680459|4055573|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4232246|NCT00680459|4055574|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4232247|NCT00680459|4055572|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4232248|NCT00680459|4055573|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4232249|NCT00680459|4055574|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4232250|NCT00680459|4055572|B3||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4232251|NCT00680459|4055573|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4232252|NCT00680459|4055574|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4232253|NCT00680407|4055585|B4||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4232254|NCT00680407|4055586|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4232255|NCT00680407|4055587|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4232256|NCT00680407|4055588|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4232257|NCT00680407|4055585|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4232258|NCT00680407|4055586|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4232259|NCT00680407|4055587|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4232260|NCT00680407|4055588|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4232261|NCT00680407|4055585|B4|||Age||years|Mean|48.3|48.3|Standard Deviation|10.95|10.95|||
4232262|NCT00680407|4055586|B3|||Age||years|Mean|49.51|49.51|Standard Deviation|10.89|10.89|||
4232263|NCT00680407|4055587|B2|||Age||years|Mean|48.2|48.2|Standard Deviation|11.43|11.43|||
4232264|NCT00680407|4055588|B1|||Age||years|Mean|47.3|47.3|Standard Deviation|10.83|10.83|||
4232265|NCT00680368|4055604|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4232266|NCT00680368|4055604|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4232267|NCT00680368|4055604|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4232268|NCT00680368|4055604|B1||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
4232269|NCT00680368|4055604|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232270|NCT00680316|4055610|B3||Male|Gender||Participants|Count of Participants|2|2.0||||||
4232271|NCT00680316|4055611|B2||Male|Gender||Participants|Count of Participants|2|2.0||||||
4232272|NCT00680316|4055612|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4232273|NCT00680316|4055610|B3||Female|Gender||Participants|Count of Participants|1|1.0||||||
4232274|NCT00680316|4055611|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
4232275|NCT00680316|4055612|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
4232276|NCT00680316|4055610|B3|||Age||years|Mean|4.9|4.9|Standard Deviation|1.2|1.2|||
4232277|NCT00680316|4055611|B2|||Age||years|Mean|4.6|4.6|Standard Deviation|1.5|1.5|||
4232278|NCT00680316|4055612|B1|||Age||years|Mean|5.6|5.6|Standard Deviation|||||
4232279|NCT00680225|4055625|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4232280|NCT00680225|4055625|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4232281|NCT00680225|4055625|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4232282|NCT00680225|4055625|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4232283|NCT00680225|4055625|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232284|NCT00680186|4055630|B3|No PE and no DVT||Investigator assessed acute symptomatic deep vein thrombosis (DVT) of leg or pulmonary embolism (PE)||participants|Number|2|2.0||||||
4232285|NCT00680186|4055631|B2|No PE and no DVT||Investigator assessed acute symptomatic deep vein thrombosis (DVT) of leg or pulmonary embolism (PE)||participants|Number|1|1.0||||||
4232286|NCT00680186|4055632|B1|No PE and no DVT||Investigator assessed acute symptomatic deep vein thrombosis (DVT) of leg or pulmonary embolism (PE)||participants|Number|1|1.0||||||
4232287|NCT00680186|4055630|B3|Symptomatic DVT||Investigator assessed acute symptomatic deep vein thrombosis (DVT) of leg or pulmonary embolism (PE)||participants|Number|1750|1750.0||||||
4232288|NCT00680186|4055631|B2|Symptomatic DVT||Investigator assessed acute symptomatic deep vein thrombosis (DVT) of leg or pulmonary embolism (PE)||participants|Number|873|873.0||||||
4232289|NCT00680186|4055632|B1|Symptomatic DVT||Investigator assessed acute symptomatic deep vein thrombosis (DVT) of leg or pulmonary embolism (PE)||participants|Number|877|877.0||||||
4232290|NCT00680186|4055630|B3|Symptomatic PE||Investigator assessed acute symptomatic deep vein thrombosis (DVT) of leg or pulmonary embolism (PE)||participants|Number|595|595.0||||||
4232291|NCT00680186|4055631|B2|Symptomatic PE||Investigator assessed acute symptomatic deep vein thrombosis (DVT) of leg or pulmonary embolism (PE)||participants|Number|297|297.0||||||
4232292|NCT00680186|4055632|B1|Symptomatic PE||Investigator assessed acute symptomatic deep vein thrombosis (DVT) of leg or pulmonary embolism (PE)||participants|Number|298|298.0||||||
4232293|NCT00680186|4055630|B3|Symptomatic PE and symptomatic DVT||Investigator assessed acute symptomatic deep vein thrombosis (DVT) of leg or pulmonary embolism (PE)||participants|Number|221|221.0||||||
4232294|NCT00680186|4055631|B2|Symptomatic PE and symptomatic DVT||Investigator assessed acute symptomatic deep vein thrombosis (DVT) of leg or pulmonary embolism (PE)||participants|Number|117|117.0||||||
4232295|NCT00680186|4055632|B1|Symptomatic PE and symptomatic DVT||Investigator assessed acute symptomatic deep vein thrombosis (DVT) of leg or pulmonary embolism (PE)||participants|Number|104|104.0||||||
4232296|NCT00680186|4055630|B3||Male|Sex: Female, Male||Participants|Count of Participants|1557|1557.0||||||
4232297|NCT00680186|4055631|B2||Male|Sex: Female, Male||Participants|Count of Participants|776|776.0||||||
4232298|NCT00680186|4055632|B1||Male|Sex: Female, Male||Participants|Count of Participants|781|781.0||||||
4232299|NCT00680186|4055630|B3||Female|Sex: Female, Male||Participants|Count of Participants|1011|1011.0||||||
4232300|NCT00680186|4055631|B2||Female|Sex: Female, Male||Participants|Count of Participants|512|512.0||||||
4232301|NCT00680186|4055632|B1||Female|Sex: Female, Male||Participants|Count of Participants|499|499.0||||||
4232302|NCT00680186|4055630|B3|||Age||Years|Mean|54.9|54.9|Standard Deviation|16.22|16.22|||
4232303|NCT00680186|4055631|B2|||Age||Years|Mean|55.1|55.1|Standard Deviation|16.26|16.26|||
4232304|NCT00680186|4055632|B1|||Age||Years|Mean|54.7|54.7|Standard Deviation|16.19|16.19|||
4232305|NCT00680121|4055657|B3|||Age 1st Drinking (years)||years|Mean|16|16.0|Standard Deviation|4.3|4.3|||
4232306|NCT00680121|4055658|B2|||Age 1st Drinking (years)||years|Mean|15|15.0|Standard Deviation|3.2|3.2|||
4232307|NCT00680121|4055659|B1|||Age 1st Drinking (years)||years|Mean|16|16.0|Standard Deviation|5.2|5.2|||
4232308|NCT00680121|4055657|B3|||Duration of Abuse (years)||years|Mean|32|32.0|Standard Deviation|8.8|8.8|||
4232309|NCT00680121|4055658|B2|||Duration of Abuse (years)||years|Mean|33|33.0|Standard Deviation|7.6|7.6|||
4232310|NCT00680121|4055659|B1|||Duration of Abuse (years)||years|Mean|31|31.0|Standard Deviation|9.8|9.8|||
4232311|NCT00680121|4055657|B3|||Alcoholism Severity|The alcoholism severity scale measures the severity of a person's dependence to alcohol. The severity is measured from 0 (least severe) to 33 (most severe).|scores on a scale|Mean|17.2|17.2|Standard Deviation|5.8|5.8|||
4232312|NCT00680121|4055658|B2|||Alcoholism Severity|The alcoholism severity scale measures the severity of a person's dependence to alcohol. The severity is measured from 0 (least severe) to 33 (most severe).|scores on a scale|Mean|16.4|16.4|Standard Deviation|5.3|5.3|||
4232313|NCT00680121|4055659|B1|||Alcoholism Severity|The alcoholism severity scale measures the severity of a person's dependence to alcohol. The severity is measured from 0 (least severe) to 33 (most severe).|scores on a scale|Mean|17.9|17.9|Standard Deviation|6.2|6.2|||
4232314|NCT00680121|4055657|B3|Negative for FH of alcoholism||Familial History (FH) of Alcoholism||participants|Number|18|18.0||||||
4232315|NCT00680121|4055658|B2|Negative for FH of alcoholism||Familial History (FH) of Alcoholism||participants|Number|9|9.0||||||
4232316|NCT00680121|4055659|B1|Negative for FH of alcoholism||Familial History (FH) of Alcoholism||participants|Number|9|9.0||||||
4232317|NCT00680121|4055657|B3|Positive for FH of alcoholism||Familial History (FH) of Alcoholism||participants|Number|102|102.0||||||
4232318|NCT00680121|4055658|B2|Positive for FH of alcoholism||Familial History (FH) of Alcoholism||participants|Number|51|51.0||||||
4232319|NCT00680121|4055659|B1|Positive for FH of alcoholism||Familial History (FH) of Alcoholism||participants|Number|51|51.0||||||
4232320|NCT00680121|4055657|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4232321|NCT00680121|4055658|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4232322|NCT00680121|4055659|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4232323|NCT00680121|4055657|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232324|NCT00680121|4055658|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232325|NCT00680121|4055659|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232326|NCT00680121|4055657|B3||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4232327|NCT00680121|4055658|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4232328|NCT00680121|4055659|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4232329|NCT00680121|4055657|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4232330|NCT00680121|4055658|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4232331|NCT00680121|4055659|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4232332|NCT00680121|4055657|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232333|NCT00680121|4055658|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232334|NCT00680121|4055659|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232335|NCT00680121|4055657|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232336|NCT00680121|4055658|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232337|NCT00680121|4055659|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232338|NCT00680121|4055657|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232339|NCT00680121|4055658|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232340|NCT00680121|4055659|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232341|NCT00680121|4055657|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4232342|NCT00680121|4055658|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4232343|NCT00680121|4055659|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4232344|NCT00680121|4055657|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4232345|NCT00680121|4055658|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4232346|NCT00680121|4055659|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4232347|NCT00680121|4055657|B3|||Age||years|Mean|47.5|47.5|Standard Deviation|7.9|7.9|||
4232348|NCT00680121|4055658|B2|||Age||years|Mean|48.1|48.1|Standard Deviation|6.9|6.9|||
4232349|NCT00680121|4055659|B1|||Age||years|Mean|46.9|46.9|Standard Deviation|8.7|8.7|||
4232350|NCT00680056|4055672|B3|Brazil||Region of Enrollment||participants|Number|33.0|33.0||||||
4232351|NCT00680056|4055673|B2|Brazil||Region of Enrollment||participants|Number|17|17.0||||||
4232352|NCT00680056|4055674|B1|Brazil||Region of Enrollment||participants|Number|16|16.0||||||
4232353|NCT00680056|4055672|B3||Male|Sex: Female, Male||Participants|Count of Participants|26.0|26.0||||||
4232354|NCT00680056|4055673|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4232355|NCT00680056|4055674|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4232356|NCT00680056|4055672|B3||Female|Sex: Female, Male||Participants|Count of Participants|7.0|7.0||||||
4232357|NCT00680056|4055673|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4232358|NCT00680056|4055674|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4232359|NCT00680056|4055672|B3|||Age||years|Mean|64.9|64.9|Standard Deviation|8.5|8.5|||
4232360|NCT00680056|4055673|B2|||Age||years|Mean|67.2|67.2|Standard Deviation|6.8|6.8|||
4232361|NCT00680056|4055674|B1|||Age||years|Mean|62.0|62.0|Standard Deviation|8.2|8.2|||
4232362|NCT00680056|4055672|B3||>=65 years|Age||Participants|Count of Participants|17.0|17.0||||||
4232363|NCT00680056|4055673|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4232364|NCT00680056|4055674|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4232365|NCT00680056|4055672|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16.0|16.0||||||
4232366|NCT00680056|4055673|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4232367|NCT00680056|4055674|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4232368|NCT00680056|4055672|B3||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4232369|NCT00680056|4055673|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232370|NCT00680056|4055674|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232371|NCT00680043|4055683|B4||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4232372|NCT00680043|4055684|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4232373|NCT00680043|4055685|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4232374|NCT00680043|4055686|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4232375|NCT00680043|4055683|B4||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4232376|NCT00680043|4055684|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4232377|NCT00680043|4055685|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4232378|NCT00680043|4055686|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4232379|NCT00680043|4055683|B4|||Age||years|Mean|49.7|49.7|Standard Deviation|13.10|13.1|||
4232380|NCT00680043|4055684|B3|||Age||years|Mean|51.4|51.4|Standard Deviation|14.16|14.16|||
4232381|NCT00680043|4055685|B2|||Age||years|Mean|48.8|48.8|Standard Deviation|13.55|13.55|||
4232382|NCT00680043|4055686|B1|||Age||years|Mean|48.8|48.8|Standard Deviation|11.71|11.71|||
4232383|NCT00680043|4055683|B4||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4232384|NCT00680043|4055684|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4232385|NCT00680043|4055685|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4232386|NCT00680043|4055686|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4232387|NCT00680043|4055683|B4||Between 18 and 65 years|Age||Participants|Count of Participants|98|98.0||||||
4232388|NCT00680043|4055684|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4232389|NCT00680043|4055685|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4232390|NCT00680043|4055686|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4232391|NCT00680043|4055683|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232392|NCT00680043|4055684|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232393|NCT00680043|4055685|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232394|NCT00680043|4055686|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232395|NCT00680017|4055702|B3|Puerto Rico||Region of Enrollment||participants|Number|19|19.0||||||
4232396|NCT00680017|4055703|B2|Puerto Rico||Region of Enrollment||participants|Number|8|8.0||||||
4232397|NCT00680017|4055704|B1|Puerto Rico||Region of Enrollment||participants|Number|11|11.0||||||
4232398|NCT00680017|4055702|B3|United States||Region of Enrollment||participants|Number|261|261.0||||||
4232399|NCT00680017|4055703|B2|United States||Region of Enrollment||participants|Number|132|132.0||||||
4232400|NCT00680017|4055704|B1|United States||Region of Enrollment||participants|Number|129|129.0||||||
4232401|NCT00680017|4055702|B3||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4232402|NCT00680017|4055703|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4232403|NCT00680017|4055704|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4232404|NCT00680017|4055702|B3||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4232405|NCT00680017|4055703|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4232406|NCT00680017|4055704|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4232407|NCT00680017|4055702|B3|||Age||years|Mean|66.2|66.2|Standard Deviation|10.80|10.8|||
4232408|NCT00680017|4055703|B2|||Age||years|Mean|67.4|67.4|Standard Deviation|11.15|11.15|||
4232409|NCT00680017|4055704|B1|||Age||years|Mean|65.1|65.1|Standard Deviation|10.35|10.35|||
4232410|NCT00680017|4055702|B3||>=65 years|Age||Participants|Count of Participants|165|165.0||||||
4232411|NCT00680017|4055703|B2||>=65 years|Age||Participants|Count of Participants|92|92.0||||||
4232412|NCT00680017|4055704|B1||>=65 years|Age||Participants|Count of Participants|73|73.0||||||
4232413|NCT00680017|4055702|B3||Between 18 and 65 years|Age||Participants|Count of Participants|115|115.0||||||
4232414|NCT00680017|4055703|B2||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4232415|NCT00680017|4055704|B1||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
4232416|NCT00680017|4055702|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232417|NCT00680017|4055703|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232418|NCT00680017|4055704|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232419|NCT00679952|4055713|B3|Korea, Republic of||Region of Enrollment||participants|Number|168|168.0||||||
4232420|NCT00679952|4055714|B2|Korea, Republic of||Region of Enrollment||participants|Number|82|82.0||||||
4232421|NCT00679952|4055715|B1|Korea, Republic of||Region of Enrollment||participants|Number|86|86.0||||||
4232422|NCT00679952|4055713|B3||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4232423|NCT00679952|4055714|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4232424|NCT00679952|4055715|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4232425|NCT00679952|4055713|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4232426|NCT00679952|4055714|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4232427|NCT00679952|4055715|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4232428|NCT00679952|4055713|B3|||Age||years|Mean|61.2|61.2|Standard Deviation|10.6|10.6|||
4232429|NCT00679952|4055714|B2|||Age||years|Mean|61.4|61.4|Standard Deviation|11.1|11.1|||
4232430|NCT00679952|4055715|B1|||Age||years|Mean|60.7|60.7|Standard Deviation|10.1|10.1|||
4232431|NCT00679952|4055713|B3||>=65 years|Age||Participants|Count of Participants|60|60.0||||||
4232432|NCT00679952|4055714|B2||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
4232433|NCT00679952|4055715|B1||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4232434|NCT00679952|4055713|B3||Between 18 and 65 years|Age||Participants|Count of Participants|108|108.0||||||
4232435|NCT00679952|4055714|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4232436|NCT00679952|4055715|B1||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4232437|NCT00679952|4055713|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232438|NCT00679952|4055714|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232439|NCT00679952|4055715|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232440|NCT00679939|4055722|B3|East Asia||Race/Ethnicity, Customized|Baseline Characteristics were summarized for all participants in the Safety Population, comprised of all randomized participants who received at least one dose of study medication. One participant in the Metformin arm did not receive study medication and was not included in the Safety Population.|participants|Number|6|6.0||||||
4232441|NCT00679939|4055723|B2|East Asia||Race/Ethnicity, Customized|Baseline Characteristics were summarized for all participants in the Safety Population, comprised of all randomized participants who received at least one dose of study medication. One participant in the Metformin arm did not receive study medication and was not included in the Safety Population.|participants|Number|2|2.0||||||
4232442|NCT00679939|4055724|B1|East Asia||Race/Ethnicity, Customized|Baseline Characteristics were summarized for all participants in the Safety Population, comprised of all randomized participants who received at least one dose of study medication. One participant in the Metformin arm did not receive study medication and was not included in the Safety Population.|participants|Number|4|4.0||||||
4232443|NCT00679939|4055722|B3|Mixed Race||Race/Ethnicity, Customized|Baseline Characteristics were summarized for all participants in the Safety Population, comprised of all randomized participants who received at least one dose of study medication. One participant in the Metformin arm did not receive study medication and was not included in the Safety Population.|participants|Number|5|5.0||||||
4232444|NCT00679939|4055723|B2|Mixed Race||Race/Ethnicity, Customized|Baseline Characteristics were summarized for all participants in the Safety Population, comprised of all randomized participants who received at least one dose of study medication. One participant in the Metformin arm did not receive study medication and was not included in the Safety Population.|participants|Number|2|2.0||||||
4232445|NCT00679939|4055724|B1|Mixed Race||Race/Ethnicity, Customized|Baseline Characteristics were summarized for all participants in the Safety Population, comprised of all randomized participants who received at least one dose of study medication. One participant in the Metformin arm did not receive study medication and was not included in the Safety Population.|participants|Number|3|3.0||||||
4232446|NCT00679939|4055722|B3|South East Asian||Race/Ethnicity, Customized|Baseline Characteristics were summarized for all participants in the Safety Population, comprised of all randomized participants who received at least one dose of study medication. One participant in the Metformin arm did not receive study medication and was not included in the Safety Population.|participants|Number|10|10.0||||||
4232447|NCT00679939|4055723|B2|South East Asian||Race/Ethnicity, Customized|Baseline Characteristics were summarized for all participants in the Safety Population, comprised of all randomized participants who received at least one dose of study medication. One participant in the Metformin arm did not receive study medication and was not included in the Safety Population.|participants|Number|6|6.0||||||
4232448|NCT00679939|4055724|B1|South East Asian||Race/Ethnicity, Customized|Baseline Characteristics were summarized for all participants in the Safety Population, comprised of all randomized participants who received at least one dose of study medication. One participant in the Metformin arm did not receive study medication and was not included in the Safety Population.|participants|Number|4|4.0||||||
4232449|NCT00679939|4055722|B3|Asian - Central/South Asian||Race/Ethnicity, Customized|Baseline Characteristics were summarized for all participants in the Safety Population, comprised of all randomized participants who received at least one dose of study medication. One participant in the Metformin arm did not receive study medication and was not included in the Safety Population.|participants|Number|23|23.0||||||
4232450|NCT00679939|4055723|B2|Asian - Central/South Asian||Race/Ethnicity, Customized|Baseline Characteristics were summarized for all participants in the Safety Population, comprised of all randomized participants who received at least one dose of study medication. One participant in the Metformin arm did not receive study medication and was not included in the Safety Population.|participants|Number|10|10.0||||||
4232451|NCT00679939|4055724|B1|Asian - Central/South Asian||Race/Ethnicity, Customized|Baseline Characteristics were summarized for all participants in the Safety Population, comprised of all randomized participants who received at least one dose of study medication. One participant in the Metformin arm did not receive study medication and was not included in the Safety Population.|participants|Number|13|13.0||||||
4232452|NCT00679939|4055722|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized|Baseline Characteristics were summarized for all participants in the Safety Population, comprised of all randomized participants who received at least one dose of study medication. One participant in the Metformin arm did not receive study medication and was not included in the Safety Population.|participants|Number|11|11.0||||||
4232453|NCT00679939|4055723|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized|Baseline Characteristics were summarized for all participants in the Safety Population, comprised of all randomized participants who received at least one dose of study medication. One participant in the Metformin arm did not receive study medication and was not included in the Safety Population.|participants|Number|5|5.0||||||
4232454|NCT00679939|4055724|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized|Baseline Characteristics were summarized for all participants in the Safety Population, comprised of all randomized participants who received at least one dose of study medication. One participant in the Metformin arm did not receive study medication and was not included in the Safety Population.|participants|Number|6|6.0||||||
4232455|NCT00679939|4055722|B3|African American/African||Race/Ethnicity, Customized|Baseline Characteristics were summarized for all participants in the Safety Population, comprised of all randomized participants who received at least one dose of study medication. One participant in the Metformin arm did not receive study medication and was not included in the Safety Population.|participants|Number|10|10.0||||||
4232456|NCT00679939|4055723|B2|African American/African||Race/Ethnicity, Customized|Baseline Characteristics were summarized for all participants in the Safety Population, comprised of all randomized participants who received at least one dose of study medication. One participant in the Metformin arm did not receive study medication and was not included in the Safety Population.|participants|Number|8|8.0||||||
4232457|NCT00679939|4055724|B1|African American/African||Race/Ethnicity, Customized|Baseline Characteristics were summarized for all participants in the Safety Population, comprised of all randomized participants who received at least one dose of study medication. One participant in the Metformin arm did not receive study medication and was not included in the Safety Population.|participants|Number|2|2.0||||||
4232458|NCT00679939|4055722|B3|White – White/Caucasian/European||Race/Ethnicity, Customized|Baseline Characteristics were summarized for all participants in the Safety Population, comprised of all randomized participants who received at least one dose of study medication. One participant in the Metformin arm did not receive study medication and was not included in the Safety Population.|participants|Number|160|160.0||||||
4232495|NCT00679783|4055885|B8|||Age||Year|Mean|52.9|52.9|Standard Deviation|13|13.0|||
4232459|NCT00679939|4055723|B2|White – White/Caucasian/European||Race/Ethnicity, Customized|Baseline Characteristics were summarized for all participants in the Safety Population, comprised of all randomized participants who received at least one dose of study medication. One participant in the Metformin arm did not receive study medication and was not included in the Safety Population.|participants|Number|78|78.0||||||
4232460|NCT00679939|4055724|B1|White – White/Caucasian/European||Race/Ethnicity, Customized|Baseline Characteristics were summarized for all participants in the Safety Population, comprised of all randomized participants who received at least one dose of study medication. One participant in the Metformin arm did not receive study medication and was not included in the Safety Population.|participants|Number|82|82.0||||||
4232461|NCT00679939|4055722|B3||Male|Sex: Female, Male|Baseline Characteristics were summarized for all participants in the Safety Population, comprised of all randomized participants who received at least one dose of study medication. One participant in the Metformin arm did not receive study medication and was not included in the Safety Population.|Participants|Count of Participants|0|0.0||||||
4232462|NCT00679939|4055723|B2||Male|Sex: Female, Male|Baseline Characteristics were summarized for all participants in the Safety Population, comprised of all randomized participants who received at least one dose of study medication. One participant in the Metformin arm did not receive study medication and was not included in the Safety Population.|Participants|Count of Participants|0|0.0||||||
4232463|NCT00679939|4055724|B1||Male|Sex: Female, Male|Baseline Characteristics were summarized for all participants in the Safety Population, comprised of all randomized participants who received at least one dose of study medication. One participant in the Metformin arm did not receive study medication and was not included in the Safety Population.|Participants|Count of Participants|0|0.0||||||
4232464|NCT00679939|4055722|B3||Female|Sex: Female, Male|Baseline Characteristics were summarized for all participants in the Safety Population, comprised of all randomized participants who received at least one dose of study medication. One participant in the Metformin arm did not receive study medication and was not included in the Safety Population.|Participants|Count of Participants|225|225.0||||||
4232465|NCT00679939|4055723|B2||Female|Sex: Female, Male|Baseline Characteristics were summarized for all participants in the Safety Population, comprised of all randomized participants who received at least one dose of study medication. One participant in the Metformin arm did not receive study medication and was not included in the Safety Population.|Participants|Count of Participants|111|111.0||||||
4232466|NCT00679939|4055724|B1||Female|Sex: Female, Male|Baseline Characteristics were summarized for all participants in the Safety Population, comprised of all randomized participants who received at least one dose of study medication. One participant in the Metformin arm did not receive study medication and was not included in the Safety Population.|Participants|Count of Participants|114|114.0||||||
4232467|NCT00679939|4055722|B3|||Age|Baseline Characteristics were summarized for all participants in the Safety Population, comprised of all randomized participants who received at least one dose of study medication. One participant in the Metformin arm did not receive study medication and was not included in the Safety Population.|Years|Mean|63.8|63.8|Standard Deviation|6.52|6.52|||
4232468|NCT00679939|4055723|B2|||Age|Baseline Characteristics were summarized for all participants in the Safety Population, comprised of all randomized participants who received at least one dose of study medication. One participant in the Metformin arm did not receive study medication and was not included in the Safety Population.|Years|Mean|64.0|64.0|Standard Deviation|6.46|6.46|||
4232469|NCT00679939|4055724|B1|||Age|Baseline Characteristics were summarized for all participants in the Safety Population, comprised of all randomized participants who received at least one dose of study medication. One participant in the Metformin arm did not receive study medication and was not included in the Safety Population.|Years|Mean|63.6|63.6|Standard Deviation|6.61|6.61|||
4232470|NCT00679913|4055874|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4232471|NCT00679913|4055875|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4232472|NCT00679913|4055876|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4232473|NCT00679913|4055874|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4232474|NCT00679913|4055875|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4232475|NCT00679913|4055876|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4232476|NCT00679913|4055874|B3|||Age||years|Mean|62.7|62.7|Standard Deviation|9.1|9.1|||
4232477|NCT00679913|4055875|B2|||Age||years|Mean|63.4|63.4|Standard Deviation|9.5|9.5|||
4232478|NCT00679913|4055876|B1|||Age||years|Mean|62|62.0|Standard Deviation|8.7|8.7|||
4232479|NCT00679783|4055885|B8||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4232480|NCT00679783|4055886|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4232481|NCT00679783|4055887|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4232482|NCT00679783|4055888|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4232483|NCT00679783|4055889|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4232484|NCT00679783|4055890|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4232485|NCT00679783|4055891|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4232486|NCT00679783|4055892|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4232487|NCT00679783|4055885|B8||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4232488|NCT00679783|4055886|B7||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4232489|NCT00679783|4055887|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4232490|NCT00679783|4055888|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4232491|NCT00679783|4055889|B4||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4232492|NCT00679783|4055890|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4232493|NCT00679783|4055891|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4232494|NCT00679783|4055892|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4232496|NCT00679783|4055886|B7|||Age||Year|Mean|48.8|48.8|Standard Deviation|5.5|5.5|||
4232497|NCT00679783|4055887|B6|||Age||Year|Mean|44.8|44.8|Standard Deviation|15.5|15.5|||
4232498|NCT00679783|4055888|B5|||Age||Year|Mean|49.4|49.4|Standard Deviation|20.5|20.5|||
4232499|NCT00679783|4055889|B4|||Age||Year|Mean|61|61.0|Standard Deviation|9.5|9.5|||
4232500|NCT00679783|4055890|B3|||Age||Year|Mean|60.3|60.3|Standard Deviation|12.9|12.9|||
4232501|NCT00679783|4055891|B2|||Age||Year|Mean|53.7|53.7|Standard Deviation|7.3|7.3|||
4232502|NCT00679783|4055892|B1|||Age||Year|Mean|60|60.0|Standard Deviation|18.7|18.7|||
4232503|NCT00679627|4055949|B3|Ukraine||Region of Enrollment||participants|Number|334|334.0||||||
4232504|NCT00679627|4055950|B2|Ukraine||Region of Enrollment||participants|Number|168|168.0||||||
4232505|NCT00679627|4055951|B1|Ukraine||Region of Enrollment||participants|Number|166|166.0||||||
4232506|NCT00679627|4055949|B3|Slovenia||Region of Enrollment||participants|Number|26|26.0||||||
4232507|NCT00679627|4055950|B2|Slovenia||Region of Enrollment||participants|Number|13|13.0||||||
4232508|NCT00679627|4055951|B1|Slovenia||Region of Enrollment||participants|Number|13|13.0||||||
4232509|NCT00679627|4055949|B3|Slovakia||Region of Enrollment||participants|Number|173|173.0||||||
4232510|NCT00679627|4055950|B2|Slovakia||Region of Enrollment||participants|Number|88|88.0||||||
4232511|NCT00679627|4055951|B1|Slovakia||Region of Enrollment||participants|Number|85|85.0||||||
4232512|NCT00679627|4055949|B3|Russia||Region of Enrollment||participants|Number|545|545.0||||||
4232513|NCT00679627|4055950|B2|Russia||Region of Enrollment||participants|Number|271|271.0||||||
4232514|NCT00679627|4055951|B1|Russia||Region of Enrollment||participants|Number|274|274.0||||||
4232515|NCT00679627|4055949|B3|Romania||Region of Enrollment||participants|Number|168|168.0||||||
4232516|NCT00679627|4055950|B2|Romania||Region of Enrollment||participants|Number|84|84.0||||||
4232517|NCT00679627|4055951|B1|Romania||Region of Enrollment||participants|Number|84|84.0||||||
4232518|NCT00679627|4055949|B3|Lithuania||Region of Enrollment||participants|Number|44|44.0||||||
4232519|NCT00679627|4055950|B2|Lithuania||Region of Enrollment||participants|Number|21|21.0||||||
4232520|NCT00679627|4055951|B1|Lithuania||Region of Enrollment||participants|Number|23|23.0||||||
4232521|NCT00679627|4055949|B3|Latvia||Region of Enrollment||participants|Number|4|4.0||||||
4232522|NCT00679627|4055950|B2|Latvia||Region of Enrollment||participants|Number|2|2.0||||||
4232523|NCT00679627|4055951|B1|Latvia||Region of Enrollment||participants|Number|2|2.0||||||
4232524|NCT00679627|4055949|B3|Italy||Region of Enrollment||participants|Number|49|49.0||||||
4232525|NCT00679627|4055950|B2|Italy||Region of Enrollment||participants|Number|24|24.0||||||
4232526|NCT00679627|4055951|B1|Italy||Region of Enrollment||participants|Number|25|25.0||||||
4232527|NCT00679627|4055949|B3|Greece||Region of Enrollment||participants|Number|71|71.0||||||
4232528|NCT00679627|4055950|B2|Greece||Region of Enrollment||participants|Number|36|36.0||||||
4232529|NCT00679627|4055951|B1|Greece||Region of Enrollment||participants|Number|35|35.0||||||
4232530|NCT00679627|4055949|B3|Germany||Region of Enrollment||participants|Number|439|439.0||||||
4232531|NCT00679627|4055950|B2|Germany||Region of Enrollment||participants|Number|221|221.0||||||
4232532|NCT00679627|4055951|B1|Germany||Region of Enrollment||participants|Number|218|218.0||||||
4232533|NCT00679627|4055949|B3|France||Region of Enrollment||participants|Number|21|21.0||||||
4232534|NCT00679627|4055950|B2|France||Region of Enrollment||participants|Number|11|11.0||||||
4232535|NCT00679627|4055951|B1|France||Region of Enrollment||participants|Number|10|10.0||||||
4232536|NCT00679627|4055949|B3|Estonia||Region of Enrollment||participants|Number|104|104.0||||||
4232537|NCT00679627|4055950|B2|Estonia||Region of Enrollment||participants|Number|51|51.0||||||
4232538|NCT00679627|4055951|B1|Estonia||Region of Enrollment||participants|Number|53|53.0||||||
4232539|NCT00679627|4055949|B3|Czech Republic||Region of Enrollment||participants|Number|67|67.0||||||
4232540|NCT00679627|4055950|B2|Czech Republic||Region of Enrollment||participants|Number|34|34.0||||||
4232541|NCT00679627|4055951|B1|Czech Republic||Region of Enrollment||participants|Number|33|33.0||||||
4232542|NCT00679627|4055949|B3||Male|Sex: Female, Male||Participants|Count of Participants|720|720.0||||||
4232543|NCT00679627|4055950|B2||Male|Sex: Female, Male||Participants|Count of Participants|353|353.0||||||
4232544|NCT00679627|4055951|B1||Male|Sex: Female, Male||Participants|Count of Participants|367|367.0||||||
4232545|NCT00679627|4055949|B3||Female|Sex: Female, Male||Participants|Count of Participants|1325|1325.0||||||
4232546|NCT00679627|4055950|B2||Female|Sex: Female, Male||Participants|Count of Participants|671|671.0||||||
4232547|NCT00679627|4055951|B1||Female|Sex: Female, Male||Participants|Count of Participants|654|654.0||||||
4232548|NCT00679627|4055949|B3|>=76||Age, Customized||participants|Number|888|888.0||||||
4232549|NCT00679627|4055950|B2|>=76||Age, Customized||participants|Number|446|446.0||||||
4232550|NCT00679627|4055951|B1|>=76||Age, Customized||participants|Number|442|442.0||||||
4232551|NCT00679627|4055949|B3|61-<76||Age, Customized||participants|Number|933|933.0||||||
4232552|NCT00679627|4055950|B2|61-<76||Age, Customized||participants|Number|466|466.0||||||
4232553|NCT00679627|4055951|B1|61-<76||Age, Customized||participants|Number|467|467.0||||||
4232554|NCT00679627|4055949|B3|<61||Age, Customized||participants|Number|224|224.0||||||
4232555|NCT00679627|4055950|B2|<61||Age, Customized||participants|Number|112|112.0||||||
4232556|NCT00679627|4055951|B1|<61||Age, Customized||participants|Number|112|112.0||||||
4232557|NCT00679627|4055949|B3|||Age||participants|Mean|73.1|73.1|Standard Deviation|8.77|8.77|||
4232558|NCT00679627|4055950|B2|||Age||participants|Mean|73|73.0|Standard Deviation|8.88|8.88|||
4232559|NCT00679627|4055951|B1|||Age||participants|Mean|73.2|73.2|Standard Deviation|8.67|8.67|||
4232560|NCT00679432|4055974|B5|India||Region of Enrollment||participants|Number|162|162.0||||||
4232561|NCT00679432|4055975|B4|India||Region of Enrollment||participants|Number|42|42.0||||||
4232562|NCT00679432|4055976|B3|India||Region of Enrollment||participants|Number|39|39.0||||||
4232563|NCT00679432|4055977|B2|India||Region of Enrollment||participants|Number|40|40.0||||||
4232564|NCT00679432|4055978|B1|India||Region of Enrollment||participants|Number|41|41.0||||||
4232565|NCT00679432|4055974|B5|Canada||Region of Enrollment||participants|Number|23|23.0||||||
4232566|NCT00679432|4055975|B4|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4232567|NCT00679432|4055976|B3|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4232568|NCT00679432|4055977|B2|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4232569|NCT00679432|4055978|B1|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4232570|NCT00679432|4055974|B5|United States||Region of Enrollment||participants|Number|304|304.0||||||
4232571|NCT00679432|4055975|B4|United States||Region of Enrollment||participants|Number|76|76.0||||||
4232572|NCT00679432|4055976|B3|United States||Region of Enrollment||participants|Number|77|77.0||||||
4232573|NCT00679432|4055977|B2|United States||Region of Enrollment||participants|Number|76|76.0||||||
4232574|NCT00679432|4055978|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
4232575|NCT00679432|4055974|B5||Male|Sex: Female, Male||Participants|Count of Participants|273|273.0||||||
4232576|NCT00679432|4055975|B4||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4232577|NCT00679432|4055976|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4232578|NCT00679432|4055977|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4232579|NCT00679432|4055978|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4232580|NCT00679432|4055974|B5||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4232581|NCT00679432|4055975|B4||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4232582|NCT00679432|4055976|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4232583|NCT00679432|4055977|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4232584|NCT00679432|4055978|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4232585|NCT00679432|4055974|B5|||Age||years|Mean|42.7|42.7|Standard Deviation|12.8|12.8|||
4232586|NCT00679432|4055975|B4|||Age||years|Mean|44|44.0|Standard Deviation|12.4|12.4|||
4232587|NCT00679432|4055976|B3|||Age||years|Mean|41.7|41.7|Standard Deviation|13.6|13.6|||
4232588|NCT00679432|4055977|B2|||Age||years|Mean|41.7|41.7|Standard Deviation|12.2|12.2|||
4232589|NCT00679432|4055978|B1|||Age||years|Mean|43.2|43.2|Standard Deviation|13|13.0|||
4232590|NCT00679432|4055974|B5||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4232591|NCT00679432|4055975|B4||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4232592|NCT00679432|4055976|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4232593|NCT00679432|4055977|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4232594|NCT00679432|4055978|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4232595|NCT00679432|4055974|B5||Between 18 and 65 years|Age||Participants|Count of Participants|472|472.0||||||
4232596|NCT00679432|4055975|B4||Between 18 and 65 years|Age||Participants|Count of Participants|118|118.0||||||
4232597|NCT00679432|4055976|B3||Between 18 and 65 years|Age||Participants|Count of Participants|115|115.0||||||
4232598|NCT00679432|4055977|B2||Between 18 and 65 years|Age||Participants|Count of Participants|122|122.0||||||
4232599|NCT00679432|4055978|B1||Between 18 and 65 years|Age||Participants|Count of Participants|117|117.0||||||
4232600|NCT00679432|4055974|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232601|NCT00679432|4055975|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232602|NCT00679432|4055976|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232603|NCT00679432|4055977|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232604|NCT00679432|4055978|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232605|NCT00679380|4055999|B5|Israel||Region of Enrollment||participants|Number|2|2.0||||||
4232606|NCT00679380|4056000|B4|Israel||Region of Enrollment||participants|Number|0|0.0||||||
4232607|NCT00679380|4056001|B3|Israel||Region of Enrollment||participants|Number|1|1.0||||||
4232608|NCT00679380|4056002|B2|Israel||Region of Enrollment||participants|Number|0|0.0||||||
4232609|NCT00679380|4056003|B1|Israel||Region of Enrollment||participants|Number|1|1.0||||||
4232610|NCT00679380|4055999|B5|Sweden||Region of Enrollment||participants|Number|6|6.0||||||
4232611|NCT00679380|4056000|B4|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
4232612|NCT00679380|4056001|B3|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
4232613|NCT00679380|4056002|B2|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
4232614|NCT00679380|4056003|B1|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
4232615|NCT00679380|4055999|B5|Latvia||Region of Enrollment||participants|Number|6|6.0||||||
4232616|NCT00679380|4056000|B4|Latvia||Region of Enrollment||participants|Number|2|2.0||||||
4232617|NCT00679380|4056001|B3|Latvia||Region of Enrollment||participants|Number|0|0.0||||||
4232618|NCT00679380|4056002|B2|Latvia||Region of Enrollment||participants|Number|2|2.0||||||
4232619|NCT00679380|4056003|B1|Latvia||Region of Enrollment||participants|Number|2|2.0||||||
4232620|NCT00679380|4055999|B5|Australia||Region of Enrollment||participants|Number|7|7.0||||||
4232621|NCT00679380|4056000|B4|Australia||Region of Enrollment||participants|Number|2|2.0||||||
4232622|NCT00679380|4056001|B3|Australia||Region of Enrollment||participants|Number|3|3.0||||||
4232623|NCT00679380|4056002|B2|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4232624|NCT00679380|4056003|B1|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4232625|NCT00679380|4055999|B5|Romania||Region of Enrollment||participants|Number|11|11.0||||||
4232626|NCT00679380|4056000|B4|Romania||Region of Enrollment||participants|Number|3|3.0||||||
4232627|NCT00679380|4056001|B3|Romania||Region of Enrollment||participants|Number|1|1.0||||||
4232628|NCT00679380|4056002|B2|Romania||Region of Enrollment||participants|Number|5|5.0||||||
4232629|NCT00679380|4056003|B1|Romania||Region of Enrollment||participants|Number|2|2.0||||||
4232630|NCT00679380|4055999|B5|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
4232631|NCT00679380|4056000|B4|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
4232632|NCT00679380|4056001|B3|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
4232633|NCT00679380|4056002|B2|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
4232634|NCT00679380|4056003|B1|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
4232635|NCT00679380|4055999|B5|Poland||Region of Enrollment||participants|Number|43|43.0||||||
4232636|NCT00679380|4056000|B4|Poland||Region of Enrollment||participants|Number|9|9.0||||||
4232637|NCT00679380|4056001|B3|Poland||Region of Enrollment||participants|Number|13|13.0||||||
4232638|NCT00679380|4056002|B2|Poland||Region of Enrollment||participants|Number|14|14.0||||||
4232639|NCT00679380|4056003|B1|Poland||Region of Enrollment||participants|Number|7|7.0||||||
4232640|NCT00679380|4055999|B5|France||Region of Enrollment||participants|Number|3|3.0||||||
4232641|NCT00679380|4056000|B4|France||Region of Enrollment||participants|Number|1|1.0||||||
4232642|NCT00679380|4056001|B3|France||Region of Enrollment||participants|Number|1|1.0||||||
4232643|NCT00679380|4056002|B2|France||Region of Enrollment||participants|Number|1|1.0||||||
4232644|NCT00679380|4056003|B1|France||Region of Enrollment||participants|Number|0|0.0||||||
4232645|NCT00679380|4055999|B5|Italy||Region of Enrollment||participants|Number|61|61.0||||||
4232646|NCT00679380|4056000|B4|Italy||Region of Enrollment||participants|Number|13|13.0||||||
4232647|NCT00679380|4056001|B3|Italy||Region of Enrollment||participants|Number|18|18.0||||||
4232648|NCT00679380|4056002|B2|Italy||Region of Enrollment||participants|Number|12|12.0||||||
4232649|NCT00679380|4056003|B1|Italy||Region of Enrollment||participants|Number|18|18.0||||||
4232650|NCT00679380|4055999|B5|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
4232651|NCT00679380|4056000|B4|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4232652|NCT00679380|4056001|B3|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4232653|NCT00679380|4056002|B2|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4232654|NCT00679380|4056003|B1|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4232655|NCT00679380|4055999|B5|Russian Federation||Region of Enrollment||participants|Number|121|121.0||||||
4232656|NCT00679380|4056000|B4|Russian Federation||Region of Enrollment||participants|Number|28|28.0||||||
4232657|NCT00679380|4056001|B3|Russian Federation||Region of Enrollment||participants|Number|34|34.0||||||
4232658|NCT00679380|4056002|B2|Russian Federation||Region of Enrollment||participants|Number|35|35.0||||||
4232659|NCT00679380|4056003|B1|Russian Federation||Region of Enrollment||participants|Number|24|24.0||||||
4232660|NCT00679380|4055999|B5|Lithuania||Region of Enrollment||participants|Number|59|59.0||||||
4232661|NCT00679380|4056000|B4|Lithuania||Region of Enrollment||participants|Number|12|12.0||||||
4232662|NCT00679380|4056001|B3|Lithuania||Region of Enrollment||participants|Number|11|11.0||||||
4232663|NCT00679380|4056002|B2|Lithuania||Region of Enrollment||participants|Number|17|17.0||||||
4232664|NCT00679380|4056003|B1|Lithuania||Region of Enrollment||participants|Number|19|19.0||||||
4232665|NCT00679380|4055999|B5|Ukraine||Region of Enrollment||participants|Number|25|25.0||||||
4232666|NCT00679380|4056000|B4|Ukraine||Region of Enrollment||participants|Number|5|5.0||||||
4232667|NCT00679380|4056001|B3|Ukraine||Region of Enrollment||participants|Number|7|7.0||||||
4232668|NCT00679380|4056002|B2|Ukraine||Region of Enrollment||participants|Number|6|6.0||||||
4232669|NCT00679380|4056003|B1|Ukraine||Region of Enrollment||participants|Number|7|7.0||||||
4232670|NCT00679380|4055999|B5|Slovakia||Region of Enrollment||participants|Number|27|27.0||||||
4232671|NCT00679380|4056000|B4|Slovakia||Region of Enrollment||participants|Number|7|7.0||||||
4232672|NCT00679380|4056001|B3|Slovakia||Region of Enrollment||participants|Number|5|5.0||||||
4232673|NCT00679380|4056002|B2|Slovakia||Region of Enrollment||participants|Number|5|5.0||||||
4232674|NCT00679380|4056003|B1|Slovakia||Region of Enrollment||participants|Number|10|10.0||||||
4232675|NCT00679380|4055999|B5|Estonia||Region of Enrollment||participants|Number|28|28.0||||||
4232676|NCT00679380|4056000|B4|Estonia||Region of Enrollment||participants|Number|5|5.0||||||
4232677|NCT00679380|4056001|B3|Estonia||Region of Enrollment||participants|Number|6|6.0||||||
4232678|NCT00679380|4056002|B2|Estonia||Region of Enrollment||participants|Number|6|6.0||||||
4232679|NCT00679380|4056003|B1|Estonia||Region of Enrollment||participants|Number|11|11.0||||||
4232680|NCT00679380|4055999|B5||Male|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
4232681|NCT00679380|4056000|B4||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4232682|NCT00679380|4056001|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4232683|NCT00679380|4056002|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4232684|NCT00679380|4056003|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4232685|NCT00679380|4055999|B5||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4232686|NCT00679380|4056000|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4232687|NCT00679380|4056001|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4232688|NCT00679380|4056002|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4232689|NCT00679380|4056003|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4232690|NCT00679380|4055999|B5|||Age||years|Mean|43.6|43.6|Standard Deviation|13.6|13.6|||
4232691|NCT00679380|4056000|B4|||Age||years|Mean|44.8|44.8|Standard Deviation|13.0|13.0|||
4232692|NCT00679380|4056001|B3|||Age||years|Mean|43.4|43.4|Standard Deviation|14.0|14.0|||
4232693|NCT00679380|4056002|B2|||Age||years|Mean|42.8|42.8|Standard Deviation|13.9|13.9|||
4232694|NCT00679380|4056003|B1|||Age||years|Mean|43.6|43.6|Standard Deviation|13.6|13.6|||
4232695|NCT00679380|4055999|B5||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4232696|NCT00679380|4056000|B4||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4232697|NCT00679380|4056001|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4232698|NCT00679380|4056002|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4232699|NCT00679380|4056003|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4232700|NCT00679380|4055999|B5||Between 18 and 65 years|Age||Participants|Count of Participants|388|388.0||||||
4232701|NCT00679380|4056000|B4||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
4232702|NCT00679380|4056001|B3||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
4232703|NCT00679380|4056002|B2||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
4232704|NCT00679380|4056003|B1||Between 18 and 65 years|Age||Participants|Count of Participants|102|102.0||||||
4232705|NCT00679380|4055999|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232706|NCT00679380|4056000|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232707|NCT00679380|4056001|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232708|NCT00679380|4056002|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232709|NCT00679380|4056003|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232710|NCT00679367|4056024|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232711|NCT00679367|4056024|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232712|NCT00679367|4056024|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4232713|NCT00679367|4056024|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4232714|NCT00679367|4056024|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232715|NCT00679367|4056024|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232716|NCT00679367|4056024|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232717|NCT00679367|4056024|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
4232718|NCT00679367|4056024|B1||Female|Gender||Participants|Count of Participants|10|10.0||||||
4232719|NCT00679367|4056024|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4232720|NCT00679367|4056024|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4232721|NCT00679367|4056024|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232722|NCT00679354|4056030|B1|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4232723|NCT00679354|4056030|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4232724|NCT00679354|4056030|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4232725|NCT00679354|4056030|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4232726|NCT00679354|4056030|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4232727|NCT00679354|4056030|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4232728|NCT00679354|4056030|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4232729|NCT00679354|4056030|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232730|NCT00679354|4056030|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4232731|NCT00679354|4056030|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4232732|NCT00679354|4056030|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4232733|NCT00679354|4056030|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232734|NCT00679354|4056030|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232735|NCT00679354|4056030|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4232736|NCT00679354|4056030|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4232737|NCT00679354|4056030|B1|||Age||years|Median|13|13.0|Full Range|||1.0|20.0|
4232738|NCT00679341|4056046|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4232739|NCT00679341|4056047|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4232740|NCT00679341|4056048|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4232741|NCT00679341|4056046|B3||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4232742|NCT00679341|4056047|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4232743|NCT00679341|4056048|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4232744|NCT00679341|4056046|B3|||Age||years|Mean|53.2|53.2|Standard Deviation|11.7|11.7|||
4232745|NCT00679341|4056047|B2|||Age||years|Mean|52.1|52.1|Standard Deviation|10.7|10.7|||
4232746|NCT00679341|4056048|B1|||Age||years|Mean|54.3|54.3|Standard Deviation|12.6|12.6|||
4232747|NCT00679302|4056067|B3|United States||Region of Enrollment||participants|Number|161|161.0||||||
4232748|NCT00679302|4056068|B2|United States||Region of Enrollment||participants|Number|77|77.0||||||
4232749|NCT00679302|4056069|B1|United States||Region of Enrollment||participants|Number|84|84.0||||||
4232750|NCT00679302|4056067|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4232751|NCT00679302|4056068|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4232752|NCT00679302|4056069|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4232753|NCT00679302|4056067|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4232754|NCT00679302|4056068|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4232755|NCT00679302|4056069|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4232756|NCT00679302|4056067|B3|||Age||years|Mean|4.5|4.5|Standard Deviation|0.5|0.5|||
4232757|NCT00679302|4056068|B2|||Age||years|Mean|4.5|4.5|Standard Deviation|0.5|0.5|||
4232758|NCT00679302|4056069|B1|||Age||years|Mean|4.5|4.5|Standard Deviation|0.5|0.5|||
4232759|NCT00679302|4056067|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4232760|NCT00679302|4056068|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4232761|NCT00679302|4056069|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4232762|NCT00679302|4056067|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4232763|NCT00679302|4056068|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4232764|NCT00679302|4056069|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4232765|NCT00679302|4056067|B3||<=18 years|Age||Participants|Count of Participants|161|161.0||||||
4232766|NCT00679302|4056068|B2||<=18 years|Age||Participants|Count of Participants|77|77.0||||||
4232767|NCT00679302|4056069|B1||<=18 years|Age||Participants|Count of Participants|84|84.0||||||
4232768|NCT00679289|4056078|B4|||Body Mass Index||kg/m^2|Median|26.5|26.5|Full Range|||18.3|45.9|
4232769|NCT00679289|4056079|B3|||Body Mass Index||kg/m^2|Median|26.3|26.3|Full Range|||18.3|45.9|
4232770|NCT00679289|4056080|B2|||Body Mass Index||kg/m^2|Median|29.4|29.4|Full Range|||27.6|39.2|
4232771|NCT00679289|4056081|B1|||Body Mass Index||kg/m^2|Median|24.4|24.4|Full Range|||20.7|26.5|
4232772|NCT00679289|4056078|B4|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
4232773|NCT00679289|4056079|B3|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
4232774|NCT00679289|4056080|B2|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4232775|NCT00679289|4056081|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4232776|NCT00679289|4056078|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232777|NCT00679289|4056079|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232778|NCT00679289|4056080|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232779|NCT00679289|4056081|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232780|NCT00679289|4056078|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232781|NCT00679289|4056079|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232782|NCT00679289|4056080|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232783|NCT00679289|4056081|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232784|NCT00679289|4056078|B4||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4232785|NCT00679289|4056079|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4232786|NCT00679289|4056080|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4232787|NCT00679289|4056081|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4232788|NCT00679289|4056078|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232789|NCT00679289|4056079|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232790|NCT00679289|4056080|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232791|NCT00679289|4056081|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232792|NCT00679289|4056078|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232793|NCT00679289|4056079|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232794|NCT00679289|4056080|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232795|NCT00679289|4056081|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232796|NCT00679289|4056078|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232797|NCT00679289|4056079|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232798|NCT00679289|4056080|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232799|NCT00679289|4056081|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232800|NCT00679289|4056078|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232801|NCT00679289|4056079|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232802|NCT00679289|4056080|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232803|NCT00679289|4056081|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232804|NCT00679289|4056078|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232805|NCT00679289|4056079|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232806|NCT00679289|4056080|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232807|NCT00679289|4056081|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232808|NCT00679289|4056078|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4232809|NCT00679289|4056079|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4232810|NCT00679289|4056080|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4232811|NCT00679289|4056081|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4232812|NCT00679289|4056078|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232813|NCT00679289|4056079|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232814|NCT00679289|4056080|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232815|NCT00679289|4056081|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232816|NCT00679289|4056078|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4232817|NCT00679289|4056079|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4232818|NCT00679289|4056080|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4232819|NCT00679289|4056081|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4232820|NCT00679289|4056078|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4232821|NCT00679289|4056079|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4232822|NCT00679289|4056080|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4232823|NCT00679289|4056081|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4232824|NCT00679289|4056078|B4|||Age||years|Median|54|54.0|Full Range|||27.0|73.0|
4232825|NCT00679289|4056079|B3|||Age||years|Median|54|54.0|Full Range|||36.0|72.0|
4232826|NCT00679289|4056080|B2|||Age||years|Median|61|61.0|Full Range|||31.0|73.0|
4232827|NCT00679289|4056081|B1|||Age||years|Median|55|55.0|Full Range|||27.0|70.0|
4232828|NCT00679263|4056102|B4|United States||Region of Enrollment||participants|Number|28|28.0||||||
4232829|NCT00679263|4056103|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4232830|NCT00679263|4056104|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4232831|NCT00679263|4056105|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4232832|NCT00679263|4056102|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4232833|NCT00679263|4056103|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4232834|NCT00679263|4056104|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4232835|NCT00679263|4056105|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4232836|NCT00679263|4056102|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4232837|NCT00679263|4056103|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4232838|NCT00679263|4056104|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4232839|NCT00679263|4056105|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4232840|NCT00679263|4056102|B4|||Age||years|Mean|32.7|32.7|Standard Deviation|10.83|10.83|||
4232841|NCT00679263|4056103|B3|||Age||years|Mean|36.7|36.7|Standard Deviation|9.65|9.65|||
4232842|NCT00679263|4056104|B2|||Age||years|Mean|36.7|36.7|Standard Deviation|9.65|9.65|||
4232843|NCT00679263|4056105|B1|||Age||years|Mean|30.5|30.5|Standard Deviation|11.25|11.25|||
4232844|NCT00679263|4056102|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4232845|NCT00679263|4056103|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4232846|NCT00679263|4056104|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4232847|NCT00679263|4056105|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4232848|NCT00679263|4056102|B4||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4232849|NCT00679263|4056103|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4232850|NCT00679263|4056104|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4232851|NCT00679263|4056105|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4232852|NCT00679263|4056102|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232853|NCT00679263|4056103|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232854|NCT00679263|4056104|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232855|NCT00679263|4056105|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232856|NCT00679211|4056118|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4232857|NCT00679211|4056118|B1||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4232858|NCT00679211|4056118|B1|||Age||years|Mean|53.0|53.0|Standard Deviation|9.1|9.1|34.0|77.0|
4232859|NCT00679172|4056130|B6|United States||Region of Enrollment||participants|Number|187|187.0||||||
4232860|NCT00679172|4056131|B5|United States||Region of Enrollment||participants|Number|37|37.0||||||
4232861|NCT00679172|4056132|B4|United States||Region of Enrollment||participants|Number|39|39.0||||||
4232862|NCT00679172|4056133|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4232863|NCT00679172|4056134|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
4232864|NCT00679172|4056135|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4232865|NCT00679172|4056130|B6||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4232866|NCT00679172|4056131|B5||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4232867|NCT00679172|4056132|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4232868|NCT00679172|4056133|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4232869|NCT00679172|4056134|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4232870|NCT00679172|4056135|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4232871|NCT00679172|4056130|B6||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4232872|NCT00679172|4056131|B5||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4232873|NCT00679172|4056132|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4232874|NCT00679172|4056133|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4232875|NCT00679172|4056134|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4232876|NCT00679172|4056135|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4232877|NCT00679172|4056130|B6|||Age||years|Mean|32.4|32.4|Standard Deviation|9.79|9.79|||
4232878|NCT00679172|4056131|B5|||Age||years|Mean|32.3|32.3|Standard Deviation|10.01|10.01|||
4232879|NCT00679172|4056132|B4|||Age||years|Mean|31.3|31.3|Standard Deviation|9.21|9.21|||
4232880|NCT00679172|4056133|B3|||Age||years|Mean|32.0|32.0|Standard Deviation|9.99|9.99|||
4232881|NCT00679172|4056134|B2|||Age||years|Mean|33.1|33.1|Standard Deviation|10.00|10.0|||
4232882|NCT00679172|4056135|B1|||Age||years|Mean|33.2|33.2|Standard Deviation|10.13|10.13|||
4232883|NCT00679172|4056130|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4232884|NCT00679172|4056131|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4232885|NCT00679172|4056132|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4232886|NCT00679172|4056133|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4232887|NCT00679172|4056134|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4232888|NCT00679172|4056135|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4232889|NCT00679172|4056130|B6||Between 18 and 65 years|Age||Participants|Count of Participants|183|183.0||||||
4232890|NCT00679172|4056131|B5||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4232891|NCT00679172|4056132|B4||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4232892|NCT00679172|4056133|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4232893|NCT00679172|4056134|B2||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4232894|NCT00679172|4056135|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4232895|NCT00679172|4056130|B6||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4232896|NCT00679172|4056131|B5||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4232897|NCT00679172|4056132|B4||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4232898|NCT00679172|4056133|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4232899|NCT00679172|4056134|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232900|NCT00679172|4056135|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4232901|NCT00679081|4056202|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4232902|NCT00679081|4056202|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4232903|NCT00679081|4056202|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4232904|NCT00679081|4056202|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4232905|NCT00679081|4056202|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4232906|NCT00679081|4056202|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4232907|NCT00679081|4056202|B1|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4232908|NCT00679081|4056202|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4232909|NCT00679081|4056202|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4232910|NCT00679081|4056202|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232911|NCT00679081|4056202|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4232912|NCT00679081|4056202|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4232913|NCT00679081|4056202|B1|||Age||years|Mean|42.5|42.5|Standard Deviation|11.0|11.0|||
4232914|NCT00679081|4056202|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4232915|NCT00679081|4056202|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4232916|NCT00679081|4056202|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4232917|NCT00679055|4056210|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4232918|NCT00679055|4056211|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4232919|NCT00679055|4056212|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4232920|NCT00679055|4056210|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4232921|NCT00679055|4056211|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4232922|NCT00679055|4056212|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4232923|NCT00679055|4056210|B3|||Age||years|Mean|69.0|69.0|Standard Deviation|7.82|7.82|||
4232924|NCT00679055|4056211|B2|||Age||years|Mean|70.8|70.8|Standard Deviation|8.6|8.6|||
4232925|NCT00679055|4056212|B1|||Age||years|Mean|67.6|67.6|Standard Deviation|7.4|7.4|||
4232926|NCT00679029|4056223|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4232927|NCT00679029|4056223|B1|Black, Not Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4232928|NCT00679029|4056223|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4232929|NCT00679029|4056223|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4232930|NCT00679029|4056223|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4232931|NCT00679029|4056223|B1|>=19 years of age||Age, Customized||Participants|Count of Participants|15|15.0||||||
4232932|NCT00678899|4056230|B1|||AzBio sentences|The AzBio Sentence Test consists of 15 lists of 20 sentences each. AzBio sentences are spoken by different talkers in a conversational style with limited contextual cues that the listener can use to predict or ‘fill in’ unintelligible words. Each list includes 5 sentences from 4 different male and female speakers. Each word in the sentence counts towards the overall score.|percent correct|Mean|16.3|16.3|Standard Deviation|14.4|14.4|||
4232933|NCT00678899|4056230|B1|||Monosyllabic words|The test consists of 10 recorded lists of 50 monosyllabic words in CD format. For this study, two lists will be administered in quiet at a level equal to 60 dBA in the sound field and scored as a total number of words correct, which will be expressed as a percentage correct for this study.|percent correct|Mean|28.4|28.4|Standard Deviation|14.7|14.7|||
4232934|NCT00678899|4056230|B1|||Duration of severe to profound high frequency hearing loss||years|Mean|13.1|13.1|Standard Deviation|7.2|7.2|||
4232935|NCT00678899|4056230|B1|||Duration of hearing loss||years|Mean|28.1|28.1|Standard Deviation|14.9|14.9|||
4232936|NCT00678899|4056230|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4232937|NCT00678899|4056230|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4232938|NCT00678899|4056230|B1|||Age||years|Mean|64.1|64.1|Standard Deviation|14.7|14.7|||
4232939|NCT00678886|4056237|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232940|NCT00678886|4056238|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232941|NCT00678886|4056239|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232942|NCT00678886|4056237|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4232943|NCT00678886|4056238|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4232944|NCT00678886|4056239|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4232945|NCT00678886|4056237|B3||White|Race (NIH/OMB)||Participants|Count of Participants|254|254.0||||||
4232946|NCT00678886|4056238|B2||White|Race (NIH/OMB)||Participants|Count of Participants|169|169.0||||||
4232947|NCT00678886|4056239|B1||White|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
4232948|NCT00678886|4056237|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4232949|NCT00678886|4056238|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4232950|NCT00678886|4056239|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4232951|NCT00678886|4056237|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232952|NCT00678886|4056238|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232953|NCT00678886|4056239|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232954|NCT00678886|4056237|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4232955|NCT00678886|4056238|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4232956|NCT00678886|4056239|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4232957|NCT00678886|4056237|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4232958|NCT00678886|4056238|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4232959|NCT00678886|4056239|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4232960|NCT00678886|4056237|B3||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4232961|NCT00678886|4056238|B2||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4232962|NCT00678886|4056239|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4232963|NCT00678886|4056237|B3||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4232964|NCT00678886|4056238|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4232965|NCT00678886|4056239|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4232966|NCT00678886|4056237|B3|||Age||Years|Mean|24.9|24.9|Standard Deviation|6.73|6.73|||
4232967|NCT00678886|4056238|B2|||Age||Years|Mean|24.7|24.7|Standard Deviation|6.54|6.54|||
4232968|NCT00678886|4056239|B1|||Age||Years|Mean|25.2|25.2|Standard Deviation|7.13|7.13|||
4232969|NCT00678834|4056286|B4|United States||Region of Enrollment||participants|Number|80|80.0||||||
4232970|NCT00678834|4056287|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4232971|NCT00678834|4056288|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4232972|NCT00678834|4056289|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4232973|NCT00678834|4056286|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4232974|NCT00678834|4056287|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4232975|NCT00678834|4056288|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4232976|NCT00678834|4056289|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4232977|NCT00678834|4056286|B4||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4232978|NCT00678834|4056287|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4232979|NCT00678834|4056288|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4232980|NCT00678834|4056289|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4232981|NCT00678834|4056286|B4|||Age||years|Mean|40.37|40.37|Standard Deviation|4.61|4.61|||
4232982|NCT00678834|4056287|B3|||Age||years|Mean|30.24|30.24|Standard Deviation|8.59|8.59|||
4232983|NCT00678834|4056288|B2|||Age||years|Mean|54|54.0|Standard Deviation|11.56|11.56|||
4232984|NCT00678834|4056289|B1|||Age||years|Mean|49.37|49.37|Standard Deviation|12.81|12.81|||
4232985|NCT00678795|4056309|B3|Romania||Region of Enrollment||participants|Number|18|18.0||||||
4232986|NCT00678795|4056310|B2|Romania||Region of Enrollment||participants|Number|9|9.0||||||
4232987|NCT00678795|4056311|B1|Romania||Region of Enrollment||participants|Number|9|9.0||||||
4232988|NCT00678795|4056309|B3|Belgium||Region of Enrollment||participants|Number|49|49.0||||||
4232989|NCT00678795|4056310|B2|Belgium||Region of Enrollment||participants|Number|26|26.0||||||
4232990|NCT00678795|4056311|B1|Belgium||Region of Enrollment||participants|Number|23|23.0||||||
4232991|NCT00678795|4056309|B3|United Kingdom||Region of Enrollment||participants|Number|68|68.0||||||
4232992|NCT00678795|4056310|B2|United Kingdom||Region of Enrollment||participants|Number|33|33.0||||||
4232993|NCT00678795|4056311|B1|United Kingdom||Region of Enrollment||participants|Number|35|35.0||||||
4232994|NCT00678795|4056309|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4232995|NCT00678795|4056310|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4232996|NCT00678795|4056311|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4232997|NCT00678795|4056309|B3||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4232998|NCT00678795|4056310|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4232999|NCT00678795|4056311|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4233000|NCT00678795|4056309|B3|||Age||years|Mean|47.69|47.69|Standard Deviation|10.31|10.31|||
4233001|NCT00678795|4056310|B2|||Age||years|Mean|46.79|46.79|Standard Deviation|11.20|11.2|||
4233002|NCT00678795|4056311|B1|||Age||years|Mean|48.61|48.61|Standard Deviation|9.31|9.31|||
4233003|NCT00678795|4056309|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4233004|NCT00678795|4056310|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4233005|NCT00678795|4056311|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4233006|NCT00678795|4056309|B3||Between 18 and 65 years|Age||Participants|Count of Participants|129|129.0||||||
4233007|NCT00678795|4056310|B2||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4233008|NCT00678795|4056311|B1||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4233009|NCT00678795|4056309|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233010|NCT00678795|4056310|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233011|NCT00678795|4056311|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233012|NCT00678691|4056332|B3|United States||Region of Enrollment||participants|Number|55|55.0||||||
4233013|NCT00678691|4056333|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4233014|NCT00678691|4056334|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4233015|NCT00678691|4056332|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4233016|NCT00678691|4056333|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4233017|NCT00678691|4056334|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4233018|NCT00678691|4056332|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4233019|NCT00678691|4056333|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4233020|NCT00678691|4056334|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4233021|NCT00678691|4056332|B3|||Age||years|Mean|49|49.0|Standard Deviation|4|4.0|||
4233022|NCT00678691|4056333|B2|||Age||years|Mean|47|47.0|Standard Deviation|4|4.0|||
4233023|NCT00678691|4056334|B1|||Age||years|Mean|50|50.0|Standard Deviation|4|4.0|||
4233024|NCT00678691|4056332|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4233025|NCT00678691|4056333|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4233026|NCT00678691|4056334|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4233027|NCT00678691|4056332|B3||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4233028|NCT00678691|4056333|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4233029|NCT00678691|4056334|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4233030|NCT00678691|4056332|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233031|NCT00678691|4056333|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233032|NCT00678691|4056334|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233033|NCT00678652|4056341|B5|United States||Region of Enrollment||participants|Number|36|36.0||||||
4233034|NCT00678652|4056342|B4|United States||Region of Enrollment||participants|Number|9|9.0||||||
4233035|NCT00678652|4056343|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4233036|NCT00678652|4056344|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4233037|NCT00678652|4056345|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4233038|NCT00678652|4056341|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233039|NCT00678652|4056342|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233040|NCT00678652|4056343|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233041|NCT00678652|4056344|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233042|NCT00678652|4056345|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233043|NCT00678652|4056341|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233044|NCT00678652|4056342|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233045|NCT00678652|4056343|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233046|NCT00678652|4056344|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233047|NCT00678652|4056345|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233048|NCT00678652|4056341|B5||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4233049|NCT00678652|4056342|B4||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4233050|NCT00678652|4056343|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4233051|NCT00678652|4056344|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4233052|NCT00678652|4056345|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4233053|NCT00678652|4056341|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4233054|NCT00678652|4056342|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4233055|NCT00678652|4056343|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4233056|NCT00678652|4056344|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4233057|NCT00678652|4056345|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4233058|NCT00678652|4056341|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4233059|NCT00678652|4056342|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233060|NCT00678652|4056343|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4233061|NCT00678652|4056344|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233062|NCT00678652|4056345|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233063|NCT00678652|4056341|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233064|NCT00678652|4056342|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233065|NCT00678652|4056343|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233066|NCT00678652|4056344|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233067|NCT00678652|4056345|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233068|NCT00678652|4056341|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4233069|NCT00678652|4056342|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233070|NCT00678652|4056343|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233071|NCT00678652|4056344|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233072|NCT00678652|4056345|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4233073|NCT00678652|4056341|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4233074|NCT00678652|4056342|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4233075|NCT00678652|4056343|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4233076|NCT00678652|4056344|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4233077|NCT00678652|4056345|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4233078|NCT00678652|4056341|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233079|NCT00678652|4056342|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233080|NCT00678652|4056343|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233081|NCT00678652|4056344|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233082|NCT00678652|4056345|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233083|NCT00678652|4056341|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4233084|NCT00678652|4056342|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4233085|NCT00678652|4056343|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233086|NCT00678652|4056344|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233087|NCT00678652|4056345|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233088|NCT00678652|4056341|B5||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4233089|NCT00678652|4056342|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4233090|NCT00678652|4056343|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4233091|NCT00678652|4056344|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4233092|NCT00678652|4056345|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4233093|NCT00678652|4056341|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4233094|NCT00678652|4056342|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4233095|NCT00678652|4056343|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4233096|NCT00678652|4056344|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4233097|NCT00678652|4056345|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4233098|NCT00678652|4056341|B5|18 - 45||Age, Customized|18 - 45 years old|Participants|Count of Participants|36|36.0||||||
4233099|NCT00678652|4056342|B4|18 - 45||Age, Customized|18 - 45 years old|Participants|Count of Participants|9|9.0||||||
4233100|NCT00678652|4056343|B3|18 - 45||Age, Customized|18 - 45 years old|Participants|Count of Participants|9|9.0||||||
4233101|NCT00678652|4056344|B2|18 - 45||Age, Customized|18 - 45 years old|Participants|Count of Participants|9|9.0||||||
4233102|NCT00678652|4056345|B1|18 - 45||Age, Customized|18 - 45 years old|Participants|Count of Participants|9|9.0||||||
4233103|NCT00678639|4056370|B3|United States||Region of Enrollment||participants|Number|110|110.0||||||
4233104|NCT00678639|4056371|B2|United States||Region of Enrollment||participants|Number|57|57.0||||||
4233105|NCT00678639|4056372|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
4233106|NCT00678639|4056370|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4233107|NCT00678639|4056371|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4233108|NCT00678639|4056372|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4233109|NCT00678639|4056370|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4233110|NCT00678639|4056371|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4233111|NCT00678639|4056372|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4233112|NCT00678639|4056370|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4233113|NCT00678639|4056371|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4233114|NCT00678639|4056372|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4233115|NCT00678639|4056370|B3||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
4233116|NCT00678639|4056371|B2||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4233117|NCT00678639|4056372|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4233118|NCT00678639|4056370|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233119|NCT00678639|4056371|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233120|NCT00678639|4056372|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233121|NCT00678587|4056386|B3|||Model for End-Stage Liver Disease (MELD) Score at Baseline|MELD uses the following formula to calculate a participant’s likelihood of dying within 3 months from liver disease: 3.8 x log (e) (bilirubin milligrams [mg]/deciliter [dL]) + 11.2 x log (e) (international ratio for prothrombin time) + 9.6 log (e) (creatinine mg/dL). Scores range from 6 (least ill) to 40 (most ill): 40 or more, 71.3% mortality; 30-39, 52.6% mortality; 20-29, 19.6% mortality; 10-19, 6.0% mortality; <9, 1.9% mortality. The number of participants analyzed is 140 for placebo and 135 for Eltrombopag; not all participants were compliant and had their baseline MELD score measured.|scores on a scale|Median|12|12.0|Full Range|||6.0|25.0|
4233122|NCT00678587|4056387|B2|||Model for End-Stage Liver Disease (MELD) Score at Baseline|MELD uses the following formula to calculate a participant’s likelihood of dying within 3 months from liver disease: 3.8 x log (e) (bilirubin milligrams [mg]/deciliter [dL]) + 11.2 x log (e) (international ratio for prothrombin time) + 9.6 log (e) (creatinine mg/dL). Scores range from 6 (least ill) to 40 (most ill): 40 or more, 71.3% mortality; 30-39, 52.6% mortality; 20-29, 19.6% mortality; 10-19, 6.0% mortality; <9, 1.9% mortality. The number of participants analyzed is 140 for placebo and 135 for Eltrombopag; not all participants were compliant and had their baseline MELD score measured.|scores on a scale|Median|12|12.0|Full Range|||6.0|24.0|
4233123|NCT00678587|4056388|B1|||Model for End-Stage Liver Disease (MELD) Score at Baseline|MELD uses the following formula to calculate a participant’s likelihood of dying within 3 months from liver disease: 3.8 x log (e) (bilirubin milligrams [mg]/deciliter [dL]) + 11.2 x log (e) (international ratio for prothrombin time) + 9.6 log (e) (creatinine mg/dL). Scores range from 6 (least ill) to 40 (most ill): 40 or more, 71.3% mortality; 30-39, 52.6% mortality; 20-29, 19.6% mortality; 10-19, 6.0% mortality; <9, 1.9% mortality. The number of participants analyzed is 140 for placebo and 135 for Eltrombopag; not all participants were compliant and had their baseline MELD score measured.|scores on a scale|Median|12|12.0|Full Range|||6.0|25.0|
4233124|NCT00678587|4056386|B3|Child-Pugh Class C||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15; 5=mild, 15=severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess liver disease severity. A CP score of 5 or 6 is classified as Class A (mild), a score of 7-9 is classified as Class B (moderate), and a score >=10 is classified as Class C (severe). Participants with a CP score <10 were enrolled in the study. The number of participants analyzed is 140 for placebo and 135 for Eltrombopag; not all participants were compliant and had their baseline CP score measured.|participants|Number|27|27.0||||||
4233125|NCT00678587|4056387|B2|Child-Pugh Class C||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15; 5=mild, 15=severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess liver disease severity. A CP score of 5 or 6 is classified as Class A (mild), a score of 7-9 is classified as Class B (moderate), and a score >=10 is classified as Class C (severe). Participants with a CP score <10 were enrolled in the study. The number of participants analyzed is 140 for placebo and 135 for Eltrombopag; not all participants were compliant and had their baseline CP score measured.|participants|Number|10|10.0||||||
4233126|NCT00678587|4056388|B1|Child-Pugh Class C||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15; 5=mild, 15=severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess liver disease severity. A CP score of 5 or 6 is classified as Class A (mild), a score of 7-9 is classified as Class B (moderate), and a score >=10 is classified as Class C (severe). Participants with a CP score <10 were enrolled in the study. The number of participants analyzed is 140 for placebo and 135 for Eltrombopag; not all participants were compliant and had their baseline CP score measured.|participants|Number|17|17.0||||||
4233127|NCT00678587|4056386|B3|Child-Pugh Class B||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15; 5=mild, 15=severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess liver disease severity. A CP score of 5 or 6 is classified as Class A (mild), a score of 7-9 is classified as Class B (moderate), and a score >=10 is classified as Class C (severe). Participants with a CP score <10 were enrolled in the study. The number of participants analyzed is 140 for placebo and 135 for Eltrombopag; not all participants were compliant and had their baseline CP score measured.|participants|Number|121|121.0||||||
4233162|NCT00678574|4056422|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4233128|NCT00678587|4056387|B2|Child-Pugh Class B||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15; 5=mild, 15=severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess liver disease severity. A CP score of 5 or 6 is classified as Class A (mild), a score of 7-9 is classified as Class B (moderate), and a score >=10 is classified as Class C (severe). Participants with a CP score <10 were enrolled in the study. The number of participants analyzed is 140 for placebo and 135 for Eltrombopag; not all participants were compliant and had their baseline CP score measured.|participants|Number|57|57.0||||||
4233129|NCT00678587|4056388|B1|Child-Pugh Class B||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15; 5=mild, 15=severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess liver disease severity. A CP score of 5 or 6 is classified as Class A (mild), a score of 7-9 is classified as Class B (moderate), and a score >=10 is classified as Class C (severe). Participants with a CP score <10 were enrolled in the study. The number of participants analyzed is 140 for placebo and 135 for Eltrombopag; not all participants were compliant and had their baseline CP score measured.|participants|Number|64|64.0||||||
4233130|NCT00678587|4056386|B3|Child-Pugh Class A||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15; 5=mild, 15=severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess liver disease severity. A CP score of 5 or 6 is classified as Class A (mild), a score of 7-9 is classified as Class B (moderate), and a score >=10 is classified as Class C (severe). Participants with a CP score <10 were enrolled in the study. The number of participants analyzed is 140 for placebo and 135 for Eltrombopag; not all participants were compliant and had their baseline CP score measured.|participants|Number|127|127.0||||||
4233131|NCT00678587|4056387|B2|Child-Pugh Class A||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15; 5=mild, 15=severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess liver disease severity. A CP score of 5 or 6 is classified as Class A (mild), a score of 7-9 is classified as Class B (moderate), and a score >=10 is classified as Class C (severe). Participants with a CP score <10 were enrolled in the study. The number of participants analyzed is 140 for placebo and 135 for Eltrombopag; not all participants were compliant and had their baseline CP score measured.|participants|Number|68|68.0||||||
4233132|NCT00678587|4056388|B1|Child-Pugh Class A||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15; 5=mild, 15=severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess liver disease severity. A CP score of 5 or 6 is classified as Class A (mild), a score of 7-9 is classified as Class B (moderate), and a score >=10 is classified as Class C (severe). Participants with a CP score <10 were enrolled in the study. The number of participants analyzed is 140 for placebo and 135 for Eltrombopag; not all participants were compliant and had their baseline CP score measured.|participants|Number|59|59.0||||||
4233133|NCT00678587|4056386|B3|Native Hawaiian/Other Pacific Islander and White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4233134|NCT00678587|4056387|B2|Native Hawaiian/Other Pacific Islander and White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4233135|NCT00678587|4056388|B1|Native Hawaiian/Other Pacific Islander and White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4233136|NCT00678587|4056386|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4233137|NCT00678587|4056387|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4233138|NCT00678587|4056388|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4233139|NCT00678587|4056386|B3|Japanese/East Asian/South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4233140|NCT00678587|4056387|B2|Japanese/East Asian/South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4233141|NCT00678587|4056388|B1|Japanese/East Asian/South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4233142|NCT00678587|4056386|B3|Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
4233143|NCT00678587|4056387|B2|Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4233144|NCT00678587|4056388|B1|Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4233145|NCT00678587|4056386|B3|White||Race/Ethnicity, Customized||participants|Number|178|178.0||||||
4233146|NCT00678587|4056387|B2|White||Race/Ethnicity, Customized||participants|Number|85|85.0||||||
4233147|NCT00678587|4056388|B1|White||Race/Ethnicity, Customized||participants|Number|93|93.0||||||
4233148|NCT00678587|4056386|B3||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4233149|NCT00678587|4056387|B2||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4233150|NCT00678587|4056388|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4233151|NCT00678587|4056386|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4233152|NCT00678587|4056387|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4233153|NCT00678587|4056388|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4233154|NCT00678587|4056386|B3|||Age||Years|Mean|52.5|52.5|Standard Deviation|11.44|11.44|||
4233155|NCT00678587|4056387|B2|||Age||Years|Mean|51.6|51.6|Standard Deviation|11.04|11.04|||
4233156|NCT00678587|4056388|B1|||Age||Years|Mean|53.5|53.5|Standard Deviation|11.78|11.78|||
4233157|NCT00678574|4056421|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4233158|NCT00678574|4056421|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4233159|NCT00678574|4056422|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4233160|NCT00678574|4056423|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4233161|NCT00678574|4056421|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4233163|NCT00678574|4056423|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4233164|NCT00678574|4056421|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4233165|NCT00678574|4056422|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4233166|NCT00678574|4056423|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4233167|NCT00678574|4056421|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4233168|NCT00678574|4056422|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4233169|NCT00678574|4056423|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4233170|NCT00678574|4056421|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233171|NCT00678574|4056422|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233172|NCT00678574|4056423|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233173|NCT00678535|4056430|B3||Male|Sex: Female, Male||Participants|Count of Participants|673|673.0||||||
4233174|NCT00678535|4056431|B2||Male|Sex: Female, Male||Participants|Count of Participants|334|334.0||||||
4233175|NCT00678535|4056432|B1||Male|Sex: Female, Male||Participants|Count of Participants|339|339.0||||||
4233176|NCT00678535|4056430|B3||Female|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
4233177|NCT00678535|4056431|B2||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4233178|NCT00678535|4056432|B1||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4233179|NCT00678535|4056430|B3|||Age||years|Mean|58.3|58.3|Standard Deviation|11.00|11.0|||
4233180|NCT00678535|4056431|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|10.83|10.83|||
4233181|NCT00678535|4056432|B1|||Age||years|Mean|58.0|58.0|Standard Deviation|11.16|11.16|||
4233182|NCT00678470|4056449|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4233183|NCT00678470|4056449|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4233184|NCT00678470|4056449|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4233185|NCT00678470|4056449|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4233186|NCT00678470|4056449|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4233187|NCT00678470|4056449|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233188|NCT00678444|4056453|B3|||State-Trait Anxiety Inventory-State scale|Range: 40-160. Higher score represents higher anxiety level/more anxiety.|units on a scale|Mean|39.3|39.3|Standard Deviation|11.7|11.7|||
4233189|NCT00678444|4056454|B2|||State-Trait Anxiety Inventory-State scale|Range: 40-160. Higher score represents higher anxiety level/more anxiety.|units on a scale|Mean|40.7|40.7|Standard Deviation|11.7|11.7|||
4233190|NCT00678444|4056455|B1|||State-Trait Anxiety Inventory-State scale|Range: 40-160. Higher score represents higher anxiety level/more anxiety.|units on a scale|Mean|37.9|37.9|Standard Deviation|11.6|11.6|||
4233191|NCT00678444|4056453|B3|||Personal Health Questionnaire-9|Range: 1-27 Higher scores represent worsening degrees of depression.|units on a scale|Median|2|2.0|Inter-Quartile Range|||0.0|5.0|
4233192|NCT00678444|4056454|B2|||Personal Health Questionnaire-9|Range: 1-27 Higher scores represent worsening degrees of depression.|units on a scale|Median|2|2.0|Inter-Quartile Range|||0.0|5.0|
4233193|NCT00678444|4056455|B1|||Personal Health Questionnaire-9|Range: 1-27 Higher scores represent worsening degrees of depression.|units on a scale|Median|2|2.0|Inter-Quartile Range|||0.0|5.0|
4233194|NCT00678444|4056453|B3|||Pelvic Floor Impact Questionnaire-7|Range: 0-300 Higher score represents greater impact of pelvic floor disorders on quality of life.|units on a scale|Median|50|50.0|Inter-Quartile Range|||26.0|99.0|
4233195|NCT00678444|4056454|B2|||Pelvic Floor Impact Questionnaire-7|Range: 0-300 Higher score represents greater impact of pelvic floor disorders on quality of life.|units on a scale|Median|59|59.0|Inter-Quartile Range|||33.0|105.0|
4233196|NCT00678444|4056455|B1|||Pelvic Floor Impact Questionnaire-7|Range: 0-300 Higher score represents greater impact of pelvic floor disorders on quality of life.|units on a scale|Median|41|41.0|Inter-Quartile Range|||19.0|93.0|
4233197|NCT00678444|4056453|B3|||Pelvic Floor Distress Inventory-20|Range: 0-300 (total) Higher score represents more bother from pelvic floor disorder symptoms.|units on a scale|Median|94|94.0|Inter-Quartile Range|||60.0|131.0|
4233198|NCT00678444|4056454|B2|||Pelvic Floor Distress Inventory-20|Range: 0-300 (total) Higher score represents more bother from pelvic floor disorder symptoms.|units on a scale|Median|103|103.0|Inter-Quartile Range|||64.0|142.0|
4233199|NCT00678444|4056455|B1|||Pelvic Floor Distress Inventory-20|Range: 0-300 (total) Higher score represents more bother from pelvic floor disorder symptoms.|units on a scale|Median|84|84.0|Inter-Quartile Range|||56.0|120.0|
4233200|NCT00678444|4056453|B3|||Mini-Mental Status Examination|Range: 0-30. Higher score represents better cognitive function.|units on a scale|Median|30|30.0|Inter-Quartile Range|||29.0|30.0|
4233201|NCT00678444|4056454|B2|||Mini-Mental Status Examination|Range: 0-30. Higher score represents better cognitive function.|units on a scale|Median|30|30.0|Inter-Quartile Range|||29.0|30.0|
4233202|NCT00678444|4056455|B1|||Mini-Mental Status Examination|Range: 0-30. Higher score represents better cognitive function.|units on a scale|Median|30|30.0|Inter-Quartile Range|||29.0|30.0|
4233203|NCT00678444|4056453|B3|United States||Region of Enrollment||participants|Number|199|199.0||||||
4233204|NCT00678444|4056454|B2|United States||Region of Enrollment||participants|Number|99|99.0||||||
4233205|NCT00678444|4056455|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
4233206|NCT00678444|4056453|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233207|NCT00678444|4056454|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233208|NCT00678444|4056455|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233209|NCT00678444|4056453|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233210|NCT00678444|4056454|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233211|NCT00678444|4056455|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233212|NCT00678444|4056453|B3||White|Race (NIH/OMB)||Participants|Count of Participants|194|194.0||||||
4233213|NCT00678444|4056454|B2||White|Race (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
4233214|NCT00678444|4056455|B1||White|Race (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
4233215|NCT00678444|4056453|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4233216|NCT00678444|4056454|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4233217|NCT00678444|4056455|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4233218|NCT00678444|4056453|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233219|NCT00678444|4056454|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233220|NCT00678444|4056455|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233221|NCT00678444|4056453|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233222|NCT00678444|4056454|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233223|NCT00678444|4056455|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233224|NCT00678444|4056453|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233225|NCT00678444|4056454|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233226|NCT00678444|4056455|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233227|NCT00678444|4056453|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4233228|NCT00678444|4056454|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4233229|NCT00678444|4056455|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4233230|NCT00678444|4056453|B3||Female|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4233231|NCT00678444|4056454|B2||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4233232|NCT00678444|4056455|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4233233|NCT00678444|4056453|B3|||Age||years|Mean|58.7|58.7|Standard Deviation|10.8|10.8|||
4233234|NCT00678444|4056454|B2|||Age||years|Mean|59.7|59.7|Standard Deviation|11.7|11.7|||
4233235|NCT00678444|4056455|B1|||Age||years|Mean|57.7|57.7|Standard Deviation|9.8|9.8|||
4233236|NCT00678418|4056464|B3|Russian Federation||Region of Enrollment||participants|Number|250|250.0||||||
4233237|NCT00678418|4056465|B2|Russian Federation||Region of Enrollment||participants|Number|124|124.0||||||
4233238|NCT00678418|4056466|B1|Russian Federation||Region of Enrollment||participants|Number|126|126.0||||||
4233239|NCT00678418|4056464|B3||Male|Gender||Participants|Count of Participants|220|220.0||||||
4233240|NCT00678418|4056465|B2||Male|Gender||Participants|Count of Participants|107|107.0||||||
4233241|NCT00678418|4056466|B1||Male|Gender||Participants|Count of Participants|113|113.0||||||
4233242|NCT00678418|4056464|B3||Female|Gender||Participants|Count of Participants|30|30.0||||||
4233243|NCT00678418|4056465|B2||Female|Gender||Participants|Count of Participants|17|17.0||||||
4233244|NCT00678418|4056466|B1||Female|Gender||Participants|Count of Participants|13|13.0||||||
4233245|NCT00678418|4056464|B3|||Age||years|Mean|29.6|29.6|Standard Deviation|4.2|4.2|||
4233246|NCT00678418|4056465|B2|||Age||years|Mean|29.7|29.7|Standard Deviation|3.6|3.6|||
4233247|NCT00678418|4056466|B1|||Age||years|Mean|29.4|29.4|Standard Deviation|4.8|4.8|||
4233248|NCT00678418|4056464|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4233249|NCT00678418|4056465|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4233250|NCT00678418|4056466|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4233251|NCT00678418|4056464|B3||Between 18 and 65 years|Age||Participants|Count of Participants|250|250.0||||||
4233252|NCT00678418|4056465|B2||Between 18 and 65 years|Age||Participants|Count of Participants|124|124.0||||||
4233253|NCT00678418|4056466|B1||Between 18 and 65 years|Age||Participants|Count of Participants|126|126.0||||||
4233254|NCT00678418|4056464|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233255|NCT00678418|4056465|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233256|NCT00678418|4056466|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233257|NCT00678392|4056481|B3||Male|Sex: Female, Male||Participants|Count of Participants|523|523.0||||||
4233258|NCT00678392|4056482|B2||Male|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
4233259|NCT00678392|4056483|B1||Male|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
4233260|NCT00678392|4056481|B3||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4233261|NCT00678392|4056482|B2||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4233262|NCT00678392|4056483|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4233263|NCT00678392|4056481|B3|Greater than or equal to (>=) 65 years||Age, Customized||Participants|Number|247|247.0||||||
4233264|NCT00678392|4056482|B2|Greater than or equal to (>=) 65 years||Age, Customized||Participants|Number|124|124.0||||||
4233265|NCT00678392|4056483|B1|Greater than or equal to (>=) 65 years||Age, Customized||Participants|Number|123|123.0||||||
4233266|NCT00678392|4056481|B3|Less than (<) 65 years||Age, Customized||Participants|Number|476|476.0||||||
4233267|NCT00678392|4056482|B2|Less than (<) 65 years||Age, Customized||Participants|Number|238|238.0||||||
4233268|NCT00678392|4056483|B1|Less than (<) 65 years||Age, Customized||Participants|Number|238|238.0||||||
4233269|NCT00678379|4056516|B4|United States||Region of Enrollment||participants|Number|120|120.0||||||
4233270|NCT00678379|4056517|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4233271|NCT00678379|4056518|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4233272|NCT00678379|4056519|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4233273|NCT00678379|4056516|B4||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4233274|NCT00678379|4056517|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4233275|NCT00678379|4056518|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4233276|NCT00678379|4056519|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4233277|NCT00678379|4056516|B4||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4233278|NCT00678379|4056517|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4233279|NCT00678379|4056518|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4233280|NCT00678379|4056519|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4233281|NCT00678379|4056516|B4|||Age||years|Median|7|7.0|Full Range|||5.0|12.0|
4233282|NCT00678379|4056517|B3|||Age||years|Median|8|8.0|Full Range|||5.0|12.0|
4233283|NCT00678379|4056518|B2|||Age||years|Median|7|7.0|Full Range|||5.0|11.0|
4233284|NCT00678379|4056519|B1|||Age||years|Median|6|6.0|Full Range|||5.0|9.0|
4233285|NCT00678301|4056547|B3|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|357|357.0||||||
4233286|NCT00678301|4056548|B2|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|118|118.0||||||
4233287|NCT00678301|4056549|B1|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|239|239.0||||||
4233288|NCT00678301|4056547|B3|Male||Sex/Gender, Customized||Participants|Count of Participants|176|176.0||||||
4233289|NCT00678301|4056548|B2|Male||Sex/Gender, Customized||Participants|Count of Participants|56|56.0||||||
4233290|NCT00678301|4056549|B1|Male||Sex/Gender, Customized||Participants|Count of Participants|120|120.0||||||
4233291|NCT00678301|4056547|B3|Female||Sex/Gender, Customized||Participants|Count of Participants|181|181.0||||||
4233292|NCT00678301|4056548|B2|Female||Sex/Gender, Customized||Participants|Count of Participants|62|62.0||||||
4233293|NCT00678301|4056549|B1|Female||Sex/Gender, Customized||Participants|Count of Participants|119|119.0||||||
4233294|NCT00678301|4056547|B3|||Age||Weeks|Geometric Mean|7.07|7.07|Standard Deviation|1.16|1.16|||
4233295|NCT00678301|4056548|B2|||Age||Weeks|Geometric Mean|7|7.0|Standard Deviation|1.18|1.18|||
4233296|NCT00678301|4056549|B1|||Age||Weeks|Geometric Mean|7.1|7.1|Standard Deviation|1.15|1.15|||
4233297|NCT00678288|4056606|B3|intermediate MSKCC score||Memorial Sloane Kettering Cancer Center (MSKCC) score|The MSKCC score is a prognostic score obtained by adding 1 point for each of 5 risk factors: 1. Absence of prior nephrectomy, 2. Corrected serum calcium > 10 mg/dL, 3. Hemoglobin < lower limit of normal, 4. Lactate dehydrogenase (LDH) > 1.5X upper limit of normal, 5. Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) ≥ 2 (The ECOG PS is a scale that measures how cancer affects a patient. The scale ranges from 0 [fully active] to 5 [dead]). A Low MSKCC score is 0 risk factors, Intermediate is 1-2 risk factors, and Poor is 3-5 risk factors.|participants|Number|12|12.0||||||
4233298|NCT00678288|4056607|B2|intermediate MSKCC score||Memorial Sloane Kettering Cancer Center (MSKCC) score|The MSKCC score is a prognostic score obtained by adding 1 point for each of 5 risk factors: 1. Absence of prior nephrectomy, 2. Corrected serum calcium > 10 mg/dL, 3. Hemoglobin < lower limit of normal, 4. Lactate dehydrogenase (LDH) > 1.5X upper limit of normal, 5. Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) ≥ 2 (The ECOG PS is a scale that measures how cancer affects a patient. The scale ranges from 0 [fully active] to 5 [dead]). A Low MSKCC score is 0 risk factors, Intermediate is 1-2 risk factors, and Poor is 3-5 risk factors.|participants|Number|5|5.0||||||
4233299|NCT00678288|4056608|B1|intermediate MSKCC score||Memorial Sloane Kettering Cancer Center (MSKCC) score|The MSKCC score is a prognostic score obtained by adding 1 point for each of 5 risk factors: 1. Absence of prior nephrectomy, 2. Corrected serum calcium > 10 mg/dL, 3. Hemoglobin < lower limit of normal, 4. Lactate dehydrogenase (LDH) > 1.5X upper limit of normal, 5. Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) ≥ 2 (The ECOG PS is a scale that measures how cancer affects a patient. The scale ranges from 0 [fully active] to 5 [dead]). A Low MSKCC score is 0 risk factors, Intermediate is 1-2 risk factors, and Poor is 3-5 risk factors.|participants|Number|7|7.0||||||
4233300|NCT00678288|4056606|B3|low MSKCC score||Memorial Sloane Kettering Cancer Center (MSKCC) score|The MSKCC score is a prognostic score obtained by adding 1 point for each of 5 risk factors: 1. Absence of prior nephrectomy, 2. Corrected serum calcium > 10 mg/dL, 3. Hemoglobin < lower limit of normal, 4. Lactate dehydrogenase (LDH) > 1.5X upper limit of normal, 5. Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) ≥ 2 (The ECOG PS is a scale that measures how cancer affects a patient. The scale ranges from 0 [fully active] to 5 [dead]). A Low MSKCC score is 0 risk factors, Intermediate is 1-2 risk factors, and Poor is 3-5 risk factors.|participants|Number|4|4.0||||||
4233301|NCT00678288|4056607|B2|low MSKCC score||Memorial Sloane Kettering Cancer Center (MSKCC) score|The MSKCC score is a prognostic score obtained by adding 1 point for each of 5 risk factors: 1. Absence of prior nephrectomy, 2. Corrected serum calcium > 10 mg/dL, 3. Hemoglobin < lower limit of normal, 4. Lactate dehydrogenase (LDH) > 1.5X upper limit of normal, 5. Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) ≥ 2 (The ECOG PS is a scale that measures how cancer affects a patient. The scale ranges from 0 [fully active] to 5 [dead]). A Low MSKCC score is 0 risk factors, Intermediate is 1-2 risk factors, and Poor is 3-5 risk factors.|participants|Number|1|1.0||||||
4233302|NCT00678288|4056608|B1|low MSKCC score||Memorial Sloane Kettering Cancer Center (MSKCC) score|The MSKCC score is a prognostic score obtained by adding 1 point for each of 5 risk factors: 1. Absence of prior nephrectomy, 2. Corrected serum calcium > 10 mg/dL, 3. Hemoglobin < lower limit of normal, 4. Lactate dehydrogenase (LDH) > 1.5X upper limit of normal, 5. Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) ≥ 2 (The ECOG PS is a scale that measures how cancer affects a patient. The scale ranges from 0 [fully active] to 5 [dead]). A Low MSKCC score is 0 risk factors, Intermediate is 1-2 risk factors, and Poor is 3-5 risk factors.|participants|Number|3|3.0||||||
4233303|NCT00678288|4056606|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4233304|NCT00678288|4056607|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4233305|NCT00678288|4056608|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4233306|NCT00678288|4056606|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4233307|NCT00678288|4056607|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4233308|NCT00678288|4056608|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4233309|NCT00678288|4056606|B3|||Age||years|Median|58.5|58.5|Full Range|||41.0|73.0|
4233310|NCT00678288|4056607|B2|||Age||years|Median|60.5|60.5|Full Range|||48.0|73.0|
4233311|NCT00678288|4056608|B1|||Age||years|Median|57|57.0|Full Range|||41.0|67.0|
4233312|NCT00678249|4056623|B4|United States||Region of Enrollment||participants|Number|227|227.0||||||
4233313|NCT00678249|4056624|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
4233314|NCT00678249|4056625|B2|United States||Region of Enrollment||participants|Number|93|93.0||||||
4233315|NCT00678249|4056626|B1|United States||Region of Enrollment||participants|Number|97|97.0||||||
4233316|NCT00678249|4056623|B4||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4233317|NCT00678249|4056624|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4233318|NCT00678249|4056625|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4233319|NCT00678249|4056626|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4233320|NCT00678249|4056623|B4||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4233321|NCT00678249|4056624|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4233322|NCT00678249|4056625|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4233323|NCT00678249|4056626|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4233324|NCT00678249|4056623|B4|||Age||years|Mean|60.36|60.36|Standard Deviation|14.09|14.09|||
4233325|NCT00678249|4056624|B3|||Age||years|Mean|62.16|62.16|Standard Deviation|11.84|11.84|||
4233326|NCT00678249|4056625|B2|||Age||years|Mean|59.83|59.83|Standard Deviation|13.58|13.58|||
4233327|NCT00678249|4056626|B1|||Age||years|Mean|61.83|61.83|Standard Deviation|14.63|14.63|||
4233328|NCT00678249|4056623|B4||>=65 years|Age||Participants|Count of Participants|104|104.0||||||
4233329|NCT00678249|4056624|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4233330|NCT00678249|4056625|B2||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
4233331|NCT00678249|4056626|B1||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
4233332|NCT00678249|4056623|B4||Between 18 and 65 years|Age||Participants|Count of Participants|123|123.0||||||
4233333|NCT00678249|4056624|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4233334|NCT00678249|4056625|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4233335|NCT00678249|4056626|B1||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4233336|NCT00678249|4056623|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233337|NCT00678249|4056624|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233338|NCT00678249|4056625|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233339|NCT00678249|4056626|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233340|NCT00678210|4056660|B5||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4233341|NCT00678210|4056661|B4||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4233342|NCT00678210|4056662|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4233343|NCT00678210|4056663|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4233344|NCT00678210|4056664|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4233345|NCT00678210|4056660|B5||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4233346|NCT00678210|4056661|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4233347|NCT00678210|4056662|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4233348|NCT00678210|4056663|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4233349|NCT00678210|4056664|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4233350|NCT00678210|4056660|B5|Greater than or equal to 65 years||Age, Customized||participants|Number|12|12.0||||||
4233351|NCT00678210|4056661|B4|Greater than or equal to 65 years||Age, Customized||participants|Number|2|2.0||||||
4233352|NCT00678210|4056662|B3|Greater than or equal to 65 years||Age, Customized||participants|Number|5|5.0||||||
4233353|NCT00678210|4056663|B2|Greater than or equal to 65 years||Age, Customized||participants|Number|1|1.0||||||
4233354|NCT00678210|4056664|B1|Greater than or equal to 65 years||Age, Customized||participants|Number|4|4.0||||||
4233355|NCT00678210|4056660|B5|54 to 64 years||Age, Customized||participants|Number|34|34.0||||||
4233356|NCT00678210|4056661|B4|54 to 64 years||Age, Customized||participants|Number|10|10.0||||||
4233357|NCT00678210|4056662|B3|54 to 64 years||Age, Customized||participants|Number|6|6.0||||||
4233358|NCT00678210|4056663|B2|54 to 64 years||Age, Customized||participants|Number|9|9.0||||||
4233359|NCT00678210|4056664|B1|54 to 64 years||Age, Customized||participants|Number|9|9.0||||||
4233360|NCT00678210|4056660|B5|45 to 54 years||Age, Customized||participants|Number|55|55.0||||||
4233361|NCT00678210|4056661|B4|45 to 54 years||Age, Customized||participants|Number|18|18.0||||||
4233362|NCT00678210|4056662|B3|45 to 54 years||Age, Customized||participants|Number|10|10.0||||||
4233363|NCT00678210|4056663|B2|45 to 54 years||Age, Customized||participants|Number|14|14.0||||||
4233364|NCT00678210|4056664|B1|45 to 54 years||Age, Customized||participants|Number|13|13.0||||||
4233365|NCT00678210|4056660|B5|18 to 44 years||Age, Customized||participants|Number|96|96.0||||||
4233366|NCT00678210|4056661|B4|18 to 44 years||Age, Customized||participants|Number|20|20.0||||||
4233367|NCT00678210|4056662|B3|18 to 44 years||Age, Customized||participants|Number|28|28.0||||||
4233368|NCT00678210|4056663|B2|18 to 44 years||Age, Customized||participants|Number|25|25.0||||||
4233369|NCT00678210|4056664|B1|18 to 44 years||Age, Customized||participants|Number|23|23.0||||||
4233370|NCT00678080|4056701|B3|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
4233371|NCT00678080|4056702|B2|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4233372|NCT00678080|4056703|B1|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4233373|NCT00678080|4056701|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4233374|NCT00678080|4056702|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4233375|NCT00678080|4056703|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4233376|NCT00678080|4056701|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4233377|NCT00678080|4056702|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4233378|NCT00678080|4056703|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4233379|NCT00678080|4056701|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4233380|NCT00678080|4056702|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4233381|NCT00678080|4056703|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4233382|NCT00678080|4056701|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4233383|NCT00678080|4056702|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4233384|NCT00678080|4056703|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4233385|NCT00678080|4056701|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4233386|NCT00678080|4056702|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4233387|NCT00678080|4056703|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4233388|NCT00678080|4056701|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4233389|NCT00678080|4056702|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4233390|NCT00678080|4056703|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4233391|NCT00678080|4056701|B3|||Age||years|Mean|31.5|31.5|Standard Deviation|4.8|4.8|||
4233392|NCT00678080|4056702|B2|||Age||years|Mean|32.3|32.3|Standard Deviation|4.3|4.3|||
4233393|NCT00678080|4056703|B1|||Age||years|Mean|30.9|30.9|Standard Deviation|5.5|5.5|||
4233394|NCT00678041|4056728|B3|Male||Sex/Gender, Customized||participants|Number|0|0.0||||||
4233395|NCT00678041|4056729|B2|Male||Sex/Gender, Customized||participants|Number|0|0.0||||||
4233396|NCT00678041|4056730|B1|Male||Sex/Gender, Customized||participants|Number|0|0.0||||||
4233397|NCT00678041|4056728|B3|Female||Sex/Gender, Customized||participants|Number|10|10.0||||||
4233398|NCT00678041|4056729|B2|Female||Sex/Gender, Customized||participants|Number|5|5.0||||||
4233399|NCT00678041|4056730|B1|Female||Sex/Gender, Customized||participants|Number|5|5.0||||||
4233400|NCT00678041|4056728|B3|at least 18 yrs of age||Age, Customized||participants|Number|10|10.0||||||
4233401|NCT00678041|4056729|B2|at least 18 yrs of age||Age, Customized||participants|Number|5|5.0||||||
4233402|NCT00678041|4056730|B1|at least 18 yrs of age||Age, Customized||participants|Number|5|5.0||||||
4233403|NCT00678015|4056743|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4233404|NCT00678015|4056743|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4233405|NCT00678015|4056743|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4233406|NCT00678015|4056743|B1|||Age||years|Median|67.5|67.5|Full Range|||55.0|86.0|
4233407|NCT00677924|4056750|B3|Belgium||Region of Enrollment||participants|Number|9|9.0||||||
4233408|NCT00677924|4056751|B2|Belgium||Region of Enrollment||participants|Number|6|6.0||||||
4233409|NCT00677924|4056752|B1|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
4233410|NCT00677924|4056750|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4233411|NCT00677924|4056751|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4233412|NCT00677924|4056752|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4233413|NCT00677924|4056750|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4233414|NCT00677924|4056751|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4233415|NCT00677924|4056752|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4233416|NCT00677924|4056750|B3|||Age||years|Median|61|61.0|Full Range|||33.0|76.0|
4233417|NCT00677924|4056751|B2|||Age||years|Median|61|61.0|Full Range|||33.0|76.0|
4233418|NCT00677924|4056752|B1|||Age||years|Median|61|61.0|Full Range|||57.0|66.0|
4233419|NCT00677924|4056750|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4233420|NCT00677924|4056751|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4233421|NCT00677924|4056752|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4233422|NCT00677924|4056750|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4233423|NCT00677924|4056751|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4233424|NCT00677924|4056752|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4233425|NCT00677924|4056750|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233426|NCT00677924|4056751|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233427|NCT00677924|4056752|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233428|NCT00677898|4056761|B3|United States||Region of Enrollment||participants|Number|239|239.0||||||
4233429|NCT00677898|4056762|B2|United States||Region of Enrollment||participants|Number|120|120.0||||||
4233430|NCT00677898|4056763|B1|United States||Region of Enrollment||participants|Number|119|119.0||||||
4233431|NCT00677898|4056761|B3||Male|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
4233432|NCT00677898|4056762|B2||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4233433|NCT00677898|4056763|B1||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4233434|NCT00677898|4056761|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4233435|NCT00677898|4056762|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4233436|NCT00677898|4056763|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4233437|NCT00677898|4056761|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4233438|NCT00677898|4056762|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4233439|NCT00677898|4056763|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4233440|NCT00677898|4056761|B3||Between 18 and 65 years|Age||Participants|Count of Participants|227|227.0||||||
4233441|NCT00677898|4056762|B2||Between 18 and 65 years|Age||Participants|Count of Participants|116|116.0||||||
4233442|NCT00677898|4056763|B1||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
4233443|NCT00677898|4056761|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233444|NCT00677898|4056762|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233445|NCT00677898|4056763|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233446|NCT00677898|4056761|B3|||Age||years|Mean|54.3|54.3|Standard Deviation|8.3|8.3|||
4233447|NCT00677898|4056762|B2|||Age||years|Mean|53.5|53.5|Standard Deviation|8.6|8.6|||
4233448|NCT00677898|4056763|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|8.0|8.0|||
4233449|NCT00677833|4056780|B5||Male|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4233450|NCT00677833|4056781|B4||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4233451|NCT00677833|4056782|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4233452|NCT00677833|4056783|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4233453|NCT00677833|4056784|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4233454|NCT00677833|4056780|B5||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4233455|NCT00677833|4056781|B4||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4233456|NCT00677833|4056782|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4233457|NCT00677833|4056783|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4233458|NCT00677833|4056784|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4233459|NCT00677833|4056780|B5|5 years - 12 years||Age, Customized||Participants|Number|109|109.0||||||
4233460|NCT00677833|4056781|B4|5 years - 12 years||Age, Customized||Participants|Number|2|2.0||||||
4233461|NCT00677833|4056782|B3|5 years - 12 years||Age, Customized||Participants|Number|1|1.0||||||
4233462|NCT00677833|4056783|B2|5 years - 12 years||Age, Customized||Participants|Number|51|51.0||||||
4233463|NCT00677833|4056784|B1|5 years - 12 years||Age, Customized||Participants|Number|55|55.0||||||
4233464|NCT00677833|4056780|B5|6 months - less than 5 years||Age, Customized||Participants|Number|252|252.0||||||
4233465|NCT00677833|4056781|B4|6 months - less than 5 years||Age, Customized||Participants|Number|129|129.0||||||
4233466|NCT00677833|4056782|B3|6 months - less than 5 years||Age, Customized||Participants|Number|123|123.0||||||
4233467|NCT00677833|4056783|B2|6 months - less than 5 years||Age, Customized||Participants|Number|0|0.0||||||
4233468|NCT00677833|4056784|B1|6 months - less than 5 years||Age, Customized||Participants|Number|0|0.0||||||
4233469|NCT00677820|4056835|B3|United States||Region of Enrollment||participants|Number|300|300.0||||||
4233470|NCT00677820|4056836|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
4233471|NCT00677820|4056837|B1|United States||Region of Enrollment||participants|Number|240|240.0||||||
4233472|NCT00677820|4056835|B3|Other||Race (NIH/OMB)||participants|Number|8|8.0||||||
4233473|NCT00677820|4056836|B2|Other||Race (NIH/OMB)||participants|Number|2|2.0||||||
4233474|NCT00677820|4056837|B1|Other||Race (NIH/OMB)||participants|Number|6|6.0||||||
4233475|NCT00677820|4056835|B3|More than one race||Race (NIH/OMB)||participants|Number|6|6.0||||||
4233476|NCT00677820|4056836|B2|More than one race||Race (NIH/OMB)||participants|Number|2|2.0||||||
4233477|NCT00677820|4056837|B1|More than one race||Race (NIH/OMB)||participants|Number|4|4.0||||||
4233478|NCT00677820|4056835|B3|White||Race (NIH/OMB)||participants|Number|259|259.0||||||
4233479|NCT00677820|4056836|B2|White||Race (NIH/OMB)||participants|Number|49|49.0||||||
4233480|NCT00677820|4056837|B1|White||Race (NIH/OMB)||participants|Number|210|210.0||||||
4233481|NCT00677820|4056835|B3|Black or African American||Race (NIH/OMB)||participants|Number|17|17.0||||||
4233482|NCT00677820|4056836|B2|Black or African American||Race (NIH/OMB)||participants|Number|4|4.0||||||
4233483|NCT00677820|4056837|B1|Black or African American||Race (NIH/OMB)||participants|Number|13|13.0||||||
4233484|NCT00677820|4056835|B3|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|1|1.0||||||
4233485|NCT00677820|4056836|B2|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4233486|NCT00677820|4056837|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|1|1.0||||||
4233487|NCT00677820|4056835|B3|Asian||Race (NIH/OMB)||participants|Number|7|7.0||||||
4233488|NCT00677820|4056836|B2|Asian||Race (NIH/OMB)||participants|Number|2|2.0||||||
4233489|NCT00677820|4056837|B1|Asian||Race (NIH/OMB)||participants|Number|5|5.0||||||
4233490|NCT00677820|4056835|B3|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|2|2.0||||||
4233491|NCT00677820|4056836|B2|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|1|1.0||||||
4233492|NCT00677820|4056837|B1|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|1|1.0||||||
4233493|NCT00677820|4056835|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233494|NCT00677820|4056836|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233495|NCT00677820|4056837|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233496|NCT00677820|4056835|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|246|246.0||||||
4233497|NCT00677820|4056836|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4233498|NCT00677820|4056837|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|201|201.0||||||
4233499|NCT00677820|4056835|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4233500|NCT00677820|4056836|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4233501|NCT00677820|4056837|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4233502|NCT00677820|4056835|B3||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4233503|NCT00677820|4056836|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4233504|NCT00677820|4056837|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4233505|NCT00677820|4056835|B3||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4233506|NCT00677820|4056836|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4233507|NCT00677820|4056837|B1||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4233508|NCT00677820|4056835|B3|||Age||years|Mean|31.3|31.3|Standard Deviation|8.5|8.5|||
4233509|NCT00677820|4056836|B2|||Age||years|Mean|32.0|32.0|Standard Deviation|9.3|9.3|||
4233510|NCT00677820|4056837|B1|||Age||years|Mean|31.2|31.2|Standard Deviation|8.3|8.3|||
4233511|NCT00677807|4056856|B4||Male|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
4233512|NCT00677807|4056857|B3||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4233513|NCT00677807|4056858|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4233514|NCT00677807|4056859|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4233515|NCT00677807|4056856|B4||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4233516|NCT00677807|4056857|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4233517|NCT00677807|4056858|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4233518|NCT00677807|4056859|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4233519|NCT00677807|4056856|B4|||Age|All Baseline Measures were based on the safety population consisting of all participants who received at least one dose of study drug in the extension study.|years|Mean|62.6|62.6|Standard Deviation|9.21|9.21|||
4233520|NCT00677807|4056857|B3|||Age|All Baseline Measures were based on the safety population consisting of all participants who received at least one dose of study drug in the extension study.|years|Mean|62.8|62.8|Standard Deviation|9.18|9.18|||
4233521|NCT00677807|4056858|B2|||Age|All Baseline Measures were based on the safety population consisting of all participants who received at least one dose of study drug in the extension study.|years|Mean|62.5|62.5|Standard Deviation|9.00|9.0|||
4233522|NCT00677807|4056859|B1|||Age|All Baseline Measures were based on the safety population consisting of all participants who received at least one dose of study drug in the extension study.|years|Mean|62.5|62.5|Standard Deviation|9.52|9.52|||
4233523|NCT00677690|4056890|B3|Italy||Region of Enrollment||participants|Number|83|83.0||||||
4233524|NCT00677690|4056891|B2|Italy||Region of Enrollment||participants|Number|41|41.0||||||
4233525|NCT00677690|4056892|B1|Italy||Region of Enrollment||participants|Number|42|42.0||||||
4233526|NCT00677690|4056890|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4233527|NCT00677690|4056891|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4233528|NCT00677690|4056892|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4233529|NCT00677690|4056890|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4233530|NCT00677690|4056891|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4233531|NCT00677690|4056892|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4233532|NCT00677690|4056890|B3|||Age||years|Mean|62.1|62.1|Standard Deviation|8.4|8.4|||
4233533|NCT00677690|4056891|B2|||Age||years|Mean|62.8|62.8|Standard Deviation|5.4|5.4|||
4233534|NCT00677690|4056892|B1|||Age||years|Mean|61.4|61.4|Standard Deviation|7.6|7.6|||
4233535|NCT00677690|4056890|B3||>=65 years|Age||Participants|Count of Participants|63|63.0||||||
4233536|NCT00677690|4056891|B2||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4233537|NCT00677690|4056892|B1||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4233538|NCT00677690|4056890|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4233539|NCT00677690|4056891|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4233540|NCT00677690|4056892|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4233541|NCT00677690|4056890|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233542|NCT00677690|4056891|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233543|NCT00677690|4056892|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233544|NCT00677534|4056907|B1|||Monocyte Vitamin D receptor (VDR) expression||MFI|Mean|572.7|572.7|Standard Deviation|172.3|172.3|||
4233545|NCT00677534|4056907|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4233546|NCT00677534|4056907|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4233547|NCT00677534|4056907|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4233548|NCT00677534|4056907|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4233549|NCT00677534|4056907|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4233550|NCT00677534|4056907|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233551|NCT00677365|4056911|B5|Europe||Region of Enrollment||Participants|Number|27|27.0||||||
4233552|NCT00677365|4056912|B4|Europe||Region of Enrollment||Participants|Number|7|7.0||||||
4233553|NCT00677365|4056913|B3|Europe||Region of Enrollment||Participants|Number|7|7.0||||||
4233554|NCT00677365|4056914|B2|Europe||Region of Enrollment||Participants|Number|6|6.0||||||
4233555|NCT00677365|4056915|B1|Europe||Region of Enrollment||Participants|Number|7|7.0||||||
4233556|NCT00677365|4056911|B5|United States||Region of Enrollment||Participants|Number|124|124.0||||||
4233557|NCT00677365|4056912|B4|United States||Region of Enrollment||Participants|Number|32|32.0||||||
4233558|NCT00677365|4056913|B3|United States||Region of Enrollment||Participants|Number|30|30.0||||||
4233559|NCT00677365|4056914|B2|United States||Region of Enrollment||Participants|Number|32|32.0||||||
4233560|NCT00677365|4056915|B1|United States||Region of Enrollment||Participants|Number|30|30.0||||||
4233561|NCT00677365|4056911|B5||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4233562|NCT00677365|4056912|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4233563|NCT00677365|4056913|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4233564|NCT00677365|4056914|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4233565|NCT00677365|4056915|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4233566|NCT00677365|4056911|B5||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4233567|NCT00677365|4056912|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4233568|NCT00677365|4056913|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4233569|NCT00677365|4056914|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4233570|NCT00677365|4056915|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4233571|NCT00677365|4056911|B5|||Age||years|Mean|28.7|28.7|Standard Deviation|9.02|9.02|||
4233572|NCT00677365|4056912|B4|||Age||years|Mean|29.2|29.2|Standard Deviation|9.98|9.98|||
4233573|NCT00677365|4056913|B3|||Age||years|Mean|27.5|27.5|Standard Deviation|9.05|9.05|||
4233574|NCT00677365|4056914|B2|||Age||years|Mean|28.0|28.0|Standard Deviation|6.86|6.86|||
4233575|NCT00677365|4056915|B1|||Age||years|Mean|30.1|30.1|Standard Deviation|9.94|9.94|||
4233576|NCT00677352|4056948|B3||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4233577|NCT00677352|4056949|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4233578|NCT00677352|4056950|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4233579|NCT00677352|4056948|B3||Female|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4233580|NCT00677352|4056949|B2||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4233581|NCT00677352|4056950|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4233582|NCT00677352|4056948|B3|>= 65 years||Age, Customized||participants|Number|0|0.0||||||
4233583|NCT00677352|4056949|B2|>= 65 years||Age, Customized||participants|Number|0|0.0||||||
4233584|NCT00677352|4056950|B1|>= 65 years||Age, Customized||participants|Number|0|0.0||||||
4233585|NCT00677352|4056948|B3|45 -64 years||Age, Customized||participants|Number|74|74.0||||||
4233586|NCT00677352|4056949|B2|45 -64 years||Age, Customized||participants|Number|36|36.0||||||
4233587|NCT00677352|4056950|B1|45 -64 years||Age, Customized||participants|Number|38|38.0||||||
4233588|NCT00677352|4056948|B3|18 - 44 years||Age, Customized||participants|Number|245|245.0||||||
4233589|NCT00677352|4056949|B2|18 - 44 years||Age, Customized||participants|Number|126|126.0||||||
4233590|NCT00677352|4056950|B1|18 - 44 years||Age, Customized||participants|Number|119|119.0||||||
4233591|NCT00677352|4056948|B3|< 18 years||Age, Customized||participants|Number|0|0.0||||||
4233592|NCT00677352|4056949|B2|< 18 years||Age, Customized||participants|Number|0|0.0||||||
4233593|NCT00677352|4056950|B1|< 18 years||Age, Customized||participants|Number|0|0.0||||||
4233594|NCT00677235|4056969|B3|United States||Region of Enrollment||participants|Number|270|270.0||||||
4233595|NCT00677235|4056970|B2|United States||Region of Enrollment||participants|Number|132|132.0||||||
4233596|NCT00677235|4056971|B1|United States||Region of Enrollment||participants|Number|138|138.0||||||
4233597|NCT00677235|4056969|B3||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4233598|NCT00677235|4056970|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4233599|NCT00677235|4056971|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4233600|NCT00677235|4056969|B3||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4233601|NCT00677235|4056970|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4233602|NCT00677235|4056971|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4233603|NCT00677235|4056969|B3||>=65 years|Age||Participants|Count of Participants|136|136.0||||||
4233604|NCT00677235|4056970|B2||>=65 years|Age||Participants|Count of Participants|63|63.0||||||
4233605|NCT00677235|4056971|B1||>=65 years|Age||Participants|Count of Participants|73|73.0||||||
4233606|NCT00677235|4056969|B3||Between 18 and 65 years|Age||Participants|Count of Participants|134|134.0||||||
4233607|NCT00677235|4056970|B2||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
4233608|NCT00677235|4056971|B1||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4233609|NCT00677235|4056969|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233610|NCT00677235|4056970|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233611|NCT00677235|4056971|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233612|NCT00677235|4056969|B3|||Age||years|Median|63.5|63.5|Full Range|||24.0|89.0|
4233613|NCT00677235|4056970|B2|||Age||years|Median|63|63.0|Full Range|||24.0|88.0|
4233614|NCT00677235|4056971|B1|||Age||years|Median|64|64.0|Full Range|||26.0|89.0|
4233615|NCT00677092|4057012|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4233616|NCT00677092|4057012|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4233617|NCT00677092|4057012|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|14.2|14.2|||
4233618|NCT00677040|4057021|B1|||tissue oxygenation of nontreated breast|oxygenation was not measured prior to radiothearpy|mmHg|Mean|66.3|66.3|Standard Deviation|22.8|22.8|||
4233619|NCT00677040|4057021|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4233620|NCT00677040|4057021|B1||Male|Sex: Female, Male|20 female breast cancer patients were invited to participate one year after receiving radiation for part of their breast cancer treatment. Transcutaneous oxygen levels were measured for both breasts. Oxygen levels in the treated and non-treated breast were compared. The non treated breast levels serve as baseline levels.|Participants|Count of Participants|0|0.0||||||
4233621|NCT00677040|4057021|B1||Female|Sex: Female, Male|20 female breast cancer patients were invited to participate one year after receiving radiation for part of their breast cancer treatment. Transcutaneous oxygen levels were measured for both breasts. Oxygen levels in the treated and non-treated breast were compared. The non treated breast levels serve as baseline levels.|Participants|Count of Participants|20|20.0||||||
4233622|NCT00677040|4057021|B1|||Age||years|Mean|63|63.0|Full Range|||41.0|82.0|
4233623|NCT00677040|4057021|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4233624|NCT00677040|4057021|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4233625|NCT00677040|4057021|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233626|NCT00677014|4057026|B4|Europe||Region of Enrollment||participants|Number|68|68.0||||||
4233627|NCT00677014|4057027|B3|Europe||Region of Enrollment||participants|Number|25|25.0||||||
4233628|NCT00677014|4057028|B2|Europe||Region of Enrollment||participants|Number|22|22.0||||||
4233629|NCT00677014|4057029|B1|Europe||Region of Enrollment||participants|Number|21|21.0||||||
4233630|NCT00677014|4057026|B4|United States||Region of Enrollment||participants|Number|912|912.0||||||
4233631|NCT00677014|4057027|B3|United States||Region of Enrollment||participants|Number|307|307.0||||||
4233632|NCT00677014|4057028|B2|United States||Region of Enrollment||participants|Number|301|301.0||||||
4233633|NCT00677014|4057029|B1|United States||Region of Enrollment||participants|Number|304|304.0||||||
4233634|NCT00677014|4057026|B4||Male|Sex: Female, Male||Participants|Count of Participants|666|666.0||||||
4233635|NCT00677014|4057027|B3||Male|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4233636|NCT00677014|4057028|B2||Male|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
4233637|NCT00677014|4057029|B1||Male|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4233638|NCT00677014|4057026|B4||Female|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
4233639|NCT00677014|4057027|B3||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4233640|NCT00677014|4057028|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4233641|NCT00677014|4057029|B1||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4233642|NCT00677014|4057026|B4|||Age||years|Mean|66.1|66.1|Standard Deviation|11.0|11.0|||
4233643|NCT00677014|4057027|B3|||Age||years|Mean|66.1|66.1|Standard Deviation|11.3|11.3|||
4233644|NCT00677014|4057028|B2|||Age||years|Mean|65.8|65.8|Standard Deviation|11.2|11.2|||
4233645|NCT00677014|4057029|B1|||Age||years|Mean|66.4|66.4|Standard Deviation|10.6|10.6|||
4233646|NCT00677014|4057026|B4||>=65 years|Age||Participants|Count of Participants|578|578.0||||||
4233647|NCT00677014|4057027|B3||>=65 years|Age||Participants|Count of Participants|200|200.0||||||
4233648|NCT00677014|4057028|B2||>=65 years|Age||Participants|Count of Participants|189|189.0||||||
4233649|NCT00677014|4057029|B1||>=65 years|Age||Participants|Count of Participants|189|189.0||||||
4233650|NCT00677014|4057026|B4||Between 18 and 65 years|Age||Participants|Count of Participants|402|402.0||||||
4233651|NCT00677014|4057027|B3||Between 18 and 65 years|Age||Participants|Count of Participants|132|132.0||||||
4233652|NCT00677014|4057028|B2||Between 18 and 65 years|Age||Participants|Count of Participants|134|134.0||||||
4233653|NCT00677014|4057029|B1||Between 18 and 65 years|Age||Participants|Count of Participants|136|136.0||||||
4233654|NCT00677014|4057026|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233655|NCT00677014|4057027|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233656|NCT00677014|4057028|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233657|NCT00677014|4057029|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233658|NCT00676897|4057039|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4233659|NCT00676897|4057040|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4233660|NCT00676897|4057041|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4233661|NCT00676897|4057039|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233662|NCT00676897|4057040|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233663|NCT00676897|4057041|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233664|NCT00676897|4057039|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233665|NCT00676897|4057040|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233666|NCT00676897|4057041|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233667|NCT00676897|4057039|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4233668|NCT00676897|4057040|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4233669|NCT00676897|4057041|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4233670|NCT00676897|4057039|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4233671|NCT00676897|4057040|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4233672|NCT00676897|4057041|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4233673|NCT00676897|4057039|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233674|NCT00676897|4057040|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233675|NCT00676897|4057041|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233676|NCT00676897|4057039|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233677|NCT00676897|4057040|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233678|NCT00676897|4057041|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233679|NCT00676897|4057039|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233680|NCT00676897|4057040|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233681|NCT00676897|4057041|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233682|NCT00676897|4057039|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233683|NCT00676897|4057040|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233684|NCT00676897|4057041|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233685|NCT00676897|4057039|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4233686|NCT00676897|4057040|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4233687|NCT00676897|4057041|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4233688|NCT00676897|4057039|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233689|NCT00676897|4057040|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233690|NCT00676897|4057041|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4233691|NCT00676897|4057039|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4233692|NCT00676897|4057040|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4233693|NCT00676897|4057041|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4233694|NCT00676897|4057039|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4233695|NCT00676897|4057040|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4233696|NCT00676897|4057041|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4233697|NCT00676897|4057039|B3|||Age||years|Mean|58.72|58.72|Standard Deviation|17.19|17.19|||
4233698|NCT00676897|4057040|B2|||Age||years|Mean|54|54.0|Standard Deviation|16|16.0|||
4233699|NCT00676897|4057041|B1|||Age||years|Mean|65|65.0|Standard Deviation|18|18.0|||
4233700|NCT00676806|4057050|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4233701|NCT00676806|4057051|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4233702|NCT00676806|4057052|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4233703|NCT00676806|4057050|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4233704|NCT00676806|4057051|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4233705|NCT00676806|4057052|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4233706|NCT00676806|4057050|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4233707|NCT00676806|4057051|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4233708|NCT00676806|4057052|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4233709|NCT00676806|4057050|B3|||Age||years|Mean|52.8|52.8|Standard Deviation|12|12.0|||
4233710|NCT00676806|4057051|B2|||Age||years|Mean|62.6|62.6|Standard Deviation|2.3|2.3|||
4233711|NCT00676806|4057052|B1|||Age||years|Mean|43|43.0|Standard Deviation|8.1|8.1|||
4233712|NCT00676806|4057050|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4233713|NCT00676806|4057051|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4233714|NCT00676806|4057052|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4233715|NCT00676806|4057050|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4233716|NCT00676806|4057051|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4233717|NCT00676806|4057052|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4233718|NCT00676806|4057050|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233719|NCT00676806|4057051|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233720|NCT00676806|4057052|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233721|NCT00676793|4057069|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4233722|NCT00676793|4057069|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4233723|NCT00676793|4057069|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4233724|NCT00676793|4057069|B1|||Age||years|Mean|51.8|51.8|Standard Deviation|7.7|7.7|||
4233725|NCT00676793|4057069|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4233726|NCT00676793|4057069|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4233727|NCT00676793|4057069|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233728|NCT00676780|4057074|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4233729|NCT00676780|4057074|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4233730|NCT00676780|4057074|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4233731|NCT00676780|4057074|B1|||Age||years|Mean|58.6|58.6|Standard Deviation|7.1|7.1|||
4233732|NCT00676780|4057074|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4233733|NCT00676780|4057074|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4233734|NCT00676780|4057074|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233735|NCT00676715|4057080|B5||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4233736|NCT00676715|4057081|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4233737|NCT00676715|4057082|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4233738|NCT00676715|4057083|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4233739|NCT00676715|4057084|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4233740|NCT00676715|4057080|B5||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4233741|NCT00676715|4057081|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4233742|NCT00676715|4057082|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4233743|NCT00676715|4057083|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4233744|NCT00676715|4057084|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4233745|NCT00676715|4057080|B5|||Age||years|Mean|37.6|37.6|Standard Deviation|8.8|8.8|||
4233746|NCT00676715|4057081|B4|||Age||years|Mean|38.1|38.1|Standard Deviation|9.3|9.3|||
4233747|NCT00676715|4057082|B3|||Age||years|Mean|38.5|38.5|Standard Deviation|8.7|8.7|||
4233748|NCT00676715|4057083|B2|||Age||years|Mean|35.6|35.6|Standard Deviation|8.5|8.5|||
4233749|NCT00676715|4057084|B1|||Age||years|Mean|38.0|38.0|Standard Deviation|8.8|8.8|||
4233750|NCT00676689|4057117|B1|Both||Primary Indication||participants|Number|62|62.0||||||
4233751|NCT00676689|4057117|B1|Pulmonary Regurgitation||Primary Indication||participants|Number|10|10.0||||||
4233752|NCT00676689|4057117|B1|Pulmonary Stenosis||Primary Indication||participants|Number|7|7.0||||||
4233753|NCT00676689|4057117|B1|Class III/IV||New York Heart Association Group|"Class Patient Symptoms I No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, shortness of breath.~II Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, shortness of breath.~III Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~IV Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases."|participants|Number|25|25.0||||||
4233754|NCT00676689|4057117|B1|Class I/II||New York Heart Association Group|"Class Patient Symptoms I No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, shortness of breath.~II Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, shortness of breath.~III Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~IV Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases."|participants|Number|54|54.0||||||
4233755|NCT00676689|4057117|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4233756|NCT00676689|4057117|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4233757|NCT00676689|4057117|B1|||Age||years|Mean|28.0|28.0|Standard Deviation|13.97|13.97|||
4233758|NCT00676676|4057123|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4233759|NCT00676676|4057123|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4233760|NCT00676676|4057123|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4233761|NCT00676676|4057123|B1|||Age||years|Mean|48.1|48.1|Standard Deviation|12.2|12.2|||
4233762|NCT00676676|4057123|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4233763|NCT00676676|4057123|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4233764|NCT00676676|4057123|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233765|NCT00676650|4057127|B3||Male|Sex: Female, Male||Participants|Count of Participants|873|873.0||||||
4233766|NCT00676650|4057128|B2||Male|Sex: Female, Male||Participants|Count of Participants|289|289.0||||||
4233767|NCT00676650|4057129|B1||Male|Sex: Female, Male||Participants|Count of Participants|584|584.0||||||
4233768|NCT00676650|4057127|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4233769|NCT00676650|4057128|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4233770|NCT00676650|4057129|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4233771|NCT00676650|4057127|B3|greater than or equal to (>=) 65 years||Age, Customized||participants|Number|596|596.0||||||
4233772|NCT00676650|4057128|B2|greater than or equal to (>=) 65 years||Age, Customized||participants|Number|192|192.0||||||
4233773|NCT00676650|4057129|B1|greater than or equal to (>=) 65 years||Age, Customized||participants|Number|404|404.0||||||
4233774|NCT00676650|4057127|B3|45 - 64 years||Age, Customized||participants|Number|274|274.0||||||
4233775|NCT00676650|4057128|B2|45 - 64 years||Age, Customized||participants|Number|97|97.0||||||
4233776|NCT00676650|4057129|B1|45 - 64 years||Age, Customized||participants|Number|177|177.0||||||
4233777|NCT00676650|4057127|B3|18 - 44 years||Age, Customized||participants|Number|3|3.0||||||
4233778|NCT00676650|4057128|B2|18 - 44 years||Age, Customized||participants|Number|0|0.0||||||
4233779|NCT00676650|4057129|B1|18 - 44 years||Age, Customized||participants|Number|3|3.0||||||
4233780|NCT00676585|4057148|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4233781|NCT00676585|4057149|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4233782|NCT00676585|4057150|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4233783|NCT00676585|4057148|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4233784|NCT00676585|4057149|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4233785|NCT00676585|4057150|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4233786|NCT00676585|4057148|B3|||Age||years|Mean|69|69.0|Standard Deviation|14|14.0|||
4233787|NCT00676585|4057149|B2|||Age||years|Mean|66|66.0|Standard Deviation|15|15.0|||
4233788|NCT00676585|4057150|B1|||Age||years|Mean|71|71.0|Standard Deviation|13|13.0|||
4233789|NCT00676520|4057161|B1|United States||Region of Enrollment||participants|Number|8040|8040.0||||||
4233790|NCT00676520|4057161|B1||Male|Sex: Female, Male||Participants|Count of Participants|5599|5599.0||||||
4233791|NCT00676520|4057161|B1||Female|Sex: Female, Male||Participants|Count of Participants|2441|2441.0||||||
4233792|NCT00676520|4057161|B1|||Age||years|Mean|64.58|64.58|Standard Deviation|10.82|10.82|||
4233793|NCT00676520|4057161|B1||>=65 years|Age||Participants|Count of Participants|3919|3919.0||||||
4233794|NCT00676520|4057161|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4121|4121.0||||||
4233795|NCT00676520|4057161|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233796|NCT00676494|4057218|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4233797|NCT00676494|4057218|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4233798|NCT00676494|4057218|B1|||Age||years|Mean|71.9|71.9|Standard Deviation|8.4|8.4|||
4233799|NCT00676494|4057218|B1||>=65 years|Age||Participants|Count of Participants|134|134.0||||||
4233800|NCT00676494|4057218|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4233801|NCT00676494|4057218|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233802|NCT00676455|4057224|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4233803|NCT00676455|4057224|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4233804|NCT00676455|4057224|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4233805|NCT00676455|4057224|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4233806|NCT00676455|4057224|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4233807|NCT00676455|4057224|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233808|NCT00676403|4057229|B7||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4233809|NCT00676403|4057230|B6||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4233810|NCT00676403|4057231|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4233811|NCT00676403|4057232|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4233812|NCT00676403|4057233|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4233813|NCT00676403|4057234|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4233814|NCT00676403|4057235|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4233815|NCT00676403|4057229|B7||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4233816|NCT00676403|4057230|B6||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4233817|NCT00676403|4057231|B5||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4233818|NCT00676403|4057232|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4233819|NCT00676403|4057233|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4233820|NCT00676403|4057234|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4233821|NCT00676403|4057235|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4233822|NCT00676403|4057229|B7|>=65 years||Age, Customized||participants|Number|3|3.0||||||
4233823|NCT00676403|4057230|B6|>=65 years||Age, Customized||participants|Number|1|1.0||||||
4233824|NCT00676403|4057231|B5|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4233825|NCT00676403|4057232|B4|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4233826|NCT00676403|4057233|B3|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4233827|NCT00676403|4057234|B2|>=65 years||Age, Customized||participants|Number|2|2.0||||||
4233828|NCT00676403|4057235|B1|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4233829|NCT00676403|4057229|B7|45 - 64 years||Age, Customized||participants|Number|104|104.0||||||
4233830|NCT00676403|4057230|B6|45 - 64 years||Age, Customized||participants|Number|19|19.0||||||
4233831|NCT00676403|4057231|B5|45 - 64 years||Age, Customized||participants|Number|15|15.0||||||
4233832|NCT00676403|4057232|B4|45 - 64 years||Age, Customized||participants|Number|20|20.0||||||
4233833|NCT00676403|4057233|B3|45 - 64 years||Age, Customized||participants|Number|16|16.0||||||
4233834|NCT00676403|4057234|B2|45 - 64 years||Age, Customized||participants|Number|15|15.0||||||
4233835|NCT00676403|4057235|B1|45 - 64 years||Age, Customized||participants|Number|19|19.0||||||
4233836|NCT00676403|4057229|B7|18 - 44 years||Age, Customized||participants|Number|30|30.0||||||
4233837|NCT00676403|4057230|B6|18 - 44 years||Age, Customized||participants|Number|3|3.0||||||
4233838|NCT00676403|4057231|B5|18 - 44 years||Age, Customized||participants|Number|9|9.0||||||
4233839|NCT00676403|4057232|B4|18 - 44 years||Age, Customized||participants|Number|2|2.0||||||
4233840|NCT00676403|4057233|B3|18 - 44 years||Age, Customized||participants|Number|7|7.0||||||
4233841|NCT00676403|4057234|B2|18 - 44 years||Age, Customized||participants|Number|5|5.0||||||
4233842|NCT00676403|4057235|B1|18 - 44 years||Age, Customized||participants|Number|4|4.0||||||
4233843|NCT00676364|4057368|B3|United States||Region of Enrollment||participants|Number|114|114.0||||||
4233844|NCT00676364|4057369|B2|United States||Region of Enrollment||participants|Number|57|57.0||||||
4233845|NCT00676364|4057370|B1|United States||Region of Enrollment||participants|Number|57|57.0||||||
4233846|NCT00676364|4057368|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4233847|NCT00676364|4057369|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4233848|NCT00676364|4057370|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4233849|NCT00676364|4057368|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4233850|NCT00676364|4057369|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4233851|NCT00676364|4057370|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4233852|NCT00676364|4057368|B3|||Age||years|Mean|11.6|11.6|Standard Deviation|3.7|3.7|||
4233853|NCT00676364|4057369|B2|||Age||years|Mean|11.6|11.6|Standard Deviation|3.7|3.7|||
4233854|NCT00676364|4057370|B1|||Age||years|Mean|11.6|11.6|Standard Deviation|3.7|3.7|||
4233855|NCT00676364|4057368|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4233856|NCT00676364|4057369|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4233857|NCT00676364|4057370|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4233858|NCT00676364|4057368|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4233859|NCT00676364|4057369|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4233860|NCT00676364|4057370|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4233861|NCT00676364|4057368|B3||<=18 years|Age||Participants|Count of Participants|114|114.0||||||
4233862|NCT00676364|4057369|B2||<=18 years|Age||Participants|Count of Participants|57|57.0||||||
4233863|NCT00676364|4057370|B1||<=18 years|Age||Participants|Count of Participants|57|57.0||||||
4233864|NCT00676338|4057379|B5|||Weight||kg|Mean|87.0|87.0|Standard Deviation|18.83|18.83|||
4233865|NCT00676338|4057380|B4|||Weight||kg|Mean|88.7|88.7|Standard Deviation|18.65|18.65|||
4233866|NCT00676338|4057381|B3|||Weight||kg|Mean|86.1|86.1|Standard Deviation|17.77|17.77|||
4233867|NCT00676338|4057382|B2|||Weight||kg|Mean|85.9|85.9|Standard Deviation|19.57|19.57|||
4233868|NCT00676338|4057383|B1|||Weight||kg|Mean|87.5|87.5|Standard Deviation|18.88|18.88|||
4233869|NCT00676338|4057379|B5|||Glycosylated hemoglobin (HbA1c)||percentage of total hemoglobin|Mean|8.5|8.5|Standard Deviation|1.22|1.22|||
4233870|NCT00676338|4057380|B4|||Glycosylated hemoglobin (HbA1c)||percentage of total hemoglobin|Mean|8.5|8.5|Standard Deviation|1.25|1.25|||
4233871|NCT00676338|4057381|B3|||Glycosylated hemoglobin (HbA1c)||percentage of total hemoglobin|Mean|8.5|8.5|Standard Deviation|1.24|1.24|||
4233872|NCT00676338|4057382|B2|||Glycosylated hemoglobin (HbA1c)||percentage of total hemoglobin|Mean|8.6|8.6|Standard Deviation|1.20|1.2|||
4233873|NCT00676338|4057383|B1|||Glycosylated hemoglobin (HbA1c)||percentage of total hemoglobin|Mean|8.5|8.5|Standard Deviation|1.19|1.19|||
4233874|NCT00676338|4057379|B5||Male|Sex: Female, Male||Participants|Count of Participants|484|484.0||||||
4233875|NCT00676338|4057380|B4||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4233876|NCT00676338|4057381|B3||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4233877|NCT00676338|4057382|B2||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4233878|NCT00676338|4057383|B1||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4233879|NCT00676338|4057379|B5||Female|Sex: Female, Male||Participants|Count of Participants|336|336.0||||||
4233880|NCT00676338|4057380|B4||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4233881|NCT00676338|4057381|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4233882|NCT00676338|4057382|B2||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4233883|NCT00676338|4057383|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4233884|NCT00676338|4057379|B5|||Age||years|Mean|53.7|53.7|Standard Deviation|11.02|11.02|||
4233885|NCT00676338|4057380|B4|||Age||years|Mean|52.3|52.3|Standard Deviation|11.05|11.05|||
4233886|NCT00676338|4057381|B3|||Age||years|Mean|55.3|55.3|Standard Deviation|10.96|10.96|||
4233887|NCT00676338|4057382|B2|||Age||years|Mean|53.7|53.7|Standard Deviation|11.08|11.08|||
4233888|NCT00676338|4057383|B1|||Age||years|Mean|53.7|53.7|Standard Deviation|10.91|10.91|||
4233889|NCT00676338|4057379|B5||>=65 years|Age||Participants|Count of Participants|109|109.0||||||
4233890|NCT00676338|4057380|B4||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4233891|NCT00676338|4057381|B3||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4233892|NCT00676338|4057382|B2||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4233893|NCT00676338|4057383|B1||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4233894|NCT00676338|4057379|B5||Between 18 and 65 years|Age||Participants|Count of Participants|711|711.0||||||
4233895|NCT00676338|4057380|B4||Between 18 and 65 years|Age||Participants|Count of Participants|144|144.0||||||
4233896|NCT00676338|4057381|B3||Between 18 and 65 years|Age||Participants|Count of Participants|135|135.0||||||
4233897|NCT00676338|4057382|B2||Between 18 and 65 years|Age||Participants|Count of Participants|215|215.0||||||
4233898|NCT00676338|4057383|B1||Between 18 and 65 years|Age||Participants|Count of Participants|217|217.0||||||
4233899|NCT00676338|4057379|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233900|NCT00676338|4057380|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233901|NCT00676338|4057381|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233902|NCT00676338|4057382|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233903|NCT00676338|4057383|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4233904|NCT00676208|4057436|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
4233905|NCT00676208|4057437|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4233906|NCT00676208|4057438|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4233907|NCT00676208|4057436|B3|Not collected||Sex/Gender, Customized||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4233908|NCT00676208|4057437|B2|Not collected||Sex/Gender, Customized||participants|Number|NA|||||||Gender of participants not relevant to study focus
4233909|NCT00676208|4057438|B1|Not collected||Sex/Gender, Customized||participants|Number|NA|||||||Gender of participants not relevant to study focus
4233910|NCT00676208|4057436|B3||>=65 years|Age||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4233911|NCT00676208|4057437|B2||>=65 years|Age||Participants|Count of Participants|NA|||||||Age of participants not relevant to study focus
4233912|NCT00676208|4057438|B1||>=65 years|Age||Participants|Count of Participants|NA|||||||Age of participants not relevant to study focus
4233913|NCT00676208|4057436|B3||Between 18 and 65 years|Age||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4233914|NCT00676208|4057437|B2||Between 18 and 65 years|Age||Participants|Count of Participants|NA|||||||Age of participants not relevant to study focus
4233915|NCT00676208|4057438|B1||Between 18 and 65 years|Age||Participants|Count of Participants|NA|||||||Age of participants not relevant to study focus
4233916|NCT00676208|4057436|B3||<=18 years|Age||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4233917|NCT00676208|4057437|B2||<=18 years|Age||Participants|Count of Participants|NA|||||||Age of participants not relevant to study focus
4233918|NCT00676208|4057438|B1||<=18 years|Age||Participants|Count of Participants|NA|||||||Age of participants not relevant to study focus
4233919|NCT00676195|4057447|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4233920|NCT00676195|4057447|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4233921|NCT00676195|4057447|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4233922|NCT00676195|4057447|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4233923|NCT00676195|4057447|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4233924|NCT00676195|4057447|B1||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
4233925|NCT00676182|4057455|B3|Single||Marital status||participants|Number|4|4.0||||||
4233926|NCT00676182|4057456|B2|Single||Marital status||participants|Number|0|0.0||||||
4233927|NCT00676182|4057457|B1|Single||Marital status||participants|Number|4|4.0||||||
4233928|NCT00676182|4057455|B3|Never Married||Marital status||participants|Number|26|26.0||||||
4233929|NCT00676182|4057456|B2|Never Married||Marital status||participants|Number|6|6.0||||||
4233930|NCT00676182|4057457|B1|Never Married||Marital status||participants|Number|20|20.0||||||
4233931|NCT00676182|4057455|B3|Divorced||Marital status||participants|Number|6|6.0||||||
4233932|NCT00676182|4057456|B2|Divorced||Marital status||participants|Number|1|1.0||||||
4233933|NCT00676182|4057457|B1|Divorced||Marital status||participants|Number|5|5.0||||||
4233934|NCT00676182|4057455|B3|Married||Marital status||participants|Number|39|39.0||||||
4233935|NCT00676182|4057456|B2|Married||Marital status||participants|Number|7|7.0||||||
4233936|NCT00676182|4057457|B1|Married||Marital status||participants|Number|32|32.0||||||
4233937|NCT00676182|4057455|B3|$80,000+||Annual Income||participants|Number|3|3.0||||||
4233938|NCT00676182|4057456|B2|$80,000+||Annual Income||participants|Number|0|0.0||||||
4233939|NCT00676182|4057457|B1|$80,000+||Annual Income||participants|Number|3|3.0||||||
4233940|NCT00676182|4057455|B3|$50,000-79,999||Annual Income||participants|Number|3|3.0||||||
4233941|NCT00676182|4057456|B2|$50,000-79,999||Annual Income||participants|Number|1|1.0||||||
4233942|NCT00676182|4057457|B1|$50,000-79,999||Annual Income||participants|Number|2|2.0||||||
4233943|NCT00676182|4057455|B3|$30,000-49,999||Annual Income||participants|Number|17|17.0||||||
4233944|NCT00676182|4057456|B2|$30,000-49,999||Annual Income||participants|Number|4|4.0||||||
4233945|NCT00676182|4057457|B1|$30,000-49,999||Annual Income||participants|Number|13|13.0||||||
4233946|NCT00676182|4057455|B3|$10,000-29,999||Annual Income||participants|Number|31|31.0||||||
4233947|NCT00676182|4057456|B2|$10,000-29,999||Annual Income||participants|Number|6|6.0||||||
4233948|NCT00676182|4057457|B1|$10,000-29,999||Annual Income||participants|Number|25|25.0||||||
4233949|NCT00676182|4057455|B3|$0-9999||Annual Income||participants|Number|21|21.0||||||
4233950|NCT00676182|4057456|B2|$0-9999||Annual Income||participants|Number|3|3.0||||||
4233951|NCT00676182|4057457|B1|$0-9999||Annual Income||participants|Number|18|18.0||||||
4233952|NCT00676182|4057455|B3|80-100%||Service Connected Disability Rating|Percent of service-connected disability|participants|Number|14|14.0||||||
4233953|NCT00676182|4057456|B2|80-100%||Service Connected Disability Rating|Percent of service-connected disability|participants|Number|3|3.0||||||
4233954|NCT00676182|4057457|B1|80-100%||Service Connected Disability Rating|Percent of service-connected disability|participants|Number|11|11.0||||||
4233955|NCT00676182|4057455|B3|70-80%||Service Connected Disability Rating|Percent of service-connected disability|participants|Number|12|12.0||||||
4233956|NCT00676182|4057456|B2|70-80%||Service Connected Disability Rating|Percent of service-connected disability|participants|Number|3|3.0||||||
4233957|NCT00676182|4057457|B1|70-80%||Service Connected Disability Rating|Percent of service-connected disability|participants|Number|9|9.0||||||
4233958|NCT00676182|4057455|B3|40-60%||Service Connected Disability Rating|Percent of service-connected disability|participants|Number|17|17.0||||||
4233959|NCT00676182|4057456|B2|40-60%||Service Connected Disability Rating|Percent of service-connected disability|participants|Number|3|3.0||||||
4233960|NCT00676182|4057457|B1|40-60%||Service Connected Disability Rating|Percent of service-connected disability|participants|Number|14|14.0||||||
4233961|NCT00676182|4057455|B3|10-30%||Service Connected Disability Rating|Percent of service-connected disability|participants|Number|10|10.0||||||
4233962|NCT00676182|4057456|B2|10-30%||Service Connected Disability Rating|Percent of service-connected disability|participants|Number|0|0.0||||||
4233963|NCT00676182|4057457|B1|10-30%||Service Connected Disability Rating|Percent of service-connected disability|participants|Number|10|10.0||||||
4233964|NCT00676182|4057455|B3|0%||Service Connected Disability Rating|Percent of service-connected disability|participants|Number|22|22.0||||||
4233965|NCT00676182|4057456|B2|0%||Service Connected Disability Rating|Percent of service-connected disability|participants|Number|5|5.0||||||
4233966|NCT00676182|4057457|B1|0%||Service Connected Disability Rating|Percent of service-connected disability|participants|Number|17|17.0||||||
4233967|NCT00676182|4057455|B3|United States||Region of Enrollment||participants|Number|75|75.0||||||
4233968|NCT00676182|4057456|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4233969|NCT00676182|4057457|B1|United States||Region of Enrollment||participants|Number|61|61.0||||||
4233970|NCT00676182|4057455|B3|Unanswered||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4233971|NCT00676182|4057456|B2|Unanswered||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4233972|NCT00676182|4057457|B1|Unanswered||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4233973|NCT00676182|4057455|B3|Native Hawaiian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4233974|NCT00676182|4057456|B2|Native Hawaiian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4233975|NCT00676182|4057457|B1|Native Hawaiian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4233976|NCT00676182|4057455|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4233977|NCT00676182|4057456|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4233978|NCT00676182|4057457|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4233979|NCT00676182|4057455|B3|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4233980|NCT00676182|4057456|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4233981|NCT00676182|4057457|B1|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4233982|NCT00676182|4057455|B3|White||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4233983|NCT00676182|4057456|B2|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4233984|NCT00676182|4057457|B1|White||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4233985|NCT00676182|4057455|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4233986|NCT00676182|4057456|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4233987|NCT00676182|4057457|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4233988|NCT00676182|4057455|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4233989|NCT00676182|4057456|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4233990|NCT00676182|4057457|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4233991|NCT00676182|4057455|B3|50+ years||Age, Customized||participants|Number|4|4.0||||||
4233992|NCT00676182|4057456|B2|50+ years||Age, Customized||participants|Number|1|1.0||||||
4233993|NCT00676182|4057457|B1|50+ years||Age, Customized||participants|Number|3|3.0||||||
4233994|NCT00676182|4057455|B3|40-49 years||Age, Customized||participants|Number|14|14.0||||||
4233995|NCT00676182|4057456|B2|40-49 years||Age, Customized||participants|Number|7|7.0||||||
4233996|NCT00676182|4057457|B1|40-49 years||Age, Customized||participants|Number|7|7.0||||||
4233997|NCT00676182|4057455|B3|30-39 years||Age, Customized||participants|Number|18|18.0||||||
4233998|NCT00676182|4057456|B2|30-39 years||Age, Customized||participants|Number|3|3.0||||||
4233999|NCT00676182|4057457|B1|30-39 years||Age, Customized||participants|Number|15|15.0||||||
4234000|NCT00676182|4057455|B3|18-29 years||Age, Customized||participants|Number|39|39.0||||||
4234001|NCT00676182|4057456|B2|18-29 years||Age, Customized||participants|Number|3|3.0||||||
4234002|NCT00676182|4057457|B1|18-29 years||Age, Customized||participants|Number|36|36.0||||||
4234003|NCT00676143|4057470|B3||Male|Sex: Female, Male||Participants|Count of Participants|410|410.0||||||
4234004|NCT00676143|4057471|B2||Male|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
4234005|NCT00676143|4057472|B1||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4234006|NCT00676143|4057470|B3||Female|Sex: Female, Male||Participants|Count of Participants|683|683.0||||||
4234007|NCT00676143|4057471|B2||Female|Sex: Female, Male||Participants|Count of Participants|421|421.0||||||
4234008|NCT00676143|4057472|B1||Female|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
4234009|NCT00676143|4057470|B3|>=65 years||Age, Customized||Number of participants|Number|864|864.0||||||
4234010|NCT00676143|4057471|B2|>=65 years||Age, Customized||Number of participants|Number|522|522.0||||||
4234011|NCT00676143|4057472|B1|>=65 years||Age, Customized||Number of participants|Number|342|342.0||||||
4234012|NCT00676143|4057470|B3|<65 years||Age, Customized||Number of participants|Number|229|229.0||||||
4234013|NCT00676143|4057471|B2|<65 years||Age, Customized||Number of participants|Number|132|132.0||||||
4234014|NCT00676143|4057472|B1|<65 years||Age, Customized||Number of participants|Number|97|97.0||||||
4234015|NCT00676143|4057470|B3|||Age||Years|Mean|70.7|70.7|Standard Deviation|7.71|7.71|||
4234016|NCT00676143|4057471|B2|||Age||Years|Mean|71.0|71.0|Standard Deviation|7.67|7.67|||
4234017|NCT00676143|4057472|B1|||Age||Years|Mean|70.3|70.3|Standard Deviation|7.75|7.75|||
4234018|NCT00676130|4057511|B3|United States||Region of Enrollment||participants|Number|153|153.0||||||
4234019|NCT00676130|4057512|B2|United States||Region of Enrollment||participants|Number|77|77.0||||||
4234020|NCT00676130|4057513|B1|United States||Region of Enrollment||participants|Number|76|76.0||||||
4234021|NCT00676130|4057511|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4234022|NCT00676130|4057512|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4234023|NCT00676130|4057513|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4234024|NCT00676130|4057511|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4234025|NCT00676130|4057512|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4234026|NCT00676130|4057513|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4234027|NCT00676130|4057511|B3|||Age||years|Mean|34.71|34.71|Standard Deviation|15.23|15.23|||
4234028|NCT00676130|4057512|B2|||Age||years|Mean|32.43|32.43|Standard Deviation|15.15|15.15|||
4234029|NCT00676130|4057513|B1|||Age||years|Mean|37.03|37.03|Standard Deviation|15.07|15.07|||
4234030|NCT00676130|4057511|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4234031|NCT00676130|4057512|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4234032|NCT00676130|4057513|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4234033|NCT00676130|4057511|B3||Between 18 and 65 years|Age||Participants|Count of Participants|137|137.0||||||
4234034|NCT00676130|4057512|B2||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
4234035|NCT00676130|4057513|B1||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
4234036|NCT00676130|4057511|B3||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4234037|NCT00676130|4057512|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4234038|NCT00676130|4057513|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4234039|NCT00676091|4057522|B3||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4234040|NCT00676091|4057523|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4234041|NCT00676091|4057524|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4234042|NCT00676091|4057522|B3||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4234043|NCT00676091|4057523|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4234044|NCT00676091|4057524|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4234045|NCT00676091|4057522|B3|||Age||months|Mean|2.2|2.2|Standard Deviation|0.2|0.2|||
4234046|NCT00676091|4057523|B2|||Age||months|Mean|2.2|2.2|Standard Deviation|0.2|0.2|||
4234047|NCT00676091|4057524|B1|||Age||months|Mean|2.2|2.2|Standard Deviation|0.2|0.2|||
4234048|NCT00676065|4057557|B4|Europe||Region of Enrollment|This study was conducted in seven European countries: Austria, Belgium, Denmark, France, Germany, the Netherlands, and UK.|participants|Number|58303|58303.0||||||
4234049|NCT00676065|4057558|B3|Europe||Region of Enrollment|This study was conducted in seven European countries: Austria, Belgium, Denmark, France, Germany, the Netherlands, and UK.|participants|Number|26341|26341.0||||||
4234050|NCT00676065|4057559|B2|Europe||Region of Enrollment|This study was conducted in seven European countries: Austria, Belgium, Denmark, France, Germany, the Netherlands, and UK.|participants|Number|15428|15428.0||||||
4234051|NCT00676065|4057560|B1|Europe||Region of Enrollment|This study was conducted in seven European countries: Austria, Belgium, Denmark, France, Germany, the Netherlands, and UK.|participants|Number|16534|16534.0||||||
4234052|NCT00676065|4057557|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4234053|NCT00676065|4057558|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4234054|NCT00676065|4057559|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4234055|NCT00676065|4057560|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4234056|NCT00676065|4057557|B4||Female|Sex: Female, Male||Participants|Count of Participants|58303|58303.0||||||
4234057|NCT00676065|4057558|B3||Female|Sex: Female, Male||Participants|Count of Participants|26341|26341.0||||||
4234058|NCT00676065|4057559|B2||Female|Sex: Female, Male||Participants|Count of Participants|15428|15428.0||||||
4234059|NCT00676065|4057560|B1||Female|Sex: Female, Male||Participants|Count of Participants|16534|16534.0||||||
4234060|NCT00676065|4057557|B4|||Age||years|Mean|25.2|25.2|Standard Deviation|8.2|8.2|||
4234061|NCT00676065|4057558|B3|||Age||years|Mean|24.8|24.8|Standard Deviation|7.8|7.8|||
4234062|NCT00676065|4057559|B2|||Age||years|Mean|25.1|25.1|Standard Deviation|8.7|8.7|||
4234063|NCT00676065|4057560|B1|||Age||years|Mean|25.9|25.9|Standard Deviation|8.1|8.1|||
4234064|NCT00676052|4057576|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234065|NCT00676052|4057577|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234066|NCT00676052|4057578|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234067|NCT00676052|4057579|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234068|NCT00676052|4057580|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234069|NCT00676052|4057581|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234070|NCT00676052|4057582|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234071|NCT00676052|4057576|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4234072|NCT00676052|4057577|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234073|NCT00676052|4057578|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4234074|NCT00676052|4057579|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234075|NCT00676052|4057580|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4234076|NCT00676052|4057581|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234077|NCT00676052|4057582|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234078|NCT00676052|4057576|B7||White|Race (NIH/OMB)||Participants|Count of Participants|512|512.0||||||
4234079|NCT00676052|4057577|B6||White|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
4234080|NCT00676052|4057578|B5||White|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
4234081|NCT00676052|4057579|B4||White|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
4234082|NCT00676052|4057580|B3||White|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4234083|NCT00676052|4057581|B2||White|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4234084|NCT00676052|4057582|B1||White|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
4234085|NCT00676052|4057576|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4234086|NCT00676052|4057577|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4234087|NCT00676052|4057578|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4234088|NCT00676052|4057579|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4234089|NCT00676052|4057580|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4234090|NCT00676052|4057581|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4234091|NCT00676052|4057582|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4234092|NCT00676052|4057576|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234093|NCT00676052|4057577|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234094|NCT00676052|4057578|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234095|NCT00676052|4057579|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234096|NCT00676052|4057580|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234097|NCT00676052|4057581|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234098|NCT00676052|4057582|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234099|NCT00676052|4057576|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4234100|NCT00676052|4057577|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4234101|NCT00676052|4057578|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4234102|NCT00676052|4057579|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4234103|NCT00676052|4057580|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4234104|NCT00676052|4057581|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4234105|NCT00676052|4057582|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4234106|NCT00676052|4057576|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4234107|NCT00676052|4057577|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4234108|NCT00676052|4057578|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234109|NCT00676052|4057579|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234110|NCT00676052|4057580|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234111|NCT00676052|4057581|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4234112|NCT00676052|4057582|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4234113|NCT00676052|4057576|B7||Male|Sex: Female, Male||Participants|Count of Participants|341|341.0||||||
4234114|NCT00676052|4057577|B6||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4234115|NCT00676052|4057578|B5||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4234116|NCT00676052|4057579|B4||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4234117|NCT00676052|4057580|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4234118|NCT00676052|4057581|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4234119|NCT00676052|4057582|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4234120|NCT00676052|4057576|B7||Female|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4234121|NCT00676052|4057577|B6||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4234122|NCT00676052|4057578|B5||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4234123|NCT00676052|4057579|B4||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4234124|NCT00676052|4057580|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4234125|NCT00676052|4057581|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4234126|NCT00676052|4057582|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4234127|NCT00676052|4057576|B7|||Age||Years|Mean|62.4|62.4|Standard Deviation|8.58|8.58|||
4234128|NCT00676052|4057577|B6|||Age||Years|Mean|64.1|64.1|Standard Deviation|8.30|8.3|||
4234129|NCT00676052|4057578|B5|||Age||Years|Mean|61.7|61.7|Standard Deviation|8.77|8.77|||
4234130|NCT00676052|4057579|B4|||Age||Years|Mean|62.8|62.8|Standard Deviation|6.99|6.99|||
4234131|NCT00676052|4057580|B3|||Age||Years|Mean|62.2|62.2|Standard Deviation|8.70|8.7|||
4234132|NCT00676052|4057581|B2|||Age||Years|Mean|62.2|62.2|Standard Deviation|9.75|9.75|||
4234133|NCT00676052|4057582|B1|||Age||Years|Mean|61.4|61.4|Standard Deviation|8.73|8.73|||
4234134|NCT00675987|4057623|B3|United States||Region of Enrollment||participants|Number|53|53.0||||||
4234135|NCT00675987|4057624|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4234136|NCT00675987|4057625|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4234137|NCT00675987|4057623|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4234138|NCT00675987|4057624|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4234139|NCT00675987|4057625|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4234140|NCT00675987|4057623|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4234141|NCT00675987|4057624|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4234142|NCT00675987|4057625|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4234143|NCT00675987|4057623|B3|||Age||years|Mean|52.5|52.5|Standard Deviation|9.5|9.5|||
4234144|NCT00675987|4057624|B2|||Age||years|Mean|53.8|53.8|Standard Deviation|8.3|8.3|||
4234145|NCT00675987|4057625|B1|||Age||years|Mean|51.1|51.1|Standard Deviation|10.5|10.5|||
4234146|NCT00675987|4057623|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4234147|NCT00675987|4057624|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4234148|NCT00675987|4057625|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4234149|NCT00675987|4057623|B3||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4234150|NCT00675987|4057624|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4234151|NCT00675987|4057625|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4234152|NCT00675987|4057623|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4234153|NCT00675987|4057624|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4234154|NCT00675987|4057625|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4234155|NCT00675948|4057648|B3|Belgium||Region of Enrollment||participants|Number|9|9.0||||||
4234156|NCT00675948|4057649|B2|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4234157|NCT00675948|4057650|B1|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
4234158|NCT00675948|4057648|B3|United Kingdom||Region of Enrollment||participants|Number|34|34.0||||||
4234159|NCT00675948|4057649|B2|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4234160|NCT00675948|4057650|B1|United Kingdom||Region of Enrollment||participants|Number|31|31.0||||||
4234161|NCT00675948|4057648|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4234162|NCT00675948|4057649|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4234163|NCT00675948|4057650|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4234164|NCT00675948|4057648|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4234165|NCT00675948|4057649|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4234166|NCT00675948|4057650|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4234167|NCT00675948|4057648|B3|||Age||years|Mean|57.6|57.6|Standard Deviation|12.94|12.94|||
4234168|NCT00675948|4057649|B2|||Age||years|Mean|58.6|58.6|Standard Deviation|6.28|6.28|||
4234169|NCT00675948|4057650|B1|||Age||years|Mean|57.5|57.5|Standard Deviation|13.5|13.5|||
4234170|NCT00675948|4057648|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4234171|NCT00675948|4057649|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4234172|NCT00675948|4057650|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4234173|NCT00675948|4057648|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4234174|NCT00675948|4057649|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4234175|NCT00675948|4057650|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4234176|NCT00675948|4057648|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4234177|NCT00675948|4057649|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4234178|NCT00675948|4057650|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4234179|NCT00675922|4057661|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4234180|NCT00675922|4057661|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4234181|NCT00675922|4057661|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4234182|NCT00675922|4057661|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4234183|NCT00675922|4057661|B1||<=18 years|Age||Participants|Count of Participants|86|86.0||||||
4234184|NCT00675909|4057666|B4|United States||Region of Enrollment||participants|Number|180|180.0||||||
4234185|NCT00675909|4057667|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4234186|NCT00675909|4057668|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
4234187|NCT00675909|4057669|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4234188|NCT00675909|4057666|B4||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4234189|NCT00675909|4057667|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4234190|NCT00675909|4057668|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4234191|NCT00675909|4057669|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4234192|NCT00675909|4057666|B4||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4234193|NCT00675909|4057667|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4234194|NCT00675909|4057668|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4234195|NCT00675909|4057669|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4234196|NCT00675909|4057666|B4|||Age||years|Mean|3.3|3.3|Standard Deviation|1.4|1.4|||
4234197|NCT00675909|4057667|B3|||Age||years|Mean|3.2|3.2|Standard Deviation|1.3|1.3|||
4234198|NCT00675909|4057668|B2|||Age||years|Mean|3.7|3.7|Standard Deviation|1.4|1.4|||
4234199|NCT00675909|4057669|B1|||Age||years|Mean|3.1|3.1|Standard Deviation|1.5|1.5|||
4234200|NCT00675909|4057666|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4234201|NCT00675909|4057667|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4234202|NCT00675909|4057668|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4234203|NCT00675909|4057669|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4234204|NCT00675909|4057666|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4234205|NCT00675909|4057667|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4234206|NCT00675909|4057668|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4234207|NCT00675909|4057669|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4234208|NCT00675909|4057666|B4||<=18 years|Age||Participants|Count of Participants|180|180.0||||||
4234209|NCT00675909|4057667|B3||<=18 years|Age||Participants|Count of Participants|60|60.0||||||
4234210|NCT00675909|4057668|B2||<=18 years|Age||Participants|Count of Participants|60|60.0||||||
4234211|NCT00675909|4057669|B1||<=18 years|Age||Participants|Count of Participants|60|60.0||||||
4234212|NCT00675792|4057691|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4234213|NCT00675792|4057692|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4234214|NCT00675792|4057693|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4234215|NCT00675792|4057691|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4234216|NCT00675792|4057692|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4234217|NCT00675792|4057693|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4234218|NCT00675792|4057691|B3|||Age||years|Mean|51|51.0|Standard Deviation|10|10.0|||
4234219|NCT00675792|4057692|B2|||Age||years|Mean|52|52.0|Standard Deviation|9|9.0|||
4234220|NCT00675792|4057693|B1|||Age||years|Mean|49|49.0|Standard Deviation|11|11.0|||
4234221|NCT00675766|4057710|B5|United States||Region of Enrollment||participants|Number|223|223.0||||||
4234222|NCT00675766|4057711|B4|United States||Region of Enrollment||participants|Number|37|37.0||||||
4234223|NCT00675766|4057712|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4234224|NCT00675766|4057713|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4234225|NCT00675766|4057714|B1|United States||Region of Enrollment||participants|Number|106|106.0||||||
4234226|NCT00675766|4057710|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234227|NCT00675766|4057711|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234228|NCT00675766|4057712|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234229|NCT00675766|4057713|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234230|NCT00675766|4057714|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234231|NCT00675766|4057710|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4234232|NCT00675766|4057711|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4234233|NCT00675766|4057712|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4234234|NCT00675766|4057713|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4234235|NCT00675766|4057714|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4234236|NCT00675766|4057710|B5||White|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
4234237|NCT00675766|4057711|B4||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4234238|NCT00675766|4057712|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4234239|NCT00675766|4057713|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4234240|NCT00675766|4057714|B1||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4234241|NCT00675766|4057710|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
4234242|NCT00675766|4057711|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4234243|NCT00675766|4057712|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4234244|NCT00675766|4057713|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4234245|NCT00675766|4057714|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4234246|NCT00675766|4057710|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234247|NCT00675766|4057711|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234248|NCT00675766|4057712|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234249|NCT00675766|4057713|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234250|NCT00675766|4057714|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234251|NCT00675766|4057710|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4234252|NCT00675766|4057711|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4234253|NCT00675766|4057712|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4234254|NCT00675766|4057713|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4234255|NCT00675766|4057714|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4234256|NCT00675766|4057710|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4234257|NCT00675766|4057711|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234258|NCT00675766|4057712|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4234259|NCT00675766|4057713|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234260|NCT00675766|4057714|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4234261|NCT00675766|4057710|B5||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4234262|NCT00675766|4057711|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4234263|NCT00675766|4057712|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4234264|NCT00675766|4057713|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4234265|NCT00675766|4057714|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4234266|NCT00675766|4057710|B5||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4234267|NCT00675766|4057711|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4234268|NCT00675766|4057712|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4234269|NCT00675766|4057713|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4234270|NCT00675766|4057714|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4234271|NCT00675766|4057710|B5|50 years and older||Age, Customized||participants|Number|156|156.0||||||
4234272|NCT00675766|4057711|B4|50 years and older||Age, Customized||participants|Number|0|0.0||||||
4234273|NCT00675766|4057712|B3|50 years and older||Age, Customized||participants|Number|50|50.0||||||
4234274|NCT00675766|4057713|B2|50 years and older||Age, Customized||participants|Number|0|0.0||||||
4234275|NCT00675766|4057714|B1|50 years and older||Age, Customized||participants|Number|106|106.0||||||
4234276|NCT00675766|4057710|B5|Between 18 and 40 years old||Age, Customized||participants|Number|67|67.0||||||
4234277|NCT00675766|4057711|B4|Between 18 and 40 years old||Age, Customized||participants|Number|37|37.0||||||
4234278|NCT00675766|4057712|B3|Between 18 and 40 years old||Age, Customized||participants|Number|0|0.0||||||
4234279|NCT00675766|4057713|B2|Between 18 and 40 years old||Age, Customized||participants|Number|30|30.0||||||
4234280|NCT00675766|4057714|B1|Between 18 and 40 years old||Age, Customized||participants|Number|0|0.0||||||
4234281|NCT00675597|4057727|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4234282|NCT00675597|4057727|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4234283|NCT00675597|4057727|B1|||Age||years|Mean|64.6|64.6|Full Range|||50.0|81.0|
4234284|NCT00675584|4057731|B3|United States||Region of Enrollment||participants|Number|278|278.0||||||
4234285|NCT00675584|4057732|B2|United States||Region of Enrollment||participants|Number|139|139.0||||||
4234286|NCT00675584|4057733|B1|United States||Region of Enrollment||participants|Number|139|139.0||||||
4234287|NCT00675584|4057731|B3||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4234288|NCT00675584|4057732|B2||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4234289|NCT00675584|4057733|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4234290|NCT00675584|4057731|B3||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4234291|NCT00675584|4057732|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4234292|NCT00675584|4057733|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4234293|NCT00675584|4057731|B3|||Age||years|Mean|2.9|2.9|Standard Deviation|0.9|0.9|||
4234294|NCT00675584|4057732|B2|||Age||years|Mean|2.9|2.9|Standard Deviation|0.9|0.9|||
4234295|NCT00675584|4057733|B1|||Age||years|Mean|2.9|2.9|Standard Deviation|0.9|0.9|||
4234296|NCT00675584|4057731|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4234297|NCT00675584|4057732|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4234298|NCT00675584|4057733|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4234299|NCT00675584|4057731|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4234300|NCT00675584|4057732|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4234301|NCT00675584|4057733|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4234302|NCT00675584|4057731|B3||<=18 years|Age||Participants|Count of Participants|278|278.0||||||
4234303|NCT00675584|4057732|B2||<=18 years|Age||Participants|Count of Participants|139|139.0||||||
4234304|NCT00675584|4057733|B1||<=18 years|Age||Participants|Count of Participants|139|139.0||||||
4234305|NCT00675558|4057760|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4234306|NCT00675558|4057761|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4234307|NCT00675558|4057762|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4234308|NCT00675558|4057763|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4234309|NCT00675558|4057760|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4234310|NCT00675558|4057761|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4234311|NCT00675558|4057762|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4234312|NCT00675558|4057763|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4234313|NCT00675558|4057760|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||0|0.0|||
4234314|NCT00675558|4057761|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||0|0.0|||
4234315|NCT00675558|4057762|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||0|0.0|||
4234316|NCT00675558|4057763|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||0|0.0|||
4234317|NCT00675558|4057760|B4||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||0|0.0|||
4234318|NCT00675558|4057761|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||0|0.0|||
4234319|NCT00675558|4057762|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||0|0.0|||
4234320|NCT00675558|4057763|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||0|0.0|||
4234321|NCT00675558|4057760|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||0|0.0|||
4234322|NCT00675558|4057761|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||0|0.0|||
4234323|NCT00675558|4057762|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||0|0.0|||
4234324|NCT00675558|4057763|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||0|0.0|||
4234325|NCT00675506|4057779|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4234326|NCT00675506|4057780|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4234327|NCT00675506|4057781|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4234328|NCT00675506|4057779|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4234329|NCT00675506|4057780|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4234330|NCT00675506|4057781|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4234331|NCT00675506|4057779|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4234332|NCT00675506|4057780|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4234333|NCT00675506|4057781|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4234334|NCT00675506|4057779|B3|||Age||years|Mean|41.2|41.2|Standard Deviation|8.4|8.4|||
4234335|NCT00675506|4057780|B2|||Age||years|Mean|39.9|39.9|Standard Deviation|9.5|9.5|||
4234336|NCT00675506|4057781|B1|||Age||years|Mean|42.5|42.5|Standard Deviation|7.1|7.1|||
4234337|NCT00675506|4057779|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4234338|NCT00675506|4057780|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4234339|NCT00675506|4057781|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4234340|NCT00675506|4057779|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4234341|NCT00675506|4057780|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4234342|NCT00675506|4057781|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4234343|NCT00675506|4057779|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4234344|NCT00675506|4057780|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4234345|NCT00675506|4057781|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4234346|NCT00675441|4057798|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4234347|NCT00675441|4057798|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4234348|NCT00675441|4057798|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4234349|NCT00675441|4057798|B1|||Age||years|Median|55|55.0|Full Range|||35.0|64.0|
4234350|NCT00675428|4057802|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4234351|NCT00675428|4057803|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4234352|NCT00675428|4057804|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4234353|NCT00675428|4057802|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4234354|NCT00675428|4057803|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4234355|NCT00675428|4057804|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4234356|NCT00675428|4057802|B3|||Age||years|Median|67.5|67.5|Full Range|||50.0|75.0|
4234357|NCT00675428|4057803|B2|||Age||years|Median|68.0|68.0|Full Range|||50.0|75.0|
4234358|NCT00675428|4057804|B1|||Age||years|Median|67.0|67.0|Full Range|||57.0|75.0|
4234359|NCT00675415|4057823|B3|United States||Region of Enrollment||participants|Number|247|247.0||||||
4234360|NCT00675415|4057824|B2|United States||Region of Enrollment||participants|Number|123|123.0||||||
4234361|NCT00675415|4057825|B1|United States||Region of Enrollment||participants|Number|124|124.0||||||
4234362|NCT00675415|4057823|B3||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4234363|NCT00675415|4057824|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4234364|NCT00675415|4057825|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4234365|NCT00675415|4057823|B3||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4234366|NCT00675415|4057824|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4234367|NCT00675415|4057825|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4234368|NCT00675415|4057823|B3|||Age||years|Mean|60.7|60.7|Standard Deviation|14.3|14.3|||
4234369|NCT00675415|4057824|B2|||Age||years|Mean|60.6|60.6|Standard Deviation|14.3|14.3|||
4234370|NCT00675415|4057825|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|14.4|14.4|||
4234371|NCT00675259|4057838|B1|Not evaluated||Axillary lymph node status before NCT|NCT=neoadjuvant chemotherapy SLNB=sentinel lymph node biopsy|patients|Number|1|1.0||||||
4234372|NCT00675259|4057838|B1|Negative by SLNB||Axillary lymph node status before NCT|NCT=neoadjuvant chemotherapy SLNB=sentinel lymph node biopsy|patients|Number|8|8.0||||||
4234373|NCT00675259|4057838|B1|Negative by core biopsy||Axillary lymph node status before NCT|NCT=neoadjuvant chemotherapy SLNB=sentinel lymph node biopsy|patients|Number|5|5.0||||||
4234374|NCT00675259|4057838|B1|Positive by SLNB||Axillary lymph node status before NCT|NCT=neoadjuvant chemotherapy SLNB=sentinel lymph node biopsy|patients|Number|4|4.0||||||
4234375|NCT00675259|4057838|B1|Positive by core biopsy||Axillary lymph node status before NCT|NCT=neoadjuvant chemotherapy SLNB=sentinel lymph node biopsy|patients|Number|15|15.0||||||
4234376|NCT00675259|4057838|B1|ER and PR positive||Receptor status (all HER2/neu negative)|ER=estrogen receptor HER2/neu=human epidermal growth factor receptor 2 PR=progesterone receptor|patients|Number|21|21.0||||||
4234377|NCT00675259|4057838|B1|Triple negative||Receptor status (all HER2/neu negative)|ER=estrogen receptor HER2/neu=human epidermal growth factor receptor 2 PR=progesterone receptor|patients|Number|12|12.0||||||
4234378|NCT00675259|4057838|B1|Postmenopausal||Menopausal status||patients|Number|12|12.0||||||
4234379|NCT00675259|4057838|B1|Premenopausal||Menopausal status||patients|Number|21|21.0||||||
4234380|NCT00675259|4057838|B1|United States||Region of Enrollment||patients|Number|33|33.0||||||
4234381|NCT00675259|4057838|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234382|NCT00675259|4057838|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234383|NCT00675259|4057838|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4234384|NCT00675259|4057838|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4234385|NCT00675259|4057838|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234386|NCT00675259|4057838|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4234387|NCT00675259|4057838|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234388|NCT00675259|4057838|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4234389|NCT00675259|4057838|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4234390|NCT00675259|4057838|B1|||Age||years|Median|48|48.0|Full Range|||28.0|74.0|
4234391|NCT00675103|4057847|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4234392|NCT00675103|4057847|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4234393|NCT00675103|4057847|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4234394|NCT00675103|4057847|B1|||Age||years|Mean|66.4|66.4|Standard Deviation|8.77|8.77|||
4234395|NCT00675103|4057847|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4234396|NCT00675103|4057847|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4234397|NCT00675103|4057847|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4234398|NCT00674986|4057852|B3||Male|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
4234399|NCT00674986|4057853|B2||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4234400|NCT00674986|4057854|B1||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4234401|NCT00674986|4057852|B3||Female|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
4234402|NCT00674986|4057853|B2||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4234403|NCT00674986|4057854|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4234404|NCT00674986|4057852|B3|||Age||years|Mean|55.8|55.8|Standard Deviation|10.7|10.7|||
4234405|NCT00674986|4057853|B2|||Age||years|Mean|54.8|54.8|Standard Deviation|10.1|10.1|||
4234406|NCT00674986|4057854|B1|||Age||years|Mean|57.0|57.0|Standard Deviation|11.2|11.2|||
4234407|NCT00674973|4057874|B3||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4234408|NCT00674973|4057875|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4234409|NCT00674973|4057876|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4234410|NCT00674973|4057874|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4234411|NCT00674973|4057875|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4234412|NCT00674973|4057876|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4234413|NCT00674973|4057874|B3|Greater than (>) 65 years||Age, Customized||participants|Number|73|73.0||||||
4234414|NCT00674973|4057875|B2|Greater than (>) 65 years||Age, Customized||participants|Number|42|42.0||||||
4234415|NCT00674973|4057876|B1|Greater than (>) 65 years||Age, Customized||participants|Number|31|31.0||||||
4234416|NCT00674973|4057874|B3|Less than (<) 65 years||Age, Customized||participants|Number|134|134.0||||||
4234417|NCT00674973|4057875|B2|Less than (<) 65 years||Age, Customized||participants|Number|62|62.0||||||
4234418|NCT00674973|4057876|B1|Less than (<) 65 years||Age, Customized||participants|Number|72|72.0||||||
4234419|NCT00674817|4057891|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
4234420|NCT00674817|4057891|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4234421|NCT00674817|4057891|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4234422|NCT00674817|4057891|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4234423|NCT00674817|4057891|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4234424|NCT00674817|4057891|B1|Years||Age||Years|Mean|63.1|63.1|Standard Deviation|6.58|6.58|||
4234425|NCT00674765|4058037|B3|United States||Region of Enrollment||participants|Number|156|156.0||||||
4234426|NCT00674765|4058038|B2|United States||Region of Enrollment||participants|Number|75|75.0||||||
4234427|NCT00674765|4058039|B1|United States||Region of Enrollment||participants|Number|81|81.0||||||
4234428|NCT00674765|4058037|B3||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4234429|NCT00674765|4058038|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4234430|NCT00674765|4058039|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4234431|NCT00674765|4058037|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4234432|NCT00674765|4058038|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4234433|NCT00674765|4058039|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4234434|NCT00674765|4058037|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4234435|NCT00674765|4058038|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4234436|NCT00674765|4058039|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4234437|NCT00674765|4058037|B3||Between 18 and 65 years|Age||Participants|Count of Participants|156|156.0||||||
4234438|NCT00674765|4058038|B2||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4234439|NCT00674765|4058039|B1||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
4234440|NCT00674765|4058037|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4234441|NCT00674765|4058038|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4234442|NCT00674765|4058039|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4234443|NCT00674765|4058037|B3|||Age||years|Mean|44.4|44.4|Standard Deviation|10.1|10.1|||
4234444|NCT00674765|4058038|B2|||Age||years|Mean|45.4|45.4|Standard Deviation|11.3|11.3|||
4234445|NCT00674765|4058039|B1|||Age||years|Mean|43.0|43.0|Standard Deviation|9.9|9.9|||
4234446|NCT00674739|4058046|B4|United States||Region of Enrollment||participants|Number|470|470.0||||||
4234447|NCT00674739|4058047|B3|United States||Region of Enrollment||participants|Number|97|97.0||||||
4234448|NCT00674739|4058048|B2|United States||Region of Enrollment||participants|Number|195|195.0||||||
4234449|NCT00674739|4058049|B1|United States||Region of Enrollment||participants|Number|178|178.0||||||
4234450|NCT00674739|4058046|B4||Male|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
4234451|NCT00674739|4058047|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4234452|NCT00674739|4058048|B2||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4234453|NCT00674739|4058049|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4234454|NCT00674739|4058046|B4||Female|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4234455|NCT00674739|4058047|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4234456|NCT00674739|4058048|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4234457|NCT00674739|4058049|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4234458|NCT00674739|4058046|B4|||Age||years|Mean|32.2|32.2|Standard Deviation|11.3|11.3|||
4234459|NCT00674739|4058047|B3|||Age||years|Mean|30.5|30.5|Standard Deviation|10.6|10.6|||
4234460|NCT00674739|4058048|B2|||Age||years|Mean|32.5|32.5|Standard Deviation|11.6|11.6|||
4234461|NCT00674739|4058049|B1|||Age||years|Mean|32.7|32.7|Standard Deviation|11.3|11.3|||
4234462|NCT00674739|4058046|B4||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4234463|NCT00674739|4058047|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4234464|NCT00674739|4058048|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4234465|NCT00674739|4058049|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4234466|NCT00674739|4058046|B4||Between 18 and 65 years|Age||Participants|Count of Participants|453|453.0||||||
4234467|NCT00674739|4058047|B3||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
4234468|NCT00674739|4058048|B2||Between 18 and 65 years|Age||Participants|Count of Participants|189|189.0||||||
4234469|NCT00674739|4058049|B1||Between 18 and 65 years|Age||Participants|Count of Participants|173|173.0||||||
4234470|NCT00674739|4058046|B4||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4234471|NCT00674739|4058047|B3||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4234472|NCT00674739|4058048|B2||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4234473|NCT00674739|4058049|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4234474|NCT00674700|4058065|B4||Male|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
4234475|NCT00674700|4058066|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4234476|NCT00674700|4058067|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4234477|NCT00674700|4058068|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4234478|NCT00674700|4058065|B4||Female|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
4234479|NCT00674700|4058066|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4234480|NCT00674700|4058067|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4234481|NCT00674700|4058068|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4234482|NCT00674700|4058065|B4|||Age||years|Mean|29.7|29.7|Standard Deviation|8.64|8.64|||
4234483|NCT00674700|4058066|B3|||Age||years|Mean|30.0|30.0|Standard Deviation|8.96|8.96|||
4234484|NCT00674700|4058067|B2|||Age||years|Mean|30.1|30.1|Standard Deviation|8.43|8.43|||
4234485|NCT00674700|4058068|B1|||Age||years|Mean|29.0|29.0|Standard Deviation|8.52|8.52|||
4234486|NCT00674661|4058081|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4234487|NCT00674661|4058082|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4234488|NCT00674661|4058083|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4234489|NCT00674661|4058081|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234490|NCT00674661|4058082|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234491|NCT00674661|4058083|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234492|NCT00674661|4058081|B3||White|Race (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
4234493|NCT00674661|4058082|B2||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4234494|NCT00674661|4058083|B1||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4234495|NCT00674661|4058081|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4234496|NCT00674661|4058082|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4234497|NCT00674661|4058083|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4234498|NCT00674661|4058081|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234499|NCT00674661|4058082|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234500|NCT00674661|4058083|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234501|NCT00674661|4058081|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4234502|NCT00674661|4058082|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4234503|NCT00674661|4058083|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4234504|NCT00674661|4058081|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234505|NCT00674661|4058082|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234506|NCT00674661|4058083|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234507|NCT00674661|4058081|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
4234508|NCT00674661|4058082|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4234509|NCT00674661|4058083|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4234510|NCT00674661|4058081|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4234511|NCT00674661|4058082|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4234512|NCT00674661|4058083|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4234513|NCT00674661|4058081|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4234514|NCT00674661|4058082|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4234515|NCT00674661|4058083|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4234516|NCT00674661|4058081|B3||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4234517|NCT00674661|4058082|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4234518|NCT00674661|4058083|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4234519|NCT00674661|4058081|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4234520|NCT00674661|4058082|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4234521|NCT00674661|4058083|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4234522|NCT00674661|4058081|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4234523|NCT00674661|4058082|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4234524|NCT00674661|4058083|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4234525|NCT00674661|4058081|B3||Between 18 and 65 years|Age||Participants|Count of Participants|130|130.0||||||
4234526|NCT00674661|4058082|B2||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4234527|NCT00674661|4058083|B1||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
4234528|NCT00674661|4058081|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4234529|NCT00674661|4058082|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4234530|NCT00674661|4058083|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4234531|NCT00674622|4058090|B4|United States||Region of Enrollment||participants|Number|66|66.0||||||
4234532|NCT00674622|4058091|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4234533|NCT00674622|4058092|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4234534|NCT00674622|4058093|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4234535|NCT00674622|4058090|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4234536|NCT00674622|4058091|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4234537|NCT00674622|4058092|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4234538|NCT00674622|4058093|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4234539|NCT00674622|4058090|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4234540|NCT00674622|4058091|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4234541|NCT00674622|4058092|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4234542|NCT00674622|4058093|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4234543|NCT00674622|4058090|B4|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4234544|NCT00674622|4058091|B3|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4234545|NCT00674622|4058092|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4234546|NCT00674622|4058093|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4234547|NCT00674622|4058090|B4|White||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
4234548|NCT00674622|4058091|B3|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4234549|NCT00674622|4058092|B2|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4234550|NCT00674622|4058093|B1|White||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4234551|NCT00674622|4058090|B4||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4234552|NCT00674622|4058091|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4234553|NCT00674622|4058092|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4234554|NCT00674622|4058093|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4234555|NCT00674622|4058090|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4234556|NCT00674622|4058091|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4234557|NCT00674622|4058092|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4234558|NCT00674622|4058093|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4234559|NCT00674622|4058090|B4|||Age||years|Mean|49|49.0|Full Range|||32.0|65.0|
4234560|NCT00674622|4058091|B3|||Age||years|Mean|50|50.0|Full Range|||39.0|63.0|
4234561|NCT00674622|4058092|B2|||Age||years|Mean|50|50.0|Full Range|||34.0|65.0|
4234562|NCT00674622|4058093|B1|||Age||years|Mean|49|49.0|Full Range|||32.0|64.0|
4234563|NCT00674609|4058115|B4|Romania||Region of Enrollment||participants|Number|105|105.0||||||
4234564|NCT00674609|4058116|B3|Romania||Region of Enrollment||participants|Number|35|35.0||||||
4234565|NCT00674609|4058117|B2|Romania||Region of Enrollment||participants|Number|36|36.0||||||
4234566|NCT00674609|4058118|B1|Romania||Region of Enrollment||participants|Number|34|34.0||||||
4234567|NCT00674609|4058115|B4|Belgium||Region of Enrollment||participants|Number|11|11.0||||||
4234568|NCT00674609|4058116|B3|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
4234569|NCT00674609|4058117|B2|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
4234570|NCT00674609|4058118|B1|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
4234571|NCT00674609|4058115|B4|United Kingdom||Region of Enrollment||participants|Number|61|61.0||||||
4234572|NCT00674609|4058116|B3|United Kingdom||Region of Enrollment||participants|Number|21|21.0||||||
4234573|NCT00674609|4058117|B2|United Kingdom||Region of Enrollment||participants|Number|18|18.0||||||
4234574|NCT00674609|4058118|B1|United Kingdom||Region of Enrollment||participants|Number|22|22.0||||||
4234575|NCT00674609|4058115|B4||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4234576|NCT00674609|4058116|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4234577|NCT00674609|4058117|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4234578|NCT00674609|4058118|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4234579|NCT00674609|4058115|B4||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4234580|NCT00674609|4058116|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4234581|NCT00674609|4058117|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4234582|NCT00674609|4058118|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4234583|NCT00674609|4058115|B4|||Age||years|Mean|60.2|60.2|Standard Deviation|12.25|12.25|||
4234584|NCT00674609|4058116|B3|||Age||years|Mean|60.1|60.1|Standard Deviation|12.31|12.31|||
4234585|NCT00674609|4058117|B2|||Age||years|Mean|61.3|61.3|Standard Deviation|12.5|12.5|||
4234586|NCT00674609|4058118|B1|||Age||years|Mean|59.4|59.4|Standard Deviation|12.08|12.08|||
4234587|NCT00674609|4058115|B4||>=65 years|Age||Participants|Count of Participants|62|62.0||||||
4234588|NCT00674609|4058116|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4234589|NCT00674609|4058117|B2||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4234590|NCT00674609|4058118|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4234591|NCT00674609|4058115|B4||Between 18 and 65 years|Age||Participants|Count of Participants|115|115.0||||||
4234592|NCT00674609|4058116|B3||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4234593|NCT00674609|4058117|B2||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4234594|NCT00674609|4058118|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4234595|NCT00674609|4058115|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4234596|NCT00674609|4058116|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4234597|NCT00674609|4058117|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4234598|NCT00674609|4058118|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4234599|NCT00674583|4058152|B3|Not specified||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4234600|NCT00674583|4058153|B2|Not specified||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4234601|NCT00674583|4058154|B1|Not specified||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4234602|NCT00674583|4058152|B3|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|354|354.0||||||
4234603|NCT00674583|4058153|B2|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|87|87.0||||||
4234604|NCT00674583|4058154|B1|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|267|267.0||||||
4234605|NCT00674583|4058152|B3|White-Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
4234606|NCT00674583|4058153|B2|White-Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4234607|NCT00674583|4058154|B1|White-Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
4234608|NCT00674583|4058152|B3|Asian-South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4234609|NCT00674583|4058153|B2|Asian-South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4234610|NCT00674583|4058154|B1|Asian-South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4234611|NCT00674583|4058152|B3|Asian-Japanese heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4234612|NCT00674583|4058153|B2|Asian-Japanese heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4234613|NCT00674583|4058154|B1|Asian-Japanese heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4234614|NCT00674583|4058152|B3|Asian-East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4234615|NCT00674583|4058153|B2|Asian-East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4234616|NCT00674583|4058154|B1|Asian-East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4234617|NCT00674583|4058152|B3|Asian-Central/South Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4234618|NCT00674583|4058153|B2|Asian-Central/South Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4234619|NCT00674583|4058154|B1|Asian-Central/South Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4234620|NCT00674583|4058152|B3|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
4234621|NCT00674583|4058153|B2|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4234622|NCT00674583|4058154|B1|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4234623|NCT00674583|4058152|B3||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4234624|NCT00674583|4058153|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4234625|NCT00674583|4058154|B1||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4234626|NCT00674583|4058152|B3||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4234627|NCT00674583|4058153|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4234628|NCT00674583|4058154|B1||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4234629|NCT00674583|4058152|B3|||Age||Years|Mean|5.6|5.6|Standard Deviation|2.47|2.47|||
4234630|NCT00674583|4058153|B2|||Age||Years|Mean|5.6|5.6|Standard Deviation|2.32|2.32|||
4234631|NCT00674583|4058154|B1|||Age||Years|Mean|5.6|5.6|Standard Deviation|2.52|2.52|||
4234632|NCT00674492|4058179|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4234633|NCT00674492|4058179|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4234634|NCT00674492|4058179|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4234635|NCT00674492|4058179|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4234636|NCT00674492|4058179|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4234637|NCT00674492|4058179|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4234638|NCT00674492|4058179|B1|||Age||years|Mean|57|57.0|Full Range|||50.0|69.0|
4234639|NCT00674466|4058183|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4234640|NCT00674466|4058184|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234641|NCT00674466|4058185|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4234642|NCT00674466|4058186|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4234643|NCT00674466|4058183|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234644|NCT00674466|4058184|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234645|NCT00674466|4058185|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234646|NCT00674466|4058186|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234647|NCT00674466|4058183|B4||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4234648|NCT00674466|4058184|B3||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4234649|NCT00674466|4058185|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4234650|NCT00674466|4058186|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4234651|NCT00674466|4058183|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4234652|NCT00674466|4058184|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4234653|NCT00674466|4058185|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4234654|NCT00674466|4058186|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4234655|NCT00674466|4058183|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234656|NCT00674466|4058184|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234657|NCT00674466|4058185|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234658|NCT00674466|4058186|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234659|NCT00674466|4058183|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4234660|NCT00674466|4058184|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234661|NCT00674466|4058185|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234662|NCT00674466|4058186|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4234663|NCT00674466|4058183|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234664|NCT00674466|4058184|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234665|NCT00674466|4058185|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234666|NCT00674466|4058186|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234667|NCT00674466|4058183|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234668|NCT00674466|4058184|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234669|NCT00674466|4058185|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234670|NCT00674466|4058186|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234671|NCT00674466|4058183|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4234672|NCT00674466|4058184|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4234673|NCT00674466|4058185|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4234674|NCT00674466|4058186|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4234738|NCT00674297|4058292|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4234675|NCT00674466|4058183|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4234676|NCT00674466|4058184|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4234677|NCT00674466|4058185|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4234678|NCT00674466|4058186|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4234679|NCT00674466|4058183|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4234680|NCT00674466|4058184|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4234681|NCT00674466|4058185|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4234682|NCT00674466|4058186|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4234683|NCT00674466|4058183|B4||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4234684|NCT00674466|4058184|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4234685|NCT00674466|4058185|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4234686|NCT00674466|4058186|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4234687|NCT00674466|4058183|B4|||Age||years|Mean|55.7|55.7|Standard Deviation|9.14|9.14|||
4234688|NCT00674466|4058184|B3|||Age||years|Mean|55.2|55.2|Standard Deviation|8.26|8.26|||
4234689|NCT00674466|4058185|B2|||Age||years|Mean|55.5|55.5|Standard Deviation|11.06|11.06|||
4234690|NCT00674466|4058186|B1|||Age||years|Mean|56.2|56.2|Standard Deviation|8.05|8.05|||
4234691|NCT00674362|4058202|B3|Italy||Region of Enrollment||participants|Number|10|10.0||||||
4234692|NCT00674362|4058203|B2|Italy||Region of Enrollment||participants|Number|4|4.0||||||
4234693|NCT00674362|4058204|B1|Italy||Region of Enrollment||participants|Number|6|6.0||||||
4234694|NCT00674362|4058202|B3|Germany||Region of Enrollment||participants|Number|62|62.0||||||
4234695|NCT00674362|4058203|B2|Germany||Region of Enrollment||participants|Number|31|31.0||||||
4234696|NCT00674362|4058204|B1|Germany||Region of Enrollment||participants|Number|31|31.0||||||
4234697|NCT00674362|4058202|B3|Austria||Region of Enrollment||participants|Number|32|32.0||||||
4234698|NCT00674362|4058203|B2|Austria||Region of Enrollment||participants|Number|15|15.0||||||
4234699|NCT00674362|4058204|B1|Austria||Region of Enrollment||participants|Number|17|17.0||||||
4234700|NCT00674362|4058202|B3|Poland||Region of Enrollment||participants|Number|86|86.0||||||
4234701|NCT00674362|4058203|B2|Poland||Region of Enrollment||participants|Number|46|46.0||||||
4234702|NCT00674362|4058204|B1|Poland||Region of Enrollment||participants|Number|40|40.0||||||
4234703|NCT00674362|4058202|B3|France||Region of Enrollment||participants|Number|4|4.0||||||
4234704|NCT00674362|4058203|B2|France||Region of Enrollment||participants|Number|2|2.0||||||
4234705|NCT00674362|4058204|B1|France||Region of Enrollment||participants|Number|2|2.0||||||
4234706|NCT00674362|4058202|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4234707|NCT00674362|4058203|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4234708|NCT00674362|4058204|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4234709|NCT00674362|4058202|B3||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4234710|NCT00674362|4058203|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4234711|NCT00674362|4058204|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4234712|NCT00674362|4058202|B3|||Age||years|Mean|53.8|53.8|Standard Deviation|12.1|12.1|||
4234713|NCT00674362|4058203|B2|||Age||years|Mean|54.0|54.0|Standard Deviation|12.4|12.4|||
4234714|NCT00674362|4058204|B1|||Age||years|Mean|53.6|53.6|Standard Deviation|11.9|11.9|||
4234715|NCT00674362|4058202|B3||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
4234716|NCT00674362|4058203|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4234717|NCT00674362|4058204|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4234718|NCT00674362|4058202|B3||Between 18 and 65 years|Age||Participants|Count of Participants|158|158.0||||||
4234719|NCT00674362|4058203|B2||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4234720|NCT00674362|4058204|B1||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
4234721|NCT00674362|4058202|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4234722|NCT00674362|4058203|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4234723|NCT00674362|4058204|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4234724|NCT00674323|4058270|B4||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4234725|NCT00674323|4058271|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4234726|NCT00674323|4058272|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4234727|NCT00674323|4058273|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4234728|NCT00674323|4058270|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4234729|NCT00674323|4058271|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4234730|NCT00674323|4058272|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4234731|NCT00674323|4058273|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4234732|NCT00674323|4058270|B4|||Age||years|Mean|65.1|65.1|Standard Deviation|9.21|9.21|||
4234733|NCT00674323|4058271|B3|||Age||years|Mean|69.3|69.3|Standard Deviation|8.27|8.27|||
4234734|NCT00674323|4058272|B2|||Age||years|Mean|62.2|62.2|Standard Deviation|9.77|9.77|||
4234735|NCT00674323|4058273|B1|||Age||years|Mean|63.8|63.8|Standard Deviation|8.30|8.3|||
4234736|NCT00674297|4058292|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4234737|NCT00674297|4058292|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
4234739|NCT00674297|4058292|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4234740|NCT00674297|4058292|B1||>=65 years|Age|Ages between 18 and 65|Participants|Count of Participants|0|0.0||||||
4234741|NCT00674297|4058292|B1||Between 18 and 65 years|Age|Ages between 18 and 65|Participants|Count of Participants|41|41.0||||||
4234742|NCT00674297|4058292|B1||<=18 years|Age|Ages between 18 and 65|Participants|Count of Participants|0|0.0||||||
4234743|NCT00674206|4058310|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4234744|NCT00674206|4058310|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4234745|NCT00674206|4058310|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4234746|NCT00674206|4058310|B1|||Age||participants|Median|55|55.0|Full Range|||32.0|66.0|
4234747|NCT00674154|4058315|B3|Denmark||Region of Enrollment||participants|Number|46|46.0||||||
4234748|NCT00674154|4058316|B2|Denmark||Region of Enrollment||participants|Number|23|23.0||||||
4234749|NCT00674154|4058317|B1|Denmark||Region of Enrollment||participants|Number|23|23.0||||||
4234750|NCT00674154|4058315|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4234751|NCT00674154|4058316|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4234752|NCT00674154|4058317|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4234753|NCT00674154|4058315|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4234754|NCT00674154|4058316|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4234755|NCT00674154|4058317|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4234756|NCT00674154|4058315|B3|||Age||years|Mean|58|58.0|Standard Deviation|13|13.0|||
4234757|NCT00674154|4058316|B2|||Age||years|Mean|57|57.0|Standard Deviation|13|13.0|||
4234758|NCT00674154|4058317|B1|||Age||years|Mean|58|58.0|Standard Deviation|14|14.0|||
4234759|NCT00674154|4058315|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4234760|NCT00674154|4058316|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4234761|NCT00674154|4058317|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4234762|NCT00674154|4058315|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4234763|NCT00674154|4058316|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4234764|NCT00674154|4058317|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4234765|NCT00674154|4058315|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4234766|NCT00674154|4058316|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4234767|NCT00674154|4058317|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4234768|NCT00674128|4058324|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4234769|NCT00674128|4058325|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4234770|NCT00674128|4058326|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4234771|NCT00674128|4058324|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4234772|NCT00674128|4058325|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4234773|NCT00674128|4058326|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4234774|NCT00674128|4058324|B3|||Age||years|Mean|77|77.0|Standard Deviation|10|10.0|||
4234775|NCT00674128|4058325|B2|||Age||years|Mean|77.6|77.6|Standard Deviation|9.2|9.2|||
4234776|NCT00674128|4058326|B1|||Age||years|Mean|77|77.0|Standard Deviation|10|10.0|||
4234777|NCT00674115|4058333|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4234778|NCT00674115|4058333|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4234779|NCT00674115|4058333|B1|||Age||years|Mean|25.3|25.3|Standard Deviation|4.37|4.37|||
4234780|NCT00673959|4058345|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4234781|NCT00673959|4058345|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4234782|NCT00673959|4058345|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4234783|NCT00673959|4058345|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4234784|NCT00673959|4058345|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4234785|NCT00673933|4058352|B1|vehicle treated area||Non inflammatory lesions||Lesion|Mean|5.4|5.4|Full Range|||2.0|17.0|
4234786|NCT00673933|4058352|B1|Visonac treated area||Non inflammatory lesions||Lesion|Mean|6.5|6.5|Full Range|||1.0|21.0|
4234787|NCT00673933|4058352|B1|vehicle treated area||Inflammatory lesions||lesion|Mean|6.0|6.0|Full Range|||5.0|10.0|
4234788|NCT00673933|4058352|B1|Visonac treated area||Inflammatory lesions||lesion|Mean|5.9|5.9|Full Range|||5.0|11.0|
4234789|NCT00673933|4058352|B1|Skin type VI||Skin type|Skin type according to the Fitzpatrick Classification Scale. Skin type V: Brown, dark brown.Very rarely burns, tans very easily Skin type VI: Black, very dark brown to black. Never burns, tans very easily, deeply pigmented|participants|Number|2|2.0||||||
4234790|NCT00673933|4058352|B1|Skin type V||Skin type|Skin type according to the Fitzpatrick Classification Scale. Skin type V: Brown, dark brown.Very rarely burns, tans very easily Skin type VI: Black, very dark brown to black. Never burns, tans very easily, deeply pigmented|participants|Number|18|18.0||||||
4234791|NCT00673933|4058352|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4234792|NCT00673933|4058352|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4234793|NCT00673933|4058352|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4234794|NCT00673933|4058352|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4234795|NCT00673933|4058352|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4234796|NCT00673933|4058352|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4234963|NCT00673452|4058504|B2|No||Alcohol Consumption||participants|Number|177|177.0||||||
4234797|NCT00673881|4058368|B1|||Low density lipoprotein cholesterol (LDL)|Mean fasting (> 12 hours) LDL cholesterol measured at screening, Day 0, 1PM and Day 1, 1AM (Visit 1), Day 10 (Visit 4); 23 values, per protocol population|mg/dL|Mean|144|144.0|Standard Deviation|40|40.0|||
4234798|NCT00673881|4058368|B1|||High Density Lipoprotein Cholesterol (HDL)|Mean fasting (> 12 hours) HDL cholesterol measured at screening, Day 0, 1PM and Day 1, 1AM (Visit 1), Day 10 (Visit 4); 23 values, per protocol population|mg/dL|Mean|34|34.0|Standard Deviation|8.2|8.2|||
4234799|NCT00673881|4058368|B1|||Triglycerides (TG)|Mean fasting (> 12 hours) triglycerides measured at screening, Day 0, 1PM and Day 1, 1AM (Visit 1), Day 10 (Visit 4);23 values, per protocol population|mg/dL|Mean|241|241.0|Standard Deviation|122|122.0|||
4234800|NCT00673881|4058368|B1|||Total cholesterol (TC)|Mean of fasting (> 12 hours) total cholesterol measured at screening, Day 0, 1PM and Day 1, 1AM (Visit 1),Day 10 (Visit 4);23 values, per protocol population|mg/dL|Mean|221|221.0|Standard Deviation|45|45.0|||
4234801|NCT00673881|4058368|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4234802|NCT00673881|4058368|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4234803|NCT00673881|4058368|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4234804|NCT00673881|4058368|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4234805|NCT00673881|4058368|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4234806|NCT00673881|4058368|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4234807|NCT00673855|4058375|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4234808|NCT00673855|4058375|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4234809|NCT00673855|4058375|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4234810|NCT00673855|4058375|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4234811|NCT00673855|4058375|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4234812|NCT00673816|4058382|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4234813|NCT00673816|4058382|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4234814|NCT00673816|4058382|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4234815|NCT00673816|4058382|B1|||Age||years|Mean|48.5|48.5|Full Range|4.95|4.95|45.0|52.0|
4234816|NCT00673816|4058382|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4234817|NCT00673816|4058382|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4234818|NCT00673816|4058382|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4234819|NCT00673764|4058389|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4234820|NCT00673764|4058389|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4234821|NCT00673764|4058389|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4234822|NCT00673764|4058389|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4234823|NCT00673764|4058389|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4234824|NCT00673738|4058398|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4234825|NCT00673738|4058398|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4234826|NCT00673738|4058398|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4234827|NCT00673738|4058398|B1|||Age||years|Median|72|72.0|Full Range|||58.0|83.0|
4234828|NCT00673738|4058398|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4234829|NCT00673738|4058398|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4234830|NCT00673738|4058398|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4234831|NCT00673712|4058404|B3|United States||Region of Enrollment||participants|Number|647|647.0||||||
4234832|NCT00673712|4058405|B2|United States||Region of Enrollment||participants|Number|326|326.0||||||
4234833|NCT00673712|4058406|B1|United States||Region of Enrollment||participants|Number|321|321.0||||||
4234834|NCT00673712|4058404|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4234835|NCT00673712|4058405|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4234836|NCT00673712|4058406|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4234837|NCT00673712|4058404|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4234838|NCT00673712|4058405|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4234839|NCT00673712|4058406|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4234840|NCT00673712|4058404|B3||White|Race (NIH/OMB)||Participants|Count of Participants|550|550.0||||||
4234841|NCT00673712|4058405|B2||White|Race (NIH/OMB)||Participants|Count of Participants|277|277.0||||||
4234842|NCT00673712|4058406|B1||White|Race (NIH/OMB)||Participants|Count of Participants|273|273.0||||||
4234843|NCT00673712|4058404|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4234844|NCT00673712|4058405|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4234845|NCT00673712|4058406|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4234846|NCT00673712|4058404|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234847|NCT00673712|4058405|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234848|NCT00673712|4058406|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234849|NCT00673712|4058404|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4234850|NCT00673712|4058405|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4234851|NCT00673712|4058406|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4234852|NCT00673712|4058404|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234853|NCT00673712|4058405|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234854|NCT00673712|4058406|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4234855|NCT00673712|4058404|B3||Male|Sex: Female, Male||Participants|Count of Participants|449|449.0||||||
4234856|NCT00673712|4058405|B2||Male|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4234857|NCT00673712|4058406|B1||Male|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
4234858|NCT00673712|4058404|B3||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4234859|NCT00673712|4058405|B2||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4234860|NCT00673712|4058406|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4234861|NCT00673712|4058404|B3|||Age||years|Mean|64.7|64.7|Standard Deviation|11.8|11.8|||
4234862|NCT00673712|4058405|B2|||Age||years|Mean|65.2|65.2|Standard Deviation|11.5|11.5|||
4234863|NCT00673712|4058406|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|12.1|12.1|||
4234864|NCT00673673|4058417|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4234865|NCT00673673|4058417|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4234866|NCT00673673|4058417|B1|||Age||years|Median|62|62.0|Full Range|||27.0|79.0|
4234867|NCT00673660|4058423|B1|Unknown||Sex/Gender, Customized||participants|Number|2|2.0||||||
4234868|NCT00673660|4058423|B1|Male||Sex/Gender, Customized||participants|Number|187|187.0||||||
4234869|NCT00673660|4058423|B1|Female||Sex/Gender, Customized||participants|Number|186|186.0||||||
4234870|NCT00673660|4058423|B1|||Age||years|Mean|59.7|59.7|Standard Deviation|10.6|10.6|||
4234871|NCT00673595|4058434|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4234872|NCT00673595|4058435|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4234873|NCT00673595|4058436|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4234874|NCT00673595|4058434|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4234875|NCT00673595|4058435|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4234876|NCT00673595|4058436|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4234877|NCT00673595|4058434|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4234878|NCT00673595|4058435|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4234879|NCT00673595|4058436|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4234880|NCT00673595|4058434|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4234881|NCT00673595|4058435|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4234882|NCT00673595|4058436|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4234883|NCT00673595|4058434|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4234884|NCT00673595|4058435|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4234885|NCT00673595|4058436|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4234886|NCT00673595|4058434|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4234887|NCT00673595|4058435|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4234888|NCT00673595|4058436|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4234889|NCT00673465|4058445|B1|||24-hour plasma glucose (AUC/duration)|Mean 24-hour plasma glucose at baseline. Area under the plasma glucose curve (AUC)/duration is presented as mg/dL and was calculated by dividing AUC (mg/dL*hr) by the duration in hours.|mg/dL|Mean|207|207.0|Standard Deviation|34|34.0|||
4234890|NCT00673465|4058445|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4234891|NCT00673465|4058445|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4234892|NCT00673465|4058445|B1|||Age||Years|Mean|54.1|54.1|Standard Deviation|8.1|8.1|||
4234893|NCT00673452|4058503|B3|||Weight||kilograms (kg)|Mean|85.00|85.0|Standard Deviation|20.74|20.74|||
4234894|NCT00673452|4058504|B2|||Weight||kilograms (kg)|Mean|85.98|85.98|Standard Deviation|21.65|21.65|||
4234895|NCT00673452|4058505|B1|||Weight||kilograms (kg)|Mean|84.01|84.01|Standard Deviation|19.76|19.76|||
4234896|NCT00673452|4058503|B3|Reduced Motivation Dimension||The Multidimensional Fatigue Inventory (MFI) Dimension Scores|The Multidimensional Fatigue Inventory (MFI) is a 20- item, self-reporting instrument designed to collect data on the following 5 dimensions: general fatigue, physical fatigue, mental fatigue, reduced motivation, and reduced activity. Each dimension score is derived by summing the scores of the 4 individual items that pertain to each dimension. Item scores range from 1 to 5; thus, dimensional scores range from 4 to 20 with a higher score reflecting greater levels of fatigue.|units on a scale|Mean|12.50|12.5|Standard Deviation|3.70|3.7|||
4234897|NCT00673452|4058504|B2|Reduced Motivation Dimension||The Multidimensional Fatigue Inventory (MFI) Dimension Scores|The Multidimensional Fatigue Inventory (MFI) is a 20- item, self-reporting instrument designed to collect data on the following 5 dimensions: general fatigue, physical fatigue, mental fatigue, reduced motivation, and reduced activity. Each dimension score is derived by summing the scores of the 4 individual items that pertain to each dimension. Item scores range from 1 to 5; thus, dimensional scores range from 4 to 20 with a higher score reflecting greater levels of fatigue.|units on a scale|Mean|12.59|12.59|Standard Deviation|3.70|3.7|||
4234898|NCT00673452|4058505|B1|Reduced Motivation Dimension||The Multidimensional Fatigue Inventory (MFI) Dimension Scores|The Multidimensional Fatigue Inventory (MFI) is a 20- item, self-reporting instrument designed to collect data on the following 5 dimensions: general fatigue, physical fatigue, mental fatigue, reduced motivation, and reduced activity. Each dimension score is derived by summing the scores of the 4 individual items that pertain to each dimension. Item scores range from 1 to 5; thus, dimensional scores range from 4 to 20 with a higher score reflecting greater levels of fatigue.|units on a scale|Mean|12.41|12.41|Standard Deviation|3.69|3.69|||
4234899|NCT00673452|4058503|B3|Reduced Activity Dimension||The Multidimensional Fatigue Inventory (MFI) Dimension Scores|The Multidimensional Fatigue Inventory (MFI) is a 20- item, self-reporting instrument designed to collect data on the following 5 dimensions: general fatigue, physical fatigue, mental fatigue, reduced motivation, and reduced activity. Each dimension score is derived by summing the scores of the 4 individual items that pertain to each dimension. Item scores range from 1 to 5; thus, dimensional scores range from 4 to 20 with a higher score reflecting greater levels of fatigue.|units on a scale|Mean|13.67|13.67|Standard Deviation|3.98|3.98|||
4234900|NCT00673452|4058504|B2|Reduced Activity Dimension||The Multidimensional Fatigue Inventory (MFI) Dimension Scores|The Multidimensional Fatigue Inventory (MFI) is a 20- item, self-reporting instrument designed to collect data on the following 5 dimensions: general fatigue, physical fatigue, mental fatigue, reduced motivation, and reduced activity. Each dimension score is derived by summing the scores of the 4 individual items that pertain to each dimension. Item scores range from 1 to 5; thus, dimensional scores range from 4 to 20 with a higher score reflecting greater levels of fatigue.|units on a scale|Mean|13.57|13.57|Standard Deviation|3.90|3.9|||
4234901|NCT00673452|4058505|B1|Reduced Activity Dimension||The Multidimensional Fatigue Inventory (MFI) Dimension Scores|The Multidimensional Fatigue Inventory (MFI) is a 20- item, self-reporting instrument designed to collect data on the following 5 dimensions: general fatigue, physical fatigue, mental fatigue, reduced motivation, and reduced activity. Each dimension score is derived by summing the scores of the 4 individual items that pertain to each dimension. Item scores range from 1 to 5; thus, dimensional scores range from 4 to 20 with a higher score reflecting greater levels of fatigue.|units on a scale|Mean|13.78|13.78|Standard Deviation|4.06|4.06|||
4234902|NCT00673452|4058503|B3|Physical Fatigue Dimension||The Multidimensional Fatigue Inventory (MFI) Dimension Scores|The Multidimensional Fatigue Inventory (MFI) is a 20- item, self-reporting instrument designed to collect data on the following 5 dimensions: general fatigue, physical fatigue, mental fatigue, reduced motivation, and reduced activity. Each dimension score is derived by summing the scores of the 4 individual items that pertain to each dimension. Item scores range from 1 to 5; thus, dimensional scores range from 4 to 20 with a higher score reflecting greater levels of fatigue.|units on a scale|Mean|15.44|15.44|Standard Deviation|3.55|3.55|||
4234903|NCT00673452|4058504|B2|Physical Fatigue Dimension||The Multidimensional Fatigue Inventory (MFI) Dimension Scores|The Multidimensional Fatigue Inventory (MFI) is a 20- item, self-reporting instrument designed to collect data on the following 5 dimensions: general fatigue, physical fatigue, mental fatigue, reduced motivation, and reduced activity. Each dimension score is derived by summing the scores of the 4 individual items that pertain to each dimension. Item scores range from 1 to 5; thus, dimensional scores range from 4 to 20 with a higher score reflecting greater levels of fatigue.|units on a scale|Mean|15.40|15.4|Standard Deviation|3.61|3.61|||
4234904|NCT00673452|4058505|B1|Physical Fatigue Dimension||The Multidimensional Fatigue Inventory (MFI) Dimension Scores|The Multidimensional Fatigue Inventory (MFI) is a 20- item, self-reporting instrument designed to collect data on the following 5 dimensions: general fatigue, physical fatigue, mental fatigue, reduced motivation, and reduced activity. Each dimension score is derived by summing the scores of the 4 individual items that pertain to each dimension. Item scores range from 1 to 5; thus, dimensional scores range from 4 to 20 with a higher score reflecting greater levels of fatigue.|units on a scale|Mean|15.48|15.48|Standard Deviation|3.50|3.5|||
4234905|NCT00673452|4058503|B3|Mental Fatigue Dimension||The Multidimensional Fatigue Inventory (MFI) Dimension Scores|The Multidimensional Fatigue Inventory (MFI) is a 20- item, self-reporting instrument designed to collect data on the following 5 dimensions: general fatigue, physical fatigue, mental fatigue, reduced motivation, and reduced activity. Each dimension score is derived by summing the scores of the 4 individual items that pertain to each dimension. Item scores range from 1 to 5; thus, dimensional scores range from 4 to 20 with a higher score reflecting greater levels of fatigue.|units on a scale|Mean|13.12|13.12|Standard Deviation|4.24|4.24|||
4234906|NCT00673452|4058504|B2|Mental Fatigue Dimension||The Multidimensional Fatigue Inventory (MFI) Dimension Scores|The Multidimensional Fatigue Inventory (MFI) is a 20- item, self-reporting instrument designed to collect data on the following 5 dimensions: general fatigue, physical fatigue, mental fatigue, reduced motivation, and reduced activity. Each dimension score is derived by summing the scores of the 4 individual items that pertain to each dimension. Item scores range from 1 to 5; thus, dimensional scores range from 4 to 20 with a higher score reflecting greater levels of fatigue.|units on a scale|Mean|12.97|12.97|Standard Deviation|4.30|4.3|||
4234907|NCT00673452|4058505|B1|Mental Fatigue Dimension||The Multidimensional Fatigue Inventory (MFI) Dimension Scores|The Multidimensional Fatigue Inventory (MFI) is a 20- item, self-reporting instrument designed to collect data on the following 5 dimensions: general fatigue, physical fatigue, mental fatigue, reduced motivation, and reduced activity. Each dimension score is derived by summing the scores of the 4 individual items that pertain to each dimension. Item scores range from 1 to 5; thus, dimensional scores range from 4 to 20 with a higher score reflecting greater levels of fatigue.|units on a scale|Mean|13.28|13.28|Standard Deviation|4.17|4.17|||
4234908|NCT00673452|4058503|B3|General Fatigue Dimension||The Multidimensional Fatigue Inventory (MFI) Dimension Scores|The Multidimensional Fatigue Inventory (MFI) is a 20- item, self-reporting instrument designed to collect data on the following 5 dimensions: general fatigue, physical fatigue, mental fatigue, reduced motivation, and reduced activity. Each dimension score is derived by summing the scores of the 4 individual items that pertain to each dimension. Item scores range from 1 to 5; thus, dimensional scores range from 4 to 20 with a higher score reflecting greater levels of fatigue.|units on a scale|Mean|17.11|17.11|Standard Deviation|2.89|2.89|||
4234909|NCT00673452|4058504|B2|General Fatigue Dimension||The Multidimensional Fatigue Inventory (MFI) Dimension Scores|The Multidimensional Fatigue Inventory (MFI) is a 20- item, self-reporting instrument designed to collect data on the following 5 dimensions: general fatigue, physical fatigue, mental fatigue, reduced motivation, and reduced activity. Each dimension score is derived by summing the scores of the 4 individual items that pertain to each dimension. Item scores range from 1 to 5; thus, dimensional scores range from 4 to 20 with a higher score reflecting greater levels of fatigue.|units on a scale|Mean|17.16|17.16|Standard Deviation|2.87|2.87|||
4234933|NCT00673452|4058504|B2|||Height||centimeters (cm)|Mean|163.75|163.75|Standard Deviation|8.48|8.48|||
4234934|NCT00673452|4058505|B1|||Height||centimeters (cm)|Mean|163.00|163.0|Standard Deviation|8.38|8.38|||
4234964|NCT00673452|4058505|B1|No||Alcohol Consumption||participants|Number|174|174.0||||||
4234910|NCT00673452|4058505|B1|General Fatigue Dimension||The Multidimensional Fatigue Inventory (MFI) Dimension Scores|The Multidimensional Fatigue Inventory (MFI) is a 20- item, self-reporting instrument designed to collect data on the following 5 dimensions: general fatigue, physical fatigue, mental fatigue, reduced motivation, and reduced activity. Each dimension score is derived by summing the scores of the 4 individual items that pertain to each dimension. Item scores range from 1 to 5; thus, dimensional scores range from 4 to 20 with a higher score reflecting greater levels of fatigue.|units on a scale|Mean|17.05|17.05|Standard Deviation|2.91|2.91|||
4234911|NCT00673452|4058503|B3|||Patient’s Global Impressions of Severity (PGI-S)|The PGI-Severity scale is a patient-rated instrument that measures perceived severity of symptoms. It is a 7-point scale where a score of 1 indicates that the patient is “Normal, not at all ill,” a score of 4 indicates that the patient has experienced “Moderately ill,” and a score of 7 indicates that the patient is “Among the most extremely ill patients.”|units on a scale|Mean|3.77|3.77|Standard Deviation|1.34|1.34|||
4234912|NCT00673452|4058504|B2|||Patient’s Global Impressions of Severity (PGI-S)|The PGI-Severity scale is a patient-rated instrument that measures perceived severity of symptoms. It is a 7-point scale where a score of 1 indicates that the patient is “Normal, not at all ill,” a score of 4 indicates that the patient has experienced “Moderately ill,” and a score of 7 indicates that the patient is “Among the most extremely ill patients.”|units on a scale|Mean|3.66|3.66|Standard Deviation|1.43|1.43|||
4234913|NCT00673452|4058505|B1|||Patient’s Global Impressions of Severity (PGI-S)|The PGI-Severity scale is a patient-rated instrument that measures perceived severity of symptoms. It is a 7-point scale where a score of 1 indicates that the patient is “Normal, not at all ill,” a score of 4 indicates that the patient has experienced “Moderately ill,” and a score of 7 indicates that the patient is “Among the most extremely ill patients.”|units on a scale|Mean|3.88|3.88|Standard Deviation|1.24|1.24|||
4234914|NCT00673452|4058503|B3|||Massachusetts General Hospital Cognitive and Physical Functioning Questionnaire (MGH-CPFQ) Total|"The MGH-CPFQ is a self-report instrument consisting of seven questions pertaining to an individual's cognitive and physical well-being. Each question is rated 1 = greater than normal to 6 = totally absent. Total score ranges from 7 to 42."|units on a scale|Mean|26.67|26.67|Standard Deviation|6.30|6.3|||
4234915|NCT00673452|4058504|B2|||Massachusetts General Hospital Cognitive and Physical Functioning Questionnaire (MGH-CPFQ) Total|"The MGH-CPFQ is a self-report instrument consisting of seven questions pertaining to an individual's cognitive and physical well-being. Each question is rated 1 = greater than normal to 6 = totally absent. Total score ranges from 7 to 42."|units on a scale|Mean|26.63|26.63|Standard Deviation|6.29|6.29|||
4234916|NCT00673452|4058505|B1|||Massachusetts General Hospital Cognitive and Physical Functioning Questionnaire (MGH-CPFQ) Total|"The MGH-CPFQ is a self-report instrument consisting of seven questions pertaining to an individual's cognitive and physical well-being. Each question is rated 1 = greater than normal to 6 = totally absent. Total score ranges from 7 to 42."|units on a scale|Mean|26.71|26.71|Standard Deviation|6.33|6.33|||
4234917|NCT00673452|4058503|B3|Stiffness||Likert Scale Rating of Mood, Anxiety, Sleep, Pain, and Stiffness|Patient-rated likert scale assessment of: Mood - feeling low, sad or depressed (0 = not feeling low, sad or depressed to 10 = feeling extremely low, sad, or depressed); Anxious - anxious feelings (0 = not feeling anxious to 10 = extremely anxious); Sleep - how much patient is bothered by sleep difficulties (0 = not bothered to 10 = extremely bothered); Pain - how much patient is bothered by painful physical discomforts (0 = not bothered to 10 = extremely bothered); Stiffness - how stiff patient has felt in past 24 hours (0 = has not felt any stiffness to 10 = has felt extremely stiff).|units on a scale|Mean|7.07|7.07|Standard Deviation|1.92|1.92|||
4234918|NCT00673452|4058504|B2|Stiffness||Likert Scale Rating of Mood, Anxiety, Sleep, Pain, and Stiffness|Patient-rated likert scale assessment of: Mood - feeling low, sad or depressed (0 = not feeling low, sad or depressed to 10 = feeling extremely low, sad, or depressed); Anxious - anxious feelings (0 = not feeling anxious to 10 = extremely anxious); Sleep - how much patient is bothered by sleep difficulties (0 = not bothered to 10 = extremely bothered); Pain - how much patient is bothered by painful physical discomforts (0 = not bothered to 10 = extremely bothered); Stiffness - how stiff patient has felt in past 24 hours (0 = has not felt any stiffness to 10 = has felt extremely stiff).|units on a scale|Mean|7.12|7.12|Standard Deviation|1.84|1.84|||
4234919|NCT00673452|4058505|B1|Stiffness||Likert Scale Rating of Mood, Anxiety, Sleep, Pain, and Stiffness|Patient-rated likert scale assessment of: Mood - feeling low, sad or depressed (0 = not feeling low, sad or depressed to 10 = feeling extremely low, sad, or depressed); Anxious - anxious feelings (0 = not feeling anxious to 10 = extremely anxious); Sleep - how much patient is bothered by sleep difficulties (0 = not bothered to 10 = extremely bothered); Pain - how much patient is bothered by painful physical discomforts (0 = not bothered to 10 = extremely bothered); Stiffness - how stiff patient has felt in past 24 hours (0 = has not felt any stiffness to 10 = has felt extremely stiff).|units on a scale|Mean|7.02|7.02|Standard Deviation|2.00|2.0|||
4234920|NCT00673452|4058503|B3|Sleep||Likert Scale Rating of Mood, Anxiety, Sleep, Pain, and Stiffness|Patient-rated likert scale assessment of: Mood - feeling low, sad or depressed (0 = not feeling low, sad or depressed to 10 = feeling extremely low, sad, or depressed); Anxious - anxious feelings (0 = not feeling anxious to 10 = extremely anxious); Sleep - how much patient is bothered by sleep difficulties (0 = not bothered to 10 = extremely bothered); Pain - how much patient is bothered by painful physical discomforts (0 = not bothered to 10 = extremely bothered); Stiffness - how stiff patient has felt in past 24 hours (0 = has not felt any stiffness to 10 = has felt extremely stiff).|units on a scale|Mean|6.78|6.78|Standard Deviation|2.62|2.62|||
4234921|NCT00673452|4058504|B2|Sleep||Likert Scale Rating of Mood, Anxiety, Sleep, Pain, and Stiffness|Patient-rated likert scale assessment of: Mood - feeling low, sad or depressed (0 = not feeling low, sad or depressed to 10 = feeling extremely low, sad, or depressed); Anxious - anxious feelings (0 = not feeling anxious to 10 = extremely anxious); Sleep - how much patient is bothered by sleep difficulties (0 = not bothered to 10 = extremely bothered); Pain - how much patient is bothered by painful physical discomforts (0 = not bothered to 10 = extremely bothered); Stiffness - how stiff patient has felt in past 24 hours (0 = has not felt any stiffness to 10 = has felt extremely stiff).|units on a scale|Mean|6.81|6.81|Standard Deviation|2.67|2.67|||
4234961|NCT00673452|4058505|B1|Yes||Generalized Anxiety Disorder (GAD) Status|GAD as defined by the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).|participants|Number|19|19.0||||||
4234962|NCT00673452|4058503|B3|No||Alcohol Consumption||participants|Number|351|351.0||||||
4234922|NCT00673452|4058505|B1|Sleep||Likert Scale Rating of Mood, Anxiety, Sleep, Pain, and Stiffness|Patient-rated likert scale assessment of: Mood - feeling low, sad or depressed (0 = not feeling low, sad or depressed to 10 = feeling extremely low, sad, or depressed); Anxious - anxious feelings (0 = not feeling anxious to 10 = extremely anxious); Sleep - how much patient is bothered by sleep difficulties (0 = not bothered to 10 = extremely bothered); Pain - how much patient is bothered by painful physical discomforts (0 = not bothered to 10 = extremely bothered); Stiffness - how stiff patient has felt in past 24 hours (0 = has not felt any stiffness to 10 = has felt extremely stiff).|units on a scale|Mean|6.74|6.74|Standard Deviation|2.56|2.56|||
4234923|NCT00673452|4058503|B3|Pain||Likert Scale Rating of Mood, Anxiety, Sleep, Pain, and Stiffness|Patient-rated likert scale assessment of: Mood - feeling low, sad or depressed (0 = not feeling low, sad or depressed to 10 = feeling extremely low, sad, or depressed); Anxious - anxious feelings (0 = not feeling anxious to 10 = extremely anxious); Sleep - how much patient is bothered by sleep difficulties (0 = not bothered to 10 = extremely bothered); Pain - how much patient is bothered by painful physical discomforts (0 = not bothered to 10 = extremely bothered); Stiffness - how stiff patient has felt in past 24 hours (0 = has not felt any stiffness to 10 = has felt extremely stiff).|units on a scale|Mean|7.35|7.35|Standard Deviation|1.85|1.85|||
4234924|NCT00673452|4058504|B2|Pain||Likert Scale Rating of Mood, Anxiety, Sleep, Pain, and Stiffness|Patient-rated likert scale assessment of: Mood - feeling low, sad or depressed (0 = not feeling low, sad or depressed to 10 = feeling extremely low, sad, or depressed); Anxious - anxious feelings (0 = not feeling anxious to 10 = extremely anxious); Sleep - how much patient is bothered by sleep difficulties (0 = not bothered to 10 = extremely bothered); Pain - how much patient is bothered by painful physical discomforts (0 = not bothered to 10 = extremely bothered); Stiffness - how stiff patient has felt in past 24 hours (0 = has not felt any stiffness to 10 = has felt extremely stiff).|units on a scale|Mean|7.45|7.45|Standard Deviation|1.83|1.83|||
4234925|NCT00673452|4058505|B1|Pain||Likert Scale Rating of Mood, Anxiety, Sleep, Pain, and Stiffness|Patient-rated likert scale assessment of: Mood - feeling low, sad or depressed (0 = not feeling low, sad or depressed to 10 = feeling extremely low, sad, or depressed); Anxious - anxious feelings (0 = not feeling anxious to 10 = extremely anxious); Sleep - how much patient is bothered by sleep difficulties (0 = not bothered to 10 = extremely bothered); Pain - how much patient is bothered by painful physical discomforts (0 = not bothered to 10 = extremely bothered); Stiffness - how stiff patient has felt in past 24 hours (0 = has not felt any stiffness to 10 = has felt extremely stiff).|units on a scale|Mean|7.25|7.25|Standard Deviation|1.87|1.87|||
4234926|NCT00673452|4058503|B3|Mood||Likert Scale Rating of Mood, Anxiety, Sleep, Pain, and Stiffness|Patient-rated likert scale assessment of: Mood - feeling low, sad or depressed (0 = not feeling low, sad or depressed to 10 = feeling extremely low, sad, or depressed); Anxious - anxious feelings (0 = not feeling anxious to 10 = extremely anxious); Sleep - how much patient is bothered by sleep difficulties (0 = not bothered to 10 = extremely bothered); Pain - how much patient is bothered by painful physical discomforts (0 = not bothered to 10 = extremely bothered); Stiffness - how stiff patient has felt in past 24 hours (0 = has not felt any stiffness to 10 = has felt extremely stiff).|units on a scale|Mean|3.91|3.91|Standard Deviation|2.77|2.77|||
4234927|NCT00673452|4058504|B2|Mood||Likert Scale Rating of Mood, Anxiety, Sleep, Pain, and Stiffness|Patient-rated likert scale assessment of: Mood - feeling low, sad or depressed (0 = not feeling low, sad or depressed to 10 = feeling extremely low, sad, or depressed); Anxious - anxious feelings (0 = not feeling anxious to 10 = extremely anxious); Sleep - how much patient is bothered by sleep difficulties (0 = not bothered to 10 = extremely bothered); Pain - how much patient is bothered by painful physical discomforts (0 = not bothered to 10 = extremely bothered); Stiffness - how stiff patient has felt in past 24 hours (0 = has not felt any stiffness to 10 = has felt extremely stiff).|units on a scale|Mean|4.04|4.04|Standard Deviation|2.77|2.77|||
4234928|NCT00673452|4058505|B1|Mood||Likert Scale Rating of Mood, Anxiety, Sleep, Pain, and Stiffness|Patient-rated likert scale assessment of: Mood - feeling low, sad or depressed (0 = not feeling low, sad or depressed to 10 = feeling extremely low, sad, or depressed); Anxious - anxious feelings (0 = not feeling anxious to 10 = extremely anxious); Sleep - how much patient is bothered by sleep difficulties (0 = not bothered to 10 = extremely bothered); Pain - how much patient is bothered by painful physical discomforts (0 = not bothered to 10 = extremely bothered); Stiffness - how stiff patient has felt in past 24 hours (0 = has not felt any stiffness to 10 = has felt extremely stiff).|units on a scale|Mean|3.78|3.78|Standard Deviation|2.76|2.76|||
4234929|NCT00673452|4058503|B3|Anxiety||Likert Scale Rating of Mood, Anxiety, Sleep, Pain, and Stiffness|Patient-rated likert scale assessment of: Mood - feeling low, sad or depressed (0 = not feeling low, sad or depressed to 10 = feeling extremely low, sad, or depressed); Anxious - anxious feelings (0 = not feeling anxious to 10 = extremely anxious); Sleep - how much patient is bothered by sleep difficulties (0 = not bothered to 10 = extremely bothered); Pain - how much patient is bothered by painful physical discomforts (0 = not bothered to 10 = extremely bothered); Stiffness - how stiff patient has felt in past 24 hours (0 = has not felt any stiffness to 10 = has felt extremely stiff).|units on a scale|Mean|3.88|3.88|Standard Deviation|2.86|2.86|||
4234930|NCT00673452|4058504|B2|Anxiety||Likert Scale Rating of Mood, Anxiety, Sleep, Pain, and Stiffness|Patient-rated likert scale assessment of: Mood - feeling low, sad or depressed (0 = not feeling low, sad or depressed to 10 = feeling extremely low, sad, or depressed); Anxious - anxious feelings (0 = not feeling anxious to 10 = extremely anxious); Sleep - how much patient is bothered by sleep difficulties (0 = not bothered to 10 = extremely bothered); Pain - how much patient is bothered by painful physical discomforts (0 = not bothered to 10 = extremely bothered); Stiffness - how stiff patient has felt in past 24 hours (0 = has not felt any stiffness to 10 = has felt extremely stiff).|units on a scale|Mean|4.08|4.08|Standard Deviation|2.90|2.9|||
4234931|NCT00673452|4058505|B1|Anxiety||Likert Scale Rating of Mood, Anxiety, Sleep, Pain, and Stiffness|Patient-rated likert scale assessment of: Mood - feeling low, sad or depressed (0 = not feeling low, sad or depressed to 10 = feeling extremely low, sad, or depressed); Anxious - anxious feelings (0 = not feeling anxious to 10 = extremely anxious); Sleep - how much patient is bothered by sleep difficulties (0 = not bothered to 10 = extremely bothered); Pain - how much patient is bothered by painful physical discomforts (0 = not bothered to 10 = extremely bothered); Stiffness - how stiff patient has felt in past 24 hours (0 = has not felt any stiffness to 10 = has felt extremely stiff).|units on a scale|Mean|3.68|3.68|Standard Deviation|2.81|2.81|||
4234932|NCT00673452|4058503|B3|||Height||centimeters (cm)|Mean|163.38|163.38|Standard Deviation|8.43|8.43|||
4234935|NCT00673452|4058503|B3|||Brief Pain Inventory (BPI) Average Pain Score|A self-reported scale that measures the severity of pain based on the average pain over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|6.45|6.45|Standard Deviation|1.58|1.58|||
4234936|NCT00673452|4058504|B2|||Brief Pain Inventory (BPI) Average Pain Score|A self-reported scale that measures the severity of pain based on the average pain over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|6.46|6.46|Standard Deviation|1.62|1.62|||
4234937|NCT00673452|4058505|B1|||Brief Pain Inventory (BPI) Average Pain Score|A self-reported scale that measures the severity of pain based on the average pain over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|6.45|6.45|Standard Deviation|1.54|1.54|||
4234938|NCT00673452|4058503|B3|||Beck Depression Inventory II (BDI-II) Total Score|Beck Depression Inventory-II (BDI-II) is a 21-item patient-completed questionnaire designed to assess characteristics of depression. Each item is rated on a 4-point scale (0 = not present; 3 = present in the extreme). This questionnaire will be used to rate the severity of depressive symptoms and any improvement during the course of the trial. The total score ranges from 0 to 63; the higher the score, the more severe the depressive symptoms.|units on a scale|Mean|16.18|16.18|Standard Deviation|10.38|10.38|||
4234939|NCT00673452|4058504|B2|||Beck Depression Inventory II (BDI-II) Total Score|Beck Depression Inventory-II (BDI-II) is a 21-item patient-completed questionnaire designed to assess characteristics of depression. Each item is rated on a 4-point scale (0 = not present; 3 = present in the extreme). This questionnaire will be used to rate the severity of depressive symptoms and any improvement during the course of the trial. The total score ranges from 0 to 63; the higher the score, the more severe the depressive symptoms.|units on a scale|Mean|16.20|16.2|Standard Deviation|10.35|10.35|||
4234940|NCT00673452|4058505|B1|||Beck Depression Inventory II (BDI-II) Total Score|Beck Depression Inventory-II (BDI-II) is a 21-item patient-completed questionnaire designed to assess characteristics of depression. Each item is rated on a 4-point scale (0 = not present; 3 = present in the extreme). This questionnaire will be used to rate the severity of depressive symptoms and any improvement during the course of the trial. The total score ranges from 0 to 63; the higher the score, the more severe the depressive symptoms.|units on a scale|Mean|16.16|16.16|Standard Deviation|10.43|10.43|||
4234941|NCT00673452|4058503|B3|||Beck Anxiety Inventory (BAI) Total Score|Beck Anxiety Inventory (BAI) is a 21-item patientcompleted questionnaire designed to assess characteristics of anxiety. Each item is rated on a 4-point scale (0 = not present; 3 = present in the extreme). This questionnaire will be used to rate the severity of anxiety symptoms and any improvement during the course of the trial. The total score ranges from 0 to 63; the higher the score, the more severe the anxiety symptoms.|units on a scale|Mean|13.00|13.0|Standard Deviation|9.52|9.52|||
4234942|NCT00673452|4058504|B2|||Beck Anxiety Inventory (BAI) Total Score|Beck Anxiety Inventory (BAI) is a 21-item patientcompleted questionnaire designed to assess characteristics of anxiety. Each item is rated on a 4-point scale (0 = not present; 3 = present in the extreme). This questionnaire will be used to rate the severity of anxiety symptoms and any improvement during the course of the trial. The total score ranges from 0 to 63; the higher the score, the more severe the anxiety symptoms.|units on a scale|Mean|13.18|13.18|Standard Deviation|9.77|9.77|||
4234943|NCT00673452|4058505|B1|||Beck Anxiety Inventory (BAI) Total Score|Beck Anxiety Inventory (BAI) is a 21-item patientcompleted questionnaire designed to assess characteristics of anxiety. Each item is rated on a 4-point scale (0 = not present; 3 = present in the extreme). This questionnaire will be used to rate the severity of anxiety symptoms and any improvement during the course of the trial. The total score ranges from 0 to 63; the higher the score, the more severe the anxiety symptoms.|units on a scale|Mean|12.83|12.83|Standard Deviation|9.28|9.28|||
4234944|NCT00673452|4058503|B3|No||Tobacco Use||participants|Number|431|431.0||||||
4234945|NCT00673452|4058504|B2|No||Tobacco Use||participants|Number|225|225.0||||||
4234946|NCT00673452|4058505|B1|No||Tobacco Use||participants|Number|206|206.0||||||
4234947|NCT00673452|4058503|B3|Yes||Tobacco Use||participants|Number|99|99.0||||||
4234948|NCT00673452|4058504|B2|Yes||Tobacco Use||participants|Number|42|42.0||||||
4234949|NCT00673452|4058505|B1|Yes||Tobacco Use||participants|Number|57|57.0||||||
4234950|NCT00673452|4058503|B3|No||Major Depressive Disorder (MDD) Status|MDD as defined by the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).|participants|Number|433|433.0||||||
4234951|NCT00673452|4058504|B2|No||Major Depressive Disorder (MDD) Status|MDD as defined by the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).|participants|Number|214|214.0||||||
4234952|NCT00673452|4058505|B1|No||Major Depressive Disorder (MDD) Status|MDD as defined by the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).|participants|Number|219|219.0||||||
4234953|NCT00673452|4058503|B3|Yes||Major Depressive Disorder (MDD) Status|MDD as defined by the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).|participants|Number|97|97.0||||||
4234954|NCT00673452|4058504|B2|Yes||Major Depressive Disorder (MDD) Status|MDD as defined by the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).|participants|Number|53|53.0||||||
4234955|NCT00673452|4058505|B1|Yes||Major Depressive Disorder (MDD) Status|MDD as defined by the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).|participants|Number|44|44.0||||||
4234956|NCT00673452|4058503|B3|No||Generalized Anxiety Disorder (GAD) Status|GAD as defined by the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).|participants|Number|487|487.0||||||
4234957|NCT00673452|4058504|B2|No||Generalized Anxiety Disorder (GAD) Status|GAD as defined by the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).|participants|Number|243|243.0||||||
4234958|NCT00673452|4058505|B1|No||Generalized Anxiety Disorder (GAD) Status|GAD as defined by the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).|participants|Number|244|244.0||||||
4234959|NCT00673452|4058503|B3|Yes||Generalized Anxiety Disorder (GAD) Status|GAD as defined by the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).|participants|Number|43|43.0||||||
4234960|NCT00673452|4058504|B2|Yes||Generalized Anxiety Disorder (GAD) Status|GAD as defined by the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).|participants|Number|24|24.0||||||
4234965|NCT00673452|4058503|B3|Yes||Alcohol Consumption||participants|Number|179|179.0||||||
4234966|NCT00673452|4058504|B2|Yes||Alcohol Consumption||participants|Number|90|90.0||||||
4234967|NCT00673452|4058505|B1|Yes||Alcohol Consumption||participants|Number|89|89.0||||||
4234968|NCT00673452|4058503|B3|United States||Region of Enrollment||participants|Number|530|530.0||||||
4234969|NCT00673452|4058504|B2|United States||Region of Enrollment||participants|Number|267|267.0||||||
4234970|NCT00673452|4058505|B1|United States||Region of Enrollment||participants|Number|263|263.0||||||
4234971|NCT00673452|4058503|B3|Other - Not Specified||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4234972|NCT00673452|4058504|B2|Other - Not Specified||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4234973|NCT00673452|4058505|B1|Other - Not Specified||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4234974|NCT00673452|4058503|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
4234975|NCT00673452|4058504|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4234976|NCT00673452|4058505|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4234977|NCT00673452|4058503|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|410|410.0||||||
4234978|NCT00673452|4058504|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|206|206.0||||||
4234979|NCT00673452|4058505|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|204|204.0||||||
4234980|NCT00673452|4058503|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4234981|NCT00673452|4058504|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4234982|NCT00673452|4058505|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4234983|NCT00673452|4058503|B3||Female|Sex: Female, Male||Participants|Count of Participants|494|494.0||||||
4234984|NCT00673452|4058504|B2||Female|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
4234985|NCT00673452|4058505|B1||Female|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
4234986|NCT00673452|4058503|B3|||Age||years|Mean|50.18|50.18|Standard Deviation|11.05|11.05|||
4234987|NCT00673452|4058504|B2|||Age||years|Mean|49.62|49.62|Standard Deviation|10.84|10.84|||
4234988|NCT00673452|4058505|B1|||Age||years|Mean|50.74|50.74|Standard Deviation|11.26|11.26|||
4234989|NCT00673439|4058540|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4234990|NCT00673439|4058540|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4234991|NCT00673439|4058540|B1|Over 18 years of age||Age, Customized||participants|Number|3|3.0||||||
4234992|NCT00673400|4058544|B1|Switzerland||Region of Enrollment||participants|Number|52|52.0||||||
4234993|NCT00673400|4058544|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4234994|NCT00673400|4058544|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4234995|NCT00673400|4058544|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|12.9|12.9|||
4234996|NCT00673400|4058544|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4234997|NCT00673400|4058544|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4234998|NCT00673400|4058544|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4234999|NCT00673387|4058561|B9|||Body Mass Index|Body Mass Index (BMI)calculated using baseline weight and height; BMI = kg body weight/meters of height^2. Weight, height measured on Day 1. If Day 1 value missing or value obtained after the first dose, the last available value prior to Day 1 was used.|(kg/m^2)|Mean|36.80|36.8|Standard Deviation|4.379|4.379|||
4235000|NCT00673387|4058562|B8|||Body Mass Index|Body Mass Index (BMI)calculated using baseline weight and height; BMI = kg body weight/meters of height^2. Weight, height measured on Day 1. If Day 1 value missing or value obtained after the first dose, the last available value prior to Day 1 was used.|(kg/m^2)|Mean|36.68|36.68|Standard Deviation|4.504|4.504|||
4235001|NCT00673387|4058563|B7|||Body Mass Index|Body Mass Index (BMI)calculated using baseline weight and height; BMI = kg body weight/meters of height^2. Weight, height measured on Day 1. If Day 1 value missing or value obtained after the first dose, the last available value prior to Day 1 was used.|(kg/m^2)|Mean|36.96|36.96|Standard Deviation|4.406|4.406|||
4235002|NCT00673387|4058564|B6|||Body Mass Index|Body Mass Index (BMI)calculated using baseline weight and height; BMI = kg body weight/meters of height^2. Weight, height measured on Day 1. If Day 1 value missing or value obtained after the first dose, the last available value prior to Day 1 was used.|(kg/m^2)|Mean|36.80|36.8|Standard Deviation|4.260|4.26|||
4235003|NCT00673387|4058565|B5|||Body Mass Index|Body Mass Index (BMI)calculated using baseline weight and height; BMI = kg body weight/meters of height^2. Weight, height measured on Day 1. If Day 1 value missing or value obtained after the first dose, the last available value prior to Day 1 was used.|(kg/m^2)|Mean|36.65|36.65|Standard Deviation|4.379|4.379|||
4235004|NCT00673387|4058566|B4|||Body Mass Index|Body Mass Index (BMI)calculated using baseline weight and height; BMI = kg body weight/meters of height^2. Weight, height measured on Day 1. If Day 1 value missing or value obtained after the first dose, the last available value prior to Day 1 was used.|(kg/m^2)|Mean|36.88|36.88|Standard Deviation|4.336|4.336|||
4235005|NCT00673387|4058567|B3|||Body Mass Index|Body Mass Index (BMI)calculated using baseline weight and height; BMI = kg body weight/meters of height^2. Weight, height measured on Day 1. If Day 1 value missing or value obtained after the first dose, the last available value prior to Day 1 was used.|(kg/m^2)|Mean|36.62|36.62|Standard Deviation|4.478|4.478|||
4235006|NCT00673387|4058568|B2|||Body Mass Index|Body Mass Index (BMI)calculated using baseline weight and height; BMI = kg body weight/meters of height^2. Weight, height measured on Day 1. If Day 1 value missing or value obtained after the first dose, the last available value prior to Day 1 was used.|(kg/m^2)|Mean|36.93|36.93|Standard Deviation|4.389|4.389|||
4235007|NCT00673387|4058569|B1|||Body Mass Index|Body Mass Index (BMI)calculated using baseline weight and height; BMI = kg body weight/meters of height^2. Weight, height measured on Day 1. If Day 1 value missing or value obtained after the first dose, the last available value prior to Day 1 was used.|(kg/m^2)|Mean|36.88|36.88|Standard Deviation|4.473|4.473|||
4235008|NCT00673387|4058561|B9|United States||Region of Enrollment||participants|Number|608|608.0||||||
4235009|NCT00673387|4058562|B8|United States||Region of Enrollment||participants|Number|75|75.0||||||
4235010|NCT00673387|4058563|B7|United States||Region of Enrollment||participants|Number|78|78.0||||||
4235011|NCT00673387|4058564|B6|United States||Region of Enrollment||participants|Number|78|78.0||||||
4235012|NCT00673387|4058565|B5|United States||Region of Enrollment||participants|Number|78|78.0||||||
4235013|NCT00673387|4058566|B4|United States||Region of Enrollment||participants|Number|75|75.0||||||
4235014|NCT00673387|4058567|B3|United States||Region of Enrollment||participants|Number|72|72.0||||||
4235015|NCT00673387|4058568|B2|United States||Region of Enrollment||participants|Number|77|77.0||||||
4235016|NCT00673387|4058569|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
4235017|NCT00673387|4058561|B9||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4235018|NCT00673387|4058562|B8||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4235019|NCT00673387|4058563|B7||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4235020|NCT00673387|4058564|B6||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4235021|NCT00673387|4058565|B5||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4235022|NCT00673387|4058566|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4235023|NCT00673387|4058567|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4235024|NCT00673387|4058568|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4235025|NCT00673387|4058569|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4235026|NCT00673387|4058561|B9||Female|Sex: Female, Male||Participants|Count of Participants|428|428.0||||||
4235027|NCT00673387|4058562|B8||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4235028|NCT00673387|4058563|B7||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4235029|NCT00673387|4058564|B6||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4235030|NCT00673387|4058565|B5||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4235031|NCT00673387|4058566|B4||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4235032|NCT00673387|4058567|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4235033|NCT00673387|4058568|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4235034|NCT00673387|4058569|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4235035|NCT00673387|4058561|B9|||Age||years|Mean|44.6|44.6|Standard Deviation|10.98|10.98|||
4235036|NCT00673387|4058562|B8|||Age||years|Mean|44.7|44.7|Standard Deviation|11.32|11.32|||
4235037|NCT00673387|4058563|B7|||Age||years|Mean|45.2|45.2|Standard Deviation|10.07|10.07|||
4235038|NCT00673387|4058564|B6|||Age||years|Mean|44.4|44.4|Standard Deviation|10.87|10.87|||
4235039|NCT00673387|4058565|B5|||Age||years|Mean|46.8|46.8|Standard Deviation|10.54|10.54|||
4235040|NCT00673387|4058566|B4|||Age||years|Mean|45.8|45.8|Standard Deviation|10.80|10.8|||
4235041|NCT00673387|4058567|B3|||Age||years|Mean|45.9|45.9|Standard Deviation|10.92|10.92|||
4235042|NCT00673387|4058568|B2|||Age||years|Mean|42.0|42.0|Standard Deviation|11.42|11.42|||
4235043|NCT00673387|4058569|B1|||Age||years|Mean|41.9|41.9|Standard Deviation|11.35|11.35|||
4235044|NCT00673361|4058792|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4235045|NCT00673361|4058792|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4235046|NCT00673361|4058792|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4235047|NCT00673361|4058792|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4235048|NCT00673361|4058792|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4235049|NCT00673361|4058792|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4235050|NCT00673361|4058792|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4235051|NCT00673361|4058792|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4235052|NCT00673361|4058792|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4235053|NCT00673361|4058792|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4235054|NCT00673361|4058792|B1|||Age, Customized|Subjects age 18+|participants|Number|9|9.0||||||
4235055|NCT00673257|4058796|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4235056|NCT00673257|4058796|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4235057|NCT00673257|4058796|B1||White|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
4235058|NCT00673257|4058796|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4235059|NCT00673257|4058796|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4235060|NCT00673257|4058796|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4235061|NCT00673257|4058796|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4235062|NCT00673257|4058796|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4235063|NCT00673257|4058796|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
4235064|NCT00673257|4058796|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4235065|NCT00673257|4058796|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4235066|NCT00673257|4058796|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4235067|NCT00673257|4058796|B1|||Age||years|Mean|11.5|11.5|Standard Deviation|5.1|5.1|||
4235068|NCT00673257|4058796|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4235069|NCT00673257|4058796|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4235070|NCT00673257|4058796|B1||<=18 years|Age||Participants|Count of Participants|99|99.0||||||
4235071|NCT00673231|4058801|B5|||Fasting plasma glucose||mg/dl|Mean|177.58|177.58|Standard Deviation|57.950|57.95|||
4235072|NCT00673231|4058802|B4|||Fasting plasma glucose||mg/dl|Mean|173.09|173.09|Standard Deviation|54.916|54.916|||
4235073|NCT00673231|4058803|B3|||Fasting plasma glucose||mg/dl|Mean|185.38|185.38|Standard Deviation|58.712|58.712|||
4235074|NCT00673231|4058804|B2|||Fasting plasma glucose||mg/dl|Mean|180.11|180.11|Standard Deviation|59.9|59.9|||
4235075|NCT00673231|4058805|B1|||Fasting plasma glucose||mg/dl|Mean|170.62|170.62|Standard Deviation|57.165|57.165|||
4235076|NCT00673231|4058801|B5|||HbA1C||Percent|Mean|8.53|8.53|Standard Deviation|0.819|0.819|||
4235077|NCT00673231|4058802|B4|||HbA1C||Percent|Mean|8.57|8.57|Standard Deviation|0.820|0.82|||
4235078|NCT00673231|4058803|B3|||HbA1C||Percent|Mean|8.62|8.62|Standard Deviation|0.892|0.892|||
4235079|NCT00673231|4058804|B2|||HbA1C||Percent|Mean|8.46|8.46|Standard Deviation|0.780|0.78|||
4235080|NCT00673231|4058805|B1|||HbA1C||Percent|Mean|8.47|8.47|Standard Deviation|0.768|0.768|||
4235081|NCT00673231|4058801|B5|||Body Mass Index||kg/m2|Mean|33.11|33.11|Standard Deviation|5.303|5.303|||
4235082|NCT00673231|4058802|B4|||Body Mass Index||kg/m2|Mean|33.41|33.41|Standard Deviation|5.061|5.061|||
4235083|NCT00673231|4058803|B3|||Body Mass Index||kg/m2|Mean|32.97|32.97|Standard Deviation|5.261|5.261|||
4235084|NCT00673231|4058804|B2|||Body Mass Index||kg/m2|Mean|32.95|32.95|Standard Deviation|5.032|5.032|||
4235085|NCT00673231|4058805|B1|||Body Mass Index||kg/m2|Mean|33.14|33.14|Standard Deviation|5.862|5.862|||
4235086|NCT00673231|4058801|B5|Other||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4235087|NCT00673231|4058802|B4|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4235088|NCT00673231|4058803|B3|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4235089|NCT00673231|4058804|B2|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4235090|NCT00673231|4058805|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4235091|NCT00673231|4058801|B5|Asian||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4235092|NCT00673231|4058802|B4|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4235093|NCT00673231|4058803|B3|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4235094|NCT00673231|4058804|B2|Asian||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4235095|NCT00673231|4058805|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4235096|NCT00673231|4058801|B5|Black/African American||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4235097|NCT00673231|4058802|B4|Black/African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4235098|NCT00673231|4058803|B3|Black/African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4235099|NCT00673231|4058804|B2|Black/African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4235100|NCT00673231|4058805|B1|Black/African American||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4235101|NCT00673231|4058801|B5|White||Race/Ethnicity, Customized||Participants|Number|760|760.0||||||
4235102|NCT00673231|4058802|B4|White||Race/Ethnicity, Customized||Participants|Number|184|184.0||||||
4235103|NCT00673231|4058803|B3|White||Race/Ethnicity, Customized||Participants|Number|200|200.0||||||
4235104|NCT00673231|4058804|B2|White||Race/Ethnicity, Customized||Participants|Number|190|190.0||||||
4235105|NCT00673231|4058805|B1|White||Race/Ethnicity, Customized||Participants|Number|186|186.0||||||
4235106|NCT00673231|4058801|B5||Male|Sex: Female, Male||Participants|Count of Participants|382|382.0||||||
4235107|NCT00673231|4058802|B4||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4235108|NCT00673231|4058803|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4235109|NCT00673231|4058804|B2||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4235110|NCT00673231|4058805|B1||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4235111|NCT00673231|4058801|B5||Female|Sex: Female, Male||Participants|Count of Participants|418|418.0||||||
4235112|NCT00673231|4058802|B4||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4235113|NCT00673231|4058803|B3||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4235114|NCT00673231|4058804|B2||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4235115|NCT00673231|4058805|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4235116|NCT00673231|4058801|B5|||Age||Years|Mean|59.3|59.3|Standard Deviation|8.22|8.22|||
4235117|NCT00673231|4058802|B4|||Age||Years|Mean|59.3|59.3|Standard Deviation|8.75|8.75|||
4235118|NCT00673231|4058803|B3|||Age||Years|Mean|59.3|59.3|Standard Deviation|7.91|7.91|||
4235119|NCT00673231|4058804|B2|||Age||Years|Mean|59.8|59.8|Standard Deviation|7.64|7.64|||
4235120|NCT00673231|4058805|B1|||Age||Years|Mean|58.8|58.8|Standard Deviation|8.61|8.61|||
4235121|NCT00673179|4058838|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4235122|NCT00673179|4058840|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4235123|NCT00673179|4058838|B3|Male||Gender||participants|Number|4|4.0||||||
4235124|NCT00673179|4058840|B1|Male||Gender||participants|Number|4|4.0||||||
4235125|NCT00673179|4058838|B3|Female||Gender||participants|Number|3|3.0||||||
4235126|NCT00673179|4058840|B1|Female||Gender||participants|Number|3|3.0||||||
4235127|NCT00673179|4058838|B3|||Age||years|Median|14|14.0|Full Range|||11.0|18.0|
4235128|NCT00673179|4058840|B1|||Age||years|Median|14|14.0|Full Range|||11.0|18.0|
4235183|NCT00672984|4058914|B4|United States||Region of Enrollment||participants|Number|83|83.0||||||
4235129|NCT00673153|4058847|B1||Good-risk Group|Risk Group|"Poor-risk Group: patients aged ≥70 years and performance status 2-3; Good-risk Group: aged 60-69 years with performance status 0-3, or aged ≥70 years and performance status 0-1~Performance status based on Eastern Cooperative Oncology Group's scale, abbreviated below:~0 Fully active~Restricted in strenuous activity but capable of a light or sedentary work activities,~Ambulatory and capable of all selfcare but unable to carry out any work activities;~Capable of only limited selfcare;~Completely disabled; cannot carry on any selfcare; confined to bed or chair~Dead"|Participants|Count of Participants|21|21.0||||||
4235130|NCT00673153|4058847|B1||Poor-risk Group|Risk Group|"Poor-risk Group: patients aged ≥70 years and performance status 2-3; Good-risk Group: aged 60-69 years with performance status 0-3, or aged ≥70 years and performance status 0-1~Performance status based on Eastern Cooperative Oncology Group's scale, abbreviated below:~0 Fully active~Restricted in strenuous activity but capable of a light or sedentary work activities,~Ambulatory and capable of all selfcare but unable to carry out any work activities;~Capable of only limited selfcare;~Completely disabled; cannot carry on any selfcare; confined to bed or chair~Dead"|Participants|Count of Participants|10|10.0||||||
4235131|NCT00673153|4058847|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4235132|NCT00673153|4058847|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4235133|NCT00673153|4058847|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4235134|NCT00673153|4058847|B1|||Age||years|Mean|72|72.0|Full Range|||61.0|80.0|
4235135|NCT00673127|4058855|B1|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4235136|NCT00673127|4058855|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
4235137|NCT00673127|4058855|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4235138|NCT00673127|4058855|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4235139|NCT00673127|4058855|B1|||Age||years|Mean|62|62.0|Standard Deviation|7|7.0|||
4235140|NCT00673127|4058855|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4235141|NCT00673127|4058855|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4235142|NCT00673127|4058855|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235143|NCT00673114|4058860|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4235144|NCT00673114|4058860|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4235145|NCT00673114|4058860|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4235146|NCT00673114|4058860|B1|||Age||years|Mean|16.3|16.3|Standard Deviation|3.0|3.0|||
4235147|NCT00673114|4058860|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4235148|NCT00673114|4058860|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4235149|NCT00673114|4058860|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4235150|NCT00673075|4058871|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
4235151|NCT00673075|4058872|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4235152|NCT00673075|4058873|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4235153|NCT00673075|4058871|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4235154|NCT00673075|4058872|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4235155|NCT00673075|4058873|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4235156|NCT00673075|4058871|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4235157|NCT00673075|4058872|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4235158|NCT00673075|4058873|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4235159|NCT00673075|4058871|B3|||Age||years|Mean|63.4|63.4|Standard Deviation|10.7|10.7|||
4235160|NCT00673075|4058872|B2|||Age||years|Mean|66.6|66.6|Standard Deviation|10.3|10.3|||
4235161|NCT00673075|4058873|B1|||Age||years|Mean|60.6|60.6|Standard Deviation|10.5|10.5|||
4235162|NCT00673075|4058871|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4235163|NCT00673075|4058872|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4235164|NCT00673075|4058873|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4235165|NCT00673075|4058871|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4235166|NCT00673075|4058872|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4235167|NCT00673075|4058873|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4235168|NCT00673075|4058871|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235169|NCT00673075|4058872|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235170|NCT00673075|4058873|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235171|NCT00673049|4058888|B3||Male|Sex: Female, Male||Participants|Count of Participants|453|453.0||||||
4235172|NCT00673049|4058889|B2||Male|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
4235173|NCT00673049|4058890|B1||Male|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
4235174|NCT00673049|4058888|B3||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4235175|NCT00673049|4058889|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4235176|NCT00673049|4058890|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4235177|NCT00673049|4058888|B3|>=70 years||Age, Customized||participants|Number|135|135.0||||||
4235178|NCT00673049|4058889|B2|>=70 years||Age, Customized||participants|Number|68|68.0||||||
4235179|NCT00673049|4058890|B1|>=70 years||Age, Customized||participants|Number|67|67.0||||||
4235180|NCT00673049|4058888|B3|<70 years||Age, Customized||participants|Number|448|448.0||||||
4235181|NCT00673049|4058889|B2|<70 years||Age, Customized||participants|Number|222|222.0||||||
4235182|NCT00673049|4058890|B1|<70 years||Age, Customized||participants|Number|226|226.0||||||
4235184|NCT00672984|4058915|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
4235185|NCT00672984|4058916|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4235186|NCT00672984|4058917|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4235187|NCT00672984|4058914|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4235188|NCT00672984|4058915|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4235189|NCT00672984|4058916|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4235190|NCT00672984|4058917|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4235191|NCT00672984|4058914|B4||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4235192|NCT00672984|4058915|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4235193|NCT00672984|4058916|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4235194|NCT00672984|4058917|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4235195|NCT00672984|4058914|B4|||Age||years|Mean|29.4|29.4|Standard Deviation|8.61|8.61|||
4235196|NCT00672984|4058915|B3|||Age||years|Mean|30.2|30.2|Standard Deviation|8.71|8.71|||
4235197|NCT00672984|4058916|B2|||Age||years|Mean|30.8|30.8|Standard Deviation|10.02|10.02|||
4235198|NCT00672984|4058917|B1|||Age||years|Mean|27.7|27.7|Standard Deviation|7.55|7.55|||
4235199|NCT00672984|4058914|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4235200|NCT00672984|4058915|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4235201|NCT00672984|4058916|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4235202|NCT00672984|4058917|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4235203|NCT00672984|4058914|B4||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
4235204|NCT00672984|4058915|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4235205|NCT00672984|4058916|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4235206|NCT00672984|4058917|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4235207|NCT00672984|4058914|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235208|NCT00672984|4058915|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235209|NCT00672984|4058916|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235210|NCT00672984|4058917|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235211|NCT00672958|4058968|B3|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|scores on a scale|Mean|4.8|4.8|Standard Deviation|0.67|0.67|||
4235212|NCT00672958|4058969|B2|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|scores on a scale|Mean|4.8|4.8|Standard Deviation|0.68|0.68|||
4235213|NCT00672958|4058970|B1|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|scores on a scale|Mean|4.8|4.8|Standard Deviation|0.66|0.66|||
4235214|NCT00672958|4058968|B3|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 to 56, where <17 indicates mild severity, 18–24 mild to moderate severity and 25–30 moderate to severe. Total scores above 30 are rare, but indicate very severe anxiety.|scores on a scale|Mean|19.4|19.4|Standard Deviation|5.73|5.73|||
4235215|NCT00672958|4058969|B2|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 to 56, where <17 indicates mild severity, 18–24 mild to moderate severity and 25–30 moderate to severe. Total scores above 30 are rare, but indicate very severe anxiety.|scores on a scale|Mean|19.3|19.3|Standard Deviation|5.24|5.24|||
4235216|NCT00672958|4058970|B1|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 to 56, where <17 indicates mild severity, 18–24 mild to moderate severity and 25–30 moderate to severe. Total scores above 30 are rare, but indicate very severe anxiety.|scores on a scale|Mean|19.5|19.5|Standard Deviation|6.19|6.19|||
4235217|NCT00672958|4058968|B3|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|34.1|34.1|Standard Deviation|3.40|3.4|||
4235218|NCT00672958|4058969|B2|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|34.1|34.1|Standard Deviation|3.39|3.39|||
4235219|NCT00672958|4058970|B1|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|34.0|34.0|Standard Deviation|3.41|3.41|||
4235220|NCT00672958|4058968|B3|||24-item Hamilton Depression Scale total score|The 24-item Hamilton Depression Scale (HAM-D24) is a clinician-rated 24-item scale for assessing the severity of depression symptoms. The scores for each item range from 0 to 4 or 0 to 2, where 0 represents no symptoms. The rating is based on the past 7 days prior to the time of assessment. The total score ranges from 0 to 74, where a higher score indicates a greater depressive state.|scores on a scale|Mean|32.5|32.5|Standard Deviation|5.46|5.46|||
4235221|NCT00672958|4058969|B2|||24-item Hamilton Depression Scale total score|The 24-item Hamilton Depression Scale (HAM-D24) is a clinician-rated 24-item scale for assessing the severity of depression symptoms. The scores for each item range from 0 to 4 or 0 to 2, where 0 represents no symptoms. The rating is based on the past 7 days prior to the time of assessment. The total score ranges from 0 to 74, where a higher score indicates a greater depressive state.|scores on a scale|Mean|32.7|32.7|Standard Deviation|5.42|5.42|||
4235222|NCT00672958|4058970|B1|||24-item Hamilton Depression Scale total score|The 24-item Hamilton Depression Scale (HAM-D24) is a clinician-rated 24-item scale for assessing the severity of depression symptoms. The scores for each item range from 0 to 4 or 0 to 2, where 0 represents no symptoms. The rating is based on the past 7 days prior to the time of assessment. The total score ranges from 0 to 74, where a higher score indicates a greater depressive state.|scores on a scale|Mean|32.2|32.2|Standard Deviation|5.50|5.5|||
4235223|NCT00672958|4058968|B3|Daily||Alcohol consumption||participants|Number|19|19.0||||||
4235224|NCT00672958|4058969|B2|Daily||Alcohol consumption||participants|Number|8|8.0||||||
4235225|NCT00672958|4058970|B1|Daily||Alcohol consumption||participants|Number|11|11.0||||||
4235226|NCT00672958|4058968|B3|2-to-6 times/week||Alcohol consumption||participants|Number|54|54.0||||||
4235227|NCT00672958|4058969|B2|2-to-6 times/week||Alcohol consumption||participants|Number|21|21.0||||||
4235228|NCT00672958|4058970|B1|2-to-6 times/week||Alcohol consumption||participants|Number|33|33.0||||||
4235229|NCT00672958|4058968|B3|Once per week||Alcohol consumption||participants|Number|87|87.0||||||
4235230|NCT00672958|4058969|B2|Once per week||Alcohol consumption||participants|Number|41|41.0||||||
4235231|NCT00672958|4058970|B1|Once per week||Alcohol consumption||participants|Number|46|46.0||||||
4235232|NCT00672958|4058968|B3|Once monthly or less often||Alcohol consumption||participants|Number|226|226.0||||||
4235233|NCT00672958|4058969|B2|Once monthly or less often||Alcohol consumption||participants|Number|124|124.0||||||
4235234|NCT00672958|4058970|B1|Once monthly or less often||Alcohol consumption||participants|Number|102|102.0||||||
4235235|NCT00672958|4058968|B3|Never||Alcohol consumption||participants|Number|214|214.0||||||
4235236|NCT00672958|4058969|B2|Never||Alcohol consumption||participants|Number|106|106.0||||||
4235237|NCT00672958|4058970|B1|Never||Alcohol consumption||participants|Number|108|108.0||||||
4235238|NCT00672958|4058968|B3|Ex-smoker||Smoking classification||participants|Number|118|118.0||||||
4235239|NCT00672958|4058969|B2|Ex-smoker||Smoking classification||participants|Number|61|61.0||||||
4235240|NCT00672958|4058970|B1|Ex-smoker||Smoking classification||participants|Number|57|57.0||||||
4235241|NCT00672958|4058968|B3|Current smoker||Smoking classification||participants|Number|240|240.0||||||
4235242|NCT00672958|4058969|B2|Current smoker||Smoking classification||participants|Number|116|116.0||||||
4235243|NCT00672958|4058970|B1|Current smoker||Smoking classification||participants|Number|124|124.0||||||
4235244|NCT00672958|4058968|B3|Never smoked||Smoking classification||participants|Number|242|242.0||||||
4235245|NCT00672958|4058969|B2|Never smoked||Smoking classification||participants|Number|123|123.0||||||
4235246|NCT00672958|4058970|B1|Never smoked||Smoking classification||participants|Number|119|119.0||||||
4235247|NCT00672958|4058968|B3|||Waist circumference||cm|Mean|96.90|96.9|Standard Deviation|18.366|18.366|||
4235248|NCT00672958|4058969|B2|||Waist circumference||cm|Mean|96.22|96.22|Standard Deviation|18.961|18.961|||
4235249|NCT00672958|4058970|B1|||Waist circumference||cm|Mean|97.58|97.58|Standard Deviation|17.757|17.757|||
4235250|NCT00672958|4058968|B3|||Body Mass Index (BMI)||kg/m^2|Mean|30.66|30.66|Standard Deviation|7.946|7.946|||
4235251|NCT00672958|4058969|B2|||Body Mass Index (BMI)||kg/m^2|Mean|30.48|30.48|Standard Deviation|8.217|8.217|||
4235252|NCT00672958|4058970|B1|||Body Mass Index (BMI)||kg/m^2|Mean|30.84|30.84|Standard Deviation|7.675|7.675|||
4235253|NCT00672958|4058968|B3|||Height||cm|Mean|169.51|169.51|Standard Deviation|9.843|9.843|||
4235254|NCT00672958|4058969|B2|||Height||cm|Mean|168.67|168.67|Standard Deviation|9.815|9.815|||
4235255|NCT00672958|4058970|B1|||Height||cm|Mean|170.36|170.36|Standard Deviation|9.815|9.815|||
4235256|NCT00672958|4058968|B3|||Weight||kg|Mean|88.08|88.08|Standard Deviation|23.453|23.453|||
4235257|NCT00672958|4058969|B2|||Weight||kg|Mean|86.63|86.63|Standard Deviation|23.528|23.528|||
4235258|NCT00672958|4058970|B1|||Weight||kg|Mean|89.53|89.53|Standard Deviation|23.326|23.326|||
4235259|NCT00672958|4058968|B3|United States||Region of Enrollment||participants|Number|600|600.0||||||
4235260|NCT00672958|4058969|B2|United States||Region of Enrollment||participants|Number|300|300.0||||||
4235261|NCT00672958|4058970|B1|United States||Region of Enrollment||participants|Number|300|300.0||||||
4235262|NCT00672958|4058968|B3|Non-Hispanic/Non-Latino||Race/Ethnicity, Customized||participants|Number|530|530.0||||||
4235263|NCT00672958|4058969|B2|Non-Hispanic/Non-Latino||Race/Ethnicity, Customized||participants|Number|266|266.0||||||
4235264|NCT00672958|4058970|B1|Non-Hispanic/Non-Latino||Race/Ethnicity, Customized||participants|Number|264|264.0||||||
4235265|NCT00672958|4058968|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
4235266|NCT00672958|4058969|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4235267|NCT00672958|4058970|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4235268|NCT00672958|4058968|B3|Native Hawaiian/ Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4235269|NCT00672958|4058969|B2|Native Hawaiian/ Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4235270|NCT00672958|4058970|B1|Native Hawaiian/ Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4235271|NCT00672958|4058968|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4235272|NCT00672958|4058969|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4235273|NCT00672958|4058970|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4235274|NCT00672958|4058968|B3|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4235275|NCT00672958|4058969|B2|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4235276|NCT00672958|4058970|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4235277|NCT00672958|4058968|B3|Black||Race/Ethnicity, Customized||participants|Number|159|159.0||||||
4235278|NCT00672958|4058969|B2|Black||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
4235279|NCT00672958|4058970|B1|Black||Race/Ethnicity, Customized||participants|Number|78|78.0||||||
4235280|NCT00672958|4058968|B3|Caucasian (White, including Hispanic)||Race/Ethnicity, Customized||participants|Number|425|425.0||||||
4235281|NCT00672958|4058969|B2|Caucasian (White, including Hispanic)||Race/Ethnicity, Customized||participants|Number|209|209.0||||||
4235282|NCT00672958|4058970|B1|Caucasian (White, including Hispanic)||Race/Ethnicity, Customized||participants|Number|216|216.0||||||
4235283|NCT00672958|4058968|B3||Male|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
4235284|NCT00672958|4058969|B2||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4235285|NCT00672958|4058970|B1||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4235286|NCT00672958|4058968|B3||Female|Sex: Female, Male||Participants|Count of Participants|350|350.0||||||
4235287|NCT00672958|4058969|B2||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4235288|NCT00672958|4058970|B1||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4235289|NCT00672958|4058968|B3|||Age||years|Mean|42.4|42.4|Standard Deviation|12.86|12.86|||
4235290|NCT00672958|4058969|B2|||Age||years|Mean|42.5|42.5|Standard Deviation|13.04|13.04|||
4235291|NCT00672958|4058970|B1|||Age||years|Mean|42.4|42.4|Standard Deviation|12.70|12.7|||
4235292|NCT00672932|4059001|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4235293|NCT00672932|4059002|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4235294|NCT00672932|4059003|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4235295|NCT00672932|4059001|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4235296|NCT00672932|4059002|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4235297|NCT00672932|4059003|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4235298|NCT00672932|4059001|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4235299|NCT00672932|4059002|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4235300|NCT00672932|4059003|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4235301|NCT00672932|4059001|B3|||Age||years|Mean|53.9|53.9|Standard Deviation|6.1|6.1|||
4235302|NCT00672932|4059002|B2|||Age||years|Mean|54.3|54.3|Standard Deviation|5.3|5.3|||
4235303|NCT00672932|4059003|B1|||Age||years|Mean|52.7|52.7|Standard Deviation|6.4|6.4|||
4235304|NCT00672932|4059001|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4235305|NCT00672932|4059002|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4235306|NCT00672932|4059003|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4235307|NCT00672932|4059001|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4235308|NCT00672932|4059002|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4235309|NCT00672932|4059003|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4235310|NCT00672932|4059001|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235311|NCT00672932|4059002|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235312|NCT00672932|4059003|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235313|NCT00672854|4059012|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4235314|NCT00672854|4059013|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4235315|NCT00672854|4059014|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4235316|NCT00672854|4059012|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4235317|NCT00672854|4059013|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4235318|NCT00672854|4059014|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4235319|NCT00672854|4059012|B3||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4235320|NCT00672854|4059013|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4235321|NCT00672854|4059014|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4235322|NCT00672854|4059012|B3||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4235323|NCT00672854|4059013|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4235324|NCT00672854|4059014|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4235325|NCT00672854|4059012|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235326|NCT00672854|4059013|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235327|NCT00672854|4059014|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235328|NCT00672854|4059012|B3|||Age||years|Mean|48.9|48.9|Standard Deviation|17|17.0|||
4235329|NCT00672854|4059013|B2|||Age||years|Mean|46.4|46.4|Standard Deviation|19|19.0|||
4235330|NCT00672854|4059014|B1|||Age||years|Mean|51.3|51.3|Standard Deviation|15|15.0|||
4235331|NCT00672841|4059035|B3|United States||Region of Enrollment||participants|Number|64|64.0||||||
4235332|NCT00672841|4059036|B2|United States||Region of Enrollment||participants|Number|47|47.0||||||
4235333|NCT00672841|4059037|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4235334|NCT00672841|4059035|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4235335|NCT00672841|4059036|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4235336|NCT00672841|4059037|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4235337|NCT00672841|4059035|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4235338|NCT00672841|4059036|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4235339|NCT00672841|4059037|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4235340|NCT00672841|4059035|B3|||Age||years|Mean|53|53.0|Standard Deviation|19|19.0|||
4235341|NCT00672841|4059036|B2|||Age||years|Mean|53|53.0|Standard Deviation|20|20.0|||
4235342|NCT00672841|4059037|B1|||Age||years|Mean|53|53.0|Standard Deviation|19|19.0|||
4235343|NCT00672841|4059035|B3||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4235344|NCT00672841|4059036|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4235345|NCT00672841|4059037|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4235346|NCT00672841|4059035|B3||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4235347|NCT00672841|4059036|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4235348|NCT00672841|4059037|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4235349|NCT00672841|4059035|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235350|NCT00672841|4059036|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235351|NCT00672841|4059037|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235352|NCT00672737|4059050|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
4235353|NCT00672737|4059050|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4235354|NCT00672737|4059050|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4235355|NCT00672737|4059050|B1|||Age||years|Mean|36|36.0|Standard Deviation|11|11.0|||
4235356|NCT00672737|4059050|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4235357|NCT00672737|4059050|B1||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4235358|NCT00672737|4059050|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235359|NCT00672646|4059057|B4||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4235360|NCT00672646|4059058|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4235361|NCT00672646|4059059|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4235362|NCT00672646|4059060|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4235363|NCT00672646|4059057|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4235364|NCT00672646|4059058|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4235365|NCT00672646|4059059|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4235366|NCT00672646|4059060|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4235367|NCT00672646|4059057|B4|||Age||year|Mean|21.5|21.5|Standard Deviation|4.6|4.6|||
4235368|NCT00672646|4059058|B3|||Age||year|Mean|21.9|21.9|Standard Deviation|4.8|4.8|||
4235369|NCT00672646|4059059|B2|||Age||year|Mean|21|21.0|Standard Deviation|4.8|4.8|||
4235370|NCT00672646|4059060|B1|||Age||year|Mean|21.5|21.5|Standard Deviation|4.4|4.4|||
4235371|NCT00672633|4059085|B3|||Triglycerides|Fasting Triglycerides|mg/dl|Mean|227|227.0|Standard Deviation|49|49.0|||
4235372|NCT00672633|4059086|B2|||Triglycerides|Fasting Triglycerides|mg/dl|Mean|225|225.0|Standard Deviation|55|55.0|||
4235373|NCT00672633|4059087|B1|||Triglycerides|Fasting Triglycerides|mg/dl|Mean|230|230.0|Standard Deviation|44|44.0|||
4235374|NCT00672633|4059085|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4235375|NCT00672633|4059086|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4235376|NCT00672633|4059087|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4235377|NCT00672633|4059085|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4235378|NCT00672633|4059086|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4235379|NCT00672633|4059087|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4235380|NCT00672633|4059085|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4235381|NCT00672633|4059086|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4235382|NCT00672633|4059087|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4235383|NCT00672633|4059085|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4235384|NCT00672633|4059086|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4235385|NCT00672633|4059087|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4235386|NCT00672633|4059085|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4235387|NCT00672633|4059086|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4235388|NCT00672633|4059087|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4235389|NCT00672633|4059085|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4235390|NCT00672633|4059086|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4235391|NCT00672633|4059087|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4235392|NCT00672633|4059085|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4235393|NCT00672633|4059086|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4235394|NCT00672633|4059087|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4235395|NCT00672633|4059085|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4235396|NCT00672633|4059086|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4235397|NCT00672633|4059087|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4235398|NCT00672633|4059085|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4235399|NCT00672633|4059086|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4235400|NCT00672633|4059087|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4235401|NCT00672633|4059085|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4235402|NCT00672633|4059086|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4235403|NCT00672633|4059087|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4235404|NCT00672633|4059085|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4235405|NCT00672633|4059086|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4235406|NCT00672633|4059087|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4235407|NCT00672633|4059085|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4235408|NCT00672633|4059086|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4235409|NCT00672633|4059087|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4235410|NCT00672633|4059085|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4235411|NCT00672633|4059086|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4235412|NCT00672633|4059087|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4235413|NCT00672633|4059085|B3|||Age||years|Mean|14.0|14.0|Standard Deviation|2.6|2.6|||
4235414|NCT00672633|4059086|B2|||Age||years|Mean|14.7|14.7|Standard Deviation|2.7|2.7|||
4235415|NCT00672633|4059087|B1|||Age||years|Mean|13.3|13.3|Standard Deviation|2.4|2.4|||
4235416|NCT00672633|4059085|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4235417|NCT00672633|4059086|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4235418|NCT00672633|4059087|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4235419|NCT00672633|4059085|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4235420|NCT00672633|4059086|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4235421|NCT00672633|4059087|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4235422|NCT00672633|4059085|B3||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
4235423|NCT00672633|4059086|B2||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4235424|NCT00672633|4059087|B1||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4235425|NCT00672620|4059098|B5|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|scores on a scale|Mean|4.5|4.5|Standard Deviation|0.64|0.64|||
4235426|NCT00672620|4059099|B4|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|scores on a scale|Mean|4.5|4.5|Standard Deviation|0.67|0.67|||
4235427|NCT00672620|4059100|B3|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|scores on a scale|Mean|4.6|4.6|Standard Deviation|0.65|0.65|||
4235428|NCT00672620|4059101|B2|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|scores on a scale|Mean|4.6|4.6|Standard Deviation|0.62|0.62|||
4235494|NCT00672620|4059102|B1|||Height||cm|Mean|168.98|168.98|Standard Deviation|9.141|9.141|||
4235495|NCT00672620|4059098|B5|||Weight||kg|Mean|86.34|86.34|Standard Deviation|22.823|22.823|||
4235429|NCT00672620|4059102|B1|||Clinical Global Impression - Severity scale score|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale where the clinician rates the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis on the following scale: 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|scores on a scale|Mean|4.5|4.5|Standard Deviation|0.62|0.62|||
4235430|NCT00672620|4059098|B5|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 to 56, where <17 indicates mild severity, 18–24 mild to moderate severity and 25–30 moderate to severe. Total scores above 30 are rare, but indicate very severe anxiety.|scores on a scale|Mean|18.5|18.5|Standard Deviation|5.53|5.53|||
4235431|NCT00672620|4059099|B4|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 to 56, where <17 indicates mild severity, 18–24 mild to moderate severity and 25–30 moderate to severe. Total scores above 30 are rare, but indicate very severe anxiety.|scores on a scale|Mean|17.4|17.4|Standard Deviation|5.47|5.47|||
4235432|NCT00672620|4059100|B3|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 to 56, where <17 indicates mild severity, 18–24 mild to moderate severity and 25–30 moderate to severe. Total scores above 30 are rare, but indicate very severe anxiety.|scores on a scale|Mean|18.7|18.7|Standard Deviation|5.74|5.74|||
4235433|NCT00672620|4059101|B2|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 to 56, where <17 indicates mild severity, 18–24 mild to moderate severity and 25–30 moderate to severe. Total scores above 30 are rare, but indicate very severe anxiety.|scores on a scale|Mean|19.3|19.3|Standard Deviation|5.22|5.22|||
4235434|NCT00672620|4059102|B1|||Hamilton Anxiety Scale Total Score|Hamilton Anxiety Scale (HAM-A) is an anxiety rating scale consisting of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behavior at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total scores range from 0 to 56, where <17 indicates mild severity, 18–24 mild to moderate severity and 25–30 moderate to severe. Total scores above 30 are rare, but indicate very severe anxiety.|scores on a scale|Mean|18.8|18.8|Standard Deviation|5.53|5.53|||
4235435|NCT00672620|4059098|B5|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|29.8|29.8|Standard Deviation|4.45|4.45|||
4235436|NCT00672620|4059099|B4|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|29.4|29.4|Standard Deviation|4.31|4.31|||
4235437|NCT00672620|4059100|B3|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|30.1|30.1|Standard Deviation|4.51|4.51|||
4235438|NCT00672620|4059101|B2|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|29.8|29.8|Standard Deviation|4.61|4.61|||
4235439|NCT00672620|4059102|B1|||Montgomery Åsberg Depression Rating Scale (MADRS) total score|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 to 6. The 10 items represent the core symptoms of depressive illness. The overall score ranges from 0 (symptoms absent) to 60 (severe depression).|scores on a scale|Mean|30.0|30.0|Standard Deviation|4.39|4.39|||
4235440|NCT00672620|4059098|B5|||24-item Hamilton Depression Scale total score|The 24-item Hamilton Depression Scale (HAM-D24) is a clinician-rated 24-item scale for assessing the severity of depression symptoms. The scores for each item range from 0 to 4 or 0 to 2, where 0 represents no symptoms. The rating is based on the past 7 days prior to the time of assessment. The total score ranges from 0 to 74, where a higher score indicates a greater depressive state.|scores on a scale|Mean|29.5|29.5|Standard Deviation|5.55|5.55|||
4235441|NCT00672620|4059099|B4|||24-item Hamilton Depression Scale total score|The 24-item Hamilton Depression Scale (HAM-D24) is a clinician-rated 24-item scale for assessing the severity of depression symptoms. The scores for each item range from 0 to 4 or 0 to 2, where 0 represents no symptoms. The rating is based on the past 7 days prior to the time of assessment. The total score ranges from 0 to 74, where a higher score indicates a greater depressive state.|scores on a scale|Mean|28.7|28.7|Standard Deviation|5.08|5.08|||
4235496|NCT00672620|4059099|B4|||Weight||kg|Mean|87.44|87.44|Standard Deviation|20.695|20.695|||
4235497|NCT00672620|4059100|B3|||Weight||kg|Mean|88.61|88.61|Standard Deviation|25.779|25.779|||
4235442|NCT00672620|4059100|B3|||24-item Hamilton Depression Scale total score|The 24-item Hamilton Depression Scale (HAM-D24) is a clinician-rated 24-item scale for assessing the severity of depression symptoms. The scores for each item range from 0 to 4 or 0 to 2, where 0 represents no symptoms. The rating is based on the past 7 days prior to the time of assessment. The total score ranges from 0 to 74, where a higher score indicates a greater depressive state.|scores on a scale|Mean|29.8|29.8|Standard Deviation|5.58|5.58|||
4235443|NCT00672620|4059101|B2|||24-item Hamilton Depression Scale total score|The 24-item Hamilton Depression Scale (HAM-D24) is a clinician-rated 24-item scale for assessing the severity of depression symptoms. The scores for each item range from 0 to 4 or 0 to 2, where 0 represents no symptoms. The rating is based on the past 7 days prior to the time of assessment. The total score ranges from 0 to 74, where a higher score indicates a greater depressive state.|scores on a scale|Mean|29.8|29.8|Standard Deviation|5.42|5.42|||
4235444|NCT00672620|4059102|B1|||24-item Hamilton Depression Scale total score|The 24-item Hamilton Depression Scale (HAM-D24) is a clinician-rated 24-item scale for assessing the severity of depression symptoms. The scores for each item range from 0 to 4 or 0 to 2, where 0 represents no symptoms. The rating is based on the past 7 days prior to the time of assessment. The total score ranges from 0 to 74, where a higher score indicates a greater depressive state.|scores on a scale|Mean|29.5|29.5|Standard Deviation|6.05|6.05|||
4235445|NCT00672620|4059098|B5|Daily||Alcohol consumption||participants|Number|17|17.0||||||
4235446|NCT00672620|4059099|B4|Daily||Alcohol consumption||participants|Number|3|3.0||||||
4235447|NCT00672620|4059100|B3|Daily||Alcohol consumption||participants|Number|3|3.0||||||
4235448|NCT00672620|4059101|B2|Daily||Alcohol consumption||participants|Number|9|9.0||||||
4235449|NCT00672620|4059102|B1|Daily||Alcohol consumption||participants|Number|2|2.0||||||
4235450|NCT00672620|4059098|B5|2-to-6 times/week||Alcohol consumption||participants|Number|87|87.0||||||
4235451|NCT00672620|4059099|B4|2-to-6 times/week||Alcohol consumption||participants|Number|28|28.0||||||
4235452|NCT00672620|4059100|B3|2-to-6 times/week||Alcohol consumption||participants|Number|17|17.0||||||
4235453|NCT00672620|4059101|B2|2-to-6 times/week||Alcohol consumption||participants|Number|20|20.0||||||
4235454|NCT00672620|4059102|B1|2-to-6 times/week||Alcohol consumption||participants|Number|22|22.0||||||
4235455|NCT00672620|4059098|B5|Once per week||Alcohol consumption||participants|Number|93|93.0||||||
4235456|NCT00672620|4059099|B4|Once per week||Alcohol consumption||participants|Number|21|21.0||||||
4235457|NCT00672620|4059100|B3|Once per week||Alcohol consumption||participants|Number|23|23.0||||||
4235458|NCT00672620|4059101|B2|Once per week||Alcohol consumption||participants|Number|26|26.0||||||
4235459|NCT00672620|4059102|B1|Once per week||Alcohol consumption||participants|Number|23|23.0||||||
4235460|NCT00672620|4059098|B5|Once monthly or less often||Alcohol consumption||participants|Number|218|218.0||||||
4235461|NCT00672620|4059099|B4|Once monthly or less often||Alcohol consumption||participants|Number|51|51.0||||||
4235462|NCT00672620|4059100|B3|Once monthly or less often||Alcohol consumption||participants|Number|62|62.0||||||
4235463|NCT00672620|4059101|B2|Once monthly or less often||Alcohol consumption||participants|Number|49|49.0||||||
4235464|NCT00672620|4059102|B1|Once monthly or less often||Alcohol consumption||participants|Number|56|56.0||||||
4235465|NCT00672620|4059098|B5|Never||Alcohol consumption||participants|Number|196|196.0||||||
4235466|NCT00672620|4059099|B4|Never||Alcohol consumption||participants|Number|49|49.0||||||
4235467|NCT00672620|4059100|B3|Never||Alcohol consumption||participants|Number|48|48.0||||||
4235468|NCT00672620|4059101|B2|Never||Alcohol consumption||participants|Number|49|49.0||||||
4235469|NCT00672620|4059102|B1|Never||Alcohol consumption||participants|Number|50|50.0||||||
4235470|NCT00672620|4059098|B5|Ex-smoker||Smoking Classification||participants|Number|126|126.0||||||
4235471|NCT00672620|4059099|B4|Ex-smoker||Smoking Classification||participants|Number|41|41.0||||||
4235472|NCT00672620|4059100|B3|Ex-smoker||Smoking Classification||participants|Number|21|21.0||||||
4235473|NCT00672620|4059101|B2|Ex-smoker||Smoking Classification||participants|Number|30|30.0||||||
4235474|NCT00672620|4059102|B1|Ex-smoker||Smoking Classification||participants|Number|34|34.0||||||
4235475|NCT00672620|4059098|B5|Current smoker||Smoking Classification||participants|Number|170|170.0||||||
4235476|NCT00672620|4059099|B4|Current smoker||Smoking Classification||participants|Number|36|36.0||||||
4235477|NCT00672620|4059100|B3|Current smoker||Smoking Classification||participants|Number|45|45.0||||||
4235478|NCT00672620|4059101|B2|Current smoker||Smoking Classification||participants|Number|42|42.0||||||
4235479|NCT00672620|4059102|B1|Current smoker||Smoking Classification||participants|Number|47|47.0||||||
4235480|NCT00672620|4059098|B5|Never smoked||Smoking Classification||participants|Number|315|315.0||||||
4235481|NCT00672620|4059099|B4|Never smoked||Smoking Classification||participants|Number|75|75.0||||||
4235482|NCT00672620|4059100|B3|Never smoked||Smoking Classification||participants|Number|87|87.0||||||
4235483|NCT00672620|4059101|B2|Never smoked||Smoking Classification||participants|Number|81|81.0||||||
4235484|NCT00672620|4059102|B1|Never smoked||Smoking Classification||participants|Number|72|72.0||||||
4235485|NCT00672620|4059098|B5|||Body Mass Index (BMI)||kg/m^2|Mean|30.15|30.15|Standard Deviation|7.649|7.649|||
4235486|NCT00672620|4059099|B4|||Body Mass Index (BMI)||kg/m^2|Mean|30.14|30.14|Standard Deviation|6.773|6.773|||
4235487|NCT00672620|4059100|B3|||Body Mass Index (BMI)||kg/m^2|Mean|31.38|31.38|Standard Deviation|8.846|8.846|||
4235488|NCT00672620|4059101|B2|||Body Mass Index (BMI)||kg/m^2|Mean|29.48|29.48|Standard Deviation|7.479|7.479|||
4235489|NCT00672620|4059102|B1|||Body Mass Index (BMI)||kg/m^2|Mean|29.58|29.58|Standard Deviation|7.263|7.263|||
4235490|NCT00672620|4059098|B5|||Height||cm|Mean|169.21|169.21|Standard Deviation|9.515|9.515|||
4235491|NCT00672620|4059099|B4|||Height||cm|Mean|170.37|170.37|Standard Deviation|9.624|9.624|||
4235492|NCT00672620|4059100|B3|||Height||cm|Mean|167.98|167.98|Standard Deviation|9.833|9.833|||
4235493|NCT00672620|4059101|B2|||Height||cm|Mean|169.50|169.5|Standard Deviation|9.385|9.385|||
4235498|NCT00672620|4059101|B2|||Weight||kg|Mean|85.08|85.08|Standard Deviation|24.126|24.126|||
4235499|NCT00672620|4059102|B1|||Weight||kg|Mean|84.22|84.22|Standard Deviation|20.144|20.144|||
4235500|NCT00672620|4059098|B5|United States||Region of Enrollment||participants|Number|611|611.0||||||
4235501|NCT00672620|4059099|B4|United States||Region of Enrollment||participants|Number|152|152.0||||||
4235502|NCT00672620|4059100|B3|United States||Region of Enrollment||participants|Number|153|153.0||||||
4235503|NCT00672620|4059101|B2|United States||Region of Enrollment||participants|Number|153|153.0||||||
4235504|NCT00672620|4059102|B1|United States||Region of Enrollment||participants|Number|153|153.0||||||
4235505|NCT00672620|4059098|B5|Non-Hispanic/Non-Latino||Race/Ethnicity, Customized|Number of participants for whom Ethnicity data were available were 153, 153, 152 and 151 respectively.|participants|Number|506|506.0||||||
4235506|NCT00672620|4059099|B4|Non-Hispanic/Non-Latino||Race/Ethnicity, Customized|Number of participants for whom Ethnicity data were available were 153, 153, 152 and 151 respectively.|participants|Number|123|123.0||||||
4235507|NCT00672620|4059100|B3|Non-Hispanic/Non-Latino||Race/Ethnicity, Customized|Number of participants for whom Ethnicity data were available were 153, 153, 152 and 151 respectively.|participants|Number|133|133.0||||||
4235508|NCT00672620|4059101|B2|Non-Hispanic/Non-Latino||Race/Ethnicity, Customized|Number of participants for whom Ethnicity data were available were 153, 153, 152 and 151 respectively.|participants|Number|132|132.0||||||
4235509|NCT00672620|4059102|B1|Non-Hispanic/Non-Latino||Race/Ethnicity, Customized|Number of participants for whom Ethnicity data were available were 153, 153, 152 and 151 respectively.|participants|Number|118|118.0||||||
4235510|NCT00672620|4059098|B5|Hispanic/Latino||Race/Ethnicity, Customized|Number of participants for whom Ethnicity data were available were 153, 153, 152 and 151 respectively.|participants|Number|103|103.0||||||
4235511|NCT00672620|4059099|B4|Hispanic/Latino||Race/Ethnicity, Customized|Number of participants for whom Ethnicity data were available were 153, 153, 152 and 151 respectively.|participants|Number|28|28.0||||||
4235512|NCT00672620|4059100|B3|Hispanic/Latino||Race/Ethnicity, Customized|Number of participants for whom Ethnicity data were available were 153, 153, 152 and 151 respectively.|participants|Number|19|19.0||||||
4235513|NCT00672620|4059101|B2|Hispanic/Latino||Race/Ethnicity, Customized|Number of participants for whom Ethnicity data were available were 153, 153, 152 and 151 respectively.|participants|Number|21|21.0||||||
4235514|NCT00672620|4059102|B1|Hispanic/Latino||Race/Ethnicity, Customized|Number of participants for whom Ethnicity data were available were 153, 153, 152 and 151 respectively.|participants|Number|35|35.0||||||
4235515|NCT00672620|4059098|B5|Native Hawaiian/ Other Pacific Islander||Race/Ethnicity, Customized|Number of participants for whom Race data were available were 153, 153, 151 and 151 respectively.|participants|Number|2|2.0||||||
4235516|NCT00672620|4059099|B4|Native Hawaiian/ Other Pacific Islander||Race/Ethnicity, Customized|Number of participants for whom Race data were available were 153, 153, 151 and 151 respectively.|participants|Number|1|1.0||||||
4235517|NCT00672620|4059100|B3|Native Hawaiian/ Other Pacific Islander||Race/Ethnicity, Customized|Number of participants for whom Race data were available were 153, 153, 151 and 151 respectively.|participants|Number|0|0.0||||||
4235518|NCT00672620|4059101|B2|Native Hawaiian/ Other Pacific Islander||Race/Ethnicity, Customized|Number of participants for whom Race data were available were 153, 153, 151 and 151 respectively.|participants|Number|1|1.0||||||
4235519|NCT00672620|4059102|B1|Native Hawaiian/ Other Pacific Islander||Race/Ethnicity, Customized|Number of participants for whom Race data were available were 153, 153, 151 and 151 respectively.|participants|Number|0|0.0||||||
4235520|NCT00672620|4059098|B5|American Indian or Alaska Native||Race/Ethnicity, Customized|Number of participants for whom Race data were available were 153, 153, 151 and 151 respectively.|participants|Number|3|3.0||||||
4235521|NCT00672620|4059099|B4|American Indian or Alaska Native||Race/Ethnicity, Customized|Number of participants for whom Race data were available were 153, 153, 151 and 151 respectively.|participants|Number|0|0.0||||||
4235522|NCT00672620|4059100|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|Number of participants for whom Race data were available were 153, 153, 151 and 151 respectively.|participants|Number|0|0.0||||||
4235523|NCT00672620|4059101|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|Number of participants for whom Race data were available were 153, 153, 151 and 151 respectively.|participants|Number|2|2.0||||||
4235524|NCT00672620|4059102|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Number of participants for whom Race data were available were 153, 153, 151 and 151 respectively.|participants|Number|1|1.0||||||
4235525|NCT00672620|4059098|B5|Asian||Race/Ethnicity, Customized|Number of participants for whom Race data were available were 153, 153, 151 and 151 respectively.|participants|Number|12|12.0||||||
4235526|NCT00672620|4059099|B4|Asian||Race/Ethnicity, Customized|Number of participants for whom Race data were available were 153, 153, 151 and 151 respectively.|participants|Number|3|3.0||||||
4235527|NCT00672620|4059100|B3|Asian||Race/Ethnicity, Customized|Number of participants for whom Race data were available were 153, 153, 151 and 151 respectively.|participants|Number|3|3.0||||||
4235528|NCT00672620|4059101|B2|Asian||Race/Ethnicity, Customized|Number of participants for whom Race data were available were 153, 153, 151 and 151 respectively.|participants|Number|3|3.0||||||
4235529|NCT00672620|4059102|B1|Asian||Race/Ethnicity, Customized|Number of participants for whom Race data were available were 153, 153, 151 and 151 respectively.|participants|Number|3|3.0||||||
4235530|NCT00672620|4059098|B5|Black||Race/Ethnicity, Customized|Number of participants for whom Race data were available were 153, 153, 151 and 151 respectively.|participants|Number|139|139.0||||||
4235531|NCT00672620|4059099|B4|Black||Race/Ethnicity, Customized|Number of participants for whom Race data were available were 153, 153, 151 and 151 respectively.|participants|Number|36|36.0||||||
4235532|NCT00672620|4059100|B3|Black||Race/Ethnicity, Customized|Number of participants for whom Race data were available were 153, 153, 151 and 151 respectively.|participants|Number|40|40.0||||||
4235533|NCT00672620|4059101|B2|Black||Race/Ethnicity, Customized|Number of participants for whom Race data were available were 153, 153, 151 and 151 respectively.|participants|Number|35|35.0||||||
4235534|NCT00672620|4059102|B1|Black||Race/Ethnicity, Customized|Number of participants for whom Race data were available were 153, 153, 151 and 151 respectively.|participants|Number|28|28.0||||||
4235535|NCT00672620|4059098|B5|Caucasian (White, including Hispanic)||Race/Ethnicity, Customized|Number of participants for whom Race data were available were 153, 153, 151 and 151 respectively.|participants|Number|452|452.0||||||
4235536|NCT00672620|4059099|B4|Caucasian (White, including Hispanic)||Race/Ethnicity, Customized|Number of participants for whom Race data were available were 153, 153, 151 and 151 respectively.|participants|Number|111|111.0||||||
4235537|NCT00672620|4059100|B3|Caucasian (White, including Hispanic)||Race/Ethnicity, Customized|Number of participants for whom Race data were available were 153, 153, 151 and 151 respectively.|participants|Number|108|108.0||||||
4235538|NCT00672620|4059101|B2|Caucasian (White, including Hispanic)||Race/Ethnicity, Customized|Number of participants for whom Race data were available were 153, 153, 151 and 151 respectively.|participants|Number|112|112.0||||||
4235539|NCT00672620|4059102|B1|Caucasian (White, including Hispanic)||Race/Ethnicity, Customized|Number of participants for whom Race data were available were 153, 153, 151 and 151 respectively.|participants|Number|121|121.0||||||
4235540|NCT00672620|4059098|B5||Male|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4235541|NCT00672620|4059099|B4||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4235542|NCT00672620|4059100|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4235543|NCT00672620|4059101|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4235544|NCT00672620|4059102|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4235545|NCT00672620|4059098|B5||Female|Sex: Female, Male||Participants|Count of Participants|388|388.0||||||
4235546|NCT00672620|4059099|B4||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4235547|NCT00672620|4059100|B3||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4235548|NCT00672620|4059101|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4235549|NCT00672620|4059102|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4235550|NCT00672620|4059098|B5|>55 years||Age, Customized||participants|Number|114|114.0||||||
4235551|NCT00672620|4059099|B4|>55 years||Age, Customized||participants|Number|29|29.0||||||
4235552|NCT00672620|4059100|B3|>55 years||Age, Customized||participants|Number|28|28.0||||||
4235553|NCT00672620|4059101|B2|>55 years||Age, Customized||participants|Number|26|26.0||||||
4235554|NCT00672620|4059102|B1|>55 years||Age, Customized||participants|Number|31|31.0||||||
4235555|NCT00672620|4059098|B5|≤55 years||Age, Customized||participants|Number|497|497.0||||||
4235556|NCT00672620|4059099|B4|≤55 years||Age, Customized||participants|Number|123|123.0||||||
4235557|NCT00672620|4059100|B3|≤55 years||Age, Customized||participants|Number|125|125.0||||||
4235558|NCT00672620|4059101|B2|≤55 years||Age, Customized||participants|Number|127|127.0||||||
4235559|NCT00672620|4059102|B1|≤55 years||Age, Customized||participants|Number|122|122.0||||||
4235560|NCT00672620|4059098|B5|||Age||years|Mean|42.7|42.7|Standard Deviation|13.70|13.7|||
4235561|NCT00672620|4059099|B4|||Age||years|Mean|42.7|42.7|Standard Deviation|14.38|14.38|||
4235562|NCT00672620|4059100|B3|||Age||years|Mean|43.1|43.1|Standard Deviation|13.89|13.89|||
4235563|NCT00672620|4059101|B2|||Age||years|Mean|42.6|42.6|Standard Deviation|12.85|12.85|||
4235564|NCT00672620|4059102|B1|||Age||years|Mean|42.6|42.6|Standard Deviation|13.76|13.76|||
4235565|NCT00672594|4059159|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4235566|NCT00672594|4059159|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4235567|NCT00672594|4059159|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|6.2|6.2|||
4235568|NCT00672555|4059170|B1|Switzerland||Region of Enrollment||participants|Number|70|70.0||||||
4235569|NCT00672555|4059170|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4235570|NCT00672555|4059170|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4235571|NCT00672555|4059170|B1|||Age||years|Mean|26.1|26.1|Standard Deviation|7.3|7.3|||
4235572|NCT00672555|4059170|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4235573|NCT00672555|4059170|B1||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4235574|NCT00672555|4059170|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235575|NCT00672490|4059179|B3||Male|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4235576|NCT00672490|4059180|B2||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4235577|NCT00672490|4059181|B1||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4235578|NCT00672490|4059179|B3||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4235579|NCT00672490|4059180|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4235580|NCT00672490|4059181|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4235581|NCT00672490|4059179|B3|||Age||years|Mean|33.36|33.36|Standard Deviation|11.68|11.68|||
4235582|NCT00672490|4059180|B2|||Age||years|Mean|32.43|32.43|Standard Deviation|11.14|11.14|||
4235583|NCT00672490|4059181|B1|||Age||years|Mean|34.3|34.3|Standard Deviation|12.16|12.16|||
4235584|NCT00672477|4059204|B3|Missing||Glomerular filtration rate||participants|Number|6|6.0||||||
4235585|NCT00672477|4059205|B2|Missing||Glomerular filtration rate||participants|Number|3|3.0||||||
4235586|NCT00672477|4059206|B1|Missing||Glomerular filtration rate||participants|Number|3|3.0||||||
4235587|NCT00672477|4059204|B3|≥ 30 mL/min/1.73 m^2||Glomerular filtration rate||participants|Number|218|218.0||||||
4235588|NCT00672477|4059205|B2|≥ 30 mL/min/1.73 m^2||Glomerular filtration rate||participants|Number|108|108.0||||||
4235589|NCT00672477|4059206|B1|≥ 30 mL/min/1.73 m^2||Glomerular filtration rate||participants|Number|110|110.0||||||
4235590|NCT00672477|4059204|B3|< 30 mL/min/1.73 m^2||Glomerular filtration rate||participants|Number|6|6.0||||||
4235591|NCT00672477|4059205|B2|< 30 mL/min/1.73 m^2||Glomerular filtration rate||participants|Number|3|3.0||||||
4235592|NCT00672477|4059206|B1|< 30 mL/min/1.73 m^2||Glomerular filtration rate||participants|Number|3|3.0||||||
4235593|NCT00672477|4059204|B3|≥ 62 kg||Weight||participants|Number|144|144.0||||||
4235594|NCT00672477|4059205|B2|≥ 62 kg||Weight||participants|Number|73|73.0||||||
4235595|NCT00672477|4059206|B1|≥ 62 kg||Weight||participants|Number|71|71.0||||||
4235596|NCT00672477|4059204|B3|< 62 kg||Weight||participants|Number|86|86.0||||||
4235597|NCT00672477|4059205|B2|< 62 kg||Weight||participants|Number|41|41.0||||||
4235598|NCT00672477|4059206|B1|< 62 kg||Weight||participants|Number|45|45.0||||||
4235599|NCT00672477|4059204|B3|Other||Underlying Advanced Illness||participants|Number|20|20.0||||||
4235600|NCT00672477|4059205|B2|Other||Underlying Advanced Illness||participants|Number|14|14.0||||||
4235601|NCT00672477|4059206|B1|Other||Underlying Advanced Illness||participants|Number|6|6.0||||||
4235602|NCT00672477|4059204|B3|Neurologic disease||Underlying Advanced Illness||participants|Number|7|7.0||||||
4235603|NCT00672477|4059205|B2|Neurologic disease||Underlying Advanced Illness||participants|Number|3|3.0||||||
4235604|NCT00672477|4059206|B1|Neurologic disease||Underlying Advanced Illness||participants|Number|4|4.0||||||
4235605|NCT00672477|4059204|B3|Cardiovascular disease||Underlying Advanced Illness||participants|Number|24|24.0||||||
4235606|NCT00672477|4059205|B2|Cardiovascular disease||Underlying Advanced Illness||participants|Number|11|11.0||||||
4235607|NCT00672477|4059206|B1|Cardiovascular disease||Underlying Advanced Illness||participants|Number|13|13.0||||||
4235608|NCT00672477|4059204|B3|Pulmonary disease (other than malignancy)||Underlying Advanced Illness||participants|Number|27|27.0||||||
4235609|NCT00672477|4059205|B2|Pulmonary disease (other than malignancy)||Underlying Advanced Illness||participants|Number|13|13.0||||||
4235610|NCT00672477|4059206|B1|Pulmonary disease (other than malignancy)||Underlying Advanced Illness||participants|Number|14|14.0||||||
4235611|NCT00672477|4059204|B3|Cancer||Underlying Advanced Illness||participants|Number|152|152.0||||||
4235612|NCT00672477|4059205|B2|Cancer||Underlying Advanced Illness||participants|Number|73|73.0||||||
4235613|NCT00672477|4059206|B1|Cancer||Underlying Advanced Illness||participants|Number|79|79.0||||||
4235614|NCT00672477|4059204|B3||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4235615|NCT00672477|4059205|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4235616|NCT00672477|4059206|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4235617|NCT00672477|4059204|B3||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4235618|NCT00672477|4059205|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4235619|NCT00672477|4059206|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4235620|NCT00672477|4059204|B3|||Age||years|Mean|65.49|65.49|Standard Deviation|12.92|12.92|||
4235621|NCT00672477|4059205|B2|||Age||years|Mean|65.67|65.67|Standard Deviation|12.97|12.97|||
4235622|NCT00672477|4059206|B1|||Age||years|Mean|65.31|65.31|Standard Deviation|12.92|12.92|||
4235623|NCT00672477|4059204|B3||>=65 years|Age||Participants|Count of Participants|113|113.0||||||
4235624|NCT00672477|4059205|B2||>=65 years|Age||Participants|Count of Participants|57|57.0||||||
4235625|NCT00672477|4059206|B1||>=65 years|Age||Participants|Count of Participants|56|56.0||||||
4235626|NCT00672477|4059204|B3||Between 18 and 65 years|Age||Participants|Count of Participants|117|117.0||||||
4235627|NCT00672477|4059205|B2||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4235628|NCT00672477|4059206|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4235629|NCT00672477|4059204|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235630|NCT00672477|4059205|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235631|NCT00672477|4059206|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235632|NCT00672451|4059215|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4235633|NCT00672451|4059216|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4235634|NCT00672451|4059217|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4235635|NCT00672451|4059215|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4235636|NCT00672451|4059216|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4235637|NCT00672451|4059217|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4235638|NCT00672451|4059215|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4235639|NCT00672451|4059216|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4235640|NCT00672451|4059217|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4235641|NCT00672451|4059215|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4235642|NCT00672451|4059216|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4235643|NCT00672451|4059217|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4235644|NCT00672451|4059215|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235645|NCT00672451|4059216|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235646|NCT00672451|4059217|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235647|NCT00672438|4059226|B3|United States||Region of Enrollment||participants|Number|242|242.0||||||
4235648|NCT00672438|4059227|B2|United States||Region of Enrollment||participants|Number|120|120.0||||||
4235649|NCT00672438|4059228|B1|United States||Region of Enrollment||participants|Number|122|122.0||||||
4235650|NCT00672438|4059226|B3||Male|Gender||Participants|Count of Participants|92|92.0||||||
4235651|NCT00672438|4059227|B2||Male|Gender||Participants|Count of Participants|46|46.0||||||
4235652|NCT00672438|4059228|B1||Male|Gender||Participants|Count of Participants|46|46.0||||||
4235653|NCT00672438|4059226|B3||Female|Gender||Participants|Count of Participants|150|150.0||||||
4235654|NCT00672438|4059227|B2||Female|Gender||Participants|Count of Participants|74|74.0||||||
4235655|NCT00672438|4059228|B1||Female|Gender||Participants|Count of Participants|76|76.0||||||
4235656|NCT00672438|4059226|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4235657|NCT00672438|4059227|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4235658|NCT00672438|4059228|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4235659|NCT00672438|4059226|B3||Between 18 and 65 years|Age||Participants|Count of Participants|242|242.0||||||
4235660|NCT00672438|4059227|B2||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
4235661|NCT00672438|4059228|B1||Between 18 and 65 years|Age||Participants|Count of Participants|122|122.0||||||
4235662|NCT00672438|4059226|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235663|NCT00672438|4059227|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235664|NCT00672438|4059228|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235665|NCT00672256|4059260|B1|United States||Region of Enrollment||participants|Number|62|62.0||||||
4235666|NCT00672256|4059260|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4235667|NCT00672256|4059260|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4235668|NCT00672256|4059260|B1|||Age||years|Mean|32.5|32.5|Standard Deviation|10.03|10.03|||
4235669|NCT00672256|4059260|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4235670|NCT00672256|4059260|B1||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4235671|NCT00672256|4059260|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235672|NCT00672243|4059267|B1|Receiving EIAEDs||Enzyme-inducing anti-epileptic drug (EIAED) status||participants|Number|8|8.0||||||
4235673|NCT00672243|4059267|B1|Not receiving EIAEDs||Enzyme-inducing anti-epileptic drug (EIAED) status||participants|Number|24|24.0||||||
4235674|NCT00672243|4059267|B1|No||Received prior bevacizumab||participants|Number|23|23.0||||||
4235675|NCT00672243|4059267|B1|Yes||Received prior bevacizumab||participants|Number|9|9.0||||||
4235676|NCT00672243|4059267|B1|70||Karnofsky Performance Scale (KPS)|Karnofsky Performance Scores (KPS) range from 0-100 (100=Normal, no complaints; no evidence of disease; 90=Able to carry on normal activity; minor signs or symptoms of disease; 80=Normal activity with efforts; some signs or symptoms of disease; 70=Cares for self; unable to carry on normal activity or to do active work. Scores between intervals are possible.|participants|Number|5|5.0||||||
4235677|NCT00672243|4059267|B1|80||Karnofsky Performance Scale (KPS)|Karnofsky Performance Scores (KPS) range from 0-100 (100=Normal, no complaints; no evidence of disease; 90=Able to carry on normal activity; minor signs or symptoms of disease; 80=Normal activity with efforts; some signs or symptoms of disease; 70=Cares for self; unable to carry on normal activity or to do active work. Scores between intervals are possible.|participants|Number|9|9.0||||||
4235678|NCT00672243|4059267|B1|85||Karnofsky Performance Scale (KPS)|Karnofsky Performance Scores (KPS) range from 0-100 (100=Normal, no complaints; no evidence of disease; 90=Able to carry on normal activity; minor signs or symptoms of disease; 80=Normal activity with efforts; some signs or symptoms of disease; 70=Cares for self; unable to carry on normal activity or to do active work. Scores between intervals are possible.|participants|Number|1|1.0||||||
4235679|NCT00672243|4059267|B1|90||Karnofsky Performance Scale (KPS)|Karnofsky Performance Scores (KPS) range from 0-100 (100=Normal, no complaints; no evidence of disease; 90=Able to carry on normal activity; minor signs or symptoms of disease; 80=Normal activity with efforts; some signs or symptoms of disease; 70=Cares for self; unable to carry on normal activity or to do active work. Scores between intervals are possible.|participants|Number|13|13.0||||||
4235680|NCT00672243|4059267|B1|100||Karnofsky Performance Scale (KPS)|Karnofsky Performance Scores (KPS) range from 0-100 (100=Normal, no complaints; no evidence of disease; 90=Able to carry on normal activity; minor signs or symptoms of disease; 80=Normal activity with efforts; some signs or symptoms of disease; 70=Cares for self; unable to carry on normal activity or to do active work. Scores between intervals are possible.|participants|Number|4|4.0||||||
4235681|NCT00672243|4059267|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4235682|NCT00672243|4059267|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4235683|NCT00672243|4059267|B1|||Age, Customized||years|Median|54|54.0|Full Range|||40.0|71.0|
4235684|NCT00672243|4059267|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4235685|NCT00672243|4059267|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4235686|NCT00672243|4059267|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235687|NCT00672204|4059275|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4235688|NCT00672204|4059275|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4235689|NCT00672204|4059275|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4235690|NCT00672204|4059275|B1|||Age||years|Mean|43.1|43.1|Standard Deviation|9.4|9.4|||
4235691|NCT00672204|4059275|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4235692|NCT00672204|4059275|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4235693|NCT00672204|4059275|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235694|NCT00672178|4059279|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4235695|NCT00672178|4059279|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4235696|NCT00672178|4059279|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
4235697|NCT00672178|4059279|B1|||Age||years|Mean|52|52.0|Standard Deviation|||||
4235698|NCT00672178|4059279|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4235699|NCT00672178|4059279|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4235700|NCT00672178|4059279|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235701|NCT00672139|4059283|B3|Missing||Glomerular filtration rate||participants|Number|4|4.0||||||
4235702|NCT00672139|4059284|B2|Missing||Glomerular filtration rate||participants|Number|3|3.0||||||
4235703|NCT00672139|4059285|B1|Missing||Glomerular filtration rate||participants|Number|1|1.0||||||
4235704|NCT00672139|4059283|B3|≥ 30 mL/min/1.73 m^2||Glomerular filtration rate||participants|Number|143|143.0||||||
4235705|NCT00672139|4059284|B2|≥ 30 mL/min/1.73 m^2||Glomerular filtration rate||participants|Number|89|89.0||||||
4235706|NCT00672139|4059285|B1|≥ 30 mL/min/1.73 m^2||Glomerular filtration rate||participants|Number|54|54.0||||||
4235707|NCT00672139|4059283|B3|< 30 mL/min/1.73 m^2||Glomerular filtration rate||participants|Number|2|2.0||||||
4235708|NCT00672139|4059284|B2|< 30 mL/min/1.73 m^2||Glomerular filtration rate||participants|Number|0|0.0||||||
4235709|NCT00672139|4059285|B1|< 30 mL/min/1.73 m^2||Glomerular filtration rate||participants|Number|2|2.0||||||
4235710|NCT00672139|4059283|B3|≥ 62 kg||Weight||participants|Number|95|95.0||||||
4235711|NCT00672139|4059284|B2|≥ 62 kg||Weight||participants|Number|92|92.0||||||
4235712|NCT00672139|4059285|B1|≥ 62 kg||Weight||participants|Number|3|3.0||||||
4235713|NCT00672139|4059283|B3|38 to < 62 kg||Weight||participants|Number|54|54.0||||||
4235714|NCT00672139|4059284|B2|38 to < 62 kg||Weight||participants|Number|0|0.0||||||
4235715|NCT00672139|4059285|B1|38 to < 62 kg||Weight||participants|Number|54|54.0||||||
4235716|NCT00672139|4059283|B3|Other||Underlying Advanced Illness||Participants|Number|14|14.0||||||
4235717|NCT00672139|4059284|B2|Other||Underlying Advanced Illness||Participants|Number|7|7.0||||||
4235718|NCT00672139|4059285|B1|Other||Underlying Advanced Illness||Participants|Number|7|7.0||||||
4235719|NCT00672139|4059283|B3|Neurologic disease||Underlying Advanced Illness||Participants|Number|6|6.0||||||
4235720|NCT00672139|4059284|B2|Neurologic disease||Underlying Advanced Illness||Participants|Number|3|3.0||||||
4235721|NCT00672139|4059285|B1|Neurologic disease||Underlying Advanced Illness||Participants|Number|3|3.0||||||
4235722|NCT00672139|4059283|B3|Cardiovascular disease||Underlying Advanced Illness||Participants|Number|19|19.0||||||
4235723|NCT00672139|4059284|B2|Cardiovascular disease||Underlying Advanced Illness||Participants|Number|15|15.0||||||
4235724|NCT00672139|4059285|B1|Cardiovascular disease||Underlying Advanced Illness||Participants|Number|4|4.0||||||
4235725|NCT00672139|4059283|B3|Pulmonary disease||Underlying Advanced Illness||Participants|Number|25|25.0||||||
4235726|NCT00672139|4059284|B2|Pulmonary disease||Underlying Advanced Illness||Participants|Number|18|18.0||||||
4235727|NCT00672139|4059285|B1|Pulmonary disease||Underlying Advanced Illness||Participants|Number|7|7.0||||||
4235728|NCT00672139|4059283|B3|Cancer||Underlying Advanced Illness||Participants|Number|85|85.0||||||
4235729|NCT00672139|4059284|B2|Cancer||Underlying Advanced Illness||Participants|Number|49|49.0||||||
4235730|NCT00672139|4059285|B1|Cancer||Underlying Advanced Illness||Participants|Number|36|36.0||||||
4235731|NCT00672139|4059283|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4235732|NCT00672139|4059284|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4235733|NCT00672139|4059285|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4235734|NCT00672139|4059283|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4235735|NCT00672139|4059284|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4235736|NCT00672139|4059285|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4235737|NCT00672139|4059283|B3|||Age||years|Mean|65.92|65.92|Standard Deviation|12.98|12.98|||
4235738|NCT00672139|4059284|B2|||Age||years|Mean|64.59|64.59|Standard Deviation|11.98|11.98|||
4235739|NCT00672139|4059285|B1|||Age||years|Mean|68.07|68.07|Standard Deviation|14.29|14.29|||
4235740|NCT00672139|4059283|B3||>=65 years|Age||Participants|Count of Participants|79|79.0||||||
4235741|NCT00672139|4059284|B2||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
4235742|NCT00672139|4059285|B1||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
4235743|NCT00672139|4059283|B3||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4235744|NCT00672139|4059284|B2||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4235745|NCT00672139|4059285|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4235746|NCT00672139|4059283|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235747|NCT00672139|4059284|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235748|NCT00672139|4059285|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235749|NCT00672100|4059292|B4|United States||Region of Enrollment||participants|Number|36|36.0||||||
4235750|NCT00672100|4059293|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4235751|NCT00672100|4059294|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4235752|NCT00672100|4059295|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4235753|NCT00672100|4059292|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4235754|NCT00672100|4059293|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4235755|NCT00672100|4059294|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4235756|NCT00672100|4059295|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4235757|NCT00672100|4059292|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4235758|NCT00672100|4059293|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4235759|NCT00672100|4059294|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4235760|NCT00672100|4059295|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4235761|NCT00672100|4059292|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4235762|NCT00672100|4059293|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4235763|NCT00672100|4059294|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4235764|NCT00672100|4059295|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4235765|NCT00672100|4059292|B4||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4235766|NCT00672100|4059293|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4235767|NCT00672100|4059294|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4235768|NCT00672100|4059295|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4235769|NCT00672100|4059292|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235770|NCT00672100|4059293|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235771|NCT00672100|4059294|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235772|NCT00672100|4059295|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235773|NCT00671970|4059312|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4235774|NCT00671970|4059313|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4235775|NCT00671970|4059314|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4235776|NCT00671970|4059312|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4235777|NCT00671970|4059313|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4235778|NCT00671970|4059314|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4235779|NCT00671970|4059312|B3|||Age||years|Median|49.98|49.98|Standard Deviation|13.05|13.05|24.1|72.2|
4235780|NCT00671970|4059313|B2|||Age||years|Median|51.5|51.5|Standard Deviation|13.4|13.4|24.1|70.4|
4235781|NCT00671970|4059314|B1|||Age||years|Median|48.8|48.8|Standard Deviation|12.8|12.8|26.0|72.2|
4235782|NCT00671931|4059338|B6|United States||Region of Enrollment||participants|Number|44|44.0||||||
4235783|NCT00671931|4059339|B5|United States||Region of Enrollment||participants|Number|8|8.0||||||
4235784|NCT00671931|4059340|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
4235785|NCT00671931|4059341|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4235786|NCT00671931|4059342|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4235787|NCT00671931|4059343|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4235788|NCT00671931|4059338|B6||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4235789|NCT00671931|4059339|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4235790|NCT00671931|4059340|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4235791|NCT00671931|4059341|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4235792|NCT00671931|4059342|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4235793|NCT00671931|4059343|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4235794|NCT00671931|4059338|B6||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4235795|NCT00671931|4059339|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4235796|NCT00671931|4059340|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4235797|NCT00671931|4059341|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4235798|NCT00671931|4059342|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4235799|NCT00671931|4059343|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4235800|NCT00671931|4059338|B6|||Age||years|Mean|15|15.0|Standard Deviation|2|2.0|||
4235801|NCT00671931|4059339|B5|||Age||years|Mean|15|15.0|Standard Deviation|2|2.0|||
4235802|NCT00671931|4059340|B4|||Age||years|Mean|15|15.0|Standard Deviation|2|2.0|||
4235803|NCT00671931|4059341|B3|||Age||years|Mean|15|15.0|Standard Deviation|2|2.0|||
4235804|NCT00671931|4059342|B2|||Age||years|Mean|15|15.0|Standard Deviation|2|2.0|||
4235805|NCT00671931|4059343|B1|||Age||years|Mean|16|16.0|Standard Deviation|2|2.0|||
4235806|NCT00671931|4059338|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4235807|NCT00671931|4059339|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4235808|NCT00671931|4059340|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4235809|NCT00671931|4059341|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4235810|NCT00671931|4059342|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4235811|NCT00671931|4059343|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4235812|NCT00671931|4059338|B6||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4235813|NCT00671931|4059339|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4235814|NCT00671931|4059340|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4235815|NCT00671931|4059341|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4235816|NCT00671931|4059342|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4235817|NCT00671931|4059343|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4235818|NCT00671931|4059338|B6||<=18 years|Age||Participants|Count of Participants|43|43.0||||||
4235819|NCT00671931|4059339|B5||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4235820|NCT00671931|4059340|B4||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4235821|NCT00671931|4059341|B3||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4235822|NCT00671931|4059342|B2||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4235823|NCT00671931|4059343|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4235824|NCT00671918|4059359|B1|Israel||Region of Enrollment||participants|Number|18|18.0||||||
4235825|NCT00671918|4059359|B1|United States||Region of Enrollment||participants|Number|161|161.0||||||
4235826|NCT00671918|4059359|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4235827|NCT00671918|4059359|B1||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4235828|NCT00671918|4059359|B1|||Age||years|Mean|58.5|58.5|Standard Deviation|14.1|14.1|||
4235829|NCT00671918|4059359|B1||>=65 years|Age||Participants|Count of Participants|59|59.0||||||
4235830|NCT00671918|4059359|B1||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
4235831|NCT00671918|4059359|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235832|NCT00671879|4059364|B4|United States||Region of Enrollment||participants|Number|840|840.0||||||
4235833|NCT00671879|4059365|B3|United States||Region of Enrollment||participants|Number|280|280.0||||||
4235834|NCT00671879|4059366|B2|United States||Region of Enrollment||participants|Number|279|279.0||||||
4235835|NCT00671879|4059367|B1|United States||Region of Enrollment||participants|Number|281|281.0||||||
4235836|NCT00671879|4059364|B4||Male|Sex: Female, Male||Participants|Count of Participants|402|402.0||||||
4235837|NCT00671879|4059365|B3||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4235838|NCT00671879|4059366|B2||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4235839|NCT00671879|4059367|B1||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4235840|NCT00671879|4059364|B4||Female|Sex: Female, Male||Participants|Count of Participants|438|438.0||||||
4235841|NCT00671879|4059365|B3||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4235842|NCT00671879|4059366|B2||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4235843|NCT00671879|4059367|B1||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4235844|NCT00671879|4059364|B4|||Age||years|Mean|41.5|41.5|Standard Deviation|12.0|12.0|||
4235845|NCT00671879|4059365|B3|||Age||years|Mean|41.4|41.4|Standard Deviation|11.86|11.86|||
4235846|NCT00671879|4059366|B2|||Age||years|Mean|41.6|41.6|Standard Deviation|11.79|11.79|||
4235847|NCT00671879|4059367|B1|||Age||years|Mean|41.5|41.5|Standard Deviation|12.35|12.35|||
4235848|NCT00671879|4059364|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4235849|NCT00671879|4059365|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4235850|NCT00671879|4059366|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4235851|NCT00671879|4059367|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4235852|NCT00671879|4059364|B4||Between 18 and 65 years|Age||Participants|Count of Participants|838|838.0||||||
4235853|NCT00671879|4059365|B3||Between 18 and 65 years|Age||Participants|Count of Participants|280|280.0||||||
4235854|NCT00671879|4059366|B2||Between 18 and 65 years|Age||Participants|Count of Participants|279|279.0||||||
4235855|NCT00671879|4059367|B1||Between 18 and 65 years|Age||Participants|Count of Participants|279|279.0||||||
4235856|NCT00671879|4059364|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235857|NCT00671879|4059365|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235858|NCT00671879|4059366|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235859|NCT00671879|4059367|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235860|NCT00671853|4059380|B3|United States||Region of Enrollment||participants|Number|91|91.0||||||
4235861|NCT00671853|4059381|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
4235862|NCT00671853|4059382|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4235863|NCT00671853|4059380|B3||Male|Gender||Participants|Count of Participants|48|48.0||||||
4235864|NCT00671853|4059381|B2||Male|Gender||Participants|Count of Participants|24|24.0||||||
4235865|NCT00671853|4059382|B1||Male|Gender||Participants|Count of Participants|24|24.0||||||
4235866|NCT00671853|4059380|B3||Female|Gender||Participants|Count of Participants|43|43.0||||||
4235867|NCT00671853|4059381|B2||Female|Gender||Participants|Count of Participants|21|21.0||||||
4235868|NCT00671853|4059382|B1||Female|Gender||Participants|Count of Participants|22|22.0||||||
4235869|NCT00671853|4059380|B3|||Age||years|Mean|37.7|37.7|Standard Deviation|11.6|11.6|||
4235870|NCT00671853|4059381|B2|||Age||years|Mean|37.4|37.4|Standard Deviation|11.3|11.3|||
4235871|NCT00671853|4059382|B1|||Age||years|Mean|38.0|38.0|Standard Deviation|12|12.0|||
4235872|NCT00671853|4059380|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4235873|NCT00671853|4059381|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4235874|NCT00671853|4059382|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4235875|NCT00671853|4059380|B3||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
4235876|NCT00671853|4059381|B2||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4235877|NCT00671853|4059382|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4235878|NCT00671853|4059380|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235879|NCT00671853|4059381|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235880|NCT00671853|4059382|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235881|NCT00671788|4059399|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4235882|NCT00671788|4059399|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4235883|NCT00671788|4059399|B1|80-89 years||Age, Customized||participants|Number|2|2.0||||||
4235884|NCT00671788|4059399|B1|70-79 years||Age, Customized||participants|Number|6|6.0||||||
4235885|NCT00671788|4059399|B1|60-69 years||Age, Customized||participants|Number|13|13.0||||||
4235886|NCT00671788|4059399|B1|50-59 years||Age, Customized||participants|Number|9|9.0||||||
4235887|NCT00671788|4059399|B1|40-49 years||Age, Customized||participants|Number|4|4.0||||||
4235927|NCT00671723|4059419|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4235928|NCT00671723|4059416|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235888|NCT00671749|4059406|B1|VI||Fitzpatrick Skin Type|"Investigator assessment based on the standard Fitzpatrick Skin Test (Scale I to VI). Example:~TYPE 1: Highly sensitive, always burns, never tans. TYPE 2: Very sun sensitive, burns easily, tans minimally. TYPE 3: Sun sensitive skin, sometimes burns, slowly tans to light brown. TYPE 4: Minimally sun sensitive, burns minimally, always tans to moderate brown.~TYPE 5: Sun insensitive skin, rarely burns, tans well. TYPE 6: Sun insensitive, never burns, deeply pigmented"|participants|Number|8|8.0||||||
4235889|NCT00671749|4059406|B1|V||Fitzpatrick Skin Type|"Investigator assessment based on the standard Fitzpatrick Skin Test (Scale I to VI). Example:~TYPE 1: Highly sensitive, always burns, never tans. TYPE 2: Very sun sensitive, burns easily, tans minimally. TYPE 3: Sun sensitive skin, sometimes burns, slowly tans to light brown. TYPE 4: Minimally sun sensitive, burns minimally, always tans to moderate brown.~TYPE 5: Sun insensitive skin, rarely burns, tans well. TYPE 6: Sun insensitive, never burns, deeply pigmented"|participants|Number|4|4.0||||||
4235890|NCT00671749|4059406|B1|IV||Fitzpatrick Skin Type|"Investigator assessment based on the standard Fitzpatrick Skin Test (Scale I to VI). Example:~TYPE 1: Highly sensitive, always burns, never tans. TYPE 2: Very sun sensitive, burns easily, tans minimally. TYPE 3: Sun sensitive skin, sometimes burns, slowly tans to light brown. TYPE 4: Minimally sun sensitive, burns minimally, always tans to moderate brown.~TYPE 5: Sun insensitive skin, rarely burns, tans well. TYPE 6: Sun insensitive, never burns, deeply pigmented"|participants|Number|22|22.0||||||
4235891|NCT00671749|4059406|B1|III||Fitzpatrick Skin Type|"Investigator assessment based on the standard Fitzpatrick Skin Test (Scale I to VI). Example:~TYPE 1: Highly sensitive, always burns, never tans. TYPE 2: Very sun sensitive, burns easily, tans minimally. TYPE 3: Sun sensitive skin, sometimes burns, slowly tans to light brown. TYPE 4: Minimally sun sensitive, burns minimally, always tans to moderate brown.~TYPE 5: Sun insensitive skin, rarely burns, tans well. TYPE 6: Sun insensitive, never burns, deeply pigmented"|participants|Number|38|38.0||||||
4235892|NCT00671749|4059406|B1|II||Fitzpatrick Skin Type|"Investigator assessment based on the standard Fitzpatrick Skin Test (Scale I to VI). Example:~TYPE 1: Highly sensitive, always burns, never tans. TYPE 2: Very sun sensitive, burns easily, tans minimally. TYPE 3: Sun sensitive skin, sometimes burns, slowly tans to light brown. TYPE 4: Minimally sun sensitive, burns minimally, always tans to moderate brown.~TYPE 5: Sun insensitive skin, rarely burns, tans well. TYPE 6: Sun insensitive, never burns, deeply pigmented"|participants|Number|27|27.0||||||
4235893|NCT00671749|4059406|B1|I||Fitzpatrick Skin Type|"Investigator assessment based on the standard Fitzpatrick Skin Test (Scale I to VI). Example:~TYPE 1: Highly sensitive, always burns, never tans. TYPE 2: Very sun sensitive, burns easily, tans minimally. TYPE 3: Sun sensitive skin, sometimes burns, slowly tans to light brown. TYPE 4: Minimally sun sensitive, burns minimally, always tans to moderate brown.~TYPE 5: Sun insensitive skin, rarely burns, tans well. TYPE 6: Sun insensitive, never burns, deeply pigmented"|participants|Number|1|1.0||||||
4235894|NCT00671749|4059406|B1|||Duration of Acne||years|Mean|4.0|4.0|Standard Deviation|3.91|3.91|||
4235895|NCT00671749|4059406|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4235896|NCT00671749|4059406|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
4235897|NCT00671749|4059406|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4235898|NCT00671749|4059406|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4235899|NCT00671749|4059406|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4235900|NCT00671749|4059406|B1||White|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
4235901|NCT00671749|4059406|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4235902|NCT00671749|4059406|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4235903|NCT00671749|4059406|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4235904|NCT00671749|4059406|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4235905|NCT00671749|4059406|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4235906|NCT00671749|4059406|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4235907|NCT00671749|4059406|B1|||Age||years|Mean|18.2|18.2|Standard Deviation|5.40|5.4|||
4235908|NCT00671723|4059416|B4|United States||Region of Enrollment||participants|Number|33|33.0||||||
4235909|NCT00671723|4059417|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4235910|NCT00671723|4059418|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4235911|NCT00671723|4059419|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4235912|NCT00671723|4059416|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4235913|NCT00671723|4059417|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4235914|NCT00671723|4059418|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4235915|NCT00671723|4059419|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4235916|NCT00671723|4059416|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4235917|NCT00671723|4059417|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4235918|NCT00671723|4059418|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4235919|NCT00671723|4059419|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4235920|NCT00671723|4059416|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4235921|NCT00671723|4059417|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4235922|NCT00671723|4059418|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4235923|NCT00671723|4059419|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4235924|NCT00671723|4059416|B4||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4235925|NCT00671723|4059417|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4235926|NCT00671723|4059418|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4235929|NCT00671723|4059417|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235930|NCT00671723|4059418|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235931|NCT00671723|4059419|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235932|NCT00671723|4059416|B4|||Age||years|Mean|47|47.0|Standard Deviation|16|16.0|||
4235933|NCT00671723|4059417|B3|||Age||years|Mean|49|49.0|Standard Deviation|18|18.0|||
4235934|NCT00671723|4059418|B2|||Age||years|Mean|48|48.0|Standard Deviation|15|15.0|||
4235935|NCT00671723|4059419|B1|||Age||years|Mean|45|45.0|Standard Deviation|15|15.0|||
4235936|NCT00671671|4059432|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4235937|NCT00671671|4059433|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4235938|NCT00671671|4059434|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4235939|NCT00671671|4059432|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4235940|NCT00671671|4059433|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4235941|NCT00671671|4059434|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4235942|NCT00671671|4059432|B3|greater than or equal to (>=) 65 years||Age, Customized||participants|Number|1|1.0||||||
4235943|NCT00671671|4059433|B2|greater than or equal to (>=) 65 years||Age, Customized||participants|Number|1|1.0||||||
4235944|NCT00671671|4059434|B1|greater than or equal to (>=) 65 years||Age, Customized||participants|Number|0|0.0||||||
4235945|NCT00671671|4059432|B3|45 to 64 years||Age, Customized||participants|Number|16|16.0||||||
4235946|NCT00671671|4059433|B2|45 to 64 years||Age, Customized||participants|Number|7|7.0||||||
4235947|NCT00671671|4059434|B1|45 to 64 years||Age, Customized||participants|Number|9|9.0||||||
4235948|NCT00671671|4059432|B3|18 to 44 years||Age, Customized||participants|Number|3|3.0||||||
4235949|NCT00671671|4059433|B2|18 to 44 years||Age, Customized||participants|Number|2|2.0||||||
4235950|NCT00671671|4059434|B1|18 to 44 years||Age, Customized||participants|Number|1|1.0||||||
4235951|NCT00671606|4059461|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4235952|NCT00671606|4059461|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4235953|NCT00671606|4059461|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4235954|NCT00671606|4059461|B1|||Age||years|Median|56|56.0|Full Range|||49.0|65.0|
4235955|NCT00671554|4059465|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4235956|NCT00671554|4059465|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4235957|NCT00671554|4059465|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4235958|NCT00671554|4059465|B1|||Age||years|Mean|70|70.0|Standard Deviation|5.29|5.29|||
4235959|NCT00671554|4059465|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4235960|NCT00671554|4059465|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4235961|NCT00671554|4059465|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235962|NCT00671528|4059470|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4235963|NCT00671528|4059471|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4235964|NCT00671528|4059472|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4235965|NCT00671528|4059473|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4235966|NCT00671528|4059470|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4235967|NCT00671528|4059471|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4235968|NCT00671528|4059472|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4235969|NCT00671528|4059473|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4235970|NCT00671528|4059470|B4|>=65 years||Age, Customized||participants|Number|2|2.0||||||
4235971|NCT00671528|4059471|B3|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4235972|NCT00671528|4059472|B2|>=65 years||Age, Customized||participants|Number|1|1.0||||||
4235973|NCT00671528|4059473|B1|>=65 years||Age, Customized||participants|Number|1|1.0||||||
4235974|NCT00671528|4059470|B4|Between 18 and 65 years||Age, Customized||participants|Number|1|1.0||||||
4235975|NCT00671528|4059471|B3|Between 18 and 65 years||Age, Customized||participants|Number|1|1.0||||||
4235976|NCT00671528|4059472|B2|Between 18 and 65 years||Age, Customized||participants|Number|0|0.0||||||
4235977|NCT00671528|4059473|B1|Between 18 and 65 years||Age, Customized||participants|Number|0|0.0||||||
4235978|NCT00671515|4059486|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4235979|NCT00671515|4059486|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
4235980|NCT00671515|4059486|B1||Female|Gender||Participants|Count of Participants|20|20.0||||||
4235981|NCT00671515|4059486|B1|||Age||years|Mean|44.6|44.6|Standard Deviation|10.2|10.2|||
4235982|NCT00671515|4059486|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4235983|NCT00671515|4059486|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4235984|NCT00671515|4059486|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4235985|NCT00671502|4059491|B4|United States||Region of Enrollment||participants|Number|840|840.0||||||
4235986|NCT00671502|4059492|B3|United States||Region of Enrollment||participants|Number|279|279.0||||||
4235987|NCT00671502|4059493|B2|United States||Region of Enrollment||participants|Number|280|280.0||||||
4235988|NCT00671502|4059494|B1|United States||Region of Enrollment||participants|Number|281|281.0||||||
4235989|NCT00671502|4059491|B4||Male|Sex: Female, Male||Participants|Count of Participants|427|427.0||||||
4235990|NCT00671502|4059492|B3||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4235991|NCT00671502|4059493|B2||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4235992|NCT00671502|4059494|B1||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4235993|NCT00671502|4059491|B4||Female|Sex: Female, Male||Participants|Count of Participants|413|413.0||||||
4235994|NCT00671502|4059492|B3||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4235995|NCT00671502|4059493|B2||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4235996|NCT00671502|4059494|B1||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4235997|NCT00671502|4059491|B4|||Age||years|Mean|40.9|40.9|Standard Deviation|12.78|12.78|||
4235998|NCT00671502|4059492|B3|||Age||years|Mean|40.9|40.9|Standard Deviation|12.72|12.72|||
4235999|NCT00671502|4059493|B2|||Age||years|Mean|41.4|41.4|Standard Deviation|12.6|12.6|||
4236000|NCT00671502|4059494|B1|||Age||years|Mean|40.3|40.3|Standard Deviation|13.05|13.05|||
4236001|NCT00671502|4059491|B4||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4236002|NCT00671502|4059492|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4236003|NCT00671502|4059493|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4236004|NCT00671502|4059494|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4236005|NCT00671502|4059491|B4||Between 18 and 65 years|Age||Participants|Count of Participants|831|831.0||||||
4236006|NCT00671502|4059492|B3||Between 18 and 65 years|Age||Participants|Count of Participants|275|275.0||||||
4236007|NCT00671502|4059493|B2||Between 18 and 65 years|Age||Participants|Count of Participants|278|278.0||||||
4236008|NCT00671502|4059494|B1||Between 18 and 65 years|Age||Participants|Count of Participants|278|278.0||||||
4236009|NCT00671502|4059491|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236010|NCT00671502|4059492|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236011|NCT00671502|4059493|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236012|NCT00671502|4059494|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236013|NCT00671437|4059504|B1|No||Prior Cetuximab Exposure||participants|Number|19|19.0||||||
4236014|NCT00671437|4059504|B1|Yes||Prior Cetuximab Exposure||participants|Number|8|8.0||||||
4236015|NCT00671437|4059504|B1|Hypopharynx||Primary Tumor Site||participants|Number|5|5.0||||||
4236016|NCT00671437|4059504|B1|Larynx||Primary Tumor Site||participants|Number|4|4.0||||||
4236017|NCT00671437|4059504|B1|Oropharynx||Primary Tumor Site||participants|Number|8|8.0||||||
4236018|NCT00671437|4059504|B1|Oral cavity||Primary Tumor Site||participants|Number|10|10.0||||||
4236019|NCT00671437|4059504|B1|No||Smoking history||participants|Number|3|3.0||||||
4236020|NCT00671437|4059504|B1|Yes||Smoking history||participants|Number|24|24.0||||||
4236021|NCT00671437|4059504|B1|Performance Status 2||Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status Grade 0 Fully active able to carry on all predisease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (light house work/office work)~Ambulatory, capable of all selfcare but unable to carry out any work activities. Up & about more than 50% of waking hours~Capable of limited selfcare, confined to bed/chair more than 50% of waking hours~Completely disabled. Cannot carry on selfcare. Totally confined to bed/chair~Dead"|participants|Number|9|9.0||||||
4236022|NCT00671437|4059504|B1|Performance Status 1||Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status Grade 0 Fully active able to carry on all predisease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (light house work/office work)~Ambulatory, capable of all selfcare but unable to carry out any work activities. Up & about more than 50% of waking hours~Capable of limited selfcare, confined to bed/chair more than 50% of waking hours~Completely disabled. Cannot carry on selfcare. Totally confined to bed/chair~Dead"|participants|Number|13|13.0||||||
4236023|NCT00671437|4059504|B1|Performance Status 0||Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status Grade 0 Fully active able to carry on all predisease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (light house work/office work)~Ambulatory, capable of all selfcare but unable to carry out any work activities. Up & about more than 50% of waking hours~Capable of limited selfcare, confined to bed/chair more than 50% of waking hours~Completely disabled. Cannot carry on selfcare. Totally confined to bed/chair~Dead"|participants|Number|5|5.0||||||
4236024|NCT00671437|4059504|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4236025|NCT00671437|4059504|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236026|NCT00671437|4059504|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236027|NCT00671437|4059504|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4236028|NCT00671437|4059504|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4236029|NCT00671437|4059504|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236030|NCT00671437|4059504|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4236031|NCT00671437|4059504|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236032|NCT00671437|4059504|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4236033|NCT00671437|4059504|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4236034|NCT00671437|4059504|B1|||Age||years|Median|63|63.0|Full Range|||35.0|87.0|
4236035|NCT00671437|4059504|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4236036|NCT00671437|4059504|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4236037|NCT00671437|4059504|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236038|NCT00671177|4059523|B3||Male|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
4236039|NCT00671177|4059524|B2||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4236040|NCT00671177|4059525|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4236041|NCT00671177|4059523|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4236042|NCT00671177|4059524|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4236043|NCT00671177|4059525|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4236044|NCT00671177|4059523|B3|||Age||years|Mean|62.5|62.5|Standard Deviation|8.9|8.9|||
4236045|NCT00671177|4059524|B2|||Age||years|Mean|62.5|62.5|Standard Deviation|8.9|8.9|||
4236046|NCT00671177|4059525|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|8.9|8.9|||
4236047|NCT00671060|4059536|B3|Vietnam||Region of Enrollment||participants|Number|140|140.0||||||
4236048|NCT00671060|4059537|B2|Vietnam||Region of Enrollment||participants|Number|70|70.0||||||
4236049|NCT00671060|4059538|B1|Vietnam||Region of Enrollment||participants|Number|70|70.0||||||
4236050|NCT00671060|4059536|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4236051|NCT00671060|4059537|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4236052|NCT00671060|4059538|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4236053|NCT00671060|4059536|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4236054|NCT00671060|4059537|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4236055|NCT00671060|4059538|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4236056|NCT00671060|4059536|B3||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4236057|NCT00671060|4059537|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4236058|NCT00671060|4059538|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4236059|NCT00671060|4059536|B3|||Age||years|Mean|25.7|25.7|Standard Deviation|5.7|5.7|||
4236060|NCT00671060|4059537|B2|||Age||years|Mean|25.8|25.8|Standard Deviation|5.9|5.9|||
4236061|NCT00671060|4059538|B1|||Age||years|Mean|25.6|25.6|Standard Deviation|5.6|5.6|||
4236062|NCT00671060|4059536|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4236063|NCT00671060|4059537|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4236064|NCT00671060|4059538|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4236065|NCT00671060|4059536|B3||Between 18 and 65 years|Age||Participants|Count of Participants|146|146.0||||||
4236066|NCT00671060|4059537|B2||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4236067|NCT00671060|4059538|B1||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4236068|NCT00671060|4059536|B3||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4236069|NCT00671060|4059537|B2||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4236070|NCT00671060|4059538|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4236071|NCT00671034|4059545|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4236072|NCT00671034|4059546|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4236073|NCT00671034|4059547|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4236074|NCT00671034|4059548|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4236075|NCT00671034|4059545|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236076|NCT00671034|4059546|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236077|NCT00671034|4059547|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236078|NCT00671034|4059548|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236079|NCT00671034|4059545|B4||White|Race (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
4236080|NCT00671034|4059546|B3||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4236081|NCT00671034|4059547|B2||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4236082|NCT00671034|4059548|B1||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4236083|NCT00671034|4059545|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4236084|NCT00671034|4059546|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4236085|NCT00671034|4059547|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4236086|NCT00671034|4059548|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4236087|NCT00671034|4059545|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4236088|NCT00671034|4059546|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236089|NCT00671034|4059547|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4236090|NCT00671034|4059548|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4236091|NCT00671034|4059545|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4236092|NCT00671034|4059546|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4236093|NCT00671034|4059547|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4236094|NCT00671034|4059548|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4236095|NCT00671034|4059545|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236096|NCT00671034|4059546|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236097|NCT00671034|4059547|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236098|NCT00671034|4059548|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236099|NCT00671034|4059545|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4236100|NCT00671034|4059546|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4236101|NCT00671034|4059547|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4236102|NCT00671034|4059548|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4236103|NCT00671034|4059545|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|116|116.0||||||
4236104|NCT00671034|4059546|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4236105|NCT00671034|4059547|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4236106|NCT00671034|4059548|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4236107|NCT00671034|4059545|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4236108|NCT00671034|4059546|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4236109|NCT00671034|4059547|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4236110|NCT00671034|4059548|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4236111|NCT00671034|4059545|B4||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4236112|NCT00671034|4059546|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4236113|NCT00671034|4059547|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4236114|NCT00671034|4059548|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4236115|NCT00671034|4059545|B4||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4236116|NCT00671034|4059546|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4236117|NCT00671034|4059547|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4236118|NCT00671034|4059548|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4236119|NCT00671034|4059545|B4|||Age||years|Mean|11.3|11.3|Standard Deviation|5.72|5.72|||
4236120|NCT00671034|4059546|B3|||Age||years|Mean|10.79|10.79|Standard Deviation|5.54|5.54|||
4236121|NCT00671034|4059547|B2|||Age||years|Mean|9.9|9.9|Standard Deviation|6.09|6.09|||
4236122|NCT00671034|4059548|B1|||Age||years|Mean|11.9|11.9|Standard Deviation|5.58|5.58|||
4236123|NCT00671034|4059545|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4236124|NCT00671034|4059546|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4236125|NCT00671034|4059547|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4236126|NCT00671034|4059548|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4236127|NCT00671034|4059545|B4||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4236128|NCT00671034|4059546|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4236129|NCT00671034|4059547|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4236130|NCT00671034|4059548|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4236131|NCT00671034|4059545|B4||<=18 years|Age||Participants|Count of Participants|153|153.0||||||
4236132|NCT00671034|4059546|B3||<=18 years|Age||Participants|Count of Participants|51|51.0||||||
4236133|NCT00671034|4059547|B2||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
4236134|NCT00671034|4059548|B1||<=18 years|Age||Participants|Count of Participants|62|62.0||||||
4236135|NCT00670982|4059585|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
4236136|NCT00670982|4059586|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4236137|NCT00670982|4059587|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4236138|NCT00670982|4059585|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4236139|NCT00670982|4059586|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4236140|NCT00670982|4059587|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4236141|NCT00670982|4059585|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4236142|NCT00670982|4059586|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4236143|NCT00670982|4059587|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4236144|NCT00670982|4059585|B3|||Age||years|Mean|50.3|50.3|Standard Deviation|7.9|7.9|||
4236145|NCT00670982|4059586|B2|||Age||years|Mean|46.7|46.7|Standard Deviation|6.9|6.9|||
4236146|NCT00670982|4059587|B1|||Age||years|Mean|51.5|51.5|Standard Deviation|8|8.0|||
4236147|NCT00670982|4059585|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4236148|NCT00670982|4059586|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4236149|NCT00670982|4059587|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4236150|NCT00670982|4059585|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4236151|NCT00670982|4059586|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4236152|NCT00670982|4059587|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4236153|NCT00670982|4059585|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236154|NCT00670982|4059586|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236155|NCT00670982|4059587|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236156|NCT00670956|4059597|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4236157|NCT00670956|4059597|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236158|NCT00670956|4059597|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236159|NCT00670956|4059597|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236160|NCT00670956|4059597|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236161|NCT00670956|4059597|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236162|NCT00670956|4059597|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4236163|NCT00670956|4059597|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236164|NCT00670956|4059597|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4236165|NCT00670956|4059597|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4236166|NCT00670956|4059597|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4236167|NCT00670956|4059597|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4236168|NCT00670956|4059597|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236169|NCT00670930|4059603|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4236170|NCT00670930|4059604|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4236171|NCT00670930|4059605|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4236172|NCT00670930|4059603|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4236173|NCT00670930|4059604|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4236174|NCT00670930|4059605|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4236175|NCT00670930|4059603|B3|||Age|Demographics analysis based on Intent to treat population.|Years|Mean|43.1|43.1|Standard Deviation|9.8|9.8|||
4236176|NCT00670930|4059604|B2|||Age|Demographics analysis based on Intent to treat population.|Years|Mean|41.8|41.8|Standard Deviation|10.43|10.43|||
4236177|NCT00670930|4059605|B1|||Age|Demographics analysis based on Intent to treat population.|Years|Mean|43.7|43.7|Standard Deviation|9.66|9.66|||
4236178|NCT00670800|4059620|B3|||HOMA-IR|Homeostatic model assessment insulin resistance measured in milliunits per Liters|mU/L|Median|2.150|2.15|Inter-Quartile Range|||1.1|2.775|
4236179|NCT00670800|4059621|B2|||HOMA-IR|Homeostatic model assessment insulin resistance measured in milliunits per Liters|mU/L|Median|1|1.0|Inter-Quartile Range|||0.8|1.2|
4236180|NCT00670800|4059622|B1|||HOMA-IR|Homeostatic model assessment insulin resistance measured in milliunits per Liters|mU/L|Median|2.7|2.7|Inter-Quartile Range|||2.1|3.3|
4236181|NCT00670800|4059620|B3|||Homeostatic Model Assessment (HOMA)|Homeostatic model assessment sensitivity reported in percentage|% - percentage|Median|46.65|46.65|Inter-Quartile Range|||36.375|91.025|
4236182|NCT00670800|4059621|B2|||Homeostatic Model Assessment (HOMA)|Homeostatic model assessment sensitivity reported in percentage|% - percentage|Median|95.4|95.4|Inter-Quartile Range|||82.6|108.2|
4236183|NCT00670800|4059622|B1|||Homeostatic Model Assessment (HOMA)|Homeostatic model assessment sensitivity reported in percentage|% - percentage|Median|36.6|36.6|Inter-Quartile Range|||27.3|45.9|
4236184|NCT00670800|4059620|B3|||Fasting Glucose|Fasting Glucose measured in milligrams/deciliter|mg/dl|Median|89|89.0|Inter-Quartile Range|||85.25|95.75|
4236185|NCT00670800|4059621|B2|||Fasting Glucose|Fasting Glucose measured in milligrams/deciliter|mg/dl|Median|89|89.0|Inter-Quartile Range|||82.0|96.0|
4236186|NCT00670800|4059622|B1|||Fasting Glucose|Fasting Glucose measured in milligrams/deciliter|mg/dl|Median|87|87.0|Inter-Quartile Range|||72.0|102.0|
4236187|NCT00670800|4059620|B3|||Fasting Insulin|Fasting Insulin measured in microunits/milliliter|uU/ml|Median|17.25|17.25|Inter-Quartile Range|||8.475|21.475|
4236188|NCT00670800|4059621|B2|||Fasting Insulin|Fasting Insulin measured in microunits/milliliter|uU/ml|Median|8.1|8.1|Inter-Quartile Range|||7.2|9.0|
4236189|NCT00670800|4059622|B1|||Fasting Insulin|Fasting Insulin measured in microunits/milliliter|uU/ml|Median|21.4|21.4|Inter-Quartile Range|||16.3|26.5|
4236190|NCT00670800|4059620|B3|||Triglycerides|Triglycerides measured in measured in milligrams/deciliter|mg/dl|Median|73|73.0|Inter-Quartile Range|||59.75|112.25|
4236191|NCT00670800|4059621|B2|||Triglycerides|Triglycerides measured in measured in milligrams/deciliter|mg/dl|Median|72|72.0|Inter-Quartile Range|||45.0|109.0|
4236192|NCT00670800|4059622|B1|||Triglycerides|Triglycerides measured in measured in milligrams/deciliter|mg/dl|Median|74|74.0|Inter-Quartile Range|||32.0|116.0|
4236193|NCT00670800|4059620|B3|||HDL|High-density lipoprotein measured in milligrams/deciliter|mg/dl|Median|55.5|55.5|Inter-Quartile Range|||47.0|76.0|
4236194|NCT00670800|4059621|B2|||HDL|High-density lipoprotein measured in milligrams/deciliter|mg/dl|Median|76|76.0|Inter-Quartile Range|||52.0|100.0|
4236195|NCT00670800|4059622|B1|||HDL|High-density lipoprotein measured in milligrams/deciliter|mg/dl|Median|47|47.0|Inter-Quartile Range|||30.0|64.0|
4236196|NCT00670800|4059620|B3|||DHEAS|Dehydroepiandrosterone Sulfate (DHEAS)measured in micrograms/deciliter|ug/dl|Median|191|191.0|Inter-Quartile Range|||145.0|236.5|
4236197|NCT00670800|4059621|B2|||DHEAS|Dehydroepiandrosterone Sulfate (DHEAS)measured in micrograms/deciliter|ug/dl|Median|189|189.0|Inter-Quartile Range|||101.0|277.0|
4236198|NCT00670800|4059622|B1|||DHEAS|Dehydroepiandrosterone Sulfate (DHEAS)measured in micrograms/deciliter|ug/dl|Median|200|200.0|Inter-Quartile Range|||112.0|288.0|
4236199|NCT00670800|4059620|B3|||Total Cholesterol|Total cholesterol measured in milligrams over deciliter|mg/dl|Median|174|174.0|Inter-Quartile Range|||140.25|195.0|
4236200|NCT00670800|4059621|B2|||Total Cholesterol|Total cholesterol measured in milligrams over deciliter|mg/dl|Median|179|179.0|Inter-Quartile Range|||119.0|239.0|
4236201|NCT00670800|4059622|B1|||Total Cholesterol|Total cholesterol measured in milligrams over deciliter|mg/dl|Median|157|157.0|Inter-Quartile Range|||111.0|203.0|
4236202|NCT00670800|4059620|B3|||Total Testosterone|Total Testosterone measured in nanograms over milliliters|ng/ml|Median|.55|0.55|Inter-Quartile Range|||0.37|0.825|
4236203|NCT00670800|4059621|B2|||Total Testosterone|Total Testosterone measured in nanograms over milliliters|ng/ml|Median|.36|0.36|Inter-Quartile Range|||0.04|0.68|
4236204|NCT00670800|4059622|B1|||Total Testosterone|Total Testosterone measured in nanograms over milliliters|ng/ml|Median|.7|0.7|Inter-Quartile Range|||0.19|1.21|
4236205|NCT00670800|4059620|B3|||Free Testosterone|Free testosterone measured in picograms over milliliters|pg/ml|Median|1|1.0|Inter-Quartile Range|||0.525|1.4|
4236206|NCT00670800|4059621|B2|||Free Testosterone|Free testosterone measured in picograms over milliliters|pg/ml|Median|.5|0.5|Inter-Quartile Range|||0.3|0.7|
4236207|NCT00670800|4059622|B1|||Free Testosterone|Free testosterone measured in picograms over milliliters|pg/ml|Median|1.5|1.5|Inter-Quartile Range|||0.6|2.4|
4236208|NCT00670800|4059620|B3|||Waist Circumference|Waist circumference measured in cm|cm|Median|92|92.0|Inter-Quartile Range|||73.5|103.5|
4236209|NCT00670800|4059621|B2|||Waist Circumference|Waist circumference measured in cm|cm|Median|72|72.0|Inter-Quartile Range|||58.5|85.5|
4236210|NCT00670800|4059622|B1|||Waist Circumference|Waist circumference measured in cm|cm|Median|102|102.0|Inter-Quartile Range|||74.4|129.6|
4236211|NCT00670800|4059620|B3|||BMI (Body Mass Index)|lbs/inches squared (pounds over inches squared)|lbs/inch^2|Median|29.5|29.5|Inter-Quartile Range|||22.95|37.75|
4236212|NCT00670800|4059621|B2|||BMI (Body Mass Index)|lbs/inches squared (pounds over inches squared)|lbs/inch^2|Median|23|23.0|Inter-Quartile Range|||19.9|26.1|
4236213|NCT00670800|4059622|B1|||BMI (Body Mass Index)|lbs/inches squared (pounds over inches squared)|lbs/inch^2|Median|35.3|35.3|Inter-Quartile Range|||19.1|51.5|
4236214|NCT00670800|4059620|B3|||Weight|Body weight measured in pounds (lbs)|pounds (lbs)|Median|170.48|170.48|Inter-Quartile Range|||138.1|202.9|
4236215|NCT00670800|4059621|B2|||Weight|Body weight measured in pounds (lbs)|pounds (lbs)|Median|123.7|123.7|Inter-Quartile Range|||106.0|141.4|
4236216|NCT00670800|4059622|B1|||Weight|Body weight measured in pounds (lbs)|pounds (lbs)|Median|203.9|203.9|Inter-Quartile Range|||161.0|246.8|
4236217|NCT00670800|4059620|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4236218|NCT00670800|4059621|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4236219|NCT00670800|4059622|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4236220|NCT00670800|4059620|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4236221|NCT00670800|4059621|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4236222|NCT00670800|4059622|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4236223|NCT00670800|4059620|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4236224|NCT00670800|4059621|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4236225|NCT00670800|4059622|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4236226|NCT00670800|4059620|B3|||Age||years|Mean|26.4|26.4|Standard Deviation|4|4.0|||
4236227|NCT00670800|4059621|B2|||Age||years|Mean|26.6|26.6|Standard Deviation|4|4.0|||
4236228|NCT00670800|4059622|B1|||Age||years|Mean|26.3|26.3|Standard Deviation|4|4.0|||
4236229|NCT00670800|4059620|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4236230|NCT00670800|4059621|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4236231|NCT00670800|4059622|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4236232|NCT00670800|4059620|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4236233|NCT00670800|4059621|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4236234|NCT00670800|4059622|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4236235|NCT00670800|4059620|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236236|NCT00670800|4059621|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236237|NCT00670800|4059622|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236238|NCT00670774|4059639|B1|||Donor Specific Alloantibody|The presence and amount of donor specific alloantibody (DSA) was assessed using cell-based T- and B-flow cytometric crossmatch channel shift. The channel shift is the observed number of channels (raw fluorescence) above the negative control. The units for DSA are mean channel fluorescence (MCF) shifts from negative control (MCF shift from NC).|MCF shift from NC|Mean|330|330.0|Standard Deviation|84|84.0|||
4236239|NCT00670774|4059639|B1|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
4236240|NCT00670774|4059639|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4236241|NCT00670774|4059639|B1|Caucasian white||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
4236242|NCT00670774|4059639|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4236243|NCT00670774|4059639|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4236244|NCT00670774|4059639|B1|||Age||years|Mean|48.6|48.6|Standard Deviation|12.5|12.5|||
4236245|NCT00670748|4059650|B5|United States||Region of Enrollment||participants|Number|45|45.0||||||
4236246|NCT00670748|4059651|B4|United States||Region of Enrollment||participants|Number|5|5.0||||||
4236247|NCT00670748|4059652|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4236248|NCT00670748|4059653|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4236249|NCT00670748|4059654|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4236250|NCT00670748|4059650|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4236251|NCT00670748|4059651|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236252|NCT00670748|4059652|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4236253|NCT00670748|4059653|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4236254|NCT00670748|4059654|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4236255|NCT00670748|4059650|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236256|NCT00670748|4059651|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236257|NCT00670748|4059652|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236258|NCT00670748|4059653|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236259|NCT00670748|4059654|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236260|NCT00670748|4059650|B5||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4236261|NCT00670748|4059651|B4||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4236262|NCT00670748|4059652|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4236263|NCT00670748|4059653|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4236264|NCT00670748|4059654|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4236265|NCT00670748|4059650|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236266|NCT00670748|4059651|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236267|NCT00670748|4059652|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236268|NCT00670748|4059653|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236269|NCT00670748|4059654|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236270|NCT00670748|4059650|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236271|NCT00670748|4059651|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236272|NCT00670748|4059652|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236273|NCT00670748|4059653|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236274|NCT00670748|4059654|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236275|NCT00670748|4059650|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4236276|NCT00670748|4059651|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236277|NCT00670748|4059652|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236278|NCT00670748|4059653|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4236279|NCT00670748|4059654|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236280|NCT00670748|4059650|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236281|NCT00670748|4059651|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236282|NCT00670748|4059652|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236283|NCT00670748|4059653|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236284|NCT00670748|4059654|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236285|NCT00670748|4059650|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236286|NCT00670748|4059651|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236287|NCT00670748|4059652|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236288|NCT00670748|4059653|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236289|NCT00670748|4059654|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236290|NCT00670748|4059650|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4236291|NCT00670748|4059651|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4236292|NCT00670748|4059652|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4236293|NCT00670748|4059653|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4236294|NCT00670748|4059654|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4236295|NCT00670748|4059650|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4236296|NCT00670748|4059651|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236297|NCT00670748|4059652|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4236298|NCT00670748|4059653|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4236299|NCT00670748|4059654|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4236300|NCT00670748|4059650|B5||Male|Gender||Participants|Count of Participants|29|29.0||||||
4236301|NCT00670748|4059651|B4||Male|Gender||Participants|Count of Participants|3|3.0||||||
4236302|NCT00670748|4059652|B3||Male|Gender||Participants|Count of Participants|5|5.0||||||
4236303|NCT00670748|4059653|B2||Male|Gender||Participants|Count of Participants|9|9.0||||||
4236304|NCT00670748|4059654|B1||Male|Gender||Participants|Count of Participants|12|12.0||||||
4236305|NCT00670748|4059650|B5||Female|Gender||Participants|Count of Participants|16|16.0||||||
4236306|NCT00670748|4059651|B4||Female|Gender||Participants|Count of Participants|2|2.0||||||
4236307|NCT00670748|4059652|B3||Female|Gender||Participants|Count of Participants|2|2.0||||||
4236308|NCT00670748|4059653|B2||Female|Gender||Participants|Count of Participants|7|7.0||||||
4236309|NCT00670748|4059654|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
4236310|NCT00670748|4059650|B5|||Age||years|Mean|43.6|43.6|Standard Deviation|13.3|13.3|||
4236311|NCT00670748|4059651|B4|||Age||years|Mean|38.8|38.8|Standard Deviation|16.0|16.0|||
4236312|NCT00670748|4059652|B3|||Age||years|Mean|44.4|44.4|Standard Deviation|10.4|10.4|||
4236313|NCT00670748|4059653|B2|||Age||years|Mean|38.9|38.9|Standard Deviation|14.1|14.1|||
4236314|NCT00670748|4059654|B1|||Age||years|Mean|49.2|49.2|Standard Deviation|11.6|11.6|||
4236315|NCT00670748|4059650|B5||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4236316|NCT00670748|4059651|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4236317|NCT00670748|4059652|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4236318|NCT00670748|4059653|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4236319|NCT00670748|4059654|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4236320|NCT00670748|4059650|B5||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4236321|NCT00670748|4059651|B4||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4236322|NCT00670748|4059652|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4236323|NCT00670748|4059653|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4236324|NCT00670748|4059654|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4236325|NCT00670748|4059650|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236326|NCT00670748|4059651|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236327|NCT00670748|4059652|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236328|NCT00670748|4059653|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236329|NCT00670748|4059654|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236330|NCT00670709|4059675|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4236331|NCT00670709|4059676|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4236332|NCT00670709|4059677|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4236333|NCT00670709|4059675|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4236334|NCT00670709|4059676|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4236335|NCT00670709|4059677|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4236336|NCT00670709|4059675|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4236337|NCT00670709|4059676|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4236338|NCT00670709|4059677|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4236339|NCT00670709|4059675|B3|||Age||years|Mean|46.85|46.85|Standard Deviation|10.5|10.5|||
4236340|NCT00670709|4059676|B2|||Age||years|Mean|47.3|47.3|Standard Deviation|9.7|9.7|||
4236341|NCT00670709|4059677|B1|||Age||years|Mean|46.4|46.4|Standard Deviation|11.3|11.3|||
4236342|NCT00670709|4059675|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4236343|NCT00670709|4059676|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4236344|NCT00670709|4059677|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4236345|NCT00670709|4059675|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4236346|NCT00670709|4059676|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4236347|NCT00670709|4059677|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4236348|NCT00670709|4059675|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236349|NCT00670709|4059676|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236350|NCT00670709|4059677|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236351|NCT00670540|4059692|B1|Belgium||Region of Enrollment||participants|Number|27|27.0||||||
4236352|NCT00670540|4059692|B1|Guadeloupe||Region of Enrollment||participants|Number|321|321.0||||||
4236353|NCT00670540|4059692|B1|France||Region of Enrollment||participants|Number|7908|7908.0||||||
4236354|NCT00670540|4059692|B1||Male|Sex: Female, Male||Participants|Count of Participants|3193|3193.0||||||
4236355|NCT00670540|4059692|B1||Female|Sex: Female, Male||Participants|Count of Participants|5063|5063.0||||||
4236356|NCT00670540|4059692|B1|||Age||years|Mean|62|62.0|Standard Deviation|18|18.0|||
4236357|NCT00670462|4059702|B3|||BMI (kg/m2)||kg/m2|Mean|34.9|34.9|Standard Deviation|2.8|2.8|||
4236358|NCT00670462|4059703|B2|||BMI (kg/m2)||kg/m2|Mean|34.6|34.6|Standard Deviation|2.8|2.8|||
4236359|NCT00670462|4059704|B1|||BMI (kg/m2)||kg/m2|Mean|35.2|35.2|Standard Deviation|2.8|2.8|||
4236360|NCT00670462|4059702|B3|||energy expenditure (kcal/wk)||kcal/wk|Mean|919.2|919.2|Standard Deviation|1112.95|1112.95|||
4236361|NCT00670462|4059703|B2|||energy expenditure (kcal/wk)||kcal/wk|Mean|954.2|954.2|Standard Deviation|1267.2|1267.2|||
4236362|NCT00670462|4059704|B1|||energy expenditure (kcal/wk)||kcal/wk|Mean|884.2|884.2|Standard Deviation|958.7|958.7|||
4236363|NCT00670462|4059702|B3|||energy intake (kcal/day)||kcal/day|Mean|1978.4|1978.4|Standard Deviation|921.5|921.5|||
4236364|NCT00670462|4059703|B2|||energy intake (kcal/day)||kcal/day|Mean|1976.4|1976.4|Standard Deviation|922.7|922.7|||
4236365|NCT00670462|4059704|B1|||energy intake (kcal/day)||kcal/day|Mean|1980.4|1980.4|Standard Deviation|924.7|924.7|||
4236366|NCT00670462|4059702|B3|United States||Region of Enrollment||participants|Number|213|213.0||||||
4236367|NCT00670462|4059703|B2|United States||Region of Enrollment||participants|Number|107|107.0||||||
4236368|NCT00670462|4059704|B1|United States||Region of Enrollment||participants|Number|106|106.0||||||
4236369|NCT00670462|4059702|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4236370|NCT00670462|4059703|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4236371|NCT00670462|4059704|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4236372|NCT00670462|4059702|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4236373|NCT00670462|4059703|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4236374|NCT00670462|4059704|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4236375|NCT00670462|4059702|B3||White|Race (NIH/OMB)||Participants|Count of Participants|143|143.0||||||
4236376|NCT00670462|4059703|B2||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
4236377|NCT00670462|4059704|B1||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4236378|NCT00670462|4059702|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4236379|NCT00670462|4059703|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4236380|NCT00670462|4059704|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4236381|NCT00670462|4059702|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4236382|NCT00670462|4059703|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236383|NCT00670462|4059704|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4236384|NCT00670462|4059702|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4236385|NCT00670462|4059703|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4236386|NCT00670462|4059704|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4236387|NCT00670462|4059702|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4236388|NCT00670462|4059703|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236389|NCT00670462|4059704|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4236390|NCT00670462|4059702|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4236391|NCT00670462|4059703|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4236392|NCT00670462|4059704|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4236393|NCT00670462|4059702|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4236394|NCT00670462|4059703|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4236395|NCT00670462|4059704|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4236396|NCT00670462|4059702|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4236397|NCT00670462|4059703|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4236398|NCT00670462|4059704|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4236399|NCT00670462|4059702|B3||Between 18 and 65 years|Age||Participants|Count of Participants|205|205.0||||||
4236400|NCT00670462|4059703|B2||Between 18 and 65 years|Age||Participants|Count of Participants|103|103.0||||||
4236401|NCT00670462|4059704|B1||Between 18 and 65 years|Age||Participants|Count of Participants|102|102.0||||||
4236402|NCT00670462|4059702|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236403|NCT00670462|4059703|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236404|NCT00670462|4059704|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236405|NCT00670462|4059702|B3|||Age||years|Mean|48.8|48.8|Standard Deviation|10.5|10.5|||
4236406|NCT00670462|4059703|B2|||Age||years|Mean|48.5|48.5|Standard Deviation|10.5|10.5|||
4236407|NCT00670462|4059704|B1|||Age||years|Mean|49.1|49.1|Standard Deviation|10.6|10.6|||
4236408|NCT00670449|4059733|B5||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4236409|NCT00670449|4059734|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4236410|NCT00670449|4059735|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4236411|NCT00670449|4059736|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4236412|NCT00670449|4059737|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4236413|NCT00670449|4059733|B5||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4236414|NCT00670449|4059734|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4236415|NCT00670449|4059735|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4236416|NCT00670449|4059736|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4236417|NCT00670449|4059737|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4236418|NCT00670449|4059733|B5|||Age||years|Mean|35.1|35.1|Standard Deviation|8.78|8.78|||
4236419|NCT00670449|4059734|B4|||Age||years|Mean|35.5|35.5|Standard Deviation|8.44|8.44|||
4236420|NCT00670449|4059735|B3|||Age||years|Mean|34.2|34.2|Standard Deviation|9.08|9.08|||
4236421|NCT00670449|4059736|B2|||Age||years|Mean|35.7|35.7|Standard Deviation|8.81|8.81|||
4236422|NCT00670449|4059737|B1|||Age||years|Mean|34.9|34.9|Standard Deviation|8.95|8.95|||
4236423|NCT00670306|4059764|B1|Canada||Region of Enrollment||participants|Number|114|114.0||||||
4236424|NCT00670306|4059764|B1|United States||Region of Enrollment||participants|Number|414|414.0||||||
4236425|NCT00670306|4059764|B1||Male|Sex: Female, Male||Participants|Count of Participants|528|528.0||||||
4236426|NCT00670306|4059764|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4236427|NCT00670306|4059764|B1|||Age||years|Mean|64.9|64.9|Standard Deviation|8.2|8.2|||
4236428|NCT00670306|4059764|B1||>=65 years|Age||Participants|Count of Participants|227|227.0||||||
4236429|NCT00670306|4059764|B1||Between 18 and 65 years|Age||Participants|Count of Participants|301|301.0||||||
4236430|NCT00670306|4059764|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236431|NCT00670267|4059768|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4236432|NCT00670267|4059768|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4236433|NCT00670267|4059768|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4236434|NCT00670267|4059768|B1|||Age||years|Mean|32.6|32.6|Full Range|||18.0|49.0|
4236435|NCT00670267|4059768|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4236436|NCT00670267|4059768|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4236437|NCT00670267|4059768|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4236438|NCT00670241|4059776|B4|Canada||Region of Enrollment||participants|Number|458|458.0||||||
4236439|NCT00670241|4059777|B3|Canada||Region of Enrollment||participants|Number|91|91.0||||||
4236440|NCT00670241|4059778|B2|Canada||Region of Enrollment||participants|Number|184|184.0||||||
4236441|NCT00670241|4059779|B1|Canada||Region of Enrollment||participants|Number|183|183.0||||||
4236442|NCT00670241|4059776|B4||Male|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
4236443|NCT00670241|4059777|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4236444|NCT00670241|4059778|B2||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4236445|NCT00670241|4059779|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4236446|NCT00670241|4059776|B4||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4236447|NCT00670241|4059777|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4236448|NCT00670241|4059778|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4236449|NCT00670241|4059779|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4236450|NCT00670241|4059776|B4|||Age||years|Mean|51.6|51.6|Standard Deviation|14.0|14.0|||
4236451|NCT00670241|4059777|B3|||Age||years|Mean|52.8|52.8|Standard Deviation|14.9|14.9|||
4236452|NCT00670241|4059778|B2|||Age||years|Mean|51.7|51.7|Standard Deviation|13.4|13.4|||
4236453|NCT00670241|4059779|B1|||Age||years|Mean|50.9|50.9|Standard Deviation|14.3|14.3|||
4236454|NCT00670241|4059776|B4||>=65 years|Age||Participants|Count of Participants|81|81.0||||||
4236455|NCT00670241|4059777|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4236456|NCT00670241|4059778|B2||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4236457|NCT00670241|4059779|B1||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
4236458|NCT00670241|4059776|B4||Between 18 and 65 years|Age||Participants|Count of Participants|377|377.0||||||
4236459|NCT00670241|4059777|B3||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
4236460|NCT00670241|4059778|B2||Between 18 and 65 years|Age||Participants|Count of Participants|155|155.0||||||
4236461|NCT00670241|4059779|B1||Between 18 and 65 years|Age||Participants|Count of Participants|148|148.0||||||
4236462|NCT00670241|4059776|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236463|NCT00670241|4059777|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236464|NCT00670241|4059778|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236465|NCT00670241|4059779|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236466|NCT00670228|4059801|B3|Yes||Myocardial Infarction (MI) duration greater than 3 hours||participants|Number|11|11.0||||||
4236467|NCT00670228|4059802|B2|Yes||Myocardial Infarction (MI) duration greater than 3 hours||participants|Number|6|6.0||||||
4236468|NCT00670228|4059803|B1|Yes||Myocardial Infarction (MI) duration greater than 3 hours||participants|Number|5|5.0||||||
4236469|NCT00670228|4059801|B3|No||Myocardial Infarction (MI) duration greater than 3 hours||participants|Number|22|22.0||||||
4236470|NCT00670228|4059802|B2|No||Myocardial Infarction (MI) duration greater than 3 hours||participants|Number|9|9.0||||||
4236471|NCT00670228|4059803|B1|No||Myocardial Infarction (MI) duration greater than 3 hours||participants|Number|13|13.0||||||
4236472|NCT00670228|4059801|B3|||Mean time to Percutaneous Coronary Intervention (PCI)||minutes|Mean|106.07|106.07|Standard Deviation|88.21|88.21|||
4236473|NCT00670228|4059802|B2|||Mean time to Percutaneous Coronary Intervention (PCI)||minutes|Mean|101.54|101.54|Standard Deviation|51.47|51.47|||
4236474|NCT00670228|4059803|B1|||Mean time to Percutaneous Coronary Intervention (PCI)||minutes|Mean|110.00|110.0|Standard Deviation|112.69|112.69|||
4236475|NCT00670228|4059801|B3|||Duration of Diabetes at study entry|One data is missing for the Standard Glycemic Care (SGC) arm (n=14 subjects).|Years|Mean|8.50|8.5|Standard Deviation|7.79|7.79|||
4236476|NCT00670228|4059802|B2|||Duration of Diabetes at study entry|One data is missing for the Standard Glycemic Care (SGC) arm (n=14 subjects).|Years|Mean|7.50|7.5|Standard Deviation|6.80|6.8|||
4236477|NCT00670228|4059803|B1|||Duration of Diabetes at study entry|One data is missing for the Standard Glycemic Care (SGC) arm (n=14 subjects).|Years|Mean|9.50|9.5|Standard Deviation|9.20|9.2|||
4236478|NCT00670228|4059801|B3|No||Diabetes diagnosis at study entry||participants|Number|20|20.0||||||
4236479|NCT00670228|4059802|B2|No||Diabetes diagnosis at study entry||participants|Number|8|8.0||||||
4236480|NCT00670228|4059803|B1|No||Diabetes diagnosis at study entry||participants|Number|12|12.0||||||
4236481|NCT00670228|4059801|B3|Yes||Diabetes diagnosis at study entry||participants|Number|13|13.0||||||
4236482|NCT00670228|4059802|B2|Yes||Diabetes diagnosis at study entry||participants|Number|7|7.0||||||
4236483|NCT00670228|4059803|B1|Yes||Diabetes diagnosis at study entry||participants|Number|6|6.0||||||
4236484|NCT00670228|4059801|B3|||Body Mass Index (BMI)|BMI = body weight in kilograms/height in meters squared|Kg/m^2|Mean|27.65|27.65|Standard Deviation|3.64|3.64|||
4236485|NCT00670228|4059802|B2|||Body Mass Index (BMI)|BMI = body weight in kilograms/height in meters squared|Kg/m^2|Mean|28.49|28.49|Standard Deviation|3.92|3.92|||
4236486|NCT00670228|4059803|B1|||Body Mass Index (BMI)|BMI = body weight in kilograms/height in meters squared|Kg/m^2|Mean|26.95|26.95|Standard Deviation|3.34|3.34|||
4236487|NCT00670228|4059801|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4236488|NCT00670228|4059802|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4236489|NCT00670228|4059803|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4236490|NCT00670228|4059801|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4236491|NCT00670228|4059802|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4236492|NCT00670228|4059803|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4236493|NCT00670228|4059801|B3|||Age||years|Mean|61.88|61.88|Standard Deviation|10.89|10.89|||
4236494|NCT00670228|4059802|B2|||Age||years|Mean|62.80|62.8|Standard Deviation|11.12|11.12|||
4236495|NCT00670228|4059803|B1|||Age||years|Mean|61.11|61.11|Standard Deviation|10.95|10.95|||
4236496|NCT00670202|4059816|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4236497|NCT00670202|4059818|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4236498|NCT00670202|4059816|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236499|NCT00670202|4059818|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236500|NCT00670202|4059816|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236501|NCT00670202|4059818|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236502|NCT00670202|4059816|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4236503|NCT00670202|4059818|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4236504|NCT00670202|4059816|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236505|NCT00670202|4059818|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236506|NCT00670202|4059816|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236507|NCT00670202|4059818|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236508|NCT00670202|4059816|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236509|NCT00670202|4059818|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236510|NCT00670202|4059816|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236511|NCT00670202|4059818|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236512|NCT00670202|4059816|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4236513|NCT00670202|4059818|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4236514|NCT00670202|4059816|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4236515|NCT00670202|4059818|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4236516|NCT00670202|4059816|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4236517|NCT00670202|4059818|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4236518|NCT00670202|4059816|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4236519|NCT00670202|4059818|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4236520|NCT00670202|4059816|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236521|NCT00670202|4059818|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236522|NCT00670111|4059825|B4|United States||Region of Enrollment||participants|Number|32|32.0||||||
4236523|NCT00670111|4059826|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4236524|NCT00670111|4059827|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4236525|NCT00670111|4059828|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4236526|NCT00670111|4059825|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4236527|NCT00670111|4059826|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4236528|NCT00670111|4059827|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4236529|NCT00670111|4059828|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4236530|NCT00670111|4059825|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4236531|NCT00670111|4059826|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4236532|NCT00670111|4059827|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4236533|NCT00670111|4059828|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4236534|NCT00670111|4059825|B4|||Age||years|Mean|67.6|67.6|Standard Deviation|10.5|10.5|||
4236535|NCT00670111|4059826|B3|||Age||years|Mean|68.1|68.1|Standard Deviation|11.0|11.0|||
4236536|NCT00670111|4059827|B2|||Age||years|Mean|65.8|65.8|Standard Deviation|12.1|12.1|||
4236537|NCT00670111|4059828|B1|||Age||years|Mean|68.4|68.4|Standard Deviation|7.1|7.1|||
4236538|NCT00670111|4059825|B4||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4236539|NCT00670111|4059826|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4236540|NCT00670111|4059827|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4236541|NCT00670111|4059828|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4236542|NCT00670111|4059825|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4236543|NCT00670111|4059826|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4236544|NCT00670111|4059827|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4236545|NCT00670111|4059828|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4236546|NCT00670111|4059825|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236547|NCT00670111|4059826|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236548|NCT00670111|4059827|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236549|NCT00670111|4059828|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236550|NCT00670046|4059838|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236551|NCT00670046|4059839|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236552|NCT00670046|4059840|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236553|NCT00670046|4059838|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236554|NCT00670046|4059839|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236555|NCT00670046|4059840|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236556|NCT00670046|4059838|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4236557|NCT00670046|4059839|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4236558|NCT00670046|4059840|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4236559|NCT00670046|4059838|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236560|NCT00670046|4059839|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236561|NCT00670046|4059840|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236562|NCT00670046|4059838|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236563|NCT00670046|4059839|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236564|NCT00670046|4059840|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236565|NCT00670046|4059838|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236566|NCT00670046|4059839|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236567|NCT00670046|4059840|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236568|NCT00670046|4059838|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236569|NCT00670046|4059839|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236570|NCT00670046|4059840|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236571|NCT00670046|4059838|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236572|NCT00670046|4059839|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236573|NCT00670046|4059840|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236574|NCT00670046|4059838|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4236575|NCT00670046|4059839|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4236576|NCT00670046|4059840|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4236577|NCT00670046|4059838|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236578|NCT00670046|4059839|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236579|NCT00670046|4059840|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236580|NCT00670046|4059838|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4236581|NCT00670046|4059839|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4236582|NCT00670046|4059840|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4236583|NCT00670046|4059838|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4236584|NCT00670046|4059839|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4236585|NCT00670046|4059840|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4236586|NCT00670046|4059838|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4236587|NCT00670046|4059839|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4236588|NCT00670046|4059840|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4236589|NCT00670046|4059838|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4236590|NCT00670046|4059839|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4236591|NCT00670046|4059840|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4236592|NCT00670046|4059838|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236593|NCT00670046|4059839|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236594|NCT00670046|4059840|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236595|NCT00670007|4059855|B1|Estonia||Region of Enrollment||participants|Number|2|2.0||||||
4236596|NCT00670007|4059855|B1|Germany||Region of Enrollment||participants|Number|15|15.0||||||
4236597|NCT00670007|4059855|B1|Australia||Region of Enrollment||participants|Number|17|17.0||||||
4236598|NCT00670007|4059855|B1|Denmark||Region of Enrollment||participants|Number|35|35.0||||||
4236599|NCT00670007|4059855|B1|Poland||Region of Enrollment||participants|Number|4|4.0||||||
4236600|NCT00670007|4059855|B1|Finland||Region of Enrollment||participants|Number|3|3.0||||||
4236601|NCT00670007|4059855|B1|Ireland||Region of Enrollment||participants|Number|19|19.0||||||
4236602|NCT00670007|4059855|B1|Romania||Region of Enrollment||participants|Number|1|1.0||||||
4236603|NCT00670007|4059855|B1|Czech Republic||Region of Enrollment||participants|Number|2|2.0||||||
4236604|NCT00670007|4059855|B1|Sweden||Region of Enrollment||participants|Number|17|17.0||||||
4236605|NCT00670007|4059855|B1|Canada||Region of Enrollment||participants|Number|25|25.0||||||
4236606|NCT00670007|4059855|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4236607|NCT00670007|4059855|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4236608|NCT00670007|4059855|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4236609|NCT00670007|4059855|B1||Between 18 and 65 years|Age||Participants|Count of Participants|130|130.0||||||
4236610|NCT00670007|4059855|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236611|NCT00669955|4059880|B3|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
4236612|NCT00669955|4059881|B2|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4236613|NCT00669955|4059882|B1|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4236614|NCT00669955|4059880|B3|Poland||Region of Enrollment||participants|Number|184|184.0||||||
4236615|NCT00669955|4059881|B2|Poland||Region of Enrollment||participants|Number|93|93.0||||||
4236616|NCT00669955|4059882|B1|Poland||Region of Enrollment||participants|Number|91|91.0||||||
4236617|NCT00669955|4059880|B3|Germany||Region of Enrollment||participants|Number|183|183.0||||||
4236618|NCT00669955|4059881|B2|Germany||Region of Enrollment||participants|Number|91|91.0||||||
4236619|NCT00669955|4059882|B1|Germany||Region of Enrollment||participants|Number|92|92.0||||||
4236620|NCT00669955|4059880|B3|France||Region of Enrollment||participants|Number|32|32.0||||||
4236621|NCT00669955|4059881|B2|France||Region of Enrollment||participants|Number|17|17.0||||||
4236622|NCT00669955|4059882|B1|France||Region of Enrollment||participants|Number|15|15.0||||||
4236623|NCT00669955|4059880|B3|Spain||Region of Enrollment||participants|Number|13|13.0||||||
4236624|NCT00669955|4059881|B2|Spain||Region of Enrollment||participants|Number|6|6.0||||||
4236625|NCT00669955|4059882|B1|Spain||Region of Enrollment||participants|Number|7|7.0||||||
4236626|NCT00669955|4059880|B3|Italy||Region of Enrollment||participants|Number|20|20.0||||||
4236627|NCT00669955|4059881|B2|Italy||Region of Enrollment||participants|Number|10|10.0||||||
4236628|NCT00669955|4059882|B1|Italy||Region of Enrollment||participants|Number|10|10.0||||||
4236629|NCT00669955|4059880|B3||Male|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4236630|NCT00669955|4059881|B2||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4236631|NCT00669955|4059882|B1||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4236632|NCT00669955|4059880|B3||Female|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4236633|NCT00669955|4059881|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4236634|NCT00669955|4059882|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4236635|NCT00669955|4059880|B3|||Age||years|Mean|48.24|48.24|Standard Deviation|14.58|14.58|||
4236636|NCT00669955|4059881|B2|||Age||years|Mean|47.95|47.95|Standard Deviation|14.52|14.52|||
4236637|NCT00669955|4059882|B1|||Age||years|Mean|48.53|48.53|Standard Deviation|14.64|14.64|||
4236638|NCT00669955|4059880|B3||>=65 years|Age||Participants|Count of Participants|62|62.0||||||
4236639|NCT00669955|4059881|B2||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4236640|NCT00669955|4059882|B1||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
4236641|NCT00669955|4059880|B3||Between 18 and 65 years|Age||Participants|Count of Participants|378|378.0||||||
4236642|NCT00669955|4059881|B2||Between 18 and 65 years|Age||Participants|Count of Participants|194|194.0||||||
4236643|NCT00669955|4059882|B1||Between 18 and 65 years|Age||Participants|Count of Participants|184|184.0||||||
4236644|NCT00669955|4059880|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236645|NCT00669955|4059881|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236646|NCT00669955|4059882|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236647|NCT00669942|4059901|B13||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4236648|NCT00669942|4059902|B12||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4236649|NCT00669942|4059903|B11||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4236650|NCT00669942|4059904|B10||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4236651|NCT00669942|4059905|B9||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4236652|NCT00669942|4059906|B8||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4236653|NCT00669942|4059907|B7||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4236654|NCT00669942|4059908|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4236655|NCT00669942|4059909|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4236656|NCT00669942|4059910|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4236657|NCT00669942|4059911|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4236658|NCT00669942|4059912|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4236659|NCT00669942|4059913|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4236660|NCT00669942|4059901|B13||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4236661|NCT00669942|4059902|B12||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4236662|NCT00669942|4059903|B11||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4236663|NCT00669942|4059904|B10||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4236664|NCT00669942|4059905|B9||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4236665|NCT00669942|4059906|B8||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4236666|NCT00669942|4059907|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4236667|NCT00669942|4059908|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4236668|NCT00669942|4059909|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4236669|NCT00669942|4059910|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4236670|NCT00669942|4059911|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4236671|NCT00669942|4059912|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4236672|NCT00669942|4059913|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4236673|NCT00669942|4059901|B13|||Age||Years|Mean|46.07|46.07|Standard Deviation|10.83|10.83|||
4236674|NCT00669942|4059902|B12|||Age||Years|Mean|42.5|42.5|Standard Deviation|10.61|10.61|||
4236675|NCT00669942|4059903|B11|||Age||Years|Mean|22.3|22.3|Standard Deviation|2.31|2.31|||
4236676|NCT00669942|4059904|B10|||Age||Years|Mean|26.7|26.7|Standard Deviation|10.02|10.02|||
4236677|NCT00669942|4059905|B9|||Age||Years|Mean|49.8|49.8|Standard Deviation|15.19|15.19|||
4236678|NCT00669942|4059906|B8|||Age||Years|Mean|49.9|49.9|Standard Deviation|8.53|8.53|||
4236679|NCT00669942|4059907|B7|||Age||Years|Mean|56.0|56.0|Standard Deviation|12.00|12.0|||
4236680|NCT00669942|4059908|B6|||Age||Years|Mean|60.8|60.8|Standard Deviation|8.66|8.66|||
4236681|NCT00669942|4059909|B5|||Age||Years|Mean|57.8|57.8|Standard Deviation|3.41|3.41|||
4236682|NCT00669942|4059910|B4|||Age||Years|Mean|63.2|63.2|Standard Deviation|9.45|9.45|||
4236683|NCT00669942|4059911|B3|||Age||Years|Mean|51.2|51.2|Standard Deviation|9.50|9.5|||
4236684|NCT00669942|4059912|B2|||Age||Years|Mean|58.8|58.8|Standard Deviation|13.61|13.61|||
4236685|NCT00669942|4059913|B1|||Age||Years|Mean|57.6|57.6|Standard Deviation|8.04|8.04|||
4236686|NCT00669916|4059986|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4236687|NCT00669916|4059987|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4236688|NCT00669916|4059988|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4236689|NCT00669916|4059986|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4236690|NCT00669916|4059987|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4236691|NCT00669916|4059988|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4236692|NCT00669916|4059986|B3|||Age||Years|Mean|50.8|50.8|Standard Deviation|10.37|10.37|||
4236693|NCT00669916|4059987|B2|||Age||Years|Mean|50.9|50.9|Standard Deviation|12.04|12.04|||
4236694|NCT00669916|4059988|B1|||Age||Years|Mean|50.7|50.7|Standard Deviation|8.73|8.73|||
4236695|NCT00669903|4060003|B5|||Baseline Positive and Negative Syndrome Scale (PANSS) total score|Baseline Positive and Negative Syndrome Scale (PANSS) total score. Best value for PANSS total score = 30 to worse value for PANSS total score = 210|Points of PANSS score|Mean|70.4|70.4|Standard Deviation|11.9|11.9|||
4236696|NCT00669903|4060004|B4|||Baseline Positive and Negative Syndrome Scale (PANSS) total score|Baseline Positive and Negative Syndrome Scale (PANSS) total score. Best value for PANSS total score = 30 to worse value for PANSS total score = 210|Points of PANSS score|Mean|69.5|69.5|Standard Deviation|13.2|13.2|||
4236697|NCT00669903|4060005|B3|||Baseline Positive and Negative Syndrome Scale (PANSS) total score|Baseline Positive and Negative Syndrome Scale (PANSS) total score. Best value for PANSS total score = 30 to worse value for PANSS total score = 210|Points of PANSS score|Mean|72.1|72.1|Standard Deviation|12.2|12.2|||
4236698|NCT00669903|4060006|B2|||Baseline Positive and Negative Syndrome Scale (PANSS) total score|Baseline Positive and Negative Syndrome Scale (PANSS) total score. Best value for PANSS total score = 30 to worse value for PANSS total score = 210|Points of PANSS score|Mean|71.8|71.8|Standard Deviation|12.0|12.0|||
4236699|NCT00669903|4060007|B1|||Baseline Positive and Negative Syndrome Scale (PANSS) total score|Baseline Positive and Negative Syndrome Scale (PANSS) total score. Best value for PANSS total score = 30 to worse value for PANSS total score = 210|Points of PANSS score|Mean|67.9|67.9|Standard Deviation|10.3|10.3|||
4236700|NCT00669903|4060003|B5|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4236701|NCT00669903|4060004|B4|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4236702|NCT00669903|4060005|B3|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4236703|NCT00669903|4060006|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4236704|NCT00669903|4060007|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4236705|NCT00669903|4060003|B5|Black||Race/Ethnicity, Customized||Participants|Number|86|86.0||||||
4236706|NCT00669903|4060004|B4|Black||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4236707|NCT00669903|4060005|B3|Black||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4236708|NCT00669903|4060006|B2|Black||Race/Ethnicity, Customized||Participants|Number|33|33.0||||||
4236709|NCT00669903|4060007|B1|Black||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4236710|NCT00669903|4060003|B5|Caucasian||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4236711|NCT00669903|4060004|B4|Caucasian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4236712|NCT00669903|4060005|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4236713|NCT00669903|4060006|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4236714|NCT00669903|4060007|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4236715|NCT00669903|4060003|B5||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4236716|NCT00669903|4060004|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4236717|NCT00669903|4060005|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4236718|NCT00669903|4060006|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4236719|NCT00669903|4060007|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4236720|NCT00669903|4060003|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4236721|NCT00669903|4060004|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4236722|NCT00669903|4060005|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4236723|NCT00669903|4060006|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4236724|NCT00669903|4060007|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4236725|NCT00669903|4060003|B5|||Age||Years|Mean|40.0|40.0|Standard Deviation|9.9|9.9|||
4236726|NCT00669903|4060004|B4|||Age||Years|Mean|40.0|40.0|Standard Deviation|9.8|9.8|||
4236727|NCT00669903|4060005|B3|||Age||Years|Mean|38.3|38.3|Standard Deviation|9.8|9.8|||
4236728|NCT00669903|4060006|B2|||Age||Years|Mean|41.7|41.7|Standard Deviation|9.2|9.2|||
4236729|NCT00669903|4060007|B1|||Age||Years|Mean|38.5|38.5|Standard Deviation|11.2|11.2|||
4236730|NCT00669877|4060040|B1|United States||Region of Enrollment||participants|Number|56|56.0||||||
4236731|NCT00669877|4060040|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4236732|NCT00669877|4060040|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4236733|NCT00669877|4060040|B1|||Age||years|Median|41|41.0|Full Range|||17.0|77.0|
4236734|NCT00669864|4060045|B1|||Weight|Weight measured at baseline (week 0)|kg|Mean|68.1|68.1|Standard Deviation|12.2|12.2|||
4236735|NCT00669864|4060045|B1|||HbA1c|HbA1c (Glycosylated Haemoglobin A1c) at baseline (week 0)|percentage (%) of total haemoglobin|Mean|8.16|8.16|Standard Deviation|0.89|0.89|||
4236736|NCT00669864|4060045|B1|||Duration of diabetes|Number of years since diagnosis|Years|Mean|8.54|8.54|Standard Deviation|5.49|5.49|||
4236737|NCT00669864|4060045|B1|||BMI|BMI (Body Mass Index) measured at baseline (week 0)|kg/m^2|Mean|24.89|24.89|Standard Deviation|3.28|3.28|||
4236738|NCT00669864|4060045|B1|Animal insulin||Previous treatment||Participants|Number|2|2.0||||||
4236739|NCT00669864|4060045|B1|Basal human insulin||Previous treatment||Participants|Number|169|169.0||||||
4236740|NCT00669864|4060045|B1|Basal insulin analogue||Previous treatment||Participants|Number|122|122.0||||||
4236741|NCT00669864|4060045|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236742|NCT00669864|4060045|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236743|NCT00669864|4060045|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236744|NCT00669864|4060045|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236745|NCT00669864|4060045|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236746|NCT00669864|4060045|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|293|293.0||||||
4236747|NCT00669864|4060045|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236748|NCT00669864|4060045|B1||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4236749|NCT00669864|4060045|B1||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4236750|NCT00669864|4060045|B1|||Age||Years|Mean|54|54.0|Standard Deviation|9.6|9.6|||
4236751|NCT00669682|4060054|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4236752|NCT00669682|4060054|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4236753|NCT00669682|4060054|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4236754|NCT00669682|4060054|B1|||Age||years|Mean|60|60.0|Standard Deviation|10|10.0|||
4236755|NCT00669682|4060054|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4236756|NCT00669682|4060054|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4236757|NCT00669682|4060054|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236758|NCT00669669|4060059|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236759|NCT00669669|4060059|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4236760|NCT00669669|4060059|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4236761|NCT00669669|4060059|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236762|NCT00669669|4060059|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236763|NCT00669669|4060059|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4236764|NCT00669669|4060059|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4236765|NCT00669669|4060059|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4236766|NCT00669669|4060059|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4236767|NCT00669669|4060059|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4236768|NCT00669669|4060059|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4236769|NCT00669669|4060059|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236770|NCT00669617|4060064|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4236771|NCT00669617|4060064|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4236772|NCT00669617|4060064|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|8.37|8.37|||
4236773|NCT00669578|4060080|B3|United States||Region of Enrollment||participants|Number|77|77.0||||||
4236774|NCT00669578|4060081|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4236775|NCT00669578|4060082|B1|United States||Region of Enrollment||participants|Number|65|65.0||||||
4236776|NCT00669578|4060080|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4236777|NCT00669578|4060081|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4236778|NCT00669578|4060082|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4236779|NCT00669578|4060080|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4236780|NCT00669578|4060081|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4236781|NCT00669578|4060082|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4236782|NCT00669578|4060080|B3|||Age||years|Median|67|67.0|Full Range|||42.0|87.0|
4236783|NCT00669578|4060081|B2|||Age||years|Median|66|66.0|Full Range|||51.0|83.0|
4236784|NCT00669578|4060082|B1|||Age||years|Median|68|68.0|Full Range|9.7|9.7|42.0|87.0|
4236785|NCT00669552|4060096|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4236786|NCT00669552|4060096|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4236787|NCT00669552|4060096|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4236788|NCT00669552|4060096|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4236789|NCT00669552|4060096|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236790|NCT00669539|4060100|B3|||Ocular Alignment|Minimum ocular alignment in prism diopters at distance or near defined from the simultaneous prism and cover test. Lower values of ocular alignment are better than higher values.|prism diopters|Mean|7.6|7.6|Standard Deviation|10.6|10.6|||
4236791|NCT00669539|4060101|B2|||Ocular Alignment|Minimum ocular alignment in prism diopters at distance or near defined from the simultaneous prism and cover test. Lower values of ocular alignment are better than higher values.|prism diopters|Mean|11.1|11.1|Standard Deviation|14.5|14.5|||
4236792|NCT00669539|4060102|B1|||Ocular Alignment|Minimum ocular alignment in prism diopters at distance or near defined from the simultaneous prism and cover test. Lower values of ocular alignment are better than higher values.|prism diopters|Mean|5.7|5.7|Standard Deviation|7.0|7.0|||
4236793|NCT00669539|4060100|B3|>8 prism diopters (worse)||Ocular Alignment|Minimum ocular alignment in prism diopters at distance or near defined from the simultaneous prism and cover test. Lower values of ocular alignment are better than higher values.|participants|Number|46|46.0||||||
4236794|NCT00669539|4060101|B2|>8 prism diopters (worse)||Ocular Alignment|Minimum ocular alignment in prism diopters at distance or near defined from the simultaneous prism and cover test. Lower values of ocular alignment are better than higher values.|participants|Number|23|23.0||||||
4236795|NCT00669539|4060102|B1|>8 prism diopters (worse)||Ocular Alignment|Minimum ocular alignment in prism diopters at distance or near defined from the simultaneous prism and cover test. Lower values of ocular alignment are better than higher values.|participants|Number|23|23.0||||||
4236796|NCT00669539|4060100|B3|1-8 prism diopters||Ocular Alignment|Minimum ocular alignment in prism diopters at distance or near defined from the simultaneous prism and cover test. Lower values of ocular alignment are better than higher values.|participants|Number|63|63.0||||||
4236797|NCT00669539|4060101|B2|1-8 prism diopters||Ocular Alignment|Minimum ocular alignment in prism diopters at distance or near defined from the simultaneous prism and cover test. Lower values of ocular alignment are better than higher values.|participants|Number|15|15.0||||||
4236798|NCT00669539|4060102|B1|1-8 prism diopters||Ocular Alignment|Minimum ocular alignment in prism diopters at distance or near defined from the simultaneous prism and cover test. Lower values of ocular alignment are better than higher values.|participants|Number|48|48.0||||||
4236799|NCT00669539|4060100|B3|0 prism diopters (better)||Ocular Alignment|Minimum ocular alignment in prism diopters at distance or near defined from the simultaneous prism and cover test. Lower values of ocular alignment are better than higher values.|participants|Number|37|37.0||||||
4236800|NCT00669539|4060101|B2|0 prism diopters (better)||Ocular Alignment|Minimum ocular alignment in prism diopters at distance or near defined from the simultaneous prism and cover test. Lower values of ocular alignment are better than higher values.|participants|Number|14|14.0||||||
4236801|NCT00669539|4060102|B1|0 prism diopters (better)||Ocular Alignment|Minimum ocular alignment in prism diopters at distance or near defined from the simultaneous prism and cover test. Lower values of ocular alignment are better than higher values.|participants|Number|23|23.0||||||
4236802|NCT00669539|4060100|B3|||Spherical Equivalent Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value in the fellow eye. Larger values indicate more refractive error; larger spherical equivalent values are worse than smaller values.|diopters|Mean|2.90|2.9|Standard Deviation|1.65|1.65|||
4236803|NCT00669539|4060101|B2|||Spherical Equivalent Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value in the fellow eye. Larger values indicate more refractive error; larger spherical equivalent values are worse than smaller values.|diopters|Mean|3.44|3.44|Standard Deviation|1.62|1.62|||
4236804|NCT00669539|4060102|B1|||Spherical Equivalent Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value in the fellow eye. Larger values indicate more refractive error; larger spherical equivalent values are worse than smaller values.|diopters|Mean|2.61|2.61|Standard Deviation|1.60|1.6|||
4236805|NCT00669539|4060100|B3|>=+4.00 diopters (worse)||Spherical Equivalent Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value in the fellow eye. Larger values indicate more refractive error; larger spherical equivalent values are worse than smaller values.|participants|Number|35|35.0||||||
4236806|NCT00669539|4060101|B2|>=+4.00 diopters (worse)||Spherical Equivalent Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value in the fellow eye. Larger values indicate more refractive error; larger spherical equivalent values are worse than smaller values.|participants|Number|17|17.0||||||
4236807|NCT00669539|4060102|B1|>=+4.00 diopters (worse)||Spherical Equivalent Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value in the fellow eye. Larger values indicate more refractive error; larger spherical equivalent values are worse than smaller values.|participants|Number|18|18.0||||||
4236808|NCT00669539|4060100|B3|+3.00 to <+4.00 diopters||Spherical Equivalent Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value in the fellow eye. Larger values indicate more refractive error; larger spherical equivalent values are worse than smaller values.|participants|Number|21|21.0||||||
4236809|NCT00669539|4060101|B2|+3.00 to <+4.00 diopters||Spherical Equivalent Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value in the fellow eye. Larger values indicate more refractive error; larger spherical equivalent values are worse than smaller values.|participants|Number|12|12.0||||||
4236810|NCT00669539|4060102|B1|+3.00 to <+4.00 diopters||Spherical Equivalent Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value in the fellow eye. Larger values indicate more refractive error; larger spherical equivalent values are worse than smaller values.|participants|Number|9|9.0||||||
4236811|NCT00669539|4060100|B3|+2.00 to <+3.00 diopters||Spherical Equivalent Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value in the fellow eye. Larger values indicate more refractive error; larger spherical equivalent values are worse than smaller values.|participants|Number|49|49.0||||||
4236812|NCT00669539|4060101|B2|+2.00 to <+3.00 diopters||Spherical Equivalent Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value in the fellow eye. Larger values indicate more refractive error; larger spherical equivalent values are worse than smaller values.|participants|Number|17|17.0||||||
4236855|NCT00669539|4060102|B1|White||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
4236813|NCT00669539|4060102|B1|+2.00 to <+3.00 diopters||Spherical Equivalent Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value in the fellow eye. Larger values indicate more refractive error; larger spherical equivalent values are worse than smaller values.|participants|Number|32|32.0||||||
4236814|NCT00669539|4060100|B3|+1.00 to <+2.00 diopters||Spherical Equivalent Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value in the fellow eye. Larger values indicate more refractive error; larger spherical equivalent values are worse than smaller values.|participants|Number|29|29.0||||||
4236815|NCT00669539|4060101|B2|+1.00 to <+2.00 diopters||Spherical Equivalent Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value in the fellow eye. Larger values indicate more refractive error; larger spherical equivalent values are worse than smaller values.|participants|Number|5|5.0||||||
4236816|NCT00669539|4060102|B1|+1.00 to <+2.00 diopters||Spherical Equivalent Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value in the fellow eye. Larger values indicate more refractive error; larger spherical equivalent values are worse than smaller values.|participants|Number|24|24.0||||||
4236817|NCT00669539|4060100|B3|0 to <+1.00 diopters (better)||Spherical Equivalent Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value in the fellow eye. Larger values indicate more refractive error; larger spherical equivalent values are worse than smaller values.|participants|Number|12|12.0||||||
4236818|NCT00669539|4060101|B2|0 to <+1.00 diopters (better)||Spherical Equivalent Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value in the fellow eye. Larger values indicate more refractive error; larger spherical equivalent values are worse than smaller values.|participants|Number|1|1.0||||||
4236819|NCT00669539|4060102|B1|0 to <+1.00 diopters (better)||Spherical Equivalent Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value in the fellow eye. Larger values indicate more refractive error; larger spherical equivalent values are worse than smaller values.|participants|Number|11|11.0||||||
4236820|NCT00669539|4060100|B3|||Spherical Equivalent Refractive Error in Amblyopic Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value in the amblyoic eye. Larger values indicate more refractive error; larger spherical equivalent values are worse than smaller values.|diopters|Mean|4.31|4.31|Standard Deviation|1.83|1.83|||
4236821|NCT00669539|4060101|B2|||Spherical Equivalent Refractive Error in Amblyopic Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value in the amblyoic eye. Larger values indicate more refractive error; larger spherical equivalent values are worse than smaller values.|diopters|Mean|3.69|3.69|Standard Deviation|1.74|1.74|||
4236822|NCT00669539|4060102|B1|||Spherical Equivalent Refractive Error in Amblyopic Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value in the amblyoic eye. Larger values indicate more refractive error; larger spherical equivalent values are worse than smaller values.|diopters|Mean|4.65|4.65|Standard Deviation|1.79|1.79|||
4236823|NCT00669539|4060100|B3|>=+4.00 diopters (worse)||Spherical Equivalent Refractive Error in Amblyopic Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value in the amblyopic eye. Larger values indicate more refractive error; larger spherical equivalent values are worse than smaller values.|participants|Number|84|84.0||||||
4236824|NCT00669539|4060101|B2|>=+4.00 diopters (worse)||Spherical Equivalent Refractive Error in Amblyopic Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value in the amblyopic eye. Larger values indicate more refractive error; larger spherical equivalent values are worse than smaller values.|participants|Number|21|21.0||||||
4236825|NCT00669539|4060102|B1|>=+4.00 diopters (worse)||Spherical Equivalent Refractive Error in Amblyopic Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value in the amblyopic eye. Larger values indicate more refractive error; larger spherical equivalent values are worse than smaller values.|participants|Number|63|63.0||||||
4236826|NCT00669539|4060100|B3|+3.00 to <+4.00 diopters||Spherical Equivalent Refractive Error in Amblyopic Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value in the amblyopic eye. Larger values indicate more refractive error; larger spherical equivalent values are worse than smaller values.|participants|Number|27|27.0||||||
4236827|NCT00669539|4060101|B2|+3.00 to <+4.00 diopters||Spherical Equivalent Refractive Error in Amblyopic Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value in the amblyopic eye. Larger values indicate more refractive error; larger spherical equivalent values are worse than smaller values.|participants|Number|10|10.0||||||
4236828|NCT00669539|4060102|B1|+3.00 to <+4.00 diopters||Spherical Equivalent Refractive Error in Amblyopic Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value in the amblyopic eye. Larger values indicate more refractive error; larger spherical equivalent values are worse than smaller values.|participants|Number|17|17.0||||||
4236829|NCT00669539|4060100|B3|+2.00 to <+3.00 diopters||Spherical Equivalent Refractive Error in Amblyopic Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value in the amblyopic eye. Larger values indicate more refractive error; larger spherical equivalent values are worse than smaller values.|participants|Number|22|22.0||||||
4236830|NCT00669539|4060101|B2|+2.00 to <+3.00 diopters||Spherical Equivalent Refractive Error in Amblyopic Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value in the amblyopic eye. Larger values indicate more refractive error; larger spherical equivalent values are worse than smaller values.|participants|Number|17|17.0||||||
4236831|NCT00669539|4060102|B1|+2.00 to <+3.00 diopters||Spherical Equivalent Refractive Error in Amblyopic Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value in the amblyopic eye. Larger values indicate more refractive error; larger spherical equivalent values are worse than smaller values.|participants|Number|5|5.0||||||
4236856|NCT00669539|4060100|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4236832|NCT00669539|4060100|B3|+1.00 to <+2.00 diopters||Spherical Equivalent Refractive Error in Amblyopic Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value in the amblyopic eye. Larger values indicate more refractive error; larger spherical equivalent values are worse than smaller values.|participants|Number|11|11.0||||||
4236833|NCT00669539|4060101|B2|+1.00 to <+2.00 diopters||Spherical Equivalent Refractive Error in Amblyopic Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value in the amblyopic eye. Larger values indicate more refractive error; larger spherical equivalent values are worse than smaller values.|participants|Number|3|3.0||||||
4236834|NCT00669539|4060102|B1|+1.00 to <+2.00 diopters||Spherical Equivalent Refractive Error in Amblyopic Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value in the amblyopic eye. Larger values indicate more refractive error; larger spherical equivalent values are worse than smaller values.|participants|Number|8|8.0||||||
4236835|NCT00669539|4060100|B3|0 to <+1.00 diopters (better)||Spherical Equivalent Refractive Error in Amblyopic Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value in the amblyopic eye. Larger values indicate more refractive error; larger spherical equivalent values are worse than smaller values.|participants|Number|2|2.0||||||
4236836|NCT00669539|4060101|B2|0 to <+1.00 diopters (better)||Spherical Equivalent Refractive Error in Amblyopic Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value in the amblyopic eye. Larger values indicate more refractive error; larger spherical equivalent values are worse than smaller values.|participants|Number|1|1.0||||||
4236837|NCT00669539|4060102|B1|0 to <+1.00 diopters (better)||Spherical Equivalent Refractive Error in Amblyopic Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value in the amblyopic eye. Larger values indicate more refractive error; larger spherical equivalent values are worse than smaller values.|participants|Number|1|1.0||||||
4236838|NCT00669539|4060100|B3|||Interocular Difference in Distance Visual Acuity|The difference between eyes in logMAR visual acuity was calculated. Larger positive values of the difference indicate better visual acuity in the fellow eye, larger negative values indicate better visual acuity in the amblyopic eye, and small values indicate similar visual acuities between the eyes.|logMAR lines|Mean|5.2|5.2|Standard Deviation|2.3|2.3|||
4236839|NCT00669539|4060101|B2|||Interocular Difference in Distance Visual Acuity|The difference between eyes in logMAR visual acuity was calculated. Larger positive values of the difference indicate better visual acuity in the fellow eye, larger negative values indicate better visual acuity in the amblyopic eye, and small values indicate similar visual acuities between the eyes.|logMAR lines|Mean|4.9|4.9|Standard Deviation|2.2|2.2|||
4236840|NCT00669539|4060102|B1|||Interocular Difference in Distance Visual Acuity|The difference between eyes in logMAR visual acuity was calculated. Larger positive values of the difference indicate better visual acuity in the fellow eye, larger negative values indicate better visual acuity in the amblyopic eye, and small values indicate similar visual acuities between the eyes.|logMAR lines|Mean|5.4|5.4|Standard Deviation|2.4|2.4|||
4236841|NCT00669539|4060100|B3|||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in the fellow eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 (best) to 20/800 (worst). Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|logMAR|Mean|0.12|0.12|Standard Deviation|0.12|0.12|||
4236842|NCT00669539|4060101|B2|||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in the fellow eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 (best) to 20/800 (worst). Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|logMAR|Mean|0.16|0.16|Standard Deviation|0.11|0.11|||
4236843|NCT00669539|4060102|B1|||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in the fellow eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 (best) to 20/800 (worst). Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|logMAR|Mean|0.09|0.09|Standard Deviation|0.12|0.12|||
4236844|NCT00669539|4060100|B3|||Distance Visual Acuity Amblyopic Eye|Visual acuity was measured in the amblyopic eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 (best) to 20/800 (worst). Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|logMAR|Mean|0.64|0.64|Standard Deviation|0.24|0.24|||
4236845|NCT00669539|4060101|B2|||Distance Visual Acuity Amblyopic Eye|Visual acuity was measured in the amblyopic eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 (best) to 20/800 (worst). Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|logMAR|Mean|0.65|0.65|Standard Deviation|0.26|0.26|||
4236846|NCT00669539|4060102|B1|||Distance Visual Acuity Amblyopic Eye|Visual acuity was measured in the amblyopic eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 (best) to 20/800 (worst). Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|logMAR|Mean|0.64|0.64|Standard Deviation|0.24|0.24|||
4236847|NCT00669539|4060100|B3|Unknown/not reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4236848|NCT00669539|4060101|B2|Unknown/not reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4236849|NCT00669539|4060102|B1|Unknown/not reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4236850|NCT00669539|4060100|B3|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4236851|NCT00669539|4060101|B2|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4236852|NCT00669539|4060102|B1|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4236853|NCT00669539|4060100|B3|White||Race/Ethnicity, Customized||participants|Number|119|119.0||||||
4236854|NCT00669539|4060101|B2|White||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4236857|NCT00669539|4060101|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4236858|NCT00669539|4060102|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4236859|NCT00669539|4060100|B3|Black/Aftican American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4236860|NCT00669539|4060101|B2|Black/Aftican American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4236861|NCT00669539|4060102|B1|Black/Aftican American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4236862|NCT00669539|4060100|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4236863|NCT00669539|4060101|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4236864|NCT00669539|4060102|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4236865|NCT00669539|4060100|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4236866|NCT00669539|4060101|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4236867|NCT00669539|4060102|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4236868|NCT00669539|4060100|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4236869|NCT00669539|4060101|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4236870|NCT00669539|4060102|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4236871|NCT00669539|4060100|B3|6 to <7 years||Age, Customized|Age at enrollment in years|participants|Number|31|31.0||||||
4236872|NCT00669539|4060101|B2|6 to <7 years||Age, Customized|Age at enrollment in years|participants|Number|5|5.0||||||
4236873|NCT00669539|4060102|B1|6 to <7 years||Age, Customized|Age at enrollment in years|participants|Number|26|26.0||||||
4236874|NCT00669539|4060100|B3|5 to <6 years||Age, Customized|Age at enrollment in years|participants|Number|34|34.0||||||
4236875|NCT00669539|4060101|B2|5 to <6 years||Age, Customized|Age at enrollment in years|participants|Number|15|15.0||||||
4236876|NCT00669539|4060102|B1|5 to <6 years||Age, Customized|Age at enrollment in years|participants|Number|19|19.0||||||
4236877|NCT00669539|4060100|B3|4 to <5 years||Age, Customized|Age at enrollment in years|participants|Number|51|51.0||||||
4236878|NCT00669539|4060101|B2|4 to <5 years||Age, Customized|Age at enrollment in years|participants|Number|16|16.0||||||
4236879|NCT00669539|4060102|B1|4 to <5 years||Age, Customized|Age at enrollment in years|participants|Number|35|35.0||||||
4236880|NCT00669539|4060100|B3|3 to <4 years||Age, Customized|Age at enrollment in years|participants|Number|30|30.0||||||
4236881|NCT00669539|4060101|B2|3 to <4 years||Age, Customized|Age at enrollment in years|participants|Number|16|16.0||||||
4236882|NCT00669539|4060102|B1|3 to <4 years||Age, Customized|Age at enrollment in years|participants|Number|14|14.0||||||
4236883|NCT00669539|4060100|B3|||Age|Age at enrollment in years|years|Mean|4.9|4.9|Standard Deviation|1.1|1.1|||
4236884|NCT00669539|4060101|B2|||Age|Age at enrollment in years|years|Mean|4.7|4.7|Standard Deviation|1.0|1.0|||
4236885|NCT00669539|4060102|B1|||Age|Age at enrollment in years|years|Mean|5.1|5.1|Standard Deviation|1.1|1.1|||
4236886|NCT00669461|4060109|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4236887|NCT00669461|4060109|B1||Male|Gender||Participants|Count of Participants|1|1.0||||||
4236888|NCT00669461|4060109|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
4236889|NCT00669461|4060109|B1|||Age||years|Mean|73|73.0|Standard Deviation|0|0.0|||
4236890|NCT00669461|4060109|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4236891|NCT00669461|4060109|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4236892|NCT00669461|4060109|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236893|NCT00669396|4060114|B3|United States||Region of Enrollment||participants|Number|57|57.0||||||
4236894|NCT00669396|4060115|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
4236895|NCT00669396|4060116|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4236896|NCT00669396|4060114|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4236897|NCT00669396|4060115|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4236898|NCT00669396|4060116|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4236899|NCT00669396|4060114|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4236900|NCT00669396|4060115|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4236901|NCT00669396|4060116|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4236902|NCT00669396|4060114|B3|||Age||years|Mean|23.7|23.7|Standard Deviation|5.6|5.6|||
4236903|NCT00669396|4060115|B2|||Age||years|Mean|23.0|23.0|Standard Deviation|4.7|4.7|||
4236904|NCT00669396|4060116|B1|||Age||years|Mean|24.7|24.7|Standard Deviation|6.7|6.7|||
4236905|NCT00669396|4060114|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4236906|NCT00669396|4060115|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4236907|NCT00669396|4060116|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4236908|NCT00669396|4060114|B3||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4236909|NCT00669396|4060115|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4236910|NCT00669396|4060116|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4236911|NCT00669396|4060114|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236912|NCT00669396|4060115|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236913|NCT00669396|4060116|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236914|NCT00669331|4060129|B3|Both (Diffuse and Focal)||Extent of Bronchiectasis||participants|Number|60|60.0||||||
4236915|NCT00669331|4060130|B2|Both (Diffuse and Focal)||Extent of Bronchiectasis||participants|Number|37|37.0||||||
4236916|NCT00669331|4060131|B1|Both (Diffuse and Focal)||Extent of Bronchiectasis||participants|Number|23|23.0||||||
4236917|NCT00669331|4060129|B3|Focal||Extent of Bronchiectasis||participants|Number|150|150.0||||||
4236918|NCT00669331|4060130|B2|Focal||Extent of Bronchiectasis||participants|Number|73|73.0||||||
4236919|NCT00669331|4060131|B1|Focal||Extent of Bronchiectasis||participants|Number|77|77.0||||||
4236920|NCT00669331|4060129|B3|Diffuse||Extent of Bronchiectasis||participants|Number|251|251.0||||||
4236921|NCT00669331|4060130|B2|Diffuse||Extent of Bronchiectasis||participants|Number|118|118.0||||||
4236922|NCT00669331|4060131|B1|Diffuse||Extent of Bronchiectasis||participants|Number|133|133.0||||||
4236923|NCT00669331|4060129|B3|>=60%||Baseline % of Predicted FEV1||participants|Number|253|253.0||||||
4236924|NCT00669331|4060130|B2|>=60%||Baseline % of Predicted FEV1||participants|Number|121|121.0||||||
4236925|NCT00669331|4060131|B1|>=60%||Baseline % of Predicted FEV1||participants|Number|132|132.0||||||
4236926|NCT00669331|4060129|B3|<60%||Baseline % of Predicted FEV1||participants|Number|208|208.0||||||
4236927|NCT00669331|4060130|B2|<60%||Baseline % of Predicted FEV1||participants|Number|107|107.0||||||
4236928|NCT00669331|4060131|B1|<60%||Baseline % of Predicted FEV1||participants|Number|101|101.0||||||
4236929|NCT00669331|4060129|B3|||Baseline Pulmonary Exacerbation rate||events/year|Mean|3.22|3.22|Standard Deviation|1.39|1.39|||
4236930|NCT00669331|4060130|B2|||Baseline Pulmonary Exacerbation rate||events/year|Mean|3.25|3.25|Standard Deviation|1.40|1.4|||
4236931|NCT00669331|4060131|B1|||Baseline Pulmonary Exacerbation rate||events/year|Mean|3.20|3.2|Standard Deviation|1.38|1.38|||
4236932|NCT00669331|4060129|B3||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4236933|NCT00669331|4060130|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4236934|NCT00669331|4060131|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4236935|NCT00669331|4060129|B3||Female|Sex: Female, Male||Participants|Count of Participants|289|289.0||||||
4236936|NCT00669331|4060130|B2||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4236937|NCT00669331|4060131|B1||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4236938|NCT00669331|4060129|B3|||Age||years|Mean|59.77|59.77|Standard Deviation|13.55|13.55|||
4236939|NCT00669331|4060130|B2|||Age||years|Mean|60.26|60.26|Standard Deviation|13.02|13.02|||
4236940|NCT00669331|4060131|B1|||Age||years|Mean|59.30|59.3|Standard Deviation|14.06|14.06|||
4236941|NCT00669318|4060174|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4236942|NCT00669318|4060174|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4236943|NCT00669318|4060174|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4236944|NCT00669318|4060174|B1|||Age||years|Median|61|61.0|Full Range|||47.0|78.0|
4236945|NCT00669279|4060182|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
4236946|NCT00669279|4060183|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4236947|NCT00669279|4060184|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4236948|NCT00669279|4060182|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4236949|NCT00669279|4060183|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4236950|NCT00669279|4060184|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4236951|NCT00669279|4060182|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4236952|NCT00669279|4060183|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4236953|NCT00669279|4060184|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4236954|NCT00669279|4060182|B3|||Age||years|Mean|46.9|46.9|Standard Deviation|11.5|11.5|||
4236955|NCT00669279|4060183|B2|||Age||years|Mean|46.1|46.1|Standard Deviation|9.9|9.9|||
4236956|NCT00669279|4060184|B1|||Age||years|Mean|47.7|47.7|Standard Deviation|13.1|13.1|||
4236957|NCT00669279|4060182|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4236958|NCT00669279|4060183|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4236959|NCT00669279|4060184|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4236960|NCT00669279|4060182|B3||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4236961|NCT00669279|4060183|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4236962|NCT00669279|4060184|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4236963|NCT00669279|4060182|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236964|NCT00669279|4060183|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236965|NCT00669279|4060184|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4236966|NCT00669240|4060191|B1|Self-payment||Source of reimbursement|Source of funding for the cost of varenicline treatment. Some participants listed more than one source of funding and are represented in more than 1 category.|participants|Number|353|353.0||||||
4236967|NCT00669240|4060191|B1|Private insurance||Source of reimbursement|Source of funding for the cost of varenicline treatment. Some participants listed more than one source of funding and are represented in more than 1 category.|participants|Number|2|2.0||||||
4236968|NCT00669240|4060191|B1|Public insurance||Source of reimbursement|Source of funding for the cost of varenicline treatment. Some participants listed more than one source of funding and are represented in more than 1 category.|participants|Number|214|214.0||||||
4236969|NCT00669240|4060191|B1|Depression||Smoking-related concurrent illnesses and cardiovascular risk factors|Some participants may have had more than 1 condition and may be represented in more than 1 category, and some participants may not have had any condition.|participants|Number|52|52.0||||||
4236970|NCT00669240|4060191|B1|Psychiatric disorders (excluding depression)||Smoking-related concurrent illnesses and cardiovascular risk factors|Some participants may have had more than 1 condition and may be represented in more than 1 category, and some participants may not have had any condition.|participants|Number|18|18.0||||||
4236971|NCT00669240|4060191|B1|Epilepsy||Smoking-related concurrent illnesses and cardiovascular risk factors|Some participants may have had more than 1 condition and may be represented in more than 1 category, and some participants may not have had any condition.|participants|Number|9|9.0||||||
4236972|NCT00669240|4060191|B1|Lung cancer||Smoking-related concurrent illnesses and cardiovascular risk factors|Some participants may have had more than 1 condition and may be represented in more than 1 category, and some participants may not have had any condition.|participants|Number|10|10.0||||||
4236973|NCT00669240|4060191|B1|Chronic obstructive pulmonary disease (COPD)||Smoking-related concurrent illnesses and cardiovascular risk factors|Some participants may have had more than 1 condition and may be represented in more than 1 category, and some participants may not have had any condition.|participants|Number|100|100.0||||||
4236974|NCT00669240|4060191|B1|Cardiovascular disease||Smoking-related concurrent illnesses and cardiovascular risk factors|Some participants may have had more than 1 condition and may be represented in more than 1 category, and some participants may not have had any condition.|participants|Number|54|54.0||||||
4236975|NCT00669240|4060191|B1|Hypertension||Smoking-related concurrent illnesses and cardiovascular risk factors|Some participants may have had more than 1 condition and may be represented in more than 1 category, and some participants may not have had any condition.|participants|Number|110|110.0||||||
4236976|NCT00669240|4060191|B1|Raised cholesterol||Smoking-related concurrent illnesses and cardiovascular risk factors|Some participants may have had more than 1 condition and may be represented in more than 1 category, and some participants may not have had any condition.|participants|Number|114|114.0||||||
4236977|NCT00669240|4060191|B1|Diabetes||Smoking-related concurrent illnesses and cardiovascular risk factors|Some participants may have had more than 1 condition and may be represented in more than 1 category, and some participants may not have had any condition.|participants|Number|31|31.0||||||
4236978|NCT00669240|4060191|B1|Smoking ban in public places||Reasons for quitting smoking|Each participant was asked to supply the top 2 reasons for giving up smoking this time; not all participants supplied 2 reasons.|participants|Number|35|35.0||||||
4236979|NCT00669240|4060191|B1|Body image / appearance||Reasons for quitting smoking|Each participant was asked to supply the top 2 reasons for giving up smoking this time; not all participants supplied 2 reasons.|participants|Number|84|84.0||||||
4236980|NCT00669240|4060191|B1|Money / cost||Reasons for quitting smoking|Each participant was asked to supply the top 2 reasons for giving up smoking this time; not all participants supplied 2 reasons.|participants|Number|159|159.0||||||
4236981|NCT00669240|4060191|B1|Health reasons||Reasons for quitting smoking|Each participant was asked to supply the top 2 reasons for giving up smoking this time; not all participants supplied 2 reasons.|participants|Number|495|495.0||||||
4236982|NCT00669240|4060191|B1|Family / friends||Reasons for quitting smoking|Each participant was asked to supply the top 2 reasons for giving up smoking this time; not all participants supplied 2 reasons.|participants|Number|255|255.0||||||
4236983|NCT00669240|4060191|B1|||Total score on the Fagerstrom Test for Nicotine Dependence|The self-administered Fagerstrom Test for Nicotine Dependence questionnaire assesses level of nicotine dependence. Total score: 0-2=very low dependence; 3-4=low dependence; 5=medium dependence; 6-7=high dependence; 8-10=very high dependence.|scores on a scale|Mean|6.1|6.1|Full Range|||0.0|10.0|
4236984|NCT00669240|4060191|B1|||Number of participants with quit smoking history|Number of participants who provided at least one reason for prior relapse (= number of participants with at least one prior quit smoking attempt)|participants|Number|426|426.0||||||
4236985|NCT00669240|4060191|B1|||Average number of cigarettes participants smoked per day||cigarettes per day|Mean|25.3|25.3|Full Range|||5.0|100.0|
4236986|NCT00669240|4060191|B1|||Number of years participants smoked||years|Mean|27.0|27.0|Full Range|||2.0|60.0|
4236987|NCT00669240|4060191|B1|Unspecified||Sex/Gender, Customized||participants|Number|8|8.0||||||
4236988|NCT00669240|4060191|B1|Female||Sex/Gender, Customized||participants|Number|248|248.0||||||
4236989|NCT00669240|4060191|B1|Male||Sex/Gender, Customized||participants|Number|295|295.0||||||
4236990|NCT00669240|4060191|B1|Unspecified||Age, Customized||participants|Number|3|3.0||||||
4236991|NCT00669240|4060191|B1|>65 years||Age, Customized||participants|Number|26|26.0||||||
4236992|NCT00669240|4060191|B1|>=55 years and <=65 years||Age, Customized||participants|Number|107|107.0||||||
4236993|NCT00669240|4060191|B1|<55 years||Age, Customized||participants|Number|415|415.0||||||
4236994|NCT00669214|4060205|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4236995|NCT00669214|4060206|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4236996|NCT00669214|4060207|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4236997|NCT00669214|4060205|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4236998|NCT00669214|4060206|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4236999|NCT00669214|4060207|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4237000|NCT00669214|4060205|B3|||Age||years|Mean|43.04|43.04|Standard Deviation|14.37|14.37|||
4237001|NCT00669214|4060206|B2|||Age||years|Mean|43.16|43.16|Standard Deviation|13.46|13.46|||
4237002|NCT00669214|4060207|B1|||Age||years|Mean|42.78|42.78|Standard Deviation|16.53|16.53|||
4237003|NCT00669110|4060240|B3|Testes Stage 5||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|3|3.0||||||
4237004|NCT00669110|4060241|B2|Testes Stage 5||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|3|3.0||||||
4237089|NCT00669071|4060279|B1|||Age||years|Mean|43.3|43.3|Standard Deviation|9.0|9.0|||
4237090|NCT00669032|4060298|B3|||Duration knee osteoarthritis||years|Mean|7.5|7.5|Standard Deviation|7.6|7.6|||
4237005|NCT00669110|4060242|B1|Testes Stage 5||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|0|0.0||||||
4237006|NCT00669110|4060240|B3|Testes Stage 4||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|3|3.0||||||
4237007|NCT00669110|4060241|B2|Testes Stage 4||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|3|3.0||||||
4237008|NCT00669110|4060242|B1|Testes Stage 4||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|0|0.0||||||
4237009|NCT00669110|4060240|B3|Testes Stage 3||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|5|5.0||||||
4237010|NCT00669110|4060241|B2|Testes Stage 3||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|3|3.0||||||
4237011|NCT00669110|4060242|B1|Testes Stage 3||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|2|2.0||||||
4237012|NCT00669110|4060240|B3|Testes Stage 2||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|3|3.0||||||
4237013|NCT00669110|4060241|B2|Testes Stage 2||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|1|1.0||||||
4237014|NCT00669110|4060242|B1|Testes Stage 2||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|2|2.0||||||
4237015|NCT00669110|4060240|B3|Testes Stage 1||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|5|5.0||||||
4237016|NCT00669110|4060241|B2|Testes Stage 1||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|0|0.0||||||
4237017|NCT00669110|4060242|B1|Testes Stage 1||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|5|5.0||||||
4237018|NCT00669110|4060240|B3|Pubic hair Stage 5||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|2|2.0||||||
4237019|NCT00669110|4060241|B2|Pubic hair Stage 5||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|2|2.0||||||
4237091|NCT00669032|4060299|B2|||Duration knee osteoarthritis||years|Mean|8.1|8.1|Standard Deviation|8.4|8.4|||
4237092|NCT00669032|4060300|B1|||Duration knee osteoarthritis||years|Mean|6.9|6.9|Standard Deviation|6.8|6.8|||
4237093|NCT00669032|4060298|B3|||Body Mass Index (BMI)||kg/m^2|Mean|28.6|28.6|Standard Deviation|2.7|2.7|||
4237020|NCT00669110|4060242|B1|Pubic hair Stage 5||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|0|0.0||||||
4237021|NCT00669110|4060240|B3|Pubic hair Stage 4||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|4|4.0||||||
4237022|NCT00669110|4060241|B2|Pubic hair Stage 4||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|4|4.0||||||
4237023|NCT00669110|4060242|B1|Pubic hair Stage 4||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|0|0.0||||||
4237024|NCT00669110|4060240|B3|Pubic hair Stage 3||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|4|4.0||||||
4237025|NCT00669110|4060241|B2|Pubic hair Stage 3||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|3|3.0||||||
4237026|NCT00669110|4060242|B1|Pubic hair Stage 3||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|1|1.0||||||
4237027|NCT00669110|4060240|B3|Pubic hair Stage 2||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|3|3.0||||||
4237028|NCT00669110|4060241|B2|Pubic hair Stage 2||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|1|1.0||||||
4237029|NCT00669110|4060242|B1|Pubic hair Stage 2||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|2|2.0||||||
4237030|NCT00669110|4060240|B3|Pubic hair Stage 1||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|6|6.0||||||
4237031|NCT00669110|4060241|B2|Pubic hair Stage 1||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|0|0.0||||||
4237032|NCT00669110|4060242|B1|Pubic hair Stage 1||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|6|6.0||||||
4237033|NCT00669110|4060240|B3|Penis Stage 5||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|3|3.0||||||
4237034|NCT00669110|4060241|B2|Penis Stage 5||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|3|3.0||||||
4237094|NCT00669032|4060299|B2|||Body Mass Index (BMI)||kg/m^2|Mean|28.7|28.7|Standard Deviation|2.6|2.6|||
4237095|NCT00669032|4060300|B1|||Body Mass Index (BMI)||kg/m^2|Mean|28.4|28.4|Standard Deviation|2.7|2.7|||
4237096|NCT00669032|4060298|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4237035|NCT00669110|4060242|B1|Penis Stage 5||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|0|0.0||||||
4237036|NCT00669110|4060240|B3|Penis Stage 4||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|3|3.0||||||
4237037|NCT00669110|4060241|B2|Penis Stage 4||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|3|3.0||||||
4237038|NCT00669110|4060242|B1|Penis Stage 4||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|0|0.0||||||
4237039|NCT00669110|4060240|B3|Penis Stage 3||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|3|3.0||||||
4237040|NCT00669110|4060241|B2|Penis Stage 3||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|2|2.0||||||
4237041|NCT00669110|4060242|B1|Penis Stage 3||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|1|1.0||||||
4237042|NCT00669110|4060240|B3|Penis Stage 2||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|5|5.0||||||
4237043|NCT00669110|4060241|B2|Penis Stage 2||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|2|2.0||||||
4237044|NCT00669110|4060242|B1|Penis Stage 2||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|3|3.0||||||
4237045|NCT00669110|4060240|B3|Penis Stage 1||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|5|5.0||||||
4237046|NCT00669110|4060241|B2|Penis Stage 1||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|0|0.0||||||
4237047|NCT00669110|4060242|B1|Penis Stage 1||Number of participants for Tanner Assessment: Males|Male pubertal development of secondary sexual characteristics documented by size of genitalia and pubic hair development (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity, size). N=9 Children, 10 Adolescent participants at observation. Participants may be represented in > than 1 test category.|participants|Number|5|5.0||||||
4237048|NCT00669110|4060240|B3|Pubic hair Stage 5||Number of participants for Tanner Assessment: Females|Female pubertal development of secondary sexual characteristics documented by pubic hair development and breast size (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size). N=9 Children, 9 Adolescent participants at observation. Participants may be represented in more than 1 test category.|participants|Number|5|5.0||||||
4237049|NCT00669110|4060241|B2|Pubic hair Stage 5||Number of participants for Tanner Assessment: Females|Female pubertal development of secondary sexual characteristics documented by pubic hair development and breast size (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size). N=9 Children, 9 Adolescent participants at observation. Participants may be represented in more than 1 test category.|participants|Number|5|5.0||||||
4237097|NCT00669032|4060299|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4237098|NCT00669032|4060300|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4237099|NCT00669032|4060298|B3||Female|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
4237050|NCT00669110|4060242|B1|Pubic hair Stage 5||Number of participants for Tanner Assessment: Females|Female pubertal development of secondary sexual characteristics documented by pubic hair development and breast size (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size). N=9 Children, 9 Adolescent participants at observation. Participants may be represented in more than 1 test category.|participants|Number|0|0.0||||||
4237051|NCT00669110|4060240|B3|Pubic hair Stage 4||Number of participants for Tanner Assessment: Females|Female pubertal development of secondary sexual characteristics documented by pubic hair development and breast size (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size). N=9 Children, 9 Adolescent participants at observation. Participants may be represented in more than 1 test category.|participants|Number|2|2.0||||||
4237052|NCT00669110|4060241|B2|Pubic hair Stage 4||Number of participants for Tanner Assessment: Females|Female pubertal development of secondary sexual characteristics documented by pubic hair development and breast size (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size). N=9 Children, 9 Adolescent participants at observation. Participants may be represented in more than 1 test category.|participants|Number|2|2.0||||||
4237053|NCT00669110|4060242|B1|Pubic hair Stage 4||Number of participants for Tanner Assessment: Females|Female pubertal development of secondary sexual characteristics documented by pubic hair development and breast size (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size). N=9 Children, 9 Adolescent participants at observation. Participants may be represented in more than 1 test category.|participants|Number|0|0.0||||||
4237054|NCT00669110|4060240|B3|Pubic hair Stage 3||Number of participants for Tanner Assessment: Females|Female pubertal development of secondary sexual characteristics documented by pubic hair development and breast size (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size). N=9 Children, 9 Adolescent participants at observation. Participants may be represented in more than 1 test category.|participants|Number|0|0.0||||||
4237055|NCT00669110|4060241|B2|Pubic hair Stage 3||Number of participants for Tanner Assessment: Females|Female pubertal development of secondary sexual characteristics documented by pubic hair development and breast size (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size). N=9 Children, 9 Adolescent participants at observation. Participants may be represented in more than 1 test category.|participants|Number|0|0.0||||||
4237056|NCT00669110|4060242|B1|Pubic hair Stage 3||Number of participants for Tanner Assessment: Females|Female pubertal development of secondary sexual characteristics documented by pubic hair development and breast size (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size). N=9 Children, 9 Adolescent participants at observation. Participants may be represented in more than 1 test category.|participants|Number|0|0.0||||||
4237057|NCT00669110|4060240|B3|Pubic hair Stage 2||Number of participants for Tanner Assessment: Females|Female pubertal development of secondary sexual characteristics documented by pubic hair development and breast size (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size). N=9 Children, 9 Adolescent participants at observation. Participants may be represented in more than 1 test category.|participants|Number|5|5.0||||||
4237058|NCT00669110|4060241|B2|Pubic hair Stage 2||Number of participants for Tanner Assessment: Females|Female pubertal development of secondary sexual characteristics documented by pubic hair development and breast size (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size). N=9 Children, 9 Adolescent participants at observation. Participants may be represented in more than 1 test category.|participants|Number|2|2.0||||||
4237059|NCT00669110|4060242|B1|Pubic hair Stage 2||Number of participants for Tanner Assessment: Females|Female pubertal development of secondary sexual characteristics documented by pubic hair development and breast size (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size). N=9 Children, 9 Adolescent participants at observation. Participants may be represented in more than 1 test category.|participants|Number|3|3.0||||||
4237060|NCT00669110|4060240|B3|Pubic hair Stage 1||Number of participants for Tanner Assessment: Females|Female pubertal development of secondary sexual characteristics documented by pubic hair development and breast size (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size). N=9 Children, 9 Adolescent participants at observation. Participants may be represented in more than 1 test category.|participants|Number|6|6.0||||||
4237061|NCT00669110|4060241|B2|Pubic hair Stage 1||Number of participants for Tanner Assessment: Females|Female pubertal development of secondary sexual characteristics documented by pubic hair development and breast size (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size). N=9 Children, 9 Adolescent participants at observation. Participants may be represented in more than 1 test category.|participants|Number|0|0.0||||||
4237062|NCT00669110|4060242|B1|Pubic hair Stage 1||Number of participants for Tanner Assessment: Females|Female pubertal development of secondary sexual characteristics documented by pubic hair development and breast size (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size). N=9 Children, 9 Adolescent participants at observation. Participants may be represented in more than 1 test category.|participants|Number|6|6.0||||||
4237063|NCT00669110|4060240|B3|Breasts Stage 5||Number of participants for Tanner Assessment: Females|Female pubertal development of secondary sexual characteristics documented by pubic hair development and breast size (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size). N=9 Children, 9 Adolescent participants at observation. Participants may be represented in more than 1 test category.|participants|Number|7|7.0||||||
4237064|NCT00669110|4060241|B2|Breasts Stage 5||Number of participants for Tanner Assessment: Females|Female pubertal development of secondary sexual characteristics documented by pubic hair development and breast size (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size). N=9 Children, 9 Adolescent participants at observation. Participants may be represented in more than 1 test category.|participants|Number|7|7.0||||||
4237100|NCT00669032|4060299|B2||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4237101|NCT00669032|4060300|B1||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4237065|NCT00669110|4060242|B1|Breasts Stage 5||Number of participants for Tanner Assessment: Females|Female pubertal development of secondary sexual characteristics documented by pubic hair development and breast size (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size). N=9 Children, 9 Adolescent participants at observation. Participants may be represented in more than 1 test category.|participants|Number|0|0.0||||||
4237066|NCT00669110|4060240|B3|Breasts Stage 4||Number of participants for Tanner Assessment: Females|Female pubertal development of secondary sexual characteristics documented by pubic hair development and breast size (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size). N=9 Children, 9 Adolescent participants at observation. Participants may be represented in more than 1 test category.|participants|Number|1|1.0||||||
4237067|NCT00669110|4060241|B2|Breasts Stage 4||Number of participants for Tanner Assessment: Females|Female pubertal development of secondary sexual characteristics documented by pubic hair development and breast size (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size). N=9 Children, 9 Adolescent participants at observation. Participants may be represented in more than 1 test category.|participants|Number|1|1.0||||||
4237068|NCT00669110|4060242|B1|Breasts Stage 4||Number of participants for Tanner Assessment: Females|Female pubertal development of secondary sexual characteristics documented by pubic hair development and breast size (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size). N=9 Children, 9 Adolescent participants at observation. Participants may be represented in more than 1 test category.|participants|Number|0|0.0||||||
4237069|NCT00669110|4060240|B3|Breasts Stage 3||Number of participants for Tanner Assessment: Females|Female pubertal development of secondary sexual characteristics documented by pubic hair development and breast size (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size). N=9 Children, 9 Adolescent participants at observation. Participants may be represented in more than 1 test category.|participants|Number|1|1.0||||||
4237070|NCT00669110|4060241|B2|Breasts Stage 3||Number of participants for Tanner Assessment: Females|Female pubertal development of secondary sexual characteristics documented by pubic hair development and breast size (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size). N=9 Children, 9 Adolescent participants at observation. Participants may be represented in more than 1 test category.|participants|Number|0|0.0||||||
4237071|NCT00669110|4060242|B1|Breasts Stage 3||Number of participants for Tanner Assessment: Females|Female pubertal development of secondary sexual characteristics documented by pubic hair development and breast size (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size). N=9 Children, 9 Adolescent participants at observation. Participants may be represented in more than 1 test category.|participants|Number|1|1.0||||||
4237072|NCT00669110|4060240|B3|Breasts Stage 2||Number of participants for Tanner Assessment: Females|Female pubertal development of secondary sexual characteristics documented by pubic hair development and breast size (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size). N=9 Children, 9 Adolescent participants at observation. Participants may be represented in more than 1 test category.|participants|Number|5|5.0||||||
4237073|NCT00669110|4060241|B2|Breasts Stage 2||Number of participants for Tanner Assessment: Females|Female pubertal development of secondary sexual characteristics documented by pubic hair development and breast size (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size). N=9 Children, 9 Adolescent participants at observation. Participants may be represented in more than 1 test category.|participants|Number|1|1.0||||||
4237074|NCT00669110|4060242|B1|Breasts Stage 2||Number of participants for Tanner Assessment: Females|Female pubertal development of secondary sexual characteristics documented by pubic hair development and breast size (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size). N=9 Children, 9 Adolescent participants at observation. Participants may be represented in more than 1 test category.|participants|Number|4|4.0||||||
4237075|NCT00669110|4060240|B3|Breasts Stage 1||Number of participants for Tanner Assessment: Females|Female pubertal development of secondary sexual characteristics documented by pubic hair development and breast size (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size). N=9 Children, 9 Adolescent participants at observation. Participants may be represented in more than 1 test category.|participants|Number|4|4.0||||||
4237076|NCT00669110|4060241|B2|Breasts Stage 1||Number of participants for Tanner Assessment: Females|Female pubertal development of secondary sexual characteristics documented by pubic hair development and breast size (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size). N=9 Children, 9 Adolescent participants at observation. Participants may be represented in more than 1 test category.|participants|Number|0|0.0||||||
4237077|NCT00669110|4060242|B1|Breasts Stage 1||Number of participants for Tanner Assessment: Females|Female pubertal development of secondary sexual characteristics documented by pubic hair development and breast size (test categories). Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size). N=9 Children, 9 Adolescent participants at observation. Participants may be represented in more than 1 test category.|participants|Number|4|4.0||||||
4237078|NCT00669110|4060240|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4237079|NCT00669110|4060241|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4237080|NCT00669110|4060242|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4237081|NCT00669110|4060240|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4237082|NCT00669110|4060241|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4237083|NCT00669110|4060242|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4237084|NCT00669110|4060240|B3|||Age||years|Mean|11.60|11.6|Standard Deviation|2.46|2.46|||
4237085|NCT00669110|4060241|B2|||Age||years|Mean|13.55|13.55|Standard Deviation|1.64|1.64|||
4237086|NCT00669110|4060242|B1|||Age||years|Mean|9.65|9.65|Standard Deviation|1.31|1.31|||
4237087|NCT00669071|4060279|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4237088|NCT00669071|4060279|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4237102|NCT00669032|4060298|B3|||Age||years|Mean|63.4|63.4|Standard Deviation|8.6|8.6|||
4237103|NCT00669032|4060299|B2|||Age||years|Mean|63.9|63.9|Standard Deviation|8.9|8.9|||
4237104|NCT00669032|4060300|B1|||Age||years|Mean|63|63.0|Standard Deviation|8.2|8.2|||
4237105|NCT00669019|4060329|B1|1||Performance Status|"ECOG performance status scores on a scale of 0-5, higher is worse~0 = Fully active, able to carry on all pre-disease performance without restriction~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~= Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours~= Capable of only limited self-care, confined to bed/chair more than 50% of waking hours~= Completely disabled. Cannot carry on any self-care. Totally confined to bed/chair~= Dead"|participants|Number|10|10.0||||||
4237106|NCT00669019|4060329|B1|0||Performance Status|"ECOG performance status scores on a scale of 0-5, higher is worse~0 = Fully active, able to carry on all pre-disease performance without restriction~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~= Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours~= Capable of only limited self-care, confined to bed/chair more than 50% of waking hours~= Completely disabled. Cannot carry on any self-care. Totally confined to bed/chair~= Dead"|participants|Number|13|13.0||||||
4237107|NCT00669019|4060329|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4237108|NCT00669019|4060329|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4237109|NCT00669019|4060329|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4237110|NCT00669019|4060329|B1|||Age||years|Median|63|63.0|Full Range|||25.0|80.0|
4237111|NCT00668902|4060334|B4|||BMI||kg/m^2|Mean|24.2|24.2|Standard Deviation|1.039|1.039|||
4237112|NCT00668902|4060335|B3|||BMI||kg/m^2|Mean|23|23.0|Standard Deviation|1.3|1.3|||
4237113|NCT00668902|4060336|B2|||BMI||kg/m^2|Mean|24.8|24.8|Standard Deviation|3.5|3.5|||
4237114|NCT00668902|4060337|B1|||BMI||kg/m^2|Mean|24.8|24.8|Standard Deviation|3.6|3.6|||
4237115|NCT00668902|4060334|B4|United States||Region of Enrollment||participants|Number|25|25.0||||||
4237116|NCT00668902|4060335|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4237117|NCT00668902|4060336|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4237118|NCT00668902|4060337|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4237119|NCT00668902|4060334|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4237120|NCT00668902|4060335|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4237121|NCT00668902|4060336|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4237122|NCT00668902|4060337|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4237123|NCT00668902|4060334|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4237124|NCT00668902|4060335|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4237125|NCT00668902|4060336|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4237126|NCT00668902|4060337|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4237127|NCT00668902|4060334|B4|||Age||years|Mean|25.63|25.63|Standard Deviation|1.159|1.159|||
4237128|NCT00668902|4060335|B3|||Age||years|Mean|24.3|24.3|Standard Deviation|3.3|3.3|||
4237129|NCT00668902|4060336|B2|||Age||years|Mean|26.4|26.4|Standard Deviation|6.1|6.1|||
4237130|NCT00668902|4060337|B1|||Age||years|Mean|26.2|26.2|Standard Deviation|5.3|5.3|||
4237131|NCT00668863|4060347|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4237132|NCT00668863|4060347|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4237133|NCT00668863|4060347|B1|>=65 years||Age, Customized||participants|Number|21|21.0||||||
4237134|NCT00668863|4060347|B1|45 to 64 years||Age, Customized||participants|Number|44|44.0||||||
4237135|NCT00668863|4060347|B1|<=44 years||Age, Customized||participants|Number|6|6.0||||||
4237136|NCT00668811|4060366|B1|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4237137|NCT00668811|4060366|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4237138|NCT00668811|4060366|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4237139|NCT00668811|4060366|B1|||Age||years|Median|61|61.0|Inter-Quartile Range|||25.0|80.0|
4237140|NCT00668785|4060371|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4237141|NCT00668785|4060371|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4237142|NCT00668785|4060371|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4237143|NCT00668785|4060371|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4237144|NCT00668785|4060371|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4237145|NCT00668785|4060371|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4237146|NCT00668746|4060377|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
4237147|NCT00668746|4060378|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4237148|NCT00668746|4060379|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4237149|NCT00668746|4060377|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4237150|NCT00668746|4060378|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4237151|NCT00668746|4060379|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4237152|NCT00668746|4060377|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4237153|NCT00668746|4060378|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4237154|NCT00668746|4060379|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4237155|NCT00668746|4060377|B3|||Age||years|Mean|56.00|56.0|Standard Deviation|10.55|10.55|||
4237156|NCT00668746|4060378|B2|||Age||years|Mean|52.83|52.83|Standard Deviation|9.90|9.9|||
4237157|NCT00668746|4060379|B1|||Age||years|Mean|57.65|57.65|Standard Deviation|10.71|10.71|||
4237158|NCT00668733|4060398|B3|United States||Region of Enrollment||participants|Number|179|179.0||||||
4237159|NCT00668733|4060399|B2|United States||Region of Enrollment||participants|Number|90|90.0||||||
4237160|NCT00668733|4060400|B1|United States||Region of Enrollment||participants|Number|89|89.0||||||
4237161|NCT00668733|4060398|B3||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4237162|NCT00668733|4060399|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4237163|NCT00668733|4060400|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4237164|NCT00668733|4060398|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4237165|NCT00668733|4060399|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4237166|NCT00668733|4060400|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4237167|NCT00668733|4060398|B3|||Age||years|Mean|64.5|64.5|Standard Deviation|10.5|10.5|||
4237168|NCT00668733|4060399|B2|||Age||years|Mean|64.0|64.0|Standard Deviation|10.2|10.2|||
4237169|NCT00668733|4060400|B1|||Age||years|Mean|65.0|65.0|Standard Deviation|10.9|10.9|||
4237170|NCT00668733|4060398|B3||>=65 years|Age||Participants|Count of Participants|87|87.0||||||
4237171|NCT00668733|4060399|B2||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
4237172|NCT00668733|4060400|B1||>=65 years|Age||Participants|Count of Participants|47|47.0||||||
4237173|NCT00668733|4060398|B3||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
4237174|NCT00668733|4060399|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4237175|NCT00668733|4060400|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4237176|NCT00668733|4060398|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4237177|NCT00668733|4060399|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4237178|NCT00668733|4060400|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4237179|NCT00668564|4060407|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4237180|NCT00668564|4060407|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4237181|NCT00668564|4060407|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4237182|NCT00668564|4060407|B1|||Age||years|Mean|4.7|4.7|Standard Deviation|4.3|4.3|||
4237183|NCT00668564|4060407|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4237184|NCT00668564|4060407|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4237185|NCT00668564|4060407|B1||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
4237186|NCT00668525|4060412|B4|United States||Region of Enrollment||participants|Number|864|864.0||||||
4237187|NCT00668525|4060413|B3|United States||Region of Enrollment||participants|Number|218|218.0||||||
4237188|NCT00668525|4060414|B2|United States||Region of Enrollment||participants|Number|324|324.0||||||
4237189|NCT00668525|4060415|B1|United States||Region of Enrollment||participants|Number|322|322.0||||||
4237190|NCT00668525|4060412|B4||Male|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
4237191|NCT00668525|4060413|B3||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4237192|NCT00668525|4060414|B2||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4237193|NCT00668525|4060415|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4237194|NCT00668525|4060412|B4||Female|Sex: Female, Male||Participants|Count of Participants|564|564.0||||||
4237195|NCT00668525|4060413|B3||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4237196|NCT00668525|4060414|B2||Female|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4237197|NCT00668525|4060415|B1||Female|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4237198|NCT00668525|4060412|B4|||Age||years|Mean|41.3|41.3|Standard Deviation|12.2|12.2|||
4237199|NCT00668525|4060413|B3|||Age||years|Mean|42.3|42.3|Standard Deviation|12.7|12.7|||
4237200|NCT00668525|4060414|B2|||Age||years|Mean|40.4|40.4|Standard Deviation|11.9|11.9|||
4237201|NCT00668525|4060415|B1|||Age||years|Mean|41.4|41.4|Standard Deviation|12.3|12.3|||
4237202|NCT00668525|4060412|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4237203|NCT00668525|4060413|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4237204|NCT00668525|4060414|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4237205|NCT00668525|4060415|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4237206|NCT00668525|4060412|B4||Between 18 and 65 years|Age||Participants|Count of Participants|864|864.0||||||
4237207|NCT00668525|4060413|B3||Between 18 and 65 years|Age||Participants|Count of Participants|218|218.0||||||
4237208|NCT00668525|4060414|B2||Between 18 and 65 years|Age||Participants|Count of Participants|324|324.0||||||
4237209|NCT00668525|4060415|B1||Between 18 and 65 years|Age||Participants|Count of Participants|322|322.0||||||
4237210|NCT00668525|4060412|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4237211|NCT00668525|4060413|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4237212|NCT00668525|4060414|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4237213|NCT00668525|4060415|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4237214|NCT00668434|4060428|B3|United States||Region of Enrollment||participants|Number|269|269.0||||||
4237215|NCT00668434|4060429|B2|United States||Region of Enrollment||participants|Number|88|88.0||||||
4237216|NCT00668434|4060430|B1|United States||Region of Enrollment||participants|Number|181|181.0||||||
4237217|NCT00668434|4060428|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4237218|NCT00668434|4060429|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4237219|NCT00668434|4060430|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4237220|NCT00668434|4060428|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|207|207.0||||||
4237221|NCT00668434|4060429|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4237222|NCT00668434|4060430|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|147|147.0||||||
4237223|NCT00668434|4060428|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4237224|NCT00668434|4060429|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4237225|NCT00668434|4060430|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4237226|NCT00668434|4060428|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4237227|NCT00668434|4060429|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4237228|NCT00668434|4060430|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4237229|NCT00668434|4060428|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4237230|NCT00668434|4060429|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4237231|NCT00668434|4060430|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4237232|NCT00668434|4060428|B3||White|Race (NIH/OMB)||Participants|Count of Participants|179|179.0||||||
4237233|NCT00668434|4060429|B2||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4237234|NCT00668434|4060430|B1||White|Race (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
4237235|NCT00668434|4060428|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4237236|NCT00668434|4060429|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4237237|NCT00668434|4060430|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4237238|NCT00668434|4060428|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4237239|NCT00668434|4060429|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4237240|NCT00668434|4060430|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4237241|NCT00668434|4060428|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4237242|NCT00668434|4060429|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4237243|NCT00668434|4060430|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4237244|NCT00668434|4060428|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4237245|NCT00668434|4060429|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4237246|NCT00668434|4060430|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4237247|NCT00668434|4060428|B3||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4237248|NCT00668434|4060429|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4237249|NCT00668434|4060430|B1||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4237250|NCT00668434|4060428|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4237251|NCT00668434|4060429|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4237252|NCT00668434|4060430|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4237253|NCT00668434|4060428|B3|||Age||years|Mean|46.0|46.0|Standard Deviation|12.1|12.1|||
4237254|NCT00668434|4060429|B2|||Age||years|Mean|46.7|46.7|Standard Deviation|12.6|12.6|||
4237255|NCT00668434|4060430|B1|||Age||years|Mean|45.6|45.6|Standard Deviation|11.8|11.8|||
4237256|NCT00668395|4060443|B4|||Body weight||kg|Mean|74|74.0|Standard Deviation|13.4|13.4|||
4237257|NCT00668395|4060444|B3|||Body weight||kg|Mean|65|65.0|Standard Deviation|5.3|5.3|||
4237258|NCT00668395|4060445|B2|||Body weight||kg|Mean|77.2|77.2|Standard Deviation|14.1|14.1|||
4237259|NCT00668395|4060446|B1|||Body weight||kg|Mean|73.6|73.6|Standard Deviation|13|13.0|||
4237260|NCT00668395|4060443|B4|||BMI|A number of demographic parameters were collected at screening and during the completion of the study (exit).|kg/m2|Mean|24.2|24.2|Standard Deviation|3.7|3.7|||
4237261|NCT00668395|4060444|B3|||BMI|A number of demographic parameters were collected at screening and during the completion of the study (exit).|kg/m2|Mean|22.0|22.0|Standard Deviation|3.0|3.0|||
4237262|NCT00668395|4060445|B2|||BMI|A number of demographic parameters were collected at screening and during the completion of the study (exit).|kg/m2|Mean|25.4|25.4|Standard Deviation|4.1|4.1|||
4237263|NCT00668395|4060446|B1|||BMI|A number of demographic parameters were collected at screening and during the completion of the study (exit).|kg/m2|Mean|23.9|23.9|Standard Deviation|3.5|3.5|||
4237264|NCT00668395|4060443|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4237265|NCT00668395|4060444|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4237266|NCT00668395|4060445|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4237267|NCT00668395|4060446|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4237268|NCT00668395|4060443|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4237269|NCT00668395|4060444|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4237270|NCT00668395|4060445|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4237271|NCT00668395|4060446|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4237272|NCT00668395|4060443|B4||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4237273|NCT00668395|4060444|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4237274|NCT00668395|4060445|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4237275|NCT00668395|4060446|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4237276|NCT00668395|4060443|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4237277|NCT00668395|4060444|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4237278|NCT00668395|4060445|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4237279|NCT00668395|4060446|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4237280|NCT00668395|4060443|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4237281|NCT00668395|4060444|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4237282|NCT00668395|4060445|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4237283|NCT00668395|4060446|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4237284|NCT00668395|4060443|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4237285|NCT00668395|4060444|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4237286|NCT00668395|4060445|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4237287|NCT00668395|4060446|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4237288|NCT00668395|4060443|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4237289|NCT00668395|4060444|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4237290|NCT00668395|4060445|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4237291|NCT00668395|4060446|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4237292|NCT00668395|4060443|B4||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4237293|NCT00668395|4060444|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4237294|NCT00668395|4060445|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4237295|NCT00668395|4060446|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4237296|NCT00668395|4060443|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4237297|NCT00668395|4060444|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4237298|NCT00668395|4060445|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4237299|NCT00668395|4060446|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4237300|NCT00668395|4060443|B4|||Age||years|Mean|28.2|28.2|Standard Deviation|9.8|9.8|||
4237301|NCT00668395|4060444|B3|||Age||years|Mean|23.2|23.2|Standard Deviation|3.9|3.9|||
4237302|NCT00668395|4060445|B2|||Age||years|Mean|29.5|29.5|Standard Deviation|9.9|9.9|||
4237303|NCT00668395|4060446|B1|||Age||years|Mean|28.3|28.3|Standard Deviation|10.2|10.2|||
4237304|NCT00668382|4060456|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4237305|NCT00668382|4060456|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4237306|NCT00668382|4060456|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4237307|NCT00668382|4060456|B1|||Age||years|Mean|60|60.0|Standard Deviation|12.5|12.5|||
4237308|NCT00668382|4060456|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4237309|NCT00668382|4060456|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4237310|NCT00668382|4060456|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4237311|NCT00668317|4060460|B1|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4237312|NCT00668317|4060460|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4237313|NCT00668317|4060460|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4237314|NCT00668317|4060460|B1|||Age||years|Mean|49.8|49.8|Standard Deviation|8.53|8.53|||
4237315|NCT00668317|4060460|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4237316|NCT00668317|4060460|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4237317|NCT00668317|4060460|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4237318|NCT00668265|4060464|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4237319|NCT00668265|4060465|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4237320|NCT00668265|4060466|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4237321|NCT00668265|4060464|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4237322|NCT00668265|4060465|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4237323|NCT00668265|4060466|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4237324|NCT00668265|4060464|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4237325|NCT00668265|4060465|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4237326|NCT00668265|4060466|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4237327|NCT00668265|4060464|B3|||Age||years|Mean|43.8|43.8|Standard Deviation|9|9.0|||
4237328|NCT00668265|4060465|B2|||Age||years|Mean|45|45.0|Standard Deviation|9|9.0|||
4237329|NCT00668265|4060466|B1|||Age||years|Mean|43|43.0|Standard Deviation|7.0|7.0|||
4237330|NCT00668265|4060464|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4237331|NCT00668265|4060465|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4237332|NCT00668265|4060466|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4237333|NCT00668265|4060464|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4237334|NCT00668265|4060465|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4237335|NCT00668265|4060466|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4237336|NCT00668265|4060464|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4237337|NCT00668265|4060465|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4237338|NCT00668265|4060466|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4237339|NCT00668200|4060475|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4237340|NCT00668200|4060475|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4237341|NCT00668200|4060475|B1|||Age||years|Mean|71.5|71.5|Standard Deviation|12.98|12.98|39.0|94.0|
4237342|NCT00668148|4060481|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4237343|NCT00668148|4060481|B1|Germany||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4237344|NCT00668148|4060481|B1|Belgium||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4237345|NCT00668148|4060481|B1|Spain||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4237346|NCT00668148|4060481|B1|Poland||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4237347|NCT00668148|4060481|B1|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
4237348|NCT00668148|4060481|B1|France||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4237349|NCT00668148|4060481|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4237350|NCT00668148|4060481|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4237351|NCT00668148|4060481|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|101|101.0||||||
4237352|NCT00668148|4060481|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4237353|NCT00668148|4060481|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
4237354|NCT00668148|4060481|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4237355|NCT00668148|4060481|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4237356|NCT00668148|4060481|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4237357|NCT00668148|4060481|B1|||Age||years|Median|47.0|47.0|Full Range|10.3|10.3|17.0|82.0|
4237358|NCT00667992|4060518|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4237359|NCT00667992|4060519|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4237360|NCT00667992|4060520|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4237361|NCT00667992|4060518|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4237362|NCT00667992|4060519|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4237363|NCT00667992|4060520|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4237364|NCT00667992|4060518|B3|||Age||years|Mean|39.75|39.75|Full Range|||18.0|65.0|
4237365|NCT00667992|4060519|B2|||Age||years|Mean|39.5|39.5|Full Range|||18.0|64.0|
4237366|NCT00667992|4060520|B1|||Age||years|Mean|40.0|40.0|Full Range|||19.0|65.0|
4237367|NCT00667875|4060575|B4||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4237368|NCT00667875|4060576|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4237369|NCT00667875|4060577|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4237370|NCT00667875|4060578|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4237371|NCT00667875|4060575|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4237372|NCT00667875|4060576|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4237373|NCT00667875|4060577|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4237374|NCT00667875|4060578|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4237375|NCT00667875|4060575|B4|||Age||years|Mean|47.6|47.6|Standard Deviation|10.2|10.2|||
4237376|NCT00667875|4060576|B3|||Age||years|Mean|48.4|48.4|Standard Deviation|10.2|10.2|||
4237377|NCT00667875|4060577|B2|||Age||years|Mean|47.2|47.2|Standard Deviation|11.3|11.3|||
4237378|NCT00667875|4060578|B1|||Age||years|Mean|47|47.0|Standard Deviation|9.6|9.6|||
4237379|NCT00667849|4060597|B3|United States||Region of Enrollment||participants|Number|334|334.0||||||
4237380|NCT00667849|4060598|B2|United States||Region of Enrollment||participants|Number|166|166.0||||||
4237381|NCT00667849|4060599|B1|United States||Region of Enrollment||participants|Number|168|168.0||||||
4237382|NCT00667849|4060597|B3|Canada||Region of Enrollment||participants|Number|167|167.0||||||
4237383|NCT00667849|4060598|B2|Canada||Region of Enrollment||participants|Number|85|85.0||||||
4237384|NCT00667849|4060599|B1|Canada||Region of Enrollment||participants|Number|82|82.0||||||
4237385|NCT00667849|4060597|B3||Male|Sex: Female, Male||Participants|Count of Participants|345|345.0||||||
4237386|NCT00667849|4060598|B2||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4237387|NCT00667849|4060599|B1||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4237388|NCT00667849|4060597|B3||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4237389|NCT00667849|4060598|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4237390|NCT00667849|4060599|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4237391|NCT00667849|4060597|B3|||Age||years|Mean|38.3|38.3|Standard Deviation|13.9|13.9|||
4237392|NCT00667849|4060598|B2|||Age||years|Mean|39.1|39.1|Standard Deviation|14.6|14.6|||
4237393|NCT00667849|4060599|B1|||Age||years|Mean|37.1|37.1|Standard Deviation|13.2|13.2|||
4237394|NCT00667849|4060597|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4237395|NCT00667849|4060598|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4237396|NCT00667849|4060599|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4237397|NCT00667849|4060597|B3||Between 18 and 65 years|Age||Participants|Count of Participants|483|483.0||||||
4237398|NCT00667849|4060598|B2||Between 18 and 65 years|Age||Participants|Count of Participants|239|239.0||||||
4237399|NCT00667849|4060599|B1||Between 18 and 65 years|Age||Participants|Count of Participants|244|244.0||||||
4237400|NCT00667849|4060597|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4237401|NCT00667849|4060598|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4237402|NCT00667849|4060599|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4237403|NCT00667810|4060610|B5||Male|Sex: Female, Male||Participants|Count of Participants|381|381.0||||||
4237404|NCT00667810|4060611|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4237405|NCT00667810|4060612|B3||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4237406|NCT00667810|4060613|B2||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4237407|NCT00667810|4060614|B1||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4237408|NCT00667810|4060610|B5||Female|Sex: Female, Male||Participants|Count of Participants|504|504.0||||||
4237409|NCT00667810|4060611|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4237410|NCT00667810|4060612|B3||Female|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4237411|NCT00667810|4060613|B2||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4237412|NCT00667810|4060614|B1||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4237413|NCT00667810|4060610|B5|≥65 years||Age, Customized||Years|Number|610|610.0||||||
4237414|NCT00667810|4060611|B4|≥65 years||Age, Customized||Years|Number|5|5.0||||||
4237415|NCT00667810|4060612|B3|≥65 years||Age, Customized||Years|Number|229|229.0||||||
4237416|NCT00667810|4060613|B2|≥65 years||Age, Customized||Years|Number|182|182.0||||||
4237417|NCT00667810|4060614|B1|≥65 years||Age, Customized||Years|Number|194|194.0||||||
4237418|NCT00667810|4060610|B5|<65 years||Age, Customized||Years|Number|275|275.0||||||
4237419|NCT00667810|4060611|B4|<65 years||Age, Customized||Years|Number|6|6.0||||||
4237420|NCT00667810|4060612|B3|<65 years||Age, Customized||Years|Number|115|115.0||||||
4237421|NCT00667810|4060613|B2|<65 years||Age, Customized||Years|Number|81|81.0||||||
4237422|NCT00667810|4060614|B1|<65 years||Age, Customized||Years|Number|73|73.0||||||
4237423|NCT00667810|4060610|B5|||Age||Years|Mean|70.6|70.6|Standard Deviation|9.63|9.63|||
4237424|NCT00667810|4060611|B4|||Age||Years|Mean|66.5|66.5|Standard Deviation|7.94|7.94|||
4237425|NCT00667810|4060612|B3|||Age||Years|Mean|69.9|69.9|Standard Deviation|9.76|9.76|||
4237426|NCT00667810|4060613|B2|||Age||Years|Mean|70.8|70.8|Standard Deviation|9.73|9.73|||
4237427|NCT00667810|4060614|B1|||Age||Years|Mean|71.4|71.4|Standard Deviation|9.38|9.38|||
4237428|NCT00667745|4060674|B3|United States||Region of Enrollment||participants|Number|283|283.0||||||
4237429|NCT00667745|4060675|B2|United States||Region of Enrollment||participants|Number|142|142.0||||||
4237430|NCT00667745|4060676|B1|United States||Region of Enrollment||participants|Number|141|141.0||||||
4237431|NCT00667745|4060674|B3||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4237432|NCT00667745|4060675|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4237433|NCT00667745|4060676|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4237434|NCT00667745|4060674|B3||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4237435|NCT00667745|4060675|B2||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4237436|NCT00667745|4060676|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4237437|NCT00667745|4060674|B3|||Age||years|Mean|39.1|39.1|Standard Deviation|12.3|12.3|||
4237438|NCT00667745|4060675|B2|||Age||years|Mean|39.4|39.4|Standard Deviation|13.0|13.0|||
4237439|NCT00667745|4060676|B1|||Age||years|Mean|38.7|38.7|Standard Deviation|11.7|11.7|||
4237440|NCT00667745|4060674|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4237441|NCT00667745|4060675|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4237442|NCT00667745|4060676|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4237443|NCT00667745|4060674|B3||Between 18 and 65 years|Age||Participants|Count of Participants|283|283.0||||||
4237444|NCT00667745|4060675|B2||Between 18 and 65 years|Age||Participants|Count of Participants|142|142.0||||||
4237445|NCT00667745|4060676|B1||Between 18 and 65 years|Age||Participants|Count of Participants|141|141.0||||||
4237446|NCT00667745|4060674|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4237447|NCT00667745|4060675|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4237448|NCT00667745|4060676|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4237449|NCT00667732|4060691|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4237450|NCT00667732|4060692|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4237451|NCT00667732|4060693|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4237452|NCT00667732|4060691|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4237453|NCT00667732|4060692|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4237454|NCT00667732|4060693|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4237455|NCT00667732|4060691|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4237456|NCT00667732|4060692|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4237457|NCT00667732|4060693|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4237458|NCT00667732|4060691|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4237459|NCT00667732|4060692|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4237460|NCT00667732|4060693|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4237461|NCT00667732|4060691|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4237462|NCT00667732|4060692|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4237463|NCT00667732|4060693|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4237464|NCT00667693|4060706|B3|4: Only hard palate visible||Mallampati score||participants|Number|4|4.0||||||
4237465|NCT00667693|4060707|B2|4: Only hard palate visible||Mallampati score||participants|Number|4|4.0||||||
4237466|NCT00667693|4060708|B1|4: Only hard palate visible||Mallampati score||participants|Number|0|0.0||||||
4237467|NCT00667693|4060706|B3|3: Soft palate, base of uvula visible||Mallampati score||participants|Number|20|20.0||||||
4237468|NCT00667693|4060707|B2|3: Soft palate, base of uvula visible||Mallampati score||participants|Number|7|7.0||||||
4237469|NCT00667693|4060708|B1|3: Soft palate, base of uvula visible||Mallampati score||participants|Number|13|13.0||||||
4237470|NCT00667693|4060706|B3|2: Soft palate, uvula, fauces visible||Mallampati score||participants|Number|39|39.0||||||
4237471|NCT00667693|4060707|B2|2: Soft palate, uvula, fauces visible||Mallampati score||participants|Number|18|18.0||||||
4237472|NCT00667693|4060708|B1|2: Soft palate, uvula, fauces visible||Mallampati score||participants|Number|21|21.0||||||
4237473|NCT00667693|4060706|B3|1: Soft palate, uvula, fauces, pillars visible||Mallampati score||participants|Number|35|35.0||||||
4237474|NCT00667693|4060707|B2|1: Soft palate, uvula, fauces, pillars visible||Mallampati score||participants|Number|21|21.0||||||
4237475|NCT00667693|4060708|B1|1: Soft palate, uvula, fauces, pillars visible||Mallampati score||participants|Number|14|14.0||||||
4237476|NCT00667693|4060706|B3|IV: severe systemic disease that threats to life||ASA status|American Society of Anesthesiology (ASA) physical status classification system|participants|Number|5|5.0||||||
4237477|NCT00667693|4060707|B2|IV: severe systemic disease that threats to life||ASA status|American Society of Anesthesiology (ASA) physical status classification system|participants|Number|3|3.0||||||
4237478|NCT00667693|4060708|B1|IV: severe systemic disease that threats to life||ASA status|American Society of Anesthesiology (ASA) physical status classification system|participants|Number|2|2.0||||||
4237479|NCT00667693|4060706|B3|III: severe systemic disease||ASA status|American Society of Anesthesiology (ASA) physical status classification system|participants|Number|72|72.0||||||
4237480|NCT00667693|4060707|B2|III: severe systemic disease||ASA status|American Society of Anesthesiology (ASA) physical status classification system|participants|Number|32|32.0||||||
4237481|NCT00667693|4060708|B1|III: severe systemic disease||ASA status|American Society of Anesthesiology (ASA) physical status classification system|participants|Number|40|40.0||||||
4237482|NCT00667693|4060706|B3|II: mild systemic disease||ASA status|American Society of Anesthesiology (ASA) physical status classification system|participants|Number|22|22.0||||||
4237483|NCT00667693|4060707|B2|II: mild systemic disease||ASA status|American Society of Anesthesiology (ASA) physical status classification system|participants|Number|15|15.0||||||
4237484|NCT00667693|4060708|B1|II: mild systemic disease||ASA status|American Society of Anesthesiology (ASA) physical status classification system|participants|Number|7|7.0||||||
4237485|NCT00667693|4060706|B3|United States||Region of Enrollment||participants|Number|99|99.0||||||
4237486|NCT00667693|4060707|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
4237487|NCT00667693|4060708|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
4237488|NCT00667693|4060706|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4237489|NCT00667693|4060707|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4237490|NCT00667693|4060708|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4237491|NCT00667693|4060706|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4237492|NCT00667693|4060707|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4237493|NCT00667693|4060708|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4237494|NCT00667693|4060706|B3|||Age||years|Mean|49|49.0|Standard Deviation|13|13.0|||
4237495|NCT00667693|4060707|B2|||Age||years|Mean|50|50.0|Standard Deviation|12|12.0|||
4237496|NCT00667693|4060708|B1|||Age||years|Mean|49|49.0|Standard Deviation|14|14.0|||
4237497|NCT00667615|4060723|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4237498|NCT00667615|4060723|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4237499|NCT00667615|4060723|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4237500|NCT00667615|4060723|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4237501|NCT00667615|4060723|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4237502|NCT00667615|4060723|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4237503|NCT00667615|4060723|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4237504|NCT00667615|4060723|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4237505|NCT00667615|4060723|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4237506|NCT00667615|4060723|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4237507|NCT00667615|4060723|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4237508|NCT00667615|4060723|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4237509|NCT00667615|4060723|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4237510|NCT00667615|4060723|B1|||Age||years|Median|76|76.0|Full Range|||69.0|88.0|
4237511|NCT00667602|4060728|B4||Male|Sex: Female, Male||Participants|Count of Participants|357|357.0||||||
4237512|NCT00667602|4060729|B3||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4237513|NCT00667602|4060730|B2||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4237514|NCT00667602|4060731|B1||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4237515|NCT00667602|4060728|B4||Female|Sex: Female, Male||Participants|Count of Participants|305|305.0||||||
4237516|NCT00667602|4060729|B3||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4237517|NCT00667602|4060730|B2||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4237518|NCT00667602|4060731|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4237519|NCT00667602|4060728|B4|||Age||Days|Mean|209.2|209.2|Standard Deviation|22.6|22.6|||
4237520|NCT00667602|4060729|B3|||Age||Days|Mean|209.3|209.3|Standard Deviation|21.9|21.9|||
4237521|NCT00667602|4060730|B2|||Age||Days|Mean|209.8|209.8|Standard Deviation|22.2|22.2|||
4237522|NCT00667602|4060731|B1|||Age||Days|Mean|208.4|208.4|Standard Deviation|23.7|23.7|||
4237523|NCT00667589|4060779|B5|United States||Region of Enrollment||participants|Number|6|6.0||||||
4237524|NCT00667589|4060780|B4|United States||Region of Enrollment||participants|Number|2|2.0||||||
4237525|NCT00667589|4060781|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4237526|NCT00667589|4060783|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4237527|NCT00667589|4060779|B5|Male||Gender||participants|Number|2|2.0||||||
4237528|NCT00667589|4060780|B4|Male||Gender||participants|Number|0|0.0||||||
4237529|NCT00667589|4060781|B3|Male||Gender||participants|Number|1|1.0||||||
4237530|NCT00667589|4060783|B1|Male||Gender||participants|Number|1|1.0||||||
4237531|NCT00667589|4060779|B5|Female||Gender||participants|Number|4|4.0||||||
4237532|NCT00667589|4060780|B4|Female||Gender||participants|Number|2|2.0||||||
4237533|NCT00667589|4060781|B3|Female||Gender||participants|Number|2|2.0||||||
4237534|NCT00667589|4060783|B1|Female||Gender||participants|Number|0|0.0||||||
4237535|NCT00667589|4060779|B5|||Age||years|Mean|62.0|62.0|Standard Deviation|9.3|9.3|||
4237536|NCT00667589|4060780|B4|||Age||years|Mean|60.5|60.5|Standard Deviation|3.5|3.5|||
4237537|NCT00667589|4060781|B3|||Age||years|Mean|63.3|63.3|Standard Deviation|12.7|12.7|||
4237538|NCT00667589|4060783|B1|||Age||years|Mean|61.0|61.0|Standard Deviation|0|0.0|||
4237539|NCT00667589|4060779|B5|>=65 years||Age||participants|Number|2|2.0||||||
4237540|NCT00667589|4060780|B4|>=65 years||Age||participants|Number|0|0.0||||||
4237541|NCT00667589|4060781|B3|>=65 years||Age||participants|Number|2|2.0||||||
4237542|NCT00667589|4060783|B1|>=65 years||Age||participants|Number|0|0.0||||||
4237543|NCT00667589|4060779|B5|Between 18 and 65 years||Age||participants|Number|4|4.0||||||
4237544|NCT00667589|4060780|B4|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
4237545|NCT00667589|4060781|B3|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
4237546|NCT00667589|4060783|B1|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
4237547|NCT00667589|4060779|B5|<=18 years||Age||participants|Number|0|0.0||||||
4237548|NCT00667589|4060780|B4|<=18 years||Age||participants|Number|0|0.0||||||
4237549|NCT00667589|4060781|B3|<=18 years||Age||participants|Number|0|0.0||||||
4237550|NCT00667589|4060783|B1|<=18 years||Age||participants|Number|0|0.0||||||
4237551|NCT00667576|4060796|B6|Japan||Region of Enrollment||participants|Number|153|153.0||||||
4237552|NCT00667576|4060797|B5|Japan||Region of Enrollment||participants|Number|30|30.0||||||
4237553|NCT00667576|4060798|B4|Japan||Region of Enrollment||participants|Number|31|31.0||||||
4237554|NCT00667576|4060799|B3|Japan||Region of Enrollment||participants|Number|31|31.0||||||
4237555|NCT00667576|4060800|B2|Japan||Region of Enrollment||participants|Number|31|31.0||||||
4237556|NCT00667576|4060801|B1|Japan||Region of Enrollment||participants|Number|30|30.0||||||
4237557|NCT00667576|4060796|B6||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4237558|NCT00667576|4060797|B5||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4237559|NCT00667576|4060798|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4237560|NCT00667576|4060799|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4237561|NCT00667576|4060800|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4237562|NCT00667576|4060801|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4237563|NCT00667576|4060796|B6||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4237564|NCT00667576|4060797|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4237565|NCT00667576|4060798|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4237566|NCT00667576|4060799|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4237567|NCT00667576|4060800|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4237568|NCT00667576|4060801|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4237569|NCT00667576|4060796|B6|||Age||years|Mean|61.3|61.3|Standard Deviation|11.86|11.86|||
4237570|NCT00667576|4060797|B5|||Age||years|Mean|64.1|64.1|Standard Deviation|11.98|11.98|||
4237571|NCT00667576|4060798|B4|||Age||years|Mean|61.5|61.5|Standard Deviation|11.17|11.17|||
4237572|NCT00667576|4060799|B3|||Age||years|Mean|58.1|58.1|Standard Deviation|12.35|12.35|||
4237573|NCT00667576|4060800|B2|||Age||years|Mean|60.7|60.7|Standard Deviation|11.80|11.8|||
4237574|NCT00667576|4060801|B1|||Age||years|Mean|62.1|62.1|Standard Deviation|11.94|11.94|||
4237575|NCT00667576|4060796|B6||>=65 years|Age||Participants|Count of Participants|66|66.0||||||
4237576|NCT00667576|4060797|B5||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4237577|NCT00667576|4060798|B4||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4237578|NCT00667576|4060799|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4237579|NCT00667576|4060800|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4237580|NCT00667576|4060801|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4237581|NCT00667576|4060796|B6||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
4237582|NCT00667576|4060797|B5||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4237583|NCT00667576|4060798|B4||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4237584|NCT00667576|4060799|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4237585|NCT00667576|4060800|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4237586|NCT00667576|4060801|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4237587|NCT00667576|4060796|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4237588|NCT00667576|4060797|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4237589|NCT00667576|4060798|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4237590|NCT00667576|4060799|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4237591|NCT00667576|4060800|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4237592|NCT00667576|4060801|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4237593|NCT00667563|4060852|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4237594|NCT00667563|4060852|B1||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4237595|NCT00667563|4060852|B1|||Age||years|Mean|30.8|30.8|Standard Deviation|5.2|5.2|||
4237596|NCT00667511|4060862|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4237597|NCT00667511|4060862|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4237598|NCT00667511|4060862|B1|||Age||years|Mean|53|53.0|Standard Deviation|13|13.0|||
4237599|NCT00667459|4060870|B3|No||Preop Work Status||participants|Number|191|191.0||||||
4237600|NCT00667459|4060871|B2|No||Preop Work Status||participants|Number|99|99.0||||||
4237601|NCT00667459|4060872|B1|No||Preop Work Status||participants|Number|92|92.0||||||
4237602|NCT00667459|4060870|B3|Yes||Preop Work Status||participants|Number|354|354.0||||||
4237603|NCT00667459|4060871|B2|Yes||Preop Work Status||participants|Number|166|166.0||||||
4237604|NCT00667459|4060872|B1|Yes||Preop Work Status||participants|Number|188|188.0||||||
4237605|NCT00667459|4060870|B3|No||Alcohol Used||participants|Number|254|254.0||||||
4237606|NCT00667459|4060871|B2|No||Alcohol Used||participants|Number|124|124.0||||||
4237607|NCT00667459|4060872|B1|No||Alcohol Used||participants|Number|130|130.0||||||
4237608|NCT00667459|4060870|B3|Yes||Alcohol Used||participants|Number|291|291.0||||||
4237609|NCT00667459|4060871|B2|Yes||Alcohol Used||participants|Number|141|141.0||||||
4237610|NCT00667459|4060872|B1|Yes||Alcohol Used||participants|Number|150|150.0||||||
4237611|NCT00667459|4060870|B3|No||Tobacco Used||participants|Number|379|379.0||||||
4237612|NCT00667459|4060871|B2|No||Tobacco Used||participants|Number|173|173.0||||||
4237613|NCT00667459|4060872|B1|No||Tobacco Used||participants|Number|206|206.0||||||
4237614|NCT00667459|4060870|B3|Yes||Tobacco Used||participants|Number|166|166.0||||||
4237615|NCT00667459|4060871|B2|Yes||Tobacco Used||participants|Number|92|92.0||||||
4237616|NCT00667459|4060872|B1|Yes||Tobacco Used||participants|Number|74|74.0||||||
4237617|NCT00667459|4060870|B3|No||Unresolved Spinal Litigation||participants|Number|479|479.0||||||
4237618|NCT00667459|4060871|B2|No||Unresolved Spinal Litigation||participants|Number|233|233.0||||||
4237619|NCT00667459|4060872|B1|No||Unresolved Spinal Litigation||participants|Number|246|246.0||||||
4237620|NCT00667459|4060870|B3|Yes||Unresolved Spinal Litigation||participants|Number|66|66.0||||||
4237621|NCT00667459|4060871|B2|Yes||Unresolved Spinal Litigation||participants|Number|32|32.0||||||
4237622|NCT00667459|4060872|B1|Yes||Unresolved Spinal Litigation||participants|Number|34|34.0||||||
4237623|NCT00667459|4060870|B3|No||Worker's Compensation Case||participants|Number|478|478.0||||||
4237624|NCT00667459|4060871|B2|No||Worker's Compensation Case||participants|Number|230|230.0||||||
4237625|NCT00667459|4060872|B1|No||Worker's Compensation Case||participants|Number|248|248.0||||||
4237626|NCT00667459|4060870|B3|Yes||Worker's Compensation Case||participants|Number|67|67.0||||||
4237627|NCT00667459|4060871|B2|Yes||Worker's Compensation Case||participants|Number|35|35.0||||||
4237628|NCT00667459|4060872|B1|Yes||Worker's Compensation Case||participants|Number|32|32.0||||||
4237629|NCT00667459|4060870|B3|Unknown||Education Level||participants|Number|3|3.0||||||
4237630|NCT00667459|4060871|B2|Unknown||Education Level||participants|Number|1|1.0||||||
4237631|NCT00667459|4060872|B1|Unknown||Education Level||participants|Number|2|2.0||||||
4237632|NCT00667459|4060870|B3|> High School||Education Level||participants|Number|379|379.0||||||
4237633|NCT00667459|4060871|B2|> High School||Education Level||participants|Number|173|173.0||||||
4237634|NCT00667459|4060872|B1|> High School||Education Level||participants|Number|206|206.0||||||
4237635|NCT00667459|4060870|B3|High School||Education Level||participants|Number|134|134.0||||||
4237636|NCT00667459|4060871|B2|High School||Education Level||participants|Number|77|77.0||||||
4237637|NCT00667459|4060872|B1|High School||Education Level||participants|Number|57|57.0||||||
4237638|NCT00667459|4060870|B3|< High School||Education Level||participants|Number|29|29.0||||||
4237639|NCT00667459|4060871|B2|< High School||Education Level||participants|Number|14|14.0||||||
4237640|NCT00667459|4060872|B1|< High School||Education Level||participants|Number|15|15.0||||||
4237641|NCT00667459|4060870|B3|Widowed||Marital Status||participants|Number|4|4.0||||||
4237642|NCT00667459|4060871|B2|Widowed||Marital Status||participants|Number|2|2.0||||||
4237643|NCT00667459|4060872|B1|Widowed||Marital Status||participants|Number|2|2.0||||||
4237644|NCT00667459|4060870|B3|Separated||Marital Status||participants|Number|10|10.0||||||
4237645|NCT00667459|4060871|B2|Separated||Marital Status||participants|Number|3|3.0||||||
4237646|NCT00667459|4060872|B1|Separated||Marital Status||participants|Number|7|7.0||||||
4237647|NCT00667459|4060870|B3|Divorced||Marital Status||participants|Number|66|66.0||||||
4237648|NCT00667459|4060871|B2|Divorced||Marital Status||participants|Number|24|24.0||||||
4237649|NCT00667459|4060872|B1|Divorced||Marital Status||participants|Number|42|42.0||||||
4237650|NCT00667459|4060870|B3|Married||Marital Status||participants|Number|393|393.0||||||
4237651|NCT00667459|4060871|B2|Married||Marital Status||participants|Number|204|204.0||||||
4237652|NCT00667459|4060872|B1|Married||Marital Status||participants|Number|189|189.0||||||
4237653|NCT00667459|4060870|B3|Single||Marital Status||participants|Number|72|72.0||||||
4237654|NCT00667459|4060871|B2|Single||Marital Status||participants|Number|32|32.0||||||
4237655|NCT00667459|4060872|B1|Single||Marital Status||participants|Number|40|40.0||||||
4237656|NCT00667459|4060870|B3|||Weight||lbs.|Mean|185.8|185.8|Standard Deviation|43.3|43.3|||
4237657|NCT00667459|4060871|B2|||Weight||lbs.|Mean|184.7|184.7|Standard Deviation|41.5|41.5|||
4237658|NCT00667459|4060872|B1|||Weight||lbs.|Mean|186.9|186.9|Standard Deviation|45.0|45.0|||
4237659|NCT00667459|4060870|B3|||Height||in.|Mean|67.6|67.6|Standard Deviation|4.2|4.2|||
4237660|NCT00667459|4060871|B2|||Height||in.|Mean|67.5|67.5|Standard Deviation|4.2|4.2|||
4237661|NCT00667459|4060872|B1|||Height||in.|Mean|67.7|67.7|Standard Deviation|4.1|4.1|||
4237662|NCT00667459|4060870|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4237663|NCT00667459|4060871|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4237664|NCT00667459|4060872|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4237665|NCT00667459|4060870|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4237666|NCT00667459|4060871|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4237667|NCT00667459|4060872|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4237668|NCT00667459|4060870|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4237669|NCT00667459|4060871|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4237670|NCT00667459|4060872|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4237671|NCT00667459|4060870|B3|Black||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4237672|NCT00667459|4060871|B2|Black||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4237673|NCT00667459|4060872|B1|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4237674|NCT00667459|4060870|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|514|514.0||||||
4237675|NCT00667459|4060871|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|243|243.0||||||
4237676|NCT00667459|4060872|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|271|271.0||||||
4237677|NCT00667459|4060870|B3||Male|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4237678|NCT00667459|4060871|B2||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4237679|NCT00667459|4060872|B1||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4237680|NCT00667459|4060870|B3||Female|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
4237681|NCT00667459|4060871|B2||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4237682|NCT00667459|4060872|B1||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4237683|NCT00667459|4060870|B3|||Age||years|Mean|44.2|44.2|Standard Deviation|8.8|8.8|||
4237684|NCT00667459|4060871|B2|||Age||years|Mean|43.9|43.9|Standard Deviation|8.8|8.8|||
4237685|NCT00667459|4060872|B1|||Age||years|Mean|44.5|44.5|Standard Deviation|8.8|8.8|||
4237686|NCT00667446|4060913|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4237687|NCT00667446|4060914|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4237688|NCT00667446|4060915|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4237689|NCT00667446|4060913|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4237690|NCT00667446|4060914|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4237691|NCT00667446|4060915|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4237692|NCT00667446|4060913|B3|||Age||years|Mean|8.47|8.47|Standard Deviation|1.60|1.6|||
4237693|NCT00667446|4060914|B2|||Age||years|Mean|8.45|8.45|Standard Deviation|1.52|1.52|||
4237694|NCT00667446|4060915|B1|||Age||years|Mean|8.50|8.5|Standard Deviation|1.71|1.71|||
4237695|NCT00667420|4060938|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4237696|NCT00667420|4060938|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4237697|NCT00667420|4060938|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4237698|NCT00667420|4060938|B1|||Age||years|Mean|59|59.0|Full Range|NA||40.0|66.0|
4237699|NCT00667420|4060938|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4237700|NCT00667420|4060938|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4237701|NCT00667420|4060938|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4237702|NCT00667394|4060946|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4237703|NCT00667394|4060947|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4237704|NCT00667394|4060948|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4237705|NCT00667394|4060946|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4237706|NCT00667394|4060947|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4237707|NCT00667394|4060948|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4237708|NCT00667394|4060946|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4237709|NCT00667394|4060947|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4237710|NCT00667394|4060948|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4237711|NCT00667394|4060946|B3||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4237712|NCT00667394|4060947|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4237713|NCT00667394|4060948|B1||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4237714|NCT00667394|4060946|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4237715|NCT00667394|4060947|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4237716|NCT00667394|4060948|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4237717|NCT00667394|4060946|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4237718|NCT00667394|4060947|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4237719|NCT00667394|4060948|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4237720|NCT00667394|4060946|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4237721|NCT00667394|4060947|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4237722|NCT00667394|4060948|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4237723|NCT00667394|4060946|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4237724|NCT00667394|4060947|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4237725|NCT00667394|4060948|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4237726|NCT00667394|4060946|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4237727|NCT00667394|4060947|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4237728|NCT00667394|4060948|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4237729|NCT00667394|4060946|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4237730|NCT00667394|4060947|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4237731|NCT00667394|4060948|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4237732|NCT00667394|4060946|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4237733|NCT00667394|4060947|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4237734|NCT00667394|4060948|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4237735|NCT00667394|4060946|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4237736|NCT00667394|4060947|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4237737|NCT00667394|4060948|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4237738|NCT00667394|4060946|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4237739|NCT00667394|4060947|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4237740|NCT00667394|4060948|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4237741|NCT00667394|4060946|B3|||Age||years|Mean|54.37|54.37|Standard Deviation|11.46|11.46|||
4237742|NCT00667394|4060947|B2|||Age||years|Mean|63|63.0|Standard Deviation|0|0.0|||
4237743|NCT00667394|4060948|B1|||Age||years|Mean|54.16|54.16|Standard Deviation|11.52|11.52|||
4237744|NCT00667394|4060946|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4237745|NCT00667394|4060947|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4237746|NCT00667394|4060948|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4237747|NCT00667394|4060946|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4237748|NCT00667394|4060947|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4237749|NCT00667394|4060948|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4237750|NCT00667394|4060946|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4237751|NCT00667394|4060947|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4237752|NCT00667394|4060948|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4237753|NCT00667381|4060957|B3|United States||Region of Enrollment||participants|Number|1004|1004.0||||||
4237754|NCT00667381|4060958|B2|United States||Region of Enrollment||participants|Number|503|503.0||||||
4237755|NCT00667381|4060959|B1|United States||Region of Enrollment||participants|Number|501|501.0||||||
4237756|NCT00667381|4060957|B3||Male|Sex: Female, Male||Participants|Count of Participants|737|737.0||||||
4237757|NCT00667381|4060958|B2||Male|Sex: Female, Male||Participants|Count of Participants|371|371.0||||||
4237758|NCT00667381|4060959|B1||Male|Sex: Female, Male||Participants|Count of Participants|366|366.0||||||
4237759|NCT00667381|4060957|B3||Female|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
4237760|NCT00667381|4060958|B2||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4237761|NCT00667381|4060959|B1||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4237762|NCT00667381|4060957|B3|||Age||years|Mean|63.8|63.8|Standard Deviation|11.9|11.9|||
4237763|NCT00667381|4060958|B2|||Age||years|Mean|63.5|63.5|Standard Deviation|12.4|12.4|||
4237764|NCT00667381|4060959|B1|||Age||years|Mean|64.2|64.2|Standard Deviation|11.4|11.4|||
4237765|NCT00667381|4060957|B3||>=65 years|Age||Participants|Count of Participants|476|476.0||||||
4237766|NCT00667381|4060958|B2||>=65 years|Age||Participants|Count of Participants|230|230.0||||||
4237767|NCT00667381|4060959|B1||>=65 years|Age||Participants|Count of Participants|246|246.0||||||
4237768|NCT00667381|4060957|B3||Between 18 and 65 years|Age||Participants|Count of Participants|528|528.0||||||
4237769|NCT00667381|4060958|B2||Between 18 and 65 years|Age||Participants|Count of Participants|273|273.0||||||
4237770|NCT00667381|4060959|B1||Between 18 and 65 years|Age||Participants|Count of Participants|255|255.0||||||
4237771|NCT00667381|4060957|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4237772|NCT00667381|4060958|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4237773|NCT00667381|4060959|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4237774|NCT00667368|4060974|B3|United States||Region of Enrollment||participants|Number|1365|1365.0||||||
4237775|NCT00667368|4060975|B2|United States||Region of Enrollment||participants|Number|683|683.0||||||
4237776|NCT00667368|4060976|B1|United States||Region of Enrollment||participants|Number|682|682.0||||||
4237777|NCT00667368|4060974|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4237778|NCT00667368|4060975|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4237779|NCT00667368|4060976|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4237780|NCT00667368|4060974|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
4237781|NCT00667368|4060975|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4237782|NCT00667368|4060976|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4237783|NCT00667368|4060974|B3||White|Race (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
4237784|NCT00667368|4060975|B2||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4237785|NCT00667368|4060976|B1||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4237786|NCT00667368|4060974|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1065|1065.0||||||
4237787|NCT00667368|4060975|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|530|530.0||||||
4237788|NCT00667368|4060976|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|535|535.0||||||
4237789|NCT00667368|4060974|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4237790|NCT00667368|4060975|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4237791|NCT00667368|4060976|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4237792|NCT00667368|4060974|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4237793|NCT00667368|4060975|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4237794|NCT00667368|4060976|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4237795|NCT00667368|4060974|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4237796|NCT00667368|4060975|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4237797|NCT00667368|4060976|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4237798|NCT00667368|4060974|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4237799|NCT00667368|4060975|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4237800|NCT00667368|4060976|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4237801|NCT00667368|4060974|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1243|1243.0||||||
4237802|NCT00667368|4060975|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|623|623.0||||||
4237803|NCT00667368|4060976|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|620|620.0||||||
4237804|NCT00667368|4060974|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
4237805|NCT00667368|4060975|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4237806|NCT00667368|4060976|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4237807|NCT00667368|4060974|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4237808|NCT00667368|4060975|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4237809|NCT00667368|4060976|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4237810|NCT00667368|4060974|B3||Female|Sex: Female, Male||Participants|Count of Participants|1365|1365.0||||||
4237811|NCT00667368|4060975|B2||Female|Sex: Female, Male||Participants|Count of Participants|683|683.0||||||
4237812|NCT00667368|4060976|B1||Female|Sex: Female, Male||Participants|Count of Participants|682|682.0||||||
4237813|NCT00667368|4060974|B3|||Age||years|Mean|21|21.0|Standard Deviation|2|2.0|||
4237814|NCT00667368|4060975|B2|||Age||years|Mean|21|21.0|Standard Deviation|2|2.0|||
4237815|NCT00667368|4060976|B1|||Age||years|Mean|21|21.0|Standard Deviation|2|2.0|||
4237816|NCT00667355|4060985|B1|Japan||Region of Enrollment||subjects|Number|41|41.0||||||
4237817|NCT00667355|4060985|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4237818|NCT00667355|4060985|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4237819|NCT00667355|4060985|B1|||Age||years|Mean|37.2|37.2|Standard Deviation|12.17|12.17|||
4237820|NCT00667355|4060985|B1|>65 years||Age, Customized||subjects|Number|0|0.0||||||
4237821|NCT00667355|4060985|B1|Between 40 and 65 years||Age, Customized||subjects|Number|16|16.0||||||
4237822|NCT00667355|4060985|B1|<40 years||Age, Customized||subjects|Number|25|25.0||||||
4237823|NCT00667342|4061007|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4237824|NCT00667342|4061008|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4237825|NCT00667342|4061010|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4237826|NCT00667342|4061007|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4237827|NCT00667342|4061008|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4237828|NCT00667342|4061010|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4237829|NCT00667342|4061007|B4|||Age||years|Median|12|12.0|Full Range|||6.0|20.0|
4237830|NCT00667342|4061008|B3|||Age||years|Median|12|12.0|Full Range|||8.0|20.0|
4237831|NCT00667342|4061010|B1|||Age||years|Median|12|12.0|Full Range|||6.0|20.0|
4237832|NCT00667342|4061007|B4|||Age||years|Mean|12.9|12.9|Standard Deviation|3.6|3.6|||
4237833|NCT00667342|4061008|B3|||Age||years|Mean|13.3|13.3|Standard Deviation|4.2|4.2|||
4237834|NCT00667342|4061010|B1|||Age||years|Mean|12.7|12.7|Standard Deviation|3.5|3.5|||
4237835|NCT00667277|4061050|B1|Post-Polycythemia Vera Myelofibrosis (Post PV MF)||Diagnosis||participants|Number|2|2.0||||||
4237836|NCT00667277|4061050|B1|Post-essential Thrombocythemia Myelofibrosis||Diagnosis||participants|Number|3|3.0||||||
4237837|NCT00667277|4061050|B1|Primary Myelofibrosis (PMF)||Diagnosis||participants|Number|8|8.0||||||
4237838|NCT00667277|4061050|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4237839|NCT00667277|4061050|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4237840|NCT00667277|4061050|B1|||Age||years|Mean|69.6|69.6|Standard Deviation|11.0|11.0|||
4237841|NCT00667251|4061055|B3|Missing||Central Review EGFR Status||Participants|Number|129|129.0||||||
4237842|NCT00667251|4061056|B2|Missing||Central Review EGFR Status||Participants|Number|68|68.0||||||
4237843|NCT00667251|4061057|B1|Missing||Central Review EGFR Status||Participants|Number|61|61.0||||||
4237844|NCT00667251|4061055|B3|Negative||Central Review EGFR Status||Participants|Number|375|375.0||||||
4237845|NCT00667251|4061056|B2|Negative||Central Review EGFR Status||Participants|Number|181|181.0||||||
4237846|NCT00667251|4061057|B1|Negative||Central Review EGFR Status||Participants|Number|194|194.0||||||
4237847|NCT00667251|4061055|B3|Positive (>0)||Central Review EGFR Status||Participants|Number|148|148.0||||||
4237848|NCT00667251|4061056|B2|Positive (>0)||Central Review EGFR Status||Participants|Number|77|77.0||||||
4237849|NCT00667251|4061057|B1|Positive (>0)||Central Review EGFR Status||Participants|Number|71|71.0||||||
4237850|NCT00667251|4061055|B3|Missing||Central Review CK5 Status||Participants|Number|125|125.0||||||
4237851|NCT00667251|4061056|B2|Missing||Central Review CK5 Status||Participants|Number|67|67.0||||||
4237852|NCT00667251|4061057|B1|Missing||Central Review CK5 Status||Participants|Number|58|58.0||||||
4237853|NCT00667251|4061055|B3|Negative||Central Review CK5 Status||Participants|Number|428|428.0||||||
4237854|NCT00667251|4061056|B2|Negative||Central Review CK5 Status||Participants|Number|218|218.0||||||
4237855|NCT00667251|4061057|B1|Negative||Central Review CK5 Status||Participants|Number|210|210.0||||||
4237856|NCT00667251|4061055|B3|Positive (>0)||Central Review CK5 Status||Participants|Number|99|99.0||||||
4237857|NCT00667251|4061056|B2|Positive (>0)||Central Review CK5 Status||Participants|Number|41|41.0||||||
4237858|NCT00667251|4061057|B1|Positive (>0)||Central Review CK5 Status||Participants|Number|58|58.0||||||
4237859|NCT00667251|4061055|B3|||Central Review ki67||% cells positive|Geometric Mean|32.37|32.37|Full Range|||0.0|100.0|
4237860|NCT00667251|4061056|B2|||Central Review ki67||% cells positive|Geometric Mean|31.43|31.43|Full Range|||0.0|90.0|
4237861|NCT00667251|4061057|B1|||Central Review ki67||% cells positive|Geometric Mean|33.33|33.33|Full Range|||0.0|100.0|
4237862|NCT00667251|4061055|B3|Missing||Central Review PR Status||Participants|Number|38|38.0||||||
4237863|NCT00667251|4061056|B2|Missing||Central Review PR Status||Participants|Number|18|18.0||||||
4237864|NCT00667251|4061057|B1|Missing||Central Review PR Status||Participants|Number|20|20.0||||||
4237865|NCT00667251|4061055|B3|Negative||Central Review PR Status||Participants|Number|394|394.0||||||
4237866|NCT00667251|4061056|B2|Negative||Central Review PR Status||Participants|Number|204|204.0||||||
4237867|NCT00667251|4061057|B1|Negative||Central Review PR Status||Participants|Number|190|190.0||||||
4237868|NCT00667251|4061055|B3|Positive (>0)||Central Review PR Status||Participants|Number|220|220.0||||||
4237869|NCT00667251|4061056|B2|Positive (>0)||Central Review PR Status||Participants|Number|104|104.0||||||
4237870|NCT00667251|4061057|B1|Positive (>0)||Central Review PR Status||Participants|Number|116|116.0||||||
4237871|NCT00667251|4061055|B3|Missing||Central Review ER Status||Participants|Number|28|28.0||||||
4237872|NCT00667251|4061056|B2|Missing||Central Review ER Status||Participants|Number|11|11.0||||||
4237873|NCT00667251|4061057|B1|Missing||Central Review ER Status||Participants|Number|17|17.0||||||
4237874|NCT00667251|4061055|B3|Negative||Central Review ER Status||Participants|Number|203|203.0||||||
4237875|NCT00667251|4061056|B2|Negative||Central Review ER Status||Participants|Number|107|107.0||||||
4237876|NCT00667251|4061057|B1|Negative||Central Review ER Status||Participants|Number|96|96.0||||||
4237877|NCT00667251|4061055|B3|Positive (>0)||Central Review ER Status||Participants|Number|421|421.0||||||
4237878|NCT00667251|4061056|B2|Positive (>0)||Central Review ER Status||Participants|Number|208|208.0||||||
4237879|NCT00667251|4061057|B1|Positive (>0)||Central Review ER Status||Participants|Number|213|213.0||||||
4237880|NCT00667251|4061055|B3|Unknown||Central Review HER2/Neu Status||Participants|Number|19|19.0||||||
4237881|NCT00667251|4061056|B2|Unknown||Central Review HER2/Neu Status||Participants|Number|8|8.0||||||
4237882|NCT00667251|4061057|B1|Unknown||Central Review HER2/Neu Status||Participants|Number|11|11.0||||||
4237883|NCT00667251|4061055|B3|Equivocal IHC and FISH||Central Review HER2/Neu Status||Participants|Number|14|14.0||||||
4237884|NCT00667251|4061056|B2|Equivocal IHC and FISH||Central Review HER2/Neu Status||Participants|Number|5|5.0||||||
4237885|NCT00667251|4061057|B1|Equivocal IHC and FISH||Central Review HER2/Neu Status||Participants|Number|9|9.0||||||
4237886|NCT00667251|4061055|B3|Negative IHC and FISH||Central Review HER2/Neu Status||Participants|Number|82|82.0||||||
4237887|NCT00667251|4061056|B2|Negative IHC and FISH||Central Review HER2/Neu Status||Participants|Number|46|46.0||||||
4237888|NCT00667251|4061057|B1|Negative IHC and FISH||Central Review HER2/Neu Status||Participants|Number|36|36.0||||||
4237889|NCT00667251|4061055|B3|Positive IHC or FISH||Central Review HER2/Neu Status||Participants|Number|537|537.0||||||
4237890|NCT00667251|4061056|B2|Positive IHC or FISH||Central Review HER2/Neu Status||Participants|Number|267|267.0||||||
4237891|NCT00667251|4061057|B1|Positive IHC or FISH||Central Review HER2/Neu Status||Participants|Number|270|270.0||||||
4237892|NCT00667251|4061055|B3|No||Liver Metastasis||Participants|Number|353|353.0||||||
4237893|NCT00667251|4061056|B2|No||Liver Metastasis||Participants|Number|176|176.0||||||
4237894|NCT00667251|4061057|B1|No||Liver Metastasis||Participants|Number|177|177.0||||||
4237895|NCT00667251|4061055|B3|Yes||Liver Metastasis||Participants|Number|299|299.0||||||
4237896|NCT00667251|4061056|B2|Yes||Liver Metastasis||Participants|Number|150|150.0||||||
4237897|NCT00667251|4061057|B1|Yes||Liver Metastasis||Participants|Number|149|149.0||||||
4237898|NCT00667251|4061055|B3|Missing||Prior (Neo) Adjuvant Other Therapy||Participants|Number|1|1.0||||||
4237899|NCT00667251|4061056|B2|Missing||Prior (Neo) Adjuvant Other Therapy||Participants|Number|1|1.0||||||
4237900|NCT00667251|4061057|B1|Missing||Prior (Neo) Adjuvant Other Therapy||Participants|Number|0|0.0||||||
4237901|NCT00667251|4061055|B3|No||Prior (Neo) Adjuvant Other Therapy||Participants|Number|644|644.0||||||
4237902|NCT00667251|4061056|B2|No||Prior (Neo) Adjuvant Other Therapy||Participants|Number|323|323.0||||||
4237903|NCT00667251|4061057|B1|No||Prior (Neo) Adjuvant Other Therapy||Participants|Number|321|321.0||||||
4237904|NCT00667251|4061055|B3|Yes||Prior (Neo) Adjuvant Other Therapy||Participants|Number|7|7.0||||||
4237905|NCT00667251|4061056|B2|Yes||Prior (Neo) Adjuvant Other Therapy||Participants|Number|2|2.0||||||
4237906|NCT00667251|4061057|B1|Yes||Prior (Neo) Adjuvant Other Therapy||Participants|Number|5|5.0||||||
4237907|NCT00667251|4061055|B3|3-Weekly Docetaxel||Planned Taxane Therapy||Participants|Number|360|360.0||||||
4237908|NCT00667251|4061056|B2|3-Weekly Docetaxel||Planned Taxane Therapy||Participants|Number|180|180.0||||||
4237909|NCT00667251|4061057|B1|3-Weekly Docetaxel||Planned Taxane Therapy||Participants|Number|180|180.0||||||
4237910|NCT00667251|4061055|B3|Weekly Paclitaxel||Planned Taxane Therapy||Participants|Number|292|292.0||||||
4237911|NCT00667251|4061056|B2|Weekly Paclitaxel||Planned Taxane Therapy||Participants|Number|146|146.0||||||
4237912|NCT00667251|4061057|B1|Weekly Paclitaxel||Planned Taxane Therapy||Participants|Number|146|146.0||||||
4237913|NCT00667251|4061055|B3|Missing||Prior (Neo) Adjuvant/Metastatic Radiotherapy||Participants|Number|2|2.0||||||
4237914|NCT00667251|4061056|B2|Missing||Prior (Neo) Adjuvant/Metastatic Radiotherapy||Participants|Number|1|1.0||||||
4237915|NCT00667251|4061057|B1|Missing||Prior (Neo) Adjuvant/Metastatic Radiotherapy||Participants|Number|1|1.0||||||
4237916|NCT00667251|4061055|B3|No||Prior (Neo) Adjuvant/Metastatic Radiotherapy||Participants|Number|363|363.0||||||
4237917|NCT00667251|4061056|B2|No||Prior (Neo) Adjuvant/Metastatic Radiotherapy||Participants|Number|176|176.0||||||
4237918|NCT00667251|4061057|B1|No||Prior (Neo) Adjuvant/Metastatic Radiotherapy||Participants|Number|187|187.0||||||
4237919|NCT00667251|4061055|B3|Yes||Prior (Neo) Adjuvant/Metastatic Radiotherapy||Participants|Number|287|287.0||||||
4237920|NCT00667251|4061056|B2|Yes||Prior (Neo) Adjuvant/Metastatic Radiotherapy||Participants|Number|149|149.0||||||
4237921|NCT00667251|4061057|B1|Yes||Prior (Neo) Adjuvant/Metastatic Radiotherapy||Participants|Number|138|138.0||||||
4237922|NCT00667251|4061055|B3|Missing||Prior (Neo) Adjuvant/Metastatic Endocrine Therapy||Participants|Number|1|1.0||||||
4237923|NCT00667251|4061056|B2|Missing||Prior (Neo) Adjuvant/Metastatic Endocrine Therapy||Participants|Number|1|1.0||||||
4237924|NCT00667251|4061057|B1|Missing||Prior (Neo) Adjuvant/Metastatic Endocrine Therapy||Participants|Number|0|0.0||||||
4237925|NCT00667251|4061055|B3|No||Prior (Neo) Adjuvant/Metastatic Endocrine Therapy||Participants|Number|402|402.0||||||
4237926|NCT00667251|4061056|B2|No||Prior (Neo) Adjuvant/Metastatic Endocrine Therapy||Participants|Number|198|198.0||||||
4237927|NCT00667251|4061057|B1|No||Prior (Neo) Adjuvant/Metastatic Endocrine Therapy||Participants|Number|204|204.0||||||
4237928|NCT00667251|4061055|B3|Yes||Prior (Neo) Adjuvant/Metastatic Endocrine Therapy||Participants|Number|249|249.0||||||
4237929|NCT00667251|4061056|B2|Yes||Prior (Neo) Adjuvant/Metastatic Endocrine Therapy||Participants|Number|127|127.0||||||
4237930|NCT00667251|4061057|B1|Yes||Prior (Neo) Adjuvant/Metastatic Endocrine Therapy||Participants|Number|122|122.0||||||
4237931|NCT00667251|4061055|B3|Missing||Disease Status||Participants|Number|2|2.0||||||
4237932|NCT00667251|4061056|B2|Missing||Disease Status||Participants|Number|1|1.0||||||
4237933|NCT00667251|4061057|B1|Missing||Disease Status||Participants|Number|1|1.0||||||
4237934|NCT00667251|4061055|B3|Metastatic Relapse||Disease Status||Participants|Number|374|374.0||||||
4237935|NCT00667251|4061056|B2|Metastatic Relapse||Disease Status||Participants|Number|187|187.0||||||
4237936|NCT00667251|4061057|B1|Metastatic Relapse||Disease Status||Participants|Number|187|187.0||||||
4237937|NCT00667251|4061055|B3|Primary Diagnosis||Disease Status||Participants|Number|276|276.0||||||
4237938|NCT00667251|4061056|B2|Primary Diagnosis||Disease Status||Participants|Number|138|138.0||||||
4237939|NCT00667251|4061057|B1|Primary Diagnosis||Disease Status||Participants|Number|138|138.0||||||
4237940|NCT00667251|4061055|B3|No||Prior (Neo) Adjuvant Other Chemotherapy||Participants|Number|345|345.0||||||
4237941|NCT00667251|4061056|B2|No||Prior (Neo) Adjuvant Other Chemotherapy||Participants|Number|165|165.0||||||
4237942|NCT00667251|4061057|B1|No||Prior (Neo) Adjuvant Other Chemotherapy||Participants|Number|180|180.0||||||
4237943|NCT00667251|4061055|B3|Yes||Prior (Neo) Adjuvant Other Chemotherapy||Participants|Number|307|307.0||||||
4237944|NCT00667251|4061056|B2|Yes||Prior (Neo) Adjuvant Other Chemotherapy||Participants|Number|161|161.0||||||
4237945|NCT00667251|4061057|B1|Yes||Prior (Neo) Adjuvant Other Chemotherapy||Participants|Number|146|146.0||||||
4237946|NCT00667251|4061055|B3|No||Prior (Neo) Adjuvant Anthracyclines||Participants|Number|384|384.0||||||
4237947|NCT00667251|4061056|B2|No||Prior (Neo) Adjuvant Anthracyclines||Participants|Number|186|186.0||||||
4237948|NCT00667251|4061057|B1|No||Prior (Neo) Adjuvant Anthracyclines||Participants|Number|198|198.0||||||
4237949|NCT00667251|4061055|B3|Yes||Prior (Neo) Adjuvant Anthracyclines||Participants|Number|268|268.0||||||
4237950|NCT00667251|4061056|B2|Yes||Prior (Neo) Adjuvant Anthracyclines||Participants|Number|140|140.0||||||
4237951|NCT00667251|4061057|B1|Yes||Prior (Neo) Adjuvant Anthracyclines||Participants|Number|128|128.0||||||
4237952|NCT00667251|4061055|B3|No||Prior (Neo) Adjuvant Taxane Chemotherapy||Participants|Number|518|518.0||||||
4237953|NCT00667251|4061056|B2|No||Prior (Neo) Adjuvant Taxane Chemotherapy||Participants|Number|257|257.0||||||
4237954|NCT00667251|4061057|B1|No||Prior (Neo) Adjuvant Taxane Chemotherapy||Participants|Number|261|261.0||||||
4237955|NCT00667251|4061055|B3|Yes||Prior (Neo) Adjuvant Taxane Chemotherapy||Participants|Number|134|134.0||||||
4237956|NCT00667251|4061056|B2|Yes||Prior (Neo) Adjuvant Taxane Chemotherapy||Participants|Number|69|69.0||||||
4237957|NCT00667251|4061057|B1|Yes||Prior (Neo) Adjuvant Taxane Chemotherapy||Participants|Number|65|65.0||||||
4237958|NCT00667251|4061055|B3|No||Prior (Neo) Adjuvant Anti-HER2/neu Targeted Therapy||Participants|Number|534|534.0||||||
4237959|NCT00667251|4061056|B2|No||Prior (Neo) Adjuvant Anti-HER2/neu Targeted Therapy||Participants|Number|267|267.0||||||
4237960|NCT00667251|4061057|B1|No||Prior (Neo) Adjuvant Anti-HER2/neu Targeted Therapy||Participants|Number|267|267.0||||||
4237961|NCT00667251|4061055|B3|Yes||Prior (Neo) Adjuvant Anti-HER2/neu Targeted Therapy||Participants|Number|118|118.0||||||
4237962|NCT00667251|4061056|B2|Yes||Prior (Neo) Adjuvant Anti-HER2/neu Targeted Therapy||Participants|Number|59|59.0||||||
4237963|NCT00667251|4061057|B1|Yes||Prior (Neo) Adjuvant Anti-HER2/neu Targeted Therapy||Participants|Number|59|59.0||||||
4237964|NCT00667251|4061055|B3|ECOG 2||Performance Status|Grade 0= Fully active, able to carry on all pre-disease performance without restriction. Grade 1= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work. Grade 2= Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours Grade 3= Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours. Grade 4= Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair. Grade 5= Dead|Participants|Number|22|22.0||||||
4237965|NCT00667251|4061056|B2|ECOG 2||Performance Status|Grade 0= Fully active, able to carry on all pre-disease performance without restriction. Grade 1= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work. Grade 2= Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours Grade 3= Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours. Grade 4= Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair. Grade 5= Dead|Participants|Number|10|10.0||||||
4237966|NCT00667251|4061057|B1|ECOG 2||Performance Status|Grade 0= Fully active, able to carry on all pre-disease performance without restriction. Grade 1= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work. Grade 2= Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours Grade 3= Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours. Grade 4= Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair. Grade 5= Dead|Participants|Number|12|12.0||||||
4237967|NCT00667251|4061055|B3|ECOG 1||Performance Status|Grade 0= Fully active, able to carry on all pre-disease performance without restriction. Grade 1= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work. Grade 2= Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours Grade 3= Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours. Grade 4= Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair. Grade 5= Dead|Participants|Number|230|230.0||||||
4237968|NCT00667251|4061056|B2|ECOG 1||Performance Status|Grade 0= Fully active, able to carry on all pre-disease performance without restriction. Grade 1= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work. Grade 2= Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours Grade 3= Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours. Grade 4= Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair. Grade 5= Dead|Participants|Number|112|112.0||||||
4237969|NCT00667251|4061057|B1|ECOG 1||Performance Status|Grade 0= Fully active, able to carry on all pre-disease performance without restriction. Grade 1= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work. Grade 2= Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours Grade 3= Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours. Grade 4= Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair. Grade 5= Dead|Participants|Number|118|118.0||||||
4237970|NCT00667251|4061055|B3|ECOG 0||Performance Status|Grade 0= Fully active, able to carry on all pre-disease performance without restriction. Grade 1= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work. Grade 2= Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours Grade 3= Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours. Grade 4= Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair. Grade 5= Dead|Participants|Number|400|400.0||||||
4237971|NCT00667251|4061056|B2|ECOG 0||Performance Status|Grade 0= Fully active, able to carry on all pre-disease performance without restriction. Grade 1= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work. Grade 2= Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours Grade 3= Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours. Grade 4= Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair. Grade 5= Dead|Participants|Number|204|204.0||||||
4237972|NCT00667251|4061057|B1|ECOG 0||Performance Status|Grade 0= Fully active, able to carry on all pre-disease performance without restriction. Grade 1= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work. Grade 2= Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours Grade 3= Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours. Grade 4= Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair. Grade 5= Dead|Participants|Number|196|196.0||||||
4237973|NCT00667251|4061055|B3|Korea, Republic of||Region of Enrollment||Country|Number|36|36.0||||||
4237974|NCT00667251|4061056|B2|Korea, Republic of||Region of Enrollment||Country|Number|19|19.0||||||
4237975|NCT00667251|4061057|B1|Korea, Republic of||Region of Enrollment||Country|Number|17|17.0||||||
4237976|NCT00667251|4061055|B3|Japan||Region of Enrollment||Country|Number|42|42.0||||||
4237977|NCT00667251|4061056|B2|Japan||Region of Enrollment||Country|Number|20|20.0||||||
4237978|NCT00667251|4061057|B1|Japan||Region of Enrollment||Country|Number|22|22.0||||||
4237979|NCT00667251|4061055|B3|Germany||Region of Enrollment||Country|Number|66|66.0||||||
4237980|NCT00667251|4061056|B2|Germany||Region of Enrollment||Country|Number|34|34.0||||||
4237981|NCT00667251|4061057|B1|Germany||Region of Enrollment||Country|Number|32|32.0||||||
4237982|NCT00667251|4061055|B3|Netherlands||Region of Enrollment||Country|Number|14|14.0||||||
4237983|NCT00667251|4061056|B2|Netherlands||Region of Enrollment||Country|Number|7|7.0||||||
4237984|NCT00667251|4061057|B1|Netherlands||Region of Enrollment||Country|Number|7|7.0||||||
4237985|NCT00667251|4061055|B3|Australia||Region of Enrollment||Country|Number|30|30.0||||||
4237986|NCT00667251|4061056|B2|Australia||Region of Enrollment||Country|Number|13|13.0||||||
4237987|NCT00667251|4061057|B1|Australia||Region of Enrollment||Country|Number|17|17.0||||||
4237988|NCT00667251|4061055|B3|Belgium||Region of Enrollment||Country|Number|9|9.0||||||
4237989|NCT00667251|4061056|B2|Belgium||Region of Enrollment||Country|Number|6|6.0||||||
4237990|NCT00667251|4061057|B1|Belgium||Region of Enrollment||Country|Number|3|3.0||||||
4237991|NCT00667251|4061055|B3|Poland||Region of Enrollment||Country|Number|19|19.0||||||
4237992|NCT00667251|4061056|B2|Poland||Region of Enrollment||Country|Number|12|12.0||||||
4237993|NCT00667251|4061057|B1|Poland||Region of Enrollment||Country|Number|7|7.0||||||
4237994|NCT00667251|4061055|B3|Argentina||Region of Enrollment||Country|Number|12|12.0||||||
4237995|NCT00667251|4061056|B2|Argentina||Region of Enrollment||Country|Number|4|4.0||||||
4237996|NCT00667251|4061057|B1|Argentina||Region of Enrollment||Country|Number|8|8.0||||||
4237997|NCT00667251|4061055|B3|Canada||Region of Enrollment||Country|Number|75|75.0||||||
4237998|NCT00667251|4061056|B2|Canada||Region of Enrollment||Country|Number|36|36.0||||||
4237999|NCT00667251|4061057|B1|Canada||Region of Enrollment||Country|Number|39|39.0||||||
4238000|NCT00667251|4061055|B3|Mexico||Region of Enrollment||Country|Number|9|9.0||||||
4238001|NCT00667251|4061056|B2|Mexico||Region of Enrollment||Country|Number|6|6.0||||||
4238002|NCT00667251|4061057|B1|Mexico||Region of Enrollment||Country|Number|3|3.0||||||
4238003|NCT00667251|4061055|B3|France||Region of Enrollment||Country|Number|10|10.0||||||
4238004|NCT00667251|4061056|B2|France||Region of Enrollment||Country|Number|5|5.0||||||
4238005|NCT00667251|4061057|B1|France||Region of Enrollment||Country|Number|5|5.0||||||
4238006|NCT00667251|4061055|B3|India||Region of Enrollment||Country|Number|8|8.0||||||
4238007|NCT00667251|4061056|B2|India||Region of Enrollment||Country|Number|4|4.0||||||
4238008|NCT00667251|4061057|B1|India||Region of Enrollment||Country|Number|4|4.0||||||
4238009|NCT00667251|4061055|B3|Italy||Region of Enrollment||Country|Number|13|13.0||||||
4238010|NCT00667251|4061056|B2|Italy||Region of Enrollment||Country|Number|8|8.0||||||
4238011|NCT00667251|4061057|B1|Italy||Region of Enrollment||Country|Number|5|5.0||||||
4238012|NCT00667251|4061055|B3|United Kingdom||Region of Enrollment||Country|Number|65|65.0||||||
4238013|NCT00667251|4061056|B2|United Kingdom||Region of Enrollment||Country|Number|32|32.0||||||
4238014|NCT00667251|4061057|B1|United Kingdom||Region of Enrollment||Country|Number|33|33.0||||||
4238015|NCT00667251|4061055|B3|Israel||Region of Enrollment||Country|Number|31|31.0||||||
4238016|NCT00667251|4061056|B2|Israel||Region of Enrollment||Country|Number|15|15.0||||||
4238017|NCT00667251|4061057|B1|Israel||Region of Enrollment||Country|Number|16|16.0||||||
4238018|NCT00667251|4061055|B3|Russian Federation||Region of Enrollment||Country|Number|101|101.0||||||
4238019|NCT00667251|4061056|B2|Russian Federation||Region of Enrollment||Country|Number|46|46.0||||||
4238020|NCT00667251|4061057|B1|Russian Federation||Region of Enrollment||Country|Number|55|55.0||||||
4238021|NCT00667251|4061055|B3|Ukraine||Region of Enrollment||Country|Number|8|8.0||||||
4238022|NCT00667251|4061056|B2|Ukraine||Region of Enrollment||Country|Number|4|4.0||||||
4238023|NCT00667251|4061057|B1|Ukraine||Region of Enrollment||Country|Number|4|4.0||||||
4238024|NCT00667251|4061055|B3|Spain||Region of Enrollment||Country|Number|38|38.0||||||
4238025|NCT00667251|4061056|B2|Spain||Region of Enrollment||Country|Number|19|19.0||||||
4238026|NCT00667251|4061057|B1|Spain||Region of Enrollment||Country|Number|19|19.0||||||
4238027|NCT00667251|4061055|B3|Thailand||Region of Enrollment||Country|Number|21|21.0||||||
4238028|NCT00667251|4061056|B2|Thailand||Region of Enrollment||Country|Number|12|12.0||||||
4238029|NCT00667251|4061057|B1|Thailand||Region of Enrollment||Country|Number|9|9.0||||||
4238030|NCT00667251|4061055|B3|Taiwan||Region of Enrollment||Country|Number|22|22.0||||||
4238031|NCT00667251|4061056|B2|Taiwan||Region of Enrollment||Country|Number|11|11.0||||||
4238032|NCT00667251|4061057|B1|Taiwan||Region of Enrollment||Country|Number|11|11.0||||||
4238033|NCT00667251|4061055|B3|United States||Region of Enrollment||Country|Number|23|23.0||||||
4238034|NCT00667251|4061056|B2|United States||Region of Enrollment||Country|Number|13|13.0||||||
4238035|NCT00667251|4061057|B1|United States||Region of Enrollment||Country|Number|10|10.0||||||
4238036|NCT00667251|4061055|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4238037|NCT00667251|4061056|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4238038|NCT00667251|4061057|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4238039|NCT00667251|4061055|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238040|NCT00667251|4061056|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238041|NCT00667251|4061057|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238042|NCT00667251|4061055|B3||White|Race (NIH/OMB)||Participants|Count of Participants|480|480.0||||||
4238043|NCT00667251|4061056|B2||White|Race (NIH/OMB)||Participants|Count of Participants|234|234.0||||||
4238044|NCT00667251|4061057|B1||White|Race (NIH/OMB)||Participants|Count of Participants|246|246.0||||||
4238045|NCT00667251|4061055|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4238046|NCT00667251|4061056|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4238047|NCT00667251|4061057|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4238048|NCT00667251|4061055|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4238049|NCT00667251|4061056|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238050|NCT00667251|4061057|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4238051|NCT00667251|4061055|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|141|141.0||||||
4238052|NCT00667251|4061056|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4238053|NCT00667251|4061057|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4238054|NCT00667251|4061055|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4238055|NCT00667251|4061056|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4238056|NCT00667251|4061057|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4238057|NCT00667251|4061055|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4238058|NCT00667251|4061056|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4238059|NCT00667251|4061057|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4238060|NCT00667251|4061055|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|571|571.0||||||
4238061|NCT00667251|4061056|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|283|283.0||||||
4238062|NCT00667251|4061057|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|288|288.0||||||
4238063|NCT00667251|4061055|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4238064|NCT00667251|4061056|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4238065|NCT00667251|4061057|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4238066|NCT00667251|4061055|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4238067|NCT00667251|4061056|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4238068|NCT00667251|4061057|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4238069|NCT00667251|4061055|B3||Female|Sex: Female, Male||Participants|Count of Participants|652|652.0||||||
4238070|NCT00667251|4061056|B2||Female|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
4238071|NCT00667251|4061057|B1||Female|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
4238072|NCT00667251|4061055|B3|||Age||years|Median|54.9|54.9|Full Range|||26.6|87.1|
4238073|NCT00667251|4061056|B2|||Age||years|Median|54.4|54.4|Full Range|29.3-84.3|29.3|29.3|84.3|
4238074|NCT00667251|4061057|B1|||Age||years|Median|55.4|55.4|Full Range|26.6-87.1|26.6|26.6|87.1|
4238075|NCT00667251|4061055|B3||>=65 years|Age||Participants|Count of Participants|129|129.0||||||
4238076|NCT00667251|4061056|B2||>=65 years|Age||Participants|Count of Participants|63|63.0||||||
4238077|NCT00667251|4061057|B1||>=65 years|Age||Participants|Count of Participants|66|66.0||||||
4238078|NCT00667251|4061055|B3||Between 18 and 65 years|Age||Participants|Count of Participants|523|523.0||||||
4238079|NCT00667251|4061056|B2||Between 18 and 65 years|Age||Participants|Count of Participants|263|263.0||||||
4238080|NCT00667251|4061057|B1||Between 18 and 65 years|Age||Participants|Count of Participants|260|260.0||||||
4238081|NCT00667251|4061055|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4238082|NCT00667251|4061056|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4238083|NCT00667251|4061057|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4238084|NCT00667225|4061082|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
4238085|NCT00667225|4061083|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4238086|NCT00667225|4061084|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4238087|NCT00667225|4061082|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4238088|NCT00667225|4061083|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4238089|NCT00667225|4061084|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4238090|NCT00667225|4061082|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4238091|NCT00667225|4061083|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4238092|NCT00667225|4061084|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4238093|NCT00667225|4061082|B3|||Age||years|Mean|7|7.0|Standard Deviation|1.3|1.3|||
4238094|NCT00667225|4061083|B2|||Age||years|Mean|6.7|6.7|Standard Deviation|1.8|1.8|||
4238095|NCT00667225|4061084|B1|||Age||years|Mean|7.3|7.3|Standard Deviation|1.7|1.7|||
4238096|NCT00667225|4061082|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4238097|NCT00667225|4061083|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4238098|NCT00667225|4061084|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4238099|NCT00667225|4061082|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4238100|NCT00667225|4061083|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4238101|NCT00667225|4061084|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4238102|NCT00667225|4061082|B3||<=18 years|Age||Participants|Count of Participants|29|29.0||||||
4238103|NCT00667225|4061083|B2||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4238104|NCT00667225|4061084|B1||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4238105|NCT00667186|4061093|B3|United States||Region of Enrollment||participants|Number|9572|9572.0||||||
4238106|NCT00667186|4061094|B2|United States||Region of Enrollment||participants|Number|4,880|4.0||||||
4238107|NCT00667186|4061095|B1|United States||Region of Enrollment||participants|Number|4,692|4.0||||||
4238108|NCT00667186|4061093|B3||Male|Sex: Female, Male||Participants|Count of Participants|4769|4769.0||||||
4238109|NCT00667186|4061094|B2||Male|Sex: Female, Male||Participants|Count of Participants|2450|2450.0||||||
4238110|NCT00667186|4061095|B1||Male|Sex: Female, Male||Participants|Count of Participants|2319|2319.0||||||
4238111|NCT00667186|4061093|B3||Female|Sex: Female, Male||Participants|Count of Participants|4803|4803.0||||||
4238112|NCT00667186|4061094|B2||Female|Sex: Female, Male||Participants|Count of Participants|2430|2430.0||||||
4238113|NCT00667186|4061095|B1||Female|Sex: Female, Male||Participants|Count of Participants|2373|2373.0||||||
4238114|NCT00667186|4061093|B3|||Age||years|Mean|39|39.0|Standard Deviation|13|13.0|||
4238115|NCT00667186|4061094|B2|||Age||years|Mean|39|39.0|Standard Deviation|13|13.0|||
4238116|NCT00667186|4061095|B1|||Age||years|Mean|39|39.0|Standard Deviation|13|13.0|||
4238117|NCT00667095|4061104|B3|||Median Number of Pads Per Day||pads|Median|5|5.0|Full Range|||1.0|9.0|
4238118|NCT00667095|4061105|B2|||Median Number of Pads Per Day||pads|Median|5|5.0|Full Range|||3.0|8.0|
4238119|NCT00667095|4061106|B1|||Median Number of Pads Per Day||pads|Median|4|4.0|Full Range|||1.0|9.0|
4238120|NCT00667095|4061104|B3|||Median 24 Hour Pad Weight|Prior to the baseline visit, the study coordinator weighed standard pads provided to the subject for the study time period. The study coordinator instructed the subject to bring in any pads used during the 24-hour period prior to the baseline visit. The study coordinator recorded the 24-hour pad weight into the study dataset.|g|Median|166|166.0|Full Range|||0.0|1618.0|
4238121|NCT00667095|4061105|B2|||Median 24 Hour Pad Weight|Prior to the baseline visit, the study coordinator weighed standard pads provided to the subject for the study time period. The study coordinator instructed the subject to bring in any pads used during the 24-hour period prior to the baseline visit. The study coordinator recorded the 24-hour pad weight into the study dataset.|g|Median|179|179.0|Full Range|||5.0|1618.0|
4238122|NCT00667095|4061106|B1|||Median 24 Hour Pad Weight|Prior to the baseline visit, the study coordinator weighed standard pads provided to the subject for the study time period. The study coordinator instructed the subject to bring in any pads used during the 24-hour period prior to the baseline visit. The study coordinator recorded the 24-hour pad weight into the study dataset.|g|Median|166|166.0|Full Range|||0.0|585.0|
4238123|NCT00667095|4061104|B3|||Incontinent Episodes during 24 Hours|The study coordinator instructed the subject to keep record of any incontinence episodes during the 24-hour period prior to their baseline visit.|Episodes|Median|4|4.0|Full Range|||0.0|9.0|
4238124|NCT00667095|4061105|B2|||Incontinent Episodes during 24 Hours|The study coordinator instructed the subject to keep record of any incontinence episodes during the 24-hour period prior to their baseline visit.|Episodes|Median|3|3.0|Full Range|||1.0|9.0|
4238125|NCT00667095|4061106|B1|||Incontinent Episodes during 24 Hours|The study coordinator instructed the subject to keep record of any incontinence episodes during the 24-hour period prior to their baseline visit.|Episodes|Median|6|6.0|Full Range|||0.0|8.0|
4238126|NCT00667095|4061104|B3|||Post-Void Residual Urine||mL|Median|17|17.0|Full Range|||1.0|116.0|
4238127|NCT00667095|4061105|B2|||Post-Void Residual Urine||mL|Median|29|29.0|Full Range|||0.0|116.0|
4238128|NCT00667095|4061106|B1|||Post-Void Residual Urine||mL|Median|15|15.0|Full Range|||0.0|91.0|
4238129|NCT00667095|4061104|B3|||Body Mass Index|Body Mass Index (BMI) is a health index for comparing weight to height. BMI is a person's weight in kilograms (kg) divided by his or her height in meters squared. The body mass index is an indication if a person is at a suitable weight for his height on an approximation of body fat. A body mass index of under 20 is considered to be underweight, while a body mass index between 20 to 25 is considered healthy. A body mass index in the range of 25 to 30 is regarded as overweight. A body mass index over 30 is regarded as obese.|kg/m^2|Median|27|27.0|Full Range|||19.0|40.0|
4238130|NCT00667095|4061105|B2|||Body Mass Index|Body Mass Index (BMI) is a health index for comparing weight to height. BMI is a person's weight in kilograms (kg) divided by his or her height in meters squared. The body mass index is an indication if a person is at a suitable weight for his height on an approximation of body fat. A body mass index of under 20 is considered to be underweight, while a body mass index between 20 to 25 is considered healthy. A body mass index in the range of 25 to 30 is regarded as overweight. A body mass index over 30 is regarded as obese.|kg/m^2|Median|30|30.0|Full Range|||19.0|40.0|
4238131|NCT00667095|4061106|B1|||Body Mass Index|Body Mass Index (BMI) is a health index for comparing weight to height. BMI is a person's weight in kilograms (kg) divided by his or her height in meters squared. The body mass index is an indication if a person is at a suitable weight for his height on an approximation of body fat. A body mass index of under 20 is considered to be underweight, while a body mass index between 20 to 25 is considered healthy. A body mass index in the range of 25 to 30 is regarded as overweight. A body mass index over 30 is regarded as obese.|kg/m^2|Median|26|26.0|Full Range|||22.0|38.0|
4238132|NCT00667095|4061104|B3|≥ 3 vaginal births||Number of Vaginal Births||participants|Number|10|10.0||||||
4238133|NCT00667095|4061105|B2|≥ 3 vaginal births||Number of Vaginal Births||participants|Number|6|6.0||||||
4238134|NCT00667095|4061106|B1|≥ 3 vaginal births||Number of Vaginal Births||participants|Number|4|4.0||||||
4238135|NCT00667095|4061104|B3|1-2 vaginal births||Number of Vaginal Births||participants|Number|5|5.0||||||
4238136|NCT00667095|4061105|B2|1-2 vaginal births||Number of Vaginal Births||participants|Number|1|1.0||||||
4238137|NCT00667095|4061106|B1|1-2 vaginal births||Number of Vaginal Births||participants|Number|4|4.0||||||
4238138|NCT00667095|4061104|B3|0 vaginal births||Number of Vaginal Births||participants|Number|6|6.0||||||
4238139|NCT00667095|4061105|B2|0 vaginal births||Number of Vaginal Births||participants|Number|3|3.0||||||
4238140|NCT00667095|4061106|B1|0 vaginal births||Number of Vaginal Births||participants|Number|3|3.0||||||
4238141|NCT00667095|4061104|B3|No previous UTIs||History of Urinary Tract Infections (UTIs)||participants|Number|1|1.0||||||
4238142|NCT00667095|4061105|B2|No previous UTIs||History of Urinary Tract Infections (UTIs)||participants|Number|0|0.0||||||
4238143|NCT00667095|4061106|B1|No previous UTIs||History of Urinary Tract Infections (UTIs)||participants|Number|1|1.0||||||
4238144|NCT00667095|4061104|B3|Previous history of UTIs||History of Urinary Tract Infections (UTIs)||participants|Number|20|20.0||||||
4238145|NCT00667095|4061105|B2|Previous history of UTIs||History of Urinary Tract Infections (UTIs)||participants|Number|10|10.0||||||
4238146|NCT00667095|4061106|B1|Previous history of UTIs||History of Urinary Tract Infections (UTIs)||participants|Number|10|10.0||||||
4238147|NCT00667095|4061104|B3|No hypertension||History of Hypertension||participants|Number|8|8.0||||||
4238148|NCT00667095|4061105|B2|No hypertension||History of Hypertension||participants|Number|3|3.0||||||
4238149|NCT00667095|4061106|B1|No hypertension||History of Hypertension||participants|Number|5|5.0||||||
4238150|NCT00667095|4061104|B3|Hypertension||History of Hypertension||participants|Number|13|13.0||||||
4238151|NCT00667095|4061105|B2|Hypertension||History of Hypertension||participants|Number|7|7.0||||||
4238152|NCT00667095|4061106|B1|Hypertension||History of Hypertension||participants|Number|6|6.0||||||
4238153|NCT00667095|4061104|B3|Current smoker||Smoking Status||participants|Number|1|1.0||||||
4238154|NCT00667095|4061105|B2|Current smoker||Smoking Status||participants|Number|0|0.0||||||
4238155|NCT00667095|4061106|B1|Current smoker||Smoking Status||participants|Number|1|1.0||||||
4238156|NCT00667095|4061104|B3|Past smoker||Smoking Status||participants|Number|10|10.0||||||
4238157|NCT00667095|4061105|B2|Past smoker||Smoking Status||participants|Number|4|4.0||||||
4238158|NCT00667095|4061106|B1|Past smoker||Smoking Status||participants|Number|6|6.0||||||
4238159|NCT00667095|4061104|B3|Never smoked||Smoking Status||participants|Number|10|10.0||||||
4238160|NCT00667095|4061105|B2|Never smoked||Smoking Status||participants|Number|6|6.0||||||
4238161|NCT00667095|4061106|B1|Never smoked||Smoking Status||participants|Number|4|4.0||||||
4238162|NCT00667095|4061104|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4238163|NCT00667095|4061105|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4238164|NCT00667095|4061106|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4238165|NCT00667095|4061104|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4238166|NCT00667095|4061105|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4238167|NCT00667095|4061106|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4238168|NCT00667095|4061104|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4238169|NCT00667095|4061105|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4238170|NCT00667095|4061106|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4238171|NCT00667095|4061104|B3|||Age||years|Median|68|68.0|Full Range|||36.0|93.0|
4238172|NCT00667095|4061105|B2|||Age||years|Median|71|71.0|Full Range|||38.0|93.0|
4238173|NCT00667095|4061106|B1|||Age||years|Median|58|58.0|Full Range|||36.0|85.0|
4238174|NCT00666978|4061127|B3|||California Tobacco Survey: Inhale deeply|"Question asks Which statement best describes how or whether you inhale? Response options include 'I inhale deeply into my chest', I inhale partly into my chest', I inhale as far back as my throat', 'I inhale back into my throat', 'I just puff, I don't really inhale'.~Reporting number of participants who answered 'I inhale deeply into my chest'."|Participants|Count of Participants|126|126.0||||||
4238175|NCT00666978|4061128|B2|||California Tobacco Survey: Inhale deeply|"Question asks Which statement best describes how or whether you inhale? Response options include 'I inhale deeply into my chest', I inhale partly into my chest', I inhale as far back as my throat', 'I inhale back into my throat', 'I just puff, I don't really inhale'.~Reporting number of participants who answered 'I inhale deeply into my chest'."|Participants|Count of Participants|61|61.0||||||
4238176|NCT00666978|4061129|B1|||California Tobacco Survey: Inhale deeply|"Question asks Which statement best describes how or whether you inhale? Response options include 'I inhale deeply into my chest', I inhale partly into my chest', I inhale as far back as my throat', 'I inhale back into my throat', 'I just puff, I don't really inhale'.~Reporting number of participants who answered 'I inhale deeply into my chest'."|Participants|Count of Participants|65|65.0||||||
4238177|NCT00666978|4061127|B3|||Smoke-free household||Participants|Count of Participants|132|132.0||||||
4238178|NCT00666978|4061128|B2|||Smoke-free household||Participants|Count of Participants|67|67.0||||||
4238179|NCT00666978|4061129|B1|||Smoke-free household||Participants|Count of Participants|65|65.0||||||
4238180|NCT00666978|4061127|B3|||Confidence Scale|Confidence to quit smoking scale asking about how confident you are that you could quit smoking completely in the next week. 1 item scale. Scale of 0 = not confident and 10 = extremely confident.|units on a scale|Mean|7.9|7.9|Standard Deviation|2.4|2.4|||
4238277|NCT00666965|4061141|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4238278|NCT00666965|4061142|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4238181|NCT00666978|4061128|B2|||Confidence Scale|Confidence to quit smoking scale asking about how confident you are that you could quit smoking completely in the next week. 1 item scale. Scale of 0 = not confident and 10 = extremely confident.|units on a scale|Mean|7.8|7.8|Standard Deviation|2.0|2.0|||
4238182|NCT00666978|4061129|B1|||Confidence Scale|Confidence to quit smoking scale asking about how confident you are that you could quit smoking completely in the next week. 1 item scale. Scale of 0 = not confident and 10 = extremely confident.|units on a scale|Mean|7.9|7.9|Standard Deviation|2.1|2.1|||
4238183|NCT00666978|4061127|B3|||Motivation Scale|Motivation to quit smoking scale asking about how important it is to quit smoking in the next week. 1 item scale. Scale of 0 = not important and 10 = extremely important.|units on a scale|Mean|9.7|9.7|Standard Deviation|0.8|0.8|||
4238184|NCT00666978|4061128|B2|||Motivation Scale|Motivation to quit smoking scale asking about how important it is to quit smoking in the next week. 1 item scale. Scale of 0 = not important and 10 = extremely important.|units on a scale|Mean|9.8|9.8|Standard Deviation|0.7|0.7|||
4238185|NCT00666978|4061129|B1|||Motivation Scale|Motivation to quit smoking scale asking about how important it is to quit smoking in the next week. 1 item scale. Scale of 0 = not important and 10 = extremely important.|units on a scale|Mean|9.7|9.7|Standard Deviation|0.8|0.8|||
4238186|NCT00666978|4061127|B3|||Age started smoking regularly||years|Mean|21.1|21.1|Standard Deviation|7.1|7.1|||
4238187|NCT00666978|4061128|B2|||Age started smoking regularly||years|Mean|21.3|21.3|Standard Deviation|7.4|7.4|||
4238188|NCT00666978|4061129|B1|||Age started smoking regularly||years|Mean|21.1|21.1|Standard Deviation|6.7|6.7|||
4238189|NCT00666978|4061127|B3|||Age of first cigarette||years|Mean|17.6|17.6|Standard Deviation|5.9|5.9|||
4238190|NCT00666978|4061128|B2|||Age of first cigarette||years|Mean|18.1|18.1|Standard Deviation|7.3|7.3|||
4238191|NCT00666978|4061129|B1|||Age of first cigarette||years|Mean|17.5|17.5|Standard Deviation|5.8|5.8|||
4238192|NCT00666978|4061127|B3|||Pharmacotherapy use during most recent quit attempt||Participants|Count of Participants|133|133.0||||||
4238193|NCT00666978|4061128|B2|||Pharmacotherapy use during most recent quit attempt||Participants|Count of Participants|61|61.0||||||
4238194|NCT00666978|4061129|B1|||Pharmacotherapy use during most recent quit attempt||Participants|Count of Participants|72|72.0||||||
4238195|NCT00666978|4061127|B3|||Quit Attempts|Number of 24-hour quit attempts made in the past year.|Quit Attempts|Mean|3.7|3.7|Standard Deviation|7.7|7.7|||
4238196|NCT00666978|4061128|B2|||Quit Attempts|Number of 24-hour quit attempts made in the past year.|Quit Attempts|Mean|3.9|3.9|Standard Deviation|7.4|7.4|||
4238197|NCT00666978|4061129|B1|||Quit Attempts|Number of 24-hour quit attempts made in the past year.|Quit Attempts|Mean|3.5|3.5|Standard Deviation|7.9|7.9|||
4238198|NCT00666978|4061127|B3|||Smoke Menthol Cigarettes||Participants|Count of Participants|452|452.0||||||
4238199|NCT00666978|4061128|B2|||Smoke Menthol Cigarettes||Participants|Count of Participants|228|228.0||||||
4238200|NCT00666978|4061129|B1|||Smoke Menthol Cigarettes||Participants|Count of Participants|224|224.0||||||
4238201|NCT00666978|4061127|B3|||Time to first cigarette,< or = 30 minutes||Participants|Count of Participants|390|390.0||||||
4238202|NCT00666978|4061128|B2|||Time to first cigarette,< or = 30 minutes||Participants|Count of Participants|199|199.0||||||
4238203|NCT00666978|4061129|B1|||Time to first cigarette,< or = 30 minutes||Participants|Count of Participants|191|191.0||||||
4238204|NCT00666978|4061127|B3|||Fagerstrom Test for Nicotine Dependence- 6 item|FTND assessed nicotine dependence: possible total score ranges from 0 to 10. 0 indicates minimum physical nicotine dependence and 10 indicates maximum physical nicotine dependence.|score|Mean|3.2|3.2|Standard Deviation|1.7|1.7|||
4238205|NCT00666978|4061128|B2|||Fagerstrom Test for Nicotine Dependence- 6 item|FTND assessed nicotine dependence: possible total score ranges from 0 to 10. 0 indicates minimum physical nicotine dependence and 10 indicates maximum physical nicotine dependence.|score|Mean|3.3|3.3|Standard Deviation|1.7|1.7|||
4238206|NCT00666978|4061129|B1|||Fagerstrom Test for Nicotine Dependence- 6 item|FTND assessed nicotine dependence: possible total score ranges from 0 to 10. 0 indicates minimum physical nicotine dependence and 10 indicates maximum physical nicotine dependence.|score|Mean|3.1|3.1|Standard Deviation|1.7|1.7|||
4238207|NCT00666978|4061127|B3|||Cigarettes per day||cigarettes per day|Mean|8.0|8.0|Standard Deviation|2.5|2.5|||
4238208|NCT00666978|4061128|B2|||Cigarettes per day||cigarettes per day|Mean|7.9|7.9|Standard Deviation|2.4|2.4|||
4238209|NCT00666978|4061129|B1|||Cigarettes per day||cigarettes per day|Mean|8.0|8.0|Standard Deviation|2.6|2.6|||
4238210|NCT00666978|4061127|B3|||Exhaled Carbon monoxide||ppm|Mean|16.4|16.4|Standard Deviation|10.0|10.0|||
4238211|NCT00666978|4061128|B2|||Exhaled Carbon monoxide||ppm|Mean|17.1|17.1|Standard Deviation|10.5|10.5|||
4238212|NCT00666978|4061129|B1|||Exhaled Carbon monoxide||ppm|Mean|15.8|15.8|Standard Deviation|9.4|9.4|||
4238213|NCT00666978|4061127|B3|||Serum Cotinine||ng/ml|Mean|275.8|275.8|Standard Deviation|155.8|155.8|||
4238214|NCT00666978|4061128|B2|||Serum Cotinine||ng/ml|Mean|283.0|283.0|Standard Deviation|151.2|151.2|||
4238215|NCT00666978|4061129|B1|||Serum Cotinine||ng/ml|Mean|268.7|268.7|Standard Deviation|160.2|160.2|||
4238216|NCT00666978|4061127|B3|||Stress (PSS-4)|PSS-4 assessed self-appraised global stress: possible total score ranges from 0 to 16. Higher scores indicate more stress.|units on a scale|Mean|5.2|5.2|Standard Deviation|3.2|3.2|||
4238217|NCT00666978|4061128|B2|||Stress (PSS-4)|PSS-4 assessed self-appraised global stress: possible total score ranges from 0 to 16. Higher scores indicate more stress.|units on a scale|Mean|5.5|5.5|Standard Deviation|3.3|3.3|||
4238218|NCT00666978|4061129|B1|||Stress (PSS-4)|PSS-4 assessed self-appraised global stress: possible total score ranges from 0 to 16. Higher scores indicate more stress.|units on a scale|Mean|4.9|4.9|Standard Deviation|3.1|3.1|||
4238219|NCT00666978|4061127|B3|||Depression(CESD-10) score|CESD-10 assessed distress associated with depressive symptoms: possible total score ranges from 0 to 30, with a score of 10 or greater reflecting clinically significant depression.|units on a scale|Mean|7.7|7.7|Standard Deviation|5.2|5.2|||
4238279|NCT00666965|4061143|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4238220|NCT00666978|4061128|B2|||Depression(CESD-10) score|CESD-10 assessed distress associated with depressive symptoms: possible total score ranges from 0 to 30, with a score of 10 or greater reflecting clinically significant depression.|units on a scale|Mean|8.2|8.2|Standard Deviation|5.5|5.5|||
4238221|NCT00666978|4061129|B1|||Depression(CESD-10) score|CESD-10 assessed distress associated with depressive symptoms: possible total score ranges from 0 to 30, with a score of 10 or greater reflecting clinically significant depression.|units on a scale|Mean|7.2|7.2|Standard Deviation|4.9|4.9|||
4238222|NCT00666978|4061127|B3|||BMI||kg/m 2|Mean|31.1|31.1|Standard Deviation|7.9|7.9|||
4238223|NCT00666978|4061128|B2|||BMI||kg/m 2|Mean|31.1|31.1|Standard Deviation|8.1|8.1|||
4238224|NCT00666978|4061129|B1|||BMI||kg/m 2|Mean|31.1|31.1|Standard Deviation|7.6|7.6|||
4238225|NCT00666978|4061127|B3|||Weight||lbs|Mean|195.5|195.5|Standard Deviation|52.9|52.9|||
4238226|NCT00666978|4061128|B2|||Weight||lbs|Mean|194.8|194.8|Standard Deviation|54.0|54.0|||
4238227|NCT00666978|4061129|B1|||Weight||lbs|Mean|196.1|196.1|Standard Deviation|51.8|51.8|||
4238228|NCT00666978|4061127|B3|||Education > or = high school||Participants|Count of Participants|454|454.0||||||
4238229|NCT00666978|4061128|B2|||Education > or = high school||Participants|Count of Participants|229|229.0||||||
4238230|NCT00666978|4061129|B1|||Education > or = high school||Participants|Count of Participants|225|225.0||||||
4238231|NCT00666978|4061127|B3|||Monthly family income <$1800||Participants|Count of Participants|327|327.0||||||
4238232|NCT00666978|4061128|B2|||Monthly family income <$1800||Participants|Count of Participants|158|158.0||||||
4238233|NCT00666978|4061129|B1|||Monthly family income <$1800||Participants|Count of Participants|169|169.0||||||
4238234|NCT00666978|4061127|B3|||Married or living with partner||Participants|Count of Participants|166|166.0||||||
4238235|NCT00666978|4061128|B2|||Married or living with partner||Participants|Count of Participants|75|75.0||||||
4238236|NCT00666978|4061129|B1|||Married or living with partner||Participants|Count of Participants|91|91.0||||||
4238237|NCT00666978|4061127|B3|United States||Region of Enrollment||participants|Number|540|540.0||||||
4238238|NCT00666978|4061128|B2|United States||Region of Enrollment||participants|Number|270|270.0||||||
4238239|NCT00666978|4061129|B1|United States||Region of Enrollment||participants|Number|270|270.0||||||
4238240|NCT00666978|4061127|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238241|NCT00666978|4061128|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238242|NCT00666978|4061129|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238243|NCT00666978|4061127|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238244|NCT00666978|4061128|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238245|NCT00666978|4061129|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238246|NCT00666978|4061127|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238247|NCT00666978|4061128|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238248|NCT00666978|4061129|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238249|NCT00666978|4061127|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|540|540.0||||||
4238250|NCT00666978|4061128|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|270|270.0||||||
4238251|NCT00666978|4061129|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|270|270.0||||||
4238252|NCT00666978|4061127|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238253|NCT00666978|4061128|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238254|NCT00666978|4061129|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238255|NCT00666978|4061127|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238256|NCT00666978|4061128|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238257|NCT00666978|4061129|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238258|NCT00666978|4061127|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238259|NCT00666978|4061128|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238260|NCT00666978|4061129|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238261|NCT00666978|4061127|B3||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4238262|NCT00666978|4061128|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4238263|NCT00666978|4061129|B1||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4238264|NCT00666978|4061127|B3||Female|Sex: Female, Male||Participants|Count of Participants|357|357.0||||||
4238265|NCT00666978|4061128|B2||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4238266|NCT00666978|4061129|B1||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4238267|NCT00666978|4061127|B3|||Age||years|Mean|46.5|46.5|Standard Deviation|11.3|11.3|||
4238268|NCT00666978|4061128|B2|||Age||years|Mean|46.2|46.2|Standard Deviation|11.5|11.5|||
4238269|NCT00666978|4061129|B1|||Age||years|Mean|46.8|46.8|Standard Deviation|11.1|11.1|||
4238270|NCT00666965|4061139|B5|Japan||Region of Enrollment||participants|Number|227|227.0||||||
4238271|NCT00666965|4061140|B4|Japan||Region of Enrollment||participants|Number|56|56.0||||||
4238272|NCT00666965|4061141|B3|Japan||Region of Enrollment||participants|Number|57|57.0||||||
4238273|NCT00666965|4061142|B2|Japan||Region of Enrollment||participants|Number|57|57.0||||||
4238274|NCT00666965|4061143|B1|Japan||Region of Enrollment||participants|Number|57|57.0||||||
4238275|NCT00666965|4061139|B5||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4238276|NCT00666965|4061140|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4238280|NCT00666965|4061139|B5||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4238281|NCT00666965|4061140|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4238282|NCT00666965|4061141|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4238283|NCT00666965|4061142|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4238284|NCT00666965|4061143|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4238285|NCT00666965|4061139|B5|||Age||years|Mean|49.6|49.6|Standard Deviation|13.1|13.1|||
4238286|NCT00666965|4061140|B4|||Age||years|Mean|51.0|51.0|Standard Deviation|12.4|12.4|||
4238287|NCT00666965|4061141|B3|||Age||years|Mean|48.3|48.3|Standard Deviation|14.1|14.1|||
4238288|NCT00666965|4061142|B2|||Age||years|Mean|50.6|50.6|Standard Deviation|13.0|13.0|||
4238289|NCT00666965|4061143|B1|||Age||years|Mean|48.6|48.6|Standard Deviation|13.1|13.1|||
4238290|NCT00666965|4061139|B5||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
4238291|NCT00666965|4061140|B4||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4238292|NCT00666965|4061141|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4238293|NCT00666965|4061142|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4238294|NCT00666965|4061143|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4238295|NCT00666965|4061139|B5||Between 18 and 65 years|Age||Participants|Count of Participants|193|193.0||||||
4238296|NCT00666965|4061140|B4||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4238297|NCT00666965|4061141|B3||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4238298|NCT00666965|4061142|B2||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4238299|NCT00666965|4061143|B1||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4238300|NCT00666965|4061139|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4238301|NCT00666965|4061140|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4238302|NCT00666965|4061141|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4238303|NCT00666965|4061142|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4238304|NCT00666965|4061143|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4238305|NCT00666926|4061176|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4238306|NCT00666926|4061176|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4238307|NCT00666926|4061176|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|11.3|11.3|||
4238308|NCT00666848|4061482|B4|United States||Region of Enrollment||participants|Number|24|24.0||||||
4238309|NCT00666848|4061483|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4238310|NCT00666848|4061484|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4238311|NCT00666848|4061485|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4238312|NCT00666848|4061482|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4238313|NCT00666848|4061483|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4238314|NCT00666848|4061484|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4238315|NCT00666848|4061485|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4238316|NCT00666848|4061482|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4238317|NCT00666848|4061483|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4238318|NCT00666848|4061484|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4238319|NCT00666848|4061485|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4238320|NCT00666848|4061482|B4|||Age||years|Mean|43|43.0|Standard Deviation|2.2|2.2|||
4238321|NCT00666848|4061483|B3|||Age||years|Mean|41|41.0|Standard Deviation|9.1|9.1|||
4238322|NCT00666848|4061484|B2|||Age||years|Mean|44|44.0|Standard Deviation|13.9|13.9|||
4238323|NCT00666848|4061485|B1|||Age||years|Mean|42|42.0|Standard Deviation|9.8|9.8|||
4238324|NCT00666848|4061482|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4238325|NCT00666848|4061483|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4238326|NCT00666848|4061484|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4238327|NCT00666848|4061485|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4238328|NCT00666848|4061482|B4||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4238329|NCT00666848|4061483|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4238330|NCT00666848|4061484|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4238331|NCT00666848|4061485|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4238332|NCT00666848|4061482|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4238333|NCT00666848|4061483|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4238334|NCT00666848|4061484|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4238335|NCT00666848|4061485|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4238336|NCT00666835|4061498|B3|||Body weight||kg|Mean|76.2|76.2|Standard Deviation|16.2|16.2|||
4238337|NCT00666835|4061499|B2|||Body weight||kg|Mean|76.0|76.0|Standard Deviation|17.7|17.7|||
4238338|NCT00666835|4061500|B1|||Body weight||kg|Mean|76.3|76.3|Standard Deviation|15.5|15.5|||
4238339|NCT00666835|4061498|B3|Germany||Region of Enrollment||participants|Number|371|371.0||||||
4238340|NCT00666835|4061499|B2|Germany||Region of Enrollment||participants|Number|127|127.0||||||
4238341|NCT00666835|4061500|B1|Germany||Region of Enrollment||participants|Number|244|244.0||||||
4238342|NCT00666835|4061498|B3|Austria||Region of Enrollment||participants|Number|107|107.0||||||
4238343|NCT00666835|4061499|B2|Austria||Region of Enrollment||participants|Number|37|37.0||||||
4238344|NCT00666835|4061500|B1|Austria||Region of Enrollment||participants|Number|70|70.0||||||
4238345|NCT00666835|4061498|B3||Male|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
4238346|NCT00666835|4061499|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4238347|NCT00666835|4061500|B1||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4238348|NCT00666835|4061498|B3||Female|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
4238349|NCT00666835|4061499|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4238350|NCT00666835|4061500|B1||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4238351|NCT00666835|4061498|B3|||Age||years|Mean|62.4|62.4|Standard Deviation|14.2|14.2|||
4238352|NCT00666835|4061499|B2|||Age||years|Mean|62.6|62.6|Standard Deviation|13.8|13.8|||
4238353|NCT00666835|4061500|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|14.4|14.4|||
4238354|NCT00666835|4061498|B3||>=65 years|Age||Participants|Count of Participants|249|249.0||||||
4238355|NCT00666835|4061499|B2||>=65 years|Age||Participants|Count of Participants|80|80.0||||||
4238356|NCT00666835|4061500|B1||>=65 years|Age||Participants|Count of Participants|169|169.0||||||
4238357|NCT00666835|4061498|B3||Between 18 and 65 years|Age||Participants|Count of Participants|229|229.0||||||
4238358|NCT00666835|4061499|B2||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
4238359|NCT00666835|4061500|B1||Between 18 and 65 years|Age||Participants|Count of Participants|145|145.0||||||
4238360|NCT00666835|4061498|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4238361|NCT00666835|4061499|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4238362|NCT00666835|4061500|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4238363|NCT00666757|4061509|B3|||World Health Organization Health and Work Performance Questionnaire (HPQ), Absolute Presenteeism|"The HPQ was used to assess the participant's performance at work. Participants rated their overall performance on the days worked in the last week on a scale of 0 (worst performance) to 10 (top performance). Values were then multiplied by 10 to create a percentage scale between 0 and 100 percent. Absolute presenteeism equals the difference between the score for self and score for average worker in same job."|units on a scale|Mean|49.74|49.74|Standard Deviation|23.16|23.16|||
4238364|NCT00666757|4061510|B2|||World Health Organization Health and Work Performance Questionnaire (HPQ), Absolute Presenteeism|"The HPQ was used to assess the participant's performance at work. Participants rated their overall performance on the days worked in the last week on a scale of 0 (worst performance) to 10 (top performance). Values were then multiplied by 10 to create a percentage scale between 0 and 100 percent. Absolute presenteeism equals the difference between the score for self and score for average worker in same job."|units on a scale|Mean|50.63|50.63|Standard Deviation|23.86|23.86|||
4238365|NCT00666757|4061511|B1|||World Health Organization Health and Work Performance Questionnaire (HPQ), Absolute Presenteeism|"The HPQ was used to assess the participant's performance at work. Participants rated their overall performance on the days worked in the last week on a scale of 0 (worst performance) to 10 (top performance). Values were then multiplied by 10 to create a percentage scale between 0 and 100 percent. Absolute presenteeism equals the difference between the score for self and score for average worker in same job."|units on a scale|Mean|48.85|48.85|Standard Deviation|22.47|22.47|||
4238366|NCT00666757|4061509|B3|||World Health Organization Health and Work Performance Questionnaire (HPQ), Absolute Absenteeism|The HPQ was used to assess the total hours of missed work (absenteeism) per week. The calculation for absolute absenteeism is actual hours worked minus expected hours equals number of missed work days.|hours lost per week|Mean|31.00|31.0|Standard Deviation|66.48|66.48|||
4238367|NCT00666757|4061510|B2|||World Health Organization Health and Work Performance Questionnaire (HPQ), Absolute Absenteeism|The HPQ was used to assess the total hours of missed work (absenteeism) per week. The calculation for absolute absenteeism is actual hours worked minus expected hours equals number of missed work days.|hours lost per week|Mean|33.29|33.29|Standard Deviation|72.90|72.9|||
4238368|NCT00666757|4061511|B1|||World Health Organization Health and Work Performance Questionnaire (HPQ), Absolute Absenteeism|The HPQ was used to assess the total hours of missed work (absenteeism) per week. The calculation for absolute absenteeism is actual hours worked minus expected hours equals number of missed work days.|hours lost per week|Mean|28.64|28.64|Standard Deviation|59.28|59.28|||
4238369|NCT00666757|4061509|B3|||Weight||kilograms (kg)|Mean|86.42|86.42|Standard Deviation|23.18|23.18|||
4238370|NCT00666757|4061510|B2|||Weight||kilograms (kg)|Mean|86.23|86.23|Standard Deviation|23.97|23.97|||
4238371|NCT00666757|4061511|B1|||Weight||kilograms (kg)|Mean|86.62|86.62|Standard Deviation|22.37|22.37|||
4238372|NCT00666757|4061509|B3|||Sheehan Disability Scale (SDS) Item 3: Symptoms Disrupted Family Life/Home Responsibilities|The SDS is completed by the participant and Item 3 is used to assess the effect of the participant's symptoms on their family life/home responsibilities. Scores range from 0 to 10 with higher values indicating greater disruption in the participant's family life/home responsibilities.|units on a scale|Mean|7.67|7.67|Standard Deviation|2.15|2.15|||
4238373|NCT00666757|4061510|B2|||Sheehan Disability Scale (SDS) Item 3: Symptoms Disrupted Family Life/Home Responsibilities|The SDS is completed by the participant and Item 3 is used to assess the effect of the participant's symptoms on their family life/home responsibilities. Scores range from 0 to 10 with higher values indicating greater disruption in the participant's family life/home responsibilities.|units on a scale|Mean|7.68|7.68|Standard Deviation|2.28|2.28|||
4238374|NCT00666757|4061511|B1|||Sheehan Disability Scale (SDS) Item 3: Symptoms Disrupted Family Life/Home Responsibilities|The SDS is completed by the participant and Item 3 is used to assess the effect of the participant's symptoms on their family life/home responsibilities. Scores range from 0 to 10 with higher values indicating greater disruption in the participant's family life/home responsibilities.|units on a scale|Mean|7.67|7.67|Standard Deviation|2.02|2.02|||
4238418|NCT00666757|4061510|B2|||History, Met Diagnosis of Major Mood Disorder (MDD)||participants|Number|378|378.0||||||
4238419|NCT00666757|4061511|B1|||History, Met Diagnosis of Major Mood Disorder (MDD)||participants|Number|372|372.0||||||
4238375|NCT00666757|4061509|B3|||Sheehan Disability Scale (SDS) Item 2: Symptoms Disrupted Social Life/Leisure Activities|The SDS is completed by the participant and is used to assess the effect of the participant's symptoms on their work/social/family life. Total scores range from 0 to 30 with higher values indicating greater disruption in the participant's work/social/family life.|units on a scale|Mean|7.82|7.82|Standard Deviation|2.05|2.05|||
4238376|NCT00666757|4061510|B2|||Sheehan Disability Scale (SDS) Item 2: Symptoms Disrupted Social Life/Leisure Activities|The SDS is completed by the participant and is used to assess the effect of the participant's symptoms on their work/social/family life. Total scores range from 0 to 30 with higher values indicating greater disruption in the participant's work/social/family life.|units on a scale|Mean|7.82|7.82|Standard Deviation|2.13|2.13|||
4238377|NCT00666757|4061511|B1|||Sheehan Disability Scale (SDS) Item 2: Symptoms Disrupted Social Life/Leisure Activities|The SDS is completed by the participant and is used to assess the effect of the participant's symptoms on their work/social/family life. Total scores range from 0 to 30 with higher values indicating greater disruption in the participant's work/social/family life.|units on a scale|Mean|7.81|7.81|Standard Deviation|1.97|1.97|||
4238378|NCT00666757|4061509|B3|||Sheehan Disability Scale (SDS) Item 1: Symptoms Disrupted Work/School|The SDS is completed by the participant and Item 1 is used to assess the effect of the participant's symptoms on their work/school schedule. Scores range from 0 to 10 with higher values indicating greater disruption in the participant's work/school life.|units on a scale|Mean|7.05|7.05|Standard Deviation|2.42|2.42|||
4238379|NCT00666757|4061510|B2|||Sheehan Disability Scale (SDS) Item 1: Symptoms Disrupted Work/School|The SDS is completed by the participant and Item 1 is used to assess the effect of the participant's symptoms on their work/school schedule. Scores range from 0 to 10 with higher values indicating greater disruption in the participant's work/school life.|units on a scale|Mean|7.09|7.09|Standard Deviation|2.45|2.45|||
4238380|NCT00666757|4061511|B1|||Sheehan Disability Scale (SDS) Item 1: Symptoms Disrupted Work/School|The SDS is completed by the participant and Item 1 is used to assess the effect of the participant's symptoms on their work/school schedule. Scores range from 0 to 10 with higher values indicating greater disruption in the participant's work/school life.|units on a scale|Mean|7.00|7.0|Standard Deviation|2.40|2.4|||
4238381|NCT00666757|4061509|B3|||Sheehan Disability Scale (SDS) Global Functional Impairment Score|The SDS Global Functional Impairment Score is a total score that is calculated by summing the SDS Item 1, 2, and 3; the score ranges from 0 (unimpaired) to 30 (highly impaired).|units on a scale|Mean|22.71|22.71|Standard Deviation|5.79|5.79|||
4238382|NCT00666757|4061510|B2|||Sheehan Disability Scale (SDS) Global Functional Impairment Score|The SDS Global Functional Impairment Score is a total score that is calculated by summing the SDS Item 1, 2, and 3; the score ranges from 0 (unimpaired) to 30 (highly impaired).|units on a scale|Mean|22.72|22.72|Standard Deviation|6.05|6.05|||
4238383|NCT00666757|4061511|B1|||Sheehan Disability Scale (SDS) Global Functional Impairment Score|The SDS Global Functional Impairment Score is a total score that is calculated by summing the SDS Item 1, 2, and 3; the score ranges from 0 (unimpaired) to 30 (highly impaired).|units on a scale|Mean|22.70|22.7|Standard Deviation|5.52|5.52|||
4238384|NCT00666757|4061509|B3|||Quick Inventory of Depressive Symptomatology (QIDS-SR) Total Score|The QIDS-SR Total Score is a 16-item, participant-rated short form of the Inventory of Depressive Symptomatology that assesses 9 domains: sad mood, concentration, self-outlook, suicidal ideation, involvement, energy/fatigability, sleep disturbance, appetite/weight increase/decrease and psychomotor agitation/retardation. Scores range from 0 (none) to 27 (very severe) depression.|units on a scale|Mean|21.67|21.67|Standard Deviation|1.701|1.701|||
4238385|NCT00666757|4061510|B2|||Quick Inventory of Depressive Symptomatology (QIDS-SR) Total Score|The QIDS-SR Total Score is a 16-item, participant-rated short form of the Inventory of Depressive Symptomatology that assesses 9 domains: sad mood, concentration, self-outlook, suicidal ideation, involvement, energy/fatigability, sleep disturbance, appetite/weight increase/decrease and psychomotor agitation/retardation. Scores range from 0 (none) to 27 (very severe) depression.|units on a scale|Mean|21.70|21.7|Standard Deviation|1.70|1.7|||
4238386|NCT00666757|4061511|B1|||Quick Inventory of Depressive Symptomatology (QIDS-SR) Total Score|The QIDS-SR Total Score is a 16-item, participant-rated short form of the Inventory of Depressive Symptomatology that assesses 9 domains: sad mood, concentration, self-outlook, suicidal ideation, involvement, energy/fatigability, sleep disturbance, appetite/weight increase/decrease and psychomotor agitation/retardation. Scores range from 0 (none) to 27 (very severe) depression.|units on a scale|Mean|21.64|21.64|Standard Deviation|1.71|1.71|||
4238387|NCT00666757|4061509|B3|||History, Time Since Most Recent MDD Episode|Number of months since most recent MDD episode|months|Mean|11.84|11.84|Standard Deviation|25.57|25.57|||
4238388|NCT00666757|4061510|B2|||History, Time Since Most Recent MDD Episode|Number of months since most recent MDD episode|months|Mean|11.92|11.92|Standard Deviation|30.69|30.69|||
4238389|NCT00666757|4061511|B1|||History, Time Since Most Recent MDD Episode|Number of months since most recent MDD episode|months|Mean|11.76|11.76|Standard Deviation|19.06|19.06|||
4238390|NCT00666757|4061509|B3|||History, Number of Previous MDD Episodes|Number of previous MDD episodes|episodes|Mean|5.91|5.91|Standard Deviation|13.37|13.37|||
4238391|NCT00666757|4061510|B2|||History, Number of Previous MDD Episodes|Number of previous MDD episodes|episodes|Mean|5.09|5.09|Standard Deviation|11.08|11.08|||
4238392|NCT00666757|4061511|B1|||History, Number of Previous MDD Episodes|Number of previous MDD episodes|episodes|Mean|6.74|6.74|Standard Deviation|15.32|15.32|||
4238393|NCT00666757|4061509|B3|||History, Age at First Episode|Age when first MDD episode occurred|years|Mean|30.97|30.97|Standard Deviation|14.34|14.34|||
4238394|NCT00666757|4061510|B2|||History, Age at First Episode|Age when first MDD episode occurred|years|Mean|30.42|30.42|Standard Deviation|14.30|14.3|||
4238395|NCT00666757|4061511|B1|||History, Age at First Episode|Age when first MDD episode occurred|years|Mean|31.53|31.53|Standard Deviation|14.39|14.39|||
4238396|NCT00666757|4061509|B3|||Brief Pain Inventory (BPI) Average 24-Hour Pain Score|The BPI is a self-reported scale measuring pain severity and pain-specific interference on function on a scale ranging from 0 (no pain) to 10 (pain as bad as you can imagine).|units on a scale|Mean|2.81|2.81|Standard Deviation|2.77|2.77|||
4238420|NCT00666757|4061509|B3|United States||Region of Enrollment|United States study|participants|Number|750|750.0||||||
4238510|NCT00666718|4061569|B3|Czech Republic||Region of Enrollment||participants|Number|77|77.0||||||
4238397|NCT00666757|4061510|B2|||Brief Pain Inventory (BPI) Average 24-Hour Pain Score|The BPI is a self-reported scale measuring pain severity and pain-specific interference on function on a scale ranging from 0 (no pain) to 10 (pain as bad as you can imagine).|units on a scale|Mean|2.98|2.98|Standard Deviation|2.79|2.79|||
4238398|NCT00666757|4061511|B1|||Brief Pain Inventory (BPI) Average 24-Hour Pain Score|The BPI is a self-reported scale measuring pain severity and pain-specific interference on function on a scale ranging from 0 (no pain) to 10 (pain as bad as you can imagine).|units on a scale|Mean|2.64|2.64|Standard Deviation|2.74|2.74|||
4238399|NCT00666757|4061509|B3|||17-Item Hamilton Depression Rating Scale (HAMD-17) Total Score|The HAMD-17 Total Score is a rater-administered assessment of depression severity and improvement, with total score ranges from 0 (not at all depressed) to 52 (most severely depressed).|units on a scale|Mean|25.03|25.03|Standard Deviation|4.34|4.34|||
4238400|NCT00666757|4061510|B2|||17-Item Hamilton Depression Rating Scale (HAMD-17) Total Score|The HAMD-17 Total Score is a rater-administered assessment of depression severity and improvement, with total score ranges from 0 (not at all depressed) to 52 (most severely depressed).|units on a scale|Mean|25.03|25.03|Standard Deviation|4.24|4.24|||
4238401|NCT00666757|4061511|B1|||17-Item Hamilton Depression Rating Scale (HAMD-17) Total Score|The HAMD-17 Total Score is a rater-administered assessment of depression severity and improvement, with total score ranges from 0 (not at all depressed) to 52 (most severely depressed).|units on a scale|Mean|25.03|25.03|Standard Deviation|4.44|4.44|||
4238402|NCT00666757|4061509|B3|||17-Item Hamilton Depression Rating Scale (HAMD-17) Sleep Subscale Score|The HAMD-17 Sleep Subscale consists of Items 4, 5, 6 and evaluates initial, middle, and late insomnia. Total subscale scores range from 0 (no difficulty) to 6 (difficulty).|units on a scale|Mean|4.75|4.75|Standard Deviation|1.34|1.34|||
4238403|NCT00666757|4061510|B2|||17-Item Hamilton Depression Rating Scale (HAMD-17) Sleep Subscale Score|The HAMD-17 Sleep Subscale consists of Items 4, 5, 6 and evaluates initial, middle, and late insomnia. Total subscale scores range from 0 (no difficulty) to 6 (difficulty).|units on a scale|Mean|4.77|4.77|Standard Deviation|1.33|1.33|||
4238404|NCT00666757|4061511|B1|||17-Item Hamilton Depression Rating Scale (HAMD-17) Sleep Subscale Score|The HAMD-17 Sleep Subscale consists of Items 4, 5, 6 and evaluates initial, middle, and late insomnia. Total subscale scores range from 0 (no difficulty) to 6 (difficulty).|units on a scale|Mean|4.73|4.73|Standard Deviation|1.35|1.35|||
4238405|NCT00666757|4061509|B3|||17-Item Hamilton Depression Rating Scale (HAMD-17) Retardation Subscale|The HAMD-17 Retardation subscale consists of Items 1, 7, 8, 14 and evaluates dysfunction in mood, work, and sexual activity, as well as overall motor retardation. Total subscale scores range from 0 (normal) to 14 (severe).|units on a scale|Mean|8.45|8.45|Standard Deviation|1.55|1.55|||
4238406|NCT00666757|4061510|B2|||17-Item Hamilton Depression Rating Scale (HAMD-17) Retardation Subscale|The HAMD-17 Retardation subscale consists of Items 1, 7, 8, 14 and evaluates dysfunction in mood, work, and sexual activity, as well as overall motor retardation. Total subscale scores range from 0 (normal) to 14 (severe).|units on a scale|Mean|8.53|8.53|Standard Deviation|1.54|1.54|||
4238407|NCT00666757|4061511|B1|||17-Item Hamilton Depression Rating Scale (HAMD-17) Retardation Subscale|The HAMD-17 Retardation subscale consists of Items 1, 7, 8, 14 and evaluates dysfunction in mood, work, and sexual activity, as well as overall motor retardation. Total subscale scores range from 0 (normal) to 14 (severe).|units on a scale|Mean|8.36|8.36|Standard Deviation|1.55|1.55|||
4238408|NCT00666757|4061509|B3|||17-Item Hamilton Depression Rating Scale (HAMD-17) Maier Subscale Score|"HAMD-17 Maier Subscale consists of Items 1, 2, 7, 8, 9, 10 and represents the core symptoms of depression. Total subscale scores range from 0 (normal) to 24 (severe)."|units on a scale|Mean|12.47|12.47|Standard Deviation|2.27|2.27|||
4238409|NCT00666757|4061510|B2|||17-Item Hamilton Depression Rating Scale (HAMD-17) Maier Subscale Score|"HAMD-17 Maier Subscale consists of Items 1, 2, 7, 8, 9, 10 and represents the core symptoms of depression. Total subscale scores range from 0 (normal) to 24 (severe)."|units on a scale|Mean|12.48|12.48|Standard Deviation|2.22|2.22|||
4238410|NCT00666757|4061511|B1|||17-Item Hamilton Depression Rating Scale (HAMD-17) Maier Subscale Score|"HAMD-17 Maier Subscale consists of Items 1, 2, 7, 8, 9, 10 and represents the core symptoms of depression. Total subscale scores range from 0 (normal) to 24 (severe)."|units on a scale|Mean|12.47|12.47|Standard Deviation|2.33|2.33|||
4238411|NCT00666757|4061509|B3|||17-Item Hamilton Depression Rating Scale (HAMD-17) Bech Subscale Score|HAMD-17 Bech subscale consists of items 1, 2, 7, 8, 10, and 13 used to evaluate core symptoms of Major Depressive Disorder (MDD). Total subscale scores range from 0 (normal) to 22 (severe).|units on a scale|Mean|13.05|13.05|Standard Deviation|2.04|2.04|||
4238412|NCT00666757|4061510|B2|||17-Item Hamilton Depression Rating Scale (HAMD-17) Bech Subscale Score|HAMD-17 Bech subscale consists of items 1, 2, 7, 8, 10, and 13 used to evaluate core symptoms of Major Depressive Disorder (MDD). Total subscale scores range from 0 (normal) to 22 (severe).|units on a scale|Mean|13.13|13.13|Standard Deviation|1.95|1.95|||
4238413|NCT00666757|4061511|B1|||17-Item Hamilton Depression Rating Scale (HAMD-17) Bech Subscale Score|HAMD-17 Bech subscale consists of items 1, 2, 7, 8, 10, and 13 used to evaluate core symptoms of Major Depressive Disorder (MDD). Total subscale scores range from 0 (normal) to 22 (severe).|units on a scale|Mean|12.97|12.97|Standard Deviation|2.13|2.13|||
4238414|NCT00666757|4061509|B3|||17-Item Hamilton Depression Rating Scale (HAMD-17) Anxiety/Somatization Subscale Score|HAMD-17 Anxiety/Somatization subscale consists of items 10, 11, 12, 13, 15, and 17 evaluates agitation, and severity of psychic and somatic manifestations of anxiety. Total subscale scores range from 0 (normal) to 18 (severe).|units on a scale|Mean|7.43|7.43|Standard Deviation|2.23|2.23|||
4238415|NCT00666757|4061510|B2|||17-Item Hamilton Depression Rating Scale (HAMD-17) Anxiety/Somatization Subscale Score|HAMD-17 Anxiety/Somatization subscale consists of items 10, 11, 12, 13, 15, and 17 evaluates agitation, and severity of psychic and somatic manifestations of anxiety. Total subscale scores range from 0 (normal) to 18 (severe).|units on a scale|Mean|7.42|7.42|Standard Deviation|2.25|2.25|||
4238416|NCT00666757|4061511|B1|||17-Item Hamilton Depression Rating Scale (HAMD-17) Anxiety/Somatization Subscale Score|HAMD-17 Anxiety/Somatization subscale consists of items 10, 11, 12, 13, 15, and 17 evaluates agitation, and severity of psychic and somatic manifestations of anxiety. Total subscale scores range from 0 (normal) to 18 (severe).|units on a scale|Mean|7.45|7.45|Standard Deviation|2.22|2.22|||
4238417|NCT00666757|4061509|B3|||History, Met Diagnosis of Major Mood Disorder (MDD)||participants|Number|750|750.0||||||
4238421|NCT00666757|4061510|B2|United States||Region of Enrollment|United States study|participants|Number|378|378.0||||||
4238422|NCT00666757|4061511|B1|United States||Region of Enrollment|United States study|participants|Number|372|372.0||||||
4238423|NCT00666757|4061509|B3|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4238424|NCT00666757|4061510|B2|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4238425|NCT00666757|4061511|B1|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4238426|NCT00666757|4061509|B3|Other||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4238427|NCT00666757|4061510|B2|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4238428|NCT00666757|4061511|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4238429|NCT00666757|4061509|B3|Western Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4238430|NCT00666757|4061510|B2|Western Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4238431|NCT00666757|4061511|B1|Western Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4238432|NCT00666757|4061509|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|111|111.0||||||
4238433|NCT00666757|4061510|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
4238434|NCT00666757|4061511|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
4238435|NCT00666757|4061509|B3|East/Southeast Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4238436|NCT00666757|4061510|B2|East/Southeast Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4238437|NCT00666757|4061511|B1|East/Southeast Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4238438|NCT00666757|4061509|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|472|472.0||||||
4238439|NCT00666757|4061510|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|241|241.0||||||
4238440|NCT00666757|4061511|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|231|231.0||||||
4238441|NCT00666757|4061509|B3|African Descent||Race/Ethnicity, Customized||participants|Number|144|144.0||||||
4238442|NCT00666757|4061510|B2|African Descent||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
4238443|NCT00666757|4061511|B1|African Descent||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
4238444|NCT00666757|4061509|B3||Male|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
4238445|NCT00666757|4061510|B2||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4238446|NCT00666757|4061511|B1||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4238447|NCT00666757|4061509|B3||Female|Sex: Female, Male||Participants|Count of Participants|496|496.0||||||
4238448|NCT00666757|4061510|B2||Female|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
4238449|NCT00666757|4061511|B1||Female|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
4238450|NCT00666757|4061509|B3|||Age||years|Mean|44.1|44.1|Standard Deviation|13.02|13.02|||
4238451|NCT00666757|4061510|B2|||Age||years|Mean|43.8|43.8|Standard Deviation|13.05|13.05|||
4238452|NCT00666757|4061511|B1|||Age||years|Mean|44.3|44.3|Standard Deviation|13.01|13.01|||
4238453|NCT00666718|4061569|B3|||Previous Insulin Treatment|The dose is calculated as the total dose from the most recently applied previous insulins before randomization.|Units (IU)|Mean|37.3|37.3|Standard Deviation|25.67|25.67|||
4238454|NCT00666718|4061570|B2|||Previous Insulin Treatment|The dose is calculated as the total dose from the most recently applied previous insulins before randomization.|Units (IU)|Mean|37.6|37.6|Standard Deviation|25.75|25.75|||
4238455|NCT00666718|4061571|B1|||Previous Insulin Treatment|The dose is calculated as the total dose from the most recently applied previous insulins before randomization.|Units (IU)|Mean|36.9|36.9|Standard Deviation|25.65|25.65|||
4238456|NCT00666718|4061569|B3|||Duration of Diabetes||Years|Mean|12.3|12.3|Standard Deviation|6.86|6.86|||
4238457|NCT00666718|4061570|B2|||Duration of Diabetes||Years|Mean|11.8|11.8|Standard Deviation|6.66|6.66|||
4238458|NCT00666718|4061571|B1|||Duration of Diabetes||Years|Mean|12.7|12.7|Standard Deviation|7.04|7.04|||
4238459|NCT00666718|4061569|B3|||Hemoglobin A1c (HbA1c)||Percent of glycosylated hemoglobin|Mean|8.82|8.82|Standard Deviation|0.894|0.894|||
4238460|NCT00666718|4061570|B2|||Hemoglobin A1c (HbA1c)||Percent of glycosylated hemoglobin|Mean|8.82|8.82|Standard Deviation|0.895|0.895|||
4238461|NCT00666718|4061571|B1|||Hemoglobin A1c (HbA1c)||Percent of glycosylated hemoglobin|Mean|8.83|8.83|Standard Deviation|0.896|0.896|||
4238462|NCT00666718|4061569|B3|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|33.13|33.13|Standard Deviation|5.017|5.017|||
4238463|NCT00666718|4061570|B2|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|33.00|33.0|Standard Deviation|5.004|5.004|||
4238464|NCT00666718|4061571|B1|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|33.27|33.27|Standard Deviation|5.040|5.04|||
4238465|NCT00666718|4061569|B3|||Body Weight||kilograms (kg)|Mean|92.06|92.06|Standard Deviation|17.161|17.161|||
4238466|NCT00666718|4061570|B2|||Body Weight||kilograms (kg)|Mean|90.60|90.6|Standard Deviation|17.075|17.075|||
4238467|NCT00666718|4061571|B1|||Body Weight||kilograms (kg)|Mean|93.53|93.53|Standard Deviation|17.168|17.168|||
4238468|NCT00666718|4061569|B3|Missing Data||Number of Insulin Injections/Inhalations Per Day|The number of insulin injections/inhalations is calculated as the sum of injections per day from the most recently applied insulins before randomization.|Participants|Number|1|1.0||||||
4238469|NCT00666718|4061570|B2|Missing Data||Number of Insulin Injections/Inhalations Per Day|The number of insulin injections/inhalations is calculated as the sum of injections per day from the most recently applied insulins before randomization.|Participants|Number|1|1.0||||||
4238470|NCT00666718|4061571|B1|Missing Data||Number of Insulin Injections/Inhalations Per Day|The number of insulin injections/inhalations is calculated as the sum of injections per day from the most recently applied insulins before randomization.|Participants|Number|0|0.0||||||
4238471|NCT00666718|4061569|B3|>=5 Insulin Injections/Inhalations per day||Number of Insulin Injections/Inhalations Per Day|The number of insulin injections/inhalations is calculated as the sum of injections per day from the most recently applied insulins before randomization.|Participants|Number|6|6.0||||||
4238472|NCT00666718|4061570|B2|>=5 Insulin Injections/Inhalations per day||Number of Insulin Injections/Inhalations Per Day|The number of insulin injections/inhalations is calculated as the sum of injections per day from the most recently applied insulins before randomization.|Participants|Number|0|0.0||||||
4238473|NCT00666718|4061571|B1|>=5 Insulin Injections/Inhalations per day||Number of Insulin Injections/Inhalations Per Day|The number of insulin injections/inhalations is calculated as the sum of injections per day from the most recently applied insulins before randomization.|Participants|Number|6|6.0||||||
4238474|NCT00666718|4061569|B3|4 Insulin Injections/Inhalations per day||Number of Insulin Injections/Inhalations Per Day|The number of insulin injections/inhalations is calculated as the sum of injections per day from the most recently applied insulins before randomization.|Participants|Number|30|30.0||||||
4238475|NCT00666718|4061570|B2|4 Insulin Injections/Inhalations per day||Number of Insulin Injections/Inhalations Per Day|The number of insulin injections/inhalations is calculated as the sum of injections per day from the most recently applied insulins before randomization.|Participants|Number|14|14.0||||||
4238476|NCT00666718|4061571|B1|4 Insulin Injections/Inhalations per day||Number of Insulin Injections/Inhalations Per Day|The number of insulin injections/inhalations is calculated as the sum of injections per day from the most recently applied insulins before randomization.|Participants|Number|16|16.0||||||
4238477|NCT00666718|4061569|B3|3 Insulin Injections/Inhalations per day||Number of Insulin Injections/Inhalations Per Day|The number of insulin injections/inhalations is calculated as the sum of injections per day from the most recently applied insulins before randomization.|Participants|Number|62|62.0||||||
4238478|NCT00666718|4061570|B2|3 Insulin Injections/Inhalations per day||Number of Insulin Injections/Inhalations Per Day|The number of insulin injections/inhalations is calculated as the sum of injections per day from the most recently applied insulins before randomization.|Participants|Number|32|32.0||||||
4238479|NCT00666718|4061571|B1|3 Insulin Injections/Inhalations per day||Number of Insulin Injections/Inhalations Per Day|The number of insulin injections/inhalations is calculated as the sum of injections per day from the most recently applied insulins before randomization.|Participants|Number|30|30.0||||||
4238480|NCT00666718|4061569|B3|2 Insulin Injections/Inhalations per day||Number of Insulin Injections/Inhalations Per Day|The number of insulin injections/inhalations is calculated as the sum of injections per day from the most recently applied insulins before randomization.|Participants|Number|65|65.0||||||
4238481|NCT00666718|4061570|B2|2 Insulin Injections/Inhalations per day||Number of Insulin Injections/Inhalations Per Day|The number of insulin injections/inhalations is calculated as the sum of injections per day from the most recently applied insulins before randomization.|Participants|Number|34|34.0||||||
4238482|NCT00666718|4061571|B1|2 Insulin Injections/Inhalations per day||Number of Insulin Injections/Inhalations Per Day|The number of insulin injections/inhalations is calculated as the sum of injections per day from the most recently applied insulins before randomization.|Participants|Number|31|31.0||||||
4238483|NCT00666718|4061569|B3|1 Insulin Injection/Inhalation per day||Number of Insulin Injections/Inhalations Per Day|The number of insulin injections/inhalations is calculated as the sum of injections per day from the most recently applied insulins before randomization.|Participants|Number|210|210.0||||||
4238484|NCT00666718|4061570|B2|1 Insulin Injection/Inhalation per day||Number of Insulin Injections/Inhalations Per Day|The number of insulin injections/inhalations is calculated as the sum of injections per day from the most recently applied insulins before randomization.|Participants|Number|106|106.0||||||
4238485|NCT00666718|4061571|B1|1 Insulin Injection/Inhalation per day||Number of Insulin Injections/Inhalations Per Day|The number of insulin injections/inhalations is calculated as the sum of injections per day from the most recently applied insulins before randomization.|Participants|Number|104|104.0||||||
4238486|NCT00666718|4061569|B3|Turkey||Region of Enrollment||participants|Number|15|15.0||||||
4238487|NCT00666718|4061570|B2|Turkey||Region of Enrollment||participants|Number|7|7.0||||||
4238488|NCT00666718|4061571|B1|Turkey||Region of Enrollment||participants|Number|8|8.0||||||
4238489|NCT00666718|4061569|B3|Slovakia||Region of Enrollment||participants|Number|34|34.0||||||
4238490|NCT00666718|4061570|B2|Slovakia||Region of Enrollment||participants|Number|12|12.0||||||
4238491|NCT00666718|4061571|B1|Slovakia||Region of Enrollment||participants|Number|22|22.0||||||
4238492|NCT00666718|4061569|B3|Romania||Region of Enrollment||participants|Number|40|40.0||||||
4238493|NCT00666718|4061570|B2|Romania||Region of Enrollment||participants|Number|25|25.0||||||
4238494|NCT00666718|4061571|B1|Romania||Region of Enrollment||participants|Number|15|15.0||||||
4238495|NCT00666718|4061569|B3|Poland||Region of Enrollment||participants|Number|75|75.0||||||
4238496|NCT00666718|4061570|B2|Poland||Region of Enrollment||participants|Number|43|43.0||||||
4238497|NCT00666718|4061571|B1|Poland||Region of Enrollment||participants|Number|32|32.0||||||
4238498|NCT00666718|4061569|B3|Italy||Region of Enrollment||participants|Number|45|45.0||||||
4238499|NCT00666718|4061570|B2|Italy||Region of Enrollment||participants|Number|26|26.0||||||
4238500|NCT00666718|4061571|B1|Italy||Region of Enrollment||participants|Number|19|19.0||||||
4238501|NCT00666718|4061569|B3|Greece||Region of Enrollment||participants|Number|27|27.0||||||
4238502|NCT00666718|4061570|B2|Greece||Region of Enrollment||participants|Number|15|15.0||||||
4238503|NCT00666718|4061571|B1|Greece||Region of Enrollment||participants|Number|12|12.0||||||
4238504|NCT00666718|4061569|B3|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
4238505|NCT00666718|4061570|B2|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4238506|NCT00666718|4061571|B1|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
4238507|NCT00666718|4061569|B3|Germany||Region of Enrollment||participants|Number|42|42.0||||||
4238508|NCT00666718|4061570|B2|Germany||Region of Enrollment||participants|Number|20|20.0||||||
4238509|NCT00666718|4061571|B1|Germany||Region of Enrollment||participants|Number|22|22.0||||||
4238511|NCT00666718|4061570|B2|Czech Republic||Region of Enrollment||participants|Number|35|35.0||||||
4238512|NCT00666718|4061571|B1|Czech Republic||Region of Enrollment||participants|Number|42|42.0||||||
4238513|NCT00666718|4061569|B3|Belgium||Region of Enrollment||participants|Number|7|7.0||||||
4238514|NCT00666718|4061570|B2|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
4238515|NCT00666718|4061571|B1|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
4238516|NCT00666718|4061569|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4238517|NCT00666718|4061570|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4238518|NCT00666718|4061571|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4238519|NCT00666718|4061569|B3|African||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4238520|NCT00666718|4061570|B2|African||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4238521|NCT00666718|4061571|B1|African||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4238522|NCT00666718|4061569|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|372|372.0||||||
4238523|NCT00666718|4061570|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|186|186.0||||||
4238524|NCT00666718|4061571|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|186|186.0||||||
4238525|NCT00666718|4061569|B3||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4238526|NCT00666718|4061570|B2||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4238527|NCT00666718|4061571|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4238528|NCT00666718|4061569|B3||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4238529|NCT00666718|4061570|B2||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4238530|NCT00666718|4061571|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4238531|NCT00666718|4061569|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|8.22|8.22|||
4238532|NCT00666718|4061570|B2|||Age||years|Mean|59.3|59.3|Standard Deviation|8.36|8.36|||
4238533|NCT00666718|4061571|B1|||Age||years|Mean|60.3|60.3|Standard Deviation|8.07|8.07|||
4238534|NCT00666705|4061598|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4238535|NCT00666705|4061598|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4238536|NCT00666705|4061598|B1|||Age||years|Mean|36.3|36.3|Standard Deviation|9.1|9.1|||
4238537|NCT00666679|4061615|B3|||Total Peripheral Blood Eosinophils||10^3/microliters|Mean|0.42|0.42|Standard Deviation|0.35|0.35|||
4238538|NCT00666679|4061616|B2|||Total Peripheral Blood Eosinophils||10^3/microliters|Mean|0.38|0.38|Standard Deviation|0.31|0.31|||
4238539|NCT00666679|4061617|B1|||Total Peripheral Blood Eosinophils||10^3/microliters|Mean|0.46|0.46|Standard Deviation|0.39|0.39|||
4238540|NCT00666679|4061615|B3|||Total Daily Beta-Agonist Use||Puffs|Mean|3.53|3.53|Standard Deviation|2.34|2.34|||
4238541|NCT00666679|4061616|B2|||Total Daily Beta-Agonist Use||Puffs|Mean|3.55|3.55|Standard Deviation|2.19|2.19|||
4238542|NCT00666679|4061617|B1|||Total Daily Beta-Agonist Use||Puffs|Mean|3.52|3.52|Standard Deviation|2.49|2.49|||
4238543|NCT00666679|4061615|B3|||Nighttime Asthma Symptom Score (0 [best] to 3 [worst] Point Scale)||Units on a Scale|Mean|0.49|0.49|Standard Deviation|0.50|0.5|||
4238544|NCT00666679|4061616|B2|||Nighttime Asthma Symptom Score (0 [best] to 3 [worst] Point Scale)||Units on a Scale|Mean|0.46|0.46|Standard Deviation|0.48|0.48|||
4238545|NCT00666679|4061617|B1|||Nighttime Asthma Symptom Score (0 [best] to 3 [worst] Point Scale)||Units on a Scale|Mean|0.51|0.51|Standard Deviation|0.53|0.53|||
4238546|NCT00666679|4061615|B3|||FEV1 (Forced Expiratory Volume in One Second)||L (Liter)|Mean|2.16|2.16|Standard Deviation|0.61|0.61|||
4238547|NCT00666679|4061616|B2|||FEV1 (Forced Expiratory Volume in One Second)||L (Liter)|Mean|2.18|2.18|Standard Deviation|0.55|0.55|||
4238548|NCT00666679|4061617|B1|||FEV1 (Forced Expiratory Volume in One Second)||L (Liter)|Mean|2.14|2.14|Standard Deviation|0.67|0.67|||
4238549|NCT00666679|4061615|B3|||Daytime Asthma Symptom Score (0 [best] to 6 [worst] Point Scale)||Units on a Scale|Mean|2.11|2.11|Standard Deviation|0.85|0.85|||
4238550|NCT00666679|4061616|B2|||Daytime Asthma Symptom Score (0 [best] to 6 [worst] Point Scale)||Units on a Scale|Mean|2.18|2.18|Standard Deviation|0.81|0.81|||
4238551|NCT00666679|4061617|B1|||Daytime Asthma Symptom Score (0 [best] to 6 [worst] Point Scale)||Units on a Scale|Mean|2.04|2.04|Standard Deviation|0.90|0.9|||
4238552|NCT00666679|4061615|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4238553|NCT00666679|4061616|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4238554|NCT00666679|4061617|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4238555|NCT00666679|4061615|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4238556|NCT00666679|4061616|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4238557|NCT00666679|4061617|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4238558|NCT00666679|4061615|B3|||Age||years|Mean|40.9|40.9|Standard Deviation|15.2|15.2|||
4238559|NCT00666679|4061616|B2|||Age||years|Mean|42.6|42.6|Standard Deviation|14.8|14.8|||
4238560|NCT00666679|4061617|B1|||Age||years|Mean|39.2|39.2|Standard Deviation|15.5|15.5|||
4238561|NCT00666666|4061638|B1|Bone/node metastases||Metastatic disease||participants|Number|52|52.0||||||
4238562|NCT00666666|4061638|B1|Visceral metastases||Metastatic disease||participants|Number|3|3.0||||||
4238563|NCT00666666|4061638|B1|Not assessed||Gleason Score|A system of grading prostate cancer tissue based on how it looks under a microscope. Gleason scores range from 2 to 10 and indicate how likely it is that a tumor will spread. A low Gleason score means the cancer tissue is similar to normal prostate tissue and the tumor is less likely to spread; a high Gleason score means the cancer tissue is very different from normal and the tumor is more likely to spread.|participants|Number|2|2.0||||||
4238609|NCT00666588|4061646|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4238564|NCT00666666|4061638|B1|Gleason Score 10||Gleason Score|A system of grading prostate cancer tissue based on how it looks under a microscope. Gleason scores range from 2 to 10 and indicate how likely it is that a tumor will spread. A low Gleason score means the cancer tissue is similar to normal prostate tissue and the tumor is less likely to spread; a high Gleason score means the cancer tissue is very different from normal and the tumor is more likely to spread.|participants|Number|3|3.0||||||
4238565|NCT00666666|4061638|B1|Gleason Score 9||Gleason Score|A system of grading prostate cancer tissue based on how it looks under a microscope. Gleason scores range from 2 to 10 and indicate how likely it is that a tumor will spread. A low Gleason score means the cancer tissue is similar to normal prostate tissue and the tumor is less likely to spread; a high Gleason score means the cancer tissue is very different from normal and the tumor is more likely to spread.|participants|Number|24|24.0||||||
4238566|NCT00666666|4061638|B1|Gleason Score 8||Gleason Score|A system of grading prostate cancer tissue based on how it looks under a microscope. Gleason scores range from 2 to 10 and indicate how likely it is that a tumor will spread. A low Gleason score means the cancer tissue is similar to normal prostate tissue and the tumor is less likely to spread; a high Gleason score means the cancer tissue is very different from normal and the tumor is more likely to spread.|participants|Number|12|12.0||||||
4238567|NCT00666666|4061638|B1|Gleason Score 7||Gleason Score|A system of grading prostate cancer tissue based on how it looks under a microscope. Gleason scores range from 2 to 10 and indicate how likely it is that a tumor will spread. A low Gleason score means the cancer tissue is similar to normal prostate tissue and the tumor is less likely to spread; a high Gleason score means the cancer tissue is very different from normal and the tumor is more likely to spread.|participants|Number|13|13.0||||||
4238568|NCT00666666|4061638|B1|Gleason Score 6||Gleason Score|A system of grading prostate cancer tissue based on how it looks under a microscope. Gleason scores range from 2 to 10 and indicate how likely it is that a tumor will spread. A low Gleason score means the cancer tissue is similar to normal prostate tissue and the tumor is less likely to spread; a high Gleason score means the cancer tissue is very different from normal and the tumor is more likely to spread.|participants|Number|1|1.0||||||
4238569|NCT00666666|4061638|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4238570|NCT00666666|4061638|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238571|NCT00666666|4061638|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238572|NCT00666666|4061638|B1||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4238573|NCT00666666|4061638|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4238574|NCT00666666|4061638|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238575|NCT00666666|4061638|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238576|NCT00666666|4061638|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238577|NCT00666666|4061638|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238578|NCT00666666|4061638|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4238579|NCT00666666|4061638|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238580|NCT00666666|4061638|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4238581|NCT00666666|4061638|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4238582|NCT00666666|4061638|B1|||Age||Years|Median|61.5|61.5|Full Range|||45.0|82.0|
4238583|NCT00666666|4061638|B1|||Age||years|Mean|62.58|62.58|Standard Deviation|8.925|8.925|||
4238584|NCT00666666|4061638|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4238585|NCT00666666|4061638|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4238586|NCT00666666|4061638|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4238587|NCT00666588|4061644|B5|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4238588|NCT00666588|4061645|B4|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4238589|NCT00666588|4061646|B3|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4238590|NCT00666588|4061647|B2|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4238591|NCT00666588|4061648|B1|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4238592|NCT00666588|4061644|B5|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4238593|NCT00666588|4061645|B4|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4238594|NCT00666588|4061646|B3|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4238595|NCT00666588|4061647|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4238596|NCT00666588|4061648|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4238597|NCT00666588|4061644|B5|United States||Region of Enrollment||participants|Number|48|48.0||||||
4238598|NCT00666588|4061645|B4|United States||Region of Enrollment||participants|Number|20|20.0||||||
4238599|NCT00666588|4061646|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4238600|NCT00666588|4061647|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4238601|NCT00666588|4061648|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4238602|NCT00666588|4061644|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4238603|NCT00666588|4061645|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4238604|NCT00666588|4061646|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238605|NCT00666588|4061647|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238606|NCT00666588|4061648|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4238607|NCT00666588|4061644|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4238608|NCT00666588|4061645|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4238610|NCT00666588|4061647|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4238611|NCT00666588|4061648|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4238612|NCT00666588|4061644|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4238613|NCT00666588|4061645|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4238614|NCT00666588|4061646|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4238615|NCT00666588|4061647|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238616|NCT00666588|4061648|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4238617|NCT00666588|4061644|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4238618|NCT00666588|4061645|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4238619|NCT00666588|4061646|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4238620|NCT00666588|4061647|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238621|NCT00666588|4061648|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4238622|NCT00666588|4061644|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238623|NCT00666588|4061645|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238624|NCT00666588|4061646|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238625|NCT00666588|4061647|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238626|NCT00666588|4061648|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238627|NCT00666588|4061644|B5||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4238628|NCT00666588|4061645|B4||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4238629|NCT00666588|4061646|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4238630|NCT00666588|4061647|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4238631|NCT00666588|4061648|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4238632|NCT00666588|4061644|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4238633|NCT00666588|4061645|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4238634|NCT00666588|4061646|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4238635|NCT00666588|4061647|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4238636|NCT00666588|4061648|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4238637|NCT00666588|4061644|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238638|NCT00666588|4061645|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238639|NCT00666588|4061646|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238640|NCT00666588|4061647|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238641|NCT00666588|4061648|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238642|NCT00666588|4061644|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4238643|NCT00666588|4061645|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4238644|NCT00666588|4061646|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4238645|NCT00666588|4061647|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4238646|NCT00666588|4061648|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4238647|NCT00666588|4061644|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238648|NCT00666588|4061645|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238649|NCT00666588|4061646|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238650|NCT00666588|4061647|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238651|NCT00666588|4061648|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238652|NCT00666588|4061644|B5||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4238653|NCT00666588|4061645|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4238654|NCT00666588|4061646|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4238655|NCT00666588|4061647|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4238656|NCT00666588|4061648|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4238657|NCT00666588|4061644|B5||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4238658|NCT00666588|4061645|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4238659|NCT00666588|4061646|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4238660|NCT00666588|4061647|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4238661|NCT00666588|4061648|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4238662|NCT00666588|4061644|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4238663|NCT00666588|4061645|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4238664|NCT00666588|4061646|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4238665|NCT00666588|4061647|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4238666|NCT00666588|4061648|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4238667|NCT00666588|4061644|B5||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4238668|NCT00666588|4061645|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4238669|NCT00666588|4061646|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4238670|NCT00666588|4061647|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4238671|NCT00666588|4061648|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4238672|NCT00666588|4061644|B5||<=18 years|Age||Participants|Count of Participants|46|46.0||||||
4238673|NCT00666588|4061645|B4||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
4238674|NCT00666588|4061646|B3||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4238675|NCT00666588|4061647|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4238676|NCT00666588|4061648|B1||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4238677|NCT00666588|4061644|B5|||Age||days|Mean|3984.06|3984.06|Standard Deviation|2081.29|2081.29|||
4238678|NCT00666588|4061645|B4|||Age||days|Mean|3365.0|3365.0|Standard Deviation|2227.99|2227.99|||
4238679|NCT00666588|4061646|B3|||Age||days|Mean|2812.5|2812.5|Standard Deviation|1769.83|1769.83|||
4238680|NCT00666588|4061647|B2|||Age||days|Mean|5637.0|5637.0|Standard Deviation|1757.39|1757.39|||
4238681|NCT00666588|4061648|B1|||Age||days|Mean|4121.72|4121.72|Standard Deviation|2569.95|2569.95|||
4238682|NCT00666562|4061681|B4|United States||Region of Enrollment||participants|Number|31|31.0||||||
4238683|NCT00666562|4061682|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4238684|NCT00666562|4061683|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4238685|NCT00666562|4061684|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4238686|NCT00666562|4061681|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238687|NCT00666562|4061682|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238688|NCT00666562|4061683|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238689|NCT00666562|4061684|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238690|NCT00666562|4061681|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238691|NCT00666562|4061682|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238692|NCT00666562|4061683|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238693|NCT00666562|4061684|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238694|NCT00666562|4061681|B4||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4238695|NCT00666562|4061682|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4238696|NCT00666562|4061683|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4238697|NCT00666562|4061684|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4238698|NCT00666562|4061681|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4238699|NCT00666562|4061682|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4238700|NCT00666562|4061683|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238701|NCT00666562|4061684|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238702|NCT00666562|4061681|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238703|NCT00666562|4061682|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238704|NCT00666562|4061683|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238705|NCT00666562|4061684|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238706|NCT00666562|4061681|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238707|NCT00666562|4061682|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238708|NCT00666562|4061683|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238709|NCT00666562|4061684|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238710|NCT00666562|4061681|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238711|NCT00666562|4061682|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238712|NCT00666562|4061683|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238713|NCT00666562|4061684|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238714|NCT00666562|4061681|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238715|NCT00666562|4061682|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238716|NCT00666562|4061683|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238717|NCT00666562|4061684|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238718|NCT00666562|4061681|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4238719|NCT00666562|4061682|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4238720|NCT00666562|4061683|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4238721|NCT00666562|4061684|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4238722|NCT00666562|4061681|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4238723|NCT00666562|4061682|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4238724|NCT00666562|4061683|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4238725|NCT00666562|4061684|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4238726|NCT00666562|4061681|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4238727|NCT00666562|4061682|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4238728|NCT00666562|4061683|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4238729|NCT00666562|4061684|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4238730|NCT00666562|4061681|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4238731|NCT00666562|4061682|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4238732|NCT00666562|4061683|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4238733|NCT00666562|4061684|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4238734|NCT00666562|4061681|B4|||Age||years|Mean|67.23|67.23|Standard Deviation|8.69|8.69|||
4238735|NCT00666562|4061682|B3|||Age||years|Mean|66.20|66.2|Standard Deviation|9.55|9.55|||
4238736|NCT00666562|4061683|B2|||Age||years|Mean|65.20|65.2|Standard Deviation|9.50|9.5|||
4238737|NCT00666562|4061684|B1|||Age||years|Mean|70.00|70.0|Standard Deviation|7.04|7.04|||
4238738|NCT00666562|4061681|B4||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4238739|NCT00666562|4061682|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4238740|NCT00666562|4061683|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4238741|NCT00666562|4061684|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4238742|NCT00666562|4061681|B4||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4238743|NCT00666562|4061682|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4238744|NCT00666562|4061683|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4238745|NCT00666562|4061684|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4238746|NCT00666562|4061681|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4238747|NCT00666562|4061682|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4238748|NCT00666562|4061683|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4238749|NCT00666562|4061684|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4238750|NCT00666536|4061731|B3||Male|Sex: Female, Male||Participants|Count of Participants|409|409.0||||||
4238751|NCT00666536|4061732|B2||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4238752|NCT00666536|4061733|B1||Male|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4238753|NCT00666536|4061731|B3||Female|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
4238754|NCT00666536|4061732|B2||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4238755|NCT00666536|4061733|B1||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4238756|NCT00666536|4061731|B3|||Age||years|Mean|54.7|54.7|Standard Deviation|10.98|10.98|||
4238757|NCT00666536|4061732|B2|||Age||years|Mean|55.0|55.0|Standard Deviation|10.98|10.98|||
4238758|NCT00666536|4061733|B1|||Age||years|Mean|54.4|54.4|Standard Deviation|10.98|10.98|||
4238759|NCT00666536|4061731|B3|>=65 years||Age, Customized||participants|Number|129|129.0||||||
4238760|NCT00666536|4061732|B2|>=65 years||Age, Customized||participants|Number|65|65.0||||||
4238761|NCT00666536|4061733|B1|>=65 years||Age, Customized||participants|Number|64|64.0||||||
4238762|NCT00666536|4061731|B3|< 65 years||Age, Customized||participants|Number|594|594.0||||||
4238763|NCT00666536|4061732|B2|< 65 years||Age, Customized||participants|Number|292|292.0||||||
4238764|NCT00666536|4061733|B1|< 65 years||Age, Customized||participants|Number|302|302.0||||||
4238765|NCT00666458|4061750|B3||Male|Sex: Female, Male||Participants|Count of Participants|392|392.0||||||
4238766|NCT00666458|4061751|B2||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4238767|NCT00666458|4061752|B1||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4238768|NCT00666458|4061750|B3||Female|Sex: Female, Male||Participants|Count of Participants|409|409.0||||||
4238769|NCT00666458|4061751|B2||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4238770|NCT00666458|4061752|B1||Female|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
4238771|NCT00666458|4061750|B3|||Age||years|Mean|58.42|58.42|Standard Deviation|10.32|10.32|||
4238772|NCT00666458|4061751|B2|||Age||years|Mean|58.07|58.07|Standard Deviation|10.51|10.51|||
4238773|NCT00666458|4061752|B1|||Age||years|Mean|58.77|58.77|Standard Deviation|10.14|10.14|||
4238774|NCT00666406|4061765|B1|Germany||Region of Enrollment||participants|Number|9|9.0||||||
4238775|NCT00666406|4061765|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4238776|NCT00666406|4061765|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4238777|NCT00666406|4061765|B1|||Age||years|Mean|37.3|37.3|Standard Deviation|14.9|14.9|||
4238778|NCT00666328|4061841|B1|||Baseline Diastolic Blood Pressure (DBP)||mm Hg|Mean|85.7|85.7|Standard Deviation|12.89|12.89|||
4238779|NCT00666328|4061841|B1|||Baseline Systolic Blood Pressure (SBP)||mm Hg|Mean|186.5|186.5|Standard Deviation|20.39|20.39|||
4238780|NCT00666328|4061841|B1|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4238781|NCT00666328|4061841|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4238782|NCT00666328|4061841|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4238783|NCT00666328|4061841|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4238784|NCT00666328|4061841|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4238785|NCT00666328|4061841|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4238840|NCT00666224|4062022|B2|Hungary||Region of Enrollment||participants|Number|15|15.0||||||
4238786|NCT00666328|4061841|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4238787|NCT00666328|4061841|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4238788|NCT00666328|4061841|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4238789|NCT00666328|4061841|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4238790|NCT00666328|4061841|B1|||Age||participants|Mean|63.9|63.9|Standard Deviation|12.14|12.14|||
4238791|NCT00666276|4061854|B1|Absent||Complications|Complications is the patient's current experiences with illnesses, operations, injuries and treatments. The physician of this survey made the diagnosis. (e.g. hypertension, diabetes, etc.)|participants|Number|73|73.0||||||
4238792|NCT00666276|4061854|B1|Present||Complications|Complications is the patient's current experiences with illnesses, operations, injuries and treatments. The physician of this survey made the diagnosis. (e.g. hypertension, diabetes, etc.)|participants|Number|897|897.0||||||
4238793|NCT00666276|4061854|B1|Severe||Target disease Severity||participants|Number|447|447.0||||||
4238794|NCT00666276|4061854|B1|Moderate||Target disease Severity||participants|Number|455|455.0||||||
4238795|NCT00666276|4061854|B1|Mild||Target disease Severity||participants|Number|68|68.0||||||
4238796|NCT00666276|4061854|B1|Other||Target disease|The physician in charge of the study made the diagnosis of Target disease based on symptoms.|participants|Number|91|91.0||||||
4238797|NCT00666276|4061854|B1|Multiple infection||Target disease|The physician in charge of the study made the diagnosis of Target disease based on symptoms.|participants|Number|141|141.0||||||
4238798|NCT00666276|4061854|B1|Pneumonia||Target disease|The physician in charge of the study made the diagnosis of Target disease based on symptoms.|participants|Number|377|377.0||||||
4238799|NCT00666276|4061854|B1|Secondary infection in injury, Burn and operative||Target disease|The physician in charge of the study made the diagnosis of Target disease based on symptoms.|participants|Number|136|136.0||||||
4238800|NCT00666276|4061854|B1|Deep-seated skin infection||Target disease|The physician in charge of the study made the diagnosis of Target disease based on symptoms.|participants|Number|33|33.0||||||
4238801|NCT00666276|4061854|B1|Sepsis||Target disease|The physician in charge of the study made the diagnosis of Target disease based on symptoms.|participants|Number|192|192.0||||||
4238802|NCT00666276|4061854|B1||Male|Sex: Female, Male||Participants|Count of Participants|662|662.0||||||
4238803|NCT00666276|4061854|B1||Female|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
4238804|NCT00666276|4061854|B1|>=65 years||Age, Customized||participants|Number|688|688.0||||||
4238805|NCT00666276|4061854|B1|<65 years||Age, Customized||participants|Number|282|282.0||||||
4238806|NCT00666263|4061878|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4238807|NCT00666263|4061878|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4238808|NCT00666263|4061878|B1|||Age||years|Mean|51.64|51.64|Standard Deviation|10.25|10.25|||
4238809|NCT00666224|4062021|B3|Did not use corticosteroids||Participants Who Used Corticosteroids for Initial Attack||participants|Number|173|173.0||||||
4238810|NCT00666224|4062022|B2|Did not use corticosteroids||Participants Who Used Corticosteroids for Initial Attack||participants|Number|79|79.0||||||
4238811|NCT00666224|4062023|B1|Did not use corticosteroids||Participants Who Used Corticosteroids for Initial Attack||participants|Number|94|94.0||||||
4238812|NCT00666224|4062021|B3|Used corticosteroids||Participants Who Used Corticosteroids for Initial Attack||participants|Number|308|308.0||||||
4238813|NCT00666224|4062022|B2|Used corticosteroids||Participants Who Used Corticosteroids for Initial Attack||participants|Number|159|159.0||||||
4238814|NCT00666224|4062023|B1|Used corticosteroids||Participants Who Used Corticosteroids for Initial Attack||participants|Number|149|149.0||||||
4238815|NCT00666224|4062021|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
4238816|NCT00666224|4062022|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4238817|NCT00666224|4062023|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4238818|NCT00666224|4062021|B3|United Kingdom||Region of Enrollment||participants|Number|27|27.0||||||
4238819|NCT00666224|4062022|B2|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
4238820|NCT00666224|4062023|B1|United Kingdom||Region of Enrollment||participants|Number|15|15.0||||||
4238821|NCT00666224|4062021|B3|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
4238822|NCT00666224|4062022|B2|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
4238823|NCT00666224|4062023|B1|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
4238824|NCT00666224|4062021|B3|Spain||Region of Enrollment||participants|Number|45|45.0||||||
4238825|NCT00666224|4062022|B2|Spain||Region of Enrollment||participants|Number|22|22.0||||||
4238826|NCT00666224|4062023|B1|Spain||Region of Enrollment||participants|Number|23|23.0||||||
4238827|NCT00666224|4062021|B3|Romania||Region of Enrollment||participants|Number|58|58.0||||||
4238828|NCT00666224|4062022|B2|Romania||Region of Enrollment||participants|Number|30|30.0||||||
4238829|NCT00666224|4062023|B1|Romania||Region of Enrollment||participants|Number|28|28.0||||||
4238830|NCT00666224|4062021|B3|Norway||Region of Enrollment||participants|Number|4|4.0||||||
4238831|NCT00666224|4062022|B2|Norway||Region of Enrollment||participants|Number|2|2.0||||||
4238832|NCT00666224|4062023|B1|Norway||Region of Enrollment||participants|Number|2|2.0||||||
4238833|NCT00666224|4062021|B3|New Zealand||Region of Enrollment||participants|Number|7|7.0||||||
4238834|NCT00666224|4062022|B2|New Zealand||Region of Enrollment||participants|Number|3|3.0||||||
4238835|NCT00666224|4062023|B1|New Zealand||Region of Enrollment||participants|Number|4|4.0||||||
4238836|NCT00666224|4062021|B3|Italy||Region of Enrollment||participants|Number|113|113.0||||||
4238837|NCT00666224|4062022|B2|Italy||Region of Enrollment||participants|Number|57|57.0||||||
4238838|NCT00666224|4062023|B1|Italy||Region of Enrollment||participants|Number|56|56.0||||||
4238839|NCT00666224|4062021|B3|Hungary||Region of Enrollment||participants|Number|31|31.0||||||
4238841|NCT00666224|4062023|B1|Hungary||Region of Enrollment||participants|Number|16|16.0||||||
4238842|NCT00666224|4062021|B3|Germany||Region of Enrollment||participants|Number|63|63.0||||||
4238843|NCT00666224|4062022|B2|Germany||Region of Enrollment||participants|Number|31|31.0||||||
4238844|NCT00666224|4062023|B1|Germany||Region of Enrollment||participants|Number|32|32.0||||||
4238845|NCT00666224|4062021|B3|France||Region of Enrollment||participants|Number|22|22.0||||||
4238846|NCT00666224|4062022|B2|France||Region of Enrollment||participants|Number|11|11.0||||||
4238847|NCT00666224|4062023|B1|France||Region of Enrollment||participants|Number|11|11.0||||||
4238848|NCT00666224|4062021|B3|Finland||Region of Enrollment||participants|Number|20|20.0||||||
4238849|NCT00666224|4062022|B2|Finland||Region of Enrollment||participants|Number|10|10.0||||||
4238850|NCT00666224|4062023|B1|Finland||Region of Enrollment||participants|Number|10|10.0||||||
4238851|NCT00666224|4062021|B3|Denmark||Region of Enrollment||participants|Number|11|11.0||||||
4238852|NCT00666224|4062022|B2|Denmark||Region of Enrollment||participants|Number|6|6.0||||||
4238853|NCT00666224|4062023|B1|Denmark||Region of Enrollment||participants|Number|5|5.0||||||
4238854|NCT00666224|4062021|B3|Austria||Region of Enrollment||participants|Number|11|11.0||||||
4238855|NCT00666224|4062022|B2|Austria||Region of Enrollment||participants|Number|6|6.0||||||
4238856|NCT00666224|4062023|B1|Austria||Region of Enrollment||participants|Number|5|5.0||||||
4238857|NCT00666224|4062021|B3|Australia||Region of Enrollment||participants|Number|13|13.0||||||
4238858|NCT00666224|4062022|B2|Australia||Region of Enrollment||participants|Number|6|6.0||||||
4238859|NCT00666224|4062023|B1|Australia||Region of Enrollment||participants|Number|7|7.0||||||
4238860|NCT00666224|4062021|B3|Argentina||Region of Enrollment||participants|Number|13|13.0||||||
4238861|NCT00666224|4062022|B2|Argentina||Region of Enrollment||participants|Number|6|6.0||||||
4238862|NCT00666224|4062023|B1|Argentina||Region of Enrollment||participants|Number|7|7.0||||||
4238863|NCT00666224|4062021|B3|Other (not specified)||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4238864|NCT00666224|4062022|B2|Other (not specified)||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4238865|NCT00666224|4062023|B1|Other (not specified)||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4238866|NCT00666224|4062021|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4238867|NCT00666224|4062022|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4238868|NCT00666224|4062023|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4238869|NCT00666224|4062021|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|462|462.0||||||
4238870|NCT00666224|4062022|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|229|229.0||||||
4238871|NCT00666224|4062023|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|233|233.0||||||
4238872|NCT00666224|4062021|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4238873|NCT00666224|4062022|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4238874|NCT00666224|4062023|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4238875|NCT00666224|4062021|B3|Asian / Oriental||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4238876|NCT00666224|4062022|B2|Asian / Oriental||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4238877|NCT00666224|4062023|B1|Asian / Oriental||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4238878|NCT00666224|4062021|B3||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4238879|NCT00666224|4062022|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4238880|NCT00666224|4062023|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4238881|NCT00666224|4062021|B3||Female|Sex: Female, Male||Participants|Count of Participants|322|322.0||||||
4238882|NCT00666224|4062022|B2||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4238883|NCT00666224|4062023|B1||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4238884|NCT00666224|4062021|B3|||Age||years|Mean|31.2|31.2|Standard Deviation|6.9|6.9|||
4238885|NCT00666224|4062022|B2|||Age||years|Mean|30.8|30.8|Standard Deviation|7.0|7.0|||
4238886|NCT00666224|4062023|B1|||Age||years|Mean|31.5|31.5|Standard Deviation|6.9|6.9|||
4238887|NCT00666224|4062021|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4238888|NCT00666224|4062022|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4238889|NCT00666224|4062023|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4238890|NCT00666224|4062021|B3||Between 18 and 65 years|Age||Participants|Count of Participants|481|481.0||||||
4238891|NCT00666224|4062022|B2||Between 18 and 65 years|Age||Participants|Count of Participants|238|238.0||||||
4238892|NCT00666224|4062023|B1||Between 18 and 65 years|Age||Participants|Count of Participants|243|243.0||||||
4238893|NCT00666224|4062021|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4238894|NCT00666224|4062022|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4238895|NCT00666224|4062023|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4238896|NCT00666211|4062041|B3|United States||Region of Enrollment||participants|Number|98|98.0||||||
4238897|NCT00666211|4062042|B2|United States||Region of Enrollment||participants|Number|56|56.0||||||
4238898|NCT00666211|4062043|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4238899|NCT00666211|4062041|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4238900|NCT00666211|4062042|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4238901|NCT00666211|4062043|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4238902|NCT00666211|4062041|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4238903|NCT00666211|4062042|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4238904|NCT00666211|4062043|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4238905|NCT00666211|4062041|B3|||Age||years|Mean|56|56.0|Standard Deviation|1|1.0|||
4238906|NCT00666211|4062042|B2|||Age||years|Mean|56.4|56.4|Standard Deviation|1|1.0|||
4238907|NCT00666211|4062043|B1|||Age||years|Mean|55.6|55.6|Standard Deviation|1|1.0|||
4238908|NCT00666211|4062041|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4238909|NCT00666211|4062042|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4238910|NCT00666211|4062043|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4238911|NCT00666211|4062041|B3||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
4238912|NCT00666211|4062042|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4238913|NCT00666211|4062043|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4238914|NCT00666211|4062041|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4238915|NCT00666211|4062042|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4238916|NCT00666211|4062043|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4238917|NCT00666198|4062062|B1|Not Classified||WHO Functional Classification of PAH|This system grades PAH severity according to the functional status of the patient. The grades range from Functional Class (FC) I, where the patient's disease does not affect their day-to-day activities, to FC IV, where patients are severely functionally impaired, even at rest. This functional classification system links symptoms with activity limitations, and allows clinicians to quickly predict disease progression and prognosis, as well as the need for specific treatment regimens, irrespective of the underlying etiology of PAH.|Participants|Number|124|124.0||||||
4238918|NCT00666198|4062062|B1|Class IV||WHO Functional Classification of PAH|This system grades PAH severity according to the functional status of the patient. The grades range from Functional Class (FC) I, where the patient's disease does not affect their day-to-day activities, to FC IV, where patients are severely functionally impaired, even at rest. This functional classification system links symptoms with activity limitations, and allows clinicians to quickly predict disease progression and prognosis, as well as the need for specific treatment regimens, irrespective of the underlying etiology of PAH.|Participants|Number|545|545.0||||||
4238919|NCT00666198|4062062|B1|Class III||WHO Functional Classification of PAH|This system grades PAH severity according to the functional status of the patient. The grades range from Functional Class (FC) I, where the patient's disease does not affect their day-to-day activities, to FC IV, where patients are severely functionally impaired, even at rest. This functional classification system links symptoms with activity limitations, and allows clinicians to quickly predict disease progression and prognosis, as well as the need for specific treatment regimens, irrespective of the underlying etiology of PAH.|Participants|Number|1279|1279.0||||||
4238920|NCT00666198|4062062|B1|Class II||WHO Functional Classification of PAH|This system grades PAH severity according to the functional status of the patient. The grades range from Functional Class (FC) I, where the patient's disease does not affect their day-to-day activities, to FC IV, where patients are severely functionally impaired, even at rest. This functional classification system links symptoms with activity limitations, and allows clinicians to quickly predict disease progression and prognosis, as well as the need for specific treatment regimens, irrespective of the underlying etiology of PAH.|Participants|Number|1012|1012.0||||||
4238921|NCT00666198|4062062|B1|Class I||WHO Functional Classification of PAH|This system grades PAH severity according to the functional status of the patient. The grades range from Functional Class (FC) I, where the patient's disease does not affect their day-to-day activities, to FC IV, where patients are severely functionally impaired, even at rest. This functional classification system links symptoms with activity limitations, and allows clinicians to quickly predict disease progression and prognosis, as well as the need for specific treatment regimens, irrespective of the underlying etiology of PAH.|Participants|Number|344|344.0||||||
4238922|NCT00666198|4062062|B1|Unknown||Disease Type|"Categorization of PAH in the study. * indicates Associated Pulmonary Arterial Hypertension (APAH). ** refers to Pulmonary Veno Occlusive Disease/Pulmonary Capillary Hemangiomatosis."|Participants|Number|1|1.0||||||
4238923|NCT00666198|4062062|B1|Other Than PAH||Disease Type|"Categorization of PAH in the study. * indicates Associated Pulmonary Arterial Hypertension (APAH). ** refers to Pulmonary Veno Occlusive Disease/Pulmonary Capillary Hemangiomatosis."|Participants|Number|665|665.0||||||
4238924|NCT00666198|4062062|B1|Other PAH (Portal Hypertention/HIV Infection etc.)||Disease Type|"Categorization of PAH in the study. * indicates Associated Pulmonary Arterial Hypertension (APAH). ** refers to Pulmonary Veno Occlusive Disease/Pulmonary Capillary Hemangiomatosis."|Participants|Number|139|139.0||||||
4238925|NCT00666198|4062062|B1|Persistent PH of the Newborn (PPHN)||Disease Type|"Categorization of PAH in the study. * indicates Associated Pulmonary Arterial Hypertension (APAH). ** refers to Pulmonary Veno Occlusive Disease/Pulmonary Capillary Hemangiomatosis."|Participants|Number|59|59.0||||||
4238926|NCT00666198|4062062|B1|PVOD/PCH**||Disease Type|"Categorization of PAH in the study. * indicates Associated Pulmonary Arterial Hypertension (APAH). ** refers to Pulmonary Veno Occlusive Disease/Pulmonary Capillary Hemangiomatosis."|Participants|Number|44|44.0||||||
4238927|NCT00666198|4062062|B1|Congenital Systemic to Pulmonary Shunts*||Disease Type|"Categorization of PAH in the study. * indicates Associated Pulmonary Arterial Hypertension (APAH). ** refers to Pulmonary Veno Occlusive Disease/Pulmonary Capillary Hemangiomatosis."|Participants|Number|985|985.0||||||
4238928|NCT00666198|4062062|B1|Collagen Vascular Disease*||Disease Type|"Categorization of PAH in the study. * indicates Associated Pulmonary Arterial Hypertension (APAH). ** refers to Pulmonary Veno Occlusive Disease/Pulmonary Capillary Hemangiomatosis."|Participants|Number|666|666.0||||||
4238929|NCT00666198|4062062|B1|Idiopathic/Familial PAH (IPAH/FPAH)||Disease Type|"Categorization of PAH in the study. * indicates Associated Pulmonary Arterial Hypertension (APAH). ** refers to Pulmonary Veno Occlusive Disease/Pulmonary Capillary Hemangiomatosis."|Participants|Number|745|745.0||||||
4238930|NCT00666198|4062062|B1|Male||Sex/Gender, Customized||Participants|Number|1247|1247.0||||||
4238931|NCT00666198|4062062|B1|Female||Sex/Gender, Customized||Participants|Number|2057|2057.0||||||
4238932|NCT00666198|4062062|B1|≥15 years||Age, Customized||Participants|Number|2254|2254.0||||||
4238933|NCT00666198|4062062|B1|˂15 years||Age, Customized||Participants|Number|1050|1050.0||||||
4238934|NCT00666198|4062062|B1|≥65 years||Age, Customized||Participants|Number|898|898.0||||||
4238935|NCT00666198|4062062|B1|˂65 years||Age, Customized||Participants|Number|2406|2406.0||||||
4238936|NCT00666029|4062075|B3|United Kingdom||Region of Enrollment||participants|Number|39|39.0||||||
4238937|NCT00666029|4062076|B2|United Kingdom||Region of Enrollment||participants|Number|19|19.0||||||
4238938|NCT00666029|4062077|B1|United Kingdom||Region of Enrollment||participants|Number|20|20.0||||||
4238939|NCT00666029|4062075|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4238940|NCT00666029|4062076|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4238941|NCT00666029|4062077|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4238942|NCT00666029|4062075|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4238943|NCT00666029|4062076|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4238944|NCT00666029|4062077|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4238945|NCT00666029|4062075|B3|||Age||years|Mean|51.4|51.4|Standard Deviation|9.0|9.0|||
4238946|NCT00666029|4062076|B2|||Age||years|Mean|51.4|51.4|Standard Deviation|9.0|9.0|||
4238947|NCT00666029|4062077|B1|||Age||years|Mean|51.4|51.4|Standard Deviation|9.0|9.0|||
4238948|NCT00666029|4062075|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4238949|NCT00666029|4062076|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4238950|NCT00666029|4062077|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4238951|NCT00666029|4062075|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4238952|NCT00666029|4062076|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4238953|NCT00666029|4062077|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4238954|NCT00666029|4062075|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4238955|NCT00666029|4062076|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4238956|NCT00666029|4062077|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4238957|NCT00665925|4062086|B5||Male|Sex: Female, Male|Please note, baseline data were only calculated for the placebo qd and placebo bid groups. Data from the placebo groups were only pooled for the efficacy analyses.|Participants|Count of Participants|67|67.0||||||
4238958|NCT00665925|4062087|B4||Male|Sex: Female, Male|Please note, baseline data were only calculated for the placebo qd and placebo bid groups. Data from the placebo groups were only pooled for the efficacy analyses.|Participants|Count of Participants|21|21.0||||||
4238959|NCT00665925|4062088|B3||Male|Sex: Female, Male|Please note, baseline data were only calculated for the placebo qd and placebo bid groups. Data from the placebo groups were only pooled for the efficacy analyses.|Participants|Count of Participants|24|24.0||||||
4238960|NCT00665925|4062089|B2||Male|Sex: Female, Male|Please note, baseline data were only calculated for the placebo qd and placebo bid groups. Data from the placebo groups were only pooled for the efficacy analyses.|Participants|Count of Participants|12|12.0||||||
4238961|NCT00665925|4062090|B1||Male|Sex: Female, Male|Please note, baseline data were only calculated for the placebo qd and placebo bid groups. Data from the placebo groups were only pooled for the efficacy analyses.|Participants|Count of Participants|10|10.0||||||
4238962|NCT00665925|4062086|B5||Female|Sex: Female, Male|Please note, baseline data were only calculated for the placebo qd and placebo bid groups. Data from the placebo groups were only pooled for the efficacy analyses.|Participants|Count of Participants|390|390.0||||||
4238963|NCT00665925|4062087|B4||Female|Sex: Female, Male|Please note, baseline data were only calculated for the placebo qd and placebo bid groups. Data from the placebo groups were only pooled for the efficacy analyses.|Participants|Count of Participants|131|131.0||||||
4238964|NCT00665925|4062088|B3||Female|Sex: Female, Male|Please note, baseline data were only calculated for the placebo qd and placebo bid groups. Data from the placebo groups were only pooled for the efficacy analyses.|Participants|Count of Participants|128|128.0||||||
4238965|NCT00665925|4062089|B2||Female|Sex: Female, Male|Please note, baseline data were only calculated for the placebo qd and placebo bid groups. Data from the placebo groups were only pooled for the efficacy analyses.|Participants|Count of Participants|64|64.0||||||
4238966|NCT00665925|4062090|B1||Female|Sex: Female, Male|Please note, baseline data were only calculated for the placebo qd and placebo bid groups. Data from the placebo groups were only pooled for the efficacy analyses.|Participants|Count of Participants|67|67.0||||||
4238967|NCT00665925|4062086|B5|||Age|Please note, baseline data were only calculated for the placebo qd and placebo bid groups. Data from the placebo groups were only pooled for the efficacy analyses.|Years|Mean|52.5|52.5|Standard Deviation|12.80|12.8|||
4238968|NCT00665925|4062087|B4|||Age|Please note, baseline data were only calculated for the placebo qd and placebo bid groups. Data from the placebo groups were only pooled for the efficacy analyses.|Years|Mean|52.5|52.5|Standard Deviation|12.97|12.97|||
4238969|NCT00665925|4062088|B3|||Age|Please note, baseline data were only calculated for the placebo qd and placebo bid groups. Data from the placebo groups were only pooled for the efficacy analyses.|Years|Mean|52.6|52.6|Standard Deviation|12.31|12.31|||
4238970|NCT00665925|4062089|B2|||Age|Please note, baseline data were only calculated for the placebo qd and placebo bid groups. Data from the placebo groups were only pooled for the efficacy analyses.|Years|Mean|53.4|53.4|Standard Deviation|12.66|12.66|||
4238971|NCT00665925|4062090|B1|||Age|Please note, baseline data were only calculated for the placebo qd and placebo bid groups. Data from the placebo groups were only pooled for the efficacy analyses.|Years|Mean|51.3|51.3|Standard Deviation|13.68|13.68|||
4238972|NCT00665847|4062504|B1|>=12 to <18 years||Age Customized||participants|Number|60|60.0||||||
4238973|NCT00665847|4062504|B1|>=6 to <12 years||Age Customized||participants|Number|41|41.0||||||
4238974|NCT00665847|4062504|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4238975|NCT00665847|4062504|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4238976|NCT00665847|4062504|B1|||Age||years|Mean|12.2|12.2|Standard Deviation|2.99|2.99|||
4238977|NCT00665704|4062516|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4238978|NCT00665704|4062516|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4238979|NCT00665704|4062516|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4238980|NCT00665704|4062516|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4238981|NCT00665704|4062516|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4238982|NCT00665704|4062516|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4238983|NCT00665704|4062516|B1|||Age||years|Mean|48|48.0|Full Range|||29.0|63.0|
4238984|NCT00665652|4062521|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4238985|NCT00665652|4062521|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4238986|NCT00665652|4062521|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4238987|NCT00665652|4062521|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4238988|NCT00665652|4062521|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4238989|NCT00665652|4062521|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4238990|NCT00665652|4062521|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4238991|NCT00665652|4062521|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4238992|NCT00665652|4062521|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4238993|NCT00665626|4062525|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4238994|NCT00665626|4062526|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4238995|NCT00665626|4062527|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4238996|NCT00665626|4062525|B3||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4238997|NCT00665626|4062526|B2||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4238998|NCT00665626|4062527|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4238999|NCT00665626|4062525|B3|||Age||Years|Mean|56.0|56.0|Standard Deviation|11.71|11.71|||
4239000|NCT00665626|4062526|B2|||Age||Years|Mean|56.0|56.0|Standard Deviation|11.45|11.45|||
4239001|NCT00665626|4062527|B1|||Age||Years|Mean|56.0|56.0|Standard Deviation|12.29|12.29|||
4239002|NCT00665470|4062594|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4239003|NCT00665470|4062596|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4239004|NCT00665470|4062594|B3|Unknown or Not Reported||Race (NIH/OMB)||Participants|Number|0|0.0||||||
4239005|NCT00665470|4062596|B1|Unknown or Not Reported||Race (NIH/OMB)||Participants|Number|0|0.0||||||
4239006|NCT00665470|4062594|B3|More than one race||Race (NIH/OMB)||Participants|Number|0|0.0||||||
4239007|NCT00665470|4062596|B1|More than one race||Race (NIH/OMB)||Participants|Number|0|0.0||||||
4239008|NCT00665470|4062594|B3|White||Race (NIH/OMB)||Participants|Number|9|9.0||||||
4239009|NCT00665470|4062596|B1|White||Race (NIH/OMB)||Participants|Number|9|9.0||||||
4239010|NCT00665470|4062594|B3|Black or African American||Race (NIH/OMB)||Participants|Number|1|1.0||||||
4239011|NCT00665470|4062596|B1|Black or African American||Race (NIH/OMB)||Participants|Number|1|1.0||||||
4239012|NCT00665470|4062594|B3|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||Participants|Number|0|0.0||||||
4239013|NCT00665470|4062596|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||Participants|Number|0|0.0||||||
4239014|NCT00665470|4062594|B3|Asian||Race (NIH/OMB)||Participants|Number|0|0.0||||||
4239015|NCT00665470|4062596|B1|Asian||Race (NIH/OMB)||Participants|Number|0|0.0||||||
4239016|NCT00665470|4062594|B3|American Indian or Alaska Native||Race (NIH/OMB)||Participants|Number|0|0.0||||||
4239017|NCT00665470|4062596|B1|American Indian or Alaska Native||Race (NIH/OMB)||Participants|Number|0|0.0||||||
4239018|NCT00665470|4062594|B3|Unknown or Not Reported||Ethnicity (NIH/OMB)||Participants|Number|0|0.0||||||
4239019|NCT00665470|4062596|B1|Unknown or Not Reported||Ethnicity (NIH/OMB)||Participants|Number|0|0.0||||||
4239020|NCT00665470|4062594|B3|Not Hispanic or Latino||Ethnicity (NIH/OMB)||Participants|Number|10|10.0||||||
4239021|NCT00665470|4062596|B1|Not Hispanic or Latino||Ethnicity (NIH/OMB)||Participants|Number|10|10.0||||||
4239022|NCT00665470|4062594|B3|Hispanic or Latino||Ethnicity (NIH/OMB)||Participants|Number|0|0.0||||||
4239023|NCT00665470|4062596|B1|Hispanic or Latino||Ethnicity (NIH/OMB)||Participants|Number|0|0.0||||||
4239024|NCT00665470|4062594|B3|Male||Gender||participants|Number|8|8.0||||||
4239025|NCT00665470|4062596|B1|Male||Gender||participants|Number|8|8.0||||||
4239026|NCT00665470|4062594|B3|Female||Gender||participants|Number|2|2.0||||||
4239027|NCT00665470|4062596|B1|Female||Gender||participants|Number|2|2.0||||||
4239028|NCT00665470|4062594|B3|||Age||years|Mean|54.36|54.36|Standard Deviation|9.23|9.23|||
4239029|NCT00665470|4062596|B1|||Age||years|Mean|54.36|54.36|Standard Deviation|9.23|9.23|||
4239030|NCT00665470|4062594|B3|>=65 years||Age||participants|Number|1|1.0||||||
4239031|NCT00665470|4062596|B1|>=65 years||Age||participants|Number|1|1.0||||||
4239032|NCT00665470|4062594|B3|Between 18 and 65 years||Age||participants|Number|9|9.0||||||
4239033|NCT00665470|4062596|B1|Between 18 and 65 years||Age||participants|Number|9|9.0||||||
4239034|NCT00665470|4062594|B3|<=18 years||Age||participants|Number|0|0.0||||||
4239035|NCT00665470|4062596|B1|<=18 years||Age||participants|Number|0|0.0||||||
4239036|NCT00665457|4062605|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4239037|NCT00665457|4062605|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4239038|NCT00665457|4062605|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4239039|NCT00665457|4062605|B1|||Age||years|Mean|46.3|46.3|Full Range|||40.0|58.0|
4239040|NCT00665444|4062610|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4239041|NCT00665444|4062610|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4239042|NCT00665444|4062610|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4239043|NCT00665444|4062610|B1|||Age||years|Mean|56.7|56.7|Standard Deviation|4.7|4.7|||
4239044|NCT00665444|4062610|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4239045|NCT00665444|4062610|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4239046|NCT00665444|4062610|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4239047|NCT00665431|4062619|B4||Male|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4239048|NCT00665431|4062620|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4239049|NCT00665431|4062621|B2||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4239050|NCT00665431|4062622|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4239051|NCT00665431|4062619|B4||Female|Sex: Female, Male||Participants|Count of Participants|388|388.0||||||
4239052|NCT00665431|4062620|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4239053|NCT00665431|4062621|B2||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4239054|NCT00665431|4062622|B1||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4239055|NCT00665431|4062619|B4|||Age||years|Mean|61.9|61.9|Standard Deviation|8.5|8.5|||
4239056|NCT00665431|4062620|B3|||Age||years|Mean|61.6|61.6|Standard Deviation|8.7|8.7|||
4239057|NCT00665431|4062621|B2|||Age||years|Mean|62.3|62.3|Standard Deviation|8.4|8.4|||
4239058|NCT00665431|4062622|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|8.6|8.6|||
4239059|NCT00665366|4062665|B3|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4239060|NCT00665366|4062666|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4239061|NCT00665366|4062667|B1|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4239062|NCT00665366|4062665|B3|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4239063|NCT00665366|4062666|B2|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4239064|NCT00665366|4062667|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4239065|NCT00665366|4062665|B3|Black/African American||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4239066|NCT00665366|4062666|B2|Black/African American||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4239067|NCT00665366|4062667|B1|Black/African American||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4239068|NCT00665366|4062665|B3|White||Race/Ethnicity, Customized||Participants|Number|351|351.0||||||
4239069|NCT00665366|4062666|B2|White||Race/Ethnicity, Customized||Participants|Number|172|172.0||||||
4239070|NCT00665366|4062667|B1|White||Race/Ethnicity, Customized||Participants|Number|179|179.0||||||
4239071|NCT00665366|4062665|B3||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4239072|NCT00665366|4062666|B2||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4239073|NCT00665366|4062667|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4239074|NCT00665366|4062665|B3||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4239075|NCT00665366|4062666|B2||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4239076|NCT00665366|4062667|B1||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4239077|NCT00665366|4062665|B3|||Age||Years|Mean|44.65|44.65|Standard Deviation|12.57|12.57|||
4239078|NCT00665366|4062666|B2|||Age||Years|Mean|44.37|44.37|Standard Deviation|12.13|12.13|||
4239079|NCT00665366|4062667|B1|||Age||Years|Mean|44.92|44.92|Standard Deviation|12.99|12.99|||
4239080|NCT00665353|4062696|B1|Detectable after >= 22 and < 30 weeks||Prior hepatitis C virus (HCV) non-response type||participants|Number|6|6.0||||||
4239081|NCT00665353|4062696|B1|< 2 log10 drop AND detectable >= 10 and < 22 weeks||Prior hepatitis C virus (HCV) non-response type||participants|Number|13|13.0||||||
4239082|NCT00665353|4062696|B1|||Homeostasis Model of Assessment - Insulin Resistance (HOMA-IR)||mg/dL x mIU/L / 405|Mean|6.3|6.3|Standard Deviation|3.5|3.5|||
4239083|NCT00665353|4062696|B1|||Fasting insulin||mIU/L|Mean|25|25.0|Standard Deviation|13|13.0|||
4239084|NCT00665353|4062696|B1|||Fasting glucose||mg/dL|Mean|100|100.0|Standard Deviation|12|12.0|||
4239085|NCT00665353|4062696|B1|||Gamma-glutamyl transferase|N=14, 5 had missing results.|U/L|Mean|154|154.0|Standard Deviation|127|127.0|||
4239086|NCT00665353|4062696|B1|||Aspartate Aminotransferase (AST)||* ULN|Mean|1.5|1.5|Standard Deviation|0.9|0.9|||
4239087|NCT00665353|4062696|B1|||Alanine Aminotransferase (ALT)||* ULN|Mean|1.4|1.4|Standard Deviation|1.2|1.2|||
4239088|NCT00665353|4062696|B1|||Direct bilirubin||* ULN|Mean|1.0|1.0|Standard Deviation|0.6|0.6|||
4239089|NCT00665353|4062696|B1|||Platelets||cells/mm^3|Mean|185842|185842.0|Standard Deviation|67375|67375.0|||
4239090|NCT00665353|4062696|B1|||Absolute neutrophil count||cells/mm^3|Mean|2501|2501.0|Standard Deviation|1031|1031.0|||
4239091|NCT00665353|4062696|B1|||Hemoglobin||g/dL|Mean|14.4|14.4|Standard Deviation|1.5|1.5|||
4239092|NCT00665353|4062696|B1|||Thyrotropin|N=17, 2 were missing results|mIU/L|Mean|1.49|1.49|Standard Deviation|0.67|0.67|||
4239093|NCT00665353|4062696|B1|> 500 cells/mm^3||Nadir CD4 count||participants|Number|1|1.0||||||
4239094|NCT00665353|4062696|B1|201 - 500 cells/mm^3||Nadir CD4 count||participants|Number|6|6.0||||||
4239095|NCT00665353|4062696|B1|101 - 200 cells/mm^3||Nadir CD4 count||participants|Number|4|4.0||||||
4239096|NCT00665353|4062696|B1|51 - 100 cells/mm^3||Nadir CD4 count||participants|Number|4|4.0||||||
4239097|NCT00665353|4062696|B1|<= 50 cells/mm^3||Nadir CD4 count||participants|Number|4|4.0||||||
4239098|NCT00665353|4062696|B1|||CD4 count||cells/mm^3|Mean|567|567.0|Standard Deviation|192|192.0|||
4239099|NCT00665353|4062696|B1|100 - 499 copies/mL||HIV-1 RNA||participants|Number|2|2.0||||||
4239100|NCT00665353|4062696|B1|50 - 99 copies/mL||HIV-1 RNA||participants|Number|2|2.0||||||
4239101|NCT00665353|4062696|B1|< 50 copies/mL||HIV-1 RNA||participants|Number|15|15.0||||||
4239102|NCT00665353|4062696|B1|||Body Mass Index (BMI)|Body Mass Index (weight in kilograms divided by height in meters squared)|kg/m^2|Mean|27.7|27.7|Standard Deviation|4.1|4.1|||
4239103|NCT00665353|4062696|B1|Previously||IV drug history|Self-reported|participants|Number|12|12.0||||||
4239104|NCT00665353|4062696|B1|Never||IV drug history|Self-reported|participants|Number|7|7.0||||||
4239105|NCT00665353|4062696|B1|60 - 69 years||Age||participants|Number|1|1.0||||||
4239106|NCT00665353|4062696|B1|50 - 59 years||Age||participants|Number|8|8.0||||||
4239107|NCT00665353|4062696|B1|40 - 49 years||Age||participants|Number|9|9.0||||||
4239108|NCT00665353|4062696|B1|30 - 39 years||Age||participants|Number|1|1.0||||||
4239109|NCT00665353|4062696|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4239110|NCT00665353|4062696|B1|Hispanic (regardless of race)||Race/Ethnicity, Customized|Derived from self-reported race and ethnicity.|participants|Number|2|2.0||||||
4239111|NCT00665353|4062696|B1|Black non-Hispanic||Race/Ethnicity, Customized|Derived from self-reported race and ethnicity.|participants|Number|9|9.0||||||
4239112|NCT00665353|4062696|B1|White non-Hispanic||Race/Ethnicity, Customized|Derived from self-reported race and ethnicity.|participants|Number|8|8.0||||||
4239113|NCT00665353|4062696|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4239114|NCT00665353|4062696|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4239115|NCT00665353|4062696|B1|||Age||years|Mean|49|49.0|Standard Deviation|7|7.0|||
4239116|NCT00665132|4062706|B1|||Average pain level|Brief Pain Inventory (BPI) is an 11-point numerical rating scale (NRS) used to rate pain intensity, where zero (0) indicates ‘‘no pain’’ and 10 indicates ‘‘pain as bad as you can imagine.’’ At enrollment, participants circled the number that best described how much baseline pain they had 'on average' (mean score).|units on a scale|Mean|6.7|6.7|Standard Deviation|1.6|1.6|||
4239117|NCT00665132|4062706|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4239118|NCT00665132|4062706|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4239119|NCT00665132|4062706|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4239120|NCT00665132|4062706|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4239121|NCT00665132|4062706|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4239122|NCT00665132|4062706|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4239123|NCT00665132|4062706|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4239124|NCT00665132|4062706|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4239125|NCT00665132|4062706|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4239126|NCT00665132|4062706|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4239127|NCT00665132|4062706|B1|||Age||years|Mean|53.7|53.7|Standard Deviation|7.7|7.7|||
4239128|NCT00665002|4062713|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4239129|NCT00665002|4062713|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4239130|NCT00665002|4062713|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4239131|NCT00665002|4062713|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4239132|NCT00665002|4062713|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4239133|NCT00665002|4062713|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4239134|NCT00665002|4062713|B1|||Age||years|Mean|73|73.0|Full Range|||65.0|82.0|
4239135|NCT00664755|4062718|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4239136|NCT00664755|4062719|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4239137|NCT00664755|4062720|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4239138|NCT00664755|4062718|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4239139|NCT00664755|4062719|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4239140|NCT00664755|4062720|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4239141|NCT00664755|4062718|B3||White|Race (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
4239142|NCT00664755|4062719|B2||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4239143|NCT00664755|4062720|B1||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4239144|NCT00664755|4062718|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4239145|NCT00664755|4062719|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4239146|NCT00664755|4062720|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4239147|NCT00664755|4062718|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4239148|NCT00664755|4062719|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4239149|NCT00664755|4062720|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4239150|NCT00664755|4062718|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4239151|NCT00664755|4062719|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4239152|NCT00664755|4062720|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4239153|NCT00664755|4062718|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4239154|NCT00664755|4062719|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4239155|NCT00664755|4062720|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4239156|NCT00664755|4062718|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4239157|NCT00664755|4062719|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4239158|NCT00664755|4062720|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4239159|NCT00664755|4062718|B3||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4239160|NCT00664755|4062719|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4239161|NCT00664755|4062720|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4239162|NCT00664755|4062718|B3|||Age||years|Mean|31.9|31.9|Standard Deviation|7.7|7.7|||
4239163|NCT00664755|4062719|B2|||Age||years|Mean|33.0|33.0|Standard Deviation|7.4|7.4|||
4239164|NCT00664755|4062720|B1|||Age||years|Mean|30.7|30.7|Standard Deviation|7.9|7.9|||
4239165|NCT00664742|4062727|B1|Gender not recorded||Sex/Gender, Customized||participants|Number|3|3.0||||||
4239166|NCT00664742|4062727|B1|Male||Sex/Gender, Customized||participants|Number|183|183.0||||||
4239167|NCT00664742|4062727|B1|Female||Sex/Gender, Customized||participants|Number|421|421.0||||||
4239168|NCT00664742|4062727|B1|||Age||years|Mean|54|54.0|Standard Deviation|10|10.0|||
4239169|NCT00664560|4062732|B4||Male|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4239170|NCT00664560|4062733|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4239171|NCT00664560|4062734|B2||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4239172|NCT00664560|4062735|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4239173|NCT00664560|4062732|B4||Female|Sex: Female, Male||Participants|Count of Participants|392|392.0||||||
4239174|NCT00664560|4062733|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4239175|NCT00664560|4062734|B2||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4239176|NCT00664560|4062735|B1||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4239177|NCT00664560|4062732|B4|||Age||years|Mean|61.9|61.9|Standard Deviation|7.9|7.9|||
4239178|NCT00664560|4062733|B3|||Age||years|Mean|61.6|61.6|Standard Deviation|8.2|8.2|||
4239179|NCT00664560|4062734|B2|||Age||years|Mean|61.5|61.5|Standard Deviation|8.0|8.0|||
4239180|NCT00664560|4062735|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|7.7|7.7|||
4239181|NCT00664534|4062778|B3|||Glycosylated Hemoglobin (HbA1c)||percent glycosylated hemoglobin|Mean|9.02|9.02|Standard Deviation|0.966|0.966|||
4239182|NCT00664534|4062779|B2|||Glycosylated Hemoglobin (HbA1c)||percent glycosylated hemoglobin|Mean|8.98|8.98|Standard Deviation|0.945|0.945|||
4239183|NCT00664534|4062780|B1|||Glycosylated Hemoglobin (HbA1c)||percent glycosylated hemoglobin|Mean|9.07|9.07|Standard Deviation|0.988|0.988|||
4239184|NCT00664534|4062778|B3|Brazil||Region of Enrollment||participants|Number|13|13.0||||||
4239185|NCT00664534|4062779|B2|Brazil||Region of Enrollment||participants|Number|5|5.0||||||
4239186|NCT00664534|4062780|B1|Brazil||Region of Enrollment||participants|Number|8|8.0||||||
4239187|NCT00664534|4062778|B3|India||Region of Enrollment||participants|Number|58|58.0||||||
4239188|NCT00664534|4062779|B2|India||Region of Enrollment||participants|Number|28|28.0||||||
4239189|NCT00664534|4062780|B1|India||Region of Enrollment||participants|Number|30|30.0||||||
4239190|NCT00664534|4062778|B3|Turkey||Region of Enrollment||participants|Number|26|26.0||||||
4239191|NCT00664534|4062779|B2|Turkey||Region of Enrollment||participants|Number|13|13.0||||||
4239192|NCT00664534|4062780|B1|Turkey||Region of Enrollment||participants|Number|13|13.0||||||
4239193|NCT00664534|4062778|B3|Romania||Region of Enrollment||participants|Number|50|50.0||||||
4239194|NCT00664534|4062779|B2|Romania||Region of Enrollment||participants|Number|25|25.0||||||
4239195|NCT00664534|4062780|B1|Romania||Region of Enrollment||participants|Number|25|25.0||||||
4239196|NCT00664534|4062778|B3|Spain||Region of Enrollment||participants|Number|40|40.0||||||
4239197|NCT00664534|4062779|B2|Spain||Region of Enrollment||participants|Number|22|22.0||||||
4239198|NCT00664534|4062780|B1|Spain||Region of Enrollment||participants|Number|18|18.0||||||
4239199|NCT00664534|4062778|B3|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4239200|NCT00664534|4062779|B2|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4239201|NCT00664534|4062780|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4239202|NCT00664534|4062778|B3|Mexico||Region of Enrollment||participants|Number|71|71.0||||||
4239203|NCT00664534|4062779|B2|Mexico||Region of Enrollment||participants|Number|33|33.0||||||
4239204|NCT00664534|4062780|B1|Mexico||Region of Enrollment||participants|Number|38|38.0||||||
4239205|NCT00664534|4062778|B3|Egypt||Region of Enrollment||participants|Number|64|64.0||||||
4239206|NCT00664534|4062779|B2|Egypt||Region of Enrollment||participants|Number|33|33.0||||||
4239207|NCT00664534|4062780|B1|Egypt||Region of Enrollment||participants|Number|31|31.0||||||
4239208|NCT00664534|4062778|B3|Portugal||Region of Enrollment||participants|Number|15|15.0||||||
4239209|NCT00664534|4062779|B2|Portugal||Region of Enrollment||participants|Number|8|8.0||||||
4239210|NCT00664534|4062780|B1|Portugal||Region of Enrollment||participants|Number|7|7.0||||||
4239211|NCT00664534|4062778|B3|West Asian||Race/Ethnicity, Customized||Participants|Number|38|38.0||||||
4239212|NCT00664534|4062779|B2|West Asian||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4239213|NCT00664534|4062780|B1|West Asian||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4239214|NCT00664534|4062778|B3|East Asian||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
4239215|NCT00664534|4062779|B2|East Asian||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4239216|NCT00664534|4062780|B1|East Asian||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4239217|NCT00664534|4062778|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|84|84.0||||||
4239218|NCT00664534|4062779|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
4239219|NCT00664534|4062780|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|44|44.0||||||
4239220|NCT00664534|4062778|B3|African||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4239221|NCT00664534|4062779|B2|African||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4239222|NCT00664534|4062780|B1|African||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4239223|NCT00664534|4062778|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|198|198.0||||||
4239224|NCT00664534|4062779|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|101|101.0||||||
4239225|NCT00664534|4062780|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|97|97.0||||||
4239226|NCT00664534|4062778|B3||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4239227|NCT00664534|4062779|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4239228|NCT00664534|4062780|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4239229|NCT00664534|4062778|B3||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4239230|NCT00664534|4062779|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4239231|NCT00664534|4062780|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4239232|NCT00664534|4062778|B3|||Age||years|Mean|54.29|54.29|Standard Deviation|8.770|8.77|||
4239233|NCT00664534|4062779|B2|||Age||years|Mean|54.33|54.33|Standard Deviation|8.944|8.944|||
4239234|NCT00664534|4062780|B1|||Age||years|Mean|54.24|54.24|Standard Deviation|8.621|8.621|||
4239235|NCT00664521|4062807|B3||Male|Gender||Participants|Count of Participants|7|7.0||||||
4239236|NCT00664521|4062808|B2||Male|Gender||Participants|Count of Participants|1|1.0||||||
4239237|NCT00664521|4062809|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
4239238|NCT00664521|4062807|B3||Female|Gender||Participants|Count of Participants|20|20.0||||||
4239239|NCT00664521|4062808|B2||Female|Gender||Participants|Count of Participants|8|8.0||||||
4239240|NCT00664521|4062809|B1||Female|Gender||Participants|Count of Participants|12|12.0||||||
4239241|NCT00664521|4062807|B3|||Age||years|Mean|57.2|57.2|Standard Deviation|11.0|11.0|||
4239242|NCT00664521|4062808|B2|||Age||years|Mean|57.7|57.7|Standard Deviation|11.5|11.5|||
4239243|NCT00664521|4062809|B1|||Age||years|Mean|57.0|57.0|Standard Deviation|11.0|11.0|||
4239244|NCT00664430|4062830|B1|Brazil||Region of Enrollment||participants|Number|13|13.0||||||
4239245|NCT00664430|4062830|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4239246|NCT00664430|4062830|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4239247|NCT00664430|4062830|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4239248|NCT00664430|4062830|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4239249|NCT00664430|4062830|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4239250|NCT00664326|4062836|B1||Intermediate|Overall Motzer Score|The Motzer score (high/poor risk, intermediate risk, low risk) is based on the number of the following poor prognostic features a participant possessed: ECOG >2, serum lactate dehydrogenase concentration > 1.5 times the upper limit of normal, hemoglobin < lower limit of normal, corrected calcium concentration > 10 mg/dl, and absence of prior nephrectomy. Participants who had none of these features = low risk; participants with 1 or 2 of these features = intermediate risk; participants with 3 or more of these features = high/poor risk and were excluded from participating in the study.|Participants|Count of Participants|25|25.0||||||
4239251|NCT00664326|4062836|B1||Low|Overall Motzer Score|The Motzer score (high/poor risk, intermediate risk, low risk) is based on the number of the following poor prognostic features a participant possessed: ECOG >2, serum lactate dehydrogenase concentration > 1.5 times the upper limit of normal, hemoglobin < lower limit of normal, corrected calcium concentration > 10 mg/dl, and absence of prior nephrectomy. Participants who had none of these features = low risk; participants with 1 or 2 of these features = intermediate risk; participants with 3 or more of these features = high/poor risk and were excluded from participating in the study.|Participants|Count of Participants|24|24.0||||||
4239252|NCT00664326|4062836|B1||1|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS ranged from Grades 0 to 5 (death). Grade 0 (fully active, able to carry on all pre-diseases performance without restriction) and Grade 1 (restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature) were inclusion criteria.|Participants|Count of Participants|19|19.0||||||
4239253|NCT00664326|4062836|B1||0|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS ranged from Grades 0 to 5 (death). Grade 0 (fully active, able to carry on all pre-diseases performance without restriction) and Grade 1 (restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature) were inclusion criteria.|Participants|Count of Participants|30|30.0||||||
4239254|NCT00664326|4062836|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4239255|NCT00664326|4062836|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4239256|NCT00664326|4062836|B1|||Age||Years|Median|62.0|62.0|Full Range|||40.0|76.0|
4239257|NCT00664209|4062855|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4239258|NCT00664209|4062855|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4239259|NCT00664209|4062855|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4239260|NCT00664209|4062855|B1|||Age||years|Mean|62.4|62.4|Full Range|||51.0|73.0|
4239261|NCT00664105|4062863|B1|United States||Region of Enrollment||participants|Number|63|63.0||||||
4239262|NCT00664105|4062863|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4239263|NCT00664105|4062863|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4239264|NCT00664105|4062863|B1|||Age||years|Mean|63|63.0|Standard Deviation|1|1.0|||
4239265|NCT00664105|4062863|B1||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4239266|NCT00664105|4062863|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4239267|NCT00664105|4062863|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4239268|NCT00664066|4062870|B1|Germany||Region of Enrollment||participants|Number|3|3.0||||||
4239269|NCT00664066|4062870|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4239270|NCT00664066|4062870|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4239271|NCT00664066|4062870|B1|||Age||years|Mean|57.0|57.0|Full Range|0.0|0.0|57.0|57.0|
4239272|NCT00664066|4062870|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4239273|NCT00664066|4062870|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4239274|NCT00664066|4062870|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4239275|NCT00663962|4062874|B3|Canada||Region of Enrollment||participants|Number|15|15.0||||||
4239276|NCT00663962|4062875|B2|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4239277|NCT00663962|4062876|B1|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4239278|NCT00663962|4062874|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4239279|NCT00663962|4062875|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4239280|NCT00663962|4062876|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4239281|NCT00663962|4062874|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4239282|NCT00663962|4062875|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4239283|NCT00663962|4062876|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4239284|NCT00663962|4062874|B3|||Age||years|Mean|57.6|57.6|Standard Deviation|17.7|17.7|||
4239285|NCT00663962|4062875|B2|||Age||years|Mean|55.0|55.0|Standard Deviation|18.6|18.6|||
4239286|NCT00663962|4062876|B1|||Age||years|Mean|60.6|60.6|Standard Deviation|17.6|17.6|||
4239287|NCT00663962|4062874|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4239288|NCT00663962|4062875|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4239289|NCT00663962|4062876|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4239290|NCT00663962|4062874|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4239291|NCT00663962|4062875|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4239292|NCT00663962|4062876|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4239293|NCT00663962|4062874|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4239294|NCT00663962|4062875|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4239295|NCT00663962|4062876|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4239296|NCT00663923|4062883|B1|||uncorrected distance visual acuity|Uncorrected VA is attained before correction of refractive errors .the data are the LogMAR values calculated from the snellen chart using the visual acuity conversion chart(the units would be LogMAR).Any patient with better vision can see the smallest letters at 20 feet(20/20=0.00 LogMAR).Higher LogMAR values represent worse outcome.Log MAR(logarithmic minimum angle of resolution)notation has gained widespread use in statistical calculations.|log MAR|Mean|1.11|1.11|Standard Deviation|0.36|0.36|||
4239297|NCT00663923|4062883|B1|||Spherical equivalent|"Average of the maximum and minimum powers,which equals the sphere power plus half the cylinder power.Participant population was the same as baseline population.~It was measured by refraction(using autorefractor).Diopter is a unit of measurement of the optical power of any refracting surface ,which is reciprocal of the focal length measured in meters."|Diopter|Mean|-5.19|-5.19|Standard Deviation|2.47|2.47|||
4239298|NCT00663923|4062883|B1|||high order aberration|Although lower- order aberrations decrease after laser vision correction,higher -order aberrations may increase after conventional PRK or lasik.Higher-order aberration is Composed of delicate irregularities within the cornea not correctable by spectacles.It is measured using aberrometer.In this study OPD scan was used for aberrometry which is one of the methods of wavefront analysis.Participant population was the same as baseline population.|micron|Mean|0.36|0.36|Standard Deviation|0.10|0.1|||
4239299|NCT00663923|4062883|B1|||corrected distance visual acuity|Corrected VA is attained after correction of refractive errors using lenses of varying powers .the data are the LogMAR values calculated from the snellen chart using the visual acuity conversion chart(the units would be LogMAR).Any patient with better vision can see the smallest letters at 20 feet(20/20=0.00 LogMAR).Higher LogMAR values represent worse outcome.LogMAR(logarithmic minimum angle of resolution)notation has gained widespread use in statistical calculations.|logMAR|Mean|0.06|0.06|Standard Deviation|0.11|0.11|||
4239300|NCT00663923|4062883|B1|||astigmatism|"In compound myopic astigmatism the meridians of maximum and minimum power are both too strong.So both line images fall short of the retina.Participant population was the same as baseline population.~It was measured by refraction(using autorefractor).Diopter is a unit of measurement of the optical power of any refracting surface ,which is reciprocal of the focal length measured in meters."|diopter|Mean|-2.49|-2.49|Standard Deviation|0.83|0.83|||
4239301|NCT00663923|4062883|B1|||Target induced astigmatism(TIA)|It is vector of astigmatic change intended to be induced by the surgery. Participant population was the same as baseline participants. It was measured by refraction(using autorefractor) and vector analysis(using special software).Diopter is a unit of measurement of the optical power of any refracting surface ,which is reciprocal of the focal length measured in meters.|Diopter|Mean|1.86|1.86|Standard Deviation|0.60|0.6|||
4239302|NCT00663923|4062883|B1|Iran, Islamic Republic of||Region of Enrollment||participants|Number|50|50.0||||||
4239303|NCT00663923|4062883|B1||Male|Sex: Female, Male|one eye of 39 females and 11 males underwent PRK by cross-cylinder approach and the other eye underwent PRK by single method|Participants|Count of Participants|11|11.0||||||
4239304|NCT00663923|4062883|B1||Female|Sex: Female, Male|one eye of 39 females and 11 males underwent PRK by cross-cylinder approach and the other eye underwent PRK by single method|Participants|Count of Participants|39|39.0||||||
4239305|NCT00663923|4062883|B1|||Age||years|Mean|28.46|28.46|Standard Deviation|7.05|7.05|||
4239306|NCT00663923|4062883|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4239307|NCT00663923|4062883|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4239308|NCT00663923|4062883|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4239309|NCT00663858|4062897|B4|Italy||Region of Enrollment||participants|Number|3|3.0||||||
4239310|NCT00663858|4062898|B3|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4239311|NCT00663858|4062899|B2|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4239312|NCT00663858|4062900|B1|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4239313|NCT00663858|4062897|B4|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4239314|NCT00663858|4062898|B3|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4239315|NCT00663858|4062899|B2|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4239316|NCT00663858|4062900|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4239317|NCT00663858|4062897|B4|Netherlands||Region of Enrollment||participants|Number|46|46.0||||||
4239318|NCT00663858|4062898|B3|Netherlands||Region of Enrollment||participants|Number|10|10.0||||||
4239319|NCT00663858|4062899|B2|Netherlands||Region of Enrollment||participants|Number|13|13.0||||||
4239320|NCT00663858|4062900|B1|Netherlands||Region of Enrollment||participants|Number|23|23.0||||||
4239321|NCT00663858|4062897|B4|Germany||Region of Enrollment||participants|Number|28|28.0||||||
4239322|NCT00663858|4062898|B3|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4239323|NCT00663858|4062899|B2|Germany||Region of Enrollment||participants|Number|7|7.0||||||
4239324|NCT00663858|4062900|B1|Germany||Region of Enrollment||participants|Number|15|15.0||||||
4239325|NCT00663858|4062897|B4|Bulgaria||Region of Enrollment||participants|Number|81|81.0||||||
4239326|NCT00663858|4062898|B3|Bulgaria||Region of Enrollment||participants|Number|20|20.0||||||
4239327|NCT00663858|4062899|B2|Bulgaria||Region of Enrollment||participants|Number|20|20.0||||||
4239328|NCT00663858|4062900|B1|Bulgaria||Region of Enrollment||participants|Number|41|41.0||||||
4239329|NCT00663858|4062897|B4|Romania||Region of Enrollment||participants|Number|108|108.0||||||
4239330|NCT00663858|4062898|B3|Romania||Region of Enrollment||participants|Number|26|26.0||||||
4239331|NCT00663858|4062899|B2|Romania||Region of Enrollment||participants|Number|28|28.0||||||
4239332|NCT00663858|4062900|B1|Romania||Region of Enrollment||participants|Number|54|54.0||||||
4239333|NCT00663858|4062897|B4|Macedonia, The Former Yugoslav Republic of||Region of Enrollment||participants|Number|12|12.0||||||
4239334|NCT00663858|4062898|B3|Macedonia, The Former Yugoslav Republic of||Region of Enrollment||participants|Number|3|3.0||||||
4239335|NCT00663858|4062899|B2|Macedonia, The Former Yugoslav Republic of||Region of Enrollment||participants|Number|3|3.0||||||
4239336|NCT00663858|4062900|B1|Macedonia, The Former Yugoslav Republic of||Region of Enrollment||participants|Number|6|6.0||||||
4239337|NCT00663858|4062897|B4|Czech Republic||Region of Enrollment||participants|Number|67|67.0||||||
4239338|NCT00663858|4062898|B3|Czech Republic||Region of Enrollment||participants|Number|19|19.0||||||
4239339|NCT00663858|4062899|B2|Czech Republic||Region of Enrollment||participants|Number|15|15.0||||||
4239340|NCT00663858|4062900|B1|Czech Republic||Region of Enrollment||participants|Number|33|33.0||||||
4239341|NCT00663858|4062897|B4|Belarus||Region of Enrollment||participants|Number|73|73.0||||||
4239342|NCT00663858|4062898|B3|Belarus||Region of Enrollment||participants|Number|18|18.0||||||
4239343|NCT00663858|4062899|B2|Belarus||Region of Enrollment||participants|Number|18|18.0||||||
4239344|NCT00663858|4062900|B1|Belarus||Region of Enrollment||participants|Number|37|37.0||||||
4239345|NCT00663858|4062897|B4|France||Region of Enrollment||participants|Number|1|1.0||||||
4239346|NCT00663858|4062898|B3|France||Region of Enrollment||participants|Number|0|0.0||||||
4239347|NCT00663858|4062899|B2|France||Region of Enrollment||participants|Number|1|1.0||||||
4239348|NCT00663858|4062900|B1|France||Region of Enrollment||participants|Number|0|0.0||||||
4239349|NCT00663858|4062897|B4||Male|Sex: Female, Male||Participants|Count of Participants|420|420.0||||||
4239350|NCT00663858|4062898|B3||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4239351|NCT00663858|4062899|B2||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4239352|NCT00663858|4062900|B1||Male|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4239353|NCT00663858|4062897|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4239354|NCT00663858|4062898|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4239355|NCT00663858|4062899|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4239356|NCT00663858|4062900|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4239357|NCT00663858|4062897|B4|||Age||years|Mean|66.83|66.83|Standard Deviation|7.71|7.71|||
4239358|NCT00663858|4062898|B3|||Age||years|Mean|67.72|67.72|Standard Deviation|7.17|7.17|||
4239359|NCT00663858|4062899|B2|||Age||years|Mean|66.50|66.5|Standard Deviation|7.29|7.29|||
4239360|NCT00663858|4062900|B1|||Age||years|Mean|66.58|66.58|Standard Deviation|8.16|8.16|||
4239361|NCT00663858|4062897|B4||>=65 years|Age||Participants|Count of Participants|237|237.0||||||
4239362|NCT00663858|4062898|B3||>=65 years|Age||Participants|Count of Participants|65|65.0||||||
4239363|NCT00663858|4062899|B2||>=65 years|Age||Participants|Count of Participants|61|61.0||||||
4239364|NCT00663858|4062900|B1||>=65 years|Age||Participants|Count of Participants|111|111.0||||||
4239365|NCT00663858|4062897|B4||Between 18 and 65 years|Age||Participants|Count of Participants|183|183.0||||||
4239366|NCT00663858|4062898|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4239367|NCT00663858|4062899|B2||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4239368|NCT00663858|4062900|B1||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
4239369|NCT00663858|4062897|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4239370|NCT00663858|4062898|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4239371|NCT00663858|4062899|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4239372|NCT00663858|4062900|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4239373|NCT00663819|4062910|B3|United States||Region of Enrollment||participants|Number|258|258.0||||||
4239374|NCT00663819|4062911|B2|United States||Region of Enrollment||participants|Number|135|135.0||||||
4239375|NCT00663819|4062912|B1|United States||Region of Enrollment||participants|Number|123|123.0||||||
4239376|NCT00663819|4062910|B3||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4239377|NCT00663819|4062911|B2||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4239378|NCT00663819|4062912|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4239379|NCT00663819|4062910|B3||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4239380|NCT00663819|4062911|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4239381|NCT00663819|4062912|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4239382|NCT00663819|4062910|B3|||Age||years|Mean|55.4|55.4|Full Range|||18.8|83.8|
4239383|NCT00663819|4062911|B2|||Age||years|Mean|56.1|56.1|Full Range|||21.6|82.9|
4239384|NCT00663819|4062912|B1|||Age||years|Mean|54.7|54.7|Full Range|||18.8|83.8|
4239385|NCT00663793|4062925|B3|||Weight||kilogram|Mean|86|86.0|Standard Deviation|20|20.0|||
4239386|NCT00663793|4062926|B2|||Weight||kilogram|Mean|89|89.0|Standard Deviation|22|22.0|||
4239387|NCT00663793|4062927|B1|||Weight||kilogram|Mean|83|83.0|Standard Deviation|18|18.0|||
4239388|NCT00663793|4062925|B3|||Testosterone (T)||nmol/L|Mean|15.65|15.65|Standard Deviation|5.7|5.7|||
4239389|NCT00663793|4062926|B2|||Testosterone (T)||nmol/L|Mean|16.8|16.8|Standard Deviation|8.9|8.9|||
4239390|NCT00663793|4062927|B1|||Testosterone (T)||nmol/L|Mean|14.5|14.5|Standard Deviation|2.5|2.5|||
4239391|NCT00663793|4062925|B3|||Sex Hormone Binding Globulin (SHBG)||nmol/L|Mean|34|34.0|Standard Deviation|16.2|16.2|||
4239392|NCT00663793|4062926|B2|||Sex Hormone Binding Globulin (SHBG)||nmol/L|Mean|32.5|32.5|Standard Deviation|19.6|19.6|||
4239393|NCT00663793|4062927|B1|||Sex Hormone Binding Globulin (SHBG)||nmol/L|Mean|35.5|35.5|Standard Deviation|12.8|12.8|||
4239394|NCT00663793|4062925|B3|||Height||centimeters|Mean|178.5|178.5|Standard Deviation|6|6.0|||
4239395|NCT00663793|4062926|B2|||Height||centimeters|Mean|179|179.0|Standard Deviation|7|7.0|||
4239396|NCT00663793|4062927|B1|||Height||centimeters|Mean|178|178.0|Standard Deviation|5|5.0|||
4239397|NCT00663793|4062925|B3|||Estradiol||pmol/L|Mean|92.0|92.0|Standard Deviation|35.0|35.0|||
4239398|NCT00663793|4062926|B2|||Estradiol||pmol/L|Mean|114|114.0|Standard Deviation|54|54.0|||
4239399|NCT00663793|4062927|B1|||Estradiol||pmol/L|Mean|70.1|70.1|Standard Deviation|16.1|16.1|||
4239400|NCT00663793|4062925|B3|||Body Mass Index (BMI)||kg/m^2|Mean|27|27.0|Standard Deviation|4|4.0|||
4239401|NCT00663793|4062926|B2|||Body Mass Index (BMI)||kg/m^2|Mean|28|28.0|Standard Deviation|8|8.0|||
4239402|NCT00663793|4062927|B1|||Body Mass Index (BMI)||kg/m^2|Mean|26|26.0|Standard Deviation|4|4.0|||
4239403|NCT00663793|4062925|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4239404|NCT00663793|4062926|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4239405|NCT00663793|4062927|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4239406|NCT00663793|4062925|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4239407|NCT00663793|4062926|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4239408|NCT00663793|4062927|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4239409|NCT00663793|4062925|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4239410|NCT00663793|4062926|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4239411|NCT00663793|4062927|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4239412|NCT00663793|4062925|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4239413|NCT00663793|4062926|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4239414|NCT00663793|4062927|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4239415|NCT00663793|4062925|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4239416|NCT00663793|4062926|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4239417|NCT00663793|4062927|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4239418|NCT00663793|4062925|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4239419|NCT00663793|4062926|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4239420|NCT00663793|4062927|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4239421|NCT00663702|4062938|B3|Missing||Participant Weight at Baseline||Participants|Number|3|3.0||||||
4239422|NCT00663702|4062939|B2|Missing||Participant Weight at Baseline||Participants|Number|0|0.0||||||
4239423|NCT00663702|4062940|B1|Missing||Participant Weight at Baseline||Participants|Number|3|3.0||||||
4239424|NCT00663702|4062938|B3|Greater than 100 kilograms||Participant Weight at Baseline||Participants|Number|13|13.0||||||
4239425|NCT00663702|4062939|B2|Greater than 100 kilograms||Participant Weight at Baseline||Participants|Number|3|3.0||||||
4239426|NCT00663702|4062940|B1|Greater than 100 kilograms||Participant Weight at Baseline||Participants|Number|10|10.0||||||
4239427|NCT00663702|4062938|B3|60-100 kilograms||Participant Weight at Baseline||Participants|Number|84|84.0||||||
4239428|NCT00663702|4062939|B2|60-100 kilograms||Participant Weight at Baseline||Participants|Number|54|54.0||||||
4239429|NCT00663702|4062940|B1|60-100 kilograms||Participant Weight at Baseline||Participants|Number|30|30.0||||||
4239430|NCT00663702|4062938|B3|Less than 60 kilograms||Participant Weight at Baseline||Participants|Number|23|23.0||||||
4239431|NCT00663702|4062939|B2|Less than 60 kilograms||Participant Weight at Baseline||Participants|Number|14|14.0||||||
4239432|NCT00663702|4062940|B1|Less than 60 kilograms||Participant Weight at Baseline||Participants|Number|9|9.0||||||
4239433|NCT00663702|4062938|B3|||Mean Number of Swollen Joints at Baseline||Joints|Mean|4.8|4.8|Standard Deviation|6.1|6.1|||
4239434|NCT00663702|4062939|B2|||Mean Number of Swollen Joints at Baseline||Joints|Mean|4.3|4.3|Standard Deviation|5.9|5.9|||
4239435|NCT00663702|4062940|B1|||Mean Number of Swollen Joints at Baseline||Joints|Mean|5.4|5.4|Standard Deviation|6.4|6.4|||
4239436|NCT00663702|4062938|B3|||Mean Number of Tender Joints at Baseline||Joints|Mean|8.9|8.9|Standard Deviation|12.5|12.5|||
4239437|NCT00663702|4062939|B2|||Mean Number of Tender Joints at Baseline||Joints|Mean|8.8|8.8|Standard Deviation|12.4|12.4|||
4239438|NCT00663702|4062940|B1|||Mean Number of Tender Joints at Baseline||Joints|Mean|9.1|9.1|Standard Deviation|12.8|12.8|||
4239439|NCT00663702|4062938|B3|||Mean Baseline 28 Joint Disease Activity Score (DAS 28)|The DAS 28 is a 28-item joint disease activity score used to quantify disease expression and progression in rheumatoid arthritis. Severity is indicated with increasing item score on the scale with 0=no joints affected and 28=all joints affected.|Score on a scale|Mean|3.39|3.39|Standard Deviation|1.26|1.26|||
4239440|NCT00663702|4062939|B2|||Mean Baseline 28 Joint Disease Activity Score (DAS 28)|The DAS 28 is a 28-item joint disease activity score used to quantify disease expression and progression in rheumatoid arthritis. Severity is indicated with increasing item score on the scale with 0=no joints affected and 28=all joints affected.|Score on a scale|Mean|3.28|3.28|Standard Deviation|1.29|1.29|||
4239441|NCT00663702|4062940|B1|||Mean Baseline 28 Joint Disease Activity Score (DAS 28)|The DAS 28 is a 28-item joint disease activity score used to quantify disease expression and progression in rheumatoid arthritis. Severity is indicated with increasing item score on the scale with 0=no joints affected and 28=all joints affected.|Score on a scale|Mean|3.55|3.55|Standard Deviation|1.20|1.2|||
4239442|NCT00663702|4062938|B3|||Mean Baseline High Sensitivity C-Reactive Protein Level||μg/mL|Mean|0.93|0.93|Standard Deviation|0.79|0.79|||
4239443|NCT00663702|4062939|B2|||Mean Baseline High Sensitivity C-Reactive Protein Level||μg/mL|Mean|0.92|0.92|Standard Deviation|0.88|0.88|||
4239444|NCT00663702|4062940|B1|||Mean Baseline High Sensitivity C-Reactive Protein Level||μg/mL|Mean|0.94|0.94|Standard Deviation|0.65|0.65|||
4239445|NCT00663702|4062938|B3|South America||Region of Enrollment||Participants|Number|55|55.0||||||
4239446|NCT00663702|4062939|B2|South America||Region of Enrollment||Participants|Number|55|55.0||||||
4239447|NCT00663702|4062940|B1|South America||Region of Enrollment||Participants|Number|0|0.0||||||
4239448|NCT00663702|4062938|B3|North America||Region of Enrollment||Participants|Number|68|68.0||||||
4239449|NCT00663702|4062939|B2|North America||Region of Enrollment||Participants|Number|16|16.0||||||
4239450|NCT00663702|4062940|B1|North America||Region of Enrollment||Participants|Number|52|52.0||||||
4239451|NCT00663702|4062938|B3|Other||Race/Ethnicity, Customized||Partcipants|Number|1|1.0||||||
4239452|NCT00663702|4062939|B2|Other||Race/Ethnicity, Customized||Partcipants|Number|0|0.0||||||
4239453|NCT00663702|4062940|B1|Other||Race/Ethnicity, Customized||Partcipants|Number|1|1.0||||||
4239454|NCT00663702|4062938|B3|Asian||Race/Ethnicity, Customized||Partcipants|Number|1|1.0||||||
4239455|NCT00663702|4062939|B2|Asian||Race/Ethnicity, Customized||Partcipants|Number|1|1.0||||||
4239456|NCT00663702|4062940|B1|Asian||Race/Ethnicity, Customized||Partcipants|Number|0|0.0||||||
4239457|NCT00663702|4062938|B3|American Indian/Alaska Native||Race/Ethnicity, Customized||Partcipants|Number|1|1.0||||||
4239458|NCT00663702|4062939|B2|American Indian/Alaska Native||Race/Ethnicity, Customized||Partcipants|Number|0|0.0||||||
4239459|NCT00663702|4062940|B1|American Indian/Alaska Native||Race/Ethnicity, Customized||Partcipants|Number|1|1.0||||||
4239460|NCT00663702|4062938|B3|Black/African American||Race/Ethnicity, Customized||Partcipants|Number|3|3.0||||||
4239461|NCT00663702|4062939|B2|Black/African American||Race/Ethnicity, Customized||Partcipants|Number|0|0.0||||||
4239462|NCT00663702|4062940|B1|Black/African American||Race/Ethnicity, Customized||Partcipants|Number|3|3.0||||||
4239463|NCT00663702|4062938|B3|White||Race/Ethnicity, Customized||Partcipants|Number|117|117.0||||||
4239464|NCT00663702|4062939|B2|White||Race/Ethnicity, Customized||Partcipants|Number|70|70.0||||||
4239465|NCT00663702|4062940|B1|White||Race/Ethnicity, Customized||Partcipants|Number|47|47.0||||||
4239466|NCT00663702|4062938|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4239467|NCT00663702|4062939|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4239468|NCT00663702|4062940|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4239469|NCT00663702|4062938|B3||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4239470|NCT00663702|4062939|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4239471|NCT00663702|4062940|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4239472|NCT00663702|4062938|B3|||Age||Years|Mean|54.3|54.3|Standard Deviation|12.5|12.5|||
4239473|NCT00663702|4062939|B2|||Age||Years|Mean|52.8|52.8|Standard Deviation|13.8|13.8|||
4239474|NCT00663702|4062940|B1|||Age||Years|Mean|56.5|56.5|Standard Deviation|10.2|10.2|||
4239475|NCT00663403|4062964|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4239476|NCT00663403|4062964|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4239477|NCT00663403|4062964|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4239478|NCT00663403|4062964|B1|||Age||years|Mean|51|51.0|Standard Deviation|14|14.0|||
4239479|NCT00663403|4062964|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4239480|NCT00663403|4062964|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4239481|NCT00663403|4062964|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4239482|NCT00663260|4062974|B4|OTHER REGIMEN||Pre-Enrollment Anti-Hyperglycemic Therapy||Participants|Number|21|21.0||||||
4239483|NCT00663260|4062975|B3|OTHER REGIMEN||Pre-Enrollment Anti-Hyperglycemic Therapy||Participants|Number|7|7.0||||||
4239484|NCT00663260|4062976|B2|OTHER REGIMEN||Pre-Enrollment Anti-Hyperglycemic Therapy||Participants|Number|7|7.0||||||
4239485|NCT00663260|4062977|B1|OTHER REGIMEN||Pre-Enrollment Anti-Hyperglycemic Therapy||Participants|Number|7|7.0||||||
4239486|NCT00663260|4062974|B4|THIAZOLIINEDIONE-BASED REGIMEN||Pre-Enrollment Anti-Hyperglycemic Therapy||Participants|Number|4|4.0||||||
4239487|NCT00663260|4062975|B3|THIAZOLIINEDIONE-BASED REGIMEN||Pre-Enrollment Anti-Hyperglycemic Therapy||Participants|Number|2|2.0||||||
4239488|NCT00663260|4062976|B2|THIAZOLIINEDIONE-BASED REGIMEN||Pre-Enrollment Anti-Hyperglycemic Therapy||Participants|Number|1|1.0||||||
4239489|NCT00663260|4062977|B1|THIAZOLIINEDIONE-BASED REGIMEN||Pre-Enrollment Anti-Hyperglycemic Therapy||Participants|Number|1|1.0||||||
4239490|NCT00663260|4062974|B4|SULFONYLUREA-BASED REGIMEN||Pre-Enrollment Anti-Hyperglycemic Therapy||Participants|Number|63|63.0||||||
4239491|NCT00663260|4062975|B3|SULFONYLUREA-BASED REGIMEN||Pre-Enrollment Anti-Hyperglycemic Therapy||Participants|Number|21|21.0||||||
4239492|NCT00663260|4062976|B2|SULFONYLUREA-BASED REGIMEN||Pre-Enrollment Anti-Hyperglycemic Therapy||Participants|Number|21|21.0||||||
4239493|NCT00663260|4062977|B1|SULFONYLUREA-BASED REGIMEN||Pre-Enrollment Anti-Hyperglycemic Therapy||Participants|Number|21|21.0||||||
4239494|NCT00663260|4062974|B4|INSULIN-BASED REGIMEN||Pre-Enrollment Anti-Hyperglycemic Therapy||Participants|Number|164|164.0||||||
4239495|NCT00663260|4062975|B3|INSULIN-BASED REGIMEN||Pre-Enrollment Anti-Hyperglycemic Therapy||Participants|Number|55|55.0||||||
4239496|NCT00663260|4062976|B2|INSULIN-BASED REGIMEN||Pre-Enrollment Anti-Hyperglycemic Therapy||Participants|Number|54|54.0||||||
4239497|NCT00663260|4062977|B1|INSULIN-BASED REGIMEN||Pre-Enrollment Anti-Hyperglycemic Therapy||Participants|Number|55|55.0||||||
4239498|NCT00663260|4062974|B4|||Weight||kg|Mean|92.69|92.69|Standard Deviation|19.529|19.529|||
4239499|NCT00663260|4062975|B3|||Weight||kg|Mean|93.25|93.25|Standard Deviation|17.309|17.309|||
4239500|NCT00663260|4062976|B2|||Weight||kg|Mean|95.23|95.23|Standard Deviation|20.909|20.909|||
4239501|NCT00663260|4062977|B1|||Weight||kg|Mean|89.61|89.61|Standard Deviation|20.046|20.046|||
4239502|NCT00663260|4062974|B4|OTHER||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4239503|NCT00663260|4062975|B3|OTHER||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4239504|NCT00663260|4062976|B2|OTHER||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4239505|NCT00663260|4062977|B1|OTHER||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4239506|NCT00663260|4062974|B4|ASIAN||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4239507|NCT00663260|4062975|B3|ASIAN||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4239508|NCT00663260|4062976|B2|ASIAN||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4239509|NCT00663260|4062977|B1|ASIAN||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4239510|NCT00663260|4062974|B4|BLACK OR AFRICAN AMERICAN||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4239511|NCT00663260|4062975|B3|BLACK OR AFRICAN AMERICAN||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4239512|NCT00663260|4062976|B2|BLACK OR AFRICAN AMERICAN||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4239513|NCT00663260|4062977|B1|BLACK OR AFRICAN AMERICAN||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4239514|NCT00663260|4062974|B4|WHITE||Race/Ethnicity, Customized||Participants|Number|211|211.0||||||
4239515|NCT00663260|4062975|B3|WHITE||Race/Ethnicity, Customized||Participants|Number|77|77.0||||||
4239516|NCT00663260|4062976|B2|WHITE||Race/Ethnicity, Customized||Participants|Number|65|65.0||||||
4239517|NCT00663260|4062977|B1|WHITE||Race/Ethnicity, Customized||Participants|Number|69|69.0||||||
4239518|NCT00663260|4062974|B4|Female||Sex/Gender, Customized||Participants|Number|88|88.0||||||
4239519|NCT00663260|4062975|B3|Female||Sex/Gender, Customized||Participants|Number|29|29.0||||||
4239520|NCT00663260|4062976|B2|Female||Sex/Gender, Customized||Participants|Number|28|28.0||||||
4239521|NCT00663260|4062977|B1|Female||Sex/Gender, Customized||Participants|Number|31|31.0||||||
4239522|NCT00663260|4062974|B4|Male||Sex/Gender, Customized||Participants|Number|164|164.0||||||
4239523|NCT00663260|4062975|B3|Male||Sex/Gender, Customized||Participants|Number|56|56.0||||||
4239524|NCT00663260|4062976|B2|Male||Sex/Gender, Customized||Participants|Number|55|55.0||||||
4239525|NCT00663260|4062977|B1|Male||Sex/Gender, Customized||Participants|Number|53|53.0||||||
4239526|NCT00663260|4062974|B4|65 years and older||Age, Customized||Participants|Number|148|148.0||||||
4239527|NCT00663260|4062975|B3|65 years and older||Age, Customized||Participants|Number|56|56.0||||||
4239528|NCT00663260|4062976|B2|65 years and older||Age, Customized||Participants|Number|44|44.0||||||
4239529|NCT00663260|4062977|B1|65 years and older||Age, Customized||Participants|Number|48|48.0||||||
4239530|NCT00663260|4062974|B4|Younger than 65 years||Age, Customized||Participants|Number|104|104.0||||||
4239531|NCT00663260|4062975|B3|Younger than 65 years||Age, Customized||Participants|Number|29|29.0||||||
4239532|NCT00663260|4062976|B2|Younger than 65 years||Age, Customized||Participants|Number|39|39.0||||||
4239533|NCT00663260|4062977|B1|Younger than 65 years||Age, Customized||Participants|Number|36|36.0||||||
4239534|NCT00663260|4062974|B4|||Age||Years|Mean|67|67.0|Standard Deviation|8.4|8.4|||
4239535|NCT00663260|4062975|B3|||Age||Years|Mean|68|68.0|Standard Deviation|7.7|7.7|||
4239536|NCT00663260|4062976|B2|||Age||Years|Mean|66|66.0|Standard Deviation|8.9|8.9|||
4239537|NCT00663260|4062977|B1|||Age||Years|Mean|67|67.0|Standard Deviation|8.6|8.6|||
4239538|NCT00663234|4062993|B1|Other ARV regimen||Antiretroviral (ARV) Regimen at entry, Categorical|ARV regimens are categorized based on whether or not they contain Protease Inhibitors (PIs) and/or Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs).|participants|Number|2|2.0||||||
4239539|NCT00663234|4062993|B1|At least one NNRTI and no PI||Antiretroviral (ARV) Regimen at entry, Categorical|ARV regimens are categorized based on whether or not they contain Protease Inhibitors (PIs) and/or Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs).|participants|Number|4|4.0||||||
4239822|NCT00662909|4063355|B3|Mixed||Type of overactive bladder (OAB)||participants|Number|161|161.0||||||
4239540|NCT00663234|4062993|B1|At least one PI and no NNRTI||Antiretroviral (ARV) Regimen at entry, Categorical|ARV regimens are categorized based on whether or not they contain Protease Inhibitors (PIs) and/or Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs).|participants|Number|17|17.0||||||
4239541|NCT00663234|4062993|B1|At least one PI and at least one NNRTI||Antiretroviral (ARV) Regimen at entry, Categorical|ARV regimens are categorized based on whether or not they contain Protease Inhibitors (PIs) and/or Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs).|participants|Number|5|5.0||||||
4239542|NCT00663234|4062993|B1|<Lower limit of quantification of assay||HIV-1 RNA, Categorical||participants|Number|20|20.0||||||
4239543|NCT00663234|4062993|B1|>=Lower limit of quantification of assay||HIV-1 RNA, Categorical||participants|Number|8|8.0||||||
4239544|NCT00663234|4062993|B1|>=25%||CD4 Percent at screening, Categorical||participants|Number|26|26.0||||||
4239545|NCT00663234|4062993|B1|15% to <25%||CD4 Percent at screening, Categorical||participants|Number|2|2.0||||||
4239546|NCT00663234|4062993|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4239547|NCT00663234|4062993|B1|Asian, Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4239548|NCT00663234|4062993|B1|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4239549|NCT00663234|4062993|B1|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4239550|NCT00663234|4062993|B1|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4239551|NCT00663234|4062993|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4239552|NCT00663234|4062993|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4239553|NCT00663234|4062993|B1|19 - <24 years old||Age, Customized||participants|Number|9|9.0||||||
4239554|NCT00663234|4062993|B1|15 - <19 years old||Age, Customized||participants|Number|12|12.0||||||
4239555|NCT00663234|4062993|B1|10 - <15 years old||Age, Customized||participants|Number|7|7.0||||||
4239556|NCT00663234|4062993|B1|||Age||years|Mean|17|17.0|Standard Deviation|4|4.0|||
4239557|NCT00663208|4063019|B8||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4239558|NCT00663208|4063020|B7||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4239559|NCT00663208|4063021|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4239560|NCT00663208|4063022|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4239561|NCT00663208|4063023|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4239562|NCT00663208|4063024|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4239563|NCT00663208|4063025|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4239564|NCT00663208|4063026|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4239565|NCT00663208|4063019|B8||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4239566|NCT00663208|4063020|B7||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4239567|NCT00663208|4063021|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4239568|NCT00663208|4063022|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4239569|NCT00663208|4063023|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4239570|NCT00663208|4063024|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4239571|NCT00663208|4063025|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4239572|NCT00663208|4063026|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4239573|NCT00663208|4063019|B8|||Age||years|Mean|44.5|44.5|Standard Deviation|7.65|7.65|||
4239574|NCT00663208|4063020|B7|||Age||years|Mean|48.0|48.0|Standard Deviation|4.20|4.2|||
4239575|NCT00663208|4063021|B6|||Age||years|Mean|44.3|44.3|Standard Deviation|6.90|6.9|||
4239576|NCT00663208|4063022|B5|||Age||years|Mean|44.8|44.8|Standard Deviation|6.40|6.4|||
4239577|NCT00663208|4063023|B4|||Age||years|Mean|39.5|39.5|Standard Deviation|7.55|7.55|||
4239578|NCT00663208|4063024|B3|||Age||years|Mean|47.5|47.5|Standard Deviation|3.70|3.7|||
4239579|NCT00663208|4063025|B2|||Age||years|Mean|46.5|46.5|Standard Deviation|13.00|13.0|||
4239580|NCT00663208|4063026|B1|||Age||years|Mean|39.5|39.5|Standard Deviation|9.95|9.95|||
4239581|NCT00663169|4063182|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4239582|NCT00663169|4063183|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4239583|NCT00663169|4063184|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4239584|NCT00663169|4063182|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4239585|NCT00663169|4063183|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4239586|NCT00663169|4063184|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4239587|NCT00663169|4063182|B3|||Age||years|Mean|46.3|46.3|Standard Deviation|7.28|7.28|||
4239588|NCT00663169|4063183|B2|||Age||years|Mean|46.0|46.0|Standard Deviation|3.46|3.46|||
4239589|NCT00663169|4063184|B1|||Age||years|Mean|46.7|46.7|Standard Deviation|10.97|10.97|||
4239590|NCT00663117|4063208|B3|||Crohn's Disease Activity Index (CDAI) score|"The CDAI score is a number unit calculated from symptoms recorded by the subject over a 7-day period before each visit, weight, hemoglobin, and physical exam findings. The score ranges from 0 to 450. A score of 220 is considered 'active' disease. A score of 150 is considered remission. A drop of 70-points in the score is considered a response to therapy."|CDAI score|Mean|346|346.0|Standard Deviation|17.5|17.5|||
4239591|NCT00663117|4063209|B2|||Crohn's Disease Activity Index (CDAI) score|"The CDAI score is a number unit calculated from symptoms recorded by the subject over a 7-day period before each visit, weight, hemoglobin, and physical exam findings. The score ranges from 0 to 450. A score of 220 is considered 'active' disease. A score of 150 is considered remission. A drop of 70-points in the score is considered a response to therapy."|CDAI score|Mean|365|365.0|Standard Deviation|16|16.0|||
4239592|NCT00663117|4063210|B1|||Crohn's Disease Activity Index (CDAI) score|"The CDAI score is a number unit calculated from symptoms recorded by the subject over a 7-day period before each visit, weight, hemoglobin, and physical exam findings. The score ranges from 0 to 450. A score of 220 is considered 'active' disease. A score of 150 is considered remission. A drop of 70-points in the score is considered a response to therapy."|CDAI score|Mean|327|327.0|Standard Deviation|19|19.0|||
4239593|NCT00663117|4063208|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4239594|NCT00663117|4063209|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4239595|NCT00663117|4063210|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4239596|NCT00663117|4063208|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4239597|NCT00663117|4063209|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4239598|NCT00663117|4063210|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4239599|NCT00663117|4063208|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4239600|NCT00663117|4063209|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4239601|NCT00663117|4063210|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4239602|NCT00663117|4063208|B3|||Age||years|Mean|42.3|42.3|Standard Deviation|2.5|2.5|||
4239603|NCT00663117|4063209|B2|||Age||years|Mean|40.5|40.5|Standard Deviation|2.4|2.4|||
4239604|NCT00663117|4063210|B1|||Age||years|Mean|44.8|44.8|Standard Deviation|2.8|2.8|||
4239605|NCT00663117|4063208|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4239606|NCT00663117|4063209|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4239607|NCT00663117|4063210|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4239608|NCT00663117|4063208|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4239609|NCT00663117|4063209|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4239610|NCT00663117|4063210|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4239611|NCT00663117|4063208|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4239612|NCT00663117|4063209|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4239613|NCT00663117|4063210|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4239614|NCT00663052|4063223|B3|||Mean Number of Doctor Visits||Visits|Mean|3.0|3.0|Standard Deviation|3.51|3.51|||
4239615|NCT00663052|4063224|B2|||Mean Number of Doctor Visits||Visits|Mean|3.0|3.0|Standard Deviation|3.68|3.68|||
4239616|NCT00663052|4063225|B1|||Mean Number of Doctor Visits||Visits|Mean|2.9|2.9|Standard Deviation|3.36|3.36|||
4239617|NCT00663052|4063223|B3|||Number of Participants With Doctor Visits||Participants|Number|119|119.0||||||
4239618|NCT00663052|4063224|B2|||Number of Participants With Doctor Visits||Participants|Number|61|61.0||||||
4239619|NCT00663052|4063225|B1|||Number of Participants With Doctor Visits||Participants|Number|58|58.0||||||
4239620|NCT00663052|4063223|B3|||Mean Number of Emergency Room Days||Days|Mean|8.7|8.7|Standard Deviation|6.45|6.45|||
4239621|NCT00663052|4063224|B2|||Mean Number of Emergency Room Days||Days|Mean|9.4|9.4|Standard Deviation|7.31|7.31|||
4239622|NCT00663052|4063225|B1|||Mean Number of Emergency Room Days||Days|Mean|7.8|7.8|Standard Deviation|5.64|5.64|||
4239623|NCT00663052|4063223|B3|||Number of Participants With Emergency Room Visits||Participants|Number|14|14.0||||||
4239624|NCT00663052|4063224|B2|||Number of Participants With Emergency Room Visits||Participants|Number|8|8.0||||||
4239625|NCT00663052|4063225|B1|||Number of Participants With Emergency Room Visits||Participants|Number|6|6.0||||||
4239626|NCT00663052|4063223|B3|||Mean Functional Assessment of Chronic Illness Therapy (FACIT) Fatigue Questionnaire Total Scores|FACIT Fatigue questionnaire: Participant rated 13- item questionnaire to assess fatigue. For each question, participant rates his / her condition for the past week on a 5-point Likert scale ranging from 0 (not at all) to 4 (very much). Higher scores always represent less fatigue (Total score range= 0 to 52).|Units on scale|Mean|37.3|37.3|Standard Deviation|10.4|10.4|||
4239627|NCT00663052|4063224|B2|||Mean Functional Assessment of Chronic Illness Therapy (FACIT) Fatigue Questionnaire Total Scores|FACIT Fatigue questionnaire: Participant rated 13- item questionnaire to assess fatigue. For each question, participant rates his / her condition for the past week on a 5-point Likert scale ranging from 0 (not at all) to 4 (very much). Higher scores always represent less fatigue (Total score range= 0 to 52).|Units on scale|Mean|36.7|36.7|Standard Deviation|10.8|10.8|||
4239628|NCT00663052|4063225|B1|||Mean Functional Assessment of Chronic Illness Therapy (FACIT) Fatigue Questionnaire Total Scores|FACIT Fatigue questionnaire: Participant rated 13- item questionnaire to assess fatigue. For each question, participant rates his / her condition for the past week on a 5-point Likert scale ranging from 0 (not at all) to 4 (very much). Higher scores always represent less fatigue (Total score range= 0 to 52).|Units on scale|Mean|37.9|37.9|Standard Deviation|10.0|10.0|||
4239629|NCT00663052|4063223|B3|Sleep Problem Index II||Mean Medical Outcomes Study (MOS) Sleep Scale Scores|MOS scale has 12 questions to assess sleep quality & quantity: 1)time to fall asleep, 2)hours of sleep/night in past 4 weeks,3)sleep not peaceful, 4)got enough sleep to feel rested in morning,5)awaken short of breath/headache 6)feel drowsy in day,7)trouble going to sleep, 8)wake up during sleep; trouble going back to sleep,9)trouble staying awake in day, 10)Snoring,11)take naps in day,12)get amount of sleep needed. Sleep problem index(SPI) I:mean of 4,5,7,8,9,12; SPI II:mean of 1,3,4,5,6,7,8,9,12. All reported responses are on scale:0-100, higher scores indicate greater intensity of attribute.|Units on scale|Mean|34.0|34.0|Standard Deviation|18.9|18.9|||
4239672|NCT00663052|4063224|B2|||Mean Euro Quality of Life 5 Dimension (EQ-5D) Utility Index Scores|"EQ-5D: participant rated questionnaire to assess health-related quality of life in terms of a single utility score. Health State Profile component assesses level of current health for 5 domains; 1 indicates better health state (no problems); 3 indicates worst health state (example confined to bed)."|Units on scale|Mean|0.66|0.66|Standard Deviation|0.31|0.31|||
4239823|NCT00662909|4063356|B2|Mixed||Type of overactive bladder (OAB)||participants|Number|160|160.0||||||
4239630|NCT00663052|4063224|B2|Sleep Problem Index II||Mean Medical Outcomes Study (MOS) Sleep Scale Scores|MOS scale has 12 questions to assess sleep quality & quantity: 1)time to fall asleep, 2)hours of sleep/night in past 4 weeks,3)sleep not peaceful, 4)got enough sleep to feel rested in morning,5)awaken short of breath/headache 6)feel drowsy in day,7)trouble going to sleep, 8)wake up during sleep; trouble going back to sleep,9)trouble staying awake in day, 10)Snoring,11)take naps in day,12)get amount of sleep needed. Sleep problem index(SPI) I:mean of 4,5,7,8,9,12; SPI II:mean of 1,3,4,5,6,7,8,9,12. All reported responses are on scale:0-100, higher scores indicate greater intensity of attribute.|Units on scale|Mean|34.2|34.2|Standard Deviation|19.6|19.6|||
4239631|NCT00663052|4063225|B1|Sleep Problem Index II||Mean Medical Outcomes Study (MOS) Sleep Scale Scores|MOS scale has 12 questions to assess sleep quality & quantity: 1)time to fall asleep, 2)hours of sleep/night in past 4 weeks,3)sleep not peaceful, 4)got enough sleep to feel rested in morning,5)awaken short of breath/headache 6)feel drowsy in day,7)trouble going to sleep, 8)wake up during sleep; trouble going back to sleep,9)trouble staying awake in day, 10)Snoring,11)take naps in day,12)get amount of sleep needed. Sleep problem index(SPI) I:mean of 4,5,7,8,9,12; SPI II:mean of 1,3,4,5,6,7,8,9,12. All reported responses are on scale:0-100, higher scores indicate greater intensity of attribute.|Units on scale|Mean|33.9|33.9|Standard Deviation|18.2|18.2|||
4239632|NCT00663052|4063223|B3|Sleep Problem Index I||Mean Medical Outcomes Study (MOS) Sleep Scale Scores|MOS scale has 12 questions to assess sleep quality & quantity: 1)time to fall asleep, 2)hours of sleep/night in past 4 weeks,3)sleep not peaceful, 4)got enough sleep to feel rested in morning,5)awaken short of breath/headache 6)feel drowsy in day,7)trouble going to sleep, 8)wake up during sleep; trouble going back to sleep,9)trouble staying awake in day, 10)Snoring,11)take naps in day,12)get amount of sleep needed. Sleep problem index(SPI) I:mean of 4,5,7,8,9,12; SPI II:mean of 1,3,4,5,6,7,8,9,12. All reported responses are on scale:0-100, higher scores indicate greater intensity of attribute.|Units on scale|Mean|32.7|32.7|Standard Deviation|18.9|18.9|||
4239633|NCT00663052|4063224|B2|Sleep Problem Index I||Mean Medical Outcomes Study (MOS) Sleep Scale Scores|MOS scale has 12 questions to assess sleep quality & quantity: 1)time to fall asleep, 2)hours of sleep/night in past 4 weeks,3)sleep not peaceful, 4)got enough sleep to feel rested in morning,5)awaken short of breath/headache 6)feel drowsy in day,7)trouble going to sleep, 8)wake up during sleep; trouble going back to sleep,9)trouble staying awake in day, 10)Snoring,11)take naps in day,12)get amount of sleep needed. Sleep problem index(SPI) I:mean of 4,5,7,8,9,12; SPI II:mean of 1,3,4,5,6,7,8,9,12. All reported responses are on scale:0-100, higher scores indicate greater intensity of attribute.|Units on scale|Mean|32.9|32.9|Standard Deviation|19.1|19.1|||
4239634|NCT00663052|4063225|B1|Sleep Problem Index I||Mean Medical Outcomes Study (MOS) Sleep Scale Scores|MOS scale has 12 questions to assess sleep quality & quantity: 1)time to fall asleep, 2)hours of sleep/night in past 4 weeks,3)sleep not peaceful, 4)got enough sleep to feel rested in morning,5)awaken short of breath/headache 6)feel drowsy in day,7)trouble going to sleep, 8)wake up during sleep; trouble going back to sleep,9)trouble staying awake in day, 10)Snoring,11)take naps in day,12)get amount of sleep needed. Sleep problem index(SPI) I:mean of 4,5,7,8,9,12; SPI II:mean of 1,3,4,5,6,7,8,9,12. All reported responses are on scale:0-100, higher scores indicate greater intensity of attribute.|Units on scale|Mean|32.5|32.5|Standard Deviation|18.7|18.7|||
4239635|NCT00663052|4063223|B3|Sleep Quantity||Mean Medical Outcomes Study (MOS) Sleep Scale Scores|MOS scale has 12 questions to assess sleep quality & quantity: 1)time to fall asleep, 2)hours of sleep/night in past 4 weeks,3)sleep not peaceful, 4)got enough sleep to feel rested in morning,5)awaken short of breath/headache 6)feel drowsy in day,7)trouble going to sleep, 8)wake up during sleep; trouble going back to sleep,9)trouble staying awake in day, 10)Snoring,11)take naps in day,12)get amount of sleep needed. Sleep problem index(SPI) I:mean of 4,5,7,8,9,12; SPI II:mean of 1,3,4,5,6,7,8,9,12. All reported responses are on scale:0-100, higher scores indicate greater intensity of attribute.|Units on scale|Mean|6.9|6.9|Standard Deviation|1.4|1.4|||
4239636|NCT00663052|4063224|B2|Sleep Quantity||Mean Medical Outcomes Study (MOS) Sleep Scale Scores|MOS scale has 12 questions to assess sleep quality & quantity: 1)time to fall asleep, 2)hours of sleep/night in past 4 weeks,3)sleep not peaceful, 4)got enough sleep to feel rested in morning,5)awaken short of breath/headache 6)feel drowsy in day,7)trouble going to sleep, 8)wake up during sleep; trouble going back to sleep,9)trouble staying awake in day, 10)Snoring,11)take naps in day,12)get amount of sleep needed. Sleep problem index(SPI) I:mean of 4,5,7,8,9,12; SPI II:mean of 1,3,4,5,6,7,8,9,12. All reported responses are on scale:0-100, higher scores indicate greater intensity of attribute.|Units on scale|Mean|6.9|6.9|Standard Deviation|1.4|1.4|||
4239637|NCT00663052|4063225|B1|Sleep Quantity||Mean Medical Outcomes Study (MOS) Sleep Scale Scores|MOS scale has 12 questions to assess sleep quality & quantity: 1)time to fall asleep, 2)hours of sleep/night in past 4 weeks,3)sleep not peaceful, 4)got enough sleep to feel rested in morning,5)awaken short of breath/headache 6)feel drowsy in day,7)trouble going to sleep, 8)wake up during sleep; trouble going back to sleep,9)trouble staying awake in day, 10)Snoring,11)take naps in day,12)get amount of sleep needed. Sleep problem index(SPI) I:mean of 4,5,7,8,9,12; SPI II:mean of 1,3,4,5,6,7,8,9,12. All reported responses are on scale:0-100, higher scores indicate greater intensity of attribute.|Units on scale|Mean|6.9|6.9|Standard Deviation|1.4|1.4|||
4239638|NCT00663052|4063223|B3|Sleep Disturbance||Mean Medical Outcomes Study (MOS) Sleep Scale Scores|MOS scale has 12 questions to assess sleep quality & quantity: 1)time to fall asleep, 2)hours of sleep/night in past 4 weeks,3)sleep not peaceful, 4)got enough sleep to feel rested in morning,5)awaken short of breath/headache 6)feel drowsy in day,7)trouble going to sleep, 8)wake up during sleep; trouble going back to sleep,9)trouble staying awake in day, 10)Snoring,11)take naps in day,12)get amount of sleep needed. Sleep problem index(SPI) I:mean of 4,5,7,8,9,12; SPI II:mean of 1,3,4,5,6,7,8,9,12. All reported responses are on scale:0-100, higher scores indicate greater intensity of attribute.|Units on scale|Mean|34.7|34.7|Standard Deviation|23.6|23.6|||
4239639|NCT00663052|4063224|B2|Sleep Disturbance||Mean Medical Outcomes Study (MOS) Sleep Scale Scores|MOS scale has 12 questions to assess sleep quality & quantity: 1)time to fall asleep, 2)hours of sleep/night in past 4 weeks,3)sleep not peaceful, 4)got enough sleep to feel rested in morning,5)awaken short of breath/headache 6)feel drowsy in day,7)trouble going to sleep, 8)wake up during sleep; trouble going back to sleep,9)trouble staying awake in day, 10)Snoring,11)take naps in day,12)get amount of sleep needed. Sleep problem index(SPI) I:mean of 4,5,7,8,9,12; SPI II:mean of 1,3,4,5,6,7,8,9,12. All reported responses are on scale:0-100, higher scores indicate greater intensity of attribute.|Units on scale|Mean|34.4|34.4|Standard Deviation|23.8|23.8|||
4239824|NCT00662909|4063357|B1|Mixed||Type of overactive bladder (OAB)||participants|Number|185|185.0||||||
4239640|NCT00663052|4063225|B1|Sleep Disturbance||Mean Medical Outcomes Study (MOS) Sleep Scale Scores|MOS scale has 12 questions to assess sleep quality & quantity: 1)time to fall asleep, 2)hours of sleep/night in past 4 weeks,3)sleep not peaceful, 4)got enough sleep to feel rested in morning,5)awaken short of breath/headache 6)feel drowsy in day,7)trouble going to sleep, 8)wake up during sleep; trouble going back to sleep,9)trouble staying awake in day, 10)Snoring,11)take naps in day,12)get amount of sleep needed. Sleep problem index(SPI) I:mean of 4,5,7,8,9,12; SPI II:mean of 1,3,4,5,6,7,8,9,12. All reported responses are on scale:0-100, higher scores indicate greater intensity of attribute.|Units on scale|Mean|35.0|35.0|Standard Deviation|23.6|23.6|||
4239641|NCT00663052|4063223|B3|Sleep Adequacy||Mean Medical Outcomes Study (MOS) Sleep Scale Scores|MOS scale has 12 questions to assess sleep quality & quantity: 1)time to fall asleep, 2)hours of sleep/night in past 4 weeks,3)sleep not peaceful, 4)got enough sleep to feel rested in morning,5)awaken short of breath/headache 6)feel drowsy in day,7)trouble going to sleep, 8)wake up during sleep; trouble going back to sleep,9)trouble staying awake in day, 10)Snoring,11)take naps in day,12)get amount of sleep needed. Sleep problem index(SPI) I:mean of 4,5,7,8,9,12; SPI II:mean of 1,3,4,5,6,7,8,9,12. All reported responses are on scale:0-100, higher scores indicate greater intensity of attribute.|Units on scale|Mean|54.3|54.3|Standard Deviation|26.6|26.6|||
4239642|NCT00663052|4063224|B2|Sleep Adequacy||Mean Medical Outcomes Study (MOS) Sleep Scale Scores|MOS scale has 12 questions to assess sleep quality & quantity: 1)time to fall asleep, 2)hours of sleep/night in past 4 weeks,3)sleep not peaceful, 4)got enough sleep to feel rested in morning,5)awaken short of breath/headache 6)feel drowsy in day,7)trouble going to sleep, 8)wake up during sleep; trouble going back to sleep,9)trouble staying awake in day, 10)Snoring,11)take naps in day,12)get amount of sleep needed. Sleep problem index(SPI) I:mean of 4,5,7,8,9,12; SPI II:mean of 1,3,4,5,6,7,8,9,12. All reported responses are on scale:0-100, higher scores indicate greater intensity of attribute.|Units on scale|Mean|54.0|54.0|Standard Deviation|27.3|27.3|||
4239643|NCT00663052|4063225|B1|Sleep Adequacy||Mean Medical Outcomes Study (MOS) Sleep Scale Scores|MOS scale has 12 questions to assess sleep quality & quantity: 1)time to fall asleep, 2)hours of sleep/night in past 4 weeks,3)sleep not peaceful, 4)got enough sleep to feel rested in morning,5)awaken short of breath/headache 6)feel drowsy in day,7)trouble going to sleep, 8)wake up during sleep; trouble going back to sleep,9)trouble staying awake in day, 10)Snoring,11)take naps in day,12)get amount of sleep needed. Sleep problem index(SPI) I:mean of 4,5,7,8,9,12; SPI II:mean of 1,3,4,5,6,7,8,9,12. All reported responses are on scale:0-100, higher scores indicate greater intensity of attribute.|Units on scale|Mean|54.6|54.6|Standard Deviation|25.9|25.9|||
4239644|NCT00663052|4063223|B3|Sleep Short of Breath or Headache||Mean Medical Outcomes Study (MOS) Sleep Scale Scores|MOS scale has 12 questions to assess sleep quality & quantity: 1)time to fall asleep, 2)hours of sleep/night in past 4 weeks,3)sleep not peaceful, 4)got enough sleep to feel rested in morning,5)awaken short of breath/headache 6)feel drowsy in day,7)trouble going to sleep, 8)wake up during sleep; trouble going back to sleep,9)trouble staying awake in day, 10)Snoring,11)take naps in day,12)get amount of sleep needed. Sleep problem index(SPI) I:mean of 4,5,7,8,9,12; SPI II:mean of 1,3,4,5,6,7,8,9,12. All reported responses are on scale:0-100, higher scores indicate greater intensity of attribute.|Units on scale|Mean|13.8|13.8|Standard Deviation|20.5|20.5|||
4239645|NCT00663052|4063224|B2|Sleep Short of Breath or Headache||Mean Medical Outcomes Study (MOS) Sleep Scale Scores|MOS scale has 12 questions to assess sleep quality & quantity: 1)time to fall asleep, 2)hours of sleep/night in past 4 weeks,3)sleep not peaceful, 4)got enough sleep to feel rested in morning,5)awaken short of breath/headache 6)feel drowsy in day,7)trouble going to sleep, 8)wake up during sleep; trouble going back to sleep,9)trouble staying awake in day, 10)Snoring,11)take naps in day,12)get amount of sleep needed. Sleep problem index(SPI) I:mean of 4,5,7,8,9,12; SPI II:mean of 1,3,4,5,6,7,8,9,12. All reported responses are on scale:0-100, higher scores indicate greater intensity of attribute.|Units on scale|Mean|14.3|14.3|Standard Deviation|20.7|20.7|||
4239646|NCT00663052|4063225|B1|Sleep Short of Breath or Headache||Mean Medical Outcomes Study (MOS) Sleep Scale Scores|MOS scale has 12 questions to assess sleep quality & quantity: 1)time to fall asleep, 2)hours of sleep/night in past 4 weeks,3)sleep not peaceful, 4)got enough sleep to feel rested in morning,5)awaken short of breath/headache 6)feel drowsy in day,7)trouble going to sleep, 8)wake up during sleep; trouble going back to sleep,9)trouble staying awake in day, 10)Snoring,11)take naps in day,12)get amount of sleep needed. Sleep problem index(SPI) I:mean of 4,5,7,8,9,12; SPI II:mean of 1,3,4,5,6,7,8,9,12. All reported responses are on scale:0-100, higher scores indicate greater intensity of attribute.|Units on scale|Mean|13.2|13.2|Standard Deviation|20.4|20.4|||
4239647|NCT00663052|4063223|B3|Sleep Somnolence||Mean Medical Outcomes Study (MOS) Sleep Scale Scores|MOS scale has 12 questions to assess sleep quality & quantity: 1)time to fall asleep, 2)hours of sleep/night in past 4 weeks,3)sleep not peaceful, 4)got enough sleep to feel rested in morning,5)awaken short of breath/headache 6)feel drowsy in day,7)trouble going to sleep, 8)wake up during sleep; trouble going back to sleep,9)trouble staying awake in day, 10)Snoring,11)take naps in day,12)get amount of sleep needed. Sleep problem index(SPI) I:mean of 4,5,7,8,9,12; SPI II:mean of 1,3,4,5,6,7,8,9,12. All reported responses are on scale:0-100, higher scores indicate greater intensity of attribute.|Units on scale|Mean|30.4|30.4|Standard Deviation|19.5|19.5|||
4239648|NCT00663052|4063224|B2|Sleep Somnolence||Mean Medical Outcomes Study (MOS) Sleep Scale Scores|MOS scale has 12 questions to assess sleep quality & quantity: 1)time to fall asleep, 2)hours of sleep/night in past 4 weeks,3)sleep not peaceful, 4)got enough sleep to feel rested in morning,5)awaken short of breath/headache 6)feel drowsy in day,7)trouble going to sleep, 8)wake up during sleep; trouble going back to sleep,9)trouble staying awake in day, 10)Snoring,11)take naps in day,12)get amount of sleep needed. Sleep problem index(SPI) I:mean of 4,5,7,8,9,12; SPI II:mean of 1,3,4,5,6,7,8,9,12. All reported responses are on scale:0-100, higher scores indicate greater intensity of attribute.|Units on scale|Mean|30.9|30.9|Standard Deviation|19.3|19.3|||
4239649|NCT00663052|4063225|B1|Sleep Somnolence||Mean Medical Outcomes Study (MOS) Sleep Scale Scores|MOS scale has 12 questions to assess sleep quality & quantity: 1)time to fall asleep, 2)hours of sleep/night in past 4 weeks,3)sleep not peaceful, 4)got enough sleep to feel rested in morning,5)awaken short of breath/headache 6)feel drowsy in day,7)trouble going to sleep, 8)wake up during sleep; trouble going back to sleep,9)trouble staying awake in day, 10)Snoring,11)take naps in day,12)get amount of sleep needed. Sleep problem index(SPI) I:mean of 4,5,7,8,9,12; SPI II:mean of 1,3,4,5,6,7,8,9,12. All reported responses are on scale:0-100, higher scores indicate greater intensity of attribute.|Units on scale|Mean|29.9|29.9|Standard Deviation|19.9|19.9|||
4239650|NCT00663052|4063223|B3|Sleep Snoring||Mean Medical Outcomes Study (MOS) Sleep Scale Scores|MOS scale has 12 questions to assess sleep quality & quantity: 1)time to fall asleep, 2)hours of sleep/night in past 4 weeks,3)sleep not peaceful, 4)got enough sleep to feel rested in morning,5)awaken short of breath/headache 6)feel drowsy in day,7)trouble going to sleep, 8)wake up during sleep; trouble going back to sleep,9)trouble staying awake in day, 10)Snoring,11)take naps in day,12)get amount of sleep needed. Sleep problem index(SPI) I:mean of 4,5,7,8,9,12; SPI II:mean of 1,3,4,5,6,7,8,9,12. All reported responses are on scale:0-100, higher scores indicate greater intensity of attribute.|Units on scale|Mean|41.9|41.9|Standard Deviation|30.5|30.5|||
4239651|NCT00663052|4063224|B2|Sleep Snoring||Mean Medical Outcomes Study (MOS) Sleep Scale Scores|MOS scale has 12 questions to assess sleep quality & quantity: 1)time to fall asleep, 2)hours of sleep/night in past 4 weeks,3)sleep not peaceful, 4)got enough sleep to feel rested in morning,5)awaken short of breath/headache 6)feel drowsy in day,7)trouble going to sleep, 8)wake up during sleep; trouble going back to sleep,9)trouble staying awake in day, 10)Snoring,11)take naps in day,12)get amount of sleep needed. Sleep problem index(SPI) I:mean of 4,5,7,8,9,12; SPI II:mean of 1,3,4,5,6,7,8,9,12. All reported responses are on scale:0-100, higher scores indicate greater intensity of attribute.|Units on scale|Mean|45.7|45.7|Standard Deviation|31.0|31.0|||
4239652|NCT00663052|4063225|B1|Sleep Snoring||Mean Medical Outcomes Study (MOS) Sleep Scale Scores|MOS scale has 12 questions to assess sleep quality & quantity: 1)time to fall asleep, 2)hours of sleep/night in past 4 weeks,3)sleep not peaceful, 4)got enough sleep to feel rested in morning,5)awaken short of breath/headache 6)feel drowsy in day,7)trouble going to sleep, 8)wake up during sleep; trouble going back to sleep,9)trouble staying awake in day, 10)Snoring,11)take naps in day,12)get amount of sleep needed. Sleep problem index(SPI) I:mean of 4,5,7,8,9,12; SPI II:mean of 1,3,4,5,6,7,8,9,12. All reported responses are on scale:0-100, higher scores indicate greater intensity of attribute.|Units on scale|Mean|37.9|37.9|Standard Deviation|29.6|29.6|||
4239653|NCT00663052|4063223|B3|Percent Work Time Missed||Work Productivity and Activity Impairment: Psoriasis (WPAI:PSO)|WPAI:PSO - participant rated questionnaire to assess effect of psoriasis on ability to work and perform regular activities in 4 areas: percent activity impairment (0 [no effect on daily activities] to 100 [psoriasis completely prevented from doing daily activities]), percent impairment while working (0 [no effect] to 100 [completely prevented from working]); percent work time missed due to psoriasis, and percent overall work impairment (0 [no effect] to 100 [completely prevented from working]).|Percentage of indicated parameter|Mean|5.45|5.45|Standard Deviation|17.67|17.67|||
4239654|NCT00663052|4063224|B2|Percent Work Time Missed||Work Productivity and Activity Impairment: Psoriasis (WPAI:PSO)|WPAI:PSO - participant rated questionnaire to assess effect of psoriasis on ability to work and perform regular activities in 4 areas: percent activity impairment (0 [no effect on daily activities] to 100 [psoriasis completely prevented from doing daily activities]), percent impairment while working (0 [no effect] to 100 [completely prevented from working]); percent work time missed due to psoriasis, and percent overall work impairment (0 [no effect] to 100 [completely prevented from working]).|Percentage of indicated parameter|Mean|7.19|7.19|Standard Deviation|18.92|18.92|||
4239655|NCT00663052|4063225|B1|Percent Work Time Missed||Work Productivity and Activity Impairment: Psoriasis (WPAI:PSO)|WPAI:PSO - participant rated questionnaire to assess effect of psoriasis on ability to work and perform regular activities in 4 areas: percent activity impairment (0 [no effect on daily activities] to 100 [psoriasis completely prevented from doing daily activities]), percent impairment while working (0 [no effect] to 100 [completely prevented from working]); percent work time missed due to psoriasis, and percent overall work impairment (0 [no effect] to 100 [completely prevented from working]).|Percentage of indicated parameter|Mean|3.60|3.6|Standard Deviation|16.14|16.14|||
4239656|NCT00663052|4063223|B3|Percent Overall Work Impairment Due to Problem||Work Productivity and Activity Impairment: Psoriasis (WPAI:PSO)|WPAI:PSO - participant rated questionnaire to assess effect of psoriasis on ability to work and perform regular activities in 4 areas: percent activity impairment (0 [no effect on daily activities] to 100 [psoriasis completely prevented from doing daily activities]), percent impairment while working (0 [no effect] to 100 [completely prevented from working]); percent work time missed due to psoriasis, and percent overall work impairment (0 [no effect] to 100 [completely prevented from working]).|Percentage of indicated parameter|Mean|27.54|27.54|Standard Deviation|26.30|26.3|||
4239657|NCT00663052|4063224|B2|Percent Overall Work Impairment Due to Problem||Work Productivity and Activity Impairment: Psoriasis (WPAI:PSO)|WPAI:PSO - participant rated questionnaire to assess effect of psoriasis on ability to work and perform regular activities in 4 areas: percent activity impairment (0 [no effect on daily activities] to 100 [psoriasis completely prevented from doing daily activities]), percent impairment while working (0 [no effect] to 100 [completely prevented from working]); percent work time missed due to psoriasis, and percent overall work impairment (0 [no effect] to 100 [completely prevented from working]).|Percentage of indicated parameter|Mean|29.51|29.51|Standard Deviation|28.66|28.66|||
4239658|NCT00663052|4063225|B1|Percent Overall Work Impairment Due to Problem||Work Productivity and Activity Impairment: Psoriasis (WPAI:PSO)|WPAI:PSO - participant rated questionnaire to assess effect of psoriasis on ability to work and perform regular activities in 4 areas: percent activity impairment (0 [no effect on daily activities] to 100 [psoriasis completely prevented from doing daily activities]), percent impairment while working (0 [no effect] to 100 [completely prevented from working]); percent work time missed due to psoriasis, and percent overall work impairment (0 [no effect] to 100 [completely prevented from working]).|Percentage of indicated parameter|Mean|25.45|25.45|Standard Deviation|23.53|23.53|||
4239659|NCT00663052|4063223|B3|Percent Impairment While Working Due to Problem||Work Productivity and Activity Impairment: Psoriasis (WPAI:PSO)|WPAI:PSO - participant rated questionnaire to assess effect of psoriasis on ability to work and perform regular activities in 4 areas: percent activity impairment (0 [no effect on daily activities] to 100 [psoriasis completely prevented from doing daily activities]), percent impairment while working (0 [no effect] to 100 [completely prevented from working]); percent work time missed due to psoriasis, and percent overall work impairment (0 [no effect] to 100 [completely prevented from working]).|Percentage of indicated parameter|Mean|25.27|25.27|Standard Deviation|25.29|25.29|||
4239749|NCT00663052|4063223|B3|PGA Clear (0)||Number of Participants Achieving the Physician Global Assessment (PGA) of Psoriasis Reponses|PGA of Psoriasis: score based on dermatologist's assessment of head, scalp, and neck psoriasis (averaged over all lesions). The PGA of Psoriasis scale ranges from 0 (no psorasis) to 5 (severe disease). PGA score of 0 = Status of Clear; 1 = Almost Clear and 2 = Mild.|Participants|Number|0|0.0||||||
4239660|NCT00663052|4063224|B2|Percent Impairment While Working Due to Problem||Work Productivity and Activity Impairment: Psoriasis (WPAI:PSO)|WPAI:PSO - participant rated questionnaire to assess effect of psoriasis on ability to work and perform regular activities in 4 areas: percent activity impairment (0 [no effect on daily activities] to 100 [psoriasis completely prevented from doing daily activities]), percent impairment while working (0 [no effect] to 100 [completely prevented from working]); percent work time missed due to psoriasis, and percent overall work impairment (0 [no effect] to 100 [completely prevented from working]).|Percentage of indicated parameter|Mean|26.09|26.09|Standard Deviation|27.08|27.08|||
4239661|NCT00663052|4063225|B1|Percent Impairment While Working Due to Problem||Work Productivity and Activity Impairment: Psoriasis (WPAI:PSO)|WPAI:PSO - participant rated questionnaire to assess effect of psoriasis on ability to work and perform regular activities in 4 areas: percent activity impairment (0 [no effect on daily activities] to 100 [psoriasis completely prevented from doing daily activities]), percent impairment while working (0 [no effect] to 100 [completely prevented from working]); percent work time missed due to psoriasis, and percent overall work impairment (0 [no effect] to 100 [completely prevented from working]).|Percentage of indicated parameter|Mean|24.36|24.36|Standard Deviation|23.28|23.28|||
4239662|NCT00663052|4063223|B3|Percent Activity Impairment Due to Problem||Work Productivity and Activity Impairment: Psoriasis (WPAI:PSO)|WPAI:PSO - participant rated questionnaire to assess effect of psoriasis on ability to work and perform regular activities in 4 areas: percent activity impairment (0 [no effect on daily activities] to 100 [psoriasis completely prevented from doing daily activities]), percent impairment while working (0 [no effect] to 100 [completely prevented from working]); percent work time missed due to psoriasis, and percent overall work impairment (0 [no effect] to 100 [completely prevented from working]).|Percentage of indicated parameter|Mean|39.96|39.96|Standard Deviation|29.93|29.93|||
4239663|NCT00663052|4063224|B2|Percent Activity Impairment Due to Problem||Work Productivity and Activity Impairment: Psoriasis (WPAI:PSO)|WPAI:PSO - participant rated questionnaire to assess effect of psoriasis on ability to work and perform regular activities in 4 areas: percent activity impairment (0 [no effect on daily activities] to 100 [psoriasis completely prevented from doing daily activities]), percent impairment while working (0 [no effect] to 100 [completely prevented from working]); percent work time missed due to psoriasis, and percent overall work impairment (0 [no effect] to 100 [completely prevented from working]).|Percentage of indicated parameter|Mean|40.15|40.15|Standard Deviation|30.94|30.94|||
4239664|NCT00663052|4063225|B1|Percent Activity Impairment Due to Problem||Work Productivity and Activity Impairment: Psoriasis (WPAI:PSO)|WPAI:PSO - participant rated questionnaire to assess effect of psoriasis on ability to work and perform regular activities in 4 areas: percent activity impairment (0 [no effect on daily activities] to 100 [psoriasis completely prevented from doing daily activities]), percent impairment while working (0 [no effect] to 100 [completely prevented from working]); percent work time missed due to psoriasis, and percent overall work impairment (0 [no effect] to 100 [completely prevented from working]).|Percentage of indicated parameter|Mean|39.77|39.77|Standard Deviation|28.96|28.96|||
4239665|NCT00663052|4063223|B3|HADS Depression Score||Mean Hospital Anxiety and Depression Scale (HADS) Anxiety and Depression Scores|HADS: participant rated questionnaire with 2 subscales for anxiety and depression. Each subscale comprised of 7 items with range 0 (no presence of anxiety or depression) to 3 (severe feeling of anxiety or depression). Total score 0 to 21 for each subscale; higher score indicates greater severity of anxiety and depression symptoms.|Units on scale|Mean|6.2|6.2|Standard Deviation|4.1|4.1|||
4239666|NCT00663052|4063224|B2|HADS Depression Score||Mean Hospital Anxiety and Depression Scale (HADS) Anxiety and Depression Scores|HADS: participant rated questionnaire with 2 subscales for anxiety and depression. Each subscale comprised of 7 items with range 0 (no presence of anxiety or depression) to 3 (severe feeling of anxiety or depression). Total score 0 to 21 for each subscale; higher score indicates greater severity of anxiety and depression symptoms.|Units on scale|Mean|6.5|6.5|Standard Deviation|4.1|4.1|||
4239667|NCT00663052|4063225|B1|HADS Depression Score||Mean Hospital Anxiety and Depression Scale (HADS) Anxiety and Depression Scores|HADS: participant rated questionnaire with 2 subscales for anxiety and depression. Each subscale comprised of 7 items with range 0 (no presence of anxiety or depression) to 3 (severe feeling of anxiety or depression). Total score 0 to 21 for each subscale; higher score indicates greater severity of anxiety and depression symptoms.|Units on scale|Mean|6.0|6.0|Standard Deviation|4.1|4.1|||
4239668|NCT00663052|4063223|B3|HADS Anxiety Score||Mean Hospital Anxiety and Depression Scale (HADS) Anxiety and Depression Scores|HADS: participant rated questionnaire with 2 subscales for anxiety and depression. Each subscale comprised of 7 items with range 0 (no presence of anxiety or depression) to 3 (severe feeling of anxiety or depression). Total score 0 to 21 for each subscale; higher score indicates greater severity of anxiety and depression symptoms.|Units on scale|Mean|7.0|7.0|Standard Deviation|4.3|4.3|||
4239669|NCT00663052|4063224|B2|HADS Anxiety Score||Mean Hospital Anxiety and Depression Scale (HADS) Anxiety and Depression Scores|HADS: participant rated questionnaire with 2 subscales for anxiety and depression. Each subscale comprised of 7 items with range 0 (no presence of anxiety or depression) to 3 (severe feeling of anxiety or depression). Total score 0 to 21 for each subscale; higher score indicates greater severity of anxiety and depression symptoms.|Units on scale|Mean|6.9|6.9|Standard Deviation|4.1|4.1|||
4239670|NCT00663052|4063225|B1|HADS Anxiety Score||Mean Hospital Anxiety and Depression Scale (HADS) Anxiety and Depression Scores|HADS: participant rated questionnaire with 2 subscales for anxiety and depression. Each subscale comprised of 7 items with range 0 (no presence of anxiety or depression) to 3 (severe feeling of anxiety or depression). Total score 0 to 21 for each subscale; higher score indicates greater severity of anxiety and depression symptoms.|Units on scale|Mean|7.2|7.2|Standard Deviation|4.4|4.4|||
4239671|NCT00663052|4063223|B3|||Mean Euro Quality of Life 5 Dimension (EQ-5D) Utility Index Scores|"EQ-5D: participant rated questionnaire to assess health-related quality of life in terms of a single utility score. Health State Profile component assesses level of current health for 5 domains; 1 indicates better health state (no problems); 3 indicates worst health state (example confined to bed)."|Units on scale|Mean|0.65|0.65|Standard Deviation|0.31|0.31|||
4239750|NCT00663052|4063224|B2|PGA Clear (0)||Number of Participants Achieving the Physician Global Assessment (PGA) of Psoriasis Reponses|PGA of Psoriasis: score based on dermatologist's assessment of head, scalp, and neck psoriasis (averaged over all lesions). The PGA of Psoriasis scale ranges from 0 (no psorasis) to 5 (severe disease). PGA score of 0 = Status of Clear; 1 = Almost Clear and 2 = Mild.|Participants|Number|0|0.0||||||
4239673|NCT00663052|4063225|B1|||Mean Euro Quality of Life 5 Dimension (EQ-5D) Utility Index Scores|"EQ-5D: participant rated questionnaire to assess health-related quality of life in terms of a single utility score. Health State Profile component assesses level of current health for 5 domains; 1 indicates better health state (no problems); 3 indicates worst health state (example confined to bed)."|Units on scale|Mean|0.65|0.65|Standard Deviation|0.30|0.3|||
4239674|NCT00663052|4063223|B3|||Mean Dermatology Life Quality Index (DLQI) Total Score|DLQI is the dermatology-specific quality of life measure used for psoriatic population. The 10-item questionnaire has a score range of 0 to 30 with higher scores indicating poor quality of life. An estimate of the minimal clinically important difference of the DLQI total score is a 5 point improvement. Total score range: 0 (best) to 30 (worst).|Units on scale|Mean|14.6|14.6|Standard Deviation|7.7|7.7|||
4239675|NCT00663052|4063224|B2|||Mean Dermatology Life Quality Index (DLQI) Total Score|DLQI is the dermatology-specific quality of life measure used for psoriatic population. The 10-item questionnaire has a score range of 0 to 30 with higher scores indicating poor quality of life. An estimate of the minimal clinically important difference of the DLQI total score is a 5 point improvement. Total score range: 0 (best) to 30 (worst).|Units on scale|Mean|15.0|15.0|Standard Deviation|8.0|8.0|||
4239676|NCT00663052|4063225|B1|||Mean Dermatology Life Quality Index (DLQI) Total Score|DLQI is the dermatology-specific quality of life measure used for psoriatic population. The 10-item questionnaire has a score range of 0 to 30 with higher scores indicating poor quality of life. An estimate of the minimal clinically important difference of the DLQI total score is a 5 point improvement. Total score range: 0 (best) to 30 (worst).|Units on scale|Mean|14.1|14.1|Standard Deviation|7.3|7.3|||
4239677|NCT00663052|4063223|B3|Satisfaction with primary psoriasis treatment||Number of Participants Who were Considered Satisfied According to Psoriasis Subject Satisfaction|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Participants|Number|59|59.0||||||
4239678|NCT00663052|4063224|B2|Satisfaction with primary psoriasis treatment||Number of Participants Who were Considered Satisfied According to Psoriasis Subject Satisfaction|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Participants|Number|28|28.0||||||
4239679|NCT00663052|4063225|B1|Satisfaction with primary psoriasis treatment||Number of Participants Who were Considered Satisfied According to Psoriasis Subject Satisfaction|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Participants|Number|31|31.0||||||
4239680|NCT00663052|4063223|B3|Satisfaction with health state||Number of Participants Who were Considered Satisfied According to Psoriasis Subject Satisfaction|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Participants|Number|53|53.0||||||
4239681|NCT00663052|4063224|B2|Satisfaction with health state||Number of Participants Who were Considered Satisfied According to Psoriasis Subject Satisfaction|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Participants|Number|28|28.0||||||
4239682|NCT00663052|4063225|B1|Satisfaction with health state||Number of Participants Who were Considered Satisfied According to Psoriasis Subject Satisfaction|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Participants|Number|25|25.0||||||
4239683|NCT00663052|4063223|B3|Would like to continue with my current treatment||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|2.1|2.1|Standard Deviation|1.6|1.6|||
4239684|NCT00663052|4063224|B2|Would like to continue with my current treatment||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|2.2|2.2|Standard Deviation|1.6|1.6|||
4239685|NCT00663052|4063225|B1|Would like to continue with my current treatment||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|2.0|2.0|Standard Deviation|1.6|1.6|||
4239686|NCT00663052|4063223|B3|Satisfaction with psoriasis treatment in general||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|1.4|1.4|Standard Deviation|1.1|1.1|||
4239825|NCT00662909|4063354|B4|Urge Incontinence||Type of overactive bladder (OAB)||participants|Number|394|394.0||||||
4239826|NCT00662909|4063355|B3|Urge Incontinence||Type of overactive bladder (OAB)||participants|Number|123|123.0||||||
4239687|NCT00663052|4063224|B2|Satisfaction with psoriasis treatment in general||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|1.4|1.4|Standard Deviation|1.1|1.1|||
4239688|NCT00663052|4063225|B1|Satisfaction with psoriasis treatment in general||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|1.4|1.4|Standard Deviation|1.2|1.2|||
4239689|NCT00663052|4063223|B3|How your skin affects social, leisure activities||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|1.4|1.4|Standard Deviation|1.1|1.1|||
4239690|NCT00663052|4063224|B2|How your skin affects social, leisure activities||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|1.3|1.3|Standard Deviation|1.0|1.0|||
4239691|NCT00663052|4063225|B1|How your skin affects social, leisure activities||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|1.5|1.5|Standard Deviation|1.2|1.2|||
4239692|NCT00663052|4063223|B3|How others respond to your appearance||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|1.7|1.7|Standard Deviation|1.0|1.0|||
4239693|NCT00663052|4063224|B2|How others respond to your appearance||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|1.8|1.8|Standard Deviation|1.0|1.0|||
4239694|NCT00663052|4063225|B1|How others respond to your appearance||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|1.6|1.6|Standard Deviation|1.0|1.0|||
4239695|NCT00663052|4063223|B3|Fatigue||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|1.9|1.9|Standard Deviation|1.0|1.0|||
4239696|NCT00663052|4063224|B2|Fatigue||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|1.8|1.8|Standard Deviation|1.0|1.0|||
4239697|NCT00663052|4063225|B1|Fatigue||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|2.0|2.0|Standard Deviation|1.0|1.0|||
4239698|NCT00663052|4063223|B3|Depression||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|1.9|1.9|Standard Deviation|1.1|1.1|||
4239699|NCT00663052|4063224|B2|Depression||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|1.9|1.9|Standard Deviation|1.1|1.1|||
4239700|NCT00663052|4063225|B1|Depression||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|2.0|2.0|Standard Deviation|1.1|1.1|||
4239827|NCT00662909|4063356|B2|Urge Incontinence||Type of overactive bladder (OAB)||participants|Number|144|144.0||||||
4239701|NCT00663052|4063223|B3|Anxiety||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|1.7|1.7|Standard Deviation|1.1|1.1|||
4239702|NCT00663052|4063224|B2|Anxiety||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|1.7|1.7|Standard Deviation|1.1|1.1|||
4239703|NCT00663052|4063225|B1|Anxiety||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|1.8|1.8|Standard Deviation|1.1|1.1|||
4239704|NCT00663052|4063223|B3|Comfort level with your appearance||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|1.3|1.3|Standard Deviation|1.0|1.0|||
4239705|NCT00663052|4063224|B2|Comfort level with your appearance||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|1.2|1.2|Standard Deviation|1.0|1.0|||
4239706|NCT00663052|4063225|B1|Comfort level with your appearance||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|1.3|1.3|Standard Deviation|1.1|1.1|||
4239707|NCT00663052|4063223|B3|Joint pain||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|1.8|1.8|Standard Deviation|1.3|1.3|||
4239708|NCT00663052|4063224|B2|Joint pain||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|1.8|1.8|Standard Deviation|1.4|1.4|||
4239709|NCT00663052|4063225|B1|Joint pain||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|1.8|1.8|Standard Deviation|1.3|1.3|||
4239710|NCT00663052|4063223|B3|Skin pain||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|1.5|1.5|Standard Deviation|1.1|1.1|||
4239711|NCT00663052|4063224|B2|Skin pain||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|1.5|1.5|Standard Deviation|1.1|1.1|||
4239712|NCT00663052|4063225|B1|Skin pain||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|1.5|1.5|Standard Deviation|1.2|1.2|||
4239713|NCT00663052|4063223|B3|Burning sensation in the skin||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|1.5|1.5|Standard Deviation|1.1|1.1|||
4239714|NCT00663052|4063224|B2|Burning sensation in the skin||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|1.5|1.5|Standard Deviation|1.1|1.1|||
4239795|NCT00662909|4063356|B2|||Mean number of nocturia episodes per 24 hours|The average number of times a patient waked at night to urinate (excluding incontinence only episodes) recorded for 3 days prior to the Baseline visit in the patient micturition diary.|nocturia episodes|Mean|1.89|1.89|Standard Deviation|1.602|1.602|||
4239715|NCT00663052|4063225|B1|Burning sensation in the skin||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|1.5|1.5|Standard Deviation|1.1|1.1|||
4239716|NCT00663052|4063223|B3|Skin bleeding||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|1.7|1.7|Standard Deviation|1.1|1.1|||
4239717|NCT00663052|4063224|B2|Skin bleeding||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|1.8|1.8|Standard Deviation|1.2|1.2|||
4239718|NCT00663052|4063225|B1|Skin bleeding||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|1.7|1.7|Standard Deviation|1.0|1.0|||
4239719|NCT00663052|4063223|B3|Skin tightness||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|1.2|1.2|Standard Deviation|1.0|1.0|||
4239720|NCT00663052|4063224|B2|Skin tightness||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|1.2|1.2|Standard Deviation|1.0|1.0|||
4239721|NCT00663052|4063225|B1|Skin tightness||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|1.2|1.2|Standard Deviation|0.9|0.9|||
4239722|NCT00663052|4063223|B3|Skin redness||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|1.0|1.0|Standard Deviation|0.9|0.9|||
4239723|NCT00663052|4063224|B2|Skin redness||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|1.0|1.0|Standard Deviation|0.9|0.9|||
4239724|NCT00663052|4063225|B1|Skin redness||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|1.1|1.1|Standard Deviation|0.9|0.9|||
4239725|NCT00663052|4063223|B3|Flaking skin||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|1.0|1.0|Standard Deviation|0.9|0.9|||
4239726|NCT00663052|4063224|B2|Flaking skin||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|1.0|1.0|Standard Deviation|0.9|0.9|||
4239727|NCT00663052|4063225|B1|Flaking skin||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|1.0|1.0|Standard Deviation|0.9|0.9|||
4239728|NCT00663052|4063223|B3|Overall appearance of your skin||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|0.9|0.9|Standard Deviation|0.9|0.9|||
4239796|NCT00662909|4063357|B1|||Mean number of nocturia episodes per 24 hours|The average number of times a patient waked at night to urinate (excluding incontinence only episodes) recorded for 3 days prior to the Baseline visit in the patient micturition diary.|nocturia episodes|Mean|1.96|1.96|Standard Deviation|1.639|1.639|||
4239729|NCT00663052|4063224|B2|Overall appearance of your skin||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|0.9|0.9|Standard Deviation|0.9|0.9|||
4239730|NCT00663052|4063225|B1|Overall appearance of your skin||Mean Psoriasis Subject Satisfaction Questionnaire (PSSQ) Scores|PSSQ: participant’s assessment which includes 18 items, 16 items (1-16) scored using Likert score with scores from 0 (very dissatisfied) to 4 (very satisfied) and 5 (never had this problem). Only those participants who do not have score of 5 at baseline were included in the item 1-16 analyses. Two items (17, 18) are with Yes/No answers.|Units on scale|Mean|0.9|0.9|Standard Deviation|0.8|0.8|||
4239731|NCT00663052|4063223|B3|Consider primary psoriasis therapy satisfactory||Number of Participants Evaluated Using Psoriasis Physician Satisfaction Questionnaire (PPSQ)|PPSQ includes two global satisfaction questions to which physicians respond either ‘satisfactory’ or ‘not satisfactory'.|Participants|Number|32|32.0||||||
4239732|NCT00663052|4063224|B2|Consider primary psoriasis therapy satisfactory||Number of Participants Evaluated Using Psoriasis Physician Satisfaction Questionnaire (PPSQ)|PPSQ includes two global satisfaction questions to which physicians respond either ‘satisfactory’ or ‘not satisfactory'.|Participants|Number|17|17.0||||||
4239733|NCT00663052|4063225|B1|Consider primary psoriasis therapy satisfactory||Number of Participants Evaluated Using Psoriasis Physician Satisfaction Questionnaire (PPSQ)|PPSQ includes two global satisfaction questions to which physicians respond either ‘satisfactory’ or ‘not satisfactory'.|Participants|Number|15|15.0||||||
4239734|NCT00663052|4063223|B3|Consider patient's condition satisfactory||Number of Participants Evaluated Using Psoriasis Physician Satisfaction Questionnaire (PPSQ)|PPSQ includes two global satisfaction questions to which physicians respond either ‘satisfactory’ or ‘not satisfactory'.|Participants|Number|32|32.0||||||
4239735|NCT00663052|4063224|B2|Consider patient's condition satisfactory||Number of Participants Evaluated Using Psoriasis Physician Satisfaction Questionnaire (PPSQ)|PPSQ includes two global satisfaction questions to which physicians respond either ‘satisfactory’ or ‘not satisfactory'.|Participants|Number|16|16.0||||||
4239736|NCT00663052|4063225|B1|Consider patient's condition satisfactory||Number of Participants Evaluated Using Psoriasis Physician Satisfaction Questionnaire (PPSQ)|PPSQ includes two global satisfaction questions to which physicians respond either ‘satisfactory’ or ‘not satisfactory'.|Participants|Number|16|16.0||||||
4239737|NCT00663052|4063223|B3|||Number of Participants Not Using Topical Preparations|Moderate topical steroids to very potent topical steroids, topical vitamin D analogs, topical steroids in combination with vitamin D analogs, and anthralin compounds were prohibited for 14 days before the baseline visit until week 12.|Participants|Number|244|244.0||||||
4239738|NCT00663052|4063224|B2|||Number of Participants Not Using Topical Preparations|Moderate topical steroids to very potent topical steroids, topical vitamin D analogs, topical steroids in combination with vitamin D analogs, and anthralin compounds were prohibited for 14 days before the baseline visit until week 12.|Participants|Number|124|124.0||||||
4239739|NCT00663052|4063225|B1|||Number of Participants Not Using Topical Preparations|Moderate topical steroids to very potent topical steroids, topical vitamin D analogs, topical steroids in combination with vitamin D analogs, and anthralin compounds were prohibited for 14 days before the baseline visit until week 12.|Participants|Number|120|120.0||||||
4239740|NCT00663052|4063223|B3|||Percent Body Surface Area (BSA) of Involvement||Percentage of BSA|Mean|33.0|33.0|Standard Deviation|20.2|20.2|||
4239741|NCT00663052|4063224|B2|||Percent Body Surface Area (BSA) of Involvement||Percentage of BSA|Mean|32.9|32.9|Standard Deviation|21.0|21.0|||
4239742|NCT00663052|4063225|B1|||Percent Body Surface Area (BSA) of Involvement||Percentage of BSA|Mean|33.0|33.0|Standard Deviation|19.4|19.4|||
4239743|NCT00663052|4063223|B3|PGA Clear/Almost Clear/Mild (0,1,2)||Number of Participants Achieving the Physician Global Assessment (PGA) of Psoriasis Reponses|PGA of Psoriasis: score based on dermatologist's assessment of head, scalp, and neck psoriasis (averaged over all lesions). The PGA of Psoriasis scale ranges from 0 (no psorasis) to 5 (severe disease). PGA score of 0 = Status of Clear; 1 = Almost Clear and 2 = Mild.|Participants|Number|30|30.0||||||
4239744|NCT00663052|4063224|B2|PGA Clear/Almost Clear/Mild (0,1,2)||Number of Participants Achieving the Physician Global Assessment (PGA) of Psoriasis Reponses|PGA of Psoriasis: score based on dermatologist's assessment of head, scalp, and neck psoriasis (averaged over all lesions). The PGA of Psoriasis scale ranges from 0 (no psorasis) to 5 (severe disease). PGA score of 0 = Status of Clear; 1 = Almost Clear and 2 = Mild.|Participants|Number|17|17.0||||||
4239745|NCT00663052|4063225|B1|PGA Clear/Almost Clear/Mild (0,1,2)||Number of Participants Achieving the Physician Global Assessment (PGA) of Psoriasis Reponses|PGA of Psoriasis: score based on dermatologist's assessment of head, scalp, and neck psoriasis (averaged over all lesions). The PGA of Psoriasis scale ranges from 0 (no psorasis) to 5 (severe disease). PGA score of 0 = Status of Clear; 1 = Almost Clear and 2 = Mild.|Participants|Number|13|13.0||||||
4239746|NCT00663052|4063223|B3|PGA Clear/Almost Clear (0,1)||Number of Participants Achieving the Physician Global Assessment (PGA) of Psoriasis Reponses|PGA of Psoriasis: score based on dermatologist's assessment of head, scalp, and neck psoriasis (averaged over all lesions). The PGA of Psoriasis scale ranges from 0 (no psorasis) to 5 (severe disease). PGA score of 0 = Status of Clear; 1 = Almost Clear and 2 = Mild.|Participants|Number|1|1.0||||||
4239747|NCT00663052|4063224|B2|PGA Clear/Almost Clear (0,1)||Number of Participants Achieving the Physician Global Assessment (PGA) of Psoriasis Reponses|PGA of Psoriasis: score based on dermatologist's assessment of head, scalp, and neck psoriasis (averaged over all lesions). The PGA of Psoriasis scale ranges from 0 (no psorasis) to 5 (severe disease). PGA score of 0 = Status of Clear; 1 = Almost Clear and 2 = Mild.|Participants|Number|1|1.0||||||
4239748|NCT00663052|4063225|B1|PGA Clear/Almost Clear (0,1)||Number of Participants Achieving the Physician Global Assessment (PGA) of Psoriasis Reponses|PGA of Psoriasis: score based on dermatologist's assessment of head, scalp, and neck psoriasis (averaged over all lesions). The PGA of Psoriasis scale ranges from 0 (no psorasis) to 5 (severe disease). PGA score of 0 = Status of Clear; 1 = Almost Clear and 2 = Mild.|Participants|Number|0|0.0||||||
4239821|NCT00662909|4063354|B4|Mixed||Type of overactive bladder (OAB)||participants|Number|506|506.0||||||
4239751|NCT00663052|4063225|B1|PGA Clear (0)||Number of Participants Achieving the Physician Global Assessment (PGA) of Psoriasis Reponses|PGA of Psoriasis: score based on dermatologist's assessment of head, scalp, and neck psoriasis (averaged over all lesions). The PGA of Psoriasis scale ranges from 0 (no psorasis) to 5 (severe disease). PGA score of 0 = Status of Clear; 1 = Almost Clear and 2 = Mild.|Participants|Number|0|0.0||||||
4239752|NCT00663052|4063223|B3|||Mean Psoriasis Area and Severity Index (PASI) Score|PASI: Combined assessment of lesion severity and area affected into single score; range: 0(no disease) to 72(maximal disease). Body was divided into 4 sections (head, arms, trunk, legs); each area was scored by itself and scores were combined for final PASI.|Units on scale|Mean|21.2|21.2|Standard Deviation|9.4|9.4|||
4239753|NCT00663052|4063224|B2|||Mean Psoriasis Area and Severity Index (PASI) Score|PASI: Combined assessment of lesion severity and area affected into single score; range: 0(no disease) to 72(maximal disease). Body was divided into 4 sections (head, arms, trunk, legs); each area was scored by itself and scores were combined for final PASI.|Units on scale|Mean|20.9|20.9|Standard Deviation|9.4|9.4|||
4239754|NCT00663052|4063225|B1|||Mean Psoriasis Area and Severity Index (PASI) Score|PASI: Combined assessment of lesion severity and area affected into single score; range: 0(no disease) to 72(maximal disease). Body was divided into 4 sections (head, arms, trunk, legs); each area was scored by itself and scores were combined for final PASI.|Units on scale|Mean|21.4|21.4|Standard Deviation|9.4|9.4|||
4239755|NCT00663052|4063223|B3||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4239756|NCT00663052|4063224|B2||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4239757|NCT00663052|4063225|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4239758|NCT00663052|4063223|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4239759|NCT00663052|4063224|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4239760|NCT00663052|4063225|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4239761|NCT00663052|4063223|B3|||Age||Years|Mean|43.90|43.9|Standard Deviation|12.66|12.66|||
4239762|NCT00663052|4063224|B2|||Age||Years|Mean|43.85|43.85|Standard Deviation|12.69|12.69|||
4239763|NCT00663052|4063225|B1|||Age||Years|Mean|43.95|43.95|Standard Deviation|12.68|12.68|||
4239764|NCT00663039|4063306|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4239765|NCT00663039|4063306|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4239766|NCT00663039|4063306|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4239767|NCT00663039|4063306|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4239768|NCT00663039|4063306|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4239769|NCT00663039|4063306|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4239770|NCT00663039|4063306|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4239771|NCT00663039|4063306|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4239772|NCT00663039|4063306|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4239773|NCT00663039|4063306|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4239774|NCT00663039|4063306|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4239775|NCT00663039|4063306|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4239776|NCT00663039|4063306|B1|||Age||years|Mean|51.9|51.9|Standard Deviation|10.54|10.54|||
4239777|NCT00663026|4063329|B4||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4239778|NCT00663026|4063330|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4239779|NCT00663026|4063331|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4239780|NCT00663026|4063332|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4239781|NCT00663026|4063329|B4||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4239782|NCT00663026|4063330|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4239783|NCT00663026|4063331|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4239784|NCT00663026|4063332|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4239785|NCT00663026|4063329|B4|||Age||years|Mean|72.90|72.9|Standard Deviation|8.85|8.85|||
4239786|NCT00663026|4063330|B3|||Age||years|Mean|72.42|72.42|Standard Deviation|8.83|8.83|||
4239787|NCT00663026|4063331|B2|||Age||years|Mean|71.28|71.28|Standard Deviation|8.73|8.73|||
4239788|NCT00663026|4063332|B1|||Age||years|Mean|76.16|76.16|Standard Deviation|8.63|8.63|||
4239789|NCT00662909|4063354|B4|||Mean number of pads used per 24 hours|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|pads|Mean|0.95|0.95|Standard Deviation|1.741|1.741|||
4239790|NCT00662909|4063355|B3|||Mean number of pads used per 24 hours|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|pads|Mean|0.90|0.9|Standard Deviation|1.722|1.722|||
4239791|NCT00662909|4063356|B2|||Mean number of pads used per 24 hours|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|pads|Mean|0.94|0.94|Standard Deviation|1.685|1.685|||
4239792|NCT00662909|4063357|B1|||Mean number of pads used per 24 hours|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|pads|Mean|0.99|0.99|Standard Deviation|1.814|1.814|||
4239793|NCT00662909|4063354|B4|||Mean number of nocturia episodes per 24 hours|The average number of times a patient waked at night to urinate (excluding incontinence only episodes) recorded for 3 days prior to the Baseline visit in the patient micturition diary.|nocturia episodes|Mean|1.97|1.97|Standard Deviation|1.652|1.652|||
4239794|NCT00662909|4063355|B3|||Mean number of nocturia episodes per 24 hours|The average number of times a patient waked at night to urinate (excluding incontinence only episodes) recorded for 3 days prior to the Baseline visit in the patient micturition diary.|nocturia episodes|Mean|2.06|2.06|Standard Deviation|1.715|1.715|||
4239797|NCT00662909|4063354|B4|||Mean level of urgency|Average of patients’ ratings on the degree of urgency associated with each micturition and/or incontinence episode recorded in a 3-day micturition diary according to the following 5-point categorical scale (Patient Perception of Intensity of Urgency Scale): 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet.|Scores on a scale|Mean|2.45|2.45|Standard Deviation|0.541|0.541|||
4239798|NCT00662909|4063355|B3|||Mean level of urgency|Average of patients’ ratings on the degree of urgency associated with each micturition and/or incontinence episode recorded in a 3-day micturition diary according to the following 5-point categorical scale (Patient Perception of Intensity of Urgency Scale): 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet.|Scores on a scale|Mean|2.45|2.45|Standard Deviation|0.544|0.544|||
4239799|NCT00662909|4063356|B2|||Mean level of urgency|Average of patients’ ratings on the degree of urgency associated with each micturition and/or incontinence episode recorded in a 3-day micturition diary according to the following 5-point categorical scale (Patient Perception of Intensity of Urgency Scale): 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet.|Scores on a scale|Mean|2.46|2.46|Standard Deviation|0.541|0.541|||
4239800|NCT00662909|4063357|B1|||Mean level of urgency|Average of patients’ ratings on the degree of urgency associated with each micturition and/or incontinence episode recorded in a 3-day micturition diary according to the following 5-point categorical scale (Patient Perception of Intensity of Urgency Scale): 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet.|Scores on a scale|Mean|2.45|2.45|Standard Deviation|0.538|0.538|||
4239801|NCT00662909|4063354|B4|||Mean number of urgency episodes (grade 3 or 4) per 24 hours|Urgency episodes were those classified by the patient in a 3-day micturition diary as 3 or 4 on the following 5-point categorical scale (Patient Perception of Intensity of Urgency Scale): 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet.|urgency episodes|Mean|5.83|5.83|Standard Deviation|3.573|3.573|||
4239802|NCT00662909|4063355|B3|||Mean number of urgency episodes (grade 3 or 4) per 24 hours|Urgency episodes were those classified by the patient in a 3-day micturition diary as 3 or 4 on the following 5-point categorical scale (Patient Perception of Intensity of Urgency Scale): 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet.|urgency episodes|Mean|5.95|5.95|Standard Deviation|3.610|3.61|||
4239803|NCT00662909|4063356|B2|||Mean number of urgency episodes (grade 3 or 4) per 24 hours|Urgency episodes were those classified by the patient in a 3-day micturition diary as 3 or 4 on the following 5-point categorical scale (Patient Perception of Intensity of Urgency Scale): 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet.|urgency episodes|Mean|5.92|5.92|Standard Deviation|3.829|3.829|||
4239804|NCT00662909|4063357|B1|||Mean number of urgency episodes (grade 3 or 4) per 24 hours|Urgency episodes were those classified by the patient in a 3-day micturition diary as 3 or 4 on the following 5-point categorical scale (Patient Perception of Intensity of Urgency Scale): 0: No urgency; 1: Mild urgency; 2: Moderate urgency, could delay voiding a short while; 3: Severe urgency, could not delay voiding; 4: Urge incontinence, leaked before arriving to the toilet.|urgency episodes|Mean|5.63|5.63|Standard Deviation|3.265|3.265|||
4239805|NCT00662909|4063354|B4|||Mean volume voided per micturition|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|mL|Mean|156.7|156.7|Standard Deviation|59.64|59.64|||
4239806|NCT00662909|4063355|B3|||Mean volume voided per micturition|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|mL|Mean|157.6|157.6|Standard Deviation|60.20|60.2|||
4239807|NCT00662909|4063356|B2|||Mean volume voided per micturition|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|mL|Mean|155.2|155.2|Standard Deviation|58.67|58.67|||
4239808|NCT00662909|4063357|B1|||Mean volume voided per micturition|Recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|mL|Mean|157.2|157.2|Standard Deviation|60.16|60.16|||
4239809|NCT00662909|4063354|B4|||Mean number of micturitions per 24 hours|The average number of micturitions (urinations) recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|micturitions|Mean|11.66|11.66|Standard Deviation|3.358|3.358|||
4239810|NCT00662909|4063355|B3|||Mean number of micturitions per 24 hours|The average number of micturitions (urinations) recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|micturitions|Mean|11.69|11.69|Standard Deviation|3.357|3.357|||
4239811|NCT00662909|4063356|B2|||Mean number of micturitions per 24 hours|The average number of micturitions (urinations) recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|micturitions|Mean|11.78|11.78|Standard Deviation|3.447|3.447|||
4239812|NCT00662909|4063357|B1|||Mean number of micturitions per 24 hours|The average number of micturitions (urinations) recorded by the patient in a micturition diary for 3 days prior to the Baseline visit.|micturitions|Mean|11.52|11.52|Standard Deviation|3.273|3.273|||
4239813|NCT00662909|4063354|B4|||Duration of OAB symptoms||months|Mean|88.4|88.4|Standard Deviation|103.02|103.02|||
4239814|NCT00662909|4063355|B3|||Duration of OAB symptoms||months|Mean|90.8|90.8|Standard Deviation|107.83|107.83|||
4239815|NCT00662909|4063356|B2|||Duration of OAB symptoms||months|Mean|83.8|83.8|Standard Deviation|93.76|93.76|||
4239816|NCT00662909|4063357|B1|||Duration of OAB symptoms||months|Mean|90.6|90.6|Standard Deviation|106.95|106.95|||
4239817|NCT00662909|4063354|B4|Frequency||Type of overactive bladder (OAB)||participants|Number|428|428.0||||||
4239818|NCT00662909|4063355|B3|Frequency||Type of overactive bladder (OAB)||participants|Number|149|149.0||||||
4239819|NCT00662909|4063356|B2|Frequency||Type of overactive bladder (OAB)||participants|Number|138|138.0||||||
4239820|NCT00662909|4063357|B1|Frequency||Type of overactive bladder (OAB)||participants|Number|141|141.0||||||
4239828|NCT00662909|4063357|B1|Urge Incontinence||Type of overactive bladder (OAB)||participants|Number|127|127.0||||||
4239829|NCT00662909|4063354|B4|Other||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4239830|NCT00662909|4063355|B3|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4239831|NCT00662909|4063356|B2|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4239832|NCT00662909|4063357|B1|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4239833|NCT00662909|4063354|B4|Asian||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4239834|NCT00662909|4063355|B3|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4239835|NCT00662909|4063356|B2|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4239836|NCT00662909|4063357|B1|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4239837|NCT00662909|4063354|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|116|116.0||||||
4239838|NCT00662909|4063355|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4239839|NCT00662909|4063356|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4239840|NCT00662909|4063357|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4239841|NCT00662909|4063354|B4|White||Race/Ethnicity, Customized||participants|Number|1167|1167.0||||||
4239842|NCT00662909|4063355|B3|White||Race/Ethnicity, Customized||participants|Number|381|381.0||||||
4239843|NCT00662909|4063356|B2|White||Race/Ethnicity, Customized||participants|Number|391|391.0||||||
4239844|NCT00662909|4063357|B1|White||Race/Ethnicity, Customized||participants|Number|395|395.0||||||
4239845|NCT00662909|4063354|B4||Male|Sex: Female, Male||Participants|Count of Participants|341|341.0||||||
4239846|NCT00662909|4063355|B3||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4239847|NCT00662909|4063356|B2||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4239848|NCT00662909|4063357|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4239849|NCT00662909|4063354|B4||Female|Sex: Female, Male||Participants|Count of Participants|987|987.0||||||
4239850|NCT00662909|4063355|B3||Female|Sex: Female, Male||Participants|Count of Participants|320|320.0||||||
4239851|NCT00662909|4063356|B2||Female|Sex: Female, Male||Participants|Count of Participants|322|322.0||||||
4239852|NCT00662909|4063357|B1||Female|Sex: Female, Male||Participants|Count of Participants|345|345.0||||||
4239853|NCT00662909|4063354|B4|||Age|Baseline Measure data are provided for all randomized patients who took at least 1 dose of double-blind study drug (Safety Analysis Set).|years|Mean|60.1|60.1|Standard Deviation|13.54|13.54|||
4239854|NCT00662909|4063355|B3|||Age|Baseline Measure data are provided for all randomized patients who took at least 1 dose of double-blind study drug (Safety Analysis Set).|years|Mean|61.0|61.0|Standard Deviation|13.25|13.25|||
4239855|NCT00662909|4063356|B2|||Age|Baseline Measure data are provided for all randomized patients who took at least 1 dose of double-blind study drug (Safety Analysis Set).|years|Mean|59.2|59.2|Standard Deviation|13.53|13.53|||
4239856|NCT00662909|4063357|B1|||Age|Baseline Measure data are provided for all randomized patients who took at least 1 dose of double-blind study drug (Safety Analysis Set).|years|Mean|60.1|60.1|Standard Deviation|13.79|13.79|||
4239857|NCT00662857|4063457|B1|||Body mass index (BMI)||kg/m squared|Mean|26.61|26.61|Standard Deviation|2.772|2.772|||
4239858|NCT00662857|4063457|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4239859|NCT00662857|4063457|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4239860|NCT00662857|4063457|B1|||Age||years|Mean|37.4|37.4|Standard Deviation|12.71|12.71|||
4239861|NCT00662831|4063471|B3||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4239862|NCT00662831|4063472|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4239863|NCT00662831|4063473|B1||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4239864|NCT00662831|4063471|B3||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4239865|NCT00662831|4063472|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4239866|NCT00662831|4063473|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4239867|NCT00662831|4063471|B3|||Age||years|Mean|64.8|64.8|Standard Deviation|10.5|10.5|||
4239868|NCT00662831|4063472|B2|||Age||years|Mean|64.7|64.7|Standard Deviation|10.9|10.9|||
4239869|NCT00662831|4063473|B1|||Age||years|Mean|64.8|64.8|Standard Deviation|10.3|10.3|||
4239870|NCT00662818|4063512|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4239871|NCT00662818|4063513|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4239872|NCT00662818|4063514|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4239873|NCT00662818|4063512|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4239874|NCT00662818|4063513|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4239875|NCT00662818|4063514|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4239876|NCT00662818|4063512|B3|||Age||Years|Mean|56.1|56.1|Standard Deviation|10.0|10.0|||
4239877|NCT00662818|4063513|B2|||Age||Years|Mean|55.7|55.7|Standard Deviation|10.0|10.0|||
4239878|NCT00662818|4063514|B1|||Age||Years|Mean|56.6|56.6|Standard Deviation|10.1|10.1|||
4239879|NCT00662675|4063537|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4239880|NCT00662675|4063538|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4239881|NCT00662675|4063539|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4239882|NCT00662675|4063537|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4239883|NCT00662675|4063538|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4239884|NCT00662675|4063539|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4239885|NCT00662675|4063537|B3||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4239886|NCT00662675|4063538|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4239887|NCT00662675|4063539|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4239888|NCT00662675|4063537|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4239889|NCT00662675|4063538|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4239890|NCT00662675|4063539|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4239891|NCT00662675|4063537|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4239892|NCT00662675|4063538|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4239893|NCT00662675|4063539|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4239894|NCT00662675|4063537|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4239895|NCT00662675|4063538|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4239896|NCT00662675|4063539|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4239897|NCT00662675|4063537|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4239898|NCT00662675|4063538|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4239899|NCT00662675|4063539|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4239900|NCT00662675|4063537|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4239901|NCT00662675|4063538|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4239902|NCT00662675|4063539|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4239903|NCT00662675|4063537|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4239904|NCT00662675|4063538|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4239905|NCT00662675|4063539|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4239906|NCT00662675|4063537|B3|||Age||years|Mean|23.7|23.7|Standard Deviation|12.39|12.39|||
4239907|NCT00662675|4063538|B2|||Age||years|Mean|24|24.0|Standard Deviation|13.44|13.44|||
4239908|NCT00662675|4063539|B1|||Age||years|Mean|23.4|23.4|Standard Deviation|11.58|11.58|||
4239909|NCT00662649|4063550|B5||Male|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
4239910|NCT00662649|4063551|B4||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4239911|NCT00662649|4063552|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4239912|NCT00662649|4063553|B2||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4239913|NCT00662649|4063554|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4239914|NCT00662649|4063550|B5||Female|Sex: Female, Male||Participants|Count of Participants|651|651.0||||||
4239915|NCT00662649|4063551|B4||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4239916|NCT00662649|4063552|B3||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4239917|NCT00662649|4063553|B2||Female|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
4239918|NCT00662649|4063554|B1||Female|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4239919|NCT00662649|4063550|B5|||Age|All demographic measurements are based on extension randomized/safety population.|years|Mean|37.0|37.0|Standard Deviation|8.73|8.73|||
4239920|NCT00662649|4063551|B4|||Age|All demographic measurements are based on extension randomized/safety population.|years|Mean|38.1|38.1|Standard Deviation|8.26|8.26|||
4239921|NCT00662649|4063552|B3|||Age|All demographic measurements are based on extension randomized/safety population.|years|Mean|36.6|36.6|Standard Deviation|9.21|9.21|||
4239922|NCT00662649|4063553|B2|||Age|All demographic measurements are based on extension randomized/safety population.|years|Mean|36.5|36.5|Standard Deviation|8.60|8.6|||
4239923|NCT00662649|4063554|B1|||Age|All demographic measurements are based on extension randomized/safety population.|years|Mean|37.2|37.2|Standard Deviation|8.87|8.87|||
4239924|NCT00662558|4063596|B3||Male|Sex: Female, Male||Participants|Count of Participants|342|342.0||||||
4239925|NCT00662558|4063597|B2||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4239926|NCT00662558|4063598|B1||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4239927|NCT00662558|4063596|B3||Female|Sex: Female, Male||Participants|Count of Participants|450|450.0||||||
4239928|NCT00662558|4063597|B2||Female|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
4239929|NCT00662558|4063598|B1||Female|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
4239930|NCT00662558|4063596|B3|> = 65 years||Age, Customized||participants|Number|88|88.0||||||
4239931|NCT00662558|4063597|B2|> = 65 years||Age, Customized||participants|Number|47|47.0||||||
4239932|NCT00662558|4063598|B1|> = 65 years||Age, Customized||participants|Number|41|41.0||||||
4239933|NCT00662558|4063596|B3|45 to 64 years||Age, Customized||participants|Number|373|373.0||||||
4239934|NCT00662558|4063597|B2|45 to 64 years||Age, Customized||participants|Number|182|182.0||||||
4239935|NCT00662558|4063598|B1|45 to 64 years||Age, Customized||participants|Number|191|191.0||||||
4239936|NCT00662558|4063596|B3|18 to 44 years||Age, Customized||participants|Number|331|331.0||||||
4239937|NCT00662558|4063597|B2|18 to 44 years||Age, Customized||participants|Number|167|167.0||||||
4239938|NCT00662558|4063598|B1|18 to 44 years||Age, Customized||participants|Number|164|164.0||||||
4239939|NCT00662545|4063631|B3|||HBV DNA at enrollment|hepatitis B DNA level|log10 IU/ML|Median|3.2|3.2|Full Range|||1.9|7.7|
4239940|NCT00662545|4063632|B2|||HBV DNA at enrollment|hepatitis B DNA level|log10 IU/ML|Median|3.8|3.8|Full Range|||1.9|7.7|
4239941|NCT00662545|4063633|B1|||HBV DNA at enrollment|hepatitis B DNA level|log10 IU/ML|Median|3.2|3.2|Full Range|||2.4|6.4|
4239942|NCT00662545|4063631|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4239943|NCT00662545|4063632|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4239944|NCT00662545|4063633|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4239945|NCT00662545|4063631|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4239946|NCT00662545|4063632|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4239947|NCT00662545|4063633|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4239948|NCT00662545|4063631|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4239949|NCT00662545|4063632|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4239950|NCT00662545|4063633|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4239951|NCT00662545|4063631|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4239952|NCT00662545|4063632|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4239953|NCT00662545|4063633|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4239954|NCT00662545|4063631|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4239955|NCT00662545|4063632|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4239956|NCT00662545|4063633|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4239957|NCT00662545|4063631|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4239958|NCT00662545|4063632|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4239959|NCT00662545|4063633|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4239960|NCT00662532|4063648|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
4239961|NCT00662532|4063649|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4239962|NCT00662532|4063650|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4239963|NCT00662532|4063648|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4239964|NCT00662532|4063649|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4239965|NCT00662532|4063650|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4239966|NCT00662532|4063648|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4239967|NCT00662532|4063649|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4239968|NCT00662532|4063650|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4239969|NCT00662532|4063648|B3|||Age||years|Mean|66.82|66.82|Standard Deviation|11.58|11.58|||
4239970|NCT00662532|4063649|B2|||Age||years|Mean|66.05|66.05|Standard Deviation|10.97|10.97|||
4239971|NCT00662532|4063650|B1|||Age||years|Mean|67.59|67.59|Standard Deviation|12.37|12.37|||
4239972|NCT00662389|4063661|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4239973|NCT00662389|4063661|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4239974|NCT00662389|4063661|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4239975|NCT00662389|4063661|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|3.6|3.6|||
4239976|NCT00662389|4063661|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4239977|NCT00662389|4063661|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4239978|NCT00662389|4063661|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4239979|NCT00662363|4063664|B3|United States||Region of Enrollment||participants|Number|64|64.0||||||
4239980|NCT00662363|4063665|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
4239981|NCT00662363|4063666|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4239982|NCT00662363|4063664|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4239983|NCT00662363|4063665|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4239984|NCT00662363|4063666|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4239985|NCT00662363|4063664|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4239986|NCT00662363|4063665|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4239987|NCT00662363|4063666|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4239988|NCT00662363|4063664|B3|||Age||years|Mean|71.6|71.6|Standard Deviation|11.5|11.5|||
4239989|NCT00662363|4063665|B2|||Age||years|Mean|72.2|72.2|Standard Deviation|10.5|10.5|||
4239990|NCT00662363|4063666|B1|||Age||years|Mean|70.9|70.9|Standard Deviation|11.8|11.8|||
4239991|NCT00662363|4063664|B3||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4239992|NCT00662363|4063665|B2||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4239993|NCT00662363|4063666|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4239994|NCT00662363|4063664|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4239995|NCT00662363|4063665|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4239996|NCT00662363|4063666|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4239997|NCT00662363|4063664|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4239998|NCT00662363|4063665|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4239999|NCT00662363|4063666|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4240000|NCT00662311|4063675|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240001|NCT00662311|4063678|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240002|NCT00662311|4063675|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4240003|NCT00662311|4063678|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4240004|NCT00662311|4063675|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240005|NCT00662311|4063678|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240006|NCT00662311|4063675|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4240007|NCT00662311|4063678|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4240008|NCT00662311|4063675|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4240009|NCT00662311|4063678|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4240010|NCT00662311|4063675|B4|||Age||years|Mean|77|77.0|Full Range|||74.0|80.0|
4240011|NCT00662311|4063678|B1|||Age||years|Mean|77|77.0|Full Range|||74.0|80.0|
4240012|NCT00662207|4063703|B1|||Number of Participants with Upper-Motor-Neuron Injuries for SCI||participants|Number|3|3.0||||||
4240013|NCT00662207|4063703|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4240014|NCT00662207|4063703|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4240015|NCT00662207|4063703|B1|Between 50 and 60 years old||Age, Customized||participants|Number|3|3.0||||||
4240016|NCT00662155|4063710|B5|United States||Region of Enrollment||participants|Number|55|55.0||||||
4240017|NCT00662155|4063711|B4|United States||Region of Enrollment||participants|Number|14|14.0||||||
4240018|NCT00662155|4063712|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4240019|NCT00662155|4063713|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4240020|NCT00662155|4063714|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4240021|NCT00662155|4063710|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4240022|NCT00662155|4063711|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4240023|NCT00662155|4063712|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4240024|NCT00662155|4063713|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4240025|NCT00662155|4063714|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4240026|NCT00662155|4063710|B5||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4240027|NCT00662155|4063711|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4240028|NCT00662155|4063712|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4240029|NCT00662155|4063713|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4240030|NCT00662155|4063714|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4240031|NCT00662155|4063710|B5|||Age||years|Mean|37|37.0|Standard Deviation|2.8|2.8|||
4240032|NCT00662155|4063711|B4|||Age||years|Mean|34.5|34.5|Standard Deviation|2.7|2.7|||
4240033|NCT00662155|4063712|B3|||Age||years|Mean|39.2|39.2|Standard Deviation|2.8|2.8|||
4240034|NCT00662155|4063713|B2|||Age||years|Mean|34.0|34.0|Standard Deviation|2.6|2.6|||
4240035|NCT00662155|4063714|B1|||Age||years|Mean|39.5|39.5|Standard Deviation|2.8|2.8|||
4240036|NCT00662129|4063731|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4240037|NCT00662129|4063731|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4240038|NCT00662129|4063731|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4240039|NCT00662129|4063731|B1|||Age||years|Median|55.5|55.5|Full Range|||27.0|77.0|
4240040|NCT00662038|4063741|B1||Male|Sex: Female, Male||Participants|Count of Participants|790|790.0||||||
4240041|NCT00662038|4063741|B1||Female|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
4240042|NCT00662038|4063741|B1|||Age||years|Mean|68.5|68.5|Standard Deviation|7.47|7.47|||
4240043|NCT00662025|4063745|B1|Score 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Score 0: Fully active, able to carry on all pre-disease performance without restriction.~Score 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work."|participants|Number|6|6.0||||||
4240044|NCT00662025|4063745|B1|Score 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Score 0: Fully active, able to carry on all pre-disease performance without restriction.~Score 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work."|participants|Number|57|57.0||||||
4240045|NCT00662025|4063745|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4240046|NCT00662025|4063745|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4240047|NCT00662025|4063745|B1|>=65 years||Age, Customized||participants|Number|7|7.0||||||
4240048|NCT00662025|4063745|B1|>=45 years and 64 years >=||Age, Customized||participants|Number|43|43.0||||||
4240049|NCT00662025|4063745|B1|>=20 years and 44 years >=||Age, Customized||participants|Number|13|13.0||||||
4240050|NCT00662025|4063745|B1|||Age||years|Mean|52.9|52.9|Full Range|||26.0|76.0|
4240051|NCT00662012|4063765|B1|||Lesion data - Number of lesions|Number of lesions on body|Lesions|Mean|5.0|5.0|Standard Deviation|5.04|5.04|||
4240052|NCT00662012|4063765|B1|||Lesion data - Duration since onset||Days|Mean|111.6|111.6|Standard Deviation|47.62|47.62|||
4240053|NCT00662012|4063765|B1|United States||Region of Enrollment|All subjects must be willing to locate to the WRAMC area during treatment|participants|Number|414|414.0||||||
4240054|NCT00662012|4063765|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4240055|NCT00662012|4063765|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240056|NCT00662012|4063765|B1||White|Race (NIH/OMB)||Participants|Count of Participants|295|295.0||||||
4240057|NCT00662012|4063765|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4240058|NCT00662012|4063765|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240059|NCT00662012|4063765|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4240060|NCT00662012|4063765|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240061|NCT00662012|4063765|B1||Male|Gender||Participants|Count of Participants|405|405.0||||||
4240062|NCT00662012|4063765|B1||Female|Gender||Participants|Count of Participants|9|9.0||||||
4240063|NCT00662012|4063765|B1|||Age||years|Mean|28.1|28.1|Standard Deviation|7.96|7.96|||
4240064|NCT00661999|4063770|B4|||Baseline Transferrin Saturation||Percentage Saturation|Mean|21.5|21.5|Standard Deviation|12.69|12.69|||
4240065|NCT00661999|4063771|B3|||Baseline Transferrin Saturation||Percentage Saturation|Mean|22.2|22.2|Standard Deviation|13.36|13.36|||
4240066|NCT00661999|4063772|B2|||Baseline Transferrin Saturation||Percentage Saturation|Mean|19.6|19.6|Standard Deviation|11.7|11.7|||
4240067|NCT00661999|4063773|B1|||Baseline Transferrin Saturation||Percentage Saturation|Mean|22.5|22.5|Standard Deviation|12.81|12.81|||
4240068|NCT00661999|4063770|B4|||Baseline Ferritin||µg/L|Mean|465.3|465.3|Standard Deviation|496.41|496.41|||
4240069|NCT00661999|4063771|B3|||Baseline Ferritin||µg/L|Mean|456.0|456.0|Standard Deviation|479.27|479.27|||
4240070|NCT00661999|4063772|B2|||Baseline Ferritin||µg/L|Mean|479.5|479.5|Standard Deviation|484.15|484.15|||
4240071|NCT00661999|4063773|B1|||Baseline Ferritin||µg/L|Mean|460.5|460.5|Standard Deviation|526.99|526.99|||
4240072|NCT00661999|4063770|B4|||Height||cm|Mean|167.1|167.1|Standard Deviation|9.24|9.24|||
4240073|NCT00661999|4063771|B3|||Height||cm|Mean|166.8|166.8|Standard Deviation|9.36|9.36|||
4240074|NCT00661999|4063772|B2|||Height||cm|Mean|167.7|167.7|Standard Deviation|8.93|8.93|||
4240075|NCT00661999|4063773|B1|||Height||cm|Mean|166.9|166.9|Standard Deviation|9.44|9.44|||
4240076|NCT00661999|4063770|B4|||Weight||kg|Mean|77.7|77.7|Standard Deviation|18.75|18.75|||
4240077|NCT00661999|4063771|B3|||Weight||kg|Mean|76.4|76.4|Standard Deviation|17.68|17.68|||
4240078|NCT00661999|4063772|B2|||Weight||kg|Mean|79.4|79.4|Standard Deviation|19.75|19.75|||
4240079|NCT00661999|4063773|B1|||Weight||kg|Mean|77.4|77.4|Standard Deviation|18.74|18.74|||
4240080|NCT00661999|4063770|B4|Both||Tumor Type||Participants|Number|3|3.0||||||
4240081|NCT00661999|4063771|B3|Both||Tumor Type||Participants|Number|1|1.0||||||
4240082|NCT00661999|4063772|B2|Both||Tumor Type||Participants|Number|1|1.0||||||
4240083|NCT00661999|4063773|B1|Both||Tumor Type||Participants|Number|1|1.0||||||
4240084|NCT00661999|4063770|B4|Solid Tumor||Tumor Type||Participants|Number|462|462.0||||||
4240085|NCT00661999|4063771|B3|Solid Tumor||Tumor Type||Participants|Number|151|151.0||||||
4240086|NCT00661999|4063772|B2|Solid Tumor||Tumor Type||Participants|Number|154|154.0||||||
4240087|NCT00661999|4063773|B1|Solid Tumor||Tumor Type||Participants|Number|157|157.0||||||
4240088|NCT00661999|4063770|B4|Hematologic Neoplasm||Tumor Type||Participants|Number|25|25.0||||||
4240089|NCT00661999|4063771|B3|Hematologic Neoplasm||Tumor Type||Participants|Number|11|11.0||||||
4240090|NCT00661999|4063772|B2|Hematologic Neoplasm||Tumor Type||Participants|Number|8|8.0||||||
4240091|NCT00661999|4063773|B1|Hematologic Neoplasm||Tumor Type||Participants|Number|6|6.0||||||
4240092|NCT00661999|4063770|B4|No||Platinum-Containing Regimen||Participants|Number|254|254.0||||||
4240093|NCT00661999|4063771|B3|No||Platinum-Containing Regimen||Participants|Number|85|85.0||||||
4240094|NCT00661999|4063772|B2|No||Platinum-Containing Regimen||Participants|Number|84|84.0||||||
4240095|NCT00661999|4063773|B1|No||Platinum-Containing Regimen||Participants|Number|85|85.0||||||
4240096|NCT00661999|4063770|B4|Yes||Platinum-Containing Regimen||Participants|Number|236|236.0||||||
4240097|NCT00661999|4063771|B3|Yes||Platinum-Containing Regimen||Participants|Number|78|78.0||||||
4240098|NCT00661999|4063772|B2|Yes||Platinum-Containing Regimen||Participants|Number|79|79.0||||||
4240099|NCT00661999|4063773|B1|Yes||Platinum-Containing Regimen||Participants|Number|79|79.0||||||
4240100|NCT00661999|4063770|B4|Severe: Hemoglobin <9.5||Degree of Anemia||Participants|Number|121|121.0||||||
4240101|NCT00661999|4063771|B3|Severe: Hemoglobin <9.5||Degree of Anemia||Participants|Number|40|40.0||||||
4240102|NCT00661999|4063772|B2|Severe: Hemoglobin <9.5||Degree of Anemia||Participants|Number|40|40.0||||||
4240103|NCT00661999|4063773|B1|Severe: Hemoglobin <9.5||Degree of Anemia||Participants|Number|41|41.0||||||
4240104|NCT00661999|4063770|B4|Mild: Hemoglobin>=9.5||Degree of Anemia||Participants|Number|369|369.0||||||
4240105|NCT00661999|4063771|B3|Mild: Hemoglobin>=9.5||Degree of Anemia||Participants|Number|123|123.0||||||
4240106|NCT00661999|4063772|B2|Mild: Hemoglobin>=9.5||Degree of Anemia||Participants|Number|123|123.0||||||
4240107|NCT00661999|4063773|B1|Mild: Hemoglobin>=9.5||Degree of Anemia||Participants|Number|123|123.0||||||
4240108|NCT00661999|4063770|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4240109|NCT00661999|4063771|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4240110|NCT00661999|4063772|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4240111|NCT00661999|4063773|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4240112|NCT00661999|4063770|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240113|NCT00661999|4063771|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240114|NCT00661999|4063772|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240115|NCT00661999|4063773|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240116|NCT00661999|4063770|B4||White|Race (NIH/OMB)||Participants|Count of Participants|458|458.0||||||
4240117|NCT00661999|4063771|B3||White|Race (NIH/OMB)||Participants|Count of Participants|156|156.0||||||
4240118|NCT00661999|4063772|B2||White|Race (NIH/OMB)||Participants|Count of Participants|147|147.0||||||
4240119|NCT00661999|4063773|B1||White|Race (NIH/OMB)||Participants|Count of Participants|155|155.0||||||
4240120|NCT00661999|4063770|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4240121|NCT00661999|4063771|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4240122|NCT00661999|4063772|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4240123|NCT00661999|4063773|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4240124|NCT00661999|4063770|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240125|NCT00661999|4063771|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240126|NCT00661999|4063772|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240127|NCT00661999|4063773|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240128|NCT00661999|4063770|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4240129|NCT00661999|4063771|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4240130|NCT00661999|4063772|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4240131|NCT00661999|4063773|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240132|NCT00661999|4063770|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4240133|NCT00661999|4063771|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4240134|NCT00661999|4063772|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4240135|NCT00661999|4063773|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240136|NCT00661999|4063770|B4||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4240137|NCT00661999|4063771|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4240138|NCT00661999|4063772|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4240139|NCT00661999|4063773|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4240140|NCT00661999|4063770|B4||Female|Sex: Female, Male||Participants|Count of Participants|320|320.0||||||
4240141|NCT00661999|4063771|B3||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4240142|NCT00661999|4063772|B2||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4240143|NCT00661999|4063773|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4240144|NCT00661999|4063770|B4|||Age||years|Mean|63|63.0|Standard Deviation|12|12.0|||
4240145|NCT00661999|4063771|B3|||Age||years|Mean|63|63.0|Standard Deviation|11|11.0|||
4240146|NCT00661999|4063772|B2|||Age||years|Mean|63|63.0|Standard Deviation|13|13.0|||
4240147|NCT00661999|4063773|B1|||Age||years|Mean|64|64.0|Standard Deviation|11|11.0|||
4240148|NCT00661960|4063828|B4|United States||Region of Enrollment||participants|Number|25|25.0||||||
4240149|NCT00661960|4063829|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4240150|NCT00661960|4063830|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4240151|NCT00661960|4063831|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4240152|NCT00661960|4063828|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4240153|NCT00661960|4063829|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4240154|NCT00661960|4063830|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4240155|NCT00661960|4063831|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4240156|NCT00661960|4063828|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4240157|NCT00661960|4063829|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4240158|NCT00661960|4063830|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4240159|NCT00661960|4063831|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4240160|NCT00661960|4063828|B4|||Age||years|Mean|38|38.0|Standard Deviation|5|5.0|||
4240161|NCT00661960|4063829|B3|||Age||years|Mean|45|45.0|Standard Deviation|5|5.0|||
4240162|NCT00661960|4063830|B2|||Age||years|Mean|37|37.0|Standard Deviation|5|5.0|||
4240163|NCT00661960|4063831|B1|||Age||years|Mean|35|35.0|Standard Deviation|5|5.0|||
4240164|NCT00661960|4063828|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4240165|NCT00661960|4063829|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4240166|NCT00661960|4063830|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4240167|NCT00661960|4063831|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4240168|NCT00661960|4063828|B4||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4240169|NCT00661960|4063829|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4240170|NCT00661960|4063830|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4240171|NCT00661960|4063831|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4240172|NCT00661960|4063828|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4240173|NCT00661960|4063829|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4240174|NCT00661960|4063830|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4240175|NCT00661960|4063831|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4240176|NCT00661895|4063841|B3|United States||Region of Enrollment||participants|Number|99|99.0||||||
4240177|NCT00661895|4063842|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
4240178|NCT00661895|4063843|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
4240179|NCT00661895|4063841|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4240180|NCT00661895|4063842|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4240181|NCT00661895|4063843|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4240182|NCT00661895|4063841|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4240183|NCT00661895|4063842|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4240184|NCT00661895|4063843|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4240185|NCT00661895|4063841|B3|||Age||years|Mean|49.8|49.8|Standard Deviation|10.4|10.4|||
4240186|NCT00661895|4063842|B2|||Age||years|Mean|50|50.0|Standard Deviation|11|11.0|||
4240187|NCT00661895|4063843|B1|||Age||years|Mean|49.6|49.6|Standard Deviation|9.81|9.81|||
4240188|NCT00661895|4063841|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4240189|NCT00661895|4063842|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4240190|NCT00661895|4063843|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4240191|NCT00661895|4063841|B3||Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
4240192|NCT00661895|4063842|B2||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4240193|NCT00661895|4063843|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4240194|NCT00661895|4063841|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4240195|NCT00661895|4063842|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4240196|NCT00661895|4063843|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4240197|NCT00661830|4063850|B3|||Sum Sizes of target lesions||mm|Mean|92.06|92.06|Standard Deviation|54.07|54.07|||
4240198|NCT00661830|4063851|B2|||Sum Sizes of target lesions||mm|Mean|95.02|95.02|Standard Deviation|54.07|54.07|||
4240199|NCT00661830|4063852|B1|||Sum Sizes of target lesions||mm|Mean|89.17|89.17|Standard Deviation|56.29|56.29|||
4240200|NCT00661830|4063850|B3|Missing||Number of non-target lesions||participants|Number|19|19.0||||||
4240201|NCT00661830|4063851|B2|Missing||Number of non-target lesions||participants|Number|8|8.0||||||
4240202|NCT00661830|4063852|B1|Missing||Number of non-target lesions||participants|Number|11|11.0||||||
4240203|NCT00661830|4063850|B3|5||Number of non-target lesions||participants|Number|1|1.0||||||
4240204|NCT00661830|4063851|B2|5||Number of non-target lesions||participants|Number|0|0.0||||||
4240205|NCT00661830|4063852|B1|5||Number of non-target lesions||participants|Number|1|1.0||||||
4240206|NCT00661830|4063850|B3|4||Number of non-target lesions||participants|Number|2|2.0||||||
4240207|NCT00661830|4063851|B2|4||Number of non-target lesions||participants|Number|0|0.0||||||
4240208|NCT00661830|4063852|B1|4||Number of non-target lesions||participants|Number|2|2.0||||||
4240209|NCT00661830|4063850|B3|3||Number of non-target lesions||participants|Number|14|14.0||||||
4240210|NCT00661830|4063851|B2|3||Number of non-target lesions||participants|Number|8|8.0||||||
4240211|NCT00661830|4063852|B1|3||Number of non-target lesions||participants|Number|6|6.0||||||
4240212|NCT00661830|4063850|B3|2||Number of non-target lesions||participants|Number|22|22.0||||||
4240213|NCT00661830|4063851|B2|2||Number of non-target lesions||participants|Number|16|16.0||||||
4240214|NCT00661830|4063852|B1|2||Number of non-target lesions||participants|Number|6|6.0||||||
4240215|NCT00661830|4063850|B3|1||Number of non-target lesions||participants|Number|39|39.0||||||
4240216|NCT00661830|4063851|B2|1||Number of non-target lesions||participants|Number|16|16.0||||||
4240217|NCT00661830|4063852|B1|1||Number of non-target lesions||participants|Number|23|23.0||||||
4240218|NCT00661830|4063850|B3|7||Number of target lesions||participants|Number|2|2.0||||||
4240219|NCT00661830|4063851|B2|7||Number of target lesions||participants|Number|0|0.0||||||
4240220|NCT00661830|4063852|B1|7||Number of target lesions||participants|Number|2|2.0||||||
4240221|NCT00661830|4063850|B3|6||Number of target lesions||participants|Number|2|2.0||||||
4240222|NCT00661830|4063851|B2|6||Number of target lesions||participants|Number|1|1.0||||||
4240223|NCT00661830|4063852|B1|6||Number of target lesions||participants|Number|1|1.0||||||
4240224|NCT00661830|4063850|B3|5||Number of target lesions||participants|Number|11|11.0||||||
4240225|NCT00661830|4063851|B2|5||Number of target lesions||participants|Number|7|7.0||||||
4240226|NCT00661830|4063852|B1|5||Number of target lesions||participants|Number|4|4.0||||||
4240227|NCT00661830|4063850|B3|4||Number of target lesions||participants|Number|8|8.0||||||
4240228|NCT00661830|4063851|B2|4||Number of target lesions||participants|Number|4|4.0||||||
4240229|NCT00661830|4063852|B1|4||Number of target lesions||participants|Number|4|4.0||||||
4240230|NCT00661830|4063850|B3|3||Number of target lesions||participants|Number|13|13.0||||||
4240231|NCT00661830|4063851|B2|3||Number of target lesions||participants|Number|9|9.0||||||
4240232|NCT00661830|4063852|B1|3||Number of target lesions||participants|Number|4|4.0||||||
4240233|NCT00661830|4063850|B3|2||Number of target lesions||participants|Number|26|26.0||||||
4240234|NCT00661830|4063851|B2|2||Number of target lesions||participants|Number|10|10.0||||||
4240235|NCT00661830|4063852|B1|2||Number of target lesions||participants|Number|16|16.0||||||
4240236|NCT00661830|4063850|B3|1||Number of target lesions||participants|Number|35|35.0||||||
4240237|NCT00661830|4063851|B2|1||Number of target lesions||participants|Number|17|17.0||||||
4240238|NCT00661830|4063852|B1|1||Number of target lesions||participants|Number|18|18.0||||||
4240239|NCT00661830|4063850|B3|Missing||ECOG Performance Status||participants|Number|6|6.0||||||
4240240|NCT00661830|4063851|B2|Missing||ECOG Performance Status||participants|Number|4|4.0||||||
4240241|NCT00661830|4063852|B1|Missing||ECOG Performance Status||participants|Number|2|2.0||||||
4240242|NCT00661830|4063850|B3|4||ECOG Performance Status||participants|Number|0|0.0||||||
4240243|NCT00661830|4063851|B2|4||ECOG Performance Status||participants|Number|0|0.0||||||
4240244|NCT00661830|4063852|B1|4||ECOG Performance Status||participants|Number|0|0.0||||||
4240245|NCT00661830|4063850|B3|3||ECOG Performance Status||participants|Number|0|0.0||||||
4240246|NCT00661830|4063851|B2|3||ECOG Performance Status||participants|Number|0|0.0||||||
4240247|NCT00661830|4063852|B1|3||ECOG Performance Status||participants|Number|0|0.0||||||
4240248|NCT00661830|4063850|B3|2||ECOG Performance Status||participants|Number|1|1.0||||||
4240249|NCT00661830|4063851|B2|2||ECOG Performance Status||participants|Number|1|1.0||||||
4240250|NCT00661830|4063852|B1|2||ECOG Performance Status||participants|Number|0|0.0||||||
4240251|NCT00661830|4063850|B3|1||ECOG Performance Status||participants|Number|25|25.0||||||
4240252|NCT00661830|4063851|B2|1||ECOG Performance Status||participants|Number|8|8.0||||||
4240253|NCT00661830|4063852|B1|1||ECOG Performance Status||participants|Number|17|17.0||||||
4240254|NCT00661830|4063850|B3|0||ECOG Performance Status||participants|Number|65|65.0||||||
4240255|NCT00661830|4063851|B2|0||ECOG Performance Status||participants|Number|35|35.0||||||
4240256|NCT00661830|4063852|B1|0||ECOG Performance Status||participants|Number|30|30.0||||||
4240257|NCT00661830|4063850|B3|||Time since histological diagnosis|is defined as difference between date of first histological diagnosis and date of first visit|days|Mean|216.73|216.73|Standard Deviation|581.55|581.55|||
4240258|NCT00661830|4063851|B2|||Time since histological diagnosis|is defined as difference between date of first histological diagnosis and date of first visit|days|Mean|275.81|275.81|Standard Deviation|748.51|748.51|||
4240259|NCT00661830|4063852|B1|||Time since histological diagnosis|is defined as difference between date of first histological diagnosis and date of first visit|days|Mean|158.86|158.86|Standard Deviation|347.69|347.69|||
4240260|NCT00661830|4063850|B3|Missing||Grading of adenocarcinoma||participants|Number|8|8.0||||||
4240261|NCT00661830|4063851|B2|Missing||Grading of adenocarcinoma||participants|Number|5|5.0||||||
4240262|NCT00661830|4063852|B1|Missing||Grading of adenocarcinoma||participants|Number|3|3.0||||||
4240263|NCT00661830|4063850|B3|4 (undifferentiated)||Grading of adenocarcinoma||participants|Number|1|1.0||||||
4240264|NCT00661830|4063851|B2|4 (undifferentiated)||Grading of adenocarcinoma||participants|Number|0|0.0||||||
4240265|NCT00661830|4063852|B1|4 (undifferentiated)||Grading of adenocarcinoma||participants|Number|1|1.0||||||
4240266|NCT00661830|4063850|B3|3 (poorly differentiated)||Grading of adenocarcinoma||participants|Number|33|33.0||||||
4240267|NCT00661830|4063851|B2|3 (poorly differentiated)||Grading of adenocarcinoma||participants|Number|13|13.0||||||
4240268|NCT00661830|4063852|B1|3 (poorly differentiated)||Grading of adenocarcinoma||participants|Number|20|20.0||||||
4240269|NCT00661830|4063850|B3|2 (moderately differentiated)||Grading of adenocarcinoma||participants|Number|53|53.0||||||
4240270|NCT00661830|4063851|B2|2 (moderately differentiated)||Grading of adenocarcinoma||participants|Number|30|30.0||||||
4240271|NCT00661830|4063852|B1|2 (moderately differentiated)||Grading of adenocarcinoma||participants|Number|23|23.0||||||
4240272|NCT00661830|4063850|B3|1 (well differentiated)||Grading of adenocarcinoma||participants|Number|2|2.0||||||
4240273|NCT00661830|4063851|B2|1 (well differentiated)||Grading of adenocarcinoma||participants|Number|0|0.0||||||
4240274|NCT00661830|4063852|B1|1 (well differentiated)||Grading of adenocarcinoma||participants|Number|2|2.0||||||
4240275|NCT00661830|4063850|B3|Adeno carcinoma, hepatic metastases||Type of Adenocarcinoma||participants|Number|22|22.0||||||
4240276|NCT00661830|4063851|B2|Adeno carcinoma, hepatic metastases||Type of Adenocarcinoma||participants|Number|12|12.0||||||
4240277|NCT00661830|4063852|B1|Adeno carcinoma, hepatic metastases||Type of Adenocarcinoma||participants|Number|10|10.0||||||
4240278|NCT00661830|4063850|B3|Adeno carcinoma, intrahepatic bile ducts||Type of Adenocarcinoma||participants|Number|62|62.0||||||
4240279|NCT00661830|4063851|B2|Adeno carcinoma, intrahepatic bile ducts||Type of Adenocarcinoma||participants|Number|29|29.0||||||
4240280|NCT00661830|4063852|B1|Adeno carcinoma, intrahepatic bile ducts||Type of Adenocarcinoma||participants|Number|33|33.0||||||
4240281|NCT00661830|4063850|B3|Adeno carcinoma, gall bladder||Type of Adenocarcinoma||participants|Number|13|13.0||||||
4240282|NCT00661830|4063851|B2|Adeno carcinoma, gall bladder||Type of Adenocarcinoma||participants|Number|7|7.0||||||
4240283|NCT00661830|4063852|B1|Adeno carcinoma, gall bladder||Type of Adenocarcinoma||participants|Number|6|6.0||||||
4240284|NCT00661830|4063850|B3|Germany||Region of Enrollment||participants|Number|97|97.0||||||
4240285|NCT00661830|4063851|B2|Germany||Region of Enrollment||participants|Number|48|48.0||||||
4240286|NCT00661830|4063852|B1|Germany||Region of Enrollment||participants|Number|49|49.0||||||
4240287|NCT00661830|4063850|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240288|NCT00661830|4063851|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240289|NCT00661830|4063852|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240290|NCT00661830|4063850|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240291|NCT00661830|4063851|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240292|NCT00661830|4063852|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240293|NCT00661830|4063850|B3||White|Race (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
4240294|NCT00661830|4063851|B2||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4240295|NCT00661830|4063852|B1||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4240296|NCT00661830|4063850|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240297|NCT00661830|4063851|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240298|NCT00661830|4063852|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240299|NCT00661830|4063850|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240300|NCT00661830|4063851|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240301|NCT00661830|4063852|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240302|NCT00661830|4063850|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240303|NCT00661830|4063851|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240304|NCT00661830|4063852|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240305|NCT00661830|4063850|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240306|NCT00661830|4063851|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240307|NCT00661830|4063852|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240308|NCT00661830|4063850|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4240309|NCT00661830|4063851|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4240310|NCT00661830|4063852|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4240311|NCT00661830|4063850|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4240312|NCT00661830|4063851|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4240313|NCT00661830|4063852|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4240314|NCT00661830|4063850|B3|||Age||years|Mean|62.91|62.91|Standard Deviation|10.50|10.5|||
4240315|NCT00661830|4063851|B2|||Age||years|Mean|63.23|63.23|Standard Deviation|11.92|11.92|||
4240316|NCT00661830|4063852|B1|||Age||years|Mean|62.59|62.59|Standard Deviation|9.01|9.01|||
4240317|NCT00661778|4063865|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4240318|NCT00661778|4063865|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4240319|NCT00661778|4063865|B1|||Age||Years|Mean|58.31|58.31|Standard Deviation|9.54|9.54|||
4240320|NCT00661726|4063872|B1|No||Documented Concomitant Mutation at the alpha-globin locus||participants|Number|5|5.0||||||
4240321|NCT00661726|4063872|B1|Yes||Documented Concomitant Mutation at the alpha-globin locus||participants|Number|1|1.0||||||
4240322|NCT00661726|4063872|B1|||Baseline Hemoglobin||g/dl|Mean|7.9|7.9|Standard Deviation|1.8|1.8|||
4240323|NCT00661726|4063872|B1|No||Received transfusion in preceding year but > 120 days before protocol therapy||participants|Number|2|2.0||||||
4240324|NCT00661726|4063872|B1|Yes||Received transfusion in preceding year but > 120 days before protocol therapy||participants|Number|4|4.0||||||
4240325|NCT00661726|4063872|B1|No||Patients that had been splenectomized||participants|Number|1|1.0||||||
4240326|NCT00661726|4063872|B1|Yes||Patients that had been splenectomized||participants|Number|5|5.0||||||
4240327|NCT00661726|4063872|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4240328|NCT00661726|4063872|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4240329|NCT00661726|4063872|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4240330|NCT00661726|4063872|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4240331|NCT00661726|4063872|B1|||Age||years|Mean|39.2|39.2|Standard Deviation|11.8|11.8|||
4240332|NCT00661726|4063872|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4240333|NCT00661726|4063872|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4240334|NCT00661726|4063872|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4240335|NCT00661713|4063887|B9||Male|Sex: Female, Male||Participants|Count of Participants|718|718.0||||||
4240336|NCT00661713|4063888|B8||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4240337|NCT00661713|4063889|B7||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4240338|NCT00661713|4063890|B6||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4240339|NCT00661713|4063891|B5||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4240340|NCT00661713|4063892|B4||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4240341|NCT00661713|4063893|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4240342|NCT00661713|4063894|B2||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4240343|NCT00661713|4063895|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4240344|NCT00661713|4063887|B9||Female|Sex: Female, Male||Participants|Count of Participants|913|913.0||||||
4240345|NCT00661713|4063888|B8||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4240346|NCT00661713|4063889|B7||Female|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4240347|NCT00661713|4063890|B6||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4240348|NCT00661713|4063891|B5||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4240349|NCT00661713|4063892|B4||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4240350|NCT00661713|4063893|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4240351|NCT00661713|4063894|B2||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4240352|NCT00661713|4063895|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4240353|NCT00661713|4063887|B9|||Age||years|Mean|13.8|13.8|Standard Deviation|1.9|1.9|||
4240354|NCT00661713|4063888|B8|||Age||years|Mean|13.8|13.8|Standard Deviation|2|2.0|||
4240355|NCT00661713|4063889|B7|||Age||years|Mean|13.8|13.8|Standard Deviation|1.9|1.9|||
4240356|NCT00661713|4063890|B6|||Age||years|Mean|13.7|13.7|Standard Deviation|1.8|1.8|||
4240357|NCT00661713|4063891|B5|||Age||years|Mean|13.7|13.7|Standard Deviation|1.9|1.9|||
4240358|NCT00661713|4063892|B4|||Age||years|Mean|13.9|13.9|Standard Deviation|1.9|1.9|||
4240359|NCT00661713|4063893|B3|||Age||years|Mean|13.9|13.9|Standard Deviation|1.9|1.9|||
4240360|NCT00661713|4063894|B2|||Age||years|Mean|13.8|13.8|Standard Deviation|1.9|1.9|||
4240361|NCT00661713|4063895|B1|||Age||years|Mean|13.8|13.8|Standard Deviation|1.9|1.9|||
4240362|NCT00661687|4063992|B1|White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4240363|NCT00661687|4063992|B1|Asian||Race/Ethnicity, Customized||Participants|Number|203|203.0||||||
4240364|NCT00661687|4063992|B1||Male|Sex: Female, Male|Gender was measured in the eligible population of 204 participants (408 eyes).|Participants|Count of Participants|74|74.0||||||
4240365|NCT00661687|4063992|B1||Female|Sex: Female, Male|Gender was measured in the eligible population of 204 participants (408 eyes).|Participants|Count of Participants|130|130.0||||||
4240366|NCT00661687|4063992|B1|||Age|Mean and standard deviation measured on the eligible population of 204|Years|Mean|28.1|28.1|Standard Deviation|6.97|6.97|||
4240367|NCT00661674|4064002|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4240368|NCT00661674|4064002|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4240369|NCT00661674|4064002|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4240370|NCT00661674|4064002|B1|||Age||years|Mean|21.1|21.1|Standard Deviation|2.18|2.18|||
4240371|NCT00661661|4064018|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4240372|NCT00661661|4064019|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4240373|NCT00661661|4064020|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4240374|NCT00661661|4064018|B3||Female|Sex: Female, Male||Participants|Count of Participants|404|404.0||||||
4240375|NCT00661661|4064019|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4240376|NCT00661661|4064020|B1||Female|Sex: Female, Male||Participants|Count of Participants|318|318.0||||||
4240377|NCT00661661|4064018|B3|||Age||years|Mean|52.6|52.6|Standard Deviation|11.4|11.4|||
4240378|NCT00661661|4064019|B2|||Age||years|Mean|49.3|49.3|Standard Deviation|11.7|11.7|||
4240379|NCT00661661|4064020|B1|||Age||years|Mean|53.5|53.5|Standard Deviation|11.2|11.2|||
4240380|NCT00661622|4064095|B3|United States||Region of Enrollment||participants|Number|52|52.0||||||
4240381|NCT00661622|4064096|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4240382|NCT00661622|4064097|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4240383|NCT00661622|4064095|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240384|NCT00661622|4064096|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240385|NCT00661622|4064097|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240386|NCT00661622|4064095|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4240387|NCT00661622|4064096|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4240388|NCT00661622|4064097|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4240389|NCT00661622|4064095|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240390|NCT00661622|4064096|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240391|NCT00661622|4064097|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240392|NCT00661622|4064095|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240393|NCT00661622|4064096|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240394|NCT00661622|4064097|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240395|NCT00661622|4064095|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240396|NCT00661622|4064096|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240397|NCT00661622|4064097|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240398|NCT00661622|4064095|B3||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4240399|NCT00661622|4064096|B2||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4240400|NCT00661622|4064097|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4240401|NCT00661622|4064095|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240402|NCT00661622|4064096|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240403|NCT00661622|4064097|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240404|NCT00661622|4064095|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240405|NCT00661622|4064096|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240406|NCT00661622|4064097|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240407|NCT00661622|4064095|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240408|NCT00661622|4064096|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240409|NCT00661622|4064097|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240410|NCT00661622|4064095|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240411|NCT00661622|4064096|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240412|NCT00661622|4064097|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240413|NCT00661622|4064095|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4240414|NCT00661622|4064096|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4240415|NCT00661622|4064097|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4240416|NCT00661622|4064095|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4240417|NCT00661622|4064096|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4240418|NCT00661622|4064097|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4240419|NCT00661622|4064095|B3|||Age||years|Median|58|58.0|Full Range|||28.0|90.0|
4240420|NCT00661622|4064096|B2|||Age||years|Median|62|62.0|Full Range|||32.0|90.0|
4240421|NCT00661622|4064097|B1|||Age||years|Median|56|56.0|Full Range|||28.0|81.0|
4240422|NCT00661609|4064112|B1|Black and African||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4240423|NCT00661609|4064112|B1|White||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4240424|NCT00661609|4064112|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4240425|NCT00661609|4064112|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4240426|NCT00661609|4064112|B1|>=75 Years||Age, Customized||Participants|Number|5|5.0||||||
4240427|NCT00661609|4064112|B1|>=65 - <75 Years||Age, Customized||Participants|Number|19|19.0||||||
4240428|NCT00661609|4064112|B1|>=18 - <65 Years||Age, Customized||Participants|Number|17|17.0||||||
4240429|NCT00661583|4064119|B4|United States||Region of Enrollment||participants|Number|30|30.0||||||
4240430|NCT00661583|4064120|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4240431|NCT00661583|4064121|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4240432|NCT00661583|4064122|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4240433|NCT00661583|4064119|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4240434|NCT00661583|4064120|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4240435|NCT00661583|4064121|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4240436|NCT00661583|4064122|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4240437|NCT00661583|4064119|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4240438|NCT00661583|4064120|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4240439|NCT00661583|4064121|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4240440|NCT00661583|4064122|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4240441|NCT00661583|4064119|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4240442|NCT00661583|4064120|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4240443|NCT00661583|4064121|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4240444|NCT00661583|4064122|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4240445|NCT00661583|4064119|B4||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4240446|NCT00661583|4064120|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4240447|NCT00661583|4064121|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4240448|NCT00661583|4064122|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4240449|NCT00661583|4064119|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4240450|NCT00661583|4064120|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4240451|NCT00661583|4064121|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4240452|NCT00661583|4064122|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4240453|NCT00661570|4064141|B1|Netherlands||Region of Enrollment||patients|Number|26|26.0||||||
4240454|NCT00661570|4064141|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4240455|NCT00661570|4064141|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4240456|NCT00661570|4064141|B1|||Age||years|Mean|67.69|67.69|Standard Deviation|12.18|12.18|||
4240457|NCT00661570|4064141|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4240458|NCT00661570|4064141|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4240459|NCT00661570|4064141|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4240460|NCT00661557|4064148|B3|White - Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4240461|NCT00661557|4064149|B2|White - Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4240462|NCT00661557|4064150|B1|White - Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4240463|NCT00661557|4064148|B3|White - Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|269|269.0||||||
4240464|NCT00661557|4064149|B2|White - Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|77|77.0||||||
4240465|NCT00661557|4064150|B1|White - Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|192|192.0||||||
4240466|NCT00661557|4064148|B3||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4240467|NCT00661557|4064149|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4240468|NCT00661557|4064150|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4240469|NCT00661557|4064148|B3||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4240470|NCT00661557|4064149|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4240471|NCT00661557|4064150|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4240472|NCT00661557|4064148|B3|||Age||Years|Mean|14.13|14.13|Standard Deviation|6.91|6.91|||
4240473|NCT00661557|4064149|B2|||Age||Years|Mean|14.2|14.2|Standard Deviation|7.23|7.23|||
4240474|NCT00661557|4064150|B1|||Age||Years|Mean|14.1|14.1|Standard Deviation|6.79|6.79|||
4240475|NCT00661544|4064175|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4240476|NCT00661544|4064175|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4240477|NCT00661544|4064175|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4240478|NCT00661544|4064175|B1|||Age, Customized||years|Median|54|54.0|Full Range|||35.0|70.0|
4240479|NCT00661531|4064179|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4240480|NCT00661531|4064179|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240481|NCT00661531|4064179|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240482|NCT00661531|4064179|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4240483|NCT00661531|4064179|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4240484|NCT00661531|4064179|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240485|NCT00661531|4064179|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240486|NCT00661531|4064179|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240487|NCT00661531|4064179|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4240488|NCT00661531|4064179|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4240489|NCT00661531|4064179|B1|||Age||years|Median|64|64.0|Full Range|||53.0|80.0|
4240490|NCT00661531|4064179|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4240491|NCT00661531|4064179|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4240492|NCT00661531|4064179|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4240493|NCT00661505|4064184|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4240494|NCT00661505|4064184|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4240495|NCT00661505|4064184|B1|||Age||years|Mean|50.4|50.4|Standard Deviation|13.80|13.8|||
4240496|NCT00661492|4064210|B3|United States||Region of Enrollment||participants|Number|115|115.0||||||
4240497|NCT00661492|4064211|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4240498|NCT00661492|4064212|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
4240499|NCT00661492|4064210|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4240500|NCT00661492|4064211|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4240501|NCT00661492|4064212|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4240502|NCT00661492|4064210|B3|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4240503|NCT00661492|4064211|B2|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4240504|NCT00661492|4064212|B1|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4240505|NCT00661492|4064210|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4240506|NCT00661492|4064211|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4240507|NCT00661492|4064212|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4240508|NCT00661492|4064210|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|97|97.0||||||
4240509|NCT00661492|4064211|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4240510|NCT00661492|4064212|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
4240511|NCT00661492|4064210|B3||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4240512|NCT00661492|4064211|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4240513|NCT00661492|4064212|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4240514|NCT00661492|4064210|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4240515|NCT00661492|4064211|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4240516|NCT00661492|4064212|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4240517|NCT00661492|4064210|B3|||Age||years|Mean|71.2|71.2|Standard Deviation|8.5|8.5|||
4240518|NCT00661492|4064211|B2|||Age||years|Mean|70.7|70.7|Standard Deviation|8.1|8.1|||
4240519|NCT00661492|4064212|B1|||Age||years|Mean|71.5|71.5|Standard Deviation|8.7|8.7|||
4240520|NCT00661492|4064210|B3||>=65 years|Age||Participants|Count of Participants|90|90.0||||||
4240521|NCT00661492|4064211|B2||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4240522|NCT00661492|4064212|B1||>=65 years|Age||Participants|Count of Participants|58|58.0||||||
4240523|NCT00661492|4064210|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4240524|NCT00661492|4064211|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4240525|NCT00661492|4064212|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4240526|NCT00661492|4064210|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4240527|NCT00661492|4064211|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4240528|NCT00661492|4064212|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4240529|NCT00661479|4064233|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4240530|NCT00661479|4064234|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4240531|NCT00661479|4064235|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4240532|NCT00661479|4064236|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4240533|NCT00661479|4064237|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4240534|NCT00661479|4064233|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4240535|NCT00661479|4064234|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4240536|NCT00661479|4064235|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4240537|NCT00661479|4064236|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4240538|NCT00661479|4064237|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4240539|NCT00661479|4064233|B5|||Age||Years|Mean|51.3|51.3|Standard Deviation|16.36|16.36|||
4240540|NCT00661479|4064234|B4|||Age||Years|Mean|69.0|69.0|Standard Deviation|5.29|5.29|||
4240541|NCT00661479|4064235|B3|||Age||Years|Mean|48.7|48.7|Standard Deviation|4.04|4.04|||
4240542|NCT00661479|4064236|B2|||Age||Years|Mean|56.3|56.3|Standard Deviation|6.03|6.03|||
4240543|NCT00661479|4064237|B1|||Age||Years|Mean|46.3|46.3|Standard Deviation|18.70|18.7|||
4240544|NCT00661453|4064253|B1|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4240545|NCT00661453|4064253|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4240546|NCT00661453|4064253|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4240547|NCT00661453|4064253|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4240548|NCT00661453|4064253|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4240549|NCT00661453|4064253|B1|||Age||months|Mean|5.52|5.52|Standard Deviation|2.72|2.72|||
4240550|NCT00661427|4064257|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4240551|NCT00661427|4064258|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4240552|NCT00661427|4064259|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4240553|NCT00661427|4064257|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4240554|NCT00661427|4064258|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4240555|NCT00661427|4064259|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4240556|NCT00661427|4064257|B3||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4240557|NCT00661427|4064258|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4240558|NCT00661427|4064259|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4240559|NCT00661427|4064257|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4240560|NCT00661427|4064258|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4240561|NCT00661427|4064259|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4240562|NCT00661427|4064257|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4240563|NCT00661427|4064258|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4240564|NCT00661427|4064259|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4240565|NCT00661388|4064268|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4240566|NCT00661388|4064268|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4240567|NCT00661388|4064268|B1|||Age||years|Mean|52.8|52.8|Standard Deviation|16.36|16.36|||
4240568|NCT00661362|4064289|B3||Male|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4240569|NCT00661362|4064290|B2||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4240570|NCT00661362|4064291|B1||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4240571|NCT00661362|4064289|B3||Female|Sex: Female, Male||Participants|Count of Participants|295|295.0||||||
4240572|NCT00661362|4064290|B2||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4240573|NCT00661362|4064291|B1||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4240574|NCT00661362|4064289|B3|||Age||Years|Mean|54.05|54.05|Standard Deviation|10.24|10.24|||
4240575|NCT00661362|4064290|B2|||Age||Years|Mean|54.36|54.36|Standard Deviation|10.06|10.06|||
4240576|NCT00661362|4064291|B1|||Age||Years|Mean|53.75|53.75|Standard Deviation|10.42|10.42|||
4240577|NCT00661271|4064308|B3|United States||Region of Enrollment||Participants|Count of Participants|72|72.0||||||
4240578|NCT00661271|4064309|B2|United States||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
4240579|NCT00661271|4064310|B1|United States||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
4240580|NCT00661271|4064308|B3|Not Reported||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
4240581|NCT00661271|4064309|B2|Not Reported||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
4240582|NCT00661271|4064310|B1|Not Reported||Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
4240583|NCT00661271|4064308|B3|Male||Sex/Gender, Customized||Participants|Count of Participants|38|38.0||||||
4240584|NCT00661271|4064309|B2|Male||Sex/Gender, Customized||Participants|Count of Participants|16|16.0||||||
4240585|NCT00661271|4064310|B1|Male||Sex/Gender, Customized||Participants|Count of Participants|22|22.0||||||
4240586|NCT00661271|4064308|B3|Female||Sex/Gender, Customized||Participants|Count of Participants|34|34.0||||||
4240587|NCT00661271|4064309|B2|Female||Sex/Gender, Customized||Participants|Count of Participants|18|18.0||||||
4240588|NCT00661271|4064310|B1|Female||Sex/Gender, Customized||Participants|Count of Participants|16|16.0||||||
4240589|NCT00661271|4064308|B3|Not Reported||Age, Customized||Participants|Count of Participants|17|17.0||||||
4240590|NCT00661271|4064309|B2|Not Reported||Age, Customized||Participants|Count of Participants|8|8.0||||||
4240591|NCT00661271|4064310|B1|Not Reported||Age, Customized||Participants|Count of Participants|9|9.0||||||
4240592|NCT00661271|4064308|B3|Between 18 and 65 years||Age, Customized||Participants|Count of Participants|39|39.0||||||
4240593|NCT00661271|4064309|B2|Between 18 and 65 years||Age, Customized||Participants|Count of Participants|18|18.0||||||
4240594|NCT00661271|4064310|B1|Between 18 and 65 years||Age, Customized||Participants|Count of Participants|21|21.0||||||
4240595|NCT00661271|4064308|B3|<18 years||Age, Customized||Participants|Count of Participants|16|16.0||||||
4240596|NCT00661271|4064309|B2|<18 years||Age, Customized||Participants|Count of Participants|8|8.0||||||
4240597|NCT00661271|4064310|B1|<18 years||Age, Customized||Participants|Count of Participants|8|8.0||||||
4240598|NCT00661271|4064308|B3|||Age|All study participants were 14-22 years old; however, 17 participants did not report their exact age. 29 participants contributed age data for the MBSR program arm and 26 participants contributed age data for the HT program arm.|years|Mean|18.71|18.71|Standard Deviation|2.31|2.31|||
4240599|NCT00661271|4064309|B2|||Age|All study participants were 14-22 years old; however, 17 participants did not report their exact age. 29 participants contributed age data for the MBSR program arm and 26 participants contributed age data for the HT program arm.|years|Mean|18.46|18.46|Standard Deviation|2.20|2.2|||
4240600|NCT00661271|4064310|B1|||Age|All study participants were 14-22 years old; however, 17 participants did not report their exact age. 29 participants contributed age data for the MBSR program arm and 26 participants contributed age data for the HT program arm.|years|Mean|18.93|18.93|Standard Deviation|2.42|2.42|||
4240601|NCT00661258|4064319|B3|China||Region of Enrollment||participants|Number|68|68.0||||||
4240602|NCT00661258|4064320|B2|China||Region of Enrollment||participants|Number|34|34.0||||||
4240603|NCT00661258|4064321|B1|China||Region of Enrollment||participants|Number|34|34.0||||||
4240604|NCT00661258|4064319|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4240605|NCT00661258|4064320|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4240606|NCT00661258|4064321|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4240607|NCT00661258|4064319|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4240608|NCT00661258|4064320|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4240609|NCT00661258|4064321|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4240610|NCT00661258|4064319|B3|||Age||years|Mean|35.6|35.6|Standard Deviation|8.2|8.2|||
4240611|NCT00661258|4064320|B2|||Age||years|Mean|35.1|35.1|Standard Deviation|8.0|8.0|||
4240612|NCT00661258|4064321|B1|||Age||years|Mean|36.1|36.1|Standard Deviation|8.3|8.3|||
4240613|NCT00661258|4064319|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4240614|NCT00661258|4064320|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4240615|NCT00661258|4064321|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4240616|NCT00661258|4064319|B3||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
4240617|NCT00661258|4064320|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4240618|NCT00661258|4064321|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4240619|NCT00661258|4064319|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4240620|NCT00661258|4064320|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4240621|NCT00661258|4064321|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4240622|NCT00661193|4064330|B3||Unknown|Weight Loss Past 6 Months||Participants|Count of Participants|2|2.0||||||
4240623|NCT00661193|4064331|B2||Unknown|Weight Loss Past 6 Months||Participants|Count of Participants|1|1.0||||||
4240624|NCT00661193|4064332|B1||Unknown|Weight Loss Past 6 Months||Participants|Count of Participants|1|1.0||||||
4240625|NCT00661193|4064330|B3||>20%|Weight Loss Past 6 Months||Participants|Count of Participants|2|2.0||||||
4240626|NCT00661193|4064331|B2||>20%|Weight Loss Past 6 Months||Participants|Count of Participants|1|1.0||||||
4240627|NCT00661193|4064332|B1||>20%|Weight Loss Past 6 Months||Participants|Count of Participants|1|1.0||||||
4240628|NCT00661193|4064330|B3||10-20%|Weight Loss Past 6 Months||Participants|Count of Participants|4|4.0||||||
4240629|NCT00661193|4064331|B2||10-20%|Weight Loss Past 6 Months||Participants|Count of Participants|1|1.0||||||
4240630|NCT00661193|4064332|B1||10-20%|Weight Loss Past 6 Months||Participants|Count of Participants|3|3.0||||||
4240631|NCT00661193|4064330|B3||5-<10%|Weight Loss Past 6 Months||Participants|Count of Participants|21|21.0||||||
4240632|NCT00661193|4064331|B2||5-<10%|Weight Loss Past 6 Months||Participants|Count of Participants|7|7.0||||||
4240633|NCT00661193|4064332|B1||5-<10%|Weight Loss Past 6 Months||Participants|Count of Participants|14|14.0||||||
4240634|NCT00661193|4064330|B3||<5%|Weight Loss Past 6 Months||Participants|Count of Participants|30|30.0||||||
4240635|NCT00661193|4064331|B2||<5%|Weight Loss Past 6 Months||Participants|Count of Participants|16|16.0||||||
4240636|NCT00661193|4064332|B1||<5%|Weight Loss Past 6 Months||Participants|Count of Participants|14|14.0||||||
4240637|NCT00661193|4064330|B3||IV|Stage||Participants|Count of Participants|57|57.0||||||
4240638|NCT00661193|4064331|B2||IV|Stage||Participants|Count of Participants|25|25.0||||||
4240639|NCT00661193|4064332|B1||IV|Stage||Participants|Count of Participants|32|32.0||||||
4240640|NCT00661193|4064330|B3||IIIB|Stage||Participants|Count of Participants|2|2.0||||||
4240641|NCT00661193|4064331|B2||IIIB|Stage||Participants|Count of Participants|1|1.0||||||
4240642|NCT00661193|4064332|B1||IIIB|Stage||Participants|Count of Participants|1|1.0||||||
4240643|NCT00661193|4064330|B3||Never|Smoking History||Participants|Count of Participants|12|12.0||||||
4240644|NCT00661193|4064331|B2||Never|Smoking History||Participants|Count of Participants|6|6.0||||||
4240645|NCT00661193|4064332|B1||Never|Smoking History||Participants|Count of Participants|6|6.0||||||
4240646|NCT00661193|4064330|B3||Former|Smoking History||Participants|Count of Participants|28|28.0||||||
4240647|NCT00661193|4064331|B2||Former|Smoking History||Participants|Count of Participants|11|11.0||||||
4240648|NCT00661193|4064332|B1||Former|Smoking History||Participants|Count of Participants|17|17.0||||||
4240649|NCT00661193|4064330|B3||Current|Smoking History||Participants|Count of Participants|19|19.0||||||
4240650|NCT00661193|4064331|B2||Current|Smoking History||Participants|Count of Participants|9|9.0||||||
4240651|NCT00661193|4064332|B1||Current|Smoking History||Participants|Count of Participants|10|10.0||||||
4240652|NCT00661193|4064330|B3||Other|Histology||Participants|Count of Participants|1|1.0||||||
4240653|NCT00661193|4064331|B2||Other|Histology||Participants|Count of Participants|0|0.0||||||
4240654|NCT00661193|4064332|B1||Other|Histology||Participants|Count of Participants|1|1.0||||||
4240655|NCT00661193|4064330|B3||Large Cell|Histology||Participants|Count of Participants|1|1.0||||||
4240656|NCT00661193|4064331|B2||Large Cell|Histology||Participants|Count of Participants|1|1.0||||||
4240657|NCT00661193|4064332|B1||Large Cell|Histology||Participants|Count of Participants|0|0.0||||||
4240658|NCT00661193|4064330|B3||Squamous|Histology||Participants|Count of Participants|7|7.0||||||
4240659|NCT00661193|4064331|B2||Squamous|Histology||Participants|Count of Participants|2|2.0||||||
4240660|NCT00661193|4064332|B1||Squamous|Histology||Participants|Count of Participants|5|5.0||||||
4240661|NCT00661193|4064330|B3||Adenocarcinoma|Histology||Participants|Count of Participants|50|50.0||||||
4240662|NCT00661193|4064331|B2||Adenocarcinoma|Histology||Participants|Count of Participants|23|23.0||||||
4240663|NCT00661193|4064332|B1||Adenocarcinoma|Histology||Participants|Count of Participants|27|27.0||||||
4240664|NCT00661193|4064330|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4240665|NCT00661193|4064331|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4240666|NCT00661193|4064332|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240667|NCT00661193|4064330|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240668|NCT00661193|4064331|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240669|NCT00661193|4064332|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240670|NCT00661193|4064330|B3||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4240671|NCT00661193|4064331|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4240672|NCT00661193|4064332|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4240673|NCT00661193|4064330|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4240674|NCT00661193|4064331|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4240675|NCT00661193|4064332|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4240676|NCT00661193|4064330|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4240677|NCT00661193|4064331|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240678|NCT00661193|4064332|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4240679|NCT00661193|4064330|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4240680|NCT00661193|4064331|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4240681|NCT00661193|4064332|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4240682|NCT00661193|4064330|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240683|NCT00661193|4064331|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240684|NCT00661193|4064332|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240685|NCT00661193|4064330|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4240686|NCT00661193|4064331|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4240687|NCT00661193|4064332|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4240688|NCT00661193|4064330|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4240689|NCT00661193|4064331|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4240690|NCT00661193|4064332|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4240691|NCT00661193|4064330|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4240692|NCT00661193|4064331|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4240693|NCT00661193|4064332|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4240694|NCT00661193|4064330|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4240695|NCT00661193|4064331|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4240696|NCT00661193|4064332|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4240697|NCT00661193|4064330|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4240698|NCT00661193|4064331|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4240699|NCT00661193|4064332|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4240700|NCT00661193|4064330|B3|||Age||years|Median|72.4|72.4|Full Range|||40.9|85.9|
4240701|NCT00661193|4064331|B2|||Age||years|Median|70.8|70.8|Full Range|||40.9|85.9|
4240702|NCT00661193|4064332|B1|||Age||years|Median|74.9|74.9|Full Range|||45.2|84.9|
4240703|NCT00661141|4064341|B4|Not Born in Japan||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4240704|NCT00661141|4064342|B3|Not Born in Japan||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4240705|NCT00661141|4064343|B2|Not Born in Japan||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4240706|NCT00661141|4064344|B1|Not Born in Japan||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4240707|NCT00661141|4064341|B4|Born in Japan||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
4240708|NCT00661141|4064342|B3|Born in Japan||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4240709|NCT00661141|4064343|B2|Born in Japan||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4240710|NCT00661141|4064344|B1|Born in Japan||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4240711|NCT00661141|4064341|B4|Japanese Ancestry||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
4240712|NCT00661141|4064342|B3|Japanese Ancestry||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4240713|NCT00661141|4064343|B2|Japanese Ancestry||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4240714|NCT00661141|4064344|B1|Japanese Ancestry||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
4240715|NCT00661141|4064341|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
4240716|NCT00661141|4064342|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4240717|NCT00661141|4064343|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4240718|NCT00661141|4064344|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
4240719|NCT00661141|4064341|B4|Not Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
4240720|NCT00661141|4064342|B3|Not Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4240721|NCT00661141|4064343|B2|Not Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4240722|NCT00661141|4064344|B1|Not Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
4240723|NCT00661141|4064341|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4240724|NCT00661141|4064342|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4240725|NCT00661141|4064343|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4240726|NCT00661141|4064344|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4240727|NCT00661141|4064341|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4240728|NCT00661141|4064342|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4240729|NCT00661141|4064343|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4240730|NCT00661141|4064344|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4240731|NCT00661141|4064341|B4|||Age||years|Mean|34|34.0|Full Range|||22.0|50.0|
4240732|NCT00661141|4064342|B3|||Age||years|Mean|34|34.0|Full Range|||23.0|43.0|
4240733|NCT00661141|4064343|B2|||Age||years|Mean|29|29.0|Full Range|||22.0|44.0|
4240734|NCT00661141|4064344|B1|||Age||years|Mean|38|38.0|Full Range|||28.0|50.0|
4240735|NCT00661089|4064556|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4240736|NCT00661089|4064557|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4240737|NCT00661089|4064558|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4240738|NCT00661089|4064556|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4240739|NCT00661089|4064557|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4240740|NCT00661089|4064558|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4240741|NCT00661089|4064556|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4240742|NCT00661089|4064557|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4240743|NCT00661089|4064558|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4240744|NCT00661089|4064556|B3|||Age||years|Mean|60.00|60.0|Standard Deviation|8.95|8.95|||
4240745|NCT00661089|4064557|B2|||Age||years|Mean|58.9|58.9|Standard Deviation|10.3|10.3|||
4240746|NCT00661089|4064558|B1|||Age||years|Mean|60.2|60.2|Standard Deviation|7.8|7.8|||
4240747|NCT00661089|4064556|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4240748|NCT00661089|4064557|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4240749|NCT00661089|4064558|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4240750|NCT00661089|4064556|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4240751|NCT00661089|4064557|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4240752|NCT00661089|4064558|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4240753|NCT00661089|4064556|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4240754|NCT00661089|4064557|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4240755|NCT00661089|4064558|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4240756|NCT00661037|4064567|B3|Italy||Region of Enrollment||participants|Number|2120|2120.0||||||
4240757|NCT00661037|4064568|B2|Italy||Region of Enrollment||participants|Number|1284|1284.0||||||
4240758|NCT00661037|4064569|B1|Italy||Region of Enrollment||participants|Number|836|836.0||||||
4240759|NCT00661037|4064567|B3||Male|Sex: Female, Male||Participants|Count of Participants|1700|1700.0||||||
4240760|NCT00661037|4064568|B2||Male|Sex: Female, Male||Participants|Count of Participants|1016|1016.0||||||
4240761|NCT00661037|4064569|B1||Male|Sex: Female, Male||Participants|Count of Participants|684|684.0||||||
4240762|NCT00661037|4064567|B3||Female|Sex: Female, Male||Participants|Count of Participants|420|420.0||||||
4240763|NCT00661037|4064568|B2||Female|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
4240764|NCT00661037|4064569|B1||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4240765|NCT00661037|4064567|B3|||Age||years|Mean|66|66.0|Standard Deviation|11|11.0|||
4240766|NCT00661037|4064568|B2|||Age||years|Mean|67|67.0|Standard Deviation|11|11.0|||
4240767|NCT00661037|4064569|B1|||Age||years|Mean|66|66.0|Standard Deviation|12|12.0|||
4240768|NCT00660985|4064580|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
4240769|NCT00660985|4064581|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4240770|NCT00660985|4064582|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4240771|NCT00660985|4064580|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4240772|NCT00660985|4064581|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4240773|NCT00660985|4064582|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4240774|NCT00660985|4064580|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4240775|NCT00660985|4064581|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4240776|NCT00660985|4064582|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4240777|NCT00660985|4064580|B3|||Age||years|Mean|22.4|22.4|Standard Deviation|4.46|4.46|||
4240778|NCT00660985|4064581|B2|||Age||years|Mean|21.3|21.3|Standard Deviation|3.78|3.78|||
4240779|NCT00660985|4064582|B1|||Age||years|Mean|23.4|23.4|Standard Deviation|4.87|4.87|||
4240780|NCT00660985|4064580|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4240781|NCT00660985|4064581|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4240782|NCT00660985|4064582|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4240783|NCT00660985|4064580|B3||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4240784|NCT00660985|4064581|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4240785|NCT00660985|4064582|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4240786|NCT00660985|4064580|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4240787|NCT00660985|4064581|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4240788|NCT00660985|4064582|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4240789|NCT00660907|4064605|B3|||FPG||ng/mL|Mean|163.07|163.07|Standard Deviation|39.708|39.708|||
4240790|NCT00660907|4064606|B2|||FPG||ng/mL|Mean|163.91|163.91|Standard Deviation|41.559|41.559|||
4240791|NCT00660907|4064607|B1|||FPG||ng/mL|Mean|162.24|162.24|Standard Deviation|37.796|37.796|||
4240792|NCT00660907|4064605|B3|||HbA1c||percent|Mean|7.72|7.72|Standard Deviation|0.870|0.87|||
4240793|NCT00660907|4064606|B2|||HbA1c||percent|Mean|7.74|7.74|Standard Deviation|0.886|0.886|||
4240794|NCT00660907|4064607|B1|||HbA1c||percent|Mean|7.69|7.69|Standard Deviation|0.855|0.855|||
4240795|NCT00660907|4064605|B3|||BMI||kg/m2|Mean|31.47|31.47|Standard Deviation|5.081|5.081|||
4240796|NCT00660907|4064606|B2|||BMI||kg/m2|Mean|31.23|31.23|Standard Deviation|5.053|5.053|||
4240797|NCT00660907|4064607|B1|||BMI||kg/m2|Mean|31.71|31.71|Standard Deviation|5.104|5.104|||
4240798|NCT00660907|4064605|B3|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
4240799|NCT00660907|4064606|B2|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
4240800|NCT00660907|4064607|B1|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
4240801|NCT00660907|4064605|B3|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4240802|NCT00660907|4064606|B2|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4240803|NCT00660907|4064607|B1|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4240804|NCT00660907|4064605|B3|White||Race/Ethnicity, Customized||Participants|Number|650|650.0||||||
4240805|NCT00660907|4064606|B2|White||Race/Ethnicity, Customized||Participants|Number|323|323.0||||||
4240806|NCT00660907|4064607|B1|White||Race/Ethnicity, Customized||Participants|Number|327|327.0||||||
4240807|NCT00660907|4064605|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|50|50.0||||||
4240808|NCT00660907|4064606|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
4240809|NCT00660907|4064607|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|26|26.0||||||
4240810|NCT00660907|4064605|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4240811|NCT00660907|4064606|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4240812|NCT00660907|4064607|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4240813|NCT00660907|4064605|B3|Asian||Race/Ethnicity, Customized||Participants|Number|61|61.0||||||
4240814|NCT00660907|4064606|B2|Asian||Race/Ethnicity, Customized||Participants|Number|34|34.0||||||
4240815|NCT00660907|4064607|B1|Asian||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
4240816|NCT00660907|4064605|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4240817|NCT00660907|4064606|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4240818|NCT00660907|4064607|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4240819|NCT00660907|4064605|B3||Male|Sex: Female, Male||Participants|Count of Participants|441|441.0||||||
4240820|NCT00660907|4064606|B2||Male|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
4240821|NCT00660907|4064607|B1||Male|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
4240822|NCT00660907|4064605|B3||Female|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
4240823|NCT00660907|4064606|B2||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4240824|NCT00660907|4064607|B1||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4240825|NCT00660907|4064605|B3|||Age||years|Mean|58.4|58.4|Standard Deviation|9.58|9.58|||
4240826|NCT00660907|4064606|B2|||Age||years|Mean|58.6|58.6|Standard Deviation|9.80|9.8|||
4240827|NCT00660907|4064607|B1|||Age||years|Mean|58.1|58.1|Standard Deviation|9.37|9.37|||
4240828|NCT00660829|4064620|B3|United States||Region of Enrollment|Number of participants based on ITT population|participants|Number|532|532.0||||||
4240829|NCT00660829|4064621|B2|United States||Region of Enrollment|Number of participants based on ITT population|participants|Number|266|266.0||||||
4240830|NCT00660829|4064622|B1|United States||Region of Enrollment|Number of participants based on ITT population|participants|Number|266|266.0||||||
4240831|NCT00660829|4064620|B3||Male|Sex: Female, Male|Number of participants based on ITT population|Participants|Count of Participants|186|186.0||||||
4240832|NCT00660829|4064621|B2||Male|Sex: Female, Male|Number of participants based on ITT population|Participants|Count of Participants|91|91.0||||||
4240833|NCT00660829|4064622|B1||Male|Sex: Female, Male|Number of participants based on ITT population|Participants|Count of Participants|95|95.0||||||
4240834|NCT00660829|4064620|B3||Female|Sex: Female, Male|Number of participants based on ITT population|Participants|Count of Participants|346|346.0||||||
4240835|NCT00660829|4064621|B2||Female|Sex: Female, Male|Number of participants based on ITT population|Participants|Count of Participants|175|175.0||||||
4240836|NCT00660829|4064622|B1||Female|Sex: Female, Male|Number of participants based on ITT population|Participants|Count of Participants|171|171.0||||||
4240837|NCT00660829|4064620|B3|||Age|Number of participants based on ITT population|years|Mean|40.2|40.2|Standard Deviation|14.46|14.46|||
4240838|NCT00660829|4064621|B2|||Age|Number of participants based on ITT population|years|Mean|40.9|40.9|Standard Deviation|14.51|14.51|||
4240839|NCT00660829|4064622|B1|||Age|Number of participants based on ITT population|years|Mean|39.5|39.5|Standard Deviation|14.41|14.41|||
4240840|NCT00660829|4064620|B3||>=65 years|Age|Number of participants based on ITT population|Participants|Count of Participants|27|27.0||||||
4240841|NCT00660829|4064621|B2||>=65 years|Age|Number of participants based on ITT population|Participants|Count of Participants|16|16.0||||||
4240842|NCT00660829|4064622|B1||>=65 years|Age|Number of participants based on ITT population|Participants|Count of Participants|11|11.0||||||
4240843|NCT00660829|4064620|B3||Between 18 and 65 years|Age|Number of participants based on ITT population|Participants|Count of Participants|471|471.0||||||
4240844|NCT00660829|4064621|B2||Between 18 and 65 years|Age|Number of participants based on ITT population|Participants|Count of Participants|230|230.0||||||
4240845|NCT00660829|4064622|B1||Between 18 and 65 years|Age|Number of participants based on ITT population|Participants|Count of Participants|241|241.0||||||
4240846|NCT00660829|4064620|B3||<=18 years|Age|Number of participants based on ITT population|Participants|Count of Participants|34|34.0||||||
4240847|NCT00660829|4064621|B2||<=18 years|Age|Number of participants based on ITT population|Participants|Count of Participants|20|20.0||||||
4240848|NCT00660829|4064622|B1||<=18 years|Age|Number of participants based on ITT population|Participants|Count of Participants|14|14.0||||||
4240849|NCT00660816|4064639|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
4240850|NCT00660816|4064640|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4240851|NCT00660816|4064641|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4240852|NCT00660816|4064639|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4240853|NCT00660816|4064640|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4240854|NCT00660816|4064641|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4240855|NCT00660816|4064639|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240856|NCT00660816|4064640|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240857|NCT00660816|4064641|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240858|NCT00660816|4064639|B3||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4240859|NCT00660816|4064640|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4240860|NCT00660816|4064641|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4240861|NCT00660816|4064639|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4240862|NCT00660816|4064640|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4240863|NCT00660816|4064641|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4240864|NCT00660816|4064639|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4240865|NCT00660816|4064640|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240866|NCT00660816|4064641|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4240867|NCT00660816|4064639|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240868|NCT00660816|4064640|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240869|NCT00660816|4064641|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240870|NCT00660816|4064639|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240871|NCT00660816|4064640|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240872|NCT00660816|4064641|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240873|NCT00660816|4064639|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4240874|NCT00660816|4064640|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4240875|NCT00660816|4064641|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4240876|NCT00660816|4064639|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4240877|NCT00660816|4064640|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4240878|NCT00660816|4064641|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4240879|NCT00660816|4064639|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4240880|NCT00660816|4064640|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4240881|NCT00660816|4064641|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4240882|NCT00660816|4064639|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4240883|NCT00660816|4064640|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4240884|NCT00660816|4064641|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4240885|NCT00660816|4064639|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4240886|NCT00660816|4064640|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4240887|NCT00660816|4064641|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4240888|NCT00660816|4064639|B3|||Age||years|Mean|65.3|65.3|Full Range|10.78|10.78|44.0|84.0|
4240889|NCT00660816|4064640|B2|||Age||years|Mean|63.6|63.6|Full Range|10.62|10.62|46.0|84.0|
4240890|NCT00660816|4064641|B1|||Age||years|Mean|67.0|67.0|Full Range|11.08|11.08|44.0|83.0|
4240891|NCT00660699|4064654|B1|>100||CA 19-9 (tumor marker)|"Generally the higher the CA19-9 level the more the cancer is growing~High CA 19-9 levels can also be caused by non-cancerous conditions such as gallstones, a blockage of the bile duct (jaundice), pancreatitis, cystic fibrosis, and liver disease."|participants|Number|5|5.0||||||
4240892|NCT00660699|4064654|B1|40-100||CA 19-9 (tumor marker)|"Generally the higher the CA19-9 level the more the cancer is growing~High CA 19-9 levels can also be caused by non-cancerous conditions such as gallstones, a blockage of the bile duct (jaundice), pancreatitis, cystic fibrosis, and liver disease."|participants|Number|11|11.0||||||
4240893|NCT00660699|4064654|B1|<40||CA 19-9 (tumor marker)|"Generally the higher the CA19-9 level the more the cancer is growing~High CA 19-9 levels can also be caused by non-cancerous conditions such as gallstones, a blockage of the bile duct (jaundice), pancreatitis, cystic fibrosis, and liver disease."|participants|Number|34|34.0||||||
4240894|NCT00660699|4064654|B1|Not Reported||Lymphovascular involvement||participants|Number|5|5.0||||||
4240895|NCT00660699|4064654|B1|No||Lymphovascular involvement||participants|Number|9|9.0||||||
4240896|NCT00660699|4064654|B1|Yes||Lymphovascular involvement||participants|Number|36|36.0||||||
4240897|NCT00660699|4064654|B1|Not reported||Differentiation|Well-differentiated cancer cells look more like normal cells and tend to grow and spread more slowly than poorly differentiated or undifferentiated cancer cells.|participants|Number|1|1.0||||||
4240898|NCT00660699|4064654|B1|Poor||Differentiation|Well-differentiated cancer cells look more like normal cells and tend to grow and spread more slowly than poorly differentiated or undifferentiated cancer cells.|participants|Number|28|28.0||||||
4240899|NCT00660699|4064654|B1|Moderate||Differentiation|Well-differentiated cancer cells look more like normal cells and tend to grow and spread more slowly than poorly differentiated or undifferentiated cancer cells.|participants|Number|17|17.0||||||
4240900|NCT00660699|4064654|B1|Well||Differentiation|Well-differentiated cancer cells look more like normal cells and tend to grow and spread more slowly than poorly differentiated or undifferentiated cancer cells.|participants|Number|4|4.0||||||
4240901|NCT00660699|4064654|B1|X||N-stage|"N describes the spread to nearby (regional) lymph nodes.~X: Nearby (regional) lymph nodes cannot be assessed.~N0: The cancer has not spread to nearby lymph nodes.~N1: The cancer has spread to nearby lymph nodes."|participants|Number|4|4.0||||||
4240902|NCT00660699|4064654|B1|1||N-stage|"N describes the spread to nearby (regional) lymph nodes.~X: Nearby (regional) lymph nodes cannot be assessed.~N0: The cancer has not spread to nearby lymph nodes.~N1: The cancer has spread to nearby lymph nodes."|participants|Number|36|36.0||||||
4240903|NCT00660699|4064654|B1|0||N-stage|"N describes the spread to nearby (regional) lymph nodes.~X: Nearby (regional) lymph nodes cannot be assessed.~N0: The cancer has not spread to nearby lymph nodes.~N1: The cancer has spread to nearby lymph nodes."|participants|Number|10|10.0||||||
4240904|NCT00660699|4064654|B1|4||T-stage|"T describes the size of the main (primary) tumor and whether it has grown outside the primary site and into nearby organs.~T1 is generally associated with a better outcome and the outcome generally worsens as you increase the T number"|participants|Number|2|2.0||||||
4240905|NCT00660699|4064654|B1|3||T-stage|"T describes the size of the main (primary) tumor and whether it has grown outside the primary site and into nearby organs.~T1 is generally associated with a better outcome and the outcome generally worsens as you increase the T number"|participants|Number|35|35.0||||||
4240906|NCT00660699|4064654|B1|2||T-stage|"T describes the size of the main (primary) tumor and whether it has grown outside the primary site and into nearby organs.~T1 is generally associated with a better outcome and the outcome generally worsens as you increase the T number"|participants|Number|11|11.0||||||
4240907|NCT00660699|4064654|B1|1||T-stage|"T describes the size of the main (primary) tumor and whether it has grown outside the primary site and into nearby organs.~T1 is generally associated with a better outcome and the outcome generally worsens as you increase the T number"|participants|Number|2|2.0||||||
4240908|NCT00660699|4064654|B1|Ampullary cancer||Disease type||participants|Number|9|9.0||||||
4240909|NCT00660699|4064654|B1|Biliary tract cancer||Disease type||participants|Number|12|12.0||||||
4240910|NCT00660699|4064654|B1|Pancreatic cancer||Disease type||participants|Number|29|29.0||||||
4240911|NCT00660699|4064654|B1|IV||Overall stage|"-There are some staging differences between biliary tract cancer, pancreatic cancer, and ampullary cancer but general staging information is listed below:~Stage I (best outcome) and Stage II means that there is only cancer in the primary site with no spread to local lymph nodes or spread to other sites of the body.~Stage III means that the cancer is in the primary site, possibly in nerves and blood vessels around the primary site, and may be in nearby lymph nodes.~Stage IV means that the cancer has spread to distant parts of the body (worst outcome)"|participants|Number|0|0.0||||||
4240912|NCT00660699|4064654|B1|III||Overall stage|"-There are some staging differences between biliary tract cancer, pancreatic cancer, and ampullary cancer but general staging information is listed below:~Stage I (best outcome) and Stage II means that there is only cancer in the primary site with no spread to local lymph nodes or spread to other sites of the body.~Stage III means that the cancer is in the primary site, possibly in nerves and blood vessels around the primary site, and may be in nearby lymph nodes.~Stage IV means that the cancer has spread to distant parts of the body (worst outcome)"|participants|Number|1|1.0||||||
4240913|NCT00660699|4064654|B1|II||Overall stage|"-There are some staging differences between biliary tract cancer, pancreatic cancer, and ampullary cancer but general staging information is listed below:~Stage I (best outcome) and Stage II means that there is only cancer in the primary site with no spread to local lymph nodes or spread to other sites of the body.~Stage III means that the cancer is in the primary site, possibly in nerves and blood vessels around the primary site, and may be in nearby lymph nodes.~Stage IV means that the cancer has spread to distant parts of the body (worst outcome)"|participants|Number|46|46.0||||||
4240914|NCT00660699|4064654|B1|I||Overall stage|"-There are some staging differences between biliary tract cancer, pancreatic cancer, and ampullary cancer but general staging information is listed below:~Stage I (best outcome) and Stage II means that there is only cancer in the primary site with no spread to local lymph nodes or spread to other sites of the body.~Stage III means that the cancer is in the primary site, possibly in nerves and blood vessels around the primary site, and may be in nearby lymph nodes.~Stage IV means that the cancer has spread to distant parts of the body (worst outcome)"|participants|Number|3|3.0||||||
4240915|NCT00660699|4064654|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4240916|NCT00660699|4064654|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4240917|NCT00660699|4064654|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4240918|NCT00660699|4064654|B1|||Age||years|Median|59|59.0|Full Range|||41.0|76.0|
4240919|NCT00660660|4064668|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4240920|NCT00660660|4064669|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4240921|NCT00660660|4064670|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4240922|NCT00660660|4064668|B3||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4240923|NCT00660660|4064669|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4240924|NCT00660660|4064670|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4240925|NCT00660660|4064668|B3|||Age||Years|Mean|46.9|46.9|Standard Deviation|12.3|12.3|||
4240926|NCT00660660|4064669|B2|||Age||Years|Mean|46.8|46.8|Standard Deviation|12.9|12.9|||
4240927|NCT00660660|4064670|B1|||Age||Years|Mean|47.0|47.0|Standard Deviation|11.7|11.7|||
4240928|NCT00660595|4064769|B3|Male||Gender|randomised participants|Participants|Number|1|1.0||||||
4240929|NCT00660595|4064770|B2|Male||Gender|randomised participants|Participants|Number|1|1.0||||||
4240930|NCT00660595|4064771|B1|Male||Gender|randomised participants|Participants|Number|0|0.0||||||
4240931|NCT00660595|4064769|B3|Female||Gender|randomised participants|Participants|Number|2|2.0||||||
4240932|NCT00660595|4064770|B2|Female||Gender|randomised participants|Participants|Number|1|1.0||||||
4240933|NCT00660595|4064771|B1|Female||Gender|randomised participants|Participants|Number|1|1.0||||||
4240934|NCT00660595|4064769|B3|||Age||years|Mean|49|49.0|Full Range|||47.0|63.0|
4240935|NCT00660595|4064770|B2|||Age||years|Mean|51|51.0|Full Range|||39.0|63.0|
4240936|NCT00660595|4064771|B1|||Age||years|Mean|47|47.0|Full Range|||47.0|47.0|
4240937|NCT00660543|4064784|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4240938|NCT00660543|4064784|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4240939|NCT00660543|4064784|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4240940|NCT00660543|4064784|B1|||Age||years|Mean|60|60.0|Full Range|||43.0|81.0|
4240941|NCT00660543|4064784|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4240942|NCT00660543|4064784|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4240943|NCT00660543|4064784|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4240944|NCT00660517|4064793|B5|United States||Region of Enrollment||participants|Number|607|607.0||||||
4240945|NCT00660517|4064794|B4|United States||Region of Enrollment||participants|Number|151|151.0||||||
4240946|NCT00660517|4064795|B3|United States||Region of Enrollment||participants|Number|151|151.0||||||
4240947|NCT00660517|4064796|B2|United States||Region of Enrollment||participants|Number|152|152.0||||||
4240948|NCT00660517|4064797|B1|United States||Region of Enrollment||participants|Number|153|153.0||||||
4240949|NCT00660517|4064793|B5||Male|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4240950|NCT00660517|4064794|B4||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4240951|NCT00660517|4064795|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4240952|NCT00660517|4064796|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4240953|NCT00660517|4064797|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4240954|NCT00660517|4064793|B5||Female|Sex: Female, Male||Participants|Count of Participants|396|396.0||||||
4240955|NCT00660517|4064794|B4||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4240956|NCT00660517|4064795|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4240957|NCT00660517|4064796|B2||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4240958|NCT00660517|4064797|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4240959|NCT00660517|4064793|B5|||Age||years|Mean|39.2|39.2|Standard Deviation|14.3|14.3|||
4240960|NCT00660517|4064794|B4|||Age||years|Mean|39.9|39.9|Standard Deviation|14.7|14.7|||
4240961|NCT00660517|4064795|B3|||Age||years|Mean|38.1|38.1|Standard Deviation|14.2|14.2|||
4240962|NCT00660517|4064796|B2|||Age||years|Mean|39.5|39.5|Standard Deviation|14.1|14.1|||
4240963|NCT00660517|4064797|B1|||Age||years|Mean|39.5|39.5|Standard Deviation|14.2|14.2|||
4240964|NCT00660517|4064793|B5||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4240965|NCT00660517|4064794|B4||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4240966|NCT00660517|4064795|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4240967|NCT00660517|4064796|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4240968|NCT00660517|4064797|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4240969|NCT00660517|4064793|B5||Between 18 and 65 years|Age||Participants|Count of Participants|536|536.0||||||
4240970|NCT00660517|4064794|B4||Between 18 and 65 years|Age||Participants|Count of Participants|131|131.0||||||
4240971|NCT00660517|4064795|B3||Between 18 and 65 years|Age||Participants|Count of Participants|137|137.0||||||
4240972|NCT00660517|4064796|B2||Between 18 and 65 years|Age||Participants|Count of Participants|132|132.0||||||
4240973|NCT00660517|4064797|B1||Between 18 and 65 years|Age||Participants|Count of Participants|136|136.0||||||
4240974|NCT00660517|4064793|B5||<=18 years|Age||Participants|Count of Participants|43|43.0||||||
4240975|NCT00660517|4064794|B4||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4240976|NCT00660517|4064795|B3||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4240977|NCT00660517|4064796|B2||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4240978|NCT00660517|4064797|B1||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4240979|NCT00660504|4064818|B3|China||Region of Enrollment||participants|Number|299|299.0||||||
4240980|NCT00660504|4064819|B2|China||Region of Enrollment||participants|Number|150|150.0||||||
4240981|NCT00660504|4064820|B1|China||Region of Enrollment||participants|Number|149|149.0||||||
4240982|NCT00660504|4064818|B3||Male|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
4240983|NCT00660504|4064819|B2||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4240984|NCT00660504|4064820|B1||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4240985|NCT00660504|4064818|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4240986|NCT00660504|4064819|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4240987|NCT00660504|4064820|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4240988|NCT00660504|4064818|B3|||Age||years|Mean|56.78|56.78|Standard Deviation|9.92|9.92|||
4240989|NCT00660504|4064819|B2|||Age||years|Mean|57.45|57.45|Standard Deviation|9.78|9.78|||
4240990|NCT00660504|4064820|B1|||Age||years|Mean|56.1|56.1|Standard Deviation|10.03|10.03|||
4240991|NCT00660400|4064833|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4240992|NCT00660400|4064833|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4240993|NCT00660400|4064833|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4240994|NCT00660400|4064833|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4240995|NCT00660400|4064833|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4240996|NCT00660400|4064833|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4240997|NCT00660400|4064833|B1|||Age||years|Median|55|55.0|Full Range|||26.0|67.0|
4240998|NCT00660387|4064840|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4240999|NCT00660387|4064841|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4241000|NCT00660387|4064842|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4241001|NCT00660387|4064840|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4241002|NCT00660387|4064841|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4241003|NCT00660387|4064842|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4241004|NCT00660387|4064840|B3|>=65 years||Age, Customized||participants|Number|35|35.0||||||
4241005|NCT00660387|4064841|B2|>=65 years||Age, Customized||participants|Number|19|19.0||||||
4241006|NCT00660387|4064842|B1|>=65 years||Age, Customized||participants|Number|16|16.0||||||
4241007|NCT00660387|4064840|B3|<65 years||Age, Customized||participants|Number|36|36.0||||||
4241008|NCT00660387|4064841|B2|<65 years||Age, Customized||participants|Number|15|15.0||||||
4241009|NCT00660387|4064842|B1|<65 years||Age, Customized||participants|Number|21|21.0||||||
4241010|NCT00660387|4064840|B3|||Age||years|Mean|64.4|64.4|Standard Deviation|8.3|8.3|||
4241011|NCT00660387|4064841|B2|||Age||years|Mean|65.1|65.1|Standard Deviation|6.8|6.8|||
4241012|NCT00660387|4064842|B1|||Age||years|Mean|63.7|63.7|Standard Deviation|9.5|9.5|||
4241013|NCT00660348|4064895|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4241014|NCT00660348|4064897|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4241015|NCT00660348|4064895|B3|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
4241016|NCT00660348|4064897|B1|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
4241017|NCT00660348|4064895|B3|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|1|1.0||||||
4241018|NCT00660348|4064897|B1|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|1|1.0||||||
4241019|NCT00660348|4064895|B3|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
4241020|NCT00660348|4064897|B1|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
4241021|NCT00660348|4064895|B3|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4241022|NCT00660348|4064897|B1|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4241023|NCT00660348|4064895|B3|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4241024|NCT00660348|4064897|B1|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4241025|NCT00660348|4064895|B3|White||Race (NIH/OMB)||participants|Number|1|1.0||||||
4241026|NCT00660348|4064897|B1|White||Race (NIH/OMB)||participants|Number|1|1.0||||||
4241027|NCT00660348|4064895|B3|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
4241028|NCT00660348|4064897|B1|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
4241029|NCT00660348|4064895|B3|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4241030|NCT00660348|4064897|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4241031|NCT00660348|4064895|B3|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
4241032|NCT00660348|4064897|B1|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
4241033|NCT00660348|4064895|B3|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
4241034|NCT00660348|4064897|B1|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
4241035|NCT00660348|4064895|B3|Male||Gender||participants|Number|0|0.0||||||
4241036|NCT00660348|4064897|B1|Male||Gender||participants|Number|0|0.0||||||
4241037|NCT00660348|4064895|B3|Female||Gender||participants|Number|1|1.0||||||
4241038|NCT00660348|4064897|B1|Female||Gender||participants|Number|1|1.0||||||
4241039|NCT00660348|4064895|B3|>=65 years||Age||participants|Number|0|0.0||||||
4241040|NCT00660348|4064897|B1|>=65 years||Age||participants|Number|0|0.0||||||
4241041|NCT00660348|4064895|B3|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
4241042|NCT00660348|4064897|B1|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
4241043|NCT00660348|4064895|B3|<=18 years||Age||participants|Number|0|0.0||||||
4241044|NCT00660348|4064897|B1|<=18 years||Age||participants|Number|0|0.0||||||
4241045|NCT00660348|4064895|B3|||Age|Years|years|Mean|55|55.0|Full Range|||55.0|55.0|
4241046|NCT00660348|4064897|B1|||Age|Years|years|Mean|55|55.0|Full Range|||55.0|55.0|
4241047|NCT00660309|4064904|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4241048|NCT00660309|4064905|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4241049|NCT00660309|4064906|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4241050|NCT00660309|4064904|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4241051|NCT00660309|4064905|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4241052|NCT00660309|4064906|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4241053|NCT00660309|4064904|B3|||Age||years|Mean|57.1|57.1|Standard Deviation|9.73|9.73|||
4241054|NCT00660309|4064905|B2|||Age||years|Mean|57.7|57.7|Standard Deviation|8.14|8.14|||
4241055|NCT00660309|4064906|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|11.20|11.2|||
4241056|NCT00660192|4064946|B3|||Pain|Pain score on the Visual Analog scale. VAS ranges from 0-10, with 0 being no pain, and 10 being worst pain.|units on a scale|Mean|8.24|8.24|Full Range|||0.0|10.0|
4241057|NCT00660192|4064947|B2|||Pain|Pain score on the Visual Analog scale. VAS ranges from 0-10, with 0 being no pain, and 10 being worst pain.|units on a scale|Mean|8.3|8.3|Full Range|||0.0|10.0|
4241058|NCT00660192|4064948|B1|||Pain|Pain score on the Visual Analog scale. VAS ranges from 0-10, with 0 being no pain, and 10 being worst pain.|units on a scale|Mean|8.1|8.1|Full Range|||0.0|10.0|
4241059|NCT00660192|4064946|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4241060|NCT00660192|4064947|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4241061|NCT00660192|4064948|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4241062|NCT00660192|4064946|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4241063|NCT00660192|4064947|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4241064|NCT00660192|4064948|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4241065|NCT00660192|4064946|B3|||Age||years|Mean|60|60.0|Full Range|||18.0|80.0|
4241066|NCT00660192|4064947|B2|||Age||years|Mean|61|61.0|Full Range|||18.0|80.0|
4241067|NCT00660192|4064948|B1|||Age||years|Mean|59|59.0|Full Range|||18.0|80.0|
4241068|NCT00660179|4064957|B4|Class IV||World Health Organisation Functional Class|"Class I: no limitation of usual physical activity (PA) which does not increase dyspnea, fatigue, chest pain, or presyncope.~Class II: mild limitation of PA. No discomfort at rest. Normal PA increases dyspnea, fatigue, chest pain, or presyncope.~Class III: marked limitation of PA. No discomfort at rest. Less than ordinary activity increases dyspnea, fatigue, chest pain, or presyncope.~Class IV: unable to perform any PA and who may have signs of right ventricular failure. Dyspnea and/or fatigue may be present at rest and symptoms are increased by almost any PA."|participants|Number|14|14.0||||||
4241069|NCT00660179|4064958|B3|Class IV||World Health Organisation Functional Class|"Class I: no limitation of usual physical activity (PA) which does not increase dyspnea, fatigue, chest pain, or presyncope.~Class II: mild limitation of PA. No discomfort at rest. Normal PA increases dyspnea, fatigue, chest pain, or presyncope.~Class III: marked limitation of PA. No discomfort at rest. Less than ordinary activity increases dyspnea, fatigue, chest pain, or presyncope.~Class IV: unable to perform any PA and who may have signs of right ventricular failure. Dyspnea and/or fatigue may be present at rest and symptoms are increased by almost any PA."|participants|Number|5|5.0||||||
4241070|NCT00660179|4064959|B2|Class IV||World Health Organisation Functional Class|"Class I: no limitation of usual physical activity (PA) which does not increase dyspnea, fatigue, chest pain, or presyncope.~Class II: mild limitation of PA. No discomfort at rest. Normal PA increases dyspnea, fatigue, chest pain, or presyncope.~Class III: marked limitation of PA. No discomfort at rest. Less than ordinary activity increases dyspnea, fatigue, chest pain, or presyncope.~Class IV: unable to perform any PA and who may have signs of right ventricular failure. Dyspnea and/or fatigue may be present at rest and symptoms are increased by almost any PA."|participants|Number|5|5.0||||||
4241071|NCT00660179|4064960|B1|Class IV||World Health Organisation Functional Class|"Class I: no limitation of usual physical activity (PA) which does not increase dyspnea, fatigue, chest pain, or presyncope.~Class II: mild limitation of PA. No discomfort at rest. Normal PA increases dyspnea, fatigue, chest pain, or presyncope.~Class III: marked limitation of PA. No discomfort at rest. Less than ordinary activity increases dyspnea, fatigue, chest pain, or presyncope.~Class IV: unable to perform any PA and who may have signs of right ventricular failure. Dyspnea and/or fatigue may be present at rest and symptoms are increased by almost any PA."|participants|Number|4|4.0||||||
4241072|NCT00660179|4064957|B4|Class III||World Health Organisation Functional Class|"Class I: no limitation of usual physical activity (PA) which does not increase dyspnea, fatigue, chest pain, or presyncope.~Class II: mild limitation of PA. No discomfort at rest. Normal PA increases dyspnea, fatigue, chest pain, or presyncope.~Class III: marked limitation of PA. No discomfort at rest. Less than ordinary activity increases dyspnea, fatigue, chest pain, or presyncope.~Class IV: unable to perform any PA and who may have signs of right ventricular failure. Dyspnea and/or fatigue may be present at rest and symptoms are increased by almost any PA."|participants|Number|337|337.0||||||
4241073|NCT00660179|4064958|B3|Class III||World Health Organisation Functional Class|"Class I: no limitation of usual physical activity (PA) which does not increase dyspnea, fatigue, chest pain, or presyncope.~Class II: mild limitation of PA. No discomfort at rest. Normal PA increases dyspnea, fatigue, chest pain, or presyncope.~Class III: marked limitation of PA. No discomfort at rest. Less than ordinary activity increases dyspnea, fatigue, chest pain, or presyncope.~Class IV: unable to perform any PA and who may have signs of right ventricular failure. Dyspnea and/or fatigue may be present at rest and symptoms are increased by almost any PA."|participants|Number|116|116.0||||||
4241092|NCT00660179|4064957|B4|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4241093|NCT00660179|4064958|B3|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4241074|NCT00660179|4064959|B2|Class III||World Health Organisation Functional Class|"Class I: no limitation of usual physical activity (PA) which does not increase dyspnea, fatigue, chest pain, or presyncope.~Class II: mild limitation of PA. No discomfort at rest. Normal PA increases dyspnea, fatigue, chest pain, or presyncope.~Class III: marked limitation of PA. No discomfort at rest. Less than ordinary activity increases dyspnea, fatigue, chest pain, or presyncope.~Class IV: unable to perform any PA and who may have signs of right ventricular failure. Dyspnea and/or fatigue may be present at rest and symptoms are increased by almost any PA."|participants|Number|105|105.0||||||
4241075|NCT00660179|4064960|B1|Class III||World Health Organisation Functional Class|"Class I: no limitation of usual physical activity (PA) which does not increase dyspnea, fatigue, chest pain, or presyncope.~Class II: mild limitation of PA. No discomfort at rest. Normal PA increases dyspnea, fatigue, chest pain, or presyncope.~Class III: marked limitation of PA. No discomfort at rest. Less than ordinary activity increases dyspnea, fatigue, chest pain, or presyncope.~Class IV: unable to perform any PA and who may have signs of right ventricular failure. Dyspnea and/or fatigue may be present at rest and symptoms are increased by almost any PA."|participants|Number|116|116.0||||||
4241076|NCT00660179|4064957|B4|Class II||World Health Organisation Functional Class|"Class I: no limitation of usual physical activity (PA) which does not increase dyspnea, fatigue, chest pain, or presyncope.~Class II: mild limitation of PA. No discomfort at rest. Normal PA increases dyspnea, fatigue, chest pain, or presyncope.~Class III: marked limitation of PA. No discomfort at rest. Less than ordinary activity increases dyspnea, fatigue, chest pain, or presyncope.~Class IV: unable to perform any PA and who may have signs of right ventricular failure. Dyspnea and/or fatigue may be present at rest and symptoms are increased by almost any PA."|participants|Number|387|387.0||||||
4241077|NCT00660179|4064958|B3|Class II||World Health Organisation Functional Class|"Class I: no limitation of usual physical activity (PA) which does not increase dyspnea, fatigue, chest pain, or presyncope.~Class II: mild limitation of PA. No discomfort at rest. Normal PA increases dyspnea, fatigue, chest pain, or presyncope.~Class III: marked limitation of PA. No discomfort at rest. Less than ordinary activity increases dyspnea, fatigue, chest pain, or presyncope.~Class IV: unable to perform any PA and who may have signs of right ventricular failure. Dyspnea and/or fatigue may be present at rest and symptoms are increased by almost any PA."|participants|Number|120|120.0||||||
4241078|NCT00660179|4064959|B2|Class II||World Health Organisation Functional Class|"Class I: no limitation of usual physical activity (PA) which does not increase dyspnea, fatigue, chest pain, or presyncope.~Class II: mild limitation of PA. No discomfort at rest. Normal PA increases dyspnea, fatigue, chest pain, or presyncope.~Class III: marked limitation of PA. No discomfort at rest. Less than ordinary activity increases dyspnea, fatigue, chest pain, or presyncope.~Class IV: unable to perform any PA and who may have signs of right ventricular failure. Dyspnea and/or fatigue may be present at rest and symptoms are increased by almost any PA."|participants|Number|138|138.0||||||
4241079|NCT00660179|4064960|B1|Class II||World Health Organisation Functional Class|"Class I: no limitation of usual physical activity (PA) which does not increase dyspnea, fatigue, chest pain, or presyncope.~Class II: mild limitation of PA. No discomfort at rest. Normal PA increases dyspnea, fatigue, chest pain, or presyncope.~Class III: marked limitation of PA. No discomfort at rest. Less than ordinary activity increases dyspnea, fatigue, chest pain, or presyncope.~Class IV: unable to perform any PA and who may have signs of right ventricular failure. Dyspnea and/or fatigue may be present at rest and symptoms are increased by almost any PA."|participants|Number|129|129.0||||||
4241080|NCT00660179|4064957|B4|Class I||World Health Organisation Functional Class|"Class I: no limitation of usual physical activity (PA) which does not increase dyspnea, fatigue, chest pain, or presyncope.~Class II: mild limitation of PA. No discomfort at rest. Normal PA increases dyspnea, fatigue, chest pain, or presyncope.~Class III: marked limitation of PA. No discomfort at rest. Less than ordinary activity increases dyspnea, fatigue, chest pain, or presyncope.~Class IV: unable to perform any PA and who may have signs of right ventricular failure. Dyspnea and/or fatigue may be present at rest and symptoms are increased by almost any PA."|participants|Number|1|1.0||||||
4241081|NCT00660179|4064958|B3|Class I||World Health Organisation Functional Class|"Class I: no limitation of usual physical activity (PA) which does not increase dyspnea, fatigue, chest pain, or presyncope.~Class II: mild limitation of PA. No discomfort at rest. Normal PA increases dyspnea, fatigue, chest pain, or presyncope.~Class III: marked limitation of PA. No discomfort at rest. Less than ordinary activity increases dyspnea, fatigue, chest pain, or presyncope.~Class IV: unable to perform any PA and who may have signs of right ventricular failure. Dyspnea and/or fatigue may be present at rest and symptoms are increased by almost any PA."|participants|Number|1|1.0||||||
4241082|NCT00660179|4064959|B2|Class I||World Health Organisation Functional Class|"Class I: no limitation of usual physical activity (PA) which does not increase dyspnea, fatigue, chest pain, or presyncope.~Class II: mild limitation of PA. No discomfort at rest. Normal PA increases dyspnea, fatigue, chest pain, or presyncope.~Class III: marked limitation of PA. No discomfort at rest. Less than ordinary activity increases dyspnea, fatigue, chest pain, or presyncope.~Class IV: unable to perform any PA and who may have signs of right ventricular failure. Dyspnea and/or fatigue may be present at rest and symptoms are increased by almost any PA."|participants|Number|0|0.0||||||
4241083|NCT00660179|4064960|B1|Class I||World Health Organisation Functional Class|"Class I: no limitation of usual physical activity (PA) which does not increase dyspnea, fatigue, chest pain, or presyncope.~Class II: mild limitation of PA. No discomfort at rest. Normal PA increases dyspnea, fatigue, chest pain, or presyncope.~Class III: marked limitation of PA. No discomfort at rest. Less than ordinary activity increases dyspnea, fatigue, chest pain, or presyncope.~Class IV: unable to perform any PA and who may have signs of right ventricular failure. Dyspnea and/or fatigue may be present at rest and symptoms are increased by almost any PA."|participants|Number|0|0.0||||||
4241084|NCT00660179|4064957|B4|Ukraine||Region of Enrollment||participants|Number|14|14.0||||||
4241085|NCT00660179|4064958|B3|Ukraine||Region of Enrollment||participants|Number|5|5.0||||||
4241086|NCT00660179|4064959|B2|Ukraine||Region of Enrollment||participants|Number|5|5.0||||||
4241087|NCT00660179|4064960|B1|Ukraine||Region of Enrollment||participants|Number|4|4.0||||||
4241088|NCT00660179|4064957|B4|United States||Region of Enrollment||participants|Number|67|67.0||||||
4241089|NCT00660179|4064958|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4241090|NCT00660179|4064959|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4241091|NCT00660179|4064960|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4241094|NCT00660179|4064959|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4241095|NCT00660179|4064960|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4241096|NCT00660179|4064957|B4|Turkey||Region of Enrollment||participants|Number|3|3.0||||||
4241097|NCT00660179|4064958|B3|Turkey||Region of Enrollment||participants|Number|1|1.0||||||
4241098|NCT00660179|4064959|B2|Turkey||Region of Enrollment||participants|Number|1|1.0||||||
4241099|NCT00660179|4064960|B1|Turkey||Region of Enrollment||participants|Number|1|1.0||||||
4241100|NCT00660179|4064957|B4|Thailand||Region of Enrollment||participants|Number|25|25.0||||||
4241101|NCT00660179|4064958|B3|Thailand||Region of Enrollment||participants|Number|9|9.0||||||
4241102|NCT00660179|4064959|B2|Thailand||Region of Enrollment||participants|Number|7|7.0||||||
4241103|NCT00660179|4064960|B1|Thailand||Region of Enrollment||participants|Number|9|9.0||||||
4241104|NCT00660179|4064957|B4|Taiwan||Region of Enrollment||participants|Number|14|14.0||||||
4241105|NCT00660179|4064958|B3|Taiwan||Region of Enrollment||participants|Number|5|5.0||||||
4241106|NCT00660179|4064959|B2|Taiwan||Region of Enrollment||participants|Number|5|5.0||||||
4241107|NCT00660179|4064960|B1|Taiwan||Region of Enrollment||participants|Number|4|4.0||||||
4241108|NCT00660179|4064957|B4|Sweden||Region of Enrollment||participants|Number|7|7.0||||||
4241109|NCT00660179|4064958|B3|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
4241110|NCT00660179|4064959|B2|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
4241111|NCT00660179|4064960|B1|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
4241112|NCT00660179|4064957|B4|Spain||Region of Enrollment||participants|Number|15|15.0||||||
4241113|NCT00660179|4064958|B3|Spain||Region of Enrollment||participants|Number|6|6.0||||||
4241114|NCT00660179|4064959|B2|Spain||Region of Enrollment||participants|Number|5|5.0||||||
4241115|NCT00660179|4064960|B1|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4241116|NCT00660179|4064957|B4|South Africa||Region of Enrollment||participants|Number|24|24.0||||||
4241117|NCT00660179|4064958|B3|South Africa||Region of Enrollment||participants|Number|8|8.0||||||
4241118|NCT00660179|4064959|B2|South Africa||Region of Enrollment||participants|Number|7|7.0||||||
4241119|NCT00660179|4064960|B1|South Africa||Region of Enrollment||participants|Number|9|9.0||||||
4241120|NCT00660179|4064957|B4|Slovakia||Region of Enrollment||participants|Number|6|6.0||||||
4241121|NCT00660179|4064958|B3|Slovakia||Region of Enrollment||participants|Number|3|3.0||||||
4241122|NCT00660179|4064959|B2|Slovakia||Region of Enrollment||participants|Number|2|2.0||||||
4241123|NCT00660179|4064960|B1|Slovakia||Region of Enrollment||participants|Number|1|1.0||||||
4241124|NCT00660179|4064957|B4|Singapore||Region of Enrollment||participants|Number|13|13.0||||||
4241125|NCT00660179|4064958|B3|Singapore||Region of Enrollment||participants|Number|4|4.0||||||
4241126|NCT00660179|4064959|B2|Singapore||Region of Enrollment||participants|Number|5|5.0||||||
4241127|NCT00660179|4064960|B1|Singapore||Region of Enrollment||participants|Number|4|4.0||||||
4241128|NCT00660179|4064957|B4|Serbia||Region of Enrollment||participants|Number|16|16.0||||||
4241129|NCT00660179|4064958|B3|Serbia||Region of Enrollment||participants|Number|4|4.0||||||
4241130|NCT00660179|4064959|B2|Serbia||Region of Enrollment||participants|Number|5|5.0||||||
4241131|NCT00660179|4064960|B1|Serbia||Region of Enrollment||participants|Number|7|7.0||||||
4241132|NCT00660179|4064957|B4|Russian Federation||Region of Enrollment||participants|Number|72|72.0||||||
4241133|NCT00660179|4064958|B3|Russian Federation||Region of Enrollment||participants|Number|23|23.0||||||
4241134|NCT00660179|4064959|B2|Russian Federation||Region of Enrollment||participants|Number|24|24.0||||||
4241135|NCT00660179|4064960|B1|Russian Federation||Region of Enrollment||participants|Number|25|25.0||||||
4241136|NCT00660179|4064957|B4|Romania||Region of Enrollment||participants|Number|16|16.0||||||
4241137|NCT00660179|4064958|B3|Romania||Region of Enrollment||participants|Number|6|6.0||||||
4241138|NCT00660179|4064959|B2|Romania||Region of Enrollment||participants|Number|5|5.0||||||
4241139|NCT00660179|4064960|B1|Romania||Region of Enrollment||participants|Number|5|5.0||||||
4241140|NCT00660179|4064957|B4|Poland||Region of Enrollment||participants|Number|21|21.0||||||
4241141|NCT00660179|4064958|B3|Poland||Region of Enrollment||participants|Number|7|7.0||||||
4241142|NCT00660179|4064959|B2|Poland||Region of Enrollment||participants|Number|7|7.0||||||
4241143|NCT00660179|4064960|B1|Poland||Region of Enrollment||participants|Number|7|7.0||||||
4241144|NCT00660179|4064957|B4|Peru||Region of Enrollment||participants|Number|7|7.0||||||
4241145|NCT00660179|4064958|B3|Peru||Region of Enrollment||participants|Number|2|2.0||||||
4241146|NCT00660179|4064959|B2|Peru||Region of Enrollment||participants|Number|2|2.0||||||
4241147|NCT00660179|4064960|B1|Peru||Region of Enrollment||participants|Number|3|3.0||||||
4241148|NCT00660179|4064957|B4|Norway||Region of Enrollment||participants|Number|2|2.0||||||
4241149|NCT00660179|4064958|B3|Norway||Region of Enrollment||participants|Number|1|1.0||||||
4241150|NCT00660179|4064959|B2|Norway||Region of Enrollment||participants|Number|0|0.0||||||
4241151|NCT00660179|4064960|B1|Norway||Region of Enrollment||participants|Number|1|1.0||||||
4241152|NCT00660179|4064957|B4|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4241153|NCT00660179|4064958|B3|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4241154|NCT00660179|4064959|B2|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4241155|NCT00660179|4064960|B1|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4241156|NCT00660179|4064957|B4|Mexico||Region of Enrollment||participants|Number|40|40.0||||||
4241157|NCT00660179|4064958|B3|Mexico||Region of Enrollment||participants|Number|14|14.0||||||
4241158|NCT00660179|4064959|B2|Mexico||Region of Enrollment||participants|Number|13|13.0||||||
4241159|NCT00660179|4064960|B1|Mexico||Region of Enrollment||participants|Number|13|13.0||||||
4241160|NCT00660179|4064957|B4|Malaysia||Region of Enrollment||participants|Number|7|7.0||||||
4241161|NCT00660179|4064958|B3|Malaysia||Region of Enrollment||participants|Number|3|3.0||||||
4241162|NCT00660179|4064959|B2|Malaysia||Region of Enrollment||participants|Number|2|2.0||||||
4241163|NCT00660179|4064960|B1|Malaysia||Region of Enrollment||participants|Number|2|2.0||||||
4241164|NCT00660179|4064957|B4|Italy||Region of Enrollment||participants|Number|5|5.0||||||
4241165|NCT00660179|4064958|B3|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4241166|NCT00660179|4064959|B2|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4241167|NCT00660179|4064960|B1|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4241168|NCT00660179|4064957|B4|Israel||Region of Enrollment||participants|Number|20|20.0||||||
4241169|NCT00660179|4064958|B3|Israel||Region of Enrollment||participants|Number|8|8.0||||||
4241170|NCT00660179|4064959|B2|Israel||Region of Enrollment||participants|Number|6|6.0||||||
4241171|NCT00660179|4064960|B1|Israel||Region of Enrollment||participants|Number|6|6.0||||||
4241172|NCT00660179|4064957|B4|India||Region of Enrollment||participants|Number|47|47.0||||||
4241173|NCT00660179|4064958|B3|India||Region of Enrollment||participants|Number|15|15.0||||||
4241174|NCT00660179|4064959|B2|India||Region of Enrollment||participants|Number|17|17.0||||||
4241175|NCT00660179|4064960|B1|India||Region of Enrollment||participants|Number|15|15.0||||||
4241176|NCT00660179|4064957|B4|Hungary||Region of Enrollment||participants|Number|6|6.0||||||
4241177|NCT00660179|4064958|B3|Hungary||Region of Enrollment||participants|Number|2|2.0||||||
4241178|NCT00660179|4064959|B2|Hungary||Region of Enrollment||participants|Number|3|3.0||||||
4241179|NCT00660179|4064960|B1|Hungary||Region of Enrollment||participants|Number|1|1.0||||||
4241180|NCT00660179|4064957|B4|Hong Kong||Region of Enrollment||participants|Number|4|4.0||||||
4241181|NCT00660179|4064958|B3|Hong Kong||Region of Enrollment||participants|Number|1|1.0||||||
4241182|NCT00660179|4064959|B2|Hong Kong||Region of Enrollment||participants|Number|2|2.0||||||
4241183|NCT00660179|4064960|B1|Hong Kong||Region of Enrollment||participants|Number|1|1.0||||||
4241184|NCT00660179|4064957|B4|Germany||Region of Enrollment||participants|Number|44|44.0||||||
4241185|NCT00660179|4064958|B3|Germany||Region of Enrollment||participants|Number|13|13.0||||||
4241186|NCT00660179|4064959|B2|Germany||Region of Enrollment||participants|Number|14|14.0||||||
4241187|NCT00660179|4064960|B1|Germany||Region of Enrollment||participants|Number|17|17.0||||||
4241188|NCT00660179|4064957|B4|France||Region of Enrollment||participants|Number|11|11.0||||||
4241189|NCT00660179|4064958|B3|France||Region of Enrollment||participants|Number|3|3.0||||||
4241190|NCT00660179|4064959|B2|France||Region of Enrollment||participants|Number|3|3.0||||||
4241191|NCT00660179|4064960|B1|France||Region of Enrollment||participants|Number|5|5.0||||||
4241192|NCT00660179|4064957|B4|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
4241193|NCT00660179|4064958|B3|Denmark||Region of Enrollment||participants|Number|0|0.0||||||
4241194|NCT00660179|4064959|B2|Denmark||Region of Enrollment||participants|Number|0|0.0||||||
4241195|NCT00660179|4064960|B1|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
4241196|NCT00660179|4064957|B4|Croatia||Region of Enrollment||participants|Number|1|1.0||||||
4241197|NCT00660179|4064958|B3|Croatia||Region of Enrollment||participants|Number|1|1.0||||||
4241198|NCT00660179|4064959|B2|Croatia||Region of Enrollment||participants|Number|0|0.0||||||
4241199|NCT00660179|4064960|B1|Croatia||Region of Enrollment||participants|Number|0|0.0||||||
4241200|NCT00660179|4064957|B4|Colombia||Region of Enrollment||participants|Number|9|9.0||||||
4241201|NCT00660179|4064958|B3|Colombia||Region of Enrollment||participants|Number|3|3.0||||||
4241202|NCT00660179|4064959|B2|Colombia||Region of Enrollment||participants|Number|3|3.0||||||
4241203|NCT00660179|4064960|B1|Colombia||Region of Enrollment||participants|Number|3|3.0||||||
4241204|NCT00660179|4064957|B4|China||Region of Enrollment||participants|Number|87|87.0||||||
4241205|NCT00660179|4064958|B3|China||Region of Enrollment||participants|Number|27|27.0||||||
4241206|NCT00660179|4064959|B2|China||Region of Enrollment||participants|Number|29|29.0||||||
4241207|NCT00660179|4064960|B1|China||Region of Enrollment||participants|Number|31|31.0||||||
4241208|NCT00660179|4064957|B4|Chile||Region of Enrollment||participants|Number|28|28.0||||||
4241209|NCT00660179|4064958|B3|Chile||Region of Enrollment||participants|Number|9|9.0||||||
4241210|NCT00660179|4064959|B2|Chile||Region of Enrollment||participants|Number|10|10.0||||||
4241211|NCT00660179|4064960|B1|Chile||Region of Enrollment||participants|Number|9|9.0||||||
4241212|NCT00660179|4064957|B4|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4241213|NCT00660179|4064958|B3|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4241214|NCT00660179|4064959|B2|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4241215|NCT00660179|4064960|B1|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4241216|NCT00660179|4064957|B4|Bulgaria||Region of Enrollment||participants|Number|6|6.0||||||
4241217|NCT00660179|4064958|B3|Bulgaria||Region of Enrollment||participants|Number|2|2.0||||||
4241218|NCT00660179|4064959|B2|Bulgaria||Region of Enrollment||participants|Number|3|3.0||||||
4241219|NCT00660179|4064960|B1|Bulgaria||Region of Enrollment||participants|Number|1|1.0||||||
4241220|NCT00660179|4064957|B4|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
4241221|NCT00660179|4064958|B3|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4241222|NCT00660179|4064959|B2|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
4241223|NCT00660179|4064960|B1|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4241224|NCT00660179|4064957|B4|Belarus||Region of Enrollment||participants|Number|23|23.0||||||
4241225|NCT00660179|4064958|B3|Belarus||Region of Enrollment||participants|Number|8|8.0||||||
4241226|NCT00660179|4064959|B2|Belarus||Region of Enrollment||participants|Number|8|8.0||||||
4241227|NCT00660179|4064960|B1|Belarus||Region of Enrollment||participants|Number|7|7.0||||||
4241228|NCT00660179|4064957|B4|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4241229|NCT00660179|4064958|B3|Austria||Region of Enrollment||participants|Number|2|2.0||||||
4241230|NCT00660179|4064959|B2|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4241231|NCT00660179|4064960|B1|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4241232|NCT00660179|4064957|B4|Australia||Region of Enrollment||participants|Number|10|10.0||||||
4241233|NCT00660179|4064958|B3|Australia||Region of Enrollment||participants|Number|4|4.0||||||
4241234|NCT00660179|4064959|B2|Australia||Region of Enrollment||participants|Number|4|4.0||||||
4241235|NCT00660179|4064960|B1|Australia||Region of Enrollment||participants|Number|2|2.0||||||
4241236|NCT00660179|4064957|B4|Argentina||Region of Enrollment||participants|Number|43|43.0||||||
4241237|NCT00660179|4064958|B3|Argentina||Region of Enrollment||participants|Number|13|13.0||||||
4241238|NCT00660179|4064959|B2|Argentina||Region of Enrollment||participants|Number|16|16.0||||||
4241239|NCT00660179|4064960|B1|Argentina||Region of Enrollment||participants|Number|14|14.0||||||
4241240|NCT00660179|4064957|B4|Male||Gender||participants|Number|174|174.0||||||
4241241|NCT00660179|4064958|B3|Male||Gender||participants|Number|48|48.0||||||
4241242|NCT00660179|4064959|B2|Male||Gender||participants|Number|61|61.0||||||
4241243|NCT00660179|4064960|B1|Male||Gender||participants|Number|65|65.0||||||
4241244|NCT00660179|4064957|B4|Female||Gender||participants|Number|565|565.0||||||
4241245|NCT00660179|4064958|B3|Female||Gender||participants|Number|194|194.0||||||
4241246|NCT00660179|4064959|B2|Female||Gender||participants|Number|187|187.0||||||
4241247|NCT00660179|4064960|B1|Female||Gender||participants|Number|184|184.0||||||
4241248|NCT00660179|4064957|B4|||Age||years|Mean|45.6|45.6|Standard Deviation|16.13|16.13|||
4241249|NCT00660179|4064958|B3|||Age||years|Mean|45.5|45.5|Standard Deviation|14.99|14.99|||
4241250|NCT00660179|4064959|B2|||Age||years|Mean|44.5|44.5|Standard Deviation|16.26|16.26|||
4241251|NCT00660179|4064960|B1|||Age||years|Mean|46.7|46.7|Standard Deviation|17.03|17.03|||
4241252|NCT00660179|4064957|B4|>=65 years||Age||participants|Number|103|103.0||||||
4241253|NCT00660179|4064958|B3|>=65 years||Age||participants|Number|27|27.0||||||
4241254|NCT00660179|4064959|B2|>=65 years||Age||participants|Number|33|33.0||||||
4241255|NCT00660179|4064960|B1|>=65 years||Age||participants|Number|43|43.0||||||
4241256|NCT00660179|4064957|B4|Between 18 and 65 years||Age||participants|Number|616|616.0||||||
4241257|NCT00660179|4064958|B3|Between 18 and 65 years||Age||participants|Number|209|209.0||||||
4241258|NCT00660179|4064959|B2|Between 18 and 65 years||Age||participants|Number|208|208.0||||||
4241259|NCT00660179|4064960|B1|Between 18 and 65 years||Age||participants|Number|199|199.0||||||
4241260|NCT00660179|4064957|B4|<=18 years||Age||participants|Number|20|20.0||||||
4241261|NCT00660179|4064958|B3|<=18 years||Age||participants|Number|6|6.0||||||
4241262|NCT00660179|4064959|B2|<=18 years||Age||participants|Number|7|7.0||||||
4241263|NCT00660179|4064960|B1|<=18 years||Age||participants|Number|7|7.0||||||
4241264|NCT00660075|4064994|B3|Canada||Region of Enrollment||participants|Number|36|36.0||||||
4241265|NCT00660075|4064995|B2|Canada||Region of Enrollment||participants|Number|18|18.0||||||
4241266|NCT00660075|4064996|B1|Canada||Region of Enrollment||participants|Number|18|18.0||||||
4241267|NCT00660075|4064994|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4241268|NCT00660075|4064995|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4241269|NCT00660075|4064996|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4241270|NCT00660075|4064994|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4241271|NCT00660075|4064995|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4241272|NCT00660075|4064996|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4241273|NCT00660075|4064994|B3|||Age||years|Mean|58.1|58.1|Standard Deviation|6.4|6.4|||
4241274|NCT00660075|4064995|B2|||Age||years|Mean|58.8|58.8|Standard Deviation|6.3|6.3|||
4241275|NCT00660075|4064996|B1|||Age||years|Mean|57.4|57.4|Standard Deviation|6.5|6.5|||
4241276|NCT00660075|4064994|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4241277|NCT00660075|4064995|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4241278|NCT00660075|4064996|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4241279|NCT00660075|4064994|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4241280|NCT00660075|4064995|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4241281|NCT00660075|4064996|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4241282|NCT00660075|4064994|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4241283|NCT00660075|4064995|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4241284|NCT00660075|4064996|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4241285|NCT00660049|4065003|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4241286|NCT00660049|4065003|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4241287|NCT00660049|4065003|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4241288|NCT00660049|4065003|B1|||Age||years|Median|55|55.0|Full Range|||18.0|86.0|
4241289|NCT00660049|4065003|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4241290|NCT00660049|4065003|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4241291|NCT00660049|4065003|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4241292|NCT00660023|4065007|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4241293|NCT00660023|4065007|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4241294|NCT00660023|4065007|B1|||Age||years|Median|63.5|63.5|Full Range|||22.0|88.0|
4241295|NCT00660010|4065018|B1|United States||Region of Enrollment||subjects|Number|55|55.0||||||
4241296|NCT00660010|4065018|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4241297|NCT00660010|4065018|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4241298|NCT00660010|4065018|B1|||Age||years|Mean|6.9|6.9|Standard Deviation|1.86|1.86|||
4241299|NCT00660010|4065018|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4241300|NCT00660010|4065018|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4241301|NCT00660010|4065018|B1||<=18 years|Age||Participants|Count of Participants|55|55.0||||||
4241302|NCT00659984|4065032|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4241303|NCT00659984|4065032|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4241304|NCT00659984|4065032|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4241305|NCT00659984|4065032|B1|||Age||years|Median|8|8.0|Full Range|||3.0|30.0|
4241306|NCT00659945|4065043|B3|||Emesis|Emesis = the reflex action of ejecting stomach contents through the mouth (definition from Bantam Medical Dictionary). The condition was patients with 2 or more major risk factors were eligible for the study. Major PONV patient-related risk factors for inclusion into the study were 1) female gender 2) history of PONV or history of motion sickness 3) non-smoking status, and 4) postoperative use of opioids.|participants|Number|150|150.0||||||
4241307|NCT00659945|4065044|B2|||Emesis|Emesis = the reflex action of ejecting stomach contents through the mouth (definition from Bantam Medical Dictionary). The condition was patients with 2 or more major risk factors were eligible for the study. Major PONV patient-related risk factors for inclusion into the study were 1) female gender 2) history of PONV or history of motion sickness 3) non-smoking status, and 4) postoperative use of opioids.|participants|Number|75|75.0||||||
4241308|NCT00659945|4065045|B1|||Emesis|Emesis = the reflex action of ejecting stomach contents through the mouth (definition from Bantam Medical Dictionary). The condition was patients with 2 or more major risk factors were eligible for the study. Major PONV patient-related risk factors for inclusion into the study were 1) female gender 2) history of PONV or history of motion sickness 3) non-smoking status, and 4) postoperative use of opioids.|participants|Number|75|75.0||||||
4241309|NCT00659945|4065043|B3|United States||Region of Enrollment||participants|Number|150|150.0||||||
4241310|NCT00659945|4065044|B2|United States||Region of Enrollment||participants|Number|75|75.0||||||
4241311|NCT00659945|4065045|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
4241312|NCT00659945|4065043|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4241313|NCT00659945|4065044|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4241314|NCT00659945|4065045|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4241315|NCT00659945|4065043|B3||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4241316|NCT00659945|4065044|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4241317|NCT00659945|4065045|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4241318|NCT00659945|4065043|B3|||Age||years|Mean|44.5|44.5|Standard Deviation|15.3|15.3|||
4241319|NCT00659945|4065044|B2|||Age||years|Mean|45.3|45.3|Standard Deviation|16.3|16.3|||
4241320|NCT00659945|4065045|B1|||Age||years|Mean|43.7|43.7|Standard Deviation|14.3|14.3|||
4241321|NCT00659945|4065043|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4241322|NCT00659945|4065044|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4241323|NCT00659945|4065045|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4241324|NCT00659945|4065043|B3||Between 18 and 65 years|Age||Participants|Count of Participants|150|150.0||||||
4241325|NCT00659945|4065044|B2||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4241326|NCT00659945|4065045|B1||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4241327|NCT00659945|4065043|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4241328|NCT00659945|4065044|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4241329|NCT00659945|4065045|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4241330|NCT00659880|4065052|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4241331|NCT00659880|4065052|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4241332|NCT00659880|4065052|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4241333|NCT00659880|4065052|B1|||Age||years|Mean|31.7|31.7|Standard Deviation|7.6|7.6|||
4241334|NCT00659815|4065057|B3|United States||Region of Enrollment||participants|Number|308|308.0||||||
4241335|NCT00659815|4065058|B2|United States||Region of Enrollment||participants|Number|151|151.0||||||
4241336|NCT00659815|4065059|B1|United States||Region of Enrollment||participants|Number|157|157.0||||||
4241337|NCT00659815|4065057|B3|White||Race/Ethnicity, Customized||Participants|Number|280|280.0||||||
4241338|NCT00659815|4065058|B2|White||Race/Ethnicity, Customized||Participants|Number|136|136.0||||||
4241339|NCT00659815|4065059|B1|White||Race/Ethnicity, Customized||Participants|Number|144|144.0||||||
4241340|NCT00659815|4065057|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4241341|NCT00659815|4065058|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4241342|NCT00659815|4065059|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4241343|NCT00659815|4065057|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4241344|NCT00659815|4065058|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4241345|NCT00659815|4065059|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4241346|NCT00659815|4065057|B3|Asian||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4241347|NCT00659815|4065058|B2|Asian||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4241348|NCT00659815|4065059|B1|Asian||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4241349|NCT00659815|4065057|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4241350|NCT00659815|4065058|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4241351|NCT00659815|4065059|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4241352|NCT00659815|4065057|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4241353|NCT00659815|4065058|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4241354|NCT00659815|4065059|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4241355|NCT00659815|4065057|B3||Female|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4241356|NCT00659815|4065058|B2||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4241357|NCT00659815|4065059|B1||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4241358|NCT00659815|4065057|B3|>=18 and <=65 years||Age, Customized||Participants|Number|308|308.0||||||
4241359|NCT00659815|4065058|B2|>=18 and <=65 years||Age, Customized||Participants|Number|151|151.0||||||
4241360|NCT00659815|4065059|B1|>=18 and <=65 years||Age, Customized||Participants|Number|157|157.0||||||
4241361|NCT00659789|4065070|B3|||Total time on ART||months|Median|108|108.0|Full Range|||13.0|276.0|
4241362|NCT00659789|4065071|B2|||Total time on ART||months|Median|112|112.0|Full Range|||13.0|197.0|
4241363|NCT00659789|4065072|B1|||Total time on ART||months|Median|95.5|95.5|Full Range|||13.0|276.0|
4241364|NCT00659789|4065070|B3|||Pre-ART HIV-1 viral load||copies/mL|Median|75398|75398.0|Full Range|||120.0|2500000.0|
4241365|NCT00659789|4065071|B2|||Pre-ART HIV-1 viral load||copies/mL|Median|25630|25630.0|Full Range|||412.0|1460000.0|
4241366|NCT00659789|4065072|B1|||Pre-ART HIV-1 viral load||copies/mL|Median|94810|94810.0|Full Range|||120.0|2500000.0|
4241367|NCT00659789|4065070|B3|||Pre-ART CD4||10^6 cells/L|Median|357|357.0|Full Range|||177.0|1396.0|
4241368|NCT00659789|4065071|B2|||Pre-ART CD4||10^6 cells/L|Median|370|370.0|Full Range|||207.0|924.0|
4241369|NCT00659789|4065072|B1|||Pre-ART CD4||10^6 cells/L|Median|339|339.0|Full Range|||177.0|1396.0|
4241370|NCT00659789|4065070|B3|||CD4 nadir||10^6 cells/L|Median|298|298.0|Full Range|||200.0|734.0|
4241371|NCT00659789|4065071|B2|||CD4 nadir||10^6 cells/L|Median|285|285.0|Full Range|||200.0|724.0|
4241372|NCT00659789|4065072|B1|||CD4 nadir||10^6 cells/L|Median|300|300.0|Full Range|||200.0|734.0|
4241373|NCT00659789|4065070|B3|||Time since HIV diagnosis (days)||days|Median|4309|4309.0|Full Range|||466.0|8990.0|
4241374|NCT00659789|4065071|B2|||Time since HIV diagnosis (days)||days|Median|4480|4480.0|Full Range|||814.0|8990.0|
4241375|NCT00659789|4065072|B1|||Time since HIV diagnosis (days)||days|Median|3861|3861.0|Full Range|||466.0|8794.0|
4241376|NCT00659789|4065070|B3|||Height||cm|Median|175|175.0|Full Range|||155.0|200.0|
4241377|NCT00659789|4065071|B2|||Height||cm|Median|175|175.0|Full Range|||159.0|200.0|
4241378|NCT00659789|4065072|B1|||Height||cm|Median|175|175.0|Full Range|||155.0|190.0|
4241379|NCT00659789|4065070|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241380|NCT00659789|4065071|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241381|NCT00659789|4065072|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241382|NCT00659789|4065070|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241383|NCT00659789|4065071|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241384|NCT00659789|4065072|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241385|NCT00659789|4065070|B3||White|Race (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
4241386|NCT00659789|4065071|B2||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4241387|NCT00659789|4065072|B1||White|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
4241388|NCT00659789|4065070|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4241389|NCT00659789|4065071|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4241390|NCT00659789|4065072|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4241391|NCT00659789|4065070|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241392|NCT00659789|4065071|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241393|NCT00659789|4065072|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241394|NCT00659789|4065070|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4241395|NCT00659789|4065071|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4241396|NCT00659789|4065072|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241397|NCT00659789|4065070|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241398|NCT00659789|4065071|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241399|NCT00659789|4065072|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241400|NCT00659789|4065070|B3||Male|Gender||Participants|Count of Participants|116|116.0||||||
4241401|NCT00659789|4065071|B2||Male|Gender||Participants|Count of Participants|38|38.0||||||
4241402|NCT00659789|4065072|B1||Male|Gender||Participants|Count of Participants|78|78.0||||||
4241403|NCT00659789|4065070|B3||Female|Gender||Participants|Count of Participants|19|19.0||||||
4241404|NCT00659789|4065071|B2||Female|Gender||Participants|Count of Participants|5|5.0||||||
4241405|NCT00659789|4065072|B1||Female|Gender||Participants|Count of Participants|14|14.0||||||
4241406|NCT00659789|4065070|B3|Age, Categorial|>=55 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
4241407|NCT00659789|4065071|B2|Age, Categorial|>=55 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
4241408|NCT00659789|4065072|B1|Age, Categorial|>=55 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
4241409|NCT00659789|4065070|B3|Age, Categorial|Between 15 and 55|Age, Customized||Participants|Count of Participants|135|135.0||||||
4241410|NCT00659789|4065071|B2|Age, Categorial|Between 15 and 55|Age, Customized||Participants|Count of Participants|43|43.0||||||
4241411|NCT00659789|4065072|B1|Age, Categorial|Between 15 and 55|Age, Customized||Participants|Count of Participants|92|92.0||||||
4241412|NCT00659789|4065070|B3|Age, Categorial|<=18 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
4241413|NCT00659789|4065071|B2|Age, Categorial|<=18 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
4241414|NCT00659789|4065072|B1|Age, Categorial|<=18 years|Age, Customized||Participants|Count of Participants|0|0.0||||||
4241415|NCT00659737|4065089|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4241416|NCT00659737|4065090|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4241417|NCT00659737|4065091|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4241418|NCT00659737|4065089|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4241419|NCT00659737|4065090|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4241420|NCT00659737|4065091|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4241421|NCT00659737|4065089|B3|||Age||Years|Mean|46.8|46.8|Standard Deviation|11.17|11.17|||
4241422|NCT00659737|4065090|B2|||Age||Years|Mean|46.3|46.3|Standard Deviation|11.06|11.06|||
4241423|NCT00659737|4065091|B1|||Age||Years|Mean|47.2|47.2|Standard Deviation|11.27|11.27|||
4241424|NCT00659724|4065098|B1|||Height||inches|Mean|65.6|65.6|Standard Deviation|4.3|4.3|||
4241425|NCT00659724|4065098|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4241426|NCT00659724|4065098|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4241427|NCT00659724|4065098|B1|||Age||years|Mean|66.0|66.0|Standard Deviation|11.1|11.1|||
4241428|NCT00659633|4065116|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4241429|NCT00659633|4065116|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241430|NCT00659633|4065116|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241431|NCT00659633|4065116|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4241432|NCT00659633|4065116|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4241433|NCT00659633|4065116|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241434|NCT00659633|4065116|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241435|NCT00659633|4065116|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241436|NCT00659633|4065116|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4241437|NCT00659633|4065116|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4241438|NCT00659633|4065116|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4241439|NCT00659633|4065116|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4241440|NCT00659633|4065116|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4241441|NCT00659607|4065120|B1||Male|Sex: Female, Male|Gender not recorded for 15 patients|Participants|Count of Participants|1860|1860.0||||||
4241442|NCT00659607|4065120|B1||Female|Sex: Female, Male|Gender not recorded for 15 patients|Participants|Count of Participants|2057|2057.0||||||
4241443|NCT00659607|4065120|B1|||Age|Date of birth not recorded for 15 patients,|years|Mean|60|60.0|Standard Deviation|12|12.0|||
4241444|NCT00659581|4065138|B1||Male|Sex: Female, Male||Participants|Count of Participants|10165|10165.0||||||
4241445|NCT00659581|4065138|B1||Female|Sex: Female, Male||Participants|Count of Participants|10278|10278.0||||||
4241446|NCT00659581|4065138|B1|||Age||years old|Mean|64.6|64.6|Standard Deviation|12.0|12.0|||
4241447|NCT00659529|4065150|B1|||FEV1% predicted||% predicted|Mean|77.5|77.5|Standard Deviation|19.6|19.6|||
4241448|NCT00659529|4065150|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4241449|NCT00659529|4065150|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4241450|NCT00659529|4065150|B1|||Age||years|Mean|25.7|25.7|Standard Deviation|5.5|5.5|||
4241451|NCT00659490|4065154|B4|Unknown||Sex/Gender, Customized||Participants|Number|151|151.0||||||
4241452|NCT00659490|4065155|B3|Unknown||Sex/Gender, Customized||Participants|Number|31|31.0||||||
4241453|NCT00659490|4065156|B2|Unknown||Sex/Gender, Customized||Participants|Number|59|59.0||||||
4241454|NCT00659490|4065157|B1|Unknown||Sex/Gender, Customized||Participants|Number|61|61.0||||||
4241455|NCT00659490|4065154|B4|||Age||Years|Mean|20.7|20.7|Full Range|||18.0|39.0|
4241456|NCT00659490|4065155|B3|||Age||Years|Mean|20.5|20.5|Full Range|||18.0|35.0|
4241457|NCT00659490|4065156|B2|||Age||Years|Mean|21.0|21.0|Full Range|||18.0|39.0|
4241458|NCT00659490|4065157|B1|||Age||Years|Mean|20.6|20.6|Full Range|||18.0|35.0|
4241459|NCT00659438|4065230|B3||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4241460|NCT00659438|4065231|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4241461|NCT00659438|4065232|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4241462|NCT00659438|4065230|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4241463|NCT00659438|4065231|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4241464|NCT00659438|4065232|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4241465|NCT00659438|4065230|B3|||Age||years|Mean|71.51|71.51|Standard Deviation|7.30|7.3|||
4241466|NCT00659438|4065231|B2|||Age||years|Mean|72.23|72.23|Standard Deviation|6.92|6.92|||
4241467|NCT00659438|4065232|B1|||Age||years|Mean|70.77|70.77|Standard Deviation|7.68|7.68|||
4241468|NCT00659425|4065255|B11||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4241469|NCT00659425|4065256|B10||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4241470|NCT00659425|4065257|B9||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4241471|NCT00659425|4065258|B8||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4241472|NCT00659425|4065259|B7||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4241473|NCT00659425|4065260|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4241474|NCT00659425|4065261|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4241475|NCT00659425|4065262|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4241476|NCT00659425|4065263|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4241477|NCT00659425|4065264|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4241478|NCT00659425|4065265|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4241479|NCT00659425|4065255|B11||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4241480|NCT00659425|4065256|B10||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4241481|NCT00659425|4065257|B9||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4241482|NCT00659425|4065258|B8||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4241483|NCT00659425|4065259|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4241484|NCT00659425|4065260|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4241485|NCT00659425|4065261|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4241486|NCT00659425|4065262|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4241487|NCT00659425|4065263|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4241488|NCT00659425|4065264|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4241489|NCT00659425|4065265|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4241490|NCT00659425|4065255|B11|||Age||Years|Mean|12.7|12.7|Standard Deviation|5.9|5.9|||
4241491|NCT00659425|4065256|B10|||Age||Years|Mean|14.3|14.3|Standard Deviation|5.5|5.5|||
4241492|NCT00659425|4065257|B9|||Age||Years|Mean|12.8|12.8|Standard Deviation|8.3|8.3|||
4241493|NCT00659425|4065258|B8|||Age||Years|Mean|13.8|13.8|Standard Deviation|6.3|6.3|||
4241494|NCT00659425|4065259|B7|||Age||Years|Mean|8.6|8.6|Standard Deviation|5.3|5.3|||
4241495|NCT00659425|4065260|B6|||Age||Years|Mean|14|14.0|Standard Deviation|4.7|4.7|||
4241496|NCT00659425|4065261|B5|||Age||Years|Mean|9|9.0|Standard Deviation|2.7|2.7|||
4241497|NCT00659425|4065262|B4|||Age||Years|Mean|12.8|12.8|Standard Deviation|6.8|6.8|||
4241498|NCT00659425|4065263|B3|||Age||Years|Mean|17|17.0|Standard Deviation|NA||||Standard Deviation is not evaluable for single participant.
4241499|NCT00659425|4065264|B2|||Age||Years|Mean|8|8.0|Standard Deviation|NA||||Standard Deviation is not evaluable for single participant.
4241500|NCT00659425|4065265|B1|||Age||Years|Mean|17|17.0|Standard Deviation|NA||||Standard Deviation is not evaluable for single participant.
4241501|NCT00659373|4065503|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4241502|NCT00659373|4065504|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4241503|NCT00659373|4065505|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4241504|NCT00659373|4065503|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4241505|NCT00659373|4065504|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4241506|NCT00659373|4065505|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4241507|NCT00659373|4065503|B3|||Age||years|Median|45|45.0|Inter-Quartile Range|||41.0|49.0|
4241508|NCT00659373|4065504|B2|||Age||years|Median|45|45.0|Inter-Quartile Range|||41.0|47.0|
4241509|NCT00659373|4065505|B1|||Age||years|Median|46|46.0|Inter-Quartile Range|||43.0|50.0|
4241510|NCT00659360|4065512|B1|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4241511|NCT00659360|4065512|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4241512|NCT00659360|4065512|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4241513|NCT00659360|4065512|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4241514|NCT00659360|4065512|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4241515|NCT00659360|4065512|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4241516|NCT00659360|4065512|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4241517|NCT00659360|4065512|B1|||Age||years|Median|65|65.0|Full Range|||22.0|79.0|
4241518|NCT00659334|4065521|B8|United States||Region of Enrollment||participants|Number|116|116.0||||||
4241519|NCT00659334|4065522|B7|United States||Region of Enrollment||participants|Number|21|21.0||||||
4241520|NCT00659334|4065524|B5|United States||Region of Enrollment||participants|Number|1|1.0||||||
4241521|NCT00659334|4065525|B4|United States||Region of Enrollment||participants|Number|2|2.0||||||
4241522|NCT00659334|4065526|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4241523|NCT00659334|4065527|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
4241524|NCT00659334|4065528|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4241525|NCT00659334|4065521|B8||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4241526|NCT00659334|4065522|B7||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4241527|NCT00659334|4065524|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4241528|NCT00659334|4065525|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4241529|NCT00659334|4065526|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4241530|NCT00659334|4065527|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4241531|NCT00659334|4065528|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4241532|NCT00659334|4065521|B8||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4241533|NCT00659334|4065522|B7||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4241534|NCT00659334|4065524|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4241535|NCT00659334|4065525|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4241536|NCT00659334|4065526|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4241537|NCT00659334|4065527|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4241538|NCT00659334|4065528|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4241539|NCT00659334|4065521|B8|||Age||years|Mean|48.8|48.8|Standard Deviation|15.1|15.1|||
4241540|NCT00659334|4065522|B7|||Age||years|Mean|43.0|43.0|Standard Deviation|15.3|15.3|||
4241541|NCT00659334|4065524|B5|||Age||years|Mean|14.1|14.1|Standard Deviation|0|0.0|||
4241542|NCT00659334|4065525|B4|||Age||years|Mean|14.7|14.7|Standard Deviation|1.4|1.4|||
4241543|NCT00659334|4065526|B3|||Age||years|Mean|45.4|45.4|Standard Deviation|14.2|14.2|||
4241544|NCT00659334|4065527|B2|||Age||years|Mean|48.4|48.4|Standard Deviation|12.8|12.8|||
4241545|NCT00659334|4065528|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|13.2|13.2|||
4241546|NCT00659334|4065521|B8||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4241547|NCT00659334|4065522|B7||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4241548|NCT00659334|4065524|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4241549|NCT00659334|4065525|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4241550|NCT00659334|4065526|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4241551|NCT00659334|4065527|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4241552|NCT00659334|4065528|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4241553|NCT00659334|4065521|B8||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
4241554|NCT00659334|4065522|B7||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4241555|NCT00659334|4065524|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4241556|NCT00659334|4065525|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4241557|NCT00659334|4065526|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4241558|NCT00659334|4065527|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4241559|NCT00659334|4065528|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4241560|NCT00659334|4065521|B8||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4241561|NCT00659334|4065522|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4241562|NCT00659334|4065524|B5||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4241563|NCT00659334|4065525|B4||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4241564|NCT00659334|4065526|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4241565|NCT00659334|4065527|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4241566|NCT00659334|4065528|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4241567|NCT00659295|4065550|B3|Japan, n=420, 2240||Duration of diabetes (12 months' participation)||years|Mean|13.9|13.9|Standard Deviation|9.1|9.1|||
4241568|NCT00659295|4065551|B2|Japan, n=420, 2240||Duration of diabetes (12 months' participation)||years|Mean|14.2|14.2|Standard Deviation|8.9|8.9|||
4241569|NCT00659295|4065552|B1|Japan, n=420, 2240||Duration of diabetes (12 months' participation)||years|Mean|12.1|12.1|Standard Deviation|10|10.0|||
4241570|NCT00659295|4065550|B3|France, n=628, 1117||Duration of diabetes (12 months' participation)||years|Mean|15.5|15.5|Standard Deviation|10|10.0|||
4241571|NCT00659295|4065551|B2|France, n=628, 1117||Duration of diabetes (12 months' participation)||years|Mean|14.6|14.6|Standard Deviation|8.9|8.9|||
4241572|NCT00659295|4065552|B1|France, n=628, 1117||Duration of diabetes (12 months' participation)||years|Mean|17|17.0|Standard Deviation|12|12.0|||
4241573|NCT00659295|4065550|B3|Finland, n=796, 245||Duration of diabetes (12 months' participation)||years|Mean|18.3|18.3|Standard Deviation|11.2|11.2|||
4241574|NCT00659295|4065551|B2|Finland, n=796, 245||Duration of diabetes (12 months' participation)||years|Mean|13.3|13.3|Standard Deviation|7.6|7.6|||
4241575|NCT00659295|4065552|B1|Finland, n=796, 245||Duration of diabetes (12 months' participation)||years|Mean|19.8|19.8|Standard Deviation|12.3|12.3|||
4241576|NCT00659295|4065550|B3|United Kingdom/Ireland, n=2260, 1827||Duration of diabetes (6 months' participation)||years|Mean|13.5|13.5|Standard Deviation|10.2|10.2|||
4241577|NCT00659295|4065551|B2|United Kingdom/Ireland, n=2260, 1827||Duration of diabetes (6 months' participation)||years|Mean|11.3|11.3|Standard Deviation|7.7|7.7|||
4241578|NCT00659295|4065552|B1|United Kingdom/Ireland, n=2260, 1827||Duration of diabetes (6 months' participation)||years|Mean|15.2|15.2|Standard Deviation|12.3|12.3|||
4241579|NCT00659295|4065550|B3|Tunisia, n=21, 316||Duration of diabetes (6 months' participation)||years|Mean|11.3|11.3|Standard Deviation|6.5|6.5|||
4241771|NCT00659230|4065590|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4241580|NCT00659295|4065551|B2|Tunisia, n=21, 316||Duration of diabetes (6 months' participation)||years|Mean|11.5|11.5|Standard Deviation|6.4|6.4|||
4241581|NCT00659295|4065552|B1|Tunisia, n=21, 316||Duration of diabetes (6 months' participation)||years|Mean|8.2|8.2|Standard Deviation|7.7|7.7|||
4241582|NCT00659295|4065550|B3|Sweden, n=547, 96||Duration of diabetes (6 months' participation)||years|Mean|18.7|18.7|Standard Deviation|13.2|13.2|||
4241583|NCT00659295|4065551|B2|Sweden, n=547, 96||Duration of diabetes (6 months' participation)||years|Mean|13.6|13.6|Standard Deviation|7.4|7.4|||
4241584|NCT00659295|4065552|B1|Sweden, n=547, 96||Duration of diabetes (6 months' participation)||years|Mean|19.6|19.6|Standard Deviation|14.2|14.2|||
4241585|NCT00659295|4065550|B3|South Korea, n=214, 8701||Duration of diabetes (6 months' participation)||years|Mean|10.1|10.1|Standard Deviation|6.8|6.8|||
4241586|NCT00659295|4065551|B2|South Korea, n=214, 8701||Duration of diabetes (6 months' participation)||years|Mean|10.1|10.1|Standard Deviation|6.8|6.8|||
4241587|NCT00659295|4065552|B1|South Korea, n=214, 8701||Duration of diabetes (6 months' participation)||years|Mean|9.4|9.4|Standard Deviation|7.7|7.7|||
4241588|NCT00659295|4065550|B3|South Africa, n=196, 243||Duration of diabetes (6 months' participation)||years|Mean|10.5|10.5|Standard Deviation|8.3|8.3|||
4241589|NCT00659295|4065551|B2|South Africa, n=196, 243||Duration of diabetes (6 months' participation)||years|Mean|9.9|9.9|Standard Deviation|7.4|7.4|||
4241590|NCT00659295|4065552|B1|South Africa, n=196, 243||Duration of diabetes (6 months' participation)||years|Mean|11.3|11.3|Standard Deviation|9.4|9.4|||
4241591|NCT00659295|4065550|B3|Saudi Arabia, n=96, 494||Duration of diabetes (6 months' participation)||years|Mean|8.8|8.8|Standard Deviation|5.7|5.7|||
4241592|NCT00659295|4065551|B2|Saudi Arabia, n=96, 494||Duration of diabetes (6 months' participation)||years|Mean|9.1|9.1|Standard Deviation|5.6|5.6|||
4241593|NCT00659295|4065552|B1|Saudi Arabia, n=96, 494||Duration of diabetes (6 months' participation)||years|Mean|7.2|7.2|Standard Deviation|6.3|6.3|||
4241594|NCT00659295|4065550|B3|Netherlands, n=88, 318||Duration of diabetes (6 months' participation)||years|Mean|11.0|11.0|Standard Deviation|8.5|8.5|||
4241595|NCT00659295|4065551|B2|Netherlands, n=88, 318||Duration of diabetes (6 months' participation)||years|Mean|9.6|9.6|Standard Deviation|6.9|6.9|||
4241596|NCT00659295|4065552|B1|Netherlands, n=88, 318||Duration of diabetes (6 months' participation)||years|Mean|16.0|16.0|Standard Deviation|14.5|14.5|||
4241597|NCT00659295|4065550|B3|Italy, n=175, 1292||Duration of diabetes (6 months' participation)||years|Mean|14.7|14.7|Standard Deviation|9.0|9.0|||
4241598|NCT00659295|4065551|B2|Italy, n=175, 1292||Duration of diabetes (6 months' participation)||years|Mean|14.7|14.7|Standard Deviation|8.6|8.6|||
4241599|NCT00659295|4065552|B1|Italy, n=175, 1292||Duration of diabetes (6 months' participation)||years|Mean|14.6|14.6|Standard Deviation|11.6|11.6|||
4241600|NCT00659295|4065550|B3|India, n=139, 3178||Duration of diabetes (6 months' participation)||years|Mean|8.4|8.4|Standard Deviation|5.5|5.5|||
4241601|NCT00659295|4065551|B2|India, n=139, 3178||Duration of diabetes (6 months' participation)||years|Mean|8.5|8.5|Standard Deviation|5.5|5.5|||
4241602|NCT00659295|4065552|B1|India, n=139, 3178||Duration of diabetes (6 months' participation)||years|Mean|6.6|6.6|Standard Deviation|6.2|6.2|||
4241603|NCT00659295|4065550|B3|Greece, n=129, 956||Duration of diabetes (6 months' participation)||years|Mean|13.2|13.2|Standard Deviation|7.9|7.9|||
4241604|NCT00659295|4065551|B2|Greece, n=129, 956||Duration of diabetes (6 months' participation)||years|Mean|13.4|13.4|Standard Deviation|7.6|7.6|||
4241605|NCT00659295|4065552|B1|Greece, n=129, 956||Duration of diabetes (6 months' participation)||years|Mean|11.9|11.9|Standard Deviation|9.9|9.9|||
4241606|NCT00659295|4065550|B3|Czech Republic, n=856, 807||Duration of diabetes (6 months' participation)||years|Mean|13.7|13.7|Standard Deviation|9.5|9.5|||
4241607|NCT00659295|4065551|B2|Czech Republic, n=856, 807||Duration of diabetes (6 months' participation)||years|Mean|12.8|12.8|Standard Deviation|7.8|7.8|||
4241608|NCT00659295|4065552|B1|Czech Republic, n=856, 807||Duration of diabetes (6 months' participation)||years|Mean|14.5|14.5|Standard Deviation|11.1|11.1|||
4241609|NCT00659295|4065550|B3|Belgium/Luxembourg, n=329, 38||Duration of diabetes (6 months' participation)||years|Mean|17.3|17.3|Standard Deviation|12.0|12.0|||
4241610|NCT00659295|4065551|B2|Belgium/Luxembourg, n=329, 38||Duration of diabetes (6 months' participation)||years|Mean|14.0|14.0|Standard Deviation|9.2|9.2|||
4241611|NCT00659295|4065552|B1|Belgium/Luxembourg, n=329, 38||Duration of diabetes (6 months' participation)||years|Mean|17.7|17.7|Standard Deviation|12.3|12.3|||
4241612|NCT00659295|4065550|B3|Turkey, n=612, 2127||Duration of diabetes (3 months' participation)||years|Mean|10.1|10.1|Standard Deviation|6.6|6.6|||
4241613|NCT00659295|4065551|B2|Turkey, n=612, 2127||Duration of diabetes (3 months' participation)||years|Mean|10.6|10.6|Standard Deviation|6.6|6.6|||
4241614|NCT00659295|4065552|B1|Turkey, n=612, 2127||Duration of diabetes (3 months' participation)||years|Mean|8.2|8.2|Standard Deviation|6.7|6.7|||
4241615|NCT00659295|4065550|B3|Slovenia, n=90, 208||Duration of diabetes (3 months' participation)||years|Mean|15.0|15.0|Standard Deviation|9.5|9.5|||
4241616|NCT00659295|4065551|B2|Slovenia, n=90, 208||Duration of diabetes (3 months' participation)||years|Mean|13.7|13.7|Standard Deviation|8.0|8.0|||
4241617|NCT00659295|4065552|B1|Slovenia, n=90, 208||Duration of diabetes (3 months' participation)||years|Mean|18.1|18.1|Standard Deviation|13.0|13.0|||
4241618|NCT00659295|4065550|B3|Russia, n=1112, 2509||Duration of diabetes (3 months' participation)||years|Mean|9.2|9.2|Standard Deviation|6.5|6.5|||
4241619|NCT00659295|4065551|B2|Russia, n=1112, 2509||Duration of diabetes (3 months' participation)||years|Mean|9.5|9.5|Standard Deviation|5.8|5.8|||
4241620|NCT00659295|4065552|B1|Russia, n=1112, 2509||Duration of diabetes (3 months' participation)||years|Mean|8.5|8.5|Standard Deviation|8.2|8.2|||
4241621|NCT00659295|4065550|B3|Lebanon, n=63, 192||Duration of diabetes (3 months' participation)||years|Mean|12.0|12.0|Standard Deviation|7.2|7.2|||
4241622|NCT00659295|4065551|B2|Lebanon, n=63, 192||Duration of diabetes (3 months' participation)||years|Mean|12.2|12.2|Standard Deviation|7.1|7.1|||
4241623|NCT00659295|4065552|B1|Lebanon, n=63, 192||Duration of diabetes (3 months' participation)||years|Mean|11.4|11.4|Standard Deviation|7.7|7.7|||
4241624|NCT00659295|4065550|B3|Israel, n=286, 721||Duration of diabetes (3 months' participation)||years|Mean|15.3|15.3|Standard Deviation|10.0|10.0|||
4241625|NCT00659295|4065551|B2|Israel, n=286, 721||Duration of diabetes (3 months' participation)||years|Mean|15.7|15.7|Standard Deviation|9.1|9.1|||
4241626|NCT00659295|4065552|B1|Israel, n=286, 721||Duration of diabetes (3 months' participation)||years|Mean|14.3|14.3|Standard Deviation|12.4|12.4|||
4241627|NCT00659295|4065550|B3|Germany, n=2607, 7468||Duration of diabetes (3 months' participation)||years|Mean|12.3|12.3|Standard Deviation|8.6|8.6|||
4241628|NCT00659295|4065551|B2|Germany, n=2607, 7468||Duration of diabetes (3 months' participation)||years|Mean|10.6|10.6|Standard Deviation|7.2|7.2|||
4241629|NCT00659295|4065552|B1|Germany, n=2607, 7468||Duration of diabetes (3 months' participation)||years|Mean|17.2|17.2|Standard Deviation|12.5|12.5|||
4241630|NCT00659295|4065550|B3|Denmark, n=312, 76||Duration of diabetes (3 months' participation)||years|Mean|18.7|18.7|Standard Deviation|11.4|11.4|||
4241631|NCT00659295|4065551|B2|Denmark, n=312, 76||Duration of diabetes (3 months' participation)||years|Mean|11.8|11.8|Standard Deviation|6.6|6.6|||
4241632|NCT00659295|4065552|B1|Denmark, n=312, 76||Duration of diabetes (3 months' participation)||years|Mean|20.4|20.4|Standard Deviation|12.6|12.6|||
4241633|NCT00659295|4065550|B3|Brazil, n=959, 1141||Duration of diabetes (3 months' participation)||years|Mean|13.2|13.2|Standard Deviation|9.3|9.3|||
4241634|NCT00659295|4065551|B2|Brazil, n=959, 1141||Duration of diabetes (3 months' participation)||years|Mean|13.7|13.7|Standard Deviation|9.0|9.0|||
4241635|NCT00659295|4065552|B1|Brazil, n=959, 1141||Duration of diabetes (3 months' participation)||years|Mean|12.6|12.6|Standard Deviation|9.7|9.7|||
4241636|NCT00659295|4065550|B3|Austria, n=330, 428||Duration of diabetes (3 months' participation)||years|Mean|15.1|15.1|Standard Deviation|10.7|10.7|||
4241637|NCT00659295|4065551|B2|Austria, n=330, 428||Duration of diabetes (3 months' participation)||years|Mean|12.5|12.5|Standard Deviation|8.5|8.5|||
4241638|NCT00659295|4065552|B1|Austria, n=330, 428||Duration of diabetes (3 months' participation)||years|Mean|18.5|18.5|Standard Deviation|13.6|13.6|||
4241639|NCT00659295|4065550|B3|Not specified||Sex/Gender, Customized||participants|Number|19|19.0||||||
4241640|NCT00659295|4065551|B2|Not specified||Sex/Gender, Customized||participants|Number|13|13.0||||||
4241641|NCT00659295|4065552|B1|Not specified||Sex/Gender, Customized||participants|Number|6|6.0||||||
4241642|NCT00659295|4065550|B3|Male||Sex/Gender, Customized||participants|Number|25111|25111.0||||||
4241643|NCT00659295|4065551|B2|Male||Sex/Gender, Customized||participants|Number|18453|18453.0||||||
4241644|NCT00659295|4065552|B1|Male||Sex/Gender, Customized||participants|Number|6658|6658.0||||||
4241645|NCT00659295|4065550|B3|Female||Sex/Gender, Customized||participants|Number|26040|26040.0||||||
4241646|NCT00659295|4065551|B2|Female||Sex/Gender, Customized||participants|Number|19175|19175.0||||||
4241647|NCT00659295|4065552|B1|Female||Sex/Gender, Customized||participants|Number|6865|6865.0||||||
4241648|NCT00659295|4065550|B3|Japan, n=490, 2801||Age|Age: 12 months' participation|years|Mean|60.2|60.2|Standard Deviation|13.3|13.3|||
4241649|NCT00659295|4065551|B2|Japan, n=490, 2801||Age|Age: 12 months' participation|years|Mean|61.9|61.9|Standard Deviation|12.8|12.8|||
4241650|NCT00659295|4065552|B1|Japan, n=490, 2801||Age|Age: 12 months' participation|years|Mean|50.5|50.5|Standard Deviation|16.1|16.1|||
4241651|NCT00659295|4065550|B3|France, n=641, 1127||Age|Age: 12 months' participation|years|Mean|57.0|57.0|Standard Deviation|13.4|13.4|||
4241652|NCT00659295|4065551|B2|France, n=641, 1127||Age|Age: 12 months' participation|years|Mean|62.6|62.6|Standard Deviation|11.9|11.9|||
4241653|NCT00659295|4065552|B1|France, n=641, 1127||Age|Age: 12 months' participation|years|Mean|47.1|47.1|Standard Deviation|16.1|16.1|||
4241654|NCT00659295|4065550|B3|Finland, n=809, 249||Age|Age: 12 months' participation|years|Mean|45.9|45.9|Standard Deviation|13.5|13.5|||
4241655|NCT00659295|4065551|B2|Finland, n=809, 249||Age|Age: 12 months' participation|years|Mean|58.8|58.8|Standard Deviation|10.7|10.7|||
4241656|NCT00659295|4065552|B1|Finland, n=809, 249||Age|Age: 12 months' participation|years|Mean|41.9|41.9|Standard Deviation|14.3|14.3|||
4241657|NCT00659295|4065550|B3|United Kingdom/Ireland, n=2292, 1832||Age|Age: 6 months' participation|years|Mean|46.0|46.0|Standard Deviation|15.0|15.0|||
4241658|NCT00659295|4065551|B2|United Kingdom/Ireland, n=2292, 1832||Age|Age: 6 months' participation|years|Mean|59.2|59.2|Standard Deviation|11.7|11.7|||
4241659|NCT00659295|4065552|B1|United Kingdom/Ireland, n=2292, 1832||Age|Age: 6 months' participation|years|Mean|35.5|35.5|Standard Deviation|17.6|17.6|||
4241660|NCT00659295|4065550|B3|Tunisia, n=21, 316||Age|Age: 6 months' participation|years|Mean|55.5|55.5|Standard Deviation|11.4|11.4|||
4241661|NCT00659295|4065551|B2|Tunisia, n=21, 316||Age|Age: 6 months' participation|years|Mean|57.6|57.6|Standard Deviation|11.1|11.1|||
4241662|NCT00659295|4065552|B1|Tunisia, n=21, 316||Age|Age: 6 months' participation|years|Mean|24.5|24.5|Standard Deviation|15.9|15.9|||
4241663|NCT00659295|4065550|B3|Sweden, n=553, 95||Age|Age: 6 months' participation|years|Mean|44.8|44.8|Standard Deviation|16.6|16.6|||
4241664|NCT00659295|4065551|B2|Sweden, n=553, 95||Age|Age: 6 months' participation|years|Mean|61.3|61.3|Standard Deviation|11.2|11.2|||
4241665|NCT00659295|4065552|B1|Sweden, n=553, 95||Age|Age: 6 months' participation|years|Mean|42.0|42.0|Standard Deviation|17.5|17.5|||
4241666|NCT00659295|4065550|B3|South Korea, n=224, 8854||Age|Age: 6 months' participation|years|Mean|56.4|56.4|Standard Deviation|12.5|12.5|||
4241667|NCT00659295|4065551|B2|South Korea, n=224, 8854||Age|Age: 6 months' participation|years|Mean|56.9|56.9|Standard Deviation|12.4|12.4|||
4241668|NCT00659295|4065552|B1|South Korea, n=224, 8854||Age|Age: 6 months' participation|years|Mean|36.0|36.0|Standard Deviation|16.0|16.0|||
4241669|NCT00659295|4065550|B3|South Africa, n=207, 247||Age|Age: 6 months' participation|years|Mean|44.3|44.3|Standard Deviation|13.8|13.8|||
4241772|NCT00659230|4065591|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4241670|NCT00659295|4065551|B2|South Africa, n=207, 247||Age|Age: 6 months' participation|years|Mean|53.3|53.3|Standard Deviation|11.9|11.9|||
4241671|NCT00659295|4065552|B1|South Africa, n=207, 247||Age|Age: 6 months' participation|years|Mean|33.6|33.6|Standard Deviation|16.0|16.0|||
4241672|NCT00659295|4065550|B3|Saudi Arabia, n=104, 503||Age|Age: 6 months' participation|years|Mean|45.7|45.7|Standard Deviation|10.9|10.9|||
4241673|NCT00659295|4065551|B2|Saudi Arabia, n=104, 503||Age|Age: 6 months' participation|years|Mean|50.0|50.0|Standard Deviation|10.5|10.5|||
4241674|NCT00659295|4065552|B1|Saudi Arabia, n=104, 503||Age|Age: 6 months' participation|years|Mean|25.0|25.0|Standard Deviation|13.1|13.1|||
4241675|NCT00659295|4065550|B3|Netherlands, n=92, 324||Age|Age: 6 months' participation|years|Mean|55.3|55.3|Standard Deviation|13.8|13.8|||
4241676|NCT00659295|4065551|B2|Netherlands, n=92, 324||Age|Age: 6 months' participation|years|Mean|59.7|59.7|Standard Deviation|13.0|13.0|||
4241677|NCT00659295|4065552|B1|Netherlands, n=92, 324||Age|Age: 6 months' participation|years|Mean|39.9|39.9|Standard Deviation|16.6|16.6|||
4241678|NCT00659295|4065550|B3|Italy, n=177, 1297||Age|Age: 6 months' participation|years|Mean|62.5|62.5|Standard Deviation|11.5|11.5|||
4241679|NCT00659295|4065551|B2|Italy, n=177, 1297||Age|Age: 6 months' participation|years|Mean|64.9|64.9|Standard Deviation|9.8|9.8|||
4241680|NCT00659295|4065552|B1|Italy, n=177, 1297||Age|Age: 6 months' participation|years|Mean|44.6|44.6|Standard Deviation|16.0|16.0|||
4241681|NCT00659295|4065550|B3|India, n=142, 3162||Age|Age: 6 months' participation|years|Mean|51.7|51.7|Standard Deviation|10.4|10.4|||
4241682|NCT00659295|4065551|B2|India, n=142, 3162||Age|Age: 6 months' participation|years|Mean|52.6|52.6|Standard Deviation|10.1|10.1|||
4241683|NCT00659295|4065552|B1|India, n=142, 3162||Age|Age: 6 months' participation|years|Mean|31.4|31.4|Standard Deviation|17.0|17.0|||
4241684|NCT00659295|4065550|B3|Greece, n=125, 923||Age|Age: 6 months' participation|years|Mean|60.9|60.9|Standard Deviation|11.8|11.8|||
4241685|NCT00659295|4065551|B2|Greece, n=125, 923||Age|Age: 6 months' participation|years|Mean|64.9|64.9|Standard Deviation|11.2|11.2|||
4241686|NCT00659295|4065552|B1|Greece, n=125, 923||Age|Age: 6 months' participation|years|Mean|31.6|31.6|Standard Deviation|16.3|16.3|||
4241687|NCT00659295|4065550|B3|Czech Republic, n=861, 820||Age|Age: 6 months' participation|years|Mean|52.2|52.2|Standard Deviation|13.8|13.8|||
4241688|NCT00659295|4065551|B2|Czech Republic, n=861, 820||Age|Age: 6 months' participation|years|Mean|59.4|59.4|Standard Deviation|10.7|10.7|||
4241689|NCT00659295|4065552|B1|Czech Republic, n=861, 820||Age|Age: 6 months' participation|years|Mean|45.3|45.3|Standard Deviation|16.8|16.8|||
4241690|NCT00659295|4065550|B3|Belgium/Luxembourg, n=330, 38||Age|Age: 6 months' participation|years|Mean|47.0|47.0|Standard Deviation|14.8|14.8|||
4241691|NCT00659295|4065551|B2|Belgium/Luxembourg, n=330, 38||Age|Age: 6 months' participation|years|Mean|62.4|62.4|Standard Deviation|9.6|9.6|||
4241692|NCT00659295|4065552|B1|Belgium/Luxembourg, n=330, 38||Age|Age: 6 months' participation|years|Mean|45.2|45.2|Standard Deviation|15.4|15.4|||
4241693|NCT00659295|4065550|B3|Turkey, n=622, 2132||Age|Age: 3 months' participation|years|Mean|49.8|49.8|Standard Deviation|11.6|11.6|||
4241694|NCT00659295|4065551|B2|Turkey, n=622, 2132||Age|Age: 3 months' participation|years|Mean|55.9|55.9|Standard Deviation|10.5|10.5|||
4241695|NCT00659295|4065552|B1|Turkey, n=622, 2132||Age|Age: 3 months' participation|years|Mean|28.9|28.9|Standard Deviation|15.2|15.2|||
4241696|NCT00659295|4065550|B3|Slovenia, n=91, 209||Age|Age: 3 months' participation|years|Mean|54.0|54.0|Standard Deviation|11.4|11.4|||
4241697|NCT00659295|4065551|B2|Slovenia, n=91, 209||Age|Age: 3 months' participation|years|Mean|59.1|59.1|Standard Deviation|10.0|10.0|||
4241698|NCT00659295|4065552|B1|Slovenia, n=91, 209||Age|Age: 3 months' participation|years|Mean|42.3|42.3|Standard Deviation|14.5|14.5|||
4241699|NCT00659295|4065550|B3|Russia, n=1121, 2515||Age|Age: 3 months' participation|years|Mean|49.4|49.4|Standard Deviation|11.6|11.6|||
4241700|NCT00659295|4065551|B2|Russia, n=1121, 2515||Age|Age: 3 months' participation|years|Mean|58.7|58.7|Standard Deviation|9.8|9.8|||
4241701|NCT00659295|4065552|B1|Russia, n=1121, 2515||Age|Age: 3 months' participation|years|Mean|28.5|28.5|Standard Deviation|15.8|15.8|||
4241702|NCT00659295|4065550|B3|Lebanon, n=63, 192||Age|Age: 3 months' participation|years|Mean|50.6|50.6|Standard Deviation|11.3|11.3|||
4241703|NCT00659295|4065551|B2|Lebanon, n=63, 192||Age|Age: 3 months' participation|years|Mean|58.2|58.2|Standard Deviation|11.6|11.6|||
4241704|NCT00659295|4065552|B1|Lebanon, n=63, 192||Age|Age: 3 months' participation|years|Mean|27.6|27.6|Standard Deviation|10.3|10.3|||
4241705|NCT00659295|4065550|B3|Israel, n=295, 722||Age|Age: 3 months' participation|years|Mean|53.3|53.3|Standard Deviation|13.7|13.7|||
4241706|NCT00659295|4065551|B2|Israel, n=295, 722||Age|Age: 3 months' participation|years|Mean|60.2|60.2|Standard Deviation|11.1|11.1|||
4241707|NCT00659295|4065552|B1|Israel, n=295, 722||Age|Age: 3 months' participation|years|Mean|36.5|36.5|Standard Deviation|20.0|20.0|||
4241708|NCT00659295|4065550|B3|Germany, n=2640, 7526||Age|Age: 3 months' participation|years|Mean|57.8|57.8|Standard Deviation|11.8|11.8|||
4241709|NCT00659295|4065551|B2|Germany, n=2640, 7526||Age|Age: 3 months' participation|years|Mean|62.3|62.3|Standard Deviation|10.4|10.4|||
4241710|NCT00659295|4065552|B1|Germany, n=2640, 7526||Age|Age: 3 months' participation|years|Mean|45.0|45.0|Standard Deviation|15.7|15.7|||
4241711|NCT00659295|4065550|B3|Denmark, n=312, 77||Age|Age: 3 months' participation|years|Mean|48.7|48.7|Standard Deviation|12.8|12.8|||
4241712|NCT00659295|4065551|B2|Denmark, n=312, 77||Age|Age: 3 months' participation|years|Mean|61.4|61.4|Standard Deviation|10.9|10.9|||
4241713|NCT00659295|4065552|B1|Denmark, n=312, 77||Age|Age: 3 months' participation|years|Mean|45.6|45.6|Standard Deviation|13.3|13.3|||
4241714|NCT00659295|4065550|B3|Brazil, n=962, 1136||Age|Age: 3 months' participation|years|Mean|46.2|46.2|Standard Deviation|14.1|14.1|||
4241715|NCT00659295|4065551|B2|Brazil, n=962, 1136||Age|Age: 3 months' participation|years|Mean|60.3|60.3|Standard Deviation|12.9|12.9|||
4241716|NCT00659295|4065552|B1|Brazil, n=962, 1136||Age|Age: 3 months' participation|years|Mean|29.6|29.6|Standard Deviation|15.5|15.5|||
4241717|NCT00659295|4065550|B3|Austria, n=331, 430||Age|Age: 3 months' participation|years|Mean|52.6|52.6|Standard Deviation|12.5|12.5|||
4241718|NCT00659295|4065551|B2|Austria, n=331, 430||Age|Age: 3 months' participation|years|Mean|60.8|60.8|Standard Deviation|11.5|11.5|||
4241719|NCT00659295|4065552|B1|Austria, n=331, 430||Age|Age: 3 months' participation|years|Mean|41.9|41.9|Standard Deviation|13.8|13.8|||
4241720|NCT00659269|4065559|B3|United States||Region of Enrollment||participants|Number|319|319.0||||||
4241721|NCT00659269|4065560|B2|United States||Region of Enrollment||participants|Number|162|162.0||||||
4241722|NCT00659269|4065561|B1|United States||Region of Enrollment||participants|Number|157|157.0||||||
4241723|NCT00659269|4065559|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4241724|NCT00659269|4065560|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4241725|NCT00659269|4065561|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4241726|NCT00659269|4065559|B3||Female|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4241727|NCT00659269|4065560|B2||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4241728|NCT00659269|4065561|B1||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4241729|NCT00659269|4065559|B3|||Age||years|Median|55|55.0|Full Range|||18.0|83.0|
4241730|NCT00659269|4065560|B2|||Age||years|Median|54.5|54.5|Full Range|||18.0|80.0|
4241731|NCT00659269|4065561|B1|||Age||years|Median|56|56.0|Full Range|||23.0|83.0|
4241732|NCT00659230|4065590|B3|||CAPS-D Score (primary outcome)|CAPS-D is the subscore for the hyperarousal symptoms cluster of PTSD; higher score is more severe; range is 0-40.|units on a scale|Mean|25.82|25.82|Standard Deviation|6.06|6.06|||
4241733|NCT00659230|4065591|B2|||CAPS-D Score (primary outcome)|CAPS-D is the subscore for the hyperarousal symptoms cluster of PTSD; higher score is more severe; range is 0-40.|units on a scale|Mean|26.07|26.07|Standard Deviation|6.01|6.01|||
4241734|NCT00659230|4065592|B1|||CAPS-D Score (primary outcome)|CAPS-D is the subscore for the hyperarousal symptoms cluster of PTSD; higher score is more severe; range is 0-40.|units on a scale|Mean|25.59|25.59|Standard Deviation|6.17|6.17|||
4241735|NCT00659230|4065590|B3|United States||Region of Enrollment||participants|Number|91|91.0||||||
4241736|NCT00659230|4065591|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
4241737|NCT00659230|4065592|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4241738|NCT00659230|4065590|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241739|NCT00659230|4065591|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241740|NCT00659230|4065592|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241741|NCT00659230|4065590|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4241742|NCT00659230|4065591|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4241743|NCT00659230|4065592|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4241744|NCT00659230|4065590|B3||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4241745|NCT00659230|4065591|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4241746|NCT00659230|4065592|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4241747|NCT00659230|4065590|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4241748|NCT00659230|4065591|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4241749|NCT00659230|4065592|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4241750|NCT00659230|4065590|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241751|NCT00659230|4065591|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241752|NCT00659230|4065592|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241753|NCT00659230|4065590|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241754|NCT00659230|4065591|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241755|NCT00659230|4065592|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241756|NCT00659230|4065590|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241757|NCT00659230|4065591|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241758|NCT00659230|4065592|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241759|NCT00659230|4065590|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241760|NCT00659230|4065591|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241761|NCT00659230|4065592|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241762|NCT00659230|4065590|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
4241763|NCT00659230|4065591|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4241764|NCT00659230|4065592|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4241765|NCT00659230|4065590|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4241766|NCT00659230|4065591|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4241767|NCT00659230|4065592|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4241768|NCT00659230|4065590|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4241769|NCT00659230|4065591|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4241770|NCT00659230|4065592|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4241773|NCT00659230|4065592|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4241774|NCT00659230|4065590|B3|||Age||years|Mean|37.96|37.96|Standard Deviation|10.88|10.88|||
4241775|NCT00659230|4065591|B2|||Age||years|Mean|39.33|39.33|Standard Deviation|11.01|11.01|||
4241776|NCT00659230|4065592|B1|||Age||years|Mean|36.61|36.61|Standard Deviation|10.49|10.49|||
4241777|NCT00659165|4065605|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4241778|NCT00659165|4065606|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4241779|NCT00659165|4065607|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4241780|NCT00659165|4065605|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4241781|NCT00659165|4065606|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4241782|NCT00659165|4065607|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4241783|NCT00659165|4065605|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4241784|NCT00659165|4065606|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4241785|NCT00659165|4065607|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4241786|NCT00659165|4065605|B3|||Age|Data for all enrolled subjects.|years|Mean|35|35.0|Standard Deviation|11|11.0|||
4241787|NCT00659165|4065606|B2|||Age|Data for all enrolled subjects.|years|Mean|33|33.0|Standard Deviation|8|8.0|||
4241788|NCT00659165|4065607|B1|||Age|Data for all enrolled subjects.|years|Mean|37|37.0|Standard Deviation|14|14.0|||
4241789|NCT00659165|4065605|B3||>=65 years|Age|Data for all enrolled subjects in this crossover study.|Participants|Count of Participants|0|0.0||||||
4241790|NCT00659165|4065606|B2||>=65 years|Age|Data for all enrolled subjects in this crossover study.|Participants|Count of Participants|0|0.0||||||
4241791|NCT00659165|4065607|B1||>=65 years|Age|Data for all enrolled subjects in this crossover study.|Participants|Count of Participants|0|0.0||||||
4241792|NCT00659165|4065605|B3||Between 18 and 65 years|Age|Data for all enrolled subjects in this crossover study.|Participants|Count of Participants|10|10.0||||||
4241793|NCT00659165|4065606|B2||Between 18 and 65 years|Age|Data for all enrolled subjects in this crossover study.|Participants|Count of Participants|5|5.0||||||
4241794|NCT00659165|4065607|B1||Between 18 and 65 years|Age|Data for all enrolled subjects in this crossover study.|Participants|Count of Participants|5|5.0||||||
4241795|NCT00659165|4065605|B3||<=18 years|Age|Data for all enrolled subjects in this crossover study.|Participants|Count of Participants|0|0.0||||||
4241796|NCT00659165|4065606|B2||<=18 years|Age|Data for all enrolled subjects in this crossover study.|Participants|Count of Participants|0|0.0||||||
4241797|NCT00659165|4065607|B1||<=18 years|Age|Data for all enrolled subjects in this crossover study.|Participants|Count of Participants|0|0.0||||||
4241798|NCT00659061|4065614|B3||Male|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
4241799|NCT00659061|4065615|B2||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4241800|NCT00659061|4065616|B1||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4241801|NCT00659061|4065614|B3||Female|Sex: Female, Male||Participants|Count of Participants|327|327.0||||||
4241802|NCT00659061|4065615|B2||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4241803|NCT00659061|4065616|B1||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4241804|NCT00659061|4065614|B3|||Age||months|Mean|12.2|12.2|Standard Deviation|3.3|3.3|||
4241805|NCT00659061|4065615|B2|||Age||months|Mean|12.3|12.3|Standard Deviation|3.3|3.3|||
4241806|NCT00659061|4065616|B1|||Age||months|Mean|12|12.0|Standard Deviation|3.2|3.2|||
4241807|NCT00658996|4065635|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4241808|NCT00658996|4065635|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4241809|NCT00658996|4065635|B1|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4241810|NCT00658996|4065635|B1|Asian||Race/Ethnicity, Customized||participants|Number|216|216.0||||||
4241811|NCT00658996|4065635|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4241812|NCT00658996|4065635|B1||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4241813|NCT00658996|4065635|B1|||Age||Years|Mean|28.7|28.7|Standard Deviation|7.19|7.19|||
4241814|NCT00658814|4065646|B3|Unknown||Hispanic||participants|Number|15|15.0||||||
4241815|NCT00658814|4065647|B2|Unknown||Hispanic||participants|Number|3|3.0||||||
4241816|NCT00658814|4065648|B1|Unknown||Hispanic||participants|Number|12|12.0||||||
4241817|NCT00658814|4065646|B3|No||Hispanic||participants|Number|114|114.0||||||
4241818|NCT00658814|4065647|B2|No||Hispanic||participants|Number|50|50.0||||||
4241819|NCT00658814|4065648|B1|No||Hispanic||participants|Number|64|64.0||||||
4241820|NCT00658814|4065646|B3|Yes||Hispanic||participants|Number|4|4.0||||||
4241821|NCT00658814|4065647|B2|Yes||Hispanic||participants|Number|1|1.0||||||
4241822|NCT00658814|4065648|B1|Yes||Hispanic||participants|Number|3|3.0||||||
4241823|NCT00658814|4065646|B3|White||Race/Ethnicity, Customized||participants|Number|127|127.0||||||
4241824|NCT00658814|4065647|B2|White||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
4241825|NCT00658814|4065648|B1|White||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
4241826|NCT00658814|4065646|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4241827|NCT00658814|4065647|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4241828|NCT00658814|4065648|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4241829|NCT00658814|4065646|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4241830|NCT00658814|4065647|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4241831|NCT00658814|4065648|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4241832|NCT00658814|4065646|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4241833|NCT00658814|4065647|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4241834|NCT00658814|4065648|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4241835|NCT00658814|4065646|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4241836|NCT00658814|4065647|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4241837|NCT00658814|4065648|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4241838|NCT00658814|4065646|B3|||Age||years|Median|73.4|73.4|Full Range|||60.5|88.7|
4241839|NCT00658814|4065647|B2|||Age||years|Median|76|76.0|Full Range|||70.3|87.0|
4241840|NCT00658814|4065648|B1|||Age||years|Median|71.2|71.2|Full Range|||60.5|88.7|
4241841|NCT00658788|4065663|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241842|NCT00658788|4065663|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4241843|NCT00658788|4065663|B1||White|Race (NIH/OMB)||Participants|Count of Participants|273|273.0||||||
4241844|NCT00658788|4065663|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4241845|NCT00658788|4065663|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241846|NCT00658788|4065663|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4241847|NCT00658788|4065663|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4241848|NCT00658788|4065663|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241849|NCT00658788|4065663|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|278|278.0||||||
4241850|NCT00658788|4065663|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4241851|NCT00658788|4065663|B1||Male|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4241852|NCT00658788|4065663|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4241853|NCT00658788|4065663|B1|||Age||years|Mean|48.6|48.6|Standard Deviation|14.9|14.9|||
4241854|NCT00658775|4065716|B3||Male|Sex: Female, Male||Participants|Count of Participants|691|691.0||||||
4241855|NCT00658775|4065717|B2||Male|Sex: Female, Male||Participants|Count of Participants|349|349.0||||||
4241856|NCT00658775|4065718|B1||Male|Sex: Female, Male||Participants|Count of Participants|342|342.0||||||
4241857|NCT00658775|4065716|B3||Female|Sex: Female, Male||Participants|Count of Participants|374|374.0||||||
4241858|NCT00658775|4065717|B2||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4241859|NCT00658775|4065718|B1||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4241860|NCT00658775|4065716|B3|||Age||Years|Mean|50|50.0|Standard Deviation|13.12|13.12|||
4241861|NCT00658775|4065717|B2|||Age||Years|Mean|51|51.0|Standard Deviation|12.79|12.79|||
4241862|NCT00658775|4065718|B1|||Age||Years|Mean|49.1|49.1|Standard Deviation|13.38|13.38|||
4241863|NCT00658736|4065729|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4241864|NCT00658736|4065729|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4241865|NCT00658736|4065730|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4241866|NCT00658736|4065731|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4241867|NCT00658736|4065729|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4241868|NCT00658736|4065730|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4241869|NCT00658736|4065731|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4241870|NCT00658736|4065729|B3|||Age||years|Mean|41.7|41.7|Standard Deviation|11.9|11.9|||
4241871|NCT00658736|4065730|B2|||Age||years|Mean|44.1|44.1|Standard Deviation|12.5|12.5|||
4241872|NCT00658736|4065731|B1|||Age||years|Mean|39.5|39.5|Standard Deviation|10.9|10.9|||
4241873|NCT00658723|4065740|B3|United States||Region of Enrollment||participants|Number|141|141.0||||||
4241874|NCT00658723|4065741|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4241875|NCT00658723|4065742|B1|United States||Region of Enrollment||participants|Number|111|111.0||||||
4241876|NCT00658723|4065740|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4241877|NCT00658723|4065741|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4241878|NCT00658723|4065742|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241879|NCT00658723|4065740|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241880|NCT00658723|4065741|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241881|NCT00658723|4065742|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241882|NCT00658723|4065740|B3||White|Race (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
4241883|NCT00658723|4065741|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4241884|NCT00658723|4065742|B1||White|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4241885|NCT00658723|4065740|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4241886|NCT00658723|4065741|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4241887|NCT00658723|4065742|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4241888|NCT00658723|4065740|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241889|NCT00658723|4065741|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241890|NCT00658723|4065742|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241891|NCT00658723|4065740|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4241892|NCT00658723|4065741|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4241893|NCT00658723|4065742|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241894|NCT00658723|4065740|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241895|NCT00658723|4065741|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241896|NCT00658723|4065742|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241897|NCT00658723|4065740|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4241898|NCT00658723|4065741|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4241899|NCT00658723|4065742|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4241900|NCT00658723|4065740|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4241901|NCT00658723|4065741|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4241902|NCT00658723|4065742|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4241903|NCT00658723|4065740|B3||>=65 years|Age||Participants|Count of Participants|57|57.0||||||
4241904|NCT00658723|4065741|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4241905|NCT00658723|4065742|B1||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4241906|NCT00658723|4065740|B3||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
4241907|NCT00658723|4065741|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4241908|NCT00658723|4065742|B1||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4241909|NCT00658723|4065740|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4241910|NCT00658723|4065741|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4241911|NCT00658723|4065742|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4241912|NCT00658697|4065771|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4241913|NCT00658697|4065771|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241914|NCT00658697|4065771|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241915|NCT00658697|4065771|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4241916|NCT00658697|4065771|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4241917|NCT00658697|4065771|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241918|NCT00658697|4065771|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4241919|NCT00658697|4065771|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4241920|NCT00658697|4065771|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4241921|NCT00658697|4065771|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4241922|NCT00658697|4065771|B1|||Age||years|Median|58|58.0|Inter-Quartile Range|||55.0|62.0|
4241923|NCT00658684|4065779|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4241924|NCT00658684|4065780|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4241925|NCT00658684|4065781|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4241926|NCT00658684|4065782|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4241927|NCT00658684|4065779|B4||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4241928|NCT00658684|4065780|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4241929|NCT00658684|4065781|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4241930|NCT00658684|4065782|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4241931|NCT00658684|4065779|B4|||Age||years|Mean|52.7|52.7|Standard Deviation|12.6|12.6|||
4241932|NCT00658684|4065780|B3|||Age||years|Mean|57.0|57.0|Standard Deviation|11.7|11.7|||
4241933|NCT00658684|4065781|B2|||Age||years|Mean|54.7|54.7|Standard Deviation|10.5|10.5|||
4241934|NCT00658684|4065782|B1|||Age||years|Mean|51.0|51.0|Standard Deviation|13.1|13.1|||
4241935|NCT00658658|4065835|B6|White or Caucasian||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4241936|NCT00658658|4065836|B5|White or Caucasian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4241937|NCT00658658|4065837|B4|White or Caucasian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4241938|NCT00658658|4065838|B3|White or Caucasian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4241939|NCT00658658|4065839|B2|White or Caucasian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4241940|NCT00658658|4065840|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4241941|NCT00658658|4065835|B6|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4241942|NCT00658658|4065836|B5|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4241943|NCT00658658|4065837|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4241944|NCT00658658|4065838|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4241945|NCT00658658|4065839|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4241946|NCT00658658|4065840|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4241947|NCT00658658|4065835|B6|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4241948|NCT00658658|4065836|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4241949|NCT00658658|4065837|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4241950|NCT00658658|4065838|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4241951|NCT00658658|4065839|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4241952|NCT00658658|4065840|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4241953|NCT00658658|4065835|B6|Black (or African American)||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4241954|NCT00658658|4065836|B5|Black (or African American)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4241955|NCT00658658|4065837|B4|Black (or African American)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4241956|NCT00658658|4065838|B3|Black (or African American)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4241957|NCT00658658|4065839|B2|Black (or African American)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4241958|NCT00658658|4065840|B1|Black (or African American)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4241959|NCT00658658|4065835|B6|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4241960|NCT00658658|4065836|B5|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4241961|NCT00658658|4065837|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4241962|NCT00658658|4065838|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4241963|NCT00658658|4065839|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4241964|NCT00658658|4065840|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4241965|NCT00658658|4065835|B6||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4241966|NCT00658658|4065836|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4241967|NCT00658658|4065837|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4241968|NCT00658658|4065838|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4241969|NCT00658658|4065839|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4241970|NCT00658658|4065840|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4241971|NCT00658658|4065835|B6||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4241972|NCT00658658|4065836|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4241973|NCT00658658|4065837|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4241974|NCT00658658|4065838|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4241975|NCT00658658|4065839|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4241976|NCT00658658|4065840|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4241977|NCT00658658|4065835|B6|||Age||years|Mean|11.8|11.8|Standard Deviation|4.1|4.1|||
4241978|NCT00658658|4065836|B5|||Age||years|Mean|8.4|8.4|Standard Deviation|2.8|2.8|||
4241979|NCT00658658|4065837|B4|||Age||years|Mean|7.8|7.8|Standard Deviation|3.1|3.1|||
4241980|NCT00658658|4065838|B3|||Age||years|Mean|15.8|15.8|Standard Deviation|1.9|1.9|||
4241981|NCT00658658|4065839|B2|||Age||years|Mean|15.6|15.6|Standard Deviation|1.5|1.5|||
4241982|NCT00658658|4065840|B1|||Age||years|Mean|13.2|13.2|Standard Deviation|0.8|0.8|||
4241983|NCT00658632|4065901|B3||Male|Sex: Female, Male||Participants|Count of Participants|648|648.0||||||
4241984|NCT00658632|4065902|B2||Male|Sex: Female, Male||Participants|Count of Participants|318|318.0||||||
4241985|NCT00658632|4065903|B1||Male|Sex: Female, Male||Participants|Count of Participants|330|330.0||||||
4241986|NCT00658632|4065901|B3||Female|Sex: Female, Male||Participants|Count of Participants|730|730.0||||||
4241987|NCT00658632|4065902|B2||Female|Sex: Female, Male||Participants|Count of Participants|379|379.0||||||
4241988|NCT00658632|4065903|B1||Female|Sex: Female, Male||Participants|Count of Participants|351|351.0||||||
4241989|NCT00658632|4065901|B3|||Age||Years|Mean|46.8|46.8|Standard Deviation|13.08|13.08|||
4241990|NCT00658632|4065902|B2|||Age||Years|Mean|47|47.0|Standard Deviation|13.02|13.02|||
4241991|NCT00658632|4065903|B1|||Age||Years|Mean|46.6|46.6|Standard Deviation|13.16|13.16|||
4241992|NCT00658619|4065914|B6||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4241993|NCT00658619|4065915|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4241994|NCT00658619|4065916|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4241995|NCT00658619|4065917|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4241996|NCT00658619|4065918|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4241997|NCT00658619|4065919|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4241998|NCT00658619|4065914|B6||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4241999|NCT00658619|4065915|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4242000|NCT00658619|4065916|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4242001|NCT00658619|4065917|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4242002|NCT00658619|4065918|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4242003|NCT00658619|4065919|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4242004|NCT00658619|4065914|B6|||Age||Years|Mean|77.0|77.0|Standard Deviation|8.33|8.33|||
4242005|NCT00658619|4065915|B5|||Age||Years|Mean|78.4|78.4|Standard Deviation|5.80|5.8|||
4242006|NCT00658619|4065916|B4|||Age||Years|Mean|77.0|77.0|Standard Deviation|9.13|9.13|||
4242007|NCT00658619|4065917|B3|||Age||Years|Mean|75.6|75.6|Standard Deviation|8.78|8.78|||
4242008|NCT00658619|4065918|B2|||Age||Years|Mean|79.0|79.0|Standard Deviation|3.00|3.0|||
4242009|NCT00658619|4065919|B1|||Age||Years|Mean|85.0|85.0|Standard Deviation|3.61|3.61|||
4242010|NCT00658606|4065943|B3|||PASI Score|The PASI score is a tool that allows investigators to assign an objective number to the degree of severity of a person’s psoriasis, and considers: redness, scaling and thickness. Values for PASI score range from 0 (least) to 72 (worst).|Score|Mean|17.7|17.7|Standard Deviation|5.6|5.6|||
4242060|NCT00658567|4065973|B3|||Age||years|Mean|72.1|72.1|Standard Deviation|8.15|8.15|||
4242011|NCT00658606|4065944|B2|||PASI Score|The PASI score is a tool that allows investigators to assign an objective number to the degree of severity of a person’s psoriasis, and considers: redness, scaling and thickness. Values for PASI score range from 0 (least) to 72 (worst).|Score|Mean|17.5|17.5|Standard Deviation|5.2|5.2|||
4242012|NCT00658606|4065945|B1|||PASI Score|The PASI score is a tool that allows investigators to assign an objective number to the degree of severity of a person’s psoriasis, and considers: redness, scaling and thickness. Values for PASI score range from 0 (least) to 72 (worst).|Score|Mean|17.8|17.8|Standard Deviation|6.0|6.0|||
4242013|NCT00658606|4065943|B3|||DLQI Score|The DLQI questionnaire is intended to measure how much a subject’s skin problem affects the subject’s life. Subjects provide answers considering the past week. The scale of the DQLI ranges from 0 (best) to 30 (worst).|Score|Mean|6.1|6.1|Standard Deviation|9|9.0|||
4242014|NCT00658606|4065944|B2|||DLQI Score|The DLQI questionnaire is intended to measure how much a subject’s skin problem affects the subject’s life. Subjects provide answers considering the past week. The scale of the DQLI ranges from 0 (best) to 30 (worst).|Score|Mean|5.9|5.9|Standard Deviation|7|7.0|||
4242015|NCT00658606|4065945|B1|||DLQI Score|The DLQI questionnaire is intended to measure how much a subject’s skin problem affects the subject’s life. Subjects provide answers considering the past week. The scale of the DQLI ranges from 0 (best) to 30 (worst).|Score|Mean|6.1|6.1|Standard Deviation|10|10.0|||
4242016|NCT00658606|4065943|B3|||BSA Score|The percentage of Body Surface Area (BSA) covered with Psoriasis.|Percentage of BSA|Mean|21.0|21.0|Standard Deviation|11.3|11.3|||
4242017|NCT00658606|4065944|B2|||BSA Score|The percentage of Body Surface Area (BSA) covered with Psoriasis.|Percentage of BSA|Mean|20.0|20.0|Standard Deviation|9.4|9.4|||
4242018|NCT00658606|4065945|B1|||BSA Score|The percentage of Body Surface Area (BSA) covered with Psoriasis.|Percentage of BSA|Mean|21.9|21.9|Standard Deviation|13.0|13.0|||
4242019|NCT00658606|4065943|B3|||PGA Score|The PGA scale is a tool used to evaluate the degree of overall lesion severity. The scale ranges from 0 (clear) to 5 (very severe).|Score|Mean|3.3|3.3|Standard Deviation|0.6|0.6|||
4242020|NCT00658606|4065944|B2|||PGA Score|The PGA scale is a tool used to evaluate the degree of overall lesion severity. The scale ranges from 0 (clear) to 5 (very severe).|Score|Mean|3.4|3.4|Standard Deviation|0.6|0.6|||
4242021|NCT00658606|4065945|B1|||PGA Score|The PGA scale is a tool used to evaluate the degree of overall lesion severity. The scale ranges from 0 (clear) to 5 (very severe).|Score|Mean|3.3|3.3|Standard Deviation|0.7|0.7|||
4242022|NCT00658606|4065943|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4242023|NCT00658606|4065944|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4242024|NCT00658606|4065945|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4242025|NCT00658606|4065943|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|85|85.0||||||
4242026|NCT00658606|4065944|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4242027|NCT00658606|4065945|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4242028|NCT00658606|4065943|B3|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4242029|NCT00658606|4065944|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4242030|NCT00658606|4065945|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4242031|NCT00658606|4065943|B3|Asian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4242032|NCT00658606|4065944|B2|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4242033|NCT00658606|4065945|B1|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4242034|NCT00658606|4065943|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4242035|NCT00658606|4065944|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4242036|NCT00658606|4065945|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4242037|NCT00658606|4065943|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4242038|NCT00658606|4065944|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4242039|NCT00658606|4065945|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4242040|NCT00658606|4065943|B3|||Age||years|Mean|47.7|47.7|Standard Deviation|14.0|14.0|||
4242041|NCT00658606|4065944|B2|||Age||years|Mean|47.1|47.1|Standard Deviation|14.2|14.2|||
4242042|NCT00658606|4065945|B1|||Age||years|Mean|48.2|48.2|Standard Deviation|13.8|13.8|||
4242043|NCT00658567|4065972|B4|Europe||Region of Enrollment||participants|Number|68|68.0||||||
4242044|NCT00658567|4065973|B3|Europe||Region of Enrollment||participants|Number|23|23.0||||||
4242045|NCT00658567|4065974|B2|Europe||Region of Enrollment||participants|Number|24|24.0||||||
4242046|NCT00658567|4065975|B1|Europe||Region of Enrollment||participants|Number|21|21.0||||||
4242047|NCT00658567|4065972|B4|United States||Region of Enrollment||participants|Number|53|53.0||||||
4242048|NCT00658567|4065973|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4242049|NCT00658567|4065974|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4242050|NCT00658567|4065975|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4242051|NCT00658567|4065972|B4||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4242052|NCT00658567|4065973|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4242053|NCT00658567|4065974|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4242054|NCT00658567|4065975|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4242055|NCT00658567|4065972|B4||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4242056|NCT00658567|4065973|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4242057|NCT00658567|4065974|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4242058|NCT00658567|4065975|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4242059|NCT00658567|4065972|B4|||Age||years|Mean|72.0|72.0|Standard Deviation|7.82|7.82|||
4242061|NCT00658567|4065974|B2|||Age||years|Mean|71.0|71.0|Standard Deviation|7.44|7.44|||
4242062|NCT00658567|4065975|B1|||Age||years|Mean|73.0|73.0|Standard Deviation|7.91|7.91|||
4242063|NCT00658567|4065972|B4||>=65 years|Age||Participants|Count of Participants|100|100.0||||||
4242064|NCT00658567|4065973|B3||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
4242065|NCT00658567|4065974|B2||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
4242066|NCT00658567|4065975|B1||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4242067|NCT00658567|4065972|B4||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4242068|NCT00658567|4065973|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4242069|NCT00658567|4065974|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4242070|NCT00658567|4065975|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4242071|NCT00658567|4065972|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242072|NCT00658567|4065973|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242073|NCT00658567|4065974|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242074|NCT00658567|4065975|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242075|NCT00658541|4065988|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4242076|NCT00658541|4065988|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242077|NCT00658541|4065988|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242078|NCT00658541|4065988|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4242079|NCT00658541|4065988|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4242080|NCT00658541|4065988|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242081|NCT00658541|4065988|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4242082|NCT00658541|4065988|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242083|NCT00658541|4065988|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4242084|NCT00658541|4065988|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4242085|NCT00658541|4065988|B1|||Age||years|Mean|30.21|30.21|Standard Deviation|11.45|11.45|||
4242086|NCT00658541|4065988|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4242087|NCT00658541|4065988|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4242088|NCT00658541|4065988|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242089|NCT00658528|4065999|B3||Male|Sex: Female, Male||Participants|Count of Participants|647|647.0||||||
4242090|NCT00658528|4066000|B2||Male|Sex: Female, Male||Participants|Count of Participants|322|322.0||||||
4242091|NCT00658528|4066001|B1||Male|Sex: Female, Male||Participants|Count of Participants|325|325.0||||||
4242092|NCT00658528|4065999|B3||Female|Sex: Female, Male||Participants|Count of Participants|408|408.0||||||
4242093|NCT00658528|4066000|B2||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4242094|NCT00658528|4066001|B1||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
4242095|NCT00658528|4065999|B3|||Age||Years|Mean|48.5|48.5|Standard Deviation|13.23|13.23|||
4242096|NCT00658528|4066000|B2|||Age||Years|Mean|48|48.0|Standard Deviation|13.38|13.38|||
4242097|NCT00658528|4066001|B1|||Age||Years|Mean|49|49.0|Standard Deviation|13.09|13.09|||
4242098|NCT00658411|4066012|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4242099|NCT00658411|4066012|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4242100|NCT00658411|4066012|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4242101|NCT00658411|4066012|B1|||Age||years|Mean|48|48.0|Standard Deviation|9.8|9.8|||
4242102|NCT00658411|4066012|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4242103|NCT00658411|4066012|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4242104|NCT00658411|4066012|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242105|NCT00658385|4066020|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4242106|NCT00658385|4066020|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4242107|NCT00658385|4066020|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4242108|NCT00658385|4066020|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4242109|NCT00658385|4066020|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242110|NCT00658359|4066024|B4||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4242111|NCT00658359|4066025|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4242112|NCT00658359|4066026|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4242113|NCT00658359|4066027|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4242114|NCT00658359|4066024|B4||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4242115|NCT00658359|4066025|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4242116|NCT00658359|4066026|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4242117|NCT00658359|4066027|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4242118|NCT00658359|4066024|B4|||Age||Years|Mean|46.8|46.8|Standard Deviation|12.2|12.2|||
4242119|NCT00658359|4066025|B3|||Age||Years|Mean|48.5|48.5|Standard Deviation|10.9|10.9|||
4242120|NCT00658359|4066026|B2|||Age||Years|Mean|45.7|45.7|Standard Deviation|12.6|12.6|||
4242121|NCT00658359|4066027|B1|||Age||Years|Mean|46.4|46.4|Standard Deviation|12.7|12.7|||
4242122|NCT00658333|4066115|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4242123|NCT00658333|4066116|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4242124|NCT00658333|4066117|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4242125|NCT00658333|4066115|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4242126|NCT00658333|4066116|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4242127|NCT00658333|4066117|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4242128|NCT00658333|4066115|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4242129|NCT00658333|4066116|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4242130|NCT00658333|4066117|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4242131|NCT00658333|4066115|B3|||Age||years|Mean|50.5|50.5|Standard Deviation|12.30|12.3|||
4242132|NCT00658333|4066116|B2|||Age||years|Mean|49.8|49.8|Standard Deviation|12.45|12.45|||
4242133|NCT00658333|4066117|B1|||Age||years|Mean|51.3|51.3|Standard Deviation|12.54|12.54|||
4242134|NCT00658320|4066126|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4242135|NCT00658320|4066127|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4242136|NCT00658320|4066128|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4242137|NCT00658320|4066126|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4242138|NCT00658320|4066127|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4242139|NCT00658320|4066128|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4242140|NCT00658320|4066126|B3|||Age||years|Mean|40.5|40.5|Standard Deviation|12.92|12.92|||
4242141|NCT00658320|4066127|B2|||Age||years|Mean|38.6|38.6|Standard Deviation|11.36|11.36|||
4242142|NCT00658320|4066128|B1|||Age||years|Mean|42.5|42.5|Standard Deviation|14.13|14.13|||
4242143|NCT00658138|4066152|B1|Italy||Region of Enrollment||participants|Number|61|61.0||||||
4242144|NCT00658138|4066152|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4242145|NCT00658138|4066152|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4242146|NCT00658138|4066152|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4242147|NCT00658138|4066152|B1||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4242148|NCT00658138|4066152|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242149|NCT00658112|4066157|B1|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4242150|NCT00658112|4066157|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242151|NCT00658112|4066157|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242152|NCT00658112|4066157|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4242153|NCT00658112|4066157|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4242154|NCT00658112|4066157|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242155|NCT00658112|4066157|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4242156|NCT00658112|4066157|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242157|NCT00658112|4066157|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4242158|NCT00658112|4066157|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4242159|NCT00658112|4066157|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4242160|NCT00658112|4066157|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4242161|NCT00658112|4066157|B1||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4242162|NCT00657709|4066161|B6||Male|Sex: Female, Male||Participants|Count of Participants|1859|1859.0||||||
4242163|NCT00657709|4066162|B5||Male|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
4242164|NCT00657709|4066163|B4||Male|Sex: Female, Male||Participants|Count of Participants|341|341.0||||||
4242165|NCT00657709|4066164|B3||Male|Sex: Female, Male||Participants|Count of Participants|404|404.0||||||
4242166|NCT00657709|4066165|B2||Male|Sex: Female, Male||Participants|Count of Participants|428|428.0||||||
4242167|NCT00657709|4066166|B1||Male|Sex: Female, Male||Participants|Count of Participants|430|430.0||||||
4242168|NCT00657709|4066161|B6||Female|Sex: Female, Male||Participants|Count of Participants|1771|1771.0||||||
4242169|NCT00657709|4066162|B5||Female|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
4242170|NCT00657709|4066163|B4||Female|Sex: Female, Male||Participants|Count of Participants|318|318.0||||||
4242171|NCT00657709|4066164|B3||Female|Sex: Female, Male||Participants|Count of Participants|416|416.0||||||
4242172|NCT00657709|4066165|B2||Female|Sex: Female, Male||Participants|Count of Participants|400|400.0||||||
4242173|NCT00657709|4066166|B1||Female|Sex: Female, Male||Participants|Count of Participants|403|403.0||||||
4242174|NCT00657709|4066161|B6|||Age||Days|Mean|73.5|73.5|Standard Deviation|9.5|9.5|||
4242175|NCT00657709|4066162|B5|||Age||Days|Mean|70.6|70.6|Standard Deviation|9.7|9.7|||
4242176|NCT00657709|4066163|B4|||Age||Days|Mean|74.7|74.7|Standard Deviation|9.3|9.3|||
4242177|NCT00657709|4066164|B3|||Age||Days|Mean|73.3|73.3|Standard Deviation|9.4|9.4|||
4242178|NCT00657709|4066165|B2|||Age||Days|Mean|74.1|74.1|Standard Deviation|9.6|9.6|||
4242179|NCT00657709|4066166|B1|||Age||Days|Mean|73.8|73.8|Standard Deviation|9.5|9.5|||
4242180|NCT00657657|4066211|B1||Male|Gender||Participants|Count of Participants|10|10.0||||||
4242181|NCT00657657|4066211|B1||Female|Gender||Participants|Count of Participants|19|19.0||||||
4242182|NCT00657657|4066211|B1|||Age||years|Mean|19.9|19.9|Standard Deviation|0.35|0.35|||
4242183|NCT00657618|4066219|B1|United States||Region of Enrollment||participants|Number|77|77.0||||||
4242184|NCT00657553|4066224|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4242185|NCT00657553|4066225|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4242186|NCT00657553|4066226|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4242187|NCT00657553|4066224|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4242188|NCT00657553|4066225|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4242189|NCT00657553|4066226|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4242190|NCT00657553|4066224|B3|||Age||years|Mean|63|63.0|Standard Deviation|7.3|7.3|||
4242191|NCT00657553|4066225|B2|||Age||years|Mean|64.4|64.4|Standard Deviation|7|7.0|||
4242192|NCT00657553|4066226|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|7.89|7.89|||
4242193|NCT00657553|4066224|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4242194|NCT00657553|4066225|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4242195|NCT00657553|4066226|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4242196|NCT00657553|4066224|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4242197|NCT00657553|4066225|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4242198|NCT00657553|4066226|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4242199|NCT00657553|4066224|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242200|NCT00657553|4066225|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242201|NCT00657553|4066226|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242202|NCT00657540|4066233|B3|||Baseline VAS Pain Score (mm)|The Visual Analog Scale (VAS) ranged from 0 (no pain) to 100 mm (worst possible pain).|mm|Mean|76.7|76.7|Standard Deviation|14.96|14.96|||
4242203|NCT00657540|4066234|B2|||Baseline VAS Pain Score (mm)|The Visual Analog Scale (VAS) ranged from 0 (no pain) to 100 mm (worst possible pain).|mm|Mean|73.8|73.8|Standard Deviation|16.14|16.14|||
4242204|NCT00657540|4066235|B1|||Baseline VAS Pain Score (mm)|The Visual Analog Scale (VAS) ranged from 0 (no pain) to 100 mm (worst possible pain).|mm|Mean|79.7|79.7|Standard Deviation|13.16|13.16|||
4242205|NCT00657540|4066233|B3|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
4242206|NCT00657540|4066234|B2|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
4242207|NCT00657540|4066235|B1|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
4242208|NCT00657540|4066233|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4242209|NCT00657540|4066234|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4242210|NCT00657540|4066235|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4242211|NCT00657540|4066233|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242212|NCT00657540|4066234|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242213|NCT00657540|4066235|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242214|NCT00657540|4066233|B3||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4242215|NCT00657540|4066234|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4242216|NCT00657540|4066235|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4242217|NCT00657540|4066233|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4242218|NCT00657540|4066234|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242219|NCT00657540|4066235|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4242220|NCT00657540|4066233|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242221|NCT00657540|4066234|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242222|NCT00657540|4066235|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242223|NCT00657540|4066233|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242224|NCT00657540|4066234|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242225|NCT00657540|4066235|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242226|NCT00657540|4066233|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4242227|NCT00657540|4066234|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242228|NCT00657540|4066235|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4242229|NCT00657540|4066233|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242230|NCT00657540|4066234|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242231|NCT00657540|4066235|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242232|NCT00657540|4066233|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4242233|NCT00657540|4066234|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4242234|NCT00657540|4066235|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4242235|NCT00657540|4066233|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4242236|NCT00657540|4066234|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4242237|NCT00657540|4066235|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4242238|NCT00657540|4066233|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4242239|NCT00657540|4066234|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4242240|NCT00657540|4066235|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4242241|NCT00657540|4066233|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4242242|NCT00657540|4066234|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4242243|NCT00657540|4066235|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4242244|NCT00657540|4066233|B3|||Age||years|Mean|39.2|39.2|Standard Deviation|16.57|16.57|||
4242245|NCT00657540|4066234|B2|||Age||years|Mean|41.0|41.0|Standard Deviation|17.84|17.84|||
4242246|NCT00657540|4066235|B1|||Age||years|Mean|37.3|37.3|Standard Deviation|15.18|15.18|||
4242247|NCT00657371|4066250|B1|United States||Region of Enrollment||participants|Number|288|288.0||||||
4242248|NCT00657371|4066250|B1||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4242249|NCT00657371|4066250|B1||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4242250|NCT00657371|4066250|B1|||Age||years|Mean|63|63.0|Full Range|6.5|6.5|55.0|80.0|
4242251|NCT00657358|4066255|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4242252|NCT00657358|4066255|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4242253|NCT00657358|4066255|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4242254|NCT00657358|4066255|B1|||Age||years|Mean|25|25.0|Standard Deviation|4|4.0|||
4242255|NCT00657358|4066255|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4242256|NCT00657358|4066255|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4242257|NCT00657358|4066255|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242258|NCT00657280|4066263|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4242259|NCT00657280|4066263|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4242260|NCT00657280|4066263|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4242261|NCT00657280|4066263|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4242262|NCT00657280|4066263|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4242263|NCT00657280|4066263|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242264|NCT00657280|4066263|B1|||Age||years|Mean|51|51.0|Full Range|||43.0|60.0|
4242265|NCT00657267|4066267|B1|||Karnofsky performance status (KPS) at registration|"KPS scores:~100% normal 90% normal activity; minor signs or symptoms 80% normal activity w/ effort; some signs or symptoms 70% cares for self; unable to do normal activity or active work 60% requires occasional assistance, but cares for most personal needs 50% requires considerable assistance and frequent medical care 40% disabled; requires special care and assistance 30% severely disabled; hospital admission is indicated but death not imminent 20% very sick; hospitalization necessary; active supportive treatment necessary 10% moribund; fatal processes progressing rapidly 0% dead"|%|Median|90|90.0|Full Range|||60.0|100.0|
4242266|NCT00657267|4066267|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4242267|NCT00657267|4066267|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4242268|NCT00657267|4066267|B1||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4242269|NCT00657267|4066267|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4242270|NCT00657267|4066267|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242271|NCT00657267|4066267|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242272|NCT00657267|4066267|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242273|NCT00657267|4066267|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4242274|NCT00657267|4066267|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4242275|NCT00657267|4066267|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4242276|NCT00657267|4066267|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4242277|NCT00657267|4066267|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4242278|NCT00657267|4066267|B1|||Age||years|Mean|57|57.0|Full Range|||25.0|79.0|
4242279|NCT00657267|4066267|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4242280|NCT00657267|4066267|B1||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4242281|NCT00657267|4066267|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242282|NCT00657150|4066275|B3|||Body Mass Index N=(1003;992;1995)||kg/m^2|Mean|27.8|27.8|Standard Deviation|4.8|4.8|||
4242283|NCT00657150|4066276|B2|||Body Mass Index N=(1003;992;1995)||kg/m^2|Mean|27.8|27.8|Standard Deviation|4.8|4.8|||
4242284|NCT00657150|4066277|B1|||Body Mass Index N=(1003;992;1995)||kg/m^2|Mean|27.8|27.8|Standard Deviation|4.8|4.8|||
4242285|NCT00657150|4066275|B3||Male|Sex: Female, Male||Participants|Count of Participants|971|971.0||||||
4242286|NCT00657150|4066276|B2||Male|Sex: Female, Male||Participants|Count of Participants|502|502.0||||||
4242287|NCT00657150|4066277|B1||Male|Sex: Female, Male||Participants|Count of Participants|469|469.0||||||
4242288|NCT00657150|4066275|B3||Female|Sex: Female, Male||Participants|Count of Participants|1042|1042.0||||||
4242289|NCT00657150|4066276|B2||Female|Sex: Female, Male||Participants|Count of Participants|501|501.0||||||
4242290|NCT00657150|4066277|B1||Female|Sex: Female, Male||Participants|Count of Participants|541|541.0||||||
4242291|NCT00657150|4066275|B3|||Age||Years|Mean|62.0|62.0|Standard Deviation|11.4|11.4|||
4242292|NCT00657150|4066276|B2|||Age||Years|Mean|62.0|62.0|Standard Deviation|11.3|11.3|||
4242293|NCT00657150|4066277|B1|||Age||Years|Mean|61.9|61.9|Standard Deviation|11.5|11.5|||
4242294|NCT00657046|4066306|B4|United States||Region of Enrollment||participants|Number|85|85.0||||||
4242295|NCT00657046|4066307|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4242296|NCT00657046|4066308|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
4242297|NCT00657046|4066309|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4242298|NCT00657046|4066306|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242299|NCT00657046|4066307|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242300|NCT00657046|4066308|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242301|NCT00657046|4066309|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242302|NCT00657046|4066306|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242303|NCT00657046|4066307|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242304|NCT00657046|4066308|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242305|NCT00657046|4066309|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242306|NCT00657046|4066306|B4||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4242307|NCT00657046|4066307|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4242308|NCT00657046|4066308|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4242309|NCT00657046|4066309|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4242310|NCT00657046|4066306|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4242311|NCT00657046|4066307|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4242312|NCT00657046|4066308|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4242313|NCT00657046|4066309|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4242314|NCT00657046|4066306|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242315|NCT00657046|4066307|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242316|NCT00657046|4066308|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242317|NCT00657046|4066309|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242318|NCT00657046|4066306|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242319|NCT00657046|4066307|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242320|NCT00657046|4066308|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242321|NCT00657046|4066309|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242322|NCT00657046|4066306|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242323|NCT00657046|4066307|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242324|NCT00657046|4066308|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242325|NCT00657046|4066309|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242326|NCT00657046|4066306|B4||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4242327|NCT00657046|4066307|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4242328|NCT00657046|4066308|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4242329|NCT00657046|4066309|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4242330|NCT00657046|4066306|B4||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4242331|NCT00657046|4066307|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4242332|NCT00657046|4066308|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4242333|NCT00657046|4066309|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4242334|NCT00657046|4066306|B4|||Age||years|Mean|60.0|60.0|Standard Deviation|14.34|14.34|||
4242335|NCT00657046|4066307|B3|||Age||years|Mean|60.2|60.2|Standard Deviation|16.00|16.0|||
4242336|NCT00657046|4066308|B2|||Age||years|Mean|59.7|59.7|Standard Deviation|14.98|14.98|||
4242337|NCT00657046|4066309|B1|||Age||years|Mean|60.3|60.3|Standard Deviation|12.71|12.71|||
4242338|NCT00657020|4066343|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4242339|NCT00657020|4066343|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4242340|NCT00657020|4066343|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4242341|NCT00657020|4066343|B1|||Age||years|Mean|30.82|30.82|Standard Deviation|8.428|8.428|||
4242342|NCT00656968|4066372|B3|Taiwan||Region of Enrollment||participants|Number|232|232.0||||||
4242343|NCT00656968|4066373|B2|Taiwan||Region of Enrollment||participants|Number|117|117.0||||||
4242344|NCT00656968|4066374|B1|Taiwan||Region of Enrollment||participants|Number|115|115.0||||||
4242345|NCT00656968|4066372|B3||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4242346|NCT00656968|4066373|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4242347|NCT00656968|4066374|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4242348|NCT00656968|4066372|B3||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4242349|NCT00656968|4066373|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4242350|NCT00656968|4066374|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4242351|NCT00656968|4066372|B3|||Age||years|Mean|51.74|51.74|Standard Deviation|11.6|11.6|||
4242352|NCT00656968|4066373|B2|||Age||years|Mean|51.7|51.7|Standard Deviation|12|12.0|||
4242353|NCT00656968|4066374|B1|||Age||years|Mean|51.8|51.8|Standard Deviation|11.3|11.3|||
4242354|NCT00656968|4066372|B3||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
4242355|NCT00656968|4066373|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4242356|NCT00656968|4066374|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4242357|NCT00656968|4066372|B3||Between 18 and 65 years|Age||Participants|Count of Participants|197|197.0||||||
4242358|NCT00656968|4066373|B2||Between 18 and 65 years|Age||Participants|Count of Participants|99|99.0||||||
4242359|NCT00656968|4066374|B1||Between 18 and 65 years|Age||Participants|Count of Participants|98|98.0||||||
4242360|NCT00656968|4066372|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242361|NCT00656968|4066373|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242362|NCT00656968|4066374|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242363|NCT00656916|4066383|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4242364|NCT00656916|4066385|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4242365|NCT00656916|4066383|B3|Male||Gender||participants|Number|0|0.0||||||
4242366|NCT00656916|4066385|B1|Male||Gender||participants|Number|0|0.0||||||
4242367|NCT00656916|4066383|B3|Female||Gender||participants|Number|1|1.0||||||
4242368|NCT00656916|4066385|B1|Female||Gender||participants|Number|1|1.0||||||
4242369|NCT00656916|4066383|B3|||Age||years|Median|46|46.0|Full Range|||46.0|46.0|
4242370|NCT00656916|4066385|B1|||Age||years|Median|46|46.0|Full Range|0|0.0|46.0|46.0|
4242371|NCT00656851|4066392|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4242372|NCT00656851|4066393|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4242373|NCT00656851|4066394|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4242374|NCT00656851|4066392|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4242375|NCT00656851|4066393|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4242376|NCT00656851|4066394|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4242377|NCT00656851|4066392|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4242378|NCT00656851|4066393|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4242379|NCT00656851|4066394|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4242380|NCT00656851|4066392|B3|||Age||years|Mean|42|42.0|Standard Deviation|6|6.0|||
4242381|NCT00656851|4066393|B2|||Age||years|Mean|41|41.0|Standard Deviation|6|6.0|||
4242382|NCT00656851|4066394|B1|||Age||years|Mean|42|42.0|Standard Deviation|7|7.0|||
4242383|NCT00656851|4066392|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4242384|NCT00656851|4066393|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4242385|NCT00656851|4066394|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4242386|NCT00656851|4066392|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4242387|NCT00656851|4066393|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4242388|NCT00656851|4066394|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4242389|NCT00656851|4066392|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242390|NCT00656851|4066393|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242391|NCT00656851|4066394|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242392|NCT00656799|4066417|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4242393|NCT00656799|4066417|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4242394|NCT00656799|4066417|B1|||Age||years|Mean|76|76.0|Standard Deviation|7|7.0|||
4242395|NCT00656669|4066439|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242396|NCT00656669|4066439|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242397|NCT00656669|4066439|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4242398|NCT00656669|4066439|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4242399|NCT00656669|4066439|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242400|NCT00656669|4066439|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4242401|NCT00656669|4066439|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242402|NCT00656669|4066439|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242403|NCT00656669|4066439|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4242404|NCT00656669|4066439|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4242405|NCT00656669|4066439|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4242406|NCT00656669|4066439|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4242407|NCT00656669|4066439|B1|||Age||Years|Mean|48.3|48.3|Standard Deviation|8.86|8.86|||
4242408|NCT00656669|4066439|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4242409|NCT00656669|4066439|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4242410|NCT00656669|4066439|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242411|NCT00656656|4066448|B1|Germany||Region of Enrollment||participants|Number|23|23.0||||||
4242412|NCT00656656|4066448|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4242413|NCT00656656|4066448|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4242414|NCT00656656|4066448|B1|||Age||years|Mean|55|55.0|Full Range|||26.0|75.0|
4242415|NCT00656656|4066448|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4242416|NCT00656656|4066448|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4242417|NCT00656656|4066448|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242418|NCT00656630|4066453|B4|United States||Region of Enrollment||participants|Number|68|68.0||||||
4242419|NCT00656630|4066454|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4242420|NCT00656630|4066455|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4242421|NCT00656630|4066456|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4242422|NCT00656630|4066453|B4||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4242423|NCT00656630|4066454|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4242424|NCT00656630|4066455|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4242425|NCT00656630|4066456|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4242426|NCT00656630|4066453|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4242427|NCT00656630|4066454|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4242428|NCT00656630|4066455|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4242429|NCT00656630|4066456|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4242430|NCT00656630|4066453|B4|||Age||years|Mean|37.97|37.97|Standard Deviation|11.42|11.42|||
4242431|NCT00656630|4066454|B3|||Age||years|Mean|42.84|42.84|Standard Deviation|10.37|10.37|||
4242432|NCT00656630|4066455|B2|||Age||years|Mean|36.37|36.37|Standard Deviation|12.45|12.45|||
4242433|NCT00656630|4066456|B1|||Age||years|Mean|35.73|35.73|Standard Deviation|10.10|10.1|||
4242434|NCT00656617|4066478|B1|United States||Region of Enrollment||participants|Number|106|106.0||||||
4242435|NCT00656617|4066478|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4242436|NCT00656617|4066478|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4242437|NCT00656617|4066478|B1|||Age||years|Median|52|52.0|Full Range|||19.0|65.0|
4242438|NCT00656513|4066484|B4||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4242439|NCT00656513|4066485|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4242440|NCT00656513|4066486|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4242441|NCT00656513|4066487|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4242442|NCT00656513|4066484|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4242443|NCT00656513|4066485|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4242444|NCT00656513|4066486|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4242445|NCT00656513|4066487|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4242446|NCT00656513|4066484|B4|||Age||years|Median|58|58.0|Full Range|||24.0|83.0|
4242447|NCT00656513|4066485|B3|||Age||years|Median|58|58.0|Full Range|||42.0|83.0|
4242448|NCT00656513|4066486|B2|||Age||years|Median|59|59.0|Full Range|||29.0|78.0|
4242449|NCT00656513|4066487|B1|||Age||years|Median|60|60.0|Full Range|||24.0|80.0|
4242450|NCT00656487|4066508|B4||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4242451|NCT00656487|4066509|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4242452|NCT00656487|4066510|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4242453|NCT00656487|4066511|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4242454|NCT00656487|4066508|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4242455|NCT00656487|4066509|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4242456|NCT00656487|4066510|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4242457|NCT00656487|4066511|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4242458|NCT00656487|4066508|B4|||Age||years|Mean|23.32|23.32|Standard Deviation|2.51|2.51|||
4242459|NCT00656487|4066509|B3|||Age||years|Mean|24.15|24.15|Standard Deviation|2.83|2.83|||
4242460|NCT00656487|4066510|B2|||Age||years|Mean|23.53|23.53|Standard Deviation|2.76|2.76|||
4242461|NCT00656487|4066511|B1|||Age||years|Mean|22.33|22.33|Standard Deviation|1.53|1.53|||
4242462|NCT00656474|4066536|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4242463|NCT00656474|4066536|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4242464|NCT00656474|4066536|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4242465|NCT00656474|4066536|B1|||Age||years|Mean|50.3|50.3|Standard Deviation|8.93|8.93|||
4242466|NCT00656474|4066536|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4242467|NCT00656474|4066536|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4242468|NCT00656474|4066536|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242469|NCT00656448|4066543|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4242470|NCT00656448|4066544|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4242471|NCT00656448|4066545|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4242472|NCT00656448|4066543|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4242473|NCT00656448|4066544|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4242474|NCT00656448|4066545|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4242475|NCT00656448|4066543|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4242476|NCT00656448|4066544|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4242477|NCT00656448|4066545|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4242478|NCT00656448|4066543|B3|||Age||years|Median|62|62.0|Full Range|||22.0|79.0|
4242479|NCT00656448|4066544|B2|||Age||years|Median|62|62.0|Full Range|||34.0|79.0|
4242480|NCT00656448|4066545|B1|||Age||years|Median|61|61.0|Full Range|||22.0|67.0|
4242481|NCT00656370|4066554|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4242482|NCT00656370|4066554|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4242483|NCT00656370|4066554|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4242484|NCT00656370|4066554|B1|||Age||years|Mean|41|41.0|Standard Deviation|14.9|14.9|||
4242485|NCT00656370|4066554|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4242486|NCT00656370|4066554|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4242487|NCT00656370|4066554|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242488|NCT00656305|4066568|B3|Russia||Region of Enrollment||participants|Number|44|44.0||||||
4242489|NCT00656305|4066569|B2|Russia||Region of Enrollment||participants|Number|10|10.0||||||
4242490|NCT00656305|4066570|B1|Russia||Region of Enrollment||participants|Number|34|34.0||||||
4242491|NCT00656305|4066568|B3|Israel||Region of Enrollment||participants|Number|22|22.0||||||
4242492|NCT00656305|4066569|B2|Israel||Region of Enrollment||participants|Number|5|5.0||||||
4242493|NCT00656305|4066570|B1|Israel||Region of Enrollment||participants|Number|17|17.0||||||
4242494|NCT00656305|4066568|B3|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4242495|NCT00656305|4066569|B2|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4242496|NCT00656305|4066570|B1|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4242497|NCT00656305|4066568|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
4242498|NCT00656305|4066569|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4242499|NCT00656305|4066570|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4242500|NCT00656305|4066568|B3|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4242501|NCT00656305|4066569|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4242502|NCT00656305|4066570|B1|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4242503|NCT00656305|4066568|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242504|NCT00656305|4066569|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242505|NCT00656305|4066570|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242506|NCT00656305|4066568|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4242507|NCT00656305|4066569|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242508|NCT00656305|4066570|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4242509|NCT00656305|4066568|B3||White|Race (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
4242510|NCT00656305|4066569|B2||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4242511|NCT00656305|4066570|B1||White|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
4242512|NCT00656305|4066568|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4242513|NCT00656305|4066569|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242514|NCT00656305|4066570|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4242515|NCT00656305|4066568|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242516|NCT00656305|4066569|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242517|NCT00656305|4066570|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242518|NCT00656305|4066568|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4242519|NCT00656305|4066569|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4242520|NCT00656305|4066570|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4242521|NCT00656305|4066568|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242522|NCT00656305|4066569|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242523|NCT00656305|4066570|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242524|NCT00656305|4066568|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4242525|NCT00656305|4066569|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4242526|NCT00656305|4066570|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4242527|NCT00656305|4066568|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4242528|NCT00656305|4066569|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4242529|NCT00656305|4066570|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4242530|NCT00656305|4066568|B3|||Age||years|Mean|57.8|57.8|Standard Deviation|11.9|11.9|||
4242531|NCT00656305|4066569|B2|||Age||years|Mean|56.8|56.8|Standard Deviation|10.5|10.5|||
4242532|NCT00656305|4066570|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|13.3|13.3|||
4242533|NCT00656292|4066581|B3|United States||Region of Enrollment||participants|Number|61|61.0||||||
4242534|NCT00656292|4066582|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4242535|NCT00656292|4066583|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4242536|NCT00656292|4066581|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4242537|NCT00656292|4066582|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4242538|NCT00656292|4066583|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4242539|NCT00656292|4066581|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4242540|NCT00656292|4066582|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4242541|NCT00656292|4066583|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4242542|NCT00656292|4066581|B3|||Age||years|Mean|55.6|55.6|Standard Deviation|15.8|15.8|||
4242543|NCT00656292|4066582|B2|||Age||years|Mean|56.3|56.3|Standard Deviation|15.6|15.6|||
4242544|NCT00656292|4066583|B1|||Age||years|Mean|54.9|54.9|Standard Deviation|16.2|16.2|||
4242545|NCT00656201|4066600|B3|United States||Region of Enrollment||participants|Number|468|468.0||||||
4242546|NCT00656201|4066601|B2|United States||Region of Enrollment||participants|Number|233|233.0||||||
4242547|NCT00656201|4066602|B1|United States||Region of Enrollment||participants|Number|235|235.0||||||
4242548|NCT00656201|4066600|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4242549|NCT00656201|4066601|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4242550|NCT00656201|4066602|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4242551|NCT00656201|4066600|B3||Female|Sex: Female, Male||Participants|Count of Participants|468|468.0||||||
4242552|NCT00656201|4066601|B2||Female|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
4242553|NCT00656201|4066602|B1||Female|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4242554|NCT00656201|4066600|B3|||Age||years|Mean|34.1|34.1|Standard Deviation|3.4|3.4|||
4242555|NCT00656201|4066601|B2|||Age||years|Mean|34.2|34.2|Standard Deviation|3.5|3.5|||
4242556|NCT00656201|4066602|B1|||Age||years|Mean|34.0|34.0|Standard Deviation|3.3|3.3|||
4242557|NCT00656201|4066600|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4242558|NCT00656201|4066601|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4242559|NCT00656201|4066602|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4242560|NCT00656201|4066600|B3||Between 18 and 65 years|Age||Participants|Count of Participants|468|468.0||||||
4242561|NCT00656201|4066601|B2||Between 18 and 65 years|Age||Participants|Count of Participants|233|233.0||||||
4242562|NCT00656201|4066602|B1||Between 18 and 65 years|Age||Participants|Count of Participants|235|235.0||||||
4242563|NCT00656201|4066600|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242564|NCT00656201|4066601|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242565|NCT00656201|4066602|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242566|NCT00656175|4066609|B3|North America||Region of Enrollment|Subjects were recruited from 5 centers in North America between September 2008 and July 2010.|Participants|Number|39|39.0||||||
4242567|NCT00656175|4066610|B2|North America||Region of Enrollment|Subjects were recruited from 5 centers in North America between September 2008 and July 2010.|Participants|Number|21|21.0||||||
4242568|NCT00656175|4066611|B1|North America||Region of Enrollment|Subjects were recruited from 5 centers in North America between September 2008 and July 2010.|Participants|Number|18|18.0||||||
4242569|NCT00656175|4066609|B3|Asian||Race/Ethnicity, Customized|Subjects were recruited from 5 centers in North America between September 2008 and July 2010. Age 18 or older, documented HIV-1 infection, central fat accumulation at screening and <400 copies/mL for the 6 months prior to entry, current ART with a nucleoside (NRTI) backbone of tenofovir or abacavir AND emtricitabine or lamivudine PLUS either a PI or NNRTI, no change in ART for 12 weeks prior to screening, and ability and willingness to provide informed consent.|Participants|Number|1|1.0||||||
4242570|NCT00656175|4066610|B2|Asian||Race/Ethnicity, Customized|Subjects were recruited from 5 centers in North America between September 2008 and July 2010. Age 18 or older, documented HIV-1 infection, central fat accumulation at screening and <400 copies/mL for the 6 months prior to entry, current ART with a nucleoside (NRTI) backbone of tenofovir or abacavir AND emtricitabine or lamivudine PLUS either a PI or NNRTI, no change in ART for 12 weeks prior to screening, and ability and willingness to provide informed consent.|Participants|Number|0|0.0||||||
4242571|NCT00656175|4066611|B1|Asian||Race/Ethnicity, Customized|Subjects were recruited from 5 centers in North America between September 2008 and July 2010. Age 18 or older, documented HIV-1 infection, central fat accumulation at screening and <400 copies/mL for the 6 months prior to entry, current ART with a nucleoside (NRTI) backbone of tenofovir or abacavir AND emtricitabine or lamivudine PLUS either a PI or NNRTI, no change in ART for 12 weeks prior to screening, and ability and willingness to provide informed consent.|Participants|Number|1|1.0||||||
4242572|NCT00656175|4066609|B3|White||Race/Ethnicity, Customized|Subjects were recruited from 5 centers in North America between September 2008 and July 2010. Age 18 or older, documented HIV-1 infection, central fat accumulation at screening and <400 copies/mL for the 6 months prior to entry, current ART with a nucleoside (NRTI) backbone of tenofovir or abacavir AND emtricitabine or lamivudine PLUS either a PI or NNRTI, no change in ART for 12 weeks prior to screening, and ability and willingness to provide informed consent.|Participants|Number|8|8.0||||24.0||
4242573|NCT00656175|4066610|B2|White||Race/Ethnicity, Customized|Subjects were recruited from 5 centers in North America between September 2008 and July 2010. Age 18 or older, documented HIV-1 infection, central fat accumulation at screening and <400 copies/mL for the 6 months prior to entry, current ART with a nucleoside (NRTI) backbone of tenofovir or abacavir AND emtricitabine or lamivudine PLUS either a PI or NNRTI, no change in ART for 12 weeks prior to screening, and ability and willingness to provide informed consent.|Participants|Number|5|5.0||||||
4242574|NCT00656175|4066611|B1|White||Race/Ethnicity, Customized|Subjects were recruited from 5 centers in North America between September 2008 and July 2010. Age 18 or older, documented HIV-1 infection, central fat accumulation at screening and <400 copies/mL for the 6 months prior to entry, current ART with a nucleoside (NRTI) backbone of tenofovir or abacavir AND emtricitabine or lamivudine PLUS either a PI or NNRTI, no change in ART for 12 weeks prior to screening, and ability and willingness to provide informed consent.|Participants|Number|3|3.0||||||
4242575|NCT00656175|4066609|B3|Hispanic||Race/Ethnicity, Customized|Subjects were recruited from 5 centers in North America between September 2008 and July 2010. Age 18 or older, documented HIV-1 infection, central fat accumulation at screening and <400 copies/mL for the 6 months prior to entry, current ART with a nucleoside (NRTI) backbone of tenofovir or abacavir AND emtricitabine or lamivudine PLUS either a PI or NNRTI, no change in ART for 12 weeks prior to screening, and ability and willingness to provide informed consent.|Participants|Number|8|8.0||||||
4242651|NCT00656019|4066647|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4242576|NCT00656175|4066610|B2|Hispanic||Race/Ethnicity, Customized|Subjects were recruited from 5 centers in North America between September 2008 and July 2010. Age 18 or older, documented HIV-1 infection, central fat accumulation at screening and <400 copies/mL for the 6 months prior to entry, current ART with a nucleoside (NRTI) backbone of tenofovir or abacavir AND emtricitabine or lamivudine PLUS either a PI or NNRTI, no change in ART for 12 weeks prior to screening, and ability and willingness to provide informed consent.|Participants|Number|3|3.0||||||
4242577|NCT00656175|4066611|B1|Hispanic||Race/Ethnicity, Customized|Subjects were recruited from 5 centers in North America between September 2008 and July 2010. Age 18 or older, documented HIV-1 infection, central fat accumulation at screening and <400 copies/mL for the 6 months prior to entry, current ART with a nucleoside (NRTI) backbone of tenofovir or abacavir AND emtricitabine or lamivudine PLUS either a PI or NNRTI, no change in ART for 12 weeks prior to screening, and ability and willingness to provide informed consent.|Participants|Number|5|5.0||||||
4242578|NCT00656175|4066609|B3|African-American||Race/Ethnicity, Customized|Subjects were recruited from 5 centers in North America between September 2008 and July 2010. Age 18 or older, documented HIV-1 infection, central fat accumulation at screening and <400 copies/mL for the 6 months prior to entry, current ART with a nucleoside (NRTI) backbone of tenofovir or abacavir AND emtricitabine or lamivudine PLUS either a PI or NNRTI, no change in ART for 12 weeks prior to screening, and ability and willingness to provide informed consent.|Participants|Number|22|22.0||||||
4242579|NCT00656175|4066610|B2|African-American||Race/Ethnicity, Customized|Subjects were recruited from 5 centers in North America between September 2008 and July 2010. Age 18 or older, documented HIV-1 infection, central fat accumulation at screening and <400 copies/mL for the 6 months prior to entry, current ART with a nucleoside (NRTI) backbone of tenofovir or abacavir AND emtricitabine or lamivudine PLUS either a PI or NNRTI, no change in ART for 12 weeks prior to screening, and ability and willingness to provide informed consent.|Participants|Number|13|13.0||||||
4242580|NCT00656175|4066611|B1|African-American||Race/Ethnicity, Customized|Subjects were recruited from 5 centers in North America between September 2008 and July 2010. Age 18 or older, documented HIV-1 infection, central fat accumulation at screening and <400 copies/mL for the 6 months prior to entry, current ART with a nucleoside (NRTI) backbone of tenofovir or abacavir AND emtricitabine or lamivudine PLUS either a PI or NNRTI, no change in ART for 12 weeks prior to screening, and ability and willingness to provide informed consent.|Participants|Number|9|9.0||||||
4242581|NCT00656175|4066609|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4242582|NCT00656175|4066610|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4242583|NCT00656175|4066611|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4242584|NCT00656175|4066609|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4242585|NCT00656175|4066610|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4242586|NCT00656175|4066611|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4242587|NCT00656175|4066609|B3|||Age||years|Mean|37|37.0|Standard Deviation|49|49.0|||
4242588|NCT00656175|4066610|B2|||Age||years|Mean|36|36.0|Standard Deviation|51|51.0|||
4242589|NCT00656175|4066611|B1|||Age||years|Mean|39|39.0|Standard Deviation|47|47.0|||
4242590|NCT00656175|4066609|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4242591|NCT00656175|4066610|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4242592|NCT00656175|4066611|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4242593|NCT00656175|4066609|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4242594|NCT00656175|4066610|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4242595|NCT00656175|4066611|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4242596|NCT00656175|4066609|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242597|NCT00656175|4066610|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242598|NCT00656175|4066611|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242599|NCT00656136|4066618|B3|ECOG score = 2||Baseline Eastern Cooperative Oncology Group (ECOG) performance score|"ECOG Performance Score was measured on 6 point scale where 0=Fully active, 1=Restricted in physically strenuous activity and 2=Ambulatory and capable of all self care but unable to carry out any work activities, 3=Capable of only limited self care, confined to bed or chair 50% or more of waking hours, 4=Bedbound, and 5=Death."|Number of participants|Number|45|45.0||||||
4242600|NCT00656136|4066619|B2|ECOG score = 2||Baseline Eastern Cooperative Oncology Group (ECOG) performance score|"ECOG Performance Score was measured on 6 point scale where 0=Fully active, 1=Restricted in physically strenuous activity and 2=Ambulatory and capable of all self care but unable to carry out any work activities, 3=Capable of only limited self care, confined to bed or chair 50% or more of waking hours, 4=Bedbound, and 5=Death."|Number of participants|Number|30|30.0||||||
4242601|NCT00656136|4066620|B1|ECOG score = 2||Baseline Eastern Cooperative Oncology Group (ECOG) performance score|"ECOG Performance Score was measured on 6 point scale where 0=Fully active, 1=Restricted in physically strenuous activity and 2=Ambulatory and capable of all self care but unable to carry out any work activities, 3=Capable of only limited self care, confined to bed or chair 50% or more of waking hours, 4=Bedbound, and 5=Death."|Number of participants|Number|15|15.0||||||
4242602|NCT00656136|4066618|B3|ECOG score = 1||Baseline Eastern Cooperative Oncology Group (ECOG) performance score|"ECOG Performance Score was measured on 6 point scale where 0=Fully active, 1=Restricted in physically strenuous activity and 2=Ambulatory and capable of all self care but unable to carry out any work activities, 3=Capable of only limited self care, confined to bed or chair 50% or more of waking hours, 4=Bedbound, and 5=Death."|Number of participants|Number|395|395.0||||||
4242603|NCT00656136|4066619|B2|ECOG score = 1||Baseline Eastern Cooperative Oncology Group (ECOG) performance score|"ECOG Performance Score was measured on 6 point scale where 0=Fully active, 1=Restricted in physically strenuous activity and 2=Ambulatory and capable of all self care but unable to carry out any work activities, 3=Capable of only limited self care, confined to bed or chair 50% or more of waking hours, 4=Bedbound, and 5=Death."|Number of participants|Number|268|268.0||||||
4242652|NCT00656019|4066648|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242604|NCT00656136|4066620|B1|ECOG score = 1||Baseline Eastern Cooperative Oncology Group (ECOG) performance score|"ECOG Performance Score was measured on 6 point scale where 0=Fully active, 1=Restricted in physically strenuous activity and 2=Ambulatory and capable of all self care but unable to carry out any work activities, 3=Capable of only limited self care, confined to bed or chair 50% or more of waking hours, 4=Bedbound, and 5=Death."|Number of participants|Number|127|127.0||||||
4242605|NCT00656136|4066618|B3|ECOG score = 0||Baseline Eastern Cooperative Oncology Group (ECOG) performance score|"ECOG Performance Score was measured on 6 point scale where 0=Fully active, 1=Restricted in physically strenuous activity and 2=Ambulatory and capable of all self care but unable to carry out any work activities, 3=Capable of only limited self care, confined to bed or chair 50% or more of waking hours, 4=Bedbound, and 5=Death."|Number of participants|Number|145|145.0||||||
4242606|NCT00656136|4066619|B2|ECOG score = 0||Baseline Eastern Cooperative Oncology Group (ECOG) performance score|"ECOG Performance Score was measured on 6 point scale where 0=Fully active, 1=Restricted in physically strenuous activity and 2=Ambulatory and capable of all self care but unable to carry out any work activities, 3=Capable of only limited self care, confined to bed or chair 50% or more of waking hours, 4=Bedbound, and 5=Death."|Number of participants|Number|92|92.0||||||
4242607|NCT00656136|4066620|B1|ECOG score = 0||Baseline Eastern Cooperative Oncology Group (ECOG) performance score|"ECOG Performance Score was measured on 6 point scale where 0=Fully active, 1=Restricted in physically strenuous activity and 2=Ambulatory and capable of all self care but unable to carry out any work activities, 3=Capable of only limited self care, confined to bed or chair 50% or more of waking hours, 4=Bedbound, and 5=Death."|Number of participants|Number|53|53.0||||||
4242608|NCT00656136|4066618|B3|Other||Race/Ethnicity, Customized||Number of participants|Number|5|5.0||||||
4242609|NCT00656136|4066619|B2|Other||Race/Ethnicity, Customized||Number of participants|Number|4|4.0||||||
4242610|NCT00656136|4066620|B1|Other||Race/Ethnicity, Customized||Number of participants|Number|1|1.0||||||
4242611|NCT00656136|4066618|B3|Other Asian||Race/Ethnicity, Customized||Number of participants|Number|50|50.0||||||
4242612|NCT00656136|4066619|B2|Other Asian||Race/Ethnicity, Customized||Number of participants|Number|38|38.0||||||
4242613|NCT00656136|4066620|B1|Other Asian||Race/Ethnicity, Customized||Number of participants|Number|12|12.0||||||
4242614|NCT00656136|4066618|B3|Eastern Asian||Race/Ethnicity, Customized||Number of participants|Number|337|337.0||||||
4242615|NCT00656136|4066619|B2|Eastern Asian||Race/Ethnicity, Customized||Number of participants|Number|227|227.0||||||
4242616|NCT00656136|4066620|B1|Eastern Asian||Race/Ethnicity, Customized||Number of participants|Number|110|110.0||||||
4242617|NCT00656136|4066618|B3|Caucasian||Race/Ethnicity, Customized||Number of participants|Number|193|193.0||||||
4242618|NCT00656136|4066619|B2|Caucasian||Race/Ethnicity, Customized||Number of participants|Number|121|121.0||||||
4242619|NCT00656136|4066620|B1|Caucasian||Race/Ethnicity, Customized||Number of participants|Number|72|72.0||||||
4242620|NCT00656136|4066618|B3||Male|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
4242621|NCT00656136|4066619|B2||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4242622|NCT00656136|4066620|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4242623|NCT00656136|4066618|B3||Female|Sex: Female, Male||Participants|Count of Participants|348|348.0||||||
4242624|NCT00656136|4066619|B2||Female|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
4242625|NCT00656136|4066620|B1||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4242626|NCT00656136|4066618|B3|||Age||years|Mean|58|58.0|Standard Deviation|10.6|10.6|||
4242627|NCT00656136|4066619|B2|||Age||years|Mean|58|58.0|Standard Deviation|10.8|10.8|||
4242628|NCT00656136|4066620|B1|||Age||years|Mean|59|59.0|Standard Deviation|10.4|10.4|||
4242629|NCT00656084|4066631|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4242630|NCT00656084|4066631|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4242631|NCT00656084|4066631|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4242632|NCT00656084|4066631|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4242633|NCT00656084|4066631|B1|||Age||years|Mean|68|68.0|Standard Deviation|12.3|12.3|||
4242634|NCT00656058|4066638|B1|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4242635|NCT00656058|4066638|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242636|NCT00656058|4066638|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242637|NCT00656058|4066638|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4242638|NCT00656058|4066638|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4242639|NCT00656058|4066638|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242640|NCT00656058|4066638|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4242641|NCT00656058|4066638|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242642|NCT00656058|4066638|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242643|NCT00656058|4066638|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4242644|NCT00656058|4066638|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4242645|NCT00656058|4066638|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4242646|NCT00656058|4066638|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4242647|NCT00656058|4066638|B1|||Age||years|Mean|45.29|45.29|Standard Deviation|15.65|15.65|||
4242648|NCT00656058|4066638|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4242649|NCT00656058|4066638|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4242650|NCT00656058|4066638|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4242653|NCT00656019|4066649|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4242654|NCT00656019|4066650|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242655|NCT00656019|4066651|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4242656|NCT00656019|4066647|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242657|NCT00656019|4066648|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242658|NCT00656019|4066649|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242659|NCT00656019|4066650|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242660|NCT00656019|4066651|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242661|NCT00656019|4066647|B5||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4242662|NCT00656019|4066648|B4||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4242663|NCT00656019|4066649|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4242664|NCT00656019|4066650|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4242665|NCT00656019|4066651|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4242666|NCT00656019|4066647|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242667|NCT00656019|4066648|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242668|NCT00656019|4066649|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242669|NCT00656019|4066650|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242670|NCT00656019|4066651|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242671|NCT00656019|4066647|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4242672|NCT00656019|4066648|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4242673|NCT00656019|4066649|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242674|NCT00656019|4066650|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242675|NCT00656019|4066651|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242676|NCT00656019|4066647|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4242677|NCT00656019|4066648|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4242678|NCT00656019|4066649|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4242679|NCT00656019|4066650|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4242680|NCT00656019|4066651|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4242681|NCT00656019|4066647|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242682|NCT00656019|4066648|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242683|NCT00656019|4066649|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242684|NCT00656019|4066650|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242685|NCT00656019|4066651|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242686|NCT00656019|4066647|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4242687|NCT00656019|4066648|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4242688|NCT00656019|4066649|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4242689|NCT00656019|4066650|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242690|NCT00656019|4066651|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242691|NCT00656019|4066647|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4242692|NCT00656019|4066648|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4242693|NCT00656019|4066649|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4242694|NCT00656019|4066650|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4242695|NCT00656019|4066651|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4242696|NCT00656019|4066647|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4242697|NCT00656019|4066648|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4242698|NCT00656019|4066649|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4242699|NCT00656019|4066650|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4242700|NCT00656019|4066651|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4242701|NCT00656019|4066647|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4242702|NCT00656019|4066648|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4242703|NCT00656019|4066649|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4242704|NCT00656019|4066650|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4242705|NCT00656019|4066651|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4242706|NCT00656019|4066647|B5||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4242707|NCT00656019|4066648|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4242708|NCT00656019|4066649|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4242709|NCT00656019|4066650|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4242710|NCT00656019|4066651|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4242711|NCT00656019|4066647|B5||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4242712|NCT00656019|4066648|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4242713|NCT00656019|4066649|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4242714|NCT00656019|4066650|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4242715|NCT00656019|4066651|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4242716|NCT00656019|4066647|B5||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4242717|NCT00656019|4066648|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4242718|NCT00656019|4066649|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4242719|NCT00656019|4066650|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4242720|NCT00656019|4066651|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4242721|NCT00656019|4066647|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242722|NCT00656019|4066648|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242723|NCT00656019|4066649|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242724|NCT00656019|4066650|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242725|NCT00656019|4066651|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242726|NCT00655889|4066664|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242727|NCT00655889|4066664|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242728|NCT00655889|4066664|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4242729|NCT00655889|4066664|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242730|NCT00655889|4066664|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242731|NCT00655889|4066664|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242732|NCT00655889|4066664|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242733|NCT00655889|4066664|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4242734|NCT00655889|4066664|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4242735|NCT00655889|4066664|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4242736|NCT00655889|4066664|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4242737|NCT00655889|4066664|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242738|NCT00655876|4066669|B3||Male|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
4242739|NCT00655876|4066670|B2||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4242740|NCT00655876|4066671|B1||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4242741|NCT00655876|4066669|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4242742|NCT00655876|4066670|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4242743|NCT00655876|4066671|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4242744|NCT00655876|4066669|B3|||Age||years|Median|64|64.0|Full Range|||32.0|87.0|
4242745|NCT00655876|4066670|B2|||Age||years|Median|63|63.0|Full Range|||32.0|85.0|
4242746|NCT00655876|4066671|B1|||Age||years|Median|65|65.0|Full Range|||39.0|87.0|
4242747|NCT00655863|4066688|B4|||Diabetes duration||years|Mean|5.69|5.69|Standard Deviation|3.548|3.548|||
4242748|NCT00655863|4066689|B3|||Diabetes duration||years|Mean|5.03|5.03|Standard Deviation|3.791|3.791|||
4242749|NCT00655863|4066690|B2|||Diabetes duration||years|Mean|6.40|6.4|Standard Deviation|3.622|3.622|||
4242750|NCT00655863|4066691|B1|||Diabetes duration||years|Mean|5.55|5.55|Standard Deviation|3.243|3.243|||
4242751|NCT00655863|4066688|B4|||Body Mass Index (BMI)||kg/m2|Mean|31.46|31.46|Standard Deviation|3.898|3.898|||
4242752|NCT00655863|4066689|B3|||Body Mass Index (BMI)||kg/m2|Mean|31.15|31.15|Standard Deviation|3.503|3.503|||
4242753|NCT00655863|4066690|B2|||Body Mass Index (BMI)||kg/m2|Mean|31.09|31.09|Standard Deviation|4.196|4.196|||
4242754|NCT00655863|4066691|B1|||Body Mass Index (BMI)||kg/m2|Mean|32.12|32.12|Standard Deviation|3.997|3.997|||
4242755|NCT00655863|4066688|B4|||Height||cm|Mean|175.0|175.0|Standard Deviation|8.91|8.91|||
4242756|NCT00655863|4066689|B3|||Height||cm|Mean|172.8|172.8|Standard Deviation|10.97|10.97|||
4242757|NCT00655863|4066690|B2|||Height||cm|Mean|173.9|173.9|Standard Deviation|8.17|8.17|||
4242758|NCT00655863|4066691|B1|||Height||cm|Mean|178.3|178.3|Standard Deviation|6.74|6.74|||
4242759|NCT00655863|4066688|B4|||Weight||kg|Mean|96.24|96.24|Standard Deviation|12.471|12.471|||
4242760|NCT00655863|4066689|B3|||Weight||kg|Mean|93.05|93.05|Standard Deviation|13.160|13.16|||
4242761|NCT00655863|4066690|B2|||Weight||kg|Mean|93.68|93.68|Standard Deviation|10.816|10.816|||
4242762|NCT00655863|4066691|B1|||Weight||kg|Mean|101.83|101.83|Standard Deviation|11.989|11.989|||
4242763|NCT00655863|4066688|B4|||Race (NIH/OMB)|White|Participants|Count of Participants|71|71.0||||||
4242764|NCT00655863|4066689|B3|||Race (NIH/OMB)|White|Participants|Count of Participants|22|22.0||||||
4242765|NCT00655863|4066690|B2|||Race (NIH/OMB)|White|Participants|Count of Participants|25|25.0||||||
4242766|NCT00655863|4066691|B1|||Race (NIH/OMB)|White|Participants|Count of Participants|24|24.0||||||
4242767|NCT00655863|4066688|B4|Sweden||Region of Enrollment||participants|Number|43|43.0||||||
4242768|NCT00655863|4066689|B3|Sweden||Region of Enrollment||participants|Number|13|13.0||||||
4242769|NCT00655863|4066690|B2|Sweden||Region of Enrollment||participants|Number|15|15.0||||||
4242770|NCT00655863|4066691|B1|Sweden||Region of Enrollment||participants|Number|15|15.0||||||
4242771|NCT00655863|4066688|B4|Netherlands||Region of Enrollment||participants|Number|28|28.0||||||
4242772|NCT00655863|4066689|B3|Netherlands||Region of Enrollment||participants|Number|9|9.0||||||
4242773|NCT00655863|4066690|B2|Netherlands||Region of Enrollment||participants|Number|10|10.0||||||
4242774|NCT00655863|4066691|B1|Netherlands||Region of Enrollment||participants|Number|9|9.0||||||
4242775|NCT00655863|4066688|B4||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4242776|NCT00655863|4066689|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4242777|NCT00655863|4066690|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4242778|NCT00655863|4066691|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4242779|NCT00655863|4066688|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4242780|NCT00655863|4066689|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4242781|NCT00655863|4066690|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4242782|NCT00655863|4066691|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4242783|NCT00655863|4066688|B4|||Age||years|Mean|59.0|59.0|Standard Deviation|6.45|6.45|||
4242784|NCT00655863|4066689|B3|||Age||years|Mean|59.1|59.1|Standard Deviation|6.94|6.94|||
4242785|NCT00655863|4066690|B2|||Age||years|Mean|58.7|58.7|Standard Deviation|6.47|6.47|||
4242786|NCT00655863|4066691|B1|||Age||years|Mean|59.1|59.1|Standard Deviation|6.23|6.23|||
4242787|NCT00655850|4066752|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4242788|NCT00655850|4066752|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242789|NCT00655850|4066752|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242790|NCT00655850|4066752|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4242791|NCT00655850|4066752|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4242792|NCT00655850|4066752|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242793|NCT00655850|4066752|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242794|NCT00655850|4066752|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242795|NCT00655850|4066752|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4242796|NCT00655850|4066752|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4242797|NCT00655850|4066752|B1|||Age||years|Median|59.5|59.5|Full Range|||37.0|76.0|
4242798|NCT00655824|4066759|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|92|92.0||||||
4242799|NCT00655824|4066759|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4242800|NCT00655824|4066759|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4242801|NCT00655824|4066759|B1|||Age||Years|Mean|52.9|52.9|Standard Deviation|10.73|10.73|||
4242802|NCT00655811|4066793|B1|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
4242803|NCT00655811|4066793|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4242804|NCT00655811|4066793|B1|East Asians||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4242805|NCT00655811|4066793|B1|Caucasians||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4242806|NCT00655811|4066793|B1|African Americans||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4242807|NCT00655811|4066793|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4242808|NCT00655811|4066793|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4242809|NCT00655811|4066793|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4242810|NCT00655811|4066793|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4242811|NCT00655811|4066793|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242812|NCT00655746|4066807|B1|||Body Mass Index (BMI)||kg/m2|Mean|25.4|25.4|Standard Deviation|2.9|2.9|||
4242813|NCT00655746|4066807|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4242814|NCT00655746|4066807|B1|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4242815|NCT00655746|4066807|B1|Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4242816|NCT00655746|4066807|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4242817|NCT00655746|4066807|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4242818|NCT00655746|4066807|B1|||Age||years|Mean|37|37.0|Standard Deviation|6|6.0|||
4242819|NCT00655733|4066824|B3|Ukraine||Region of Enrollment||participants|Number|28|28.0||||||
4242820|NCT00655733|4066825|B2|Ukraine||Region of Enrollment||participants|Number|15|15.0||||||
4242821|NCT00655733|4066826|B1|Ukraine||Region of Enrollment||participants|Number|13|13.0||||||
4242822|NCT00655733|4066824|B3|United States||Region of Enrollment||participants|Number|73|73.0||||||
4242823|NCT00655733|4066825|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
4242824|NCT00655733|4066826|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4242825|NCT00655733|4066824|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4242826|NCT00655733|4066825|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4242827|NCT00655733|4066826|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4242828|NCT00655733|4066824|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4242829|NCT00655733|4066825|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4242830|NCT00655733|4066826|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4242831|NCT00655733|4066824|B3|||Age||years|Mean|44.4|44.4|Standard Deviation|13.9|13.9|||
4242832|NCT00655733|4066825|B2|||Age||years|Mean|46.5|46.5|Standard Deviation|14.2|14.2|||
4242833|NCT00655733|4066826|B1|||Age||years|Mean|42.4|42.4|Standard Deviation|13.4|13.4|||
4242834|NCT00655733|4066824|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4242835|NCT00655733|4066825|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4242836|NCT00655733|4066826|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4242837|NCT00655733|4066824|B3||Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
4242838|NCT00655733|4066825|B2||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4242839|NCT00655733|4066826|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4242840|NCT00655733|4066824|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242841|NCT00655733|4066825|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242842|NCT00655733|4066826|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242843|NCT00655668|4066833|B1|Peripheral T-cell lymphoma, not otherwise charac||Non-Hodgkin's Lymphoma Diagnosis/Histopathology|"Non-Hodgkin's Lymphoma Diagnosis/Histopathology as assessed by local laboratory at study baseline.~Cutaneous T-cell lymphoma,mycosis fungoides varient Extranodal Natural Killer (NK)T-cell lymphoma, nasal type Peripheral T-cell lymphoma, not otherwise characterized"|Participants|Number|20|20.0||||||
4242844|NCT00655668|4066833|B1|Extranodal NK T-cell lymphoma, nasal type||Non-Hodgkin's Lymphoma Diagnosis/Histopathology|"Non-Hodgkin's Lymphoma Diagnosis/Histopathology as assessed by local laboratory at study baseline.~Cutaneous T-cell lymphoma,mycosis fungoides varient Extranodal Natural Killer (NK)T-cell lymphoma, nasal type Peripheral T-cell lymphoma, not otherwise characterized"|Participants|Number|1|1.0||||||
4242845|NCT00655668|4066833|B1|Cutaneous T-cell lymphoma, mycosis fungoides var.||Non-Hodgkin's Lymphoma Diagnosis/Histopathology|"Non-Hodgkin's Lymphoma Diagnosis/Histopathology as assessed by local laboratory at study baseline.~Cutaneous T-cell lymphoma,mycosis fungoides varient Extranodal Natural Killer (NK)T-cell lymphoma, nasal type Peripheral T-cell lymphoma, not otherwise characterized"|Participants|Number|3|3.0||||||
4242846|NCT00655668|4066833|B1|Angioimmunoblastic T-cell lymphoma||Non-Hodgkin's Lymphoma Diagnosis/Histopathology|"Non-Hodgkin's Lymphoma Diagnosis/Histopathology as assessed by local laboratory at study baseline.~Cutaneous T-cell lymphoma,mycosis fungoides varient Extranodal Natural Killer (NK)T-cell lymphoma, nasal type Peripheral T-cell lymphoma, not otherwise characterized"|Participants|Number|26|26.0||||||
4242847|NCT00655668|4066833|B1|Anaplastic large cell lymphoma, primary systemic||Non-Hodgkin's Lymphoma Diagnosis/Histopathology|"Non-Hodgkin's Lymphoma Diagnosis/Histopathology as assessed by local laboratory at study baseline.~Cutaneous T-cell lymphoma,mycosis fungoides varient Extranodal Natural Killer (NK)T-cell lymphoma, nasal type Peripheral T-cell lymphoma, not otherwise characterized"|Participants|Number|3|3.0||||||
4242848|NCT00655668|4066833|B1|Anaplastic large cell lymphoma, primary cutaneous||Non-Hodgkin's Lymphoma Diagnosis/Histopathology|"Non-Hodgkin's Lymphoma Diagnosis/Histopathology as assessed by local laboratory at study baseline.~Cutaneous T-cell lymphoma,mycosis fungoides varient Extranodal Natural Killer (NK)T-cell lymphoma, nasal type Peripheral T-cell lymphoma, not otherwise characterized"|Participants|Number|1|1.0||||||
4242849|NCT00655668|4066833|B1|Australia||Region of Enrollment||participants|Number|8|8.0||||||
4242850|NCT00655668|4066833|B1|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
4242851|NCT00655668|4066833|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4242852|NCT00655668|4066833|B1|France||Region of Enrollment||participants|Number|40|40.0||||||
4242853|NCT00655668|4066833|B1|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4242854|NCT00655668|4066833|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4242855|NCT00655668|4066833|B1|White||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4242856|NCT00655668|4066833|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4242857|NCT00655668|4066833|B1|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4242858|NCT00655668|4066833|B1|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4242859|NCT00655668|4066833|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4242860|NCT00655668|4066833|B1||Male|Gender||Participants|Count of Participants|36|36.0||||||
4242861|NCT00655668|4066833|B1||Female|Gender||Participants|Count of Participants|18|18.0||||||
4242862|NCT00655668|4066833|B1|>65 years||Age, Customized||participants|Number|26|26.0||||||
4242863|NCT00655668|4066833|B1|>18 years and < = 65 years||Age, Customized||participants|Number|28|28.0||||||
4242864|NCT00655668|4066833|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4242865|NCT00655668|4066833|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|11.25|11.25|||
4242866|NCT00655642|4066841|B5|United States||Region of Enrollment||participants|Number|171|171.0||||||
4242867|NCT00655642|4066842|B4|United States||Region of Enrollment||participants|Number|41|41.0||||||
4242868|NCT00655642|4066843|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
4242869|NCT00655642|4066844|B2|United States||Region of Enrollment||participants|Number|43|43.0||||||
4242870|NCT00655642|4066845|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4242871|NCT00655642|4066841|B5||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4242872|NCT00655642|4066842|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4242873|NCT00655642|4066843|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4242874|NCT00655642|4066844|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4242875|NCT00655642|4066845|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4242876|NCT00655642|4066841|B5||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4242877|NCT00655642|4066842|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4242878|NCT00655642|4066843|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4242879|NCT00655642|4066844|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4242880|NCT00655642|4066845|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4242881|NCT00655642|4066841|B5|||Age||years|Mean|37.14|37.14|Standard Deviation|15.882|15.882|||
4242882|NCT00655642|4066842|B4|||Age||years|Mean|35.44|35.44|Standard Deviation|14.589|14.589|||
4242883|NCT00655642|4066843|B3|||Age||years|Mean|35.47|35.47|Standard Deviation|16.036|16.036|||
4242884|NCT00655642|4066844|B2|||Age||years|Mean|38.72|38.72|Standard Deviation|16.076|16.076|||
4242885|NCT00655642|4066845|B1|||Age||years|Mean|39.98|39.98|Standard Deviation|16.895|16.895|||
4242886|NCT00655642|4066841|B5||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4242887|NCT00655642|4066842|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4242888|NCT00655642|4066843|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4242889|NCT00655642|4066844|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4242890|NCT00655642|4066845|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4242891|NCT00655642|4066841|B5||Between 18 and 65 years|Age||Participants|Count of Participants|158|158.0||||||
4242892|NCT00655642|4066842|B4||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4242893|NCT00655642|4066843|B3||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4242894|NCT00655642|4066844|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4242895|NCT00655642|4066845|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4242896|NCT00655642|4066841|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242897|NCT00655642|4066842|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242898|NCT00655642|4066843|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242899|NCT00655642|4066844|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242900|NCT00655642|4066845|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242901|NCT00655629|4066858|B3|||Body Mass Index (BMI)||Kilograms per square meter (kg/m^2)|Mean|28.8|28.8|Standard Deviation|4.3|4.3|||
4242902|NCT00655629|4066859|B2|||Body Mass Index (BMI)||Kilograms per square meter (kg/m^2)|Mean|28.7|28.7|Standard Deviation|4.2|4.2|||
4242903|NCT00655629|4066860|B1|||Body Mass Index (BMI)||Kilograms per square meter (kg/m^2)|Mean|28.9|28.9|Standard Deviation|4.4|4.4|||
4242904|NCT00655629|4066858|B3||Male|Sex: Female, Male||Participants|Count of Participants|337|337.0||||||
4242905|NCT00655629|4066859|B2||Male|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4242906|NCT00655629|4066860|B1||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4242907|NCT00655629|4066858|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4242908|NCT00655629|4066859|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4242909|NCT00655629|4066860|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4242910|NCT00655629|4066858|B3|>=65 years||Age, Customized||participants|Number|167|167.0||||||
4242911|NCT00655629|4066859|B2|>=65 years||Age, Customized||participants|Number|82|82.0||||||
4242912|NCT00655629|4066860|B1|>=65 years||Age, Customized||participants|Number|85|85.0||||||
4242913|NCT00655629|4066858|B3|<65 years||Age, Customized||participants|Number|170|170.0||||||
4242914|NCT00655629|4066859|B2|<65 years||Age, Customized||participants|Number|84|84.0||||||
4242915|NCT00655629|4066860|B1|<65 years||Age, Customized||participants|Number|86|86.0||||||
4242916|NCT00655564|4066897|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4242917|NCT00655564|4066897|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4242918|NCT00655564|4066897|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4242919|NCT00655564|4066897|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4242920|NCT00655564|4066897|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4242921|NCT00655564|4066897|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242922|NCT00655551|4066902|B4|United States||Region of Enrollment||participants|Number|100|100.0||||||
4242923|NCT00655551|4066903|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4242924|NCT00655551|4066904|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
4242925|NCT00655551|4066905|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4242926|NCT00655551|4066902|B4||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4242927|NCT00655551|4066903|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4242928|NCT00655551|4066904|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4242929|NCT00655551|4066905|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4242930|NCT00655551|4066902|B4||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4242931|NCT00655551|4066903|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4242932|NCT00655551|4066904|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4242933|NCT00655551|4066905|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4242934|NCT00655551|4066902|B4|||Age||years|Mean|39.0|39.0|Standard Deviation|11.66|11.66|||
4242935|NCT00655551|4066903|B3|||Age||years|Mean|39.6|39.6|Standard Deviation|12.24|12.24|||
4242936|NCT00655551|4066904|B2|||Age||years|Mean|38.6|38.6|Standard Deviation|11.53|11.53|||
4242937|NCT00655551|4066905|B1|||Age||years|Mean|39.1|39.1|Standard Deviation|11.77|11.77|||
4242938|NCT00655551|4066902|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4242939|NCT00655551|4066903|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4242940|NCT00655551|4066904|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4242941|NCT00655551|4066905|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4242942|NCT00655551|4066902|B4||Between 18 and 65 years|Age||Participants|Count of Participants|98|98.0||||||
4242943|NCT00655551|4066903|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4242944|NCT00655551|4066904|B2||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4242945|NCT00655551|4066905|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4242946|NCT00655551|4066902|B4||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4242947|NCT00655551|4066903|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242948|NCT00655551|4066904|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4242949|NCT00655551|4066905|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4242950|NCT00655486|4066921|B1|United States||Region of Enrollment||participants|Number|97|97.0||||||
4242951|NCT00655486|4066921|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4242952|NCT00655486|4066921|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4242953|NCT00655486|4066921|B1|||Age||years|Mean|38.8|38.8|Standard Deviation|11.71|11.71|||
4242954|NCT00655486|4066921|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4242955|NCT00655486|4066921|B1||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
4242956|NCT00655486|4066921|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4242957|NCT00655356|4066926|B3|United States||Region of Enrollment||participants|Number|218|218.0||||||
4242958|NCT00655356|4066927|B2|United States||Region of Enrollment||participants|Number|108|108.0||||||
4242959|NCT00655356|4066928|B1|United States||Region of Enrollment||participants|Number|110|110.0||||||
4242960|NCT00655356|4066926|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242961|NCT00655356|4066927|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242962|NCT00655356|4066928|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242963|NCT00655356|4066926|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4242964|NCT00655356|4066927|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4242965|NCT00655356|4066928|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4242966|NCT00655356|4066926|B3||White|Race (NIH/OMB)||Participants|Count of Participants|193|193.0||||||
4242967|NCT00655356|4066927|B2||White|Race (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
4242968|NCT00655356|4066928|B1||White|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
4242969|NCT00655356|4066926|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4242970|NCT00655356|4066927|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4242971|NCT00655356|4066928|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4242972|NCT00655356|4066926|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242973|NCT00655356|4066927|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242974|NCT00655356|4066928|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242975|NCT00655356|4066926|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242976|NCT00655356|4066927|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242977|NCT00655356|4066928|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242978|NCT00655356|4066926|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242979|NCT00655356|4066927|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242980|NCT00655356|4066928|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242981|NCT00655356|4066926|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242982|NCT00655356|4066927|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242983|NCT00655356|4066928|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4242984|NCT00655356|4066926|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|194|194.0||||||
4242985|NCT00655356|4066927|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4242986|NCT00655356|4066928|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
4242987|NCT00655356|4066926|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4242988|NCT00655356|4066927|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4242989|NCT00655356|4066928|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4242990|NCT00655356|4066926|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4242991|NCT00655356|4066927|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4242992|NCT00655356|4066928|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4242993|NCT00655356|4066926|B3||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4242994|NCT00655356|4066927|B2||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4242995|NCT00655356|4066928|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4242996|NCT00655356|4066926|B3|||Age||years|Mean|54.6|54.6|Standard Deviation|9.92|9.92|||
4242997|NCT00655356|4066927|B2|||Age||years|Mean|55.4|55.4|Standard Deviation|9.42|9.42|||
4242998|NCT00655356|4066928|B1|||Age||years|Mean|53.9|53.9|Standard Deviation|10.38|10.38|||
4242999|NCT00655083|4066941|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4243000|NCT00655083|4066942|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4243001|NCT00655083|4066943|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4243002|NCT00655083|4066941|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4243003|NCT00655083|4066942|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4243004|NCT00655083|4066943|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4243005|NCT00655083|4066941|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4243006|NCT00655083|4066942|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4243007|NCT00655083|4066943|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4243008|NCT00655083|4066941|B3|Age Group 18 to 24 weeks||Age, Customized||participants|Number|4|4.0||||||
4243009|NCT00655083|4066942|B2|Age Group 18 to 24 weeks||Age, Customized||participants|Number|0|0.0||||||
4243010|NCT00655083|4066943|B1|Age Group 18 to 24 weeks||Age, Customized||participants|Number|4|4.0||||||
4243011|NCT00655083|4066941|B3|Age Group 12 to <18 weeks||Age, Customized||participants|Number|9|9.0||||||
4243012|NCT00655083|4066942|B2|Age Group 12 to <18 weeks||Age, Customized||participants|Number|5|5.0||||||
4243013|NCT00655083|4066943|B1|Age Group 12 to <18 weeks||Age, Customized||participants|Number|4|4.0||||||
4243014|NCT00655083|4066941|B3|Age Group 6 to <12 weeks||Age, Customized||participants|Number|7|7.0||||||
4243015|NCT00655083|4066942|B2|Age Group 6 to <12 weeks||Age, Customized||participants|Number|3|3.0||||||
4243016|NCT00655083|4066943|B1|Age Group 6 to <12 weeks||Age, Customized||participants|Number|4|4.0||||||
4243017|NCT00654992|4066956|B3|Korea, Republic of||Region of Enrollment||participants|Number|71.0|71.0||||||
4243018|NCT00654992|4066957|B2|Korea, Republic of||Region of Enrollment||participants|Number|35|35.0||||||
4243019|NCT00654992|4066958|B1|Korea, Republic of||Region of Enrollment||participants|Number|36|36.0||||||
4243020|NCT00654992|4066956|B3||Male|Sex: Female, Male||Participants|Count of Participants|53.0|53.0||||||
4243021|NCT00654992|4066957|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4243022|NCT00654992|4066958|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4243023|NCT00654992|4066956|B3||Female|Sex: Female, Male||Participants|Count of Participants|18.0|18.0||||||
4243024|NCT00654992|4066957|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4243025|NCT00654992|4066958|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4243026|NCT00654992|4066956|B3|||Age||years|Mean|67|67.0|Standard Deviation|10|10.0|||
4243027|NCT00654992|4066957|B2|||Age||years|Mean|69|69.0|Standard Deviation|8|8.0|||
4243028|NCT00654992|4066958|B1|||Age||years|Mean|65|65.0|Standard Deviation|11|11.0|||
4243029|NCT00654992|4066956|B3||>=65 years|Age||Participants|Count of Participants|42.0|42.0||||||
4243030|NCT00654992|4066957|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4243031|NCT00654992|4066958|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4243032|NCT00654992|4066956|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29.0|29.0||||||
4243033|NCT00654992|4066957|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4243034|NCT00654992|4066958|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4243035|NCT00654992|4066956|B3||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4243036|NCT00654992|4066957|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4243037|NCT00654992|4066958|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4243038|NCT00654953|4066965|B4|United States||Region of Enrollment||participants|Number|102|102.0||||||
4243039|NCT00654953|4066966|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4243040|NCT00654953|4066967|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
4243041|NCT00654953|4066968|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4243042|NCT00654953|4066965|B4||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4243043|NCT00654953|4066966|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4243044|NCT00654953|4066967|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4243045|NCT00654953|4066968|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4243046|NCT00654953|4066965|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4243047|NCT00654953|4066966|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4243048|NCT00654953|4066967|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4243049|NCT00654953|4066968|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4243050|NCT00654953|4066965|B4|||Age||years|Mean|39.31|39.31|Standard Deviation|7.48|7.48|||
4243051|NCT00654953|4066966|B3|||Age||years|Mean|39.40|39.4|Standard Deviation|7.81|7.81|||
4243052|NCT00654953|4066967|B2|||Age||years|Mean|39.78|39.78|Standard Deviation|8.36|8.36|||
4243053|NCT00654953|4066968|B1|||Age||years|Mean|38.74|38.74|Standard Deviation|6.32|6.32|||
4243054|NCT00654953|4066965|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4243055|NCT00654953|4066966|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4243056|NCT00654953|4066967|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4243057|NCT00654953|4066968|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4243058|NCT00654953|4066965|B4||Between 18 and 65 years|Age||Participants|Count of Participants|102|102.0||||||
4243059|NCT00654953|4066966|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4243060|NCT00654953|4066967|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4243061|NCT00654953|4066968|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4243062|NCT00654953|4066965|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4243063|NCT00654953|4066966|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4243064|NCT00654953|4066967|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4243065|NCT00654953|4066968|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4243066|NCT00654940|4066978|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4243067|NCT00654940|4066979|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4243068|NCT00654940|4066980|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4243069|NCT00654940|4066978|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4243070|NCT00654940|4066979|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4243071|NCT00654940|4066980|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4243072|NCT00654940|4066978|B3|>=65 years||Age, Customized||years|Number|5|5.0||0|0.0|||
4243073|NCT00654940|4066979|B2|>=65 years||Age, Customized||years|Number|1|1.0||0|0.0|||
4243074|NCT00654940|4066980|B1|>=65 years||Age, Customized||years|Number|4|4.0||0|0.0|||
4243075|NCT00654940|4066978|B3|45 - 64 years||Age, Customized||years|Number|13|13.0||||||
4243076|NCT00654940|4066979|B2|45 - 64 years||Age, Customized||years|Number|8|8.0||11.8|11.8|||
4243077|NCT00654940|4066980|B1|45 - 64 years||Age, Customized||years|Number|5|5.0||16.7|16.7|||
4243078|NCT00654940|4066978|B3|18 - 44 years||Age, Customized||years|Number|7|7.0||0|0.0|||
4243079|NCT00654940|4066979|B2|18 - 44 years||Age, Customized||years|Number|3|3.0||0|0.0|||
4243080|NCT00654940|4066980|B1|18 - 44 years||Age, Customized||years|Number|4|4.0||0|0.0|||
4243081|NCT00654927|4066993|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243082|NCT00654927|4066993|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4243083|NCT00654927|4066993|B1||White|Race (NIH/OMB)||Participants|Count of Participants|171|171.0||||||
4243084|NCT00654927|4066993|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4243085|NCT00654927|4066993|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243086|NCT00654927|4066993|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243087|NCT00654927|4066993|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243088|NCT00654927|4066993|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4243089|NCT00654927|4066993|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4243090|NCT00654927|4066993|B1|||Age||years|Mean|51.9|51.9|Standard Deviation|7.67|7.67|||
4243091|NCT00654927|4066993|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4243092|NCT00654927|4066993|B1||Between 18 and 65 years|Age||Participants|Count of Participants|174|174.0||||||
4243093|NCT00654927|4066993|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4243094|NCT00654901|4067001|B5|Mexico||Region of Enrollment||Participants|Number|881|881.0||||||
4243095|NCT00654901|4067002|B4|Mexico||Region of Enrollment||Participants|Number|113|113.0||||||
4243096|NCT00654901|4067003|B3|Mexico||Region of Enrollment||Participants|Number|252|252.0||||||
4243097|NCT00654901|4067004|B2|Mexico||Region of Enrollment||Participants|Number|262|262.0||||||
4243098|NCT00654901|4067005|B1|Mexico||Region of Enrollment||Participants|Number|254|254.0||||||
4243099|NCT00654901|4067001|B5||Male|Sex: Female, Male||Participants|Count of Participants|443|443.0||||||
4243100|NCT00654901|4067002|B4||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4243101|NCT00654901|4067003|B3||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4243102|NCT00654901|4067004|B2||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4243103|NCT00654901|4067005|B1||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4243104|NCT00654901|4067001|B5||Female|Sex: Female, Male||Participants|Count of Participants|438|438.0||||||
4243105|NCT00654901|4067002|B4||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4243106|NCT00654901|4067003|B3||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4243107|NCT00654901|4067004|B2||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4243108|NCT00654901|4067005|B1||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4243109|NCT00654901|4067001|B5|||Age||Months|Mean|17.3|17.3|Standard Deviation|1.47|1.47|||
4243110|NCT00654901|4067002|B4|||Age||Months|Mean|17.1|17.1|Standard Deviation|1.51|1.51|||
4243111|NCT00654901|4067003|B3|||Age||Months|Mean|17.4|17.4|Standard Deviation|1.42|1.42|||
4243112|NCT00654901|4067004|B2|||Age||Months|Mean|17.2|17.2|Standard Deviation|1.47|1.47|||
4243113|NCT00654901|4067005|B1|||Age||Months|Mean|17.3|17.3|Standard Deviation|1.51|1.51|||
4243114|NCT00654901|4067001|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4243115|NCT00654901|4067002|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4243116|NCT00654901|4067003|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4243117|NCT00654901|4067004|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4243118|NCT00654901|4067005|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4243119|NCT00654901|4067001|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4243120|NCT00654901|4067002|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4243121|NCT00654901|4067003|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4243122|NCT00654901|4067004|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4243123|NCT00654901|4067005|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4243124|NCT00654901|4067001|B5||<=18 years|Age||Participants|Count of Participants|881|881.0||||||
4243125|NCT00654901|4067002|B4||<=18 years|Age||Participants|Count of Participants|113|113.0||||||
4243126|NCT00654901|4067003|B3||<=18 years|Age||Participants|Count of Participants|252|252.0||||||
4243127|NCT00654901|4067004|B2||<=18 years|Age||Participants|Count of Participants|262|262.0||||||
4243128|NCT00654901|4067005|B1||<=18 years|Age||Participants|Count of Participants|254|254.0||||||
4243129|NCT00654875|4067026|B3||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4243130|NCT00654875|4067027|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4243131|NCT00654875|4067028|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4243132|NCT00654875|4067026|B3||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4243133|NCT00654875|4067027|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4243134|NCT00654875|4067028|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4243135|NCT00654875|4067026|B3|||Age||years|Mean|54|54.0|Standard Deviation|10.3|10.3|||
4243136|NCT00654875|4067027|B2|||Age||years|Mean|54|54.0|Standard Deviation|10.2|10.2|||
4243137|NCT00654875|4067028|B1|||Age||years|Mean|55|55.0|Standard Deviation|10.3|10.3|||
4243138|NCT00654836|4067047|B1|No||Prior adjuvant therapy was endocrine therapy||participants|Number|14|14.0||||||
4243139|NCT00654836|4067047|B1|Yes||Prior adjuvant therapy was endocrine therapy||participants|Number|18|18.0||||||
4243140|NCT00654836|4067047|B1|No||Prior adjuvant therapy was chemotherapy||participants|Number|15|15.0||||||
4243141|NCT00654836|4067047|B1|Yes||Prior adjuvant therapy was chemotherapy||participants|Number|17|17.0||||||
4243142|NCT00654836|4067047|B1|No||Site of Metastatic Disease was Distant Lymph Nodes||participants|Number|25|25.0||||||
4243143|NCT00654836|4067047|B1|Yes||Site of Metastatic Disease was Distant Lymph Nodes||participants|Number|7|7.0||||||
4243144|NCT00654836|4067047|B1|No||Site of Metastatic Disease was Lung||participants|Number|23|23.0||||||
4243145|NCT00654836|4067047|B1|Yes||Site of Metastatic Disease was Lung||participants|Number|9|9.0||||||
4243146|NCT00654836|4067047|B1|No||Site of Metastatic Disease was Loco-regional||participants|Number|20|20.0||||||
4243147|NCT00654836|4067047|B1|Yes||Site of Metastatic Disease was Loco-regional||participants|Number|12|12.0||||||
4243148|NCT00654836|4067047|B1|No||Site of Metastatic Disease was Liver||participants|Number|18|18.0||||||
4243149|NCT00654836|4067047|B1|Yes||Site of Metastatic Disease was Liver||participants|Number|14|14.0||||||
4243150|NCT00654836|4067047|B1|No||Site of Metastatic Disease was Bone||participants|Number|12|12.0||||||
4243151|NCT00654836|4067047|B1|Yes||Site of Metastatic Disease was Bone||participants|Number|20|20.0||||||
4243152|NCT00654836|4067047|B1|Undetermined||Eastern Cooperative Oncology Group (ECOG) Performance Status|The ECOG performance status utilizes a five point grading scale from 0 to 5, with higher values indicating worse patient status. (0 = Fully Active, 1 = Restricted in Physically Activity, 2 = Ambulatory and Capable of Self Care, 3 = Limited Self Care, 4 = Completely Disabled, 5 = Dead).|participants|Number|2|2.0||||||
4243153|NCT00654836|4067047|B1|ECOG 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|The ECOG performance status utilizes a five point grading scale from 0 to 5, with higher values indicating worse patient status. (0 = Fully Active, 1 = Restricted in Physically Activity, 2 = Ambulatory and Capable of Self Care, 3 = Limited Self Care, 4 = Completely Disabled, 5 = Dead).|participants|Number|1|1.0||||||
4243154|NCT00654836|4067047|B1|ECOG 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|The ECOG performance status utilizes a five point grading scale from 0 to 5, with higher values indicating worse patient status. (0 = Fully Active, 1 = Restricted in Physically Activity, 2 = Ambulatory and Capable of Self Care, 3 = Limited Self Care, 4 = Completely Disabled, 5 = Dead).|participants|Number|7|7.0||||||
4243155|NCT00654836|4067047|B1|ECOG 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|The ECOG performance status utilizes a five point grading scale from 0 to 5, with higher values indicating worse patient status. (0 = Fully Active, 1 = Restricted in Physically Activity, 2 = Ambulatory and Capable of Self Care, 3 = Limited Self Care, 4 = Completely Disabled, 5 = Dead).|participants|Number|22|22.0||||||
4243156|NCT00654836|4067047|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4243157|NCT00654836|4067047|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4243158|NCT00654836|4067047|B1|||Age||years|Median|58.38|58.38|Inter-Quartile Range|||49.25|65.0|
4243159|NCT00654784|4067053|B3|Belgium||Region of Enrollment||participants|Number|21|21.0||||||
4243160|NCT00654784|4067054|B2|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
4243161|NCT00654784|4067055|B1|Belgium||Region of Enrollment||participants|Number|13|13.0||||||
4243162|NCT00654784|4067053|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4243163|NCT00654784|4067054|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4243164|NCT00654784|4067055|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4243165|NCT00654784|4067053|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4243166|NCT00654784|4067054|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4243167|NCT00654784|4067055|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4243168|NCT00654784|4067053|B3|||Age||years|Mean|12.4|12.4|Standard Deviation|2.0|2.0|||
4243169|NCT00654784|4067054|B2|||Age||years|Mean|10.8|10.8|Standard Deviation|1.9|1.9|||
4243170|NCT00654784|4067055|B1|||Age||years|Mean|13.4|13.4|Standard Deviation|2.1|2.1|||
4243171|NCT00654784|4067053|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4243172|NCT00654784|4067054|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4243173|NCT00654784|4067055|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4243174|NCT00654784|4067053|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4243175|NCT00654784|4067054|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4243176|NCT00654784|4067055|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4243177|NCT00654784|4067053|B3||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
4243178|NCT00654784|4067054|B2||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4243179|NCT00654784|4067055|B1||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4243180|NCT00654745|4067062|B1|||Years with diabetes||years|Mean|6.44|6.44|Standard Deviation|5.978|5.978|||
4243181|NCT00654745|4067062|B1|||Seated Systolic Blood Pressure||mm Hg|Mean|158.8|158.8|Standard Deviation|13.14|13.14|||
4243182|NCT00654745|4067062|B1|||Seated Diastolic Blood Pressure||mm Hg|Mean|89.1|89.1|Standard Deviation|10.13|10.13|||
4243183|NCT00654745|4067062|B1|||Pulse rate||beats per minute|Mean|73.75|73.75|Standard Deviation|11.909|11.909|||
4243184|NCT00654745|4067062|B1|||Mean 24-hour ambulatory systolic blood pressure||mm Hg|Mean|144.4|144.4|Standard Deviation|11.74|11.74|||
4243185|NCT00654745|4067062|B1|||Mean 24-hour ambulatory diastolic blood pressure||mm Hg|Mean|81.6|81.6|Standard Deviation|9.76|9.76|||
4243186|NCT00654745|4067062|B1|||Body mass index||mg/m2|Mean|32.80|32.8|Standard Deviation|5.947|5.947|||
4243187|NCT00654745|4067062|B1|Stage 2||Stage of hypertension|Stage 1 or Stage 2 Hypertension. Stage 1 = Blood pressure > 140/90 mm Hg. Stage 2 = systolic >160 mm Hg or diastolic > 100 mm Hg|participants|Number|92|92.0||||||
4243188|NCT00654745|4067062|B1|Stage 1||Stage of hypertension|Stage 1 or Stage 2 Hypertension. Stage 1 = Blood pressure > 140/90 mm Hg. Stage 2 = systolic >160 mm Hg or diastolic > 100 mm Hg|participants|Number|115|115.0||||||
4243189|NCT00654745|4067062|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243190|NCT00654745|4067062|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243191|NCT00654745|4067062|B1||White|Race (NIH/OMB)||Participants|Count of Participants|162|162.0||||||
4243192|NCT00654745|4067062|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4243193|NCT00654745|4067062|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4243194|NCT00654745|4067062|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4243195|NCT00654745|4067062|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4243196|NCT00654745|4067062|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243197|NCT00654745|4067062|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|153|153.0||||||
4243198|NCT00654745|4067062|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4243199|NCT00654745|4067062|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4243200|NCT00654745|4067062|B1||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4243201|NCT00654745|4067062|B1|||Age||years|Mean|59.1|59.1|Standard Deviation|9.50|9.5|||
4243202|NCT00654654|4067100|B1|Non-white participants||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4243203|NCT00654654|4067100|B1|White participants||Race/Ethnicity, Customized||Participants|Number|48|48.0||||||
4243204|NCT00654654|4067100|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4243205|NCT00654654|4067100|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4243206|NCT00654654|4067100|B1|||Age||years|Mean|47.4|47.4|Standard Deviation|7.0|7.0|||
4243207|NCT00654641|4067105|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
4243208|NCT00654641|4067106|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4243209|NCT00654641|4067107|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4243210|NCT00654641|4067105|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4243211|NCT00654641|4067106|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4243212|NCT00654641|4067107|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4243213|NCT00654641|4067105|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4243214|NCT00654641|4067106|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4243215|NCT00654641|4067107|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4243216|NCT00654641|4067105|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4243217|NCT00654641|4067106|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4243218|NCT00654641|4067107|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4243219|NCT00654641|4067105|B3||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4243220|NCT00654641|4067106|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4243221|NCT00654641|4067107|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4243222|NCT00654641|4067105|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4243223|NCT00654641|4067106|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4243224|NCT00654641|4067107|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4243225|NCT00654628|4067114|B1|||Sitting Systolic Blood Pressure||mm Hg|Mean|133.3|133.3|Standard Deviation|16.6|16.6|||
4243226|NCT00654628|4067114|B1|||Sitting Diastolic Blood Pressure||mm Hg|Mean|78.5|78.5|Standard Deviation|10.2|10.2|||
4243227|NCT00654628|4067114|B1|||Baseline value of Triglycerides||mg/dL|Median|145|145.0|Full Range|||89.0|206.0|
4243228|NCT00654628|4067114|B1|||Baseline value of High Density Lipoprotein-C||mg/dL|Mean|47.1|47.1|Standard Deviation|11.4|11.4|||
4243229|NCT00654628|4067114|B1|||Baseline value of Total Cholesterol||mg/dL|Mean|243.7|243.7|Standard Deviation|43.9|43.9|||
4243230|NCT00654628|4067114|B1|||Baseline value of Low Density Lipoprotein-C||mg/dL|Mean|156.8|156.8|Standard Deviation|30.8|30.8|||
4243231|NCT00654628|4067114|B1|||Body Mass Index||kg/m2|Mean|25.5|25.5|Standard Deviation|3.4|3.4|||
4243232|NCT00654628|4067114|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4243233|NCT00654628|4067114|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4243234|NCT00654628|4067114|B1|||Age||years|Mean|57.9|57.9|Standard Deviation|10.4|10.4|||
4243235|NCT00654615|4067129|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4243236|NCT00654615|4067130|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4243237|NCT00654615|4067131|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4243238|NCT00654615|4067129|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4243239|NCT00654615|4067130|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4243240|NCT00654615|4067131|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4243241|NCT00654615|4067129|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4243242|NCT00654615|4067130|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4243243|NCT00654615|4067131|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4243244|NCT00654615|4067129|B3|||Age|Participants between the ages of 18 and 80 were enrolled.|years|Mean|55|55.0|Standard Deviation|15|15.0|||
4243245|NCT00654615|4067130|B2|||Age|Participants between the ages of 18 and 80 were enrolled.|years|Mean|55|55.0|Standard Deviation|16|16.0|||
4243246|NCT00654615|4067131|B1|||Age|Participants between the ages of 18 and 80 were enrolled.|years|Mean|55|55.0|Standard Deviation|14|14.0|||
4243247|NCT00654615|4067129|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4243248|NCT00654615|4067130|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4243249|NCT00654615|4067131|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4243250|NCT00654615|4067129|B3||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4243251|NCT00654615|4067130|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4243252|NCT00654615|4067131|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4243253|NCT00654615|4067129|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4243254|NCT00654615|4067130|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4243255|NCT00654615|4067131|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4243256|NCT00654511|4067140|B5|United States||Region of Enrollment||participants|Number|101|101.0||||||
4243257|NCT00654511|4067141|B4|United States||Region of Enrollment||participants|Number|25|25.0||||||
4243258|NCT00654511|4067142|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4243259|NCT00654511|4067143|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4243260|NCT00654511|4067144|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4243261|NCT00654511|4067140|B5||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4243262|NCT00654511|4067141|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4243263|NCT00654511|4067142|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4243264|NCT00654511|4067143|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4243265|NCT00654511|4067144|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4243266|NCT00654511|4067140|B5||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4243267|NCT00654511|4067141|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4243268|NCT00654511|4067142|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4243269|NCT00654511|4067143|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4243270|NCT00654511|4067144|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4243271|NCT00654511|4067140|B5|||Age||years|Mean|4.77|4.77|Standard Deviation|2.34|2.34|||
4243272|NCT00654511|4067141|B4|||Age||years|Mean|4.92|4.92|Standard Deviation|2.27|2.27|||
4243273|NCT00654511|4067142|B3|||Age||years|Mean|5.17|5.17|Standard Deviation|2.33|2.33|||
4243274|NCT00654511|4067143|B2|||Age||years|Mean|4.83|4.83|Standard Deviation|2.45|2.45|||
4243275|NCT00654511|4067144|B1|||Age||years|Mean|4.17|4.17|Standard Deviation|2.33|2.33|||
4243276|NCT00654511|4067140|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4243277|NCT00654511|4067141|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4243278|NCT00654511|4067142|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4243279|NCT00654511|4067143|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4243280|NCT00654511|4067144|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4243281|NCT00654511|4067140|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4243282|NCT00654511|4067141|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4243283|NCT00654511|4067142|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4243284|NCT00654511|4067143|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4243285|NCT00654511|4067144|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4243286|NCT00654511|4067140|B5||<=18 years|Age||Participants|Count of Participants|101|101.0||||||
4243287|NCT00654511|4067141|B4||<=18 years|Age||Participants|Count of Participants|25|25.0||||||
4243288|NCT00654511|4067142|B3||<=18 years|Age||Participants|Count of Participants|25|25.0||||||
4243289|NCT00654511|4067143|B2||<=18 years|Age||Participants|Count of Participants|25|25.0||||||
4243290|NCT00654511|4067144|B1||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
4243291|NCT00654498|4067161|B3||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4243292|NCT00654498|4067162|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4243293|NCT00654498|4067163|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4243294|NCT00654498|4067161|B3||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4243295|NCT00654498|4067162|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4243296|NCT00654498|4067163|B1||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4243297|NCT00654498|4067161|B3|||Age||Years|Mean|56.6|56.6|Standard Deviation|11.87|11.87|||
4243298|NCT00654498|4067162|B2|||Age||Years|Mean|56.86|56.86|Standard Deviation|11.89|11.89|||
4243299|NCT00654498|4067163|B1|||Age||Years|Mean|56.46|56.46|Standard Deviation|11.88|11.88|||
4243300|NCT00654420|4067192|B5||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4243301|NCT00654420|4067193|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4243302|NCT00654420|4067194|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4243303|NCT00654420|4067195|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4243304|NCT00654420|4067196|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4243305|NCT00654420|4067192|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4243306|NCT00654420|4067193|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4243307|NCT00654420|4067194|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4243308|NCT00654420|4067195|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4243309|NCT00654420|4067196|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4243310|NCT00654420|4067192|B5|||Age||years|Mean|60.2|60.2|Standard Deviation|8.95|8.95|||
4243311|NCT00654420|4067193|B4|||Age||years|Mean|58.5|58.5|Standard Deviation|10.35|10.35|||
4243312|NCT00654420|4067194|B3|||Age||years|Mean|61.9|61.9|Standard Deviation|7.83|7.83|||
4243313|NCT00654420|4067195|B2|||Age||years|Mean|61.9|61.9|Standard Deviation|7.68|7.68|||
4243314|NCT00654420|4067196|B1|||Age||years|Mean|53.8|53.8|Standard Deviation|3.86|3.86|||
4243315|NCT00654381|4067221|B5||Male|Sex: Female, Male||Participants|Count of Participants|395|395.0||||||
4243316|NCT00654381|4067222|B4||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4243317|NCT00654381|4067223|B3||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4243318|NCT00654381|4067224|B2||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4243319|NCT00654381|4067225|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4243320|NCT00654381|4067221|B5||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4243321|NCT00654381|4067222|B4||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4243322|NCT00654381|4067223|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4243323|NCT00654381|4067224|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4243324|NCT00654381|4067225|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4243325|NCT00654381|4067221|B5|||Age||years|Mean|60.0|60.0|Standard Deviation|9.7|9.7|||
4243326|NCT00654381|4067222|B4|||Age||years|Mean|58.5|58.5|Standard Deviation|9.9|9.9|||
4243327|NCT00654381|4067223|B3|||Age||years|Mean|61.3|61.3|Standard Deviation|10|10.0|||
4243328|NCT00654381|4067224|B2|||Age||years|Mean|60.3|60.3|Standard Deviation|9.4|9.4|||
4243329|NCT00654381|4067225|B1|||Age||years|Mean|59.7|59.7|Standard Deviation|8.9|8.9|||
4243330|NCT00654368|4067264|B4|> 5.1||Disease Activity Score (DAS28-ESR)|The DAS28 is a composite score to measure disease activity in patients with rheumatoid arthritis, derived from the following variables: • The number of swollen and tender joints assessed using the 28-joint count; • Erythrocyte sedimentation rate (ESR); • Patient's global assessment of disease activity measured on a 100 mm visual analog scale. The DAS28 score ranges from zero to ten. A DAS28 score above 5.1 means high disease activity.|participants|Number|154|154.0||||||
4243331|NCT00654368|4067265|B3|> 5.1||Disease Activity Score (DAS28-ESR)|The DAS28 is a composite score to measure disease activity in patients with rheumatoid arthritis, derived from the following variables: • The number of swollen and tender joints assessed using the 28-joint count; • Erythrocyte sedimentation rate (ESR); • Patient's global assessment of disease activity measured on a 100 mm visual analog scale. The DAS28 score ranges from zero to ten. A DAS28 score above 5.1 means high disease activity.|participants|Number|66|66.0||||||
4243332|NCT00654368|4067266|B2|> 5.1||Disease Activity Score (DAS28-ESR)|The DAS28 is a composite score to measure disease activity in patients with rheumatoid arthritis, derived from the following variables: • The number of swollen and tender joints assessed using the 28-joint count; • Erythrocyte sedimentation rate (ESR); • Patient's global assessment of disease activity measured on a 100 mm visual analog scale. The DAS28 score ranges from zero to ten. A DAS28 score above 5.1 means high disease activity.|participants|Number|55|55.0||||||
4243333|NCT00654368|4067267|B1|> 5.1||Disease Activity Score (DAS28-ESR)|The DAS28 is a composite score to measure disease activity in patients with rheumatoid arthritis, derived from the following variables: • The number of swollen and tender joints assessed using the 28-joint count; • Erythrocyte sedimentation rate (ESR); • Patient's global assessment of disease activity measured on a 100 mm visual analog scale. The DAS28 score ranges from zero to ten. A DAS28 score above 5.1 means high disease activity.|participants|Number|33|33.0||||||
4243334|NCT00654368|4067264|B4|<= 5.1||Disease Activity Score (DAS28-ESR)|The DAS28 is a composite score to measure disease activity in patients with rheumatoid arthritis, derived from the following variables: • The number of swollen and tender joints assessed using the 28-joint count; • Erythrocyte sedimentation rate (ESR); • Patient's global assessment of disease activity measured on a 100 mm visual analog scale. The DAS28 score ranges from zero to ten. A DAS28 score above 5.1 means high disease activity.|participants|Number|104|104.0||||||
4243385|NCT00654368|4067267|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4243386|NCT00654368|4067264|B4||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4243387|NCT00654368|4067265|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4243388|NCT00654368|4067266|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4243335|NCT00654368|4067265|B3|<= 5.1||Disease Activity Score (DAS28-ESR)|The DAS28 is a composite score to measure disease activity in patients with rheumatoid arthritis, derived from the following variables: • The number of swollen and tender joints assessed using the 28-joint count; • Erythrocyte sedimentation rate (ESR); • Patient's global assessment of disease activity measured on a 100 mm visual analog scale. The DAS28 score ranges from zero to ten. A DAS28 score above 5.1 means high disease activity.|participants|Number|41|41.0||||||
4243336|NCT00654368|4067266|B2|<= 5.1||Disease Activity Score (DAS28-ESR)|The DAS28 is a composite score to measure disease activity in patients with rheumatoid arthritis, derived from the following variables: • The number of swollen and tender joints assessed using the 28-joint count; • Erythrocyte sedimentation rate (ESR); • Patient's global assessment of disease activity measured on a 100 mm visual analog scale. The DAS28 score ranges from zero to ten. A DAS28 score above 5.1 means high disease activity.|participants|Number|43|43.0||||||
4243337|NCT00654368|4067267|B1|<= 5.1||Disease Activity Score (DAS28-ESR)|The DAS28 is a composite score to measure disease activity in patients with rheumatoid arthritis, derived from the following variables: • The number of swollen and tender joints assessed using the 28-joint count; • Erythrocyte sedimentation rate (ESR); • Patient's global assessment of disease activity measured on a 100 mm visual analog scale. The DAS28 score ranges from zero to ten. A DAS28 score above 5.1 means high disease activity.|participants|Number|20|20.0||||||
4243338|NCT00654368|4067264|B4|Combination/Other||Reimbursement type||participants|Number|46|46.0||||||
4243339|NCT00654368|4067265|B3|Combination/Other||Reimbursement type||participants|Number|15|15.0||||||
4243340|NCT00654368|4067266|B2|Combination/Other||Reimbursement type||participants|Number|17|17.0||||||
4243341|NCT00654368|4067267|B1|Combination/Other||Reimbursement type||participants|Number|14|14.0||||||
4243342|NCT00654368|4067264|B4|Public||Reimbursement type||participants|Number|86|86.0||||||
4243343|NCT00654368|4067265|B3|Public||Reimbursement type||participants|Number|37|37.0||||||
4243344|NCT00654368|4067266|B2|Public||Reimbursement type||participants|Number|33|33.0||||||
4243345|NCT00654368|4067267|B1|Public||Reimbursement type||participants|Number|16|16.0||||||
4243346|NCT00654368|4067264|B4|Private||Reimbursement type||participants|Number|126|126.0||||||
4243347|NCT00654368|4067265|B3|Private||Reimbursement type||participants|Number|55|55.0||||||
4243348|NCT00654368|4067266|B2|Private||Reimbursement type||participants|Number|48|48.0||||||
4243349|NCT00654368|4067267|B1|Private||Reimbursement type||participants|Number|23|23.0||||||
4243350|NCT00654368|4067264|B4|>= 2 years||Duration of rheumatoid arthritis||participants|Number|201|201.0||||||
4243351|NCT00654368|4067265|B3|>= 2 years||Duration of rheumatoid arthritis||participants|Number|84|84.0||||||
4243352|NCT00654368|4067266|B2|>= 2 years||Duration of rheumatoid arthritis||participants|Number|75|75.0||||||
4243353|NCT00654368|4067267|B1|>= 2 years||Duration of rheumatoid arthritis||participants|Number|42|42.0||||||
4243354|NCT00654368|4067264|B4|< 2 years||Duration of rheumatoid arthritis||participants|Number|57|57.0||||||
4243355|NCT00654368|4067265|B3|< 2 years||Duration of rheumatoid arthritis||participants|Number|23|23.0||||||
4243356|NCT00654368|4067266|B2|< 2 years||Duration of rheumatoid arthritis||participants|Number|23|23.0||||||
4243357|NCT00654368|4067267|B1|< 2 years||Duration of rheumatoid arthritis||participants|Number|11|11.0||||||
4243358|NCT00654368|4067264|B4|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4243359|NCT00654368|4067265|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4243360|NCT00654368|4067266|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4243361|NCT00654368|4067267|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4243362|NCT00654368|4067264|B4|Aborigine||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4243363|NCT00654368|4067265|B3|Aborigine||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4243364|NCT00654368|4067266|B2|Aborigine||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4243365|NCT00654368|4067267|B1|Aborigine||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4243366|NCT00654368|4067264|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4243367|NCT00654368|4067265|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4243368|NCT00654368|4067266|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4243369|NCT00654368|4067267|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4243370|NCT00654368|4067264|B4|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4243371|NCT00654368|4067265|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4243372|NCT00654368|4067266|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4243373|NCT00654368|4067267|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4243374|NCT00654368|4067264|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4243375|NCT00654368|4067265|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4243376|NCT00654368|4067266|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4243377|NCT00654368|4067267|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4243378|NCT00654368|4067264|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4243379|NCT00654368|4067265|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4243380|NCT00654368|4067266|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4243381|NCT00654368|4067267|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4243382|NCT00654368|4067264|B4|White or Caucasian||Race/Ethnicity, Customized||participants|Number|246|246.0||||||
4243383|NCT00654368|4067265|B3|White or Caucasian||Race/Ethnicity, Customized||participants|Number|103|103.0||||||
4243384|NCT00654368|4067266|B2|White or Caucasian||Race/Ethnicity, Customized||participants|Number|96|96.0||||||
4243389|NCT00654368|4067267|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4243390|NCT00654368|4067264|B4||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4243391|NCT00654368|4067265|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4243392|NCT00654368|4067266|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4243393|NCT00654368|4067267|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4243394|NCT00654368|4067264|B4|||Age||years|Mean|54.7|54.7|Standard Deviation|12.5|12.5|||
4243395|NCT00654368|4067265|B3|||Age||years|Mean|54.4|54.4|Standard Deviation|12.7|12.7|||
4243396|NCT00654368|4067266|B2|||Age||years|Mean|54.3|54.3|Standard Deviation|11.9|11.9|||
4243397|NCT00654368|4067267|B1|||Age||years|Mean|56.2|56.2|Standard Deviation|13.4|13.4|||
4243398|NCT00654355|4067300|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4243399|NCT00654355|4067301|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4243400|NCT00654355|4067302|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4243401|NCT00654355|4067300|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4243402|NCT00654355|4067301|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4243403|NCT00654355|4067302|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4243404|NCT00654355|4067300|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4243405|NCT00654355|4067301|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4243406|NCT00654355|4067302|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4243407|NCT00654355|4067300|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4243408|NCT00654355|4067301|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4243409|NCT00654355|4067302|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4243410|NCT00654355|4067300|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4243411|NCT00654355|4067301|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4243412|NCT00654355|4067302|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4243413|NCT00654355|4067300|B3||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4243414|NCT00654355|4067301|B2||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4243415|NCT00654355|4067302|B1||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4243416|NCT00654329|4067313|B5|United States||Region of Enrollment||participants|Number|101|101.0||||||
4243417|NCT00654329|4067314|B4|United States||Region of Enrollment||participants|Number|27|27.0||||||
4243418|NCT00654329|4067315|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4243419|NCT00654329|4067316|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4243420|NCT00654329|4067317|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4243421|NCT00654329|4067313|B5||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4243422|NCT00654329|4067314|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4243423|NCT00654329|4067315|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4243424|NCT00654329|4067316|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4243425|NCT00654329|4067317|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4243426|NCT00654329|4067313|B5||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4243427|NCT00654329|4067314|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4243428|NCT00654329|4067315|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4243429|NCT00654329|4067316|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4243430|NCT00654329|4067317|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4243431|NCT00654329|4067313|B5|||Age||years|Mean|2.14|2.14|Standard Deviation|1.42|1.42|||
4243432|NCT00654329|4067314|B4|||Age||years|Mean|2.17|2.17|Standard Deviation|1.66|1.66|||
4243433|NCT00654329|4067315|B3|||Age||years|Mean|2.25|2.25|Standard Deviation|1.47|1.47|||
4243434|NCT00654329|4067316|B2|||Age||years|Mean|2.17|2.17|Standard Deviation|1.51|1.51|||
4243435|NCT00654329|4067317|B1|||Age||years|Mean|1.92|1.92|Standard Deviation|.94|0.94|||
4243436|NCT00654329|4067313|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4243437|NCT00654329|4067314|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4243438|NCT00654329|4067315|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4243439|NCT00654329|4067316|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4243440|NCT00654329|4067317|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4243441|NCT00654329|4067313|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4243442|NCT00654329|4067314|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4243443|NCT00654329|4067315|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4243444|NCT00654329|4067316|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4243445|NCT00654329|4067317|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4243446|NCT00654329|4067313|B5||<=18 years|Age||Participants|Count of Participants|101|101.0||||||
4243447|NCT00654329|4067314|B4||<=18 years|Age||Participants|Count of Participants|27|27.0||||||
4243448|NCT00654329|4067315|B3||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
4243449|NCT00654329|4067316|B2||<=18 years|Age||Participants|Count of Participants|28|28.0||||||
4243450|NCT00654329|4067317|B1||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
4243451|NCT00654186|4067334|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4243452|NCT00654186|4067334|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4243453|NCT00654186|4067334|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4243454|NCT00654186|4067334|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4243455|NCT00654186|4067334|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4243456|NCT00654186|4067334|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4243457|NCT00654147|4067340|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
4243458|NCT00654147|4067341|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4243459|NCT00654147|4067342|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4243460|NCT00654147|4067340|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243461|NCT00654147|4067341|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243462|NCT00654147|4067342|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243463|NCT00654147|4067340|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243464|NCT00654147|4067341|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243465|NCT00654147|4067342|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243466|NCT00654147|4067340|B3||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4243467|NCT00654147|4067341|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4243468|NCT00654147|4067342|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4243469|NCT00654147|4067340|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4243470|NCT00654147|4067341|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4243471|NCT00654147|4067342|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4243472|NCT00654147|4067340|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243473|NCT00654147|4067341|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243474|NCT00654147|4067342|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243475|NCT00654147|4067340|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243476|NCT00654147|4067341|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243477|NCT00654147|4067342|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243478|NCT00654147|4067340|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243479|NCT00654147|4067341|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243480|NCT00654147|4067342|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243481|NCT00654147|4067340|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243482|NCT00654147|4067341|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243483|NCT00654147|4067342|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243484|NCT00654147|4067340|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4243485|NCT00654147|4067341|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4243486|NCT00654147|4067342|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4243487|NCT00654147|4067340|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4243488|NCT00654147|4067341|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4243489|NCT00654147|4067342|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4243490|NCT00654147|4067340|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4243491|NCT00654147|4067341|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4243492|NCT00654147|4067342|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4243493|NCT00654147|4067340|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4243494|NCT00654147|4067341|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4243495|NCT00654147|4067342|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4243496|NCT00654147|4067340|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4243497|NCT00654147|4067341|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4243498|NCT00654147|4067342|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4243499|NCT00654147|4067340|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4243500|NCT00654147|4067341|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4243501|NCT00654147|4067342|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4243502|NCT00654147|4067340|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4243503|NCT00654147|4067341|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4243504|NCT00654147|4067342|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4243505|NCT00654095|4067359|B1|Japan||Region of Enrollment||participants|Number|146|146.0||||||
4243506|NCT00654095|4067359|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4243507|NCT00654095|4067359|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4243508|NCT00654095|4067359|B1|||Age, Customized|>=20 Years|Participants|Number|146|146.0||||||
4243509|NCT00654069|4067363|B4|United States||Region of Enrollment||participants|Number|405|405.0||||||
4243510|NCT00654069|4067364|B3|United States||Region of Enrollment||participants|Number|134|134.0||||||
4243511|NCT00654069|4067365|B2|United States||Region of Enrollment||participants|Number|135|135.0||||||
4243512|NCT00654069|4067366|B1|United States||Region of Enrollment||participants|Number|136|136.0||||||
4243513|NCT00654069|4067363|B4||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4243514|NCT00654069|4067364|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4243515|NCT00654069|4067365|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4243516|NCT00654069|4067366|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4243517|NCT00654069|4067363|B4||Female|Sex: Female, Male||Participants|Count of Participants|359|359.0||||||
4243518|NCT00654069|4067364|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4243519|NCT00654069|4067365|B2||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4243520|NCT00654069|4067366|B1||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4243521|NCT00654069|4067363|B4|||Age||years|Mean|41.8|41.8|Full Range|||18.0|77.0|
4243522|NCT00654069|4067364|B3|||Age||years|Mean|41.6|41.6|Full Range|||18.0|77.0|
4243523|NCT00654069|4067365|B2|||Age||years|Mean|41.8|41.8|Full Range|||18.0|76.0|
4243524|NCT00654069|4067366|B1|||Age||years|Mean|42.0|42.0|Full Range|||18.0|71.0|
4243525|NCT00654069|4067363|B4||>=65 years|Age||Participants|Count of Participants|55|55.0||||||
4243526|NCT00654069|4067364|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4243527|NCT00654069|4067365|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4243528|NCT00654069|4067366|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4243529|NCT00654069|4067363|B4||Between 18 and 65 years|Age||Participants|Count of Participants|350|350.0||||||
4243530|NCT00654069|4067364|B3||Between 18 and 65 years|Age||Participants|Count of Participants|116|116.0||||||
4243531|NCT00654069|4067365|B2||Between 18 and 65 years|Age||Participants|Count of Participants|117|117.0||||||
4243532|NCT00654069|4067366|B1||Between 18 and 65 years|Age||Participants|Count of Participants|117|117.0||||||
4243533|NCT00654069|4067363|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4243534|NCT00654069|4067364|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4243535|NCT00654069|4067365|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4243536|NCT00654069|4067366|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4243537|NCT00654030|4067376|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4243538|NCT00654030|4067376|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4243539|NCT00654030|4067376|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4243540|NCT00654030|4067376|B1|||Age||years|Mean|67|67.0|Standard Deviation|11.21|11.21|||
4243541|NCT00654030|4067376|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4243542|NCT00654030|4067376|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4243543|NCT00654030|4067376|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4243544|NCT00654004|4067380|B3|Europe||Region of Enrollment||participants|Number|1|1.0||||||
4243545|NCT00654004|4067381|B2|Europe||Region of Enrollment||participants|Number|0|0.0||||||
4243546|NCT00654004|4067382|B1|Europe||Region of Enrollment||participants|Number|1|1.0||||||
4243547|NCT00654004|4067380|B3|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4243548|NCT00654004|4067381|B2|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4243549|NCT00654004|4067382|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4243550|NCT00654004|4067380|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4243551|NCT00654004|4067381|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4243552|NCT00654004|4067382|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4243553|NCT00654004|4067380|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4243554|NCT00654004|4067381|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4243555|NCT00654004|4067382|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4243556|NCT00654004|4067380|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4243557|NCT00654004|4067381|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4243558|NCT00654004|4067382|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4243559|NCT00654004|4067380|B3|||Age||years|Mean|14.3|14.3|Standard Deviation|7.7|7.7|||
4243560|NCT00654004|4067381|B2|||Age||years|Mean|15|15.0|Standard Deviation|7|7.0|||
4243561|NCT00654004|4067382|B1|||Age||years|Mean|14|14.0|Standard Deviation|8|8.0|||
4243562|NCT00654004|4067380|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4243563|NCT00654004|4067381|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4243564|NCT00654004|4067382|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4243565|NCT00654004|4067380|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4243566|NCT00654004|4067381|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4243567|NCT00654004|4067382|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4243568|NCT00654004|4067380|B3||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
4243569|NCT00654004|4067381|B2||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4243570|NCT00654004|4067382|B1||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4243571|NCT00653939|4067397|B3|IV||Stage of Disease at Study Entry||participants|Number|54|54.0||||||
4243572|NCT00653939|4067398|B2|IV||Stage of Disease at Study Entry||participants|Number|29|29.0||||||
4243573|NCT00653939|4067399|B1|IV||Stage of Disease at Study Entry||participants|Number|25|25.0||||||
4243574|NCT00653939|4067397|B3|IIIB||Stage of Disease at Study Entry||participants|Number|6|6.0||||||
4243575|NCT00653939|4067398|B2|IIIB||Stage of Disease at Study Entry||participants|Number|2|2.0||||||
4243576|NCT00653939|4067399|B1|IIIB||Stage of Disease at Study Entry||participants|Number|4|4.0||||||
4243577|NCT00653939|4067397|B3|No||Prior Radiation Due to NSCLC||participants|Number|52|52.0||||||
4243578|NCT00653939|4067398|B2|No||Prior Radiation Due to NSCLC||participants|Number|27|27.0||||||
4243579|NCT00653939|4067399|B1|No||Prior Radiation Due to NSCLC||participants|Number|25|25.0||||||
4243580|NCT00653939|4067397|B3|Yes||Prior Radiation Due to NSCLC||participants|Number|8|8.0||||||
4243581|NCT00653939|4067398|B2|Yes||Prior Radiation Due to NSCLC||participants|Number|4|4.0||||||
4243582|NCT00653939|4067399|B1|Yes||Prior Radiation Due to NSCLC||participants|Number|4|4.0||||||
4243583|NCT00653939|4067397|B3|Information Missing||Subject Given Radiation Therapy||participants|Number|1|1.0||||||
4243584|NCT00653939|4067398|B2|Information Missing||Subject Given Radiation Therapy||participants|Number|0|0.0||||||
4243585|NCT00653939|4067399|B1|Information Missing||Subject Given Radiation Therapy||participants|Number|1|1.0||||||
4243586|NCT00653939|4067397|B3|No||Subject Given Radiation Therapy||participants|Number|50|50.0||||||
4243587|NCT00653939|4067398|B2|No||Subject Given Radiation Therapy||participants|Number|27|27.0||||||
4243588|NCT00653939|4067399|B1|No||Subject Given Radiation Therapy||participants|Number|23|23.0||||||
4243589|NCT00653939|4067397|B3|Yes||Subject Given Radiation Therapy||participants|Number|9|9.0||||||
4243590|NCT00653939|4067398|B2|Yes||Subject Given Radiation Therapy||participants|Number|4|4.0||||||
4243591|NCT00653939|4067399|B1|Yes||Subject Given Radiation Therapy||participants|Number|5|5.0||||||
4243592|NCT00653939|4067397|B3|No||Prior Surgery Due to NSCLC||participants|Number|55|55.0||||||
4243593|NCT00653939|4067398|B2|No||Prior Surgery Due to NSCLC||participants|Number|29|29.0||||||
4243594|NCT00653939|4067399|B1|No||Prior Surgery Due to NSCLC||participants|Number|26|26.0||||||
4243595|NCT00653939|4067397|B3|Yes||Prior Surgery Due to NSCLC||participants|Number|5|5.0||||||
4243596|NCT00653939|4067398|B2|Yes||Prior Surgery Due to NSCLC||participants|Number|2|2.0||||||
4243597|NCT00653939|4067399|B1|Yes||Prior Surgery Due to NSCLC||participants|Number|3|3.0||||||
4243598|NCT00653939|4067397|B3|No||Surgery Performed||participants|Number|51|51.0||||||
4243599|NCT00653939|4067398|B2|No||Surgery Performed||participants|Number|27|27.0||||||
4243600|NCT00653939|4067399|B1|No||Surgery Performed||participants|Number|24|24.0||||||
4243601|NCT00653939|4067397|B3|Yes||Surgery Performed||participants|Number|9|9.0||||||
4243602|NCT00653939|4067398|B2|Yes||Surgery Performed||participants|Number|4|4.0||||||
4243603|NCT00653939|4067399|B1|Yes||Surgery Performed||participants|Number|5|5.0||||||
4243604|NCT00653939|4067397|B3|1 - Restricted in physically strenuous activity||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)||participants|Number|28|28.0||||||
4243605|NCT00653939|4067398|B2|1 - Restricted in physically strenuous activity||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)||participants|Number|15|15.0||||||
4243606|NCT00653939|4067399|B1|1 - Restricted in physically strenuous activity||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)||participants|Number|13|13.0||||||
4243607|NCT00653939|4067397|B3|0 - Fully active||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)||participants|Number|32|32.0||||||
4243608|NCT00653939|4067398|B2|0 - Fully active||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)||participants|Number|16|16.0||||||
4243609|NCT00653939|4067399|B1|0 - Fully active||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)||participants|Number|16|16.0||||||
4243610|NCT00653939|4067397|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4243611|NCT00653939|4067398|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
4243612|NCT00653939|4067399|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4243613|NCT00653939|4067397|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4243614|NCT00653939|4067398|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4243615|NCT00653939|4067399|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4243616|NCT00653939|4067397|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243617|NCT00653939|4067398|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243618|NCT00653939|4067399|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243619|NCT00653939|4067397|B3||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4243620|NCT00653939|4067398|B2||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4243621|NCT00653939|4067399|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4243622|NCT00653939|4067397|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243623|NCT00653939|4067398|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243624|NCT00653939|4067399|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243625|NCT00653939|4067397|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243626|NCT00653939|4067398|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243627|NCT00653939|4067399|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243628|NCT00653939|4067397|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243629|NCT00653939|4067398|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243630|NCT00653939|4067399|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243631|NCT00653939|4067397|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243632|NCT00653939|4067398|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243633|NCT00653939|4067399|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243634|NCT00653939|4067397|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4243635|NCT00653939|4067398|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4243636|NCT00653939|4067399|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4243637|NCT00653939|4067397|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4243638|NCT00653939|4067398|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4243639|NCT00653939|4067399|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4243640|NCT00653939|4067397|B3|||Age||years|Mean|62.2|62.2|Standard Deviation|9.5|9.5|||
4243641|NCT00653939|4067398|B2|||Age||years|Mean|61.0|61.0|Standard Deviation|9.4|9.4|||
4243642|NCT00653939|4067399|B1|||Age||years|Mean|63.5|63.5|Standard Deviation|9.5|9.5|||
4243643|NCT00653861|4067416|B1|United States||Region of Enrollment||participants|Number|72|72.0||||||
4243644|NCT00653861|4067416|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4243645|NCT00653861|4067416|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4243646|NCT00653861|4067416|B1|||Age||years|Mean|51.9|51.9|Standard Deviation|9.03|9.03|||
4243647|NCT00653861|4067416|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4243648|NCT00653861|4067416|B1||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
4243649|NCT00653861|4067416|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4243650|NCT00653523|4067425|B1|Japan||Region of Enrollment||participants|Number|151|151.0||||||
4243651|NCT00653523|4067425|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4243652|NCT00653523|4067425|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4243653|NCT00653523|4067425|B1|||Age, Customized|Age 20 years and older|Participants|Number|151|151.0||||||
4243654|NCT00653328|4067429|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4243655|NCT00653328|4067429|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4243656|NCT00653328|4067429|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4243657|NCT00653328|4067429|B1|||Age||years|Mean|66|66.0|Standard Deviation|1|1.0|||
4243658|NCT00653328|4067429|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4243659|NCT00653328|4067429|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4243660|NCT00653328|4067429|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4243661|NCT00653263|4067436|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4243662|NCT00653263|4067436|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4243663|NCT00653263|4067436|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4243664|NCT00653263|4067436|B1|||Age||years|Mean|32.67|32.67|Standard Deviation|5.8|5.8|||
4243665|NCT00653263|4067436|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4243666|NCT00653263|4067436|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4243667|NCT00653263|4067436|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4243668|NCT00653224|4067442|B3|United States||Region of Enrollment||participants|Number|580|580.0||||||
4243669|NCT00653224|4067443|B2|United States||Region of Enrollment||participants|Number|287|287.0||||||
4243670|NCT00653224|4067444|B1|United States||Region of Enrollment||participants|Number|293|293.0||||||
4243671|NCT00653224|4067442|B3||Male|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4243672|NCT00653224|4067443|B2||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4243673|NCT00653224|4067444|B1||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4243674|NCT00653224|4067442|B3||Female|Sex: Female, Male||Participants|Count of Participants|351|351.0||||||
4243675|NCT00653224|4067443|B2||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4243676|NCT00653224|4067444|B1||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4243677|NCT00653224|4067442|B3|||Age||years|Mean|38.13|38.13|Standard Deviation|11.60|11.6|||
4243678|NCT00653224|4067443|B2|||Age||years|Mean|38.73|38.73|Standard Deviation|11.50|11.5|||
4243679|NCT00653224|4067444|B1|||Age||years|Mean|37.53|37.53|Standard Deviation|11.68|11.68|||
4243680|NCT00653159|4067629|B3|No||Presence of STI at screening visit|Number of participants who tested positive for one or more of the following sexually transmitted infections (STI) during the screening visit: chlamydia, gonorrhea, trichomonas, and vaginal warts.|participants|Number|19|19.0||||||
4243681|NCT00653159|4067630|B2|No||Presence of STI at screening visit|Number of participants who tested positive for one or more of the following sexually transmitted infections (STI) during the screening visit: chlamydia, gonorrhea, trichomonas, and vaginal warts.|participants|Number|9|9.0||||||
4243682|NCT00653159|4067631|B1|No||Presence of STI at screening visit|Number of participants who tested positive for one or more of the following sexually transmitted infections (STI) during the screening visit: chlamydia, gonorrhea, trichomonas, and vaginal warts.|participants|Number|10|10.0||||||
4243683|NCT00653159|4067629|B3|Yes||Presence of STI at screening visit|Number of participants who tested positive for one or more of the following sexually transmitted infections (STI) during the screening visit: chlamydia, gonorrhea, trichomonas, and vaginal warts.|participants|Number|4|4.0||||||
4243684|NCT00653159|4067630|B2|Yes||Presence of STI at screening visit|Number of participants who tested positive for one or more of the following sexually transmitted infections (STI) during the screening visit: chlamydia, gonorrhea, trichomonas, and vaginal warts.|participants|Number|3|3.0||||||
4243730|NCT00653159|4067631|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243685|NCT00653159|4067631|B1|Yes||Presence of STI at screening visit|Number of participants who tested positive for one or more of the following sexually transmitted infections (STI) during the screening visit: chlamydia, gonorrhea, trichomonas, and vaginal warts.|participants|Number|1|1.0||||||
4243686|NCT00653159|4067629|B3|No||Previous STI|Number of participants who have previously tested positive for one or more of the following sexually transmitted infections (STI) during the screening visit: chlamydia, gonorrhea, trichomonas, and vaginal warts.|participants|Number|17|17.0||||||
4243687|NCT00653159|4067630|B2|No||Previous STI|Number of participants who have previously tested positive for one or more of the following sexually transmitted infections (STI) during the screening visit: chlamydia, gonorrhea, trichomonas, and vaginal warts.|participants|Number|10|10.0||||||
4243688|NCT00653159|4067631|B1|No||Previous STI|Number of participants who have previously tested positive for one or more of the following sexually transmitted infections (STI) during the screening visit: chlamydia, gonorrhea, trichomonas, and vaginal warts.|participants|Number|7|7.0||||||
4243689|NCT00653159|4067629|B3|Yes||Previous STI|Number of participants who have previously tested positive for one or more of the following sexually transmitted infections (STI) during the screening visit: chlamydia, gonorrhea, trichomonas, and vaginal warts.|participants|Number|6|6.0||||||
4243690|NCT00653159|4067630|B2|Yes||Previous STI|Number of participants who have previously tested positive for one or more of the following sexually transmitted infections (STI) during the screening visit: chlamydia, gonorrhea, trichomonas, and vaginal warts.|participants|Number|2|2.0||||||
4243691|NCT00653159|4067631|B1|Yes||Previous STI|Number of participants who have previously tested positive for one or more of the following sexually transmitted infections (STI) during the screening visit: chlamydia, gonorrhea, trichomonas, and vaginal warts.|participants|Number|4|4.0||||||
4243692|NCT00653159|4067629|B3|Nulliparous||Parous|A parous female participant has given birth one or more times. A female is nulliparous if she has never given birth.|participants|Number|12|12.0||||||
4243693|NCT00653159|4067630|B2|Nulliparous||Parous|A parous female participant has given birth one or more times. A female is nulliparous if she has never given birth.|participants|Number|8|8.0||||||
4243694|NCT00653159|4067631|B1|Nulliparous||Parous|A parous female participant has given birth one or more times. A female is nulliparous if she has never given birth.|participants|Number|4|4.0||||||
4243695|NCT00653159|4067629|B3|Parous||Parous|A parous female participant has given birth one or more times. A female is nulliparous if she has never given birth.|participants|Number|11|11.0||||||
4243696|NCT00653159|4067630|B2|Parous||Parous|A parous female participant has given birth one or more times. A female is nulliparous if she has never given birth.|participants|Number|4|4.0||||||
4243697|NCT00653159|4067631|B1|Parous||Parous|A parous female participant has given birth one or more times. A female is nulliparous if she has never given birth.|participants|Number|7|7.0||||||
4243698|NCT00653159|4067629|B3|Some college/current college student||Education||participants|Number|2|2.0||||||
4243699|NCT00653159|4067630|B2|Some college/current college student||Education||participants|Number|1|1.0||||||
4243700|NCT00653159|4067631|B1|Some college/current college student||Education||participants|Number|1|1.0||||||
4243701|NCT00653159|4067629|B3|High school diploma/GED||Education||participants|Number|2|2.0||||||
4243702|NCT00653159|4067630|B2|High school diploma/GED||Education||participants|Number|0|0.0||||||
4243703|NCT00653159|4067631|B1|High school diploma/GED||Education||participants|Number|2|2.0||||||
4243704|NCT00653159|4067629|B3|Current high school student||Education||participants|Number|18|18.0||||||
4243705|NCT00653159|4067630|B2|Current high school student||Education||participants|Number|10|10.0||||||
4243706|NCT00653159|4067631|B1|Current high school student||Education||participants|Number|8|8.0||||||
4243707|NCT00653159|4067629|B3|8th grade or less||Education||participants|Number|1|1.0||||||
4243708|NCT00653159|4067630|B2|8th grade or less||Education||participants|Number|1|1.0||||||
4243709|NCT00653159|4067631|B1|8th grade or less||Education||participants|Number|0|0.0||||||
4243710|NCT00653159|4067629|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243711|NCT00653159|4067630|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243712|NCT00653159|4067631|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243713|NCT00653159|4067629|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4243714|NCT00653159|4067630|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4243715|NCT00653159|4067631|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243716|NCT00653159|4067629|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4243717|NCT00653159|4067630|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4243718|NCT00653159|4067631|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4243719|NCT00653159|4067629|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4243720|NCT00653159|4067630|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4243721|NCT00653159|4067631|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4243722|NCT00653159|4067629|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243723|NCT00653159|4067630|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243724|NCT00653159|4067631|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243725|NCT00653159|4067629|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4243726|NCT00653159|4067630|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243727|NCT00653159|4067631|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4243728|NCT00653159|4067629|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243729|NCT00653159|4067630|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243731|NCT00653159|4067629|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243732|NCT00653159|4067630|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243733|NCT00653159|4067631|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243734|NCT00653159|4067629|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4243735|NCT00653159|4067630|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4243736|NCT00653159|4067631|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4243737|NCT00653159|4067629|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4243738|NCT00653159|4067630|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4243739|NCT00653159|4067631|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4243740|NCT00653159|4067629|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4243741|NCT00653159|4067630|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4243742|NCT00653159|4067631|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4243743|NCT00653159|4067629|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4243744|NCT00653159|4067630|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4243745|NCT00653159|4067631|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4243746|NCT00653159|4067629|B3|||Age||years|Median|16.5|16.5|Full Range|||14.0|18.0|
4243747|NCT00653159|4067630|B2|||Age||years|Median|16.5|16.5|Full Range|||14.0|18.0|
4243748|NCT00653159|4067631|B1|||Age||years|Median|17|17.0|Full Range|||15.0|18.0|
4243749|NCT00653133|4067646|B3|United States||Region of Enrollment||participants|Number|1821|1821.0||||||
4243750|NCT00653133|4067647|B2|United States||Region of Enrollment||participants|Number|497|497.0||||||
4243751|NCT00653133|4067648|B1|United States||Region of Enrollment||participants|Number|1324|1324.0||||||
4243752|NCT00653133|4067646|B3||Male|Sex: Female, Male||Participants|Count of Participants|958|958.0||||||
4243753|NCT00653133|4067647|B2||Male|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
4243754|NCT00653133|4067648|B1||Male|Sex: Female, Male||Participants|Count of Participants|675|675.0||||||
4243755|NCT00653133|4067646|B3||Female|Sex: Female, Male||Participants|Count of Participants|863|863.0||||||
4243756|NCT00653133|4067647|B2||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4243757|NCT00653133|4067648|B1||Female|Sex: Female, Male||Participants|Count of Participants|649|649.0||||||
4243758|NCT00653133|4067646|B3|||Age||years|Mean|57.3|57.3|Standard Deviation|16.6|16.6|||
4243759|NCT00653133|4067647|B2|||Age||years|Mean|57.7|57.7|Standard Deviation|17.2|17.2|||
4243760|NCT00653133|4067648|B1|||Age||years|Mean|57.1|57.1|Standard Deviation|16.4|16.4|||
4243761|NCT00653133|4067646|B3||>=65 years|Age||Participants|Count of Participants|660|660.0||||||
4243762|NCT00653133|4067647|B2||>=65 years|Age||Participants|Count of Participants|191|191.0||||||
4243763|NCT00653133|4067648|B1||>=65 years|Age||Participants|Count of Participants|469|469.0||||||
4243764|NCT00653133|4067646|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1149|1149.0||||||
4243765|NCT00653133|4067647|B2||Between 18 and 65 years|Age||Participants|Count of Participants|306|306.0||||||
4243766|NCT00653133|4067648|B1||Between 18 and 65 years|Age||Participants|Count of Participants|843|843.0||||||
4243767|NCT00653133|4067646|B3||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4243768|NCT00653133|4067647|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4243769|NCT00653133|4067648|B1||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4243770|NCT00653068|4067655|B5|Australia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4243771|NCT00653068|4067657|B3|Australia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4243772|NCT00653068|4067659|B1|Australia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4243773|NCT00653068|4067655|B5|United States||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
4243774|NCT00653068|4067657|B3|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4243775|NCT00653068|4067659|B1|United States||Region of Enrollment||Participants|Count of Participants|51|51.0||||||
4243776|NCT00653068|4067655|B5|Canada||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4243777|NCT00653068|4067657|B3|Canada||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4243778|NCT00653068|4067659|B1|Canada||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4243779|NCT00653068|4067655|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4243780|NCT00653068|4067657|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4243781|NCT00653068|4067659|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4243782|NCT00653068|4067655|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243783|NCT00653068|4067657|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243784|NCT00653068|4067659|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243785|NCT00653068|4067655|B5||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4243786|NCT00653068|4067657|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4243787|NCT00653068|4067659|B1||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4243788|NCT00653068|4067655|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4243789|NCT00653068|4067657|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4243790|NCT00653068|4067659|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4243791|NCT00653068|4067655|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243792|NCT00653068|4067657|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243793|NCT00653068|4067659|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243794|NCT00653068|4067655|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4243795|NCT00653068|4067657|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4243796|NCT00653068|4067659|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4243797|NCT00653068|4067655|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4243798|NCT00653068|4067657|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243799|NCT00653068|4067659|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4243800|NCT00653068|4067655|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4243801|NCT00653068|4067657|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4243802|NCT00653068|4067659|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4243803|NCT00653068|4067655|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4243804|NCT00653068|4067657|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4243805|NCT00653068|4067659|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4243806|NCT00653068|4067655|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4243807|NCT00653068|4067657|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4243808|NCT00653068|4067659|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4243809|NCT00653068|4067655|B5||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4243810|NCT00653068|4067657|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4243811|NCT00653068|4067659|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4243812|NCT00653068|4067655|B5||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4243813|NCT00653068|4067657|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4243814|NCT00653068|4067659|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4243815|NCT00653068|4067655|B5|||Age||years|Median|1|1.0|Full Range|||0.0|14.0|
4243816|NCT00653068|4067657|B3|||Age||years|Median|4|4.0|Full Range|||3.0|14.0|
4243817|NCT00653068|4067659|B1|||Age||years|Median|1|1.0|Full Range|||0.0|2.0|
4243818|NCT00653068|4067655|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4243819|NCT00653068|4067657|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4243820|NCT00653068|4067659|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4243821|NCT00653068|4067655|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4243822|NCT00653068|4067657|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4243823|NCT00653068|4067659|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4243824|NCT00653068|4067655|B5||<=18 years|Age||Participants|Count of Participants|70|70.0||||||
4243825|NCT00653068|4067657|B3||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4243826|NCT00653068|4067659|B1||<=18 years|Age||Participants|Count of Participants|58|58.0||||||
4243827|NCT00652951|4067670|B4|Geographic ancestry|Unspecified|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4243828|NCT00652951|4067671|B3|Geographic ancestry|Unspecified|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4243829|NCT00652951|4067672|B2|Geographic ancestry|Unspecified|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4243830|NCT00652951|4067673|B1|Geographic ancestry|Unspecified|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4243831|NCT00652951|4067670|B4|Geographic ancestry|White - Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|769|769.0||||||
4243832|NCT00652951|4067671|B3|Geographic ancestry|White - Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|256|256.0||||||
4243833|NCT00652951|4067672|B2|Geographic ancestry|White - Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|255|255.0||||||
4243834|NCT00652951|4067673|B1|Geographic ancestry|White - Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|258|258.0||||||
4243835|NCT00652951|4067670|B4|Geographic ancestry|White - Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4243836|NCT00652951|4067671|B3|Geographic ancestry|White - Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4243837|NCT00652951|4067672|B2|Geographic ancestry|White - Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4243838|NCT00652951|4067673|B1|Geographic ancestry|White - Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4243839|NCT00652951|4067670|B4|Geographic ancestry|Asian - Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4243840|NCT00652951|4067671|B3|Geographic ancestry|Asian - Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4243841|NCT00652951|4067672|B2|Geographic ancestry|Asian - Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4243842|NCT00652951|4067673|B1|Geographic ancestry|Asian - Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4243843|NCT00652951|4067670|B4|Geographic ancestry|African heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4243844|NCT00652951|4067671|B3|Geographic ancestry|African heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4243845|NCT00652951|4067672|B2|Geographic ancestry|African heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4243846|NCT00652951|4067673|B1|Geographic ancestry|African heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4243847|NCT00652951|4067670|B4||Male|Sex: Female, Male||Participants|Count of Participants|396|396.0||||||
4243848|NCT00652951|4067671|B3||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4243849|NCT00652951|4067672|B2||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4243850|NCT00652951|4067673|B1||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4243851|NCT00652951|4067670|B4||Female|Sex: Female, Male||Participants|Count of Participants|384|384.0||||||
4243852|NCT00652951|4067671|B3||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4243853|NCT00652951|4067672|B2||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4243854|NCT00652951|4067673|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4243855|NCT00652951|4067670|B4|||Age||Weeks|Mean|7.53|7.53|Standard Deviation|1.25|1.25|||
4243856|NCT00652951|4067671|B3|||Age||Weeks|Mean|7.6|7.6|Standard Deviation|1.26|1.26|||
4243857|NCT00652951|4067672|B2|||Age||Weeks|Mean|7.6|7.6|Standard Deviation|1.29|1.29|||
4243858|NCT00652951|4067673|B1|||Age||Weeks|Mean|7.4|7.4|Standard Deviation|1.2|1.2|||
4243859|NCT00652938|4067809|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4243860|NCT00652938|4067810|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4243861|NCT00652938|4067811|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4243862|NCT00652938|4067812|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4243863|NCT00652938|4067809|B4||Female|Sex: Female, Male||Participants|Count of Participants|741|741.0||||||
4243864|NCT00652938|4067810|B3||Female|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
4243865|NCT00652938|4067811|B2||Female|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
4243866|NCT00652938|4067812|B1||Female|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
4243867|NCT00652938|4067809|B4|||Age||years|Mean|11.4|11.4|Standard Deviation|2.16|2.16|||
4243868|NCT00652938|4067810|B3|||Age||years|Mean|11.4|11.4|Standard Deviation|2.17|2.17|||
4243869|NCT00652938|4067811|B2|||Age||years|Mean|11.3|11.3|Standard Deviation|2.14|2.14|||
4243870|NCT00652938|4067812|B1|||Age||years|Mean|11.4|11.4|Standard Deviation|2.17|2.17|||
4243871|NCT00652899|4067879|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4243872|NCT00652899|4067879|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4243873|NCT00652899|4067879|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4243874|NCT00652899|4067879|B1|||Age||years|Mean|55|55.0|Standard Deviation|5.19|5.19|||
4243875|NCT00652899|4067879|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4243876|NCT00652899|4067879|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4243877|NCT00652899|4067879|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4243878|NCT00652834|4067889|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4243879|NCT00652834|4067889|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4243880|NCT00652834|4067889|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4243881|NCT00652834|4067889|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4243882|NCT00652834|4067889|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4243883|NCT00652834|4067889|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4243884|NCT00652834|4067889|B1|||Age||years|Median|45|45.0|Standard Deviation|11.69|11.69|||
4243885|NCT00652743|4067893|B4|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4243886|NCT00652743|4067893|B4||Male|Sex: Female, Male||Participants|Count of Participants|424|424.0||||||
4243887|NCT00652743|4067894|B3||Male|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
4243888|NCT00652743|4067895|B2||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4243889|NCT00652743|4067896|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4243890|NCT00652743|4067893|B4||Female|Sex: Female, Male||Participants|Count of Participants|420|420.0||||||
4243891|NCT00652743|4067894|B3||Female|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4243892|NCT00652743|4067895|B2||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4243893|NCT00652743|4067896|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4243894|NCT00652743|4067893|B4|||Age||Years|Mean|34.93|34.93|Standard Deviation|9.75|9.75|||
4243895|NCT00652743|4067894|B3|||Age||Years|Mean|35.4|35.4|Standard Deviation|9.71|9.71|||
4243896|NCT00652743|4067895|B2|||Age||Years|Mean|35.3|35.3|Standard Deviation|9.23|9.23|||
4243897|NCT00652743|4067896|B1|||Age||Years|Mean|34.1|34.1|Standard Deviation|10.33|10.33|||
4243898|NCT00652626|4067973|B8|Multiple myeloma||Cancer Diagnosis: Extension Phase||participants|Number|0|0.0||||||
4243899|NCT00652626|4067974|B7|Multiple myeloma||Cancer Diagnosis: Extension Phase||participants|Number|0|0.0||||||
4243900|NCT00652626|4067975|B6|Multiple myeloma||Cancer Diagnosis: Extension Phase||participants|Number|0|0.0||||||
4243901|NCT00652626|4067976|B5|Multiple myeloma||Cancer Diagnosis: Extension Phase||participants|Number|0|0.0||||||
4243902|NCT00652626|4067977|B4|Multiple myeloma||Cancer Diagnosis: Extension Phase||participants|Number|0|0.0||||||
4243903|NCT00652626|4067978|B3|Multiple myeloma||Cancer Diagnosis: Extension Phase||participants|Number|0|0.0||||||
4243904|NCT00652626|4067979|B2|Multiple myeloma||Cancer Diagnosis: Extension Phase||participants|Number|0|0.0||||||
4243905|NCT00652626|4067980|B1|Multiple myeloma||Cancer Diagnosis: Extension Phase||participants|Number|0|0.0||||||
4243906|NCT00652626|4067973|B8|Solid tumor||Cancer Diagnosis: Extension Phase||participants|Number|15|15.0||||||
4243907|NCT00652626|4067974|B7|Solid tumor||Cancer Diagnosis: Extension Phase||participants|Number|3|3.0||||||
4243908|NCT00652626|4067975|B6|Solid tumor||Cancer Diagnosis: Extension Phase||participants|Number|12|12.0||||||
4243909|NCT00652626|4067976|B5|Solid tumor||Cancer Diagnosis: Extension Phase||participants|Number|0|0.0||||||
4243910|NCT00652626|4067977|B4|Solid tumor||Cancer Diagnosis: Extension Phase||participants|Number|0|0.0||||||
4243911|NCT00652626|4067978|B3|Solid tumor||Cancer Diagnosis: Extension Phase||participants|Number|0|0.0||||||
4243912|NCT00652626|4067979|B2|Solid tumor||Cancer Diagnosis: Extension Phase||participants|Number|0|0.0||||||
4243913|NCT00652626|4067980|B1|Solid tumor||Cancer Diagnosis: Extension Phase||participants|Number|0|0.0||||||
4243914|NCT00652626|4067973|B8|Chronic myelomonocytic leukemia||Cancer Diagnosis: Extension Phase||participants|Number|0|0.0||||||
4243915|NCT00652626|4067974|B7|Chronic myelomonocytic leukemia||Cancer Diagnosis: Extension Phase||participants|Number|0|0.0||||||
4243916|NCT00652626|4067975|B6|Chronic myelomonocytic leukemia||Cancer Diagnosis: Extension Phase||participants|Number|0|0.0||||||
4243917|NCT00652626|4067976|B5|Chronic myelomonocytic leukemia||Cancer Diagnosis: Extension Phase||participants|Number|0|0.0||||||
4243918|NCT00652626|4067977|B4|Chronic myelomonocytic leukemia||Cancer Diagnosis: Extension Phase||participants|Number|0|0.0||||||
4243919|NCT00652626|4067978|B3|Chronic myelomonocytic leukemia||Cancer Diagnosis: Extension Phase||participants|Number|0|0.0||||||
4243920|NCT00652626|4067979|B2|Chronic myelomonocytic leukemia||Cancer Diagnosis: Extension Phase||participants|Number|0|0.0||||||
4243921|NCT00652626|4067980|B1|Chronic myelomonocytic leukemia||Cancer Diagnosis: Extension Phase||participants|Number|0|0.0||||||
4243922|NCT00652626|4067973|B8|Myelodysplastic syndrome-RAEB-T||Cancer Diagnosis: Extension Phase||participants|Number|1|1.0||||||
4243923|NCT00652626|4067974|B7|Myelodysplastic syndrome-RAEB-T||Cancer Diagnosis: Extension Phase||participants|Number|0|0.0||||||
4243924|NCT00652626|4067975|B6|Myelodysplastic syndrome-RAEB-T||Cancer Diagnosis: Extension Phase||participants|Number|1|1.0||||||
4243925|NCT00652626|4067976|B5|Myelodysplastic syndrome-RAEB-T||Cancer Diagnosis: Extension Phase||participants|Number|0|0.0||||||
4243926|NCT00652626|4067977|B4|Myelodysplastic syndrome-RAEB-T||Cancer Diagnosis: Extension Phase||participants|Number|0|0.0||||||
4243927|NCT00652626|4067978|B3|Myelodysplastic syndrome-RAEB-T||Cancer Diagnosis: Extension Phase||participants|Number|0|0.0||||||
4243928|NCT00652626|4067979|B2|Myelodysplastic syndrome-RAEB-T||Cancer Diagnosis: Extension Phase||participants|Number|0|0.0||||||
4243929|NCT00652626|4067980|B1|Myelodysplastic syndrome-RAEB-T||Cancer Diagnosis: Extension Phase||participants|Number|0|0.0||||||
4243930|NCT00652626|4067973|B8|Myelodysplastic syndrome-RARS||Cancer Diagnosis: Extension Phase||participants|Number|1|1.0||||||
4243931|NCT00652626|4067974|B7|Myelodysplastic syndrome-RARS||Cancer Diagnosis: Extension Phase||participants|Number|0|0.0||||||
4243932|NCT00652626|4067975|B6|Myelodysplastic syndrome-RARS||Cancer Diagnosis: Extension Phase||participants|Number|1|1.0||||||
4243933|NCT00652626|4067976|B5|Myelodysplastic syndrome-RARS||Cancer Diagnosis: Extension Phase||participants|Number|0|0.0||||||
4243934|NCT00652626|4067977|B4|Myelodysplastic syndrome-RARS||Cancer Diagnosis: Extension Phase||participants|Number|0|0.0||||||
4243935|NCT00652626|4067978|B3|Myelodysplastic syndrome-RARS||Cancer Diagnosis: Extension Phase||participants|Number|0|0.0||||||
4243936|NCT00652626|4067979|B2|Myelodysplastic syndrome-RARS||Cancer Diagnosis: Extension Phase||participants|Number|0|0.0||||||
4243937|NCT00652626|4067980|B1|Myelodysplastic syndrome-RARS||Cancer Diagnosis: Extension Phase||participants|Number|0|0.0||||||
4243938|NCT00652626|4067973|B8|Myelodysplastic syndrome-RA||Cancer Diagnosis: Extension Phase||participants|Number|1|1.0||||||
4243939|NCT00652626|4067974|B7|Myelodysplastic syndrome-RA||Cancer Diagnosis: Extension Phase||participants|Number|1|1.0||||||
4243940|NCT00652626|4067975|B6|Myelodysplastic syndrome-RA||Cancer Diagnosis: Extension Phase||participants|Number|0|0.0||||||
4243941|NCT00652626|4067976|B5|Myelodysplastic syndrome-RA||Cancer Diagnosis: Extension Phase||participants|Number|0|0.0||||||
4243942|NCT00652626|4067977|B4|Myelodysplastic syndrome-RA||Cancer Diagnosis: Extension Phase||participants|Number|0|0.0||||||
4243943|NCT00652626|4067978|B3|Myelodysplastic syndrome-RA||Cancer Diagnosis: Extension Phase||participants|Number|0|0.0||||||
4243944|NCT00652626|4067979|B2|Myelodysplastic syndrome-RA||Cancer Diagnosis: Extension Phase||participants|Number|0|0.0||||||
4243945|NCT00652626|4067980|B1|Myelodysplastic syndrome-RA||Cancer Diagnosis: Extension Phase||participants|Number|0|0.0||||||
4243946|NCT00652626|4067973|B8|Multiple myeloma||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|1|1.0||||||
4243947|NCT00652626|4067974|B7|Multiple myeloma||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|0|0.0||||||
4243948|NCT00652626|4067975|B6|Multiple myeloma||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|0|0.0||||||
4243949|NCT00652626|4067976|B5|Multiple myeloma||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|0|0.0||||||
4243950|NCT00652626|4067977|B4|Multiple myeloma||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|0|0.0||||||
4243951|NCT00652626|4067978|B3|Multiple myeloma||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|0|0.0||||||
4243952|NCT00652626|4067979|B2|Multiple myeloma||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|0|0.0||||||
4243953|NCT00652626|4067980|B1|Multiple myeloma||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|1|1.0||||||
4243954|NCT00652626|4067973|B8|Solid tumor||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|20|20.0||||||
4243955|NCT00652626|4067974|B7|Solid tumor||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|0|0.0||||||
4243956|NCT00652626|4067975|B6|Solid tumor||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|0|0.0||||||
4243957|NCT00652626|4067976|B5|Solid tumor||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|4|4.0||||||
4243958|NCT00652626|4067977|B4|Solid tumor||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|5|5.0||||||
4243959|NCT00652626|4067978|B3|Solid tumor||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|5|5.0||||||
4243960|NCT00652626|4067979|B2|Solid tumor||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|3|3.0||||||
4243961|NCT00652626|4067980|B1|Solid tumor||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|3|3.0||||||
4243962|NCT00652626|4067973|B8|Chronic myelomonocytic leukemia||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|1|1.0||||||
4243963|NCT00652626|4067974|B7|Chronic myelomonocytic leukemia||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|0|0.0||||||
4243964|NCT00652626|4067975|B6|Chronic myelomonocytic leukemia||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|0|0.0||||||
4243965|NCT00652626|4067976|B5|Chronic myelomonocytic leukemia||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|1|1.0||||||
4243966|NCT00652626|4067977|B4|Chronic myelomonocytic leukemia||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|0|0.0||||||
4243967|NCT00652626|4067978|B3|Chronic myelomonocytic leukemia||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|0|0.0||||||
4243968|NCT00652626|4067979|B2|Chronic myelomonocytic leukemia||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|0|0.0||||||
4243969|NCT00652626|4067980|B1|Chronic myelomonocytic leukemia||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|0|0.0||||||
4244031|NCT00652626|4067978|B3|0||Eastern Cooperative Oncology Group (ECOG) Performance Status: Extension Phase||participants|Number|0|0.0||||||
4243970|NCT00652626|4067973|B8|Myelodysplastic syndrome-RAEB-T||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|2|2.0||||||
4243971|NCT00652626|4067974|B7|Myelodysplastic syndrome-RAEB-T||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|0|0.0||||||
4243972|NCT00652626|4067975|B6|Myelodysplastic syndrome-RAEB-T||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|0|0.0||||||
4243973|NCT00652626|4067976|B5|Myelodysplastic syndrome-RAEB-T||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|0|0.0||||||
4243974|NCT00652626|4067977|B4|Myelodysplastic syndrome-RAEB-T||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|0|0.0||||||
4243975|NCT00652626|4067978|B3|Myelodysplastic syndrome-RAEB-T||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|0|0.0||||||
4243976|NCT00652626|4067979|B2|Myelodysplastic syndrome-RAEB-T||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|1|1.0||||||
4243977|NCT00652626|4067980|B1|Myelodysplastic syndrome-RAEB-T||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|1|1.0||||||
4243978|NCT00652626|4067973|B8|Myelodysplastic syndrome-RARS||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|1|1.0||||||
4243979|NCT00652626|4067974|B7|Myelodysplastic syndrome-RARS||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|0|0.0||||||
4243980|NCT00652626|4067975|B6|Myelodysplastic syndrome-RARS||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|0|0.0||||||
4243981|NCT00652626|4067976|B5|Myelodysplastic syndrome-RARS||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|0|0.0||||||
4243982|NCT00652626|4067977|B4|Myelodysplastic syndrome-RARS||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|0|0.0||||||
4243983|NCT00652626|4067978|B3|Myelodysplastic syndrome-RARS||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|1|1.0||||||
4243984|NCT00652626|4067979|B2|Myelodysplastic syndrome-RARS||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|0|0.0||||||
4243985|NCT00652626|4067980|B1|Myelodysplastic syndrome-RARS||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|0|0.0||||||
4243986|NCT00652626|4067973|B8|Myelodysplastic syndrome-RA||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|2|2.0||||||
4243987|NCT00652626|4067974|B7|Myelodysplastic syndrome-RA||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|0|0.0||||||
4243988|NCT00652626|4067975|B6|Myelodysplastic syndrome-RA||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|0|0.0||||||
4243989|NCT00652626|4067976|B5|Myelodysplastic syndrome-RA||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|1|1.0||||||
4243990|NCT00652626|4067977|B4|Myelodysplastic syndrome-RA||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|0|0.0||||||
4243991|NCT00652626|4067978|B3|Myelodysplastic syndrome-RA||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|0|0.0||||||
4243992|NCT00652626|4067979|B2|Myelodysplastic syndrome-RA||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|1|1.0||||||
4243993|NCT00652626|4067980|B1|Myelodysplastic syndrome-RA||Cancer Diagnosis: Initial Treatment Phase|MDS = myelodysplastic syndrome; MM = multiple myeloma; RA = refractory anemia; RAEB-T = refractory anemia with excess blasts in transformation; RARS = refractory anemia with ringed sideroblasts; CMML = chronic myelomonocytic leukemia.|participants|Number|0|0.0||||||
4243994|NCT00652626|4067973|B8|Extension Period||Body Surface Area (BSA)||m^2|Mean|1.9|1.9|Standard Deviation|0.31|0.31|||
4243995|NCT00652626|4067974|B7|Extension Period||Body Surface Area (BSA)||m^2|Mean|1.9|1.9|Standard Deviation|0.06|0.06|||
4243996|NCT00652626|4067975|B6|Extension Period||Body Surface Area (BSA)||m^2|Mean|1.9|1.9|Standard Deviation|0.35|0.35|||
4243997|NCT00652626|4067976|B5|Extension Period||Body Surface Area (BSA)||m^2|Mean|NA||Standard Deviation|NA||||Data provided for extension treatment period arms only
4243998|NCT00652626|4067977|B4|Extension Period||Body Surface Area (BSA)||m^2|Mean|NA||Standard Deviation|NA||||Data provided for extension treatment period arms only
4243999|NCT00652626|4067978|B3|Extension Period||Body Surface Area (BSA)||m^2|Mean|NA||Standard Deviation|NA||||Data provided for extension treatment period arms only
4244000|NCT00652626|4067979|B2|Extension Period||Body Surface Area (BSA)||m^2|Mean|NA||Standard Deviation|NA||||Data provided for extension treatment period arms only
4244001|NCT00652626|4067980|B1|Extension Period||Body Surface Area (BSA)||m^2|Mean|NA||Standard Deviation|NA||||Data provided for extension treatment period arms only
4244002|NCT00652626|4067973|B8|Initial Treatment Period||Body Surface Area (BSA)||m^2|Mean|1.9|1.9|Standard Deviation|0.27|0.27|||
4244003|NCT00652626|4067974|B7|Initial Treatment Period||Body Surface Area (BSA)||m^2|Mean|NA||Standard Deviation|NA||||Data provided for initial treatment period arms only
4244004|NCT00652626|4067975|B6|Initial Treatment Period||Body Surface Area (BSA)||m^2|Mean|NA||Standard Deviation|NA||||Data provided for initial treatment period arms only
4244005|NCT00652626|4067976|B5|Initial Treatment Period||Body Surface Area (BSA)||m^2|Mean|1.8|1.8|Standard Deviation|0.15|0.15|||
4244006|NCT00652626|4067977|B4|Initial Treatment Period||Body Surface Area (BSA)||m^2|Mean|1.6|1.6|Standard Deviation|0.15|0.15|||
4244007|NCT00652626|4067978|B3|Initial Treatment Period||Body Surface Area (BSA)||m^2|Mean|1.9|1.9|Standard Deviation|0.42|0.42|||
4244008|NCT00652626|4067979|B2|Initial Treatment Period||Body Surface Area (BSA)||m^2|Mean|1.9|1.9|Standard Deviation|0.28|0.28|||
4244009|NCT00652626|4067980|B1|Initial Treatment Period||Body Surface Area (BSA)||m^2|Mean|2.0|2.0|Standard Deviation|0.20|0.2|||
4244010|NCT00652626|4067973|B8|2||Eastern Cooperative Oncology Group (ECOG) Performance Status: Extension Phase||participants|Number|1|1.0||||||
4244011|NCT00652626|4067974|B7|2||Eastern Cooperative Oncology Group (ECOG) Performance Status: Extension Phase||participants|Number|0|0.0||||||
4244012|NCT00652626|4067975|B6|2||Eastern Cooperative Oncology Group (ECOG) Performance Status: Extension Phase||participants|Number|1|1.0||||||
4244013|NCT00652626|4067976|B5|2||Eastern Cooperative Oncology Group (ECOG) Performance Status: Extension Phase||participants|Number|0|0.0||||||
4244014|NCT00652626|4067977|B4|2||Eastern Cooperative Oncology Group (ECOG) Performance Status: Extension Phase||participants|Number|0|0.0||||||
4244015|NCT00652626|4067978|B3|2||Eastern Cooperative Oncology Group (ECOG) Performance Status: Extension Phase||participants|Number|0|0.0||||||
4244016|NCT00652626|4067979|B2|2||Eastern Cooperative Oncology Group (ECOG) Performance Status: Extension Phase||participants|Number|0|0.0||||||
4244017|NCT00652626|4067980|B1|2||Eastern Cooperative Oncology Group (ECOG) Performance Status: Extension Phase||participants|Number|0|0.0||||||
4244018|NCT00652626|4067973|B8|1||Eastern Cooperative Oncology Group (ECOG) Performance Status: Extension Phase||participants|Number|14|14.0||||||
4244019|NCT00652626|4067974|B7|1||Eastern Cooperative Oncology Group (ECOG) Performance Status: Extension Phase||participants|Number|3|3.0||||||
4244020|NCT00652626|4067975|B6|1||Eastern Cooperative Oncology Group (ECOG) Performance Status: Extension Phase||participants|Number|11|11.0||||||
4244021|NCT00652626|4067976|B5|1||Eastern Cooperative Oncology Group (ECOG) Performance Status: Extension Phase||participants|Number|0|0.0||||||
4244022|NCT00652626|4067977|B4|1||Eastern Cooperative Oncology Group (ECOG) Performance Status: Extension Phase||participants|Number|0|0.0||||||
4244023|NCT00652626|4067978|B3|1||Eastern Cooperative Oncology Group (ECOG) Performance Status: Extension Phase||participants|Number|0|0.0||||||
4244024|NCT00652626|4067979|B2|1||Eastern Cooperative Oncology Group (ECOG) Performance Status: Extension Phase||participants|Number|0|0.0||||||
4244025|NCT00652626|4067980|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status: Extension Phase||participants|Number|0|0.0||||||
4244026|NCT00652626|4067973|B8|0||Eastern Cooperative Oncology Group (ECOG) Performance Status: Extension Phase||participants|Number|3|3.0||||||
4244027|NCT00652626|4067974|B7|0||Eastern Cooperative Oncology Group (ECOG) Performance Status: Extension Phase||participants|Number|1|1.0||||||
4244028|NCT00652626|4067975|B6|0||Eastern Cooperative Oncology Group (ECOG) Performance Status: Extension Phase||participants|Number|2|2.0||||||
4244029|NCT00652626|4067976|B5|0||Eastern Cooperative Oncology Group (ECOG) Performance Status: Extension Phase||participants|Number|0|0.0||||||
4244030|NCT00652626|4067977|B4|0||Eastern Cooperative Oncology Group (ECOG) Performance Status: Extension Phase||participants|Number|0|0.0||||||
4244032|NCT00652626|4067979|B2|0||Eastern Cooperative Oncology Group (ECOG) Performance Status: Extension Phase||participants|Number|0|0.0||||||
4244033|NCT00652626|4067980|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status: Extension Phase||participants|Number|0|0.0||||||
4244034|NCT00652626|4067973|B8|2||Eastern Cooperative Oncology Group (ECOG) Performance Status: Initial Treatment Phase|Scale used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis. 0 = fully active, no restrictions; 1 = restricted but ambulatory and capable of light work; 2 = ambulatory and capable of self-care but unable to work. 3 = Capable of only limited self care, confined to bed or chair more than 50% of waking hours. 4 = Completely disabled. Cannot carry on any self care. Totally confined to bed or chair. 5 = Dead.|participants|Number|2|2.0||||||
4244035|NCT00652626|4067974|B7|2||Eastern Cooperative Oncology Group (ECOG) Performance Status: Initial Treatment Phase|Scale used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis. 0 = fully active, no restrictions; 1 = restricted but ambulatory and capable of light work; 2 = ambulatory and capable of self-care but unable to work. 3 = Capable of only limited self care, confined to bed or chair more than 50% of waking hours. 4 = Completely disabled. Cannot carry on any self care. Totally confined to bed or chair. 5 = Dead.|participants|Number|0|0.0||||||
4244036|NCT00652626|4067975|B6|2||Eastern Cooperative Oncology Group (ECOG) Performance Status: Initial Treatment Phase|Scale used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis. 0 = fully active, no restrictions; 1 = restricted but ambulatory and capable of light work; 2 = ambulatory and capable of self-care but unable to work. 3 = Capable of only limited self care, confined to bed or chair more than 50% of waking hours. 4 = Completely disabled. Cannot carry on any self care. Totally confined to bed or chair. 5 = Dead.|participants|Number|0|0.0||||||
4244037|NCT00652626|4067976|B5|2||Eastern Cooperative Oncology Group (ECOG) Performance Status: Initial Treatment Phase|Scale used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis. 0 = fully active, no restrictions; 1 = restricted but ambulatory and capable of light work; 2 = ambulatory and capable of self-care but unable to work. 3 = Capable of only limited self care, confined to bed or chair more than 50% of waking hours. 4 = Completely disabled. Cannot carry on any self care. Totally confined to bed or chair. 5 = Dead.|participants|Number|1|1.0||||||
4244038|NCT00652626|4067977|B4|2||Eastern Cooperative Oncology Group (ECOG) Performance Status: Initial Treatment Phase|Scale used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis. 0 = fully active, no restrictions; 1 = restricted but ambulatory and capable of light work; 2 = ambulatory and capable of self-care but unable to work. 3 = Capable of only limited self care, confined to bed or chair more than 50% of waking hours. 4 = Completely disabled. Cannot carry on any self care. Totally confined to bed or chair. 5 = Dead.|participants|Number|0|0.0||||||
4244039|NCT00652626|4067978|B3|2||Eastern Cooperative Oncology Group (ECOG) Performance Status: Initial Treatment Phase|Scale used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis. 0 = fully active, no restrictions; 1 = restricted but ambulatory and capable of light work; 2 = ambulatory and capable of self-care but unable to work. 3 = Capable of only limited self care, confined to bed or chair more than 50% of waking hours. 4 = Completely disabled. Cannot carry on any self care. Totally confined to bed or chair. 5 = Dead.|participants|Number|1|1.0||||||
4244040|NCT00652626|4067979|B2|2||Eastern Cooperative Oncology Group (ECOG) Performance Status: Initial Treatment Phase|Scale used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis. 0 = fully active, no restrictions; 1 = restricted but ambulatory and capable of light work; 2 = ambulatory and capable of self-care but unable to work. 3 = Capable of only limited self care, confined to bed or chair more than 50% of waking hours. 4 = Completely disabled. Cannot carry on any self care. Totally confined to bed or chair. 5 = Dead.|participants|Number|0|0.0||||||
4244041|NCT00652626|4067980|B1|2||Eastern Cooperative Oncology Group (ECOG) Performance Status: Initial Treatment Phase|Scale used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis. 0 = fully active, no restrictions; 1 = restricted but ambulatory and capable of light work; 2 = ambulatory and capable of self-care but unable to work. 3 = Capable of only limited self care, confined to bed or chair more than 50% of waking hours. 4 = Completely disabled. Cannot carry on any self care. Totally confined to bed or chair. 5 = Dead.|participants|Number|0|0.0||||||
4244042|NCT00652626|4067973|B8|1||Eastern Cooperative Oncology Group (ECOG) Performance Status: Initial Treatment Phase|Scale used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis. 0 = fully active, no restrictions; 1 = restricted but ambulatory and capable of light work; 2 = ambulatory and capable of self-care but unable to work. 3 = Capable of only limited self care, confined to bed or chair more than 50% of waking hours. 4 = Completely disabled. Cannot carry on any self care. Totally confined to bed or chair. 5 = Dead.|participants|Number|18|18.0||||||
4244043|NCT00652626|4067974|B7|1||Eastern Cooperative Oncology Group (ECOG) Performance Status: Initial Treatment Phase|Scale used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis. 0 = fully active, no restrictions; 1 = restricted but ambulatory and capable of light work; 2 = ambulatory and capable of self-care but unable to work. 3 = Capable of only limited self care, confined to bed or chair more than 50% of waking hours. 4 = Completely disabled. Cannot carry on any self care. Totally confined to bed or chair. 5 = Dead.|participants|Number|0|0.0||||||
4244100|NCT00652626|4067975|B6|White||Race/Ethnicity, Customized|Data provided for initial treatment phase groups only.|participants|Number|0|0.0||||||
4244101|NCT00652626|4067976|B5|White||Race/Ethnicity, Customized|Data provided for initial treatment phase groups only.|participants|Number|4|4.0||||||
4244044|NCT00652626|4067975|B6|1||Eastern Cooperative Oncology Group (ECOG) Performance Status: Initial Treatment Phase|Scale used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis. 0 = fully active, no restrictions; 1 = restricted but ambulatory and capable of light work; 2 = ambulatory and capable of self-care but unable to work. 3 = Capable of only limited self care, confined to bed or chair more than 50% of waking hours. 4 = Completely disabled. Cannot carry on any self care. Totally confined to bed or chair. 5 = Dead.|participants|Number|0|0.0||||||
4244045|NCT00652626|4067976|B5|1||Eastern Cooperative Oncology Group (ECOG) Performance Status: Initial Treatment Phase|Scale used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis. 0 = fully active, no restrictions; 1 = restricted but ambulatory and capable of light work; 2 = ambulatory and capable of self-care but unable to work. 3 = Capable of only limited self care, confined to bed or chair more than 50% of waking hours. 4 = Completely disabled. Cannot carry on any self care. Totally confined to bed or chair. 5 = Dead.|participants|Number|3|3.0||||||
4244046|NCT00652626|4067977|B4|1||Eastern Cooperative Oncology Group (ECOG) Performance Status: Initial Treatment Phase|Scale used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis. 0 = fully active, no restrictions; 1 = restricted but ambulatory and capable of light work; 2 = ambulatory and capable of self-care but unable to work. 3 = Capable of only limited self care, confined to bed or chair more than 50% of waking hours. 4 = Completely disabled. Cannot carry on any self care. Totally confined to bed or chair. 5 = Dead.|participants|Number|5|5.0||||||
4244047|NCT00652626|4067978|B3|1||Eastern Cooperative Oncology Group (ECOG) Performance Status: Initial Treatment Phase|Scale used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis. 0 = fully active, no restrictions; 1 = restricted but ambulatory and capable of light work; 2 = ambulatory and capable of self-care but unable to work. 3 = Capable of only limited self care, confined to bed or chair more than 50% of waking hours. 4 = Completely disabled. Cannot carry on any self care. Totally confined to bed or chair. 5 = Dead.|participants|Number|4|4.0||||||
4244048|NCT00652626|4067979|B2|1||Eastern Cooperative Oncology Group (ECOG) Performance Status: Initial Treatment Phase|Scale used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis. 0 = fully active, no restrictions; 1 = restricted but ambulatory and capable of light work; 2 = ambulatory and capable of self-care but unable to work. 3 = Capable of only limited self care, confined to bed or chair more than 50% of waking hours. 4 = Completely disabled. Cannot carry on any self care. Totally confined to bed or chair. 5 = Dead.|participants|Number|3|3.0||||||
4244049|NCT00652626|4067980|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status: Initial Treatment Phase|Scale used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis. 0 = fully active, no restrictions; 1 = restricted but ambulatory and capable of light work; 2 = ambulatory and capable of self-care but unable to work. 3 = Capable of only limited self care, confined to bed or chair more than 50% of waking hours. 4 = Completely disabled. Cannot carry on any self care. Totally confined to bed or chair. 5 = Dead.|participants|Number|3|3.0||||||
4244050|NCT00652626|4067973|B8|0||Eastern Cooperative Oncology Group (ECOG) Performance Status: Initial Treatment Phase|Scale used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis. 0 = fully active, no restrictions; 1 = restricted but ambulatory and capable of light work; 2 = ambulatory and capable of self-care but unable to work. 3 = Capable of only limited self care, confined to bed or chair more than 50% of waking hours. 4 = Completely disabled. Cannot carry on any self care. Totally confined to bed or chair. 5 = Dead.|participants|Number|7|7.0||||||
4244051|NCT00652626|4067974|B7|0||Eastern Cooperative Oncology Group (ECOG) Performance Status: Initial Treatment Phase|Scale used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis. 0 = fully active, no restrictions; 1 = restricted but ambulatory and capable of light work; 2 = ambulatory and capable of self-care but unable to work. 3 = Capable of only limited self care, confined to bed or chair more than 50% of waking hours. 4 = Completely disabled. Cannot carry on any self care. Totally confined to bed or chair. 5 = Dead.|participants|Number|0|0.0||||||
4244052|NCT00652626|4067975|B6|0||Eastern Cooperative Oncology Group (ECOG) Performance Status: Initial Treatment Phase|Scale used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis. 0 = fully active, no restrictions; 1 = restricted but ambulatory and capable of light work; 2 = ambulatory and capable of self-care but unable to work. 3 = Capable of only limited self care, confined to bed or chair more than 50% of waking hours. 4 = Completely disabled. Cannot carry on any self care. Totally confined to bed or chair. 5 = Dead.|participants|Number|0|0.0||||||
4244053|NCT00652626|4067976|B5|0||Eastern Cooperative Oncology Group (ECOG) Performance Status: Initial Treatment Phase|Scale used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis. 0 = fully active, no restrictions; 1 = restricted but ambulatory and capable of light work; 2 = ambulatory and capable of self-care but unable to work. 3 = Capable of only limited self care, confined to bed or chair more than 50% of waking hours. 4 = Completely disabled. Cannot carry on any self care. Totally confined to bed or chair. 5 = Dead.|participants|Number|2|2.0||||||
4244054|NCT00652626|4067977|B4|0||Eastern Cooperative Oncology Group (ECOG) Performance Status: Initial Treatment Phase|Scale used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis. 0 = fully active, no restrictions; 1 = restricted but ambulatory and capable of light work; 2 = ambulatory and capable of self-care but unable to work. 3 = Capable of only limited self care, confined to bed or chair more than 50% of waking hours. 4 = Completely disabled. Cannot carry on any self care. Totally confined to bed or chair. 5 = Dead.|participants|Number|0|0.0||||||
4244055|NCT00652626|4067978|B3|0||Eastern Cooperative Oncology Group (ECOG) Performance Status: Initial Treatment Phase|Scale used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis. 0 = fully active, no restrictions; 1 = restricted but ambulatory and capable of light work; 2 = ambulatory and capable of self-care but unable to work. 3 = Capable of only limited self care, confined to bed or chair more than 50% of waking hours. 4 = Completely disabled. Cannot carry on any self care. Totally confined to bed or chair. 5 = Dead.|participants|Number|1|1.0||||||
4244056|NCT00652626|4067979|B2|0||Eastern Cooperative Oncology Group (ECOG) Performance Status: Initial Treatment Phase|Scale used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis. 0 = fully active, no restrictions; 1 = restricted but ambulatory and capable of light work; 2 = ambulatory and capable of self-care but unable to work. 3 = Capable of only limited self care, confined to bed or chair more than 50% of waking hours. 4 = Completely disabled. Cannot carry on any self care. Totally confined to bed or chair. 5 = Dead.|participants|Number|2|2.0||||||
4244057|NCT00652626|4067980|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status: Initial Treatment Phase|Scale used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis. 0 = fully active, no restrictions; 1 = restricted but ambulatory and capable of light work; 2 = ambulatory and capable of self-care but unable to work. 3 = Capable of only limited self care, confined to bed or chair more than 50% of waking hours. 4 = Completely disabled. Cannot carry on any self care. Totally confined to bed or chair. 5 = Dead.|participants|Number|2|2.0||||||
4244058|NCT00652626|4067973|B8|White||Race: Extension Phase||participants|Number|13|13.0||||||
4244059|NCT00652626|4067974|B7|White||Race: Extension Phase||participants|Number|4|4.0||||||
4244060|NCT00652626|4067975|B6|White||Race: Extension Phase||participants|Number|9|9.0||||||
4244061|NCT00652626|4067976|B5|White||Race: Extension Phase||participants|Number|0|0.0||||||
4244062|NCT00652626|4067977|B4|White||Race: Extension Phase||participants|Number|0|0.0||||||
4244063|NCT00652626|4067978|B3|White||Race: Extension Phase||participants|Number|0|0.0||||||
4244064|NCT00652626|4067979|B2|White||Race: Extension Phase||participants|Number|0|0.0||||||
4244065|NCT00652626|4067980|B1|White||Race: Extension Phase||participants|Number|0|0.0||||||
4244066|NCT00652626|4067973|B8|Black||Race: Extension Phase||participants|Number|5|5.0||||||
4244067|NCT00652626|4067974|B7|Black||Race: Extension Phase||participants|Number|0|0.0||||||
4244068|NCT00652626|4067975|B6|Black||Race: Extension Phase||participants|Number|5|5.0||||||
4244069|NCT00652626|4067976|B5|Black||Race: Extension Phase||participants|Number|0|0.0||||||
4244070|NCT00652626|4067977|B4|Black||Race: Extension Phase||participants|Number|0|0.0||||||
4244071|NCT00652626|4067978|B3|Black||Race: Extension Phase||participants|Number|0|0.0||||||
4244072|NCT00652626|4067979|B2|Black||Race: Extension Phase||participants|Number|0|0.0||||||
4244073|NCT00652626|4067980|B1|Black||Race: Extension Phase||participants|Number|0|0.0||||||
4244074|NCT00652626|4067973|B8|Male||Gender of Extension Period Participants||participants|Number|8|8.0||||||
4244075|NCT00652626|4067974|B7|Male||Gender of Extension Period Participants||participants|Number|2|2.0||||||
4244076|NCT00652626|4067975|B6|Male||Gender of Extension Period Participants||participants|Number|6|6.0||||||
4244077|NCT00652626|4067976|B5|Male||Gender of Extension Period Participants||participants|Number|0|0.0||||||
4244078|NCT00652626|4067977|B4|Male||Gender of Extension Period Participants||participants|Number|0|0.0||||||
4244079|NCT00652626|4067978|B3|Male||Gender of Extension Period Participants||participants|Number|0|0.0||||||
4244080|NCT00652626|4067979|B2|Male||Gender of Extension Period Participants||participants|Number|0|0.0||||||
4244081|NCT00652626|4067980|B1|Male||Gender of Extension Period Participants||participants|Number|0|0.0||||||
4244082|NCT00652626|4067973|B8|Female||Gender of Extension Period Participants||participants|Number|10|10.0||||||
4244083|NCT00652626|4067974|B7|Female||Gender of Extension Period Participants||participants|Number|2|2.0||||||
4244084|NCT00652626|4067975|B6|Female||Gender of Extension Period Participants||participants|Number|8|8.0||||||
4244085|NCT00652626|4067976|B5|Female||Gender of Extension Period Participants||participants|Number|0|0.0||||||
4244086|NCT00652626|4067977|B4|Female||Gender of Extension Period Participants||participants|Number|0|0.0||||||
4244087|NCT00652626|4067978|B3|Female||Gender of Extension Period Participants||participants|Number|0|0.0||||||
4244088|NCT00652626|4067979|B2|Female||Gender of Extension Period Participants||participants|Number|0|0.0||||||
4244089|NCT00652626|4067980|B1|Female||Gender of Extension Period Participants||participants|Number|0|0.0||||||
4244090|NCT00652626|4067973|B8|United States||Region of Enrollment|Data provided for initial treatment phase groups only.|participants|Number|27|27.0||||||
4244091|NCT00652626|4067974|B7|United States||Region of Enrollment|Data provided for initial treatment phase groups only.|participants|Number|0|0.0||||||
4244092|NCT00652626|4067975|B6|United States||Region of Enrollment|Data provided for initial treatment phase groups only.|participants|Number|0|0.0||||||
4244093|NCT00652626|4067976|B5|United States||Region of Enrollment|Data provided for initial treatment phase groups only.|participants|Number|6|6.0||||||
4244094|NCT00652626|4067977|B4|United States||Region of Enrollment|Data provided for initial treatment phase groups only.|participants|Number|5|5.0||||||
4244095|NCT00652626|4067978|B3|United States||Region of Enrollment|Data provided for initial treatment phase groups only.|participants|Number|6|6.0||||||
4244096|NCT00652626|4067979|B2|United States||Region of Enrollment|Data provided for initial treatment phase groups only.|participants|Number|5|5.0||||||
4244097|NCT00652626|4067980|B1|United States||Region of Enrollment|Data provided for initial treatment phase groups only.|participants|Number|5|5.0||||||
4244098|NCT00652626|4067973|B8|White||Race/Ethnicity, Customized|Data provided for initial treatment phase groups only.|participants|Number|19|19.0||||||
4244099|NCT00652626|4067974|B7|White||Race/Ethnicity, Customized|Data provided for initial treatment phase groups only.|participants|Number|0|0.0||||||
4244102|NCT00652626|4067977|B4|White||Race/Ethnicity, Customized|Data provided for initial treatment phase groups only.|participants|Number|3|3.0||||||
4244103|NCT00652626|4067978|B3|White||Race/Ethnicity, Customized|Data provided for initial treatment phase groups only.|participants|Number|5|5.0||||||
4244104|NCT00652626|4067979|B2|White||Race/Ethnicity, Customized|Data provided for initial treatment phase groups only.|participants|Number|3|3.0||||||
4244105|NCT00652626|4067980|B1|White||Race/Ethnicity, Customized|Data provided for initial treatment phase groups only.|participants|Number|4|4.0||||||
4244106|NCT00652626|4067973|B8|Black||Race/Ethnicity, Customized|Data provided for initial treatment phase groups only.|participants|Number|8|8.0||||||
4244107|NCT00652626|4067974|B7|Black||Race/Ethnicity, Customized|Data provided for initial treatment phase groups only.|participants|Number|0|0.0||||||
4244108|NCT00652626|4067975|B6|Black||Race/Ethnicity, Customized|Data provided for initial treatment phase groups only.|participants|Number|0|0.0||||||
4244109|NCT00652626|4067976|B5|Black||Race/Ethnicity, Customized|Data provided for initial treatment phase groups only.|participants|Number|2|2.0||||||
4244110|NCT00652626|4067977|B4|Black||Race/Ethnicity, Customized|Data provided for initial treatment phase groups only.|participants|Number|2|2.0||||||
4244111|NCT00652626|4067978|B3|Black||Race/Ethnicity, Customized|Data provided for initial treatment phase groups only.|participants|Number|1|1.0||||||
4244112|NCT00652626|4067979|B2|Black||Race/Ethnicity, Customized|Data provided for initial treatment phase groups only.|participants|Number|2|2.0||||||
4244113|NCT00652626|4067980|B1|Black||Race/Ethnicity, Customized|Data provided for initial treatment phase groups only.|participants|Number|1|1.0||||||
4244114|NCT00652626|4067973|B8|Male||Gender|Data provided for initial treatment phase groups only.|participants|Number|11|11.0||||||
4244115|NCT00652626|4067974|B7|Male||Gender|Data provided for initial treatment phase groups only.|participants|Number|0|0.0||||||
4244116|NCT00652626|4067975|B6|Male||Gender|Data provided for initial treatment phase groups only.|participants|Number|0|0.0||||||
4244117|NCT00652626|4067976|B5|Male||Gender|Data provided for initial treatment phase groups only.|participants|Number|3|3.0||||||
4244118|NCT00652626|4067977|B4|Male||Gender|Data provided for initial treatment phase groups only.|participants|Number|1|1.0||||||
4244119|NCT00652626|4067978|B3|Male||Gender|Data provided for initial treatment phase groups only.|participants|Number|3|3.0||||||
4244120|NCT00652626|4067979|B2|Male||Gender|Data provided for initial treatment phase groups only.|participants|Number|2|2.0||||||
4244121|NCT00652626|4067980|B1|Male||Gender|Data provided for initial treatment phase groups only.|participants|Number|2|2.0||||||
4244122|NCT00652626|4067973|B8|Female||Gender|Data provided for initial treatment phase groups only.|participants|Number|16|16.0||||||
4244123|NCT00652626|4067974|B7|Female||Gender|Data provided for initial treatment phase groups only.|participants|Number|0|0.0||||||
4244124|NCT00652626|4067975|B6|Female||Gender|Data provided for initial treatment phase groups only.|participants|Number|0|0.0||||||
4244125|NCT00652626|4067976|B5|Female||Gender|Data provided for initial treatment phase groups only.|participants|Number|3|3.0||||||
4244126|NCT00652626|4067977|B4|Female||Gender|Data provided for initial treatment phase groups only.|participants|Number|4|4.0||||||
4244127|NCT00652626|4067978|B3|Female||Gender|Data provided for initial treatment phase groups only.|participants|Number|3|3.0||||||
4244128|NCT00652626|4067979|B2|Female||Gender|Data provided for initial treatment phase groups only.|participants|Number|3|3.0||||||
4244129|NCT00652626|4067980|B1|Female||Gender|Data provided for initial treatment phase groups only.|participants|Number|3|3.0||||||
4244130|NCT00652626|4067973|B8|Extension Treatment Period||Age||years|Mean|62.4|62.4|Standard Deviation|10.15|10.15|||
4244131|NCT00652626|4067974|B7|Extension Treatment Period||Age||years|Mean|68.8|68.8|Standard Deviation|11.0|11.0|||
4244132|NCT00652626|4067975|B6|Extension Treatment Period||Age||years|Mean|60.6|60.6|Standard Deviation|9.52|9.52|||
4244133|NCT00652626|4067976|B5|Extension Treatment Period||Age||years|Mean|NA||Standard Deviation|NA||||Data provided for extension treatment period arms only
4244134|NCT00652626|4067977|B4|Extension Treatment Period||Age||years|Mean|NA||Standard Deviation|NA||||Data provided for extension treatment period arms only
4244135|NCT00652626|4067978|B3|Extension Treatment Period||Age||years|Mean|NA||Standard Deviation|NA||||Data provided for extension treatment period arms only
4244136|NCT00652626|4067979|B2|Extension Treatment Period||Age||years|Mean|NA||Standard Deviation|NA||||Data provided for extension treatment period arms only
4244137|NCT00652626|4067980|B1|Extension Treatment Period||Age||years|Mean|NA||Standard Deviation|NA||||Data provided for extension treatment period arms only
4244138|NCT00652626|4067973|B8|Initial Treatment Period||Age||years|Mean|63.5|63.5|Standard Deviation|12.32|12.32|||
4244139|NCT00652626|4067974|B7|Initial Treatment Period||Age||years|Mean|NA||Standard Deviation|NA||||Data provided for initial treatment period arms only
4244140|NCT00652626|4067975|B6|Initial Treatment Period||Age||years|Mean|NA||Standard Deviation|NA||||Data for provided initial treatment period arms only
4244141|NCT00652626|4067976|B5|Initial Treatment Period||Age||years|Mean|74.5|74.5|Standard Deviation|12.58|12.58|||
4244142|NCT00652626|4067977|B4|Initial Treatment Period||Age||years|Mean|57.0|57.0|Standard Deviation|12.02|12.02|||
4244143|NCT00652626|4067978|B3|Initial Treatment Period||Age||years|Mean|53.5|53.5|Standard Deviation|10.19|10.19|||
4244144|NCT00652626|4067979|B2|Initial Treatment Period||Age||years|Mean|64.6|64.6|Standard Deviation|9.63|9.63|||
4244145|NCT00652626|4067980|B1|Initial Treatment Period||Age||years|Mean|67.6|67.6|Standard Deviation|3.78|3.78|||
4244146|NCT00652366|4068050|B6||Male|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
4244147|NCT00652366|4068051|B5||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4244148|NCT00652366|4068052|B4||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4244149|NCT00652366|4068053|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4244150|NCT00652366|4068054|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4244151|NCT00652366|4068055|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4244152|NCT00652366|4068050|B6||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4244153|NCT00652366|4068051|B5||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4244154|NCT00652366|4068052|B4||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4244155|NCT00652366|4068053|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4244156|NCT00652366|4068054|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4244157|NCT00652366|4068055|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4244158|NCT00652366|4068050|B6|≥ 65 Years||Age, Customized||participants|Number|205|205.0||||||
4244159|NCT00652366|4068051|B5|≥ 65 Years||Age, Customized||participants|Number|15|15.0||||||
4244160|NCT00652366|4068052|B4|≥ 65 Years||Age, Customized||participants|Number|82|82.0||||||
4244161|NCT00652366|4068053|B3|≥ 65 Years||Age, Customized||participants|Number|36|36.0||||||
4244162|NCT00652366|4068054|B2|≥ 65 Years||Age, Customized||participants|Number|32|32.0||||||
4244163|NCT00652366|4068055|B1|≥ 65 Years||Age, Customized||participants|Number|40|40.0||||||
4244164|NCT00652366|4068050|B6|Less Than (<) 65 Years||Age, Customized||participants|Number|261|261.0||||||
4244165|NCT00652366|4068051|B5|Less Than (<) 65 Years||Age, Customized||participants|Number|21|21.0||||||
4244166|NCT00652366|4068052|B4|Less Than (<) 65 Years||Age, Customized||participants|Number|97|97.0||||||
4244167|NCT00652366|4068053|B3|Less Than (<) 65 Years||Age, Customized||participants|Number|34|34.0||||||
4244168|NCT00652366|4068054|B2|Less Than (<) 65 Years||Age, Customized||participants|Number|43|43.0||||||
4244169|NCT00652366|4068055|B1|Less Than (<) 65 Years||Age, Customized||participants|Number|66|66.0||||||
4244170|NCT00652340|4068092|B3|United States||Region of Enrollment||participants|Number|120|120.0||||||
4244171|NCT00652340|4068093|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
4244172|NCT00652340|4068094|B1|United States||Region of Enrollment||participants|Number|78|78.0||||||
4244173|NCT00652340|4068092|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4244174|NCT00652340|4068093|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4244175|NCT00652340|4068094|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4244176|NCT00652340|4068092|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4244177|NCT00652340|4068093|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4244178|NCT00652340|4068094|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4244179|NCT00652340|4068092|B3|||Age||years|Mean|62.9|62.9|Standard Deviation|10.94|10.94|||
4244180|NCT00652340|4068093|B2|||Age||years|Mean|64.6|64.6|Standard Deviation|11.16|11.16|||
4244181|NCT00652340|4068094|B1|||Age||years|Mean|62.1|62.1|Standard Deviation|10.78|10.78|||
4244182|NCT00652340|4068092|B3||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
4244183|NCT00652340|4068093|B2||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4244184|NCT00652340|4068094|B1||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4244185|NCT00652340|4068092|B3||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
4244186|NCT00652340|4068093|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4244187|NCT00652340|4068094|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4244188|NCT00652340|4068092|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244189|NCT00652340|4068093|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244190|NCT00652340|4068094|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244191|NCT00652327|4068103|B3|Taiwan, Province Of China||Region of Enrollment||Participants|Number|83|83.0||||||
4244192|NCT00652327|4068104|B2|Taiwan, Province Of China||Region of Enrollment||Participants|Number|41|41.0||||||
4244193|NCT00652327|4068105|B1|Taiwan, Province Of China||Region of Enrollment||Participants|Number|42|42.0||||||
4244194|NCT00652327|4068103|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4244195|NCT00652327|4068104|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4244196|NCT00652327|4068105|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4244197|NCT00652327|4068103|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4244198|NCT00652327|4068104|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4244199|NCT00652327|4068105|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4244200|NCT00652327|4068103|B3|>=83 years||Age, Customized||Participants|Number|0|0.0||||||
4244201|NCT00652327|4068104|B2|>=83 years||Age, Customized||Participants|Number|0|0.0||||||
4244202|NCT00652327|4068105|B1|>=83 years||Age, Customized||Participants|Number|0|0.0||||||
4244203|NCT00652327|4068103|B3|Between 18 and 83 years||Age, Customized||Participants|Number|83|83.0||||||
4244204|NCT00652327|4068104|B2|Between 18 and 83 years||Age, Customized||Participants|Number|41|41.0||||||
4244205|NCT00652327|4068105|B1|Between 18 and 83 years||Age, Customized||Participants|Number|42|42.0||||||
4244206|NCT00652327|4068103|B3|<=18 years||Age, Customized||Participants|Number|0|0.0||||||
4244207|NCT00652327|4068104|B2|<=18 years||Age, Customized||Participants|Number|0|0.0||||||
4244208|NCT00652327|4068105|B1|<=18 years||Age, Customized||Participants|Number|0|0.0||||||
4244209|NCT00652314|4068112|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4244210|NCT00652314|4068113|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4244211|NCT00652314|4068114|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4244212|NCT00652314|4068112|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4244213|NCT00652314|4068113|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4244214|NCT00652314|4068114|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4244215|NCT00652314|4068112|B3|>= to 18 Years||Age, Customized||participants|Number|97|97.0||||||
4244216|NCT00652314|4068113|B2|>= to 18 Years||Age, Customized||participants|Number|35|35.0||||||
4244217|NCT00652314|4068114|B1|>= to 18 Years||Age, Customized||participants|Number|62|62.0||||||
4244218|NCT00652145|4068129|B3|No||Prior anti-tumor necrosis factor agent||participants|Number|50|50.0||||||
4244219|NCT00652145|4068130|B2|No||Prior anti-tumor necrosis factor agent||participants|Number|26|26.0||||||
4244220|NCT00652145|4068131|B1|No||Prior anti-tumor necrosis factor agent||participants|Number|24|24.0||||||
4244221|NCT00652145|4068129|B3|Yes||Prior anti-tumor necrosis factor agent||participants|Number|2|2.0||||||
4244222|NCT00652145|4068130|B2|Yes||Prior anti-tumor necrosis factor agent||participants|Number|0|0.0||||||
4244223|NCT00652145|4068131|B1|Yes||Prior anti-tumor necrosis factor agent||participants|Number|2|2.0||||||
4244224|NCT00652145|4068129|B3|No||Prior cyclosporine||participants|Number|51|51.0||||||
4244225|NCT00652145|4068130|B2|No||Prior cyclosporine||participants|Number|25|25.0||||||
4244226|NCT00652145|4068131|B1|No||Prior cyclosporine||participants|Number|26|26.0||||||
4244227|NCT00652145|4068129|B3|Yes||Prior cyclosporine||participants|Number|1|1.0||||||
4244228|NCT00652145|4068130|B2|Yes||Prior cyclosporine||participants|Number|1|1.0||||||
4244229|NCT00652145|4068131|B1|Yes||Prior cyclosporine||participants|Number|0|0.0||||||
4244230|NCT00652145|4068129|B3|No||Prior rectal corticosteroids||participants|Number|39|39.0||||||
4244231|NCT00652145|4068130|B2|No||Prior rectal corticosteroids||participants|Number|19|19.0||||||
4244232|NCT00652145|4068131|B1|No||Prior rectal corticosteroids||participants|Number|20|20.0||||||
4244233|NCT00652145|4068129|B3|Yes||Prior rectal corticosteroids||participants|Number|13|13.0||||||
4244234|NCT00652145|4068130|B2|Yes||Prior rectal corticosteroids||participants|Number|7|7.0||||||
4244235|NCT00652145|4068131|B1|Yes||Prior rectal corticosteroids||participants|Number|6|6.0||||||
4244236|NCT00652145|4068129|B3|No||Prior corticosteroids||participants|Number|24|24.0||||||
4244237|NCT00652145|4068130|B2|No||Prior corticosteroids||participants|Number|9|9.0||||||
4244238|NCT00652145|4068131|B1|No||Prior corticosteroids||participants|Number|15|15.0||||||
4244239|NCT00652145|4068129|B3|Yes||Prior corticosteroids||participants|Number|28|28.0||||||
4244240|NCT00652145|4068130|B2|Yes||Prior corticosteroids||participants|Number|17|17.0||||||
4244241|NCT00652145|4068131|B1|Yes||Prior corticosteroids||participants|Number|11|11.0||||||
4244242|NCT00652145|4068129|B3|No||Current thiopurine||participants|Number|42|42.0||||||
4244243|NCT00652145|4068130|B2|No||Current thiopurine||participants|Number|22|22.0||||||
4244244|NCT00652145|4068131|B1|No||Current thiopurine||participants|Number|20|20.0||||||
4244245|NCT00652145|4068129|B3|Yes||Current thiopurine||participants|Number|10|10.0||||||
4244246|NCT00652145|4068130|B2|Yes||Current thiopurine||participants|Number|4|4.0||||||
4244247|NCT00652145|4068131|B1|Yes||Current thiopurine||participants|Number|6|6.0||||||
4244248|NCT00652145|4068129|B3|No||Current rectal mesalamine||participants|Number|48|48.0||||||
4244249|NCT00652145|4068130|B2|No||Current rectal mesalamine||participants|Number|24|24.0||||||
4244250|NCT00652145|4068131|B1|No||Current rectal mesalamine||participants|Number|24|24.0||||||
4244251|NCT00652145|4068129|B3|Yes||Current rectal mesalamine||participants|Number|4|4.0||||||
4244252|NCT00652145|4068130|B2|Yes||Current rectal mesalamine||participants|Number|2|2.0||||||
4244253|NCT00652145|4068131|B1|Yes||Current rectal mesalamine||participants|Number|2|2.0||||||
4244254|NCT00652145|4068129|B3|None||Currrent oral mesalamine||participants|Number|9|9.0||||||
4244255|NCT00652145|4068130|B2|None||Currrent oral mesalamine||participants|Number|5|5.0||||||
4244256|NCT00652145|4068131|B1|None||Currrent oral mesalamine||participants|Number|4|4.0||||||
4244257|NCT00652145|4068129|B3|MMX formulation||Currrent oral mesalamine||participants|Number|26|26.0||||||
4244258|NCT00652145|4068130|B2|MMX formulation||Currrent oral mesalamine||participants|Number|12|12.0||||||
4244259|NCT00652145|4068131|B1|MMX formulation||Currrent oral mesalamine||participants|Number|14|14.0||||||
4244260|NCT00652145|4068129|B3|Non-MMX formulation||Currrent oral mesalamine||participants|Number|17|17.0||||||
4244261|NCT00652145|4068130|B2|Non-MMX formulation||Currrent oral mesalamine||participants|Number|9|9.0||||||
4244262|NCT00652145|4068131|B1|Non-MMX formulation||Currrent oral mesalamine||participants|Number|8|8.0||||||
4244263|NCT00652145|4068129|B3|||Median fecal calprotectin immediately before randomization||µg/g|Median|195|195.0|Inter-Quartile Range|||69.0|461.0|
4244264|NCT00652145|4068130|B2|||Median fecal calprotectin immediately before randomization||µg/g|Median|214|214.0|Inter-Quartile Range|||80.0|439.0|
4244265|NCT00652145|4068131|B1|||Median fecal calprotectin immediately before randomization||µg/g|Median|174|174.0|Inter-Quartile Range|||67.0|439.0|
4244266|NCT00652145|4068129|B3|||Median of duration of remission at baseline||years|Median|0.4|0.4|Inter-Quartile Range|||0.2|1.0|
4244267|NCT00652145|4068130|B2|||Median of duration of remission at baseline||years|Median|0.5|0.5|Inter-Quartile Range|||0.2|1.1|
4244268|NCT00652145|4068131|B1|||Median of duration of remission at baseline||years|Median|0.3|0.3|Inter-Quartile Range|||0.2|1.0|
4244269|NCT00652145|4068129|B3|||Median duration of UC||years|Median|8.9|8.9|Inter-Quartile Range|||2.8|15.9|
4244270|NCT00652145|4068130|B2|||Median duration of UC||years|Median|6.5|6.5|Inter-Quartile Range|||2.2|11.9|
4244271|NCT00652145|4068131|B1|||Median duration of UC||years|Median|11.9|11.9|Inter-Quartile Range|||3.7|19.8|
4244272|NCT00652145|4068129|B3|Other||Extent of disease||participants|Number|1|1.0||||||
4244273|NCT00652145|4068130|B2|Other||Extent of disease||participants|Number|1|1.0||||||
4244274|NCT00652145|4068131|B1|Other||Extent of disease||participants|Number|0|0.0||||||
4244275|NCT00652145|4068129|B3|Extensive||Extent of disease||participants|Number|20|20.0||||||
4244276|NCT00652145|4068130|B2|Extensive||Extent of disease||participants|Number|11|11.0||||||
4244277|NCT00652145|4068131|B1|Extensive||Extent of disease||participants|Number|9|9.0||||||
4244278|NCT00652145|4068129|B3|Left-sided||Extent of disease||participants|Number|21|21.0||||||
4244279|NCT00652145|4068130|B2|Left-sided||Extent of disease||participants|Number|12|12.0||||||
4244280|NCT00652145|4068131|B1|Left-sided||Extent of disease||participants|Number|9|9.0||||||
4244281|NCT00652145|4068129|B3|Proctitis||Extent of disease||participants|Number|10|10.0||||||
4244282|NCT00652145|4068130|B2|Proctitis||Extent of disease||participants|Number|2|2.0||||||
4244283|NCT00652145|4068131|B1|Proctitis||Extent of disease||participants|Number|8|8.0||||||
4244284|NCT00652145|4068129|B3|Never||Tobacco use||participants|Number|36|36.0||||||
4244285|NCT00652145|4068130|B2|Never||Tobacco use||participants|Number|16|16.0||||||
4244286|NCT00652145|4068131|B1|Never||Tobacco use||participants|Number|20|20.0||||||
4244287|NCT00652145|4068129|B3|Prior||Tobacco use||participants|Number|14|14.0||||||
4244288|NCT00652145|4068130|B2|Prior||Tobacco use||participants|Number|8|8.0||||||
4244289|NCT00652145|4068131|B1|Prior||Tobacco use||participants|Number|6|6.0||||||
4244290|NCT00652145|4068129|B3|Current||Tobacco use||participants|Number|2|2.0||||||
4244291|NCT00652145|4068130|B2|Current||Tobacco use||participants|Number|2|2.0||||||
4244292|NCT00652145|4068131|B1|Current||Tobacco use||participants|Number|0|0.0||||||
4244293|NCT00652145|4068129|B3|United States||Region of Enrollment||participants|Number|52|52.0||||||
4244294|NCT00652145|4068130|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4244295|NCT00652145|4068131|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4244296|NCT00652145|4068129|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4244297|NCT00652145|4068130|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4244298|NCT00652145|4068131|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4244299|NCT00652145|4068129|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4244300|NCT00652145|4068130|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4244301|NCT00652145|4068131|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4244302|NCT00652145|4068129|B3||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4244303|NCT00652145|4068130|B2||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4244304|NCT00652145|4068131|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4244305|NCT00652145|4068129|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4244306|NCT00652145|4068130|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4244307|NCT00652145|4068131|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4244308|NCT00652145|4068129|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4244309|NCT00652145|4068130|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4244310|NCT00652145|4068131|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4244311|NCT00652145|4068129|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4244312|NCT00652145|4068130|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4244313|NCT00652145|4068131|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4244314|NCT00652145|4068129|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4244315|NCT00652145|4068130|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4244316|NCT00652145|4068131|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4244317|NCT00652145|4068129|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4244318|NCT00652145|4068130|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4244319|NCT00652145|4068131|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4244320|NCT00652145|4068129|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4244321|NCT00652145|4068130|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4244322|NCT00652145|4068131|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4244323|NCT00652145|4068129|B3|||Age||years|Median|46.5|46.5|Inter-Quartile Range|||32.0|58.0|
4244324|NCT00652145|4068130|B2|||Age||years|Median|48.8|48.8|Inter-Quartile Range|||33.5|60.4|
4244325|NCT00652145|4068131|B1|||Age||years|Median|43.8|43.8|Inter-Quartile Range|||30.5|57.1|
4244326|NCT00652093|4068142|B7|United States||Region of Enrollment||participants|Number|24|24.0||||||
4244327|NCT00652093|4068143|B6|United States||Region of Enrollment||participants|Number|4|4.0||||||
4244328|NCT00652093|4068144|B5|United States||Region of Enrollment||participants|Number|4|4.0||||||
4244329|NCT00652093|4068145|B4|United States||Region of Enrollment||participants|Number|4|4.0||||||
4244330|NCT00652093|4068146|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4244331|NCT00652093|4068147|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4244332|NCT00652093|4068148|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4244333|NCT00652093|4068142|B7||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4244334|NCT00652093|4068143|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4244335|NCT00652093|4068144|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4244336|NCT00652093|4068145|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4244337|NCT00652093|4068146|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4244338|NCT00652093|4068147|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4244339|NCT00652093|4068148|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4244340|NCT00652093|4068142|B7||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4244341|NCT00652093|4068143|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4244342|NCT00652093|4068144|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4244343|NCT00652093|4068145|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4244344|NCT00652093|4068146|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4244345|NCT00652093|4068147|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4244346|NCT00652093|4068148|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4244347|NCT00652093|4068142|B7|||Age||years|Mean|71.3|71.3|Standard Deviation|9.0|9.0|||
4244348|NCT00652093|4068143|B6|||Age||years|Mean|63.3|63.3|Standard Deviation|6.8|6.8|||
4244349|NCT00652093|4068144|B5|||Age||years|Mean|76.0|76.0|Standard Deviation|15.2|15.2|||
4244350|NCT00652093|4068145|B4|||Age||years|Mean|70.0|70.0|Standard Deviation|4.8|4.8|||
4244351|NCT00652093|4068146|B3|||Age||years|Mean|76.0|76.0|Standard Deviation|12|12.0|||
4244352|NCT00652093|4068147|B2|||Age||years|Mean|73.0|73.0|Standard Deviation|3.2|3.2|||
4244353|NCT00652093|4068148|B1|||Age||years|Mean|69.5|69.5|Standard Deviation|4|4.0|||
4244354|NCT00652093|4068142|B7||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4244355|NCT00652093|4068143|B6||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4244356|NCT00652093|4068144|B5||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4244357|NCT00652093|4068145|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4244358|NCT00652093|4068146|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4244359|NCT00652093|4068147|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4244360|NCT00652093|4068148|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4244361|NCT00652093|4068142|B7||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4244362|NCT00652093|4068143|B6||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4244363|NCT00652093|4068144|B5||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4244364|NCT00652093|4068145|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4244365|NCT00652093|4068146|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4244366|NCT00652093|4068147|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4244367|NCT00652093|4068148|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4244368|NCT00652093|4068142|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244369|NCT00652093|4068143|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244370|NCT00652093|4068144|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244371|NCT00652093|4068145|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244372|NCT00652093|4068146|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244373|NCT00652093|4068147|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244374|NCT00652093|4068148|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244375|NCT00652028|4068233|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4244376|NCT00652028|4068234|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4244377|NCT00652028|4068235|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4244378|NCT00652028|4068236|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4244379|NCT00652028|4068237|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4244380|NCT00652028|4068233|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4244381|NCT00652028|4068234|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4244382|NCT00652028|4068235|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4244383|NCT00652028|4068236|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4244384|NCT00652028|4068237|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4244385|NCT00652028|4068233|B5||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4244386|NCT00652028|4068234|B4||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4244387|NCT00652028|4068235|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4244388|NCT00652028|4068236|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4244389|NCT00652028|4068237|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4244390|NCT00652028|4068233|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4244391|NCT00652028|4068234|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4244392|NCT00652028|4068235|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4244393|NCT00652028|4068236|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4244394|NCT00652028|4068237|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4244395|NCT00652028|4068233|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4244396|NCT00652028|4068234|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4244397|NCT00652028|4068235|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4244398|NCT00652028|4068236|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4244399|NCT00652028|4068237|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4244400|NCT00652028|4068233|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4244401|NCT00652028|4068234|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4244402|NCT00652028|4068235|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4244403|NCT00652028|4068236|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4244404|NCT00652028|4068237|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4244405|NCT00652028|4068233|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4244406|NCT00652028|4068234|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4244407|NCT00652028|4068235|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4244408|NCT00652028|4068236|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4244409|NCT00652028|4068237|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4244410|NCT00652028|4068233|B5||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4244411|NCT00652028|4068234|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4244412|NCT00652028|4068235|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4244413|NCT00652028|4068236|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4244414|NCT00652028|4068237|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4244415|NCT00652028|4068233|B5||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4244416|NCT00652028|4068234|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4244417|NCT00652028|4068235|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4244418|NCT00652028|4068236|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4244419|NCT00652028|4068237|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4244420|NCT00652028|4068233|B5|≥6 through <17 years||Age, Customized||participants|Number|33|33.0||||||
4244421|NCT00652028|4068234|B4|≥6 through <17 years||Age, Customized||participants|Number|8|8.0||||||
4244422|NCT00652028|4068235|B3|≥6 through <17 years||Age, Customized||participants|Number|9|9.0||||||
4244423|NCT00652028|4068236|B2|≥6 through <17 years||Age, Customized||participants|Number|8|8.0||||||
4244424|NCT00652028|4068237|B1|≥6 through <17 years||Age, Customized||participants|Number|8|8.0||||||
4244425|NCT00652028|4068233|B5|≥2 through <6 years||Age, Customized||participants|Number|26|26.0||||||
4244426|NCT00652028|4068234|B4|≥2 through <6 years||Age, Customized||participants|Number|6|6.0||||||
4244427|NCT00652028|4068235|B3|≥2 through <6 years||Age, Customized||participants|Number|6|6.0||||||
4244428|NCT00652028|4068236|B2|≥2 through <6 years||Age, Customized||participants|Number|6|6.0||||||
4244429|NCT00652028|4068237|B1|≥2 through <6 years||Age, Customized||participants|Number|8|8.0||||||
4244430|NCT00652028|4068233|B5|||Age||years|Mean|7.395|7.395|Standard Deviation|4.1571|4.1571|||
4244431|NCT00652028|4068234|B4|||Age||years|Mean|7.462|7.462|Standard Deviation|4.2259|4.2259|||
4244432|NCT00652028|4068235|B3|||Age||years|Mean|8.379|8.379|Standard Deviation|4.4962|4.4962|||
4244433|NCT00652028|4068236|B2|||Age||years|Mean|7.457|7.457|Standard Deviation|4.5990|4.599|||
4244434|NCT00652028|4068237|B1|||Age||years|Mean|6.358|6.358|Standard Deviation|3.4673|3.4673|||
4244435|NCT00651924|4068282|B3|||Pain Severity|"10 point likert scale: 0 No Pain at All - 10 Worst Pain Imaginable~Missing data for 11 patients (Phase 1- 9; Phase 2 - 2)"|units on a scale|Mean|6.21|6.21|Standard Deviation|1.50|1.5|||
4244436|NCT00651924|4068283|B2|||Pain Severity|"10 point likert scale: 0 No Pain at All - 10 Worst Pain Imaginable~Missing data for 11 patients (Phase 1- 9; Phase 2 - 2)"|units on a scale|Mean|5.88|5.88|Standard Deviation|0.63|0.63|||
4244437|NCT00651924|4068284|B1|||Pain Severity|"10 point likert scale: 0 No Pain at All - 10 Worst Pain Imaginable~Missing data for 11 patients (Phase 1- 9; Phase 2 - 2)"|units on a scale|Mean|6.33|6.33|Standard Deviation|1.77|1.77|||
4244438|NCT00651924|4068282|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4244439|NCT00651924|4068283|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4244440|NCT00651924|4068284|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4244441|NCT00651924|4068282|B3|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4244442|NCT00651924|4068283|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4244443|NCT00651924|4068284|B1|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4244444|NCT00651924|4068282|B3|White||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4244445|NCT00651924|4068283|B2|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4244446|NCT00651924|4068284|B1|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4244447|NCT00651924|4068282|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4244448|NCT00651924|4068283|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4244449|NCT00651924|4068284|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4244450|NCT00651924|4068282|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4244451|NCT00651924|4068283|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4244452|NCT00651924|4068284|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4244453|NCT00651924|4068282|B3|||Age||years|Mean|55|55.0|Standard Deviation|11|11.0|||
4244454|NCT00651924|4068283|B2|||Age||years|Mean|56|56.0|Standard Deviation|17|17.0|||
4244455|NCT00651924|4068284|B1|||Age||years|Mean|55|55.0|Standard Deviation|8.25|8.25|||
4244456|NCT00651820|4068291|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4244457|NCT00651820|4068291|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4244458|NCT00651820|4068291|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4244459|NCT00651820|4068291|B1|||Age||years|Mean|37.6|37.6|Standard Deviation|8.2|8.2|||
4244460|NCT00651820|4068291|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4244461|NCT00651820|4068291|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4244462|NCT00651820|4068291|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244463|NCT00651794|4068298|B4|United States||Region of Enrollment||participants|Number|93|93.0||||||
4244464|NCT00651794|4068299|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4244465|NCT00651794|4068300|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
4244466|NCT00651794|4068301|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4244467|NCT00651794|4068298|B4|Unknown||Sex/Gender, Customized||participants|Number|98|98.0||||||
4244468|NCT00651794|4068299|B3|Unknown||Sex/Gender, Customized||participants|Number|31|31.0||||||
4244469|NCT00651794|4068300|B2|Unknown||Sex/Gender, Customized||participants|Number|31|31.0||||||
4244470|NCT00651794|4068301|B1|Unknown||Sex/Gender, Customized||participants|Number|36|36.0||||||
4244471|NCT00651794|4068298|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4244472|NCT00651794|4068299|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4244473|NCT00651794|4068300|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4244474|NCT00651794|4068301|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4244475|NCT00651794|4068298|B4||Between 18 and 65 years|Age||Participants|Count of Participants|98|98.0||||||
4244476|NCT00651794|4068299|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4244477|NCT00651794|4068300|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4244478|NCT00651794|4068301|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4244479|NCT00651794|4068298|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244480|NCT00651794|4068299|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244481|NCT00651794|4068300|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244482|NCT00651794|4068301|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244483|NCT00651755|4068323|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4244484|NCT00651755|4068323|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4244485|NCT00651755|4068323|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4244486|NCT00651755|4068323|B1|||Age||years|Median|58|58.0|Full Range|||22.0|87.0|
4244487|NCT00651625|4068340|B3|United States||Region of Enrollment||participants|Number|437|437.0||||||
4244488|NCT00651625|4068341|B2|United States||Region of Enrollment||participants|Number|218|218.0||||||
4244489|NCT00651625|4068342|B1|United States||Region of Enrollment||participants|Number|219|219.0||||||
4244490|NCT00651625|4068340|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4244491|NCT00651625|4068341|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4244492|NCT00651625|4068342|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4244493|NCT00651625|4068340|B3||Female|Sex: Female, Male||Participants|Count of Participants|352|352.0||||||
4244494|NCT00651625|4068341|B2||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4244495|NCT00651625|4068342|B1||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4244496|NCT00651625|4068340|B3|||Age||years|Mean|52.0|52.0|Standard Deviation|12.3|12.3|||
4244497|NCT00651625|4068341|B2|||Age||years|Mean|51.7|51.7|Standard Deviation|14.8|14.8|||
4244498|NCT00651625|4068342|B1|||Age||years|Mean|52.2|52.2|Standard Deviation|9.7|9.7|||
4244499|NCT00651625|4068340|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4244500|NCT00651625|4068341|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4244501|NCT00651625|4068342|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4244502|NCT00651625|4068340|B3||Between 18 and 65 years|Age||Participants|Count of Participants|437|437.0||||||
4244503|NCT00651625|4068341|B2||Between 18 and 65 years|Age||Participants|Count of Participants|218|218.0||||||
4244504|NCT00651625|4068342|B1||Between 18 and 65 years|Age||Participants|Count of Participants|219|219.0||||||
4244505|NCT00651625|4068340|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244506|NCT00651625|4068341|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244507|NCT00651625|4068342|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244508|NCT00651482|4068355|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4244509|NCT00651482|4068355|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4244510|NCT00651482|4068355|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4244511|NCT00651482|4068355|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4244512|NCT00651482|4068355|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4244513|NCT00651482|4068355|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4244514|NCT00651482|4068355|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4244515|NCT00651482|4068355|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4244516|NCT00651482|4068355|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4244517|NCT00651482|4068355|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4244518|NCT00651482|4068355|B1|||Age||years|Median|55|55.0|Full Range|||41.0|77.0|
4244519|NCT00651313|4068367|B3|United States||Region of Enrollment||participants|Number|84|84.0||||||
4244520|NCT00651313|4068368|B2|United States||Region of Enrollment||participants|Number|43|43.0||||||
4244521|NCT00651313|4068369|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4244522|NCT00651313|4068367|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4244523|NCT00651313|4068368|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4244524|NCT00651313|4068369|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4244525|NCT00651313|4068367|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4244526|NCT00651313|4068368|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4244527|NCT00651313|4068369|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4244528|NCT00651313|4068367|B3|||Age||years|Mean|27.1|27.1|Standard Deviation|6.92|6.92|||
4244529|NCT00651313|4068368|B2|||Age||years|Mean|27.7|27.7|Standard Deviation|6.69|6.69|||
4244530|NCT00651313|4068369|B1|||Age||years|Mean|26.5|26.5|Standard Deviation|7.20|7.2|||
4244531|NCT00651313|4068367|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4244532|NCT00651313|4068368|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4244533|NCT00651313|4068369|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4244534|NCT00651313|4068367|B3||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
4244535|NCT00651313|4068368|B2||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4244536|NCT00651313|4068369|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4244537|NCT00651313|4068367|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244538|NCT00651313|4068368|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244539|NCT00651313|4068369|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244540|NCT00651261|4068376|B3|ITD Allelic ratio >=0.7||FLT3 mutational subtype|Mutations in the gene encoding the trans-membrane tyrosine kinase FLT3. FLT3 internal tandem duplications (ITD) mutation which results in a duplication between 3 and greater than 100 amino acids most commonly located in the juxtamembrane region. Tyrosine kinase domain (TKD) point mutations are the remainder of those with FLT3 mutations. FLT3 testing was done centrally.|participants|Number|214|214.0||||||
4244541|NCT00651261|4068377|B2|ITD Allelic ratio >=0.7||FLT3 mutational subtype|Mutations in the gene encoding the trans-membrane tyrosine kinase FLT3. FLT3 internal tandem duplications (ITD) mutation which results in a duplication between 3 and greater than 100 amino acids most commonly located in the juxtamembrane region. Tyrosine kinase domain (TKD) point mutations are the remainder of those with FLT3 mutations. FLT3 testing was done centrally.|participants|Number|106|106.0||||||
4244542|NCT00651261|4068378|B1|ITD Allelic ratio >=0.7||FLT3 mutational subtype|Mutations in the gene encoding the trans-membrane tyrosine kinase FLT3. FLT3 internal tandem duplications (ITD) mutation which results in a duplication between 3 and greater than 100 amino acids most commonly located in the juxtamembrane region. Tyrosine kinase domain (TKD) point mutations are the remainder of those with FLT3 mutations. FLT3 testing was done centrally.|participants|Number|108|108.0||||||
4244543|NCT00651261|4068376|B3|ITD Allelic ratio <0.7||FLT3 mutational subtype|Mutations in the gene encoding the trans-membrane tyrosine kinase FLT3. FLT3 internal tandem duplications (ITD) mutation which results in a duplication between 3 and greater than 100 amino acids most commonly located in the juxtamembrane region. Tyrosine kinase domain (TKD) point mutations are the remainder of those with FLT3 mutations. FLT3 testing was done centrally.|participants|Number|341|341.0||||||
4244544|NCT00651261|4068377|B2|ITD Allelic ratio <0.7||FLT3 mutational subtype|Mutations in the gene encoding the trans-membrane tyrosine kinase FLT3. FLT3 internal tandem duplications (ITD) mutation which results in a duplication between 3 and greater than 100 amino acids most commonly located in the juxtamembrane region. Tyrosine kinase domain (TKD) point mutations are the remainder of those with FLT3 mutations. FLT3 testing was done centrally.|participants|Number|170|170.0||||||
4244545|NCT00651261|4068378|B1|ITD Allelic ratio <0.7||FLT3 mutational subtype|Mutations in the gene encoding the trans-membrane tyrosine kinase FLT3. FLT3 internal tandem duplications (ITD) mutation which results in a duplication between 3 and greater than 100 amino acids most commonly located in the juxtamembrane region. Tyrosine kinase domain (TKD) point mutations are the remainder of those with FLT3 mutations. FLT3 testing was done centrally.|participants|Number|171|171.0||||||
4244546|NCT00651261|4068376|B3|TKD (No ITD)||FLT3 mutational subtype|Mutations in the gene encoding the trans-membrane tyrosine kinase FLT3. FLT3 internal tandem duplications (ITD) mutation which results in a duplication between 3 and greater than 100 amino acids most commonly located in the juxtamembrane region. Tyrosine kinase domain (TKD) point mutations are the remainder of those with FLT3 mutations. FLT3 testing was done centrally.|participants|Number|162|162.0||||||
4244547|NCT00651261|4068377|B2|TKD (No ITD)||FLT3 mutational subtype|Mutations in the gene encoding the trans-membrane tyrosine kinase FLT3. FLT3 internal tandem duplications (ITD) mutation which results in a duplication between 3 and greater than 100 amino acids most commonly located in the juxtamembrane region. Tyrosine kinase domain (TKD) point mutations are the remainder of those with FLT3 mutations. FLT3 testing was done centrally.|participants|Number|81|81.0||||||
4244548|NCT00651261|4068378|B1|TKD (No ITD)||FLT3 mutational subtype|Mutations in the gene encoding the trans-membrane tyrosine kinase FLT3. FLT3 internal tandem duplications (ITD) mutation which results in a duplication between 3 and greater than 100 amino acids most commonly located in the juxtamembrane region. Tyrosine kinase domain (TKD) point mutations are the remainder of those with FLT3 mutations. FLT3 testing was done centrally.|participants|Number|81|81.0||||||
4244549|NCT00651261|4068376|B3|Hungary||Region of Enrollment||participants|Number|2|2.0||||||
4244550|NCT00651261|4068377|B2|Hungary||Region of Enrollment||participants|Number|2|2.0||||||
4244551|NCT00651261|4068378|B1|Hungary||Region of Enrollment||participants|Number|0|0.0||||||
4244552|NCT00651261|4068376|B3|Slovakia||Region of Enrollment||participants|Number|4|4.0||||||
4244553|NCT00651261|4068377|B2|Slovakia||Region of Enrollment||participants|Number|2|2.0||||||
4244554|NCT00651261|4068378|B1|Slovakia||Region of Enrollment||participants|Number|2|2.0||||||
4244555|NCT00651261|4068376|B3|Czech Republic||Region of Enrollment||participants|Number|11|11.0||||||
4244556|NCT00651261|4068377|B2|Czech Republic||Region of Enrollment||participants|Number|6|6.0||||||
4244557|NCT00651261|4068378|B1|Czech Republic||Region of Enrollment||participants|Number|5|5.0||||||
4244558|NCT00651261|4068376|B3|Italy||Region of Enrollment||participants|Number|105|105.0||||||
4244559|NCT00651261|4068377|B2|Italy||Region of Enrollment||participants|Number|44|44.0||||||
4244560|NCT00651261|4068378|B1|Italy||Region of Enrollment||participants|Number|61|61.0||||||
4244561|NCT00651261|4068376|B3|Austria||Region of Enrollment||participants|Number|12|12.0||||||
4244562|NCT00651261|4068377|B2|Austria||Region of Enrollment||participants|Number|5|5.0||||||
4244563|NCT00651261|4068378|B1|Austria||Region of Enrollment||participants|Number|7|7.0||||||
4244564|NCT00651261|4068376|B3|Spain||Region of Enrollment||participants|Number|22|22.0||||||
4244565|NCT00651261|4068377|B2|Spain||Region of Enrollment||participants|Number|15|15.0||||||
4244566|NCT00651261|4068378|B1|Spain||Region of Enrollment||participants|Number|7|7.0||||||
4244567|NCT00651261|4068376|B3|Australia||Region of Enrollment||participants|Number|2|2.0||||||
4244568|NCT00651261|4068377|B2|Australia||Region of Enrollment||participants|Number|2|2.0||||||
4244569|NCT00651261|4068378|B1|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4244570|NCT00651261|4068376|B3|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
4244571|NCT00651261|4068377|B2|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
4244572|NCT00651261|4068378|B1|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
4244573|NCT00651261|4068376|B3|France||Region of Enrollment||participants|Number|5|5.0||||||
4244574|NCT00651261|4068377|B2|France||Region of Enrollment||participants|Number|2|2.0||||||
4244575|NCT00651261|4068378|B1|France||Region of Enrollment||participants|Number|3|3.0||||||
4244576|NCT00651261|4068376|B3|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
4244577|NCT00651261|4068377|B2|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
4244578|NCT00651261|4068378|B1|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
4244579|NCT00651261|4068376|B3|Germany||Region of Enrollment||participants|Number|305|305.0||||||
4244580|NCT00651261|4068377|B2|Germany||Region of Enrollment||participants|Number|157|157.0||||||
4244581|NCT00651261|4068378|B1|Germany||Region of Enrollment||participants|Number|148|148.0||||||
4244582|NCT00651261|4068376|B3|United States||Region of Enrollment||participants|Number|223|223.0||||||
4244583|NCT00651261|4068377|B2|United States||Region of Enrollment||participants|Number|106|106.0||||||
4244584|NCT00651261|4068378|B1|United States||Region of Enrollment||participants|Number|117|117.0||||||
4244585|NCT00651261|4068376|B3|Canada||Region of Enrollment||participants|Number|13|13.0||||||
4244586|NCT00651261|4068377|B2|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4244587|NCT00651261|4068378|B1|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4244588|NCT00651261|4068376|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|408|408.0||||||
4244589|NCT00651261|4068377|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|213|213.0||||||
4244590|NCT00651261|4068378|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|195|195.0||||||
4244591|NCT00651261|4068376|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4244592|NCT00651261|4068377|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4244593|NCT00651261|4068378|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4244594|NCT00651261|4068376|B3||White|Race (NIH/OMB)||Participants|Count of Participants|275|275.0||||||
4244595|NCT00651261|4068377|B2||White|Race (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
4244596|NCT00651261|4068378|B1||White|Race (NIH/OMB)||Participants|Count of Participants|147|147.0||||||
4244597|NCT00651261|4068376|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4244598|NCT00651261|4068377|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4244599|NCT00651261|4068378|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4244600|NCT00651261|4068376|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4244601|NCT00651261|4068377|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4244602|NCT00651261|4068378|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4244603|NCT00651261|4068376|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4244604|NCT00651261|4068377|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4244605|NCT00651261|4068378|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4244606|NCT00651261|4068376|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4244607|NCT00651261|4068377|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4244608|NCT00651261|4068378|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4244609|NCT00651261|4068376|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|491|491.0||||||
4244610|NCT00651261|4068377|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|243|243.0||||||
4244611|NCT00651261|4068378|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|248|248.0||||||
4244612|NCT00651261|4068376|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|210|210.0||||||
4244613|NCT00651261|4068377|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
4244614|NCT00651261|4068378|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
4244615|NCT00651261|4068376|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4244616|NCT00651261|4068377|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4244617|NCT00651261|4068378|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4244618|NCT00651261|4068376|B3||Male|Sex: Female, Male||Participants|Count of Participants|319|319.0||||||
4244619|NCT00651261|4068377|B2||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4244620|NCT00651261|4068378|B1||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4244621|NCT00651261|4068376|B3||Female|Sex: Female, Male||Participants|Count of Participants|398|398.0||||||
4244622|NCT00651261|4068377|B2||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4244623|NCT00651261|4068378|B1||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4244624|NCT00651261|4068376|B3|||Age||years|Median|47.9|47.9|Full Range|||18.0|60.9|
4244625|NCT00651261|4068377|B2|||Age||years|Median|48.6|48.6|Full Range|||18.0|60.9|
4244626|NCT00651261|4068378|B1|||Age||years|Median|47.1|47.1|Full Range|||19.0|59.8|
4244627|NCT00651183|4068393|B3|missing||Sex/Gender, Customized|"Baseline data are presented for the safety analysis set (including data of all 286 patients - 189 early PD patients / 97 advanced PD patients - reported to have received at least one dose of study drug, i.e. pramipexole).~For two patients the participating physicians did not enter the gender in the CRF, therefore, they were listed as missing"|participants|Number|2|2.0||||||
4244628|NCT00651183|4068394|B2|missing||Sex/Gender, Customized|"Baseline data are presented for the safety analysis set (including data of all 286 patients - 189 early PD patients / 97 advanced PD patients - reported to have received at least one dose of study drug, i.e. pramipexole).~For two patients the participating physicians did not enter the gender in the CRF, therefore, they were listed as missing"|participants|Number|1|1.0||||||
4244629|NCT00651183|4068395|B1|missing||Sex/Gender, Customized|"Baseline data are presented for the safety analysis set (including data of all 286 patients - 189 early PD patients / 97 advanced PD patients - reported to have received at least one dose of study drug, i.e. pramipexole).~For two patients the participating physicians did not enter the gender in the CRF, therefore, they were listed as missing"|participants|Number|1|1.0||||||
4244630|NCT00651183|4068393|B3|Male||Sex/Gender, Customized|"Baseline data are presented for the safety analysis set (including data of all 286 patients - 189 early PD patients / 97 advanced PD patients - reported to have received at least one dose of study drug, i.e. pramipexole).~For two patients the participating physicians did not enter the gender in the CRF, therefore, they were listed as missing"|participants|Number|169|169.0||||||
4244631|NCT00651183|4068394|B2|Male||Sex/Gender, Customized|"Baseline data are presented for the safety analysis set (including data of all 286 patients - 189 early PD patients / 97 advanced PD patients - reported to have received at least one dose of study drug, i.e. pramipexole).~For two patients the participating physicians did not enter the gender in the CRF, therefore, they were listed as missing"|participants|Number|61|61.0||||||
4244632|NCT00651183|4068395|B1|Male||Sex/Gender, Customized|"Baseline data are presented for the safety analysis set (including data of all 286 patients - 189 early PD patients / 97 advanced PD patients - reported to have received at least one dose of study drug, i.e. pramipexole).~For two patients the participating physicians did not enter the gender in the CRF, therefore, they were listed as missing"|participants|Number|108|108.0||||||
4244633|NCT00651183|4068393|B3|Female||Sex/Gender, Customized|"Baseline data are presented for the safety analysis set (including data of all 286 patients - 189 early PD patients / 97 advanced PD patients - reported to have received at least one dose of study drug, i.e. pramipexole).~For two patients the participating physicians did not enter the gender in the CRF, therefore, they were listed as missing"|participants|Number|115|115.0||||||
4244634|NCT00651183|4068394|B2|Female||Sex/Gender, Customized|"Baseline data are presented for the safety analysis set (including data of all 286 patients - 189 early PD patients / 97 advanced PD patients - reported to have received at least one dose of study drug, i.e. pramipexole).~For two patients the participating physicians did not enter the gender in the CRF, therefore, they were listed as missing"|participants|Number|35|35.0||||||
4244635|NCT00651183|4068395|B1|Female||Sex/Gender, Customized|"Baseline data are presented for the safety analysis set (including data of all 286 patients - 189 early PD patients / 97 advanced PD patients - reported to have received at least one dose of study drug, i.e. pramipexole).~For two patients the participating physicians did not enter the gender in the CRF, therefore, they were listed as missing"|participants|Number|80|80.0||||||
4244636|NCT00651183|4068393|B3|||Age|Baseline data are presented for the safety analysis set (including data of all 286 patients - 189 early PD patients / 97 advanced PD patients - reported to have received at least one dose of study drug, i.e. pramipexole). For Age, Continuous the number of patients with age information collected was 187 for Early PD and 94 for Advanced PD.|years|Mean|70.6|70.6|Standard Deviation|8.96|8.96|||
4244637|NCT00651183|4068394|B2|||Age|Baseline data are presented for the safety analysis set (including data of all 286 patients - 189 early PD patients / 97 advanced PD patients - reported to have received at least one dose of study drug, i.e. pramipexole). For Age, Continuous the number of patients with age information collected was 187 for Early PD and 94 for Advanced PD.|years|Mean|73.8|73.8|Standard Deviation|6.97|6.97|||
4244638|NCT00651183|4068395|B1|||Age|Baseline data are presented for the safety analysis set (including data of all 286 patients - 189 early PD patients / 97 advanced PD patients - reported to have received at least one dose of study drug, i.e. pramipexole). For Age, Continuous the number of patients with age information collected was 187 for Early PD and 94 for Advanced PD.|years|Mean|69.1|69.1|Standard Deviation|9.44|9.44|||
4244639|NCT00651157|4068408|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4244640|NCT00651157|4068408|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4244641|NCT00651157|4068408|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4244642|NCT00651157|4068408|B1|||Age||years|Median|65|65.0|Full Range|||22.0|80.0|
4244643|NCT00651118|4068414|B5|United States||Region of Enrollment||participants|Number|832|832.0||||||
4244644|NCT00651118|4068415|B4|United States||Region of Enrollment||participants|Number|210|210.0||||||
4244645|NCT00651118|4068416|B3|United States||Region of Enrollment||participants|Number|208|208.0||||||
4244646|NCT00651118|4068417|B2|United States||Region of Enrollment||participants|Number|207|207.0||||||
4244647|NCT00651118|4068418|B1|United States||Region of Enrollment||participants|Number|207|207.0||||||
4244648|NCT00651118|4068414|B5||Male|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
4244649|NCT00651118|4068415|B4||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4244650|NCT00651118|4068416|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4244651|NCT00651118|4068417|B2||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4244652|NCT00651118|4068418|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4244653|NCT00651118|4068414|B5||Female|Sex: Female, Male||Participants|Count of Participants|532|532.0||||||
4244654|NCT00651118|4068415|B4||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4244655|NCT00651118|4068416|B3||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4244656|NCT00651118|4068417|B2||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4244657|NCT00651118|4068418|B1||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4244658|NCT00651118|4068414|B5|||Age||years|Mean|37.3|37.3|Standard Deviation|14.7|14.7|||
4244659|NCT00651118|4068415|B4|||Age||years|Mean|37.3|37.3|Standard Deviation|16.0|16.0|||
4244660|NCT00651118|4068416|B3|||Age||years|Mean|36.2|36.2|Standard Deviation|14.6|14.6|||
4244661|NCT00651118|4068417|B2|||Age||years|Mean|38.6|38.6|Standard Deviation|14.1|14.1|||
4244662|NCT00651118|4068418|B1|||Age||years|Mean|37.3|37.3|Standard Deviation|14.1|14.1|||
4244663|NCT00651118|4068414|B5||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4244664|NCT00651118|4068415|B4||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4244665|NCT00651118|4068416|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4244666|NCT00651118|4068417|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4244667|NCT00651118|4068418|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4244668|NCT00651118|4068414|B5||Between 18 and 65 years|Age||Participants|Count of Participants|706|706.0||||||
4244669|NCT00651118|4068415|B4||Between 18 and 65 years|Age||Participants|Count of Participants|166|166.0||||||
4244670|NCT00651118|4068416|B3||Between 18 and 65 years|Age||Participants|Count of Participants|172|172.0||||||
4244671|NCT00651118|4068417|B2||Between 18 and 65 years|Age||Participants|Count of Participants|185|185.0||||||
4244672|NCT00651118|4068418|B1||Between 18 and 65 years|Age||Participants|Count of Participants|183|183.0||||||
4244673|NCT00651118|4068414|B5||<=18 years|Age||Participants|Count of Participants|98|98.0||||||
4244674|NCT00651118|4068415|B4||<=18 years|Age||Participants|Count of Participants|36|36.0||||||
4244675|NCT00651118|4068416|B3||<=18 years|Age||Participants|Count of Participants|28|28.0||||||
4244676|NCT00651118|4068417|B2||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4244677|NCT00651118|4068418|B1||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
4244678|NCT00651040|4068439|B3|Poland||Region of Enrollment||participants|Number|1|1.0||||||
4244679|NCT00651040|4068440|B2|Poland||Region of Enrollment||participants|Number|1|1.0||||||
4244680|NCT00651040|4068441|B1|Poland||Region of Enrollment||participants|Number|0|0.0||||||
4244681|NCT00651040|4068439|B3|Hungary||Region of Enrollment||participants|Number|1|1.0||||||
4244682|NCT00651040|4068440|B2|Hungary||Region of Enrollment||participants|Number|1|1.0||||||
4244683|NCT00651040|4068441|B1|Hungary||Region of Enrollment||participants|Number|0|0.0||||||
4244684|NCT00651040|4068439|B3|Switzerland||Region of Enrollment||participants|Number|4|4.0||||||
4244685|NCT00651040|4068440|B2|Switzerland||Region of Enrollment||participants|Number|4|4.0||||||
4244686|NCT00651040|4068441|B1|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
4244687|NCT00651040|4068439|B3|Sweden||Region of Enrollment||participants|Number|4|4.0||||||
4244688|NCT00651040|4068440|B2|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
4244689|NCT00651040|4068441|B1|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
4244690|NCT00651040|4068439|B3|Czech Republic||Region of Enrollment||participants|Number|21|21.0||||||
4244691|NCT00651040|4068440|B2|Czech Republic||Region of Enrollment||participants|Number|8|8.0||||||
4244692|NCT00651040|4068441|B1|Czech Republic||Region of Enrollment||participants|Number|13|13.0||||||
4244693|NCT00651040|4068439|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4244694|NCT00651040|4068440|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4244695|NCT00651040|4068441|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4244696|NCT00651040|4068439|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4244697|NCT00651040|4068440|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4244698|NCT00651040|4068441|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4244699|NCT00651040|4068439|B3|||Age||years|Mean|52.6|52.6|Standard Deviation|15.7|15.7|||
4244700|NCT00651040|4068440|B2|||Age||years|Mean|53.5|53.5|Standard Deviation|17.4|17.4|||
4244701|NCT00651040|4068441|B1|||Age||years|Mean|51.6|51.6|Standard Deviation|14.4|14.4|||
4244702|NCT00650858|4068448|B4|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4244703|NCT00650858|4068449|B3|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4244704|NCT00650858|4068450|B2|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4244705|NCT00650858|4068451|B1|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4244706|NCT00650858|4068448|B4|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4244707|NCT00650858|4068449|B3|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4244708|NCT00650858|4068450|B2|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4244709|NCT00650858|4068451|B1|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4244710|NCT00650858|4068448|B4|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4244711|NCT00650858|4068449|B3|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4244712|NCT00650858|4068450|B2|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4244713|NCT00650858|4068451|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4244714|NCT00650858|4068448|B4|United States||Region of Enrollment||participants|Number|47|47.0||||||
4244715|NCT00650858|4068449|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4244716|NCT00650858|4068450|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4244717|NCT00650858|4068451|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4244718|NCT00650858|4068448|B4||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4244719|NCT00650858|4068449|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4244720|NCT00650858|4068450|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4244721|NCT00650858|4068451|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4244722|NCT00650858|4068448|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4244723|NCT00650858|4068449|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4244724|NCT00650858|4068450|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4244725|NCT00650858|4068451|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4244726|NCT00650858|4068448|B4|||Age||years|Mean|55.6|55.6|Standard Deviation|10.3|10.3|||
4244727|NCT00650858|4068449|B3|||Age||years|Mean|57.0|57.0|Standard Deviation|10.2|10.2|||
4244728|NCT00650858|4068450|B2|||Age||years|Mean|57.3|57.3|Standard Deviation|8.3|8.3|||
4244729|NCT00650858|4068451|B1|||Age||years|Mean|47.6|47.6|Standard Deviation|9.8|9.8|||
4244730|NCT00650858|4068448|B4||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4244731|NCT00650858|4068449|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4244732|NCT00650858|4068450|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4244733|NCT00650858|4068451|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4244734|NCT00650858|4068448|B4||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4244735|NCT00650858|4068449|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4244736|NCT00650858|4068450|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4244737|NCT00650858|4068451|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4244738|NCT00650858|4068448|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244739|NCT00650858|4068449|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244740|NCT00650858|4068450|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244741|NCT00650858|4068451|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244742|NCT00650845|4068482|B3|Italy||Region of Enrollment||participants|Number|16|16.0||||||
4244743|NCT00650845|4068483|B2|Italy||Region of Enrollment||participants|Number|16|16.0||||||
4244744|NCT00650845|4068484|B1|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4244745|NCT00650845|4068482|B3|Spain||Region of Enrollment||participants|Number|40|40.0||||||
4244746|NCT00650845|4068483|B2|Spain||Region of Enrollment||participants|Number|23|23.0||||||
4244747|NCT00650845|4068484|B1|Spain||Region of Enrollment||participants|Number|17|17.0||||||
4244748|NCT00650845|4068482|B3|Belgium||Region of Enrollment||participants|Number|21|21.0||||||
4244749|NCT00650845|4068483|B2|Belgium||Region of Enrollment||participants|Number|7|7.0||||||
4244750|NCT00650845|4068484|B1|Belgium||Region of Enrollment||participants|Number|14|14.0||||||
4244751|NCT00650845|4068482|B3|France||Region of Enrollment||participants|Number|55|55.0||||||
4244752|NCT00650845|4068483|B2|France||Region of Enrollment||participants|Number|11|11.0||||||
4244753|NCT00650845|4068484|B1|France||Region of Enrollment||participants|Number|44|44.0||||||
4244754|NCT00650845|4068482|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4244755|NCT00650845|4068483|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4244756|NCT00650845|4068484|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4244757|NCT00650845|4068482|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4244758|NCT00650845|4068483|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4244759|NCT00650845|4068484|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4244760|NCT00650845|4068482|B3||>=65 years|Age||Participants|Count of Participants|88|88.0||||||
4244761|NCT00650845|4068483|B2||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
4244762|NCT00650845|4068484|B1||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
4244763|NCT00650845|4068482|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4244764|NCT00650845|4068483|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4244765|NCT00650845|4068484|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4244766|NCT00650845|4068482|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244767|NCT00650845|4068483|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244768|NCT00650845|4068484|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244769|NCT00650845|4068482|B3|||Age||years|Mean|67.9|67.9|Standard Deviation|12.0|12.0|||
4244770|NCT00650845|4068483|B2|||Age||years|Mean|66.2|66.2|Standard Deviation|12.2|12.2|||
4244771|NCT00650845|4068484|B1|||Age||years|Mean|69.6|69.6|Standard Deviation|11.5|11.5|||
4244772|NCT00650806|4068501|B5|UNITED STATES||Region Enroll||participants|Number|360|360.0||||||
4244773|NCT00650806|4068502|B4|UNITED STATES||Region Enroll||participants|Number|91|91.0||||||
4244774|NCT00650806|4068503|B3|UNITED STATES||Region Enroll||participants|Number|89|89.0||||||
4244775|NCT00650806|4068504|B2|UNITED STATES||Region Enroll||participants|Number|94|94.0||||||
4244776|NCT00650806|4068505|B1|UNITED STATES||Region Enroll||participants|Number|86|86.0||||||
4244777|NCT00650806|4068501|B5|PUERTO RICO||Region Enroll||participants|Number|16|16.0||||||
4244778|NCT00650806|4068502|B4|PUERTO RICO||Region Enroll||participants|Number|5|5.0||||||
4244779|NCT00650806|4068503|B3|PUERTO RICO||Region Enroll||participants|Number|4|4.0||||||
4244780|NCT00650806|4068504|B2|PUERTO RICO||Region Enroll||participants|Number|4|4.0||||||
4244781|NCT00650806|4068505|B1|PUERTO RICO||Region Enroll||participants|Number|3|3.0||||||
4244782|NCT00650806|4068501|B5||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4244783|NCT00650806|4068502|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4244784|NCT00650806|4068503|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4244785|NCT00650806|4068504|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4244786|NCT00650806|4068505|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4244787|NCT00650806|4068501|B5||Female|Sex: Female, Male||Participants|Count of Participants|323|323.0||||||
4244788|NCT00650806|4068502|B4||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4244789|NCT00650806|4068503|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4244790|NCT00650806|4068504|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4244791|NCT00650806|4068505|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4244792|NCT00650806|4068501|B5|||Age||years|Mean|44.8|44.8|Standard Deviation|11.4|11.4|||
4244793|NCT00650806|4068502|B4|||Age||years|Mean|43.5|43.5|Standard Deviation|10.99|10.99|||
4244794|NCT00650806|4068503|B3|||Age||years|Mean|45.8|45.8|Standard Deviation|10.95|10.95|||
4244795|NCT00650806|4068504|B2|||Age||years|Mean|44.9|44.9|Standard Deviation|11.8|11.8|||
4244796|NCT00650806|4068505|B1|||Age||years|Mean|45.1|45.1|Standard Deviation|11.92|11.92|||
4244797|NCT00650806|4068501|B5||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4244798|NCT00650806|4068502|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4244799|NCT00650806|4068503|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4244800|NCT00650806|4068504|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4244801|NCT00650806|4068505|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4244802|NCT00650806|4068501|B5||Between 18 and 65 years|Age||Participants|Count of Participants|372|372.0||||||
4244803|NCT00650806|4068502|B4||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
4244804|NCT00650806|4068503|B3||Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
4244805|NCT00650806|4068504|B2||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
4244806|NCT00650806|4068505|B1||Between 18 and 65 years|Age||Participants|Count of Participants|88|88.0||||||
4244807|NCT00650806|4068501|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244808|NCT00650806|4068502|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244809|NCT00650806|4068503|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244810|NCT00650806|4068504|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244811|NCT00650806|4068505|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244812|NCT00650767|4068546|B5|Past Smoker||Smoking Status||participants|Number|15|15.0||||||
4244813|NCT00650767|4068547|B4|Past Smoker||Smoking Status||participants|Number|2|2.0||||||
4244814|NCT00650767|4068548|B3|Past Smoker||Smoking Status||participants|Number|5|5.0||||||
4244815|NCT00650767|4068549|B2|Past Smoker||Smoking Status||participants|Number|1|1.0||||||
4244816|NCT00650767|4068550|B1|Past Smoker||Smoking Status||participants|Number|7|7.0||||||
4244817|NCT00650767|4068546|B5|Never Smoked||Smoking Status||participants|Number|149|149.0||||||
4244818|NCT00650767|4068547|B4|Never Smoked||Smoking Status||participants|Number|36|36.0||||||
4244819|NCT00650767|4068548|B3|Never Smoked||Smoking Status||participants|Number|36|36.0||||||
4244820|NCT00650767|4068549|B2|Never Smoked||Smoking Status||participants|Number|39|39.0||||||
4244821|NCT00650767|4068550|B1|Never Smoked||Smoking Status||participants|Number|38|38.0||||||
4244822|NCT00650767|4068546|B5|Current Smoker||Smoking Status||participants|Number|37|37.0||||||
4244823|NCT00650767|4068547|B4|Current Smoker||Smoking Status||participants|Number|12|12.0||||||
4244824|NCT00650767|4068548|B3|Current Smoker||Smoking Status||participants|Number|9|9.0||||||
4244825|NCT00650767|4068549|B2|Current Smoker||Smoking Status||participants|Number|10|10.0||||||
4244826|NCT00650767|4068550|B1|Current Smoker||Smoking Status||participants|Number|6|6.0||||||
4244827|NCT00650767|4068546|B5|||Height||centimeters|Mean|158.7|158.7|Standard Deviation|8.25|8.25|||
4244828|NCT00650767|4068547|B4|||Height||centimeters|Mean|158.0|158.0|Standard Deviation|7.44|7.44|||
4244829|NCT00650767|4068548|B3|||Height||centimeters|Mean|158.6|158.6|Standard Deviation|9.22|9.22|||
4244830|NCT00650767|4068549|B2|||Height||centimeters|Mean|159.5|159.5|Standard Deviation|8.11|8.11|||
4244831|NCT00650767|4068550|B1|||Height||centimeters|Mean|160.2|160.2|Standard Deviation|8.63|8.63|||
4244832|NCT00650767|4068546|B5|||Weight||kilogram|Mean|69.2|69.2|Standard Deviation|15.49|15.49|||
4244833|NCT00650767|4068547|B4|||Weight||kilogram|Mean|67.2|67.2|Standard Deviation|13.86|13.86|||
4244834|NCT00650767|4068548|B3|||Weight||kilogram|Mean|72.1|72.1|Standard Deviation|17.95|17.95|||
4244835|NCT00650767|4068549|B2|||Weight||kilogram|Mean|68.2|68.2|Standard Deviation|14.17|14.17|||
4244836|NCT00650767|4068550|B1|||Weight||kilogram|Mean|74.1|74.1|Standard Deviation|18.26|18.26|||
4244837|NCT00650767|4068546|B5|Not Hispanic Or Latino||Race/Ethnicity, Customized||participants|Number|109|109.0||||||
4244838|NCT00650767|4068547|B4|Not Hispanic Or Latino||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4244839|NCT00650767|4068548|B3|Not Hispanic Or Latino||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4244840|NCT00650767|4068549|B2|Not Hispanic Or Latino||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4244841|NCT00650767|4068550|B1|Not Hispanic Or Latino||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4244842|NCT00650767|4068546|B5|Hispanic Or Latino||Race/Ethnicity, Customized||participants|Number|92|92.0||||||
4244843|NCT00650767|4068547|B4|Hispanic Or Latino||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4244844|NCT00650767|4068548|B3|Hispanic Or Latino||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4244845|NCT00650767|4068549|B2|Hispanic Or Latino||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4244846|NCT00650767|4068550|B1|Hispanic Or Latino||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4244847|NCT00650767|4068546|B5||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4244848|NCT00650767|4068547|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4244849|NCT00650767|4068548|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4244850|NCT00650767|4068549|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4244851|NCT00650767|4068550|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4244852|NCT00650767|4068546|B5||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4244853|NCT00650767|4068547|B4||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4244854|NCT00650767|4068548|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4244855|NCT00650767|4068549|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4244856|NCT00650767|4068550|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4244857|NCT00650767|4068546|B5|||Age||years|Mean|52.6|52.6|Standard Deviation|11.89|11.89|||
4244858|NCT00650767|4068547|B4|||Age||years|Mean|51.4|51.4|Standard Deviation|11.74|11.74|||
4244859|NCT00650767|4068548|B3|||Age||years|Mean|54.8|54.8|Standard Deviation|11.88|11.88|||
4244860|NCT00650767|4068549|B2|||Age||years|Mean|51.6|51.6|Standard Deviation|11.98|11.98|||
4244861|NCT00650767|4068550|B1|||Age||years|Mean|52.0|52.0|Standard Deviation|12.67|12.67|||
4244862|NCT00650767|4068546|B5||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4244863|NCT00650767|4068547|B4||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4244864|NCT00650767|4068548|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4244865|NCT00650767|4068549|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4244866|NCT00650767|4068550|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4244867|NCT00650767|4068546|B5||Between 18 and 65 years|Age||Participants|Count of Participants|174|174.0||||||
4244868|NCT00650767|4068547|B4||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4244869|NCT00650767|4068548|B3||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4244870|NCT00650767|4068549|B2||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4244871|NCT00650767|4068550|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4244872|NCT00650767|4068546|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244873|NCT00650767|4068547|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244874|NCT00650767|4068548|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244875|NCT00650767|4068549|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244876|NCT00650767|4068550|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244877|NCT00650585|4069055|B3||Male|Sex: Female, Male||Participants|Count of Participants|4109|4109.0||||||
4244878|NCT00650585|4069056|B2||Male|Sex: Female, Male||Participants|Count of Participants|1939|1939.0||||||
4244879|NCT00650585|4069057|B1||Male|Sex: Female, Male||Participants|Count of Participants|2170|2170.0||||||
4244880|NCT00650585|4069055|B3||Female|Sex: Female, Male||Participants|Count of Participants|4229|4229.0||||||
4244881|NCT00650585|4069056|B2||Female|Sex: Female, Male||Participants|Count of Participants|2051|2051.0||||||
4244882|NCT00650585|4069057|B1||Female|Sex: Female, Male||Participants|Count of Participants|2178|2178.0||||||
4244883|NCT00650585|4069055|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4244884|NCT00650585|4069056|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4244885|NCT00650585|4069057|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4244886|NCT00650585|4069055|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4244887|NCT00650585|4069056|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4244888|NCT00650585|4069057|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4244889|NCT00650585|4069055|B3||<=18 years|Age||Participants|Count of Participants|8338|8338.0||||||
4244890|NCT00650585|4069056|B2||<=18 years|Age||Participants|Count of Participants|3990|3990.0||||||
4244891|NCT00650585|4069057|B1||<=18 years|Age||Participants|Count of Participants|4348|4348.0||||||
4244892|NCT00650546|4069078|B1|||NAS score|steatosis, inflammation, ballooning. Each catagory has a 1 to 3 value given and the total of all 3 catagories equals the NAS overall score. 1] The NAFLD Activity Score (NAS) is an underweight sum of steatosis (score 0-3), inflammation (score 0-3), ballooning scores (0-2). The NAS can range from 0-8 with the higher score indicating more aggressive disease|units on a scale|Median|4|4.0|Full Range|||3.0|5.0|
4244953|NCT00650078|4069139|B1|Hungary||Region of Enrollment||participants|Number|67|67.0||||||
4244893|NCT00650546|4069078|B1|||Number of participants who had NAFLD Activity Score (NAS) pre/post 24-28 wks. after treatment|The NAFLD Activity Score (NAS) is an underweight sum of steatosis (score 0-3), inflammation (score 0-3), ballooning scores (0-2). The NAS can range from 0-8 with the higher score indicating more aggressive disease.|participants|Number|8|8.0||||||
4244894|NCT00650546|4069078|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4244895|NCT00650546|4069078|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4244896|NCT00650546|4069078|B1|||Age||years|Mean|54|54.0|Inter-Quartile Range|||36.0|65.0|
4244897|NCT00650546|4069078|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4244898|NCT00650546|4069078|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4244899|NCT00650546|4069078|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244900|NCT00650260|4069083|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4244901|NCT00650260|4069084|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4244902|NCT00650260|4069085|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4244903|NCT00650260|4069083|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4244904|NCT00650260|4069084|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4244905|NCT00650260|4069085|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4244906|NCT00650260|4069083|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4244907|NCT00650260|4069084|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4244908|NCT00650260|4069085|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4244909|NCT00650260|4069083|B3|||Age||years|Mean|48.7|48.7|Standard Deviation|16.5|16.5|||
4244910|NCT00650260|4069084|B2|||Age||years|Mean|46.5|46.5|Standard Deviation|14|14.0|||
4244911|NCT00650260|4069085|B1|||Age||years|Mean|51.1|51.1|Standard Deviation|18.3|18.3|||
4244912|NCT00650260|4069083|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4244913|NCT00650260|4069084|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4244914|NCT00650260|4069085|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4244915|NCT00650260|4069083|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4244916|NCT00650260|4069084|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4244917|NCT00650260|4069085|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4244918|NCT00650260|4069083|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244919|NCT00650260|4069084|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244920|NCT00650260|4069085|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244921|NCT00650104|4069102|B1|||Weight|Weight was captured during collection of demography data at baseline.|kilograms (kg)|Mean|79.24|79.24|Standard Deviation|16.8|16.8|||
4244922|NCT00650104|4069102|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4244923|NCT00650104|4069102|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4244924|NCT00650104|4069102|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4244925|NCT00650104|4069102|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4244926|NCT00650104|4069102|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
4244927|NCT00650104|4069102|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4244928|NCT00650104|4069102|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4244929|NCT00650104|4069102|B1|||Age||years|Mean|65.1|65.1|Standard Deviation|9.85|9.85|||
4244930|NCT00650091|4069115|B3||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4244931|NCT00650091|4069116|B2||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4244932|NCT00650091|4069117|B1||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4244933|NCT00650091|4069115|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4244934|NCT00650091|4069116|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4244935|NCT00650091|4069117|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4244936|NCT00650091|4069115|B3|||Age||years|Mean|67.8|67.8|Standard Deviation|8.3|8.3|||
4244937|NCT00650091|4069116|B2|||Age||years|Mean|67.2|67.2|Standard Deviation|8.2|8.2|||
4244938|NCT00650091|4069117|B1|||Age||years|Mean|68.3|68.3|Standard Deviation|6.4|6.4|||
4244939|NCT00650078|4069137|B3|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
4244940|NCT00650078|4069138|B2|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4244941|NCT00650078|4069139|B1|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
4244942|NCT00650078|4069137|B3|Germany||Region of Enrollment||participants|Number|3|3.0||||||
4244943|NCT00650078|4069138|B2|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4244944|NCT00650078|4069139|B1|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4244945|NCT00650078|4069137|B3|Poland||Region of Enrollment||participants|Number|145|145.0||||||
4244946|NCT00650078|4069138|B2|Poland||Region of Enrollment||participants|Number|47|47.0||||||
4244947|NCT00650078|4069139|B1|Poland||Region of Enrollment||participants|Number|98|98.0||||||
4244948|NCT00650078|4069137|B3|Canada||Region of Enrollment||participants|Number|13|13.0||||||
4244949|NCT00650078|4069138|B2|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4244950|NCT00650078|4069139|B1|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4244951|NCT00650078|4069137|B3|Hungary||Region of Enrollment||participants|Number|102|102.0||||||
4244952|NCT00650078|4069138|B2|Hungary||Region of Enrollment||participants|Number|35|35.0||||||
4244954|NCT00650078|4069137|B3|United States||Region of Enrollment||participants|Number|75|75.0||||||
4244955|NCT00650078|4069138|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4244956|NCT00650078|4069139|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4244957|NCT00650078|4069137|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4244958|NCT00650078|4069138|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4244959|NCT00650078|4069139|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4244960|NCT00650078|4069137|B3||Female|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
4244961|NCT00650078|4069138|B2||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4244962|NCT00650078|4069139|B1||Female|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4244963|NCT00650078|4069137|B3|||Age||years|Mean|57.2|57.2|Standard Deviation|9.76|9.76|||
4244964|NCT00650078|4069138|B2|||Age||years|Mean|57.5|57.5|Standard Deviation|9.55|9.55|||
4244965|NCT00650078|4069139|B1|||Age||years|Mean|57.1|57.1|Standard Deviation|9.89|9.89|||
4244966|NCT00650078|4069137|B3||>=65 years|Age||Participants|Count of Participants|69|69.0||||||
4244967|NCT00650078|4069138|B2||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4244968|NCT00650078|4069139|B1||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
4244969|NCT00650078|4069137|B3||Between 18 and 65 years|Age||Participants|Count of Participants|281|281.0||||||
4244970|NCT00650078|4069138|B2||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
4244971|NCT00650078|4069139|B1||Between 18 and 65 years|Age||Participants|Count of Participants|186|186.0||||||
4244972|NCT00650078|4069137|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244973|NCT00650078|4069138|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244974|NCT00650078|4069139|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244975|NCT00649961|4069148|B1|United Kingdom||Region of Enrollment||participants|Number|18|18.0||||||
4244976|NCT00649961|4069148|B1||Male|Gender||Participants|Count of Participants|9|9.0||||||
4244977|NCT00649961|4069148|B1||Female|Gender||Participants|Count of Participants|9|9.0||||||
4244978|NCT00649961|4069148|B1|||Age, Customized|less than 31 weeks less than 7 days|weeks|Median|26.63|26.63|Full Range|||24.71|30.28|
4244979|NCT00649792|4069152|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4244980|NCT00649792|4069152|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4244981|NCT00649792|4069152|B1||White|Race (NIH/OMB)||Participants|Count of Participants|201|201.0||||||
4244982|NCT00649792|4069152|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4244983|NCT00649792|4069152|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4244984|NCT00649792|4069152|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4244985|NCT00649792|4069152|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4244986|NCT00649792|4069152|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4244987|NCT00649792|4069152|B1||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4244988|NCT00649792|4069152|B1|||Age||years|Mean|52.0|52.0|Standard Deviation|9.59|9.59|||
4244989|NCT00649792|4069152|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4244990|NCT00649792|4069152|B1||Between 18 and 65 years|Age||Participants|Count of Participants|201|201.0||||||
4244991|NCT00649792|4069152|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4244992|NCT00649428|4069160|B3|United States||Region of Enrollment||participants|Number|203|203.0||||||
4244993|NCT00649428|4069161|B2|United States||Region of Enrollment||participants|Number|103|103.0||||||
4244994|NCT00649428|4069162|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
4244995|NCT00649428|4069160|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4244996|NCT00649428|4069161|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4244997|NCT00649428|4069162|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4244998|NCT00649428|4069160|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4244999|NCT00649428|4069161|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245000|NCT00649428|4069162|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245001|NCT00649428|4069160|B3||White|Race (NIH/OMB)||Participants|Count of Participants|193|193.0||||||
4245002|NCT00649428|4069161|B2||White|Race (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
4245003|NCT00649428|4069162|B1||White|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
4245004|NCT00649428|4069160|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4245005|NCT00649428|4069161|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4245006|NCT00649428|4069162|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4245007|NCT00649428|4069160|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245008|NCT00649428|4069161|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245009|NCT00649428|4069162|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245010|NCT00649428|4069160|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4245011|NCT00649428|4069161|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245012|NCT00649428|4069162|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4245013|NCT00649428|4069160|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4245014|NCT00649428|4069161|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4245015|NCT00649428|4069162|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245016|NCT00649428|4069160|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245017|NCT00649428|4069161|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245018|NCT00649428|4069162|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245019|NCT00649428|4069160|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|186|186.0||||||
4245020|NCT00649428|4069161|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4245021|NCT00649428|4069162|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4245022|NCT00649428|4069160|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4245023|NCT00649428|4069161|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4245024|NCT00649428|4069162|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4245025|NCT00649428|4069160|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4245026|NCT00649428|4069161|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4245027|NCT00649428|4069162|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4245028|NCT00649428|4069160|B3||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4245029|NCT00649428|4069161|B2||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4245030|NCT00649428|4069162|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4245031|NCT00649428|4069160|B3|||Age||years|Mean|56.7|56.7|Standard Deviation|8.12|8.12|||
4245032|NCT00649428|4069161|B2|||Age||years|Mean|55.9|55.9|Standard Deviation|7.87|7.87|||
4245033|NCT00649428|4069162|B1|||Age||years|Mean|57.5|57.5|Standard Deviation|8.32|8.32|||
4245034|NCT00649389|4069175|B5|||Duration of hypertension||years|Mean|9.94|9.94|Standard Deviation|9.571|9.571|||
4245035|NCT00649389|4069176|B4|||Duration of hypertension||years|Mean|9.54|9.54|Standard Deviation|9.558|9.558|||
4245036|NCT00649389|4069177|B3|||Duration of hypertension||years|Mean|9.73|9.73|Standard Deviation|8.983|8.983|||
4245037|NCT00649389|4069178|B2|||Duration of hypertension||years|Mean|10.34|10.34|Standard Deviation|9.826|9.826|||
4245038|NCT00649389|4069179|B1|||Duration of hypertension||years|Mean|10.12|10.12|Standard Deviation|9.865|9.865|||
4245039|NCT00649389|4069175|B5|Greater than or equal to 30 kg/m2||Body Mass Index||Participants|Number|1555|1555.0||||||
4245040|NCT00649389|4069176|B4|Greater than or equal to 30 kg/m2||Body Mass Index||Participants|Number|387|387.0||||||
4245041|NCT00649389|4069177|B3|Greater than or equal to 30 kg/m2||Body Mass Index||Participants|Number|370|370.0||||||
4245042|NCT00649389|4069178|B2|Greater than or equal to 30 kg/m2||Body Mass Index||Participants|Number|399|399.0||||||
4245043|NCT00649389|4069179|B1|Greater than or equal to 30 kg/m2||Body Mass Index||Participants|Number|399|399.0||||||
4245044|NCT00649389|4069175|B5|Less than 30 kg/m2||Body Mass Index||Participants|Number|937|937.0||||||
4245045|NCT00649389|4069176|B4|Less than 30 kg/m2||Body Mass Index||Participants|Number|240|240.0||||||
4245046|NCT00649389|4069177|B3|Less than 30 kg/m2||Body Mass Index||Participants|Number|230|230.0||||||
4245047|NCT00649389|4069178|B2|Less than 30 kg/m2||Body Mass Index||Participants|Number|238|238.0||||||
4245048|NCT00649389|4069179|B1|Less than 30 kg/m2||Body Mass Index||Participants|Number|229|229.0||||||
4245049|NCT00649389|4069175|B5|||Weight||kg|Mean|96.0|96.0|Standard Deviation|22.94|22.94|||
4245050|NCT00649389|4069176|B4|||Weight||kg|Mean|96.0|96.0|Standard Deviation|23.24|23.24|||
4245051|NCT00649389|4069177|B3|||Weight||kg|Mean|96.1|96.1|Standard Deviation|23.41|23.41|||
4245052|NCT00649389|4069178|B2|||Weight||kg|Mean|96.1|96.1|Standard Deviation|22.55|22.55|||
4245053|NCT00649389|4069179|B1|||Weight||kg|Mean|95.9|95.9|Standard Deviation|22.65|22.65|||
4245054|NCT00649389|4069175|B5|Not diabetic||Diabetes Status||Participants|Number|2105|2105.0||||||
4245055|NCT00649389|4069176|B4|Not diabetic||Diabetes Status||Participants|Number|531|531.0||||||
4245056|NCT00649389|4069177|B3|Not diabetic||Diabetes Status||Participants|Number|508|508.0||||||
4245057|NCT00649389|4069178|B2|Not diabetic||Diabetes Status||Participants|Number|538|538.0||||||
4245058|NCT00649389|4069179|B1|Not diabetic||Diabetes Status||Participants|Number|528|528.0||||||
4245059|NCT00649389|4069175|B5|Diabetic||Diabetes Status||Participants|Number|387|387.0||||||
4245060|NCT00649389|4069176|B4|Diabetic||Diabetes Status||Participants|Number|96|96.0||||||
4245061|NCT00649389|4069177|B3|Diabetic||Diabetes Status||Participants|Number|92|92.0||||||
4245062|NCT00649389|4069178|B2|Diabetic||Diabetes Status||Participants|Number|99|99.0||||||
4245063|NCT00649389|4069179|B1|Diabetic||Diabetes Status||Participants|Number|100|100.0||||||
4245064|NCT00649389|4069175|B5|Unknown or Not Reported||Race/Ethnicity, Customized|Race of participants as selected by participant. Participants were allowed to choose more than one race category; therefore, the total for an arm may be greater than the number of participants|Participants|Number|15|15.0||||||
4245065|NCT00649389|4069176|B4|Unknown or Not Reported||Race/Ethnicity, Customized|Race of participants as selected by participant. Participants were allowed to choose more than one race category; therefore, the total for an arm may be greater than the number of participants|Participants|Number|6|6.0||||||
4245066|NCT00649389|4069177|B3|Unknown or Not Reported||Race/Ethnicity, Customized|Race of participants as selected by participant. Participants were allowed to choose more than one race category; therefore, the total for an arm may be greater than the number of participants|Participants|Number|5|5.0||||||
4245147|NCT00648895|4069225|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4245067|NCT00649389|4069178|B2|Unknown or Not Reported||Race/Ethnicity, Customized|Race of participants as selected by participant. Participants were allowed to choose more than one race category; therefore, the total for an arm may be greater than the number of participants|Participants|Number|4|4.0||||||
4245068|NCT00649389|4069179|B1|Unknown or Not Reported||Race/Ethnicity, Customized|Race of participants as selected by participant. Participants were allowed to choose more than one race category; therefore, the total for an arm may be greater than the number of participants|Participants|Number|0|0.0||||||
4245069|NCT00649389|4069175|B5|White||Race/Ethnicity, Customized|Race of participants as selected by participant. Participants were allowed to choose more than one race category; therefore, the total for an arm may be greater than the number of participants|Participants|Number|1658|1658.0||||||
4245070|NCT00649389|4069176|B4|White||Race/Ethnicity, Customized|Race of participants as selected by participant. Participants were allowed to choose more than one race category; therefore, the total for an arm may be greater than the number of participants|Participants|Number|415|415.0||||||
4245071|NCT00649389|4069177|B3|White||Race/Ethnicity, Customized|Race of participants as selected by participant. Participants were allowed to choose more than one race category; therefore, the total for an arm may be greater than the number of participants|Participants|Number|391|391.0||||||
4245072|NCT00649389|4069178|B2|White||Race/Ethnicity, Customized|Race of participants as selected by participant. Participants were allowed to choose more than one race category; therefore, the total for an arm may be greater than the number of participants|Participants|Number|421|421.0||||||
4245073|NCT00649389|4069179|B1|White||Race/Ethnicity, Customized|Race of participants as selected by participant. Participants were allowed to choose more than one race category; therefore, the total for an arm may be greater than the number of participants|Participants|Number|431|431.0||||||
4245074|NCT00649389|4069175|B5|Black/African American||Race/Ethnicity, Customized|Race of participants as selected by participant. Participants were allowed to choose more than one race category; therefore, the total for an arm may be greater than the number of participants|Participants|Number|757|757.0||||||
4245075|NCT00649389|4069176|B4|Black/African American||Race/Ethnicity, Customized|Race of participants as selected by participant. Participants were allowed to choose more than one race category; therefore, the total for an arm may be greater than the number of participants|Participants|Number|184|184.0||||||
4245076|NCT00649389|4069177|B3|Black/African American||Race/Ethnicity, Customized|Race of participants as selected by participant. Participants were allowed to choose more than one race category; therefore, the total for an arm may be greater than the number of participants|Participants|Number|192|192.0||||||
4245077|NCT00649389|4069178|B2|Black/African American||Race/Ethnicity, Customized|Race of participants as selected by participant. Participants were allowed to choose more than one race category; therefore, the total for an arm may be greater than the number of participants|Participants|Number|200|200.0||||||
4245078|NCT00649389|4069179|B1|Black/African American||Race/Ethnicity, Customized|Race of participants as selected by participant. Participants were allowed to choose more than one race category; therefore, the total for an arm may be greater than the number of participants|Participants|Number|181|181.0||||||
4245079|NCT00649389|4069175|B5|Hawaiian/Pacific Islander||Race/Ethnicity, Customized|Race of participants as selected by participant. Participants were allowed to choose more than one race category; therefore, the total for an arm may be greater than the number of participants|Participants|Number|4|4.0||||||
4245080|NCT00649389|4069176|B4|Hawaiian/Pacific Islander||Race/Ethnicity, Customized|Race of participants as selected by participant. Participants were allowed to choose more than one race category; therefore, the total for an arm may be greater than the number of participants|Participants|Number|2|2.0||||||
4245081|NCT00649389|4069177|B3|Hawaiian/Pacific Islander||Race/Ethnicity, Customized|Race of participants as selected by participant. Participants were allowed to choose more than one race category; therefore, the total for an arm may be greater than the number of participants|Participants|Number|1|1.0||||||
4245082|NCT00649389|4069178|B2|Hawaiian/Pacific Islander||Race/Ethnicity, Customized|Race of participants as selected by participant. Participants were allowed to choose more than one race category; therefore, the total for an arm may be greater than the number of participants|Participants|Number|1|1.0||||||
4245083|NCT00649389|4069179|B1|Hawaiian/Pacific Islander||Race/Ethnicity, Customized|Race of participants as selected by participant. Participants were allowed to choose more than one race category; therefore, the total for an arm may be greater than the number of participants|Participants|Number|0|0.0||||||
4245084|NCT00649389|4069175|B5|Asian||Race/Ethnicity, Customized|Race of participants as selected by participant. Participants were allowed to choose more than one race category; therefore, the total for an arm may be greater than the number of participants|Participants|Number|49|49.0||||||
4245085|NCT00649389|4069176|B4|Asian||Race/Ethnicity, Customized|Race of participants as selected by participant. Participants were allowed to choose more than one race category; therefore, the total for an arm may be greater than the number of participants|Participants|Number|19|19.0||||||
4245086|NCT00649389|4069177|B3|Asian||Race/Ethnicity, Customized|Race of participants as selected by participant. Participants were allowed to choose more than one race category; therefore, the total for an arm may be greater than the number of participants|Participants|Number|7|7.0||||||
4245087|NCT00649389|4069178|B2|Asian||Race/Ethnicity, Customized|Race of participants as selected by participant. Participants were allowed to choose more than one race category; therefore, the total for an arm may be greater than the number of participants|Participants|Number|10|10.0||||||
4245088|NCT00649389|4069179|B1|Asian||Race/Ethnicity, Customized|Race of participants as selected by participant. Participants were allowed to choose more than one race category; therefore, the total for an arm may be greater than the number of participants|Participants|Number|13|13.0||||||
4245089|NCT00649389|4069175|B5|American Indian/Alaskan Native||Race/Ethnicity, Customized|Race of participants as selected by participant. Participants were allowed to choose more than one race category; therefore, the total for an arm may be greater than the number of participants|Participants|Number|9|9.0||||||
4245090|NCT00649389|4069176|B4|American Indian/Alaskan Native||Race/Ethnicity, Customized|Race of participants as selected by participant. Participants were allowed to choose more than one race category; therefore, the total for an arm may be greater than the number of participants|Participants|Number|1|1.0||||||
4245091|NCT00649389|4069177|B3|American Indian/Alaskan Native||Race/Ethnicity, Customized|Race of participants as selected by participant. Participants were allowed to choose more than one race category; therefore, the total for an arm may be greater than the number of participants|Participants|Number|4|4.0||||||
4245092|NCT00649389|4069178|B2|American Indian/Alaskan Native||Race/Ethnicity, Customized|Race of participants as selected by participant. Participants were allowed to choose more than one race category; therefore, the total for an arm may be greater than the number of participants|Participants|Number|1|1.0||||||
4245093|NCT00649389|4069179|B1|American Indian/Alaskan Native||Race/Ethnicity, Customized|Race of participants as selected by participant. Participants were allowed to choose more than one race category; therefore, the total for an arm may be greater than the number of participants|Participants|Number|3|3.0||||||
4245094|NCT00649389|4069175|B5||Male|Sex: Female, Male||Participants|Count of Participants|1318|1318.0||||||
4245095|NCT00649389|4069176|B4||Male|Sex: Female, Male||Participants|Count of Participants|320|320.0||||||
4245096|NCT00649389|4069177|B3||Male|Sex: Female, Male||Participants|Count of Participants|334|334.0||||||
4245097|NCT00649389|4069178|B2||Male|Sex: Female, Male||Participants|Count of Participants|339|339.0||||||
4245098|NCT00649389|4069179|B1||Male|Sex: Female, Male||Participants|Count of Participants|325|325.0||||||
4245099|NCT00649389|4069175|B5||Female|Sex: Female, Male||Participants|Count of Participants|1174|1174.0||||||
4245100|NCT00649389|4069176|B4||Female|Sex: Female, Male||Participants|Count of Participants|307|307.0||||||
4245101|NCT00649389|4069177|B3||Female|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
4245102|NCT00649389|4069178|B2||Female|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
4245103|NCT00649389|4069179|B1||Female|Sex: Female, Male||Participants|Count of Participants|303|303.0||||||
4245104|NCT00649389|4069175|B5|||Age||years|Mean|55.1|55.1|Standard Deviation|10.94|10.94|||
4245105|NCT00649389|4069176|B4|||Age||years|Mean|54.7|54.7|Standard Deviation|11.22|11.22|||
4245106|NCT00649389|4069177|B3|||Age||years|Mean|54.6|54.6|Standard Deviation|10.82|10.82|||
4245107|NCT00649389|4069178|B2|||Age||years|Mean|55.9|55.9|Standard Deviation|10.78|10.78|||
4245108|NCT00649389|4069179|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|10.93|10.93|||
4245109|NCT00649389|4069175|B5||>=65 years|Age||Participants|Count of Participants|471|471.0||||||
4245110|NCT00649389|4069176|B4||>=65 years|Age||Participants|Count of Participants|123|123.0||||||
4245111|NCT00649389|4069177|B3||>=65 years|Age||Participants|Count of Participants|96|96.0||||||
4245112|NCT00649389|4069178|B2||>=65 years|Age||Participants|Count of Participants|132|132.0||||||
4245113|NCT00649389|4069179|B1||>=65 years|Age||Participants|Count of Participants|120|120.0||||||
4245114|NCT00649389|4069175|B5||Between 18 and 65 years|Age||Participants|Count of Participants|2021|2021.0||||||
4245115|NCT00649389|4069176|B4||Between 18 and 65 years|Age||Participants|Count of Participants|504|504.0||||||
4245116|NCT00649389|4069177|B3||Between 18 and 65 years|Age||Participants|Count of Participants|504|504.0||||||
4245117|NCT00649389|4069178|B2||Between 18 and 65 years|Age||Participants|Count of Participants|505|505.0||||||
4245118|NCT00649389|4069179|B1||Between 18 and 65 years|Age||Participants|Count of Participants|508|508.0||||||
4245119|NCT00649389|4069175|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4245120|NCT00649389|4069176|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4245121|NCT00649389|4069177|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4245122|NCT00649389|4069178|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4245123|NCT00649389|4069179|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4245124|NCT00649220|4069204|B1|Germany||Region of Enrollment||participants|Number|19|19.0||||||
4245125|NCT00649220|4069204|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4245126|NCT00649220|4069204|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4245127|NCT00649220|4069204|B1|Between 50 and 85 years||Age, Customized||participants|Number|19|19.0||||||
4245128|NCT00649220|4069204|B1|||Age||years|Mean|72.4|72.4|Standard Deviation|9.7|9.7|||
4245129|NCT00648908|4069215|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4245130|NCT00648908|4069215|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4245131|NCT00648908|4069215|B1||White|Race (NIH/OMB)||Participants|Count of Participants|251|251.0||||||
4245132|NCT00648908|4069215|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4245133|NCT00648908|4069215|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245134|NCT00648908|4069215|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4245135|NCT00648908|4069215|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245136|NCT00648908|4069215|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4245137|NCT00648908|4069215|B1||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4245138|NCT00648908|4069215|B1|Age (years)||Age||Years|Mean|52.1|52.1|Standard Deviation|8.75|8.75|||
4245139|NCT00648908|4069215|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4245140|NCT00648908|4069215|B1||Between 18 and 65 years|Age||Participants|Count of Participants|256|256.0||||||
4245141|NCT00648908|4069215|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4245142|NCT00648895|4069223|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4245143|NCT00648895|4069224|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4245144|NCT00648895|4069225|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4245145|NCT00648895|4069223|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4245146|NCT00648895|4069224|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4245148|NCT00648895|4069223|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4245149|NCT00648895|4069224|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4245150|NCT00648895|4069225|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4245151|NCT00648895|4069223|B3|||Age||years|Mean|63.4|63.4|Standard Deviation|9.7|9.7|||
4245152|NCT00648895|4069224|B2|||Age||years|Mean|67.3|67.3|Standard Deviation|11.6|11.6|||
4245153|NCT00648895|4069225|B1|||Age||years|Mean|59.5|59.5|Standard Deviation|5.8|5.8|||
4245154|NCT00648895|4069223|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4245155|NCT00648895|4069224|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4245156|NCT00648895|4069225|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4245157|NCT00648895|4069223|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4245158|NCT00648895|4069224|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4245159|NCT00648895|4069225|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4245160|NCT00648895|4069223|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4245161|NCT00648895|4069224|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4245162|NCT00648895|4069225|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4245163|NCT00648167|4069232|B1|Puerto Rico||Region of Enrollment||participants|Number|5|5.0||||||
4245164|NCT00648167|4069232|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4245165|NCT00648167|4069232|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4245166|NCT00648167|4069232|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4245167|NCT00648167|4069232|B1|||Age||years|Mean|53.46|53.46|Standard Deviation|11.48|11.48|||
4245168|NCT00648115|4069236|B4|United States||Region of Enrollment||participants|Number|111|111.0||||||
4245169|NCT00648115|4069237|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
4245170|NCT00648115|4069238|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
4245171|NCT00648115|4069239|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4245172|NCT00648115|4069236|B4|White/Non-Minority||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4245173|NCT00648115|4069237|B3|White/Non-Minority||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4245174|NCT00648115|4069238|B2|White/Non-Minority||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4245175|NCT00648115|4069239|B1|White/Non-Minority||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4245176|NCT00648115|4069236|B4|Racial/Ethnic Minority||Race/Ethnicity, Customized||participants|Number|101|101.0||||||
4245177|NCT00648115|4069237|B3|Racial/Ethnic Minority||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4245178|NCT00648115|4069238|B2|Racial/Ethnic Minority||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4245179|NCT00648115|4069239|B1|Racial/Ethnic Minority||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4245180|NCT00648115|4069236|B4||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4245181|NCT00648115|4069237|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4245182|NCT00648115|4069238|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4245183|NCT00648115|4069239|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4245184|NCT00648115|4069236|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4245185|NCT00648115|4069237|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4245186|NCT00648115|4069238|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4245187|NCT00648115|4069239|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4245188|NCT00648115|4069236|B4|||Age||years|Mean|51.0|51.0|Standard Deviation|4.7|4.7|||
4245189|NCT00648115|4069237|B3|||Age||years|Mean|51.2|51.2|Standard Deviation|5.3|5.3|||
4245190|NCT00648115|4069238|B2|||Age||years|Mean|50.4|50.4|Standard Deviation|4.5|4.5|||
4245191|NCT00648115|4069239|B1|||Age||years|Mean|51.4|51.4|Standard Deviation|4.7|4.7|||
4245192|NCT00648037|4069252|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4245193|NCT00648037|4069252|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4245194|NCT00648037|4069252|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4245195|NCT00648037|4069252|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4245196|NCT00648037|4069252|B1||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4245197|NCT00647998|4069256|B3|||Prior aortic surgery||Participants|Count of Participants|13|13.0||||||
4245198|NCT00647998|4069257|B2|||Prior aortic surgery||Participants|Count of Participants|7|7.0||||||
4245199|NCT00647998|4069258|B1|||Prior aortic surgery||Participants|Count of Participants|6|6.0||||||
4245200|NCT00647998|4069256|B3|||Prior stroke||Participants|Count of Participants|6|6.0||||||
4245201|NCT00647998|4069257|B2|||Prior stroke||Participants|Count of Participants|3|3.0||||||
4245202|NCT00647998|4069258|B1|||Prior stroke||Participants|Count of Participants|3|3.0||||||
4245203|NCT00647998|4069256|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4245204|NCT00647998|4069257|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4245205|NCT00647998|4069258|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4245206|NCT00647998|4069256|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4245207|NCT00647998|4069257|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4245208|NCT00647998|4069258|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4245209|NCT00647998|4069256|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4245210|NCT00647998|4069257|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4245211|NCT00647998|4069258|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4245212|NCT00647998|4069256|B3|||Age||years|Median|59|59.0|Inter-Quartile Range|||55.0|67.0|
4245213|NCT00647998|4069257|B2|||Age||years|Median|62|62.0|Inter-Quartile Range|||58.0|64.0|
4245214|NCT00647998|4069258|B1|||Age||years|Median|57|57.0|Inter-Quartile Range|||55.0|67.0|
4245215|NCT00647699|4069269|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4245216|NCT00647699|4069270|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4245217|NCT00647699|4069271|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4245218|NCT00647699|4069269|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245219|NCT00647699|4069270|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245220|NCT00647699|4069271|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245221|NCT00647699|4069269|B3||White|Race (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
4245222|NCT00647699|4069270|B2||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4245223|NCT00647699|4069271|B1||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4245224|NCT00647699|4069269|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4245225|NCT00647699|4069270|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4245226|NCT00647699|4069271|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4245227|NCT00647699|4069269|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245228|NCT00647699|4069270|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245229|NCT00647699|4069271|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245230|NCT00647699|4069269|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4245231|NCT00647699|4069270|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4245232|NCT00647699|4069271|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245233|NCT00647699|4069269|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245234|NCT00647699|4069270|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245235|NCT00647699|4069271|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245236|NCT00647699|4069269|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4245237|NCT00647699|4069270|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4245238|NCT00647699|4069271|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4245239|NCT00647699|4069269|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4245240|NCT00647699|4069270|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4245241|NCT00647699|4069271|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4245242|NCT00647699|4069269|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4245243|NCT00647699|4069270|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4245244|NCT00647699|4069271|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4245245|NCT00647699|4069269|B3||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4245246|NCT00647699|4069270|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4245247|NCT00647699|4069271|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4245248|NCT00647699|4069269|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4245249|NCT00647699|4069270|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4245250|NCT00647699|4069271|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4245251|NCT00647699|4069269|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4245252|NCT00647699|4069270|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4245253|NCT00647699|4069271|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4245254|NCT00647699|4069269|B3||Between 18 and 65 years|Age||Participants|Count of Participants|137|137.0||||||
4245255|NCT00647699|4069270|B2||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4245256|NCT00647699|4069271|B1||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4245257|NCT00647699|4069269|B3||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4245258|NCT00647699|4069270|B2||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4245259|NCT00647699|4069271|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4245260|NCT00647556|4069278|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4245261|NCT00647556|4069279|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4245262|NCT00647556|4069280|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4245263|NCT00647556|4069278|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4245264|NCT00647556|4069279|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4245265|NCT00647556|4069280|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4245266|NCT00647556|4069278|B3|||Age||years|Mean|61.1|61.1|Standard Deviation|10.33|10.33|||
4245267|NCT00647556|4069279|B2|||Age||years|Mean|61.3|61.3|Standard Deviation|9.58|9.58|||
4245268|NCT00647556|4069280|B1|||Age||years|Mean|60.9|60.9|Standard Deviation|11.37|11.37|||
4245269|NCT00647400|4069295|B3|Japan||Region of Enrollment||participants|Number|147|147.0||||||
4245270|NCT00647400|4069296|B2|Japan||Region of Enrollment||participants|Number|58|58.0||||||
4245271|NCT00647400|4069297|B1|Japan||Region of Enrollment||participants|Number|89|89.0||||||
4245272|NCT00647400|4069295|B3||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4245273|NCT00647400|4069296|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4245274|NCT00647400|4069297|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4245275|NCT00647400|4069295|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4245276|NCT00647400|4069296|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4245277|NCT00647400|4069297|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4245278|NCT00647400|4069295|B3|||Age||years|Mean|44.2|44.2|Standard Deviation|12.82|12.82|||
4245279|NCT00647400|4069296|B2|||Age||years|Mean|42.9|42.9|Standard Deviation|11.88|11.88|||
4245280|NCT00647400|4069297|B1|||Age||years|Mean|45.1|45.1|Standard Deviation|13.39|13.39|||
4245281|NCT00647400|4069295|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4245282|NCT00647400|4069296|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4245283|NCT00647400|4069297|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4245284|NCT00647400|4069295|B3||Between 18 and 65 years|Age||Participants|Count of Participants|136|136.0||||||
4245285|NCT00647400|4069296|B2||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4245286|NCT00647400|4069297|B1||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4245287|NCT00647400|4069295|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4245288|NCT00647400|4069296|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4245289|NCT00647400|4069297|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4245290|NCT00647270|4069308|B4||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4245291|NCT00647270|4069309|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4245292|NCT00647270|4069310|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4245293|NCT00647270|4069311|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4245294|NCT00647270|4069308|B4||Female|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
4245295|NCT00647270|4069309|B3||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4245296|NCT00647270|4069310|B2||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4245297|NCT00647270|4069311|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4245298|NCT00647270|4069308|B4|||Age||years|Mean|56.4|56.4|Standard Deviation|12.58|12.58|||
4245299|NCT00647270|4069309|B3|||Age||years|Mean|56.3|56.3|Standard Deviation|12.43|12.43|||
4245300|NCT00647270|4069310|B2|||Age||years|Mean|57.2|57.2|Standard Deviation|12.79|12.79|||
4245301|NCT00647270|4069311|B1|||Age||years|Mean|54.4|54.4|Standard Deviation|12.46|12.46|||
4245302|NCT00647270|4069308|B4|>= 65 years||Age, Customized||participants|Number|116|116.0||||||
4245303|NCT00647270|4069309|B3|>= 65 years||Age, Customized||participants|Number|57|57.0||||||
4245304|NCT00647270|4069310|B2|>= 65 years||Age, Customized||participants|Number|46|46.0||||||
4245305|NCT00647270|4069311|B1|>= 65 years||Age, Customized||participants|Number|13|13.0||||||
4245306|NCT00647270|4069308|B4|< 65 years||Age, Customized||participants|Number|304|304.0||||||
4245307|NCT00647270|4069309|B3|< 65 years||Age, Customized||participants|Number|148|148.0||||||
4245308|NCT00647270|4069310|B2|< 65 years||Age, Customized||participants|Number|113|113.0||||||
4245309|NCT00647270|4069311|B1|< 65 years||Age, Customized||participants|Number|43|43.0||||||
4245310|NCT00646958|4069336|B4||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4245311|NCT00646958|4069337|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4245312|NCT00646958|4069338|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4245313|NCT00646958|4069339|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4245314|NCT00646958|4069336|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4245315|NCT00646958|4069337|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4245316|NCT00646958|4069338|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4245317|NCT00646958|4069339|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4245318|NCT00646958|4069336|B4|||Age||years|Mean|43.3|43.3|Standard Deviation|14.10|14.1|||
4245319|NCT00646958|4069337|B3|||Age||years|Mean|43.7|43.7|Standard Deviation|16.33|16.33|||
4245320|NCT00646958|4069338|B2|||Age||years|Mean|43.6|43.6|Standard Deviation|13.65|13.65|||
4245321|NCT00646958|4069339|B1|||Age||years|Mean|42.8|42.8|Standard Deviation|12.43|12.43|||
4245322|NCT00646776|4069352|B3|||Weight Continuous||kg|Mean|80.3|80.3|Standard Deviation|13.5|13.5|||
4245323|NCT00646776|4069353|B2|||Weight Continuous||kg|Mean|81.3|81.3|Standard Deviation|14.9|14.9|||
4245324|NCT00646776|4069354|B1|||Weight Continuous||kg|Mean|79.1|79.1|Standard Deviation|12.0|12.0|||
4245325|NCT00646776|4069352|B3|||Height Continuous||cm|Mean|174.1|174.1|Standard Deviation|8.8|8.8|||
4245326|NCT00646776|4069353|B2|||Height Continuous||cm|Mean|174.4|174.4|Standard Deviation|10.0|10.0|||
4245327|NCT00646776|4069354|B1|||Height Continuous||cm|Mean|173.7|173.7|Standard Deviation|7.3|7.3|||
4245328|NCT00646776|4069352|B3|||Body Mass Index (BMI)|BMI is defined as the individual's body weight divided by the square of his or her height.|kg/m^2|Mean|26.4|26.4|Standard Deviation|3.3|3.3|||
4245385|NCT00646646|4069415|B5|United States||Region of Enrollment||participants|Number|65|65.0||||||
4245329|NCT00646776|4069353|B2|||Body Mass Index (BMI)|BMI is defined as the individual's body weight divided by the square of his or her height.|kg/m^2|Mean|26.6|26.6|Standard Deviation|3.5|3.5|||
4245330|NCT00646776|4069354|B1|||Body Mass Index (BMI)|BMI is defined as the individual's body weight divided by the square of his or her height.|kg/m^2|Mean|26.1|26.1|Standard Deviation|3.2|3.2|||
4245331|NCT00646776|4069352|B3|Other Race||Race/Ethnicity, Customized|Other race comprises American Indian/Alaskan|participants|Number|2|2.0||||||
4245332|NCT00646776|4069353|B2|Other Race||Race/Ethnicity, Customized|Other race comprises American Indian/Alaskan|participants|Number|1|1.0||||||
4245333|NCT00646776|4069354|B1|Other Race||Race/Ethnicity, Customized|Other race comprises American Indian/Alaskan|participants|Number|1|1.0||||||
4245334|NCT00646776|4069352|B3|Asian||Race/Ethnicity, Customized|Other race comprises American Indian/Alaskan|participants|Number|2|2.0||||||
4245335|NCT00646776|4069353|B2|Asian||Race/Ethnicity, Customized|Other race comprises American Indian/Alaskan|participants|Number|0|0.0||||||
4245336|NCT00646776|4069354|B1|Asian||Race/Ethnicity, Customized|Other race comprises American Indian/Alaskan|participants|Number|2|2.0||||||
4245337|NCT00646776|4069352|B3|Black or African American||Race/Ethnicity, Customized|Other race comprises American Indian/Alaskan|participants|Number|15|15.0||||||
4245338|NCT00646776|4069353|B2|Black or African American||Race/Ethnicity, Customized|Other race comprises American Indian/Alaskan|participants|Number|12|12.0||||||
4245339|NCT00646776|4069354|B1|Black or African American||Race/Ethnicity, Customized|Other race comprises American Indian/Alaskan|participants|Number|3|3.0||||||
4245340|NCT00646776|4069352|B3|Caucasian||Race/Ethnicity, Customized|Other race comprises American Indian/Alaskan|participants|Number|14|14.0||||||
4245341|NCT00646776|4069353|B2|Caucasian||Race/Ethnicity, Customized|Other race comprises American Indian/Alaskan|participants|Number|5|5.0||||||
4245342|NCT00646776|4069354|B1|Caucasian||Race/Ethnicity, Customized|Other race comprises American Indian/Alaskan|participants|Number|9|9.0||||||
4245343|NCT00646776|4069352|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245344|NCT00646776|4069353|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245345|NCT00646776|4069354|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245346|NCT00646776|4069352|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4245347|NCT00646776|4069353|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4245348|NCT00646776|4069354|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4245349|NCT00646776|4069352|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4245350|NCT00646776|4069353|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4245351|NCT00646776|4069354|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4245352|NCT00646776|4069352|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4245353|NCT00646776|4069353|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4245354|NCT00646776|4069354|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4245355|NCT00646776|4069352|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4245356|NCT00646776|4069353|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4245357|NCT00646776|4069354|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4245358|NCT00646776|4069352|B3|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4245359|NCT00646776|4069353|B2|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4245360|NCT00646776|4069354|B1|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4245361|NCT00646776|4069352|B3|<65 years||Age, Customized||participants|Number|33|33.0||||||
4245362|NCT00646776|4069353|B2|<65 years||Age, Customized||participants|Number|18|18.0||||||
4245363|NCT00646776|4069354|B1|<65 years||Age, Customized||participants|Number|15|15.0||||||
4245364|NCT00646776|4069352|B3|||Age||years|Mean|36|36.0|Standard Deviation|7|7.0|||
4245365|NCT00646776|4069353|B2|||Age||years|Mean|37|37.0|Standard Deviation|9|9.0|||
4245366|NCT00646776|4069354|B1|||Age||years|Mean|36|36.0|Standard Deviation|5|5.0|||
4245367|NCT00646763|4069402|B3|Myeloma||Disease type||participants|Number|25|25.0||||||
4245368|NCT00646763|4069403|B2|Myeloma||Disease type||participants|Number|11|11.0||||||
4245369|NCT00646763|4069404|B1|Myeloma||Disease type||participants|Number|14|14.0||||||
4245370|NCT00646763|4069402|B3|Lymphoma||Disease type||participants|Number|10|10.0||||||
4245371|NCT00646763|4069403|B2|Lymphoma||Disease type||participants|Number|6|6.0||||||
4245372|NCT00646763|4069404|B1|Lymphoma||Disease type||participants|Number|4|4.0||||||
4245373|NCT00646763|4069402|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
4245374|NCT00646763|4069403|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4245375|NCT00646763|4069404|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4245376|NCT00646763|4069402|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4245377|NCT00646763|4069403|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4245378|NCT00646763|4069404|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4245379|NCT00646763|4069402|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4245380|NCT00646763|4069403|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4245381|NCT00646763|4069404|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4245382|NCT00646763|4069402|B3|||Age, Customized||Mean|Mean|53|53.0|Standard Deviation|15.21|15.21|||
4245383|NCT00646763|4069403|B2|||Age, Customized||Mean|Mean|52|52.0|Standard Deviation|17.02|17.02|||
4245384|NCT00646763|4069404|B1|||Age, Customized||Mean|Mean|53|53.0|Standard Deviation|13.76|13.76|||
4245386|NCT00646646|4069416|B4|United States||Region of Enrollment||participants|Number|20|20.0||||||
4245387|NCT00646646|4069417|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4245388|NCT00646646|4069418|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4245389|NCT00646646|4069419|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4245390|NCT00646646|4069415|B5||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4245391|NCT00646646|4069416|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4245392|NCT00646646|4069417|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4245393|NCT00646646|4069418|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4245394|NCT00646646|4069419|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4245395|NCT00646646|4069415|B5||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4245396|NCT00646646|4069416|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4245397|NCT00646646|4069417|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4245398|NCT00646646|4069418|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4245399|NCT00646646|4069419|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4245400|NCT00646646|4069415|B5|||Age||years|Mean|33.16666|33.16666|Standard Deviation|2.09797|2.09797|||
4245401|NCT00646646|4069416|B4|||Age||years|Mean|34.93333|34.93333|Standard Deviation|12.49838|12.49838|||
4245402|NCT00646646|4069417|B3|||Age||years|Mean|34.93333|34.93333|Standard Deviation|11.09998|11.09998|||
4245403|NCT00646646|4069418|B2|||Age||years|Mean|32|32.0|Standard Deviation|6.94879|6.94879|||
4245404|NCT00646646|4069419|B1|||Age||years|Mean|30.8|30.8|Standard Deviation|9.22109|9.22109|||
4245405|NCT00646646|4069415|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4245406|NCT00646646|4069416|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4245407|NCT00646646|4069417|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4245408|NCT00646646|4069418|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4245409|NCT00646646|4069419|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4245410|NCT00646646|4069415|B5||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4245411|NCT00646646|4069416|B4||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4245412|NCT00646646|4069417|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4245413|NCT00646646|4069418|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4245414|NCT00646646|4069419|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4245415|NCT00646646|4069415|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4245416|NCT00646646|4069416|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4245417|NCT00646646|4069417|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4245418|NCT00646646|4069418|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4245419|NCT00646646|4069419|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4245420|NCT00646581|4069432|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4245421|NCT00646581|4069433|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4245422|NCT00646581|4069434|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4245423|NCT00646581|4069432|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4245424|NCT00646581|4069433|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4245425|NCT00646581|4069434|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4245426|NCT00646581|4069432|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4245427|NCT00646581|4069433|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4245428|NCT00646581|4069434|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4245429|NCT00646581|4069432|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4245430|NCT00646581|4069433|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4245431|NCT00646581|4069434|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4245432|NCT00646581|4069432|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4245433|NCT00646581|4069433|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4245434|NCT00646581|4069434|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4245435|NCT00646581|4069432|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4245436|NCT00646581|4069433|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4245437|NCT00646581|4069434|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4245438|NCT00646399|4069451|B3|901-1200g||Birth Weight||grams|Mean|1043.4|1043.4|Standard Deviation|86.05|86.05|||
4245439|NCT00646399|4069452|B2|901-1200g||Birth Weight||grams|Mean|1039.0|1039.0|Standard Deviation|85.72|85.72|||
4245440|NCT00646399|4069453|B1|901-1200g||Birth Weight||grams|Mean|1047.8|1047.8|Standard Deviation|86.25|86.25|||
4245441|NCT00646399|4069451|B3|600-900g||Birth Weight||grams|Mean|760.7|760.7|Standard Deviation|87.70|87.7|||
4245442|NCT00646399|4069452|B2|600-900g||Birth Weight||grams|Mean|762.7|762.7|Standard Deviation|85.05|85.05|||
4245443|NCT00646399|4069453|B1|600-900g||Birth Weight||grams|Mean|758.8|758.8|Standard Deviation|90.28|90.28|||
4245444|NCT00646399|4069451|B3|901-1200g||Birth Weight||Participants|Number|827|827.0||||||
4245445|NCT00646399|4069452|B2|901-1200g||Birth Weight||Participants|Number|416|416.0||||||
4245446|NCT00646399|4069453|B1|901-1200g||Birth Weight||Participants|Number|411|411.0||||||
4245447|NCT00646399|4069451|B3|600-900g||Birth Weight||Participants|Number|752|752.0||||||
4245448|NCT00646399|4069452|B2|600-900g||Birth Weight||Participants|Number|371|371.0||||||
4245449|NCT00646399|4069453|B1|600-900g||Birth Weight||Participants|Number|381|381.0||||||
4245450|NCT00646399|4069451|B3|Germany||Region of Enrollment||participants|Number|40|40.0||||||
4245451|NCT00646399|4069452|B2|Germany||Region of Enrollment||participants|Number|17|17.0||||||
4245452|NCT00646399|4069453|B1|Germany||Region of Enrollment||participants|Number|23|23.0||||||
4245453|NCT00646399|4069451|B3|United Kingdom||Region of Enrollment||participants|Number|53|53.0||||||
4245454|NCT00646399|4069452|B2|United Kingdom||Region of Enrollment||participants|Number|28|28.0||||||
4245455|NCT00646399|4069453|B1|United Kingdom||Region of Enrollment||participants|Number|25|25.0||||||
4245456|NCT00646399|4069451|B3|Italy||Region of Enrollment||participants|Number|57|57.0||||||
4245457|NCT00646399|4069452|B2|Italy||Region of Enrollment||participants|Number|30|30.0||||||
4245458|NCT00646399|4069453|B1|Italy||Region of Enrollment||participants|Number|27|27.0||||||
4245459|NCT00646399|4069451|B3|Spain||Region of Enrollment||participants|Number|111|111.0||||||
4245460|NCT00646399|4069452|B2|Spain||Region of Enrollment||participants|Number|57|57.0||||||
4245461|NCT00646399|4069453|B1|Spain||Region of Enrollment||participants|Number|54|54.0||||||
4245462|NCT00646399|4069451|B3|Canada||Region of Enrollment||participants|Number|119|119.0||||||
4245463|NCT00646399|4069452|B2|Canada||Region of Enrollment||participants|Number|59|59.0||||||
4245464|NCT00646399|4069453|B1|Canada||Region of Enrollment||participants|Number|60|60.0||||||
4245465|NCT00646399|4069451|B3|United States||Region of Enrollment||participants|Number|1199|1199.0||||||
4245466|NCT00646399|4069452|B2|United States||Region of Enrollment||participants|Number|596|596.0||||||
4245467|NCT00646399|4069453|B1|United States||Region of Enrollment||participants|Number|603|603.0||||||
4245468|NCT00646399|4069451|B3||Male|Sex: Female, Male||Participants|Count of Participants|796|796.0||||||
4245469|NCT00646399|4069452|B2||Male|Sex: Female, Male||Participants|Count of Participants|394|394.0||||||
4245470|NCT00646399|4069453|B1||Male|Sex: Female, Male||Participants|Count of Participants|402|402.0||||||
4245471|NCT00646399|4069451|B3||Female|Sex: Female, Male||Participants|Count of Participants|783|783.0||||||
4245472|NCT00646399|4069452|B2||Female|Sex: Female, Male||Participants|Count of Participants|393|393.0||||||
4245473|NCT00646399|4069453|B1||Female|Sex: Female, Male||Participants|Count of Participants|390|390.0||||||
4245474|NCT00646399|4069451|B3|901-1200g||Age|Gestational Age|Weeks|Mean|28.0|28.0|Standard Deviation|1.75|1.75|||
4245475|NCT00646399|4069452|B2|901-1200g||Age|Gestational Age|Weeks|Mean|27.9|27.9|Standard Deviation|1.73|1.73|||
4245476|NCT00646399|4069453|B1|901-1200g||Age|Gestational Age|Weeks|Mean|28.0|28.0|Standard Deviation|1.77|1.77|||
4245477|NCT00646399|4069451|B3|600-900g||Age|Gestational Age|Weeks|Mean|25.8|25.8|Standard Deviation|1.76|1.76|||
4245478|NCT00646399|4069452|B2|600-900g||Age|Gestational Age|Weeks|Mean|25.9|25.9|Standard Deviation|1.83|1.83|||
4245479|NCT00646399|4069453|B1|600-900g||Age|Gestational Age|Weeks|Mean|25.7|25.7|Standard Deviation|1.67|1.67|||
4245480|NCT00646282|4069460|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4245481|NCT00646282|4069461|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4245482|NCT00646282|4069462|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4245483|NCT00646282|4069460|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4245484|NCT00646282|4069461|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4245485|NCT00646282|4069462|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4245486|NCT00646282|4069460|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4245487|NCT00646282|4069461|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4245488|NCT00646282|4069462|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4245489|NCT00646282|4069460|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4245490|NCT00646282|4069461|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4245491|NCT00646282|4069462|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4245492|NCT00646282|4069460|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4245493|NCT00646282|4069461|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4245494|NCT00646282|4069462|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4245495|NCT00646048|4069469|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4245496|NCT00646048|4069469|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4245497|NCT00646048|4069469|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4245498|NCT00646048|4069469|B1|||Age||years|Mean|73.1|73.1|Standard Deviation|7.9|7.9|||
4245499|NCT00646048|4069469|B1||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4245500|NCT00646048|4069469|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4245501|NCT00646048|4069469|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4245502|NCT00645970|4069475|B3|Other||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4245503|NCT00645970|4069476|B2|Other||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4245504|NCT00645970|4069477|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4245505|NCT00645970|4069475|B3|Black||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4245506|NCT00645970|4069476|B2|Black||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4245507|NCT00645970|4069477|B1|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4245508|NCT00645970|4069475|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4245509|NCT00645970|4069476|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4245510|NCT00645970|4069477|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4245511|NCT00645970|4069475|B3|White||Race/Ethnicity, Customized||participants|Number|278|278.0||||||
4245512|NCT00645970|4069476|B2|White||Race/Ethnicity, Customized||participants|Number|158|158.0||||||
4245513|NCT00645970|4069477|B1|White||Race/Ethnicity, Customized||participants|Number|120|120.0||||||
4245514|NCT00645970|4069475|B3||Male|Sex: Female, Male||Participants|Count of Participants|327|327.0||||||
4245515|NCT00645970|4069476|B2||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4245516|NCT00645970|4069477|B1||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4245517|NCT00645970|4069475|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4245518|NCT00645970|4069476|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4245519|NCT00645970|4069477|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4245520|NCT00645970|4069475|B3|||Age||years|Mean|35.1|35.1|Standard Deviation|9.7|9.7|||
4245521|NCT00645970|4069476|B2|||Age||years|Mean|36.6|36.6|Standard Deviation|10.3|10.3|||
4245522|NCT00645970|4069477|B1|||Age||years|Mean|32.9|32.9|Standard Deviation|8.2|8.2|||
4245523|NCT00645944|4069484|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4245524|NCT00645944|4069485|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4245525|NCT00645944|4069486|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4245526|NCT00645944|4069484|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4245527|NCT00645944|4069485|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4245528|NCT00645944|4069486|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4245529|NCT00645944|4069484|B3|||Age||years|Mean|46.5|46.5|Standard Deviation|12.9|12.9|||
4245530|NCT00645944|4069485|B2|||Age||years|Mean|47.5|47.5|Standard Deviation|10.2|10.2|||
4245531|NCT00645944|4069486|B1|||Age||years|Mean|45.7|45.7|Standard Deviation|7.4|7.4|||
4245532|NCT00645853|4069493|B3||Male|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
4245533|NCT00645853|4069494|B2||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4245534|NCT00645853|4069495|B1||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4245535|NCT00645853|4069493|B3||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4245536|NCT00645853|4069494|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4245537|NCT00645853|4069495|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4245538|NCT00645853|4069493|B3|||Age||Years|Mean|68.95|68.95|Full Range|||33.0|93.0|
4245539|NCT00645853|4069494|B2|||Age||Years|Mean|68.0|68.0|Full Range|||33.0|86.0|
4245540|NCT00645853|4069495|B1|||Age||Years|Mean|69.9|69.9|Full Range|||34.0|93.0|
4245541|NCT00645827|4069514|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4245542|NCT00645827|4069515|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4245543|NCT00645827|4069516|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4245544|NCT00645827|4069514|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245545|NCT00645827|4069515|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245546|NCT00645827|4069516|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245547|NCT00645827|4069514|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245548|NCT00645827|4069515|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245549|NCT00645827|4069516|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245550|NCT00645827|4069514|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4245551|NCT00645827|4069515|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4245552|NCT00645827|4069516|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4245553|NCT00645827|4069514|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4245554|NCT00645827|4069515|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4245555|NCT00645827|4069516|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4245556|NCT00645827|4069514|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245557|NCT00645827|4069515|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245558|NCT00645827|4069516|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245559|NCT00645827|4069514|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245560|NCT00645827|4069515|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245561|NCT00645827|4069516|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245562|NCT00645827|4069514|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245563|NCT00645827|4069515|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245564|NCT00645827|4069516|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245565|NCT00645827|4069514|B3|Unknown||Sex/Gender, Customized|Gender not collected|participants|Number|31|31.0||||||
4245566|NCT00645827|4069515|B2|Unknown||Sex/Gender, Customized|Gender not collected|participants|Number|17|17.0||||||
4245567|NCT00645827|4069516|B1|Unknown||Sex/Gender, Customized|Gender not collected|participants|Number|14|14.0||||||
4245568|NCT00645827|4069514|B3|Age > 18 years old||Age, Customized|Age > 18 years old|participants|Number|31|31.0||||||
4245569|NCT00645827|4069515|B2|Age > 18 years old||Age, Customized|Age > 18 years old|participants|Number|17|17.0||||||
4245570|NCT00645827|4069516|B1|Age > 18 years old||Age, Customized|Age > 18 years old|participants|Number|14|14.0||||||
4245571|NCT00645788|4069523|B5|||Forced expiratory volume in 1 second (FEV1)||Percentage of predicted FEV1|Mean|54.6|54.6|Standard Deviation|11.4|11.4|||
4245572|NCT00645788|4069524|B4|||Forced expiratory volume in 1 second (FEV1)||Percentage of predicted FEV1|Mean|52.7|52.7|Standard Deviation|10.7|10.7|||
4245573|NCT00645788|4069525|B3|||Forced expiratory volume in 1 second (FEV1)||Percentage of predicted FEV1|Mean|54.8|54.8|Standard Deviation|10.6|10.6|||
4245574|NCT00645788|4069526|B2|||Forced expiratory volume in 1 second (FEV1)||Percentage of predicted FEV1|Mean|54.7|54.7|Standard Deviation|12.3|12.3|||
4245575|NCT00645788|4069527|B1|||Forced expiratory volume in 1 second (FEV1)||Percentage of predicted FEV1|Mean|55.0|55.0|Standard Deviation|11.3|11.3|||
4245576|NCT00645788|4069523|B5||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4245577|NCT00645788|4069524|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4245578|NCT00645788|4069525|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4245579|NCT00645788|4069526|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4245580|NCT00645788|4069527|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4245581|NCT00645788|4069523|B5||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4245582|NCT00645788|4069524|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4245583|NCT00645788|4069525|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4245584|NCT00645788|4069526|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4245585|NCT00645788|4069527|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4245586|NCT00645788|4069523|B5|||Age||Years|Mean|29.3|29.3|Standard Deviation|10.1|10.1|||
4245587|NCT00645788|4069524|B4|||Age||Years|Mean|29.1|29.1|Standard Deviation|9.4|9.4|||
4245588|NCT00645788|4069525|B3|||Age||Years|Mean|31.7|31.7|Standard Deviation|12.1|12.1|||
4245589|NCT00645788|4069526|B2|||Age||Years|Mean|29.3|29.3|Standard Deviation|9.5|9.5|||
4245590|NCT00645788|4069527|B1|||Age||Years|Mean|27.7|27.7|Standard Deviation|9.3|9.3|||
4245591|NCT00645762|4069580|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
4245592|NCT00645762|4069580|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4245593|NCT00645762|4069580|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4245594|NCT00645762|4069580|B1|||Age||years|Mean|47.3|47.3|Standard Deviation|13.7|13.7|||
4245595|NCT00645671|4069586|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4245596|NCT00645671|4069587|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4245597|NCT00645671|4069588|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4245598|NCT00645671|4069586|B3|White||Race/Ethnicity, Customized||participants|Number|362|362.0||||||
4245599|NCT00645671|4069587|B2|White||Race/Ethnicity, Customized||participants|Number|179|179.0||||||
4245600|NCT00645671|4069588|B1|White||Race/Ethnicity, Customized||participants|Number|183|183.0||||||
4245601|NCT00645671|4069586|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4245602|NCT00645671|4069587|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4245603|NCT00645671|4069588|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4245604|NCT00645671|4069586|B3|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4245605|NCT00645671|4069587|B2|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4245606|NCT00645671|4069588|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4245607|NCT00645671|4069586|B3||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4245608|NCT00645671|4069587|B2||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4245609|NCT00645671|4069588|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4245610|NCT00645671|4069586|B3||Female|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
4245611|NCT00645671|4069587|B2||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4245612|NCT00645671|4069588|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4245613|NCT00645671|4069586|B3|||Age||years|Mean|69.2|69.2|Standard Deviation|9.08|9.08|||
4245614|NCT00645671|4069587|B2|||Age||years|Mean|69.2|69.2|Standard Deviation|8.77|8.77|||
4245615|NCT00645671|4069588|B1|||Age||years|Mean|69.2|69.2|Standard Deviation|9.39|9.39|||
4245616|NCT00645593|4069601|B3|||Prior neoadjuvant or or adjuvant chemotherapy||participants|Number|14|14.0||||||
4245617|NCT00645593|4069602|B2|||Prior neoadjuvant or or adjuvant chemotherapy||participants|Number|8|8.0||||||
4245618|NCT00645593|4069603|B1|||Prior neoadjuvant or or adjuvant chemotherapy||participants|Number|6|6.0||||||
4245619|NCT00645593|4069601|B3|||Primary in place|The area of primary cancer (where the cancer originated) remains intact and has not been excised.|participants|Number|65|65.0||||||
4245620|NCT00645593|4069602|B2|||Primary in place|The area of primary cancer (where the cancer originated) remains intact and has not been excised.|participants|Number|47|47.0||||||
4245621|NCT00645593|4069603|B1|||Primary in place|The area of primary cancer (where the cancer originated) remains intact and has not been excised.|participants|Number|18|18.0||||||
4245622|NCT00645593|4069601|B3|||Prior cystectomy or nephroureterectomy|The number of participants that have had a prior cystectomy or nephroureterectomy.|participants|Number|23|23.0||||||
4245623|NCT00645593|4069602|B2|||Prior cystectomy or nephroureterectomy|The number of participants that have had a prior cystectomy or nephroureterectomy.|participants|Number|13|13.0||||||
4245624|NCT00645593|4069603|B1|||Prior cystectomy or nephroureterectomy|The number of participants that have had a prior cystectomy or nephroureterectomy.|participants|Number|10|10.0||||||
4245665|NCT00645567|4069616|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4245625|NCT00645593|4069601|B3|||Unresectable disease|The number of participants presenting with unresectable disease.|participants|Number|5|5.0||||||
4245626|NCT00645593|4069602|B2|||Unresectable disease|The number of participants presenting with unresectable disease.|participants|Number|4|4.0||||||
4245627|NCT00645593|4069603|B1|||Unresectable disease|The number of participants presenting with unresectable disease.|participants|Number|1|1.0||||||
4245628|NCT00645593|4069601|B3|||Local recurrence|The number of participants presenting with local recurrence.|participants|Number|3|3.0||||||
4245629|NCT00645593|4069602|B2|||Local recurrence|The number of participants presenting with local recurrence.|participants|Number|2|2.0||||||
4245630|NCT00645593|4069603|B1|||Local recurrence|The number of participants presenting with local recurrence.|participants|Number|1|1.0||||||
4245631|NCT00645593|4069601|B3|||Distant metastasis|The number of participants presenting with distant metastasis.|participants|Number|80|80.0||||||
4245632|NCT00645593|4069602|B2|||Distant metastasis|The number of participants presenting with distant metastasis.|participants|Number|54|54.0||||||
4245633|NCT00645593|4069603|B1|||Distant metastasis|The number of participants presenting with distant metastasis.|participants|Number|26|26.0||||||
4245634|NCT00645593|4069601|B3|||Bladder primary|Number of participants with cancer that originated within the bladder.|participants|Number|65|65.0||||||
4245635|NCT00645593|4069602|B2|||Bladder primary|Number of participants with cancer that originated within the bladder.|participants|Number|45|45.0||||||
4245636|NCT00645593|4069603|B1|||Bladder primary|Number of participants with cancer that originated within the bladder.|participants|Number|20|20.0||||||
4245637|NCT00645593|4069601|B3|2||ECOG performance status|The Eastern Cooperative Oncology Group (ECOG) performance status is an attempt to quantify cancer patients' general well-being and activities of daily life. The scoring system runs from 0 to 5 where 0 represents perfect health and 5 represents death.|participants|Number|3|3.0||||||
4245638|NCT00645593|4069602|B2|2||ECOG performance status|The Eastern Cooperative Oncology Group (ECOG) performance status is an attempt to quantify cancer patients' general well-being and activities of daily life. The scoring system runs from 0 to 5 where 0 represents perfect health and 5 represents death.|participants|Number|1|1.0||||||
4245639|NCT00645593|4069603|B1|2||ECOG performance status|The Eastern Cooperative Oncology Group (ECOG) performance status is an attempt to quantify cancer patients' general well-being and activities of daily life. The scoring system runs from 0 to 5 where 0 represents perfect health and 5 represents death.|participants|Number|2|2.0||||||
4245640|NCT00645593|4069601|B3|1||ECOG performance status|The Eastern Cooperative Oncology Group (ECOG) performance status is an attempt to quantify cancer patients' general well-being and activities of daily life. The scoring system runs from 0 to 5 where 0 represents perfect health and 5 represents death.|participants|Number|34|34.0||||||
4245641|NCT00645593|4069602|B2|1||ECOG performance status|The Eastern Cooperative Oncology Group (ECOG) performance status is an attempt to quantify cancer patients' general well-being and activities of daily life. The scoring system runs from 0 to 5 where 0 represents perfect health and 5 represents death.|participants|Number|26|26.0||||||
4245642|NCT00645593|4069603|B1|1||ECOG performance status|The Eastern Cooperative Oncology Group (ECOG) performance status is an attempt to quantify cancer patients' general well-being and activities of daily life. The scoring system runs from 0 to 5 where 0 represents perfect health and 5 represents death.|participants|Number|8|8.0||||||
4245643|NCT00645593|4069601|B3|0||ECOG performance status|The Eastern Cooperative Oncology Group (ECOG) performance status is an attempt to quantify cancer patients' general well-being and activities of daily life. The scoring system runs from 0 to 5 where 0 represents perfect health and 5 represents death.|participants|Number|51|51.0||||||
4245644|NCT00645593|4069602|B2|0||ECOG performance status|The Eastern Cooperative Oncology Group (ECOG) performance status is an attempt to quantify cancer patients' general well-being and activities of daily life. The scoring system runs from 0 to 5 where 0 represents perfect health and 5 represents death.|participants|Number|33|33.0||||||
4245645|NCT00645593|4069603|B1|0||ECOG performance status|The Eastern Cooperative Oncology Group (ECOG) performance status is an attempt to quantify cancer patients' general well-being and activities of daily life. The scoring system runs from 0 to 5 where 0 represents perfect health and 5 represents death.|participants|Number|18|18.0||||||
4245646|NCT00645593|4069601|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4245647|NCT00645593|4069602|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4245648|NCT00645593|4069603|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4245649|NCT00645593|4069601|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4245650|NCT00645593|4069602|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4245651|NCT00645593|4069603|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4245652|NCT00645593|4069601|B3|||Age||years|Median|61|61.0|Full Range|||32.0|79.0|
4245653|NCT00645593|4069602|B2|||Age||years|Median|60.9|60.9|Full Range|||32.8|79.4|
4245654|NCT00645593|4069603|B1|||Age||years|Median|65.8|65.8|Full Range|||41.0|79.9|
4245655|NCT00645567|4069616|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4245656|NCT00645567|4069616|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245657|NCT00645567|4069616|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245658|NCT00645567|4069616|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245659|NCT00645567|4069616|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245660|NCT00645567|4069616|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245661|NCT00645567|4069616|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245662|NCT00645567|4069616|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4245663|NCT00645567|4069616|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245664|NCT00645567|4069616|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245666|NCT00645567|4069616|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4245667|NCT00645567|4069616|B1|||Age||years|Mean|47.8|47.8|Standard Deviation|11.1|11.1|||
4245668|NCT00645528|4069624|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4245669|NCT00645528|4069624|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4245670|NCT00645528|4069624|B1|||Age||years|Mean|65|65.0|Standard Deviation|11.3|11.3|||
4245671|NCT00645411|4069633|B5||Male|Sex: Female, Male||Participants|Count of Participants|1857|1857.0||||||
4245672|NCT00645411|4069634|B4||Male|Sex: Female, Male||Participants|Count of Participants|528|528.0||||||
4245673|NCT00645411|4069635|B3||Male|Sex: Female, Male||Participants|Count of Participants|813|813.0||||||
4245674|NCT00645411|4069636|B2||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4245675|NCT00645411|4069637|B1||Male|Sex: Female, Male||Participants|Count of Participants|352|352.0||||||
4245676|NCT00645411|4069633|B5||Female|Sex: Female, Male||Participants|Count of Participants|1747|1747.0||||||
4245677|NCT00645411|4069634|B4||Female|Sex: Female, Male||Participants|Count of Participants|494|494.0||||||
4245678|NCT00645411|4069635|B3||Female|Sex: Female, Male||Participants|Count of Participants|795|795.0||||||
4245679|NCT00645411|4069636|B2||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4245680|NCT00645411|4069637|B1||Female|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
4245681|NCT00645411|4069633|B5|||Age||years|Mean|7.4|7.4|Standard Deviation|3.7|3.7|||
4245682|NCT00645411|4069634|B4|||Age||years|Mean|5.4|5.4|Standard Deviation|1.7|1.7|||
4245683|NCT00645411|4069635|B3|||Age||years|Mean|5.5|5.5|Standard Deviation|1.7|1.7|||
4245684|NCT00645411|4069636|B2|||Age||years|Mean|12.6|12.6|Standard Deviation|2.5|2.5|||
4245685|NCT00645411|4069637|B1|||Age||years|Mean|12.6|12.6|Standard Deviation|2.6|2.6|||
4245686|NCT00645359|4069672|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4245687|NCT00645359|4069672|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4245688|NCT00645359|4069672|B1|||Age||years|Mean|61|61.0|Full Range|||35.0|77.0|
4245689|NCT00645333|4069677|B1|2+||Number of Prior Metastatic Chemotherapy Regimens|Number of prior metastatic chemotherapy regimens. Patients may have more than one prior metastatic chemotherapy regimen and therefore the total numbers for all categories (all prior metastatic chemotherapy regimens) may be greater than the overall number of baseline participants.|Participants|Number|21|21.0||||||
4245690|NCT00645333|4069677|B1|1||Number of Prior Metastatic Chemotherapy Regimens|Number of prior metastatic chemotherapy regimens. Patients may have more than one prior metastatic chemotherapy regimen and therefore the total numbers for all categories (all prior metastatic chemotherapy regimens) may be greater than the overall number of baseline participants.|Participants|Number|2|2.0||||||
4245691|NCT00645333|4069677|B1|0||Number of Prior Metastatic Chemotherapy Regimens|Number of prior metastatic chemotherapy regimens. Patients may have more than one prior metastatic chemotherapy regimen and therefore the total numbers for all categories (all prior metastatic chemotherapy regimens) may be greater than the overall number of baseline participants.|Participants|Number|7|7.0||||||
4245692|NCT00645333|4069677|B1|Chemotherapy and Hormonal Therapy||Prior Therapy For Metastatic Disease|Prior therapy for metastatic disease. Patients may have had more than one prior therapy and therefore the total numbers for all categories (all prior therapies) may be greater than the overall number of baseline participants.|Participants|Number|16|16.0||||||
4245693|NCT00645333|4069677|B1|Hormonal Therapy||Prior Therapy For Metastatic Disease|Prior therapy for metastatic disease. Patients may have had more than one prior therapy and therefore the total numbers for all categories (all prior therapies) may be greater than the overall number of baseline participants.|Participants|Number|0|0.0||||||
4245694|NCT00645333|4069677|B1|Chemotherapy||Prior Therapy For Metastatic Disease|Prior therapy for metastatic disease. Patients may have had more than one prior therapy and therefore the total numbers for all categories (all prior therapies) may be greater than the overall number of baseline participants.|Participants|Number|7|7.0||||||
4245695|NCT00645333|4069677|B1|None||Prior Therapy For Metastatic Disease|Prior therapy for metastatic disease. Patients may have had more than one prior therapy and therefore the total numbers for all categories (all prior therapies) may be greater than the overall number of baseline participants.|Participants|Number|7|7.0||||||
4245696|NCT00645333|4069677|B1|Positive||HER-2/neu status||Participants|Number|2|2.0||||||
4245697|NCT00645333|4069677|B1|Negative||HER-2/neu status||Participants|Number|28|28.0||||||
4245698|NCT00645333|4069677|B1|ER negative and PgR negative||Tumor Hormone Receptor Status||Participants|Number|12|12.0||||||
4245699|NCT00645333|4069677|B1|ER positive/or PgR positive||Tumor Hormone Receptor Status||Participants|Number|18|18.0||||||
4245700|NCT00645333|4069677|B1|>=3||Number of Metastatic Sites||participants|Number|14|14.0||||||
4245701|NCT00645333|4069677|B1|2||Number of Metastatic Sites||participants|Number|6|6.0||||||
4245702|NCT00645333|4069677|B1|1||Number of Metastatic Sites||participants|Number|6|6.0||||||
4245703|NCT00645333|4069677|B1|0||Number of Metastatic Sites||participants|Number|4|4.0||||||
4245704|NCT00645333|4069677|B1|Other||Metastatic sites (multiple sites possible)|Metastatic sites at baseline. Patients may have more than one metastatic site at baseline and therefore the total numbers for all categories (all metastatic sites) may be greater than the overall number of baseline participants.|Participants|Number|7|7.0||||||
4245705|NCT00645333|4069677|B1|Skin||Metastatic sites (multiple sites possible)|Metastatic sites at baseline. Patients may have more than one metastatic site at baseline and therefore the total numbers for all categories (all metastatic sites) may be greater than the overall number of baseline participants.|Participants|Number|5|5.0||||||
4245706|NCT00645333|4069677|B1|Lymph Nodes||Metastatic sites (multiple sites possible)|Metastatic sites at baseline. Patients may have more than one metastatic site at baseline and therefore the total numbers for all categories (all metastatic sites) may be greater than the overall number of baseline participants.|Participants|Number|11|11.0||||||
4245764|NCT00644995|4069758|B1|||Age||years|Mean|45.4|45.4|Standard Deviation|11.8|11.8|||
4245707|NCT00645333|4069677|B1|Liver||Metastatic sites (multiple sites possible)|Metastatic sites at baseline. Patients may have more than one metastatic site at baseline and therefore the total numbers for all categories (all metastatic sites) may be greater than the overall number of baseline participants.|Participants|Number|13|13.0||||||
4245708|NCT00645333|4069677|B1|Lung/Pleura||Metastatic sites (multiple sites possible)|Metastatic sites at baseline. Patients may have more than one metastatic site at baseline and therefore the total numbers for all categories (all metastatic sites) may be greater than the overall number of baseline participants.|Participants|Number|16|16.0||||||
4245709|NCT00645333|4069677|B1|Bone||Metastatic sites (multiple sites possible)|Metastatic sites at baseline. Patients may have more than one metastatic site at baseline and therefore the total numbers for all categories (all metastatic sites) may be greater than the overall number of baseline participants.|Participants|Number|12|12.0||||||
4245710|NCT00645333|4069677|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4245711|NCT00645333|4069677|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4245712|NCT00645333|4069677|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4245713|NCT00645333|4069677|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4245714|NCT00645333|4069677|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4245715|NCT00645333|4069677|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4245716|NCT00645164|4069682|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
4245717|NCT00645164|4069682|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4245718|NCT00645164|4069682|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4245719|NCT00645164|4069682|B1|||Age||years|Mean|38.8|38.8|Standard Deviation|12.1|12.1|||
4245720|NCT00645164|4069682|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4245721|NCT00645164|4069682|B1||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4245722|NCT00645164|4069682|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4245723|NCT00645099|4069686|B3|||Weight||kg|Mean|76.9|76.9|Standard Deviation|16.8|16.8|||
4245724|NCT00645099|4069687|B2|||Weight||kg|Mean|77.9|77.9|Standard Deviation|16.5|16.5|||
4245725|NCT00645099|4069688|B1|||Weight||kg|Mean|75.9|75.9|Standard Deviation|17.0|17.0|||
4245726|NCT00645099|4069686|B3|||Waist||cm|Mean|92.7|92.7|Standard Deviation|14.9|14.9|||
4245727|NCT00645099|4069687|B2|||Waist||cm|Mean|93.3|93.3|Standard Deviation|15.6|15.6|||
4245728|NCT00645099|4069688|B1|||Waist||cm|Mean|92.2|92.2|Standard Deviation|14.4|14.4|||
4245729|NCT00645099|4069686|B3|||Body Mass Index (BMI)||kg/m²|Mean|26.9|26.9|Standard Deviation|6.03|6.03|||
4245730|NCT00645099|4069687|B2|||Body Mass Index (BMI)||kg/m²|Mean|27.0|27.0|Standard Deviation|5.73|5.73|||
4245731|NCT00645099|4069688|B1|||Body Mass Index (BMI)||kg/m²|Mean|26.9|26.9|Standard Deviation|6.31|6.31|||
4245732|NCT00645099|4069686|B3||Male|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
4245733|NCT00645099|4069687|B2||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4245734|NCT00645099|4069688|B1||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4245735|NCT00645099|4069686|B3||Female|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4245736|NCT00645099|4069687|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4245737|NCT00645099|4069688|B1||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4245738|NCT00645099|4069686|B3|||Age||years|Mean|38.2|38.2|Standard Deviation|11.2|11.2|||
4245739|NCT00645099|4069687|B2|||Age||years|Mean|37.5|37.5|Standard Deviation|11.4|11.4|||
4245740|NCT00645099|4069688|B1|||Age||years|Mean|38.8|38.8|Standard Deviation|11.1|11.1|||
4245741|NCT00645047|4069731|B3|United States||Region of Enrollment||participants|Number|207|207.0||||||
4245742|NCT00645047|4069732|B2|United States||Region of Enrollment||participants|Number|104|104.0||||||
4245743|NCT00645047|4069733|B1|United States||Region of Enrollment||participants|Number|103|103.0||||||
4245744|NCT00645047|4069731|B3||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4245745|NCT00645047|4069732|B2||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4245746|NCT00645047|4069733|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4245747|NCT00645047|4069731|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4245748|NCT00645047|4069732|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4245749|NCT00645047|4069733|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4245750|NCT00645047|4069731|B3|||Age||years|Mean|48.4|48.4|Standard Deviation|14.1|14.1|||
4245751|NCT00645047|4069732|B2|||Age||years|Mean|45.6|45.6|Standard Deviation|13.5|13.5|||
4245752|NCT00645047|4069733|B1|||Age||years|Mean|51.4|51.4|Standard Deviation|14.1|14.1|||
4245753|NCT00644995|4069756|B3|United States||Region of Enrollment||participants|Number|52|52.0||||||
4245754|NCT00644995|4069757|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4245755|NCT00644995|4069758|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4245756|NCT00644995|4069756|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4245757|NCT00644995|4069757|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4245758|NCT00644995|4069758|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4245759|NCT00644995|4069756|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4245760|NCT00644995|4069757|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4245761|NCT00644995|4069758|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4245762|NCT00644995|4069756|B3|||Age||years|Mean|44.5|44.5|Standard Deviation|11.8|11.8|||
4245763|NCT00644995|4069757|B2|||Age||years|Mean|43.5|43.5|Standard Deviation|11.8|11.8|||
4245765|NCT00644995|4069756|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4245766|NCT00644995|4069757|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4245767|NCT00644995|4069758|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4245768|NCT00644995|4069756|B3||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4245769|NCT00644995|4069757|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4245770|NCT00644995|4069758|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4245771|NCT00644995|4069756|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4245772|NCT00644995|4069757|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4245773|NCT00644995|4069758|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4245774|NCT00644969|4069777|B3|||Number of participants with suicidal behavior and / or ideation on Columbia Suicide Severity Rating|"Clinician rated assessment of suicidal behavior and / or intent: Suicidal behavior=a yes response to any of 5 suicidal behavior questions on C-SSRS; Suicidal ideation=a yes response to any one of 5 suicidal ideations questions on C-SSRS. Number of participants assessed= 84, 42 for Varenicline and placebo, respectively."|participants|Number|1|1.0||||||
4245775|NCT00644969|4069778|B2|||Number of participants with suicidal behavior and / or ideation on Columbia Suicide Severity Rating|"Clinician rated assessment of suicidal behavior and / or intent: Suicidal behavior=a yes response to any of 5 suicidal behavior questions on C-SSRS; Suicidal ideation=a yes response to any one of 5 suicidal ideations questions on C-SSRS. Number of participants assessed= 84, 42 for Varenicline and placebo, respectively."|participants|Number|1|1.0||||||
4245776|NCT00644969|4069779|B1|||Number of participants with suicidal behavior and / or ideation on Columbia Suicide Severity Rating|"Clinician rated assessment of suicidal behavior and / or intent: Suicidal behavior=a yes response to any of 5 suicidal behavior questions on C-SSRS; Suicidal ideation=a yes response to any one of 5 suicidal ideations questions on C-SSRS. Number of participants assessed= 84, 42 for Varenicline and placebo, respectively."|participants|Number|0|0.0||||||
4245777|NCT00644969|4069777|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4245778|NCT00644969|4069778|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4245779|NCT00644969|4069779|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4245780|NCT00644969|4069777|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4245781|NCT00644969|4069778|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4245782|NCT00644969|4069779|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4245783|NCT00644969|4069777|B3|45 to 64 years||Age, Customized||participants|Number|65|65.0||||||
4245784|NCT00644969|4069778|B2|45 to 64 years||Age, Customized||participants|Number|23|23.0||||||
4245785|NCT00644969|4069779|B1|45 to 64 years||Age, Customized||participants|Number|42|42.0||||||
4245786|NCT00644969|4069777|B3|35 to 44 years||Age, Customized||participants|Number|19|19.0||||||
4245787|NCT00644969|4069778|B2|35 to 44 years||Age, Customized||participants|Number|9|9.0||||||
4245788|NCT00644969|4069779|B1|35 to 44 years||Age, Customized||participants|Number|10|10.0||||||
4245789|NCT00644969|4069777|B3|18 to 34 years||Age, Customized||participants|Number|44|44.0||||||
4245790|NCT00644969|4069778|B2|18 to 34 years||Age, Customized||participants|Number|11|11.0||||||
4245791|NCT00644969|4069779|B1|18 to 34 years||Age, Customized||participants|Number|33|33.0||||||
4245792|NCT00644917|4069826|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4245793|NCT00644917|4069826|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4245794|NCT00644917|4069826|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4245795|NCT00644917|4069826|B1|||Age||years|Mean|37.5|37.5|Standard Deviation|10.7|10.7|||
4245796|NCT00644917|4069826|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4245797|NCT00644917|4069826|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4245798|NCT00644917|4069826|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4245799|NCT00644787|4069834|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4245800|NCT00644787|4069834|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4245801|NCT00644787|4069834|B1|||Age||Years|Mean|68.7|68.7|Standard Deviation|9.52|9.52|||
4245802|NCT00644657|4069864|B1|||"The percentage of platelets that are coated-Platelets as measured by dual-agonist stimulation"|In each patient the percentage of platelets that are collagen coated will be measured in each patient before clopidogrel administration.|percent coated platelets|Mean|40.0|40.0|Standard Deviation|14.3|14.3|||
4245803|NCT00644657|4069864|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4245804|NCT00644657|4069864|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4245805|NCT00644657|4069864|B1|||Age||years|Mean|64|64.0|Standard Deviation|9|9.0|||
4245806|NCT00644592|4069869|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4245807|NCT00644592|4069870|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4245808|NCT00644592|4069871|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4245809|NCT00644592|4069869|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4245810|NCT00644592|4069870|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4245811|NCT00644592|4069871|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4245812|NCT00644592|4069869|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4245813|NCT00644592|4069870|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4245814|NCT00644592|4069871|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4245815|NCT00644592|4069869|B3|||Age||years|Mean|27.5|27.5|Standard Deviation|11.9|11.9|||
4245816|NCT00644592|4069870|B2|||Age||years|Mean|26.0|26.0|Standard Deviation|6.6|6.6|||
4245817|NCT00644592|4069871|B1|||Age||years|Mean|29.2|29.2|Standard Deviation|17.1|17.1|||
4245818|NCT00644592|4069869|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4245819|NCT00644592|4069870|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4245820|NCT00644592|4069871|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4245821|NCT00644592|4069869|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4245822|NCT00644592|4069870|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4245823|NCT00644592|4069871|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4245824|NCT00644592|4069869|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4245825|NCT00644592|4069870|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4245826|NCT00644592|4069871|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4245827|NCT00644358|4069878|B1|||Height||cm|Mean|168.4|168.4|Standard Deviation|9.62|9.62|||
4245828|NCT00644358|4069878|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4245829|NCT00644358|4069878|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245830|NCT00644358|4069878|B1||White|Race (NIH/OMB)||Participants|Count of Participants|479|479.0||||||
4245831|NCT00644358|4069878|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
4245832|NCT00644358|4069878|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4245833|NCT00644358|4069878|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4245834|NCT00644358|4069878|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4245835|NCT00644358|4069878|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4245836|NCT00644358|4069878|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|545|545.0||||||
4245837|NCT00644358|4069878|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4245838|NCT00644358|4069878|B1||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4245839|NCT00644358|4069878|B1||Female|Sex: Female, Male||Participants|Count of Participants|407|407.0||||||
4245840|NCT00644358|4069878|B1|||Age||years|Mean|42.8|42.8|Standard Deviation|12.47|12.47|||
4245841|NCT00644332|4069885|B1|||Weight||kg|Mean|76.7|76.7|Standard Deviation|17.6|17.6|||
4245842|NCT00644332|4069885|B1|||Body Mass Index||kg/m^2|Mean|29.5|29.5|Standard Deviation|6.3|6.3|||
4245843|NCT00644332|4069885|B1|United States||Region of Enrollment||participants|Number|171|171.0||||||
4245844|NCT00644332|4069885|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4245845|NCT00644332|4069885|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|143|143.0||||||
4245846|NCT00644332|4069885|B1|Black||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4245847|NCT00644332|4069885|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4245848|NCT00644332|4069885|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4245849|NCT00644332|4069885|B1||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4245850|NCT00644332|4069885|B1|||Age||years|Mean|64.6|64.6|Standard Deviation|12.0|12.0|||
4245851|NCT00644280|4069898|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4245852|NCT00644280|4069899|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4245853|NCT00644280|4069900|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4245854|NCT00644280|4069898|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4245855|NCT00644280|4069899|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4245856|NCT00644280|4069900|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4245857|NCT00644280|4069898|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4245858|NCT00644280|4069899|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4245859|NCT00644280|4069900|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4245860|NCT00644280|4069898|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4245861|NCT00644280|4069899|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4245862|NCT00644280|4069900|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4245863|NCT00644280|4069898|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4245864|NCT00644280|4069899|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4245865|NCT00644280|4069900|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4245866|NCT00644280|4069898|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4245867|NCT00644280|4069899|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4245868|NCT00644280|4069900|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4245869|NCT00644228|4069909|B3||ISS Stage III|ISS Stage|"International Staging System (ISS) Criteria:~Stage I: Serum β2-microglobulin < 3.5mg/L and Serum Albumin ≥ 3.5 g/dL; expected median survival is 62 months. Stage II*: Not Stage I or III; expected median survival is 44 months. Stage III: Serum β2-microglobulin > 5.5 mg/L; expected median survival is 29 months.~*There are two categories for stage II: serum β2-microglobulin < 3.5 mg/L but serum albumin < 3.5 g/dL; or serum β2-microglobulin 3.5 to < 5.5 mg/L irrespective of the serum albumin level."|Participants|Count of Participants|157|157.0||||||
4245911|NCT00644059|4069939|B3|||Age||Months|Mean|32.2|32.2|Standard Deviation|19.8|19.8|||
4245912|NCT00644059|4069940|B2|||Age||Months|Mean|32.6|32.6|Standard Deviation|20.1|20.1|||
4245913|NCT00644059|4069941|B1|||Age||Months|Mean|31.9|31.9|Standard Deviation|19.8|19.8|||
4245914|NCT00643916|4070027|B7|United States||Region of Enrollment||participants|Number|378|378.0||||||
4245870|NCT00644228|4069910|B2||ISS Stage III|ISS Stage|"International Staging System (ISS) Criteria:~Stage I: Serum β2-microglobulin < 3.5mg/L and Serum Albumin ≥ 3.5 g/dL; expected median survival is 62 months. Stage II*: Not Stage I or III; expected median survival is 44 months. Stage III: Serum β2-microglobulin > 5.5 mg/L; expected median survival is 29 months.~*There are two categories for stage II: serum β2-microglobulin < 3.5 mg/L but serum albumin < 3.5 g/dL; or serum β2-microglobulin 3.5 to < 5.5 mg/L irrespective of the serum albumin level."|Participants|Count of Participants|78|78.0||||||
4245871|NCT00644228|4069911|B1||ISS Stage III|ISS Stage|"International Staging System (ISS) Criteria:~Stage I: Serum β2-microglobulin < 3.5mg/L and Serum Albumin ≥ 3.5 g/dL; expected median survival is 62 months. Stage II*: Not Stage I or III; expected median survival is 44 months. Stage III: Serum β2-microglobulin > 5.5 mg/L; expected median survival is 29 months.~*There are two categories for stage II: serum β2-microglobulin < 3.5 mg/L but serum albumin < 3.5 g/dL; or serum β2-microglobulin 3.5 to < 5.5 mg/L irrespective of the serum albumin level."|Participants|Count of Participants|79|79.0||||||
4245872|NCT00644228|4069909|B3||ISS Stage I or II|ISS Stage|"International Staging System (ISS) Criteria:~Stage I: Serum β2-microglobulin < 3.5mg/L and Serum Albumin ≥ 3.5 g/dL; expected median survival is 62 months. Stage II*: Not Stage I or III; expected median survival is 44 months. Stage III: Serum β2-microglobulin > 5.5 mg/L; expected median survival is 29 months.~*There are two categories for stage II: serum β2-microglobulin < 3.5 mg/L but serum albumin < 3.5 g/dL; or serum β2-microglobulin 3.5 to < 5.5 mg/L irrespective of the serum albumin level."|Participants|Count of Participants|314|314.0||||||
4245873|NCT00644228|4069910|B2||ISS Stage I or II|ISS Stage|"International Staging System (ISS) Criteria:~Stage I: Serum β2-microglobulin < 3.5mg/L and Serum Albumin ≥ 3.5 g/dL; expected median survival is 62 months. Stage II*: Not Stage I or III; expected median survival is 44 months. Stage III: Serum β2-microglobulin > 5.5 mg/L; expected median survival is 29 months.~*There are two categories for stage II: serum β2-microglobulin < 3.5 mg/L but serum albumin < 3.5 g/dL; or serum β2-microglobulin 3.5 to < 5.5 mg/L irrespective of the serum albumin level."|Participants|Count of Participants|164|164.0||||||
4245874|NCT00644228|4069911|B1||ISS Stage I or II|ISS Stage|"International Staging System (ISS) Criteria:~Stage I: Serum β2-microglobulin < 3.5mg/L and Serum Albumin ≥ 3.5 g/dL; expected median survival is 62 months. Stage II*: Not Stage I or III; expected median survival is 44 months. Stage III: Serum β2-microglobulin > 5.5 mg/L; expected median survival is 29 months.~*There are two categories for stage II: serum β2-microglobulin < 3.5 mg/L but serum albumin < 3.5 g/dL; or serum β2-microglobulin 3.5 to < 5.5 mg/L irrespective of the serum albumin level."|Participants|Count of Participants|150|150.0||||||
4245875|NCT00644228|4069909|B3||Male|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4245876|NCT00644228|4069910|B2||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4245877|NCT00644228|4069911|B1||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4245878|NCT00644228|4069909|B3||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4245879|NCT00644228|4069910|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4245880|NCT00644228|4069911|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4245881|NCT00644228|4069909|B3||>=65 years|Age||Participants|Count of Participants|202|202.0||||||
4245882|NCT00644228|4069910|B2||>=65 years|Age||Participants|Count of Participants|93|93.0||||||
4245883|NCT00644228|4069911|B1||>=65 years|Age||Participants|Count of Participants|109|109.0||||||
4245884|NCT00644228|4069909|B3||Between 18 and 65 years|Age||Participants|Count of Participants|269|269.0||||||
4245885|NCT00644228|4069910|B2||Between 18 and 65 years|Age||Participants|Count of Participants|149|149.0||||||
4245886|NCT00644228|4069911|B1||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
4245887|NCT00644228|4069909|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4245888|NCT00644228|4069910|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4245889|NCT00644228|4069911|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4245890|NCT00644189|4069922|B1||lymphoplasmacytic lymphoma (LPL)|Histologies||Participants|Count of Participants|1|1.0||||||
4245891|NCT00644189|4069922|B1||T-cell lymphoma (TCL)|Histologies||Participants|Count of Participants|0|0.0||||||
4245892|NCT00644189|4069922|B1||mantle cell lymphoma (MCL)|Histologies||Participants|Count of Participants|6|6.0||||||
4245893|NCT00644189|4069922|B1||marginal zone lymphoma (MZL)|Histologies||Participants|Count of Participants|7|7.0||||||
4245894|NCT00644189|4069922|B1||diffuse large B-cell lymphoma (DLBCL)|Histologies||Participants|Count of Participants|3|3.0||||||
4245895|NCT00644189|4069922|B1||small lymphocytic lymphoma (SLL)|Histologies||Participants|Count of Participants|6|6.0||||||
4245896|NCT00644189|4069922|B1||follicular lymphoma (FL)|Histologies||Participants|Count of Participants|7|7.0||||||
4245897|NCT00644189|4069922|B1|||Number of prior regimens||number of prior regimens|Median|1|1.0|Full Range|||1.0|7.0|
4245898|NCT00644189|4069922|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4245899|NCT00644189|4069922|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4245900|NCT00644189|4069922|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4245901|NCT00644189|4069922|B1|||Age||years|Median|62|62.0|Full Range|||47.0|88.0|
4245902|NCT00644059|4069938|B4||Male|Sex: Female, Male||Participants|Count of Participants|2553|2553.0||||||
4245903|NCT00644059|4069939|B3||Male|Sex: Female, Male||Participants|Count of Participants|550|550.0||||||
4245904|NCT00644059|4069940|B2||Male|Sex: Female, Male||Participants|Count of Participants|946|946.0||||||
4245905|NCT00644059|4069941|B1||Male|Sex: Female, Male||Participants|Count of Participants|1057|1057.0||||||
4245906|NCT00644059|4069938|B4||Female|Sex: Female, Male||Participants|Count of Participants|2349|2349.0||||||
4245907|NCT00644059|4069939|B3||Female|Sex: Female, Male||Participants|Count of Participants|484|484.0||||||
4245908|NCT00644059|4069940|B2||Female|Sex: Female, Male||Participants|Count of Participants|903|903.0||||||
4245909|NCT00644059|4069941|B1||Female|Sex: Female, Male||Participants|Count of Participants|962|962.0||||||
4245910|NCT00644059|4069938|B4|||Age||Months|Mean|32.2|32.2|Standard Deviation|19.9|19.9|||
4245915|NCT00643916|4070028|B6|United States||Region of Enrollment||participants|Number|67|67.0||||||
4245916|NCT00643916|4070029|B5|United States||Region of Enrollment||participants|Number|59|59.0||||||
4245917|NCT00643916|4070030|B4|United States||Region of Enrollment||participants|Number|62|62.0||||||
4245918|NCT00643916|4070031|B3|United States||Region of Enrollment||participants|Number|68|68.0||||||
4245919|NCT00643916|4070032|B2|United States||Region of Enrollment||participants|Number|67|67.0||||||
4245920|NCT00643916|4070033|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4245921|NCT00643916|4070027|B7||Male|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4245922|NCT00643916|4070028|B6||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4245923|NCT00643916|4070029|B5||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4245924|NCT00643916|4070030|B4||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4245925|NCT00643916|4070031|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4245926|NCT00643916|4070032|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4245927|NCT00643916|4070033|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4245928|NCT00643916|4070027|B7||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4245929|NCT00643916|4070028|B6||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4245930|NCT00643916|4070029|B5||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4245931|NCT00643916|4070030|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4245932|NCT00643916|4070031|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4245933|NCT00643916|4070032|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4245934|NCT00643916|4070033|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4245935|NCT00643916|4070027|B7|||Age||Months|Mean|18.7|18.7|Standard Deviation|14.6|14.6|||
4245936|NCT00643916|4070028|B6|||Age||Months|Mean|48.0|48.0|Standard Deviation|10.3|10.3|||
4245937|NCT00643916|4070029|B5|||Age||Months|Mean|17.9|17.9|Standard Deviation|0.3|0.3|||
4245938|NCT00643916|4070030|B4|||Age||Months|Mean|14.9|14.9|Standard Deviation|0.3|0.3|||
4245939|NCT00643916|4070031|B3|||Age||Months|Mean|11.9|11.9|Standard Deviation|0.3|0.3|||
4245940|NCT00643916|4070032|B2|||Age||Months|Mean|8.9|8.9|Standard Deviation|0.3|0.3|||
4245941|NCT00643916|4070033|B1|||Age||Months|Mean|8.9|8.9|Standard Deviation|0.4|0.4|||
4245942|NCT00643916|4070027|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4245943|NCT00643916|4070028|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4245944|NCT00643916|4070029|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4245945|NCT00643916|4070030|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4245946|NCT00643916|4070031|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4245947|NCT00643916|4070032|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4245948|NCT00643916|4070033|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4245949|NCT00643916|4070027|B7||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4245950|NCT00643916|4070028|B6||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4245951|NCT00643916|4070029|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4245952|NCT00643916|4070030|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4245953|NCT00643916|4070031|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4245954|NCT00643916|4070032|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4245955|NCT00643916|4070033|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4245956|NCT00643916|4070027|B7||<=18 years|Age||Participants|Count of Participants|378|378.0||||||
4245957|NCT00643916|4070028|B6||<=18 years|Age||Participants|Count of Participants|67|67.0||||||
4245958|NCT00643916|4070029|B5||<=18 years|Age||Participants|Count of Participants|59|59.0||||||
4245959|NCT00643916|4070030|B4||<=18 years|Age||Participants|Count of Participants|62|62.0||||||
4245960|NCT00643916|4070031|B3||<=18 years|Age||Participants|Count of Participants|68|68.0||||||
4245961|NCT00643916|4070032|B2||<=18 years|Age||Participants|Count of Participants|67|67.0||||||
4245962|NCT00643916|4070033|B1||<=18 years|Age||Participants|Count of Participants|55|55.0||||||
4245963|NCT00643851|4070058|B4|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4245964|NCT00643851|4070059|B3|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4245965|NCT00643851|4070060|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4245966|NCT00643851|4070061|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4245967|NCT00643851|4070058|B4|Asian||Race/Ethnicity, Customized||Participants|Number|100|100.0||||||
4245968|NCT00643851|4070059|B3|Asian||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
4245969|NCT00643851|4070060|B2|Asian||Race/Ethnicity, Customized||Participants|Number|33|33.0||||||
4245970|NCT00643851|4070061|B1|Asian||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
4245971|NCT00643851|4070058|B4|Black/African American||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4245972|NCT00643851|4070059|B3|Black/African American||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4245973|NCT00643851|4070060|B2|Black/African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4245974|NCT00643851|4070061|B1|Black/African American||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4245975|NCT00643851|4070058|B4|White||Race/Ethnicity, Customized||Participants|Number|477|477.0||||||
4245976|NCT00643851|4070059|B3|White||Race/Ethnicity, Customized||Participants|Number|158|158.0||||||
4245977|NCT00643851|4070060|B2|White||Race/Ethnicity, Customized||Participants|Number|166|166.0||||||
4245978|NCT00643851|4070061|B1|White||Race/Ethnicity, Customized||Participants|Number|153|153.0||||||
4245979|NCT00643851|4070058|B4|Female||Sex/Gender, Customized||Participants|Number|333|333.0||||||
4245980|NCT00643851|4070059|B3|Female||Sex/Gender, Customized||Participants|Number|106|106.0||||||
4245981|NCT00643851|4070060|B2|Female||Sex/Gender, Customized||Participants|Number|111|111.0||||||
4245982|NCT00643851|4070061|B1|Female||Sex/Gender, Customized||Participants|Number|116|116.0||||||
4245983|NCT00643851|4070058|B4|Male||Sex/Gender, Customized||Participants|Number|265|265.0||||||
4245984|NCT00643851|4070059|B3|Male||Sex/Gender, Customized||Participants|Number|95|95.0||||||
4245985|NCT00643851|4070060|B2|Male||Sex/Gender, Customized||Participants|Number|92|92.0||||||
4245986|NCT00643851|4070061|B1|Male||Sex/Gender, Customized||Participants|Number|78|78.0||||||
4245987|NCT00643851|4070058|B4|75 years and older||Age, Customized||Participants|Number|4|4.0||||||
4245988|NCT00643851|4070059|B3|75 years and older||Age, Customized||Participants|Number|1|1.0||||||
4245989|NCT00643851|4070060|B2|75 years and older||Age, Customized||Participants|Number|3|3.0||||||
4245990|NCT00643851|4070061|B1|75 years and older||Age, Customized||Participants|Number|0|0.0||||||
4245991|NCT00643851|4070058|B4|65 to younger than 75 years||Age, Customized||Participants|Number|50|50.0||||||
4245992|NCT00643851|4070059|B3|65 to younger than 75 years||Age, Customized||Participants|Number|16|16.0||||||
4245993|NCT00643851|4070060|B2|65 to younger than 75 years||Age, Customized||Participants|Number|17|17.0||||||
4245994|NCT00643851|4070061|B1|65 to younger than 75 years||Age, Customized||Participants|Number|17|17.0||||||
4245995|NCT00643851|4070058|B4|Younger than 65 years||Age, Customized||Participants|Number|544|544.0||||||
4245996|NCT00643851|4070059|B3|Younger than 65 years||Age, Customized||Participants|Number|184|184.0||||||
4245997|NCT00643851|4070060|B2|Younger than 65 years||Age, Customized||Participants|Number|183|183.0||||||
4245998|NCT00643851|4070061|B1|Younger than 65 years||Age, Customized||Participants|Number|177|177.0||||||
4245999|NCT00643851|4070058|B4|||Age||Years|Mean|52.0|52.0|Standard Deviation|9.77|9.77|||
4246000|NCT00643851|4070059|B3|||Age||Years|Mean|51.8|51.8|Standard Deviation|9.80|9.8|||
4246001|NCT00643851|4070060|B2|||Age||Years|Mean|52.3|52.3|Standard Deviation|10.20|10.2|||
4246002|NCT00643851|4070061|B1|||Age||Years|Mean|51.7|51.7|Standard Deviation|9.31|9.31|||
4246003|NCT00643760|4070086|B6|Not Provided||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|5|5.0||||||
4246004|NCT00643760|4070087|B5|Not Provided||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|2|2.0||||||
4246005|NCT00643760|4070088|B4|Not Provided||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|2|2.0||||||
4246006|NCT00643760|4070089|B3|Not Provided||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|1|1.0||||||
4246007|NCT00643760|4070090|B2|Not Provided||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|0|0.0||||||
4246008|NCT00643760|4070091|B1|Not Provided||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|0|0.0||||||
4246009|NCT00643760|4070086|B6|Mixed Race||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|2|2.0||||||
4246010|NCT00643760|4070087|B5|Mixed Race||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|0|0.0||||||
4246011|NCT00643760|4070088|B4|Mixed Race||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|1|1.0||||||
4246012|NCT00643760|4070089|B3|Mixed Race||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|1|1.0||||||
4246013|NCT00643760|4070090|B2|Mixed Race||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|0|0.0||||||
4246014|NCT00643760|4070091|B1|Mixed Race||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|0|0.0||||||
4246015|NCT00643760|4070086|B6|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|328|328.0||||||
4246016|NCT00643760|4070087|B5|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|52|52.0||||||
4246017|NCT00643760|4070088|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|89|89.0||||||
4246018|NCT00643760|4070089|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|45|45.0||||||
4246019|NCT00643760|4070090|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|44|44.0||||||
4246020|NCT00643760|4070091|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|98|98.0||||||
4246021|NCT00643760|4070086|B6|White - Arabic/North African Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|5|5.0||||||
4246022|NCT00643760|4070087|B5|White - Arabic/North African Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|0|0.0||||||
4246023|NCT00643760|4070088|B4|White - Arabic/North African Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|1|1.0||||||
4246024|NCT00643760|4070089|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|2|2.0||||||
4246025|NCT00643760|4070090|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|2|2.0||||||
4246026|NCT00643760|4070091|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|0|0.0||||||
4246027|NCT00643760|4070086|B6|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|3|3.0||||||
4246028|NCT00643760|4070087|B5|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|0|0.0||||||
4246029|NCT00643760|4070088|B4|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|2|2.0||||||
4246030|NCT00643760|4070089|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|0|0.0||||||
4246117|NCT00643448|4070269|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4246031|NCT00643760|4070090|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|1|1.0||||||
4246032|NCT00643760|4070091|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|0|0.0||||||
4246033|NCT00643760|4070086|B6|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|1|1.0||||||
4246034|NCT00643760|4070087|B5|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|0|0.0||||||
4246035|NCT00643760|4070088|B4|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|1|1.0||||||
4246036|NCT00643760|4070089|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|0|0.0||||||
4246037|NCT00643760|4070090|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|0|0.0||||||
4246038|NCT00643760|4070091|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|0|0.0||||||
4246039|NCT00643760|4070086|B6|American Indian or Alaskan Native||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|2|2.0||||||
4246040|NCT00643760|4070087|B5|American Indian or Alaskan Native||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|0|0.0||||||
4246041|NCT00643760|4070088|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|0|0.0||||||
4246042|NCT00643760|4070089|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|0|0.0||||||
4246043|NCT00643760|4070090|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|0|0.0||||||
4246044|NCT00643760|4070091|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|2|2.0||||||
4246045|NCT00643760|4070086|B6|African American/African Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|74|74.0||||||
4246046|NCT00643760|4070087|B5|African American/African Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|12|12.0||||||
4246047|NCT00643760|4070088|B4|African American/African Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|20|20.0||||||
4246113|NCT00643487|4070263|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4246048|NCT00643760|4070089|B3|African American/African Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|7|7.0||||||
4246049|NCT00643760|4070090|B2|African American/African Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|15|15.0||||||
4246050|NCT00643760|4070091|B1|African American/African Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|participants|Number|20|20.0||||||
4246051|NCT00643760|4070086|B6||Male|Sex: Female, Male|Gender of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|Participants|Count of Participants|249|249.0||||||
4246052|NCT00643760|4070087|B5||Male|Sex: Female, Male|Gender of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|Participants|Count of Participants|34|34.0||||||
4246053|NCT00643760|4070088|B4||Male|Sex: Female, Male|Gender of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|Participants|Count of Participants|71|71.0||||||
4246054|NCT00643760|4070089|B3||Male|Sex: Female, Male|Gender of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|Participants|Count of Participants|37|37.0||||||
4246055|NCT00643760|4070090|B2||Male|Sex: Female, Male|Gender of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|Participants|Count of Participants|34|34.0||||||
4246056|NCT00643760|4070091|B1||Male|Sex: Female, Male|Gender of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|Participants|Count of Participants|73|73.0||||||
4246057|NCT00643760|4070086|B6||Female|Sex: Female, Male|Gender of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|Participants|Count of Participants|171|171.0||||||
4246058|NCT00643760|4070087|B5||Female|Sex: Female, Male|Gender of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|Participants|Count of Participants|32|32.0||||||
4246059|NCT00643760|4070088|B4||Female|Sex: Female, Male|Gender of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|Participants|Count of Participants|45|45.0||||||
4246060|NCT00643760|4070089|B3||Female|Sex: Female, Male|Gender of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|Participants|Count of Participants|19|19.0||||||
4246061|NCT00643760|4070090|B2||Female|Sex: Female, Male|Gender of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|Participants|Count of Participants|28|28.0||||||
4246062|NCT00643760|4070091|B1||Female|Sex: Female, Male|Gender of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|Participants|Count of Participants|47|47.0||||||
4246063|NCT00643760|4070086|B6|||Age|Age in years of the Intent-to-Treat (ITT) Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|Years|Mean|58.7|58.7|Standard Deviation|10.20|10.2|||
4246064|NCT00643760|4070087|B5|||Age|Age in years of the Intent-to-Treat (ITT) Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|Years|Mean|57.7|57.7|Standard Deviation|10.59|10.59|||
4246114|NCT00643487|4070263|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4246115|NCT00643448|4070267|B4||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4246116|NCT00643448|4070268|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4246065|NCT00643760|4070088|B4|||Age|Age in years of the Intent-to-Treat (ITT) Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|Years|Mean|57.5|57.5|Standard Deviation|9.87|9.87|||
4246066|NCT00643760|4070089|B3|||Age|Age in years of the Intent-to-Treat (ITT) Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|Years|Mean|60.8|60.8|Standard Deviation|8.97|8.97|||
4246067|NCT00643760|4070090|B2|||Age|Age in years of the Intent-to-Treat (ITT) Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|Years|Mean|57.5|57.5|Standard Deviation|10.32|10.32|||
4246068|NCT00643760|4070091|B1|||Age|Age in years of the Intent-to-Treat (ITT) Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics. This population does not include all participants randomized to study treatment.|Years|Mean|60.1|60.1|Standard Deviation|10.63|10.63|||
4246069|NCT00643682|4070197|B3|United States||Region of Enrollment||participants|Number|969|969.0||||||
4246070|NCT00643682|4070198|B2|United States||Region of Enrollment||participants|Number|492|492.0||||||
4246071|NCT00643682|4070199|B1|United States||Region of Enrollment||participants|Number|477|477.0||||||
4246072|NCT00643682|4070197|B3||Male|Sex: Female, Male||Participants|Count of Participants|403|403.0||||||
4246073|NCT00643682|4070198|B2||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4246074|NCT00643682|4070199|B1||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4246075|NCT00643682|4070197|B3||Female|Sex: Female, Male||Participants|Count of Participants|566|566.0||||||
4246076|NCT00643682|4070198|B2||Female|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
4246077|NCT00643682|4070199|B1||Female|Sex: Female, Male||Participants|Count of Participants|279|279.0||||||
4246078|NCT00643682|4070197|B3|||Age||years|Mean|57|57.0|Standard Deviation|8|8.0|||
4246079|NCT00643682|4070198|B2|||Age||years|Mean|57|57.0|Standard Deviation|7|7.0|||
4246080|NCT00643682|4070199|B1|||Age||years|Mean|57|57.0|Standard Deviation|8|8.0|||
4246081|NCT00643604|4070212|B1|||Baseline 6 Minute Walk Distance (6MWD)||meters|Mean|466.6|466.6|Full Range|||343.0|565.0|
4246082|NCT00643604|4070212|B1|Class III||World Health Organization (WHO) functional Class at time of transition|Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Inability to carry out any physical activity without symptoms.|participants|Number|2|2.0||||||
4246083|NCT00643604|4070212|B1|Class II||World Health Organization (WHO) functional Class at time of transition|Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Inability to carry out any physical activity without symptoms.|participants|Number|5|5.0||||||
4246084|NCT00643604|4070212|B1|Portal Hypertension||PAH etiology||participants|Number|1|1.0||||||
4246085|NCT00643604|4070212|B1|Collagen Vascular Disease||PAH etiology||participants|Number|1|1.0||||||
4246086|NCT00643604|4070212|B1|Idiopathic PAH||PAH etiology||participants|Number|5|5.0||||||
4246087|NCT00643604|4070212|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4246088|NCT00643604|4070212|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4246089|NCT00643604|4070212|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4246090|NCT00643604|4070212|B1|||Age||years|Mean|43.6|43.6|Full Range|32-58|32.0|32.0|58.0|
4246091|NCT00643604|4070212|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4246092|NCT00643604|4070212|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4246093|NCT00643604|4070212|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4246094|NCT00643578|4070229|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4246095|NCT00643578|4070229|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4246096|NCT00643578|4070229|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4246097|NCT00643578|4070229|B1|||Age||years|Mean|36.8|36.8|Standard Deviation|14.5|14.5|||
4246098|NCT00643578|4070229|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4246099|NCT00643578|4070229|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4246100|NCT00643578|4070229|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4246101|NCT00643565|4070238|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4246102|NCT00643565|4070239|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4246103|NCT00643565|4070240|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4246104|NCT00643565|4070238|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4246105|NCT00643565|4070239|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4246106|NCT00643565|4070240|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4246107|NCT00643565|4070238|B3|||Age||years|Mean|10.4|10.4|Standard Deviation|4.9|4.9|||
4246108|NCT00643565|4070239|B2|||Age||years|Mean|10.3|10.3|Standard Deviation|4.9|4.9|||
4246109|NCT00643565|4070240|B1|||Age||years|Mean|10.5|10.5|Standard Deviation|4.8|4.8|||
4246110|NCT00643487|4070263|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4246111|NCT00643487|4070263|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4246112|NCT00643487|4070263|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4246118|NCT00643448|4070270|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4246119|NCT00643448|4070267|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4246120|NCT00643448|4070268|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4246121|NCT00643448|4070269|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4246122|NCT00643448|4070270|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4246123|NCT00643448|4070267|B4|Age (years)||Age||Years|Mean|64.5|64.5|Standard Deviation|9.5|9.5|||
4246124|NCT00643448|4070268|B3|Age (years)||Age||Years|Mean|64|64.0|Standard Deviation|9|9.0|||
4246125|NCT00643448|4070269|B2|Age (years)||Age||Years|Mean|64|64.0|Standard Deviation|10|10.0|||
4246126|NCT00643448|4070270|B1|Age (years)||Age||Years|Mean|65|65.0|Standard Deviation|10|10.0|||
4246127|NCT00643201|4070287|B3|Adjudicated PE||Index Event Classification|Participants with events of either deep vein thrombosis (DVT) or pulmonary embolism (PE) were enrolled. If a participant had both DVT and PE, the participant was classified to PE. Each participant was counted once in a category but could be counted in more than one category. An Independent Central Adjudication Committee (ICAC) reviewed participants in a blinded manner. The ICAC included a chairman and independent reviewers who were physicians with experience in vascular medicine and thrombosis. The ICAC adjudicated all index events (proximal DVT and/or PE).|participants|Number|1836|1836.0||||||
4246128|NCT00643201|4070288|B2|Adjudicated PE||Index Event Classification|Participants with events of either deep vein thrombosis (DVT) or pulmonary embolism (PE) were enrolled. If a participant had both DVT and PE, the participant was classified to PE. Each participant was counted once in a category but could be counted in more than one category. An Independent Central Adjudication Committee (ICAC) reviewed participants in a blinded manner. The ICAC included a chairman and independent reviewers who were physicians with experience in vascular medicine and thrombosis. The ICAC adjudicated all index events (proximal DVT and/or PE).|participants|Number|906|906.0||||||
4246129|NCT00643201|4070289|B1|Adjudicated PE||Index Event Classification|Participants with events of either deep vein thrombosis (DVT) or pulmonary embolism (PE) were enrolled. If a participant had both DVT and PE, the participant was classified to PE. Each participant was counted once in a category but could be counted in more than one category. An Independent Central Adjudication Committee (ICAC) reviewed participants in a blinded manner. The ICAC included a chairman and independent reviewers who were physicians with experience in vascular medicine and thrombosis. The ICAC adjudicated all index events (proximal DVT and/or PE).|participants|Number|930|930.0||||||
4246130|NCT00643201|4070287|B3|Adjudicated Proximal DVT||Index Event Classification|Participants with events of either deep vein thrombosis (DVT) or pulmonary embolism (PE) were enrolled. If a participant had both DVT and PE, the participant was classified to PE. Each participant was counted once in a category but could be counted in more than one category. An Independent Central Adjudication Committee (ICAC) reviewed participants in a blinded manner. The ICAC included a chairman and independent reviewers who were physicians with experience in vascular medicine and thrombosis. The ICAC adjudicated all index events (proximal DVT and/or PE).|participants|Number|3532|3532.0||||||
4246131|NCT00643201|4070288|B2|Adjudicated Proximal DVT||Index Event Classification|Participants with events of either deep vein thrombosis (DVT) or pulmonary embolism (PE) were enrolled. If a participant had both DVT and PE, the participant was classified to PE. Each participant was counted once in a category but could be counted in more than one category. An Independent Central Adjudication Committee (ICAC) reviewed participants in a blinded manner. The ICAC included a chairman and independent reviewers who were physicians with experience in vascular medicine and thrombosis. The ICAC adjudicated all index events (proximal DVT and/or PE).|participants|Number|1783|1783.0||||||
4246132|NCT00643201|4070289|B1|Adjudicated Proximal DVT||Index Event Classification|Participants with events of either deep vein thrombosis (DVT) or pulmonary embolism (PE) were enrolled. If a participant had both DVT and PE, the participant was classified to PE. Each participant was counted once in a category but could be counted in more than one category. An Independent Central Adjudication Committee (ICAC) reviewed participants in a blinded manner. The ICAC included a chairman and independent reviewers who were physicians with experience in vascular medicine and thrombosis. The ICAC adjudicated all index events (proximal DVT and/or PE).|participants|Number|1749|1749.0||||||
4246133|NCT00643201|4070287|B3|PE||Index Event Classification|Participants with events of either deep vein thrombosis (DVT) or pulmonary embolism (PE) were enrolled. If a participant had both DVT and PE, the participant was classified to PE. Each participant was counted once in a category but could be counted in more than one category. An Independent Central Adjudication Committee (ICAC) reviewed participants in a blinded manner. The ICAC included a chairman and independent reviewers who were physicians with experience in vascular medicine and thrombosis. The ICAC adjudicated all index events (proximal DVT and/or PE).|participants|Number|1803|1803.0||||||
4246134|NCT00643201|4070288|B2|PE||Index Event Classification|Participants with events of either deep vein thrombosis (DVT) or pulmonary embolism (PE) were enrolled. If a participant had both DVT and PE, the participant was classified to PE. Each participant was counted once in a category but could be counted in more than one category. An Independent Central Adjudication Committee (ICAC) reviewed participants in a blinded manner. The ICAC included a chairman and independent reviewers who were physicians with experience in vascular medicine and thrombosis. The ICAC adjudicated all index events (proximal DVT and/or PE).|participants|Number|890|890.0||||||
4246135|NCT00643201|4070289|B1|PE||Index Event Classification|Participants with events of either deep vein thrombosis (DVT) or pulmonary embolism (PE) were enrolled. If a participant had both DVT and PE, the participant was classified to PE. Each participant was counted once in a category but could be counted in more than one category. An Independent Central Adjudication Committee (ICAC) reviewed participants in a blinded manner. The ICAC included a chairman and independent reviewers who were physicians with experience in vascular medicine and thrombosis. The ICAC adjudicated all index events (proximal DVT and/or PE).|participants|Number|913|913.0||||||
4246207|NCT00643201|4070289|B1|India||Region of Enrollment||participants|Number|101|101.0||||||
4246208|NCT00643201|4070287|B3|Italy||Region of Enrollment||participants|Number|336|336.0||||||
4246209|NCT00643201|4070288|B2|Italy||Region of Enrollment||participants|Number|169|169.0||||||
4246210|NCT00643201|4070289|B1|Italy||Region of Enrollment||participants|Number|167|167.0||||||
4246211|NCT00643201|4070287|B3|Russian Federation||Region of Enrollment||participants|Number|352|352.0||||||
4246136|NCT00643201|4070287|B3|Proximal DVT||Index Event Classification|Participants with events of either deep vein thrombosis (DVT) or pulmonary embolism (PE) were enrolled. If a participant had both DVT and PE, the participant was classified to PE. Each participant was counted once in a category but could be counted in more than one category. An Independent Central Adjudication Committee (ICAC) reviewed participants in a blinded manner. The ICAC included a chairman and independent reviewers who were physicians with experience in vascular medicine and thrombosis. The ICAC adjudicated all index events (proximal DVT and/or PE).|participants|Number|3592|3592.0||||||
4246137|NCT00643201|4070288|B2|Proximal DVT||Index Event Classification|Participants with events of either deep vein thrombosis (DVT) or pulmonary embolism (PE) were enrolled. If a participant had both DVT and PE, the participant was classified to PE. Each participant was counted once in a category but could be counted in more than one category. An Independent Central Adjudication Committee (ICAC) reviewed participants in a blinded manner. The ICAC included a chairman and independent reviewers who were physicians with experience in vascular medicine and thrombosis. The ICAC adjudicated all index events (proximal DVT and/or PE).|participants|Number|1814|1814.0||||||
4246138|NCT00643201|4070289|B1|Proximal DVT||Index Event Classification|Participants with events of either deep vein thrombosis (DVT) or pulmonary embolism (PE) were enrolled. If a participant had both DVT and PE, the participant was classified to PE. Each participant was counted once in a category but could be counted in more than one category. An Independent Central Adjudication Committee (ICAC) reviewed participants in a blinded manner. The ICAC included a chairman and independent reviewers who were physicians with experience in vascular medicine and thrombosis. The ICAC adjudicated all index events (proximal DVT and/or PE).|participants|Number|1778|1778.0||||||
4246139|NCT00643201|4070287|B3|Not Reported||Qualifying index Venous Thromboembolic Embolism|Both the 2004 and 2008 American College of Chest Physicians (ACCP) recommendations for treatment of venous thromboembolic events (VTE) were used during this study and recommendations were consistent. Participants with provoked and unprovoked index events were summarized. For unprovoked events in participants with certain risk factors and medical conditions, such as cancer, an idiopathic event, presence of pro-thrombotic genotype, or presence of a marker indicative of an increased risk of recurrent thromboembolism treatment for 6 months or longer is supported by the ACCP guidelines.|participants|Number|6|6.0||||||
4246140|NCT00643201|4070288|B2|Not Reported||Qualifying index Venous Thromboembolic Embolism|Both the 2004 and 2008 American College of Chest Physicians (ACCP) recommendations for treatment of venous thromboembolic events (VTE) were used during this study and recommendations were consistent. Participants with provoked and unprovoked index events were summarized. For unprovoked events in participants with certain risk factors and medical conditions, such as cancer, an idiopathic event, presence of pro-thrombotic genotype, or presence of a marker indicative of an increased risk of recurrent thromboembolism treatment for 6 months or longer is supported by the ACCP guidelines.|participants|Number|3|3.0||||||
4246141|NCT00643201|4070289|B1|Not Reported||Qualifying index Venous Thromboembolic Embolism|Both the 2004 and 2008 American College of Chest Physicians (ACCP) recommendations for treatment of venous thromboembolic events (VTE) were used during this study and recommendations were consistent. Participants with provoked and unprovoked index events were summarized. For unprovoked events in participants with certain risk factors and medical conditions, such as cancer, an idiopathic event, presence of pro-thrombotic genotype, or presence of a marker indicative of an increased risk of recurrent thromboembolism treatment for 6 months or longer is supported by the ACCP guidelines.|participants|Number|3|3.0||||||
4246142|NCT00643201|4070287|B3|Unprovoked Index VTE||Qualifying index Venous Thromboembolic Embolism|Both the 2004 and 2008 American College of Chest Physicians (ACCP) recommendations for treatment of venous thromboembolic events (VTE) were used during this study and recommendations were consistent. Participants with provoked and unprovoked index events were summarized. For unprovoked events in participants with certain risk factors and medical conditions, such as cancer, an idiopathic event, presence of pro-thrombotic genotype, or presence of a marker indicative of an increased risk of recurrent thromboembolism treatment for 6 months or longer is supported by the ACCP guidelines.|participants|Number|4845|4845.0||||||
4246143|NCT00643201|4070288|B2|Unprovoked Index VTE||Qualifying index Venous Thromboembolic Embolism|Both the 2004 and 2008 American College of Chest Physicians (ACCP) recommendations for treatment of venous thromboembolic events (VTE) were used during this study and recommendations were consistent. Participants with provoked and unprovoked index events were summarized. For unprovoked events in participants with certain risk factors and medical conditions, such as cancer, an idiopathic event, presence of pro-thrombotic genotype, or presence of a marker indicative of an increased risk of recurrent thromboembolism treatment for 6 months or longer is supported by the ACCP guidelines.|participants|Number|2429|2429.0||||||
4246144|NCT00643201|4070289|B1|Unprovoked Index VTE||Qualifying index Venous Thromboembolic Embolism|Both the 2004 and 2008 American College of Chest Physicians (ACCP) recommendations for treatment of venous thromboembolic events (VTE) were used during this study and recommendations were consistent. Participants with provoked and unprovoked index events were summarized. For unprovoked events in participants with certain risk factors and medical conditions, such as cancer, an idiopathic event, presence of pro-thrombotic genotype, or presence of a marker indicative of an increased risk of recurrent thromboembolism treatment for 6 months or longer is supported by the ACCP guidelines.|participants|Number|2416|2416.0||||||
4246145|NCT00643201|4070287|B3|Provoked Index VTE||Qualifying index Venous Thromboembolic Embolism|Both the 2004 and 2008 American College of Chest Physicians (ACCP) recommendations for treatment of venous thromboembolic events (VTE) were used during this study and recommendations were consistent. Participants with provoked and unprovoked index events were summarized. For unprovoked events in participants with certain risk factors and medical conditions, such as cancer, an idiopathic event, presence of pro-thrombotic genotype, or presence of a marker indicative of an increased risk of recurrent thromboembolism treatment for 6 months or longer is supported by the ACCP guidelines.|participants|Number|544|544.0||||||
4246146|NCT00643201|4070288|B2|Provoked Index VTE||Qualifying index Venous Thromboembolic Embolism|Both the 2004 and 2008 American College of Chest Physicians (ACCP) recommendations for treatment of venous thromboembolic events (VTE) were used during this study and recommendations were consistent. Participants with provoked and unprovoked index events were summarized. For unprovoked events in participants with certain risk factors and medical conditions, such as cancer, an idiopathic event, presence of pro-thrombotic genotype, or presence of a marker indicative of an increased risk of recurrent thromboembolism treatment for 6 months or longer is supported by the ACCP guidelines.|participants|Number|272|272.0||||||
4246147|NCT00643201|4070289|B1|Provoked Index VTE||Qualifying index Venous Thromboembolic Embolism|Both the 2004 and 2008 American College of Chest Physicians (ACCP) recommendations for treatment of venous thromboembolic events (VTE) were used during this study and recommendations were consistent. Participants with provoked and unprovoked index events were summarized. For unprovoked events in participants with certain risk factors and medical conditions, such as cancer, an idiopathic event, presence of pro-thrombotic genotype, or presence of a marker indicative of an increased risk of recurrent thromboembolism treatment for 6 months or longer is supported by the ACCP guidelines.|participants|Number|272|272.0||||||
4246148|NCT00643201|4070287|B3|Germany||Region of Enrollment||participants|Number|407|407.0||||||
4246149|NCT00643201|4070288|B2|Germany||Region of Enrollment||participants|Number|205|205.0||||||
4246150|NCT00643201|4070289|B1|Germany||Region of Enrollment||participants|Number|202|202.0||||||
4246151|NCT00643201|4070287|B3|Norway||Region of Enrollment||participants|Number|72|72.0||||||
4246152|NCT00643201|4070288|B2|Norway||Region of Enrollment||participants|Number|32|32.0||||||
4246153|NCT00643201|4070289|B1|Norway||Region of Enrollment||participants|Number|40|40.0||||||
4246154|NCT00643201|4070287|B3|Romania||Region of Enrollment||participants|Number|74|74.0||||||
4246155|NCT00643201|4070288|B2|Romania||Region of Enrollment||participants|Number|41|41.0||||||
4246156|NCT00643201|4070289|B1|Romania||Region of Enrollment||participants|Number|33|33.0||||||
4246157|NCT00643201|4070287|B3|Singapore||Region of Enrollment||participants|Number|10|10.0||||||
4246158|NCT00643201|4070288|B2|Singapore||Region of Enrollment||participants|Number|5|5.0||||||
4246159|NCT00643201|4070289|B1|Singapore||Region of Enrollment||participants|Number|5|5.0||||||
4246160|NCT00643201|4070287|B3|Brazil||Region of Enrollment||participants|Number|158|158.0||||||
4246161|NCT00643201|4070288|B2|Brazil||Region of Enrollment||participants|Number|81|81.0||||||
4246162|NCT00643201|4070289|B1|Brazil||Region of Enrollment||participants|Number|77|77.0||||||
4246163|NCT00643201|4070287|B3|Poland||Region of Enrollment||participants|Number|119|119.0||||||
4246164|NCT00643201|4070288|B2|Poland||Region of Enrollment||participants|Number|59|59.0||||||
4246165|NCT00643201|4070289|B1|Poland||Region of Enrollment||participants|Number|60|60.0||||||
4246166|NCT00643201|4070287|B3|Argentina||Region of Enrollment||participants|Number|33|33.0||||||
4246167|NCT00643201|4070288|B2|Argentina||Region of Enrollment||participants|Number|16|16.0||||||
4246168|NCT00643201|4070289|B1|Argentina||Region of Enrollment||participants|Number|17|17.0||||||
4246169|NCT00643201|4070287|B3|Canada||Region of Enrollment||participants|Number|299|299.0||||||
4246170|NCT00643201|4070288|B2|Canada||Region of Enrollment||participants|Number|152|152.0||||||
4246171|NCT00643201|4070289|B1|Canada||Region of Enrollment||participants|Number|147|147.0||||||
4246172|NCT00643201|4070287|B3|Mexico||Region of Enrollment||participants|Number|116|116.0||||||
4246173|NCT00643201|4070288|B2|Mexico||Region of Enrollment||participants|Number|57|57.0||||||
4246174|NCT00643201|4070289|B1|Mexico||Region of Enrollment||participants|Number|59|59.0||||||
4246175|NCT00643201|4070287|B3|Hungary||Region of Enrollment||participants|Number|273|273.0||||||
4246176|NCT00643201|4070288|B2|Hungary||Region of Enrollment||participants|Number|128|128.0||||||
4246177|NCT00643201|4070289|B1|Hungary||Region of Enrollment||participants|Number|145|145.0||||||
4246178|NCT00643201|4070287|B3|Czech Republic||Region of Enrollment||participants|Number|274|274.0||||||
4246179|NCT00643201|4070288|B2|Czech Republic||Region of Enrollment||participants|Number|134|134.0||||||
4246180|NCT00643201|4070289|B1|Czech Republic||Region of Enrollment||participants|Number|140|140.0||||||
4246181|NCT00643201|4070287|B3|Austria||Region of Enrollment||participants|Number|79|79.0||||||
4246182|NCT00643201|4070288|B2|Austria||Region of Enrollment||participants|Number|39|39.0||||||
4246183|NCT00643201|4070289|B1|Austria||Region of Enrollment||participants|Number|40|40.0||||||
4246184|NCT00643201|4070287|B3|Korea, Republic of||Region of Enrollment||participants|Number|4|4.0||||||
4246185|NCT00643201|4070288|B2|Korea, Republic of||Region of Enrollment||participants|Number|2|2.0||||||
4246186|NCT00643201|4070289|B1|Korea, Republic of||Region of Enrollment||participants|Number|2|2.0||||||
4246187|NCT00643201|4070287|B3|China||Region of Enrollment||participants|Number|227|227.0||||||
4246188|NCT00643201|4070288|B2|China||Region of Enrollment||participants|Number|114|114.0||||||
4246189|NCT00643201|4070289|B1|China||Region of Enrollment||participants|Number|113|113.0||||||
4246190|NCT00643201|4070287|B3|South Africa||Region of Enrollment||participants|Number|147|147.0||||||
4246191|NCT00643201|4070288|B2|South Africa||Region of Enrollment||participants|Number|77|77.0||||||
4246192|NCT00643201|4070289|B1|South Africa||Region of Enrollment||participants|Number|70|70.0||||||
4246193|NCT00643201|4070287|B3|Denmark||Region of Enrollment||participants|Number|141|141.0||||||
4246194|NCT00643201|4070288|B2|Denmark||Region of Enrollment||participants|Number|72|72.0||||||
4246195|NCT00643201|4070289|B1|Denmark||Region of Enrollment||participants|Number|69|69.0||||||
4246196|NCT00643201|4070287|B3|Australia||Region of Enrollment||participants|Number|120|120.0||||||
4246197|NCT00643201|4070288|B2|Australia||Region of Enrollment||participants|Number|64|64.0||||||
4246198|NCT00643201|4070289|B1|Australia||Region of Enrollment||participants|Number|56|56.0||||||
4246199|NCT00643201|4070287|B3|Malaysia||Region of Enrollment||participants|Number|2|2.0||||||
4246200|NCT00643201|4070288|B2|Malaysia||Region of Enrollment||participants|Number|2|2.0||||||
4246201|NCT00643201|4070289|B1|Malaysia||Region of Enrollment||participants|Number|0|0.0||||||
4246202|NCT00643201|4070287|B3|France||Region of Enrollment||participants|Number|289|289.0||||||
4246203|NCT00643201|4070288|B2|France||Region of Enrollment||participants|Number|149|149.0||||||
4246204|NCT00643201|4070289|B1|France||Region of Enrollment||participants|Number|140|140.0||||||
4246205|NCT00643201|4070287|B3|India||Region of Enrollment||participants|Number|200|200.0||||||
4246206|NCT00643201|4070288|B2|India||Region of Enrollment||participants|Number|99|99.0||||||
4246212|NCT00643201|4070288|B2|Russian Federation||Region of Enrollment||participants|Number|174|174.0||||||
4246213|NCT00643201|4070289|B1|Russian Federation||Region of Enrollment||participants|Number|178|178.0||||||
4246214|NCT00643201|4070287|B3|Israel||Region of Enrollment||participants|Number|325|325.0||||||
4246215|NCT00643201|4070288|B2|Israel||Region of Enrollment||participants|Number|163|163.0||||||
4246216|NCT00643201|4070289|B1|Israel||Region of Enrollment||participants|Number|162|162.0||||||
4246217|NCT00643201|4070287|B3|Ukraine||Region of Enrollment||participants|Number|424|424.0||||||
4246218|NCT00643201|4070288|B2|Ukraine||Region of Enrollment||participants|Number|211|211.0||||||
4246219|NCT00643201|4070289|B1|Ukraine||Region of Enrollment||participants|Number|213|213.0||||||
4246220|NCT00643201|4070287|B3|Spain||Region of Enrollment||participants|Number|107|107.0||||||
4246221|NCT00643201|4070288|B2|Spain||Region of Enrollment||participants|Number|51|51.0||||||
4246222|NCT00643201|4070289|B1|Spain||Region of Enrollment||participants|Number|56|56.0||||||
4246223|NCT00643201|4070287|B3|Hong Kong||Region of Enrollment||participants|Number|3|3.0||||||
4246224|NCT00643201|4070288|B2|Hong Kong||Region of Enrollment||participants|Number|1|1.0||||||
4246225|NCT00643201|4070289|B1|Hong Kong||Region of Enrollment||participants|Number|2|2.0||||||
4246226|NCT00643201|4070287|B3|United States||Region of Enrollment||participants|Number|785|785.0||||||
4246227|NCT00643201|4070288|B2|United States||Region of Enrollment||participants|Number|398|398.0||||||
4246228|NCT00643201|4070289|B1|United States||Region of Enrollment||participants|Number|387|387.0||||||
4246229|NCT00643201|4070287|B3|Portugal||Region of Enrollment||participants|Number|19|19.0||||||
4246230|NCT00643201|4070288|B2|Portugal||Region of Enrollment||participants|Number|9|9.0||||||
4246231|NCT00643201|4070289|B1|Portugal||Region of Enrollment||participants|Number|10|10.0||||||
4246232|NCT00643201|4070287|B3|Ethnicity Not Reported||Race/Ethnicity, Customized|Ethnicity was not collected outside of the United States.|participants|Number|4610|4610.0||||||
4246233|NCT00643201|4070288|B2|Ethnicity Not Reported||Race/Ethnicity, Customized|Ethnicity was not collected outside of the United States.|participants|Number|2306|2306.0||||||
4246234|NCT00643201|4070289|B1|Ethnicity Not Reported||Race/Ethnicity, Customized|Ethnicity was not collected outside of the United States.|participants|Number|2304|2304.0||||||
4246235|NCT00643201|4070287|B3|Not Hispanic or Latino||Race/Ethnicity, Customized|Ethnicity was not collected outside of the United States.|participants|Number|747|747.0||||||
4246236|NCT00643201|4070288|B2|Not Hispanic or Latino||Race/Ethnicity, Customized|Ethnicity was not collected outside of the United States.|participants|Number|380|380.0||||||
4246237|NCT00643201|4070289|B1|Not Hispanic or Latino||Race/Ethnicity, Customized|Ethnicity was not collected outside of the United States.|participants|Number|367|367.0||||||
4246238|NCT00643201|4070287|B3|Hispanic or Latino||Race/Ethnicity, Customized|Ethnicity was not collected outside of the United States.|participants|Number|38|38.0||||||
4246239|NCT00643201|4070288|B2|Hispanic or Latino||Race/Ethnicity, Customized|Ethnicity was not collected outside of the United States.|participants|Number|18|18.0||||||
4246240|NCT00643201|4070289|B1|Hispanic or Latino||Race/Ethnicity, Customized|Ethnicity was not collected outside of the United States.|participants|Number|20|20.0||||||
4246241|NCT00643201|4070287|B3|Race Not Reported||Race/Ethnicity, Customized|Ethnicity was not collected outside of the United States.|participants|Number|95|95.0||||||
4246242|NCT00643201|4070288|B2|Race Not Reported||Race/Ethnicity, Customized|Ethnicity was not collected outside of the United States.|participants|Number|50|50.0||||||
4246243|NCT00643201|4070289|B1|Race Not Reported||Race/Ethnicity, Customized|Ethnicity was not collected outside of the United States.|participants|Number|45|45.0||||||
4246244|NCT00643201|4070287|B3|Other Race||Race/Ethnicity, Customized|Ethnicity was not collected outside of the United States.|participants|Number|174|174.0||||||
4246245|NCT00643201|4070288|B2|Other Race||Race/Ethnicity, Customized|Ethnicity was not collected outside of the United States.|participants|Number|85|85.0||||||
4246246|NCT00643201|4070289|B1|Other Race||Race/Ethnicity, Customized|Ethnicity was not collected outside of the United States.|participants|Number|89|89.0||||||
4246247|NCT00643201|4070287|B3|Asian||Race/Ethnicity, Customized|Ethnicity was not collected outside of the United States.|participants|Number|453|453.0||||||
4246248|NCT00643201|4070288|B2|Asian||Race/Ethnicity, Customized|Ethnicity was not collected outside of the United States.|participants|Number|226|226.0||||||
4246249|NCT00643201|4070289|B1|Asian||Race/Ethnicity, Customized|Ethnicity was not collected outside of the United States.|participants|Number|227|227.0||||||
4246250|NCT00643201|4070287|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|Ethnicity was not collected outside of the United States.|participants|Number|8|8.0||||||
4246251|NCT00643201|4070288|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|Ethnicity was not collected outside of the United States.|participants|Number|2|2.0||||||
4246252|NCT00643201|4070289|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Ethnicity was not collected outside of the United States.|participants|Number|6|6.0||||||
4246253|NCT00643201|4070287|B3|Black or African American||Race/Ethnicity, Customized|Ethnicity was not collected outside of the United States.|participants|Number|204|204.0||||||
4246254|NCT00643201|4070288|B2|Black or African American||Race/Ethnicity, Customized|Ethnicity was not collected outside of the United States.|participants|Number|98|98.0||||||
4246255|NCT00643201|4070289|B1|Black or African American||Race/Ethnicity, Customized|Ethnicity was not collected outside of the United States.|participants|Number|106|106.0||||||
4246256|NCT00643201|4070287|B3|White||Race/Ethnicity, Customized|Ethnicity was not collected outside of the United States.|participants|Number|4461|4461.0||||||
4246257|NCT00643201|4070288|B2|White||Race/Ethnicity, Customized|Ethnicity was not collected outside of the United States.|participants|Number|2243|2243.0||||||
4246258|NCT00643201|4070289|B1|White||Race/Ethnicity, Customized|Ethnicity was not collected outside of the United States.|participants|Number|2218|2218.0||||||
4246259|NCT00643201|4070287|B3||Male|Sex: Female, Male||Participants|Count of Participants|3167|3167.0||||||
4246260|NCT00643201|4070288|B2||Male|Sex: Female, Male||Participants|Count of Participants|1598|1598.0||||||
4246261|NCT00643201|4070289|B1||Male|Sex: Female, Male||Participants|Count of Participants|1569|1569.0||||||
4246262|NCT00643201|4070287|B3||Female|Sex: Female, Male||Participants|Count of Participants|2228|2228.0||||||
4246263|NCT00643201|4070288|B2||Female|Sex: Female, Male||Participants|Count of Participants|1106|1106.0||||||
4246264|NCT00643201|4070289|B1||Female|Sex: Female, Male||Participants|Count of Participants|1122|1122.0||||||
4246265|NCT00643201|4070287|B3|Greater than, equal to (>=) 75||Age, Customized||participants|Number|774|774.0||||||
4246266|NCT00643201|4070288|B2|Greater than, equal to (>=) 75||Age, Customized||participants|Number|372|372.0||||||
4246267|NCT00643201|4070289|B1|Greater than, equal to (>=) 75||Age, Customized||participants|Number|402|402.0||||||
4246268|NCT00643201|4070287|B3|65 to < 75||Age, Customized||participants|Number|1130|1130.0||||||
4246269|NCT00643201|4070288|B2|65 to < 75||Age, Customized||participants|Number|570|570.0||||||
4246270|NCT00643201|4070289|B1|65 to < 75||Age, Customized||participants|Number|560|560.0||||||
4246271|NCT00643201|4070287|B3|Less than (<) 65||Age, Customized||participants|Number|3491|3491.0||||||
4246272|NCT00643201|4070288|B2|Less than (<) 65||Age, Customized||participants|Number|1762|1762.0||||||
4246273|NCT00643201|4070289|B1|Less than (<) 65||Age, Customized||participants|Number|1729|1729.0||||||
4246274|NCT00643201|4070287|B3|||Age||years|Mean|56.9|56.9|Standard Deviation|16.00|16.0|||
4246275|NCT00643201|4070288|B2|||Age||years|Mean|56.7|56.7|Standard Deviation|16.01|16.01|||
4246276|NCT00643201|4070289|B1|||Age||years|Mean|57.2|57.2|Standard Deviation|15.98|15.98|||
4246277|NCT00643123|4070336|B3||Student|Employment Status||Participants|Count of Participants|1|1.0||||||
4246278|NCT00643123|4070337|B2||Student|Employment Status||Participants|Count of Participants|0|0.0||||||
4246279|NCT00643123|4070338|B1||Student|Employment Status||Participants|Count of Participants|1|1.0||||||
4246280|NCT00643123|4070336|B3||Disabled|Employment Status||Participants|Count of Participants|3|3.0||||||
4246281|NCT00643123|4070337|B2||Disabled|Employment Status||Participants|Count of Participants|2|2.0||||||
4246282|NCT00643123|4070338|B1||Disabled|Employment Status||Participants|Count of Participants|1|1.0||||||
4246283|NCT00643123|4070336|B3||Unemployed|Employment Status||Participants|Count of Participants|15|15.0||||||
4246284|NCT00643123|4070337|B2||Unemployed|Employment Status||Participants|Count of Participants|6|6.0||||||
4246285|NCT00643123|4070338|B1||Unemployed|Employment Status||Participants|Count of Participants|9|9.0||||||
4246286|NCT00643123|4070336|B3||Employed|Employment Status||Participants|Count of Participants|8|8.0||||||
4246287|NCT00643123|4070337|B2||Employed|Employment Status||Participants|Count of Participants|4|4.0||||||
4246288|NCT00643123|4070338|B1||Employed|Employment Status||Participants|Count of Participants|4|4.0||||||
4246289|NCT00643123|4070336|B3||Not Reported|Marital Status||Participants|Count of Participants|2|2.0||||||
4246290|NCT00643123|4070337|B2||Not Reported|Marital Status||Participants|Count of Participants|0|0.0||||||
4246291|NCT00643123|4070338|B1||Not Reported|Marital Status||Participants|Count of Participants|2|2.0||||||
4246292|NCT00643123|4070336|B3||Divorced|Marital Status||Participants|Count of Participants|7|7.0||||||
4246293|NCT00643123|4070337|B2||Divorced|Marital Status||Participants|Count of Participants|3|3.0||||||
4246294|NCT00643123|4070338|B1||Divorced|Marital Status||Participants|Count of Participants|4|4.0||||||
4246295|NCT00643123|4070336|B3||Married|Marital Status||Participants|Count of Participants|4|4.0||||||
4246296|NCT00643123|4070337|B2||Married|Marital Status||Participants|Count of Participants|3|3.0||||||
4246297|NCT00643123|4070338|B1||Married|Marital Status||Participants|Count of Participants|1|1.0||||||
4246298|NCT00643123|4070336|B3||Never Married|Marital Status||Participants|Count of Participants|14|14.0||||||
4246299|NCT00643123|4070337|B2||Never Married|Marital Status||Participants|Count of Participants|6|6.0||||||
4246300|NCT00643123|4070338|B1||Never Married|Marital Status||Participants|Count of Participants|8|8.0||||||
4246301|NCT00643123|4070336|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
4246302|NCT00643123|4070337|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4246303|NCT00643123|4070338|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4246304|NCT00643123|4070336|B3|Race or Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4246305|NCT00643123|4070337|B2|Race or Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4246306|NCT00643123|4070338|B1|Race or Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4246307|NCT00643123|4070336|B3|Race or Ethnicity|African-American|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4246308|NCT00643123|4070337|B2|Race or Ethnicity|African-American|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4246309|NCT00643123|4070338|B1|Race or Ethnicity|African-American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4246310|NCT00643123|4070336|B3|Race or Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4246311|NCT00643123|4070337|B2|Race or Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4246312|NCT00643123|4070338|B1|Race or Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4246313|NCT00643123|4070336|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4246314|NCT00643123|4070337|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4246315|NCT00643123|4070338|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4246316|NCT00643123|4070336|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4246317|NCT00643123|4070337|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4246318|NCT00643123|4070338|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4246319|NCT00643123|4070336|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4246320|NCT00643123|4070337|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4246321|NCT00643123|4070338|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4246322|NCT00643123|4070336|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4246323|NCT00643123|4070337|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4246324|NCT00643123|4070338|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4246325|NCT00643123|4070336|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4246326|NCT00643123|4070337|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4246327|NCT00643123|4070338|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4246328|NCT00643097|4070345|B4||Male|Gender||Participants|Count of Participants|30|30.0||||||
4246329|NCT00643097|4070346|B3||Male|Gender||Participants|Count of Participants|6|6.0||||||
4246330|NCT00643097|4070347|B2||Male|Gender||Participants|Count of Participants|11|11.0||||||
4246331|NCT00643097|4070348|B1||Male|Gender||Participants|Count of Participants|13|13.0||||||
4246332|NCT00643097|4070345|B4||Female|Gender||Participants|Count of Participants|10|10.0||||||
4246333|NCT00643097|4070346|B3||Female|Gender||Participants|Count of Participants|4|4.0||||||
4246334|NCT00643097|4070347|B2||Female|Gender||Participants|Count of Participants|1|1.0||||||
4246335|NCT00643097|4070348|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
4246336|NCT00643097|4070345|B4|||Age||years|Median|53|53.0|Full Range|||29.0|83.0|
4246337|NCT00643097|4070346|B3|||Age||years|Median|59|59.0|Full Range|||49.0|66.0|
4246338|NCT00643097|4070347|B2|||Age||years|Median|57|57.0|Full Range|||41.0|83.0|
4246339|NCT00643097|4070348|B1|||Age||years|Median|52|52.0|Full Range|||29.0|67.0|
4246340|NCT00643006|4070367|B3|Sweden||Region of Enrollment||participants|Number|67|67.0||||||
4246341|NCT00643006|4070368|B2|Sweden||Region of Enrollment||participants|Number|33|33.0||||||
4246342|NCT00643006|4070369|B1|Sweden||Region of Enrollment||participants|Number|34|34.0||||||
4246343|NCT00643006|4070367|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4246344|NCT00643006|4070368|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4246345|NCT00643006|4070369|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4246346|NCT00643006|4070367|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4246347|NCT00643006|4070368|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4246348|NCT00643006|4070369|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4246349|NCT00643006|4070367|B3|||Age||years|Mean|49|49.0|Standard Deviation|7.7|7.7|||
4246350|NCT00643006|4070368|B2|||Age||years|Mean|50|50.0|Standard Deviation|7.6|7.6|||
4246351|NCT00643006|4070369|B1|||Age||years|Mean|48|48.0|Standard Deviation|7.8|7.8|||
4246352|NCT00643006|4070367|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4246353|NCT00643006|4070368|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4246354|NCT00643006|4070369|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4246355|NCT00643006|4070367|B3||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
4246356|NCT00643006|4070368|B2||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4246357|NCT00643006|4070369|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4246358|NCT00643006|4070367|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4246359|NCT00643006|4070368|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4246360|NCT00643006|4070369|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4246361|NCT00642993|4070378|B3||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4246362|NCT00642993|4070379|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4246363|NCT00642993|4070380|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4246364|NCT00642993|4070378|B3||Female|Sex: Female, Male||Participants|Count of Participants|279|279.0||||||
4246365|NCT00642993|4070379|B2||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4246366|NCT00642993|4070380|B1||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4246367|NCT00642993|4070378|B3|||Age||Years|Mean|53.0|53.0|Standard Deviation|10.1|10.1|||
4246368|NCT00642993|4070379|B2|||Age||Years|Mean|52.8|52.8|Standard Deviation|10.4|10.4|||
4246369|NCT00642993|4070380|B1|||Age||Years|Mean|53.2|53.2|Standard Deviation|9.9|9.9|||
4246370|NCT00642902|4070395|B5||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4246371|NCT00642902|4070396|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4246372|NCT00642902|4070397|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4246373|NCT00642902|4070398|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4246374|NCT00642902|4070399|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4246375|NCT00642902|4070395|B5||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4246376|NCT00642902|4070396|B4||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4246377|NCT00642902|4070397|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4246378|NCT00642902|4070398|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4246379|NCT00642902|4070399|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4246380|NCT00642902|4070395|B5|||Age||years|Mean|37.7|37.7|Standard Deviation|9.9|9.9|||
4246381|NCT00642902|4070396|B4|||Age||years|Mean|37.5|37.5|Standard Deviation|10.5|10.5|||
4246382|NCT00642902|4070397|B3|||Age||years|Mean|38.0|38.0|Standard Deviation|10.1|10.1|||
4246383|NCT00642902|4070398|B2|||Age||years|Mean|37.5|37.5|Standard Deviation|8.5|8.5|||
4246384|NCT00642902|4070399|B1|||Age||years|Mean|37.7|37.7|Standard Deviation|10.5|10.5|||
4246385|NCT00642850|4070424|B1||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4246386|NCT00642850|4070424|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4246387|NCT00642850|4070424|B1|||Age||years|Mean|64.9|64.9|Standard Deviation|11.56|11.56|||
4246388|NCT00642811|4070434|B7||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4246389|NCT00642811|4070435|B6||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4246390|NCT00642811|4070436|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4246391|NCT00642811|4070437|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4246392|NCT00642811|4070438|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4246393|NCT00642811|4070439|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4246394|NCT00642811|4070440|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4246395|NCT00642811|4070434|B7||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4246396|NCT00642811|4070435|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4246397|NCT00642811|4070436|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4246398|NCT00642811|4070437|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4246399|NCT00642811|4070438|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4246400|NCT00642811|4070439|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4246401|NCT00642811|4070440|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4246402|NCT00642811|4070434|B7|||Age||year|Mean|64.8|64.8|Standard Deviation|7.95|7.95|||
4246403|NCT00642811|4070435|B6|||Age||year|Mean|61.57|61.57|Standard Deviation|8.22|8.22|||
4246404|NCT00642811|4070436|B5|||Age||year|Mean|63.21|63.21|Standard Deviation|9.23|9.23|||
4246405|NCT00642811|4070437|B4|||Age||year|Mean|64.56|64.56|Standard Deviation|8.56|8.56|||
4246406|NCT00642811|4070438|B3|||Age||year|Mean|65.46|65.46|Standard Deviation|8.68|8.68|||
4246407|NCT00642811|4070439|B2|||Age||year|Mean|64.57|64.57|Standard Deviation|6.31|6.31|||
4246408|NCT00642811|4070440|B1|||Age||year|Mean|67.25|67.25|Standard Deviation|8.12|8.12|||
4246409|NCT00642772|4070467|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4246410|NCT00642772|4070467|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4246411|NCT00642772|4070467|B1|||Age||years|Mean|62|62.0|Standard Deviation|11|11.0|||
4246412|NCT00642759|4070471|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4246413|NCT00642759|4070471|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4246414|NCT00642759|4070471|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4246415|NCT00642759|4070471|B1|||Age||years|Median|64|64.0|Full Range|||42.0|76.0|
4246416|NCT00642759|4070471|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4246417|NCT00642759|4070471|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4246418|NCT00642759|4070471|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4246419|NCT00642746|4070478|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4246420|NCT00642746|4070479|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4246421|NCT00642746|4070480|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4246422|NCT00642746|4070478|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4246423|NCT00642746|4070479|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4246424|NCT00642746|4070480|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4246425|NCT00642746|4070478|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4246426|NCT00642746|4070479|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4246427|NCT00642746|4070480|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4246428|NCT00642746|4070478|B3|>=65 years||Age||participants|Number|3|3.0||||||
4246429|NCT00642746|4070479|B2|>=65 years||Age||participants|Number|0|0.0||||||
4246430|NCT00642746|4070480|B1|>=65 years||Age||participants|Number|3|3.0||||||
4246431|NCT00642746|4070478|B3|Between 18 and 65 years||Age||participants|Number|7|7.0||||||
4246432|NCT00642746|4070479|B2|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
4246433|NCT00642746|4070480|B1|Between 18 and 65 years||Age||participants|Number|6|6.0||||||
4246434|NCT00642746|4070478|B3|<=18 years||Age||participants|Number|0|0.0||||||
4246435|NCT00642746|4070479|B2|<=18 years||Age||participants|Number|0|0.0||||||
4246436|NCT00642746|4070480|B1|<=18 years||Age||participants|Number|0|0.0||||||
4246437|NCT00642707|4070491|B5|United States||Region of Enrollment||participants|Number|44|44.0||||||
4246438|NCT00642707|4070492|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
4246439|NCT00642707|4070493|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4246440|NCT00642707|4070494|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4246441|NCT00642707|4070495|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4246442|NCT00642707|4070491|B5||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4246443|NCT00642707|4070492|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4246444|NCT00642707|4070493|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4246445|NCT00642707|4070494|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4246446|NCT00642707|4070495|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4246447|NCT00642707|4070491|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4246448|NCT00642707|4070492|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4246449|NCT00642707|4070493|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4246450|NCT00642707|4070494|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4246451|NCT00642707|4070495|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4246452|NCT00642707|4070491|B5|||Age||years|Mean|42.4|42.4|Standard Deviation|7.09|7.09|||
4246453|NCT00642707|4070492|B4|||Age||years|Mean|42.4|42.4|Standard Deviation|7.44|7.44|||
4246454|NCT00642707|4070493|B3|||Age||years|Mean|46.4|46.4|Standard Deviation|8.18|8.18|||
4246455|NCT00642707|4070494|B2|||Age||years|Mean|41.9|41.9|Standard Deviation|5.46|5.46|||
4246456|NCT00642707|4070495|B1|||Age||years|Mean|38.5|38.5|Standard Deviation|5.13|5.13|||
4246457|NCT00642707|4070491|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4246458|NCT00642707|4070492|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4246459|NCT00642707|4070493|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4246460|NCT00642707|4070494|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4246461|NCT00642707|4070495|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4246462|NCT00642707|4070491|B5||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4246463|NCT00642707|4070492|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4246464|NCT00642707|4070493|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4246465|NCT00642707|4070494|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4246466|NCT00642707|4070495|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4246467|NCT00642707|4070491|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4246468|NCT00642707|4070492|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4246469|NCT00642707|4070493|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4246470|NCT00642707|4070494|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4246471|NCT00642707|4070495|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4246472|NCT00642694|4070508|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
4246473|NCT00642694|4070509|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4246474|NCT00642694|4070510|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4246475|NCT00642694|4070508|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4246476|NCT00642694|4070509|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4246477|NCT00642694|4070510|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4246478|NCT00642694|4070508|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4246479|NCT00642694|4070509|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4246480|NCT00642694|4070510|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4246481|NCT00642694|4070508|B3|||Age||years|Mean|42.3|42.3|Standard Deviation|11.6|11.6|||
4246482|NCT00642694|4070509|B2|||Age||years|Mean|42.0|42.0|Standard Deviation|11.4|11.4|||
4246483|NCT00642694|4070510|B1|||Age||years|Mean|42.6|42.6|Standard Deviation|12.4|12.4|||
4246484|NCT00642694|4070508|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4246485|NCT00642694|4070509|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4246486|NCT00642694|4070510|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4246487|NCT00642694|4070508|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4246488|NCT00642694|4070509|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4246489|NCT00642694|4070510|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4246490|NCT00642694|4070508|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4246491|NCT00642694|4070509|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4246492|NCT00642694|4070510|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4246493|NCT00642668|4070519|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4246494|NCT00642668|4070519|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4246495|NCT00642668|4070519|B1|||Age||years|Median|77|77.0|Full Range|||42.0|89.0|
4246496|NCT00642642|4070527|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4246497|NCT00642642|4070527|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4246498|NCT00642642|4070527|B1||White|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
4246499|NCT00642642|4070527|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4246500|NCT00642642|4070527|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4246501|NCT00642642|4070527|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4246502|NCT00642642|4070527|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4246503|NCT00642642|4070527|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4246504|NCT00642642|4070527|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
4246505|NCT00642642|4070527|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4246506|NCT00642642|4070527|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4246507|NCT00642642|4070527|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4246508|NCT00642642|4070527|B1|||Age||years|Mean|41.7|41.7|Standard Deviation|10.57|10.57|||
4246509|NCT00642642|4070527|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4246510|NCT00642642|4070527|B1||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
4246511|NCT00642642|4070527|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4246512|NCT00642616|4070540|B5||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4246513|NCT00642616|4070541|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4246514|NCT00642616|4070542|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4246515|NCT00642616|4070543|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4246516|NCT00642616|4070544|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4246517|NCT00642616|4070540|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4246518|NCT00642616|4070541|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4246519|NCT00642616|4070542|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4246520|NCT00642616|4070543|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4246521|NCT00642616|4070544|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4246522|NCT00642616|4070540|B5|||Age||years|Mean|64.03|64.03|Standard Deviation|12.71|12.71|||
4246523|NCT00642616|4070541|B4|||Age||years|Mean|68.88|68.88|Standard Deviation|8.20|8.2|||
4246524|NCT00642616|4070542|B3|||Age||years|Mean|67.44|67.44|Standard Deviation|8.38|8.38|||
4246525|NCT00642616|4070543|B2|||Age||years|Mean|49.75|49.75|Standard Deviation|15.73|15.73|||
4246526|NCT00642616|4070544|B1|||Age||years|Mean|69.00|69.0|Standard Deviation|7.26|7.26|||
4246527|NCT00642603|4070569|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4246528|NCT00642603|4070570|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4246529|NCT00642603|4070571|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4246530|NCT00642603|4070569|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4246531|NCT00642603|4070570|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4246532|NCT00642603|4070571|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4246533|NCT00642603|4070569|B3|||Age||years|Mean|62.3|62.3|Standard Deviation|11.04|11.04|||
4246534|NCT00642603|4070570|B2|||Age||years|Mean|60.6|60.6|Standard Deviation|9.89|9.89|||
4246535|NCT00642603|4070571|B1|||Age||years|Mean|63.9|63.9|Standard Deviation|12.06|12.06|||
4246536|NCT00642473|4070578|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4246537|NCT00642473|4070579|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4246538|NCT00642473|4070580|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4246539|NCT00642473|4070578|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4246540|NCT00642473|4070579|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4246541|NCT00642473|4070580|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4246542|NCT00642473|4070578|B3|||Age||years|Mean|69|69.0|Standard Deviation|11.8|11.8|||
4246543|NCT00642473|4070579|B2|||Age||years|Mean|70|70.0|Standard Deviation|13.1|13.1|||
4246544|NCT00642473|4070580|B1|||Age||years|Mean|68|68.0|Standard Deviation|10.8|10.8|||
4246545|NCT00642460|4070593|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4246546|NCT00642460|4070594|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4246547|NCT00642460|4070595|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4246548|NCT00642460|4070593|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4246549|NCT00642460|4070594|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4246550|NCT00642460|4070595|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4246551|NCT00642460|4070593|B3|13 to 17||Age, Customized||years|Number|37|37.0||||||
4246552|NCT00642460|4070594|B2|13 to 17||Age, Customized||years|Number|11|11.0||||||
4246553|NCT00642460|4070595|B1|13 to 17||Age, Customized||years|Number|26|26.0||||||
4246554|NCT00642460|4070593|B3|6 to 12||Age, Customized||years|Number|48|48.0||||||
4246555|NCT00642460|4070594|B2|6 to 12||Age, Customized||years|Number|15|15.0||||||
4246556|NCT00642460|4070595|B1|6 to 12||Age, Customized||years|Number|33|33.0||||||
4246557|NCT00642460|4070593|B3|2 to 5||Age, Customized||years|Number|27|27.0||||||
4246558|NCT00642460|4070594|B2|2 to 5||Age, Customized||years|Number|11|11.0||||||
4246559|NCT00642460|4070595|B1|2 to 5||Age, Customized||years|Number|16|16.0||||||
4246560|NCT00642382|4070664|B3||Male|Sex: Female, Male||||0|0.0||||||
4246561|NCT00642382|4070664|B3||Female|Sex: Female, Male||||0|0.0||||||
4246562|NCT00642382|4070664|B3||>=65 years|Age||||0|0.0||||||
4246563|NCT00642382|4070664|B3||Between 18 and 65 years|Age||||0|0.0||||||
4246564|NCT00642382|4070664|B3||<=18 years|Age||||0|0.0||||||
4246565|NCT00642369|4070673|B3|China||Region of Enrollment||participants|Number|60|60.0||||||
4246566|NCT00642369|4070674|B2|China||Region of Enrollment||participants|Number|30|30.0||||||
4246567|NCT00642369|4070675|B1|China||Region of Enrollment||participants|Number|30|30.0||||||
4246568|NCT00642369|4070673|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4246569|NCT00642369|4070674|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4246570|NCT00642369|4070675|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4246571|NCT00642369|4070673|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4246572|NCT00642369|4070674|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4246573|NCT00642369|4070675|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4246574|NCT00642369|4070673|B3|||Age||years|Mean|26.3|26.3|Standard Deviation|8.2|8.2|||
4246575|NCT00642369|4070674|B2|||Age||years|Mean|27.9|27.9|Standard Deviation|6.7|6.7|||
4246576|NCT00642369|4070675|B1|||Age||years|Mean|25.0|25.0|Standard Deviation|10.1|10.1|||
4246577|NCT00642369|4070673|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4246578|NCT00642369|4070674|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4246579|NCT00642369|4070675|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4246580|NCT00642369|4070673|B3||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4246581|NCT00642369|4070674|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4246582|NCT00642369|4070675|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4246583|NCT00642369|4070673|B3||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4246584|NCT00642369|4070674|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4246585|NCT00642369|4070675|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4246586|NCT00642356|4070684|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4246587|NCT00642356|4070685|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4246588|NCT00642356|4070686|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4246589|NCT00642356|4070684|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4246590|NCT00642356|4070685|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4246591|NCT00642356|4070686|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4246592|NCT00642356|4070684|B3|>= 65 years||Age, Customized||Participants|Number|13|13.0||||||
4246593|NCT00642356|4070685|B2|>= 65 years||Age, Customized||Participants|Number|7|7.0||||||
4246594|NCT00642356|4070686|B1|>= 65 years||Age, Customized||Participants|Number|6|6.0||||||
4246595|NCT00642356|4070684|B3|Between 18 and 65 years||Age, Customized||Participants|Number|1|1.0||||||
4246596|NCT00642356|4070685|B2|Between 18 and 65 years||Age, Customized||Participants|Number|0|0.0||||||
4246597|NCT00642356|4070686|B1|Between 18 and 65 years||Age, Customized||Participants|Number|1|1.0||||||
4246598|NCT00642356|4070684|B3|<=18 years||Age, Customized||Participants|Number|0|0.0||||||
4246599|NCT00642356|4070685|B2|<=18 years||Age, Customized||Participants|Number|0|0.0||||||
4246600|NCT00642356|4070686|B1|<=18 years||Age, Customized||Participants|Number|0|0.0||||||
4246601|NCT00642304|4070695|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4246602|NCT00642304|4070695|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4246603|NCT00642304|4070695|B1|||Age||years|Mean|64.5|64.5|Standard Deviation|16.83|16.83|||
4246604|NCT00642278|4070704|B8|UNITED STATES||Region Enroll||participants|Number|135|135.0||||||
4246605|NCT00642278|4070705|B7|UNITED STATES||Region Enroll||participants|Number|21|21.0||||||
4246606|NCT00642278|4070706|B6|UNITED STATES||Region Enroll||participants|Number|20|20.0||||||
4246607|NCT00642278|4070707|B5|UNITED STATES||Region Enroll||participants|Number|18|18.0||||||
4246608|NCT00642278|4070708|B4|UNITED STATES||Region Enroll||participants|Number|18|18.0||||||
4246609|NCT00642278|4070709|B3|UNITED STATES||Region Enroll||participants|Number|16|16.0||||||
4246610|NCT00642278|4070710|B2|UNITED STATES||Region Enroll||participants|Number|21|21.0||||||
4246611|NCT00642278|4070711|B1|UNITED STATES||Region Enroll||participants|Number|21|21.0||||||
4246612|NCT00642278|4070704|B8|UNITED KINGDOM||Region Enroll||participants|Number|10|10.0||||||
4246613|NCT00642278|4070705|B7|UNITED KINGDOM||Region Enroll||participants|Number|2|2.0||||||
4246614|NCT00642278|4070706|B6|UNITED KINGDOM||Region Enroll||participants|Number|1|1.0||||||
4246615|NCT00642278|4070707|B5|UNITED KINGDOM||Region Enroll||participants|Number|3|3.0||||||
4246616|NCT00642278|4070708|B4|UNITED KINGDOM||Region Enroll||participants|Number|1|1.0||||||
4246617|NCT00642278|4070709|B3|UNITED KINGDOM||Region Enroll||participants|Number|2|2.0||||||
4246618|NCT00642278|4070710|B2|UNITED KINGDOM||Region Enroll||participants|Number|0|0.0||||||
4246619|NCT00642278|4070711|B1|UNITED KINGDOM||Region Enroll||participants|Number|1|1.0||||||
4246620|NCT00642278|4070704|B8|RUSSIAN FEDERATION||Region Enroll||participants|Number|32|32.0||||||
4246621|NCT00642278|4070705|B7|RUSSIAN FEDERATION||Region Enroll||participants|Number|4|4.0||||||
4246622|NCT00642278|4070706|B6|RUSSIAN FEDERATION||Region Enroll||participants|Number|3|3.0||||||
4246623|NCT00642278|4070707|B5|RUSSIAN FEDERATION||Region Enroll||participants|Number|6|6.0||||||
4246624|NCT00642278|4070708|B4|RUSSIAN FEDERATION||Region Enroll||participants|Number|2|2.0||||||
4246625|NCT00642278|4070709|B3|RUSSIAN FEDERATION||Region Enroll||participants|Number|5|5.0||||||
4246626|NCT00642278|4070710|B2|RUSSIAN FEDERATION||Region Enroll||participants|Number|7|7.0||||||
4246627|NCT00642278|4070711|B1|RUSSIAN FEDERATION||Region Enroll||participants|Number|5|5.0||||||
4246628|NCT00642278|4070704|B8|ROMANIA||Region Enroll||participants|Number|46|46.0||||||
4246629|NCT00642278|4070705|B7|ROMANIA||Region Enroll||participants|Number|8|8.0||||||
4246630|NCT00642278|4070706|B6|ROMANIA||Region Enroll||participants|Number|5|5.0||||||
4246631|NCT00642278|4070707|B5|ROMANIA||Region Enroll||participants|Number|6|6.0||||||
4246632|NCT00642278|4070708|B4|ROMANIA||Region Enroll||participants|Number|6|6.0||||||
4246633|NCT00642278|4070709|B3|ROMANIA||Region Enroll||participants|Number|4|4.0||||||
4246634|NCT00642278|4070710|B2|ROMANIA||Region Enroll||participants|Number|8|8.0||||||
4246635|NCT00642278|4070711|B1|ROMANIA||Region Enroll||participants|Number|9|9.0||||||
4246636|NCT00642278|4070704|B8|POLAND||Region Enroll||participants|Number|39|39.0||||||
4246637|NCT00642278|4070705|B7|POLAND||Region Enroll||participants|Number|9|9.0||||||
4246638|NCT00642278|4070706|B6|POLAND||Region Enroll||participants|Number|5|5.0||||||
4246639|NCT00642278|4070707|B5|POLAND||Region Enroll||participants|Number|6|6.0||||||
4246640|NCT00642278|4070708|B4|POLAND||Region Enroll||participants|Number|7|7.0||||||
4246641|NCT00642278|4070709|B3|POLAND||Region Enroll||participants|Number|4|4.0||||||
4246642|NCT00642278|4070710|B2|POLAND||Region Enroll||participants|Number|5|5.0||||||
4246643|NCT00642278|4070711|B1|POLAND||Region Enroll||participants|Number|3|3.0||||||
4246644|NCT00642278|4070704|B8|MEXICO||Region Enroll||participants|Number|50|50.0||||||
4246645|NCT00642278|4070705|B7|MEXICO||Region Enroll||participants|Number|2|2.0||||||
4246646|NCT00642278|4070706|B6|MEXICO||Region Enroll||participants|Number|14|14.0||||||
4246647|NCT00642278|4070707|B5|MEXICO||Region Enroll||participants|Number|6|6.0||||||
4246648|NCT00642278|4070708|B4|MEXICO||Region Enroll||participants|Number|9|9.0||||||
4246649|NCT00642278|4070709|B3|MEXICO||Region Enroll||participants|Number|9|9.0||||||
4246650|NCT00642278|4070710|B2|MEXICO||Region Enroll||participants|Number|6|6.0||||||
4246651|NCT00642278|4070711|B1|MEXICO||Region Enroll||participants|Number|4|4.0||||||
4246652|NCT00642278|4070704|B8|MALAYSIA||Region Enroll||participants|Number|19|19.0||||||
4246653|NCT00642278|4070705|B7|MALAYSIA||Region Enroll||participants|Number|3|3.0||||||
4246654|NCT00642278|4070706|B6|MALAYSIA||Region Enroll||participants|Number|1|1.0||||||
4246655|NCT00642278|4070707|B5|MALAYSIA||Region Enroll||participants|Number|4|4.0||||||
4246656|NCT00642278|4070708|B4|MALAYSIA||Region Enroll||participants|Number|2|2.0||||||
4246657|NCT00642278|4070709|B3|MALAYSIA||Region Enroll||participants|Number|6|6.0||||||
4246658|NCT00642278|4070710|B2|MALAYSIA||Region Enroll||participants|Number|0|0.0||||||
4246659|NCT00642278|4070711|B1|MALAYSIA||Region Enroll||participants|Number|3|3.0||||||
4246660|NCT00642278|4070704|B8|INDIA||Region Enroll||participants|Number|30|30.0||||||
4246661|NCT00642278|4070705|B7|INDIA||Region Enroll||participants|Number|4|4.0||||||
4246662|NCT00642278|4070706|B6|INDIA||Region Enroll||participants|Number|6|6.0||||||
4246663|NCT00642278|4070707|B5|INDIA||Region Enroll||participants|Number|2|2.0||||||
4246664|NCT00642278|4070708|B4|INDIA||Region Enroll||participants|Number|5|5.0||||||
4246665|NCT00642278|4070709|B3|INDIA||Region Enroll||participants|Number|3|3.0||||||
4246666|NCT00642278|4070710|B2|INDIA||Region Enroll||participants|Number|6|6.0||||||
4246667|NCT00642278|4070711|B1|INDIA||Region Enroll||participants|Number|4|4.0||||||
4246668|NCT00642278|4070704|B8|CZECH REPUBLIC||Region Enroll||participants|Number|17|17.0||||||
4246669|NCT00642278|4070705|B7|CZECH REPUBLIC||Region Enroll||participants|Number|2|2.0||||||
4246670|NCT00642278|4070706|B6|CZECH REPUBLIC||Region Enroll||participants|Number|2|2.0||||||
4246671|NCT00642278|4070707|B5|CZECH REPUBLIC||Region Enroll||participants|Number|0|0.0||||||
4246672|NCT00642278|4070708|B4|CZECH REPUBLIC||Region Enroll||participants|Number|6|6.0||||||
4246673|NCT00642278|4070709|B3|CZECH REPUBLIC||Region Enroll||participants|Number|2|2.0||||||
4246674|NCT00642278|4070710|B2|CZECH REPUBLIC||Region Enroll||participants|Number|3|3.0||||||
4246675|NCT00642278|4070711|B1|CZECH REPUBLIC||Region Enroll||participants|Number|2|2.0||||||
4246676|NCT00642278|4070704|B8|CANADA||Region Enroll||participants|Number|53|53.0||||||
4246677|NCT00642278|4070705|B7|CANADA||Region Enroll||participants|Number|7|7.0||||||
4246678|NCT00642278|4070706|B6|CANADA||Region Enroll||participants|Number|4|4.0||||||
4246679|NCT00642278|4070707|B5|CANADA||Region Enroll||participants|Number|8|8.0||||||
4246680|NCT00642278|4070708|B4|CANADA||Region Enroll||participants|Number|8|8.0||||||
4246681|NCT00642278|4070709|B3|CANADA||Region Enroll||participants|Number|9|9.0||||||
4246682|NCT00642278|4070710|B2|CANADA||Region Enroll||participants|Number|6|6.0||||||
4246683|NCT00642278|4070711|B1|CANADA||Region Enroll||participants|Number|11|11.0||||||
4246684|NCT00642278|4070704|B8|BULGARIA||Region Enroll||participants|Number|10|10.0||||||
4246685|NCT00642278|4070705|B7|BULGARIA||Region Enroll||participants|Number|1|1.0||||||
4246686|NCT00642278|4070706|B6|BULGARIA||Region Enroll||participants|Number|3|3.0||||||
4246687|NCT00642278|4070707|B5|BULGARIA||Region Enroll||participants|Number|3|3.0||||||
4246688|NCT00642278|4070708|B4|BULGARIA||Region Enroll||participants|Number|0|0.0||||||
4246689|NCT00642278|4070709|B3|BULGARIA||Region Enroll||participants|Number|1|1.0||||||
4246690|NCT00642278|4070710|B2|BULGARIA||Region Enroll||participants|Number|1|1.0||||||
4246691|NCT00642278|4070711|B1|BULGARIA||Region Enroll||participants|Number|1|1.0||||||
4246692|NCT00642278|4070704|B8|ARGENTINA||Region Enroll||participants|Number|10|10.0||||||
4246693|NCT00642278|4070705|B7|ARGENTINA||Region Enroll||participants|Number|2|2.0||||||
4246694|NCT00642278|4070706|B6|ARGENTINA||Region Enroll||participants|Number|0|0.0||||||
4246695|NCT00642278|4070707|B5|ARGENTINA||Region Enroll||participants|Number|2|2.0||||||
4246696|NCT00642278|4070708|B4|ARGENTINA||Region Enroll||participants|Number|1|1.0||||||
4246697|NCT00642278|4070709|B3|ARGENTINA||Region Enroll||participants|Number|3|3.0||||||
4246698|NCT00642278|4070710|B2|ARGENTINA||Region Enroll||participants|Number|1|1.0||||||
4246699|NCT00642278|4070711|B1|ARGENTINA||Region Enroll||participants|Number|1|1.0||||||
4246700|NCT00642278|4070704|B8||Male|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
4246701|NCT00642278|4070705|B7||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4246702|NCT00642278|4070706|B6||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4246703|NCT00642278|4070707|B5||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4246704|NCT00642278|4070708|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4246705|NCT00642278|4070709|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4246706|NCT00642278|4070710|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4246707|NCT00642278|4070711|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4246708|NCT00642278|4070704|B8||Female|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
4246709|NCT00642278|4070705|B7||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4246710|NCT00642278|4070706|B6||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4246711|NCT00642278|4070707|B5||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4246712|NCT00642278|4070708|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4246713|NCT00642278|4070709|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4246714|NCT00642278|4070710|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4246715|NCT00642278|4070711|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4246716|NCT00642278|4070704|B8|||Age||years|Mean|52.9|52.9|Standard Deviation|8.06|8.06|||
4246717|NCT00642278|4070705|B7|||Age||years|Mean|51.7|51.7|Standard Deviation|8.09|8.09|||
4246718|NCT00642278|4070706|B6|||Age||years|Mean|55.2|55.2|Standard Deviation|7.14|7.14|||
4246719|NCT00642278|4070707|B5|||Age||years|Mean|52.3|52.3|Standard Deviation|6.88|6.88|||
4246720|NCT00642278|4070708|B4|||Age||years|Mean|52.9|52.9|Standard Deviation|9.56|9.56|||
4246721|NCT00642278|4070709|B3|||Age||years|Mean|51.7|51.7|Standard Deviation|7.95|7.95|||
4246722|NCT00642278|4070710|B2|||Age||years|Mean|53.3|53.3|Standard Deviation|8.48|8.48|||
4246723|NCT00642278|4070711|B1|||Age||years|Mean|53.3|53.3|Standard Deviation|7.82|7.82|||
4246724|NCT00642278|4070704|B8||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4246725|NCT00642278|4070705|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4246726|NCT00642278|4070706|B6||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4246727|NCT00642278|4070707|B5||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4246728|NCT00642278|4070708|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4246729|NCT00642278|4070709|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4246730|NCT00642278|4070710|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4246731|NCT00642278|4070711|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4246732|NCT00642278|4070704|B8||Between 18 and 65 years|Age||Participants|Count of Participants|438|438.0||||||
4246733|NCT00642278|4070705|B7||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4246734|NCT00642278|4070706|B6||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4246735|NCT00642278|4070707|B5||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4246736|NCT00642278|4070708|B4||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4246737|NCT00642278|4070709|B3||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4246738|NCT00642278|4070710|B2||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4246739|NCT00642278|4070711|B1||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4246740|NCT00642278|4070704|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4246741|NCT00642278|4070705|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4246742|NCT00642278|4070706|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4246743|NCT00642278|4070707|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4246744|NCT00642278|4070708|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4246745|NCT00642278|4070709|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4246746|NCT00642278|4070710|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4246747|NCT00642278|4070711|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4246748|NCT00642174|4070768|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
4246749|NCT00642174|4070769|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4246750|NCT00642174|4070770|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4246751|NCT00642174|4070768|B3|West Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4246752|NCT00642174|4070769|B2|West Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4246753|NCT00642174|4070770|B1|West Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4246754|NCT00642174|4070768|B3|East Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4246755|NCT00642174|4070769|B2|East Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4246756|NCT00642174|4070770|B1|East Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4246757|NCT00642174|4070768|B3|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4246758|NCT00642174|4070769|B2|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4246759|NCT00642174|4070770|B1|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4246760|NCT00642174|4070768|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4246761|NCT00642174|4070769|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4246762|NCT00642174|4070770|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4246763|NCT00642174|4070768|B3|African||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4246764|NCT00642174|4070769|B2|African||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4246765|NCT00642174|4070770|B1|African||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4246766|NCT00642174|4070768|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4246767|NCT00642174|4070769|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4246768|NCT00642174|4070770|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4246769|NCT00642174|4070768|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4246770|NCT00642174|4070769|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4246771|NCT00642174|4070770|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4246772|NCT00642174|4070768|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4246773|NCT00642174|4070769|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4246774|NCT00642174|4070770|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4246775|NCT00642174|4070768|B3|||Age||years|Mean|61.3|61.3|Standard Deviation|8.76|8.76|||
4246776|NCT00642174|4070769|B2|||Age||years|Mean|62.4|62.4|Standard Deviation|8.14|8.14|||
4246777|NCT00642174|4070770|B1|||Age||years|Mean|60.3|60.3|Standard Deviation|9.43|9.43|||
4246778|NCT00641862|4070785|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4246779|NCT00641862|4070786|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4246780|NCT00641862|4070787|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4246781|NCT00641862|4070785|B3||Female|Sex: Female, Male||Participants|Count of Participants|366|366.0||||||
4246782|NCT00641862|4070786|B2||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4246783|NCT00641862|4070787|B1||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4246784|NCT00641862|4070785|B3|||Age||years|Median|22|22.0|Inter-Quartile Range|||20.0|24.0|
4246785|NCT00641862|4070786|B2|||Age||years|Median|22|22.0|Inter-Quartile Range|||20.0|24.0|
4246786|NCT00641862|4070787|B1|||Age||years|Median|22|22.0|Inter-Quartile Range|||20.0|24.0|
4246787|NCT00641797|4070794|B3|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
4246788|NCT00641797|4070795|B2|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4246789|NCT00641797|4070796|B1|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4246790|NCT00641797|4070794|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4246791|NCT00641797|4070795|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4246792|NCT00641797|4070796|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4246793|NCT00641797|4070794|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4246794|NCT00641797|4070795|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4246795|NCT00641797|4070796|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4246796|NCT00641797|4070794|B3|||Age||years|Mean|61.5|61.5|Standard Deviation|11.9|11.9|||
4246797|NCT00641797|4070795|B2|||Age||years|Mean|64|64.0|Standard Deviation|11.2|11.2|||
4246798|NCT00641797|4070796|B1|||Age||years|Mean|59|59.0|Standard Deviation|12.6|12.6|||
4246799|NCT00641745|4070803|B3|South Africa||Region of Enrollment|There were 9 subjects randomized to lurasidone but did not take study drug and thus there is a discrepancy of 9 subjects in the lurasidone treatment group between the participant population and the overall number of baseline participants.|participants|Number|91|91.0||||||
4246800|NCT00641745|4070804|B2|South Africa||Region of Enrollment|There were 9 subjects randomized to lurasidone but did not take study drug and thus there is a discrepancy of 9 subjects in the lurasidone treatment group between the participant population and the overall number of baseline participants.|participants|Number|32|32.0||||||
4246801|NCT00641745|4070805|B1|South Africa||Region of Enrollment|There were 9 subjects randomized to lurasidone but did not take study drug and thus there is a discrepancy of 9 subjects in the lurasidone treatment group between the participant population and the overall number of baseline participants.|participants|Number|59|59.0||||||
4246802|NCT00641745|4070803|B3|Chile||Region of Enrollment|There were 9 subjects randomized to lurasidone but did not take study drug and thus there is a discrepancy of 9 subjects in the lurasidone treatment group between the participant population and the overall number of baseline participants.|participants|Number|26|26.0||||||
4246803|NCT00641745|4070804|B2|Chile||Region of Enrollment|There were 9 subjects randomized to lurasidone but did not take study drug and thus there is a discrepancy of 9 subjects in the lurasidone treatment group between the participant population and the overall number of baseline participants.|participants|Number|7|7.0||||||
4246804|NCT00641745|4070805|B1|Chile||Region of Enrollment|There were 9 subjects randomized to lurasidone but did not take study drug and thus there is a discrepancy of 9 subjects in the lurasidone treatment group between the participant population and the overall number of baseline participants.|participants|Number|19|19.0||||||
4246805|NCT00641745|4070803|B3|Israel||Region of Enrollment|There were 9 subjects randomized to lurasidone but did not take study drug and thus there is a discrepancy of 9 subjects in the lurasidone treatment group between the participant population and the overall number of baseline participants.|participants|Number|3|3.0||||||
4246806|NCT00641745|4070804|B2|Israel||Region of Enrollment|There were 9 subjects randomized to lurasidone but did not take study drug and thus there is a discrepancy of 9 subjects in the lurasidone treatment group between the participant population and the overall number of baseline participants.|participants|Number|0|0.0||||||
4246807|NCT00641745|4070805|B1|Israel||Region of Enrollment|There were 9 subjects randomized to lurasidone but did not take study drug and thus there is a discrepancy of 9 subjects in the lurasidone treatment group between the participant population and the overall number of baseline participants.|participants|Number|3|3.0||||||
4246808|NCT00641745|4070803|B3|Croatia||Region of Enrollment|There were 9 subjects randomized to lurasidone but did not take study drug and thus there is a discrepancy of 9 subjects in the lurasidone treatment group between the participant population and the overall number of baseline participants.|participants|Number|12|12.0||||||
4246809|NCT00641745|4070804|B2|Croatia||Region of Enrollment|There were 9 subjects randomized to lurasidone but did not take study drug and thus there is a discrepancy of 9 subjects in the lurasidone treatment group between the participant population and the overall number of baseline participants.|participants|Number|5|5.0||||||
4246907|NCT00641719|4070812|B3|||Race/Ethnicity, Customized|All participants were Japanese.|participants|Number|258|258.0||||||
4246810|NCT00641745|4070805|B1|Croatia||Region of Enrollment|There were 9 subjects randomized to lurasidone but did not take study drug and thus there is a discrepancy of 9 subjects in the lurasidone treatment group between the participant population and the overall number of baseline participants.|participants|Number|7|7.0||||||
4246811|NCT00641745|4070803|B3|Thailand||Region of Enrollment|There were 9 subjects randomized to lurasidone but did not take study drug and thus there is a discrepancy of 9 subjects in the lurasidone treatment group between the participant population and the overall number of baseline participants.|participants|Number|16|16.0||||||
4246812|NCT00641745|4070804|B2|Thailand||Region of Enrollment|There were 9 subjects randomized to lurasidone but did not take study drug and thus there is a discrepancy of 9 subjects in the lurasidone treatment group between the participant population and the overall number of baseline participants.|participants|Number|3|3.0||||||
4246813|NCT00641745|4070805|B1|Thailand||Region of Enrollment|There were 9 subjects randomized to lurasidone but did not take study drug and thus there is a discrepancy of 9 subjects in the lurasidone treatment group between the participant population and the overall number of baseline participants.|participants|Number|13|13.0||||||
4246814|NCT00641745|4070803|B3|Brazil||Region of Enrollment|There were 9 subjects randomized to lurasidone but did not take study drug and thus there is a discrepancy of 9 subjects in the lurasidone treatment group between the participant population and the overall number of baseline participants.|participants|Number|24|24.0||||||
4246815|NCT00641745|4070804|B2|Brazil||Region of Enrollment|There were 9 subjects randomized to lurasidone but did not take study drug and thus there is a discrepancy of 9 subjects in the lurasidone treatment group between the participant population and the overall number of baseline participants.|participants|Number|9|9.0||||||
4246816|NCT00641745|4070805|B1|Brazil||Region of Enrollment|There were 9 subjects randomized to lurasidone but did not take study drug and thus there is a discrepancy of 9 subjects in the lurasidone treatment group between the participant population and the overall number of baseline participants.|participants|Number|15|15.0||||||
4246817|NCT00641745|4070803|B3|Argentina||Region of Enrollment|There were 9 subjects randomized to lurasidone but did not take study drug and thus there is a discrepancy of 9 subjects in the lurasidone treatment group between the participant population and the overall number of baseline participants.|participants|Number|37|37.0||||||
4246818|NCT00641745|4070804|B2|Argentina||Region of Enrollment|There were 9 subjects randomized to lurasidone but did not take study drug and thus there is a discrepancy of 9 subjects in the lurasidone treatment group between the participant population and the overall number of baseline participants.|participants|Number|13|13.0||||||
4246819|NCT00641745|4070805|B1|Argentina||Region of Enrollment|There were 9 subjects randomized to lurasidone but did not take study drug and thus there is a discrepancy of 9 subjects in the lurasidone treatment group between the participant population and the overall number of baseline participants.|participants|Number|24|24.0||||||
4246820|NCT00641745|4070803|B3|United States||Region of Enrollment|There were 9 subjects randomized to lurasidone but did not take study drug and thus there is a discrepancy of 9 subjects in the lurasidone treatment group between the participant population and the overall number of baseline participants.|participants|Number|412|412.0||||||
4246821|NCT00641745|4070804|B2|United States||Region of Enrollment|There were 9 subjects randomized to lurasidone but did not take study drug and thus there is a discrepancy of 9 subjects in the lurasidone treatment group between the participant population and the overall number of baseline participants.|participants|Number|133|133.0||||||
4246822|NCT00641745|4070805|B1|United States||Region of Enrollment|There were 9 subjects randomized to lurasidone but did not take study drug and thus there is a discrepancy of 9 subjects in the lurasidone treatment group between the participant population and the overall number of baseline participants.|participants|Number|279|279.0||||||
4246823|NCT00641745|4070803|B3|Male||Gender|There were 9 subjects randomized to lurasidone but did not take study drug and thus there is a discrepancy of 9 subjects in the lurasidone treatment group between the participant population and the overall number of baseline participants.|participants|Number|428|428.0||||||
4246824|NCT00641745|4070804|B2|Male||Gender|There were 9 subjects randomized to lurasidone but did not take study drug and thus there is a discrepancy of 9 subjects in the lurasidone treatment group between the participant population and the overall number of baseline participants.|participants|Number|126|126.0||||||
4246825|NCT00641745|4070805|B1|Male||Gender|There were 9 subjects randomized to lurasidone but did not take study drug and thus there is a discrepancy of 9 subjects in the lurasidone treatment group between the participant population and the overall number of baseline participants.|participants|Number|302|302.0||||||
4246826|NCT00641745|4070803|B3|Female||Gender|There were 9 subjects randomized to lurasidone but did not take study drug and thus there is a discrepancy of 9 subjects in the lurasidone treatment group between the participant population and the overall number of baseline participants.|participants|Number|193|193.0||||||
4246827|NCT00641745|4070804|B2|Female||Gender|There were 9 subjects randomized to lurasidone but did not take study drug and thus there is a discrepancy of 9 subjects in the lurasidone treatment group between the participant population and the overall number of baseline participants.|participants|Number|76|76.0||||||
4246828|NCT00641745|4070805|B1|Female||Gender|There were 9 subjects randomized to lurasidone but did not take study drug and thus there is a discrepancy of 9 subjects in the lurasidone treatment group between the participant population and the overall number of baseline participants.|participants|Number|117|117.0||||||
4246829|NCT00641745|4070803|B3|||Age||years|Mean|41.7|41.7|Standard Deviation|11.3|11.3|||
4246830|NCT00641745|4070804|B2|||Age||years|Mean|41.6|41.6|Standard Deviation|11.3|11.3|||
4246831|NCT00641745|4070805|B1|||Age||years|Mean|41.7|41.7|Standard Deviation|11.3|11.3|||
4246832|NCT00641719|4070812|B3|Pain Right Now||Brief Pain Inventory (BPI) - Pain Severity|A self-reported scale that measures the severity of pain based on the average pain, least pain, and worst pain experienced over the past 24 hours, and the pain right now. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|3.5|3.5|Standard Deviation|2.1|2.1|||
4246833|NCT00641719|4070813|B2|Pain Right Now||Brief Pain Inventory (BPI) - Pain Severity|A self-reported scale that measures the severity of pain based on the average pain, least pain, and worst pain experienced over the past 24 hours, and the pain right now. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|3.6|3.6|Standard Deviation|2.1|2.1|||
4246834|NCT00641719|4070814|B1|Pain Right Now||Brief Pain Inventory (BPI) - Pain Severity|A self-reported scale that measures the severity of pain based on the average pain, least pain, and worst pain experienced over the past 24 hours, and the pain right now. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|3.4|3.4|Standard Deviation|2.1|2.1|||
4246835|NCT00641719|4070812|B3|Average Pain||Brief Pain Inventory (BPI) - Pain Severity|A self-reported scale that measures the severity of pain based on the average pain, least pain, and worst pain experienced over the past 24 hours, and the pain right now. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|3.9|3.9|Standard Deviation|1.9|1.9|||
4246836|NCT00641719|4070813|B2|Average Pain||Brief Pain Inventory (BPI) - Pain Severity|A self-reported scale that measures the severity of pain based on the average pain, least pain, and worst pain experienced over the past 24 hours, and the pain right now. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|4.0|4.0|Standard Deviation|1.9|1.9|||
4246837|NCT00641719|4070814|B1|Average Pain||Brief Pain Inventory (BPI) - Pain Severity|A self-reported scale that measures the severity of pain based on the average pain, least pain, and worst pain experienced over the past 24 hours, and the pain right now. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|3.8|3.8|Standard Deviation|1.9|1.9|||
4246838|NCT00641719|4070812|B3|Least Pain||Brief Pain Inventory (BPI) - Pain Severity|A self-reported scale that measures the severity of pain based on the average pain, least pain, and worst pain experienced over the past 24 hours, and the pain right now. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|3.0|3.0|Standard Deviation|2.0|2.0|||
4246839|NCT00641719|4070813|B2|Least Pain||Brief Pain Inventory (BPI) - Pain Severity|A self-reported scale that measures the severity of pain based on the average pain, least pain, and worst pain experienced over the past 24 hours, and the pain right now. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|3.1|3.1|Standard Deviation|2.1|2.1|||
4246840|NCT00641719|4070814|B1|Least Pain||Brief Pain Inventory (BPI) - Pain Severity|A self-reported scale that measures the severity of pain based on the average pain, least pain, and worst pain experienced over the past 24 hours, and the pain right now. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|2.8|2.8|Standard Deviation|2.0|2.0|||
4246841|NCT00641719|4070812|B3|Worst Pain||Brief Pain Inventory (BPI) - Pain Severity|A self-reported scale that measures the severity of pain based on the average pain, least pain, and worst pain experienced over the past 24 hours, and the pain right now. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|4.8|4.8|Standard Deviation|2.0|2.0|||
4246842|NCT00641719|4070813|B2|Worst Pain||Brief Pain Inventory (BPI) - Pain Severity|A self-reported scale that measures the severity of pain based on the average pain, least pain, and worst pain experienced over the past 24 hours, and the pain right now. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|4.9|4.9|Standard Deviation|2.0|2.0|||
4246843|NCT00641719|4070814|B1|Worst Pain||Brief Pain Inventory (BPI) - Pain Severity|A self-reported scale that measures the severity of pain based on the average pain, least pain, and worst pain experienced over the past 24 hours, and the pain right now. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|4.7|4.7|Standard Deviation|2.0|2.0|||
4246844|NCT00641719|4070812|B3|Average Interference Score||Brief Pain Inventory (BPI) Interference|Self-reported scale measures interference of pain on function in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Scores range from 0 (does not interfere) to 10 (completely interferes). Average interference = self-reported scale measures interference of pain on average of 7 questions assessing interference of pain for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Average Interference scores range from 0 (does not interfere) to 10 (completely interferes).|units on a scale|Mean|2.23|2.23|Standard Deviation|2.07|2.07|||
4246845|NCT00641719|4070813|B2|Average Interference Score||Brief Pain Inventory (BPI) Interference|Self-reported scale measures interference of pain on function in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Scores range from 0 (does not interfere) to 10 (completely interferes). Average interference = self-reported scale measures interference of pain on average of 7 questions assessing interference of pain for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Average Interference scores range from 0 (does not interfere) to 10 (completely interferes).|units on a scale|Mean|2.32|2.32|Standard Deviation|2.06|2.06|||
4246846|NCT00641719|4070814|B1|Average Interference Score||Brief Pain Inventory (BPI) Interference|Self-reported scale measures interference of pain on function in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Scores range from 0 (does not interfere) to 10 (completely interferes). Average interference = self-reported scale measures interference of pain on average of 7 questions assessing interference of pain for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Average Interference scores range from 0 (does not interfere) to 10 (completely interferes).|units on a scale|Mean|2.14|2.14|Standard Deviation|2.09|2.09|||
4246847|NCT00641719|4070812|B3|Enjoyment of Life||Brief Pain Inventory (BPI) Interference|Self-reported scale measures interference of pain on function in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Scores range from 0 (does not interfere) to 10 (completely interferes). Average interference = self-reported scale measures interference of pain on average of 7 questions assessing interference of pain for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Average Interference scores range from 0 (does not interfere) to 10 (completely interferes).|units on a scale|Mean|2.0|2.0|Standard Deviation|2.1|2.1|||
4246908|NCT00641719|4070813|B2|||Race/Ethnicity, Customized|All participants were Japanese.|participants|Number|129|129.0||||||
4246909|NCT00641719|4070814|B1|||Race/Ethnicity, Customized|All participants were Japanese.|participants|Number|129|129.0||||||
4246910|NCT00641719|4070812|B3||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4246848|NCT00641719|4070813|B2|Enjoyment of Life||Brief Pain Inventory (BPI) Interference|Self-reported scale measures interference of pain on function in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Scores range from 0 (does not interfere) to 10 (completely interferes). Average interference = self-reported scale measures interference of pain on average of 7 questions assessing interference of pain for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Average Interference scores range from 0 (does not interfere) to 10 (completely interferes).|units on a scale|Mean|2.1|2.1|Standard Deviation|2.1|2.1|||
4246849|NCT00641719|4070814|B1|Enjoyment of Life||Brief Pain Inventory (BPI) Interference|Self-reported scale measures interference of pain on function in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Scores range from 0 (does not interfere) to 10 (completely interferes). Average interference = self-reported scale measures interference of pain on average of 7 questions assessing interference of pain for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Average Interference scores range from 0 (does not interfere) to 10 (completely interferes).|units on a scale|Mean|1.9|1.9|Standard Deviation|2.1|2.1|||
4246850|NCT00641719|4070812|B3|Sleep||Brief Pain Inventory (BPI) Interference|Self-reported scale measures interference of pain on function in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Scores range from 0 (does not interfere) to 10 (completely interferes). Average interference = self-reported scale measures interference of pain on average of 7 questions assessing interference of pain for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Average Interference scores range from 0 (does not interfere) to 10 (completely interferes).|units on a scale|Mean|2.3|2.3|Standard Deviation|2.4|2.4|||
4246851|NCT00641719|4070813|B2|Sleep||Brief Pain Inventory (BPI) Interference|Self-reported scale measures interference of pain on function in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Scores range from 0 (does not interfere) to 10 (completely interferes). Average interference = self-reported scale measures interference of pain on average of 7 questions assessing interference of pain for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Average Interference scores range from 0 (does not interfere) to 10 (completely interferes).|units on a scale|Mean|2.5|2.5|Standard Deviation|2.4|2.4|||
4246852|NCT00641719|4070814|B1|Sleep||Brief Pain Inventory (BPI) Interference|Self-reported scale measures interference of pain on function in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Scores range from 0 (does not interfere) to 10 (completely interferes). Average interference = self-reported scale measures interference of pain on average of 7 questions assessing interference of pain for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Average Interference scores range from 0 (does not interfere) to 10 (completely interferes).|units on a scale|Mean|2.2|2.2|Standard Deviation|2.3|2.3|||
4246853|NCT00641719|4070812|B3|Relation to People||Brief Pain Inventory (BPI) Interference|Self-reported scale measures interference of pain on function in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Scores range from 0 (does not interfere) to 10 (completely interferes). Average interference = self-reported scale measures interference of pain on average of 7 questions assessing interference of pain for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Average Interference scores range from 0 (does not interfere) to 10 (completely interferes).|units on a scale|Mean|1.8|1.8|Standard Deviation|2.1|2.1|||
4246854|NCT00641719|4070813|B2|Relation to People||Brief Pain Inventory (BPI) Interference|Self-reported scale measures interference of pain on function in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Scores range from 0 (does not interfere) to 10 (completely interferes). Average interference = self-reported scale measures interference of pain on average of 7 questions assessing interference of pain for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Average Interference scores range from 0 (does not interfere) to 10 (completely interferes).|units on a scale|Mean|1.9|1.9|Standard Deviation|2.1|2.1|||
4246855|NCT00641719|4070814|B1|Relation to People||Brief Pain Inventory (BPI) Interference|Self-reported scale measures interference of pain on function in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Scores range from 0 (does not interfere) to 10 (completely interferes). Average interference = self-reported scale measures interference of pain on average of 7 questions assessing interference of pain for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Average Interference scores range from 0 (does not interfere) to 10 (completely interferes).|units on a scale|Mean|1.6|1.6|Standard Deviation|2.1|2.1|||
4246856|NCT00641719|4070812|B3|Normal Work||Brief Pain Inventory (BPI) Interference|Self-reported scale measures interference of pain on function in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Scores range from 0 (does not interfere) to 10 (completely interferes). Average interference = self-reported scale measures interference of pain on average of 7 questions assessing interference of pain for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Average Interference scores range from 0 (does not interfere) to 10 (completely interferes).|units on a scale|Mean|2.3|2.3|Standard Deviation|2.3|2.3|||
4246857|NCT00641719|4070813|B2|Normal Work||Brief Pain Inventory (BPI) Interference|Self-reported scale measures interference of pain on function in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Scores range from 0 (does not interfere) to 10 (completely interferes). Average interference = self-reported scale measures interference of pain on average of 7 questions assessing interference of pain for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Average Interference scores range from 0 (does not interfere) to 10 (completely interferes).|units on a scale|Mean|2.3|2.3|Standard Deviation|2.2|2.2|||
4246911|NCT00641719|4070813|B2||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4246912|NCT00641719|4070814|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4246858|NCT00641719|4070814|B1|Normal Work||Brief Pain Inventory (BPI) Interference|Self-reported scale measures interference of pain on function in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Scores range from 0 (does not interfere) to 10 (completely interferes). Average interference = self-reported scale measures interference of pain on average of 7 questions assessing interference of pain for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Average Interference scores range from 0 (does not interfere) to 10 (completely interferes).|units on a scale|Mean|2.3|2.3|Standard Deviation|2.3|2.3|||
4246859|NCT00641719|4070812|B3|Walking Ability||Brief Pain Inventory (BPI) Interference|Self-reported scale measures interference of pain on function in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Scores range from 0 (does not interfere) to 10 (completely interferes). Average interference = self-reported scale measures interference of pain on average of 7 questions assessing interference of pain for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Average Interference scores range from 0 (does not interfere) to 10 (completely interferes).|units on a scale|Mean|2.3|2.3|Standard Deviation|2.2|2.2|||
4246860|NCT00641719|4070813|B2|Walking Ability||Brief Pain Inventory (BPI) Interference|Self-reported scale measures interference of pain on function in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Scores range from 0 (does not interfere) to 10 (completely interferes). Average interference = self-reported scale measures interference of pain on average of 7 questions assessing interference of pain for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Average Interference scores range from 0 (does not interfere) to 10 (completely interferes).|units on a scale|Mean|2.3|2.3|Standard Deviation|2.1|2.1|||
4246861|NCT00641719|4070814|B1|Walking Ability||Brief Pain Inventory (BPI) Interference|Self-reported scale measures interference of pain on function in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Scores range from 0 (does not interfere) to 10 (completely interferes). Average interference = self-reported scale measures interference of pain on average of 7 questions assessing interference of pain for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Average Interference scores range from 0 (does not interfere) to 10 (completely interferes).|units on a scale|Mean|2.2|2.2|Standard Deviation|2.4|2.4|||
4246862|NCT00641719|4070812|B3|Mood||Brief Pain Inventory (BPI) Interference|Self-reported scale measures interference of pain on function in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Scores range from 0 (does not interfere) to 10 (completely interferes). Average interference = self-reported scale measures interference of pain on average of 7 questions assessing interference of pain for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Average Interference scores range from 0 (does not interfere) to 10 (completely interferes).|units on a scale|Mean|2.3|2.3|Standard Deviation|2.2|2.2|||
4246863|NCT00641719|4070813|B2|Mood||Brief Pain Inventory (BPI) Interference|Self-reported scale measures interference of pain on function in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Scores range from 0 (does not interfere) to 10 (completely interferes). Average interference = self-reported scale measures interference of pain on average of 7 questions assessing interference of pain for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Average Interference scores range from 0 (does not interfere) to 10 (completely interferes).|units on a scale|Mean|2.4|2.4|Standard Deviation|2.2|2.2|||
4246864|NCT00641719|4070814|B1|Mood||Brief Pain Inventory (BPI) Interference|Self-reported scale measures interference of pain on function in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Scores range from 0 (does not interfere) to 10 (completely interferes). Average interference = self-reported scale measures interference of pain on average of 7 questions assessing interference of pain for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Average Interference scores range from 0 (does not interfere) to 10 (completely interferes).|units on a scale|Mean|2.3|2.3|Standard Deviation|2.3|2.3|||
4246865|NCT00641719|4070812|B3|General Activity||Brief Pain Inventory (BPI) Interference|Self-reported scale measures interference of pain on function in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Scores range from 0 (does not interfere) to 10 (completely interferes). Average interference = self-reported scale measures interference of pain on average of 7 questions assessing interference of pain for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Average Interference scores range from 0 (does not interfere) to 10 (completely interferes).|units on a scale|Mean|2.6|2.6|Standard Deviation|2.3|2.3|||
4246866|NCT00641719|4070813|B2|General Activity||Brief Pain Inventory (BPI) Interference|Self-reported scale measures interference of pain on function in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Scores range from 0 (does not interfere) to 10 (completely interferes). Average interference = self-reported scale measures interference of pain on average of 7 questions assessing interference of pain for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Average Interference scores range from 0 (does not interfere) to 10 (completely interferes).|units on a scale|Mean|2.7|2.7|Standard Deviation|2.2|2.2|||
4246867|NCT00641719|4070814|B1|General Activity||Brief Pain Inventory (BPI) Interference|Self-reported scale measures interference of pain on function in past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Scores range from 0 (does not interfere) to 10 (completely interferes). Average interference = self-reported scale measures interference of pain on average of 7 questions assessing interference of pain for general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Average Interference scores range from 0 (does not interfere) to 10 (completely interferes).|units on a scale|Mean|2.5|2.5|Standard Deviation|2.4|2.4|||
4246913|NCT00641719|4070812|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4246914|NCT00641719|4070813|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4246868|NCT00641719|4070812|B3|||Beck Depression Inventory - II (BDI-II)|A 21-item, participant-completed questionnaire to assess characteristics of depression. Each of the 21 items corresponding to a symptom of depression is summed to give a single score. There is a 4-point scale for each item ranging from 0 to 3. Total score of 0-13 is considered minimal range, 14-19 is mild, 20-28 is moderate, and 29-63 is severe.|units on a scale|Mean|6.1|6.1|Standard Deviation|6.4|6.4|||
4246869|NCT00641719|4070813|B2|||Beck Depression Inventory - II (BDI-II)|A 21-item, participant-completed questionnaire to assess characteristics of depression. Each of the 21 items corresponding to a symptom of depression is summed to give a single score. There is a 4-point scale for each item ranging from 0 to 3. Total score of 0-13 is considered minimal range, 14-19 is mild, 20-28 is moderate, and 29-63 is severe.|units on a scale|Mean|6.1|6.1|Standard Deviation|6.4|6.4|||
4246870|NCT00641719|4070814|B1|||Beck Depression Inventory - II (BDI-II)|A 21-item, participant-completed questionnaire to assess characteristics of depression. Each of the 21 items corresponding to a symptom of depression is summed to give a single score. There is a 4-point scale for each item ranging from 0 to 3. Total score of 0-13 is considered minimal range, 14-19 is mild, 20-28 is moderate, and 29-63 is severe.|units on a scale|Mean|6.1|6.1|Standard Deviation|6.4|6.4|||
4246871|NCT00641719|4070812|B3|||Patient's Global Impressions of Improvement (PGI-I) Rate|A scale that measures the participant's perception of improvement at the time of assessment compared with the start of treatment. The score ranges from 1 (very much better) to 7 (very much worse).|units on a scale|Mean|3.1|3.1|Standard Deviation|1.1|1.1|||
4246872|NCT00641719|4070813|B2|||Patient's Global Impressions of Improvement (PGI-I) Rate|A scale that measures the participant's perception of improvement at the time of assessment compared with the start of treatment. The score ranges from 1 (very much better) to 7 (very much worse).|units on a scale|Mean|3.1|3.1|Standard Deviation|1.1|1.1|||
4246873|NCT00641719|4070814|B1|||Patient's Global Impressions of Improvement (PGI-I) Rate|A scale that measures the participant's perception of improvement at the time of assessment compared with the start of treatment. The score ranges from 1 (very much better) to 7 (very much worse).|units on a scale|Mean|3.0|3.0|Standard Deviation|1.1|1.1|||
4246874|NCT00641719|4070812|B3|||Duration of Diabetic Neuropathy||years|Mean|4.10|4.1|Standard Deviation|3.55|3.55|||
4246875|NCT00641719|4070813|B2|||Duration of Diabetic Neuropathy||years|Mean|4.29|4.29|Standard Deviation|3.91|3.91|||
4246876|NCT00641719|4070814|B1|||Duration of Diabetic Neuropathy||years|Mean|3.91|3.91|Standard Deviation|3.16|3.16|||
4246877|NCT00641719|4070812|B3|||Body Mass Index (BMI)|Body mass index (BMI) is an estimate of body fat based on body weight divided by height squared (kg/m^2).|kilograms/meters squared (kg/m^2)|Mean|23.78|23.78|Standard Deviation|3.62|3.62|||
4246878|NCT00641719|4070813|B2|||Body Mass Index (BMI)|Body mass index (BMI) is an estimate of body fat based on body weight divided by height squared (kg/m^2).|kilograms/meters squared (kg/m^2)|Mean|23.77|23.77|Standard Deviation|3.49|3.49|||
4246879|NCT00641719|4070814|B1|||Body Mass Index (BMI)|Body mass index (BMI) is an estimate of body fat based on body weight divided by height squared (kg/m^2).|kilograms/meters squared (kg/m^2)|Mean|23.79|23.79|Standard Deviation|3.77|3.77|||
4246880|NCT00641719|4070812|B3|||Weight||kilograms (kg)|Mean|64.45|64.45|Standard Deviation|11.84|11.84|||
4246881|NCT00641719|4070813|B2|||Weight||kilograms (kg)|Mean|64.98|64.98|Standard Deviation|11.57|11.57|||
4246882|NCT00641719|4070814|B1|||Weight||kilograms (kg)|Mean|63.91|63.91|Standard Deviation|12.13|12.13|||
4246883|NCT00641719|4070812|B3|||Height||centimeters (cm)|Mean|164.41|164.41|Standard Deviation|8.44|8.44|||
4246884|NCT00641719|4070813|B2|||Height||centimeters (cm)|Mean|165.12|165.12|Standard Deviation|7.75|7.75|||
4246885|NCT00641719|4070814|B1|||Height||centimeters (cm)|Mean|163.69|163.69|Standard Deviation|9.04|9.04|||
4246886|NCT00641719|4070812|B3|Type II||Type of Diabetes|Type I diabetes is insulin dependent diabetes. Type II diabetes is non-insulin dependent diabetes.|participants|Number|246|246.0||||||
4246887|NCT00641719|4070813|B2|Type II||Type of Diabetes|Type I diabetes is insulin dependent diabetes. Type II diabetes is non-insulin dependent diabetes.|participants|Number|125|125.0||||||
4246888|NCT00641719|4070814|B1|Type II||Type of Diabetes|Type I diabetes is insulin dependent diabetes. Type II diabetes is non-insulin dependent diabetes.|participants|Number|121|121.0||||||
4246889|NCT00641719|4070812|B3|Type I||Type of Diabetes|Type I diabetes is insulin dependent diabetes. Type II diabetes is non-insulin dependent diabetes.|participants|Number|12|12.0||||||
4246890|NCT00641719|4070813|B2|Type I||Type of Diabetes|Type I diabetes is insulin dependent diabetes. Type II diabetes is non-insulin dependent diabetes.|participants|Number|4|4.0||||||
4246891|NCT00641719|4070814|B1|Type I||Type of Diabetes|Type I diabetes is insulin dependent diabetes. Type II diabetes is non-insulin dependent diabetes.|participants|Number|8|8.0||||||
4246892|NCT00641719|4070812|B3|Unknown||Duration of Diabetes||participants|Number|5|5.0||||||
4246893|NCT00641719|4070813|B2|Unknown||Duration of Diabetes||participants|Number|2|2.0||||||
4246894|NCT00641719|4070814|B1|Unknown||Duration of Diabetes||participants|Number|3|3.0||||||
4246895|NCT00641719|4070812|B3|Greater Than or Equal to 10 Years||Duration of Diabetes||participants|Number|155|155.0||||||
4246896|NCT00641719|4070813|B2|Greater Than or Equal to 10 Years||Duration of Diabetes||participants|Number|79|79.0||||||
4246897|NCT00641719|4070814|B1|Greater Than or Equal to 10 Years||Duration of Diabetes||participants|Number|76|76.0||||||
4246898|NCT00641719|4070812|B3|5 to 10 Years||Duration of Diabetes||participants|Number|50|50.0||||||
4246899|NCT00641719|4070813|B2|5 to 10 Years||Duration of Diabetes||participants|Number|23|23.0||||||
4246900|NCT00641719|4070814|B1|5 to 10 Years||Duration of Diabetes||participants|Number|27|27.0||||||
4246901|NCT00641719|4070812|B3|Less Than 5 Years||Duration of Diabetes||participants|Number|48|48.0||||||
4246902|NCT00641719|4070813|B2|Less Than 5 Years||Duration of Diabetes||participants|Number|25|25.0||||||
4246903|NCT00641719|4070814|B1|Less Than 5 Years||Duration of Diabetes||participants|Number|23|23.0||||||
4246904|NCT00641719|4070812|B3|Japan||Region of Enrollment||participants|Number|258|258.0||||||
4246905|NCT00641719|4070813|B2|Japan||Region of Enrollment||participants|Number|129|129.0||||||
4246906|NCT00641719|4070814|B1|Japan||Region of Enrollment||participants|Number|129|129.0||||||
4246915|NCT00641719|4070814|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4246916|NCT00641719|4070812|B3|||Age||years|Mean|60.1|60.1|Standard Deviation|10.0|10.0|||
4246917|NCT00641719|4070813|B2|||Age||years|Mean|60.0|60.0|Standard Deviation|9.6|9.6|||
4246918|NCT00641719|4070814|B1|||Age||years|Mean|60.2|60.2|Standard Deviation|10.5|10.5|||
4246919|NCT00641706|4070837|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
4246920|NCT00641706|4070838|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4246921|NCT00641706|4070839|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4246922|NCT00641706|4070837|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4246923|NCT00641706|4070838|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4246924|NCT00641706|4070839|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4246925|NCT00641706|4070837|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4246926|NCT00641706|4070838|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4246927|NCT00641706|4070839|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4246928|NCT00641706|4070837|B3|||Age||years|Median|52|52.0|Full Range|||33.0|80.0|
4246929|NCT00641706|4070838|B2|||Age||years|Median|51|51.0|Full Range|||39.0|60.0|
4246930|NCT00641706|4070839|B1|||Age||years|Median|52|52.0|Full Range|||33.0|80.0|
4246931|NCT00641667|4070852|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4246932|NCT00641667|4070852|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4246933|NCT00641667|4070852|B1|||Age||Years|Mean|63.80|63.8|Standard Deviation|12.67|12.67|||
4246934|NCT00641641|4070862|B1|Australia||Region of Enrollment||participants|Number|16|16.0||||||
4246935|NCT00641641|4070862|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4246936|NCT00641641|4070862|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4246937|NCT00641641|4070862|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4246938|NCT00641641|4070862|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4246939|NCT00641641|4070862|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4246940|NCT00641563|4070866|B1|Switzerland||Region of Enrollment||participants|Number|10|10.0||||||
4246941|NCT00641563|4070866|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4246942|NCT00641563|4070866|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4246943|NCT00641563|4070866|B1|||Age||years|Mean|24|24.0|Standard Deviation|3|3.0|||
4246944|NCT00641563|4070866|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4246945|NCT00641563|4070866|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4246946|NCT00641563|4070866|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4246947|NCT00641537|4070875|B6||Male|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4246948|NCT00641537|4070876|B5||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4246949|NCT00641537|4070877|B4||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4246950|NCT00641537|4070878|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4246951|NCT00641537|4070879|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4246952|NCT00641537|4070880|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4246953|NCT00641537|4070875|B6||Female|Sex: Female, Male||Participants|Count of Participants|531|531.0||||||
4246954|NCT00641537|4070876|B5||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4246955|NCT00641537|4070877|B4||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4246956|NCT00641537|4070878|B3||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4246957|NCT00641537|4070879|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4246958|NCT00641537|4070880|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4246959|NCT00641537|4070875|B6|||Age||years|Mean|41.1|41.1|Standard Deviation|10.1|10.1|||
4246960|NCT00641537|4070876|B5|||Age||years|Mean|41.6|41.6|Standard Deviation|9.6|9.6|||
4246961|NCT00641537|4070877|B4|||Age||years|Mean|41.4|41.4|Standard Deviation|10.1|10.1|||
4246962|NCT00641537|4070878|B3|||Age||years|Mean|40.6|40.6|Standard Deviation|10.5|10.5|||
4246963|NCT00641537|4070879|B2|||Age||years|Mean|40.8|40.8|Standard Deviation|9.6|9.6|||
4246964|NCT00641537|4070880|B1|||Age||years|Mean|40.7|40.7|Standard Deviation|10.7|10.7|||
4246965|NCT00641147|4070940|B3|||Baseline size of polyps in mm||polyps|Mean|2.6|2.6|Standard Deviation|1.3|1.3|||
4246966|NCT00641147|4070941|B2|||Baseline size of polyps in mm||polyps|Mean|2.3|2.3|Standard Deviation|0.6|0.6|||
4246967|NCT00641147|4070942|B1|||Baseline size of polyps in mm||polyps|Mean|3.1|3.1|Standard Deviation|1.7|1.7|||
4246968|NCT00641147|4070940|B3|||Baseline number of polyps||polyps|Mean|20.9|20.9|Standard Deviation|16.6|16.6|||
4246969|NCT00641147|4070941|B2|||Baseline number of polyps||polyps|Mean|18.7|18.7|Standard Deviation|13.1|13.1|||
4246970|NCT00641147|4070942|B1|||Baseline number of polyps||polyps|Mean|23.3|23.3|Standard Deviation|19.7|19.7|||
4246971|NCT00641147|4070940|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4246972|NCT00641147|4070941|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4246973|NCT00641147|4070942|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4246974|NCT00641147|4070940|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4246975|NCT00641147|4070941|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247033|NCT00641056|4070987|B1||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
4246976|NCT00641147|4070942|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4246977|NCT00641147|4070940|B3||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4246978|NCT00641147|4070941|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4246979|NCT00641147|4070942|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4246980|NCT00641147|4070940|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4246981|NCT00641147|4070941|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4246982|NCT00641147|4070942|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4246983|NCT00641147|4070940|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4246984|NCT00641147|4070941|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4246985|NCT00641147|4070942|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4246986|NCT00641147|4070940|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4246987|NCT00641147|4070941|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4246988|NCT00641147|4070942|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4246989|NCT00641147|4070940|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4246990|NCT00641147|4070941|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4246991|NCT00641147|4070942|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4246992|NCT00641147|4070940|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4246993|NCT00641147|4070941|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4246994|NCT00641147|4070942|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4246995|NCT00641147|4070940|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4246996|NCT00641147|4070941|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4246997|NCT00641147|4070942|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4246998|NCT00641147|4070940|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4246999|NCT00641147|4070941|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4247000|NCT00641147|4070942|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4247001|NCT00641147|4070940|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4247002|NCT00641147|4070941|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4247003|NCT00641147|4070942|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4247004|NCT00641147|4070940|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4247005|NCT00641147|4070941|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4247006|NCT00641147|4070942|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4247007|NCT00641147|4070940|B3|||Age||years|Mean|41.5|41.5|Standard Deviation|15.3|15.3|||
4247008|NCT00641147|4070941|B2|||Age||years|Mean|38.7|38.7|Standard Deviation|15.0|15.0|||
4247009|NCT00641147|4070942|B1|||Age||years|Mean|44.5|44.5|Standard Deviation|15.4|15.4|||
4247010|NCT00641056|4070985|B3|Met+Sulfonylurea (SU)||Background Oral Antidiabetic Agent (OAD)||participants|Number|135|135.0||||||
4247011|NCT00641056|4070986|B2|Met+Sulfonylurea (SU)||Background Oral Antidiabetic Agent (OAD)||participants|Number|66|66.0||||||
4247012|NCT00641056|4070987|B1|Met+Sulfonylurea (SU)||Background Oral Antidiabetic Agent (OAD)||participants|Number|69|69.0||||||
4247013|NCT00641056|4070985|B3|Metformin (Met)||Background Oral Antidiabetic Agent (OAD)||participants|Number|321|321.0||||||
4247014|NCT00641056|4070986|B2|Metformin (Met)||Background Oral Antidiabetic Agent (OAD)||participants|Number|157|157.0||||||
4247015|NCT00641056|4070987|B1|Metformin (Met)||Background Oral Antidiabetic Agent (OAD)||participants|Number|164|164.0||||||
4247016|NCT00641056|4070985|B3|||Weight||kg|Mean|90.90|90.9|Standard Deviation|17.509|17.509|||
4247017|NCT00641056|4070986|B2|||Weight||kg|Mean|90.56|90.56|Standard Deviation|16.348|16.348|||
4247018|NCT00641056|4070987|B1|||Weight||kg|Mean|91.22|91.22|Standard Deviation|18.582|18.582|||
4247019|NCT00641056|4070985|B3|||Glycosylated hemoglobin (HbA1c)||percentage of total hemoglobin|Mean|8.31|8.31|Standard Deviation|1.057|1.057|||
4247020|NCT00641056|4070986|B2|||Glycosylated hemoglobin (HbA1c)||percentage of total hemoglobin|Mean|8.29|8.29|Standard Deviation|1.020|1.02|||
4247021|NCT00641056|4070987|B1|||Glycosylated hemoglobin (HbA1c)||percentage of total hemoglobin|Mean|8.32|8.32|Standard Deviation|1.094|1.094|||
4247022|NCT00641056|4070985|B3||Male|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
4247023|NCT00641056|4070986|B2||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4247024|NCT00641056|4070987|B1||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4247025|NCT00641056|4070985|B3||Female|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
4247026|NCT00641056|4070986|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4247027|NCT00641056|4070987|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4247028|NCT00641056|4070985|B3|||Age||years|Mean|57.9|57.9|Standard Deviation|9.41|9.41|||
4247029|NCT00641056|4070986|B2|||Age||years|Mean|58.3|58.3|Standard Deviation|9.08|9.08|||
4247030|NCT00641056|4070987|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|9.72|9.72|||
4247031|NCT00641056|4070985|B3||>=65 years|Age||Participants|Count of Participants|105|105.0||||||
4247032|NCT00641056|4070986|B2||>=65 years|Age||Participants|Count of Participants|56|56.0||||||
4247034|NCT00641056|4070985|B3||Between 18 and 65 years|Age||Participants|Count of Participants|351|351.0||||||
4247035|NCT00641056|4070986|B2||Between 18 and 65 years|Age||Participants|Count of Participants|167|167.0||||||
4247036|NCT00641056|4070987|B1||Between 18 and 65 years|Age||Participants|Count of Participants|184|184.0||||||
4247037|NCT00641056|4070985|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4247038|NCT00641056|4070986|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4247039|NCT00641056|4070987|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4247040|NCT00641043|4071014|B3|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|189.9|189.9|Standard Deviation|43.0|43.0|||
4247041|NCT00641043|4071015|B2|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|189.8|189.8|Standard Deviation|42.7|42.7|||
4247042|NCT00641043|4071016|B1|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|190.3|190.3|Standard Deviation|43.8|43.8|||
4247043|NCT00641043|4071014|B3|||Glycosylated haemoglobin A1 (HbA1c)||Percent|Mean|8.59|8.59|Standard Deviation|0.82|0.82|||
4247044|NCT00641043|4071015|B2|||Glycosylated haemoglobin A1 (HbA1c)||Percent|Mean|8.60|8.6|Standard Deviation|0.79|0.79|||
4247045|NCT00641043|4071016|B1|||Glycosylated haemoglobin A1 (HbA1c)||Percent|Mean|8.58|8.58|Standard Deviation|0.87|0.87|||
4247046|NCT00641043|4071014|B3|||Body mass index continuous||kg/m^2|Mean|29.02|29.02|Standard Deviation|4.85|4.85|||
4247047|NCT00641043|4071015|B2|||Body mass index continuous||kg/m^2|Mean|28.68|28.68|Standard Deviation|4.82|4.82|||
4247048|NCT00641043|4071016|B1|||Body mass index continuous||kg/m^2|Mean|29.72|29.72|Standard Deviation|4.84|4.84|||
4247049|NCT00641043|4071014|B3||Male|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
4247050|NCT00641043|4071015|B2||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4247051|NCT00641043|4071016|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4247052|NCT00641043|4071014|B3||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4247053|NCT00641043|4071015|B2||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4247054|NCT00641043|4071016|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4247055|NCT00641043|4071014|B3|||Age||Years|Mean|57.5|57.5|Standard Deviation|9.8|9.8|||
4247056|NCT00641043|4071015|B2|||Age||Years|Mean|57.7|57.7|Standard Deviation|9.6|9.6|||
4247057|NCT00641043|4071016|B1|||Age||Years|Mean|57.1|57.1|Standard Deviation|10.1|10.1|||
4247058|NCT00640978|4071047|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4247059|NCT00640978|4071047|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4247060|NCT00640978|4071047|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4247061|NCT00640978|4071047|B1|||Age||years|Mean|63|63.0|Full Range|||34.0|75.0|
4247062|NCT00640926|4071051|B4|Russian Federation||Region of Enrollment||participants|Number|45|45.0||||||
4247063|NCT00640926|4071052|B3|Russian Federation||Region of Enrollment||participants|Number|15|15.0||||||
4247064|NCT00640926|4071053|B2|Russian Federation||Region of Enrollment||participants|Number|15|15.0||||||
4247065|NCT00640926|4071054|B1|Russian Federation||Region of Enrollment||participants|Number|15|15.0||||||
4247066|NCT00640926|4071051|B4|Canada||Region of Enrollment||participants|Number|51|51.0||||||
4247067|NCT00640926|4071052|B3|Canada||Region of Enrollment||participants|Number|21|21.0||||||
4247068|NCT00640926|4071053|B2|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4247069|NCT00640926|4071054|B1|Canada||Region of Enrollment||participants|Number|14|14.0||||||
4247070|NCT00640926|4071051|B4|United States||Region of Enrollment||participants|Number|62|62.0||||||
4247071|NCT00640926|4071052|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4247072|NCT00640926|4071053|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4247073|NCT00640926|4071054|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4247074|NCT00640926|4071051|B4||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4247075|NCT00640926|4071052|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4247076|NCT00640926|4071053|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4247077|NCT00640926|4071054|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4247078|NCT00640926|4071051|B4||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4247079|NCT00640926|4071052|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4247080|NCT00640926|4071053|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4247081|NCT00640926|4071054|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4247082|NCT00640926|4071051|B4|||Age||years|Mean|50.7|50.7|Standard Deviation|16.20|16.2|||
4247083|NCT00640926|4071052|B3|||Age||years|Mean|52.1|52.1|Standard Deviation|15.61|15.61|||
4247084|NCT00640926|4071053|B2|||Age||years|Mean|50.4|50.4|Standard Deviation|14.55|14.55|||
4247085|NCT00640926|4071054|B1|||Age||years|Mean|49.6|49.6|Standard Deviation|18.37|18.37|||
4247086|NCT00640835|4071067|B3|Grade 3||Severity Grading of Oral Mucosa|"Safety and tolerability were evaluated at baseline by oral cavity examination. Oral mucosa was graded as follows:~Grade 0: Normal mucosa Grade 1: Localized mucosal erythema and/or irritation without ulceration Grade 2: Erythema and/or irritation and induration without ulceration Grade 3: Ulceration, with or without any other combination of signs"|Participants|Number|1|1.0||||||
4247087|NCT00640835|4071068|B2|Grade 3||Severity Grading of Oral Mucosa|"Safety and tolerability were evaluated at baseline by oral cavity examination. Oral mucosa was graded as follows:~Grade 0: Normal mucosa Grade 1: Localized mucosal erythema and/or irritation without ulceration Grade 2: Erythema and/or irritation and induration without ulceration Grade 3: Ulceration, with or without any other combination of signs"|Participants|Number|1|1.0||||||
4247113|NCT00640835|4071067|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247173|NCT00640822|4071079|B3|||Age||years|Mean|48.8|48.8|Standard Deviation|14.2|14.2|||
4247088|NCT00640835|4071069|B1|Grade 3||Severity Grading of Oral Mucosa|"Safety and tolerability were evaluated at baseline by oral cavity examination. Oral mucosa was graded as follows:~Grade 0: Normal mucosa Grade 1: Localized mucosal erythema and/or irritation without ulceration Grade 2: Erythema and/or irritation and induration without ulceration Grade 3: Ulceration, with or without any other combination of signs"|Participants|Number|0|0.0||||||
4247089|NCT00640835|4071067|B3|Grade 2||Severity Grading of Oral Mucosa|"Safety and tolerability were evaluated at baseline by oral cavity examination. Oral mucosa was graded as follows:~Grade 0: Normal mucosa Grade 1: Localized mucosal erythema and/or irritation without ulceration Grade 2: Erythema and/or irritation and induration without ulceration Grade 3: Ulceration, with or without any other combination of signs"|Participants|Number|1|1.0||||||
4247090|NCT00640835|4071068|B2|Grade 2||Severity Grading of Oral Mucosa|"Safety and tolerability were evaluated at baseline by oral cavity examination. Oral mucosa was graded as follows:~Grade 0: Normal mucosa Grade 1: Localized mucosal erythema and/or irritation without ulceration Grade 2: Erythema and/or irritation and induration without ulceration Grade 3: Ulceration, with or without any other combination of signs"|Participants|Number|1|1.0||||||
4247091|NCT00640835|4071069|B1|Grade 2||Severity Grading of Oral Mucosa|"Safety and tolerability were evaluated at baseline by oral cavity examination. Oral mucosa was graded as follows:~Grade 0: Normal mucosa Grade 1: Localized mucosal erythema and/or irritation without ulceration Grade 2: Erythema and/or irritation and induration without ulceration Grade 3: Ulceration, with or without any other combination of signs"|Participants|Number|0|0.0||||||
4247092|NCT00640835|4071067|B3|Grade 1||Severity Grading of Oral Mucosa|"Safety and tolerability were evaluated at baseline by oral cavity examination. Oral mucosa was graded as follows:~Grade 0: Normal mucosa Grade 1: Localized mucosal erythema and/or irritation without ulceration Grade 2: Erythema and/or irritation and induration without ulceration Grade 3: Ulceration, with or without any other combination of signs"|Participants|Number|3|3.0||||||
4247093|NCT00640835|4071068|B2|Grade 1||Severity Grading of Oral Mucosa|"Safety and tolerability were evaluated at baseline by oral cavity examination. Oral mucosa was graded as follows:~Grade 0: Normal mucosa Grade 1: Localized mucosal erythema and/or irritation without ulceration Grade 2: Erythema and/or irritation and induration without ulceration Grade 3: Ulceration, with or without any other combination of signs"|Participants|Number|1|1.0||||||
4247094|NCT00640835|4071069|B1|Grade 1||Severity Grading of Oral Mucosa|"Safety and tolerability were evaluated at baseline by oral cavity examination. Oral mucosa was graded as follows:~Grade 0: Normal mucosa Grade 1: Localized mucosal erythema and/or irritation without ulceration Grade 2: Erythema and/or irritation and induration without ulceration Grade 3: Ulceration, with or without any other combination of signs"|Participants|Number|2|2.0||||||
4247095|NCT00640835|4071067|B3|Grade 0||Severity Grading of Oral Mucosa|"Safety and tolerability were evaluated at baseline by oral cavity examination. Oral mucosa was graded as follows:~Grade 0: Normal mucosa Grade 1: Localized mucosal erythema and/or irritation without ulceration Grade 2: Erythema and/or irritation and induration without ulceration Grade 3: Ulceration, with or without any other combination of signs"|Participants|Number|377|377.0||||||
4247096|NCT00640835|4071068|B2|Grade 0||Severity Grading of Oral Mucosa|"Safety and tolerability were evaluated at baseline by oral cavity examination. Oral mucosa was graded as follows:~Grade 0: Normal mucosa Grade 1: Localized mucosal erythema and/or irritation without ulceration Grade 2: Erythema and/or irritation and induration without ulceration Grade 3: Ulceration, with or without any other combination of signs"|Participants|Number|185|185.0||||||
4247097|NCT00640835|4071069|B1|Grade 0||Severity Grading of Oral Mucosa|"Safety and tolerability were evaluated at baseline by oral cavity examination. Oral mucosa was graded as follows:~Grade 0: Normal mucosa Grade 1: Localized mucosal erythema and/or irritation without ulceration Grade 2: Erythema and/or irritation and induration without ulceration Grade 3: Ulceration, with or without any other combination of signs"|Participants|Number|192|192.0||||||
4247098|NCT00640835|4071067|B3|>50||Age|The age categories used for this study were slightly different than the standard values and are reflected as reported in the study.|Participants|Number|39|39.0||||||
4247099|NCT00640835|4071068|B2|>50||Age|The age categories used for this study were slightly different than the standard values and are reflected as reported in the study.|Participants|Number|22|22.0||||||
4247100|NCT00640835|4071069|B1|>50||Age|The age categories used for this study were slightly different than the standard values and are reflected as reported in the study.|Participants|Number|17|17.0||||||
4247101|NCT00640835|4071067|B3|36 - 50||Age|The age categories used for this study were slightly different than the standard values and are reflected as reported in the study.|Participants|Number|138|138.0||||||
4247102|NCT00640835|4071068|B2|36 - 50||Age|The age categories used for this study were slightly different than the standard values and are reflected as reported in the study.|Participants|Number|67|67.0||||||
4247103|NCT00640835|4071069|B1|36 - 50||Age|The age categories used for this study were slightly different than the standard values and are reflected as reported in the study.|Participants|Number|71|71.0||||||
4247104|NCT00640835|4071067|B3|21 - 35||Age|The age categories used for this study were slightly different than the standard values and are reflected as reported in the study.|Participants|Number|201|201.0||||||
4247105|NCT00640835|4071068|B2|21 - 35||Age|The age categories used for this study were slightly different than the standard values and are reflected as reported in the study.|Participants|Number|99|99.0||||||
4247106|NCT00640835|4071069|B1|21 - 35||Age|The age categories used for this study were slightly different than the standard values and are reflected as reported in the study.|Participants|Number|102|102.0||||||
4247107|NCT00640835|4071067|B3|<21||Age|The age categories used for this study were slightly different than the standard values and are reflected as reported in the study.|Participants|Number|4|4.0||||||
4247108|NCT00640835|4071068|B2|<21||Age|The age categories used for this study were slightly different than the standard values and are reflected as reported in the study.|Participants|Number|0|0.0||||||
4247109|NCT00640835|4071069|B1|<21||Age|The age categories used for this study were slightly different than the standard values and are reflected as reported in the study.|Participants|Number|4|4.0||||||
4247110|NCT00640835|4071067|B3|United States||Region of Enrollment||participants|Number|382|382.0||||||
4247111|NCT00640835|4071068|B2|United States||Region of Enrollment||participants|Number|188|188.0||||||
4247112|NCT00640835|4071069|B1|United States||Region of Enrollment||participants|Number|194|194.0||||||
4247114|NCT00640835|4071068|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247115|NCT00640835|4071069|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247116|NCT00640835|4071067|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247117|NCT00640835|4071068|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247118|NCT00640835|4071069|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247119|NCT00640835|4071067|B3||White|Race (NIH/OMB)||Participants|Count of Participants|379|379.0||||||
4247120|NCT00640835|4071068|B2||White|Race (NIH/OMB)||Participants|Count of Participants|187|187.0||||||
4247121|NCT00640835|4071069|B1||White|Race (NIH/OMB)||Participants|Count of Participants|192|192.0||||||
4247122|NCT00640835|4071067|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4247123|NCT00640835|4071068|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4247124|NCT00640835|4071069|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4247125|NCT00640835|4071067|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247126|NCT00640835|4071068|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247127|NCT00640835|4071069|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247128|NCT00640835|4071067|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4247129|NCT00640835|4071068|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247130|NCT00640835|4071069|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4247131|NCT00640835|4071067|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247132|NCT00640835|4071068|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247133|NCT00640835|4071069|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247134|NCT00640835|4071067|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247135|NCT00640835|4071068|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247136|NCT00640835|4071069|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247137|NCT00640835|4071067|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|382|382.0||||||
4247138|NCT00640835|4071068|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|188|188.0||||||
4247139|NCT00640835|4071069|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|194|194.0||||||
4247140|NCT00640835|4071067|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247141|NCT00640835|4071068|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247142|NCT00640835|4071069|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247143|NCT00640835|4071067|B3||Male|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
4247144|NCT00640835|4071068|B2||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4247145|NCT00640835|4071069|B1||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4247146|NCT00640835|4071067|B3||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4247147|NCT00640835|4071068|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4247148|NCT00640835|4071069|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4247149|NCT00640835|4071067|B3|||Age||years|Mean|36.4|36.4|Standard Deviation|10.14|10.14|||
4247150|NCT00640835|4071068|B2|||Age||years|Mean|36.7|36.7|Standard Deviation|10.09|10.09|||
4247151|NCT00640835|4071069|B1|||Age||years|Mean|36.1|36.1|Standard Deviation|10.19|10.19|||
4247152|NCT00640822|4071078|B4|United Kingdom||Region of Enrollment||participants|Number|228|228.0||||||
4247153|NCT00640822|4071079|B3|United Kingdom||Region of Enrollment||participants|Number|27|27.0||||||
4247154|NCT00640822|4071080|B2|United Kingdom||Region of Enrollment||participants|Number|105|105.0||||||
4247155|NCT00640822|4071081|B1|United Kingdom||Region of Enrollment||participants|Number|96|96.0||||||
4247156|NCT00640822|4071078|B4|Canada||Region of Enrollment||participants|Number|297|297.0||||||
4247157|NCT00640822|4071079|B3|Canada||Region of Enrollment||participants|Number|37|37.0||||||
4247158|NCT00640822|4071080|B2|Canada||Region of Enrollment||participants|Number|129|129.0||||||
4247159|NCT00640822|4071081|B1|Canada||Region of Enrollment||participants|Number|131|131.0||||||
4247160|NCT00640822|4071078|B4|France||Region of Enrollment||participants|Number|216|216.0||||||
4247161|NCT00640822|4071079|B3|France||Region of Enrollment||participants|Number|38|38.0||||||
4247162|NCT00640822|4071080|B2|France||Region of Enrollment||participants|Number|83|83.0||||||
4247163|NCT00640822|4071081|B1|France||Region of Enrollment||participants|Number|95|95.0||||||
4247164|NCT00640822|4071078|B4||Male|Sex: Female, Male||Participants|Count of Participants|438|438.0||||||
4247165|NCT00640822|4071079|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4247166|NCT00640822|4071080|B2||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4247167|NCT00640822|4071081|B1||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4247168|NCT00640822|4071078|B4||Female|Sex: Female, Male||Participants|Count of Participants|303|303.0||||||
4247169|NCT00640822|4071079|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4247170|NCT00640822|4071080|B2||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4247171|NCT00640822|4071081|B1||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4247172|NCT00640822|4071078|B4|||Age||years|Mean|48.5|48.5|Standard Deviation|15.3|15.3|||
4247174|NCT00640822|4071080|B2|||Age||years|Mean|49|49.0|Standard Deviation|15.5|15.5|||
4247175|NCT00640822|4071081|B1|||Age||years|Mean|48|48.0|Standard Deviation|15.5|15.5|||
4247176|NCT00640653|4071091|B6|No||Ever had sexual intercourse||participants|Number|509|509.0||||||
4247177|NCT00640653|4071092|B5|No||Ever had sexual intercourse||participants|Number|99|99.0||||||
4247178|NCT00640653|4071093|B4|No||Ever had sexual intercourse||participants|Number|107|107.0||||||
4247179|NCT00640653|4071094|B3|No||Ever had sexual intercourse||participants|Number|97|97.0||||||
4247180|NCT00640653|4071095|B2|No||Ever had sexual intercourse||participants|Number|106|106.0||||||
4247181|NCT00640653|4071096|B1|No||Ever had sexual intercourse||participants|Number|100|100.0||||||
4247182|NCT00640653|4071091|B6|Yes||Ever had sexual intercourse||participants|Number|153|153.0||||||
4247183|NCT00640653|4071092|B5|Yes||Ever had sexual intercourse||participants|Number|35|35.0||||||
4247184|NCT00640653|4071093|B4|Yes||Ever had sexual intercourse||participants|Number|27|27.0||||||
4247185|NCT00640653|4071094|B3|Yes||Ever had sexual intercourse||participants|Number|32|32.0||||||
4247186|NCT00640653|4071095|B2|Yes||Ever had sexual intercourse||participants|Number|28|28.0||||||
4247187|NCT00640653|4071096|B1|Yes||Ever had sexual intercourse||participants|Number|31|31.0||||||
4247188|NCT00640653|4071091|B6|No||Live with both parents||participants|Number|441|441.0||||||
4247189|NCT00640653|4071092|B5|No||Live with both parents||participants|Number|88|88.0||||||
4247190|NCT00640653|4071093|B4|No||Live with both parents||participants|Number|91|91.0||||||
4247191|NCT00640653|4071094|B3|No||Live with both parents||participants|Number|89|89.0||||||
4247192|NCT00640653|4071095|B2|No||Live with both parents||participants|Number|88|88.0||||||
4247193|NCT00640653|4071096|B1|No||Live with both parents||participants|Number|85|85.0||||||
4247194|NCT00640653|4071091|B6|Yes||Live with both parents||participants|Number|221|221.0||||||
4247195|NCT00640653|4071092|B5|Yes||Live with both parents||participants|Number|46|46.0||||||
4247196|NCT00640653|4071093|B4|Yes||Live with both parents||participants|Number|43|43.0||||||
4247197|NCT00640653|4071094|B3|Yes||Live with both parents||participants|Number|40|40.0||||||
4247198|NCT00640653|4071095|B2|Yes||Live with both parents||participants|Number|46|46.0||||||
4247199|NCT00640653|4071096|B1|Yes||Live with both parents||participants|Number|46|46.0||||||
4247200|NCT00640653|4071091|B6|8th||Grade in School||participants|Number|296|296.0||||||
4247201|NCT00640653|4071092|B5|8th||Grade in School||participants|Number|57|57.0||||||
4247202|NCT00640653|4071093|B4|8th||Grade in School||participants|Number|57|57.0||||||
4247203|NCT00640653|4071094|B3|8th||Grade in School||participants|Number|56|56.0||||||
4247204|NCT00640653|4071095|B2|8th||Grade in School||participants|Number|63|63.0||||||
4247205|NCT00640653|4071096|B1|8th||Grade in School||participants|Number|63|63.0||||||
4247206|NCT00640653|4071091|B6|7th||Grade in School||participants|Number|366|366.0||||||
4247207|NCT00640653|4071092|B5|7th||Grade in School||participants|Number|77|77.0||||||
4247208|NCT00640653|4071093|B4|7th||Grade in School||participants|Number|77|77.0||||||
4247209|NCT00640653|4071094|B3|7th||Grade in School||participants|Number|73|73.0||||||
4247210|NCT00640653|4071095|B2|7th||Grade in School||participants|Number|71|71.0||||||
4247211|NCT00640653|4071096|B1|7th||Grade in School||participants|Number|68|68.0||||||
4247212|NCT00640653|4071091|B6|United States||Region of Enrollment||participants|Number|662|662.0||||||
4247213|NCT00640653|4071092|B5|United States||Region of Enrollment||participants|Number|134|134.0||||||
4247214|NCT00640653|4071093|B4|United States||Region of Enrollment||participants|Number|134|134.0||||||
4247215|NCT00640653|4071094|B3|United States||Region of Enrollment||participants|Number|129|129.0||||||
4247216|NCT00640653|4071095|B2|United States||Region of Enrollment||participants|Number|134|134.0||||||
4247217|NCT00640653|4071096|B1|United States||Region of Enrollment||participants|Number|131|131.0||||||
4247218|NCT00640653|4071091|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247219|NCT00640653|4071092|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247220|NCT00640653|4071093|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247221|NCT00640653|4071094|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247222|NCT00640653|4071095|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247223|NCT00640653|4071096|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247224|NCT00640653|4071091|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247225|NCT00640653|4071092|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247226|NCT00640653|4071093|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247227|NCT00640653|4071094|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247228|NCT00640653|4071095|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247229|NCT00640653|4071096|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247230|NCT00640653|4071091|B6||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247231|NCT00640653|4071092|B5||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247232|NCT00640653|4071093|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247233|NCT00640653|4071094|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247234|NCT00640653|4071095|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247235|NCT00640653|4071096|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247236|NCT00640653|4071091|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|662|662.0||||||
4247297|NCT00640614|4071133|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4247237|NCT00640653|4071092|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
4247238|NCT00640653|4071093|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
4247239|NCT00640653|4071094|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
4247240|NCT00640653|4071095|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
4247241|NCT00640653|4071096|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
4247242|NCT00640653|4071091|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247243|NCT00640653|4071092|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247244|NCT00640653|4071093|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247245|NCT00640653|4071094|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247246|NCT00640653|4071095|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247247|NCT00640653|4071096|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247248|NCT00640653|4071091|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247249|NCT00640653|4071092|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247250|NCT00640653|4071093|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247251|NCT00640653|4071094|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247252|NCT00640653|4071095|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247253|NCT00640653|4071096|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247254|NCT00640653|4071091|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247255|NCT00640653|4071092|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247256|NCT00640653|4071093|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247257|NCT00640653|4071094|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247258|NCT00640653|4071095|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247259|NCT00640653|4071096|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247260|NCT00640653|4071091|B6||Male|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
4247261|NCT00640653|4071092|B5||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4247262|NCT00640653|4071093|B4||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4247263|NCT00640653|4071094|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4247264|NCT00640653|4071095|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4247265|NCT00640653|4071096|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4247266|NCT00640653|4071091|B6||Female|Sex: Female, Male||Participants|Count of Participants|354|354.0||||||
4247267|NCT00640653|4071092|B5||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4247268|NCT00640653|4071093|B4||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4247269|NCT00640653|4071094|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4247270|NCT00640653|4071095|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4247271|NCT00640653|4071096|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4247272|NCT00640653|4071091|B6|||Age||years|Mean|12.0|12.0|Standard Deviation|0.8|0.8|||
4247273|NCT00640653|4071092|B5|||Age||years|Mean|12.0|12.0|Standard Deviation|0.8|0.8|||
4247274|NCT00640653|4071093|B4|||Age||years|Mean|12.0|12.0|Standard Deviation|0.8|0.8|||
4247275|NCT00640653|4071094|B3|||Age||years|Mean|11.9|11.9|Standard Deviation|0.8|0.8|||
4247276|NCT00640653|4071095|B2|||Age||years|Mean|11.9|11.9|Standard Deviation|0.8|0.8|||
4247277|NCT00640653|4071096|B1|||Age||years|Mean|12.0|12.0|Standard Deviation|0.8|0.8|||
4247278|NCT00640614|4071132|B3|Denmark||Region of Enrollment||participants|Number|30|30.0||||||
4247279|NCT00640614|4071133|B2|Denmark||Region of Enrollment||participants|Number|2|2.0||||||
4247280|NCT00640614|4071134|B1|Denmark||Region of Enrollment||participants|Number|28|28.0||||||
4247281|NCT00640614|4071132|B3|Canada||Region of Enrollment||participants|Number|23|23.0||||||
4247282|NCT00640614|4071133|B2|Canada||Region of Enrollment||participants|Number|23|23.0||||||
4247283|NCT00640614|4071134|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4247284|NCT00640614|4071132|B3|United States||Region of Enrollment||participants|Number|182|182.0||||||
4247285|NCT00640614|4071133|B2|United States||Region of Enrollment||participants|Number|85|85.0||||||
4247286|NCT00640614|4071134|B1|United States||Region of Enrollment||participants|Number|97|97.0||||||
4247287|NCT00640614|4071132|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4247288|NCT00640614|4071133|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4247289|NCT00640614|4071134|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4247290|NCT00640614|4071132|B3||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4247291|NCT00640614|4071133|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4247292|NCT00640614|4071134|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4247293|NCT00640614|4071132|B3|||Age||years|Mean|50.4|50.4|Standard Deviation|14.75|14.75|||
4247294|NCT00640614|4071133|B2|||Age||years|Mean|51.2|51.2|Standard Deviation|14.75|14.75|||
4247295|NCT00640614|4071134|B1|||Age||years|Mean|49.6|49.6|Standard Deviation|14.93|14.93|||
4247296|NCT00640614|4071132|B3||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
4247298|NCT00640614|4071134|B1||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4247299|NCT00640614|4071132|B3||Between 18 and 65 years|Age||Participants|Count of Participants|186|186.0||||||
4247300|NCT00640614|4071133|B2||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
4247301|NCT00640614|4071134|B1||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
4247302|NCT00640614|4071132|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4247303|NCT00640614|4071133|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4247304|NCT00640614|4071134|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4247305|NCT00640601|4071177|B1||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4247306|NCT00640601|4071177|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4247307|NCT00640601|4071177|B1|||Age||Years|Mean|37.8|37.8|Standard Deviation|12.12|12.12|||
4247308|NCT00640562|4071191|B3||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4247309|NCT00640562|4071192|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4247310|NCT00640562|4071193|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4247311|NCT00640562|4071191|B3||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4247312|NCT00640562|4071192|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4247313|NCT00640562|4071193|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4247314|NCT00640562|4071191|B3|||Age|Number of participants is lower than number in Participants Flow module. 6 participants, 2 in Seroquel XR and 4 in Risperidone, were not valid for safety population because they did not assume any study drug administration.|years|Mean|42.27|42.27|Standard Deviation|11.10|11.1|||
4247315|NCT00640562|4071192|B2|||Age|Number of participants is lower than number in Participants Flow module. 6 participants, 2 in Seroquel XR and 4 in Risperidone, were not valid for safety population because they did not assume any study drug administration.|years|Mean|42.08|42.08|Standard Deviation|11.48|11.48|||
4247316|NCT00640562|4071193|B1|||Age|Number of participants is lower than number in Participants Flow module. 6 participants, 2 in Seroquel XR and 4 in Risperidone, were not valid for safety population because they did not assume any study drug administration.|years|Mean|42.46|42.46|Standard Deviation|10.71|10.71|||
4247317|NCT00640510|4071220|B3|||Positive and Negative Syndrome Scale-Excited Component|Measures excitability and consists of the following 5 items from the PANSS: Excitement, Hostility, Tension, Uncooperativeness, and Poor Impulse Control. Each item is rated on a scale from 1 (Absent) to 7 (Extreme). The sum of the 5 items is defined as the PANSS-EC total score which ranges from 5 to 35.|units on a scale|Mean|23.5|23.5|Standard Deviation|3.7|3.7|||
4247318|NCT00640510|4071221|B2|||Positive and Negative Syndrome Scale-Excited Component|Measures excitability and consists of the following 5 items from the PANSS: Excitement, Hostility, Tension, Uncooperativeness, and Poor Impulse Control. Each item is rated on a scale from 1 (Absent) to 7 (Extreme). The sum of the 5 items is defined as the PANSS-EC total score which ranges from 5 to 35.|units on a scale|Mean|23.5|23.5|Standard Deviation|3.8|3.8|||
4247319|NCT00640510|4071222|B1|||Positive and Negative Syndrome Scale-Excited Component|Measures excitability and consists of the following 5 items from the PANSS: Excitement, Hostility, Tension, Uncooperativeness, and Poor Impulse Control. Each item is rated on a scale from 1 (Absent) to 7 (Extreme). The sum of the 5 items is defined as the PANSS-EC total score which ranges from 5 to 35.|units on a scale|Mean|23.6|23.6|Standard Deviation|3.8|3.8|||
4247320|NCT00640510|4071220|B3|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square centimeters|Mean|21.7|21.7|Standard Deviation|3.3|3.3|||
4247321|NCT00640510|4071221|B2|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square centimeters|Mean|22.8|22.8|Standard Deviation|3.6|3.6|||
4247322|NCT00640510|4071222|B1|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square centimeters|Mean|20.7|20.7|Standard Deviation|2.9|2.9|||
4247323|NCT00640510|4071220|B3|||Agitation-Calmness Evaluation Scale (ACES)|The ACES differentiates agitation, calmness, and sleep-state, using a 9-point scale: 1 (Marked Agitation) to 9 (Unarousable).|units on a scale|Mean|1.8|1.8|Standard Deviation|0.4|0.4|||
4247324|NCT00640510|4071221|B2|||Agitation-Calmness Evaluation Scale (ACES)|The ACES differentiates agitation, calmness, and sleep-state, using a 9-point scale: 1 (Marked Agitation) to 9 (Unarousable).|units on a scale|Mean|1.8|1.8|Standard Deviation|0.4|0.4|||
4247325|NCT00640510|4071222|B1|||Agitation-Calmness Evaluation Scale (ACES)|The ACES differentiates agitation, calmness, and sleep-state, using a 9-point scale: 1 (Marked Agitation) to 9 (Unarousable).|units on a scale|Mean|1.8|1.8|Standard Deviation|0.4|0.4|||
4247326|NCT00640510|4071220|B3|||Age at Onset||years|Mean|22.0|22.0|Standard Deviation|6.2|6.2|||
4247327|NCT00640510|4071221|B2|||Age at Onset||years|Mean|21.3|21.3|Standard Deviation|6.1|6.1|||
4247328|NCT00640510|4071222|B1|||Age at Onset||years|Mean|22.6|22.6|Standard Deviation|6.4|6.4|||
4247329|NCT00640510|4071220|B3|No||Pre-Therapy Antipsychotic Usage||participants|Number|2|2.0||||||
4247330|NCT00640510|4071221|B2|No||Pre-Therapy Antipsychotic Usage||participants|Number|1|1.0||||||
4247331|NCT00640510|4071222|B1|No||Pre-Therapy Antipsychotic Usage||participants|Number|1|1.0||||||
4247332|NCT00640510|4071220|B3|Yes (<1000 milligrams/day)||Pre-Therapy Antipsychotic Usage||participants|Number|18|18.0||||||
4247333|NCT00640510|4071221|B2|Yes (<1000 milligrams/day)||Pre-Therapy Antipsychotic Usage||participants|Number|9|9.0||||||
4247334|NCT00640510|4071222|B1|Yes (<1000 milligrams/day)||Pre-Therapy Antipsychotic Usage||participants|Number|9|9.0||||||
4247335|NCT00640510|4071220|B3|Yes (>=1000 milligrams/day)||Pre-Therapy Antipsychotic Usage||participants|Number|13|13.0||||||
4247336|NCT00640510|4071221|B2|Yes (>=1000 milligrams/day)||Pre-Therapy Antipsychotic Usage||participants|Number|6|6.0||||||
4247337|NCT00640510|4071222|B1|Yes (>=1000 milligrams/day)||Pre-Therapy Antipsychotic Usage||participants|Number|7|7.0||||||
4247384|NCT00640341|4071301|B2|United States||Region of Enrollment||Participants|Number|167|167.0||||||
4247338|NCT00640510|4071220|B3|Residual||Diagnostic and Statistical Manual of Mental Disorders Fourth Edition, Text Revision Diagnosis||participants|Number|2|2.0||||||
4247339|NCT00640510|4071221|B2|Residual||Diagnostic and Statistical Manual of Mental Disorders Fourth Edition, Text Revision Diagnosis||participants|Number|2|2.0||||||
4247340|NCT00640510|4071222|B1|Residual||Diagnostic and Statistical Manual of Mental Disorders Fourth Edition, Text Revision Diagnosis||participants|Number|0|0.0||||||
4247341|NCT00640510|4071220|B3|Undifferentiated||Diagnostic and Statistical Manual of Mental Disorders Fourth Edition, Text Revision Diagnosis||participants|Number|1|1.0||||||
4247342|NCT00640510|4071221|B2|Undifferentiated||Diagnostic and Statistical Manual of Mental Disorders Fourth Edition, Text Revision Diagnosis||participants|Number|0|0.0||||||
4247343|NCT00640510|4071222|B1|Undifferentiated||Diagnostic and Statistical Manual of Mental Disorders Fourth Edition, Text Revision Diagnosis||participants|Number|1|1.0||||||
4247344|NCT00640510|4071220|B3|Paranoid||Diagnostic and Statistical Manual of Mental Disorders Fourth Edition, Text Revision Diagnosis||participants|Number|14|14.0||||||
4247345|NCT00640510|4071221|B2|Paranoid||Diagnostic and Statistical Manual of Mental Disorders Fourth Edition, Text Revision Diagnosis||participants|Number|7|7.0||||||
4247346|NCT00640510|4071222|B1|Paranoid||Diagnostic and Statistical Manual of Mental Disorders Fourth Edition, Text Revision Diagnosis||participants|Number|7|7.0||||||
4247347|NCT00640510|4071220|B3|Disorganized||Diagnostic and Statistical Manual of Mental Disorders Fourth Edition, Text Revision Diagnosis||participants|Number|14|14.0||||||
4247348|NCT00640510|4071221|B2|Disorganized||Diagnostic and Statistical Manual of Mental Disorders Fourth Edition, Text Revision Diagnosis||participants|Number|7|7.0||||||
4247349|NCT00640510|4071222|B1|Disorganized||Diagnostic and Statistical Manual of Mental Disorders Fourth Edition, Text Revision Diagnosis||participants|Number|7|7.0||||||
4247350|NCT00640510|4071220|B3|Catatonic||Diagnostic and Statistical Manual of Mental Disorders Fourth Edition, Text Revision Diagnosis||participants|Number|2|2.0||||||
4247351|NCT00640510|4071221|B2|Catatonic||Diagnostic and Statistical Manual of Mental Disorders Fourth Edition, Text Revision Diagnosis||participants|Number|0|0.0||||||
4247352|NCT00640510|4071222|B1|Catatonic||Diagnostic and Statistical Manual of Mental Disorders Fourth Edition, Text Revision Diagnosis||participants|Number|2|2.0||||||
4247353|NCT00640510|4071220|B3|No||Diabetes Mellitus||participants|Number|29|29.0||||||
4247354|NCT00640510|4071221|B2|No||Diabetes Mellitus||participants|Number|14|14.0||||||
4247355|NCT00640510|4071222|B1|No||Diabetes Mellitus||participants|Number|15|15.0||||||
4247356|NCT00640510|4071220|B3|Yes||Diabetes Mellitus||participants|Number|4|4.0||||||
4247357|NCT00640510|4071221|B2|Yes||Diabetes Mellitus||participants|Number|2|2.0||||||
4247358|NCT00640510|4071222|B1|Yes||Diabetes Mellitus||participants|Number|2|2.0||||||
4247359|NCT00640510|4071220|B3|Japan||Region of Enrollment||participants|Number|33|33.0||||||
4247360|NCT00640510|4071221|B2|Japan||Region of Enrollment||participants|Number|16|16.0||||||
4247361|NCT00640510|4071222|B1|Japan||Region of Enrollment||participants|Number|17|17.0||||||
4247362|NCT00640510|4071220|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4247363|NCT00640510|4071221|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4247364|NCT00640510|4071222|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4247365|NCT00640510|4071220|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4247366|NCT00640510|4071221|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4247367|NCT00640510|4071222|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4247368|NCT00640510|4071220|B3|||Age||years|Mean|46.7|46.7|Standard Deviation|11.8|11.8|||
4247369|NCT00640510|4071221|B2|||Age||years|Mean|45.9|45.9|Standard Deviation|11.5|11.5|||
4247370|NCT00640510|4071222|B1|||Age||years|Mean|47.4|47.4|Standard Deviation|12.4|12.4|||
4247371|NCT00640393|4071235|B1|||DLQI - Dermatology life quality index|"The aim of this questionnaire is to measure how much one's skin problem has affected one's life over the week prior to the visit.~Scale is from 0 best to 30 worst."|Units on a scale|Mean|12.9|12.9|Standard Deviation|6.7|6.7|||
4247372|NCT00640393|4071235|B1|||BSA - Body surface area|Percentage of the body affected by psoriasis.|Percentage of the body affected|Mean|21.7|21.7|Standard Deviation|14.2|14.2|||
4247373|NCT00640393|4071235|B1|||PGA - Physician's Global Assessment.|"The degree of overall lesion severity at the time of the physician's evaluation of the patient evaluated using the following scale:~0 = clear~1 = minimal~2 = mild~3 = moderate~4 = severe~5 = very severe~The scale evaluates plaque elevation, scaling and erythema."|Units on a scale|Mean|3.6|3.6|Standard Deviation|0.7|0.7|||
4247374|NCT00640393|4071235|B1|||PASI - (Psoriasis area and severity index)|"Four anatomic sites (head, upper extremities, trunk and lower extremities) are assessed for erythema, induration (plaque thickness), and desquamation (scaling) as seen on the day of the examination. The severity of each sign is assessed using a 5-point scale~0 = No symptoms~1 = Slight~2 = Moderate~3 = Marked~4 = Very marked~The area affected by psoriasis within a given anatomic site is estimated as a percentage of the total area of that anatomic site and assigned a numerical value according to the degree of psoriatic involvement from 0-6 Total scale 0 = best and 72 = worst"|Total units on a scale|Mean|17.1|17.1|Standard Deviation|7.4|7.4|||
4247375|NCT00640393|4071235|B1|Canada||Region of Enrollment||participants|Number|99|99.0||||||
4247376|NCT00640393|4071235|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4247377|NCT00640393|4071235|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4247378|NCT00640393|4071235|B1|||Age||years|Mean|43.9|43.9|Standard Deviation|12.9|12.9|||
4247379|NCT00640393|4071235|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4247380|NCT00640393|4071235|B1||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
4247381|NCT00640393|4071235|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4247382|NCT00640341|4071299|B4|United States||Region of Enrollment||Participants|Number|500|500.0||||||
4247383|NCT00640341|4071300|B3|United States||Region of Enrollment||Participants|Number|168|168.0||||||
4247385|NCT00640341|4071302|B1|United States||Region of Enrollment||Participants|Number|165|165.0||||||
4247386|NCT00640341|4071299|B4||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4247387|NCT00640341|4071300|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4247388|NCT00640341|4071301|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4247389|NCT00640341|4071302|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4247390|NCT00640341|4071299|B4||Female|Sex: Female, Male||Participants|Count of Participants|376|376.0||||||
4247391|NCT00640341|4071300|B3||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4247392|NCT00640341|4071301|B2||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4247393|NCT00640341|4071302|B1||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4247394|NCT00640341|4071299|B4|Age 18 to 65 years||Age, Customized||Participants|Number|500|500.0||||||
4247395|NCT00640341|4071300|B3|Age 18 to 65 years||Age, Customized||Participants|Number|168|168.0||||||
4247396|NCT00640341|4071301|B2|Age 18 to 65 years||Age, Customized||Participants|Number|167|167.0||||||
4247397|NCT00640341|4071302|B1|Age 18 to 65 years||Age, Customized||Participants|Number|165|165.0||||||
4247398|NCT00640328|4071318|B7|White/Caucasian||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4247399|NCT00640328|4071319|B6|White/Caucasian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4247400|NCT00640328|4071320|B5|White/Caucasian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4247401|NCT00640328|4071321|B4|White/Caucasian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4247402|NCT00640328|4071322|B3|White/Caucasian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4247403|NCT00640328|4071323|B2|White/Caucasian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4247404|NCT00640328|4071324|B1|White/Caucasian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4247405|NCT00640328|4071318|B7||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4247406|NCT00640328|4071319|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4247407|NCT00640328|4071320|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4247408|NCT00640328|4071321|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4247409|NCT00640328|4071322|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4247410|NCT00640328|4071323|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4247411|NCT00640328|4071324|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4247412|NCT00640328|4071318|B7||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4247413|NCT00640328|4071319|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4247414|NCT00640328|4071320|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4247415|NCT00640328|4071321|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4247416|NCT00640328|4071322|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4247417|NCT00640328|4071323|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4247418|NCT00640328|4071324|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4247419|NCT00640328|4071318|B7|||Age||Years|Mean|36.3|36.3|Standard Deviation|7.9|7.9|||
4247420|NCT00640328|4071319|B6|||Age||Years|Mean|44.0|44.0|Standard Deviation|8.1|8.1|||
4247421|NCT00640328|4071320|B5|||Age||Years|Mean|27.0|27.0|Standard Deviation|2.2|2.2|||
4247422|NCT00640328|4071321|B4|||Age||Years|Mean|37.0|37.0|Standard Deviation|6.5|6.5|||
4247423|NCT00640328|4071322|B3|||Age||Years|Mean|33.7|33.7|Standard Deviation|8.4|8.4|||
4247424|NCT00640328|4071323|B2|||Age||Years|Mean|36.6|36.6|Standard Deviation|7.0|7.0|||
4247425|NCT00640328|4071324|B1|||Age||Years|Mean|38.0|38.0|Standard Deviation|9.0|9.0|||
4247426|NCT00640315|4071493|B3||Male|Gender||Participants|Count of Participants|12|12.0||||||
4247427|NCT00640315|4071494|B2||Male|Gender||Participants|Count of Participants|7|7.0||||||
4247428|NCT00640315|4071495|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
4247429|NCT00640315|4071493|B3||Female|Gender||Participants|Count of Participants|11|11.0||||||
4247430|NCT00640315|4071494|B2||Female|Gender||Participants|Count of Participants|6|6.0||||||
4247431|NCT00640315|4071495|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
4247432|NCT00640315|4071493|B3|||Age||Years|Mean|68.4|68.4|Standard Deviation|7.1|7.1|56.0|82.0|
4247433|NCT00640315|4071494|B2|||Age||Years|Mean|69.2|69.2|Standard Deviation|5.7|5.7|61.0|79.0|
4247434|NCT00640315|4071495|B1|||Age||Years|Mean|67.5|67.5|Standard Deviation|8.9|8.9|56.0|82.0|
4247435|NCT00640289|4071622|B1|United States||Region of Enrollment||Participants|Count of Participants|72|72.0||||||
4247436|NCT00640289|4071622|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4247437|NCT00640289|4071622|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4247438|NCT00640289|4071622|B1|≥65 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
4247439|NCT00640289|4071622|B1|16 to<65 years||Age, Customized||Participants|Count of Participants|28|28.0||||||
4247440|NCT00640289|4071622|B1|2 to<16 years||Age, Customized||Participants|Count of Participants|34|34.0||||||
4247441|NCT00640289|4071622|B1|<2 years||Age, Customized||Participants|Count of Participants|9|9.0||||||
4247442|NCT00640289|4071622|B1|||Age||years|Mean|15.0|15.0|Standard Deviation|14.09|14.09|||
4247443|NCT00640250|4071627|B1|Denmark||Region of Enrollment||participants|Number|21|21.0||||||
4247444|NCT00640250|4071627|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4247445|NCT00640250|4071627|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4247446|NCT00640250|4071627|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4247447|NCT00640250|4071627|B1|||Age||years|Mean|52.2|52.2|Standard Deviation|14.7|14.7|||
4247448|NCT00640250|4071627|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4247449|NCT00640250|4071627|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4247450|NCT00640250|4071627|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4247451|NCT00640224|4071730|B5|United States||Region of Enrollment||participants|Number|37|37.0||||||
4247452|NCT00640224|4071733|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4247453|NCT00640224|4071734|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4247454|NCT00640224|4071730|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4247455|NCT00640224|4071733|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4247456|NCT00640224|4071734|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4247457|NCT00640224|4071730|B5||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4247458|NCT00640224|4071733|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4247459|NCT00640224|4071734|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4247460|NCT00640224|4071730|B5|Age||Age||years|Mean|16.0|16.0|Standard Deviation|4.3|4.3|||
4247461|NCT00640224|4071733|B2|Age||Age||years|Mean|16.2|16.2|Standard Deviation|4.5|4.5|||
4247462|NCT00640224|4071734|B1|Age||Age||years|Mean|15.7|15.7|Standard Deviation|4.1|4.1|||
4247463|NCT00640224|4071730|B5|Age|>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4247464|NCT00640224|4071733|B2|Age|>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4247465|NCT00640224|4071734|B1|Age|>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4247466|NCT00640224|4071730|B5|Age|Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4247467|NCT00640224|4071733|B2|Age|Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4247468|NCT00640224|4071734|B1|Age|Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4247469|NCT00640224|4071730|B5|Age|<=18 years|Age||Participants|Count of Participants|34|34.0||||||
4247470|NCT00640224|4071733|B2|Age|<=18 years|Age||Participants|Count of Participants|18|18.0||||||
4247471|NCT00640224|4071734|B1|Age|<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4247472|NCT00640042|4071835|B1|Missing||Risk level for opioid misuse or abuse|Investigator determined classification of potential risk based on assessment of urine drug tests and patient history and questionnaires|participants|Number|7|7.0||||||
4247473|NCT00640042|4071835|B1|High||Risk level for opioid misuse or abuse|Investigator determined classification of potential risk based on assessment of urine drug tests and patient history and questionnaires|participants|Number|19|19.0||||||
4247474|NCT00640042|4071835|B1|Moderate||Risk level for opioid misuse or abuse|Investigator determined classification of potential risk based on assessment of urine drug tests and patient history and questionnaires|participants|Number|767|767.0||||||
4247475|NCT00640042|4071835|B1|Low||Risk level for opioid misuse or abuse|Investigator determined classification of potential risk based on assessment of urine drug tests and patient history and questionnaires|participants|Number|694|694.0||||||
4247476|NCT00640042|4071835|B1|Missing||Sex/Gender, Customized||participants|Number|18|18.0||||||
4247477|NCT00640042|4071835|B1|Male||Sex/Gender, Customized||participants|Number|630|630.0||||||
4247478|NCT00640042|4071835|B1|Female||Sex/Gender, Customized||participants|Number|839|839.0||||||
4247479|NCT00640042|4071835|B1|||Age||years|Mean|52.7|52.7|Standard Deviation|13.62|13.62|||
4247480|NCT00640016|4071847|B5||Male|Gender||Participants|Count of Participants|3|3.0||||||
4247481|NCT00640016|4071848|B4||Male|Gender||Participants|Count of Participants|1|1.0||||||
4247482|NCT00640016|4071849|B3||Male|Gender||Participants|Count of Participants|2|2.0||||||
4247483|NCT00640016|4071850|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
4247484|NCT00640016|4071851|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4247485|NCT00640016|4071847|B5||Female|Gender||Participants|Count of Participants|11|11.0||||||
4247486|NCT00640016|4071848|B4||Female|Gender||Participants|Count of Participants|3|3.0||||||
4247487|NCT00640016|4071849|B3||Female|Gender||Participants|Count of Participants|2|2.0||||||
4247488|NCT00640016|4071850|B2||Female|Gender||Participants|Count of Participants|3|3.0||||||
4247489|NCT00640016|4071851|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
4247490|NCT00640016|4071847|B5|||Age||years|Mean|37.00|37.0|Standard Deviation|11.708|11.708|||
4247491|NCT00640016|4071848|B4|||Age||years|Mean|40.75|40.75|Standard Deviation|15.086|15.086|||
4247492|NCT00640016|4071849|B3|||Age||years|Mean|37.75|37.75|Standard Deviation|9.878|9.878|||
4247493|NCT00640016|4071850|B2|||Age||years|Mean|34.00|34.0|Standard Deviation|14.933|14.933|||
4247494|NCT00640016|4071851|B1|||Age||years|Mean|34.00|34.0|Standard Deviation|11.136|11.136|||
4247495|NCT00639860|4071898|B1|||Stent to apex of socket||mm|Median|16.5|16.5|Full Range|||11.0|20.0|
4247496|NCT00639860|4071898|B1|||Stent to midosseous crest||mm|Mean|4.7|4.7|Full Range|||3.0|7.0|
4247497|NCT00639860|4071898|B1|||Stent to distal osseous crest||mm|Mean|4.1|4.1|Full Range|||2.0|6.0|
4247498|NCT00639860|4071898|B1|||Stent to mesial osseous crest||mm|Mean|4.0|4.0|Full Range|||2.0|6.0|
4247499|NCT00639860|4071898|B1|||Stent to buccal plate||mm|Mean|5.6|5.6|Full Range|||4.0|8.0|
4247500|NCT00639860|4071898|B1|||Socket width (meiodistal)||mm|Mean|5.1|5.1|Full Range|||4.0|8.0|
4247501|NCT00639860|4071898|B1|||Socket width (buccopalatal)||mm|Mean|8.3|8.3|Full Range|||7.0|10.0|
4247502|NCT00639860|4071898|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4247503|NCT00639860|4071898|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4247504|NCT00639860|4071898|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4247505|NCT00639860|4071898|B1|||Age, Customized||years|Median|47.7|47.7|Full Range|||25.0|64.0|
4247506|NCT00639769|4071906|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4247507|NCT00639769|4071906|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4247508|NCT00639769|4071906|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4247509|NCT00639769|4071906|B1|||Age||years|Mean|58|58.0|Standard Deviation|1|1.0|||
4247510|NCT00639769|4071906|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4247511|NCT00639769|4071906|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4247512|NCT00639769|4071906|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4247513|NCT00639717|4071911|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4247514|NCT00639717|4071911|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4247515|NCT00639717|4071911|B1|||Age||years|Median|60|60.0|Full Range|||18.0|71.0|
4247516|NCT00639678|4071919|B5|Hispanic or Latino origin||Race/Ethnicity, Customized||Participants|Number|36|36.0||||||
4247517|NCT00639678|4071920|B4|Hispanic or Latino origin||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4247518|NCT00639678|4071921|B3|Hispanic or Latino origin||Race/Ethnicity, Customized||Participants|Number|28|28.0||||||
4247519|NCT00639678|4071922|B2|Hispanic or Latino origin||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4247520|NCT00639678|4071923|B1|Hispanic or Latino origin||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4247521|NCT00639678|4071919|B5|Multiracial||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4247522|NCT00639678|4071920|B4|Multiracial||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4247523|NCT00639678|4071921|B3|Multiracial||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4247524|NCT00639678|4071922|B2|Multiracial||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4247525|NCT00639678|4071923|B1|Multiracial||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4247526|NCT00639678|4071919|B5|Not Listed||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4247527|NCT00639678|4071920|B4|Not Listed||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4247528|NCT00639678|4071921|B3|Not Listed||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4247529|NCT00639678|4071922|B2|Not Listed||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4247530|NCT00639678|4071923|B1|Not Listed||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4247531|NCT00639678|4071919|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4247532|NCT00639678|4071920|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4247533|NCT00639678|4071921|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4247534|NCT00639678|4071922|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4247535|NCT00639678|4071923|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4247536|NCT00639678|4071919|B5|Black or African American||Race/Ethnicity, Customized||Participants|Number|28|28.0||||||
4247537|NCT00639678|4071920|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4247538|NCT00639678|4071921|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
4247539|NCT00639678|4071922|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4247540|NCT00639678|4071923|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4247541|NCT00639678|4071919|B5|Asian||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4247542|NCT00639678|4071920|B4|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4247543|NCT00639678|4071921|B3|Asian||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4247544|NCT00639678|4071922|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4247545|NCT00639678|4071923|B1|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4247546|NCT00639678|4071919|B5|White||Race/Ethnicity, Customized||Participants|Number|225|225.0||||||
4247547|NCT00639678|4071920|B4|White||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
4247548|NCT00639678|4071921|B3|White||Race/Ethnicity, Customized||Participants|Number|143|143.0||||||
4247549|NCT00639678|4071922|B2|White||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4247550|NCT00639678|4071923|B1|White||Race/Ethnicity, Customized||Participants|Number|57|57.0||||||
4247551|NCT00639678|4071919|B5||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4247552|NCT00639678|4071920|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4247553|NCT00639678|4071921|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4247554|NCT00639678|4071922|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4247555|NCT00639678|4071923|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4247556|NCT00639678|4071919|B5||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4247557|NCT00639678|4071920|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4247558|NCT00639678|4071921|B3||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4247559|NCT00639678|4071922|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4247560|NCT00639678|4071923|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4247561|NCT00639678|4071919|B5|||Age||Years|Mean|41.0|41.0|Standard Deviation|16.4|16.4|||
4247562|NCT00639678|4071920|B4|||Age||Years|Mean|48.5|48.5|Standard Deviation|14.6|14.6|||
4247563|NCT00639678|4071921|B3|||Age||Years|Mean|40.3|40.3|Standard Deviation|16.3|16.3|||
4247564|NCT00639678|4071922|B2|||Age||Years|Mean|52.2|52.2|Standard Deviation|13.8|13.8|||
4247565|NCT00639678|4071923|B1|||Age||Years|Mean|39.8|39.8|Standard Deviation|16.8|16.8|||
4247566|NCT00639509|4071991|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4247567|NCT00639509|4071991|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4247568|NCT00639509|4071991|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4247569|NCT00639509|4071991|B1|||Age||years|Mean|67.5|67.5|Standard Deviation|9.469631093|9.469631093|||
4247570|NCT00639509|4071991|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4247571|NCT00639509|4071991|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4247572|NCT00639509|4071991|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4247573|NCT00639457|4071997|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
4247574|NCT00639457|4071998|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4247575|NCT00639457|4071999|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4247576|NCT00639457|4071997|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4247577|NCT00639457|4071998|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4247578|NCT00639457|4071999|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4247579|NCT00639457|4071997|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4247580|NCT00639457|4071998|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4247581|NCT00639457|4071999|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4247582|NCT00639457|4071997|B3|||Age||years|Mean|45|45.0|Standard Deviation|2|2.0|||
4247583|NCT00639457|4071998|B2|||Age||years|Mean|46|46.0|Standard Deviation|2|2.0|||
4247584|NCT00639457|4071999|B1|||Age||years|Mean|44|44.0|Standard Deviation|2|2.0|||
4247585|NCT00639457|4071997|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4247586|NCT00639457|4071998|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4247587|NCT00639457|4071999|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4247588|NCT00639457|4071997|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4247589|NCT00639457|4071998|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4247590|NCT00639457|4071999|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4247591|NCT00639457|4071997|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4247592|NCT00639457|4071998|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4247593|NCT00639457|4071999|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4247594|NCT00639418|4072034|B5||Male|Sex: Female, Male|Gender was not collected.|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4247595|NCT00639418|4072035|B4||Male|Sex: Female, Male|Gender was not collected.|Participants|Count of Participants|NA|||||||Gender was not collected.
4247596|NCT00639418|4072036|B3||Male|Sex: Female, Male|Gender was not collected.|Participants|Count of Participants|NA|||||||Gender was not collected.
4247597|NCT00639418|4072037|B2||Male|Sex: Female, Male|Gender was not collected.|Participants|Count of Participants|NA|||||||Gender was not collected.
4247598|NCT00639418|4072038|B1||Male|Sex: Female, Male|Gender was not collected.|Participants|Count of Participants|NA|||||||Gender was not collected.
4247599|NCT00639418|4072034|B5||Female|Sex: Female, Male|Gender was not collected.|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4247600|NCT00639418|4072035|B4||Female|Sex: Female, Male|Gender was not collected.|Participants|Count of Participants|NA|||||||Gender was not collected.
4247601|NCT00639418|4072036|B3||Female|Sex: Female, Male|Gender was not collected.|Participants|Count of Participants|NA|||||||Gender was not collected.
4247602|NCT00639418|4072037|B2||Female|Sex: Female, Male|Gender was not collected.|Participants|Count of Participants|NA|||||||Gender was not collected.
4247603|NCT00639418|4072038|B1||Female|Sex: Female, Male|Gender was not collected.|Participants|Count of Participants|NA|||||||Gender was not collected.
4247604|NCT00639418|4072034|B5|||Age, Customized|Number of participants in each age group|participants|Number|147494|147494.0||||||
4247605|NCT00639418|4072035|B4|||Age, Customized|Number of participants in each age group|participants|Number|46930|46930.0||||||
4247606|NCT00639418|4072036|B3|||Age, Customized|Number of participants in each age group|participants|Number|36496|36496.0||||||
4247607|NCT00639418|4072037|B2|||Age, Customized|Number of participants in each age group|participants|Number|35967|35967.0||||||
4247608|NCT00639418|4072038|B1|||Age, Customized|Number of participants in each age group|participants|Number|28101|28101.0||||||
4247609|NCT00639379|4072059|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4247610|NCT00639379|4072059|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4247611|NCT00639379|4072059|B1|||Age||years|Mean|31.6|31.6|Standard Deviation|8.05|8.05|||
4247612|NCT00639223|4072074|B3|United States||Region of Enrollment||participants|Number|43|43.0||||||
4247613|NCT00639223|4072075|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4247614|NCT00639223|4072076|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4247615|NCT00639223|4072074|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4247616|NCT00639223|4072075|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4247617|NCT00639223|4072076|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4247618|NCT00639223|4072074|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4247619|NCT00639223|4072075|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4247620|NCT00639223|4072076|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4247621|NCT00639223|4072074|B3|||Age||years|Mean|62.7|62.7|Standard Deviation|7.7|7.7|||
4247622|NCT00639223|4072075|B2|||Age||years|Mean|62.4|62.4|Standard Deviation|8.9|8.9|||
4247623|NCT00639223|4072076|B1|||Age||years|Mean|62.9|62.9|Standard Deviation|6.6|6.6|||
4247624|NCT00639223|4072074|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4247625|NCT00639223|4072075|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4247626|NCT00639223|4072076|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4247627|NCT00639223|4072074|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4247628|NCT00639223|4072075|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4247629|NCT00639223|4072076|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4247630|NCT00639223|4072074|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4247631|NCT00639223|4072075|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4247632|NCT00639223|4072076|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4247633|NCT00639158|4072085|B3||Male|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
4247634|NCT00639158|4072086|B2||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4247635|NCT00639158|4072087|B1||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4247636|NCT00639158|4072085|B3||Female|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
4247637|NCT00639158|4072086|B2||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4247638|NCT00639158|4072087|B1||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4247639|NCT00639158|4072085|B3|United States||Age||participants|Mean|55.4|55.4|Standard Deviation|10.99|10.99|||
4247640|NCT00639158|4072086|B2|United States||Age||participants|Mean|56.4|56.4|Standard Deviation|10.67|10.67|||
4247641|NCT00639158|4072087|B1|United States||Age||participants|Mean|54.4|54.4|Standard Deviation|11.23|11.23|||
4247642|NCT00639158|4072085|B3|||Age||years|Mean|55.4|55.4|Standard Deviation|10.99|10.99|||
4247643|NCT00639158|4072086|B2|||Age||years|Mean|56.4|56.4|Standard Deviation|10.67|10.67|||
4247644|NCT00639158|4072087|B1|||Age||years|Mean|54.4|54.4|Standard Deviation|11.23|11.23|||
4247645|NCT00639158|4072085|B3||>=65 years|Age||Participants|Count of Participants|109|109.0||||||
4247646|NCT00639158|4072086|B2||>=65 years|Age||Participants|Count of Participants|64|64.0||||||
4247647|NCT00639158|4072087|B1||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
4247648|NCT00639158|4072085|B3||Between 18 and 65 years|Age||Participants|Count of Participants|433|433.0||||||
4247649|NCT00639158|4072086|B2||Between 18 and 65 years|Age||Participants|Count of Participants|206|206.0||||||
4247650|NCT00639158|4072087|B1||Between 18 and 65 years|Age||Participants|Count of Participants|227|227.0||||||
4247651|NCT00639158|4072085|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4247652|NCT00639158|4072086|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4247653|NCT00639158|4072087|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4247654|NCT00639093|4072108|B3|||Nicotine addiction|As stated in the Eligibility Criteria, participants had to be smokers (10 cigarettes per day minimum) wanting but incapable to quit.|Participants|Number|91|91.0||||||
4247655|NCT00639093|4072109|B2|||Nicotine addiction|As stated in the Eligibility Criteria, participants had to be smokers (10 cigarettes per day minimum) wanting but incapable to quit.|Participants|Number|46|46.0||||||
4247656|NCT00639093|4072110|B1|||Nicotine addiction|As stated in the Eligibility Criteria, participants had to be smokers (10 cigarettes per day minimum) wanting but incapable to quit.|Participants|Number|45|45.0||||||
4247657|NCT00639093|4072108|B3|Canada||Region of Enrollment||participants|Number|91|91.0||||||
4247658|NCT00639093|4072109|B2|Canada||Region of Enrollment||participants|Number|46|46.0||||||
4247659|NCT00639093|4072110|B1|Canada||Region of Enrollment||participants|Number|45|45.0||||||
4247660|NCT00639093|4072108|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4247661|NCT00639093|4072109|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4247662|NCT00639093|4072110|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4247663|NCT00639093|4072108|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4247664|NCT00639093|4072109|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4247665|NCT00639093|4072110|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4247666|NCT00639093|4072108|B3||>=65 years|Age|Aged above 18.|Participants|Count of Participants|0|0.0||||||
4247667|NCT00639093|4072109|B2||>=65 years|Age|Aged above 18.|Participants|Count of Participants|0|0.0||||||
4247668|NCT00639093|4072110|B1||>=65 years|Age|Aged above 18.|Participants|Count of Participants|0|0.0||||||
4247669|NCT00639093|4072108|B3||Between 18 and 65 years|Age|Aged above 18.|Participants|Count of Participants|91|91.0||||||
4247670|NCT00639093|4072109|B2||Between 18 and 65 years|Age|Aged above 18.|Participants|Count of Participants|46|46.0||||||
4247671|NCT00639093|4072110|B1||Between 18 and 65 years|Age|Aged above 18.|Participants|Count of Participants|45|45.0||||||
4247672|NCT00639093|4072108|B3||<=18 years|Age|Aged above 18.|Participants|Count of Participants|0|0.0||||||
4247673|NCT00639093|4072109|B2||<=18 years|Age|Aged above 18.|Participants|Count of Participants|0|0.0||||||
4247674|NCT00639093|4072110|B1||<=18 years|Age|Aged above 18.|Participants|Count of Participants|0|0.0||||||
4247675|NCT00639002|4072117|B1|Unknown||Stage of multiple myeloma at initial diagnosis||participants|Number|5|5.0||||||
4247676|NCT00639002|4072117|B1|III||Stage of multiple myeloma at initial diagnosis||participants|Number|4|4.0||||||
4247677|NCT00639002|4072117|B1|II||Stage of multiple myeloma at initial diagnosis||participants|Number|4|4.0||||||
4247678|NCT00639002|4072117|B1|I||Stage of multiple myeloma at initial diagnosis||participants|Number|0|0.0||||||
4247709|NCT00638963|4072168|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4247710|NCT00638963|4072166|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4247679|NCT00639002|4072117|B1||Unknown or Not Reported|Race (NIH/OMB)|"Stage I: Relatively few cancer cells have spread throughout the body. Levels of red blood cells and calcium in the blood are normal. No bone tumors. M-protein in the blood or urine is very low. Possibly no symptoms of disease.~Stage II: A moderate number of cancer cells have spread throughout the body.~Stage III: A large number of cancer cells have spread throughout the body. There may be 1 or more of the following:~Decreased red blood cells, causing anemia~High amounts of calcium in the blood~More than 3 bone tumors (plasmacytomas)~High levels of M-protein in blood or urine"|Participants|Count of Participants|0|0.0||||||
4247680|NCT00639002|4072117|B1||More than one race|Race (NIH/OMB)|"Stage I: Relatively few cancer cells have spread throughout the body. Levels of red blood cells and calcium in the blood are normal. No bone tumors. M-protein in the blood or urine is very low. Possibly no symptoms of disease.~Stage II: A moderate number of cancer cells have spread throughout the body.~Stage III: A large number of cancer cells have spread throughout the body. There may be 1 or more of the following:~Decreased red blood cells, causing anemia~High amounts of calcium in the blood~More than 3 bone tumors (plasmacytomas)~High levels of M-protein in blood or urine"|Participants|Count of Participants|0|0.0||||||
4247681|NCT00639002|4072117|B1||White|Race (NIH/OMB)|"Stage I: Relatively few cancer cells have spread throughout the body. Levels of red blood cells and calcium in the blood are normal. No bone tumors. M-protein in the blood or urine is very low. Possibly no symptoms of disease.~Stage II: A moderate number of cancer cells have spread throughout the body.~Stage III: A large number of cancer cells have spread throughout the body. There may be 1 or more of the following:~Decreased red blood cells, causing anemia~High amounts of calcium in the blood~More than 3 bone tumors (plasmacytomas)~High levels of M-protein in blood or urine"|Participants|Count of Participants|10|10.0||||||
4247682|NCT00639002|4072117|B1||Black or African American|Race (NIH/OMB)|"Stage I: Relatively few cancer cells have spread throughout the body. Levels of red blood cells and calcium in the blood are normal. No bone tumors. M-protein in the blood or urine is very low. Possibly no symptoms of disease.~Stage II: A moderate number of cancer cells have spread throughout the body.~Stage III: A large number of cancer cells have spread throughout the body. There may be 1 or more of the following:~Decreased red blood cells, causing anemia~High amounts of calcium in the blood~More than 3 bone tumors (plasmacytomas)~High levels of M-protein in blood or urine"|Participants|Count of Participants|3|3.0||||||
4247683|NCT00639002|4072117|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|"Stage I: Relatively few cancer cells have spread throughout the body. Levels of red blood cells and calcium in the blood are normal. No bone tumors. M-protein in the blood or urine is very low. Possibly no symptoms of disease.~Stage II: A moderate number of cancer cells have spread throughout the body.~Stage III: A large number of cancer cells have spread throughout the body. There may be 1 or more of the following:~Decreased red blood cells, causing anemia~High amounts of calcium in the blood~More than 3 bone tumors (plasmacytomas)~High levels of M-protein in blood or urine"|Participants|Count of Participants|0|0.0||||||
4247684|NCT00639002|4072117|B1||Asian|Race (NIH/OMB)|"Stage I: Relatively few cancer cells have spread throughout the body. Levels of red blood cells and calcium in the blood are normal. No bone tumors. M-protein in the blood or urine is very low. Possibly no symptoms of disease.~Stage II: A moderate number of cancer cells have spread throughout the body.~Stage III: A large number of cancer cells have spread throughout the body. There may be 1 or more of the following:~Decreased red blood cells, causing anemia~High amounts of calcium in the blood~More than 3 bone tumors (plasmacytomas)~High levels of M-protein in blood or urine"|Participants|Count of Participants|0|0.0||||||
4247685|NCT00639002|4072117|B1||American Indian or Alaska Native|Race (NIH/OMB)|"Stage I: Relatively few cancer cells have spread throughout the body. Levels of red blood cells and calcium in the blood are normal. No bone tumors. M-protein in the blood or urine is very low. Possibly no symptoms of disease.~Stage II: A moderate number of cancer cells have spread throughout the body.~Stage III: A large number of cancer cells have spread throughout the body. There may be 1 or more of the following:~Decreased red blood cells, causing anemia~High amounts of calcium in the blood~More than 3 bone tumors (plasmacytomas)~High levels of M-protein in blood or urine"|Participants|Count of Participants|0|0.0||||||
4247686|NCT00639002|4072117|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4247687|NCT00639002|4072117|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4247688|NCT00639002|4072117|B1|||Age||years|Mean|74.7|74.7|Standard Deviation|8.36|8.36|||
4247689|NCT00638989|4072123|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4247690|NCT00638989|4072124|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4247691|NCT00638989|4072125|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4247692|NCT00638989|4072126|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4247693|NCT00638989|4072123|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4247694|NCT00638989|4072124|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4247695|NCT00638989|4072125|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4247696|NCT00638989|4072126|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4247697|NCT00638989|4072123|B4|||Age||years|Mean|32.5|32.5|Standard Deviation|10.1|10.1|||
4247698|NCT00638989|4072124|B3|||Age||years|Mean|27.8|27.8|Standard Deviation|10.4|10.4|||
4247699|NCT00638989|4072125|B2|||Age||years|Mean|39.3|39.3|Standard Deviation|8.6|8.6|||
4247700|NCT00638989|4072126|B1|||Age||years|Mean|30.4|30.4|Standard Deviation|8.3|8.3|||
4247701|NCT00638963|4072166|B3|Italy||Region of Enrollment||participants|Number|6|6.0||||||
4247702|NCT00638963|4072167|B2|Italy||Region of Enrollment||participants|Number|3|3.0||||||
4247703|NCT00638963|4072168|B1|Italy||Region of Enrollment||participants|Number|3|3.0||||||
4247704|NCT00638963|4072166|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4247705|NCT00638963|4072167|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4247706|NCT00638963|4072168|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4247707|NCT00638963|4072166|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4247708|NCT00638963|4072167|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4247711|NCT00638963|4072167|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4247712|NCT00638963|4072168|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4247713|NCT00638963|4072166|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4247714|NCT00638963|4072167|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4247715|NCT00638963|4072168|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4247716|NCT00638963|4072166|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4247717|NCT00638963|4072167|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4247718|NCT00638963|4072168|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4247719|NCT00638937|4072188|B1|Canada||Region of Enrollment||participants|Number|37|37.0||||||
4247720|NCT00638937|4072188|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4247721|NCT00638937|4072188|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4247722|NCT00638937|4072188|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4247723|NCT00638937|4072188|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4247724|NCT00638937|4072188|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4247725|NCT00638937|4072188|B1|||Age||years|Median|65|65.0|Full Range|||33.0|78.0|
4247726|NCT00638924|4072199|B1|Brazil||Region of Enrollment||participants|Number|40|40.0||||||
4247727|NCT00638924|4072199|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4247728|NCT00638924|4072199|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4247729|NCT00638924|4072199|B1|||Age||years|Mean|24|24.0|Standard Deviation|1.8|1.8|||
4247730|NCT00638924|4072199|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4247731|NCT00638924|4072199|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4247732|NCT00638924|4072199|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4247733|NCT00638885|4072204|B1|United States||Region of Enrollment||participants|Number|142|142.0||||||
4247734|NCT00638885|4072204|B1||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4247735|NCT00638885|4072204|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4247736|NCT00638885|4072204|B1|||Age||years|Mean|53|53.0|Standard Deviation|2|2.0|||
4247737|NCT00638885|4072204|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4247738|NCT00638885|4072204|B1||Between 18 and 65 years|Age||Participants|Count of Participants|142|142.0||||||
4247739|NCT00638885|4072204|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4247740|NCT00638846|4072208|B3|Male||Gender|Gender of 2 subjects assigned to balafilcon A is unknown.|participants|Number|91|91.0||||||
4247741|NCT00638846|4072209|B2|Male||Gender|Gender of 2 subjects assigned to balafilcon A is unknown.|participants|Number|45|45.0||||||
4247742|NCT00638846|4072210|B1|Male||Gender|Gender of 2 subjects assigned to balafilcon A is unknown.|participants|Number|46|46.0||||||
4247743|NCT00638846|4072208|B3|Female||Gender|Gender of 2 subjects assigned to balafilcon A is unknown.|participants|Number|183|183.0||||||
4247744|NCT00638846|4072209|B2|Female||Gender|Gender of 2 subjects assigned to balafilcon A is unknown.|participants|Number|92|92.0||||||
4247745|NCT00638846|4072210|B1|Female||Gender|Gender of 2 subjects assigned to balafilcon A is unknown.|participants|Number|91|91.0||||||
4247746|NCT00638846|4072208|B3|||Age||years|Mean|29.97|29.97|Standard Deviation|7.33|7.33|||
4247747|NCT00638846|4072209|B2|||Age||years|Mean|30.13|30.13|Standard Deviation|7.69|7.69|||
4247748|NCT00638846|4072210|B1|||Age||years|Mean|29.81|29.81|Standard Deviation|6.99|6.99|||
4247749|NCT00638820|4072227|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4247750|NCT00638820|4072227|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4247751|NCT00638820|4072227|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4247752|NCT00638820|4072227|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4247753|NCT00638820|4072227|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4247754|NCT00638820|4072227|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4247755|NCT00638716|4072234|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4247756|NCT00638716|4072235|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4247757|NCT00638716|4072236|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4247758|NCT00638716|4072237|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4247759|NCT00638716|4072234|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247760|NCT00638716|4072235|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247761|NCT00638716|4072236|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247762|NCT00638716|4072237|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247763|NCT00638716|4072234|B4||White|Race (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
4247764|NCT00638716|4072235|B3||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4247765|NCT00638716|4072236|B2||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4247766|NCT00638716|4072237|B1||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4247767|NCT00638716|4072234|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4247768|NCT00638716|4072235|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4247769|NCT00638716|4072236|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4247770|NCT00638716|4072237|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4247771|NCT00638716|4072234|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247772|NCT00638716|4072235|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247773|NCT00638716|4072236|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247774|NCT00638716|4072237|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247775|NCT00638716|4072234|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4247776|NCT00638716|4072235|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4247777|NCT00638716|4072236|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4247778|NCT00638716|4072237|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4247779|NCT00638716|4072234|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4247780|NCT00638716|4072235|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4247781|NCT00638716|4072236|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4247782|NCT00638716|4072237|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247783|NCT00638716|4072234|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247784|NCT00638716|4072235|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247785|NCT00638716|4072236|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247786|NCT00638716|4072237|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4247787|NCT00638716|4072234|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
4247788|NCT00638716|4072235|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4247789|NCT00638716|4072236|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4247790|NCT00638716|4072237|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4247791|NCT00638716|4072234|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4247792|NCT00638716|4072235|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4247793|NCT00638716|4072236|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4247794|NCT00638716|4072237|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4247795|NCT00638716|4072234|B4||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4247796|NCT00638716|4072235|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4247797|NCT00638716|4072236|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4247798|NCT00638716|4072237|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4247799|NCT00638716|4072234|B4||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4247800|NCT00638716|4072235|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4247801|NCT00638716|4072236|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4247802|NCT00638716|4072237|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4247803|NCT00638716|4072234|B4|||Age||years|Mean|55.9|55.9|Standard Deviation|11.99|11.99|||
4247804|NCT00638716|4072235|B3|||Age||years|Mean|57.2|57.2|Standard Deviation|13.05|13.05|||
4247805|NCT00638716|4072236|B2|||Age||years|Mean|55.1|55.1|Standard Deviation|12.24|12.24|||
4247806|NCT00638716|4072237|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|10.46|10.46|||
4247807|NCT00638690|4072253|B3|United States||Region of Enrollment||participants|Number|498|498.0||||||
4247808|NCT00638690|4072254|B2|United States||Region of Enrollment||participants|Number|162|162.0||||||
4247809|NCT00638690|4072255|B1|United States||Region of Enrollment||participants|Number|336|336.0||||||
4247810|NCT00638690|4072253|B3|United Kingdom||Region of Enrollment||participants|Number|180|180.0||||||
4247811|NCT00638690|4072254|B2|United Kingdom||Region of Enrollment||participants|Number|61|61.0||||||
4247812|NCT00638690|4072255|B1|United Kingdom||Region of Enrollment||participants|Number|119|119.0||||||
4247813|NCT00638690|4072253|B3|Spain||Region of Enrollment||participants|Number|16|16.0||||||
4247814|NCT00638690|4072254|B2|Spain||Region of Enrollment||participants|Number|3|3.0||||||
4247815|NCT00638690|4072255|B1|Spain||Region of Enrollment||participants|Number|13|13.0||||||
4247816|NCT00638690|4072253|B3|Republic of Ireland||Region of Enrollment||participants|Number|14|14.0||||||
4247817|NCT00638690|4072254|B2|Republic of Ireland||Region of Enrollment||participants|Number|7|7.0||||||
4247818|NCT00638690|4072255|B1|Republic of Ireland||Region of Enrollment||participants|Number|7|7.0||||||
4247819|NCT00638690|4072253|B3|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
4247820|NCT00638690|4072254|B2|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
4247821|NCT00638690|4072255|B1|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
4247822|NCT00638690|4072253|B3|Italy||Region of Enrollment||participants|Number|33|33.0||||||
4247823|NCT00638690|4072254|B2|Italy||Region of Enrollment||participants|Number|12|12.0||||||
4247824|NCT00638690|4072255|B1|Italy||Region of Enrollment||participants|Number|21|21.0||||||
4247825|NCT00638690|4072253|B3|Hungary||Region of Enrollment||participants|Number|7|7.0||||||
4247826|NCT00638690|4072254|B2|Hungary||Region of Enrollment||participants|Number|2|2.0||||||
4247827|NCT00638690|4072255|B1|Hungary||Region of Enrollment||participants|Number|5|5.0||||||
4247828|NCT00638690|4072253|B3|Germany||Region of Enrollment||participants|Number|38|38.0||||||
4247829|NCT00638690|4072254|B2|Germany||Region of Enrollment||participants|Number|12|12.0||||||
4247830|NCT00638690|4072255|B1|Germany||Region of Enrollment||participants|Number|26|26.0||||||
4247831|NCT00638690|4072253|B3|France||Region of Enrollment||participants|Number|90|90.0||||||
4247832|NCT00638690|4072254|B2|France||Region of Enrollment||participants|Number|33|33.0||||||
4247833|NCT00638690|4072255|B1|France||Region of Enrollment||participants|Number|57|57.0||||||
4247834|NCT00638690|4072253|B3|Canada||Region of Enrollment||participants|Number|154|154.0||||||
4247835|NCT00638690|4072254|B2|Canada||Region of Enrollment||participants|Number|57|57.0||||||
4247836|NCT00638690|4072255|B1|Canada||Region of Enrollment||participants|Number|97|97.0||||||
4247837|NCT00638690|4072253|B3|Belgium||Region of Enrollment||participants|Number|43|43.0||||||
4247838|NCT00638690|4072254|B2|Belgium||Region of Enrollment||participants|Number|11|11.0||||||
4247839|NCT00638690|4072255|B1|Belgium||Region of Enrollment||participants|Number|32|32.0||||||
4247840|NCT00638690|4072253|B3|Austria||Region of Enrollment||participants|Number|12|12.0||||||
4247841|NCT00638690|4072254|B2|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4247842|NCT00638690|4072255|B1|Austria||Region of Enrollment||participants|Number|11|11.0||||||
4247843|NCT00638690|4072253|B3|Australia||Region of Enrollment||participants|Number|104|104.0||||||
4247844|NCT00638690|4072254|B2|Australia||Region of Enrollment||participants|Number|35|35.0||||||
4247845|NCT00638690|4072255|B1|Australia||Region of Enrollment||participants|Number|69|69.0||||||
4247846|NCT00638690|4072253|B3||Male|Sex: Female, Male||Participants|Count of Participants|1195|1195.0||||||
4247847|NCT00638690|4072254|B2||Male|Sex: Female, Male||Participants|Count of Participants|398|398.0||||||
4247848|NCT00638690|4072255|B1||Male|Sex: Female, Male||Participants|Count of Participants|797|797.0||||||
4247849|NCT00638690|4072253|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4247850|NCT00638690|4072254|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4247851|NCT00638690|4072255|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4247852|NCT00638690|4072253|B3|||Age||years|Mean|69|69.0|Standard Deviation|8.46|8.46|||
4247853|NCT00638690|4072254|B2|||Age||years|Mean|68.9|68.9|Standard Deviation|8.61|8.61|||
4247854|NCT00638690|4072255|B1|||Age||years|Mean|69.1|69.1|Standard Deviation|8.4|8.4|||
4247855|NCT00638651|4072269|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4247856|NCT00638651|4072269|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4247857|NCT00638651|4072269|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4247858|NCT00638651|4072269|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4247859|NCT00638651|4072269|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4247860|NCT00638508|4072274|B3|||Age|Age of the participating patients, reported in years.|years|Median|27|27.0|Full Range|||18.0|45.0|
4247861|NCT00638508|4072275|B2|||Age|Age of the participating patients, reported in years.|years|Median|26|26.0|Full Range|||18.0|45.0|
4247862|NCT00638508|4072276|B1|||Age|Age of the participating patients, reported in years.|years|Median|27|27.0|Full Range|||18.0|45.0|
4247863|NCT00638508|4072274|B3|||Rescue analgesia utilization|Data is obtained regarding use of additional pain medications for breakthrough pain like morphine and acetaminophen with codeine. Rescue analgesics are converted to morphine equivalents and reported in milligrams.|milligrams|Mean|5.2|5.2|Standard Deviation|2.8|2.8|||
4247864|NCT00638508|4072275|B2|||Rescue analgesia utilization|Data is obtained regarding use of additional pain medications for breakthrough pain like morphine and acetaminophen with codeine. Rescue analgesics are converted to morphine equivalents and reported in milligrams.|milligrams|Mean|4.0|4.0|Standard Deviation|2.9|2.9|||
4247865|NCT00638508|4072276|B1|||Rescue analgesia utilization|Data is obtained regarding use of additional pain medications for breakthrough pain like morphine and acetaminophen with codeine. Rescue analgesics are converted to morphine equivalents and reported in milligrams.|milligrams|Mean|6.3|6.3|Standard Deviation|1.9|1.9|||
4247866|NCT00638508|4072274|B3|||Pain score|"Patients report pain scores using Visual Analog Scale (VAS) . This scale measures the severity of pain and ranges from from 1-10, 1 being minimal pain intensity and 10 being maximal pain intensity."|units on a scale|Mean|6.40|6.4|Standard Deviation|2.6|2.6|||
4247867|NCT00638508|4072275|B2|||Pain score|"Patients report pain scores using Visual Analog Scale (VAS) . This scale measures the severity of pain and ranges from from 1-10, 1 being minimal pain intensity and 10 being maximal pain intensity."|units on a scale|Mean|6.2|6.2|Standard Deviation|2.9|2.9|||
4247868|NCT00638508|4072276|B1|||Pain score|"Patients report pain scores using Visual Analog Scale (VAS) . This scale measures the severity of pain and ranges from from 1-10, 1 being minimal pain intensity and 10 being maximal pain intensity."|units on a scale|Mean|6.7|6.7|Standard Deviation|2.2|2.2|||
4247869|NCT00638508|4072274|B3|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
4247870|NCT00638508|4072275|B2|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4247871|NCT00638508|4072276|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4247872|NCT00638508|4072274|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4247873|NCT00638508|4072275|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4247874|NCT00638508|4072276|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4247875|NCT00638508|4072274|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4247876|NCT00638508|4072275|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4247877|NCT00638508|4072276|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4247878|NCT00638508|4072274|B3|||Age||years|Mean|25|25.0|Full Range|||18.0|45.0|
4247879|NCT00638508|4072275|B2|||Age||years|Mean|25|25.0|Full Range|||18.0|45.0|
4247880|NCT00638508|4072276|B1|||Age||years|Mean|25|25.0|Full Range|||18.0|45.0|
4247881|NCT00638443|4072321|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4247882|NCT00638443|4072321|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4247883|NCT00638443|4072321|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4247884|NCT00638443|4072321|B1|||Age||years|Mean|69.76|69.76|Standard Deviation|8.22|8.22|||
4247885|NCT00638443|4072321|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4247886|NCT00638443|4072321|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4247887|NCT00638443|4072321|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4247888|NCT00638404|4072350|B3|United States||Region of Enrollment||Participants|Count of Participants|292|292.0||||||
4247889|NCT00638404|4072351|B2|United States||Region of Enrollment||Participants|Count of Participants|100|100.0||||||
4247890|NCT00638404|4072352|B1|United States||Region of Enrollment||Participants|Count of Participants|192|192.0||||||
4247891|NCT00638404|4072350|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|220|220.0||||||
4247892|NCT00638404|4072351|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|80|80.0||||||
4247893|NCT00638404|4072352|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|140|140.0||||||
4247894|NCT00638404|4072350|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4247895|NCT00638404|4072351|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4247896|NCT00638404|4072352|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4247897|NCT00638404|4072350|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|62|62.0||||||
4247898|NCT00638404|4072351|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
4247899|NCT00638404|4072352|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
4247900|NCT00638404|4072350|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4247901|NCT00638404|4072351|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4247902|NCT00638404|4072352|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4247903|NCT00638404|4072350|B3||Female|Sex: Female, Male||Participants|Count of Participants|292|292.0||||||
4247904|NCT00638404|4072351|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4247905|NCT00638404|4072352|B1||Female|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4247906|NCT00638404|4072350|B3|||Age||years|Mean|34.95|34.95|Standard Deviation|9.5|9.5|||
4247907|NCT00638404|4072351|B2|||Age||years|Mean|44.5|44.5|Standard Deviation|9.0|9.0|||
4247908|NCT00638404|4072352|B1|||Age||years|Mean|30|30.0|Standard Deviation|4.8|4.8|||
4247909|NCT00638404|4072350|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4247910|NCT00638404|4072351|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4247911|NCT00638404|4072352|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4247912|NCT00638404|4072350|B3||Between 18 and 65 years|Age||Participants|Count of Participants|292|292.0||||||
4247913|NCT00638404|4072351|B2||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4247914|NCT00638404|4072352|B1||Between 18 and 65 years|Age||Participants|Count of Participants|192|192.0||||||
4247915|NCT00638404|4072350|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4247916|NCT00638404|4072351|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4247917|NCT00638404|4072352|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4247918|NCT00638378|4072365|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4247919|NCT00638378|4072365|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4247920|NCT00638378|4072365|B1|||Age||years|Mean|70.4|70.4|Standard Deviation|7.11|7.11|||
4247921|NCT00638365|4072372|B4|United States||Region of Enrollment||participants|Number|27|27.0||||||
4247922|NCT00638365|4072373|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4247923|NCT00638365|4072374|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4247924|NCT00638365|4072375|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4247925|NCT00638365|4072372|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4247926|NCT00638365|4072373|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4247927|NCT00638365|4072374|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4247928|NCT00638365|4072375|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4247929|NCT00638365|4072372|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4247930|NCT00638365|4072373|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4247931|NCT00638365|4072374|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4247932|NCT00638365|4072375|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4247933|NCT00638365|4072372|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4247934|NCT00638365|4072373|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4247935|NCT00638365|4072374|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4247936|NCT00638365|4072375|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4247937|NCT00638365|4072372|B4||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4247938|NCT00638365|4072373|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4247939|NCT00638365|4072374|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4247940|NCT00638365|4072375|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4247941|NCT00638365|4072372|B4||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4247942|NCT00638365|4072373|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4247943|NCT00638365|4072374|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4247944|NCT00638365|4072375|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4247945|NCT00638274|4072385|B3|United States||Region of Enrollment||participants|Number|345|345.0||||||
4247946|NCT00638274|4072386|B2|United States||Region of Enrollment||participants|Number|172|172.0||||||
4247947|NCT00638274|4072387|B1|United States||Region of Enrollment||participants|Number|173|173.0||||||
4247948|NCT00638274|4072385|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4247949|NCT00638274|4072386|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4247950|NCT00638274|4072387|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4247951|NCT00638274|4072385|B3||Female|Sex: Female, Male||Participants|Count of Participants|345|345.0||||||
4247952|NCT00638274|4072386|B2||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4247953|NCT00638274|4072387|B1||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4247954|NCT00638274|4072385|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4247955|NCT00638274|4072386|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4247956|NCT00638274|4072387|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4247957|NCT00638274|4072385|B3||Between 18 and 65 years|Age||Participants|Count of Participants|345|345.0||||||
4247958|NCT00638274|4072386|B2||Between 18 and 65 years|Age||Participants|Count of Participants|172|172.0||||||
4247959|NCT00638274|4072387|B1||Between 18 and 65 years|Age||Participants|Count of Participants|173|173.0||||||
4247960|NCT00638274|4072385|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4247961|NCT00638274|4072386|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4247962|NCT00638274|4072387|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4247963|NCT00638235|4072396|B10||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4247964|NCT00638235|4072397|B9||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4247965|NCT00638235|4072398|B8||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4247966|NCT00638235|4072399|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4247967|NCT00638235|4072400|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4247968|NCT00638235|4072401|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4247969|NCT00638235|4072402|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4247970|NCT00638235|4072403|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4247971|NCT00638235|4072404|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4247972|NCT00638235|4072405|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4247973|NCT00638235|4072396|B10||Female|Sex: Female, Male||Participants|Count of Participants|698|698.0||||||
4247974|NCT00638235|4072397|B9||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4247975|NCT00638235|4072398|B8||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4247976|NCT00638235|4072399|B7||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4247977|NCT00638235|4072400|B6||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4247978|NCT00638235|4072401|B5||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4247979|NCT00638235|4072402|B4||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4247980|NCT00638235|4072403|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4247981|NCT00638235|4072404|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4247982|NCT00638235|4072405|B1||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4247983|NCT00638235|4072396|B10|||Age||years|Mean|NA||Standard Deviation|0|0.0|||Mean age of the cohort was not analyzed and access to the database to calculate mean age for total is no longer available.
4247984|NCT00638235|4072397|B9|||Age||years|Mean|63.9|63.9|Standard Deviation|9.8|9.8|||
4247985|NCT00638235|4072398|B8|||Age||years|Mean|65.4|65.4|Standard Deviation|8.4|8.4|||
4247986|NCT00638235|4072399|B7|||Age||years|Mean|63.4|63.4|Standard Deviation|9.6|9.6|||
4247987|NCT00638235|4072400|B6|||Age||years|Mean|62.5|62.5|Standard Deviation|11.6|11.6|||
4247988|NCT00638235|4072401|B5|||Age||years|Mean|63.3|63.3|Standard Deviation|11.8|11.8|||
4247989|NCT00638235|4072402|B4|||Age||years|Mean|63.4|63.4|Standard Deviation|11.1|11.1|||
4247990|NCT00638235|4072403|B3|||Age||years|Mean|69.7|69.7|Standard Deviation|10.9|10.9|||
4247991|NCT00638235|4072404|B2|||Age||years|Mean|63.4|63.4|Standard Deviation|9.0|9.0|||
4247992|NCT00638235|4072405|B1|||Age||years|Mean|59.7|59.7|Standard Deviation|12.2|12.2|||
4247993|NCT00638222|4072811|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
4247994|NCT00638222|4072812|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4247995|NCT00638222|4072811|B4|Male||Gender||participants|Number|6|6.0||||||
4247996|NCT00638222|4072812|B3|Male||Gender||participants|Number|6|6.0||||||
4247997|NCT00638222|4072811|B4|Female||Gender||participants|Number|0|0.0||||||
4247998|NCT00638222|4072812|B3|Female||Gender||participants|Number|0|0.0||||||
4247999|NCT00638222|4072811|B4|>=65 years||Age||participants|Number|2|2.0||||||
4248000|NCT00638222|4072812|B3|>=65 years||Age||participants|Number|2|2.0||||||
4248001|NCT00638222|4072811|B4|Between 18 and 65 years||Age||participants|Number|4|4.0||||||
4248002|NCT00638222|4072812|B3|Between 18 and 65 years||Age||participants|Number|4|4.0||||||
4248003|NCT00638222|4072811|B4|<=18 years||Age||participants|Number|0|0.0||||||
4248004|NCT00638222|4072812|B3|<=18 years||Age||participants|Number|0|0.0||||||
4248005|NCT00638222|4072811|B4|||Age||years|Mean|55|55.0|Standard Deviation|15|15.0|||
4248006|NCT00638222|4072812|B3|||Age||years|Mean|55|55.0|Standard Deviation|15|15.0|||
4248007|NCT00638183|4072823|B1||Male|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4248008|NCT00638183|4072823|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4248009|NCT00638183|4072823|B1|Unknown||Age, Customized||Participants|Number|7|7.0||||||
4248010|NCT00638183|4072823|B1|>=75 years||Age, Customized||Participants|Number|103|103.0||||||
4248011|NCT00638183|4072823|B1|65≤ to <75 years||Age, Customized||Participants|Number|88|88.0||||||
4248012|NCT00638183|4072823|B1|<65 years||Age, Customized||Participants|Number|51|51.0||||||
4248013|NCT00638157|4072830|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4248014|NCT00638157|4072831|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4248015|NCT00638157|4072832|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4248016|NCT00638157|4072830|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4248017|NCT00638157|4072831|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4248018|NCT00638157|4072832|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4248019|NCT00638157|4072830|B3|||Age||years|Mean|42.1|42.1|Standard Deviation|10.71|10.71|||
4248020|NCT00638157|4072831|B2|||Age||years|Mean|45.3|45.3|Standard Deviation|9.90|9.9|||
4248021|NCT00638157|4072832|B1|||Age||years|Mean|38.9|38.9|Standard Deviation|10.93|10.93|||
4248022|NCT00638027|4072841|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4248023|NCT00638027|4072842|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4248024|NCT00638027|4072843|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4248025|NCT00638027|4072841|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4248026|NCT00638027|4072842|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4248027|NCT00638027|4072843|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4248028|NCT00638027|4072841|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4248029|NCT00638027|4072842|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4248030|NCT00638027|4072843|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4248031|NCT00638027|4072841|B3|||Age||years|Mean|52.5|52.5|Standard Deviation|9.8|9.8|||
4248032|NCT00638027|4072842|B2|||Age||years|Mean|52.1|52.1|Standard Deviation|12.2|12.2|||
4248033|NCT00638027|4072843|B1|||Age||years|Mean|52.9|52.9|Standard Deviation|7.5|7.5|||
4248034|NCT00638027|4072841|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4248035|NCT00638027|4072842|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4248036|NCT00638027|4072843|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4248037|NCT00638027|4072841|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4248038|NCT00638027|4072842|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4248039|NCT00638027|4072843|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4248040|NCT00638027|4072841|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248041|NCT00638027|4072842|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248042|NCT00638027|4072843|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248043|NCT00638014|4072854|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
4248044|NCT00638014|4072855|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4248045|NCT00638014|4072856|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4248046|NCT00638014|4072854|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4248047|NCT00638014|4072855|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4248048|NCT00638014|4072856|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4248049|NCT00638014|4072854|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4248050|NCT00638014|4072855|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4248051|NCT00638014|4072856|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4248052|NCT00638014|4072854|B3|||Age||years|Mean|62.4|62.4|Standard Deviation|9.6|9.6|||
4248053|NCT00638014|4072855|B2|||Age||years|Mean|61.8|61.8|Standard Deviation|10.0|10.0|||
4248054|NCT00638014|4072856|B1|||Age||years|Mean|63.0|63.0|Standard Deviation|9.2|9.2|||
4248055|NCT00638014|4072854|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4248056|NCT00638014|4072855|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4248057|NCT00638014|4072856|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4248058|NCT00638014|4072854|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4248059|NCT00638014|4072855|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4248060|NCT00638014|4072856|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4248061|NCT00638014|4072854|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248062|NCT00638014|4072855|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248063|NCT00638014|4072856|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248064|NCT00637923|4072865|B3|United States||Region of Enrollment||participants|Number|112|112.0||||||
4248065|NCT00637923|4072866|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4248066|NCT00637923|4072867|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
4248067|NCT00637923|4072865|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4248068|NCT00637923|4072866|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4248069|NCT00637923|4072867|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4248070|NCT00637923|4072865|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4248071|NCT00637923|4072866|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4248072|NCT00637923|4072867|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4248073|NCT00637923|4072865|B3|||Age||years|Mean|50|50.0|Standard Deviation|7|7.0|||
4248074|NCT00637923|4072866|B2|||Age||years|Mean|51|51.0|Standard Deviation|8|8.0|||
4248075|NCT00637923|4072867|B1|||Age||years|Mean|50|50.0|Standard Deviation|7|7.0|||
4248076|NCT00637923|4072865|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4248077|NCT00637923|4072866|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4248078|NCT00637923|4072867|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4248079|NCT00637923|4072865|B3||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
4248080|NCT00637923|4072866|B2||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4248081|NCT00637923|4072867|B1||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
4248082|NCT00637923|4072865|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248083|NCT00637923|4072866|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248084|NCT00637923|4072867|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248085|NCT00637806|4072888|B4|United States||Region of Enrollment||participants|Number|4|4.0||||||
4248086|NCT00637806|4072889|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4248087|NCT00637806|4072891|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4248088|NCT00637806|4072888|B4|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4248089|NCT00637806|4072889|B3|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4248090|NCT00637806|4072891|B1|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4248091|NCT00637806|4072888|B4|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4248092|NCT00637806|4072889|B3|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4248093|NCT00637806|4072891|B1|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4248094|NCT00637806|4072888|B4|White||Race (NIH/OMB)||participants|Number|3|3.0||||||
4248095|NCT00637806|4072889|B3|White||Race (NIH/OMB)||participants|Number|1|1.0||||||
4248096|NCT00637806|4072891|B1|White||Race (NIH/OMB)||participants|Number|2|2.0||||||
4248097|NCT00637806|4072888|B4|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
4248098|NCT00637806|4072889|B3|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
4248099|NCT00637806|4072891|B1|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
4248100|NCT00637806|4072888|B4|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4248101|NCT00637806|4072889|B3|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4248102|NCT00637806|4072891|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4248103|NCT00637806|4072888|B4|Asian||Race (NIH/OMB)||participants|Number|1|1.0||||||
4248104|NCT00637806|4072889|B3|Asian||Race (NIH/OMB)||participants|Number|1|1.0||||||
4248105|NCT00637806|4072891|B1|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
4248106|NCT00637806|4072888|B4|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
4248107|NCT00637806|4072889|B3|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
4248108|NCT00637806|4072891|B1|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
4248109|NCT00637806|4072888|B4|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
4248110|NCT00637806|4072889|B3|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
4248111|NCT00637806|4072891|B1|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
4248112|NCT00637806|4072888|B4|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|4|4.0||||||
4248113|NCT00637806|4072889|B3|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|2|2.0||||||
4248114|NCT00637806|4072891|B1|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|2|2.0||||||
4248115|NCT00637806|4072888|B4|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
4248116|NCT00637806|4072889|B3|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
4248117|NCT00637806|4072891|B1|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
4248118|NCT00637806|4072888|B4|Male||Gender||participants|Number|3|3.0||||||
4248119|NCT00637806|4072889|B3|Male||Gender||participants|Number|2|2.0||||||
4248120|NCT00637806|4072891|B1|Male||Gender||participants|Number|1|1.0||||||
4248121|NCT00637806|4072888|B4|Female||Gender||participants|Number|1|1.0||||||
4248122|NCT00637806|4072889|B3|Female||Gender||participants|Number|0|0.0||||||
4248123|NCT00637806|4072891|B1|Female||Gender||participants|Number|1|1.0||||||
4248124|NCT00637806|4072888|B4|>=65 years||Age||participants|Number|3|3.0||||||
4248125|NCT00637806|4072889|B3|>=65 years||Age||participants|Number|2|2.0||||||
4248126|NCT00637806|4072891|B1|>=65 years||Age||participants|Number|1|1.0||||||
4248127|NCT00637806|4072888|B4|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
4248128|NCT00637806|4072889|B3|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
4248129|NCT00637806|4072891|B1|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
4248130|NCT00637806|4072888|B4|<=18 years||Age||participants|Number|0|0.0||||||
4248131|NCT00637806|4072889|B3|<=18 years||Age||participants|Number|0|0.0||||||
4248132|NCT00637806|4072891|B1|<=18 years||Age||participants|Number|0|0.0||||||
4248133|NCT00637780|4072912|B1||Male|Gender||Participants|Count of Participants|1|1.0||||||
4248134|NCT00637780|4072912|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
4248135|NCT00637780|4072912|B1|||Age||years|Mean|15.0|15.0|Standard Deviation|1.4|1.4|||
4248136|NCT00637728|4072927|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4248137|NCT00637728|4072928|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4248138|NCT00637728|4072929|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4248139|NCT00637728|4072927|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248140|NCT00637728|4072928|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248141|NCT00637728|4072929|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248142|NCT00637728|4072927|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248143|NCT00637728|4072928|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248144|NCT00637728|4072929|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248145|NCT00637728|4072927|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4248146|NCT00637728|4072928|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248147|NCT00637728|4072929|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4248148|NCT00637728|4072927|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4248149|NCT00637728|4072928|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4248150|NCT00637728|4072929|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4248151|NCT00637728|4072927|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248152|NCT00637728|4072928|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248153|NCT00637728|4072929|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248154|NCT00637728|4072927|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248155|NCT00637728|4072928|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248156|NCT00637728|4072929|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248157|NCT00637728|4072927|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248158|NCT00637728|4072928|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248159|NCT00637728|4072929|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248160|NCT00637728|4072927|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248161|NCT00637728|4072928|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248162|NCT00637728|4072929|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248163|NCT00637728|4072927|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4248164|NCT00637728|4072928|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4248165|NCT00637728|4072929|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4248166|NCT00637728|4072927|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248167|NCT00637728|4072928|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248168|NCT00637728|4072929|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248169|NCT00637728|4072927|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4248170|NCT00637728|4072928|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4248171|NCT00637728|4072929|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4248172|NCT00637728|4072927|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4248173|NCT00637728|4072928|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4248174|NCT00637728|4072929|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4248175|NCT00637728|4072927|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4248176|NCT00637728|4072928|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4248177|NCT00637728|4072929|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4248178|NCT00637728|4072927|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4248179|NCT00637728|4072928|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4248180|NCT00637728|4072929|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4248181|NCT00637728|4072927|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248182|NCT00637728|4072928|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248183|NCT00637728|4072929|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248184|NCT00637572|4072944|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4248185|NCT00637572|4072945|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4248186|NCT00637572|4072946|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4248187|NCT00637572|4072944|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4248188|NCT00637572|4072945|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4248189|NCT00637572|4072946|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4248190|NCT00637572|4072944|B3|||Age||years|Mean|36.8|36.8|Standard Deviation|7.23|7.23|||
4248191|NCT00637572|4072945|B2|||Age||years|Mean|36.3|36.3|Standard Deviation|7.22|7.22|||
4248192|NCT00637572|4072946|B1|||Age||years|Mean|37.3|37.3|Standard Deviation|7.32|7.32|||
4248193|NCT00637494|4072973|B3|United States||Region of Enrollment||participants|Number|292|292.0||||||
4248194|NCT00637494|4072974|B2|United States||Region of Enrollment||participants|Number|151|151.0||||||
4248195|NCT00637494|4072975|B1|United States||Region of Enrollment||participants|Number|141|141.0||||||
4248196|NCT00637494|4072973|B3||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4248197|NCT00637494|4072974|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4248198|NCT00637494|4072975|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4248199|NCT00637494|4072973|B3||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4248200|NCT00637494|4072974|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4248201|NCT00637494|4072975|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4248202|NCT00637494|4072973|B3|||Age||years|Mean|46.2|46.2|Standard Deviation|9.3|9.3|||
4248203|NCT00637494|4072974|B2|||Age||years|Mean|47.0|47.0|Standard Deviation|9.5|9.5|||
4248204|NCT00637494|4072975|B1|||Age||years|Mean|45.4|45.4|Standard Deviation|9.0|9.0|||
4248205|NCT00637494|4072973|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4248206|NCT00637494|4072974|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4248207|NCT00637494|4072975|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4248208|NCT00637494|4072973|B3||Between 18 and 65 years|Age||Participants|Count of Participants|288|288.0||||||
4248209|NCT00637494|4072974|B2||Between 18 and 65 years|Age||Participants|Count of Participants|147|147.0||||||
4248210|NCT00637494|4072975|B1||Between 18 and 65 years|Age||Participants|Count of Participants|141|141.0||||||
4248211|NCT00637494|4072973|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248212|NCT00637494|4072974|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248213|NCT00637494|4072975|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248214|NCT00637416|4072984|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4248215|NCT00637416|4072985|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4248216|NCT00637416|4072986|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4248217|NCT00637416|4072984|B3||Male|Gender||Participants|Count of Participants|5|5.0||||||
4248218|NCT00637416|4072985|B2||Male|Gender||Participants|Count of Participants|3|3.0||||||
4248219|NCT00637416|4072986|B1||Male|Gender||Participants|Count of Participants|2|2.0||||||
4248220|NCT00637416|4072984|B3||Female|Gender||Participants|Count of Participants|4|4.0||||||
4248221|NCT00637416|4072985|B2||Female|Gender||Participants|Count of Participants|2|2.0||||||
4248222|NCT00637416|4072986|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
4248223|NCT00637416|4072984|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4248224|NCT00637416|4072985|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4248225|NCT00637416|4072986|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4248226|NCT00637416|4072984|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4248227|NCT00637416|4072985|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4248228|NCT00637416|4072986|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4248229|NCT00637416|4072984|B3||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4248230|NCT00637416|4072985|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4248231|NCT00637416|4072986|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4248232|NCT00637377|4072993|B5|||Best Corrected Visual Acuity (BCVA), assessed by ETDRS chart|Information retrieved from all baseline participants. Only participants with a ETDRS (Early Treatment Diabetic Retinopathy Study) Best Corrected Visual Acuity letter score of 73 to 25 (= Acuity of 20/40 to 20/320) in the study eye at 4 meters were included; a higher score represents better functioning.|Letters correctly read|Mean|52.4|52.4|Standard Deviation|13.9|13.9|||
4248233|NCT00637377|4072994|B4|||Best Corrected Visual Acuity (BCVA), assessed by ETDRS chart|Information retrieved from all baseline participants. Only participants with a ETDRS (Early Treatment Diabetic Retinopathy Study) Best Corrected Visual Acuity letter score of 73 to 25 (= Acuity of 20/40 to 20/320) in the study eye at 4 meters were included; a higher score represents better functioning.|Letters correctly read|Mean|51.6|51.6|Standard Deviation|13.9|13.9|||
4248234|NCT00637377|4072995|B3|||Best Corrected Visual Acuity (BCVA), assessed by ETDRS chart|Information retrieved from all baseline participants. Only participants with a ETDRS (Early Treatment Diabetic Retinopathy Study) Best Corrected Visual Acuity letter score of 73 to 25 (= Acuity of 20/40 to 20/320) in the study eye at 4 meters were included; a higher score represents better functioning.|Letters correctly read|Mean|51.6|51.6|Standard Deviation|14.2|14.2|||
4248235|NCT00637377|4072996|B2|||Best Corrected Visual Acuity (BCVA), assessed by ETDRS chart|Information retrieved from all baseline participants. Only participants with a ETDRS (Early Treatment Diabetic Retinopathy Study) Best Corrected Visual Acuity letter score of 73 to 25 (= Acuity of 20/40 to 20/320) in the study eye at 4 meters were included; a higher score represents better functioning.|Letters correctly read|Mean|52.8|52.8|Standard Deviation|13.9|13.9|||
4248236|NCT00637377|4072997|B1|||Best Corrected Visual Acuity (BCVA), assessed by ETDRS chart|Information retrieved from all baseline participants. Only participants with a ETDRS (Early Treatment Diabetic Retinopathy Study) Best Corrected Visual Acuity letter score of 73 to 25 (= Acuity of 20/40 to 20/320) in the study eye at 4 meters were included; a higher score represents better functioning.|Letters correctly read|Mean|53.8|53.8|Standard Deviation|13.5|13.5|||
4248237|NCT00637377|4072993|B5|||Baseline total lesion size|Information retrieved from 1198/1202 baseline participants.|mm^2|Mean|8.28|8.28|Standard Deviation|5.82|5.82|||
4248238|NCT00637377|4072994|B4|||Baseline total lesion size|Information retrieved from 1198/1202 baseline participants.|mm^2|Mean|8.22|8.22|Standard Deviation|5.87|5.87|||
4248239|NCT00637377|4072995|B3|||Baseline total lesion size|Information retrieved from 1198/1202 baseline participants.|mm^2|Mean|8.17|8.17|Standard Deviation|5.51|5.51|||
4248240|NCT00637377|4072996|B2|||Baseline total lesion size|Information retrieved from 1198/1202 baseline participants.|mm^2|Mean|8.72|8.72|Standard Deviation|6.14|6.14|||
4248241|NCT00637377|4072997|B1|||Baseline total lesion size|Information retrieved from 1198/1202 baseline participants.|mm^2|Mean|8.01|8.01|Standard Deviation|5.74|5.74|||
4248242|NCT00637377|4072993|B5|Missing||Baseline lesion type|Information retrieved from 1197/1202 baseline participants.|participants|Number|5|5.0||||||
4248243|NCT00637377|4072994|B4|Missing||Baseline lesion type|Information retrieved from 1197/1202 baseline participants.|participants|Number|2|2.0||||||
4248244|NCT00637377|4072995|B3|Missing||Baseline lesion type|Information retrieved from 1197/1202 baseline participants.|participants|Number|0|0.0||||||
4248245|NCT00637377|4072996|B2|Missing||Baseline lesion type|Information retrieved from 1197/1202 baseline participants.|participants|Number|2|2.0||||||
4248246|NCT00637377|4072997|B1|Missing||Baseline lesion type|Information retrieved from 1197/1202 baseline participants.|participants|Number|1|1.0||||||
4248247|NCT00637377|4072993|B5|Occult||Baseline lesion type|Information retrieved from 1197/1202 baseline participants.|participants|Number|462|462.0||||||
4248248|NCT00637377|4072994|B4|Occult||Baseline lesion type|Information retrieved from 1197/1202 baseline participants.|participants|Number|110|110.0||||||
4248249|NCT00637377|4072995|B3|Occult||Baseline lesion type|Information retrieved from 1197/1202 baseline participants.|participants|Number|113|113.0||||||
4248250|NCT00637377|4072996|B2|Occult||Baseline lesion type|Information retrieved from 1197/1202 baseline participants.|participants|Number|123|123.0||||||
4248251|NCT00637377|4072997|B1|Occult||Baseline lesion type|Information retrieved from 1197/1202 baseline participants.|participants|Number|116|116.0||||||
4248252|NCT00637377|4072993|B5|Minimally classic||Baseline lesion type|Information retrieved from 1197/1202 baseline participants.|participants|Number|425|425.0||||||
4248253|NCT00637377|4072994|B4|Minimally classic||Baseline lesion type|Information retrieved from 1197/1202 baseline participants.|participants|Number|106|106.0||||||
4248254|NCT00637377|4072995|B3|Minimally classic||Baseline lesion type|Information retrieved from 1197/1202 baseline participants.|participants|Number|103|103.0||||||
4248255|NCT00637377|4072996|B2|Minimally classic||Baseline lesion type|Information retrieved from 1197/1202 baseline participants.|participants|Number|112|112.0||||||
4248256|NCT00637377|4072997|B1|Minimally classic||Baseline lesion type|Information retrieved from 1197/1202 baseline participants.|participants|Number|104|104.0||||||
4248257|NCT00637377|4072993|B5|Predominantly classic||Baseline lesion type|Information retrieved from 1197/1202 baseline participants.|participants|Number|310|310.0||||||
4248258|NCT00637377|4072994|B4|Predominantly classic||Baseline lesion type|Information retrieved from 1197/1202 baseline participants.|participants|Number|88|88.0||||||
4248259|NCT00637377|4072995|B3|Predominantly classic||Baseline lesion type|Information retrieved from 1197/1202 baseline participants.|participants|Number|80|80.0||||||
4248260|NCT00637377|4072996|B2|Predominantly classic||Baseline lesion type|Information retrieved from 1197/1202 baseline participants.|participants|Number|72|72.0||||||
4248261|NCT00637377|4072997|B1|Predominantly classic||Baseline lesion type|Information retrieved from 1197/1202 baseline participants.|participants|Number|70|70.0||||||
4248262|NCT00637377|4072993|B5|||Area of Choroidal Neovascularization (CNV)|Information retrieved from 1200/1202 baseline participants.|mm^2|Mean|7.83|7.83|Standard Deviation|5.48|5.48|||
4248263|NCT00637377|4072994|B4|||Area of Choroidal Neovascularization (CNV)|Information retrieved from 1200/1202 baseline participants.|mm^2|Mean|7.75|7.75|Standard Deviation|5.52|5.52|||
4248264|NCT00637377|4072995|B3|||Area of Choroidal Neovascularization (CNV)|Information retrieved from 1200/1202 baseline participants.|mm^2|Mean|7.70|7.7|Standard Deviation|5.26|5.26|||
4248265|NCT00637377|4072996|B2|||Area of Choroidal Neovascularization (CNV)|Information retrieved from 1200/1202 baseline participants.|mm^2|Mean|8.25|8.25|Standard Deviation|5.77|5.77|||
4248266|NCT00637377|4072997|B1|||Area of Choroidal Neovascularization (CNV)|Information retrieved from 1200/1202 baseline participants.|mm^2|Mean|7.59|7.59|Standard Deviation|5.34|5.34|||
4248267|NCT00637377|4072993|B5|||National Eye Institute 25-item Visual Function Questionnaire (NEI VFQ-25) total score|Information retrieved from 1201/1202 baseline participants. The possible range of the NEI VFQ-25 total score is between 0 (worst possible) and 100 (best possible).|scores on a scale|Mean|72.10|72.1|Standard Deviation|18.99|18.99|||
4248268|NCT00637377|4072994|B4|||National Eye Institute 25-item Visual Function Questionnaire (NEI VFQ-25) total score|Information retrieved from 1201/1202 baseline participants. The possible range of the NEI VFQ-25 total score is between 0 (worst possible) and 100 (best possible).|scores on a scale|Mean|71.30|71.3|Standard Deviation|19.06|19.06|||
4248269|NCT00637377|4072995|B3|||National Eye Institute 25-item Visual Function Questionnaire (NEI VFQ-25) total score|Information retrieved from 1201/1202 baseline participants. The possible range of the NEI VFQ-25 total score is between 0 (worst possible) and 100 (best possible).|scores on a scale|Mean|74.04|74.04|Standard Deviation|18.22|18.22|||
4248270|NCT00637377|4072996|B2|||National Eye Institute 25-item Visual Function Questionnaire (NEI VFQ-25) total score|Information retrieved from 1201/1202 baseline participants. The possible range of the NEI VFQ-25 total score is between 0 (worst possible) and 100 (best possible).|scores on a scale|Mean|70.27|70.27|Standard Deviation|19.41|19.41|||
4248271|NCT00637377|4072997|B1|||National Eye Institute 25-item Visual Function Questionnaire (NEI VFQ-25) total score|Information retrieved from 1201/1202 baseline participants. The possible range of the NEI VFQ-25 total score is between 0 (worst possible) and 100 (best possible).|scores on a scale|Mean|72.90|72.9|Standard Deviation|19.09|19.09|||
4248272|NCT00637377|4072993|B5|Missing||Race|Information retrieved from all baseline participants.|participants|Number|66|66.0||||||
4248273|NCT00637377|4072994|B4|Missing||Race|Information retrieved from all baseline participants.|participants|Number|18|18.0||||||
4248274|NCT00637377|4072995|B3|Missing||Race|Information retrieved from all baseline participants.|participants|Number|15|15.0||||||
4248275|NCT00637377|4072996|B2|Missing||Race|Information retrieved from all baseline participants.|participants|Number|16|16.0||||||
4248276|NCT00637377|4072997|B1|Missing||Race|Information retrieved from all baseline participants.|participants|Number|17|17.0||||||
4248327|NCT00637312|4073027|B2|||Age||years|Mean|45.6|45.6|Standard Deviation|9.1|9.1|||
4248277|NCT00637377|4072993|B5|Asian||Race|Information retrieved from all baseline participants.|participants|Number|257|257.0||||||
4248278|NCT00637377|4072994|B4|Asian||Race|Information retrieved from all baseline participants.|participants|Number|69|69.0||||||
4248279|NCT00637377|4072995|B3|Asian||Race|Information retrieved from all baseline participants.|participants|Number|61|61.0||||||
4248280|NCT00637377|4072996|B2|Asian||Race|Information retrieved from all baseline participants.|participants|Number|67|67.0||||||
4248281|NCT00637377|4072997|B1|Asian||Race|Information retrieved from all baseline participants.|participants|Number|60|60.0||||||
4248282|NCT00637377|4072993|B5|Black or African American||Race|Information retrieved from all baseline participants.|participants|Number|4|4.0||||||
4248283|NCT00637377|4072994|B4|Black or African American||Race|Information retrieved from all baseline participants.|participants|Number|2|2.0||||||
4248284|NCT00637377|4072995|B3|Black or African American||Race|Information retrieved from all baseline participants.|participants|Number|1|1.0||||||
4248285|NCT00637377|4072996|B2|Black or African American||Race|Information retrieved from all baseline participants.|participants|Number|0|0.0||||||
4248286|NCT00637377|4072997|B1|Black or African American||Race|Information retrieved from all baseline participants.|participants|Number|1|1.0||||||
4248287|NCT00637377|4072993|B5|White||Race|Information retrieved from all baseline participants.|participants|Number|875|875.0||||||
4248288|NCT00637377|4072994|B4|White||Race|Information retrieved from all baseline participants.|participants|Number|217|217.0||||||
4248289|NCT00637377|4072995|B3|White||Race|Information retrieved from all baseline participants.|participants|Number|219|219.0||||||
4248290|NCT00637377|4072996|B2|White||Race|Information retrieved from all baseline participants.|participants|Number|226|226.0||||||
4248291|NCT00637377|4072997|B1|White||Race|Information retrieved from all baseline participants.|participants|Number|213|213.0||||||
4248292|NCT00637377|4072993|B5|Hispanic or Latino||Ethnicity|Information retrieved from all baseline participants.|participants|Number|212|212.0||||||
4248293|NCT00637377|4072994|B4|Hispanic or Latino||Ethnicity|Information retrieved from all baseline participants.|participants|Number|55|55.0||||||
4248294|NCT00637377|4072995|B3|Hispanic or Latino||Ethnicity|Information retrieved from all baseline participants.|participants|Number|55|55.0||||||
4248295|NCT00637377|4072996|B2|Hispanic or Latino||Ethnicity|Information retrieved from all baseline participants.|participants|Number|50|50.0||||||
4248296|NCT00637377|4072997|B1|Hispanic or Latino||Ethnicity|Information retrieved from all baseline participants.|participants|Number|52|52.0||||||
4248297|NCT00637377|4072993|B5|Not Hispanic or Latino||Ethnicity|Information retrieved from all baseline participants.|participants|Number|990|990.0||||||
4248298|NCT00637377|4072994|B4|Not Hispanic or Latino||Ethnicity|Information retrieved from all baseline participants.|participants|Number|251|251.0||||||
4248299|NCT00637377|4072995|B3|Not Hispanic or Latino||Ethnicity|Information retrieved from all baseline participants.|participants|Number|241|241.0||||||
4248300|NCT00637377|4072996|B2|Not Hispanic or Latino||Ethnicity|Information retrieved from all baseline participants.|participants|Number|259|259.0||||||
4248301|NCT00637377|4072997|B1|Not Hispanic or Latino||Ethnicity|Information retrieved from all baseline participants.|participants|Number|239|239.0||||||
4248302|NCT00637377|4072993|B5||Male|Sex: Female, Male|Information retrieved from all baseline participants.|Participants|Count of Participants|535|535.0||||||
4248303|NCT00637377|4072994|B4||Male|Sex: Female, Male|Information retrieved from all baseline participants.|Participants|Count of Participants|131|131.0||||||
4248304|NCT00637377|4072995|B3||Male|Sex: Female, Male|Information retrieved from all baseline participants.|Participants|Count of Participants|149|149.0||||||
4248305|NCT00637377|4072996|B2||Male|Sex: Female, Male|Information retrieved from all baseline participants.|Participants|Count of Participants|133|133.0||||||
4248306|NCT00637377|4072997|B1||Male|Sex: Female, Male|Information retrieved from all baseline participants.|Participants|Count of Participants|122|122.0||||||
4248307|NCT00637377|4072993|B5||Female|Sex: Female, Male|Information retrieved from all baseline participants.|Participants|Count of Participants|667|667.0||||||
4248308|NCT00637377|4072994|B4||Female|Sex: Female, Male|Information retrieved from all baseline participants.|Participants|Count of Participants|175|175.0||||||
4248309|NCT00637377|4072995|B3||Female|Sex: Female, Male|Information retrieved from all baseline participants.|Participants|Count of Participants|147|147.0||||||
4248310|NCT00637377|4072996|B2||Female|Sex: Female, Male|Information retrieved from all baseline participants.|Participants|Count of Participants|176|176.0||||||
4248311|NCT00637377|4072997|B1||Female|Sex: Female, Male|Information retrieved from all baseline participants.|Participants|Count of Participants|169|169.0||||||
4248312|NCT00637377|4072993|B5|||Age||years|Mean|73.9|73.9|Standard Deviation|8.7|8.7|||
4248313|NCT00637377|4072994|B4|||Age||years|Mean|73.8|73.8|Standard Deviation|8.6|8.6|||
4248314|NCT00637377|4072995|B3|||Age||years|Mean|74.7|74.7|Standard Deviation|8.6|8.6|||
4248315|NCT00637377|4072996|B2|||Age||years|Mean|74.1|74.1|Standard Deviation|8.5|8.5|||
4248316|NCT00637377|4072997|B1|||Age||years|Mean|73.0|73.0|Standard Deviation|9.0|9.0|||
4248317|NCT00637312|4073026|B3|United States||Region of Enrollment||participants|Number|108|108.0||||||
4248318|NCT00637312|4073027|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
4248319|NCT00637312|4073028|B1|United States||Region of Enrollment||participants|Number|72|72.0||||||
4248320|NCT00637312|4073026|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4248321|NCT00637312|4073027|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4248322|NCT00637312|4073028|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4248323|NCT00637312|4073026|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4248324|NCT00637312|4073027|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4248325|NCT00637312|4073028|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4248326|NCT00637312|4073026|B3|||Age||years|Mean|43.9|43.9|Standard Deviation|8.7|8.7|||
4248328|NCT00637312|4073028|B1|||Age||years|Mean|43|43.0|Standard Deviation|8.5|8.5|||
4248329|NCT00637312|4073026|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4248330|NCT00637312|4073027|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4248331|NCT00637312|4073028|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4248332|NCT00637312|4073026|B3||Between 18 and 65 years|Age||Participants|Count of Participants|108|108.0||||||
4248333|NCT00637312|4073027|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4248334|NCT00637312|4073028|B1||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
4248335|NCT00637312|4073026|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248336|NCT00637312|4073027|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248337|NCT00637312|4073028|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248338|NCT00637299|4073035|B3|Italy||Region of Enrollment||participants|Number|20|20.0||||||
4248339|NCT00637299|4073036|B2|Italy||Region of Enrollment||participants|Number|10|10.0||||||
4248340|NCT00637299|4073037|B1|Italy||Region of Enrollment||participants|Number|10|10.0||||||
4248341|NCT00637299|4073035|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4248342|NCT00637299|4073036|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4248343|NCT00637299|4073037|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4248344|NCT00637299|4073035|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4248345|NCT00637299|4073036|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4248346|NCT00637299|4073037|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4248347|NCT00637299|4073035|B3|||Age||years|Mean|63.8|63.8|Standard Deviation|5.1|5.1|||
4248348|NCT00637299|4073036|B2|||Age||years|Mean|63.5|63.5|Standard Deviation|4.7|4.7|||
4248349|NCT00637299|4073037|B1|||Age||years|Mean|64.2|64.2|Standard Deviation|5.5|5.5|||
4248350|NCT00637299|4073035|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4248351|NCT00637299|4073036|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4248352|NCT00637299|4073037|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4248353|NCT00637299|4073035|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4248354|NCT00637299|4073036|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4248355|NCT00637299|4073037|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4248356|NCT00637299|4073035|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248357|NCT00637299|4073036|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248358|NCT00637299|4073037|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248359|NCT00637273|4073046|B4|||Weight||kg|Mean|88.0|88.0|Standard Deviation|20.08|20.08|||
4248360|NCT00637273|4073047|B3|||Weight||kg|Mean|87.9|87.9|Standard Deviation|20.49|20.49|||
4248361|NCT00637273|4073048|B2|||Weight||kg|Mean|87.0|87.0|Standard Deviation|20.25|20.25|||
4248362|NCT00637273|4073049|B1|||Weight||kg|Mean|89.1|89.1|Standard Deviation|19.55|19.55|||
4248363|NCT00637273|4073046|B4|||Glycosylated hemoglobin (HbA1c)||percentage of total hemoglobin|Mean|8.5|8.5|Standard Deviation|1.15|1.15|||
4248364|NCT00637273|4073047|B3|||Glycosylated hemoglobin (HbA1c)||percentage of total hemoglobin|Mean|8.5|8.5|Standard Deviation|1.08|1.08|||
4248365|NCT00637273|4073048|B2|||Glycosylated hemoglobin (HbA1c)||percentage of total hemoglobin|Mean|8.5|8.5|Standard Deviation|1.17|1.17|||
4248366|NCT00637273|4073049|B1|||Glycosylated hemoglobin (HbA1c)||percentage of total hemoglobin|Mean|8.6|8.6|Standard Deviation|1.20|1.2|||
4248367|NCT00637273|4073046|B4||Male|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
4248368|NCT00637273|4073047|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4248369|NCT00637273|4073048|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4248370|NCT00637273|4073049|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4248371|NCT00637273|4073046|B4||Female|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
4248372|NCT00637273|4073047|B3||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4248373|NCT00637273|4073048|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4248374|NCT00637273|4073049|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4248375|NCT00637273|4073046|B4|||Age||years|Mean|52.5|52.5|Standard Deviation|10.28|10.28|||
4248376|NCT00637273|4073047|B3|||Age||years|Mean|53.0|53.0|Standard Deviation|9.92|9.92|||
4248377|NCT00637273|4073048|B2|||Age||years|Mean|52.2|52.2|Standard Deviation|10.54|10.54|||
4248378|NCT00637273|4073049|B1|||Age||years|Mean|52.4|52.4|Standard Deviation|10.41|10.41|||
4248379|NCT00637273|4073046|B4||>=65 years|Age||Participants|Count of Participants|59|59.0||||||
4248380|NCT00637273|4073047|B3||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4248381|NCT00637273|4073048|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4248382|NCT00637273|4073049|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4248383|NCT00637273|4073046|B4||Between 18 and 65 years|Age||Participants|Count of Participants|432|432.0||||||
4248384|NCT00637273|4073047|B3||Between 18 and 65 years|Age||Participants|Count of Participants|143|143.0||||||
4248385|NCT00637273|4073048|B2||Between 18 and 65 years|Age||Participants|Count of Participants|149|149.0||||||
4248386|NCT00637273|4073049|B1||Between 18 and 65 years|Age||Participants|Count of Participants|140|140.0||||||
4248387|NCT00637273|4073046|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248388|NCT00637273|4073047|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248389|NCT00637273|4073048|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248390|NCT00637273|4073049|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248391|NCT00637247|4073092|B3|United States||Region of Enrollment||participants|Number|142|142.0||||||
4248392|NCT00637247|4073093|B2|United States||Region of Enrollment||participants|Number|70|70.0||||||
4248393|NCT00637247|4073094|B1|United States||Region of Enrollment||participants|Number|72|72.0||||||
4248394|NCT00637247|4073092|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4248395|NCT00637247|4073093|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4248396|NCT00637247|4073094|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4248397|NCT00637247|4073092|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4248398|NCT00637247|4073093|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4248399|NCT00637247|4073094|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4248400|NCT00637247|4073092|B3|||Age||years|Mean|65.5|65.5|Standard Deviation|10.8|10.8|||
4248401|NCT00637247|4073093|B2|||Age||years|Mean|64.9|64.9|Standard Deviation|11.1|11.1|||
4248402|NCT00637247|4073094|B1|||Age||years|Mean|66.1|66.1|Standard Deviation|10.6|10.6|||
4248403|NCT00637247|4073092|B3||>=65 years|Age||Participants|Count of Participants|77|77.0||||||
4248404|NCT00637247|4073093|B2||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4248405|NCT00637247|4073094|B1||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4248406|NCT00637247|4073092|B3||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4248407|NCT00637247|4073093|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4248408|NCT00637247|4073094|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4248409|NCT00637247|4073092|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248410|NCT00637247|4073093|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248411|NCT00637247|4073094|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248412|NCT00637195|4073105|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4248413|NCT00637195|4073106|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4248414|NCT00637195|4073107|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4248415|NCT00637195|4073105|B3||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4248416|NCT00637195|4073106|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4248417|NCT00637195|4073107|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4248418|NCT00637195|4073105|B3|||Age||years|Mean|22.3|22.3|Standard Deviation|1.42|1.42|||
4248419|NCT00637195|4073106|B2|||Age||years|Mean|22.1|22.1|Standard Deviation|1.32|1.32|||
4248420|NCT00637195|4073107|B1|||Age||years|Mean|22.4|22.4|Standard Deviation|1.51|1.51|||
4248421|NCT00637156|4073142|B3|No||Preoperative Work Status||participants|Number|138|138.0||||||
4248422|NCT00637156|4073143|B2|No||Preoperative Work Status||participants|Number|75|75.0||||||
4248423|NCT00637156|4073144|B1|No||Preoperative Work Status||participants|Number|63|63.0||||||
4248424|NCT00637156|4073142|B3|Yes||Preoperative Work Status||participants|Number|259|259.0||||||
4248425|NCT00637156|4073143|B2|Yes||Preoperative Work Status||participants|Number|113|113.0||||||
4248426|NCT00637156|4073144|B1|Yes||Preoperative Work Status||participants|Number|146|146.0||||||
4248427|NCT00637156|4073142|B3|No||Alcohol Used||participants|Number|193|193.0||||||
4248428|NCT00637156|4073143|B2|No||Alcohol Used||participants|Number|100|100.0||||||
4248429|NCT00637156|4073144|B1|No||Alcohol Used||participants|Number|93|93.0||||||
4248430|NCT00637156|4073142|B3|Yes||Alcohol Used||participants|Number|204|204.0||||||
4248431|NCT00637156|4073143|B2|Yes||Alcohol Used||participants|Number|88|88.0||||||
4248432|NCT00637156|4073144|B1|Yes||Alcohol Used||participants|Number|116|116.0||||||
4248433|NCT00637156|4073142|B3|No||Unresolved Spinal litigation||participants|Number|396|396.0||||||
4248434|NCT00637156|4073143|B2|No||Unresolved Spinal litigation||participants|Number|187|187.0||||||
4248435|NCT00637156|4073144|B1|No||Unresolved Spinal litigation||participants|Number|209|209.0||||||
4248436|NCT00637156|4073142|B3|Yes||Unresolved Spinal litigation||participants|Number|1|1.0||||||
4248437|NCT00637156|4073143|B2|Yes||Unresolved Spinal litigation||participants|Number|1|1.0||||||
4248438|NCT00637156|4073144|B1|Yes||Unresolved Spinal litigation||participants|Number|0|0.0||||||
4248439|NCT00637156|4073142|B3|No||Worker's Compensation||participants|Number|352|352.0||||||
4248440|NCT00637156|4073143|B2|No||Worker's Compensation||participants|Number|169|169.0||||||
4248441|NCT00637156|4073144|B1|No||Worker's Compensation||participants|Number|183|183.0||||||
4248442|NCT00637156|4073142|B3|Yes||Worker's Compensation||participants|Number|45|45.0||||||
4248443|NCT00637156|4073143|B2|Yes||Worker's Compensation||participants|Number|19|19.0||||||
4248444|NCT00637156|4073144|B1|Yes||Worker's Compensation||participants|Number|26|26.0||||||
4248445|NCT00637156|4073142|B3|>High school||Education Level||participants|Number|229|229.0||||||
4248446|NCT00637156|4073143|B2|>High school||Education Level||participants|Number|104|104.0||||||
4248447|NCT00637156|4073144|B1|>High school||Education Level||participants|Number|125|125.0||||||
4248448|NCT00637156|4073142|B3|High school||Education Level||participants|Number|127|127.0||||||
4248449|NCT00637156|4073143|B2|High school||Education Level||participants|Number|64|64.0||||||
4248450|NCT00637156|4073144|B1|High school||Education Level||participants|Number|63|63.0||||||
4248451|NCT00637156|4073142|B3|<High school||Education Level||participants|Number|41|41.0||||||
4248452|NCT00637156|4073143|B2|<High school||Education Level||participants|Number|20|20.0||||||
4248453|NCT00637156|4073144|B1|<High school||Education Level||participants|Number|21|21.0||||||
4248454|NCT00637156|4073142|B3|Widowed||Marital Status||participants|Number|3|3.0||||||
4248455|NCT00637156|4073143|B2|Widowed||Marital Status||participants|Number|1|1.0||||||
4248456|NCT00637156|4073144|B1|Widowed||Marital Status||participants|Number|2|2.0||||||
4248457|NCT00637156|4073142|B3|Separated||Marital Status||participants|Number|6|6.0||||||
4248458|NCT00637156|4073143|B2|Separated||Marital Status||participants|Number|2|2.0||||||
4248459|NCT00637156|4073144|B1|Separated||Marital Status||participants|Number|4|4.0||||||
4248460|NCT00637156|4073142|B3|Divorced||Marital Status||participants|Number|55|55.0||||||
4248461|NCT00637156|4073143|B2|Divorced||Marital Status||participants|Number|23|23.0||||||
4248462|NCT00637156|4073144|B1|Divorced||Marital Status||participants|Number|32|32.0||||||
4248463|NCT00637156|4073142|B3|Married||Marital Status||participants|Number|279|279.0||||||
4248464|NCT00637156|4073143|B2|Married||Marital Status||participants|Number|133|133.0||||||
4248465|NCT00637156|4073144|B1|Married||Marital Status||participants|Number|146|146.0||||||
4248466|NCT00637156|4073142|B3|Single||Marital Status||participants|Number|54|54.0||||||
4248467|NCT00637156|4073143|B2|Single||Marital Status||participants|Number|29|29.0||||||
4248468|NCT00637156|4073144|B1|Single||Marital Status||participants|Number|25|25.0||||||
4248469|NCT00637156|4073142|B3|||BMI||kg/m^2|Mean|28.4|28.4|Standard Deviation|5.3|5.3|||
4248470|NCT00637156|4073143|B2|||BMI||kg/m^2|Mean|28.6|28.6|Standard Deviation|4.9|4.9|||
4248471|NCT00637156|4073144|B1|||BMI||kg/m^2|Mean|28.2|28.2|Standard Deviation|5.6|5.6|||
4248472|NCT00637156|4073142|B3|||Weight||lbs|Mean|184.0|184.0|Standard Deviation|40.1|40.1|||
4248473|NCT00637156|4073143|B2|||Weight||lbs|Mean|186.3|186.3|Standard Deviation|37.2|37.2|||
4248474|NCT00637156|4073144|B1|||Weight||lbs|Mean|182.1|182.1|Standard Deviation|42.6|42.6|||
4248475|NCT00637156|4073142|B3|||Height||inches|Mean|67.4|67.4|Standard Deviation|3.9|3.9|||
4248476|NCT00637156|4073143|B2|||Height||inches|Mean|67.6|67.6|Standard Deviation|4.0|4.0|||
4248477|NCT00637156|4073144|B1|||Height||inches|Mean|67.2|67.2|Standard Deviation|3.9|3.9|||
4248478|NCT00637156|4073142|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4248479|NCT00637156|4073143|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4248480|NCT00637156|4073144|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4248481|NCT00637156|4073142|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4248482|NCT00637156|4073143|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4248483|NCT00637156|4073144|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4248484|NCT00637156|4073142|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4248485|NCT00637156|4073143|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4248486|NCT00637156|4073144|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4248487|NCT00637156|4073142|B3|Black||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4248488|NCT00637156|4073143|B2|Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4248489|NCT00637156|4073144|B1|Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4248490|NCT00637156|4073142|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|367|367.0||||||
4248491|NCT00637156|4073143|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|172|172.0||||||
4248492|NCT00637156|4073144|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|195|195.0||||||
4248493|NCT00637156|4073142|B3||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4248494|NCT00637156|4073143|B2||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4248495|NCT00637156|4073144|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4248496|NCT00637156|4073142|B3||Female|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
4248497|NCT00637156|4073143|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4248498|NCT00637156|4073144|B1||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4248499|NCT00637156|4073142|B3|||Age||years|Mean|47.2|47.2|Standard Deviation|8.0|8.0|||
4248500|NCT00637156|4073143|B2|||Age||years|Mean|47.3|47.3|Standard Deviation|7.7|7.7|||
4248501|NCT00637156|4073144|B1|||Age||years|Mean|47.1|47.1|Standard Deviation|8.3|8.3|||
4248502|NCT00637000|4073185|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
4248503|NCT00637000|4073186|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4248504|NCT00637000|4073187|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4248505|NCT00637000|4073185|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248506|NCT00637000|4073186|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248507|NCT00637000|4073187|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248508|NCT00637000|4073185|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248509|NCT00637000|4073186|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248510|NCT00637000|4073187|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248511|NCT00637000|4073185|B3||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4248512|NCT00637000|4073186|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4248513|NCT00637000|4073187|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4248514|NCT00637000|4073185|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4248515|NCT00637000|4073186|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4248516|NCT00637000|4073187|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4248575|NCT00636818|4073253|B1|Korea, Republic of||Region of Enrollment||participants|Number|17|17.0||||||
4248517|NCT00637000|4073185|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4248518|NCT00637000|4073186|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4248519|NCT00637000|4073187|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248520|NCT00637000|4073185|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248521|NCT00637000|4073186|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248522|NCT00637000|4073187|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248523|NCT00637000|4073185|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248524|NCT00637000|4073186|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248525|NCT00637000|4073187|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248526|NCT00637000|4073185|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248527|NCT00637000|4073186|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248528|NCT00637000|4073187|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248529|NCT00637000|4073185|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4248530|NCT00637000|4073186|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4248531|NCT00637000|4073187|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4248532|NCT00637000|4073185|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248533|NCT00637000|4073186|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248534|NCT00637000|4073187|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248535|NCT00637000|4073185|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4248536|NCT00637000|4073186|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4248537|NCT00637000|4073187|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4248538|NCT00637000|4073185|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4248539|NCT00637000|4073186|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4248540|NCT00637000|4073187|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4248541|NCT00637000|4073185|B3|||Age||years|Mean|40.2|40.2|Standard Deviation|8.9|8.9|||
4248542|NCT00637000|4073186|B2|||Age||years|Mean|40.2|40.2|Standard Deviation|7.9|7.9|||
4248543|NCT00637000|4073187|B1|||Age||years|Mean|40.2|40.2|Standard Deviation|10|10.0|||
4248544|NCT00637000|4073185|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4248545|NCT00637000|4073186|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4248546|NCT00637000|4073187|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4248547|NCT00637000|4073185|B3||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4248548|NCT00637000|4073186|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4248549|NCT00637000|4073187|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4248550|NCT00637000|4073185|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248551|NCT00637000|4073186|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248552|NCT00637000|4073187|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248553|NCT00636987|4073228|B1|United States||Region of Enrollment||participants|Number|297|297.0||||||
4248554|NCT00636987|4073228|B1||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4248555|NCT00636987|4073228|B1||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4248556|NCT00636987|4073228|B1|||Age||years|Mean|72.2|72.2|Standard Deviation|9.4|9.4|||
4248557|NCT00636961|4073236|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4248558|NCT00636961|4073237|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4248559|NCT00636961|4073238|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4248560|NCT00636961|4073236|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4248561|NCT00636961|4073237|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4248562|NCT00636961|4073238|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4248563|NCT00636961|4073236|B3|||Age|Baseline measurements are based on total randomized patients.|years|Mean|61.3|61.3|Standard Deviation|7.22|7.22|||
4248564|NCT00636961|4073237|B2|||Age|Baseline measurements are based on total randomized patients.|years|Mean|59.8|59.8|Standard Deviation|5.81|5.81|||
4248565|NCT00636961|4073238|B1|||Age|Baseline measurements are based on total randomized patients.|years|Mean|62.6|62.6|Standard Deviation|8.30|8.3|||
4248566|NCT00636818|4073253|B1|||Weight||kilograms (kg)|Mean|64.53|64.53|Standard Deviation|9.27|9.27|||
4248567|NCT00636818|4073253|B1|||Height||centimeters (cm)|Mean|168.98|168.98|Standard Deviation|6.04|6.04|||
4248568|NCT00636818|4073253|B1|East Asian||Race/Ethnicity||participants|Number|44|44.0||||||
4248569|NCT00636818|4073253|B1|Unknown||Prior Stimulant Exposure||participants|Number|1|1.0||||||
4248570|NCT00636818|4073253|B1|Yes||Prior Stimulant Exposure||participants|Number|13|13.0||||||
4248571|NCT00636818|4073253|B1|No||Prior Stimulant Exposure||participants|Number|30|30.0||||||
4248572|NCT00636818|4073253|B1|Mixed||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype||participants|Number|17|17.0||||||
4248573|NCT00636818|4073253|B1|Hyperactive/Impulsive||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype||participants|Number|2|2.0||||||
4248574|NCT00636818|4073253|B1|Inattentive||Attention-Deficit/Hyperactivity Disorder (ADHD) Subtype||participants|Number|25|25.0||||||
4248576|NCT00636818|4073253|B1|China||Region of Enrollment||participants|Number|15|15.0||||||
4248577|NCT00636818|4073253|B1|Taiwan||Region of Enrollment||participants|Number|12|12.0||||||
4248578|NCT00636818|4073253|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4248579|NCT00636818|4073253|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4248580|NCT00636818|4073253|B1|||Age||years|Mean|28.24|28.24|Standard Deviation|9.02|9.02|||
4248581|NCT00636805|4073268|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4248582|NCT00636805|4073268|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4248583|NCT00636805|4073268|B1|||Age||years|Mean|53.2|53.2|Standard Deviation|13.1|13.1|||
4248584|NCT00636792|4073278|B1|United States||Region of Enrollment||participants|Number|73|73.0||||||
4248585|NCT00636792|4073278|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4248586|NCT00636792|4073278|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4248587|NCT00636792|4073278|B1|||Age||years|Mean|59.8|59.8|Standard Deviation|10.36|10.36|||
4248588|NCT00636792|4073278|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4248589|NCT00636792|4073278|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4248590|NCT00636792|4073278|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248591|NCT00636701|4073283|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4248592|NCT00636701|4073284|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4248593|NCT00636701|4073285|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4248594|NCT00636701|4073283|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4248595|NCT00636701|4073284|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4248596|NCT00636701|4073285|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4248597|NCT00636701|4073283|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4248598|NCT00636701|4073284|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4248599|NCT00636701|4073285|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4248600|NCT00636701|4073283|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4248601|NCT00636701|4073284|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4248602|NCT00636701|4073285|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4248603|NCT00636701|4073283|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4248604|NCT00636701|4073284|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4248605|NCT00636701|4073285|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4248606|NCT00636701|4073283|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248607|NCT00636701|4073284|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248608|NCT00636701|4073285|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248609|NCT00636675|4073292|B3|United States||Region of Enrollment||Participants|Count of Participants|1401|1401.0||||||
4248610|NCT00636675|4073293|B2|United States||Region of Enrollment||Participants|Count of Participants|658|658.0||||||
4248611|NCT00636675|4073294|B1|United States||Region of Enrollment||Participants|Count of Participants|743|743.0||||||
4248612|NCT00636675|4073292|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
4248613|NCT00636675|4073293|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4248614|NCT00636675|4073294|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4248615|NCT00636675|4073292|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4248616|NCT00636675|4073293|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4248617|NCT00636675|4073294|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4248618|NCT00636675|4073292|B3||White|Race (NIH/OMB)||Participants|Count of Participants|612|612.0||||||
4248619|NCT00636675|4073293|B2||White|Race (NIH/OMB)||Participants|Count of Participants|296|296.0||||||
4248620|NCT00636675|4073294|B1||White|Race (NIH/OMB)||Participants|Count of Participants|316|316.0||||||
4248621|NCT00636675|4073292|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|618|618.0||||||
4248622|NCT00636675|4073293|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|281|281.0||||||
4248623|NCT00636675|4073294|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|337|337.0||||||
4248624|NCT00636675|4073292|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4248625|NCT00636675|4073293|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4248626|NCT00636675|4073294|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248627|NCT00636675|4073292|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4248628|NCT00636675|4073293|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4248629|NCT00636675|4073294|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4248630|NCT00636675|4073292|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4248631|NCT00636675|4073293|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4248632|NCT00636675|4073294|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4248633|NCT00636675|4073292|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
4248634|NCT00636675|4073293|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4248635|NCT00636675|4073294|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4248636|NCT00636675|4073292|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1280|1280.0||||||
4248637|NCT00636675|4073293|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|599|599.0||||||
4248638|NCT00636675|4073294|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|681|681.0||||||
4248639|NCT00636675|4073292|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4248640|NCT00636675|4073293|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4248641|NCT00636675|4073294|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4248642|NCT00636675|4073292|B3||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4248643|NCT00636675|4073293|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4248644|NCT00636675|4073294|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4248645|NCT00636675|4073292|B3||Female|Sex: Female, Male||Participants|Count of Participants|1154|1154.0||||||
4248646|NCT00636675|4073293|B2||Female|Sex: Female, Male||Participants|Count of Participants|554|554.0||||||
4248647|NCT00636675|4073294|B1||Female|Sex: Female, Male||Participants|Count of Participants|600|600.0||||||
4248648|NCT00636675|4073292|B3|Age|>=65 years|Age||Participants|Count of Participants|253|253.0||||||
4248649|NCT00636675|4073293|B2|Age|>=65 years|Age||Participants|Count of Participants|137|137.0||||||
4248650|NCT00636675|4073294|B1|Age|>=65 years|Age||Participants|Count of Participants|116|116.0||||||
4248651|NCT00636675|4073292|B3|Age|Between 18 and 65 years|Age||Participants|Count of Participants|1124|1124.0||||||
4248652|NCT00636675|4073293|B2|Age|Between 18 and 65 years|Age||Participants|Count of Participants|509|509.0||||||
4248653|NCT00636675|4073294|B1|Age|Between 18 and 65 years|Age||Participants|Count of Participants|615|615.0||||||
4248654|NCT00636675|4073292|B3|Age|<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248655|NCT00636675|4073293|B2|Age|<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248656|NCT00636675|4073294|B1|Age|<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248657|NCT00636649|4073305|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4248658|NCT00636649|4073306|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4248659|NCT00636649|4073307|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4248660|NCT00636649|4073305|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4248661|NCT00636649|4073306|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4248662|NCT00636649|4073307|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4248663|NCT00636649|4073305|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4248664|NCT00636649|4073306|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4248665|NCT00636649|4073307|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4248666|NCT00636649|4073305|B3|||Age||years|Mean|45.0|45.0|Standard Deviation|13.0|13.0|||
4248667|NCT00636649|4073306|B2|||Age||years|Mean|44.8|44.8|Standard Deviation|12.3|12.3|||
4248668|NCT00636649|4073307|B1|||Age||years|Mean|45.2|45.2|Standard Deviation|13.7|13.7|||
4248669|NCT00636649|4073305|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4248670|NCT00636649|4073306|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4248671|NCT00636649|4073307|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4248672|NCT00636649|4073305|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4248673|NCT00636649|4073306|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4248674|NCT00636649|4073307|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4248675|NCT00636649|4073305|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248676|NCT00636649|4073306|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248677|NCT00636649|4073307|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248678|NCT00636636|4073336|B3|Other||Race/Ethnicity, Customized||Participants|Number|31|31.0||||||
4248679|NCT00636636|4073337|B2|Other||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4248680|NCT00636636|4073338|B1|Other||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4248681|NCT00636636|4073336|B3|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4248682|NCT00636636|4073337|B2|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4248683|NCT00636636|4073338|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4248684|NCT00636636|4073336|B3|Black||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4248685|NCT00636636|4073337|B2|Black||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4248686|NCT00636636|4073338|B1|Black||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4248687|NCT00636636|4073336|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|400|400.0||||||
4248688|NCT00636636|4073337|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|204|204.0||||||
4248689|NCT00636636|4073338|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|196|196.0||||||
4248690|NCT00636636|4073336|B3||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4248691|NCT00636636|4073337|B2||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4248692|NCT00636636|4073338|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4248693|NCT00636636|4073336|B3||Female|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
4248694|NCT00636636|4073337|B2||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4248695|NCT00636636|4073338|B1||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4248696|NCT00636636|4073336|B3|>=75 years||Age, Customized|Of the 452 subjects randomized, 2 subjects were excluded from the intent-to-treat (ITT) population: 1 subject had no baseline data recorded, and 1 subject was randomized twice. Baseline demographics were calculated on the ITT population of 450 participants.|participants|Number|112|112.0||||||
4248697|NCT00636636|4073337|B2|>=75 years||Age, Customized|Of the 452 subjects randomized, 2 subjects were excluded from the intent-to-treat (ITT) population: 1 subject had no baseline data recorded, and 1 subject was randomized twice. Baseline demographics were calculated on the ITT population of 450 participants.|participants|Number|55|55.0||||||
4248698|NCT00636636|4073338|B1|>=75 years||Age, Customized|Of the 452 subjects randomized, 2 subjects were excluded from the intent-to-treat (ITT) population: 1 subject had no baseline data recorded, and 1 subject was randomized twice. Baseline demographics were calculated on the ITT population of 450 participants.|participants|Number|57|57.0||||||
4248699|NCT00636636|4073336|B3|65 to 74 years||Age, Customized|Of the 452 subjects randomized, 2 subjects were excluded from the intent-to-treat (ITT) population: 1 subject had no baseline data recorded, and 1 subject was randomized twice. Baseline demographics were calculated on the ITT population of 450 participants.|participants|Number|168|168.0||||||
4248700|NCT00636636|4073337|B2|65 to 74 years||Age, Customized|Of the 452 subjects randomized, 2 subjects were excluded from the intent-to-treat (ITT) population: 1 subject had no baseline data recorded, and 1 subject was randomized twice. Baseline demographics were calculated on the ITT population of 450 participants.|participants|Number|86|86.0||||||
4248701|NCT00636636|4073338|B1|65 to 74 years||Age, Customized|Of the 452 subjects randomized, 2 subjects were excluded from the intent-to-treat (ITT) population: 1 subject had no baseline data recorded, and 1 subject was randomized twice. Baseline demographics were calculated on the ITT population of 450 participants.|participants|Number|82|82.0||||||
4248702|NCT00636636|4073336|B3|<65 years||Age, Customized|Of the 452 subjects randomized, 2 subjects were excluded from the intent-to-treat (ITT) population: 1 subject had no baseline data recorded, and 1 subject was randomized twice. Baseline demographics were calculated on the ITT population of 450 participants.|participants|Number|170|170.0||||||
4248703|NCT00636636|4073337|B2|<65 years||Age, Customized|Of the 452 subjects randomized, 2 subjects were excluded from the intent-to-treat (ITT) population: 1 subject had no baseline data recorded, and 1 subject was randomized twice. Baseline demographics were calculated on the ITT population of 450 participants.|participants|Number|89|89.0||||||
4248704|NCT00636636|4073338|B1|<65 years||Age, Customized|Of the 452 subjects randomized, 2 subjects were excluded from the intent-to-treat (ITT) population: 1 subject had no baseline data recorded, and 1 subject was randomized twice. Baseline demographics were calculated on the ITT population of 450 participants.|participants|Number|81|81.0||||||
4248705|NCT00636636|4073336|B3|||Age||years|Mean|65.6|65.6|Standard Deviation|12.2|12.2|||
4248706|NCT00636636|4073337|B2|||Age||years|Mean|65.9|65.9|Standard Deviation|11.1|11.1|||
4248707|NCT00636636|4073338|B1|||Age||years|Mean|65.3|65.3|Standard Deviation|13.3|13.3|||
4248708|NCT00636610|4073353|B3||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4248709|NCT00636610|4073354|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4248710|NCT00636610|4073355|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4248711|NCT00636610|4073353|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4248712|NCT00636610|4073354|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4248713|NCT00636610|4073355|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4248714|NCT00636610|4073353|B3|||Age||years|Mean|60.6|60.6|Standard Deviation|10.7|10.7|||
4248715|NCT00636610|4073354|B2|||Age||years|Mean|60.4|60.4|Standard Deviation|11.0|11.0|||
4248716|NCT00636610|4073355|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|10.4|10.4|||
4248717|NCT00636441|4073366|B8|United States||Region of Enrollment||participants|Number|56|56.0||||||
4248718|NCT00636441|4073367|B7|United States||Region of Enrollment||participants|Number|18|18.0||||||
4248719|NCT00636441|4073368|B6|United States||Region of Enrollment||participants|Number|7|7.0||||||
4248720|NCT00636441|4073369|B5|United States||Region of Enrollment||participants|Number|6|6.0||||||
4248721|NCT00636441|4073370|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
4248722|NCT00636441|4073371|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4248723|NCT00636441|4073372|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4248724|NCT00636441|4073373|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4248725|NCT00636441|4073366|B8||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4248726|NCT00636441|4073367|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4248727|NCT00636441|4073368|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4248728|NCT00636441|4073369|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4248729|NCT00636441|4073370|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4248730|NCT00636441|4073371|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4248731|NCT00636441|4073372|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4248732|NCT00636441|4073373|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4248733|NCT00636441|4073366|B8||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4248734|NCT00636441|4073367|B7||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4248735|NCT00636441|4073368|B6||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4248736|NCT00636441|4073369|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4248737|NCT00636441|4073370|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4248738|NCT00636441|4073371|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4248739|NCT00636441|4073372|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4248740|NCT00636441|4073373|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4248741|NCT00636441|4073366|B8|||Age||years|Median|52.4|52.4|Standard Deviation|10.5|10.5|||
4248742|NCT00636441|4073367|B7|||Age||years|Median|52.5|52.5|Standard Deviation|13.0|13.0|||
4248743|NCT00636441|4073368|B6|||Age||years|Median|58.9|58.9|Standard Deviation|12.9|12.9|||
4248744|NCT00636441|4073369|B5|||Age||years|Median|53.5|53.5|Standard Deviation|6.7|6.7|||
4248745|NCT00636441|4073370|B4|||Age||years|Median|48.8|48.8|Standard Deviation|9.1|9.1|||
4248746|NCT00636441|4073371|B3|||Age||years|Median|52.6|52.6|Standard Deviation|8.0|8.0|||
4248747|NCT00636441|4073372|B2|||Age||years|Median|51.2|51.2|Standard Deviation|7.3|7.3|||
4248748|NCT00636441|4073373|B1|||Age||years|Median|48.6|48.6|Standard Deviation|8.7|8.7|||
4248749|NCT00636389|4073408|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4248750|NCT00636389|4073408|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4248751|NCT00636389|4073408|B1|||Age||years|Mean|50.2|50.2|Standard Deviation|9.1|9.1|||
4248752|NCT00636389|4073408|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4248753|NCT00636389|4073408|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4248754|NCT00636389|4073408|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248755|NCT00636363|4073419|B4|United States||Region of Enrollment||participants|Number|535|535.0||||||
4248756|NCT00636363|4073420|B3|United States||Region of Enrollment||participants|Number|181|181.0||||||
4248757|NCT00636363|4073421|B2|United States||Region of Enrollment||participants|Number|176|176.0||||||
4248758|NCT00636363|4073422|B1|United States||Region of Enrollment||participants|Number|178|178.0||||||
4248759|NCT00636363|4073419|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248760|NCT00636363|4073420|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248761|NCT00636363|4073421|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248762|NCT00636363|4073422|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248763|NCT00636363|4073419|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|514|514.0||||||
4248764|NCT00636363|4073420|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|174|174.0||||||
4248765|NCT00636363|4073421|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|172|172.0||||||
4248766|NCT00636363|4073422|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|168|168.0||||||
4248767|NCT00636363|4073419|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4248768|NCT00636363|4073420|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4248769|NCT00636363|4073421|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4248770|NCT00636363|4073422|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4248771|NCT00636363|4073419|B4||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4248772|NCT00636363|4073420|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4248773|NCT00636363|4073421|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4248774|NCT00636363|4073422|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4248775|NCT00636363|4073419|B4||Female|Sex: Female, Male||Participants|Count of Participants|383|383.0||||||
4248776|NCT00636363|4073420|B3||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4248777|NCT00636363|4073421|B2||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4248778|NCT00636363|4073422|B1||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4248779|NCT00636363|4073419|B4|18-66 years of age||Age, Customized||Participants|Number|535|535.0||||||
4248780|NCT00636363|4073420|B3|18-66 years of age||Age, Customized||Participants|Number|181|181.0||||||
4248781|NCT00636363|4073421|B2|18-66 years of age||Age, Customized||Participants|Number|176|176.0||||||
4248782|NCT00636363|4073422|B1|18-66 years of age||Age, Customized||Participants|Number|178|178.0||||||
4248783|NCT00636220|4073438|B1|||Participants with known HIV reactivity|participants with known HIV reactivity|Participants|Number|101|101.0||||||
4248784|NCT00636220|4073438|B1|||Fresh Oral Fluid Samples with known HIV reactivity|Fresh Oral Fluid samples were collected from participants with known HIV+ status. HIV reactivity was clinically or serologically confirmed.|samples|Number|101|101.0||||||
4248785|NCT00636220|4073438|B1|United States||Region of Enrollment||participants|Number|101|101.0||||||
4248786|NCT00636220|4073438|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4248787|NCT00636220|4073438|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4248788|NCT00636220|4073438|B1|||Age||years|Mean|46|46.0|Standard Deviation|7.1|7.1|||
4248789|NCT00636220|4073438|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4248790|NCT00636220|4073438|B1||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
4248791|NCT00636220|4073438|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248792|NCT00636207|4073442|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4248793|NCT00636207|4073443|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4248794|NCT00636207|4073444|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4248795|NCT00636207|4073445|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4248796|NCT00636207|4073442|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4248797|NCT00636207|4073443|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4248798|NCT00636207|4073444|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4248799|NCT00636207|4073445|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4248800|NCT00636207|4073442|B4|||Age||years|Mean|33.8|33.8|Standard Deviation|11.78|11.78|||
4248801|NCT00636207|4073443|B3|||Age||years|Mean|36.3|36.3|Standard Deviation|10.32|10.32|||
4248802|NCT00636207|4073444|B2|||Age||years|Mean|31.0|31.0|Standard Deviation|12.68|12.68|||
4248803|NCT00636207|4073445|B1|||Age||years|Mean|37.4|37.4|Standard Deviation|10.45|10.45|||
4248804|NCT00636194|4073513|B3|Asian||Race/Ethnicity, Customized||participants|Number|350|350.0||||||
4248805|NCT00636194|4073514|B2|Asian||Race/Ethnicity, Customized||participants|Number|175|175.0||||||
4248806|NCT00636194|4073515|B1|Asian||Race/Ethnicity, Customized||participants|Number|175|175.0||||||
4248807|NCT00636194|4073513|B3||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4248808|NCT00636194|4073514|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4248809|NCT00636194|4073515|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4248810|NCT00636194|4073513|B3||Female|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
4248811|NCT00636194|4073514|B2||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4248812|NCT00636194|4073515|B1||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4248813|NCT00636194|4073513|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4248814|NCT00636194|4073514|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4248815|NCT00636194|4073515|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4248816|NCT00636194|4073513|B3||Between 18 and 65 years|Age||Participants|Count of Participants|350|350.0||||||
4248817|NCT00636194|4073514|B2||Between 18 and 65 years|Age||Participants|Count of Participants|175|175.0||||||
4248818|NCT00636194|4073515|B1||Between 18 and 65 years|Age||Participants|Count of Participants|175|175.0||||||
4248819|NCT00636194|4073513|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248820|NCT00636194|4073514|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248821|NCT00636194|4073515|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248822|NCT00636168|4073526|B3|Macroscopic||Lymph Node Involvement|AJCC classification of regional lymph nodes: Clinically occult (microscopic) metastasis and Clinically palpable (macroscopic) metastasis.|participants|Number|548|548.0||||||
4248823|NCT00636168|4073527|B2|Macroscopic||Lymph Node Involvement|AJCC classification of regional lymph nodes: Clinically occult (microscopic) metastasis and Clinically palpable (macroscopic) metastasis.|participants|Number|283|283.0||||||
4248824|NCT00636168|4073528|B1|Macroscopic||Lymph Node Involvement|AJCC classification of regional lymph nodes: Clinically occult (microscopic) metastasis and Clinically palpable (macroscopic) metastasis.|participants|Number|265|265.0||||||
4248825|NCT00636168|4073526|B3|Microscopic||Lymph Node Involvement|AJCC classification of regional lymph nodes: Clinically occult (microscopic) metastasis and Clinically palpable (macroscopic) metastasis.|participants|Number|403|403.0||||||
4248826|NCT00636168|4073527|B2|Microscopic||Lymph Node Involvement|AJCC classification of regional lymph nodes: Clinically occult (microscopic) metastasis and Clinically palpable (macroscopic) metastasis.|participants|Number|193|193.0||||||
4248827|NCT00636168|4073528|B1|Microscopic||Lymph Node Involvement|AJCC classification of regional lymph nodes: Clinically occult (microscopic) metastasis and Clinically palpable (macroscopic) metastasis.|participants|Number|210|210.0||||||
4248828|NCT00636168|4073526|B3|N3||Category of Regional Lymph Node Classification|AJCC classification of regional lymph nodes: NX=Cannot be assessed; N0=No lymph node metastasis; N1=Metastasis to 1 lymph node; N2=Metastasis to 2 or 3 nodes or intralymphatic regional metastasis without nodal metastases; N3=Metastasis in more than 4 regional nodes, or matted lymph nodes, or intransit metastasis or satellite(s) with metastatic regional node(s)|participants|Number|193|193.0||||||
4248829|NCT00636168|4073527|B2|N3||Category of Regional Lymph Node Classification|AJCC classification of regional lymph nodes: NX=Cannot be assessed; N0=No lymph node metastasis; N1=Metastasis to 1 lymph node; N2=Metastasis to 2 or 3 nodes or intralymphatic regional metastasis without nodal metastases; N3=Metastasis in more than 4 regional nodes, or matted lymph nodes, or intransit metastasis or satellite(s) with metastatic regional node(s)|participants|Number|98|98.0||||||
4248830|NCT00636168|4073528|B1|N3||Category of Regional Lymph Node Classification|AJCC classification of regional lymph nodes: NX=Cannot be assessed; N0=No lymph node metastasis; N1=Metastasis to 1 lymph node; N2=Metastasis to 2 or 3 nodes or intralymphatic regional metastasis without nodal metastases; N3=Metastasis in more than 4 regional nodes, or matted lymph nodes, or intransit metastasis or satellite(s) with metastatic regional node(s)|participants|Number|95|95.0||||||
4248831|NCT00636168|4073526|B3|N2||Category of Regional Lymph Node Classification|AJCC classification of regional lymph nodes: NX=Cannot be assessed; N0=No lymph node metastasis; N1=Metastasis to 1 lymph node; N2=Metastasis to 2 or 3 nodes or intralymphatic regional metastasis without nodal metastases; N3=Metastasis in more than 4 regional nodes, or matted lymph nodes, or intransit metastasis or satellite(s) with metastatic regional node(s)|participants|Number|321|321.0||||||
4248832|NCT00636168|4073527|B2|N2||Category of Regional Lymph Node Classification|AJCC classification of regional lymph nodes: NX=Cannot be assessed; N0=No lymph node metastasis; N1=Metastasis to 1 lymph node; N2=Metastasis to 2 or 3 nodes or intralymphatic regional metastasis without nodal metastases; N3=Metastasis in more than 4 regional nodes, or matted lymph nodes, or intransit metastasis or satellite(s) with metastatic regional node(s)|participants|Number|158|158.0||||||
4248833|NCT00636168|4073528|B1|N2||Category of Regional Lymph Node Classification|AJCC classification of regional lymph nodes: NX=Cannot be assessed; N0=No lymph node metastasis; N1=Metastasis to 1 lymph node; N2=Metastasis to 2 or 3 nodes or intralymphatic regional metastasis without nodal metastases; N3=Metastasis in more than 4 regional nodes, or matted lymph nodes, or intransit metastasis or satellite(s) with metastatic regional node(s)|participants|Number|163|163.0||||||
4248834|NCT00636168|4073526|B3|N1||Category of Regional Lymph Node Classification|AJCC classification of regional lymph nodes: NX=Cannot be assessed; N0=No lymph node metastasis; N1=Metastasis to 1 lymph node; N2=Metastasis to 2 or 3 nodes or intralymphatic regional metastasis without nodal metastases; N3=Metastasis in more than 4 regional nodes, or matted lymph nodes, or intransit metastasis or satellite(s) with metastatic regional node(s)|participants|Number|437|437.0||||||
4248835|NCT00636168|4073527|B2|N1||Category of Regional Lymph Node Classification|AJCC classification of regional lymph nodes: NX=Cannot be assessed; N0=No lymph node metastasis; N1=Metastasis to 1 lymph node; N2=Metastasis to 2 or 3 nodes or intralymphatic regional metastasis without nodal metastases; N3=Metastasis in more than 4 regional nodes, or matted lymph nodes, or intransit metastasis or satellite(s) with metastatic regional node(s)|participants|Number|220|220.0||||||
4248836|NCT00636168|4073528|B1|N1||Category of Regional Lymph Node Classification|AJCC classification of regional lymph nodes: NX=Cannot be assessed; N0=No lymph node metastasis; N1=Metastasis to 1 lymph node; N2=Metastasis to 2 or 3 nodes or intralymphatic regional metastasis without nodal metastases; N3=Metastasis in more than 4 regional nodes, or matted lymph nodes, or intransit metastasis or satellite(s) with metastatic regional node(s)|participants|Number|217|217.0||||||
4248837|NCT00636168|4073526|B3|N0||Category of Regional Lymph Node Classification|AJCC classification of regional lymph nodes: NX=Cannot be assessed; N0=No lymph node metastasis; N1=Metastasis to 1 lymph node; N2=Metastasis to 2 or 3 nodes or intralymphatic regional metastasis without nodal metastases; N3=Metastasis in more than 4 regional nodes, or matted lymph nodes, or intransit metastasis or satellite(s) with metastatic regional node(s)|participants|Number|0|0.0||||||
4248838|NCT00636168|4073527|B2|N0||Category of Regional Lymph Node Classification|AJCC classification of regional lymph nodes: NX=Cannot be assessed; N0=No lymph node metastasis; N1=Metastasis to 1 lymph node; N2=Metastasis to 2 or 3 nodes or intralymphatic regional metastasis without nodal metastases; N3=Metastasis in more than 4 regional nodes, or matted lymph nodes, or intransit metastasis or satellite(s) with metastatic regional node(s)|participants|Number|0|0.0||||||
4248839|NCT00636168|4073528|B1|N0||Category of Regional Lymph Node Classification|AJCC classification of regional lymph nodes: NX=Cannot be assessed; N0=No lymph node metastasis; N1=Metastasis to 1 lymph node; N2=Metastasis to 2 or 3 nodes or intralymphatic regional metastasis without nodal metastases; N3=Metastasis in more than 4 regional nodes, or matted lymph nodes, or intransit metastasis or satellite(s) with metastatic regional node(s)|participants|Number|0|0.0||||||
4248840|NCT00636168|4073526|B3|Ulceration Unknown||Ulceration of Primary Tumor|Ulceration of the primary tumor is taken into consideration in determining what Tumor Node Metastasis (TMN) stage a tumor is classified.|participants|Number|50|50.0||||||
4248841|NCT00636168|4073527|B2|Ulceration Unknown||Ulceration of Primary Tumor|Ulceration of the primary tumor is taken into consideration in determining what Tumor Node Metastasis (TMN) stage a tumor is classified.|participants|Number|29|29.0||||||
4248842|NCT00636168|4073528|B1|Ulceration Unknown||Ulceration of Primary Tumor|Ulceration of the primary tumor is taken into consideration in determining what Tumor Node Metastasis (TMN) stage a tumor is classified.|participants|Number|21|21.0||||||
4248843|NCT00636168|4073526|B3|Ulceration Present||Ulceration of Primary Tumor|Ulceration of the primary tumor is taken into consideration in determining what Tumor Node Metastasis (TMN) stage a tumor is classified.|participants|Number|400|400.0||||||
4248844|NCT00636168|4073527|B2|Ulceration Present||Ulceration of Primary Tumor|Ulceration of the primary tumor is taken into consideration in determining what Tumor Node Metastasis (TMN) stage a tumor is classified.|participants|Number|203|203.0||||||
4248845|NCT00636168|4073528|B1|Ulceration Present||Ulceration of Primary Tumor|Ulceration of the primary tumor is taken into consideration in determining what Tumor Node Metastasis (TMN) stage a tumor is classified.|participants|Number|197|197.0||||||
4248846|NCT00636168|4073526|B3|Ulceration Absent||Ulceration of Primary Tumor|Ulceration of the primary tumor is taken into consideration in determining what Tumor Node Metastasis (TMN) stage a tumor is classified.|participants|Number|501|501.0||||||
4248847|NCT00636168|4073527|B2|Ulceration Absent||Ulceration of Primary Tumor|Ulceration of the primary tumor is taken into consideration in determining what Tumor Node Metastasis (TMN) stage a tumor is classified.|participants|Number|244|244.0||||||
4248848|NCT00636168|4073528|B1|Ulceration Absent||Ulceration of Primary Tumor|Ulceration of the primary tumor is taken into consideration in determining what Tumor Node Metastasis (TMN) stage a tumor is classified.|participants|Number|257|257.0||||||
4248849|NCT00636168|4073526|B3|Not Reported||Breslow's Thickness|Breslow's Thickness is a measure of the vertical thickness of a cutaneous melanoma lesion and is reported in millimeters (mm).|participants|Number|44|44.0||||||
4248850|NCT00636168|4073527|B2|Not Reported||Breslow's Thickness|Breslow's Thickness is a measure of the vertical thickness of a cutaneous melanoma lesion and is reported in millimeters (mm).|participants|Number|27|27.0||||||
4248851|NCT00636168|4073528|B1|Not Reported||Breslow's Thickness|Breslow's Thickness is a measure of the vertical thickness of a cutaneous melanoma lesion and is reported in millimeters (mm).|participants|Number|17|17.0||||||
4248852|NCT00636168|4073526|B3|> 4 mm||Breslow's Thickness|Breslow's Thickness is a measure of the vertical thickness of a cutaneous melanoma lesion and is reported in millimeters (mm).|participants|Number|226|226.0||||||
4248853|NCT00636168|4073527|B2|> 4 mm||Breslow's Thickness|Breslow's Thickness is a measure of the vertical thickness of a cutaneous melanoma lesion and is reported in millimeters (mm).|participants|Number|112|112.0||||||
4248854|NCT00636168|4073528|B1|> 4 mm||Breslow's Thickness|Breslow's Thickness is a measure of the vertical thickness of a cutaneous melanoma lesion and is reported in millimeters (mm).|participants|Number|114|114.0||||||
4248855|NCT00636168|4073526|B3|>2 to <= 4 mm||Breslow's Thickness|Breslow's Thickness is a measure of the vertical thickness of a cutaneous melanoma lesion and is reported in millimeters (mm).|participants|Number|296|296.0||||||
4248856|NCT00636168|4073527|B2|>2 to <= 4 mm||Breslow's Thickness|Breslow's Thickness is a measure of the vertical thickness of a cutaneous melanoma lesion and is reported in millimeters (mm).|participants|Number|132|132.0||||||
4248857|NCT00636168|4073528|B1|>2 to <= 4 mm||Breslow's Thickness|Breslow's Thickness is a measure of the vertical thickness of a cutaneous melanoma lesion and is reported in millimeters (mm).|participants|Number|164|164.0||||||
4248858|NCT00636168|4073526|B3|>1 to <= 2 mm||Breslow's Thickness|Breslow's Thickness is a measure of the vertical thickness of a cutaneous melanoma lesion and is reported in millimeters (mm).|participants|Number|255|255.0||||||
4248859|NCT00636168|4073527|B2|>1 to <= 2 mm||Breslow's Thickness|Breslow's Thickness is a measure of the vertical thickness of a cutaneous melanoma lesion and is reported in millimeters (mm).|participants|Number|135|135.0||||||
4248860|NCT00636168|4073528|B1|>1 to <= 2 mm||Breslow's Thickness|Breslow's Thickness is a measure of the vertical thickness of a cutaneous melanoma lesion and is reported in millimeters (mm).|participants|Number|120|120.0||||||
4248861|NCT00636168|4073526|B3|<= 1 mm||Breslow's Thickness|Breslow's Thickness is a measure of the vertical thickness of a cutaneous melanoma lesion and is reported in millimeters (mm).|participants|Number|130|130.0||||||
4248862|NCT00636168|4073527|B2|<= 1 mm||Breslow's Thickness|Breslow's Thickness is a measure of the vertical thickness of a cutaneous melanoma lesion and is reported in millimeters (mm).|participants|Number|70|70.0||||||
4248863|NCT00636168|4073528|B1|<= 1 mm||Breslow's Thickness|Breslow's Thickness is a measure of the vertical thickness of a cutaneous melanoma lesion and is reported in millimeters (mm).|participants|Number|60|60.0||||||
4248864|NCT00636168|4073526|B3|Stage IIIc with >=4 positive lymph nodes||Stage at Study Entry|According to American Joint Committee on Cancer (AJCC 2002) Classification, the stage III TNM System was defined at baseline based on the number of metastatic nodes (1, 2-3, > or =4), the type of lymph node involvement (micro- vs. macrometastasis) (N1, 2 or 3) and the ulceration status of the tumor (Ta or Tb). Once the T and N are determined in the absence of distant metastasis (M0), they are combined, and a stage of IIIA, IIIB or IIIC is assigned based on the combination.|participants|Number|193|193.0||||||
4248865|NCT00636168|4073527|B2|Stage IIIc with >=4 positive lymph nodes||Stage at Study Entry|According to American Joint Committee on Cancer (AJCC 2002) Classification, the stage III TNM System was defined at baseline based on the number of metastatic nodes (1, 2-3, > or =4), the type of lymph node involvement (micro- vs. macrometastasis) (N1, 2 or 3) and the ulceration status of the tumor (Ta or Tb). Once the T and N are determined in the absence of distant metastasis (M0), they are combined, and a stage of IIIA, IIIB or IIIC is assigned based on the combination.|participants|Number|98|98.0||||||
4248866|NCT00636168|4073528|B1|Stage IIIc with >=4 positive lymph nodes||Stage at Study Entry|According to American Joint Committee on Cancer (AJCC 2002) Classification, the stage III TNM System was defined at baseline based on the number of metastatic nodes (1, 2-3, > or =4), the type of lymph node involvement (micro- vs. macrometastasis) (N1, 2 or 3) and the ulceration status of the tumor (Ta or Tb). Once the T and N are determined in the absence of distant metastasis (M0), they are combined, and a stage of IIIA, IIIB or IIIC is assigned based on the combination.|participants|Number|95|95.0||||||
4248867|NCT00636168|4073526|B3|Stage IIIc with 1-3 positive lymph nodes||Stage at Study Entry|According to American Joint Committee on Cancer (AJCC 2002) Classification, the stage III TNM System was defined at baseline based on the number of metastatic nodes (1, 2-3, > or =4), the type of lymph node involvement (micro- vs. macrometastasis) (N1, 2 or 3) and the ulceration status of the tumor (Ta or Tb). Once the T and N are determined in the absence of distant metastasis (M0), they are combined, and a stage of IIIA, IIIB or IIIC is assigned based on the combination.|participants|Number|152|152.0||||||
4248868|NCT00636168|4073527|B2|Stage IIIc with 1-3 positive lymph nodes||Stage at Study Entry|According to American Joint Committee on Cancer (AJCC 2002) Classification, the stage III TNM System was defined at baseline based on the number of metastatic nodes (1, 2-3, > or =4), the type of lymph node involvement (micro- vs. macrometastasis) (N1, 2 or 3) and the ulceration status of the tumor (Ta or Tb). Once the T and N are determined in the absence of distant metastasis (M0), they are combined, and a stage of IIIA, IIIB or IIIC is assigned based on the combination.|participants|Number|83|83.0||||||
4248869|NCT00636168|4073528|B1|Stage IIIc with 1-3 positive lymph nodes||Stage at Study Entry|According to American Joint Committee on Cancer (AJCC 2002) Classification, the stage III TNM System was defined at baseline based on the number of metastatic nodes (1, 2-3, > or =4), the type of lymph node involvement (micro- vs. macrometastasis) (N1, 2 or 3) and the ulceration status of the tumor (Ta or Tb). Once the T and N are determined in the absence of distant metastasis (M0), they are combined, and a stage of IIIA, IIIB or IIIC is assigned based on the combination.|participants|Number|69|69.0||||||
4248870|NCT00636168|4073526|B3|Stage IIIb||Stage at Study Entry|According to American Joint Committee on Cancer (AJCC 2002) Classification, the stage III TNM System was defined at baseline based on the number of metastatic nodes (1, 2-3, > or =4), the type of lymph node involvement (micro- vs. macrometastasis) (N1, 2 or 3) and the ulceration status of the tumor (Ta or Tb). Once the T and N are determined in the absence of distant metastasis (M0), they are combined, and a stage of IIIA, IIIB or IIIC is assigned based on the combination.|participants|Number|420|420.0||||||
4248871|NCT00636168|4073527|B2|Stage IIIb||Stage at Study Entry|According to American Joint Committee on Cancer (AJCC 2002) Classification, the stage III TNM System was defined at baseline based on the number of metastatic nodes (1, 2-3, > or =4), the type of lymph node involvement (micro- vs. macrometastasis) (N1, 2 or 3) and the ulceration status of the tumor (Ta or Tb). Once the T and N are determined in the absence of distant metastasis (M0), they are combined, and a stage of IIIA, IIIB or IIIC is assigned based on the combination.|participants|Number|207|207.0||||||
4248872|NCT00636168|4073528|B1|Stage IIIb||Stage at Study Entry|According to American Joint Committee on Cancer (AJCC 2002) Classification, the stage III TNM System was defined at baseline based on the number of metastatic nodes (1, 2-3, > or =4), the type of lymph node involvement (micro- vs. macrometastasis) (N1, 2 or 3) and the ulceration status of the tumor (Ta or Tb). Once the T and N are determined in the absence of distant metastasis (M0), they are combined, and a stage of IIIA, IIIB or IIIC is assigned based on the combination.|participants|Number|213|213.0||||||
4248873|NCT00636168|4073526|B3|Stage IIIa||Stage at Study Entry|According to American Joint Committee on Cancer (AJCC 2002) Classification, the stage III TNM System was defined at baseline based on the number of metastatic nodes (1, 2-3, > or =4), the type of lymph node involvement (micro- vs. macrometastasis) (N1, 2 or 3) and the ulceration status of the tumor (Ta or Tb). Once the T and N are determined in the absence of distant metastasis (M0), they are combined, and a stage of IIIA, IIIB or IIIC is assigned based on the combination.|participants|Number|186|186.0||||||
4248874|NCT00636168|4073527|B2|Stage IIIa||Stage at Study Entry|According to American Joint Committee on Cancer (AJCC 2002) Classification, the stage III TNM System was defined at baseline based on the number of metastatic nodes (1, 2-3, > or =4), the type of lymph node involvement (micro- vs. macrometastasis) (N1, 2 or 3) and the ulceration status of the tumor (Ta or Tb). Once the T and N are determined in the absence of distant metastasis (M0), they are combined, and a stage of IIIA, IIIB or IIIC is assigned based on the combination.|participants|Number|88|88.0||||||
4248894|NCT00636168|4073526|B3|Netherlands||Region of Enrollment||participants|Number|23|23.0||||||
4248895|NCT00636168|4073527|B2|Netherlands||Region of Enrollment||participants|Number|12|12.0||||||
4248896|NCT00636168|4073528|B1|Netherlands||Region of Enrollment||participants|Number|11|11.0||||||
4248897|NCT00636168|4073526|B3|Australia||Region of Enrollment||participants|Number|37|37.0||||||
4248875|NCT00636168|4073528|B1|Stage IIIa||Stage at Study Entry|According to American Joint Committee on Cancer (AJCC 2002) Classification, the stage III TNM System was defined at baseline based on the number of metastatic nodes (1, 2-3, > or =4), the type of lymph node involvement (micro- vs. macrometastasis) (N1, 2 or 3) and the ulceration status of the tumor (Ta or Tb). Once the T and N are determined in the absence of distant metastasis (M0), they are combined, and a stage of IIIA, IIIB or IIIC is assigned based on the combination.|participants|Number|98|98.0||||||
4248876|NCT00636168|4073526|B3|ECOG PS 2||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|1|1.0||||||
4248877|NCT00636168|4073527|B2|ECOG PS 2||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|0|0.0||||||
4248878|NCT00636168|4073528|B1|ECOG PS 2||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|1|1.0||||||
4248879|NCT00636168|4073526|B3|ECOG PS 1||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|57|57.0||||||
4248880|NCT00636168|4073527|B2|ECOG PS 1||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|28|28.0||||||
4248881|NCT00636168|4073528|B1|ECOG PS 1||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|29|29.0||||||
4248882|NCT00636168|4073526|B3|ECOG PS 0||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|893|893.0||||||
4248883|NCT00636168|4073527|B2|ECOG PS 0||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|448|448.0||||||
4248884|NCT00636168|4073528|B1|ECOG PS 0||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|445|445.0||||||
4248885|NCT00636168|4073526|B3|Sweden||Region of Enrollment||participants|Number|11|11.0||||||
4248886|NCT00636168|4073527|B2|Sweden||Region of Enrollment||participants|Number|5|5.0||||||
4248887|NCT00636168|4073528|B1|Sweden||Region of Enrollment||participants|Number|6|6.0||||||
4248888|NCT00636168|4073526|B3|Norway||Region of Enrollment||participants|Number|11|11.0||||||
4248889|NCT00636168|4073527|B2|Norway||Region of Enrollment||participants|Number|6|6.0||||||
4248890|NCT00636168|4073528|B1|Norway||Region of Enrollment||participants|Number|5|5.0||||||
4248891|NCT00636168|4073526|B3|Germany||Region of Enrollment||participants|Number|77|77.0||||||
4248892|NCT00636168|4073527|B2|Germany||Region of Enrollment||participants|Number|38|38.0||||||
4248893|NCT00636168|4073528|B1|Germany||Region of Enrollment||participants|Number|39|39.0||||||
4248898|NCT00636168|4073527|B2|Australia||Region of Enrollment||participants|Number|18|18.0||||||
4248899|NCT00636168|4073528|B1|Australia||Region of Enrollment||participants|Number|19|19.0||||||
4248900|NCT00636168|4073526|B3|Denmark||Region of Enrollment||participants|Number|59|59.0||||||
4248901|NCT00636168|4073527|B2|Denmark||Region of Enrollment||participants|Number|29|29.0||||||
4248902|NCT00636168|4073528|B1|Denmark||Region of Enrollment||participants|Number|30|30.0||||||
4248903|NCT00636168|4073526|B3|Poland||Region of Enrollment||participants|Number|11|11.0||||||
4248904|NCT00636168|4073527|B2|Poland||Region of Enrollment||participants|Number|6|6.0||||||
4248905|NCT00636168|4073528|B1|Poland||Region of Enrollment||participants|Number|5|5.0||||||
4248906|NCT00636168|4073526|B3|Belgium||Region of Enrollment||participants|Number|16|16.0||||||
4248907|NCT00636168|4073527|B2|Belgium||Region of Enrollment||participants|Number|9|9.0||||||
4248908|NCT00636168|4073528|B1|Belgium||Region of Enrollment||participants|Number|7|7.0||||||
4248909|NCT00636168|4073526|B3|Canada||Region of Enrollment||participants|Number|24|24.0||||||
4248910|NCT00636168|4073527|B2|Canada||Region of Enrollment||participants|Number|13|13.0||||||
4248911|NCT00636168|4073528|B1|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4248912|NCT00636168|4073526|B3|Czech Republic||Region of Enrollment||participants|Number|20|20.0||||||
4248913|NCT00636168|4073527|B2|Czech Republic||Region of Enrollment||participants|Number|10|10.0||||||
4248914|NCT00636168|4073528|B1|Czech Republic||Region of Enrollment||participants|Number|10|10.0||||||
4248915|NCT00636168|4073526|B3|France||Region of Enrollment||participants|Number|144|144.0||||||
4248916|NCT00636168|4073527|B2|France||Region of Enrollment||participants|Number|73|73.0||||||
4248917|NCT00636168|4073528|B1|France||Region of Enrollment||participants|Number|71|71.0||||||
4248918|NCT00636168|4073526|B3|United Kingdom||Region of Enrollment||participants|Number|36|36.0||||||
4248919|NCT00636168|4073527|B2|United Kingdom||Region of Enrollment||participants|Number|17|17.0||||||
4248920|NCT00636168|4073528|B1|United Kingdom||Region of Enrollment||participants|Number|19|19.0||||||
4248921|NCT00636168|4073526|B3|Italy||Region of Enrollment||participants|Number|144|144.0||||||
4248922|NCT00636168|4073527|B2|Italy||Region of Enrollment||participants|Number|72|72.0||||||
4248923|NCT00636168|4073528|B1|Italy||Region of Enrollment||participants|Number|72|72.0||||||
4248924|NCT00636168|4073526|B3|Switzerland||Region of Enrollment||participants|Number|41|41.0||||||
4248925|NCT00636168|4073527|B2|Switzerland||Region of Enrollment||participants|Number|19|19.0||||||
4248926|NCT00636168|4073528|B1|Switzerland||Region of Enrollment||participants|Number|22|22.0||||||
4248927|NCT00636168|4073526|B3|Russian Federation||Region of Enrollment||participants|Number|54|54.0||||||
4248928|NCT00636168|4073527|B2|Russian Federation||Region of Enrollment||participants|Number|27|27.0||||||
4248929|NCT00636168|4073528|B1|Russian Federation||Region of Enrollment||participants|Number|27|27.0||||||
4248930|NCT00636168|4073526|B3|Austria||Region of Enrollment||participants|Number|9|9.0||||||
4248931|NCT00636168|4073527|B2|Austria||Region of Enrollment||participants|Number|6|6.0||||||
4248932|NCT00636168|4073528|B1|Austria||Region of Enrollment||participants|Number|3|3.0||||||
4248933|NCT00636168|4073526|B3|Spain||Region of Enrollment||participants|Number|11|11.0||||||
4248934|NCT00636168|4073527|B2|Spain||Region of Enrollment||participants|Number|6|6.0||||||
4248935|NCT00636168|4073528|B1|Spain||Region of Enrollment||participants|Number|5|5.0||||||
4248936|NCT00636168|4073526|B3|Finland||Region of Enrollment||participants|Number|11|11.0||||||
4248937|NCT00636168|4073527|B2|Finland||Region of Enrollment||participants|Number|6|6.0||||||
4248938|NCT00636168|4073528|B1|Finland||Region of Enrollment||participants|Number|5|5.0||||||
4248939|NCT00636168|4073526|B3|United States||Region of Enrollment||participants|Number|212|212.0||||||
4248940|NCT00636168|4073527|B2|United States||Region of Enrollment||participants|Number|104|104.0||||||
4248941|NCT00636168|4073528|B1|United States||Region of Enrollment||participants|Number|108|108.0||||||
4248942|NCT00636168|4073526|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4248943|NCT00636168|4073527|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248944|NCT00636168|4073528|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4248945|NCT00636168|4073526|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248946|NCT00636168|4073527|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248947|NCT00636168|4073528|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248948|NCT00636168|4073526|B3||White|Race (NIH/OMB)||Participants|Count of Participants|946|946.0||||||
4248949|NCT00636168|4073527|B2||White|Race (NIH/OMB)||Participants|Count of Participants|476|476.0||||||
4248950|NCT00636168|4073528|B1||White|Race (NIH/OMB)||Participants|Count of Participants|470|470.0||||||
4248951|NCT00636168|4073526|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248952|NCT00636168|4073527|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248953|NCT00636168|4073528|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248954|NCT00636168|4073526|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4248955|NCT00636168|4073527|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248956|NCT00636168|4073528|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4248957|NCT00636168|4073526|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4248958|NCT00636168|4073527|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248959|NCT00636168|4073528|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4248960|NCT00636168|4073526|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248961|NCT00636168|4073527|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248962|NCT00636168|4073528|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248963|NCT00636168|4073526|B3||Male|Sex: Female, Male||Participants|Count of Participants|589|589.0||||||
4248964|NCT00636168|4073527|B2||Male|Sex: Female, Male||Participants|Count of Participants|293|293.0||||||
4248965|NCT00636168|4073528|B1||Male|Sex: Female, Male||Participants|Count of Participants|296|296.0||||||
4248966|NCT00636168|4073526|B3||Female|Sex: Female, Male||Participants|Count of Participants|362|362.0||||||
4248967|NCT00636168|4073527|B2||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4248968|NCT00636168|4073528|B1||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4248969|NCT00636168|4073526|B3|||Age||years|Mean|51.1|51.1|Standard Deviation|12.86|12.86|||
4248970|NCT00636168|4073527|B2|||Age||years|Mean|51.5|51.5|Standard Deviation|12.82|12.82|||
4248971|NCT00636168|4073528|B1|||Age||years|Mean|50.7|50.7|Standard Deviation|12.90|12.9|||
4248972|NCT00636155|4073549|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248973|NCT00636155|4073549|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248974|NCT00636155|4073549|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4248975|NCT00636155|4073549|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4248976|NCT00636155|4073549|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248977|NCT00636155|4073549|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4248978|NCT00636155|4073549|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4248979|NCT00636155|4073549|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4248980|NCT00636155|4073549|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4248981|NCT00636155|4073549|B1|||Age||years|Median|62|62.0|Full Range|||45.0|77.0|
4248982|NCT00636155|4073549|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4248983|NCT00636155|4073549|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4248984|NCT00636155|4073549|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4248985|NCT00636077|4073555|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4248986|NCT00636077|4073555|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4248987|NCT00636077|4073555|B1|||Age||Years|Mean|60|60.0|Full Range|||32.0|83.0|
4248988|NCT00635999|4073588|B4|United States||Region of Enrollment||participants|Number|76|76.0||||||
4248989|NCT00635999|4073589|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4248990|NCT00635999|4073590|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4248991|NCT00635999|4073591|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4248992|NCT00635999|4073588|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4248993|NCT00635999|4073589|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4248994|NCT00635999|4073590|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4248995|NCT00635999|4073591|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4248996|NCT00635999|4073588|B4||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4248997|NCT00635999|4073589|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4248998|NCT00635999|4073590|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4248999|NCT00635999|4073591|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4249000|NCT00635999|4073588|B4|||Age||years|Mean|37.36|37.36|Standard Deviation|11.78|11.78|||
4249001|NCT00635999|4073589|B3|||Age||years|Mean|35.64|35.64|Standard Deviation|13.92|13.92|||
4249002|NCT00635999|4073590|B2|||Age||years|Mean|38.42|38.42|Standard Deviation|11.10|11.1|||
4249003|NCT00635999|4073591|B1|||Age||years|Mean|38.02|38.02|Standard Deviation|10.36|10.36|||
4249004|NCT00635999|4073588|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4249005|NCT00635999|4073589|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4249006|NCT00635999|4073590|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4249007|NCT00635999|4073591|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4249008|NCT00635999|4073588|B4||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
4249009|NCT00635999|4073589|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4249010|NCT00635999|4073590|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4249011|NCT00635999|4073591|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4249012|NCT00635999|4073588|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4249013|NCT00635999|4073589|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4249014|NCT00635999|4073590|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4249015|NCT00635999|4073591|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4249016|NCT00635882|4073604|B7||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4249017|NCT00635882|4073605|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4249018|NCT00635882|4073606|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4249019|NCT00635882|4073607|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4249020|NCT00635882|4073608|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4249021|NCT00635882|4073609|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4249022|NCT00635882|4073610|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4249023|NCT00635882|4073604|B7||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4249024|NCT00635882|4073605|B6||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4249025|NCT00635882|4073606|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4249026|NCT00635882|4073607|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4249027|NCT00635882|4073608|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4249028|NCT00635882|4073609|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4249029|NCT00635882|4073610|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4249030|NCT00635882|4073604|B7|> or = to 65 years||Age, Customized||participants|Number|6|6.0||||||
4249031|NCT00635882|4073605|B6|> or = to 65 years||Age, Customized||participants|Number|2|2.0||||||
4249032|NCT00635882|4073606|B5|> or = to 65 years||Age, Customized||participants|Number|0|0.0||||||
4249033|NCT00635882|4073607|B4|> or = to 65 years||Age, Customized||participants|Number|0|0.0||||||
4249034|NCT00635882|4073608|B3|> or = to 65 years||Age, Customized||participants|Number|1|1.0||||||
4249035|NCT00635882|4073609|B2|> or = to 65 years||Age, Customized||participants|Number|3|3.0||||||
4249036|NCT00635882|4073610|B1|> or = to 65 years||Age, Customized||participants|Number|0|0.0||||||
4249037|NCT00635882|4073604|B7|18 to <65 years||Age, Customized||participants|Number|87|87.0||||||
4249038|NCT00635882|4073605|B6|18 to <65 years||Age, Customized||participants|Number|11|11.0||||||
4249039|NCT00635882|4073606|B5|18 to <65 years||Age, Customized||participants|Number|16|16.0||||||
4249040|NCT00635882|4073607|B4|18 to <65 years||Age, Customized||participants|Number|15|15.0||||||
4249041|NCT00635882|4073608|B3|18 to <65 years||Age, Customized||participants|Number|11|11.0||||||
4249042|NCT00635882|4073609|B2|18 to <65 years||Age, Customized||participants|Number|14|14.0||||||
4249043|NCT00635882|4073610|B1|18 to <65 years||Age, Customized||participants|Number|20|20.0||||||
4249044|NCT00635830|4073677|B3|||Pulse||Beats per minute (BPM)|Mean|68.58|68.58|Standard Deviation|4.72|4.72|||
4249045|NCT00635830|4073678|B2|||Pulse||Beats per minute (BPM)|Mean|65.40|65.4|Standard Deviation|2.68|2.68|||
4249046|NCT00635830|4073679|B1|||Pulse||Beats per minute (BPM)|Mean|71.75|71.75|Standard Deviation|4.17|4.17|||
4249047|NCT00635830|4073677|B3|||Body Temperature||Degrees Celsius|Mean|36.49|36.49|Standard Deviation|0.33|0.33|||
4249048|NCT00635830|4073678|B2|||Body Temperature||Degrees Celsius|Mean|36.35|36.35|Standard Deviation|0.24|0.24|||
4249049|NCT00635830|4073679|B1|||Body Temperature||Degrees Celsius|Mean|36.64|36.64|Standard Deviation|0.35|0.35|||
4249050|NCT00635830|4073677|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4249051|NCT00635830|4073678|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4249052|NCT00635830|4073679|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4249053|NCT00635830|4073677|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4249054|NCT00635830|4073678|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4249055|NCT00635830|4073679|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4249056|NCT00635830|4073677|B3|||Age||years|Mean|18.73|18.73|Standard Deviation|5.45|5.45|||
4249057|NCT00635830|4073678|B2|||Age||years|Mean|13.82|13.82|Standard Deviation|9.6|9.6|||
4249058|NCT00635830|4073679|B1|||Age||years|Mean|23.64|23.64|Standard Deviation|2.39|2.39|||
4249059|NCT00635817|4073686|B5|North America||Region of Enrollment||Participants|Number|84|84.0||||||
4249060|NCT00635817|4073687|B4|North America||Region of Enrollment||Participants|Number|21|21.0||||||
4249061|NCT00635817|4073688|B3|North America||Region of Enrollment||Participants|Number|21|21.0||||||
4249062|NCT00635817|4073689|B2|North America||Region of Enrollment||Participants|Number|21|21.0||||||
4249063|NCT00635817|4073690|B1|North America||Region of Enrollment||Participants|Number|21|21.0||||||
4249064|NCT00635817|4073686|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4249065|NCT00635817|4073687|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4249066|NCT00635817|4073688|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4249067|NCT00635817|4073689|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4249068|NCT00635817|4073690|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4249069|NCT00635817|4073686|B5||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4249070|NCT00635817|4073687|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4249071|NCT00635817|4073688|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4249072|NCT00635817|4073689|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4249073|NCT00635817|4073690|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4249074|NCT00635817|4073686|B5|||Age||Years|Mean|7.8|7.8|Standard Deviation|1.73|1.73|||
4249075|NCT00635817|4073687|B4|||Age||Years|Mean|8.4|8.4|Standard Deviation|1.75|1.75|||
4249076|NCT00635817|4073688|B3|||Age||Years|Mean|7.3|7.3|Standard Deviation|1.74|1.74|||
4249077|NCT00635817|4073689|B2|||Age||Years|Mean|8.1|8.1|Standard Deviation|1.83|1.83|||
4249078|NCT00635817|4073690|B1|||Age||Years|Mean|7.4|7.4|Standard Deviation|1.47|1.47|||
4249079|NCT00635817|4073686|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4249080|NCT00635817|4073687|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4249081|NCT00635817|4073688|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4249082|NCT00635817|4073689|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4249083|NCT00635817|4073690|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4249084|NCT00635817|4073686|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4249085|NCT00635817|4073687|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4249086|NCT00635817|4073688|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4249087|NCT00635817|4073689|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4249088|NCT00635817|4073690|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4249089|NCT00635817|4073686|B5||<=18 years|Age||Participants|Count of Participants|84|84.0||||||
4249090|NCT00635817|4073687|B4||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
4249091|NCT00635817|4073688|B3||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
4249092|NCT00635817|4073689|B2||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
4249093|NCT00635817|4073690|B1||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
4249094|NCT00635804|4073737|B9||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4249095|NCT00635804|4073738|B8||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4249096|NCT00635804|4073739|B7||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4249097|NCT00635804|4073740|B6||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4249098|NCT00635804|4073741|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4249099|NCT00635804|4073742|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4249100|NCT00635804|4073743|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4249101|NCT00635804|4073744|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4249102|NCT00635804|4073745|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4249103|NCT00635804|4073737|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4249104|NCT00635804|4073738|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4249105|NCT00635804|4073739|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4249106|NCT00635804|4073740|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4249107|NCT00635804|4073741|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4249108|NCT00635804|4073742|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4249109|NCT00635804|4073743|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4249110|NCT00635804|4073744|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4249111|NCT00635804|4073745|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4249112|NCT00635804|4073737|B9|||Age||years|Mean|39.9|39.9|Standard Deviation|10.9|10.9|||
4249113|NCT00635804|4073738|B8|||Age||years|Mean|39.4|39.4|Standard Deviation|10.0|10.0|||
4249114|NCT00635804|4073739|B7|||Age||years|Mean|45.0|45.0|Standard Deviation|5.2|5.2|||
4249115|NCT00635804|4073740|B6|||Age||years|Mean|47.5|47.5|Standard Deviation|8.8|8.8|||
4249116|NCT00635804|4073741|B5|||Age||years|Mean|39.2|39.2|Standard Deviation|7.3|7.3|||
4249117|NCT00635804|4073742|B4|||Age||years|Mean|34.0|34.0|Standard Deviation|14.9|14.9|||
4249118|NCT00635804|4073743|B3|||Age||years|Mean|37.0|37.0|Standard Deviation|13.0|13.0|||
4249119|NCT00635804|4073744|B2|||Age||years|Mean|36.3|36.3|Standard Deviation|13.5|13.5|||
4249120|NCT00635804|4073745|B1|||Age||years|Mean|37.1|37.1|Standard Deviation|8.7|8.7|||
4249121|NCT00635778|4073849|B8||ECOG PS = 2|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Participants were assessed for ECOG PS: Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory & able to carry out work of a light or sedentary nature; Grade 2: Ambulatory & capable of all self-care but unable to carry out any work activities, up & about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled, cannot carry on any self-care, totally confined to bed or chair or Grade 5: Dead.|Participants|Count of Participants|4|4.0||||||
4249122|NCT00635778|4073850|B7||ECOG PS = 2|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Participants were assessed for ECOG PS: Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory & able to carry out work of a light or sedentary nature; Grade 2: Ambulatory & capable of all self-care but unable to carry out any work activities, up & about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled, cannot carry on any self-care, totally confined to bed or chair or Grade 5: Dead.|Participants|Count of Participants|1|1.0||||||
4249123|NCT00635778|4073851|B6||ECOG PS = 2|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Participants were assessed for ECOG PS: Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory & able to carry out work of a light or sedentary nature; Grade 2: Ambulatory & capable of all self-care but unable to carry out any work activities, up & about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled, cannot carry on any self-care, totally confined to bed or chair or Grade 5: Dead.|Participants|Count of Participants|1|1.0||||||
4249124|NCT00635778|4073852|B5||ECOG PS = 2|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Participants were assessed for ECOG PS: Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory & able to carry out work of a light or sedentary nature; Grade 2: Ambulatory & capable of all self-care but unable to carry out any work activities, up & about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled, cannot carry on any self-care, totally confined to bed or chair or Grade 5: Dead.|Participants|Count of Participants|0|0.0||||||
4249125|NCT00635778|4073853|B4||ECOG PS = 2|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Participants were assessed for ECOG PS: Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory & able to carry out work of a light or sedentary nature; Grade 2: Ambulatory & capable of all self-care but unable to carry out any work activities, up & about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled, cannot carry on any self-care, totally confined to bed or chair or Grade 5: Dead.|Participants|Count of Participants|1|1.0||||||
4249126|NCT00635778|4073854|B3||ECOG PS = 2|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Participants were assessed for ECOG PS: Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory & able to carry out work of a light or sedentary nature; Grade 2: Ambulatory & capable of all self-care but unable to carry out any work activities, up & about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled, cannot carry on any self-care, totally confined to bed or chair or Grade 5: Dead.|Participants|Count of Participants|0|0.0||||||
4249127|NCT00635778|4073855|B2||ECOG PS = 2|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Participants were assessed for ECOG PS: Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory & able to carry out work of a light or sedentary nature; Grade 2: Ambulatory & capable of all self-care but unable to carry out any work activities, up & about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled, cannot carry on any self-care, totally confined to bed or chair or Grade 5: Dead.|Participants|Count of Participants|0|0.0||||||
4249128|NCT00635778|4073856|B1||ECOG PS = 2|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Participants were assessed for ECOG PS: Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory & able to carry out work of a light or sedentary nature; Grade 2: Ambulatory & capable of all self-care but unable to carry out any work activities, up & about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled, cannot carry on any self-care, totally confined to bed or chair or Grade 5: Dead.|Participants|Count of Participants|1|1.0||||||
4249129|NCT00635778|4073849|B8||ECOG PS = 1|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Participants were assessed for ECOG PS: Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory & able to carry out work of a light or sedentary nature; Grade 2: Ambulatory & capable of all self-care but unable to carry out any work activities, up & about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled, cannot carry on any self-care, totally confined to bed or chair or Grade 5: Dead.|Participants|Count of Participants|26|26.0||||||
4249130|NCT00635778|4073850|B7||ECOG PS = 1|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Participants were assessed for ECOG PS: Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory & able to carry out work of a light or sedentary nature; Grade 2: Ambulatory & capable of all self-care but unable to carry out any work activities, up & about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled, cannot carry on any self-care, totally confined to bed or chair or Grade 5: Dead.|Participants|Count of Participants|1|1.0||||||
4249131|NCT00635778|4073851|B6||ECOG PS = 1|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Participants were assessed for ECOG PS: Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory & able to carry out work of a light or sedentary nature; Grade 2: Ambulatory & capable of all self-care but unable to carry out any work activities, up & about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled, cannot carry on any self-care, totally confined to bed or chair or Grade 5: Dead.|Participants|Count of Participants|10|10.0||||||
4249132|NCT00635778|4073852|B5||ECOG PS = 1|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Participants were assessed for ECOG PS: Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory & able to carry out work of a light or sedentary nature; Grade 2: Ambulatory & capable of all self-care but unable to carry out any work activities, up & about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled, cannot carry on any self-care, totally confined to bed or chair or Grade 5: Dead.|Participants|Count of Participants|5|5.0||||||
4249133|NCT00635778|4073853|B4||ECOG PS = 1|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Participants were assessed for ECOG PS: Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory & able to carry out work of a light or sedentary nature; Grade 2: Ambulatory & capable of all self-care but unable to carry out any work activities, up & about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled, cannot carry on any self-care, totally confined to bed or chair or Grade 5: Dead.|Participants|Count of Participants|6|6.0||||||
4249134|NCT00635778|4073854|B3||ECOG PS = 1|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Participants were assessed for ECOG PS: Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory & able to carry out work of a light or sedentary nature; Grade 2: Ambulatory & capable of all self-care but unable to carry out any work activities, up & about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled, cannot carry on any self-care, totally confined to bed or chair or Grade 5: Dead.|Participants|Count of Participants|2|2.0||||||
4249146|NCT00635778|4073850|B7|||Number of Prior Chemotherapy Regimens||Regimens|Mean|2.5|2.5|Standard Deviation|0.8|0.8|||
4249575|NCT00635362|4074046|B3|$10,000-$30,000||Annual Income||participants|Number|13|13.0||||||
4249135|NCT00635778|4073855|B2||ECOG PS = 1|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Participants were assessed for ECOG PS: Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory & able to carry out work of a light or sedentary nature; Grade 2: Ambulatory & capable of all self-care but unable to carry out any work activities, up & about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled, cannot carry on any self-care, totally confined to bed or chair or Grade 5: Dead.|Participants|Count of Participants|2|2.0||||||
4249136|NCT00635778|4073856|B1||ECOG PS = 1|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Participants were assessed for ECOG PS: Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory & able to carry out work of a light or sedentary nature; Grade 2: Ambulatory & capable of all self-care but unable to carry out any work activities, up & about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled, cannot carry on any self-care, totally confined to bed or chair or Grade 5: Dead.|Participants|Count of Participants|0|0.0||||||
4249137|NCT00635778|4073849|B8||ECOG PS = 0|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Participants were assessed for ECOG PS: Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory & able to carry out work of a light or sedentary nature; Grade 2: Ambulatory & capable of all self-care but unable to carry out any work activities, up & about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled, cannot carry on any self-care, totally confined to bed or chair or Grade 5: Dead.|Participants|Count of Participants|20|20.0||||||
4249138|NCT00635778|4073850|B7||ECOG PS = 0|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Participants were assessed for ECOG PS: Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory & able to carry out work of a light or sedentary nature; Grade 2: Ambulatory & capable of all self-care but unable to carry out any work activities, up & about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled, cannot carry on any self-care, totally confined to bed or chair or Grade 5: Dead.|Participants|Count of Participants|4|4.0||||||
4249139|NCT00635778|4073851|B6||ECOG PS = 0|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Participants were assessed for ECOG PS: Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory & able to carry out work of a light or sedentary nature; Grade 2: Ambulatory & capable of all self-care but unable to carry out any work activities, up & about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled, cannot carry on any self-care, totally confined to bed or chair or Grade 5: Dead.|Participants|Count of Participants|10|10.0||||||
4249140|NCT00635778|4073852|B5||ECOG PS = 0|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Participants were assessed for ECOG PS: Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory & able to carry out work of a light or sedentary nature; Grade 2: Ambulatory & capable of all self-care but unable to carry out any work activities, up & about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled, cannot carry on any self-care, totally confined to bed or chair or Grade 5: Dead.|Participants|Count of Participants|3|3.0||||||
4249141|NCT00635778|4073853|B4||ECOG PS = 0|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Participants were assessed for ECOG PS: Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory & able to carry out work of a light or sedentary nature; Grade 2: Ambulatory & capable of all self-care but unable to carry out any work activities, up & about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled, cannot carry on any self-care, totally confined to bed or chair or Grade 5: Dead.|Participants|Count of Participants|1|1.0||||||
4249142|NCT00635778|4073854|B3||ECOG PS = 0|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Participants were assessed for ECOG PS: Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory & able to carry out work of a light or sedentary nature; Grade 2: Ambulatory & capable of all self-care but unable to carry out any work activities, up & about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled, cannot carry on any self-care, totally confined to bed or chair or Grade 5: Dead.|Participants|Count of Participants|1|1.0||||||
4249143|NCT00635778|4073855|B2||ECOG PS = 0|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Participants were assessed for ECOG PS: Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory & able to carry out work of a light or sedentary nature; Grade 2: Ambulatory & capable of all self-care but unable to carry out any work activities, up & about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled, cannot carry on any self-care, totally confined to bed or chair or Grade 5: Dead.|Participants|Count of Participants|1|1.0||||||
4249144|NCT00635778|4073856|B1||ECOG PS = 0|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Participants were assessed for ECOG PS: Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory & able to carry out work of a light or sedentary nature; Grade 2: Ambulatory & capable of all self-care but unable to carry out any work activities, up & about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled, cannot carry on any self-care, totally confined to bed or chair or Grade 5: Dead.|Participants|Count of Participants|0|0.0||||||
4249145|NCT00635778|4073849|B8|||Number of Prior Chemotherapy Regimens||Regimens|Mean|2.9|2.9|Standard Deviation|0.4|0.4|||
4249248|NCT00635661|4073922|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4249147|NCT00635778|4073851|B6|||Number of Prior Chemotherapy Regimens||Regimens|Mean|2.9|2.9|Standard Deviation|0.3|0.3|||
4249148|NCT00635778|4073852|B5|||Number of Prior Chemotherapy Regimens||Regimens|Mean|3.0|3.0|Standard Deviation|0.0|0.0|||
4249149|NCT00635778|4073853|B4|||Number of Prior Chemotherapy Regimens||Regimens|Mean|3.0|3.0|Standard Deviation|0.0|0.0|||
4249150|NCT00635778|4073854|B3|||Number of Prior Chemotherapy Regimens||Regimens|Mean|3.0|3.0|Standard Deviation|0.0|0.0|||
4249151|NCT00635778|4073855|B2|||Number of Prior Chemotherapy Regimens||Regimens|Mean|2.7|2.7|Standard Deviation|0.6|0.6|||
4249152|NCT00635778|4073856|B1|||Number of Prior Chemotherapy Regimens||Regimens|Mean|3.0|3.0|Standard Deviation|NA||||Not calculated on only 1 participant
4249153|NCT00635778|4073849|B8||Unknown or Not Reported|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|7|7.0||||||
4249154|NCT00635778|4073850|B7||Unknown or Not Reported|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|1|1.0||||||
4249155|NCT00635778|4073851|B6||Unknown or Not Reported|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|2|2.0||||||
4249156|NCT00635778|4073852|B5||Unknown or Not Reported|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|3|3.0||||||
4249157|NCT00635778|4073853|B4||Unknown or Not Reported|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|1|1.0||||||
4249158|NCT00635778|4073854|B3||Unknown or Not Reported|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|0|0.0||||||
4249159|NCT00635778|4073855|B2||Unknown or Not Reported|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|0|0.0||||||
4249160|NCT00635778|4073856|B1||Unknown or Not Reported|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|0|0.0||||||
4249161|NCT00635778|4073849|B8||More than one race|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|0|0.0||||||
4249162|NCT00635778|4073850|B7||More than one race|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|0|0.0||||||
4249163|NCT00635778|4073851|B6||More than one race|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|0|0.0||||||
4249164|NCT00635778|4073852|B5||More than one race|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|0|0.0||||||
4249165|NCT00635778|4073853|B4||More than one race|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|0|0.0||||||
4249166|NCT00635778|4073854|B3||More than one race|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|0|0.0||||||
4249167|NCT00635778|4073855|B2||More than one race|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|0|0.0||||||
4249168|NCT00635778|4073856|B1||More than one race|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|0|0.0||||||
4249169|NCT00635778|4073849|B8||White|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|38|38.0||||||
4249170|NCT00635778|4073850|B7||White|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|5|5.0||||||
4249171|NCT00635778|4073851|B6||White|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|17|17.0||||||
4249172|NCT00635778|4073852|B5||White|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|4|4.0||||||
4249173|NCT00635778|4073853|B4||White|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|6|6.0||||||
4249174|NCT00635778|4073854|B3||White|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|2|2.0||||||
4249175|NCT00635778|4073855|B2||White|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|3|3.0||||||
4249176|NCT00635778|4073856|B1||White|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|1|1.0||||||
4249177|NCT00635778|4073849|B8||Black or African American|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|1|1.0||||||
4249178|NCT00635778|4073850|B7||Black or African American|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|0|0.0||||||
4249179|NCT00635778|4073851|B6||Black or African American|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|1|1.0||||||
4249180|NCT00635778|4073852|B5||Black or African American|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|0|0.0||||||
4249181|NCT00635778|4073853|B4||Black or African American|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|0|0.0||||||
4249182|NCT00635778|4073854|B3||Black or African American|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|0|0.0||||||
4249183|NCT00635778|4073855|B2||Black or African American|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|0|0.0||||||
4249184|NCT00635778|4073856|B1||Black or African American|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|0|0.0||||||
4249185|NCT00635778|4073849|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|0|0.0||||||
4249186|NCT00635778|4073850|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|0|0.0||||||
4249187|NCT00635778|4073851|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|0|0.0||||||
4249188|NCT00635778|4073852|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|0|0.0||||||
4249189|NCT00635778|4073853|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|0|0.0||||||
4249190|NCT00635778|4073854|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|0|0.0||||||
4249191|NCT00635778|4073855|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|0|0.0||||||
4249192|NCT00635778|4073856|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|0|0.0||||||
4249193|NCT00635778|4073849|B8||Asian|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|4|4.0||||||
4249194|NCT00635778|4073850|B7||Asian|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|0|0.0||||||
4249195|NCT00635778|4073851|B6||Asian|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|1|1.0||||||
4249196|NCT00635778|4073852|B5||Asian|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|1|1.0||||||
4249197|NCT00635778|4073853|B4||Asian|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|1|1.0||||||
4249198|NCT00635778|4073854|B3||Asian|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|1|1.0||||||
4249199|NCT00635778|4073855|B2||Asian|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|0|0.0||||||
4249200|NCT00635778|4073856|B1||Asian|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|0|0.0||||||
4249201|NCT00635778|4073849|B8||American Indian or Alaska Native|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|0|0.0||||||
4249202|NCT00635778|4073850|B7||American Indian or Alaska Native|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|0|0.0||||||
4249203|NCT00635778|4073851|B6||American Indian or Alaska Native|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|0|0.0||||||
4249204|NCT00635778|4073852|B5||American Indian or Alaska Native|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|0|0.0||||||
4249205|NCT00635778|4073853|B4||American Indian or Alaska Native|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|0|0.0||||||
4249206|NCT00635778|4073854|B3||American Indian or Alaska Native|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|0|0.0||||||
4249207|NCT00635778|4073855|B2||American Indian or Alaska Native|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|0|0.0||||||
4249208|NCT00635778|4073856|B1||American Indian or Alaska Native|Race (NIH/OMB)|The race of participants is presented.|Participants|Count of Participants|0|0.0||||||
4249209|NCT00635778|4073849|B8||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4249210|NCT00635778|4073850|B7||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4249211|NCT00635778|4073851|B6||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4249212|NCT00635778|4073852|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4249213|NCT00635778|4073853|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4249214|NCT00635778|4073854|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4249215|NCT00635778|4073855|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4249216|NCT00635778|4073856|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4249217|NCT00635778|4073849|B8||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4249218|NCT00635778|4073850|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4249219|NCT00635778|4073851|B6||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4249220|NCT00635778|4073852|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4249221|NCT00635778|4073853|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4249222|NCT00635778|4073854|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4249223|NCT00635778|4073855|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4249224|NCT00635778|4073856|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4249225|NCT00635778|4073849|B8|||Age||Years|Mean|61.0|61.0|Standard Deviation|12.7|12.7|||
4249226|NCT00635778|4073850|B7|||Age||Years|Mean|53.7|53.7|Standard Deviation|21.2|21.2|||
4249227|NCT00635778|4073851|B6|||Age||Years|Mean|58.1|58.1|Standard Deviation|11.8|11.8|||
4249228|NCT00635778|4073852|B5|||Age||Years|Mean|59.1|59.1|Standard Deviation|7.6|7.6|||
4249229|NCT00635778|4073853|B4|||Age||Years|Mean|71.3|71.3|Standard Deviation|6.5|6.5|||
4249230|NCT00635778|4073854|B3|||Age||Years|Mean|60.3|60.3|Standard Deviation|8.6|8.6|||
4249231|NCT00635778|4073855|B2|||Age||Years|Mean|74.3|74.3|Standard Deviation|9.9|9.9|||
4249232|NCT00635778|4073856|B1|||Age||Years|Mean|62.0|62.0|Standard Deviation|NA||||Not calculated for only 1 participant
4249233|NCT00635700|4073913|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4249234|NCT00635700|4073914|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4249235|NCT00635700|4073915|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4249236|NCT00635700|4073913|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4249237|NCT00635700|4073914|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4249238|NCT00635700|4073915|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4249239|NCT00635700|4073913|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4249240|NCT00635700|4073914|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4249241|NCT00635700|4073915|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4249242|NCT00635700|4073913|B3|||Age||years|Mean|22.3|22.3|Standard Deviation|4.2|4.2|||
4249243|NCT00635700|4073914|B2|||Age||years|Mean|22.6|22.6|Standard Deviation|3.7|3.7|||
4249244|NCT00635700|4073915|B1|||Age||years|Mean|21.9|21.9|Standard Deviation|4.7|4.7|||
4249245|NCT00635661|4073922|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4249246|NCT00635661|4073922|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4249247|NCT00635661|4073922|B1|||Age||years|Mean|66.1|66.1|Standard Deviation|15.4|15.4|||
4249249|NCT00635661|4073922|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4249250|NCT00635661|4073922|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4249251|NCT00635648|4073926|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4249252|NCT00635648|4073926|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4249253|NCT00635648|4073926|B1|||Age||years|Mean|50.4|50.4|Standard Deviation|18.3|18.3|||
4249254|NCT00635609|4073933|B3|Other||Race||participants|Number|44|44.0||||||
4249255|NCT00635609|4073934|B2|Other||Race||participants|Number|21|21.0||||||
4249256|NCT00635609|4073935|B1|Other||Race||participants|Number|23|23.0||||||
4249257|NCT00635609|4073933|B3|Caucasian||Race||participants|Number|40|40.0||||||
4249258|NCT00635609|4073934|B2|Caucasian||Race||participants|Number|18|18.0||||||
4249259|NCT00635609|4073935|B1|Caucasian||Race||participants|Number|22|22.0||||||
4249260|NCT00635609|4073933|B3|Black||Race||participants|Number|8|8.0||||||
4249261|NCT00635609|4073934|B2|Black||Race||participants|Number|5|5.0||||||
4249262|NCT00635609|4073935|B1|Black||Race||participants|Number|3|3.0||||||
4249263|NCT00635609|4073933|B3|Asian or Pacific Islander||Race||participants|Number|1|1.0||||||
4249264|NCT00635609|4073934|B2|Asian or Pacific Islander||Race||participants|Number|1|1.0||||||
4249265|NCT00635609|4073935|B1|Asian or Pacific Islander||Race||participants|Number|0|0.0||||||
4249266|NCT00635609|4073933|B3|Not of Hispanic origin||Ethnic Origin||participants|Number|40|40.0||||||
4249267|NCT00635609|4073934|B2|Not of Hispanic origin||Ethnic Origin||participants|Number|19|19.0||||||
4249268|NCT00635609|4073935|B1|Not of Hispanic origin||Ethnic Origin||participants|Number|21|21.0||||||
4249269|NCT00635609|4073933|B3|Hispanic||Ethnic Origin||participants|Number|53|53.0||||||
4249270|NCT00635609|4073934|B2|Hispanic||Ethnic Origin||participants|Number|26|26.0||||||
4249271|NCT00635609|4073935|B1|Hispanic||Ethnic Origin||participants|Number|27|27.0||||||
4249272|NCT00635609|4073933|B3|United States||Region of Enrollment||participants|Number|93|93.0||||||
4249273|NCT00635609|4073934|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
4249274|NCT00635609|4073935|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4249275|NCT00635609|4073933|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4249276|NCT00635609|4073934|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4249277|NCT00635609|4073935|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4249278|NCT00635609|4073933|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4249279|NCT00635609|4073934|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4249280|NCT00635609|4073935|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4249281|NCT00635609|4073933|B3|||Age||years|Mean|20.1|20.1|Standard Deviation|6.9|6.9|||
4249282|NCT00635609|4073934|B2|||Age||years|Mean|20.9|20.9|Standard Deviation|7.9|7.9|||
4249283|NCT00635609|4073935|B1|||Age||years|Mean|19.3|19.3|Standard Deviation|5.8|5.8|||
4249284|NCT00635609|4073933|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4249285|NCT00635609|4073934|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4249286|NCT00635609|4073935|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4249287|NCT00635609|4073933|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4249288|NCT00635609|4073934|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4249289|NCT00635609|4073935|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4249290|NCT00635609|4073933|B3||<=18 years|Age||Participants|Count of Participants|49|49.0||||||
4249291|NCT00635609|4073934|B2||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
4249292|NCT00635609|4073935|B1||<=18 years|Age||Participants|Count of Participants|28|28.0||||||
4249293|NCT00635570|4073946|B3|No||Pregnant ever|Only of those who had ever had vaginal sexual intercourse ; 125 for contraceptive vaginal ring and 127 for oral contraceptive.|participants|Number|216|216.0||||||
4249294|NCT00635570|4073947|B2|No||Pregnant ever|Only of those who had ever had vaginal sexual intercourse ; 125 for contraceptive vaginal ring and 127 for oral contraceptive.|participants|Number|115|115.0||||||
4249295|NCT00635570|4073948|B1|No||Pregnant ever|Only of those who had ever had vaginal sexual intercourse ; 125 for contraceptive vaginal ring and 127 for oral contraceptive.|participants|Number|101|101.0||||||
4249296|NCT00635570|4073946|B3|Yes||Pregnant ever|Only of those who had ever had vaginal sexual intercourse ; 125 for contraceptive vaginal ring and 127 for oral contraceptive.|participants|Number|36|36.0||||||
4249297|NCT00635570|4073947|B2|Yes||Pregnant ever|Only of those who had ever had vaginal sexual intercourse ; 125 for contraceptive vaginal ring and 127 for oral contraceptive.|participants|Number|12|12.0||||||
4249298|NCT00635570|4073948|B1|Yes||Pregnant ever|Only of those who had ever had vaginal sexual intercourse ; 125 for contraceptive vaginal ring and 127 for oral contraceptive.|participants|Number|24|24.0||||||
4249299|NCT00635570|4073946|B3|Missing||Frequency of sex in current or most recent relationship|Only of those who had ever had vaginal sexual intercourse ; 125 for contraceptive vaginal ring and 127 for oral contraceptive.|participants|Number|2|2.0||||||
4249300|NCT00635570|4073947|B2|Missing||Frequency of sex in current or most recent relationship|Only of those who had ever had vaginal sexual intercourse ; 125 for contraceptive vaginal ring and 127 for oral contraceptive.|participants|Number|2|2.0||||||
4249301|NCT00635570|4073948|B1|Missing||Frequency of sex in current or most recent relationship|Only of those who had ever had vaginal sexual intercourse ; 125 for contraceptive vaginal ring and 127 for oral contraceptive.|participants|Number|0|0.0||||||
4249302|NCT00635570|4073946|B3|More than 3 times a week||Frequency of sex in current or most recent relationship|Only of those who had ever had vaginal sexual intercourse ; 125 for contraceptive vaginal ring and 127 for oral contraceptive.|participants|Number|70|70.0||||||
4249523|NCT00635427|4074022|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4249303|NCT00635570|4073947|B2|More than 3 times a week||Frequency of sex in current or most recent relationship|Only of those who had ever had vaginal sexual intercourse ; 125 for contraceptive vaginal ring and 127 for oral contraceptive.|participants|Number|36|36.0||||||
4249304|NCT00635570|4073948|B1|More than 3 times a week||Frequency of sex in current or most recent relationship|Only of those who had ever had vaginal sexual intercourse ; 125 for contraceptive vaginal ring and 127 for oral contraceptive.|participants|Number|34|34.0||||||
4249305|NCT00635570|4073946|B3|2 or 3 times a week||Frequency of sex in current or most recent relationship|Only of those who had ever had vaginal sexual intercourse ; 125 for contraceptive vaginal ring and 127 for oral contraceptive.|participants|Number|65|65.0||||||
4249306|NCT00635570|4073947|B2|2 or 3 times a week||Frequency of sex in current or most recent relationship|Only of those who had ever had vaginal sexual intercourse ; 125 for contraceptive vaginal ring and 127 for oral contraceptive.|participants|Number|37|37.0||||||
4249307|NCT00635570|4073948|B1|2 or 3 times a week||Frequency of sex in current or most recent relationship|Only of those who had ever had vaginal sexual intercourse ; 125 for contraceptive vaginal ring and 127 for oral contraceptive.|participants|Number|28|28.0||||||
4249308|NCT00635570|4073946|B3|Approximately once a week||Frequency of sex in current or most recent relationship|Only of those who had ever had vaginal sexual intercourse ; 125 for contraceptive vaginal ring and 127 for oral contraceptive.|participants|Number|46|46.0||||||
4249309|NCT00635570|4073947|B2|Approximately once a week||Frequency of sex in current or most recent relationship|Only of those who had ever had vaginal sexual intercourse ; 125 for contraceptive vaginal ring and 127 for oral contraceptive.|participants|Number|21|21.0||||||
4249310|NCT00635570|4073948|B1|Approximately once a week||Frequency of sex in current or most recent relationship|Only of those who had ever had vaginal sexual intercourse ; 125 for contraceptive vaginal ring and 127 for oral contraceptive.|participants|Number|25|25.0||||||
4249311|NCT00635570|4073946|B3|2 or 3 times a month||Frequency of sex in current or most recent relationship|Only of those who had ever had vaginal sexual intercourse ; 125 for contraceptive vaginal ring and 127 for oral contraceptive.|participants|Number|37|37.0||||||
4249312|NCT00635570|4073947|B2|2 or 3 times a month||Frequency of sex in current or most recent relationship|Only of those who had ever had vaginal sexual intercourse ; 125 for contraceptive vaginal ring and 127 for oral contraceptive.|participants|Number|18|18.0||||||
4249313|NCT00635570|4073948|B1|2 or 3 times a month||Frequency of sex in current or most recent relationship|Only of those who had ever had vaginal sexual intercourse ; 125 for contraceptive vaginal ring and 127 for oral contraceptive.|participants|Number|19|19.0||||||
4249314|NCT00635570|4073946|B3|Once a month or less||Frequency of sex in current or most recent relationship|Only of those who had ever had vaginal sexual intercourse ; 125 for contraceptive vaginal ring and 127 for oral contraceptive.|participants|Number|26|26.0||||||
4249315|NCT00635570|4073947|B2|Once a month or less||Frequency of sex in current or most recent relationship|Only of those who had ever had vaginal sexual intercourse ; 125 for contraceptive vaginal ring and 127 for oral contraceptive.|participants|Number|11|11.0||||||
4249316|NCT00635570|4073948|B1|Once a month or less||Frequency of sex in current or most recent relationship|Only of those who had ever had vaginal sexual intercourse ; 125 for contraceptive vaginal ring and 127 for oral contraceptive.|participants|Number|15|15.0||||||
4249317|NCT00635570|4073946|B3|None||Frequency of sex in current or most recent relationship|Only of those who had ever had vaginal sexual intercourse ; 125 for contraceptive vaginal ring and 127 for oral contraceptive.|participants|Number|6|6.0||||||
4249318|NCT00635570|4073947|B2|None||Frequency of sex in current or most recent relationship|Only of those who had ever had vaginal sexual intercourse ; 125 for contraceptive vaginal ring and 127 for oral contraceptive.|participants|Number|2|2.0||||||
4249319|NCT00635570|4073948|B1|None||Frequency of sex in current or most recent relationship|Only of those who had ever had vaginal sexual intercourse ; 125 for contraceptive vaginal ring and 127 for oral contraceptive.|participants|Number|4|4.0||||||
4249320|NCT00635570|4073946|B3|No||Vaginal sex in the past month|Only of those who had ever had vaginal sexual intercourse ; 125 for contraceptive vaginal ring and 127 for oral contraceptive.|participants|Number|50|50.0||||||
4249321|NCT00635570|4073947|B2|No||Vaginal sex in the past month|Only of those who had ever had vaginal sexual intercourse ; 125 for contraceptive vaginal ring and 127 for oral contraceptive.|participants|Number|25|25.0||||||
4249322|NCT00635570|4073948|B1|No||Vaginal sex in the past month|Only of those who had ever had vaginal sexual intercourse ; 125 for contraceptive vaginal ring and 127 for oral contraceptive.|participants|Number|25|25.0||||||
4249323|NCT00635570|4073946|B3|Yes||Vaginal sex in the past month|Only of those who had ever had vaginal sexual intercourse ; 125 for contraceptive vaginal ring and 127 for oral contraceptive.|participants|Number|202|202.0||||||
4249324|NCT00635570|4073947|B2|Yes||Vaginal sex in the past month|Only of those who had ever had vaginal sexual intercourse ; 125 for contraceptive vaginal ring and 127 for oral contraceptive.|participants|Number|102|102.0||||||
4249325|NCT00635570|4073948|B1|Yes||Vaginal sex in the past month|Only of those who had ever had vaginal sexual intercourse ; 125 for contraceptive vaginal ring and 127 for oral contraceptive.|participants|Number|100|100.0||||||
4249326|NCT00635570|4073946|B3|||Age at sexual debut|Only of those who had ever had vaginal sexual intercourse ; 125 for contraceptive vaginal ring and 127 for oral contraceptive.|Years|Median|17.6|17.6|Full Range|||13.0|27.0|
4249327|NCT00635570|4073947|B2|||Age at sexual debut|Only of those who had ever had vaginal sexual intercourse ; 125 for contraceptive vaginal ring and 127 for oral contraceptive.|Years|Median|17.8|17.8|Full Range|||13.0|27.0|
4249328|NCT00635570|4073948|B1|||Age at sexual debut|Only of those who had ever had vaginal sexual intercourse ; 125 for contraceptive vaginal ring and 127 for oral contraceptive.|Years|Median|17.4|17.4|Full Range|||15.0|26.0|
4249329|NCT00635570|4073946|B3|Missing||Relationship status||participants|Number|2|2.0||||||
4249330|NCT00635570|4073947|B2|Missing||Relationship status||participants|Number|2|2.0||||||
4249331|NCT00635570|4073948|B1|Missing||Relationship status||participants|Number|0|0.0||||||
4249332|NCT00635570|4073946|B3|Not in a committed relationship||Relationship status||participants|Number|98|98.0||||||
4249333|NCT00635570|4073947|B2|Not in a committed relationship||Relationship status||participants|Number|41|41.0||||||
4249334|NCT00635570|4073948|B1|Not in a committed relationship||Relationship status||participants|Number|57|57.0||||||
4249335|NCT00635570|4073946|B3|A committed relationship, not living w/ a partner||Relationship status||participants|Number|139|139.0||||||
4249336|NCT00635570|4073947|B2|A committed relationship, not living w/ a partner||Relationship status||participants|Number|79|79.0||||||
4249337|NCT00635570|4073948|B1|A committed relationship, not living w/ a partner||Relationship status||participants|Number|60|60.0||||||
4249338|NCT00635570|4073946|B3|Living with a partner in a committed relationship||Relationship status||participants|Number|34|34.0||||||
4249339|NCT00635570|4073947|B2|Living with a partner in a committed relationship||Relationship status||participants|Number|15|15.0||||||
4249340|NCT00635570|4073948|B1|Living with a partner in a committed relationship||Relationship status||participants|Number|19|19.0||||||
4249341|NCT00635570|4073946|B3|Missing||Religious preference||participants|Number|3|3.0||||||
4249342|NCT00635570|4073947|B2|Missing||Religious preference||participants|Number|2|2.0||||||
4249343|NCT00635570|4073948|B1|Missing||Religious preference||participants|Number|1|1.0||||||
4249344|NCT00635570|4073946|B3|None||Religious preference||participants|Number|91|91.0||||||
4249345|NCT00635570|4073947|B2|None||Religious preference||participants|Number|37|37.0||||||
4249346|NCT00635570|4073948|B1|None||Religious preference||participants|Number|54|54.0||||||
4249347|NCT00635570|4073946|B3|Other||Religious preference||participants|Number|45|45.0||||||
4249348|NCT00635570|4073947|B2|Other||Religious preference||participants|Number|27|27.0||||||
4249349|NCT00635570|4073948|B1|Other||Religious preference||participants|Number|18|18.0||||||
4249350|NCT00635570|4073946|B3|Baptist||Religious preference||participants|Number|24|24.0||||||
4249351|NCT00635570|4073947|B2|Baptist||Religious preference||participants|Number|13|13.0||||||
4249352|NCT00635570|4073948|B1|Baptist||Religious preference||participants|Number|11|11.0||||||
4249353|NCT00635570|4073946|B3|Protestant||Religious preference||participants|Number|41|41.0||||||
4249354|NCT00635570|4073947|B2|Protestant||Religious preference||participants|Number|22|22.0||||||
4249355|NCT00635570|4073948|B1|Protestant||Religious preference||participants|Number|19|19.0||||||
4249356|NCT00635570|4073946|B3|Catholic||Religious preference||participants|Number|69|69.0||||||
4249357|NCT00635570|4073947|B2|Catholic||Religious preference||participants|Number|36|36.0||||||
4249358|NCT00635570|4073948|B1|Catholic||Religious preference||participants|Number|33|33.0||||||
4249359|NCT00635570|4073946|B3|Missing||Location||participants|Number|1|1.0||||||
4249360|NCT00635570|4073947|B2|Missing||Location||participants|Number|0|0.0||||||
4249361|NCT00635570|4073948|B1|Missing||Location||participants|Number|1|1.0||||||
4249362|NCT00635570|4073946|B3|Off campus||Location||participants|Number|209|209.0||||||
4249363|NCT00635570|4073947|B2|Off campus||Location||participants|Number|103|103.0||||||
4249364|NCT00635570|4073948|B1|Off campus||Location||participants|Number|106|106.0||||||
4249365|NCT00635570|4073946|B3|Dorm||Location||participants|Number|63|63.0||||||
4249366|NCT00635570|4073947|B2|Dorm||Location||participants|Number|34|34.0||||||
4249367|NCT00635570|4073948|B1|Dorm||Location||participants|Number|29|29.0||||||
4249368|NCT00635570|4073946|B3|Missing||Living arrangement||participants|Number|1|1.0||||||
4249369|NCT00635570|4073947|B2|Missing||Living arrangement||participants|Number|0|0.0||||||
4249370|NCT00635570|4073948|B1|Missing||Living arrangement||participants|Number|1|1.0||||||
4249371|NCT00635570|4073946|B3|With family||Living arrangement||participants|Number|61|61.0||||||
4249372|NCT00635570|4073947|B2|With family||Living arrangement||participants|Number|31|31.0||||||
4249373|NCT00635570|4073948|B1|With family||Living arrangement||participants|Number|30|30.0||||||
4249374|NCT00635570|4073946|B3|With others, not partner||Living arrangement||participants|Number|117|117.0||||||
4249375|NCT00635570|4073947|B2|With others, not partner||Living arrangement||participants|Number|63|63.0||||||
4249376|NCT00635570|4073948|B1|With others, not partner||Living arrangement||participants|Number|54|54.0||||||
4249377|NCT00635570|4073946|B3|With partner||Living arrangement||participants|Number|27|27.0||||||
4249378|NCT00635570|4073947|B2|With partner||Living arrangement||participants|Number|11|11.0||||||
4249379|NCT00635570|4073948|B1|With partner||Living arrangement||participants|Number|16|16.0||||||
4249380|NCT00635570|4073946|B3|Alone||Living arrangement||participants|Number|67|67.0||||||
4249381|NCT00635570|4073947|B2|Alone||Living arrangement||participants|Number|32|32.0||||||
4249382|NCT00635570|4073948|B1|Alone||Living arrangement||participants|Number|35|35.0||||||
4249383|NCT00635570|4073946|B3|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4249384|NCT00635570|4073947|B2|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4249385|NCT00635570|4073948|B1|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4249386|NCT00635570|4073946|B3|Non-Hispanic other/multiple||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4249387|NCT00635570|4073947|B2|Non-Hispanic other/multiple||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4249388|NCT00635570|4073948|B1|Non-Hispanic other/multiple||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4249389|NCT00635570|4073946|B3|Non-Hispanic Asian||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4249390|NCT00635570|4073947|B2|Non-Hispanic Asian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4249391|NCT00635570|4073948|B1|Non-Hispanic Asian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4249392|NCT00635570|4073946|B3|Non-Hispanic African American||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4249393|NCT00635570|4073947|B2|Non-Hispanic African American||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4249394|NCT00635570|4073948|B1|Non-Hispanic African American||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4249395|NCT00635570|4073946|B3|Non-Hispanic White||Race/Ethnicity, Customized||participants|Number|125|125.0||||||
4249396|NCT00635570|4073947|B2|Non-Hispanic White||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
4249397|NCT00635570|4073948|B1|Non-Hispanic White||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
4249398|NCT00635570|4073946|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4249399|NCT00635570|4073947|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4249400|NCT00635570|4073948|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4249401|NCT00635570|4073946|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4249402|NCT00635570|4073947|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4249403|NCT00635570|4073948|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4249404|NCT00635570|4073946|B3||Female|Sex: Female, Male||Participants|Count of Participants|273|273.0||||||
4249405|NCT00635570|4073947|B2||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4249406|NCT00635570|4073948|B1||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4249407|NCT00635570|4073946|B3|||Age||years|Mean|22.1|22.1|Full Range|||18.0|38.0|
4249408|NCT00635570|4073947|B2|||Age||years|Mean|22|22.0|Full Range|||18.0|34.0|
4249409|NCT00635570|4073948|B1|||Age||years|Mean|22.3|22.3|Full Range|||18.0|38.0|
4249410|NCT00635492|4073961|B3|Combination of 4 OADs||Concomitant Oral Anti-Diabetic Medication|Number of patients on oral antidiabetic (OAD) medication at baseline. No differentiation possible if patients who did not report OADs actually took no OADs or just did not report them.|Number of Patients|Number|20|20.0||||||
4249411|NCT00635492|4073962|B2|Combination of 4 OADs||Concomitant Oral Anti-Diabetic Medication|Number of patients on oral antidiabetic (OAD) medication at baseline. No differentiation possible if patients who did not report OADs actually took no OADs or just did not report them.|Number of Patients|Number|9|9.0||||||
4249412|NCT00635492|4073963|B1|Combination of 4 OADs||Concomitant Oral Anti-Diabetic Medication|Number of patients on oral antidiabetic (OAD) medication at baseline. No differentiation possible if patients who did not report OADs actually took no OADs or just did not report them.|Number of Patients|Number|11|11.0||||||
4249413|NCT00635492|4073961|B3|Combination of 3 OADs||Concomitant Oral Anti-Diabetic Medication|Number of patients on oral antidiabetic (OAD) medication at baseline. No differentiation possible if patients who did not report OADs actually took no OADs or just did not report them.|Number of Patients|Number|230|230.0||||||
4249414|NCT00635492|4073962|B2|Combination of 3 OADs||Concomitant Oral Anti-Diabetic Medication|Number of patients on oral antidiabetic (OAD) medication at baseline. No differentiation possible if patients who did not report OADs actually took no OADs or just did not report them.|Number of Patients|Number|112|112.0||||||
4249415|NCT00635492|4073963|B1|Combination of 3 OADs||Concomitant Oral Anti-Diabetic Medication|Number of patients on oral antidiabetic (OAD) medication at baseline. No differentiation possible if patients who did not report OADs actually took no OADs or just did not report them.|Number of Patients|Number|118|118.0||||||
4249416|NCT00635492|4073961|B3|Combination of 2 OADs||Concomitant Oral Anti-Diabetic Medication|Number of patients on oral antidiabetic (OAD) medication at baseline. No differentiation possible if patients who did not report OADs actually took no OADs or just did not report them.|Number of Patients|Number|1075|1075.0||||||
4249417|NCT00635492|4073962|B2|Combination of 2 OADs||Concomitant Oral Anti-Diabetic Medication|Number of patients on oral antidiabetic (OAD) medication at baseline. No differentiation possible if patients who did not report OADs actually took no OADs or just did not report them.|Number of Patients|Number|523|523.0||||||
4249418|NCT00635492|4073963|B1|Combination of 2 OADs||Concomitant Oral Anti-Diabetic Medication|Number of patients on oral antidiabetic (OAD) medication at baseline. No differentiation possible if patients who did not report OADs actually took no OADs or just did not report them.|Number of Patients|Number|552|552.0||||||
4249419|NCT00635492|4073961|B3|Single OAD||Concomitant Oral Anti-Diabetic Medication|Number of patients on oral antidiabetic (OAD) medication at baseline. No differentiation possible if patients who did not report OADs actually took no OADs or just did not report them.|Number of Patients|Number|859|859.0||||||
4249420|NCT00635492|4073962|B2|Single OAD||Concomitant Oral Anti-Diabetic Medication|Number of patients on oral antidiabetic (OAD) medication at baseline. No differentiation possible if patients who did not report OADs actually took no OADs or just did not report them.|Number of Patients|Number|476|476.0||||||
4249421|NCT00635492|4073963|B1|Single OAD||Concomitant Oral Anti-Diabetic Medication|Number of patients on oral antidiabetic (OAD) medication at baseline. No differentiation possible if patients who did not report OADs actually took no OADs or just did not report them.|Number of Patients|Number|383|383.0||||||
4249422|NCT00635492|4073961|B3|No OAD||Concomitant Oral Anti-Diabetic Medication|Number of patients on oral antidiabetic (OAD) medication at baseline. No differentiation possible if patients who did not report OADs actually took no OADs or just did not report them.|Number of Patients|Number|204|204.0||||||
4249423|NCT00635492|4073962|B2|No OAD||Concomitant Oral Anti-Diabetic Medication|Number of patients on oral antidiabetic (OAD) medication at baseline. No differentiation possible if patients who did not report OADs actually took no OADs or just did not report them.|Number of Patients|Number|154|154.0||||||
4249424|NCT00635492|4073963|B1|No OAD||Concomitant Oral Anti-Diabetic Medication|Number of patients on oral antidiabetic (OAD) medication at baseline. No differentiation possible if patients who did not report OADs actually took no OADs or just did not report them.|Number of Patients|Number|50|50.0||||||
4249425|NCT00635492|4073961|B3|||Duration of Diabetes||years|Mean|9.1|9.1|Standard Deviation|6.7|6.7|||
4249426|NCT00635492|4073962|B2|||Duration of Diabetes||years|Mean|9.8|9.8|Standard Deviation|7.3|7.3|||
4249427|NCT00635492|4073963|B1|||Duration of Diabetes||years|Mean|8.2|8.2|Standard Deviation|5.7|5.7|||
4249428|NCT00635492|4073961|B3|||Body Mass Index (BMI)||kg/m2|Mean|32.3|32.3|Standard Deviation|6.6|6.6|||
4249429|NCT00635492|4073962|B2|||Body Mass Index (BMI)||kg/m2|Mean|29.7|29.7|Standard Deviation|5.4|5.4|||
4249430|NCT00635492|4073963|B1|||Body Mass Index (BMI)||kg/m2|Mean|35.3|35.3|Standard Deviation|6.6|6.6|||
4249431|NCT00635492|4073961|B3|||Body Weight||kg|Mean|92.1|92.1|Standard Deviation|21.4|21.4|||
4249432|NCT00635492|4073962|B2|||Body Weight||kg|Mean|84.2|84.2|Standard Deviation|17.6|17.6|||
4249433|NCT00635492|4073963|B1|||Body Weight||kg|Mean|101.2|101.2|Standard Deviation|21.8|21.8|||
4249434|NCT00635492|4073961|B3|||Glycosylated hemoglobin (HbA1c)||percentage of total hemoglobin|Mean|8.8|8.8|Standard Deviation|1.7|1.7|||
4249435|NCT00635492|4073962|B2|||Glycosylated hemoglobin (HbA1c)||percentage of total hemoglobin|Mean|9.2|9.2|Standard Deviation|1.9|1.9|||
4249436|NCT00635492|4073963|B1|||Glycosylated hemoglobin (HbA1c)||percentage of total hemoglobin|Mean|8.4|8.4|Standard Deviation|1.4|1.4|||
4249437|NCT00635492|4073961|B3|Belgium||Region of Enrollment||participants|Number|279|279.0||||||
4249438|NCT00635492|4073962|B2|Belgium||Region of Enrollment||participants|Number|163|163.0||||||
4249439|NCT00635492|4073963|B1|Belgium||Region of Enrollment||participants|Number|116|116.0||||||
4249440|NCT00635492|4073961|B3|Sweden||Region of Enrollment||participants|Number|169|169.0||||||
4249441|NCT00635492|4073962|B2|Sweden||Region of Enrollment||participants|Number|85|85.0||||||
4249442|NCT00635492|4073963|B1|Sweden||Region of Enrollment||participants|Number|84|84.0||||||
4249443|NCT00635492|4073961|B3|Germany||Region of Enrollment||participants|Number|822|822.0||||||
4249444|NCT00635492|4073962|B2|Germany||Region of Enrollment||participants|Number|438|438.0||||||
4249445|NCT00635492|4073963|B1|Germany||Region of Enrollment||participants|Number|384|384.0||||||
4249446|NCT00635492|4073961|B3|Denmark||Region of Enrollment||participants|Number|59|59.0||||||
4249447|NCT00635492|4073962|B2|Denmark||Region of Enrollment||participants|Number|16|16.0||||||
4249448|NCT00635492|4073963|B1|Denmark||Region of Enrollment||participants|Number|43|43.0||||||
4249449|NCT00635492|4073961|B3|Greece||Region of Enrollment||participants|Number|807|807.0||||||
4249450|NCT00635492|4073962|B2|Greece||Region of Enrollment||participants|Number|488|488.0||||||
4249451|NCT00635492|4073963|B1|Greece||Region of Enrollment||participants|Number|319|319.0||||||
4249452|NCT00635492|4073961|B3|France||Region of Enrollment||participants|Number|252|252.0||||||
4249453|NCT00635492|4073962|B2|France||Region of Enrollment||participants|Number|84|84.0||||||
4249454|NCT00635492|4073963|B1|France||Region of Enrollment||participants|Number|168|168.0||||||
4249455|NCT00635492|4073961|B3||Male|Sex: Female, Male||Participants|Count of Participants|1331|1331.0||||||
4249456|NCT00635492|4073962|B2||Male|Sex: Female, Male||Participants|Count of Participants|733|733.0||||||
4249457|NCT00635492|4073963|B1||Male|Sex: Female, Male||Participants|Count of Participants|598|598.0||||||
4249458|NCT00635492|4073961|B3||Female|Sex: Female, Male||Participants|Count of Participants|1057|1057.0||||||
4249459|NCT00635492|4073962|B2||Female|Sex: Female, Male||Participants|Count of Participants|541|541.0||||||
4249460|NCT00635492|4073963|B1||Female|Sex: Female, Male||Participants|Count of Participants|516|516.0||||||
4249461|NCT00635492|4073961|B3|||Age||years|Mean|61.1|61.1|Standard Deviation|10.9|10.9|||
4249462|NCT00635492|4073962|B2|||Age||years|Mean|63.7|63.7|Standard Deviation|10.9|10.9|||
4249463|NCT00635492|4073963|B1|||Age||years|Mean|58.1|58.1|Standard Deviation|10.1|10.1|||
4249464|NCT00635479|4074008|B3|United States||Region of Enrollment||participants|Number|115|115.0||||||
4249465|NCT00635479|4074009|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
4249466|NCT00635479|4074010|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4249467|NCT00635479|4074008|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4249468|NCT00635479|4074009|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4249469|NCT00635479|4074010|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4249470|NCT00635479|4074008|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4249471|NCT00635479|4074009|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4249472|NCT00635479|4074010|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4249473|NCT00635479|4074008|B3|||Age||years|Mean|47.6|47.6|Standard Deviation|19.9|19.9|||
4249474|NCT00635479|4074009|B2|||Age||years|Mean|48.3|48.3|Standard Deviation|20.1|20.1|||
4249475|NCT00635479|4074010|B1|||Age||years|Mean|47.2|47.2|Standard Deviation|19.6|19.6|||
4249476|NCT00635427|4074017|B6|||Baseline Spleen volume per treatment group|Baseline was defined as data collected prior to the first dose in the core study (TKT032, TKT034, and HT-GCB-039). Normal spleen volume is defined as 0.2 percentage of body weight.|Multiple of Normal|Mean|13.07|13.07|Full Range|||1.2|65.1|
4249477|NCT00635427|4074018|B5|||Baseline Spleen volume per treatment group|Baseline was defined as data collected prior to the first dose in the core study (TKT032, TKT034, and HT-GCB-039). Normal spleen volume is defined as 0.2 percentage of body weight.|Multiple of Normal|Mean|4.1|4.1|Full Range|||1.2|15.8|
4249478|NCT00635427|4074019|B4|||Baseline Spleen volume per treatment group|Baseline was defined as data collected prior to the first dose in the core study (TKT032, TKT034, and HT-GCB-039). Normal spleen volume is defined as 0.2 percentage of body weight.|Multiple of Normal|Mean|23.52|23.52|Full Range|||3.1|44.4|
4249479|NCT00635427|4074020|B3|||Baseline Spleen volume per treatment group|Baseline was defined as data collected prior to the first dose in the core study (TKT032, TKT034, and HT-GCB-039). Normal spleen volume is defined as 0.2 percentage of body weight.|Multiple of Normal|Mean|12.69|12.69|Full Range|||7.2|31.6|
4249480|NCT00635427|4074021|B2|||Baseline Spleen volume per treatment group|Baseline was defined as data collected prior to the first dose in the core study (TKT032, TKT034, and HT-GCB-039). Normal spleen volume is defined as 0.2 percentage of body weight.|Multiple of Normal|Mean|18.48|18.48|Full Range|||5.7|36.9|
4249481|NCT00635427|4074022|B1|||Baseline Spleen volume per treatment group|Baseline was defined as data collected prior to the first dose in the core study (TKT032, TKT034, and HT-GCB-039). Normal spleen volume is defined as 0.2 percentage of body weight.|Multiple of Normal|Mean|23.08|23.08|Full Range|||4.8|65.1|
4249482|NCT00635427|4074017|B6|||Baseline liver volume per treatment group|Baseline was defined as data collected prior to the first dose in the core study (TKT032, TKT034, and HGT-GCB-039). Normal liver volume was defined as 2.5 percent of body weight.|Percent (%) body weight|Mean|1.302|1.302|Full Range|||0.6|3.2|
4249574|NCT00635362|4074048|B1|>$30,000||Annual Income||participants|Number|9|9.0||||||
4249483|NCT00635427|4074018|B5|||Baseline liver volume per treatment group|Baseline was defined as data collected prior to the first dose in the core study (TKT032, TKT034, and HGT-GCB-039). Normal liver volume was defined as 2.5 percent of body weight.|Percent (%) body weight|Mean|0.82|0.82|Full Range|||0.6|1.3|
4249484|NCT00635427|4074019|B4|||Baseline liver volume per treatment group|Baseline was defined as data collected prior to the first dose in the core study (TKT032, TKT034, and HGT-GCB-039). Normal liver volume was defined as 2.5 percent of body weight.|Percent (%) body weight|Mean|1.68|1.68|Full Range|||0.7|2.8|
4249485|NCT00635427|4074020|B3|||Baseline liver volume per treatment group|Baseline was defined as data collected prior to the first dose in the core study (TKT032, TKT034, and HGT-GCB-039). Normal liver volume was defined as 2.5 percent of body weight.|Percent (%) body weight|Mean|1.59|1.59|Full Range|||0.8|2.2|
4249486|NCT00635427|4074021|B2|||Baseline liver volume per treatment group|Baseline was defined as data collected prior to the first dose in the core study (TKT032, TKT034, and HGT-GCB-039). Normal liver volume was defined as 2.5 percent of body weight.|Percent (%) body weight|Mean|1.63|1.63|Full Range|||1.0|3.2|
4249487|NCT00635427|4074022|B1|||Baseline liver volume per treatment group|Baseline was defined as data collected prior to the first dose in the core study (TKT032, TKT034, and HGT-GCB-039). Normal liver volume was defined as 2.5 percent of body weight.|Percent (%) body weight|Mean|1.64|1.64|Full Range|||1.1|2.9|
4249488|NCT00635427|4074017|B6|||Baseline platelet counts per treatment group|Baseline was defined as data collected prior to the first dose in the core study (TKT032, TKT034, and HGT-GCB-039).|x10^9/L|Mean|144.81|144.81|Full Range|||13.0|430.0|
4249489|NCT00635427|4074018|B5|||Baseline platelet counts per treatment group|Baseline was defined as data collected prior to the first dose in the core study (TKT032, TKT034, and HGT-GCB-039).|x10^9/L|Mean|165.4|165.4|Full Range|||29.0|399.0|
4249490|NCT00635427|4074019|B4|||Baseline platelet counts per treatment group|Baseline was defined as data collected prior to the first dose in the core study (TKT032, TKT034, and HGT-GCB-039).|x10^9/L|Mean|186.3|186.3|Full Range|||63.0|430.0|
4249491|NCT00635427|4074020|B3|||Baseline platelet counts per treatment group|Baseline was defined as data collected prior to the first dose in the core study (TKT032, TKT034, and HGT-GCB-039).|x10^9/L|Mean|160.1|160.1|Full Range|||44.0|310.0|
4249492|NCT00635427|4074021|B2|||Baseline platelet counts per treatment group|Baseline was defined as data collected prior to the first dose in the core study (TKT032, TKT034, and HGT-GCB-039).|x10^9/L|Mean|79.4|79.4|Full Range|||47.0|139.0|
4249493|NCT00635427|4074022|B1|||Baseline platelet counts per treatment group|Baseline was defined as data collected prior to the first dose in the core study (TKT032, TKT034, and HGT-GCB-039).|x10^9/L|Mean|69.3|69.3|Full Range|||13.0|146.0|
4249494|NCT00635427|4074017|B6|||Baseline hemoglobin concentration per treatment group|Baseline was defined as data collected prior to the first dose in the core study (TKT032, TKT034, and HGT-GCB-039).|gram per deciliter|Mean|12.09|12.09|Full Range|||7.1|16.5|
4249495|NCT00635427|4074018|B5|||Baseline hemoglobin concentration per treatment group|Baseline was defined as data collected prior to the first dose in the core study (TKT032, TKT034, and HGT-GCB-039).|gram per deciliter|Mean|13.82|13.82|Full Range|||10.7|16.5|
4249496|NCT00635427|4074019|B4|||Baseline hemoglobin concentration per treatment group|Baseline was defined as data collected prior to the first dose in the core study (TKT032, TKT034, and HGT-GCB-039).|gram per deciliter|Mean|10.58|10.58|Full Range|||8.1|13.1|
4249497|NCT00635427|4074020|B3|||Baseline hemoglobin concentration per treatment group|Baseline was defined as data collected prior to the first dose in the core study (TKT032, TKT034, and HGT-GCB-039).|gram per deciliter|Mean|11.56|11.56|Full Range|||9.7|14.4|
4249498|NCT00635427|4074021|B2|||Baseline hemoglobin concentration per treatment group|Baseline was defined as data collected prior to the first dose in the core study (TKT032, TKT034, and HGT-GCB-039).|gram per deciliter|Mean|10.68|10.68|Full Range|||7.1|12.3|
4249499|NCT00635427|4074022|B1|||Baseline hemoglobin concentration per treatment group|Baseline was defined as data collected prior to the first dose in the core study (TKT032, TKT034, and HGT-GCB-039).|gram per deciliter|Mean|10.68|10.68|Full Range|||8.5|12.9|
4249500|NCT00635427|4074017|B6|No||Splenectomy status||Participants|Number|71|71.0||||||
4249501|NCT00635427|4074018|B5|No||Splenectomy status||Participants|Number|35|35.0||||||
4249502|NCT00635427|4074019|B4|No||Splenectomy status||Participants|Number|6|6.0||||||
4249503|NCT00635427|4074020|B3|No||Splenectomy status||Participants|Number|7|7.0||||||
4249504|NCT00635427|4074021|B2|No||Splenectomy status||Participants|Number|11|11.0||||||
4249505|NCT00635427|4074022|B1|No||Splenectomy status||Participants|Number|12|12.0||||||
4249506|NCT00635427|4074017|B6|Yes||Splenectomy status||Participants|Number|22|22.0||||||
4249507|NCT00635427|4074018|B5|Yes||Splenectomy status||Participants|Number|3|3.0||||||
4249508|NCT00635427|4074019|B4|Yes||Splenectomy status||Participants|Number|10|10.0||||||
4249509|NCT00635427|4074020|B3|Yes||Splenectomy status||Participants|Number|9|9.0||||||
4249510|NCT00635427|4074021|B2|Yes||Splenectomy status||Participants|Number|0|0.0||||||
4249511|NCT00635427|4074022|B1|Yes||Splenectomy status||Participants|Number|0|0.0||||||
4249512|NCT00635427|4074017|B6||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4249513|NCT00635427|4074018|B5||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4249514|NCT00635427|4074019|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4249515|NCT00635427|4074020|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4249516|NCT00635427|4074021|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4249517|NCT00635427|4074022|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4249518|NCT00635427|4074017|B6||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4249519|NCT00635427|4074018|B5||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4249520|NCT00635427|4074019|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4249521|NCT00635427|4074020|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4249522|NCT00635427|4074021|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4249524|NCT00635427|4074017|B6|Greater than or equal to 65 years||Age, Customized|Age at the time the informed consent was obtained in the core study.|Participants|Number|3|3.0||||||
4249525|NCT00635427|4074018|B5|Greater than or equal to 65 years||Age, Customized|Age at the time the informed consent was obtained in the core study.|Participants|Number|3|3.0||||||
4249526|NCT00635427|4074019|B4|Greater than or equal to 65 years||Age, Customized|Age at the time the informed consent was obtained in the core study.|Participants|Number|0|0.0||||||
4249527|NCT00635427|4074020|B3|Greater than or equal to 65 years||Age, Customized|Age at the time the informed consent was obtained in the core study.|Participants|Number|0|0.0||||||
4249528|NCT00635427|4074021|B2|Greater than or equal to 65 years||Age, Customized|Age at the time the informed consent was obtained in the core study.|Participants|Number|0|0.0||||||
4249529|NCT00635427|4074022|B1|Greater than or equal to 65 years||Age, Customized|Age at the time the informed consent was obtained in the core study.|Participants|Number|0|0.0||||||
4249530|NCT00635427|4074017|B6|Between 18 and 65 years||Age, Customized|Age at the time the informed consent was obtained in the core study.|Participants|Number|68|68.0||||||
4249531|NCT00635427|4074018|B5|Between 18 and 65 years||Age, Customized|Age at the time the informed consent was obtained in the core study.|Participants|Number|26|26.0||||||
4249532|NCT00635427|4074019|B4|Between 18 and 65 years||Age, Customized|Age at the time the informed consent was obtained in the core study.|Participants|Number|11|11.0||||||
4249533|NCT00635427|4074020|B3|Between 18 and 65 years||Age, Customized|Age at the time the informed consent was obtained in the core study.|Participants|Number|13|13.0||||||
4249534|NCT00635427|4074021|B2|Between 18 and 65 years||Age, Customized|Age at the time the informed consent was obtained in the core study.|Participants|Number|8|8.0||||||
4249535|NCT00635427|4074022|B1|Between 18 and 65 years||Age, Customized|Age at the time the informed consent was obtained in the core study.|Participants|Number|10|10.0||||||
4249536|NCT00635427|4074017|B6|At least 18 years||Age, Customized|Age at the time the informed consent was obtained in the core study.|Participants|Number|22|22.0||||||
4249537|NCT00635427|4074018|B5|At least 18 years||Age, Customized|Age at the time the informed consent was obtained in the core study.|Participants|Number|9|9.0||||||
4249538|NCT00635427|4074019|B4|At least 18 years||Age, Customized|Age at the time the informed consent was obtained in the core study.|Participants|Number|5|5.0||||||
4249539|NCT00635427|4074020|B3|At least 18 years||Age, Customized|Age at the time the informed consent was obtained in the core study.|Participants|Number|3|3.0||||||
4249540|NCT00635427|4074021|B2|At least 18 years||Age, Customized|Age at the time the informed consent was obtained in the core study.|Participants|Number|3|3.0||||||
4249541|NCT00635427|4074022|B1|At least 18 years||Age, Customized|Age at the time the informed consent was obtained in the core study.|Participants|Number|2|2.0||||||
4249542|NCT00635427|4074017|B6|||Age|Age at the time the informed consent was obtained in the core study.|Years|Mean|31.4|31.4|Standard Deviation|17.15|17.15|||
4249543|NCT00635427|4074018|B5|||Age|Age at the time the informed consent was obtained in the core study.|Years|Mean|34.3|34.3|Standard Deviation|17.94|17.94|||
4249544|NCT00635427|4074019|B4|||Age|Age at the time the informed consent was obtained in the core study.|Years|Mean|25|25.0|Standard Deviation|17.33|17.33|||
4249545|NCT00635427|4074020|B3|||Age|Age at the time the informed consent was obtained in the core study.|Years|Mean|32.9|32.9|Standard Deviation|16.14|16.14|||
4249546|NCT00635427|4074021|B2|||Age|Age at the time the informed consent was obtained in the core study.|Years|Mean|22|22.0|Standard Deviation|11.08|11.08|||
4249547|NCT00635427|4074022|B1|||Age|Age at the time the informed consent was obtained in the core study.|Years|Mean|32.5|32.5|Standard Deviation|16.75|16.75|||
4249548|NCT00635362|4074046|B3|3 or more||Parity at Enrollment||participants|Number|6|6.0||||||
4249549|NCT00635362|4074047|B2|3 or more||Parity at Enrollment||participants|Number|3|3.0||||||
4249550|NCT00635362|4074048|B1|3 or more||Parity at Enrollment||participants|Number|3|3.0||||||
4249551|NCT00635362|4074046|B3|2||Parity at Enrollment||participants|Number|17|17.0||||||
4249552|NCT00635362|4074047|B2|2||Parity at Enrollment||participants|Number|9|9.0||||||
4249553|NCT00635362|4074048|B1|2||Parity at Enrollment||participants|Number|8|8.0||||||
4249554|NCT00635362|4074046|B3|1||Parity at Enrollment||participants|Number|17|17.0||||||
4249555|NCT00635362|4074047|B2|1||Parity at Enrollment||participants|Number|7|7.0||||||
4249556|NCT00635362|4074048|B1|1||Parity at Enrollment||participants|Number|10|10.0||||||
4249557|NCT00635362|4074046|B3|0||Parity at Enrollment||participants|Number|2|2.0||||||
4249558|NCT00635362|4074047|B2|0||Parity at Enrollment||participants|Number|1|1.0||||||
4249559|NCT00635362|4074048|B1|0||Parity at Enrollment||participants|Number|1|1.0||||||
4249560|NCT00635362|4074046|B3|||Gestational Age at Delivery||weeks|Mean|38.4|38.4|Standard Deviation|1.6|1.6|||
4249561|NCT00635362|4074047|B2|||Gestational Age at Delivery||weeks|Mean|38.4|38.4|Standard Deviation|1.5|1.5|||
4249562|NCT00635362|4074048|B1|||Gestational Age at Delivery||weeks|Mean|38.3|38.3|Standard Deviation|1.7|1.7|||
4249563|NCT00635362|4074046|B3|Unknown/Not given||Insurance Coverage||participants|Number|1|1.0||||||
4249564|NCT00635362|4074047|B2|Unknown/Not given||Insurance Coverage||participants|Number|0|0.0||||||
4249565|NCT00635362|4074048|B1|Unknown/Not given||Insurance Coverage||participants|Number|1|1.0||||||
4249566|NCT00635362|4074046|B3|Private||Insurance Coverage||participants|Number|11|11.0||||||
4249567|NCT00635362|4074047|B2|Private||Insurance Coverage||participants|Number|6|6.0||||||
4249568|NCT00635362|4074048|B1|Private||Insurance Coverage||participants|Number|5|5.0||||||
4249569|NCT00635362|4074046|B3|Medicaid||Insurance Coverage||participants|Number|30|30.0||||||
4249570|NCT00635362|4074047|B2|Medicaid||Insurance Coverage||participants|Number|14|14.0||||||
4249571|NCT00635362|4074048|B1|Medicaid||Insurance Coverage||participants|Number|16|16.0||||||
4249572|NCT00635362|4074046|B3|>$30,000||Annual Income||participants|Number|16|16.0||||||
4249573|NCT00635362|4074047|B2|>$30,000||Annual Income||participants|Number|7|7.0||||||
4249576|NCT00635362|4074047|B2|$10,000-$30,000||Annual Income||participants|Number|7|7.0||||||
4249577|NCT00635362|4074048|B1|$10,000-$30,000||Annual Income||participants|Number|6|6.0||||||
4249578|NCT00635362|4074046|B3|<$10,000||Annual Income||participants|Number|13|13.0||||||
4249579|NCT00635362|4074047|B2|<$10,000||Annual Income||participants|Number|6|6.0||||||
4249580|NCT00635362|4074048|B1|<$10,000||Annual Income||participants|Number|7|7.0||||||
4249581|NCT00635362|4074046|B3|Married||Marital Status||participants|Number|17|17.0||||||
4249582|NCT00635362|4074047|B2|Married||Marital Status||participants|Number|8|8.0||||||
4249583|NCT00635362|4074048|B1|Married||Marital Status||participants|Number|9|9.0||||||
4249584|NCT00635362|4074046|B3|Single, living with partner||Marital Status||participants|Number|3|3.0||||||
4249585|NCT00635362|4074047|B2|Single, living with partner||Marital Status||participants|Number|2|2.0||||||
4249586|NCT00635362|4074048|B1|Single, living with partner||Marital Status||participants|Number|1|1.0||||||
4249587|NCT00635362|4074046|B3|Single||Marital Status||participants|Number|22|22.0||||||
4249588|NCT00635362|4074047|B2|Single||Marital Status||participants|Number|10|10.0||||||
4249589|NCT00635362|4074048|B1|Single||Marital Status||participants|Number|12|12.0||||||
4249590|NCT00635362|4074046|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4249591|NCT00635362|4074047|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4249592|NCT00635362|4074048|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4249593|NCT00635362|4074046|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4249594|NCT00635362|4074047|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4249595|NCT00635362|4074048|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4249596|NCT00635362|4074046|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249597|NCT00635362|4074047|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249598|NCT00635362|4074048|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249599|NCT00635362|4074046|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4249600|NCT00635362|4074047|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4249601|NCT00635362|4074048|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4249602|NCT00635362|4074046|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4249603|NCT00635362|4074047|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4249604|NCT00635362|4074048|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4249605|NCT00635362|4074046|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249606|NCT00635362|4074047|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249607|NCT00635362|4074048|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249608|NCT00635362|4074046|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249609|NCT00635362|4074047|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249610|NCT00635362|4074048|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249611|NCT00635362|4074046|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249612|NCT00635362|4074047|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249613|NCT00635362|4074048|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249614|NCT00635362|4074046|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249615|NCT00635362|4074047|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249616|NCT00635362|4074048|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249617|NCT00635362|4074046|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4249618|NCT00635362|4074047|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4249619|NCT00635362|4074048|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4249620|NCT00635362|4074046|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4249621|NCT00635362|4074047|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249622|NCT00635362|4074048|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4249623|NCT00635362|4074046|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4249624|NCT00635362|4074047|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4249625|NCT00635362|4074048|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4249626|NCT00635362|4074046|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4249627|NCT00635362|4074047|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4249628|NCT00635362|4074048|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4249629|NCT00635362|4074046|B3|||Age||years|Mean|27.8|27.8|Standard Deviation|5.7|5.7|||
4249630|NCT00635362|4074047|B2|||Age||years|Mean|27.1|27.1|Standard Deviation|6.2|6.2|||
4249631|NCT00635362|4074048|B1|||Age||years|Mean|28.4|28.4|Standard Deviation|5.3|5.3|||
4249632|NCT00635362|4074046|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4249633|NCT00635362|4074047|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4249634|NCT00635362|4074048|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4249722|NCT00635219|4074115|B6||Male|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
4249635|NCT00635362|4074046|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4249636|NCT00635362|4074047|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4249637|NCT00635362|4074048|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4249638|NCT00635362|4074046|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4249639|NCT00635362|4074047|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4249640|NCT00635362|4074048|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4249641|NCT00635349|4074063|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4249642|NCT00635349|4074064|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4249643|NCT00635349|4074065|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4249644|NCT00635349|4074063|B3||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4249645|NCT00635349|4074064|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4249646|NCT00635349|4074065|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4249647|NCT00635349|4074063|B3|||Age||years|Mean|61.1|61.1|Standard Deviation|7.9|7.9|||
4249648|NCT00635349|4074064|B2|||Age||years|Mean|62.3|62.3|Standard Deviation|7.6|7.6|||
4249649|NCT00635349|4074065|B1|||Age||years|Mean|60.0|60.0|Standard Deviation|8.0|8.0|||
4249650|NCT00635232|4074084|B6|United States||Region of Enrollment||participants|Number|261|261.0||||||
4249651|NCT00635232|4074085|B5|United States||Region of Enrollment||participants|Number|28|28.0||||||
4249652|NCT00635232|4074086|B4|United States||Region of Enrollment||participants|Number|58|58.0||||||
4249653|NCT00635232|4074087|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
4249654|NCT00635232|4074088|B2|United States||Region of Enrollment||participants|Number|59|59.0||||||
4249655|NCT00635232|4074089|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
4249656|NCT00635232|4074084|B6||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4249657|NCT00635232|4074085|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4249658|NCT00635232|4074086|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4249659|NCT00635232|4074087|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4249660|NCT00635232|4074088|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4249661|NCT00635232|4074089|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4249662|NCT00635232|4074084|B6||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4249663|NCT00635232|4074085|B5||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4249664|NCT00635232|4074086|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4249665|NCT00635232|4074087|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4249666|NCT00635232|4074088|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4249667|NCT00635232|4074089|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4249668|NCT00635232|4074084|B6|||Age||years|Mean|52.9|52.9|Standard Deviation|9.66|9.66|||
4249669|NCT00635232|4074085|B5|||Age||years|Mean|51.4|51.4|Standard Deviation|9.92|9.92|||
4249670|NCT00635232|4074086|B4|||Age||years|Mean|53.4|53.4|Standard Deviation|10.71|10.71|||
4249671|NCT00635232|4074087|B3|||Age||years|Mean|53.2|53.2|Standard Deviation|10.58|10.58|||
4249672|NCT00635232|4074088|B2|||Age||years|Mean|54.2|54.2|Standard Deviation|8.12|8.12|||
4249673|NCT00635232|4074089|B1|||Age||years|Mean|51.5|51.5|Standard Deviation|8.97|8.97|||
4249674|NCT00635232|4074084|B6||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4249675|NCT00635232|4074085|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4249676|NCT00635232|4074086|B4||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4249677|NCT00635232|4074087|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4249678|NCT00635232|4074088|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4249679|NCT00635232|4074089|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4249680|NCT00635232|4074084|B6||Between 18 and 65 years|Age||Participants|Count of Participants|231|231.0||||||
4249681|NCT00635232|4074085|B5||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4249682|NCT00635232|4074086|B4||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4249683|NCT00635232|4074087|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4249684|NCT00635232|4074088|B2||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4249685|NCT00635232|4074089|B1||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4249686|NCT00635232|4074084|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4249687|NCT00635232|4074085|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4249688|NCT00635232|4074086|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4249689|NCT00635232|4074087|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4249690|NCT00635232|4074088|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4249691|NCT00635232|4074089|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4249692|NCT00635219|4074115|B6|||HAM-A|The Hamilton Anxiety Rating Scale (HAM-A) consists of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behaviour at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic, and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total score from 0 to 56. The higher the score, the more severe.|units on a scale|Mean|23.0|23.0|Standard Deviation|6.3|6.3|||
4249723|NCT00635219|4074116|B5||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4249693|NCT00635219|4074116|B5|||HAM-A|The Hamilton Anxiety Rating Scale (HAM-A) consists of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behaviour at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic, and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total score from 0 to 56. The higher the score, the more severe.|units on a scale|Mean|22.8|22.8|Standard Deviation|6.4|6.4|||
4249694|NCT00635219|4074117|B4|||HAM-A|The Hamilton Anxiety Rating Scale (HAM-A) consists of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behaviour at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic, and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total score from 0 to 56. The higher the score, the more severe.|units on a scale|Mean|23.4|23.4|Standard Deviation|6.3|6.3|||
4249695|NCT00635219|4074118|B3|||HAM-A|The Hamilton Anxiety Rating Scale (HAM-A) consists of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behaviour at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic, and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total score from 0 to 56. The higher the score, the more severe.|units on a scale|Mean|23.5|23.5|Standard Deviation|6.2|6.2|||
4249696|NCT00635219|4074119|B2|||HAM-A|The Hamilton Anxiety Rating Scale (HAM-A) consists of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behaviour at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic, and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total score from 0 to 56. The higher the score, the more severe.|units on a scale|Mean|22.2|22.2|Standard Deviation|6.7|6.7|||
4249697|NCT00635219|4074120|B1|||HAM-A|The Hamilton Anxiety Rating Scale (HAM-A) consists of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behaviour at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic, and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total score from 0 to 56. The higher the score, the more severe.|units on a scale|Mean|23.1|23.1|Standard Deviation|5.6|5.6|||
4249698|NCT00635219|4074115|B6|||SDS|The Sheehan Disability Scale (SDS) comprises self-rated items designed to measure impairment. The patient rates the extent to which his or her (1) work, (2) social life or leisure activities and (3) home life or family responsibilities are impaired on a 10-point visual analogue scales, on which 0 = normal functioning and 10 = severe functional impairment. The three items may be summed into a single dimensional measure of global functional impairment that ranges from 0 (unimpaired) to 30 (highly impaired). The higher the score, the more severe.|units on a scale|Mean|19.6|19.6|Standard Deviation|6.2|6.2|||
4249699|NCT00635219|4074116|B5|||SDS|The Sheehan Disability Scale (SDS) comprises self-rated items designed to measure impairment. The patient rates the extent to which his or her (1) work, (2) social life or leisure activities and (3) home life or family responsibilities are impaired on a 10-point visual analogue scales, on which 0 = normal functioning and 10 = severe functional impairment. The three items may be summed into a single dimensional measure of global functional impairment that ranges from 0 (unimpaired) to 30 (highly impaired). The higher the score, the more severe.|units on a scale|Mean|19.2|19.2|Standard Deviation|5.9|5.9|||
4249700|NCT00635219|4074117|B4|||SDS|The Sheehan Disability Scale (SDS) comprises self-rated items designed to measure impairment. The patient rates the extent to which his or her (1) work, (2) social life or leisure activities and (3) home life or family responsibilities are impaired on a 10-point visual analogue scales, on which 0 = normal functioning and 10 = severe functional impairment. The three items may be summed into a single dimensional measure of global functional impairment that ranges from 0 (unimpaired) to 30 (highly impaired). The higher the score, the more severe.|units on a scale|Mean|19.6|19.6|Standard Deviation|6.5|6.5|||
4249701|NCT00635219|4074118|B3|||SDS|The Sheehan Disability Scale (SDS) comprises self-rated items designed to measure impairment. The patient rates the extent to which his or her (1) work, (2) social life or leisure activities and (3) home life or family responsibilities are impaired on a 10-point visual analogue scales, on which 0 = normal functioning and 10 = severe functional impairment. The three items may be summed into a single dimensional measure of global functional impairment that ranges from 0 (unimpaired) to 30 (highly impaired). The higher the score, the more severe.|units on a scale|Mean|19.6|19.6|Standard Deviation|6.2|6.2|||
4249702|NCT00635219|4074119|B2|||SDS|The Sheehan Disability Scale (SDS) comprises self-rated items designed to measure impairment. The patient rates the extent to which his or her (1) work, (2) social life or leisure activities and (3) home life or family responsibilities are impaired on a 10-point visual analogue scales, on which 0 = normal functioning and 10 = severe functional impairment. The three items may be summed into a single dimensional measure of global functional impairment that ranges from 0 (unimpaired) to 30 (highly impaired). The higher the score, the more severe.|units on a scale|Mean|19.4|19.4|Standard Deviation|6.5|6.5|||
4249703|NCT00635219|4074120|B1|||SDS|The Sheehan Disability Scale (SDS) comprises self-rated items designed to measure impairment. The patient rates the extent to which his or her (1) work, (2) social life or leisure activities and (3) home life or family responsibilities are impaired on a 10-point visual analogue scales, on which 0 = normal functioning and 10 = severe functional impairment. The three items may be summed into a single dimensional measure of global functional impairment that ranges from 0 (unimpaired) to 30 (highly impaired). The higher the score, the more severe.|units on a scale|Mean|19.9|19.9|Standard Deviation|5.8|5.8|||
4249704|NCT00635219|4074115|B6|||CGI-S|The Clinical Global Impression - Severity of Illness (CGI-S) is a 7-point scale rated from 1 (normal, not at all ill) to 7 (among the most extremely ill patients). The investigator should use his/her total clinical experience with this patient population to judge how mentally ill the patient is at the time of rating.|units on a scale|Mean|4.8|4.8|Standard Deviation|0.7|0.7|||
4249705|NCT00635219|4074116|B5|||CGI-S|The Clinical Global Impression - Severity of Illness (CGI-S) is a 7-point scale rated from 1 (normal, not at all ill) to 7 (among the most extremely ill patients). The investigator should use his/her total clinical experience with this patient population to judge how mentally ill the patient is at the time of rating.|units on a scale|Mean|4.7|4.7|Standard Deviation|0.7|0.7|||
4249724|NCT00635219|4074117|B4||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4249706|NCT00635219|4074117|B4|||CGI-S|The Clinical Global Impression - Severity of Illness (CGI-S) is a 7-point scale rated from 1 (normal, not at all ill) to 7 (among the most extremely ill patients). The investigator should use his/her total clinical experience with this patient population to judge how mentally ill the patient is at the time of rating.|units on a scale|Mean|4.7|4.7|Standard Deviation|0.7|0.7|||
4249707|NCT00635219|4074118|B3|||CGI-S|The Clinical Global Impression - Severity of Illness (CGI-S) is a 7-point scale rated from 1 (normal, not at all ill) to 7 (among the most extremely ill patients). The investigator should use his/her total clinical experience with this patient population to judge how mentally ill the patient is at the time of rating.|units on a scale|Mean|4.8|4.8|Standard Deviation|0.7|0.7|||
4249708|NCT00635219|4074119|B2|||CGI-S|The Clinical Global Impression - Severity of Illness (CGI-S) is a 7-point scale rated from 1 (normal, not at all ill) to 7 (among the most extremely ill patients). The investigator should use his/her total clinical experience with this patient population to judge how mentally ill the patient is at the time of rating.|units on a scale|Mean|4.8|4.8|Standard Deviation|0.7|0.7|||
4249709|NCT00635219|4074120|B1|||CGI-S|The Clinical Global Impression - Severity of Illness (CGI-S) is a 7-point scale rated from 1 (normal, not at all ill) to 7 (among the most extremely ill patients). The investigator should use his/her total clinical experience with this patient population to judge how mentally ill the patient is at the time of rating.|units on a scale|Mean|4.8|4.8|Standard Deviation|0.7|0.7|||
4249710|NCT00635219|4074115|B6|||HAM-D-24|The Hamilton Depression Scale - 24 Items (HAM-D-24) measures depression severity. Items are rated on a scale from 0 (symptoms not present) to a maximum of 2 to 4 (symptom extremely severe) for a total score range of 0 to 76. The higher the score, the more severe.|units on a scale|Mean|30.2|30.2|Standard Deviation|5.6|5.6|||
4249711|NCT00635219|4074116|B5|||HAM-D-24|The Hamilton Depression Scale - 24 Items (HAM-D-24) measures depression severity. Items are rated on a scale from 0 (symptoms not present) to a maximum of 2 to 4 (symptom extremely severe) for a total score range of 0 to 76. The higher the score, the more severe.|units on a scale|Mean|29.9|29.9|Standard Deviation|5.8|5.8|||
4249712|NCT00635219|4074117|B4|||HAM-D-24|The Hamilton Depression Scale - 24 Items (HAM-D-24) measures depression severity. Items are rated on a scale from 0 (symptoms not present) to a maximum of 2 to 4 (symptom extremely severe) for a total score range of 0 to 76. The higher the score, the more severe.|units on a scale|Mean|30.4|30.4|Standard Deviation|5.4|5.4|||
4249713|NCT00635219|4074118|B3|||HAM-D-24|The Hamilton Depression Scale - 24 Items (HAM-D-24) measures depression severity. Items are rated on a scale from 0 (symptoms not present) to a maximum of 2 to 4 (symptom extremely severe) for a total score range of 0 to 76. The higher the score, the more severe.|units on a scale|Mean|31.3|31.3|Standard Deviation|5.8|5.8|||
4249714|NCT00635219|4074119|B2|||HAM-D-24|The Hamilton Depression Scale - 24 Items (HAM-D-24) measures depression severity. Items are rated on a scale from 0 (symptoms not present) to a maximum of 2 to 4 (symptom extremely severe) for a total score range of 0 to 76. The higher the score, the more severe.|units on a scale|Mean|29.6|29.6|Standard Deviation|5.8|5.8|||
4249715|NCT00635219|4074120|B1|||HAM-D-24|The Hamilton Depression Scale - 24 Items (HAM-D-24) measures depression severity. Items are rated on a scale from 0 (symptoms not present) to a maximum of 2 to 4 (symptom extremely severe) for a total score range of 0 to 76. The higher the score, the more severe.|units on a scale|Mean|29.8|29.8|Standard Deviation|5.1|5.1|||
4249716|NCT00635219|4074115|B6|||MADRS|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 (no symptom) to 6 (severe symptom). The 10 items represent the core symptoms of depressive illness. The rating should be based on a clinical interview with the patient, moving from broadly phrased questions about symptoms to more detailed ones, which allow a precise rating of severity, covering the last 7 days. Total score from 0 to 60. The higher the score, the more severe.|units on a scale|Mean|31.9|31.9|Standard Deviation|4.3|4.3|||
4249717|NCT00635219|4074116|B5|||MADRS|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 (no symptom) to 6 (severe symptom). The 10 items represent the core symptoms of depressive illness. The rating should be based on a clinical interview with the patient, moving from broadly phrased questions about symptoms to more detailed ones, which allow a precise rating of severity, covering the last 7 days. Total score from 0 to 60. The higher the score, the more severe.|units on a scale|Mean|31.4|31.4|Standard Deviation|4.2|4.2|||
4249718|NCT00635219|4074117|B4|||MADRS|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 (no symptom) to 6 (severe symptom). The 10 items represent the core symptoms of depressive illness. The rating should be based on a clinical interview with the patient, moving from broadly phrased questions about symptoms to more detailed ones, which allow a precise rating of severity, covering the last 7 days. Total score from 0 to 60. The higher the score, the more severe.|units on a scale|Mean|31.8|31.8|Standard Deviation|3.9|3.9|||
4249719|NCT00635219|4074118|B3|||MADRS|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 (no symptom) to 6 (severe symptom). The 10 items represent the core symptoms of depressive illness. The rating should be based on a clinical interview with the patient, moving from broadly phrased questions about symptoms to more detailed ones, which allow a precise rating of severity, covering the last 7 days. Total score from 0 to 60. The higher the score, the more severe.|units on a scale|Mean|32.7|32.7|Standard Deviation|4.8|4.8|||
4249720|NCT00635219|4074119|B2|||MADRS|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 (no symptom) to 6 (severe symptom). The 10 items represent the core symptoms of depressive illness. The rating should be based on a clinical interview with the patient, moving from broadly phrased questions about symptoms to more detailed ones, which allow a precise rating of severity, covering the last 7 days. Total score from 0 to 60. The higher the score, the more severe.|units on a scale|Mean|31.6|31.6|Standard Deviation|4.0|4.0|||
4249721|NCT00635219|4074120|B1|||MADRS|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 (no symptom) to 6 (severe symptom). The 10 items represent the core symptoms of depressive illness. The rating should be based on a clinical interview with the patient, moving from broadly phrased questions about symptoms to more detailed ones, which allow a precise rating of severity, covering the last 7 days. Total score from 0 to 60. The higher the score, the more severe.|units on a scale|Mean|31.7|31.7|Standard Deviation|4.3|4.3|||
4249725|NCT00635219|4074118|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4249726|NCT00635219|4074119|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4249727|NCT00635219|4074120|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4249728|NCT00635219|4074115|B6||Female|Sex: Female, Male||Participants|Count of Participants|522|522.0||||||
4249729|NCT00635219|4074116|B5||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4249730|NCT00635219|4074117|B4||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4249731|NCT00635219|4074118|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4249732|NCT00635219|4074119|B2||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4249733|NCT00635219|4074120|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4249734|NCT00635219|4074115|B6|||Age||years|Mean|44.9|44.9|Standard Deviation|12.7|12.7|||
4249735|NCT00635219|4074116|B5|||Age||years|Mean|45.3|45.3|Standard Deviation|12.0|12.0|||
4249736|NCT00635219|4074117|B4|||Age||years|Mean|45.2|45.2|Standard Deviation|13.1|13.1|||
4249737|NCT00635219|4074118|B3|||Age||years|Mean|44.7|44.7|Standard Deviation|13.1|13.1|||
4249738|NCT00635219|4074119|B2|||Age||years|Mean|46.0|46.0|Standard Deviation|12.5|12.5|||
4249739|NCT00635219|4074120|B1|||Age||years|Mean|43.4|43.4|Standard Deviation|12.5|12.5|||
4249740|NCT00635167|4074181|B1|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4249741|NCT00635167|4074181|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4249742|NCT00635167|4074181|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4249743|NCT00635167|4074181|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4249744|NCT00635167|4074181|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4249745|NCT00635167|4074181|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4249746|NCT00635154|4074187|B1|No||Prior treatment for M-protein||participants|Number|44|44.0||||||
4249747|NCT00635154|4074187|B1|Yes||Prior treatment for M-protein||participants|Number|10|10.0||||||
4249748|NCT00635154|4074187|B1|Indolent Multiple Myeloma (IMM)||Diagnosis||participants|Number|10|10.0||||||
4249749|NCT00635154|4074187|B1|Smoldering Multiple Myeloma (SMM)||Diagnosis||participants|Number|44|44.0||||||
4249750|NCT00635154|4074187|B1|United States||Region of Enrollment||participants|Number|54|54.0||||||
4249751|NCT00635154|4074187|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4249752|NCT00635154|4074187|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4249753|NCT00635154|4074187|B1|||Age||years|Median|60.0|60.0|Full Range|||38.0|79.0|
4249754|NCT00635128|4074197|B3|Not specified||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4249755|NCT00635128|4074198|B2|Not specified||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4249756|NCT00635128|4074199|B1|Not specified||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4249757|NCT00635128|4074197|B3|White-Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4249758|NCT00635128|4074198|B2|White-Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4249759|NCT00635128|4074199|B1|White-Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4249760|NCT00635128|4074197|B3|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|410|410.0||||||
4249761|NCT00635128|4074198|B2|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|63|63.0||||||
4249762|NCT00635128|4074199|B1|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|347|347.0||||||
4249763|NCT00635128|4074197|B3||Male|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4249764|NCT00635128|4074198|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4249765|NCT00635128|4074199|B1||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4249766|NCT00635128|4074197|B3||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4249767|NCT00635128|4074198|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4249768|NCT00635128|4074199|B1||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4249769|NCT00635128|4074197|B3|||Age||Years|Mean|11.38|11.38|Standard Deviation|0.94|0.94|||
4249770|NCT00635128|4074198|B2|||Age||Years|Mean|11.3|11.3|Standard Deviation|0.72|0.72|||
4249771|NCT00635128|4074199|B1|||Age||Years|Mean|11.4|11.4|Standard Deviation|0.97|0.97|||
4249772|NCT00635102|4074228|B3|United States||Region of Enrollment||participants|Number|57|57.0||||||
4249773|NCT00635102|4074229|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4249774|NCT00635102|4074230|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4249775|NCT00635102|4074228|B3||Male|Gender||Participants|Count of Participants|50|50.0||||||
4249776|NCT00635102|4074229|B2||Male|Gender||Participants|Count of Participants|23|23.0||||||
4249777|NCT00635102|4074230|B1||Male|Gender||Participants|Count of Participants|27|27.0||||||
4249778|NCT00635102|4074228|B3||Female|Gender||Participants|Count of Participants|7|7.0||||||
4249779|NCT00635102|4074229|B2||Female|Gender||Participants|Count of Participants|7|7.0||||||
4249780|NCT00635102|4074230|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
4249781|NCT00635102|4074228|B3|||Age||years|Mean|37.9|37.9|Standard Deviation|.17|0.17|||
4249782|NCT00635102|4074229|B2|||Age||years|Mean|31.9|31.9|Standard Deviation|10|10.0|||
4249783|NCT00635102|4074230|B1|||Age||years|Mean|43.6|43.6|Standard Deviation|9.5|9.5|||
4249784|NCT00635102|4074228|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4249785|NCT00635102|4074229|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4249786|NCT00635102|4074230|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4249787|NCT00635102|4074228|B3||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4249788|NCT00635102|4074229|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4249789|NCT00635102|4074230|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4249790|NCT00635102|4074228|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4249791|NCT00635102|4074229|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4249792|NCT00635102|4074230|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4249793|NCT00635089|4074325|B1||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4249794|NCT00635089|4074325|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4249795|NCT00635089|4074325|B1|12 to 19 years||Age, Customized||participants|Number|109|109.0||||||
4249796|NCT00635089|4074325|B1|5 to 11 years||Age, Customized||participants|Number|81|81.0||||||
4249797|NCT00635089|4074325|B1|||Age||years|Mean|12.1|12.1|Standard Deviation|3.97|3.97|||
4249798|NCT00635050|4074352|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4249799|NCT00635050|4074352|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4249800|NCT00635050|4074352|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4249801|NCT00635050|4074352|B1|||Age||years|Median|49|49.0|Full Range|||34.0|69.0|
4249802|NCT00635024|4074359|B1|No||Parameters of Hematologic Response|Bone marrow plasma cells > 30%|participants|Number|0|0.0||||||
4249803|NCT00635024|4074359|B1|Yes||Parameters of Hematologic Response|Bone marrow plasma cells > 30%|participants|Number|1|1.0||||||
4249804|NCT00635024|4074359|B1|No||Parameters of Hematologic Response|Urine M-Spike >= 200 mg/24 hours|participants|Number|0|0.0||||||
4249805|NCT00635024|4074359|B1|Yes||Parameters of Hematologic Response|Urine M-Spike >= 200 mg/24 hours|participants|Number|1|1.0||||||
4249806|NCT00635024|4074359|B1|No||Parameters of Hematologic Response|Serum immunoglobulin free light chain >= 10 mg/dL|participants|Number|0|0.0||||||
4249807|NCT00635024|4074359|B1|Yes||Parameters of Hematologic Response|Serum immunoglobulin free light chain >= 10 mg/dL|participants|Number|1|1.0||||||
4249808|NCT00635024|4074359|B1|No||Parameters of Hematologic Response|Serum M-Spike >=1 g/dL|participants|Number|0|0.0||||||
4249809|NCT00635024|4074359|B1|Yes||Parameters of Hematologic Response|Serum M-Spike >=1 g/dL|participants|Number|1|1.0||||||
4249810|NCT00635024|4074359|B1|No||Prior Stem Cell Transplant||participants|Number|0|0.0||||||
4249811|NCT00635024|4074359|B1|Yes||Prior Stem Cell Transplant||participants|Number|1|1.0||||||
4249812|NCT00635024|4074359|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4249813|NCT00635024|4074359|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4249814|NCT00635024|4074359|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
4249815|NCT00635024|4074359|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4249816|NCT00635024|4074359|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4249817|NCT00635024|4074359|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4249818|NCT00634933|4074367|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4249819|NCT00634933|4074368|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4249820|NCT00634933|4074369|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4249821|NCT00634933|4074370|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4249822|NCT00634933|4074367|B4||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4249823|NCT00634933|4074368|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4249824|NCT00634933|4074369|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4249825|NCT00634933|4074370|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4249826|NCT00634933|4074367|B4|||Age||years|Mean|52.05|52.05|Standard Deviation|11.81|11.81|||
4249827|NCT00634933|4074368|B3|||Age||years|Mean|52.55|52.55|Standard Deviation|13.00|13.0|||
4249828|NCT00634933|4074369|B2|||Age||years|Mean|52.99|52.99|Standard Deviation|11.33|11.33|||
4249829|NCT00634933|4074370|B1|||Age||years|Mean|50.62|50.62|Standard Deviation|11.07|11.07|||
4249830|NCT00634920|4074440|B4|Oriental||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4249831|NCT00634920|4074441|B3|Oriental||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4249832|NCT00634920|4074442|B2|Oriental||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4249833|NCT00634920|4074443|B1|Oriental||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4249834|NCT00634920|4074440|B4|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4249835|NCT00634920|4074441|B3|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4249836|NCT00634920|4074442|B2|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4249837|NCT00634920|4074443|B1|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4249838|NCT00634920|4074440|B4|Caucasian||Race/Ethnicity, Customized||Participants|Number|337|337.0||||||
4249839|NCT00634920|4074441|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|136|136.0||||||
4249840|NCT00634920|4074442|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|100|100.0||||||
4249841|NCT00634920|4074443|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|101|101.0||||||
4249842|NCT00634920|4074440|B4||Male|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
4249843|NCT00634920|4074441|B3||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4249844|NCT00634920|4074442|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4249845|NCT00634920|4074443|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4249846|NCT00634920|4074440|B4||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4249847|NCT00634920|4074441|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4249848|NCT00634920|4074442|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4249849|NCT00634920|4074443|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4249850|NCT00634920|4074440|B4|||Age||Years|Mean|55.0|55.0|Standard Deviation|12.0|12.0|||
4249851|NCT00634920|4074441|B3|||Age||Years|Mean|56.3|56.3|Standard Deviation|12.5|12.5|||
4249852|NCT00634920|4074442|B2|||Age||Years|Mean|53.3|53.3|Standard Deviation|12.3|12.3|||
4249853|NCT00634920|4074443|B1|||Age||Years|Mean|55.0|55.0|Standard Deviation|10.9|10.9|||
4249854|NCT00634907|4074487|B3|United States||Region of Enrollment||participants|Number|229|229.0||||||
4249855|NCT00634907|4074488|B2|United States||Region of Enrollment||participants|Number|115|115.0||||||
4249856|NCT00634907|4074489|B1|United States||Region of Enrollment||participants|Number|114|114.0||||||
4249857|NCT00634907|4074487|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4249858|NCT00634907|4074488|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4249859|NCT00634907|4074489|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4249860|NCT00634907|4074487|B3||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4249861|NCT00634907|4074488|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4249862|NCT00634907|4074489|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4249863|NCT00634907|4074487|B3|||Age||years|Mean|58.75|58.75|Standard Deviation|12.49|12.49|||
4249864|NCT00634907|4074488|B2|||Age||years|Mean|59.25|59.25|Standard Deviation|12.83|12.83|||
4249865|NCT00634907|4074489|B1|||Age||years|Mean|58.18|58.18|Standard Deviation|12.14|12.14|||
4249866|NCT00634907|4074487|B3||>=65 years|Age||Participants|Count of Participants|71|71.0||||||
4249867|NCT00634907|4074488|B2||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
4249868|NCT00634907|4074489|B1||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4249869|NCT00634907|4074487|B3||Between 18 and 65 years|Age||Participants|Count of Participants|158|158.0||||||
4249870|NCT00634907|4074488|B2||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4249871|NCT00634907|4074489|B1||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
4249872|NCT00634907|4074487|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4249873|NCT00634907|4074488|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4249874|NCT00634907|4074489|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4249875|NCT00634842|4074512|B3|||Glycosylated haemoglobin (HbA1c)|Level of glycosylated haemoglobin (HbA1c) measured at baseline|percentage|Mean|8.0|8.0|Standard Deviation|0.6|0.6|||
4249876|NCT00634842|4074513|B2|||Glycosylated haemoglobin (HbA1c)|Level of glycosylated haemoglobin (HbA1c) measured at baseline|percentage|Mean|7.9|7.9|Standard Deviation|0.6|0.6|||
4249877|NCT00634842|4074514|B1|||Glycosylated haemoglobin (HbA1c)|Level of glycosylated haemoglobin (HbA1c) measured at baseline|percentage|Mean|8.0|8.0|Standard Deviation|0.6|0.6|||
4249878|NCT00634842|4074512|B3|||Fasting plasma glucose (FPG)|Level of fasting plasma glucose (FPG) measured at baseline|mg/dL|Mean|163.5|163.5|Standard Deviation|41.7|41.7|||
4249879|NCT00634842|4074513|B2|||Fasting plasma glucose (FPG)|Level of fasting plasma glucose (FPG) measured at baseline|mg/dL|Mean|163.1|163.1|Standard Deviation|40.4|40.4|||
4249880|NCT00634842|4074514|B1|||Fasting plasma glucose (FPG)|Level of fasting plasma glucose (FPG) measured at baseline|mg/dL|Mean|164.0|164.0|Standard Deviation|43.1|43.1|||
4249881|NCT00634842|4074512|B3||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4249882|NCT00634842|4074513|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4249883|NCT00634842|4074514|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4249884|NCT00634842|4074512|B3||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4249885|NCT00634842|4074513|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4249886|NCT00634842|4074514|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4249887|NCT00634842|4074512|B3|||Age||years|Mean|56.9|56.9|Standard Deviation|10.0|10.0|||
4249888|NCT00634842|4074513|B2|||Age||years|Mean|57.2|57.2|Standard Deviation|10.6|10.6|||
4249889|NCT00634842|4074514|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|9.4|9.4|||
4249890|NCT00634751|4074527|B5|United States||Region of Enrollment||participants|Number|48|48.0||||||
4249891|NCT00634751|4074528|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
4249892|NCT00634751|4074529|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4249893|NCT00634751|4074530|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4249894|NCT00634751|4074531|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4249895|NCT00634751|4074527|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4249896|NCT00634751|4074528|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4249897|NCT00634751|4074529|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249898|NCT00634751|4074530|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249899|NCT00634751|4074531|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249900|NCT00634751|4074527|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249901|NCT00634751|4074528|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249902|NCT00634751|4074529|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249903|NCT00634751|4074530|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249904|NCT00634751|4074531|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249905|NCT00634751|4074527|B5||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4249906|NCT00634751|4074528|B4||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4249907|NCT00634751|4074529|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4249908|NCT00634751|4074530|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4249909|NCT00634751|4074531|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4249910|NCT00634751|4074527|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249911|NCT00634751|4074528|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249912|NCT00634751|4074529|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249913|NCT00634751|4074530|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249914|NCT00634751|4074531|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249915|NCT00634751|4074527|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249916|NCT00634751|4074528|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249917|NCT00634751|4074529|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249918|NCT00634751|4074530|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249919|NCT00634751|4074531|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249920|NCT00634751|4074527|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4249921|NCT00634751|4074528|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249922|NCT00634751|4074529|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249923|NCT00634751|4074530|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4249924|NCT00634751|4074531|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249925|NCT00634751|4074527|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249926|NCT00634751|4074528|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249927|NCT00634751|4074529|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249928|NCT00634751|4074530|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249929|NCT00634751|4074531|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249930|NCT00634751|4074527|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4249931|NCT00634751|4074528|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4249932|NCT00634751|4074529|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4249933|NCT00634751|4074530|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249934|NCT00634751|4074531|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4249935|NCT00634751|4074527|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4249936|NCT00634751|4074528|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4249937|NCT00634751|4074529|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4249938|NCT00634751|4074530|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4249939|NCT00634751|4074531|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4249940|NCT00634751|4074527|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4249941|NCT00634751|4074528|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4249942|NCT00634751|4074529|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4249943|NCT00634751|4074530|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249944|NCT00634751|4074531|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249945|NCT00634751|4074527|B5||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4249946|NCT00634751|4074528|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4249947|NCT00634751|4074529|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4249948|NCT00634751|4074530|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4249949|NCT00634751|4074531|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4249950|NCT00634751|4074527|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4249951|NCT00634751|4074528|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4249952|NCT00634751|4074529|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4249953|NCT00634751|4074530|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4249954|NCT00634751|4074531|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4249955|NCT00634751|4074527|B5|>= 80 years of age||Age, Customized||Participants|Count of Participants|2|2.0||||||
4249956|NCT00634751|4074528|B4|>= 80 years of age||Age, Customized||Participants|Count of Participants|0|0.0||||||
4249957|NCT00634751|4074529|B3|>= 80 years of age||Age, Customized||Participants|Count of Participants|1|1.0||||||
4249958|NCT00634751|4074530|B2|>= 80 years of age||Age, Customized||Participants|Count of Participants|0|0.0||||||
4249959|NCT00634751|4074531|B1|>= 80 years of age||Age, Customized||Participants|Count of Participants|1|1.0||||||
4249960|NCT00634751|4074527|B5|70-79 years of age||Age, Customized||Participants|Count of Participants|12|12.0||||||
4249961|NCT00634751|4074528|B4|70-79 years of age||Age, Customized||Participants|Count of Participants|2|2.0||||||
4249962|NCT00634751|4074529|B3|70-79 years of age||Age, Customized||Participants|Count of Participants|7|7.0||||||
4249963|NCT00634751|4074530|B2|70-79 years of age||Age, Customized||Participants|Count of Participants|0|0.0||||||
4249964|NCT00634751|4074531|B1|70-79 years of age||Age, Customized||Participants|Count of Participants|3|3.0||||||
4249965|NCT00634751|4074527|B5|60-69 years of age||Age, Customized||Participants|Count of Participants|16|16.0||||||
4249966|NCT00634751|4074528|B4|60-69 years of age||Age, Customized||Participants|Count of Participants|2|2.0||||||
4249967|NCT00634751|4074529|B3|60-69 years of age||Age, Customized||Participants|Count of Participants|7|7.0||||||
4249968|NCT00634751|4074530|B2|60-69 years of age||Age, Customized||Participants|Count of Participants|4|4.0||||||
4249969|NCT00634751|4074531|B1|60-69 years of age||Age, Customized||Participants|Count of Participants|3|3.0||||||
4249970|NCT00634751|4074527|B5|50-59 years of age||Age, Customized||Participants|Count of Participants|13|13.0||||||
4249971|NCT00634751|4074528|B4|50-59 years of age||Age, Customized||Participants|Count of Participants|2|2.0||||||
4249972|NCT00634751|4074529|B3|50-59 years of age||Age, Customized||Participants|Count of Participants|8|8.0||||||
4249973|NCT00634751|4074530|B2|50-59 years of age||Age, Customized||Participants|Count of Participants|2|2.0||||||
4249974|NCT00634751|4074531|B1|50-59 years of age||Age, Customized||Participants|Count of Participants|1|1.0||||||
4249975|NCT00634751|4074527|B5|=< 50 years of age||Age, Customized||Participants|Count of Participants|5|5.0||||||
4249976|NCT00634751|4074528|B4|=< 50 years of age||Age, Customized||Participants|Count of Participants|2|2.0||||||
4249977|NCT00634751|4074529|B3|=< 50 years of age||Age, Customized||Participants|Count of Participants|1|1.0||||||
4249978|NCT00634751|4074530|B2|=< 50 years of age||Age, Customized||Participants|Count of Participants|1|1.0||||||
4249979|NCT00634751|4074531|B1|=< 50 years of age||Age, Customized||Participants|Count of Participants|1|1.0||||||
4249980|NCT00634647|4074552|B1|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
4249981|NCT00634647|4074552|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4249982|NCT00634647|4074552|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249983|NCT00634647|4074552|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4249984|NCT00634647|4074552|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4249985|NCT00634647|4074552|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249986|NCT00634647|4074552|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249987|NCT00634647|4074552|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249988|NCT00634647|4074552|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4249989|NCT00634647|4074552|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4249990|NCT00634647|4074552|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4249991|NCT00634647|4074552|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4249992|NCT00634647|4074552|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4249993|NCT00634647|4074552|B1|||Age||years|Mean|64.83|64.83|Standard Deviation|9.71|9.71|||
4249994|NCT00634647|4074552|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4249995|NCT00634647|4074552|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4249996|NCT00634647|4074552|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4249997|NCT00634621|4074558|B1|Spain||Region of Enrollment||participants|Number|283|283.0||||||
4249998|NCT00634621|4074558|B1||Male|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
4249999|NCT00634621|4074558|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4250000|NCT00634621|4074558|B1|||Age||years|Mean|67.5|67.5|Standard Deviation|10.8|10.8|||
4250001|NCT00634621|4074558|B1||>=65 years|Age||Participants|Count of Participants|173|173.0||||||
4250002|NCT00634621|4074558|B1||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
4250003|NCT00634621|4074558|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4250004|NCT00634582|4074566|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4250005|NCT00634582|4074566|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4250006|NCT00634582|4074566|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4250007|NCT00634582|4074566|B1|||Age||years|Mean|81.8|81.8|Standard Deviation|2.3|2.3|||
4250008|NCT00634582|4074566|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4250009|NCT00634582|4074566|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4250010|NCT00634582|4074566|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4250011|NCT00634569|4074570|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250012|NCT00634569|4074571|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250013|NCT00634569|4074572|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250014|NCT00634569|4074570|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250015|NCT00634569|4074571|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250016|NCT00634569|4074572|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250017|NCT00634569|4074570|B3||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4250018|NCT00634569|4074571|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4250019|NCT00634569|4074572|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4250020|NCT00634569|4074570|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4250021|NCT00634569|4074571|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4250022|NCT00634569|4074572|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250023|NCT00634569|4074570|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250024|NCT00634569|4074571|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250025|NCT00634569|4074572|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250026|NCT00634569|4074570|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250027|NCT00634569|4074571|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250028|NCT00634569|4074572|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250029|NCT00634569|4074570|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250030|NCT00634569|4074571|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250031|NCT00634569|4074572|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250032|NCT00634569|4074570|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250033|NCT00634569|4074571|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250034|NCT00634569|4074572|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250035|NCT00634569|4074570|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4250036|NCT00634569|4074571|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4250037|NCT00634569|4074572|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4250038|NCT00634569|4074570|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250039|NCT00634569|4074571|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250040|NCT00634569|4074572|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250041|NCT00634569|4074570|B3||Male|Gender||Participants|Count of Participants|19|19.0||||||
4250042|NCT00634569|4074571|B2||Male|Gender||Participants|Count of Participants|9|9.0||||||
4250043|NCT00634569|4074572|B1||Male|Gender||Participants|Count of Participants|10|10.0||||||
4250044|NCT00634569|4074570|B3||Female|Gender||Participants|Count of Participants|5|5.0||||||
4250045|NCT00634569|4074571|B2||Female|Gender||Participants|Count of Participants|1|1.0||||||
4250046|NCT00634569|4074572|B1||Female|Gender||Participants|Count of Participants|4|4.0||||||
4250047|NCT00634569|4074570|B3|||Age||years|Mean|9.0|9.0|Standard Deviation|4.53|4.53|||
4250048|NCT00634569|4074571|B2|||Age||years|Mean|9.7|9.7|Standard Deviation|4.9|4.9|||
4250049|NCT00634569|4074572|B1|||Age||years|Mean|8.6|8.6|Standard Deviation|4.3|4.3|||
4250050|NCT00634543|4074585|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4250051|NCT00634543|4074586|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4250052|NCT00634543|4074587|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4250053|NCT00634543|4074585|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4250054|NCT00634543|4074586|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4250055|NCT00634543|4074587|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4250056|NCT00634543|4074585|B3|||Age||Years|Mean|57.4|57.4|Standard Deviation|8.4|8.4|||
4250057|NCT00634543|4074586|B2|||Age||Years|Mean|56.6|56.6|Standard Deviation|9.3|9.3|||
4250058|NCT00634543|4074587|B1|||Age||Years|Mean|58.2|58.2|Standard Deviation|7.4|7.4|||
4250059|NCT00634504|4074604|B3|||Pre-glucarpidase (Arm A) or Pre-LV (Arm B) methotrexate plasma conc (umol/L)||micromol/L|Mean|21.94|21.94|Standard Deviation|21.94|21.94|||
4250060|NCT00634504|4074605|B2|||Pre-glucarpidase (Arm A) or Pre-LV (Arm B) methotrexate plasma conc (umol/L)||micromol/L|Mean|6.49|6.49|Standard Deviation|11.00|11.0|||
4250061|NCT00634504|4074606|B1|||Pre-glucarpidase (Arm A) or Pre-LV (Arm B) methotrexate plasma conc (umol/L)||micromol/L|Mean|34.58|34.58|Standard Deviation|48.59|48.59|||
4250062|NCT00634504|4074604|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250063|NCT00634504|4074605|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250064|NCT00634504|4074606|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250065|NCT00634504|4074604|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4250066|NCT00634504|4074605|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4250067|NCT00634504|4074606|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4250068|NCT00634504|4074604|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4250069|NCT00634504|4074605|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4250070|NCT00634504|4074606|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4250071|NCT00634504|4074604|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4250072|NCT00634504|4074605|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4250073|NCT00634504|4074606|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4250074|NCT00634504|4074604|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250135|NCT00634270|4074628|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4250075|NCT00634504|4074605|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250076|NCT00634504|4074606|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250077|NCT00634504|4074604|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4250078|NCT00634504|4074605|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250079|NCT00634504|4074606|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4250080|NCT00634504|4074604|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4250081|NCT00634504|4074605|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250082|NCT00634504|4074606|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4250083|NCT00634504|4074604|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4250084|NCT00634504|4074605|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4250085|NCT00634504|4074606|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4250086|NCT00634504|4074604|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4250087|NCT00634504|4074605|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4250088|NCT00634504|4074606|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4250089|NCT00634504|4074604|B3|||Age||years|Mean|20.2|20.2|Standard Deviation|18.22|18.22|||
4250090|NCT00634504|4074605|B2|||Age||years|Mean|12.6|12.6|Standard Deviation|7.84|7.84|||
4250091|NCT00634504|4074606|B1|||Age||years|Mean|26.4|26.4|Standard Deviation|22.07|22.07|||
4250092|NCT00634322|4074613|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4250093|NCT00634322|4074614|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4250094|NCT00634322|4074615|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4250095|NCT00634322|4074616|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4250096|NCT00634322|4074613|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4250097|NCT00634322|4074614|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4250098|NCT00634322|4074615|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4250099|NCT00634322|4074616|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4250100|NCT00634322|4074613|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4250101|NCT00634322|4074614|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4250102|NCT00634322|4074615|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4250103|NCT00634322|4074616|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4250104|NCT00634322|4074613|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4250105|NCT00634322|4074614|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4250106|NCT00634322|4074615|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4250107|NCT00634322|4074616|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4250108|NCT00634322|4074613|B4||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4250109|NCT00634322|4074614|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4250110|NCT00634322|4074615|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4250111|NCT00634322|4074616|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4250112|NCT00634270|4074626|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
4250113|NCT00634270|4074627|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4250114|NCT00634270|4074628|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
4250115|NCT00634270|4074626|B3|Unknown or Not Reports||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4250116|NCT00634270|4074627|B2|Unknown or Not Reports||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4250117|NCT00634270|4074628|B1|Unknown or Not Reports||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4250118|NCT00634270|4074626|B3|White||Race/Ethnicity, Customized||Participants|Number|45|45.0||||||
4250119|NCT00634270|4074627|B2|White||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4250120|NCT00634270|4074628|B1|White||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
4250121|NCT00634270|4074626|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4250122|NCT00634270|4074627|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4250123|NCT00634270|4074628|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4250124|NCT00634270|4074626|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4250125|NCT00634270|4074627|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4250126|NCT00634270|4074628|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4250127|NCT00634270|4074626|B3|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4250128|NCT00634270|4074627|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4250129|NCT00634270|4074628|B1|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4250130|NCT00634270|4074626|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4250131|NCT00634270|4074627|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4250132|NCT00634270|4074628|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4250133|NCT00634270|4074626|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4250134|NCT00634270|4074627|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4250136|NCT00634270|4074626|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4250137|NCT00634270|4074627|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4250138|NCT00634270|4074628|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4250139|NCT00634270|4074626|B3|||Age||years|Mean|10.46|10.46|Full Range|||3.0|45.0|
4250140|NCT00634270|4074627|B2|||Age||years|Mean|16|16.0|Full Range|||3.0|35.0|
4250141|NCT00634270|4074628|B1|||Age||years|Mean|9|9.0|Full Range|||3.0|45.0|
4250142|NCT00634244|4074655|B4|Unknown/Missing||Disease status||participants|Number|1|1.0||||||
4250143|NCT00634244|4074656|B3|Unknown/Missing||Disease status||participants|Number|1|1.0||||||
4250144|NCT00634244|4074657|B2|Unknown/Missing||Disease status||participants|Number|0|0.0||||||
4250145|NCT00634244|4074658|B1|Unknown/Missing||Disease status||participants|Number|0|0.0||||||
4250146|NCT00634244|4074655|B4|Refractory||Disease status||participants|Number|45|45.0||||||
4250147|NCT00634244|4074656|B3|Refractory||Disease status||participants|Number|10|10.0||||||
4250148|NCT00634244|4074657|B2|Refractory||Disease status||participants|Number|17|17.0||||||
4250149|NCT00634244|4074658|B1|Refractory||Disease status||participants|Number|18|18.0||||||
4250150|NCT00634244|4074655|B4|6-12 mos after 1st CR||Disease status||participants|Number|19|19.0||||||
4250151|NCT00634244|4074656|B3|6-12 mos after 1st CR||Disease status||participants|Number|3|3.0||||||
4250152|NCT00634244|4074657|B2|6-12 mos after 1st CR||Disease status||participants|Number|8|8.0||||||
4250153|NCT00634244|4074658|B1|6-12 mos after 1st CR||Disease status||participants|Number|8|8.0||||||
4250154|NCT00634244|4074655|B4|< 6 months after 1st CR||Disease status||participants|Number|26|26.0||||||
4250155|NCT00634244|4074656|B3|< 6 months after 1st CR||Disease status||participants|Number|6|6.0||||||
4250156|NCT00634244|4074657|B2|< 6 months after 1st CR||Disease status||participants|Number|11|11.0||||||
4250157|NCT00634244|4074658|B1|< 6 months after 1st CR||Disease status||participants|Number|9|9.0||||||
4250158|NCT00634244|4074655|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4250159|NCT00634244|4074656|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4250160|NCT00634244|4074657|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4250161|NCT00634244|4074658|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250162|NCT00634244|4074655|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4250163|NCT00634244|4074656|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4250164|NCT00634244|4074657|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250165|NCT00634244|4074658|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250166|NCT00634244|4074655|B4||White|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
4250167|NCT00634244|4074656|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4250168|NCT00634244|4074657|B2||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4250169|NCT00634244|4074658|B1||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4250170|NCT00634244|4074655|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4250171|NCT00634244|4074656|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4250172|NCT00634244|4074657|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4250173|NCT00634244|4074658|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4250174|NCT00634244|4074655|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250175|NCT00634244|4074656|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250176|NCT00634244|4074657|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250177|NCT00634244|4074658|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250178|NCT00634244|4074655|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4250179|NCT00634244|4074656|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4250180|NCT00634244|4074657|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4250181|NCT00634244|4074658|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4250182|NCT00634244|4074655|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250183|NCT00634244|4074656|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250184|NCT00634244|4074657|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250185|NCT00634244|4074658|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250186|NCT00634244|4074655|B4||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4250187|NCT00634244|4074656|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4250188|NCT00634244|4074657|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4250189|NCT00634244|4074658|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4250190|NCT00634244|4074655|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4250191|NCT00634244|4074656|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4250192|NCT00634244|4074657|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4250193|NCT00634244|4074658|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4250194|NCT00634244|4074655|B4|||Age||years|Median|57|57.0|Full Range|||19.0|69.0|
4250195|NCT00634244|4074656|B3|||Age||years|Median|52|52.0|Full Range|||22.0|68.0|
4250196|NCT00634244|4074657|B2|||Age||years|Median|62|62.0|Full Range|||19.0|69.0|
4250197|NCT00634244|4074658|B1|||Age||years|Median|55|55.0|Full Range|||23.0|67.0|
4250198|NCT00634179|4074671|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4250199|NCT00634179|4074671|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250200|NCT00634179|4074671|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250201|NCT00634179|4074671|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4250202|NCT00634179|4074671|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4250203|NCT00634179|4074671|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250204|NCT00634179|4074671|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250205|NCT00634179|4074671|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250206|NCT00634179|4074671|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4250207|NCT00634179|4074671|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4250208|NCT00634179|4074671|B1|||Age||years|Median|58|58.0|Full Range|||28.0|71.0|
4250209|NCT00634166|4074678|B3|United States||Region of Enrollment||participants|Number|220|220.0||||||
4250210|NCT00634166|4074679|B2|United States||Region of Enrollment||participants|Number|138|138.0||||||
4250211|NCT00634166|4074680|B1|United States||Region of Enrollment||participants|Number|82|82.0||||||
4250212|NCT00634166|4074678|B3|Male||Sex/Gender, Customized||participants|Number|172|172.0||||||
4250213|NCT00634166|4074679|B2|Male||Sex/Gender, Customized||participants|Number|109|109.0||||||
4250214|NCT00634166|4074680|B1|Male||Sex/Gender, Customized||participants|Number|63|63.0||||||
4250215|NCT00634166|4074678|B3|Female||Sex/Gender, Customized||participants|Number|48|48.0||||||
4250216|NCT00634166|4074679|B2|Female||Sex/Gender, Customized||participants|Number|29|29.0||||||
4250217|NCT00634166|4074680|B1|Female||Sex/Gender, Customized||participants|Number|19|19.0||||||
4250218|NCT00634166|4074678|B3|>= 18 years||Age, Customized||participants|Number|204|204.0||||||
4250219|NCT00634166|4074679|B2|>= 18 years||Age, Customized||participants|Number|133|133.0||||||
4250220|NCT00634166|4074680|B1|>= 18 years||Age, Customized||participants|Number|71|71.0||||||
4250221|NCT00634166|4074678|B3|<18 years||Age, Customized||participants|Number|16|16.0||||||
4250222|NCT00634166|4074679|B2|<18 years||Age, Customized||participants|Number|5|5.0||||||
4250223|NCT00634166|4074680|B1|<18 years||Age, Customized||participants|Number|11|11.0||||||
4250224|NCT00634166|4074678|B3|||Age||years|Mean|42.6|42.6|Standard Deviation|18.44|18.44|||
4250225|NCT00634166|4074679|B2|||Age||years|Mean|44.7|44.7|Standard Deviation|17.87|17.87|||
4250226|NCT00634166|4074680|B1|||Age||years|Mean|38.9|38.9|Standard Deviation|18.91|18.91|||
4250227|NCT00634114|4074687|B4|Missing||Sex/Gender, Customized|1 participant was excluded in Esomeprazole 10 mg as they did not take any investigational drug.|Participants|Number|1|1.0||||0.0|0.0|
4250228|NCT00634114|4074688|B3|Missing||Sex/Gender, Customized|1 participant was excluded in Esomeprazole 10 mg as they did not take any investigational drug.|Participants|Number|0|0.0||||0.0|0.0|
4250229|NCT00634114|4074689|B2|Missing||Sex/Gender, Customized|1 participant was excluded in Esomeprazole 10 mg as they did not take any investigational drug.|Participants|Number|1|1.0||||1.0|0.0|
4250230|NCT00634114|4074690|B1|Missing||Sex/Gender, Customized|1 participant was excluded in Esomeprazole 10 mg as they did not take any investigational drug.|Participants|Number|0|0.0||||0.0|0.0|
4250231|NCT00634114|4074687|B4|Male||Sex/Gender, Customized|1 participant was excluded in Esomeprazole 10 mg as they did not take any investigational drug.|Participants|Number|434|434.0||||0.0|0.0|
4250232|NCT00634114|4074688|B3|Male||Sex/Gender, Customized|1 participant was excluded in Esomeprazole 10 mg as they did not take any investigational drug.|Participants|Number|145|145.0||||42.0|0.0|
4250233|NCT00634114|4074689|B2|Male||Sex/Gender, Customized|1 participant was excluded in Esomeprazole 10 mg as they did not take any investigational drug.|Participants|Number|147|147.0||||51.0|0.0|
4250234|NCT00634114|4074690|B1|Male||Sex/Gender, Customized|1 participant was excluded in Esomeprazole 10 mg as they did not take any investigational drug.|Participants|Number|142|142.0||||46.0|0.0|
4250235|NCT00634114|4074687|B4|Female||Sex/Gender, Customized|1 participant was excluded in Esomeprazole 10 mg as they did not take any investigational drug.|Participants|Number|139|139.0||||0.0|0.0|
4250236|NCT00634114|4074688|B3|Female||Sex/Gender, Customized|1 participant was excluded in Esomeprazole 10 mg as they did not take any investigational drug.|Participants|Number|42|42.0||||145.0|0.0|
4250237|NCT00634114|4074689|B2|Female||Sex/Gender, Customized|1 participant was excluded in Esomeprazole 10 mg as they did not take any investigational drug.|Participants|Number|51|51.0||||137.0|0.0|
4250238|NCT00634114|4074690|B1|Female||Sex/Gender, Customized|1 participant was excluded in Esomeprazole 10 mg as they did not take any investigational drug.|Participants|Number|46|46.0||||142.0|0.0|
4250239|NCT00634114|4074687|B4|Missing||Age, Customized||Participants|Number|1|1.0||||0.0|0.0|
4250240|NCT00634114|4074688|B3|Missing||Age, Customized||Participants|Number|0|0.0||||0.0|0.0|
4250241|NCT00634114|4074689|B2|Missing||Age, Customized||Participants|Number|1|1.0||||1.0|0.0|
4250242|NCT00634114|4074690|B1|Missing||Age, Customized||Participants|Number|0|0.0||||0.0|0.0|
4250243|NCT00634114|4074687|B4|>=75||Age, Customized||Participants|Number|40|40.0||||0.0|0.0|
4250244|NCT00634114|4074688|B3|>=75||Age, Customized||Participants|Number|12|12.0||||12.0|0.0|
4250245|NCT00634114|4074689|B2|>=75||Age, Customized||Participants|Number|16|16.0||||16.0|0.0|
4250246|NCT00634114|4074690|B1|>=75||Age, Customized||Participants|Number|12|12.0||||12.0|0.0|
4250247|NCT00634114|4074687|B4|65-74||Age, Customized||Participants|Number|124|124.0||||0.0|0.0|
4250248|NCT00634114|4074688|B3|65-74||Age, Customized||Participants|Number|38|38.0||||38.0|0.0|
4250249|NCT00634114|4074689|B2|65-74||Age, Customized||Participants|Number|41|41.0||||41.0|0.0|
4250250|NCT00634114|4074690|B1|65-74||Age, Customized||Participants|Number|45|45.0||||45.0|0.0|
4250251|NCT00634114|4074687|B4|<65||Age, Customized||Participants|Number|399|399.0||||0.0|0.0|
4250252|NCT00634114|4074688|B3|<65||Age, Customized||Participants|Number|137|137.0||||137.0|0.0|
4250253|NCT00634114|4074689|B2|<65||Age, Customized||Participants|Number|131|131.0||||131.0|0.0|
4250254|NCT00634114|4074690|B1|<65||Age, Customized||Participants|Number|131|131.0||||131.0|0.0|
4250255|NCT00634088|4074706|B5|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4250256|NCT00634088|4074708|B3|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4250257|NCT00634088|4074709|B2|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4250258|NCT00634088|4074710|B1|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4250259|NCT00634088|4074706|B5|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4250260|NCT00634088|4074708|B3|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4250261|NCT00634088|4074709|B2|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4250262|NCT00634088|4074710|B1|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4250263|NCT00634088|4074706|B5|White||Race (NIH/OMB)||participants|Number|9|9.0||||||
4250264|NCT00634088|4074708|B3|White||Race (NIH/OMB)||participants|Number|1|1.0||||||
4250265|NCT00634088|4074709|B2|White||Race (NIH/OMB)||participants|Number|3|3.0||||||
4250266|NCT00634088|4074710|B1|White||Race (NIH/OMB)||participants|Number|5|5.0||||||
4250267|NCT00634088|4074706|B5|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
4250268|NCT00634088|4074708|B3|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
4250269|NCT00634088|4074709|B2|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
4250270|NCT00634088|4074710|B1|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
4250271|NCT00634088|4074706|B5|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4250272|NCT00634088|4074708|B3|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4250273|NCT00634088|4074709|B2|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4250274|NCT00634088|4074710|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4250275|NCT00634088|4074706|B5|Asian||Race (NIH/OMB)||participants|Number|1|1.0||||||
4250276|NCT00634088|4074708|B3|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
4250277|NCT00634088|4074709|B2|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
4250278|NCT00634088|4074710|B1|Asian||Race (NIH/OMB)||participants|Number|1|1.0||||||
4250279|NCT00634088|4074706|B5|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
4250280|NCT00634088|4074708|B3|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
4250281|NCT00634088|4074709|B2|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
4250282|NCT00634088|4074710|B1|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
4250283|NCT00634088|4074706|B5|Male||Gender||participants|Number|0|0.0||||||
4250284|NCT00634088|4074708|B3|Male||Gender||participants|Number|0|0.0||||||
4250285|NCT00634088|4074709|B2|Male||Gender||participants|Number|0|0.0||||||
4250286|NCT00634088|4074710|B1|Male||Gender||participants|Number|0|0.0||||||
4250287|NCT00634088|4074706|B5|Female||Gender||participants|Number|10|10.0||||||
4250288|NCT00634088|4074708|B3|Female||Gender||participants|Number|1|1.0||||||
4250289|NCT00634088|4074709|B2|Female||Gender||participants|Number|3|3.0||||||
4250290|NCT00634088|4074710|B1|Female||Gender||participants|Number|6|6.0||||||
4250291|NCT00634088|4074706|B5|65 years and older||Age, Customized||participants|Number|1|1.0||||||
4250292|NCT00634088|4074708|B3|65 years and older||Age, Customized||participants|Number|0|0.0||||||
4250293|NCT00634088|4074709|B2|65 years and older||Age, Customized||participants|Number|0|0.0||||||
4250294|NCT00634088|4074710|B1|65 years and older||Age, Customized||participants|Number|1|1.0||||||
4250295|NCT00634088|4074706|B5|50 years and older to younger than 65 years||Age, Customized||participants|Number|7|7.0||||||
4250296|NCT00634088|4074708|B3|50 years and older to younger than 65 years||Age, Customized||participants|Number|1|1.0||||||
4250297|NCT00634088|4074709|B2|50 years and older to younger than 65 years||Age, Customized||participants|Number|2|2.0||||||
4250298|NCT00634088|4074710|B1|50 years and older to younger than 65 years||Age, Customized||participants|Number|4|4.0||||||
4250299|NCT00634088|4074706|B5|Younger than 50 years||Age, Customized||participants|Number|2|2.0||||||
4250300|NCT00634088|4074708|B3|Younger than 50 years||Age, Customized||participants|Number|0|0.0||||||
4250301|NCT00634088|4074709|B2|Younger than 50 years||Age, Customized||participants|Number|1|1.0||||||
4250302|NCT00634088|4074710|B1|Younger than 50 years||Age, Customized||participants|Number|1|1.0||||||
4250303|NCT00634049|4074764|B1|Missing||T-cell immunosuppressant use|T-cell immunosuppressant use was defined as yes for patients who noted treatment with other recognized T-cell immunosuppressants among the list of host factors on the categorization of IFD eCRF. Along with the investigators’ assessment, participants who took certain prior medications could have been considered based on the medical evaluation. T-cell immunosuppressant use was defined as no for participants who completed the categorization of IFD eCRF and did not meet the criterion in the previous sentences. Otherwise, T-cell immunosuppressant use was missing.|participants|Number|37|37.0||||||
4250304|NCT00634049|4074764|B1|No||T-cell immunosuppressant use|T-cell immunosuppressant use was defined as yes for patients who noted treatment with other recognized T-cell immunosuppressants among the list of host factors on the categorization of IFD eCRF. Along with the investigators’ assessment, participants who took certain prior medications could have been considered based on the medical evaluation. T-cell immunosuppressant use was defined as no for participants who completed the categorization of IFD eCRF and did not meet the criterion in the previous sentences. Otherwise, T-cell immunosuppressant use was missing.|participants|Number|48|48.0||||||
4250305|NCT00634049|4074764|B1|Yes||T-cell immunosuppressant use|T-cell immunosuppressant use was defined as yes for patients who noted treatment with other recognized T-cell immunosuppressants among the list of host factors on the categorization of IFD eCRF. Along with the investigators’ assessment, participants who took certain prior medications could have been considered based on the medical evaluation. T-cell immunosuppressant use was defined as no for participants who completed the categorization of IFD eCRF and did not meet the criterion in the previous sentences. Otherwise, T-cell immunosuppressant use was missing.|participants|Number|61|61.0||||||
4250306|NCT00634049|4074764|B1|No||Corticosteroid use|Corticosteroid use was defined as yes for participants who were administered corticosteroids for 21 days out of 28 days leading up to first administration of study drug. Otherwise, corticosteroid use equaled no.|participants|Number|111|111.0||||||
4250307|NCT00634049|4074764|B1|Yes||Corticosteroid use|Corticosteroid use was defined as yes for participants who were administered corticosteroids for 21 days out of 28 days leading up to first administration of study drug. Otherwise, corticosteroid use equaled no.|participants|Number|35|35.0||||||
4250308|NCT00634049|4074764|B1|Missing||Neutropenic|Baseline neutropenic status was defined as yes for patients who noted recently resolved or ongoing neutropenia among the list of host factors on the categorization of IFD eCRF. Baseline neutropenic status was defined as no for patients who completed the categorization of IFD eCRF and did not meet the criterion in the previous sentence. Otherwise, baseline neutropenic status was missing.|participants|Number|42|42.0||||||
4250309|NCT00634049|4074764|B1|No||Neutropenic|Baseline neutropenic status was defined as yes for patients who noted recently resolved or ongoing neutropenia among the list of host factors on the categorization of IFD eCRF. Baseline neutropenic status was defined as no for patients who completed the categorization of IFD eCRF and did not meet the criterion in the previous sentence. Otherwise, baseline neutropenic status was missing.|participants|Number|66|66.0||||||
4250310|NCT00634049|4074764|B1|Yes||Neutropenic|Baseline neutropenic status was defined as yes for patients who noted recently resolved or ongoing neutropenia among the list of host factors on the categorization of IFD eCRF. Baseline neutropenic status was defined as no for patients who completed the categorization of IFD eCRF and did not meet the criterion in the previous sentence. Otherwise, baseline neutropenic status was missing.|participants|Number|38|38.0||||||
4250311|NCT00634049|4074764|B1|No||Uncontrolled malignancy|Uncontrolled malignancy status was defined as yes for participants who noted a malignancy for diagnosis and new diagnosis/active disease or relapse for present status on the primary underlying disease or condition eCRF. Otherwise, uncontrolled malignancy status equaled no.|participants|Number|100|100.0||||||
4250312|NCT00634049|4074764|B1|Yes||Uncontrolled malignancy|Uncontrolled malignancy status was defined as yes for participants who noted a malignancy for diagnosis and new diagnosis/active disease or relapse for present status on the primary underlying disease or condition eCRF. Otherwise, uncontrolled malignancy status equaled no.|participants|Number|46|46.0||||||
4250313|NCT00634049|4074764|B1|No||Allogeneic Bone Marrow Transplant (BMT)/Hematopoietic Stem Cell Transplant (HSCT)|Allogeneic BMT/HSCT status was defined as yes for participants who noted allogeneic for type of transplant and bone marrow cells for type of cells on the primary underlying disease or condition electronic case report form (eCRF). Otherwise, allogeneic BMT/HSCT status equaled no.|participants|Number|120|120.0||||||
4250314|NCT00634049|4074764|B1|Yes||Allogeneic Bone Marrow Transplant (BMT)/Hematopoietic Stem Cell Transplant (HSCT)|Allogeneic BMT/HSCT status was defined as yes for participants who noted allogeneic for type of transplant and bone marrow cells for type of cells on the primary underlying disease or condition electronic case report form (eCRF). Otherwise, allogeneic BMT/HSCT status equaled no.|participants|Number|26|26.0||||||
4250315|NCT00634049|4074764|B1|No||Hematologic malignancy||participants|Number|83|83.0||||||
4250316|NCT00634049|4074764|B1|Yes||Hematologic malignancy||participants|Number|63|63.0||||||
4250317|NCT00634049|4074764|B1|Missing||Therapy status||participants|Number|3|3.0||||||
4250318|NCT00634049|4074764|B1|Intolerant||Therapy status||participants|Number|12|12.0||||||
4250319|NCT00634049|4074764|B1|Refractory||Therapy status||participants|Number|38|38.0||||||
4250320|NCT00634049|4074764|B1|Primary Therapy||Therapy status||participants|Number|93|93.0||||||
4250321|NCT00634049|4074764|B1|United States||Region of Enrollment||participants|Number|56|56.0||||||
4250322|NCT00634049|4074764|B1|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4250323|NCT00634049|4074764|B1|Belgium||Region of Enrollment||participants|Number|13|13.0||||||
4250324|NCT00634049|4074764|B1|Thailand||Region of Enrollment||participants|Number|14|14.0||||||
4250325|NCT00634049|4074764|B1|Korea, Republic of||Region of Enrollment||participants|Number|2|2.0||||||
4250326|NCT00634049|4074764|B1|Russian Federation||Region of Enrollment||participants|Number|2|2.0||||||
4250327|NCT00634049|4074764|B1|Mexico||Region of Enrollment||participants|Number|8|8.0||||||
4250328|NCT00634049|4074764|B1|Lebanon||Region of Enrollment||participants|Number|1|1.0||||||
4250329|NCT00634049|4074764|B1|Israel||Region of Enrollment||participants|Number|21|21.0||||||
4250330|NCT00634049|4074764|B1|India||Region of Enrollment||participants|Number|5|5.0||||||
4250331|NCT00634049|4074764|B1|Brazil||Region of Enrollment||participants|Number|20|20.0||||||
4250332|NCT00634049|4074764|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|124|124.0||||||
4250333|NCT00634049|4074764|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4250334|NCT00634049|4074764|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4250335|NCT00634049|4074764|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250336|NCT00634049|4074764|B1||White|Race (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
4250337|NCT00634049|4074764|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4250338|NCT00634049|4074764|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250339|NCT00634049|4074764|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4250340|NCT00634049|4074764|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250341|NCT00634049|4074764|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4250342|NCT00634049|4074764|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4250343|NCT00634049|4074764|B1|||Age||years|Mean|49.9|49.9|Standard Deviation|16.78|16.78|||
4250344|NCT00634036|4074841|B3|||FEV1/FVC (% predicted after bronchodilator use)||% predicted|Mean|94.35|94.35|Standard Deviation|19.51|19.51|||
4250345|NCT00634036|4074842|B2|||FEV1/FVC (% predicted after bronchodilator use)||% predicted|Mean|97.8|97.8|Standard Deviation|7.82|7.82|||
4250346|NCT00634036|4074843|B1|||FEV1/FVC (% predicted after bronchodilator use)||% predicted|Mean|90.9|90.9|Standard Deviation|31.2|31.2|||
4250347|NCT00634036|4074841|B3|||FVC (% predicted after bronchodilator use)||% predicted|Mean|83.9|83.9|Standard Deviation|21.95|21.95|||
4250348|NCT00634036|4074842|B2|||FVC (% predicted after bronchodilator use)||% predicted|Mean|88.3|88.3|Standard Deviation|16.3|16.3|||
4250349|NCT00634036|4074843|B1|||FVC (% predicted after bronchodilator use)||% predicted|Mean|79.5|79.5|Standard Deviation|27.6|27.6|||
4250350|NCT00634036|4074841|B3|||FEV1 (% predicted after bronchodilator use)||% predicted|Mean|82.7|82.7|Standard Deviation|14.85|14.85|||
4250351|NCT00634036|4074842|B2|||FEV1 (% predicted after bronchodilator use)||% predicted|Mean|88.1|88.1|Standard Deviation|4.6|4.6|||
4250352|NCT00634036|4074843|B1|||FEV1 (% predicted after bronchodilator use)||% predicted|Mean|77.3|77.3|Standard Deviation|25.1|25.1|||
4250353|NCT00634036|4074841|B3|||FEV1/FVC (% predicted before bronchodilator use)||% predicted|Mean|95.1|95.1|Standard Deviation|11.16|11.16|||
4250354|NCT00634036|4074842|B2|||FEV1/FVC (% predicted before bronchodilator use)||% predicted|Mean|94.9|94.9|Standard Deviation|11.12|11.12|||
4250355|NCT00634036|4074843|B1|||FEV1/FVC (% predicted before bronchodilator use)||% predicted|Mean|95.3|95.3|Standard Deviation|11.2|11.2|||
4250356|NCT00634036|4074841|B3|||FVC (% predicted before bronchodilator use)||% predicted|Mean|86.05|86.05|Standard Deviation|14.95|14.95|||
4250357|NCT00634036|4074842|B2|||FVC (% predicted before bronchodilator use)||% predicted|Mean|85.3|85.3|Standard Deviation|16.2|16.2|||
4250358|NCT00634036|4074843|B1|||FVC (% predicted before bronchodilator use)||% predicted|Mean|86.8|86.8|Standard Deviation|13.7|13.7|||
4250359|NCT00634036|4074841|B3|||FEV1 (% predicted before bronchodilator use)||% predicted|Mean|81.9|81.9|Standard Deviation|13.65|13.65|||
4250360|NCT00634036|4074842|B2|||FEV1 (% predicted before bronchodilator use)||% predicted|Mean|81.5|81.5|Standard Deviation|15.2|15.2|||
4250361|NCT00634036|4074843|B1|||FEV1 (% predicted before bronchodilator use)||% predicted|Mean|82.3|82.3|Standard Deviation|12.1|12.1|||
4250362|NCT00634036|4074841|B3|||Juniper Asthma Control|Scale Range: minimum 1.0; maximum 6.0 Higher values represent increased asthma symptoms A score greater than 1.5 is considered compatible with uncontrolled asthma|scores on a scale|Mean|2.115|2.115|Standard Deviation|.965|0.965|||
4250363|NCT00634036|4074842|B2|||Juniper Asthma Control|Scale Range: minimum 1.0; maximum 6.0 Higher values represent increased asthma symptoms A score greater than 1.5 is considered compatible with uncontrolled asthma|scores on a scale|Mean|2.48|2.48|Standard Deviation|1.3|1.3|||
4250364|NCT00634036|4074843|B1|||Juniper Asthma Control|Scale Range: minimum 1.0; maximum 6.0 Higher values represent increased asthma symptoms A score greater than 1.5 is considered compatible with uncontrolled asthma|scores on a scale|Mean|1.75|1.75|Standard Deviation|.63|0.63|||
4250365|NCT00634036|4074841|B3|||Immunoglobulin E||IU/ml|Mean|433.1|433.1|Standard Deviation|428.95|428.95|||
4250366|NCT00634036|4074842|B2|||Immunoglobulin E||IU/ml|Mean|575|575.0|Standard Deviation|544.7|544.7|||
4250367|NCT00634036|4074843|B1|||Immunoglobulin E||IU/ml|Mean|291.2|291.2|Standard Deviation|313.2|313.2|||
4250368|NCT00634036|4074841|B3|||Exhaled Nitric Oxide||ppb|Mean|29.2|29.2|Standard Deviation|28.1|28.1|||
4250369|NCT00634036|4074842|B2|||Exhaled Nitric Oxide||ppb|Mean|30.8|30.8|Standard Deviation|28.4|28.4|||
4250370|NCT00634036|4074843|B1|||Exhaled Nitric Oxide||ppb|Mean|27.6|27.6|Standard Deviation|27.8|27.8|||
4250371|NCT00634036|4074841|B3|Did not use short acting beta agonist||Short acting beta agonist||participants|Number|1|1.0||||||
4250372|NCT00634036|4074842|B2|Did not use short acting beta agonist||Short acting beta agonist||participants|Number|0|0.0||||||
4250373|NCT00634036|4074843|B1|Did not use short acting beta agonist||Short acting beta agonist||participants|Number|1|1.0||||||
4250374|NCT00634036|4074841|B3|Used short acting beta agonist||Short acting beta agonist||participants|Number|22|22.0||||||
4250375|NCT00634036|4074842|B2|Used short acting beta agonist||Short acting beta agonist||participants|Number|11|11.0||||||
4250376|NCT00634036|4074843|B1|Used short acting beta agonist||Short acting beta agonist||participants|Number|11|11.0||||||
4250377|NCT00634036|4074841|B3|Did not use long acting beta agonist||Long acting beta agonist||participants|Number|4|4.0||||||
4250378|NCT00634036|4074842|B2|Did not use long acting beta agonist||Long acting beta agonist||participants|Number|2|2.0||||||
4250379|NCT00634036|4074843|B1|Did not use long acting beta agonist||Long acting beta agonist||participants|Number|2|2.0||||||
4250380|NCT00634036|4074841|B3|Used long acting beta agonist||Long acting beta agonist||participants|Number|19|19.0||||||
4250381|NCT00634036|4074842|B2|Used long acting beta agonist||Long acting beta agonist||participants|Number|9|9.0||||||
4250382|NCT00634036|4074843|B1|Used long acting beta agonist||Long acting beta agonist||participants|Number|10|10.0||||||
4250383|NCT00634036|4074841|B3|Low dose||Inhaled corticosteroid||participants|Number|2|2.0||||||
4250384|NCT00634036|4074842|B2|Low dose||Inhaled corticosteroid||participants|Number|2|2.0||||||
4250385|NCT00634036|4074843|B1|Low dose||Inhaled corticosteroid||participants|Number|0|0.0||||||
4250386|NCT00634036|4074841|B3|Medium dose||Inhaled corticosteroid||participants|Number|12|12.0||||||
4250387|NCT00634036|4074842|B2|Medium dose||Inhaled corticosteroid||participants|Number|4|4.0||||||
4250388|NCT00634036|4074843|B1|Medium dose||Inhaled corticosteroid||participants|Number|8|8.0||||||
4250389|NCT00634036|4074841|B3|High dose||Inhaled corticosteroid||participants|Number|9|9.0||||||
4250390|NCT00634036|4074842|B2|High dose||Inhaled corticosteroid||participants|Number|5|5.0||||||
4250391|NCT00634036|4074843|B1|High dose||Inhaled corticosteroid||participants|Number|4|4.0||||||
4250392|NCT00634036|4074841|B3|Did not use oral steroids||Oral steroids in last 12 months||participants|Number|12|12.0||||||
4250393|NCT00634036|4074842|B2|Did not use oral steroids||Oral steroids in last 12 months||participants|Number|7|7.0||||||
4250394|NCT00634036|4074843|B1|Did not use oral steroids||Oral steroids in last 12 months||participants|Number|5|5.0||||||
4250395|NCT00634036|4074841|B3|Used oral steroids||Oral steroids in last 12 months||participants|Number|11|11.0||||||
4250396|NCT00634036|4074842|B2|Used oral steroids||Oral steroids in last 12 months||participants|Number|4|4.0||||||
4250397|NCT00634036|4074843|B1|Used oral steroids||Oral steroids in last 12 months||participants|Number|7|7.0||||||
4250398|NCT00634036|4074841|B3|No reported exacerbation||Asthma exacerbation in last 12 months||participants|Number|10|10.0||||||
4250399|NCT00634036|4074842|B2|No reported exacerbation||Asthma exacerbation in last 12 months||participants|Number|4|4.0||||||
4250400|NCT00634036|4074843|B1|No reported exacerbation||Asthma exacerbation in last 12 months||participants|Number|6|6.0||||||
4250401|NCT00634036|4074841|B3|Reported an exacerbation||Asthma exacerbation in last 12 months||participants|Number|13|13.0||||||
4250402|NCT00634036|4074842|B2|Reported an exacerbation||Asthma exacerbation in last 12 months||participants|Number|7|7.0||||||
4250403|NCT00634036|4074843|B1|Reported an exacerbation||Asthma exacerbation in last 12 months||participants|Number|6|6.0||||||
4250404|NCT00634036|4074841|B3|Participants without Depression||Depression||participants|Number|10|10.0||||||
4250405|NCT00634036|4074842|B2|Participants without Depression||Depression||participants|Number|5|5.0||||||
4250406|NCT00634036|4074843|B1|Participants without Depression||Depression||participants|Number|5|5.0||||||
4250407|NCT00634036|4074841|B3|Participants reporting Depression||Depression||participants|Number|13|13.0||||||
4250408|NCT00634036|4074842|B2|Participants reporting Depression||Depression||participants|Number|6|6.0||||||
4250409|NCT00634036|4074843|B1|Participants reporting Depression||Depression||participants|Number|7|7.0||||||
4250410|NCT00634036|4074841|B3|Participants without GERD||Gastroesophageal Reflux Disease (GERD)||participants|Number|11|11.0||||||
4250411|NCT00634036|4074842|B2|Participants without GERD||Gastroesophageal Reflux Disease (GERD)||participants|Number|6|6.0||||||
4250412|NCT00634036|4074843|B1|Participants without GERD||Gastroesophageal Reflux Disease (GERD)||participants|Number|5|5.0||||||
4250413|NCT00634036|4074841|B3|Participants with GERD||Gastroesophageal Reflux Disease (GERD)||participants|Number|12|12.0||||||
4250414|NCT00634036|4074842|B2|Participants with GERD||Gastroesophageal Reflux Disease (GERD)||participants|Number|5|5.0||||||
4250415|NCT00634036|4074843|B1|Participants with GERD||Gastroesophageal Reflux Disease (GERD)||participants|Number|7|7.0||||||
4250416|NCT00634036|4074841|B3|Non-allergic||Seasonal allergies||participants|Number|3|3.0||||||
4250417|NCT00634036|4074842|B2|Non-allergic||Seasonal allergies||participants|Number|1|1.0||||||
4250418|NCT00634036|4074843|B1|Non-allergic||Seasonal allergies||participants|Number|2|2.0||||||
4250419|NCT00634036|4074841|B3|Reported allergies||Seasonal allergies||participants|Number|20|20.0||||||
4250420|NCT00634036|4074842|B2|Reported allergies||Seasonal allergies||participants|Number|10|10.0||||||
4250421|NCT00634036|4074843|B1|Reported allergies||Seasonal allergies||participants|Number|10|10.0||||||
4250422|NCT00634036|4074841|B3|||Body Mass Index||kg/m^2|Mean|41.15|41.15|Standard Deviation|7.3|7.3|||
4250423|NCT00634036|4074842|B2|||Body Mass Index||kg/m^2|Mean|43.5|43.5|Standard Deviation|7.8|7.8|||
4250424|NCT00634036|4074843|B1|||Body Mass Index||kg/m^2|Mean|38.8|38.8|Standard Deviation|6.8|6.8|||
4250425|NCT00634036|4074841|B3|||Age asthma onset||years|Mean|18|18.0|Standard Deviation|14.95|14.95|||
4250426|NCT00634036|4074842|B2|||Age asthma onset||years|Mean|21|21.0|Standard Deviation|18.9|18.9|||
4250427|NCT00634036|4074843|B1|||Age asthma onset||years|Mean|15|15.0|Standard Deviation|11|11.0|||
4250428|NCT00634036|4074841|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4250429|NCT00634036|4074842|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4250430|NCT00634036|4074843|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4250431|NCT00634036|4074841|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250432|NCT00634036|4074842|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250433|NCT00634036|4074843|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250434|NCT00634036|4074841|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250435|NCT00634036|4074842|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250436|NCT00634036|4074843|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250437|NCT00634036|4074841|B3||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4250438|NCT00634036|4074842|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4250439|NCT00634036|4074843|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4250440|NCT00634036|4074841|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4250441|NCT00634036|4074842|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4250442|NCT00634036|4074843|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4250443|NCT00634036|4074841|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250444|NCT00634036|4074842|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250445|NCT00634036|4074843|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250446|NCT00634036|4074841|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250447|NCT00634036|4074842|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250448|NCT00634036|4074843|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250449|NCT00634036|4074841|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250450|NCT00634036|4074842|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250451|NCT00634036|4074843|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250452|NCT00634036|4074841|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4250453|NCT00634036|4074842|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4250454|NCT00634036|4074843|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4250455|NCT00634036|4074841|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4250456|NCT00634036|4074842|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4250457|NCT00634036|4074843|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4250458|NCT00634036|4074841|B3|||Age||years|Mean|40.2|40.2|Standard Deviation|12.05|12.05|||
4250459|NCT00634036|4074842|B2|||Age||years|Mean|41|41.0|Standard Deviation|14.1|14.1|||
4250460|NCT00634036|4074843|B1|||Age||years|Mean|39.4|39.4|Standard Deviation|10|10.0|||
4250461|NCT00634036|4074841|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4250462|NCT00634036|4074842|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4250463|NCT00634036|4074843|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4250464|NCT00634036|4074841|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4250465|NCT00634036|4074842|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4250466|NCT00634036|4074843|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4250467|NCT00634036|4074841|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4250468|NCT00634036|4074842|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4250469|NCT00634036|4074843|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4250470|NCT00634010|4074856|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4250471|NCT00634010|4074857|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4250472|NCT00634010|4074858|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4250473|NCT00634010|4074856|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250474|NCT00634010|4074857|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250475|NCT00634010|4074858|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250476|NCT00634010|4074856|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250477|NCT00634010|4074857|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250478|NCT00634010|4074858|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250479|NCT00634010|4074856|B3||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4250480|NCT00634010|4074857|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4250481|NCT00634010|4074858|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4250482|NCT00634010|4074856|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4250483|NCT00634010|4074857|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4250484|NCT00634010|4074858|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4250485|NCT00634010|4074856|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250486|NCT00634010|4074857|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250487|NCT00634010|4074858|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250488|NCT00634010|4074856|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4250489|NCT00634010|4074857|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250490|NCT00634010|4074858|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4250491|NCT00634010|4074856|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250492|NCT00634010|4074857|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250493|NCT00634010|4074858|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250494|NCT00634010|4074856|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250495|NCT00634010|4074857|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250496|NCT00634010|4074858|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250497|NCT00634010|4074856|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4250498|NCT00634010|4074857|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4250499|NCT00634010|4074858|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4250500|NCT00634010|4074856|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4250501|NCT00634010|4074857|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4250502|NCT00634010|4074858|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4250503|NCT00634010|4074856|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4250504|NCT00634010|4074857|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4250505|NCT00634010|4074858|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4250506|NCT00634010|4074856|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4250507|NCT00634010|4074857|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4250508|NCT00634010|4074858|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4250509|NCT00634010|4074856|B3|||Age||years|Mean|57.4|57.4|Standard Deviation|10.430|10.43|||
4250510|NCT00634010|4074857|B2|||Age||years|Mean|60.39|60.39|Standard Deviation|12.069|12.069|||
4250511|NCT00634010|4074858|B1|||Age||years|Mean|56.00|56.0|Standard Deviation|8.677|8.677|||
4250512|NCT00633984|4074865|B3|United States||Region of Enrollment||participants|Number|169|169.0||||||
4250513|NCT00633984|4074866|B2|United States||Region of Enrollment||participants|Number|82|82.0||||||
4250514|NCT00633984|4074867|B1|United States||Region of Enrollment||participants|Number|87|87.0||||||
4250515|NCT00633984|4074865|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4250516|NCT00633984|4074866|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4250517|NCT00633984|4074867|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4250518|NCT00633984|4074865|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4250519|NCT00633984|4074866|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4250520|NCT00633984|4074867|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4250521|NCT00633984|4074865|B3|||Age||years|Mean|32.6|32.6|Standard Deviation|10.4|10.4|||
4250522|NCT00633984|4074866|B2|||Age||years|Mean|30.5|30.5|Standard Deviation|9.8|9.8|||
4250523|NCT00633984|4074867|B1|||Age||years|Mean|34.6|34.6|Standard Deviation|10.5|10.5|||
4250524|NCT00633932|4074876|B4|Missing||Sex/Gender, Customized||Participants|Number|3|3.0||||||
4250525|NCT00633932|4074877|B3|Missing||Sex/Gender, Customized||Participants|Number|1|1.0||||||
4250526|NCT00633932|4074878|B2|Missing||Sex/Gender, Customized||Participants|Number|1|1.0||||||
4250527|NCT00633932|4074879|B1|Missing||Sex/Gender, Customized||Participants|Number|1|1.0||||||
4250528|NCT00633932|4074876|B4|Female||Sex/Gender, Customized||Participants|Number|159|159.0||||||
4250529|NCT00633932|4074877|B3|Female||Sex/Gender, Customized||Participants|Number|56|56.0||||||
4250530|NCT00633932|4074878|B2|Female||Sex/Gender, Customized||Participants|Number|52|52.0||||||
4250531|NCT00633932|4074879|B1|Female||Sex/Gender, Customized||Participants|Number|51|51.0||||||
4250532|NCT00633932|4074876|B4|Male||Sex/Gender, Customized||Participants|Number|410|410.0||||||
4250533|NCT00633932|4074877|B3|Male||Sex/Gender, Customized||Participants|Number|134|134.0||||||
4250534|NCT00633932|4074878|B2|Male||Sex/Gender, Customized||Participants|Number|137|137.0||||||
4250535|NCT00633932|4074879|B1|Male||Sex/Gender, Customized||Participants|Number|139|139.0||||||
4250536|NCT00633932|4074876|B4|Missing||Age, Customized||Participants|Number|3|3.0||||||
4250537|NCT00633932|4074877|B3|Missing||Age, Customized||Participants|Number|1|1.0||||||
4250538|NCT00633932|4074878|B2|Missing||Age, Customized||Participants|Number|1|1.0||||||
4250539|NCT00633932|4074879|B1|Missing||Age, Customized||Participants|Number|1|1.0||||||
4250540|NCT00633932|4074876|B4|>= 75 years||Age, Customized||Participants|Number|54|54.0||||||
4250541|NCT00633932|4074877|B3|>= 75 years||Age, Customized||Participants|Number|20|20.0||||||
4250542|NCT00633932|4074878|B2|>= 75 years||Age, Customized||Participants|Number|18|18.0||||||
4250543|NCT00633932|4074879|B1|>= 75 years||Age, Customized||Participants|Number|16|16.0||||||
4250544|NCT00633932|4074876|B4|65 - 74 years||Age, Customized||Participants|Number|127|127.0||||||
4250545|NCT00633932|4074877|B3|65 - 74 years||Age, Customized||Participants|Number|44|44.0||||||
4250546|NCT00633932|4074878|B2|65 - 74 years||Age, Customized||Participants|Number|36|36.0||||||
4250547|NCT00633932|4074879|B1|65 - 74 years||Age, Customized||Participants|Number|47|47.0||||||
4250548|NCT00633932|4074876|B4|< 65 years||Age, Customized||Participants|Number|388|388.0||||||
4250549|NCT00633932|4074877|B3|< 65 years||Age, Customized||Participants|Number|126|126.0||||||
4250550|NCT00633932|4074878|B2|< 65 years||Age, Customized||Participants|Number|135|135.0||||||
4250551|NCT00633932|4074879|B1|< 65 years||Age, Customized||Participants|Number|127|127.0||||||
4250552|NCT00633919|4074892|B3|Spain||Region of Enrollment||participants|Number|124|124.0||||||
4250553|NCT00633919|4074893|B2|Spain||Region of Enrollment||participants|Number|61|61.0||||||
4250554|NCT00633919|4074894|B1|Spain||Region of Enrollment||participants|Number|63|63.0||||||
4250555|NCT00633919|4074892|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4250556|NCT00633919|4074893|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4250557|NCT00633919|4074894|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4250558|NCT00633919|4074892|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4250559|NCT00633919|4074893|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4250560|NCT00633919|4074894|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4250561|NCT00633919|4074892|B3|||Age||years|Mean|31|31.0|Standard Deviation|8.6|8.6|||
4250562|NCT00633919|4074893|B2|||Age||years|Mean|30|30.0|Standard Deviation|9.0|9.0|||
4250563|NCT00633919|4074894|B1|||Age||years|Mean|32|32.0|Standard Deviation|8.0|8.0|||
4250564|NCT00633919|4074892|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4250565|NCT00633919|4074893|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4250566|NCT00633919|4074894|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4250567|NCT00633919|4074892|B3||Between 18 and 65 years|Age||Participants|Count of Participants|124|124.0||||||
4250568|NCT00633919|4074893|B2||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4250569|NCT00633919|4074894|B1||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4250570|NCT00633919|4074892|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4250571|NCT00633919|4074893|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4250572|NCT00633919|4074894|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4250573|NCT00633893|4074909|B4|PE||Index Event Classification|Number of participants with Proximal DVT (defined at the site) and number with PE (defined at the site). In the event a participant had both proximal DVT and PE, the participant was classified to PE.|participants|Number|860|860.0||||||
4250574|NCT00633893|4074910|B3|PE||Index Event Classification|Number of participants with Proximal DVT (defined at the site) and number with PE (defined at the site). In the event a participant had both proximal DVT and PE, the participant was classified to PE.|participants|Number|278|278.0||||||
4250575|NCT00633893|4074911|B2|PE||Index Event Classification|Number of participants with Proximal DVT (defined at the site) and number with PE (defined at the site). In the event a participant had both proximal DVT and PE, the participant was classified to PE.|participants|Number|286|286.0||||||
4250576|NCT00633893|4074912|B1|PE||Index Event Classification|Number of participants with Proximal DVT (defined at the site) and number with PE (defined at the site). In the event a participant had both proximal DVT and PE, the participant was classified to PE.|participants|Number|296|296.0||||||
4250577|NCT00633893|4074909|B4|Proximal DVT||Index Event Classification|Number of participants with Proximal DVT (defined at the site) and number with PE (defined at the site). In the event a participant had both proximal DVT and PE, the participant was classified to PE.|participants|Number|1622|1622.0||||||
4250578|NCT00633893|4074910|B3|Proximal DVT||Index Event Classification|Number of participants with Proximal DVT (defined at the site) and number with PE (defined at the site). In the event a participant had both proximal DVT and PE, the participant was classified to PE.|participants|Number|551|551.0||||||
4250579|NCT00633893|4074911|B2|Proximal DVT||Index Event Classification|Number of participants with Proximal DVT (defined at the site) and number with PE (defined at the site). In the event a participant had both proximal DVT and PE, the participant was classified to PE.|participants|Number|527|527.0||||||
4250580|NCT00633893|4074912|B1|Proximal DVT||Index Event Classification|Number of participants with Proximal DVT (defined at the site) and number with PE (defined at the site). In the event a participant had both proximal DVT and PE, the participant was classified to PE.|participants|Number|544|544.0||||||
4250581|NCT00633893|4074909|B4|Germany||Region of Enrollment||participants|Number|177|177.0||||||
4250582|NCT00633893|4074910|B3|Germany||Region of Enrollment||participants|Number|60|60.0||||||
4250583|NCT00633893|4074911|B2|Germany||Region of Enrollment||participants|Number|55|55.0||||||
4250584|NCT00633893|4074912|B1|Germany||Region of Enrollment||participants|Number|62|62.0||||||
4250585|NCT00633893|4074909|B4|Norway||Region of Enrollment||participants|Number|28|28.0||||||
4250586|NCT00633893|4074910|B3|Norway||Region of Enrollment||participants|Number|10|10.0||||||
4250587|NCT00633893|4074911|B2|Norway||Region of Enrollment||participants|Number|9|9.0||||||
4250588|NCT00633893|4074912|B1|Norway||Region of Enrollment||participants|Number|9|9.0||||||
4250589|NCT00633893|4074909|B4|Romania||Region of Enrollment||participants|Number|20|20.0||||||
4250590|NCT00633893|4074910|B3|Romania||Region of Enrollment||participants|Number|7|7.0||||||
4250591|NCT00633893|4074911|B2|Romania||Region of Enrollment||participants|Number|7|7.0||||||
4250592|NCT00633893|4074912|B1|Romania||Region of Enrollment||participants|Number|6|6.0||||||
4250593|NCT00633893|4074909|B4|Singapore||Region of Enrollment||participants|Number|6|6.0||||||
4250594|NCT00633893|4074910|B3|Singapore||Region of Enrollment||participants|Number|3|3.0||||||
4250595|NCT00633893|4074911|B2|Singapore||Region of Enrollment||participants|Number|2|2.0||||||
4250596|NCT00633893|4074912|B1|Singapore||Region of Enrollment||participants|Number|1|1.0||||||
4250597|NCT00633893|4074909|B4|Brazil||Region of Enrollment||participants|Number|73|73.0||||||
4250598|NCT00633893|4074910|B3|Brazil||Region of Enrollment||participants|Number|30|30.0||||||
4250599|NCT00633893|4074911|B2|Brazil||Region of Enrollment||participants|Number|24|24.0||||||
4250600|NCT00633893|4074912|B1|Brazil||Region of Enrollment||participants|Number|19|19.0||||||
4250601|NCT00633893|4074909|B4|Poland||Region of Enrollment||participants|Number|137|137.0||||||
4250602|NCT00633893|4074910|B3|Poland||Region of Enrollment||participants|Number|48|48.0||||||
4250603|NCT00633893|4074911|B2|Poland||Region of Enrollment||participants|Number|44|44.0||||||
4250604|NCT00633893|4074912|B1|Poland||Region of Enrollment||participants|Number|45|45.0||||||
4250605|NCT00633893|4074909|B4|Argentina||Region of Enrollment||participants|Number|22|22.0||||||
4250606|NCT00633893|4074910|B3|Argentina||Region of Enrollment||participants|Number|6|6.0||||||
4250607|NCT00633893|4074911|B2|Argentina||Region of Enrollment||participants|Number|9|9.0||||||
4250608|NCT00633893|4074912|B1|Argentina||Region of Enrollment||participants|Number|7|7.0||||||
4250609|NCT00633893|4074909|B4|Canada||Region of Enrollment||participants|Number|54|54.0||||||
4250610|NCT00633893|4074910|B3|Canada||Region of Enrollment||participants|Number|15|15.0||||||
4250611|NCT00633893|4074911|B2|Canada||Region of Enrollment||participants|Number|17|17.0||||||
4250612|NCT00633893|4074912|B1|Canada||Region of Enrollment||participants|Number|22|22.0||||||
4250613|NCT00633893|4074909|B4|Mexico||Region of Enrollment||participants|Number|62|62.0||||||
4250614|NCT00633893|4074910|B3|Mexico||Region of Enrollment||participants|Number|22|22.0||||||
4250615|NCT00633893|4074911|B2|Mexico||Region of Enrollment||participants|Number|18|18.0||||||
4250616|NCT00633893|4074912|B1|Mexico||Region of Enrollment||participants|Number|22|22.0||||||
4250617|NCT00633893|4074909|B4|Czech Republic||Region of Enrollment||participants|Number|140|140.0||||||
4250618|NCT00633893|4074910|B3|Czech Republic||Region of Enrollment||participants|Number|48|48.0||||||
4250619|NCT00633893|4074911|B2|Czech Republic||Region of Enrollment||participants|Number|49|49.0||||||
4250620|NCT00633893|4074912|B1|Czech Republic||Region of Enrollment||participants|Number|43|43.0||||||
4250621|NCT00633893|4074909|B4|United Kingdom||Region of Enrollment||participants|Number|92|92.0||||||
4250622|NCT00633893|4074910|B3|United Kingdom||Region of Enrollment||participants|Number|30|30.0||||||
4250623|NCT00633893|4074911|B2|United Kingdom||Region of Enrollment||participants|Number|29|29.0||||||
4250624|NCT00633893|4074912|B1|United Kingdom||Region of Enrollment||participants|Number|33|33.0||||||
4250625|NCT00633893|4074909|B4|Austria||Region of Enrollment||participants|Number|31|31.0||||||
4250626|NCT00633893|4074910|B3|Austria||Region of Enrollment||participants|Number|11|11.0||||||
4250627|NCT00633893|4074911|B2|Austria||Region of Enrollment||participants|Number|8|8.0||||||
4250628|NCT00633893|4074912|B1|Austria||Region of Enrollment||participants|Number|12|12.0||||||
4250629|NCT00633893|4074909|B4|Korea, Republic of||Region of Enrollment||participants|Number|9|9.0||||||
4250630|NCT00633893|4074910|B3|Korea, Republic of||Region of Enrollment||participants|Number|2|2.0||||||
4250631|NCT00633893|4074911|B2|Korea, Republic of||Region of Enrollment||participants|Number|3|3.0||||||
4250632|NCT00633893|4074912|B1|Korea, Republic of||Region of Enrollment||participants|Number|4|4.0||||||
4250633|NCT00633893|4074909|B4|South Africa||Region of Enrollment||participants|Number|106|106.0||||||
4250634|NCT00633893|4074910|B3|South Africa||Region of Enrollment||participants|Number|30|30.0||||||
4250635|NCT00633893|4074911|B2|South Africa||Region of Enrollment||participants|Number|42|42.0||||||
4250636|NCT00633893|4074912|B1|South Africa||Region of Enrollment||participants|Number|34|34.0||||||
4250637|NCT00633893|4074909|B4|Denmark||Region of Enrollment||participants|Number|147|147.0||||||
4250638|NCT00633893|4074910|B3|Denmark||Region of Enrollment||participants|Number|42|42.0||||||
4250639|NCT00633893|4074911|B2|Denmark||Region of Enrollment||participants|Number|58|58.0||||||
4250640|NCT00633893|4074912|B1|Denmark||Region of Enrollment||participants|Number|47|47.0||||||
4250641|NCT00633893|4074909|B4|Australia||Region of Enrollment||participants|Number|89|89.0||||||
4250642|NCT00633893|4074910|B3|Australia||Region of Enrollment||participants|Number|31|31.0||||||
4250643|NCT00633893|4074911|B2|Australia||Region of Enrollment||participants|Number|28|28.0||||||
4250644|NCT00633893|4074912|B1|Australia||Region of Enrollment||participants|Number|30|30.0||||||
4250645|NCT00633893|4074909|B4|France||Region of Enrollment||participants|Number|165|165.0||||||
4250646|NCT00633893|4074910|B3|France||Region of Enrollment||participants|Number|50|50.0||||||
4250647|NCT00633893|4074911|B2|France||Region of Enrollment||participants|Number|55|55.0||||||
4250648|NCT00633893|4074912|B1|France||Region of Enrollment||participants|Number|60|60.0||||||
4250649|NCT00633893|4074909|B4|India||Region of Enrollment||participants|Number|71|71.0||||||
4250650|NCT00633893|4074910|B3|India||Region of Enrollment||participants|Number|24|24.0||||||
4250651|NCT00633893|4074911|B2|India||Region of Enrollment||participants|Number|23|23.0||||||
4250652|NCT00633893|4074912|B1|India||Region of Enrollment||participants|Number|24|24.0||||||
4250653|NCT00633893|4074909|B4|Italy||Region of Enrollment||participants|Number|193|193.0||||||
4250654|NCT00633893|4074910|B3|Italy||Region of Enrollment||participants|Number|61|61.0||||||
4250655|NCT00633893|4074911|B2|Italy||Region of Enrollment||participants|Number|65|65.0||||||
4250656|NCT00633893|4074912|B1|Italy||Region of Enrollment||participants|Number|67|67.0||||||
4250657|NCT00633893|4074909|B4|Israel||Region of Enrollment||participants|Number|102|102.0||||||
4250658|NCT00633893|4074910|B3|Israel||Region of Enrollment||participants|Number|34|34.0||||||
4250659|NCT00633893|4074911|B2|Israel||Region of Enrollment||participants|Number|34|34.0||||||
4250660|NCT00633893|4074912|B1|Israel||Region of Enrollment||participants|Number|34|34.0||||||
4250661|NCT00633893|4074909|B4|Russian Federation||Region of Enrollment||participants|Number|140|140.0||||||
4250662|NCT00633893|4074910|B3|Russian Federation||Region of Enrollment||participants|Number|46|46.0||||||
4250663|NCT00633893|4074911|B2|Russian Federation||Region of Enrollment||participants|Number|49|49.0||||||
4250664|NCT00633893|4074912|B1|Russian Federation||Region of Enrollment||participants|Number|45|45.0||||||
4250665|NCT00633893|4074909|B4|Chile||Region of Enrollment||participants|Number|5|5.0||||||
4250666|NCT00633893|4074910|B3|Chile||Region of Enrollment||participants|Number|2|2.0||||||
4250667|NCT00633893|4074911|B2|Chile||Region of Enrollment||participants|Number|1|1.0||||||
4250668|NCT00633893|4074912|B1|Chile||Region of Enrollment||participants|Number|2|2.0||||||
4250669|NCT00633893|4074909|B4|Ukraine||Region of Enrollment||participants|Number|252|252.0||||||
4250670|NCT00633893|4074910|B3|Ukraine||Region of Enrollment||participants|Number|88|88.0||||||
4250671|NCT00633893|4074911|B2|Ukraine||Region of Enrollment||participants|Number|77|77.0||||||
4250672|NCT00633893|4074912|B1|Ukraine||Region of Enrollment||participants|Number|87|87.0||||||
4250673|NCT00633893|4074909|B4|Spain||Region of Enrollment||participants|Number|78|78.0||||||
4250674|NCT00633893|4074910|B3|Spain||Region of Enrollment||participants|Number|26|26.0||||||
4250675|NCT00633893|4074911|B2|Spain||Region of Enrollment||participants|Number|25|25.0||||||
4250676|NCT00633893|4074912|B1|Spain||Region of Enrollment||participants|Number|27|27.0||||||
4250677|NCT00633893|4074909|B4|Hong Kong||Region of Enrollment||participants|Number|11|11.0||||||
4250678|NCT00633893|4074910|B3|Hong Kong||Region of Enrollment||participants|Number|4|4.0||||||
4250679|NCT00633893|4074911|B2|Hong Kong||Region of Enrollment||participants|Number|3|3.0||||||
4250680|NCT00633893|4074912|B1|Hong Kong||Region of Enrollment||participants|Number|4|4.0||||||
4250681|NCT00633893|4074909|B4|Philippines||Region of Enrollment||participants|Number|11|11.0||||||
4250682|NCT00633893|4074910|B3|Philippines||Region of Enrollment||participants|Number|3|3.0||||||
4250683|NCT00633893|4074911|B2|Philippines||Region of Enrollment||participants|Number|3|3.0||||||
4250684|NCT00633893|4074912|B1|Philippines||Region of Enrollment||participants|Number|5|5.0||||||
4250685|NCT00633893|4074909|B4|United States||Region of Enrollment||participants|Number|259|259.0||||||
4250686|NCT00633893|4074910|B3|United States||Region of Enrollment||participants|Number|96|96.0||||||
4250687|NCT00633893|4074911|B2|United States||Region of Enrollment||participants|Number|75|75.0||||||
4250688|NCT00633893|4074912|B1|United States||Region of Enrollment||participants|Number|88|88.0||||||
4250689|NCT00633893|4074909|B4|Portugal||Region of Enrollment||participants|Number|2|2.0||||||
4250690|NCT00633893|4074910|B3|Portugal||Region of Enrollment||participants|Number|0|0.0||||||
4250691|NCT00633893|4074911|B2|Portugal||Region of Enrollment||participants|Number|1|1.0||||||
4250692|NCT00633893|4074912|B1|Portugal||Region of Enrollment||participants|Number|1|1.0||||||
4250693|NCT00633893|4074909|B4||Male|Sex: Female, Male||Participants|Count of Participants|1424|1424.0||||||
4250694|NCT00633893|4074910|B3||Male|Sex: Female, Male||Participants|Count of Participants|468|468.0||||||
4250695|NCT00633893|4074911|B2||Male|Sex: Female, Male||Participants|Count of Participants|469|469.0||||||
4250696|NCT00633893|4074912|B1||Male|Sex: Female, Male||Participants|Count of Participants|487|487.0||||||
4250697|NCT00633893|4074909|B4||Female|Sex: Female, Male||Participants|Count of Participants|1058|1058.0||||||
4250698|NCT00633893|4074910|B3||Female|Sex: Female, Male||Participants|Count of Participants|361|361.0||||||
4250699|NCT00633893|4074911|B2||Female|Sex: Female, Male||Participants|Count of Participants|344|344.0||||||
4250700|NCT00633893|4074912|B1||Female|Sex: Female, Male||Participants|Count of Participants|353|353.0||||||
4250701|NCT00633893|4074909|B4|||Age||years|Mean|56.7|56.7|Standard Deviation|15.4|15.4|||
4250702|NCT00633893|4074910|B3|||Age||years|Mean|57.1|57.1|Standard Deviation|15.2|15.2|||
4250703|NCT00633893|4074911|B2|||Age||years|Mean|56.4|56.4|Standard Deviation|15.6|15.6|||
4250704|NCT00633893|4074912|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|15.3|15.3|||
4250705|NCT00633880|4074985|B4|Other||Primary Clinical Diagnosis||participants|Number|4|4.0||||||
4250706|NCT00633880|4074986|B3|Other||Primary Clinical Diagnosis||participants|Number|1|1.0||||||
4250707|NCT00633880|4074987|B2|Other||Primary Clinical Diagnosis||participants|Number|2|2.0||||||
4250708|NCT00633880|4074988|B1|Other||Primary Clinical Diagnosis||participants|Number|1|1.0||||||
4250709|NCT00633880|4074985|B4|Non-Diabetic Autonomic Neuropathy||Primary Clinical Diagnosis||participants|Number|7|7.0||||||
4250710|NCT00633880|4074986|B3|Non-Diabetic Autonomic Neuropathy||Primary Clinical Diagnosis||participants|Number|3|3.0||||||
4250711|NCT00633880|4074987|B2|Non-Diabetic Autonomic Neuropathy||Primary Clinical Diagnosis||participants|Number|2|2.0||||||
4250712|NCT00633880|4074988|B1|Non-Diabetic Autonomic Neuropathy||Primary Clinical Diagnosis||participants|Number|2|2.0||||||
4250713|NCT00633880|4074985|B4|Dopamine Beta-Hydroxylase Deficiency||Primary Clinical Diagnosis||participants|Number|1|1.0||||||
4250714|NCT00633880|4074986|B3|Dopamine Beta-Hydroxylase Deficiency||Primary Clinical Diagnosis||participants|Number|1|1.0||||||
4250715|NCT00633880|4074987|B2|Dopamine Beta-Hydroxylase Deficiency||Primary Clinical Diagnosis||participants|Number|0|0.0||||||
4250716|NCT00633880|4074988|B1|Dopamine Beta-Hydroxylase Deficiency||Primary Clinical Diagnosis||participants|Number|0|0.0||||||
4250717|NCT00633880|4074985|B4|Pure Autonomic Failure||Primary Clinical Diagnosis||participants|Number|36|36.0||||||
4250718|NCT00633880|4074986|B3|Pure Autonomic Failure||Primary Clinical Diagnosis||participants|Number|10|10.0||||||
4250719|NCT00633880|4074987|B2|Pure Autonomic Failure||Primary Clinical Diagnosis||participants|Number|8|8.0||||||
4250720|NCT00633880|4074988|B1|Pure Autonomic Failure||Primary Clinical Diagnosis||participants|Number|18|18.0||||||
4250721|NCT00633880|4074985|B4|Multiple System Atrophy||Primary Clinical Diagnosis||participants|Number|51|51.0||||||
4250722|NCT00633880|4074986|B3|Multiple System Atrophy||Primary Clinical Diagnosis||participants|Number|13|13.0||||||
4250723|NCT00633880|4074987|B2|Multiple System Atrophy||Primary Clinical Diagnosis||participants|Number|17|17.0||||||
4250724|NCT00633880|4074988|B1|Multiple System Atrophy||Primary Clinical Diagnosis||participants|Number|21|21.0||||||
4250725|NCT00633880|4074985|B4|Parkinson's Disease||Primary Clinical Diagnosis||participants|Number|82|82.0||||||
4250726|NCT00633880|4074986|B3|Parkinson's Disease||Primary Clinical Diagnosis||participants|Number|23|23.0||||||
4250727|NCT00633880|4074987|B2|Parkinson's Disease||Primary Clinical Diagnosis||participants|Number|21|21.0||||||
4250728|NCT00633880|4074988|B1|Parkinson's Disease||Primary Clinical Diagnosis||participants|Number|38|38.0||||||
4250729|NCT00633880|4074985|B4|New Zealand||Region of Enrollment||participants|Number|3|3.0||||||
4250730|NCT00633880|4074986|B3|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
4250731|NCT00633880|4074987|B2|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
4250732|NCT00633880|4074988|B1|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
4250733|NCT00633880|4074985|B4|Australia||Region of Enrollment||participants|Number|16|16.0||||||
4250734|NCT00633880|4074986|B3|Australia||Region of Enrollment||participants|Number|6|6.0||||||
4250735|NCT00633880|4074987|B2|Australia||Region of Enrollment||participants|Number|2|2.0||||||
4250736|NCT00633880|4074988|B1|Australia||Region of Enrollment||participants|Number|8|8.0||||||
4250737|NCT00633880|4074985|B4|Poland||Region of Enrollment||participants|Number|23|23.0||||||
4250738|NCT00633880|4074986|B3|Poland||Region of Enrollment||participants|Number|8|8.0||||||
4250739|NCT00633880|4074987|B2|Poland||Region of Enrollment||participants|Number|10|10.0||||||
4250740|NCT00633880|4074988|B1|Poland||Region of Enrollment||participants|Number|5|5.0||||||
4250741|NCT00633880|4074985|B4|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
4250742|NCT00633880|4074986|B3|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4250743|NCT00633880|4074987|B2|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4250744|NCT00633880|4074988|B1|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4250745|NCT00633880|4074985|B4|Canada||Region of Enrollment||participants|Number|19|19.0||||||
4250746|NCT00633880|4074986|B3|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4250747|NCT00633880|4074987|B2|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4250748|NCT00633880|4074988|B1|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4250749|NCT00633880|4074985|B4|United States||Region of Enrollment||participants|Number|110|110.0||||||
4250750|NCT00633880|4074986|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4250751|NCT00633880|4074987|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4250752|NCT00633880|4074988|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
4250753|NCT00633880|4074985|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250754|NCT00633880|4074986|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250755|NCT00633880|4074987|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250756|NCT00633880|4074988|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250757|NCT00633880|4074985|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250758|NCT00633880|4074986|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250759|NCT00633880|4074987|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250760|NCT00633880|4074988|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250761|NCT00633880|4074985|B4||White|Race (NIH/OMB)||Participants|Count of Participants|178|178.0||||||
4250762|NCT00633880|4074986|B3||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4250763|NCT00633880|4074987|B2||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4250764|NCT00633880|4074988|B1||White|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
4250765|NCT00633880|4074985|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250766|NCT00633880|4074986|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250767|NCT00633880|4074987|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250768|NCT00633880|4074988|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250769|NCT00633880|4074985|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250770|NCT00633880|4074986|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250771|NCT00633880|4074987|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250772|NCT00633880|4074988|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250773|NCT00633880|4074985|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4250774|NCT00633880|4074986|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4250775|NCT00633880|4074987|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4250776|NCT00633880|4074988|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250777|NCT00633880|4074985|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4250778|NCT00633880|4074986|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4250779|NCT00633880|4074987|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250780|NCT00633880|4074988|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4250781|NCT00633880|4074985|B4||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4250782|NCT00633880|4074986|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4250783|NCT00633880|4074987|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4250784|NCT00633880|4074988|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4250785|NCT00633880|4074985|B4||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4250786|NCT00633880|4074986|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4250787|NCT00633880|4074987|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4250788|NCT00633880|4074988|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4250789|NCT00633880|4074985|B4|||Age||years|Mean|66.9|66.9|Standard Deviation|11.62|11.62|||
4250790|NCT00633880|4074986|B3|||Age||years|Mean|66.6|66.6|Standard Deviation|11.25|11.25|||
4250791|NCT00633880|4074987|B2|||Age||years|Mean|63.1|63.1|Standard Deviation|13.76|13.76|||
4250792|NCT00633880|4074988|B1|||Age||years|Mean|69.5|69.5|Standard Deviation|9.74|9.74|||
4250793|NCT00633867|4075017|B3|United Kingdom||Region of Enrollment||participants|Number|120|120.0||||||
4250794|NCT00633867|4075018|B2|United Kingdom||Region of Enrollment||participants|Number|60|60.0||||||
4250795|NCT00633867|4075019|B1|United Kingdom||Region of Enrollment||participants|Number|60|60.0||||||
4250796|NCT00633867|4075017|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4250797|NCT00633867|4075018|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4250798|NCT00633867|4075019|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4250799|NCT00633867|4075017|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4250800|NCT00633867|4075018|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4250801|NCT00633867|4075019|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4250802|NCT00633867|4075017|B3|||Age, Customized||Years|Median|54|54.0|Inter-Quartile Range|||40.0|66.5|
4250803|NCT00633867|4075018|B2|||Age, Customized||Years|Median|60.5|60.5|Inter-Quartile Range|||41.3|70.0|
4250804|NCT00633867|4075019|B1|||Age, Customized||Years|Median|48|48.0|Inter-Quartile Range|||39.0|63.5|
4250805|NCT00633750|4075026|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
4250806|NCT00633750|4075026|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4250807|NCT00633750|4075026|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4250808|NCT00633750|4075026|B1|||Age||years|Mean|56|56.0|Standard Deviation|1|1.0|||
4250809|NCT00633750|4075026|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4250810|NCT00633750|4075026|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4250811|NCT00633750|4075026|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4250812|NCT00633594|4075032|B4|Previously Treated||Previous Treatment for Mantle Cell Lymphoma (MCL)|Includes participants with relapsed or refractory MCL who have received one previous treatment prior to starting study treatment, and those with previously untreated MCL prior to starting study treatment.|participants|Number|10|10.0||||||
4250813|NCT00633594|4075033|B3|Previously Treated||Previous Treatment for Mantle Cell Lymphoma (MCL)|Includes participants with relapsed or refractory MCL who have received one previous treatment prior to starting study treatment, and those with previously untreated MCL prior to starting study treatment.|participants|Number|5|5.0||||||
4250814|NCT00633594|4075034|B2|Previously Treated||Previous Treatment for Mantle Cell Lymphoma (MCL)|Includes participants with relapsed or refractory MCL who have received one previous treatment prior to starting study treatment, and those with previously untreated MCL prior to starting study treatment.|participants|Number|1|1.0||||||
4250815|NCT00633594|4075035|B1|Previously Treated||Previous Treatment for Mantle Cell Lymphoma (MCL)|Includes participants with relapsed or refractory MCL who have received one previous treatment prior to starting study treatment, and those with previously untreated MCL prior to starting study treatment.|participants|Number|4|4.0||||||
4250816|NCT00633594|4075032|B4|Previously Untreated||Previous Treatment for Mantle Cell Lymphoma (MCL)|Includes participants with relapsed or refractory MCL who have received one previous treatment prior to starting study treatment, and those with previously untreated MCL prior to starting study treatment.|participants|Number|29|29.0||||||
4250817|NCT00633594|4075033|B3|Previously Untreated||Previous Treatment for Mantle Cell Lymphoma (MCL)|Includes participants with relapsed or refractory MCL who have received one previous treatment prior to starting study treatment, and those with previously untreated MCL prior to starting study treatment.|participants|Number|21|21.0||||||
4250818|NCT00633594|4075034|B2|Previously Untreated||Previous Treatment for Mantle Cell Lymphoma (MCL)|Includes participants with relapsed or refractory MCL who have received one previous treatment prior to starting study treatment, and those with previously untreated MCL prior to starting study treatment.|participants|Number|7|7.0||||||
4250819|NCT00633594|4075035|B1|Previously Untreated||Previous Treatment for Mantle Cell Lymphoma (MCL)|Includes participants with relapsed or refractory MCL who have received one previous treatment prior to starting study treatment, and those with previously untreated MCL prior to starting study treatment.|participants|Number|1|1.0||||||
4250820|NCT00633594|4075032|B4|United States||Region of Enrollment||participants|Number|39|39.0||||||
4250821|NCT00633594|4075033|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4250822|NCT00633594|4075034|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4250823|NCT00633594|4075035|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4250824|NCT00633594|4075032|B4||Male|Gender||Participants|Count of Participants|29|29.0||||||
4250825|NCT00633594|4075033|B3||Male|Gender||Participants|Count of Participants|19|19.0||||||
4250826|NCT00633594|4075034|B2||Male|Gender||Participants|Count of Participants|6|6.0||||||
4250827|NCT00633594|4075035|B1||Male|Gender||Participants|Count of Participants|4|4.0||||||
4250828|NCT00633594|4075032|B4||Female|Gender||Participants|Count of Participants|10|10.0||||||
4250829|NCT00633594|4075033|B3||Female|Gender||Participants|Count of Participants|7|7.0||||||
4250830|NCT00633594|4075034|B2||Female|Gender||Participants|Count of Participants|2|2.0||||||
4250831|NCT00633594|4075035|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
4250832|NCT00633594|4075032|B4|Previously Untreated : Male||Sex/Gender, Customized|Gender based on participants' previous treatment prior to initiating study treatment (previously treated and previously untreated)|Participants|Count of Participants|23|23.0||||||
4250833|NCT00633594|4075033|B3|Previously Untreated : Male||Sex/Gender, Customized|Gender based on participants' previous treatment prior to initiating study treatment (previously treated and previously untreated)|Participants|Count of Participants|16|16.0||||||
4250834|NCT00633594|4075034|B2|Previously Untreated : Male||Sex/Gender, Customized|Gender based on participants' previous treatment prior to initiating study treatment (previously treated and previously untreated)|Participants|Count of Participants|6|6.0||||||
4250835|NCT00633594|4075035|B1|Previously Untreated : Male||Sex/Gender, Customized|Gender based on participants' previous treatment prior to initiating study treatment (previously treated and previously untreated)|Participants|Count of Participants|1|1.0||||||
4250836|NCT00633594|4075032|B4|Previously Untreated : Female||Sex/Gender, Customized|Gender based on participants' previous treatment prior to initiating study treatment (previously treated and previously untreated)|Participants|Count of Participants|6|6.0||||||
4250837|NCT00633594|4075033|B3|Previously Untreated : Female||Sex/Gender, Customized|Gender based on participants' previous treatment prior to initiating study treatment (previously treated and previously untreated)|Participants|Count of Participants|5|5.0||||||
4250838|NCT00633594|4075034|B2|Previously Untreated : Female||Sex/Gender, Customized|Gender based on participants' previous treatment prior to initiating study treatment (previously treated and previously untreated)|Participants|Count of Participants|1|1.0||||||
4250839|NCT00633594|4075035|B1|Previously Untreated : Female||Sex/Gender, Customized|Gender based on participants' previous treatment prior to initiating study treatment (previously treated and previously untreated)|Participants|Count of Participants|0|0.0||||||
4250840|NCT00633594|4075032|B4|Previously Treated : Male||Sex/Gender, Customized|Gender based on participants' previous treatment prior to initiating study treatment (previously treated and previously untreated)|Participants|Count of Participants|6|6.0||||||
4250841|NCT00633594|4075033|B3|Previously Treated : Male||Sex/Gender, Customized|Gender based on participants' previous treatment prior to initiating study treatment (previously treated and previously untreated)|Participants|Count of Participants|3|3.0||||||
4250842|NCT00633594|4075034|B2|Previously Treated : Male||Sex/Gender, Customized|Gender based on participants' previous treatment prior to initiating study treatment (previously treated and previously untreated)|Participants|Count of Participants|0|0.0||||||
4250843|NCT00633594|4075035|B1|Previously Treated : Male||Sex/Gender, Customized|Gender based on participants' previous treatment prior to initiating study treatment (previously treated and previously untreated)|Participants|Count of Participants|3|3.0||||||
4250844|NCT00633594|4075032|B4|Previously Treated : Female||Sex/Gender, Customized|Gender based on participants' previous treatment prior to initiating study treatment (previously treated and previously untreated)|Participants|Count of Participants|4|4.0||||||
4250845|NCT00633594|4075033|B3|Previously Treated : Female||Sex/Gender, Customized|Gender based on participants' previous treatment prior to initiating study treatment (previously treated and previously untreated)|Participants|Count of Participants|2|2.0||||||
4250846|NCT00633594|4075034|B2|Previously Treated : Female||Sex/Gender, Customized|Gender based on participants' previous treatment prior to initiating study treatment (previously treated and previously untreated)|Participants|Count of Participants|1|1.0||||||
4250847|NCT00633594|4075035|B1|Previously Treated : Female||Sex/Gender, Customized|Gender based on participants' previous treatment prior to initiating study treatment (previously treated and previously untreated)|Participants|Count of Participants|1|1.0||||||
4250848|NCT00633594|4075032|B4|Previously Untreated : >= 65 years||Age, Customized||Participants|Count of Participants|20|20.0||||||
4250849|NCT00633594|4075033|B3|Previously Untreated : >= 65 years||Age, Customized||Participants|Count of Participants|14|14.0||||||
4250850|NCT00633594|4075034|B2|Previously Untreated : >= 65 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
4250851|NCT00633594|4075035|B1|Previously Untreated : >= 65 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
4250852|NCT00633594|4075032|B4|Previously Untreated : Between 18 and 65 years||Age, Customized||Participants|Count of Participants|9|9.0||||||
4250853|NCT00633594|4075033|B3|Previously Untreated : Between 18 and 65 years||Age, Customized||Participants|Count of Participants|7|7.0||||||
4250854|NCT00633594|4075034|B2|Previously Untreated : Between 18 and 65 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
4250855|NCT00633594|4075035|B1|Previously Untreated : Between 18 and 65 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4250856|NCT00633594|4075032|B4|Previously Untreated : <= 18 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4250857|NCT00633594|4075033|B3|Previously Untreated : <= 18 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4250858|NCT00633594|4075034|B2|Previously Untreated : <= 18 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4250859|NCT00633594|4075035|B1|Previously Untreated : <= 18 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4250860|NCT00633594|4075032|B4|Previously Treated : >= 65 years||Age, Customized||Participants|Count of Participants|7|7.0||||||
4250861|NCT00633594|4075033|B3|Previously Treated : >= 65 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
4250862|NCT00633594|4075034|B2|Previously Treated : >= 65 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
4250863|NCT00633594|4075035|B1|Previously Treated : >= 65 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
4250864|NCT00633594|4075032|B4|Previously Treated : Between 18 and 65 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
4250865|NCT00633594|4075033|B3|Previously Treated : Between 18 and 65 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4250866|NCT00633594|4075034|B2|Previously Treated : Between 18 and 65 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4250867|NCT00633594|4075035|B1|Previously Treated : Between 18 and 65 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
4250868|NCT00633594|4075032|B4|Previously Treated : <= 18 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4250869|NCT00633594|4075033|B3|Previously Treated : <= 18 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4250870|NCT00633594|4075034|B2|Previously Treated : <= 18 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4250871|NCT00633594|4075035|B1|Previously Treated : <= 18 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4250872|NCT00633594|4075032|B4|||Age||years|Median|69|69.0|Full Range|||52.0|88.0|
4250873|NCT00633594|4075033|B3|||Age||years|Median|69|69.0|Full Range|||55.0|88.0|
4250874|NCT00633594|4075034|B2|||Age||years|Median|69|69.0|Full Range|||60.0|80.0|
4250875|NCT00633594|4075035|B1|||Age||years|Median|60|60.0|Full Range|||52.0|70.0|
4250876|NCT00633594|4075032|B4||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4250877|NCT00633594|4075033|B3||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4250878|NCT00633594|4075034|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4250879|NCT00633594|4075035|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4250880|NCT00633594|4075032|B4||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4250881|NCT00633594|4075033|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4250882|NCT00633594|4075034|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4250883|NCT00633594|4075035|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4250884|NCT00633594|4075032|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4250885|NCT00633594|4075033|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4250886|NCT00633594|4075034|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4250887|NCT00633594|4075035|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4250888|NCT00633477|4075064|B3|Smoking history not available||Smoking Classification||Participant|Number|1|1.0||||||
4250889|NCT00633477|4075065|B2|Smoking history not available||Smoking Classification||Participant|Number|0|0.0||||||
4250890|NCT00633477|4075066|B1|Smoking history not available||Smoking Classification||Participant|Number|1|1.0||||||
4250891|NCT00633477|4075064|B3|Ex-smoker||Smoking Classification||Participant|Number|7|7.0||||||
4250892|NCT00633477|4075065|B2|Ex-smoker||Smoking Classification||Participant|Number|4|4.0||||||
4250893|NCT00633477|4075066|B1|Ex-smoker||Smoking Classification||Participant|Number|3|3.0||||||
4250894|NCT00633477|4075064|B3|Current smoker||Smoking Classification||Participant|Number|3|3.0||||||
4250895|NCT00633477|4075065|B2|Current smoker||Smoking Classification||Participant|Number|3|3.0||||||
4250896|NCT00633477|4075066|B1|Current smoker||Smoking Classification||Participant|Number|0|0.0||||||
4250897|NCT00633477|4075064|B3|Never smoked||Smoking Classification||Participant|Number|6|6.0||||||
4250898|NCT00633477|4075065|B2|Never smoked||Smoking Classification||Participant|Number|4|4.0||||||
4250899|NCT00633477|4075066|B1|Never smoked||Smoking Classification||Participant|Number|2|2.0||||||
4250900|NCT00633477|4075064|B3|||Body Mass Index||kg/m2|Mean|22.19|22.19|Standard Deviation|5.36|5.36|||
4250901|NCT00633477|4075065|B2|||Body Mass Index||kg/m2|Mean|22.59|22.59|Standard Deviation|6.12|6.12|||
4250902|NCT00633477|4075066|B1|||Body Mass Index||kg/m2|Mean|21.46|21.46|Standard Deviation|3.97|3.97|||
4250903|NCT00633477|4075064|B3|||Height||cm|Mean|159.9|159.9|Standard Deviation|6.9|6.9|||
4250904|NCT00633477|4075065|B2|||Height||cm|Mean|160.7|160.7|Standard Deviation|7.4|7.4|||
4250905|NCT00633477|4075066|B1|||Height||cm|Mean|158.3|158.3|Standard Deviation|6.0|6.0|||
4250906|NCT00633477|4075064|B3|||Weight||kg|Mean|56.84|56.84|Standard Deviation|15.4|15.4|||
4250907|NCT00633477|4075065|B2|||Weight||kg|Mean|58.24|58.24|Standard Deviation|17.1|17.1|||
4250908|NCT00633477|4075066|B1|||Weight||kg|Mean|54.27|54.27|Standard Deviation|12.9|12.9|||
4250909|NCT00633477|4075064|B3|Unknown or Not Reported||Ethnicity||Participants|Number|16|16.0||||||
4250910|NCT00633477|4075065|B2|Unknown or Not Reported||Ethnicity||Participants|Number|10|10.0||||||
4250911|NCT00633477|4075066|B1|Unknown or Not Reported||Ethnicity||Participants|Number|6|6.0||||||
4250912|NCT00633477|4075064|B3|Not Hispanic or Latino||Ethnicity||Participants|Number|1|1.0||||||
4250913|NCT00633477|4075065|B2|Not Hispanic or Latino||Ethnicity||Participants|Number|1|1.0||||||
4250914|NCT00633477|4075066|B1|Not Hispanic or Latino||Ethnicity||Participants|Number|0|0.0||||||
4250915|NCT00633477|4075064|B3|Hispanic or Latino||Ethnicity||Participants|Number|0|0.0||||||
4250916|NCT00633477|4075065|B2|Hispanic or Latino||Ethnicity||Participants|Number|0|0.0||||||
4250917|NCT00633477|4075066|B1|Hispanic or Latino||Ethnicity||Participants|Number|0|0.0||||||
4250918|NCT00633477|4075064|B3|More than one race||Race||Participants|Number|0|0.0||||||
4250919|NCT00633477|4075065|B2|More than one race||Race||Participants|Number|0|0.0||||||
4250920|NCT00633477|4075066|B1|More than one race||Race||Participants|Number|0|0.0||||||
4250921|NCT00633477|4075064|B3|White||Race||Participants|Number|1|1.0||||||
4250922|NCT00633477|4075065|B2|White||Race||Participants|Number|1|1.0||||||
4250923|NCT00633477|4075066|B1|White||Race||Participants|Number|0|0.0||||||
4250924|NCT00633477|4075064|B3|Black or African American||Race||Participants|Number|0|0.0||||||
4250925|NCT00633477|4075065|B2|Black or African American||Race||Participants|Number|0|0.0||||||
4250926|NCT00633477|4075066|B1|Black or African American||Race||Participants|Number|0|0.0||||||
4250927|NCT00633477|4075064|B3|Native Hawaiian or Other Pacific Islander||Race||Participants|Number|0|0.0||||||
4250928|NCT00633477|4075065|B2|Native Hawaiian or Other Pacific Islander||Race||Participants|Number|0|0.0||||||
4250929|NCT00633477|4075066|B1|Native Hawaiian or Other Pacific Islander||Race||Participants|Number|0|0.0||||||
4250930|NCT00633477|4075064|B3|Asian||Race||Participants|Number|16|16.0||||||
4250931|NCT00633477|4075065|B2|Asian||Race||Participants|Number|10|10.0||||||
4250932|NCT00633477|4075066|B1|Asian||Race||Participants|Number|6|6.0||||||
4250933|NCT00633477|4075064|B3|American Indian or Alaska Native||Race||Participants|Number|0|0.0||||||
4250934|NCT00633477|4075065|B2|American Indian or Alaska Native||Race||Participants|Number|0|0.0||||||
4250935|NCT00633477|4075066|B1|American Indian or Alaska Native||Race||Participants|Number|0|0.0||||||
4250936|NCT00633477|4075064|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4250937|NCT00633477|4075065|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4250938|NCT00633477|4075066|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4250939|NCT00633477|4075064|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4250940|NCT00633477|4075065|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4250941|NCT00633477|4075066|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4250942|NCT00633477|4075064|B3|≥75||Age, Customized||Participants|Number|11|11.0||||||
4250943|NCT00633477|4075065|B2|≥75||Age, Customized||Participants|Number|7|7.0||||||
4250944|NCT00633477|4075066|B1|≥75||Age, Customized||Participants|Number|4|4.0||||||
4250945|NCT00633477|4075064|B3|60 - <75||Age, Customized||Participants|Number|5|5.0||||||
4250946|NCT00633477|4075065|B2|60 - <75||Age, Customized||Participants|Number|3|3.0||||||
4250947|NCT00633477|4075066|B1|60 - <75||Age, Customized||Participants|Number|2|2.0||||||
4250948|NCT00633477|4075064|B3|45 - <60||Age, Customized||Participants|Number|1|1.0||||||
4250949|NCT00633477|4075065|B2|45 - <60||Age, Customized||Participants|Number|1|1.0||||||
4250950|NCT00633477|4075066|B1|45 - <60||Age, Customized||Participants|Number|0|0.0||||||
4250951|NCT00633477|4075064|B3|18 - <45||Age, Customized||Participants|Number|0|0.0||||||
4250952|NCT00633477|4075065|B2|18 - <45||Age, Customized||Participants|Number|0|0.0||||||
4250953|NCT00633477|4075066|B1|18 - <45||Age, Customized||Participants|Number|0|0.0||||||
4250954|NCT00633477|4075064|B3|||Age||years|Mean|77.4|77.4|Standard Deviation|11.14|11.14|||
4250955|NCT00633477|4075065|B2|||Age||years|Mean|77.8|77.8|Standard Deviation|13.56|13.56|||
4250956|NCT00633477|4075066|B1|||Age||years|Mean|76.7|76.7|Standard Deviation|5.28|5.28|||
4250957|NCT00633464|4075081|B3|Adjuvant and Neo-adjuvant||Setting of Prior Chemotherapy|Participants may have received chemotherapy in more than one setting.|participants|Number|11|11.0||||||
4250958|NCT00633464|4075082|B2|Adjuvant and Neo-adjuvant||Setting of Prior Chemotherapy|Participants may have received chemotherapy in more than one setting.|participants|Number|3|3.0||||||
4250959|NCT00633464|4075083|B1|Adjuvant and Neo-adjuvant||Setting of Prior Chemotherapy|Participants may have received chemotherapy in more than one setting.|participants|Number|8|8.0||||||
4250960|NCT00633464|4075081|B3|Neo-adjuvant therapy||Setting of Prior Chemotherapy|Participants may have received chemotherapy in more than one setting.|participants|Number|40|40.0||||||
4250961|NCT00633464|4075082|B2|Neo-adjuvant therapy||Setting of Prior Chemotherapy|Participants may have received chemotherapy in more than one setting.|participants|Number|20|20.0||||||
4250962|NCT00633464|4075083|B1|Neo-adjuvant therapy||Setting of Prior Chemotherapy|Participants may have received chemotherapy in more than one setting.|participants|Number|20|20.0||||||
4250963|NCT00633464|4075081|B3|Adjuvant therapy||Setting of Prior Chemotherapy|Participants may have received chemotherapy in more than one setting.|participants|Number|50|50.0||||||
4250964|NCT00633464|4075082|B2|Adjuvant therapy||Setting of Prior Chemotherapy|Participants may have received chemotherapy in more than one setting.|participants|Number|22|22.0||||||
4250965|NCT00633464|4075083|B1|Adjuvant therapy||Setting of Prior Chemotherapy|Participants may have received chemotherapy in more than one setting.|participants|Number|28|28.0||||||
4250966|NCT00633464|4075081|B3|Not Reported||Karnofsky Performance Status|"Karnofsky Performance Status classifies patients according to their functional impairment. Scores range from 0-100 units on a scale, the lower the score, the worse the survival for most serious illnesses.~100: Normal, no complaints; 90: Able to carry on normal activities; minor signs or symptoms of disease; 80: Normal activity with effort; some signs or symptoms of disease."|participants|Number|1|1.0||||||
4250967|NCT00633464|4075082|B2|Not Reported||Karnofsky Performance Status|"Karnofsky Performance Status classifies patients according to their functional impairment. Scores range from 0-100 units on a scale, the lower the score, the worse the survival for most serious illnesses.~100: Normal, no complaints; 90: Able to carry on normal activities; minor signs or symptoms of disease; 80: Normal activity with effort; some signs or symptoms of disease."|participants|Number|1|1.0||||||
4250968|NCT00633464|4075083|B1|Not Reported||Karnofsky Performance Status|"Karnofsky Performance Status classifies patients according to their functional impairment. Scores range from 0-100 units on a scale, the lower the score, the worse the survival for most serious illnesses.~100: Normal, no complaints; 90: Able to carry on normal activities; minor signs or symptoms of disease; 80: Normal activity with effort; some signs or symptoms of disease."|participants|Number|0|0.0||||||
4250969|NCT00633464|4075081|B3|80||Karnofsky Performance Status|"Karnofsky Performance Status classifies patients according to their functional impairment. Scores range from 0-100 units on a scale, the lower the score, the worse the survival for most serious illnesses.~100: Normal, no complaints; 90: Able to carry on normal activities; minor signs or symptoms of disease; 80: Normal activity with effort; some signs or symptoms of disease."|participants|Number|21|21.0||||||
4250970|NCT00633464|4075082|B2|80||Karnofsky Performance Status|"Karnofsky Performance Status classifies patients according to their functional impairment. Scores range from 0-100 units on a scale, the lower the score, the worse the survival for most serious illnesses.~100: Normal, no complaints; 90: Able to carry on normal activities; minor signs or symptoms of disease; 80: Normal activity with effort; some signs or symptoms of disease."|participants|Number|10|10.0||||||
4250971|NCT00633464|4075083|B1|80||Karnofsky Performance Status|"Karnofsky Performance Status classifies patients according to their functional impairment. Scores range from 0-100 units on a scale, the lower the score, the worse the survival for most serious illnesses.~100: Normal, no complaints; 90: Able to carry on normal activities; minor signs or symptoms of disease; 80: Normal activity with effort; some signs or symptoms of disease."|participants|Number|11|11.0||||||
4250972|NCT00633464|4075081|B3|90||Karnofsky Performance Status|"Karnofsky Performance Status classifies patients according to their functional impairment. Scores range from 0-100 units on a scale, the lower the score, the worse the survival for most serious illnesses.~100: Normal, no complaints; 90: Able to carry on normal activities; minor signs or symptoms of disease; 80: Normal activity with effort; some signs or symptoms of disease."|participants|Number|11|11.0||||||
4250973|NCT00633464|4075082|B2|90||Karnofsky Performance Status|"Karnofsky Performance Status classifies patients according to their functional impairment. Scores range from 0-100 units on a scale, the lower the score, the worse the survival for most serious illnesses.~100: Normal, no complaints; 90: Able to carry on normal activities; minor signs or symptoms of disease; 80: Normal activity with effort; some signs or symptoms of disease."|participants|Number|5|5.0||||||
4250974|NCT00633464|4075083|B1|90||Karnofsky Performance Status|"Karnofsky Performance Status classifies patients according to their functional impairment. Scores range from 0-100 units on a scale, the lower the score, the worse the survival for most serious illnesses.~100: Normal, no complaints; 90: Able to carry on normal activities; minor signs or symptoms of disease; 80: Normal activity with effort; some signs or symptoms of disease."|participants|Number|6|6.0||||||
4250975|NCT00633464|4075081|B3|100||Karnofsky Performance Status|"Karnofsky Performance Status classifies patients according to their functional impairment. Scores range from 0-100 units on a scale, the lower the score, the worse the survival for most serious illnesses.~100: Normal, no complaints; 90: Able to carry on normal activities; minor signs or symptoms of disease; 80: Normal activity with effort; some signs or symptoms of disease."|participants|Number|46|46.0||||||
4250976|NCT00633464|4075082|B2|100||Karnofsky Performance Status|"Karnofsky Performance Status classifies patients according to their functional impairment. Scores range from 0-100 units on a scale, the lower the score, the worse the survival for most serious illnesses.~100: Normal, no complaints; 90: Able to carry on normal activities; minor signs or symptoms of disease; 80: Normal activity with effort; some signs or symptoms of disease."|participants|Number|23|23.0||||||
4251037|NCT00633256|4075130|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4250977|NCT00633464|4075083|B1|100||Karnofsky Performance Status|"Karnofsky Performance Status classifies patients according to their functional impairment. Scores range from 0-100 units on a scale, the lower the score, the worse the survival for most serious illnesses.~100: Normal, no complaints; 90: Able to carry on normal activities; minor signs or symptoms of disease; 80: Normal activity with effort; some signs or symptoms of disease."|participants|Number|23|23.0||||||
4250978|NCT00633464|4075081|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4250979|NCT00633464|4075082|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4250980|NCT00633464|4075083|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4250981|NCT00633464|4075081|B3|White||Race/Ethnicity, Customized||participants|Number|78|78.0||||||
4250982|NCT00633464|4075082|B2|White||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4250983|NCT00633464|4075083|B1|White||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4250984|NCT00633464|4075081|B3|Female||Sex/Gender, Customized||participants|Number|79|79.0||||||
4250985|NCT00633464|4075082|B2|Female||Sex/Gender, Customized||participants|Number|39|39.0||||||
4250986|NCT00633464|4075083|B1|Female||Sex/Gender, Customized||participants|Number|40|40.0||||||
4250987|NCT00633464|4075081|B3|>=65||Age, Customized||participants|Number|12|12.0||||||
4250988|NCT00633464|4075082|B2|>=65||Age, Customized||participants|Number|7|7.0||||||
4250989|NCT00633464|4075083|B1|>=65||Age, Customized||participants|Number|5|5.0||||||
4250990|NCT00633464|4075081|B3|< 65||Age, Customized||participants|Number|67|67.0||||||
4250991|NCT00633464|4075082|B2|< 65||Age, Customized||participants|Number|32|32.0||||||
4250992|NCT00633464|4075083|B1|< 65||Age, Customized||participants|Number|35|35.0||||||
4250993|NCT00633464|4075081|B3|||Age, Customized||years|Median|53.0|53.0|Full Range|||29.0|79.0|
4250994|NCT00633464|4075082|B2|||Age, Customized||years|Median|50.0|50.0|Full Range|||31.0|79.0|
4250995|NCT00633464|4075083|B1|||Age, Customized||years|Median|53.0|53.0|Full Range|||29.0|75.0|
4250996|NCT00633399|4075104|B3|United States||Region of Enrollment||participants|Number|139|139.0||||||
4250997|NCT00633399|4075105|B2|United States||Region of Enrollment||participants|Number|68|68.0||||||
4250998|NCT00633399|4075106|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
4250999|NCT00633399|4075104|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4251000|NCT00633399|4075105|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4251001|NCT00633399|4075106|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4251002|NCT00633399|4075104|B3||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4251003|NCT00633399|4075105|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4251004|NCT00633399|4075106|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4251005|NCT00633399|4075104|B3|||Age||Years|Mean|44.5|44.5|Standard Deviation|12.9|12.9|||
4251006|NCT00633399|4075105|B2|||Age||Years|Mean|44.2|44.2|Standard Deviation|11.0|11.0|||
4251007|NCT00633399|4075106|B1|||Age||Years|Mean|44.7|44.7|Standard Deviation|13.8|13.8|||
4251008|NCT00633360|4075117|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4251009|NCT00633360|4075118|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4251010|NCT00633360|4075119|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4251011|NCT00633360|4075117|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4251012|NCT00633360|4075118|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4251013|NCT00633360|4075119|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4251014|NCT00633360|4075117|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4251015|NCT00633360|4075118|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4251016|NCT00633360|4075119|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4251017|NCT00633360|4075117|B3|||Age||years|Mean|27.2|27.2|Standard Deviation|7.1|7.1|||
4251018|NCT00633360|4075118|B2|||Age||years|Mean|26.3|26.3|Standard Deviation|7.1|7.1|||
4251019|NCT00633360|4075119|B1|||Age||years|Mean|28.1|28.1|Standard Deviation|7.3|7.3|||
4251020|NCT00633256|4075128|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4251021|NCT00633256|4075129|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4251022|NCT00633256|4075130|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4251023|NCT00633256|4075128|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4251024|NCT00633256|4075129|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4251025|NCT00633256|4075130|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4251026|NCT00633256|4075128|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4251027|NCT00633256|4075129|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4251028|NCT00633256|4075130|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4251029|NCT00633256|4075128|B3|||Age||years|Mean|41.3|41.3|Standard Deviation|9.1|9.1|||
4251030|NCT00633256|4075129|B2|||Age||years|Mean|41.5|41.5|Standard Deviation|11.5|11.5|||
4251031|NCT00633256|4075130|B1|||Age||years|Mean|41.1|41.1|Standard Deviation|6.2|6.2|||
4251032|NCT00633256|4075128|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4251033|NCT00633256|4075129|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4251034|NCT00633256|4075130|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4251035|NCT00633256|4075128|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4251036|NCT00633256|4075129|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4251038|NCT00633256|4075128|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4251039|NCT00633256|4075129|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4251040|NCT00633256|4075130|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4251041|NCT00633243|4075141|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4251042|NCT00633243|4075142|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4251043|NCT00633243|4075143|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4251044|NCT00633243|4075141|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4251045|NCT00633243|4075142|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4251046|NCT00633243|4075143|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4251047|NCT00633243|4075141|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4251048|NCT00633243|4075142|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4251049|NCT00633243|4075143|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4251050|NCT00633243|4075141|B3|||Age||years|Mean|42|42.0|Full Range|||29.0|54.0|
4251051|NCT00633243|4075142|B2|||Age||years|Mean|43|43.0|Full Range|||36.0|54.0|
4251052|NCT00633243|4075143|B1|||Age||years|Mean|40|40.0|Full Range|||29.0|51.0|
4251053|NCT00633217|4075150|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4251054|NCT00633217|4075151|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4251055|NCT00633217|4075152|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4251056|NCT00633217|4075150|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4251057|NCT00633217|4075151|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4251058|NCT00633217|4075152|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4251059|NCT00633217|4075150|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|226|226.0||||||
4251060|NCT00633217|4075151|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|117|117.0||||||
4251061|NCT00633217|4075152|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|109|109.0||||||
4251062|NCT00633217|4075150|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4251063|NCT00633217|4075151|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4251064|NCT00633217|4075152|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4251065|NCT00633217|4075150|B3||Male|Gender||Participants|Count of Participants|132|132.0||||||
4251066|NCT00633217|4075151|B2||Male|Gender||Participants|Count of Participants|66|66.0||||||
4251067|NCT00633217|4075152|B1||Male|Gender||Participants|Count of Participants|66|66.0||||||
4251068|NCT00633217|4075150|B3||Female|Gender||Participants|Count of Participants|115|115.0||||||
4251069|NCT00633217|4075151|B2||Female|Gender||Participants|Count of Participants|60|60.0||||||
4251070|NCT00633217|4075152|B1||Female|Gender||Participants|Count of Participants|55|55.0||||||
4251071|NCT00633217|4075150|B3|||Age||years|Mean|61.6|61.6|Full Range|||40.0|86.0|
4251072|NCT00633217|4075151|B2|||Age||years|Mean|63.4|63.4|Full Range|||45.0|86.0|
4251073|NCT00633217|4075152|B1|||Age||years|Mean|61.6|61.6|Full Range|||40.0|84.0|
4251074|NCT00633152|4075163|B3|United States||Region of Enrollment||participants|Number|150|150.0||||||
4251075|NCT00633152|4075164|B2|United States||Region of Enrollment||participants|Number|47|47.0||||||
4251076|NCT00633152|4075165|B1|United States||Region of Enrollment||participants|Number|103|103.0||||||
4251077|NCT00633152|4075163|B3||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4251078|NCT00633152|4075164|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4251079|NCT00633152|4075165|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4251080|NCT00633152|4075163|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4251081|NCT00633152|4075164|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4251082|NCT00633152|4075165|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4251083|NCT00633152|4075163|B3|||Age||years|Mean|39.7|39.7|Standard Deviation|13.36|13.36|||
4251084|NCT00633152|4075164|B2|||Age||years|Mean|39.9|39.9|Standard Deviation|14.58|14.58|||
4251085|NCT00633152|4075165|B1|||Age||years|Mean|39.6|39.6|Standard Deviation|12.83|12.83|||
4251086|NCT00633139|4075174|B4|Denmark||Region of Enrollment||participants|Number|13|13.0||||||
4251087|NCT00633139|4075175|B3|Denmark||Region of Enrollment||participants|Number|4|4.0||||||
4251088|NCT00633139|4075176|B2|Denmark||Region of Enrollment||participants|Number|5|5.0||||||
4251089|NCT00633139|4075177|B1|Denmark||Region of Enrollment||participants|Number|4|4.0||||||
4251090|NCT00633139|4075174|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4251091|NCT00633139|4075175|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4251092|NCT00633139|4075176|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4251093|NCT00633139|4075177|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4251094|NCT00633139|4075174|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4251095|NCT00633139|4075175|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4251096|NCT00633139|4075176|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4251097|NCT00633139|4075177|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4251098|NCT00633139|4075174|B4|||Age||months|Mean|36.69|36.69|Standard Deviation|9.59|9.59|||
4251099|NCT00633139|4075175|B3|||Age||months|Mean|30.75|30.75|Standard Deviation|7.27|7.27|||
4251100|NCT00633139|4075176|B2|||Age||months|Mean|41.80|41.8|Standard Deviation|10.13|10.13|||
4251101|NCT00633139|4075177|B1|||Age||months|Mean|36.25|36.25|Standard Deviation|9.32|9.32|||
4251102|NCT00633139|4075174|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4251103|NCT00633139|4075175|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4251104|NCT00633139|4075176|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4251105|NCT00633139|4075177|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4251106|NCT00633139|4075174|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4251107|NCT00633139|4075175|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4251108|NCT00633139|4075176|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4251109|NCT00633139|4075177|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4251110|NCT00633139|4075174|B4||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4251111|NCT00633139|4075175|B3||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4251112|NCT00633139|4075176|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4251113|NCT00633139|4075177|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4251114|NCT00633126|4075193|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4251115|NCT00633126|4075193|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4251116|NCT00633126|4075193|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4251117|NCT00633126|4075193|B1|<=18 years||Age, Customized||participants|Number|9|9.0||||||
4251118|NCT00633126|4075193|B1|||Age||years|Mean|13.7|13.7|Standard Deviation|1.80|1.8|||
4251119|NCT00633087|4075198|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4251120|NCT00633087|4075198|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4251121|NCT00633087|4075198|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4251122|NCT00633087|4075198|B1|||Age||years|Mean|65.3|65.3|Standard Deviation|12.0|12.0|||
4251123|NCT00633087|4075198|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4251124|NCT00633087|4075198|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4251125|NCT00633087|4075198|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4251126|NCT00633074|4075205|B3||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4251127|NCT00633074|4075206|B2||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4251128|NCT00633074|4075207|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4251129|NCT00633074|4075205|B3||Female|Sex: Female, Male||Participants|Count of Participants|520|520.0||||||
4251130|NCT00633074|4075206|B2||Female|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
4251131|NCT00633074|4075207|B1||Female|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
4251132|NCT00633074|4075205|B3|||Age||Years|Mean|71.85|71.85|Standard Deviation|4.95|4.95|||
4251133|NCT00633074|4075206|B2|||Age||Years|Mean|71.7|71.7|Standard Deviation|4.88|4.88|||
4251134|NCT00633074|4075207|B1|||Age||Years|Mean|72|72.0|Standard Deviation|5.02|5.02|||
4251135|NCT00633022|4075236|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251136|NCT00633022|4075237|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251137|NCT00633022|4075238|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251138|NCT00633022|4075239|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251139|NCT00633022|4075236|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251140|NCT00633022|4075237|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251141|NCT00633022|4075238|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251142|NCT00633022|4075239|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251143|NCT00633022|4075236|B4||White|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
4251144|NCT00633022|4075237|B3||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4251145|NCT00633022|4075238|B2||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4251146|NCT00633022|4075239|B1||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4251147|NCT00633022|4075236|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4251148|NCT00633022|4075237|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4251149|NCT00633022|4075238|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4251150|NCT00633022|4075239|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4251151|NCT00633022|4075236|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251152|NCT00633022|4075237|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251153|NCT00633022|4075238|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251154|NCT00633022|4075239|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251155|NCT00633022|4075236|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4251156|NCT00633022|4075237|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4251157|NCT00633022|4075238|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4251158|NCT00633022|4075239|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4251159|NCT00633022|4075236|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251160|NCT00633022|4075237|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251161|NCT00633022|4075238|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251162|NCT00633022|4075239|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251163|NCT00633022|4075236|B4||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4251164|NCT00633022|4075237|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4251165|NCT00633022|4075238|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4251166|NCT00633022|4075239|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4251167|NCT00633022|4075236|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4251168|NCT00633022|4075237|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4251169|NCT00633022|4075238|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4251170|NCT00633022|4075239|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4251171|NCT00633022|4075236|B4|||Age||Years|Mean|63.8|63.8|Standard Deviation|6.13|6.13|||
4251172|NCT00633022|4075237|B3|||Age||Years|Mean|63.7|63.7|Standard Deviation|6.37|6.37|||
4251173|NCT00633022|4075238|B2|||Age||Years|Mean|65.3|65.3|Standard Deviation|5.94|5.94|||
4251174|NCT00633022|4075239|B1|||Age||Years|Mean|62.3|62.3|Standard Deviation|5.90|5.9|||
4251175|NCT00633009|4075276|B4|United States||Region of Enrollment||participants|Number|50|50.0||||||
4251176|NCT00633009|4075277|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4251177|NCT00633009|4075278|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4251178|NCT00633009|4075279|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4251179|NCT00633009|4075276|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4251180|NCT00633009|4075277|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4251181|NCT00633009|4075278|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4251182|NCT00633009|4075279|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4251183|NCT00633009|4075276|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4251184|NCT00633009|4075277|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4251185|NCT00633009|4075278|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4251186|NCT00633009|4075279|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4251187|NCT00633009|4075276|B4|||Age||years|Mean|31|31.0|Standard Deviation|12|12.0|||
4251188|NCT00633009|4075277|B3|||Age||years|Mean|35|35.0|Standard Deviation|13|13.0|||
4251189|NCT00633009|4075278|B2|||Age||years|Mean|28|28.0|Standard Deviation|12|12.0|||
4251190|NCT00633009|4075279|B1|||Age||years|Mean|34|34.0|Standard Deviation|11|11.0|||
4251191|NCT00633009|4075276|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4251192|NCT00633009|4075277|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4251193|NCT00633009|4075278|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4251194|NCT00633009|4075279|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4251195|NCT00633009|4075276|B4||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4251196|NCT00633009|4075277|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4251197|NCT00633009|4075278|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4251198|NCT00633009|4075279|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4251199|NCT00633009|4075276|B4||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4251200|NCT00633009|4075277|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4251201|NCT00633009|4075278|B2||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4251202|NCT00633009|4075279|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4251203|NCT00632970|4075292|B3|||HIV seropositive with viral load < 10,000||Participants|Number|6|6.0||||||
4251204|NCT00632970|4075293|B2|||HIV seropositive with viral load < 10,000||Participants|Number|3|3.0||||||
4251205|NCT00632970|4075294|B1|||HIV seropositive with viral load < 10,000||Participants|Number|3|3.0||||||
4251206|NCT00632970|4075292|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4251207|NCT00632970|4075293|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4251208|NCT00632970|4075294|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4251209|NCT00632970|4075292|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4251210|NCT00632970|4075293|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4251211|NCT00632970|4075294|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4251212|NCT00632970|4075292|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251213|NCT00632970|4075293|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251214|NCT00632970|4075294|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251215|NCT00632970|4075292|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251216|NCT00632970|4075293|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251217|NCT00632970|4075294|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251218|NCT00632970|4075292|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251219|NCT00632970|4075293|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251220|NCT00632970|4075294|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251221|NCT00632970|4075292|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251222|NCT00632970|4075293|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251223|NCT00632970|4075294|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251224|NCT00632970|4075292|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4251225|NCT00632970|4075293|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4251226|NCT00632970|4075294|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4251227|NCT00632970|4075292|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4251228|NCT00632970|4075293|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4251229|NCT00632970|4075294|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4251230|NCT00632970|4075292|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251231|NCT00632970|4075293|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251232|NCT00632970|4075294|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251233|NCT00632970|4075292|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251234|NCT00632970|4075293|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251235|NCT00632970|4075294|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251236|NCT00632970|4075292|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251237|NCT00632970|4075293|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251238|NCT00632970|4075294|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251239|NCT00632970|4075292|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4251240|NCT00632970|4075293|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4251241|NCT00632970|4075294|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4251242|NCT00632970|4075292|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4251243|NCT00632970|4075293|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4251244|NCT00632970|4075294|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4251245|NCT00632970|4075292|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4251246|NCT00632970|4075293|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4251247|NCT00632970|4075294|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4251248|NCT00632970|4075292|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4251249|NCT00632970|4075293|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4251250|NCT00632970|4075294|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4251251|NCT00632970|4075292|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4251252|NCT00632970|4075293|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4251253|NCT00632970|4075294|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4251254|NCT00632931|4075303|B1|Three or more Prior Systemic Anti-Cancer Therapies||Number of Prior Systemic Anti-Cancer Therapies||Participants|Number|22|22.0||||||
4251255|NCT00632931|4075303|B1|Two Prior Systemic Anti-Cancer Therapies||Number of Prior Systemic Anti-Cancer Therapies||Participants|Number|3|3.0||||||
4251256|NCT00632931|4075303|B1|One Prior Systemic Anti-Cancer Therapy||Number of Prior Systemic Anti-Cancer Therapies||Participants|Number|0|0.0||||||
4251257|NCT00632931|4075303|B1|Three or More Prior Radiation Therapies||Number of Prior Radiation Therapies||Participants|Number|3|3.0||||||
4251258|NCT00632931|4075303|B1|Two Prior Radiation Therapies||Number of Prior Radiation Therapies||Participants|Number|1|1.0||||||
4251259|NCT00632931|4075303|B1|One Prior Radiation Therapy||Number of Prior Radiation Therapies||Participants|Number|7|7.0||||||
4251260|NCT00632931|4075303|B1|None||Number of Prior Radiation Therapies||Participants|Number|14|14.0||||||
4251261|NCT00632931|4075303|B1|2 = In bed <50% of the time||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Scale: 0 = Normal Activity, 1 = Symptoms, but ambulatory, 2 = In bed <50% of the time, 3 = In bed >50% of the time, 4 = 100% Bedridden, 5 = Dead|Participants|Number|3|3.0||||||
4251262|NCT00632931|4075303|B1|1 = Symptoms, but ambulatory||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Scale: 0 = Normal Activity, 1 = Symptoms, but ambulatory, 2 = In bed <50% of the time, 3 = In bed >50% of the time, 4 = 100% Bedridden, 5 = Dead|Participants|Number|13|13.0||||||
4251263|NCT00632931|4075303|B1|0 = Normal Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Scale: 0 = Normal Activity, 1 = Symptoms, but ambulatory, 2 = In bed <50% of the time, 3 = In bed >50% of the time, 4 = 100% Bedridden, 5 = Dead|Participants|Number|9|9.0||||||
4251264|NCT00632931|4075303|B1|Thyroid||Cancer Type||Participants|Number|1|1.0||||||
4251265|NCT00632931|4075303|B1|Pancreatic||Cancer Type||Participants|Number|1|1.0||||||
4251266|NCT00632931|4075303|B1|Mucinous carcinoma||Cancer Type||Participants|Number|1|1.0||||||
4251267|NCT00632931|4075303|B1|Gastrointestinal||Cancer Type||Participants|Number|1|1.0||||||
4251268|NCT00632931|4075303|B1|Breast||Cancer Type||Participants|Number|1|1.0||||||
4251269|NCT00632931|4075303|B1|Basocellular||Cancer Type||Participants|Number|1|1.0||||||
4251270|NCT00632931|4075303|B1|Anal||Cancer Type||Participants|Number|1|1.0||||||
4251271|NCT00632931|4075303|B1|Soft Tissue||Cancer Type||Participants|Number|2|2.0||||||
4251272|NCT00632931|4075303|B1|Uterine||Cancer Type||Participants|Number|2|2.0||||||
4251273|NCT00632931|4075303|B1|Mesothelioma||Cancer Type||Participants|Number|3|3.0||||||
4251274|NCT00632931|4075303|B1|Lung||Cancer Type||Participants|Number|3|3.0||||||
4251275|NCT00632931|4075303|B1|Colon||Cancer Type||Participants|Number|3|3.0||||||
4251276|NCT00632931|4075303|B1|Ovarian||Cancer Type||Participants|Number|5|5.0||||||
4251277|NCT00632931|4075303|B1|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4251278|NCT00632931|4075303|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4251279|NCT00632931|4075303|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4251280|NCT00632931|4075303|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4251281|NCT00632931|4075303|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4251282|NCT00632931|4075303|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4251283|NCT00632931|4075303|B1|||Age||years|Mean|59.4|59.4|Full Range|||29.0|78.0|
4251284|NCT00632814|4075324|B4|||Stockholm Joint Score|The assessment of joint function using Stockholm Joint Score. The minimum value is 0 (the best condition), and the maximum value is 140 (the worst condition).|scores on a scale|Mean|5.5|5.5|Standard Deviation|5.2|5.2|||
4251285|NCT00632814|4075325|B3|||Stockholm Joint Score|The assessment of joint function using Stockholm Joint Score. The minimum value is 0 (the best condition), and the maximum value is 140 (the worst condition).|scores on a scale|Mean|7.1|7.1|Standard Deviation|4.6|4.6|||
4251286|NCT00632814|4075326|B2|||Stockholm Joint Score|The assessment of joint function using Stockholm Joint Score. The minimum value is 0 (the best condition), and the maximum value is 140 (the worst condition).|scores on a scale|Mean|5.9|5.9|Standard Deviation|5.8|5.8|||
4251287|NCT00632814|4075327|B1|||Stockholm Joint Score|The assessment of joint function using Stockholm Joint Score. The minimum value is 0 (the best condition), and the maximum value is 140 (the worst condition).|scores on a scale|Mean|3.9|3.9|Standard Deviation|4.8|4.8|||
4251288|NCT00632814|4075324|B4|Any joint bleedings||Number of participants with bleeding rates in previous 6-9 Months||participants|Number|26|26.0||||||
4251289|NCT00632814|4075325|B3|Any joint bleedings||Number of participants with bleeding rates in previous 6-9 Months||participants|Number|6|6.0||||||
4251290|NCT00632814|4075326|B2|Any joint bleedings||Number of participants with bleeding rates in previous 6-9 Months||participants|Number|11|11.0||||||
4251291|NCT00632814|4075327|B1|Any joint bleedings||Number of participants with bleeding rates in previous 6-9 Months||participants|Number|9|9.0||||||
4251292|NCT00632814|4075324|B4|Any bleedings||Number of participants with bleeding rates in previous 6-9 Months||participants|Number|29|29.0||||||
4251293|NCT00632814|4075325|B3|Any bleedings||Number of participants with bleeding rates in previous 6-9 Months||participants|Number|8|8.0||||||
4251294|NCT00632814|4075326|B2|Any bleedings||Number of participants with bleeding rates in previous 6-9 Months||participants|Number|11|11.0||||||
4251295|NCT00632814|4075327|B1|Any bleedings||Number of participants with bleeding rates in previous 6-9 Months||participants|Number|10|10.0||||||
4251296|NCT00632814|4075324|B4|No bleedings||Number of participants with bleeding rates in previous 6-9 Months||participants|Number|3|3.0||||||
4251297|NCT00632814|4075325|B3|No bleedings||Number of participants with bleeding rates in previous 6-9 Months||participants|Number|0|0.0||||||
4251298|NCT00632814|4075326|B2|No bleedings||Number of participants with bleeding rates in previous 6-9 Months||participants|Number|2|2.0||||||
4251299|NCT00632814|4075327|B1|No bleedings||Number of participants with bleeding rates in previous 6-9 Months||participants|Number|1|1.0||||||
4251300|NCT00632814|4075324|B4|||Percentage of participants with Target Joint Present||Percentage of participants|Number|178|178.0||||||
4251301|NCT00632814|4075325|B3|||Percentage of participants with Target Joint Present||Percentage of participants|Number|88|88.0||||||
4251302|NCT00632814|4075326|B2|||Percentage of participants with Target Joint Present||Percentage of participants|Number|54|54.0||||||
4251303|NCT00632814|4075327|B1|||Percentage of participants with Target Joint Present||Percentage of participants|Number|36|36.0||||||
4251304|NCT00632814|4075324|B4|>=100 ED||Number of participants with different exposure days (ED)||participants|Number|20|20.0||||||
4251305|NCT00632814|4075325|B3|>=100 ED||Number of participants with different exposure days (ED)||participants|Number|4|4.0||||||
4251306|NCT00632814|4075326|B2|>=100 ED||Number of participants with different exposure days (ED)||participants|Number|11|11.0||||||
4251307|NCT00632814|4075327|B1|>=100 ED||Number of participants with different exposure days (ED)||participants|Number|5|5.0||||||
4251308|NCT00632814|4075324|B4|20 to <100 ED||Number of participants with different exposure days (ED)||participants|Number|10|10.0||||||
4251309|NCT00632814|4075325|B3|20 to <100 ED||Number of participants with different exposure days (ED)||participants|Number|4|4.0||||||
4251310|NCT00632814|4075326|B2|20 to <100 ED||Number of participants with different exposure days (ED)||participants|Number|2|2.0||||||
4251311|NCT00632814|4075327|B1|20 to <100 ED||Number of participants with different exposure days (ED)||participants|Number|4|4.0||||||
4251312|NCT00632814|4075324|B4|1 to <20 ED||Number of participants with different exposure days (ED)||participants|Number|1|1.0||||||
4251313|NCT00632814|4075325|B3|1 to <20 ED||Number of participants with different exposure days (ED)||participants|Number|0|0.0||||||
4251314|NCT00632814|4075326|B2|1 to <20 ED||Number of participants with different exposure days (ED)||participants|Number|0|0.0||||||
4251315|NCT00632814|4075327|B1|1 to <20 ED||Number of participants with different exposure days (ED)||participants|Number|1|1.0||||||
4251316|NCT00632814|4075324|B4|0 ED||Number of participants with different exposure days (ED)||participants|Number|1|1.0||||||
4251317|NCT00632814|4075325|B3|0 ED||Number of participants with different exposure days (ED)||participants|Number|0|0.0||||||
4251318|NCT00632814|4075326|B2|0 ED||Number of participants with different exposure days (ED)||participants|Number|0|0.0||||||
4251319|NCT00632814|4075327|B1|0 ED||Number of participants with different exposure days (ED)||participants|Number|1|1.0||||||
4251320|NCT00632814|4075324|B4|||FVIII trough level at Baseline||Percentage of FVIII activity|Mean|1.34|1.34|Standard Deviation|1.24|1.24|||
4251321|NCT00632814|4075325|B3|||FVIII trough level at Baseline||Percentage of FVIII activity|Mean|0.77|0.77|Standard Deviation|0.24|0.24|||
4251322|NCT00632814|4075326|B2|||FVIII trough level at Baseline||Percentage of FVIII activity|Mean|1.62|1.62|Standard Deviation|1.79|1.79|||
4251323|NCT00632814|4075327|B1|||FVIII trough level at Baseline||Percentage of FVIII activity|Mean|1.43|1.43|Standard Deviation|0.70|0.7|||
4251324|NCT00632814|4075324|B4|Prophylaxis||Number of participants on Prophylaxis Prior to Screening|Number of participants on prophylaxis versus on-demand therapy before screening|pariticipants|Number|12|12.0||||||
4251325|NCT00632814|4075325|B3|Prophylaxis||Number of participants on Prophylaxis Prior to Screening|Number of participants on prophylaxis versus on-demand therapy before screening|pariticipants|Number|3|3.0||||||
4251326|NCT00632814|4075326|B2|Prophylaxis||Number of participants on Prophylaxis Prior to Screening|Number of participants on prophylaxis versus on-demand therapy before screening|pariticipants|Number|7|7.0||||||
4251327|NCT00632814|4075327|B1|Prophylaxis||Number of participants on Prophylaxis Prior to Screening|Number of participants on prophylaxis versus on-demand therapy before screening|pariticipants|Number|2|2.0||||||
4251328|NCT00632814|4075324|B4|On demand||Number of participants on Prophylaxis Prior to Screening|Number of participants on prophylaxis versus on-demand therapy before screening|pariticipants|Number|20|20.0||||||
4251329|NCT00632814|4075325|B3|On demand||Number of participants on Prophylaxis Prior to Screening|Number of participants on prophylaxis versus on-demand therapy before screening|pariticipants|Number|5|5.0||||||
4251330|NCT00632814|4075326|B2|On demand||Number of participants on Prophylaxis Prior to Screening|Number of participants on prophylaxis versus on-demand therapy before screening|pariticipants|Number|6|6.0||||||
4251331|NCT00632814|4075327|B1|On demand||Number of participants on Prophylaxis Prior to Screening|Number of participants on prophylaxis versus on-demand therapy before screening|pariticipants|Number|9|9.0||||||
4251332|NCT00632814|4075324|B4|||Height||Centimeters|Mean|113.09|113.09|Standard Deviation|24.63|24.63|||
4251333|NCT00632814|4075325|B3|||Height||Centimeters|Mean|122.00|122.0|Standard Deviation|20.74|20.74|||
4251334|NCT00632814|4075326|B2|||Height||Centimeters|Mean|120.31|120.31|Standard Deviation|23.75|23.75|||
4251335|NCT00632814|4075327|B1|||Height||Centimeters|Mean|98.09|98.09|Standard Deviation|22.88|22.88|||
4251336|NCT00632814|4075324|B4|||Body Weight||Kilograms|Mean|22.28|22.28|Standard Deviation|10.93|10.93|||
4251337|NCT00632814|4075325|B3|||Body Weight||Kilograms|Mean|25.45|25.45|Standard Deviation|9.87|9.87|||
4251338|NCT00632814|4075326|B2|||Body Weight||Kilograms|Mean|24.39|24.39|Standard Deviation|11.35|11.35|||
4251339|NCT00632814|4075327|B1|||Body Weight||Kilograms|Mean|17.48|17.48|Standard Deviation|10.43|10.43|||
4251340|NCT00632814|4075324|B4|Asian||Ethnicity||participants|Number|1|1.0||||||
4251341|NCT00632814|4075325|B3|Asian||Ethnicity||participants|Number|1|1.0||||||
4251342|NCT00632814|4075326|B2|Asian||Ethnicity||participants|Number|0|0.0||||||
4251343|NCT00632814|4075327|B1|Asian||Ethnicity||participants|Number|0|0.0||||||
4251344|NCT00632814|4075324|B4|Caucasian||Ethnicity||participants|Number|31|31.0||||||
4251345|NCT00632814|4075325|B3|Caucasian||Ethnicity||participants|Number|7|7.0||||||
4251346|NCT00632814|4075326|B2|Caucasian||Ethnicity||participants|Number|13|13.0||||||
4251347|NCT00632814|4075327|B1|Caucasian||Ethnicity||participants|Number|11|11.0||||||
4251348|NCT00632814|4075324|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4251349|NCT00632814|4075325|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4251350|NCT00632814|4075326|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4251351|NCT00632814|4075327|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4251352|NCT00632814|4075324|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4251353|NCT00632814|4075325|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4251354|NCT00632814|4075326|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4251355|NCT00632814|4075327|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4251356|NCT00632814|4075324|B4|||Age||years|Mean|5.09|5.09|Standard Deviation|3.47|3.47|||
4251357|NCT00632814|4075325|B3|||Age||years|Mean|6.00|6.0|Standard Deviation|3.12|3.12|||
4251358|NCT00632814|4075326|B2|||Age||years|Mean|6.08|6.08|Standard Deviation|3.50|3.5|||
4251359|NCT00632814|4075327|B1|||Age||years|Mean|3.27|3.27|Standard Deviation|3.20|3.2|||
4251360|NCT00632749|4075361|B15||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4251361|NCT00632749|4075362|B14||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4251362|NCT00632749|4075363|B13||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4251363|NCT00632749|4075364|B12||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4251364|NCT00632749|4075365|B11||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4251365|NCT00632749|4075366|B10||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4251366|NCT00632749|4075367|B9||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4251367|NCT00632749|4075368|B8||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4251368|NCT00632749|4075369|B7||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4251369|NCT00632749|4075370|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4251370|NCT00632749|4075371|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4251371|NCT00632749|4075372|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4251372|NCT00632749|4075373|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4251373|NCT00632749|4075374|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4251374|NCT00632749|4075375|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4251375|NCT00632749|4075361|B15||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4251376|NCT00632749|4075362|B14||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4251377|NCT00632749|4075363|B13||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4251378|NCT00632749|4075364|B12||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4251379|NCT00632749|4075365|B11||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4251380|NCT00632749|4075366|B10||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4251381|NCT00632749|4075367|B9||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4251382|NCT00632749|4075368|B8||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4251383|NCT00632749|4075369|B7||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4251384|NCT00632749|4075370|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4251385|NCT00632749|4075371|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4251386|NCT00632749|4075372|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4251387|NCT00632749|4075373|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4251388|NCT00632749|4075374|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4251389|NCT00632749|4075375|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4251390|NCT00632749|4075361|B15|||Age||years|Mean|72.2|72.2|Standard Deviation|7.6|7.6|||
4251391|NCT00632749|4075362|B14|||Age||years|Mean|63.3|63.3|Standard Deviation|5.6|5.6|||
4251392|NCT00632749|4075363|B13|||Age||years|Mean|63.3|63.3|Standard Deviation|5.1|5.1|||
4251393|NCT00632749|4075364|B12|||Age||years|Mean|69.5|69.5|Standard Deviation|11.8|11.8|||
4251394|NCT00632749|4075365|B11|||Age||years|Mean|72.3|72.3|Standard Deviation|4.4|4.4|||
4251395|NCT00632749|4075366|B10|||Age||years|Mean|78.3|78.3|Standard Deviation|4.0|4.0|||
4251396|NCT00632749|4075367|B9|||Age||years|Mean|79.0|79.0|Standard Deviation|4.4|4.4|||
4251397|NCT00632749|4075368|B8|||Age||years|Mean|73.5|73.5|Standard Deviation|6.6|6.6|||
4251398|NCT00632749|4075369|B7|||Age||years|Mean|74.3|74.3|Standard Deviation|4.1|4.1|||
4251399|NCT00632749|4075370|B6|||Age||years|Mean|72.3|72.3|Standard Deviation|5.1|5.1|||
4251400|NCT00632749|4075371|B5|||Age||years|Mean|67.4|67.4|Standard Deviation|9.3|9.3|||
4251401|NCT00632749|4075372|B4|||Age||years|Mean|77.5|77.5|Standard Deviation|4.0|4.0|||
4251402|NCT00632749|4075373|B3|||Age||years|Mean|79.3|79.3|Standard Deviation|8.4|8.4|||
4251403|NCT00632749|4075374|B2|||Age||years|Mean|71.3|71.3|Standard Deviation|2.5|2.5|||
4251404|NCT00632749|4075375|B1|||Age||years|Mean|76.0|76.0|Standard Deviation|5.8|5.8|||
4251405|NCT00632736|4075682|B1|||Body Mass Index (BMI)|BMI is a measure of body fat based on height and weight and is calculated as weight (kilograms) divided by height (meters squared).|kilograms per square meters (kg/m^2)|Mean|26.5|26.5|Standard Deviation|4.48|4.48|||
4251406|NCT00632736|4075682|B1|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4251407|NCT00632736|4075682|B1|South Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4251408|NCT00632736|4075682|B1|East & South East Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4251409|NCT00632736|4075682|B1|Arabic/North African||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4251410|NCT00632736|4075682|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4251411|NCT00632736|4075682|B1|American Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4251412|NCT00632736|4075682|B1|White/Caucasian||Race/Ethnicity, Customized||participants|Number|409|409.0||||||
4251413|NCT00632736|4075682|B1||Male|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
4251414|NCT00632736|4075682|B1||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4251415|NCT00632736|4075682|B1|||Age||Years|Mean|64.3|64.3|Standard Deviation|9.81|9.81|||
4251416|NCT00632632|4075687|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4251417|NCT00632632|4075688|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4251418|NCT00632632|4075689|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4251419|NCT00632632|4075687|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4251420|NCT00632632|4075688|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4251421|NCT00632632|4075689|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4251422|NCT00632632|4075687|B3|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4251423|NCT00632632|4075688|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4251424|NCT00632632|4075689|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4251425|NCT00632632|4075687|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4251426|NCT00632632|4075688|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4251427|NCT00632632|4075689|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4251428|NCT00632632|4075687|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4251429|NCT00632632|4075688|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4251430|NCT00632632|4075689|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4251431|NCT00632632|4075687|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4251432|NCT00632632|4075688|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4251433|NCT00632632|4075689|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4251434|NCT00632632|4075687|B3|||Age||years|Mean|45.84|45.84|Standard Deviation|10.50|10.5|||
4251435|NCT00632632|4075688|B2|||Age||years|Mean|43.75|43.75|Standard Deviation|8.72|8.72|||
4251436|NCT00632632|4075689|B1|||Age||years|Mean|47.77|47.77|Standard Deviation|11.92|11.92|||
4251437|NCT00632619|4075700|B3|United States||Region of Enrollment||participants|Number|68|68.0||||||
4251438|NCT00632619|4075701|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
4251439|NCT00632619|4075702|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4251440|NCT00632619|4075700|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4251441|NCT00632619|4075701|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4251442|NCT00632619|4075702|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4251443|NCT00632619|4075700|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4251444|NCT00632619|4075701|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4251445|NCT00632619|4075702|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4251446|NCT00632619|4075700|B3|||Age||years|Mean|9.3|9.3|Standard Deviation|1.5|1.5|||
4251447|NCT00632619|4075701|B2|||Age||years|Mean|9.3|9.3|Standard Deviation|1.6|1.6|||
4251448|NCT00632619|4075702|B1|||Age||years|Mean|9.4|9.4|Standard Deviation|1.5|1.5|||
4251449|NCT00632619|4075700|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4251450|NCT00632619|4075701|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4251451|NCT00632619|4075702|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4251452|NCT00632619|4075700|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4251453|NCT00632619|4075701|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4251454|NCT00632619|4075702|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4251455|NCT00632619|4075700|B3||<=18 years|Age||Participants|Count of Participants|68|68.0||||||
4251456|NCT00632619|4075701|B2||<=18 years|Age||Participants|Count of Participants|35|35.0||||||
4251457|NCT00632619|4075702|B1||<=18 years|Age||Participants|Count of Participants|33|33.0||||||
4251458|NCT00632541|4075717|B1|Prior Radiation Therapy||Prior Radiation Therapy|Prior Radiation Therapy; none, any|participants|Number|11|11.0||||||
4251459|NCT00632541|4075717|B1|No Prior Radiation Therapy||Prior Radiation Therapy|Prior Radiation Therapy; none, any|participants|Number|7|7.0||||||
4251460|NCT00632541|4075717|B1|Prior Hormone Therapy||Prior Hormone Therapy|Prior hormone therapy; none or any.|participants|Number|9|9.0||||||
4251461|NCT00632541|4075717|B1|No Prior Hormone Therapy||Prior Hormone Therapy|Prior hormone therapy; none or any.|participants|Number|9|9.0||||||
4251462|NCT00632541|4075717|B1|Prior Chemotherapy Regimens 1-2||Prior Chemotherapy Regimens|Prior chemotherapy regimens - 0 - regimens, 1-2 regimens|participants|Number|17|17.0||||||
4251463|NCT00632541|4075717|B1|Prior Chemotherapy Regimens - 0||Prior Chemotherapy Regimens|Prior chemotherapy regimens - 0 - regimens, 1-2 regimens|participants|Number|1|1.0||||||
4251464|NCT00632541|4075717|B1|ER+/PR+/HER2 unknown||Breast Cancer Subtype|Estrogen receptor (ER), progesterone receptor (PR), human epidermal receptor 2 (HER2) status - positive (+), negative (-).|participants|Number|2|2.0||||||
4251465|NCT00632541|4075717|B1|ER+/PR+/HER2-||Breast Cancer Subtype|Estrogen receptor (ER), progesterone receptor (PR), human epidermal receptor 2 (HER2) status - positive (+), negative (-).|participants|Number|3|3.0||||||
4251466|NCT00632541|4075717|B1|ER+/PR-/HER2-||Breast Cancer Subtype|Estrogen receptor (ER), progesterone receptor (PR), human epidermal receptor 2 (HER2) status - positive (+), negative (-).|participants|Number|4|4.0||||||
4251467|NCT00632541|4075717|B1|ER-/PR-/HER2+||Breast Cancer Subtype|Estrogen receptor (ER), progesterone receptor (PR), human epidermal receptor 2 (HER2) status - positive (+), negative (-).|participants|Number|1|1.0||||||
4251468|NCT00632541|4075717|B1|ER-/PR-/HER2-||Breast Cancer Subtype|Estrogen receptor (ER), progesterone receptor (PR), human epidermal receptor 2 (HER2) status - positive (+), negative (-).|participants|Number|8|8.0||||||
4251469|NCT00632541|4075717|B1|ECOG = 1||ECOG Performance Status|Eastern Cooperative Oncology Group performance status - scale from zero to five, 0 - fully functional, 5 - dead.|participants|Number|5|5.0||||||
4251470|NCT00632541|4075717|B1|ECOG = 0||ECOG Performance Status|Eastern Cooperative Oncology Group performance status - scale from zero to five, 0 - fully functional, 5 - dead.|participants|Number|13|13.0||||||
4251471|NCT00632541|4075717|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4251472|NCT00632541|4075717|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251473|NCT00632541|4075717|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251474|NCT00632541|4075717|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4251475|NCT00632541|4075717|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4251476|NCT00632541|4075717|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251477|NCT00632541|4075717|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251478|NCT00632541|4075717|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251479|NCT00632541|4075717|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4251480|NCT00632541|4075717|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4251481|NCT00632541|4075717|B1|||Age||years|Median|56|56.0|Full Range|||33.0|75.0|
4251482|NCT00632502|4075724|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4251483|NCT00632502|4075725|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4251484|NCT00632502|4075726|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4251485|NCT00632502|4075724|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4251486|NCT00632502|4075725|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4251487|NCT00632502|4075726|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4251488|NCT00632502|4075724|B3|||Age||Years|Mean|50.6|50.6|Standard Deviation|9.6|9.6|||
4251489|NCT00632502|4075725|B2|||Age||Years|Mean|53.9|53.9|Standard Deviation|6.8|6.8|||
4251490|NCT00632502|4075726|B1|||Age||Years|Mean|48.7|48.7|Standard Deviation|10.6|10.6|||
4251491|NCT00632489|4075752|B4|United States||Region of Enrollment||participants|Number|20|20.0||||||
4251492|NCT00632489|4075754|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4251493|NCT00632489|4075755|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4251494|NCT00632489|4075752|B4|Male||Gender||participants|Number|7|7.0||||||
4251495|NCT00632489|4075754|B2|Male||Gender||participants|Number|0|0.0||||||
4251496|NCT00632489|4075755|B1|Male||Gender||participants|Number|7|7.0||||||
4251497|NCT00632489|4075752|B4|Female||Gender||participants|Number|13|13.0||||||
4251498|NCT00632489|4075754|B2|Female||Gender||participants|Number|5|5.0||||||
4251499|NCT00632489|4075755|B1|Female||Gender||participants|Number|8|8.0||||||
4251500|NCT00632489|4075752|B4|||Age||years|Median|56|56.0|Full Range|||45.0|69.0|
4251501|NCT00632489|4075754|B2|||Age||years|Median|66|66.0|Full Range|||64.0|68.0|
4251502|NCT00632489|4075755|B1|||Age||years|Median|54|54.0|Full Range|||45.0|69.0|
4251503|NCT00632463|4075768|B4|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
4251504|NCT00632463|4075769|B3|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
4251505|NCT00632463|4075770|B2|New Zealand||Region of Enrollment||participants|Number|0|0.0||||||
4251506|NCT00632463|4075771|B1|New Zealand||Region of Enrollment||participants|Number|0|0.0||||||
4251507|NCT00632463|4075768|B4|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4251508|NCT00632463|4075769|B3|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4251509|NCT00632463|4075770|B2|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4251510|NCT00632463|4075771|B1|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4251511|NCT00632463|4075768|B4|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4251512|NCT00632463|4075769|B3|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4251513|NCT00632463|4075770|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4251514|NCT00632463|4075771|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4251515|NCT00632463|4075768|B4|United States||Region of Enrollment||participants|Number|17|17.0||||||
4251516|NCT00632463|4075769|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4251517|NCT00632463|4075770|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4251518|NCT00632463|4075771|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4251519|NCT00632463|4075768|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4251520|NCT00632463|4075769|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4251521|NCT00632463|4075770|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4251522|NCT00632463|4075771|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4251523|NCT00632463|4075768|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4251524|NCT00632463|4075769|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4251525|NCT00632463|4075770|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4251526|NCT00632463|4075771|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4251527|NCT00632463|4075768|B4|||Age||years|Mean|38.04|38.04|Standard Deviation|25.03|25.03|||
4251528|NCT00632463|4075769|B3|||Age||years|Mean|44.14|44.14|Standard Deviation|25.06|25.06|||
4251529|NCT00632463|4075770|B2|||Age||years|Mean|33|33.0|Standard Deviation|23.25|23.25|||
4251530|NCT00632463|4075771|B1|||Age||years|Mean|37|37.0|Standard Deviation|29.06|29.06|||
4251531|NCT00632463|4075768|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4251532|NCT00632463|4075769|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4251533|NCT00632463|4075770|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4251534|NCT00632463|4075771|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4251535|NCT00632463|4075768|B4||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4251536|NCT00632463|4075769|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4251537|NCT00632463|4075770|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4251538|NCT00632463|4075771|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4251539|NCT00632463|4075768|B4||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4251540|NCT00632463|4075769|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4251541|NCT00632463|4075770|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4251542|NCT00632463|4075771|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4251543|NCT00632424|4075787|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4251544|NCT00632424|4075788|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4251545|NCT00632424|4075789|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4251546|NCT00632424|4075790|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4251547|NCT00632424|4075787|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4251548|NCT00632424|4075788|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4251549|NCT00632424|4075789|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4251550|NCT00632424|4075790|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4251551|NCT00632424|4075787|B4|Less than 65 years||Age, Customized||participants|Number|12|12.0||||||
4251552|NCT00632424|4075788|B3|Less than 65 years||Age, Customized||participants|Number|6|6.0||||||
4251553|NCT00632424|4075789|B2|Less than 65 years||Age, Customized||participants|Number|4|4.0||||||
4251554|NCT00632424|4075790|B1|Less than 65 years||Age, Customized||participants|Number|2|2.0||||||
4251555|NCT00632424|4075787|B4|Greater than, equal to 65 years||Age, Customized||participants|Number|6|6.0||||||
4251556|NCT00632424|4075788|B3|Greater than, equal to 65 years||Age, Customized||participants|Number|0|0.0||||||
4251557|NCT00632424|4075789|B2|Greater than, equal to 65 years||Age, Customized||participants|Number|5|5.0||||||
4251558|NCT00632424|4075790|B1|Greater than, equal to 65 years||Age, Customized||participants|Number|1|1.0||||||
4251559|NCT00632424|4075787|B4|||Age||years|Median|59.0|59.0|Full Range|||27.0|75.0|
4251560|NCT00632424|4075788|B3|||Age||years|Median|56.0|56.0|Full Range|||27.0|60.0|
4251561|NCT00632424|4075789|B2|||Age||years|Median|69.0|69.0|Full Range|||39.0|75.0|
4251562|NCT00632424|4075790|B1|||Age||years|Median|59.0|59.0|Full Range|||47.0|70.0|
4251563|NCT00632411|4075812|B3|United States||Region of Enrollment||participants|Number|1298|1298.0||||||
4251564|NCT00632411|4075813|B2|United States||Region of Enrollment||participants|Number|649|649.0||||||
4251565|NCT00632411|4075814|B1|United States||Region of Enrollment||participants|Number|649|649.0||||||
4251566|NCT00632411|4075812|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4251567|NCT00632411|4075813|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4251568|NCT00632411|4075814|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4251569|NCT00632411|4075812|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4251570|NCT00632411|4075813|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4251571|NCT00632411|4075814|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4251572|NCT00632411|4075812|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1002|1002.0||||||
4251573|NCT00632411|4075813|B2||White|Race (NIH/OMB)||Participants|Count of Participants|509|509.0||||||
4251574|NCT00632411|4075814|B1||White|Race (NIH/OMB)||Participants|Count of Participants|493|493.0||||||
4251575|NCT00632411|4075812|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|160|160.0||||||
4251576|NCT00632411|4075813|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4251577|NCT00632411|4075814|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
4251578|NCT00632411|4075812|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4251579|NCT00632411|4075813|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4251580|NCT00632411|4075814|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4251581|NCT00632411|4075812|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4251582|NCT00632411|4075813|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4251583|NCT00632411|4075814|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4251584|NCT00632411|4075812|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4251585|NCT00632411|4075813|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4251586|NCT00632411|4075814|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4251587|NCT00632411|4075812|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4251588|NCT00632411|4075813|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251589|NCT00632411|4075814|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4251590|NCT00632411|4075812|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1173|1173.0||||||
4251591|NCT00632411|4075813|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|588|588.0||||||
4251592|NCT00632411|4075814|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|585|585.0||||||
4251593|NCT00632411|4075812|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
4251594|NCT00632411|4075813|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4251595|NCT00632411|4075814|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4251596|NCT00632411|4075812|B3||Male|Sex: Female, Male||Participants|Count of Participants|736|736.0||||||
4251597|NCT00632411|4075813|B2||Male|Sex: Female, Male||Participants|Count of Participants|378|378.0||||||
4251598|NCT00632411|4075814|B1||Male|Sex: Female, Male||Participants|Count of Participants|358|358.0||||||
4251599|NCT00632411|4075812|B3||Female|Sex: Female, Male||Participants|Count of Participants|562|562.0||||||
4251600|NCT00632411|4075813|B2||Female|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
4251601|NCT00632411|4075814|B1||Female|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
4251602|NCT00632411|4075812|B3|||Age||years|Mean|39.50|39.5|Standard Deviation|13.73|13.73|||
4251603|NCT00632411|4075813|B2|||Age||years|Mean|39.42|39.42|Standard Deviation|13.82|13.82|||
4251604|NCT00632411|4075814|B1|||Age||years|Mean|39.59|39.59|Standard Deviation|13.65|13.65|||
4251605|NCT00632411|4075812|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4251606|NCT00632411|4075813|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4251607|NCT00632411|4075814|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4251608|NCT00632411|4075812|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1298|1298.0||||||
4251609|NCT00632411|4075813|B2||Between 18 and 65 years|Age||Participants|Count of Participants|649|649.0||||||
4251610|NCT00632411|4075814|B1||Between 18 and 65 years|Age||Participants|Count of Participants|649|649.0||||||
4251611|NCT00632411|4075812|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4251612|NCT00632411|4075813|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4251613|NCT00632411|4075814|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4251614|NCT00632281|4075821|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4251615|NCT00632281|4075821|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4251616|NCT00632281|4075821|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4251617|NCT00632281|4075821|B1|||Age||years|Mean|72.3|72.3|Standard Deviation|9.8|9.8|||
4251618|NCT00632281|4075821|B1||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4251619|NCT00632281|4075821|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4251620|NCT00632281|4075821|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4251621|NCT00632229|4075826|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
4251622|NCT00632229|4075827|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4251623|NCT00632229|4075828|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4251624|NCT00632229|4075826|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4251625|NCT00632229|4075827|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4251626|NCT00632229|4075828|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4251627|NCT00632229|4075826|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4251628|NCT00632229|4075827|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4251629|NCT00632229|4075828|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4251630|NCT00632229|4075826|B3|||Age||years|Mean|43.7|43.7|Standard Deviation|11.4|11.4|||
4251631|NCT00632229|4075827|B2|||Age||years|Mean|45.7|45.7|Standard Deviation|12.27|12.27|||
4251632|NCT00632229|4075828|B1|||Age||years|Mean|42.59|42.59|Standard Deviation|9.99|9.99|||
4251633|NCT00632229|4075826|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4251634|NCT00632229|4075827|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4251635|NCT00632229|4075828|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4251636|NCT00632229|4075826|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4251637|NCT00632229|4075827|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4251638|NCT00632229|4075828|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4251639|NCT00632229|4075826|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4251640|NCT00632229|4075827|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4251641|NCT00632229|4075828|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4251642|NCT00632203|4075837|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4251643|NCT00632203|4075838|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4251644|NCT00632203|4075839|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4251645|NCT00632203|4075837|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4251646|NCT00632203|4075838|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4251647|NCT00632203|4075839|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4251648|NCT00632203|4075837|B3|||Age||years|Mean|65.0|65.0|Standard Deviation|10.0|10.0|||
4251649|NCT00632203|4075838|B2|||Age||years|Mean|65.1|65.1|Standard Deviation|10.8|10.8|||
4251650|NCT00632203|4075839|B1|||Age||years|Mean|64.8|64.8|Standard Deviation|9.4|9.4|||
4251651|NCT00632125|4075858|B1|Germany||Region of Enrollment||participants|Number|701|701.0||||||
4251652|NCT00632125|4075858|B1|France||Region of Enrollment||participants|Number|1|1.0||||||
4251653|NCT00632125|4075858|B1|Bulgaria||Region of Enrollment||participants|Number|45|45.0||||||
4251654|NCT00632125|4075858|B1|Italy||Region of Enrollment||participants|Number|205|205.0||||||
4251655|NCT00632125|4075858|B1|Poland||Region of Enrollment||participants|Number|220|220.0||||||
4251656|NCT00632125|4075858|B1|Ukraine||Region of Enrollment||participants|Number|204|204.0||||||
4251657|NCT00632125|4075858|B1|Macedonia, The Former Yugoslav Republic of||Region of Enrollment||participants|Number|143|143.0||||||
4251658|NCT00632125|4075858|B1|Romania||Region of Enrollment||participants|Number|103|103.0||||||
4251659|NCT00632125|4075858|B1|Russian Federation||Region of Enrollment||participants|Number|29|29.0||||||
4251660|NCT00632125|4075858|B1|Austria||Region of Enrollment||participants|Number|44|44.0||||||
4251661|NCT00632125|4075858|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4251662|NCT00632125|4075858|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251663|NCT00632125|4075858|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1671|1671.0||||||
4251664|NCT00632125|4075858|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4251665|NCT00632125|4075858|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251666|NCT00632125|4075858|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4251667|NCT00632125|4075858|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251668|NCT00632125|4075858|B1||Male|Sex: Female, Male||Participants|Count of Participants|958|958.0||||||
4251669|NCT00632125|4075858|B1||Female|Sex: Female, Male||Participants|Count of Participants|737|737.0||||||
4251670|NCT00632125|4075858|B1|||Age||years|Mean|61.8|61.8|Standard Deviation|15.4|15.4|||
4251671|NCT00632099|4075862|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4251672|NCT00632099|4075863|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4251673|NCT00632099|4075864|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4251674|NCT00632099|4075862|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4251675|NCT00632099|4075863|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4251676|NCT00632099|4075864|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4251677|NCT00632099|4075862|B3|Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4251678|NCT00632099|4075863|B2|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4251679|NCT00632099|4075864|B1|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4251680|NCT00632099|4075862|B3|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4251681|NCT00632099|4075863|B2|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4251682|NCT00632099|4075864|B1|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4251683|NCT00632099|4075862|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4251684|NCT00632099|4075863|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4251685|NCT00632099|4075864|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4251686|NCT00632099|4075862|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4251687|NCT00632099|4075863|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4251688|NCT00632099|4075864|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4251689|NCT00632099|4075862|B3|||Age||years|Mean|43|43.0|Standard Deviation|8|8.0|||
4251690|NCT00632099|4075863|B2|||Age||years|Mean|45|45.0|Standard Deviation|8|8.0|||
4251691|NCT00632099|4075864|B1|||Age||years|Mean|41|41.0|Standard Deviation|9|9.0|||
4251692|NCT00632021|4075871|B3||Self-pay/other|Insurance status||Participants|Count of Participants|61|61.0||||||
4251693|NCT00632021|4075872|B2||Self-pay/other|Insurance status||Participants|Count of Participants|35|35.0||||||
4251694|NCT00632021|4075873|B1||Self-pay/other|Insurance status||Participants|Count of Participants|26|26.0||||||
4251695|NCT00632021|4075871|B3||Commercial|Insurance status||Participants|Count of Participants|370|370.0||||||
4251696|NCT00632021|4075872|B2||Commercial|Insurance status||Participants|Count of Participants|167|167.0||||||
4251697|NCT00632021|4075873|B1||Commercial|Insurance status||Participants|Count of Participants|203|203.0||||||
4251698|NCT00632021|4075871|B3||Medicaid|Insurance status||Participants|Count of Participants|81|81.0||||||
4251699|NCT00632021|4075872|B2||Medicaid|Insurance status||Participants|Count of Participants|44|44.0||||||
4251700|NCT00632021|4075873|B1||Medicaid|Insurance status||Participants|Count of Participants|37|37.0||||||
4251701|NCT00632021|4075871|B3||Medicare|Insurance status||Participants|Count of Participants|339|339.0||||||
4251702|NCT00632021|4075872|B2||Medicare|Insurance status||Participants|Count of Participants|177|177.0||||||
4251703|NCT00632021|4075873|B1||Medicare|Insurance status||Participants|Count of Participants|162|162.0||||||
4251704|NCT00632021|4075871|B3||Single/living alone|Marital status||Participants|Count of Participants|369|369.0||||||
4251705|NCT00632021|4075872|B2||Single/living alone|Marital status||Participants|Count of Participants|197|197.0||||||
4251706|NCT00632021|4075873|B1||Single/living alone|Marital status||Participants|Count of Participants|172|172.0||||||
4251707|NCT00632021|4075871|B3||Married/cohabitating|Marital status||Participants|Count of Participants|482|482.0||||||
4251708|NCT00632021|4075872|B2||Married/cohabitating|Marital status||Participants|Count of Participants|226|226.0||||||
4251709|NCT00632021|4075873|B1||Married/cohabitating|Marital status||Participants|Count of Participants|256|256.0||||||
4251710|NCT00632021|4075871|B3|Prior coronary revascularization procedure||Comorbidities||participants|Number|398|398.0||||||
4251711|NCT00632021|4075872|B2|Prior coronary revascularization procedure||Comorbidities||participants|Number|203|203.0||||||
4251712|NCT00632021|4075873|B1|Prior coronary revascularization procedure||Comorbidities||participants|Number|195|195.0||||||
4251713|NCT00632021|4075871|B3|Prior stroke or cerebrovascular event||Comorbidities||participants|Number|71|71.0||||||
4251714|NCT00632021|4075872|B2|Prior stroke or cerebrovascular event||Comorbidities||participants|Number|30|30.0||||||
4251715|NCT00632021|4075873|B1|Prior stroke or cerebrovascular event||Comorbidities||participants|Number|41|41.0||||||
4251716|NCT00632021|4075871|B3|Prior myocardial infarction||Comorbidities||participants|Number|173|173.0||||||
4251717|NCT00632021|4075872|B2|Prior myocardial infarction||Comorbidities||participants|Number|100|100.0||||||
4251718|NCT00632021|4075873|B1|Prior myocardial infarction||Comorbidities||participants|Number|73|73.0||||||
4251719|NCT00632021|4075871|B3|Coronary artery disease||Comorbidities||participants|Number|436|436.0||||||
4251720|NCT00632021|4075872|B2|Coronary artery disease||Comorbidities||participants|Number|225|225.0||||||
4251721|NCT00632021|4075873|B1|Coronary artery disease||Comorbidities||participants|Number|211|211.0||||||
4251722|NCT00632021|4075871|B3|Hypercholesterolemia||Comorbidities||participants|Number|470|470.0||||||
4251723|NCT00632021|4075872|B2|Hypercholesterolemia||Comorbidities||participants|Number|234|234.0||||||
4251724|NCT00632021|4075873|B1|Hypercholesterolemia||Comorbidities||participants|Number|236|236.0||||||
4251725|NCT00632021|4075871|B3|Hypertension||Comorbidities||participants|Number|602|602.0||||||
4251726|NCT00632021|4075872|B2|Hypertension||Comorbidities||participants|Number|306|306.0||||||
4251727|NCT00632021|4075873|B1|Hypertension||Comorbidities||participants|Number|296|296.0||||||
4251728|NCT00632021|4075871|B3|Diabetes||Comorbidities||participants|Number|335|335.0||||||
4251729|NCT00632021|4075872|B2|Diabetes||Comorbidities||participants|Number|140|140.0||||||
4251730|NCT00632021|4075873|B1|Diabetes||Comorbidities||participants|Number|195|195.0||||||
4251731|NCT00632021|4075871|B3|||Number of pre-admission medications||Medications|Median|8|8.0|Inter-Quartile Range|||4.0|11.0|
4251732|NCT00632021|4075872|B2|||Number of pre-admission medications||Medications|Median|8|8.0|Inter-Quartile Range|||4.0|11.0|
4251905|NCT00631670|4075984|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4251733|NCT00632021|4075873|B1|||Number of pre-admission medications||Medications|Median|7|7.0|Inter-Quartile Range|||4.0|11.0|
4251734|NCT00632021|4075871|B3||No|Has primary care provider||Participants|Count of Participants|73|73.0||||||
4251735|NCT00632021|4075872|B2||No|Has primary care provider||Participants|Count of Participants|37|37.0||||||
4251736|NCT00632021|4075873|B1||No|Has primary care provider||Participants|Count of Participants|36|36.0||||||
4251737|NCT00632021|4075871|B3||Yes|Has primary care provider||Participants|Count of Participants|778|778.0||||||
4251738|NCT00632021|4075872|B2||Yes|Has primary care provider||Participants|Count of Participants|386|386.0||||||
4251739|NCT00632021|4075873|B1||Yes|Has primary care provider||Participants|Count of Participants|392|392.0||||||
4251740|NCT00632021|4075871|B3||Missing|Cognition (Mini cog score)||Participants|Count of Participants|2|2.0||||||
4251741|NCT00632021|4075872|B2||Missing|Cognition (Mini cog score)||Participants|Count of Participants|0|0.0||||||
4251742|NCT00632021|4075873|B1||Missing|Cognition (Mini cog score)||Participants|Count of Participants|2|2.0||||||
4251743|NCT00632021|4075871|B3||Not impaired|Cognition (Mini cog score)||Participants|Count of Participants|751|751.0||||||
4251744|NCT00632021|4075872|B2||Not impaired|Cognition (Mini cog score)||Participants|Count of Participants|371|371.0||||||
4251745|NCT00632021|4075873|B1||Not impaired|Cognition (Mini cog score)||Participants|Count of Participants|380|380.0||||||
4251746|NCT00632021|4075871|B3||Impaired|Cognition (Mini cog score)||Participants|Count of Participants|98|98.0||||||
4251747|NCT00632021|4075872|B2||Impaired|Cognition (Mini cog score)||Participants|Count of Participants|52|52.0||||||
4251748|NCT00632021|4075873|B1||Impaired|Cognition (Mini cog score)||Participants|Count of Participants|46|46.0||||||
4251749|NCT00632021|4075871|B3||Missing|Income||Participants|Count of Participants|74|74.0||||||
4251750|NCT00632021|4075872|B2||Missing|Income||Participants|Count of Participants|37|37.0||||||
4251751|NCT00632021|4075873|B1||Missing|Income||Participants|Count of Participants|37|37.0||||||
4251752|NCT00632021|4075871|B3||75K+|Income||Participants|Count of Participants|224|224.0||||||
4251753|NCT00632021|4075872|B2||75K+|Income||Participants|Count of Participants|105|105.0||||||
4251754|NCT00632021|4075873|B1||75K+|Income||Participants|Count of Participants|119|119.0||||||
4251755|NCT00632021|4075871|B3||50K to <75K|Income||Participants|Count of Participants|118|118.0||||||
4251756|NCT00632021|4075872|B2||50K to <75K|Income||Participants|Count of Participants|58|58.0||||||
4251757|NCT00632021|4075873|B1||50K to <75K|Income||Participants|Count of Participants|60|60.0||||||
4251758|NCT00632021|4075871|B3||35K to <50K|Income||Participants|Count of Participants|110|110.0||||||
4251759|NCT00632021|4075872|B2||35K to <50K|Income||Participants|Count of Participants|54|54.0||||||
4251760|NCT00632021|4075873|B1||35K to <50K|Income||Participants|Count of Participants|56|56.0||||||
4251761|NCT00632021|4075871|B3||25K to <35K|Income||Participants|Count of Participants|98|98.0||||||
4251762|NCT00632021|4075872|B2||25K to <35K|Income||Participants|Count of Participants|49|49.0||||||
4251763|NCT00632021|4075873|B1||25K to <35K|Income||Participants|Count of Participants|49|49.0||||||
4251764|NCT00632021|4075871|B3||20K to <25K|Income||Participants|Count of Participants|103|103.0||||||
4251765|NCT00632021|4075872|B2||20K to <25K|Income||Participants|Count of Participants|56|56.0||||||
4251766|NCT00632021|4075873|B1||20K to <25K|Income||Participants|Count of Participants|47|47.0||||||
4251767|NCT00632021|4075871|B3||15K to <20K|Income||Participants|Count of Participants|42|42.0||||||
4251768|NCT00632021|4075872|B2||15K to <20K|Income||Participants|Count of Participants|23|23.0||||||
4251769|NCT00632021|4075873|B1||15K to <20K|Income||Participants|Count of Participants|19|19.0||||||
4251770|NCT00632021|4075871|B3||10K to <15K|Income||Participants|Count of Participants|45|45.0||||||
4251771|NCT00632021|4075872|B2||10K to <15K|Income||Participants|Count of Participants|21|21.0||||||
4251772|NCT00632021|4075873|B1||10K to <15K|Income||Participants|Count of Participants|24|24.0||||||
4251773|NCT00632021|4075871|B3||<10K|Income||Participants|Count of Participants|37|37.0||||||
4251774|NCT00632021|4075872|B2||<10K|Income||Participants|Count of Participants|20|20.0||||||
4251775|NCT00632021|4075873|B1||<10K|Income||Participants|Count of Participants|17|17.0||||||
4251776|NCT00632021|4075871|B3|||Education||years|Median|14|14.0|Inter-Quartile Range|||12.0|16.0|
4251777|NCT00632021|4075872|B2|||Education||years|Median|14|14.0|Inter-Quartile Range|||12.0|16.0|
4251778|NCT00632021|4075873|B1|||Education||years|Median|14|14.0|Inter-Quartile Range|||12.0|16.0|
4251779|NCT00632021|4075871|B3||Spanish|Language||Participants|Count of Participants|12|12.0||||||
4251780|NCT00632021|4075872|B2||Spanish|Language||Participants|Count of Participants|9|9.0||||||
4251781|NCT00632021|4075873|B1||Spanish|Language||Participants|Count of Participants|3|3.0||||||
4251782|NCT00632021|4075871|B3||English|Language||Participants|Count of Participants|839|839.0||||||
4251783|NCT00632021|4075872|B2||English|Language||Participants|Count of Participants|414|414.0||||||
4251784|NCT00632021|4075873|B1||English|Language||Participants|Count of Participants|425|425.0||||||
4251785|NCT00632021|4075871|B3||Missing|Health literacy (sTOFHLA score)|Short Test of Functional Health Literacy in Adults|Participants|Count of Participants|20|20.0||||||
4251786|NCT00632021|4075872|B2||Missing|Health literacy (sTOFHLA score)|Short Test of Functional Health Literacy in Adults|Participants|Count of Participants|9|9.0||||||
4251787|NCT00632021|4075873|B1||Missing|Health literacy (sTOFHLA score)|Short Test of Functional Health Literacy in Adults|Participants|Count of Participants|11|11.0||||||
4251788|NCT00632021|4075871|B3||Adequate|Health literacy (sTOFHLA score)|Short Test of Functional Health Literacy in Adults|Participants|Count of Participants|671|671.0||||||
4251789|NCT00632021|4075872|B2||Adequate|Health literacy (sTOFHLA score)|Short Test of Functional Health Literacy in Adults|Participants|Count of Participants|331|331.0||||||
4251790|NCT00632021|4075873|B1||Adequate|Health literacy (sTOFHLA score)|Short Test of Functional Health Literacy in Adults|Participants|Count of Participants|340|340.0||||||
4251791|NCT00632021|4075871|B3||Marginal|Health literacy (sTOFHLA score)|Short Test of Functional Health Literacy in Adults|Participants|Count of Participants|74|74.0||||||
4251792|NCT00632021|4075872|B2||Marginal|Health literacy (sTOFHLA score)|Short Test of Functional Health Literacy in Adults|Participants|Count of Participants|36|36.0||||||
4251793|NCT00632021|4075873|B1||Marginal|Health literacy (sTOFHLA score)|Short Test of Functional Health Literacy in Adults|Participants|Count of Participants|38|38.0||||||
4251794|NCT00632021|4075871|B3||Inadequate|Health literacy (sTOFHLA score)|Short Test of Functional Health Literacy in Adults|Participants|Count of Participants|86|86.0||||||
4251795|NCT00632021|4075872|B2||Inadequate|Health literacy (sTOFHLA score)|Short Test of Functional Health Literacy in Adults|Participants|Count of Participants|47|47.0||||||
4251796|NCT00632021|4075873|B1||Inadequate|Health literacy (sTOFHLA score)|Short Test of Functional Health Literacy in Adults|Participants|Count of Participants|39|39.0||||||
4251797|NCT00632021|4075871|B3||Brigham and Women’s Hospital|Study Site||Participants|Count of Participants|454|454.0||||||
4251798|NCT00632021|4075872|B2||Brigham and Women’s Hospital|Study Site||Participants|Count of Participants|226|226.0||||||
4251799|NCT00632021|4075873|B1||Brigham and Women’s Hospital|Study Site||Participants|Count of Participants|228|228.0||||||
4251800|NCT00632021|4075871|B3||Vanderbilt University Hospital|Study Site||Participants|Count of Participants|397|397.0||||||
4251801|NCT00632021|4075872|B2||Vanderbilt University Hospital|Study Site||Participants|Count of Participants|197|197.0||||||
4251802|NCT00632021|4075873|B1||Vanderbilt University Hospital|Study Site||Participants|Count of Participants|200|200.0||||||
4251803|NCT00632021|4075871|B3|United States||Region of Enrollment||Number of participants|Number|851|851.0||||||
4251804|NCT00632021|4075872|B2|United States||Region of Enrollment||Number of participants|Number|423|423.0||||||
4251805|NCT00632021|4075873|B1|United States||Region of Enrollment||Number of participants|Number|428|428.0||||||
4251806|NCT00632021|4075871|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4251807|NCT00632021|4075872|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4251808|NCT00632021|4075873|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4251809|NCT00632021|4075871|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251810|NCT00632021|4075872|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251811|NCT00632021|4075873|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251812|NCT00632021|4075871|B3||White|Race (NIH/OMB)||Participants|Count of Participants|654|654.0||||||
4251813|NCT00632021|4075872|B2||White|Race (NIH/OMB)||Participants|Count of Participants|319|319.0||||||
4251814|NCT00632021|4075873|B1||White|Race (NIH/OMB)||Participants|Count of Participants|335|335.0||||||
4251815|NCT00632021|4075871|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|148|148.0||||||
4251816|NCT00632021|4075872|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
4251817|NCT00632021|4075873|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
4251818|NCT00632021|4075871|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4251819|NCT00632021|4075872|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4251820|NCT00632021|4075873|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4251821|NCT00632021|4075871|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4251822|NCT00632021|4075872|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4251823|NCT00632021|4075873|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4251824|NCT00632021|4075871|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4251825|NCT00632021|4075872|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4251826|NCT00632021|4075873|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4251827|NCT00632021|4075871|B3||Male|Sex: Female, Male||Participants|Count of Participants|499|499.0||||||
4251828|NCT00632021|4075872|B2||Male|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
4251829|NCT00632021|4075873|B1||Male|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
4251830|NCT00632021|4075871|B3||Female|Sex: Female, Male||Participants|Count of Participants|352|352.0||||||
4251831|NCT00632021|4075872|B2||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4251832|NCT00632021|4075873|B1||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4251833|NCT00632021|4075871|B3|||Age||years|Mean|60|60.0|Standard Deviation|14|14.0|||
4251834|NCT00632021|4075872|B2|||Age||years|Mean|61|61.0|Standard Deviation|14|14.0|||
4251835|NCT00632021|4075873|B1|||Age||years|Mean|59|59.0|Standard Deviation|14|14.0|||
4251836|NCT00631969|4075882|B3|>= 65 years||Body Mass Index (BMI)||Kilograms per square meter (kg/m^2)|Mean|27.0|27.0|Standard Deviation|3.4|3.4|||
4251837|NCT00631969|4075883|B2|>= 65 years||Body Mass Index (BMI)||Kilograms per square meter (kg/m^2)|Mean|27.1|27.1|Standard Deviation|3.6|3.6|||
4251838|NCT00631969|4075884|B1|>= 65 years||Body Mass Index (BMI)||Kilograms per square meter (kg/m^2)|Mean|26.9|26.9|Standard Deviation|3.2|3.2|||
4251839|NCT00631969|4075882|B3|< 65 years||Body Mass Index (BMI)||Kilograms per square meter (kg/m^2)|Mean|27.7|27.7|Standard Deviation|3.9|3.9|||
4251840|NCT00631969|4075883|B2|< 65 years||Body Mass Index (BMI)||Kilograms per square meter (kg/m^2)|Mean|27.9|27.9|Standard Deviation|4.3|4.3|||
4251841|NCT00631969|4075884|B1|< 65 years||Body Mass Index (BMI)||Kilograms per square meter (kg/m^2)|Mean|27.5|27.5|Standard Deviation|3.5|3.5|||
4251842|NCT00631969|4075882|B3|All age groups||Body Mass Index (BMI)||Kilograms per square meter (kg/m^2)|Mean|27.3|27.3|Standard Deviation|3.7|3.7|||
4251843|NCT00631969|4075883|B2|All age groups||Body Mass Index (BMI)||Kilograms per square meter (kg/m^2)|Mean|27.5|27.5|Standard Deviation|4.0|4.0|||
4251844|NCT00631969|4075884|B1|All age groups||Body Mass Index (BMI)||Kilograms per square meter (kg/m^2)|Mean|27.2|27.2|Standard Deviation|3.4|3.4|||
4251845|NCT00631969|4075882|B3||Male|Sex: Female, Male||Participants|Count of Participants|358|358.0||||||
4251846|NCT00631969|4075883|B2||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4251847|NCT00631969|4075884|B1||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4251848|NCT00631969|4075882|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4251849|NCT00631969|4075883|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4251850|NCT00631969|4075884|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4251851|NCT00631969|4075882|B3|>=65 years||Age, Customized||Participants|Number|190|190.0||||||
4251852|NCT00631969|4075883|B2|>=65 years||Age, Customized||Participants|Number|93|93.0||||||
4251853|NCT00631969|4075884|B1|>=65 years||Age, Customized||Participants|Number|97|97.0||||||
4251854|NCT00631969|4075882|B3|<65 years||Age, Customized||Participants|Number|168|168.0||||||
4251855|NCT00631969|4075883|B2|<65 years||Age, Customized||Participants|Number|81|81.0||||||
4251856|NCT00631969|4075884|B1|<65 years||Age, Customized||Participants|Number|87|87.0||||||
4251857|NCT00631917|4075929|B3||Male|Sex: Female, Male||Participants|Count of Participants|386|386.0||||||
4251858|NCT00631917|4075930|B2||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4251859|NCT00631917|4075931|B1||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4251860|NCT00631917|4075929|B3||Female|Sex: Female, Male||Participants|Count of Participants|388|388.0||||||
4251861|NCT00631917|4075930|B2||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4251862|NCT00631917|4075931|B1||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4251863|NCT00631917|4075929|B3|65 years and greater||Age, Customized||Participants|Number|162|162.0||||||
4251864|NCT00631917|4075930|B2|65 years and greater||Age, Customized||Participants|Number|86|86.0||||||
4251865|NCT00631917|4075931|B1|65 years and greater||Age, Customized||Participants|Number|76|76.0||||||
4251866|NCT00631917|4075929|B3|< 65 years||Age, Customized||Participants|Number|612|612.0||||||
4251867|NCT00631917|4075930|B2|< 65 years||Age, Customized||Participants|Number|313|313.0||||||
4251868|NCT00631917|4075931|B1|< 65 years||Age, Customized||Participants|Number|299|299.0||||||
4251869|NCT00631917|4075929|B3|||Age||years|Mean|59.3|59.3|Standard Deviation|6.81|6.81|||
4251870|NCT00631917|4075930|B2|||Age||years|Mean|59.3|59.3|Standard Deviation|6.65|6.65|||
4251871|NCT00631917|4075931|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|6.99|6.99|||
4251872|NCT00631748|4075946|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4251873|NCT00631748|4075947|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
4251874|NCT00631748|4075948|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4251875|NCT00631748|4075946|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4251876|NCT00631748|4075947|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4251877|NCT00631748|4075948|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4251878|NCT00631748|4075946|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4251879|NCT00631748|4075947|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4251880|NCT00631748|4075948|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4251881|NCT00631748|4075946|B3|||Age||years|Mean|47.90|47.9|Standard Deviation|8.38|8.38|||
4251882|NCT00631748|4075947|B2|||Age||years|Mean|47.71|47.71|Standard Deviation|9.69|9.69|||
4251883|NCT00631748|4075948|B1|||Age||years|Mean|48.11|48.11|Standard Deviation|6.97|6.97|||
4251884|NCT00631748|4075946|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4251885|NCT00631748|4075947|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4251886|NCT00631748|4075948|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4251887|NCT00631748|4075946|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4251888|NCT00631748|4075947|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4251889|NCT00631748|4075948|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4251890|NCT00631748|4075946|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4251891|NCT00631748|4075947|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4251892|NCT00631748|4075948|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4251893|NCT00631696|4075957|B3||Male|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
4251894|NCT00631696|4075958|B2||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4251895|NCT00631696|4075959|B1||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4251896|NCT00631696|4075957|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4251897|NCT00631696|4075958|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4251898|NCT00631696|4075959|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4251899|NCT00631696|4075957|B3|Between 45 and 64 years||Age, Customized||participants|Number|27|27.0||||||
4251900|NCT00631696|4075958|B2|Between 45 and 64 years||Age, Customized||participants|Number|16|16.0||||||
4251901|NCT00631696|4075959|B1|Between 45 and 64 years||Age, Customized||participants|Number|11|11.0||||||
4251902|NCT00631696|4075957|B3|Between 18 and 44 years||Age, Customized||participants|Number|193|193.0||||||
4251903|NCT00631696|4075958|B2|Between 18 and 44 years||Age, Customized||participants|Number|93|93.0||||||
4251904|NCT00631696|4075959|B1|Between 18 and 44 years||Age, Customized||participants|Number|100|100.0||||||
4251906|NCT00631670|4075986|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4251907|NCT00631670|4075984|B3|Male||Gender||participants|Number|12|12.0||||||
4251908|NCT00631670|4075986|B1|Male||Gender||participants|Number|12|12.0||||||
4251909|NCT00631670|4075984|B3|Female||Gender||participants|Number|9|9.0||||||
4251910|NCT00631670|4075986|B1|Female||Gender||participants|Number|9|9.0||||||
4251911|NCT00631670|4075984|B3|||Age||years|Mean|58.5|58.5|Standard Deviation|15.9|15.9|||
4251912|NCT00631670|4075986|B1|||Age||years|Mean|58.5|58.5|Standard Deviation|15.9|15.9|||
4251913|NCT00631670|4075984|B3|>=65 years||Age||participants|Number|8|8.0||||||
4251914|NCT00631670|4075986|B1|>=65 years||Age||participants|Number|8|8.0||||||
4251915|NCT00631670|4075984|B3|Between 18 and 65 years||Age||participants|Number|13|13.0||||||
4251916|NCT00631670|4075986|B1|Between 18 and 65 years||Age||participants|Number|13|13.0||||||
4251917|NCT00631670|4075984|B3|<=18 years||Age||participants|Number|0|0.0||||||
4251918|NCT00631670|4075986|B1|<=18 years||Age||participants|Number|0|0.0||||||
4251919|NCT00631657|4076001|B3||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4251920|NCT00631657|4076002|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4251921|NCT00631657|4076003|B1||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4251922|NCT00631657|4076001|B3||Female|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
4251923|NCT00631657|4076002|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4251924|NCT00631657|4076003|B1||Female|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4251925|NCT00631657|4076001|B3|||Age||years|Mean|47.8|47.8|Standard Deviation|11.3|11.3|||
4251926|NCT00631657|4076002|B2|||Age||years|Mean|49.0|49.0|Standard Deviation|11.1|11.1|||
4251927|NCT00631657|4076003|B1|||Age||years|Mean|47.4|47.4|Standard Deviation|11.4|11.4|||
4251928|NCT00631566|4076032|B4|>/= 500 cells/mm3||CD4 by category||Participants|Count of Participants|314|314.0||||||
4251929|NCT00631566|4076033|B3|>/= 500 cells/mm3||CD4 by category||Participants|Count of Participants|290|290.0||||||
4251930|NCT00631566|4076034|B2|>/= 500 cells/mm3||CD4 by category||Participants|Count of Participants|14|14.0||||||
4251931|NCT00631566|4076035|B1|>/= 500 cells/mm3||CD4 by category||Participants|Count of Participants|10|10.0||||||
4251932|NCT00631566|4076032|B4|350-499 cells/mm3||CD4 by category||Participants|Count of Participants|133|133.0||||||
4251933|NCT00631566|4076033|B3|350-499 cells/mm3||CD4 by category||Participants|Count of Participants|117|117.0||||||
4251934|NCT00631566|4076034|B2|350-499 cells/mm3||CD4 by category||Participants|Count of Participants|12|12.0||||||
4251935|NCT00631566|4076035|B1|350-499 cells/mm3||CD4 by category||Participants|Count of Participants|4|4.0||||||
4251936|NCT00631566|4076032|B4|<350 cells/mm3||CD4 by category||Participants|Count of Participants|102|102.0||||||
4251937|NCT00631566|4076033|B3|<350 cells/mm3||CD4 by category||Participants|Count of Participants|93|93.0||||||
4251938|NCT00631566|4076034|B2|<350 cells/mm3||CD4 by category||Participants|Count of Participants|2|2.0||||||
4251939|NCT00631566|4076035|B1|<350 cells/mm3||CD4 by category||Participants|Count of Participants|7|7.0||||||
4251940|NCT00631566|4076032|B4|||Current CD4 count||cells/mm3|Median|529|529.0|Inter-Quartile Range|||402.0|704.0|
4251941|NCT00631566|4076033|B3|||Current CD4 count||cells/mm3|Median|534|534.0|Inter-Quartile Range|||404.0|706.0|
4251942|NCT00631566|4076034|B2|||Current CD4 count||cells/mm3|Median|500|500.0|Inter-Quartile Range|||424.0|618.0|
4251943|NCT00631566|4076035|B1|||Current CD4 count||cells/mm3|Median|494|494.0|Inter-Quartile Range|||312.0|695.0|
4251944|NCT00631566|4076032|B4|United States||Region of Enrollment||participants|Number|550|550.0||||||
4251945|NCT00631566|4076033|B3|United States||Region of Enrollment||participants|Number|501|501.0||||||
4251946|NCT00631566|4076034|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4251947|NCT00631566|4076035|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4251948|NCT00631566|4076032|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
4251949|NCT00631566|4076033|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
4251950|NCT00631566|4076034|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4251951|NCT00631566|4076035|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4251952|NCT00631566|4076032|B4|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|196|196.0||||||
4251953|NCT00631566|4076033|B3|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|174|174.0||||||
4251954|NCT00631566|4076034|B2|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4251955|NCT00631566|4076035|B1|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4251956|NCT00631566|4076032|B4|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|311|311.0||||||
4251957|NCT00631566|4076033|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|287|287.0||||||
4251958|NCT00631566|4076034|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
4251959|NCT00631566|4076035|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4251960|NCT00631566|4076032|B4||Male|Sex: Female, Male||Participants|Count of Participants|513|513.0||||||
4251961|NCT00631566|4076033|B3||Male|Sex: Female, Male||Participants|Count of Participants|465|465.0||||||
4251962|NCT00631566|4076034|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4251963|NCT00631566|4076035|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4251964|NCT00631566|4076032|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4251965|NCT00631566|4076033|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4251966|NCT00631566|4076034|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4251967|NCT00631566|4076035|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4251968|NCT00631566|4076032|B4|||Age||years|Median|42|42.0|Inter-Quartile Range|||33.0|49.0|
4251969|NCT00631566|4076033|B3|||Age||years|Median|42|42.0|Inter-Quartile Range|||32.0|49.0|
4251970|NCT00631566|4076034|B2|||Age||years|Median|46|46.0|Inter-Quartile Range|||38.0|52.0|
4251971|NCT00631566|4076035|B1|||Age||years|Median|41|41.0|Inter-Quartile Range|||34.0|47.0|
4251972|NCT00631540|4076054|B1|Site Reported||Percent Stenosis at Baseline|Baseline stenosis was determined by angiography.|Percent|Mean|82.5|82.5|Standard Deviation|8.1|8.1|||
4251973|NCT00631540|4076054|B1|Core Lab||Percent Stenosis at Baseline|Baseline stenosis was determined by angiography.|Percent|Mean|57.4|57.4|Standard Deviation|13.8|13.8|||
4251974|NCT00631540|4076054|B1|||Number of Antihypertensive Medications per Patient||Antihypertensive Medications|Mean|2.7|2.7|Standard Deviation|1.2|1.2|||
4251975|NCT00631540|4076054|B1|||Diastolic Blood Pressure||mmHg|Mean|73.9|73.9|Standard Deviation|12.9|12.9|||
4251976|NCT00631540|4076054|B1|||Systolic Blood Pressure||mmHg|Mean|150.3|150.3|Standard Deviation|20.6|20.6|||
4251977|NCT00631540|4076054|B1|||Estimated Glomerular Filtration Rate||ml/min|Mean|60.7|60.7|Standard Deviation|28.8|28.8|||
4251978|NCT00631540|4076054|B1|||Serum Creatinine||mg/dl|Mean|1.3|1.3|Standard Deviation|0.5|0.5|||
4251979|NCT00631540|4076054|B1|No Congestive Heart Failure||Congestive Heart Failure||Participants|Number|74|74.0||||||
4251980|NCT00631540|4076054|B1|Congestive Heart Failure||Congestive Heart Failure||Participants|Number|26|26.0||||||
4251981|NCT00631540|4076054|B1|No Renal Insufficiency||Renal Insufficiency|Renal Insufficiency was defined by the physician, based on the patient's medical history.|Participants|Number|54|54.0||||||
4251982|NCT00631540|4076054|B1|Renal Insufficiency||Renal Insufficiency|Renal Insufficiency was defined by the physician, based on the patient's medical history.|Participants|Number|46|46.0||||||
4251983|NCT00631540|4076054|B1|No Hypertension||Hypertension|Pre-hypertension: Systolic 120-139 mmHg, Diastolic 80-89 mmHg Stage 1: Systolic 140-159 mmHg, Diastolic 90-99 mmHg Stage 2: Systolic >160 mmHg, Diastolic > 100 mmHg If systolic and diastolic pressures were in different categories, the higher category was chosen.|Participants|Number|3|3.0||||||
4251984|NCT00631540|4076054|B1|Hypertension||Hypertension|Pre-hypertension: Systolic 120-139 mmHg, Diastolic 80-89 mmHg Stage 1: Systolic 140-159 mmHg, Diastolic 90-99 mmHg Stage 2: Systolic >160 mmHg, Diastolic > 100 mmHg If systolic and diastolic pressures were in different categories, the higher category was chosen.|Participants|Number|97|97.0||||||
4251985|NCT00631540|4076054|B1|United States||Region of Enrollment||Participants|Number|100|100.0||||||
4251986|NCT00631540|4076054|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4251987|NCT00631540|4076054|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4251988|NCT00631540|4076054|B1|||Age||Years|Mean|72|72.0|Standard Deviation|10|10.0|||
4251989|NCT00631488|4076063|B4||Male|Gender||Participants|Count of Participants|89|89.0||||||
4251990|NCT00631488|4076064|B3||Male|Gender||Participants|Count of Participants|34|34.0||||||
4251991|NCT00631488|4076065|B2||Male|Gender||Participants|Count of Participants|23|23.0||||||
4251992|NCT00631488|4076066|B1||Male|Gender||Participants|Count of Participants|32|32.0||||||
4251993|NCT00631488|4076063|B4||Female|Gender||Participants|Count of Participants|57|57.0||||||
4251994|NCT00631488|4076064|B3||Female|Gender||Participants|Count of Participants|15|15.0||||||
4251995|NCT00631488|4076065|B2||Female|Gender||Participants|Count of Participants|26|26.0||||||
4251996|NCT00631488|4076066|B1||Female|Gender||Participants|Count of Participants|16|16.0||||||
4251997|NCT00631488|4076063|B4|||Age||years|Mean|53.2|53.2|Standard Deviation|8.8|8.8|||
4251998|NCT00631488|4076064|B3|||Age||years|Mean|53.8|53.8|Standard Deviation|8.7|8.7|||
4251999|NCT00631488|4076065|B2|||Age||years|Mean|52.0|52.0|Standard Deviation|9.7|9.7|||
4252000|NCT00631488|4076066|B1|||Age||years|Mean|53.6|53.6|Standard Deviation|8.0|8.0|||
4252001|NCT00631475|4076088|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4252002|NCT00631475|4076088|B1|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4252003|NCT00631475|4076088|B1|Switzerland||Region of Enrollment||participants|Number|4|4.0||||||
4252004|NCT00631475|4076088|B1|Spain||Region of Enrollment||participants|Number|8|8.0||||||
4252005|NCT00631475|4076088|B1|Korea, Republic of||Region of Enrollment||participants|Number|5|5.0||||||
4252006|NCT00631475|4076088|B1|Japan||Region of Enrollment||participants|Number|8|8.0||||||
4252007|NCT00631475|4076088|B1|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4252008|NCT00631475|4076088|B1|Israel||Region of Enrollment||participants|Number|4|4.0||||||
4252009|NCT00631475|4076088|B1|Ireland||Region of Enrollment||participants|Number|1|1.0||||||
4252010|NCT00631475|4076088|B1|Germany||Region of Enrollment||participants|Number|11|11.0||||||
4252011|NCT00631475|4076088|B1|France||Region of Enrollment||participants|Number|3|3.0||||||
4252012|NCT00631475|4076088|B1|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
4252013|NCT00631475|4076088|B1|Canada||Region of Enrollment||participants|Number|14|14.0||||||
4252014|NCT00631475|4076088|B1|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4252015|NCT00631475|4076088|B1|Australia||Region of Enrollment||participants|Number|12|12.0||||||
4252016|NCT00631475|4076088|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4252017|NCT00631475|4076088|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4252018|NCT00631475|4076088|B1|>70 years||Age, Customized||participants|Number|32|32.0||||||
4252019|NCT00631475|4076088|B1|61-70 years||Age, Customized||participants|Number|62|62.0||||||
4252020|NCT00631475|4076088|B1|41-60 years||Age, Customized||participants|Number|33|33.0||||||
4252021|NCT00631475|4076088|B1|18-40 years||Age, Customized||participants|Number|1|1.0||||||
4252022|NCT00631475|4076088|B1|||Age||years|Mean|65.4|65.4|Standard Deviation|8.2|8.2|||
4252023|NCT00631449|4076096|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4252024|NCT00631449|4076097|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4252025|NCT00631449|4076098|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4252026|NCT00631449|4076096|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4252027|NCT00631449|4076097|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4252028|NCT00631449|4076098|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4252029|NCT00631449|4076096|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4252030|NCT00631449|4076097|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4252031|NCT00631449|4076098|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4252032|NCT00631449|4076096|B3|||Age||years|Mean|51.0|51.0|Standard Deviation|9.1|9.1|||
4252033|NCT00631449|4076097|B2|||Age||years|Mean|51.2|51.2|Standard Deviation|8.0|8.0|||
4252034|NCT00631449|4076098|B1|||Age||years|Mean|50.7|50.7|Standard Deviation|10.3|10.3|||
4252035|NCT00631449|4076096|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4252036|NCT00631449|4076097|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4252037|NCT00631449|4076098|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4252038|NCT00631449|4076096|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4252039|NCT00631449|4076097|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4252040|NCT00631449|4076098|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4252041|NCT00631449|4076096|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252042|NCT00631449|4076097|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252043|NCT00631449|4076098|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252044|NCT00631410|4076105|B3|Score 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Score 0: Fully active, able to carry on all pre-disease performance without restriction; Score~1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, such as light house work and office work."|participants|Number|1|1.0||||||
4252045|NCT00631410|4076106|B2|Score 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Score 0: Fully active, able to carry on all pre-disease performance without restriction; Score~1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, such as light house work and office work."|participants|Number|0|0.0||||||
4252046|NCT00631410|4076107|B1|Score 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Score 0: Fully active, able to carry on all pre-disease performance without restriction; Score~1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, such as light house work and office work."|participants|Number|1|1.0||||||
4252047|NCT00631410|4076105|B3|Score 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Score 0: Fully active, able to carry on all pre-disease performance without restriction; Score~1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, such as light house work and office work."|participants|Number|11|11.0||||||
4252048|NCT00631410|4076106|B2|Score 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Score 0: Fully active, able to carry on all pre-disease performance without restriction; Score~1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, such as light house work and office work."|participants|Number|6|6.0||||||
4252049|NCT00631410|4076107|B1|Score 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Score 0: Fully active, able to carry on all pre-disease performance without restriction; Score~1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, such as light house work and office work."|participants|Number|5|5.0||||||
4252050|NCT00631410|4076105|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4252051|NCT00631410|4076106|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4252052|NCT00631410|4076107|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4252053|NCT00631410|4076105|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4252054|NCT00631410|4076106|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4252055|NCT00631410|4076107|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4252056|NCT00631410|4076105|B3|>=65 years||Age, Customized||participants|Number|5|5.0||||||
4252057|NCT00631410|4076106|B2|>=65 years||Age, Customized||participants|Number|3|3.0||||||
4252058|NCT00631410|4076107|B1|>=65 years||Age, Customized||participants|Number|2|2.0||||||
4252059|NCT00631410|4076105|B3|45-64 years||Age, Customized||participants|Number|7|7.0||||||
4252060|NCT00631410|4076106|B2|45-64 years||Age, Customized||participants|Number|3|3.0||||||
4252061|NCT00631410|4076107|B1|45-64 years||Age, Customized||participants|Number|4|4.0||||||
4252062|NCT00631410|4076105|B3|20-44 years||Age, Customized||participants|Number|0|0.0||||||
4252063|NCT00631410|4076106|B2|20-44 years||Age, Customized||participants|Number|0|0.0||||||
4252064|NCT00631410|4076107|B1|20-44 years||Age, Customized||participants|Number|0|0.0||||||
4252065|NCT00631371|4076125|B3||Male|Sex: Female, Male||Participants|Count of Participants|556|556.0||||||
4252066|NCT00631371|4076126|B2||Male|Sex: Female, Male||Participants|Count of Participants|270|270.0||||||
4252067|NCT00631371|4076127|B1||Male|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
4252068|NCT00631371|4076125|B3||Female|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4252069|NCT00631371|4076126|B2||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4252070|NCT00631371|4076127|B1||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4252071|NCT00631371|4076125|B3|||Age||years|Mean|58.4|58.4|Standard Deviation|10.2|10.2|||
4252072|NCT00631371|4076126|B2|||Age||years|Mean|58.2|58.2|Standard Deviation|10.4|10.4|||
4252073|NCT00631371|4076127|B1|||Age||years|Mean|58.6|58.6|Standard Deviation|10.1|10.1|||
4252074|NCT00631358|4076140|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4252075|NCT00631358|4076141|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4252076|NCT00631358|4076142|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4252077|NCT00631358|4076140|B3||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4252078|NCT00631358|4076141|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4252079|NCT00631358|4076142|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4252080|NCT00631358|4076140|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4252081|NCT00631358|4076141|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4252082|NCT00631358|4076142|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4252083|NCT00631358|4076140|B3||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
4252084|NCT00631358|4076141|B2||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4252085|NCT00631358|4076142|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4252086|NCT00631358|4076140|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252087|NCT00631358|4076141|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252088|NCT00631358|4076142|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252089|NCT00631189|4076157|B5|Male||Gender||Participants|Number|167|167.0||||||
4252090|NCT00631189|4076158|B4|Male||Gender||Participants|Number|64|64.0||||||
4252091|NCT00631189|4076159|B3|Male||Gender||Participants|Number|48|48.0||||||
4252092|NCT00631189|4076160|B2|Male||Gender||Participants|Number|55|55.0||||||
4252093|NCT00631189|4076157|B5|Female||Gender||Participants|Number|150|150.0||||||
4252094|NCT00631189|4076158|B4|Female||Gender||Participants|Number|46|46.0||||||
4252095|NCT00631189|4076159|B3|Female||Gender||Participants|Number|55|55.0||||||
4252096|NCT00631189|4076160|B2|Female||Gender||Participants|Number|49|49.0||||||
4252097|NCT00631189|4076157|B5|||Age||years|Mean|57.18|57.18|Standard Deviation|9.95|9.95|||
4252098|NCT00631189|4076158|B4|||Age||years|Mean|57.04|57.04|Standard Deviation|9.32|9.32|||
4252099|NCT00631189|4076159|B3|||Age||years|Mean|57.23|57.23|Standard Deviation|10.8|10.8|||
4252100|NCT00631189|4076160|B2|||Age||years|Mean|57.31|57.31|Standard Deviation|10.59|10.59|||
4252101|NCT00631137|4076206|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4252102|NCT00631137|4076208|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4252103|NCT00631137|4076206|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4252104|NCT00631137|4076208|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4252105|NCT00631137|4076206|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4252106|NCT00631137|4076208|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4252107|NCT00631137|4076206|B3|||Age, Customized||years|Number|29|29.0||||||
4252108|NCT00631137|4076208|B1|||Age, Customized||years|Number|29|29.0||||||
4252109|NCT00631020|4076227|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4252110|NCT00631020|4076227|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4252111|NCT00631020|4076227|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4252112|NCT00631020|4076227|B1|||Age||years|Mean|19|19.0|Standard Deviation|1.7|1.7|||
4252113|NCT00631007|4076236|B7|||Hemoglobin A1c||Percent|Mean|8.3|8.3|Standard Deviation|0.72|0.72|||
4252114|NCT00631007|4076237|B6|||Hemoglobin A1c||Percent|Mean|8.4|8.4|Standard Deviation|0.80|0.8|||
4252115|NCT00631007|4076238|B5|||Hemoglobin A1c||Percent|Mean|8.2|8.2|Standard Deviation|0.67|0.67|||
4252116|NCT00631007|4076239|B4|||Hemoglobin A1c||Percent|Mean|8.3|8.3|Standard Deviation|0.65|0.65|||
4252117|NCT00631007|4076240|B3|||Hemoglobin A1c||Percent|Mean|8.5|8.5|Standard Deviation|0.69|0.69|||
4252118|NCT00631007|4076241|B2|||Hemoglobin A1c||Percent|Mean|8.3|8.3|Standard Deviation|0.71|0.71|||
4252119|NCT00631007|4076242|B1|||Hemoglobin A1c||Percent|Mean|8.3|8.3|Standard Deviation|0.76|0.76|||
4252120|NCT00631007|4076236|B7|Mexico||Region of Enrollment||participants|Number|61|61.0||||||
4252121|NCT00631007|4076237|B6|Mexico||Region of Enrollment||participants|Number|12|12.0||||||
4252122|NCT00631007|4076238|B5|Mexico||Region of Enrollment||participants|Number|9|9.0||||||
4252123|NCT00631007|4076239|B4|Mexico||Region of Enrollment||participants|Number|9|9.0||||||
4252124|NCT00631007|4076240|B3|Mexico||Region of Enrollment||participants|Number|11|11.0||||||
4252125|NCT00631007|4076241|B2|Mexico||Region of Enrollment||participants|Number|11|11.0||||||
4252126|NCT00631007|4076242|B1|Mexico||Region of Enrollment||participants|Number|9|9.0||||||
4252127|NCT00631007|4076236|B7|United States||Region of Enrollment||participants|Number|305|305.0||||||
4252128|NCT00631007|4076237|B6|United States||Region of Enrollment||participants|Number|49|49.0||||||
4252129|NCT00631007|4076238|B5|United States||Region of Enrollment||participants|Number|51|51.0||||||
4252130|NCT00631007|4076239|B4|United States||Region of Enrollment||participants|Number|52|52.0||||||
4252131|NCT00631007|4076240|B3|United States||Region of Enrollment||participants|Number|52|52.0||||||
4252132|NCT00631007|4076241|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
4252133|NCT00631007|4076242|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4252134|NCT00631007|4076236|B7||White|Race (NIH/OMB)||Participants|Count of Participants|280|280.0||||||
4252135|NCT00631007|4076237|B6||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4252136|NCT00631007|4076238|B5||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4252137|NCT00631007|4076239|B4||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4252138|NCT00631007|4076240|B3||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4252139|NCT00631007|4076241|B2||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4252140|NCT00631007|4076242|B1||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4252141|NCT00631007|4076236|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4252142|NCT00631007|4076237|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4252143|NCT00631007|4076238|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4252144|NCT00631007|4076239|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4252145|NCT00631007|4076240|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4252146|NCT00631007|4076241|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4252147|NCT00631007|4076242|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4252148|NCT00631007|4076236|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4252149|NCT00631007|4076237|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4252150|NCT00631007|4076238|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4252151|NCT00631007|4076239|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4252152|NCT00631007|4076240|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4252153|NCT00631007|4076241|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4252154|NCT00631007|4076242|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4252155|NCT00631007|4076236|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4252156|NCT00631007|4076237|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4252157|NCT00631007|4076238|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4252158|NCT00631007|4076239|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4252159|NCT00631007|4076240|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4252160|NCT00631007|4076241|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4252161|NCT00631007|4076242|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4252162|NCT00631007|4076236|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4252163|NCT00631007|4076237|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4252164|NCT00631007|4076238|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4252165|NCT00631007|4076239|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4252166|NCT00631007|4076240|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4252167|NCT00631007|4076241|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4252168|NCT00631007|4076242|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4252169|NCT00631007|4076236|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|186|186.0||||||
4252170|NCT00631007|4076237|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4252171|NCT00631007|4076238|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4252172|NCT00631007|4076239|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4252173|NCT00631007|4076240|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4252174|NCT00631007|4076241|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4252175|NCT00631007|4076242|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4252176|NCT00631007|4076236|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|180|180.0||||||
4252177|NCT00631007|4076237|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4252178|NCT00631007|4076238|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4252179|NCT00631007|4076239|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4252180|NCT00631007|4076240|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4252181|NCT00631007|4076241|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4252182|NCT00631007|4076242|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4252183|NCT00631007|4076236|B7||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4252184|NCT00631007|4076237|B6||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4252185|NCT00631007|4076238|B5||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4252186|NCT00631007|4076239|B4||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4252187|NCT00631007|4076240|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4252188|NCT00631007|4076241|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4252189|NCT00631007|4076242|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4252190|NCT00631007|4076236|B7||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4252191|NCT00631007|4076237|B6||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4252192|NCT00631007|4076238|B5||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4252193|NCT00631007|4076239|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4252194|NCT00631007|4076240|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4252195|NCT00631007|4076241|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4252196|NCT00631007|4076242|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4252197|NCT00631007|4076236|B7|||Age||years|Mean|55.8|55.8|Standard Deviation|9.50|9.5|||
4252198|NCT00631007|4076237|B6|||Age||years|Mean|55.3|55.3|Standard Deviation|10.93|10.93|||
4252199|NCT00631007|4076238|B5|||Age||years|Mean|55.8|55.8|Standard Deviation|10.40|10.4|||
4252200|NCT00631007|4076239|B4|||Age||years|Mean|54.8|54.8|Standard Deviation|9.76|9.76|||
4252201|NCT00631007|4076240|B3|||Age||years|Mean|56.1|56.1|Standard Deviation|7.98|7.98|||
4252202|NCT00631007|4076241|B2|||Age||years|Mean|58.0|58.0|Standard Deviation|9.18|9.18|||
4252203|NCT00631007|4076242|B1|||Age||years|Mean|54.9|54.9|Standard Deviation|8.48|8.48|||
4252204|NCT00630994|4076267|B1|Post Polycythemia Vera (PV) Myelofibrosis||Category of Primary myelofibrosis||participants|Number|1|1.0||||||
4252205|NCT00630994|4076267|B1|Post Essential Thrombocythemia (ET) Myelofibrosis||Category of Primary myelofibrosis||participants|Number|1|1.0||||||
4252206|NCT00630994|4076267|B1|Primary Myelofibrosis||Category of Primary myelofibrosis||participants|Number|2|2.0||||||
4252207|NCT00630994|4076267|B1|No||Prior thrombosis||participants|Number|2|2.0||||||
4252208|NCT00630994|4076267|B1|Yes||Prior thrombosis||participants|Number|2|2.0||||||
4252209|NCT00630994|4076267|B1|No||Prior bleeding events felt to be related to underlying disease||participants|Number|4|4.0||||||
4252210|NCT00630994|4076267|B1|Yes||Prior bleeding events felt to be related to underlying disease||participants|Number|0|0.0||||||
4252211|NCT00630994|4076267|B1|No||Prior disease specific therapy (including drugs, stem cell transplant, or splenectomy)||participants|Number|2|2.0||||||
4252212|NCT00630994|4076267|B1|Yes||Prior disease specific therapy (including drugs, stem cell transplant, or splenectomy)||participants|Number|2|2.0||||||
4252213|NCT00630994|4076267|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4252214|NCT00630994|4076267|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4252215|NCT00630994|4076267|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4252216|NCT00630994|4076267|B1|||Age||years|Mean|64.8|64.8|Standard Deviation|6.6|6.6|||
4252217|NCT00630955|4076275|B4|United States||Region of Enrollment||participants|Number|111|111.0||||||
4252218|NCT00630955|4076276|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4252219|NCT00630955|4076277|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4252220|NCT00630955|4076278|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4252221|NCT00630955|4076275|B4||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4252222|NCT00630955|4076276|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4252223|NCT00630955|4076277|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4252224|NCT00630955|4076278|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4252225|NCT00630955|4076275|B4||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4252226|NCT00630955|4076276|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4252227|NCT00630955|4076277|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4252228|NCT00630955|4076278|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4252229|NCT00630955|4076275|B4|||Age||years|Mean|31.0|31.0|Standard Deviation|8.6|8.6|||
4252230|NCT00630955|4076276|B3|||Age||years|Mean|31.3|31.3|Standard Deviation|8.8|8.8|||
4252231|NCT00630955|4076277|B2|||Age||years|Mean|32.4|32.4|Standard Deviation|9.3|9.3|||
4252232|NCT00630955|4076278|B1|||Age||years|Mean|29.1|29.1|Standard Deviation|7.2|7.2|||
4252233|NCT00630955|4076275|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4252234|NCT00630955|4076276|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4252235|NCT00630955|4076277|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4252236|NCT00630955|4076278|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4252237|NCT00630955|4076275|B4||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
4252238|NCT00630955|4076276|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4252239|NCT00630955|4076277|B2||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4252240|NCT00630955|4076278|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4252241|NCT00630955|4076275|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252242|NCT00630955|4076276|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252243|NCT00630955|4076277|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252244|NCT00630955|4076278|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252245|NCT00630916|4076297|B1|Canada||Region of Enrollment||participants|Number|143|143.0||||||
4252246|NCT00630916|4076297|B1|United States||Region of Enrollment||participants|Number|556|556.0||||||
4252247|NCT00630916|4076297|B1||Male|Sex: Female, Male||Participants|Count of Participants|397|397.0||||||
4252248|NCT00630916|4076297|B1||Female|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
4252249|NCT00630916|4076297|B1|||Age||years|Mean|74.3|74.3|Standard Deviation|8.4|8.4|||
4252250|NCT00630916|4076297|B1||>=65 years|Age||Participants|Count of Participants|603|603.0||||||
4252251|NCT00630916|4076297|B1||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
4252252|NCT00630916|4076297|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252253|NCT00630877|4076304|B4|United States||Region of Enrollment||participants|Number|271|271.0||||||
4252254|NCT00630877|4076305|B3|United States||Region of Enrollment||participants|Number|90|90.0||||||
4252255|NCT00630877|4076306|B2|United States||Region of Enrollment||participants|Number|90|90.0||||||
4252256|NCT00630877|4076307|B1|United States||Region of Enrollment||participants|Number|91|91.0||||||
4252257|NCT00630877|4076304|B4||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4252258|NCT00630877|4076305|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4252259|NCT00630877|4076306|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4252260|NCT00630877|4076307|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4252261|NCT00630877|4076304|B4||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4252262|NCT00630877|4076305|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4252263|NCT00630877|4076306|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4252264|NCT00630877|4076307|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4252265|NCT00630877|4076304|B4|||Age||years|Mean|53.6|53.6|Standard Deviation|12.20|12.2|||
4252266|NCT00630877|4076305|B3|||Age||years|Mean|52.9|52.9|Standard Deviation|12.26|12.26|||
4252267|NCT00630877|4076306|B2|||Age||years|Mean|53.7|53.7|Standard Deviation|12.74|12.74|||
4252268|NCT00630877|4076307|B1|||Age||years|Mean|54.1|54.1|Standard Deviation|11.68|11.68|||
4252269|NCT00630864|4076327|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4252270|NCT00630864|4076327|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4252271|NCT00630864|4076327|B1|||Age||years|Mean|63.10|63.1|Standard Deviation|9.86|9.86|||
4252272|NCT00630838|4076364|B3|Egypt||Region of Enrollment||participants|Number|42|42.0||||||
4252273|NCT00630838|4076365|B2|Egypt||Region of Enrollment||participants|Number|20|20.0||||||
4252274|NCT00630838|4076366|B1|Egypt||Region of Enrollment||participants|Number|22|22.0||||||
4252275|NCT00630838|4076364|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4252276|NCT00630838|4076365|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4252277|NCT00630838|4076366|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4252278|NCT00630838|4076364|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4252279|NCT00630838|4076365|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4252280|NCT00630838|4076366|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4252281|NCT00630838|4076364|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4252282|NCT00630838|4076365|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4252283|NCT00630838|4076366|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4252284|NCT00630838|4076364|B3|||Age||months|Mean|30|30.0|Standard Deviation|5.6|5.6|||
4252285|NCT00630838|4076365|B2|||Age||months|Mean|28|28.0|Standard Deviation|4.9|4.9|||
4252286|NCT00630838|4076366|B1|||Age||months|Mean|32|32.0|Standard Deviation|7.6|7.6|||
4252287|NCT00630838|4076364|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4252288|NCT00630838|4076365|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4252289|NCT00630838|4076366|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4252290|NCT00630838|4076364|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4252291|NCT00630838|4076365|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4252292|NCT00630838|4076366|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4252293|NCT00630838|4076364|B3||<=18 years|Age||Participants|Count of Participants|62|62.0||||||
4252294|NCT00630838|4076365|B2||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4252295|NCT00630838|4076366|B1||<=18 years|Age||Participants|Count of Participants|32|32.0||||||
4252296|NCT00630825|4076375|B5|||Duration of Diabetes||years|Mean|8.30|8.3|Standard Deviation|6.41|6.41|||
4252297|NCT00630825|4076376|B4|||Duration of Diabetes||years|Mean|7.48|7.48|Standard Deviation|5.41|5.41|||
4252298|NCT00630825|4076377|B3|||Duration of Diabetes||years|Mean|8.97|8.97|Standard Deviation|7.62|7.62|||
4252299|NCT00630825|4076378|B2|||Duration of Diabetes||years|Mean|8.13|8.13|Standard Deviation|5.43|5.43|||
4252300|NCT00630825|4076379|B1|||Duration of Diabetes||years|Mean|8.63|8.63|Standard Deviation|6.92|6.92|||
4252301|NCT00630825|4076375|B5|||Body Weight||kilograms (kg)|Mean|96.18|96.18|Standard Deviation|16.68|16.68|||
4252302|NCT00630825|4076376|B4|||Body Weight||kilograms (kg)|Mean|94.74|94.74|Standard Deviation|15.21|15.21|||
4252303|NCT00630825|4076377|B3|||Body Weight||kilograms (kg)|Mean|94.76|94.76|Standard Deviation|16.53|16.53|||
4252304|NCT00630825|4076378|B2|||Body Weight||kilograms (kg)|Mean|96.68|96.68|Standard Deviation|16.51|16.51|||
4252305|NCT00630825|4076379|B1|||Body Weight||kilograms (kg)|Mean|98.60|98.6|Standard Deviation|18.41|18.41|||
4252306|NCT00630825|4076375|B5|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meters (kg/m^2)|Mean|33.92|33.92|Standard Deviation|4.10|4.1|||
4252307|NCT00630825|4076376|B4|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meters (kg/m^2)|Mean|33.89|33.89|Standard Deviation|4.31|4.31|||
4252308|NCT00630825|4076377|B3|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meters (kg/m^2)|Mean|33.70|33.7|Standard Deviation|4.11|4.11|||
4252309|NCT00630825|4076378|B2|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meters (kg/m^2)|Mean|33.85|33.85|Standard Deviation|3.95|3.95|||
4252422|NCT00630734|4076487|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4252310|NCT00630825|4076379|B1|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meters (kg/m^2)|Mean|34.24|34.24|Standard Deviation|4.11|4.11|||
4252311|NCT00630825|4076375|B5|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|8.24|8.24|Standard Deviation|0.93|0.93|||
4252312|NCT00630825|4076376|B4|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|8.05|8.05|Standard Deviation|0.82|0.82|||
4252313|NCT00630825|4076377|B3|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|8.25|8.25|Standard Deviation|0.89|0.89|||
4252314|NCT00630825|4076378|B2|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|8.25|8.25|Standard Deviation|0.99|0.99|||
4252315|NCT00630825|4076379|B1|||Glycosylated Hemoglobin (HbA1c)||percentage of glycosylated hemoglobin|Mean|8.43|8.43|Standard Deviation|0.99|0.99|||
4252316|NCT00630825|4076375|B5|Puerto Rico||Region of Enrollment||participants|Number|35|35.0||||||
4252317|NCT00630825|4076376|B4|Puerto Rico||Region of Enrollment||participants|Number|8|8.0||||||
4252318|NCT00630825|4076377|B3|Puerto Rico||Region of Enrollment||participants|Number|9|9.0||||||
4252319|NCT00630825|4076378|B2|Puerto Rico||Region of Enrollment||participants|Number|9|9.0||||||
4252320|NCT00630825|4076379|B1|Puerto Rico||Region of Enrollment||participants|Number|9|9.0||||||
4252321|NCT00630825|4076375|B5|United States||Region of Enrollment||participants|Number|227|227.0||||||
4252322|NCT00630825|4076376|B4|United States||Region of Enrollment||participants|Number|58|58.0||||||
4252323|NCT00630825|4076377|B3|United States||Region of Enrollment||participants|Number|57|57.0||||||
4252324|NCT00630825|4076378|B2|United States||Region of Enrollment||participants|Number|56|56.0||||||
4252325|NCT00630825|4076379|B1|United States||Region of Enrollment||participants|Number|56|56.0||||||
4252326|NCT00630825|4076375|B5|Native American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4252327|NCT00630825|4076376|B4|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4252328|NCT00630825|4076377|B3|Native American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4252329|NCT00630825|4076378|B2|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4252330|NCT00630825|4076379|B1|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4252331|NCT00630825|4076375|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|88|88.0||||||
4252332|NCT00630825|4076376|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4252333|NCT00630825|4076377|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4252334|NCT00630825|4076378|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4252335|NCT00630825|4076379|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4252336|NCT00630825|4076375|B5|East Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4252337|NCT00630825|4076376|B4|East Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4252338|NCT00630825|4076377|B3|East Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4252339|NCT00630825|4076378|B2|East Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4252340|NCT00630825|4076379|B1|East Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4252341|NCT00630825|4076375|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|151|151.0||||||
4252342|NCT00630825|4076376|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4252343|NCT00630825|4076377|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4252344|NCT00630825|4076378|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4252345|NCT00630825|4076379|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4252346|NCT00630825|4076375|B5|African||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4252347|NCT00630825|4076376|B4|African||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4252348|NCT00630825|4076377|B3|African||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4252349|NCT00630825|4076378|B2|African||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4252350|NCT00630825|4076379|B1|African||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4252351|NCT00630825|4076375|B5||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4252352|NCT00630825|4076376|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4252353|NCT00630825|4076377|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4252354|NCT00630825|4076378|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4252355|NCT00630825|4076379|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4252356|NCT00630825|4076375|B5||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4252357|NCT00630825|4076376|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4252358|NCT00630825|4076377|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4252359|NCT00630825|4076378|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4252360|NCT00630825|4076379|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4252361|NCT00630825|4076375|B5|||Age||years|Mean|56.65|56.65|Standard Deviation|11.84|11.84|||
4252362|NCT00630825|4076376|B4|||Age||years|Mean|55.96|55.96|Standard Deviation|12.49|12.49|||
4252363|NCT00630825|4076377|B3|||Age||years|Mean|58.65|58.65|Standard Deviation|11.69|11.69|||
4252364|NCT00630825|4076378|B2|||Age||years|Mean|57.46|57.46|Standard Deviation|11.72|11.72|||
4252365|NCT00630825|4076379|B1|||Age||years|Mean|54.49|54.49|Standard Deviation|11.28|11.28|||
4252366|NCT00630786|4076451|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4252367|NCT00630786|4076452|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4252368|NCT00630786|4076453|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4252369|NCT00630786|4076454|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4252370|NCT00630786|4076451|B4|White or Caucasian||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4252371|NCT00630786|4076452|B3|White or Caucasian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4252372|NCT00630786|4076453|B2|White or Caucasian||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4252373|NCT00630786|4076454|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4252374|NCT00630786|4076451|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4252375|NCT00630786|4076452|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4252376|NCT00630786|4076453|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4252377|NCT00630786|4076454|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4252378|NCT00630786|4076451|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4252379|NCT00630786|4076452|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4252380|NCT00630786|4076453|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4252381|NCT00630786|4076454|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4252382|NCT00630786|4076451|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4252383|NCT00630786|4076452|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4252384|NCT00630786|4076453|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4252385|NCT00630786|4076454|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4252386|NCT00630786|4076451|B4|||Age||years|Mean|62.42|62.42|Standard Deviation|12.54|12.54|||
4252387|NCT00630786|4076452|B3|||Age||years|Mean|58.63|58.63|Standard Deviation|13.65|13.65|||
4252388|NCT00630786|4076453|B2|||Age||years|Mean|64.32|64.32|Standard Deviation|12.35|12.35|||
4252389|NCT00630786|4076454|B1|||Age||years|Mean|61.53|61.53|Standard Deviation|12.53|12.53|||
4252390|NCT00630747|4076475|B1|||Baseline Cardiac Left Ventricular Mass Index (LVMI)||gram per meter^2 (g/m^2)|Mean|97.64|97.64|Standard Deviation|36.606|36.606|||
4252391|NCT00630747|4076475|B1|||Baseline Normalized Urine Glycosaminoglycans (GAG) Levels||microgram(mcg)GAG/mg creatinine|Mean|361.96|361.96|Standard Deviation|136.132|136.132|||
4252392|NCT00630747|4076475|B1|||Baseline Combined Liver and Spleen Volume||cubic centimeters (cc)|Mean|1504.8|1504.8|Standard Deviation|417.21|417.21|||
4252393|NCT00630747|4076475|B1|||Baseline Passive Joint Range of Motion (JROM)|Global JROM (% normal range of motion) is the average of 11 ratios multiplied by 100. Ratios are Left/Right means of passive range of motion in Shoulder (Flexion/Extension, Abduction, Internal/External Rotation), Elbow (Flexion/Extension), Wrist (Flexion/Extension), Index Finger (Flexion/Extension [Combined MCP, PIP, DIP motion]), Hip (Flexion/Extension, Abduction, Internal/External Rotation), Knee (Flexion/Extension), and Ankle (Dorsiflexion) divided by the normal range (American Academy of Orthopedic Surgeons and American Medical Association).|percentage of JROM|Mean|67.44|67.44|Standard Deviation|9.042|9.042|||
4252394|NCT00630747|4076475|B1|||Baseline Distance Walked in the 6-minute Walk Test (6MWT)||meters (m)|Mean|400.3|400.3|Standard Deviation|100.25|100.25|||
4252395|NCT00630747|4076475|B1|||Baseline Percent Predicted Forced Vital Capacity (FVC)||percent predicted FVC|Mean|56.160|56.16|Standard Deviation|14.897|14.897|||
4252396|NCT00630747|4076475|B1|South America||Region of Enrollment||participants|Number|20|20.0||||||
4252397|NCT00630747|4076475|B1|North America||Region of Enrollment||participants|Number|34|34.0||||||
4252398|NCT00630747|4076475|B1|Europe||Region of Enrollment||participants|Number|40|40.0||||||
4252399|NCT00630747|4076475|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4252400|NCT00630747|4076475|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4252401|NCT00630747|4076475|B1||White|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
4252402|NCT00630747|4076475|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4252403|NCT00630747|4076475|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4252404|NCT00630747|4076475|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4252405|NCT00630747|4076475|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4252406|NCT00630747|4076475|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4252407|NCT00630747|4076475|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
4252408|NCT00630747|4076475|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4252409|NCT00630747|4076475|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4252410|NCT00630747|4076475|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4252411|NCT00630747|4076475|B1|||Age||years|Mean|14.52|14.52|Standard Deviation|6.634|6.634|||
4252412|NCT00630747|4076475|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4252413|NCT00630747|4076475|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4252414|NCT00630747|4076475|B1||<=18 years|Age||Participants|Count of Participants|70|70.0||||||
4252415|NCT00630734|4076484|B4|United States||Region of Enrollment||participants|Number|28|28.0||||||
4252416|NCT00630734|4076485|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4252417|NCT00630734|4076486|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4252418|NCT00630734|4076487|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4252419|NCT00630734|4076484|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4252420|NCT00630734|4076485|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4252421|NCT00630734|4076486|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4252423|NCT00630734|4076484|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4252424|NCT00630734|4076485|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4252425|NCT00630734|4076486|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4252426|NCT00630734|4076487|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4252427|NCT00630734|4076484|B4|||Age||years|Mean|36|36.0|Standard Deviation|11|11.0|||
4252428|NCT00630734|4076485|B3|||Age||years|Mean|39|39.0|Standard Deviation|11|11.0|||
4252429|NCT00630734|4076486|B2|||Age||years|Mean|37|37.0|Standard Deviation|12|12.0|||
4252430|NCT00630734|4076487|B1|||Age||years|Mean|36|36.0|Standard Deviation|11|11.0|||
4252431|NCT00630734|4076484|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4252432|NCT00630734|4076485|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4252433|NCT00630734|4076486|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4252434|NCT00630734|4076487|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4252435|NCT00630734|4076484|B4||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4252436|NCT00630734|4076485|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4252437|NCT00630734|4076486|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4252438|NCT00630734|4076487|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4252439|NCT00630734|4076484|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252440|NCT00630734|4076485|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252441|NCT00630734|4076486|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252442|NCT00630734|4076487|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252443|NCT00630539|4076524|B5|||Alcohol||drinks/week|Mean|1.4|1.4|Standard Deviation|2.1|2.1|||
4252444|NCT00630539|4076525|B4|||Alcohol||drinks/week|Mean|1.5|1.5|Standard Deviation|2.3|2.3|||
4252445|NCT00630539|4076526|B3|||Alcohol||drinks/week|Mean|1.2|1.2|Standard Deviation|1.7|1.7|||
4252446|NCT00630539|4076527|B2|||Alcohol||drinks/week|Mean|1.8|1.8|Standard Deviation|2.4|2.4|||
4252447|NCT00630539|4076528|B1|||Alcohol||drinks/week|Mean|0.9|0.9|Standard Deviation|1.9|1.9|||
4252448|NCT00630539|4076524|B5|||BMI||kg/m^2|Mean|25.61|25.61|Standard Deviation|3.90|3.9|||
4252449|NCT00630539|4076525|B4|||BMI||kg/m^2|Mean|25.28|25.28|Standard Deviation|3.20|3.2|||
4252450|NCT00630539|4076526|B3|||BMI||kg/m^2|Mean|25.50|25.5|Standard Deviation|4.99|4.99|||
4252451|NCT00630539|4076527|B2|||BMI||kg/m^2|Mean|24.78|24.78|Standard Deviation|3.44|3.44|||
4252452|NCT00630539|4076528|B1|||BMI||kg/m^2|Mean|26.89|26.89|Standard Deviation|3.95|3.95|||
4252453|NCT00630539|4076524|B5|||Height||m|Mean|1.626|1.626|Standard Deviation|0.055|0.055|||
4252454|NCT00630539|4076525|B4|||Height||m|Mean|1.617|1.617|Standard Deviation|.058|0.058|||
4252455|NCT00630539|4076526|B3|||Height||m|Mean|1.641|1.641|Standard Deviation|.062|0.062|||
4252456|NCT00630539|4076527|B2|||Height||m|Mean|1.636|1.636|Standard Deviation|.051|0.051|||
4252457|NCT00630539|4076528|B1|||Height||m|Mean|1.609|1.609|Standard Deviation|0.049|0.049|||
4252458|NCT00630539|4076524|B5|||Weight||kg|Mean|67.7|67.7|Standard Deviation|10.4|10.4|||
4252459|NCT00630539|4076525|B4|||Weight||kg|Mean|65.9|65.9|Standard Deviation|7.4|7.4|||
4252460|NCT00630539|4076526|B3|||Weight||kg|Mean|68.7|68.7|Standard Deviation|13.5|13.5|||
4252461|NCT00630539|4076527|B2|||Weight||kg|Mean|66.5|66.5|Standard Deviation|10.6|10.6|||
4252462|NCT00630539|4076528|B1|||Weight||kg|Mean|69.6|69.6|Standard Deviation|10.1|10.1|||
4252463|NCT00630539|4076524|B5|Participants||Race/Ethnicity, Customized||participants|Number|126|126.0||||||
4252464|NCT00630539|4076525|B4|Participants||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4252465|NCT00630539|4076526|B3|Participants||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4252466|NCT00630539|4076527|B2|Participants||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4252467|NCT00630539|4076528|B1|Participants||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4252468|NCT00630539|4076524|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4252469|NCT00630539|4076525|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4252470|NCT00630539|4076526|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4252471|NCT00630539|4076527|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4252472|NCT00630539|4076528|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4252473|NCT00630539|4076524|B5||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4252474|NCT00630539|4076525|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4252475|NCT00630539|4076526|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4252476|NCT00630539|4076527|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4252477|NCT00630539|4076528|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4252478|NCT00630539|4076524|B5|||Age||years|Mean|62.4|62.4|Standard Deviation|6.4|6.4|||
4252479|NCT00630539|4076525|B4|||Age||years|Mean|62.0|62.0|Standard Deviation|6.8|6.8|||
4252480|NCT00630539|4076526|B3|||Age||years|Mean|63.4|63.4|Standard Deviation|7.1|7.1|||
4252481|NCT00630539|4076527|B2|||Age||years|Mean|61.5|61.5|Standard Deviation|5.6|5.6|||
4252482|NCT00630539|4076528|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|6.0|6.0|||
4252483|NCT00630409|4076622|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4252484|NCT00630409|4076622|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4252485|NCT00630409|4076622|B1|||Age||years|Median|59|59.0|Full Range|||47.0|73.0|
4252486|NCT00630396|4076627|B1|||Symptom onset to study drug infusion time|"This is the average time from when the patient was last known to be normal to the moment the study drug began infusing intravenously."|minutes|Mean|307.4|307.4|Standard Deviation|50.0|50.0|||
4252487|NCT00630396|4076627|B1|||NIH Stroke Scale at baseline|The National Institutes of Health (NIH) Stroke Scale was designed to assess, score, and reliably communicate the level of impairment in a stroke patient. The maximum score is a 42, and the minimum score is a 0. A 42 represents the most severe stroke as scored by the NIH Stroke Scale.|Units on a scale|Mean|8.7|8.7|Standard Deviation|5.8|5.8|||
4252488|NCT00630396|4076627|B1|Total amount of subjects that did not receive t-PA||Subjects receiving t-PA then minocycline|Patients that received tissue plasminogen activator (tPA) were also eligible for the MINOS trial. Once tPA had finished infusing, the research team would commence with the study drug infusion.|Participants|Number|24|24.0||||||
4252489|NCT00630396|4076627|B1|Total amount of subjects that received t-PA||Subjects receiving t-PA then minocycline|Patients that received tissue plasminogen activator (tPA) were also eligible for the MINOS trial. Once tPA had finished infusing, the research team would commence with the study drug infusion.|Participants|Number|36|36.0||||||
4252490|NCT00630396|4076627|B1|||Weight||Kg|Mean|81.6|81.6|Standard Deviation|21.6|21.6|||
4252491|NCT00630396|4076627|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4252492|NCT00630396|4076627|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4252493|NCT00630396|4076627|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4252494|NCT00630396|4076627|B1||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4252495|NCT00630396|4076627|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4252496|NCT00630396|4076627|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4252497|NCT00630396|4076627|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4252498|NCT00630396|4076627|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4252499|NCT00630396|4076627|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4252500|NCT00630396|4076627|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4252501|NCT00630396|4076627|B1|Overall age||Age||years|Mean|65|65.0|Standard Deviation|13.7|13.7|||
4252502|NCT00630396|4076627|B1||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4252503|NCT00630396|4076627|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4252504|NCT00630396|4076627|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252505|NCT00630344|4076633|B1|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
4252506|NCT00630344|4076633|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4252507|NCT00630344|4076633|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4252508|NCT00630344|4076633|B1|||Age||years|Median|68|68.0|Inter-Quartile Range|||60.0|72.0|
4252509|NCT00630344|4076633|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4252510|NCT00630344|4076633|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4252511|NCT00630344|4076633|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252512|NCT00630331|4076642|B4|Not Available||Sex/Gender, Customized||Subjects|Number|3|3.0||||||
4252513|NCT00630331|4076643|B3|Not Available||Sex/Gender, Customized||Subjects|Number|2|2.0||||||
4252514|NCT00630331|4076644|B2|Not Available||Sex/Gender, Customized||Subjects|Number|1|1.0||||||
4252515|NCT00630331|4076645|B1|Not Available||Sex/Gender, Customized||Subjects|Number|0|0.0||||||
4252516|NCT00630331|4076642|B4|Male||Sex/Gender, Customized||Subjects|Number|5111|5111.0||||||
4252517|NCT00630331|4076643|B3|Male||Sex/Gender, Customized||Subjects|Number|1722|1722.0||||||
4252518|NCT00630331|4076644|B2|Male||Sex/Gender, Customized||Subjects|Number|1649|1649.0||||||
4252519|NCT00630331|4076645|B1|Male||Sex/Gender, Customized||Subjects|Number|1740|1740.0||||||
4252520|NCT00630331|4076642|B4|Female||Sex/Gender, Customized||Subjects|Number|6290|6290.0||||||
4252521|NCT00630331|4076643|B3|Female||Sex/Gender, Customized||Subjects|Number|2176|2176.0||||||
4252522|NCT00630331|4076644|B2|Female||Sex/Gender, Customized||Subjects|Number|2026|2026.0||||||
4252523|NCT00630331|4076645|B1|Female||Sex/Gender, Customized||Subjects|Number|2088|2088.0||||||
4252524|NCT00630331|4076642|B4|||Age||years|Mean|32.8|32.8|Standard Deviation|10.2|10.2|||
4252525|NCT00630331|4076643|B3|||Age||years|Mean|32.7|32.7|Standard Deviation|10.2|10.2|||
4252526|NCT00630331|4076644|B2|||Age||years|Mean|33.0|33.0|Standard Deviation|10.2|10.2|||
4252527|NCT00630331|4076645|B1|||Age||years|Mean|32.7|32.7|Standard Deviation|10.1|10.1|||
4252528|NCT00630305|4076688|B1|Australia||Region of Enrollment||participants|Number|37|37.0||||||
4252529|NCT00630305|4076688|B1||Male|Gender||Participants|Count of Participants|12|12.0||||||
4252530|NCT00630305|4076688|B1||Female|Gender||Participants|Count of Participants|25|25.0||||||
4252531|NCT00630305|4076688|B1|||Age||years|Mean|25.9|25.9|Standard Deviation|7.7|7.7|||
4252532|NCT00630305|4076688|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4252533|NCT00630305|4076688|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4252534|NCT00630305|4076688|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252535|NCT00630292|4076710|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4252536|NCT00630292|4076710|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4252537|NCT00630292|4076710|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4252538|NCT00630292|4076710|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|5.49|5.49|||
4252539|NCT00630292|4076710|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4252540|NCT00630292|4076710|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4252541|NCT00630292|4076710|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252542|NCT00630058|4076714|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4252543|NCT00630058|4076715|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4252544|NCT00630058|4076716|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4252545|NCT00630058|4076714|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4252546|NCT00630058|4076715|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4252547|NCT00630058|4076716|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4252548|NCT00630058|4076714|B3|||Age||years|Mean|52.2|52.2|Standard Deviation|7.8|7.8|||
4252549|NCT00630058|4076715|B2|||Age||years|Mean|54.3|54.3|Standard Deviation|8.5|8.5|||
4252550|NCT00630058|4076716|B1|||Age||years|Mean|50.1|50.1|Standard Deviation|6.8|6.8|||
4252551|NCT00629850|4076733|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4252552|NCT00629850|4076734|B2|United States||Region of Enrollment||participants|Number|0|0.0||||||
4252553|NCT00629850|4076735|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4252554|NCT00629850|4076733|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4252555|NCT00629850|4076734|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4252556|NCT00629850|4076735|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4252557|NCT00629850|4076733|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4252558|NCT00629850|4076734|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4252559|NCT00629850|4076735|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4252560|NCT00629850|4076733|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4252561|NCT00629850|4076734|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4252562|NCT00629850|4076735|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4252563|NCT00629850|4076733|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4252564|NCT00629850|4076734|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4252565|NCT00629850|4076735|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4252566|NCT00629850|4076733|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252567|NCT00629850|4076734|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252568|NCT00629850|4076735|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252569|NCT00629772|4076746|B3|||Palmoplantar Psoriasis Surface Area PPSA|Efficacy by comparing the mean percent PPSA. The surface affected by psoriasis on palms and soles is estimated on the day of the visit as a percentage of the total surface of palms and soles affected by psoriasis. Each palm represents 20% and each sole 30%. As a rule of thumb half a palm equals 10% of the total surface area of palm and soles. A sole completely covered with psoriasis would have a PPSA of 30% (if the other sole and the palms are unaffected) while a palm completely covered with psoriasis would have a PPSA of 20% (if the other palm and the soles are unaffected).|Percentage of affected area|Mean|38.8|38.8|Standard Deviation|20.9|20.9|||
4252570|NCT00629772|4076747|B2|||Palmoplantar Psoriasis Surface Area PPSA|Efficacy by comparing the mean percent PPSA. The surface affected by psoriasis on palms and soles is estimated on the day of the visit as a percentage of the total surface of palms and soles affected by psoriasis. Each palm represents 20% and each sole 30%. As a rule of thumb half a palm equals 10% of the total surface area of palm and soles. A sole completely covered with psoriasis would have a PPSA of 30% (if the other sole and the palms are unaffected) while a palm completely covered with psoriasis would have a PPSA of 20% (if the other palm and the soles are unaffected).|Percentage of affected area|Mean|37.1|37.1|Standard Deviation|21.0|21.0|||
4252571|NCT00629772|4076748|B1|||Palmoplantar Psoriasis Surface Area PPSA|Efficacy by comparing the mean percent PPSA. The surface affected by psoriasis on palms and soles is estimated on the day of the visit as a percentage of the total surface of palms and soles affected by psoriasis. Each palm represents 20% and each sole 30%. As a rule of thumb half a palm equals 10% of the total surface area of palm and soles. A sole completely covered with psoriasis would have a PPSA of 30% (if the other sole and the palms are unaffected) while a palm completely covered with psoriasis would have a PPSA of 20% (if the other palm and the soles are unaffected).|Percentage of affected area|Mean|40.4|40.4|Standard Deviation|21.6|21.6|||
4252572|NCT00629772|4076746|B3|||Physician's Global Assessment (PGA)|"Efficacy by comparing the mean Physician's Global Assessment(PGA).~0 = clear~1 = almost clear~2 = Mild~3 = Moderate~4 = Severe~5 = Very severe"|Units on as scale|Mean|3.7|3.7|Standard Deviation|0.6|0.6|||
4252573|NCT00629772|4076747|B2|||Physician's Global Assessment (PGA)|"Efficacy by comparing the mean Physician's Global Assessment(PGA).~0 = clear~1 = almost clear~2 = Mild~3 = Moderate~4 = Severe~5 = Very severe"|Units on as scale|Mean|3.5|3.5|Standard Deviation|0.7|0.7|||
4252574|NCT00629772|4076748|B1|||Physician's Global Assessment (PGA)|"Efficacy by comparing the mean Physician's Global Assessment(PGA).~0 = clear~1 = almost clear~2 = Mild~3 = Moderate~4 = Severe~5 = Very severe"|Units on as scale|Mean|3.8|3.8|Standard Deviation|0.6|0.6|||
4252575|NCT00629772|4076746|B3|||Dermatology Life Quality Index (DLQI)|"Impact on quality of life with the Dermatology Life Quality Index (DLQI) The aim of the questionnaire is to measure how much a patient's skin problem has affected their life over the previous week.~0-1 = no effect at all on patient's life~2-5 = small effect on patient's life~6-10 = moderate effect on patient's life~11-20 = very large effect on patient's life~21-30 = extremely large effect on patient's life"|Units on a scale|Mean|10.8|10.8|Standard Deviation|5.8|5.8|||
4252576|NCT00629772|4076747|B2|||Dermatology Life Quality Index (DLQI)|"Impact on quality of life with the Dermatology Life Quality Index (DLQI) The aim of the questionnaire is to measure how much a patient's skin problem has affected their life over the previous week.~0-1 = no effect at all on patient's life~2-5 = small effect on patient's life~6-10 = moderate effect on patient's life~11-20 = very large effect on patient's life~21-30 = extremely large effect on patient's life"|Units on a scale|Mean|9.8|9.8|Standard Deviation|4.4|4.4|||
4252577|NCT00629772|4076748|B1|||Dermatology Life Quality Index (DLQI)|"Impact on quality of life with the Dermatology Life Quality Index (DLQI) The aim of the questionnaire is to measure how much a patient's skin problem has affected their life over the previous week.~0-1 = no effect at all on patient's life~2-5 = small effect on patient's life~6-10 = moderate effect on patient's life~11-20 = very large effect on patient's life~21-30 = extremely large effect on patient's life"|Units on a scale|Mean|11.9|11.9|Standard Deviation|6.9|6.9|||
4252578|NCT00629772|4076746|B3|||Modified Palmoplantar Pustulosis Area and Severity Index (m-PPPASI)|"m-PPPASI = (E + I + D) Area X 0.2 (R palm) + (E + I + D) Area X 0.2 (L palm) + (E + I + D) Area X 0.3 (R sole) + (E + I + D) Area X 0.3 (L sole).~Erythema, induration and desquamation are evaluated on a scale of 0 to 4 while area is evaluated on a scale of 0 to 6. The PPASI score can vary from 0 (absence of disease) to 72 (most severe palmoplantar psoriasis possible)."|Units on a scale|Mean|25.4|25.4|Standard Deviation|11.7|11.7|||
4252579|NCT00629772|4076747|B2|||Modified Palmoplantar Pustulosis Area and Severity Index (m-PPPASI)|"m-PPPASI = (E + I + D) Area X 0.2 (R palm) + (E + I + D) Area X 0.2 (L palm) + (E + I + D) Area X 0.3 (R sole) + (E + I + D) Area X 0.3 (L sole).~Erythema, induration and desquamation are evaluated on a scale of 0 to 4 while area is evaluated on a scale of 0 to 6. The PPASI score can vary from 0 (absence of disease) to 72 (most severe palmoplantar psoriasis possible)."|Units on a scale|Mean|24.1|24.1|Standard Deviation|11.4|11.4|||
4252580|NCT00629772|4076748|B1|||Modified Palmoplantar Pustulosis Area and Severity Index (m-PPPASI)|"m-PPPASI = (E + I + D) Area X 0.2 (R palm) + (E + I + D) Area X 0.2 (L palm) + (E + I + D) Area X 0.3 (R sole) + (E + I + D) Area X 0.3 (L sole).~Erythema, induration and desquamation are evaluated on a scale of 0 to 4 while area is evaluated on a scale of 0 to 6. The PPASI score can vary from 0 (absence of disease) to 72 (most severe palmoplantar psoriasis possible)."|Units on a scale|Mean|26.7|26.7|Standard Deviation|12.4|12.4|||
4252581|NCT00629772|4076746|B3|Canada||Region of Enrollment||participants|Number|24|24.0||||||
4252582|NCT00629772|4076747|B2|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4252583|NCT00629772|4076748|B1|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4252584|NCT00629772|4076746|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4252585|NCT00629772|4076747|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4252586|NCT00629772|4076748|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4252587|NCT00629772|4076746|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4252588|NCT00629772|4076747|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4252589|NCT00629772|4076748|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4252590|NCT00629772|4076746|B3|||Age||years|Mean|53.87|53.87|Standard Deviation|13.92|13.92|||
4252591|NCT00629772|4076747|B2|||Age||years|Mean|57.83|57.83|Standard Deviation|12.42|12.42|||
4252592|NCT00629772|4076748|B1|||Age||years|Mean|49.92|49.92|Standard Deviation|14.74|14.74|||
4252593|NCT00629772|4076746|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4252594|NCT00629772|4076747|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4252595|NCT00629772|4076748|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4252596|NCT00629772|4076746|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4252597|NCT00629772|4076747|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4252598|NCT00629772|4076748|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4252599|NCT00629772|4076746|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252600|NCT00629772|4076747|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252601|NCT00629772|4076748|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252602|NCT00629707|4076767|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4252603|NCT00629707|4076768|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4252604|NCT00629707|4076769|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4252605|NCT00629707|4076767|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4252606|NCT00629707|4076768|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4252607|NCT00629707|4076769|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4252608|NCT00629707|4076767|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4252609|NCT00629707|4076768|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4252610|NCT00629707|4076769|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4252611|NCT00629707|4076767|B3|||Age||years|Mean|12.9|12.9|Standard Deviation|3.1|3.1|||
4252612|NCT00629707|4076768|B2|||Age||years|Mean|11.4|11.4|Standard Deviation|1.8|1.8|||
4252613|NCT00629707|4076769|B1|||Age||years|Mean|14.2|14.2|Standard Deviation|3.4|3.4|||
4252614|NCT00629707|4076767|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4252615|NCT00629707|4076768|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4252616|NCT00629707|4076769|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4252617|NCT00629707|4076767|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4252618|NCT00629707|4076768|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4252619|NCT00629707|4076769|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4252620|NCT00629707|4076767|B3||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
4252621|NCT00629707|4076768|B2||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4252622|NCT00629707|4076769|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4252623|NCT00629525|4076776|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4252624|NCT00629525|4076776|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4252625|NCT00629525|4076776|B1|||Age||years|Median|71|71.0|Full Range|||52.0|91.0|
4252626|NCT00629499|4076784|B1|United States||Region of Enrollment||participants|Number|63|63.0||||||
4252627|NCT00629499|4076784|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4252628|NCT00629499|4076784|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4252629|NCT00629499|4076784|B1|||Age||years|Median|57|57.0|Full Range|||27.0|78.0|
4252630|NCT00629265|4076788|B3|United States||Region of Enrollment||participants|Number|170|170.0||||||
4252631|NCT00629265|4076789|B2|United States||Region of Enrollment||participants|Number|54|54.0||||||
4252632|NCT00629265|4076790|B1|United States||Region of Enrollment||participants|Number|116|116.0||||||
4252633|NCT00629265|4076788|B3||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4252634|NCT00629265|4076789|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4252635|NCT00629265|4076790|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4252636|NCT00629265|4076788|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4252637|NCT00629265|4076789|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4252638|NCT00629265|4076790|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4252639|NCT00629265|4076788|B3|||Age||years|Mean|61.9|61.9|Standard Deviation|9.6|9.6|||
4252640|NCT00629265|4076789|B2|||Age||years|Mean|61.5|61.5|Standard Deviation|10.6|10.6|||
4252641|NCT00629265|4076790|B1|||Age||years|Mean|62.1|62.1|Standard Deviation|9.2|9.2|||
4252642|NCT00629239|4076799|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4252643|NCT00629239|4076800|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4252644|NCT00629239|4076801|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4252645|NCT00629239|4076799|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4252646|NCT00629239|4076800|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4252647|NCT00629239|4076801|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4252648|NCT00629239|4076799|B3|||Age||years|Mean|65|65.0|Full Range|||42.0|78.0|
4252649|NCT00629239|4076800|B2|||Age||years|Mean|66|66.0|Full Range|||42.0|77.0|
4252650|NCT00629239|4076801|B1|||Age||years|Mean|65|65.0|Full Range|||51.0|78.0|
4252651|NCT00629122|4076834|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4252652|NCT00629122|4076835|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4252653|NCT00629122|4076836|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4252654|NCT00629122|4076834|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4252655|NCT00629122|4076835|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4252656|NCT00629122|4076836|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4252657|NCT00629122|4076834|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4252658|NCT00629122|4076835|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4252659|NCT00629122|4076836|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4252660|NCT00629122|4076834|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4252661|NCT00629122|4076835|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4252662|NCT00629122|4076836|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4252663|NCT00629122|4076834|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4252664|NCT00629122|4076835|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4252665|NCT00629122|4076836|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4252666|NCT00629122|4076834|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252667|NCT00629122|4076835|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252668|NCT00629122|4076836|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252669|NCT00629018|4076853|B3|Slovenia||Region of Enrollment||participants|Number|110|110.0||||||
4252670|NCT00629018|4076854|B2|Slovenia||Region of Enrollment||participants|Number|55|55.0||||||
4252671|NCT00629018|4076855|B1|Slovenia||Region of Enrollment||participants|Number|55|55.0||||||
4252672|NCT00629018|4076853|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4252673|NCT00629018|4076854|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4252674|NCT00629018|4076855|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4252675|NCT00629018|4076853|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4252676|NCT00629018|4076854|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4252677|NCT00629018|4076855|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4252678|NCT00629018|4076853|B3|||Age||years|Mean|54|54.0|Standard Deviation|9|9.0|||
4252679|NCT00629018|4076854|B2|||Age||years|Mean|55|55.0|Standard Deviation|7|7.0|||
4252680|NCT00629018|4076855|B1|||Age||years|Mean|53|53.0|Standard Deviation|8|8.0|||
4252681|NCT00629018|4076853|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4252682|NCT00629018|4076854|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4252683|NCT00629018|4076855|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4252684|NCT00629018|4076853|B3||Between 18 and 65 years|Age||Participants|Count of Participants|105|105.0||||||
4252685|NCT00629018|4076854|B2||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4252686|NCT00629018|4076855|B1||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4252687|NCT00629018|4076853|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252688|NCT00629018|4076854|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252689|NCT00629018|4076855|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252690|NCT00628927|4076864|B3|United States||Region of Enrollment||participants|Number|213|213.0||||||
4252691|NCT00628927|4076865|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4252692|NCT00628927|4076866|B1|United States||Region of Enrollment||participants|Number|183|183.0||||||
4252693|NCT00628927|4076864|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4252694|NCT00628927|4076865|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4252695|NCT00628927|4076866|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4252696|NCT00628927|4076864|B3||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4252697|NCT00628927|4076865|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4252698|NCT00628927|4076866|B1||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4252699|NCT00628927|4076864|B3|||Age||years|Mean|39.4|39.4|Standard Deviation|9.5|9.5|||
4252700|NCT00628927|4076865|B2|||Age||years|Mean|44.5|44.5|Standard Deviation|9.5|9.5|||
4252701|NCT00628927|4076866|B1|||Age||years|Mean|38.6|38.6|Standard Deviation|9.3|9.3|||
4252702|NCT00628927|4076864|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4252703|NCT00628927|4076865|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4252704|NCT00628927|4076866|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4252705|NCT00628927|4076864|B3||Between 18 and 65 years|Age||Participants|Count of Participants|213|213.0||||||
4252706|NCT00628927|4076865|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4252707|NCT00628927|4076866|B1||Between 18 and 65 years|Age||Participants|Count of Participants|183|183.0||||||
4252708|NCT00628927|4076864|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252709|NCT00628927|4076865|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252710|NCT00628927|4076866|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252711|NCT00628901|4076878|B3|||Maximal Thickness of the myometrium||mm|Mean|25.9|25.9|Standard Deviation|7.8|7.8|||
4252712|NCT00628901|4076879|B2|||Maximal Thickness of the myometrium||mm|Mean|25.0|25.0|Standard Deviation|7.4|7.4|||
4252713|NCT00628901|4076880|B1|||Maximal Thickness of the myometrium||mm|Mean|26.8|26.8|Standard Deviation|8.1|8.1|||
4252714|NCT00628901|4076878|B3|No||Obvious contribution to the uterine blood supply from the ovarian artery||participants|Number|59|59.0||||||
4252715|NCT00628901|4076879|B2|No||Obvious contribution to the uterine blood supply from the ovarian artery||participants|Number|29|29.0||||||
4252716|NCT00628901|4076880|B1|No||Obvious contribution to the uterine blood supply from the ovarian artery||participants|Number|30|30.0||||||
4252717|NCT00628901|4076878|B3|Yes||Obvious contribution to the uterine blood supply from the ovarian artery||participants|Number|1|1.0||||||
4252718|NCT00628901|4076879|B2|Yes||Obvious contribution to the uterine blood supply from the ovarian artery||participants|Number|1|1.0||||||
4252719|NCT00628901|4076880|B1|Yes||Obvious contribution to the uterine blood supply from the ovarian artery||participants|Number|0|0.0||||||
4252720|NCT00628901|4076878|B3|Other||Adnexal Pathology|"This measure contains the number of subjects with adnexal pathology noted. If adnexal pathology was noted, it was further classified to be endometrioma/endometriosis, cyst, or other.~Not all subjects had adnexal pathology noted. The sum for all categories in the arm/group does not equal the overall number of participants in the group."|participants|Number|2|2.0||||||
4252721|NCT00628901|4076879|B2|Other||Adnexal Pathology|"This measure contains the number of subjects with adnexal pathology noted. If adnexal pathology was noted, it was further classified to be endometrioma/endometriosis, cyst, or other.~Not all subjects had adnexal pathology noted. The sum for all categories in the arm/group does not equal the overall number of participants in the group."|participants|Number|0|0.0||||||
4252722|NCT00628901|4076880|B1|Other||Adnexal Pathology|"This measure contains the number of subjects with adnexal pathology noted. If adnexal pathology was noted, it was further classified to be endometrioma/endometriosis, cyst, or other.~Not all subjects had adnexal pathology noted. The sum for all categories in the arm/group does not equal the overall number of participants in the group."|participants|Number|2|2.0||||||
4252723|NCT00628901|4076878|B3|Cyst||Adnexal Pathology|"This measure contains the number of subjects with adnexal pathology noted. If adnexal pathology was noted, it was further classified to be endometrioma/endometriosis, cyst, or other.~Not all subjects had adnexal pathology noted. The sum for all categories in the arm/group does not equal the overall number of participants in the group."|participants|Number|5|5.0||||||
4252724|NCT00628901|4076879|B2|Cyst||Adnexal Pathology|"This measure contains the number of subjects with adnexal pathology noted. If adnexal pathology was noted, it was further classified to be endometrioma/endometriosis, cyst, or other.~Not all subjects had adnexal pathology noted. The sum for all categories in the arm/group does not equal the overall number of participants in the group."|participants|Number|2|2.0||||||
4252725|NCT00628901|4076880|B1|Cyst||Adnexal Pathology|"This measure contains the number of subjects with adnexal pathology noted. If adnexal pathology was noted, it was further classified to be endometrioma/endometriosis, cyst, or other.~Not all subjects had adnexal pathology noted. The sum for all categories in the arm/group does not equal the overall number of participants in the group."|participants|Number|3|3.0||||||
4252726|NCT00628901|4076878|B3|Endometrioma/Endometriosis||Adnexal Pathology|"This measure contains the number of subjects with adnexal pathology noted. If adnexal pathology was noted, it was further classified to be endometrioma/endometriosis, cyst, or other.~Not all subjects had adnexal pathology noted. The sum for all categories in the arm/group does not equal the overall number of participants in the group."|participants|Number|1|1.0||||||
4252727|NCT00628901|4076879|B2|Endometrioma/Endometriosis||Adnexal Pathology|"This measure contains the number of subjects with adnexal pathology noted. If adnexal pathology was noted, it was further classified to be endometrioma/endometriosis, cyst, or other.~Not all subjects had adnexal pathology noted. The sum for all categories in the arm/group does not equal the overall number of participants in the group."|participants|Number|1|1.0||||||
4252728|NCT00628901|4076880|B1|Endometrioma/Endometriosis||Adnexal Pathology|"This measure contains the number of subjects with adnexal pathology noted. If adnexal pathology was noted, it was further classified to be endometrioma/endometriosis, cyst, or other.~Not all subjects had adnexal pathology noted. The sum for all categories in the arm/group does not equal the overall number of participants in the group."|participants|Number|0|0.0||||||
4252729|NCT00628901|4076878|B3|No||Ovaries seen||participants|Number|2|2.0||||||
4252730|NCT00628901|4076879|B2|No||Ovaries seen||participants|Number|1|1.0||||||
4252731|NCT00628901|4076880|B1|No||Ovaries seen||participants|Number|1|1.0||||||
4252732|NCT00628901|4076878|B3|Yes||Ovaries seen||participants|Number|58|58.0||||||
4252733|NCT00628901|4076879|B2|Yes||Ovaries seen||participants|Number|29|29.0||||||
4252734|NCT00628901|4076880|B1|Yes||Ovaries seen||participants|Number|29|29.0||||||
4252735|NCT00628901|4076878|B3|Severly Decreased/Infarcted||Assessment of myometrial perfusion||participants|Number|0|0.0||||||
4252736|NCT00628901|4076879|B2|Severly Decreased/Infarcted||Assessment of myometrial perfusion||participants|Number|0|0.0||||||
4252737|NCT00628901|4076880|B1|Severly Decreased/Infarcted||Assessment of myometrial perfusion||participants|Number|0|0.0||||||
4252738|NCT00628901|4076878|B3|Moderately Decreased||Assessment of myometrial perfusion||participants|Number|0|0.0||||||
4252739|NCT00628901|4076879|B2|Moderately Decreased||Assessment of myometrial perfusion||participants|Number|0|0.0||||||
4252740|NCT00628901|4076880|B1|Moderately Decreased||Assessment of myometrial perfusion||participants|Number|0|0.0||||||
4252741|NCT00628901|4076878|B3|Mildly Decreased||Assessment of myometrial perfusion||participants|Number|1|1.0||||||
4252742|NCT00628901|4076879|B2|Mildly Decreased||Assessment of myometrial perfusion||participants|Number|1|1.0||||||
4252743|NCT00628901|4076880|B1|Mildly Decreased||Assessment of myometrial perfusion||participants|Number|0|0.0||||||
4252744|NCT00628901|4076878|B3|Normal||Assessment of myometrial perfusion||participants|Number|58|58.0||||||
4252745|NCT00628901|4076879|B2|Normal||Assessment of myometrial perfusion||participants|Number|28|28.0||||||
4252746|NCT00628901|4076880|B1|Normal||Assessment of myometrial perfusion||participants|Number|30|30.0||||||
4252747|NCT00628901|4076878|B3|No||Presence of myometrial scar||participants|Number|46|46.0||||||
4252748|NCT00628901|4076879|B2|No||Presence of myometrial scar||participants|Number|23|23.0||||||
4252749|NCT00628901|4076880|B1|No||Presence of myometrial scar||participants|Number|23|23.0||||||
4252750|NCT00628901|4076878|B3|Yes||Presence of myometrial scar||participants|Number|14|14.0||||||
4252751|NCT00628901|4076879|B2|Yes||Presence of myometrial scar||participants|Number|7|7.0||||||
4252752|NCT00628901|4076880|B1|Yes||Presence of myometrial scar||participants|Number|7|7.0||||||
4252753|NCT00628901|4076878|B3|No||Presence of endometrial scar||participants|Number|60|60.0||||||
4252754|NCT00628901|4076879|B2|No||Presence of endometrial scar||participants|Number|30|30.0||||||
4252755|NCT00628901|4076880|B1|No||Presence of endometrial scar||participants|Number|30|30.0||||||
4252756|NCT00628901|4076878|B3|Yes||Presence of endometrial scar||participants|Number|0|0.0||||||
4252757|NCT00628901|4076879|B2|Yes||Presence of endometrial scar||participants|Number|0|0.0||||||
4252758|NCT00628901|4076880|B1|Yes||Presence of endometrial scar||participants|Number|0|0.0||||||
4252759|NCT00628901|4076878|B3|Cannot Determine||Concomitant adenomyosis|"This measure contains the number of subjects with concomitant adenomyosis. If concomitant adenomyosis was noted, it was further classified as focal or diffuse.~Not all subjects had concomitant adenomyosis noted. The sum for all categories in the arm/group does not equal the overall number of participants in the group, because the value only indicates if the measure was present."|participants|Number|0|0.0||||||
4252760|NCT00628901|4076879|B2|Cannot Determine||Concomitant adenomyosis|"This measure contains the number of subjects with concomitant adenomyosis. If concomitant adenomyosis was noted, it was further classified as focal or diffuse.~Not all subjects had concomitant adenomyosis noted. The sum for all categories in the arm/group does not equal the overall number of participants in the group, because the value only indicates if the measure was present."|participants|Number|0|0.0||||||
4252761|NCT00628901|4076880|B1|Cannot Determine||Concomitant adenomyosis|"This measure contains the number of subjects with concomitant adenomyosis. If concomitant adenomyosis was noted, it was further classified as focal or diffuse.~Not all subjects had concomitant adenomyosis noted. The sum for all categories in the arm/group does not equal the overall number of participants in the group, because the value only indicates if the measure was present."|participants|Number|0|0.0||||||
4252762|NCT00628901|4076878|B3|Diffuse||Concomitant adenomyosis|"This measure contains the number of subjects with concomitant adenomyosis. If concomitant adenomyosis was noted, it was further classified as focal or diffuse.~Not all subjects had concomitant adenomyosis noted. The sum for all categories in the arm/group does not equal the overall number of participants in the group, because the value only indicates if the measure was present."|participants|Number|4|4.0||||||
4252763|NCT00628901|4076879|B2|Diffuse||Concomitant adenomyosis|"This measure contains the number of subjects with concomitant adenomyosis. If concomitant adenomyosis was noted, it was further classified as focal or diffuse.~Not all subjects had concomitant adenomyosis noted. The sum for all categories in the arm/group does not equal the overall number of participants in the group, because the value only indicates if the measure was present."|participants|Number|2|2.0||||||
4252764|NCT00628901|4076880|B1|Diffuse||Concomitant adenomyosis|"This measure contains the number of subjects with concomitant adenomyosis. If concomitant adenomyosis was noted, it was further classified as focal or diffuse.~Not all subjects had concomitant adenomyosis noted. The sum for all categories in the arm/group does not equal the overall number of participants in the group, because the value only indicates if the measure was present."|participants|Number|2|2.0||||||
4252765|NCT00628901|4076878|B3|Focal||Concomitant adenomyosis|"This measure contains the number of subjects with concomitant adenomyosis. If concomitant adenomyosis was noted, it was further classified as focal or diffuse.~Not all subjects had concomitant adenomyosis noted. The sum for all categories in the arm/group does not equal the overall number of participants in the group, because the value only indicates if the measure was present."|participants|Number|12|12.0||||||
4252825|NCT00628901|4076878|B3|0 fibroids||Number of fibroids present less than 2 cm||participants|Number|6|6.0||||||
4252766|NCT00628901|4076879|B2|Focal||Concomitant adenomyosis|"This measure contains the number of subjects with concomitant adenomyosis. If concomitant adenomyosis was noted, it was further classified as focal or diffuse.~Not all subjects had concomitant adenomyosis noted. The sum for all categories in the arm/group does not equal the overall number of participants in the group, because the value only indicates if the measure was present."|participants|Number|5|5.0||||||
4252767|NCT00628901|4076880|B1|Focal||Concomitant adenomyosis|"This measure contains the number of subjects with concomitant adenomyosis. If concomitant adenomyosis was noted, it was further classified as focal or diffuse.~Not all subjects had concomitant adenomyosis noted. The sum for all categories in the arm/group does not equal the overall number of participants in the group, because the value only indicates if the measure was present."|participants|Number|7|7.0||||||
4252768|NCT00628901|4076878|B3|||Minimal thickness of the myometrium||mm|Mean|10.3|10.3|Standard Deviation|4.7|4.7|||
4252769|NCT00628901|4076879|B2|||Minimal thickness of the myometrium||mm|Mean|9.5|9.5|Standard Deviation|4.2|4.2|||
4252770|NCT00628901|4076880|B1|||Minimal thickness of the myometrium||mm|Mean|11.2|11.2|Standard Deviation|5.1|5.1|||
4252771|NCT00628901|4076878|B3|||Maximal thickness of the endometrium||mm|Mean|8.1|8.1|Standard Deviation|3.2|3.2|||
4252772|NCT00628901|4076879|B2|||Maximal thickness of the endometrium||mm|Mean|8.9|8.9|Standard Deviation|3.3|3.3|||
4252773|NCT00628901|4076880|B1|||Maximal thickness of the endometrium||mm|Mean|7.3|7.3|Standard Deviation|2.8|2.8|||
4252774|NCT00628901|4076878|B3|||Maximal thickness of junctional zone||mm|Mean|11.2|11.2|Standard Deviation|7.2|7.2|||
4252775|NCT00628901|4076879|B2|||Maximal thickness of junctional zone||mm|Mean|10.9|10.9|Standard Deviation|7.9|7.9|||
4252776|NCT00628901|4076880|B1|||Maximal thickness of junctional zone||mm|Mean|11.4|11.4|Standard Deviation|6.6|6.6|||
4252777|NCT00628901|4076878|B3|||Uterine Volume||cm^3|Mean|1514.2|1514.2|Standard Deviation|1214.5|1214.5|||
4252778|NCT00628901|4076879|B2|||Uterine Volume||cm^3|Mean|1491.6|1491.6|Standard Deviation|1456.5|1456.5|||
4252779|NCT00628901|4076880|B1|||Uterine Volume||cm^3|Mean|1536.7|1536.7|Standard Deviation|937.3|937.3|||
4252780|NCT00628901|4076878|B3|||Dominant fibroid volume||cm^3|Mean|172.2|172.2|Standard Deviation|232.5|232.5|||
4252781|NCT00628901|4076879|B2|||Dominant fibroid volume||cm^3|Mean|141.1|141.1|Standard Deviation|179.6|179.6|||
4252782|NCT00628901|4076880|B1|||Dominant fibroid volume||cm^3|Mean|203.3|203.3|Standard Deviation|275.1|275.1|||
4252783|NCT00628901|4076878|B3|Cannot determine||Type of fibroid present|The type of fibroid present is determined from the baseline MRI. A participant may have more than one type of fibroid present, thus the number may not add up to 30 per group or 60 total. The analysis indicates the number of participants with each type of fibroid, thus the sum for all categories in the arm/group does not equal the overall number of participants in the group.|participants|Number|0|0.0||||||
4252784|NCT00628901|4076879|B2|Cannot determine||Type of fibroid present|The type of fibroid present is determined from the baseline MRI. A participant may have more than one type of fibroid present, thus the number may not add up to 30 per group or 60 total. The analysis indicates the number of participants with each type of fibroid, thus the sum for all categories in the arm/group does not equal the overall number of participants in the group.|participants|Number|0|0.0||||||
4252785|NCT00628901|4076880|B1|Cannot determine||Type of fibroid present|The type of fibroid present is determined from the baseline MRI. A participant may have more than one type of fibroid present, thus the number may not add up to 30 per group or 60 total. The analysis indicates the number of participants with each type of fibroid, thus the sum for all categories in the arm/group does not equal the overall number of participants in the group.|participants|Number|0|0.0||||||
4252786|NCT00628901|4076878|B3|Other, specify||Type of fibroid present|The type of fibroid present is determined from the baseline MRI. A participant may have more than one type of fibroid present, thus the number may not add up to 30 per group or 60 total. The analysis indicates the number of participants with each type of fibroid, thus the sum for all categories in the arm/group does not equal the overall number of participants in the group.|participants|Number|0|0.0||||||
4252787|NCT00628901|4076879|B2|Other, specify||Type of fibroid present|The type of fibroid present is determined from the baseline MRI. A participant may have more than one type of fibroid present, thus the number may not add up to 30 per group or 60 total. The analysis indicates the number of participants with each type of fibroid, thus the sum for all categories in the arm/group does not equal the overall number of participants in the group.|participants|Number|0|0.0||||||
4252788|NCT00628901|4076880|B1|Other, specify||Type of fibroid present|The type of fibroid present is determined from the baseline MRI. A participant may have more than one type of fibroid present, thus the number may not add up to 30 per group or 60 total. The analysis indicates the number of participants with each type of fibroid, thus the sum for all categories in the arm/group does not equal the overall number of participants in the group.|participants|Number|0|0.0||||||
4252789|NCT00628901|4076878|B3|Transmural||Type of fibroid present|The type of fibroid present is determined from the baseline MRI. A participant may have more than one type of fibroid present, thus the number may not add up to 30 per group or 60 total. The analysis indicates the number of participants with each type of fibroid, thus the sum for all categories in the arm/group does not equal the overall number of participants in the group.|participants|Number|31|31.0||||||
4252790|NCT00628901|4076879|B2|Transmural||Type of fibroid present|The type of fibroid present is determined from the baseline MRI. A participant may have more than one type of fibroid present, thus the number may not add up to 30 per group or 60 total. The analysis indicates the number of participants with each type of fibroid, thus the sum for all categories in the arm/group does not equal the overall number of participants in the group.|participants|Number|17|17.0||||||
4252791|NCT00628901|4076880|B1|Transmural||Type of fibroid present|The type of fibroid present is determined from the baseline MRI. A participant may have more than one type of fibroid present, thus the number may not add up to 30 per group or 60 total. The analysis indicates the number of participants with each type of fibroid, thus the sum for all categories in the arm/group does not equal the overall number of participants in the group.|participants|Number|14|14.0||||||
4252826|NCT00628901|4076879|B2|0 fibroids||Number of fibroids present less than 2 cm||participants|Number|3|3.0||||||
4252827|NCT00628901|4076880|B1|0 fibroids||Number of fibroids present less than 2 cm||participants|Number|3|3.0||||||
4252792|NCT00628901|4076878|B3|Intramural||Type of fibroid present|The type of fibroid present is determined from the baseline MRI. A participant may have more than one type of fibroid present, thus the number may not add up to 30 per group or 60 total. The analysis indicates the number of participants with each type of fibroid, thus the sum for all categories in the arm/group does not equal the overall number of participants in the group.|participants|Number|56|56.0||||||
4252793|NCT00628901|4076879|B2|Intramural||Type of fibroid present|The type of fibroid present is determined from the baseline MRI. A participant may have more than one type of fibroid present, thus the number may not add up to 30 per group or 60 total. The analysis indicates the number of participants with each type of fibroid, thus the sum for all categories in the arm/group does not equal the overall number of participants in the group.|participants|Number|28|28.0||||||
4252794|NCT00628901|4076880|B1|Intramural||Type of fibroid present|The type of fibroid present is determined from the baseline MRI. A participant may have more than one type of fibroid present, thus the number may not add up to 30 per group or 60 total. The analysis indicates the number of participants with each type of fibroid, thus the sum for all categories in the arm/group does not equal the overall number of participants in the group.|participants|Number|28|28.0||||||
4252795|NCT00628901|4076878|B3|Subserosal||Type of fibroid present|The type of fibroid present is determined from the baseline MRI. A participant may have more than one type of fibroid present, thus the number may not add up to 30 per group or 60 total. The analysis indicates the number of participants with each type of fibroid, thus the sum for all categories in the arm/group does not equal the overall number of participants in the group.|participants|Number|50|50.0||||||
4252796|NCT00628901|4076879|B2|Subserosal||Type of fibroid present|The type of fibroid present is determined from the baseline MRI. A participant may have more than one type of fibroid present, thus the number may not add up to 30 per group or 60 total. The analysis indicates the number of participants with each type of fibroid, thus the sum for all categories in the arm/group does not equal the overall number of participants in the group.|participants|Number|24|24.0||||||
4252797|NCT00628901|4076880|B1|Subserosal||Type of fibroid present|The type of fibroid present is determined from the baseline MRI. A participant may have more than one type of fibroid present, thus the number may not add up to 30 per group or 60 total. The analysis indicates the number of participants with each type of fibroid, thus the sum for all categories in the arm/group does not equal the overall number of participants in the group.|participants|Number|26|26.0||||||
4252798|NCT00628901|4076878|B3|Submucosal||Type of fibroid present|The type of fibroid present is determined from the baseline MRI. A participant may have more than one type of fibroid present, thus the number may not add up to 30 per group or 60 total. The analysis indicates the number of participants with each type of fibroid, thus the sum for all categories in the arm/group does not equal the overall number of participants in the group.|participants|Number|36|36.0||||||
4252799|NCT00628901|4076879|B2|Submucosal||Type of fibroid present|The type of fibroid present is determined from the baseline MRI. A participant may have more than one type of fibroid present, thus the number may not add up to 30 per group or 60 total. The analysis indicates the number of participants with each type of fibroid, thus the sum for all categories in the arm/group does not equal the overall number of participants in the group.|participants|Number|20|20.0||||||
4252800|NCT00628901|4076880|B1|Submucosal||Type of fibroid present|The type of fibroid present is determined from the baseline MRI. A participant may have more than one type of fibroid present, thus the number may not add up to 30 per group or 60 total. The analysis indicates the number of participants with each type of fibroid, thus the sum for all categories in the arm/group does not equal the overall number of participants in the group.|participants|Number|16|16.0||||||
4252801|NCT00628901|4076878|B3|>10 fibroids||Number of fibroids present less than 2 cm||participants|Number|16|16.0||||||
4252802|NCT00628901|4076879|B2|>10 fibroids||Number of fibroids present less than 2 cm||participants|Number|9|9.0||||||
4252803|NCT00628901|4076880|B1|>10 fibroids||Number of fibroids present less than 2 cm||participants|Number|7|7.0||||||
4252804|NCT00628901|4076878|B3|7-10 fibroids||Number of fibroids present less than 2 cm||participants|Number|8|8.0||||||
4252805|NCT00628901|4076879|B2|7-10 fibroids||Number of fibroids present less than 2 cm||participants|Number|4|4.0||||||
4252806|NCT00628901|4076880|B1|7-10 fibroids||Number of fibroids present less than 2 cm||participants|Number|4|4.0||||||
4252807|NCT00628901|4076878|B3|6 fibroids||Number of fibroids present less than 2 cm||participants|Number|6|6.0||||||
4252808|NCT00628901|4076879|B2|6 fibroids||Number of fibroids present less than 2 cm||participants|Number|3|3.0||||||
4252809|NCT00628901|4076880|B1|6 fibroids||Number of fibroids present less than 2 cm||participants|Number|3|3.0||||||
4252810|NCT00628901|4076878|B3|5 fibroids||Number of fibroids present less than 2 cm||participants|Number|6|6.0||||||
4252811|NCT00628901|4076879|B2|5 fibroids||Number of fibroids present less than 2 cm||participants|Number|4|4.0||||||
4252812|NCT00628901|4076880|B1|5 fibroids||Number of fibroids present less than 2 cm||participants|Number|2|2.0||||||
4252813|NCT00628901|4076878|B3|4 fibroids||Number of fibroids present less than 2 cm||participants|Number|6|6.0||||||
4252814|NCT00628901|4076879|B2|4 fibroids||Number of fibroids present less than 2 cm||participants|Number|2|2.0||||||
4252815|NCT00628901|4076880|B1|4 fibroids||Number of fibroids present less than 2 cm||participants|Number|4|4.0||||||
4252816|NCT00628901|4076878|B3|3 fibroids||Number of fibroids present less than 2 cm||participants|Number|4|4.0||||||
4252817|NCT00628901|4076879|B2|3 fibroids||Number of fibroids present less than 2 cm||participants|Number|1|1.0||||||
4252818|NCT00628901|4076880|B1|3 fibroids||Number of fibroids present less than 2 cm||participants|Number|3|3.0||||||
4252819|NCT00628901|4076878|B3|2 fibroids||Number of fibroids present less than 2 cm||participants|Number|3|3.0||||||
4252820|NCT00628901|4076879|B2|2 fibroids||Number of fibroids present less than 2 cm||participants|Number|1|1.0||||||
4252821|NCT00628901|4076880|B1|2 fibroids||Number of fibroids present less than 2 cm||participants|Number|2|2.0||||||
4252822|NCT00628901|4076878|B3|1 fibroid||Number of fibroids present less than 2 cm||participants|Number|5|5.0||||||
4252823|NCT00628901|4076879|B2|1 fibroid||Number of fibroids present less than 2 cm||participants|Number|3|3.0||||||
4252824|NCT00628901|4076880|B1|1 fibroid||Number of fibroids present less than 2 cm||participants|Number|2|2.0||||||
4252828|NCT00628901|4076878|B3|>10 fibroids||Number of fibroids present greater than 2cm||particpants|Number|10|10.0||||||
4252829|NCT00628901|4076879|B2|>10 fibroids||Number of fibroids present greater than 2cm||particpants|Number|7|7.0||||||
4252830|NCT00628901|4076880|B1|>10 fibroids||Number of fibroids present greater than 2cm||particpants|Number|3|3.0||||||
4252831|NCT00628901|4076878|B3|7-10 fibroids||Number of fibroids present greater than 2cm||particpants|Number|11|11.0||||||
4252832|NCT00628901|4076879|B2|7-10 fibroids||Number of fibroids present greater than 2cm||particpants|Number|5|5.0||||||
4252833|NCT00628901|4076880|B1|7-10 fibroids||Number of fibroids present greater than 2cm||particpants|Number|6|6.0||||||
4252834|NCT00628901|4076878|B3|6 fibroids||Number of fibroids present greater than 2cm||particpants|Number|5|5.0||||||
4252835|NCT00628901|4076879|B2|6 fibroids||Number of fibroids present greater than 2cm||particpants|Number|2|2.0||||||
4252836|NCT00628901|4076880|B1|6 fibroids||Number of fibroids present greater than 2cm||particpants|Number|3|3.0||||||
4252837|NCT00628901|4076878|B3|5 fibroids||Number of fibroids present greater than 2cm||particpants|Number|4|4.0||||||
4252838|NCT00628901|4076879|B2|5 fibroids||Number of fibroids present greater than 2cm||particpants|Number|2|2.0||||||
4252839|NCT00628901|4076880|B1|5 fibroids||Number of fibroids present greater than 2cm||particpants|Number|2|2.0||||||
4252840|NCT00628901|4076878|B3|4 fibroids||Number of fibroids present greater than 2cm||particpants|Number|4|4.0||||||
4252841|NCT00628901|4076879|B2|4 fibroids||Number of fibroids present greater than 2cm||particpants|Number|2|2.0||||||
4252842|NCT00628901|4076880|B1|4 fibroids||Number of fibroids present greater than 2cm||particpants|Number|2|2.0||||||
4252843|NCT00628901|4076878|B3|3 fibroids||Number of fibroids present greater than 2cm||particpants|Number|14|14.0||||||
4252844|NCT00628901|4076879|B2|3 fibroids||Number of fibroids present greater than 2cm||particpants|Number|4|4.0||||||
4252845|NCT00628901|4076880|B1|3 fibroids||Number of fibroids present greater than 2cm||particpants|Number|10|10.0||||||
4252846|NCT00628901|4076878|B3|2 fibroids||Number of fibroids present greater than 2cm||particpants|Number|7|7.0||||||
4252847|NCT00628901|4076879|B2|2 fibroids||Number of fibroids present greater than 2cm||particpants|Number|5|5.0||||||
4252848|NCT00628901|4076880|B1|2 fibroids||Number of fibroids present greater than 2cm||particpants|Number|2|2.0||||||
4252849|NCT00628901|4076878|B3|1 fibroid||Number of fibroids present greater than 2cm||particpants|Number|4|4.0||||||
4252850|NCT00628901|4076879|B2|1 fibroid||Number of fibroids present greater than 2cm||particpants|Number|3|3.0||||||
4252851|NCT00628901|4076880|B1|1 fibroid||Number of fibroids present greater than 2cm||particpants|Number|1|1.0||||||
4252852|NCT00628901|4076878|B3|0 fibroids||Number of fibroids present greater than 2cm||particpants|Number|1|1.0||||||
4252853|NCT00628901|4076879|B2|0 fibroids||Number of fibroids present greater than 2cm||particpants|Number|0|0.0||||||
4252854|NCT00628901|4076880|B1|0 fibroids||Number of fibroids present greater than 2cm||particpants|Number|1|1.0||||||
4252855|NCT00628901|4076878|B3|Other||Fibroid Related Symptoms|Fibroid related symptoms is collected on the baseline CRF. A participant may have multiple symptoms present, thus the number may not add up to 30 per group or 60 total. The analysis indicates the number of participants with each symptom, thus the sum for all categories in the arm/group does not equal the overall number of participants in the group.|particpants|Number|18|18.0||||||
4252856|NCT00628901|4076879|B2|Other||Fibroid Related Symptoms|Fibroid related symptoms is collected on the baseline CRF. A participant may have multiple symptoms present, thus the number may not add up to 30 per group or 60 total. The analysis indicates the number of participants with each symptom, thus the sum for all categories in the arm/group does not equal the overall number of participants in the group.|particpants|Number|10|10.0||||||
4252857|NCT00628901|4076880|B1|Other||Fibroid Related Symptoms|Fibroid related symptoms is collected on the baseline CRF. A participant may have multiple symptoms present, thus the number may not add up to 30 per group or 60 total. The analysis indicates the number of participants with each symptom, thus the sum for all categories in the arm/group does not equal the overall number of participants in the group.|particpants|Number|8|8.0||||||
4252858|NCT00628901|4076878|B3|Pelvic Pain||Fibroid Related Symptoms|Fibroid related symptoms is collected on the baseline CRF. A participant may have multiple symptoms present, thus the number may not add up to 30 per group or 60 total. The analysis indicates the number of participants with each symptom, thus the sum for all categories in the arm/group does not equal the overall number of participants in the group.|particpants|Number|45|45.0||||||
4252859|NCT00628901|4076879|B2|Pelvic Pain||Fibroid Related Symptoms|Fibroid related symptoms is collected on the baseline CRF. A participant may have multiple symptoms present, thus the number may not add up to 30 per group or 60 total. The analysis indicates the number of participants with each symptom, thus the sum for all categories in the arm/group does not equal the overall number of participants in the group.|particpants|Number|23|23.0||||||
4252860|NCT00628901|4076880|B1|Pelvic Pain||Fibroid Related Symptoms|Fibroid related symptoms is collected on the baseline CRF. A participant may have multiple symptoms present, thus the number may not add up to 30 per group or 60 total. The analysis indicates the number of participants with each symptom, thus the sum for all categories in the arm/group does not equal the overall number of participants in the group.|particpants|Number|22|22.0||||||
4252861|NCT00628901|4076878|B3|Bulk/pressure||Fibroid Related Symptoms|Fibroid related symptoms is collected on the baseline CRF. A participant may have multiple symptoms present, thus the number may not add up to 30 per group or 60 total. The analysis indicates the number of participants with each symptom, thus the sum for all categories in the arm/group does not equal the overall number of participants in the group.|particpants|Number|45|45.0||||||
4252862|NCT00628901|4076879|B2|Bulk/pressure||Fibroid Related Symptoms|Fibroid related symptoms is collected on the baseline CRF. A participant may have multiple symptoms present, thus the number may not add up to 30 per group or 60 total. The analysis indicates the number of participants with each symptom, thus the sum for all categories in the arm/group does not equal the overall number of participants in the group.|particpants|Number|25|25.0||||||
4252898|NCT00628901|4076879|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4252899|NCT00628901|4076880|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4252863|NCT00628901|4076880|B1|Bulk/pressure||Fibroid Related Symptoms|Fibroid related symptoms is collected on the baseline CRF. A participant may have multiple symptoms present, thus the number may not add up to 30 per group or 60 total. The analysis indicates the number of participants with each symptom, thus the sum for all categories in the arm/group does not equal the overall number of participants in the group.|particpants|Number|20|20.0||||||
4252864|NCT00628901|4076878|B3|Abnormal Bleeding||Fibroid Related Symptoms|Fibroid related symptoms is collected on the baseline CRF. A participant may have multiple symptoms present, thus the number may not add up to 30 per group or 60 total. The analysis indicates the number of participants with each symptom, thus the sum for all categories in the arm/group does not equal the overall number of participants in the group.|particpants|Number|55|55.0||||||
4252865|NCT00628901|4076879|B2|Abnormal Bleeding||Fibroid Related Symptoms|Fibroid related symptoms is collected on the baseline CRF. A participant may have multiple symptoms present, thus the number may not add up to 30 per group or 60 total. The analysis indicates the number of participants with each symptom, thus the sum for all categories in the arm/group does not equal the overall number of participants in the group.|particpants|Number|27|27.0||||||
4252866|NCT00628901|4076880|B1|Abnormal Bleeding||Fibroid Related Symptoms|Fibroid related symptoms is collected on the baseline CRF. A participant may have multiple symptoms present, thus the number may not add up to 30 per group or 60 total. The analysis indicates the number of participants with each symptom, thus the sum for all categories in the arm/group does not equal the overall number of participants in the group.|particpants|Number|28|28.0||||||
4252867|NCT00628901|4076878|B3|# of participants without concurrent gyneco diseas||Previous or concurrent gynecological disease(s)||partcipants|Number|48|48.0||||||
4252868|NCT00628901|4076879|B2|# of participants without concurrent gyneco diseas||Previous or concurrent gynecological disease(s)||partcipants|Number|23|23.0||||||
4252869|NCT00628901|4076880|B1|# of participants without concurrent gyneco diseas||Previous or concurrent gynecological disease(s)||partcipants|Number|25|25.0||||||
4252870|NCT00628901|4076878|B3|# of participants with concurrent gyneco disease||Previous or concurrent gynecological disease(s)||partcipants|Number|12|12.0||||||
4252871|NCT00628901|4076879|B2|# of participants with concurrent gyneco disease||Previous or concurrent gynecological disease(s)||partcipants|Number|7|7.0||||||
4252872|NCT00628901|4076880|B1|# of participants with concurrent gyneco disease||Previous or concurrent gynecological disease(s)||partcipants|Number|5|5.0||||||
4252873|NCT00628901|4076878|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4252874|NCT00628901|4076879|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4252875|NCT00628901|4076880|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4252876|NCT00628901|4076878|B3||Unknown or Not Reported|Race (NIH/OMB)|Two participants in the Embosphere group had missing values for Race.|Participants|Count of Participants|2|2.0||||||
4252877|NCT00628901|4076879|B2||Unknown or Not Reported|Race (NIH/OMB)|Two participants in the Embosphere group had missing values for Race.|Participants|Count of Participants|2|2.0||||||
4252878|NCT00628901|4076880|B1||Unknown or Not Reported|Race (NIH/OMB)|Two participants in the Embosphere group had missing values for Race.|Participants|Count of Participants|0|0.0||||||
4252879|NCT00628901|4076878|B3||More than one race|Race (NIH/OMB)|Two participants in the Embosphere group had missing values for Race.|Participants|Count of Participants|2|2.0||||||
4252880|NCT00628901|4076879|B2||More than one race|Race (NIH/OMB)|Two participants in the Embosphere group had missing values for Race.|Participants|Count of Participants|2|2.0||||||
4252881|NCT00628901|4076880|B1||More than one race|Race (NIH/OMB)|Two participants in the Embosphere group had missing values for Race.|Participants|Count of Participants|0|0.0||||||
4252882|NCT00628901|4076878|B3||White|Race (NIH/OMB)|Two participants in the Embosphere group had missing values for Race.|Participants|Count of Participants|13|13.0||||||
4252883|NCT00628901|4076879|B2||White|Race (NIH/OMB)|Two participants in the Embosphere group had missing values for Race.|Participants|Count of Participants|6|6.0||||||
4252884|NCT00628901|4076880|B1||White|Race (NIH/OMB)|Two participants in the Embosphere group had missing values for Race.|Participants|Count of Participants|7|7.0||||||
4252885|NCT00628901|4076878|B3||Black or African American|Race (NIH/OMB)|Two participants in the Embosphere group had missing values for Race.|Participants|Count of Participants|41|41.0||||||
4252886|NCT00628901|4076879|B2||Black or African American|Race (NIH/OMB)|Two participants in the Embosphere group had missing values for Race.|Participants|Count of Participants|20|20.0||||||
4252887|NCT00628901|4076880|B1||Black or African American|Race (NIH/OMB)|Two participants in the Embosphere group had missing values for Race.|Participants|Count of Participants|21|21.0||||||
4252888|NCT00628901|4076878|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Two participants in the Embosphere group had missing values for Race.|Participants|Count of Participants|0|0.0||||||
4252889|NCT00628901|4076879|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Two participants in the Embosphere group had missing values for Race.|Participants|Count of Participants|0|0.0||||||
4252890|NCT00628901|4076880|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Two participants in the Embosphere group had missing values for Race.|Participants|Count of Participants|0|0.0||||||
4252891|NCT00628901|4076878|B3||Asian|Race (NIH/OMB)|Two participants in the Embosphere group had missing values for Race.|Participants|Count of Participants|2|2.0||||||
4252892|NCT00628901|4076879|B2||Asian|Race (NIH/OMB)|Two participants in the Embosphere group had missing values for Race.|Participants|Count of Participants|0|0.0||||||
4252893|NCT00628901|4076880|B1||Asian|Race (NIH/OMB)|Two participants in the Embosphere group had missing values for Race.|Participants|Count of Participants|2|2.0||||||
4252894|NCT00628901|4076878|B3||American Indian or Alaska Native|Race (NIH/OMB)|Two participants in the Embosphere group had missing values for Race.|Participants|Count of Participants|0|0.0||||||
4252895|NCT00628901|4076879|B2||American Indian or Alaska Native|Race (NIH/OMB)|Two participants in the Embosphere group had missing values for Race.|Participants|Count of Participants|0|0.0||||||
4252896|NCT00628901|4076880|B1||American Indian or Alaska Native|Race (NIH/OMB)|Two participants in the Embosphere group had missing values for Race.|Participants|Count of Participants|0|0.0||||||
4252897|NCT00628901|4076878|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4252900|NCT00628901|4076878|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4252901|NCT00628901|4076879|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4252902|NCT00628901|4076880|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4252903|NCT00628901|4076878|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4252904|NCT00628901|4076879|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4252905|NCT00628901|4076880|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4252906|NCT00628901|4076878|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4252907|NCT00628901|4076879|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4252908|NCT00628901|4076880|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4252909|NCT00628901|4076878|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4252910|NCT00628901|4076879|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4252911|NCT00628901|4076880|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4252912|NCT00628901|4076878|B3|||Age||years|Mean|42.8|42.8|Standard Deviation|5.3|5.3|||
4252913|NCT00628901|4076879|B2|||Age||years|Mean|41.7|41.7|Standard Deviation|5.4|5.4|||
4252914|NCT00628901|4076880|B1|||Age||years|Mean|43.9|43.9|Standard Deviation|5|5.0|||
4252915|NCT00628901|4076878|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4252916|NCT00628901|4076879|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4252917|NCT00628901|4076880|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4252918|NCT00628901|4076878|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4252919|NCT00628901|4076879|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4252920|NCT00628901|4076880|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4252921|NCT00628901|4076878|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252922|NCT00628901|4076879|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252923|NCT00628901|4076880|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252924|NCT00628862|4076909|B4||Male|Sex: Female, Male||Participants|Count of Participants|539|539.0||||||
4252925|NCT00628862|4076910|B3||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4252926|NCT00628862|4076911|B2||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4252927|NCT00628862|4076912|B1||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4252928|NCT00628862|4076909|B4||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4252929|NCT00628862|4076910|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4252930|NCT00628862|4076911|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4252931|NCT00628862|4076912|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4252932|NCT00628862|4076909|B4|||Age||Years|Mean|66.75|66.75|Standard Deviation|9.4|9.4|||
4252933|NCT00628862|4076910|B3|||Age||Years|Mean|66.3|66.3|Standard Deviation|9.7|9.7|||
4252934|NCT00628862|4076911|B2|||Age||Years|Mean|67.2|67.2|Standard Deviation|9.2|9.2|||
4252935|NCT00628862|4076912|B1|||Age||Years|Mean|66.7|66.7|Standard Deviation|9.4|9.4|||
4252936|NCT00628758|4076958|B3||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4252937|NCT00628758|4076959|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4252938|NCT00628758|4076960|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4252939|NCT00628758|4076958|B3||Female|Sex: Female, Male||Participants|Count of Participants|336|336.0||||||
4252940|NCT00628758|4076959|B2||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4252941|NCT00628758|4076960|B1||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4252942|NCT00628758|4076958|B3|||Age||years|Mean|44.7|44.7|Standard Deviation|12.4|12.4|||
4252943|NCT00628758|4076959|B2|||Age||years|Mean|45.17|45.17|Standard Deviation|12.71|12.71|||
4252944|NCT00628758|4076960|B1|||Age||years|Mean|44.28|44.28|Standard Deviation|12.09|12.09|||
4252945|NCT00628628|4076973|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
4252946|NCT00628628|4076974|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4252947|NCT00628628|4076975|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4252948|NCT00628628|4076973|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4252949|NCT00628628|4076974|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4252950|NCT00628628|4076975|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4252951|NCT00628628|4076973|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4252952|NCT00628628|4076974|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4252953|NCT00628628|4076975|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4252954|NCT00628628|4076973|B3|||Age||years|Median|60|60.0|Full Range|||27.0|82.0|
4252955|NCT00628628|4076974|B2|||Age||years|Median|58|58.0|Full Range|||27.0|81.0|
4252956|NCT00628628|4076975|B1|||Age||years|Median|62|62.0|Full Range|||27.0|82.0|
4252957|NCT00628589|4076982|B4|United States||Region of Enrollment||participants|Number|344|344.0||||||
4252958|NCT00628589|4076983|B3|United States||Region of Enrollment||participants|Number|113|113.0||||||
4252959|NCT00628589|4076984|B2|United States||Region of Enrollment||participants|Number|116|116.0||||||
4252960|NCT00628589|4076985|B1|United States||Region of Enrollment||participants|Number|115|115.0||||||
4252961|NCT00628589|4076982|B4||Male|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
4252962|NCT00628589|4076983|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4252963|NCT00628589|4076984|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4252964|NCT00628589|4076985|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4252965|NCT00628589|4076982|B4||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4252966|NCT00628589|4076983|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4252967|NCT00628589|4076984|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4252968|NCT00628589|4076985|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4252969|NCT00628589|4076982|B4|||Age||years|Mean|43.1|43.1|Standard Deviation|9.84|9.84|||
4252970|NCT00628589|4076983|B3|||Age||years|Mean|42.2|42.2|Standard Deviation|9.82|9.82|||
4252971|NCT00628589|4076984|B2|||Age||years|Mean|43.2|43.2|Standard Deviation|10.24|10.24|||
4252972|NCT00628589|4076985|B1|||Age||years|Mean|43.9|43.9|Standard Deviation|9.45|9.45|||
4252973|NCT00628589|4076982|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4252974|NCT00628589|4076983|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4252975|NCT00628589|4076984|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4252976|NCT00628589|4076985|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4252977|NCT00628589|4076982|B4||Between 18 and 65 years|Age||Participants|Count of Participants|344|344.0||||||
4252978|NCT00628589|4076983|B3||Between 18 and 65 years|Age||Participants|Count of Participants|113|113.0||||||
4252979|NCT00628589|4076984|B2||Between 18 and 65 years|Age||Participants|Count of Participants|116|116.0||||||
4252980|NCT00628589|4076985|B1||Between 18 and 65 years|Age||Participants|Count of Participants|115|115.0||||||
4252981|NCT00628589|4076982|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252982|NCT00628589|4076983|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252983|NCT00628589|4076984|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252984|NCT00628589|4076985|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252985|NCT00628498|4077001|B1||Male|Sex: Female, Male||Participants|Count of Participants|651|651.0||||||
4252986|NCT00628498|4077001|B1||Female|Sex: Female, Male||Participants|Count of Participants|503|503.0||||||
4252987|NCT00628498|4077001|B1|||Age|Age at time of HSCT/chemo|years|Mean|19.32|19.32|Standard Deviation|20.004|20.004|||
4252988|NCT00628446|4077005|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4252989|NCT00628446|4077005|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4252990|NCT00628446|4077005|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4252991|NCT00628446|4077005|B1|||Age||years|Mean|55|55.0|Standard Deviation|7.2|7.2|||
4252992|NCT00628446|4077005|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4252993|NCT00628446|4077005|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4252994|NCT00628446|4077005|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4252995|NCT00628407|4077010|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4252996|NCT00628407|4077010|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4252997|NCT00628407|4077010|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4252998|NCT00628407|4077010|B1|||Age||years|Mean|2.2|2.2|Standard Deviation|2|2.0|||
4252999|NCT00628407|4077010|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4253000|NCT00628407|4077010|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4253001|NCT00628407|4077010|B1||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4253002|NCT00628355|4077014|B3|Brazil||Region of Enrollment||participants|Number|28|28.0||||||
4253003|NCT00628355|4077015|B2|Brazil||Region of Enrollment||participants|Number|14|14.0||||||
4253004|NCT00628355|4077016|B1|Brazil||Region of Enrollment||participants|Number|14|14.0||||||
4253005|NCT00628355|4077014|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4253006|NCT00628355|4077015|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4253007|NCT00628355|4077016|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4253008|NCT00628355|4077014|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4253009|NCT00628355|4077015|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4253010|NCT00628355|4077016|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4253011|NCT00628355|4077014|B3|||Age||years|Mean|37.6|37.6|Standard Deviation|3.1|3.1|||
4253012|NCT00628355|4077015|B2|||Age||years|Mean|38.5|38.5|Standard Deviation|2.8|2.8|||
4253013|NCT00628355|4077016|B1|||Age||years|Mean|36.8|36.8|Standard Deviation|3.2|3.2|||
4253014|NCT00628355|4077014|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4253015|NCT00628355|4077015|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4253016|NCT00628355|4077016|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4253017|NCT00628355|4077014|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4253018|NCT00628355|4077015|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4253019|NCT00628355|4077016|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4253020|NCT00628355|4077014|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4253021|NCT00628355|4077015|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4253022|NCT00628355|4077016|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4253023|NCT00628251|4077025|B4|Deleterious BRCA2 mutation||BRCA status||Participants|Number|16|16.0||||||
4253024|NCT00628251|4077026|B3|Deleterious BRCA2 mutation||BRCA status||Participants|Number|6|6.0||||||
4253025|NCT00628251|4077027|B2|Deleterious BRCA2 mutation||BRCA status||Participants|Number|4|4.0||||||
4253026|NCT00628251|4077028|B1|Deleterious BRCA2 mutation||BRCA status||Participants|Number|6|6.0||||||
4253027|NCT00628251|4077025|B4|Deleterious BRCA1 mutation||BRCA status||Participants|Number|81|81.0||||||
4253028|NCT00628251|4077026|B3|Deleterious BRCA1 mutation||BRCA status||Participants|Number|27|27.0||||||
4253029|NCT00628251|4077027|B2|Deleterious BRCA1 mutation||BRCA status||Participants|Number|28|28.0||||||
4253030|NCT00628251|4077028|B1|Deleterious BRCA1 mutation||BRCA status||Participants|Number|26|26.0||||||
4253031|NCT00628251|4077025|B4|Other||Race/Ethnicity, Customized|Jewish ethnicity|Participants|Number|5|5.0||||||
4253032|NCT00628251|4077026|B3|Other||Race/Ethnicity, Customized|Jewish ethnicity|Participants|Number|0|0.0||||||
4253033|NCT00628251|4077027|B2|Other||Race/Ethnicity, Customized|Jewish ethnicity|Participants|Number|1|1.0||||||
4253034|NCT00628251|4077028|B1|Other||Race/Ethnicity, Customized|Jewish ethnicity|Participants|Number|4|4.0||||||
4253035|NCT00628251|4077025|B4|Not applicable||Race/Ethnicity, Customized|Jewish ethnicity|Participants|Number|60|60.0||||||
4253036|NCT00628251|4077026|B3|Not applicable||Race/Ethnicity, Customized|Jewish ethnicity|Participants|Number|19|19.0||||||
4253037|NCT00628251|4077027|B2|Not applicable||Race/Ethnicity, Customized|Jewish ethnicity|Participants|Number|21|21.0||||||
4253038|NCT00628251|4077028|B1|Not applicable||Race/Ethnicity, Customized|Jewish ethnicity|Participants|Number|20|20.0||||||
4253039|NCT00628251|4077025|B4|Sephardic Jewish||Race/Ethnicity, Customized|Jewish ethnicity|Participants|Number|2|2.0||||||
4253040|NCT00628251|4077026|B3|Sephardic Jewish||Race/Ethnicity, Customized|Jewish ethnicity|Participants|Number|2|2.0||||||
4253041|NCT00628251|4077027|B2|Sephardic Jewish||Race/Ethnicity, Customized|Jewish ethnicity|Participants|Number|0|0.0||||||
4253042|NCT00628251|4077028|B1|Sephardic Jewish||Race/Ethnicity, Customized|Jewish ethnicity|Participants|Number|0|0.0||||||
4253043|NCT00628251|4077025|B4|Ashkenazi Jewish||Race/Ethnicity, Customized|Jewish ethnicity|Participants|Number|29|29.0||||||
4253044|NCT00628251|4077026|B3|Ashkenazi Jewish||Race/Ethnicity, Customized|Jewish ethnicity|Participants|Number|11|11.0||||||
4253045|NCT00628251|4077027|B2|Ashkenazi Jewish||Race/Ethnicity, Customized|Jewish ethnicity|Participants|Number|10|10.0||||||
4253046|NCT00628251|4077028|B1|Ashkenazi Jewish||Race/Ethnicity, Customized|Jewish ethnicity|Participants|Number|8|8.0||||||
4253047|NCT00628251|4077025|B4|African-Caribbean||Race/Ethnicity, Customized|Jewish ethnicity|Participants|Number|1|1.0||||||
4253048|NCT00628251|4077026|B3|African-Caribbean||Race/Ethnicity, Customized|Jewish ethnicity|Participants|Number|1|1.0||||||
4253049|NCT00628251|4077027|B2|African-Caribbean||Race/Ethnicity, Customized|Jewish ethnicity|Participants|Number|0|0.0||||||
4253050|NCT00628251|4077028|B1|African-Caribbean||Race/Ethnicity, Customized|Jewish ethnicity|Participants|Number|0|0.0||||||
4253051|NCT00628251|4077025|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4253052|NCT00628251|4077026|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4253053|NCT00628251|4077027|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4253054|NCT00628251|4077028|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4253055|NCT00628251|4077025|B4||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4253056|NCT00628251|4077026|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4253057|NCT00628251|4077027|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4253058|NCT00628251|4077028|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4253059|NCT00628251|4077025|B4|||Age||Years|Mean|55.5|55.5|Standard Deviation|8.92|8.92|||
4253060|NCT00628251|4077026|B3|||Age||Years|Mean|54.3|54.3|Standard Deviation|9.32|9.32|||
4253061|NCT00628251|4077027|B2|||Age||Years|Mean|53.8|53.8|Standard Deviation|8.77|8.77|||
4253062|NCT00628251|4077028|B1|||Age||Years|Mean|57.2|57.2|Standard Deviation|8.53|8.53|||
4253063|NCT00628212|4077069|B5||Male|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
4253064|NCT00628212|4077070|B4||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4253065|NCT00628212|4077071|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4253066|NCT00628212|4077072|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4253067|NCT00628212|4077073|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4253068|NCT00628212|4077069|B5||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4253069|NCT00628212|4077070|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4253070|NCT00628212|4077071|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4253071|NCT00628212|4077072|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4253072|NCT00628212|4077073|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4253073|NCT00628212|4077069|B5|||Age||years|Mean|58.2|58.2|Standard Deviation|9.6|9.6|||
4253074|NCT00628212|4077070|B4|||Age||years|Mean|57.5|57.5|Standard Deviation|10.4|10.4|||
4253075|NCT00628212|4077071|B3|||Age||years|Mean|59.2|59.2|Standard Deviation|9.5|9.5|||
4253076|NCT00628212|4077072|B2|||Age||years|Mean|57.7|57.7|Standard Deviation|9.1|9.1|||
4253077|NCT00628212|4077073|B1|||Age||years|Mean|58.5|58.5|Standard Deviation|9.6|9.6|||
4253078|NCT00628147|4077098|B3||Male|Gender||Participants|Count of Participants|275|275.0||||||
4253079|NCT00628147|4077099|B2||Male|Gender||Participants|Count of Participants|138|138.0||||||
4253080|NCT00628147|4077100|B1||Male|Gender||Participants|Count of Participants|137|137.0||||||
4253081|NCT00628147|4077098|B3||Female|Gender||Participants|Count of Participants|9|9.0||||||
4253082|NCT00628147|4077099|B2||Female|Gender||Participants|Count of Participants|4|4.0||||||
4253083|NCT00628147|4077100|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
4253084|NCT00628147|4077098|B3|||Age||years|Mean|64|64.0|Standard Deviation|10|10.0|||
4253085|NCT00628147|4077099|B2|||Age||years|Mean|64|64.0|Standard Deviation|10|10.0|||
4253086|NCT00628147|4077100|B1|||Age||years|Mean|64|64.0|Standard Deviation|10|10.0|||
4253087|NCT00628134|4077113|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4253088|NCT00628134|4077113|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4253089|NCT00628134|4077113|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4253090|NCT00628134|4077113|B1|||Age||years|Mean|28|28.0|Standard Deviation|9|9.0|||
4253091|NCT00628134|4077113|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4253092|NCT00628134|4077113|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4253093|NCT00628134|4077113|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4253094|NCT00628108|4077122|B3|United States||Region of Enrollment||participants|Number|69|69.0||||||
4253095|NCT00628108|4077123|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
4253096|NCT00628108|4077124|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4253097|NCT00628108|4077122|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4253098|NCT00628108|4077123|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4253099|NCT00628108|4077124|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4253100|NCT00628108|4077122|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4253101|NCT00628108|4077123|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4253102|NCT00628108|4077124|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4253103|NCT00628108|4077122|B3|||Age||months|Mean|8.93|8.93|Standard Deviation|1.67|1.67|||
4253104|NCT00628108|4077123|B2|||Age||months|Mean|8.87|8.87|Standard Deviation|1.63|1.63|||
4253105|NCT00628108|4077124|B1|||Age||months|Mean|9.03|9.03|Standard Deviation|1.80|1.8|||
4253106|NCT00628108|4077122|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4253107|NCT00628108|4077123|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4253108|NCT00628108|4077124|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4253109|NCT00628108|4077122|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4253110|NCT00628108|4077123|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4253111|NCT00628108|4077124|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4253112|NCT00628108|4077122|B3||<=18 years|Age||Participants|Count of Participants|69|69.0||||||
4253113|NCT00628108|4077123|B2||<=18 years|Age||Participants|Count of Participants|45|45.0||||||
4253114|NCT00628108|4077124|B1||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
4253115|NCT00628030|4077155|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4253116|NCT00628030|4077156|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4253117|NCT00628030|4077157|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4253118|NCT00628030|4077155|B3||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4253119|NCT00628030|4077156|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4253120|NCT00628030|4077157|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4253121|NCT00628030|4077155|B3|Child Age||Age||years|Mean|8.60|8.6|Standard Deviation|1.50|1.5|||
4253122|NCT00628030|4077156|B2|Child Age||Age||years|Mean|8.48|8.48|Standard Deviation|1.53|1.53|||
4253123|NCT00628030|4077157|B1|Child Age||Age||years|Mean|8.70|8.7|Standard Deviation|1.47|1.47|||
4253124|NCT00628030|4077155|B3|Adult Age||Age||years|Mean|39.90|39.9|Standard Deviation|7.40|7.4|||
4253125|NCT00628030|4077156|B2|Adult Age||Age||years|Mean|40.32|40.32|Standard Deviation|7.81|7.81|||
4253126|NCT00628030|4077157|B1|Adult Age||Age||years|Mean|38.80|38.8|Standard Deviation|6.71|6.71|||
4253127|NCT00627978|4077172|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4253128|NCT00627978|4077173|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4253129|NCT00627978|4077174|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4253130|NCT00627978|4077172|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4253131|NCT00627978|4077173|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4253132|NCT00627978|4077174|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4253133|NCT00627978|4077172|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4253134|NCT00627978|4077173|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4253135|NCT00627978|4077174|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4253136|NCT00627978|4077172|B3|||Age||years|Mean|54.4|54.4|Full Range|||35.0|70.0|
4253137|NCT00627978|4077173|B2|||Age||years|Mean|51|51.0|Full Range|||35.0|63.0|
4253138|NCT00627978|4077174|B1|||Age||years|Mean|55.8|55.8|Full Range|||39.0|70.0|
4253139|NCT00627978|4077172|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4253140|NCT00627978|4077173|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4253141|NCT00627978|4077174|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4253142|NCT00627978|4077172|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4253143|NCT00627978|4077173|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4253144|NCT00627978|4077174|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4253145|NCT00627978|4077172|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4253146|NCT00627978|4077173|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4253147|NCT00627978|4077174|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4253148|NCT00627926|4077181|B4|Israel||Region of Enrollment||participants|Number|60|60.0||||||
4253149|NCT00627926|4077182|B3|Israel||Region of Enrollment||participants|Number|24|24.0||||||
4253150|NCT00627926|4077183|B2|Israel||Region of Enrollment||participants|Number|17|17.0||||||
4253151|NCT00627926|4077184|B1|Israel||Region of Enrollment||participants|Number|19|19.0||||||
4253152|NCT00627926|4077181|B4|Australia||Region of Enrollment||participants|Number|46|46.0||||||
4253153|NCT00627926|4077182|B3|Australia||Region of Enrollment||participants|Number|18|18.0||||||
4253154|NCT00627926|4077183|B2|Australia||Region of Enrollment||participants|Number|14|14.0||||||
4253155|NCT00627926|4077184|B1|Australia||Region of Enrollment||participants|Number|14|14.0||||||
4253156|NCT00627926|4077181|B4|Argentina||Region of Enrollment||participants|Number|17|17.0||||||
4253157|NCT00627926|4077182|B3|Argentina||Region of Enrollment||participants|Number|3|3.0||||||
4253158|NCT00627926|4077183|B2|Argentina||Region of Enrollment||participants|Number|6|6.0||||||
4253159|NCT00627926|4077184|B1|Argentina||Region of Enrollment||participants|Number|8|8.0||||||
4253160|NCT00627926|4077181|B4|Europe||Region of Enrollment||participants|Number|310|310.0||||||
4253161|NCT00627926|4077182|B3|Europe||Region of Enrollment||participants|Number|104|104.0||||||
4253162|NCT00627926|4077183|B2|Europe||Region of Enrollment||participants|Number|100|100.0||||||
4253163|NCT00627926|4077184|B1|Europe||Region of Enrollment||participants|Number|106|106.0||||||
4253164|NCT00627926|4077181|B4|North America||Region of Enrollment||participants|Number|655|655.0||||||
4253165|NCT00627926|4077182|B3|North America||Region of Enrollment||participants|Number|214|214.0||||||
4253166|NCT00627926|4077183|B2|North America||Region of Enrollment||participants|Number|227|227.0||||||
4253167|NCT00627926|4077184|B1|North America||Region of Enrollment||participants|Number|214|214.0||||||
4253168|NCT00627926|4077181|B4||Male|Sex: Female, Male||Participants|Count of Participants|636|636.0||||||
4253169|NCT00627926|4077182|B3||Male|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4253170|NCT00627926|4077183|B2||Male|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4253171|NCT00627926|4077184|B1||Male|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4253172|NCT00627926|4077181|B4||Female|Sex: Female, Male||Participants|Count of Participants|452|452.0||||||
4253173|NCT00627926|4077182|B3||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4253174|NCT00627926|4077183|B2||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4253175|NCT00627926|4077184|B1||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4253176|NCT00627926|4077181|B4|||Age||years|Mean|46.8|46.8|Standard Deviation|10.6|10.6|||
4253177|NCT00627926|4077182|B3|||Age||years|Mean|46.5|46.5|Standard Deviation|10.8|10.8|||
4253178|NCT00627926|4077183|B2|||Age||years|Mean|47.0|47.0|Standard Deviation|10.9|10.9|||
4253179|NCT00627926|4077184|B1|||Age||years|Mean|46.8|46.8|Standard Deviation|10.0|10.0|||
4253180|NCT00627926|4077181|B4||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4253181|NCT00627926|4077182|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4253182|NCT00627926|4077183|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4253183|NCT00627926|4077184|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4253184|NCT00627926|4077181|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1069|1069.0||||||
4253185|NCT00627926|4077182|B3||Between 18 and 65 years|Age||Participants|Count of Participants|353|353.0||||||
4253186|NCT00627926|4077183|B2||Between 18 and 65 years|Age||Participants|Count of Participants|359|359.0||||||
4253187|NCT00627926|4077184|B1||Between 18 and 65 years|Age||Participants|Count of Participants|357|357.0||||||
4253188|NCT00627926|4077181|B4||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4253189|NCT00627926|4077182|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4253190|NCT00627926|4077183|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4253191|NCT00627926|4077184|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4253192|NCT00627861|4077230|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4253193|NCT00627861|4077230|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4253194|NCT00627861|4077230|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4253195|NCT00627861|4077230|B1|||Age||years|Mean|55|55.0|Standard Deviation|||||
4253196|NCT00627861|4077230|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4253197|NCT00627861|4077230|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4253198|NCT00627861|4077230|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4253199|NCT00627705|4077236|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
4253200|NCT00627705|4077237|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4253201|NCT00627705|4077238|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4253202|NCT00627705|4077236|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4253203|NCT00627705|4077237|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4253204|NCT00627705|4077238|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4253205|NCT00627705|4077236|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4253206|NCT00627705|4077237|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4253207|NCT00627705|4077238|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4253208|NCT00627705|4077236|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4253209|NCT00627705|4077237|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4253210|NCT00627705|4077238|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4253211|NCT00627705|4077236|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4253212|NCT00627705|4077237|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4253213|NCT00627705|4077238|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4253214|NCT00627705|4077236|B3||<=18 years|Age||Participants|Count of Participants|33|33.0||||||
4253215|NCT00627705|4077237|B2||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
4253216|NCT00627705|4077238|B1||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4253217|NCT00627679|4077259|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4253218|NCT00627679|4077259|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4253219|NCT00627679|4077259|B1|||Age||years|Mean|23.3|23.3|Standard Deviation|4.3|4.3|||
4253220|NCT00627523|4077288|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4253221|NCT00627523|4077289|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4253222|NCT00627523|4077290|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4253223|NCT00627523|4077288|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4253224|NCT00627523|4077289|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4253225|NCT00627523|4077290|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4253226|NCT00627523|4077288|B3|||Age||Months|Mean|24.67|24.67|Standard Deviation|3.263|3.263|||
4253227|NCT00627523|4077289|B2|||Age||Months|Mean|24.44|24.44|Standard Deviation|3.324|3.324|||
4253228|NCT00627523|4077290|B1|||Age||Months|Mean|24.91|24.91|Standard Deviation|3.262|3.262|||
4253229|NCT00627497|4077315|B5|Leg Pain Score (0-20)||Pain Status|Numerical rating scales are used to evaluate back pain and leg pain intensity and frequency. Patients will rate their pain intensity on a scale from 0-10, with a score of 0 representing “no pain” and a score of 10 representing “pain as bad as it could be.” Similarly, patients will record their back pain frequency on a scale from 0-10, with a score of 0 being “pain none of the time” and a score of 10 being “pain all of the time.” A patient’s total pain score will be the sum of pain intensity and frequency scores (0 min, 20 max).|Scores on a scale|Mean|17.0|17.0|Standard Deviation|2.0|2.0|||
4253230|NCT00627497|4077316|B4|Leg Pain Score (0-20)||Pain Status|Numerical rating scales are used to evaluate back pain and leg pain intensity and frequency. Patients will rate their pain intensity on a scale from 0-10, with a score of 0 representing “no pain” and a score of 10 representing “pain as bad as it could be.” Similarly, patients will record their back pain frequency on a scale from 0-10, with a score of 0 being “pain none of the time” and a score of 10 being “pain all of the time.” A patient’s total pain score will be the sum of pain intensity and frequency scores (0 min, 20 max).|Scores on a scale|Mean|16.0|16.0|Standard Deviation|4.2|4.2|||
4253231|NCT00627497|4077317|B3|Leg Pain Score (0-20)||Pain Status|Numerical rating scales are used to evaluate back pain and leg pain intensity and frequency. Patients will rate their pain intensity on a scale from 0-10, with a score of 0 representing “no pain” and a score of 10 representing “pain as bad as it could be.” Similarly, patients will record their back pain frequency on a scale from 0-10, with a score of 0 being “pain none of the time” and a score of 10 being “pain all of the time.” A patient’s total pain score will be the sum of pain intensity and frequency scores (0 min, 20 max).|Scores on a scale|Mean|16.8|16.8|Standard Deviation|3.9|3.9|||
4253232|NCT00627497|4077318|B2|Leg Pain Score (0-20)||Pain Status|Numerical rating scales are used to evaluate back pain and leg pain intensity and frequency. Patients will rate their pain intensity on a scale from 0-10, with a score of 0 representing “no pain” and a score of 10 representing “pain as bad as it could be.” Similarly, patients will record their back pain frequency on a scale from 0-10, with a score of 0 being “pain none of the time” and a score of 10 being “pain all of the time.” A patient’s total pain score will be the sum of pain intensity and frequency scores (0 min, 20 max).|Scores on a scale|Mean|17.1|17.1|Standard Deviation|1.7|1.7|||
4253233|NCT00627497|4077319|B1|Leg Pain Score (0-20)||Pain Status|Numerical rating scales are used to evaluate back pain and leg pain intensity and frequency. Patients will rate their pain intensity on a scale from 0-10, with a score of 0 representing “no pain” and a score of 10 representing “pain as bad as it could be.” Similarly, patients will record their back pain frequency on a scale from 0-10, with a score of 0 being “pain none of the time” and a score of 10 being “pain all of the time.” A patient’s total pain score will be the sum of pain intensity and frequency scores (0 min, 20 max).|Scores on a scale|Mean|17.2|17.2|Standard Deviation|1.5|1.5|||
4253234|NCT00627497|4077315|B5|Back Pain Score (0-20)||Pain Status|Numerical rating scales are used to evaluate back pain and leg pain intensity and frequency. Patients will rate their pain intensity on a scale from 0-10, with a score of 0 representing “no pain” and a score of 10 representing “pain as bad as it could be.” Similarly, patients will record their back pain frequency on a scale from 0-10, with a score of 0 being “pain none of the time” and a score of 10 being “pain all of the time.” A patient’s total pain score will be the sum of pain intensity and frequency scores (0 min, 20 max).|Scores on a scale|Mean|13.3|13.3|Standard Deviation|3.3|3.3|||
4253235|NCT00627497|4077316|B4|Back Pain Score (0-20)||Pain Status|Numerical rating scales are used to evaluate back pain and leg pain intensity and frequency. Patients will rate their pain intensity on a scale from 0-10, with a score of 0 representing “no pain” and a score of 10 representing “pain as bad as it could be.” Similarly, patients will record their back pain frequency on a scale from 0-10, with a score of 0 being “pain none of the time” and a score of 10 being “pain all of the time.” A patient’s total pain score will be the sum of pain intensity and frequency scores (0 min, 20 max).|Scores on a scale|Mean|11.5|11.5|Standard Deviation|0.7|0.7|||
4253249|NCT00627497|4077315|B5|||Oswestry Disability Index (ODI) Score|The Oswestry Disability Index (ODI) Questionnaire was used to assess patient pain and ability to function. The ODI score ranges from 0-100. The best score is 0 (no disability) and worst is 100 (maximum disability).|Scores on a scale|Mean|50.9|50.9|Standard Deviation|9.0|9.0|||
4253306|NCT00627458|4077382|B2|Geographic ancestry|Not specified|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4253236|NCT00627497|4077317|B3|Back Pain Score (0-20)||Pain Status|Numerical rating scales are used to evaluate back pain and leg pain intensity and frequency. Patients will rate their pain intensity on a scale from 0-10, with a score of 0 representing “no pain” and a score of 10 representing “pain as bad as it could be.” Similarly, patients will record their back pain frequency on a scale from 0-10, with a score of 0 being “pain none of the time” and a score of 10 being “pain all of the time.” A patient’s total pain score will be the sum of pain intensity and frequency scores (0 min, 20 max).|Scores on a scale|Mean|15.0|15.0|Standard Deviation|3.4|3.4|||
4253237|NCT00627497|4077318|B2|Back Pain Score (0-20)||Pain Status|Numerical rating scales are used to evaluate back pain and leg pain intensity and frequency. Patients will rate their pain intensity on a scale from 0-10, with a score of 0 representing “no pain” and a score of 10 representing “pain as bad as it could be.” Similarly, patients will record their back pain frequency on a scale from 0-10, with a score of 0 being “pain none of the time” and a score of 10 being “pain all of the time.” A patient’s total pain score will be the sum of pain intensity and frequency scores (0 min, 20 max).|Scores on a scale|Mean|12.0|12.0|Standard Deviation|3.5|3.5|||
4253238|NCT00627497|4077319|B1|Back Pain Score (0-20)||Pain Status|Numerical rating scales are used to evaluate back pain and leg pain intensity and frequency. Patients will rate their pain intensity on a scale from 0-10, with a score of 0 representing “no pain” and a score of 10 representing “pain as bad as it could be.” Similarly, patients will record their back pain frequency on a scale from 0-10, with a score of 0 being “pain none of the time” and a score of 10 being “pain all of the time.” A patient’s total pain score will be the sum of pain intensity and frequency scores (0 min, 20 max).|Scores on a scale|Mean|14.1|14.1|Standard Deviation|3.1|3.1|||
4253239|NCT00627497|4077315|B5|Mental Component Summary (SF-36 MCS)||General Health Status|The Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) was used to assess general health status. The SF-36 results are summarized into two components, a physical component summary (PCS) and a mental component summary (MCS). The score for PCS and MCS is between 0 and 100, with higher scores denoting better quality of life. No overall score (SF-36) was reported.|Scores on a scale|Mean|50.7|50.7|Standard Deviation|9.8|9.8|||
4253240|NCT00627497|4077316|B4|Mental Component Summary (SF-36 MCS)||General Health Status|The Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) was used to assess general health status. The SF-36 results are summarized into two components, a physical component summary (PCS) and a mental component summary (MCS). The score for PCS and MCS is between 0 and 100, with higher scores denoting better quality of life. No overall score (SF-36) was reported.|Scores on a scale|Mean|59.9|59.9|Standard Deviation|4.2|4.2|||
4253241|NCT00627497|4077317|B3|Mental Component Summary (SF-36 MCS)||General Health Status|The Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) was used to assess general health status. The SF-36 results are summarized into two components, a physical component summary (PCS) and a mental component summary (MCS). The score for PCS and MCS is between 0 and 100, with higher scores denoting better quality of life. No overall score (SF-36) was reported.|Scores on a scale|Mean|46.0|46.0|Standard Deviation|10.7|10.7|||
4253242|NCT00627497|4077318|B2|Mental Component Summary (SF-36 MCS)||General Health Status|The Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) was used to assess general health status. The SF-36 results are summarized into two components, a physical component summary (PCS) and a mental component summary (MCS). The score for PCS and MCS is between 0 and 100, with higher scores denoting better quality of life. No overall score (SF-36) was reported.|Scores on a scale|Mean|49.7|49.7|Standard Deviation|10.5|10.5|||
4253243|NCT00627497|4077319|B1|Mental Component Summary (SF-36 MCS)||General Health Status|The Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) was used to assess general health status. The SF-36 results are summarized into two components, a physical component summary (PCS) and a mental component summary (MCS). The score for PCS and MCS is between 0 and 100, with higher scores denoting better quality of life. No overall score (SF-36) was reported.|Scores on a scale|Mean|51.7|51.7|Standard Deviation|9.2|9.2|||
4253244|NCT00627497|4077315|B5|Physical Component Summary (SF- 36 PCS)||General Health Status|The Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) was used to assess general health status. The SF-36 results are summarized into two components, a physical component summary (PCS) and a mental component summary (MCS). The score for PCS and MCS is between 0 and 100, with higher scores denoting better quality of life. No overall score (SF-36) was reported.|Scores on a scale|Mean|26.7|26.7|Standard Deviation|6.0|6.0|||
4253245|NCT00627497|4077316|B4|Physical Component Summary (SF- 36 PCS)||General Health Status|The Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) was used to assess general health status. The SF-36 results are summarized into two components, a physical component summary (PCS) and a mental component summary (MCS). The score for PCS and MCS is between 0 and 100, with higher scores denoting better quality of life. No overall score (SF-36) was reported.|Scores on a scale|Mean|24.0|24.0|Standard Deviation|1.5|1.5|||
4253246|NCT00627497|4077317|B3|Physical Component Summary (SF- 36 PCS)||General Health Status|The Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) was used to assess general health status. The SF-36 results are summarized into two components, a physical component summary (PCS) and a mental component summary (MCS). The score for PCS and MCS is between 0 and 100, with higher scores denoting better quality of life. No overall score (SF-36) was reported.|Scores on a scale|Mean|27.0|27.0|Standard Deviation|3.7|3.7|||
4253247|NCT00627497|4077318|B2|Physical Component Summary (SF- 36 PCS)||General Health Status|The Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) was used to assess general health status. The SF-36 results are summarized into two components, a physical component summary (PCS) and a mental component summary (MCS). The score for PCS and MCS is between 0 and 100, with higher scores denoting better quality of life. No overall score (SF-36) was reported.|Scores on a scale|Mean|26.6|26.6|Standard Deviation|4.7|4.7|||
4253248|NCT00627497|4077319|B1|Physical Component Summary (SF- 36 PCS)||General Health Status|The Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) was used to assess general health status. The SF-36 results are summarized into two components, a physical component summary (PCS) and a mental component summary (MCS). The score for PCS and MCS is between 0 and 100, with higher scores denoting better quality of life. No overall score (SF-36) was reported.|Scores on a scale|Mean|27.0|27.0|Standard Deviation|7.9|7.9|||
4253305|NCT00627458|4077381|B3|Geographic ancestry|Not specified|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4253250|NCT00627497|4077316|B4|||Oswestry Disability Index (ODI) Score|The Oswestry Disability Index (ODI) Questionnaire was used to assess patient pain and ability to function. The ODI score ranges from 0-100. The best score is 0 (no disability) and worst is 100 (maximum disability).|Scores on a scale|Mean|44.0|44.0|Standard Deviation|2.8|2.8|||
4253251|NCT00627497|4077317|B3|||Oswestry Disability Index (ODI) Score|The Oswestry Disability Index (ODI) Questionnaire was used to assess patient pain and ability to function. The ODI score ranges from 0-100. The best score is 0 (no disability) and worst is 100 (maximum disability).|Scores on a scale|Mean|52.0|52.0|Standard Deviation|10.7|10.7|||
4253252|NCT00627497|4077318|B2|||Oswestry Disability Index (ODI) Score|The Oswestry Disability Index (ODI) Questionnaire was used to assess patient pain and ability to function. The ODI score ranges from 0-100. The best score is 0 (no disability) and worst is 100 (maximum disability).|Scores on a scale|Mean|49.6|49.6|Standard Deviation|8.4|8.4|||
4253253|NCT00627497|4077319|B1|||Oswestry Disability Index (ODI) Score|The Oswestry Disability Index (ODI) Questionnaire was used to assess patient pain and ability to function. The ODI score ranges from 0-100. The best score is 0 (no disability) and worst is 100 (maximum disability).|Scores on a scale|Mean|52.6|52.6|Standard Deviation|9.7|9.7|||
4253254|NCT00627497|4077315|B5|||Weight||lbs|Mean|195.3|195.3|Standard Deviation|41.5|41.5|||
4253255|NCT00627497|4077316|B4|||Weight||lbs|Mean|144.5|144.5|Standard Deviation|36.1|36.1|||
4253256|NCT00627497|4077317|B3|||Weight||lbs|Mean|194.0|194.0|Standard Deviation|43.3|43.3|||
4253257|NCT00627497|4077318|B2|||Weight||lbs|Mean|187.2|187.2|Standard Deviation|36.2|36.2|||
4253258|NCT00627497|4077319|B1|||Weight||lbs|Mean|209.9|209.9|Standard Deviation|42.0|42.0|||
4253259|NCT00627497|4077315|B5|||Height||in.|Mean|68.5|68.5|Standard Deviation|4.0|4.0|||
4253260|NCT00627497|4077316|B4|||Height||in.|Mean|65.5|65.5|Standard Deviation|0.7|0.7|||
4253261|NCT00627497|4077317|B3|||Height||in.|Mean|69.3|69.3|Standard Deviation|4.3|4.3|||
4253262|NCT00627497|4077318|B2|||Height||in.|Mean|66.9|66.9|Standard Deviation|4.4|4.4|||
4253263|NCT00627497|4077319|B1|||Height||in.|Mean|70.1|70.1|Standard Deviation|3.2|3.2|||
4253264|NCT00627497|4077315|B5|other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4253265|NCT00627497|4077316|B4|other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4253266|NCT00627497|4077317|B3|other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4253267|NCT00627497|4077318|B2|other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4253268|NCT00627497|4077319|B1|other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4253269|NCT00627497|4077315|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4253270|NCT00627497|4077316|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4253271|NCT00627497|4077317|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4253272|NCT00627497|4077318|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4253273|NCT00627497|4077319|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4253274|NCT00627497|4077315|B5|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4253275|NCT00627497|4077316|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4253276|NCT00627497|4077317|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4253277|NCT00627497|4077318|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4253278|NCT00627497|4077319|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4253279|NCT00627497|4077315|B5|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4253280|NCT00627497|4077316|B4|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4253281|NCT00627497|4077317|B3|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4253282|NCT00627497|4077318|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4253283|NCT00627497|4077319|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4253284|NCT00627497|4077315|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4253285|NCT00627497|4077316|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4253286|NCT00627497|4077317|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4253287|NCT00627497|4077318|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4253288|NCT00627497|4077319|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4253289|NCT00627497|4077315|B5||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4253290|NCT00627497|4077316|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4253291|NCT00627497|4077317|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4253292|NCT00627497|4077318|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4253293|NCT00627497|4077319|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4253294|NCT00627497|4077315|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4253295|NCT00627497|4077316|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4253296|NCT00627497|4077317|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4253297|NCT00627497|4077318|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4253298|NCT00627497|4077319|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4253299|NCT00627497|4077315|B5|||Age||years|Mean|54.7|54.7|Standard Deviation|9.8|9.8|||
4253300|NCT00627497|4077316|B4|||Age||years|Mean|54.5|54.5|Standard Deviation|7.8|7.8|||
4253301|NCT00627497|4077317|B3|||Age||years|Mean|47.8|47.8|Standard Deviation|16.1|16.1|||
4253302|NCT00627497|4077318|B2|||Age||years|Mean|54.8|54.8|Standard Deviation|9.7|9.7|||
4253303|NCT00627497|4077319|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|8.3|8.3|||
4253304|NCT00627458|4077380|B4|Geographic ancestry|Not specified|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4253307|NCT00627458|4077383|B1|Geographic ancestry|Not specified|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4253308|NCT00627458|4077380|B4|Geographic ancestry|White-Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4253309|NCT00627458|4077381|B3|Geographic ancestry|White-Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4253310|NCT00627458|4077382|B2|Geographic ancestry|White-Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4253311|NCT00627458|4077383|B1|Geographic ancestry|White-Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4253312|NCT00627458|4077380|B4|Geographic ancestry|White-Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|394|394.0||||||
4253313|NCT00627458|4077381|B3|Geographic ancestry|White-Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|135|135.0||||||
4253314|NCT00627458|4077382|B2|Geographic ancestry|White-Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|134|134.0||||||
4253315|NCT00627458|4077383|B1|Geographic ancestry|White-Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|125|125.0||||||
4253316|NCT00627458|4077380|B4||Male|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4253317|NCT00627458|4077381|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4253318|NCT00627458|4077382|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4253319|NCT00627458|4077383|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4253320|NCT00627458|4077380|B4||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4253321|NCT00627458|4077381|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4253322|NCT00627458|4077382|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4253323|NCT00627458|4077383|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4253324|NCT00627458|4077380|B4|||Age||Months|Mean|17.90|17.9|Standard Deviation|1.09|1.09|||
4253325|NCT00627458|4077381|B3|||Age||Months|Mean|17.8|17.8|Standard Deviation|1.11|1.11|||
4253326|NCT00627458|4077382|B2|||Age||Months|Mean|18|18.0|Standard Deviation|1.03|1.03|||
4253327|NCT00627458|4077383|B1|||Age||Months|Mean|17.9|17.9|Standard Deviation|1.12|1.12|||
4253328|NCT00627445|4077458|B3|||Weight||kg|Mean|69.9|69.9|Standard Deviation|9.7|9.7|||
4253329|NCT00627445|4077459|B2|||Weight||kg|Mean|70.5|70.5|Standard Deviation|9.7|9.7|||
4253330|NCT00627445|4077460|B1|||Weight||kg|Mean|69.2|69.2|Standard Deviation|9.8|9.8|||
4253331|NCT00627445|4077458|B3|||Height|Height at screening|cm|Mean|163.2|163.2|Standard Deviation|8.1|8.1|||
4253332|NCT00627445|4077459|B2|||Height|Height at screening|cm|Mean|163.7|163.7|Standard Deviation|8.4|8.4|||
4253333|NCT00627445|4077460|B1|||Height|Height at screening|cm|Mean|162.8|162.8|Standard Deviation|7.9|7.9|||
4253334|NCT00627445|4077458|B3|||BMI|BMI = Body Mass Index at randomisation|kg/m2|Mean|26.17|26.17|Standard Deviation|2.71|2.71|||
4253335|NCT00627445|4077459|B2|||BMI|BMI = Body Mass Index at randomisation|kg/m2|Mean|26.27|26.27|Standard Deviation|2.73|2.73|||
4253336|NCT00627445|4077460|B1|||BMI|BMI = Body Mass Index at randomisation|kg/m2|Mean|26.06|26.06|Standard Deviation|2.70|2.7|||
4253337|NCT00627445|4077458|B3||Male|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4253338|NCT00627445|4077459|B2||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4253339|NCT00627445|4077460|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4253340|NCT00627445|4077458|B3||Female|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
4253341|NCT00627445|4077459|B2||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4253342|NCT00627445|4077460|B1||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4253343|NCT00627445|4077458|B3|||Age|Age at screening|years|Mean|55.5|55.5|Standard Deviation|8.6|8.6|||
4253344|NCT00627445|4077459|B2|||Age|Age at screening|years|Mean|55.5|55.5|Standard Deviation|8.6|8.6|||
4253345|NCT00627445|4077460|B1|||Age|Age at screening|years|Mean|55.5|55.5|Standard Deviation|8.6|8.6|||
4253346|NCT00627406|4077481|B5|Denmark||Region of Enrollment||participants|Number|384|384.0||||||
4253347|NCT00627406|4077482|B4|Denmark||Region of Enrollment||participants|Number|141|141.0||||||
4253348|NCT00627406|4077483|B3|Denmark||Region of Enrollment||participants|Number|125|125.0||||||
4253349|NCT00627406|4077484|B2|Denmark||Region of Enrollment||participants|Number|58|58.0||||||
4253350|NCT00627406|4077485|B1|Denmark||Region of Enrollment||participants|Number|60|60.0||||||
4253351|NCT00627406|4077481|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4253352|NCT00627406|4077482|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4253353|NCT00627406|4077483|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4253354|NCT00627406|4077484|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4253355|NCT00627406|4077485|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4253356|NCT00627406|4077481|B5||Female|Sex: Female, Male||Participants|Count of Participants|384|384.0||||||
4253357|NCT00627406|4077482|B4||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4253358|NCT00627406|4077483|B3||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4253359|NCT00627406|4077484|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4253360|NCT00627406|4077485|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4253361|NCT00627406|4077481|B5|||Age||years|Mean|30.2|30.2|Standard Deviation|4.0|4.0|||
4253362|NCT00627406|4077482|B4|||Age||years|Mean|31.5|31.5|Standard Deviation|3.7|3.7|||
4253363|NCT00627406|4077483|B3|||Age||years|Mean|30.8|30.8|Standard Deviation|3.9|3.9|||
4253364|NCT00627406|4077484|B2|||Age||years|Mean|29.8|29.8|Standard Deviation|3.8|3.8|||
4253365|NCT00627406|4077485|B1|||Age||years|Mean|28.5|28.5|Standard Deviation|5.2|5.2|||
4253366|NCT00627406|4077481|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4253367|NCT00627406|4077482|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4253368|NCT00627406|4077483|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4253369|NCT00627406|4077484|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4253370|NCT00627406|4077485|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4253371|NCT00627406|4077481|B5||Between 18 and 65 years|Age||Participants|Count of Participants|384|384.0||||||
4253372|NCT00627406|4077482|B4||Between 18 and 65 years|Age||Participants|Count of Participants|141|141.0||||||
4253373|NCT00627406|4077483|B3||Between 18 and 65 years|Age||Participants|Count of Participants|125|125.0||||||
4253374|NCT00627406|4077484|B2||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4253375|NCT00627406|4077485|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4253376|NCT00627406|4077481|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4253377|NCT00627406|4077482|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4253378|NCT00627406|4077483|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4253379|NCT00627406|4077484|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4253380|NCT00627406|4077485|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4253381|NCT00627393|4077502|B3|Tissue fungal infection||Infection type||participants|Number|40|40.0||||||
4253382|NCT00627393|4077503|B2|Tissue fungal infection||Infection type||participants|Number|21|21.0||||||
4253383|NCT00627393|4077504|B1|Tissue fungal infection||Infection type||participants|Number|19|19.0||||||
4253384|NCT00627393|4077502|B3|Fungemia only||Infection type||participants|Number|13|13.0||||||
4253385|NCT00627393|4077503|B2|Fungemia only||Infection type||participants|Number|5|5.0||||||
4253386|NCT00627393|4077504|B1|Fungemia only||Infection type||participants|Number|8|8.0||||||
4253387|NCT00627393|4077502|B3|Tissue bacterial infection||Infection type||participants|Number|28|28.0||||||
4253388|NCT00627393|4077503|B2|Tissue bacterial infection||Infection type||participants|Number|13|13.0||||||
4253389|NCT00627393|4077504|B1|Tissue bacterial infection||Infection type||participants|Number|15|15.0||||||
4253390|NCT00627393|4077502|B3|Bacteremia only||Infection type||participants|Number|33|33.0||||||
4253391|NCT00627393|4077503|B2|Bacteremia only||Infection type||participants|Number|17|17.0||||||
4253392|NCT00627393|4077504|B1|Bacteremia only||Infection type||participants|Number|16|16.0||||||
4253393|NCT00627393|4077502|B3|3 to 5||Zubrod score|"The Zubrod scoring system ranks patients on their functionality on a scale from 0-5. Zubrod score category 0 to 2 represents asymptomatic, symptomatic but completely ambulatory, or symptomatic and 50% in bed during the day. Zubrod score category 3 to 5 represents symptomatic and more than 50% in bed (but not bedbound), being bedbound or completely disabled, or being moribund."|participants|Number|77|77.0||||||
4253394|NCT00627393|4077503|B2|3 to 5||Zubrod score|"The Zubrod scoring system ranks patients on their functionality on a scale from 0-5. Zubrod score category 0 to 2 represents asymptomatic, symptomatic but completely ambulatory, or symptomatic and 50% in bed during the day. Zubrod score category 3 to 5 represents symptomatic and more than 50% in bed (but not bedbound), being bedbound or completely disabled, or being moribund."|participants|Number|38|38.0||||||
4253395|NCT00627393|4077504|B1|3 to 5||Zubrod score|"The Zubrod scoring system ranks patients on their functionality on a scale from 0-5. Zubrod score category 0 to 2 represents asymptomatic, symptomatic but completely ambulatory, or symptomatic and 50% in bed during the day. Zubrod score category 3 to 5 represents symptomatic and more than 50% in bed (but not bedbound), being bedbound or completely disabled, or being moribund."|participants|Number|39|39.0||||||
4253396|NCT00627393|4077502|B3|0 to 2||Zubrod score|"The Zubrod scoring system ranks patients on their functionality on a scale from 0-5. Zubrod score category 0 to 2 represents asymptomatic, symptomatic but completely ambulatory, or symptomatic and 50% in bed during the day. Zubrod score category 3 to 5 represents symptomatic and more than 50% in bed (but not bedbound), being bedbound or completely disabled, or being moribund."|participants|Number|37|37.0||||||
4253397|NCT00627393|4077503|B2|0 to 2||Zubrod score|"The Zubrod scoring system ranks patients on their functionality on a scale from 0-5. Zubrod score category 0 to 2 represents asymptomatic, symptomatic but completely ambulatory, or symptomatic and 50% in bed during the day. Zubrod score category 3 to 5 represents symptomatic and more than 50% in bed (but not bedbound), being bedbound or completely disabled, or being moribund."|participants|Number|18|18.0||||||
4253398|NCT00627393|4077504|B1|0 to 2||Zubrod score|"The Zubrod scoring system ranks patients on their functionality on a scale from 0-5. Zubrod score category 0 to 2 represents asymptomatic, symptomatic but completely ambulatory, or symptomatic and 50% in bed during the day. Zubrod score category 3 to 5 represents symptomatic and more than 50% in bed (but not bedbound), being bedbound or completely disabled, or being moribund."|participants|Number|19|19.0||||||
4253399|NCT00627393|4077502|B3|||ANC prior to randomization|"ANC = Absolute neutrophil count.~Subjects with ANC less than 500/mm^3 were considered to have severe neutropenia."|x10^9 cells/L|Mean|0.052|0.052|Standard Deviation|0.094|0.094|||
4253400|NCT00627393|4077503|B2|||ANC prior to randomization|"ANC = Absolute neutrophil count.~Subjects with ANC less than 500/mm^3 were considered to have severe neutropenia."|x10^9 cells/L|Mean|0.058|0.058|Standard Deviation|0.096|0.096|||
4253401|NCT00627393|4077504|B1|||ANC prior to randomization|"ANC = Absolute neutrophil count.~Subjects with ANC less than 500/mm^3 were considered to have severe neutropenia."|x10^9 cells/L|Mean|0.046|0.046|Standard Deviation|0.091|0.091|||
4253402|NCT00627393|4077502|B3|HST (or preparation for HST)||Cause of neutropenia||participants|Number|17|17.0||||||
4253403|NCT00627393|4077503|B2|HST (or preparation for HST)||Cause of neutropenia||participants|Number|9|9.0||||||
4253404|NCT00627393|4077504|B1|HST (or preparation for HST)||Cause of neutropenia||participants|Number|8|8.0||||||
4253405|NCT00627393|4077502|B3|Infection||Cause of neutropenia||participants|Number|10|10.0||||||
4253406|NCT00627393|4077503|B2|Infection||Cause of neutropenia||participants|Number|3|3.0||||||
4253407|NCT00627393|4077504|B1|Infection||Cause of neutropenia||participants|Number|7|7.0||||||
4253408|NCT00627393|4077502|B3|Chemotherapy only||Cause of neutropenia||participants|Number|87|87.0||||||
4253409|NCT00627393|4077503|B2|Chemotherapy only||Cause of neutropenia||participants|Number|44|44.0||||||
4253410|NCT00627393|4077504|B1|Chemotherapy only||Cause of neutropenia||participants|Number|43|43.0||||||
4253411|NCT00627393|4077502|B3|||Weight||kg|Mean|77.3|77.3|Standard Deviation|22.2|22.2|||
4253412|NCT00627393|4077503|B2|||Weight||kg|Mean|78.7|78.7|Standard Deviation|20.6|20.6|||
4253413|NCT00627393|4077504|B1|||Weight||kg|Mean|76.0|76.0|Standard Deviation|23.8|23.8|||
4253414|NCT00627393|4077502|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4253415|NCT00627393|4077503|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4253416|NCT00627393|4077504|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4253417|NCT00627393|4077502|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4253418|NCT00627393|4077503|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4253419|NCT00627393|4077504|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4253420|NCT00627393|4077502|B3||White|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
4253421|NCT00627393|4077503|B2||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4253422|NCT00627393|4077504|B1||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4253423|NCT00627393|4077502|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4253424|NCT00627393|4077503|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4253425|NCT00627393|4077504|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4253426|NCT00627393|4077502|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4253427|NCT00627393|4077503|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4253428|NCT00627393|4077504|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4253429|NCT00627393|4077502|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4253430|NCT00627393|4077503|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4253431|NCT00627393|4077504|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4253432|NCT00627393|4077502|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4253433|NCT00627393|4077503|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4253434|NCT00627393|4077504|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4253435|NCT00627393|4077502|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4253436|NCT00627393|4077503|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4253437|NCT00627393|4077504|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4253438|NCT00627393|4077502|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
4253439|NCT00627393|4077503|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4253440|NCT00627393|4077504|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4253441|NCT00627393|4077502|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4253442|NCT00627393|4077503|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4253443|NCT00627393|4077504|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4253444|NCT00627393|4077502|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4253445|NCT00627393|4077503|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4253446|NCT00627393|4077504|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4253447|NCT00627393|4077502|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4253448|NCT00627393|4077503|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4253449|NCT00627393|4077504|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4253450|NCT00627393|4077502|B3|||Age||years|Mean|51.9|51.9|Standard Deviation|18.3|18.3|||
4253451|NCT00627393|4077503|B2|||Age||years|Mean|54.8|54.8|Standard Deviation|16.3|16.3|||
4253452|NCT00627393|4077504|B1|||Age||years|Mean|49.1|49.1|Standard Deviation|19.8|19.8|||
4253453|NCT00627393|4077502|B3||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
4253454|NCT00627393|4077503|B2||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4253455|NCT00627393|4077504|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4253456|NCT00627393|4077502|B3||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4253457|NCT00627393|4077503|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4253458|NCT00627393|4077504|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4253459|NCT00627393|4077502|B3||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4253460|NCT00627393|4077503|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4253461|NCT00627393|4077504|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4253462|NCT00627367|4077524|B3|||Analgesics taken at home||Participants|Count of Participants|61|61.0||||||
4253463|NCT00627367|4077525|B2|||Analgesics taken at home||Participants|Count of Participants|26|26.0||||||
4253464|NCT00627367|4077526|B1|||Analgesics taken at home||Participants|Count of Participants|35|35.0||||||
4253465|NCT00627367|4077524|B3|||Nausea/vomiting||Participants|Count of Participants|98|98.0||||||
4253466|NCT00627367|4077525|B2|||Nausea/vomiting||Participants|Count of Participants|54|54.0||||||
4253467|NCT00627367|4077526|B1|||Nausea/vomiting||Participants|Count of Participants|44|44.0||||||
4253468|NCT00627367|4077524|B3|10||Pain Intensity|"Pain intensity is measured on a numerical rating score (NRS) scale of 0 (no pain) to 10 (worst pain imaginable). This pain intensity measure is the pain intensity of the patient before treatment in the Emergency Department."|Participants|Count of Participants|122|122.0||||||
4253469|NCT00627367|4077525|B2|10||Pain Intensity|"Pain intensity is measured on a numerical rating score (NRS) scale of 0 (no pain) to 10 (worst pain imaginable). This pain intensity measure is the pain intensity of the patient before treatment in the Emergency Department."|Participants|Count of Participants|55|55.0||||||
4253470|NCT00627367|4077526|B1|10||Pain Intensity|"Pain intensity is measured on a numerical rating score (NRS) scale of 0 (no pain) to 10 (worst pain imaginable). This pain intensity measure is the pain intensity of the patient before treatment in the Emergency Department."|Participants|Count of Participants|67|67.0||||||
4253471|NCT00627367|4077524|B3|9||Pain Intensity|"Pain intensity is measured on a numerical rating score (NRS) scale of 0 (no pain) to 10 (worst pain imaginable). This pain intensity measure is the pain intensity of the patient before treatment in the Emergency Department."|Participants|Count of Participants|25|25.0||||||
4253472|NCT00627367|4077525|B2|9||Pain Intensity|"Pain intensity is measured on a numerical rating score (NRS) scale of 0 (no pain) to 10 (worst pain imaginable). This pain intensity measure is the pain intensity of the patient before treatment in the Emergency Department."|Participants|Count of Participants|14|14.0||||||
4253473|NCT00627367|4077526|B1|9||Pain Intensity|"Pain intensity is measured on a numerical rating score (NRS) scale of 0 (no pain) to 10 (worst pain imaginable). This pain intensity measure is the pain intensity of the patient before treatment in the Emergency Department."|Participants|Count of Participants|11|11.0||||||
4253474|NCT00627367|4077524|B3|8||Pain Intensity|"Pain intensity is measured on a numerical rating score (NRS) scale of 0 (no pain) to 10 (worst pain imaginable). This pain intensity measure is the pain intensity of the patient before treatment in the Emergency Department."|Participants|Count of Participants|48|48.0||||||
4253475|NCT00627367|4077525|B2|8||Pain Intensity|"Pain intensity is measured on a numerical rating score (NRS) scale of 0 (no pain) to 10 (worst pain imaginable). This pain intensity measure is the pain intensity of the patient before treatment in the Emergency Department."|Participants|Count of Participants|26|26.0||||||
4253476|NCT00627367|4077526|B1|8||Pain Intensity|"Pain intensity is measured on a numerical rating score (NRS) scale of 0 (no pain) to 10 (worst pain imaginable). This pain intensity measure is the pain intensity of the patient before treatment in the Emergency Department."|Participants|Count of Participants|22|22.0||||||
4253477|NCT00627367|4077524|B3|3-7||Pain Intensity|"Pain intensity is measured on a numerical rating score (NRS) scale of 0 (no pain) to 10 (worst pain imaginable). This pain intensity measure is the pain intensity of the patient before treatment in the Emergency Department."|Participants|Count of Participants|23|23.0||||||
4253478|NCT00627367|4077525|B2|3-7||Pain Intensity|"Pain intensity is measured on a numerical rating score (NRS) scale of 0 (no pain) to 10 (worst pain imaginable). This pain intensity measure is the pain intensity of the patient before treatment in the Emergency Department."|Participants|Count of Participants|15|15.0||||||
4253479|NCT00627367|4077526|B1|3-7||Pain Intensity|"Pain intensity is measured on a numerical rating score (NRS) scale of 0 (no pain) to 10 (worst pain imaginable). This pain intensity measure is the pain intensity of the patient before treatment in the Emergency Department."|Participants|Count of Participants|8|8.0||||||
4253480|NCT00627367|4077524|B3|Other||Location of Pain||Participants|Count of Participants|86|86.0||||||
4253481|NCT00627367|4077525|B2|Other||Location of Pain||Participants|Count of Participants|37|37.0||||||
4253482|NCT00627367|4077526|B1|Other||Location of Pain||Participants|Count of Participants|49|49.0||||||
4253483|NCT00627367|4077524|B3|Abdomen||Location of Pain||Participants|Count of Participants|132|132.0||||||
4253484|NCT00627367|4077525|B2|Abdomen||Location of Pain||Participants|Count of Participants|73|73.0||||||
4253485|NCT00627367|4077526|B1|Abdomen||Location of Pain||Participants|Count of Participants|59|59.0||||||
4253486|NCT00627367|4077524|B3|||Weight||lbs|Mean|178|178.0|Standard Deviation|51|51.0|||
4253487|NCT00627367|4077525|B2|||Weight||lbs|Mean|177|177.0|Standard Deviation|49|49.0|||
4253488|NCT00627367|4077526|B1|||Weight||lbs|Mean|179|179.0|Standard Deviation|52|52.0|||
4253489|NCT00627367|4077524|B3|United States||Region of Enrollment||Participants|Count of Participants|218|218.0||||||
4253490|NCT00627367|4077525|B2|United States||Region of Enrollment||Participants|Count of Participants|110|110.0||||||
4253491|NCT00627367|4077526|B1|United States||Region of Enrollment||Participants|Count of Participants|108|108.0||||||
4253492|NCT00627367|4077524|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4253493|NCT00627367|4077525|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4253494|NCT00627367|4077526|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4253495|NCT00627367|4077524|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|138|138.0||||||
4253496|NCT00627367|4077525|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|66|66.0||||||
4253497|NCT00627367|4077526|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|72|72.0||||||
4253498|NCT00627367|4077524|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4253499|NCT00627367|4077525|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4253500|NCT00627367|4077526|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4253501|NCT00627367|4077524|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|59|59.0||||||
4253502|NCT00627367|4077525|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
4253503|NCT00627367|4077526|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
4253504|NCT00627367|4077524|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4253505|NCT00627367|4077525|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4253506|NCT00627367|4077526|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4253507|NCT00627367|4077524|B3||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4253508|NCT00627367|4077525|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4253509|NCT00627367|4077526|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4253510|NCT00627367|4077524|B3|||Age||years|Mean|41|41.0|Standard Deviation|12|12.0|||
4253511|NCT00627367|4077525|B2|||Age||years|Mean|41|41.0|Standard Deviation|12|12.0|||
4253512|NCT00627367|4077526|B1|||Age||years|Mean|40|40.0|Standard Deviation|11|11.0|||
4253513|NCT00627094|4077539|B3|Germany||Region of Enrollment||participants|Number|44|44.0||||||
4253514|NCT00627094|4077540|B2|Germany||Region of Enrollment||participants|Number|22|22.0||||||
4253515|NCT00627094|4077541|B1|Germany||Region of Enrollment||participants|Number|22|22.0||||||
4253516|NCT00627094|4077539|B3|Denmark||Region of Enrollment||participants|Number|64|64.0||||||
4253517|NCT00627094|4077540|B2|Denmark||Region of Enrollment||participants|Number|32|32.0||||||
4253518|NCT00627094|4077541|B1|Denmark||Region of Enrollment||participants|Number|32|32.0||||||
4253519|NCT00627094|4077539|B3|Spain||Region of Enrollment||participants|Number|6|6.0||||||
4253520|NCT00627094|4077540|B2|Spain||Region of Enrollment||participants|Number|3|3.0||||||
4253521|NCT00627094|4077541|B1|Spain||Region of Enrollment||participants|Number|3|3.0||||||
4253522|NCT00627094|4077539|B3|France||Region of Enrollment||participants|Number|6|6.0||||||
4253523|NCT00627094|4077540|B2|France||Region of Enrollment||participants|Number|3|3.0||||||
4253524|NCT00627094|4077541|B1|France||Region of Enrollment||participants|Number|3|3.0||||||
4253525|NCT00627094|4077539|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4253526|NCT00627094|4077540|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4253527|NCT00627094|4077541|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4253528|NCT00627094|4077539|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4253529|NCT00627094|4077540|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4253530|NCT00627094|4077541|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4253531|NCT00627094|4077539|B3|Age||Age||YEARS|Mean|70.6|70.6|Standard Deviation|12.7|12.7|||
4253532|NCT00627094|4077540|B2|Age||Age||YEARS|Mean|69.5|69.5|Standard Deviation|12.5|12.5|||
4253533|NCT00627094|4077541|B1|Age||Age||YEARS|Mean|71.6|71.6|Standard Deviation|12.8|12.8|||
4253534|NCT00627042|4077554|B1|Hepatitis B and C Negative||Hepatitis B and C Status|Number of participants with hepatitis status data (N=39). Participants whose hepatitis status is hepatitis B and C positive are not counted in the hepatitis B positive or hepatitis C positive category.|participants|Number|15|15.0||||||
4253535|NCT00627042|4077554|B1|Hepatitis B and C Positive||Hepatitis B and C Status|Number of participants with hepatitis status data (N=39). Participants whose hepatitis status is hepatitis B and C positive are not counted in the hepatitis B positive or hepatitis C positive category.|participants|Number|2|2.0||||||
4253536|NCT00627042|4077554|B1|Hepatitis C Positive||Hepatitis B and C Status|Number of participants with hepatitis status data (N=39). Participants whose hepatitis status is hepatitis B and C positive are not counted in the hepatitis B positive or hepatitis C positive category.|participants|Number|19|19.0||||||
4253537|NCT00627042|4077554|B1|Hepatitis B Positive||Hepatitis B and C Status|Number of participants with hepatitis status data (N=39). Participants whose hepatitis status is hepatitis B and C positive are not counted in the hepatitis B positive or hepatitis C positive category.|participants|Number|3|3.0||||||
4253538|NCT00627042|4077554|B1|Absent||Extrahepatic Metastasis Status|The number of participants with extrahepatic metastasis (metastases originating or occurring outside the liver) present or absent.|participants|Number|10|10.0||||||
4253539|NCT00627042|4077554|B1|Present||Extrahepatic Metastasis Status|The number of participants with extrahepatic metastasis (metastases originating or occurring outside the liver) present or absent.|participants|Number|32|32.0||||||
4253540|NCT00627042|4077554|B1|Missing||Macrovascular Invasion|The number of participants with macrovascular invasion (gross vascular invasion of major portal or hepatic veins) present, absent, not available, or missing.|participants|Number|1|1.0||||||
4253541|NCT00627042|4077554|B1|Not Available||Macrovascular Invasion|The number of participants with macrovascular invasion (gross vascular invasion of major portal or hepatic veins) present, absent, not available, or missing.|participants|Number|2|2.0||||||
4253542|NCT00627042|4077554|B1|Absent||Macrovascular Invasion|The number of participants with macrovascular invasion (gross vascular invasion of major portal or hepatic veins) present, absent, not available, or missing.|participants|Number|32|32.0||||||
4253543|NCT00627042|4077554|B1|Present||Macrovascular Invasion|The number of participants with macrovascular invasion (gross vascular invasion of major portal or hepatic veins) present, absent, not available, or missing.|participants|Number|7|7.0||||||
4253544|NCT00627042|4077554|B1|C||Barcelona Stage|Barcelona Clinic Liver Cancer stage A, B, C [Franca AV et al., Braz J Med Biol Res. 2004;37(11):1689-1705]. Based on tumor burden (TB, amount of cancer in body), Child-Pugh (CP) class, Eastern Cooperative Oncology Group performance status test (PST) functional impairment [0 (Fully Active) to 5 (Death)]. Stage A [TB=single nodule or 3 nodules <3 cm, CP=A or B, PST=0 (fully active)]. Stage B (TB=single nodule >5 cm or multinodular, CP=A or B, PST=0). Stage C [TB=vascular invasion and/or metastasis, CP=A or B, PST=1 or 2 (ambulatory, restricted work activity or ambulatory, no work activity)].|participants|Number|36|36.0||||||
4253545|NCT00627042|4077554|B1|B||Barcelona Stage|Barcelona Clinic Liver Cancer stage A, B, C [Franca AV et al., Braz J Med Biol Res. 2004;37(11):1689-1705]. Based on tumor burden (TB, amount of cancer in body), Child-Pugh (CP) class, Eastern Cooperative Oncology Group performance status test (PST) functional impairment [0 (Fully Active) to 5 (Death)]. Stage A [TB=single nodule or 3 nodules <3 cm, CP=A or B, PST=0 (fully active)]. Stage B (TB=single nodule >5 cm or multinodular, CP=A or B, PST=0). Stage C [TB=vascular invasion and/or metastasis, CP=A or B, PST=1 or 2 (ambulatory, restricted work activity or ambulatory, no work activity)].|participants|Number|4|4.0||||||
4253546|NCT00627042|4077554|B1|A||Barcelona Stage|Barcelona Clinic Liver Cancer stage A, B, C [Franca AV et al., Braz J Med Biol Res. 2004;37(11):1689-1705]. Based on tumor burden (TB, amount of cancer in body), Child-Pugh (CP) class, Eastern Cooperative Oncology Group performance status test (PST) functional impairment [0 (Fully Active) to 5 (Death)]. Stage A [TB=single nodule or 3 nodules <3 cm, CP=A or B, PST=0 (fully active)]. Stage B (TB=single nodule >5 cm or multinodular, CP=A or B, PST=0). Stage C [TB=vascular invasion and/or metastasis, CP=A or B, PST=1 or 2 (ambulatory, restricted work activity or ambulatory, no work activity)].|participants|Number|2|2.0||||||
4253547|NCT00627042|4077554|B1|B||Child-Pugh Score|The Child-Pugh classification was used to assess the prognosis of chronic liver disease. The score employed 5 clinical measures of liver disease: encephalopathy, ascites, albumin, prothrombin time, and bilirubin. Each measure was scored from 1 (normal) and 3 (most severe derangement). The total score for the Child-Pugh assessment was calculated as the sum of the 5 contributing scores with a total possible score of 15. Chronic liver disease was classified into Child-Pugh classes A to C, employing the total score from above: 5-6=Class A; 7-9=Class B; 10-15=Class C.|participants|Number|11|11.0||||||
4253548|NCT00627042|4077554|B1|A||Child-Pugh Score|The Child-Pugh classification was used to assess the prognosis of chronic liver disease. The score employed 5 clinical measures of liver disease: encephalopathy, ascites, albumin, prothrombin time, and bilirubin. Each measure was scored from 1 (normal) and 3 (most severe derangement). The total score for the Child-Pugh assessment was calculated as the sum of the 5 contributing scores with a total possible score of 15. Chronic liver disease was classified into Child-Pugh classes A to C, employing the total score from above: 5-6=Class A; 7-9=Class B; 10-15=Class C.|participants|Number|31|31.0||||||
4253549|NCT00627042|4077554|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4253550|NCT00627042|4077554|B1|Race Other: Greek||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4253551|NCT00627042|4077554|B1|Race Other: Black and Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4253552|NCT00627042|4077554|B1|Race Other: Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4253553|NCT00627042|4077554|B1|White||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4253554|NCT00627042|4077554|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4253555|NCT00627042|4077554|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4253556|NCT00627042|4077554|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4253557|NCT00627042|4077554|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4253558|NCT00627042|4077554|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4253559|NCT00627042|4077554|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4253560|NCT00627042|4077554|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4253561|NCT00627042|4077554|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4253562|NCT00627042|4077554|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4253563|NCT00627042|4077554|B1|>=65 years||Age, Customized||participants|Number|15|15.0||||||
4253564|NCT00627042|4077554|B1|Between 18 and 65 years||Age, Customized||participants|Number|27|27.0||10.70|10.7|||
4253565|NCT00627016|4077564|B3|6-7 Nights||Number of Nights with Sleep Disturbances Related to Gastroesophageal Reflux Disease (GERD) Symptoms|Baseline diary data were summarized using the non-missing diary entries from Study Day -8 to -2, inclusive.|participants|Number|132|132.0||||||
4253566|NCT00627016|4077565|B2|6-7 Nights||Number of Nights with Sleep Disturbances Related to Gastroesophageal Reflux Disease (GERD) Symptoms|Baseline diary data were summarized using the non-missing diary entries from Study Day -8 to -2, inclusive.|participants|Number|72|72.0||||||
4253567|NCT00627016|4077566|B1|6-7 Nights||Number of Nights with Sleep Disturbances Related to Gastroesophageal Reflux Disease (GERD) Symptoms|Baseline diary data were summarized using the non-missing diary entries from Study Day -8 to -2, inclusive.|participants|Number|60|60.0||||||
4253568|NCT00627016|4077564|B3|4-5 Nights||Number of Nights with Sleep Disturbances Related to Gastroesophageal Reflux Disease (GERD) Symptoms|Baseline diary data were summarized using the non-missing diary entries from Study Day -8 to -2, inclusive.|participants|Number|100|100.0||||||
4253569|NCT00627016|4077565|B2|4-5 Nights||Number of Nights with Sleep Disturbances Related to Gastroesophageal Reflux Disease (GERD) Symptoms|Baseline diary data were summarized using the non-missing diary entries from Study Day -8 to -2, inclusive.|participants|Number|47|47.0||||||
4253570|NCT00627016|4077566|B1|4-5 Nights||Number of Nights with Sleep Disturbances Related to Gastroesophageal Reflux Disease (GERD) Symptoms|Baseline diary data were summarized using the non-missing diary entries from Study Day -8 to -2, inclusive.|participants|Number|53|53.0||||||
4253571|NCT00627016|4077564|B3|0-3 Nights||Number of Nights with Sleep Disturbances Related to Gastroesophageal Reflux Disease (GERD) Symptoms|Baseline diary data were summarized using the non-missing diary entries from Study Day -8 to -2, inclusive.|participants|Number|73|73.0||||||
4253572|NCT00627016|4077565|B2|0-3 Nights||Number of Nights with Sleep Disturbances Related to Gastroesophageal Reflux Disease (GERD) Symptoms|Baseline diary data were summarized using the non-missing diary entries from Study Day -8 to -2, inclusive.|participants|Number|33|33.0||||||
4253573|NCT00627016|4077566|B1|0-3 Nights||Number of Nights with Sleep Disturbances Related to Gastroesophageal Reflux Disease (GERD) Symptoms|Baseline diary data were summarized using the non-missing diary entries from Study Day -8 to -2, inclusive.|participants|Number|40|40.0||||||
4253574|NCT00627016|4077564|B3|6-7 days||Number of Days with Night Heartburn|Baseline diary data were summarized using the non-missing diary entries from Study Day -8 to -2, inclusive.|participants|Number|218|218.0||||||
4253575|NCT00627016|4077565|B2|6-7 days||Number of Days with Night Heartburn|Baseline diary data were summarized using the non-missing diary entries from Study Day -8 to -2, inclusive.|participants|Number|111|111.0||||||
4253576|NCT00627016|4077566|B1|6-7 days||Number of Days with Night Heartburn|Baseline diary data were summarized using the non-missing diary entries from Study Day -8 to -2, inclusive.|participants|Number|107|107.0||||||
4253577|NCT00627016|4077564|B3|4-5 days||Number of Days with Night Heartburn|Baseline diary data were summarized using the non-missing diary entries from Study Day -8 to -2, inclusive.|participants|Number|74|74.0||||||
4253578|NCT00627016|4077565|B2|4-5 days||Number of Days with Night Heartburn|Baseline diary data were summarized using the non-missing diary entries from Study Day -8 to -2, inclusive.|participants|Number|38|38.0||||||
4253579|NCT00627016|4077566|B1|4-5 days||Number of Days with Night Heartburn|Baseline diary data were summarized using the non-missing diary entries from Study Day -8 to -2, inclusive.|participants|Number|36|36.0||||||
4253580|NCT00627016|4077564|B3|0-3 days||Number of Days with Night Heartburn|Baseline diary data were summarized using the non-missing diary entries from Study Day -8 to -2, inclusive.|participants|Number|13|13.0||||||
4253581|NCT00627016|4077565|B2|0-3 days||Number of Days with Night Heartburn|Baseline diary data were summarized using the non-missing diary entries from Study Day -8 to -2, inclusive.|participants|Number|3|3.0||||||
4253582|NCT00627016|4077566|B1|0-3 days||Number of Days with Night Heartburn|Baseline diary data were summarized using the non-missing diary entries from Study Day -8 to -2, inclusive.|participants|Number|10|10.0||||||
4253583|NCT00627016|4077564|B3|United States||Region of Enrollment||participants|Number|305|305.0||||||
4253584|NCT00627016|4077565|B2|United States||Region of Enrollment||participants|Number|152|152.0||||||
4253585|NCT00627016|4077566|B1|United States||Region of Enrollment||participants|Number|153|153.0||||||
4253586|NCT00627016|4077564|B3||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4253587|NCT00627016|4077565|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4253588|NCT00627016|4077566|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4253589|NCT00627016|4077564|B3||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4253590|NCT00627016|4077565|B2||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4253591|NCT00627016|4077566|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4253592|NCT00627016|4077564|B3|||Age||years|Mean|44.2|44.2|Standard Deviation|11.87|11.87|||
4253593|NCT00627016|4077565|B2|||Age||years|Mean|44.6|44.6|Standard Deviation|11.29|11.29|||
4253594|NCT00627016|4077566|B1|||Age||years|Mean|43.9|43.9|Standard Deviation|12.45|12.45|||
4253595|NCT00627016|4077564|B3|>=65 years||Age, Customized||participants|Number|4|4.0||||||
4253596|NCT00627016|4077565|B2|>=65 years||Age, Customized||participants|Number|2|2.0||||||
4253597|NCT00627016|4077566|B1|>=65 years||Age, Customized||participants|Number|2|2.0||||||
4253598|NCT00627016|4077564|B3|45 to <65 years||Age, Customized||participants|Number|151|151.0||||||
4253599|NCT00627016|4077565|B2|45 to <65 years||Age, Customized||participants|Number|75|75.0||||||
4253600|NCT00627016|4077566|B1|45 to <65 years||Age, Customized||participants|Number|76|76.0||||||
4253601|NCT00627016|4077564|B3|<45 years||Age, Customized||participants|Number|150|150.0||||||
4253602|NCT00627016|4077565|B2|<45 years||Age, Customized||participants|Number|75|75.0||||||
4253603|NCT00627016|4077566|B1|<45 years||Age, Customized||participants|Number|75|75.0||||||
4253604|NCT00626925|4077577|B3|||Mean Daily Alcohol Consumption||Number of SD Drinks per day|Mean|5.314|5.314|Standard Deviation|1.875|1.875|||
4253605|NCT00626925|4077578|B2|||Mean Daily Alcohol Consumption||Number of SD Drinks per day|Mean|5.207|5.207|Standard Deviation|1.735|1.735|||
4253606|NCT00626925|4077579|B1|||Mean Daily Alcohol Consumption||Number of SD Drinks per day|Mean|5.426|5.426|Standard Deviation|2.019|2.019|||
4253607|NCT00626925|4077577|B3|AA||Genotype||Participants|Number|23|23.0||||||
4253608|NCT00626925|4077578|B2|AA||Genotype||Participants|Number|8|8.0||||||
4253609|NCT00626925|4077579|B1|AA||Genotype||Participants|Number|15|15.0||||||
4253610|NCT00626925|4077577|B3|AC||Genotype||Participants|Number|61|61.0||||||
4253611|NCT00626925|4077578|B2|AC||Genotype||Participants|Number|32|32.0||||||
4253612|NCT00626925|4077579|B1|AC||Genotype||Participants|Number|29|29.0||||||
4253613|NCT00626925|4077577|B3|CC||Genotype||Participants|Number|54|54.0||||||
4253614|NCT00626925|4077578|B2|CC||Genotype||Participants|Number|31|31.0||||||
4253615|NCT00626925|4077579|B1|CC||Genotype||Participants|Number|23|23.0||||||
4253616|NCT00626925|4077577|B3|No lifetime Major Depression episode||Lifetime major depression (M.D.)|Lifetime episode of major depression based on a Structured Clinical Interview for DSM-IV (SCID-I/P) (First et al. 2001). The SCID Module A: Mood Episodes was used to classify patients according to the presence or absence of Lifetime episode of major depression. The SCID-I/P is a procedure designed to determine diagnoses and symptoms according to DSM-IV (American Psychiatric Association 1994).|# of participants|Number|98|98.0||||||
4253617|NCT00626925|4077578|B2|No lifetime Major Depression episode||Lifetime major depression (M.D.)|Lifetime episode of major depression based on a Structured Clinical Interview for DSM-IV (SCID-I/P) (First et al. 2001). The SCID Module A: Mood Episodes was used to classify patients according to the presence or absence of Lifetime episode of major depression. The SCID-I/P is a procedure designed to determine diagnoses and symptoms according to DSM-IV (American Psychiatric Association 1994).|# of participants|Number|49|49.0||||||
4253618|NCT00626925|4077579|B1|No lifetime Major Depression episode||Lifetime major depression (M.D.)|Lifetime episode of major depression based on a Structured Clinical Interview for DSM-IV (SCID-I/P) (First et al. 2001). The SCID Module A: Mood Episodes was used to classify patients according to the presence or absence of Lifetime episode of major depression. The SCID-I/P is a procedure designed to determine diagnoses and symptoms according to DSM-IV (American Psychiatric Association 1994).|# of participants|Number|49|49.0||||||
4253619|NCT00626925|4077577|B3|Lifetime episode Major Depression||Lifetime major depression (M.D.)|Lifetime episode of major depression based on a Structured Clinical Interview for DSM-IV (SCID-I/P) (First et al. 2001). The SCID Module A: Mood Episodes was used to classify patients according to the presence or absence of Lifetime episode of major depression. The SCID-I/P is a procedure designed to determine diagnoses and symptoms according to DSM-IV (American Psychiatric Association 1994).|# of participants|Number|40|40.0||||||
4253645|NCT00626925|4077579|B1|Less than $40,000||Annual Income|Annual income measured in categorical amounts|participants|Number|6|6.0||||||
4253646|NCT00626925|4077577|B3|Not married||Marital Status|Total number married|Number of participants|Number|54|54.0||||||
4253647|NCT00626925|4077578|B2|Not married||Marital Status|Total number married|Number of participants|Number|26|26.0||||||
4253620|NCT00626925|4077578|B2|Lifetime episode Major Depression||Lifetime major depression (M.D.)|Lifetime episode of major depression based on a Structured Clinical Interview for DSM-IV (SCID-I/P) (First et al. 2001). The SCID Module A: Mood Episodes was used to classify patients according to the presence or absence of Lifetime episode of major depression. The SCID-I/P is a procedure designed to determine diagnoses and symptoms according to DSM-IV (American Psychiatric Association 1994).|# of participants|Number|22|22.0||||||
4253621|NCT00626925|4077579|B1|Lifetime episode Major Depression||Lifetime major depression (M.D.)|Lifetime episode of major depression based on a Structured Clinical Interview for DSM-IV (SCID-I/P) (First et al. 2001). The SCID Module A: Mood Episodes was used to classify patients according to the presence or absence of Lifetime episode of major depression. The SCID-I/P is a procedure designed to determine diagnoses and symptoms according to DSM-IV (American Psychiatric Association 1994).|# of participants|Number|18|18.0||||||
4253622|NCT00626925|4077577|B3|||Short Index of Problems|The Short Inventory of Problems (SIP). The SIP, a 15-item instrument, yields a total score that ranges from 0 to 45, higher score worse outcomes. The SIP was derived from the Drinker Inventory of Consequences (DrInC), which was developed for use in Project MATCH (Miller and Tonigan 1995). We (Feinn et al. 2003) have found that, like the DrInC, the SIP measures a single factor of alcohol-related problems. Given that it is substantially shorter than the DrInC, we will use the SIP as a measure of alcohol-related consequences.|units on a scale|Mean|15.20|15.2|Standard Deviation|7.6|7.6|||
4253623|NCT00626925|4077578|B2|||Short Index of Problems|The Short Inventory of Problems (SIP). The SIP, a 15-item instrument, yields a total score that ranges from 0 to 45, higher score worse outcomes. The SIP was derived from the Drinker Inventory of Consequences (DrInC), which was developed for use in Project MATCH (Miller and Tonigan 1995). We (Feinn et al. 2003) have found that, like the DrInC, the SIP measures a single factor of alcohol-related problems. Given that it is substantially shorter than the DrInC, we will use the SIP as a measure of alcohol-related consequences.|units on a scale|Mean|15.5|15.5|Standard Deviation|6.7|6.7|||
4253624|NCT00626925|4077579|B1|||Short Index of Problems|The Short Inventory of Problems (SIP). The SIP, a 15-item instrument, yields a total score that ranges from 0 to 45, higher score worse outcomes. The SIP was derived from the Drinker Inventory of Consequences (DrInC), which was developed for use in Project MATCH (Miller and Tonigan 1995). We (Feinn et al. 2003) have found that, like the DrInC, the SIP measures a single factor of alcohol-related problems. Given that it is substantially shorter than the DrInC, we will use the SIP as a measure of alcohol-related consequences.|units on a scale|Mean|14.9|14.9|Standard Deviation|8.6|8.6|||
4253625|NCT00626925|4077577|B3|||Proportion of abstinent days|Proportion of abstinent days, 90 days preceding the screening visit.|Proportion of abstinent days|Mean|0.12|0.12|Standard Deviation|0.15|0.15|||
4253626|NCT00626925|4077578|B2|||Proportion of abstinent days|Proportion of abstinent days, 90 days preceding the screening visit.|Proportion of abstinent days|Mean|0.12|0.12|Standard Deviation|0.15|0.15|||
4253627|NCT00626925|4077579|B1|||Proportion of abstinent days|Proportion of abstinent days, 90 days preceding the screening visit.|Proportion of abstinent days|Mean|0.13|0.13|Standard Deviation|0.16|0.16|||
4253628|NCT00626925|4077577|B3|||Beck Depression Inventory score|Total Beck Depression Inventory score The Beck Depression Inventory (BDI), a 21-item self-report measure of depressive symptoms, yields a total score that ranges from 0 to 63, higher scores indicating higher depression (Beck et al. 1961). The BDI is generally regarded as a sensitive self-report measure of depressive symptoms, and will be used to explore the relation between depressive symptoms and response to medication and counseling.|units on a scale|Mean|6.48|6.48|Standard Deviation|5.07|5.07|||
4253629|NCT00626925|4077578|B2|||Beck Depression Inventory score|Total Beck Depression Inventory score The Beck Depression Inventory (BDI), a 21-item self-report measure of depressive symptoms, yields a total score that ranges from 0 to 63, higher scores indicating higher depression (Beck et al. 1961). The BDI is generally regarded as a sensitive self-report measure of depressive symptoms, and will be used to explore the relation between depressive symptoms and response to medication and counseling.|units on a scale|Mean|6.8|6.8|Standard Deviation|5.3|5.3|||
4253630|NCT00626925|4077579|B1|||Beck Depression Inventory score|Total Beck Depression Inventory score The Beck Depression Inventory (BDI), a 21-item self-report measure of depressive symptoms, yields a total score that ranges from 0 to 63, higher scores indicating higher depression (Beck et al. 1961). The BDI is generally regarded as a sensitive self-report measure of depressive symptoms, and will be used to explore the relation between depressive symptoms and response to medication and counseling.|units on a scale|Mean|6.1|6.1|Standard Deviation|4.8|4.8|||
4253631|NCT00626925|4077577|B3|Missing||Annual Income|Annual income measured in categorical amounts|participants|Number|1|1.0||||||
4253632|NCT00626925|4077578|B2|Missing||Annual Income|Annual income measured in categorical amounts|participants|Number|0|0.0||||||
4253633|NCT00626925|4077579|B1|Missing||Annual Income|Annual income measured in categorical amounts|participants|Number|1|1.0||||||
4253634|NCT00626925|4077577|B3|$120,000 or more||Annual Income|Annual income measured in categorical amounts|participants|Number|56|56.0||||||
4253635|NCT00626925|4077578|B2|$120,000 or more||Annual Income|Annual income measured in categorical amounts|participants|Number|28|28.0||||||
4253636|NCT00626925|4077579|B1|$120,000 or more||Annual Income|Annual income measured in categorical amounts|participants|Number|28|28.0||||||
4253637|NCT00626925|4077577|B3|$80,000 –$119,000||Annual Income|Annual income measured in categorical amounts|participants|Number|37|37.0||||||
4253638|NCT00626925|4077578|B2|$80,000 –$119,000||Annual Income|Annual income measured in categorical amounts|participants|Number|19|19.0||||||
4253639|NCT00626925|4077579|B1|$80,000 –$119,000||Annual Income|Annual income measured in categorical amounts|participants|Number|18|18.0||||||
4253640|NCT00626925|4077577|B3|$40,000–$79,999||Annual Income|Annual income measured in categorical amounts|participants|Number|29|29.0||||||
4253641|NCT00626925|4077578|B2|$40,000–$79,999||Annual Income|Annual income measured in categorical amounts|participants|Number|15|15.0||||||
4253642|NCT00626925|4077579|B1|$40,000–$79,999||Annual Income|Annual income measured in categorical amounts|participants|Number|14|14.0||||||
4253643|NCT00626925|4077577|B3|Less than $40,000||Annual Income|Annual income measured in categorical amounts|participants|Number|15|15.0||||||
4253644|NCT00626925|4077578|B2|Less than $40,000||Annual Income|Annual income measured in categorical amounts|participants|Number|9|9.0||||||
4253648|NCT00626925|4077579|B1|Not married||Marital Status|Total number married|Number of participants|Number|28|28.0||||||
4253649|NCT00626925|4077577|B3|Married||Marital Status|Total number married|Number of participants|Number|84|84.0||||||
4253650|NCT00626925|4077578|B2|Married||Marital Status|Total number married|Number of participants|Number|45|45.0||||||
4253651|NCT00626925|4077579|B1|Married||Marital Status|Total number married|Number of participants|Number|39|39.0||||||
4253652|NCT00626925|4077577|B3|||Education|Level of Education measured in years of education.|years|Mean|15.5|15.5|Standard Deviation|2.5|2.5|||
4253653|NCT00626925|4077578|B2|||Education|Level of Education measured in years of education.|years|Mean|15.3|15.3|Standard Deviation|2.5|2.5|||
4253654|NCT00626925|4077579|B1|||Education|Level of Education measured in years of education.|years|Mean|15.8|15.8|Standard Deviation|2.5|2.5|||
4253655|NCT00626925|4077577|B3|University of Pennsylvania||Location of enrollment|Connecticut subjects were enrolled at the University of Connecticut and Philadelphia subjects at the University of Pennsylvania.|participants|Number|62|62.0||||||
4253656|NCT00626925|4077578|B2|University of Pennsylvania||Location of enrollment|Connecticut subjects were enrolled at the University of Connecticut and Philadelphia subjects at the University of Pennsylvania.|participants|Number|34|34.0||||||
4253657|NCT00626925|4077579|B1|University of Pennsylvania||Location of enrollment|Connecticut subjects were enrolled at the University of Connecticut and Philadelphia subjects at the University of Pennsylvania.|participants|Number|28|28.0||||||
4253658|NCT00626925|4077577|B3|University Of Connecticut||Location of enrollment|Connecticut subjects were enrolled at the University of Connecticut and Philadelphia subjects at the University of Pennsylvania.|participants|Number|76|76.0||||||
4253659|NCT00626925|4077578|B2|University Of Connecticut||Location of enrollment|Connecticut subjects were enrolled at the University of Connecticut and Philadelphia subjects at the University of Pennsylvania.|participants|Number|37|37.0||||||
4253660|NCT00626925|4077579|B1|University Of Connecticut||Location of enrollment|Connecticut subjects were enrolled at the University of Connecticut and Philadelphia subjects at the University of Pennsylvania.|participants|Number|39|39.0||||||
4253661|NCT00626925|4077577|B3|||Proportion Heavy drinking Days preceding screening visit|Proportion of Heavy drinking Days, 90 days preceding the screening visit|Proportion Heavy drinking days|Mean|.66|0.66|Standard Deviation|.27|0.27|||
4253662|NCT00626925|4077578|B2|||Proportion Heavy drinking Days preceding screening visit|Proportion of Heavy drinking Days, 90 days preceding the screening visit|Proportion Heavy drinking days|Mean|.66|0.66|Standard Deviation|.27|0.27|||
4253663|NCT00626925|4077579|B1|||Proportion Heavy drinking Days preceding screening visit|Proportion of Heavy drinking Days, 90 days preceding the screening visit|Proportion Heavy drinking days|Mean|.67|0.67|Standard Deviation|.27|0.27|||
4253664|NCT00626925|4077577|B3||Unknown or Not Reported|Race (NIH/OMB)|We collect information about race from participants|Participants|Count of Participants|1|1.0||||||
4253665|NCT00626925|4077578|B2||Unknown or Not Reported|Race (NIH/OMB)|We collect information about race from participants|Participants|Count of Participants|0|0.0||||||
4253666|NCT00626925|4077579|B1||Unknown or Not Reported|Race (NIH/OMB)|We collect information about race from participants|Participants|Count of Participants|1|1.0||||||
4253667|NCT00626925|4077577|B3||More than one race|Race (NIH/OMB)|We collect information about race from participants|Participants|Count of Participants|0|0.0||||||
4253668|NCT00626925|4077578|B2||More than one race|Race (NIH/OMB)|We collect information about race from participants|Participants|Count of Participants|0|0.0||||||
4253669|NCT00626925|4077579|B1||More than one race|Race (NIH/OMB)|We collect information about race from participants|Participants|Count of Participants|0|0.0||||||
4253670|NCT00626925|4077577|B3||White|Race (NIH/OMB)|We collect information about race from participants|Participants|Count of Participants|122|122.0||||||
4253671|NCT00626925|4077578|B2||White|Race (NIH/OMB)|We collect information about race from participants|Participants|Count of Participants|66|66.0||||||
4253672|NCT00626925|4077579|B1||White|Race (NIH/OMB)|We collect information about race from participants|Participants|Count of Participants|56|56.0||||||
4253673|NCT00626925|4077577|B3||Black or African American|Race (NIH/OMB)|We collect information about race from participants|Participants|Count of Participants|14|14.0||||||
4253674|NCT00626925|4077578|B2||Black or African American|Race (NIH/OMB)|We collect information about race from participants|Participants|Count of Participants|4|4.0||||||
4253675|NCT00626925|4077579|B1||Black or African American|Race (NIH/OMB)|We collect information about race from participants|Participants|Count of Participants|10|10.0||||||
4253676|NCT00626925|4077577|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|We collect information about race from participants|Participants|Count of Participants|0|0.0||||||
4253677|NCT00626925|4077578|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|We collect information about race from participants|Participants|Count of Participants|0|0.0||||||
4253678|NCT00626925|4077579|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|We collect information about race from participants|Participants|Count of Participants|0|0.0||||||
4253679|NCT00626925|4077577|B3||Asian|Race (NIH/OMB)|We collect information about race from participants|Participants|Count of Participants|1|1.0||||||
4253680|NCT00626925|4077578|B2||Asian|Race (NIH/OMB)|We collect information about race from participants|Participants|Count of Participants|1|1.0||||||
4253681|NCT00626925|4077579|B1||Asian|Race (NIH/OMB)|We collect information about race from participants|Participants|Count of Participants|0|0.0||||||
4253682|NCT00626925|4077577|B3||American Indian or Alaska Native|Race (NIH/OMB)|We collect information about race from participants|Participants|Count of Participants|0|0.0||||||
4253683|NCT00626925|4077578|B2||American Indian or Alaska Native|Race (NIH/OMB)|We collect information about race from participants|Participants|Count of Participants|0|0.0||||||
4253684|NCT00626925|4077579|B1||American Indian or Alaska Native|Race (NIH/OMB)|We collect information about race from participants|Participants|Count of Participants|0|0.0||||||
4253685|NCT00626925|4077577|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4253686|NCT00626925|4077578|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4253687|NCT00626925|4077579|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4253688|NCT00626925|4077577|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4253689|NCT00626925|4077578|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4253690|NCT00626925|4077579|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4253691|NCT00626925|4077577|B3|||Age|Enrollment was open to participants age 18 to 65 years old|years|Mean|51.07|51.07|Standard Deviation|8.3|8.3|||
4253692|NCT00626925|4077578|B2|||Age|Enrollment was open to participants age 18 to 65 years old|years|Mean|52.8|52.8|Standard Deviation|7.4|7.4|||
4253693|NCT00626925|4077579|B1|||Age|Enrollment was open to participants age 18 to 65 years old|years|Mean|49.3|49.3|Standard Deviation|9|9.0|||
4253694|NCT00626821|4077612|B1|Male||Gender|Gender is unknown for 2 participants|participants|Number|1474|1474.0||||||
4253695|NCT00626821|4077612|B1|Female||Gender|Gender is unknown for 2 participants|participants|Number|1541|1541.0||||||
4253696|NCT00626821|4077612|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|14.3|14.3|||
4253697|NCT00626808|4077616|B5||Male|Sex: Female, Male|Gender was not collected for this database study.|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4253698|NCT00626808|4077617|B4||Male|Sex: Female, Male|Gender was not collected for this database study.|Participants|Count of Participants|NA|||||||Gender was not collected from database.
4253699|NCT00626808|4077618|B3||Male|Sex: Female, Male|Gender was not collected for this database study.|Participants|Count of Participants|NA|||||||Gender was not collected from database.
4253700|NCT00626808|4077619|B2||Male|Sex: Female, Male|Gender was not collected for this database study.|Participants|Count of Participants|NA|||||||Gender was not collected from database.
4253701|NCT00626808|4077620|B1||Male|Sex: Female, Male|Gender was not collected for this database study.|Participants|Count of Participants|NA|||||||Gender was not collected from database.
4253702|NCT00626808|4077616|B5||Female|Sex: Female, Male|Gender was not collected for this database study.|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4253703|NCT00626808|4077617|B4||Female|Sex: Female, Male|Gender was not collected for this database study.|Participants|Count of Participants|NA|||||||Gender was not collected from database.
4253704|NCT00626808|4077618|B3||Female|Sex: Female, Male|Gender was not collected for this database study.|Participants|Count of Participants|NA|||||||Gender was not collected from database.
4253705|NCT00626808|4077619|B2||Female|Sex: Female, Male|Gender was not collected for this database study.|Participants|Count of Participants|NA|||||||Gender was not collected from database.
4253706|NCT00626808|4077620|B1||Female|Sex: Female, Male|Gender was not collected for this database study.|Participants|Count of Participants|NA|||||||Gender was not collected from database.
4253707|NCT00626808|4077616|B5|>= 24 months||Age, Customized||children|Number|67233|67233.0||||||
4253708|NCT00626808|4077617|B4|>= 24 months||Age, Customized||children|Number|2906|2906.0||||||
4253709|NCT00626808|4077618|B3|>= 24 months||Age, Customized||children|Number|30011|30011.0||||||
4253710|NCT00626808|4077619|B2|>= 24 months||Age, Customized||children|Number|34316|34316.0||||||
4253711|NCT00626808|4077620|B1|>= 24 months||Age, Customized||children|Number|0|0.0||||||
4253712|NCT00626808|4077616|B5|< 24 months||Age, Customized||children|Number|254464|254464.0||||||
4253713|NCT00626808|4077617|B4|< 24 months||Age, Customized||children|Number|0|0.0||||||
4253714|NCT00626808|4077618|B3|< 24 months||Age, Customized||children|Number|0|0.0||||||
4253715|NCT00626808|4077619|B2|< 24 months||Age, Customized||children|Number|0|0.0||||||
4253716|NCT00626808|4077620|B1|< 24 months||Age, Customized||children|Number|254464|254464.0||||||
4253717|NCT00626795|4077689|B4|South Africa||Region of Enrollment||Participants|Count of Participants|377|377.0||||||
4253718|NCT00626795|4077690|B3|South Africa||Region of Enrollment||Participants|Count of Participants|132|132.0||||||
4253719|NCT00626795|4077691|B2|South Africa||Region of Enrollment||Participants|Count of Participants|126|126.0||||||
4253720|NCT00626795|4077692|B1|South Africa||Region of Enrollment||Participants|Count of Participants|119|119.0||||||
4253721|NCT00626795|4077689|B4|United States||Region of Enrollment||Participants|Count of Participants|237|237.0||||||
4253722|NCT00626795|4077690|B3|United States||Region of Enrollment||Participants|Count of Participants|73|73.0||||||
4253723|NCT00626795|4077691|B2|United States||Region of Enrollment||Participants|Count of Participants|79|79.0||||||
4253724|NCT00626795|4077692|B1|United States||Region of Enrollment||Participants|Count of Participants|85|85.0||||||
4253725|NCT00626795|4077689|B4|Participants randomized to blinded treatment|Male|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
4253726|NCT00626795|4077690|B3|Participants randomized to blinded treatment|Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4253727|NCT00626795|4077691|B2|Participants randomized to blinded treatment|Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4253728|NCT00626795|4077692|B1|Participants randomized to blinded treatment|Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4253729|NCT00626795|4077689|B4|Participants randomized to blinded treatment|Female|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
4253730|NCT00626795|4077690|B3|Participants randomized to blinded treatment|Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4253731|NCT00626795|4077691|B2|Participants randomized to blinded treatment|Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4253732|NCT00626795|4077692|B1|Participants randomized to blinded treatment|Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4253733|NCT00626795|4077689|B4|Participants assigned to open-label TD1414 TID|Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4253734|NCT00626795|4077691|B2|Participants assigned to open-label TD1414 TID|Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4253735|NCT00626795|4077689|B4|Participants assigned to open-label TD1414 TID|Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4253736|NCT00626795|4077691|B2|Participants assigned to open-label TD1414 TID|Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4253737|NCT00626795|4077689|B4|Participants randomized to blinded treatment|≥2 to <6 years old|Age, Customized||Participants|Count of Participants|0|0.0||||||
4253738|NCT00626795|4077690|B3|Participants randomized to blinded treatment|≥2 to <6 years old|Age, Customized||Participants|Count of Participants|0|0.0||||||
4253739|NCT00626795|4077691|B2|Participants randomized to blinded treatment|≥2 to <6 years old|Age, Customized||Participants|Count of Participants|0|0.0||||||
4253740|NCT00626795|4077692|B1|Participants randomized to blinded treatment|≥2 to <6 years old|Age, Customized||Participants|Count of Participants|0|0.0||||||
4253741|NCT00626795|4077689|B4|Participants randomized to blinded treatment|≥6 to <12 years old|Age, Customized||Participants|Count of Participants|0|0.0||||||
4253742|NCT00626795|4077690|B3|Participants randomized to blinded treatment|≥6 to <12 years old|Age, Customized||Participants|Count of Participants|0|0.0||||||
4253743|NCT00626795|4077691|B2|Participants randomized to blinded treatment|≥6 to <12 years old|Age, Customized||Participants|Count of Participants|0|0.0||||||
4253744|NCT00626795|4077692|B1|Participants randomized to blinded treatment|≥6 to <12 years old|Age, Customized||Participants|Count of Participants|0|0.0||||||
4253745|NCT00626795|4077689|B4|Participants randomized to blinded treatment|≥12 to <16 years old|Age, Customized||Participants|Count of Participants|32|32.0||||||
4253746|NCT00626795|4077690|B3|Participants randomized to blinded treatment|≥12 to <16 years old|Age, Customized||Participants|Count of Participants|10|10.0||||||
4253747|NCT00626795|4077691|B2|Participants randomized to blinded treatment|≥12 to <16 years old|Age, Customized||Participants|Count of Participants|11|11.0||||||
4253748|NCT00626795|4077692|B1|Participants randomized to blinded treatment|≥12 to <16 years old|Age, Customized||Participants|Count of Participants|11|11.0||||||
4253749|NCT00626795|4077689|B4|Participants randomized to blinded treatment|≥16 years old|Age, Customized||Participants|Count of Participants|582|582.0||||||
4253750|NCT00626795|4077690|B3|Participants randomized to blinded treatment|≥16 years old|Age, Customized||Participants|Count of Participants|195|195.0||||||
4253751|NCT00626795|4077691|B2|Participants randomized to blinded treatment|≥16 years old|Age, Customized||Participants|Count of Participants|194|194.0||||||
4253752|NCT00626795|4077692|B1|Participants randomized to blinded treatment|≥16 years old|Age, Customized||Participants|Count of Participants|193|193.0||||||
4253753|NCT00626795|4077689|B4|Participants assigned to open-label TD1414 TID|≥2 to <6 years old|Age, Customized||Participants|Count of Participants|16|16.0||||||
4253754|NCT00626795|4077690|B3|Participants assigned to open-label TD1414 TID|≥2 to <6 years old|Age, Customized||Participants|Count of Participants|0|0.0||||||
4253755|NCT00626795|4077691|B2|Participants assigned to open-label TD1414 TID|≥2 to <6 years old|Age, Customized||Participants|Count of Participants|16|16.0||||||
4253756|NCT00626795|4077692|B1|Participants assigned to open-label TD1414 TID|≥2 to <6 years old|Age, Customized||Participants|Count of Participants|0|0.0||||||
4253757|NCT00626795|4077689|B4|Participants assigned to open-label TD1414 TID|≥6 to <12 years old|Age, Customized||Participants|Count of Participants|16|16.0||||||
4253758|NCT00626795|4077690|B3|Participants assigned to open-label TD1414 TID|≥6 to <12 years old|Age, Customized||Participants|Count of Participants|0|0.0||||||
4253759|NCT00626795|4077691|B2|Participants assigned to open-label TD1414 TID|≥6 to <12 years old|Age, Customized||Participants|Count of Participants|16|16.0||||||
4253760|NCT00626795|4077692|B1|Participants assigned to open-label TD1414 TID|≥6 to <12 years old|Age, Customized||Participants|Count of Participants|0|0.0||||||
4253761|NCT00626795|4077689|B4|Participants assigned to open-label TD1414 TID|≥12 to <16 years old|Age, Customized||Participants|Count of Participants|16|16.0||||||
4253762|NCT00626795|4077690|B3|Participants assigned to open-label TD1414 TID|≥12 to <16 years old|Age, Customized||Participants|Count of Participants|0|0.0||||||
4253763|NCT00626795|4077691|B2|Participants assigned to open-label TD1414 TID|≥12 to <16 years old|Age, Customized||Participants|Count of Participants|16|16.0||||||
4253764|NCT00626795|4077692|B1|Participants assigned to open-label TD1414 TID|≥12 to <16 years old|Age, Customized||Participants|Count of Participants|0|0.0||||||
4253765|NCT00626795|4077689|B4|Participants assigned to open-label TD1414 TID|≥16 years old|Age, Customized||Participants|Count of Participants|17|17.0||||||
4253766|NCT00626795|4077690|B3|Participants assigned to open-label TD1414 TID|≥16 years old|Age, Customized||Participants|Count of Participants|0|0.0||||||
4253767|NCT00626795|4077691|B2|Participants assigned to open-label TD1414 TID|≥16 years old|Age, Customized||Participants|Count of Participants|17|17.0||||||
4253768|NCT00626795|4077692|B1|Participants assigned to open-label TD1414 TID|≥16 years old|Age, Customized||Participants|Count of Participants|0|0.0||||||
4253769|NCT00626795|4077689|B4|Participants randomized to blinded treatment||Age||years|Mean|37.7|37.7|Standard Deviation|14.8|14.8|||
4253770|NCT00626795|4077690|B3|Participants randomized to blinded treatment||Age||years|Mean|38.3|38.3|Standard Deviation|15.3|15.3|||
4253771|NCT00626795|4077691|B2|Participants randomized to blinded treatment||Age||years|Mean|36.3|36.3|Standard Deviation|14.3|14.3|||
4253772|NCT00626795|4077692|B1|Participants randomized to blinded treatment||Age||years|Mean|38.6|38.6|Standard Deviation|14.8|14.8|||
4253773|NCT00626795|4077689|B4|Participants assigned to open-label TD1414 TID||Age||years|Mean|18.4|18.4|Standard Deviation|20.0|20.0|||
4253774|NCT00626795|4077691|B2|Participants assigned to open-label TD1414 TID||Age||years|Mean|18.4|18.4|Standard Deviation|20.0|20.0|||
4253775|NCT00626782|4077721|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4253776|NCT00626782|4077722|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4253777|NCT00626782|4077723|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4253778|NCT00626782|4077721|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4253779|NCT00626782|4077722|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4253780|NCT00626782|4077723|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4253781|NCT00626782|4077721|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4253782|NCT00626782|4077722|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4253783|NCT00626782|4077723|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4253784|NCT00626782|4077721|B3||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4253785|NCT00626782|4077722|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4253786|NCT00626782|4077723|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4253787|NCT00626782|4077721|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4253788|NCT00626782|4077722|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4253789|NCT00626782|4077723|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4253790|NCT00626782|4077721|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4253791|NCT00626782|4077722|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4253792|NCT00626782|4077723|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4253793|NCT00626782|4077721|B3|||Age||Years|Median|67.75|67.75|Full Range|||40.0|90.0|
4253794|NCT00626782|4077722|B2|||Age||Years|Median|68.5|68.5|Full Range|||42.0|90.0|
4253795|NCT00626782|4077723|B1|||Age||Years|Median|67|67.0|Full Range|||40.0|85.0|
4253796|NCT00626743|4077732|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4253797|NCT00626743|4077733|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4253798|NCT00626743|4077734|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4253799|NCT00626743|4077732|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4253800|NCT00626743|4077733|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4253801|NCT00626743|4077734|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4253802|NCT00626743|4077732|B3|||Age||years|Mean|50.69|50.69|Standard Deviation|8.52|8.52|||
4253803|NCT00626743|4077733|B2|||Age||years|Mean|54.00|54.0|Standard Deviation|10.56|10.56|||
4253804|NCT00626743|4077734|B1|||Age||years|Mean|48.63|48.63|Standard Deviation|6.93|6.93|||
4253805|NCT00626639|4077743|B3|White or Caucasian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4253806|NCT00626639|4077744|B2|White or Caucasian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4253807|NCT00626639|4077745|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4253808|NCT00626639|4077743|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4253809|NCT00626639|4077744|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4253810|NCT00626639|4077745|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4253811|NCT00626639|4077743|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4253812|NCT00626639|4077744|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4253813|NCT00626639|4077745|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4253814|NCT00626639|4077743|B3|||Age||years|Median|52.0|52.0|Full Range|||38.0|68.0|
4253815|NCT00626639|4077744|B2|||Age||years|Median|52.0|52.0|Full Range|||44.0|65.0|
4253816|NCT00626639|4077745|B1|||Age||years|Median|53.0|53.0|Full Range|||38.0|68.0|
4253817|NCT00626626|4077764|B3|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4253818|NCT00626626|4077765|B2|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4253819|NCT00626626|4077766|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4253820|NCT00626626|4077764|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4253821|NCT00626626|4077765|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4253822|NCT00626626|4077766|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4253823|NCT00626626|4077764|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4253824|NCT00626626|4077765|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4253825|NCT00626626|4077766|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4253826|NCT00626626|4077764|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4253827|NCT00626626|4077765|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4253828|NCT00626626|4077766|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4253829|NCT00626626|4077764|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4253830|NCT00626626|4077765|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4253831|NCT00626626|4077766|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4253832|NCT00626626|4077764|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4253833|NCT00626626|4077765|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4253834|NCT00626626|4077766|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4253835|NCT00626574|4077777|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4253836|NCT00626574|4077778|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4253837|NCT00626574|4077779|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4253838|NCT00626574|4077777|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4253839|NCT00626574|4077778|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4253840|NCT00626574|4077779|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4253841|NCT00626574|4077777|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4253842|NCT00626574|4077778|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4253843|NCT00626574|4077779|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4253844|NCT00626574|4077777|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4253845|NCT00626574|4077778|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4253846|NCT00626574|4077779|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4253847|NCT00626574|4077777|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4253848|NCT00626574|4077778|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4253849|NCT00626574|4077779|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4253850|NCT00626574|4077777|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4253851|NCT00626574|4077778|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4253852|NCT00626574|4077779|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4253853|NCT00626561|4077792|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4253854|NCT00626561|4077792|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4253855|NCT00626561|4077792|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4253856|NCT00626561|4077792|B1|||Age||years|Median|33|33.0|Full Range|||32.0|76.0|
4253857|NCT00626548|4077796|B3||Male|Sex: Female, Male||Participants|Count of Participants|1421|1421.0||||||
4253858|NCT00626548|4077797|B2||Male|Sex: Female, Male||Participants|Count of Participants|716|716.0||||||
4253859|NCT00626548|4077798|B1||Male|Sex: Female, Male||Participants|Count of Participants|705|705.0||||||
4253860|NCT00626548|4077796|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4253861|NCT00626548|4077797|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4253862|NCT00626548|4077798|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4253863|NCT00626548|4077796|B3|Overall||Age||years|Mean|72.45|72.45|Standard Deviation|7.8|7.8|||
4253864|NCT00626548|4077797|B2|Overall||Age||years|Mean|72.5|72.5|Standard Deviation|7.8|7.8|||
4253865|NCT00626548|4077798|B1|Overall||Age||years|Mean|72.4|72.4|Standard Deviation|7.8|7.8|||
4253866|NCT00626522|4077807|B7||Male|Sex: Female, Male||Participants|Count of Participants|443|443.0||||||
4253867|NCT00626522|4077808|B6||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4253868|NCT00626522|4077809|B5||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4253869|NCT00626522|4077810|B4||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4253870|NCT00626522|4077811|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4253871|NCT00626522|4077812|B2||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4253872|NCT00626522|4077813|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4253873|NCT00626522|4077807|B7||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4253874|NCT00626522|4077808|B6||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4253875|NCT00626522|4077809|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4253876|NCT00626522|4077810|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4253877|NCT00626522|4077811|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4253878|NCT00626522|4077812|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4253879|NCT00626522|4077813|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4253880|NCT00626522|4077807|B7|||Age||Years|Mean|63.3|63.3|Standard Deviation|8.8|8.8|||
4253881|NCT00626522|4077808|B6|||Age||Years|Mean|60.7|60.7|Standard Deviation|7.8|7.8|||
4253882|NCT00626522|4077809|B5|||Age||Years|Mean|64.0|64.0|Standard Deviation|9.8|9.8|||
4253883|NCT00626522|4077810|B4|||Age||Years|Mean|63.7|63.7|Standard Deviation|9.3|9.3|||
4253884|NCT00626522|4077811|B3|||Age||Years|Mean|63.9|63.9|Standard Deviation|8.1|8.1|||
4253885|NCT00626522|4077812|B2|||Age||Years|Mean|63.6|63.6|Standard Deviation|8.9|8.9|||
4253886|NCT00626522|4077813|B1|||Age||Years|Mean|62.9|62.9|Standard Deviation|9.0|9.0|||
4253887|NCT00626444|4077856|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4253888|NCT00626444|4077856|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4253889|NCT00626444|4077856|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4253890|NCT00626444|4077856|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4253891|NCT00626444|4077856|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4253892|NCT00626444|4077856|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4253893|NCT00626444|4077856|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4253894|NCT00626444|4077856|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4253895|NCT00626444|4077856|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4253896|NCT00626444|4077856|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4253897|NCT00626444|4077856|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4253898|NCT00626444|4077856|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4253899|NCT00626444|4077856|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4253900|NCT00626444|4077856|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4253901|NCT00626444|4077856|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4253902|NCT00626444|4077856|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4253903|NCT00626444|4077856|B1|||Age||years|Mean|55.3|55.3|Standard Deviation|2.9|2.9|||
4253904|NCT00626431|4077861|B3|United States||Region of Enrollment||participants|Number|310|310.0||||||
4253905|NCT00626431|4077862|B2|United States||Region of Enrollment||participants|Number|159|159.0||||||
4253906|NCT00626431|4077863|B1|United States||Region of Enrollment||participants|Number|151|151.0||||||
4253907|NCT00626431|4077861|B3||Male|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
4253908|NCT00626431|4077862|B2||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4253909|NCT00626431|4077863|B1||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4253910|NCT00626431|4077861|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4253911|NCT00626431|4077862|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4253912|NCT00626431|4077863|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4253913|NCT00626431|4077861|B3||>=65 years|Age||Participants|Count of Participants|259|259.0||||||
4253914|NCT00626431|4077862|B2||>=65 years|Age||Participants|Count of Participants|126|126.0||||||
4253915|NCT00626431|4077863|B1||>=65 years|Age||Participants|Count of Participants|133|133.0||||||
4253916|NCT00626431|4077861|B3||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4253917|NCT00626431|4077862|B2||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4253918|NCT00626431|4077863|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4253919|NCT00626431|4077861|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4253920|NCT00626431|4077862|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4253921|NCT00626431|4077863|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4253922|NCT00626405|4077879|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4253923|NCT00626405|4077880|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4253924|NCT00626405|4077881|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4253925|NCT00626405|4077879|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4253926|NCT00626405|4077880|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4253927|NCT00626405|4077881|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4253928|NCT00626405|4077879|B3|||Age||Years|Median|57|57.0|Full Range|||22.0|83.0|
4253929|NCT00626405|4077880|B2|||Age||Years|Median|57|57.0|Full Range|||22.0|83.0|
4253930|NCT00626405|4077881|B1|||Age||Years|Median|57|57.0|Full Range|||25.0|82.0|
4253931|NCT00626392|4077892|B7|United States||Region of Enrollment|Includes only those subjects who entered the coadministration period and received at least one dose of study medication.|participants|Number|256.0|256.0||||||
4253932|NCT00626392|4077893|B6|United States||Region of Enrollment|Includes only those subjects who entered the coadministration period and received at least one dose of study medication.|participants|Number|44|44.0||||||
4253933|NCT00626392|4077894|B5|United States||Region of Enrollment|Includes only those subjects who entered the coadministration period and received at least one dose of study medication.|participants|Number|41|41.0||||||
4253934|NCT00626392|4077895|B4|United States||Region of Enrollment|Includes only those subjects who entered the coadministration period and received at least one dose of study medication.|participants|Number|43|43.0||||||
4253935|NCT00626392|4077896|B3|United States||Region of Enrollment|Includes only those subjects who entered the coadministration period and received at least one dose of study medication.|participants|Number|41|41.0||||||
4253936|NCT00626392|4077897|B2|United States||Region of Enrollment|Includes only those subjects who entered the coadministration period and received at least one dose of study medication.|participants|Number|43|43.0||||||
4253937|NCT00626392|4077898|B1|United States||Region of Enrollment|Includes only those subjects who entered the coadministration period and received at least one dose of study medication.|participants|Number|44|44.0||||||
4253938|NCT00626392|4077892|B7||Male|Sex: Female, Male|Includes only those subjects who entered the coadministration period and received at least one dose of study medication.|Participants|Count of Participants|132.0|132.0||||||
4253939|NCT00626392|4077893|B6||Male|Sex: Female, Male|Includes only those subjects who entered the coadministration period and received at least one dose of study medication.|Participants|Count of Participants|21|21.0||||||
4253940|NCT00626392|4077894|B5||Male|Sex: Female, Male|Includes only those subjects who entered the coadministration period and received at least one dose of study medication.|Participants|Count of Participants|20|20.0||||||
4253941|NCT00626392|4077895|B4||Male|Sex: Female, Male|Includes only those subjects who entered the coadministration period and received at least one dose of study medication.|Participants|Count of Participants|28|28.0||||||
4253942|NCT00626392|4077896|B3||Male|Sex: Female, Male|Includes only those subjects who entered the coadministration period and received at least one dose of study medication.|Participants|Count of Participants|20|20.0||||||
4253943|NCT00626392|4077897|B2||Male|Sex: Female, Male|Includes only those subjects who entered the coadministration period and received at least one dose of study medication.|Participants|Count of Participants|20|20.0||||||
4253944|NCT00626392|4077898|B1||Male|Sex: Female, Male|Includes only those subjects who entered the coadministration period and received at least one dose of study medication.|Participants|Count of Participants|23|23.0||||||
4253945|NCT00626392|4077892|B7||Female|Sex: Female, Male|Includes only those subjects who entered the coadministration period and received at least one dose of study medication.|Participants|Count of Participants|124.0|124.0||||||
4253946|NCT00626392|4077893|B6||Female|Sex: Female, Male|Includes only those subjects who entered the coadministration period and received at least one dose of study medication.|Participants|Count of Participants|23|23.0||||||
4253947|NCT00626392|4077894|B5||Female|Sex: Female, Male|Includes only those subjects who entered the coadministration period and received at least one dose of study medication.|Participants|Count of Participants|21|21.0||||||
4253948|NCT00626392|4077895|B4||Female|Sex: Female, Male|Includes only those subjects who entered the coadministration period and received at least one dose of study medication.|Participants|Count of Participants|15|15.0||||||
4253949|NCT00626392|4077896|B3||Female|Sex: Female, Male|Includes only those subjects who entered the coadministration period and received at least one dose of study medication.|Participants|Count of Participants|21|21.0||||||
4253950|NCT00626392|4077897|B2||Female|Sex: Female, Male|Includes only those subjects who entered the coadministration period and received at least one dose of study medication.|Participants|Count of Participants|23|23.0||||||
4253951|NCT00626392|4077898|B1||Female|Sex: Female, Male|Includes only those subjects who entered the coadministration period and received at least one dose of study medication.|Participants|Count of Participants|21|21.0||||||
4253952|NCT00626392|4077892|B7|||Age|Includes only those subjects who entered the coadministration period and received at least one dose of study medication.|Years|Mean|52.8|52.8|Standard Deviation|11.73|11.73|||
4253953|NCT00626392|4077893|B6|||Age|Includes only those subjects who entered the coadministration period and received at least one dose of study medication.|Years|Mean|52.3|52.3|Standard Deviation|12.45|12.45|||
4253954|NCT00626392|4077894|B5|||Age|Includes only those subjects who entered the coadministration period and received at least one dose of study medication.|Years|Mean|54.8|54.8|Standard Deviation|11.08|11.08|||
4253955|NCT00626392|4077895|B4|||Age|Includes only those subjects who entered the coadministration period and received at least one dose of study medication.|Years|Mean|53.7|53.7|Standard Deviation|12.4|12.4|||
4253956|NCT00626392|4077896|B3|||Age|Includes only those subjects who entered the coadministration period and received at least one dose of study medication.|Years|Mean|51.5|51.5|Standard Deviation|12.58|12.58|||
4253957|NCT00626392|4077897|B2|||Age|Includes only those subjects who entered the coadministration period and received at least one dose of study medication.|Years|Mean|49.0|49.0|Standard Deviation|10.48|10.48|||
4253958|NCT00626392|4077898|B1|||Age|Includes only those subjects who entered the coadministration period and received at least one dose of study medication.|Years|Mean|55.5|55.5|Standard Deviation|10.62|10.62|||
4253959|NCT00626327|4077919|B4||Male|Sex: Female, Male||Participants|Count of Participants|823|823.0||||||
4253960|NCT00626327|4077920|B3||Male|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
4253961|NCT00626327|4077921|B2||Male|Sex: Female, Male||Participants|Count of Participants|312|312.0||||||
4253962|NCT00626327|4077922|B1||Male|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
4253963|NCT00626327|4077919|B4||Female|Sex: Female, Male||Participants|Count of Participants|807|807.0||||||
4253964|NCT00626327|4077920|B3||Female|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
4253965|NCT00626327|4077921|B2||Female|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
4253966|NCT00626327|4077922|B1||Female|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4253967|NCT00626327|4077919|B4|||Age||months|Mean|9.8|9.8|Standard Deviation|1.9|1.9|||
4253968|NCT00626327|4077920|B3|||Age||months|Mean|8.5|8.5|Standard Deviation|0.8|0.8|||
4253969|NCT00626327|4077921|B2|||Age||months|Mean|12.1|12.1|Standard Deviation|0.3|0.3|||
4253970|NCT00626327|4077922|B1|||Age||months|Mean|8.5|8.5|Standard Deviation|0.8|0.8|||
4253971|NCT00626275|4077950|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4253972|NCT00626275|4077950|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4253973|NCT00626275|4077950|B1|||Age||years|Mean|54.6|54.6|Standard Deviation|8.91|8.91|||
4253974|NCT00626210|4077997|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4253975|NCT00626210|4077997|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4253976|NCT00626210|4077997|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4253977|NCT00626210|4077997|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4253978|NCT00626210|4077997|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4253979|NCT00626210|4077997|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4253980|NCT00626093|4078001|B1|United States||Region of Enrollment||participants|Number|77|77.0||||||
4253981|NCT00626093|4078001|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4253982|NCT00626093|4078001|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4253983|NCT00626093|4078001|B1|||Age||years|Mean|69.9|69.9|Standard Deviation|11.2|11.2|||
4253984|NCT00626093|4078001|B1||>=65 years|Age||Participants|Count of Participants|52|52.0||||||
4253985|NCT00626093|4078001|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4253986|NCT00626093|4078001|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4253987|NCT00626028|4078006|B3|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
4253988|NCT00626028|4078007|B2|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4253989|NCT00626028|4078008|B1|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4253990|NCT00626028|4078006|B3|Netherlands||Region of Enrollment||participants|Number|11|11.0||||||
4253991|NCT00626028|4078007|B2|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
4253992|NCT00626028|4078008|B1|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
4253993|NCT00626028|4078006|B3|Spain||Region of Enrollment||participants|Number|24|24.0||||||
4253994|NCT00626028|4078007|B2|Spain||Region of Enrollment||participants|Number|12|12.0||||||
4253995|NCT00626028|4078008|B1|Spain||Region of Enrollment||participants|Number|12|12.0||||||
4253996|NCT00626028|4078006|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4253997|NCT00626028|4078007|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4253998|NCT00626028|4078008|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4253999|NCT00626028|4078006|B3|France||Region of Enrollment||participants|Number|57|57.0||||||
4254000|NCT00626028|4078007|B2|France||Region of Enrollment||participants|Number|27|27.0||||||
4254001|NCT00626028|4078008|B1|France||Region of Enrollment||participants|Number|30|30.0||||||
4254002|NCT00626028|4078006|B3||Male|Sex: Female, Male|Data for baseline measures are for the overall intent-to treat population - total 136 participants|Participants|Count of Participants|68|68.0||||||
4254053|NCT00625742|4078165|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4254003|NCT00626028|4078007|B2||Male|Sex: Female, Male|Data for baseline measures are for the overall intent-to treat population - total 136 participants|Participants|Count of Participants|34|34.0||||||
4254004|NCT00626028|4078008|B1||Male|Sex: Female, Male|Data for baseline measures are for the overall intent-to treat population - total 136 participants|Participants|Count of Participants|34|34.0||||||
4254005|NCT00626028|4078006|B3||Female|Sex: Female, Male|Data for baseline measures are for the overall intent-to treat population - total 136 participants|Participants|Count of Participants|68|68.0||||||
4254006|NCT00626028|4078007|B2||Female|Sex: Female, Male|Data for baseline measures are for the overall intent-to treat population - total 136 participants|Participants|Count of Participants|34|34.0||||||
4254007|NCT00626028|4078008|B1||Female|Sex: Female, Male|Data for baseline measures are for the overall intent-to treat population - total 136 participants|Participants|Count of Participants|34|34.0||||||
4254008|NCT00626028|4078006|B3|||Age|Data for baseline measures are for the overall intent-to treat population - total 136 participants|years|Mean|5.9|5.9|Standard Deviation|5.58|5.58|||
4254009|NCT00626028|4078007|B2|||Age|Data for baseline measures are for the overall intent-to treat population - total 136 participants|years|Mean|5.9|5.9|Standard Deviation|5.58|5.58|||
4254010|NCT00626028|4078008|B1|||Age|Data for baseline measures are for the overall intent-to treat population - total 136 participants|years|Mean|5.9|5.9|Standard Deviation|5.58|5.58|||
4254011|NCT00626028|4078006|B3||>=65 years|Age|Data for baseline measures are for the overall intent-to treat population - total 136 participants|Participants|Count of Participants|0|0.0||||||
4254012|NCT00626028|4078007|B2||>=65 years|Age|Data for baseline measures are for the overall intent-to treat population - total 136 participants|Participants|Count of Participants|0|0.0||||||
4254013|NCT00626028|4078008|B1||>=65 years|Age|Data for baseline measures are for the overall intent-to treat population - total 136 participants|Participants|Count of Participants|0|0.0||||||
4254014|NCT00626028|4078006|B3||Between 18 and 65 years|Age|Data for baseline measures are for the overall intent-to treat population - total 136 participants|Participants|Count of Participants|0|0.0||||||
4254015|NCT00626028|4078007|B2||Between 18 and 65 years|Age|Data for baseline measures are for the overall intent-to treat population - total 136 participants|Participants|Count of Participants|0|0.0||||||
4254016|NCT00626028|4078008|B1||Between 18 and 65 years|Age|Data for baseline measures are for the overall intent-to treat population - total 136 participants|Participants|Count of Participants|0|0.0||||||
4254017|NCT00626028|4078006|B3||<=18 years|Age|Data for baseline measures are for the overall intent-to treat population - total 136 participants|Participants|Count of Participants|136|136.0||||||
4254018|NCT00626028|4078007|B2||<=18 years|Age|Data for baseline measures are for the overall intent-to treat population - total 136 participants|Participants|Count of Participants|68|68.0||||||
4254019|NCT00626028|4078008|B1||<=18 years|Age|Data for baseline measures are for the overall intent-to treat population - total 136 participants|Participants|Count of Participants|68|68.0||||||
4254020|NCT00625989|4078019|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4254021|NCT00625989|4078019|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4254022|NCT00625989|4078019|B1|||Age||years|Mean|28.6|28.6|Standard Deviation|3.2|3.2|||
4254023|NCT00625989|4078019|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4254024|NCT00625989|4078019|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4254025|NCT00625989|4078019|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4254026|NCT00625872|4078027|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4254027|NCT00625872|4078028|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4254028|NCT00625872|4078029|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4254029|NCT00625872|4078027|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4254030|NCT00625872|4078028|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4254031|NCT00625872|4078029|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4254032|NCT00625872|4078027|B3|||Age||Years|Mean|7.1|7.1|Standard Deviation|1.3|1.3|||
4254033|NCT00625872|4078028|B2|||Age||Years|Mean|7.6|7.6|Standard Deviation|1.4|1.4|||
4254034|NCT00625872|4078029|B1|||Age||Years|Mean|6.6|6.6|Standard Deviation|1.0|1.0|||
4254035|NCT00625820|4078140|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4254036|NCT00625820|4078140|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4254037|NCT00625820|4078140|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4254038|NCT00625820|4078140|B1|||Age||years|Mean|59.9|59.9|Standard Deviation|11.2|11.2|||
4254039|NCT00625820|4078140|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4254040|NCT00625820|4078140|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4254041|NCT00625820|4078140|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4254042|NCT00625807|4078146|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4254043|NCT00625807|4078147|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4254044|NCT00625807|4078148|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4254045|NCT00625807|4078146|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4254046|NCT00625807|4078147|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4254047|NCT00625807|4078148|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4254048|NCT00625807|4078146|B3|||Age||years|Mean|37.9|37.9|Standard Deviation|6.5|6.5|||
4254049|NCT00625807|4078147|B2|||Age||years|Mean|37|37.0|Standard Deviation|4.7|4.7|||
4254050|NCT00625807|4078148|B1|||Age||years|Mean|39|39.0|Standard Deviation|8.7|8.7|||
4254051|NCT00625742|4078165|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4254052|NCT00625742|4078165|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4254054|NCT00625742|4078165|B1|||Age||years|Median|57|57.0|Full Range|||34.0|91.0|
4254055|NCT00625729|4078170|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4254056|NCT00625729|4078170|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4254057|NCT00625729|4078170|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4254058|NCT00625729|4078170|B1|||Age||years|Mean|52.2|52.2|Standard Deviation|13.6|13.6|||
4254059|NCT00625729|4078170|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4254060|NCT00625729|4078170|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4254061|NCT00625729|4078170|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4254062|NCT00625586|4078179|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4254063|NCT00625586|4078179|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4254064|NCT00625586|4078179|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4254065|NCT00625586|4078179|B1|||Age||years|Mean|61|61.0|Standard Deviation|NA||||Only 2 patients enrolled. Statistical analysis not performed.
4254066|NCT00625586|4078179|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4254067|NCT00625586|4078179|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4254068|NCT00625586|4078179|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4254069|NCT00625443|4078189|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4254070|NCT00625443|4078190|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4254071|NCT00625443|4078191|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4254072|NCT00625443|4078192|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4254073|NCT00625443|4078189|B4||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4254074|NCT00625443|4078190|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4254075|NCT00625443|4078191|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4254076|NCT00625443|4078192|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4254077|NCT00625443|4078189|B4|||Age||Years|Geometric Mean|50.1|50.1|Standard Deviation|18.25|18.25|||
4254078|NCT00625443|4078190|B3|||Age||Years|Geometric Mean|50.4|50.4|Standard Deviation|15.65|15.65|||
4254079|NCT00625443|4078191|B2|||Age||Years|Geometric Mean|52.5|52.5|Standard Deviation|18.44|18.44|||
4254080|NCT00625443|4078192|B1|||Age||Years|Geometric Mean|44.7|44.7|Standard Deviation|21.09|21.09|||
4254081|NCT00625404|4078222|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4254082|NCT00625404|4078223|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4254083|NCT00625404|4078224|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4254084|NCT00625404|4078222|B3||Female|Sex: Female, Male||Participants|Count of Participants|2120|2120.0||||||
4254085|NCT00625404|4078223|B2||Female|Sex: Female, Male||Participants|Count of Participants|1058|1058.0||||||
4254086|NCT00625404|4078224|B1||Female|Sex: Female, Male||Participants|Count of Participants|1062|1062.0||||||
4254087|NCT00625404|4078222|B3|||Age||years|Median|23|23.0|Full Range|18-35|18.0|18.0|35.0|
4254088|NCT00625404|4078223|B2|||Age||years|Median|23|23.0|Full Range|18-35|18.0|18.0|35.0|
4254089|NCT00625404|4078224|B1|||Age||years|Median|23|23.0|Full Range|18-35|18.0|18.0|35.0|
4254090|NCT00625404|4078222|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4254091|NCT00625404|4078223|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4254092|NCT00625404|4078224|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4254093|NCT00625404|4078222|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2120|2120.0||||||
4254094|NCT00625404|4078223|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1058|1058.0||||||
4254095|NCT00625404|4078224|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1062|1062.0||||||
4254096|NCT00625404|4078222|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4254097|NCT00625404|4078223|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4254098|NCT00625404|4078224|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4254099|NCT00625391|4078253|B5|United States||Region of Enrollment||participants|Number|171|171.0||||||
4254100|NCT00625391|4078254|B4|United States||Region of Enrollment||participants|Number|38|38.0||||||
4254101|NCT00625391|4078255|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4254102|NCT00625391|4078256|B2|United States||Region of Enrollment||participants|Number|47|47.0||||||
4254103|NCT00625391|4078257|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4254104|NCT00625391|4078253|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4254105|NCT00625391|4078254|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4254106|NCT00625391|4078255|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4254107|NCT00625391|4078256|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4254108|NCT00625391|4078257|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4254109|NCT00625391|4078253|B5||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4254110|NCT00625391|4078254|B4||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4254111|NCT00625391|4078255|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4254112|NCT00625391|4078256|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4254113|NCT00625391|4078257|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4254114|NCT00625391|4078253|B5|||Age||years|Mean|57.4|57.4|Standard Deviation|6.9|6.9|||
4254115|NCT00625391|4078254|B4|||Age||years|Mean|57.6|57.6|Standard Deviation|6.7|6.7|||
4254116|NCT00625391|4078255|B3|||Age||years|Mean|58.3|58.3|Standard Deviation|7.7|7.7|||
4254117|NCT00625391|4078256|B2|||Age||years|Mean|56.5|56.5|Standard Deviation|5.5|5.5|||
4254118|NCT00625391|4078257|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|7.5|7.5|||
4254119|NCT00625391|4078253|B5||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4254120|NCT00625391|4078254|B4||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4254121|NCT00625391|4078255|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4254122|NCT00625391|4078256|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4254123|NCT00625391|4078257|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4254124|NCT00625391|4078253|B5||Between 18 and 65 years|Age||Participants|Count of Participants|149|149.0||||||
4254125|NCT00625391|4078254|B4||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4254126|NCT00625391|4078255|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4254127|NCT00625391|4078256|B2||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4254128|NCT00625391|4078257|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4254129|NCT00625391|4078253|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4254130|NCT00625391|4078254|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4254131|NCT00625391|4078255|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4254132|NCT00625391|4078256|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4254133|NCT00625391|4078257|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4254134|NCT00625365|4078274|B1||Male|Sex: Female, Male||Participants|Count of Participants|653|653.0||||||
4254135|NCT00625365|4078274|B1||Female|Sex: Female, Male||Participants|Count of Participants|400|400.0||||||
4254136|NCT00625365|4078274|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|12.9|12.9|||
4254137|NCT00625365|4078274|B1||>=65 years|Age||Participants|Count of Participants|444|444.0||||||
4254138|NCT00625365|4078274|B1||Between 18 and 65 years|Age||Participants|Count of Participants|609|609.0||||||
4254139|NCT00625365|4078274|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4254140|NCT00625183|4078280|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4254141|NCT00625183|4078280|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4254142|NCT00625183|4078280|B1|||Age||years|Mean|56.48|56.48|Standard Deviation|6.8|6.8|||
4254143|NCT00625131|4078289|B3|United States||Region of Enrollment||participants|Number|82|82.0||||||
4254144|NCT00625131|4078290|B2|United States||Region of Enrollment||participants|Number|44|44.0||||||
4254145|NCT00625131|4078291|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4254146|NCT00625131|4078289|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4254147|NCT00625131|4078290|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254148|NCT00625131|4078291|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4254149|NCT00625131|4078289|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
4254150|NCT00625131|4078290|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4254151|NCT00625131|4078291|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4254152|NCT00625131|4078289|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4254153|NCT00625131|4078290|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254154|NCT00625131|4078291|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4254155|NCT00625131|4078289|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4254156|NCT00625131|4078290|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254157|NCT00625131|4078291|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4254158|NCT00625131|4078289|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4254159|NCT00625131|4078290|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4254160|NCT00625131|4078291|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4254161|NCT00625131|4078289|B3||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4254162|NCT00625131|4078290|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4254163|NCT00625131|4078291|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4254164|NCT00625131|4078289|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4254165|NCT00625131|4078290|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4254166|NCT00625131|4078291|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4254167|NCT00625131|4078289|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254168|NCT00625131|4078290|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254169|NCT00625131|4078291|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254170|NCT00625131|4078289|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4254171|NCT00625131|4078290|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254172|NCT00625131|4078291|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4254173|NCT00625131|4078289|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254174|NCT00625131|4078290|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254175|NCT00625131|4078291|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254176|NCT00625131|4078289|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4254177|NCT00625131|4078290|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4254178|NCT00625131|4078291|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4254179|NCT00625131|4078289|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4254180|NCT00625131|4078290|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4254181|NCT00625131|4078291|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4254182|NCT00625131|4078289|B3|||Age||years|Mean|44.79|44.79|Standard Deviation|10.51|10.51|||
4254183|NCT00625131|4078290|B2|||Age||years|Mean|44.48|44.48|Standard Deviation|11.31|11.31|||
4254184|NCT00625131|4078291|B1|||Age||years|Mean|45.16|45.16|Standard Deviation|9.61|9.61|||
4254185|NCT00624923|4078303|B3|||Statin use||participants|Number|248|248.0||||||
4254186|NCT00624923|4078304|B2|||Statin use||participants|Number|122|122.0||||||
4254187|NCT00624923|4078305|B1|||Statin use||participants|Number|126|126.0||||||
4254188|NCT00624923|4078303|B3|United States||Region of Enrollment||participants|Number|251|251.0||||||
4254189|NCT00624923|4078304|B2|United States||Region of Enrollment||participants|Number|124|124.0||||||
4254190|NCT00624923|4078305|B1|United States||Region of Enrollment||participants|Number|127|127.0||||||
4254191|NCT00624923|4078303|B3||Male|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
4254192|NCT00624923|4078304|B2||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4254193|NCT00624923|4078305|B1||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4254194|NCT00624923|4078303|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4254195|NCT00624923|4078304|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4254196|NCT00624923|4078305|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4254197|NCT00624923|4078303|B3|||Age||years|Mean|60.8|60.8|Standard Deviation|7.0|7.0|||
4254198|NCT00624923|4078304|B2|||Age||years|Mean|60.1|60.1|Standard Deviation|7.2|7.2|||
4254199|NCT00624923|4078305|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|6.8|6.8|||
4254200|NCT00624832|4078312|B5||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4254201|NCT00624832|4078313|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4254202|NCT00624832|4078314|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4254203|NCT00624832|4078315|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4254204|NCT00624832|4078316|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4254205|NCT00624832|4078312|B5||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4254206|NCT00624832|4078313|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4254207|NCT00624832|4078314|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4254208|NCT00624832|4078315|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4254209|NCT00624832|4078316|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4254210|NCT00624832|4078312|B5|||Age||years|Mean|32|32.0|Standard Deviation|10.9|10.9|||
4254211|NCT00624832|4078313|B4|||Age||years|Mean|34|34.0|Standard Deviation|10.4|10.4|||
4254212|NCT00624832|4078314|B3|||Age||years|Mean|26|26.0|Standard Deviation|6.0|6.0|||
4254213|NCT00624832|4078315|B2|||Age||years|Mean|29|29.0|Standard Deviation|11.0|11.0|||
4254214|NCT00624832|4078316|B1|||Age||years|Mean|36|36.0|Standard Deviation|11.9|11.9|||
4254215|NCT00624806|4078331|B3|Other||Baseline Self-Reported Skin Behaviors||participants|Number|2|2.0||||||
4254216|NCT00624806|4078332|B2|Other||Baseline Self-Reported Skin Behaviors||participants|Number|0|0.0||||||
4254217|NCT00624806|4078333|B1|Other||Baseline Self-Reported Skin Behaviors||participants|Number|2|2.0||||||
4254218|NCT00624806|4078331|B3|Keep skin clean and dry||Baseline Self-Reported Skin Behaviors||participants|Number|14|14.0||||||
4254219|NCT00624806|4078332|B2|Keep skin clean and dry||Baseline Self-Reported Skin Behaviors||participants|Number|5|5.0||||||
4254220|NCT00624806|4078333|B1|Keep skin clean and dry||Baseline Self-Reported Skin Behaviors||participants|Number|9|9.0||||||
4254221|NCT00624806|4078331|B3|No tight clothing/shoes||Baseline Self-Reported Skin Behaviors||participants|Number|13|13.0||||||
4254222|NCT00624806|4078332|B2|No tight clothing/shoes||Baseline Self-Reported Skin Behaviors||participants|Number|5|5.0||||||
4254223|NCT00624806|4078333|B1|No tight clothing/shoes||Baseline Self-Reported Skin Behaviors||participants|Number|8|8.0||||||
4254224|NCT00624806|4078331|B3|Safety in transfers||Baseline Self-Reported Skin Behaviors||participants|Number|10|10.0||||||
4254225|NCT00624806|4078332|B2|Safety in transfers||Baseline Self-Reported Skin Behaviors||participants|Number|3|3.0||||||
4254226|NCT00624806|4078333|B1|Safety in transfers||Baseline Self-Reported Skin Behaviors||participants|Number|7|7.0||||||
4254227|NCT00624806|4078331|B3|Appropriate Cushion||Baseline Self-Reported Skin Behaviors||participants|Number|9|9.0||||||
4254228|NCT00624806|4078332|B2|Appropriate Cushion||Baseline Self-Reported Skin Behaviors||participants|Number|2|2.0||||||
4254229|NCT00624806|4078333|B1|Appropriate Cushion||Baseline Self-Reported Skin Behaviors||participants|Number|7|7.0||||||
4254230|NCT00624806|4078331|B3|Hygiene||Baseline Self-Reported Skin Behaviors||participants|Number|13|13.0||||||
4254231|NCT00624806|4078332|B2|Hygiene||Baseline Self-Reported Skin Behaviors||participants|Number|5|5.0||||||
4254232|NCT00624806|4078333|B1|Hygiene||Baseline Self-Reported Skin Behaviors||participants|Number|8|8.0||||||
4254233|NCT00624806|4078331|B3|Pressure releases/Tilts/Weight shifts||Baseline Self-Reported Skin Behaviors||participants|Number|13|13.0||||||
4254234|NCT00624806|4078332|B2|Pressure releases/Tilts/Weight shifts||Baseline Self-Reported Skin Behaviors||participants|Number|4|4.0||||||
4254235|NCT00624806|4078333|B1|Pressure releases/Tilts/Weight shifts||Baseline Self-Reported Skin Behaviors||participants|Number|9|9.0||||||
4254236|NCT00624806|4078331|B3|Good Nutrition||Baseline Self-Reported Skin Behaviors||participants|Number|14|14.0||||||
4254237|NCT00624806|4078332|B2|Good Nutrition||Baseline Self-Reported Skin Behaviors||participants|Number|5|5.0||||||
4254238|NCT00624806|4078333|B1|Good Nutrition||Baseline Self-Reported Skin Behaviors||participants|Number|9|9.0||||||
4254239|NCT00624806|4078331|B3|Daily Skin Inspection||Baseline Self-Reported Skin Behaviors||participants|Number|12|12.0||||||
4254240|NCT00624806|4078332|B2|Daily Skin Inspection||Baseline Self-Reported Skin Behaviors||participants|Number|4|4.0||||||
4254241|NCT00624806|4078333|B1|Daily Skin Inspection||Baseline Self-Reported Skin Behaviors||participants|Number|8|8.0||||||
4254242|NCT00624806|4078331|B3|N/A||Current Pressure Ulcer Stage||participants|Number|11|11.0||||||
4254243|NCT00624806|4078332|B2|N/A||Current Pressure Ulcer Stage||participants|Number|4|4.0||||||
4254244|NCT00624806|4078333|B1|N/A||Current Pressure Ulcer Stage||participants|Number|7|7.0||||||
4254245|NCT00624806|4078331|B3|Unknown||Current Pressure Ulcer Stage||participants|Number|1|1.0||||||
4254246|NCT00624806|4078332|B2|Unknown||Current Pressure Ulcer Stage||participants|Number|0|0.0||||||
4254247|NCT00624806|4078333|B1|Unknown||Current Pressure Ulcer Stage||participants|Number|1|1.0||||||
4254248|NCT00624806|4078331|B3|Stage IV = Full thickness||Current Pressure Ulcer Stage||participants|Number|3|3.0||||||
4254249|NCT00624806|4078332|B2|Stage IV = Full thickness||Current Pressure Ulcer Stage||participants|Number|1|1.0||||||
4254250|NCT00624806|4078333|B1|Stage IV = Full thickness||Current Pressure Ulcer Stage||participants|Number|2|2.0||||||
4254251|NCT00624806|4078331|B3|Stage III = Full thickness||Current Pressure Ulcer Stage||participants|Number|1|1.0||||||
4254252|NCT00624806|4078332|B2|Stage III = Full thickness||Current Pressure Ulcer Stage||participants|Number|1|1.0||||||
4254253|NCT00624806|4078333|B1|Stage III = Full thickness||Current Pressure Ulcer Stage||participants|Number|0|0.0||||||
4254254|NCT00624806|4078331|B3|Stage II = Partial thickness||Current Pressure Ulcer Stage||participants|Number|0|0.0||||||
4254255|NCT00624806|4078332|B2|Stage II = Partial thickness||Current Pressure Ulcer Stage||participants|Number|0|0.0||||||
4254256|NCT00624806|4078333|B1|Stage II = Partial thickness||Current Pressure Ulcer Stage||participants|Number|0|0.0||||||
4254257|NCT00624806|4078331|B3|Stage I = Intact skin/non-blanchable redness||Current Pressure Ulcer Stage||participants|Number|2|2.0||||||
4254258|NCT00624806|4078332|B2|Stage I = Intact skin/non-blanchable redness||Current Pressure Ulcer Stage||participants|Number|2|2.0||||||
4254259|NCT00624806|4078333|B1|Stage I = Intact skin/non-blanchable redness||Current Pressure Ulcer Stage||participants|Number|0|0.0||||||
4254260|NCT00624806|4078331|B3|N/A||Current Pressure Ulcer Location||participants|Number|11|11.0||||||
4254261|NCT00624806|4078332|B2|N/A||Current Pressure Ulcer Location||participants|Number|4|4.0||||||
4254262|NCT00624806|4078333|B1|N/A||Current Pressure Ulcer Location||participants|Number|7|7.0||||||
4254263|NCT00624806|4078331|B3|Other||Current Pressure Ulcer Location||participants|Number|2|2.0||||||
4254264|NCT00624806|4078332|B2|Other||Current Pressure Ulcer Location||participants|Number|2|2.0||||||
4254265|NCT00624806|4078333|B1|Other||Current Pressure Ulcer Location||participants|Number|0|0.0||||||
4254266|NCT00624806|4078331|B3|Sacrum||Current Pressure Ulcer Location||participants|Number|3|3.0||||||
4254267|NCT00624806|4078332|B2|Sacrum||Current Pressure Ulcer Location||participants|Number|2|2.0||||||
4254268|NCT00624806|4078333|B1|Sacrum||Current Pressure Ulcer Location||participants|Number|1|1.0||||||
4254269|NCT00624806|4078331|B3|Ischium||Current Pressure Ulcer Location||participants|Number|2|2.0||||||
4254270|NCT00624806|4078332|B2|Ischium||Current Pressure Ulcer Location||participants|Number|0|0.0||||||
4254271|NCT00624806|4078333|B1|Ischium||Current Pressure Ulcer Location||participants|Number|2|2.0||||||
4254272|NCT00624806|4078331|B3|||Number of Current Pressure Ulcers||pressure ulcers|Mean|0.89|0.89|Full Range|||0.0|6.0|
4254273|NCT00624806|4078332|B2|||Number of Current Pressure Ulcers||pressure ulcers|Mean|0.5|0.5|Full Range|||0.0|2.0|
4254274|NCT00624806|4078333|B1|||Number of Current Pressure Ulcers||pressure ulcers|Mean|1.2|1.2|Full Range|||0.0|6.0|
4254275|NCT00624806|4078331|B3|N/A||Prior Ulcer Surgery Locations||participants|Number|7|7.0||||||
4254276|NCT00624806|4078332|B2|N/A||Prior Ulcer Surgery Locations||participants|Number|2|2.0||||||
4254277|NCT00624806|4078333|B1|N/A||Prior Ulcer Surgery Locations||participants|Number|5|5.0||||||
4254278|NCT00624806|4078331|B3|Lateral Malleolus||Prior Ulcer Surgery Locations||participants|Number|1|1.0||||||
4254279|NCT00624806|4078332|B2|Lateral Malleolus||Prior Ulcer Surgery Locations||participants|Number|1|1.0||||||
4254280|NCT00624806|4078333|B1|Lateral Malleolus||Prior Ulcer Surgery Locations||participants|Number|0|0.0||||||
4254281|NCT00624806|4078331|B3|Coccyx||Prior Ulcer Surgery Locations||participants|Number|1|1.0||||||
4254282|NCT00624806|4078332|B2|Coccyx||Prior Ulcer Surgery Locations||participants|Number|0|0.0||||||
4254283|NCT00624806|4078333|B1|Coccyx||Prior Ulcer Surgery Locations||participants|Number|1|1.0||||||
4254284|NCT00624806|4078331|B3|Sacrum||Prior Ulcer Surgery Locations||participants|Number|4|4.0||||||
4254285|NCT00624806|4078332|B2|Sacrum||Prior Ulcer Surgery Locations||participants|Number|4|4.0||||||
4254286|NCT00624806|4078333|B1|Sacrum||Prior Ulcer Surgery Locations||participants|Number|0|0.0||||||
4254287|NCT00624806|4078331|B3|Trochanter||Prior Ulcer Surgery Locations||participants|Number|1|1.0||||||
4254288|NCT00624806|4078332|B2|Trochanter||Prior Ulcer Surgery Locations||participants|Number|0|0.0||||||
4254289|NCT00624806|4078333|B1|Trochanter||Prior Ulcer Surgery Locations||participants|Number|1|1.0||||||
4254290|NCT00624806|4078331|B3|Ischium||Prior Ulcer Surgery Locations||participants|Number|4|4.0||||||
4254291|NCT00624806|4078332|B2|Ischium||Prior Ulcer Surgery Locations||participants|Number|1|1.0||||||
4254292|NCT00624806|4078333|B1|Ischium||Prior Ulcer Surgery Locations||participants|Number|3|3.0||||||
4254293|NCT00624806|4078331|B3|||Number of Prior Pressure Ulcer Surgeries||surgeries|Mean|0.61|0.61|Full Range|||0.0|3.0|
4254294|NCT00624806|4078332|B2|||Number of Prior Pressure Ulcer Surgeries||surgeries|Mean|0.63|0.63|Full Range|||0.0|3.0|
4254295|NCT00624806|4078333|B1|||Number of Prior Pressure Ulcer Surgeries||surgeries|Mean|0.6|0.6|Full Range|||0.0|3.0|
4254296|NCT00624806|4078331|B3|Medial Malleolus||Prior Ulcer Locations|It is possible for participants to have >1 ulcer, in multiple locations.|pressure ulcers|Number|1|1.0||||||
4254297|NCT00624806|4078332|B2|Medial Malleolus||Prior Ulcer Locations|It is possible for participants to have >1 ulcer, in multiple locations.|pressure ulcers|Number|1|1.0||||||
4254298|NCT00624806|4078333|B1|Medial Malleolus||Prior Ulcer Locations|It is possible for participants to have >1 ulcer, in multiple locations.|pressure ulcers|Number|0|0.0||||||
4254299|NCT00624806|4078331|B3|Lateral Malleolus||Prior Ulcer Locations|It is possible for participants to have >1 ulcer, in multiple locations.|pressure ulcers|Number|1|1.0||||||
4254300|NCT00624806|4078332|B2|Lateral Malleolus||Prior Ulcer Locations|It is possible for participants to have >1 ulcer, in multiple locations.|pressure ulcers|Number|1|1.0||||||
4254301|NCT00624806|4078333|B1|Lateral Malleolus||Prior Ulcer Locations|It is possible for participants to have >1 ulcer, in multiple locations.|pressure ulcers|Number|0|0.0||||||
4254302|NCT00624806|4078331|B3|Heel||Prior Ulcer Locations|It is possible for participants to have >1 ulcer, in multiple locations.|pressure ulcers|Number|2|2.0||||||
4254303|NCT00624806|4078332|B2|Heel||Prior Ulcer Locations|It is possible for participants to have >1 ulcer, in multiple locations.|pressure ulcers|Number|1|1.0||||||
4254304|NCT00624806|4078333|B1|Heel||Prior Ulcer Locations|It is possible for participants to have >1 ulcer, in multiple locations.|pressure ulcers|Number|1|1.0||||||
4254305|NCT00624806|4078331|B3|Coccyx||Prior Ulcer Locations|It is possible for participants to have >1 ulcer, in multiple locations.|pressure ulcers|Number|3|3.0||||||
4254306|NCT00624806|4078332|B2|Coccyx||Prior Ulcer Locations|It is possible for participants to have >1 ulcer, in multiple locations.|pressure ulcers|Number|2|2.0||||||
4254307|NCT00624806|4078333|B1|Coccyx||Prior Ulcer Locations|It is possible for participants to have >1 ulcer, in multiple locations.|pressure ulcers|Number|1|1.0||||||
4254308|NCT00624806|4078331|B3|Sacrum||Prior Ulcer Locations|It is possible for participants to have >1 ulcer, in multiple locations.|pressure ulcers|Number|4|4.0||||||
4254309|NCT00624806|4078332|B2|Sacrum||Prior Ulcer Locations|It is possible for participants to have >1 ulcer, in multiple locations.|pressure ulcers|Number|3|3.0||||||
4254310|NCT00624806|4078333|B1|Sacrum||Prior Ulcer Locations|It is possible for participants to have >1 ulcer, in multiple locations.|pressure ulcers|Number|1|1.0||||||
4254311|NCT00624806|4078331|B3|Trochanter||Prior Ulcer Locations|It is possible for participants to have >1 ulcer, in multiple locations.|pressure ulcers|Number|4|4.0||||||
4254312|NCT00624806|4078332|B2|Trochanter||Prior Ulcer Locations|It is possible for participants to have >1 ulcer, in multiple locations.|pressure ulcers|Number|1|1.0||||||
4254313|NCT00624806|4078333|B1|Trochanter||Prior Ulcer Locations|It is possible for participants to have >1 ulcer, in multiple locations.|pressure ulcers|Number|3|3.0||||||
4254314|NCT00624806|4078331|B3|Ischium||Prior Ulcer Locations|It is possible for participants to have >1 ulcer, in multiple locations.|pressure ulcers|Number|6|6.0||||||
4254315|NCT00624806|4078332|B2|Ischium||Prior Ulcer Locations|It is possible for participants to have >1 ulcer, in multiple locations.|pressure ulcers|Number|2|2.0||||||
4254316|NCT00624806|4078333|B1|Ischium||Prior Ulcer Locations|It is possible for participants to have >1 ulcer, in multiple locations.|pressure ulcers|Number|4|4.0||||||
4254317|NCT00624806|4078331|B3|||Number of prior pressure ulcers (PrU)||pressure ulcers|Mean|2|2.0|Full Range|||0.0|6.0|
4254318|NCT00624806|4078332|B2|||Number of prior pressure ulcers (PrU)||pressure ulcers|Mean|1.7|1.7|Full Range|||0.0|6.0|
4254319|NCT00624806|4078333|B1|||Number of prior pressure ulcers (PrU)||pressure ulcers|Mean|2.43|2.43|Full Range|||0.0|6.0|
4254320|NCT00624806|4078331|B3|Other Relatives||Receive regular assistance from:||participants|Number|3|3.0||||||
4254321|NCT00624806|4078332|B2|Other Relatives||Receive regular assistance from:||participants|Number|1|1.0||||||
4254322|NCT00624806|4078333|B1|Other Relatives||Receive regular assistance from:||participants|Number|2|2.0||||||
4254323|NCT00624806|4078331|B3|Partner/Significant Other||Receive regular assistance from:||participants|Number|2|2.0||||||
4254324|NCT00624806|4078332|B2|Partner/Significant Other||Receive regular assistance from:||participants|Number|1|1.0||||||
4254325|NCT00624806|4078333|B1|Partner/Significant Other||Receive regular assistance from:||participants|Number|1|1.0||||||
4254326|NCT00624806|4078331|B3|Paid Attendant||Receive regular assistance from:||participants|Number|8|8.0||||||
4254327|NCT00624806|4078332|B2|Paid Attendant||Receive regular assistance from:||participants|Number|3|3.0||||||
4254328|NCT00624806|4078333|B1|Paid Attendant||Receive regular assistance from:||participants|Number|5|5.0||||||
4254329|NCT00624806|4078331|B3|Spouse||Receive regular assistance from:||participants|Number|5|5.0||||||
4254330|NCT00624806|4078332|B2|Spouse||Receive regular assistance from:||participants|Number|3|3.0||||||
4254331|NCT00624806|4078333|B1|Spouse||Receive regular assistance from:||participants|Number|2|2.0||||||
4254332|NCT00624806|4078331|B3|N/A||Amputees||participants|Number|16|16.0||||||
4254333|NCT00624806|4078332|B2|N/A||Amputees||participants|Number|7|7.0||||||
4254334|NCT00624806|4078333|B1|N/A||Amputees||participants|Number|9|9.0||||||
4254335|NCT00624806|4078331|B3|Right Lower Extremity||Amputees||participants|Number|2|2.0||||||
4254336|NCT00624806|4078332|B2|Right Lower Extremity||Amputees||participants|Number|1|1.0||||||
4254337|NCT00624806|4078333|B1|Right Lower Extremity||Amputees||participants|Number|1|1.0||||||
4254338|NCT00624806|4078331|B3|Unknown||Urinary Management||participants|Number|2|2.0||||||
4254339|NCT00624806|4078332|B2|Unknown||Urinary Management||participants|Number|1|1.0||||||
4254340|NCT00624806|4078333|B1|Unknown||Urinary Management||participants|Number|1|1.0||||||
4254341|NCT00624806|4078331|B3|Other||Urinary Management||participants|Number|6|6.0||||||
4254342|NCT00624806|4078332|B2|Other||Urinary Management||participants|Number|1|1.0||||||
4254343|NCT00624806|4078333|B1|Other||Urinary Management||participants|Number|5|5.0||||||
4254344|NCT00624806|4078331|B3|Condom Catheter||Urinary Management||participants|Number|2|2.0||||||
4254345|NCT00624806|4078332|B2|Condom Catheter||Urinary Management||participants|Number|0|0.0||||||
4254346|NCT00624806|4078333|B1|Condom Catheter||Urinary Management||participants|Number|2|2.0||||||
4254347|NCT00624806|4078331|B3|Intermittent Catheter||Urinary Management||participants|Number|8|8.0||||||
4254348|NCT00624806|4078332|B2|Intermittent Catheter||Urinary Management||participants|Number|6|6.0||||||
4254349|NCT00624806|4078333|B1|Intermittent Catheter||Urinary Management||participants|Number|2|2.0||||||
4254350|NCT00624806|4078331|B3|Unknown||American Spinal Injury Association (ASIA) Score||participants|Number|3|3.0||||||
4254351|NCT00624806|4078332|B2|Unknown||American Spinal Injury Association (ASIA) Score||participants|Number|0|0.0||||||
4254352|NCT00624806|4078333|B1|Unknown||American Spinal Injury Association (ASIA) Score||participants|Number|3|3.0||||||
4254353|NCT00624806|4078331|B3|D = Motor Incomplete||American Spinal Injury Association (ASIA) Score||participants|Number|2|2.0||||||
4254354|NCT00624806|4078332|B2|D = Motor Incomplete||American Spinal Injury Association (ASIA) Score||participants|Number|1|1.0||||||
4254355|NCT00624806|4078333|B1|D = Motor Incomplete||American Spinal Injury Association (ASIA) Score||participants|Number|1|1.0||||||
4254356|NCT00624806|4078331|B3|C = Motor Incomplete||American Spinal Injury Association (ASIA) Score||participants|Number|2|2.0||||||
4254357|NCT00624806|4078332|B2|C = Motor Incomplete||American Spinal Injury Association (ASIA) Score||participants|Number|1|1.0||||||
4254358|NCT00624806|4078333|B1|C = Motor Incomplete||American Spinal Injury Association (ASIA) Score||participants|Number|1|1.0||||||
4254359|NCT00624806|4078331|B3|B = Sensory Incomplete||American Spinal Injury Association (ASIA) Score||participants|Number|4|4.0||||||
4254360|NCT00624806|4078332|B2|B = Sensory Incomplete||American Spinal Injury Association (ASIA) Score||participants|Number|2|2.0||||||
4254361|NCT00624806|4078333|B1|B = Sensory Incomplete||American Spinal Injury Association (ASIA) Score||participants|Number|2|2.0||||||
4254362|NCT00624806|4078331|B3|A = Complete||American Spinal Injury Association (ASIA) Score||participants|Number|7|7.0||||||
4254363|NCT00624806|4078332|B2|A = Complete||American Spinal Injury Association (ASIA) Score||participants|Number|4|4.0||||||
4254364|NCT00624806|4078333|B1|A = Complete||American Spinal Injury Association (ASIA) Score||participants|Number|3|3.0||||||
4254365|NCT00624806|4078331|B3|N/A||Level of Injury||participants|Number|2|2.0||||||
4254366|NCT00624806|4078332|B2|N/A||Level of Injury||participants|Number|0|0.0||||||
4254367|NCT00624806|4078333|B1|N/A||Level of Injury||participants|Number|2|2.0||||||
4254368|NCT00624806|4078331|B3|Lumbar||Level of Injury||participants|Number|1|1.0||||||
4254369|NCT00624806|4078332|B2|Lumbar||Level of Injury||participants|Number|0|0.0||||||
4254370|NCT00624806|4078333|B1|Lumbar||Level of Injury||participants|Number|1|1.0||||||
4254371|NCT00624806|4078331|B3|Thoracic||Level of Injury||participants|Number|3|3.0||||||
4254372|NCT00624806|4078332|B2|Thoracic||Level of Injury||participants|Number|2|2.0||||||
4254373|NCT00624806|4078333|B1|Thoracic||Level of Injury||participants|Number|1|1.0||||||
4254374|NCT00624806|4078331|B3|Cervical||Level of Injury||participants|Number|12|12.0||||||
4254375|NCT00624806|4078332|B2|Cervical||Level of Injury||participants|Number|6|6.0||||||
4254376|NCT00624806|4078333|B1|Cervical||Level of Injury||participants|Number|6|6.0||||||
4254377|NCT00624806|4078331|B3|Other etiology||Spinal Cord Injury (SCI) Etiology||participants|Number|4|4.0||||||
4254378|NCT00624806|4078332|B2|Other etiology||Spinal Cord Injury (SCI) Etiology||participants|Number|1|1.0||||||
4254379|NCT00624806|4078333|B1|Other etiology||Spinal Cord Injury (SCI) Etiology||participants|Number|3|3.0||||||
4254380|NCT00624806|4078331|B3|Gunshot wound||Spinal Cord Injury (SCI) Etiology||participants|Number|3|3.0||||||
4254381|NCT00624806|4078332|B2|Gunshot wound||Spinal Cord Injury (SCI) Etiology||participants|Number|2|2.0||||||
4254382|NCT00624806|4078333|B1|Gunshot wound||Spinal Cord Injury (SCI) Etiology||participants|Number|1|1.0||||||
4254383|NCT00624806|4078331|B3|Fall||Spinal Cord Injury (SCI) Etiology||participants|Number|3|3.0||||||
4254384|NCT00624806|4078332|B2|Fall||Spinal Cord Injury (SCI) Etiology||participants|Number|2|2.0||||||
4254385|NCT00624806|4078333|B1|Fall||Spinal Cord Injury (SCI) Etiology||participants|Number|1|1.0||||||
4254386|NCT00624806|4078331|B3|Diving||Spinal Cord Injury (SCI) Etiology||participants|Number|1|1.0||||||
4254387|NCT00624806|4078332|B2|Diving||Spinal Cord Injury (SCI) Etiology||participants|Number|1|1.0||||||
4254388|NCT00624806|4078333|B1|Diving||Spinal Cord Injury (SCI) Etiology||participants|Number|0|0.0||||||
4254389|NCT00624806|4078331|B3|Vehicular accident||Spinal Cord Injury (SCI) Etiology||participants|Number|7|7.0||||||
4254390|NCT00624806|4078332|B2|Vehicular accident||Spinal Cord Injury (SCI) Etiology||participants|Number|2|2.0||||||
4254391|NCT00624806|4078333|B1|Vehicular accident||Spinal Cord Injury (SCI) Etiology||participants|Number|5|5.0||||||
4254392|NCT00624806|4078331|B3|||Duration of Injury in years||years|Mean|18.4|18.4|Full Range|||0.98|53.0|
4254393|NCT00624806|4078332|B2|||Duration of Injury in years||years|Mean|18.81|18.81|Full Range|||6.4|53.0|
4254394|NCT00624806|4078333|B1|||Duration of Injury in years||years|Mean|17.94|17.94|Full Range|||0.98|28.34|
4254395|NCT00624806|4078331|B3|Other||Past Work History||participants|Number|4|4.0||||||
4254396|NCT00624806|4078332|B2|Other||Past Work History||participants|Number|3|3.0||||||
4254397|NCT00624806|4078333|B1|Other||Past Work History||participants|Number|1|1.0||||||
4254398|NCT00624806|4078331|B3|Administrator, professional, manager||Past Work History||participants|Number|3|3.0||||||
4254399|NCT00624806|4078332|B2|Administrator, professional, manager||Past Work History||participants|Number|1|1.0||||||
4254400|NCT00624806|4078333|B1|Administrator, professional, manager||Past Work History||participants|Number|2|2.0||||||
4254401|NCT00624806|4078331|B3|Clerical, sales worker||Past Work History||participants|Number|2|2.0||||||
4254402|NCT00624806|4078332|B2|Clerical, sales worker||Past Work History||participants|Number|0|0.0||||||
4254403|NCT00624806|4078333|B1|Clerical, sales worker||Past Work History||participants|Number|2|2.0||||||
4254404|NCT00624806|4078331|B3|Skilled manual worker, crafstman||Past Work History||participants|Number|2|2.0||||||
4254405|NCT00624806|4078332|B2|Skilled manual worker, crafstman||Past Work History||participants|Number|1|1.0||||||
4254406|NCT00624806|4078333|B1|Skilled manual worker, crafstman||Past Work History||participants|Number|1|1.0||||||
4254407|NCT00624806|4078331|B3|Unskilled worker||Past Work History||participants|Number|2|2.0||||||
4254408|NCT00624806|4078332|B2|Unskilled worker||Past Work History||participants|Number|0|0.0||||||
4254409|NCT00624806|4078333|B1|Unskilled worker||Past Work History||participants|Number|2|2.0||||||
4254410|NCT00624806|4078331|B3|Never worked||Past Work History||participants|Number|1|1.0||||||
4254411|NCT00624806|4078332|B2|Never worked||Past Work History||participants|Number|1|1.0||||||
4254412|NCT00624806|4078333|B1|Never worked||Past Work History||participants|Number|0|0.0||||||
4254413|NCT00624806|4078331|B3|Semi-skilled worker||Past Work History||participants|Number|4|4.0||||||
4254414|NCT00624806|4078332|B2|Semi-skilled worker||Past Work History||participants|Number|2|2.0||||||
4254415|NCT00624806|4078333|B1|Semi-skilled worker||Past Work History||participants|Number|2|2.0||||||
4254416|NCT00624806|4078331|B3|||Years Since Employment||years|Mean|12.12|12.12|Full Range|||0.27|31.2|
4254417|NCT00624806|4078332|B2|||Years Since Employment||years|Mean|14.64|14.64|Full Range|||7.42|26.3|
4254418|NCT00624806|4078333|B1|||Years Since Employment||years|Mean|10.43|10.43|Full Range|||0.27|31.2|
4254419|NCT00624806|4078331|B3|Small business owner||Current employment status||participants|Number|1|1.0||||||
4254420|NCT00624806|4078332|B2|Small business owner||Current employment status||participants|Number|1|1.0||||||
4254421|NCT00624806|4078333|B1|Small business owner||Current employment status||participants|Number|0|0.0||||||
4254422|NCT00624806|4078331|B3|Not working||Current employment status||participants|Number|17|17.0||||||
4254423|NCT00624806|4078332|B2|Not working||Current employment status||participants|Number|7|7.0||||||
4254424|NCT00624806|4078333|B1|Not working||Current employment status||participants|Number|10|10.0||||||
4254425|NCT00624806|4078331|B3|Graduate school||Education||participants|Number|4|4.0||||||
4254426|NCT00624806|4078332|B2|Graduate school||Education||participants|Number|3|3.0||||||
4254427|NCT00624806|4078333|B1|Graduate school||Education||participants|Number|1|1.0||||||
4254428|NCT00624806|4078331|B3|College graduate||Education||participants|Number|1|1.0||||||
4254429|NCT00624806|4078332|B2|College graduate||Education||participants|Number|0|0.0||||||
4254430|NCT00624806|4078333|B1|College graduate||Education||participants|Number|1|1.0||||||
4254431|NCT00624806|4078331|B3|Some college||Education||participants|Number|5|5.0||||||
4254432|NCT00624806|4078332|B2|Some college||Education||participants|Number|2|2.0||||||
4254433|NCT00624806|4078333|B1|Some college||Education||participants|Number|3|3.0||||||
4254434|NCT00624806|4078331|B3|Some high school||Education||participants|Number|2|2.0||||||
4254435|NCT00624806|4078332|B2|Some high school||Education||participants|Number|1|1.0||||||
4254436|NCT00624806|4078333|B1|Some high school||Education||participants|Number|1|1.0||||||
4254437|NCT00624806|4078331|B3|High school graduate||Education||participants|Number|6|6.0||||||
4254438|NCT00624806|4078332|B2|High school graduate||Education||participants|Number|2|2.0||||||
4254439|NCT00624806|4078333|B1|High school graduate||Education||participants|Number|4|4.0||||||
4254440|NCT00624806|4078331|B3|Apartment||Residence type||participants|Number|4|4.0||||||
4254441|NCT00624806|4078332|B2|Apartment||Residence type||participants|Number|2|2.0||||||
4254442|NCT00624806|4078333|B1|Apartment||Residence type||participants|Number|2|2.0||||||
4254443|NCT00624806|4078331|B3|House||Residence type||participants|Number|14|14.0||||||
4254444|NCT00624806|4078332|B2|House||Residence type||participants|Number|6|6.0||||||
4254445|NCT00624806|4078333|B1|House||Residence type||participants|Number|8|8.0||||||
4254446|NCT00624806|4078331|B3|Widowed||Marital status||participants|Number|1|1.0||||||
4254447|NCT00624806|4078332|B2|Widowed||Marital status||participants|Number|0|0.0||||||
4254448|NCT00624806|4078333|B1|Widowed||Marital status||participants|Number|1|1.0||||||
4254449|NCT00624806|4078331|B3|Married||Marital status||participants|Number|5|5.0||||||
4254450|NCT00624806|4078332|B2|Married||Marital status||participants|Number|3|3.0||||||
4254451|NCT00624806|4078333|B1|Married||Marital status||participants|Number|2|2.0||||||
4254452|NCT00624806|4078331|B3|Never married||Marital status||participants|Number|5|5.0||||||
4254453|NCT00624806|4078332|B2|Never married||Marital status||participants|Number|2|2.0||||||
4254454|NCT00624806|4078333|B1|Never married||Marital status||participants|Number|3|3.0||||||
4254455|NCT00624806|4078331|B3|Divorced||Marital status||participants|Number|7|7.0||||||
4254456|NCT00624806|4078332|B2|Divorced||Marital status||participants|Number|3|3.0||||||
4254457|NCT00624806|4078333|B1|Divorced||Marital status||participants|Number|4|4.0||||||
4254458|NCT00624806|4078331|B3|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4254459|NCT00624806|4078332|B2|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4254460|NCT00624806|4078333|B1|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4254461|NCT00624806|4078331|B3|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4254462|NCT00624806|4078332|B2|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4254463|NCT00624806|4078333|B1|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4254464|NCT00624806|4078331|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4254465|NCT00624806|4078332|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4254466|NCT00624806|4078333|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4254467|NCT00624806|4078331|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4254468|NCT00624806|4078332|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4254469|NCT00624806|4078333|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4254470|NCT00624806|4078331|B3|||Age||years|Mean|50.67|50.67|Standard Deviation|13.29|13.29|||
4254471|NCT00624806|4078332|B2|||Age||years|Mean|49.75|49.75|Standard Deviation|14.89|14.89|||
4254472|NCT00624806|4078333|B1|||Age||years|Mean|51.4|51.4|Standard Deviation|12.64|12.64|||
4254473|NCT00624780|4078344|B7||Male|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
4254474|NCT00624780|4078345|B6||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4254475|NCT00624780|4078346|B5||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4254476|NCT00624780|4078347|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4254477|NCT00624780|4078348|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4254478|NCT00624780|4078349|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4254479|NCT00624780|4078350|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4254480|NCT00624780|4078344|B7||Female|Sex: Female, Male||Participants|Count of Participants|374|374.0||||||
4254481|NCT00624780|4078345|B6||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4254482|NCT00624780|4078346|B5||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4254483|NCT00624780|4078347|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4254484|NCT00624780|4078348|B3||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4254485|NCT00624780|4078349|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4254486|NCT00624780|4078350|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4254487|NCT00624780|4078344|B7|Greater than or equal to 65 years||Age, Customized||participants|Number|4|4.0||||||
4254488|NCT00624780|4078345|B6|Greater than or equal to 65 years||Age, Customized||participants|Number|0|0.0||||||
4254489|NCT00624780|4078346|B5|Greater than or equal to 65 years||Age, Customized||participants|Number|1|1.0||||||
4254490|NCT00624780|4078347|B4|Greater than or equal to 65 years||Age, Customized||participants|Number|0|0.0||||||
4254491|NCT00624780|4078348|B3|Greater than or equal to 65 years||Age, Customized||participants|Number|3|3.0||||||
4254492|NCT00624780|4078349|B2|Greater than or equal to 65 years||Age, Customized||participants|Number|0|0.0||||||
4254493|NCT00624780|4078350|B1|Greater than or equal to 65 years||Age, Customized||participants|Number|0|0.0||||||
4254494|NCT00624780|4078344|B7|45 to 64 years||Age, Customized||participants|Number|265|265.0||||||
4254495|NCT00624780|4078345|B6|45 to 64 years||Age, Customized||participants|Number|23|23.0||||||
4254496|NCT00624780|4078346|B5|45 to 64 years||Age, Customized||participants|Number|66|66.0||||||
4254497|NCT00624780|4078347|B4|45 to 64 years||Age, Customized||participants|Number|24|24.0||||||
4254498|NCT00624780|4078348|B3|45 to 64 years||Age, Customized||participants|Number|51|51.0||||||
4254499|NCT00624780|4078349|B2|45 to 64 years||Age, Customized||participants|Number|22|22.0||||||
4254500|NCT00624780|4078350|B1|45 to 64 years||Age, Customized||participants|Number|79|79.0||||||
4254501|NCT00624780|4078344|B7|18 to 44 years||Age, Customized||participants|Number|346|346.0||||||
4254502|NCT00624780|4078345|B6|18 to 44 years||Age, Customized||participants|Number|27|27.0||||||
4254503|NCT00624780|4078346|B5|18 to 44 years||Age, Customized||participants|Number|86|86.0||||||
4254504|NCT00624780|4078347|B4|18 to 44 years||Age, Customized||participants|Number|28|28.0||||||
4254505|NCT00624780|4078348|B3|18 to 44 years||Age, Customized||participants|Number|100|100.0||||||
4254506|NCT00624780|4078349|B2|18 to 44 years||Age, Customized||participants|Number|30|30.0||||||
4254507|NCT00624780|4078350|B1|18 to 44 years||Age, Customized||participants|Number|75|75.0||||||
4254508|NCT00624585|4078537|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4254509|NCT00624585|4078537|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4254510|NCT00624585|4078537|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4254511|NCT00624585|4078537|B1|||Age||years|Mean|73.5|73.5|Full Range|||60.0|84.0|
4254512|NCT00624559|4078544|B5|United States||Region of Enrollment||participants|Number|12|12.0||||||
4254513|NCT00624559|4078545|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
4254514|NCT00624559|4078546|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4254515|NCT00624559|4078547|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4254516|NCT00624559|4078548|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4254517|NCT00624559|4078544|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4254518|NCT00624559|4078545|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4254519|NCT00624559|4078546|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4254520|NCT00624559|4078547|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4254521|NCT00624559|4078548|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4254522|NCT00624559|4078544|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4254523|NCT00624559|4078545|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4254524|NCT00624559|4078546|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4254525|NCT00624559|4078547|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4254526|NCT00624559|4078548|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4254527|NCT00624559|4078544|B5|||Age||years|Mean|35|35.0|Standard Deviation|2|2.0|||
4254528|NCT00624559|4078545|B4|||Age||years|Mean|35|35.0|Standard Deviation|2|2.0|||
4254529|NCT00624559|4078546|B3|||Age||years|Mean|35|35.0|Standard Deviation|2|2.0|||
4254530|NCT00624559|4078547|B2|||Age||years|Mean|35|35.0|Standard Deviation|2|2.0|||
4254531|NCT00624559|4078548|B1|||Age||years|Mean|35|35.0|Standard Deviation|2|2.0|||
4254532|NCT00624559|4078544|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4254533|NCT00624559|4078545|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4254534|NCT00624559|4078546|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4254535|NCT00624559|4078547|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4254536|NCT00624559|4078548|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4254537|NCT00624559|4078544|B5||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4254538|NCT00624559|4078545|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4254539|NCT00624559|4078546|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4254540|NCT00624559|4078547|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4254541|NCT00624559|4078548|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4254542|NCT00624559|4078544|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4254543|NCT00624559|4078545|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4254544|NCT00624559|4078546|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4254545|NCT00624559|4078547|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4254546|NCT00624559|4078548|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4254547|NCT00624520|4078565|B3|United States||Region of Enrollment|Madison and Milwaukee study sites, US|participants|Number|103|103.0||||||
4254548|NCT00624520|4078566|B2|United States||Region of Enrollment|Madison and Milwaukee study sites, US|participants|Number|47|47.0||||||
4254549|NCT00624520|4078567|B1|United States||Region of Enrollment|Madison and Milwaukee study sites, US|participants|Number|56|56.0||||||
4254550|NCT00624520|4078565|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254551|NCT00624520|4078566|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254552|NCT00624520|4078567|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254553|NCT00624520|4078565|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
4254554|NCT00624520|4078566|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4254555|NCT00624520|4078567|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4254556|NCT00624520|4078565|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4254557|NCT00624520|4078566|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4254558|NCT00624520|4078567|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254559|NCT00624520|4078565|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254560|NCT00624520|4078566|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254561|NCT00624520|4078567|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254562|NCT00624520|4078565|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254563|NCT00624520|4078566|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254564|NCT00624520|4078567|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254565|NCT00624520|4078565|B3||White|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
4254566|NCT00624520|4078566|B2||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4254567|NCT00624520|4078567|B1||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4254568|NCT00624520|4078565|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4254569|NCT00624520|4078566|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4254570|NCT00624520|4078567|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4254571|NCT00624520|4078565|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254572|NCT00624520|4078566|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254573|NCT00624520|4078567|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254574|NCT00624520|4078565|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254575|NCT00624520|4078566|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254576|NCT00624520|4078567|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254577|NCT00624520|4078565|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254578|NCT00624520|4078566|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254579|NCT00624520|4078567|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254580|NCT00624520|4078565|B3||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4254581|NCT00624520|4078566|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4254582|NCT00624520|4078567|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4254583|NCT00624520|4078565|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4254584|NCT00624520|4078566|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4254585|NCT00624520|4078567|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4254586|NCT00624520|4078565|B3||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4254587|NCT00624520|4078566|B2||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4254588|NCT00624520|4078567|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4254589|NCT00624520|4078565|B3||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4254590|NCT00624520|4078566|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4254591|NCT00624520|4078567|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4254592|NCT00624520|4078565|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4254593|NCT00624520|4078566|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4254594|NCT00624520|4078567|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4254595|NCT00624520|4078565|B3|||Age||Years|Mean|65.7|65.7|Standard Deviation|8.9|8.9|||
4254596|NCT00624520|4078566|B2|||Age||Years|Mean|66.2|66.2|Standard Deviation|8.6|8.6|||
4254597|NCT00624520|4078567|B1|||Age||Years|Mean|65.7|65.7|Standard Deviation|9.0|9.0|||
4254598|NCT00624468|4078593|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4254599|NCT00624468|4078594|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4254600|NCT00624468|4078595|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4254601|NCT00624468|4078593|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4254602|NCT00624468|4078594|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4254603|NCT00624468|4078595|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4254604|NCT00624468|4078593|B3|||Age||years|Mean|31.4|31.4|Standard Deviation|8.7|8.7|||
4254605|NCT00624468|4078594|B2|||Age||years|Mean|30.6|30.6|Standard Deviation|10.2|10.2|||
4254606|NCT00624468|4078595|B1|||Age||years|Mean|32.3|32.3|Standard Deviation|7.1|7.1|||
4254607|NCT00624442|4078624|B6|United Kingdom||Region of Enrollment||participants|Number|29|29.0||||||
4254608|NCT00624442|4078625|B5|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4254609|NCT00624442|4078626|B4|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4254610|NCT00624442|4078627|B3|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4254611|NCT00624442|4078628|B2|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4254612|NCT00624442|4078629|B1|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
4254613|NCT00624442|4078624|B6|Russian Federation||Region of Enrollment||participants|Number|11|11.0||||||
4254614|NCT00624442|4078625|B5|Russian Federation||Region of Enrollment||participants|Number|1|1.0||||||
4254615|NCT00624442|4078626|B4|Russian Federation||Region of Enrollment||participants|Number|2|2.0||||||
4254616|NCT00624442|4078627|B3|Russian Federation||Region of Enrollment||participants|Number|4|4.0||||||
4254617|NCT00624442|4078628|B2|Russian Federation||Region of Enrollment||participants|Number|4|4.0||||||
4254618|NCT00624442|4078629|B1|Russian Federation||Region of Enrollment||participants|Number|0|0.0||||||
4254619|NCT00624442|4078624|B6|Georgia||Region of Enrollment||participants|Number|2|2.0||||||
4254620|NCT00624442|4078625|B5|Georgia||Region of Enrollment||participants|Number|2|2.0||||||
4254621|NCT00624442|4078626|B4|Georgia||Region of Enrollment||participants|Number|0|0.0||||||
4254622|NCT00624442|4078627|B3|Georgia||Region of Enrollment||participants|Number|0|0.0||||||
4254623|NCT00624442|4078628|B2|Georgia||Region of Enrollment||participants|Number|0|0.0||||||
4254624|NCT00624442|4078629|B1|Georgia||Region of Enrollment||participants|Number|0|0.0||||||
4254625|NCT00624442|4078624|B6|United States||Region of Enrollment||participants|Number|3|3.0||||||
4254626|NCT00624442|4078625|B5|United States||Region of Enrollment||participants|Number|2|2.0||||||
4254627|NCT00624442|4078626|B4|United States||Region of Enrollment||participants|Number|1|1.0||||||
4254628|NCT00624442|4078627|B3|United States||Region of Enrollment||participants|Number|0|0.0||||||
4254629|NCT00624442|4078628|B2|United States||Region of Enrollment||participants|Number|0|0.0||||||
4254630|NCT00624442|4078629|B1|United States||Region of Enrollment||participants|Number|0|0.0||||||
4254631|NCT00624442|4078624|B6||Male|Gender||Participants|Count of Participants|39|39.0||||||
4254632|NCT00624442|4078625|B5||Male|Gender||Participants|Count of Participants|8|8.0||||||
4254633|NCT00624442|4078626|B4||Male|Gender||Participants|Count of Participants|5|5.0||||||
4254634|NCT00624442|4078627|B3||Male|Gender||Participants|Count of Participants|10|10.0||||||
4254635|NCT00624442|4078628|B2||Male|Gender||Participants|Count of Participants|8|8.0||||||
4254636|NCT00624442|4078629|B1||Male|Gender||Participants|Count of Participants|8|8.0||||||
4254637|NCT00624442|4078624|B6||Female|Gender||Participants|Count of Participants|6|6.0||||||
4254638|NCT00624442|4078625|B5||Female|Gender||Participants|Count of Participants|2|2.0||||||
4254639|NCT00624442|4078626|B4||Female|Gender||Participants|Count of Participants|3|3.0||||||
4254640|NCT00624442|4078627|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
4254641|NCT00624442|4078628|B2||Female|Gender||Participants|Count of Participants|1|1.0||||||
4254642|NCT00624442|4078629|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
4254643|NCT00624442|4078624|B6|||Age||years|Mean|57.5|57.5|Standard Deviation|13.2|13.2|||
4254644|NCT00624442|4078625|B5|||Age||years|Mean|57.0|57.0|Standard Deviation|14.0|14.0|||
4254645|NCT00624442|4078626|B4|||Age||years|Mean|52.6|52.6|Standard Deviation|18.0|18.0|||
4254646|NCT00624442|4078627|B3|||Age||years|Mean|62.0|62.0|Standard Deviation|8.2|8.2|||
4254647|NCT00624442|4078628|B2|||Age||years|Mean|56.0|56.0|Standard Deviation|14.3|14.3|||
4254648|NCT00624442|4078629|B1|||Age||years|Mean|59.0|59.0|Standard Deviation|11.9|11.9|||
4254649|NCT00624442|4078624|B6||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4254650|NCT00624442|4078625|B5||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4254651|NCT00624442|4078626|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4254652|NCT00624442|4078627|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4254653|NCT00624442|4078628|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4254654|NCT00624442|4078629|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4254655|NCT00624442|4078624|B6||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4254656|NCT00624442|4078625|B5||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4254657|NCT00624442|4078626|B4||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4254658|NCT00624442|4078627|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4254659|NCT00624442|4078628|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4254660|NCT00624442|4078629|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4254661|NCT00624442|4078624|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4254662|NCT00624442|4078625|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4254663|NCT00624442|4078626|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4254664|NCT00624442|4078627|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4254665|NCT00624442|4078628|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4254666|NCT00624442|4078629|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4254667|NCT00624416|4078659|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4254668|NCT00624416|4078659|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4254669|NCT00624416|4078659|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4254670|NCT00624416|4078659|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4254671|NCT00624416|4078659|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4254672|NCT00624416|4078659|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4254673|NCT00624377|4078665|B1|||Height|The number is different than the overall number of baseline participants because some of the CRF have lost during the follow up of the patient.|cm|Mean|162.57|162.57|Standard Deviation|7.38|7.38|||
4254674|NCT00624377|4078665|B1|||Weight|The number is different than the overall number of baseline participants because some of the CRF have lost during the follow up of the patient.|kg|Mean|61.94|61.94|Standard Deviation|11.60|11.6|||
4254675|NCT00624377|4078665|B1|Male||Gender|The number is different than the overall number of baseline participants because some of the CRF have lost during the follow up of the patient.|Participants|Number|1781|1781.0||||||
4254676|NCT00624377|4078665|B1|Female||Gender|The number is different than the overall number of baseline participants because some of the CRF have lost during the follow up of the patient.|Participants|Number|245|245.0||||||
4254677|NCT00624377|4078665|B1|||Age, Customized|The number is different than the overall number of baseline participants because some of the CRF have lost during the follow up of the patient.|Year|Mean|72.87|72.87|Standard Deviation|10.32|10.32|||
4254678|NCT00624338|4078676|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4254679|NCT00624338|4078677|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4254680|NCT00624338|4078678|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4254681|NCT00624338|4078679|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4254682|NCT00624338|4078676|B4||Female|Sex: Female, Male||Participants|Count of Participants|430|430.0||||||
4254683|NCT00624338|4078677|B3||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4254684|NCT00624338|4078678|B2||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4254685|NCT00624338|4078679|B1||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4254686|NCT00624338|4078676|B4|||Age||years|Mean|39.0|39.0|Standard Deviation|12.2|12.2|||
4254687|NCT00624338|4078677|B3|||Age||years|Mean|39.0|39.0|Standard Deviation|12.1|12.1|||
4254688|NCT00624338|4078678|B2|||Age||years|Mean|39.0|39.0|Standard Deviation|12.8|12.8|||
4254689|NCT00624338|4078679|B1|||Age||years|Mean|39.1|39.1|Standard Deviation|12.0|12.0|||
4254690|NCT00624286|4078701|B3||Male|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4254691|NCT00624286|4078702|B2||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4254692|NCT00624286|4078703|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4254693|NCT00624286|4078701|B3||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4254694|NCT00624286|4078702|B2||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4254695|NCT00624286|4078703|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4254696|NCT00624286|4078701|B3|||Age||years|Mean|63.0|63.0|Standard Deviation|9.75|9.75|||
4254697|NCT00624286|4078702|B2|||Age||years|Mean|63.2|63.2|Standard Deviation|9.62|9.62|||
4254698|NCT00624286|4078703|B1|||Age||years|Mean|62.9|62.9|Standard Deviation|9.89|9.89|||
4254699|NCT00624234|4078712|B7|||Woodcock Johnson Achievement Tests|This metric measures reading abilities (word recognition and decoding) as assessed by standard educational assessments (Woodcock Johnson Psychoeducational Battery - 3rd Edition Normative Update; WJ-III NU). The scores are reported as age-normed standard scores, with higher scores reflecting better performance on the measure (mean=100, standard deviation=15, such that a score >130 would be very superior and a score <70 would be very low). The Basic Reading score is a normed composite of the WJ-III subtests Letter-Word Identification and Word Attack, representing word-level reading skill.|units on a scale|Mean|86.88|86.88|Standard Deviation|14.48|14.48|||
4254733|NCT00624221|4078737|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4254734|NCT00624221|4078738|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4254735|NCT00624221|4078739|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4254700|NCT00624234|4078713|B6|||Woodcock Johnson Achievement Tests|This metric measures reading abilities (word recognition and decoding) as assessed by standard educational assessments (Woodcock Johnson Psychoeducational Battery - 3rd Edition Normative Update; WJ-III NU). The scores are reported as age-normed standard scores, with higher scores reflecting better performance on the measure (mean=100, standard deviation=15, such that a score >130 would be very superior and a score <70 would be very low). The Basic Reading score is a normed composite of the WJ-III subtests Letter-Word Identification and Word Attack, representing word-level reading skill.|units on a scale|Mean|79.64|79.64|Standard Deviation|9.66|9.66|||
4254701|NCT00624234|4078714|B5|||Woodcock Johnson Achievement Tests|This metric measures reading abilities (word recognition and decoding) as assessed by standard educational assessments (Woodcock Johnson Psychoeducational Battery - 3rd Edition Normative Update; WJ-III NU). The scores are reported as age-normed standard scores, with higher scores reflecting better performance on the measure (mean=100, standard deviation=15, such that a score >130 would be very superior and a score <70 would be very low). The Basic Reading score is a normed composite of the WJ-III subtests Letter-Word Identification and Word Attack, representing word-level reading skill.|units on a scale|Mean|79.67|79.67|Standard Deviation|9.59|9.59|||
4254702|NCT00624234|4078715|B4|||Woodcock Johnson Achievement Tests|This metric measures reading abilities (word recognition and decoding) as assessed by standard educational assessments (Woodcock Johnson Psychoeducational Battery - 3rd Edition Normative Update; WJ-III NU). The scores are reported as age-normed standard scores, with higher scores reflecting better performance on the measure (mean=100, standard deviation=15, such that a score >130 would be very superior and a score <70 would be very low). The Basic Reading score is a normed composite of the WJ-III subtests Letter-Word Identification and Word Attack, representing word-level reading skill.|units on a scale|Mean|77.57|77.57|Standard Deviation|13.47|13.47|||
4254703|NCT00624234|4078716|B3|||Woodcock Johnson Achievement Tests|This metric measures reading abilities (word recognition and decoding) as assessed by standard educational assessments (Woodcock Johnson Psychoeducational Battery - 3rd Edition Normative Update; WJ-III NU). The scores are reported as age-normed standard scores, with higher scores reflecting better performance on the measure (mean=100, standard deviation=15, such that a score >130 would be very superior and a score <70 would be very low). The Basic Reading score is a normed composite of the WJ-III subtests Letter-Word Identification and Word Attack, representing word-level reading skill.|units on a scale|Mean|103.81|103.81|Standard Deviation|7.41|7.41|||
4254704|NCT00624234|4078717|B2|||Woodcock Johnson Achievement Tests|This metric measures reading abilities (word recognition and decoding) as assessed by standard educational assessments (Woodcock Johnson Psychoeducational Battery - 3rd Edition Normative Update; WJ-III NU). The scores are reported as age-normed standard scores, with higher scores reflecting better performance on the measure (mean=100, standard deviation=15, such that a score >130 would be very superior and a score <70 would be very low). The Basic Reading score is a normed composite of the WJ-III subtests Letter-Word Identification and Word Attack, representing word-level reading skill.|units on a scale|Mean|85.78|85.78|Standard Deviation|7.24|7.24|||
4254705|NCT00624234|4078718|B1|||Woodcock Johnson Achievement Tests|This metric measures reading abilities (word recognition and decoding) as assessed by standard educational assessments (Woodcock Johnson Psychoeducational Battery - 3rd Edition Normative Update; WJ-III NU). The scores are reported as age-normed standard scores, with higher scores reflecting better performance on the measure (mean=100, standard deviation=15, such that a score >130 would be very superior and a score <70 would be very low). The Basic Reading score is a normed composite of the WJ-III subtests Letter-Word Identification and Word Attack, representing word-level reading skill.|units on a scale|Mean|78.25|78.25|Standard Deviation|9.05|9.05|||
4254706|NCT00624234|4078712|B7||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4254707|NCT00624234|4078713|B6||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4254708|NCT00624234|4078714|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4254709|NCT00624234|4078715|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4254710|NCT00624234|4078716|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4254711|NCT00624234|4078717|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4254712|NCT00624234|4078718|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4254713|NCT00624234|4078712|B7||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4254714|NCT00624234|4078713|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4254715|NCT00624234|4078714|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4254716|NCT00624234|4078715|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4254717|NCT00624234|4078716|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4254718|NCT00624234|4078717|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4254719|NCT00624234|4078718|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4254720|NCT00624234|4078712|B7|||Age||years|Mean|10.18|10.18|Standard Deviation|1.79|1.79|||
4254721|NCT00624234|4078713|B6|||Age||years|Mean|10.72|10.72|Standard Deviation|2.25|2.25|||
4254722|NCT00624234|4078714|B5|||Age||years|Mean|10.33|10.33|Standard Deviation|2.12|2.12|||
4254723|NCT00624234|4078715|B4|||Age||years|Mean|10.08|10.08|Standard Deviation|1.63|1.63|||
4254724|NCT00624234|4078716|B3|||Age||years|Mean|9.70|9.7|Standard Deviation|1.53|1.53|||
4254725|NCT00624234|4078717|B2|||Age||years|Mean|11.06|11.06|Standard Deviation|1.48|1.48|||
4254726|NCT00624234|4078718|B1|||Age||years|Mean|9.62|9.62|Standard Deviation|1.13|1.13|||
4254727|NCT00624221|4078737|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4254728|NCT00624221|4078738|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4254729|NCT00624221|4078739|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4254730|NCT00624221|4078737|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4254731|NCT00624221|4078738|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4254732|NCT00624221|4078739|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4254736|NCT00624221|4078737|B3|||Age||years|Mean|71|71.0|Standard Deviation|12|12.0|||
4254737|NCT00624221|4078738|B2|||Age||years|Mean|72|72.0|Standard Deviation|13|13.0|||
4254738|NCT00624221|4078739|B1|||Age||years|Mean|70|70.0|Standard Deviation|12|12.0|||
4254739|NCT00624195|4078746|B3|United States||Region of Enrollment||participants|Number|59|59.0||||||
4254740|NCT00624195|4078747|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4254741|NCT00624195|4078748|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4254742|NCT00624195|4078746|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4254743|NCT00624195|4078747|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4254744|NCT00624195|4078748|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4254745|NCT00624195|4078746|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4254746|NCT00624195|4078747|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4254747|NCT00624195|4078748|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4254748|NCT00624195|4078746|B3|||Age||years|Mean|44.5|44.5|Standard Deviation|9.9|9.9|||
4254749|NCT00624195|4078747|B2|||Age||years|Mean|43.6|43.6|Standard Deviation|11.1|11.1|||
4254750|NCT00624195|4078748|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|8.8|8.8|||
4254751|NCT00624195|4078746|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4254752|NCT00624195|4078747|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4254753|NCT00624195|4078748|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4254754|NCT00624195|4078746|B3||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4254755|NCT00624195|4078747|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4254756|NCT00624195|4078748|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4254757|NCT00624195|4078746|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4254758|NCT00624195|4078747|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4254759|NCT00624195|4078748|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4254760|NCT00624065|4078755|B3|Baseline Sitting Diastolic Blood Pressure (DBP)||Baseline Blood Pressure||mm/Hg|Mean|92.2|92.2|Standard Deviation|7.50|7.5|||
4254761|NCT00624065|4078756|B2|Baseline Sitting Diastolic Blood Pressure (DBP)||Baseline Blood Pressure||mm/Hg|Mean|92.2|92.2|Standard Deviation|6.84|6.84|||
4254762|NCT00624065|4078757|B1|Baseline Sitting Diastolic Blood Pressure (DBP)||Baseline Blood Pressure||mm/Hg|Mean|92.2|92.2|Standard Deviation|8.12|8.12|||
4254763|NCT00624065|4078755|B3|Baseline Sitting Systolic Blood Pressure (SBP)||Baseline Blood Pressure||mm/Hg|Mean|149.3|149.3|Standard Deviation|10.27|10.27|||
4254764|NCT00624065|4078756|B2|Baseline Sitting Systolic Blood Pressure (SBP)||Baseline Blood Pressure||mm/Hg|Mean|148.8|148.8|Standard Deviation|10.30|10.3|||
4254765|NCT00624065|4078757|B1|Baseline Sitting Systolic Blood Pressure (SBP)||Baseline Blood Pressure||mm/Hg|Mean|149.8|149.8|Standard Deviation|10.25|10.25|||
4254766|NCT00624065|4078755|B3|AA/AH & White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4254767|NCT00624065|4078756|B2|AA/AH & White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4254768|NCT00624065|4078757|B1|AA/AH & White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4254769|NCT00624065|4078755|B3|AA/AH & American Indian or Alaska Native & White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4254770|NCT00624065|4078756|B2|AA/AH & American Indian or Alaska Native & White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4254771|NCT00624065|4078757|B1|AA/AH & American Indian or Alaska Native & White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4254772|NCT00624065|4078755|B3|AA/AH & American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4254773|NCT00624065|4078756|B2|AA/AH & American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4254774|NCT00624065|4078757|B1|AA/AH & American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4254775|NCT00624065|4078755|B3|White||Race/Ethnicity, Customized||Participants|Number|328|328.0||||||
4254776|NCT00624065|4078756|B2|White||Race/Ethnicity, Customized||Participants|Number|178|178.0||||||
4254777|NCT00624065|4078757|B1|White||Race/Ethnicity, Customized||Participants|Number|150|150.0||||||
4254778|NCT00624065|4078755|B3|Mixed Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4254779|NCT00624065|4078756|B2|Mixed Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4254780|NCT00624065|4078757|B1|Mixed Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4254781|NCT00624065|4078755|B3|Japanese/East Asian/South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4254782|NCT00624065|4078756|B2|Japanese/East Asian/South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4254783|NCT00624065|4078757|B1|Japanese/East Asian/South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4254784|NCT00624065|4078755|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4254785|NCT00624065|4078756|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4254786|NCT00624065|4078757|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4254787|NCT00624065|4078755|B3|African American/African Heritage (AA/AH)||Race/Ethnicity, Customized||Participants|Number|74|74.0||||||
4254788|NCT00624065|4078756|B2|African American/African Heritage (AA/AH)||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
4254789|NCT00624065|4078757|B1|African American/African Heritage (AA/AH)||Race/Ethnicity, Customized||Participants|Number|45|45.0||||||
4254790|NCT00624065|4078755|B3||Male|Gender||Participants|Count of Participants|242|242.0||||||
4254791|NCT00624065|4078756|B2||Male|Gender||Participants|Count of Participants|121|121.0||||||
4254792|NCT00624065|4078757|B1||Male|Gender||Participants|Count of Participants|121|121.0||||||
4254793|NCT00624065|4078755|B3||Female|Gender||Participants|Count of Participants|190|190.0||||||
4254794|NCT00624065|4078756|B2||Female|Gender||Participants|Count of Participants|95|95.0||||||
4254795|NCT00624065|4078757|B1||Female|Gender||Participants|Count of Participants|95|95.0||||||
4254796|NCT00624065|4078755|B3|||Age||years|Mean|54.1|54.1|Standard Deviation|10.9|10.9|||
4254797|NCT00624065|4078756|B2|||Age||years|Mean|54.1|54.1|Standard Deviation|9.8|9.8|||
4254798|NCT00624065|4078757|B1|||Age||years|Mean|54.0|54.0|Standard Deviation|11.9|11.9|||
4254799|NCT00624052|4078766|B5||Male|Sex: Female, Male||Participants|Count of Participants|471|471.0||||||
4254800|NCT00624052|4078767|B4||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4254801|NCT00624052|4078768|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4254802|NCT00624052|4078769|B2||Male|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4254803|NCT00624052|4078770|B1||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4254804|NCT00624052|4078766|B5||Female|Sex: Female, Male||Participants|Count of Participants|367|367.0||||||
4254805|NCT00624052|4078767|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4254806|NCT00624052|4078768|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4254807|NCT00624052|4078769|B2||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
4254808|NCT00624052|4078770|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4254809|NCT00624052|4078766|B5|||Age||Years|Mean|56.4|56.4|Standard Deviation|9.7|9.7|||
4254810|NCT00624052|4078767|B4|||Age||Years|Mean|53.3|53.3|Standard Deviation|10.3|10.3|||
4254811|NCT00624052|4078768|B3|||Age||Years|Mean|55.2|55.2|Standard Deviation|9.7|9.7|||
4254812|NCT00624052|4078769|B2|||Age||Years|Mean|57.3|57.3|Standard Deviation|9.4|9.4|||
4254813|NCT00624052|4078770|B1|||Age||Years|Mean|56.2|56.2|Standard Deviation|9.9|9.9|||
4254814|NCT00624013|4078822|B3|United States||Region of Enrollment||participants|Number|89|89.0||||||
4254815|NCT00624013|4078823|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
4254816|NCT00624013|4078824|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4254817|NCT00624013|4078822|B3|African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4254818|NCT00624013|4078823|B2|African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4254819|NCT00624013|4078824|B1|African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4254820|NCT00624013|4078822|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|78|78.0||||||
4254821|NCT00624013|4078823|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4254822|NCT00624013|4078824|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4254823|NCT00624013|4078822|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4254824|NCT00624013|4078823|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4254825|NCT00624013|4078824|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4254826|NCT00624013|4078822|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4254827|NCT00624013|4078823|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4254828|NCT00624013|4078824|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4254829|NCT00624013|4078822|B3|||Age||years|Mean|53|53.0|Standard Deviation|8|8.0|||
4254830|NCT00624013|4078823|B2|||Age||years|Mean|52|52.0|Standard Deviation|8|8.0|||
4254831|NCT00624013|4078824|B1|||Age||years|Mean|53|53.0|Standard Deviation|10|10.0|||
4254832|NCT00623935|4078850|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4254833|NCT00623935|4078850|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4254834|NCT00623935|4078850|B1|||Age||years|Median|61|61.0|Full Range|||55.0|70.0|
4254835|NCT00623831|4078855|B3|100%||Baseline Karnofsky Performance Status|100%: Normal no complaints; no evidence of disease. 90%: Able to carry on normal activity; minor signs or symptoms of disease. 80%: Normal activity with effort; some signs or symptoms of disease. 70%: Cares for self; unable to carry on normal activity or to do active work.|Participants|Count of Participants|7|7.0||||||
4254836|NCT00623831|4078856|B2|100%||Baseline Karnofsky Performance Status|100%: Normal no complaints; no evidence of disease. 90%: Able to carry on normal activity; minor signs or symptoms of disease. 80%: Normal activity with effort; some signs or symptoms of disease. 70%: Cares for self; unable to carry on normal activity or to do active work.|Participants|Count of Participants|4|4.0||||||
4254837|NCT00623831|4078857|B1|100%||Baseline Karnofsky Performance Status|100%: Normal no complaints; no evidence of disease. 90%: Able to carry on normal activity; minor signs or symptoms of disease. 80%: Normal activity with effort; some signs or symptoms of disease. 70%: Cares for self; unable to carry on normal activity or to do active work.|Participants|Count of Participants|3|3.0||||||
4254838|NCT00623831|4078855|B3|90%||Baseline Karnofsky Performance Status|100%: Normal no complaints; no evidence of disease. 90%: Able to carry on normal activity; minor signs or symptoms of disease. 80%: Normal activity with effort; some signs or symptoms of disease. 70%: Cares for self; unable to carry on normal activity or to do active work.|Participants|Count of Participants|4|4.0||||||
4254839|NCT00623831|4078856|B2|90%||Baseline Karnofsky Performance Status|100%: Normal no complaints; no evidence of disease. 90%: Able to carry on normal activity; minor signs or symptoms of disease. 80%: Normal activity with effort; some signs or symptoms of disease. 70%: Cares for self; unable to carry on normal activity or to do active work.|Participants|Count of Participants|0|0.0||||||
4254840|NCT00623831|4078857|B1|90%||Baseline Karnofsky Performance Status|100%: Normal no complaints; no evidence of disease. 90%: Able to carry on normal activity; minor signs or symptoms of disease. 80%: Normal activity with effort; some signs or symptoms of disease. 70%: Cares for self; unable to carry on normal activity or to do active work.|Participants|Count of Participants|4|4.0||||||
4254841|NCT00623831|4078855|B3|80%||Baseline Karnofsky Performance Status|100%: Normal no complaints; no evidence of disease. 90%: Able to carry on normal activity; minor signs or symptoms of disease. 80%: Normal activity with effort; some signs or symptoms of disease. 70%: Cares for self; unable to carry on normal activity or to do active work.|Participants|Count of Participants|4|4.0||||||
4254842|NCT00623831|4078856|B2|80%||Baseline Karnofsky Performance Status|100%: Normal no complaints; no evidence of disease. 90%: Able to carry on normal activity; minor signs or symptoms of disease. 80%: Normal activity with effort; some signs or symptoms of disease. 70%: Cares for self; unable to carry on normal activity or to do active work.|Participants|Count of Participants|0|0.0||||||
4254843|NCT00623831|4078857|B1|80%||Baseline Karnofsky Performance Status|100%: Normal no complaints; no evidence of disease. 90%: Able to carry on normal activity; minor signs or symptoms of disease. 80%: Normal activity with effort; some signs or symptoms of disease. 70%: Cares for self; unable to carry on normal activity or to do active work.|Participants|Count of Participants|4|4.0||||||
4254844|NCT00623831|4078855|B3|70%||Baseline Karnofsky Performance Status|100%: Normal no complaints; no evidence of disease. 90%: Able to carry on normal activity; minor signs or symptoms of disease. 80%: Normal activity with effort; some signs or symptoms of disease. 70%: Cares for self; unable to carry on normal activity or to do active work.|Participants|Count of Participants|2|2.0||||||
4254845|NCT00623831|4078856|B2|70%||Baseline Karnofsky Performance Status|100%: Normal no complaints; no evidence of disease. 90%: Able to carry on normal activity; minor signs or symptoms of disease. 80%: Normal activity with effort; some signs or symptoms of disease. 70%: Cares for self; unable to carry on normal activity or to do active work.|Participants|Count of Participants|0|0.0||||||
4254846|NCT00623831|4078857|B1|70%||Baseline Karnofsky Performance Status|100%: Normal no complaints; no evidence of disease. 90%: Able to carry on normal activity; minor signs or symptoms of disease. 80%: Normal activity with effort; some signs or symptoms of disease. 70%: Cares for self; unable to carry on normal activity or to do active work.|Participants|Count of Participants|2|2.0||||||
4254847|NCT00623831|4078855|B3|||Stage IV Disease at Study Entry||Participants|Count of Participants|17|17.0||||||
4254848|NCT00623831|4078856|B2|||Stage IV Disease at Study Entry||Participants|Count of Participants|4|4.0||||||
4254849|NCT00623831|4078857|B1|||Stage IV Disease at Study Entry||Participants|Count of Participants|13|13.0||||||
4254850|NCT00623831|4078855|B3|Transitional cell carcinoma||Diagnosis at Study Entry||Participants|Count of Participants|1|1.0||||||
4254851|NCT00623831|4078856|B2|Transitional cell carcinoma||Diagnosis at Study Entry||Participants|Count of Participants|0|0.0||||||
4254852|NCT00623831|4078857|B1|Transitional cell carcinoma||Diagnosis at Study Entry||Participants|Count of Participants|1|1.0||||||
4254853|NCT00623831|4078855|B3|Breast cancer||Diagnosis at Study Entry||Participants|Count of Participants|1|1.0||||||
4254854|NCT00623831|4078856|B2|Breast cancer||Diagnosis at Study Entry||Participants|Count of Participants|1|1.0||||||
4254855|NCT00623831|4078857|B1|Breast cancer||Diagnosis at Study Entry||Participants|Count of Participants|0|0.0||||||
4254856|NCT00623831|4078855|B3|Head and neck cancer||Diagnosis at Study Entry||Participants|Count of Participants|1|1.0||||||
4254857|NCT00623831|4078856|B2|Head and neck cancer||Diagnosis at Study Entry||Participants|Count of Participants|0|0.0||||||
4254858|NCT00623831|4078857|B1|Head and neck cancer||Diagnosis at Study Entry||Participants|Count of Participants|1|1.0||||||
4254859|NCT00623831|4078855|B3|Prostate cancer||Diagnosis at Study Entry||Participants|Count of Participants|2|2.0||||||
4254860|NCT00623831|4078856|B2|Prostate cancer||Diagnosis at Study Entry||Participants|Count of Participants|0|0.0||||||
4254861|NCT00623831|4078857|B1|Prostate cancer||Diagnosis at Study Entry||Participants|Count of Participants|2|2.0||||||
4254862|NCT00623831|4078855|B3|Sarcoma||Diagnosis at Study Entry||Participants|Count of Participants|3|3.0||||||
4254863|NCT00623831|4078856|B2|Sarcoma||Diagnosis at Study Entry||Participants|Count of Participants|1|1.0||||||
4254864|NCT00623831|4078857|B1|Sarcoma||Diagnosis at Study Entry||Participants|Count of Participants|2|2.0||||||
4254865|NCT00623831|4078855|B3|Melanoma||Diagnosis at Study Entry||Participants|Count of Participants|9|9.0||||||
4254866|NCT00623831|4078856|B2|Melanoma||Diagnosis at Study Entry||Participants|Count of Participants|2|2.0||||||
4254867|NCT00623831|4078857|B1|Melanoma||Diagnosis at Study Entry||Participants|Count of Participants|7|7.0||||||
4254868|NCT00623831|4078855|B3|Germany||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
4254869|NCT00623831|4078856|B2|Germany||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4254870|NCT00623831|4078857|B1|Germany||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4254871|NCT00623831|4078855|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254872|NCT00623831|4078856|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254873|NCT00623831|4078857|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254874|NCT00623831|4078855|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254875|NCT00623831|4078856|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254876|NCT00623831|4078857|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254877|NCT00623831|4078855|B3||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4254878|NCT00623831|4078856|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4254879|NCT00623831|4078857|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4254880|NCT00623831|4078855|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254881|NCT00623831|4078856|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254882|NCT00623831|4078857|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254883|NCT00623831|4078855|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254884|NCT00623831|4078856|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254885|NCT00623831|4078857|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254886|NCT00623831|4078855|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254887|NCT00623831|4078856|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254888|NCT00623831|4078857|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254889|NCT00623831|4078855|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254890|NCT00623831|4078856|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254891|NCT00623831|4078857|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254892|NCT00623831|4078855|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4254893|NCT00623831|4078856|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254894|NCT00623831|4078857|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4254895|NCT00623831|4078855|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4254896|NCT00623831|4078856|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4254897|NCT00623831|4078857|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4254898|NCT00623831|4078855|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254899|NCT00623831|4078856|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254900|NCT00623831|4078857|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254901|NCT00623831|4078855|B3||Male|Gender||Participants|Count of Participants|9|9.0||||||
4254902|NCT00623831|4078856|B2||Male|Gender||Participants|Count of Participants|2|2.0||||||
4254903|NCT00623831|4078857|B1||Male|Gender||Participants|Count of Participants|7|7.0||||||
4254904|NCT00623831|4078855|B3||Female|Gender||Participants|Count of Participants|8|8.0||||||
4254905|NCT00623831|4078856|B2||Female|Gender||Participants|Count of Participants|2|2.0||||||
4254906|NCT00623831|4078857|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
4254907|NCT00623831|4078855|B3|||Age||years|Mean|57.4|57.4|Standard Deviation|11.6|11.6|||
4254908|NCT00623831|4078856|B2|||Age||years|Mean|55.5|55.5|Standard Deviation|11.3|11.3|||
4254909|NCT00623831|4078857|B1|||Age||years|Mean|58.0|58.0|Standard Deviation|11.7|11.7|||
4254910|NCT00623831|4078855|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4254911|NCT00623831|4078856|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4254912|NCT00623831|4078857|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4254913|NCT00623831|4078855|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4254914|NCT00623831|4078856|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4254915|NCT00623831|4078857|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4254916|NCT00623831|4078855|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4254917|NCT00623831|4078856|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4254918|NCT00623831|4078857|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4254919|NCT00623805|4078868|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4254920|NCT00623805|4078869|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4254921|NCT00623805|4078870|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4254922|NCT00623805|4078868|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4254923|NCT00623805|4078869|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4254924|NCT00623805|4078870|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4254925|NCT00623805|4078868|B3|||Age||years|Mean|57.2|57.2|Standard Deviation|11.2|11.2|||
4254926|NCT00623805|4078869|B2|||Age||years|Mean|57.6|57.6|Standard Deviation|11.3|11.3|||
4254927|NCT00623805|4078870|B1|||Age||years|Mean|56.9|56.9|Standard Deviation|11.2|11.2|||
4254928|NCT00623779|4078885|B4||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4254929|NCT00623779|4078886|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4254930|NCT00623779|4078887|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4254931|NCT00623779|4078888|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4254932|NCT00623779|4078885|B4||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4254933|NCT00623779|4078886|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4254934|NCT00623779|4078887|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4254935|NCT00623779|4078888|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4254936|NCT00623779|4078885|B4|||Age||Years|Mean|70|70.0|Standard Deviation|8.68|8.68|||
4254937|NCT00623779|4078886|B3|||Age||Years|Mean|68.8|68.8|Standard Deviation|9.36|9.36|||
4254938|NCT00623779|4078887|B2|||Age||Years|Mean|71.6|71.6|Standard Deviation|8.51|8.51|||
4254939|NCT00623779|4078888|B1|||Age||Years|Mean|72.5|72.5|Standard Deviation|8|8.0|||
4254940|NCT00623766|4078937|B3|1||Eastern Cooperative Oncology Group (ECOG) score|ECOG performance status assesses a participant's physical ability on a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score of 0=best status and 5=worst status.|Units on a scale|Number|33|33.0||||||
4254941|NCT00623766|4078938|B2|1||Eastern Cooperative Oncology Group (ECOG) score|ECOG performance status assesses a participant's physical ability on a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score of 0=best status and 5=worst status.|Units on a scale|Number|7|7.0||||||
4254942|NCT00623766|4078939|B1|1||Eastern Cooperative Oncology Group (ECOG) score|ECOG performance status assesses a participant's physical ability on a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score of 0=best status and 5=worst status.|Units on a scale|Number|26|26.0||||||
4254943|NCT00623766|4078937|B3|0||Eastern Cooperative Oncology Group (ECOG) score|ECOG performance status assesses a participant's physical ability on a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score of 0=best status and 5=worst status.|Units on a scale|Number|39|39.0||||||
4254944|NCT00623766|4078938|B2|0||Eastern Cooperative Oncology Group (ECOG) score|ECOG performance status assesses a participant's physical ability on a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score of 0=best status and 5=worst status.|Units on a scale|Number|14|14.0||||||
4254945|NCT00623766|4078939|B1|0||Eastern Cooperative Oncology Group (ECOG) score|ECOG performance status assesses a participant's physical ability on a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score of 0=best status and 5=worst status.|Units on a scale|Number|25|25.0||||||
4254946|NCT00623766|4078937|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254947|NCT00623766|4078938|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254948|NCT00623766|4078939|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254949|NCT00623766|4078937|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254950|NCT00623766|4078938|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254951|NCT00623766|4078939|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254952|NCT00623766|4078937|B3||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4254953|NCT00623766|4078938|B2||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4254954|NCT00623766|4078939|B1||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4254955|NCT00623766|4078937|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254956|NCT00623766|4078938|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254957|NCT00623766|4078939|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254958|NCT00623766|4078937|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254959|NCT00623766|4078938|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254960|NCT00623766|4078939|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254961|NCT00623766|4078937|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254962|NCT00623766|4078938|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254963|NCT00623766|4078939|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254964|NCT00623766|4078937|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254965|NCT00623766|4078938|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254966|NCT00623766|4078939|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4254967|NCT00623766|4078937|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4254968|NCT00623766|4078938|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4254969|NCT00623766|4078939|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4254970|NCT00623766|4078937|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4254971|NCT00623766|4078938|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4254972|NCT00623766|4078939|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4254973|NCT00623766|4078937|B3|65 years and older||Age, Customized||Participants|Number|16|16.0||||||
4254974|NCT00623766|4078938|B2|65 years and older||Age, Customized||Participants|Number|4|4.0||||||
4254975|NCT00623766|4078939|B1|65 years and older||Age, Customized||Participants|Number|12|12.0||||||
4254976|NCT00623766|4078937|B3|Younger than 65 years||Age, Customized||Participants|Number|56|56.0||||||
4254977|NCT00623766|4078938|B2|Younger than 65 years||Age, Customized||Participants|Number|17|17.0||||||
4254978|NCT00623766|4078939|B1|Younger than 65 years||Age, Customized||Participants|Number|39|39.0||||||
4254979|NCT00623727|4078962|B3|Prophylaxis||Previous treatment|Previous treatment was categorized as prophylaxis versus on demand|participants|Number|60|60.0||||||
4254980|NCT00623727|4078963|B2|Prophylaxis||Previous treatment|Previous treatment was categorized as prophylaxis versus on demand|participants|Number|28|28.0||||||
4254981|NCT00623727|4078964|B1|Prophylaxis||Previous treatment|Previous treatment was categorized as prophylaxis versus on demand|participants|Number|32|32.0||||||
4254982|NCT00623727|4078962|B3|On demand||Previous treatment|Previous treatment was categorized as prophylaxis versus on demand|participants|Number|79|79.0||||||
4254983|NCT00623727|4078963|B2|On demand||Previous treatment|Previous treatment was categorized as prophylaxis versus on demand|participants|Number|44|44.0||||||
4254984|NCT00623727|4078964|B1|On demand||Previous treatment|Previous treatment was categorized as prophylaxis versus on demand|participants|Number|35|35.0||||||
4254985|NCT00623727|4078962|B3|No||target joint|The presence or absence of target joints (defined as joints with at least 3 bleeds into the same joint within 6 months) was evaluated.|participants|Number|29|29.0||||||
4254986|NCT00623727|4078963|B2|No||target joint|The presence or absence of target joints (defined as joints with at least 3 bleeds into the same joint within 6 months) was evaluated.|participants|Number|16|16.0||||||
4254987|NCT00623727|4078964|B1|No||target joint|The presence or absence of target joints (defined as joints with at least 3 bleeds into the same joint within 6 months) was evaluated.|participants|Number|13|13.0||||||
4254988|NCT00623727|4078962|B3|Yes||target joint|The presence or absence of target joints (defined as joints with at least 3 bleeds into the same joint within 6 months) was evaluated.|participants|Number|110|110.0||||||
4254989|NCT00623727|4078963|B2|Yes||target joint|The presence or absence of target joints (defined as joints with at least 3 bleeds into the same joint within 6 months) was evaluated.|participants|Number|56|56.0||||||
4254990|NCT00623727|4078964|B1|Yes||target joint|The presence or absence of target joints (defined as joints with at least 3 bleeds into the same joint within 6 months) was evaluated.|participants|Number|54|54.0||||||
4254991|NCT00623727|4078962|B3||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4254992|NCT00623727|4078963|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4254993|NCT00623727|4078964|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4254994|NCT00623727|4078962|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4254995|NCT00623727|4078963|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4254996|NCT00623727|4078964|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4254997|NCT00623727|4078962|B3|||Age||years|Mean|33.5|33.5|Standard Deviation|12.2|12.2|||
4254998|NCT00623727|4078963|B2|||Age||years|Mean|34.1|34.1|Standard Deviation|13.0|13.0|||
4254999|NCT00623727|4078964|B1|||Age||years|Mean|33.0|33.0|Standard Deviation|11.3|11.3|||
4255000|NCT00623714|4078985|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4255001|NCT00623714|4078985|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4255002|NCT00623714|4078985|B1|||Age||years|Mean|25.9|25.9|Full Range|||21.0|43.0|
4255003|NCT00623636|4078994|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4255004|NCT00623636|4078995|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4255005|NCT00623636|4078996|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4255006|NCT00623636|4078994|B3||Female|Sex: Female, Male||Participants|Count of Participants|727|727.0||||||
4255007|NCT00623636|4078995|B2||Female|Sex: Female, Male||Participants|Count of Participants|365|365.0||||||
4255008|NCT00623636|4078996|B1||Female|Sex: Female, Male||Participants|Count of Participants|362|362.0||||||
4255009|NCT00623636|4078994|B3|||Age||years|Mean|40.1|40.1|Standard Deviation|11.49|11.49|||
4255010|NCT00623636|4078995|B2|||Age||years|Mean|40.5|40.5|Standard Deviation|11.30|11.3|||
4255011|NCT00623636|4078996|B1|||Age||years|Mean|39.6|39.6|Standard Deviation|11.67|11.67|||
4255012|NCT00623597|4079018|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4255013|NCT00623597|4079019|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4255014|NCT00623597|4079020|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4255015|NCT00623597|4079018|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4255016|NCT00623597|4079019|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4255017|NCT00623597|4079020|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4255018|NCT00623597|4079018|B3|||Age||years|Mean|3.1|3.1|Standard Deviation|1.75|1.75|||
4255019|NCT00623597|4079019|B2|||Age||years|Mean|4.0|4.0|Standard Deviation|1.08|1.08|||
4255020|NCT00623597|4079020|B1|||Age||years|Mean|0.8|0.8|Standard Deviation|0.45|0.45|||
4255021|NCT00623545|4079084|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4255022|NCT00623545|4079084|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4255023|NCT00623545|4079084|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4255024|NCT00623545|4079084|B1|||Age||years|Mean|40|40.0|Standard Deviation|10|10.0|||
4255025|NCT00623545|4079084|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4255026|NCT00623545|4079084|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4255027|NCT00623545|4079084|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4255028|NCT00623506|4079089|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4255029|NCT00623506|4079090|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4255030|NCT00623506|4079091|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4255031|NCT00623506|4079089|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4255032|NCT00623506|4079090|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4255033|NCT00623506|4079091|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4255034|NCT00623506|4079089|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4255035|NCT00623506|4079090|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4255036|NCT00623506|4079091|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4255037|NCT00623506|4079089|B3|||Age||years|Mean|35.76|35.76|Standard Deviation|9.97|9.97|||
4255038|NCT00623506|4079090|B2|||Age||years|Mean|36.38|36.38|Standard Deviation|9.74|9.74|||
4255039|NCT00623506|4079091|B1|||Age||years|Mean|34.27|34.27|Standard Deviation|10.51|10.51|||
4255040|NCT00623506|4079089|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4255041|NCT00623506|4079090|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4255042|NCT00623506|4079091|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4255043|NCT00623506|4079089|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4255044|NCT00623506|4079090|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4255045|NCT00623506|4079091|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4255046|NCT00623506|4079089|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4255047|NCT00623506|4079090|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4255048|NCT00623506|4079091|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4255049|NCT00623480|4079102|B3|No||Number of patients with target joints, Yes/No|A ‘target joint’ is a particular joint that has experienced repeated bleeds or at least four bleeds into one joint within a six month period.|Participants|Number|25|25.0||||||
4255050|NCT00623480|4079103|B2|No||Number of patients with target joints, Yes/No|A ‘target joint’ is a particular joint that has experienced repeated bleeds or at least four bleeds into one joint within a six month period.|Participants|Number|11|11.0||||||
4255051|NCT00623480|4079104|B1|No||Number of patients with target joints, Yes/No|A ‘target joint’ is a particular joint that has experienced repeated bleeds or at least four bleeds into one joint within a six month period.|Participants|Number|14|14.0||||||
4255052|NCT00623480|4079102|B3|Yes||Number of patients with target joints, Yes/No|A ‘target joint’ is a particular joint that has experienced repeated bleeds or at least four bleeds into one joint within a six month period.|Participants|Number|59|59.0||||||
4255053|NCT00623480|4079103|B2|Yes||Number of patients with target joints, Yes/No|A ‘target joint’ is a particular joint that has experienced repeated bleeds or at least four bleeds into one joint within a six month period.|Participants|Number|31|31.0||||||
4255054|NCT00623480|4079104|B1|Yes||Number of patients with target joints, Yes/No|A ‘target joint’ is a particular joint that has experienced repeated bleeds or at least four bleeds into one joint within a six month period.|Participants|Number|28|28.0||||||
4255055|NCT00623480|4079102|B3|||Number of bleeds during last 6 months||Bleeds|Mean|11.1|11.1|Standard Deviation|4.8|4.8|||
4255056|NCT00623480|4079103|B2|||Number of bleeds during last 6 months||Bleeds|Mean|12.2|12.2|Standard Deviation|5.1|5.1|||
4255057|NCT00623480|4079104|B1|||Number of bleeds during last 6 months||Bleeds|Mean|10.0|10.0|Standard Deviation|4.4|4.4|||
4255058|NCT00623480|4079102|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4255059|NCT00623480|4079103|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4255060|NCT00623480|4079104|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4255061|NCT00623480|4079102|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4255062|NCT00623480|4079103|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4255063|NCT00623480|4079104|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4255064|NCT00623480|4079102|B3|||Age||Years|Mean|30.6|30.6|Standard Deviation|9.2|9.2|||
4255065|NCT00623480|4079103|B2|||Age||Years|Mean|30.7|30.7|Standard Deviation|9.7|9.7|||
4255066|NCT00623480|4079104|B1|||Age||Years|Mean|30.6|30.6|Standard Deviation|8.8|8.8|||
4255067|NCT00623467|4079117|B1|Other||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4255068|NCT00623467|4079117|B1|Asian||Race/Ethnicity, Customized||participants|Number|161|161.0||||||
4255069|NCT00623467|4079117|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|87|87.0||||||
4255070|NCT00623467|4079117|B1|Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4255071|NCT00623467|4079117|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
4255072|NCT00623467|4079117|B1||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4255073|NCT00623467|4079117|B1||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4255074|NCT00623467|4079117|B1|≥ 65 years||Age, Customized||participants|Number|49|49.0||||||
4255075|NCT00623467|4079117|B1|45 - 64 years||Age, Customized||participants|Number|145|145.0||||||
4255076|NCT00623467|4079117|B1|< 45 years||Age, Customized||participants|Number|149|149.0||||||
4255077|NCT00623441|4079181|B1|No Diabetes Mellitus||Diabetes Mellitus||Participants|Number|5593|5593.0||||||
4255078|NCT00623441|4079181|B1|Non-IDDM (Non-Insulin Dependent Diabetes Mellitus)||Diabetes Mellitus||Participants|Number|2039|2039.0||||||
4255079|NCT00623441|4079181|B1|IDDM (Insulin Dependent Diabetes Mellitus)||Diabetes Mellitus||Participants|Number|682|682.0||||||
4255080|NCT00623441|4079181|B1|India||Region of Enrollment||participants|Number|586|586.0||||||
4255081|NCT00623441|4079181|B1|Africa||Region of Enrollment||participants|Number|6|6.0||||||
4255082|NCT00623441|4079181|B1|South America||Region of Enrollment||participants|Number|220|220.0||||||
4255083|NCT00623441|4079181|B1|Pacifica||Region of Enrollment||participants|Number|57|57.0||||||
4255084|NCT00623441|4079181|B1|Southeast Asia||Region of Enrollment||participants|Number|879|879.0||||||
4255085|NCT00623441|4079181|B1|Europe||Region of Enrollment||participants|Number|6566|6566.0||||||
4255086|NCT00623441|4079181|B1||Male|Sex: Female, Male||Participants|Count of Participants|6374|6374.0||||||
4255087|NCT00623441|4079181|B1||Female|Sex: Female, Male||Participants|Count of Participants|1940|1940.0||||||
4255088|NCT00623441|4079181|B1|||Age||years|Mean|63.29|63.29|Standard Deviation|11.06|11.06|||
4255089|NCT00623441|4079181|B1||>=65 years|Age||Participants|Count of Participants|4048|4048.0||||||
4255090|NCT00623441|4079181|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4266|4266.0||||||
4255091|NCT00623441|4079181|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4255092|NCT00623428|4079185|B3|U.S.||Region|Region (US and non-US) was used for stratification.|participants|Number|21|21.0||||||
4255093|NCT00623428|4079186|B2|U.S.||Region|Region (US and non-US) was used for stratification.|participants|Number|11|11.0||||||
4255094|NCT00623428|4079187|B1|U.S.||Region|Region (US and non-US) was used for stratification.|participants|Number|10|10.0||||||
4255095|NCT00623428|4079185|B3|Non-U.S.||Region|Region (US and non-US) was used for stratification.|participants|Number|167|167.0||||||
4255096|NCT00623428|4079186|B2|Non-U.S.||Region|Region (US and non-US) was used for stratification.|participants|Number|82|82.0||||||
4255097|NCT00623428|4079187|B1|Non-U.S.||Region|Region (US and non-US) was used for stratification.|participants|Number|85|85.0||||||
4255098|NCT00623428|4079185|B3|||Pre-treatment HCV ribonucleic acid (RNA)||log10 IU/mL|Mean|6.14|6.14|Standard Deviation|0.700|0.7|||
4255099|NCT00623428|4079186|B2|||Pre-treatment HCV ribonucleic acid (RNA)||log10 IU/mL|Mean|6.17|6.17|Standard Deviation|0.773|0.773|||
4255100|NCT00623428|4079187|B1|||Pre-treatment HCV ribonucleic acid (RNA)||log10 IU/mL|Mean|6.11|6.11|Standard Deviation|0.624|0.624|||
4255101|NCT00623428|4079185|B3|HCV Genotype 3||Hepatitis C virus (HCV) genotype||participants|Number|150|150.0||||||
4255102|NCT00623428|4079186|B2|HCV Genotype 3||Hepatitis C virus (HCV) genotype||participants|Number|74|74.0||||||
4255103|NCT00623428|4079187|B1|HCV Genotype 3||Hepatitis C virus (HCV) genotype||participants|Number|76|76.0||||||
4255104|NCT00623428|4079185|B3|HCV Genotype 2||Hepatitis C virus (HCV) genotype||participants|Number|38|38.0||||||
4255105|NCT00623428|4079186|B2|HCV Genotype 2||Hepatitis C virus (HCV) genotype||participants|Number|19|19.0||||||
4255106|NCT00623428|4079187|B1|HCV Genotype 2||Hepatitis C virus (HCV) genotype||participants|Number|19|19.0||||||
4255107|NCT00623428|4079185|B3|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4255108|NCT00623428|4079186|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4255109|NCT00623428|4079187|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4255110|NCT00623428|4079185|B3|Asian or oriental||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4255111|NCT00623428|4079186|B2|Asian or oriental||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4255112|NCT00623428|4079187|B1|Asian or oriental||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4255113|NCT00623428|4079185|B3|Black||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4255114|NCT00623428|4079186|B2|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4255115|NCT00623428|4079187|B1|Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4255116|NCT00623428|4079185|B3|Caucasian or white||Race/Ethnicity, Customized||participants|Number|163|163.0||||||
4255117|NCT00623428|4079186|B2|Caucasian or white||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
4255118|NCT00623428|4079187|B1|Caucasian or white||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
4255119|NCT00623428|4079185|B3||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4255120|NCT00623428|4079186|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4255121|NCT00623428|4079187|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4255122|NCT00623428|4079185|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4255123|NCT00623428|4079186|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4255124|NCT00623428|4079187|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4255125|NCT00623428|4079185|B3|> 50 years||Age, Customized||participants|Number|88|88.0||||||
4255126|NCT00623428|4079186|B2|> 50 years||Age, Customized||participants|Number|40|40.0||||||
4255127|NCT00623428|4079187|B1|> 50 years||Age, Customized||participants|Number|48|48.0||||||
4255128|NCT00623428|4079185|B3|≤ 50 years||Age, Customized||participants|Number|100|100.0||||||
4255129|NCT00623428|4079186|B2|≤ 50 years||Age, Customized||participants|Number|53|53.0||||||
4255130|NCT00623428|4079187|B1|≤ 50 years||Age, Customized||participants|Number|47|47.0||||||
4255131|NCT00623428|4079185|B3|||Age||years|Mean|48.7|48.7|Standard Deviation|9.95|9.95|||
4255132|NCT00623428|4079186|B2|||Age||years|Mean|48.6|48.6|Standard Deviation|10.12|10.12|||
4255133|NCT00623428|4079187|B1|||Age||years|Mean|48.8|48.8|Standard Deviation|9.83|9.83|||
4255134|NCT00623233|4079206|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classified participants according to their functional impairment. Scores ranged from 0-5: 0=Fully Active; 1=Ambulatory, Restricted Strenuous Activity; 2=Ambulatory, No Work Activities; 3=Partially Confined to Bed, Limited Self Care; 4=Completely Disabled; 5=Death.|participants|Number|24|24.0||||||
4255135|NCT00623233|4079206|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classified participants according to their functional impairment. Scores ranged from 0-5: 0=Fully Active; 1=Ambulatory, Restricted Strenuous Activity; 2=Ambulatory, No Work Activities; 3=Partially Confined to Bed, Limited Self Care; 4=Completely Disabled; 5=Death.|participants|Number|28|28.0||||||
4255176|NCT00623181|4079235|B1|||Age||Years|Mean|31.2|31.2|Standard Deviation|11.44|11.44|||
4255177|NCT00623181|4079233|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4255178|NCT00623181|4079234|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4255179|NCT00623181|4079235|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4255136|NCT00623233|4079206|B1|HER2/neu-||Human Epidermal Growth Factor Receptor 2 (HER2/neu)|HER2/neu status was used at baseline as a descriptor of the breast cancer tumor population that was studied. HER2/neu status had prognostic and treatment implications that made reporting of this characteristic medically relevant. Breast cancer participants with HER2/neu immunohistochemistry (IHC) 2+ were tested using fluorescence in situ hybridization (FISH). Participants who overexpressed HER2 gene amplication by way of FISH or overexpressed IHC 3+ were not eligible.|participants|Number|52|52.0||||||
4255137|NCT00623233|4079206|B1|HER2/neu+||Human Epidermal Growth Factor Receptor 2 (HER2/neu)|HER2/neu status was used at baseline as a descriptor of the breast cancer tumor population that was studied. HER2/neu status had prognostic and treatment implications that made reporting of this characteristic medically relevant. Breast cancer participants with HER2/neu immunohistochemistry (IHC) 2+ were tested using fluorescence in situ hybridization (FISH). Participants who overexpressed HER2 gene amplication by way of FISH or overexpressed IHC 3+ were not eligible.|participants|Number|0|0.0||||||
4255138|NCT00623233|4079206|B1|PR-||Progesterone Receptor (PR) Status|PR status was used at baseline as a descriptor of the breast cancer tumor population that was studied. PR status had prognostic and treatment implications that made reporting of this characteristic medically relevant.|participants|Number|22|22.0||||||
4255139|NCT00623233|4079206|B1|PR+||Progesterone Receptor (PR) Status|PR status was used at baseline as a descriptor of the breast cancer tumor population that was studied. PR status had prognostic and treatment implications that made reporting of this characteristic medically relevant.|participants|Number|30|30.0||||||
4255140|NCT00623233|4079206|B1|ER-||Estrogen Receptor (ER) Status|ER status was used at baseline as a descriptor of the breast cancer tumor population that was studied. ER status had prognostic and treatment implications that made reporting of this characteristic medically relevant.|participants|Number|19|19.0||||||
4255141|NCT00623233|4079206|B1|ER+||Estrogen Receptor (ER) Status|ER status was used at baseline as a descriptor of the breast cancer tumor population that was studied. ER status had prognostic and treatment implications that made reporting of this characteristic medically relevant.|participants|Number|33|33.0||||||
4255142|NCT00623233|4079206|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
4255143|NCT00623233|4079206|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4255144|NCT00623233|4079206|B1|African descent||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4255145|NCT00623233|4079206|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4255146|NCT00623233|4079206|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4255147|NCT00623233|4079206|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|11.66|11.66|||
4255148|NCT00623194|4079213|B1|Tanner grade 2+||Pubertal Status|"Tanner scale:~Pre-pubertal: Tanner grade 1: the vellus over the pubes is not further developed than that over the abdominal wall, i.e. no pubic hair.~Pubertal: Tanner grade 2 or more: sparse growth of long slightly pigmented downy hair, straight, or slightly curled, chiefly at base of penis or along labia."|participants|Number|63|63.0||||||
4255149|NCT00623194|4079213|B1|Tanner grade 1||Pubertal Status|"Tanner scale:~Pre-pubertal: Tanner grade 1: the vellus over the pubes is not further developed than that over the abdominal wall, i.e. no pubic hair.~Pubertal: Tanner grade 2 or more: sparse growth of long slightly pigmented downy hair, straight, or slightly curled, chiefly at base of penis or along labia."|participants|Number|83|83.0||||||
4255150|NCT00623194|4079213|B1|||BMI|Body Mass Index (BMI) at entry in NN304-1689 (NCT00435019)|kg/m^2|Mean|18.14|18.14|Standard Deviation|2.81|2.81|||
4255151|NCT00623194|4079213|B1|||Height|Height at entry in NN304-1689 (NCT00435019)|meters|Mean|1.39|1.39|Standard Deviation|0.26|0.26|||
4255152|NCT00623194|4079213|B1|13-16 years||Age|Number of subjects in each age group at entry in NN304-1689 (NCT00435019)|participants|Number|50|50.0||||||
4255153|NCT00623194|4079213|B1|6-12 years||Age|Number of subjects in each age group at entry in NN304-1689 (NCT00435019)|participants|Number|59|59.0||||||
4255154|NCT00623194|4079213|B1|2-5 years||Age|Number of subjects in each age group at entry in NN304-1689 (NCT00435019)|participants|Number|37|37.0||||||
4255155|NCT00623194|4079213|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4255156|NCT00623194|4079213|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255157|NCT00623194|4079213|B1||White|Race (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
4255158|NCT00623194|4079213|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255159|NCT00623194|4079213|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255160|NCT00623194|4079213|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255161|NCT00623194|4079213|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255162|NCT00623194|4079213|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4255163|NCT00623194|4079213|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4255164|NCT00623194|4079213|B1|||Age|Age at entry in NN304-1689 (NCT00435019)|years|Mean|10.1|10.1|Standard Deviation|4.2|4.2|||
4255165|NCT00623181|4079233|B3|United States||Region of Enrollment||participants|Number|110|110.0||||||
4255166|NCT00623181|4079234|B2|United States||Region of Enrollment||participants|Number|54|54.0||||||
4255167|NCT00623181|4079235|B1|United States||Region of Enrollment||participants|Number|56|56.0||||||
4255168|NCT00623181|4079233|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4255169|NCT00623181|4079234|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4255170|NCT00623181|4079235|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4255171|NCT00623181|4079233|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4255172|NCT00623181|4079234|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4255173|NCT00623181|4079235|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4255174|NCT00623181|4079233|B3|||Age||Years|Mean|31.27|31.27|Standard Deviation|10.98|10.98|||
4255175|NCT00623181|4079234|B2|||Age||Years|Mean|31.3|31.3|Standard Deviation|10.58|10.58|||
4255180|NCT00623181|4079233|B3||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
4255181|NCT00623181|4079234|B2||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4255182|NCT00623181|4079235|B1||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4255183|NCT00623181|4079233|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4255184|NCT00623181|4079234|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4255185|NCT00623181|4079235|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4255186|NCT00623103|4079248|B3||Male|Sex: Female, Male||Participants|Count of Participants|398|398.0||||||
4255187|NCT00623103|4079249|B2||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4255188|NCT00623103|4079250|B1||Male|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4255189|NCT00623103|4079248|B3||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4255190|NCT00623103|4079249|B2||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4255191|NCT00623103|4079250|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4255192|NCT00623103|4079248|B3|||Age||years|Mean|72.31|72.31|Standard Deviation|6.318|6.318|||
4255193|NCT00623103|4079249|B2|||Age||years|Mean|72.26|72.26|Standard Deviation|6.352|6.352|||
4255194|NCT00623103|4079250|B1|||Age||years|Mean|72.35|72.35|Standard Deviation|6.295|6.295|||
4255195|NCT00623012|4079271|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4255196|NCT00623012|4079271|B1||Male|Gender||Participants|Count of Participants|2|2.0||||||
4255197|NCT00623012|4079271|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
4255198|NCT00623012|4079271|B1|||Age, Customized||years|Mean|46|46.0|Full Range|||21.0|70.0|
4255199|NCT00622908|4079277|B3|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4255200|NCT00622908|4079278|B2|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4255201|NCT00622908|4079279|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4255202|NCT00622908|4079277|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4255203|NCT00622908|4079278|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4255204|NCT00622908|4079279|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4255205|NCT00622908|4079277|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4255206|NCT00622908|4079278|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4255207|NCT00622908|4079279|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4255208|NCT00622908|4079277|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4255209|NCT00622908|4079278|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4255210|NCT00622908|4079279|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4255211|NCT00622908|4079277|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|222|222.0||||||
4255212|NCT00622908|4079278|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|106|106.0||||||
4255213|NCT00622908|4079279|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|116|116.0||||||
4255214|NCT00622908|4079277|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4255215|NCT00622908|4079278|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4255216|NCT00622908|4079279|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4255217|NCT00622908|4079277|B3||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4255218|NCT00622908|4079278|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4255219|NCT00622908|4079279|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4255220|NCT00622908|4079277|B3|>/=60 Years||Age, Customized||Participants|Number|43|43.0||||||
4255221|NCT00622908|4079278|B2|>/=60 Years||Age, Customized||Participants|Number|23|23.0||||||
4255222|NCT00622908|4079279|B1|>/=60 Years||Age, Customized||Participants|Number|20|20.0||||||
4255223|NCT00622908|4079277|B3|20 to 59 Years||Age, Customized||Participants|Number|142|142.0||||||
4255224|NCT00622908|4079278|B2|20 to 59 Years||Age, Customized||Participants|Number|71|71.0||||||
4255225|NCT00622908|4079279|B1|20 to 59 Years||Age, Customized||Participants|Number|71|71.0||||||
4255226|NCT00622908|4079277|B3|2 to 19 Years||Age, Customized||Participants|Number|81|81.0||||||
4255227|NCT00622908|4079278|B2|2 to 19 Years||Age, Customized||Participants|Number|37|37.0||||||
4255228|NCT00622908|4079279|B1|2 to 19 Years||Age, Customized||Participants|Number|44|44.0||||||
4255229|NCT00622908|4079277|B3|< 2 years||Age, Customized||Participants|Number|3|3.0||||||
4255230|NCT00622908|4079278|B2|< 2 years||Age, Customized||Participants|Number|1|1.0||||||
4255231|NCT00622908|4079279|B1|< 2 years||Age, Customized||Participants|Number|2|2.0||||||
4255232|NCT00622908|4079277|B3|||Age||years|Mean|34.2|34.2|Standard Deviation|22.3|22.3|||
4255233|NCT00622908|4079278|B2|||Age||years|Mean|35.1|35.1|Standard Deviation|22.4|22.4|||
4255234|NCT00622908|4079279|B1|||Age||years|Mean|33.3|33.3|Standard Deviation|22.3|22.3|||
4255235|NCT00622895|4079292|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4255236|NCT00622895|4079292|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4255237|NCT00622895|4079292|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4255238|NCT00622895|4079292|B1|||Age||years|Mean|44|44.0|Full Range|||21.0|51.0|
4255239|NCT00622895|4079292|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4255240|NCT00622895|4079292|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4255241|NCT00622895|4079292|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4255242|NCT00622869|4079307|B4||Male|Sex: Female, Male||Participants|Count of Participants|523|523.0||||||
4255243|NCT00622869|4079308|B3||Male|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4255244|NCT00622869|4079309|B2||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4255245|NCT00622869|4079310|B1||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4255246|NCT00622869|4079307|B4||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4255247|NCT00622869|4079308|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4255248|NCT00622869|4079309|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4255249|NCT00622869|4079310|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4255250|NCT00622869|4079307|B4|||Age||years|Mean|53.8|53.8|Standard Deviation|9.6|9.6|||
4255251|NCT00622869|4079308|B3|||Age||years|Mean|54.5|54.5|Standard Deviation|8.7|8.7|||
4255252|NCT00622869|4079309|B2|||Age||years|Mean|53.2|53.2|Standard Deviation|10.8|10.8|||
4255253|NCT00622869|4079310|B1|||Age||years|Mean|53.6|53.6|Standard Deviation|9.2|9.2|||
4255254|NCT00622739|4079329|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
4255255|NCT00622739|4079330|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4255256|NCT00622739|4079331|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4255257|NCT00622739|4079329|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4255258|NCT00622739|4079330|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4255259|NCT00622739|4079331|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4255260|NCT00622739|4079329|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4255261|NCT00622739|4079330|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4255262|NCT00622739|4079331|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4255263|NCT00622739|4079329|B3|||Age, Customized||years|Mean|13.4|13.4|Standard Deviation|2.5|2.5|||
4255264|NCT00622739|4079330|B2|||Age, Customized||years|Mean|13.38|13.38|Standard Deviation|2.50|2.5|||
4255265|NCT00622739|4079331|B1|||Age, Customized||years|Mean|13.53|13.53|Standard Deviation|2.62|2.62|||
4255266|NCT00622726|4079338|B3|United States||Region of Enrollment||participants|Number|150|150.0||||||
4255267|NCT00622726|4079339|B2|United States||Region of Enrollment||participants|Number|75|75.0||||||
4255268|NCT00622726|4079340|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
4255269|NCT00622726|4079338|B3||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4255270|NCT00622726|4079339|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4255271|NCT00622726|4079340|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4255272|NCT00622726|4079338|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4255273|NCT00622726|4079339|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4255274|NCT00622726|4079340|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4255275|NCT00622726|4079338|B3|||Age||years|Mean|0.2|0.2|Standard Deviation|0.1|0.1|||
4255276|NCT00622726|4079339|B2|||Age||years|Mean|0.2|0.2|Standard Deviation|0.1|0.1|||
4255277|NCT00622726|4079340|B1|||Age||years|Mean|0.2|0.2|Standard Deviation|0.1|0.1|||
4255278|NCT00622726|4079338|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4255279|NCT00622726|4079339|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4255280|NCT00622726|4079340|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4255281|NCT00622726|4079338|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4255282|NCT00622726|4079339|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4255283|NCT00622726|4079340|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4255284|NCT00622726|4079338|B3||<=18 years|Age||Participants|Count of Participants|150|150.0||||||
4255285|NCT00622726|4079339|B2||<=18 years|Age||Participants|Count of Participants|75|75.0||||||
4255286|NCT00622726|4079340|B1||<=18 years|Age||Participants|Count of Participants|75|75.0||||||
4255287|NCT00622713|4079351|B1|France||Region of Enrollment||participants|Number|218|218.0||||||
4255288|NCT00622713|4079351|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4255289|NCT00622713|4079351|B1||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4255290|NCT00622713|4079351|B1|||Age|Baseline Measures are provided for the ITT population.|years|Mean|78.7|78.7|Standard Deviation|6.59|6.59|||
4255291|NCT00622700|4079359|B4|||Expanded Disability Status Scale (EDSS) Score|EDSS is an ordinal scale in half-point increments that qualifies disability in participants with MS. It consists of 8 ordinal rating scales assessing seven functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation. EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS).|units on a scale|Mean|1.67|1.67|Standard Deviation|1.00|1.0|||
4255292|NCT00622700|4079360|B3|||Expanded Disability Status Scale (EDSS) Score|EDSS is an ordinal scale in half-point increments that qualifies disability in participants with MS. It consists of 8 ordinal rating scales assessing seven functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation. EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS).|units on a scale|Mean|1.80|1.8|Standard Deviation|0.97|0.97|||
4255293|NCT00622700|4079361|B2|||Expanded Disability Status Scale (EDSS) Score|EDSS is an ordinal scale in half-point increments that qualifies disability in participants with MS. It consists of 8 ordinal rating scales assessing seven functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation. EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS).|units on a scale|Mean|1.50|1.5|Standard Deviation|1.02|1.02|||
4255354|NCT00622440|4079514|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255294|NCT00622700|4079362|B1|||Expanded Disability Status Scale (EDSS) Score|EDSS is an ordinal scale in half-point increments that qualifies disability in participants with MS. It consists of 8 ordinal rating scales assessing seven functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation. EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS).|units on a scale|Mean|1.71|1.71|Standard Deviation|1.00|1.0|||
4255295|NCT00622700|4079359|B4|Americas and Australia||Region||participants|Number|103|103.0||||||
4255296|NCT00622700|4079360|B3|Americas and Australia||Region||participants|Number|41|41.0||||||
4255297|NCT00622700|4079361|B2|Americas and Australia||Region||participants|Number|35|35.0||||||
4255298|NCT00622700|4079362|B1|Americas and Australia||Region||participants|Number|27|27.0||||||
4255299|NCT00622700|4079359|B4|Western Europe||Region||participants|Number|224|224.0||||||
4255300|NCT00622700|4079360|B3|Western Europe||Region||participants|Number|74|74.0||||||
4255301|NCT00622700|4079361|B2|Western Europe||Region||participants|Number|74|74.0||||||
4255302|NCT00622700|4079362|B1|Western Europe||Region||participants|Number|76|76.0||||||
4255303|NCT00622700|4079359|B4|Eastern Europe||Region||participants|Number|291|291.0||||||
4255304|NCT00622700|4079360|B3|Eastern Europe||Region||participants|Number|101|101.0||||||
4255305|NCT00622700|4079361|B2|Eastern Europe||Region||participants|Number|96|96.0||||||
4255306|NCT00622700|4079362|B1|Eastern Europe||Region||participants|Number|94|94.0||||||
4255307|NCT00622700|4079359|B4||Male|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4255308|NCT00622700|4079360|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4255309|NCT00622700|4079361|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4255310|NCT00622700|4079362|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4255311|NCT00622700|4079359|B4||Female|Sex: Female, Male||Participants|Count of Participants|419|419.0||||||
4255312|NCT00622700|4079360|B3||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4255313|NCT00622700|4079361|B2||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4255314|NCT00622700|4079362|B1||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4255315|NCT00622700|4079359|B4|||Age||years|Mean|32.7|32.7|Standard Deviation|8.9|8.9|||
4255316|NCT00622700|4079360|B3|||Age||years|Mean|32.8|32.8|Standard Deviation|8.1|8.1|||
4255317|NCT00622700|4079361|B2|||Age||years|Mean|31.6|31.6|Standard Deviation|9.0|9.0|||
4255318|NCT00622700|4079362|B1|||Age||years|Mean|32.0|32.0|Standard Deviation|8.4|8.4|||
4255319|NCT00622635|4079427|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4255320|NCT00622635|4079427|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4255321|NCT00622635|4079427|B1|||Age||years|Mean|65.6|65.6|Standard Deviation|9.03|9.03|||
4255322|NCT00622544|4079497|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4255323|NCT00622544|4079497|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4255324|NCT00622544|4079497|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4255325|NCT00622544|4079497|B1|||Age||years|Mean|9.9|9.9|Standard Deviation|3.1|3.1|||
4255326|NCT00622544|4079497|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4255327|NCT00622544|4079497|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4255328|NCT00622544|4079497|B1||<=18 years|Age||Participants|Count of Participants|35|35.0||||||
4255329|NCT00622518|4079502|B3|United States||Region of Enrollment||participants|Number|119|119.0||||||
4255330|NCT00622518|4079503|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
4255331|NCT00622518|4079504|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
4255332|NCT00622518|4079502|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4255333|NCT00622518|4079503|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4255334|NCT00622518|4079504|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4255335|NCT00622518|4079502|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4255336|NCT00622518|4079503|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4255337|NCT00622518|4079504|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4255338|NCT00622518|4079502|B3|||Age||years|Mean|3.5|3.5|Standard Deviation|2.4|2.4|||
4255339|NCT00622518|4079503|B2|||Age||years|Mean|3.4|3.4|Standard Deviation|2.4|2.4|||
4255340|NCT00622518|4079504|B1|||Age||years|Mean|3.6|3.6|Standard Deviation|2.5|2.5|||
4255341|NCT00622518|4079502|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4255342|NCT00622518|4079503|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4255343|NCT00622518|4079504|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4255344|NCT00622518|4079502|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4255345|NCT00622518|4079503|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4255346|NCT00622518|4079504|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4255347|NCT00622518|4079502|B3||<=18 years|Age||Participants|Count of Participants|119|119.0||||||
4255348|NCT00622518|4079503|B2||<=18 years|Age||Participants|Count of Participants|60|60.0||||||
4255349|NCT00622518|4079504|B1||<=18 years|Age||Participants|Count of Participants|59|59.0||||||
4255350|NCT00622440|4079513|B3|United States||Region of Enrollment||participants|Number|70|70.0||||||
4255351|NCT00622440|4079514|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
4255352|NCT00622440|4079515|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4255353|NCT00622440|4079513|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255355|NCT00622440|4079515|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255356|NCT00622440|4079513|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4255357|NCT00622440|4079514|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4255358|NCT00622440|4079515|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255359|NCT00622440|4079513|B3||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4255360|NCT00622440|4079514|B2||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4255361|NCT00622440|4079515|B1||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4255362|NCT00622440|4079513|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4255363|NCT00622440|4079514|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4255364|NCT00622440|4079515|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4255365|NCT00622440|4079513|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4255366|NCT00622440|4079514|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4255367|NCT00622440|4079515|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4255368|NCT00622440|4079513|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4255369|NCT00622440|4079514|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4255370|NCT00622440|4079515|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255371|NCT00622440|4079513|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255372|NCT00622440|4079514|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255373|NCT00622440|4079515|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255374|NCT00622440|4079513|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255375|NCT00622440|4079514|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255376|NCT00622440|4079515|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255377|NCT00622440|4079513|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4255378|NCT00622440|4079514|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4255379|NCT00622440|4079515|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4255380|NCT00622440|4079513|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4255381|NCT00622440|4079514|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4255382|NCT00622440|4079515|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4255383|NCT00622440|4079513|B3|MTF (transgender)||Sex/Gender, Customized||participants|Number|1|1.0||||||
4255384|NCT00622440|4079514|B2|MTF (transgender)||Sex/Gender, Customized||participants|Number|1|1.0||||||
4255385|NCT00622440|4079515|B1|MTF (transgender)||Sex/Gender, Customized||participants|Number|0|0.0||||||
4255386|NCT00622440|4079513|B3|Women||Sex/Gender, Customized||participants|Number|2|2.0||||||
4255387|NCT00622440|4079514|B2|Women||Sex/Gender, Customized||participants|Number|1|1.0||||||
4255388|NCT00622440|4079515|B1|Women||Sex/Gender, Customized||participants|Number|1|1.0||||||
4255389|NCT00622440|4079513|B3|Men||Sex/Gender, Customized||participants|Number|67|67.0||||||
4255390|NCT00622440|4079514|B2|Men||Sex/Gender, Customized||participants|Number|33|33.0||||||
4255391|NCT00622440|4079515|B1|Men||Sex/Gender, Customized||participants|Number|34|34.0||||||
4255392|NCT00622440|4079513|B3|60-74 years||Age, Customized||participants|Number|8|8.0||||||
4255393|NCT00622440|4079514|B2|60-74 years||Age, Customized||participants|Number|3|3.0||||||
4255394|NCT00622440|4079515|B1|60-74 years||Age, Customized||participants|Number|5|5.0||||||
4255395|NCT00622440|4079513|B3|40-59 years||Age, Customized||participants|Number|47|47.0||||||
4255396|NCT00622440|4079514|B2|40-59 years||Age, Customized||participants|Number|22|22.0||||||
4255397|NCT00622440|4079515|B1|40-59 years||Age, Customized||participants|Number|25|25.0||||||
4255398|NCT00622440|4079513|B3|24-39 years||Age, Customized||participants|Number|15|15.0||||||
4255399|NCT00622440|4079514|B2|24-39 years||Age, Customized||participants|Number|10|10.0||||||
4255400|NCT00622440|4079515|B1|24-39 years||Age, Customized||participants|Number|5|5.0||||||
4255401|NCT00622427|4079528|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4255402|NCT00622427|4079529|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4255403|NCT00622427|4079530|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4255404|NCT00622427|4079528|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4255405|NCT00622427|4079529|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4255406|NCT00622427|4079530|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4255407|NCT00622427|4079528|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4255408|NCT00622427|4079529|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4255409|NCT00622427|4079530|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4255410|NCT00622427|4079528|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4255411|NCT00622427|4079529|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4255412|NCT00622427|4079530|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4255413|NCT00622427|4079528|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4255414|NCT00622427|4079529|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4255415|NCT00622427|4079530|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4255416|NCT00622427|4079528|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4255417|NCT00622427|4079529|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4255418|NCT00622427|4079530|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4255419|NCT00622401|4079539|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
4255420|NCT00622401|4079541|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4255421|NCT00622401|4079542|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4255422|NCT00622401|4079539|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4255423|NCT00622401|4079541|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4255424|NCT00622401|4079542|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4255425|NCT00622401|4079539|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4255426|NCT00622401|4079541|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4255427|NCT00622401|4079542|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4255428|NCT00622401|4079539|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4255429|NCT00622401|4079541|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4255430|NCT00622401|4079542|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4255431|NCT00622401|4079539|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4255432|NCT00622401|4079541|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4255433|NCT00622401|4079542|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4255434|NCT00622401|4079539|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4255435|NCT00622401|4079541|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4255436|NCT00622401|4079542|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4255437|NCT00622388|4079551|B1|Ineligible for ASCT||Number of Participants with the Indicated Prior Therapy|Study participants had to have either prior autologous stem cell transplant (ASCT) or had to be ineligible for ASCT to be eligible for inclusion.|participants|Number|56|56.0||||||
4255438|NCT00622388|4079551|B1|Prior ASCT||Number of Participants with the Indicated Prior Therapy|Study participants had to have either prior autologous stem cell transplant (ASCT) or had to be ineligible for ASCT to be eligible for inclusion.|participants|Number|25|25.0||||||
4255439|NCT00622388|4079551|B1|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4255440|NCT00622388|4079551|B1|White||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
4255441|NCT00622388|4079551|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4255442|NCT00622388|4079551|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4255443|NCT00622388|4079551|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4255444|NCT00622388|4079551|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4255445|NCT00622388|4079551|B1|||Age||Years|Mean|64.9|64.9|Standard Deviation|14.51|14.51|||
4255446|NCT00622336|4079569|B1|Missing= Unspecified||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|12|12.0||||||
4255447|NCT00622336|4079569|B1|4 = Completely Disabled||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|0|0.0||||||
4255448|NCT00622336|4079569|B1|3 = Limited Self Care||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|1|1.0||||||
4255449|NCT00622336|4079569|B1|2 = Ambulatory; not able to work||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|44|44.0||||||
4255450|NCT00622336|4079569|B1|1 = Restricted Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|178|178.0||||||
4255500|NCT00621959|4079655|B1||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4255451|NCT00622336|4079569|B1|0 = Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living activities of the patient and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)|participants|Number|95|95.0||||||
4255452|NCT00622336|4079569|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4255453|NCT00622336|4079569|B1|White||Race/Ethnicity, Customized||Participants|Number|309|309.0||||||
4255454|NCT00622336|4079569|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4255455|NCT00622336|4079569|B1|Asian/Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4255456|NCT00622336|4079569|B1||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4255457|NCT00622336|4079569|B1||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4255458|NCT00622336|4079569|B1|≤ 65 years||Age, Customized||participants|Number|194|194.0||||||
4255459|NCT00622336|4079569|B1|> 65 years||Age, Customized||participants|Number|136|136.0||||||
4255460|NCT00622336|4079569|B1|||Age||years|Mean|63.3|63.3|Standard Deviation|9.43|9.43|||
4255461|NCT00622284|4079578|B3|||Fasting blood plasma glucose (FPG)|Baseline fasting plasma glucose (FPG) was available for 1475 patients in the FAS, 740 treated with Linagliptin and 735 patients treated with Glimepiride.|mg/dL|Mean|165.27|165.27|Standard Deviation|42.43|42.43|||
4255462|NCT00622284|4079579|B2|||Fasting blood plasma glucose (FPG)|Baseline fasting plasma glucose (FPG) was available for 1475 patients in the FAS, 740 treated with Linagliptin and 735 patients treated with Glimepiride.|mg/dL|Mean|166.09|166.09|Standard Deviation|42.05|42.05|||
4255463|NCT00622284|4079580|B1|||Fasting blood plasma glucose (FPG)|Baseline fasting plasma glucose (FPG) was available for 1475 patients in the FAS, 740 treated with Linagliptin and 735 patients treated with Glimepiride.|mg/dL|Mean|164.46|164.46|Standard Deviation|42.83|42.83|||
4255464|NCT00622284|4079578|B3|||Glycosylated haemoglobin (HbA1c)|Baseline HbA1c was available for 1519 patients in the Full Analysis Set (FAS), 764 treated with Linagliptin and 755 patients treated with Glimepiride.|Percent|Mean|7.69|7.69|Standard Deviation|0.87|0.87|||
4255465|NCT00622284|4079579|B2|||Glycosylated haemoglobin (HbA1c)|Baseline HbA1c was available for 1519 patients in the Full Analysis Set (FAS), 764 treated with Linagliptin and 755 patients treated with Glimepiride.|Percent|Mean|7.69|7.69|Standard Deviation|0.86|0.86|||
4255466|NCT00622284|4079580|B1|||Glycosylated haemoglobin (HbA1c)|Baseline HbA1c was available for 1519 patients in the Full Analysis Set (FAS), 764 treated with Linagliptin and 755 patients treated with Glimepiride.|Percent|Mean|7.69|7.69|Standard Deviation|0.88|0.88|||
4255467|NCT00622284|4079578|B3|||Weight||kg|Mean|86.46|86.46|Standard Deviation|17.14|17.14|||
4255468|NCT00622284|4079579|B2|||Weight||kg|Mean|86.77|86.77|Standard Deviation|16.69|16.69|||
4255469|NCT00622284|4079580|B1|||Weight||kg|Mean|86.14|86.14|Standard Deviation|17.57|17.57|||
4255470|NCT00622284|4079578|B3|||Body mass index (BMI) continuous||kg/m^2|Mean|30.26|30.26|Standard Deviation|4.67|4.67|||
4255471|NCT00622284|4079579|B2|||Body mass index (BMI) continuous||kg/m^2|Mean|30.31|30.31|Standard Deviation|4.57|4.57|||
4255472|NCT00622284|4079580|B1|||Body mass index (BMI) continuous||kg/m^2|Mean|30.21|30.21|Standard Deviation|4.77|4.77|||
4255473|NCT00622284|4079578|B3||Male|Sex: Female, Male||Participants|Count of Participants|933|933.0||||||
4255474|NCT00622284|4079579|B2||Male|Sex: Female, Male||Participants|Count of Participants|471|471.0||||||
4255475|NCT00622284|4079580|B1||Male|Sex: Female, Male||Participants|Count of Participants|462|462.0||||||
4255476|NCT00622284|4079578|B3||Female|Sex: Female, Male||Participants|Count of Participants|618|618.0||||||
4255477|NCT00622284|4079579|B2||Female|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
4255478|NCT00622284|4079580|B1||Female|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
4255479|NCT00622284|4079578|B3|||Age||Years|Mean|59.8|59.8|Standard Deviation|9.4|9.4|||
4255480|NCT00622284|4079579|B2|||Age||Years|Mean|59.8|59.8|Standard Deviation|9.4|9.4|||
4255481|NCT00622284|4079580|B1|||Age||Years|Mean|59.8|59.8|Standard Deviation|9.4|9.4|||
4255482|NCT00622167|4079643|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4255483|NCT00622167|4079643|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4255484|NCT00622167|4079643|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4255485|NCT00622167|4079643|B1|||Age||years|Mean|NA||Standard Deviation|NA||||Study terminated after imaging 4 subjects due to slow enrollment. No analysis performed.
4255486|NCT00622167|4079643|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4255487|NCT00622167|4079643|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4255488|NCT00622167|4079643|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4255489|NCT00621985|4079647|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4255490|NCT00621985|4079647|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4255491|NCT00621985|4079647|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4255492|NCT00621985|4079647|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4255493|NCT00621985|4079647|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4255494|NCT00621985|4079647|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4255495|NCT00621959|4079653|B3|United States||Region of Enrollment||participants|Number|596|596.0||||||
4255496|NCT00621959|4079654|B2|United States||Region of Enrollment||participants|Number|301|301.0||||||
4255497|NCT00621959|4079655|B1|United States||Region of Enrollment||participants|Number|295|295.0||||||
4255498|NCT00621959|4079653|B3||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4255499|NCT00621959|4079654|B2||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4255501|NCT00621959|4079653|B3||Female|Sex: Female, Male||Participants|Count of Participants|405|405.0||||||
4255502|NCT00621959|4079654|B2||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
4255503|NCT00621959|4079655|B1||Female|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4255504|NCT00621959|4079653|B3|||Age||years|Mean|37.18|37.18|Standard Deviation|11.52|11.52|||
4255505|NCT00621959|4079654|B2|||Age||years|Mean|37.02|37.02|Standard Deviation|11.99|11.99|||
4255506|NCT00621959|4079655|B1|||Age||years|Mean|37.36|37.36|Standard Deviation|11.05|11.05|||
4255507|NCT00621946|4079664|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4255508|NCT00621946|4079665|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4255509|NCT00621946|4079666|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4255510|NCT00621946|4079664|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4255511|NCT00621946|4079665|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4255512|NCT00621946|4079666|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4255513|NCT00621946|4079664|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255514|NCT00621946|4079665|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255515|NCT00621946|4079666|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255516|NCT00621946|4079664|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4255517|NCT00621946|4079665|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4255518|NCT00621946|4079666|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4255519|NCT00621946|4079664|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4255520|NCT00621946|4079665|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4255521|NCT00621946|4079666|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4255522|NCT00621946|4079664|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255523|NCT00621946|4079665|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255524|NCT00621946|4079666|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255525|NCT00621946|4079664|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255526|NCT00621946|4079665|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255527|NCT00621946|4079666|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255528|NCT00621946|4079664|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255529|NCT00621946|4079665|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255530|NCT00621946|4079666|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255531|NCT00621946|4079664|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4255532|NCT00621946|4079665|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4255533|NCT00621946|4079666|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4255534|NCT00621946|4079664|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4255535|NCT00621946|4079665|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4255536|NCT00621946|4079666|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4255537|NCT00621946|4079664|B3|||Age||years|Mean|45.4|45.4|Standard Deviation|11.5|11.5|||
4255538|NCT00621946|4079665|B2|||Age||years|Mean|48.6|48.6|Standard Deviation|12.7|12.7|||
4255539|NCT00621946|4079666|B1|||Age||years|Mean|42.5|42.5|Standard Deviation|9.8|9.8|||
4255540|NCT00621933|4079683|B1||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4255541|NCT00621933|4079683|B1||Female|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
4255542|NCT00621933|4079683|B1|Between 90 and 99 years||Age, Customized||participants|Number|8|8.0||||||
4255543|NCT00621933|4079683|B1|Between 80 and 89 years||Age, Customized||participants|Number|60|60.0||||||
4255544|NCT00621933|4079683|B1|Between 70 and 79 years||Age, Customized||participants|Number|138|138.0||||||
4255545|NCT00621933|4079683|B1|Between 60 and 69 years||Age, Customized||participants|Number|126|126.0||||||
4255546|NCT00621933|4079683|B1|Between 50 and 59 years||Age, Customized||participants|Number|61|61.0||||||
4255547|NCT00621933|4079683|B1|< 50 years||Age, Customized||participants|Number|6|6.0||||||
4255548|NCT00621855|4079690|B6|||Creatinine Clearance N=(372;371;411;350;373;1877)||mL/min|Mean|86.3|86.3|Standard Deviation|31.6|31.6|||
4255549|NCT00621855|4079691|B5|||Creatinine Clearance N=(372;371;411;350;373;1877)||mL/min|Mean|86.6|86.6|Standard Deviation|34.8|34.8|||
4255550|NCT00621855|4079692|B4|||Creatinine Clearance N=(372;371;411;350;373;1877)||mL/min|Mean|86.3|86.3|Standard Deviation|28.1|28.1|||
4255551|NCT00621855|4079693|B3|||Creatinine Clearance N=(372;371;411;350;373;1877)||mL/min|Mean|84.7|84.7|Standard Deviation|32|32.0|||
4255552|NCT00621855|4079694|B2|||Creatinine Clearance N=(372;371;411;350;373;1877)||mL/min|Mean|88.7|88.7|Standard Deviation|32.4|32.4|||
4255553|NCT00621855|4079695|B1|||Creatinine Clearance N=(372;371;411;350;373;1877)||mL/min|Mean|85.4|85.4|Standard Deviation|30.2|30.2|||
4255554|NCT00621855|4079690|B6|Non ST elevation myocardial infarction (NSTEMI)||Type of Index Event||participants|Number|752|752.0||||||
4255555|NCT00621855|4079691|B5|Non ST elevation myocardial infarction (NSTEMI)||Type of Index Event||participants|Number|143|143.0||||||
4255556|NCT00621855|4079692|B4|Non ST elevation myocardial infarction (NSTEMI)||Type of Index Event||participants|Number|147|147.0||||||
4255557|NCT00621855|4079693|B3|Non ST elevation myocardial infarction (NSTEMI)||Type of Index Event||participants|Number|157|157.0||||||
4255558|NCT00621855|4079694|B2|Non ST elevation myocardial infarction (NSTEMI)||Type of Index Event||participants|Number|144|144.0||||||
4255559|NCT00621855|4079695|B1|Non ST elevation myocardial infarction (NSTEMI)||Type of Index Event||participants|Number|161|161.0||||||
4255560|NCT00621855|4079690|B6|ST elevation myocardial infarction (STEMI)||Type of Index Event||participants|Number|1126|1126.0||||||
4255561|NCT00621855|4079691|B5|ST elevation myocardial infarction (STEMI)||Type of Index Event||participants|Number|230|230.0||||||
4255562|NCT00621855|4079692|B4|ST elevation myocardial infarction (STEMI)||Type of Index Event||participants|Number|204|204.0||||||
4255563|NCT00621855|4079693|B3|ST elevation myocardial infarction (STEMI)||Type of Index Event||participants|Number|254|254.0||||||
4255564|NCT00621855|4079694|B2|ST elevation myocardial infarction (STEMI)||Type of Index Event||participants|Number|227|227.0||||||
4255565|NCT00621855|4079695|B1|ST elevation myocardial infarction (STEMI)||Type of Index Event||participants|Number|211|211.0||||||
4255566|NCT00621855|4079690|B6|North America||Region of Enrollment||participants|Number|101|101.0||||||
4255567|NCT00621855|4079691|B5|North America||Region of Enrollment||participants|Number|20|20.0||||||
4255568|NCT00621855|4079692|B4|North America||Region of Enrollment||participants|Number|11|11.0||||||
4255569|NCT00621855|4079693|B3|North America||Region of Enrollment||participants|Number|21|21.0||||||
4255570|NCT00621855|4079694|B2|North America||Region of Enrollment||participants|Number|24|24.0||||||
4255571|NCT00621855|4079695|B1|North America||Region of Enrollment||participants|Number|25|25.0||||||
4255572|NCT00621855|4079690|B6|Asia||Region of Enrollment||participants|Number|419|419.0||||||
4255573|NCT00621855|4079691|B5|Asia||Region of Enrollment||participants|Number|104|104.0||||||
4255574|NCT00621855|4079692|B4|Asia||Region of Enrollment||participants|Number|51|51.0||||||
4255575|NCT00621855|4079693|B3|Asia||Region of Enrollment||participants|Number|81|81.0||||||
4255576|NCT00621855|4079694|B2|Asia||Region of Enrollment||participants|Number|99|99.0||||||
4255577|NCT00621855|4079695|B1|Asia||Region of Enrollment||participants|Number|84|84.0||||||
4255578|NCT00621855|4079690|B6|Western Europe||Region of Enrollment||participants|Number|426|426.0||||||
4255579|NCT00621855|4079691|B5|Western Europe||Region of Enrollment||participants|Number|84|84.0||||||
4255580|NCT00621855|4079692|B4|Western Europe||Region of Enrollment||participants|Number|72|72.0||||||
4255581|NCT00621855|4079693|B3|Western Europe||Region of Enrollment||participants|Number|79|79.0||||||
4255582|NCT00621855|4079694|B2|Western Europe||Region of Enrollment||participants|Number|93|93.0||||||
4255583|NCT00621855|4079695|B1|Western Europe||Region of Enrollment||participants|Number|98|98.0||||||
4255584|NCT00621855|4079690|B6|Central Europe||Region of Enrollment||participants|Number|932|932.0||||||
4255585|NCT00621855|4079691|B5|Central Europe||Region of Enrollment||participants|Number|165|165.0||||||
4255586|NCT00621855|4079692|B4|Central Europe||Region of Enrollment||participants|Number|217|217.0||||||
4255587|NCT00621855|4079693|B3|Central Europe||Region of Enrollment||participants|Number|230|230.0||||||
4255588|NCT00621855|4079694|B2|Central Europe||Region of Enrollment||participants|Number|155|155.0||||||
4255589|NCT00621855|4079695|B1|Central Europe||Region of Enrollment||participants|Number|165|165.0||||||
4255590|NCT00621855|4079690|B6|Other||Race (NIH/OMB)||participants|Number|6|6.0||||||
4255591|NCT00621855|4079691|B5|Other||Race (NIH/OMB)||participants|Number|0|0.0||||||
4255592|NCT00621855|4079692|B4|Other||Race (NIH/OMB)||participants|Number|0|0.0||||||
4255593|NCT00621855|4079693|B3|Other||Race (NIH/OMB)||participants|Number|5|5.0||||||
4255594|NCT00621855|4079694|B2|Other||Race (NIH/OMB)||participants|Number|1|1.0||||||
4255595|NCT00621855|4079695|B1|Other||Race (NIH/OMB)||participants|Number|0|0.0||||||
4255596|NCT00621855|4079690|B6|Asian||Race (NIH/OMB)||participants|Number|424|424.0||||||
4255597|NCT00621855|4079691|B5|Asian||Race (NIH/OMB)||participants|Number|105|105.0||||||
4255598|NCT00621855|4079692|B4|Asian||Race (NIH/OMB)||participants|Number|51|51.0||||||
4255599|NCT00621855|4079693|B3|Asian||Race (NIH/OMB)||participants|Number|82|82.0||||||
4255600|NCT00621855|4079694|B2|Asian||Race (NIH/OMB)||participants|Number|102|102.0||||||
4255601|NCT00621855|4079695|B1|Asian||Race (NIH/OMB)||participants|Number|84|84.0||||||
4255602|NCT00621855|4079690|B6|Black||Race (NIH/OMB)||participants|Number|1|1.0||||||
4255603|NCT00621855|4079691|B5|Black||Race (NIH/OMB)||participants|Number|0|0.0||||||
4255604|NCT00621855|4079692|B4|Black||Race (NIH/OMB)||participants|Number|0|0.0||||||
4255605|NCT00621855|4079693|B3|Black||Race (NIH/OMB)||participants|Number|0|0.0||||||
4255606|NCT00621855|4079694|B2|Black||Race (NIH/OMB)||participants|Number|1|1.0||||||
4255607|NCT00621855|4079695|B1|Black||Race (NIH/OMB)||participants|Number|0|0.0||||||
4255608|NCT00621855|4079690|B6|White||Race (NIH/OMB)||participants|Number|1447|1447.0||||||
4255609|NCT00621855|4079691|B5|White||Race (NIH/OMB)||participants|Number|268|268.0||||||
4255610|NCT00621855|4079692|B4|White||Race (NIH/OMB)||participants|Number|300|300.0||||||
4255611|NCT00621855|4079693|B3|White||Race (NIH/OMB)||participants|Number|324|324.0||||||
4255612|NCT00621855|4079694|B2|White||Race (NIH/OMB)||participants|Number|267|267.0||||||
4255613|NCT00621855|4079695|B1|White||Race (NIH/OMB)||participants|Number|288|288.0||||||
4255614|NCT00621855|4079690|B6||Male|Sex: Female, Male||Participants|Count of Participants|1428|1428.0||||||
4255615|NCT00621855|4079691|B5||Male|Sex: Female, Male||Participants|Count of Participants|292|292.0||||||
4255616|NCT00621855|4079692|B4||Male|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
4255617|NCT00621855|4079693|B3||Male|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
4255618|NCT00621855|4079694|B2||Male|Sex: Female, Male||Participants|Count of Participants|296|296.0||||||
4255619|NCT00621855|4079695|B1||Male|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
4255620|NCT00621855|4079690|B6||Female|Sex: Female, Male||Participants|Count of Participants|450|450.0||||||
4255621|NCT00621855|4079691|B5||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4255622|NCT00621855|4079692|B4||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4255623|NCT00621855|4079693|B3||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4255624|NCT00621855|4079694|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4255625|NCT00621855|4079695|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4255626|NCT00621855|4079690|B6|||Age||Years|Mean|61.8|61.8|Standard Deviation|11.4|11.4|||
4255627|NCT00621855|4079691|B5|||Age||Years|Mean|61.5|61.5|Standard Deviation|11.3|11.3|||
4255628|NCT00621855|4079692|B4|||Age||Years|Mean|62.3|62.3|Standard Deviation|10.8|10.8|||
4255629|NCT00621855|4079693|B3|||Age||Years|Mean|62.3|62.3|Standard Deviation|11.1|11.1|||
4255630|NCT00621855|4079694|B2|||Age||Years|Mean|60.7|60.7|Standard Deviation|11.7|11.7|||
4255631|NCT00621855|4079695|B1|||Age||Years|Mean|61.9|61.9|Standard Deviation|12.2|12.2|||
4255632|NCT00621842|4079741|B1|United States||Region of Enrollment||participants|Number|57|57.0||||||
4255633|NCT00621842|4079741|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4255634|NCT00621842|4079741|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4255635|NCT00621842|4079741|B1|||Age||years|Mean|66.5|66.5|Standard Deviation|6.7|6.7|||
4255636|NCT00621842|4079741|B1||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4255637|NCT00621842|4079741|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4255638|NCT00621842|4079741|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4255639|NCT00621777|4079756|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255640|NCT00621777|4079757|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255641|NCT00621777|4079758|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255642|NCT00621777|4079756|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
4255643|NCT00621777|4079757|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4255644|NCT00621777|4079758|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4255645|NCT00621777|4079756|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4255646|NCT00621777|4079757|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255647|NCT00621777|4079758|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4255648|NCT00621777|4079756|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4255649|NCT00621777|4079757|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4255650|NCT00621777|4079758|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4255651|NCT00621777|4079756|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255652|NCT00621777|4079757|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255653|NCT00621777|4079758|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255654|NCT00621777|4079756|B3||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4255655|NCT00621777|4079757|B2||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4255656|NCT00621777|4079758|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4255657|NCT00621777|4079756|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4255658|NCT00621777|4079757|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4255659|NCT00621777|4079758|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4255660|NCT00621777|4079756|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255661|NCT00621777|4079757|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255662|NCT00621777|4079758|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255663|NCT00621777|4079756|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255664|NCT00621777|4079757|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255665|NCT00621777|4079758|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255666|NCT00621777|4079756|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255667|NCT00621777|4079757|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255668|NCT00621777|4079758|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255669|NCT00621777|4079756|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4255670|NCT00621777|4079757|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4255671|NCT00621777|4079758|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4255672|NCT00621777|4079756|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4255673|NCT00621777|4079757|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4255674|NCT00621777|4079758|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4255675|NCT00621777|4079756|B3|||Age||years|Mean|47.5|47.5|Standard Deviation|10.2|10.2|||
4255676|NCT00621777|4079757|B2|||Age||years|Mean|45.7|45.7|Standard Deviation|10.3|10.3|||
4255677|NCT00621777|4079758|B1|||Age||years|Mean|51.4|51.4|Standard Deviation|9.6|9.6|||
4255678|NCT00621764|4079770|B5|Thailand||Region of Enrollment||Participants|Number|300|300.0||||||
4255679|NCT00621764|4079771|B4|Thailand||Region of Enrollment||Participants|Number|99|99.0||||||
4255680|NCT00621764|4079772|B3|Thailand||Region of Enrollment||Participants|Number|101|101.0||||||
4255681|NCT00621764|4079773|B2|Thailand||Region of Enrollment||Participants|Number|50|50.0||||||
4255682|NCT00621764|4079774|B1|Thailand||Region of Enrollment||Participants|Number|50|50.0||||||
4255683|NCT00621764|4079770|B5||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4255684|NCT00621764|4079771|B4||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4255685|NCT00621764|4079772|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4255686|NCT00621764|4079773|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4255687|NCT00621764|4079774|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4255688|NCT00621764|4079770|B5||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4255689|NCT00621764|4079771|B4||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4255690|NCT00621764|4079772|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4255691|NCT00621764|4079773|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4255692|NCT00621764|4079774|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4255693|NCT00621764|4079770|B5|||Age||Years|Mean|1.7|1.7|Standard Deviation|0.6|0.6|||
4255694|NCT00621764|4079771|B4|||Age||Years|Mean|1.3|1.3|Standard Deviation|0.2|0.2|||
4255695|NCT00621764|4079772|B3|||Age||Years|Mean|1.4|1.4|Standard Deviation|0.2|0.2|||
4255696|NCT00621764|4079773|B2|||Age||Years|Mean|2.5|2.5|Standard Deviation|0.6|0.6|||
4255697|NCT00621764|4079774|B1|||Age||Years|Mean|2.4|2.4|Standard Deviation|0.5|0.5|||
4255698|NCT00621764|4079770|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4255699|NCT00621764|4079771|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4255700|NCT00621764|4079772|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4255701|NCT00621764|4079773|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4255702|NCT00621764|4079774|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4255703|NCT00621764|4079770|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4255704|NCT00621764|4079771|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4255705|NCT00621764|4079772|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4255706|NCT00621764|4079773|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4255707|NCT00621764|4079774|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4255708|NCT00621764|4079770|B5||<=18 years|Age||Participants|Count of Participants|300|300.0||||||
4255709|NCT00621764|4079771|B4||<=18 years|Age||Participants|Count of Participants|99|99.0||||||
4255710|NCT00621764|4079772|B3||<=18 years|Age||Participants|Count of Participants|101|101.0||||||
4255711|NCT00621764|4079773|B2||<=18 years|Age||Participants|Count of Participants|50|50.0||||||
4255712|NCT00621764|4079774|B1||<=18 years|Age||Participants|Count of Participants|50|50.0||||||
4255713|NCT00621686|4079807|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
4255714|NCT00621686|4079808|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
4255715|NCT00621686|4079809|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4255716|NCT00621686|4079807|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4255717|NCT00621686|4079808|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4255718|NCT00621686|4079809|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4255719|NCT00621686|4079807|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4255720|NCT00621686|4079808|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4255721|NCT00621686|4079809|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4255722|NCT00621686|4079807|B3|||Age||years|Median|55|55.0|Full Range|||25.0|76.0|
4255723|NCT00621686|4079808|B2|||Age||years|Median|55|55.0|Full Range|||28.0|76.0|
4255724|NCT00621686|4079809|B1|||Age||years|Median|54|54.0|Full Range|||25.0|68.0|
4255725|NCT00621621|4079820|B4|United States||Region of Enrollment||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4255726|NCT00621621|4079821|B3|United States||Region of Enrollment||participants|Number|NA|||||||Regions were not collected from Publication data
4255727|NCT00621621|4079822|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4255728|NCT00621621|4079823|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
4255729|NCT00621621|4079820|B4||Male|Sex: Female, Male|Baseline demographics were only collected for actual enrolled subjects (n=75) That were ablated. This data was not available for subjects enrolled from publicaton data (675).|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4255730|NCT00621621|4079821|B3||Male|Sex: Female, Male|Baseline demographics were only collected for actual enrolled subjects (n=75) That were ablated. This data was not available for subjects enrolled from publicaton data (675).|Participants|Count of Participants|NA|||||||Data was not collected on subjects that were not ablated by the site.
4255731|NCT00621621|4079822|B2||Male|Sex: Female, Male|Baseline demographics were only collected for actual enrolled subjects (n=75) That were ablated. This data was not available for subjects enrolled from publicaton data (675).|Participants|Count of Participants|NA|||||||Data was not collected on subjects that were not ablated by the site.
4255732|NCT00621621|4079823|B1||Male|Sex: Female, Male|Baseline demographics were only collected for actual enrolled subjects (n=75) That were ablated. This data was not available for subjects enrolled from publicaton data (675).|Participants|Count of Participants|20|20.0||||||
4255787|NCT00621517|4079863|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4255788|NCT00621517|4079861|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4255733|NCT00621621|4079820|B4||Female|Sex: Female, Male|Baseline demographics were only collected for actual enrolled subjects (n=75) That were ablated. This data was not available for subjects enrolled from publicaton data (675).|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4255734|NCT00621621|4079821|B3||Female|Sex: Female, Male|Baseline demographics were only collected for actual enrolled subjects (n=75) That were ablated. This data was not available for subjects enrolled from publicaton data (675).|Participants|Count of Participants|NA|||||||Data was not collected on subjects that were not ablated by the site.
4255735|NCT00621621|4079822|B2||Female|Sex: Female, Male|Baseline demographics were only collected for actual enrolled subjects (n=75) That were ablated. This data was not available for subjects enrolled from publicaton data (675).|Participants|Count of Participants|NA|||||||Data was not collected on subjects that were not ablated by the site.
4255736|NCT00621621|4079823|B1||Female|Sex: Female, Male|Baseline demographics were only collected for actual enrolled subjects (n=75) That were ablated. This data was not available for subjects enrolled from publicaton data (675).|Participants|Count of Participants|55|55.0||||||
4255737|NCT00621621|4079820|B4|||Age||years|Mean|NA||Standard Deviation|NA||||Data was not collected on subjects that were not ablated by the site.
4255738|NCT00621621|4079821|B3|||Age||years|Mean|NA||Standard Deviation|NA||||Data was not collected on subjects that were not ablated by the site.
4255739|NCT00621621|4079822|B2|||Age||years|Mean|NA||Standard Deviation|NA||||Data was not collected on subjects that were not ablated by the site.
4255740|NCT00621621|4079823|B1|||Age||years|Mean|50.5|50.5|Standard Deviation|17.8|17.8|||
4255741|NCT00621582|4079832|B1|Missing information||Sex/Gender, Customized||participants|Number|2|2.0||||||
4255742|NCT00621582|4079832|B1|Male||Sex/Gender, Customized||participants|Number|3313|3313.0||||||
4255743|NCT00621582|4079832|B1|Female||Sex/Gender, Customized||participants|Number|1603|1603.0||||||
4255744|NCT00621582|4079832|B1|||Age||years|Mean|63.8|63.8|Standard Deviation|9.3|9.3|||
4255745|NCT00621543|4079839|B1|United States||Region of Enrollment||participants|Number|120|120.0||||||
4255746|NCT00621543|4079839|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4255747|NCT00621543|4079839|B1||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4255748|NCT00621543|4079839|B1|||Age||years|Mean|28|28.0|Standard Deviation|4|4.0|||
4255749|NCT00621543|4079839|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4255750|NCT00621543|4079839|B1||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
4255751|NCT00621543|4079839|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4255752|NCT00621530|4079844|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
4255753|NCT00621530|4079845|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
4255754|NCT00621530|4079846|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4255755|NCT00621530|4079844|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4255756|NCT00621530|4079845|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4255757|NCT00621530|4079846|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4255758|NCT00621530|4079844|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4255759|NCT00621530|4079845|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4255760|NCT00621530|4079846|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4255761|NCT00621530|4079844|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4255762|NCT00621530|4079845|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4255763|NCT00621530|4079846|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4255764|NCT00621530|4079844|B3||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4255765|NCT00621530|4079845|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4255766|NCT00621530|4079846|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4255767|NCT00621530|4079844|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4255768|NCT00621530|4079845|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4255769|NCT00621530|4079846|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4255770|NCT00621517|4079861|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4255771|NCT00621517|4079862|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
4255772|NCT00621517|4079863|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4255773|NCT00621517|4079861|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4255774|NCT00621517|4079862|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4255775|NCT00621517|4079863|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4255776|NCT00621517|4079861|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4255777|NCT00621517|4079862|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4255778|NCT00621517|4079863|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4255779|NCT00621517|4079861|B3|||Age||years|Mean|49.3|49.3|Standard Deviation|13.5|13.5|||
4255780|NCT00621517|4079862|B2|||Age||years|Mean|50.5|50.5|Standard Deviation|14.1|14.1|||
4255781|NCT00621517|4079863|B1|||Age||years|Mean|48.0|48.0|Standard Deviation|12.9|12.9|||
4255782|NCT00621517|4079861|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4255783|NCT00621517|4079862|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4255784|NCT00621517|4079863|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4255785|NCT00621517|4079861|B3||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4255786|NCT00621517|4079862|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4255789|NCT00621517|4079862|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4255790|NCT00621517|4079863|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4255791|NCT00621504|4079870|B3|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|550|550.0||||||
4255792|NCT00621504|4079871|B2|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|280|280.0||||||
4255793|NCT00621504|4079872|B1|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|270|270.0||||||
4255794|NCT00621504|4079870|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
4255795|NCT00621504|4079871|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4255796|NCT00621504|4079872|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4255797|NCT00621504|4079870|B3||Male|Sex: Female, Male||Participants|Count of Participants|386|386.0||||||
4255798|NCT00621504|4079871|B2||Male|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4255799|NCT00621504|4079872|B1||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4255800|NCT00621504|4079870|B3||Female|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
4255801|NCT00621504|4079871|B2||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4255802|NCT00621504|4079872|B1||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4255803|NCT00621504|4079870|B3|||Age||years|Mean|61.0|61.0|Standard Deviation|16.6|16.6|||
4255804|NCT00621504|4079871|B2|||Age||years|Mean|61.0|61.0|Standard Deviation|16.6|16.6|||
4255805|NCT00621504|4079872|B1|||Age||years|Mean|61.0|61.0|Standard Deviation|16.6|16.6|||
4255806|NCT00621504|4079870|B3|>= 65 years||Age, Customized||participants|Number|295|295.0||||||
4255807|NCT00621504|4079871|B2|>= 65 years||Age, Customized||participants|Number|150|150.0||||||
4255808|NCT00621504|4079872|B1|>= 65 years||Age, Customized||participants|Number|145|145.0||||||
4255809|NCT00621504|4079870|B3|<65 years||Age, Customized||participants|Number|311|311.0||||||
4255810|NCT00621504|4079871|B2|<65 years||Age, Customized||participants|Number|157|157.0||||||
4255811|NCT00621504|4079872|B1|<65 years||Age, Customized||participants|Number|154|154.0||||||
4255812|NCT00621348|4079879|B4|India||Region of Enrollment||participants|Number|167|167.0||||||
4255813|NCT00621348|4079880|B3|India||Region of Enrollment||participants|Number|56|56.0||||||
4255814|NCT00621348|4079881|B2|India||Region of Enrollment||participants|Number|53|53.0||||||
4255815|NCT00621348|4079882|B1|India||Region of Enrollment||participants|Number|58|58.0||||||
4255816|NCT00621348|4079879|B4||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4255817|NCT00621348|4079880|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4255818|NCT00621348|4079881|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4255819|NCT00621348|4079882|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4255820|NCT00621348|4079879|B4||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4255821|NCT00621348|4079880|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4255822|NCT00621348|4079881|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4255823|NCT00621348|4079882|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4255824|NCT00621348|4079879|B4|||Age||years|Mean|3.33|3.33|Standard Deviation|0.56|0.56|||
4255825|NCT00621348|4079880|B3|||Age||years|Mean|4|4.0|Standard Deviation|0.28|0.28|||
4255826|NCT00621348|4079881|B2|||Age||years|Mean|3|3.0|Standard Deviation|0.36|0.36|||
4255827|NCT00621348|4079882|B1|||Age||years|Mean|3|3.0|Standard Deviation|0.44|0.44|||
4255828|NCT00621348|4079879|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4255829|NCT00621348|4079880|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4255830|NCT00621348|4079881|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4255831|NCT00621348|4079882|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4255832|NCT00621348|4079879|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4255833|NCT00621348|4079880|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4255834|NCT00621348|4079881|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4255835|NCT00621348|4079882|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4255836|NCT00621348|4079879|B4||<=18 years|Age||Participants|Count of Participants|167|167.0||||||
4255837|NCT00621348|4079880|B3||<=18 years|Age||Participants|Count of Participants|56|56.0||||||
4255838|NCT00621348|4079881|B2||<=18 years|Age||Participants|Count of Participants|53|53.0||||||
4255839|NCT00621348|4079882|B1||<=18 years|Age||Participants|Count of Participants|58|58.0||||||
4255840|NCT00621322|4079901|B7||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4255841|NCT00621322|4079902|B6||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4255842|NCT00621322|4079903|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4255843|NCT00621322|4079904|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4255844|NCT00621322|4079905|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4255845|NCT00621322|4079906|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4255846|NCT00621322|4079907|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4255847|NCT00621322|4079901|B7||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4255848|NCT00621322|4079902|B6||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4255849|NCT00621322|4079903|B5||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4255850|NCT00621322|4079904|B4||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4255851|NCT00621322|4079905|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4255852|NCT00621322|4079906|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4255853|NCT00621322|4079907|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4255854|NCT00621322|4079901|B7|||Age||Years|Mean|31.92|31.92|Standard Deviation|8.67|8.67|||
4255855|NCT00621322|4079902|B6|||Age||Years|Mean|31.5|31.5|Standard Deviation|8.83|8.83|||
4255856|NCT00621322|4079903|B5|||Age||Years|Mean|30.6|30.6|Standard Deviation|9.17|9.17|||
4255857|NCT00621322|4079904|B4|||Age||Years|Mean|33.5|33.5|Standard Deviation|8.73|8.73|||
4255858|NCT00621322|4079905|B3|||Age||Years|Mean|30.6|30.6|Standard Deviation|9.14|9.14|||
4255859|NCT00621322|4079906|B2|||Age||Years|Mean|36.0|36.0|Standard Deviation|5.14|5.14|||
4255860|NCT00621322|4079907|B1|||Age||Years|Mean|32.1|32.1|Standard Deviation|8.10|8.1|||
4255861|NCT00621296|4079992|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4255862|NCT00621296|4079992|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4255863|NCT00621296|4079992|B1|||Age||years|Mean|56.9|56.9|Standard Deviation|6.7|6.7|||
4255864|NCT00621257|4079996|B6||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4255865|NCT00621257|4079997|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4255866|NCT00621257|4079998|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4255867|NCT00621257|4079999|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4255868|NCT00621257|4080000|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4255869|NCT00621257|4080001|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4255870|NCT00621257|4079996|B6||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4255871|NCT00621257|4079997|B5||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4255872|NCT00621257|4079998|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4255873|NCT00621257|4079999|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4255874|NCT00621257|4080000|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4255875|NCT00621257|4080001|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4255876|NCT00621257|4079996|B6|||Age||years|Mean|15.2|15.2|Standard Deviation|3.2|3.2|||
4255877|NCT00621257|4079997|B5|||Age||years|Mean|14.5|14.5|Standard Deviation|3.1|3.1|||
4255878|NCT00621257|4079998|B4|||Age||years|Mean|15.1|15.1|Standard Deviation|3.1|3.1|||
4255879|NCT00621257|4079999|B3|||Age||years|Mean|16.3|16.3|Standard Deviation|3.2|3.2|||
4255880|NCT00621257|4080000|B2|||Age||years|Mean|14.7|14.7|Standard Deviation|3.5|3.5|||
4255881|NCT00621257|4080001|B1|||Age||years|Mean|15.9|15.9|Standard Deviation|3|3.0|||
4255882|NCT00621244|4080017|B5||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4255883|NCT00621244|4080018|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4255884|NCT00621244|4080019|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4255885|NCT00621244|4080020|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4255886|NCT00621244|4080021|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4255887|NCT00621244|4080017|B5||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4255888|NCT00621244|4080018|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4255889|NCT00621244|4080019|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4255890|NCT00621244|4080020|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4255891|NCT00621244|4080021|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4255892|NCT00621244|4080017|B5|||Age||years|Mean|58.5|58.5|Standard Deviation|16.97|16.97|||
4255893|NCT00621244|4080018|B4|||Age||years|Mean|48.3|48.3|Standard Deviation|17.41|17.41|||
4255894|NCT00621244|4080019|B3|||Age||years|Mean|68.7|68.7|Standard Deviation|8.75|8.75|||
4255895|NCT00621244|4080020|B2|||Age||years|Mean|41.1|41.1|Standard Deviation|17.27|17.27|||
4255896|NCT00621244|4080021|B1|||Age||years|Mean|64.2|64.2|Standard Deviation|12.11|12.11|||
4255897|NCT00621192|4080124|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4255898|NCT00621192|4080125|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4255899|NCT00621192|4080126|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4255900|NCT00621192|4080127|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4255901|NCT00621192|4080128|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255902|NCT00621192|4080124|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4255903|NCT00621192|4080125|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4255904|NCT00621192|4080126|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255905|NCT00621192|4080127|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4255906|NCT00621192|4080128|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4255907|NCT00621192|4080124|B5||White|Race (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
4255908|NCT00621192|4080125|B4||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4255909|NCT00621192|4080126|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4255910|NCT00621192|4080127|B2||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4255911|NCT00621192|4080128|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4255912|NCT00621192|4080124|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4255969|NCT00621153|4080154|B2|||Age||years|Mean|47.80|47.8|Standard Deviation|10|10.0|||
4255913|NCT00621192|4080125|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4255914|NCT00621192|4080126|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4255915|NCT00621192|4080127|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4255916|NCT00621192|4080128|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4255917|NCT00621192|4080124|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4255918|NCT00621192|4080125|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255919|NCT00621192|4080126|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4255920|NCT00621192|4080127|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255921|NCT00621192|4080128|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4255922|NCT00621192|4080124|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4255923|NCT00621192|4080125|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4255924|NCT00621192|4080126|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255925|NCT00621192|4080127|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4255926|NCT00621192|4080128|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255927|NCT00621192|4080124|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255928|NCT00621192|4080125|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255929|NCT00621192|4080126|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255930|NCT00621192|4080127|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255931|NCT00621192|4080128|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255932|NCT00621192|4080124|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4255933|NCT00621192|4080125|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255934|NCT00621192|4080126|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4255935|NCT00621192|4080127|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4255936|NCT00621192|4080128|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4255937|NCT00621192|4080124|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|164|164.0||||||
4255938|NCT00621192|4080125|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4255939|NCT00621192|4080126|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4255940|NCT00621192|4080127|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
4255941|NCT00621192|4080128|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4255942|NCT00621192|4080124|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4255943|NCT00621192|4080125|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4255944|NCT00621192|4080126|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4255945|NCT00621192|4080127|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4255946|NCT00621192|4080128|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4255947|NCT00621192|4080124|B5||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4255948|NCT00621192|4080125|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4255949|NCT00621192|4080126|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4255950|NCT00621192|4080127|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4255951|NCT00621192|4080128|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4255952|NCT00621192|4080124|B5||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4255953|NCT00621192|4080125|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4255954|NCT00621192|4080126|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4255955|NCT00621192|4080127|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4255956|NCT00621192|4080128|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4255957|NCT00621192|4080124|B5|Mean Postnatal Age||Age|Post Natal Age|Days|Mean|27.3|27.3|Standard Deviation|21.6|21.6|||
4255958|NCT00621192|4080125|B4|Mean Postnatal Age||Age|Post Natal Age|Days|Mean|36.0|36.0|Standard Deviation|22.0|22.0|||
4255959|NCT00621192|4080126|B3|Mean Postnatal Age||Age|Post Natal Age|Days|Mean|6.5|6.5|Standard Deviation|3.5|3.5|||
4255960|NCT00621192|4080127|B2|Mean Postnatal Age||Age|Post Natal Age|Days|Mean|38.3|38.3|Standard Deviation|19.3|19.3|||
4255961|NCT00621192|4080128|B1|Mean Postnatal Age||Age|Post Natal Age|Days|Mean|8.5|8.5|Standard Deviation|3.3|3.3|||
4255962|NCT00621153|4080153|B3||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4255963|NCT00621153|4080154|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4255964|NCT00621153|4080155|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4255965|NCT00621153|4080153|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4255966|NCT00621153|4080154|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4255967|NCT00621153|4080155|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4255968|NCT00621153|4080153|B3|||Age||years|Mean|48.90|48.9|Standard Deviation|10|10.0|||
4255970|NCT00621153|4080155|B1|||Age||years|Mean|51.00|51.0|Standard Deviation|10|10.0|||
4255971|NCT00621140|4080162|B3|||Fasting plasma glucose (FPG)||mg/dL|Mean|166.0|166.0|Standard Deviation|41.1|41.1|||
4255972|NCT00621140|4080163|B2|||Fasting plasma glucose (FPG)||mg/dL|Mean|164.7|164.7|Standard Deviation|41.9|41.9|||
4255973|NCT00621140|4080164|B1|||Fasting plasma glucose (FPG)||mg/dL|Mean|168.7|168.7|Standard Deviation|39.3|39.3|||
4255974|NCT00621140|4080162|B3|||Glycosylated Hemoglobin A1 (HbA1C)||Percent|Mean|8.00|8.0|Standard Deviation|0.67|0.67|||
4255975|NCT00621140|4080163|B2|||Glycosylated Hemoglobin A1 (HbA1C)||Percent|Mean|8.00|8.0|Standard Deviation|0.87|0.87|||
4255976|NCT00621140|4080164|B1|||Glycosylated Hemoglobin A1 (HbA1C)||Percent|Mean|8.00|8.0|Standard Deviation|0.86|0.86|||
4255977|NCT00621140|4080162|B3|||Body Mass Index (BMI) continuous||kg/m^2|Mean|29.05|29.05|Standard Deviation|4.81|4.81|||
4255978|NCT00621140|4080163|B2|||Body Mass Index (BMI) continuous||kg/m^2|Mean|29.04|29.04|Standard Deviation|4.80|4.8|||
4255979|NCT00621140|4080164|B1|||Body Mass Index (BMI) continuous||kg/m^2|Mean|29.08|29.08|Standard Deviation|4.84|4.84|||
4255980|NCT00621140|4080162|B3||Male|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
4255981|NCT00621140|4080163|B2||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4255982|NCT00621140|4080164|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4255983|NCT00621140|4080162|B3||Female|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
4255984|NCT00621140|4080163|B2||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4255985|NCT00621140|4080164|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4255986|NCT00621140|4080162|B3|||Age||Years|Mean|55.7|55.7|Standard Deviation|10.2|10.2|||
4255987|NCT00621140|4080163|B2|||Age||Years|Mean|56.4|56.4|Standard Deviation|10.1|10.1|||
4255988|NCT00621140|4080164|B1|||Age||Years|Mean|54.4|54.4|Standard Deviation|10.3|10.3|||
4255989|NCT00621049|4080197|B3|United States||Region of Enrollment||participants|Number|112|112.0||||||
4255990|NCT00621049|4080198|B2|United States||Region of Enrollment||participants|Number|57|57.0||||||
4255991|NCT00621049|4080199|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4255992|NCT00621049|4080197|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4255993|NCT00621049|4080198|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4255994|NCT00621049|4080199|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4255995|NCT00621049|4080197|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4255996|NCT00621049|4080198|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4255997|NCT00621049|4080199|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4255998|NCT00621049|4080197|B3|||Age||years|Median|64|64.0|Full Range|||42.0|87.0|
4255999|NCT00621049|4080198|B2|||Age||years|Median|64|64.0|Full Range|||48.0|87.0|
4256000|NCT00621049|4080199|B1|||Age||years|Median|64|64.0|Full Range|||42.0|79.0|
4256001|NCT00621023|4080212|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4256002|NCT00621023|4080212|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4256003|NCT00621023|4080212|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4256004|NCT00621023|4080212|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4256005|NCT00621023|4080212|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4256006|NCT00621023|4080212|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4256007|NCT00620945|4080218|B1|United States||Region of Enrollment||Participants|Count of Participants|87|87.0||||||
4256008|NCT00620945|4080218|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4256009|NCT00620945|4080218|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4256010|NCT00620945|4080218|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4256011|NCT00620945|4080218|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4256012|NCT00620945|4080218|B1||<=18 years|Age||Participants|Count of Participants|87|87.0||||||
4256013|NCT00620854|4080223|B7|United States||Region of Enrollment||participants|Number|24|24.0||||||
4256014|NCT00620854|4080224|B6|United States||Region of Enrollment||participants|Number|4|4.0||||||
4256015|NCT00620854|4080225|B5|United States||Region of Enrollment||participants|Number|4|4.0||||||
4256016|NCT00620854|4080226|B4|United States||Region of Enrollment||participants|Number|4|4.0||||||
4256017|NCT00620854|4080227|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4256018|NCT00620854|4080228|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4256019|NCT00620854|4080229|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4256020|NCT00620854|4080223|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4256021|NCT00620854|4080224|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4256022|NCT00620854|4080225|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4256023|NCT00620854|4080226|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4256024|NCT00620854|4080227|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4256025|NCT00620854|4080228|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4256026|NCT00620854|4080229|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4256027|NCT00620854|4080223|B7||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4256028|NCT00620854|4080224|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4256029|NCT00620854|4080225|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4256030|NCT00620854|4080226|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4256031|NCT00620854|4080227|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4256032|NCT00620854|4080228|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4256033|NCT00620854|4080229|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4256034|NCT00620854|4080223|B7||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4256035|NCT00620854|4080224|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4256036|NCT00620854|4080225|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4256037|NCT00620854|4080226|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4256038|NCT00620854|4080227|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4256039|NCT00620854|4080228|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4256040|NCT00620854|4080229|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4256041|NCT00620854|4080223|B7||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4256042|NCT00620854|4080224|B6||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4256043|NCT00620854|4080225|B5||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4256044|NCT00620854|4080226|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4256045|NCT00620854|4080227|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4256046|NCT00620854|4080228|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4256047|NCT00620854|4080229|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4256048|NCT00620854|4080223|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4256049|NCT00620854|4080224|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4256050|NCT00620854|4080225|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4256051|NCT00620854|4080226|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4256052|NCT00620854|4080227|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4256053|NCT00620854|4080228|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4256054|NCT00620854|4080229|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4256055|NCT00620828|4080245|B3|||Lean Body Weight||kg|Mean|61.4|61.4|Standard Deviation|11.75|11.75|||
4256056|NCT00620828|4080246|B2|||Lean Body Weight||kg|Mean|62.9|62.9|Standard Deviation|11.1|11.1|||
4256057|NCT00620828|4080247|B1|||Lean Body Weight||kg|Mean|59.9|59.9|Standard Deviation|12.4|12.4|||
4256058|NCT00620828|4080245|B3|United States||Region of Enrollment||participants|Number|67|67.0||||||
4256059|NCT00620828|4080246|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
4256060|NCT00620828|4080247|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4256061|NCT00620828|4080245|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4256062|NCT00620828|4080246|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4256063|NCT00620828|4080247|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4256064|NCT00620828|4080245|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4256065|NCT00620828|4080246|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4256066|NCT00620828|4080247|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4256067|NCT00620828|4080245|B3|||Age||years|Mean|66.1|66.1|Standard Deviation|2|2.0|||
4256068|NCT00620828|4080246|B2|||Age||years|Mean|66.9|66.9|Standard Deviation|2|2.0|||
4256069|NCT00620828|4080247|B1|||Age||years|Mean|65.4|65.4|Standard Deviation|2|2.0|||
4256070|NCT00620828|4080245|B3||>=65 years|Age||Participants|Count of Participants|53|53.0||||||
4256071|NCT00620828|4080246|B2||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4256072|NCT00620828|4080247|B1||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4256073|NCT00620828|4080245|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4256074|NCT00620828|4080246|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4256075|NCT00620828|4080247|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4256076|NCT00620828|4080245|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4256077|NCT00620828|4080246|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4256078|NCT00620828|4080247|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4256079|NCT00620815|4080262|B4|Male (≥61 years of age)||Sex/Gender, Customized|Analysis was done on Full Analysis Set|participants|Number|2|2.0||||||
4256080|NCT00620815|4080263|B3|Male (≥61 years of age)||Sex/Gender, Customized|Analysis was done on Full Analysis Set|participants|Number|0|0.0||||||
4256081|NCT00620815|4080264|B2|Male (≥61 years of age)||Sex/Gender, Customized|Analysis was done on Full Analysis Set|participants|Number|0|0.0||||||
4256082|NCT00620815|4080265|B1|Male (≥61 years of age)||Sex/Gender, Customized|Analysis was done on Full Analysis Set|participants|Number|2|2.0||||||
4256083|NCT00620815|4080262|B4|Female (≥61 years of age)||Sex/Gender, Customized|Analysis was done on Full Analysis Set|participants|Number|2|2.0||||||
4256084|NCT00620815|4080263|B3|Female (≥61 years of age)||Sex/Gender, Customized|Analysis was done on Full Analysis Set|participants|Number|0|0.0||||||
4256085|NCT00620815|4080264|B2|Female (≥61 years of age)||Sex/Gender, Customized|Analysis was done on Full Analysis Set|participants|Number|1|1.0||||||
4256086|NCT00620815|4080265|B1|Female (≥61 years of age)||Sex/Gender, Customized|Analysis was done on Full Analysis Set|participants|Number|1|1.0||||||
4256087|NCT00620815|4080262|B4|Male (≤60 years of age)||Sex/Gender, Customized|Analysis was done on Full Analysis Set|participants|Number|227|227.0||||||
4256088|NCT00620815|4080263|B3|Male (≤60 years of age)||Sex/Gender, Customized|Analysis was done on Full Analysis Set|participants|Number|84|84.0||||||
4256193|NCT00620542|4080390|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4256089|NCT00620815|4080264|B2|Male (≤60 years of age)||Sex/Gender, Customized|Analysis was done on Full Analysis Set|participants|Number|73|73.0||||||
4256090|NCT00620815|4080265|B1|Male (≤60 years of age)||Sex/Gender, Customized|Analysis was done on Full Analysis Set|participants|Number|70|70.0||||||
4256091|NCT00620815|4080262|B4|Female (≤60 years of age)||Sex/Gender, Customized|Analysis was done on Full Analysis Set|participants|Number|369|369.0||||||
4256092|NCT00620815|4080263|B3|Female (≤60 years of age)||Sex/Gender, Customized|Analysis was done on Full Analysis Set|participants|Number|114|114.0||||||
4256093|NCT00620815|4080264|B2|Female (≤60 years of age)||Sex/Gender, Customized|Analysis was done on Full Analysis Set|participants|Number|129|129.0||||||
4256094|NCT00620815|4080265|B1|Female (≤60 years of age)||Sex/Gender, Customized|Analysis was done on Full Analysis Set|participants|Number|126|126.0||||||
4256095|NCT00620815|4080262|B4|≥ 61 Years||Age, Customized|A total of 601 subjects were enrolled and randomized, 199 to the T/P-A group, 203 to the A/P-T group and 199 to the A/S-A group. One subject in the A/S-A group did not meet entry criteria and so did not receive any vaccination.|participants|Number|4|4.0||||||
4256096|NCT00620815|4080263|B3|≥ 61 Years||Age, Customized|A total of 601 subjects were enrolled and randomized, 199 to the T/P-A group, 203 to the A/P-T group and 199 to the A/S-A group. One subject in the A/S-A group did not meet entry criteria and so did not receive any vaccination.|participants|Number|0|0.0||NA||||
4256097|NCT00620815|4080264|B2|≥ 61 Years||Age, Customized|A total of 601 subjects were enrolled and randomized, 199 to the T/P-A group, 203 to the A/P-T group and 199 to the A/S-A group. One subject in the A/S-A group did not meet entry criteria and so did not receive any vaccination.|participants|Number|1|1.0||0|0.0|||
4256098|NCT00620815|4080265|B1|≥ 61 Years||Age, Customized|A total of 601 subjects were enrolled and randomized, 199 to the T/P-A group, 203 to the A/P-T group and 199 to the A/S-A group. One subject in the A/S-A group did not meet entry criteria and so did not receive any vaccination.|participants|Number|3|3.0||1|1.0|||
4256099|NCT00620815|4080262|B4|≤60 years||Age, Customized|A total of 601 subjects were enrolled and randomized, 199 to the T/P-A group, 203 to the A/P-T group and 199 to the A/S-A group. One subject in the A/S-A group did not meet entry criteria and so did not receive any vaccination.|participants|Number|596|596.0||||||
4256100|NCT00620815|4080263|B3|≤60 years||Age, Customized|A total of 601 subjects were enrolled and randomized, 199 to the T/P-A group, 203 to the A/P-T group and 199 to the A/S-A group. One subject in the A/S-A group did not meet entry criteria and so did not receive any vaccination.|participants|Number|198|198.0||9.6|9.6|||
4256101|NCT00620815|4080264|B2|≤60 years||Age, Customized|A total of 601 subjects were enrolled and randomized, 199 to the T/P-A group, 203 to the A/P-T group and 199 to the A/S-A group. One subject in the A/S-A group did not meet entry criteria and so did not receive any vaccination.|participants|Number|202|202.0||9.8|9.8|||
4256102|NCT00620815|4080265|B1|≤60 years||Age, Customized|A total of 601 subjects were enrolled and randomized, 199 to the T/P-A group, 203 to the A/P-T group and 199 to the A/S-A group. One subject in the A/S-A group did not meet entry criteria and so did not receive any vaccination.|participants|Number|196|196.0||8|8.0|||
4256103|NCT00620776|4080305|B3|United States||Region of Enrollment||participants|Number|61|61.0||||||
4256104|NCT00620776|4080306|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
4256105|NCT00620776|4080307|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4256106|NCT00620776|4080305|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256107|NCT00620776|4080306|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256108|NCT00620776|4080307|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256109|NCT00620776|4080305|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256110|NCT00620776|4080306|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256111|NCT00620776|4080307|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256112|NCT00620776|4080305|B3||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4256113|NCT00620776|4080306|B2||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4256114|NCT00620776|4080307|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4256115|NCT00620776|4080305|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4256116|NCT00620776|4080306|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4256117|NCT00620776|4080307|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4256118|NCT00620776|4080305|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256119|NCT00620776|4080306|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256120|NCT00620776|4080307|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256121|NCT00620776|4080305|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4256122|NCT00620776|4080306|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256123|NCT00620776|4080307|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4256124|NCT00620776|4080305|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256125|NCT00620776|4080306|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256126|NCT00620776|4080307|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256127|NCT00620776|4080305|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256128|NCT00620776|4080306|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256129|NCT00620776|4080307|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256130|NCT00620776|4080305|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4256131|NCT00620776|4080306|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4256132|NCT00620776|4080307|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4256133|NCT00620776|4080305|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4256134|NCT00620776|4080306|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256135|NCT00620776|4080307|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4256136|NCT00620776|4080305|B3||Male|Gender||Participants|Count of Participants|26|26.0||||||
4256137|NCT00620776|4080306|B2||Male|Gender||Participants|Count of Participants|17|17.0||||||
4256138|NCT00620776|4080307|B1||Male|Gender||Participants|Count of Participants|9|9.0||||||
4256139|NCT00620776|4080305|B3||Female|Gender||Participants|Count of Participants|35|35.0||||||
4256140|NCT00620776|4080306|B2||Female|Gender||Participants|Count of Participants|18|18.0||||||
4256141|NCT00620776|4080307|B1||Female|Gender||Participants|Count of Participants|17|17.0||||||
4256142|NCT00620776|4080305|B3|||Age||years|Mean|47.0|47.0|Standard Deviation|18.3|18.3|||
4256143|NCT00620776|4080306|B2|||Age||years|Mean|46.6|46.6|Standard Deviation|19.8|19.8|||
4256144|NCT00620776|4080307|B1|||Age||years|Mean|47.5|47.5|Standard Deviation|16.0|16.0|||
4256145|NCT00620763|4080336|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4256146|NCT00620763|4080336|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4256147|NCT00620763|4080336|B1|||Age||years|Mean|56.9|56.9|Standard Deviation|3.2|3.2|||
4256148|NCT00620750|4080343|B1|United States||Region of Enrollment||participants|Number|65|65.0||||||
4256149|NCT00620750|4080343|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4256150|NCT00620750|4080343|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4256151|NCT00620750|4080343|B1|||Age||years|Mean|46|46.0|Standard Deviation|8.535196|8.535196|||
4256152|NCT00620750|4080343|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4256153|NCT00620750|4080343|B1||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4256154|NCT00620750|4080343|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4256155|NCT00620711|4080347|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4256156|NCT00620711|4080347|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4256157|NCT00620711|4080347|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4256158|NCT00620711|4080347|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4256159|NCT00620711|4080347|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4256160|NCT00620698|4080352|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4256161|NCT00620698|4080352|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4256162|NCT00620698|4080352|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4256163|NCT00620698|4080352|B1|||Age||years|Mean|56.1|56.1|Standard Deviation|12|12.0|||
4256164|NCT00620659|4080358|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4256165|NCT00620659|4080358|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4256166|NCT00620659|4080358|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4256167|NCT00620659|4080358|B1|White||Race/Ethnicity, Customized||participants|Number|102|102.0||||||
4256168|NCT00620659|4080358|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4256169|NCT00620659|4080358|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4256170|NCT00620659|4080358|B1|||Age||years|Mean|48.6|48.6|Standard Deviation|8.5|8.5|||
4256171|NCT00620555|4080381|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4256172|NCT00620555|4080381|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4256173|NCT00620555|4080381|B1|13-16 years||Age, Customized||Participants|Number|15|15.0||||||
4256174|NCT00620555|4080381|B1|5-12 years||Age, Customized||Participants|Number|42|42.0||||||
4256175|NCT00620555|4080381|B1|3-4 years||Age, Customized||Participants|Number|8|8.0||||||
4256176|NCT00620542|4080388|B3||Male|Sex: Female, Male||Participants|Count of Participants|765|765.0||||||
4256177|NCT00620542|4080389|B2||Male|Sex: Female, Male||Participants|Count of Participants|386|386.0||||||
4256178|NCT00620542|4080390|B1||Male|Sex: Female, Male||Participants|Count of Participants|379|379.0||||||
4256179|NCT00620542|4080388|B3||Female|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
4256180|NCT00620542|4080389|B2||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4256181|NCT00620542|4080390|B1||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4256182|NCT00620542|4080388|B3|Age (yrs) at Week 0||Age||years|Mean|57.6|57.6|Standard Deviation|8.55|8.55|||
4256183|NCT00620542|4080389|B2|Age (yrs) at Week 0||Age||years|Mean|57.9|57.9|Standard Deviation|8.50|8.5|||
4256184|NCT00620542|4080390|B1|Age (yrs) at Week 0||Age||years|Mean|57.4|57.4|Standard Deviation|8.60|8.6|||
4256185|NCT00620542|4080388|B3||>=65 years|Age||Participants|Count of Participants|242|242.0||||||
4256186|NCT00620542|4080389|B2||>=65 years|Age||Participants|Count of Participants|124|124.0||||||
4256187|NCT00620542|4080390|B1||>=65 years|Age||Participants|Count of Participants|118|118.0||||||
4256188|NCT00620542|4080388|B3||Between 18 and 65 years|Age||Participants|Count of Participants|797|797.0||||||
4256189|NCT00620542|4080389|B2||Between 18 and 65 years|Age||Participants|Count of Participants|395|395.0||||||
4256190|NCT00620542|4080390|B1||Between 18 and 65 years|Age||Participants|Count of Participants|402|402.0||||||
4256191|NCT00620542|4080388|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4256192|NCT00620542|4080389|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4256194|NCT00620464|4080431|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4256195|NCT00620464|4080432|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4256196|NCT00620464|4080433|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4256197|NCT00620464|4080431|B3||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4256198|NCT00620464|4080432|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4256199|NCT00620464|4080433|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4256200|NCT00620464|4080431|B3|41-45 years||Age, Customized|Despite the protocol inclusion criteria, one patient was enrolled who was older than 40 years old. The subject was 43 years old.|participants|Number|1|1.0||||||
4256201|NCT00620464|4080432|B2|41-45 years||Age, Customized|Despite the protocol inclusion criteria, one patient was enrolled who was older than 40 years old. The subject was 43 years old.|participants|Number|0|0.0||||||
4256202|NCT00620464|4080433|B1|41-45 years||Age, Customized|Despite the protocol inclusion criteria, one patient was enrolled who was older than 40 years old. The subject was 43 years old.|participants|Number|1|1.0||||||
4256203|NCT00620464|4080431|B3|36-40 years||Age, Customized|Despite the protocol inclusion criteria, one patient was enrolled who was older than 40 years old. The subject was 43 years old.|participants|Number|14|14.0||||||
4256204|NCT00620464|4080432|B2|36-40 years||Age, Customized|Despite the protocol inclusion criteria, one patient was enrolled who was older than 40 years old. The subject was 43 years old.|participants|Number|4|4.0||||||
4256205|NCT00620464|4080433|B1|36-40 years||Age, Customized|Despite the protocol inclusion criteria, one patient was enrolled who was older than 40 years old. The subject was 43 years old.|participants|Number|10|10.0||||||
4256206|NCT00620464|4080431|B3|31-35 years||Age, Customized|Despite the protocol inclusion criteria, one patient was enrolled who was older than 40 years old. The subject was 43 years old.|participants|Number|18|18.0||||||
4256207|NCT00620464|4080432|B2|31-35 years||Age, Customized|Despite the protocol inclusion criteria, one patient was enrolled who was older than 40 years old. The subject was 43 years old.|participants|Number|12|12.0||||||
4256208|NCT00620464|4080433|B1|31-35 years||Age, Customized|Despite the protocol inclusion criteria, one patient was enrolled who was older than 40 years old. The subject was 43 years old.|participants|Number|6|6.0||||||
4256209|NCT00620464|4080431|B3|26-30 years||Age, Customized|Despite the protocol inclusion criteria, one patient was enrolled who was older than 40 years old. The subject was 43 years old.|participants|Number|25|25.0||||||
4256210|NCT00620464|4080432|B2|26-30 years||Age, Customized|Despite the protocol inclusion criteria, one patient was enrolled who was older than 40 years old. The subject was 43 years old.|participants|Number|10|10.0||||||
4256211|NCT00620464|4080433|B1|26-30 years||Age, Customized|Despite the protocol inclusion criteria, one patient was enrolled who was older than 40 years old. The subject was 43 years old.|participants|Number|15|15.0||||||
4256212|NCT00620464|4080431|B3|21-25 years||Age, Customized|Despite the protocol inclusion criteria, one patient was enrolled who was older than 40 years old. The subject was 43 years old.|participants|Number|27|27.0||||||
4256213|NCT00620464|4080432|B2|21-25 years||Age, Customized|Despite the protocol inclusion criteria, one patient was enrolled who was older than 40 years old. The subject was 43 years old.|participants|Number|18|18.0||||||
4256214|NCT00620464|4080433|B1|21-25 years||Age, Customized|Despite the protocol inclusion criteria, one patient was enrolled who was older than 40 years old. The subject was 43 years old.|participants|Number|9|9.0||||||
4256215|NCT00620464|4080431|B3|18-20 years||Age, Customized|Despite the protocol inclusion criteria, one patient was enrolled who was older than 40 years old. The subject was 43 years old.|participants|Number|23|23.0||||||
4256216|NCT00620464|4080432|B2|18-20 years||Age, Customized|Despite the protocol inclusion criteria, one patient was enrolled who was older than 40 years old. The subject was 43 years old.|participants|Number|12|12.0||||||
4256217|NCT00620464|4080433|B1|18-20 years||Age, Customized|Despite the protocol inclusion criteria, one patient was enrolled who was older than 40 years old. The subject was 43 years old.|participants|Number|11|11.0||||||
4256218|NCT00620425|4080442|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4256219|NCT00620425|4080442|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4256220|NCT00620425|4080442|B1|||Age||years|Mean|31|31.0|Standard Deviation|8|8.0|||
4256221|NCT00620425|4080442|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4256222|NCT00620425|4080442|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4256223|NCT00620425|4080442|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4256224|NCT00620373|4080453|B1|personal history of breast cancer||Risk factors|"Although participants may have qualified for multiple risk factor categories, they were assigned to only one risk factor category in this table. These risk factors are listed in order of priority. The last two risk factors with respect to first and second-degree relatives with a history of breast cancer refer to subjects who qualified on the basis of family history but did not meet the Gail or Claus model risk threshold levels.~The Gail risk model focuses on nongenetic risk factors, with limited information on family history. The Claus risk model focuses on genetic risk factors."|participants|Number|73|73.0||||||
4256225|NCT00620373|4080453|B1|2 second-deg relatives history of breast cancer||Risk factors|"Although participants may have qualified for multiple risk factor categories, they were assigned to only one risk factor category in this table. These risk factors are listed in order of priority. The last two risk factors with respect to first and second-degree relatives with a history of breast cancer refer to subjects who qualified on the basis of family history but did not meet the Gail or Claus model risk threshold levels.~The Gail risk model focuses on nongenetic risk factors, with limited information on family history. The Claus risk model focuses on genetic risk factors."|participants|Number|85|85.0||||||
4256250|NCT00620373|4080453|B1|||Age||years|Mean|55.5|55.5|Full Range|||25.0|89.0|
4256251|NCT00620282|4080469|B4|||Tumor necrosis factor-alpha (TNF-alpha)||pg/mL|Mean|1.6|1.6|Standard Deviation|1.0|1.0|||
4256252|NCT00620282|4080470|B3|||Tumor necrosis factor-alpha (TNF-alpha)||pg/mL|Mean|1.4|1.4|Standard Deviation|0.5|0.5|||
4256253|NCT00620282|4080471|B2|||Tumor necrosis factor-alpha (TNF-alpha)||pg/mL|Mean|1.4|1.4|Standard Deviation|0.8|0.8|||
4256226|NCT00620373|4080453|B1|1 first-deg relative with history of breast cancer||Risk factors|"Although participants may have qualified for multiple risk factor categories, they were assigned to only one risk factor category in this table. These risk factors are listed in order of priority. The last two risk factors with respect to first and second-degree relatives with a history of breast cancer refer to subjects who qualified on the basis of family history but did not meet the Gail or Claus model risk threshold levels.~The Gail risk model focuses on nongenetic risk factors, with limited information on family history. The Claus risk model focuses on genetic risk factors."|participants|Number|82|82.0||||||
4256227|NCT00620373|4080453|B1|Gail model 5 year risk ≥ 1.6%||Risk factors|"Although participants may have qualified for multiple risk factor categories, they were assigned to only one risk factor category in this table. These risk factors are listed in order of priority. The last two risk factors with respect to first and second-degree relatives with a history of breast cancer refer to subjects who qualified on the basis of family history but did not meet the Gail or Claus model risk threshold levels.~The Gail risk model focuses on nongenetic risk factors, with limited information on family history. The Claus risk model focuses on genetic risk factors."|participants|Number|238|238.0||||||
4256228|NCT00620373|4080453|B1|Gail model 5 year risk ≥ 2.5%||Risk factors|"Although participants may have qualified for multiple risk factor categories, they were assigned to only one risk factor category in this table. These risk factors are listed in order of priority. The last two risk factors with respect to first and second-degree relatives with a history of breast cancer refer to subjects who qualified on the basis of family history but did not meet the Gail or Claus model risk threshold levels.~The Gail risk model focuses on nongenetic risk factors, with limited information on family history. The Claus risk model focuses on genetic risk factors."|participants|Number|297|297.0||||||
4256229|NCT00620373|4080453|B1|Gail or Claus model lifetime risk ≥ 20%||Risk factors|"Although participants may have qualified for multiple risk factor categories, they were assigned to only one risk factor category in this table. These risk factors are listed in order of priority. The last two risk factors with respect to first and second-degree relatives with a history of breast cancer refer to subjects who qualified on the basis of family history but did not meet the Gail or Claus model risk threshold levels.~The Gail risk model focuses on nongenetic risk factors, with limited information on family history. The Claus risk model focuses on genetic risk factors."|participants|Number|165|165.0||||||
4256230|NCT00620373|4080453|B1|Prior biopsy showing hyperplasia, etc.||Risk factors|"Although participants may have qualified for multiple risk factor categories, they were assigned to only one risk factor category in this table. These risk factors are listed in order of priority. The last two risk factors with respect to first and second-degree relatives with a history of breast cancer refer to subjects who qualified on the basis of family history but did not meet the Gail or Claus model risk threshold levels.~The Gail risk model focuses on nongenetic risk factors, with limited information on family history. The Claus risk model focuses on genetic risk factors."|participants|Number|23|23.0||||||
4256231|NCT00620373|4080453|B1|Prior chest, mediastinal, or auxiliary irradiation||Risk factors|"Although participants may have qualified for multiple risk factor categories, they were assigned to only one risk factor category in this table. These risk factors are listed in order of priority. The last two risk factors with respect to first and second-degree relatives with a history of breast cancer refer to subjects who qualified on the basis of family history but did not meet the Gail or Claus model risk threshold levels.~The Gail risk model focuses on nongenetic risk factors, with limited information on family history. The Claus risk model focuses on genetic risk factors."|participants|Number|1|1.0||||||
4256232|NCT00620373|4080453|B1|Known mutation in BRCA1 or BRCA2 gene||Risk factors|"Although participants may have qualified for multiple risk factor categories, they were assigned to only one risk factor category in this table. These risk factors are listed in order of priority. The last two risk factors with respect to first and second-degree relatives with a history of breast cancer refer to subjects who qualified on the basis of family history but did not meet the Gail or Claus model risk threshold levels.~The Gail risk model focuses on nongenetic risk factors, with limited information on family history. The Claus risk model focuses on genetic risk factors."|participants|Number|5|5.0||||||
4256233|NCT00620373|4080453|B1|Extremely dense||Mammographic breast density|Eligibility was determined by density assessed on a previous mammogram prior to study entry; mammographic density reported refers to density assessed from the study mammogram.|participants|Number|131|131.0||||||
4256234|NCT00620373|4080453|B1|Heterogeneously dense||Mammographic breast density|Eligibility was determined by density assessed on a previous mammogram prior to study entry; mammographic density reported refers to density assessed from the study mammogram.|participants|Number|702|702.0||||||
4256235|NCT00620373|4080453|B1|Scattered fibroglandular densities||Mammographic breast density|Eligibility was determined by density assessed on a previous mammogram prior to study entry; mammographic density reported refers to density assessed from the study mammogram.|participants|Number|129|129.0||||||
4256236|NCT00620373|4080453|B1|Almost entirely fat||Mammographic breast density|Eligibility was determined by density assessed on a previous mammogram prior to study entry; mammographic density reported refers to density assessed from the study mammogram.|participants|Number|7|7.0||||||
4256237|NCT00620373|4080453|B1|Surgical menopause||Menopausal status||participants|Number|51|51.0||||||
4256238|NCT00620373|4080453|B1|Postmenopause||Menopausal status||participants|Number|529|529.0||||||
4256239|NCT00620373|4080453|B1|Perimenopausal||Menopausal status||participants|Number|65|65.0||||||
4256240|NCT00620373|4080453|B1|Premenopausal||Menopausal status||participants|Number|324|324.0||||||
4256241|NCT00620373|4080453|B1|Unknown or data missing||Race or ethnicity||participants|Number|100|100.0||||||
4256242|NCT00620373|4080453|B1|American Indian or Alaskan Native||Race or ethnicity||participants|Number|1|1.0||||||
4256243|NCT00620373|4080453|B1|Asian||Race or ethnicity||participants|Number|6|6.0||||||
4256244|NCT00620373|4080453|B1|Black or African American||Race or ethnicity||participants|Number|1|1.0||||||
4256245|NCT00620373|4080453|B1|Hispanic or Latina||Race or ethnicity||participants|Number|1|1.0||||||
4256246|NCT00620373|4080453|B1|White||Race or ethnicity||participants|Number|860|860.0||||||
4256247|NCT00620373|4080453|B1|United States||Region of Enrollment||participants|Number|969|969.0||||||
4256248|NCT00620373|4080453|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4256249|NCT00620373|4080453|B1||Female|Sex: Female, Male||Participants|Count of Participants|969|969.0||||||
4256254|NCT00620282|4080472|B1|||Tumor necrosis factor-alpha (TNF-alpha)||pg/mL|Mean|2.1|2.1|Standard Deviation|1.5|1.5|||
4256255|NCT00620282|4080469|B4|||Triglycerides (TG)||mg/dL|Mean|150.8|150.8|Standard Deviation|65.7|65.7|||
4256256|NCT00620282|4080470|B3|||Triglycerides (TG)||mg/dL|Mean|141.4|141.4|Standard Deviation|67.4|67.4|||
4256257|NCT00620282|4080471|B2|||Triglycerides (TG)||mg/dL|Mean|145.9|145.9|Standard Deviation|57.5|57.5|||
4256258|NCT00620282|4080472|B1|||Triglycerides (TG)||mg/dL|Mean|165.8|165.8|Standard Deviation|72.9|72.9|||
4256259|NCT00620282|4080469|B4|||High density lipoprotein (HDL-C)||mg/dL|Mean|40.8|40.8|Standard Deviation|9.4|9.4|||
4256260|NCT00620282|4080470|B3|||High density lipoprotein (HDL-C)||mg/dL|Mean|43.5|43.5|Standard Deviation|10.3|10.3|||
4256261|NCT00620282|4080471|B2|||High density lipoprotein (HDL-C)||mg/dL|Mean|39.2|39.2|Standard Deviation|7.5|7.5|||
4256262|NCT00620282|4080472|B1|||High density lipoprotein (HDL-C)||mg/dL|Mean|39.6|39.6|Standard Deviation|10.0|10.0|||
4256263|NCT00620282|4080469|B4|||Low density lipoprotein (LDL-C)||mg/dL|Mean|96.4|96.4|Standard Deviation|24.8|24.8|||
4256264|NCT00620282|4080470|B3|||Low density lipoprotein (LDL-C)||mg/dL|Mean|94.1|94.1|Standard Deviation|18.4|18.4|||
4256265|NCT00620282|4080471|B2|||Low density lipoprotein (LDL-C)||mg/dL|Mean|92.5|92.5|Standard Deviation|23.5|23.5|||
4256266|NCT00620282|4080472|B1|||Low density lipoprotein (LDL-C)||mg/dL|Mean|102.8|102.8|Standard Deviation|31.3|31.3|||
4256267|NCT00620282|4080469|B4|||Total Cholesterol (TC)||mg/dL|Mean|162.6|162.6|Standard Deviation|30.2|30.2|||
4256268|NCT00620282|4080470|B3|||Total Cholesterol (TC)||mg/dL|Mean|160.2|160.2|Standard Deviation|24.1|24.1|||
4256269|NCT00620282|4080471|B2|||Total Cholesterol (TC)||mg/dL|Mean|157.5|157.5|Standard Deviation|32.0|32.0|||
4256270|NCT00620282|4080472|B1|||Total Cholesterol (TC)||mg/dL|Mean|170.2|170.2|Standard Deviation|34.4|34.4|||
4256271|NCT00620282|4080469|B4|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|156.6|156.6|Standard Deviation|29.4|29.4|||
4256272|NCT00620282|4080470|B3|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|163.3|163.3|Standard Deviation|33.3|33.3|||
4256273|NCT00620282|4080471|B2|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|145.2|145.2|Standard Deviation|20.1|20.1|||
4256274|NCT00620282|4080472|B1|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|160.8|160.8|Standard Deviation|31.2|31.2|||
4256275|NCT00620282|4080469|B4|||Glycosylated Haemoglobin A1c (HbA1c)||percentage of total haemoglobin|Mean|7.2|7.2|Standard Deviation|0.5|0.5|||
4256276|NCT00620282|4080470|B3|||Glycosylated Haemoglobin A1c (HbA1c)||percentage of total haemoglobin|Mean|7.3|7.3|Standard Deviation|0.5|0.5|||
4256277|NCT00620282|4080471|B2|||Glycosylated Haemoglobin A1c (HbA1c)||percentage of total haemoglobin|Mean|7.0|7.0|Standard Deviation|0.5|0.5|||
4256278|NCT00620282|4080472|B1|||Glycosylated Haemoglobin A1c (HbA1c)||percentage of total haemoglobin|Mean|7.2|7.2|Standard Deviation|0.5|0.5|||
4256279|NCT00620282|4080469|B4|||Body Weight||kg|Mean|92.56|92.56|Standard Deviation|13.38|13.38|||
4256280|NCT00620282|4080470|B3|||Body Weight||kg|Mean|91.99|91.99|Standard Deviation|13.97|13.97|||
4256281|NCT00620282|4080471|B2|||Body Weight||kg|Mean|90.63|90.63|Standard Deviation|13.47|13.47|||
4256282|NCT00620282|4080472|B1|||Body Weight||kg|Mean|95.09|95.09|Standard Deviation|13.12|13.12|||
4256283|NCT00620282|4080469|B4|||Body Mass Index (BMI)||kg/m^2|Mean|31.8|31.8|Standard Deviation|4.5|4.5|||
4256284|NCT00620282|4080470|B3|||Body Mass Index (BMI)||kg/m^2|Mean|31.1|31.1|Standard Deviation|4.9|4.9|||
4256285|NCT00620282|4080471|B2|||Body Mass Index (BMI)||kg/m^2|Mean|31.6|31.6|Standard Deviation|4.2|4.2|||
4256286|NCT00620282|4080472|B1|||Body Mass Index (BMI)||kg/m^2|Mean|32.7|32.7|Standard Deviation|4.5|4.5|||
4256287|NCT00620282|4080469|B4|Metformin||Previous Anti-diabetic Treatment||participants|Number|44|44.0||||||
4256288|NCT00620282|4080470|B3|Metformin||Previous Anti-diabetic Treatment||participants|Number|15|15.0||||||
4256289|NCT00620282|4080471|B2|Metformin||Previous Anti-diabetic Treatment||participants|Number|15|15.0||||||
4256290|NCT00620282|4080472|B1|Metformin||Previous Anti-diabetic Treatment||participants|Number|14|14.0||||||
4256291|NCT00620282|4080469|B4|Diet/Exercise||Previous Anti-diabetic Treatment||participants|Number|5|5.0||||||
4256292|NCT00620282|4080470|B3|Diet/Exercise||Previous Anti-diabetic Treatment||participants|Number|2|2.0||||||
4256293|NCT00620282|4080471|B2|Diet/Exercise||Previous Anti-diabetic Treatment||participants|Number|1|1.0||||||
4256294|NCT00620282|4080472|B1|Diet/Exercise||Previous Anti-diabetic Treatment||participants|Number|2|2.0||||||
4256295|NCT00620282|4080469|B4|||Duration of Diabetes||years|Mean|6.8|6.8|Standard Deviation|6.0|6.0|||
4256296|NCT00620282|4080470|B3|||Duration of Diabetes||years|Mean|6.8|6.8|Standard Deviation|8.1|8.1|||
4256297|NCT00620282|4080471|B2|||Duration of Diabetes||years|Mean|8.4|8.4|Standard Deviation|4.6|4.6|||
4256298|NCT00620282|4080472|B1|||Duration of Diabetes||years|Mean|5.3|5.3|Standard Deviation|4.1|4.1|||
4256299|NCT00620282|4080469|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256300|NCT00620282|4080470|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256301|NCT00620282|4080471|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256302|NCT00620282|4080472|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256303|NCT00620282|4080469|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256304|NCT00620282|4080470|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256305|NCT00620282|4080471|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256306|NCT00620282|4080472|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256307|NCT00620282|4080469|B4||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4256308|NCT00620282|4080470|B3||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4256309|NCT00620282|4080471|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4256310|NCT00620282|4080472|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4256311|NCT00620282|4080469|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256312|NCT00620282|4080470|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256313|NCT00620282|4080471|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256314|NCT00620282|4080472|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256315|NCT00620282|4080469|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256316|NCT00620282|4080470|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256317|NCT00620282|4080471|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256318|NCT00620282|4080472|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256319|NCT00620282|4080469|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256320|NCT00620282|4080470|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256321|NCT00620282|4080471|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256322|NCT00620282|4080472|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256323|NCT00620282|4080469|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256324|NCT00620282|4080470|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256325|NCT00620282|4080471|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256326|NCT00620282|4080472|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256327|NCT00620282|4080469|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256328|NCT00620282|4080470|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256329|NCT00620282|4080471|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256330|NCT00620282|4080472|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256331|NCT00620282|4080469|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4256332|NCT00620282|4080470|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4256333|NCT00620282|4080471|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4256334|NCT00620282|4080472|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4256335|NCT00620282|4080469|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256336|NCT00620282|4080470|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256337|NCT00620282|4080471|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256338|NCT00620282|4080472|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256339|NCT00620282|4080469|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4256340|NCT00620282|4080470|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4256341|NCT00620282|4080471|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4256342|NCT00620282|4080472|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4256343|NCT00620282|4080469|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4256344|NCT00620282|4080470|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4256345|NCT00620282|4080471|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4256346|NCT00620282|4080472|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4256347|NCT00620282|4080469|B4|||Age||years|Mean|58.5|58.5|Standard Deviation|7.3|7.3|||
4256348|NCT00620282|4080470|B3|||Age||years|Mean|57.7|57.7|Standard Deviation|5.3|5.3|||
4256349|NCT00620282|4080471|B2|||Age||years|Mean|60.3|60.3|Standard Deviation|7.3|7.3|||
4256350|NCT00620282|4080472|B1|||Age||years|Mean|57.7|57.7|Standard Deviation|9.0|9.0|||
4256351|NCT00620126|4080521|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
4256352|NCT00620126|4080522|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4256353|NCT00620126|4080523|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4256354|NCT00620126|4080521|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4256355|NCT00620126|4080522|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4256356|NCT00620126|4080523|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4256357|NCT00620126|4080521|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4256358|NCT00620126|4080522|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4256359|NCT00620126|4080523|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4256360|NCT00620126|4080521|B3|||Age||years|Mean|41.1|41.1|Standard Deviation|14|14.0|||
4256361|NCT00620126|4080522|B2|||Age||years|Mean|40.3|40.3|Standard Deviation|13.9|13.9|||
4256362|NCT00620126|4080523|B1|||Age||years|Mean|41.7|41.7|Standard Deviation|13.9|13.9|||
4256363|NCT00620126|4080521|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4256364|NCT00620126|4080522|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4256365|NCT00620126|4080523|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4256366|NCT00620126|4080521|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4256367|NCT00620126|4080522|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4256368|NCT00620126|4080523|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4256369|NCT00620126|4080521|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4256370|NCT00620126|4080522|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4256371|NCT00620126|4080523|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4256372|NCT00620113|4080534|B5||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4256373|NCT00620113|4080535|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4256374|NCT00620113|4080536|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4256375|NCT00620113|4080537|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4256376|NCT00620113|4080538|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4256377|NCT00620113|4080534|B5||Female|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
4256378|NCT00620113|4080535|B4||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4256379|NCT00620113|4080536|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4256380|NCT00620113|4080537|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4256381|NCT00620113|4080538|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4256382|NCT00620113|4080534|B5|||Age||years|Mean|68.2|68.2|Standard Deviation|7.1|7.1|||
4256383|NCT00620113|4080535|B4|||Age||years|Mean|68.7|68.7|Standard Deviation|7.0|7.0|||
4256384|NCT00620113|4080536|B3|||Age||years|Mean|67.5|67.5|Standard Deviation|7.4|7.4|||
4256385|NCT00620113|4080537|B2|||Age||years|Mean|69.1|69.1|Standard Deviation|7.3|7.3|||
4256386|NCT00620113|4080538|B1|||Age||years|Mean|67.7|67.7|Standard Deviation|6.8|6.8|||
4256387|NCT00620074|4080591|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4256388|NCT00620074|4080591|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4256389|NCT00620074|4080591|B1|Between 57 and 83 years||Age, Customized||participants|Number|6|6.0||||||
4256390|NCT00620035|4080599|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4256391|NCT00620035|4080599|B1||Female|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
4256392|NCT00620035|4080599|B1|36-40 years||Age, Customized||participants|Number|61|61.0||||||
4256393|NCT00620035|4080599|B1|31-35 years||Age, Customized||participants|Number|54|54.0||||||
4256394|NCT00620035|4080599|B1|26-30 years||Age, Customized||participants|Number|64|64.0||||||
4256395|NCT00620035|4080599|B1|21-25 years||Age, Customized||participants|Number|79|79.0||||||
4256396|NCT00620035|4080599|B1|18-20 years||Age, Customized||participants|Number|43|43.0||||||
4256397|NCT00620022|4080609|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4256398|NCT00620022|4080609|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4256399|NCT00620022|4080609|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|8.20|8.2|||
4256400|NCT00619983|4080618|B5|United States||Region of Enrollment||participants|Number|22|22.0||||||
4256401|NCT00619983|4080619|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
4256402|NCT00619983|4080620|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4256403|NCT00619983|4080621|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4256404|NCT00619983|4080622|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4256405|NCT00619983|4080618|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256406|NCT00619983|4080619|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256407|NCT00619983|4080620|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256408|NCT00619983|4080621|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256409|NCT00619983|4080622|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256410|NCT00619983|4080618|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256411|NCT00619983|4080619|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256412|NCT00619983|4080620|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256413|NCT00619983|4080621|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256414|NCT00619983|4080622|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256415|NCT00619983|4080618|B5||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4256416|NCT00619983|4080619|B4||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4256417|NCT00619983|4080620|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4256418|NCT00619983|4080621|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4256419|NCT00619983|4080622|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4256420|NCT00619983|4080618|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4256421|NCT00619983|4080619|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4256422|NCT00619983|4080620|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4256423|NCT00619983|4080621|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4256424|NCT00619983|4080622|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4256425|NCT00619983|4080618|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256426|NCT00619983|4080619|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256427|NCT00619983|4080620|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256428|NCT00619983|4080621|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256429|NCT00619983|4080622|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256430|NCT00619983|4080618|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256431|NCT00619983|4080619|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256432|NCT00619983|4080620|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256433|NCT00619983|4080621|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256434|NCT00619983|4080622|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256435|NCT00619983|4080618|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256436|NCT00619983|4080619|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256437|NCT00619983|4080620|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256438|NCT00619983|4080621|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256439|NCT00619983|4080622|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256440|NCT00619983|4080618|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4256441|NCT00619983|4080619|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4256442|NCT00619983|4080620|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4256443|NCT00619983|4080621|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4256444|NCT00619983|4080622|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4256445|NCT00619983|4080618|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4256446|NCT00619983|4080619|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4256447|NCT00619983|4080620|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4256448|NCT00619983|4080621|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4256449|NCT00619983|4080622|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4256450|NCT00619983|4080618|B5|||Age||years|Median|60|60.0|Full Range|||50.0|72.0|
4256451|NCT00619983|4080619|B4|||Age||years|Median|70|70.0|Full Range|||65.0|72.0|
4256452|NCT00619983|4080620|B3|||Age||years|Median|59|59.0|Full Range|||58.0|59.0|
4256453|NCT00619983|4080621|B2|||Age||years|Median|56|56.0|Full Range|||54.0|60.0|
4256454|NCT00619983|4080622|B1|||Age||years|Median|62|62.0|Full Range|||52.0|65.0|
4256455|NCT00619970|4080635|B4|United States||Region of Enrollment||participants|Number|115|115.0||||||
4256456|NCT00619970|4080636|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4256457|NCT00619970|4080637|B2|United States||Region of Enrollment||participants|Number|49|49.0||||||
4256458|NCT00619970|4080638|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4256459|NCT00619970|4080635|B4||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4256460|NCT00619970|4080636|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4256461|NCT00619970|4080637|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4256462|NCT00619970|4080638|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4256463|NCT00619970|4080635|B4||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4256464|NCT00619970|4080636|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4256465|NCT00619970|4080637|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4256466|NCT00619970|4080638|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4256467|NCT00619970|4080635|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4256468|NCT00619970|4080636|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4256469|NCT00619970|4080637|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4256470|NCT00619970|4080638|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4256471|NCT00619970|4080635|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4256472|NCT00619970|4080636|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4256473|NCT00619970|4080637|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4256474|NCT00619970|4080638|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4256475|NCT00619970|4080635|B4||<=18 years|Age||Participants|Count of Participants|115|115.0||||||
4256476|NCT00619970|4080636|B3||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
4256477|NCT00619970|4080637|B2||<=18 years|Age||Participants|Count of Participants|49|49.0||||||
4256478|NCT00619970|4080638|B1||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
4256479|NCT00619957|4080650|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
4256480|NCT00619957|4080651|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
4256481|NCT00619957|4080652|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4256482|NCT00619957|4080650|B3|Poland||Region of Enrollment||participants|Number|108|108.0||||||
4256483|NCT00619957|4080651|B2|Poland||Region of Enrollment||participants|Number|73|73.0||||||
4256484|NCT00619957|4080652|B1|Poland||Region of Enrollment||participants|Number|35|35.0||||||
4256485|NCT00619957|4080650|B3|Netherlands||Region of Enrollment||participants|Number|10|10.0||||||
4256486|NCT00619957|4080651|B2|Netherlands||Region of Enrollment||participants|Number|7|7.0||||||
4256487|NCT00619957|4080652|B1|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
4256488|NCT00619957|4080650|B3|Lebanon||Region of Enrollment||participants|Number|6|6.0||||||
4256489|NCT00619957|4080651|B2|Lebanon||Region of Enrollment||participants|Number|4|4.0||||||
4256490|NCT00619957|4080652|B1|Lebanon||Region of Enrollment||participants|Number|2|2.0||||||
4256491|NCT00619957|4080650|B3|Hungary||Region of Enrollment||participants|Number|31|31.0||||||
4256492|NCT00619957|4080651|B2|Hungary||Region of Enrollment||participants|Number|20|20.0||||||
4256493|NCT00619957|4080652|B1|Hungary||Region of Enrollment||participants|Number|11|11.0||||||
4256494|NCT00619957|4080650|B3|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
4256495|NCT00619957|4080651|B2|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4256496|NCT00619957|4080652|B1|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4256497|NCT00619957|4080650|B3|France||Region of Enrollment||participants|Number|9|9.0||||||
4256498|NCT00619957|4080651|B2|France||Region of Enrollment||participants|Number|7|7.0||||||
4256499|NCT00619957|4080652|B1|France||Region of Enrollment||participants|Number|2|2.0||||||
4256500|NCT00619957|4080650|B3|Czech Republic||Region of Enrollment||participants|Number|17|17.0||||||
4256501|NCT00619957|4080651|B2|Czech Republic||Region of Enrollment||participants|Number|12|12.0||||||
4256502|NCT00619957|4080652|B1|Czech Republic||Region of Enrollment||participants|Number|5|5.0||||||
4256503|NCT00619957|4080650|B3|Belgium||Region of Enrollment||participants|Number|36|36.0||||||
4256504|NCT00619957|4080651|B2|Belgium||Region of Enrollment||participants|Number|24|24.0||||||
4256505|NCT00619957|4080652|B1|Belgium||Region of Enrollment||participants|Number|12|12.0||||||
4256506|NCT00619957|4080650|B3|Australia||Region of Enrollment||participants|Number|10|10.0||||||
4256507|NCT00619957|4080651|B2|Australia||Region of Enrollment||participants|Number|7|7.0||||||
4256508|NCT00619957|4080652|B1|Australia||Region of Enrollment||participants|Number|3|3.0||||||
4256509|NCT00619957|4080650|B3||Male|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
4256510|NCT00619957|4080651|B2||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4256511|NCT00619957|4080652|B1||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4256512|NCT00619957|4080650|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4256513|NCT00619957|4080651|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4256514|NCT00619957|4080652|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4256515|NCT00619957|4080650|B3|>=75 years||Age, Customized|ITT Population|participants|Number|30|30.0||||||
4256516|NCT00619957|4080651|B2|>=75 years||Age, Customized|ITT Population|participants|Number|20|20.0||||||
4256517|NCT00619957|4080652|B1|>=75 years||Age, Customized|ITT Population|participants|Number|10|10.0||||||
4256518|NCT00619957|4080650|B3|Between 65 and <75 years||Age, Customized|ITT Population|participants|Number|85|85.0||||||
4256519|NCT00619957|4080651|B2|Between 65 and <75 years||Age, Customized|ITT Population|participants|Number|51|51.0||||||
4256520|NCT00619957|4080652|B1|Between 65 and <75 years||Age, Customized|ITT Population|participants|Number|34|34.0||||||
4256521|NCT00619957|4080650|B3|< 65 years||Age, Customized|ITT Population|participants|Number|169|169.0||||||
4256522|NCT00619957|4080651|B2|< 65 years||Age, Customized|ITT Population|participants|Number|120|120.0||||||
4256523|NCT00619957|4080652|B1|< 65 years||Age, Customized|ITT Population|participants|Number|49|49.0||||||
4256524|NCT00619918|4080733|B3|United States||Region of Enrollment||participants|Number|447|447.0||||||
4256525|NCT00619918|4080734|B2|United States||Region of Enrollment||participants|Number|217|217.0||||||
4256526|NCT00619918|4080735|B1|United States||Region of Enrollment||participants|Number|230|230.0||||||
4256527|NCT00619918|4080733|B3||Male|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
4256528|NCT00619918|4080734|B2||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4256529|NCT00619918|4080735|B1||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4256530|NCT00619918|4080733|B3||Female|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4256531|NCT00619918|4080734|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4256532|NCT00619918|4080735|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4256533|NCT00619918|4080733|B3|||Age||years|Mean|0.54|0.54|Standard Deviation|0.44|0.44|||
4256534|NCT00619918|4080734|B2|||Age||years|Mean|0.53|0.53|Standard Deviation|0.43|0.43|||
4256535|NCT00619918|4080735|B1|||Age||years|Mean|0.55|0.55|Standard Deviation|0.42|0.42|||
4256536|NCT00619918|4080733|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4256537|NCT00619918|4080734|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4256538|NCT00619918|4080735|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4256539|NCT00619918|4080733|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4256540|NCT00619918|4080734|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4256541|NCT00619918|4080735|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4256542|NCT00619918|4080733|B3||<=18 years|Age||Participants|Count of Participants|447|447.0||||||
4256543|NCT00619918|4080734|B2||<=18 years|Age||Participants|Count of Participants|217|217.0||||||
4256544|NCT00619918|4080735|B1||<=18 years|Age||Participants|Count of Participants|230|230.0||||||
4256545|NCT00619892|4080744|B3|||Pittsburgh Sleep Quality Index (PSQI) sleep quality|The PSQI sleep quality subscale is a self-reported measure of the patient's sleep quality over the past month, with a possible range of 0-3, where 0 = very good; 1 = fairly good; 2= fairly bad; and 3 = very bad.|units on a scale|Mean|2.6|2.6|Standard Deviation|0.6|0.6|||
4256546|NCT00619892|4080745|B2|||Pittsburgh Sleep Quality Index (PSQI) sleep quality|The PSQI sleep quality subscale is a self-reported measure of the patient's sleep quality over the past month, with a possible range of 0-3, where 0 = very good; 1 = fairly good; 2= fairly bad; and 3 = very bad.|units on a scale|Mean|2.3|2.3|Standard Deviation|0.6|0.6|||
4256575|NCT00619892|4080744|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4256547|NCT00619892|4080746|B1|||Pittsburgh Sleep Quality Index (PSQI) sleep quality|The PSQI sleep quality subscale is a self-reported measure of the patient's sleep quality over the past month, with a possible range of 0-3, where 0 = very good; 1 = fairly good; 2= fairly bad; and 3 = very bad.|units on a scale|Mean|2.9|2.9|Standard Deviation|0.6|0.6|||
4256548|NCT00619892|4080744|B3|||Pittsburgh Sleep Quality Index (PSQI) sleep hours|The PSQI sleep hours subscale is a self-reported measure of the number of hours patients slept per night over the past month.|hours slept per night|Mean|6.5|6.5|Standard Deviation|1.5|1.5|||
4256549|NCT00619892|4080745|B2|||Pittsburgh Sleep Quality Index (PSQI) sleep hours|The PSQI sleep hours subscale is a self-reported measure of the number of hours patients slept per night over the past month.|hours slept per night|Mean|6.7|6.7|Standard Deviation|1.6|1.6|||
4256550|NCT00619892|4080746|B1|||Pittsburgh Sleep Quality Index (PSQI) sleep hours|The PSQI sleep hours subscale is a self-reported measure of the number of hours patients slept per night over the past month.|hours slept per night|Mean|6.2|6.2|Standard Deviation|1.3|1.3|||
4256551|NCT00619892|4080744|B3|||Hamilton Depression Rating Scale (HAM-D)|The HAM-D is a questionnaire with 17 items. Each item on the questionnaire is scored on a 3 or 5 point scale. The total scores indicate levels of depression, where 0-7= normal; 8-13 = mild depression; 14-18 = moderate depression; 19-22 = severe depression; and 23 or greater = very severe depression.|units on a scale|Mean|13.1|13.1|Standard Deviation|5.7|5.7|||
4256552|NCT00619892|4080745|B2|||Hamilton Depression Rating Scale (HAM-D)|The HAM-D is a questionnaire with 17 items. Each item on the questionnaire is scored on a 3 or 5 point scale. The total scores indicate levels of depression, where 0-7= normal; 8-13 = mild depression; 14-18 = moderate depression; 19-22 = severe depression; and 23 or greater = very severe depression.|units on a scale|Mean|11.5|11.5|Standard Deviation|5.1|5.1|||
4256553|NCT00619892|4080746|B1|||Hamilton Depression Rating Scale (HAM-D)|The HAM-D is a questionnaire with 17 items. Each item on the questionnaire is scored on a 3 or 5 point scale. The total scores indicate levels of depression, where 0-7= normal; 8-13 = mild depression; 14-18 = moderate depression; 19-22 = severe depression; and 23 or greater = very severe depression.|units on a scale|Mean|14.6|14.6|Standard Deviation|6.2|6.2|||
4256554|NCT00619892|4080744|B3|||Hamilton Anxiety Rating Scale (HAM-A)|Hamilton Anxiety Rating Scale (HAM-A) is a questionnaire used by clinicians to rate the severity of a patient's anxiety. The scale consists of 14 items designed to assess the severity of a patient’s anxiety, each of which is rated on a scale of 0 to 4, with 4 being the most severe. Total scores can range from 0 to 56.|units on a scale|Mean|19.1|19.1|Standard Deviation|6.0|6.0|||
4256555|NCT00619892|4080745|B2|||Hamilton Anxiety Rating Scale (HAM-A)|Hamilton Anxiety Rating Scale (HAM-A) is a questionnaire used by clinicians to rate the severity of a patient's anxiety. The scale consists of 14 items designed to assess the severity of a patient’s anxiety, each of which is rated on a scale of 0 to 4, with 4 being the most severe. Total scores can range from 0 to 56.|units on a scale|Mean|17|17.0|Standard Deviation|5.2|5.2|||
4256556|NCT00619892|4080746|B1|||Hamilton Anxiety Rating Scale (HAM-A)|Hamilton Anxiety Rating Scale (HAM-A) is a questionnaire used by clinicians to rate the severity of a patient's anxiety. The scale consists of 14 items designed to assess the severity of a patient’s anxiety, each of which is rated on a scale of 0 to 4, with 4 being the most severe. Total scores can range from 0 to 56.|units on a scale|Mean|21.2|21.2|Standard Deviation|6.8|6.8|||
4256557|NCT00619892|4080744|B3|||Clinical Global Impression-Severity Scale (CGI-S)|CGI-S is a 7-point scale that requires the clinician to rate the severity of the patient's illness at the time of assessment, where 1 =normal, not at all ill; 2 = borderline mentally ill; 3 = mildly ill; 4 = moderately ill; 5 = markedly ill; 6 = severely ill; or 7 = extremely ill.|units on a scale|Mean|4.6|4.6|Standard Deviation|0.8|0.8|||
4256558|NCT00619892|4080745|B2|||Clinical Global Impression-Severity Scale (CGI-S)|CGI-S is a 7-point scale that requires the clinician to rate the severity of the patient's illness at the time of assessment, where 1 =normal, not at all ill; 2 = borderline mentally ill; 3 = mildly ill; 4 = moderately ill; 5 = markedly ill; 6 = severely ill; or 7 = extremely ill.|units on a scale|Mean|4.4|4.4|Standard Deviation|0.7|0.7|||
4256559|NCT00619892|4080746|B1|||Clinical Global Impression-Severity Scale (CGI-S)|CGI-S is a 7-point scale that requires the clinician to rate the severity of the patient's illness at the time of assessment, where 1 =normal, not at all ill; 2 = borderline mentally ill; 3 = mildly ill; 4 = moderately ill; 5 = markedly ill; 6 = severely ill; or 7 = extremely ill.|units on a scale|Mean|4.8|4.8|Standard Deviation|0.8|0.8|||
4256560|NCT00619892|4080744|B3|||Panic Disorder Severity Scale|"Possible range 0-28 (7 questions, each scored from 0 to 4, with higher numbers indicating more severe panic symptoms).~Mean (Standard Deviation)"|units on a scale|Mean|14.3|14.3|Standard Deviation|3.3|3.3|||
4256561|NCT00619892|4080745|B2|||Panic Disorder Severity Scale|"Possible range 0-28 (7 questions, each scored from 0 to 4, with higher numbers indicating more severe panic symptoms).~Mean (Standard Deviation)"|units on a scale|Mean|13.7|13.7|Standard Deviation|3|3.0|||
4256562|NCT00619892|4080746|B1|||Panic Disorder Severity Scale|"Possible range 0-28 (7 questions, each scored from 0 to 4, with higher numbers indicating more severe panic symptoms).~Mean (Standard Deviation)"|units on a scale|Mean|14.8|14.8|Standard Deviation|3.6|3.6|||
4256563|NCT00619892|4080744|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4256564|NCT00619892|4080745|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4256565|NCT00619892|4080746|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4256566|NCT00619892|4080744|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4256567|NCT00619892|4080745|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4256568|NCT00619892|4080746|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4256569|NCT00619892|4080744|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4256570|NCT00619892|4080745|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4256571|NCT00619892|4080746|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4256572|NCT00619892|4080744|B3|||Age||years|Mean|35.5|35.5|Standard Deviation|13.2|13.2|||
4256573|NCT00619892|4080745|B2|||Age||years|Mean|35.5|35.5|Standard Deviation|16.8|16.8|||
4256574|NCT00619892|4080746|B1|||Age||years|Mean|35.5|35.5|Standard Deviation|9.6|9.6|||
4256576|NCT00619892|4080745|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4256577|NCT00619892|4080746|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4256578|NCT00619892|4080744|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4256579|NCT00619892|4080745|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4256580|NCT00619892|4080746|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4256581|NCT00619892|4080744|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4256582|NCT00619892|4080745|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4256583|NCT00619892|4080746|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4256584|NCT00619866|4080755|B4||Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4256585|NCT00619866|4080756|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4256586|NCT00619866|4080757|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4256587|NCT00619866|4080758|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4256588|NCT00619866|4080755|B4||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4256589|NCT00619866|4080756|B3||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4256590|NCT00619866|4080757|B2||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4256591|NCT00619866|4080758|B1||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4256592|NCT00619866|4080755|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|126|126.0||||||
4256593|NCT00619866|4080756|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
4256594|NCT00619866|4080757|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
4256595|NCT00619866|4080758|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
4256596|NCT00619866|4080755|B4||Black|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4256597|NCT00619866|4080756|B3||Black|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4256598|NCT00619866|4080757|B2||Black|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4256599|NCT00619866|4080758|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4256600|NCT00619866|4080755|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4256601|NCT00619866|4080756|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4256602|NCT00619866|4080757|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4256603|NCT00619866|4080758|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4256604|NCT00619866|4080755|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4256605|NCT00619866|4080756|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4256606|NCT00619866|4080757|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4256607|NCT00619866|4080758|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4256608|NCT00619866|4080755|B4||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4256609|NCT00619866|4080756|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4256610|NCT00619866|4080757|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4256611|NCT00619866|4080758|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4256612|NCT00619866|4080755|B4|||Age||years|Mean|31.0|31.0|Standard Deviation|0.5|0.5|||
4256613|NCT00619866|4080756|B3|||Age||years|Mean|31.0|31.0|Standard Deviation|1.0|1.0|||
4256614|NCT00619866|4080757|B2|||Age||years|Mean|30.9|30.9|Standard Deviation|1.0|1.0|||
4256615|NCT00619866|4080758|B1|||Age||years|Mean|31.2|31.2|Standard Deviation|1.0|1.0|||
4256616|NCT00619827|4080847|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4256617|NCT00619827|4080848|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4256618|NCT00619827|4080849|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4256619|NCT00619827|4080847|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4256620|NCT00619827|4080848|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4256621|NCT00619827|4080849|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4256622|NCT00619827|4080847|B3|||Age||years|Mean|27.29|27.29|Standard Deviation|6.175|6.175|||
4256623|NCT00619827|4080848|B2|||Age||years|Mean|27.12|27.12|Standard Deviation|5.807|5.807|||
4256624|NCT00619827|4080849|B1|||Age||years|Mean|27.46|27.46|Standard Deviation|6.577|6.577|||
4256625|NCT00619801|4080856|B3|United States||Region of Enrollment||participants|Number|173|173.0||||||
4256626|NCT00619801|4080857|B2|United States||Region of Enrollment||participants|Number|114|114.0||||||
4256627|NCT00619801|4080858|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
4256628|NCT00619801|4080856|B3||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4256629|NCT00619801|4080857|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4256630|NCT00619801|4080858|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4256631|NCT00619801|4080856|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4256632|NCT00619801|4080857|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4256633|NCT00619801|4080858|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4256634|NCT00619801|4080856|B3|||Age||years|Mean|3.77|3.77|Standard Deviation|1.40|1.4|||
4256635|NCT00619801|4080857|B2|||Age||years|Mean|3.78|3.78|Standard Deviation|1.38|1.38|||
4256636|NCT00619801|4080858|B1|||Age||years|Mean|3.75|3.75|Standard Deviation|1.45|1.45|||
4256637|NCT00619801|4080856|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4256638|NCT00619801|4080857|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4256639|NCT00619801|4080858|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4256640|NCT00619801|4080856|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4256641|NCT00619801|4080857|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4256642|NCT00619801|4080858|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4256643|NCT00619801|4080856|B3||<=18 years|Age||Participants|Count of Participants|173|173.0||||||
4256644|NCT00619801|4080857|B2||<=18 years|Age||Participants|Count of Participants|114|114.0||||||
4256645|NCT00619801|4080858|B1||<=18 years|Age||Participants|Count of Participants|59|59.0||||||
4256646|NCT00619762|4080889|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4256647|NCT00619762|4080889|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4256648|NCT00619762|4080889|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4256649|NCT00619762|4080889|B1|||Age||years|Mean|49|49.0|Standard Deviation|10.6|10.6|||
4256650|NCT00619762|4080889|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4256651|NCT00619762|4080889|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4256652|NCT00619762|4080889|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4256653|NCT00619723|4080894|B3|United States||Region of Enrollment||participants|Number|130|130.0||||||
4256654|NCT00619723|4080895|B2|United States||Region of Enrollment||participants|Number|67|67.0||||||
4256655|NCT00619723|4080896|B1|United States||Region of Enrollment||participants|Number|63|63.0||||||
4256656|NCT00619723|4080894|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4256657|NCT00619723|4080895|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4256658|NCT00619723|4080896|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4256659|NCT00619723|4080894|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4256660|NCT00619723|4080895|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4256661|NCT00619723|4080896|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4256662|NCT00619723|4080894|B3|||Age||years|Mean|42.4|42.4|Standard Deviation|8.7|8.7|||
4256663|NCT00619723|4080895|B2|||Age||years|Mean|43.6|43.6|Standard Deviation|8.3|8.3|||
4256664|NCT00619723|4080896|B1|||Age||years|Mean|41.1|41.1|Standard Deviation|9.1|9.1|||
4256665|NCT00619723|4080894|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4256666|NCT00619723|4080895|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4256667|NCT00619723|4080896|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4256668|NCT00619723|4080894|B3||Between 18 and 65 years|Age||Participants|Count of Participants|130|130.0||||||
4256669|NCT00619723|4080895|B2||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
4256670|NCT00619723|4080896|B1||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4256671|NCT00619723|4080894|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4256672|NCT00619723|4080895|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4256673|NCT00619723|4080896|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4256674|NCT00619684|4080907|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256675|NCT00619684|4080907|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256676|NCT00619684|4080907|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4256677|NCT00619684|4080907|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4256678|NCT00619684|4080907|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256679|NCT00619684|4080907|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256680|NCT00619684|4080907|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256681|NCT00619684|4080907|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256682|NCT00619684|4080907|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4256683|NCT00619684|4080907|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256684|NCT00619684|4080907|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4256685|NCT00619684|4080907|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4256686|NCT00619684|4080907|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4256687|NCT00619684|4080907|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4256688|NCT00619684|4080907|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4256689|NCT00619645|4080916|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256690|NCT00619645|4080916|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256691|NCT00619645|4080916|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4256692|NCT00619645|4080916|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256693|NCT00619645|4080916|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4256694|NCT00619645|4080916|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256695|NCT00619645|4080916|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256696|NCT00619645|4080916|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256697|NCT00619645|4080916|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4256698|NCT00619645|4080916|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256699|NCT00619645|4080916|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4256700|NCT00619645|4080916|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4256701|NCT00619645|4080916|B1|||Age||years|Mean|59.4|59.4|Full Range|||53.7|67.0|
4256702|NCT00619645|4080916|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4256703|NCT00619645|4080916|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4256704|NCT00619645|4080916|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4256705|NCT00619619|4080922|B9|||Children's Depression Ratings Scale-Revised (CDRS-R) total score|CDRS-R total score: scale measures 17 depressive symptoms, of which 3 are rated 1 to 5 and 14 are rated 1 to 7 (1 = no symptom difficulties; 5 or 7 = severe clinically significant difficulties) for a total score range of 17 to 113. Lower total scores indicate lower intensity of symptoms.|scores on a scale|Mean|54.17|54.17|Standard Deviation|8.78|8.78|||
4256706|NCT00619619|4080923|B8|||Children's Depression Ratings Scale-Revised (CDRS-R) total score|CDRS-R total score: scale measures 17 depressive symptoms, of which 3 are rated 1 to 5 and 14 are rated 1 to 7 (1 = no symptom difficulties; 5 or 7 = severe clinically significant difficulties) for a total score range of 17 to 113. Lower total scores indicate lower intensity of symptoms.|scores on a scale|Mean|48.63|48.63|Standard Deviation|6.25|6.25|||
4256707|NCT00619619|4080924|B7|||Children's Depression Ratings Scale-Revised (CDRS-R) total score|CDRS-R total score: scale measures 17 depressive symptoms, of which 3 are rated 1 to 5 and 14 are rated 1 to 7 (1 = no symptom difficulties; 5 or 7 = severe clinically significant difficulties) for a total score range of 17 to 113. Lower total scores indicate lower intensity of symptoms.|scores on a scale|Mean|57.88|57.88|Standard Deviation|9.19|9.19|||
4256708|NCT00619619|4080925|B6|||Children's Depression Ratings Scale-Revised (CDRS-R) total score|CDRS-R total score: scale measures 17 depressive symptoms, of which 3 are rated 1 to 5 and 14 are rated 1 to 7 (1 = no symptom difficulties; 5 or 7 = severe clinically significant difficulties) for a total score range of 17 to 113. Lower total scores indicate lower intensity of symptoms.|scores on a scale|Mean|57.71|57.71|Standard Deviation|1.98|1.98|||
4256709|NCT00619619|4080926|B5|||Children's Depression Ratings Scale-Revised (CDRS-R) total score|CDRS-R total score: scale measures 17 depressive symptoms, of which 3 are rated 1 to 5 and 14 are rated 1 to 7 (1 = no symptom difficulties; 5 or 7 = severe clinically significant difficulties) for a total score range of 17 to 113. Lower total scores indicate lower intensity of symptoms.|scores on a scale|Mean|64.86|64.86|Standard Deviation|11.87|11.87|||
4256710|NCT00619619|4080927|B4|||Children's Depression Ratings Scale-Revised (CDRS-R) total score|CDRS-R total score: scale measures 17 depressive symptoms, of which 3 are rated 1 to 5 and 14 are rated 1 to 7 (1 = no symptom difficulties; 5 or 7 = severe clinically significant difficulties) for a total score range of 17 to 113. Lower total scores indicate lower intensity of symptoms.|scores on a scale|Mean|46.43|46.43|Standard Deviation|4.35|4.35|||
4256711|NCT00619619|4080928|B3|||Children's Depression Ratings Scale-Revised (CDRS-R) total score|CDRS-R total score: scale measures 17 depressive symptoms, of which 3 are rated 1 to 5 and 14 are rated 1 to 7 (1 = no symptom difficulties; 5 or 7 = severe clinically significant difficulties) for a total score range of 17 to 113. Lower total scores indicate lower intensity of symptoms.|scores on a scale|Mean|49.89|49.89|Standard Deviation|7.30|7.3|||
4256712|NCT00619619|4080929|B2|||Children's Depression Ratings Scale-Revised (CDRS-R) total score|CDRS-R total score: scale measures 17 depressive symptoms, of which 3 are rated 1 to 5 and 14 are rated 1 to 7 (1 = no symptom difficulties; 5 or 7 = severe clinically significant difficulties) for a total score range of 17 to 113. Lower total scores indicate lower intensity of symptoms.|scores on a scale|Mean|52.43|52.43|Standard Deviation|5.13|5.13|||
4256713|NCT00619619|4080930|B1|||Children's Depression Ratings Scale-Revised (CDRS-R) total score|CDRS-R total score: scale measures 17 depressive symptoms, of which 3 are rated 1 to 5 and 14 are rated 1 to 7 (1 = no symptom difficulties; 5 or 7 = severe clinically significant difficulties) for a total score range of 17 to 113. Lower total scores indicate lower intensity of symptoms.|scores on a scale|Mean|57.50|57.5|Standard Deviation|4.89|4.89|||
4256714|NCT00619619|4080922|B9||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4256715|NCT00619619|4080923|B8||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4256716|NCT00619619|4080924|B7||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4256717|NCT00619619|4080925|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4256718|NCT00619619|4080926|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4256719|NCT00619619|4080927|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4256720|NCT00619619|4080928|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4256721|NCT00619619|4080929|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4256722|NCT00619619|4080930|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4256723|NCT00619619|4080922|B9||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4256724|NCT00619619|4080923|B8||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4256725|NCT00619619|4080924|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4256726|NCT00619619|4080925|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4256727|NCT00619619|4080926|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4256728|NCT00619619|4080927|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4256729|NCT00619619|4080928|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4256730|NCT00619619|4080929|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4256731|NCT00619619|4080930|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4256732|NCT00619619|4080922|B9|||Age||years|Mean|11.86|11.86|Standard Deviation|2.71|2.71|||
4256733|NCT00619619|4080923|B8|||Age||years|Mean|14.00|14.0|Standard Deviation|1.60|1.6|||
4256734|NCT00619619|4080924|B7|||Age||years|Mean|14.25|14.25|Standard Deviation|1.67|1.67|||
4256735|NCT00619619|4080925|B6|||Age||years|Mean|13.14|13.14|Standard Deviation|1.46|1.46|||
4256736|NCT00619619|4080926|B5|||Age||years|Mean|15.00|15.0|Standard Deviation|1.83|1.83|||
4256737|NCT00619619|4080927|B4|||Age||years|Mean|9.71|9.71|Standard Deviation|0.95|0.95|||
4256738|NCT00619619|4080928|B3|||Age||years|Mean|9.89|9.89|Standard Deviation|1.27|1.27|||
4256739|NCT00619619|4080929|B2|||Age||years|Mean|9.57|9.57|Standard Deviation|1.13|1.13|||
4256740|NCT00619619|4080930|B1|||Age||years|Mean|8.83|8.83|Standard Deviation|1.33|1.33|||
4256741|NCT00619502|4081022|B3|Turkey||Region of Enrollment||Participants|Number|254|254.0||||||
4256742|NCT00619502|4081023|B2|Turkey||Region of Enrollment||Participants|Number|124|124.0||||||
4256743|NCT00619502|4081024|B1|Turkey||Region of Enrollment||Participants|Number|130|130.0||||||
4256744|NCT00619502|4081022|B3||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4256745|NCT00619502|4081023|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4256746|NCT00619502|4081024|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4256747|NCT00619502|4081022|B3||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4256748|NCT00619502|4081023|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4256749|NCT00619502|4081024|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4256750|NCT00619502|4081022|B3|||Age||Months|Mean|17.6|17.6|Standard Deviation|0.241|0.241|||
4256751|NCT00619502|4081023|B2|||Age||Months|Mean|17.6|17.6|Standard Deviation|0.279|0.279|||
4256752|NCT00619502|4081024|B1|||Age||Months|Mean|17.6|17.6|Standard Deviation|0.198|0.198|||
4256753|NCT00619502|4081022|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4256754|NCT00619502|4081023|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4256755|NCT00619502|4081024|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4256756|NCT00619502|4081022|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4256757|NCT00619502|4081023|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4256758|NCT00619502|4081024|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4256759|NCT00619502|4081022|B3||<=18 years|Age||Participants|Count of Participants|254|254.0||||||
4256760|NCT00619502|4081023|B2||<=18 years|Age||Participants|Count of Participants|124|124.0||||||
4256761|NCT00619502|4081024|B1||<=18 years|Age||Participants|Count of Participants|130|130.0||||||
4256762|NCT00619489|4081035|B3|Ulcerative Colitis||Inflammatory Bowel Disease Type||participants|Number|53|53.0||||||
4256763|NCT00619489|4081036|B2|Ulcerative Colitis||Inflammatory Bowel Disease Type||participants|Number|16|16.0||||||
4256764|NCT00619489|4081037|B1|Ulcerative Colitis||Inflammatory Bowel Disease Type||participants|Number|37|37.0||||||
4256765|NCT00619489|4081035|B3|Crohn’s Disease||Inflammatory Bowel Disease Type||participants|Number|19|19.0||||||
4256766|NCT00619489|4081036|B2|Crohn’s Disease||Inflammatory Bowel Disease Type||participants|Number|19|19.0||||||
4256767|NCT00619489|4081037|B1|Crohn’s Disease||Inflammatory Bowel Disease Type||participants|Number|0|0.0||||||
4256768|NCT00619489|4081035|B3|||Body Surface Area (BSA)||m^2|Mean|1.85|1.85|Standard Deviation|0.253|0.253|||
4256769|NCT00619489|4081036|B2|||Body Surface Area (BSA)||m^2|Mean|1.81|1.81|Standard Deviation|0.270|0.27|||
4256770|NCT00619489|4081037|B1|||Body Surface Area (BSA)||m^2|Mean|1.89|1.89|Standard Deviation|0.233|0.233|||
4256771|NCT00619489|4081035|B3|||Body Mass Index (BMI)||kg/m^2|Mean|25.98|25.98|Standard Deviation|5.754|5.754|||
4256772|NCT00619489|4081036|B2|||Body Mass Index (BMI)||kg/m^2|Mean|24.86|24.86|Standard Deviation|5.286|5.286|||
4256773|NCT00619489|4081037|B1|||Body Mass Index (BMI)||kg/m^2|Mean|27.04|27.04|Standard Deviation|6.045|6.045|||
4256774|NCT00619489|4081035|B3|||Weight||kg|Mean|74.01|74.01|Standard Deviation|17.868|17.868|||
4256775|NCT00619489|4081036|B2|||Weight||kg|Mean|70.81|70.81|Standard Deviation|17.820|17.82|||
4256776|NCT00619489|4081037|B1|||Weight||kg|Mean|77.03|77.03|Standard Deviation|17.620|17.62|||
4256777|NCT00619489|4081035|B3|||Height||cm|Mean|168.7|168.7|Standard Deviation|10.14|10.14|||
4256778|NCT00619489|4081036|B2|||Height||cm|Mean|168.4|168.4|Standard Deviation|11.49|11.49|||
4256779|NCT00619489|4081037|B1|||Height||cm|Mean|168.9|168.9|Standard Deviation|8.83|8.83|||
4256780|NCT00619489|4081035|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4256781|NCT00619489|4081036|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4256782|NCT00619489|4081037|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4256783|NCT00619489|4081035|B3|White||Race/Ethnicity, Customized||participants|Number|71|71.0||||||
4256784|NCT00619489|4081036|B2|White||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4256785|NCT00619489|4081037|B1|White||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4256786|NCT00619489|4081035|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4256787|NCT00619489|4081036|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4256788|NCT00619489|4081037|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256789|NCT00619489|4081035|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
4256790|NCT00619489|4081036|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4256791|NCT00619489|4081037|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4256792|NCT00619489|4081035|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256793|NCT00619489|4081036|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256794|NCT00619489|4081037|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256795|NCT00619489|4081035|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4256796|NCT00619489|4081036|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4256797|NCT00619489|4081037|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4256798|NCT00619489|4081035|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4256799|NCT00619489|4081036|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4256800|NCT00619489|4081037|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4256801|NCT00619489|4081035|B3|||Age||years|Mean|42.1|42.1|Standard Deviation|13.47|13.47|||
4256802|NCT00619489|4081036|B2|||Age||years|Mean|42.1|42.1|Standard Deviation|15.79|15.79|||
4256803|NCT00619489|4081037|B1|||Age||years|Mean|42.0|42.0|Standard Deviation|11.06|11.06|||
4256804|NCT00619476|4081056|B5|Not Provided||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|participants|Number|3|3.0||||||
4256805|NCT00619476|4081057|B4|Not Provided||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|participants|Number|0|0.0||||||
4256806|NCT00619476|4081058|B3|Not Provided||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|participants|Number|1|1.0||||||
4256807|NCT00619476|4081059|B2|Not Provided||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|participants|Number|1|1.0||||||
4256808|NCT00619476|4081060|B1|Not Provided||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|participants|Number|1|1.0||||||
4256809|NCT00619476|4081056|B5|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|participants|Number|1|1.0||||||
4256810|NCT00619476|4081057|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|participants|Number|1|1.0||||||
4256811|NCT00619476|4081058|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|participants|Number|0|0.0||||||
4256812|NCT00619476|4081059|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|participants|Number|0|0.0||||||
4256813|NCT00619476|4081060|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|participants|Number|0|0.0||||||
4256814|NCT00619476|4081056|B5|Asian - Japanese/ East Asian Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|participants|Number|3|3.0||||||
4256815|NCT00619476|4081057|B4|Asian - Japanese/ East Asian Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|participants|Number|1|1.0||||||
4256816|NCT00619476|4081058|B3|Asian - Japanese/ East Asian Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|participants|Number|1|1.0||||||
4256817|NCT00619476|4081059|B2|Asian - Japanese/ East Asian Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|participants|Number|1|1.0||||||
4256818|NCT00619476|4081060|B1|Asian - Japanese/ East Asian Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|participants|Number|0|0.0||||||
4256819|NCT00619476|4081056|B5|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|participants|Number|2|2.0||||||
4256820|NCT00619476|4081057|B4|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|participants|Number|0|0.0||||||
4256880|NCT00619359|4081165|B1|Not Applicable - Male Patients||History of Vomiting with Pregnancy|Measure is specific to female treated patients only.|Participants|Number|722|722.0||||||
4256821|NCT00619476|4081058|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|participants|Number|1|1.0||||||
4256822|NCT00619476|4081059|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|participants|Number|0|0.0||||||
4256823|NCT00619476|4081060|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|participants|Number|1|1.0||||||
4256824|NCT00619476|4081056|B5|American Indian or Alaskan Native||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|participants|Number|3|3.0||||||
4256825|NCT00619476|4081057|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|participants|Number|1|1.0||||||
4256826|NCT00619476|4081058|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|participants|Number|2|2.0||||||
4256827|NCT00619476|4081059|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|participants|Number|0|0.0||||||
4256828|NCT00619476|4081060|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|participants|Number|0|0.0||||||
4256829|NCT00619476|4081056|B5|African American/African Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|participants|Number|44|44.0||||||
4256830|NCT00619476|4081057|B4|African American/African Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|participants|Number|11|11.0||||||
4256831|NCT00619476|4081058|B3|African American/African Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|participants|Number|8|8.0||||||
4256832|NCT00619476|4081059|B2|African American/African Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|participants|Number|11|11.0||||||
4256833|NCT00619476|4081060|B1|African American/African Heritage||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|participants|Number|14|14.0||||||
4256834|NCT00619476|4081056|B5|White||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|participants|Number|315|315.0||||||
4256835|NCT00619476|4081057|B4|White||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|participants|Number|73|73.0||||||
4256836|NCT00619476|4081058|B3|White||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|participants|Number|69|69.0||||||
4256837|NCT00619476|4081059|B2|White||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|participants|Number|94|94.0||||||
4256838|NCT00619476|4081060|B1|White||Race/Ethnicity, Customized|Race of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|participants|Number|79|79.0||||||
4256839|NCT00619476|4081056|B5||Male|Sex: Female, Male|Gender of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|Participants|Count of Participants|189|189.0||||||
4256840|NCT00619476|4081057|B4||Male|Sex: Female, Male|Gender of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|Participants|Count of Participants|39|39.0||||||
4256841|NCT00619476|4081058|B3||Male|Sex: Female, Male|Gender of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|Participants|Count of Participants|47|47.0||||||
4256935|NCT00619307|4081176|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4256842|NCT00619476|4081059|B2||Male|Sex: Female, Male|Gender of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|Participants|Count of Participants|53|53.0||||||
4256843|NCT00619476|4081060|B1||Male|Sex: Female, Male|Gender of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|Participants|Count of Participants|50|50.0||||||
4256844|NCT00619476|4081056|B5||Female|Sex: Female, Male|Gender of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|Participants|Count of Participants|182|182.0||||||
4256845|NCT00619476|4081057|B4||Female|Sex: Female, Male|Gender of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|Participants|Count of Participants|48|48.0||||||
4256846|NCT00619476|4081058|B3||Female|Sex: Female, Male|Gender of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|Participants|Count of Participants|35|35.0||||||
4256847|NCT00619476|4081059|B2||Female|Sex: Female, Male|Gender of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|Participants|Count of Participants|54|54.0||||||
4256848|NCT00619476|4081060|B1||Female|Sex: Female, Male|Gender of the ITT Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|Participants|Count of Participants|45|45.0||||||
4256849|NCT00619476|4081056|B5|||Age|Age in years of the Intent-to-Treat (ITT) Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|Years|Mean|62.1|62.1|Standard Deviation|12.67|12.67|||
4256850|NCT00619476|4081057|B4|||Age|Age in years of the Intent-to-Treat (ITT) Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|Years|Mean|61.3|61.3|Standard Deviation|15.41|15.41|||
4256851|NCT00619476|4081058|B3|||Age|Age in years of the Intent-to-Treat (ITT) Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|Years|Mean|64.1|64.1|Standard Deviation|8.94|8.94|||
4256852|NCT00619476|4081059|B2|||Age|Age in years of the Intent-to-Treat (ITT) Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|Years|Mean|61.7|61.7|Standard Deviation|12.58|12.58|||
4256853|NCT00619476|4081060|B1|||Age|Age in years of the Intent-to-Treat (ITT) Population, comprised of all randomized participants who took at least one dose of investigational product and provided at least one post-baseline efficacy measurement, was used for all baseline characteristics.|Years|Mean|61.7|61.7|Standard Deviation|12.77|12.77|||
4256854|NCT00619385|4081145|B4|United States||Region of Enrollment||participants|Number|25|25.0||||||
4256855|NCT00619385|4081146|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4256856|NCT00619385|4081147|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4256857|NCT00619385|4081148|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4256858|NCT00619385|4081145|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4256859|NCT00619385|4081146|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4256860|NCT00619385|4081147|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4256861|NCT00619385|4081148|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4256862|NCT00619385|4081145|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4256863|NCT00619385|4081146|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4256864|NCT00619385|4081147|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4256865|NCT00619385|4081148|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4256866|NCT00619385|4081145|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4256867|NCT00619385|4081146|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4256868|NCT00619385|4081147|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4256869|NCT00619385|4081148|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4256870|NCT00619385|4081145|B4||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4256871|NCT00619385|4081146|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4256872|NCT00619385|4081147|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4256873|NCT00619385|4081148|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4256874|NCT00619385|4081145|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4256875|NCT00619385|4081146|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4256876|NCT00619385|4081147|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4256877|NCT00619385|4081148|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4256878|NCT00619359|4081163|B3|Not Applicable - Male Patients||History of Vomiting with Pregnancy|Measure is specific to female treated patients only.|Participants|Number|1470|1470.0||||||
4256879|NCT00619359|4081164|B2|Not Applicable - Male Patients||History of Vomiting with Pregnancy|Measure is specific to female treated patients only.|Participants|Number|748|748.0||||||
4256881|NCT00619359|4081163|B3|Female Patients with No Data - No Assessment||History of Vomiting with Pregnancy|Measure is specific to female treated patients only.|Participants|Number|5|5.0||||||
4256882|NCT00619359|4081164|B2|Female Patients with No Data - No Assessment||History of Vomiting with Pregnancy|Measure is specific to female treated patients only.|Participants|Number|3|3.0||||||
4256883|NCT00619359|4081165|B1|Female Patients with No Data - No Assessment||History of Vomiting with Pregnancy|Measure is specific to female treated patients only.|Participants|Number|2|2.0||||||
4256884|NCT00619359|4081163|B3|No||History of Vomiting with Pregnancy|Measure is specific to female treated patients only.|Participants|Number|841|841.0||||||
4256885|NCT00619359|4081164|B2|No||History of Vomiting with Pregnancy|Measure is specific to female treated patients only.|Participants|Number|421|421.0||||||
4256886|NCT00619359|4081165|B1|No||History of Vomiting with Pregnancy|Measure is specific to female treated patients only.|Participants|Number|420|420.0||||||
4256887|NCT00619359|4081163|B3|Yes||History of Vomiting with Pregnancy|Measure is specific to female treated patients only.|Participants|Number|6|6.0||||||
4256888|NCT00619359|4081164|B2|Yes||History of Vomiting with Pregnancy|Measure is specific to female treated patients only.|Participants|Number|3|3.0||||||
4256889|NCT00619359|4081165|B1|Yes||History of Vomiting with Pregnancy|Measure is specific to female treated patients only.|Participants|Number|3|3.0||||||
4256890|NCT00619359|4081163|B3|No Data - Assessment Not Completed||History of Motion Sickness|Includes treated patients only.|Participants|Number|10|10.0||||||
4256891|NCT00619359|4081164|B2|No Data - Assessment Not Completed||History of Motion Sickness|Includes treated patients only.|Participants|Number|6|6.0||||||
4256892|NCT00619359|4081165|B1|No Data - Assessment Not Completed||History of Motion Sickness|Includes treated patients only.|Participants|Number|4|4.0||||||
4256893|NCT00619359|4081163|B3|No||History of Motion Sickness|Includes treated patients only.|Participants|Number|2309|2309.0||||||
4256894|NCT00619359|4081164|B2|No||History of Motion Sickness|Includes treated patients only.|Participants|Number|1166|1166.0||||||
4256895|NCT00619359|4081165|B1|No||History of Motion Sickness|Includes treated patients only.|Participants|Number|1143|1143.0||||||
4256896|NCT00619359|4081163|B3|Yes||History of Motion Sickness|Includes treated patients only.|Participants|Number|3|3.0||||||
4256897|NCT00619359|4081164|B2|Yes||History of Motion Sickness|Includes treated patients only.|Participants|Number|3|3.0||||||
4256898|NCT00619359|4081165|B1|Yes||History of Motion Sickness|Includes treated patients only.|Participants|Number|0|0.0||||||
4256899|NCT00619359|4081163|B3|White||Race/Ethnicity, Customized||participants|Number|1303|1303.0||||||
4256900|NCT00619359|4081164|B2|White||Race/Ethnicity, Customized||participants|Number|655|655.0||||||
4256901|NCT00619359|4081165|B1|White||Race/Ethnicity, Customized||participants|Number|648|648.0||||||
4256902|NCT00619359|4081163|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4256903|NCT00619359|4081164|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4256904|NCT00619359|4081165|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4256905|NCT00619359|4081163|B3|Multi-Racial||Race/Ethnicity, Customized||participants|Number|306|306.0||||||
4256906|NCT00619359|4081164|B2|Multi-Racial||Race/Ethnicity, Customized||participants|Number|157|157.0||||||
4256907|NCT00619359|4081165|B1|Multi-Racial||Race/Ethnicity, Customized||participants|Number|149|149.0||||||
4256908|NCT00619359|4081163|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4256909|NCT00619359|4081164|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4256910|NCT00619359|4081165|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4256911|NCT00619359|4081163|B3|Asian||Race/Ethnicity, Customized||participants|Number|602|602.0||||||
4256912|NCT00619359|4081164|B2|Asian||Race/Ethnicity, Customized||participants|Number|306|306.0||||||
4256913|NCT00619359|4081165|B1|Asian||Race/Ethnicity, Customized||participants|Number|296|296.0||||||
4256914|NCT00619359|4081163|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
4256915|NCT00619359|4081164|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4256916|NCT00619359|4081165|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4256917|NCT00619359|4081163|B3||Male|Sex: Female, Male||Participants|Count of Participants|1470|1470.0||||||
4256918|NCT00619359|4081164|B2||Male|Sex: Female, Male||Participants|Count of Participants|748|748.0||||||
4256919|NCT00619359|4081165|B1||Male|Sex: Female, Male||Participants|Count of Participants|722|722.0||||||
4256920|NCT00619359|4081163|B3||Female|Sex: Female, Male||Participants|Count of Participants|852|852.0||||||
4256921|NCT00619359|4081164|B2||Female|Sex: Female, Male||Participants|Count of Participants|427|427.0||||||
4256922|NCT00619359|4081165|B1||Female|Sex: Female, Male||Participants|Count of Participants|425|425.0||||||
4256923|NCT00619359|4081163|B3|||Age||years|Mean|55.6|55.6|Full Range|||19.0|86.0|
4256924|NCT00619359|4081164|B2|||Age||years|Mean|55.9|55.9|Full Range|||19.0|82.0|
4256925|NCT00619359|4081165|B1|||Age||years|Mean|55.2|55.2|Full Range|||19.0|86.0|
4256926|NCT00619307|4081176|B3|Germany||Region of Enrollment||participants|Number|89|89.0||||||
4256927|NCT00619307|4081177|B2|Germany||Region of Enrollment||participants|Number|43|43.0||||||
4256928|NCT00619307|4081178|B1|Germany||Region of Enrollment||participants|Number|46|46.0||||||
4256929|NCT00619307|4081176|B3|France||Region of Enrollment||participants|Number|28|28.0||||||
4256930|NCT00619307|4081177|B2|France||Region of Enrollment||participants|Number|14|14.0||||||
4256931|NCT00619307|4081178|B1|France||Region of Enrollment||participants|Number|14|14.0||||||
4256932|NCT00619307|4081176|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4256933|NCT00619307|4081177|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4256934|NCT00619307|4081178|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4256936|NCT00619307|4081177|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4256937|NCT00619307|4081178|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4256938|NCT00619307|4081176|B3|||Age||years|Mean|41.6|41.6|Standard Deviation|8.6|8.6|||
4256939|NCT00619307|4081177|B2|||Age||years|Mean|41.5|41.5|Standard Deviation|8.9|8.9|||
4256940|NCT00619307|4081178|B1|||Age||years|Mean|41.7|41.7|Standard Deviation|8.4|8.4|||
4256941|NCT00619307|4081176|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4256942|NCT00619307|4081177|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4256943|NCT00619307|4081178|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4256944|NCT00619307|4081176|B3||Between 18 and 65 years|Age||Participants|Count of Participants|117|117.0||||||
4256945|NCT00619307|4081177|B2||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4256946|NCT00619307|4081178|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4256947|NCT00619307|4081176|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4256948|NCT00619307|4081177|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4256949|NCT00619307|4081178|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4256950|NCT00619255|4081193|B3|United States||Region of Enrollment||Participants|Count of Participants|120|120.0||||||
4256951|NCT00619255|4081194|B2|United States||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
4256952|NCT00619255|4081195|B1|United States||Region of Enrollment||Participants|Count of Participants|59|59.0||||||
4256953|NCT00619255|4081193|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4256954|NCT00619255|4081194|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256955|NCT00619255|4081195|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4256956|NCT00619255|4081193|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4256957|NCT00619255|4081194|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4256958|NCT00619255|4081195|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4256959|NCT00619255|4081193|B3||White|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
4256960|NCT00619255|4081194|B2||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4256961|NCT00619255|4081195|B1||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4256962|NCT00619255|4081193|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4256963|NCT00619255|4081194|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4256964|NCT00619255|4081195|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4256965|NCT00619255|4081193|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256966|NCT00619255|4081194|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256967|NCT00619255|4081195|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256968|NCT00619255|4081193|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4256969|NCT00619255|4081194|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4256970|NCT00619255|4081195|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4256971|NCT00619255|4081193|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4256972|NCT00619255|4081194|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4256973|NCT00619255|4081195|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4256974|NCT00619255|4081193|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4256975|NCT00619255|4081194|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4256976|NCT00619255|4081195|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4256977|NCT00619255|4081193|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
4256978|NCT00619255|4081194|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4256979|NCT00619255|4081195|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4256980|NCT00619255|4081193|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4256981|NCT00619255|4081194|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4256982|NCT00619255|4081195|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4256983|NCT00619255|4081193|B3||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4256984|NCT00619255|4081194|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4256985|NCT00619255|4081195|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4256986|NCT00619255|4081193|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4256987|NCT00619255|4081194|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4256988|NCT00619255|4081195|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4256989|NCT00619255|4081193|B3|||Age||years|Mean|15.5|15.5|Standard Deviation|1.9|1.9|||
4256990|NCT00619255|4081194|B2|||Age||years|Mean|15.4|15.4|Standard Deviation|1.9|1.9|||
4256991|NCT00619255|4081195|B1|||Age||years|Mean|15.6|15.6|Standard Deviation|1.9|1.9|||
4256992|NCT00619242|4081210|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4256993|NCT00619242|4081210|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4256994|NCT00619242|4081210|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4256995|NCT00619242|4081210|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4256996|NCT00619242|4081210|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4256997|NCT00619242|4081210|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4256998|NCT00619229|4081214|B3|||Body Mass Index (BMI)||kg/ (m^2)|Mean|26.45|26.45|Standard Deviation|3.31|3.31|||
4256999|NCT00619229|4081215|B2|||Body Mass Index (BMI)||kg/ (m^2)|Mean|26.70|26.7|Standard Deviation|3.32|3.32|||
4257000|NCT00619229|4081216|B1|||Body Mass Index (BMI)||kg/ (m^2)|Mean|26.20|26.2|Standard Deviation|3.38|3.38|||
4257001|NCT00619229|4081214|B3|||Height (cm)||centimeter (cm)|Mean|169.79|169.79|Standard Deviation|8.93|8.93|||
4257002|NCT00619229|4081215|B2|||Height (cm)||centimeter (cm)|Mean|168.59|168.59|Standard Deviation|8.69|8.69|||
4257003|NCT00619229|4081216|B1|||Height (cm)||centimeter (cm)|Mean|171.06|171.06|Standard Deviation|9.29|9.29|||
4257004|NCT00619229|4081214|B3|||Weight||kilogramm (kg)|Mean|76.79|76.79|Standard Deviation|14.37|14.37|||
4257005|NCT00619229|4081215|B2|||Weight||kilogramm (kg)|Mean|76.46|76.46|Standard Deviation|14.49|14.49|||
4257006|NCT00619229|4081216|B1|||Weight||kilogramm (kg)|Mean|77.14|77.14|Standard Deviation|14.71|14.71|||
4257007|NCT00619229|4081214|B3|||White||participants|Number|33|33.0||||||
4257008|NCT00619229|4081215|B2|||White||participants|Number|17|17.0||||||
4257009|NCT00619229|4081216|B1|||White||participants|Number|16|16.0||||||
4257010|NCT00619229|4081214|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4257011|NCT00619229|4081215|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4257012|NCT00619229|4081216|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4257013|NCT00619229|4081214|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4257014|NCT00619229|4081215|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4257015|NCT00619229|4081216|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4257016|NCT00619229|4081214|B3|||Age||years|Mean|73.8|73.8|Standard Deviation|8.5|8.5|||
4257017|NCT00619229|4081215|B2|||Age||years|Mean|71.7|71.7|Standard Deviation|8.1|8.1|||
4257018|NCT00619229|4081216|B1|||Age||years|Mean|76.1|76.1|Standard Deviation|8.5|8.5|||
4257019|NCT00619229|4081214|B3||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4257020|NCT00619229|4081215|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4257021|NCT00619229|4081216|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4257022|NCT00619229|4081214|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4257023|NCT00619229|4081215|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4257024|NCT00619229|4081216|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4257025|NCT00619229|4081214|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4257026|NCT00619229|4081215|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4257027|NCT00619229|4081216|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4257028|NCT00619190|4081243|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4257029|NCT00619190|4081244|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4257030|NCT00619190|4081245|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4257031|NCT00619190|4081243|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4257032|NCT00619190|4081244|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4257033|NCT00619190|4081245|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4257034|NCT00619190|4081243|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4257035|NCT00619190|4081244|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4257036|NCT00619190|4081245|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4257037|NCT00619190|4081243|B3|||Age||years|Mean|9.542|9.542|Standard Deviation|4.272|4.272|||
4257038|NCT00619190|4081244|B2|||Age||years|Mean|11.11|11.11|Standard Deviation|4.5|4.5|||
4257039|NCT00619190|4081245|B1|||Age||years|Mean|8.269|8.269|Standard Deviation|3.75|3.75|||
4257040|NCT00619190|4081243|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4257041|NCT00619190|4081244|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4257042|NCT00619190|4081245|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4257043|NCT00619190|4081243|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4257044|NCT00619190|4081244|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4257045|NCT00619190|4081245|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4257046|NCT00619190|4081243|B3||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4257047|NCT00619190|4081244|B2||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4257048|NCT00619190|4081245|B1||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
4257049|NCT00619177|4081256|B1|Missing||Sex/Gender, Customized||participants|Number|47|47.0||||||
4257050|NCT00619177|4081256|B1|Male||Sex/Gender, Customized||participants|Number|1167|1167.0||||||
4257051|NCT00619177|4081256|B1|Female||Sex/Gender, Customized||participants|Number|2355|2355.0||||||
4257052|NCT00619177|4081256|B1|||Age||years|Mean|57|57.0|Standard Deviation|13.8|13.8|||
4257053|NCT00619151|4081264|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4257054|NCT00619151|4081266|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4257055|NCT00619151|4081266|B1|Male||Sex/Gender, Customized||participants|Number|NA|||||||Study records archived and not accessible.
4257056|NCT00619151|4081266|B1|Female||Sex/Gender, Customized||participants|Number|NA|||||||Previous values entered in error. Study records archived and not accessible.
4257057|NCT00619151|4081264|B3|Unknown||Sex/Gender, Customized||participants|Number|2|2.0||||||
4257058|NCT00619151|4081266|B1|Unknown||Sex/Gender, Customized||participants|Number|2|2.0||||||
4257059|NCT00619151|4081264|B3|>= 18 years||Age, Customized||participants|Number|2|2.0||||||
4257060|NCT00619151|4081266|B1|>= 18 years||Age, Customized||participants|Number|2|2.0||||||
4257061|NCT00619151|4081264|B3|<18 years||Age, Customized||participants|Number|0|0.0||||||
4257062|NCT00619151|4081266|B1|<18 years||Age, Customized||participants|Number|0|0.0||||||
4257063|NCT00619112|4081275|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4257064|NCT00619112|4081276|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4257065|NCT00619112|4081277|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4257066|NCT00619112|4081275|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4257067|NCT00619112|4081276|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4257068|NCT00619112|4081277|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4257069|NCT00619112|4081275|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4257070|NCT00619112|4081276|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4257071|NCT00619112|4081277|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4257072|NCT00619112|4081275|B3|||Age||years|Median|53|53.0|Full Range|||27.0|70.0|
4257073|NCT00619112|4081276|B2|||Age||years|Median|48|48.0|Full Range|||27.0|70.0|
4257074|NCT00619112|4081277|B1|||Age||years|Median|55|55.0|Full Range|||30.0|68.0|
4257075|NCT00619099|4081297|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4257076|NCT00619099|4081298|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4257077|NCT00619099|4081299|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4257078|NCT00619099|4081297|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4257079|NCT00619099|4081298|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4257080|NCT00619099|4081299|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4257081|NCT00619099|4081297|B3||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4257082|NCT00619099|4081298|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4257083|NCT00619099|4081299|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4257084|NCT00619099|4081297|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4257085|NCT00619099|4081298|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4257086|NCT00619099|4081299|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4257087|NCT00619099|4081297|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4257088|NCT00619099|4081298|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4257089|NCT00619099|4081299|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4257090|NCT00619099|4081297|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4257091|NCT00619099|4081298|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4257092|NCT00619099|4081299|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4257093|NCT00619099|4081297|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4257094|NCT00619099|4081298|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4257095|NCT00619099|4081299|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4257096|NCT00619099|4081297|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4257097|NCT00619099|4081298|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4257098|NCT00619099|4081299|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4257099|NCT00619099|4081297|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4257100|NCT00619099|4081298|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4257101|NCT00619099|4081299|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4257102|NCT00619099|4081297|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4257103|NCT00619099|4081298|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4257104|NCT00619099|4081299|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4257105|NCT00619099|4081297|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4257106|NCT00619099|4081298|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4257107|NCT00619099|4081299|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4257108|NCT00619099|4081297|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4257109|NCT00619099|4081298|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4257110|NCT00619099|4081299|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4257111|NCT00619099|4081297|B3|||Age||years|Mean|68.2|68.2|Standard Deviation|13.07|13.07|||
4257112|NCT00619099|4081298|B2|||Age||years|Mean|70.5|70.5|Standard Deviation|9.86|9.86|||
4257113|NCT00619099|4081299|B1|||Age||years|Mean|66.9|66.9|Standard Deviation|14.39|14.39|||
4257114|NCT00619073|4081306|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4257115|NCT00619073|4081306|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4257116|NCT00619073|4081306|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4257117|NCT00619073|4081306|B1|Between 18 and 65 years||Age, Customized||participants|Number|15|15.0||||||
4257118|NCT00619060|4081313|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4257119|NCT00619060|4081313|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4257120|NCT00619060|4081313|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4257121|NCT00619060|4081313|B1|||Age||years|Mean|50|50.0|Standard Deviation|12|12.0|||
4257122|NCT00619060|4081313|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4257123|NCT00619060|4081313|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4257124|NCT00619060|4081313|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4257125|NCT00618995|4081322|B1|||urinary PGI2-Metabolite|urinary levels of 2,3-dinor 6-keto-PGF1a (Prostaglandin I-M) 24 hour collection|pg/mg creatinine|Median|167.5|167.5|Full Range|||79.4|356.0|
4257126|NCT00618995|4081322|B1|||urinary 11-dTxB2|urinary levels of 11-dehydrothromboxane B2 (24-hour collection)|pg/mg creatinine|Median|639.1|639.1|Full Range|||304.5|1045.6|
4257127|NCT00618995|4081322|B1|||Weight||kg|Mean|85.9|85.9|Full Range|||55.0|127.2|
4257128|NCT00618995|4081322|B1|||Height||cm|Mean|163.9|163.9|Full Range|||150.0|181.5|
4257129|NCT00618995|4081322|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4257130|NCT00618995|4081322|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4257131|NCT00618995|4081322|B1|||Age||years|Mean|55.3|55.3|Standard Deviation|6.7|6.7|||
4257132|NCT00618982|4081339|B1|Stage IV||Stage at study entry|Categorized information on tumor size, lymph node involvement and metastases. Stages I-IV. The higher the stage, the more advanced cancer.|participants|Number|82|82.0||||||
4257133|NCT00618982|4081339|B1|Stage III||Stage at study entry|Categorized information on tumor size, lymph node involvement and metastases. Stages I-IV. The higher the stage, the more advanced cancer.|participants|Number|1|1.0||||||
4257134|NCT00618982|4081339|B1|1||ECOG (Eastern Cooperative Oncology Group) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst). Status 0 = fully active; Status 1 = restricted strenuous activity, ambulatory and able to carry out work of a light or sedentary nature|participants|Number|34|34.0||||||
4257135|NCT00618982|4081339|B1|0||ECOG (Eastern Cooperative Oncology Group) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects the daily life of a patient on an ordinal scale from grade 0 (best) to grade 5 (worst). Status 0 = fully active; Status 1 = restricted strenuous activity, ambulatory and able to carry out work of a light or sedentary nature|participants|Number|49|49.0||||||
4257136|NCT00618982|4081339|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4257137|NCT00618982|4081339|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4257138|NCT00618982|4081339|B1|||Age||years|Median|61|61.0|Full Range|||33.0|80.0|
4257139|NCT00618956|4081360|B3|United States||Region of Enrollment||participants|Number|321|321.0||||||
4257140|NCT00618956|4081361|B2|United States||Region of Enrollment||participants|Number|210|210.0||||||
4257141|NCT00618956|4081362|B1|United States||Region of Enrollment||participants|Number|111|111.0||||||
4257142|NCT00618956|4081360|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4257143|NCT00618956|4081361|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4257144|NCT00618956|4081362|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4257145|NCT00618956|4081360|B3||Female|Sex: Female, Male||Participants|Count of Participants|307|307.0||||||
4257146|NCT00618956|4081361|B2||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4257147|NCT00618956|4081362|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4257148|NCT00618956|4081360|B3|>= 60 years||Age, Customized||participants|Number|53|53.0||||||
4257149|NCT00618956|4081361|B2|>= 60 years||Age, Customized||participants|Number|34|34.0||||||
4257150|NCT00618956|4081362|B1|>= 60 years||Age, Customized||participants|Number|19|19.0||||||
4257151|NCT00618956|4081360|B3|20-59 years||Age, Customized||participants|Number|265|265.0||||||
4257152|NCT00618956|4081361|B2|20-59 years||Age, Customized||participants|Number|174|174.0||||||
4257153|NCT00618956|4081362|B1|20-59 years||Age, Customized||participants|Number|91|91.0||||||
4257154|NCT00618956|4081360|B3|< 20 years||Age, Customized||participants|Number|3|3.0||||||
4257155|NCT00618956|4081361|B2|< 20 years||Age, Customized||participants|Number|2|2.0||||||
4257156|NCT00618956|4081362|B1|< 20 years||Age, Customized||participants|Number|1|1.0||||||
4257157|NCT00618956|4081360|B3|||Age||years|Mean|48.5|48.5|Standard Deviation|11.0|11.0|||
4257158|NCT00618956|4081361|B2|||Age||years|Mean|48.3|48.3|Standard Deviation|10.9|10.9|||
4257159|NCT00618956|4081362|B1|||Age||years|Mean|48.9|48.9|Standard Deviation|11.1|11.1|||
4257160|NCT00618839|4081379|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4257161|NCT00618839|4081379|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4257162|NCT00618839|4081379|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4257163|NCT00618839|4081379|B1|||Age||years|Mean|43.4|43.4|Standard Deviation|14.7|14.7|||
4257164|NCT00618839|4081379|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4257165|NCT00618839|4081379|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4257166|NCT00618839|4081379|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4257167|NCT00618826|4081388|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4257168|NCT00618826|4081388|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4257169|NCT00618826|4081388|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4257170|NCT00618826|4081388|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4257171|NCT00618826|4081388|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4257172|NCT00618826|4081388|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4257173|NCT00618826|4081388|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4257174|NCT00618826|4081388|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4257175|NCT00618826|4081388|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4257176|NCT00618826|4081388|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4257177|NCT00618826|4081388|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4257178|NCT00618826|4081388|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4257179|NCT00618826|4081388|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4257180|NCT00618826|4081388|B1|||Age||years|Median|53.5|53.5|Full Range|||34.0|74.0|
4257181|NCT00618813|4081393|B1|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4257182|NCT00618813|4081393|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4257183|NCT00618813|4081393|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4257184|NCT00618813|4081393|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4257185|NCT00618813|4081393|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4257186|NCT00618813|4081393|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4257187|NCT00618813|4081393|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4257188|NCT00618813|4081393|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4257189|NCT00618813|4081393|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4257190|NCT00618813|4081393|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4257191|NCT00618813|4081393|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4257192|NCT00618813|4081393|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4257193|NCT00618813|4081393|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4257194|NCT00618813|4081393|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4257195|NCT00618813|4081393|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4257196|NCT00618813|4081393|B1|||Age||years|Median|11|11.0|Full Range|||0.0|22.0|
4257197|NCT00618787|4081401|B3|Canada||Region of Enrollment||participants|Number|45|45.0||||||
4257198|NCT00618787|4081402|B2|Canada||Region of Enrollment||participants|Number|23|23.0||||||
4257199|NCT00618787|4081403|B1|Canada||Region of Enrollment||participants|Number|22|22.0||||||
4257200|NCT00618787|4081401|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4257201|NCT00618787|4081402|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4257202|NCT00618787|4081403|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4257203|NCT00618787|4081401|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4257204|NCT00618787|4081402|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4257205|NCT00618787|4081403|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4257206|NCT00618787|4081401|B3|||Age||years|Mean|55.8|55.8|Standard Deviation|13.13|13.13|||
4257207|NCT00618787|4081402|B2|||Age||years|Mean|55.1|55.1|Standard Deviation|11.01|11.01|||
4257208|NCT00618787|4081403|B1|||Age||years|Mean|56.4|56.4|Standard Deviation|15.28|15.28|||
4257209|NCT00618787|4081401|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4257210|NCT00618787|4081402|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4257211|NCT00618787|4081403|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4257212|NCT00618787|4081401|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4257213|NCT00618787|4081402|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4257214|NCT00618787|4081403|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4257215|NCT00618787|4081401|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4257216|NCT00618787|4081402|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4257217|NCT00618787|4081403|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4257218|NCT00618774|4081410|B3||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4257219|NCT00618774|4081411|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4257220|NCT00618774|4081412|B1||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4257221|NCT00618774|4081410|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4257222|NCT00618774|4081411|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4257223|NCT00618774|4081412|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4257224|NCT00618774|4081410|B3|||Age||Years|Mean|55.8|55.8|Standard Deviation|9|9.0|||
4257225|NCT00618774|4081411|B2|||Age||Years|Mean|51.1|51.1|Standard Deviation|8|8.0|||
4257226|NCT00618774|4081412|B1|||Age||Years|Mean|56.8|56.8|Standard Deviation|9|9.0|||
4257227|NCT00618748|4081443|B4|||CGI-BP - Overall|CGI-BP is a measure of illness severity especially adapted for bipolar illness. It allows rating of mania, depression, and overall illness. The Overall Illness score ranges from 1 (normal, not ill) to 7 (very seriously ill).|units on a scale|Mean|2.46|2.46|Standard Deviation|1.00|1.0|||
4257228|NCT00618748|4081444|B3|||CGI-BP - Overall|CGI-BP is a measure of illness severity especially adapted for bipolar illness. It allows rating of mania, depression, and overall illness. The Overall Illness score ranges from 1 (normal, not ill) to 7 (very seriously ill).|units on a scale|Mean|3.25|3.25|Standard Deviation|1.02|1.02|||
4257229|NCT00618748|4081445|B2|||CGI-BP - Overall|CGI-BP is a measure of illness severity especially adapted for bipolar illness. It allows rating of mania, depression, and overall illness. The Overall Illness score ranges from 1 (normal, not ill) to 7 (very seriously ill).|units on a scale|Mean|2.40|2.4|Standard Deviation|0.82|0.82|||
4257230|NCT00618748|4081446|B1|||CGI-BP - Overall|CGI-BP is a measure of illness severity especially adapted for bipolar illness. It allows rating of mania, depression, and overall illness. The Overall Illness score ranges from 1 (normal, not ill) to 7 (very seriously ill).|units on a scale|Mean|2.20|2.2|Standard Deviation|0.92|0.92|||
4257231|NCT00618748|4081443|B4|||CGI-BP - Depression|CGI-BP is a measure of illness severity especially adapted for bipolar illness. It allows rating of mania, depression, and overall illness. The Depression score ranges from 1 (normal, not ill) to 7 (very seriously ill).|units on a scale|Mean|2.55|2.55|Standard Deviation|1.08|1.08|||
4257232|NCT00618748|4081444|B3|||CGI-BP - Depression|CGI-BP is a measure of illness severity especially adapted for bipolar illness. It allows rating of mania, depression, and overall illness. The Depression score ranges from 1 (normal, not ill) to 7 (very seriously ill).|units on a scale|Mean|3.55|3.55|Standard Deviation|1.15|1.15|||
4257233|NCT00618748|4081445|B2|||CGI-BP - Depression|CGI-BP is a measure of illness severity especially adapted for bipolar illness. It allows rating of mania, depression, and overall illness. The Depression score ranges from 1 (normal, not ill) to 7 (very seriously ill).|units on a scale|Mean|2.48|2.48|Standard Deviation|0.82|0.82|||
4257234|NCT00618748|4081446|B1|||CGI-BP - Depression|CGI-BP is a measure of illness severity especially adapted for bipolar illness. It allows rating of mania, depression, and overall illness. The Depression score ranges from 1 (normal, not ill) to 7 (very seriously ill).|units on a scale|Mean|2.23|2.23|Standard Deviation|0.95|0.95|||
4257235|NCT00618748|4081443|B4|||Clinical Global Improvement- Bipolar (CGI-BP) - Mania|CGI-BP is a measure of illness severity especially adapted for bipolar illness. It allows rating of mania, depression, and overall illness. The Mania score ranges from 1 (normal, not ill) to 7 (very seriously ill).|units on a scale|Mean|1.05|1.05|Standard Deviation|0.26|0.26|||
4257236|NCT00618748|4081444|B3|||Clinical Global Improvement- Bipolar (CGI-BP) - Mania|CGI-BP is a measure of illness severity especially adapted for bipolar illness. It allows rating of mania, depression, and overall illness. The Mania score ranges from 1 (normal, not ill) to 7 (very seriously ill).|units on a scale|Mean|1.00|1.0|Standard Deviation|0.00|0.0|||
4257237|NCT00618748|4081445|B2|||Clinical Global Improvement- Bipolar (CGI-BP) - Mania|CGI-BP is a measure of illness severity especially adapted for bipolar illness. It allows rating of mania, depression, and overall illness. The Mania score ranges from 1 (normal, not ill) to 7 (very seriously ill).|units on a scale|Mean|1.00|1.0|Standard Deviation|0.00|0.0|||
4257238|NCT00618748|4081446|B1|||Clinical Global Improvement- Bipolar (CGI-BP) - Mania|CGI-BP is a measure of illness severity especially adapted for bipolar illness. It allows rating of mania, depression, and overall illness. The Mania score ranges from 1 (normal, not ill) to 7 (very seriously ill).|units on a scale|Mean|1.09|1.09|Standard Deviation|0.35|0.35|||
4257239|NCT00618748|4081443|B4|||Young Mania Rating Scale (YMRS) Total Score|The YMRS is an 11-item scale that measures the severity of manic episodes. Four items are rated on a scale from 0 (symptom not present) to 8 (symptom extremely severe). The remaining items are rated on a scale from 0 (symptom not present) to 4 (symptom extremely severe). The YMRS total score ranges from 0 to 60.|units on a scale|Mean|0.40|0.4|Standard Deviation|0.97|0.97|||
4257240|NCT00618748|4081444|B3|||Young Mania Rating Scale (YMRS) Total Score|The YMRS is an 11-item scale that measures the severity of manic episodes. Four items are rated on a scale from 0 (symptom not present) to 8 (symptom extremely severe). The remaining items are rated on a scale from 0 (symptom not present) to 4 (symptom extremely severe). The YMRS total score ranges from 0 to 60.|units on a scale|Mean|0.45|0.45|Standard Deviation|0.83|0.83|||
4257241|NCT00618748|4081445|B2|||Young Mania Rating Scale (YMRS) Total Score|The YMRS is an 11-item scale that measures the severity of manic episodes. Four items are rated on a scale from 0 (symptom not present) to 8 (symptom extremely severe). The remaining items are rated on a scale from 0 (symptom not present) to 4 (symptom extremely severe). The YMRS total score ranges from 0 to 60.|units on a scale|Mean|0.40|0.4|Standard Deviation|0.76|0.76|||
4257242|NCT00618748|4081446|B1|||Young Mania Rating Scale (YMRS) Total Score|The YMRS is an 11-item scale that measures the severity of manic episodes. Four items are rated on a scale from 0 (symptom not present) to 8 (symptom extremely severe). The remaining items are rated on a scale from 0 (symptom not present) to 4 (symptom extremely severe). The YMRS total score ranges from 0 to 60.|units on a scale|Mean|0.38|0.38|Standard Deviation|1.10|1.1|||
4257243|NCT00618748|4081443|B4|||Montgomery- Asberg Depression Rating Scale (MADRS) Total Score|The MADRS is a rating scale for severity of depressive mood symptoms. The MADRS has a 10-item checklist. Items are rated on a scale of 0-6, for a total score range of 0 (low severity of depressive symptoms) to 60 (high severity of depressive symptoms).|units on a scale|Mean|10.13|10.13|Standard Deviation|8.18|8.18|||
4257244|NCT00618748|4081444|B3|||Montgomery- Asberg Depression Rating Scale (MADRS) Total Score|The MADRS is a rating scale for severity of depressive mood symptoms. The MADRS has a 10-item checklist. Items are rated on a scale of 0-6, for a total score range of 0 (low severity of depressive symptoms) to 60 (high severity of depressive symptoms).|units on a scale|Mean|16.45|16.45|Standard Deviation|9.03|9.03|||
4257245|NCT00618748|4081445|B2|||Montgomery- Asberg Depression Rating Scale (MADRS) Total Score|The MADRS is a rating scale for severity of depressive mood symptoms. The MADRS has a 10-item checklist. Items are rated on a scale of 0-6, for a total score range of 0 (low severity of depressive symptoms) to 60 (high severity of depressive symptoms).|units on a scale|Mean|9.72|9.72|Standard Deviation|6.48|6.48|||
4257246|NCT00618748|4081446|B1|||Montgomery- Asberg Depression Rating Scale (MADRS) Total Score|The MADRS is a rating scale for severity of depressive mood symptoms. The MADRS has a 10-item checklist. Items are rated on a scale of 0-6, for a total score range of 0 (low severity of depressive symptoms) to 60 (high severity of depressive symptoms).|units on a scale|Mean|8.05|8.05|Standard Deviation|7.50|7.5|||
4257247|NCT00618748|4081443|B4|Japan||Region of Enrollment||participants|Number|101|101.0||||||
4257248|NCT00618748|4081444|B3|Japan||Region of Enrollment||participants|Number|20|20.0||||||
4257249|NCT00618748|4081445|B2|Japan||Region of Enrollment||participants|Number|25|25.0||||||
4257250|NCT00618748|4081446|B1|Japan||Region of Enrollment||participants|Number|56|56.0||||||
4257251|NCT00618748|4081443|B4|East Asian||Race/Ethnicity, Customized||participants|Number|101|101.0||||||
4257252|NCT00618748|4081444|B3|East Asian||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4257253|NCT00618748|4081445|B2|East Asian||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4257254|NCT00618748|4081446|B1|East Asian||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
4257255|NCT00618748|4081443|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4257256|NCT00618748|4081444|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4257257|NCT00618748|4081445|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4257258|NCT00618748|4081446|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4257259|NCT00618748|4081443|B4||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4257260|NCT00618748|4081444|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4257261|NCT00618748|4081445|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4257262|NCT00618748|4081446|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4257263|NCT00618748|4081443|B4|||Age||years|Mean|38.84|38.84|Standard Deviation|9.61|9.61|||
4257264|NCT00618748|4081444|B3|||Age||years|Mean|39.13|39.13|Standard Deviation|9.56|9.56|||
4257265|NCT00618748|4081445|B2|||Age||years|Mean|37.53|37.53|Standard Deviation|7.64|7.64|||
4257266|NCT00618748|4081446|B1|||Age||years|Mean|39.31|39.31|Standard Deviation|10.48|10.48|||
4257267|NCT00618722|4081489|B5|IV-VI||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|0|0.0||||||
4257268|NCT00618722|4081490|B4|IV-VI||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|0|0.0||||||
4257269|NCT00618722|4081491|B3|IV-VI||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|0|0.0||||||
4257270|NCT00618722|4081492|B2|IV-VI||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|0|0.0||||||
4257271|NCT00618722|4081493|B1|IV-VI||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|0|0.0||||||
4257272|NCT00618722|4081489|B5|I-III||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|84|84.0||||||
4257273|NCT00618722|4081490|B4|I-III||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|22|22.0||||||
4257274|NCT00618722|4081491|B3|I-III||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|22|22.0||||||
4257275|NCT00618722|4081492|B2|I-III||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|20|20.0||||||
4257276|NCT00618722|4081493|B1|I-III||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|20|20.0||||||
4257277|NCT00618722|4081489|B5|3||Submental Fat (SMF) Rating|"SMF Ratings:~0 = Absent submental convexity: No localized submental fat evident;~1 = Mild submental convexity: Minimal, localized submental fat;~2 = Moderate submental convexity: Prominent, localized submental fat;~3 = Severe submental convexity: Marked, localized submental fat;~4 = Extreme submental convexity."|participants|Number|33|33.0||||||
4257278|NCT00618722|4081490|B4|3||Submental Fat (SMF) Rating|"SMF Ratings:~0 = Absent submental convexity: No localized submental fat evident;~1 = Mild submental convexity: Minimal, localized submental fat;~2 = Moderate submental convexity: Prominent, localized submental fat;~3 = Severe submental convexity: Marked, localized submental fat;~4 = Extreme submental convexity."|participants|Number|9|9.0||||||
4257279|NCT00618722|4081491|B3|3||Submental Fat (SMF) Rating|"SMF Ratings:~0 = Absent submental convexity: No localized submental fat evident;~1 = Mild submental convexity: Minimal, localized submental fat;~2 = Moderate submental convexity: Prominent, localized submental fat;~3 = Severe submental convexity: Marked, localized submental fat;~4 = Extreme submental convexity."|participants|Number|9|9.0||||||
4257280|NCT00618722|4081492|B2|3||Submental Fat (SMF) Rating|"SMF Ratings:~0 = Absent submental convexity: No localized submental fat evident;~1 = Mild submental convexity: Minimal, localized submental fat;~2 = Moderate submental convexity: Prominent, localized submental fat;~3 = Severe submental convexity: Marked, localized submental fat;~4 = Extreme submental convexity."|participants|Number|8|8.0||||||
4257281|NCT00618722|4081493|B1|3||Submental Fat (SMF) Rating|"SMF Ratings:~0 = Absent submental convexity: No localized submental fat evident;~1 = Mild submental convexity: Minimal, localized submental fat;~2 = Moderate submental convexity: Prominent, localized submental fat;~3 = Severe submental convexity: Marked, localized submental fat;~4 = Extreme submental convexity."|participants|Number|7|7.0||||||
4257282|NCT00618722|4081489|B5|2||Submental Fat (SMF) Rating|"SMF Ratings:~0 = Absent submental convexity: No localized submental fat evident;~1 = Mild submental convexity: Minimal, localized submental fat;~2 = Moderate submental convexity: Prominent, localized submental fat;~3 = Severe submental convexity: Marked, localized submental fat;~4 = Extreme submental convexity."|participants|Number|51|51.0||||||
4257283|NCT00618722|4081490|B4|2||Submental Fat (SMF) Rating|"SMF Ratings:~0 = Absent submental convexity: No localized submental fat evident;~1 = Mild submental convexity: Minimal, localized submental fat;~2 = Moderate submental convexity: Prominent, localized submental fat;~3 = Severe submental convexity: Marked, localized submental fat;~4 = Extreme submental convexity."|participants|Number|13|13.0||||||
4257284|NCT00618722|4081491|B3|2||Submental Fat (SMF) Rating|"SMF Ratings:~0 = Absent submental convexity: No localized submental fat evident;~1 = Mild submental convexity: Minimal, localized submental fat;~2 = Moderate submental convexity: Prominent, localized submental fat;~3 = Severe submental convexity: Marked, localized submental fat;~4 = Extreme submental convexity."|participants|Number|13|13.0||||||
4257285|NCT00618722|4081492|B2|2||Submental Fat (SMF) Rating|"SMF Ratings:~0 = Absent submental convexity: No localized submental fat evident;~1 = Mild submental convexity: Minimal, localized submental fat;~2 = Moderate submental convexity: Prominent, localized submental fat;~3 = Severe submental convexity: Marked, localized submental fat;~4 = Extreme submental convexity."|participants|Number|12|12.0||||||
4257286|NCT00618722|4081493|B1|2||Submental Fat (SMF) Rating|"SMF Ratings:~0 = Absent submental convexity: No localized submental fat evident;~1 = Mild submental convexity: Minimal, localized submental fat;~2 = Moderate submental convexity: Prominent, localized submental fat;~3 = Severe submental convexity: Marked, localized submental fat;~4 = Extreme submental convexity."|participants|Number|13|13.0||||||
4257287|NCT00618722|4081489|B5|||Weight||kg|Mean|76.53|76.53|Standard Deviation|13.239|13.239|||
4257288|NCT00618722|4081490|B4|||Weight||kg|Mean|80.13|80.13|Standard Deviation|11.083|11.083|||
4257289|NCT00618722|4081491|B3|||Weight||kg|Mean|79.28|79.28|Standard Deviation|12.950|12.95|||
4257290|NCT00618722|4081492|B2|||Weight||kg|Mean|68.53|68.53|Standard Deviation|12.472|12.472|||
4257291|NCT00618722|4081493|B1|||Weight||kg|Mean|77.56|77.56|Standard Deviation|14.022|14.022|||
4257292|NCT00618722|4081489|B5|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4257293|NCT00618722|4081490|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4257294|NCT00618722|4081491|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4257295|NCT00618722|4081492|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4257296|NCT00618722|4081493|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4257297|NCT00618722|4081489|B5|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4257298|NCT00618722|4081490|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4257299|NCT00618722|4081491|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4257300|NCT00618722|4081492|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4257301|NCT00618722|4081493|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4257302|NCT00618722|4081489|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4257303|NCT00618722|4081490|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4257304|NCT00618722|4081491|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4257305|NCT00618722|4081492|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4257306|NCT00618722|4081493|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4257307|NCT00618722|4081489|B5|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4257308|NCT00618722|4081490|B4|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4257309|NCT00618722|4081491|B3|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4257310|NCT00618722|4081492|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4257311|NCT00618722|4081493|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4257312|NCT00618722|4081489|B5|White||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
4257313|NCT00618722|4081490|B4|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4257314|NCT00618722|4081491|B3|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4257315|NCT00618722|4081492|B2|White||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4257316|NCT00618722|4081493|B1|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4257317|NCT00618722|4081489|B5||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4257318|NCT00618722|4081490|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4257319|NCT00618722|4081491|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4257320|NCT00618722|4081492|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4257321|NCT00618722|4081493|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4257322|NCT00618722|4081489|B5||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4257323|NCT00618722|4081490|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4257324|NCT00618722|4081491|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4257325|NCT00618722|4081492|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4257326|NCT00618722|4081493|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4257327|NCT00618722|4081489|B5|||Age||years|Mean|45.5|45.5|Standard Deviation|8.55|8.55|||
4257328|NCT00618722|4081490|B4|||Age||years|Mean|48.0|48.0|Standard Deviation|9.78|9.78|||
4257329|NCT00618722|4081491|B3|||Age||years|Mean|44.4|44.4|Standard Deviation|6.95|6.95|||
4257330|NCT00618722|4081492|B2|||Age||years|Mean|45.5|45.5|Standard Deviation|7.37|7.37|||
4257331|NCT00618722|4081493|B1|||Age||years|Mean|43.9|43.9|Standard Deviation|9.71|9.71|||
4257332|NCT00618618|4081530|B5|IV - VI||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|0|0.0||||||
4257333|NCT00618618|4081531|B4|IV - VI||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|0|0.0||||||
4257334|NCT00618618|4081532|B3|IV - VI||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|0|0.0||||||
4257335|NCT00618618|4081533|B2|IV - VI||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|0|0.0||||||
4257336|NCT00618618|4081534|B1|IV - VI||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|0|0.0||||||
4257337|NCT00618618|4081530|B5|I - III||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|71|71.0||||||
4257338|NCT00618618|4081531|B4|I - III||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|14|14.0||||||
4257339|NCT00618618|4081532|B3|I - III||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|20|20.0||||||
4257371|NCT00618618|4081534|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4257372|NCT00618618|4081530|B5|||Age||years|Mean|47.1|47.1|Standard Deviation|8.69|8.69|||
4257373|NCT00618618|4081531|B4|||Age||years|Mean|49.4|49.4|Standard Deviation|10.85|10.85|||
4257340|NCT00618618|4081533|B2|I - III||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|13|13.0||||||
4257341|NCT00618618|4081534|B1|I - III||Fitzpatrick Skin Type|"Fitzpatrick Skin Type is a numerical classification schema for human skin color and typical response to ultraviolet (UV) light:~Type I: Pale white skin, blue/hazel eyes, blond/red hair; Always burns, does not tan.~Type II: Fair skin, blue eyes; Burns easily, tans poorly.~Type III: Darker white skin; Tans after initial burn.~Type IV: Light brown skin; Burns minimally, tans easily.~Type V: Brown skin; Rarely burns, tans darkly easily.~Type VI: Dark brown or black skin; Never burns, always tans darkly."|participants|Number|24|24.0||||||
4257342|NCT00618618|4081530|B5|3||Submental Fat (SMF) Rating|"SMF Ratings:~0 = Absent submental convexity: No localized submental fat evident;~1 = Mild submental convexity: Minimal, localized submental fat;~2 = Moderate submental convexity: Prominent, localized submental fat;~3 = Severe submental convexity: Marked, localized submental fat;~4 = Extreme submental convexity."|participants|Number|26|26.0||||||
4257343|NCT00618618|4081531|B4|3||Submental Fat (SMF) Rating|"SMF Ratings:~0 = Absent submental convexity: No localized submental fat evident;~1 = Mild submental convexity: Minimal, localized submental fat;~2 = Moderate submental convexity: Prominent, localized submental fat;~3 = Severe submental convexity: Marked, localized submental fat;~4 = Extreme submental convexity."|participants|Number|7|7.0||||||
4257344|NCT00618618|4081532|B3|3||Submental Fat (SMF) Rating|"SMF Ratings:~0 = Absent submental convexity: No localized submental fat evident;~1 = Mild submental convexity: Minimal, localized submental fat;~2 = Moderate submental convexity: Prominent, localized submental fat;~3 = Severe submental convexity: Marked, localized submental fat;~4 = Extreme submental convexity."|participants|Number|9|9.0||||||
4257345|NCT00618618|4081533|B2|3||Submental Fat (SMF) Rating|"SMF Ratings:~0 = Absent submental convexity: No localized submental fat evident;~1 = Mild submental convexity: Minimal, localized submental fat;~2 = Moderate submental convexity: Prominent, localized submental fat;~3 = Severe submental convexity: Marked, localized submental fat;~4 = Extreme submental convexity."|participants|Number|3|3.0||||||
4257346|NCT00618618|4081534|B1|3||Submental Fat (SMF) Rating|"SMF Ratings:~0 = Absent submental convexity: No localized submental fat evident;~1 = Mild submental convexity: Minimal, localized submental fat;~2 = Moderate submental convexity: Prominent, localized submental fat;~3 = Severe submental convexity: Marked, localized submental fat;~4 = Extreme submental convexity."|participants|Number|7|7.0||||||
4257347|NCT00618618|4081530|B5|2||Submental Fat (SMF) Rating|"SMF Ratings:~0 = Absent submental convexity: No localized submental fat evident;~1 = Mild submental convexity: Minimal, localized submental fat;~2 = Moderate submental convexity: Prominent, localized submental fat;~3 = Severe submental convexity: Marked, localized submental fat;~4 = Extreme submental convexity."|participants|Number|45|45.0||||||
4257348|NCT00618618|4081531|B4|2||Submental Fat (SMF) Rating|"SMF Ratings:~0 = Absent submental convexity: No localized submental fat evident;~1 = Mild submental convexity: Minimal, localized submental fat;~2 = Moderate submental convexity: Prominent, localized submental fat;~3 = Severe submental convexity: Marked, localized submental fat;~4 = Extreme submental convexity."|participants|Number|7|7.0||||||
4257349|NCT00618618|4081532|B3|2||Submental Fat (SMF) Rating|"SMF Ratings:~0 = Absent submental convexity: No localized submental fat evident;~1 = Mild submental convexity: Minimal, localized submental fat;~2 = Moderate submental convexity: Prominent, localized submental fat;~3 = Severe submental convexity: Marked, localized submental fat;~4 = Extreme submental convexity."|participants|Number|11|11.0||||||
4257350|NCT00618618|4081533|B2|2||Submental Fat (SMF) Rating|"SMF Ratings:~0 = Absent submental convexity: No localized submental fat evident;~1 = Mild submental convexity: Minimal, localized submental fat;~2 = Moderate submental convexity: Prominent, localized submental fat;~3 = Severe submental convexity: Marked, localized submental fat;~4 = Extreme submental convexity."|participants|Number|10|10.0||||||
4257351|NCT00618618|4081534|B1|2||Submental Fat (SMF) Rating|"SMF Ratings:~0 = Absent submental convexity: No localized submental fat evident;~1 = Mild submental convexity: Minimal, localized submental fat;~2 = Moderate submental convexity: Prominent, localized submental fat;~3 = Severe submental convexity: Marked, localized submental fat;~4 = Extreme submental convexity."|participants|Number|17|17.0||||||
4257352|NCT00618618|4081530|B5|||Weight||kg|Mean|83.78|83.78|Standard Deviation|16.074|16.074|||
4257353|NCT00618618|4081531|B4|||Weight||kg|Mean|84.78|84.78|Standard Deviation|16.381|16.381|||
4257354|NCT00618618|4081532|B3|||Weight||kg|Mean|90.80|90.8|Standard Deviation|17.128|17.128|||
4257355|NCT00618618|4081533|B2|||Weight||kg|Mean|82.10|82.1|Standard Deviation|18.204|18.204|||
4257356|NCT00618618|4081534|B1|||Weight||kg|Mean|78.31|78.31|Standard Deviation|11.987|11.987|||
4257357|NCT00618618|4081530|B5|White||Race/Ethnicity, Customized||participants|Number|71|71.0||||||
4257358|NCT00618618|4081531|B4|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4257359|NCT00618618|4081532|B3|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4257360|NCT00618618|4081533|B2|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4257361|NCT00618618|4081534|B1|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4257362|NCT00618618|4081530|B5||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4257363|NCT00618618|4081531|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4257364|NCT00618618|4081532|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4257365|NCT00618618|4081533|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4257366|NCT00618618|4081534|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4257367|NCT00618618|4081530|B5||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4257368|NCT00618618|4081531|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4257369|NCT00618618|4081532|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4257370|NCT00618618|4081533|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4257374|NCT00618618|4081532|B3|||Age||years|Mean|47.0|47.0|Standard Deviation|10.37|10.37|||
4257375|NCT00618618|4081533|B2|||Age||years|Mean|45.9|45.9|Standard Deviation|4.23|4.23|||
4257376|NCT00618618|4081534|B1|||Age||years|Mean|46.5|46.5|Standard Deviation|7.79|7.79|||
4257377|NCT00618540|4081583|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4257378|NCT00618540|4081583|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4257379|NCT00618540|4081583|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4257380|NCT00618540|4081583|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4257381|NCT00618540|4081583|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4257382|NCT00618540|4081583|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4257383|NCT00618514|4081594|B3|United States||Region of Enrollment||Limbs|Number|110|110.0||||||
4257384|NCT00618514|4081595|B2|United States||Region of Enrollment||Limbs|Number|55|55.0||||||
4257385|NCT00618514|4081596|B1|United States||Region of Enrollment||Limbs|Number|55|55.0||||||
4257386|NCT00618514|4081594|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4257387|NCT00618514|4081595|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4257388|NCT00618514|4081596|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4257389|NCT00618514|4081594|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4257390|NCT00618514|4081595|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4257391|NCT00618514|4081596|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4257392|NCT00618514|4081594|B3|||Age||years|Mean|54.1|54.1|Standard Deviation|13.5|13.5|||
4257393|NCT00618514|4081595|B2|||Age||years|Mean|53.8|53.8|Standard Deviation|14.1|14.1|||
4257394|NCT00618514|4081596|B1|||Age||years|Mean|54.4|54.4|Standard Deviation|12.7|12.7|||
4257395|NCT00618449|4081616|B3|Niger||Region of Enrollment||participants|Number|1347|1347.0||||||
4257396|NCT00618449|4081617|B2|Niger||Region of Enrollment||participants|Number|668|668.0||||||
4257397|NCT00618449|4081618|B1|Niger||Region of Enrollment||participants|Number|679|679.0||||||
4257398|NCT00618449|4081616|B3||Male|Sex: Female, Male||Participants|Count of Participants|641|641.0||||||
4257399|NCT00618449|4081617|B2||Male|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
4257400|NCT00618449|4081618|B1||Male|Sex: Female, Male||Participants|Count of Participants|327|327.0||||||
4257401|NCT00618449|4081616|B3||Female|Sex: Female, Male||Participants|Count of Participants|706|706.0||||||
4257402|NCT00618449|4081617|B2||Female|Sex: Female, Male||Participants|Count of Participants|354|354.0||||||
4257403|NCT00618449|4081618|B1||Female|Sex: Female, Male||Participants|Count of Participants|352|352.0||||||
4257404|NCT00618449|4081616|B3|>=65 years||Age, Customized||participants|Number|30|30.0||||||
4257405|NCT00618449|4081617|B2|>=65 years||Age, Customized||participants|Number|14|14.0||||||
4257406|NCT00618449|4081618|B1|>=65 years||Age, Customized||participants|Number|16|16.0||||||
4257407|NCT00618449|4081616|B3|Between 11 and 65 years||Age, Customized||participants|Number|622|622.0||||||
4257408|NCT00618449|4081617|B2|Between 11 and 65 years||Age, Customized||participants|Number|309|309.0||||||
4257409|NCT00618449|4081618|B1|Between 11 and 65 years||Age, Customized||participants|Number|313|313.0||||||
4257410|NCT00618449|4081616|B3|<=10 years||Age, Customized||participants|Number|695|695.0||||||
4257411|NCT00618449|4081617|B2|<=10 years||Age, Customized||participants|Number|345|345.0||||||
4257412|NCT00618449|4081618|B1|<=10 years||Age, Customized||participants|Number|350|350.0||||||
4257413|NCT00618449|4081616|B3|||Age||years|Mean|18.86|18.86|Standard Deviation|18.22|18.22|||
4257414|NCT00618449|4081617|B2|||Age||years|Mean|19.25|19.25|Standard Deviation|18.66|18.66|||
4257415|NCT00618449|4081618|B1|||Age||years|Mean|18.47|18.47|Standard Deviation|17.77|17.77|||
4257416|NCT00618436|4081625|B3|United States||Region of Enrollment||participants|Number|52|52.0||||||
4257417|NCT00618436|4081626|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4257418|NCT00618436|4081627|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4257419|NCT00618436|4081625|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4257420|NCT00618436|4081626|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4257421|NCT00618436|4081627|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4257422|NCT00618436|4081625|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4257423|NCT00618436|4081626|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4257424|NCT00618436|4081627|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4257425|NCT00618436|4081625|B3|||Age||years|Median|42.5|42.5|Full Range|||17.0|80.0|
4257426|NCT00618436|4081626|B2|||Age||years|Median|35|35.0|Full Range|||18.0|80.0|
4257427|NCT00618436|4081627|B1|||Age||years|Median|44|44.0|Full Range|||17.0|75.0|
4257428|NCT00618410|4081638|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4257429|NCT00618410|4081638|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4257430|NCT00618410|4081638|B1|||Age||years|Mean|30.69|30.69|Standard Deviation|8.13|8.13|||
4257431|NCT00618371|4081655|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4257432|NCT00618371|4081655|B1||Male|Gender||Participants|Count of Participants|11|11.0||||||
4257433|NCT00618371|4081655|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
4257434|NCT00618371|4081655|B1|||Age||years|Median|45.5|45.5|Standard Deviation|10.6|10.6|||
4257435|NCT00618371|4081655|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4257436|NCT00618371|4081655|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4257437|NCT00618371|4081655|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4257438|NCT00618332|4081660|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4257439|NCT00618332|4081661|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4257440|NCT00618332|4081662|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4257441|NCT00618332|4081660|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4257442|NCT00618332|4081661|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4257443|NCT00618332|4081662|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4257444|NCT00618332|4081660|B3|||Age||years|Mean|33.8|33.8|Standard Deviation|10.98|10.98|||
4257445|NCT00618332|4081661|B2|||Age||years|Mean|35|35.0|Standard Deviation|12|12.0|||
4257446|NCT00618332|4081662|B1|||Age||years|Mean|32.6|32.6|Standard Deviation|9.36|9.36|||
4257447|NCT00618072|4081685|B4|||Adiponectin||ug/mL|Mean|10.6|10.6|Standard Deviation|4.6|4.6|||
4257448|NCT00618072|4081686|B3|||Adiponectin||ug/mL|Mean|11.1|11.1|Standard Deviation|1.0|1.0|||
4257449|NCT00618072|4081687|B2|||Adiponectin||ug/mL|Mean|10.6|10.6|Standard Deviation|1.4|1.4|||
4257450|NCT00618072|4081688|B1|||Adiponectin||ug/mL|Mean|9.3|9.3|Standard Deviation|1.3|1.3|||
4257451|NCT00618072|4081685|B4|||Triglycerides||mg/dl|Mean|86.9|86.9|Standard Deviation|9.3|9.3|||
4257452|NCT00618072|4081686|B3|||Triglycerides||mg/dl|Mean|82.6|82.6|Standard Deviation|11.2|11.2|||
4257453|NCT00618072|4081687|B2|||Triglycerides||mg/dl|Mean|88.0|88.0|Standard Deviation|11.3|11.3|||
4257454|NCT00618072|4081688|B1|||Triglycerides||mg/dl|Mean|90.1|90.1|Standard Deviation|9.5|9.5|||
4257455|NCT00618072|4081685|B4|||HDL||mg/dl|Mean|58.9|58.9|Standard Deviation|2.4|2.4|||
4257456|NCT00618072|4081686|B3|||HDL||mg/dl|Mean|60.1|60.1|Standard Deviation|3.2|3.2|||
4257457|NCT00618072|4081687|B2|||HDL||mg/dl|Mean|61.6|61.6|Standard Deviation|5.7|5.7|||
4257458|NCT00618072|4081688|B1|||HDL||mg/dl|Mean|49.3|49.3|Standard Deviation|2.3|2.3|||
4257459|NCT00618072|4081685|B4|||Diastolic BP||mmHg|Mean|75.4|75.4|Standard Deviation|1.4|1.4|||
4257460|NCT00618072|4081686|B3|||Diastolic BP||mmHg|Mean|76.9|76.9|Standard Deviation|4.2|4.2|||
4257461|NCT00618072|4081687|B2|||Diastolic BP||mmHg|Mean|75.3|75.3|Standard Deviation|2.0|2.0|||
4257462|NCT00618072|4081688|B1|||Diastolic BP||mmHg|Mean|75.9|75.9|Standard Deviation|2.6|2.6|||
4257463|NCT00618072|4081685|B4|||Systolic BP||mmHg|Mean|118.2|118.2|Standard Deviation|2.1|2.1|||
4257464|NCT00618072|4081686|B3|||Systolic BP||mmHg|Mean|118.7|118.7|Standard Deviation|6.0|6.0|||
4257465|NCT00618072|4081687|B2|||Systolic BP||mmHg|Mean|114.3|114.3|Standard Deviation|3.4|3.4|||
4257466|NCT00618072|4081688|B1|||Systolic BP||mmHg|Mean|117.5|117.5|Standard Deviation|2.9|2.9|||
4257467|NCT00618072|4081685|B4|||Waist circumference||cm|Mean|94.7|94.7|Standard Deviation|1.27|1.27|||
4257468|NCT00618072|4081686|B3|||Waist circumference||cm|Mean|93.1|93.1|Standard Deviation|2.1|2.1|||
4257469|NCT00618072|4081687|B2|||Waist circumference||cm|Mean|92.9|92.9|Standard Deviation|1.8|1.8|||
4257470|NCT00618072|4081688|B1|||Waist circumference||cm|Mean|97.5|97.5|Standard Deviation|2.3|2.3|||
4257471|NCT00618072|4081685|B4|||HOMA-IR||HOMA-IR score|Mean|2.3|2.3|Standard Deviation|0.2|0.2|||
4257472|NCT00618072|4081686|B3|||HOMA-IR||HOMA-IR score|Mean|1.9|1.9|Standard Deviation|0.3|0.3|||
4257473|NCT00618072|4081687|B2|||HOMA-IR||HOMA-IR score|Mean|2.5|2.5|Standard Deviation|0.4|0.4|||
4257474|NCT00618072|4081688|B1|||HOMA-IR||HOMA-IR score|Mean|2.3|2.3|Standard Deviation|0.2|0.2|||
4257475|NCT00618072|4081685|B4|||Body Weight||kg|Mean|82.4|82.4|Standard Deviation|1.63|1.63|||
4257476|NCT00618072|4081686|B3|||Body Weight||kg|Mean|81.8|81.8|Standard Deviation|3.2|3.2|||
4257477|NCT00618072|4081687|B2|||Body Weight||kg|Mean|85.1|85.1|Standard Deviation|2.4|2.4|||
4257478|NCT00618072|4081688|B1|||Body Weight||kg|Mean|84.1|84.1|Standard Deviation|2.8|2.8|||
4257479|NCT00618072|4081685|B4|||Fasting insulin||uIU/mL|Mean|10.7|10.7|Standard Deviation|0.7|0.7|||
4257480|NCT00618072|4081686|B3|||Fasting insulin||uIU/mL|Mean|8.7|8.7|Standard Deviation|1.5|1.5|||
4257481|NCT00618072|4081687|B2|||Fasting insulin||uIU/mL|Mean|12.5|12.5|Standard Deviation|2.0|2.0|||
4257482|NCT00618072|4081688|B1|||Fasting insulin||uIU/mL|Mean|11.2|11.2|Standard Deviation|1.4|1.4|||
4257483|NCT00618072|4081685|B4|United States||Region of Enrollment||participants|Number|46|46.0||||||
4257484|NCT00618072|4081686|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4257485|NCT00618072|4081687|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4257486|NCT00618072|4081688|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4257487|NCT00618072|4081685|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4257488|NCT00618072|4081686|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4257489|NCT00618072|4081687|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4257490|NCT00618072|4081688|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4257491|NCT00618072|4081685|B4||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4257492|NCT00618072|4081686|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4257493|NCT00618072|4081687|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4257494|NCT00618072|4081688|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4257495|NCT00618072|4081685|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4257496|NCT00618072|4081686|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4257497|NCT00618072|4081687|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4257498|NCT00618072|4081688|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4257499|NCT00618072|4081685|B4||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4257500|NCT00618072|4081686|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4257501|NCT00618072|4081687|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4257502|NCT00618072|4081688|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4257503|NCT00618072|4081685|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4257504|NCT00618072|4081686|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4257505|NCT00618072|4081687|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4257506|NCT00618072|4081688|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4257507|NCT00617981|4081722|B3|Korea, Republic of||Region of Enrollment||participants|Number|174|174.0||||||
4257508|NCT00617981|4081723|B2|Korea, Republic of||Region of Enrollment||participants|Number|92|92.0||||||
4257509|NCT00617981|4081724|B1|Korea, Republic of||Region of Enrollment||participants|Number|82|82.0||||||
4257510|NCT00617981|4081722|B3|China||Region of Enrollment||participants|Number|208|208.0||||||
4257511|NCT00617981|4081723|B2|China||Region of Enrollment||participants|Number|104|104.0||||||
4257512|NCT00617981|4081724|B1|China||Region of Enrollment||participants|Number|104|104.0||||||
4257513|NCT00617981|4081722|B3|Italy||Region of Enrollment||participants|Number|49|49.0||||||
4257514|NCT00617981|4081723|B2|Italy||Region of Enrollment||participants|Number|17|17.0||||||
4257515|NCT00617981|4081724|B1|Italy||Region of Enrollment||participants|Number|32|32.0||||||
4257516|NCT00617981|4081722|B3|Japan||Region of Enrollment||participants|Number|18|18.0||||||
4257517|NCT00617981|4081723|B2|Japan||Region of Enrollment||participants|Number|10|10.0||||||
4257518|NCT00617981|4081724|B1|Japan||Region of Enrollment||participants|Number|8|8.0||||||
4257519|NCT00617981|4081722|B3|Malaysia||Region of Enrollment||participants|Number|13|13.0||||||
4257520|NCT00617981|4081723|B2|Malaysia||Region of Enrollment||participants|Number|6|6.0||||||
4257521|NCT00617981|4081724|B1|Malaysia||Region of Enrollment||participants|Number|7|7.0||||||
4257522|NCT00617981|4081722|B3|Thailand||Region of Enrollment||participants|Number|24|24.0||||||
4257523|NCT00617981|4081723|B2|Thailand||Region of Enrollment||participants|Number|8|8.0||||||
4257524|NCT00617981|4081724|B1|Thailand||Region of Enrollment||participants|Number|16|16.0||||||
4257525|NCT00617981|4081722|B3|Canada||Region of Enrollment||participants|Number|15|15.0||||||
4257526|NCT00617981|4081723|B2|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4257527|NCT00617981|4081724|B1|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4257528|NCT00617981|4081722|B3|Hong Kong||Region of Enrollment||participants|Number|15|15.0||||||
4257529|NCT00617981|4081723|B2|Hong Kong||Region of Enrollment||participants|Number|9|9.0||||||
4257530|NCT00617981|4081724|B1|Hong Kong||Region of Enrollment||participants|Number|6|6.0||||||
4257531|NCT00617981|4081722|B3|Taiwan||Region of Enrollment||participants|Number|131|131.0||||||
4257532|NCT00617981|4081723|B2|Taiwan||Region of Enrollment||participants|Number|63|63.0||||||
4257533|NCT00617981|4081724|B1|Taiwan||Region of Enrollment||participants|Number|68|68.0||||||
4257534|NCT00617981|4081722|B3|Philippines||Region of Enrollment||participants|Number|39|39.0||||||
4257535|NCT00617981|4081723|B2|Philippines||Region of Enrollment||participants|Number|21|21.0||||||
4257536|NCT00617981|4081724|B1|Philippines||Region of Enrollment||participants|Number|18|18.0||||||
4257537|NCT00617981|4081722|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4257538|NCT00617981|4081723|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4257539|NCT00617981|4081724|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4257540|NCT00617981|4081722|B3|Other||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
4257541|NCT00617981|4081723|B2|Other||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4257542|NCT00617981|4081724|B1|Other||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4257543|NCT00617981|4081722|B3|Chinese||Race/Ethnicity, Customized||participants|Number|240|240.0||||||
4257544|NCT00617981|4081723|B2|Chinese||Race/Ethnicity, Customized||participants|Number|125|125.0||||||
4257545|NCT00617981|4081724|B1|Chinese||Race/Ethnicity, Customized||participants|Number|115|115.0||||||
4257546|NCT00617981|4081722|B3|Taiwanese||Race/Ethnicity, Customized||participants|Number|128|128.0||||||
4257547|NCT00617981|4081723|B2|Taiwanese||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
4257548|NCT00617981|4081724|B1|Taiwanese||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
4257549|NCT00617981|4081722|B3|Korean||Race/Ethnicity, Customized||participants|Number|174|174.0||||||
4257550|NCT00617981|4081723|B2|Korean||Race/Ethnicity, Customized||participants|Number|91|91.0||||||
4257551|NCT00617981|4081724|B1|Korean||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
4257552|NCT00617981|4081722|B3|Japanese||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4257553|NCT00617981|4081723|B2|Japanese||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4257554|NCT00617981|4081724|B1|Japanese||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4257555|NCT00617981|4081722|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
4257556|NCT00617981|4081723|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4257557|NCT00617981|4081724|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4257558|NCT00617981|4081722|B3||Male|Sex: Female, Male||Participants|Count of Participants|530|530.0||||||
4257559|NCT00617981|4081723|B2||Male|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
4257560|NCT00617981|4081724|B1||Male|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
4257561|NCT00617981|4081722|B3||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4257562|NCT00617981|4081723|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4257563|NCT00617981|4081724|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4257564|NCT00617981|4081722|B3|Missing||Age, Customized||participants|Number|5|5.0||||||
4257565|NCT00617981|4081723|B2|Missing||Age, Customized||participants|Number|2|2.0||||||
4257566|NCT00617981|4081724|B1|Missing||Age, Customized||participants|Number|3|3.0||||||
4257567|NCT00617981|4081722|B3|85+||Age, Customized||participants|Number|6|6.0||||||
4257568|NCT00617981|4081723|B2|85+||Age, Customized||participants|Number|4|4.0||||||
4257569|NCT00617981|4081724|B1|85+||Age, Customized||participants|Number|2|2.0||||||
4257570|NCT00617981|4081722|B3|80-<85||Age, Customized||participants|Number|32|32.0||||||
4257571|NCT00617981|4081723|B2|80-<85||Age, Customized||participants|Number|13|13.0||||||
4257572|NCT00617981|4081724|B1|80-<85||Age, Customized||participants|Number|19|19.0||||||
4257573|NCT00617981|4081722|B3|75-<80||Age, Customized||participants|Number|67|67.0||||||
4257574|NCT00617981|4081723|B2|75-<80||Age, Customized||participants|Number|34|34.0||||||
4257575|NCT00617981|4081724|B1|75-<80||Age, Customized||participants|Number|33|33.0||||||
4257576|NCT00617981|4081722|B3|70-<75||Age, Customized||participants|Number|93|93.0||||||
4257577|NCT00617981|4081723|B2|70-<75||Age, Customized||participants|Number|42|42.0||||||
4257578|NCT00617981|4081724|B1|70-<75||Age, Customized||participants|Number|51|51.0||||||
4257579|NCT00617981|4081722|B3|65-<70||Age, Customized||participants|Number|89|89.0||||||
4257580|NCT00617981|4081723|B2|65-<70||Age, Customized||participants|Number|45|45.0||||||
4257581|NCT00617981|4081724|B1|65-<70||Age, Customized||participants|Number|44|44.0||||||
4257582|NCT00617981|4081722|B3|60-<65||Age, Customized||participants|Number|129|129.0||||||
4257583|NCT00617981|4081723|B2|60-<65||Age, Customized||participants|Number|64|64.0||||||
4257584|NCT00617981|4081724|B1|60-<65||Age, Customized||participants|Number|65|65.0||||||
4257585|NCT00617981|4081722|B3|55-<60||Age, Customized||participants|Number|107|107.0||||||
4257586|NCT00617981|4081723|B2|55-<60||Age, Customized||participants|Number|50|50.0||||||
4257587|NCT00617981|4081724|B1|55-<60||Age, Customized||participants|Number|57|57.0||||||
4257588|NCT00617981|4081722|B3|50-<55||Age, Customized||participants|Number|86|86.0||||||
4257589|NCT00617981|4081723|B2|50-<55||Age, Customized||participants|Number|44|44.0||||||
4257590|NCT00617981|4081724|B1|50-<55||Age, Customized||participants|Number|42|42.0||||||
4257591|NCT00617981|4081722|B3|45-<50||Age, Customized||participants|Number|43|43.0||||||
4257592|NCT00617981|4081723|B2|45-<50||Age, Customized||participants|Number|25|25.0||||||
4257593|NCT00617981|4081724|B1|45-<50||Age, Customized||participants|Number|18|18.0||||||
4257594|NCT00617981|4081722|B3|40-<45||Age, Customized||participants|Number|27|27.0||||||
4257595|NCT00617981|4081723|B2|40-<45||Age, Customized||participants|Number|14|14.0||||||
4257596|NCT00617981|4081724|B1|40-<45||Age, Customized||participants|Number|13|13.0||||||
4257597|NCT00617981|4081722|B3|<40||Age, Customized||participants|Number|17|17.0||||||
4257598|NCT00617981|4081723|B2|<40||Age, Customized||participants|Number|10|10.0||||||
4257599|NCT00617981|4081724|B1|<40||Age, Customized||participants|Number|7|7.0||||||
4257600|NCT00617942|4081731|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4257601|NCT00617942|4081732|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4257602|NCT00617942|4081733|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4257603|NCT00617942|4081731|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4257604|NCT00617942|4081732|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4257605|NCT00617942|4081733|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4257606|NCT00617942|4081731|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4257607|NCT00617942|4081732|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4257608|NCT00617942|4081733|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4257609|NCT00617942|4081731|B3|||Age||years|Mean|51.5|51.5|Full Range|||32.0|72.0|
4257610|NCT00617942|4081732|B2|||Age||years|Mean|51.6|51.6|Full Range|||35.0|70.0|
4257611|NCT00617942|4081733|B1|||Age||years|Mean|51.4|51.4|Full Range|||32.0|72.0|
4257612|NCT00617942|4081731|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4257613|NCT00617942|4081732|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4257614|NCT00617942|4081733|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4257615|NCT00617942|4081731|B3||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4257616|NCT00617942|4081732|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4257617|NCT00617942|4081733|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4257618|NCT00617942|4081731|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4257619|NCT00617942|4081732|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4257620|NCT00617942|4081733|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4257621|NCT00617929|4081746|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4257622|NCT00617929|4081746|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4257623|NCT00617929|4081746|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4257624|NCT00617929|4081746|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4257625|NCT00617929|4081746|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4257626|NCT00617903|4081756|B3|||Erythema intensity score at baseline|Erythema intensity score: 1 – Clear or almost clear; 2 – Mild; 3 – Moderate; 4 - Severe|Scores on a scale|Mean|3.0|3.0|Standard Deviation|0.5|0.5|||
4257627|NCT00617903|4081757|B2|||Erythema intensity score at baseline|Erythema intensity score: 1 – Clear or almost clear; 2 – Mild; 3 – Moderate; 4 - Severe|Scores on a scale|Mean|3.0|3.0|Standard Deviation|0.5|0.5|||
4257628|NCT00617903|4081758|B1|||Erythema intensity score at baseline|Erythema intensity score: 1 – Clear or almost clear; 2 – Mild; 3 – Moderate; 4 - Severe|Scores on a scale|Mean|3.1|3.1|Standard Deviation|0.5|0.5|||
4257629|NCT00617903|4081756|B3|||Number of inflammatory lesions per participant at Baseline||Inflammatory lesions|Mean|17.8|17.8|Standard Deviation|9.48|9.48|||
4257630|NCT00617903|4081757|B2|||Number of inflammatory lesions per participant at Baseline||Inflammatory lesions|Mean|17.6|17.6|Standard Deviation|8.36|8.36|||
4257631|NCT00617903|4081758|B1|||Number of inflammatory lesions per participant at Baseline||Inflammatory lesions|Mean|18.0|18.0|Standard Deviation|10.61|10.61|||
4257632|NCT00617903|4081756|B3|||Investigator’s Global Assessment (IGA) score at Baseline|IGA categories: 0 - Clear; 1 - Minimal; 2 - Mild; 3- Mild to Moderate; 4 - Moderate; 5 - Moderate to severe; 6 - Severe / Therapeutic success is defined as an IGA score of clear or minimal (0 to 1).|Scores on a scale|Mean|3.9|3.9|Standard Deviation|0.9|0.9|||
4257633|NCT00617903|4081757|B2|||Investigator’s Global Assessment (IGA) score at Baseline|IGA categories: 0 - Clear; 1 - Minimal; 2 - Mild; 3- Mild to Moderate; 4 - Moderate; 5 - Moderate to severe; 6 - Severe / Therapeutic success is defined as an IGA score of clear or minimal (0 to 1).|Scores on a scale|Mean|3.9|3.9|Standard Deviation|0.9|0.9|||
4257634|NCT00617903|4081758|B1|||Investigator’s Global Assessment (IGA) score at Baseline|IGA categories: 0 - Clear; 1 - Minimal; 2 - Mild; 3- Mild to Moderate; 4 - Moderate; 5 - Moderate to severe; 6 - Severe / Therapeutic success is defined as an IGA score of clear or minimal (0 to 1).|Scores on a scale|Mean|4.0|4.0|Standard Deviation|0.9|0.9|||
4257635|NCT00617903|4081756|B3|||Previous duration of rosacea||Months|Mean|90.2|90.2|Standard Deviation|70.4|70.4|||
4257636|NCT00617903|4081757|B2|||Previous duration of rosacea||Months|Mean|91.9|91.9|Standard Deviation|77.0|77.0|||
4257637|NCT00617903|4081758|B1|||Previous duration of rosacea||Months|Mean|88.5|88.5|Standard Deviation|63.8|63.8|||
4257638|NCT00617903|4081756|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4257639|NCT00617903|4081757|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4257640|NCT00617903|4081758|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4257641|NCT00617903|4081756|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4257642|NCT00617903|4081757|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4257643|NCT00617903|4081758|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4257644|NCT00617903|4081756|B3|||Age||Years|Mean|50.5|50.5|Standard Deviation|12.2|12.2|||
4257645|NCT00617903|4081757|B2|||Age||Years|Mean|51.5|51.5|Standard Deviation|12.5|12.5|||
4257646|NCT00617903|4081758|B1|||Age||Years|Mean|49.4|49.4|Standard Deviation|11.9|11.9|||
4257647|NCT00617890|4081801|B5||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4257648|NCT00617890|4081802|B4||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4257649|NCT00617890|4081803|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4257650|NCT00617890|4081804|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4257651|NCT00617890|4081805|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4257652|NCT00617890|4081801|B5||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4257653|NCT00617890|4081802|B4||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4257654|NCT00617890|4081803|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4257655|NCT00617890|4081804|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4257656|NCT00617890|4081805|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4257657|NCT00617890|4081801|B5|||Age||Years|Mean|24.3|24.3|Standard Deviation|12.8|12.8|||
4257658|NCT00617890|4081802|B4|||Age||Years|Mean|24.6|24.6|Standard Deviation|11.4|11.4|||
4257659|NCT00617890|4081803|B3|||Age||Years|Mean|27.5|27.5|Standard Deviation|15.3|15.3|||
4257660|NCT00617890|4081804|B2|||Age||Years|Mean|20.1|20.1|Standard Deviation|10.3|10.3|||
4257661|NCT00617890|4081805|B1|||Age||Years|Mean|23.7|23.7|Standard Deviation|15.5|15.5|||
4257662|NCT00617851|4081840|B5|Native Amer/Alaskan||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4257663|NCT00617851|4081841|B4|Native Amer/Alaskan||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4257664|NCT00617851|4081842|B3|Native Amer/Alaskan||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4257665|NCT00617851|4081843|B2|Native Amer/Alaskan||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4257666|NCT00617851|4081844|B1|Native Amer/Alaskan||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4257667|NCT00617851|4081840|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|1471|1471.0||||||
4257668|NCT00617851|4081841|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|214|214.0||||||
4257669|NCT00617851|4081842|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|418|418.0||||||
4257670|NCT00617851|4081843|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|418|418.0||||||
4257671|NCT00617851|4081844|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|421|421.0||||||
4257672|NCT00617851|4081840|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4257673|NCT00617851|4081841|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4257674|NCT00617851|4081842|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4257675|NCT00617851|4081843|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4257676|NCT00617851|4081844|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4257677|NCT00617851|4081840|B5|Black||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4257678|NCT00617851|4081841|B4|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4257679|NCT00617851|4081842|B3|Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4257680|NCT00617851|4081843|B2|Black||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4257681|NCT00617851|4081844|B1|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4257682|NCT00617851|4081840|B5|Arabic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4257683|NCT00617851|4081841|B4|Arabic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4257684|NCT00617851|4081842|B3|Arabic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4257685|NCT00617851|4081843|B2|Arabic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4257686|NCT00617851|4081844|B1|Arabic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4257687|NCT00617851|4081840|B5||Male|Sex: Female, Male||Participants|Count of Participants|447|447.0||||||
4257688|NCT00617851|4081841|B4||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4257689|NCT00617851|4081842|B3||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4257690|NCT00617851|4081843|B2||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4257691|NCT00617851|4081844|B1||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4257692|NCT00617851|4081840|B5||Female|Sex: Female, Male||Participants|Count of Participants|1060|1060.0||||||
4257693|NCT00617851|4081841|B4||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4257694|NCT00617851|4081842|B3||Female|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
4257695|NCT00617851|4081843|B2||Female|Sex: Female, Male||Participants|Count of Participants|306|306.0||||||
4257696|NCT00617851|4081844|B1||Female|Sex: Female, Male||Participants|Count of Participants|309|309.0||||||
4257697|NCT00617851|4081840|B5|||Age||years|Mean|31.2|31.2|Standard Deviation|8.7|8.7|||
4257698|NCT00617851|4081841|B4|||Age||years|Mean|31.3|31.3|Standard Deviation|8.7|8.7|||
4257699|NCT00617851|4081842|B3|||Age||years|Mean|31.3|31.3|Standard Deviation|8.9|8.9|||
4257700|NCT00617851|4081843|B2|||Age||years|Mean|31.2|31.2|Standard Deviation|8.6|8.6|||
4257701|NCT00617851|4081844|B1|||Age||years|Mean|31.1|31.1|Standard Deviation|8.8|8.8|||
4257702|NCT00617773|4081885|B1|Type O||ABO blood type||participants|Number|17|17.0||||||
4257703|NCT00617773|4081885|B1|Type AB||ABO blood type||participants|Number|2|2.0||||||
4257704|NCT00617773|4081885|B1|Type B||ABO blood type||participants|Number|1|1.0||||||
4257705|NCT00617773|4081885|B1|Type A||ABO blood type||participants|Number|11|11.0||||||
4257706|NCT00617773|4081885|B1|Positive (+4)||Expression of the Lewis Y antigen in tumor tissue|"Expression of Lewis Y was investigated by immunohistochemistry on primary or metastatic tumor biopsies. To determine Lewis Y expression levels, a semi-quantitative approach was used, which considered cytoplasm and membrane compartments independently. The score taken into account was from the higher expression observed, either cytoplasm or membrane.~Participants with positive expression of Lewis Y in tumor were scored, according to the percentage of positively stained cells, into the following categories: +4 (>75% positive cells); +3 (51 to 75%); +2 (26 to 50%); and +1 (1 to 25%)."|participants|Number|3|3.0||||||
4257707|NCT00617773|4081885|B1|Positive (+3)||Expression of the Lewis Y antigen in tumor tissue|"Expression of Lewis Y was investigated by immunohistochemistry on primary or metastatic tumor biopsies. To determine Lewis Y expression levels, a semi-quantitative approach was used, which considered cytoplasm and membrane compartments independently. The score taken into account was from the higher expression observed, either cytoplasm or membrane.~Participants with positive expression of Lewis Y in tumor were scored, according to the percentage of positively stained cells, into the following categories: +4 (>75% positive cells); +3 (51 to 75%); +2 (26 to 50%); and +1 (1 to 25%)."|participants|Number|8|8.0||||||
4257708|NCT00617773|4081885|B1|Positive (+2)||Expression of the Lewis Y antigen in tumor tissue|"Expression of Lewis Y was investigated by immunohistochemistry on primary or metastatic tumor biopsies. To determine Lewis Y expression levels, a semi-quantitative approach was used, which considered cytoplasm and membrane compartments independently. The score taken into account was from the higher expression observed, either cytoplasm or membrane.~Participants with positive expression of Lewis Y in tumor were scored, according to the percentage of positively stained cells, into the following categories: +4 (>75% positive cells); +3 (51 to 75%); +2 (26 to 50%); and +1 (1 to 25%)."|participants|Number|6|6.0||||||
4257709|NCT00617773|4081885|B1|Positive (+1)||Expression of the Lewis Y antigen in tumor tissue|"Expression of Lewis Y was investigated by immunohistochemistry on primary or metastatic tumor biopsies. To determine Lewis Y expression levels, a semi-quantitative approach was used, which considered cytoplasm and membrane compartments independently. The score taken into account was from the higher expression observed, either cytoplasm or membrane.~Participants with positive expression of Lewis Y in tumor were scored, according to the percentage of positively stained cells, into the following categories: +4 (>75% positive cells); +3 (51 to 75%); +2 (26 to 50%); and +1 (1 to 25%)."|participants|Number|14|14.0||||||
4257710|NCT00617773|4081885|B1|Brazil||Region of Enrollment||participants|Number|31|31.0||||||
4257711|NCT00617773|4081885|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4257712|NCT00617773|4081885|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4257713|NCT00617773|4081885|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4257714|NCT00617773|4081885|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4257715|NCT00617773|4081885|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4257716|NCT00617734|4081900|B3|2 = Ambulatory, No Work Activity||Eastern Cooperative Oncology Group Performance Status (ECOG PS) Score|ECOG performance status was used to classify participants according to their functional impairment. Score 0 = Fully active, able to carry on all pre-disease performance without restriction. Score 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, for example, light house work, office work. Score 2 = Ambulatory and capable of all self-care but unable to carry out any work activities; up and about more than 50% of waking hours.|Participants|Count of Participants|18|18.0||||||
4257737|NCT00617734|4081900|B3|||Height||centimeters (cm)|Mean|172.5|172.5|Standard Deviation|10.05|10.05|||
4257738|NCT00617734|4081901|B2|||Height||centimeters (cm)|Mean|173.3|173.3|Standard Deviation|9.56|9.56|||
4257717|NCT00617734|4081901|B2|2 = Ambulatory, No Work Activity||Eastern Cooperative Oncology Group Performance Status (ECOG PS) Score|ECOG performance status was used to classify participants according to their functional impairment. Score 0 = Fully active, able to carry on all pre-disease performance without restriction. Score 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, for example, light house work, office work. Score 2 = Ambulatory and capable of all self-care but unable to carry out any work activities; up and about more than 50% of waking hours.|Participants|Count of Participants|8|8.0||||||
4257718|NCT00617734|4081902|B1|2 = Ambulatory, No Work Activity||Eastern Cooperative Oncology Group Performance Status (ECOG PS) Score|ECOG performance status was used to classify participants according to their functional impairment. Score 0 = Fully active, able to carry on all pre-disease performance without restriction. Score 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, for example, light house work, office work. Score 2 = Ambulatory and capable of all self-care but unable to carry out any work activities; up and about more than 50% of waking hours.|Participants|Count of Participants|10|10.0||||||
4257719|NCT00617734|4081900|B3|1 = Ambulatory, Restricted Work Activity||Eastern Cooperative Oncology Group Performance Status (ECOG PS) Score|ECOG performance status was used to classify participants according to their functional impairment. Score 0 = Fully active, able to carry on all pre-disease performance without restriction. Score 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, for example, light house work, office work. Score 2 = Ambulatory and capable of all self-care but unable to carry out any work activities; up and about more than 50% of waking hours.|Participants|Count of Participants|57|57.0||||||
4257720|NCT00617734|4081901|B2|1 = Ambulatory, Restricted Work Activity||Eastern Cooperative Oncology Group Performance Status (ECOG PS) Score|ECOG performance status was used to classify participants according to their functional impairment. Score 0 = Fully active, able to carry on all pre-disease performance without restriction. Score 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, for example, light house work, office work. Score 2 = Ambulatory and capable of all self-care but unable to carry out any work activities; up and about more than 50% of waking hours.|Participants|Count of Participants|28|28.0||||||
4257721|NCT00617734|4081902|B1|1 = Ambulatory, Restricted Work Activity||Eastern Cooperative Oncology Group Performance Status (ECOG PS) Score|ECOG performance status was used to classify participants according to their functional impairment. Score 0 = Fully active, able to carry on all pre-disease performance without restriction. Score 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, for example, light house work, office work. Score 2 = Ambulatory and capable of all self-care but unable to carry out any work activities; up and about more than 50% of waking hours.|Participants|Count of Participants|29|29.0||||||
4257722|NCT00617734|4081900|B3|0 = Fully Active||Eastern Cooperative Oncology Group Performance Status (ECOG PS) Score|ECOG performance status was used to classify participants according to their functional impairment. Score 0 = Fully active, able to carry on all pre-disease performance without restriction. Score 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, for example, light house work, office work. Score 2 = Ambulatory and capable of all self-care but unable to carry out any work activities; up and about more than 50% of waking hours.|Participants|Count of Participants|16|16.0||||||
4257723|NCT00617734|4081901|B2|0 = Fully Active||Eastern Cooperative Oncology Group Performance Status (ECOG PS) Score|ECOG performance status was used to classify participants according to their functional impairment. Score 0 = Fully active, able to carry on all pre-disease performance without restriction. Score 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, for example, light house work, office work. Score 2 = Ambulatory and capable of all self-care but unable to carry out any work activities; up and about more than 50% of waking hours.|Participants|Count of Participants|8|8.0||||||
4257724|NCT00617734|4081902|B1|0 = Fully Active||Eastern Cooperative Oncology Group Performance Status (ECOG PS) Score|ECOG performance status was used to classify participants according to their functional impairment. Score 0 = Fully active, able to carry on all pre-disease performance without restriction. Score 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, for example, light house work, office work. Score 2 = Ambulatory and capable of all self-care but unable to carry out any work activities; up and about more than 50% of waking hours.|Participants|Count of Participants|8|8.0||||||
4257725|NCT00617734|4081900|B3|Abnormal||Electrocardiogram (ECG)||Participants|Count of Participants|45|45.0||||||
4257726|NCT00617734|4081901|B2|Abnormal||Electrocardiogram (ECG)||Participants|Count of Participants|18|18.0||||||
4257727|NCT00617734|4081902|B1|Abnormal||Electrocardiogram (ECG)||Participants|Count of Participants|27|27.0||||||
4257728|NCT00617734|4081900|B3|Normal||Electrocardiogram (ECG)||Participants|Count of Participants|46|46.0||||||
4257729|NCT00617734|4081901|B2|Normal||Electrocardiogram (ECG)||Participants|Count of Participants|26|26.0||||||
4257730|NCT00617734|4081902|B1|Normal||Electrocardiogram (ECG)||Participants|Count of Participants|20|20.0||||||
4257731|NCT00617734|4081900|B3|||Body Surface Area (BSA)|"BSA is the measured or calculated surface area of a human body based on body weight and height.~The Mosteller¹ formula to calculate BSA (m^2) = ([Height (centimeter) x Weight (kilograms)]/ 3600)½."|square meters (m^2)|Mean|1.81|1.81|Standard Deviation|0.254|0.254|||
4257732|NCT00617734|4081901|B2|||Body Surface Area (BSA)|"BSA is the measured or calculated surface area of a human body based on body weight and height.~The Mosteller¹ formula to calculate BSA (m^2) = ([Height (centimeter) x Weight (kilograms)]/ 3600)½."|square meters (m^2)|Mean|1.82|1.82|Standard Deviation|0.269|0.269|||
4257733|NCT00617734|4081902|B1|||Body Surface Area (BSA)|"BSA is the measured or calculated surface area of a human body based on body weight and height.~The Mosteller¹ formula to calculate BSA (m^2) = ([Height (centimeter) x Weight (kilograms)]/ 3600)½."|square meters (m^2)|Mean|1.80|1.8|Standard Deviation|0.241|0.241|||
4257734|NCT00617734|4081900|B3|||Weight||kilograms (kg)|Mean|70.7|70.7|Standard Deviation|15.93|15.93|||
4257735|NCT00617734|4081901|B2|||Weight||kilograms (kg)|Mean|70.9|70.9|Standard Deviation|18.19|18.19|||
4257736|NCT00617734|4081902|B1|||Weight||kilograms (kg)|Mean|70.5|70.5|Standard Deviation|13.68|13.68|||
4257739|NCT00617734|4081902|B1|||Height||centimeters (cm)|Mean|171.7|171.7|Standard Deviation|10.53|10.53|||
4257740|NCT00617734|4081900|B3|United States||Region of Enrollment||Participants|Count of Participants|91|91.0||||||
4257741|NCT00617734|4081901|B2|United States||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
4257742|NCT00617734|4081902|B1|United States||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
4257743|NCT00617734|4081900|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4257744|NCT00617734|4081901|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4257745|NCT00617734|4081902|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4257746|NCT00617734|4081900|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4257747|NCT00617734|4081901|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4257748|NCT00617734|4081902|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4257749|NCT00617734|4081900|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4257750|NCT00617734|4081901|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4257751|NCT00617734|4081902|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4257752|NCT00617734|4081900|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|76|76.0||||||
4257753|NCT00617734|4081901|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
4257754|NCT00617734|4081902|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
4257755|NCT00617734|4081900|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4257756|NCT00617734|4081901|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4257757|NCT00617734|4081902|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4257758|NCT00617734|4081900|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4257759|NCT00617734|4081901|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4257760|NCT00617734|4081902|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4257761|NCT00617734|4081900|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4257762|NCT00617734|4081901|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4257763|NCT00617734|4081902|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4257764|NCT00617734|4081900|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4257765|NCT00617734|4081901|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4257766|NCT00617734|4081902|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4257767|NCT00617734|4081900|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4257768|NCT00617734|4081901|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4257769|NCT00617734|4081902|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4257770|NCT00617734|4081900|B3|||Age||years|Median|60.0|60.0|Full Range|||35.0|81.0|
4257771|NCT00617734|4081901|B2|||Age||years|Median|59.0|59.0|Full Range|||35.0|76.0|
4257772|NCT00617734|4081902|B1|||Age||years|Median|60.0|60.0|Full Range|||46.0|81.0|
4257773|NCT00617708|4081921|B4|Unknown||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4257774|NCT00617708|4081922|B3|Unknown||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4257775|NCT00617708|4081923|B2|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4257776|NCT00617708|4081924|B1|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4257777|NCT00617708|4081921|B4|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|108|108.0||||||
4257778|NCT00617708|4081922|B3|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4257779|NCT00617708|4081923|B2|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
4257780|NCT00617708|4081924|B1|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4257781|NCT00617708|4081921|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4257782|NCT00617708|4081922|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4257783|NCT00617708|4081923|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4257784|NCT00617708|4081924|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4257785|NCT00617708|4081921|B4|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4257786|NCT00617708|4081922|B3|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4257787|NCT00617708|4081923|B2|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4257788|NCT00617708|4081924|B1|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4257789|NCT00617708|4081921|B4|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4257790|NCT00617708|4081922|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4257791|NCT00617708|4081923|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4257792|NCT00617708|4081924|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4257793|NCT00617708|4081921|B4|Black||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4257794|NCT00617708|4081922|B3|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4257795|NCT00617708|4081923|B2|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4257796|NCT00617708|4081924|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4257797|NCT00617708|4081921|B4|White||Race/Ethnicity, Customized||participants|Number|100|100.0||||||
4257798|NCT00617708|4081922|B3|White||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4257799|NCT00617708|4081923|B2|White||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4257800|NCT00617708|4081924|B1|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4257801|NCT00617708|4081921|B4||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4257802|NCT00617708|4081922|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4257803|NCT00617708|4081923|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4257804|NCT00617708|4081924|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4257805|NCT00617708|4081921|B4||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4257806|NCT00617708|4081922|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4257807|NCT00617708|4081923|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4257808|NCT00617708|4081924|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4257809|NCT00617708|4081921|B4|||Age||years|Median|63|63.0|Full Range|||35.0|87.0|
4257810|NCT00617708|4081922|B3|||Age||years|Median|64|64.0|Full Range|||42.0|82.0|
4257811|NCT00617708|4081923|B2|||Age||years|Median|63|63.0|Full Range|||36.0|87.0|
4257812|NCT00617708|4081924|B1|||Age||years|Median|61|61.0|Full Range|||39.0|82.0|
4257813|NCT00617669|4081941|B3||Male|Sex: Female, Male||Participants|Count of Participants|1052|1052.0||||||
4257814|NCT00617669|4081942|B2||Male|Sex: Female, Male||Participants|Count of Participants|528|528.0||||||
4257815|NCT00617669|4081943|B1||Male|Sex: Female, Male||Participants|Count of Participants|524|524.0||||||
4257816|NCT00617669|4081941|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4257817|NCT00617669|4081942|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4257818|NCT00617669|4081943|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4257819|NCT00617669|4081941|B3|overall||Age||years|Mean|7.9|7.9|Standard Deviation|67.6|67.6|||
4257820|NCT00617669|4081942|B2|overall||Age||years|Mean|7.8|7.8|Standard Deviation|67.6|67.6|||
4257821|NCT00617669|4081943|B1|overall||Age||years|Mean|8.1|8.1|Standard Deviation|67.7|67.7|||
4257822|NCT00617604|4081964|B3||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4257823|NCT00617604|4081965|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4257824|NCT00617604|4081966|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4257825|NCT00617604|4081964|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4257826|NCT00617604|4081965|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4257827|NCT00617604|4081966|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4257828|NCT00617604|4081964|B3|||Age||years|Mean|45.4|45.4|Standard Deviation|11.7|11.7|||
4257829|NCT00617604|4081965|B2|||Age||years|Mean|44.2|44.2|Standard Deviation|11.9|11.9|||
4257830|NCT00617604|4081966|B1|||Age||years|Mean|46.5|46.5|Standard Deviation|11.3|11.3|||
4257831|NCT00617591|4082011|B1|United States||Region of Enrollment||participants|Number|57|57.0||||||
4257832|NCT00617591|4082011|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4257833|NCT00617591|4082011|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4257834|NCT00617591|4082011|B1|||Age||years|Median|63|63.0|Full Range|||36.0|78.0|
4257835|NCT00617591|4082011|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4257836|NCT00617591|4082011|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4257837|NCT00617591|4082011|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4257838|NCT00617539|4082019|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4257839|NCT00617539|4082019|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4257840|NCT00617539|4082019|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4257841|NCT00617539|4082019|B1|||Age||years|Median|53.5|53.5|Full Range|||31.0|83.0|
4257842|NCT00617461|4082027|B1|American Indian or Alaska Native & White||Race/Ethnicity, Customized|Race data were collected for all participants at the beginning of the Baseline period. Participants were not included in the Intent-to-Treat (ITT) Population unless they had an average baseline pain rating of 4, were randomized, took at least one dose of investigational product and completed one post-baseline efficacy assessment.|participants|Number|1|1.0||||||
4257843|NCT00617461|4082027|B1|White||Race/Ethnicity, Customized|Race data were collected for all participants at the beginning of the Baseline period. Participants were not included in the Intent-to-Treat (ITT) Population unless they had an average baseline pain rating of 4, were randomized, took at least one dose of investigational product and completed one post-baseline efficacy assessment.|participants|Number|74|74.0||||||
4257844|NCT00617461|4082027|B1|African American/African Heritage||Race/Ethnicity, Customized|Race data were collected for all participants at the beginning of the Baseline period. Participants were not included in the Intent-to-Treat (ITT) Population unless they had an average baseline pain rating of 4, were randomized, took at least one dose of investigational product and completed one post-baseline efficacy assessment.|participants|Number|18|18.0||||||
4257845|NCT00617461|4082027|B1||Male|Sex: Female, Male|Gender data were collected for all participants at the beginning of the Baseline period. Participants were not included in the Intent-to-Treat (ITT) Population unless they had an average baseline pain rating of 4, were randomized, took at least one dose of investigational product and completed one post-baseline efficacy assessment.|Participants|Count of Participants|57|57.0||||||
4257846|NCT00617461|4082027|B1||Female|Sex: Female, Male|Gender data were collected for all participants at the beginning of the Baseline period. Participants were not included in the Intent-to-Treat (ITT) Population unless they had an average baseline pain rating of 4, were randomized, took at least one dose of investigational product and completed one post-baseline efficacy assessment.|Participants|Count of Participants|36|36.0||||||
4257847|NCT00617461|4082027|B1|||Age|Age (years) data were collected for all participants at the beginning of the Baseline period. Participants were not included in the Intent-to-Treat (ITT) Population unless they had an average baseline pain rating of 4, were randomized, took at least one dose of investigational product and completed one post-baseline efficacy assessment.|Years|Mean|63|63.0|Standard Deviation|12.15|12.15|||
4257848|NCT00617409|4082081|B4|United States||Region of Enrollment||participants|Number|69|69.0||||||
4257849|NCT00617409|4082082|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4257850|NCT00617409|4082083|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4257851|NCT00617409|4082084|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4257852|NCT00617409|4082081|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4257853|NCT00617409|4082082|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4257854|NCT00617409|4082083|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4257855|NCT00617409|4082084|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4257856|NCT00617409|4082081|B4||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4257857|NCT00617409|4082082|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4257858|NCT00617409|4082083|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4257859|NCT00617409|4082084|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4257860|NCT00617409|4082081|B4|||Age||years|Mean|62.75|62.75|Full Range|||44.0|78.0|
4257861|NCT00617409|4082082|B3|||Age||years|Mean|62.45|62.45|Full Range|||49.0|78.0|
4257862|NCT00617409|4082083|B2|||Age||years|Mean|63|63.0|Full Range|||52.0|75.0|
4257863|NCT00617409|4082084|B1|||Age||years|Mean|63|63.0|Full Range|||44.0|74.0|
4257864|NCT00617409|4082081|B4||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4257865|NCT00617409|4082082|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4257866|NCT00617409|4082083|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4257867|NCT00617409|4082084|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4257868|NCT00617409|4082081|B4||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4257869|NCT00617409|4082082|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4257870|NCT00617409|4082083|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4257871|NCT00617409|4082084|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4257872|NCT00617409|4082081|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4257873|NCT00617409|4082082|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4257874|NCT00617409|4082083|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4257875|NCT00617409|4082084|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4257876|NCT00617396|4082097|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4257877|NCT00617396|4082097|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4257878|NCT00617396|4082097|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4257879|NCT00617396|4082097|B1|||Age||years|Mean|38.8|38.8|Standard Deviation|14.5|14.5|||
4257880|NCT00617396|4082097|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4257881|NCT00617396|4082097|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4257882|NCT00617396|4082097|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4257883|NCT00617357|4082101|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4257884|NCT00617357|4082101|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4257885|NCT00617357|4082101|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|71|71.0||||||
4257886|NCT00617357|4082101|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4257887|NCT00617357|4082101|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4257888|NCT00617357|4082101|B1|||Age||years|Mean|57|57.0|Standard Deviation|14|14.0|||
4257889|NCT00617305|4082111|B4|United States||Region of Enrollment||participants|Number|38|38.0||||||
4257890|NCT00617305|4082112|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4257891|NCT00617305|4082113|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4257892|NCT00617305|4082114|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4257893|NCT00617305|4082111|B4|White||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4257894|NCT00617305|4082112|B3|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4257895|NCT00617305|4082113|B2|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4257896|NCT00617305|4082114|B1|White||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4257897|NCT00617305|4082111|B4|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4257898|NCT00617305|4082112|B3|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4257899|NCT00617305|4082113|B2|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4257900|NCT00617305|4082114|B1|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4257901|NCT00617305|4082111|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4257902|NCT00617305|4082112|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4257903|NCT00617305|4082113|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4257904|NCT00617305|4082114|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4257905|NCT00617305|4082111|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4257906|NCT00617305|4082112|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4257907|NCT00617305|4082113|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4257908|NCT00617305|4082114|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4257909|NCT00617305|4082111|B4|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4257910|NCT00617305|4082112|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4257911|NCT00617305|4082113|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4257912|NCT00617305|4082114|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4257913|NCT00617305|4082111|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4257914|NCT00617305|4082112|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4257915|NCT00617305|4082113|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4257916|NCT00617305|4082114|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4257917|NCT00617305|4082111|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4257918|NCT00617305|4082112|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4257919|NCT00617305|4082113|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4257920|NCT00617305|4082114|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4257921|NCT00617305|4082111|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4257922|NCT00617305|4082112|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4257923|NCT00617305|4082113|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4257924|NCT00617305|4082114|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4257925|NCT00617305|4082111|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4257926|NCT00617305|4082112|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4257927|NCT00617305|4082113|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4257928|NCT00617305|4082114|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4257929|NCT00617305|4082111|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4257930|NCT00617305|4082112|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4257931|NCT00617305|4082113|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4257932|NCT00617305|4082114|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4257933|NCT00617305|4082111|B4|||Age||years|Mean|47.8|47.8|Standard Deviation|13.52|13.52|||
4257934|NCT00617305|4082112|B3|||Age||years|Mean|49.0|49.0|Standard Deviation|0|0.0|||
4257935|NCT00617305|4082113|B2|||Age||years|Mean|43.5|43.5|Standard Deviation|14.89|14.89|||
4257936|NCT00617305|4082114|B1|||Age||years|Mean|48.2|48.2|Standard Deviation|13.72|13.72|||
4257937|NCT00617305|4082111|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4257938|NCT00617305|4082112|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4257939|NCT00617305|4082113|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4257940|NCT00617305|4082114|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4257941|NCT00617305|4082111|B4||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4257942|NCT00617305|4082112|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4257943|NCT00617305|4082113|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4257944|NCT00617305|4082114|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4257945|NCT00617305|4082111|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4257946|NCT00617305|4082112|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4257947|NCT00617305|4082113|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4257948|NCT00617305|4082114|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4257949|NCT00617279|4082170|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4257950|NCT00617279|4082171|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4257951|NCT00617279|4082172|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4257952|NCT00617279|4082170|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4257953|NCT00617279|4082171|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4257954|NCT00617279|4082172|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4257955|NCT00617279|4082170|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4257956|NCT00617279|4082171|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4257957|NCT00617279|4082172|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4257958|NCT00617279|4082170|B3|||Age||years|Mean|67|67.0|Standard Deviation|9|9.0|||
4257959|NCT00617279|4082171|B2|||Age||years|Mean|68|68.0|Standard Deviation|8|8.0|||
4257960|NCT00617279|4082172|B1|||Age||years|Mean|65|65.0|Standard Deviation|10|10.0|||
4257961|NCT00617279|4082170|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4257962|NCT00617279|4082171|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4257963|NCT00617279|4082172|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4257964|NCT00617279|4082170|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4257965|NCT00617279|4082171|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4257966|NCT00617279|4082172|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4257967|NCT00617279|4082170|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4257968|NCT00617279|4082171|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4257969|NCT00617279|4082172|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4257970|NCT00617240|4082227|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4257971|NCT00617240|4082228|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4257972|NCT00617240|4082229|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4257973|NCT00617240|4082227|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4257974|NCT00617240|4082228|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4257975|NCT00617240|4082229|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4257976|NCT00617240|4082227|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4257977|NCT00617240|4082228|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4257978|NCT00617240|4082229|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4257979|NCT00617240|4082227|B3|||Age||years|Mean|14.22|14.22|Standard Deviation|2.048|2.048|||
4257980|NCT00617240|4082228|B2|||Age||years|Mean|14.25|14.25|Standard Deviation|2.754|2.754|||
4257981|NCT00617240|4082229|B1|||Age||years|Mean|14.20|14.2|Standard Deviation|1.643|1.643|||
4257982|NCT00617240|4082227|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4257983|NCT00617240|4082228|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4257984|NCT00617240|4082229|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4257985|NCT00617240|4082227|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4257986|NCT00617240|4082228|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4257987|NCT00617240|4082229|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4257988|NCT00617240|4082227|B3||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4257989|NCT00617240|4082228|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4257990|NCT00617240|4082229|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4257991|NCT00617201|4082248|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4257992|NCT00617201|4082249|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4257993|NCT00617201|4082250|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4257994|NCT00617201|4082248|B3|Male||Sex/Gender, Customized||participants|Number|23|23.0||||||
4257995|NCT00617201|4082249|B2|Male||Sex/Gender, Customized||participants|Number|6|6.0||||||
4257996|NCT00617201|4082250|B1|Male||Sex/Gender, Customized||participants|Number|17|17.0||||||
4257997|NCT00617201|4082248|B3|Female||Sex/Gender, Customized||participants|Number|27|27.0||||||
4257998|NCT00617201|4082249|B2|Female||Sex/Gender, Customized||participants|Number|19|19.0||||||
4257999|NCT00617201|4082250|B1|Female||Sex/Gender, Customized||participants|Number|8|8.0||||||
4258000|NCT00617201|4082248|B3|||Age||years|Mean|42|42.0|Standard Deviation|1.7|1.7|||
4258001|NCT00617201|4082249|B2|||Age||years|Mean|44.5|44.5|Standard Deviation|1.6|1.6|||
4258002|NCT00617201|4082250|B1|||Age||years|Mean|41.6|41.6|Standard Deviation|1.6|1.6|||
4258003|NCT00617201|4082248|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4258004|NCT00617201|4082249|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4258005|NCT00617201|4082250|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4258006|NCT00617201|4082248|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4258007|NCT00617201|4082249|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4258008|NCT00617201|4082250|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4258009|NCT00617201|4082248|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4258010|NCT00617201|4082249|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4258011|NCT00617201|4082250|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4258012|NCT00617188|4082259|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4258013|NCT00617188|4082259|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4258014|NCT00617188|4082259|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4258015|NCT00617188|4082259|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4258016|NCT00617188|4082259|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4258017|NCT00617188|4082259|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4258018|NCT00617175|4082268|B3|Portugal||Region of Enrollment||participants|Number|53|53.0||||||
4258019|NCT00617175|4082269|B2|Portugal||Region of Enrollment||participants|Number|30|30.0||||||
4258020|NCT00617175|4082270|B1|Portugal||Region of Enrollment||participants|Number|23|23.0||||||
4258021|NCT00617175|4082268|B3|Poland||Region of Enrollment||participants|Number|36|36.0||||||
4258022|NCT00617175|4082269|B2|Poland||Region of Enrollment||participants|Number|14|14.0||||||
4258023|NCT00617175|4082270|B1|Poland||Region of Enrollment||participants|Number|22|22.0||||||
4258024|NCT00617175|4082268|B3|South Africa||Region of Enrollment||participants|Number|56|56.0||||||
4258025|NCT00617175|4082269|B2|South Africa||Region of Enrollment||participants|Number|24|24.0||||||
4258026|NCT00617175|4082270|B1|South Africa||Region of Enrollment||participants|Number|32|32.0||||||
4258027|NCT00617175|4082268|B3|Finland||Region of Enrollment||participants|Number|5|5.0||||||
4258028|NCT00617175|4082269|B2|Finland||Region of Enrollment||participants|Number|2|2.0||||||
4258029|NCT00617175|4082270|B1|Finland||Region of Enrollment||participants|Number|3|3.0||||||
4258030|NCT00617175|4082268|B3|Denmark||Region of Enrollment||participants|Number|23|23.0||||||
4258031|NCT00617175|4082269|B2|Denmark||Region of Enrollment||participants|Number|14|14.0||||||
4258032|NCT00617175|4082270|B1|Denmark||Region of Enrollment||participants|Number|9|9.0||||||
4258033|NCT00617175|4082268|B3|Saudi Arabia||Region of Enrollment||participants|Number|90|90.0||||||
4258034|NCT00617175|4082269|B2|Saudi Arabia||Region of Enrollment||participants|Number|45|45.0||||||
4258035|NCT00617175|4082270|B1|Saudi Arabia||Region of Enrollment||participants|Number|45|45.0||||||
4258036|NCT00617175|4082268|B3|Russian Federation||Region of Enrollment||participants|Number|27|27.0||||||
4258037|NCT00617175|4082269|B2|Russian Federation||Region of Enrollment||participants|Number|18|18.0||||||
4258038|NCT00617175|4082270|B1|Russian Federation||Region of Enrollment||participants|Number|9|9.0||||||
4258039|NCT00617175|4082268|B3|France||Region of Enrollment||participants|Number|123|123.0||||||
4258040|NCT00617175|4082269|B2|France||Region of Enrollment||participants|Number|62|62.0||||||
4258041|NCT00617175|4082270|B1|France||Region of Enrollment||participants|Number|61|61.0||||||
4258042|NCT00617175|4082268|B3|Belgium||Region of Enrollment||participants|Number|40|40.0||||||
4258043|NCT00617175|4082269|B2|Belgium||Region of Enrollment||participants|Number|22|22.0||||||
4258044|NCT00617175|4082270|B1|Belgium||Region of Enrollment||participants|Number|18|18.0||||||
4258045|NCT00617175|4082268|B3|Netherlands||Region of Enrollment||participants|Number|48|48.0||||||
4258046|NCT00617175|4082269|B2|Netherlands||Region of Enrollment||participants|Number|23|23.0||||||
4258047|NCT00617175|4082270|B1|Netherlands||Region of Enrollment||participants|Number|25|25.0||||||
4258048|NCT00617175|4082268|B3|Hungary||Region of Enrollment||participants|Number|20|20.0||||||
4258049|NCT00617175|4082269|B2|Hungary||Region of Enrollment||participants|Number|9|9.0||||||
4258050|NCT00617175|4082270|B1|Hungary||Region of Enrollment||participants|Number|11|11.0||||||
4258051|NCT00617175|4082268|B3|Italy||Region of Enrollment||participants|Number|877|877.0||||||
4258052|NCT00617175|4082269|B2|Italy||Region of Enrollment||participants|Number|429|429.0||||||
4258053|NCT00617175|4082270|B1|Italy||Region of Enrollment||participants|Number|448|448.0||||||
4258054|NCT00617175|4082268|B3|Spain||Region of Enrollment||participants|Number|392|392.0||||||
4258055|NCT00617175|4082269|B2|Spain||Region of Enrollment||participants|Number|196|196.0||||||
4258056|NCT00617175|4082270|B1|Spain||Region of Enrollment||participants|Number|196|196.0||||||
4258057|NCT00617175|4082268|B3|Germany||Region of Enrollment||participants|Number|112|112.0||||||
4258058|NCT00617175|4082269|B2|Germany||Region of Enrollment||participants|Number|60|60.0||||||
4258059|NCT00617175|4082270|B1|Germany||Region of Enrollment||participants|Number|52|52.0||||||
4258060|NCT00617175|4082268|B3||Male|Sex: Female, Male||Participants|Count of Participants|1598|1598.0||||||
4258061|NCT00617175|4082269|B2||Male|Sex: Female, Male||Participants|Count of Participants|795|795.0||||||
4258062|NCT00617175|4082270|B1||Male|Sex: Female, Male||Participants|Count of Participants|803|803.0||||||
4258063|NCT00617175|4082268|B3||Female|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
4258064|NCT00617175|4082269|B2||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4258065|NCT00617175|4082270|B1||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4258066|NCT00617175|4082268|B3|||Age||years|Mean|65.47|65.47|Standard Deviation|11.04|11.04|||
4258067|NCT00617175|4082269|B2|||Age||years|Mean|65.4|65.4|Standard Deviation|11.0|11.0|||
4258068|NCT00617175|4082270|B1|||Age||years|Mean|65.5|65.5|Standard Deviation|11.1|11.1|||
4258069|NCT00617175|4082268|B3||>=65 years|Age||Participants|Count of Participants|1121|1121.0||||||
4258070|NCT00617175|4082269|B2||>=65 years|Age||Participants|Count of Participants|558|558.0||||||
4258071|NCT00617175|4082270|B1||>=65 years|Age||Participants|Count of Participants|563|563.0||||||
4258072|NCT00617175|4082268|B3||Between 18 and 65 years|Age||Participants|Count of Participants|781|781.0||||||
4258073|NCT00617175|4082269|B2||Between 18 and 65 years|Age||Participants|Count of Participants|390|390.0||||||
4258074|NCT00617175|4082270|B1||Between 18 and 65 years|Age||Participants|Count of Participants|391|391.0||||||
4258075|NCT00617175|4082268|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4258076|NCT00617175|4082269|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4258077|NCT00617175|4082270|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4258078|NCT00617123|4082277|B3||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4258079|NCT00617123|4082278|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4258080|NCT00617123|4082279|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4258081|NCT00617123|4082277|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4258082|NCT00617123|4082278|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4258083|NCT00617123|4082279|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4258084|NCT00617123|4082277|B3|||Age||years|Mean|55.9|55.9|Standard Deviation|10.9|10.9|||
4258085|NCT00617123|4082278|B2|||Age||years|Mean|55.3|55.3|Standard Deviation|11.7|11.7|||
4258086|NCT00617123|4082279|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|10.1|10.1|||
4258087|NCT00617097|4082294|B3|over-the-counter medication use||level of menstrual symptoms||participants|Number|22|22.0||||||
4258088|NCT00617097|4082295|B2|over-the-counter medication use||level of menstrual symptoms||participants|Number|14|14.0||||||
4258089|NCT00617097|4082296|B1|over-the-counter medication use||level of menstrual symptoms||participants|Number|8|8.0||||||
4258090|NCT00617097|4082294|B3|mild cramping, no medications||level of menstrual symptoms||participants|Number|13|13.0||||||
4258091|NCT00617097|4082295|B2|mild cramping, no medications||level of menstrual symptoms||participants|Number|4|4.0||||||
4258092|NCT00617097|4082296|B1|mild cramping, no medications||level of menstrual symptoms||participants|Number|9|9.0||||||
4258093|NCT00617097|4082294|B3|easy||level of menstrual symptoms||participants|Number|15|15.0||||||
4258094|NCT00617097|4082295|B2|easy||level of menstrual symptoms||participants|Number|7|7.0||||||
4258095|NCT00617097|4082296|B1|easy||level of menstrual symptoms||participants|Number|8|8.0||||||
4258096|NCT00617097|4082294|B3|Oregon Health and Science University||institution||participants|Number|22|22.0||||||
4258097|NCT00617097|4082295|B2|Oregon Health and Science University||institution||participants|Number|11|11.0||||||
4258098|NCT00617097|4082296|B1|Oregon Health and Science University||institution||participants|Number|11|11.0||||||
4258099|NCT00617097|4082294|B3|Johns Hopkins University||institution||participants|Number|28|28.0||||||
4258100|NCT00617097|4082295|B2|Johns Hopkins University||institution||participants|Number|14|14.0||||||
4258101|NCT00617097|4082296|B1|Johns Hopkins University||institution||participants|Number|14|14.0||||||
4258102|NCT00617097|4082294|B3|attending||level of provider performing procedure||participants|Number|34|34.0||||||
4258103|NCT00617097|4082295|B2|attending||level of provider performing procedure||participants|Number|18|18.0||||||
4258104|NCT00617097|4082296|B1|attending||level of provider performing procedure||participants|Number|16|16.0||||||
4258105|NCT00617097|4082294|B3|resident/fellow||level of provider performing procedure||participants|Number|16|16.0||||||
4258106|NCT00617097|4082295|B2|resident/fellow||level of provider performing procedure||participants|Number|7|7.0||||||
4258107|NCT00617097|4082296|B1|resident/fellow||level of provider performing procedure||participants|Number|9|9.0||||||
4258108|NCT00617097|4082294|B3|Missing data||prior abortions||participants|Number|1|1.0||||||
4258109|NCT00617097|4082295|B2|Missing data||prior abortions||participants|Number|1|1.0||||||
4258110|NCT00617097|4082296|B1|Missing data||prior abortions||participants|Number|0|0.0||||||
4258111|NCT00617097|4082294|B3|1 or more||prior abortions||participants|Number|19|19.0||||||
4258112|NCT00617097|4082295|B2|1 or more||prior abortions||participants|Number|9|9.0||||||
4258113|NCT00617097|4082296|B1|1 or more||prior abortions||participants|Number|10|10.0||||||
4258114|NCT00617097|4082294|B3|0||prior abortions||participants|Number|30|30.0||||||
4258115|NCT00617097|4082295|B2|0||prior abortions||participants|Number|15|15.0||||||
4258116|NCT00617097|4082296|B1|0||prior abortions||participants|Number|15|15.0||||||
4258117|NCT00617097|4082294|B3|1 or more||prior vaginal deliveries||participants|Number|15|15.0||||||
4258118|NCT00617097|4082295|B2|1 or more||prior vaginal deliveries||participants|Number|7|7.0||||||
4258119|NCT00617097|4082296|B1|1 or more||prior vaginal deliveries||participants|Number|8|8.0||||||
4258120|NCT00617097|4082294|B3|0||prior vaginal deliveries||participants|Number|35|35.0||||||
4258121|NCT00617097|4082295|B2|0||prior vaginal deliveries||participants|Number|18|18.0||||||
4258122|NCT00617097|4082296|B1|0||prior vaginal deliveries||participants|Number|17|17.0||||||
4258123|NCT00617097|4082294|B3|Missing data||gravidity||participants|Number|1|1.0||||||
4258124|NCT00617097|4082295|B2|Missing data||gravidity||participants|Number|1|1.0||||||
4258125|NCT00617097|4082296|B1|Missing data||gravidity||participants|Number|0|0.0||||||
4258126|NCT00617097|4082294|B3|4 or greater||gravidity||participants|Number|18|18.0||||||
4258127|NCT00617097|4082295|B2|4 or greater||gravidity||participants|Number|10|10.0||||||
4258128|NCT00617097|4082296|B1|4 or greater||gravidity||participants|Number|8|8.0||||||
4258129|NCT00617097|4082294|B3|3||gravidity||participants|Number|7|7.0||||||
4258130|NCT00617097|4082295|B2|3||gravidity||participants|Number|2|2.0||||||
4258131|NCT00617097|4082296|B1|3||gravidity||participants|Number|5|5.0||||||
4258132|NCT00617097|4082294|B3|2||gravidity||participants|Number|9|9.0||||||
4258133|NCT00617097|4082295|B2|2||gravidity||participants|Number|3|3.0||||||
4258134|NCT00617097|4082296|B1|2||gravidity||participants|Number|6|6.0||||||
4258135|NCT00617097|4082294|B3|1||gravidity||participants|Number|15|15.0||||||
4258136|NCT00617097|4082295|B2|1||gravidity||participants|Number|9|9.0||||||
4258137|NCT00617097|4082296|B1|1||gravidity||participants|Number|6|6.0||||||
4258138|NCT00617097|4082294|B3|||gestational age||days|Mean|55.7|55.7|Standard Deviation|10.6|10.6|||
4258139|NCT00617097|4082295|B2|||gestational age||days|Mean|57.3|57.3|Standard Deviation|11|11.0|||
4258140|NCT00617097|4082296|B1|||gestational age||days|Mean|54|54.0|Standard Deviation|10.1|10.1|||
4258141|NCT00617097|4082294|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4258142|NCT00617097|4082295|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4258143|NCT00617097|4082296|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4258144|NCT00617097|4082294|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4258145|NCT00617097|4082295|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4258146|NCT00617097|4082296|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258147|NCT00617097|4082294|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4258148|NCT00617097|4082295|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4258149|NCT00617097|4082296|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4258150|NCT00617097|4082294|B3||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4258151|NCT00617097|4082295|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4258152|NCT00617097|4082296|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4258153|NCT00617097|4082294|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4258154|NCT00617097|4082295|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4258155|NCT00617097|4082296|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4258156|NCT00617097|4082294|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258157|NCT00617097|4082295|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258158|NCT00617097|4082296|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258159|NCT00617097|4082294|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4258160|NCT00617097|4082295|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4258161|NCT00617097|4082296|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4258162|NCT00617097|4082294|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4258163|NCT00617097|4082295|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258164|NCT00617097|4082296|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4258165|NCT00617097|4082294|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258166|NCT00617097|4082295|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258167|NCT00617097|4082296|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258168|NCT00617097|4082294|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4258169|NCT00617097|4082295|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4258170|NCT00617097|4082296|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4258171|NCT00617097|4082294|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4258172|NCT00617097|4082295|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4258173|NCT00617097|4082296|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4258174|NCT00617097|4082294|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4258175|NCT00617097|4082295|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4258176|NCT00617097|4082296|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4258177|NCT00617097|4082294|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4258178|NCT00617097|4082295|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4258179|NCT00617097|4082296|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4258180|NCT00617097|4082294|B3|||Age||years|Mean|26.3|26.3|Standard Deviation|5.8|5.8|||
4258181|NCT00617097|4082295|B2|||Age||years|Mean|25.6|25.6|Standard Deviation|5.4|5.4|||
4258182|NCT00617097|4082296|B1|||Age||years|Mean|27|27.0|Standard Deviation|6.2|6.2|||
4258183|NCT00617084|4082309|B3|Middle East||Region of Enrollment||participants|Number|38|38.0||||||
4258184|NCT00617084|4082310|B2|Middle East||Region of Enrollment||participants|Number|20|20.0||||||
4258185|NCT00617084|4082311|B1|Middle East||Region of Enrollment||participants|Number|18|18.0||||||
4258186|NCT00617084|4082309|B3|Europe||Region of Enrollment||participants|Number|2254|2254.0||||||
4258187|NCT00617084|4082310|B2|Europe||Region of Enrollment||participants|Number|1132|1132.0||||||
4258188|NCT00617084|4082311|B1|Europe||Region of Enrollment||participants|Number|1122|1122.0||||||
4258189|NCT00617084|4082309|B3||Male|Sex: Female, Male||Participants|Count of Participants|1763|1763.0||||||
4258190|NCT00617084|4082310|B2||Male|Sex: Female, Male||Participants|Count of Participants|889|889.0||||||
4258191|NCT00617084|4082311|B1||Male|Sex: Female, Male||Participants|Count of Participants|874|874.0||||||
4258192|NCT00617084|4082309|B3||Female|Sex: Female, Male||Participants|Count of Participants|529|529.0||||||
4258193|NCT00617084|4082310|B2||Female|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
4258194|NCT00617084|4082311|B1||Female|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
4258195|NCT00617084|4082309|B3|||Age||years|Mean|64.3|64.3|Standard Deviation|10.9|10.9|||
4258196|NCT00617084|4082310|B2|||Age||years|Mean|64.2|64.2|Standard Deviation|10.8|10.8|||
4258197|NCT00617084|4082311|B1|||Age||years|Mean|64.4|64.4|Standard Deviation|10.9|10.9|||
4258198|NCT00617084|4082309|B3||>=65 years|Age||Participants|Count of Participants|1184|1184.0||||||
4258199|NCT00617084|4082310|B2||>=65 years|Age||Participants|Count of Participants|589|589.0||||||
4258200|NCT00617084|4082311|B1||>=65 years|Age||Participants|Count of Participants|595|595.0||||||
4258201|NCT00617084|4082309|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1108|1108.0||||||
4258202|NCT00617084|4082310|B2||Between 18 and 65 years|Age||Participants|Count of Participants|563|563.0||||||
4258203|NCT00617084|4082311|B1||Between 18 and 65 years|Age||Participants|Count of Participants|545|545.0||||||
4258204|NCT00617084|4082309|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4258205|NCT00617084|4082310|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4258206|NCT00617084|4082311|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4258207|NCT00617058|4082320|B4|United States||Region of Enrollment||participants|Number|1|1.0||||||
4258208|NCT00617058|4082323|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4258209|NCT00617058|4082320|B4|Male||Gender||participants|Number|1|1.0||||||
4258210|NCT00617058|4082323|B1|Male||Gender||participants|Number|1|1.0||||||
4258211|NCT00617058|4082320|B4|Female||Gender||participants|Number|0|0.0||||||
4258212|NCT00617058|4082323|B1|Female||Gender||participants|Number|0|0.0||||||
4258213|NCT00617058|4082320|B4|||Age||years|Mean|17|17.0|Standard Deviation|||||
4258214|NCT00617058|4082323|B1|||Age||years|Mean|17|17.0|Standard Deviation|||||
4258215|NCT00617058|4082320|B4|>=65 years||Age||participants|Number|0|0.0||||||
4258216|NCT00617058|4082323|B1|>=65 years||Age||participants|Number|0|0.0||||||
4258217|NCT00617058|4082320|B4|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
4258218|NCT00617058|4082323|B1|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
4258219|NCT00617058|4082320|B4|<=18 years||Age||participants|Number|1|1.0||||||
4258220|NCT00617058|4082323|B1|<=18 years||Age||participants|Number|1|1.0||||||
4258221|NCT00616967|4082363|B3|ER-/PR+||Receptor Status|Estrogen receptors (ER) and Progesterone receptors (PR) are found in breast cancer cells that depend on estrogen and related hormones to grow. If breast cancer cells have estrogen receptors, the cancer is called ER-positive breast cancer (ER+) . If breast cancer cells have progesterone receptors, the cancer is called PR-positive breast cancer (PR+). If the cells do not have either of these two receptors, the cancer is called ER/PR-negative (ER- and PR-).|participants|Number|4|4.0||||||
4258222|NCT00616967|4082364|B2|ER-/PR+||Receptor Status|Estrogen receptors (ER) and Progesterone receptors (PR) are found in breast cancer cells that depend on estrogen and related hormones to grow. If breast cancer cells have estrogen receptors, the cancer is called ER-positive breast cancer (ER+) . If breast cancer cells have progesterone receptors, the cancer is called PR-positive breast cancer (PR+). If the cells do not have either of these two receptors, the cancer is called ER/PR-negative (ER- and PR-).|participants|Number|3|3.0||||||
4258223|NCT00616967|4082365|B1|ER-/PR+||Receptor Status|Estrogen receptors (ER) and Progesterone receptors (PR) are found in breast cancer cells that depend on estrogen and related hormones to grow. If breast cancer cells have estrogen receptors, the cancer is called ER-positive breast cancer (ER+) . If breast cancer cells have progesterone receptors, the cancer is called PR-positive breast cancer (PR+). If the cells do not have either of these two receptors, the cancer is called ER/PR-negative (ER- and PR-).|participants|Number|1|1.0||||||
4258224|NCT00616967|4082363|B3|ER+/PR-||Receptor Status|Estrogen receptors (ER) and Progesterone receptors (PR) are found in breast cancer cells that depend on estrogen and related hormones to grow. If breast cancer cells have estrogen receptors, the cancer is called ER-positive breast cancer (ER+) . If breast cancer cells have progesterone receptors, the cancer is called PR-positive breast cancer (PR+). If the cells do not have either of these two receptors, the cancer is called ER/PR-negative (ER- and PR-).|participants|Number|12|12.0||||||
4258225|NCT00616967|4082364|B2|ER+/PR-||Receptor Status|Estrogen receptors (ER) and Progesterone receptors (PR) are found in breast cancer cells that depend on estrogen and related hormones to grow. If breast cancer cells have estrogen receptors, the cancer is called ER-positive breast cancer (ER+) . If breast cancer cells have progesterone receptors, the cancer is called PR-positive breast cancer (PR+). If the cells do not have either of these two receptors, the cancer is called ER/PR-negative (ER- and PR-).|participants|Number|6|6.0||||||
4258226|NCT00616967|4082365|B1|ER+/PR-||Receptor Status|Estrogen receptors (ER) and Progesterone receptors (PR) are found in breast cancer cells that depend on estrogen and related hormones to grow. If breast cancer cells have estrogen receptors, the cancer is called ER-positive breast cancer (ER+) . If breast cancer cells have progesterone receptors, the cancer is called PR-positive breast cancer (PR+). If the cells do not have either of these two receptors, the cancer is called ER/PR-negative (ER- and PR-).|participants|Number|6|6.0||||||
4258227|NCT00616967|4082363|B3|ER+/PR+||Receptor Status|Estrogen receptors (ER) and Progesterone receptors (PR) are found in breast cancer cells that depend on estrogen and related hormones to grow. If breast cancer cells have estrogen receptors, the cancer is called ER-positive breast cancer (ER+) . If breast cancer cells have progesterone receptors, the cancer is called PR-positive breast cancer (PR+). If the cells do not have either of these two receptors, the cancer is called ER/PR-negative (ER- and PR-).|participants|Number|22|22.0||||||
4258228|NCT00616967|4082364|B2|ER+/PR+||Receptor Status|Estrogen receptors (ER) and Progesterone receptors (PR) are found in breast cancer cells that depend on estrogen and related hormones to grow. If breast cancer cells have estrogen receptors, the cancer is called ER-positive breast cancer (ER+) . If breast cancer cells have progesterone receptors, the cancer is called PR-positive breast cancer (PR+). If the cells do not have either of these two receptors, the cancer is called ER/PR-negative (ER- and PR-).|participants|Number|10|10.0||||||
4258229|NCT00616967|4082365|B1|ER+/PR+||Receptor Status|Estrogen receptors (ER) and Progesterone receptors (PR) are found in breast cancer cells that depend on estrogen and related hormones to grow. If breast cancer cells have estrogen receptors, the cancer is called ER-positive breast cancer (ER+) . If breast cancer cells have progesterone receptors, the cancer is called PR-positive breast cancer (PR+). If the cells do not have either of these two receptors, the cancer is called ER/PR-negative (ER- and PR-).|participants|Number|12|12.0||||||
4258230|NCT00616967|4082363|B3|ER-/PR-||Receptor Status|Estrogen receptors (ER) and Progesterone receptors (PR) are found in breast cancer cells that depend on estrogen and related hormones to grow. If breast cancer cells have estrogen receptors, the cancer is called ER-positive breast cancer (ER+) . If breast cancer cells have progesterone receptors, the cancer is called PR-positive breast cancer (PR+). If the cells do not have either of these two receptors, the cancer is called ER/PR-negative (ER- and PR-).|participants|Number|24|24.0||||||
4258231|NCT00616967|4082364|B2|ER-/PR-||Receptor Status|Estrogen receptors (ER) and Progesterone receptors (PR) are found in breast cancer cells that depend on estrogen and related hormones to grow. If breast cancer cells have estrogen receptors, the cancer is called ER-positive breast cancer (ER+) . If breast cancer cells have progesterone receptors, the cancer is called PR-positive breast cancer (PR+). If the cells do not have either of these two receptors, the cancer is called ER/PR-negative (ER- and PR-).|participants|Number|12|12.0||||||
4258232|NCT00616967|4082365|B1|ER-/PR-||Receptor Status|Estrogen receptors (ER) and Progesterone receptors (PR) are found in breast cancer cells that depend on estrogen and related hormones to grow. If breast cancer cells have estrogen receptors, the cancer is called ER-positive breast cancer (ER+) . If breast cancer cells have progesterone receptors, the cancer is called PR-positive breast cancer (PR+). If the cells do not have either of these two receptors, the cancer is called ER/PR-negative (ER- and PR-).|participants|Number|12|12.0||||||
4258233|NCT00616967|4082363|B3|Grade 3||Tumor Grade|Tumor grade is the description of a tumor based on how abnormal the tumor cells and tissue look under a microscope. It is an indicator of how quickly a tumor is likely to grow and spread. If the cells of the tumor are close to those of normal cells, the tumor is called “well-differentiated.” Tumors that are “undifferentiated” or “poorly differentiated” have abnormal-looking cells and may lack normal tissue structures. A grade = 1 means well differentiated (low grade). A grade = 2 means moderately differentiated (intermediate grade). A grade = 3 means poorly differentiated (high grade).|participants|Number|44|44.0||||||
4258262|NCT00616967|4082365|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258234|NCT00616967|4082364|B2|Grade 3||Tumor Grade|Tumor grade is the description of a tumor based on how abnormal the tumor cells and tissue look under a microscope. It is an indicator of how quickly a tumor is likely to grow and spread. If the cells of the tumor are close to those of normal cells, the tumor is called “well-differentiated.” Tumors that are “undifferentiated” or “poorly differentiated” have abnormal-looking cells and may lack normal tissue structures. A grade = 1 means well differentiated (low grade). A grade = 2 means moderately differentiated (intermediate grade). A grade = 3 means poorly differentiated (high grade).|participants|Number|24|24.0||||||
4258235|NCT00616967|4082365|B1|Grade 3||Tumor Grade|Tumor grade is the description of a tumor based on how abnormal the tumor cells and tissue look under a microscope. It is an indicator of how quickly a tumor is likely to grow and spread. If the cells of the tumor are close to those of normal cells, the tumor is called “well-differentiated.” Tumors that are “undifferentiated” or “poorly differentiated” have abnormal-looking cells and may lack normal tissue structures. A grade = 1 means well differentiated (low grade). A grade = 2 means moderately differentiated (intermediate grade). A grade = 3 means poorly differentiated (high grade).|participants|Number|20|20.0||||||
4258236|NCT00616967|4082363|B3|Grade 2||Tumor Grade|Tumor grade is the description of a tumor based on how abnormal the tumor cells and tissue look under a microscope. It is an indicator of how quickly a tumor is likely to grow and spread. If the cells of the tumor are close to those of normal cells, the tumor is called “well-differentiated.” Tumors that are “undifferentiated” or “poorly differentiated” have abnormal-looking cells and may lack normal tissue structures. A grade = 1 means well differentiated (low grade). A grade = 2 means moderately differentiated (intermediate grade). A grade = 3 means poorly differentiated (high grade).|participants|Number|18|18.0||||||
4258237|NCT00616967|4082364|B2|Grade 2||Tumor Grade|Tumor grade is the description of a tumor based on how abnormal the tumor cells and tissue look under a microscope. It is an indicator of how quickly a tumor is likely to grow and spread. If the cells of the tumor are close to those of normal cells, the tumor is called “well-differentiated.” Tumors that are “undifferentiated” or “poorly differentiated” have abnormal-looking cells and may lack normal tissue structures. A grade = 1 means well differentiated (low grade). A grade = 2 means moderately differentiated (intermediate grade). A grade = 3 means poorly differentiated (high grade).|participants|Number|7|7.0||||||
4258238|NCT00616967|4082365|B1|Grade 2||Tumor Grade|Tumor grade is the description of a tumor based on how abnormal the tumor cells and tissue look under a microscope. It is an indicator of how quickly a tumor is likely to grow and spread. If the cells of the tumor are close to those of normal cells, the tumor is called “well-differentiated.” Tumors that are “undifferentiated” or “poorly differentiated” have abnormal-looking cells and may lack normal tissue structures. A grade = 1 means well differentiated (low grade). A grade = 2 means moderately differentiated (intermediate grade). A grade = 3 means poorly differentiated (high grade).|participants|Number|11|11.0||||||
4258239|NCT00616967|4082363|B3|Positive||Nodal Status||participants|Number|38|38.0||||||
4258240|NCT00616967|4082364|B2|Positive||Nodal Status||participants|Number|17|17.0||||||
4258241|NCT00616967|4082365|B1|Positive||Nodal Status||participants|Number|21|21.0||||||
4258242|NCT00616967|4082363|B3|Negative||Nodal Status||participants|Number|24|24.0||||||
4258243|NCT00616967|4082364|B2|Negative||Nodal Status||participants|Number|14|14.0||||||
4258244|NCT00616967|4082365|B1|Negative||Nodal Status||participants|Number|10|10.0||||||
4258245|NCT00616967|4082363|B3|||Tumor Size||centimeters|Median|4|4.0|Full Range|||1.5|18.0|
4258246|NCT00616967|4082364|B2|||Tumor Size||centimeters|Median|4|4.0|Full Range|||1.5|11.5|
4258247|NCT00616967|4082365|B1|||Tumor Size||centimeters|Median|5|5.0|Full Range|||1.7|18.0|
4258248|NCT00616967|4082363|B3|ECOG 1||ECOG Performance Status|ECOG (Eastern Cooperative Oncology Group) criteria is a measure of patient performance status due to symptoms. A score of ECOG = 0 is defined as a person who is asymptomatic. A score of ECOG =1 is a defined as a person who has symptoms, but is fully ambulatory.|participants|Number|3|3.0||||||
4258249|NCT00616967|4082364|B2|ECOG 1||ECOG Performance Status|ECOG (Eastern Cooperative Oncology Group) criteria is a measure of patient performance status due to symptoms. A score of ECOG = 0 is defined as a person who is asymptomatic. A score of ECOG =1 is a defined as a person who has symptoms, but is fully ambulatory.|participants|Number|2|2.0||||||
4258250|NCT00616967|4082365|B1|ECOG 1||ECOG Performance Status|ECOG (Eastern Cooperative Oncology Group) criteria is a measure of patient performance status due to symptoms. A score of ECOG = 0 is defined as a person who is asymptomatic. A score of ECOG =1 is a defined as a person who has symptoms, but is fully ambulatory.|participants|Number|1|1.0||||||
4258251|NCT00616967|4082363|B3|ECOG 0||ECOG Performance Status|ECOG (Eastern Cooperative Oncology Group) criteria is a measure of patient performance status due to symptoms. A score of ECOG = 0 is defined as a person who is asymptomatic. A score of ECOG =1 is a defined as a person who has symptoms, but is fully ambulatory.|participants|Number|59|59.0||||||
4258252|NCT00616967|4082364|B2|ECOG 0||ECOG Performance Status|ECOG (Eastern Cooperative Oncology Group) criteria is a measure of patient performance status due to symptoms. A score of ECOG = 0 is defined as a person who is asymptomatic. A score of ECOG =1 is a defined as a person who has symptoms, but is fully ambulatory.|participants|Number|29|29.0||||||
4258253|NCT00616967|4082365|B1|ECOG 0||ECOG Performance Status|ECOG (Eastern Cooperative Oncology Group) criteria is a measure of patient performance status due to symptoms. A score of ECOG = 0 is defined as a person who is asymptomatic. A score of ECOG =1 is a defined as a person who has symptoms, but is fully ambulatory.|participants|Number|30|30.0||||||
4258254|NCT00616967|4082363|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
4258255|NCT00616967|4082364|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
4258256|NCT00616967|4082365|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4258257|NCT00616967|4082363|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4258258|NCT00616967|4082364|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4258259|NCT00616967|4082365|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4258260|NCT00616967|4082363|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258261|NCT00616967|4082364|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258263|NCT00616967|4082363|B3||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4258264|NCT00616967|4082364|B2||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4258265|NCT00616967|4082365|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4258266|NCT00616967|4082363|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4258267|NCT00616967|4082364|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4258268|NCT00616967|4082365|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4258269|NCT00616967|4082363|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258270|NCT00616967|4082364|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258271|NCT00616967|4082365|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258272|NCT00616967|4082363|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258273|NCT00616967|4082364|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258274|NCT00616967|4082365|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258275|NCT00616967|4082363|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258276|NCT00616967|4082364|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258277|NCT00616967|4082365|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258278|NCT00616967|4082363|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4258279|NCT00616967|4082364|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4258280|NCT00616967|4082365|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4258281|NCT00616967|4082363|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4258282|NCT00616967|4082364|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4258283|NCT00616967|4082365|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4258284|NCT00616967|4082363|B3|||Age||years|Median|48|48.0|Full Range|||24.0|72.0|
4258285|NCT00616967|4082364|B2|||Age||years|Median|48|48.0|Full Range|||31.0|68.0|
4258286|NCT00616967|4082365|B1|||Age||years|Median|48|48.0|Full Range|||24.0|72.0|
4258287|NCT00616941|4082376|B4|||Body Mass Index||kg/m^2|Mean|27.3|27.3|Standard Deviation|7.2|7.2|||
4258288|NCT00616941|4082377|B3|||Body Mass Index||kg/m^2|Mean|26.5|26.5|Standard Deviation|6.6|6.6|||
4258289|NCT00616941|4082378|B2|||Body Mass Index||kg/m^2|Mean|29.1|29.1|Standard Deviation|8.1|8.1|||
4258290|NCT00616941|4082379|B1|||Body Mass Index||kg/m^2|Mean|23.6|23.6|Standard Deviation|4.8|4.8|||
4258291|NCT00616941|4082376|B4|United States||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
4258292|NCT00616941|4082377|B3|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4258293|NCT00616941|4082378|B2|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4258294|NCT00616941|4082379|B1|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4258295|NCT00616941|4082376|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258296|NCT00616941|4082377|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258297|NCT00616941|4082378|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258298|NCT00616941|4082379|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258299|NCT00616941|4082376|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258300|NCT00616941|4082377|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258301|NCT00616941|4082378|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258302|NCT00616941|4082379|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258303|NCT00616941|4082376|B4||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4258304|NCT00616941|4082377|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4258305|NCT00616941|4082378|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4258306|NCT00616941|4082379|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4258307|NCT00616941|4082376|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258308|NCT00616941|4082377|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258309|NCT00616941|4082378|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258310|NCT00616941|4082379|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258311|NCT00616941|4082376|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258312|NCT00616941|4082377|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258313|NCT00616941|4082378|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258314|NCT00616941|4082379|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258315|NCT00616941|4082376|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4258316|NCT00616941|4082377|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4258317|NCT00616941|4082378|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258318|NCT00616941|4082379|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258319|NCT00616941|4082376|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258320|NCT00616941|4082377|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258321|NCT00616941|4082378|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258322|NCT00616941|4082379|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258323|NCT00616941|4082376|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258324|NCT00616941|4082377|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258325|NCT00616941|4082378|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258326|NCT00616941|4082379|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258327|NCT00616941|4082376|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4258328|NCT00616941|4082377|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4258329|NCT00616941|4082378|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4258330|NCT00616941|4082379|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4258331|NCT00616941|4082376|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258332|NCT00616941|4082377|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258333|NCT00616941|4082378|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258334|NCT00616941|4082379|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258335|NCT00616941|4082376|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4258336|NCT00616941|4082377|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4258337|NCT00616941|4082378|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4258338|NCT00616941|4082379|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4258339|NCT00616941|4082376|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4258340|NCT00616941|4082377|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4258341|NCT00616941|4082378|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4258342|NCT00616941|4082379|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4258343|NCT00616941|4082376|B4|||Age||years|Mean|57.8|57.8|Standard Deviation|8.5|8.5|||
4258344|NCT00616941|4082377|B3|||Age||years|Mean|57.1|57.1|Standard Deviation|9.5|9.5|||
4258345|NCT00616941|4082378|B2|||Age||years|Mean|58.6|58.6|Standard Deviation|7.7|7.7|||
4258346|NCT00616941|4082379|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|10.7|10.7|||
4258347|NCT00616928|4082404|B5||Male|Sex: Female, Male||Participants|Count of Participants|1992|1992.0||||||
4258348|NCT00616928|4082405|B4||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4258349|NCT00616928|4082406|B3||Male|Sex: Female, Male||Participants|Count of Participants|497|497.0||||||
4258350|NCT00616928|4082407|B2||Male|Sex: Female, Male||Participants|Count of Participants|344|344.0||||||
4258351|NCT00616928|4082408|B1||Male|Sex: Female, Male||Participants|Count of Participants|976|976.0||||||
4258352|NCT00616928|4082404|B5||Female|Sex: Female, Male||Participants|Count of Participants|2569|2569.0||||||
4258353|NCT00616928|4082405|B4||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4258354|NCT00616928|4082406|B3||Female|Sex: Female, Male||Participants|Count of Participants|621|621.0||||||
4258355|NCT00616928|4082407|B2||Female|Sex: Female, Male||Participants|Count of Participants|424|424.0||||||
4258356|NCT00616928|4082408|B1||Female|Sex: Female, Male||Participants|Count of Participants|1328|1328.0||||||
4258357|NCT00616928|4082404|B5|||Age||Years|Mean|49.5|49.5|Standard Deviation|19.50|19.5|||
4258358|NCT00616928|4082405|B4|||Age||Years|Mean|72.1|72.1|Standard Deviation|5.41|5.41|||
4258359|NCT00616928|4082406|B3|||Age||Years|Mean|71.9|71.9|Standard Deviation|5.49|5.49|||
4258360|NCT00616928|4082407|B2|||Age||Years|Mean|38.7|38.7|Standard Deviation|13.58|13.58|||
4258361|NCT00616928|4082408|B1|||Age||Years|Mean|38.5|38.5|Standard Deviation|13.64|13.64|||
4258362|NCT00616902|4082473|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258363|NCT00616902|4082474|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258364|NCT00616902|4082475|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258365|NCT00616902|4082473|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258366|NCT00616902|4082474|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258367|NCT00616902|4082475|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258368|NCT00616902|4082473|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4258369|NCT00616902|4082474|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4258370|NCT00616902|4082475|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4258371|NCT00616902|4082473|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4258372|NCT00616902|4082474|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4258373|NCT00616902|4082475|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4258374|NCT00616902|4082473|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258375|NCT00616902|4082474|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258376|NCT00616902|4082475|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258377|NCT00616902|4082473|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4258378|NCT00616902|4082474|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258379|NCT00616902|4082475|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4258380|NCT00616902|4082473|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258381|NCT00616902|4082474|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258382|NCT00616902|4082475|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4258383|NCT00616902|4082473|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4258384|NCT00616902|4082474|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4258385|NCT00616902|4082475|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4258386|NCT00616902|4082473|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4258387|NCT00616902|4082474|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4258388|NCT00616902|4082475|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4258389|NCT00616902|4082473|B3|||Age||years|Mean|56.7|56.7|Standard Deviation|12.01|12.01|||
4258390|NCT00616902|4082474|B2|||Age||years|Mean|58.8|58.8|Standard Deviation|7.05|7.05|||
4258391|NCT00616902|4082475|B1|||Age||years|Mean|54.5|54.5|Standard Deviation|16.01|16.01|||
4258392|NCT00616902|4082473|B3|>= 60 years||Age, Customized||participants|Number|6|6.0||||||
4258393|NCT00616902|4082474|B2|>= 60 years||Age, Customized||participants|Number|4|4.0||||||
4258394|NCT00616902|4082475|B1|>= 60 years||Age, Customized||participants|Number|2|2.0||||||
4258395|NCT00616902|4082473|B3|40 - < 60 years||Age, Customized||participants|Number|5|5.0||||||
4258396|NCT00616902|4082474|B2|40 - < 60 years||Age, Customized||participants|Number|2|2.0||||||
4258397|NCT00616902|4082475|B1|40 - < 60 years||Age, Customized||participants|Number|3|3.0||||||
4258398|NCT00616902|4082473|B3|< 40 years||Age, Customized||participants|Number|1|1.0||||||
4258399|NCT00616902|4082474|B2|< 40 years||Age, Customized||participants|Number|0|0.0||||||
4258400|NCT00616902|4082475|B1|< 40 years||Age, Customized||participants|Number|1|1.0||||||
4258401|NCT00616772|4082500|B3|||Posterior-wall Carotid Intima-media (cIMT) Thickness||mm|Mean|0.77|0.77|Standard Deviation|0.11|0.11|||
4258402|NCT00616772|4082501|B2|||Posterior-wall Carotid Intima-media (cIMT) Thickness||mm|Mean|0.78|0.78|Standard Deviation|0.12|0.12|||
4258403|NCT00616772|4082502|B1|||Posterior-wall Carotid Intima-media (cIMT) Thickness||mm|Mean|0.76|0.76|Standard Deviation|0.10|0.1|||
4258404|NCT00616772|4082500|B3|||Triglycerides||mg/dL|Mean|227.5|227.5|Standard Deviation|118.78|118.78|||
4258405|NCT00616772|4082501|B2|||Triglycerides||mg/dL|Mean|228.7|228.7|Standard Deviation|127.06|127.06|||
4258406|NCT00616772|4082502|B1|||Triglycerides||mg/dL|Mean|226.3|226.3|Standard Deviation|110.01|110.01|||
4258407|NCT00616772|4082500|B3|||Low-density Lipoprotein Cholesterol (LDL-C)||mg/dL|Mean|84.3|84.3|Standard Deviation|20.88|20.88|||
4258408|NCT00616772|4082501|B2|||Low-density Lipoprotein Cholesterol (LDL-C)||mg/dL|Mean|84.5|84.5|Standard Deviation|20.47|20.47|||
4258409|NCT00616772|4082502|B1|||Low-density Lipoprotein Cholesterol (LDL-C)||mg/dL|Mean|84.0|84.0|Standard Deviation|21.30|21.3|||
4258410|NCT00616772|4082500|B3||Male|Sex: Female, Male||Participants|Count of Participants|458|458.0||||||
4258411|NCT00616772|4082501|B2||Male|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4258412|NCT00616772|4082502|B1||Male|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
4258413|NCT00616772|4082500|B3||Female|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4258414|NCT00616772|4082501|B2||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4258415|NCT00616772|4082502|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4258416|NCT00616772|4082500|B3|||Age||years|Mean|60.8|60.8|Standard Deviation|8.75|8.75|||
4258417|NCT00616772|4082501|B2|||Age||years|Mean|60.7|60.7|Standard Deviation|8.79|8.79|||
4258418|NCT00616772|4082502|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|8.71|8.71|||
4258419|NCT00616759|4082517|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4258420|NCT00616759|4082518|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4258421|NCT00616759|4082519|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4258422|NCT00616759|4082517|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4258423|NCT00616759|4082518|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4258424|NCT00616759|4082519|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4258425|NCT00616759|4082517|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4258426|NCT00616759|4082518|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4258427|NCT00616759|4082519|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4258428|NCT00616759|4082517|B3|||Age||years|Mean|57.3|57.3|Standard Deviation|8.22|8.22|||
4258429|NCT00616759|4082518|B2|||Age||years|Mean|57.1|57.1|Standard Deviation|9.4|9.4|||
4258430|NCT00616759|4082519|B1|||Age||years|Mean|58.6|58.6|Standard Deviation|7.3|7.3|||
4258431|NCT00616759|4082517|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4258432|NCT00616759|4082518|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4258433|NCT00616759|4082519|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4258434|NCT00616759|4082517|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4258435|NCT00616759|4082518|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4258436|NCT00616759|4082519|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4258437|NCT00616759|4082517|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4258438|NCT00616759|4082518|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4258439|NCT00616759|4082519|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4258440|NCT00616655|4082526|B4|United States||Region of Enrollment||participants|Number|440|440.0||||||
4258441|NCT00616655|4082527|B3|United States||Region of Enrollment||participants|Number|145|145.0||||||
4258442|NCT00616655|4082528|B2|United States||Region of Enrollment||participants|Number|146|146.0||||||
4258443|NCT00616655|4082529|B1|United States||Region of Enrollment||participants|Number|149|149.0||||||
4258444|NCT00616655|4082526|B4||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4258445|NCT00616655|4082527|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4258446|NCT00616655|4082528|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4258447|NCT00616655|4082529|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4258448|NCT00616655|4082526|B4||Female|Sex: Female, Male||Participants|Count of Participants|321|321.0||||||
4258449|NCT00616655|4082527|B3||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4258450|NCT00616655|4082528|B2||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4258451|NCT00616655|4082529|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4258452|NCT00616655|4082526|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4258453|NCT00616655|4082527|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4258454|NCT00616655|4082528|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4258455|NCT00616655|4082529|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4258456|NCT00616655|4082526|B4||Between 18 and 65 years|Age||Participants|Count of Participants|440|440.0||||||
4258457|NCT00616655|4082527|B3||Between 18 and 65 years|Age||Participants|Count of Participants|145|145.0||||||
4258458|NCT00616655|4082528|B2||Between 18 and 65 years|Age||Participants|Count of Participants|146|146.0||||||
4258459|NCT00616655|4082529|B1||Between 18 and 65 years|Age||Participants|Count of Participants|149|149.0||||||
4258460|NCT00616655|4082526|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4258461|NCT00616655|4082527|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4258462|NCT00616655|4082528|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4258463|NCT00616655|4082529|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4258464|NCT00616642|4082569|B3|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4258465|NCT00616642|4082570|B2|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4258466|NCT00616642|4082569|B3|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4258467|NCT00616642|4082570|B2|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4258468|NCT00616642|4082569|B3|White||Race (NIH/OMB)||participants|Number|1|1.0||||||
4258469|NCT00616642|4082570|B2|White||Race (NIH/OMB)||participants|Number|1|1.0||||||
4258470|NCT00616642|4082569|B3|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
4258471|NCT00616642|4082570|B2|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
4258472|NCT00616642|4082569|B3|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4258473|NCT00616642|4082570|B2|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4258474|NCT00616642|4082569|B3|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
4258475|NCT00616642|4082570|B2|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
4258476|NCT00616642|4082569|B3|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
4258477|NCT00616642|4082570|B2|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
4258478|NCT00616642|4082569|B3|Male||Gender||participants|Number|0|0.0||||||
4258479|NCT00616642|4082570|B2|Male||Gender||participants|Number|0|0.0||||||
4258480|NCT00616642|4082569|B3|Female||Gender||participants|Number|1|1.0||||||
4258481|NCT00616642|4082570|B2|Female||Gender||participants|Number|1|1.0||||||
4258482|NCT00616642|4082569|B3|>=65 years||Age||participants|Number|0|0.0||||||
4258483|NCT00616642|4082570|B2|>=65 years||Age||participants|Number|0|0.0||||||
4258484|NCT00616642|4082569|B3|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
4258485|NCT00616642|4082570|B2|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
4258486|NCT00616642|4082569|B3|<=18 years||Age||participants|Number|0|0.0||||||
4258487|NCT00616642|4082570|B2|<=18 years||Age||participants|Number|0|0.0||||||
4258488|NCT00616629|4082578|B6||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4258489|NCT00616629|4082579|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4258490|NCT00616629|4082580|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4258491|NCT00616629|4082581|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4258492|NCT00616629|4082582|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4258493|NCT00616629|4082583|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4258494|NCT00616629|4082578|B6||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4258495|NCT00616629|4082579|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4258496|NCT00616629|4082580|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4258497|NCT00616629|4082581|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4258498|NCT00616629|4082582|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4258499|NCT00616629|4082583|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4258500|NCT00616629|4082578|B6|Age (years)||Age||Years|Mean|56|56.0|Standard Deviation|14.5|14.5|||
4258501|NCT00616629|4082579|B5|Age (years)||Age||Years|Mean|62|62.0|Standard Deviation|6|6.0|||
4258502|NCT00616629|4082580|B4|Age (years)||Age||Years|Mean|50|50.0|Standard Deviation|23|23.0|||
4258503|NCT00616629|4082581|B3|Age (years)||Age||Years|Mean|60|60.0|Standard Deviation|8|8.0|||
4258504|NCT00616629|4082582|B2|Age (years)||Age||Years|Mean|62|62.0|Standard Deviation|6|6.0|||
4258505|NCT00616629|4082583|B1|Age (years)||Age||Years|Mean|60|60.0|Standard Deviation|14|14.0|||
4258506|NCT00616603|4082629|B4|United States||Region of Enrollment||participants|Number|43|43.0||||||
4258507|NCT00616603|4082630|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4258508|NCT00616603|4082631|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4258509|NCT00616603|4082632|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4258510|NCT00616603|4082629|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4258511|NCT00616603|4082630|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4258512|NCT00616603|4082631|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4258513|NCT00616603|4082632|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4258514|NCT00616603|4082629|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4258515|NCT00616603|4082630|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4258516|NCT00616603|4082631|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4258517|NCT00616603|4082632|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4258518|NCT00616603|4082629|B4|||Age||years|Mean|65.525|65.525|Standard Deviation|9.140|9.14|||
4258519|NCT00616603|4082630|B3|||Age||years|Mean|67.714|67.714|Standard Deviation|7.859|7.859|||
4258520|NCT00616603|4082631|B2|||Age||years|Mean|67.692|67.692|Standard Deviation|7.357|7.357|||
4258521|NCT00616603|4082632|B1|||Age||years|Mean|63.154|63.154|Standard Deviation|10.597|10.597|||
4258522|NCT00616603|4082629|B4||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4258523|NCT00616603|4082630|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4258524|NCT00616603|4082631|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4258525|NCT00616603|4082632|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4258526|NCT00616603|4082629|B4||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4258527|NCT00616603|4082630|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4258528|NCT00616603|4082631|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4258529|NCT00616603|4082632|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4258530|NCT00616603|4082629|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4258531|NCT00616603|4082630|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4258532|NCT00616603|4082631|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4258533|NCT00616603|4082632|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4258534|NCT00616577|4082642|B4||Male|Gender||||0|0.0||||||
4258535|NCT00616577|4082642|B4||Female|Gender||||0|0.0||||||
4258536|NCT00616577|4082642|B4||>=65 years|Age||||0|0.0||||||
4258537|NCT00616577|4082642|B4||Between 18 and 65 years|Age||||0|0.0||||||
4258538|NCT00616577|4082642|B4||<=18 years|Age||||0|0.0||||||
4258539|NCT00616434|4082655|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4258540|NCT00616434|4082656|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4258541|NCT00616434|4082657|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4258542|NCT00616434|4082655|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4258543|NCT00616434|4082656|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4258544|NCT00616434|4082657|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4258545|NCT00616434|4082655|B3|||Age||years|Mean|41.0|41.0|Full Range|||20.0|65.0|
4258546|NCT00616434|4082656|B2|||Age||years|Mean|41.0|41.0|Full Range|||20.0|65.0|
4258547|NCT00616434|4082657|B1|||Age||years|Mean|41.1|41.1|Full Range|||21.0|64.0|
4258548|NCT00616421|4082668|B4||Male|Sex: Female, Male||Participants|Count of Participants|1534|1534.0||||||
4258549|NCT00616421|4082669|B3||Male|Sex: Female, Male||Participants|Count of Participants|690|690.0||||||
4258550|NCT00616421|4082670|B2||Male|Sex: Female, Male||Participants|Count of Participants|656|656.0||||||
4258551|NCT00616421|4082671|B1||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4258552|NCT00616421|4082668|B4||Female|Sex: Female, Male||Participants|Count of Participants|1373|1373.0||||||
4258553|NCT00616421|4082669|B3||Female|Sex: Female, Male||Participants|Count of Participants|580|580.0||||||
4258554|NCT00616421|4082670|B2||Female|Sex: Female, Male||Participants|Count of Participants|622|622.0||||||
4258555|NCT00616421|4082671|B1||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4258556|NCT00616421|4082668|B4|||Age||years|Mean|5.3|5.3|Standard Deviation|2.5|2.5|||
4258557|NCT00616421|4082669|B3|||Age||years|Mean|5.6|5.6|Standard Deviation|2.6|2.6|||
4258558|NCT00616421|4082670|B2|||Age||years|Mean|5.5|5.5|Standard Deviation|2.5|2.5|||
4258559|NCT00616421|4082671|B1|||Age||years|Mean|3.5|3.5|Standard Deviation|1.1|1.1|||
4258560|NCT00616343|4082710|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4258561|NCT00616343|4082710|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4258562|NCT00616343|4082710|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4258563|NCT00616343|4082710|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4258564|NCT00616343|4082710|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4258565|NCT00616343|4082710|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4258566|NCT00616343|4082710|B1|||Age||Years|Mean|66.1|66.1|Standard Deviation|16.33078|16.33078|||
4258567|NCT00616239|4082714|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4258568|NCT00616239|4082714|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4258569|NCT00616239|4082714|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4258570|NCT00616239|4082714|B1|||Age||years|Mean|54|54.0|Standard Deviation|6|6.0|||
4258571|NCT00616239|4082714|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4258572|NCT00616239|4082714|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4258573|NCT00616239|4082714|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4258574|NCT00616200|4082718|B1|North America||Region of Enrollment||participants|Number|17|17.0||||||
4258575|NCT00616200|4082718|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4258576|NCT00616200|4082718|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4258577|NCT00616200|4082718|B1|||Age||years|Mean|46|46.0|Standard Deviation|10|10.0|||
4258578|NCT00616200|4082718|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4258579|NCT00616200|4082718|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4258580|NCT00616200|4082718|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4258581|NCT00616122|4082724|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4258582|NCT00616122|4082724|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4258583|NCT00616122|4082724|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4258584|NCT00616122|4082724|B1|||Age||years|Mean|58|58.0|Standard Deviation|15|15.0|||
4258585|NCT00616122|4082724|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4258586|NCT00616122|4082724|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4258587|NCT00616122|4082724|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4258588|NCT00616109|4082731|B1|2||Performance status|"The Zubrod Performance Scale is a measure of a lung cancer patient's functionality and condition. The measure ranks patients on a scale from 0-5, with 0 being fully active and asymptomatic, 1 being symptomatic but completely ambulatory, 2 being symptomatic and 50% in bed during day, 3 being symptomatic and more than 50% in bed, but not bedbound; 4 being bedbound or completely disabled; and 5 being moribund."|participants|Number|1|1.0||||||
4258589|NCT00616109|4082731|B1|1||Performance status|"The Zubrod Performance Scale is a measure of a lung cancer patient's functionality and condition. The measure ranks patients on a scale from 0-5, with 0 being fully active and asymptomatic, 1 being symptomatic but completely ambulatory, 2 being symptomatic and 50% in bed during day, 3 being symptomatic and more than 50% in bed, but not bedbound; 4 being bedbound or completely disabled; and 5 being moribund."|participants|Number|10|10.0||||||
4258590|NCT00616109|4082731|B1|0||Performance status|"The Zubrod Performance Scale is a measure of a lung cancer patient's functionality and condition. The measure ranks patients on a scale from 0-5, with 0 being fully active and asymptomatic, 1 being symptomatic but completely ambulatory, 2 being symptomatic and 50% in bed during day, 3 being symptomatic and more than 50% in bed, but not bedbound; 4 being bedbound or completely disabled; and 5 being moribund."|participants|Number|5|5.0||||||
4258591|NCT00616109|4082731|B1|SD (stable disease)||Response to induction chemotherapy|Per response evaluation criteria in Solid Tumors Criteria (RECIST v. 1.0) for target lesions and assessed by MRI: Complete Response (CR), Disappearance of all target lesions; Partial Response (PR) >=30% decrease in the sum of the longest diameter of target lesions; Overall Response (OR) = CR + PR.|participants|Number|2|2.0||||||
4258592|NCT00616109|4082731|B1|PR (partial response)||Response to induction chemotherapy|Per response evaluation criteria in Solid Tumors Criteria (RECIST v. 1.0) for target lesions and assessed by MRI: Complete Response (CR), Disappearance of all target lesions; Partial Response (PR) >=30% decrease in the sum of the longest diameter of target lesions; Overall Response (OR) = CR + PR.|participants|Number|11|11.0||||||
4258593|NCT00616109|4082731|B1|CR (complete response)||Response to induction chemotherapy|Per response evaluation criteria in Solid Tumors Criteria (RECIST v. 1.0) for target lesions and assessed by MRI: Complete Response (CR), Disappearance of all target lesions; Partial Response (PR) >=30% decrease in the sum of the longest diameter of target lesions; Overall Response (OR) = CR + PR.|participants|Number|3|3.0||||||
4258594|NCT00616109|4082731|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4258595|NCT00616109|4082731|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4258596|NCT00616109|4082731|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4258597|NCT00616109|4082731|B1|||Age, Customized||years|Mean|66|66.0|Full Range|||34.0|80.0|
4258598|NCT00616018|4082738|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4258599|NCT00616018|4082738|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4258600|NCT00616018|4082738|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4258601|NCT00616018|4082738|B1|||Age||years|Mean|37.3|37.3|Standard Deviation|12.2|12.2|||
4258602|NCT00616018|4082738|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4258603|NCT00616018|4082738|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4258604|NCT00616018|4082738|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4258605|NCT00615992|4082743|B1|Missing||Sex/Gender, Customized|"687 eligible for efficacy analysis (complete data set available)~Throughout this report, the discrepancy between the total number of participants and the numbers analyzed for a certain parameter is due to missing data.~Number of Participant in this summary is number of patients used for analysis."|participants|Number|4|4.0||||||
4258606|NCT00615992|4082743|B1|Male||Sex/Gender, Customized|"687 eligible for efficacy analysis (complete data set available)~Throughout this report, the discrepancy between the total number of participants and the numbers analyzed for a certain parameter is due to missing data.~Number of Participant in this summary is number of patients used for analysis."|participants|Number|414|414.0||||||
4258666|NCT00615836|4082781|B4||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4258607|NCT00615992|4082743|B1|Female||Sex/Gender, Customized|"687 eligible for efficacy analysis (complete data set available)~Throughout this report, the discrepancy between the total number of participants and the numbers analyzed for a certain parameter is due to missing data.~Number of Participant in this summary is number of patients used for analysis."|participants|Number|269|269.0||||||
4258608|NCT00615992|4082743|B1|||Age||years|Mean|63.0|63.0|Standard Deviation|12.5|12.5|||
4258609|NCT00615927|4082752|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4258610|NCT00615927|4082753|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4258611|NCT00615927|4082754|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4258612|NCT00615927|4082752|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4258613|NCT00615927|4082753|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4258614|NCT00615927|4082754|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4258615|NCT00615927|4082752|B3|||Age||years|Mean|44.6|44.6|Standard Deviation|14.4|14.4|||
4258616|NCT00615927|4082753|B2|||Age||years|Mean|46.6|46.6|Standard Deviation|11.8|11.8|||
4258617|NCT00615927|4082754|B1|||Age||years|Mean|42.6|42.6|Standard Deviation|16.6|16.6|||
4258618|NCT00615914|4082769|B1||Male|Sex: Female, Male||Participants|Count of Participants|663|663.0||||||
4258619|NCT00615914|4082769|B1||Female|Sex: Female, Male||Participants|Count of Participants|890|890.0||||||
4258620|NCT00615914|4082769|B1|||Age||years|Mean|69.0|69.0|Standard Deviation|8.9|8.9|||
4258621|NCT00615901|4082776|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4258622|NCT00615901|4082776|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4258623|NCT00615901|4082776|B1||Female|Gender||Participants|Count of Participants|38|38.0||||||
4258624|NCT00615901|4082776|B1|||Age||years|Median|52|52.0|Full Range|||38.0|78.0|
4258625|NCT00615836|4082780|B5|Not Hispanic||Ethnic Origin||participants|Number|562|562.0||||||
4258626|NCT00615836|4082781|B4|Not Hispanic||Ethnic Origin||participants|Number|140|140.0||||||
4258627|NCT00615836|4082782|B3|Not Hispanic||Ethnic Origin||participants|Number|135|135.0||||||
4258628|NCT00615836|4082783|B2|Not Hispanic||Ethnic Origin||participants|Number|142|142.0||||||
4258629|NCT00615836|4082784|B1|Not Hispanic||Ethnic Origin||participants|Number|145|145.0||||||
4258630|NCT00615836|4082780|B5|Hispanic||Ethnic Origin||participants|Number|39|39.0||||||
4258631|NCT00615836|4082781|B4|Hispanic||Ethnic Origin||participants|Number|6|6.0||||||
4258632|NCT00615836|4082782|B3|Hispanic||Ethnic Origin||participants|Number|13|13.0||||||
4258633|NCT00615836|4082783|B2|Hispanic||Ethnic Origin||participants|Number|10|10.0||||||
4258634|NCT00615836|4082784|B1|Hispanic||Ethnic Origin||participants|Number|10|10.0||||||
4258635|NCT00615836|4082780|B5|Other||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4258636|NCT00615836|4082781|B4|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4258637|NCT00615836|4082782|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4258638|NCT00615836|4082783|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4258639|NCT00615836|4082784|B1|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4258640|NCT00615836|4082780|B5|Native Hawaiian/other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4258641|NCT00615836|4082781|B4|Native Hawaiian/other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4258642|NCT00615836|4082782|B3|Native Hawaiian/other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4258643|NCT00615836|4082783|B2|Native Hawaiian/other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4258644|NCT00615836|4082784|B1|Native Hawaiian/other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4258645|NCT00615836|4082780|B5|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4258646|NCT00615836|4082781|B4|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4258647|NCT00615836|4082782|B3|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4258648|NCT00615836|4082783|B2|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4258649|NCT00615836|4082784|B1|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4258650|NCT00615836|4082780|B5|Asian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4258651|NCT00615836|4082781|B4|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4258652|NCT00615836|4082782|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4258653|NCT00615836|4082783|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4258654|NCT00615836|4082784|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4258655|NCT00615836|4082780|B5|Black/African American||Race/Ethnicity, Customized||participants|Number|100|100.0||||||
4258656|NCT00615836|4082781|B4|Black/African American||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4258657|NCT00615836|4082782|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4258658|NCT00615836|4082783|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4258659|NCT00615836|4082784|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4258660|NCT00615836|4082780|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|473|473.0||||||
4258661|NCT00615836|4082781|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|111|111.0||||||
4258662|NCT00615836|4082782|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|119|119.0||||||
4258663|NCT00615836|4082783|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|120|120.0||||||
4258664|NCT00615836|4082784|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|123|123.0||||||
4258665|NCT00615836|4082780|B5||Male|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
4258667|NCT00615836|4082782|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4258668|NCT00615836|4082783|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4258669|NCT00615836|4082784|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4258670|NCT00615836|4082780|B5||Female|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4258671|NCT00615836|4082781|B4||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4258672|NCT00615836|4082782|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4258673|NCT00615836|4082783|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4258674|NCT00615836|4082784|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4258675|NCT00615836|4082780|B5|>=65 years||Age, Customized||participants|Number|319|319.0||||||
4258676|NCT00615836|4082781|B4|>=65 years||Age, Customized||participants|Number|80|80.0||||||
4258677|NCT00615836|4082782|B3|>=65 years||Age, Customized||participants|Number|77|77.0||||||
4258678|NCT00615836|4082783|B2|>=65 years||Age, Customized||participants|Number|87|87.0||||||
4258679|NCT00615836|4082784|B1|>=65 years||Age, Customized||participants|Number|75|75.0||||||
4258680|NCT00615836|4082780|B5|<65 years||Age, Customized||participants|Number|282|282.0||||||
4258681|NCT00615836|4082781|B4|<65 years||Age, Customized||participants|Number|66|66.0||||||
4258682|NCT00615836|4082782|B3|<65 years||Age, Customized||participants|Number|71|71.0||||||
4258683|NCT00615836|4082783|B2|<65 years||Age, Customized||participants|Number|65|65.0||||||
4258684|NCT00615836|4082784|B1|<65 years||Age, Customized||participants|Number|80|80.0||||||
4258685|NCT00615836|4082780|B5|||Age||years|Mean|61.9|61.9|Standard Deviation|12.97|12.97|||
4258686|NCT00615836|4082781|B4|||Age||years|Mean|62.1|62.1|Standard Deviation|12.34|12.34|||
4258687|NCT00615836|4082782|B3|||Age||years|Mean|61.6|61.6|Standard Deviation|11.80|11.8|||
4258688|NCT00615836|4082783|B2|||Age||years|Mean|62.4|62.4|Standard Deviation|13.22|13.22|||
4258689|NCT00615836|4082784|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|14.41|14.41|||
4258690|NCT00615719|4082848|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4258691|NCT00615719|4082848|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4258692|NCT00615719|4082848|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4258693|NCT00615719|4082848|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4258694|NCT00615719|4082848|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4258695|NCT00615589|4082852|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4258696|NCT00615589|4082852|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4258697|NCT00615589|4082852|B1|||Age||years|Median|54|54.0|Full Range|||45.0|70.0|
4258698|NCT00615550|4082860|B3|India||Region of Enrollment||participants|Number|146|146.0||||||
4258699|NCT00615550|4082861|B2|India||Region of Enrollment||participants|Number|73|73.0||||||
4258700|NCT00615550|4082862|B1|India||Region of Enrollment||participants|Number|73|73.0||||||
4258701|NCT00615550|4082860|B3|Italy||Region of Enrollment||participants|Number|8|8.0||||||
4258702|NCT00615550|4082861|B2|Italy||Region of Enrollment||participants|Number|5|5.0||||||
4258703|NCT00615550|4082862|B1|Italy||Region of Enrollment||participants|Number|3|3.0||||||
4258704|NCT00615550|4082860|B3|Chile||Region of Enrollment||participants|Number|2|2.0||||||
4258705|NCT00615550|4082861|B2|Chile||Region of Enrollment||participants|Number|0|0.0||||||
4258706|NCT00615550|4082862|B1|Chile||Region of Enrollment||participants|Number|2|2.0||||||
4258707|NCT00615550|4082860|B3|Israel||Region of Enrollment||participants|Number|3|3.0||||||
4258708|NCT00615550|4082861|B2|Israel||Region of Enrollment||participants|Number|3|3.0||||||
4258709|NCT00615550|4082862|B1|Israel||Region of Enrollment||participants|Number|0|0.0||||||
4258710|NCT00615550|4082860|B3|Russian Federation||Region of Enrollment||participants|Number|1|1.0||||||
4258711|NCT00615550|4082861|B2|Russian Federation||Region of Enrollment||participants|Number|1|1.0||||||
4258712|NCT00615550|4082862|B1|Russian Federation||Region of Enrollment||participants|Number|0|0.0||||||
4258713|NCT00615550|4082860|B3|South Africa||Region of Enrollment||participants|Number|21|21.0||||||
4258714|NCT00615550|4082861|B2|South Africa||Region of Enrollment||participants|Number|10|10.0||||||
4258715|NCT00615550|4082862|B1|South Africa||Region of Enrollment||participants|Number|11|11.0||||||
4258716|NCT00615550|4082860|B3|Ukraine||Region of Enrollment||participants|Number|54|54.0||||||
4258717|NCT00615550|4082861|B2|Ukraine||Region of Enrollment||participants|Number|28|28.0||||||
4258718|NCT00615550|4082862|B1|Ukraine||Region of Enrollment||participants|Number|26|26.0||||||
4258719|NCT00615550|4082860|B3|Czech Republic||Region of Enrollment||participants|Number|4|4.0||||||
4258720|NCT00615550|4082861|B2|Czech Republic||Region of Enrollment||participants|Number|3|3.0||||||
4258721|NCT00615550|4082862|B1|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
4258722|NCT00615550|4082860|B3|United States||Region of Enrollment||participants|Number|207|207.0||||||
4258723|NCT00615550|4082861|B2|United States||Region of Enrollment||participants|Number|107|107.0||||||
4258724|NCT00615550|4082862|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
4258725|NCT00615550|4082860|B3|Belarus||Region of Enrollment||participants|Number|12|12.0||||||
4258726|NCT00615550|4082861|B2|Belarus||Region of Enrollment||participants|Number|5|5.0||||||
4258727|NCT00615550|4082862|B1|Belarus||Region of Enrollment||participants|Number|7|7.0||||||
4258728|NCT00615550|4082860|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4258729|NCT00615550|4082861|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4258730|NCT00615550|4082862|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4258731|NCT00615550|4082860|B3||Female|Sex: Female, Male||Participants|Count of Participants|458|458.0||||||
4258732|NCT00615550|4082861|B2||Female|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4258733|NCT00615550|4082862|B1||Female|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4258734|NCT00615550|4082860|B3|||Age||years|Mean|26.4|26.4|Standard Deviation|5.5|5.5|||
4258735|NCT00615550|4082861|B2|||Age||years|Mean|26.5|26.5|Standard Deviation|5.8|5.8|||
4258736|NCT00615550|4082862|B1|||Age||years|Mean|26.2|26.2|Standard Deviation|5.1|5.1|||
4258737|NCT00615550|4082860|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4258738|NCT00615550|4082861|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4258739|NCT00615550|4082862|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4258740|NCT00615550|4082860|B3||Between 18 and 65 years|Age||Participants|Count of Participants|458|458.0||||||
4258741|NCT00615550|4082861|B2||Between 18 and 65 years|Age||Participants|Count of Participants|235|235.0||||||
4258742|NCT00615550|4082862|B1||Between 18 and 65 years|Age||Participants|Count of Participants|223|223.0||||||
4258743|NCT00615550|4082860|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4258744|NCT00615550|4082861|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4258745|NCT00615550|4082862|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4258746|NCT00615472|4082877|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
4258747|NCT00615472|4082878|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4258748|NCT00615472|4082879|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4258749|NCT00615472|4082877|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4258750|NCT00615472|4082878|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4258751|NCT00615472|4082879|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4258752|NCT00615472|4082877|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4258753|NCT00615472|4082878|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4258754|NCT00615472|4082879|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4258755|NCT00615472|4082877|B3|||Age||years|Mean|68|68.0|Full Range|||65.0|73.0|
4258756|NCT00615472|4082878|B2|||Age||years|Mean|69|69.0|Full Range|||66.0|73.0|
4258757|NCT00615472|4082879|B1|||Age||years|Mean|67|67.0|Full Range|||65.0|72.0|
4258758|NCT00615472|4082877|B3||>=65 years|Age||Participants|Count of Participants|58|58.0||||||
4258759|NCT00615472|4082878|B2||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4258760|NCT00615472|4082879|B1||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4258761|NCT00615472|4082877|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4258762|NCT00615472|4082878|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4258763|NCT00615472|4082879|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4258764|NCT00615472|4082877|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4258765|NCT00615472|4082878|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4258766|NCT00615472|4082879|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4258767|NCT00615459|4082886|B1||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4258768|NCT00615459|4082886|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4258769|NCT00615459|4082886|B1|||Age||years|Mean|64.5|64.5|Standard Deviation|7.92|7.92|||
4258770|NCT00615433|4082903|B5|India||Region of Enrollment||participants|Number|88|88.0||||||
4258771|NCT00615433|4082904|B4|India||Region of Enrollment||participants|Number|23|23.0||||||
4258772|NCT00615433|4082905|B3|India||Region of Enrollment||participants|Number|21|21.0||||||
4258773|NCT00615433|4082906|B2|India||Region of Enrollment||participants|Number|21|21.0||||||
4258774|NCT00615433|4082907|B1|India||Region of Enrollment||participants|Number|23|23.0||||||
4258775|NCT00615433|4082903|B5|Colombia||Region of Enrollment||participants|Number|48|48.0||||||
4258776|NCT00615433|4082904|B4|Colombia||Region of Enrollment||participants|Number|12|12.0||||||
4258777|NCT00615433|4082905|B3|Colombia||Region of Enrollment||participants|Number|12|12.0||||||
4258778|NCT00615433|4082906|B2|Colombia||Region of Enrollment||participants|Number|12|12.0||||||
4258779|NCT00615433|4082907|B1|Colombia||Region of Enrollment||participants|Number|12|12.0||||||
4258780|NCT00615433|4082903|B5|Lithuania||Region of Enrollment||participants|Number|29|29.0||||||
4258781|NCT00615433|4082904|B4|Lithuania||Region of Enrollment||participants|Number|8|8.0||||||
4258782|NCT00615433|4082905|B3|Lithuania||Region of Enrollment||participants|Number|7|7.0||||||
4258783|NCT00615433|4082906|B2|Lithuania||Region of Enrollment||participants|Number|7|7.0||||||
4258784|NCT00615433|4082907|B1|Lithuania||Region of Enrollment||participants|Number|7|7.0||||||
4258785|NCT00615433|4082903|B5|Philippines||Region of Enrollment||participants|Number|26|26.0||||||
4258786|NCT00615433|4082904|B4|Philippines||Region of Enrollment||participants|Number|5|5.0||||||
4258787|NCT00615433|4082905|B3|Philippines||Region of Enrollment||participants|Number|8|8.0||||||
4258788|NCT00615433|4082906|B2|Philippines||Region of Enrollment||participants|Number|6|6.0||||||
4258789|NCT00615433|4082907|B1|Philippines||Region of Enrollment||participants|Number|7|7.0||||||
4258790|NCT00615433|4082903|B5|United States||Region of Enrollment||participants|Number|284|284.0||||||
4258791|NCT00615433|4082904|B4|United States||Region of Enrollment||participants|Number|68|68.0||||||
4258792|NCT00615433|4082905|B3|United States||Region of Enrollment||participants|Number|74|74.0||||||
4258793|NCT00615433|4082906|B2|United States||Region of Enrollment||participants|Number|72|72.0||||||
4258794|NCT00615433|4082907|B1|United States||Region of Enrollment||participants|Number|70|70.0||||||
4258795|NCT00615433|4082903|B5||Male|Sex: Female, Male||Participants|Count of Participants|371|371.0||||||
4258796|NCT00615433|4082904|B4||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4258797|NCT00615433|4082905|B3||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4258798|NCT00615433|4082906|B2||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4258799|NCT00615433|4082907|B1||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4258800|NCT00615433|4082903|B5||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4258801|NCT00615433|4082904|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4258802|NCT00615433|4082905|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4258803|NCT00615433|4082906|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4258804|NCT00615433|4082907|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4258805|NCT00615433|4082903|B5|||Age||years|Mean|37.7|37.7|Standard Deviation|10.9|10.9|||
4258806|NCT00615433|4082904|B4|||Age||years|Mean|36.9|36.9|Standard Deviation|11.3|11.3|||
4258807|NCT00615433|4082905|B3|||Age||years|Mean|38.3|38.3|Standard Deviation|10.2|10.2|||
4258808|NCT00615433|4082906|B2|||Age||years|Mean|37.9|37.9|Standard Deviation|11.2|11.2|||
4258809|NCT00615433|4082907|B1|||Age||years|Mean|37.7|37.7|Standard Deviation|11.0|11.0|||
4258810|NCT00615290|4082924|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4258811|NCT00615290|4082924|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4258812|NCT00615290|4082924|B1|||Age||Years|Mean|43.9|43.9|Standard Deviation|6.6|6.6|||
4258813|NCT00615264|4082936|B3|Other||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4258814|NCT00615264|4082937|B2|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4258815|NCT00615264|4082938|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4258816|NCT00615264|4082936|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4258817|NCT00615264|4082937|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4258818|NCT00615264|4082938|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4258819|NCT00615264|4082936|B3|Oriental||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4258820|NCT00615264|4082937|B2|Oriental||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4258821|NCT00615264|4082938|B1|Oriental||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4258822|NCT00615264|4082936|B3|Black||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4258823|NCT00615264|4082937|B2|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4258824|NCT00615264|4082938|B1|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4258825|NCT00615264|4082936|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|424|424.0||||||
4258826|NCT00615264|4082937|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|212|212.0||||||
4258827|NCT00615264|4082938|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|212|212.0||||||
4258828|NCT00615264|4082936|B3||Male|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
4258829|NCT00615264|4082937|B2||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4258830|NCT00615264|4082938|B1||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4258831|NCT00615264|4082936|B3||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4258832|NCT00615264|4082937|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4258833|NCT00615264|4082938|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4258834|NCT00615264|4082936|B3|||Age, Customized||years|Median|25.0|25.0|Full Range|||15.0|46.0|
4258835|NCT00615264|4082937|B2|||Age, Customized||years|Median|26.0|26.0|Full Range|||15.0|46.0|
4258836|NCT00615264|4082938|B1|||Age, Customized||years|Median|25.0|25.0|Full Range|||15.0|46.0|
4258837|NCT00615264|4082936|B3|||Age||years|Mean|26.5|26.5|Standard Deviation|7.91|7.91|||
4258838|NCT00615264|4082937|B2|||Age||years|Mean|26.4|26.4|Standard Deviation|7.85|7.85|||
4258839|NCT00615264|4082938|B1|||Age||years|Mean|26.6|26.6|Standard Deviation|7.99|7.99|||
4258840|NCT00615199|4082947|B5||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4258841|NCT00615199|4082948|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4258842|NCT00615199|4082949|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4258843|NCT00615199|4082950|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4258844|NCT00615199|4082951|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4258845|NCT00615199|4082947|B5||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4258846|NCT00615199|4082948|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4258847|NCT00615199|4082949|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4258848|NCT00615199|4082950|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4258849|NCT00615199|4082951|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4258850|NCT00615199|4082947|B5|||Age||years|Mean|37.3|37.3|Standard Deviation|11.7|11.7|||
4258851|NCT00615199|4082948|B4|||Age||years|Mean|38.1|38.1|Standard Deviation|11.7|11.7|||
4258852|NCT00615199|4082949|B3|||Age||years|Mean|38.7|38.7|Standard Deviation|10.2|10.2|||
4258853|NCT00615199|4082950|B2|||Age||years|Mean|36.6|36.6|Standard Deviation|12.2|12.2|||
4258854|NCT00615199|4082951|B1|||Age||years|Mean|35.7|35.7|Standard Deviation|12.7|12.7|||
4258855|NCT00615108|4082988|B1||Male|Sex: Female, Male||Participants|Count of Participants|1623|1623.0||||||
4258856|NCT00615108|4082988|B1||Female|Sex: Female, Male||Participants|Count of Participants|1525|1525.0||||||
4258857|NCT00615108|4082988|B1|||Age||Years|Mean|61.04|61.04|Standard Deviation|12.36|12.36|||
4258858|NCT00615069|4083003|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4258859|NCT00615069|4083003|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4258860|NCT00615069|4083003|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4258861|NCT00615069|4083003|B1|||Age||years|Mean|73.9|73.9|Standard Deviation|7.8|7.8|||
4258862|NCT00615056|4083008|B5||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4258863|NCT00615056|4083009|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4258864|NCT00615056|4083010|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4258865|NCT00615056|4083011|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4258866|NCT00615056|4083012|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4258867|NCT00615056|4083008|B5||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4258868|NCT00615056|4083009|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4258869|NCT00615056|4083010|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4258870|NCT00615056|4083011|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4258871|NCT00615056|4083012|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4258872|NCT00615056|4083008|B5|Greater than and equal to 65 years||Age, Customized||Participants|Number|49|49.0||||||
4258873|NCT00615056|4083009|B4|Greater than and equal to 65 years||Age, Customized||Participants|Number|12|12.0||||||
4258874|NCT00615056|4083010|B3|Greater than and equal to 65 years||Age, Customized||Participants|Number|12|12.0||||||
4258875|NCT00615056|4083011|B2|Greater than and equal to 65 years||Age, Customized||Participants|Number|11|11.0||||||
4258876|NCT00615056|4083012|B1|Greater than and equal to 65 years||Age, Customized||Participants|Number|14|14.0||||||
4258877|NCT00615056|4083008|B5|45 to 64 years||Age, Customized||Participants|Number|107|107.0||||||
4258878|NCT00615056|4083009|B4|45 to 64 years||Age, Customized||Participants|Number|22|22.0||||||
4258879|NCT00615056|4083010|B3|45 to 64 years||Age, Customized||Participants|Number|21|21.0||||||
4258880|NCT00615056|4083011|B2|45 to 64 years||Age, Customized||Participants|Number|34|34.0||||||
4258881|NCT00615056|4083012|B1|45 to 64 years||Age, Customized||Participants|Number|30|30.0||||||
4258882|NCT00615056|4083008|B5|18 to 44 years||Age, Customized||Participants|Number|15|15.0||||||
4258883|NCT00615056|4083009|B4|18 to 44 years||Age, Customized||Participants|Number|1|1.0||||||
4258884|NCT00615056|4083010|B3|18 to 44 years||Age, Customized||Participants|Number|3|3.0||||||
4258885|NCT00615056|4083011|B2|18 to 44 years||Age, Customized||Participants|Number|6|6.0||||||
4258886|NCT00615056|4083012|B1|18 to 44 years||Age, Customized||Participants|Number|5|5.0||||||
4258887|NCT00615030|4083045|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4258888|NCT00615030|4083045|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4258889|NCT00615030|4083045|B1|||Age|Baseline measures were based on safety population.|years|Mean|64.1|64.1|Standard Deviation|8.70|8.7|||
4258890|NCT00615017|4083070|B7|No||Shock||Participants|Number|14|14.0||||||
4258891|NCT00615017|4083071|B6|No||Shock||Participants|Number|3|3.0||||||
4258892|NCT00615017|4083072|B5|No||Shock||Participants|Number|1|1.0||||||
4258893|NCT00615017|4083073|B4|No||Shock||Participants|Number|1|1.0||||||
4258894|NCT00615017|4083074|B3|No||Shock||Participants|Number|3|3.0||||||
4258895|NCT00615017|4083075|B2|No||Shock||Participants|Number|3|3.0||||||
4258896|NCT00615017|4083076|B1|No||Shock||Participants|Number|3|3.0||||||
4258897|NCT00615017|4083070|B7|Yes||Shock||Participants|Number|56|56.0||||||
4258898|NCT00615017|4083071|B6|Yes||Shock||Participants|Number|20|20.0||||||
4258899|NCT00615017|4083072|B5|Yes||Shock||Participants|Number|7|7.0||||||
4258900|NCT00615017|4083073|B4|Yes||Shock||Participants|Number|9|9.0||||||
4258901|NCT00615017|4083074|B3|Yes||Shock||Participants|Number|9|9.0||||||
4258902|NCT00615017|4083075|B2|Yes||Shock||Participants|Number|6|6.0||||||
4258903|NCT00615017|4083076|B1|Yes||Shock||Participants|Number|5|5.0||||||
4258904|NCT00615017|4083070|B7|Cardiovascular and pulmonary dysfunction||Organ failure site||Participants|Number|38|38.0||||||
4258905|NCT00615017|4083071|B6|Cardiovascular and pulmonary dysfunction||Organ failure site||Participants|Number|13|13.0||||||
4258906|NCT00615017|4083072|B5|Cardiovascular and pulmonary dysfunction||Organ failure site||Participants|Number|4|4.0||||||
4258907|NCT00615017|4083073|B4|Cardiovascular and pulmonary dysfunction||Organ failure site||Participants|Number|6|6.0||||||
4258908|NCT00615017|4083074|B3|Cardiovascular and pulmonary dysfunction||Organ failure site||Participants|Number|6|6.0||||||
4258909|NCT00615017|4083075|B2|Cardiovascular and pulmonary dysfunction||Organ failure site||Participants|Number|5|5.0||||||
4258910|NCT00615017|4083076|B1|Cardiovascular and pulmonary dysfunction||Organ failure site||Participants|Number|4|4.0||||||
4258911|NCT00615017|4083070|B7|Pulmonary dysfunction||Organ failure site||Participants|Number|13|13.0||||||
4258912|NCT00615017|4083071|B6|Pulmonary dysfunction||Organ failure site||Participants|Number|3|3.0||||||
4258913|NCT00615017|4083072|B5|Pulmonary dysfunction||Organ failure site||Participants|Number|2|2.0||||||
4258914|NCT00615017|4083073|B4|Pulmonary dysfunction||Organ failure site||Participants|Number|1|1.0||||||
4258915|NCT00615017|4083074|B3|Pulmonary dysfunction||Organ failure site||Participants|Number|3|3.0||||||
4258916|NCT00615017|4083075|B2|Pulmonary dysfunction||Organ failure site||Participants|Number|2|2.0||||||
4258917|NCT00615017|4083076|B1|Pulmonary dysfunction||Organ failure site||Participants|Number|2|2.0||||||
4258918|NCT00615017|4083070|B7|Cardiovascular||Organ failure site||Participants|Number|19|19.0||||||
4258919|NCT00615017|4083071|B6|Cardiovascular||Organ failure site||Participants|Number|7|7.0||||||
4258920|NCT00615017|4083072|B5|Cardiovascular||Organ failure site||Participants|Number|2|2.0||||||
4258921|NCT00615017|4083073|B4|Cardiovascular||Organ failure site||Participants|Number|3|3.0||||||
4258922|NCT00615017|4083074|B3|Cardiovascular||Organ failure site||Participants|Number|3|3.0||||||
4258923|NCT00615017|4083075|B2|Cardiovascular||Organ failure site||Participants|Number|2|2.0||||||
4258924|NCT00615017|4083076|B1|Cardiovascular||Organ failure site||Participants|Number|2|2.0||||||
4258925|NCT00615017|4083070|B7|Missing||Mechanical ventilation||Participants|Number|3|3.0||||||
4258926|NCT00615017|4083071|B6|Missing||Mechanical ventilation||Participants|Number|0|0.0||||||
4258927|NCT00615017|4083072|B5|Missing||Mechanical ventilation||Participants|Number|0|0.0||||||
4258928|NCT00615017|4083073|B4|Missing||Mechanical ventilation||Participants|Number|1|1.0||||||
4258929|NCT00615017|4083074|B3|Missing||Mechanical ventilation||Participants|Number|1|1.0||||||
4258930|NCT00615017|4083075|B2|Missing||Mechanical ventilation||Participants|Number|1|1.0||||||
4258931|NCT00615017|4083076|B1|Missing||Mechanical ventilation||Participants|Number|0|0.0||||||
4258932|NCT00615017|4083070|B7|No||Mechanical ventilation||Participants|Number|7|7.0||||||
4258933|NCT00615017|4083071|B6|No||Mechanical ventilation||Participants|Number|3|3.0||||||
4258934|NCT00615017|4083072|B5|No||Mechanical ventilation||Participants|Number|0|0.0||||||
4258935|NCT00615017|4083073|B4|No||Mechanical ventilation||Participants|Number|1|1.0||||||
4258936|NCT00615017|4083074|B3|No||Mechanical ventilation||Participants|Number|2|2.0||||||
4258937|NCT00615017|4083075|B2|No||Mechanical ventilation||Participants|Number|0|0.0||||||
4258938|NCT00615017|4083076|B1|No||Mechanical ventilation||Participants|Number|1|1.0||||||
4258939|NCT00615017|4083070|B7|Yes||Mechanical ventilation||Participants|Number|60|60.0||||||
4258940|NCT00615017|4083071|B6|Yes||Mechanical ventilation||Participants|Number|20|20.0||||||
4258941|NCT00615017|4083072|B5|Yes||Mechanical ventilation||Participants|Number|8|8.0||||||
4258942|NCT00615017|4083073|B4|Yes||Mechanical ventilation||Participants|Number|8|8.0||||||
4258943|NCT00615017|4083074|B3|Yes||Mechanical ventilation||Participants|Number|9|9.0||||||
4258944|NCT00615017|4083075|B2|Yes||Mechanical ventilation||Participants|Number|8|8.0||||||
4258945|NCT00615017|4083076|B1|Yes||Mechanical ventilation||Participants|Number|7|7.0||||||
4258946|NCT00615017|4083070|B7||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4258947|NCT00615017|4083071|B6||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4258948|NCT00615017|4083072|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4258949|NCT00615017|4083073|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4258950|NCT00615017|4083074|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4258951|NCT00615017|4083075|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4258952|NCT00615017|4083076|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4258953|NCT00615017|4083070|B7||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4258954|NCT00615017|4083071|B6||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4258955|NCT00615017|4083072|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4258956|NCT00615017|4083073|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4258957|NCT00615017|4083074|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4258958|NCT00615017|4083075|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4258959|NCT00615017|4083076|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4258960|NCT00615017|4083070|B7|||Age||Year|Mean|56.1|56.1|Standard Deviation|15.5|15.5|||
4258961|NCT00615017|4083071|B6|||Age||Year|Mean|58.9|58.9|Standard Deviation|17.4|17.4|||
4258962|NCT00615017|4083072|B5|||Age||Year|Mean|63.5|63.5|Standard Deviation|16.1|16.1|||
4258963|NCT00615017|4083073|B4|||Age||Year|Mean|53|53.0|Standard Deviation|17.9|17.9|||
4258964|NCT00615017|4083074|B3|||Age||Year|Mean|55.1|55.1|Standard Deviation|10.8|10.8|||
4258965|NCT00615017|4083075|B2|||Age||Year|Mean|49.7|49.7|Standard Deviation|15|15.0|||
4258966|NCT00615017|4083076|B1|||Age||Year|Mean|53|53.0|Standard Deviation|11.8|11.8|||
4258967|NCT00614991|4083233|B7|United States||Region of Enrollment||participants|Number|37|37.0||||||
4258968|NCT00614991|4083234|B6|United States||Region of Enrollment||participants|Number|6|6.0||||||
4258969|NCT00614991|4083235|B5|United States||Region of Enrollment||participants|Number|6|6.0||||||
4258970|NCT00614991|4083236|B4|United States||Region of Enrollment||participants|Number|7|7.0||||||
4258971|NCT00614991|4083237|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4258972|NCT00614991|4083238|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4258973|NCT00614991|4083239|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4258974|NCT00614991|4083233|B7||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4258975|NCT00614991|4083234|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4258976|NCT00614991|4083235|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4258977|NCT00614991|4083236|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4258978|NCT00614991|4083237|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4258979|NCT00614991|4083238|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4258980|NCT00614991|4083239|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4258981|NCT00614991|4083233|B7||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4258982|NCT00614991|4083234|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4258983|NCT00614991|4083235|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4258984|NCT00614991|4083236|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4258985|NCT00614991|4083237|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4258986|NCT00614991|4083238|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4258987|NCT00614991|4083239|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4258988|NCT00614991|4083233|B7||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4258989|NCT00614991|4083234|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4258990|NCT00614991|4083235|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4258991|NCT00614991|4083236|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4258992|NCT00614991|4083237|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4258993|NCT00614991|4083238|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4258994|NCT00614991|4083239|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4258995|NCT00614991|4083233|B7||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4258996|NCT00614991|4083234|B6||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4258997|NCT00614991|4083235|B5||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4258998|NCT00614991|4083236|B4||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4258999|NCT00614991|4083237|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4259000|NCT00614991|4083238|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4259001|NCT00614991|4083239|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4259002|NCT00614991|4083233|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259003|NCT00614991|4083234|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259004|NCT00614991|4083235|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259005|NCT00614991|4083236|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259006|NCT00614991|4083237|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259007|NCT00614991|4083238|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259008|NCT00614991|4083239|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259009|NCT00614939|4083276|B3|Oral blood glucose lowering drug||Baseline Diabetes Therapy||participants|Number|53|53.0||||||
4259010|NCT00614939|4083277|B2|Oral blood glucose lowering drug||Baseline Diabetes Therapy||participants|Number|23|23.0||||||
4259011|NCT00614939|4083278|B1|Oral blood glucose lowering drug||Baseline Diabetes Therapy||participants|Number|30|30.0||||||
4259012|NCT00614939|4083276|B3|Insulin||Baseline Diabetes Therapy||participants|Number|128|128.0||||||
4259013|NCT00614939|4083277|B2|Insulin||Baseline Diabetes Therapy||participants|Number|71|71.0||||||
4259014|NCT00614939|4083278|B1|Insulin||Baseline Diabetes Therapy||participants|Number|57|57.0||||||
4259015|NCT00614939|4083276|B3|Diabetes Therapy||Baseline Diabetes Therapy||participants|Number|167|167.0||||||
4259016|NCT00614939|4083277|B2|Diabetes Therapy||Baseline Diabetes Therapy||participants|Number|83|83.0||||||
4259017|NCT00614939|4083278|B1|Diabetes Therapy||Baseline Diabetes Therapy||participants|Number|84|84.0||||||
4259018|NCT00614939|4083276|B3|End-Stage||Baseline Renal Impairment Category||Participants|Number|39|39.0||||||
4259019|NCT00614939|4083277|B2|End-Stage||Baseline Renal Impairment Category||Participants|Number|19|19.0||||||
4259020|NCT00614939|4083278|B1|End-Stage||Baseline Renal Impairment Category||Participants|Number|20|20.0||||||
4259021|NCT00614939|4083276|B3|Severe||Baseline Renal Impairment Category||Participants|Number|41|41.0||||||
4259022|NCT00614939|4083277|B2|Severe||Baseline Renal Impairment Category||Participants|Number|18|18.0||||||
4259023|NCT00614939|4083278|B1|Severe||Baseline Renal Impairment Category||Participants|Number|23|23.0||||||
4259024|NCT00614939|4083276|B3|Moderate||Baseline Renal Impairment Category||Participants|Number|90|90.0||||||
4259025|NCT00614939|4083277|B2|Moderate||Baseline Renal Impairment Category||Participants|Number|48|48.0||||||
4259026|NCT00614939|4083278|B1|Moderate||Baseline Renal Impairment Category||Participants|Number|42|42.0||||||
4259027|NCT00614939|4083276|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4259028|NCT00614939|4083277|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4259029|NCT00614939|4083278|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4259030|NCT00614939|4083276|B3||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4259031|NCT00614939|4083277|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4259032|NCT00614939|4083278|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4259033|NCT00614939|4083276|B3|||Age||years|Mean|66.5|66.5|Standard Deviation|8.66|8.66|||
4259034|NCT00614939|4083277|B2|||Age||years|Mean|66.8|66.8|Standard Deviation|8.27|8.27|||
4259035|NCT00614939|4083278|B1|||Age||years|Mean|66.2|66.2|Standard Deviation|9.08|9.08|||
4259036|NCT00614926|4083311|B3|||Fatigue Severity Scale score >40|"Minimum score = 9, maximum = 63. Nine items, no subscales. Higher scores signify greater fatigue. Total summed scores over 40 (equal to mean item score of 4.5+) are considered to signify clinically significant fatigue and was a requirement for study eligibility."|participants|Number|32|32.0||||||
4259037|NCT00614926|4083312|B2|||Fatigue Severity Scale score >40|"Minimum score = 9, maximum = 63. Nine items, no subscales. Higher scores signify greater fatigue. Total summed scores over 40 (equal to mean item score of 4.5+) are considered to signify clinically significant fatigue and was a requirement for study eligibility."|participants|Number|7|7.0||||||
4259038|NCT00614926|4083313|B1|||Fatigue Severity Scale score >40|"Minimum score = 9, maximum = 63. Nine items, no subscales. Higher scores signify greater fatigue. Total summed scores over 40 (equal to mean item score of 4.5+) are considered to signify clinically significant fatigue and was a requirement for study eligibility."|participants|Number|25|25.0||||||
4259039|NCT00614926|4083311|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4259040|NCT00614926|4083312|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4259041|NCT00614926|4083313|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4259042|NCT00614926|4083311|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4259043|NCT00614926|4083312|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4259044|NCT00614926|4083313|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4259045|NCT00614926|4083311|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4259046|NCT00614926|4083312|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4259047|NCT00614926|4083313|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4259048|NCT00614926|4083311|B3|||Age||years|Mean|58|58.0|Standard Deviation|12|12.0|||
4259049|NCT00614926|4083312|B2|||Age||years|Mean|56|56.0|Standard Deviation|5|5.0|||
4259050|NCT00614926|4083313|B1|||Age||years|Mean|59|59.0|Standard Deviation|13|13.0|||
4259051|NCT00614926|4083311|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4259052|NCT00614926|4083312|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4259053|NCT00614926|4083313|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4259054|NCT00614926|4083311|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4259055|NCT00614926|4083312|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4259056|NCT00614926|4083313|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4259057|NCT00614926|4083311|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259058|NCT00614926|4083312|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259059|NCT00614926|4083313|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259060|NCT00614913|4083322|B1|United States||Region of Enrollment||participants|Number|76|76.0||||||
4259061|NCT00614913|4083322|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4259062|NCT00614913|4083322|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4259063|NCT00614913|4083322|B1|||Age||years|Mean|62.7|62.7|Standard Deviation|5.8|5.8|||
4259064|NCT00614913|4083322|B1||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
4259065|NCT00614913|4083322|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4259066|NCT00614913|4083322|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259067|NCT00614874|4083327|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4259068|NCT00614874|4083327|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4259069|NCT00614874|4083327|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4259070|NCT00614874|4083327|B1|||Age||years|Mean|34|34.0|Standard Deviation|24|24.0|||
4259071|NCT00614874|4083327|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4259072|NCT00614874|4083327|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4259073|NCT00614874|4083327|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259074|NCT00614744|4083334|B3|||Gestational Age||weeks|Mean|39|39.0|Standard Deviation|1|1.0|||
4259075|NCT00614744|4083335|B2|||Gestational Age||weeks|Mean|39|39.0|Standard Deviation|1|1.0|||
4259076|NCT00614744|4083336|B1|||Gestational Age||weeks|Mean|39|39.0|Standard Deviation|2|2.0|||
4259077|NCT00614744|4083334|B3|||Length||centimeters|Mean|51|51.0|Standard Deviation|3|3.0|||
4259078|NCT00614744|4083335|B2|||Length||centimeters|Mean|51|51.0|Standard Deviation|3|3.0|||
4259079|NCT00614744|4083336|B1|||Length||centimeters|Mean|51|51.0|Standard Deviation|3|3.0|||
4259080|NCT00614744|4083334|B3|||Birthweight||grams|Mean|3340|3340.0|Standard Deviation|541|541.0|||
4259081|NCT00614744|4083335|B2|||Birthweight||grams|Mean|3303|3303.0|Standard Deviation|553|553.0|||
4259082|NCT00614744|4083336|B1|||Birthweight||grams|Mean|3379|3379.0|Standard Deviation|528|528.0|||
4259083|NCT00614744|4083334|B3|Severe||Level of Encephalopathy||Participants|Count of Participants|17|17.0||||||
4259084|NCT00614744|4083335|B2|Severe||Level of Encephalopathy||Participants|Count of Participants|7|7.0||||||
4259085|NCT00614744|4083336|B1|Severe||Level of Encephalopathy||Participants|Count of Participants|10|10.0||||||
4259086|NCT00614744|4083334|B3|Moderate||Level of Encephalopathy||Participants|Count of Participants|151|151.0||||||
4259087|NCT00614744|4083335|B2|Moderate||Level of Encephalopathy||Participants|Count of Participants|78|78.0||||||
4259088|NCT00614744|4083336|B1|Moderate||Level of Encephalopathy||Participants|Count of Participants|73|73.0||||||
4259089|NCT00614744|4083334|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4259090|NCT00614744|4083335|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4259091|NCT00614744|4083336|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4259092|NCT00614744|4083334|B3||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4259093|NCT00614744|4083335|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4259094|NCT00614744|4083336|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4259095|NCT00614744|4083334|B3|> 12 Hours||Age, Customized|Age at Randomization|Participants|Count of Participants|114|114.0||||||
4259096|NCT00614744|4083335|B2|> 12 Hours||Age, Customized|Age at Randomization|Participants|Count of Participants|57|57.0||||||
4259097|NCT00614744|4083336|B1|> 12 Hours||Age, Customized|Age at Randomization|Participants|Count of Participants|57|57.0||||||
4259098|NCT00614744|4083334|B3|<= 12 Hours||Age, Customized|Age at Randomization|Participants|Count of Participants|54|54.0||||||
4259099|NCT00614744|4083335|B2|<= 12 Hours||Age, Customized|Age at Randomization|Participants|Count of Participants|28|28.0||||||
4259100|NCT00614744|4083336|B1|<= 12 Hours||Age, Customized|Age at Randomization|Participants|Count of Participants|26|26.0||||||
4259101|NCT00614614|4083361|B3|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|159|159.0||||||
4259102|NCT00614614|4083362|B2|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
4259103|NCT00614614|4083363|B1|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|127|127.0||||||
4259104|NCT00614614|4083361|B3|White - Caucasian / European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1197|1197.0||||||
4259105|NCT00614614|4083362|B2|White - Caucasian / European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|223|223.0||||||
4259106|NCT00614614|4083363|B1|White - Caucasian / European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|974|974.0||||||
4259107|NCT00614614|4083361|B3|White - Arabic / North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4259108|NCT00614614|4083362|B2|White - Arabic / North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4259109|NCT00614614|4083363|B1|White - Arabic / North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4259110|NCT00614614|4083361|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4259111|NCT00614614|4083362|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4259112|NCT00614614|4083363|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4259113|NCT00614614|4083361|B3|Asian - South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4259114|NCT00614614|4083362|B2|Asian - South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4259115|NCT00614614|4083363|B1|Asian - South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4259116|NCT00614614|4083361|B3|Asian - Japanese heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4259117|NCT00614614|4083362|B2|Asian - Japanese heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4259118|NCT00614614|4083363|B1|Asian - Japanese heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4259119|NCT00614614|4083361|B3|Asian - East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4259120|NCT00614614|4083362|B2|Asian - East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4259121|NCT00614614|4083363|B1|Asian - East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4259122|NCT00614614|4083361|B3|Asian - Central/South Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4259123|NCT00614614|4083362|B2|Asian - Central/South Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4259124|NCT00614614|4083363|B1|Asian - Central/South Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4259125|NCT00614614|4083361|B3|American Indian or Alaskan native||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4259126|NCT00614614|4083362|B2|American Indian or Alaskan native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4259127|NCT00614614|4083363|B1|American Indian or Alaskan native||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4259128|NCT00614614|4083361|B3|African heritage / African American||Race/Ethnicity, Customized||Participants|Count of Participants|155|155.0||||||
4259129|NCT00614614|4083362|B2|African heritage / African American||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
4259130|NCT00614614|4083363|B1|African heritage / African American||Race/Ethnicity, Customized||Participants|Count of Participants|135|135.0||||||
4259131|NCT00614614|4083361|B3||Male|Sex: Female, Male||Participants|Count of Participants|798|798.0||||||
4259132|NCT00614614|4083362|B2||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4259133|NCT00614614|4083363|B1||Male|Sex: Female, Male||Participants|Count of Participants|666|666.0||||||
4259134|NCT00614614|4083361|B3||Female|Sex: Female, Male||Participants|Count of Participants|756|756.0||||||
4259135|NCT00614614|4083362|B2||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4259136|NCT00614614|4083363|B1||Female|Sex: Female, Male||Participants|Count of Participants|606|606.0||||||
4259137|NCT00614614|4083361|B3|||Age||Weeks|Mean|8.6|8.6|Standard Deviation|1.25|1.25|||
4259138|NCT00614614|4083362|B2|||Age||Weeks|Mean|8.7|8.7|Standard Deviation|1.25|1.25|||
4259139|NCT00614614|4083363|B1|||Age||Weeks|Mean|8.6|8.6|Standard Deviation|1.25|1.25|||
4259140|NCT00614575|4083490|B1||Male|Sex: Female, Male|The number of patients enrolled was 1089. The number of case reports collected from the patients enrolled in this survey was 1071. Moreover the number of patients analyzed as safety analysis was 1044, because 27 patients were excluded due to protocol violations.|Participants|Count of Participants|376|376.0||||||
4259141|NCT00614575|4083490|B1||Female|Sex: Female, Male|The number of patients enrolled was 1089. The number of case reports collected from the patients enrolled in this survey was 1071. Moreover the number of patients analyzed as safety analysis was 1044, because 27 patients were excluded due to protocol violations.|Participants|Count of Participants|668|668.0||||||
4259142|NCT00614575|4083490|B1|||Age|The number of patients enrolled was 1089. The number of case reports collected from the patients enrolled in this survey was 1071. Moreover the number of patients analyzed as safety analysis was 1044, because 27 patients were excluded due to protocol violations.|years|Mean|70.5|70.5|Standard Deviation|8.6|8.6|||
4259143|NCT00614523|4083499|B3|Missing||International Prognostic Scoring System (IPSS) Total Score|"The IPSS uses three prognostic indicators to develop a score which may be useful in understanding how the MDS may progress:~the proportion of blast cells in the marrow;~the type of chromosomal changes, if any, in the marrow cells;~the presence of one or more low blood cell counts (cytopenias). Scores are sorted into one of four risk categories: 0 = low risk; 0.5-1.0 = intermediate-1; 1.5-2.0 = intermediate-2; >2.5 = high risk."|Participants|Number|8|8.0||||||
4259193|NCT00614523|4083501|B1|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4259144|NCT00614523|4083500|B2|Missing||International Prognostic Scoring System (IPSS) Total Score|"The IPSS uses three prognostic indicators to develop a score which may be useful in understanding how the MDS may progress:~the proportion of blast cells in the marrow;~the type of chromosomal changes, if any, in the marrow cells;~the presence of one or more low blood cell counts (cytopenias). Scores are sorted into one of four risk categories: 0 = low risk; 0.5-1.0 = intermediate-1; 1.5-2.0 = intermediate-2; >2.5 = high risk."|Participants|Number|6|6.0||||||
4259145|NCT00614523|4083501|B1|Missing||International Prognostic Scoring System (IPSS) Total Score|"The IPSS uses three prognostic indicators to develop a score which may be useful in understanding how the MDS may progress:~the proportion of blast cells in the marrow;~the type of chromosomal changes, if any, in the marrow cells;~the presence of one or more low blood cell counts (cytopenias). Scores are sorted into one of four risk categories: 0 = low risk; 0.5-1.0 = intermediate-1; 1.5-2.0 = intermediate-2; >2.5 = high risk."|Participants|Number|2|2.0||||||
4259146|NCT00614523|4083499|B3|1.5||International Prognostic Scoring System (IPSS) Total Score|"The IPSS uses three prognostic indicators to develop a score which may be useful in understanding how the MDS may progress:~the proportion of blast cells in the marrow;~the type of chromosomal changes, if any, in the marrow cells;~the presence of one or more low blood cell counts (cytopenias). Scores are sorted into one of four risk categories: 0 = low risk; 0.5-1.0 = intermediate-1; 1.5-2.0 = intermediate-2; >2.5 = high risk."|Participants|Number|1|1.0||||||
4259147|NCT00614523|4083500|B2|1.5||International Prognostic Scoring System (IPSS) Total Score|"The IPSS uses three prognostic indicators to develop a score which may be useful in understanding how the MDS may progress:~the proportion of blast cells in the marrow;~the type of chromosomal changes, if any, in the marrow cells;~the presence of one or more low blood cell counts (cytopenias). Scores are sorted into one of four risk categories: 0 = low risk; 0.5-1.0 = intermediate-1; 1.5-2.0 = intermediate-2; >2.5 = high risk."|Participants|Number|1|1.0||||||
4259148|NCT00614523|4083501|B1|1.5||International Prognostic Scoring System (IPSS) Total Score|"The IPSS uses three prognostic indicators to develop a score which may be useful in understanding how the MDS may progress:~the proportion of blast cells in the marrow;~the type of chromosomal changes, if any, in the marrow cells;~the presence of one or more low blood cell counts (cytopenias). Scores are sorted into one of four risk categories: 0 = low risk; 0.5-1.0 = intermediate-1; 1.5-2.0 = intermediate-2; >2.5 = high risk."|Participants|Number|0|0.0||||||
4259149|NCT00614523|4083499|B3|1||International Prognostic Scoring System (IPSS) Total Score|"The IPSS uses three prognostic indicators to develop a score which may be useful in understanding how the MDS may progress:~the proportion of blast cells in the marrow;~the type of chromosomal changes, if any, in the marrow cells;~the presence of one or more low blood cell counts (cytopenias). Scores are sorted into one of four risk categories: 0 = low risk; 0.5-1.0 = intermediate-1; 1.5-2.0 = intermediate-2; >2.5 = high risk."|Participants|Number|54|54.0||||||
4259150|NCT00614523|4083500|B2|1||International Prognostic Scoring System (IPSS) Total Score|"The IPSS uses three prognostic indicators to develop a score which may be useful in understanding how the MDS may progress:~the proportion of blast cells in the marrow;~the type of chromosomal changes, if any, in the marrow cells;~the presence of one or more low blood cell counts (cytopenias). Scores are sorted into one of four risk categories: 0 = low risk; 0.5-1.0 = intermediate-1; 1.5-2.0 = intermediate-2; >2.5 = high risk."|Participants|Number|34|34.0||||||
4259151|NCT00614523|4083501|B1|1||International Prognostic Scoring System (IPSS) Total Score|"The IPSS uses three prognostic indicators to develop a score which may be useful in understanding how the MDS may progress:~the proportion of blast cells in the marrow;~the type of chromosomal changes, if any, in the marrow cells;~the presence of one or more low blood cell counts (cytopenias). Scores are sorted into one of four risk categories: 0 = low risk; 0.5-1.0 = intermediate-1; 1.5-2.0 = intermediate-2; >2.5 = high risk."|Participants|Number|20|20.0||||||
4259152|NCT00614523|4083499|B3|0.5||International Prognostic Scoring System (IPSS) Total Score|"The IPSS uses three prognostic indicators to develop a score which may be useful in understanding how the MDS may progress:~the proportion of blast cells in the marrow;~the type of chromosomal changes, if any, in the marrow cells;~the presence of one or more low blood cell counts (cytopenias). Scores are sorted into one of four risk categories: 0 = low risk; 0.5-1.0 = intermediate-1; 1.5-2.0 = intermediate-2; >2.5 = high risk."|Participants|Number|124|124.0||||||
4259153|NCT00614523|4083500|B2|0.5||International Prognostic Scoring System (IPSS) Total Score|"The IPSS uses three prognostic indicators to develop a score which may be useful in understanding how the MDS may progress:~the proportion of blast cells in the marrow;~the type of chromosomal changes, if any, in the marrow cells;~the presence of one or more low blood cell counts (cytopenias). Scores are sorted into one of four risk categories: 0 = low risk; 0.5-1.0 = intermediate-1; 1.5-2.0 = intermediate-2; >2.5 = high risk."|Participants|Number|86|86.0||||||
4259154|NCT00614523|4083501|B1|0.5||International Prognostic Scoring System (IPSS) Total Score|"The IPSS uses three prognostic indicators to develop a score which may be useful in understanding how the MDS may progress:~the proportion of blast cells in the marrow;~the type of chromosomal changes, if any, in the marrow cells;~the presence of one or more low blood cell counts (cytopenias). Scores are sorted into one of four risk categories: 0 = low risk; 0.5-1.0 = intermediate-1; 1.5-2.0 = intermediate-2; >2.5 = high risk."|Participants|Number|38|38.0||||||
4259155|NCT00614523|4083499|B3|0||International Prognostic Scoring System (IPSS) Total Score|"The IPSS uses three prognostic indicators to develop a score which may be useful in understanding how the MDS may progress:~the proportion of blast cells in the marrow;~the type of chromosomal changes, if any, in the marrow cells;~the presence of one or more low blood cell counts (cytopenias). Scores are sorted into one of four risk categories: 0 = low risk; 0.5-1.0 = intermediate-1; 1.5-2.0 = intermediate-2; >2.5 = high risk."|Participants|Number|63|63.0||||||
4259156|NCT00614523|4083500|B2|0||International Prognostic Scoring System (IPSS) Total Score|"The IPSS uses three prognostic indicators to develop a score which may be useful in understanding how the MDS may progress:~the proportion of blast cells in the marrow;~the type of chromosomal changes, if any, in the marrow cells;~the presence of one or more low blood cell counts (cytopenias). Scores are sorted into one of four risk categories: 0 = low risk; 0.5-1.0 = intermediate-1; 1.5-2.0 = intermediate-2; >2.5 = high risk."|Participants|Number|40|40.0||||||
4259194|NCT00614523|4083499|B3|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4259195|NCT00614523|4083500|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4259196|NCT00614523|4083501|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4259157|NCT00614523|4083501|B1|0||International Prognostic Scoring System (IPSS) Total Score|"The IPSS uses three prognostic indicators to develop a score which may be useful in understanding how the MDS may progress:~the proportion of blast cells in the marrow;~the type of chromosomal changes, if any, in the marrow cells;~the presence of one or more low blood cell counts (cytopenias). Scores are sorted into one of four risk categories: 0 = low risk; 0.5-1.0 = intermediate-1; 1.5-2.0 = intermediate-2; >2.5 = high risk."|Participants|Number|23|23.0||||||
4259158|NCT00614523|4083499|B3|||Baseline Platelet Counts||10^9/L|Mean|22.0|22.0|Standard Deviation|12.0|12.0|||
4259159|NCT00614523|4083500|B2|||Baseline Platelet Counts||10^9/L|Mean|22.3|22.3|Standard Deviation|11.5|11.5|||
4259160|NCT00614523|4083501|B1|||Baseline Platelet Counts||10^9/L|Mean|21.5|21.5|Standard Deviation|13|13.0|||
4259161|NCT00614523|4083499|B3|Yes||Prior MDS Therapy|Had received MDS therapy prior to enter the study|Participants|Number|47|47.0||||||
4259162|NCT00614523|4083500|B2|Yes||Prior MDS Therapy|Had received MDS therapy prior to enter the study|Participants|Number|34|34.0||||||
4259163|NCT00614523|4083501|B1|Yes||Prior MDS Therapy|Had received MDS therapy prior to enter the study|Participants|Number|13|13.0||||||
4259164|NCT00614523|4083499|B3|No||Prior MDS Therapy|Had received MDS therapy prior to enter the study|Participants|Number|203|203.0||||||
4259165|NCT00614523|4083500|B2|No||Prior MDS Therapy|Had received MDS therapy prior to enter the study|Participants|Number|133|133.0||||||
4259166|NCT00614523|4083501|B1|No||Prior MDS Therapy|Had received MDS therapy prior to enter the study|Participants|Number|70|70.0||||||
4259167|NCT00614523|4083499|B3|MDS associated with isolated del 5Q||Myelodysplastic Syndromes World Health Organization Classification|RA: Refractory Anemia RAEB-1: Refractory Anemia with Excess Blasts-1 RAEB-2: Refractory Anemia with Excess Blasts-2 RARS: Refractory Anemia with Ringed Sideroblasts RCMD: Refractory cytopenia with multilineage dysplasia RCMD-RS: Refractory cytopenia with multilineage dysplasia and ringed sideroblasts MDS-U: Myelodysplastic syndrome – unclassified MDS associated with isolated del(5q).|Participants|Number|0|0.0||||||
4259168|NCT00614523|4083500|B2|MDS associated with isolated del 5Q||Myelodysplastic Syndromes World Health Organization Classification|RA: Refractory Anemia RAEB-1: Refractory Anemia with Excess Blasts-1 RAEB-2: Refractory Anemia with Excess Blasts-2 RARS: Refractory Anemia with Ringed Sideroblasts RCMD: Refractory cytopenia with multilineage dysplasia RCMD-RS: Refractory cytopenia with multilineage dysplasia and ringed sideroblasts MDS-U: Myelodysplastic syndrome – unclassified MDS associated with isolated del(5q).|Participants|Number|0|0.0||||||
4259169|NCT00614523|4083501|B1|MDS associated with isolated del 5Q||Myelodysplastic Syndromes World Health Organization Classification|RA: Refractory Anemia RAEB-1: Refractory Anemia with Excess Blasts-1 RAEB-2: Refractory Anemia with Excess Blasts-2 RARS: Refractory Anemia with Ringed Sideroblasts RCMD: Refractory cytopenia with multilineage dysplasia RCMD-RS: Refractory cytopenia with multilineage dysplasia and ringed sideroblasts MDS-U: Myelodysplastic syndrome – unclassified MDS associated with isolated del(5q).|Participants|Number|0|0.0||||||
4259170|NCT00614523|4083499|B3|MDS-U||Myelodysplastic Syndromes World Health Organization Classification|RA: Refractory Anemia RAEB-1: Refractory Anemia with Excess Blasts-1 RAEB-2: Refractory Anemia with Excess Blasts-2 RARS: Refractory Anemia with Ringed Sideroblasts RCMD: Refractory cytopenia with multilineage dysplasia RCMD-RS: Refractory cytopenia with multilineage dysplasia and ringed sideroblasts MDS-U: Myelodysplastic syndrome – unclassified MDS associated with isolated del(5q).|Participants|Number|28|28.0||||||
4259171|NCT00614523|4083500|B2|MDS-U||Myelodysplastic Syndromes World Health Organization Classification|RA: Refractory Anemia RAEB-1: Refractory Anemia with Excess Blasts-1 RAEB-2: Refractory Anemia with Excess Blasts-2 RARS: Refractory Anemia with Ringed Sideroblasts RCMD: Refractory cytopenia with multilineage dysplasia RCMD-RS: Refractory cytopenia with multilineage dysplasia and ringed sideroblasts MDS-U: Myelodysplastic syndrome – unclassified MDS associated with isolated del(5q).|Participants|Number|16|16.0||||||
4259172|NCT00614523|4083501|B1|MDS-U||Myelodysplastic Syndromes World Health Organization Classification|RA: Refractory Anemia RAEB-1: Refractory Anemia with Excess Blasts-1 RAEB-2: Refractory Anemia with Excess Blasts-2 RARS: Refractory Anemia with Ringed Sideroblasts RCMD: Refractory cytopenia with multilineage dysplasia RCMD-RS: Refractory cytopenia with multilineage dysplasia and ringed sideroblasts MDS-U: Myelodysplastic syndrome – unclassified MDS associated with isolated del(5q).|Participants|Number|12|12.0||||||
4259173|NCT00614523|4083499|B3|RCMD-RS||Myelodysplastic Syndromes World Health Organization Classification|RA: Refractory Anemia RAEB-1: Refractory Anemia with Excess Blasts-1 RAEB-2: Refractory Anemia with Excess Blasts-2 RARS: Refractory Anemia with Ringed Sideroblasts RCMD: Refractory cytopenia with multilineage dysplasia RCMD-RS: Refractory cytopenia with multilineage dysplasia and ringed sideroblasts MDS-U: Myelodysplastic syndrome – unclassified MDS associated with isolated del(5q).|Participants|Number|6|6.0||||||
4259174|NCT00614523|4083500|B2|RCMD-RS||Myelodysplastic Syndromes World Health Organization Classification|RA: Refractory Anemia RAEB-1: Refractory Anemia with Excess Blasts-1 RAEB-2: Refractory Anemia with Excess Blasts-2 RARS: Refractory Anemia with Ringed Sideroblasts RCMD: Refractory cytopenia with multilineage dysplasia RCMD-RS: Refractory cytopenia with multilineage dysplasia and ringed sideroblasts MDS-U: Myelodysplastic syndrome – unclassified MDS associated with isolated del(5q).|Participants|Number|4|4.0||||||
4259175|NCT00614523|4083501|B1|RCMD-RS||Myelodysplastic Syndromes World Health Organization Classification|RA: Refractory Anemia RAEB-1: Refractory Anemia with Excess Blasts-1 RAEB-2: Refractory Anemia with Excess Blasts-2 RARS: Refractory Anemia with Ringed Sideroblasts RCMD: Refractory cytopenia with multilineage dysplasia RCMD-RS: Refractory cytopenia with multilineage dysplasia and ringed sideroblasts MDS-U: Myelodysplastic syndrome – unclassified MDS associated with isolated del(5q).|Participants|Number|2|2.0||||||
4259176|NCT00614523|4083499|B3|RCMD||Myelodysplastic Syndromes World Health Organization Classification|RA: Refractory Anemia RAEB-1: Refractory Anemia with Excess Blasts-1 RAEB-2: Refractory Anemia with Excess Blasts-2 RARS: Refractory Anemia with Ringed Sideroblasts RCMD: Refractory cytopenia with multilineage dysplasia RCMD-RS: Refractory cytopenia with multilineage dysplasia and ringed sideroblasts MDS-U: Myelodysplastic syndrome – unclassified MDS associated with isolated del(5q).|Participants|Number|169|169.0||||||
4259197|NCT00614523|4083499|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4259198|NCT00614523|4083500|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4259199|NCT00614523|4083501|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4259177|NCT00614523|4083500|B2|RCMD||Myelodysplastic Syndromes World Health Organization Classification|RA: Refractory Anemia RAEB-1: Refractory Anemia with Excess Blasts-1 RAEB-2: Refractory Anemia with Excess Blasts-2 RARS: Refractory Anemia with Ringed Sideroblasts RCMD: Refractory cytopenia with multilineage dysplasia RCMD-RS: Refractory cytopenia with multilineage dysplasia and ringed sideroblasts MDS-U: Myelodysplastic syndrome – unclassified MDS associated with isolated del(5q).|Participants|Number|114|114.0||||||
4259178|NCT00614523|4083501|B1|RCMD||Myelodysplastic Syndromes World Health Organization Classification|RA: Refractory Anemia RAEB-1: Refractory Anemia with Excess Blasts-1 RAEB-2: Refractory Anemia with Excess Blasts-2 RARS: Refractory Anemia with Ringed Sideroblasts RCMD: Refractory cytopenia with multilineage dysplasia RCMD-RS: Refractory cytopenia with multilineage dysplasia and ringed sideroblasts MDS-U: Myelodysplastic syndrome – unclassified MDS associated with isolated del(5q).|Participants|Number|55|55.0||||||
4259179|NCT00614523|4083499|B3|RAEB-2||Myelodysplastic Syndromes World Health Organization Classification|RA: Refractory Anemia RAEB-1: Refractory Anemia with Excess Blasts-1 RAEB-2: Refractory Anemia with Excess Blasts-2 RARS: Refractory Anemia with Ringed Sideroblasts RCMD: Refractory cytopenia with multilineage dysplasia RCMD-RS: Refractory cytopenia with multilineage dysplasia and ringed sideroblasts MDS-U: Myelodysplastic syndrome – unclassified MDS associated with isolated del(5q).|Participants|Number|1|1.0||||||
4259180|NCT00614523|4083500|B2|RAEB-2||Myelodysplastic Syndromes World Health Organization Classification|RA: Refractory Anemia RAEB-1: Refractory Anemia with Excess Blasts-1 RAEB-2: Refractory Anemia with Excess Blasts-2 RARS: Refractory Anemia with Ringed Sideroblasts RCMD: Refractory cytopenia with multilineage dysplasia RCMD-RS: Refractory cytopenia with multilineage dysplasia and ringed sideroblasts MDS-U: Myelodysplastic syndrome – unclassified MDS associated with isolated del(5q).|Participants|Number|1|1.0||||||
4259181|NCT00614523|4083501|B1|RAEB-2||Myelodysplastic Syndromes World Health Organization Classification|RA: Refractory Anemia RAEB-1: Refractory Anemia with Excess Blasts-1 RAEB-2: Refractory Anemia with Excess Blasts-2 RARS: Refractory Anemia with Ringed Sideroblasts RCMD: Refractory cytopenia with multilineage dysplasia RCMD-RS: Refractory cytopenia with multilineage dysplasia and ringed sideroblasts MDS-U: Myelodysplastic syndrome – unclassified MDS associated with isolated del(5q).|Participants|Number|0|0.0||||||
4259182|NCT00614523|4083499|B3|RAEB-1||Myelodysplastic Syndromes World Health Organization Classification|RA: Refractory Anemia RAEB-1: Refractory Anemia with Excess Blasts-1 RAEB-2: Refractory Anemia with Excess Blasts-2 RARS: Refractory Anemia with Ringed Sideroblasts RCMD: Refractory cytopenia with multilineage dysplasia RCMD-RS: Refractory cytopenia with multilineage dysplasia and ringed sideroblasts MDS-U: Myelodysplastic syndrome – unclassified MDS associated with isolated del(5q).|Participants|Number|33|33.0||||||
4259183|NCT00614523|4083500|B2|RAEB-1||Myelodysplastic Syndromes World Health Organization Classification|RA: Refractory Anemia RAEB-1: Refractory Anemia with Excess Blasts-1 RAEB-2: Refractory Anemia with Excess Blasts-2 RARS: Refractory Anemia with Ringed Sideroblasts RCMD: Refractory cytopenia with multilineage dysplasia RCMD-RS: Refractory cytopenia with multilineage dysplasia and ringed sideroblasts MDS-U: Myelodysplastic syndrome – unclassified MDS associated with isolated del(5q).|Participants|Number|24|24.0||||||
4259184|NCT00614523|4083501|B1|RAEB-1||Myelodysplastic Syndromes World Health Organization Classification|RA: Refractory Anemia RAEB-1: Refractory Anemia with Excess Blasts-1 RAEB-2: Refractory Anemia with Excess Blasts-2 RARS: Refractory Anemia with Ringed Sideroblasts RCMD: Refractory cytopenia with multilineage dysplasia RCMD-RS: Refractory cytopenia with multilineage dysplasia and ringed sideroblasts MDS-U: Myelodysplastic syndrome – unclassified MDS associated with isolated del(5q).|Participants|Number|9|9.0||||||
4259185|NCT00614523|4083499|B3|RARS||Myelodysplastic Syndromes World Health Organization Classification|RA: Refractory Anemia RAEB-1: Refractory Anemia with Excess Blasts-1 RAEB-2: Refractory Anemia with Excess Blasts-2 RARS: Refractory Anemia with Ringed Sideroblasts RCMD: Refractory cytopenia with multilineage dysplasia RCMD-RS: Refractory cytopenia with multilineage dysplasia and ringed sideroblasts MDS-U: Myelodysplastic syndrome – unclassified MDS associated with isolated del(5q).|Participants|Number|2|2.0||||||
4259186|NCT00614523|4083500|B2|RARS||Myelodysplastic Syndromes World Health Organization Classification|RA: Refractory Anemia RAEB-1: Refractory Anemia with Excess Blasts-1 RAEB-2: Refractory Anemia with Excess Blasts-2 RARS: Refractory Anemia with Ringed Sideroblasts RCMD: Refractory cytopenia with multilineage dysplasia RCMD-RS: Refractory cytopenia with multilineage dysplasia and ringed sideroblasts MDS-U: Myelodysplastic syndrome – unclassified MDS associated with isolated del(5q).|Participants|Number|2|2.0||||||
4259187|NCT00614523|4083501|B1|RARS||Myelodysplastic Syndromes World Health Organization Classification|RA: Refractory Anemia RAEB-1: Refractory Anemia with Excess Blasts-1 RAEB-2: Refractory Anemia with Excess Blasts-2 RARS: Refractory Anemia with Ringed Sideroblasts RCMD: Refractory cytopenia with multilineage dysplasia RCMD-RS: Refractory cytopenia with multilineage dysplasia and ringed sideroblasts MDS-U: Myelodysplastic syndrome – unclassified MDS associated with isolated del(5q).|Participants|Number|0|0.0||||||
4259188|NCT00614523|4083499|B3|RA||Myelodysplastic Syndromes World Health Organization Classification|RA: Refractory Anemia RAEB-1: Refractory Anemia with Excess Blasts-1 RAEB-2: Refractory Anemia with Excess Blasts-2 RARS: Refractory Anemia with Ringed Sideroblasts RCMD: Refractory cytopenia with multilineage dysplasia RCMD-RS: Refractory cytopenia with multilineage dysplasia and ringed sideroblasts MDS-U: Myelodysplastic syndrome – unclassified MDS associated with isolated del(5q).|Participants|Number|11|11.0||||||
4259189|NCT00614523|4083500|B2|RA||Myelodysplastic Syndromes World Health Organization Classification|RA: Refractory Anemia RAEB-1: Refractory Anemia with Excess Blasts-1 RAEB-2: Refractory Anemia with Excess Blasts-2 RARS: Refractory Anemia with Ringed Sideroblasts RCMD: Refractory cytopenia with multilineage dysplasia RCMD-RS: Refractory cytopenia with multilineage dysplasia and ringed sideroblasts MDS-U: Myelodysplastic syndrome – unclassified MDS associated with isolated del(5q).|Participants|Number|6|6.0||||||
4259190|NCT00614523|4083501|B1|RA||Myelodysplastic Syndromes World Health Organization Classification|RA: Refractory Anemia RAEB-1: Refractory Anemia with Excess Blasts-1 RAEB-2: Refractory Anemia with Excess Blasts-2 RARS: Refractory Anemia with Ringed Sideroblasts RCMD: Refractory cytopenia with multilineage dysplasia RCMD-RS: Refractory cytopenia with multilineage dysplasia and ringed sideroblasts MDS-U: Myelodysplastic syndrome – unclassified MDS associated with isolated del(5q).|Participants|Number|5|5.0||||||
4259191|NCT00614523|4083499|B3|Other||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4259192|NCT00614523|4083500|B2|Other||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4259200|NCT00614523|4083499|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4259201|NCT00614523|4083500|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4259202|NCT00614523|4083501|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4259203|NCT00614523|4083499|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|235|235.0||||||
4259204|NCT00614523|4083500|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|156|156.0||||||
4259205|NCT00614523|4083501|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|79|79.0||||||
4259206|NCT00614523|4083499|B3||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4259207|NCT00614523|4083500|B2||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4259208|NCT00614523|4083501|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4259209|NCT00614523|4083499|B3||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4259210|NCT00614523|4083500|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4259211|NCT00614523|4083501|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4259212|NCT00614523|4083499|B3|||Age||years|Mean|67.9|67.9|Standard Deviation|11.8|11.8|||
4259213|NCT00614523|4083500|B2|||Age||years|Mean|68.4|68.4|Standard Deviation|12|12.0|||
4259214|NCT00614523|4083501|B1|||Age||years|Mean|67|67.0|Standard Deviation|11.5|11.5|||
4259215|NCT00614484|4083526|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4259216|NCT00614484|4083526|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4259217|NCT00614484|4083526|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4259218|NCT00614484|4083526|B1|||Age||years|Mean|66|66.0|Standard Deviation|8|8.0|||
4259219|NCT00614484|4083526|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4259220|NCT00614484|4083526|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4259221|NCT00614484|4083526|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259222|NCT00614458|4083531|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4259223|NCT00614458|4083531|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4259224|NCT00614458|4083531|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4259225|NCT00614458|4083531|B1|||Age||years|Mean|36|36.0|Standard Deviation|8|8.0|||
4259226|NCT00614458|4083531|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4259227|NCT00614458|4083531|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4259228|NCT00614458|4083531|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259229|NCT00614445|4083535|B3|United States||Region of Enrollment||participants|Number|280|280.0||||||
4259230|NCT00614445|4083536|B2|United States||Region of Enrollment||participants|Number|140|140.0||||||
4259231|NCT00614445|4083537|B1|United States||Region of Enrollment||participants|Number|140|140.0||||||
4259232|NCT00614445|4083535|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4259233|NCT00614445|4083536|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4259234|NCT00614445|4083537|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4259235|NCT00614445|4083535|B3||Female|Sex: Female, Male||Participants|Count of Participants|280|280.0||||||
4259236|NCT00614445|4083536|B2||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4259237|NCT00614445|4083537|B1||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4259238|NCT00614445|4083535|B3|||Age||years|Mean|25.5|25.5|Standard Deviation|5.8|5.8|||
4259239|NCT00614445|4083536|B2|||Age||years|Mean|25.0|25.0|Standard Deviation|5.6|5.6|||
4259240|NCT00614445|4083537|B1|||Age||years|Mean|25.9|25.9|Standard Deviation|6.0|6.0|||
4259241|NCT00614445|4083535|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4259242|NCT00614445|4083536|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4259243|NCT00614445|4083537|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4259244|NCT00614445|4083535|B3||Between 18 and 65 years|Age||Participants|Count of Participants|280|280.0||||||
4259245|NCT00614445|4083536|B2||Between 18 and 65 years|Age||Participants|Count of Participants|140|140.0||||||
4259246|NCT00614445|4083537|B1||Between 18 and 65 years|Age||Participants|Count of Participants|140|140.0||||||
4259247|NCT00614445|4083535|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259248|NCT00614445|4083536|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259249|NCT00614445|4083537|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259250|NCT00614432|4083544|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4259251|NCT00614432|4083545|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4259252|NCT00614432|4083546|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4259253|NCT00614432|4083544|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4259254|NCT00614432|4083545|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4259255|NCT00614432|4083546|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4259256|NCT00614432|4083544|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4259257|NCT00614432|4083545|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4259258|NCT00614432|4083546|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4259259|NCT00614432|4083544|B3|||Age||years|Mean|25.1|25.1|Standard Deviation|5.0|5.0|||
4259260|NCT00614432|4083545|B2|||Age||years|Mean|23.2|23.2|Standard Deviation|3.0|3.0|||
4259261|NCT00614432|4083546|B1|||Age||years|Mean|28.0|28.0|Standard Deviation|7.9|7.9|||
4259262|NCT00614432|4083544|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4259263|NCT00614432|4083545|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4259264|NCT00614432|4083546|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4259265|NCT00614432|4083544|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4259266|NCT00614432|4083545|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4259267|NCT00614432|4083546|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4259268|NCT00614432|4083544|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259269|NCT00614432|4083545|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259270|NCT00614432|4083546|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259271|NCT00614406|4083553|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4259272|NCT00614406|4083554|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4259273|NCT00614406|4083555|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4259274|NCT00614406|4083553|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4259275|NCT00614406|4083554|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4259276|NCT00614406|4083555|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4259277|NCT00614406|4083553|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4259278|NCT00614406|4083554|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4259279|NCT00614406|4083555|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4259280|NCT00614406|4083553|B3|||Age||years|Mean|27.85|27.85|Standard Deviation|0.0|0.0|||
4259281|NCT00614406|4083554|B2|||Age||years|Mean|28.8|28.8|Standard Deviation|6.1|6.1|||
4259282|NCT00614406|4083555|B1|||Age||years|Mean|27.3|27.3|Standard Deviation|5.2|5.2|||
4259283|NCT00614393|4083562|B6||Male|Sex: Female, Male||Participants|Count of Participants|364|364.0||||||
4259284|NCT00614393|4083563|B5||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4259285|NCT00614393|4083564|B4||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4259286|NCT00614393|4083565|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4259287|NCT00614393|4083566|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4259288|NCT00614393|4083567|B1||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4259289|NCT00614393|4083562|B6||Female|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4259290|NCT00614393|4083563|B5||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4259291|NCT00614393|4083564|B4||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4259292|NCT00614393|4083565|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4259293|NCT00614393|4083566|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4259294|NCT00614393|4083567|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4259295|NCT00614393|4083562|B6|||Age||Years|Mean|59.2|59.2|Standard Deviation|10.8|10.8|||
4259296|NCT00614393|4083563|B5|||Age||Years|Mean|58.4|58.4|Standard Deviation|11.1|11.1|||
4259297|NCT00614393|4083564|B4|||Age||Years|Mean|59.4|59.4|Standard Deviation|10.9|10.9|||
4259298|NCT00614393|4083565|B3|||Age||Years|Mean|64.4|64.4|Standard Deviation|8.9|8.9|||
4259299|NCT00614393|4083566|B2|||Age||Years|Mean|55.6|55.6|Standard Deviation|16.1|16.1|||
4259300|NCT00614393|4083567|B1|||Age||Years|Mean|59.6|59.6|Standard Deviation|10.2|10.2|||
4259301|NCT00614380|4083613|B5||Male|Sex: Female, Male||Participants|Count of Participants|611|611.0||||||
4259302|NCT00614380|4083614|B4||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4259303|NCT00614380|4083615|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4259304|NCT00614380|4083616|B2||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4259305|NCT00614380|4083617|B1||Male|Sex: Female, Male||Participants|Count of Participants|324|324.0||||||
4259306|NCT00614380|4083613|B5||Female|Sex: Female, Male||Participants|Count of Participants|365|365.0||||||
4259307|NCT00614380|4083614|B4||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4259308|NCT00614380|4083615|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4259309|NCT00614380|4083616|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4259310|NCT00614380|4083617|B1||Female|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
4259311|NCT00614380|4083613|B5|||Age||Years|Mean|53.9|53.9|Standard Deviation|10.6|10.6|||
4259312|NCT00614380|4083614|B4|||Age||Years|Mean|52.4|52.4|Standard Deviation|9.6|9.6|||
4259313|NCT00614380|4083615|B3|||Age||Years|Mean|54.4|54.4|Standard Deviation|10.8|10.8|||
4259314|NCT00614380|4083616|B2|||Age||Years|Mean|52.9|52.9|Standard Deviation|10.6|10.6|||
4259315|NCT00614380|4083617|B1|||Age||Years|Mean|54.8|54.8|Standard Deviation|10.9|10.9|||
4259316|NCT00614315|4083669|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4259317|NCT00614315|4083669|B1||Male|Gender||Participants|Count of Participants|13|13.0||||||
4259318|NCT00614315|4083669|B1||Female|Gender||Participants|Count of Participants|17|17.0||||||
4259319|NCT00614315|4083669|B1|||Age||years|Mean|64.8|64.8|Standard Deviation|15.14|15.14|||
4259320|NCT00614315|4083669|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4259321|NCT00614315|4083669|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4259322|NCT00614315|4083669|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259323|NCT00614198|4083674|B3|Denmark||Region of Enrollment||participants|Number|72|72.0||||||
4259324|NCT00614198|4083675|B2|Denmark||Region of Enrollment||participants|Number|34|34.0||||||
4259325|NCT00614198|4083676|B1|Denmark||Region of Enrollment||participants|Number|38|38.0||||||
4259326|NCT00614198|4083674|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4259327|NCT00614198|4083675|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4259328|NCT00614198|4083676|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4259329|NCT00614198|4083674|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4259330|NCT00614198|4083675|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4259331|NCT00614198|4083676|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4259332|NCT00614198|4083674|B3|||Age||years|Mean|8.15|8.15|Standard Deviation|2|2.0|||
4259333|NCT00614198|4083675|B2|||Age||years|Mean|8.13|8.13|Standard Deviation|2.03|2.03|||
4259334|NCT00614198|4083676|B1|||Age||years|Mean|8.22|8.22|Standard Deviation|1.99|1.99|||
4259335|NCT00614198|4083674|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4259336|NCT00614198|4083675|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4259337|NCT00614198|4083676|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4259338|NCT00614198|4083674|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4259339|NCT00614198|4083675|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4259340|NCT00614198|4083676|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4259341|NCT00614198|4083674|B3||<=18 years|Age||Participants|Count of Participants|72|72.0||||||
4259342|NCT00614198|4083675|B2||<=18 years|Age||Participants|Count of Participants|34|34.0||||||
4259343|NCT00614198|4083676|B1||<=18 years|Age||Participants|Count of Participants|38|38.0||||||
4259344|NCT00614120|4083683|B5|||Weight||kg|Mean|68.1|68.1|Standard Deviation|11.7|11.7|||
4259345|NCT00614120|4083684|B4|||Weight||kg|Mean|68.2|68.2|Standard Deviation|11.9|11.9|||
4259346|NCT00614120|4083685|B3|||Weight||kg|Mean|68.2|68.2|Standard Deviation|11.9|11.9|||
4259347|NCT00614120|4083686|B2|||Weight||kg|Mean|67.4|67.4|Standard Deviation|11.3|11.3|||
4259348|NCT00614120|4083687|B1|||Weight||kg|Mean|68.6|68.6|Standard Deviation|11.6|11.6|||
4259349|NCT00614120|4083683|B5|||Height||m|Mean|1.63|1.63|Standard Deviation|0.09|0.09|||
4259350|NCT00614120|4083684|B4|||Height||m|Mean|1.64|1.64|Standard Deviation|0.09|0.09|||
4259351|NCT00614120|4083685|B3|||Height||m|Mean|1.62|1.62|Standard Deviation|0.08|0.08|||
4259352|NCT00614120|4083686|B2|||Height||m|Mean|1.63|1.63|Standard Deviation|0.09|0.09|||
4259353|NCT00614120|4083687|B1|||Height||m|Mean|1.63|1.63|Standard Deviation|0.09|0.09|||
4259354|NCT00614120|4083683|B5|||Duration of diabetes|Number of years since diagnosis|years|Mean|7.5|7.5|Standard Deviation|5.5|5.5|||
4259355|NCT00614120|4083684|B4|||Duration of diabetes|Number of years since diagnosis|years|Mean|7.8|7.8|Standard Deviation|6.1|6.1|||
4259356|NCT00614120|4083685|B3|||Duration of diabetes|Number of years since diagnosis|years|Mean|7.2|7.2|Standard Deviation|5.2|5.2|||
4259357|NCT00614120|4083686|B2|||Duration of diabetes|Number of years since diagnosis|years|Mean|7.5|7.5|Standard Deviation|5.3|5.3|||
4259358|NCT00614120|4083687|B1|||Duration of diabetes|Number of years since diagnosis|years|Mean|7.4|7.4|Standard Deviation|5.4|5.4|||
4259359|NCT00614120|4083683|B5|||BMI|Body Mass Index|kg/m2|Mean|25.6|25.6|Standard Deviation|3.8|3.8|||
4259360|NCT00614120|4083684|B4|||BMI|Body Mass Index|kg/m2|Mean|25.3|25.3|Standard Deviation|3.7|3.7|||
4259361|NCT00614120|4083685|B3|||BMI|Body Mass Index|kg/m2|Mean|25.8|25.8|Standard Deviation|3.8|3.8|||
4259362|NCT00614120|4083686|B2|||BMI|Body Mass Index|kg/m2|Mean|25.4|25.4|Standard Deviation|3.7|3.7|||
4259363|NCT00614120|4083687|B1|||BMI|Body Mass Index|kg/m2|Mean|25.9|25.9|Standard Deviation|4.2|4.2|||
4259364|NCT00614120|4083683|B5|Combination therapy||Previous OAD treatment|OAD = Oral Anti-Diabetic Drug|participants|Number|640|640.0||||||
4259365|NCT00614120|4083684|B4|Combination therapy||Previous OAD treatment|OAD = Oral Anti-Diabetic Drug|participants|Number|163|163.0||||||
4259366|NCT00614120|4083685|B3|Combination therapy||Previous OAD treatment|OAD = Oral Anti-Diabetic Drug|participants|Number|159|159.0||||||
4259367|NCT00614120|4083686|B2|Combination therapy||Previous OAD treatment|OAD = Oral Anti-Diabetic Drug|participants|Number|159|159.0||||||
4259368|NCT00614120|4083687|B1|Combination therapy||Previous OAD treatment|OAD = Oral Anti-Diabetic Drug|participants|Number|159|159.0||||||
4259369|NCT00614120|4083683|B5|Mono-therapy||Previous OAD treatment|OAD = Oral Anti-Diabetic Drug|participants|Number|289|289.0||||||
4259370|NCT00614120|4083684|B4|Mono-therapy||Previous OAD treatment|OAD = Oral Anti-Diabetic Drug|participants|Number|68|68.0||||||
4259371|NCT00614120|4083685|B3|Mono-therapy||Previous OAD treatment|OAD = Oral Anti-Diabetic Drug|participants|Number|75|75.0||||||
4259372|NCT00614120|4083686|B2|Mono-therapy||Previous OAD treatment|OAD = Oral Anti-Diabetic Drug|participants|Number|74|74.0||||||
4259373|NCT00614120|4083687|B1|Mono-therapy||Previous OAD treatment|OAD = Oral Anti-Diabetic Drug|participants|Number|72|72.0||||||
4259374|NCT00614120|4083683|B5||Male|Sex: Female, Male||Participants|Count of Participants|514|514.0||||||
4259375|NCT00614120|4083684|B4||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4259376|NCT00614120|4083685|B3||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4259377|NCT00614120|4083686|B2||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4259378|NCT00614120|4083687|B1||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4259379|NCT00614120|4083683|B5||Female|Sex: Female, Male||Participants|Count of Participants|415|415.0||||||
4259380|NCT00614120|4083684|B4||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4259381|NCT00614120|4083685|B3||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4259382|NCT00614120|4083686|B2||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4259383|NCT00614120|4083687|B1||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4259384|NCT00614120|4083683|B5|||Age||years|Mean|53.3|53.3|Standard Deviation|9.5|9.5|||
4259385|NCT00614120|4083684|B4|||Age||years|Mean|53.6|53.6|Standard Deviation|9.7|9.7|||
4259386|NCT00614120|4083685|B3|||Age||years|Mean|52.7|52.7|Standard Deviation|9.1|9.1|||
4259387|NCT00614120|4083686|B2|||Age||years|Mean|53.5|53.5|Standard Deviation|9.6|9.6|||
4259388|NCT00614120|4083687|B1|||Age||years|Mean|53.5|53.5|Standard Deviation|9.5|9.5|||
4259389|NCT00614055|4083728|B4|||Fasting plasma glucose (FPG)||mmol/L|Mean|11.6|11.6|Standard Deviation|3.3|3.3|||
4259390|NCT00614055|4083729|B3|||Fasting plasma glucose (FPG)||mmol/L|Mean|12.1|12.1|Standard Deviation|3.5|3.5|||
4259391|NCT00614055|4083730|B2|||Fasting plasma glucose (FPG)||mmol/L|Mean|11.5|11.5|Standard Deviation|3.2|3.2|||
4259392|NCT00614055|4083731|B1|||Fasting plasma glucose (FPG)||mmol/L|Mean|11.1|11.1|Standard Deviation|3.3|3.3|||
4259393|NCT00614055|4083728|B4|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.5|8.5|Standard Deviation|1.3|1.3|||
4259394|NCT00614055|4083729|B3|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.4|8.4|Standard Deviation|1.3|1.3|||
4259395|NCT00614055|4083730|B2|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.6|8.6|Standard Deviation|1.5|1.5|||
4259396|NCT00614055|4083731|B1|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.3|8.3|Standard Deviation|1.2|1.2|||
4259397|NCT00614055|4083728|B4||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4259398|NCT00614055|4083729|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4259399|NCT00614055|4083730|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4259400|NCT00614055|4083731|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4259401|NCT00614055|4083728|B4||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4259402|NCT00614055|4083729|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4259403|NCT00614055|4083730|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4259404|NCT00614055|4083731|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4259405|NCT00614055|4083728|B4|||Age||years|Mean|59.1|59.1|Standard Deviation|8.5|8.5|||
4259406|NCT00614055|4083729|B3|||Age||years|Mean|58.4|58.4|Standard Deviation|8.4|8.4|||
4259407|NCT00614055|4083730|B2|||Age||years|Mean|60.2|60.2|Standard Deviation|8.4|8.4|||
4259408|NCT00614055|4083731|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|8.8|8.8|||
4259409|NCT00613951|4083777|B4|||Fasting plasma glucose (FPG)||mmol/L|Mean|11.6|11.6|Standard Deviation|2.9|2.9|||
4259410|NCT00613951|4083778|B3|||Fasting plasma glucose (FPG)||mmol/L|Mean|11.7|11.7|Standard Deviation|3.1|3.1|||
4259411|NCT00613951|4083779|B2|||Fasting plasma glucose (FPG)||mmol/L|Mean|11.8|11.8|Standard Deviation|2.9|2.9|||
4259412|NCT00613951|4083780|B1|||Fasting plasma glucose (FPG)||mmol/L|Mean|11.4|11.4|Standard Deviation|2.7|2.7|||
4259413|NCT00613951|4083777|B4|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.5|8.5|Standard Deviation|1.1|1.1|||
4259414|NCT00613951|4083778|B3|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.6|8.6|Standard Deviation|1.0|1.0|||
4259415|NCT00613951|4083779|B2|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.5|8.5|Standard Deviation|0.9|0.9|||
4259416|NCT00613951|4083780|B1|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.5|8.5|Standard Deviation|1.2|1.2|||
4259417|NCT00613951|4083777|B4||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4259418|NCT00613951|4083778|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4259419|NCT00613951|4083779|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4259420|NCT00613951|4083780|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4259421|NCT00613951|4083777|B4||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4259422|NCT00613951|4083778|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4259423|NCT00613951|4083779|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4259424|NCT00613951|4083780|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4259425|NCT00613951|4083777|B4|||Age||years|Mean|59.6|59.6|Standard Deviation|8.4|8.4|||
4259426|NCT00613951|4083778|B3|||Age||years|Mean|59.7|59.7|Standard Deviation|8.0|8.0|||
4259427|NCT00613951|4083779|B2|||Age||years|Mean|60.5|60.5|Standard Deviation|8.9|8.9|||
4259428|NCT00613951|4083780|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|8.5|8.5|||
4259429|NCT00613938|4083823|B5|United States||Region of Enrollment|One patient in the oxycodone 10mg group did not have a valid baseline score and was therefore excluded from the safety analysis set.|participants|Number|900|900.0||||||
4259430|NCT00613938|4083824|B4|United States||Region of Enrollment|One patient in the oxycodone 10mg group did not have a valid baseline score and was therefore excluded from the safety analysis set.|participants|Number|278|278.0||||||
4259431|NCT00613938|4083825|B3|United States||Region of Enrollment|One patient in the oxycodone 10mg group did not have a valid baseline score and was therefore excluded from the safety analysis set.|participants|Number|278|278.0||||||
4259432|NCT00613938|4083826|B2|United States||Region of Enrollment|One patient in the oxycodone 10mg group did not have a valid baseline score and was therefore excluded from the safety analysis set.|participants|Number|275|275.0||||||
4259433|NCT00613938|4083827|B1|United States||Region of Enrollment|One patient in the oxycodone 10mg group did not have a valid baseline score and was therefore excluded from the safety analysis set.|participants|Number|69|69.0||||||
4259434|NCT00613938|4083823|B5|Male||Gender|One patient in the oxycodone 10mg group did not have a valid baseline score and was therefore excluded from the safety analysis set.|participants|Number|123|123.0||||||
4259476|NCT00613925|4083860|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4259435|NCT00613938|4083824|B4|Male||Gender|One patient in the oxycodone 10mg group did not have a valid baseline score and was therefore excluded from the safety analysis set.|participants|Number|45|45.0||||||
4259436|NCT00613938|4083825|B3|Male||Gender|One patient in the oxycodone 10mg group did not have a valid baseline score and was therefore excluded from the safety analysis set.|participants|Number|30|30.0||||||
4259437|NCT00613938|4083826|B2|Male||Gender|One patient in the oxycodone 10mg group did not have a valid baseline score and was therefore excluded from the safety analysis set.|participants|Number|43|43.0||||||
4259438|NCT00613938|4083827|B1|Male||Gender|One patient in the oxycodone 10mg group did not have a valid baseline score and was therefore excluded from the safety analysis set.|participants|Number|5|5.0||||||
4259439|NCT00613938|4083823|B5|Female||Gender|One patient in the oxycodone 10mg group did not have a valid baseline score and was therefore excluded from the safety analysis set.|participants|Number|777|777.0||||||
4259440|NCT00613938|4083824|B4|Female||Gender|One patient in the oxycodone 10mg group did not have a valid baseline score and was therefore excluded from the safety analysis set.|participants|Number|233|233.0||||||
4259441|NCT00613938|4083825|B3|Female||Gender|One patient in the oxycodone 10mg group did not have a valid baseline score and was therefore excluded from the safety analysis set.|participants|Number|248|248.0||||||
4259442|NCT00613938|4083826|B2|Female||Gender|One patient in the oxycodone 10mg group did not have a valid baseline score and was therefore excluded from the safety analysis set.|participants|Number|232|232.0||||||
4259443|NCT00613938|4083827|B1|Female||Gender|One patient in the oxycodone 10mg group did not have a valid baseline score and was therefore excluded from the safety analysis set.|participants|Number|64|64.0||||||
4259444|NCT00613938|4083823|B5|||Age||years|Mean|43.1|43.1|Standard Deviation|13.05|13.05|||
4259445|NCT00613938|4083824|B4|||Age||years|Mean|43.4|43.4|Standard Deviation|13.25|13.25|||
4259446|NCT00613938|4083825|B3|||Age||years|Mean|43.5|43.5|Standard Deviation|12.57|12.57|||
4259447|NCT00613938|4083826|B2|||Age||years|Mean|42.4|42.4|Standard Deviation|13.23|13.23|||
4259448|NCT00613938|4083827|B1|||Age||years|Mean|42.8|42.8|Standard Deviation|13.65|13.65|||
4259449|NCT00613938|4083823|B5|>=65 years||Age|One patient in the oxycodone 10mg group did not have a valid baseline score and was therefore excluded from the safety analysis set.|participants|Number|34|34.0||||||
4259450|NCT00613938|4083824|B4|>=65 years||Age|One patient in the oxycodone 10mg group did not have a valid baseline score and was therefore excluded from the safety analysis set.|participants|Number|13|13.0||||||
4259451|NCT00613938|4083825|B3|>=65 years||Age|One patient in the oxycodone 10mg group did not have a valid baseline score and was therefore excluded from the safety analysis set.|participants|Number|10|10.0||||||
4259452|NCT00613938|4083826|B2|>=65 years||Age|One patient in the oxycodone 10mg group did not have a valid baseline score and was therefore excluded from the safety analysis set.|participants|Number|10|10.0||||||
4259453|NCT00613938|4083827|B1|>=65 years||Age|One patient in the oxycodone 10mg group did not have a valid baseline score and was therefore excluded from the safety analysis set.|participants|Number|1|1.0||||||
4259454|NCT00613938|4083823|B5|Between 18 and 65 years||Age|One patient in the oxycodone 10mg group did not have a valid baseline score and was therefore excluded from the safety analysis set.|participants|Number|866|866.0||||||
4259455|NCT00613938|4083824|B4|Between 18 and 65 years||Age|One patient in the oxycodone 10mg group did not have a valid baseline score and was therefore excluded from the safety analysis set.|participants|Number|265|265.0||||||
4259456|NCT00613938|4083825|B3|Between 18 and 65 years||Age|One patient in the oxycodone 10mg group did not have a valid baseline score and was therefore excluded from the safety analysis set.|participants|Number|268|268.0||||||
4259457|NCT00613938|4083826|B2|Between 18 and 65 years||Age|One patient in the oxycodone 10mg group did not have a valid baseline score and was therefore excluded from the safety analysis set.|participants|Number|265|265.0||||||
4259458|NCT00613938|4083827|B1|Between 18 and 65 years||Age|One patient in the oxycodone 10mg group did not have a valid baseline score and was therefore excluded from the safety analysis set.|participants|Number|68|68.0||||||
4259459|NCT00613938|4083823|B5|<=18 years||Age|One patient in the oxycodone 10mg group did not have a valid baseline score and was therefore excluded from the safety analysis set.|participants|Number|0|0.0||||||
4259460|NCT00613938|4083824|B4|<=18 years||Age|One patient in the oxycodone 10mg group did not have a valid baseline score and was therefore excluded from the safety analysis set.|participants|Number|0|0.0||||||
4259461|NCT00613938|4083825|B3|<=18 years||Age|One patient in the oxycodone 10mg group did not have a valid baseline score and was therefore excluded from the safety analysis set.|participants|Number|0|0.0||||||
4259462|NCT00613938|4083826|B2|<=18 years||Age|One patient in the oxycodone 10mg group did not have a valid baseline score and was therefore excluded from the safety analysis set.|participants|Number|0|0.0||||||
4259463|NCT00613938|4083827|B1|<=18 years||Age|One patient in the oxycodone 10mg group did not have a valid baseline score and was therefore excluded from the safety analysis set.|participants|Number|0|0.0||||||
4259464|NCT00613925|4083860|B3|United States||Region of Enrollment||participants|Number|70|70.0||||||
4259465|NCT00613925|4083861|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4259466|NCT00613925|4083862|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4259467|NCT00613925|4083860|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4259468|NCT00613925|4083861|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4259469|NCT00613925|4083862|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4259470|NCT00613925|4083860|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4259471|NCT00613925|4083861|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4259472|NCT00613925|4083862|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4259473|NCT00613925|4083860|B3|||Age||years|Mean|45.7|45.7|Standard Deviation|7.4|7.4|||
4259474|NCT00613925|4083861|B2|||Age||years|Mean|46.1|46.1|Standard Deviation|7.7|7.7|||
4259475|NCT00613925|4083862|B1|||Age||years|Mean|45.2|45.2|Standard Deviation|7.3|7.3|||
4259477|NCT00613925|4083861|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4259478|NCT00613925|4083862|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4259479|NCT00613925|4083860|B3||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4259480|NCT00613925|4083861|B2||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4259481|NCT00613925|4083862|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4259482|NCT00613925|4083860|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259483|NCT00613925|4083861|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259484|NCT00613925|4083862|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259485|NCT00613821|4083871|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
4259486|NCT00613821|4083872|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4259487|NCT00613821|4083873|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4259488|NCT00613821|4083871|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4259489|NCT00613821|4083872|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4259490|NCT00613821|4083873|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4259491|NCT00613821|4083871|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4259492|NCT00613821|4083872|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4259493|NCT00613821|4083873|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4259494|NCT00613821|4083871|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4259495|NCT00613821|4083872|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4259496|NCT00613821|4083873|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4259497|NCT00613821|4083871|B3||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4259498|NCT00613821|4083872|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4259499|NCT00613821|4083873|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4259500|NCT00613821|4083871|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259501|NCT00613821|4083872|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259502|NCT00613821|4083873|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259503|NCT00613730|4083880|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4259504|NCT00613730|4083880|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4259505|NCT00613730|4083880|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4259506|NCT00613730|4083880|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4259507|NCT00613730|4083880|B1|||Age||years|Median|64|64.0|Full Range|||61.0|67.0|
4259508|NCT00613626|4083886|B4|Carboplatin||Platinum Therapy||participants|Number|32|32.0||||||
4259509|NCT00613626|4083887|B3|Carboplatin||Platinum Therapy||participants|Number|0|0.0||||||
4259510|NCT00613626|4083888|B2|Carboplatin||Platinum Therapy||participants|Number|16|16.0||||||
4259511|NCT00613626|4083889|B1|Carboplatin||Platinum Therapy||participants|Number|16|16.0||||||
4259512|NCT00613626|4083886|B4|Cisplatin||Platinum Therapy||participants|Number|41|41.0||||||
4259513|NCT00613626|4083887|B3|Cisplatin||Platinum Therapy||participants|Number|7|7.0||||||
4259514|NCT00613626|4083888|B2|Cisplatin||Platinum Therapy||participants|Number|17|17.0||||||
4259515|NCT00613626|4083889|B1|Cisplatin||Platinum Therapy||participants|Number|17|17.0||||||
4259516|NCT00613626|4083886|B4|Absent||Brain Metastases||participants|Number|48|48.0||||||
4259517|NCT00613626|4083887|B3|Absent||Brain Metastases||participants|Number|2|2.0||||||
4259518|NCT00613626|4083888|B2|Absent||Brain Metastases||participants|Number|23|23.0||||||
4259519|NCT00613626|4083889|B1|Absent||Brain Metastases||participants|Number|23|23.0||||||
4259520|NCT00613626|4083886|B4|Present||Brain Metastases||participants|Number|25|25.0||||||
4259521|NCT00613626|4083887|B3|Present||Brain Metastases||participants|Number|5|5.0||||||
4259522|NCT00613626|4083888|B2|Present||Brain Metastases||participants|Number|10|10.0||||||
4259523|NCT00613626|4083889|B1|Present||Brain Metastases||participants|Number|10|10.0||||||
4259524|NCT00613626|4083886|B4|Absent||Liver Metastases||participants|Number|43|43.0||||||
4259525|NCT00613626|4083887|B3|Absent||Liver Metastases||participants|Number|6|6.0||||||
4259526|NCT00613626|4083888|B2|Absent||Liver Metastases||participants|Number|20|20.0||||||
4259527|NCT00613626|4083889|B1|Absent||Liver Metastases||participants|Number|17|17.0||||||
4259528|NCT00613626|4083886|B4|Present||Liver Metastases||participants|Number|30|30.0||||||
4259529|NCT00613626|4083887|B3|Present||Liver Metastases||participants|Number|1|1.0||||||
4259530|NCT00613626|4083888|B2|Present||Liver Metastases||participants|Number|13|13.0||||||
4259531|NCT00613626|4083889|B1|Present||Liver Metastases||participants|Number|16|16.0||||||
4259532|NCT00613626|4083886|B4|1||ECOG Performance Status|"Eastern Cooperative Oncology Group Score~0 Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|participants|Number|48|48.0||||||
4259562|NCT00613626|4083888|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259563|NCT00613626|4083889|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259564|NCT00613626|4083886|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4259533|NCT00613626|4083887|B3|1||ECOG Performance Status|"Eastern Cooperative Oncology Group Score~0 Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|participants|Number|5|5.0||||||
4259534|NCT00613626|4083888|B2|1||ECOG Performance Status|"Eastern Cooperative Oncology Group Score~0 Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|participants|Number|22|22.0||||||
4259535|NCT00613626|4083889|B1|1||ECOG Performance Status|"Eastern Cooperative Oncology Group Score~0 Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|participants|Number|21|21.0||||||
4259536|NCT00613626|4083886|B4|0||ECOG Performance Status|"Eastern Cooperative Oncology Group Score~0 Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|participants|Number|25|25.0||||||
4259537|NCT00613626|4083887|B3|0||ECOG Performance Status|"Eastern Cooperative Oncology Group Score~0 Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|participants|Number|2|2.0||||||
4259538|NCT00613626|4083888|B2|0||ECOG Performance Status|"Eastern Cooperative Oncology Group Score~0 Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|participants|Number|11|11.0||||||
4259539|NCT00613626|4083889|B1|0||ECOG Performance Status|"Eastern Cooperative Oncology Group Score~0 Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|participants|Number|12|12.0||||||
4259540|NCT00613626|4083886|B4|United States||Region of Enrollment||participants|Number|73|73.0||||||
4259541|NCT00613626|4083887|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4259542|NCT00613626|4083888|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4259543|NCT00613626|4083889|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4259544|NCT00613626|4083886|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4259545|NCT00613626|4083887|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259546|NCT00613626|4083888|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4259547|NCT00613626|4083889|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259548|NCT00613626|4083886|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259549|NCT00613626|4083887|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259550|NCT00613626|4083888|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259551|NCT00613626|4083889|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259552|NCT00613626|4083886|B4||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4259553|NCT00613626|4083887|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4259554|NCT00613626|4083888|B2||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4259555|NCT00613626|4083889|B1||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4259556|NCT00613626|4083886|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4259557|NCT00613626|4083887|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4259558|NCT00613626|4083888|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4259559|NCT00613626|4083889|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4259560|NCT00613626|4083886|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259561|NCT00613626|4083887|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259565|NCT00613626|4083887|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259566|NCT00613626|4083888|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4259567|NCT00613626|4083889|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259568|NCT00613626|4083886|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259569|NCT00613626|4083887|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259570|NCT00613626|4083888|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259571|NCT00613626|4083889|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259572|NCT00613626|4083886|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4259573|NCT00613626|4083887|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259574|NCT00613626|4083888|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4259575|NCT00613626|4083889|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4259576|NCT00613626|4083886|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4259577|NCT00613626|4083887|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4259578|NCT00613626|4083888|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4259579|NCT00613626|4083889|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4259580|NCT00613626|4083886|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259581|NCT00613626|4083887|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259582|NCT00613626|4083888|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259583|NCT00613626|4083889|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259584|NCT00613626|4083886|B4||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4259585|NCT00613626|4083887|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4259586|NCT00613626|4083888|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4259587|NCT00613626|4083889|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4259588|NCT00613626|4083886|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4259589|NCT00613626|4083887|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4259590|NCT00613626|4083888|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4259591|NCT00613626|4083889|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4259592|NCT00613626|4083886|B4|||Age||years|Mean|62.94|62.94|Standard Deviation|8.83|8.83|||
4259593|NCT00613626|4083887|B3|||Age||years|Mean|66.14|66.14|Standard Deviation|3.34|3.34|||
4259594|NCT00613626|4083888|B2|||Age||years|Mean|63.80|63.8|Standard Deviation|5.90|5.9|||
4259595|NCT00613626|4083889|B1|||Age||years|Mean|62.58|62.58|Standard Deviation|10.92|10.92|||
4259596|NCT00613574|4083907|B1||Male|Sex: Female, Male||Participants|Count of Participants|339|339.0||||||
4259597|NCT00613574|4083907|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4259598|NCT00613574|4083907|B1|||Age||years|Mean|60.2|60.2|Standard Deviation|9.2|9.2|||
4259599|NCT00613509|4083917|B3|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4259600|NCT00613509|4083918|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4259601|NCT00613509|4083919|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4259602|NCT00613509|4083917|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4259603|NCT00613509|4083918|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4259604|NCT00613509|4083919|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4259605|NCT00613509|4083917|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4259606|NCT00613509|4083918|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4259607|NCT00613509|4083919|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4259608|NCT00613509|4083917|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4259609|NCT00613509|4083918|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4259610|NCT00613509|4083919|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4259611|NCT00613509|4083917|B3|||Age||Years|Mean|52.8|52.8|Standard Deviation|14.3|14.3|||
4259612|NCT00613509|4083918|B2|||Age||Years|Mean|52.9|52.9|Standard Deviation|14.34|14.34|||
4259613|NCT00613509|4083919|B1|||Age||Years|Mean|52.6|52.6|Standard Deviation|14.23|14.23|||
4259614|NCT00613509|4083917|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4259615|NCT00613509|4083918|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4259616|NCT00613509|4083919|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4259617|NCT00613509|4083917|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4259618|NCT00613509|4083918|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4259619|NCT00613509|4083919|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4259620|NCT00613509|4083917|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259621|NCT00613509|4083918|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259622|NCT00613509|4083919|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259623|NCT00613405|4083942|B3|United States||Region of Enrollment||participants|Number|87|87.0||||||
4259624|NCT00613405|4083943|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
4259625|NCT00613405|4083944|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4259626|NCT00613405|4083942|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4259627|NCT00613405|4083943|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4259628|NCT00613405|4083944|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4259629|NCT00613405|4083942|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4259630|NCT00613405|4083943|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4259631|NCT00613405|4083944|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4259632|NCT00613405|4083942|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4259633|NCT00613405|4083943|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4259634|NCT00613405|4083944|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4259635|NCT00613405|4083942|B3||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
4259636|NCT00613405|4083943|B2||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4259637|NCT00613405|4083944|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4259638|NCT00613405|4083942|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259639|NCT00613405|4083943|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259640|NCT00613405|4083944|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259641|NCT00613379|4083951|B4|United States||Region of Enrollment||participants|Number|31|31.0||||||
4259642|NCT00613379|4083952|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4259643|NCT00613379|4083953|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4259644|NCT00613379|4083954|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4259645|NCT00613379|4083951|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4259646|NCT00613379|4083952|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4259647|NCT00613379|4083953|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4259648|NCT00613379|4083954|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4259649|NCT00613379|4083951|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4259650|NCT00613379|4083952|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4259651|NCT00613379|4083953|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4259652|NCT00613379|4083954|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4259653|NCT00613379|4083951|B4|||Age||years|Mean|40.7|40.7|Standard Deviation|10.48|10.48|||
4259654|NCT00613379|4083952|B3|||Age||years|Mean|38|38.0|Standard Deviation|11.65|11.65|||
4259655|NCT00613379|4083953|B2|||Age||years|Mean|42|42.0|Standard Deviation|9.88|9.88|||
4259656|NCT00613379|4083954|B1|||Age||years|Mean|42.5|42.5|Standard Deviation|10.17|10.17|||
4259657|NCT00613379|4083951|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4259658|NCT00613379|4083952|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4259659|NCT00613379|4083953|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4259660|NCT00613379|4083954|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4259661|NCT00613379|4083951|B4||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4259662|NCT00613379|4083952|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4259663|NCT00613379|4083953|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4259664|NCT00613379|4083954|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4259665|NCT00613379|4083951|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259666|NCT00613379|4083952|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259667|NCT00613379|4083953|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259668|NCT00613379|4083954|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259669|NCT00613366|4083964|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4259670|NCT00613366|4083965|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4259671|NCT00613366|4083966|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4259672|NCT00613366|4083964|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4259673|NCT00613366|4083965|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4259674|NCT00613366|4083966|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4259675|NCT00613366|4083964|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4259676|NCT00613366|4083965|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4259677|NCT00613366|4083966|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4259678|NCT00613366|4083964|B3|||Age||years|Mean|26|26.0|Standard Deviation|5|5.0|||
4259679|NCT00613366|4083965|B2|||Age||years|Mean|27|27.0|Standard Deviation|6|6.0|||
4259680|NCT00613366|4083966|B1|||Age||years|Mean|25|25.0|Standard Deviation|5|5.0|||
4259681|NCT00613366|4083964|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4259682|NCT00613366|4083965|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4259683|NCT00613366|4083966|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4259684|NCT00613366|4083964|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4259685|NCT00613366|4083965|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4259686|NCT00613366|4083966|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4259687|NCT00613366|4083964|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259688|NCT00613366|4083965|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259689|NCT00613366|4083966|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259690|NCT00613327|4083975|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4259691|NCT00613327|4083975|B1||Female|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
4259692|NCT00613327|4083975|B1|||Age||Years|Mean|54.93|54.93|Standard Deviation|12.36|12.36|||
4259693|NCT00613314|4083994|B1|Male||Gender|There are 32 subjects with missing gender information|Number of participants|Number|5876|5876.0||||||
4259694|NCT00613314|4083994|B1|Female||Gender|There are 32 subjects with missing gender information|Number of participants|Number|8253|8253.0||||||
4259695|NCT00613314|4083994|B1|||Age|Age summarized for 13659 subjects and 502 subjects were missing age information|Years|Mean|59|59.0|Standard Deviation|9.9|9.9|||
4259696|NCT00613301|4084002|B1||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4259697|NCT00613301|4084002|B1||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4259698|NCT00613301|4084002|B1|||Age||years|Mean|66.2|66.2|Standard Deviation|9.7|9.7|||
4259699|NCT00613106|4084009|B3|United States||Region of Enrollment||participants|Number|179|179.0||||||
4259700|NCT00613106|4084010|B2|United States||Region of Enrollment||participants|Number|47|47.0||||||
4259701|NCT00613106|4084011|B1|United States||Region of Enrollment||participants|Number|132|132.0||||||
4259702|NCT00613106|4084009|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4259703|NCT00613106|4084010|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4259704|NCT00613106|4084011|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4259705|NCT00613106|4084009|B3||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4259706|NCT00613106|4084010|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4259707|NCT00613106|4084011|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4259708|NCT00613106|4084009|B3|||Age||years|Mean|55.2|55.2|Standard Deviation|9.6|9.6|||
4259709|NCT00613106|4084010|B2|||Age||years|Mean|53.6|53.6|Standard Deviation|9.3|9.3|||
4259710|NCT00613106|4084011|B1|||Age||years|Mean|55.7|55.7|Standard Deviation|9.6|9.6|||
4259711|NCT00613106|4084009|B3||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4259712|NCT00613106|4084010|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4259713|NCT00613106|4084011|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4259714|NCT00613106|4084009|B3||Between 18 and 65 years|Age||Participants|Count of Participants|151|151.0||||||
4259715|NCT00613106|4084010|B2||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4259716|NCT00613106|4084011|B1||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
4259717|NCT00613106|4084009|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259718|NCT00613106|4084010|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259719|NCT00613106|4084011|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259720|NCT00613080|4084018|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4259721|NCT00613080|4084018|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4259722|NCT00613080|4084018|B1|||Age||years|Median|51|51.0|Full Range|||29.0|77.0|
4259723|NCT00613028|4084030|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4259724|NCT00613028|4084031|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4259725|NCT00613028|4084032|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4259726|NCT00613028|4084030|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4259727|NCT00613028|4084031|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4259728|NCT00613028|4084032|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4259729|NCT00613028|4084030|B3|||Age||years|Mean|51.9|51.9|Standard Deviation|11.8|11.8|||
4259730|NCT00613028|4084031|B2|||Age||years|Mean|51.7|51.7|Standard Deviation|13.8|13.8|||
4259731|NCT00613028|4084032|B1|||Age||years|Mean|52.1|52.1|Standard Deviation|9.1|9.1|||
4259732|NCT00613015|4084047|B7|United States||Region of Enrollment||participants|Number|109|109.0||||||
4259733|NCT00613015|4084048|B6|United States||Region of Enrollment||participants|Number|19|19.0||||||
4259734|NCT00613015|4084049|B5|United States||Region of Enrollment||participants|Number|15|15.0||||||
4259735|NCT00613015|4084050|B4|United States||Region of Enrollment||participants|Number|24|24.0||||||
4259736|NCT00613015|4084051|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4259737|NCT00613015|4084052|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4259738|NCT00613015|4084053|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4259739|NCT00613015|4084047|B7||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4259740|NCT00613015|4084048|B6||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4259741|NCT00613015|4084049|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4259742|NCT00613015|4084050|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4259743|NCT00613015|4084051|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4259744|NCT00613015|4084052|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4259745|NCT00613015|4084053|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4259746|NCT00613015|4084047|B7||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4259747|NCT00613015|4084048|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4259748|NCT00613015|4084049|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4259749|NCT00613015|4084050|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4259750|NCT00613015|4084051|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4259751|NCT00613015|4084052|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4259752|NCT00613015|4084053|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4259753|NCT00613015|4084047|B7|||Age||years|Mean|41.41|41.41|Standard Deviation|9.28|9.28|||
4259754|NCT00613015|4084048|B6|||Age||years|Mean|44|44.0|Standard Deviation|8.6|8.6|||
4259755|NCT00613015|4084049|B5|||Age||years|Mean|40.2|40.2|Standard Deviation|9.13|9.13|||
4259756|NCT00613015|4084050|B4|||Age||years|Mean|40.92|40.92|Standard Deviation|9.55|9.55|||
4259757|NCT00613015|4084051|B3|||Age||years|Mean|41|41.0|Standard Deviation|10.05|10.05|||
4259758|NCT00613015|4084052|B2|||Age||years|Mean|38.5|38.5|Standard Deviation|10.49|10.49|||
4259759|NCT00613015|4084053|B1|||Age||years|Mean|42.46|42.46|Standard Deviation|8.03|8.03|||
4259760|NCT00613015|4084047|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4259761|NCT00613015|4084048|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4259762|NCT00613015|4084049|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4259763|NCT00613015|4084050|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4259764|NCT00613015|4084051|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4259765|NCT00613015|4084052|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4259766|NCT00613015|4084053|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4259767|NCT00613015|4084047|B7||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
4259768|NCT00613015|4084048|B6||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4259769|NCT00613015|4084049|B5||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4259770|NCT00613015|4084050|B4||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4259771|NCT00613015|4084051|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4259772|NCT00613015|4084052|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4259773|NCT00613015|4084053|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4259774|NCT00613015|4084047|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259775|NCT00613015|4084048|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259776|NCT00613015|4084049|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259777|NCT00613015|4084050|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259778|NCT00613015|4084051|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259779|NCT00613015|4084052|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259780|NCT00613015|4084053|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259781|NCT00612924|4084078|B3|United States||Region of Enrollment||participants|Number|121|121.0||||||
4259782|NCT00612924|4084079|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
4259783|NCT00612924|4084080|B1|United States||Region of Enrollment||participants|Number|61|61.0||||||
4259784|NCT00612924|4084078|B3|Canada||Region of Enrollment||participants|Number|74|74.0||||||
4259785|NCT00612924|4084079|B2|Canada||Region of Enrollment||participants|Number|34|34.0||||||
4259786|NCT00612924|4084080|B1|Canada||Region of Enrollment||participants|Number|40|40.0||||||
4259787|NCT00612924|4084078|B3||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4259788|NCT00612924|4084079|B2||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4259789|NCT00612924|4084080|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4259790|NCT00612924|4084078|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4259791|NCT00612924|4084079|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4259792|NCT00612924|4084080|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4259793|NCT00612924|4084078|B3|||Age||years|Mean|71|71.0|Standard Deviation|7.2|7.2|||
4259794|NCT00612924|4084079|B2|||Age||years|Mean|71|71.0|Standard Deviation|7.3|7.3|||
4259795|NCT00612924|4084080|B1|||Age||years|Mean|71|71.0|Standard Deviation|7.1|7.1|||
4259796|NCT00612924|4084078|B3||>=65 years|Age||Participants|Count of Participants|165|165.0||||||
4259797|NCT00612924|4084079|B2||>=65 years|Age||Participants|Count of Participants|79|79.0||||||
4259798|NCT00612924|4084080|B1||>=65 years|Age||Participants|Count of Participants|86|86.0||||||
4259799|NCT00612924|4084078|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4259800|NCT00612924|4084079|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4259801|NCT00612924|4084080|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4259802|NCT00612924|4084078|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259803|NCT00612924|4084079|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259804|NCT00612924|4084080|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259805|NCT00612807|4084092|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4259806|NCT00612807|4084093|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4259807|NCT00612807|4084094|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4259808|NCT00612807|4084092|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4259809|NCT00612807|4084093|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4259810|NCT00612807|4084094|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4259811|NCT00612807|4084092|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4259812|NCT00612807|4084093|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4259813|NCT00612807|4084094|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4259814|NCT00612807|4084092|B3|||Age||years|Mean|68.5|68.5|Standard Deviation|7.2|7.2|||
4259815|NCT00612807|4084093|B2|||Age||years|Mean|67.2|67.2|Standard Deviation|7.5|7.5|||
4259816|NCT00612807|4084094|B1|||Age||years|Mean|71.2|71.2|Standard Deviation|6.0|6.0|||
4259817|NCT00612807|4084092|B3||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4259818|NCT00612807|4084093|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4259819|NCT00612807|4084094|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4259820|NCT00612807|4084092|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4259821|NCT00612807|4084093|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4259822|NCT00612807|4084094|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4259823|NCT00612807|4084092|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259824|NCT00612807|4084093|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259825|NCT00612807|4084094|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259826|NCT00612768|4084103|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4259827|NCT00612768|4084103|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4259828|NCT00612768|4084103|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4259829|NCT00612768|4084103|B1|||Age||years|Mean|51.4|51.4|Standard Deviation|16.72|16.72|||
4259830|NCT00612768|4084103|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4259831|NCT00612768|4084103|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4259832|NCT00612768|4084103|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259833|NCT00612690|4084128|B3|United States||Region of Enrollment||participants|Number|482|482.0||||||
4259834|NCT00612690|4084129|B2|United States||Region of Enrollment||participants|Number|193|193.0||||||
4259835|NCT00612690|4084130|B1|United States||Region of Enrollment||participants|Number|289|289.0||||||
4259836|NCT00612690|4084128|B3||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4259837|NCT00612690|4084129|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4259838|NCT00612690|4084130|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4259839|NCT00612690|4084128|B3||Female|Sex: Female, Male||Participants|Count of Participants|331|331.0||||||
4259840|NCT00612690|4084129|B2||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4259841|NCT00612690|4084130|B1||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4259842|NCT00612690|4084128|B3|Parents: Female||Sex/Gender, Customized||participants|Number|151|151.0||||||
4259843|NCT00612690|4084129|B2|Parents: Female||Sex/Gender, Customized||participants|Number|55|55.0||||||
4259844|NCT00612690|4084130|B1|Parents: Female||Sex/Gender, Customized||participants|Number|96|96.0||||||
4259845|NCT00612690|4084128|B3|Parents: Male||Sex/Gender, Customized||participants|Number|7|7.0||||||
4259846|NCT00612690|4084129|B2|Parents: Male||Sex/Gender, Customized||participants|Number|6|6.0||||||
4259847|NCT00612690|4084130|B1|Parents: Male||Sex/Gender, Customized||participants|Number|1|1.0||||||
4259848|NCT00612690|4084128|B3|Service Providers: Female||Sex/Gender, Customized||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4259849|NCT00612690|4084129|B2|Service Providers: Female||Sex/Gender, Customized||participants|Number|NA|||||||Service providers in this condition were not research participants.
4259850|NCT00612690|4084130|B1|Service Providers: Female||Sex/Gender, Customized||participants|Number|13|13.0||||||
4259851|NCT00612690|4084128|B3|Service Provders: Male||Sex/Gender, Customized||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4259852|NCT00612690|4084129|B2|Service Provders: Male||Sex/Gender, Customized||participants|Number|NA|||||||Service providers in this condition were not research participants.
4259853|NCT00612690|4084130|B1|Service Provders: Male||Sex/Gender, Customized||participants|Number|4|4.0||||||
4259854|NCT00612690|4084128|B3|Teachers: Female||Sex/Gender, Customized||participants|Number|120|120.0||||||
4259855|NCT00612690|4084129|B2|Teachers: Female||Sex/Gender, Customized||participants|Number|58|58.0||||||
4259856|NCT00612690|4084130|B1|Teachers: Female||Sex/Gender, Customized||participants|Number|62|62.0||||||
4259857|NCT00612690|4084128|B3|Teachers: Male||Sex/Gender, Customized||participants|Number|16|16.0||||||
4259858|NCT00612690|4084129|B2|Teachers: Male||Sex/Gender, Customized||participants|Number|7|7.0||||||
4259859|NCT00612690|4084130|B1|Teachers: Male||Sex/Gender, Customized||participants|Number|9|9.0||||||
4259860|NCT00612690|4084128|B3|Students: Female||Sex/Gender, Customized||participants|Number|47|47.0||||||
4259861|NCT00612690|4084129|B2|Students: Female||Sex/Gender, Customized||participants|Number|17|17.0||||||
4259862|NCT00612690|4084130|B1|Students: Female||Sex/Gender, Customized||participants|Number|30|30.0||||||
4259863|NCT00612690|4084128|B3|Students: Male||Sex/Gender, Customized||participants|Number|124|124.0||||||
4259864|NCT00612690|4084129|B2|Students: Male||Sex/Gender, Customized||participants|Number|50|50.0||||||
4259865|NCT00612690|4084130|B1|Students: Male||Sex/Gender, Customized||participants|Number|74|74.0||||||
4259866|NCT00612690|4084128|B3|Parents||Age||years|Mean|32.28|32.28|Standard Deviation|8.10|8.1|||
4259867|NCT00612690|4084129|B2|Parents||Age||years|Mean|32.64|32.64|Standard Deviation|8.44|8.44|||
4259868|NCT00612690|4084130|B1|Parents||Age||years|Mean|32.06|32.06|Standard Deviation|7.92|7.92|||
4259869|NCT00612690|4084128|B3|Service Providers||Age||years|Mean|32.46|32.46|Standard Deviation|8.73|8.73|||
4259870|NCT00612690|4084129|B2|Service Providers||Age||years|Mean|NA||Standard Deviation|NA||||Service providers in this condition were not research participants.
4259871|NCT00612690|4084130|B1|Service Providers||Age||years|Mean|32.46|32.46|Standard Deviation|8.73|8.73|||
4259872|NCT00612690|4084128|B3|Teachers||Age||years|Mean|38.37|38.37|Standard Deviation|12.73|12.73|||
4259873|NCT00612690|4084129|B2|Teachers||Age||years|Mean|35.58|35.58|Standard Deviation|11.46|11.46|||
4259874|NCT00612690|4084130|B1|Teachers||Age||years|Mean|41.44|41.44|Standard Deviation|13.46|13.46|||
4259875|NCT00612690|4084128|B3|Students||Age||years|Mean|7.51|7.51|Standard Deviation|1.71|1.71|||
4259876|NCT00612690|4084129|B2|Students||Age||years|Mean|7.66|7.66|Standard Deviation|1.53|1.53|||
4259877|NCT00612690|4084130|B1|Students||Age||years|Mean|7.42|7.42|Standard Deviation|1.81|1.81|||
4259878|NCT00612690|4084128|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4259879|NCT00612690|4084129|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4259880|NCT00612690|4084130|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4259881|NCT00612690|4084128|B3||Between 18 and 65 years|Age||Participants|Count of Participants|311|311.0||||||
4259882|NCT00612690|4084129|B2||Between 18 and 65 years|Age||Participants|Count of Participants|126|126.0||||||
4259883|NCT00612690|4084130|B1||Between 18 and 65 years|Age||Participants|Count of Participants|185|185.0||||||
4259884|NCT00612690|4084128|B3||<=18 years|Age||Participants|Count of Participants|171|171.0||||||
4259885|NCT00612690|4084129|B2||<=18 years|Age||Participants|Count of Participants|67|67.0||||||
4259886|NCT00612690|4084130|B1||<=18 years|Age||Participants|Count of Participants|104|104.0||||||
4259887|NCT00612677|4084139|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4259888|NCT00612677|4084139|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4259889|NCT00612677|4084139|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4259890|NCT00612677|4084139|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4259891|NCT00612677|4084139|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4259892|NCT00612677|4084139|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259893|NCT00612573|4084145|B5|United States||Region of Enrollment||participants|Number|257|257.0||||||
4259894|NCT00612573|4084146|B4|United States||Region of Enrollment||participants|Number|67|67.0||||||
4259895|NCT00612573|4084147|B3|United States||Region of Enrollment||participants|Number|61|61.0||||||
4259896|NCT00612573|4084148|B2|United States||Region of Enrollment||participants|Number|65|65.0||||||
4259897|NCT00612573|4084149|B1|United States||Region of Enrollment||participants|Number|64|64.0||||||
4259898|NCT00612573|4084145|B5||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4259899|NCT00612573|4084146|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4259900|NCT00612573|4084147|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4259901|NCT00612573|4084148|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4259902|NCT00612573|4084149|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4259903|NCT00612573|4084145|B5||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4259904|NCT00612573|4084146|B4||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4259905|NCT00612573|4084147|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4259906|NCT00612573|4084148|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4259907|NCT00612573|4084149|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4259908|NCT00612573|4084145|B5|< 18 years||Age, Customized||Participants|Number|124|124.0||||||
4259909|NCT00612573|4084146|B4|< 18 years||Age, Customized||Participants|Number|32|32.0||||||
4259910|NCT00612573|4084147|B3|< 18 years||Age, Customized||Participants|Number|34|34.0||||||
4259911|NCT00612573|4084148|B2|< 18 years||Age, Customized||Participants|Number|26|26.0||||||
4259912|NCT00612573|4084149|B1|< 18 years||Age, Customized||Participants|Number|32|32.0||||||
4259913|NCT00612573|4084145|B5|>= 18 years||Age, Customized||Participants|Number|133|133.0||||||
4259914|NCT00612573|4084146|B4|>= 18 years||Age, Customized||Participants|Number|35|35.0||||||
4259915|NCT00612573|4084147|B3|>= 18 years||Age, Customized||Participants|Number|27|27.0||||||
4259916|NCT00612573|4084148|B2|>= 18 years||Age, Customized||Participants|Number|39|39.0||||||
4259917|NCT00612573|4084149|B1|>= 18 years||Age, Customized||Participants|Number|32|32.0||||||
4259918|NCT00612573|4084145|B5|||Age||years|Mean|19.9|19.9|Standard Deviation|6.7|6.7|||
4259919|NCT00612573|4084146|B4|||Age||years|Mean|20.2|20.2|Standard Deviation|7.5|7.5|||
4259920|NCT00612573|4084147|B3|||Age||years|Mean|20.7|20.7|Standard Deviation|7.4|7.4|||
4259921|NCT00612573|4084148|B2|||Age||years|Mean|19.4|19.4|Standard Deviation|6.6|6.6|||
4259922|NCT00612573|4084149|B1|||Age||years|Mean|19.3|19.3|Standard Deviation|5.2|5.2|||
4259923|NCT00612560|4084174|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259924|NCT00612560|4084175|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259925|NCT00612560|4084176|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259926|NCT00612560|4084177|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259927|NCT00612560|4084178|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259928|NCT00612560|4084174|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259929|NCT00612560|4084175|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259930|NCT00612560|4084176|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259931|NCT00612560|4084177|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259932|NCT00612560|4084178|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259933|NCT00612560|4084174|B5||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4259934|NCT00612560|4084175|B4||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4259935|NCT00612560|4084176|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4259936|NCT00612560|4084177|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4259937|NCT00612560|4084178|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4259938|NCT00612560|4084174|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4259939|NCT00612560|4084175|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259940|NCT00612560|4084176|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259941|NCT00612560|4084177|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4259942|NCT00612560|4084178|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259943|NCT00612560|4084174|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259944|NCT00612560|4084175|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259945|NCT00612560|4084176|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259946|NCT00612560|4084177|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259947|NCT00612560|4084178|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259948|NCT00612560|4084174|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259949|NCT00612560|4084175|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259950|NCT00612560|4084176|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259951|NCT00612560|4084177|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259952|NCT00612560|4084178|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259953|NCT00612560|4084174|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259954|NCT00612560|4084175|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259955|NCT00612560|4084176|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259956|NCT00612560|4084177|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259957|NCT00612560|4084178|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4259958|NCT00612560|4084174|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4259959|NCT00612560|4084175|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4259960|NCT00612560|4084176|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4259961|NCT00612560|4084177|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4259962|NCT00612560|4084178|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4259963|NCT00612560|4084174|B5||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4259964|NCT00612560|4084175|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4259965|NCT00612560|4084176|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4259966|NCT00612560|4084177|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4259967|NCT00612560|4084178|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4259968|NCT00612560|4084174|B5|||Age||years|Mean|62|62.0|Standard Deviation|7.6|7.6|||
4259969|NCT00612560|4084175|B4|||Age||years|Mean|64|64.0|Standard Deviation|7.6|7.6|||
4259970|NCT00612560|4084176|B3|||Age||years|Mean|65|65.0|Standard Deviation|6.6|6.6|||
4259971|NCT00612560|4084177|B2|||Age||years|Mean|58|58.0|Standard Deviation|7.5|7.5|||
4259972|NCT00612560|4084178|B1|||Age||years|Mean|63|63.0|Standard Deviation|8.5|8.5|||
4259973|NCT00612560|4084174|B5||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4259974|NCT00612560|4084175|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4259975|NCT00612560|4084176|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4259976|NCT00612560|4084177|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4259977|NCT00612560|4084178|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4259978|NCT00612560|4084174|B5||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4259979|NCT00612560|4084175|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4259980|NCT00612560|4084176|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4259981|NCT00612560|4084177|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4259982|NCT00612560|4084178|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4259983|NCT00612560|4084174|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259984|NCT00612560|4084175|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259985|NCT00612560|4084176|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259986|NCT00612560|4084177|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259987|NCT00612560|4084178|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4259988|NCT00612534|4084203|B5|United States||Region of Enrollment||participants|Number|94|94.0||||||
4259989|NCT00612534|4084204|B4|United States||Region of Enrollment||participants|Number|24|24.0||||||
4259990|NCT00612534|4084205|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4259991|NCT00612534|4084206|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4259992|NCT00612534|4084207|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4259993|NCT00612534|4084203|B5||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4259994|NCT00612534|4084204|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4259995|NCT00612534|4084205|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4259996|NCT00612534|4084206|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4259997|NCT00612534|4084207|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4259998|NCT00612534|4084203|B5||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4259999|NCT00612534|4084204|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4260000|NCT00612534|4084205|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4260001|NCT00612534|4084206|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4260002|NCT00612534|4084207|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4260003|NCT00612534|4084203|B5|>=65 years||Age, Customized||participants|Number|46|46.0||||||
4260004|NCT00612534|4084204|B4|>=65 years||Age, Customized||participants|Number|13|13.0||||||
4260005|NCT00612534|4084205|B3|>=65 years||Age, Customized||participants|Number|10|10.0||||||
4260006|NCT00612534|4084206|B2|>=65 years||Age, Customized||participants|Number|14|14.0||||||
4260007|NCT00612534|4084207|B1|>=65 years||Age, Customized||participants|Number|9|9.0||||||
4260008|NCT00612534|4084203|B5|40 to 64 years||Age, Customized||participants|Number|48|48.0||||||
4260009|NCT00612534|4084204|B4|40 to 64 years||Age, Customized||participants|Number|11|11.0||||||
4260010|NCT00612534|4084205|B3|40 to 64 years||Age, Customized||participants|Number|10|10.0||||||
4260011|NCT00612534|4084206|B2|40 to 64 years||Age, Customized||participants|Number|12|12.0||||||
4260012|NCT00612534|4084207|B1|40 to 64 years||Age, Customized||participants|Number|15|15.0||||||
4260013|NCT00612534|4084203|B5|<40 years||Age, Customized||participants|Number|0|0.0||||||
4260014|NCT00612534|4084204|B4|<40 years||Age, Customized||participants|Number|0|0.0||||||
4260015|NCT00612534|4084205|B3|<40 years||Age, Customized||participants|Number|0|0.0||||||
4260016|NCT00612534|4084206|B2|<40 years||Age, Customized||participants|Number|0|0.0||||||
4260017|NCT00612534|4084207|B1|<40 years||Age, Customized||participants|Number|0|0.0||||||
4260018|NCT00612534|4084203|B5|||Age||years|Mean|62.8|62.8|Standard Deviation|8.7|8.7|||
4260019|NCT00612534|4084204|B4|||Age||years|Mean|63.3|63.3|Standard Deviation|7.6|7.6|||
4260020|NCT00612534|4084205|B3|||Age||years|Mean|62.5|62.5|Standard Deviation|8.0|8.0|||
4260021|NCT00612534|4084206|B2|||Age||years|Mean|64.6|64.6|Standard Deviation|9.6|9.6|||
4260022|NCT00612534|4084207|B1|||Age||years|Mean|60.7|60.7|Standard Deviation|9.0|9.0|||
4260023|NCT00612508|4084220|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4260024|NCT00612508|4084221|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4260025|NCT00612508|4084222|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4260026|NCT00612508|4084220|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4260027|NCT00612508|4084221|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4260028|NCT00612508|4084222|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4260029|NCT00612508|4084220|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4260030|NCT00612508|4084221|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4260031|NCT00612508|4084222|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4260032|NCT00612508|4084220|B3|||Age||years|Mean|25.8|25.8|Standard Deviation|4.1|4.1|||
4260033|NCT00612508|4084221|B2|||Age||years|Mean|24|24.0|Standard Deviation|3.4|3.4|||
4260034|NCT00612508|4084222|B1|||Age||years|Mean|28|28.0|Standard Deviation|4|4.0|||
4260035|NCT00612508|4084220|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4260036|NCT00612508|4084221|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4260037|NCT00612508|4084222|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4260038|NCT00612508|4084220|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4260039|NCT00612508|4084221|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4260040|NCT00612508|4084222|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4260041|NCT00612508|4084220|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260042|NCT00612508|4084221|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260043|NCT00612508|4084222|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260044|NCT00612456|4084231|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260045|NCT00612456|4084232|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260046|NCT00612456|4084233|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260047|NCT00612456|4084234|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260048|NCT00612456|4084231|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260049|NCT00612456|4084232|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260050|NCT00612456|4084233|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260051|NCT00612456|4084234|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260052|NCT00612456|4084231|B4||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4260053|NCT00612456|4084232|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4260054|NCT00612456|4084233|B2||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4260055|NCT00612456|4084234|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4260056|NCT00612456|4084231|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260057|NCT00612456|4084232|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260058|NCT00612456|4084233|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260059|NCT00612456|4084234|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260060|NCT00612456|4084231|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260061|NCT00612456|4084232|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260062|NCT00612456|4084233|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260063|NCT00612456|4084234|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260064|NCT00612456|4084231|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260065|NCT00612456|4084232|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260066|NCT00612456|4084233|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260067|NCT00612456|4084234|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260068|NCT00612456|4084231|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260069|NCT00612456|4084232|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260070|NCT00612456|4084233|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260071|NCT00612456|4084234|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260072|NCT00612456|4084231|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4260073|NCT00612456|4084232|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4260074|NCT00612456|4084233|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4260075|NCT00612456|4084234|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4260076|NCT00612456|4084231|B4||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4260077|NCT00612456|4084232|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4260078|NCT00612456|4084233|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4260079|NCT00612456|4084234|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4260080|NCT00612456|4084231|B4|57 to 88 years||Age, Customized||Participants|Count of Participants|70|70.0||||||
4260081|NCT00612456|4084232|B3|57 to 88 years||Age, Customized||Participants|Count of Participants|16|16.0||||||
4260082|NCT00612456|4084233|B2|57 to 88 years||Age, Customized||Participants|Count of Participants|27|27.0||||||
4260083|NCT00612456|4084234|B1|57 to 88 years||Age, Customized||Participants|Count of Participants|27|27.0||||||
4260084|NCT00612430|4084280|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4260085|NCT00612430|4084281|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4260086|NCT00612430|4084282|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4260087|NCT00612430|4084280|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4260088|NCT00612430|4084281|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4260089|NCT00612430|4084282|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4260090|NCT00612430|4084280|B3|||Age||years|Median|48.5|48.5|Full Range|24.1-70.4|24.1|24.1|70.4|
4260091|NCT00612430|4084281|B2|||Age||years|Median|54.3|54.3|Full Range|24.1-70.4|24.1|24.1|70.4|
4260092|NCT00612430|4084282|B1|||Age||years|Median|45.9|45.9|Full Range|24.5-61.7|24.5|24.5|61.7|
4260093|NCT00612352|4084297|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4260094|NCT00612352|4084298|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4260095|NCT00612352|4084299|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4260096|NCT00612352|4084297|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260097|NCT00612352|4084298|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260098|NCT00612352|4084299|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260099|NCT00612352|4084297|B3||White|Race (NIH/OMB)||Participants|Count of Participants|139|139.0||||||
4260100|NCT00612352|4084298|B2||White|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
4260101|NCT00612352|4084299|B1||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4260102|NCT00612352|4084297|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4260103|NCT00612352|4084298|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4260104|NCT00612352|4084299|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4260105|NCT00612352|4084297|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260106|NCT00612352|4084298|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260107|NCT00612352|4084299|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260108|NCT00612352|4084297|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260109|NCT00612352|4084298|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260110|NCT00612352|4084299|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260111|NCT00612352|4084297|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260112|NCT00612352|4084298|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260113|NCT00612352|4084299|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260114|NCT00612352|4084297|B3||Male|Gender||Participants|Count of Participants|92|92.0||||||
4260115|NCT00612352|4084298|B2||Male|Gender||Participants|Count of Participants|59|59.0||||||
4260116|NCT00612352|4084299|B1||Male|Gender||Participants|Count of Participants|33|33.0||||||
4260117|NCT00612352|4084297|B3||Female|Gender||Participants|Count of Participants|88|88.0||||||
4260118|NCT00612352|4084298|B2||Female|Gender||Participants|Count of Participants|56|56.0||||||
4260119|NCT00612352|4084299|B1||Female|Gender||Participants|Count of Participants|32|32.0||||||
4260120|NCT00612352|4084297|B3|||Age||years|Mean|24.08|24.08|Standard Deviation|2.60|2.6|||
4260121|NCT00612352|4084298|B2|||Age||years|Mean|24.1|24.1|Standard Deviation|2.38|2.38|||
4260122|NCT00612352|4084299|B1|||Age||years|Mean|24.06|24.06|Standard Deviation|2.97|2.97|||
4260123|NCT00612339|4084414|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4260124|NCT00612339|4084414|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4260125|NCT00612339|4084414|B1|||Age||years|Mean|58.6|58.6|Standard Deviation|7.6|7.6|||
4260126|NCT00612339|4084414|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4260127|NCT00612339|4084414|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4260128|NCT00612339|4084414|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260129|NCT00612313|4084418|B3|||Baseline CGI Severity|"Clinical Global Impression - Severity Range: 1-7~Normal, not at all ill~Borderline mentally ill~Mildly ill~Moderately ill~Markedly ill~Severly ill~Among the most extremely ill patients"|units on a scale|Mean|5.2|5.2|Standard Deviation|0.7|0.7|||
4260130|NCT00612313|4084419|B2|||Baseline CGI Severity|"Clinical Global Impression - Severity Range: 1-7~Normal, not at all ill~Borderline mentally ill~Mildly ill~Moderately ill~Markedly ill~Severly ill~Among the most extremely ill patients"|units on a scale|Mean|5.1|5.1|Standard Deviation|0.7|0.7|||
4260131|NCT00612313|4084420|B1|||Baseline CGI Severity|"Clinical Global Impression - Severity Range: 1-7~Normal, not at all ill~Borderline mentally ill~Mildly ill~Moderately ill~Markedly ill~Severly ill~Among the most extremely ill patients"|units on a scale|Mean|5.3|5.3|Standard Deviation|0.69|0.69|||
4260132|NCT00612313|4084418|B3|||Baseline CDRS-R|"Childhood Depression Rating Scale - Revised (CDRS-R) Total score range: 17-113~Scoring thresholds:~>=40: moderate to severe depression; <=28: remission"|units on a scale|Mean|58.0|58.0|Standard Deviation|7.2|7.2|||
4260133|NCT00612313|4084419|B2|||Baseline CDRS-R|"Childhood Depression Rating Scale - Revised (CDRS-R) Total score range: 17-113~Scoring thresholds:~>=40: moderate to severe depression; <=28: remission"|units on a scale|Mean|56.8|56.8|Standard Deviation|7.1|7.1|||
4260134|NCT00612313|4084420|B1|||Baseline CDRS-R|"Childhood Depression Rating Scale - Revised (CDRS-R) Total score range: 17-113~Scoring thresholds:~>=40: moderate to severe depression; <=28: remission"|units on a scale|Mean|59.2|59.2|Standard Deviation|7.0|7.0|||
4260135|NCT00612313|4084418|B3|United States||Region of Enrollment||participants|Number|144|144.0||||||
4260136|NCT00612313|4084419|B2|United States||Region of Enrollment||participants|Number|75|75.0||||||
4260137|NCT00612313|4084420|B1|United States||Region of Enrollment||participants|Number|69|69.0||||||
4260138|NCT00612313|4084418|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260139|NCT00612313|4084419|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260140|NCT00612313|4084420|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260141|NCT00612313|4084418|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4260142|NCT00612313|4084419|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4260143|NCT00612313|4084420|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4260144|NCT00612313|4084418|B3||White|Race (NIH/OMB)||Participants|Count of Participants|118|118.0||||||
4260145|NCT00612313|4084419|B2||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4260146|NCT00612313|4084420|B1||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4260147|NCT00612313|4084418|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4260148|NCT00612313|4084419|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4260149|NCT00612313|4084420|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4260150|NCT00612313|4084418|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260151|NCT00612313|4084419|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260152|NCT00612313|4084420|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260153|NCT00612313|4084418|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4260154|NCT00612313|4084419|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4260155|NCT00612313|4084420|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260156|NCT00612313|4084418|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4260157|NCT00612313|4084419|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260158|NCT00612313|4084420|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4260159|NCT00612313|4084418|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260160|NCT00612313|4084419|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260161|NCT00612313|4084420|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260282|NCT00612040|4084519|B3|||Age||years|Mean|47.2|47.2|Standard Deviation|13.5|13.5|||
4260162|NCT00612313|4084418|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
4260163|NCT00612313|4084419|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4260164|NCT00612313|4084420|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4260165|NCT00612313|4084418|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4260166|NCT00612313|4084419|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4260167|NCT00612313|4084420|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4260168|NCT00612313|4084418|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4260169|NCT00612313|4084419|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4260170|NCT00612313|4084420|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4260171|NCT00612313|4084418|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4260172|NCT00612313|4084419|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4260173|NCT00612313|4084420|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4260174|NCT00612313|4084418|B3|||Age||Years|Mean|13.8|13.8|Standard Deviation|2.6|2.6|||
4260175|NCT00612313|4084419|B2|||Age||Years|Mean|13.5|13.5|Standard Deviation|2.7|2.7|||
4260176|NCT00612313|4084420|B1|||Age||Years|Mean|14.2|14.2|Standard Deviation|2.4|2.4|||
4260177|NCT00612235|4084437|B5|United States||Region of Enrollment||participants|Number|80|80.0||||||
4260178|NCT00612235|4084438|B4|United States||Region of Enrollment||participants|Number|20|20.0||||||
4260179|NCT00612235|4084439|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4260180|NCT00612235|4084440|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4260181|NCT00612235|4084441|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4260182|NCT00612235|4084437|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4260183|NCT00612235|4084438|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4260184|NCT00612235|4084439|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4260185|NCT00612235|4084440|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4260186|NCT00612235|4084441|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4260187|NCT00612235|4084437|B5||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4260188|NCT00612235|4084438|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4260189|NCT00612235|4084439|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4260190|NCT00612235|4084440|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4260191|NCT00612235|4084441|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4260192|NCT00612235|4084437|B5|||Age||years|Mean|31.75|31.75|Standard Deviation|8.22|8.22|||
4260193|NCT00612235|4084438|B4|||Age||years|Mean|31.79|31.79|Standard Deviation|8.21|8.21|||
4260194|NCT00612235|4084439|B3|||Age||years|Mean|29.93|29.93|Standard Deviation|8.74|8.74|||
4260195|NCT00612235|4084440|B2|||Age||years|Mean|33.08|33.08|Standard Deviation|7.57|7.57|||
4260196|NCT00612235|4084441|B1|||Age||years|Mean|32.44|32.44|Standard Deviation|8.06|8.06|||
4260197|NCT00612235|4084437|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4260198|NCT00612235|4084438|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4260199|NCT00612235|4084439|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4260200|NCT00612235|4084440|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4260201|NCT00612235|4084441|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4260202|NCT00612235|4084437|B5||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4260203|NCT00612235|4084438|B4||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4260204|NCT00612235|4084439|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4260205|NCT00612235|4084440|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4260206|NCT00612235|4084441|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4260207|NCT00612235|4084437|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260208|NCT00612235|4084438|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260209|NCT00612235|4084439|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260210|NCT00612235|4084440|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260211|NCT00612235|4084441|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260212|NCT00612222|4084455|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4260213|NCT00612222|4084455|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260214|NCT00612222|4084455|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260215|NCT00612222|4084455|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4260216|NCT00612222|4084455|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260217|NCT00612222|4084455|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260218|NCT00612222|4084455|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260219|NCT00612222|4084455|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260220|NCT00612222|4084455|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260221|NCT00612222|4084455|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4260222|NCT00612222|4084455|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260223|NCT00612222|4084455|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4260224|NCT00612222|4084455|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4260225|NCT00612222|4084455|B1|||Age||years|Mean|43.8|43.8|Standard Deviation|9.9|9.9|||
4260226|NCT00612222|4084455|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4260227|NCT00612222|4084455|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4260228|NCT00612222|4084455|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260229|NCT00612105|4084461|B3|South Africa||Region of Enrollment||participants|Number|46|46.0||||||
4260230|NCT00612105|4084462|B2|South Africa||Region of Enrollment||participants|Number|15|15.0||||||
4260231|NCT00612105|4084463|B1|South Africa||Region of Enrollment||participants|Number|31|31.0||||||
4260232|NCT00612105|4084461|B3|United States||Region of Enrollment||participants|Number|141|141.0||||||
4260233|NCT00612105|4084462|B2|United States||Region of Enrollment||participants|Number|47|47.0||||||
4260234|NCT00612105|4084463|B1|United States||Region of Enrollment||participants|Number|94|94.0||||||
4260235|NCT00612105|4084461|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4260236|NCT00612105|4084462|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4260237|NCT00612105|4084463|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4260238|NCT00612105|4084461|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4260239|NCT00612105|4084462|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4260240|NCT00612105|4084463|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4260241|NCT00612105|4084461|B3|||Age||years|Mean|62.5|62.5|Standard Deviation|12.23|12.23|||
4260242|NCT00612105|4084462|B2|||Age||years|Mean|61.2|61.2|Standard Deviation|14.28|14.28|||
4260243|NCT00612105|4084463|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|11.07|11.07|||
4260244|NCT00612105|4084461|B3||>=65 years|Age||Participants|Count of Participants|89|89.0||||||
4260245|NCT00612105|4084462|B2||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4260246|NCT00612105|4084463|B1||>=65 years|Age||Participants|Count of Participants|61|61.0||||||
4260247|NCT00612105|4084461|B3||Between 18 and 65 years|Age||Participants|Count of Participants|98|98.0||||||
4260248|NCT00612105|4084462|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4260249|NCT00612105|4084463|B1||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4260250|NCT00612105|4084461|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260251|NCT00612105|4084462|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260252|NCT00612105|4084463|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260253|NCT00612066|4084514|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260254|NCT00612066|4084514|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260255|NCT00612066|4084514|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4260256|NCT00612066|4084514|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260257|NCT00612066|4084514|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260258|NCT00612066|4084514|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4260259|NCT00612066|4084514|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260260|NCT00612066|4084514|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4260261|NCT00612066|4084514|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4260262|NCT00612066|4084514|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4260263|NCT00612066|4084514|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4260264|NCT00612066|4084514|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260265|NCT00612040|4084518|B4|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.9|9.9|Standard Deviation|4.0|4.0|||
4260266|NCT00612040|4084519|B3|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.5|9.5|Standard Deviation|3.8|3.8|||
4260267|NCT00612040|4084520|B2|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.9|9.9|Standard Deviation|3.3|3.3|||
4260268|NCT00612040|4084521|B1|||Fasting plasma glucose (FPG)||mmol/L|Mean|10.3|10.3|Standard Deviation|4.8|4.8|||
4260269|NCT00612040|4084518|B4|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.4|8.4|Standard Deviation|0.9|0.9|||
4260270|NCT00612040|4084519|B3|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.3|8.3|Standard Deviation|0.8|0.8|||
4260271|NCT00612040|4084520|B2|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.4|8.4|Standard Deviation|0.9|0.9|||
4260272|NCT00612040|4084521|B1|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.5|8.5|Standard Deviation|1.0|1.0|||
4260273|NCT00612040|4084518|B4||Male|Gender||Participants|Count of Participants|106|106.0||||||
4260274|NCT00612040|4084519|B3||Male|Gender||Participants|Count of Participants|32|32.0||||||
4260275|NCT00612040|4084520|B2||Male|Gender||Participants|Count of Participants|37|37.0||||||
4260276|NCT00612040|4084521|B1||Male|Gender||Participants|Count of Participants|37|37.0||||||
4260277|NCT00612040|4084518|B4||Female|Gender||Participants|Count of Participants|72|72.0||||||
4260278|NCT00612040|4084519|B3||Female|Gender||Participants|Count of Participants|27|27.0||||||
4260279|NCT00612040|4084520|B2||Female|Gender||Participants|Count of Participants|22|22.0||||||
4260280|NCT00612040|4084521|B1||Female|Gender||Participants|Count of Participants|23|23.0||||||
4260281|NCT00612040|4084518|B4|||Age||years|Mean|45.8|45.8|Standard Deviation|12.8|12.8|||
4260283|NCT00612040|4084520|B2|||Age||years|Mean|44.5|44.5|Standard Deviation|12.7|12.7|||
4260284|NCT00612040|4084521|B1|||Age||years|Mean|45.6|45.6|Standard Deviation|12.5|12.5|||
4260285|NCT00611897|4084567|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4260286|NCT00611897|4084567|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4260287|NCT00611897|4084567|B1|||Age||years|Mean|27.0|27.0|Standard Deviation|5.6|5.6|||
4260288|NCT00611884|4084592|B5|||Fasting plasma glucose (FPG)||mmol/L|Mean|10.2|10.2|Standard Deviation|3.4|3.4|||
4260289|NCT00611884|4084593|B4|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.8|9.8|Standard Deviation|3.1|3.1|||
4260290|NCT00611884|4084594|B3|||Fasting plasma glucose (FPG)||mmol/L|Mean|10.6|10.6|Standard Deviation|3.4|3.4|||
4260291|NCT00611884|4084595|B2|||Fasting plasma glucose (FPG)||mmol/L|Mean|9.9|9.9|Standard Deviation|3.2|3.2|||
4260292|NCT00611884|4084596|B1|||Fasting plasma glucose (FPG)||mmol/L|Mean|10.6|10.6|Standard Deviation|3.6|3.6|||
4260293|NCT00611884|4084592|B5|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.7|8.7|Standard Deviation|1.1|1.1|||
4260294|NCT00611884|4084593|B4|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.7|8.7|Standard Deviation|1.1|1.1|||
4260295|NCT00611884|4084594|B3|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.8|8.8|Standard Deviation|1.1|1.1|||
4260296|NCT00611884|4084595|B2|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.6|8.6|Standard Deviation|1.2|1.2|||
4260297|NCT00611884|4084596|B1|||Glycosylated haemoglobin (HbA1c)||percentage of glycosylated haemoglobin|Mean|8.7|8.7|Standard Deviation|1.1|1.1|||
4260298|NCT00611884|4084592|B5||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4260299|NCT00611884|4084593|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4260300|NCT00611884|4084594|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4260301|NCT00611884|4084595|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4260302|NCT00611884|4084596|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4260303|NCT00611884|4084592|B5||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4260304|NCT00611884|4084593|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4260305|NCT00611884|4084594|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4260306|NCT00611884|4084595|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4260307|NCT00611884|4084596|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4260308|NCT00611884|4084592|B5|||Age||years|Mean|54.2|54.2|Standard Deviation|9.1|9.1|||
4260309|NCT00611884|4084593|B4|||Age||years|Mean|53.1|53.1|Standard Deviation|10.2|10.2|||
4260310|NCT00611884|4084594|B3|||Age||years|Mean|54.4|54.4|Standard Deviation|8.8|8.8|||
4260311|NCT00611884|4084595|B2|||Age||years|Mean|55.3|55.3|Standard Deviation|8.7|8.7|||
4260312|NCT00611884|4084596|B1|||Age||years|Mean|53.9|53.9|Standard Deviation|8.5|8.5|||
4260313|NCT00611858|4084653|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4260314|NCT00611858|4084653|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4260315|NCT00611858|4084653|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4260316|NCT00611858|4084653|B1|||Age||years|Median|56|56.0|Full Range|||40.0|71.0|
4260317|NCT00611806|4084663|B3|United States||Region of Enrollment||participants|Number|140|140.0||||||
4260318|NCT00611806|4084664|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
4260319|NCT00611806|4084665|B1|United States||Region of Enrollment||participants|Number|94|94.0||||||
4260320|NCT00611806|4084663|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4260321|NCT00611806|4084664|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4260322|NCT00611806|4084665|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4260323|NCT00611806|4084663|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4260324|NCT00611806|4084664|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4260325|NCT00611806|4084665|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4260326|NCT00611806|4084663|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4260327|NCT00611806|4084664|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4260328|NCT00611806|4084665|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4260329|NCT00611806|4084663|B3||Between 18 and 65 years|Age||Participants|Count of Participants|140|140.0||||||
4260330|NCT00611806|4084664|B2||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4260331|NCT00611806|4084665|B1||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
4260332|NCT00611806|4084663|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260333|NCT00611806|4084664|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260334|NCT00611806|4084665|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260335|NCT00611806|4084663|B3|||Age||Years|Mean|45.6|45.6|Standard Deviation|1.35|1.35|||
4260336|NCT00611806|4084664|B2|||Age||Years|Mean|45.9|45.9|Standard Deviation|1.6|1.6|||
4260337|NCT00611806|4084665|B1|||Age||Years|Mean|45.3|45.3|Standard Deviation|1.1|1.1|||
4260338|NCT00611767|4084678|B3|United States||Region of Enrollment||participants|Number|73|73.0||||||
4260339|NCT00611767|4084679|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4260340|NCT00611767|4084680|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
4260341|NCT00611767|4084678|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4260342|NCT00611767|4084679|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4260343|NCT00611767|4084680|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4260344|NCT00611767|4084678|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4260345|NCT00611767|4084679|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4260346|NCT00611767|4084680|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4260347|NCT00611767|4084678|B3|||Age||years|Mean|24.22|24.22|Standard Deviation|2.69|2.69|||
4260348|NCT00611767|4084679|B2|||Age||years|Mean|24.63|24.63|Standard Deviation|3.06|3.06|||
4260349|NCT00611767|4084680|B1|||Age||years|Mean|24.02|24.02|Standard Deviation|2.5|2.5|||
4260350|NCT00611767|4084678|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4260351|NCT00611767|4084679|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4260352|NCT00611767|4084680|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4260353|NCT00611767|4084678|B3||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4260354|NCT00611767|4084679|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4260355|NCT00611767|4084680|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4260356|NCT00611767|4084678|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260357|NCT00611767|4084679|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260358|NCT00611767|4084680|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260359|NCT00611715|4084841|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
4260360|NCT00611715|4084842|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4260361|NCT00611715|4084843|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4260362|NCT00611715|4084841|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4260363|NCT00611715|4084842|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4260364|NCT00611715|4084843|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4260365|NCT00611715|4084841|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4260366|NCT00611715|4084842|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4260367|NCT00611715|4084843|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4260368|NCT00611715|4084841|B3|||Age||years|Mean|61|61.0|Standard Deviation|1|1.0|||
4260369|NCT00611715|4084842|B2|||Age||years|Mean|54|54.0|Standard Deviation|1|1.0|||
4260370|NCT00611715|4084843|B1|||Age||years|Mean|62|62.0|Standard Deviation|1|1.0|||
4260371|NCT00611715|4084841|B3||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4260372|NCT00611715|4084842|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4260373|NCT00611715|4084843|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4260374|NCT00611715|4084841|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4260375|NCT00611715|4084842|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4260376|NCT00611715|4084843|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4260377|NCT00611715|4084841|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260378|NCT00611715|4084842|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260379|NCT00611715|4084843|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260380|NCT00611624|4084856|B1||no|lymphovascular space invasion (LVSI)||Participants|Count of Participants|28|28.0||||||
4260381|NCT00611624|4084856|B1||yes|lymphovascular space invasion (LVSI)||Participants|Count of Participants|0|0.0||||||
4260382|NCT00611624|4084856|B1||negative|HER2/neu status (invasive disease only)||Participants|Count of Participants|24|24.0||||||
4260383|NCT00611624|4084856|B1||positive|HER2/neu status (invasive disease only)||Participants|Count of Participants|0|0.0||||||
4260384|NCT00611624|4084856|B1||negative|progesterone receptor (PR)||Participants|Count of Participants|4|4.0||||||
4260385|NCT00611624|4084856|B1||positive|progesterone receptor (PR)||Participants|Count of Participants|24|24.0||||||
4260386|NCT00611624|4084856|B1||negative|estrogen receptor (ER)||Participants|Count of Participants|0|0.0||||||
4260387|NCT00611624|4084856|B1||positive|estrogen receptor (ER)||Participants|Count of Participants|28|28.0||||||
4260388|NCT00611624|4084856|B1|||Size of in situ component (DCIS patients)||centimeters (cm)|Median|0.8|0.8|Full Range|||0.3|2.2|
4260389|NCT00611624|4084856|B1|||Size of in situ component||centimeters (cm)|Median|0.8|0.8|Full Range|||0.0|2.8|
4260390|NCT00611624|4084856|B1|||Size of invasive component||centimeters (cm)|Median|1.0|1.0|Full Range|||0.1|2.0|
4260391|NCT00611624|4084856|B1||Axillary lymph node dissection|Lymph node evaluation|Only those with invasive disease were counted.|Participants|Count of Participants|0|0.0||||||
4260392|NCT00611624|4084856|B1||Sentinel lymph node|Lymph node evaluation|Only those with invasive disease were counted.|Participants|Count of Participants|24|24.0||||||
4260393|NCT00611624|4084856|B1||Invasive cribriform carcinoma|Histology||Participants|Count of Participants|1|1.0||||||
4260394|NCT00611624|4084856|B1||Invasive tubulolobular carcinoma|Histology||Participants|Count of Participants|1|1.0||||||
4260395|NCT00611624|4084856|B1||Invasive lobular carcinoma|Histology||Participants|Count of Participants|3|3.0||||||
4260396|NCT00611624|4084856|B1||Invasive ductal carcinoma|Histology||Participants|Count of Participants|19|19.0||||||
4260397|NCT00611624|4084856|B1||Ductal carcinoma in situ (DCIS)|Histology||Participants|Count of Participants|4|4.0||||||
4260398|NCT00611624|4084856|B1||T1c|Tumor Stage|Breast cancer tumor size was determined prior to study inclusion. Tis is Carcinoma in situ. T1 tumors are 2 cm or smaller. T1mi is Tumor ≤ 1 0.1cm in greatest dimension. T1a - T1c is ordered smallest to largest (all under 2 cm).|Participants|Count of Participants|11|11.0||||||
4260448|NCT00611468|4084945|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4260449|NCT00611468|4084945|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4260399|NCT00611624|4084856|B1||T1b|Tumor Stage|Breast cancer tumor size was determined prior to study inclusion. Tis is Carcinoma in situ. T1 tumors are 2 cm or smaller. T1mi is Tumor ≤ 1 0.1cm in greatest dimension. T1a - T1c is ordered smallest to largest (all under 2 cm).|Participants|Count of Participants|10|10.0||||||
4260400|NCT00611624|4084856|B1||T1a|Tumor Stage|Breast cancer tumor size was determined prior to study inclusion. Tis is Carcinoma in situ. T1 tumors are 2 cm or smaller. T1mi is Tumor ≤ 1 0.1cm in greatest dimension. T1a - T1c is ordered smallest to largest (all under 2 cm).|Participants|Count of Participants|2|2.0||||||
4260401|NCT00611624|4084856|B1||T1mi|Tumor Stage|Breast cancer tumor size was determined prior to study inclusion. Tis is Carcinoma in situ. T1 tumors are 2 cm or smaller. T1mi is Tumor ≤ 1 0.1cm in greatest dimension. T1a - T1c is ordered smallest to largest (all under 2 cm).|Participants|Count of Participants|1|1.0||||||
4260402|NCT00611624|4084856|B1||Tis|Tumor Stage|Breast cancer tumor size was determined prior to study inclusion. Tis is Carcinoma in situ. T1 tumors are 2 cm or smaller. T1mi is Tumor ≤ 1 0.1cm in greatest dimension. T1a - T1c is ordered smallest to largest (all under 2 cm).|Participants|Count of Participants|4|4.0||||||
4260403|NCT00611624|4084856|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4260404|NCT00611624|4084856|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4260405|NCT00611624|4084856|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4260406|NCT00611624|4084856|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4260407|NCT00611624|4084856|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260408|NCT00611559|4084861|B4|White - Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|283|283.0||||||
4260409|NCT00611559|4084862|B3|White - Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|57|57.0||||||
4260410|NCT00611559|4084863|B2|White - Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|115|115.0||||||
4260411|NCT00611559|4084864|B1|White - Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|111|111.0||||||
4260412|NCT00611559|4084861|B4||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4260413|NCT00611559|4084862|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4260414|NCT00611559|4084863|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4260415|NCT00611559|4084864|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4260416|NCT00611559|4084861|B4||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4260417|NCT00611559|4084862|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4260418|NCT00611559|4084863|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4260419|NCT00611559|4084864|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4260420|NCT00611559|4084861|B4|||Age||months|Mean|21.2|21.2|Standard Deviation|1.59|1.59|||
4260421|NCT00611559|4084862|B3|||Age||months|Mean|21.2|21.2|Standard Deviation|1.62|1.62|||
4260422|NCT00611559|4084863|B2|||Age||months|Mean|21.3|21.3|Standard Deviation|1.57|1.57|||
4260423|NCT00611559|4084864|B1|||Age||months|Mean|21.2|21.2|Standard Deviation|1.61|1.61|||
4260424|NCT00611533|4084925|B1|Previous HT use||Participant characteristics|OCP: Oral contraceptive pill; HT: Hormonal therapy|Participants|Count of Participants|4|4.0||||||
4260425|NCT00611533|4084925|B1|Previous OCP use||Participant characteristics|OCP: Oral contraceptive pill; HT: Hormonal therapy|Participants|Count of Participants|11|11.0||||||
4260426|NCT00611533|4084925|B1|Postmenopausal||Participant characteristics|OCP: Oral contraceptive pill; HT: Hormonal therapy|Participants|Count of Participants|10|10.0||||||
4260427|NCT00611533|4084925|B1|Perimenopausal||Participant characteristics|OCP: Oral contraceptive pill; HT: Hormonal therapy|Participants|Count of Participants|4|4.0||||||
4260428|NCT00611533|4084925|B1|||Brown attention deficit disorder scale|The total BADDS ranged from 0-120, with higher scores meaning greater problems with memory, attention and focus.|units on a scale|Mean|38.6|38.6|Standard Deviation|20.2|20.2|||
4260429|NCT00611533|4084925|B1|||Estradiol||pg/mL|Mean|31.9|31.9|Standard Deviation|32.9|32.9|||
4260430|NCT00611533|4084925|B1|||Follicle stimulating hormone||IU/L|Mean|76.0|76.0|Standard Deviation|33.8|33.8|||
4260431|NCT00611533|4084925|B1|||Months since last menstrual period||months|Mean|29.3|29.3|Standard Deviation|20.5|20.5|||
4260432|NCT00611533|4084925|B1|||Years of education||years|Mean|16.4|16.4|Standard Deviation|3.2|3.2|||
4260433|NCT00611533|4084925|B1|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4260434|NCT00611533|4084925|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4260435|NCT00611533|4084925|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4260436|NCT00611533|4084925|B1|||Age||years|Mean|54.0|54.0|Standard Deviation|2.8|2.8|||
4260437|NCT00611468|4084945|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4260438|NCT00611468|4084945|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260439|NCT00611468|4084945|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260440|NCT00611468|4084945|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4260441|NCT00611468|4084945|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4260442|NCT00611468|4084945|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260443|NCT00611468|4084945|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260444|NCT00611468|4084945|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260445|NCT00611468|4084945|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4260446|NCT00611468|4084945|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4260447|NCT00611468|4084945|B1|||Age||years|Mean|58.5|58.5|Standard Deviation|10.3|10.3|||
4260450|NCT00611468|4084945|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260451|NCT00611455|4084958|B3|Not Hispanic/Latino||Race/Ethnicity, Customized|Baseline characteristics are reported for members of the ITT Population, comprised of all randomized participants who were exposed to investigational product irrespective of their compliance to the planned course of treatment. Participants were analyzed according to their randomized treatment.|participants|Number|157|157.0||||||
4260452|NCT00611455|4084959|B2|Not Hispanic/Latino||Race/Ethnicity, Customized|Baseline characteristics are reported for members of the ITT Population, comprised of all randomized participants who were exposed to investigational product irrespective of their compliance to the planned course of treatment. Participants were analyzed according to their randomized treatment.|participants|Number|78|78.0||||||
4260453|NCT00611455|4084960|B1|Not Hispanic/Latino||Race/Ethnicity, Customized|Baseline characteristics are reported for members of the ITT Population, comprised of all randomized participants who were exposed to investigational product irrespective of their compliance to the planned course of treatment. Participants were analyzed according to their randomized treatment.|participants|Number|79|79.0||||||
4260454|NCT00611455|4084958|B3|Hispanic/Latino||Race/Ethnicity, Customized|Baseline characteristics are reported for members of the ITT Population, comprised of all randomized participants who were exposed to investigational product irrespective of their compliance to the planned course of treatment. Participants were analyzed according to their randomized treatment.|participants|Number|103|103.0||||||
4260455|NCT00611455|4084959|B2|Hispanic/Latino||Race/Ethnicity, Customized|Baseline characteristics are reported for members of the ITT Population, comprised of all randomized participants who were exposed to investigational product irrespective of their compliance to the planned course of treatment. Participants were analyzed according to their randomized treatment.|participants|Number|51|51.0||||||
4260456|NCT00611455|4084960|B1|Hispanic/Latino||Race/Ethnicity, Customized|Baseline characteristics are reported for members of the ITT Population, comprised of all randomized participants who were exposed to investigational product irrespective of their compliance to the planned course of treatment. Participants were analyzed according to their randomized treatment.|participants|Number|52|52.0||||||
4260457|NCT00611455|4084958|B3||Male|Sex: Female, Male|Baseline characteristics are reported for members of the ITT Population, comprised of all randomized participants who were exposed to investigational product irrespective of their compliance to the planned course of treatment. Participants were analyzed according to their randomized treatment.|Participants|Count of Participants|46|46.0||||||
4260458|NCT00611455|4084959|B2||Male|Sex: Female, Male|Baseline characteristics are reported for members of the ITT Population, comprised of all randomized participants who were exposed to investigational product irrespective of their compliance to the planned course of treatment. Participants were analyzed according to their randomized treatment.|Participants|Count of Participants|23|23.0||||||
4260459|NCT00611455|4084960|B1||Male|Sex: Female, Male|Baseline characteristics are reported for members of the ITT Population, comprised of all randomized participants who were exposed to investigational product irrespective of their compliance to the planned course of treatment. Participants were analyzed according to their randomized treatment.|Participants|Count of Participants|23|23.0||||||
4260460|NCT00611455|4084958|B3||Female|Sex: Female, Male|Baseline characteristics are reported for members of the ITT Population, comprised of all randomized participants who were exposed to investigational product irrespective of their compliance to the planned course of treatment. Participants were analyzed according to their randomized treatment.|Participants|Count of Participants|214|214.0||||||
4260461|NCT00611455|4084959|B2||Female|Sex: Female, Male|Baseline characteristics are reported for members of the ITT Population, comprised of all randomized participants who were exposed to investigational product irrespective of their compliance to the planned course of treatment. Participants were analyzed according to their randomized treatment.|Participants|Count of Participants|106|106.0||||||
4260462|NCT00611455|4084960|B1||Female|Sex: Female, Male|Baseline characteristics are reported for members of the ITT Population, comprised of all randomized participants who were exposed to investigational product irrespective of their compliance to the planned course of treatment. Participants were analyzed according to their randomized treatment.|Participants|Count of Participants|108|108.0||||||
4260463|NCT00611455|4084958|B3|||Age|Baseline characteristics are reported for members of the Intent-to-Treat (ITT) Population, comprised of all randomized participants who were exposed to investigational product irrespective of their compliance to the planned course of treatment. Participants were analyzed according to their randomized treatment.|Years|Mean|52.7|52.7|Standard Deviation|11.39|11.39|||
4260464|NCT00611455|4084959|B2|||Age|Baseline characteristics are reported for members of the Intent-to-Treat (ITT) Population, comprised of all randomized participants who were exposed to investigational product irrespective of their compliance to the planned course of treatment. Participants were analyzed according to their randomized treatment.|Years|Mean|51.7|51.7|Standard Deviation|11.24|11.24|||
4260465|NCT00611455|4084960|B1|||Age|Baseline characteristics are reported for members of the Intent-to-Treat (ITT) Population, comprised of all randomized participants who were exposed to investigational product irrespective of their compliance to the planned course of treatment. Participants were analyzed according to their randomized treatment.|Years|Mean|53.6|53.6|Standard Deviation|11.50|11.5|||
4260466|NCT00611442|4085088|B3|United States||Region of Enrollment||participants|Number|191|191.0||||||
4260467|NCT00611442|4085089|B2|United States||Region of Enrollment||participants|Number|96|96.0||||||
4260468|NCT00611442|4085090|B1|United States||Region of Enrollment||participants|Number|95|95.0||||||
4260469|NCT00611442|4085088|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4260470|NCT00611442|4085089|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4260471|NCT00611442|4085090|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4260472|NCT00611442|4085088|B3||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4260473|NCT00611442|4085089|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4260474|NCT00611442|4085090|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4260475|NCT00611442|4085088|B3|||Age||years|Mean|55.5|55.5|Standard Deviation|5.0|5.0|||
4260476|NCT00611442|4085089|B2|||Age||years|Mean|55.9|55.9|Standard Deviation|4.8|4.8|||
4260477|NCT00611442|4085090|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|5.2|5.2|||
4260478|NCT00611442|4085088|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4260479|NCT00611442|4085089|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4260480|NCT00611442|4085090|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4260481|NCT00611442|4085088|B3||Between 18 and 65 years|Age||Participants|Count of Participants|190|190.0||||||
4260482|NCT00611442|4085089|B2||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
4260483|NCT00611442|4085090|B1||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
4260484|NCT00611442|4085088|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260485|NCT00611442|4085089|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260486|NCT00611442|4085090|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260487|NCT00611403|4085103|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4260488|NCT00611403|4085104|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4260489|NCT00611403|4085105|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4260490|NCT00611403|4085103|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4260491|NCT00611403|4085104|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4260492|NCT00611403|4085105|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4260493|NCT00611403|4085103|B3|> 40 years||Age, Customized||participants|Number|48|48.0||||||
4260494|NCT00611403|4085104|B2|> 40 years||Age, Customized||participants|Number|24|24.0||||||
4260495|NCT00611403|4085105|B1|> 40 years||Age, Customized||participants|Number|24|24.0||||||
4260496|NCT00611403|4085103|B3|Between 30 and 40 years||Age, Customized||participants|Number|49|49.0||||||
4260497|NCT00611403|4085104|B2|Between 30 and 40 years||Age, Customized||participants|Number|24|24.0||||||
4260498|NCT00611403|4085105|B1|Between 30 and 40 years||Age, Customized||participants|Number|25|25.0||||||
4260499|NCT00611403|4085103|B3|< 30 years||Age, Customized||participants|Number|40|40.0||||||
4260500|NCT00611403|4085104|B2|< 30 years||Age, Customized||participants|Number|21|21.0||||||
4260501|NCT00611403|4085105|B1|< 30 years||Age, Customized||participants|Number|19|19.0||||||
4260502|NCT00611351|4085116|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4260503|NCT00611351|4085116|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4260504|NCT00611351|4085116|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4260505|NCT00611351|4085116|B1|||Age||years|Mean|50|50.0|Full Range|||36.0|62.0|
4260506|NCT00611325|4085123|B3|United States||Region of Enrollment||participants|Number|56|56.0||||||
4260507|NCT00611325|4085124|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4260508|NCT00611325|4085125|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4260509|NCT00611325|4085123|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4260510|NCT00611325|4085124|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4260511|NCT00611325|4085125|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4260512|NCT00611325|4085123|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4260513|NCT00611325|4085124|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4260514|NCT00611325|4085125|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4260515|NCT00611325|4085123|B3|||Age||years|Mean|53.88|53.88|Standard Deviation|11.93|11.93|||
4260516|NCT00611325|4085124|B2|||Age||years|Mean|55.03|55.03|Standard Deviation|11.36|11.36|||
4260517|NCT00611325|4085125|B1|||Age||years|Mean|52.73|52.73|Standard Deviation|12.57|12.57|||
4260518|NCT00611247|4085140|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4260519|NCT00611247|4085141|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4260520|NCT00611247|4085142|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4260521|NCT00611247|4085140|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4260522|NCT00611247|4085141|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4260523|NCT00611247|4085142|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4260524|NCT00611247|4085140|B3|||Age||years|Median|75|75.0|Full Range|||64.0|87.0|
4260525|NCT00611247|4085141|B2|||Age||years|Median|75|75.0|Full Range|||64.0|87.0|
4260526|NCT00611247|4085142|B1|||Age||years|Median|77|77.0|Full Range|||66.0|83.0|
4260527|NCT00611130|4085153|B3|United States||Region of Enrollment||participants|Number|186|186.0||||||
4260528|NCT00611130|4085154|B2|United States||Region of Enrollment||participants|Number|94|94.0||||||
4260529|NCT00611130|4085155|B1|United States||Region of Enrollment||participants|Number|92|92.0||||||
4260530|NCT00611130|4085153|B3||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4260531|NCT00611130|4085154|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4260532|NCT00611130|4085155|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4260533|NCT00611130|4085153|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4260534|NCT00611130|4085154|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4260535|NCT00611130|4085155|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4260536|NCT00611130|4085153|B3|||Age||years|Mean|44.8|44.8|Standard Deviation|7.92|7.92|||
4260537|NCT00611130|4085154|B2|||Age||years|Mean|45.0|45.0|Standard Deviation|8.33|8.33|||
4260538|NCT00611130|4085155|B1|||Age||years|Mean|44.6|44.6|Standard Deviation|7.62|7.62|||
4260539|NCT00611026|4085163|B4||Male|Sex: Female, Male||Participants|Count of Participants|367|367.0||||||
4260540|NCT00611026|4085164|B3||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4260541|NCT00611026|4085165|B2||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4260542|NCT00611026|4085166|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4260543|NCT00611026|4085163|B4||Female|Sex: Female, Male||Participants|Count of Participants|2044|2044.0||||||
4260544|NCT00611026|4085164|B3||Female|Sex: Female, Male||Participants|Count of Participants|816|816.0||||||
4260545|NCT00611026|4085165|B2||Female|Sex: Female, Male||Participants|Count of Participants|818|818.0||||||
4260546|NCT00611026|4085166|B1||Female|Sex: Female, Male||Participants|Count of Participants|410|410.0||||||
4260547|NCT00611026|4085163|B4|≥65 years||Age, Customized||participants|Number|878|878.0||||||
4260548|NCT00611026|4085164|B3|≥65 years||Age, Customized||participants|Number|330|330.0||||||
4260549|NCT00611026|4085165|B2|≥65 years||Age, Customized||participants|Number|354|354.0||||||
4260550|NCT00611026|4085166|B1|≥65 years||Age, Customized||participants|Number|194|194.0||||||
4260551|NCT00611026|4085163|B4|Between 45 and 64 years||Age, Customized||participants|Number|1150|1150.0||||||
4260552|NCT00611026|4085164|B3|Between 45 and 64 years||Age, Customized||participants|Number|474|474.0||||||
4260553|NCT00611026|4085165|B2|Between 45 and 64 years||Age, Customized||participants|Number|462|462.0||||||
4260554|NCT00611026|4085166|B1|Between 45 and 64 years||Age, Customized||participants|Number|214|214.0||||||
4260555|NCT00611026|4085163|B4|Between 18 and 44 years||Age, Customized||participants|Number|383|383.0||||||
4260556|NCT00611026|4085164|B3|Between 18 and 44 years||Age, Customized||participants|Number|156|156.0||||||
4260557|NCT00611026|4085165|B2|Between 18 and 44 years||Age, Customized||participants|Number|157|157.0||||||
4260558|NCT00611026|4085166|B1|Between 18 and 44 years||Age, Customized||participants|Number|70|70.0||||||
4260559|NCT00610987|4085232|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4260560|NCT00610987|4085233|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4260561|NCT00610987|4085234|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4260562|NCT00610987|4085232|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4260563|NCT00610987|4085233|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4260564|NCT00610987|4085234|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4260565|NCT00610987|4085232|B3|||Age||years|Mean|49.8|49.8|Standard Deviation|19.9|19.9|||
4260566|NCT00610987|4085233|B2|||Age||years|Mean|50.5|50.5|Standard Deviation|20.5|20.5|||
4260567|NCT00610987|4085234|B1|||Age||years|Mean|48.9|48.9|Standard Deviation|19.1|19.1|||
4260568|NCT00610987|4085232|B3||>=65 years|Age||Participants|Count of Participants|54|54.0||||||
4260569|NCT00610987|4085233|B2||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
4260570|NCT00610987|4085234|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4260571|NCT00610987|4085232|B3||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
4260572|NCT00610987|4085233|B2||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4260573|NCT00610987|4085234|B1||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4260574|NCT00610987|4085232|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260575|NCT00610987|4085233|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260576|NCT00610987|4085234|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260577|NCT00610883|4085241|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4260578|NCT00610883|4085241|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4260579|NCT00610883|4085241|B1|Median Age||Age, Customized||years|Median|12|12.0|Full Range|||2.0|19.0|
4260580|NCT00610857|4085245|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4260581|NCT00610857|4085245|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4260582|NCT00610857|4085245|B1|||Age||years|Median|56|56.0|Full Range|||28.0|76.0|
4260583|NCT00610740|4085252|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4260584|NCT00610740|4085252|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4260585|NCT00610740|4085252|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4260586|NCT00610740|4085252|B1|||Age|All 23 patients are included in this measure - only 18 participated and were treated.|Years|Mean|50.4|50.4|Standard Deviation|11.1|11.1|||
4260587|NCT00610740|4085252|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4260588|NCT00610740|4085252|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4260589|NCT00610740|4085252|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260590|NCT00610727|4085258|B7|United States||Region of Enrollment||participants|Number|54|54.0||||||
4260591|NCT00610727|4085259|B6|United States||Region of Enrollment||participants|Number|8|8.0||||||
4260592|NCT00610727|4085260|B5|United States||Region of Enrollment||participants|Number|8|8.0||||||
4260593|NCT00610727|4085261|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
4260594|NCT00610727|4085262|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4260595|NCT00610727|4085263|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4260596|NCT00610727|4085264|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4260597|NCT00610727|4085258|B7||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4260598|NCT00610727|4085259|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4260599|NCT00610727|4085260|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4260600|NCT00610727|4085261|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4260601|NCT00610727|4085262|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4260602|NCT00610727|4085263|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4260603|NCT00610727|4085264|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4260604|NCT00610727|4085258|B7||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4260605|NCT00610727|4085259|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4260606|NCT00610727|4085260|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4260607|NCT00610727|4085261|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4260608|NCT00610727|4085262|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4260609|NCT00610727|4085263|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4260610|NCT00610727|4085264|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4260611|NCT00610727|4085258|B7|||Age||years|Mean|25.8|25.8|Standard Deviation|7.09|7.09|||
4260612|NCT00610727|4085259|B6|||Age||years|Mean|23.5|23.5|Standard Deviation|7.03|7.03|||
4260613|NCT00610727|4085260|B5|||Age||years|Mean|28.8|28.8|Standard Deviation|10.2|10.2|||
4260614|NCT00610727|4085261|B4|||Age||years|Mean|26.4|26.4|Standard Deviation|8.94|8.94|||
4260615|NCT00610727|4085262|B3|||Age||years|Mean|25|25.0|Standard Deviation|4.57|4.57|||
4260616|NCT00610727|4085263|B2|||Age||years|Mean|25.1|25.1|Standard Deviation|3.44|3.44|||
4260617|NCT00610727|4085264|B1|||Age||years|Mean|29.4|29.4|Standard Deviation|7.86|7.86|||
4260618|NCT00610727|4085258|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4260619|NCT00610727|4085259|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4260620|NCT00610727|4085260|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4260621|NCT00610727|4085261|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4260622|NCT00610727|4085262|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4260623|NCT00610727|4085263|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4260624|NCT00610727|4085264|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4260625|NCT00610727|4085258|B7||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4260626|NCT00610727|4085259|B6||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4260627|NCT00610727|4085260|B5||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4260628|NCT00610727|4085261|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4260629|NCT00610727|4085262|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4260630|NCT00610727|4085263|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4260631|NCT00610727|4085264|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4260632|NCT00610727|4085258|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260633|NCT00610727|4085259|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260634|NCT00610727|4085260|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260635|NCT00610727|4085261|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260636|NCT00610727|4085262|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260637|NCT00610727|4085263|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260638|NCT00610727|4085264|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260639|NCT00610714|4085287|B3|Missing||Tumour Grade||Participants|Number|4|4.0||||||
4260640|NCT00610714|4085288|B2|Missing||Tumour Grade||Participants|Number|0|0.0||||||
4260641|NCT00610714|4085289|B1|Missing||Tumour Grade||Participants|Number|4|4.0||||||
4260642|NCT00610714|4085287|B3|Unassessable (GX)||Tumour Grade||Participants|Number|29|29.0||||||
4260643|NCT00610714|4085288|B2|Unassessable (GX)||Tumour Grade||Participants|Number|14|14.0||||||
4260644|NCT00610714|4085289|B1|Unassessable (GX)||Tumour Grade||Participants|Number|15|15.0||||||
4260645|NCT00610714|4085287|B3|Undifferentiated (G4)||Tumour Grade||Participants|Number|10|10.0||||||
4260646|NCT00610714|4085288|B2|Undifferentiated (G4)||Tumour Grade||Participants|Number|6|6.0||||||
4260647|NCT00610714|4085289|B1|Undifferentiated (G4)||Tumour Grade||Participants|Number|4|4.0||||||
4260648|NCT00610714|4085287|B3|Unavailable (G3)||Tumour Grade||Participants|Number|98|98.0||||||
4260649|NCT00610714|4085288|B2|Unavailable (G3)||Tumour Grade||Participants|Number|53|53.0||||||
4260650|NCT00610714|4085289|B1|Unavailable (G3)||Tumour Grade||Participants|Number|45|45.0||||||
4260651|NCT00610714|4085287|B3|Mod. Differentiated (G2)||Tumour Grade||Participants|Number|54|54.0||||||
4260652|NCT00610714|4085288|B2|Mod. Differentiated (G2)||Tumour Grade||Participants|Number|25|25.0||||||
4260653|NCT00610714|4085289|B1|Mod. Differentiated (G2)||Tumour Grade||Participants|Number|29|29.0||||||
4260654|NCT00610714|4085287|B3|Well Differentiated (G1)||Tumour Grade||Participants|Number|16|16.0||||||
4260655|NCT00610714|4085288|B2|Well Differentiated (G1)||Tumour Grade||Participants|Number|8|8.0||||||
4260656|NCT00610714|4085289|B1|Well Differentiated (G1)||Tumour Grade||Participants|Number|8|8.0||||||
4260657|NCT00610714|4085287|B3|Unavailable||Primary Tumour Location (Number of Participants)||Participants|Number|1|1.0||||||
4260658|NCT00610714|4085288|B2|Unavailable||Primary Tumour Location (Number of Participants)||Participants|Number|1|1.0||||||
4260659|NCT00610714|4085289|B1|Unavailable||Primary Tumour Location (Number of Participants)||Participants|Number|0|0.0||||||
4260660|NCT00610714|4085287|B3|Site cannot be determined||Primary Tumour Location (Number of Participants)||Participants|Number|1|1.0||||||
4260661|NCT00610714|4085288|B2|Site cannot be determined||Primary Tumour Location (Number of Participants)||Participants|Number|1|1.0||||||
4260662|NCT00610714|4085289|B1|Site cannot be determined||Primary Tumour Location (Number of Participants)||Participants|Number|0|0.0||||||
4260663|NCT00610714|4085287|B3|Uterine/fallopian tube||Primary Tumour Location (Number of Participants)||Participants|Number|4|4.0||||||
4260664|NCT00610714|4085288|B2|Uterine/fallopian tube||Primary Tumour Location (Number of Participants)||Participants|Number|1|1.0||||||
4260665|NCT00610714|4085289|B1|Uterine/fallopian tube||Primary Tumour Location (Number of Participants)||Participants|Number|3|3.0||||||
4260666|NCT00610714|4085287|B3|Peritoneum||Primary Tumour Location (Number of Participants)||Participants|Number|9|9.0||||||
4260667|NCT00610714|4085288|B2|Peritoneum||Primary Tumour Location (Number of Participants)||Participants|Number|5|5.0||||||
4260668|NCT00610714|4085289|B1|Peritoneum||Primary Tumour Location (Number of Participants)||Participants|Number|4|4.0||||||
4260669|NCT00610714|4085287|B3|Ovary||Primary Tumour Location (Number of Participants)||Participants|Number|196|196.0||||||
4260670|NCT00610714|4085288|B2|Ovary||Primary Tumour Location (Number of Participants)||Participants|Number|98|98.0||||||
4260671|NCT00610714|4085289|B1|Ovary||Primary Tumour Location (Number of Participants)||Participants|Number|98|98.0||||||
4260672|NCT00610714|4085287|B3|4||World Health Organization (WHO) Performance Status|minimum value=0=best outcome, maximum value=4=worst outcome|Participants|Number|0|0.0||||||
4260673|NCT00610714|4085288|B2|4||World Health Organization (WHO) Performance Status|minimum value=0=best outcome, maximum value=4=worst outcome|Participants|Number|0|0.0||||||
4260674|NCT00610714|4085289|B1|4||World Health Organization (WHO) Performance Status|minimum value=0=best outcome, maximum value=4=worst outcome|Participants|Number|0|0.0||||||
4260675|NCT00610714|4085287|B3|3||World Health Organization (WHO) Performance Status|minimum value=0=best outcome, maximum value=4=worst outcome|Participants|Number|0|0.0||||||
4260676|NCT00610714|4085288|B2|3||World Health Organization (WHO) Performance Status|minimum value=0=best outcome, maximum value=4=worst outcome|Participants|Number|0|0.0||||||
4260677|NCT00610714|4085289|B1|3||World Health Organization (WHO) Performance Status|minimum value=0=best outcome, maximum value=4=worst outcome|Participants|Number|0|0.0||||||
4260678|NCT00610714|4085287|B3|2||World Health Organization (WHO) Performance Status|minimum value=0=best outcome, maximum value=4=worst outcome|Participants|Number|5|5.0||||||
4260679|NCT00610714|4085288|B2|2||World Health Organization (WHO) Performance Status|minimum value=0=best outcome, maximum value=4=worst outcome|Participants|Number|1|1.0||||||
4260680|NCT00610714|4085289|B1|2||World Health Organization (WHO) Performance Status|minimum value=0=best outcome, maximum value=4=worst outcome|Participants|Number|4|4.0||||||
4260681|NCT00610714|4085287|B3|1||World Health Organization (WHO) Performance Status|minimum value=0=best outcome, maximum value=4=worst outcome|Participants|Number|83|83.0||||||
4260682|NCT00610714|4085288|B2|1||World Health Organization (WHO) Performance Status|minimum value=0=best outcome, maximum value=4=worst outcome|Participants|Number|42|42.0||||||
4260683|NCT00610714|4085289|B1|1||World Health Organization (WHO) Performance Status|minimum value=0=best outcome, maximum value=4=worst outcome|Participants|Number|41|41.0||||||
4260684|NCT00610714|4085287|B3|0||World Health Organization (WHO) Performance Status|minimum value=0=best outcome, maximum value=4=worst outcome|Participants|Number|123|123.0||||||
4260685|NCT00610714|4085288|B2|0||World Health Organization (WHO) Performance Status|minimum value=0=best outcome, maximum value=4=worst outcome|Participants|Number|63|63.0||||||
4260686|NCT00610714|4085289|B1|0||World Health Organization (WHO) Performance Status|minimum value=0=best outcome, maximum value=4=worst outcome|Participants|Number|60|60.0||||||
4260687|NCT00610714|4085287|B3|||Body Surface Area (BSA)||m^2|Mean|1.762|1.762|Standard Deviation|0.189|0.189|||
4260688|NCT00610714|4085288|B2|||Body Surface Area (BSA)||m^2|Mean|1.766|1.766|Standard Deviation|0.206|0.206|||
4260689|NCT00610714|4085289|B1|||Body Surface Area (BSA)||m^2|Mean|1.758|1.758|Standard Deviation|0.17|0.17|||
4260690|NCT00610714|4085287|B3|Other||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4260691|NCT00610714|4085288|B2|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4260692|NCT00610714|4085289|B1|Other||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4260693|NCT00610714|4085287|B3|Asian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4260694|NCT00610714|4085288|B2|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4260695|NCT00610714|4085289|B1|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4260696|NCT00610714|4085287|B3|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4260697|NCT00610714|4085288|B2|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4260698|NCT00610714|4085289|B1|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4260699|NCT00610714|4085287|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|193|193.0||||||
4260700|NCT00610714|4085288|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|99|99.0||||||
4260701|NCT00610714|4085289|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|94|94.0||||||
4260702|NCT00610714|4085287|B3|Female||Sex/Gender, Customized||Participants|Number|211|211.0||||||
4260703|NCT00610714|4085288|B2|Female||Sex/Gender, Customized||Participants|Number|106|106.0||||||
4260704|NCT00610714|4085289|B1|Female||Sex/Gender, Customized||Participants|Number|105|105.0||||||
4260705|NCT00610714|4085287|B3|||Age||Years|Mean|58.265|58.265|Standard Deviation|10.077|10.077|||
4260706|NCT00610714|4085288|B2|||Age||Years|Mean|59.1|59.1|Standard Deviation|10.2|10.2|||
4260707|NCT00610714|4085289|B1|||Age||Years|Mean|57.4|57.4|Standard Deviation|9.9|9.9|||
4260708|NCT00610701|4085300|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4260709|NCT00610701|4085301|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4260710|NCT00610701|4085302|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4260711|NCT00610701|4085300|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4260712|NCT00610701|4085301|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4260713|NCT00610701|4085302|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4260714|NCT00610701|4085300|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4260715|NCT00610701|4085301|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4260716|NCT00610701|4085302|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4260717|NCT00610701|4085300|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4260718|NCT00610701|4085301|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4260719|NCT00610701|4085302|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4260720|NCT00610701|4085300|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4260721|NCT00610701|4085301|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4260722|NCT00610701|4085302|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4260723|NCT00610701|4085300|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260724|NCT00610701|4085301|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260725|NCT00610701|4085302|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260726|NCT00610688|4085309|B4|||Maternal serum 25 hydroxy Vitamin D (25(OH)D)||nmol/L|Mean|20.7|20.7|Standard Deviation|11.6|11.6|||
4260727|NCT00610688|4085310|B3|||Maternal serum 25 hydroxy Vitamin D (25(OH)D)||nmol/L|Mean|19.6|19.6|Standard Deviation|7.7|7.7|||
4260728|NCT00610688|4085311|B2|||Maternal serum 25 hydroxy Vitamin D (25(OH)D)||nmol/L|Mean|20.5|20.5|Standard Deviation|11.9|11.9|||
4260729|NCT00610688|4085312|B1|||Maternal serum 25 hydroxy Vitamin D (25(OH)D)||nmol/L|Mean|21.5|21.5|Standard Deviation|13.0|13.0|||
4260730|NCT00610688|4085309|B4|United Arab Emirates||Region of Enrollment||participants|Number|192|192.0||||||
4260731|NCT00610688|4085310|B3|United Arab Emirates||Region of Enrollment||participants|Number|63|63.0||||||
4260732|NCT00610688|4085311|B2|United Arab Emirates||Region of Enrollment||participants|Number|65|65.0||||||
4260733|NCT00610688|4085312|B1|United Arab Emirates||Region of Enrollment||participants|Number|64|64.0||||||
4260734|NCT00610688|4085309|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4260735|NCT00610688|4085310|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4260736|NCT00610688|4085311|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4260737|NCT00610688|4085312|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4260738|NCT00610688|4085309|B4||Female|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4260739|NCT00610688|4085310|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4260740|NCT00610688|4085311|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4260741|NCT00610688|4085312|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4260742|NCT00610688|4085309|B4|||Age||years|Mean|26.9|26.9|Standard Deviation|5.3|5.3|||
4260743|NCT00610688|4085310|B3|||Age||years|Mean|25.7|25.7|Standard Deviation|5.5|5.5|||
4260744|NCT00610688|4085311|B2|||Age||years|Mean|27.4|27.4|Standard Deviation|4.8|4.8|||
4260745|NCT00610688|4085312|B1|||Age||years|Mean|27.5|27.5|Standard Deviation|5.5|5.5|||
4260746|NCT00610688|4085309|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4260747|NCT00610688|4085310|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4260748|NCT00610688|4085311|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4260749|NCT00610688|4085312|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4260750|NCT00610688|4085309|B4||Between 18 and 65 years|Age||Participants|Count of Participants|192|192.0||||||
4260751|NCT00610688|4085310|B3||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4260752|NCT00610688|4085311|B2||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4260753|NCT00610688|4085312|B1||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4260754|NCT00610688|4085309|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260755|NCT00610688|4085310|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260756|NCT00610688|4085311|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260757|NCT00610688|4085312|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260758|NCT00610675|4085328|B1||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4260759|NCT00610675|4085328|B1||Female|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
4260760|NCT00610675|4085328|B1|||Age||Years|Mean|46.5|46.5|Standard Deviation|11.5|11.5|||
4260761|NCT00610649|4085339|B12||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4260762|NCT00610649|4085340|B11||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4260763|NCT00610649|4085341|B10||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4260764|NCT00610649|4085342|B9||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4260765|NCT00610649|4085343|B8||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4260766|NCT00610649|4085344|B7||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4260767|NCT00610649|4085345|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4260768|NCT00610649|4085346|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4260769|NCT00610649|4085347|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4260770|NCT00610649|4085348|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4260771|NCT00610649|4085349|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4260772|NCT00610649|4085350|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4260773|NCT00610649|4085339|B12||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4260774|NCT00610649|4085340|B11||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4260775|NCT00610649|4085341|B10||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4260776|NCT00610649|4085342|B9||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4260777|NCT00610649|4085343|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4260778|NCT00610649|4085344|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4260779|NCT00610649|4085345|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4260780|NCT00610649|4085346|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4260781|NCT00610649|4085347|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4260782|NCT00610649|4085348|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4260783|NCT00610649|4085349|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4260784|NCT00610649|4085350|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4260785|NCT00610649|4085339|B12|||Age||years|Mean|35.4|35.4|Standard Deviation|11.3|11.3|||
4260786|NCT00610649|4085340|B11|||Age||years|Mean|31.1|31.1|Standard Deviation|6.5|6.5|||
4260787|NCT00610649|4085341|B10|||Age||years|Mean|35.6|35.6|Standard Deviation|12.8|12.8|||
4260788|NCT00610649|4085342|B9|||Age||years|Mean|38.3|38.3|Standard Deviation|14.4|14.4|||
4260789|NCT00610649|4085343|B8|||Age||years|Mean|36.5|36.5|Standard Deviation|23.3|23.3|||
4260790|NCT00610649|4085344|B7|||Age||years|Mean|40.5|40.5|Standard Deviation|6.8|6.8|||
4260791|NCT00610649|4085345|B6|||Age||years|Mean|39.0|39.0|Standard Deviation|14.1|14.1|||
4260792|NCT00610649|4085346|B5|||Age||years|Mean|35.5|35.5|Standard Deviation|9.7|9.7|||
4260793|NCT00610649|4085347|B4|||Age||years|Mean|28.5|28.5|Standard Deviation|9.2|9.2|||
4260794|NCT00610649|4085348|B3|||Age||years|Mean|42.0|42.0|Standard Deviation|14.8|14.8|||
4260795|NCT00610649|4085349|B2|||Age||years|Mean|32.5|32.5|Standard Deviation|13.4|13.4|||
4260796|NCT00610649|4085350|B1|||Age||years|Mean|28.8|28.8|Standard Deviation|5.0|5.0|||
4260797|NCT00610532|4085414|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4260798|NCT00610532|4085414|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4260799|NCT00610532|4085414|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4260800|NCT00610532|4085414|B1|||Age||years|Mean|33|33.0|Standard Deviation|11.2|11.2|||
4260801|NCT00610532|4085414|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4260802|NCT00610532|4085414|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4260803|NCT00610532|4085414|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260804|NCT00610441|4085420|B5||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4260805|NCT00610441|4085421|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4260806|NCT00610441|4085422|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4260807|NCT00610441|4085423|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4260808|NCT00610441|4085424|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4260809|NCT00610441|4085420|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4260810|NCT00610441|4085421|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4260811|NCT00610441|4085422|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4260812|NCT00610441|4085423|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4260813|NCT00610441|4085424|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4260814|NCT00610441|4085420|B5|||Age||years|Mean|37.0|37.0|Standard Deviation|8.4|8.4|||
4260815|NCT00610441|4085421|B4|||Age||years|Mean|40.7|40.7|Standard Deviation|6.3|6.3|||
4260816|NCT00610441|4085422|B3|||Age||years|Mean|36.7|36.7|Standard Deviation|8.8|8.8|||
4260817|NCT00610441|4085423|B2|||Age||years|Mean|35.1|35.1|Standard Deviation|9.2|9.2|||
4260818|NCT00610441|4085424|B1|||Age||years|Mean|34.9|34.9|Standard Deviation|8.7|8.7|||
4260819|NCT00610428|4085518|B4|United States||Region of Enrollment||participants|Number|75|75.0||||||
4260820|NCT00610428|4085519|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
4260821|NCT00610428|4085520|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4260822|NCT00610428|4085521|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4260823|NCT00610428|4085518|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4260824|NCT00610428|4085519|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4260825|NCT00610428|4085520|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4260826|NCT00610428|4085521|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4260827|NCT00610428|4085518|B4||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4260828|NCT00610428|4085519|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4260829|NCT00610428|4085520|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4260830|NCT00610428|4085521|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4260831|NCT00610428|4085518|B4|||Age||years|Mean|43.5|43.5|Standard Deviation|10.7|10.7|||
4260832|NCT00610428|4085519|B3|||Age||years|Mean|41.9|41.9|Standard Deviation|10.1|10.1|||
4260833|NCT00610428|4085520|B2|||Age||years|Mean|43.6|43.6|Standard Deviation|10.8|10.8|||
4260834|NCT00610428|4085521|B1|||Age||years|Mean|45|45.0|Standard Deviation|11.4|11.4|||
4260835|NCT00610428|4085518|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4260836|NCT00610428|4085519|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4260837|NCT00610428|4085520|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4260838|NCT00610428|4085521|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4260839|NCT00610428|4085518|B4||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4260840|NCT00610428|4085519|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4260841|NCT00610428|4085520|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4260842|NCT00610428|4085521|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4260843|NCT00610428|4085518|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260844|NCT00610428|4085519|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260845|NCT00610428|4085520|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260846|NCT00610428|4085521|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260847|NCT00610363|4085534|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260848|NCT00610363|4085535|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260849|NCT00610363|4085536|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260850|NCT00610363|4085534|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260851|NCT00610363|4085535|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260852|NCT00610363|4085536|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260853|NCT00610363|4085534|B3||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4260854|NCT00610363|4085535|B2||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4260855|NCT00610363|4085536|B1||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4260856|NCT00610363|4085534|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4260857|NCT00610363|4085535|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4260858|NCT00610363|4085536|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4260859|NCT00610363|4085534|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4260860|NCT00610363|4085535|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4260861|NCT00610363|4085536|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4260862|NCT00610363|4085534|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4260863|NCT00610363|4085535|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4260864|NCT00610363|4085536|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260865|NCT00610363|4085534|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260866|NCT00610363|4085535|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260867|NCT00610363|4085536|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260868|NCT00610363|4085534|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260869|NCT00610363|4085535|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260870|NCT00610363|4085536|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260871|NCT00610363|4085534|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
4260872|NCT00610363|4085535|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4260873|NCT00610363|4085536|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4260874|NCT00610363|4085534|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4260875|NCT00610363|4085535|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4260876|NCT00610363|4085536|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4260877|NCT00610363|4085534|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4260878|NCT00610363|4085535|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4260879|NCT00610363|4085536|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4260880|NCT00610363|4085534|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4260881|NCT00610363|4085535|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4260882|NCT00610363|4085536|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4260883|NCT00610363|4085534|B3|||Age||years|Mean|51.0|51.0|Standard Deviation|11.09|11.09|||
4260884|NCT00610363|4085535|B2|||Age||years|Mean|51.9|51.9|Standard Deviation|10.61|10.61|||
4260885|NCT00610363|4085536|B1|||Age||years|Mean|50.1|50.1|Standard Deviation|11.59|11.59|||
4260886|NCT00610311|4085555|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4260887|NCT00610311|4085555|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260888|NCT00610311|4085555|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260889|NCT00610311|4085555|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4260890|NCT00610311|4085555|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260891|NCT00610311|4085555|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260892|NCT00610311|4085555|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260893|NCT00610311|4085555|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260894|NCT00610311|4085555|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260895|NCT00610311|4085555|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4260896|NCT00610311|4085555|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260897|NCT00610311|4085555|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4260898|NCT00610311|4085555|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4260899|NCT00610311|4085555|B1|||Age||years|Mean|33.3|33.3|Standard Deviation|6.0|6.0|||
4260900|NCT00610311|4085555|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4260901|NCT00610311|4085555|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4260902|NCT00610311|4085555|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260903|NCT00610207|4085562|B1|||Body Mass Index|Three single-tract fistula patients were lost to follow-up and were excluded from the analysis on body mass index.|kg/m^2|Mean|24|24.0|Full Range|||14.0|37.0|
4260904|NCT00610207|4085562|B1|||Weight|Three single-tract fistula patients were lost to follow-up and were excluded from the analysis on weight.|pounds|Mean|148|148.0|Full Range|||85.0|208.0|
4260905|NCT00610207|4085562|B1|||Height|Three single-tract fistula patients were lost to follow-up and were excluded from the analysis on height.|inches|Mean|66|66.0|Full Range|||59.0|72.0|
4260906|NCT00610207|4085562|B1||Male|Sex: Female, Male|Three single-tract fistula patients were lost to follow-up and were excluded from the analysis on gender.|Participants|Count of Participants|9|9.0||||||
4260907|NCT00610207|4085562|B1||Female|Sex: Female, Male|Three single-tract fistula patients were lost to follow-up and were excluded from the analysis on gender.|Participants|Count of Participants|9|9.0||||||
4260908|NCT00610207|4085562|B1|||Age|Three single-tract fistula patients were lost to follow-up and were excluded from the analysis on age.|years|Mean|40.2|40.2|Full Range|||22.0|69.0|
4260909|NCT00610168|4085567|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4260910|NCT00610168|4085568|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4260911|NCT00610168|4085569|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4260912|NCT00610168|4085567|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4260913|NCT00610168|4085568|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4260914|NCT00610168|4085569|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4260915|NCT00610168|4085567|B3|||Age||Years|Mean|21.1|21.1|Standard Deviation|0.33|0.33|||
4260916|NCT00610168|4085568|B2|||Age||Years|Mean|21.1|21.1|Standard Deviation|0.38|0.38|||
4260917|NCT00610168|4085569|B1|||Age||Years|Mean|21.1|21.1|Standard Deviation|0.31|0.31|||
4260918|NCT00610155|4085589|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4260919|NCT00610155|4085589|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4260920|NCT00610155|4085589|B1|||Age||years|Mean|44.7|44.7|Standard Deviation|9.7|9.7|||
4260921|NCT00610129|4085641|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4260922|NCT00610129|4085641|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4260923|NCT00610129|4085641|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4260924|NCT00610129|4085641|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4260925|NCT00610129|4085641|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260926|NCT00609986|4085645|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4260927|NCT00609986|4085646|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4260928|NCT00609986|4085647|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4260929|NCT00609986|4085645|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260930|NCT00609986|4085646|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260931|NCT00609986|4085647|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260932|NCT00609986|4085645|B3||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4260933|NCT00609986|4085646|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4260934|NCT00609986|4085647|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4260935|NCT00609986|4085645|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4260936|NCT00609986|4085646|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4260937|NCT00609986|4085647|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4260938|NCT00609986|4085645|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260939|NCT00609986|4085646|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260940|NCT00609986|4085647|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260941|NCT00609986|4085645|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260942|NCT00609986|4085646|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260943|NCT00609986|4085647|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260944|NCT00609986|4085645|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260945|NCT00609986|4085646|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260946|NCT00609986|4085647|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4260947|NCT00609986|4085645|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4260948|NCT00609986|4085646|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4260949|NCT00609986|4085647|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4260950|NCT00609986|4085645|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4260951|NCT00609986|4085646|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4260952|NCT00609986|4085647|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4260953|NCT00609986|4085645|B3|||Age||years|Mean|57.7|57.7|Standard Deviation|9.7|9.7|||
4260954|NCT00609986|4085646|B2|||Age||years|Mean|56.3|56.3|Standard Deviation|9.6|9.6|||
4260955|NCT00609986|4085647|B1|||Age||years|Mean|58|58.0|Standard Deviation|9.8|9.8|||
4260956|NCT00609973|4085660|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
4260957|NCT00609973|4085661|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4260958|NCT00609973|4085662|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4260959|NCT00609973|4085660|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4260960|NCT00609973|4085661|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4260961|NCT00609973|4085662|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4260962|NCT00609973|4085660|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4260963|NCT00609973|4085661|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4260964|NCT00609973|4085662|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4260965|NCT00609973|4085660|B3|||Age, Customized||Years|Median|30|30.0|Full Range|||18.0|70.0|
4260966|NCT00609973|4085661|B2|||Age, Customized||Years|Median|27|27.0|Full Range|||18.0|61.0|
4260967|NCT00609973|4085662|B1|||Age, Customized||Years|Median|33|33.0|Full Range|||19.0|70.0|
4260968|NCT00609947|4085671|B1|United States||Region of Enrollment||participants|Number|241|241.0||||||
4260969|NCT00609947|4085671|B1||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4260970|NCT00609947|4085671|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4260971|NCT00609947|4085671|B1|||Age||years|Mean|63.5|63.5|Standard Deviation|10.1|10.1|||
4260972|NCT00609947|4085671|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4260973|NCT00609947|4085671|B1||Between 18 and 65 years|Age||Participants|Count of Participants|231|231.0||||||
4260974|NCT00609947|4085671|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260975|NCT00609869|4085676|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4260976|NCT00609869|4085676|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4260977|NCT00609869|4085676|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4260978|NCT00609869|4085676|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4260979|NCT00609869|4085676|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4260980|NCT00609869|4085676|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4260981|NCT00609869|4085676|B1|||Age||years|Mean|63|63.0|Full Range|||41.0|80.0|
4260982|NCT00609804|4085682|B3|United States||Region of Enrollment||participants|Number|53|53.0||||||
4260983|NCT00609804|4085683|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4260984|NCT00609804|4085684|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4260985|NCT00609804|4085682|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4260986|NCT00609804|4085683|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4260987|NCT00609804|4085684|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4260988|NCT00609804|4085682|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4260989|NCT00609804|4085683|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4260990|NCT00609804|4085684|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4260991|NCT00609804|4085682|B3|||Age||years|Median|65|65.0|Full Range|||41.0|87.0|
4260992|NCT00609804|4085683|B2|||Age||years|Median|63|63.0|Full Range|||41.0|87.0|
4260993|NCT00609804|4085684|B1|||Age||years|Median|67|67.0|Full Range|||43.0|83.0|
4260994|NCT00609765|4085695|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4260995|NCT00609765|4085695|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4260996|NCT00609765|4085695|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4260997|NCT00609765|4085695|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4260998|NCT00609765|4085695|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4260999|NCT00609765|4085695|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4261000|NCT00609739|4085700|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4261001|NCT00609739|4085700|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4261002|NCT00609739|4085700|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4261003|NCT00609739|4085700|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4261004|NCT00609739|4085700|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4261005|NCT00609739|4085700|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4261006|NCT00609674|4085707|B3|Asian & White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4261007|NCT00609674|4085708|B2|Asian & White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4261008|NCT00609674|4085709|B1|Asian & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4261009|NCT00609674|4085707|B3|African American/African Heritage & Asian & White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4261010|NCT00609674|4085708|B2|African American/African Heritage & Asian & White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4261011|NCT00609674|4085709|B1|African American/African Heritage & Asian & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4261012|NCT00609674|4085707|B3|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4261013|NCT00609674|4085708|B2|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4261014|NCT00609674|4085709|B1|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4261015|NCT00609674|4085707|B3|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4261016|NCT00609674|4085708|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4261017|NCT00609674|4085709|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4261018|NCT00609674|4085707|B3|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4261019|NCT00609674|4085708|B2|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4261020|NCT00609674|4085709|B1|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4261021|NCT00609674|4085707|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4261022|NCT00609674|4085708|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4261023|NCT00609674|4085709|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4261024|NCT00609674|4085707|B3|White||Race/Ethnicity, Customized||participants|Number|289|289.0||||||
4261025|NCT00609674|4085708|B2|White||Race/Ethnicity, Customized||participants|Number|149|149.0||||||
4261026|NCT00609674|4085709|B1|White||Race/Ethnicity, Customized||participants|Number|140|140.0||||||
4261027|NCT00609674|4085707|B3||Male|Gender||Participants|Count of Participants|213|213.0||||||
4261028|NCT00609674|4085708|B2||Male|Gender||Participants|Count of Participants|103|103.0||||||
4261029|NCT00609674|4085709|B1||Male|Gender||Participants|Count of Participants|110|110.0||||||
4261030|NCT00609674|4085707|B3||Female|Gender||Participants|Count of Participants|102|102.0||||||
4261031|NCT00609674|4085708|B2||Female|Gender||Participants|Count of Participants|57|57.0||||||
4261032|NCT00609674|4085709|B1||Female|Gender||Participants|Count of Participants|45|45.0||||||
4261033|NCT00609674|4085707|B3|||Age||years|Mean|38.7|38.7|Standard Deviation|14.61|14.61|||
4261034|NCT00609674|4085708|B2|||Age||years|Mean|38.1|38.1|Standard Deviation|14.18|14.18|||
4261035|NCT00609674|4085709|B1|||Age||years|Mean|39.3|39.3|Standard Deviation|15.06|15.06|||
4261036|NCT00609622|4085744|B3||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4261037|NCT00609622|4085745|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4261038|NCT00609622|4085746|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4261039|NCT00609622|4085744|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4261040|NCT00609622|4085745|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4261041|NCT00609622|4085746|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4261042|NCT00609622|4085744|B3|||Age||Years|Mean|59.90|59.9|Standard Deviation|10.06|10.06|||
4261043|NCT00609622|4085745|B2|||Age||Years|Mean|59.10|59.1|Standard Deviation|10.81|10.81|||
4261044|NCT00609622|4085746|B1|||Age||Years|Mean|60.60|60.6|Standard Deviation|9.26|9.26|||
4261045|NCT00609609|4085767|B3||Umbilical Cord|Graft Source||Participants|Count of Participants|5|5.0||||||
4261046|NCT00609609|4085768|B2||Umbilical Cord|Graft Source||Participants|Count of Participants|5|5.0||||||
4261047|NCT00609609|4085769|B1||Umbilical Cord|Graft Source||Participants|Count of Participants|0|0.0||||||
4261048|NCT00609609|4085767|B3||Bone Marrow|Graft Source||Participants|Count of Participants|15|15.0||||||
4261049|NCT00609609|4085768|B2||Bone Marrow|Graft Source||Participants|Count of Participants|10|10.0||||||
4261050|NCT00609609|4085769|B1||Bone Marrow|Graft Source||Participants|Count of Participants|5|5.0||||||
4261051|NCT00609609|4085767|B3||Peripheral Blood|Graft Source||Participants|Count of Participants|61|61.0||||||
4261052|NCT00609609|4085768|B2||Peripheral Blood|Graft Source||Participants|Count of Participants|36|36.0||||||
4261053|NCT00609609|4085769|B1||Peripheral Blood|Graft Source||Participants|Count of Participants|25|25.0||||||
4261054|NCT00609609|4085767|B3||Mismatched/Haploidentical|Donor Match||Participants|Count of Participants|16|16.0||||||
4261055|NCT00609609|4085768|B2||Mismatched/Haploidentical|Donor Match||Participants|Count of Participants|10|10.0||||||
4261056|NCT00609609|4085769|B1||Mismatched/Haploidentical|Donor Match||Participants|Count of Participants|6|6.0||||||
4261057|NCT00609609|4085767|B3||Matched|Donor Match||Participants|Count of Participants|65|65.0||||||
4261058|NCT00609609|4085768|B2||Matched|Donor Match||Participants|Count of Participants|41|41.0||||||
4261059|NCT00609609|4085769|B1||Matched|Donor Match||Participants|Count of Participants|24|24.0||||||
4261060|NCT00609609|4085767|B3||Unrelated|Donor Relation||Participants|Count of Participants|51|51.0||||||
4261061|NCT00609609|4085768|B2||Unrelated|Donor Relation||Participants|Count of Participants|33|33.0||||||
4261062|NCT00609609|4085769|B1||Unrelated|Donor Relation||Participants|Count of Participants|18|18.0||||||
4261063|NCT00609609|4085767|B3||Related|Donor Relation||Participants|Count of Participants|30|30.0||||||
4261064|NCT00609609|4085768|B2||Related|Donor Relation||Participants|Count of Participants|18|18.0||||||
4261065|NCT00609609|4085769|B1||Related|Donor Relation||Participants|Count of Participants|12|12.0||||||
4261066|NCT00609609|4085767|B3||Other|GVHD Prophylaxis||Participants|Count of Participants|4|4.0||||||
4261067|NCT00609609|4085768|B2||Other|GVHD Prophylaxis||Participants|Count of Participants|2|2.0||||||
4261068|NCT00609609|4085769|B1||Other|GVHD Prophylaxis||Participants|Count of Participants|2|2.0||||||
4261069|NCT00609609|4085767|B3||Tacrolimus/Mycophenolate|GVHD Prophylaxis||Participants|Count of Participants|5|5.0||||||
4261070|NCT00609609|4085768|B2||Tacrolimus/Mycophenolate|GVHD Prophylaxis||Participants|Count of Participants|5|5.0||||||
4261071|NCT00609609|4085769|B1||Tacrolimus/Mycophenolate|GVHD Prophylaxis||Participants|Count of Participants|0|0.0||||||
4261072|NCT00609609|4085767|B3||Tacrolimus/MTX|GVHD Prophylaxis||Participants|Count of Participants|72|72.0||||||
4261073|NCT00609609|4085768|B2||Tacrolimus/MTX|GVHD Prophylaxis||Participants|Count of Participants|44|44.0||||||
4261074|NCT00609609|4085769|B1||Tacrolimus/MTX|GVHD Prophylaxis||Participants|Count of Participants|28|28.0||||||
4261075|NCT00609609|4085767|B3|||Ablative Conditioned||Participants|Count of Participants|56|56.0||||||
4261076|NCT00609609|4085768|B2|||Ablative Conditioned||Participants|Count of Participants|33|33.0||||||
4261077|NCT00609609|4085769|B1|||Ablative Conditioned||Participants|Count of Participants|23|23.0||||||
4261078|NCT00609609|4085767|B3|United States||Region of Enrollment||participants|Number|81|81.0||||||
4261079|NCT00609609|4085768|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
4261080|NCT00609609|4085769|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4261081|NCT00609609|4085767|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4261082|NCT00609609|4085768|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4261083|NCT00609609|4085769|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4261084|NCT00609609|4085767|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4261085|NCT00609609|4085768|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4261086|NCT00609609|4085769|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4261087|NCT00609609|4085767|B3|||Age||years|Median|54|54.0|Full Range|||17.0|75.0|
4261088|NCT00609609|4085768|B2|||Age||years|Median|54|54.0|Full Range|||17.0|75.0|
4261089|NCT00609609|4085769|B1|||Age||years|Median|53|53.0|Full Range|||24.0|70.0|
4261090|NCT00609518|4085780|B3|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared (kilograms/square meters [kg/m^2]).|kg/m^2|Mean|25.7|25.7|Standard Deviation|4.64|4.64|||
4261091|NCT00609518|4085781|B2|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared (kilograms/square meters [kg/m^2]).|kg/m^2|Mean|26.0|26.0|Standard Deviation|5.20|5.2|||
4261092|NCT00609518|4085782|B1|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared (kilograms/square meters [kg/m^2]).|kg/m^2|Mean|25.3|25.3|Standard Deviation|3.98|3.98|||
4261093|NCT00609518|4085780|B3|IV||Disease Stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Differentiation between stage IIIA and IIIB is in accordance with the American Joint Committee on Cancer Staging Criteria for Lung Cancer.|Participants|Number|85|85.0||||||
4261094|NCT00609518|4085781|B2|IV||Disease Stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Differentiation between stage IIIA and IIIB is in accordance with the American Joint Committee on Cancer Staging Criteria for Lung Cancer.|Participants|Number|43|43.0||||||
4261095|NCT00609518|4085782|B1|IV||Disease Stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Differentiation between stage IIIA and IIIB is in accordance with the American Joint Committee on Cancer Staging Criteria for Lung Cancer.|Participants|Number|42|42.0||||||
4261096|NCT00609518|4085780|B3|IIIB||Disease Stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Differentiation between stage IIIA and IIIB is in accordance with the American Joint Committee on Cancer Staging Criteria for Lung Cancer.|Participants|Number|22|22.0||||||
4261097|NCT00609518|4085781|B2|IIIB||Disease Stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Differentiation between stage IIIA and IIIB is in accordance with the American Joint Committee on Cancer Staging Criteria for Lung Cancer.|Participants|Number|13|13.0||||||
4261098|NCT00609518|4085782|B1|IIIB||Disease Stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Differentiation between stage IIIA and IIIB is in accordance with the American Joint Committee on Cancer Staging Criteria for Lung Cancer.|Participants|Number|9|9.0||||||
4261099|NCT00609518|4085780|B3|IIIA||Disease Stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Differentiation between stage IIIA and IIIB is in accordance with the American Joint Committee on Cancer Staging Criteria for Lung Cancer.|Participants|Number|4|4.0||||||
4261100|NCT00609518|4085781|B2|IIIA||Disease Stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Differentiation between stage IIIA and IIIB is in accordance with the American Joint Committee on Cancer Staging Criteria for Lung Cancer.|Participants|Number|1|1.0||||||
4261101|NCT00609518|4085782|B1|IIIA||Disease Stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Differentiation between stage IIIA and IIIB is in accordance with the American Joint Committee on Cancer Staging Criteria for Lung Cancer.|Participants|Number|3|3.0||||||
4261102|NCT00609518|4085780|B3|Histopathological||Pathological Diagnosis||Participants|Number|73|73.0||||||
4261103|NCT00609518|4085781|B2|Histopathological||Pathological Diagnosis||Participants|Number|36|36.0||||||
4261104|NCT00609518|4085782|B1|Histopathological||Pathological Diagnosis||Participants|Number|37|37.0||||||
4261105|NCT00609518|4085780|B3|Cytological||Pathological Diagnosis||Participants|Number|38|38.0||||||
4261106|NCT00609518|4085781|B2|Cytological||Pathological Diagnosis||Participants|Number|21|21.0||||||
4261107|NCT00609518|4085782|B1|Cytological||Pathological Diagnosis||Participants|Number|17|17.0||||||
4261108|NCT00609518|4085780|B3|Current Smoker||Smoking Status||Participants|Number|17|17.0||||||
4261109|NCT00609518|4085781|B2|Current Smoker||Smoking Status||Participants|Number|9|9.0||||||
4261110|NCT00609518|4085782|B1|Current Smoker||Smoking Status||Participants|Number|8|8.0||||||
4261111|NCT00609518|4085780|B3|Never Smoked||Smoking Status||Participants|Number|29|29.0||||||
4261112|NCT00609518|4085781|B2|Never Smoked||Smoking Status||Participants|Number|15|15.0||||||
4261113|NCT00609518|4085782|B1|Never Smoked||Smoking Status||Participants|Number|14|14.0||||||
4261114|NCT00609518|4085780|B3|Past Smoker||Smoking Status||Participants|Number|65|65.0||||||
4261115|NCT00609518|4085781|B2|Past Smoker||Smoking Status||Participants|Number|33|33.0||||||
4261116|NCT00609518|4085782|B1|Past Smoker||Smoking Status||Participants|Number|32|32.0||||||
4261117|NCT00609518|4085780|B3|Not Assessed||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|1|1.0||||||
4261118|NCT00609518|4085781|B2|Not Assessed||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|1|1.0||||||
4261119|NCT00609518|4085782|B1|Not Assessed||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|0|0.0||||||
4261120|NCT00609518|4085780|B3|2- Ambulatory, No Work Activities||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|2|2.0||||||
4261121|NCT00609518|4085781|B2|2- Ambulatory, No Work Activities||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|2|2.0||||||
4261122|NCT00609518|4085782|B1|2- Ambulatory, No Work Activities||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|0|0.0||||||
4261123|NCT00609518|4085780|B3|1- Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|56|56.0||||||
4261124|NCT00609518|4085781|B2|1- Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|28|28.0||||||
4261125|NCT00609518|4085782|B1|1- Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|28|28.0||||||
4261126|NCT00609518|4085780|B3|0- Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|52|52.0||||||
4261127|NCT00609518|4085781|B2|0- Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|26|26.0||||||
4261128|NCT00609518|4085782|B1|0- Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|26|26.0||||||
4261129|NCT00609518|4085780|B3|Australia||Region of Enrollment||participants|Number|7|7.0||||||
4261130|NCT00609518|4085781|B2|Australia||Region of Enrollment||participants|Number|3|3.0||||||
4261131|NCT00609518|4085782|B1|Australia||Region of Enrollment||participants|Number|4|4.0||||||
4261132|NCT00609518|4085780|B3|Italy||Region of Enrollment||participants|Number|33|33.0||||||
4261133|NCT00609518|4085781|B2|Italy||Region of Enrollment||participants|Number|18|18.0||||||
4261134|NCT00609518|4085782|B1|Italy||Region of Enrollment||participants|Number|15|15.0||||||
4261135|NCT00609518|4085780|B3|Mexico||Region of Enrollment||participants|Number|54|54.0||||||
4261136|NCT00609518|4085781|B2|Mexico||Region of Enrollment||participants|Number|27|27.0||||||
4261137|NCT00609518|4085782|B1|Mexico||Region of Enrollment||participants|Number|27|27.0||||||
4261138|NCT00609518|4085780|B3|Spain||Region of Enrollment||participants|Number|17|17.0||||||
4261139|NCT00609518|4085781|B2|Spain||Region of Enrollment||participants|Number|9|9.0||||||
4261140|NCT00609518|4085782|B1|Spain||Region of Enrollment||participants|Number|8|8.0||||||
4261141|NCT00609518|4085780|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4261142|NCT00609518|4085781|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4261143|NCT00609518|4085782|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4261144|NCT00609518|4085780|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4261145|NCT00609518|4085781|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4261146|NCT00609518|4085782|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4261147|NCT00609518|4085780|B3|||Age||years|Mean|61.4|61.4|Standard Deviation|11.60|11.6|||
4261148|NCT00609518|4085781|B2|||Age||years|Mean|60.9|60.9|Standard Deviation|12.13|12.13|||
4261149|NCT00609518|4085782|B1|||Age||years|Mean|62.1|62.1|Standard Deviation|11.08|11.08|||
4261150|NCT00609492|4085795|B4||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4261151|NCT00609492|4085796|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4261152|NCT00609492|4085797|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4261153|NCT00609492|4085798|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4261154|NCT00609492|4085795|B4||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4261155|NCT00609492|4085796|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4261156|NCT00609492|4085797|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4261157|NCT00609492|4085798|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4261158|NCT00609492|4085795|B4|||Age||Months|Mean|16.81|16.81|Standard Deviation|0.74|0.74|||
4261159|NCT00609492|4085796|B3|||Age||Months|Mean|16.6|16.6|Standard Deviation|0.73|0.73|||
4261160|NCT00609492|4085797|B2|||Age||Months|Mean|17.2|17.2|Standard Deviation|0.68|0.68|||
4261161|NCT00609492|4085798|B1|||Age||Months|Mean|16.8|16.8|Standard Deviation|0.63|0.63|||
4261162|NCT00609466|4085882|B4|United States||Region of Enrollment||participants|Number|291|291.0||||||
4261163|NCT00609466|4085883|B3|United States||Region of Enrollment||participants|Number|99|99.0||||||
4261164|NCT00609466|4085884|B2|United States||Region of Enrollment||participants|Number|96|96.0||||||
4261165|NCT00609466|4085885|B1|United States||Region of Enrollment||participants|Number|96|96.0||||||
4261166|NCT00609466|4085882|B4||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4261167|NCT00609466|4085883|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4261168|NCT00609466|4085884|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4261169|NCT00609466|4085885|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4261170|NCT00609466|4085882|B4||Female|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
4261171|NCT00609466|4085883|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4261172|NCT00609466|4085884|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4261173|NCT00609466|4085885|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4261174|NCT00609466|4085882|B4|||Age||years|Mean|44.0|44.0|Standard Deviation|13.55|13.55|||
4261175|NCT00609466|4085883|B3|||Age||years|Mean|43.8|43.8|Standard Deviation|13.93|13.93|||
4261176|NCT00609466|4085884|B2|||Age||years|Mean|43.7|43.7|Standard Deviation|14.19|14.19|||
4261177|NCT00609466|4085885|B1|||Age||years|Mean|44.6|44.6|Standard Deviation|12.58|12.58|||
4261178|NCT00609466|4085882|B4||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4261179|NCT00609466|4085883|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4261180|NCT00609466|4085884|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4261181|NCT00609466|4085885|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4261182|NCT00609466|4085882|B4||Between 18 and 65 years|Age||Participants|Count of Participants|272|272.0||||||
4261183|NCT00609466|4085883|B3||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
4261184|NCT00609466|4085884|B2||Between 18 and 65 years|Age||Participants|Count of Participants|88|88.0||||||
4261185|NCT00609466|4085885|B1||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
4261186|NCT00609466|4085882|B4||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4261187|NCT00609466|4085883|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4261188|NCT00609466|4085884|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4261189|NCT00609466|4085885|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4261190|NCT00609362|4085913|B3|Denmark||Region of Enrollment||participants|Number|57|57.0||||||
4261191|NCT00609362|4085914|B2|Denmark||Region of Enrollment||participants|Number|28|28.0||||||
4261192|NCT00609362|4085915|B1|Denmark||Region of Enrollment||participants|Number|29|29.0||||||
4261193|NCT00609362|4085913|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4261194|NCT00609362|4085914|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4261195|NCT00609362|4085915|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4261196|NCT00609362|4085913|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4261197|NCT00609362|4085914|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4261198|NCT00609362|4085915|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4261199|NCT00609362|4085913|B3|||Age||years|Mean|65.2|65.2|Standard Deviation|3.8|3.8|||
4261200|NCT00609362|4085914|B2|||Age||years|Mean|65.3|65.3|Standard Deviation|4.3|4.3|||
4261201|NCT00609362|4085915|B1|||Age||years|Mean|65.1|65.1|Standard Deviation|3.5|3.5|||
4261202|NCT00609362|4085913|B3||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4261203|NCT00609362|4085914|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4261204|NCT00609362|4085915|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4261205|NCT00609362|4085913|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4261206|NCT00609362|4085914|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4261207|NCT00609362|4085915|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4261208|NCT00609362|4085913|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4261209|NCT00609362|4085914|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4261210|NCT00609362|4085915|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4261211|NCT00609336|4085926|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261212|NCT00609336|4085926|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261213|NCT00609336|4085926|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4261214|NCT00609336|4085926|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261215|NCT00609336|4085926|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261216|NCT00609336|4085926|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4261217|NCT00609336|4085926|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4261218|NCT00609336|4085926|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4261219|NCT00609336|4085926|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4261220|NCT00609336|4085926|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261221|NCT00609336|4085926|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4261222|NCT00609336|4085926|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4261223|NCT00609336|4085926|B1|||Age||years|Median|62|62.0|Full Range|||46.0|77.0|
4261224|NCT00609271|4085938|B3|||Framingham risk percent|"The Framingham Risk score predicts the 10-year risk of developing coronary heart disease (CHD). Risk is predicted based on gender-specific tables provided by Wilson et al (Circulation 1998: 1837-47) comprised of the sum of points obtained from the following factors: age, presence of diabetes, cigarette smoking, blood pressure, high density lipoprotein level, and total cholesterol level.~Risk calculated from this score can range from a 1% chance of developing CHD to a >= 56% chance of developing CHD in men --- and a 1% chance of developing CHD to a >=32% chance of developing CHD in women."|%|Mean|4.0|4.0|Standard Deviation|18.7|18.7|||
4261225|NCT00609271|4085939|B2|||Framingham risk percent|"The Framingham Risk score predicts the 10-year risk of developing coronary heart disease (CHD). Risk is predicted based on gender-specific tables provided by Wilson et al (Circulation 1998: 1837-47) comprised of the sum of points obtained from the following factors: age, presence of diabetes, cigarette smoking, blood pressure, high density lipoprotein level, and total cholesterol level.~Risk calculated from this score can range from a 1% chance of developing CHD to a >= 56% chance of developing CHD in men --- and a 1% chance of developing CHD to a >=32% chance of developing CHD in women."|%|Mean|4.2|4.2|Standard Deviation|3.3|3.3|||
4261226|NCT00609271|4085940|B1|||Framingham risk percent|"The Framingham Risk score predicts the 10-year risk of developing coronary heart disease (CHD). Risk is predicted based on gender-specific tables provided by Wilson et al (Circulation 1998: 1837-47) comprised of the sum of points obtained from the following factors: age, presence of diabetes, cigarette smoking, blood pressure, high density lipoprotein level, and total cholesterol level.~Risk calculated from this score can range from a 1% chance of developing CHD to a >= 56% chance of developing CHD in men --- and a 1% chance of developing CHD to a >=32% chance of developing CHD in women."|%|Mean|3.9|3.9|Standard Deviation|3.1|3.1|||
4261227|NCT00609271|4085938|B3|||Physical activity level||MET-h/wk|Mean|17.9|17.9|Standard Deviation|31.1|31.1|||
4261228|NCT00609271|4085939|B2|||Physical activity level||MET-h/wk|Mean|19.6|19.6|Standard Deviation|35.5|35.5|||
4261229|NCT00609271|4085940|B1|||Physical activity level||MET-h/wk|Mean|16.3|16.3|Standard Deviation|26.0|26.0|||
4261230|NCT00609271|4085938|B3|Lipid-Lowering||Medication use||Participants|Count of Participants|21|21.0||||||
4261231|NCT00609271|4085939|B2|Lipid-Lowering||Medication use||Participants|Count of Participants|9|9.0||||||
4261232|NCT00609271|4085940|B1|Lipid-Lowering||Medication use||Participants|Count of Participants|12|12.0||||||
4261233|NCT00609271|4085938|B3|Antihypertensive||Medication use||Participants|Count of Participants|45|45.0||||||
4261234|NCT00609271|4085939|B2|Antihypertensive||Medication use||Participants|Count of Participants|24|24.0||||||
4261235|NCT00609271|4085940|B1|Antihypertensive||Medication use||Participants|Count of Participants|21|21.0||||||
4261236|NCT00609271|4085938|B3|||C-reactive protein||nmol/L|Mean|46.7|46.7|Standard Deviation|44.5|44.5|||
4261237|NCT00609271|4085939|B2|||C-reactive protein||nmol/L|Mean|46.7|46.7|Standard Deviation|48.6|48.6|||
4261238|NCT00609271|4085940|B1|||C-reactive protein||nmol/L|Mean|46.7|46.7|Standard Deviation|40.0|40.0|||
4261239|NCT00609271|4085938|B3|||serum creatinine||mg/dL|Mean|1.0|1.0|Standard Deviation|0.1|0.1|||
4261240|NCT00609271|4085939|B2|||serum creatinine||mg/dL|Mean|1.1|1.1|Standard Deviation|0.2|0.2|||
4261241|NCT00609271|4085940|B1|||serum creatinine||mg/dL|Mean|1.0|1.0|Standard Deviation|0.2|0.2|||
4261242|NCT00609271|4085938|B3|||serum insulin||pmol/L|Mean|104.2|104.2|Standard Deviation|59.7|59.7|||
4261243|NCT00609271|4085939|B2|||serum insulin||pmol/L|Mean|105.6|105.6|Standard Deviation|54.9|54.9|||
4261244|NCT00609271|4085940|B1|||serum insulin||pmol/L|Mean|102.8|102.8|Standard Deviation|63.9|63.9|||
4261245|NCT00609271|4085938|B3|||plasma glucose||mg/dL|Mean|94.0|94.0|Standard Deviation|10.1|10.1|||
4261246|NCT00609271|4085939|B2|||plasma glucose||mg/dL|Mean|93.4|93.4|Standard Deviation|9.2|9.2|||
4261247|NCT00609271|4085940|B1|||plasma glucose||mg/dL|Mean|94.5|94.5|Standard Deviation|10.9|10.9|||
4261248|NCT00609271|4085938|B3|||triglycerides||mg/dL|Mean|119.0|119.0|Standard Deviation|69.1|69.1|||
4261249|NCT00609271|4085939|B2|||triglycerides||mg/dL|Mean|125.5|125.5|Standard Deviation|81.3|81.3|||
4261250|NCT00609271|4085940|B1|||triglycerides||mg/dL|Mean|112.6|112.6|Standard Deviation|54.1|54.1|||
4261251|NCT00609271|4085938|B3|||total-HDL cholesterol ratio||unitless|Mean|3.8|3.8|Standard Deviation|1|1.0|||
4261252|NCT00609271|4085939|B2|||total-HDL cholesterol ratio||unitless|Mean|3.8|3.8|Standard Deviation|1.0|1.0|||
4261253|NCT00609271|4085940|B1|||total-HDL cholesterol ratio||unitless|Mean|3.8|3.8|Standard Deviation|1.0|1.0|||
4261254|NCT00609271|4085938|B3|||HDL cholesterol||mg/dL|Mean|55.1|55.1|Standard Deviation|13.1|13.1|||
4261255|NCT00609271|4085939|B2|||HDL cholesterol||mg/dL|Mean|56.5|56.5|Standard Deviation|12.8|12.8|||
4261256|NCT00609271|4085940|B1|||HDL cholesterol||mg/dL|Mean|53.8|53.8|Standard Deviation|13.3|13.3|||
4261257|NCT00609271|4085938|B3|||LDL cholesterol||mg/dL|Mean|122.6|122.6|Standard Deviation|36.6|36.6|||
4261258|NCT00609271|4085939|B2|||LDL cholesterol||mg/dL|Mean|122.7|122.7|Standard Deviation|38.6|38.6|||
4261259|NCT00609271|4085940|B1|||LDL cholesterol||mg/dL|Mean|122.5|122.5|Standard Deviation|34.6|34.6|||
4261260|NCT00609271|4085938|B3|||total cholesterol||mg/dL|Mean|201.5|201.5|Standard Deviation|41.5|41.5|||
4261261|NCT00609271|4085939|B2|||total cholesterol||mg/dL|Mean|204.3|204.3|Standard Deviation|40.7|40.7|||
4261262|NCT00609271|4085940|B1|||total cholesterol||mg/dL|Mean|198.8|198.8|Standard Deviation|42.2|42.2|||
4261263|NCT00609271|4085938|B3|||diastolic blood pressure||mm Hg|Mean|78.4|78.4|Standard Deviation|8.7|8.7|||
4261264|NCT00609271|4085939|B2|||diastolic blood pressure||mm Hg|Mean|79.4|79.4|Standard Deviation|8.3|8.3|||
4261265|NCT00609271|4085940|B1|||diastolic blood pressure||mm Hg|Mean|77.5|77.5|Standard Deviation|9.0|9.0|||
4261266|NCT00609271|4085938|B3|||systolic blood pressure||mm Hg|Mean|122.6|122.6|Standard Deviation|13.5|13.5|||
4261267|NCT00609271|4085939|B2|||systolic blood pressure||mm Hg|Mean|124.9|124.9|Standard Deviation|13.8|13.8|||
4261268|NCT00609271|4085940|B1|||systolic blood pressure||mm Hg|Mean|120.3|120.3|Standard Deviation|12.8|12.8|||
4261269|NCT00609271|4085938|B3|||waist circumference||cm|Mean|109.7|109.7|Standard Deviation|10.1|10.1|||
4261270|NCT00609271|4085939|B2|||waist circumference||cm|Mean|111.0|111.0|Standard Deviation|10.7|10.7|||
4261271|NCT00609271|4085940|B1|||waist circumference||cm|Mean|108.4|108.4|Standard Deviation|9.3|9.3|||
4261272|NCT00609271|4085938|B3|||body mass index||kg/m**2|Mean|35.4|35.4|Standard Deviation|4.2|4.2|||
4261273|NCT00609271|4085939|B2|||body mass index||kg/m**2|Mean|35.6|35.6|Standard Deviation|4.5|4.5|||
4261274|NCT00609271|4085940|B1|||body mass index||kg/m**2|Mean|35.2|35.2|Standard Deviation|3.8|3.8|||
4261275|NCT00609271|4085938|B3|Lean Mass||body composition||%|Mean|60|60.0|Standard Deviation|10|10.0|||
4261276|NCT00609271|4085939|B2|Lean Mass||body composition||%|Mean|60|60.0|Standard Deviation|10|10.0|||
4261277|NCT00609271|4085940|B1|Lean Mass||body composition||%|Mean|60|60.0|Standard Deviation|10|10.0|||
4261278|NCT00609271|4085938|B3|Fat mass||body composition||%|Mean|40|40.0|Standard Deviation|10|10.0|||
4261279|NCT00609271|4085939|B2|Fat mass||body composition||%|Mean|40|40.0|Standard Deviation|10|10.0|||
4261280|NCT00609271|4085940|B1|Fat mass||body composition||%|Mean|40|40.0|Standard Deviation|10|10.0|||
4261281|NCT00609271|4085938|B3|||body weight||kg|Mean|97.1|97.1|Standard Deviation|13.1|13.1|||
4261282|NCT00609271|4085939|B2|||body weight||kg|Mean|97.9|97.9|Standard Deviation|13.5|13.5|||
4261283|NCT00609271|4085940|B1|||body weight||kg|Mean|96.3|96.3|Standard Deviation|12.7|12.7|||
4261284|NCT00609271|4085938|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4261285|NCT00609271|4085939|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4261286|NCT00609271|4085940|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4261287|NCT00609271|4085938|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4261288|NCT00609271|4085939|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4261289|NCT00609271|4085940|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4261290|NCT00609271|4085938|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4261291|NCT00609271|4085939|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4261292|NCT00609271|4085940|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4261293|NCT00609271|4085938|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|76|76.0||||||
4261294|NCT00609271|4085939|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
4261295|NCT00609271|4085940|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
4261296|NCT00609271|4085938|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|67|67.0||||||
4261297|NCT00609271|4085939|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
4261298|NCT00609271|4085940|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
4261299|NCT00609271|4085938|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4261300|NCT00609271|4085939|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4261301|NCT00609271|4085940|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4261302|NCT00609271|4085938|B3||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4261303|NCT00609271|4085939|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4261304|NCT00609271|4085940|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4261305|NCT00609271|4085938|B3|||Age||years|Mean|46.8|46.8|Standard Deviation|10.2|10.2|||
4261306|NCT00609271|4085939|B2|||Age||years|Mean|47.8|47.8|Standard Deviation|10.4|10.4|||
4261307|NCT00609271|4085940|B1|||Age||years|Mean|45.8|45.8|Standard Deviation|9.9|9.9|||
4261308|NCT00609245|4085977|B1|||presence of photoparoxysmal response||participants|Number|13|13.0||||||
4261309|NCT00609245|4085977|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4261310|NCT00609245|4085977|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4261311|NCT00609245|4085977|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4261312|NCT00609245|4085977|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4261313|NCT00609245|4085977|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4261314|NCT00609167|4085983|B3|No||Parameter of Hematologic Response - Bone Marrow Plasma Cells > 30%||participants|Number|18|18.0||||||
4261315|NCT00609167|4085984|B2|No||Parameter of Hematologic Response - Bone Marrow Plasma Cells > 30%||participants|Number|8|8.0||||||
4261316|NCT00609167|4085985|B1|No||Parameter of Hematologic Response - Bone Marrow Plasma Cells > 30%||participants|Number|10|10.0||||||
4261317|NCT00609167|4085983|B3|Yes||Parameter of Hematologic Response - Bone Marrow Plasma Cells > 30%||participants|Number|45|45.0||||||
4261318|NCT00609167|4085984|B2|Yes||Parameter of Hematologic Response - Bone Marrow Plasma Cells > 30%||participants|Number|22|22.0||||||
4261319|NCT00609167|4085985|B1|Yes||Parameter of Hematologic Response - Bone Marrow Plasma Cells > 30%||participants|Number|23|23.0||||||
4261320|NCT00609167|4085983|B3|No||Parameter of Hematologic Response - Urine M-Spike >= 200mg/24 hours||participants|Number|36|36.0||||||
4261321|NCT00609167|4085984|B2|No||Parameter of Hematologic Response - Urine M-Spike >= 200mg/24 hours||participants|Number|19|19.0||||||
4261322|NCT00609167|4085985|B1|No||Parameter of Hematologic Response - Urine M-Spike >= 200mg/24 hours||participants|Number|17|17.0||||||
4261323|NCT00609167|4085983|B3|Yes||Parameter of Hematologic Response - Urine M-Spike >= 200mg/24 hours||participants|Number|27|27.0||||||
4261324|NCT00609167|4085984|B2|Yes||Parameter of Hematologic Response - Urine M-Spike >= 200mg/24 hours||participants|Number|11|11.0||||||
4261325|NCT00609167|4085985|B1|Yes||Parameter of Hematologic Response - Urine M-Spike >= 200mg/24 hours||participants|Number|16|16.0||||||
4261326|NCT00609167|4085983|B3|No||Parameter of Hematologic Response - Serum Immunoglobulin Free Light Chain >=10mg/dL||participants|Number|13|13.0||||||
4261327|NCT00609167|4085984|B2|No||Parameter of Hematologic Response - Serum Immunoglobulin Free Light Chain >=10mg/dL||participants|Number|4|4.0||||||
4261328|NCT00609167|4085985|B1|No||Parameter of Hematologic Response - Serum Immunoglobulin Free Light Chain >=10mg/dL||participants|Number|9|9.0||||||
4261329|NCT00609167|4085983|B3|Yes||Parameter of Hematologic Response - Serum Immunoglobulin Free Light Chain >=10mg/dL||participants|Number|50|50.0||||||
4261330|NCT00609167|4085984|B2|Yes||Parameter of Hematologic Response - Serum Immunoglobulin Free Light Chain >=10mg/dL||participants|Number|26|26.0||||||
4261331|NCT00609167|4085985|B1|Yes||Parameter of Hematologic Response - Serum Immunoglobulin Free Light Chain >=10mg/dL||participants|Number|24|24.0||||||
4261332|NCT00609167|4085983|B3|No||Parameters of Hematologic Response - Serum M-spike >=1g/dL||participants|Number|20|20.0||||||
4261333|NCT00609167|4085984|B2|No||Parameters of Hematologic Response - Serum M-spike >=1g/dL||participants|Number|12|12.0||||||
4261334|NCT00609167|4085985|B1|No||Parameters of Hematologic Response - Serum M-spike >=1g/dL||participants|Number|8|8.0||||||
4261335|NCT00609167|4085983|B3|Yes||Parameters of Hematologic Response - Serum M-spike >=1g/dL||participants|Number|43|43.0||||||
4261336|NCT00609167|4085984|B2|Yes||Parameters of Hematologic Response - Serum M-spike >=1g/dL||participants|Number|18|18.0||||||
4261337|NCT00609167|4085985|B1|Yes||Parameters of Hematologic Response - Serum M-spike >=1g/dL||participants|Number|25|25.0||||||
4261338|NCT00609167|4085983|B3|Canada||Region of Enrollment||participants|Number|39|39.0||||||
4261339|NCT00609167|4085984|B2|Canada||Region of Enrollment||participants|Number|18|18.0||||||
4261340|NCT00609167|4085985|B1|Canada||Region of Enrollment||participants|Number|21|21.0||||||
4261341|NCT00609167|4085983|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4261342|NCT00609167|4085984|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4261343|NCT00609167|4085985|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4261344|NCT00609167|4085983|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4261345|NCT00609167|4085984|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4261346|NCT00609167|4085985|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4261347|NCT00609167|4085983|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4261348|NCT00609167|4085984|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4261349|NCT00609167|4085985|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4261350|NCT00609167|4085983|B3|||Age||years|Median|61|61.0|Full Range|||36.0|75.0|
4261351|NCT00609167|4085984|B2|||Age||years|Median|61|61.0|Full Range|||36.0|70.0|
4261352|NCT00609167|4085985|B1|||Age||years|Median|60|60.0|Full Range|||38.0|75.0|
4261353|NCT00609128|4086008|B1|United States||Region of Enrollment|tears were collected from olopatadine treated eye and untreated eye of participants . tears were collected from 21 participants ( not 42) not all collected tears were used in final experiments.|participants|Number|21|21.0||||||
4261354|NCT00609128|4086008|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4261355|NCT00609128|4086008|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4261356|NCT00609128|4086008|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4261357|NCT00609128|4086008|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4261358|NCT00609128|4086008|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4261359|NCT00608985|4086013|B5|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
4261360|NCT00608985|4086014|B4|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4261361|NCT00608985|4086015|B3|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4261362|NCT00608985|4086016|B2|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4261363|NCT00608985|4086017|B1|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4261364|NCT00608985|4086013|B5|Switzerland||Region of Enrollment||participants|Number|10|10.0||||||
4261365|NCT00608985|4086014|B4|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4261366|NCT00608985|4086015|B3|Switzerland||Region of Enrollment||participants|Number|4|4.0||||||
4261367|NCT00608985|4086016|B2|Switzerland||Region of Enrollment||participants|Number|4|4.0||||||
4261368|NCT00608985|4086017|B1|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4261369|NCT00608985|4086013|B5|Sweden||Region of Enrollment||participants|Number|25|25.0||||||
4261370|NCT00608985|4086014|B4|Sweden||Region of Enrollment||participants|Number|6|6.0||||||
4261371|NCT00608985|4086015|B3|Sweden||Region of Enrollment||participants|Number|5|5.0||||||
4261372|NCT00608985|4086016|B2|Sweden||Region of Enrollment||participants|Number|8|8.0||||||
4261373|NCT00608985|4086017|B1|Sweden||Region of Enrollment||participants|Number|6|6.0||||||
4261374|NCT00608985|4086013|B5|Spain||Region of Enrollment||participants|Number|18|18.0||||||
4261375|NCT00608985|4086014|B4|Spain||Region of Enrollment||participants|Number|3|3.0||||||
4261376|NCT00608985|4086015|B3|Spain||Region of Enrollment||participants|Number|5|5.0||||||
4261377|NCT00608985|4086016|B2|Spain||Region of Enrollment||participants|Number|6|6.0||||||
4261378|NCT00608985|4086017|B1|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4261379|NCT00608985|4086013|B5|South Africa||Region of Enrollment||participants|Number|53|53.0||||||
4261380|NCT00608985|4086014|B4|South Africa||Region of Enrollment||participants|Number|12|12.0||||||
4261381|NCT00608985|4086015|B3|South Africa||Region of Enrollment||participants|Number|13|13.0||||||
4261382|NCT00608985|4086016|B2|South Africa||Region of Enrollment||participants|Number|13|13.0||||||
4261383|NCT00608985|4086017|B1|South Africa||Region of Enrollment||participants|Number|15|15.0||||||
4261384|NCT00608985|4086013|B5|Poland||Region of Enrollment||participants|Number|12|12.0||||||
4261385|NCT00608985|4086014|B4|Poland||Region of Enrollment||participants|Number|3|3.0||||||
4261386|NCT00608985|4086015|B3|Poland||Region of Enrollment||participants|Number|3|3.0||||||
4261387|NCT00608985|4086016|B2|Poland||Region of Enrollment||participants|Number|3|3.0||||||
4261388|NCT00608985|4086017|B1|Poland||Region of Enrollment||participants|Number|3|3.0||||||
4261389|NCT00608985|4086013|B5|Italy||Region of Enrollment||participants|Number|10|10.0||||||
4261390|NCT00608985|4086014|B4|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4261391|NCT00608985|4086015|B3|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4261392|NCT00608985|4086016|B2|Italy||Region of Enrollment||participants|Number|3|3.0||||||
4261393|NCT00608985|4086017|B1|Italy||Region of Enrollment||participants|Number|3|3.0||||||
4261394|NCT00608985|4086013|B5|Israel||Region of Enrollment||participants|Number|21|21.0||||||
4261395|NCT00608985|4086014|B4|Israel||Region of Enrollment||participants|Number|5|5.0||||||
4261396|NCT00608985|4086015|B3|Israel||Region of Enrollment||participants|Number|6|6.0||||||
4261397|NCT00608985|4086016|B2|Israel||Region of Enrollment||participants|Number|5|5.0||||||
4261398|NCT00608985|4086017|B1|Israel||Region of Enrollment||participants|Number|5|5.0||||||
4261399|NCT00608985|4086013|B5|Hungary||Region of Enrollment||participants|Number|47|47.0||||||
4261400|NCT00608985|4086014|B4|Hungary||Region of Enrollment||participants|Number|13|13.0||||||
4261401|NCT00608985|4086015|B3|Hungary||Region of Enrollment||participants|Number|11|11.0||||||
4261402|NCT00608985|4086016|B2|Hungary||Region of Enrollment||participants|Number|11|11.0||||||
4261403|NCT00608985|4086017|B1|Hungary||Region of Enrollment||participants|Number|12|12.0||||||
4261404|NCT00608985|4086013|B5|Germany||Region of Enrollment||participants|Number|337|337.0||||||
4261405|NCT00608985|4086014|B4|Germany||Region of Enrollment||participants|Number|81|81.0||||||
4261406|NCT00608985|4086015|B3|Germany||Region of Enrollment||participants|Number|87|87.0||||||
4261407|NCT00608985|4086016|B2|Germany||Region of Enrollment||participants|Number|86|86.0||||||
4261408|NCT00608985|4086017|B1|Germany||Region of Enrollment||participants|Number|83|83.0||||||
4261409|NCT00608985|4086013|B5|France||Region of Enrollment||participants|Number|10|10.0||||||
4261410|NCT00608985|4086014|B4|France||Region of Enrollment||participants|Number|2|2.0||||||
4261411|NCT00608985|4086015|B3|France||Region of Enrollment||participants|Number|3|3.0||||||
4261412|NCT00608985|4086016|B2|France||Region of Enrollment||participants|Number|2|2.0||||||
4261413|NCT00608985|4086017|B1|France||Region of Enrollment||participants|Number|3|3.0||||||
4261414|NCT00608985|4086013|B5|Finland||Region of Enrollment||participants|Number|54|54.0||||||
4261415|NCT00608985|4086014|B4|Finland||Region of Enrollment||participants|Number|14|14.0||||||
4261416|NCT00608985|4086015|B3|Finland||Region of Enrollment||participants|Number|13|13.0||||||
4261417|NCT00608985|4086016|B2|Finland||Region of Enrollment||participants|Number|14|14.0||||||
4261418|NCT00608985|4086017|B1|Finland||Region of Enrollment||participants|Number|13|13.0||||||
4261419|NCT00608985|4086013|B5|Denmark||Region of Enrollment||participants|Number|20|20.0||||||
4261420|NCT00608985|4086014|B4|Denmark||Region of Enrollment||participants|Number|4|4.0||||||
4261421|NCT00608985|4086015|B3|Denmark||Region of Enrollment||participants|Number|5|5.0||||||
4261422|NCT00608985|4086016|B2|Denmark||Region of Enrollment||participants|Number|5|5.0||||||
4261423|NCT00608985|4086017|B1|Denmark||Region of Enrollment||participants|Number|6|6.0||||||
4261424|NCT00608985|4086013|B5|Czech Republic||Region of Enrollment||participants|Number|6|6.0||||||
4261425|NCT00608985|4086014|B4|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
4261426|NCT00608985|4086015|B3|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
4261427|NCT00608985|4086016|B2|Czech Republic||Region of Enrollment||participants|Number|2|2.0||||||
4261428|NCT00608985|4086017|B1|Czech Republic||Region of Enrollment||participants|Number|2|2.0||||||
4261429|NCT00608985|4086013|B5|Bulgaria||Region of Enrollment||participants|Number|2|2.0||||||
4261430|NCT00608985|4086014|B4|Bulgaria||Region of Enrollment||participants|Number|0|0.0||||||
4261431|NCT00608985|4086015|B3|Bulgaria||Region of Enrollment||participants|Number|1|1.0||||||
4261432|NCT00608985|4086016|B2|Bulgaria||Region of Enrollment||participants|Number|0|0.0||||||
4261433|NCT00608985|4086017|B1|Bulgaria||Region of Enrollment||participants|Number|1|1.0||||||
4261434|NCT00608985|4086013|B5|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
4261435|NCT00608985|4086014|B4|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
4261436|NCT00608985|4086015|B3|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4261437|NCT00608985|4086016|B2|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4261438|NCT00608985|4086017|B1|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
4261439|NCT00608985|4086013|B5|Austria||Region of Enrollment||participants|Number|14|14.0||||||
4261440|NCT00608985|4086014|B4|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4261441|NCT00608985|4086015|B3|Austria||Region of Enrollment||participants|Number|2|2.0||||||
4261442|NCT00608985|4086016|B2|Austria||Region of Enrollment||participants|Number|5|5.0||||||
4261443|NCT00608985|4086017|B1|Austria||Region of Enrollment||participants|Number|3|3.0||||||
4261444|NCT00608985|4086013|B5|Australia||Region of Enrollment||participants|Number|54|54.0||||||
4261445|NCT00608985|4086014|B4|Australia||Region of Enrollment||participants|Number|14|14.0||||||
4261446|NCT00608985|4086015|B3|Australia||Region of Enrollment||participants|Number|12|12.0||||||
4261447|NCT00608985|4086016|B2|Australia||Region of Enrollment||participants|Number|15|15.0||||||
4261448|NCT00608985|4086017|B1|Australia||Region of Enrollment||participants|Number|13|13.0||||||
4261449|NCT00608985|4086013|B5||Male|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
4261450|NCT00608985|4086014|B4||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4261451|NCT00608985|4086015|B3||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4261452|NCT00608985|4086016|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4261453|NCT00608985|4086017|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4261454|NCT00608985|4086013|B5||Female|Sex: Female, Male||Participants|Count of Participants|436|436.0||||||
4261455|NCT00608985|4086014|B4||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4261456|NCT00608985|4086015|B3||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4261457|NCT00608985|4086016|B2||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4261458|NCT00608985|4086017|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4261459|NCT00608985|4086013|B5|||Age||years|Mean|45.4|45.4|Standard Deviation|12.03|12.03|||
4261460|NCT00608985|4086014|B4|||Age||years|Mean|45.1|45.1|Standard Deviation|12.11|12.11|||
4261461|NCT00608985|4086015|B3|||Age||years|Mean|46.1|46.1|Standard Deviation|11.83|11.83|||
4261462|NCT00608985|4086016|B2|||Age||years|Mean|44.1|44.1|Standard Deviation|12.44|12.44|||
4261463|NCT00608985|4086017|B1|||Age||years|Mean|46.2|46.2|Standard Deviation|11.69|11.69|||
4261464|NCT00608985|4086013|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4261465|NCT00608985|4086014|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4261466|NCT00608985|4086015|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4261467|NCT00608985|4086016|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4261468|NCT00608985|4086017|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4261469|NCT00608985|4086013|B5||Between 18 and 65 years|Age||Participants|Count of Participants|707|707.0||||||
4261470|NCT00608985|4086014|B4||Between 18 and 65 years|Age||Participants|Count of Participants|168|168.0||||||
4261471|NCT00608985|4086015|B3||Between 18 and 65 years|Age||Participants|Count of Participants|176|176.0||||||
4261472|NCT00608985|4086016|B2||Between 18 and 65 years|Age||Participants|Count of Participants|186|186.0||||||
4261473|NCT00608985|4086017|B1||Between 18 and 65 years|Age||Participants|Count of Participants|177|177.0||||||
4261474|NCT00608985|4086013|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4261475|NCT00608985|4086014|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4261476|NCT00608985|4086015|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4261477|NCT00608985|4086016|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4261478|NCT00608985|4086017|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4261479|NCT00608959|4086050|B3|United States||Region of Enrollment||participants|Number|50.0|50.0||||||
4261480|NCT00608959|4086051|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4261481|NCT00608959|4086052|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4261482|NCT00608959|4086050|B3||Male|Sex: Female, Male||Participants|Count of Participants|25.0|25.0||||||
4261483|NCT00608959|4086051|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4261484|NCT00608959|4086052|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4261485|NCT00608959|4086050|B3||Female|Sex: Female, Male||Participants|Count of Participants|25.0|25.0||||||
4261486|NCT00608959|4086051|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4261487|NCT00608959|4086052|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4261488|NCT00608959|4086050|B3|||Age||years|Mean|38.6|38.6|Standard Deviation|15.13|15.13|||
4261489|NCT00608959|4086051|B2|||Age||years|Mean|36.6|36.6|Standard Deviation|15.13|15.13|||
4261490|NCT00608959|4086052|B1|||Age||years|Mean|38.6|38.6|Standard Deviation|15.13|15.13|||
4261491|NCT00608959|4086050|B3||>=65 years|Age||Participants|Count of Participants|2.0|2.0||||||
4261492|NCT00608959|4086051|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4261493|NCT00608959|4086052|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4261494|NCT00608959|4086050|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48.0|48.0||||||
4261495|NCT00608959|4086051|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4261496|NCT00608959|4086052|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4261497|NCT00608959|4086050|B3||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4261498|NCT00608959|4086051|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4261499|NCT00608959|4086052|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4261500|NCT00608907|4086062|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4261501|NCT00608907|4086063|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4261502|NCT00608907|4086064|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4261503|NCT00608907|4086065|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4261504|NCT00608907|4086062|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4261505|NCT00608907|4086063|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4261506|NCT00608907|4086064|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4261507|NCT00608907|4086065|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4261508|NCT00608907|4086062|B4|||Age||years|Mean|63.0|63.0|Standard Deviation|10.91|10.91|||
4261509|NCT00608907|4086063|B3|||Age||years|Mean|62.3|62.3|Standard Deviation|11.72|11.72|||
4261510|NCT00608907|4086064|B2|||Age||years|Mean|60.2|60.2|Standard Deviation|9.97|9.97|||
4261511|NCT00608907|4086065|B1|||Age||years|Mean|64.7|64.7|Standard Deviation|10.86|10.86|||
4261512|NCT00608907|4086062|B4||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4261513|NCT00608907|4086063|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4261514|NCT00608907|4086064|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4261515|NCT00608907|4086065|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4261516|NCT00608907|4086062|B4||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4261517|NCT00608907|4086063|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4261518|NCT00608907|4086064|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4261519|NCT00608907|4086065|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4261520|NCT00608907|4086062|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4261521|NCT00608907|4086063|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4261522|NCT00608907|4086064|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4261523|NCT00608907|4086065|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4261524|NCT00608881|4086075|B3||Male|Sex: Female, Male||Participants|Count of Participants|296|296.0||||||
4261525|NCT00608881|4086076|B2||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4261526|NCT00608881|4086077|B1||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4261527|NCT00608881|4086075|B3||Female|Sex: Female, Male||Participants|Count of Participants|313|313.0||||||
4261528|NCT00608881|4086076|B2||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4261529|NCT00608881|4086077|B1||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4261530|NCT00608881|4086075|B3|||Age||years|Mean|50.6|50.6|Standard Deviation|11.7|11.7|||
4261531|NCT00608881|4086076|B2|||Age||years|Mean|50.7|50.7|Standard Deviation|11.6|11.6|||
4261532|NCT00608881|4086077|B1|||Age||years|Mean|50.5|50.5|Standard Deviation|11.9|11.9|||
4261533|NCT00608868|4086112|B1|IV||Disease Stage|The tumor node metastasis (TNM) staging system (NSCLC) was used to determine the disease stage. Stage is usually expressed as a number on a scale of 0 through IV — with stage 0 describing non-invasive cancers that remain within their original location and stage IV describing invasive cancers that have spread outside to other parts of the body. Number of patients with different disease stage is reported.|Participants|Number|113|113.0||||||
4261534|NCT00608868|4086112|B1|III B||Disease Stage|The tumor node metastasis (TNM) staging system (NSCLC) was used to determine the disease stage. Stage is usually expressed as a number on a scale of 0 through IV — with stage 0 describing non-invasive cancers that remain within their original location and stage IV describing invasive cancers that have spread outside to other parts of the body. Number of patients with different disease stage is reported.|Participants|Number|20|20.0||||||
4261535|NCT00608868|4086112|B1|III A||Disease Stage|The tumor node metastasis (TNM) staging system (NSCLC) was used to determine the disease stage. Stage is usually expressed as a number on a scale of 0 through IV — with stage 0 describing non-invasive cancers that remain within their original location and stage IV describing invasive cancers that have spread outside to other parts of the body. Number of patients with different disease stage is reported.|Participants|Number|4|4.0||||||
4261536|NCT00608868|4086112|B1|I||Disease Stage|The tumor node metastasis (TNM) staging system (NSCLC) was used to determine the disease stage. Stage is usually expressed as a number on a scale of 0 through IV — with stage 0 describing non-invasive cancers that remain within their original location and stage IV describing invasive cancers that have spread outside to other parts of the body. Number of patients with different disease stage is reported.|Participants|Number|1|1.0||||||
4261537|NCT00608868|4086112|B1|2||World Health Organisation (WHO) Performance Status|WHO has 5 grades (0-4), 0 -Fully active, 1-Restricted in strenuous activity, 2- Ambulatory and capable of all self-care, 3-Capable of only limited self-care and 4- Completely disabled.|Participants|Number|15|15.0||||||
4261538|NCT00608868|4086112|B1|1||World Health Organisation (WHO) Performance Status|WHO has 5 grades (0-4), 0 -Fully active, 1-Restricted in strenuous activity, 2- Ambulatory and capable of all self-care, 3-Capable of only limited self-care and 4- Completely disabled.|Participants|Number|73|73.0||||||
4261539|NCT00608868|4086112|B1|0||World Health Organisation (WHO) Performance Status|WHO has 5 grades (0-4), 0 -Fully active, 1-Restricted in strenuous activity, 2- Ambulatory and capable of all self-care, 3-Capable of only limited self-care and 4- Completely disabled.|Participants|Number|50|50.0||||||
4261540|NCT00608868|4086112|B1|Other||Tumour history||Participants|Number|4|4.0||||||
4261541|NCT00608868|4086112|B1|Squamous carcinoma||Tumour history||Participants|Number|13|13.0||||||
4261542|NCT00608868|4086112|B1|Adenocarcinoma||Tumour history||Participants|Number|121|121.0||||||
4261543|NCT00608868|4086112|B1|Regular smoker||Smoking history||Participants|Number|4|4.0||||||
4261544|NCT00608868|4086112|B1|Ex-smoker||Smoking history||Participants|Number|17|17.0||||||
4261545|NCT00608868|4086112|B1|Never-smoker||Smoking history||Participants|Number|117|117.0||||||
4261546|NCT00608868|4086112|B1|Unknown||EGFR mutation status|Epidermal growth factor receptor (EGFR) mutation analysis, PCR test on exon 18, 19 and 21 of EGFR gene was used.|Participants|Number|29|29.0||||||
4261547|NCT00608868|4086112|B1|Negative||EGFR mutation status|Epidermal growth factor receptor (EGFR) mutation analysis, PCR test on exon 18, 19 and 21 of EGFR gene was used.|Participants|Number|50|50.0||||||
4261548|NCT00608868|4086112|B1|Positive||EGFR mutation status|Epidermal growth factor receptor (EGFR) mutation analysis, PCR test on exon 18, 19 and 21 of EGFR gene was used.|Participants|Number|59|59.0||||||
4261549|NCT00608868|4086112|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4261550|NCT00608868|4086112|B1||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4261551|NCT00608868|4086112|B1|>= 65 years||Age, Customized||participants|Number|66|66.0||||||
4261552|NCT00608868|4086112|B1|< 65 years||Age, Customized||participants|Number|72|72.0||||||
4261553|NCT00608842|4086119|B5||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4261554|NCT00608842|4086120|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4261555|NCT00608842|4086121|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4261556|NCT00608842|4086122|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4261557|NCT00608842|4086123|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4261558|NCT00608842|4086119|B5||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4261559|NCT00608842|4086120|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4261560|NCT00608842|4086121|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4261561|NCT00608842|4086122|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4261562|NCT00608842|4086123|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4261563|NCT00608842|4086119|B5|||Age||years|Mean|47.2|47.2|Standard Deviation|9.4|9.4|||
4261564|NCT00608842|4086120|B4|||Age||years|Mean|45.5|45.5|Standard Deviation|8.9|8.9|||
4261565|NCT00608842|4086121|B3|||Age||years|Mean|49.5|49.5|Standard Deviation|10.5|10.5|||
4261566|NCT00608842|4086122|B2|||Age||years|Mean|48.5|48.5|Standard Deviation|9.1|9.1|||
4261567|NCT00608842|4086123|B1|||Age||years|Mean|45.9|45.9|Standard Deviation|9.5|9.5|||
4261568|NCT00608829|4086160|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4261569|NCT00608829|4086160|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4261570|NCT00608829|4086160|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4261571|NCT00608829|4086160|B1|||Age||years|Mean|77.6|77.6|Standard Deviation|6.2|6.2|||
4261572|NCT00608777|4086164|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4261573|NCT00608777|4086164|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4261574|NCT00608777|4086164|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4261575|NCT00608777|4086164|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4261576|NCT00608777|4086164|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4261577|NCT00608777|4086164|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4261578|NCT00608777|4086164|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4261579|NCT00608777|4086164|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4261580|NCT00608777|4086164|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4261581|NCT00608634|4086168|B4|United States||Region of Enrollment||participants|Number|83|83.0||||||
4261582|NCT00608634|4086169|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
4261583|NCT00608634|4086170|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4261584|NCT00608634|4086171|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4261585|NCT00608634|4086168|B4||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4261586|NCT00608634|4086169|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4261587|NCT00608634|4086170|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4261588|NCT00608634|4086171|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4261589|NCT00608634|4086168|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4261590|NCT00608634|4086169|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4261591|NCT00608634|4086170|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4261592|NCT00608634|4086171|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4261593|NCT00608634|4086168|B4|||Age||years|Mean|67.7|67.7|Standard Deviation|10.4|10.4|||
4261594|NCT00608634|4086169|B3|||Age||years|Mean|67.6|67.6|Standard Deviation|10.9|10.9|||
4261595|NCT00608634|4086170|B2|||Age||years|Mean|68.8|68.8|Standard Deviation|10.6|10.6|||
4261596|NCT00608634|4086171|B1|||Age||years|Mean|66.9|66.9|Standard Deviation|9.9|9.9|||
4261597|NCT00608634|4086168|B4||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
4261598|NCT00608634|4086169|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4261599|NCT00608634|4086170|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4261600|NCT00608634|4086171|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4261601|NCT00608634|4086168|B4||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4261602|NCT00608634|4086169|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4261603|NCT00608634|4086170|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4261604|NCT00608634|4086171|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4261605|NCT00608634|4086168|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4261606|NCT00608634|4086169|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4261607|NCT00608634|4086170|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4261608|NCT00608634|4086171|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4261609|NCT00608582|4086184|B3|||Months Poststroke Onset|Number of months at entry after stroke|months|Mean|59|59.0|Standard Deviation|39|39.0|||
4261610|NCT00608582|4086185|B2|||Months Poststroke Onset|Number of months at entry after stroke|months|Mean|51|51.0|Standard Deviation|37|37.0|||
4261611|NCT00608582|4086186|B1|||Months Poststroke Onset|Number of months at entry after stroke|months|Mean|66|66.0|Standard Deviation|40|40.0|||
4261612|NCT00608582|4086184|B3|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4261613|NCT00608582|4086185|B2|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4261614|NCT00608582|4086186|B1|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4261615|NCT00608582|4086184|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261616|NCT00608582|4086185|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261617|NCT00608582|4086186|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261618|NCT00608582|4086184|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261619|NCT00608582|4086185|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261620|NCT00608582|4086186|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261621|NCT00608582|4086184|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4261622|NCT00608582|4086185|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4261623|NCT00608582|4086186|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4261624|NCT00608582|4086184|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4261625|NCT00608582|4086185|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261626|NCT00608582|4086186|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4261627|NCT00608582|4086184|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261628|NCT00608582|4086185|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261629|NCT00608582|4086186|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261630|NCT00608582|4086184|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261631|NCT00608582|4086185|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261632|NCT00608582|4086186|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261633|NCT00608582|4086184|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261634|NCT00608582|4086185|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261635|NCT00608582|4086186|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261636|NCT00608582|4086184|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261637|NCT00608582|4086185|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261638|NCT00608582|4086186|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261639|NCT00608582|4086184|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4261640|NCT00608582|4086185|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4261641|NCT00608582|4086186|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4261642|NCT00608582|4086184|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4261643|NCT00608582|4086185|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4261644|NCT00608582|4086186|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261645|NCT00608582|4086184|B3||Male|Gender||Participants|Count of Participants|20|20.0||||||
4261646|NCT00608582|4086185|B2||Male|Gender||Participants|Count of Participants|9|9.0||||||
4261647|NCT00608582|4086186|B1||Male|Gender||Participants|Count of Participants|11|11.0||||||
4261648|NCT00608582|4086184|B3||Female|Gender||Participants|Count of Participants|5|5.0||||||
4261649|NCT00608582|4086185|B2||Female|Gender||Participants|Count of Participants|2|2.0||||||
4261650|NCT00608582|4086186|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
4261651|NCT00608582|4086184|B3|||Age||years|Mean|59.28|59.28|Standard Deviation|9.1|9.1|||
4261652|NCT00608582|4086185|B2|||Age||years|Mean|60.8|60.8|Standard Deviation|11|11.0|||
4261653|NCT00608582|4086186|B1|||Age||years|Mean|58.1|58.1|Standard Deviation|7.6|7.6|||
4261654|NCT00608569|4086195|B3|>=500000 copies/mL||HIV-1 RNA Viral Load Category||participants|Number|10|10.0||||||
4261655|NCT00608569|4086196|B2|>=500000 copies/mL||HIV-1 RNA Viral Load Category||participants|Number|4|4.0||||||
4261656|NCT00608569|4086197|B1|>=500000 copies/mL||HIV-1 RNA Viral Load Category||participants|Number|6|6.0||||||
4261657|NCT00608569|4086195|B3|100000-499999 copies/mL||HIV-1 RNA Viral Load Category||participants|Number|41|41.0||||||
4261658|NCT00608569|4086196|B2|100000-499999 copies/mL||HIV-1 RNA Viral Load Category||participants|Number|24|24.0||||||
4261659|NCT00608569|4086197|B1|100000-499999 copies/mL||HIV-1 RNA Viral Load Category||participants|Number|17|17.0||||||
4261660|NCT00608569|4086195|B3|10000-99999 copies/mL||HIV-1 RNA Viral Load Category||participants|Number|109|109.0||||||
4261661|NCT00608569|4086196|B2|10000-99999 copies/mL||HIV-1 RNA Viral Load Category||participants|Number|55|55.0||||||
4261662|NCT00608569|4086197|B1|10000-99999 copies/mL||HIV-1 RNA Viral Load Category||participants|Number|54|54.0||||||
4261663|NCT00608569|4086195|B3|1000-9999 copies/mL||HIV-1 RNA Viral Load Category||participants|Number|80|80.0||||||
4261664|NCT00608569|4086196|B2|1000-9999 copies/mL||HIV-1 RNA Viral Load Category||participants|Number|38|38.0||||||
4261665|NCT00608569|4086197|B1|1000-9999 copies/mL||HIV-1 RNA Viral Load Category||participants|Number|42|42.0||||||
4261666|NCT00608569|4086195|B3|401-999 copies/mL||HIV-1 RNA Viral Load Category||participants|Number|6|6.0||||||
4261667|NCT00608569|4086196|B2|401-999 copies/mL||HIV-1 RNA Viral Load Category||participants|Number|2|2.0||||||
4261668|NCT00608569|4086197|B1|401-999 copies/mL||HIV-1 RNA Viral Load Category||participants|Number|4|4.0||||||
4261669|NCT00608569|4086195|B3|<=400 copies/mL||HIV-1 RNA Viral Load Category||participants|Number|11|11.0||||||
4261670|NCT00608569|4086196|B2|<=400 copies/mL||HIV-1 RNA Viral Load Category||participants|Number|5|5.0||||||
4261671|NCT00608569|4086197|B1|<=400 copies/mL||HIV-1 RNA Viral Load Category||participants|Number|6|6.0||||||
4261730|NCT00608569|4086196|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4261672|NCT00608569|4086195|B3|||Log10 HIV-1 RNA Viral Load|The baseline HIV-1 RNA value is the result at study entry.|log10 copies/mL|Median|4.3|4.3|Inter-Quartile Range|||3.8|4.9|
4261673|NCT00608569|4086196|B2|||Log10 HIV-1 RNA Viral Load|The baseline HIV-1 RNA value is the result at study entry.|log10 copies/mL|Median|4.3|4.3|Inter-Quartile Range|||3.8|4.9|
4261674|NCT00608569|4086197|B1|||Log10 HIV-1 RNA Viral Load|The baseline HIV-1 RNA value is the result at study entry.|log10 copies/mL|Median|4.2|4.2|Inter-Quartile Range|||3.8|4.9|
4261675|NCT00608569|4086195|B3|>500 cells/mm3||CD4 Count Category||participants|Number|13|13.0||||||
4261676|NCT00608569|4086196|B2|>500 cells/mm3||CD4 Count Category||participants|Number|5|5.0||||||
4261677|NCT00608569|4086197|B1|>500 cells/mm3||CD4 Count Category||participants|Number|8|8.0||||||
4261678|NCT00608569|4086195|B3|351-500 cells/mm3||CD4 Count Category||participants|Number|21|21.0||||||
4261679|NCT00608569|4086196|B2|351-500 cells/mm3||CD4 Count Category||participants|Number|12|12.0||||||
4261680|NCT00608569|4086197|B1|351-500 cells/mm3||CD4 Count Category||participants|Number|9|9.0||||||
4261681|NCT00608569|4086195|B3|201-350 cells/mm3||CD4 Count Category||participants|Number|82|82.0||||||
4261682|NCT00608569|4086196|B2|201-350 cells/mm3||CD4 Count Category||participants|Number|47|47.0||||||
4261683|NCT00608569|4086197|B1|201-350 cells/mm3||CD4 Count Category||participants|Number|35|35.0||||||
4261684|NCT00608569|4086195|B3|101-200 cells/mm3||CD4 Count Category||participants|Number|71|71.0||||||
4261685|NCT00608569|4086196|B2|101-200 cells/mm3||CD4 Count Category||participants|Number|31|31.0||||||
4261686|NCT00608569|4086197|B1|101-200 cells/mm3||CD4 Count Category||participants|Number|40|40.0||||||
4261687|NCT00608569|4086195|B3|51-100 cells/mm3||CD4 Count Category||participants|Number|39|39.0||||||
4261688|NCT00608569|4086196|B2|51-100 cells/mm3||CD4 Count Category||participants|Number|19|19.0||||||
4261689|NCT00608569|4086197|B1|51-100 cells/mm3||CD4 Count Category||participants|Number|20|20.0||||||
4261690|NCT00608569|4086195|B3|0-50 cells/mm3||CD4 Count Category||participants|Number|31|31.0||||||
4261691|NCT00608569|4086196|B2|0-50 cells/mm3||CD4 Count Category||participants|Number|14|14.0||||||
4261692|NCT00608569|4086197|B1|0-50 cells/mm3||CD4 Count Category||participants|Number|17|17.0||||||
4261693|NCT00608569|4086195|B3|||CD4 Counts|The baseline CD4 count is the average of screening and entry values.|cells/mm3|Median|179|179.0|Inter-Quartile Range|||92.0|269.0|
4261694|NCT00608569|4086196|B2|||CD4 Counts|The baseline CD4 count is the average of screening and entry values.|cells/mm3|Median|201|201.0|Inter-Quartile Range|||97.0|292.0|
4261695|NCT00608569|4086197|B1|||CD4 Counts|The baseline CD4 count is the average of screening and entry values.|cells/mm3|Median|164|164.0|Inter-Quartile Range|||91.0|250.0|
4261696|NCT00608569|4086195|B3|Brazil||Region of Enrollment||participants|Number|6|6.0||||||
4261697|NCT00608569|4086196|B2|Brazil||Region of Enrollment||participants|Number|2|2.0||||||
4261698|NCT00608569|4086197|B1|Brazil||Region of Enrollment||participants|Number|4|4.0||||||
4261699|NCT00608569|4086195|B3|Zimbabwe||Region of Enrollment||participants|Number|33|33.0||||||
4261700|NCT00608569|4086196|B2|Zimbabwe||Region of Enrollment||participants|Number|16|16.0||||||
4261701|NCT00608569|4086197|B1|Zimbabwe||Region of Enrollment||participants|Number|17|17.0||||||
4261702|NCT00608569|4086195|B3|South Africa||Region of Enrollment||participants|Number|32|32.0||||||
4261703|NCT00608569|4086196|B2|South Africa||Region of Enrollment||participants|Number|17|17.0||||||
4261704|NCT00608569|4086197|B1|South Africa||Region of Enrollment||participants|Number|15|15.0||||||
4261705|NCT00608569|4086195|B3|Uganda||Region of Enrollment||participants|Number|50|50.0||||||
4261706|NCT00608569|4086196|B2|Uganda||Region of Enrollment||participants|Number|25|25.0||||||
4261707|NCT00608569|4086197|B1|Uganda||Region of Enrollment||participants|Number|25|25.0||||||
4261708|NCT00608569|4086195|B3|Peru||Region of Enrollment||participants|Number|46|46.0||||||
4261709|NCT00608569|4086196|B2|Peru||Region of Enrollment||participants|Number|23|23.0||||||
4261710|NCT00608569|4086197|B1|Peru||Region of Enrollment||participants|Number|23|23.0||||||
4261711|NCT00608569|4086195|B3|Botswana||Region of Enrollment||participants|Number|8|8.0||||||
4261712|NCT00608569|4086196|B2|Botswana||Region of Enrollment||participants|Number|4|4.0||||||
4261713|NCT00608569|4086197|B1|Botswana||Region of Enrollment||participants|Number|4|4.0||||||
4261714|NCT00608569|4086195|B3|Zambia||Region of Enrollment||participants|Number|9|9.0||||||
4261715|NCT00608569|4086196|B2|Zambia||Region of Enrollment||participants|Number|5|5.0||||||
4261716|NCT00608569|4086197|B1|Zambia||Region of Enrollment||participants|Number|4|4.0||||||
4261717|NCT00608569|4086195|B3|Haiti||Region of Enrollment||participants|Number|73|73.0||||||
4261718|NCT00608569|4086196|B2|Haiti||Region of Enrollment||participants|Number|36|36.0||||||
4261719|NCT00608569|4086197|B1|Haiti||Region of Enrollment||participants|Number|37|37.0||||||
4261720|NCT00608569|4086195|B3|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4261721|NCT00608569|4086196|B2|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4261722|NCT00608569|4086197|B1|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4261723|NCT00608569|4086195|B3|Hispanic (regardless of race)||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
4261724|NCT00608569|4086196|B2|Hispanic (regardless of race)||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4261725|NCT00608569|4086197|B1|Hispanic (regardless of race)||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4261726|NCT00608569|4086195|B3|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|204|204.0||||||
4261727|NCT00608569|4086196|B2|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|103|103.0||||||
4261728|NCT00608569|4086197|B1|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|101|101.0||||||
4261729|NCT00608569|4086195|B3||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4261731|NCT00608569|4086197|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4261732|NCT00608569|4086195|B3||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4261733|NCT00608569|4086196|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4261734|NCT00608569|4086197|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4261735|NCT00608569|4086195|B3|||Age||years|Mean|39.4|39.4|Standard Deviation|10.1|10.1|||
4261736|NCT00608569|4086196|B2|||Age||years|Mean|39.4|39.4|Standard Deviation|10.6|10.6|||
4261737|NCT00608569|4086197|B1|||Age||years|Mean|39.3|39.3|Standard Deviation|9.7|9.7|||
4261738|NCT00608569|4086195|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4261739|NCT00608569|4086196|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4261740|NCT00608569|4086197|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4261741|NCT00608569|4086195|B3||Between 18 and 65 years|Age||Participants|Count of Participants|250|250.0||||||
4261742|NCT00608569|4086196|B2||Between 18 and 65 years|Age||Participants|Count of Participants|123|123.0||||||
4261743|NCT00608569|4086197|B1||Between 18 and 65 years|Age||Participants|Count of Participants|127|127.0||||||
4261744|NCT00608569|4086195|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4261745|NCT00608569|4086196|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4261746|NCT00608569|4086197|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4261747|NCT00608543|4086218|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4261748|NCT00608543|4086218|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4261749|NCT00608543|4086218|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4261750|NCT00608543|4086218|B1|||Age||years|Mean|48.18|48.18|Standard Deviation|7.95|7.95|||
4261751|NCT00608543|4086218|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4261752|NCT00608543|4086218|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4261753|NCT00608543|4086218|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4261754|NCT00608530|4086227|B5|United States||Region of Enrollment||participants|Number|59|59.0||||||
4261755|NCT00608530|4086228|B4|United States||Region of Enrollment||participants|Number|31|31.0||||||
4261756|NCT00608530|4086229|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4261757|NCT00608530|4086230|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4261758|NCT00608530|4086231|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4261759|NCT00608530|4086227|B5||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4261760|NCT00608530|4086228|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4261761|NCT00608530|4086229|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4261762|NCT00608530|4086230|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4261763|NCT00608530|4086231|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4261764|NCT00608530|4086227|B5||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4261765|NCT00608530|4086228|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4261766|NCT00608530|4086229|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4261767|NCT00608530|4086230|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4261768|NCT00608530|4086231|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4261769|NCT00608530|4086227|B5|||Age||years|Mean|53.3|53.3|Standard Deviation|13.6|13.6|||
4261770|NCT00608530|4086228|B4|||Age||years|Mean|64.3|64.3|Standard Deviation|12.7|12.7|||
4261771|NCT00608530|4086229|B3|||Age||years|Mean|62.5|62.5|Standard Deviation|11.3|11.3|||
4261772|NCT00608530|4086230|B2|||Age||years|Mean|54.0|54.0|Standard Deviation|14.8|14.8|||
4261773|NCT00608530|4086231|B1|||Age||years|Mean|52.6|52.6|Standard Deviation|12.5|12.5|||
4261774|NCT00608517|4086252|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
4261775|NCT00608517|4086253|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4261776|NCT00608517|4086254|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4261777|NCT00608517|4086255|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4261778|NCT00608517|4086252|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4261779|NCT00608517|4086253|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4261780|NCT00608517|4086254|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4261781|NCT00608517|4086255|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4261782|NCT00608517|4086252|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4261783|NCT00608517|4086253|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4261784|NCT00608517|4086254|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4261785|NCT00608517|4086255|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4261786|NCT00608517|4086252|B4|||Age||years|Mean|31|31.0|Standard Deviation|1|1.0|||
4261787|NCT00608517|4086253|B3|||Age||years|Mean|42|42.0|Standard Deviation|1|1.0|||
4261788|NCT00608517|4086254|B2|||Age||years|Mean|31|31.0|Standard Deviation|1|1.0|||
4261789|NCT00608517|4086255|B1|||Age||years|Mean|8|8.0|Standard Deviation|1|1.0|||
4261790|NCT00608517|4086252|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4261791|NCT00608517|4086253|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4261792|NCT00608517|4086254|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4261793|NCT00608517|4086255|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4261794|NCT00608517|4086252|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4261795|NCT00608517|4086253|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4261796|NCT00608517|4086254|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4261797|NCT00608517|4086255|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4261798|NCT00608517|4086252|B4||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4261799|NCT00608517|4086253|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4261800|NCT00608517|4086254|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4261801|NCT00608517|4086255|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4261802|NCT00608491|4086283|B3||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4261803|NCT00608491|4086284|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4261804|NCT00608491|4086285|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4261805|NCT00608491|4086283|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4261806|NCT00608491|4086284|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4261807|NCT00608491|4086285|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4261808|NCT00608491|4086283|B3|||Age||years|Mean|68.0|68.0|Standard Deviation|12.9|12.9|||
4261809|NCT00608491|4086284|B2|||Age||years|Mean|68.9|68.9|Standard Deviation|12.0|12.0|||
4261810|NCT00608491|4086285|B1|||Age||years|Mean|67.1|67.1|Standard Deviation|13.7|13.7|||
4261811|NCT00608491|4086283|B3||>=65 years|Age||Participants|Count of Participants|111|111.0||||||
4261812|NCT00608491|4086284|B2||>=65 years|Age||Participants|Count of Participants|59|59.0||||||
4261813|NCT00608491|4086285|B1||>=65 years|Age||Participants|Count of Participants|52|52.0||||||
4261814|NCT00608491|4086283|B3||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
4261815|NCT00608491|4086284|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4261816|NCT00608491|4086285|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4261817|NCT00608491|4086283|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4261818|NCT00608491|4086284|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4261819|NCT00608491|4086285|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4261820|NCT00608465|4086430|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4261821|NCT00608465|4086430|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4261822|NCT00608465|4086430|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4261823|NCT00608465|4086430|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4261824|NCT00608465|4086430|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4261825|NCT00608465|4086430|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4261826|NCT00608426|4086435|B3|No||Other substance use disorder||participants|Number|4108|4108.0||||||
4261827|NCT00608426|4086436|B2|No||Other substance use disorder||participants|Number|2038|2038.0||||||
4261828|NCT00608426|4086437|B1|No||Other substance use disorder||participants|Number|2070|2070.0||||||
4261829|NCT00608426|4086435|B3|Yes||Other substance use disorder||participants|Number|1015|1015.0||||||
4261830|NCT00608426|4086436|B2|Yes||Other substance use disorder||participants|Number|481|481.0||||||
4261831|NCT00608426|4086437|B1|Yes||Other substance use disorder||participants|Number|534|534.0||||||
4261832|NCT00608426|4086435|B3|No||Other psychiatric disorder||participants|Number|4277|4277.0||||||
4261833|NCT00608426|4086436|B2|No||Other psychiatric disorder||participants|Number|2103|2103.0||||||
4261834|NCT00608426|4086437|B1|No||Other psychiatric disorder||participants|Number|2174|2174.0||||||
4261835|NCT00608426|4086435|B3|Yes||Other psychiatric disorder||participants|Number|846|846.0||||||
4261836|NCT00608426|4086436|B2|Yes||Other psychiatric disorder||participants|Number|416|416.0||||||
4261837|NCT00608426|4086437|B1|Yes||Other psychiatric disorder||participants|Number|430|430.0||||||
4261838|NCT00608426|4086435|B3|No||Serious mental illness||participants|Number|4785|4785.0||||||
4261839|NCT00608426|4086436|B2|No||Serious mental illness||participants|Number|2358|2358.0||||||
4261840|NCT00608426|4086437|B1|No||Serious mental illness||participants|Number|2427|2427.0||||||
4261841|NCT00608426|4086435|B3|Yes||Serious mental illness||participants|Number|338|338.0||||||
4261842|NCT00608426|4086436|B2|Yes||Serious mental illness||participants|Number|161|161.0||||||
4261843|NCT00608426|4086437|B1|Yes||Serious mental illness||participants|Number|177|177.0||||||
4261844|NCT00608426|4086435|B3|No||Post-traumatic stress disorder||participants|Number|4691|4691.0||||||
4261845|NCT00608426|4086436|B2|No||Post-traumatic stress disorder||participants|Number|2303|2303.0||||||
4261846|NCT00608426|4086437|B1|No||Post-traumatic stress disorder||participants|Number|2388|2388.0||||||
4261847|NCT00608426|4086435|B3|Yes||Post-traumatic stress disorder||participants|Number|432|432.0||||||
4261848|NCT00608426|4086436|B2|Yes||Post-traumatic stress disorder||participants|Number|216|216.0||||||
4261849|NCT00608426|4086437|B1|Yes||Post-traumatic stress disorder||participants|Number|216|216.0||||||
4261850|NCT00608426|4086435|B3|No||Anxiety Disorder||participants|Number|4587|4587.0||||||
4261851|NCT00608426|4086436|B2|No||Anxiety Disorder||participants|Number|2230|2230.0||||||
4261852|NCT00608426|4086437|B1|No||Anxiety Disorder||participants|Number|2357|2357.0||||||
4261853|NCT00608426|4086435|B3|Yes||Anxiety Disorder||participants|Number|536|536.0||||||
4261854|NCT00608426|4086436|B2|Yes||Anxiety Disorder||participants|Number|289|289.0||||||
4261855|NCT00608426|4086437|B1|Yes||Anxiety Disorder||participants|Number|247|247.0||||||
4261856|NCT00608426|4086435|B3|No||Depression||participants|Number|4006|4006.0||||||
4261857|NCT00608426|4086436|B2|No||Depression||participants|Number|1967|1967.0||||||
4261858|NCT00608426|4086437|B1|No||Depression||participants|Number|2039|2039.0||||||
4261859|NCT00608426|4086435|B3|Yes||Depression||participants|Number|1117|1117.0||||||
4261860|NCT00608426|4086436|B2|Yes||Depression||participants|Number|552|552.0||||||
4261861|NCT00608426|4086437|B1|Yes||Depression||participants|Number|565|565.0||||||
4261862|NCT00608426|4086435|B3|Two or more||Presence of psychiatric co-morbidity||participants|Number|1188|1188.0||||||
4261863|NCT00608426|4086436|B2|Two or more||Presence of psychiatric co-morbidity||participants|Number|579|579.0||||||
4261864|NCT00608426|4086437|B1|Two or more||Presence of psychiatric co-morbidity||participants|Number|609|609.0||||||
4261865|NCT00608426|4086435|B3|One||Presence of psychiatric co-morbidity||participants|Number|1217|1217.0||||||
4261866|NCT00608426|4086436|B2|One||Presence of psychiatric co-morbidity||participants|Number|605|605.0||||||
4261867|NCT00608426|4086437|B1|One||Presence of psychiatric co-morbidity||participants|Number|612|612.0||||||
4261868|NCT00608426|4086435|B3|None||Presence of psychiatric co-morbidity||participants|Number|2718|2718.0||||||
4261869|NCT00608426|4086436|B2|None||Presence of psychiatric co-morbidity||participants|Number|1335|1335.0||||||
4261870|NCT00608426|4086437|B1|None||Presence of psychiatric co-morbidity||participants|Number|1383|1383.0||||||
4261871|NCT00608426|4086435|B3|No||Smoking related respiratory disease||participants|Number|4165|4165.0||||||
4261872|NCT00608426|4086436|B2|No||Smoking related respiratory disease||participants|Number|2061|2061.0||||||
4261873|NCT00608426|4086437|B1|No||Smoking related respiratory disease||participants|Number|2104|2104.0||||||
4261874|NCT00608426|4086435|B3|Yes||Smoking related respiratory disease||participants|Number|958|958.0||||||
4261875|NCT00608426|4086436|B2|Yes||Smoking related respiratory disease||participants|Number|458|458.0||||||
4261876|NCT00608426|4086437|B1|Yes||Smoking related respiratory disease||participants|Number|500|500.0||||||
4261877|NCT00608426|4086435|B3|No||Smoking related cardiovascular disease||participants|Number|3743|3743.0||||||
4261878|NCT00608426|4086436|B2|No||Smoking related cardiovascular disease||participants|Number|1842|1842.0||||||
4261879|NCT00608426|4086437|B1|No||Smoking related cardiovascular disease||participants|Number|1901|1901.0||||||
4261880|NCT00608426|4086435|B3|Yes||Smoking related cardiovascular disease||participants|Number|1380|1380.0||||||
4261881|NCT00608426|4086436|B2|Yes||Smoking related cardiovascular disease||participants|Number|677|677.0||||||
4261882|NCT00608426|4086437|B1|Yes||Smoking related cardiovascular disease||participants|Number|703|703.0||||||
4261883|NCT00608426|4086435|B3|No cancer||Smoking related cancer||participants|Number|4995|4995.0||||||
4261884|NCT00608426|4086436|B2|No cancer||Smoking related cancer||participants|Number|2448|2448.0||||||
4261885|NCT00608426|4086437|B1|No cancer||Smoking related cancer||participants|Number|2547|2547.0||||||
4261886|NCT00608426|4086435|B3|Cancer||Smoking related cancer||participants|Number|128|128.0||||||
4261887|NCT00608426|4086436|B2|Cancer||Smoking related cancer||participants|Number|71|71.0||||||
4261888|NCT00608426|4086437|B1|Cancer||Smoking related cancer||participants|Number|57|57.0||||||
4261889|NCT00608426|4086435|B3|>50||Distance to the VA hospital, miles||participants|Number|1588|1588.0||||||
4261890|NCT00608426|4086436|B2|>50||Distance to the VA hospital, miles||participants|Number|791|791.0||||||
4261891|NCT00608426|4086437|B1|>50||Distance to the VA hospital, miles||participants|Number|797|797.0||||||
4261892|NCT00608426|4086435|B3|>25-50||Distance to the VA hospital, miles||participants|Number|861|861.0||||||
4261893|NCT00608426|4086436|B2|>25-50||Distance to the VA hospital, miles||participants|Number|436|436.0||||||
4261894|NCT00608426|4086437|B1|>25-50||Distance to the VA hospital, miles||participants|Number|425|425.0||||||
4261895|NCT00608426|4086435|B3|>10-25||Distance to the VA hospital, miles||participants|Number|1360|1360.0||||||
4261896|NCT00608426|4086436|B2|>10-25||Distance to the VA hospital, miles||participants|Number|662|662.0||||||
4261897|NCT00608426|4086437|B1|>10-25||Distance to the VA hospital, miles||participants|Number|698|698.0||||||
4261898|NCT00608426|4086435|B3|5-10||Distance to the VA hospital, miles||participants|Number|928|928.0||||||
4261899|NCT00608426|4086436|B2|5-10||Distance to the VA hospital, miles||participants|Number|456|456.0||||||
4261900|NCT00608426|4086437|B1|5-10||Distance to the VA hospital, miles||participants|Number|472|472.0||||||
4261901|NCT00608426|4086435|B3|<5||Distance to the VA hospital, miles||participants|Number|386|386.0||||||
4261902|NCT00608426|4086436|B2|<5||Distance to the VA hospital, miles||participants|Number|174|174.0||||||
4261903|NCT00608426|4086437|B1|<5||Distance to the VA hospital, miles||participants|Number|212|212.0||||||
4261904|NCT00608426|4086435|B3|Not Married||Married||participants|Number|2859|2859.0||||||
4261905|NCT00608426|4086436|B2|Not Married||Married||participants|Number|1411|1411.0||||||
4261906|NCT00608426|4086437|B1|Not Married||Married||participants|Number|1448|1448.0||||||
4261907|NCT00608426|4086435|B3|Married||Married||participants|Number|2264|2264.0||||||
4261908|NCT00608426|4086436|B2|Married||Married||participants|Number|1108|1108.0||||||
4261909|NCT00608426|4086437|B1|Married||Married||participants|Number|1156|1156.0||||||
4261910|NCT00608426|4086435|B3|Other||Race/Ethnicity, Customized||participants|Number|413|413.0||||||
4261911|NCT00608426|4086436|B2|Other||Race/Ethnicity, Customized||participants|Number|210|210.0||||||
4261912|NCT00608426|4086437|B1|Other||Race/Ethnicity, Customized||participants|Number|203|203.0||||||
4261913|NCT00608426|4086435|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|231|231.0||||||
4261914|NCT00608426|4086436|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|111|111.0||||||
4261915|NCT00608426|4086437|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|120|120.0||||||
4261916|NCT00608426|4086435|B3|Black||Race/Ethnicity, Customized||participants|Number|1163|1163.0||||||
4261917|NCT00608426|4086436|B2|Black||Race/Ethnicity, Customized||participants|Number|595|595.0||||||
4261918|NCT00608426|4086437|B1|Black||Race/Ethnicity, Customized||participants|Number|568|568.0||||||
4261919|NCT00608426|4086435|B3|White||Race/Ethnicity, Customized||participants|Number|3316|3316.0||||||
4261920|NCT00608426|4086436|B2|White||Race/Ethnicity, Customized||participants|Number|1603|1603.0||||||
4261921|NCT00608426|4086437|B1|White||Race/Ethnicity, Customized||participants|Number|1713|1713.0||||||
4261922|NCT00608426|4086435|B3||Male|Sex: Female, Male||Participants|Count of Participants|4824|4824.0||||||
4261923|NCT00608426|4086436|B2||Male|Sex: Female, Male||Participants|Count of Participants|2378|2378.0||||||
4261924|NCT00608426|4086437|B1||Male|Sex: Female, Male||Participants|Count of Participants|2446|2446.0||||||
4261925|NCT00608426|4086435|B3||Female|Sex: Female, Male||Participants|Count of Participants|299|299.0||||||
4261926|NCT00608426|4086436|B2||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4261927|NCT00608426|4086437|B1||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4261928|NCT00608426|4086435|B3|||Age||years|Mean|56.1|56.1|Standard Deviation|14.3|14.3|||
4261929|NCT00608426|4086436|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|15.1|15.1|||
4261930|NCT00608426|4086437|B1|||Age||years|Mean|56.4|56.4|Standard Deviation|10.2|10.2|||
4261931|NCT00608322|4086448|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
4261932|NCT00608322|4086449|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4261933|NCT00608322|4086450|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4261934|NCT00608322|4086448|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4261935|NCT00608322|4086449|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4261936|NCT00608322|4086450|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4261937|NCT00608322|4086448|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4261938|NCT00608322|4086449|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4261939|NCT00608322|4086450|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4261940|NCT00608322|4086448|B3|||Age||years|Mean|58|58.0|Standard Deviation|17|17.0|||
4261941|NCT00608322|4086449|B2|||Age||years|Mean|58|58.0|Standard Deviation|20|20.0|||
4261942|NCT00608322|4086450|B1|||Age||years|Mean|59|59.0|Standard Deviation|15|15.0|||
4261943|NCT00608322|4086448|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4261944|NCT00608322|4086449|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4261945|NCT00608322|4086450|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4261946|NCT00608322|4086448|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4261947|NCT00608322|4086449|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4261948|NCT00608322|4086450|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4261949|NCT00608322|4086448|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4261950|NCT00608322|4086449|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4261951|NCT00608322|4086450|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4261952|NCT00608244|4086457|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
4261953|NCT00608244|4086457|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261954|NCT00608244|4086457|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4261955|NCT00608244|4086457|B1||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4261956|NCT00608244|4086457|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4261957|NCT00608244|4086457|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4261958|NCT00608244|4086457|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4261959|NCT00608244|4086457|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4261960|NCT00608244|4086457|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4261961|NCT00608244|4086457|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4261962|NCT00608244|4086457|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4261963|NCT00608244|4086457|B1||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4261964|NCT00608244|4086457|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4261965|NCT00608244|4086457|B1|||Age||years|Mean|49.8|49.8|Standard Deviation|11.15|11.15|||
4261966|NCT00608205|4086466|B3|United States||Region of Enrollment||participants|Number|69|69.0||||||
4261967|NCT00608205|4086467|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
4261968|NCT00608205|4086468|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4261969|NCT00608205|4086466|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261970|NCT00608205|4086467|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261971|NCT00608205|4086468|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261972|NCT00608205|4086466|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261973|NCT00608205|4086467|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261974|NCT00608205|4086468|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261975|NCT00608205|4086466|B3||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4261976|NCT00608205|4086467|B2||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4261977|NCT00608205|4086468|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4261978|NCT00608205|4086466|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4261979|NCT00608205|4086467|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4261980|NCT00608205|4086468|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261981|NCT00608205|4086466|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261982|NCT00608205|4086467|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261983|NCT00608205|4086468|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261984|NCT00608205|4086466|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261985|NCT00608205|4086467|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261986|NCT00608205|4086468|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261987|NCT00608205|4086466|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261988|NCT00608205|4086467|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261989|NCT00608205|4086468|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261990|NCT00608205|4086466|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261991|NCT00608205|4086467|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261992|NCT00608205|4086468|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261993|NCT00608205|4086466|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
4261994|NCT00608205|4086467|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4261995|NCT00608205|4086468|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4261996|NCT00608205|4086466|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261997|NCT00608205|4086467|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261998|NCT00608205|4086468|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4261999|NCT00608205|4086466|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4262000|NCT00608205|4086467|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4262001|NCT00608205|4086468|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4262002|NCT00608205|4086466|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4262003|NCT00608205|4086467|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4262004|NCT00608205|4086468|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4262005|NCT00608205|4086466|B3|70-79 years||Age, Customized||participants|Number|3|3.0||||||
4262006|NCT00608205|4086467|B2|70-79 years||Age, Customized||participants|Number|2|2.0||||||
4262007|NCT00608205|4086468|B1|70-79 years||Age, Customized||participants|Number|1|1.0||||||
4262008|NCT00608205|4086466|B3|60-69 years||Age, Customized||participants|Number|23|23.0||||||
4262009|NCT00608205|4086467|B2|60-69 years||Age, Customized||participants|Number|6|6.0||||||
4262010|NCT00608205|4086468|B1|60-69 years||Age, Customized||participants|Number|17|17.0||||||
4262011|NCT00608205|4086466|B3|50-59 years||Age, Customized||participants|Number|27|27.0||||||
4262012|NCT00608205|4086467|B2|50-59 years||Age, Customized||participants|Number|16|16.0||||||
4262013|NCT00608205|4086468|B1|50-59 years||Age, Customized||participants|Number|11|11.0||||||
4262014|NCT00608205|4086466|B3|40-49 years||Age, Customized||participants|Number|16|16.0||||||
4262015|NCT00608205|4086467|B2|40-49 years||Age, Customized||participants|Number|10|10.0||||||
4262016|NCT00608205|4086468|B1|40-49 years||Age, Customized||participants|Number|6|6.0||||||
4262017|NCT00608140|4086557|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4262018|NCT00608140|4086558|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4262019|NCT00608140|4086559|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4262020|NCT00608140|4086557|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4262021|NCT00608140|4086558|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4262022|NCT00608140|4086559|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4262023|NCT00608140|4086557|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4262024|NCT00608140|4086558|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4262025|NCT00608140|4086559|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4262026|NCT00608140|4086557|B3|||Age|Standard deviation for individual arms could not be calculated because only 1 participant was evaluated in each arm. Total SD was calculated.|years|Mean|64.25|64.25|Standard Deviation|1.49|1.49|||
4262027|NCT00608140|4086558|B2|||Age|Standard deviation for individual arms could not be calculated because only 1 participant was evaluated in each arm. Total SD was calculated.|years|Mean|63|63.0|Standard Deviation|||||
4262028|NCT00608140|4086559|B1|||Age|Standard deviation for individual arms could not be calculated because only 1 participant was evaluated in each arm. Total SD was calculated.|years|Mean|65.5|65.5|Standard Deviation|||||
4262029|NCT00608140|4086557|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4262030|NCT00608140|4086558|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4262031|NCT00608140|4086559|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4262032|NCT00608140|4086557|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4262033|NCT00608140|4086558|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4262034|NCT00608140|4086559|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4262035|NCT00608140|4086557|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4262036|NCT00608140|4086558|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4262037|NCT00608140|4086559|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4262038|NCT00608023|4086583|B4||Male|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
4262039|NCT00608023|4086584|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4262040|NCT00608023|4086585|B2||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4262041|NCT00608023|4086586|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4262042|NCT00608023|4086583|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4262043|NCT00608023|4086584|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4262044|NCT00608023|4086585|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4262045|NCT00608023|4086586|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4262046|NCT00608023|4086583|B4|||Age||years|Mean|48.3|48.3|Standard Deviation|7.3|7.3|||
4262047|NCT00608023|4086584|B3|||Age||years|Mean|48.4|48.4|Standard Deviation|7.9|7.9|||
4262048|NCT00608023|4086585|B2|||Age||years|Mean|48.9|48.9|Standard Deviation|7.2|7.2|||
4262049|NCT00608023|4086586|B1|||Age||years|Mean|47.7|47.7|Standard Deviation|6.9|6.9|||
4262050|NCT00607997|4086608|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4262051|NCT00607997|4086609|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4262052|NCT00607997|4086610|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4262053|NCT00607997|4086611|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4262054|NCT00607997|4086612|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4262055|NCT00607997|4086608|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4262056|NCT00607997|4086609|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4262057|NCT00607997|4086610|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4262058|NCT00607997|4086611|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4262059|NCT00607997|4086612|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4262060|NCT00607997|4086608|B5||White|Race (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
4262061|NCT00607997|4086609|B4||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4262062|NCT00607997|4086610|B3||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4262063|NCT00607997|4086611|B2||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4262064|NCT00607997|4086612|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4262065|NCT00607997|4086608|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4262066|NCT00607997|4086609|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4262067|NCT00607997|4086610|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4262068|NCT00607997|4086611|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4262069|NCT00607997|4086612|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4262070|NCT00607997|4086608|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4262071|NCT00607997|4086609|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4262072|NCT00607997|4086610|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4262073|NCT00607997|4086611|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4262074|NCT00607997|4086612|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4262075|NCT00607997|4086608|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4262076|NCT00607997|4086609|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4262077|NCT00607997|4086610|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4262078|NCT00607997|4086611|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4262079|NCT00607997|4086612|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4262080|NCT00607997|4086608|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4262081|NCT00607997|4086609|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4262082|NCT00607997|4086610|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4262083|NCT00607997|4086611|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4262084|NCT00607997|4086612|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4262085|NCT00607997|4086608|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4262086|NCT00607997|4086609|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4262087|NCT00607997|4086610|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4262088|NCT00607997|4086611|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4262089|NCT00607997|4086612|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4262090|NCT00607997|4086608|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
4262091|NCT00607997|4086609|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4262092|NCT00607997|4086610|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4262093|NCT00607997|4086611|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4262094|NCT00607997|4086612|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4262095|NCT00607997|4086608|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4262096|NCT00607997|4086609|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4262097|NCT00607997|4086610|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4262098|NCT00607997|4086611|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4262099|NCT00607997|4086612|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4262100|NCT00607997|4086608|B5||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4262101|NCT00607997|4086609|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4262102|NCT00607997|4086610|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4262103|NCT00607997|4086611|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4262104|NCT00607997|4086612|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4262105|NCT00607997|4086608|B5||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4262106|NCT00607997|4086609|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4262107|NCT00607997|4086610|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4262108|NCT00607997|4086611|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4262109|NCT00607997|4086612|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4262110|NCT00607997|4086608|B5|||Age||years|Mean|73.6|73.6|Standard Deviation|6.14|6.14|||
4262111|NCT00607997|4086609|B4|||Age||years|Mean|76.5|76.5|Standard Deviation|5.70|5.7|||
4262112|NCT00607997|4086610|B3|||Age||years|Mean|70.5|70.5|Standard Deviation|5.68|5.68|||
4262113|NCT00607997|4086611|B2|||Age||years|Mean|74.2|74.2|Standard Deviation|5.85|5.85|||
4262114|NCT00607997|4086612|B1|||Age||years|Mean|74.1|74.1|Standard Deviation|6.20|6.2|||
4262115|NCT00607919|4086671|B3|United States||Region of Enrollment||participants|Number|209|209.0||||||
4262116|NCT00607919|4086672|B2|United States||Region of Enrollment||participants|Number|89|89.0||||||
4262117|NCT00607919|4086673|B1|United States||Region of Enrollment||participants|Number|120|120.0||||||
4262118|NCT00607919|4086671|B3|West Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4262119|NCT00607919|4086672|B2|West Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4262120|NCT00607919|4086673|B1|West Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4262121|NCT00607919|4086671|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4262122|NCT00607919|4086672|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4262123|NCT00607919|4086673|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4262124|NCT00607919|4086671|B3|East Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4262125|NCT00607919|4086672|B2|East Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4262126|NCT00607919|4086673|B1|East Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4262127|NCT00607919|4086671|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|152|152.0||||||
4262128|NCT00607919|4086672|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
4262129|NCT00607919|4086673|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|86|86.0||||||
4262130|NCT00607919|4086671|B3|African||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4262131|NCT00607919|4086672|B2|African||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4262132|NCT00607919|4086673|B1|African||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4262133|NCT00607919|4086671|B3||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4262134|NCT00607919|4086672|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4262135|NCT00607919|4086673|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4262136|NCT00607919|4086671|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4262137|NCT00607919|4086672|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4262138|NCT00607919|4086673|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4262139|NCT00607919|4086671|B3|||Age||years|Mean|12.32|12.32|Standard Deviation|1.80|1.8|||
4262140|NCT00607919|4086672|B2|||Age||years|Mean|12.44|12.44|Standard Deviation|1.90|1.9|||
4262141|NCT00607919|4086673|B1|||Age||years|Mean|12.24|12.24|Standard Deviation|1.72|1.72|||
4262142|NCT00607893|4086730|B3|United States||Region of Enrollment||participants|Number|149|149.0||||||
4262143|NCT00607893|4086731|B2|United States||Region of Enrollment||participants|Number|74|74.0||||||
4262144|NCT00607893|4086732|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
4262145|NCT00607893|4086730|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4262146|NCT00607893|4086731|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4262147|NCT00607893|4086732|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4262148|NCT00607893|4086730|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|67|67.0||||||
4262149|NCT00607893|4086731|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
4262150|NCT00607893|4086732|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
4262151|NCT00607893|4086730|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|78|78.0||||||
4262152|NCT00607893|4086731|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
4262153|NCT00607893|4086732|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
4262154|NCT00607893|4086730|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4262155|NCT00607893|4086731|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4262156|NCT00607893|4086732|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4262157|NCT00607893|4086730|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4262158|NCT00607893|4086731|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4262159|NCT00607893|4086732|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4262160|NCT00607893|4086730|B3|||Age||years|Mean|51.0|51.0|Standard Deviation|11.7|11.7|||
4262161|NCT00607893|4086731|B2|||Age||years|Mean|51.7|51.7|Standard Deviation|11.8|11.8|||
4262162|NCT00607893|4086732|B1|||Age||years|Mean|50.3|50.3|Standard Deviation|11.7|11.7|||
4262163|NCT00607880|4086759|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
4262164|NCT00607880|4086760|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
4262165|NCT00607880|4086761|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4262166|NCT00607880|4086759|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4262167|NCT00607880|4086760|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4262168|NCT00607880|4086761|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4262169|NCT00607880|4086759|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4262170|NCT00607880|4086760|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4262171|NCT00607880|4086761|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4262172|NCT00607880|4086759|B3|||Age||years|Median|65|65.0|Full Range|||31.0|93.0|
4262173|NCT00607880|4086760|B2|||Age||years|Median|64|64.0|Full Range|||31.0|81.0|
4262174|NCT00607880|4086761|B1|||Age||years|Median|65|65.0|Full Range|||35.0|93.0|
4262175|NCT00607867|4086774|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4262176|NCT00607867|4086775|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4262177|NCT00607867|4086776|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4262178|NCT00607867|4086774|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4262179|NCT00607867|4086775|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4262180|NCT00607867|4086776|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4262181|NCT00607867|4086774|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4262182|NCT00607867|4086775|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4262183|NCT00607867|4086776|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4262184|NCT00607867|4086774|B3|||Age||years|Mean|61.6|61.6|Full Range|||51.0|71.0|
4262185|NCT00607867|4086775|B2|||Age||years|Mean|61|61.0|Full Range|||53.0|66.0|
4262186|NCT00607867|4086776|B1|||Age||years|Mean|62|62.0|Full Range|||51.0|71.0|
4262187|NCT00607815|4086793|B3|||State Trait Anger Expression Inventory|Self-reported state anxiety; higher is worse; scale score is summed; range at post-treatment is 20-73.|units on a scale|Mean|27.16|27.16|Standard Deviation|5.86|5.86|||
4262188|NCT00607815|4086794|B2|||State Trait Anger Expression Inventory|Self-reported state anxiety; higher is worse; scale score is summed; range at post-treatment is 20-73.|units on a scale|Mean|26.35|26.35|Standard Deviation|6.07|6.07|||
4262189|NCT00607815|4086795|B1|||State Trait Anger Expression Inventory|Self-reported state anxiety; higher is worse; scale score is summed; range at post-treatment is 20-73.|units on a scale|Mean|28.14|28.14|Standard Deviation|5.52|5.52|||
4262190|NCT00607815|4086793|B3|||State Trait Anxiety|Self-reported trait anger; subscale score is summed; higher is worse; range at post-treatment is 10-37.|units on a scale|Mean|43.17|43.17|Standard Deviation|4.84|4.84|||
4262191|NCT00607815|4086794|B2|||State Trait Anxiety|Self-reported trait anger; subscale score is summed; higher is worse; range at post-treatment is 10-37.|units on a scale|Mean|43.14|43.14|Standard Deviation|4.18|4.18|||
4262192|NCT00607815|4086795|B1|||State Trait Anxiety|Self-reported trait anger; subscale score is summed; higher is worse; range at post-treatment is 10-37.|units on a scale|Mean|43.19|43.19|Standard Deviation|5.60|5.6|||
4262193|NCT00607815|4086793|B3|||Beck Depression Inventory|Gold-standard, self-reported depression severity measure; higher is worse; post-treatment range is 2-45. scale scores are summed.|units on a scale|Mean|27.94|27.94|Standard Deviation|9.86|9.86|||
4262194|NCT00607815|4086794|B2|||Beck Depression Inventory|Gold-standard, self-reported depression severity measure; higher is worse; post-treatment range is 2-45. scale scores are summed.|units on a scale|Mean|28.22|28.22|Standard Deviation|10.21|10.21|||
4262195|NCT00607815|4086795|B1|||Beck Depression Inventory|Gold-standard, self-reported depression severity measure; higher is worse; post-treatment range is 2-45. scale scores are summed.|units on a scale|Mean|27.70|27.7|Standard Deviation|9.68|9.68|||
4262196|NCT00607815|4086793|B3|||PTSD Checklist|17-item patient self-reported PTSD severity; higher is worse; range at post-treatment is 17-73; scale scores are summed.|units on a scale|Mean|53.65|53.65|Standard Deviation|9.52|9.52|||
4262197|NCT00607815|4086794|B2|||PTSD Checklist|17-item patient self-reported PTSD severity; higher is worse; range at post-treatment is 17-73; scale scores are summed.|units on a scale|Mean|53.49|53.49|Standard Deviation|9.33|9.33|||
4262198|NCT00607815|4086795|B1|||PTSD Checklist|17-item patient self-reported PTSD severity; higher is worse; range at post-treatment is 17-73; scale scores are summed.|units on a scale|Mean|53.83|53.83|Standard Deviation|9.87|9.87|||
4262199|NCT00607815|4086793|B3|||Clinician Administered PTSD Scale|Clinician-rated PTSD symptom severity; higher is worse; range at post-treatment is 0 to 80; scale scores are summed.|units on a scale|Mean|61.77|61.77|Standard Deviation|13.14|13.14|||
4262200|NCT00607815|4086794|B2|||Clinician Administered PTSD Scale|Clinician-rated PTSD symptom severity; higher is worse; range at post-treatment is 0 to 80; scale scores are summed.|units on a scale|Mean|62.42|62.42|Standard Deviation|14.84|14.84|||
4262262|NCT00607672|4086911|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4262201|NCT00607815|4086795|B1|||Clinician Administered PTSD Scale|Clinician-rated PTSD symptom severity; higher is worse; range at post-treatment is 0 to 80; scale scores are summed.|units on a scale|Mean|60.14|60.14|Standard Deviation|11.61|11.61|||
4262202|NCT00607815|4086793|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4262203|NCT00607815|4086794|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4262204|NCT00607815|4086795|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4262205|NCT00607815|4086793|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4262206|NCT00607815|4086794|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4262207|NCT00607815|4086795|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4262208|NCT00607815|4086793|B3|||Age||years|Mean|30.92|30.92|Standard Deviation|7.59|7.59|||
4262209|NCT00607815|4086794|B2|||Age||years|Mean|32.11|32.11|Standard Deviation|7.85|7.85|||
4262210|NCT00607815|4086795|B1|||Age||years|Mean|29.5|29.5|Standard Deviation|7.11|7.11|||
4262211|NCT00607789|4086810|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4262212|NCT00607789|4086811|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4262213|NCT00607789|4086812|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4262214|NCT00607789|4086810|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4262215|NCT00607789|4086811|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4262216|NCT00607789|4086812|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4262217|NCT00607789|4086810|B3|||Age||years|Mean|40.05|40.05|Standard Deviation|11.25|11.25|||
4262218|NCT00607789|4086811|B2|||Age||years|Mean|35.7|35.7|Standard Deviation|10.4|10.4|||
4262219|NCT00607789|4086812|B1|||Age||years|Mean|44.4|44.4|Standard Deviation|12.1|12.1|||
4262220|NCT00607789|4086810|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4262221|NCT00607789|4086811|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4262222|NCT00607789|4086812|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4262223|NCT00607789|4086810|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4262224|NCT00607789|4086811|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4262225|NCT00607789|4086812|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4262226|NCT00607789|4086810|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4262227|NCT00607789|4086811|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4262228|NCT00607789|4086812|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4262229|NCT00607724|4086821|B8||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4262230|NCT00607724|4086822|B7||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4262231|NCT00607724|4086823|B6||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4262232|NCT00607724|4086824|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4262233|NCT00607724|4086825|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4262234|NCT00607724|4086826|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4262235|NCT00607724|4086827|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4262236|NCT00607724|4086828|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4262237|NCT00607724|4086821|B8||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4262238|NCT00607724|4086822|B7||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4262239|NCT00607724|4086823|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4262240|NCT00607724|4086824|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4262241|NCT00607724|4086825|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4262242|NCT00607724|4086826|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4262243|NCT00607724|4086827|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4262244|NCT00607724|4086828|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4262245|NCT00607724|4086821|B8|||Age||years|Mean|55.0|55.0|Standard Deviation|12.6|12.6|||
4262246|NCT00607724|4086822|B7|||Age||years|Mean|54.6|54.6|Standard Deviation|11.0|11.0|||
4262247|NCT00607724|4086823|B6|||Age||years|Mean|55.3|55.3|Standard Deviation|14.8|14.8|||
4262248|NCT00607724|4086824|B5|||Age||years|Mean|54.7|54.7|Standard Deviation|11.2|11.2|||
4262249|NCT00607724|4086825|B4|||Age||years|Mean|54.2|54.2|Standard Deviation|15.3|15.3|||
4262250|NCT00607724|4086826|B3|||Age||years|Mean|42.3|42.3|Standard Deviation|15.3|15.3|||
4262251|NCT00607724|4086827|B2|||Age||years|Mean|59.9|59.9|Standard Deviation|12.6|12.6|||
4262252|NCT00607724|4086828|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|10.5|10.5|||
4262253|NCT00607672|4086910|B4|United States||Region of Enrollment||participants|Number|74|74.0||||||
4262254|NCT00607672|4086911|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4262255|NCT00607672|4086912|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4262256|NCT00607672|4086913|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4262257|NCT00607672|4086910|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4262258|NCT00607672|4086911|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4262259|NCT00607672|4086912|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4262260|NCT00607672|4086913|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4262261|NCT00607672|4086910|B4||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4262263|NCT00607672|4086912|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4262264|NCT00607672|4086913|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4262265|NCT00607672|4086910|B4|||Age||years|Mean|65.84|65.84|Standard Deviation|10.03|10.03|||
4262266|NCT00607672|4086911|B3|||Age||years|Mean|67.05|67.05|Standard Deviation|8.14|8.14|||
4262267|NCT00607672|4086912|B2|||Age||years|Mean|64.38|64.38|Standard Deviation|10.35|10.35|||
4262268|NCT00607672|4086913|B1|||Age||years|Mean|66.14|66.14|Standard Deviation|11.24|11.24|||
4262269|NCT00607672|4086910|B4||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
4262270|NCT00607672|4086911|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4262271|NCT00607672|4086912|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4262272|NCT00607672|4086913|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4262273|NCT00607672|4086910|B4||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4262274|NCT00607672|4086911|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4262275|NCT00607672|4086912|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4262276|NCT00607672|4086913|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4262277|NCT00607672|4086910|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4262278|NCT00607672|4086911|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4262279|NCT00607672|4086912|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4262280|NCT00607672|4086913|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4262281|NCT00607620|4086959|B3|Baseline|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|156|156.0||||||
4262282|NCT00607620|4086960|B2|Baseline|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|95|95.0||||||
4262283|NCT00607620|4086961|B1|Baseline|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|61|61.0||||||
4262284|NCT00607620|4086959|B3|Baseline|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4262285|NCT00607620|4086960|B2|Baseline|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4262286|NCT00607620|4086961|B1|Baseline|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4262287|NCT00607620|4086959|B3|Baseline|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
4262288|NCT00607620|4086960|B2|Baseline|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4262289|NCT00607620|4086961|B1|Baseline|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
4262290|NCT00607620|4086959|B3|Baseline|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|125|125.0||||||
4262291|NCT00607620|4086960|B2|Baseline|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|63|63.0||||||
4262292|NCT00607620|4086961|B1|Baseline|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|62|62.0||||||
4262293|NCT00607620|4086959|B3|Baseline|White|Race/Ethnicity, Customized||Participants|Count of Participants|545|545.0||||||
4262294|NCT00607620|4086960|B2|Baseline|White|Race/Ethnicity, Customized||Participants|Count of Participants|292|292.0||||||
4262295|NCT00607620|4086961|B1|Baseline|White|Race/Ethnicity, Customized||Participants|Count of Participants|253|253.0||||||
4262296|NCT00607620|4086959|B3||Male|Sex: Female, Male||Participants|Count of Participants|670|670.0||||||
4262297|NCT00607620|4086960|B2||Male|Sex: Female, Male||Participants|Count of Participants|366|366.0||||||
4262298|NCT00607620|4086961|B1||Male|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
4262299|NCT00607620|4086959|B3||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4262300|NCT00607620|4086960|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4262301|NCT00607620|4086961|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4262302|NCT00607620|4086959|B3|||Age||years|Mean|36.9|36.9|Standard Deviation|14.3|14.3|||
4262303|NCT00607620|4086960|B2|||Age||years|Mean|36.4|36.4|Standard Deviation|14.0|14.0|||
4262304|NCT00607620|4086961|B1|||Age||years|Mean|37.4|37.4|Standard Deviation|14.7|14.7|||
4262305|NCT00607594|4086976|B1|Canada||Region of Enrollment||participants|Number|21|21.0||||||
4262306|NCT00607594|4086976|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4262307|NCT00607594|4086976|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4262308|NCT00607594|4086976|B1|||Age||years|Median|63|63.0|Full Range|||43.0|83.0|
4262309|NCT00607594|4086976|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4262310|NCT00607594|4086976|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4262311|NCT00607594|4086976|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4262312|NCT00607477|4086988|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4262313|NCT00607477|4086989|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4262314|NCT00607477|4086988|B3|Male||Gender||participants|Number|1|1.0||||||
4262315|NCT00607477|4086989|B2|Male||Gender||participants|Number|1|1.0||||||
4262316|NCT00607477|4086988|B3|Female||Gender||participants|Number|1|1.0||||||
4262317|NCT00607477|4086989|B2|Female||Gender||participants|Number|1|1.0||||||
4262318|NCT00607477|4086988|B3|>=65 years||Age||participants|Number|1|1.0||||||
4262319|NCT00607477|4086989|B2|>=65 years||Age||participants|Number|1|1.0||||||
4262320|NCT00607477|4086988|B3|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
4262321|NCT00607477|4086989|B2|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
4262322|NCT00607477|4086988|B3|<=18 years||Age||participants|Number|0|0.0||||||
4262323|NCT00607477|4086989|B2|<=18 years||Age||participants|Number|0|0.0||||||
4262324|NCT00607386|4086997|B1|||Baseline Normalized Urinary Glycosaminoglycan (GAG) Level||microgram per milligram creatinine|Mean|738.3|738.3|Standard Deviation|165.21|165.21|||
4262325|NCT00607386|4086997|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4262326|NCT00607386|4086997|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4262327|NCT00607386|4086997|B1|||Age||years|Mean|4.0|4.0|Standard Deviation|1.62|1.62|||
4262328|NCT00607373|4087010|B3|>=50 kg||Weight|Participants who weighed <50 kg received the lower dose of 160 mg mipomersen or matching placebo. All other patients received a dose of 200 mg or matching placebo.|participants|Number|45|45.0||||||
4262329|NCT00607373|4087011|B2|>=50 kg||Weight|Participants who weighed <50 kg received the lower dose of 160 mg mipomersen or matching placebo. All other patients received a dose of 200 mg or matching placebo.|participants|Number|30|30.0||||||
4262330|NCT00607373|4087012|B1|>=50 kg||Weight|Participants who weighed <50 kg received the lower dose of 160 mg mipomersen or matching placebo. All other patients received a dose of 200 mg or matching placebo.|participants|Number|15|15.0||||||
4262331|NCT00607373|4087010|B3|<50 kg||Weight|Participants who weighed <50 kg received the lower dose of 160 mg mipomersen or matching placebo. All other patients received a dose of 200 mg or matching placebo.|participants|Number|6|6.0||||||
4262332|NCT00607373|4087011|B2|<50 kg||Weight|Participants who weighed <50 kg received the lower dose of 160 mg mipomersen or matching placebo. All other patients received a dose of 200 mg or matching placebo.|participants|Number|4|4.0||||||
4262333|NCT00607373|4087012|B1|<50 kg||Weight|Participants who weighed <50 kg received the lower dose of 160 mg mipomersen or matching placebo. All other patients received a dose of 200 mg or matching placebo.|participants|Number|2|2.0||||||
4262334|NCT00607373|4087010|B3|||Fasting hemoglobin A1c||percentage of total hemoglobin|Mean|5.38|5.38|Standard Deviation|0.33|0.33|||
4262335|NCT00607373|4087011|B2|||Fasting hemoglobin A1c||percentage of total hemoglobin|Mean|5.34|5.34|Standard Deviation|0.37|0.37|||
4262336|NCT00607373|4087012|B1|||Fasting hemoglobin A1c||percentage of total hemoglobin|Mean|5.47|5.47|Standard Deviation|0.22|0.22|||
4262337|NCT00607373|4087010|B3|||Fasting serum insulin||microIU/mL|Mean|10.93|10.93|Standard Deviation|12.51|12.51|||
4262338|NCT00607373|4087011|B2|||Fasting serum insulin||microIU/mL|Mean|11.54|11.54|Standard Deviation|14.78|14.78|||
4262339|NCT00607373|4087012|B1|||Fasting serum insulin||microIU/mL|Mean|9.72|9.72|Standard Deviation|5.98|5.98|||
4262340|NCT00607373|4087010|B3|Never||Alcohol Use||participants|Number|25|25.0||||||
4262341|NCT00607373|4087011|B2|Never||Alcohol Use||participants|Number|17|17.0||||||
4262342|NCT00607373|4087012|B1|Never||Alcohol Use||participants|Number|8|8.0||||||
4262343|NCT00607373|4087010|B3|Non-current||Alcohol Use||participants|Number|6|6.0||||||
4262344|NCT00607373|4087011|B2|Non-current||Alcohol Use||participants|Number|3|3.0||||||
4262345|NCT00607373|4087012|B1|Non-current||Alcohol Use||participants|Number|3|3.0||||||
4262346|NCT00607373|4087010|B3|Current||Alcohol Use||participants|Number|20|20.0||||||
4262347|NCT00607373|4087011|B2|Current||Alcohol Use||participants|Number|14|14.0||||||
4262348|NCT00607373|4087012|B1|Current||Alcohol Use||participants|Number|6|6.0||||||
4262349|NCT00607373|4087010|B3|Never||Tobacco Use||participants|Number|34|34.0||||||
4262350|NCT00607373|4087011|B2|Never||Tobacco Use||participants|Number|23|23.0||||||
4262351|NCT00607373|4087012|B1|Never||Tobacco Use||participants|Number|11|11.0||||||
4262352|NCT00607373|4087010|B3|Non-current||Tobacco Use||participants|Number|7|7.0||||||
4262353|NCT00607373|4087011|B2|Non-current||Tobacco Use||participants|Number|4|4.0||||||
4262354|NCT00607373|4087012|B1|Non-current||Tobacco Use||participants|Number|3|3.0||||||
4262355|NCT00607373|4087010|B3|Current||Tobacco Use||participants|Number|10|10.0||||||
4262356|NCT00607373|4087011|B2|Current||Tobacco Use||participants|Number|7|7.0||||||
4262357|NCT00607373|4087012|B1|Current||Tobacco Use||participants|Number|3|3.0||||||
4262358|NCT00607373|4087010|B3|Yes||Metabolic syndrome|"Yes if 3 or more risk factors are present:~1) Abdominal obesity 2) Triglycerides >=150 mg/dl * 3) High density lipoprotein cholesterol (men <40 mg/dl) (women <50 mg/dl) * 4) Systolic blood pressure >=130 or diastolic >=85 mmHg * 5) Fasting glucose >=100 mg/dl *~* = or on medication for condition"|participants|Number|8|8.0||||||
4262359|NCT00607373|4087011|B2|Yes||Metabolic syndrome|"Yes if 3 or more risk factors are present:~1) Abdominal obesity 2) Triglycerides >=150 mg/dl * 3) High density lipoprotein cholesterol (men <40 mg/dl) (women <50 mg/dl) * 4) Systolic blood pressure >=130 or diastolic >=85 mmHg * 5) Fasting glucose >=100 mg/dl *~* = or on medication for condition"|participants|Number|7|7.0||||||
4262360|NCT00607373|4087012|B1|Yes||Metabolic syndrome|"Yes if 3 or more risk factors are present:~1) Abdominal obesity 2) Triglycerides >=150 mg/dl * 3) High density lipoprotein cholesterol (men <40 mg/dl) (women <50 mg/dl) * 4) Systolic blood pressure >=130 or diastolic >=85 mmHg * 5) Fasting glucose >=100 mg/dl *~* = or on medication for condition"|participants|Number|1|1.0||||||
4262361|NCT00607373|4087010|B3|No||Metabolic syndrome|"Yes if 3 or more risk factors are present:~1) Abdominal obesity 2) Triglycerides >=150 mg/dl * 3) High density lipoprotein cholesterol (men <40 mg/dl) (women <50 mg/dl) * 4) Systolic blood pressure >=130 or diastolic >=85 mmHg * 5) Fasting glucose >=100 mg/dl *~* = or on medication for condition"|participants|Number|43|43.0||||||
4262362|NCT00607373|4087011|B2|No||Metabolic syndrome|"Yes if 3 or more risk factors are present:~1) Abdominal obesity 2) Triglycerides >=150 mg/dl * 3) High density lipoprotein cholesterol (men <40 mg/dl) (women <50 mg/dl) * 4) Systolic blood pressure >=130 or diastolic >=85 mmHg * 5) Fasting glucose >=100 mg/dl *~* = or on medication for condition"|participants|Number|27|27.0||||||
4262363|NCT00607373|4087012|B1|No||Metabolic syndrome|"Yes if 3 or more risk factors are present:~1) Abdominal obesity 2) Triglycerides >=150 mg/dl * 3) High density lipoprotein cholesterol (men <40 mg/dl) (women <50 mg/dl) * 4) Systolic blood pressure >=130 or diastolic >=85 mmHg * 5) Fasting glucose >=100 mg/dl *~* = or on medication for condition"|participants|Number|16|16.0||||||
4262364|NCT00607373|4087010|B3|||Waist/hip ratio||ratio|Mean|0.84|0.84|Standard Deviation|0.07|0.07|||
4262365|NCT00607373|4087011|B2|||Waist/hip ratio||ratio|Mean|0.85|0.85|Standard Deviation|0.06|0.06|||
4262366|NCT00607373|4087012|B1|||Waist/hip ratio||ratio|Mean|0.83|0.83|Standard Deviation|0.07|0.07|||
4262367|NCT00607373|4087010|B3|||Body Mass Index||kg/m^2|Mean|26.08|26.08|Standard Deviation|5.34|5.34|||
4262368|NCT00607373|4087011|B2|||Body Mass Index||kg/m^2|Mean|25.97|25.97|Standard Deviation|5.81|5.81|||
4262369|NCT00607373|4087012|B1|||Body Mass Index||kg/m^2|Mean|26.32|26.32|Standard Deviation|4.41|4.41|||
4262370|NCT00607373|4087010|B3|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4262371|NCT00607373|4087011|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4262372|NCT00607373|4087012|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4262373|NCT00607373|4087010|B3|Asian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4262374|NCT00607373|4087011|B2|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4262375|NCT00607373|4087012|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4262376|NCT00607373|4087010|B3|White||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4262377|NCT00607373|4087011|B2|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4262378|NCT00607373|4087012|B1|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4262379|NCT00607373|4087010|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4262380|NCT00607373|4087011|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4262381|NCT00607373|4087012|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4262382|NCT00607373|4087010|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4262383|NCT00607373|4087011|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4262384|NCT00607373|4087012|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4262385|NCT00607373|4087010|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4262386|NCT00607373|4087011|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4262387|NCT00607373|4087012|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4262388|NCT00607373|4087010|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4262389|NCT00607373|4087011|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4262390|NCT00607373|4087012|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4262391|NCT00607373|4087010|B3|||Age||years|Mean|31.3|31.3|Standard Deviation|12.4|12.4|||
4262392|NCT00607373|4087011|B2|||Age||years|Mean|30.4|30.4|Standard Deviation|11.5|11.5|||
4262393|NCT00607373|4087012|B1|||Age||years|Mean|33.0|33.0|Standard Deviation|14.1|14.1|||
4262394|NCT00607321|4087057|B1|New Zealand||Region of Enrollment||participants|Number|14|14.0||||||
4262395|NCT00607321|4087057|B1|Australia||Region of Enrollment||participants|Number|39|39.0||||||
4262396|NCT00607321|4087057|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4262397|NCT00607321|4087057|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4262398|NCT00607321|4087057|B1|||Age||years|Mean|60.4|60.4|Standard Deviation|11.74|11.74|||
4262399|NCT00607269|4087065|B3|United States||Region of Enrollment||participants|Number|131|131.0||||||
4262400|NCT00607269|4087066|B2|United States||Region of Enrollment||participants|Number|64|64.0||||||
4262401|NCT00607269|4087067|B1|United States||Region of Enrollment||participants|Number|67|67.0||||||
4262402|NCT00607269|4087065|B3||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4262403|NCT00607269|4087066|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4262404|NCT00607269|4087067|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4262405|NCT00607269|4087065|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4262406|NCT00607269|4087066|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4262407|NCT00607269|4087067|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4262408|NCT00607269|4087065|B3|||Age||years|Mean|36.4|36.4|Standard Deviation|8.7|8.7|||
4262409|NCT00607269|4087066|B2|||Age||years|Mean|36.3|36.3|Standard Deviation|8.7|8.7|||
4262410|NCT00607269|4087067|B1|||Age||years|Mean|36.5|36.5|Standard Deviation|8.7|8.7|||
4262411|NCT00607269|4087065|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4262412|NCT00607269|4087066|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4262413|NCT00607269|4087067|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4262414|NCT00607269|4087065|B3||Between 18 and 65 years|Age||Participants|Count of Participants|131|131.0||||||
4262415|NCT00607269|4087066|B2||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4262416|NCT00607269|4087067|B1||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
4262417|NCT00607269|4087065|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4262418|NCT00607269|4087066|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4262419|NCT00607269|4087067|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4262420|NCT00607243|4087080|B3|Korea, Republic of||Region of Enrollment||participants|Number|123|123.0||||||
4262421|NCT00607243|4087081|B2|Korea, Republic of||Region of Enrollment||participants|Number|41|41.0||||||
4262422|NCT00607243|4087082|B1|Korea, Republic of||Region of Enrollment||participants|Number|82|82.0||||||
4262423|NCT00607243|4087080|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4262424|NCT00607243|4087081|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4262425|NCT00607243|4087082|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4262426|NCT00607243|4087080|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4262427|NCT00607243|4087081|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4262428|NCT00607243|4087082|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4262429|NCT00607243|4087080|B3|||Age||years|Mean|24.0|24.0|Standard Deviation|2.7|2.7|||
4262430|NCT00607243|4087081|B2|||Age||years|Mean|24.3|24.3|Standard Deviation|2.8|2.8|||
4262431|NCT00607243|4087082|B1|||Age||years|Mean|23.9|23.9|Standard Deviation|2.1|2.1|||
4262432|NCT00607243|4087080|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4262433|NCT00607243|4087081|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4262434|NCT00607243|4087082|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4262435|NCT00607243|4087080|B3||Between 18 and 65 years|Age||Participants|Count of Participants|123|123.0||||||
4262436|NCT00607243|4087081|B2||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4262437|NCT00607243|4087082|B1||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
4262438|NCT00607243|4087080|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4262439|NCT00607243|4087081|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4262440|NCT00607243|4087082|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4262441|NCT00607126|4087089|B3|||EDSS|"this is a scale which measures disability. each participant will have their own individual EDSS. The EDSS is the abbreviation for the Expanded Disability Status Scale. It is scored from information obtained the neurologic exam and goes from 0-10. O is normal and 10 is dead. A higher number therefore connotes worse physical disability."|units on a scale|Mean|6.3|6.3|Full Range|||5.0|6.5|
4262442|NCT00607126|4087090|B2|||EDSS|"this is a scale which measures disability. each participant will have their own individual EDSS. The EDSS is the abbreviation for the Expanded Disability Status Scale. It is scored from information obtained the neurologic exam and goes from 0-10. O is normal and 10 is dead. A higher number therefore connotes worse physical disability."|units on a scale|Mean|6.0|6.0|Full Range|||5.0|6.5|
4262443|NCT00607126|4087091|B1|||EDSS|"this is a scale which measures disability. each participant will have their own individual EDSS. The EDSS is the abbreviation for the Expanded Disability Status Scale. It is scored from information obtained the neurologic exam and goes from 0-10. O is normal and 10 is dead. A higher number therefore connotes worse physical disability."|units on a scale|Mean|6.5|6.5|Full Range|||5.5|6.5|
4262444|NCT00607126|4087089|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4262445|NCT00607126|4087090|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4262446|NCT00607126|4087091|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4262447|NCT00607126|4087089|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4262448|NCT00607126|4087090|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4262449|NCT00607126|4087091|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4262450|NCT00607126|4087089|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4262451|NCT00607126|4087090|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4262452|NCT00607126|4087091|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4262453|NCT00607126|4087089|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4262454|NCT00607126|4087090|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4262455|NCT00607126|4087091|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4262456|NCT00607126|4087089|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4262457|NCT00607126|4087090|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4262458|NCT00607126|4087091|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4262459|NCT00607126|4087089|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4262460|NCT00607126|4087090|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4262461|NCT00607126|4087091|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4262462|NCT00607113|4087104|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
4262463|NCT00607113|4087105|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4262464|NCT00607113|4087106|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4262465|NCT00607113|4087104|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4262466|NCT00607113|4087105|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4262467|NCT00607113|4087106|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4262468|NCT00607113|4087104|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4262469|NCT00607113|4087105|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4262470|NCT00607113|4087106|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4262471|NCT00607113|4087104|B3|||Age||years|Median|59|59.0|Full Range|||22.0|81.0|
4262472|NCT00607113|4087105|B2|||Age||years|Median|60|60.0|Full Range|||33.0|74.0|
4262473|NCT00607113|4087106|B1|||Age||years|Median|57|57.0|Full Range|||22.0|81.0|
4262474|NCT00607087|4087112|B4|||Glycosylated Haemoglobin (HbA1c)||Percent|Mean|7.38|7.38|Standard Deviation|0.66|0.66|||
4262475|NCT00607087|4087113|B3|||Glycosylated Haemoglobin (HbA1c)||Percent|Mean|7.41|7.41|Standard Deviation|0.69|0.69|||
4262476|NCT00607087|4087114|B2|||Glycosylated Haemoglobin (HbA1c)||Percent|Mean|7.36|7.36|Standard Deviation|0.61|0.61|||
4262477|NCT00607087|4087115|B1|||Glycosylated Haemoglobin (HbA1c)||Percent|Mean|7.38|7.38|Standard Deviation|0.69|0.69|||
4262478|NCT00607087|4087112|B4|||Central fasting plasma glucose|"Total patients analyzed n=284 due to 4 missing data: 2 in the sequence 1 and 2 in the sequence 3 groups"|mg/dL|Mean|149.48|149.48|Standard Deviation|61.37|61.37|||
4262479|NCT00607087|4087113|B3|||Central fasting plasma glucose|"Total patients analyzed n=284 due to 4 missing data: 2 in the sequence 1 and 2 in the sequence 3 groups"|mg/dL|Mean|151.18|151.18|Standard Deviation|64.06|64.06|||
4262480|NCT00607087|4087114|B2|||Central fasting plasma glucose|"Total patients analyzed n=284 due to 4 missing data: 2 in the sequence 1 and 2 in the sequence 3 groups"|mg/dL|Mean|147.45|147.45|Standard Deviation|61.63|61.63|||
4262481|NCT00607087|4087115|B1|||Central fasting plasma glucose|"Total patients analyzed n=284 due to 4 missing data: 2 in the sequence 1 and 2 in the sequence 3 groups"|mg/dL|Mean|149.84|149.84|Standard Deviation|59.03|59.03|||
4262482|NCT00607087|4087112|B4|||Body Mass Index (BMI)||kg/m²|Mean|25.39|25.39|Standard Deviation|3.81|3.81|||
4262483|NCT00607087|4087113|B3|||Body Mass Index (BMI)||kg/m²|Mean|25.92|25.92|Standard Deviation|3.98|3.98|||
4262484|NCT00607087|4087114|B2|||Body Mass Index (BMI)||kg/m²|Mean|25.25|25.25|Standard Deviation|3.91|3.91|||
4262485|NCT00607087|4087115|B1|||Body Mass Index (BMI)||kg/m²|Mean|25.01|25.01|Standard Deviation|3.53|3.53|||
4262486|NCT00607087|4087112|B4|||Total daily basal insulin infusion|"Total patients analyzed n=285 due to 3 missing data: 2 in the sequence 1 and 1 in the sequence 2 groups"|Units|Mean|21.00|21.0|Standard Deviation|9.13|9.13|||
4262487|NCT00607087|4087113|B3|||Total daily basal insulin infusion|"Total patients analyzed n=285 due to 3 missing data: 2 in the sequence 1 and 1 in the sequence 2 groups"|Units|Mean|22.03|22.03|Standard Deviation|9.17|9.17|||
4262488|NCT00607087|4087114|B2|||Total daily basal insulin infusion|"Total patients analyzed n=285 due to 3 missing data: 2 in the sequence 1 and 1 in the sequence 2 groups"|Units|Mean|19.99|19.99|Standard Deviation|9.38|9.38|||
4262489|NCT00607087|4087115|B1|||Total daily basal insulin infusion|"Total patients analyzed n=285 due to 3 missing data: 2 in the sequence 1 and 1 in the sequence 2 groups"|Units|Mean|20.98|20.98|Standard Deviation|8.84|8.84|||
4262490|NCT00607087|4087112|B4|||Duration of treatment with CSII (continuous subcutaneous insulin infusion) at study entry||years|Mean|5.94|5.94|Standard Deviation|5.01|5.01|||
4262491|NCT00607087|4087113|B3|||Duration of treatment with CSII (continuous subcutaneous insulin infusion) at study entry||years|Mean|6.31|6.31|Standard Deviation|4.95|4.95|||
4262492|NCT00607087|4087114|B2|||Duration of treatment with CSII (continuous subcutaneous insulin infusion) at study entry||years|Mean|5.52|5.52|Standard Deviation|5.27|5.27|||
4262493|NCT00607087|4087115|B1|||Duration of treatment with CSII (continuous subcutaneous insulin infusion) at study entry||years|Mean|5.99|5.99|Standard Deviation|4.83|4.83|||
4262494|NCT00607087|4087112|B4|||Total daily bolus insulin dose|"Total patients analyzed n=285 due to 3 missing data: 2 in the sequence 1 and 1 in the sequence 2 groups"|Units|Mean|19.18|19.18|Standard Deviation|9.22|9.22|||
4262495|NCT00607087|4087113|B3|||Total daily bolus insulin dose|"Total patients analyzed n=285 due to 3 missing data: 2 in the sequence 1 and 1 in the sequence 2 groups"|Units|Mean|19.35|19.35|Standard Deviation|7.78|7.78|||
4262496|NCT00607087|4087114|B2|||Total daily bolus insulin dose|"Total patients analyzed n=285 due to 3 missing data: 2 in the sequence 1 and 1 in the sequence 2 groups"|Units|Mean|18.58|18.58|Standard Deviation|10.34|10.34|||
4262497|NCT00607087|4087115|B1|||Total daily bolus insulin dose|"Total patients analyzed n=285 due to 3 missing data: 2 in the sequence 1 and 1 in the sequence 2 groups"|Units|Mean|19.61|19.61|Standard Deviation|9.40|9.4|||
4262498|NCT00607087|4087112|B4|||Duration of treatment with insulin at study entry||years|Mean|22.73|22.73|Standard Deviation|12.67|12.67|||
4262499|NCT00607087|4087113|B3|||Duration of treatment with insulin at study entry||years|Mean|22.75|22.75|Standard Deviation|11.08|11.08|||
4262500|NCT00607087|4087114|B2|||Duration of treatment with insulin at study entry||years|Mean|23.07|23.07|Standard Deviation|13.33|13.33|||
4262501|NCT00607087|4087115|B1|||Duration of treatment with insulin at study entry||years|Mean|22.39|22.39|Standard Deviation|13.53|13.53|||
4262502|NCT00607087|4087112|B4|||Duration of treatment with previous insulin at study entry|"Total patients analyzed n=286 due to one missing data in the sequence 1 and in the sequence 2 groups"|years|Mean|4.67|4.67|Standard Deviation|3.22|3.22|||
4262503|NCT00607087|4087113|B3|||Duration of treatment with previous insulin at study entry|"Total patients analyzed n=286 due to one missing data in the sequence 1 and in the sequence 2 groups"|years|Mean|4.79|4.79|Standard Deviation|3.00|3.0|||
4262504|NCT00607087|4087114|B2|||Duration of treatment with previous insulin at study entry|"Total patients analyzed n=286 due to one missing data in the sequence 1 and in the sequence 2 groups"|years|Mean|4.37|4.37|Standard Deviation|3.05|3.05|||
4262505|NCT00607087|4087115|B1|||Duration of treatment with previous insulin at study entry|"Total patients analyzed n=286 due to one missing data in the sequence 1 and in the sequence 2 groups"|years|Mean|4.84|4.84|Standard Deviation|3.58|3.58|||
4262506|NCT00607087|4087112|B4|Insulin lispro||Previous insulin at study entry|"Total patients analyzed n=287 due to one missing data in the sequence 2 group"|participants|Number|162|162.0||||||
4262507|NCT00607087|4087113|B3|Insulin lispro||Previous insulin at study entry|"Total patients analyzed n=287 due to one missing data in the sequence 2 group"|participants|Number|50|50.0||||||
4262508|NCT00607087|4087114|B2|Insulin lispro||Previous insulin at study entry|"Total patients analyzed n=287 due to one missing data in the sequence 2 group"|participants|Number|49|49.0||||||
4262509|NCT00607087|4087115|B1|Insulin lispro||Previous insulin at study entry|"Total patients analyzed n=287 due to one missing data in the sequence 2 group"|participants|Number|63|63.0||||||
4262510|NCT00607087|4087112|B4|Insulin aspart||Previous insulin at study entry|"Total patients analyzed n=287 due to one missing data in the sequence 2 group"|participants|Number|117|117.0||||||
4262511|NCT00607087|4087113|B3|Insulin aspart||Previous insulin at study entry|"Total patients analyzed n=287 due to one missing data in the sequence 2 group"|participants|Number|42|42.0||||||
4262512|NCT00607087|4087114|B2|Insulin aspart||Previous insulin at study entry|"Total patients analyzed n=287 due to one missing data in the sequence 2 group"|participants|Number|43|43.0||||||
4262513|NCT00607087|4087115|B1|Insulin aspart||Previous insulin at study entry|"Total patients analyzed n=287 due to one missing data in the sequence 2 group"|participants|Number|32|32.0||||||
4262514|NCT00607087|4087112|B4|Insulin glulisine||Previous insulin at study entry|"Total patients analyzed n=287 due to one missing data in the sequence 2 group"|participants|Number|8|8.0||||||
4262515|NCT00607087|4087113|B3|Insulin glulisine||Previous insulin at study entry|"Total patients analyzed n=287 due to one missing data in the sequence 2 group"|participants|Number|2|2.0||||||
4262516|NCT00607087|4087114|B2|Insulin glulisine||Previous insulin at study entry|"Total patients analyzed n=287 due to one missing data in the sequence 2 group"|participants|Number|2|2.0||||||
4262517|NCT00607087|4087115|B1|Insulin glulisine||Previous insulin at study entry|"Total patients analyzed n=287 due to one missing data in the sequence 2 group"|participants|Number|4|4.0||||||
4262518|NCT00607087|4087112|B4|Korea, Republic of||Region of Enrollment||participants|Number|3|3.0||||||
4262519|NCT00607087|4087113|B3|Korea, Republic of||Region of Enrollment||participants|Number|1|1.0||||||
4262520|NCT00607087|4087114|B2|Korea, Republic of||Region of Enrollment||participants|Number|1|1.0||||||
4262521|NCT00607087|4087115|B1|Korea, Republic of||Region of Enrollment||participants|Number|1|1.0||||||
4262522|NCT00607087|4087112|B4|Sweden||Region of Enrollment||participants|Number|24|24.0||||||
4262523|NCT00607087|4087113|B3|Sweden||Region of Enrollment||participants|Number|7|7.0||||||
4262524|NCT00607087|4087114|B2|Sweden||Region of Enrollment||participants|Number|8|8.0||||||
4262525|NCT00607087|4087115|B1|Sweden||Region of Enrollment||participants|Number|9|9.0||||||
4262526|NCT00607087|4087112|B4|Italy||Region of Enrollment||participants|Number|23|23.0||||||
4262527|NCT00607087|4087113|B3|Italy||Region of Enrollment||participants|Number|7|7.0||||||
4262528|NCT00607087|4087114|B2|Italy||Region of Enrollment||participants|Number|7|7.0||||||
4262529|NCT00607087|4087115|B1|Italy||Region of Enrollment||participants|Number|9|9.0||||||
4262530|NCT00607087|4087112|B4|United Kingdom||Region of Enrollment||participants|Number|13|13.0||||||
4262531|NCT00607087|4087113|B3|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4262532|NCT00607087|4087114|B2|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4262533|NCT00607087|4087115|B1|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4262534|NCT00607087|4087112|B4|Netherlands||Region of Enrollment||participants|Number|23|23.0||||||
4262535|NCT00607087|4087113|B3|Netherlands||Region of Enrollment||participants|Number|7|7.0||||||
4262536|NCT00607087|4087114|B2|Netherlands||Region of Enrollment||participants|Number|8|8.0||||||
4262537|NCT00607087|4087115|B1|Netherlands||Region of Enrollment||participants|Number|8|8.0||||||
4262538|NCT00607087|4087112|B4|Israel||Region of Enrollment||participants|Number|32|32.0||||||
4262539|NCT00607087|4087113|B3|Israel||Region of Enrollment||participants|Number|10|10.0||||||
4262540|NCT00607087|4087114|B2|Israel||Region of Enrollment||participants|Number|11|11.0||||||
4262541|NCT00607087|4087115|B1|Israel||Region of Enrollment||participants|Number|11|11.0||||||
4262542|NCT00607087|4087112|B4|Australia||Region of Enrollment||participants|Number|11|11.0||||||
4262543|NCT00607087|4087113|B3|Australia||Region of Enrollment||participants|Number|3|3.0||||||
4262544|NCT00607087|4087114|B2|Australia||Region of Enrollment||participants|Number|4|4.0||||||
4262545|NCT00607087|4087115|B1|Australia||Region of Enrollment||participants|Number|4|4.0||||||
4262546|NCT00607087|4087112|B4|Austria||Region of Enrollment||participants|Number|24|24.0||||||
4262547|NCT00607087|4087113|B3|Austria||Region of Enrollment||participants|Number|8|8.0||||||
4262548|NCT00607087|4087114|B2|Austria||Region of Enrollment||participants|Number|9|9.0||||||
4262549|NCT00607087|4087115|B1|Austria||Region of Enrollment||participants|Number|7|7.0||||||
4262550|NCT00607087|4087112|B4|Spain||Region of Enrollment||participants|Number|30|30.0||||||
4262551|NCT00607087|4087113|B3|Spain||Region of Enrollment||participants|Number|10|10.0||||||
4262552|NCT00607087|4087114|B2|Spain||Region of Enrollment||participants|Number|9|9.0||||||
4262553|NCT00607087|4087115|B1|Spain||Region of Enrollment||participants|Number|11|11.0||||||
4262554|NCT00607087|4087112|B4|Hungary||Region of Enrollment||participants|Number|14|14.0||||||
4262555|NCT00607087|4087113|B3|Hungary||Region of Enrollment||participants|Number|6|6.0||||||
4262556|NCT00607087|4087114|B2|Hungary||Region of Enrollment||participants|Number|4|4.0||||||
4262557|NCT00607087|4087115|B1|Hungary||Region of Enrollment||participants|Number|4|4.0||||||
4262558|NCT00607087|4087112|B4|France||Region of Enrollment||participants|Number|27|27.0||||||
4262559|NCT00607087|4087113|B3|France||Region of Enrollment||participants|Number|10|10.0||||||
4262560|NCT00607087|4087114|B2|France||Region of Enrollment||participants|Number|9|9.0||||||
4262561|NCT00607087|4087115|B1|France||Region of Enrollment||participants|Number|8|8.0||||||
4262562|NCT00607087|4087112|B4|United States||Region of Enrollment||participants|Number|64|64.0||||||
4262563|NCT00607087|4087113|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4262564|NCT00607087|4087114|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4262565|NCT00607087|4087115|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4262566|NCT00607087|4087112|B4||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4262567|NCT00607087|4087113|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4262568|NCT00607087|4087114|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4262569|NCT00607087|4087115|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4262570|NCT00607087|4087112|B4||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4262571|NCT00607087|4087113|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4262572|NCT00607087|4087114|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4262573|NCT00607087|4087115|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4262574|NCT00607087|4087112|B4|||Age||years|Mean|44.43|44.43|Standard Deviation|13.39|13.39|||
4262575|NCT00607087|4087113|B3|||Age||years|Mean|44.04|44.04|Standard Deviation|12.87|12.87|||
4262576|NCT00607087|4087114|B2|||Age||years|Mean|45.84|45.84|Standard Deviation|13.59|13.59|||
4262577|NCT00607087|4087115|B1|||Age||years|Mean|43.45|43.45|Standard Deviation|13.71|13.71|||
4262578|NCT00607048|4087173|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4262579|NCT00607048|4087174|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4262580|NCT00607048|4087175|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4262581|NCT00607048|4087173|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4262582|NCT00607048|4087174|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4262583|NCT00607048|4087175|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4262584|NCT00607048|4087173|B3|||Age||years|Mean|56.4|56.4|Standard Deviation|13.0|13.0|||
4262585|NCT00607048|4087174|B2|||Age||years|Mean|54.5|54.5|Standard Deviation|12.7|12.7|||
4262586|NCT00607048|4087175|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|13.4|13.4|||
4262587|NCT00607022|4087262|B4|United States||Region of Enrollment||participants|Number|41|41.0||||||
4262588|NCT00607022|4087263|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4262589|NCT00607022|4087264|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4262590|NCT00607022|4087265|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4262591|NCT00607022|4087262|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4262592|NCT00607022|4087263|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4262593|NCT00607022|4087264|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4262594|NCT00607022|4087265|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4262595|NCT00607022|4087262|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4262596|NCT00607022|4087263|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4262597|NCT00607022|4087264|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4262598|NCT00607022|4087265|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4262599|NCT00607022|4087262|B4|||Age||years|Mean|34|34.0|Standard Deviation|7|7.0|||
4262600|NCT00607022|4087263|B3|||Age||years|Mean|34|34.0|Standard Deviation|5|5.0|||
4262601|NCT00607022|4087264|B2|||Age||years|Mean|35|35.0|Standard Deviation|8|8.0|||
4262602|NCT00607022|4087265|B1|||Age||years|Mean|34|34.0|Standard Deviation|7|7.0|||
4262603|NCT00607022|4087262|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4262604|NCT00607022|4087263|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4262605|NCT00607022|4087264|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4262606|NCT00607022|4087265|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4262607|NCT00607022|4087262|B4||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4262608|NCT00607022|4087263|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4262609|NCT00607022|4087264|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4262610|NCT00607022|4087265|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4262611|NCT00607022|4087262|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4262612|NCT00607022|4087263|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4262613|NCT00607022|4087264|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4262614|NCT00607022|4087265|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4262615|NCT00606944|4087275|B3|Korea, Republic of||Region of Enrollment||participants|Number|198|198.0||||||
4262616|NCT00606944|4087276|B2|Korea, Republic of||Region of Enrollment||participants|Number|98|98.0||||||
4262617|NCT00606944|4087277|B1|Korea, Republic of||Region of Enrollment||participants|Number|100|100.0||||||
4262618|NCT00606944|4087275|B3||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4262619|NCT00606944|4087276|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4262620|NCT00606944|4087277|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4262621|NCT00606944|4087275|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4262622|NCT00606944|4087276|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4262623|NCT00606944|4087277|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4262624|NCT00606944|4087275|B3|||Age||years|Mean|61.3|61.3|Standard Deviation|10.9|10.9|||
4262625|NCT00606944|4087276|B2|||Age||years|Mean|61.5|61.5|Standard Deviation|10.9|10.9|||
4262626|NCT00606944|4087277|B1|||Age||years|Mean|61.1|61.1|Standard Deviation|11.0|11.0|||
4262627|NCT00606944|4087275|B3||>=65 years|Age||Participants|Count of Participants|91|91.0||||||
4262628|NCT00606944|4087276|B2||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
4262629|NCT00606944|4087277|B1||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
4262630|NCT00606944|4087275|B3||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
4262631|NCT00606944|4087276|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4262632|NCT00606944|4087277|B1||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4262633|NCT00606944|4087275|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4262634|NCT00606944|4087276|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4262635|NCT00606944|4087277|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4262636|NCT00606931|4087284|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4262637|NCT00606931|4087284|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4262638|NCT00606931|4087284|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4262639|NCT00606931|4087284|B1|||Age||years|Mean|58.5|58.5|Standard Deviation|11.9|11.9|||
4262640|NCT00606931|4087284|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4262641|NCT00606931|4087284|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4262642|NCT00606931|4087284|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4262643|NCT00606905|4087290|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4262644|NCT00606905|4087291|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4262645|NCT00606905|4087292|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4262646|NCT00606905|4087290|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4262647|NCT00606905|4087291|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4262648|NCT00606905|4087292|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4262649|NCT00606905|4087290|B3|||Age||years|Mean|36|36.0|Standard Deviation|4|4.0|||
4262650|NCT00606905|4087291|B2|||Age||years|Mean|35|35.0|Standard Deviation|4|4.0|||
4262651|NCT00606905|4087292|B1|||Age||years|Mean|36|36.0|Standard Deviation|5|5.0|||
4262652|NCT00606892|4087299|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4262653|NCT00606892|4087299|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4262654|NCT00606892|4087299|B1|||Age||years|Mean|34.0|34.0|Standard Deviation|9.3|9.3|||
4262655|NCT00606892|4087299|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4262656|NCT00606892|4087299|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4262657|NCT00606892|4087299|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4262658|NCT00606801|4087332|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
4262659|NCT00606801|4087333|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4262660|NCT00606801|4087334|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4262661|NCT00606801|4087332|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4262662|NCT00606801|4087333|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4262663|NCT00606801|4087334|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4262664|NCT00606801|4087332|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4262665|NCT00606801|4087333|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4262666|NCT00606801|4087334|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4262667|NCT00606801|4087332|B3|||Age||years|Mean|42.5|42.5|Standard Deviation|6.2|6.2|||
4262668|NCT00606801|4087333|B2|||Age||years|Mean|42.7|42.7|Standard Deviation|6.3|6.3|||
4262669|NCT00606801|4087334|B1|||Age||years|Mean|42.1|42.1|Standard Deviation|5.9|5.9|||
4262670|NCT00606684|4087357|B7|American Indian or Alaska Native & White||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4262671|NCT00606684|4087358|B6|American Indian or Alaska Native & White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4262672|NCT00606684|4087359|B5|American Indian or Alaska Native & White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4262673|NCT00606684|4087360|B4|American Indian or Alaska Native & White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4262674|NCT00606684|4087361|B3|American Indian or Alaska Native & White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4262675|NCT00606684|4087362|B2|American Indian or Alaska Native & White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4262676|NCT00606684|4087363|B1|American Indian or Alaska Native & White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4262677|NCT00606684|4087357|B7|White||Race/Ethnicity, Customized||Participants|Number|515|515.0||||||
4262678|NCT00606684|4087358|B6|White||Race/Ethnicity, Customized||Participants|Number|87|87.0||||||
4262679|NCT00606684|4087359|B5|White||Race/Ethnicity, Customized||Participants|Number|84|84.0||||||
4262680|NCT00606684|4087360|B4|White||Race/Ethnicity, Customized||Participants|Number|86|86.0||||||
4262681|NCT00606684|4087361|B3|White||Race/Ethnicity, Customized||Participants|Number|84|84.0||||||
4262682|NCT00606684|4087362|B2|White||Race/Ethnicity, Customized||Participants|Number|84|84.0||||||
4262683|NCT00606684|4087363|B1|White||Race/Ethnicity, Customized||Participants|Number|90|90.0||||||
4262684|NCT00606684|4087357|B7|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||Participants|Number|55|55.0||||||
4262685|NCT00606684|4087358|B6|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4262686|NCT00606684|4087359|B5|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4262687|NCT00606684|4087360|B4|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4262688|NCT00606684|4087361|B3|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4262689|NCT00606684|4087362|B2|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4262690|NCT00606684|4087363|B1|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4262691|NCT00606684|4087357|B7|Central/South Asian HER||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4262692|NCT00606684|4087358|B6|Central/South Asian HER||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4262693|NCT00606684|4087359|B5|Central/South Asian HER||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4262694|NCT00606684|4087360|B4|Central/South Asian HER||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4262695|NCT00606684|4087361|B3|Central/South Asian HER||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4262696|NCT00606684|4087362|B2|Central/South Asian HER||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4262697|NCT00606684|4087363|B1|Central/South Asian HER||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4262698|NCT00606684|4087357|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4262699|NCT00606684|4087358|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4262700|NCT00606684|4087359|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4262701|NCT00606684|4087360|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4262702|NCT00606684|4087361|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4262703|NCT00606684|4087362|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4262704|NCT00606684|4087363|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4262705|NCT00606684|4087357|B7|African American/African Heritage (HER)||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4262706|NCT00606684|4087358|B6|African American/African Heritage (HER)||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4262707|NCT00606684|4087359|B5|African American/African Heritage (HER)||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4262708|NCT00606684|4087360|B4|African American/African Heritage (HER)||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4262709|NCT00606684|4087361|B3|African American/African Heritage (HER)||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4262710|NCT00606684|4087362|B2|African American/African Heritage (HER)||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4262711|NCT00606684|4087363|B1|African American/African Heritage (HER)||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4262712|NCT00606684|4087357|B7||Male|Gender||Participants|Count of Participants|370|370.0||||||
4262713|NCT00606684|4087358|B6||Male|Gender||Participants|Count of Participants|65|65.0||||||
4262714|NCT00606684|4087359|B5||Male|Gender||Participants|Count of Participants|59|59.0||||||
4262715|NCT00606684|4087360|B4||Male|Gender||Participants|Count of Participants|57|57.0||||||
4262716|NCT00606684|4087361|B3||Male|Gender||Participants|Count of Participants|64|64.0||||||
4262717|NCT00606684|4087362|B2||Male|Gender||Participants|Count of Participants|68|68.0||||||
4262718|NCT00606684|4087363|B1||Male|Gender||Participants|Count of Participants|57|57.0||||||
4262719|NCT00606684|4087357|B7||Female|Gender||Participants|Count of Participants|232|232.0||||||
4262720|NCT00606684|4087358|B6||Female|Gender||Participants|Count of Participants|34|34.0||||||
4262721|NCT00606684|4087359|B5||Female|Gender||Participants|Count of Participants|42|42.0||||||
4262722|NCT00606684|4087360|B4||Female|Gender||Participants|Count of Participants|44|44.0||||||
4262723|NCT00606684|4087361|B3||Female|Gender||Participants|Count of Participants|37|37.0||||||
4262724|NCT00606684|4087362|B2||Female|Gender||Participants|Count of Participants|31|31.0||||||
4262725|NCT00606684|4087363|B1||Female|Gender||Participants|Count of Participants|44|44.0||||||
4262726|NCT00606684|4087357|B7|||Age||Years|Mean|61.9|61.9|Standard Deviation|8.34|8.34|||
4262727|NCT00606684|4087358|B6|||Age||Years|Mean|61.4|61.4|Standard Deviation|8.12|8.12|||
4262728|NCT00606684|4087359|B5|||Age||Years|Mean|62.6|62.6|Standard Deviation|8.88|8.88|||
4262729|NCT00606684|4087360|B4|||Age||Years|Mean|62.6|62.6|Standard Deviation|8.03|8.03|||
4262730|NCT00606684|4087361|B3|||Age||Years|Mean|62.0|62.0|Standard Deviation|7.94|7.94|||
4262731|NCT00606684|4087362|B2|||Age||Years|Mean|61.1|61.1|Standard Deviation|8.57|8.57|||
4262732|NCT00606684|4087363|B1|||Age||Years|Mean|61.6|61.6|Standard Deviation|8.53|8.53|||
4262733|NCT00606632|4087401|B1|United States||Region of Enrollment||participants|Number|226|226.0||||||
4262734|NCT00606632|4087401|B1||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4262735|NCT00606632|4087401|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4262736|NCT00606632|4087401|B1|||Age||years|Mean|56.1|56.1|Standard Deviation|12.01|12.01|||
4262737|NCT00606632|4087401|B1||>=65 years|Age||Participants|Count of Participants|59|59.0||||||
4262738|NCT00606632|4087401|B1||Between 18 and 65 years|Age||Participants|Count of Participants|167|167.0||||||
4262739|NCT00606632|4087401|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4262740|NCT00606593|4087414|B1|United States||Region of Enrollment||participants|Number|112|112.0||||||
4262741|NCT00606593|4087414|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4262742|NCT00606593|4087414|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4262743|NCT00606593|4087414|B1|||Age||years|Mean|72.0|72.0|Standard Deviation|4.8|4.8|||
4262744|NCT00606580|4087441|B4|> 60 days||Days before treatment that index lesion was first noticed (categorical)||participants|Number|47|47.0||||||
4262745|NCT00606580|4087442|B3|> 60 days||Days before treatment that index lesion was first noticed (categorical)||participants|Number|16|16.0||||||
4262746|NCT00606580|4087443|B2|> 60 days||Days before treatment that index lesion was first noticed (categorical)||participants|Number|16|16.0||||||
4262747|NCT00606580|4087444|B1|> 60 days||Days before treatment that index lesion was first noticed (categorical)||participants|Number|15|15.0||||||
4262748|NCT00606580|4087441|B4|≤ 60 days||Days before treatment that index lesion was first noticed (categorical)||participants|Number|328|328.0||||||
4262749|NCT00606580|4087442|B3|≤ 60 days||Days before treatment that index lesion was first noticed (categorical)||participants|Number|109|109.0||||||
4262750|NCT00606580|4087443|B2|≤ 60 days||Days before treatment that index lesion was first noticed (categorical)||participants|Number|109|109.0||||||
4262751|NCT00606580|4087444|B1|≤ 60 days||Days before treatment that index lesion was first noticed (categorical)||participants|Number|110|110.0||||||
4262752|NCT00606580|4087441|B4|||Days before treatment that index lesion was first noticed||days|Mean|39.2|39.2|Standard Deviation|22.2|22.2|||
4262753|NCT00606580|4087442|B3|||Days before treatment that index lesion was first noticed||days|Mean|38.9|38.9|Standard Deviation|20.5|20.5|||
4262754|NCT00606580|4087443|B2|||Days before treatment that index lesion was first noticed||days|Mean|39.5|39.5|Standard Deviation|20.0|20.0|||
4262755|NCT00606580|4087444|B1|||Days before treatment that index lesion was first noticed||days|Mean|39.3|39.3|Standard Deviation|25.7|25.7|||
4262756|NCT00606580|4087441|B4|Area of ulceration > 100 mm^2||All ulcerated lesions||lesions|Number|174|174.0||||||
4262757|NCT00606580|4087442|B3|Area of ulceration > 100 mm^2||All ulcerated lesions||lesions|Number|57|57.0||||||
4262758|NCT00606580|4087443|B2|Area of ulceration > 100 mm^2||All ulcerated lesions||lesions|Number|52|52.0||||||
4262759|NCT00606580|4087444|B1|Area of ulceration > 100 mm^2||All ulcerated lesions||lesions|Number|65|65.0||||||
4262760|NCT00606580|4087441|B4|Area of ulceration ≤ 100 m^2||All ulcerated lesions||lesions|Number|607|607.0||||||
4262761|NCT00606580|4087442|B3|Area of ulceration ≤ 100 m^2||All ulcerated lesions||lesions|Number|222|222.0||||||
4262762|NCT00606580|4087443|B2|Area of ulceration ≤ 100 m^2||All ulcerated lesions||lesions|Number|210|210.0||||||
4262763|NCT00606580|4087444|B1|Area of ulceration ≤ 100 m^2||All ulcerated lesions||lesions|Number|175|175.0||||||
4262764|NCT00606580|4087441|B4|||All lesion ulceration area|Lesion ulceration area per lesion independent of participant|mm^2|Mean|73.8|73.8|Standard Deviation|96.5|96.5|||
4262765|NCT00606580|4087442|B3|||All lesion ulceration area|Lesion ulceration area per lesion independent of participant|mm^2|Mean|70.3|70.3|Standard Deviation|91.4|91.4|||
4262766|NCT00606580|4087443|B2|||All lesion ulceration area|Lesion ulceration area per lesion independent of participant|mm^2|Mean|65.6|65.6|Standard Deviation|91.1|91.1|||
4262767|NCT00606580|4087444|B1|||All lesion ulceration area|Lesion ulceration area per lesion independent of participant|mm^2|Mean|86.8|86.8|Standard Deviation|107|107.0|||
4262768|NCT00606580|4087441|B4|Area of ulceration > 100 mm^2||Index lesion||participants|Number|130|130.0||||||
4262769|NCT00606580|4087442|B3|Area of ulceration > 100 mm^2||Index lesion||participants|Number|36|36.0||||||
4262770|NCT00606580|4087443|B2|Area of ulceration > 100 mm^2||Index lesion||participants|Number|41|41.0||||||
4262771|NCT00606580|4087444|B1|Area of ulceration > 100 mm^2||Index lesion||participants|Number|53|53.0||||||
4262772|NCT00606580|4087441|B4|Area of ulceration ≤ 100 m^2||Index lesion||participants|Number|245|245.0||||||
4262773|NCT00606580|4087442|B3|Area of ulceration ≤ 100 m^2||Index lesion||participants|Number|89|89.0||||||
4262774|NCT00606580|4087443|B2|Area of ulceration ≤ 100 m^2||Index lesion||participants|Number|84|84.0||||||
4262775|NCT00606580|4087444|B1|Area of ulceration ≤ 100 m^2||Index lesion||participants|Number|72|72.0||||||
4262776|NCT00606580|4087441|B4|||Index lesion ulceration area|Index lesion ulceration area per participant|mm^2|Mean|105|105.0|Standard Deviation|105|105.0|||
4262777|NCT00606580|4087442|B3|||Index lesion ulceration area|Index lesion ulceration area per participant|mm^2|Mean|97.7|97.7|Standard Deviation|112|112.0|||
4262778|NCT00606580|4087443|B2|||Index lesion ulceration area|Index lesion ulceration area per participant|mm^2|Mean|90.2|90.2|Standard Deviation|74.5|74.5|||
4262779|NCT00606580|4087444|B1|||Index lesion ulceration area|Index lesion ulceration area per participant|mm^2|Mean|126|126.0|Standard Deviation|121|121.0|||
4262780|NCT00606580|4087441|B4|Ulcerative||All lesion characteristics||lesions|Number|781|781.0||||||
4262781|NCT00606580|4087442|B3|Ulcerative||All lesion characteristics||lesions|Number|279|279.0||||||
4262782|NCT00606580|4087443|B2|Ulcerative||All lesion characteristics||lesions|Number|262|262.0||||||
4262783|NCT00606580|4087444|B1|Ulcerative||All lesion characteristics||lesions|Number|240|240.0||||||
4262784|NCT00606580|4087441|B4|Papule||All lesion characteristics||lesions|Number|1|1.0||||||
4262785|NCT00606580|4087442|B3|Papule||All lesion characteristics||lesions|Number|0|0.0||||||
4262786|NCT00606580|4087443|B2|Papule||All lesion characteristics||lesions|Number|1|1.0||||||
4262787|NCT00606580|4087444|B1|Papule||All lesion characteristics||lesions|Number|0|0.0||||||
4262788|NCT00606580|4087441|B4|Other||All lesion characteristics||lesions|Number|13|13.0||||||
4262789|NCT00606580|4087442|B3|Other||All lesion characteristics||lesions|Number|3|3.0||||||
4262790|NCT00606580|4087443|B2|Other||All lesion characteristics||lesions|Number|7|7.0||||||
4262791|NCT00606580|4087444|B1|Other||All lesion characteristics||lesions|Number|3|3.0||||||
4262792|NCT00606580|4087441|B4|Nodule||All lesion characteristics||lesions|Number|1|1.0||||||
4262793|NCT00606580|4087442|B3|Nodule||All lesion characteristics||lesions|Number|0|0.0||||||
4262794|NCT00606580|4087443|B2|Nodule||All lesion characteristics||lesions|Number|1|1.0||||||
4262795|NCT00606580|4087444|B1|Nodule||All lesion characteristics||lesions|Number|0|0.0||||||
4262796|NCT00606580|4087441|B4|Flat-like||All lesion characteristics||lesions|Number|1|1.0||||||
4262797|NCT00606580|4087442|B3|Flat-like||All lesion characteristics||lesions|Number|0|0.0||||||
4262798|NCT00606580|4087443|B2|Flat-like||All lesion characteristics||lesions|Number|1|1.0||||||
4262799|NCT00606580|4087444|B1|Flat-like||All lesion characteristics||lesions|Number|0|0.0||||||
4262800|NCT00606580|4087441|B4|Number of||All lesion characteristics||lesions|Number|797|797.0||||||
4262801|NCT00606580|4087442|B3|Number of||All lesion characteristics||lesions|Number|282|282.0||||||
4262802|NCT00606580|4087443|B2|Number of||All lesion characteristics||lesions|Number|272|272.0||||||
4262803|NCT00606580|4087444|B1|Number of||All lesion characteristics||lesions|Number|243|243.0||||||
4262804|NCT00606580|4087441|B4|More than 1 lesions||Total Number of lesions per subject||participants|Number|217|217.0||||||
4262805|NCT00606580|4087442|B3|More than 1 lesions||Total Number of lesions per subject||participants|Number|75|75.0||||||
4262806|NCT00606580|4087443|B2|More than 1 lesions||Total Number of lesions per subject||participants|Number|76|76.0||||||
4262807|NCT00606580|4087444|B1|More than 1 lesions||Total Number of lesions per subject||participants|Number|66|66.0||||||
4262808|NCT00606580|4087441|B4|1 lesion||Total Number of lesions per subject||participants|Number|158|158.0||||||
4262809|NCT00606580|4087442|B3|1 lesion||Total Number of lesions per subject||participants|Number|50|50.0||||||
4262810|NCT00606580|4087443|B2|1 lesion||Total Number of lesions per subject||participants|Number|49|49.0||||||
4262811|NCT00606580|4087444|B1|1 lesion||Total Number of lesions per subject||participants|Number|59|59.0||||||
4262812|NCT00606580|4087441|B4|North African||Race/Ethnicity, Customized||participants|Number|375|375.0||||||
4262813|NCT00606580|4087442|B3|North African||Race/Ethnicity, Customized||participants|Number|125|125.0||||||
4262814|NCT00606580|4087443|B2|North African||Race/Ethnicity, Customized||participants|Number|125|125.0||||||
4262815|NCT00606580|4087444|B1|North African||Race/Ethnicity, Customized||participants|Number|125|125.0||||||
4262816|NCT00606580|4087441|B4||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4262817|NCT00606580|4087442|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4262818|NCT00606580|4087443|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4262819|NCT00606580|4087444|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4262820|NCT00606580|4087441|B4||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4262821|NCT00606580|4087442|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4262822|NCT00606580|4087443|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4262823|NCT00606580|4087444|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4262824|NCT00606580|4087441|B4|Children (5 to 11)||Age, Customized||participants|Number|93|93.0||||||
4262825|NCT00606580|4087442|B3|Children (5 to 11)||Age, Customized||participants|Number|29|29.0||||||
4262826|NCT00606580|4087443|B2|Children (5 to 11)||Age, Customized||participants|Number|26|26.0||||||
4262827|NCT00606580|4087444|B1|Children (5 to 11)||Age, Customized||participants|Number|38|38.0||||||
4262828|NCT00606580|4087441|B4|Children (12 to 17)||Age, Customized||participants|Number|92|92.0||||||
4262829|NCT00606580|4087442|B3|Children (12 to 17)||Age, Customized||participants|Number|35|35.0||||||
4262830|NCT00606580|4087443|B2|Children (12 to 17)||Age, Customized||participants|Number|33|33.0||||||
4262831|NCT00606580|4087444|B1|Children (12 to 17)||Age, Customized||participants|Number|24|24.0||||||
4262832|NCT00606580|4087441|B4|Adults||Age, Customized||participants|Number|190|190.0||||||
4262833|NCT00606580|4087442|B3|Adults||Age, Customized||participants|Number|61|61.0||||||
4262834|NCT00606580|4087443|B2|Adults||Age, Customized||participants|Number|66|66.0||||||
4262835|NCT00606580|4087444|B1|Adults||Age, Customized||participants|Number|63|63.0||||||
4262836|NCT00606580|4087441|B4|||Age||years|Mean|23.7|23.7|Standard Deviation|15.6|15.6|||
4262837|NCT00606580|4087442|B3|||Age||years|Mean|23.2|23.2|Standard Deviation|15.2|15.2|||
4262838|NCT00606580|4087443|B2|||Age||years|Mean|24.6|24.6|Standard Deviation|15.7|15.7|||
4262839|NCT00606580|4087444|B1|||Age||years|Mean|23.4|23.4|Standard Deviation|15.9|15.9|||
4262840|NCT00606554|4087487|B3|||APACHE II Score|Acute Physiology and Chronic Health Evaluation Score Range 0-72 Higher score indicates more severe illness|score|Mean|25|25.0|Standard Deviation|7.4|7.4|||
4262841|NCT00606554|4087488|B2|||APACHE II Score|Acute Physiology and Chronic Health Evaluation Score Range 0-72 Higher score indicates more severe illness|score|Mean|26.5|26.5|Standard Deviation|7.1|7.1|||
4262842|NCT00606554|4087489|B1|||APACHE II Score|Acute Physiology and Chronic Health Evaluation Score Range 0-72 Higher score indicates more severe illness|score|Mean|23.3|23.3|Standard Deviation|7.7|7.7|||
4262843|NCT00606554|4087487|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4262844|NCT00606554|4087488|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4262845|NCT00606554|4087489|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4262846|NCT00606554|4087487|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4262847|NCT00606554|4087488|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4262848|NCT00606554|4087489|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4262849|NCT00606554|4087487|B3|||Age||years|Mean|55.7|55.7|Standard Deviation|18.9|18.9|||
4262850|NCT00606554|4087488|B2|||Age||years|Mean|60.5|60.5|Standard Deviation|15.5|15.5|||
4262851|NCT00606554|4087489|B1|||Age||years|Mean|50|50.0|Standard Deviation|21|21.0|||
4262852|NCT00606502|4087510|B3|Argentina||Region of Enrollment||participants|Number|19|19.0||||||
4262853|NCT00606502|4087511|B2|Argentina||Region of Enrollment||participants|Number|8|8.0||||||
4262854|NCT00606502|4087512|B1|Argentina||Region of Enrollment||participants|Number|11|11.0||||||
4262855|NCT00606502|4087510|B3|Brazil||Region of Enrollment||participants|Number|22|22.0||||||
4262856|NCT00606502|4087511|B2|Brazil||Region of Enrollment||participants|Number|9|9.0||||||
4262857|NCT00606502|4087512|B1|Brazil||Region of Enrollment||participants|Number|13|13.0||||||
4262858|NCT00606502|4087510|B3|India||Region of Enrollment||participants|Number|23|23.0||||||
4262859|NCT00606502|4087511|B2|India||Region of Enrollment||participants|Number|12|12.0||||||
4262860|NCT00606502|4087512|B1|India||Region of Enrollment||participants|Number|11|11.0||||||
4262861|NCT00606502|4087510|B3|Hungary||Region of Enrollment||participants|Number|32|32.0||||||
4262862|NCT00606502|4087511|B2|Hungary||Region of Enrollment||participants|Number|15|15.0||||||
4262863|NCT00606502|4087512|B1|Hungary||Region of Enrollment||participants|Number|17|17.0||||||
4262864|NCT00606502|4087510|B3|Czech Republic||Region of Enrollment||participants|Number|37|37.0||||||
4262865|NCT00606502|4087511|B2|Czech Republic||Region of Enrollment||participants|Number|20|20.0||||||
4262866|NCT00606502|4087512|B1|Czech Republic||Region of Enrollment||participants|Number|17|17.0||||||
4262867|NCT00606502|4087510|B3|United States||Region of Enrollment||participants|Number|68|68.0||||||
4262868|NCT00606502|4087511|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4262869|NCT00606502|4087512|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4262870|NCT00606502|4087510|B3||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4262871|NCT00606502|4087511|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4262872|NCT00606502|4087512|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4262873|NCT00606502|4087510|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4262874|NCT00606502|4087511|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4262875|NCT00606502|4087512|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4262876|NCT00606502|4087510|B3|||Age||years|Median|63.0|63.0|Standard Deviation|9.0|9.0|||
4262877|NCT00606502|4087511|B2|||Age||years|Median|62.0|62.0|Standard Deviation|9.1|9.1|||
4262878|NCT00606502|4087512|B1|||Age||years|Median|63.0|63.0|Standard Deviation|9.0|9.0|||
4262879|NCT00606502|4087510|B3|>=65 years||Age, Customized||participants|Number|83|83.0||||||
4262880|NCT00606502|4087511|B2|>=65 years||Age, Customized||participants|Number|41|41.0||||||
4262881|NCT00606502|4087512|B1|>=65 years||Age, Customized||participants|Number|42|42.0||||||
4262882|NCT00606502|4087510|B3|Between 18 and 65 years||Age, Customized||participants|Number|118|118.0||||||
4262883|NCT00606502|4087511|B2|Between 18 and 65 years||Age, Customized||participants|Number|60|60.0||||||
4262884|NCT00606502|4087512|B1|Between 18 and 65 years||Age, Customized||participants|Number|58|58.0||||||
4262885|NCT00606489|4087525|B3|India||Region of Enrollment||participants|Number|45|45.0||||||
4262886|NCT00606489|4087526|B2|India||Region of Enrollment||participants|Number|31|31.0||||||
4262887|NCT00606489|4087527|B1|India||Region of Enrollment||participants|Number|14|14.0||||||
4262888|NCT00606489|4087525|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4262889|NCT00606489|4087526|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4262890|NCT00606489|4087527|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4262891|NCT00606489|4087525|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4262892|NCT00606489|4087526|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4262893|NCT00606489|4087527|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4262894|NCT00606489|4087525|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4262895|NCT00606489|4087526|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4262896|NCT00606489|4087527|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4262897|NCT00606489|4087525|B3|>12 years old||Age, Customized||participants|Number|61|61.0||||||
4262898|NCT00606489|4087526|B2|>12 years old||Age, Customized||participants|Number|40|40.0||||||
4262899|NCT00606489|4087527|B1|>12 years old||Age, Customized||participants|Number|21|21.0||||||
4262900|NCT00606489|4087525|B3|<=12 years old||Age, Customized||participants|Number|0|0.0||||||
4262901|NCT00606489|4087526|B2|<=12 years old||Age, Customized||participants|Number|0|0.0||||||
4262902|NCT00606489|4087527|B1|<=12 years old||Age, Customized||participants|Number|0|0.0||||||
4262903|NCT00606489|4087525|B3|||Age||years|Mean|32|32.0|Standard Deviation|11.2|11.2|||
4262904|NCT00606489|4087526|B2|||Age||years|Mean|33|33.0|Standard Deviation|10.8|10.8|||
4262905|NCT00606489|4087527|B1|||Age||years|Mean|30|30.0|Standard Deviation|11.9|11.9|||
4262906|NCT00606320|4087534|B1|Philippines||Region of Enrollment||participants|Number|12|12.0||||||
4262907|NCT00606320|4087534|B1|Indonesia||Region of Enrollment||participants|Number|4|4.0||||||
4262908|NCT00606320|4087534|B1|Malaysia||Region of Enrollment||participants|Number|6|6.0||||||
4262909|NCT00606320|4087534|B1|Japan||Region of Enrollment||participants|Number|11|11.0||||||
4262910|NCT00606320|4087534|B1|China||Region of Enrollment||participants|Number|17|17.0||||||
4262911|NCT00606320|4087534|B1|Taiwan||Region of Enrollment||participants|Number|5|5.0||||||
4262912|NCT00606320|4087534|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4262913|NCT00606320|4087534|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4262914|NCT00606320|4087534|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4262915|NCT00606320|4087534|B1||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4262916|NCT00606320|4087534|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4262917|NCT00606320|4087534|B1|||Age||years|Mean|34.5|34.5|Standard Deviation|12.45|12.45|||
4262918|NCT00606281|4087539|B3|Philippines||Region of Enrollment||participants|Number|37|37.0||||||
4262919|NCT00606281|4087540|B2|Philippines||Region of Enrollment||participants|Number|18|18.0||||||
4262920|NCT00606281|4087541|B1|Philippines||Region of Enrollment||participants|Number|19|19.0||||||
4262921|NCT00606281|4087539|B3|Malaysia||Region of Enrollment||participants|Number|25|25.0||||||
4262922|NCT00606281|4087540|B2|Malaysia||Region of Enrollment||participants|Number|13|13.0||||||
4262923|NCT00606281|4087541|B1|Malaysia||Region of Enrollment||participants|Number|12|12.0||||||
4262924|NCT00606281|4087539|B3|Indonesia||Region of Enrollment||participants|Number|15|15.0||||||
4262925|NCT00606281|4087540|B2|Indonesia||Region of Enrollment||participants|Number|8|8.0||||||
4262926|NCT00606281|4087541|B1|Indonesia||Region of Enrollment||participants|Number|7|7.0||||||
4262927|NCT00606281|4087539|B3|Japan||Region of Enrollment||participants|Number|79|79.0||||||
4262928|NCT00606281|4087540|B2|Japan||Region of Enrollment||participants|Number|40|40.0||||||
4262929|NCT00606281|4087541|B1|Japan||Region of Enrollment||participants|Number|39|39.0||||||
4262930|NCT00606281|4087539|B3|China||Region of Enrollment||participants|Number|56|56.0||||||
4262931|NCT00606281|4087540|B2|China||Region of Enrollment||participants|Number|28|28.0||||||
4262932|NCT00606281|4087541|B1|China||Region of Enrollment||participants|Number|28|28.0||||||
4262933|NCT00606281|4087539|B3|Taiwan||Region of Enrollment||participants|Number|35|35.0||||||
4262934|NCT00606281|4087540|B2|Taiwan||Region of Enrollment||participants|Number|18|18.0||||||
4262935|NCT00606281|4087541|B1|Taiwan||Region of Enrollment||participants|Number|17|17.0||||||
4262936|NCT00606281|4087539|B3||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4262937|NCT00606281|4087540|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4262938|NCT00606281|4087541|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4262939|NCT00606281|4087539|B3||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4262940|NCT00606281|4087540|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4262941|NCT00606281|4087541|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4262942|NCT00606281|4087539|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4262943|NCT00606281|4087540|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4262944|NCT00606281|4087541|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4262945|NCT00606281|4087539|B3||Between 18 and 65 years|Age||Participants|Count of Participants|242|242.0||||||
4262946|NCT00606281|4087540|B2||Between 18 and 65 years|Age||Participants|Count of Participants|123|123.0||||||
4262947|NCT00606281|4087541|B1||Between 18 and 65 years|Age||Participants|Count of Participants|119|119.0||||||
4262948|NCT00606281|4087539|B3||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4262949|NCT00606281|4087540|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4262950|NCT00606281|4087541|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4262951|NCT00606281|4087539|B3|||Age||years|Mean|37.6|37.6|Standard Deviation|12.50|12.5|||
4262952|NCT00606281|4087540|B2|||Age||years|Mean|37.8|37.8|Standard Deviation|12.69|12.69|||
4262953|NCT00606281|4087541|B1|||Age||years|Mean|37.5|37.5|Standard Deviation|12.46|12.46|||
4262954|NCT00606229|4087550|B1|Japan||Region of Enrollment||participants|Number|40|40.0||||||
4262955|NCT00606229|4087550|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4262956|NCT00606229|4087550|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4262957|NCT00606229|4087550|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4262958|NCT00606229|4087550|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4262959|NCT00606229|4087550|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4262960|NCT00606229|4087550|B1|||Age||years|Mean|40.4|40.4|Standard Deviation|10.89|10.89|||
4262961|NCT00606177|4087555|B3|Philippines||Region of Enrollment||participants|Number|16|16.0||||||
4262962|NCT00606177|4087556|B2|Philippines||Region of Enrollment||participants|Number|6|6.0||||||
4262963|NCT00606177|4087557|B1|Philippines||Region of Enrollment||participants|Number|10|10.0||||||
4262964|NCT00606177|4087555|B3|Indonesia||Region of Enrollment||participants|Number|7|7.0||||||
4262965|NCT00606177|4087556|B2|Indonesia||Region of Enrollment||participants|Number|2|2.0||||||
4262966|NCT00606177|4087557|B1|Indonesia||Region of Enrollment||participants|Number|5|5.0||||||
4262967|NCT00606177|4087555|B3|Malaysia||Region of Enrollment||participants|Number|10|10.0||||||
4262968|NCT00606177|4087556|B2|Malaysia||Region of Enrollment||participants|Number|6|6.0||||||
4262969|NCT00606177|4087557|B1|Malaysia||Region of Enrollment||participants|Number|4|4.0||||||
4262970|NCT00606177|4087555|B3|Japan||Region of Enrollment||participants|Number|32|32.0||||||
4262971|NCT00606177|4087556|B2|Japan||Region of Enrollment||participants|Number|10|10.0||||||
4262972|NCT00606177|4087557|B1|Japan||Region of Enrollment||participants|Number|22|22.0||||||
4262973|NCT00606177|4087555|B3|China||Region of Enrollment||participants|Number|18|18.0||||||
4262974|NCT00606177|4087556|B2|China||Region of Enrollment||participants|Number|9|9.0||||||
4262975|NCT00606177|4087557|B1|China||Region of Enrollment||participants|Number|9|9.0||||||
4262976|NCT00606177|4087555|B3|Taiwan||Region of Enrollment||participants|Number|13|13.0||||||
4262977|NCT00606177|4087556|B2|Taiwan||Region of Enrollment||participants|Number|9|9.0||||||
4262978|NCT00606177|4087557|B1|Taiwan||Region of Enrollment||participants|Number|4|4.0||||||
4262979|NCT00606177|4087555|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4262980|NCT00606177|4087556|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4262981|NCT00606177|4087557|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4262982|NCT00606177|4087555|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4262983|NCT00606177|4087556|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4262984|NCT00606177|4087557|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4262985|NCT00606177|4087555|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4262986|NCT00606177|4087556|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4262987|NCT00606177|4087557|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4262988|NCT00606177|4087555|B3||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
4262989|NCT00606177|4087556|B2||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4262990|NCT00606177|4087557|B1||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4262991|NCT00606177|4087555|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4262992|NCT00606177|4087556|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4262993|NCT00606177|4087557|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4262994|NCT00606177|4087555|B3|||Age||years|Mean|38.3|38.3|Standard Deviation|11.78|11.78|||
4262995|NCT00606177|4087556|B2|||Age||years|Mean|37.8|37.8|Standard Deviation|11.67|11.67|||
4262996|NCT00606177|4087557|B1|||Age||years|Mean|38.7|38.7|Standard Deviation|11.95|11.95|||
4262997|NCT00606138|4087566|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4262998|NCT00606138|4087567|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4262999|NCT00606138|4087568|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4263000|NCT00606138|4087566|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4263001|NCT00606138|4087567|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4263002|NCT00606138|4087568|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4263003|NCT00606138|4087566|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4263004|NCT00606138|4087567|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4263005|NCT00606138|4087568|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4263006|NCT00606138|4087566|B3|||Age||years|Median|59|59.0|Full Range|||50.0|73.0|
4263007|NCT00606138|4087567|B2|||Age||years|Median|67|67.0|Full Range|||60.0|73.0|
4263008|NCT00606138|4087568|B1|||Age||years|Median|57|57.0|Full Range|||50.0|62.0|
4263009|NCT00606138|4087566|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4263010|NCT00606138|4087567|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4263011|NCT00606138|4087568|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4263012|NCT00606138|4087566|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4263013|NCT00606138|4087567|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4263014|NCT00606138|4087568|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4263015|NCT00606138|4087566|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4263016|NCT00606138|4087567|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4263017|NCT00606138|4087568|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4263018|NCT00606086|4087583|B3|India||Region of Enrollment||participants|Number|6|6.0||||||
4263019|NCT00606086|4087584|B2|India||Region of Enrollment||participants|Number|2|2.0||||||
4263020|NCT00606086|4087585|B1|India||Region of Enrollment||participants|Number|4|4.0||||||
4263021|NCT00606086|4087583|B3|Europe||Region of Enrollment||participants|Number|10|10.0||||||
4263022|NCT00606086|4087584|B2|Europe||Region of Enrollment||participants|Number|4|4.0||||||
4263023|NCT00606086|4087585|B1|Europe||Region of Enrollment||participants|Number|6|6.0||||||
4263024|NCT00606086|4087583|B3|United States||Region of Enrollment||participants|Number|124|124.0||||||
4263025|NCT00606086|4087584|B2|United States||Region of Enrollment||participants|Number|62|62.0||||||
4263026|NCT00606086|4087585|B1|United States||Region of Enrollment||participants|Number|62|62.0||||||
4263027|NCT00606086|4087583|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4263028|NCT00606086|4087584|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4263029|NCT00606086|4087585|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4263030|NCT00606086|4087583|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4263031|NCT00606086|4087584|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4263032|NCT00606086|4087585|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4263033|NCT00606086|4087583|B3|||Age||years|Median|48|48.0|Full Range|||20.0|74.0|
4263034|NCT00606086|4087584|B2|||Age||years|Median|49|49.0|Full Range|||20.0|68.0|
4263035|NCT00606086|4087585|B1|||Age||years|Median|48|48.0|Full Range|||20.0|74.0|
4263036|NCT00606034|4087592|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4263037|NCT00606034|4087592|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4263038|NCT00606034|4087592|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4263039|NCT00606034|4087592|B1|||Age||years|Mean|53.86|53.86|Standard Deviation|11.2|11.2|||
4263040|NCT00606034|4087592|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4263041|NCT00606034|4087592|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4263042|NCT00606034|4087592|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4263043|NCT00606021|4087598|B3|Unknown||Lesion Response to induction phase|The lesions response is classified by the investigator according to the Response Evaluation Criteria In Solid Tumors (RECIST) guidelines. Complete Response (CR): disappearance of all target lesions; Partial Response: (PR) ≥30% decrease in sum of longest diameter of target lesions. Stable Disease (SD): neither sufficient shrinkage to qualify for PR nor sufficient increase to qualify for progressive disease (PD: ≥20% increase in sum of longest diameter of target lesions).|participants|Number|3|3.0||||||
4263044|NCT00606021|4087599|B2|Unknown||Lesion Response to induction phase|The lesions response is classified by the investigator according to the Response Evaluation Criteria In Solid Tumors (RECIST) guidelines. Complete Response (CR): disappearance of all target lesions; Partial Response: (PR) ≥30% decrease in sum of longest diameter of target lesions. Stable Disease (SD): neither sufficient shrinkage to qualify for PR nor sufficient increase to qualify for progressive disease (PD: ≥20% increase in sum of longest diameter of target lesions).|participants|Number|2|2.0||||||
4263045|NCT00606021|4087600|B1|Unknown||Lesion Response to induction phase|The lesions response is classified by the investigator according to the Response Evaluation Criteria In Solid Tumors (RECIST) guidelines. Complete Response (CR): disappearance of all target lesions; Partial Response: (PR) ≥30% decrease in sum of longest diameter of target lesions. Stable Disease (SD): neither sufficient shrinkage to qualify for PR nor sufficient increase to qualify for progressive disease (PD: ≥20% increase in sum of longest diameter of target lesions).|participants|Number|1|1.0||||||
4263046|NCT00606021|4087598|B3|Stable Disease (SD)||Lesion Response to induction phase|The lesions response is classified by the investigator according to the Response Evaluation Criteria In Solid Tumors (RECIST) guidelines. Complete Response (CR): disappearance of all target lesions; Partial Response: (PR) ≥30% decrease in sum of longest diameter of target lesions. Stable Disease (SD): neither sufficient shrinkage to qualify for PR nor sufficient increase to qualify for progressive disease (PD: ≥20% increase in sum of longest diameter of target lesions).|participants|Number|30|30.0||||||
4263047|NCT00606021|4087599|B2|Stable Disease (SD)||Lesion Response to induction phase|The lesions response is classified by the investigator according to the Response Evaluation Criteria In Solid Tumors (RECIST) guidelines. Complete Response (CR): disappearance of all target lesions; Partial Response: (PR) ≥30% decrease in sum of longest diameter of target lesions. Stable Disease (SD): neither sufficient shrinkage to qualify for PR nor sufficient increase to qualify for progressive disease (PD: ≥20% increase in sum of longest diameter of target lesions).|participants|Number|13|13.0||||||
4263048|NCT00606021|4087600|B1|Stable Disease (SD)||Lesion Response to induction phase|The lesions response is classified by the investigator according to the Response Evaluation Criteria In Solid Tumors (RECIST) guidelines. Complete Response (CR): disappearance of all target lesions; Partial Response: (PR) ≥30% decrease in sum of longest diameter of target lesions. Stable Disease (SD): neither sufficient shrinkage to qualify for PR nor sufficient increase to qualify for progressive disease (PD: ≥20% increase in sum of longest diameter of target lesions).|participants|Number|17|17.0||||||
4263049|NCT00606021|4087598|B3|Partial Response (PR)||Lesion Response to induction phase|The lesions response is classified by the investigator according to the Response Evaluation Criteria In Solid Tumors (RECIST) guidelines. Complete Response (CR): disappearance of all target lesions; Partial Response: (PR) ≥30% decrease in sum of longest diameter of target lesions. Stable Disease (SD): neither sufficient shrinkage to qualify for PR nor sufficient increase to qualify for progressive disease (PD: ≥20% increase in sum of longest diameter of target lesions).|participants|Number|21|21.0||||||
4263050|NCT00606021|4087599|B2|Partial Response (PR)||Lesion Response to induction phase|The lesions response is classified by the investigator according to the Response Evaluation Criteria In Solid Tumors (RECIST) guidelines. Complete Response (CR): disappearance of all target lesions; Partial Response: (PR) ≥30% decrease in sum of longest diameter of target lesions. Stable Disease (SD): neither sufficient shrinkage to qualify for PR nor sufficient increase to qualify for progressive disease (PD: ≥20% increase in sum of longest diameter of target lesions).|participants|Number|11|11.0||||||
4263051|NCT00606021|4087600|B1|Partial Response (PR)||Lesion Response to induction phase|The lesions response is classified by the investigator according to the Response Evaluation Criteria In Solid Tumors (RECIST) guidelines. Complete Response (CR): disappearance of all target lesions; Partial Response: (PR) ≥30% decrease in sum of longest diameter of target lesions. Stable Disease (SD): neither sufficient shrinkage to qualify for PR nor sufficient increase to qualify for progressive disease (PD: ≥20% increase in sum of longest diameter of target lesions).|participants|Number|10|10.0||||||
4263052|NCT00606021|4087598|B3|Complete Response (CR)||Lesion Response to induction phase|The lesions response is classified by the investigator according to the Response Evaluation Criteria In Solid Tumors (RECIST) guidelines. Complete Response (CR): disappearance of all target lesions; Partial Response: (PR) ≥30% decrease in sum of longest diameter of target lesions. Stable Disease (SD): neither sufficient shrinkage to qualify for PR nor sufficient increase to qualify for progressive disease (PD: ≥20% increase in sum of longest diameter of target lesions).|participants|Number|1|1.0||||||
4263053|NCT00606021|4087599|B2|Complete Response (CR)||Lesion Response to induction phase|The lesions response is classified by the investigator according to the Response Evaluation Criteria In Solid Tumors (RECIST) guidelines. Complete Response (CR): disappearance of all target lesions; Partial Response: (PR) ≥30% decrease in sum of longest diameter of target lesions. Stable Disease (SD): neither sufficient shrinkage to qualify for PR nor sufficient increase to qualify for progressive disease (PD: ≥20% increase in sum of longest diameter of target lesions).|participants|Number|1|1.0||||||
4263054|NCT00606021|4087600|B1|Complete Response (CR)||Lesion Response to induction phase|The lesions response is classified by the investigator according to the Response Evaluation Criteria In Solid Tumors (RECIST) guidelines. Complete Response (CR): disappearance of all target lesions; Partial Response: (PR) ≥30% decrease in sum of longest diameter of target lesions. Stable Disease (SD): neither sufficient shrinkage to qualify for PR nor sufficient increase to qualify for progressive disease (PD: ≥20% increase in sum of longest diameter of target lesions).|participants|Number|0|0.0||||||
4263055|NCT00606021|4087598|B3|2 - Ambulatory, unable to carry out work activity||Eastern Cooperative Oncology Group (ECOG) Performance Status at randomization of maintenance phase|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|4|4.0||||||
4263056|NCT00606021|4087599|B2|2 - Ambulatory, unable to carry out work activity||Eastern Cooperative Oncology Group (ECOG) Performance Status at randomization of maintenance phase|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|2|2.0||||||
4263057|NCT00606021|4087600|B1|2 - Ambulatory, unable to carry out work activity||Eastern Cooperative Oncology Group (ECOG) Performance Status at randomization of maintenance phase|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|2|2.0||||||
4263058|NCT00606021|4087598|B3|1 - Ambulatory, restricted strenuous activity||Eastern Cooperative Oncology Group (ECOG) Performance Status at randomization of maintenance phase|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|37|37.0||||||
4263059|NCT00606021|4087599|B2|1 - Ambulatory, restricted strenuous activity||Eastern Cooperative Oncology Group (ECOG) Performance Status at randomization of maintenance phase|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|17|17.0||||||
4263060|NCT00606021|4087600|B1|1 - Ambulatory, restricted strenuous activity||Eastern Cooperative Oncology Group (ECOG) Performance Status at randomization of maintenance phase|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|20|20.0||||||
4263061|NCT00606021|4087598|B3|0 - Fully active||Eastern Cooperative Oncology Group (ECOG) Performance Status at randomization of maintenance phase|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|14|14.0||||||
4263062|NCT00606021|4087599|B2|0 - Fully active||Eastern Cooperative Oncology Group (ECOG) Performance Status at randomization of maintenance phase|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|8|8.0||||||
4263168|NCT00605904|4087673|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4263169|NCT00605904|4087674|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4263063|NCT00606021|4087600|B1|0 - Fully active||Eastern Cooperative Oncology Group (ECOG) Performance Status at randomization of maintenance phase|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|6|6.0||||||
4263064|NCT00606021|4087598|B3|Stage IV - Metastasized||Stage of Disease at The Time of Entry into This Study||participants|Number|36|36.0||||||
4263065|NCT00606021|4087599|B2|Stage IV - Metastasized||Stage of Disease at The Time of Entry into This Study||participants|Number|17|17.0||||||
4263066|NCT00606021|4087600|B1|Stage IV - Metastasized||Stage of Disease at The Time of Entry into This Study||participants|Number|19|19.0||||||
4263067|NCT00606021|4087598|B3|Stage III B - Locally advanced||Stage of Disease at The Time of Entry into This Study||participants|Number|19|19.0||||||
4263068|NCT00606021|4087599|B2|Stage III B - Locally advanced||Stage of Disease at The Time of Entry into This Study||participants|Number|10|10.0||||||
4263069|NCT00606021|4087600|B1|Stage III B - Locally advanced||Stage of Disease at The Time of Entry into This Study||participants|Number|9|9.0||||||
4263070|NCT00606021|4087598|B3|Adenocarcinoma||Pathological Diagnosis||participants|Number|40|40.0||||||
4263071|NCT00606021|4087599|B2|Adenocarcinoma||Pathological Diagnosis||participants|Number|21|21.0||||||
4263072|NCT00606021|4087600|B1|Adenocarcinoma||Pathological Diagnosis||participants|Number|19|19.0||||||
4263073|NCT00606021|4087598|B3|Large Cells Lung Carcinoma||Pathological Diagnosis||participants|Number|13|13.0||||||
4263074|NCT00606021|4087599|B2|Large Cells Lung Carcinoma||Pathological Diagnosis||participants|Number|5|5.0||||||
4263075|NCT00606021|4087600|B1|Large Cells Lung Carcinoma||Pathological Diagnosis||participants|Number|8|8.0||||||
4263076|NCT00606021|4087598|B3|Mixed Cell Carcinoma, Lung||Pathological Diagnosis||participants|Number|2|2.0||||||
4263077|NCT00606021|4087599|B2|Mixed Cell Carcinoma, Lung||Pathological Diagnosis||participants|Number|1|1.0||||||
4263078|NCT00606021|4087600|B1|Mixed Cell Carcinoma, Lung||Pathological Diagnosis||participants|Number|1|1.0||||||
4263079|NCT00606021|4087598|B3|Lebanon||Region of Enrollment||participants|Number|11|11.0||||||
4263080|NCT00606021|4087599|B2|Lebanon||Region of Enrollment||participants|Number|7|7.0||||||
4263081|NCT00606021|4087600|B1|Lebanon||Region of Enrollment||participants|Number|4|4.0||||||
4263082|NCT00606021|4087598|B3|Saudi Arabia||Region of Enrollment||participants|Number|1|1.0||||||
4263083|NCT00606021|4087599|B2|Saudi Arabia||Region of Enrollment||participants|Number|1|1.0||||||
4263084|NCT00606021|4087600|B1|Saudi Arabia||Region of Enrollment||participants|Number|0|0.0||||||
4263085|NCT00606021|4087598|B3|Egypt||Region of Enrollment||participants|Number|43|43.0||||||
4263086|NCT00606021|4087599|B2|Egypt||Region of Enrollment||participants|Number|19|19.0||||||
4263087|NCT00606021|4087600|B1|Egypt||Region of Enrollment||participants|Number|24|24.0||||||
4263088|NCT00606021|4087598|B3|African||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4263089|NCT00606021|4087599|B2|African||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4263090|NCT00606021|4087600|B1|African||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4263091|NCT00606021|4087598|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|52|52.0||||||
4263092|NCT00606021|4087599|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|26|26.0||||||
4263093|NCT00606021|4087600|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|26|26.0||||||
4263094|NCT00606021|4087598|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4263095|NCT00606021|4087599|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4263096|NCT00606021|4087600|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4263097|NCT00606021|4087598|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4263098|NCT00606021|4087599|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4263099|NCT00606021|4087600|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4263100|NCT00606021|4087598|B3|||Age||years|Mean|60.1|60.1|Standard Deviation|11.57|11.57|||
4263101|NCT00606021|4087599|B2|||Age||years|Mean|62.9|62.9|Standard Deviation|9.97|9.97|||
4263102|NCT00606021|4087600|B1|||Age||years|Mean|57.4|57.4|Standard Deviation|12.52|12.52|||
4263103|NCT00606008|4087620|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4263104|NCT00606008|4087620|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4263105|NCT00606008|4087620|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4263106|NCT00606008|4087620|B1|||Age||years|Median|52|52.0|Full Range|||30.0|77.0|
4263107|NCT00606008|4087620|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4263108|NCT00606008|4087620|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4263109|NCT00606008|4087620|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4263110|NCT00605917|4087634|B1|other||Starting dose|Starting dose of each participant enrolled in this study|participants|Number|9|9.0||||||
4263111|NCT00605917|4087634|B1|100 mg||Starting dose|Starting dose of each participant enrolled in this study|participants|Number|6|6.0||||||
4263112|NCT00605917|4087634|B1|75 mg||Starting dose|Starting dose of each participant enrolled in this study|participants|Number|18|18.0||||||
4263113|NCT00605917|4087634|B1|50 mg||Starting dose|Starting dose of each participant enrolled in this study|participants|Number|176|176.0||||||
4263114|NCT00605917|4087634|B1|25 mg||Starting dose|Starting dose of each participant enrolled in this study|participants|Number|699|699.0||||||
4263115|NCT00605917|4087634|B1|Absent||Concomitant drug|Concomitant drugs is the drugs which participant had taken during the observation period of this study to treat for participant's illnesses, injuries etc. The physician of this survey listed all of concomitant drugs. (e.g. paroxetine, milnacipran, etc.)|participants|Number|237|237.0||||||
4263170|NCT00605904|4087675|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4263171|NCT00605865|4087686|B1|Other than Those Above||Starting Dose|Starting dose of each participant enrolled in this study|participants|Number|40|40.0||||||
4263116|NCT00605917|4087634|B1|Present||Concomitant drug|Concomitant drugs is the drugs which participant had taken during the observation period of this study to treat for participant's illnesses, injuries etc. The physician of this survey listed all of concomitant drugs. (e.g. paroxetine, milnacipran, etc.)|participants|Number|671|671.0||||||
4263117|NCT00605917|4087634|B1|Absent||Complications|Complications is the patient's current experiences with illnesses, operations, injuries and treatments. The physician of this survey made the diagnosis. (e.g. hypertension, diabetes, etc.)|participants|Number|603|603.0||||||
4263118|NCT00605917|4087634|B1|Present||Complications|Complications is the patient's current experiences with illnesses, operations, injuries and treatments. The physician of this survey made the diagnosis. (e.g. hypertension, diabetes, etc.)|participants|Number|305|305.0||||||
4263119|NCT00605917|4087634|B1|Severe||Target Disease Severity|The severity of target disease which was diagnosed by investigator|participants|Number|72|72.0||||||
4263120|NCT00605917|4087634|B1|Moderate||Target Disease Severity|The severity of target disease which was diagnosed by investigator|participants|Number|511|511.0||||||
4263121|NCT00605917|4087634|B1|Mild||Target Disease Severity|The severity of target disease which was diagnosed by investigator|participants|Number|325|325.0||||||
4263122|NCT00605917|4087634|B1||Male|Sex: Female, Male||Participants|Count of Participants|316|316.0||||||
4263123|NCT00605917|4087634|B1||Female|Sex: Female, Male||Participants|Count of Participants|592|592.0||||||
4263124|NCT00605917|4087634|B1|>=65 years||Age, Customized||participants|Number|45|45.0||||||
4263125|NCT00605917|4087634|B1|<65 years||Age, Customized||participants|Number|863|863.0||||||
4263126|NCT00605904|4087673|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263127|NCT00605904|4087674|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263128|NCT00605904|4087675|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263129|NCT00605904|4087673|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263130|NCT00605904|4087674|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263131|NCT00605904|4087675|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263132|NCT00605904|4087673|B3||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4263133|NCT00605904|4087674|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4263134|NCT00605904|4087675|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4263135|NCT00605904|4087673|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4263136|NCT00605904|4087674|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4263137|NCT00605904|4087675|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4263138|NCT00605904|4087673|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263139|NCT00605904|4087674|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263140|NCT00605904|4087675|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263141|NCT00605904|4087673|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4263142|NCT00605904|4087674|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263143|NCT00605904|4087675|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4263144|NCT00605904|4087673|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263145|NCT00605904|4087674|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263146|NCT00605904|4087675|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263147|NCT00605904|4087673|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4263148|NCT00605904|4087674|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4263149|NCT00605904|4087675|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263150|NCT00605904|4087673|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4263151|NCT00605904|4087674|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4263152|NCT00605904|4087675|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4263153|NCT00605904|4087673|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263154|NCT00605904|4087674|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263155|NCT00605904|4087675|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263156|NCT00605904|4087673|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4263157|NCT00605904|4087674|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4263158|NCT00605904|4087675|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4263159|NCT00605904|4087673|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4263160|NCT00605904|4087674|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4263161|NCT00605904|4087675|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4263162|NCT00605904|4087673|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4263163|NCT00605904|4087674|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4263164|NCT00605904|4087675|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4263165|NCT00605904|4087673|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4263166|NCT00605904|4087674|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4263167|NCT00605904|4087675|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4263172|NCT00605865|4087686|B1|100 mg||Starting Dose|Starting dose of each participant enrolled in this study|participants|Number|31|31.0||||||
4263173|NCT00605865|4087686|B1|75 mg||Starting Dose|Starting dose of each participant enrolled in this study|participants|Number|33|33.0||||||
4263174|NCT00605865|4087686|B1|50 mg||Starting Dose|Starting dose of each participant enrolled in this study|participants|Number|523|523.0||||||
4263175|NCT00605865|4087686|B1|25 mg||Starting Dose|Starting dose of each participant enrolled in this study|participants|Number|1530|1530.0||||||
4263176|NCT00605865|4087686|B1|Absent||Concomitant Drug|Concomitant drugs is the drugs which participant had taken during the observation period of this study to treat for participant's illnesses, injuries etc. The physician of this survey listed all of concomitant drugs. (e.g. paroxetine, milnacipran, etc.)|participants|Number|283|283.0||||||
4263177|NCT00605865|4087686|B1|Present||Concomitant Drug|Concomitant drugs is the drugs which participant had taken during the observation period of this study to treat for participant's illnesses, injuries etc. The physician of this survey listed all of concomitant drugs. (e.g. paroxetine, milnacipran, etc.)|participants|Number|1874|1874.0||||||
4263178|NCT00605865|4087686|B1|Absent||Complications|Complications is the patient's current experiences with illnesses, operations, injuries and treatments. The physician of this survey made the diagnosis. (e.g. hypertension, diabetes, etc.)|participants|Number|1380|1380.0||||||
4263179|NCT00605865|4087686|B1|Present||Complications|Complications is the patient's current experiences with illnesses, operations, injuries and treatments. The physician of this survey made the diagnosis. (e.g. hypertension, diabetes, etc.)|participants|Number|777|777.0||||||
4263180|NCT00605865|4087686|B1|Severe||Target Disease Severity|The severity of target disease which was diagnosed by investigator|participants|Number|166|166.0||||||
4263181|NCT00605865|4087686|B1|Moderate||Target Disease Severity|The severity of target disease which was diagnosed by investigator|participants|Number|1423|1423.0||||||
4263182|NCT00605865|4087686|B1|Mild||Target Disease Severity|The severity of target disease which was diagnosed by investigator|participants|Number|568|568.0||||||
4263183|NCT00605865|4087686|B1|Other than Those Above||Target Disease|The target disease which was diagnosed by investigator|participants|Number|81|81.0||||||
4263184|NCT00605865|4087686|B1|Depression/Depressed state and Panic Disorder||Target Disease|The target disease which was diagnosed by investigator|participants|Number|56|56.0||||||
4263185|NCT00605865|4087686|B1|Panic Disorder||Target Disease|The target disease which was diagnosed by investigator|participants|Number|150|150.0||||||
4263186|NCT00605865|4087686|B1|Depression/Depressed State||Target Disease|The target disease which was diagnosed by investigator|participants|Number|1870|1870.0||||||
4263187|NCT00605865|4087686|B1||Male|Sex: Female, Male||Participants|Count of Participants|868|868.0||||||
4263188|NCT00605865|4087686|B1||Female|Sex: Female, Male||Participants|Count of Participants|1289|1289.0||||||
4263189|NCT00605865|4087686|B1|>=65 years||Age, Customized||participants|Number|337|337.0||||||
4263190|NCT00605865|4087686|B1|<65 years||Age, Customized||participants|Number|1820|1820.0||||||
4263191|NCT00605839|4087725|B4|United States||Region of Enrollment||participants|Number|105|105.0||||||
4263192|NCT00605839|4087726|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
4263193|NCT00605839|4087727|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4263194|NCT00605839|4087728|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4263195|NCT00605839|4087725|B4||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4263196|NCT00605839|4087726|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4263197|NCT00605839|4087727|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4263198|NCT00605839|4087728|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4263199|NCT00605839|4087725|B4||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4263200|NCT00605839|4087726|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4263201|NCT00605839|4087727|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4263202|NCT00605839|4087728|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4263203|NCT00605839|4087725|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4263204|NCT00605839|4087726|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4263205|NCT00605839|4087727|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4263206|NCT00605839|4087728|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4263207|NCT00605839|4087725|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4263208|NCT00605839|4087726|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4263209|NCT00605839|4087727|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4263210|NCT00605839|4087728|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4263211|NCT00605839|4087725|B4||<=18 years|Age||Participants|Count of Participants|105|105.0||||||
4263212|NCT00605839|4087726|B3||<=18 years|Age||Participants|Count of Participants|28|28.0||||||
4263213|NCT00605839|4087727|B2||<=18 years|Age||Participants|Count of Participants|37|37.0||||||
4263214|NCT00605839|4087728|B1||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
4263215|NCT00605813|4087738|B1|Other than those Above||Starting Dose|Starting dose of each participant enrolled in this study|participants|Number|9|9.0||||||
4263216|NCT00605813|4087738|B1|100 mg||Starting Dose|Starting dose of each participant enrolled in this study|participants|Number|6|6.0||||||
4263217|NCT00605813|4087738|B1|75 mg||Starting Dose|Starting dose of each participant enrolled in this study|participants|Number|10|10.0||||||
4263218|NCT00605813|4087738|B1|50 mg||Starting Dose|Starting dose of each participant enrolled in this study|participants|Number|144|144.0||||||
4263219|NCT00605813|4087738|B1|25 mg||Starting Dose|Starting dose of each participant enrolled in this study|participants|Number|348|348.0||||||
4263273|NCT00605475|4087786|B10||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4263220|NCT00605813|4087738|B1|Absent||Concomitant Drug|Concomitant drugs is the drugs which participant had taken during the observation period of this study to treat for participant's illnesses, injuries etc. The physician of this survey listed all of concomitant drugs. (e.g. paroxetine, milnacipran, etc.)|participants|Number|47|47.0||||||
4263221|NCT00605813|4087738|B1|Present||Concomitant Drug|Concomitant drugs is the drugs which participant had taken during the observation period of this study to treat for participant's illnesses, injuries etc. The physician of this survey listed all of concomitant drugs. (e.g. paroxetine, milnacipran, etc.)|participants|Number|470|470.0||||||
4263222|NCT00605813|4087738|B1|Absent||Complications|Complications is the patient's current experiences with illnesses, operations, injuries and treatments. The physician of this survey made the diagnosis. (e.g. hypertension, diabetes, etc.)|participants|Number|319|319.0||||||
4263223|NCT00605813|4087738|B1|Present||Complications|Complications is the patient's current experiences with illnesses, operations, injuries and treatments. The physician of this survey made the diagnosis. (e.g. hypertension, diabetes, etc.)|participants|Number|198|198.0||||||
4263224|NCT00605813|4087738|B1|Severe||Target Disease Severity|The severity of target disease which was diagnosed by investigator|participants|Number|44|44.0||||||
4263225|NCT00605813|4087738|B1|Moderate||Target Disease Severity|The severity of target disease which was diagnosed by investigator|participants|Number|362|362.0||||||
4263226|NCT00605813|4087738|B1|Mild||Target Disease Severity|The severity of target disease which was diagnosed by investigator|participants|Number|111|111.0||||||
4263227|NCT00605813|4087738|B1|Other than those Above||Target Disease|The target disease which was diagnosed by investigator|participants|Number|26|26.0||||||
4263228|NCT00605813|4087738|B1|Depression/Depressed State and Panic Disorder||Target Disease|The target disease which was diagnosed by investigator|participants|Number|21|21.0||||||
4263229|NCT00605813|4087738|B1|Panic Disorder||Target Disease|The target disease which was diagnosed by investigator|participants|Number|44|44.0||||||
4263230|NCT00605813|4087738|B1|Depression/Depressed State||Target Disease|The target disease which was diagnosed by investigator|participants|Number|426|426.0||||||
4263231|NCT00605813|4087738|B1||Male|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
4263232|NCT00605813|4087738|B1||Female|Sex: Female, Male||Participants|Count of Participants|311|311.0||||||
4263233|NCT00605813|4087738|B1|>=65 years||Age, Customized||participants|Number|70|70.0||||||
4263234|NCT00605813|4087738|B1|<65 years||Age, Customized||participants|Number|447|447.0||||||
4263235|NCT00605722|4087751|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4263236|NCT00605722|4087751|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4263237|NCT00605722|4087751|B1|||Age||years|Mean|53.9|53.9|Standard Deviation|14.80|14.8|||
4263238|NCT00605696|4087761|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4263239|NCT00605696|4087762|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4263240|NCT00605696|4087763|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4263241|NCT00605696|4087761|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4263242|NCT00605696|4087762|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4263243|NCT00605696|4087763|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4263244|NCT00605696|4087761|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4263245|NCT00605696|4087762|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4263246|NCT00605696|4087763|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4263247|NCT00605696|4087761|B3|||Age||years|Mean|72|72.0|Standard Deviation|19|19.0|||
4263248|NCT00605696|4087762|B2|||Age||years|Mean|70|70.0|Standard Deviation|18|18.0|||
4263249|NCT00605696|4087763|B1|||Age||years|Mean|74|74.0|Standard Deviation|21|21.0|||
4263250|NCT00605696|4087761|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4263251|NCT00605696|4087762|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4263252|NCT00605696|4087763|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4263253|NCT00605696|4087761|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4263254|NCT00605696|4087762|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4263255|NCT00605696|4087763|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4263256|NCT00605696|4087761|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4263257|NCT00605696|4087762|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4263258|NCT00605696|4087763|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4263259|NCT00605657|4087772|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4263260|NCT00605657|4087772|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4263261|NCT00605657|4087772|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4263262|NCT00605657|4087772|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4263263|NCT00605657|4087772|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4263264|NCT00605657|4087772|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4263265|NCT00605540|4087777|B1|Brazil||Region of Enrollment||participants|Number|133|133.0||||||
4263266|NCT00605540|4087777|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4263267|NCT00605540|4087777|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4263268|NCT00605540|4087777|B1|||Age||years|Mean|64.8|64.8|Standard Deviation|9.5|9.5|||
4263269|NCT00605540|4087777|B1||>=65 years|Age||Participants|Count of Participants|67|67.0||||||
4263270|NCT00605540|4087777|B1||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4263271|NCT00605540|4087777|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4263272|NCT00605475|4087785|B11||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4263274|NCT00605475|4087787|B9||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4263275|NCT00605475|4087788|B8||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4263276|NCT00605475|4087789|B7||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4263277|NCT00605475|4087790|B6||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4263278|NCT00605475|4087791|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4263279|NCT00605475|4087792|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4263280|NCT00605475|4087793|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4263281|NCT00605475|4087794|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4263282|NCT00605475|4087795|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4263283|NCT00605475|4087785|B11||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4263284|NCT00605475|4087786|B10||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4263285|NCT00605475|4087787|B9||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4263286|NCT00605475|4087788|B8||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4263287|NCT00605475|4087789|B7||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4263288|NCT00605475|4087790|B6||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4263289|NCT00605475|4087791|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4263290|NCT00605475|4087792|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4263291|NCT00605475|4087793|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4263292|NCT00605475|4087794|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4263293|NCT00605475|4087795|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4263294|NCT00605475|4087785|B11|||Age||years|Mean|54.6|54.6|Standard Deviation|8.08|8.08|||
4263295|NCT00605475|4087786|B10|||Age||years|Mean|56|56.0|Standard Deviation|8.67|8.67|||
4263296|NCT00605475|4087787|B9|||Age||years|Mean|53.9|53.9|Standard Deviation|9.07|9.07|||
4263297|NCT00605475|4087788|B8|||Age||years|Mean|54.7|54.7|Standard Deviation|6.41|6.41|||
4263298|NCT00605475|4087789|B7|||Age||years|Mean|55.1|55.1|Standard Deviation|9.28|9.28|||
4263299|NCT00605475|4087790|B6|||Age||years|Mean|55|55.0|Standard Deviation|8.45|8.45|||
4263300|NCT00605475|4087791|B5|||Age||years|Mean|53.9|53.9|Standard Deviation|7.58|7.58|||
4263301|NCT00605475|4087792|B4|||Age||years|Mean|57.5|57.5|Standard Deviation|7.95|7.95|||
4263302|NCT00605475|4087793|B3|||Age||years|Mean|57.1|57.1|Standard Deviation|9.38|9.38|||
4263303|NCT00605475|4087794|B2|||Age||years|Mean|52|52.0|Standard Deviation|6.96|6.96|||
4263304|NCT00605475|4087795|B1|||Age||years|Mean|53|53.0|Standard Deviation|7.60|7.6|||
4263305|NCT00605423|4087926|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4263306|NCT00605423|4087927|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4263307|NCT00605423|4087928|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4263308|NCT00605423|4087926|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4263309|NCT00605423|4087927|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4263310|NCT00605423|4087928|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4263311|NCT00605423|4087926|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4263312|NCT00605423|4087927|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4263313|NCT00605423|4087928|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4263314|NCT00605423|4087926|B3|||Age||years|Mean|75.5|75.5|Standard Deviation|4.5|4.5|||
4263315|NCT00605423|4087927|B2|||Age||years|Mean|75.9|75.9|Standard Deviation|3.9|3.9|||
4263316|NCT00605423|4087928|B1|||Age||years|Mean|75.4|75.4|Standard Deviation|5.3|5.3|||
4263317|NCT00605423|4087926|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4263318|NCT00605423|4087927|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4263319|NCT00605423|4087928|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4263320|NCT00605423|4087926|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4263321|NCT00605423|4087927|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4263322|NCT00605423|4087928|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4263323|NCT00605423|4087926|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4263324|NCT00605423|4087927|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4263325|NCT00605423|4087928|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4263326|NCT00605384|4087939|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4263327|NCT00605384|4087940|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4263328|NCT00605384|4087941|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4263329|NCT00605384|4087939|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4263330|NCT00605384|4087940|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4263331|NCT00605384|4087941|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4263332|NCT00605384|4087939|B3|>=65 years||Age, Customized||participants|Number|1|1.0||||||
4263333|NCT00605384|4087940|B2|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4263334|NCT00605384|4087941|B1|>=65 years||Age, Customized||participants|Number|1|1.0||||||
4263335|NCT00605384|4087939|B3|Between 18 and 65 years||Age, Customized||participants|Number|1|1.0||||||
4263336|NCT00605384|4087940|B2|Between 18 and 65 years||Age, Customized||participants|Number|1|1.0||||||
4263337|NCT00605384|4087941|B1|Between 18 and 65 years||Age, Customized||participants|Number|0|0.0||||||
4263338|NCT00605358|4087970|B3|United States||Region of Enrollment||participants|Number|161|161.0||||||
4263339|NCT00605358|4087971|B2|United States||Region of Enrollment||participants|Number|80|80.0||||||
4263340|NCT00605358|4087972|B1|United States||Region of Enrollment||participants|Number|81|81.0||||||
4263341|NCT00605358|4087970|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263342|NCT00605358|4087971|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263343|NCT00605358|4087972|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263344|NCT00605358|4087970|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263345|NCT00605358|4087971|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263346|NCT00605358|4087972|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263347|NCT00605358|4087970|B3||White|Race (NIH/OMB)||Participants|Count of Participants|117|117.0||||||
4263348|NCT00605358|4087971|B2||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4263349|NCT00605358|4087972|B1||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4263350|NCT00605358|4087970|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4263351|NCT00605358|4087971|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4263352|NCT00605358|4087972|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4263353|NCT00605358|4087970|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4263354|NCT00605358|4087971|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4263355|NCT00605358|4087972|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263356|NCT00605358|4087970|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4263357|NCT00605358|4087971|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4263358|NCT00605358|4087972|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263359|NCT00605358|4087970|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263360|NCT00605358|4087971|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263361|NCT00605358|4087972|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263362|NCT00605358|4087970|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263363|NCT00605358|4087971|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263364|NCT00605358|4087972|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263365|NCT00605358|4087970|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|148|148.0||||||
4263366|NCT00605358|4087971|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
4263367|NCT00605358|4087972|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4263368|NCT00605358|4087970|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4263369|NCT00605358|4087971|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4263370|NCT00605358|4087972|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4263371|NCT00605358|4087970|B3||Male|Gender||Participants|Count of Participants|45|45.0||||||
4263372|NCT00605358|4087971|B2||Male|Gender||Participants|Count of Participants|31|31.0||||||
4263373|NCT00605358|4087972|B1||Male|Gender||Participants|Count of Participants|14|14.0||||||
4263374|NCT00605358|4087970|B3||Female|Gender||Participants|Count of Participants|116|116.0||||||
4263375|NCT00605358|4087971|B2||Female|Gender||Participants|Count of Participants|49|49.0||||||
4263376|NCT00605358|4087972|B1||Female|Gender||Participants|Count of Participants|67|67.0||||||
4263377|NCT00605358|4087970|B3|||Age||Years|Mean|81.9|81.9|Standard Deviation|9.3|9.3|||
4263378|NCT00605358|4087971|B2|||Age||Years|Mean|81.0|81.0|Standard Deviation|9.5|9.5|||
4263379|NCT00605358|4087972|B1|||Age||Years|Mean|82.9|82.9|Standard Deviation|9.0|9.0|||
4263380|NCT00605345|4087979|B3|Spain||Region of Enrollment||participants|Number|71|71.0||||||
4263381|NCT00605345|4087980|B2|Spain||Region of Enrollment||participants|Number|25|25.0||||||
4263382|NCT00605345|4087981|B1|Spain||Region of Enrollment||participants|Number|46|46.0||||||
4263383|NCT00605345|4087979|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4263384|NCT00605345|4087980|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4263385|NCT00605345|4087981|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4263386|NCT00605345|4087979|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4263387|NCT00605345|4087980|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4263388|NCT00605345|4087981|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4263389|NCT00605345|4087979|B3|||Age||years|Mean|55.3|55.3|Standard Deviation|10.82|10.82|||
4263390|NCT00605345|4087980|B2|||Age||years|Mean|56.7|56.7|Standard Deviation|10.49|10.49|||
4263391|NCT00605345|4087981|B1|||Age||years|Mean|54.6|54.6|Standard Deviation|11.04|11.04|||
4263392|NCT00605319|4087998|B1|||TURP|Transurethral Resection of the Prostate|participants|Number|4|4.0||||||
4263393|NCT00605319|4087998|B1|||Laser||participants|Number|13|13.0||||||
4263394|NCT00605319|4087998|B1|||Voided Volume||mL|Mean|86|86.0|Full Range|||20.0|292.0|
4263395|NCT00605319|4087998|B1|||BMI||kg/m^2|Mean|28.3|28.3|Full Range|||19.1|35.9|
4263396|NCT00605319|4087998|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4263397|NCT00605319|4087998|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4263398|NCT00605319|4087998|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4263399|NCT00605319|4087998|B1|||Age||years|Mean|72.1|72.1|Full Range|||53.0|91.0|
4263400|NCT00605306|4088008|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4263401|NCT00605306|4088009|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4263402|NCT00605306|4088010|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4263403|NCT00605306|4088008|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4263404|NCT00605306|4088009|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4263405|NCT00605306|4088010|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4263406|NCT00605306|4088008|B3|||Age||years|Mean|32.4|32.4|Standard Deviation|10.62|10.62|||
4263407|NCT00605306|4088009|B2|||Age||years|Mean|33.9|33.9|Standard Deviation|13.35|13.35|||
4263408|NCT00605306|4088010|B1|||Age||years|Mean|31.0|31.0|Standard Deviation|7.18|7.18|||
4263409|NCT00605293|4088023|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4263410|NCT00605293|4088024|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4263411|NCT00605293|4088025|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4263412|NCT00605293|4088023|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4263413|NCT00605293|4088024|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4263414|NCT00605293|4088025|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4263415|NCT00605293|4088023|B3|||Age||years|Mean|64.9|64.9|Standard Deviation|15.47|15.47|||
4263416|NCT00605293|4088024|B2|||Age||years|Mean|64.5|64.5|Standard Deviation|16.62|16.62|||
4263417|NCT00605293|4088025|B1|||Age||years|Mean|65.2|65.2|Standard Deviation|14.93|14.93|||
4263418|NCT00605280|4088042|B5||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4263419|NCT00605280|4088043|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4263420|NCT00605280|4088044|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4263421|NCT00605280|4088045|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4263422|NCT00605280|4088046|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4263423|NCT00605280|4088042|B5||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4263424|NCT00605280|4088043|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4263425|NCT00605280|4088044|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4263426|NCT00605280|4088045|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4263427|NCT00605280|4088046|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4263428|NCT00605280|4088042|B5|||Age||Years|Mean|62.5|62.5|Standard Deviation|9.7|9.7|||
4263429|NCT00605280|4088043|B4|||Age||Years|Mean|57.3|57.3|Standard Deviation|10.1|10.1|||
4263430|NCT00605280|4088044|B3|||Age||Years|Mean|64.7|64.7|Standard Deviation|8.6|8.6|||
4263431|NCT00605280|4088045|B2|||Age||Years|Mean|62.4|62.4|Standard Deviation|10.3|10.3|||
4263432|NCT00605280|4088046|B1|||Age||Years|Mean|62.5|62.5|Standard Deviation|9.2|9.2|||
4263433|NCT00605267|4088081|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4263434|NCT00605267|4088082|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4263435|NCT00605267|4088083|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4263436|NCT00605267|4088081|B3||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4263437|NCT00605267|4088082|B2||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4263438|NCT00605267|4088083|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4263439|NCT00605267|4088081|B3|50-59 years||Age, Customized||Participants|Number|21|21.0||||||
4263440|NCT00605267|4088082|B2|50-59 years||Age, Customized||Participants|Number|11|11.0||||||
4263441|NCT00605267|4088083|B1|50-59 years||Age, Customized||Participants|Number|10|10.0||||||
4263442|NCT00605267|4088081|B3|40-49 years||Age, Customized||Participants|Number|133|133.0||||||
4263443|NCT00605267|4088082|B2|40-49 years||Age, Customized||Participants|Number|68|68.0||||||
4263444|NCT00605267|4088083|B1|40-49 years||Age, Customized||Participants|Number|65|65.0||||||
4263445|NCT00605267|4088081|B3|30-39 years||Age, Customized||Participants|Number|41|41.0||||||
4263446|NCT00605267|4088082|B2|30-39 years||Age, Customized||Participants|Number|20|20.0||||||
4263447|NCT00605267|4088083|B1|30-39 years||Age, Customized||Participants|Number|21|21.0||||||
4263448|NCT00605267|4088081|B3|20-29 years||Age, Customized||Participants|Number|2|2.0||||||
4263449|NCT00605267|4088082|B2|20-29 years||Age, Customized||Participants|Number|0|0.0||||||
4263450|NCT00605267|4088083|B1|20-29 years||Age, Customized||Participants|Number|2|2.0||||||
4263451|NCT00605202|4088122|B1|Finland||Region of Enrollment||participants|Number|10|10.0||||||
4263452|NCT00605202|4088122|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4263453|NCT00605202|4088122|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4263454|NCT00605202|4088122|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4263455|NCT00605202|4088122|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4263456|NCT00605202|4088122|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4263457|NCT00605189|4088129|B4|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
4263458|NCT00605189|4088130|B3|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4263459|NCT00605189|4088131|B2|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
4263460|NCT00605189|4088132|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4263461|NCT00605189|4088129|B4|Race/Ethnicity|Other, not specified|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4263462|NCT00605189|4088130|B3|Race/Ethnicity|Other, not specified|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4263463|NCT00605189|4088131|B2|Race/Ethnicity|Other, not specified|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4263464|NCT00605189|4088132|B1|Race/Ethnicity|Other, not specified|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4263465|NCT00605189|4088129|B4|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4263466|NCT00605189|4088130|B3|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4263467|NCT00605189|4088131|B2|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4263468|NCT00605189|4088132|B1|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4263469|NCT00605189|4088129|B4|Race/Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
4263470|NCT00605189|4088130|B3|Race/Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4263471|NCT00605189|4088131|B2|Race/Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4263472|NCT00605189|4088132|B1|Race/Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4263473|NCT00605189|4088129|B4|Race/Ethnicity|Asian/Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4263474|NCT00605189|4088130|B3|Race/Ethnicity|Asian/Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4263475|NCT00605189|4088131|B2|Race/Ethnicity|Asian/Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4263476|NCT00605189|4088132|B1|Race/Ethnicity|Asian/Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4263477|NCT00605189|4088129|B4|Race/Ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4263478|NCT00605189|4088130|B3|Race/Ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4263479|NCT00605189|4088131|B2|Race/Ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4263480|NCT00605189|4088132|B1|Race/Ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4263481|NCT00605189|4088129|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4263482|NCT00605189|4088130|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4263483|NCT00605189|4088131|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4263484|NCT00605189|4088132|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4263485|NCT00605189|4088129|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4263486|NCT00605189|4088130|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4263487|NCT00605189|4088131|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4263488|NCT00605189|4088132|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4263489|NCT00605189|4088129|B4|||Age||years|Mean|54.1|54.1|Standard Deviation|9.0|9.0|||
4263490|NCT00605189|4088130|B3|||Age||years|Mean|56.0|56.0|Standard Deviation|9.1|9.1|||
4263491|NCT00605189|4088131|B2|||Age||years|Mean|53.9|53.9|Standard Deviation|8.4|8.4|||
4263492|NCT00605189|4088132|B1|||Age||years|Mean|53.6|53.6|Standard Deviation|9.8|9.8|||
4263493|NCT00605176|4088142|B4|United States||Region of Enrollment||participants|Number|479|479.0||||||
4263494|NCT00605176|4088143|B3|United States||Region of Enrollment||participants|Number|159|159.0||||||
4263495|NCT00605176|4088144|B2|United States||Region of Enrollment||participants|Number|160|160.0||||||
4263496|NCT00605176|4088145|B1|United States||Region of Enrollment||participants|Number|160|160.0||||||
4263497|NCT00605176|4088142|B4||Male|Sex: Female, Male||Participants|Count of Participants|389|389.0||||||
4263498|NCT00605176|4088143|B3||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4263499|NCT00605176|4088144|B2||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4263500|NCT00605176|4088145|B1||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4263501|NCT00605176|4088142|B4||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4263502|NCT00605176|4088143|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4263503|NCT00605176|4088144|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4263504|NCT00605176|4088145|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4263505|NCT00605176|4088142|B4|||Age||years|Mean|64.4|64.4|Standard Deviation|10.0|10.0|||
4263506|NCT00605176|4088143|B3|||Age||years|Mean|64.3|64.3|Standard Deviation|8.9|8.9|||
4263507|NCT00605176|4088144|B2|||Age||years|Mean|64.3|64.3|Standard Deviation|10.5|10.5|||
4263508|NCT00605176|4088145|B1|||Age||years|Mean|64.5|64.5|Standard Deviation|10.6|10.6|||
4263509|NCT00605176|4088142|B4||>=65 years|Age||Participants|Count of Participants|219|219.0||||||
4263510|NCT00605176|4088143|B3||>=65 years|Age||Participants|Count of Participants|69|69.0||||||
4263511|NCT00605176|4088144|B2||>=65 years|Age||Participants|Count of Participants|72|72.0||||||
4263512|NCT00605176|4088145|B1||>=65 years|Age||Participants|Count of Participants|78|78.0||||||
4263513|NCT00605176|4088142|B4||Between 18 and 65 years|Age||Participants|Count of Participants|260|260.0||||||
4263514|NCT00605176|4088143|B3||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
4263515|NCT00605176|4088144|B2||Between 18 and 65 years|Age||Participants|Count of Participants|88|88.0||||||
4263516|NCT00605176|4088145|B1||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
4263517|NCT00605176|4088142|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4263518|NCT00605176|4088143|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4263519|NCT00605176|4088144|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4263520|NCT00605176|4088145|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4263521|NCT00605150|4088164|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4263522|NCT00605150|4088164|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4263523|NCT00605150|4088164|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4263524|NCT00605150|4088164|B1|||Age||years|Mean|60.2|60.2|Standard Deviation|8.509|8.509|||
4263525|NCT00605150|4088164|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4263526|NCT00605150|4088164|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4263527|NCT00605150|4088164|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4263528|NCT00605085|4088168|B3|United States||Region of Enrollment||participants|Number|614|614.0||||||
4263529|NCT00605085|4088169|B2|United States||Region of Enrollment||participants|Number|151|151.0||||||
4263530|NCT00605085|4088170|B1|United States||Region of Enrollment||participants|Number|463|463.0||||||
4263531|NCT00605085|4088168|B3|Europe||Region of Enrollment||participants|Number|1642|1642.0||||||
4263532|NCT00605085|4088169|B2|Europe||Region of Enrollment||participants|Number|406|406.0||||||
4263533|NCT00605085|4088170|B1|Europe||Region of Enrollment||participants|Number|1236|1236.0||||||
4263534|NCT00605085|4088168|B3|Australia||Region of Enrollment||participants|Number|394|394.0||||||
4263535|NCT00605085|4088169|B2|Australia||Region of Enrollment||participants|Number|100|100.0||||||
4263536|NCT00605085|4088170|B1|Australia||Region of Enrollment||participants|Number|294|294.0||||||
4263537|NCT00605085|4088168|B3||Male|Sex: Female, Male||Participants|Count of Participants|1184|1184.0||||||
4263538|NCT00605085|4088169|B2||Male|Sex: Female, Male||Participants|Count of Participants|279|279.0||||||
4263539|NCT00605085|4088170|B1||Male|Sex: Female, Male||Participants|Count of Participants|905|905.0||||||
4263540|NCT00605085|4088168|B3||Female|Sex: Female, Male||Participants|Count of Participants|1466|1466.0||||||
4263541|NCT00605085|4088169|B2||Female|Sex: Female, Male||Participants|Count of Participants|378|378.0||||||
4263542|NCT00605085|4088170|B1||Female|Sex: Female, Male||Participants|Count of Participants|1088|1088.0||||||
4263543|NCT00605085|4088168|B3|||Age||years|Mean|33.8|33.8|Standard Deviation|13.2|13.2|||
4263544|NCT00605085|4088169|B2|||Age||years|Mean|33.4|33.4|Standard Deviation|13|13.0|||
4263545|NCT00605085|4088170|B1|||Age||years|Mean|33.9|33.9|Standard Deviation|13.3|13.3|||
4263546|NCT00605072|4088177|B4|United States||Region of Enrollment||participants|Number|53|53.0||||||
4263547|NCT00605072|4088178|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4263548|NCT00605072|4088179|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4263549|NCT00605072|4088180|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4263550|NCT00605072|4088177|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4263551|NCT00605072|4088178|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4263552|NCT00605072|4088179|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4263553|NCT00605072|4088180|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4263554|NCT00605072|4088177|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4263555|NCT00605072|4088178|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4263556|NCT00605072|4088179|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4263557|NCT00605072|4088180|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4263558|NCT00605072|4088177|B4|||Age||years|Mean|71|71.0|Standard Deviation|7|7.0|||
4263559|NCT00605072|4088178|B3|||Age||years|Mean|71|71.0|Standard Deviation|7|7.0|||
4263560|NCT00605072|4088179|B2|||Age||years|Mean|71|71.0|Standard Deviation|9|9.0|||
4263561|NCT00605072|4088180|B1|||Age||years|Mean|71|71.0|Standard Deviation|7|7.0|||
4263562|NCT00605033|4088202|B3||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4263563|NCT00605033|4088203|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4263564|NCT00605033|4088204|B1||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4263565|NCT00605033|4088202|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4263566|NCT00605033|4088203|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4263567|NCT00605033|4088204|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4263568|NCT00605033|4088202|B3|||Age||years|Mean|35.7|35.7|Standard Deviation|8.4|8.4|||
4263569|NCT00605033|4088203|B2|||Age||years|Mean|35.5|35.5|Standard Deviation|8.7|8.7|||
4263570|NCT00605033|4088204|B1|||Age||years|Mean|35.8|35.8|Standard Deviation|8.2|8.2|||
4263571|NCT00604968|4088211|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4263572|NCT00604968|4088211|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4263573|NCT00604968|4088211|B1|||Age||years|Mean|72.3|72.3|Standard Deviation|5.0|5.0|||
4263574|NCT00604968|4088211|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4263575|NCT00604968|4088211|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4263576|NCT00604968|4088211|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4263577|NCT00604825|4088224|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263578|NCT00604825|4088225|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263579|NCT00604825|4088226|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263580|NCT00604825|4088227|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263581|NCT00604825|4088228|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263582|NCT00604825|4088224|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4263583|NCT00604825|4088225|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4263584|NCT00604825|4088226|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263585|NCT00604825|4088227|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263586|NCT00604825|4088228|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263587|NCT00604825|4088224|B5||White|Race (NIH/OMB)||Participants|Count of Participants|320|320.0||||||
4263588|NCT00604825|4088225|B4||White|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
4263589|NCT00604825|4088226|B3||White|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
4263590|NCT00604825|4088227|B2||White|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
4263591|NCT00604825|4088228|B1||White|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
4263592|NCT00604825|4088224|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4263593|NCT00604825|4088225|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4263594|NCT00604825|4088226|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4263595|NCT00604825|4088227|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4263596|NCT00604825|4088228|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4263597|NCT00604825|4088224|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263598|NCT00604825|4088225|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263599|NCT00604825|4088226|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263600|NCT00604825|4088227|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263601|NCT00604825|4088228|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263602|NCT00604825|4088224|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4263603|NCT00604825|4088225|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263604|NCT00604825|4088226|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4263605|NCT00604825|4088227|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263606|NCT00604825|4088228|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4263607|NCT00604825|4088224|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4263608|NCT00604825|4088225|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4263609|NCT00604825|4088226|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263610|NCT00604825|4088227|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263611|NCT00604825|4088228|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4263612|NCT00604825|4088224|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4263613|NCT00604825|4088225|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4263614|NCT00604825|4088226|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4263615|NCT00604825|4088227|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4263616|NCT00604825|4088228|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4263617|NCT00604825|4088224|B5||Female|Sex: Female, Male||Participants|Count of Participants|356|356.0||||||
4263618|NCT00604825|4088225|B4||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4263619|NCT00604825|4088226|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4263620|NCT00604825|4088227|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4263621|NCT00604825|4088228|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4263622|NCT00604825|4088224|B5|||Age||Years|Mean|54.6|54.6|Standard Deviation|4.73|4.73|||
4263623|NCT00604825|4088225|B4|||Age||Years|Mean|54.0|54.0|Standard Deviation|5.18|5.18|||
4263624|NCT00604825|4088226|B3|||Age||Years|Mean|54.2|54.2|Standard Deviation|4.78|4.78|||
4263625|NCT00604825|4088227|B2|||Age||Years|Mean|54.9|54.9|Standard Deviation|4.72|4.72|||
4263626|NCT00604825|4088228|B1|||Age||Years|Mean|55.2|55.2|Standard Deviation|4.17|4.17|||
4263627|NCT00604812|4088429|B4|≥ 40 kg||Weight||participants|Number|18|18.0||||||
4263628|NCT00604812|4088430|B3|≥ 40 kg||Weight||participants|Number|5|5.0||||||
4263629|NCT00604812|4088431|B2|≥ 40 kg||Weight||participants|Number|13|13.0||||||
4263630|NCT00604812|4088432|B1|≥ 40 kg||Weight||participants|Number|0|0.0||||||
4263631|NCT00604812|4088429|B4|20-39 kg||Weight||participants|Number|13|13.0||||||
4263632|NCT00604812|4088430|B3|20-39 kg||Weight||participants|Number|1|1.0||||||
4263633|NCT00604812|4088431|B2|20-39 kg||Weight||participants|Number|0|0.0||||||
4263634|NCT00604812|4088432|B1|20-39 kg||Weight||participants|Number|12|12.0||||||
4263635|NCT00604812|4088429|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4263636|NCT00604812|4088430|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4263637|NCT00604812|4088431|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4263638|NCT00604812|4088432|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4263639|NCT00604812|4088429|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4263640|NCT00604812|4088430|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4263641|NCT00604812|4088431|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4263642|NCT00604812|4088432|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4263643|NCT00604812|4088429|B4|Ages 12 to 17||Age, Customized||years|Number|18|18.0||||||
4263644|NCT00604812|4088430|B3|Ages 12 to 17||Age, Customized||years|Number|6|6.0||||||
4263645|NCT00604812|4088431|B2|Ages 12 to 17||Age, Customized||years|Number|11|11.0||||||
4263646|NCT00604812|4088432|B1|Ages 12 to 17||Age, Customized||years|Number|1|1.0||||||
4263647|NCT00604812|4088429|B4|Ages 6 to <12||Age, Customized||years|Number|13|13.0||||||
4263648|NCT00604812|4088430|B3|Ages 6 to <12||Age, Customized||years|Number|0|0.0||||||
4263649|NCT00604812|4088431|B2|Ages 6 to <12||Age, Customized||years|Number|2|2.0||2.14|2.14|||
4263650|NCT00604812|4088432|B1|Ages 6 to <12||Age, Customized||years|Number|11|11.0||1.44|1.44|||
4263651|NCT00604786|4088457|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4263652|NCT00604786|4088458|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4263653|NCT00604786|4088459|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4263654|NCT00604786|4088457|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4263655|NCT00604786|4088458|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4263656|NCT00604786|4088459|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4263657|NCT00604786|4088457|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4263658|NCT00604786|4088458|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4263659|NCT00604786|4088459|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4263660|NCT00604786|4088457|B3|||Age||years|Mean|31|31.0|Full Range|||24.0|49.0|
4263661|NCT00604786|4088458|B2|||Age||years|Mean|32.3|32.3|Full Range|||25.0|49.0|
4263662|NCT00604786|4088459|B1|||Age||years|Mean|30.6|30.6|Full Range|||24.0|47.0|
4263663|NCT00604786|4088457|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4263664|NCT00604786|4088458|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4263665|NCT00604786|4088459|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4263666|NCT00604786|4088457|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4263667|NCT00604786|4088458|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4263668|NCT00604786|4088459|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4263669|NCT00604786|4088457|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4263670|NCT00604786|4088458|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4263671|NCT00604786|4088459|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4263672|NCT00604721|4088466|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4263673|NCT00604721|4088466|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4263674|NCT00604721|4088466|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4263675|NCT00604721|4088466|B1|||Age, Customized||years|Mean|57|57.0|Full Range|||48.0|77.0|
4263676|NCT00604721|4088466|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4263677|NCT00604721|4088466|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4263678|NCT00604721|4088466|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4263679|NCT00604708|4088472|B3|North America||Region of Enrollment||participants|Number|664|664.0||||||
4263680|NCT00604708|4088473|B2|North America||Region of Enrollment||participants|Number|334|334.0||||||
4263681|NCT00604708|4088474|B1|North America||Region of Enrollment||participants|Number|330|330.0||||||
4263682|NCT00604708|4088472|B3|Europe||Region of Enrollment||participants|Number|203|203.0||||||
4263683|NCT00604708|4088473|B2|Europe||Region of Enrollment||participants|Number|103|103.0||||||
4263684|NCT00604708|4088474|B1|Europe||Region of Enrollment||participants|Number|100|100.0||||||
4263685|NCT00604708|4088472|B3|Unknown||Sex/Gender, Customized||participants|Number|4|4.0||||||
4263686|NCT00604708|4088473|B2|Unknown||Sex/Gender, Customized||participants|Number|2|2.0||||||
4263687|NCT00604708|4088474|B1|Unknown||Sex/Gender, Customized||participants|Number|2|2.0||||||
4263688|NCT00604708|4088472|B3|Male||Sex/Gender, Customized||participants|Number|338|338.0||||||
4263689|NCT00604708|4088473|B2|Male||Sex/Gender, Customized||participants|Number|177|177.0||||||
4263690|NCT00604708|4088474|B1|Male||Sex/Gender, Customized||participants|Number|161|161.0||||||
4263691|NCT00604708|4088472|B3|Female||Sex/Gender, Customized||participants|Number|525|525.0||||||
4263692|NCT00604708|4088473|B2|Female||Sex/Gender, Customized||participants|Number|258|258.0||||||
4263693|NCT00604708|4088474|B1|Female||Sex/Gender, Customized||participants|Number|267|267.0||||||
4263694|NCT00604708|4088472|B3|||Age||years|Mean|41.3|41.3|Standard Deviation|14.4|14.4|||
4263695|NCT00604708|4088473|B2|||Age||years|Mean|41.1|41.1|Standard Deviation|14.4|14.4|||
4263696|NCT00604708|4088474|B1|||Age||years|Mean|41.6|41.6|Standard Deviation|14.5|14.5|||
4263697|NCT00604695|4088483|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4263698|NCT00604695|4088484|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4263699|NCT00604695|4088485|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4263700|NCT00604695|4088483|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4263701|NCT00604695|4088484|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4263702|NCT00604695|4088485|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4263703|NCT00604695|4088483|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4263704|NCT00604695|4088484|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4263705|NCT00604695|4088485|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4263706|NCT00604695|4088483|B3|||Age||years|Mean|55.4|55.4|Standard Deviation|8.2|8.2|||
4263707|NCT00604695|4088484|B2|||Age||years|Mean|55.6|55.6|Standard Deviation|8.9|8.9|||
4263708|NCT00604695|4088485|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|7.6|7.6|||
4263709|NCT00604695|4088483|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4263710|NCT00604695|4088484|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4263711|NCT00604695|4088485|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4263712|NCT00604695|4088483|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4263713|NCT00604695|4088484|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4263714|NCT00604695|4088485|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4263715|NCT00604695|4088483|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4263716|NCT00604695|4088484|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4263717|NCT00604695|4088485|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4263718|NCT00604669|4088508|B1|United States||Region of Enrollment||participants|Number|163|163.0||||||
4263719|NCT00604669|4088508|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4263720|NCT00604669|4088508|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4263721|NCT00604669|4088508|B1|||Age||years|Mean|60|60.0|Standard Deviation|17|17.0|||
4263722|NCT00604669|4088508|B1||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4263723|NCT00604669|4088508|B1||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
4263724|NCT00604669|4088508|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4263725|NCT00604565|4088512|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4263726|NCT00604565|4088513|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4263727|NCT00604565|4088514|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4263728|NCT00604565|4088512|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4263729|NCT00604565|4088513|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4263730|NCT00604565|4088514|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4263731|NCT00604565|4088512|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263732|NCT00604565|4088513|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263733|NCT00604565|4088514|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263734|NCT00604565|4088512|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263735|NCT00604565|4088513|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263736|NCT00604565|4088514|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263737|NCT00604565|4088512|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4263738|NCT00604565|4088513|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4263739|NCT00604565|4088514|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4263740|NCT00604565|4088512|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263741|NCT00604565|4088513|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263742|NCT00604565|4088514|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263743|NCT00604565|4088512|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263744|NCT00604565|4088513|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263745|NCT00604565|4088514|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263746|NCT00604565|4088512|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263747|NCT00604565|4088513|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263748|NCT00604565|4088514|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263749|NCT00604565|4088512|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263750|NCT00604565|4088513|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263751|NCT00604565|4088514|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4263752|NCT00604565|4088512|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4263753|NCT00604565|4088513|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4263754|NCT00604565|4088514|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4263755|NCT00604565|4088512|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4263756|NCT00604565|4088513|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4263757|NCT00604565|4088514|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4263758|NCT00604565|4088512|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4263759|NCT00604565|4088513|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4263760|NCT00604565|4088514|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4263761|NCT00604565|4088512|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4263762|NCT00604565|4088513|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4263763|NCT00604565|4088514|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4263764|NCT00604565|4088512|B3|||Age||years|Mean|54.0|54.0|Full Range|||39.0|67.0|
4263765|NCT00604565|4088513|B2|||Age||years|Mean|55.4|55.4|Full Range|||41.0|65.0|
4263766|NCT00604565|4088514|B1|||Age||years|Mean|51.5|51.5|Full Range|||39.0|67.0|
4263767|NCT00604552|4088523|B3|United States||Region of Enrollment||participants|Number|349|349.0||||||
4263768|NCT00604552|4088524|B2|United States||Region of Enrollment||participants|Number|160|160.0||||||
4263769|NCT00604552|4088525|B1|United States||Region of Enrollment||participants|Number|189|189.0||||||
4263770|NCT00604552|4088523|B3||Male|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
4263771|NCT00604552|4088524|B2||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4263772|NCT00604552|4088525|B1||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4263773|NCT00604552|4088523|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4263774|NCT00604552|4088524|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4263775|NCT00604552|4088525|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4263776|NCT00604552|4088523|B3|||Age||years|Mean|75.1|75.1|Standard Deviation|8.53|8.53|||
4263777|NCT00604552|4088524|B2|||Age||years|Mean|74.3|74.3|Standard Deviation|7.31|7.31|||
4263778|NCT00604552|4088525|B1|||Age||years|Mean|75.1|75.1|Standard Deviation|8.53|8.53|||
4263779|NCT00604500|4088534|B1|Chronic Obstructive Pulmonary Disease (COPD)||Number of Participants with Asthma and Chronic Obstructive Pulmonary Disease (COPD)||Participants|Number|50|50.0||||||
4263780|NCT00604500|4088534|B1|Asthma||Number of Participants with Asthma and Chronic Obstructive Pulmonary Disease (COPD)||Participants|Number|222|222.0||||||
4263781|NCT00604500|4088534|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4263782|NCT00604500|4088534|B1||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4263783|NCT00604500|4088534|B1|Age ≥ 65 years of age||Age||years|Mean|70.43|70.43|Standard Deviation|4.77|4.77|||
4263784|NCT00604500|4088534|B1|Age 18 to <65 years of age||Age||years|Mean|44.22|44.22|Standard Deviation|12.12|12.12|||
4263785|NCT00604500|4088534|B1|Age 12 to <18 years of age||Age||years|Mean|14.69|14.69|Standard Deviation|1.64|1.64|||
4263786|NCT00604461|4088541|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4263787|NCT00604461|4088541|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4263788|NCT00604461|4088541|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4263789|NCT00604461|4088541|B1|||Age, Customized||years|Median|66|66.0|Full Range|||41.0|76.0|
4263790|NCT00604461|4088541|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4263791|NCT00604461|4088541|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4263792|NCT00604461|4088541|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4263793|NCT00604383|4088546|B3|United States||Region of Enrollment||participants|Number|685|685.0||||||
4263794|NCT00604383|4088547|B2|United States||Region of Enrollment||participants|Number|340|340.0||||||
4263795|NCT00604383|4088548|B1|United States||Region of Enrollment||participants|Number|345|345.0||||||
4263796|NCT00604383|4088546|B3|Western Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4263797|NCT00604383|4088547|B2|Western Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4263798|NCT00604383|4088548|B1|Western Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4263799|NCT00604383|4088546|B3|Other||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4263800|NCT00604383|4088547|B2|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4263801|NCT00604383|4088548|B1|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4263802|NCT00604383|4088546|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4263803|NCT00604383|4088547|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4263804|NCT00604383|4088548|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4263805|NCT00604383|4088546|B3|East/Southeast Asian||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4263806|NCT00604383|4088547|B2|East/Southeast Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4263807|NCT00604383|4088548|B1|East/Southeast Asian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4263808|NCT00604383|4088546|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|532|532.0||||||
4263809|NCT00604383|4088547|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|273|273.0||||||
4263810|NCT00604383|4088548|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|259|259.0||||||
4263811|NCT00604383|4088546|B3|African Descent||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
4263812|NCT00604383|4088547|B2|African Descent||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4263813|NCT00604383|4088548|B1|African Descent||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4263814|NCT00604383|4088546|B3||Male|Sex: Female, Male||Participants|Count of Participants|433|433.0||||||
4263815|NCT00604383|4088547|B2||Male|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4263816|NCT00604383|4088548|B1||Male|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
4263817|NCT00604383|4088546|B3||Female|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
4263818|NCT00604383|4088547|B2||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4263819|NCT00604383|4088548|B1||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4263820|NCT00604383|4088546|B3|||Age||years|Mean|59.33|59.33|Standard Deviation|10.76|10.76|||
4263821|NCT00604383|4088547|B2|||Age||years|Mean|59.18|59.18|Standard Deviation|10.61|10.61|||
4263822|NCT00604383|4088548|B1|||Age||years|Mean|59.48|59.48|Standard Deviation|10.91|10.91|||
4263823|NCT00604279|4088563|B3|<18 Years||Age||Participants|Number|0|0.0||||||
4263824|NCT00604279|4088564|B2|<18 Years||Age||Participants|Number|0|0.0||||||
4263825|NCT00604279|4088565|B1|<18 Years||Age||Participants|Number|0|0.0||||||
4263826|NCT00604279|4088563|B3|>65 Years||Age||Participants|Number|0|0.0||||||
4263827|NCT00604279|4088564|B2|>65 Years||Age||Participants|Number|0|0.0||||||
4263828|NCT00604279|4088565|B1|>65 Years||Age||Participants|Number|0|0.0||||||
4263829|NCT00604279|4088563|B3|51-65 Years||Age||Participants|Number|34|34.0||||||
4263830|NCT00604279|4088564|B2|51-65 Years||Age||Participants|Number|17|17.0||||||
4263831|NCT00604279|4088565|B1|51-65 Years||Age||Participants|Number|17|17.0||||||
4263832|NCT00604279|4088563|B3|26-50 Years||Age||Participants|Number|239|239.0||||||
4263833|NCT00604279|4088564|B2|26-50 Years||Age||Participants|Number|114|114.0||||||
4263834|NCT00604279|4088565|B1|26-50 Years||Age||Participants|Number|125|125.0||||||
4263835|NCT00604279|4088563|B3|18-25 Years||Age||Participants|Number|179|179.0||||||
4263836|NCT00604279|4088564|B2|18-25 Years||Age||Participants|Number|92|92.0||||||
4263837|NCT00604279|4088565|B1|18-25 Years||Age||Participants|Number|87|87.0||||||
4263838|NCT00604279|4088563|B3||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4263839|NCT00604279|4088564|B2||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4263840|NCT00604279|4088565|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4263841|NCT00604279|4088563|B3||Female|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
4263842|NCT00604279|4088564|B2||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4263843|NCT00604279|4088565|B1||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4263844|NCT00604279|4088563|B3|||Age||years|Mean|31.7|31.7|Standard Deviation|10.88|10.88|||
4263845|NCT00604279|4088564|B2|||Age||years|Mean|31.5|31.5|Standard Deviation|11.03|11.03|||
4263846|NCT00604279|4088565|B1|||Age||years|Mean|32|32.0|Standard Deviation|10.75|10.75|||
4263847|NCT00604214|4088580|B3|||Acute Physiology and Chronic Health Evaluation II (APACHE II) Score|Acute Physiology and Chronic Health Evaluation II (APACHE II) score is a severity-of-disease classification system. Scores range from 0 to 71. Higher scores correspond to more severe disease and a higher risk of death. There were 4 participants in drotrecogin alfa (activated) and 1 participant in placebo who were unspecified and were not included in the calculation of mean and standard deviation.|units on a scale|Mean|25.31|25.31|Standard Deviation|8.10|8.1|||
4263848|NCT00604214|4088581|B2|||Acute Physiology and Chronic Health Evaluation II (APACHE II) Score|Acute Physiology and Chronic Health Evaluation II (APACHE II) score is a severity-of-disease classification system. Scores range from 0 to 71. Higher scores correspond to more severe disease and a higher risk of death. There were 4 participants in drotrecogin alfa (activated) and 1 participant in placebo who were unspecified and were not included in the calculation of mean and standard deviation.|units on a scale|Mean|25.45|25.45|Standard Deviation|8.14|8.14|||
4263849|NCT00604214|4088582|B1|||Acute Physiology and Chronic Health Evaluation II (APACHE II) Score|Acute Physiology and Chronic Health Evaluation II (APACHE II) score is a severity-of-disease classification system. Scores range from 0 to 71. Higher scores correspond to more severe disease and a higher risk of death. There were 4 participants in drotrecogin alfa (activated) and 1 participant in placebo who were unspecified and were not included in the calculation of mean and standard deviation.|units on a scale|Mean|25.17|25.17|Standard Deviation|8.06|8.06|||
4263850|NCT00604214|4088580|B3|||Liver Sequential Organ Failure Assessment (SOFA) Score|Scores range from 0 (normal) to 4 (organ failure) with an increasing score indicating increasing liver dysfunction. There were 61 participants in drotrecogin alfa (activated) and 70 participants in placebo who were unspecified and were not included in the calculation of mean and standard deviation.|units on a scale|Mean|0.54|0.54|Standard Deviation|0.87|0.87|||
4263851|NCT00604214|4088581|B2|||Liver Sequential Organ Failure Assessment (SOFA) Score|Scores range from 0 (normal) to 4 (organ failure) with an increasing score indicating increasing liver dysfunction. There were 61 participants in drotrecogin alfa (activated) and 70 participants in placebo who were unspecified and were not included in the calculation of mean and standard deviation.|units on a scale|Mean|0.53|0.53|Standard Deviation|0.88|0.88|||
4263852|NCT00604214|4088582|B1|||Liver Sequential Organ Failure Assessment (SOFA) Score|Scores range from 0 (normal) to 4 (organ failure) with an increasing score indicating increasing liver dysfunction. There were 61 participants in drotrecogin alfa (activated) and 70 participants in placebo who were unspecified and were not included in the calculation of mean and standard deviation.|units on a scale|Mean|0.55|0.55|Standard Deviation|0.85|0.85|||
4263853|NCT00604214|4088580|B3|||Coagulation Sequential Organ Failure Assessment (SOFA) Score|Scores range from 0 (normal) to 4 (organ failure) with an increasing score indicating worsening coagulopathy (decreasing platelet counts). There were 11 participants in drotrecogin alfa (activated) and 17 participants in placebo who were unspecified and were not included in the calculation of mean and standard deviation.|units on a scale|Mean|0.74|0.74|Standard Deviation|0.96|0.96|||
4263854|NCT00604214|4088581|B2|||Coagulation Sequential Organ Failure Assessment (SOFA) Score|Scores range from 0 (normal) to 4 (organ failure) with an increasing score indicating worsening coagulopathy (decreasing platelet counts). There were 11 participants in drotrecogin alfa (activated) and 17 participants in placebo who were unspecified and were not included in the calculation of mean and standard deviation.|units on a scale|Mean|0.71|0.71|Standard Deviation|0.96|0.96|||
4263855|NCT00604214|4088582|B1|||Coagulation Sequential Organ Failure Assessment (SOFA) Score|Scores range from 0 (normal) to 4 (organ failure) with an increasing score indicating worsening coagulopathy (decreasing platelet counts). There were 11 participants in drotrecogin alfa (activated) and 17 participants in placebo who were unspecified and were not included in the calculation of mean and standard deviation.|units on a scale|Mean|0.76|0.76|Standard Deviation|0.97|0.97|||
4263856|NCT00604214|4088580|B3|||Renal Sequential Organ Failure Assessment (SOFA) Score|Scores range from 0 (normal) to 4 (organ failure) with an increasing score indicating increasing renal dysfunction. There were 12 participants in drotrecogin alfa (activated) and 17 participants in placebo who were unspecified and were not included in the calculation of mean and standard deviation.|units on a scale|Mean|1.63|1.63|Standard Deviation|1.33|1.33|||
4263857|NCT00604214|4088581|B2|||Renal Sequential Organ Failure Assessment (SOFA) Score|Scores range from 0 (normal) to 4 (organ failure) with an increasing score indicating increasing renal dysfunction. There were 12 participants in drotrecogin alfa (activated) and 17 participants in placebo who were unspecified and were not included in the calculation of mean and standard deviation.|units on a scale|Mean|1.60|1.6|Standard Deviation|1.34|1.34|||
4263858|NCT00604214|4088582|B1|||Renal Sequential Organ Failure Assessment (SOFA) Score|Scores range from 0 (normal) to 4 (organ failure) with an increasing score indicating increasing renal dysfunction. There were 12 participants in drotrecogin alfa (activated) and 17 participants in placebo who were unspecified and were not included in the calculation of mean and standard deviation.|units on a scale|Mean|1.67|1.67|Standard Deviation|1.33|1.33|||
4263859|NCT00604214|4088580|B3|||Respiratory Sequential Organ Failure Assessment (SOFA) Score|Scores range from 0 (normal) to 4 (organ failure) with an increasing score indicating increasing respiratory dysfunction. There were 35 participants in drotrecogin alfa (activated) and 34 participants in placebo who were unspecified and were not included in the calculation of mean and standard deviation.|units on a scale|Mean|2.76|2.76|Standard Deviation|1.08|1.08|||
4263860|NCT00604214|4088581|B2|||Respiratory Sequential Organ Failure Assessment (SOFA) Score|Scores range from 0 (normal) to 4 (organ failure) with an increasing score indicating increasing respiratory dysfunction. There were 35 participants in drotrecogin alfa (activated) and 34 participants in placebo who were unspecified and were not included in the calculation of mean and standard deviation.|units on a scale|Mean|2.74|2.74|Standard Deviation|1.08|1.08|||
4263861|NCT00604214|4088582|B1|||Respiratory Sequential Organ Failure Assessment (SOFA) Score|Scores range from 0 (normal) to 4 (organ failure) with an increasing score indicating increasing respiratory dysfunction. There were 35 participants in drotrecogin alfa (activated) and 34 participants in placebo who were unspecified and were not included in the calculation of mean and standard deviation.|units on a scale|Mean|2.78|2.78|Standard Deviation|1.07|1.07|||
4263862|NCT00604214|4088580|B3|||Cardiovascular Sequential Organ Failure Assessment (SOFA) Score|Scores range from 0 (normal) to 4 (organ failure) with an increasing score indicating increasing cardiovascular dysfunction. There were 12 participants in drotrecogin alfa (activated) and 14 participants in placebo who were unspecified and were not included in the calculation of mean and standard deviation.|units on a scale|Mean|3.90|3.9|Standard Deviation|0.33|0.33|||
4263863|NCT00604214|4088581|B2|||Cardiovascular Sequential Organ Failure Assessment (SOFA) Score|Scores range from 0 (normal) to 4 (organ failure) with an increasing score indicating increasing cardiovascular dysfunction. There were 12 participants in drotrecogin alfa (activated) and 14 participants in placebo who were unspecified and were not included in the calculation of mean and standard deviation.|units on a scale|Mean|3.89|3.89|Standard Deviation|0.35|0.35|||
4263864|NCT00604214|4088582|B1|||Cardiovascular Sequential Organ Failure Assessment (SOFA) Score|Scores range from 0 (normal) to 4 (organ failure) with an increasing score indicating increasing cardiovascular dysfunction. There were 12 participants in drotrecogin alfa (activated) and 14 participants in placebo who were unspecified and were not included in the calculation of mean and standard deviation.|units on a scale|Mean|3.91|3.91|Standard Deviation|0.32|0.32|||
4263865|NCT00604214|4088580|B3|Unknown||Primary Site of Infection||participants|Number|2|2.0||||||
4263866|NCT00604214|4088581|B2|Unknown||Primary Site of Infection||participants|Number|1|1.0||||||
4263867|NCT00604214|4088582|B1|Unknown||Primary Site of Infection||participants|Number|1|1.0||||||
4263868|NCT00604214|4088580|B3|Urinary Tract||Primary Site of Infection||participants|Number|209|209.0||||||
4263869|NCT00604214|4088581|B2|Urinary Tract||Primary Site of Infection||participants|Number|112|112.0||||||
4263870|NCT00604214|4088582|B1|Urinary Tract||Primary Site of Infection||participants|Number|97|97.0||||||
4263871|NCT00604214|4088580|B3|Skin or Skin Structure||Primary Site of Infection||participants|Number|93|93.0||||||
4263872|NCT00604214|4088581|B2|Skin or Skin Structure||Primary Site of Infection||participants|Number|45|45.0||||||
4263873|NCT00604214|4088582|B1|Skin or Skin Structure||Primary Site of Infection||participants|Number|48|48.0||||||
4263874|NCT00604214|4088580|B3|Reproductive Tract||Primary Site of Infection||participants|Number|4|4.0||||||
4263875|NCT00604214|4088581|B2|Reproductive Tract||Primary Site of Infection||participants|Number|2|2.0||||||
4263876|NCT00604214|4088582|B1|Reproductive Tract||Primary Site of Infection||participants|Number|2|2.0||||||
4263877|NCT00604214|4088580|B3|Pleura||Primary Site of Infection||participants|Number|7|7.0||||||
4263878|NCT00604214|4088581|B2|Pleura||Primary Site of Infection||participants|Number|5|5.0||||||
4263879|NCT00604214|4088582|B1|Pleura||Primary Site of Infection||participants|Number|2|2.0||||||
4263880|NCT00604214|4088580|B3|Other||Primary Site of Infection||participants|Number|28|28.0||||||
4263881|NCT00604214|4088581|B2|Other||Primary Site of Infection||participants|Number|17|17.0||||||
4263882|NCT00604214|4088582|B1|Other||Primary Site of Infection||participants|Number|11|11.0||||||
4263883|NCT00604214|4088580|B3|Lung||Primary Site of Infection||participants|Number|744|744.0||||||
4263884|NCT00604214|4088581|B2|Lung||Primary Site of Infection||participants|Number|375|375.0||||||
4263885|NCT00604214|4088582|B1|Lung||Primary Site of Infection||participants|Number|369|369.0||||||
4263886|NCT00604214|4088580|B3|Heart||Primary Site of Infection||participants|Number|6|6.0||||||
4263887|NCT00604214|4088581|B2|Heart||Primary Site of Infection||participants|Number|3|3.0||||||
4263888|NCT00604214|4088582|B1|Heart||Primary Site of Infection||participants|Number|3|3.0||||||
4263889|NCT00604214|4088580|B3|Head||Primary Site of Infection||participants|Number|5|5.0||||||
4263890|NCT00604214|4088581|B2|Head||Primary Site of Infection||participants|Number|3|3.0||||||
4263891|NCT00604214|4088582|B1|Head||Primary Site of Infection||participants|Number|2|2.0||||||
4263892|NCT00604214|4088580|B3|Central Nervous System||Primary Site of Infection||participants|Number|20|20.0||||||
4263893|NCT00604214|4088581|B2|Central Nervous System||Primary Site of Infection||participants|Number|9|9.0||||||
4263894|NCT00604214|4088582|B1|Central Nervous System||Primary Site of Infection||participants|Number|11|11.0||||||
4263895|NCT00604214|4088580|B3|Bone||Primary Site of Infection||participants|Number|4|4.0||||||
4263896|NCT00604214|4088581|B2|Bone||Primary Site of Infection||participants|Number|2|2.0||||||
4263897|NCT00604214|4088582|B1|Bone||Primary Site of Infection||participants|Number|2|2.0||||||
4263898|NCT00604214|4088580|B3|Blood||Primary Site of Infection||participants|Number|65|65.0||||||
4263899|NCT00604214|4088581|B2|Blood||Primary Site of Infection||participants|Number|25|25.0||||||
4263900|NCT00604214|4088582|B1|Blood||Primary Site of Infection||participants|Number|40|40.0||||||
4263901|NCT00604214|4088580|B3|Abdomen||Primary Site of Infection||participants|Number|509|509.0||||||
4263902|NCT00604214|4088581|B2|Abdomen||Primary Site of Infection||participants|Number|246|246.0||||||
4263903|NCT00604214|4088582|B1|Abdomen||Primary Site of Infection||participants|Number|263|263.0||||||
4263904|NCT00604214|4088580|B3|New Zealand||Region of Enrollment||participants|Number|46|46.0||||||
4263905|NCT00604214|4088581|B2|New Zealand||Region of Enrollment||participants|Number|22|22.0||||||
4263906|NCT00604214|4088582|B1|New Zealand||Region of Enrollment||participants|Number|24|24.0||||||
4263907|NCT00604214|4088580|B3|Germany||Region of Enrollment||participants|Number|45|45.0||||||
4263908|NCT00604214|4088581|B2|Germany||Region of Enrollment||participants|Number|23|23.0||||||
4263909|NCT00604214|4088582|B1|Germany||Region of Enrollment||participants|Number|22|22.0||||||
4263910|NCT00604214|4088580|B3|Netherlands||Region of Enrollment||participants|Number|30|30.0||||||
4263911|NCT00604214|4088581|B2|Netherlands||Region of Enrollment||participants|Number|15|15.0||||||
4263912|NCT00604214|4088582|B1|Netherlands||Region of Enrollment||participants|Number|15|15.0||||||
4263913|NCT00604214|4088580|B3|Australia||Region of Enrollment||participants|Number|64|64.0||||||
4263914|NCT00604214|4088581|B2|Australia||Region of Enrollment||participants|Number|28|28.0||||||
4263915|NCT00604214|4088582|B1|Australia||Region of Enrollment||participants|Number|36|36.0||||||
4263916|NCT00604214|4088580|B3|Belgium||Region of Enrollment||participants|Number|139|139.0||||||
4263917|NCT00604214|4088581|B2|Belgium||Region of Enrollment||participants|Number|70|70.0||||||
4263918|NCT00604214|4088582|B1|Belgium||Region of Enrollment||participants|Number|69|69.0||||||
4263919|NCT00604214|4088580|B3|Brazil||Region of Enrollment||participants|Number|36|36.0||||||
4263920|NCT00604214|4088581|B2|Brazil||Region of Enrollment||participants|Number|18|18.0||||||
4263921|NCT00604214|4088582|B1|Brazil||Region of Enrollment||participants|Number|18|18.0||||||
4263922|NCT00604214|4088580|B3|Canada||Region of Enrollment||participants|Number|79|79.0||||||
4263923|NCT00604214|4088581|B2|Canada||Region of Enrollment||participants|Number|43|43.0||||||
4263924|NCT00604214|4088582|B1|Canada||Region of Enrollment||participants|Number|36|36.0||||||
4263925|NCT00604214|4088580|B3|Mexico||Region of Enrollment||participants|Number|14|14.0||||||
4263926|NCT00604214|4088581|B2|Mexico||Region of Enrollment||participants|Number|7|7.0||||||
4263927|NCT00604214|4088582|B1|Mexico||Region of Enrollment||participants|Number|7|7.0||||||
4263928|NCT00604214|4088580|B3|Czech Republic||Region of Enrollment||participants|Number|54|54.0||||||
4263929|NCT00604214|4088581|B2|Czech Republic||Region of Enrollment||participants|Number|24|24.0||||||
4263930|NCT00604214|4088582|B1|Czech Republic||Region of Enrollment||participants|Number|30|30.0||||||
4263931|NCT00604214|4088580|B3|France||Region of Enrollment||participants|Number|464|464.0||||||
4263932|NCT00604214|4088581|B2|France||Region of Enrollment||participants|Number|229|229.0||||||
4263933|NCT00604214|4088582|B1|France||Region of Enrollment||participants|Number|235|235.0||||||
4263934|NCT00604214|4088580|B3|India||Region of Enrollment||participants|Number|81|81.0||||||
4263935|NCT00604214|4088581|B2|India||Region of Enrollment||participants|Number|41|41.0||||||
4263936|NCT00604214|4088582|B1|India||Region of Enrollment||participants|Number|40|40.0||||||
4263937|NCT00604214|4088580|B3|Italy||Region of Enrollment||participants|Number|107|107.0||||||
4263938|NCT00604214|4088581|B2|Italy||Region of Enrollment||participants|Number|53|53.0||||||
4263939|NCT00604214|4088582|B1|Italy||Region of Enrollment||participants|Number|54|54.0||||||
4263940|NCT00604214|4088580|B3|United Kingdom||Region of Enrollment||participants|Number|93|93.0||||||
4263941|NCT00604214|4088581|B2|United Kingdom||Region of Enrollment||participants|Number|49|49.0||||||
4263942|NCT00604214|4088582|B1|United Kingdom||Region of Enrollment||participants|Number|44|44.0||||||
4263943|NCT00604214|4088580|B3|Switzerland||Region of Enrollment||participants|Number|18|18.0||||||
4263944|NCT00604214|4088581|B2|Switzerland||Region of Enrollment||participants|Number|10|10.0||||||
4263945|NCT00604214|4088582|B1|Switzerland||Region of Enrollment||participants|Number|8|8.0||||||
4263946|NCT00604214|4088580|B3|Spain||Region of Enrollment||participants|Number|171|171.0||||||
4263947|NCT00604214|4088581|B2|Spain||Region of Enrollment||participants|Number|84|84.0||||||
4263948|NCT00604214|4088582|B1|Spain||Region of Enrollment||participants|Number|87|87.0||||||
4263949|NCT00604214|4088580|B3|Finland||Region of Enrollment||participants|Number|87|87.0||||||
4263950|NCT00604214|4088581|B2|Finland||Region of Enrollment||participants|Number|42|42.0||||||
4263951|NCT00604214|4088582|B1|Finland||Region of Enrollment||participants|Number|45|45.0||||||
4263952|NCT00604214|4088580|B3|United States||Region of Enrollment||participants|Number|160|160.0||||||
4263953|NCT00604214|4088581|B2|United States||Region of Enrollment||participants|Number|82|82.0||||||
4263954|NCT00604214|4088582|B1|United States||Region of Enrollment||participants|Number|78|78.0||||||
4263955|NCT00604214|4088580|B3|Portugal||Region of Enrollment||participants|Number|8|8.0||||||
4263956|NCT00604214|4088581|B2|Portugal||Region of Enrollment||participants|Number|5|5.0||||||
4263957|NCT00604214|4088582|B1|Portugal||Region of Enrollment||participants|Number|3|3.0||||||
4263958|NCT00604214|4088580|B3|West Asian (Indian Subcontinent)||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
4263959|NCT00604214|4088581|B2|West Asian (Indian Subcontinent)||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4263960|NCT00604214|4088582|B1|West Asian (Indian Subcontinent)||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4263961|NCT00604214|4088580|B3|Native American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4263962|NCT00604214|4088581|B2|Native American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4263963|NCT00604214|4088582|B1|Native American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4263964|NCT00604214|4088580|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
4263965|NCT00604214|4088581|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4263966|NCT00604214|4088582|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4263967|NCT00604214|4088580|B3|East Asian/Pacific||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4263968|NCT00604214|4088581|B2|East Asian/Pacific||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4263969|NCT00604214|4088582|B1|East Asian/Pacific||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4263970|NCT00604214|4088580|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|1461|1461.0||||||
4263971|NCT00604214|4088581|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|721|721.0||||||
4263972|NCT00604214|4088582|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|740|740.0||||||
4263973|NCT00604214|4088580|B3|African||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
4263974|NCT00604214|4088581|B2|African||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4263975|NCT00604214|4088582|B1|African||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4263976|NCT00604214|4088580|B3|Aboriginal/Torres Strait Islander||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4263977|NCT00604214|4088581|B2|Aboriginal/Torres Strait Islander||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4263978|NCT00604214|4088582|B1|Aboriginal/Torres Strait Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4263979|NCT00604214|4088580|B3||Male|Sex: Female, Male||Participants|Count of Participants|957|957.0||||||
4263980|NCT00604214|4088581|B2||Male|Sex: Female, Male||Participants|Count of Participants|466|466.0||||||
4263981|NCT00604214|4088582|B1||Male|Sex: Female, Male||Participants|Count of Participants|491|491.0||||||
4263982|NCT00604214|4088580|B3||Female|Sex: Female, Male||Participants|Count of Participants|739|739.0||||||
4263983|NCT00604214|4088581|B2||Female|Sex: Female, Male||Participants|Count of Participants|379|379.0||||||
4263984|NCT00604214|4088582|B1||Female|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
4263985|NCT00604214|4088580|B3|||Age||years|Mean|63.06|63.06|Standard Deviation|15.92|15.92|||
4263986|NCT00604214|4088581|B2|||Age||years|Mean|62.70|62.7|Standard Deviation|16.41|16.41|||
4263987|NCT00604214|4088582|B1|||Age||years|Mean|63.42|63.42|Standard Deviation|15.42|15.42|||
4263988|NCT00604188|4088613|B3||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4263989|NCT00604188|4088614|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4263990|NCT00604188|4088615|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4263991|NCT00604188|4088613|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4263992|NCT00604188|4088614|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4263993|NCT00604188|4088615|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4263994|NCT00604188|4088613|B3|||Age||years|Mean|30.7|30.7|Standard Deviation|8.3|8.3|||
4263995|NCT00604188|4088614|B2|||Age||years|Mean|30.5|30.5|Standard Deviation|8.2|8.2|||
4263996|NCT00604188|4088615|B1|||Age||years|Mean|31|31.0|Standard Deviation|8.4|8.4|||
4263997|NCT00604175|4088636|B4|Unknown||Human Papillomavirus Type 18 (HPV18) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV18 antibody titers <24 mMU/mL and seropositive as HPV18 antibody titers >=24 mMU/mL.|Participants|Number|6|6.0||||||
4263998|NCT00604175|4088637|B3|Unknown||Human Papillomavirus Type 18 (HPV18) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV18 antibody titers <24 mMU/mL and seropositive as HPV18 antibody titers >=24 mMU/mL.|Participants|Number|0|0.0||||||
4263999|NCT00604175|4088638|B2|Unknown||Human Papillomavirus Type 18 (HPV18) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV18 antibody titers <24 mMU/mL and seropositive as HPV18 antibody titers >=24 mMU/mL.|Participants|Number|0|0.0||||||
4264000|NCT00604175|4088639|B1|Unknown||Human Papillomavirus Type 18 (HPV18) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV18 antibody titers <24 mMU/mL and seropositive as HPV18 antibody titers >=24 mMU/mL.|Participants|Number|6|6.0||||||
4264001|NCT00604175|4088636|B4|Seropositive||Human Papillomavirus Type 18 (HPV18) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV18 antibody titers <24 mMU/mL and seropositive as HPV18 antibody titers >=24 mMU/mL.|Participants|Number|61|61.0||||||
4264002|NCT00604175|4088637|B3|Seropositive||Human Papillomavirus Type 18 (HPV18) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV18 antibody titers <24 mMU/mL and seropositive as HPV18 antibody titers >=24 mMU/mL.|Participants|Number|20|20.0||||||
4264003|NCT00604175|4088638|B2|Seropositive||Human Papillomavirus Type 18 (HPV18) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV18 antibody titers <24 mMU/mL and seropositive as HPV18 antibody titers >=24 mMU/mL.|Participants|Number|12|12.0||||||
4264004|NCT00604175|4088639|B1|Seropositive||Human Papillomavirus Type 18 (HPV18) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV18 antibody titers <24 mMU/mL and seropositive as HPV18 antibody titers >=24 mMU/mL.|Participants|Number|29|29.0||||||
4264082|NCT00604175|4088637|B3|United States||Region of Enrollment||Participants|Number|69|69.0||||||
4264005|NCT00604175|4088636|B4|Seronegative||Human Papillomavirus Type 18 (HPV18) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV18 antibody titers <24 mMU/mL and seropositive as HPV18 antibody titers >=24 mMU/mL.|Participants|Number|248|248.0||||||
4264006|NCT00604175|4088637|B3|Seronegative||Human Papillomavirus Type 18 (HPV18) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV18 antibody titers <24 mMU/mL and seropositive as HPV18 antibody titers >=24 mMU/mL.|Participants|Number|73|73.0||||||
4264007|NCT00604175|4088638|B2|Seronegative||Human Papillomavirus Type 18 (HPV18) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV18 antibody titers <24 mMU/mL and seropositive as HPV18 antibody titers >=24 mMU/mL.|Participants|Number|83|83.0||||||
4264008|NCT00604175|4088639|B1|Seronegative||Human Papillomavirus Type 18 (HPV18) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV18 antibody titers <24 mMU/mL and seropositive as HPV18 antibody titers >=24 mMU/mL.|Participants|Number|92|92.0||||||
4264009|NCT00604175|4088636|B4|Unknown||Human Papillomavirus Type 16 (HPV16) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV16 antibody titers <20 mMU/mL and seropositive as HPV16 antibody titers >=20 mMU/mL.|Participants|Number|6|6.0||||||
4264010|NCT00604175|4088637|B3|Unknown||Human Papillomavirus Type 16 (HPV16) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV16 antibody titers <20 mMU/mL and seropositive as HPV16 antibody titers >=20 mMU/mL.|Participants|Number|0|0.0||||||
4264011|NCT00604175|4088638|B2|Unknown||Human Papillomavirus Type 16 (HPV16) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV16 antibody titers <20 mMU/mL and seropositive as HPV16 antibody titers >=20 mMU/mL.|Participants|Number|0|0.0||||||
4264012|NCT00604175|4088639|B1|Unknown||Human Papillomavirus Type 16 (HPV16) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV16 antibody titers <20 mMU/mL and seropositive as HPV16 antibody titers >=20 mMU/mL.|Participants|Number|6|6.0||||||
4264013|NCT00604175|4088636|B4|Seropositive||Human Papillomavirus Type 16 (HPV16) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV16 antibody titers <20 mMU/mL and seropositive as HPV16 antibody titers >=20 mMU/mL.|Participants|Number|100|100.0||||||
4264014|NCT00604175|4088637|B3|Seropositive||Human Papillomavirus Type 16 (HPV16) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV16 antibody titers <20 mMU/mL and seropositive as HPV16 antibody titers >=20 mMU/mL.|Participants|Number|26|26.0||||||
4264015|NCT00604175|4088638|B2|Seropositive||Human Papillomavirus Type 16 (HPV16) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV16 antibody titers <20 mMU/mL and seropositive as HPV16 antibody titers >=20 mMU/mL.|Participants|Number|30|30.0||||||
4264016|NCT00604175|4088639|B1|Seropositive||Human Papillomavirus Type 16 (HPV16) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV16 antibody titers <20 mMU/mL and seropositive as HPV16 antibody titers >=20 mMU/mL.|Participants|Number|44|44.0||||||
4264017|NCT00604175|4088636|B4|Seronegative||Human Papillomavirus Type 16 (HPV16) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV16 antibody titers <20 mMU/mL and seropositive as HPV16 antibody titers >=20 mMU/mL.|Participants|Number|209|209.0||||||
4264018|NCT00604175|4088637|B3|Seronegative||Human Papillomavirus Type 16 (HPV16) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV16 antibody titers <20 mMU/mL and seropositive as HPV16 antibody titers >=20 mMU/mL.|Participants|Number|67|67.0||||||
4264019|NCT00604175|4088638|B2|Seronegative||Human Papillomavirus Type 16 (HPV16) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV16 antibody titers <20 mMU/mL and seropositive as HPV16 antibody titers >=20 mMU/mL.|Participants|Number|65|65.0||||||
4264020|NCT00604175|4088639|B1|Seronegative||Human Papillomavirus Type 16 (HPV16) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV16 antibody titers <20 mMU/mL and seropositive as HPV16 antibody titers >=20 mMU/mL.|Participants|Number|77|77.0||||||
4264021|NCT00604175|4088636|B4|Unknown||Human Papillomavirus Type 11 (HPV11) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV11 antibody titers <16 mMU/mL and seropositive as HPV11 antibody titers >=16 mMU/mL.|Participants|Number|6|6.0||||||
4264022|NCT00604175|4088637|B3|Unknown||Human Papillomavirus Type 11 (HPV11) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV11 antibody titers <16 mMU/mL and seropositive as HPV11 antibody titers >=16 mMU/mL.|Participants|Number|0|0.0||||||
4264023|NCT00604175|4088638|B2|Unknown||Human Papillomavirus Type 11 (HPV11) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV11 antibody titers <16 mMU/mL and seropositive as HPV11 antibody titers >=16 mMU/mL.|Participants|Number|0|0.0||||||
4264024|NCT00604175|4088639|B1|Unknown||Human Papillomavirus Type 11 (HPV11) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV11 antibody titers <16 mMU/mL and seropositive as HPV11 antibody titers >=16 mMU/mL.|Participants|Number|6|6.0||||||
4264083|NCT00604175|4088638|B2|United States||Region of Enrollment||Participants|Number|80|80.0||||||
4264084|NCT00604175|4088639|B1|United States||Region of Enrollment||Participants|Number|113|113.0||||||
4264025|NCT00604175|4088636|B4|Seropositive||Human Papillomavirus Type 11 (HPV11) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV11 antibody titers <16 mMU/mL and seropositive as HPV11 antibody titers >=16 mMU/mL.|Participants|Number|64|64.0||||||
4264026|NCT00604175|4088637|B3|Seropositive||Human Papillomavirus Type 11 (HPV11) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV11 antibody titers <16 mMU/mL and seropositive as HPV11 antibody titers >=16 mMU/mL.|Participants|Number|19|19.0||||||
4264027|NCT00604175|4088638|B2|Seropositive||Human Papillomavirus Type 11 (HPV11) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV11 antibody titers <16 mMU/mL and seropositive as HPV11 antibody titers >=16 mMU/mL.|Participants|Number|23|23.0||||||
4264028|NCT00604175|4088639|B1|Seropositive||Human Papillomavirus Type 11 (HPV11) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV11 antibody titers <16 mMU/mL and seropositive as HPV11 antibody titers >=16 mMU/mL.|Participants|Number|22|22.0||||||
4264029|NCT00604175|4088636|B4|Seronegative||Human Papillomavirus Type 11 (HPV11) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV11 antibody titers <16 mMU/mL and seropositive as HPV11 antibody titers >=16 mMU/mL.|Participants|Number|245|245.0||||||
4264030|NCT00604175|4088637|B3|Seronegative||Human Papillomavirus Type 11 (HPV11) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV11 antibody titers <16 mMU/mL and seropositive as HPV11 antibody titers >=16 mMU/mL.|Participants|Number|74|74.0||||||
4264031|NCT00604175|4088638|B2|Seronegative||Human Papillomavirus Type 11 (HPV11) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV11 antibody titers <16 mMU/mL and seropositive as HPV11 antibody titers >=16 mMU/mL.|Participants|Number|72|72.0||||||
4264032|NCT00604175|4088639|B1|Seronegative||Human Papillomavirus Type 11 (HPV11) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV11 antibody titers <16 mMU/mL and seropositive as HPV11 antibody titers >=16 mMU/mL.|Participants|Number|99|99.0||||||
4264033|NCT00604175|4088636|B4|Unknown||Human Papillomavirus Type 6 (HPV6) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV6 antibody titers <20 mMU/mL and seropositive as HPV6 antibody titers >=20 mMU/mL.|Participants|Number|7|7.0||||||
4264034|NCT00604175|4088637|B3|Unknown||Human Papillomavirus Type 6 (HPV6) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV6 antibody titers <20 mMU/mL and seropositive as HPV6 antibody titers >=20 mMU/mL.|Participants|Number|0|0.0||||||
4264035|NCT00604175|4088638|B2|Unknown||Human Papillomavirus Type 6 (HPV6) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV6 antibody titers <20 mMU/mL and seropositive as HPV6 antibody titers >=20 mMU/mL.|Participants|Number|0|0.0||||||
4264036|NCT00604175|4088639|B1|Unknown||Human Papillomavirus Type 6 (HPV6) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV6 antibody titers <20 mMU/mL and seropositive as HPV6 antibody titers >=20 mMU/mL.|Participants|Number|7|7.0||||||
4264037|NCT00604175|4088636|B4|Seropositive||Human Papillomavirus Type 6 (HPV6) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV6 antibody titers <20 mMU/mL and seropositive as HPV6 antibody titers >=20 mMU/mL.|Participants|Number|126|126.0||||||
4264038|NCT00604175|4088637|B3|Seropositive||Human Papillomavirus Type 6 (HPV6) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV6 antibody titers <20 mMU/mL and seropositive as HPV6 antibody titers >=20 mMU/mL.|Participants|Number|37|37.0||||||
4264039|NCT00604175|4088638|B2|Seropositive||Human Papillomavirus Type 6 (HPV6) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV6 antibody titers <20 mMU/mL and seropositive as HPV6 antibody titers >=20 mMU/mL.|Participants|Number|35|35.0||||||
4264040|NCT00604175|4088639|B1|Seropositive||Human Papillomavirus Type 6 (HPV6) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV6 antibody titers <20 mMU/mL and seropositive as HPV6 antibody titers >=20 mMU/mL.|Participants|Number|54|54.0||||||
4264041|NCT00604175|4088636|B4|Seronegative||Human Papillomavirus Type 6 (HPV6) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV6 antibody titers <20 mMU/mL and seropositive as HPV6 antibody titers >=20 mMU/mL.|Participants|Number|182|182.0||||||
4264042|NCT00604175|4088637|B3|Seronegative||Human Papillomavirus Type 6 (HPV6) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV6 antibody titers <20 mMU/mL and seropositive as HPV6 antibody titers >=20 mMU/mL.|Participants|Number|56|56.0||||||
4264043|NCT00604175|4088638|B2|Seronegative||Human Papillomavirus Type 6 (HPV6) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV6 antibody titers <20 mMU/mL and seropositive as HPV6 antibody titers >=20 mMU/mL.|Participants|Number|60|60.0||||||
4264044|NCT00604175|4088639|B1|Seronegative||Human Papillomavirus Type 6 (HPV6) Serostatus|HPV serotyping was performed centrally using the competitive Luminex ImmunoAssay (HPV-4, cLIA) on stored serum. Seronegative status was defined as HPV6 antibody titers <20 mMU/mL and seropositive as HPV6 antibody titers >=20 mMU/mL.|Participants|Number|66|66.0||||||
4264085|NCT00604175|4088636|B4|Unknown||Race/Ethnicity, Customized|Race/ethnicity, self-reported (NIH categories).|Participants|Number|3|3.0||||||
4264086|NCT00604175|4088637|B3|Unknown||Race/Ethnicity, Customized|Race/ethnicity, self-reported (NIH categories).|Participants|Number|1|1.0||||||
4264045|NCT00604175|4088636|B4|Unknown||HIV Viral Load|A blood sample was drawn for HIV viral load testing by local laboratories. The assays used were Roche Amplicor Monitor HIV RT PCR, Roche UltraSensitive HIV RT PCR, bDNA (Versant HIV-1 RNA 3.0, 3rd), Roche COBAS AmpliPrep/Taqman HIV and Abbott RealTime HIV-1.|Participants|Number|1|1.0||||||
4264046|NCT00604175|4088637|B3|Unknown||HIV Viral Load|A blood sample was drawn for HIV viral load testing by local laboratories. The assays used were Roche Amplicor Monitor HIV RT PCR, Roche UltraSensitive HIV RT PCR, bDNA (Versant HIV-1 RNA 3.0, 3rd), Roche COBAS AmpliPrep/Taqman HIV and Abbott RealTime HIV-1.|Participants|Number|0|0.0||||||
4264047|NCT00604175|4088638|B2|Unknown||HIV Viral Load|A blood sample was drawn for HIV viral load testing by local laboratories. The assays used were Roche Amplicor Monitor HIV RT PCR, Roche UltraSensitive HIV RT PCR, bDNA (Versant HIV-1 RNA 3.0, 3rd), Roche COBAS AmpliPrep/Taqman HIV and Abbott RealTime HIV-1.|Participants|Number|1|1.0||||||
4264048|NCT00604175|4088639|B1|Unknown||HIV Viral Load|A blood sample was drawn for HIV viral load testing by local laboratories. The assays used were Roche Amplicor Monitor HIV RT PCR, Roche UltraSensitive HIV RT PCR, bDNA (Versant HIV-1 RNA 3.0, 3rd), Roche COBAS AmpliPrep/Taqman HIV and Abbott RealTime HIV-1.|Participants|Number|0|0.0||||||
4264049|NCT00604175|4088636|B4|>10,000 copies/mL||HIV Viral Load|A blood sample was drawn for HIV viral load testing by local laboratories. The assays used were Roche Amplicor Monitor HIV RT PCR, Roche UltraSensitive HIV RT PCR, bDNA (Versant HIV-1 RNA 3.0, 3rd), Roche COBAS AmpliPrep/Taqman HIV and Abbott RealTime HIV-1.|Participants|Number|113|113.0||||||
4264050|NCT00604175|4088637|B3|>10,000 copies/mL||HIV Viral Load|A blood sample was drawn for HIV viral load testing by local laboratories. The assays used were Roche Amplicor Monitor HIV RT PCR, Roche UltraSensitive HIV RT PCR, bDNA (Versant HIV-1 RNA 3.0, 3rd), Roche COBAS AmpliPrep/Taqman HIV and Abbott RealTime HIV-1.|Participants|Number|32|32.0||||||
4264051|NCT00604175|4088638|B2|>10,000 copies/mL||HIV Viral Load|A blood sample was drawn for HIV viral load testing by local laboratories. The assays used were Roche Amplicor Monitor HIV RT PCR, Roche UltraSensitive HIV RT PCR, bDNA (Versant HIV-1 RNA 3.0, 3rd), Roche COBAS AmpliPrep/Taqman HIV and Abbott RealTime HIV-1.|Participants|Number|25|25.0||||||
4264052|NCT00604175|4088639|B1|>10,000 copies/mL||HIV Viral Load|A blood sample was drawn for HIV viral load testing by local laboratories. The assays used were Roche Amplicor Monitor HIV RT PCR, Roche UltraSensitive HIV RT PCR, bDNA (Versant HIV-1 RNA 3.0, 3rd), Roche COBAS AmpliPrep/Taqman HIV and Abbott RealTime HIV-1.|Participants|Number|56|56.0||||||
4264053|NCT00604175|4088636|B4|<=10,000 copies/mL||HIV Viral Load|A blood sample was drawn for HIV viral load testing by local laboratories. The assays used were Roche Amplicor Monitor HIV RT PCR, Roche UltraSensitive HIV RT PCR, bDNA (Versant HIV-1 RNA 3.0, 3rd), Roche COBAS AmpliPrep/Taqman HIV and Abbott RealTime HIV-1.|Participants|Number|201|201.0||||||
4264054|NCT00604175|4088637|B3|<=10,000 copies/mL||HIV Viral Load|A blood sample was drawn for HIV viral load testing by local laboratories. The assays used were Roche Amplicor Monitor HIV RT PCR, Roche UltraSensitive HIV RT PCR, bDNA (Versant HIV-1 RNA 3.0, 3rd), Roche COBAS AmpliPrep/Taqman HIV and Abbott RealTime HIV-1.|Participants|Number|61|61.0||||||
4264055|NCT00604175|4088638|B2|<=10,000 copies/mL||HIV Viral Load|A blood sample was drawn for HIV viral load testing by local laboratories. The assays used were Roche Amplicor Monitor HIV RT PCR, Roche UltraSensitive HIV RT PCR, bDNA (Versant HIV-1 RNA 3.0, 3rd), Roche COBAS AmpliPrep/Taqman HIV and Abbott RealTime HIV-1.|Participants|Number|69|69.0||||||
4264056|NCT00604175|4088639|B1|<=10,000 copies/mL||HIV Viral Load|A blood sample was drawn for HIV viral load testing by local laboratories. The assays used were Roche Amplicor Monitor HIV RT PCR, Roche UltraSensitive HIV RT PCR, bDNA (Versant HIV-1 RNA 3.0, 3rd), Roche COBAS AmpliPrep/Taqman HIV and Abbott RealTime HIV-1.|Participants|Number|71|71.0||||||
4264057|NCT00604175|4088636|B4|||Nadir CD4 Cell Count||Cells/mm^3|Median|179|179.0|Inter-Quartile Range|||47.0|314.0|
4264058|NCT00604175|4088637|B3|||Nadir CD4 Cell Count||Cells/mm^3|Median|41|41.0|Inter-Quartile Range|||20.0|108.0|
4264059|NCT00604175|4088638|B2|||Nadir CD4 Cell Count||Cells/mm^3|Median|176|176.0|Inter-Quartile Range|||64.0|261.0|
4264060|NCT00604175|4088639|B1|||Nadir CD4 Cell Count||Cells/mm^3|Median|368|368.0|Inter-Quartile Range|||234.0|482.0|
4264061|NCT00604175|4088636|B4|||CD4 Cell Count||Cells/mm^3|Median|310|310.0|Inter-Quartile Range|||197.0|498.0|
4264062|NCT00604175|4088637|B3|||CD4 Cell Count||Cells/mm^3|Median|154|154.0|Inter-Quartile Range|||86.0|188.0|
4264063|NCT00604175|4088638|B2|||CD4 Cell Count||Cells/mm^3|Median|287|287.0|Inter-Quartile Range|||246.0|344.0|
4264064|NCT00604175|4088639|B1|||CD4 Cell Count||Cells/mm^3|Median|519|519.0|Inter-Quartile Range|||418.0|664.0|
4264065|NCT00604175|4088636|B4|Not on ART||HIV Antiretroviral Therapy (ART) Status||Participants|Number|106|106.0||||||
4264066|NCT00604175|4088637|B3|Not on ART||HIV Antiretroviral Therapy (ART) Status||Participants|Number|13|13.0||||||
4264067|NCT00604175|4088638|B2|Not on ART||HIV Antiretroviral Therapy (ART) Status||Participants|Number|24|24.0||||||
4264068|NCT00604175|4088639|B1|Not on ART||HIV Antiretroviral Therapy (ART) Status||Participants|Number|69|69.0||||||
4264069|NCT00604175|4088636|B4|On ART||HIV Antiretroviral Therapy (ART) Status||Participants|Number|209|209.0||||||
4264070|NCT00604175|4088637|B3|On ART||HIV Antiretroviral Therapy (ART) Status||Participants|Number|80|80.0||||||
4264071|NCT00604175|4088638|B2|On ART||HIV Antiretroviral Therapy (ART) Status||Participants|Number|71|71.0||||||
4264072|NCT00604175|4088639|B1|On ART||HIV Antiretroviral Therapy (ART) Status||Participants|Number|58|58.0||||||
4264073|NCT00604175|4088636|B4|South Africa||Region of Enrollment||Participants|Number|25|25.0||||||
4264074|NCT00604175|4088637|B3|South Africa||Region of Enrollment||Participants|Number|13|13.0||||||
4264075|NCT00604175|4088638|B2|South Africa||Region of Enrollment||Participants|Number|9|9.0||||||
4264076|NCT00604175|4088639|B1|South Africa||Region of Enrollment||Participants|Number|3|3.0||||||
4264077|NCT00604175|4088636|B4|Brazil||Region of Enrollment||Participants|Number|28|28.0||||||
4264078|NCT00604175|4088637|B3|Brazil||Region of Enrollment||Participants|Number|11|11.0||||||
4264079|NCT00604175|4088638|B2|Brazil||Region of Enrollment||Participants|Number|6|6.0||||||
4264080|NCT00604175|4088639|B1|Brazil||Region of Enrollment||Participants|Number|11|11.0||||||
4264081|NCT00604175|4088636|B4|United States||Region of Enrollment||Participants|Number|262|262.0||||||
4264087|NCT00604175|4088638|B2|Unknown||Race/Ethnicity, Customized|Race/ethnicity, self-reported (NIH categories).|Participants|Number|2|2.0||||||
4264088|NCT00604175|4088639|B1|Unknown||Race/Ethnicity, Customized|Race/ethnicity, self-reported (NIH categories).|Participants|Number|0|0.0||||||
4264089|NCT00604175|4088636|B4|Asian, Pacific Islander||Race/Ethnicity, Customized|Race/ethnicity, self-reported (NIH categories).|Participants|Number|3|3.0||||||
4264090|NCT00604175|4088637|B3|Asian, Pacific Islander||Race/Ethnicity, Customized|Race/ethnicity, self-reported (NIH categories).|Participants|Number|1|1.0||||||
4264091|NCT00604175|4088638|B2|Asian, Pacific Islander||Race/Ethnicity, Customized|Race/ethnicity, self-reported (NIH categories).|Participants|Number|0|0.0||||||
4264092|NCT00604175|4088639|B1|Asian, Pacific Islander||Race/Ethnicity, Customized|Race/ethnicity, self-reported (NIH categories).|Participants|Number|2|2.0||||||
4264093|NCT00604175|4088636|B4|Hispanic (Regardless of Race)||Race/Ethnicity, Customized|Race/ethnicity, self-reported (NIH categories).|Participants|Number|96|96.0||||||
4264094|NCT00604175|4088637|B3|Hispanic (Regardless of Race)||Race/Ethnicity, Customized|Race/ethnicity, self-reported (NIH categories).|Participants|Number|32|32.0||||||
4264095|NCT00604175|4088638|B2|Hispanic (Regardless of Race)||Race/Ethnicity, Customized|Race/ethnicity, self-reported (NIH categories).|Participants|Number|25|25.0||||||
4264096|NCT00604175|4088639|B1|Hispanic (Regardless of Race)||Race/Ethnicity, Customized|Race/ethnicity, self-reported (NIH categories).|Participants|Number|39|39.0||||||
4264097|NCT00604175|4088636|B4|Black, Non-Hispanic||Race/Ethnicity, Customized|Race/ethnicity, self-reported (NIH categories).|Participants|Number|177|177.0||||||
4264098|NCT00604175|4088637|B3|Black, Non-Hispanic||Race/Ethnicity, Customized|Race/ethnicity, self-reported (NIH categories).|Participants|Number|51|51.0||||||
4264099|NCT00604175|4088638|B2|Black, Non-Hispanic||Race/Ethnicity, Customized|Race/ethnicity, self-reported (NIH categories).|Participants|Number|59|59.0||||||
4264100|NCT00604175|4088639|B1|Black, Non-Hispanic||Race/Ethnicity, Customized|Race/ethnicity, self-reported (NIH categories).|Participants|Number|67|67.0||||||
4264101|NCT00604175|4088636|B4|White, Non-Hispanic||Race/Ethnicity, Customized|Race/ethnicity, self-reported (NIH categories).|Participants|Number|36|36.0||||||
4264102|NCT00604175|4088637|B3|White, Non-Hispanic||Race/Ethnicity, Customized|Race/ethnicity, self-reported (NIH categories).|Participants|Number|8|8.0||||||
4264103|NCT00604175|4088638|B2|White, Non-Hispanic||Race/Ethnicity, Customized|Race/ethnicity, self-reported (NIH categories).|Participants|Number|9|9.0||||||
4264104|NCT00604175|4088639|B1|White, Non-Hispanic||Race/Ethnicity, Customized|Race/ethnicity, self-reported (NIH categories).|Participants|Number|19|19.0||||||
4264105|NCT00604175|4088636|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4264106|NCT00604175|4088637|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4264107|NCT00604175|4088638|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4264108|NCT00604175|4088639|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4264109|NCT00604175|4088636|B4||Female|Sex: Female, Male||Participants|Count of Participants|315|315.0||||||
4264110|NCT00604175|4088637|B3||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4264111|NCT00604175|4088638|B2||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4264112|NCT00604175|4088639|B1||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4264113|NCT00604175|4088636|B4|40 - 45 years||Age, Customized||Participants|Number|106|106.0||||||
4264114|NCT00604175|4088637|B3|40 - 45 years||Age, Customized||Participants|Number|29|29.0||||||
4264115|NCT00604175|4088638|B2|40 - 45 years||Age, Customized||Participants|Number|41|41.0||||||
4264116|NCT00604175|4088639|B1|40 - 45 years||Age, Customized||Participants|Number|36|36.0||||||
4264117|NCT00604175|4088636|B4|35 - 39 years||Age, Customized||Participants|Number|81|81.0||||||
4264118|NCT00604175|4088637|B3|35 - 39 years||Age, Customized||Participants|Number|24|24.0||||||
4264119|NCT00604175|4088638|B2|35 - 39 years||Age, Customized||Participants|Number|26|26.0||||||
4264120|NCT00604175|4088639|B1|35 - 39 years||Age, Customized||Participants|Number|31|31.0||||||
4264121|NCT00604175|4088636|B4|30 - 34 years||Age, Customized||Participants|Number|60|60.0||||||
4264122|NCT00604175|4088637|B3|30 - 34 years||Age, Customized||Participants|Number|20|20.0||||||
4264123|NCT00604175|4088638|B2|30 - 34 years||Age, Customized||Participants|Number|14|14.0||||||
4264124|NCT00604175|4088639|B1|30 - 34 years||Age, Customized||Participants|Number|26|26.0||||||
4264125|NCT00604175|4088636|B4|25 - 29 years||Age, Customized||Participants|Number|47|47.0||||||
4264126|NCT00604175|4088637|B3|25 - 29 years||Age, Customized||Participants|Number|12|12.0||||||
4264127|NCT00604175|4088638|B2|25 - 29 years||Age, Customized||Participants|Number|11|11.0||||||
4264128|NCT00604175|4088639|B1|25 - 29 years||Age, Customized||Participants|Number|24|24.0||||||
4264129|NCT00604175|4088636|B4|18 - 24 years||Age, Customized||Participants|Number|20|20.0||||||
4264130|NCT00604175|4088637|B3|18 - 24 years||Age, Customized||Participants|Number|7|7.0||||||
4264131|NCT00604175|4088638|B2|18 - 24 years||Age, Customized||Participants|Number|3|3.0||||||
4264132|NCT00604175|4088639|B1|18 - 24 years||Age, Customized||Participants|Number|10|10.0||||||
4264133|NCT00604175|4088636|B4|13 - 17 years||Age, Customized||Participants|Number|1|1.0||||||
4264134|NCT00604175|4088637|B3|13 - 17 years||Age, Customized||Participants|Number|1|1.0||||||
4264135|NCT00604175|4088638|B2|13 - 17 years||Age, Customized||Participants|Number|0|0.0||||||
4264136|NCT00604175|4088639|B1|13 - 17 years||Age, Customized||Participants|Number|0|0.0||||||
4264137|NCT00604175|4088636|B4|||Age||years|Median|36|36.0|Inter-Quartile Range|||30.0|41.0|
4264138|NCT00604175|4088637|B3|||Age||years|Median|36|36.0|Inter-Quartile Range|||31.0|40.0|
4264139|NCT00604175|4088638|B2|||Age||years|Median|38|38.0|Inter-Quartile Range|||33.0|42.0|
4264140|NCT00604175|4088639|B1|||Age||years|Median|35|35.0|Inter-Quartile Range|||29.0|40.0|
4264141|NCT00604162|4088694|B1|Belgium||Region of Enrollment||participants|Number|47|47.0||||||
4264142|NCT00604162|4088694|B1|United Kingdom||Region of Enrollment||participants|Number|20|20.0||||||
4264143|NCT00604162|4088694|B1|Italy||Region of Enrollment||participants|Number|53|53.0||||||
4264144|NCT00604162|4088694|B1|Germany||Region of Enrollment||participants|Number|49|49.0||||||
4264145|NCT00604162|4088694|B1|Spain||Region of Enrollment||participants|Number|63|63.0||||||
4264146|NCT00604162|4088694|B1|France||Region of Enrollment||participants|Number|96|96.0||||||
4264147|NCT00604162|4088694|B1||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4264148|NCT00604162|4088694|B1||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4264149|NCT00604162|4088694|B1|||Age||years|Mean|58.5|58.5|Standard Deviation|12.1|12.1|||
4264150|NCT00604162|4088694|B1||>=65 years|Age||Participants|Count of Participants|101|101.0||||||
4264151|NCT00604162|4088694|B1||Between 18 and 65 years|Age||Participants|Count of Participants|227|227.0||||||
4264152|NCT00604162|4088694|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4264153|NCT00604045|4088705|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4264154|NCT00604045|4088706|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4264155|NCT00604045|4088707|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4264156|NCT00604045|4088705|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4264157|NCT00604045|4088706|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4264158|NCT00604045|4088707|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4264159|NCT00604045|4088705|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4264160|NCT00604045|4088706|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4264161|NCT00604045|4088707|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4264162|NCT00604045|4088705|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4264163|NCT00604045|4088706|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4264164|NCT00604045|4088707|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4264165|NCT00604045|4088705|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4264166|NCT00604045|4088706|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4264167|NCT00604045|4088707|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4264168|NCT00604045|4088705|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4264169|NCT00604045|4088706|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4264170|NCT00604045|4088707|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4264171|NCT00604019|4088714|B3|United States||Region of Enrollment||participants|Number|252|252.0||||||
4264172|NCT00604019|4088715|B2|United States||Region of Enrollment||participants|Number|118|118.0||||||
4264173|NCT00604019|4088716|B1|United States||Region of Enrollment||participants|Number|134|134.0||||||
4264174|NCT00604019|4088714|B3||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4264175|NCT00604019|4088715|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4264176|NCT00604019|4088716|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4264177|NCT00604019|4088714|B3||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4264178|NCT00604019|4088715|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4264179|NCT00604019|4088716|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4264180|NCT00604019|4088714|B3|||Age||years|Mean|57|57.0|Standard Deviation|20|20.0|||
4264181|NCT00604019|4088715|B2|||Age||years|Mean|60|60.0|Standard Deviation|15|15.0|||
4264182|NCT00604019|4088716|B1|||Age||years|Mean|56|56.0|Standard Deviation|18|18.0|||
4264183|NCT00604019|4088714|B3||>=65 years|Age||Participants|Count of Participants|52|52.0||||||
4264184|NCT00604019|4088715|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4264185|NCT00604019|4088716|B1||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
4264186|NCT00604019|4088714|B3||Between 18 and 65 years|Age||Participants|Count of Participants|200|200.0||||||
4264187|NCT00604019|4088715|B2||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4264188|NCT00604019|4088716|B1||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4264189|NCT00604019|4088714|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4264190|NCT00604019|4088715|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4264191|NCT00604019|4088716|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4264192|NCT00603993|4088723|B1|Japan||Region of Enrollment||participants|Number|88|88.0||||||
4264193|NCT00603993|4088723|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4264194|NCT00603993|4088723|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4264195|NCT00603993|4088723|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|11.0|11.0|||
4264196|NCT00603915|4088736|B1|1||Performance Status|"ECOG Performance Status is a scale and criteria to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis. A lower ECOG indicates a better outcome.~0 - fully active~- restricted in physically strenuous activity~- able to do selfcare, but unable to carry out any work activities~- capable of only limited selfcare~- completely disabled~- dead"|Participants|Number|10|10.0||||||
4264197|NCT00603915|4088736|B1|0||Performance Status|"ECOG Performance Status is a scale and criteria to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis. A lower ECOG indicates a better outcome.~0 - fully active~- restricted in physically strenuous activity~- able to do selfcare, but unable to carry out any work activities~- capable of only limited selfcare~- completely disabled~- dead"|Participants|Number|10|10.0||||||
4264198|NCT00603915|4088736|B1|Canada||Region of Enrollment||participants|Number|20|20.0||||||
4264199|NCT00603915|4088736|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4264200|NCT00603915|4088736|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4264201|NCT00603915|4088736|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4264202|NCT00603915|4088736|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4264203|NCT00603915|4088736|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4264204|NCT00603902|4088741|B4||Male|Sex: Female, Male||Participants|Count of Participants|810|810.0||||||
4264205|NCT00603902|4088742|B3||Male|Sex: Female, Male||Participants|Count of Participants|352|352.0||||||
4264206|NCT00603902|4088743|B2||Male|Sex: Female, Male||Participants|Count of Participants|313|313.0||||||
4264207|NCT00603902|4088744|B1||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4264208|NCT00603902|4088741|B4||Female|Sex: Female, Male||Participants|Count of Participants|3194|3194.0||||||
4264209|NCT00603902|4088742|B3||Female|Sex: Female, Male||Participants|Count of Participants|1249|1249.0||||||
4264210|NCT00603902|4088743|B2||Female|Sex: Female, Male||Participants|Count of Participants|1289|1289.0||||||
4264211|NCT00603902|4088744|B1||Female|Sex: Female, Male||Participants|Count of Participants|656|656.0||||||
4264212|NCT00603902|4088741|B4|||Age||years|Mean|43.8|43.8|Standard Deviation|11.76|11.76|||
4264213|NCT00603902|4088742|B3|||Age||years|Mean|43.7|43.7|Standard Deviation|11.76|11.76|||
4264214|NCT00603902|4088743|B2|||Age||years|Mean|43.8|43.8|Standard Deviation|11.81|11.81|||
4264215|NCT00603902|4088744|B1|||Age||years|Mean|43.8|43.8|Standard Deviation|11.66|11.66|||
4264216|NCT00603889|4088757|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4264217|NCT00603889|4088757|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4264218|NCT00603889|4088757|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4264219|NCT00603889|4088757|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4264220|NCT00603889|4088757|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4264221|NCT00603889|4088757|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4264222|NCT00603837|4088764|B3|||Temperature||Celsius degrees|Mean|36.3|36.3|Standard Deviation|0.66|0.66|||
4264223|NCT00603837|4088765|B2|||Temperature||Celsius degrees|Mean|36.1|36.1|Standard Deviation|0.66|0.66|||
4264224|NCT00603837|4088766|B1|||Temperature||Celsius degrees|Mean|36.5|36.5|Standard Deviation|0.67|0.67|||
4264225|NCT00603837|4088764|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
4264226|NCT00603837|4088765|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4264227|NCT00603837|4088766|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4264228|NCT00603837|4088764|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4264229|NCT00603837|4088765|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4264230|NCT00603837|4088766|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4264231|NCT00603837|4088764|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4264232|NCT00603837|4088765|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4264233|NCT00603837|4088766|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4264234|NCT00603837|4088764|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4264235|NCT00603837|4088765|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4264236|NCT00603837|4088766|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4264237|NCT00603837|4088764|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4264238|NCT00603837|4088765|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4264239|NCT00603837|4088766|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4264240|NCT00603837|4088764|B3||<=18 years|Age||Participants|Count of Participants|39|39.0||||||
4264241|NCT00603837|4088765|B2||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
4264242|NCT00603837|4088766|B1||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
4264243|NCT00603798|4088773|B4|United States||Region of Enrollment||participants|Number|490|490.0||||||
4264244|NCT00603798|4088774|B3|United States||Region of Enrollment||participants|Number|164|164.0||||||
4264245|NCT00603798|4088775|B2|United States||Region of Enrollment||participants|Number|164|164.0||||||
4264246|NCT00603798|4088776|B1|United States||Region of Enrollment||participants|Number|162|162.0||||||
4264247|NCT00603798|4088773|B4||Male|Sex: Female, Male||Participants|Count of Participants|386|386.0||||||
4264248|NCT00603798|4088774|B3||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4264249|NCT00603798|4088775|B2||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4264250|NCT00603798|4088776|B1||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4264251|NCT00603798|4088773|B4||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4264252|NCT00603798|4088774|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4264253|NCT00603798|4088775|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4264254|NCT00603798|4088776|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4264255|NCT00603798|4088773|B4|||Age||years|Mean|64.7|64.7|Standard Deviation|10.4|10.4|||
4264256|NCT00603798|4088774|B3|||Age||years|Mean|63.7|63.7|Standard Deviation|10.9|10.9|||
4264257|NCT00603798|4088775|B2|||Age||years|Mean|66.0|66.0|Standard Deviation|10.2|10.2|||
4264258|NCT00603798|4088776|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|10.2|10.2|||
4264259|NCT00603798|4088773|B4||>=65 years|Age||Participants|Count of Participants|235|235.0||||||
4264260|NCT00603798|4088774|B3||>=65 years|Age||Participants|Count of Participants|78|78.0||||||
4264261|NCT00603798|4088775|B2||>=65 years|Age||Participants|Count of Participants|89|89.0||||||
4264262|NCT00603798|4088776|B1||>=65 years|Age||Participants|Count of Participants|68|68.0||||||
4264263|NCT00603798|4088773|B4||Between 18 and 65 years|Age||Participants|Count of Participants|255|255.0||||||
4264264|NCT00603798|4088774|B3||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
4264265|NCT00603798|4088775|B2||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4264266|NCT00603798|4088776|B1||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
4264267|NCT00603798|4088773|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4264268|NCT00603798|4088774|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4264269|NCT00603798|4088775|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4264270|NCT00603798|4088776|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4264271|NCT00603746|4088795|B7|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4264272|NCT00603746|4088796|B6|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4264273|NCT00603746|4088797|B5|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4264274|NCT00603746|4088798|B4|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4264275|NCT00603746|4088799|B3|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4264276|NCT00603746|4088800|B2|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4264277|NCT00603746|4088801|B1|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4264278|NCT00603746|4088795|B7|American Indian or Alaska Native & White||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4264279|NCT00603746|4088796|B6|American Indian or Alaska Native & White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4264280|NCT00603746|4088797|B5|American Indian or Alaska Native & White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4264281|NCT00603746|4088798|B4|American Indian or Alaska Native & White||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4264282|NCT00603746|4088799|B3|American Indian or Alaska Native & White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4264283|NCT00603746|4088800|B2|American Indian or Alaska Native & White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4264284|NCT00603746|4088801|B1|American Indian or Alaska Native & White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4264285|NCT00603746|4088795|B7|American Indian or Alaska Native & Asian & White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4264286|NCT00603746|4088796|B6|American Indian or Alaska Native & Asian & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4264287|NCT00603746|4088797|B5|American Indian or Alaska Native & Asian & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4264288|NCT00603746|4088798|B4|American Indian or Alaska Native & Asian & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4264289|NCT00603746|4088799|B3|American Indian or Alaska Native & Asian & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4264290|NCT00603746|4088800|B2|American Indian or Alaska Native & Asian & White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4264291|NCT00603746|4088801|B1|American Indian or Alaska Native & Asian & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4264292|NCT00603746|4088795|B7|White||Race/Ethnicity, Customized||participants|Number|477|477.0||||||
4264293|NCT00603746|4088796|B6|White||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
4264294|NCT00603746|4088797|B5|White||Race/Ethnicity, Customized||participants|Number|80|80.0||||||
4264295|NCT00603746|4088798|B4|White||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
4264296|NCT00603746|4088799|B3|White||Race/Ethnicity, Customized||participants|Number|80|80.0||||||
4264297|NCT00603746|4088800|B2|White||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
4264298|NCT00603746|4088801|B1|White||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
4264299|NCT00603746|4088795|B7|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4264300|NCT00603746|4088796|B6|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4264301|NCT00603746|4088797|B5|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4264302|NCT00603746|4088798|B4|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4264303|NCT00603746|4088799|B3|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4264304|NCT00603746|4088800|B2|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4264305|NCT00603746|4088801|B1|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4264306|NCT00603746|4088795|B7|Central/South Asian HER||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4264307|NCT00603746|4088796|B6|Central/South Asian HER||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4264308|NCT00603746|4088797|B5|Central/South Asian HER||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4264309|NCT00603746|4088798|B4|Central/South Asian HER||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4264310|NCT00603746|4088799|B3|Central/South Asian HER||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4264311|NCT00603746|4088800|B2|Central/South Asian HER||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4264312|NCT00603746|4088801|B1|Central/South Asian HER||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4264313|NCT00603746|4088795|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4264314|NCT00603746|4088796|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4264315|NCT00603746|4088797|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4264535|NCT00603473|4089352|B1|>= 13 years and =< 15 years||Age, Customized||Subjects|Number|15|15.0||||||
4264316|NCT00603746|4088798|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4264317|NCT00603746|4088799|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4264318|NCT00603746|4088800|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4264319|NCT00603746|4088801|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4264320|NCT00603746|4088795|B7|African American/African Heritage (HER)||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4264321|NCT00603746|4088796|B6|African American/African Heritage (HER)||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4264322|NCT00603746|4088797|B5|African American/African Heritage (HER)||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4264323|NCT00603746|4088798|B4|African American/African Heritage (HER)||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4264324|NCT00603746|4088799|B3|African American/African Heritage (HER)||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4264325|NCT00603746|4088800|B2|African American/African Heritage (HER)||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4264326|NCT00603746|4088801|B1|African American/African Heritage (HER)||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4264327|NCT00603746|4088795|B7||Male|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4264328|NCT00603746|4088796|B6||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4264329|NCT00603746|4088797|B5||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4264330|NCT00603746|4088798|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4264331|NCT00603746|4088799|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4264332|NCT00603746|4088800|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4264333|NCT00603746|4088801|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4264334|NCT00603746|4088795|B7||Female|Sex: Female, Male||Participants|Count of Participants|387|387.0||||||
4264335|NCT00603746|4088796|B6||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4264336|NCT00603746|4088797|B5||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4264337|NCT00603746|4088798|B4||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4264338|NCT00603746|4088799|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4264339|NCT00603746|4088800|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4264340|NCT00603746|4088801|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4264341|NCT00603746|4088795|B7|||Age||Years|Mean|46.4|46.4|Standard Deviation|14.25|14.25|||
4264342|NCT00603746|4088796|B6|||Age||Years|Mean|46.1|46.1|Standard Deviation|13.86|13.86|||
4264343|NCT00603746|4088797|B5|||Age||Years|Mean|46.6|46.6|Standard Deviation|14.09|14.09|||
4264344|NCT00603746|4088798|B4|||Age||Years|Mean|45.7|45.7|Standard Deviation|14.38|14.38|||
4264345|NCT00603746|4088799|B3|||Age||Years|Mean|47.2|47.2|Standard Deviation|14.39|14.39|||
4264346|NCT00603746|4088800|B2|||Age||Years|Mean|45.7|45.7|Standard Deviation|15.02|15.02|||
4264347|NCT00603746|4088801|B1|||Age||Years|Mean|47.2|47.2|Standard Deviation|14.03|14.03|||
4264348|NCT00603733|4088952|B3|Canada||Region of Enrollment||participants|Number|285|285.0||||||
4264349|NCT00603733|4088953|B2|Canada||Region of Enrollment||participants|Number|146|146.0||||||
4264350|NCT00603733|4088954|B1|Canada||Region of Enrollment||participants|Number|139|139.0||||||
4264351|NCT00603733|4088952|B3|Maintenance Phase, Male||Sex/Gender, Customized||participants|Number|72|72.0||||||
4264352|NCT00603733|4088953|B2|Maintenance Phase, Male||Sex/Gender, Customized||participants|Number|39|39.0||||||
4264353|NCT00603733|4088954|B1|Maintenance Phase, Male||Sex/Gender, Customized||participants|Number|33|33.0||||||
4264354|NCT00603733|4088952|B3|Maintenance Phase, Female||Sex/Gender, Customized||participants|Number|57|57.0||||||
4264355|NCT00603733|4088953|B2|Maintenance Phase, Female||Sex/Gender, Customized||participants|Number|29|29.0||||||
4264356|NCT00603733|4088954|B1|Maintenance Phase, Female||Sex/Gender, Customized||participants|Number|28|28.0||||||
4264357|NCT00603733|4088952|B3|Active Phase, Male||Sex/Gender, Customized||participants|Number|92|92.0||||||
4264358|NCT00603733|4088953|B2|Active Phase, Male||Sex/Gender, Customized||participants|Number|44|44.0||||||
4264359|NCT00603733|4088954|B1|Active Phase, Male||Sex/Gender, Customized||participants|Number|48|48.0||||||
4264360|NCT00603733|4088952|B3|Active Phase, Female||Sex/Gender, Customized||participants|Number|64|64.0||||||
4264361|NCT00603733|4088953|B2|Active Phase, Female||Sex/Gender, Customized||participants|Number|34|34.0||||||
4264362|NCT00603733|4088954|B1|Active Phase, Female||Sex/Gender, Customized||participants|Number|30|30.0||||||
4264363|NCT00603733|4088952|B3|Maintenance Phase||Age, Customized||years|Median|46.3|46.3|Full Range|||20.0|76.0|
4264364|NCT00603733|4088953|B2|Maintenance Phase||Age, Customized||years|Median|44.5|44.5|Full Range|||23.0|76.0|
4264365|NCT00603733|4088954|B1|Maintenance Phase||Age, Customized||years|Median|48|48.0|Full Range|||20.0|65.0|
4264366|NCT00603733|4088952|B3|Active Phase||Age, Customized||years|Median|44.3|44.3|Full Range|||18.0|76.0|
4264367|NCT00603733|4088953|B2|Active Phase||Age, Customized||years|Median|43.5|43.5|Full Range|||22.0|76.0|
4264368|NCT00603733|4088954|B1|Active Phase||Age, Customized||years|Median|45|45.0|Full Range|||18.0|68.0|
4264369|NCT00603733|4088952|B3|Maintenance Phase||Age||years|Mean|46.1|46.1|Standard Deviation|12.83|12.83|||
4264370|NCT00603733|4088953|B2|Maintenance Phase||Age||years|Mean|45.8|45.8|Standard Deviation|13.45|13.45|||
4264371|NCT00603733|4088954|B1|Maintenance Phase||Age||years|Mean|46.4|46.4|Standard Deviation|12.20|12.2|||
4264372|NCT00603733|4088952|B3|Active Phase||Age||years|Mean|44.35|44.35|Standard Deviation|12.71|12.71|||
4264373|NCT00603733|4088953|B2|Active Phase||Age||years|Mean|44.5|44.5|Standard Deviation|12.53|12.53|||
4264374|NCT00603733|4088954|B1|Active Phase||Age||years|Mean|44.2|44.2|Standard Deviation|12.88|12.88|||
4264375|NCT00603720|4088965|B6|United States||Region of Enrollment||participants|Number|54|54.0||||||
4264376|NCT00603720|4088966|B5|United States||Region of Enrollment||participants|Number|12|12.0||||||
4264377|NCT00603720|4088967|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
4264378|NCT00603720|4088968|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4264379|NCT00603720|4088969|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4264380|NCT00603720|4088970|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4264381|NCT00603720|4088965|B6|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4264382|NCT00603720|4088965|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4264383|NCT00603720|4088966|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4264384|NCT00603720|4088967|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4264385|NCT00603720|4088968|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4264386|NCT00603720|4088969|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4264387|NCT00603720|4088970|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4264388|NCT00603720|4088965|B6||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4264389|NCT00603720|4088966|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4264390|NCT00603720|4088967|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4264391|NCT00603720|4088968|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4264392|NCT00603720|4088969|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4264393|NCT00603720|4088970|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4264394|NCT00603720|4088965|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4264395|NCT00603720|4088966|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4264396|NCT00603720|4088967|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4264397|NCT00603720|4088968|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4264398|NCT00603720|4088969|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4264399|NCT00603720|4088970|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4264400|NCT00603720|4088965|B6||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4264401|NCT00603720|4088966|B5||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4264402|NCT00603720|4088967|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4264403|NCT00603720|4088968|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4264404|NCT00603720|4088969|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4264405|NCT00603720|4088970|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4264406|NCT00603720|4088965|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4264407|NCT00603720|4088966|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4264408|NCT00603720|4088967|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4264409|NCT00603720|4088968|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4264410|NCT00603720|4088969|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4264411|NCT00603720|4088970|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4264412|NCT00603642|4088986|B3|||Platelet Count||10^9/L|Mean|17.5|17.5|Standard Deviation|8.4|8.4|||
4264413|NCT00603642|4088987|B2|||Platelet Count||10^9/L|Mean|18.4|18.4|Standard Deviation|8.3|8.3|||
4264414|NCT00603642|4088988|B1|||Platelet Count||10^9/L|Mean|15.8|15.8|Standard Deviation|8.6|8.6|||
4264415|NCT00603642|4088986|B3|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4264416|NCT00603642|4088987|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4264417|NCT00603642|4088988|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4264418|NCT00603642|4088986|B3|Japanese||Race/Ethnicity, Customized||Participants|Number|34|34.0||||||
4264419|NCT00603642|4088987|B2|Japanese||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4264420|NCT00603642|4088988|B1|Japanese||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4264421|NCT00603642|4088986|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4264422|NCT00603642|4088987|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4264423|NCT00603642|4088988|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4264424|NCT00603642|4088986|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4264425|NCT00603642|4088987|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4264426|NCT00603642|4088988|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4264427|NCT00603642|4088986|B3|||Age||Years|Mean|54.7|54.7|Standard Deviation|13.7|13.7|||
4264428|NCT00603642|4088987|B2|||Age||Years|Mean|58.5|58.5|Standard Deviation|12.6|12.6|||
4264429|NCT00603642|4088988|B1|||Age||Years|Mean|47.6|47.6|Standard Deviation|13.4|13.4|||
4264430|NCT00603590|4089003|B3|||Systolic Blood Pressure|Mean of two seated systolic blood pressures|mm Hg|Mean|127.5|127.5|Standard Deviation|17.5|17.5|||
4264431|NCT00603590|4089004|B2|||Systolic Blood Pressure|Mean of two seated systolic blood pressures|mm Hg|Mean|130.3|130.3|Standard Deviation|17.4|17.4|||
4264432|NCT00603590|4089005|B1|||Systolic Blood Pressure|Mean of two seated systolic blood pressures|mm Hg|Mean|124.8|124.8|Standard Deviation|17.3|17.3|||
4264433|NCT00603590|4089003|B3|||LDL cholesterol|Serum LDL cholesterol levels|mg/dL|Mean|116.6|116.6|Standard Deviation|25.2|25.2|||
4264434|NCT00603590|4089004|B2|||LDL cholesterol|Serum LDL cholesterol levels|mg/dL|Mean|116.6|116.6|Standard Deviation|24.8|24.8|||
4264435|NCT00603590|4089005|B1|||LDL cholesterol|Serum LDL cholesterol levels|mg/dL|Mean|116.7|116.7|Standard Deviation|25.8|25.8|||
4264436|NCT00603590|4089003|B3|||Diastolic Blood Pressure|Mean of two seated blood presures|mm Hg|Mean|79.8|79.8|Standard Deviation|10.1|10.1|||
4264437|NCT00603590|4089004|B2|||Diastolic Blood Pressure|Mean of two seated blood presures|mm Hg|Mean|81.2|81.2|Standard Deviation|9.7|9.7|||
4264438|NCT00603590|4089005|B1|||Diastolic Blood Pressure|Mean of two seated blood presures|mm Hg|Mean|78.4|78.4|Standard Deviation|10.4|10.4|||
4264439|NCT00603590|4089003|B3|Iran, Islamic Republic of||Region of Enrollment||participants|Number|475|475.0||||||
4264440|NCT00603590|4089004|B2|Iran, Islamic Republic of||Region of Enrollment||participants|Number|234|234.0||||||
4264441|NCT00603590|4089005|B1|Iran, Islamic Republic of||Region of Enrollment||participants|Number|241|241.0||||||
4264442|NCT00603590|4089003|B3||Male|Sex: Female, Male||Participants|Count of Participants|317|317.0||||||
4264443|NCT00603590|4089004|B2||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4264444|NCT00603590|4089005|B1||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4264445|NCT00603590|4089003|B3||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4264446|NCT00603590|4089004|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4264447|NCT00603590|4089005|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4264448|NCT00603590|4089003|B3|||Age||Years|Mean|59.0|59.0|Standard Deviation|6.9|6.9|||
4264449|NCT00603590|4089004|B2|||Age||Years|Mean|59.1|59.1|Standard Deviation|7.3|7.3|||
4264450|NCT00603590|4089005|B1|||Age||Years|Mean|59.0|59.0|Standard Deviation|6.5|6.5|||
4264451|NCT00603564|4089016|B3|Italy||Region of Enrollment||participants|Number|47|47.0||||||
4264452|NCT00603564|4089017|B2|Italy||Region of Enrollment||participants|Number|27|27.0||||||
4264453|NCT00603564|4089018|B1|Italy||Region of Enrollment||participants|Number|20|20.0||||||
4264454|NCT00603564|4089016|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4264455|NCT00603564|4089017|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4264456|NCT00603564|4089018|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4264457|NCT00603564|4089016|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4264458|NCT00603564|4089017|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4264459|NCT00603564|4089018|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4264460|NCT00603564|4089016|B3|||Age||years|Mean|69|69.0|Standard Deviation|15|15.0|||
4264461|NCT00603564|4089017|B2|||Age||years|Mean|72|72.0|Standard Deviation|13|13.0|||
4264462|NCT00603564|4089018|B1|||Age||years|Mean|65|65.0|Standard Deviation|17|17.0|||
4264463|NCT00603564|4089016|B3||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4264464|NCT00603564|4089017|B2||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4264465|NCT00603564|4089018|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4264466|NCT00603564|4089016|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4264467|NCT00603564|4089017|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4264468|NCT00603564|4089018|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4264469|NCT00603564|4089016|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4264470|NCT00603564|4089017|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4264471|NCT00603564|4089018|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4264472|NCT00603538|4089027|B4|Score 1||ECOG Performance Status|ECOG = Eastern Cooperative Oncology Group. ECOG Grade: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead.|participants|Number|3|3.0||||||
4264473|NCT00603538|4089028|B3|Score 1||ECOG Performance Status|ECOG = Eastern Cooperative Oncology Group. ECOG Grade: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead.|participants|Number|2|2.0||||||
4264474|NCT00603538|4089029|B2|Score 1||ECOG Performance Status|ECOG = Eastern Cooperative Oncology Group. ECOG Grade: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead.|participants|Number|0|0.0||||||
4264475|NCT00603538|4089030|B1|Score 1||ECOG Performance Status|ECOG = Eastern Cooperative Oncology Group. ECOG Grade: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead.|participants|Number|1|1.0||||||
4264476|NCT00603538|4089027|B4|Score 0||ECOG Performance Status|ECOG = Eastern Cooperative Oncology Group. ECOG Grade: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead.|participants|Number|16|16.0||||||
4264477|NCT00603538|4089028|B3|Score 0||ECOG Performance Status|ECOG = Eastern Cooperative Oncology Group. ECOG Grade: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead.|participants|Number|4|4.0||||||
4264536|NCT00603473|4089352|B1|>= 5 years and < 13 years||Age, Customized||Subjects|Number|63|63.0||||||
4264478|NCT00603538|4089029|B2|Score 0||ECOG Performance Status|ECOG = Eastern Cooperative Oncology Group. ECOG Grade: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead.|participants|Number|7|7.0||||||
4264479|NCT00603538|4089030|B1|Score 0||ECOG Performance Status|ECOG = Eastern Cooperative Oncology Group. ECOG Grade: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead.|participants|Number|5|5.0||||||
4264480|NCT00603538|4089027|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4264481|NCT00603538|4089028|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4264482|NCT00603538|4089029|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4264483|NCT00603538|4089030|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4264484|NCT00603538|4089027|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4264485|NCT00603538|4089028|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4264486|NCT00603538|4089029|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4264487|NCT00603538|4089030|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4264488|NCT00603538|4089027|B4|>=65 years||Age, Customized||participants|Number|5|5.0||||||
4264489|NCT00603538|4089028|B3|>=65 years||Age, Customized||participants|Number|3|3.0||||||
4264490|NCT00603538|4089029|B2|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4264491|NCT00603538|4089030|B1|>=65 years||Age, Customized||participants|Number|2|2.0||||||
4264492|NCT00603538|4089027|B4|45 to 64 years||Age, Customized||participants|Number|8|8.0||||||
4264493|NCT00603538|4089028|B3|45 to 64 years||Age, Customized||participants|Number|2|2.0||||||
4264494|NCT00603538|4089029|B2|45 to 64 years||Age, Customized||participants|Number|2|2.0||||||
4264495|NCT00603538|4089030|B1|45 to 64 years||Age, Customized||participants|Number|4|4.0||||||
4264496|NCT00603538|4089027|B4|20 to 44 years||Age, Customized||participants|Number|6|6.0||||||
4264497|NCT00603538|4089028|B3|20 to 44 years||Age, Customized||participants|Number|1|1.0||||||
4264498|NCT00603538|4089029|B2|20 to 44 years||Age, Customized||participants|Number|5|5.0||||||
4264499|NCT00603538|4089030|B1|20 to 44 years||Age, Customized||participants|Number|0|0.0||||||
4264500|NCT00603525|4089070|B3|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|99|99.0||||||
4264501|NCT00603525|4089071|B2|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
4264502|NCT00603525|4089072|B1|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4264503|NCT00603525|4089070|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
4264504|NCT00603525|4089071|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4264505|NCT00603525|4089072|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4264506|NCT00603525|4089070|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4264507|NCT00603525|4089071|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4264508|NCT00603525|4089072|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4264509|NCT00603525|4089070|B3||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4264510|NCT00603525|4089071|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4264511|NCT00603525|4089072|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4264512|NCT00603525|4089070|B3|||Age||Years|Mean|53.5|53.5|Standard Deviation|12.67|12.67|||
4264513|NCT00603525|4089071|B2|||Age||Years|Mean|53.7|53.7|Standard Deviation|13.64|13.64|||
4264514|NCT00603525|4089072|B1|||Age||Years|Mean|53.3|53.3|Standard Deviation|11.69|11.69|||
4264515|NCT00603512|4089201|B6||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4264516|NCT00603512|4089202|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4264517|NCT00603512|4089203|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4264518|NCT00603512|4089204|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4264519|NCT00603512|4089205|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4264520|NCT00603512|4089206|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4264521|NCT00603512|4089201|B6||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4264522|NCT00603512|4089202|B5||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4264523|NCT00603512|4089203|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4264524|NCT00603512|4089204|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4264525|NCT00603512|4089205|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4264526|NCT00603512|4089206|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4264527|NCT00603512|4089201|B6|||Age||Years|Mean|51.3|51.3|Standard Deviation|10.7|10.7|||
4264528|NCT00603512|4089202|B5|||Age||Years|Mean|50.6|50.6|Standard Deviation|12.4|12.4|||
4264529|NCT00603512|4089203|B4|||Age||Years|Mean|50.6|50.6|Standard Deviation|10.0|10.0|||
4264530|NCT00603512|4089204|B3|||Age||Years|Mean|50.0|50.0|Standard Deviation|9.8|9.8|||
4264531|NCT00603512|4089205|B2|||Age||Years|Mean|53.3|53.3|Standard Deviation|12.1|12.1|||
4264532|NCT00603512|4089206|B1|||Age||Years|Mean|52.0|52.0|Standard Deviation|9.4|9.4|||
4264533|NCT00603473|4089352|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4264534|NCT00603473|4089352|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4264537|NCT00603473|4089352|B1|>= 3 years and < 5 years||Age, Customized||Subjects|Number|11|11.0||||||
4264538|NCT00603447|4089358|B8|||Time Since Diagnosis||years|Median|3.1|3.1|Full Range|||0.0|22.0|
4264539|NCT00603447|4089359|B7|||Time Since Diagnosis||years|Median|2.8|2.8|Full Range|||0.0|16.0|
4264540|NCT00603447|4089360|B6|||Time Since Diagnosis||years|Median|4.3|4.3|Full Range|||1.0|12.0|
4264541|NCT00603447|4089361|B5|||Time Since Diagnosis||years|Median|3.5|3.5|Full Range|||1.0|22.0|
4264542|NCT00603447|4089362|B4|||Time Since Diagnosis||years|Median|2.8|2.8|Full Range|||0.0|9.0|
4264543|NCT00603447|4089363|B3|||Time Since Diagnosis||years|Median|3.9|3.9|Full Range|||2.0|15.0|
4264544|NCT00603447|4089364|B2|||Time Since Diagnosis||years|Median|2.4|2.4|Full Range|||2.0|5.0|
4264545|NCT00603447|4089365|B1|||Time Since Diagnosis||years|Median|3.3|3.3|Full Range|||2.0|4.0|
4264546|NCT00603447|4089358|B8|2 (Ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair.|participants|Number|5|5.0||||||
4264547|NCT00603447|4089359|B7|2 (Ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair.|participants|Number|4|4.0||||||
4264548|NCT00603447|4089360|B6|2 (Ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair.|participants|Number|0|0.0||||||
4264549|NCT00603447|4089361|B5|2 (Ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair.|participants|Number|0|0.0||||||
4264550|NCT00603447|4089362|B4|2 (Ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair.|participants|Number|0|0.0||||||
4264551|NCT00603447|4089363|B3|2 (Ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair.|participants|Number|0|0.0||||||
4264552|NCT00603447|4089364|B2|2 (Ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair.|participants|Number|1|1.0||||||
4264553|NCT00603447|4089365|B1|2 (Ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair.|participants|Number|0|0.0||||||
4264554|NCT00603447|4089358|B8|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair.|participants|Number|46|46.0||||||
4264555|NCT00603447|4089359|B7|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair.|participants|Number|17|17.0||||||
4264621|NCT00603447|4089361|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4264622|NCT00603447|4089362|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4264556|NCT00603447|4089360|B6|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair.|participants|Number|6|6.0||||||
4264557|NCT00603447|4089361|B5|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair.|participants|Number|4|4.0||||||
4264558|NCT00603447|4089362|B4|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair.|participants|Number|5|5.0||||||
4264559|NCT00603447|4089363|B3|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair.|participants|Number|5|5.0||||||
4264560|NCT00603447|4089364|B2|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair.|participants|Number|5|5.0||||||
4264561|NCT00603447|4089365|B1|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair.|participants|Number|4|4.0||||||
4264562|NCT00603447|4089358|B8|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair.|participants|Number|33|33.0||||||
4264563|NCT00603447|4089359|B7|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair.|participants|Number|23|23.0||||||
4264564|NCT00603447|4089360|B6|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair.|participants|Number|2|2.0||||||
4264565|NCT00603447|4089361|B5|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair.|participants|Number|2|2.0||||||
4264566|NCT00603447|4089362|B4|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair.|participants|Number|1|1.0||||||
4264567|NCT00603447|4089363|B3|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair.|participants|Number|3|3.0||||||
4264623|NCT00603447|4089363|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4264568|NCT00603447|4089364|B2|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair.|participants|Number|0|0.0||||||
4264569|NCT00603447|4089365|B1|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair.|participants|Number|2|2.0||||||
4264570|NCT00603447|4089358|B8|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4264571|NCT00603447|4089359|B7|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4264572|NCT00603447|4089360|B6|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4264573|NCT00603447|4089361|B5|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4264574|NCT00603447|4089362|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4264575|NCT00603447|4089363|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4264576|NCT00603447|4089364|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4264577|NCT00603447|4089365|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4264578|NCT00603447|4089358|B8|Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4264579|NCT00603447|4089359|B7|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4264580|NCT00603447|4089360|B6|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4264581|NCT00603447|4089361|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4264582|NCT00603447|4089362|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4264583|NCT00603447|4089363|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4264584|NCT00603447|4089364|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4264585|NCT00603447|4089365|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4264586|NCT00603447|4089358|B8|Caucasian||Race/Ethnicity, Customized||participants|Number|64|64.0||||||
4264587|NCT00603447|4089359|B7|Caucasian||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4264588|NCT00603447|4089360|B6|Caucasian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4264589|NCT00603447|4089361|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4264590|NCT00603447|4089362|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4264591|NCT00603447|4089363|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4264592|NCT00603447|4089364|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4264593|NCT00603447|4089365|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4264594|NCT00603447|4089358|B8|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4264595|NCT00603447|4089359|B7|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4264596|NCT00603447|4089360|B6|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4264597|NCT00603447|4089361|B5|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4264598|NCT00603447|4089362|B4|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4264599|NCT00603447|4089363|B3|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4264600|NCT00603447|4089364|B2|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4264601|NCT00603447|4089365|B1|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4264602|NCT00603447|4089358|B8|African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4264603|NCT00603447|4089359|B7|African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4264604|NCT00603447|4089360|B6|African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4264605|NCT00603447|4089361|B5|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4264606|NCT00603447|4089362|B4|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4264607|NCT00603447|4089363|B3|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4264608|NCT00603447|4089364|B2|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4264609|NCT00603447|4089365|B1|African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4264610|NCT00603447|4089358|B8||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4264611|NCT00603447|4089359|B7||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4264612|NCT00603447|4089360|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4264613|NCT00603447|4089361|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4264614|NCT00603447|4089362|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4264615|NCT00603447|4089363|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4264616|NCT00603447|4089364|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4264617|NCT00603447|4089365|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4264618|NCT00603447|4089358|B8||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4264619|NCT00603447|4089359|B7||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4264620|NCT00603447|4089360|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4264624|NCT00603447|4089364|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4264625|NCT00603447|4089365|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4264626|NCT00603447|4089358|B8|||Age||years|Mean|61.9|61.9|Standard Deviation|9.86|9.86|||
4264627|NCT00603447|4089359|B7|||Age||years|Mean|62.4|62.4|Standard Deviation|10.75|10.75|||
4264628|NCT00603447|4089360|B6|||Age||years|Mean|65.4|65.4|Standard Deviation|7.85|7.85|||
4264629|NCT00603447|4089361|B5|||Age||years|Mean|57.7|57.7|Standard Deviation|9.31|9.31|||
4264630|NCT00603447|4089362|B4|||Age||years|Mean|61.7|61.7|Standard Deviation|6.68|6.68|||
4264631|NCT00603447|4089363|B3|||Age||years|Mean|55.4|55.4|Standard Deviation|7.74|7.74|||
4264632|NCT00603447|4089364|B2|||Age||years|Mean|64.2|64.2|Standard Deviation|12.11|12.11|||
4264633|NCT00603447|4089365|B1|||Age||years|Mean|64.7|64.7|Standard Deviation|6.65|6.65|||
4264634|NCT00603408|4089393|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4264635|NCT00603408|4089393|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4264636|NCT00603408|4089393|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4264637|NCT00603408|4089393|B1|||Age||years|Median|52|52.0|Full Range|||42.0|62.0|
4264638|NCT00603382|4089404|B7|Native Hawaiian or other Pacific Islander & White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4264639|NCT00603382|4089405|B6|Native Hawaiian or other Pacific Islander & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4264640|NCT00603382|4089406|B5|Native Hawaiian or other Pacific Islander & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4264641|NCT00603382|4089407|B4|Native Hawaiian or other Pacific Islander & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4264642|NCT00603382|4089408|B3|Native Hawaiian or other Pacific Islander & White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4264643|NCT00603382|4089409|B2|Native Hawaiian or other Pacific Islander & White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4264644|NCT00603382|4089410|B1|Native Hawaiian or other Pacific Islander & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4264645|NCT00603382|4089404|B7|American Indian or Alaska Native & White||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4264646|NCT00603382|4089405|B6|American Indian or Alaska Native & White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4264647|NCT00603382|4089406|B5|American Indian or Alaska Native & White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4264648|NCT00603382|4089407|B4|American Indian or Alaska Native & White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4264649|NCT00603382|4089408|B3|American Indian or Alaska Native & White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4264650|NCT00603382|4089409|B2|American Indian or Alaska Native & White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4264651|NCT00603382|4089410|B1|American Indian or Alaska Native & White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4264652|NCT00603382|4089404|B7|AA/AHER & American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4264653|NCT00603382|4089405|B6|AA/AHER & American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4264654|NCT00603382|4089406|B5|AA/AHER & American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4264655|NCT00603382|4089407|B4|AA/AHER & American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4264656|NCT00603382|4089408|B3|AA/AHER & American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4264657|NCT00603382|4089409|B2|AA/AHER & American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4264658|NCT00603382|4089410|B1|AA/AHER & American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4264659|NCT00603382|4089404|B7|White||Race/Ethnicity, Customized||participants|Number|419|419.0||||||
4264660|NCT00603382|4089405|B6|White||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
4264661|NCT00603382|4089406|B5|White||Race/Ethnicity, Customized||participants|Number|64|64.0||||||
4264662|NCT00603382|4089407|B4|White||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
4264663|NCT00603382|4089408|B3|White||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
4264664|NCT00603382|4089409|B2|White||Race/Ethnicity, Customized||participants|Number|64|64.0||||||
4264665|NCT00603382|4089410|B1|White||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
4264666|NCT00603382|4089404|B7|Asian||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
4264667|NCT00603382|4089405|B6|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4264668|NCT00603382|4089406|B5|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4264669|NCT00603382|4089407|B4|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4264670|NCT00603382|4089408|B3|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4264671|NCT00603382|4089409|B2|Asian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4264672|NCT00603382|4089410|B1|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4264673|NCT00603382|4089404|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4264674|NCT00603382|4089405|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4264675|NCT00603382|4089406|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4264676|NCT00603382|4089407|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4264677|NCT00603382|4089408|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4264678|NCT00603382|4089409|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4264679|NCT00603382|4089410|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4264680|NCT00603382|4089404|B7|African American/African Heritage (AA/AHER)||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4264681|NCT00603382|4089405|B6|African American/African Heritage (AA/AHER)||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4264682|NCT00603382|4089406|B5|African American/African Heritage (AA/AHER)||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4264683|NCT00603382|4089407|B4|African American/African Heritage (AA/AHER)||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4264684|NCT00603382|4089408|B3|African American/African Heritage (AA/AHER)||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4264685|NCT00603382|4089409|B2|African American/African Heritage (AA/AHER)||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4264686|NCT00603382|4089410|B1|African American/African Heritage (AA/AHER)||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4264687|NCT00603382|4089404|B7||Male|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
4264688|NCT00603382|4089405|B6||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4264689|NCT00603382|4089406|B5||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4264690|NCT00603382|4089407|B4||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4264691|NCT00603382|4089408|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4264692|NCT00603382|4089409|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4264693|NCT00603382|4089410|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4264694|NCT00603382|4089404|B7||Female|Sex: Female, Male||Participants|Count of Participants|339|339.0||||||
4264695|NCT00603382|4089405|B6||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4264696|NCT00603382|4089406|B5||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4264697|NCT00603382|4089407|B4||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4264698|NCT00603382|4089408|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4264699|NCT00603382|4089409|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4264700|NCT00603382|4089410|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4264701|NCT00603382|4089404|B7|||Age||Years|Mean|38.7|38.7|Standard Deviation|15.37|15.37|||
4264702|NCT00603382|4089405|B6|||Age||Years|Mean|39.9|39.9|Standard Deviation|15.03|15.03|||
4264703|NCT00603382|4089406|B5|||Age||Years|Mean|40.7|40.7|Standard Deviation|15.96|15.96|||
4264704|NCT00603382|4089407|B4|||Age||Years|Mean|36.8|36.8|Standard Deviation|15.56|15.56|||
4264705|NCT00603382|4089408|B3|||Age||Years|Mean|38.3|38.3|Standard Deviation|14.49|14.49|||
4264706|NCT00603382|4089409|B2|||Age||Years|Mean|37.7|37.7|Standard Deviation|15.40|15.4|||
4264707|NCT00603382|4089410|B1|||Age||Years|Mean|39.2|39.2|Standard Deviation|15.82|15.82|||
4264708|NCT00603304|4089561|B3|Canada||Region of Enrollment||participants|Number|33|33.0||||||
4264709|NCT00603304|4089562|B2|Canada||Region of Enrollment||participants|Number|17|17.0||||||
4264710|NCT00603304|4089563|B1|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4264711|NCT00603304|4089561|B3|United States||Region of Enrollment||participants|Number|336|336.0||||||
4264712|NCT00603304|4089562|B2|United States||Region of Enrollment||participants|Number|169|169.0||||||
4264713|NCT00603304|4089563|B1|United States||Region of Enrollment||participants|Number|167|167.0||||||
4264714|NCT00603304|4089561|B3||Male|Sex: Female, Male||Participants|Count of Participants|369|369.0||||||
4264715|NCT00603304|4089562|B2||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4264716|NCT00603304|4089563|B1||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4264717|NCT00603304|4089561|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4264718|NCT00603304|4089562|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4264719|NCT00603304|4089563|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4264720|NCT00603304|4089561|B3|||Age||years|Mean|60.86|60.86|Standard Deviation|8.38|8.38|||
4264721|NCT00603304|4089562|B2|||Age||years|Mean|60.70|60.7|Standard Deviation|8.08|8.08|||
4264722|NCT00603304|4089563|B1|||Age||years|Mean|61.25|61.25|Standard Deviation|8.72|8.72|||
4264723|NCT00603304|4089561|B3||>=65 years|Age||Participants|Count of Participants|121|121.0||||||
4264724|NCT00603304|4089562|B2||>=65 years|Age||Participants|Count of Participants|61|61.0||||||
4264725|NCT00603304|4089563|B1||>=65 years|Age||Participants|Count of Participants|60|60.0||||||
4264726|NCT00603304|4089561|B3||Between 18 and 65 years|Age||Participants|Count of Participants|248|248.0||||||
4264727|NCT00603304|4089562|B2||Between 18 and 65 years|Age||Participants|Count of Participants|125|125.0||||||
4264728|NCT00603304|4089563|B1||Between 18 and 65 years|Age||Participants|Count of Participants|123|123.0||||||
4264729|NCT00603304|4089561|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4264730|NCT00603304|4089562|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4264731|NCT00603304|4089563|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4264732|NCT00603291|4089598|B4||Male|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
4264733|NCT00603291|4089599|B3||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4264734|NCT00603291|4089600|B2||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4264735|NCT00603291|4089601|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4264736|NCT00603291|4089598|B4||Female|Sex: Female, Male||Participants|Count of Participants|327|327.0||||||
4264737|NCT00603291|4089599|B3||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4264738|NCT00603291|4089600|B2||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4264739|NCT00603291|4089601|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4264740|NCT00603291|4089598|B4|||Age||years|Mean|52.7|52.7|Standard Deviation|8.68|8.68|||
4264741|NCT00603291|4089599|B3|||Age||years|Mean|52.0|52.0|Standard Deviation|9.32|9.32|||
4264742|NCT00603291|4089600|B2|||Age||years|Mean|53.2|53.2|Standard Deviation|8.26|8.26|||
4264743|NCT00603291|4089601|B1|||Age||years|Mean|53.1|53.1|Standard Deviation|7.98|7.98|||
4264744|NCT00603278|4089614|B7|Missing||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4264745|NCT00603278|4089615|B6|Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4264746|NCT00603278|4089616|B5|Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4264747|NCT00603278|4089617|B4|Missing||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4264748|NCT00603278|4089618|B3|Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4264749|NCT00603278|4089619|B2|Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4264750|NCT00603278|4089620|B1|Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4264751|NCT00603278|4089614|B7|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4264752|NCT00603278|4089615|B6|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4264753|NCT00603278|4089616|B5|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4264754|NCT00603278|4089617|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4264755|NCT00603278|4089618|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4264756|NCT00603278|4089619|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4264757|NCT00603278|4089620|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4264758|NCT00603278|4089614|B7|African American/African Heritage & White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4264759|NCT00603278|4089615|B6|African American/African Heritage & White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4264760|NCT00603278|4089616|B5|African American/African Heritage & White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4264761|NCT00603278|4089617|B4|African American/African Heritage & White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4264762|NCT00603278|4089618|B3|African American/African Heritage & White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4264763|NCT00603278|4089619|B2|African American/African Heritage & White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4264764|NCT00603278|4089620|B1|African American/African Heritage & White||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4264765|NCT00603278|4089614|B7|African American/African HER||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4264766|NCT00603278|4089615|B6|African American/African HER||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4264767|NCT00603278|4089616|B5|African American/African HER||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4264768|NCT00603278|4089617|B4|African American/African HER||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4264769|NCT00603278|4089618|B3|African American/African HER||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4264770|NCT00603278|4089619|B2|African American/African HER||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4264771|NCT00603278|4089620|B1|African American/African HER||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4264772|NCT00603278|4089614|B7|American Indian or Alaska Native & White||Race/Ethnicity, Customized||Participants|Number|79|79.0||||||
4264773|NCT00603278|4089615|B6|American Indian or Alaska Native & White||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4264774|NCT00603278|4089616|B5|American Indian or Alaska Native & White||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4264775|NCT00603278|4089617|B4|American Indian or Alaska Native & White||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4264776|NCT00603278|4089618|B3|American Indian or Alaska Native & White||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4264777|NCT00603278|4089619|B2|American Indian or Alaska Native & White||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4264778|NCT00603278|4089620|B1|American Indian or Alaska Native & White||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4264779|NCT00603278|4089614|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4264780|NCT00603278|4089615|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4264781|NCT00603278|4089616|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4264782|NCT00603278|4089617|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4264783|NCT00603278|4089618|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4264784|NCT00603278|4089619|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4264785|NCT00603278|4089620|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4264786|NCT00603278|4089614|B7|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||Participants|Number|142|142.0||||||
4264787|NCT00603278|4089615|B6|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
4264788|NCT00603278|4089616|B5|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
4264789|NCT00603278|4089617|B4|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4264790|NCT00603278|4089618|B3|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
4264791|NCT00603278|4089619|B2|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
4264792|NCT00603278|4089620|B1|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
4264793|NCT00603278|4089614|B7|Central/South Asian Heritage (HER)||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4264794|NCT00603278|4089615|B6|Central/South Asian Heritage (HER)||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4264795|NCT00603278|4089616|B5|Central/South Asian Heritage (HER)||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4264796|NCT00603278|4089617|B4|Central/South Asian Heritage (HER)||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4264797|NCT00603278|4089618|B3|Central/South Asian Heritage (HER)||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4264798|NCT00603278|4089619|B2|Central/South Asian Heritage (HER)||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4264799|NCT00603278|4089620|B1|Central/South Asian Heritage (HER)||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4264800|NCT00603278|4089614|B7|White||Race/Ethnicity, Customized||Participants|Number|371|371.0||||||
4264801|NCT00603278|4089615|B6|White||Race/Ethnicity, Customized||Participants|Number|61|61.0||||||
4264802|NCT00603278|4089616|B5|White||Race/Ethnicity, Customized||Participants|Number|56|56.0||||||
4264803|NCT00603278|4089617|B4|White||Race/Ethnicity, Customized||Participants|Number|63|63.0||||||
4264804|NCT00603278|4089618|B3|White||Race/Ethnicity, Customized||Participants|Number|65|65.0||||||
4264805|NCT00603278|4089619|B2|White||Race/Ethnicity, Customized||Participants|Number|64|64.0||||||
4264806|NCT00603278|4089620|B1|White||Race/Ethnicity, Customized||Participants|Number|62|62.0||||||
4264807|NCT00603278|4089614|B7||Male|Gender||Participants|Count of Participants|213|213.0||||||
4264808|NCT00603278|4089615|B6||Male|Gender||Participants|Count of Participants|38|38.0||||||
4264809|NCT00603278|4089616|B5||Male|Gender||Participants|Count of Participants|35|35.0||||||
4264810|NCT00603278|4089617|B4||Male|Gender||Participants|Count of Participants|36|36.0||||||
4264811|NCT00603278|4089618|B3||Male|Gender||Participants|Count of Participants|38|38.0||||||
4264812|NCT00603278|4089619|B2||Male|Gender||Participants|Count of Participants|33|33.0||||||
4264813|NCT00603278|4089620|B1||Male|Gender||Participants|Count of Participants|33|33.0||||||
4264814|NCT00603278|4089614|B7||Female|Gender||Participants|Count of Participants|402|402.0||||||
4264815|NCT00603278|4089615|B6||Female|Gender||Participants|Count of Participants|62|62.0||||||
4264816|NCT00603278|4089616|B5||Female|Gender||Participants|Count of Participants|64|64.0||||||
4264817|NCT00603278|4089617|B4||Female|Gender||Participants|Count of Participants|67|67.0||||||
4264818|NCT00603278|4089618|B3||Female|Gender||Participants|Count of Participants|63|63.0||||||
4264819|NCT00603278|4089619|B2||Female|Gender||Participants|Count of Participants|72|72.0||||||
4264820|NCT00603278|4089620|B1||Female|Gender||Participants|Count of Participants|74|74.0||||||
4264821|NCT00603278|4089614|B7|||Age||Years|Mean|39.4|39.4|Standard Deviation|16.14|16.14|||
4264822|NCT00603278|4089615|B6|||Age||Years|Mean|39.8|39.8|Standard Deviation|16.70|16.7|||
4264823|NCT00603278|4089616|B5|||Age||Years|Mean|40.7|40.7|Standard Deviation|15.87|15.87|||
4264824|NCT00603278|4089617|B4|||Age||Years|Mean|39.9|39.9|Standard Deviation|15.57|15.57|||
4264825|NCT00603278|4089618|B3|||Age||Years|Mean|38.8|38.8|Standard Deviation|15.97|15.97|||
4264826|NCT00603278|4089619|B2|||Age||Years|Mean|38.3|38.3|Standard Deviation|16.76|16.76|||
4264827|NCT00603278|4089620|B1|||Age||Years|Mean|39.1|39.1|Standard Deviation|16.19|16.19|||
4264828|NCT00603265|4089771|B4||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4264829|NCT00603265|4089772|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4264830|NCT00603265|4089773|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4264831|NCT00603265|4089774|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4264832|NCT00603265|4089771|B4||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4264833|NCT00603265|4089772|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4264834|NCT00603265|4089773|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4264835|NCT00603265|4089774|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4264836|NCT00603265|4089771|B4|||Age||Years|Mean|58.3|58.3|Standard Deviation|9.33|9.33|||
4264837|NCT00603265|4089772|B3|||Age||Years|Mean|56.2|56.2|Standard Deviation|8.78|8.78|||
4264838|NCT00603265|4089773|B2|||Age||Years|Mean|59.1|59.1|Standard Deviation|8.71|8.71|||
4264839|NCT00603265|4089774|B1|||Age||Years|Mean|59.7|59.7|Standard Deviation|10.17|10.17|||
4264840|NCT00603239|4089802|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4264841|NCT00603239|4089803|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4264842|NCT00603239|4089804|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4264843|NCT00603239|4089802|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4264844|NCT00603239|4089803|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4264845|NCT00603239|4089804|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4264846|NCT00603239|4089802|B3|||Age||years|Mean|54.67|54.67|Standard Deviation|8.62|8.62|||
4264847|NCT00603239|4089803|B2|||Age||years|Mean|54.12|54.12|Standard Deviation|9.36|9.36|||
4264848|NCT00603239|4089804|B1|||Age||years|Mean|54.93|54.93|Standard Deviation|8.27|8.27|||
4264849|NCT00603239|4089802|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4264850|NCT00603239|4089803|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4264851|NCT00603239|4089804|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4264852|NCT00603239|4089802|B3||Between 18 and 65 years|Age||Participants|Count of Participants|144|144.0||||||
4264853|NCT00603239|4089803|B2||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4264854|NCT00603239|4089804|B1||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
4264855|NCT00603239|4089802|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4264856|NCT00603239|4089803|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4264857|NCT00603239|4089804|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4264858|NCT00603187|4089831|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4264859|NCT00603187|4089831|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4264860|NCT00603187|4089831|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4264861|NCT00603187|4089831|B1|||Age||years|Mean|40|40.0|Standard Deviation|11|11.0|||
4264862|NCT00603187|4089831|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4264863|NCT00603187|4089831|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4264864|NCT00603187|4089831|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4264865|NCT00603044|4089837|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4264866|NCT00603044|4089838|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4264867|NCT00603044|4089839|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4264868|NCT00603044|4089837|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4264869|NCT00603044|4089838|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4264870|NCT00603044|4089839|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4264871|NCT00603044|4089837|B3|||Age||years|Mean|5.62|5.62|Standard Deviation|1.76|1.76|||
4264872|NCT00603044|4089838|B2|||Age||years|Mean|5.93|5.93|Standard Deviation|3.32|3.32|||
4264873|NCT00603044|4089839|B1|||Age||years|Mean|5.24|5.24|Standard Deviation|3.12|3.12|||
4264874|NCT00603018|4089856|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4264875|NCT00603018|4089856|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4264876|NCT00603018|4089856|B1|||Age||years|Mean|30.5|30.5|Standard Deviation|6.7|6.7|||
4264877|NCT00602979|4089861|B6||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4264878|NCT00602979|4089862|B5||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4264879|NCT00602979|4089863|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4264880|NCT00602979|4089864|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4264881|NCT00602979|4089865|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4264882|NCT00602979|4089866|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4264883|NCT00602979|4089861|B6||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4264884|NCT00602979|4089862|B5||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4264885|NCT00602979|4089863|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4264886|NCT00602979|4089864|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4264887|NCT00602979|4089865|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4264888|NCT00602979|4089866|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4264889|NCT00602979|4089861|B6|||Age||years|Mean|48.7|48.7|Standard Deviation|15.4|15.4|||
4264890|NCT00602979|4089862|B5|||Age||years|Mean|49.3|49.3|Standard Deviation|15.8|15.8|||
4264891|NCT00602979|4089863|B4|||Age||years|Mean|50.0|50.0|Standard Deviation|15.2|15.2|||
4264892|NCT00602979|4089864|B3|||Age||years|Mean|47.8|47.8|Standard Deviation|15.4|15.4|||
4264893|NCT00602979|4089865|B2|||Age||years|Mean|46.1|46.1|Standard Deviation|13.5|13.5|||
4264894|NCT00602979|4089866|B1|||Age||years|Mean|50.3|50.3|Standard Deviation|16.9|16.9|||
4264895|NCT00602953|4089882|B6|United States||Region of Enrollment||Participants|Count of Participants|101|101.0||||||
4264896|NCT00602953|4089884|B4|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4264897|NCT00602953|4089885|B3|United States||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
4264898|NCT00602953|4089886|B2|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
4264899|NCT00602953|4089887|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4264900|NCT00602953|4089882|B6||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4264901|NCT00602953|4089883|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4264902|NCT00602953|4089884|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4264903|NCT00602953|4089885|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4264904|NCT00602953|4089886|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4264905|NCT00602953|4089887|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4264906|NCT00602953|4089882|B6||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4264907|NCT00602953|4089883|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4264908|NCT00602953|4089884|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4264909|NCT00602953|4089885|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4264910|NCT00602953|4089886|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4264911|NCT00602953|4089887|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4264912|NCT00602953|4089882|B6|||Age||years|Mean|40|40.0|Standard Deviation|10|10.0|||
4264913|NCT00602953|4089884|B4|||Age||years|Mean|47|47.0|Standard Deviation|9|9.0|||
4264914|NCT00602953|4089885|B3|||Age||years|Mean|39|39.0|Standard Deviation|9|9.0|||
4264915|NCT00602953|4089886|B2|||Age||years|Mean|41|41.0|Standard Deviation|10|10.0|||
4264916|NCT00602953|4089887|B1|||Age||years|Mean|31|31.0|Standard Deviation|8|8.0|||
4264917|NCT00602953|4089882|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4264918|NCT00602953|4089883|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4264919|NCT00602953|4089884|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4264920|NCT00602953|4089885|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4264921|NCT00602953|4089886|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4264922|NCT00602953|4089887|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4264923|NCT00602953|4089882|B6||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
4264924|NCT00602953|4089883|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4264925|NCT00602953|4089884|B4||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4264926|NCT00602953|4089885|B3||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4264927|NCT00602953|4089886|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4264928|NCT00602953|4089887|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4264929|NCT00602953|4089882|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4264930|NCT00602953|4089883|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4264931|NCT00602953|4089884|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4264932|NCT00602953|4089885|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4264933|NCT00602953|4089886|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4264934|NCT00602953|4089887|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4264935|NCT00602927|4089918|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
4264936|NCT00602927|4089919|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4264937|NCT00602927|4089920|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4264938|NCT00602927|4089918|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4264939|NCT00602927|4089919|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4264940|NCT00602927|4089920|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4264941|NCT00602927|4089918|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4264942|NCT00602927|4089919|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4264943|NCT00602927|4089920|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4264944|NCT00602927|4089918|B3|||Age||years|Mean|40.42|40.42|Standard Deviation|12.84|12.84|||
4264945|NCT00602927|4089919|B2|||Age||years|Mean|39.79|39.79|Standard Deviation|12.68|12.68|||
4264946|NCT00602927|4089920|B1|||Age||years|Mean|41.05|41.05|Standard Deviation|13.32|13.32|||
4264947|NCT00602927|4089918|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4264948|NCT00602927|4089919|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4264949|NCT00602927|4089920|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4264950|NCT00602927|4089918|B3||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4264951|NCT00602927|4089919|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4264952|NCT00602927|4089920|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4264953|NCT00602927|4089918|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4264954|NCT00602927|4089919|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4264955|NCT00602927|4089920|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4264956|NCT00602836|4089929|B1|Not tested||Immunoglobulin Variable Heavy Chain (IGVH) Mutation Status|IGVH testing helps predict which patients will experience a more aggressive (if the gene is unmutated, <=2%) or less aggressive (if the gene is mutated, >2%) course of CLL. This technically complex test is only available at select medical institutions.|participants|Number|2|2.0||||||
4264957|NCT00602836|4089929|B1|Mutated||Immunoglobulin Variable Heavy Chain (IGVH) Mutation Status|IGVH testing helps predict which patients will experience a more aggressive (if the gene is unmutated, <=2%) or less aggressive (if the gene is mutated, >2%) course of CLL. This technically complex test is only available at select medical institutions.|participants|Number|20|20.0||||||
4264958|NCT00602836|4089929|B1|Unmutated||Immunoglobulin Variable Heavy Chain (IGVH) Mutation Status|IGVH testing helps predict which patients will experience a more aggressive (if the gene is unmutated, <=2%) or less aggressive (if the gene is mutated, >2%) course of CLL. This technically complex test is only available at select medical institutions.|participants|Number|22|22.0||||||
4264959|NCT00602836|4089929|B1|Negative (<30%)||CD38 Status|This test is used to predict the rate of progression from diagnosis to need for treatment in CLL. Participants with positive CD38 (>=30%) tend to experience a more aggressive course of CLL.|participants|Number|30|30.0||||||
4264960|NCT00602836|4089929|B1|Positive (>=30%)||CD38 Status|This test is used to predict the rate of progression from diagnosis to need for treatment in CLL. Participants with positive CD38 (>=30%) tend to experience a more aggressive course of CLL.|participants|Number|14|14.0||||||
4264961|NCT00602836|4089929|B1|Negative (<20%)||ZAP-70 Status|This test is used to predict the rate of progression from diagnosis to need for treatment in CLL. Participants with positive ZAP-70 (>=20%) tend to experience a more aggressive course of CLL.|participants|Number|20|20.0||||||
4264962|NCT00602836|4089929|B1|Positive (>=20%)||ZAP-70 Status|This test is used to predict the rate of progression from diagnosis to need for treatment in CLL. Participants with positive ZAP-70 (>=20%) tend to experience a more aggressive course of CLL.|participants|Number|24|24.0||||||
4264963|NCT00602836|4089929|B1|Stage III-IV||Rai Stage|Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL); higher stages reflect increasing severity. > Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis and lymphadenopathy, Rai Stage II: Lymphocytosis and hepatomegaly +/- splenomegaly, Rai Stage III: Lymphocytosis and anemia, Rai Stage IV: Lymphocytosis and thrombocytopenia|participants|Number|17|17.0||||||
4265090|NCT00602472|4089974|B3|||Body mass index (BMI) continuous||kg/m^2|Mean|28.33|28.33|Standard Deviation|4.72|4.72|||
4264964|NCT00602836|4089929|B1|Stage I-II||Rai Stage|Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL); higher stages reflect increasing severity. > Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis and lymphadenopathy, Rai Stage II: Lymphocytosis and hepatomegaly +/- splenomegaly, Rai Stage III: Lymphocytosis and anemia, Rai Stage IV: Lymphocytosis and thrombocytopenia|participants|Number|27|27.0||||||
4264965|NCT00602836|4089929|B1|Normal||Fluorescence In Situ Hybridization (FISH) Abnormalities|This test determines the presence of abnormalities in specific chromosomes of CLL cells, which are associated with more or less aggressive forms of cancer. Patients with abnormalities of chromosome 11 (deletion 11q23) and 17 (deletion 17p13) experience rapid progression of their CLL.|participants|Number|15|15.0||||||
4264966|NCT00602836|4089929|B1|Other||Fluorescence In Situ Hybridization (FISH) Abnormalities|This test determines the presence of abnormalities in specific chromosomes of CLL cells, which are associated with more or less aggressive forms of cancer. Patients with abnormalities of chromosome 11 (deletion 11q23) and 17 (deletion 17p13) experience rapid progression of their CLL.|participants|Number|2|2.0||||||
4264967|NCT00602836|4089929|B1|17p-||Fluorescence In Situ Hybridization (FISH) Abnormalities|This test determines the presence of abnormalities in specific chromosomes of CLL cells, which are associated with more or less aggressive forms of cancer. Patients with abnormalities of chromosome 11 (deletion 11q23) and 17 (deletion 17p13) experience rapid progression of their CLL.|participants|Number|1|1.0||||||
4264968|NCT00602836|4089929|B1|deletion (11q22)||Fluorescence In Situ Hybridization (FISH) Abnormalities|This test determines the presence of abnormalities in specific chromosomes of CLL cells, which are associated with more or less aggressive forms of cancer. Patients with abnormalities of chromosome 11 (deletion 11q23) and 17 (deletion 17p13) experience rapid progression of their CLL.|participants|Number|6|6.0||||||
4264969|NCT00602836|4089929|B1|Trisomy 12||Fluorescence In Situ Hybridization (FISH) Abnormalities|This test determines the presence of abnormalities in specific chromosomes of CLL cells, which are associated with more or less aggressive forms of cancer. Patients with abnormalities of chromosome 11 (deletion 11q23) and 17 (deletion 17p13) experience rapid progression of their CLL.|participants|Number|7|7.0||||||
4264970|NCT00602836|4089929|B1|deletion(13q14.2)||Fluorescence In Situ Hybridization (FISH) Abnormalities|This test determines the presence of abnormalities in specific chromosomes of CLL cells, which are associated with more or less aggressive forms of cancer. Patients with abnormalities of chromosome 11 (deletion 11q23) and 17 (deletion 17p13) experience rapid progression of their CLL.|participants|Number|13|13.0||||||
4264971|NCT00602836|4089929|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4264972|NCT00602836|4089929|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4264973|NCT00602836|4089929|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4264974|NCT00602836|4089929|B1|||Age||years|Median|65|65.0|Full Range|||44.0|78.0|
4264975|NCT00602797|4089933|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4264976|NCT00602797|4089933|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4264977|NCT00602797|4089933|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4264978|NCT00602797|4089933|B1|||Age, Customized|Age in years. Patients >70 years were eligible|years|Mean|76.9|76.9|Standard Deviation|3.6|3.6|||
4264979|NCT00602771|4089939|B3|United States||Region of Enrollment||participants|Number|84|84.0||||||
4264980|NCT00602771|4089940|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4264981|NCT00602771|4089941|B1|United States||Region of Enrollment||participants|Number|63|63.0||||||
4264982|NCT00602771|4089939|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4264983|NCT00602771|4089940|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4264984|NCT00602771|4089941|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4264985|NCT00602771|4089939|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4264986|NCT00602771|4089940|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4264987|NCT00602771|4089941|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4264988|NCT00602771|4089939|B3|||Age||years|Mean|76|76.0|Standard Deviation|20|20.0|||
4264989|NCT00602771|4089940|B2|||Age||years|Mean|78|78.0|Standard Deviation|19|19.0|||
4264990|NCT00602771|4089941|B1|||Age||years|Mean|76|76.0|Standard Deviation|20|20.0|||
4264991|NCT00602771|4089939|B3||>=65 years|Age||Participants|Count of Participants|84|84.0||||||
4264992|NCT00602771|4089940|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4264993|NCT00602771|4089941|B1||>=65 years|Age||Participants|Count of Participants|63|63.0||||||
4264994|NCT00602771|4089939|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4264995|NCT00602771|4089940|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4264996|NCT00602771|4089941|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4264997|NCT00602771|4089939|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4264998|NCT00602771|4089940|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4264999|NCT00602771|4089941|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265000|NCT00602641|4089948|B3|Unknown/Missing||International Staging System (ISS)|"The staging criteria for International Staging System:~Stage I: Serum β2 microglobulin <3.5 mg/L, Serum albumin ≥ 3.5 g/dL Stage II: Not I or III Stage III: Serum β2 microglobulin >5.5 mg/L"|participants|Number|2|2.0||||||
4265001|NCT00602641|4089949|B2|Unknown/Missing||International Staging System (ISS)|"The staging criteria for International Staging System:~Stage I: Serum β2 microglobulin <3.5 mg/L, Serum albumin ≥ 3.5 g/dL Stage II: Not I or III Stage III: Serum β2 microglobulin >5.5 mg/L"|participants|Number|0|0.0||||||
4265002|NCT00602641|4089950|B1|Unknown/Missing||International Staging System (ISS)|"The staging criteria for International Staging System:~Stage I: Serum β2 microglobulin <3.5 mg/L, Serum albumin ≥ 3.5 g/dL Stage II: Not I or III Stage III: Serum β2 microglobulin >5.5 mg/L"|participants|Number|2|2.0||||||
4265091|NCT00602472|4089975|B2|||Body mass index (BMI) continuous||kg/m^2|Mean|28.38|28.38|Standard Deviation|4.79|4.79|||
4265003|NCT00602641|4089948|B3|Stage III||International Staging System (ISS)|"The staging criteria for International Staging System:~Stage I: Serum β2 microglobulin <3.5 mg/L, Serum albumin ≥ 3.5 g/dL Stage II: Not I or III Stage III: Serum β2 microglobulin >5.5 mg/L"|participants|Number|95|95.0||||||
4265004|NCT00602641|4089949|B2|Stage III||International Staging System (ISS)|"The staging criteria for International Staging System:~Stage I: Serum β2 microglobulin <3.5 mg/L, Serum albumin ≥ 3.5 g/dL Stage II: Not I or III Stage III: Serum β2 microglobulin >5.5 mg/L"|participants|Number|46|46.0||||||
4265005|NCT00602641|4089950|B1|Stage III||International Staging System (ISS)|"The staging criteria for International Staging System:~Stage I: Serum β2 microglobulin <3.5 mg/L, Serum albumin ≥ 3.5 g/dL Stage II: Not I or III Stage III: Serum β2 microglobulin >5.5 mg/L"|participants|Number|49|49.0||||||
4265006|NCT00602641|4089948|B3|Stage II||International Staging System (ISS)|"The staging criteria for International Staging System:~Stage I: Serum β2 microglobulin <3.5 mg/L, Serum albumin ≥ 3.5 g/dL Stage II: Not I or III Stage III: Serum β2 microglobulin >5.5 mg/L"|participants|Number|128|128.0||||||
4265007|NCT00602641|4089949|B2|Stage II||International Staging System (ISS)|"The staging criteria for International Staging System:~Stage I: Serum β2 microglobulin <3.5 mg/L, Serum albumin ≥ 3.5 g/dL Stage II: Not I or III Stage III: Serum β2 microglobulin >5.5 mg/L"|participants|Number|70|70.0||||||
4265008|NCT00602641|4089950|B1|Stage II||International Staging System (ISS)|"The staging criteria for International Staging System:~Stage I: Serum β2 microglobulin <3.5 mg/L, Serum albumin ≥ 3.5 g/dL Stage II: Not I or III Stage III: Serum β2 microglobulin >5.5 mg/L"|participants|Number|58|58.0||||||
4265009|NCT00602641|4089948|B3|Stage I||International Staging System (ISS)|"The staging criteria for International Staging System:~Stage I: Serum β2 microglobulin <3.5 mg/L, Serum albumin ≥ 3.5 g/dL Stage II: Not I or III Stage III: Serum β2 microglobulin >5.5 mg/L"|participants|Number|81|81.0||||||
4265010|NCT00602641|4089949|B2|Stage I||International Staging System (ISS)|"The staging criteria for International Staging System:~Stage I: Serum β2 microglobulin <3.5 mg/L, Serum albumin ≥ 3.5 g/dL Stage II: Not I or III Stage III: Serum β2 microglobulin >5.5 mg/L"|participants|Number|36|36.0||||||
4265011|NCT00602641|4089950|B1|Stage I||International Staging System (ISS)|"The staging criteria for International Staging System:~Stage I: Serum β2 microglobulin <3.5 mg/L, Serum albumin ≥ 3.5 g/dL Stage II: Not I or III Stage III: Serum β2 microglobulin >5.5 mg/L"|participants|Number|45|45.0||||||
4265012|NCT00602641|4089948|B3||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4265013|NCT00602641|4089949|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4265014|NCT00602641|4089950|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4265015|NCT00602641|4089948|B3||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4265016|NCT00602641|4089949|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4265017|NCT00602641|4089950|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4265018|NCT00602641|4089948|B3||>=65 years|Age||Participants|Count of Participants|291|291.0||||||
4265019|NCT00602641|4089949|B2||>=65 years|Age||Participants|Count of Participants|146|146.0||||||
4265020|NCT00602641|4089950|B1||>=65 years|Age||Participants|Count of Participants|145|145.0||||||
4265021|NCT00602641|4089948|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4265022|NCT00602641|4089949|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4265023|NCT00602641|4089950|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4265024|NCT00602641|4089948|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265025|NCT00602641|4089949|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265026|NCT00602641|4089950|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265027|NCT00602537|4089963|B3|||Baseline HRSD Score for Follow-Up study|This scale refers to the 17-item Hamilton Rating Scale for Depression and measures patient depressive severity. The scale ranges from 0 to 52, with higher scores representing worse outcome.|units on a scale|Mean|4.3|4.3|Standard Deviation|2.9|2.9|||
4265028|NCT00602537|4089964|B2|||Baseline HRSD Score for Follow-Up study|This scale refers to the 17-item Hamilton Rating Scale for Depression and measures patient depressive severity. The scale ranges from 0 to 52, with higher scores representing worse outcome.|units on a scale|Mean|4.4|4.4|Standard Deviation|3.4|3.4|||
4265029|NCT00602537|4089965|B1|||Baseline HRSD Score for Follow-Up study|This scale refers to the 17-item Hamilton Rating Scale for Depression and measures patient depressive severity. The scale ranges from 0 to 52, with higher scores representing worse outcome.|units on a scale|Mean|4.3|4.3|Standard Deviation|2.8|2.8|||
4265030|NCT00602537|4089963|B3|||Duration major depressive episode||months|Median|4|4.0|Full Range|||0.0|60.0|
4265031|NCT00602537|4089964|B2|||Duration major depressive episode||months|Median|4.0|4.0|Full Range|||0.0|396.0|
4265032|NCT00602537|4089965|B1|||Duration major depressive episode||months|Median|4.5|4.5|Full Range|||0.75|60.0|
4265033|NCT00602537|4089963|B3|||Baseline YMRS score|This scale refers to the Young Mania Rating Scale and measures manic symptoms. The scale ranges from a minimum score of 0 to a maximum score of 60, with higher scores representing worse outcome.|units on a scale|Mean|0.8|0.8|Standard Deviation|1.6|1.6|||
4265034|NCT00602537|4089964|B2|||Baseline YMRS score|This scale refers to the Young Mania Rating Scale and measures manic symptoms. The scale ranges from a minimum score of 0 to a maximum score of 60, with higher scores representing worse outcome.|units on a scale|Mean|0.6|0.6|Standard Deviation|1.4|1.4|||
4265035|NCT00602537|4089965|B1|||Baseline YMRS score|This scale refers to the Young Mania Rating Scale and measures manic symptoms. The scale ranges from a minimum score of 0 to a maximum score of 60, with higher scores representing worse outcome.|units on a scale|Mean|0.8|0.8|Standard Deviation|1.7|1.7|||
4265036|NCT00602537|4089963|B3|||Baseline HRSD score|This scale refers to the 17-item Hamilton Rating Scale for Depression and measures patient depressive severity. The scale ranges from 0 to 52, with higher scores representing worse outcome.|units on a scale|Mean|19.2|19.2|Standard Deviation|3.5|3.5|||
4265092|NCT00602472|4089976|B1|||Body mass index (BMI) continuous||kg/m^2|Mean|28.16|28.16|Standard Deviation|4.52|4.52|||
4265093|NCT00602472|4089974|B3||Male|Sex: Female, Male||Participants|Count of Participants|498|498.0||||||
4265037|NCT00602537|4089964|B2|||Baseline HRSD score|This scale refers to the 17-item Hamilton Rating Scale for Depression and measures patient depressive severity. The scale ranges from 0 to 52, with higher scores representing worse outcome.|units on a scale|Mean|18.8|18.8|Standard Deviation|3.3|3.3|||
4265038|NCT00602537|4089965|B1|||Baseline HRSD score|This scale refers to the 17-item Hamilton Rating Scale for Depression and measures patient depressive severity. The scale ranges from 0 to 52, with higher scores representing worse outcome.|units on a scale|Mean|19.4|19.4|Standard Deviation|3.6|3.6|||
4265039|NCT00602537|4089963|B3|||Number of lifetime hypomanic episodes||Episodes|Mean|41.9|41.9|Standard Deviation|61.4|61.4|||
4265040|NCT00602537|4089964|B2|||Number of lifetime hypomanic episodes||Episodes|Mean|32.2|32.2|Standard Deviation|47.3|47.3|||
4265041|NCT00602537|4089965|B1|||Number of lifetime hypomanic episodes||Episodes|Mean|45.8|45.8|Standard Deviation|66.4|66.4|||
4265042|NCT00602537|4089963|B3|||Number of lifetime major depressive episodes||Episodes|Mean|29.9|29.9|Standard Deviation|11.0|11.0|||
4265043|NCT00602537|4089964|B2|||Number of lifetime major depressive episodes||Episodes|Mean|33.3|33.3|Standard Deviation|49.7|49.7|||
4265044|NCT00602537|4089965|B1|||Number of lifetime major depressive episodes||Episodes|Mean|28.4|28.4|Standard Deviation|50.4|50.4|||
4265045|NCT00602537|4089963|B3|||Age 1st hypomanic episode||years|Mean|19.4|19.4|Standard Deviation|8.5|8.5|||
4265046|NCT00602537|4089964|B2|||Age 1st hypomanic episode||years|Mean|16.2|16.2|Standard Deviation|10.0|10.0|||
4265047|NCT00602537|4089965|B1|||Age 1st hypomanic episode||years|Mean|20.7|20.7|Standard Deviation|7.6|7.6|||
4265048|NCT00602537|4089963|B3|||Age 1st major depressive episode||years|Mean|18.5|18.5|Standard Deviation|7.1|7.1|||
4265049|NCT00602537|4089964|B2|||Age 1st major depressive episode||years|Mean|17.4|17.4|Standard Deviation|5.4|5.4|||
4265050|NCT00602537|4089965|B1|||Age 1st major depressive episode||years|Mean|19.0|19.0|Standard Deviation|7.7|7.7|||
4265051|NCT00602537|4089963|B3|||Inter-episode recovery||Participants|Count of Participants|16|16.0||||||
4265052|NCT00602537|4089964|B2|||Inter-episode recovery||Participants|Count of Participants|2|2.0||||||
4265053|NCT00602537|4089965|B1|||Inter-episode recovery||Participants|Count of Participants|14|14.0||||||
4265054|NCT00602537|4089963|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265055|NCT00602537|4089964|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265056|NCT00602537|4089965|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265057|NCT00602537|4089963|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265058|NCT00602537|4089964|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265059|NCT00602537|4089965|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265060|NCT00602537|4089963|B3||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4265061|NCT00602537|4089964|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4265062|NCT00602537|4089965|B1||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4265063|NCT00602537|4089963|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4265064|NCT00602537|4089964|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4265065|NCT00602537|4089965|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4265066|NCT00602537|4089963|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265067|NCT00602537|4089964|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265068|NCT00602537|4089965|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265069|NCT00602537|4089963|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4265070|NCT00602537|4089964|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265071|NCT00602537|4089965|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4265072|NCT00602537|4089963|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265073|NCT00602537|4089964|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265074|NCT00602537|4089965|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265075|NCT00602537|4089963|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4265076|NCT00602537|4089964|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4265077|NCT00602537|4089965|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4265078|NCT00602537|4089963|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4265079|NCT00602537|4089964|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4265080|NCT00602537|4089965|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4265081|NCT00602537|4089963|B3|||Age||years|Mean|42.2|42.2|Standard Deviation|12.5|12.5|||
4265082|NCT00602537|4089964|B2|||Age||years|Mean|43.1|43.1|Standard Deviation|15.2|15.2|||
4265083|NCT00602537|4089965|B1|||Age||years|Mean|41.8|41.8|Standard Deviation|11.4|11.4|||
4265084|NCT00602472|4089974|B3|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|160.1|160.1|Standard Deviation|36.6|36.6|||
4265085|NCT00602472|4089975|B2|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|159.3|159.3|Standard Deviation|36.5|36.5|||
4265086|NCT00602472|4089976|B1|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|162.6|162.6|Standard Deviation|37.1|37.1|||
4265087|NCT00602472|4089974|B3|||Glycosylated Hemoglobin A1 (HbA1c)||Percent|Mean|8.14|8.14|Standard Deviation|0.81|0.81|||
4265088|NCT00602472|4089975|B2|||Glycosylated Hemoglobin A1 (HbA1c)||Percent|Mean|8.15|8.15|Standard Deviation|0.80|0.8|||
4265089|NCT00602472|4089976|B1|||Glycosylated Hemoglobin A1 (HbA1c)||Percent|Mean|8.14|8.14|Standard Deviation|0.84|0.84|||
4265094|NCT00602472|4089975|B2||Male|Sex: Female, Male||Participants|Count of Participants|371|371.0||||||
4265095|NCT00602472|4089976|B1||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4265096|NCT00602472|4089974|B3||Female|Sex: Female, Male||Participants|Count of Participants|557|557.0||||||
4265097|NCT00602472|4089975|B2||Female|Sex: Female, Male||Participants|Count of Participants|421|421.0||||||
4265098|NCT00602472|4089976|B1||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4265099|NCT00602472|4089974|B3|||Age||Years|Mean|58.1|58.1|Standard Deviation|9.8|9.8|||
4265100|NCT00602472|4089975|B2|||Age||Years|Mean|58.3|58.3|Standard Deviation|9.9|9.9|||
4265101|NCT00602472|4089976|B1|||Age||Years|Mean|57.6|57.6|Standard Deviation|9.7|9.7|||
4265102|NCT00602459|4090007|B5|United States||Region of Enrollment||participants|Number|347|347.0||||||
4265103|NCT00602459|4090008|B4|United States||Region of Enrollment||participants|Number|23|23.0||||||
4265104|NCT00602459|4090009|B3|United States||Region of Enrollment||participants|Number|121|121.0||||||
4265105|NCT00602459|4090010|B2|United States||Region of Enrollment||participants|Number|95|95.0||||||
4265106|NCT00602459|4090011|B1|United States||Region of Enrollment||participants|Number|108|108.0||||||
4265107|NCT00602459|4090007|B5|Canada||Region of Enrollment||participants|Number|53|53.0||||||
4265108|NCT00602459|4090008|B4|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4265109|NCT00602459|4090009|B3|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4265110|NCT00602459|4090010|B2|Canada||Region of Enrollment||participants|Number|14|14.0||||||
4265111|NCT00602459|4090011|B1|Canada||Region of Enrollment||participants|Number|15|15.0||||||
4265112|NCT00602459|4090007|B5||Male|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
4265113|NCT00602459|4090008|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4265114|NCT00602459|4090009|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4265115|NCT00602459|4090010|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4265116|NCT00602459|4090011|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4265117|NCT00602459|4090007|B5||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4265118|NCT00602459|4090008|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4265119|NCT00602459|4090009|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4265120|NCT00602459|4090010|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4265121|NCT00602459|4090011|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4265122|NCT00602459|4090007|B5||>=65 years|Age||Participants|Count of Participants|144|144.0||||||
4265123|NCT00602459|4090008|B4||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4265124|NCT00602459|4090009|B3||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
4265125|NCT00602459|4090010|B2||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
4265126|NCT00602459|4090011|B1||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
4265127|NCT00602459|4090007|B5||Between 18 and 65 years|Age||Participants|Count of Participants|256|256.0||||||
4265128|NCT00602459|4090008|B4||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4265129|NCT00602459|4090009|B3||Between 18 and 65 years|Age||Participants|Count of Participants|88|88.0||||||
4265130|NCT00602459|4090010|B2||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
4265131|NCT00602459|4090011|B1||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4265132|NCT00602459|4090007|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265133|NCT00602459|4090008|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265134|NCT00602459|4090009|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265135|NCT00602459|4090010|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265136|NCT00602459|4090011|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265137|NCT00602446|4090035|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4265138|NCT00602446|4090035|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4265139|NCT00602446|4090035|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4265140|NCT00602446|4090035|B1|||Age||years|Mean|45.7|45.7|Standard Deviation|5.0|5.0|||
4265141|NCT00602446|4090035|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4265142|NCT00602446|4090035|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4265143|NCT00602446|4090035|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265144|NCT00602420|4090040|B3|||Bone pain today or during previous 3 days (scale, 0-10)|"Any rating of bone pain from 1 to 10 was considered a day with pain. No pain is an instance in which patients scored their pain 0, and any pain for all other responses. Severe pain was similarly defined as any bone pain score greater than 5."|units on a scale|Mean|0.56|0.56|Standard Deviation|1.52|1.52|||
4265145|NCT00602420|4090041|B2|||Bone pain today or during previous 3 days (scale, 0-10)|"Any rating of bone pain from 1 to 10 was considered a day with pain. No pain is an instance in which patients scored their pain 0, and any pain for all other responses. Severe pain was similarly defined as any bone pain score greater than 5."|units on a scale|Mean|0.64|0.64|Standard Deviation|1.60|1.6|||
4265146|NCT00602420|4090042|B1|||Bone pain today or during previous 3 days (scale, 0-10)|"Any rating of bone pain from 1 to 10 was considered a day with pain. No pain is an instance in which patients scored their pain 0, and any pain for all other responses. Severe pain was similarly defined as any bone pain score greater than 5."|units on a scale|Mean|0.47|0.47|Standard Deviation|1.44|1.44|||
4265199|NCT00602420|4090041|B2|Lung||Tumor Type|Patients required to have diagnosis of nonmyeloid cancer and were approached for study participation before first dose of pegfilgrastim on day 2, 3, or 4 of chemotherapy cycle.|participants|Number|31|31.0||||||
4265147|NCT00602420|4090040|B3|||Pain at its worst in last 24 hours (scale, 0-10)|"Any rating of bone pain from 1 to 10 was considered a day with pain. No pain is an instance in which patients scored their pain 0, and any pain for all other responses. Severe pain was similarly defined as any bone pain score greater than 5."|units on a scale|Mean|1.83|1.83|Standard Deviation|2.24|2.24|||
4265148|NCT00602420|4090041|B2|||Pain at its worst in last 24 hours (scale, 0-10)|"Any rating of bone pain from 1 to 10 was considered a day with pain. No pain is an instance in which patients scored their pain 0, and any pain for all other responses. Severe pain was similarly defined as any bone pain score greater than 5."|units on a scale|Mean|1.87|1.87|Standard Deviation|2.23|2.23|||
4265149|NCT00602420|4090042|B1|||Pain at its worst in last 24 hours (scale, 0-10)|"Any rating of bone pain from 1 to 10 was considered a day with pain. No pain is an instance in which patients scored their pain 0, and any pain for all other responses. Severe pain was similarly defined as any bone pain score greater than 5."|units on a scale|Mean|1.78|1.78|Standard Deviation|2.24|2.24|||
4265150|NCT00602420|4090040|B3|Unknown||Previous Radiation Therapy||participants|Number|6|6.0||||||
4265151|NCT00602420|4090041|B2|Unknown||Previous Radiation Therapy||participants|Number|2|2.0||||||
4265152|NCT00602420|4090042|B1|Unknown||Previous Radiation Therapy||participants|Number|4|4.0||||||
4265153|NCT00602420|4090040|B3|No||Previous Radiation Therapy||participants|Number|456|456.0||||||
4265154|NCT00602420|4090041|B2|No||Previous Radiation Therapy||participants|Number|221|221.0||||||
4265155|NCT00602420|4090042|B1|No||Previous Radiation Therapy||participants|Number|235|235.0||||||
4265156|NCT00602420|4090040|B3|Yes||Previous Radiation Therapy||participants|Number|48|48.0||||||
4265157|NCT00602420|4090041|B2|Yes||Previous Radiation Therapy||participants|Number|30|30.0||||||
4265158|NCT00602420|4090042|B1|Yes||Previous Radiation Therapy||participants|Number|18|18.0||||||
4265159|NCT00602420|4090040|B3|Unknown||Previous chemotherapy||participants|Number|6|6.0||||||
4265160|NCT00602420|4090041|B2|Unknown||Previous chemotherapy||participants|Number|2|2.0||||||
4265161|NCT00602420|4090042|B1|Unknown||Previous chemotherapy||participants|Number|4|4.0||||||
4265162|NCT00602420|4090040|B3|No||Previous chemotherapy||participants|Number|369|369.0||||||
4265163|NCT00602420|4090041|B2|No||Previous chemotherapy||participants|Number|176|176.0||||||
4265164|NCT00602420|4090042|B1|No||Previous chemotherapy||participants|Number|193|193.0||||||
4265165|NCT00602420|4090040|B3|Yes||Previous chemotherapy||participants|Number|135|135.0||||||
4265166|NCT00602420|4090041|B2|Yes||Previous chemotherapy||participants|Number|75|75.0||||||
4265167|NCT00602420|4090042|B1|Yes||Previous chemotherapy||participants|Number|60|60.0||||||
4265168|NCT00602420|4090040|B3|Unknown||Previous tamoxifen||participants|Number|6|6.0||||||
4265169|NCT00602420|4090041|B2|Unknown||Previous tamoxifen||participants|Number|2|2.0||||||
4265170|NCT00602420|4090042|B1|Unknown||Previous tamoxifen||participants|Number|4|4.0||||||
4265171|NCT00602420|4090040|B3|No||Previous tamoxifen||participants|Number|485|485.0||||||
4265172|NCT00602420|4090041|B2|No||Previous tamoxifen||participants|Number|240|240.0||||||
4265173|NCT00602420|4090042|B1|No||Previous tamoxifen||participants|Number|245|245.0||||||
4265174|NCT00602420|4090040|B3|Yes||Previous tamoxifen||participants|Number|19|19.0||||||
4265175|NCT00602420|4090041|B2|Yes||Previous tamoxifen||participants|Number|11|11.0||||||
4265176|NCT00602420|4090042|B1|Yes||Previous tamoxifen||participants|Number|8|8.0||||||
4265177|NCT00602420|4090040|B3|Other||Education||participants|Number|6|6.0||||||
4265178|NCT00602420|4090041|B2|Other||Education||participants|Number|2|2.0||||||
4265179|NCT00602420|4090042|B1|Other||Education||participants|Number|4|4.0||||||
4265180|NCT00602420|4090040|B3|High school or less||Education||participants|Number|160|160.0||||||
4265181|NCT00602420|4090041|B2|High school or less||Education||participants|Number|87|87.0||||||
4265182|NCT00602420|4090042|B1|High school or less||Education||participants|Number|73|73.0||||||
4265183|NCT00602420|4090040|B3|Some college||Education||participants|Number|344|344.0||||||
4265184|NCT00602420|4090041|B2|Some college||Education||participants|Number|164|164.0||||||
4265185|NCT00602420|4090042|B1|Some college||Education||participants|Number|180|180.0||||||
4265186|NCT00602420|4090040|B3|Unknown||Marital Status||participants|Number|6|6.0||||||
4265187|NCT00602420|4090041|B2|Unknown||Marital Status||participants|Number|2|2.0||||||
4265188|NCT00602420|4090042|B1|Unknown||Marital Status||participants|Number|4|4.0||||||
4265189|NCT00602420|4090040|B3|Not Married||Marital Status||participants|Number|144|144.0||||||
4265190|NCT00602420|4090041|B2|Not Married||Marital Status||participants|Number|72|72.0||||||
4265191|NCT00602420|4090042|B1|Not Married||Marital Status||participants|Number|72|72.0||||||
4265192|NCT00602420|4090040|B3|Married||Marital Status||participants|Number|360|360.0||||||
4265193|NCT00602420|4090041|B2|Married||Marital Status||participants|Number|179|179.0||||||
4265194|NCT00602420|4090042|B1|Married||Marital Status||participants|Number|181|181.0||||||
4265195|NCT00602420|4090040|B3|Other||Tumor Type|Patients required to have diagnosis of nonmyeloid cancer and were approached for study participation before first dose of pegfilgrastim on day 2, 3, or 4 of chemotherapy cycle.|participants|Number|52|52.0||||||
4265196|NCT00602420|4090041|B2|Other||Tumor Type|Patients required to have diagnosis of nonmyeloid cancer and were approached for study participation before first dose of pegfilgrastim on day 2, 3, or 4 of chemotherapy cycle.|participants|Number|26|26.0||||||
4265197|NCT00602420|4090042|B1|Other||Tumor Type|Patients required to have diagnosis of nonmyeloid cancer and were approached for study participation before first dose of pegfilgrastim on day 2, 3, or 4 of chemotherapy cycle.|participants|Number|26|26.0||||||
4265198|NCT00602420|4090040|B3|Lung||Tumor Type|Patients required to have diagnosis of nonmyeloid cancer and were approached for study participation before first dose of pegfilgrastim on day 2, 3, or 4 of chemotherapy cycle.|participants|Number|53|53.0||||||
4265245|NCT00602355|4090051|B2|United States||Region of Enrollment||participants|Number|56|56.0||||||
4265246|NCT00602355|4090052|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
4265200|NCT00602420|4090042|B1|Lung||Tumor Type|Patients required to have diagnosis of nonmyeloid cancer and were approached for study participation before first dose of pegfilgrastim on day 2, 3, or 4 of chemotherapy cycle.|participants|Number|22|22.0||||||
4265201|NCT00602420|4090040|B3|Hematologic||Tumor Type|Patients required to have diagnosis of nonmyeloid cancer and were approached for study participation before first dose of pegfilgrastim on day 2, 3, or 4 of chemotherapy cycle.|participants|Number|35|35.0||||||
4265202|NCT00602420|4090041|B2|Hematologic||Tumor Type|Patients required to have diagnosis of nonmyeloid cancer and were approached for study participation before first dose of pegfilgrastim on day 2, 3, or 4 of chemotherapy cycle.|participants|Number|17|17.0||||||
4265203|NCT00602420|4090042|B1|Hematologic||Tumor Type|Patients required to have diagnosis of nonmyeloid cancer and were approached for study participation before first dose of pegfilgrastim on day 2, 3, or 4 of chemotherapy cycle.|participants|Number|18|18.0||||||
4265204|NCT00602420|4090040|B3|Gynecologic||Tumor Type|Patients required to have diagnosis of nonmyeloid cancer and were approached for study participation before first dose of pegfilgrastim on day 2, 3, or 4 of chemotherapy cycle.|participants|Number|29|29.0||||||
4265205|NCT00602420|4090041|B2|Gynecologic||Tumor Type|Patients required to have diagnosis of nonmyeloid cancer and were approached for study participation before first dose of pegfilgrastim on day 2, 3, or 4 of chemotherapy cycle.|participants|Number|13|13.0||||||
4265206|NCT00602420|4090042|B1|Gynecologic||Tumor Type|Patients required to have diagnosis of nonmyeloid cancer and were approached for study participation before first dose of pegfilgrastim on day 2, 3, or 4 of chemotherapy cycle.|participants|Number|16|16.0||||||
4265207|NCT00602420|4090040|B3|Breast||Tumor Type|Patients required to have diagnosis of nonmyeloid cancer and were approached for study participation before first dose of pegfilgrastim on day 2, 3, or 4 of chemotherapy cycle.|participants|Number|341|341.0||||||
4265208|NCT00602420|4090041|B2|Breast||Tumor Type|Patients required to have diagnosis of nonmyeloid cancer and were approached for study participation before first dose of pegfilgrastim on day 2, 3, or 4 of chemotherapy cycle.|participants|Number|166|166.0||||||
4265209|NCT00602420|4090042|B1|Breast||Tumor Type|Patients required to have diagnosis of nonmyeloid cancer and were approached for study participation before first dose of pegfilgrastim on day 2, 3, or 4 of chemotherapy cycle.|participants|Number|175|175.0||||||
4265210|NCT00602420|4090040|B3|United States||Region of Enrollment||participants|Number|510|510.0||||||
4265211|NCT00602420|4090041|B2|United States||Region of Enrollment||participants|Number|253|253.0||||||
4265212|NCT00602420|4090042|B1|United States||Region of Enrollment||participants|Number|257|257.0||||||
4265213|NCT00602420|4090040|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4265214|NCT00602420|4090041|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4265215|NCT00602420|4090042|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4265216|NCT00602420|4090040|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265217|NCT00602420|4090041|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265218|NCT00602420|4090042|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265219|NCT00602420|4090040|B3||White|Race (NIH/OMB)||Participants|Count of Participants|455|455.0||||||
4265220|NCT00602420|4090041|B2||White|Race (NIH/OMB)||Participants|Count of Participants|227|227.0||||||
4265221|NCT00602420|4090042|B1||White|Race (NIH/OMB)||Participants|Count of Participants|228|228.0||||||
4265222|NCT00602420|4090040|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4265223|NCT00602420|4090041|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4265224|NCT00602420|4090042|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4265225|NCT00602420|4090040|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265226|NCT00602420|4090041|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265227|NCT00602420|4090042|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265228|NCT00602420|4090040|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4265229|NCT00602420|4090041|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4265230|NCT00602420|4090042|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4265231|NCT00602420|4090040|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265232|NCT00602420|4090041|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265233|NCT00602420|4090042|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265234|NCT00602420|4090040|B3||Male|Sex: Female, Male|86% female, 14% male patients.|Participants|Count of Participants|73|73.0||||||
4265235|NCT00602420|4090041|B2||Male|Sex: Female, Male|86% female, 14% male patients.|Participants|Count of Participants|38|38.0||||||
4265236|NCT00602420|4090042|B1||Male|Sex: Female, Male|86% female, 14% male patients.|Participants|Count of Participants|35|35.0||||||
4265237|NCT00602420|4090040|B3||Female|Sex: Female, Male|86% female, 14% male patients.|Participants|Count of Participants|437|437.0||||||
4265238|NCT00602420|4090041|B2||Female|Sex: Female, Male|86% female, 14% male patients.|Participants|Count of Participants|215|215.0||||||
4265239|NCT00602420|4090042|B1||Female|Sex: Female, Male|86% female, 14% male patients.|Participants|Count of Participants|222|222.0||||||
4265240|NCT00602420|4090040|B3|||Age||years|Mean|56.2|56.2|Standard Deviation|12.0|12.0|||
4265241|NCT00602420|4090041|B2|||Age||years|Mean|56.8|56.8|Standard Deviation|11.1|11.1|||
4265242|NCT00602420|4090042|B1|||Age||years|Mean|55.6|55.6|Standard Deviation|12.8|12.8|||
4265243|NCT00602355|4090049|B4|United States||Region of Enrollment||participants|Number|162|162.0||||||
4265244|NCT00602355|4090050|B3|United States||Region of Enrollment||participants|Number|53|53.0||||||
4265247|NCT00602355|4090049|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4265248|NCT00602355|4090050|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4265249|NCT00602355|4090051|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4265250|NCT00602355|4090052|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4265251|NCT00602355|4090049|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265252|NCT00602355|4090050|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265253|NCT00602355|4090051|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265254|NCT00602355|4090052|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265255|NCT00602355|4090049|B4||White|Race (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
4265256|NCT00602355|4090050|B3||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4265257|NCT00602355|4090051|B2||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4265258|NCT00602355|4090052|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4265259|NCT00602355|4090049|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4265260|NCT00602355|4090050|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4265261|NCT00602355|4090051|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4265262|NCT00602355|4090052|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4265263|NCT00602355|4090049|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265264|NCT00602355|4090050|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265265|NCT00602355|4090051|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265266|NCT00602355|4090052|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265267|NCT00602355|4090049|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4265268|NCT00602355|4090050|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4265269|NCT00602355|4090051|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265270|NCT00602355|4090052|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4265271|NCT00602355|4090049|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265272|NCT00602355|4090050|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265273|NCT00602355|4090051|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265274|NCT00602355|4090052|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265275|NCT00602355|4090049|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4265276|NCT00602355|4090050|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265277|NCT00602355|4090051|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4265278|NCT00602355|4090052|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265279|NCT00602355|4090049|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|117|117.0||||||
4265280|NCT00602355|4090050|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4265281|NCT00602355|4090051|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4265282|NCT00602355|4090052|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4265283|NCT00602355|4090049|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4265284|NCT00602355|4090050|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4265285|NCT00602355|4090051|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4265286|NCT00602355|4090052|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4265287|NCT00602355|4090049|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4265288|NCT00602355|4090050|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4265289|NCT00602355|4090051|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4265290|NCT00602355|4090052|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4265291|NCT00602355|4090049|B4||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4265292|NCT00602355|4090050|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4265293|NCT00602355|4090051|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4265294|NCT00602355|4090052|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4265295|NCT00602355|4090049|B4|||Age||years|Mean|27.25|27.25|Standard Deviation|5.67|5.67|||
4265296|NCT00602355|4090050|B3|||Age||years|Mean|26.26|26.26|Standard Deviation|6.15|6.15|||
4265297|NCT00602355|4090051|B2|||Age||years|Mean|28.16|28.16|Standard Deviation|5.63|5.63|||
4265298|NCT00602355|4090052|B1|||Age||years|Mean|27.28|27.28|Standard Deviation|5.11|5.11|||
4265299|NCT00602355|4090049|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4265300|NCT00602355|4090050|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4265301|NCT00602355|4090051|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4265302|NCT00602355|4090052|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4265303|NCT00602355|4090049|B4||Between 18 and 65 years|Age||Participants|Count of Participants|162|162.0||||||
4265304|NCT00602355|4090050|B3||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4265305|NCT00602355|4090051|B2||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4265306|NCT00602355|4090052|B1||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4265307|NCT00602355|4090049|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265308|NCT00602355|4090050|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265309|NCT00602355|4090051|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265310|NCT00602355|4090052|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265311|NCT00602290|4090074|B4|United States||Region of Enrollment||participants|Number|143|143.0||||||
4265312|NCT00602290|4090075|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
4265313|NCT00602290|4090076|B2|United States||Region of Enrollment||participants|Number|48|48.0||||||
4265314|NCT00602290|4090077|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4265315|NCT00602290|4090074|B4||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4265316|NCT00602290|4090075|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4265317|NCT00602290|4090076|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4265318|NCT00602290|4090077|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4265319|NCT00602290|4090074|B4||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4265320|NCT00602290|4090075|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4265321|NCT00602290|4090076|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4265322|NCT00602290|4090077|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4265323|NCT00602290|4090074|B4||>=65 years|Age||Participants|Count of Participants|105|105.0||||||
4265324|NCT00602290|4090075|B3||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4265325|NCT00602290|4090076|B2||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4265326|NCT00602290|4090077|B1||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
4265327|NCT00602290|4090074|B4||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4265328|NCT00602290|4090075|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4265329|NCT00602290|4090076|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4265330|NCT00602290|4090077|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4265331|NCT00602290|4090074|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265332|NCT00602290|4090075|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265333|NCT00602290|4090076|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265334|NCT00602290|4090077|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265335|NCT00602290|4090074|B4|||Age||years|Mean|69.7|69.7|Standard Deviation|7.3|7.3|||
4265336|NCT00602290|4090075|B3|||Age||years|Mean|68.9|68.9|Standard Deviation|7.6|7.6|||
4265337|NCT00602290|4090076|B2|||Age||years|Mean|70.0|70.0|Standard Deviation|7.1|7.1|||
4265338|NCT00602290|4090077|B1|||Age||years|Mean|70.1|70.1|Standard Deviation|7.1|7.1|||
4265339|NCT00602225|4090090|B1|||Median first CR duration||weeks|Median|26|26.0|Full Range|||0.0|100.0|
4265340|NCT00602225|4090090|B1|||Unfavorable cytogenetics (at initial diagnosis)|Number of participants who had unfavorable risk cytogenetics at initial diagnosis.|Participants|Count of Participants|20|20.0||||||
4265341|NCT00602225|4090090|B1|||Intermediate cytogenetics (at initial diagnosis)|Number of participants who had intermediate risk cytogenetics at initial diagnosis.|Participants|Count of Participants|27|27.0||||||
4265342|NCT00602225|4090090|B1|||Favorable cytogenetics (at initial diagnosis)|Number of participants who had favorable risk cytogenetics at initial diagnosis.|Participants|Count of Participants|3|3.0||||||
4265343|NCT00602225|4090090|B1|||Refractory|Number of participants whose disease was considered refractory at the time of enrollment.|Participants|Count of Participants|18|18.0||||||
4265344|NCT00602225|4090090|B1|||Second or greater salvage|Number of participants for whom treatment on this protocol was considered second or greater salvage therapy.|Participants|Count of Participants|18|18.0||||||
4265345|NCT00602225|4090090|B1|||First salvage|Number of participants for whom treatment on this protocol was considered first salvage therapy.|Participants|Count of Participants|32|32.0||||||
4265346|NCT00602225|4090090|B1|||Relapsed|Number of patients with relapsed Acute Myeloid Leukemia|Participants|Count of Participants|32|32.0||||||
4265347|NCT00602225|4090090|B1|||AML Onset: secondary|Number of participants whose diagnosis of Acute Myeloid Leukemia was preceded by an Antecedent Hematological Disorder or treatment with chemotherapy/radiation.|Participants|Count of Participants|18|18.0||||||
4265348|NCT00602225|4090090|B1|||AML Onset: de novo|Number of participants whose diagnosis of Acute Myeloid Leukemia was not preceded by an Antecedent Hematological Disorder or treatment with chemotherapy/radiation.|Participants|Count of Participants|32|32.0||||||
4265349|NCT00602225|4090090|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4265350|NCT00602225|4090090|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4265351|NCT00602225|4090090|B1|||Age||years|Median|53|53.0|Full Range|||19.0|69.0|
4265352|NCT00602043|4090103|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4265353|NCT00602043|4090103|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4265354|NCT00602043|4090103|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4265355|NCT00602043|4090103|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4265356|NCT00602043|4090103|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4265357|NCT00602043|4090103|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265358|NCT00601965|4090113|B5|United States||Region of Enrollment||participants|Number|73|73.0||||||
4265359|NCT00601965|4090114|B4|United States||Region of Enrollment||participants|Number|18|18.0||||||
4265360|NCT00601965|4090115|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4265361|NCT00601965|4090116|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4265362|NCT00601965|4090117|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4265363|NCT00601965|4090113|B5|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4265364|NCT00601965|4090114|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4265365|NCT00601965|4090115|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4265366|NCT00601965|4090116|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4265367|NCT00601965|4090117|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4265368|NCT00601965|4090113|B5|African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4265369|NCT00601965|4090114|B4|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4265370|NCT00601965|4090115|B3|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4265371|NCT00601965|4090116|B2|African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4265372|NCT00601965|4090117|B1|African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4265373|NCT00601965|4090113|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4265374|NCT00601965|4090114|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4265375|NCT00601965|4090115|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4265376|NCT00601965|4090116|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4265377|NCT00601965|4090117|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4265378|NCT00601965|4090113|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
4265379|NCT00601965|4090114|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4265380|NCT00601965|4090115|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4265381|NCT00601965|4090116|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4265382|NCT00601965|4090117|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4265383|NCT00601965|4090113|B5||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4265384|NCT00601965|4090114|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4265385|NCT00601965|4090115|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4265386|NCT00601965|4090116|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4265387|NCT00601965|4090117|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4265388|NCT00601965|4090113|B5||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4265389|NCT00601965|4090114|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4265390|NCT00601965|4090115|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4265391|NCT00601965|4090116|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4265392|NCT00601965|4090117|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4265393|NCT00601965|4090113|B5||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
4265394|NCT00601965|4090114|B4||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4265395|NCT00601965|4090115|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4265396|NCT00601965|4090116|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4265397|NCT00601965|4090117|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4265398|NCT00601965|4090113|B5||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4265399|NCT00601965|4090114|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4265400|NCT00601965|4090115|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4265401|NCT00601965|4090116|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4265402|NCT00601965|4090117|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4265403|NCT00601965|4090113|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265404|NCT00601965|4090114|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265405|NCT00601965|4090115|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265406|NCT00601965|4090116|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265407|NCT00601965|4090117|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265408|NCT00601965|4090113|B5|||Age||years|Mean|69.5|69.5|Standard Deviation|7.5|7.5|||
4265409|NCT00601965|4090114|B4|||Age||years|Mean|66.9|66.9|Standard Deviation|5.7|5.7|||
4265410|NCT00601965|4090115|B3|||Age||years|Mean|70.2|70.2|Standard Deviation|8.1|8.1|||
4265411|NCT00601965|4090116|B2|||Age||years|Mean|70.3|70.3|Standard Deviation|8.6|8.6|||
4265412|NCT00601965|4090117|B1|||Age||years|Mean|70.5|70.5|Standard Deviation|7.7|7.7|||
4265413|NCT00601952|4090134|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4265414|NCT00601952|4090135|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4265415|NCT00601952|4090136|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4265416|NCT00601952|4090134|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4265417|NCT00601952|4090135|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4265418|NCT00601952|4090136|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4265419|NCT00601952|4090134|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4265420|NCT00601952|4090135|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4265421|NCT00601952|4090136|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4265422|NCT00601952|4090134|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4265423|NCT00601952|4090135|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4265424|NCT00601952|4090136|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4265425|NCT00601952|4090134|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4265426|NCT00601952|4090135|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4265427|NCT00601952|4090136|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4265428|NCT00601952|4090134|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265429|NCT00601952|4090135|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265430|NCT00601952|4090136|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265431|NCT00601926|4090143|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4265432|NCT00601926|4090143|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265433|NCT00601926|4090143|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4265434|NCT00601926|4090143|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265435|NCT00601926|4090143|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265436|NCT00601926|4090143|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265437|NCT00601926|4090143|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4265438|NCT00601926|4090143|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265439|NCT00601926|4090143|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265440|NCT00601926|4090143|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265441|NCT00601926|4090143|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265442|NCT00601926|4090143|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4265443|NCT00601926|4090143|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4265444|NCT00601926|4090143|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4265445|NCT00601926|4090143|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4265446|NCT00601926|4090143|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265447|NCT00601900|4090149|B3|Tamoxifen||Endocrine Therapy Elected||participants|Number|43|43.0||||||
4265448|NCT00601900|4090150|B2|Tamoxifen||Endocrine Therapy Elected||participants|Number|22|22.0||||||
4265449|NCT00601900|4090151|B1|Tamoxifen||Endocrine Therapy Elected||participants|Number|21|21.0||||||
4265450|NCT00601900|4090149|B3|Letrozole||Endocrine Therapy Elected||participants|Number|348|348.0||||||
4265451|NCT00601900|4090150|B2|Letrozole||Endocrine Therapy Elected||participants|Number|174|174.0||||||
4265452|NCT00601900|4090151|B1|Letrozole||Endocrine Therapy Elected||participants|Number|174|174.0||||||
4265453|NCT00601900|4090149|B3|United States||Region of Enrollment||participants|Number|391|391.0||||||
4265454|NCT00601900|4090150|B2|United States||Region of Enrollment||participants|Number|196|196.0||||||
4265455|NCT00601900|4090151|B1|United States||Region of Enrollment||participants|Number|195|195.0||||||
4265456|NCT00601900|4090149|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4265457|NCT00601900|4090150|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4265458|NCT00601900|4090151|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4265459|NCT00601900|4090149|B3||Female|Sex: Female, Male||Participants|Count of Participants|391|391.0||||||
4265460|NCT00601900|4090150|B2||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4265461|NCT00601900|4090151|B1||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4265462|NCT00601900|4090149|B3|||Age||years|Median|57.7|57.7|Full Range|||24.7|87.0|
4265463|NCT00601900|4090150|B2|||Age||years|Median|58.9|58.9|Full Range|||29.0|87.0|
4265464|NCT00601900|4090151|B1|||Age||years|Median|55.5|55.5|Full Range|||24.7|85.3|
4265465|NCT00601835|4090166|B3|United States||Region of Enrollment||participants|Number|3650|3650.0||||||
4265466|NCT00601835|4090167|B2|United States||Region of Enrollment||participants|Number|700|700.0||||||
4265467|NCT00601835|4090168|B1|United States||Region of Enrollment||participants|Number|2950|2950.0||||||
4265468|NCT00601835|4090166|B3||Male|Sex: Female, Male||Participants|Count of Participants|1618|1618.0||||||
4265469|NCT00601835|4090167|B2||Male|Sex: Female, Male||Participants|Count of Participants|297|297.0||||||
4265470|NCT00601835|4090168|B1||Male|Sex: Female, Male||Participants|Count of Participants|1321|1321.0||||||
4265471|NCT00601835|4090166|B3||Female|Sex: Female, Male||Participants|Count of Participants|2032|2032.0||||||
4265472|NCT00601835|4090167|B2||Female|Sex: Female, Male||Participants|Count of Participants|403|403.0||||||
4265473|NCT00601835|4090168|B1||Female|Sex: Female, Male||Participants|Count of Participants|1629|1629.0||||||
4265474|NCT00601835|4090166|B3|||Age||years|Mean|40.5|40.5|Standard Deviation|25.60|25.6|||
4265475|NCT00601835|4090167|B2|||Age||years|Mean|69.3|69.3|Standard Deviation|7.89|7.89|||
4265476|NCT00601835|4090168|B1|||Age||years|Mean|33.6|33.6|Standard Deviation|23.49|23.49|||
4265477|NCT00601835|4090166|B3||>=65 years|Age||Participants|Count of Participants|892|892.0||||||
4265478|NCT00601835|4090167|B2||>=65 years|Age||Participants|Count of Participants|443|443.0||||||
4265479|NCT00601835|4090168|B1||>=65 years|Age||Participants|Count of Participants|449|449.0||||||
4265480|NCT00601835|4090166|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1257|1257.0||||||
4265481|NCT00601835|4090167|B2||Between 18 and 65 years|Age||Participants|Count of Participants|257|257.0||||||
4265482|NCT00601835|4090168|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1000|1000.0||||||
4265483|NCT00601835|4090166|B3||<=18 years|Age||Participants|Count of Participants|1501|1501.0||||||
4265484|NCT00601835|4090167|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265485|NCT00601835|4090168|B1||<=18 years|Age||Participants|Count of Participants|1501|1501.0||||||
4265486|NCT00601796|4090179|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4265487|NCT00601796|4090179|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4265488|NCT00601796|4090179|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4265489|NCT00601796|4090179|B1|||Age||years|Median|64|64.0|Full Range|||49.0|85.0|
4265490|NCT00601796|4090179|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4265491|NCT00601796|4090179|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4265492|NCT00601796|4090179|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265493|NCT00601731|4090186|B13|Male 60 months||Sex/Gender, Customized||Number of subjects|Number|50|50.0||||||
4265494|NCT00601731|4090187|B12|Male 60 months||Sex/Gender, Customized||Number of subjects|Number|15|15.0||||||
4265495|NCT00601731|4090188|B11|Male 60 months||Sex/Gender, Customized||Number of subjects|Number|1|1.0||||||
4265496|NCT00601731|4090189|B10|Male 60 months||Sex/Gender, Customized||Number of subjects|Number|1|1.0||||||
4265497|NCT00601731|4090190|B9|Male 60 months||Sex/Gender, Customized||Number of subjects|Number|NA|||||||Zero participants in this subgroup.
4265498|NCT00601731|4090191|B8|Male 60 months||Sex/Gender, Customized||Number of subjects|Number|NA|||||||Zero participants in this subgroup.
4265499|NCT00601731|4090192|B7|Male 60 months||Sex/Gender, Customized||Number of subjects|Number|0|0.0||||||
4265500|NCT00601731|4090193|B6|Male 60 months||Sex/Gender, Customized||Number of subjects|Number|1|1.0||||||
4265501|NCT00601731|4090194|B5|Male 60 months||Sex/Gender, Customized||Number of subjects|Number|23|23.0||||||
4265502|NCT00601731|4090195|B4|Male 60 months||Sex/Gender, Customized||Number of subjects|Number|1|1.0||||||
4265503|NCT00601731|4090196|B3|Male 60 months||Sex/Gender, Customized||Number of subjects|Number|2|2.0||||||
4265504|NCT00601731|4090197|B2|Male 60 months||Sex/Gender, Customized||Number of subjects|Number|3|3.0||||||
4265505|NCT00601731|4090198|B1|Male 60 months||Sex/Gender, Customized||Number of subjects|Number|3|3.0||||||
4265506|NCT00601731|4090186|B13|Female 60 months||Sex/Gender, Customized||Number of subjects|Number|49|49.0||||||
4265507|NCT00601731|4090187|B12|Female 60 months||Sex/Gender, Customized||Number of subjects|Number|15|15.0||||||
4265508|NCT00601731|4090188|B11|Female 60 months||Sex/Gender, Customized||Number of subjects|Number|0|0.0||||||
4265509|NCT00601731|4090189|B10|Female 60 months||Sex/Gender, Customized||Number of subjects|Number|1|1.0||||||
4265510|NCT00601731|4090190|B9|Female 60 months||Sex/Gender, Customized||Number of subjects|Number|NA|||||||Zero participants in this subgroup.
4265511|NCT00601731|4090191|B8|Female 60 months||Sex/Gender, Customized||Number of subjects|Number|NA|||||||Zero participants in this subgroup.
4265512|NCT00601731|4090192|B7|Female 60 months||Sex/Gender, Customized||Number of subjects|Number|3|3.0||||||
4265513|NCT00601731|4090193|B6|Female 60 months||Sex/Gender, Customized||Number of subjects|Number|2|2.0||||||
4265514|NCT00601731|4090194|B5|Female 60 months||Sex/Gender, Customized||Number of subjects|Number|20|20.0||||||
4265515|NCT00601731|4090195|B4|Female 60 months||Sex/Gender, Customized||Number of subjects|Number|2|2.0||||||
4265516|NCT00601731|4090196|B3|Female 60 months||Sex/Gender, Customized||Number of subjects|Number|1|1.0||||||
4265517|NCT00601731|4090197|B2|Female 60 months||Sex/Gender, Customized||Number of subjects|Number|4|4.0||||||
4265518|NCT00601731|4090198|B1|Female 60 months||Sex/Gender, Customized||Number of subjects|Number|1|1.0||||||
4265519|NCT00601731|4090186|B13|Male 40 months||Sex/Gender, Customized||Number of subjects|Number|138|138.0||||||
4265520|NCT00601731|4090187|B12|Male 40 months||Sex/Gender, Customized||Number of subjects|Number|NA|||||||Zero participants were in this subgroup.
4265521|NCT00601731|4090188|B11|Male 40 months||Sex/Gender, Customized||Number of subjects|Number|12|12.0||||||
4265522|NCT00601731|4090189|B10|Male 40 months||Sex/Gender, Customized||Number of subjects|Number|13|13.0||||||
4265523|NCT00601731|4090190|B9|Male 40 months||Sex/Gender, Customized||Number of subjects|Number|18|18.0||||||
4265524|NCT00601731|4090191|B8|Male 40 months||Sex/Gender, Customized||Number of subjects|Number|12|12.0||||||
4265525|NCT00601731|4090192|B7|Male 40 months||Sex/Gender, Customized||Number of subjects|Number|14|14.0||||||
4265526|NCT00601731|4090193|B6|Male 40 months||Sex/Gender, Customized||Number of subjects|Number|9|9.0||||||
4265527|NCT00601731|4090194|B5|Male 40 months||Sex/Gender, Customized||Number of subjects|Number|NA|||||||Zero participants were in this subgroup.
4265528|NCT00601731|4090195|B4|Male 40 months||Sex/Gender, Customized||Number of subjects|Number|15|15.0||||||
4265529|NCT00601731|4090196|B3|Male 40 months||Sex/Gender, Customized||Number of subjects|Number|5|5.0||||||
4265530|NCT00601731|4090197|B2|Male 40 months||Sex/Gender, Customized||Number of subjects|Number|18|18.0||||||
4265531|NCT00601731|4090198|B1|Male 40 months||Sex/Gender, Customized||Number of subjects|Number|22|22.0||||||
4265532|NCT00601731|4090186|B13|Female 40 months||Sex/Gender, Customized||Number of subjects|Number|145|145.0||||||
4265533|NCT00601731|4090187|B12|Female 40 months||Sex/Gender, Customized||Number of subjects|Number|NA|||||||Zero participants were in this subgroup.
4265534|NCT00601731|4090188|B11|Female 40 months||Sex/Gender, Customized||Number of subjects|Number|14|14.0||||||
4265535|NCT00601731|4090189|B10|Female 40 months||Sex/Gender, Customized||Number of subjects|Number|12|12.0||||||
4265536|NCT00601731|4090190|B9|Female 40 months||Sex/Gender, Customized||Number of subjects|Number|10|10.0||||||
4265537|NCT00601731|4090191|B8|Female 40 months||Sex/Gender, Customized||Number of subjects|Number|15|15.0||||||
4265538|NCT00601731|4090192|B7|Female 40 months||Sex/Gender, Customized||Number of subjects|Number|9|9.0||||||
4265539|NCT00601731|4090193|B6|Female 40 months||Sex/Gender, Customized||Number of subjects|Number|19|19.0||||||
4265540|NCT00601731|4090194|B5|Female 40 months||Sex/Gender, Customized||Number of subjects|Number|NA|||||||Zero participants were in this subgroup.
4265541|NCT00601731|4090195|B4|Female 40 months||Sex/Gender, Customized||Number of subjects|Number|19|19.0||||||
4265542|NCT00601731|4090196|B3|Female 40 months||Sex/Gender, Customized||Number of subjects|Number|14|14.0||||||
4265543|NCT00601731|4090197|B2|Female 40 months||Sex/Gender, Customized||Number of subjects|Number|19|19.0||||||
4265544|NCT00601731|4090198|B1|Female 40 months||Sex/Gender, Customized||Number of subjects|Number|14|14.0||||||
4265545|NCT00601731|4090186|B13|60 months (N=4,7,3,3,43,3,3,0,0,2,1,30)||Age, Customized||months|Mean|60.88|60.88|Standard Deviation|0.16|0.16|||
4265546|NCT00601731|4090187|B12|60 months (N=4,7,3,3,43,3,3,0,0,2,1,30)||Age, Customized||months|Mean|60.6|60.6|Standard Deviation|0.6|0.6|||
4265547|NCT00601731|4090188|B11|60 months (N=4,7,3,3,43,3,3,0,0,2,1,30)||Age, Customized||months|Mean|60.0|60.0|Standard Deviation|0.0|0.0|||
4265548|NCT00601731|4090189|B10|60 months (N=4,7,3,3,43,3,3,0,0,2,1,30)||Age, Customized||months|Mean|60.5|60.5|Standard Deviation|0.7|0.7|||
4265549|NCT00601731|4090190|B9|60 months (N=4,7,3,3,43,3,3,0,0,2,1,30)||Age, Customized||months|Mean|NA||Standard Deviation|NA||||Zero participants in this subgroup.
4265550|NCT00601731|4090191|B8|60 months (N=4,7,3,3,43,3,3,0,0,2,1,30)||Age, Customized||months|Mean|NA||Standard Deviation|NA||||Zero participants in this subgroup.
4265551|NCT00601731|4090192|B7|60 months (N=4,7,3,3,43,3,3,0,0,2,1,30)||Age, Customized||months|Mean|61.3|61.3|Standard Deviation|0.6|0.6|||
4265552|NCT00601731|4090193|B6|60 months (N=4,7,3,3,43,3,3,0,0,2,1,30)||Age, Customized||months|Mean|60.3|60.3|Standard Deviation|0.6|0.6|||
4265553|NCT00601731|4090194|B5|60 months (N=4,7,3,3,43,3,3,0,0,2,1,30)||Age, Customized||months|Mean|61.9|61.9|Standard Deviation|0.3|0.3|||
4265554|NCT00601731|4090195|B4|60 months (N=4,7,3,3,43,3,3,0,0,2,1,30)||Age, Customized||months|Mean|61.7|61.7|Standard Deviation|0.6|0.6|||
4265555|NCT00601731|4090196|B3|60 months (N=4,7,3,3,43,3,3,0,0,2,1,30)||Age, Customized||months|Mean|61.0|61.0|Standard Deviation|1.0|1.0|||
4265556|NCT00601731|4090197|B2|60 months (N=4,7,3,3,43,3,3,0,0,2,1,30)||Age, Customized||months|Mean|61.3|61.3|Standard Deviation|0.5|0.5|||
4265557|NCT00601731|4090198|B1|60 months (N=4,7,3,3,43,3,3,0,0,2,1,30)||Age, Customized||months|Mean|61.3|61.3|Standard Deviation|1.0|1.0|||
4265558|NCT00601731|4090186|B13|40 months (N=36,37,19,34,0,28,23,27,28,25,26,0)||Age, Customized||months|Mean|34.78|34.78|Standard Deviation|0.31|0.31|||
4265559|NCT00601731|4090187|B12|40 months (N=36,37,19,34,0,28,23,27,28,25,26,0)||Age, Customized||months|Mean|NA||Standard Deviation|NA||||Zero participants were in this subgroup.
4265560|NCT00601731|4090188|B11|40 months (N=36,37,19,34,0,28,23,27,28,25,26,0)||Age, Customized||months|Mean|41.0|41.0|Standard Deviation|1.1|1.1|||
4265561|NCT00601731|4090189|B10|40 months (N=36,37,19,34,0,28,23,27,28,25,26,0)||Age, Customized||months|Mean|40.7|40.7|Standard Deviation|1|1.0|||
4265562|NCT00601731|4090190|B9|40 months (N=36,37,19,34,0,28,23,27,28,25,26,0)||Age, Customized||months|Mean|41.6|41.6|Standard Deviation|1|1.0|||
4265563|NCT00601731|4090191|B8|40 months (N=36,37,19,34,0,28,23,27,28,25,26,0)||Age, Customized||months|Mean|42|42.0|Standard Deviation|0.9|0.9|||
4265564|NCT00601731|4090192|B7|40 months (N=36,37,19,34,0,28,23,27,28,25,26,0)||Age, Customized||months|Mean|41.8|41.8|Standard Deviation|1.2|1.2|||
4265565|NCT00601731|4090193|B6|40 months (N=36,37,19,34,0,28,23,27,28,25,26,0)||Age, Customized||months|Mean|42|42.0|Standard Deviation|1|1.0|||
4265566|NCT00601731|4090194|B5|40 months (N=36,37,19,34,0,28,23,27,28,25,26,0)||Age, Customized||months|Mean|NA||Standard Deviation|NA||||Zero participants were in this subgroup.
4265567|NCT00601731|4090195|B4|40 months (N=36,37,19,34,0,28,23,27,28,25,26,0)||Age, Customized||months|Mean|40.6|40.6|Standard Deviation|0.8|0.8|||
4265568|NCT00601731|4090196|B3|40 months (N=36,37,19,34,0,28,23,27,28,25,26,0)||Age, Customized||months|Mean|42.6|42.6|Standard Deviation|0.5|0.5|||
4265569|NCT00601731|4090197|B2|40 months (N=36,37,19,34,0,28,23,27,28,25,26,0)||Age, Customized||months|Mean|42.6|42.6|Standard Deviation|0.6|0.6|||
4265570|NCT00601731|4090198|B1|40 months (N=36,37,19,34,0,28,23,27,28,25,26,0)||Age, Customized||months|Mean|42.4|42.4|Standard Deviation|0.7|0.7|||
4265571|NCT00601718|4090251|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265572|NCT00601718|4090251|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265573|NCT00601718|4090251|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4265574|NCT00601718|4090251|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265575|NCT00601718|4090251|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265576|NCT00601718|4090251|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4265577|NCT00601718|4090251|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4265578|NCT00601718|4090251|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4265579|NCT00601718|4090251|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4265580|NCT00601718|4090251|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265581|NCT00601718|4090251|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4265582|NCT00601718|4090251|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4265583|NCT00601718|4090251|B1|||Age||years|Median|56|56.0|Full Range|||23.0|69.0|
4265584|NCT00601640|4090258|B4|United States||Region of Enrollment||participants|Number|156|156.0||||||
4265585|NCT00601640|4090259|B3|United States||Region of Enrollment||participants|Number|52|52.0||||||
4265586|NCT00601640|4090260|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
4265587|NCT00601640|4090261|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
4265588|NCT00601640|4090258|B4||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4265589|NCT00601640|4090259|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4265590|NCT00601640|4090260|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4265591|NCT00601640|4090261|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4265592|NCT00601640|4090258|B4||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4265593|NCT00601640|4090259|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4265594|NCT00601640|4090260|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4265595|NCT00601640|4090261|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4265596|NCT00601640|4090258|B4|||Age||years|Mean|60.4|60.4|Standard Deviation|10.2|10.2|||
4265597|NCT00601640|4090259|B3|||Age||years|Mean|61.4|61.4|Standard Deviation|10.4|10.4|||
4265598|NCT00601640|4090260|B2|||Age||years|Mean|60.4|60.4|Standard Deviation|11.0|11.0|||
4265599|NCT00601640|4090261|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|9.5|9.5|||
4265600|NCT00601640|4090258|B4||>=65 years|Age||Participants|Count of Participants|54|54.0||||||
4265601|NCT00601640|4090259|B3||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4265602|NCT00601640|4090260|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4265603|NCT00601640|4090261|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4265604|NCT00601640|4090258|B4||Between 18 and 65 years|Age||Participants|Count of Participants|102|102.0||||||
4265605|NCT00601640|4090259|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4265606|NCT00601640|4090260|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4265607|NCT00601640|4090261|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4265608|NCT00601640|4090258|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265609|NCT00601640|4090259|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265610|NCT00601640|4090260|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265611|NCT00601640|4090261|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265612|NCT00601627|4090277|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4265613|NCT00601627|4090277|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4265614|NCT00601627|4090277|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4265615|NCT00601627|4090277|B1|||Age||years|Median|65|65.0|Full Range|||43.0|84.0|
4265616|NCT00601523|4090286|B3||Male|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
4265617|NCT00601523|4090287|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4265618|NCT00601523|4090288|B1||Male|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4265619|NCT00601523|4090286|B3||Female|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
4265620|NCT00601523|4090287|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4265621|NCT00601523|4090288|B1||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4265622|NCT00601523|4090286|B3|||Age||Years|Mean|62.7|62.7|Standard Deviation|9.2|9.2|||
4265623|NCT00601523|4090287|B2|||Age||Years|Mean|64.0|64.0|Standard Deviation|9.0|9.0|||
4265624|NCT00601523|4090288|B1|||Age||Years|Mean|62.2|62.2|Standard Deviation|9.2|9.2|||
4265625|NCT00601458|4090321|B4|||Propofol Use||Milligrams|Mean|355.4|355.4|Standard Deviation|121.1|121.1|||
4265626|NCT00601458|4090322|B3|||Propofol Use||Milligrams|Mean|353.9|353.9|Standard Deviation|105.8|105.8|||
4265627|NCT00601458|4090323|B2|||Propofol Use||Milligrams|Mean|364.5|364.5|Standard Deviation|122.8|122.8|||
4265628|NCT00601458|4090324|B1|||Propofol Use||Milligrams|Mean|348.4|348.4|Standard Deviation|132.9|132.9|||
4265629|NCT00601458|4090321|B4|||Lidocaine Use|Regional anesthesia required during surgery|Milliliters|Mean|15.2|15.2|Standard Deviation|2.2|2.2|||
4265630|NCT00601458|4090322|B3|||Lidocaine Use|Regional anesthesia required during surgery|Milliliters|Mean|14.6|14.6|Standard Deviation|1.6|1.6|||
4265631|NCT00601458|4090323|B2|||Lidocaine Use|Regional anesthesia required during surgery|Milliliters|Mean|15.9|15.9|Standard Deviation|2.7|2.7|||
4265632|NCT00601458|4090324|B1|||Lidocaine Use|Regional anesthesia required during surgery|Milliliters|Mean|15.0|15.0|Standard Deviation|2.3|2.3|||
4265633|NCT00601458|4090321|B4|||Body Weight||Kilograms|Mean|75.3|75.3|Standard Deviation|17.4|17.4|||
4265634|NCT00601458|4090322|B3|||Body Weight||Kilograms|Mean|77.2|77.2|Standard Deviation|16.9|16.9|||
4265635|NCT00601458|4090323|B2|||Body Weight||Kilograms|Mean|76.7|76.7|Standard Deviation|17.2|17.2|||
4265636|NCT00601458|4090324|B1|||Body Weight||Kilograms|Mean|72.3|72.3|Standard Deviation|18.1|18.1|||
4265637|NCT00601458|4090321|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4265638|NCT00601458|4090322|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4265639|NCT00601458|4090323|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4265640|NCT00601458|4090324|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4265641|NCT00601458|4090321|B4||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4265642|NCT00601458|4090322|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4265643|NCT00601458|4090323|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4265644|NCT00601458|4090324|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4265645|NCT00601458|4090321|B4|||Age||years|Mean|39.9|39.9|Standard Deviation|13.1|13.1|||
4265646|NCT00601458|4090322|B3|||Age||years|Mean|38.8|38.8|Standard Deviation|11.6|11.6|||
4265647|NCT00601458|4090323|B2|||Age||years|Mean|40.6|40.6|Standard Deviation|13.5|13.5|||
4265648|NCT00601458|4090324|B1|||Age||years|Mean|40.3|40.3|Standard Deviation|14.1|14.1|||
4265649|NCT00601419|4090337|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4265650|NCT00601419|4090337|B1||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4265651|NCT00601419|4090337|B1|>=65 years||Age, Customized||participants|Number|30|30.0||||||
4265652|NCT00601419|4090337|B1|<65 years||Age, Customized||participants|Number|196|196.0||||||
4265653|NCT00601367|4090361|B1|Missing||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4265654|NCT00601367|4090361|B1|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4265655|NCT00601367|4090361|B1|White Hispanic||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4265656|NCT00601367|4090361|B1|White||Race/Ethnicity, Customized||participants|Number|442|442.0||||||
4265657|NCT00601367|4090361|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4265658|NCT00601367|4090361|B1||Female|Sex: Female, Male||Participants|Count of Participants|480|480.0||||||
4265659|NCT00601367|4090361|B1|50 years and older||Age, Customized||participants|Number|2|2.0||||||
4265660|NCT00601367|4090361|B1|40-49 years||Age, Customized||participants|Number|170|170.0||||||
4265661|NCT00601367|4090361|B1|30-39 years||Age, Customized||participants|Number|211|211.0||||||
4265662|NCT00601367|4090361|B1|18-29 years||Age, Customized||participants|Number|97|97.0||||||
4265663|NCT00601354|4090365|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4265664|NCT00601354|4090366|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4265665|NCT00601354|4090367|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4265666|NCT00601354|4090365|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4265667|NCT00601354|4090366|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4265668|NCT00601354|4090367|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4265669|NCT00601354|4090365|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4265670|NCT00601354|4090366|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4265671|NCT00601354|4090367|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4265672|NCT00601354|4090365|B3|||Age||years|Mean|49.4|49.4|Standard Deviation|11.4|11.4|||
4265673|NCT00601354|4090366|B2|||Age||years|Mean|50.1|50.1|Standard Deviation|4.1|4.1|||
4265674|NCT00601354|4090367|B1|||Age||years|Mean|48.6|48.6|Standard Deviation|11.2|11.2|||
4265675|NCT00601354|4090365|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4265676|NCT00601354|4090366|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4265677|NCT00601354|4090367|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4265678|NCT00601354|4090365|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4265679|NCT00601354|4090366|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4265680|NCT00601354|4090367|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4265681|NCT00601354|4090365|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265682|NCT00601354|4090366|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265683|NCT00601354|4090367|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265684|NCT00601250|4090378|B3|||Fasting blood plasma glucose (FPG)||mg/dL|Mean|168.81|168.81|Standard Deviation|43.10|43.1|||
4265685|NCT00601250|4090379|B2|||Fasting blood plasma glucose (FPG)||mg/dL|Mean|169.62|169.62|Standard Deviation|43.51|43.51|||
4265686|NCT00601250|4090380|B1|||Fasting blood plasma glucose (FPG)||mg/dL|Mean|166.42|166.42|Standard Deviation|41.89|41.89|||
4265687|NCT00601250|4090378|B3|||Glycosylated haemoglobin A1 (HbA1C)||Percent|Mean|8.08|8.08|Standard Deviation|0.87|0.87|||
4265688|NCT00601250|4090379|B2|||Glycosylated haemoglobin A1 (HbA1C)||Percent|Mean|8.09|8.09|Standard Deviation|0.86|0.86|||
4265689|NCT00601250|4090380|B1|||Glycosylated haemoglobin A1 (HbA1C)||Percent|Mean|8.02|8.02|Standard Deviation|0.88|0.88|||
4265690|NCT00601250|4090378|B3|||Body Mass Index (BMI) continuous||kg/m^2|Mean|29.90|29.9|Standard Deviation|4.88|4.88|||
4265691|NCT00601250|4090379|B2|||Body Mass Index (BMI) continuous||kg/m^2|Mean|29.85|29.85|Standard Deviation|4.84|4.84|||
4265692|NCT00601250|4090380|B1|||Body Mass Index (BMI) continuous||kg/m^2|Mean|30.05|30.05|Standard Deviation|5.01|5.01|||
4265693|NCT00601250|4090378|B3||Male|Sex: Female, Male||Participants|Count of Participants|379|379.0||||||
4265694|NCT00601250|4090379|B2||Male|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
4265695|NCT00601250|4090380|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4265696|NCT00601250|4090378|B3||Female|Sex: Female, Male||Participants|Count of Participants|321|321.0||||||
4265697|NCT00601250|4090379|B2||Female|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4265698|NCT00601250|4090380|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4265699|NCT00601250|4090378|B3|||Age||Years|Mean|56.5|56.5|Standard Deviation|10.3|10.3|||
4265700|NCT00601250|4090379|B2|||Age||Years|Mean|56.5|56.5|Standard Deviation|10.1|10.1|||
4265701|NCT00601250|4090380|B1|||Age||Years|Mean|56.6|56.6|Standard Deviation|10.9|10.9|||
4265702|NCT00601172|4090415|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265703|NCT00601172|4090416|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265704|NCT00601172|4090417|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265705|NCT00601172|4090415|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265706|NCT00601172|4090416|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265707|NCT00601172|4090417|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265708|NCT00601172|4090415|B3||White|Race (NIH/OMB)||Participants|Count of Participants|644|644.0||||||
4265709|NCT00601172|4090416|B2||White|Race (NIH/OMB)||Participants|Count of Participants|318|318.0||||||
4265710|NCT00601172|4090417|B1||White|Race (NIH/OMB)||Participants|Count of Participants|326|326.0||||||
4265711|NCT00601172|4090415|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4265712|NCT00601172|4090416|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4265713|NCT00601172|4090417|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4265714|NCT00601172|4090415|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265715|NCT00601172|4090416|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265716|NCT00601172|4090417|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265717|NCT00601172|4090415|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4265718|NCT00601172|4090416|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4265719|NCT00601172|4090417|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4265720|NCT00601172|4090415|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4265721|NCT00601172|4090416|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4265722|NCT00601172|4090417|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4265723|NCT00601172|4090415|B3||Male|Sex: Female, Male||Participants|Count of Participants|392|392.0||||||
4265724|NCT00601172|4090416|B2||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4265725|NCT00601172|4090417|B1||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4265726|NCT00601172|4090415|B3||Female|Sex: Female, Male||Participants|Count of Participants|318|318.0||||||
4265727|NCT00601172|4090416|B2||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4265728|NCT00601172|4090417|B1||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4265729|NCT00601172|4090415|B3|||Age|Age data is presented for modified Intent-to-Treat (mITT) Population which comprised of all participants who were randomized, received any investigational product and had oxaliplatin administered.|Years|Mean|61.3|61.3|Standard Deviation|10.90|10.9|||
4265730|NCT00601172|4090416|B2|||Age|Age data is presented for modified Intent-to-Treat (mITT) Population which comprised of all participants who were randomized, received any investigational product and had oxaliplatin administered.|Years|Mean|61.3|61.3|Standard Deviation|11.03|11.03|||
4265731|NCT00601172|4090417|B1|||Age|Age data is presented for modified Intent-to-Treat (mITT) Population which comprised of all participants who were randomized, received any investigational product and had oxaliplatin administered.|Years|Mean|61.3|61.3|Standard Deviation|10.77|10.77|||
4265732|NCT00601146|4090467|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4265733|NCT00601146|4090467|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4265734|NCT00601146|4090467|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4265735|NCT00601146|4090467|B1|||Age||years|Mean|51|51.0|Full Range|||38.0|65.0|
4265736|NCT00601146|4090467|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4265737|NCT00601146|4090467|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4265738|NCT00601146|4090467|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265739|NCT00601107|4090471|B5|Greater Than (>) 16||Week 0/Day 1 Psoriasis Area Severity Index (PASI) Score|PASI score: range: 0 (no disease) to 72 (maximal disease). Body was divided into head (h), trunk (t), upper (u) and lower (l) extremities. For each section, percent area of skin involved (A) was estimated: 1 (less than [<] 10%) to 6 (90% - 100%), and severity was estimated by clinical signs: (erythema [E], induration [I], and desquamation [D]) on a scale: 0=no symptoms, 4=very marked. PASI score= 0.1 (E[h] + I[h] + D[h]) A[h] + 0.2 (E[u] + I[u] + D[u]) A[u] + 0.3 (E[t] + I[t] + D[t]) A[t] + 0.4 (E[l] + l[I] + D[l]) A[l]. Number of participants with PASI score <=16 and >16 are reported.|participants|Number|50|50.0||||||
4265740|NCT00601107|4090472|B4|Greater Than (>) 16||Week 0/Day 1 Psoriasis Area Severity Index (PASI) Score|PASI score: range: 0 (no disease) to 72 (maximal disease). Body was divided into head (h), trunk (t), upper (u) and lower (l) extremities. For each section, percent area of skin involved (A) was estimated: 1 (less than [<] 10%) to 6 (90% - 100%), and severity was estimated by clinical signs: (erythema [E], induration [I], and desquamation [D]) on a scale: 0=no symptoms, 4=very marked. PASI score= 0.1 (E[h] + I[h] + D[h]) A[h] + 0.2 (E[u] + I[u] + D[u]) A[u] + 0.3 (E[t] + I[t] + D[t]) A[t] + 0.4 (E[l] + l[I] + D[l]) A[l]. Number of participants with PASI score <=16 and >16 are reported.|participants|Number|11|11.0||||||
4265741|NCT00601107|4090473|B3|Greater Than (>) 16||Week 0/Day 1 Psoriasis Area Severity Index (PASI) Score|PASI score: range: 0 (no disease) to 72 (maximal disease). Body was divided into head (h), trunk (t), upper (u) and lower (l) extremities. For each section, percent area of skin involved (A) was estimated: 1 (less than [<] 10%) to 6 (90% - 100%), and severity was estimated by clinical signs: (erythema [E], induration [I], and desquamation [D]) on a scale: 0=no symptoms, 4=very marked. PASI score= 0.1 (E[h] + I[h] + D[h]) A[h] + 0.2 (E[u] + I[u] + D[u]) A[u] + 0.3 (E[t] + I[t] + D[t]) A[t] + 0.4 (E[l] + l[I] + D[l]) A[l]. Number of participants with PASI score <=16 and >16 are reported.|participants|Number|12|12.0||||||
4265742|NCT00601107|4090474|B2|Greater Than (>) 16||Week 0/Day 1 Psoriasis Area Severity Index (PASI) Score|PASI score: range: 0 (no disease) to 72 (maximal disease). Body was divided into head (h), trunk (t), upper (u) and lower (l) extremities. For each section, percent area of skin involved (A) was estimated: 1 (less than [<] 10%) to 6 (90% - 100%), and severity was estimated by clinical signs: (erythema [E], induration [I], and desquamation [D]) on a scale: 0=no symptoms, 4=very marked. PASI score= 0.1 (E[h] + I[h] + D[h]) A[h] + 0.2 (E[u] + I[u] + D[u]) A[u] + 0.3 (E[t] + I[t] + D[t]) A[t] + 0.4 (E[l] + l[I] + D[l]) A[l]. Number of participants with PASI score <=16 and >16 are reported.|participants|Number|15|15.0||||||
4265769|NCT00601107|4090471|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4265770|NCT00601107|4090472|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4265771|NCT00601107|4090473|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4265743|NCT00601107|4090475|B1|Greater Than (>) 16||Week 0/Day 1 Psoriasis Area Severity Index (PASI) Score|PASI score: range: 0 (no disease) to 72 (maximal disease). Body was divided into head (h), trunk (t), upper (u) and lower (l) extremities. For each section, percent area of skin involved (A) was estimated: 1 (less than [<] 10%) to 6 (90% - 100%), and severity was estimated by clinical signs: (erythema [E], induration [I], and desquamation [D]) on a scale: 0=no symptoms, 4=very marked. PASI score= 0.1 (E[h] + I[h] + D[h]) A[h] + 0.2 (E[u] + I[u] + D[u]) A[u] + 0.3 (E[t] + I[t] + D[t]) A[t] + 0.4 (E[l] + l[I] + D[l]) A[l]. Number of participants with PASI score <=16 and >16 are reported.|participants|Number|12|12.0||||||
4265744|NCT00601107|4090471|B5|Less Than or Equal to (<=) 16||Week 0/Day 1 Psoriasis Area Severity Index (PASI) Score|PASI score: range: 0 (no disease) to 72 (maximal disease). Body was divided into head (h), trunk (t), upper (u) and lower (l) extremities. For each section, percent area of skin involved (A) was estimated: 1 (less than [<] 10%) to 6 (90% - 100%), and severity was estimated by clinical signs: (erythema [E], induration [I], and desquamation [D]) on a scale: 0=no symptoms, 4=very marked. PASI score= 0.1 (E[h] + I[h] + D[h]) A[h] + 0.2 (E[u] + I[u] + D[u]) A[u] + 0.3 (E[t] + I[t] + D[t]) A[t] + 0.4 (E[l] + l[I] + D[l]) A[l]. Number of participants with PASI score <=16 and >16 are reported.|participants|Number|61|61.0||||||
4265745|NCT00601107|4090472|B4|Less Than or Equal to (<=) 16||Week 0/Day 1 Psoriasis Area Severity Index (PASI) Score|PASI score: range: 0 (no disease) to 72 (maximal disease). Body was divided into head (h), trunk (t), upper (u) and lower (l) extremities. For each section, percent area of skin involved (A) was estimated: 1 (less than [<] 10%) to 6 (90% - 100%), and severity was estimated by clinical signs: (erythema [E], induration [I], and desquamation [D]) on a scale: 0=no symptoms, 4=very marked. PASI score= 0.1 (E[h] + I[h] + D[h]) A[h] + 0.2 (E[u] + I[u] + D[u]) A[u] + 0.3 (E[t] + I[t] + D[t]) A[t] + 0.4 (E[l] + l[I] + D[l]) A[l]. Number of participants with PASI score <=16 and >16 are reported.|participants|Number|14|14.0||||||
4265746|NCT00601107|4090473|B3|Less Than or Equal to (<=) 16||Week 0/Day 1 Psoriasis Area Severity Index (PASI) Score|PASI score: range: 0 (no disease) to 72 (maximal disease). Body was divided into head (h), trunk (t), upper (u) and lower (l) extremities. For each section, percent area of skin involved (A) was estimated: 1 (less than [<] 10%) to 6 (90% - 100%), and severity was estimated by clinical signs: (erythema [E], induration [I], and desquamation [D]) on a scale: 0=no symptoms, 4=very marked. PASI score= 0.1 (E[h] + I[h] + D[h]) A[h] + 0.2 (E[u] + I[u] + D[u]) A[u] + 0.3 (E[t] + I[t] + D[t]) A[t] + 0.4 (E[l] + l[I] + D[l]) A[l]. Number of participants with PASI score <=16 and >16 are reported.|participants|Number|16|16.0||||||
4265747|NCT00601107|4090474|B2|Less Than or Equal to (<=) 16||Week 0/Day 1 Psoriasis Area Severity Index (PASI) Score|PASI score: range: 0 (no disease) to 72 (maximal disease). Body was divided into head (h), trunk (t), upper (u) and lower (l) extremities. For each section, percent area of skin involved (A) was estimated: 1 (less than [<] 10%) to 6 (90% - 100%), and severity was estimated by clinical signs: (erythema [E], induration [I], and desquamation [D]) on a scale: 0=no symptoms, 4=very marked. PASI score= 0.1 (E[h] + I[h] + D[h]) A[h] + 0.2 (E[u] + I[u] + D[u]) A[u] + 0.3 (E[t] + I[t] + D[t]) A[t] + 0.4 (E[l] + l[I] + D[l]) A[l]. Number of participants with PASI score <=16 and >16 are reported.|participants|Number|16|16.0||||||
4265748|NCT00601107|4090475|B1|Less Than or Equal to (<=) 16||Week 0/Day 1 Psoriasis Area Severity Index (PASI) Score|PASI score: range: 0 (no disease) to 72 (maximal disease). Body was divided into head (h), trunk (t), upper (u) and lower (l) extremities. For each section, percent area of skin involved (A) was estimated: 1 (less than [<] 10%) to 6 (90% - 100%), and severity was estimated by clinical signs: (erythema [E], induration [I], and desquamation [D]) on a scale: 0=no symptoms, 4=very marked. PASI score= 0.1 (E[h] + I[h] + D[h]) A[h] + 0.2 (E[u] + I[u] + D[u]) A[u] + 0.3 (E[t] + I[t] + D[t]) A[t] + 0.4 (E[l] + l[I] + D[l]) A[l]. Number of participants with PASI score <=16 and >16 are reported.|participants|Number|15|15.0||||||
4265749|NCT00601107|4090471|B5|||Body Mass Index (BMI)|Body mass index was calculated by dividing body weight (kilogram) by the height (meters) squared.|kilogram per square meter (kg/m^2)|Mean|32.3|32.3|Standard Deviation|8.1|8.1|||
4265750|NCT00601107|4090472|B4|||Body Mass Index (BMI)|Body mass index was calculated by dividing body weight (kilogram) by the height (meters) squared.|kilogram per square meter (kg/m^2)|Mean|32.7|32.7|Standard Deviation|9.8|9.8|||
4265751|NCT00601107|4090473|B3|||Body Mass Index (BMI)|Body mass index was calculated by dividing body weight (kilogram) by the height (meters) squared.|kilogram per square meter (kg/m^2)|Mean|30.1|30.1|Standard Deviation|6.5|6.5|||
4265752|NCT00601107|4090474|B2|||Body Mass Index (BMI)|Body mass index was calculated by dividing body weight (kilogram) by the height (meters) squared.|kilogram per square meter (kg/m^2)|Mean|33.9|33.9|Standard Deviation|8.3|8.3|||
4265753|NCT00601107|4090475|B1|||Body Mass Index (BMI)|Body mass index was calculated by dividing body weight (kilogram) by the height (meters) squared.|kilogram per square meter (kg/m^2)|Mean|32.4|32.4|Standard Deviation|7.5|7.5|||
4265754|NCT00601107|4090471|B5|Multiple||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4265755|NCT00601107|4090472|B4|Multiple||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4265756|NCT00601107|4090473|B3|Multiple||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4265757|NCT00601107|4090474|B2|Multiple||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4265758|NCT00601107|4090475|B1|Multiple||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4265759|NCT00601107|4090471|B5|White||Race/Ethnicity, Customized||participants|Number|97|97.0||||||
4265760|NCT00601107|4090472|B4|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4265761|NCT00601107|4090473|B3|White||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4265762|NCT00601107|4090474|B2|White||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4265763|NCT00601107|4090475|B1|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4265764|NCT00601107|4090471|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4265765|NCT00601107|4090472|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4265766|NCT00601107|4090473|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4265767|NCT00601107|4090474|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4265768|NCT00601107|4090475|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4265834|NCT00600821|4090629|B2|Less than 18 years||Age, Customized||Participants|Number|0|0.0||||||
4265772|NCT00601107|4090474|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4265773|NCT00601107|4090475|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4265774|NCT00601107|4090471|B5|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4265775|NCT00601107|4090472|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4265776|NCT00601107|4090473|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4265777|NCT00601107|4090474|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4265778|NCT00601107|4090475|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4265779|NCT00601107|4090471|B5||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4265780|NCT00601107|4090472|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4265781|NCT00601107|4090473|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4265782|NCT00601107|4090474|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4265783|NCT00601107|4090475|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4265784|NCT00601107|4090471|B5||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4265785|NCT00601107|4090472|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4265786|NCT00601107|4090473|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4265787|NCT00601107|4090474|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4265788|NCT00601107|4090475|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4265789|NCT00601107|4090471|B5|||Age||years|Mean|44.5|44.5|Standard Deviation|13.6|13.6|||
4265790|NCT00601107|4090472|B4|||Age||years|Mean|44.2|44.2|Standard Deviation|16.3|16.3|||
4265791|NCT00601107|4090473|B3|||Age||years|Mean|49.9|49.9|Standard Deviation|12.6|12.6|||
4265792|NCT00601107|4090474|B2|||Age||years|Mean|40.5|40.5|Standard Deviation|12.4|12.4|||
4265793|NCT00601107|4090475|B1|||Age||years|Mean|44.0|44.0|Standard Deviation|11.9|11.9|||
4265794|NCT00600938|4090496|B3||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4265795|NCT00600938|4090497|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4265796|NCT00600938|4090498|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4265797|NCT00600938|4090496|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4265798|NCT00600938|4090497|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4265799|NCT00600938|4090498|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4265800|NCT00600938|4090496|B3|||Age||Years|Mean|19.8|19.8|Standard Deviation|6.41|6.41|||
4265801|NCT00600938|4090497|B2|||Age||Years|Mean|19.7|19.7|Standard Deviation|6.32|6.32|||
4265802|NCT00600938|4090498|B1|||Age||Years|Mean|19.9|19.9|Standard Deviation|6.53|6.53|||
4265803|NCT00600886|4090563|B3||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4265804|NCT00600886|4090564|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4265805|NCT00600886|4090565|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4265806|NCT00600886|4090563|B3||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4265807|NCT00600886|4090564|B2||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4265808|NCT00600886|4090565|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4265809|NCT00600886|4090563|B3|>=65 years||Age, Customized||Participants|Number|23|23.0||||||
4265810|NCT00600886|4090564|B2|>=65 years||Age, Customized||Participants|Number|15|15.0||||||
4265811|NCT00600886|4090565|B1|>=65 years||Age, Customized||Participants|Number|8|8.0||||||
4265812|NCT00600886|4090563|B3|<65 Years||Age, Customized||Participants|Number|335|335.0||||||
4265813|NCT00600886|4090564|B2|<65 Years||Age, Customized||Participants|Number|167|167.0||||||
4265814|NCT00600886|4090565|B1|<65 Years||Age, Customized||Participants|Number|168|168.0||||||
4265815|NCT00600886|4090563|B3|||Age||Years|Mean|45.4|45.4|Standard Deviation|12.67|12.67|||
4265816|NCT00600886|4090564|B2|||Age||Years|Mean|45.6|45.6|Standard Deviation|12.97|12.97|||
4265817|NCT00600886|4090565|B1|||Age||Years|Mean|45.1|45.1|Standard Deviation|12.37|12.37|||
4265818|NCT00600821|4090628|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4265819|NCT00600821|4090629|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4265820|NCT00600821|4090630|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4265821|NCT00600821|4090628|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4265822|NCT00600821|4090629|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4265823|NCT00600821|4090630|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4265824|NCT00600821|4090628|B3|Greater than or equal to 65 years||Age, Customized||Participants|Number|38|38.0||||||
4265825|NCT00600821|4090629|B2|Greater than or equal to 65 years||Age, Customized||Participants|Number|14|14.0||||||
4265826|NCT00600821|4090630|B1|Greater than or equal to 65 years||Age, Customized||Participants|Number|24|24.0||||||
4265827|NCT00600821|4090628|B3|45 to 64 years||Age, Customized||Participants|Number|77|77.0||||||
4265828|NCT00600821|4090629|B2|45 to 64 years||Age, Customized||Participants|Number|44|44.0||||||
4265829|NCT00600821|4090630|B1|45 to 64 years||Age, Customized||Participants|Number|33|33.0||||||
4265830|NCT00600821|4090628|B3|18 to 44 years||Age, Customized||Participants|Number|3|3.0||||||
4265831|NCT00600821|4090629|B2|18 to 44 years||Age, Customized||Participants|Number|2|2.0||||||
4265832|NCT00600821|4090630|B1|18 to 44 years||Age, Customized||Participants|Number|1|1.0||||||
4265833|NCT00600821|4090628|B3|Less than 18 years||Age, Customized||Participants|Number|0|0.0||||||
4265835|NCT00600821|4090630|B1|Less than 18 years||Age, Customized||Participants|Number|0|0.0||||||
4265836|NCT00600756|4090657|B3||Male|Sex: Female, Male||Participants|Count of Participants|465|465.0||||||
4265837|NCT00600756|4090658|B2||Male|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
4265838|NCT00600756|4090659|B1||Male|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
4265839|NCT00600756|4090657|B3||Female|Sex: Female, Male||Participants|Count of Participants|333|333.0||||||
4265840|NCT00600756|4090658|B2||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4265841|NCT00600756|4090659|B1||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4265842|NCT00600756|4090657|B3|||Age||Years|Mean|39.7|39.7|Standard Deviation|11.67|11.67|||
4265843|NCT00600756|4090658|B2|||Age||Years|Mean|40.0|40.0|Standard Deviation|11.66|11.66|||
4265844|NCT00600756|4090659|B1|||Age||Years|Mean|39.3|39.3|Standard Deviation|11.7|11.7|||
4265845|NCT00600743|4090726|B5|United States||Region of Enrollment||participants|Number|23|23.0||||||
4265846|NCT00600743|4090727|B4|United States||Region of Enrollment||participants|Number|7|7.0||||||
4265847|NCT00600743|4090728|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4265848|NCT00600743|4090729|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4265849|NCT00600743|4090730|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4265850|NCT00600743|4090726|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4265851|NCT00600743|4090727|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4265852|NCT00600743|4090728|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4265853|NCT00600743|4090729|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4265854|NCT00600743|4090730|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4265855|NCT00600743|4090726|B5||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4265856|NCT00600743|4090727|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4265857|NCT00600743|4090728|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4265858|NCT00600743|4090729|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4265859|NCT00600743|4090730|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4265860|NCT00600743|4090726|B5|||Age||years|Mean|24.65|24.65|Standard Deviation|3.94|3.94|||
4265861|NCT00600743|4090727|B4|||Age||years|Mean|24.00|24.0|Standard Deviation|11.64|11.64|||
4265862|NCT00600743|4090728|B3|||Age||years|Mean|23.75|23.75|Standard Deviation|10.77|10.77|||
4265863|NCT00600743|4090729|B2|||Age||years|Mean|26.25|26.25|Standard Deviation|3.0|3.0|||
4265864|NCT00600743|4090730|B1|||Age||years|Mean|26|26.0|Standard Deviation|10.96|10.96|||
4265865|NCT00600704|4090760|B3|Greece||Region of Enrollment||participants|Number|192|192.0||||||
4265866|NCT00600704|4090761|B2|Greece||Region of Enrollment||participants|Number|92|92.0||||||
4265867|NCT00600704|4090762|B1|Greece||Region of Enrollment||participants|Number|100|100.0||||||
4265868|NCT00600704|4090760|B3||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4265869|NCT00600704|4090761|B2||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4265870|NCT00600704|4090762|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4265871|NCT00600704|4090760|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4265872|NCT00600704|4090761|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4265873|NCT00600704|4090762|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4265874|NCT00600704|4090760|B3|||Age||years|Mean|65.77|65.77|Standard Deviation|8.1|8.1|||
4265875|NCT00600704|4090761|B2|||Age||years|Mean|65.5|65.5|Standard Deviation|8.3|8.3|||
4265876|NCT00600704|4090762|B1|||Age||years|Mean|66|66.0|Standard Deviation|7.9|7.9|||
4265877|NCT00600704|4090760|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4265878|NCT00600704|4090761|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4265879|NCT00600704|4090762|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4265880|NCT00600704|4090760|B3||Between 18 and 65 years|Age||Participants|Count of Participants|192|192.0||||||
4265881|NCT00600704|4090761|B2||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
4265882|NCT00600704|4090762|B1||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4265883|NCT00600704|4090760|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265884|NCT00600704|4090761|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265885|NCT00600704|4090762|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265886|NCT00600613|4090769|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4265887|NCT00600613|4090769|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4265888|NCT00600613|4090769|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4265889|NCT00600613|4090769|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4265890|NCT00600613|4090769|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265891|NCT00600353|4090773|B3|||emetic response, adverse events, quality of care||participants|Median|9|9.0|Full Range|||0.0|18.0|
4265892|NCT00600353|4090774|B2|||emetic response, adverse events, quality of care||participants|Median|9|9.0|Full Range|||0.0|9.0|
4265893|NCT00600353|4090775|B1|||emetic response, adverse events, quality of care||participants|Median|9|9.0|Full Range|||0.0|9.0|
4265894|NCT00600353|4090773|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4265895|NCT00600353|4090774|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4265896|NCT00600353|4090775|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4265897|NCT00600353|4090773|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4265898|NCT00600353|4090774|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4265899|NCT00600353|4090775|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4265900|NCT00600353|4090773|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4265901|NCT00600353|4090774|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4265902|NCT00600353|4090775|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4265903|NCT00600353|4090773|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4265904|NCT00600353|4090774|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4265905|NCT00600353|4090775|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4265906|NCT00600353|4090773|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4265907|NCT00600353|4090774|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4265908|NCT00600353|4090775|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4265909|NCT00600353|4090773|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265910|NCT00600353|4090774|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265911|NCT00600353|4090775|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4265912|NCT00600171|4090788|B7|Asian & White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4265913|NCT00600171|4090789|B6|Asian & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4265914|NCT00600171|4090790|B5|Asian & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4265915|NCT00600171|4090791|B4|Asian & White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4265916|NCT00600171|4090792|B3|Asian & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4265917|NCT00600171|4090793|B2|Asian & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4265918|NCT00600171|4090794|B1|Asian & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4265919|NCT00600171|4090788|B7|AmIn or AN & White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4265920|NCT00600171|4090789|B6|AmIn or AN & White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4265921|NCT00600171|4090790|B5|AmIn or AN & White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4265922|NCT00600171|4090791|B4|AmIn or AN & White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4265923|NCT00600171|4090792|B3|AmIn or AN & White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4265924|NCT00600171|4090793|B2|AmIn or AN & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4265925|NCT00600171|4090794|B1|AmIn or AN & White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4265926|NCT00600171|4090788|B7|AfAm/AfH & White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4265927|NCT00600171|4090789|B6|AfAm/AfH & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4265928|NCT00600171|4090790|B5|AfAm/AfH & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4265929|NCT00600171|4090791|B4|AfAm/AfH & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4265930|NCT00600171|4090792|B3|AfAm/AfH & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4265931|NCT00600171|4090793|B2|AfAm/AfH & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4265932|NCT00600171|4090794|B1|AfAm/AfH & White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4265933|NCT00600171|4090788|B7|AfAm/AfH & AmIn or AN||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4265934|NCT00600171|4090789|B6|AfAm/AfH & AmIn or AN||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4265935|NCT00600171|4090790|B5|AfAm/AfH & AmIn or AN||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4265936|NCT00600171|4090791|B4|AfAm/AfH & AmIn or AN||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4265937|NCT00600171|4090792|B3|AfAm/AfH & AmIn or AN||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4265938|NCT00600171|4090793|B2|AfAm/AfH & AmIn or AN||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4265939|NCT00600171|4090794|B1|AfAm/AfH & AmIn or AN||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4265940|NCT00600171|4090788|B7|White||Race/Ethnicity, Customized||participants|Number|465|465.0||||||
4265941|NCT00600171|4090789|B6|White||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
4265942|NCT00600171|4090790|B5|White||Race/Ethnicity, Customized||participants|Number|75|75.0||||||
4265943|NCT00600171|4090791|B4|White||Race/Ethnicity, Customized||participants|Number|75|75.0||||||
4265944|NCT00600171|4090792|B3|White||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
4265945|NCT00600171|4090793|B2|White||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
4265946|NCT00600171|4090794|B1|White||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
4265947|NCT00600171|4090788|B7|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4265948|NCT00600171|4090789|B6|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4265949|NCT00600171|4090790|B5|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4265950|NCT00600171|4090791|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4265951|NCT00600171|4090792|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4265952|NCT00600171|4090793|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4265953|NCT00600171|4090794|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4265954|NCT00600171|4090788|B7|Japanese/East Asian (EA) Her/South EA Her||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
4265955|NCT00600171|4090789|B6|Japanese/East Asian (EA) Her/South EA Her||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4265956|NCT00600171|4090790|B5|Japanese/East Asian (EA) Her/South EA Her||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4265957|NCT00600171|4090791|B4|Japanese/East Asian (EA) Her/South EA Her||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4265958|NCT00600171|4090792|B3|Japanese/East Asian (EA) Her/South EA Her||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4265959|NCT00600171|4090793|B2|Japanese/East Asian (EA) Her/South EA Her||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4265960|NCT00600171|4090794|B1|Japanese/East Asian (EA) Her/South EA Her||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4265961|NCT00600171|4090788|B7|Central/South Asian Heritage (Her)||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4265962|NCT00600171|4090789|B6|Central/South Asian Heritage (Her)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4265963|NCT00600171|4090790|B5|Central/South Asian Heritage (Her)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4265964|NCT00600171|4090791|B4|Central/South Asian Heritage (Her)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4265965|NCT00600171|4090792|B3|Central/South Asian Heritage (Her)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4265966|NCT00600171|4090793|B2|Central/South Asian Heritage (Her)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4265967|NCT00600171|4090794|B1|Central/South Asian Heritage (Her)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4265968|NCT00600171|4090788|B7|American Indian (AmIn) or Alaska Native (AN)||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4265969|NCT00600171|4090789|B6|American Indian (AmIn) or Alaska Native (AN)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4265970|NCT00600171|4090790|B5|American Indian (AmIn) or Alaska Native (AN)||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4265971|NCT00600171|4090791|B4|American Indian (AmIn) or Alaska Native (AN)||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4265972|NCT00600171|4090792|B3|American Indian (AmIn) or Alaska Native (AN)||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4265973|NCT00600171|4090793|B2|American Indian (AmIn) or Alaska Native (AN)||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4265974|NCT00600171|4090794|B1|American Indian (AmIn) or Alaska Native (AN)||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4265975|NCT00600171|4090788|B7|African American (AfAm)/African Heritage (AfH)||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
4265976|NCT00600171|4090789|B6|African American (AfAm)/African Heritage (AfH)||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4265977|NCT00600171|4090790|B5|African American (AfAm)/African Heritage (AfH)||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4265978|NCT00600171|4090791|B4|African American (AfAm)/African Heritage (AfH)||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4265979|NCT00600171|4090792|B3|African American (AfAm)/African Heritage (AfH)||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4265980|NCT00600171|4090793|B2|African American (AfAm)/African Heritage (AfH)||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4265981|NCT00600171|4090794|B1|African American (AfAm)/African Heritage (AfH)||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4265982|NCT00600171|4090788|B7||Male|Gender||Participants|Count of Participants|269|269.0||||||
4265983|NCT00600171|4090789|B6||Male|Gender||Participants|Count of Participants|45|45.0||||||
4265984|NCT00600171|4090790|B5||Male|Gender||Participants|Count of Participants|40|40.0||||||
4265985|NCT00600171|4090791|B4||Male|Gender||Participants|Count of Participants|44|44.0||||||
4265986|NCT00600171|4090792|B3||Male|Gender||Participants|Count of Participants|50|50.0||||||
4265987|NCT00600171|4090793|B2||Male|Gender||Participants|Count of Participants|49|49.0||||||
4265988|NCT00600171|4090794|B1||Male|Gender||Participants|Count of Participants|41|41.0||||||
4265989|NCT00600171|4090788|B7||Female|Gender||Participants|Count of Participants|338|338.0||||||
4265990|NCT00600171|4090789|B6||Female|Gender||Participants|Count of Participants|57|57.0||||||
4265991|NCT00600171|4090790|B5||Female|Gender||Participants|Count of Participants|61|61.0||||||
4265992|NCT00600171|4090791|B4||Female|Gender||Participants|Count of Participants|56|56.0||||||
4265993|NCT00600171|4090792|B3||Female|Gender||Participants|Count of Participants|51|51.0||||||
4265994|NCT00600171|4090793|B2||Female|Gender||Participants|Count of Participants|52|52.0||||||
4265995|NCT00600171|4090794|B1||Female|Gender||Participants|Count of Participants|61|61.0||||||
4265996|NCT00600171|4090788|B7|||Age||Years|Mean|42.4|42.4|Standard Deviation|14.72|14.72|||
4265997|NCT00600171|4090789|B6|||Age||Years|Mean|44.0|44.0|Standard Deviation|15.22|15.22|||
4265998|NCT00600171|4090790|B5|||Age||Years|Mean|42.2|42.2|Standard Deviation|14.27|14.27|||
4265999|NCT00600171|4090791|B4|||Age||Years|Mean|41.3|41.3|Standard Deviation|15.33|15.33|||
4266000|NCT00600171|4090792|B3|||Age||Years|Mean|42.4|42.4|Standard Deviation|14.13|14.13|||
4266001|NCT00600171|4090793|B2|||Age||Years|Mean|44.4|44.4|Standard Deviation|13.50|13.5|||
4266002|NCT00600171|4090794|B1|||Age||Years|Mean|39.9|39.9|Standard Deviation|15.60|15.6|||
4266003|NCT00600119|4090867|B7|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4266004|NCT00600119|4090868|B6|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4266005|NCT00600119|4090869|B5|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4266006|NCT00600119|4090870|B4|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4266007|NCT00600119|4090871|B3|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4266008|NCT00600119|4090872|B2|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4266009|NCT00600119|4090873|B1|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4266010|NCT00600119|4090867|B7|Not Allowed to Ask||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4266011|NCT00600119|4090868|B6|Not Allowed to Ask||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4266012|NCT00600119|4090869|B5|Not Allowed to Ask||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4266013|NCT00600119|4090870|B4|Not Allowed to Ask||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4266014|NCT00600119|4090871|B3|Not Allowed to Ask||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4266015|NCT00600119|4090872|B2|Not Allowed to Ask||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4266016|NCT00600119|4090873|B1|Not Allowed to Ask||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4266017|NCT00600119|4090867|B7|Black||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
4266018|NCT00600119|4090868|B6|Black||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4266019|NCT00600119|4090869|B5|Black||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4266020|NCT00600119|4090870|B4|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4266021|NCT00600119|4090871|B3|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4266022|NCT00600119|4090872|B2|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4266023|NCT00600119|4090873|B1|Black||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4266024|NCT00600119|4090867|B7|Caucasian||Race/Ethnicity, Customized||Participants|Number|160|160.0||||||
4266025|NCT00600119|4090868|B6|Caucasian||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
4266026|NCT00600119|4090869|B5|Caucasian||Race/Ethnicity, Customized||Participants|Number|31|31.0||||||
4266027|NCT00600119|4090870|B4|Caucasian||Race/Ethnicity, Customized||Participants|Number|26|26.0||||||
4266028|NCT00600119|4090871|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
4266029|NCT00600119|4090872|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|28|28.0||||||
4266030|NCT00600119|4090873|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
4266031|NCT00600119|4090867|B7||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4266032|NCT00600119|4090868|B6||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4266033|NCT00600119|4090869|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4266034|NCT00600119|4090870|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4266035|NCT00600119|4090871|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4266036|NCT00600119|4090872|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4266037|NCT00600119|4090873|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4266038|NCT00600119|4090867|B7||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4266039|NCT00600119|4090868|B6||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4266040|NCT00600119|4090869|B5||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4266041|NCT00600119|4090870|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4266042|NCT00600119|4090871|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4266043|NCT00600119|4090872|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4266044|NCT00600119|4090873|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4266045|NCT00600119|4090867|B7|||Age||Years|Mean|49.7|49.7|Standard Deviation|11.7|11.7|||
4266046|NCT00600119|4090868|B6|||Age||Years|Mean|49.6|49.6|Standard Deviation|11.0|11.0|||
4266047|NCT00600119|4090869|B5|||Age||Years|Mean|48.4|48.4|Standard Deviation|10.2|10.2|||
4266048|NCT00600119|4090870|B4|||Age||Years|Mean|51.8|51.8|Standard Deviation|11.4|11.4|||
4266049|NCT00600119|4090871|B3|||Age||Years|Mean|51.0|51.0|Standard Deviation|13.2|13.2|||
4266050|NCT00600119|4090872|B2|||Age||Years|Mean|50.3|50.3|Standard Deviation|13.1|13.1|||
4266051|NCT00600119|4090873|B1|||Age||Years|Mean|47.5|47.5|Standard Deviation|12.0|12.0|||
4266052|NCT00600106|4090910|B3|||Waist circumference||cm.|Mean|92.5|92.5|Standard Deviation|16|16.0|||
4266053|NCT00600106|4090911|B2|||Waist circumference||cm.|Mean|93|93.0|Standard Deviation|15|15.0|||
4266054|NCT00600106|4090912|B1|||Waist circumference||cm.|Mean|92|92.0|Standard Deviation|17|17.0|||
4266055|NCT00600106|4090910|B3|||Body Mass Index||kg/m^2|Mean|31|31.0|Standard Deviation|8|8.0|||
4266056|NCT00600106|4090911|B2|||Body Mass Index||kg/m^2|Mean|31|31.0|Standard Deviation|7|7.0|||
4266057|NCT00600106|4090912|B1|||Body Mass Index||kg/m^2|Mean|31|31.0|Standard Deviation|9|9.0|||
4266058|NCT00600106|4090910|B3|||Fasting Blood Sugar||mg/dl|Mean|93.5|93.5|Standard Deviation|18.5|18.5|||
4266059|NCT00600106|4090911|B2|||Fasting Blood Sugar||mg/dl|Mean|94|94.0|Standard Deviation|20|20.0|||
4266060|NCT00600106|4090912|B1|||Fasting Blood Sugar||mg/dl|Mean|93|93.0|Standard Deviation|17|17.0|||
4266061|NCT00600106|4090910|B3|||Pulse||beats per minute|Mean|72|72.0|Standard Deviation|9.5|9.5|||
4266062|NCT00600106|4090911|B2|||Pulse||beats per minute|Mean|76|76.0|Standard Deviation|11|11.0|||
4266063|NCT00600106|4090912|B1|||Pulse||beats per minute|Mean|68|68.0|Standard Deviation|8|8.0|||
4266064|NCT00600106|4090910|B3|||Diastolic Blood Pressure||mmHg|Mean|77|77.0|Standard Deviation|11|11.0|||
4266065|NCT00600106|4090911|B2|||Diastolic Blood Pressure||mmHg|Mean|78|78.0|Standard Deviation|9|9.0|||
4266066|NCT00600106|4090912|B1|||Diastolic Blood Pressure||mmHg|Mean|76|76.0|Standard Deviation|13|13.0|||
4266067|NCT00600106|4090910|B3|||Systolic Blood Pressure||mmHg|Mean|133|133.0|Standard Deviation|18|18.0|||
4266068|NCT00600106|4090911|B2|||Systolic Blood Pressure||mmHg|Mean|136|136.0|Standard Deviation|18|18.0|||
4266069|NCT00600106|4090912|B1|||Systolic Blood Pressure||mmHg|Mean|130|130.0|Standard Deviation|18|18.0|||
4266070|NCT00600106|4090910|B3|||Triglycerides||mg/dl|Mean|133|133.0|Standard Deviation|78|78.0|||
4266071|NCT00600106|4090911|B2|||Triglycerides||mg/dl|Mean|134|134.0|Standard Deviation|64|64.0|||
4266072|NCT00600106|4090912|B1|||Triglycerides||mg/dl|Mean|132|132.0|Standard Deviation|92|92.0|||
4266073|NCT00600106|4090910|B3|||LDL-Cholesterol||mg/dl|Mean|122|122.0|Standard Deviation|44.5|44.5|||
4266074|NCT00600106|4090911|B2|||LDL-Cholesterol||mg/dl|Mean|124|124.0|Standard Deviation|38|38.0|||
4266075|NCT00600106|4090912|B1|||LDL-Cholesterol||mg/dl|Mean|120|120.0|Standard Deviation|51|51.0|||
4266076|NCT00600106|4090910|B3|||HDL-Cholesterol||mg/dl|Mean|51|51.0|Standard Deviation|12.5|12.5|||
4266077|NCT00600106|4090911|B2|||HDL-Cholesterol||mg/dl|Mean|54|54.0|Standard Deviation|9|9.0|||
4266078|NCT00600106|4090912|B1|||HDL-Cholesterol||mg/dl|Mean|48|48.0|Standard Deviation|16|16.0|||
4266079|NCT00600106|4090910|B3|||Total Cholesterol||mg/dl|Mean|200|200.0|Standard Deviation|43|43.0|||
4266080|NCT00600106|4090911|B2|||Total Cholesterol||mg/dl|Mean|205|205.0|Standard Deviation|39|39.0|||
4266081|NCT00600106|4090912|B1|||Total Cholesterol||mg/dl|Mean|195|195.0|Standard Deviation|47|47.0|||
4266082|NCT00600106|4090910|B3|No smoking||Current Smoking||participants|Number|33|33.0||||||
4266083|NCT00600106|4090911|B2|No smoking||Current Smoking||participants|Number|17|17.0||||||
4266084|NCT00600106|4090912|B1|No smoking||Current Smoking||participants|Number|16|16.0||||||
4266085|NCT00600106|4090910|B3|Smoking||Current Smoking||participants|Number|4|4.0||||||
4266086|NCT00600106|4090911|B2|Smoking||Current Smoking||participants|Number|2|2.0||||||
4266087|NCT00600106|4090912|B1|Smoking||Current Smoking||participants|Number|2|2.0||||||
4266088|NCT00600106|4090910|B3|Normal values||History of Dyslipidemia||participants|Number|19|19.0||||||
4266089|NCT00600106|4090911|B2|Normal values||History of Dyslipidemia||participants|Number|12|12.0||||||
4266090|NCT00600106|4090912|B1|Normal values||History of Dyslipidemia||participants|Number|7|7.0||||||
4266091|NCT00600106|4090910|B3|Dyslipidemia||History of Dyslipidemia||participants|Number|18|18.0||||||
4266092|NCT00600106|4090911|B2|Dyslipidemia||History of Dyslipidemia||participants|Number|7|7.0||||||
4266093|NCT00600106|4090912|B1|Dyslipidemia||History of Dyslipidemia||participants|Number|11|11.0||||||
4266094|NCT00600106|4090910|B3|No Diabetes||History of Diabetes||participants|Number|28|28.0||||||
4266095|NCT00600106|4090911|B2|No Diabetes||History of Diabetes||participants|Number|14|14.0||||||
4266096|NCT00600106|4090912|B1|No Diabetes||History of Diabetes||participants|Number|14|14.0||||||
4266097|NCT00600106|4090910|B3|History of Diabetes||History of Diabetes||participants|Number|9|9.0||||||
4266098|NCT00600106|4090911|B2|History of Diabetes||History of Diabetes||participants|Number|5|5.0||||||
4266099|NCT00600106|4090912|B1|History of Diabetes||History of Diabetes||participants|Number|4|4.0||||||
4266100|NCT00600106|4090910|B3|Normal blood pressure||History of Hypertension||participants|Number|18|18.0||||||
4266101|NCT00600106|4090911|B2|Normal blood pressure||History of Hypertension||participants|Number|5|5.0||||||
4266102|NCT00600106|4090912|B1|Normal blood pressure||History of Hypertension||participants|Number|13|13.0||||||
4266103|NCT00600106|4090910|B3|Hypertension||History of Hypertension||participants|Number|19|19.0||||||
4266104|NCT00600106|4090911|B2|Hypertension||History of Hypertension||participants|Number|14|14.0||||||
4266105|NCT00600106|4090912|B1|Hypertension||History of Hypertension||participants|Number|5|5.0||||||
4266106|NCT00600106|4090910|B3|No HT prior to entry||Current HT use prior to entry||participants|Number|23|23.0||||||
4266107|NCT00600106|4090911|B2|No HT prior to entry||Current HT use prior to entry||participants|Number|11|11.0||||||
4266108|NCT00600106|4090912|B1|No HT prior to entry||Current HT use prior to entry||participants|Number|12|12.0||||||
4266109|NCT00600106|4090910|B3|Current HT use prior to entry||Current HT use prior to entry||participants|Number|14|14.0||||||
4266110|NCT00600106|4090911|B2|Current HT use prior to entry||Current HT use prior to entry||participants|Number|8|8.0||||||
4266111|NCT00600106|4090912|B1|Current HT use prior to entry||Current HT use prior to entry||participants|Number|6|6.0||||||
4266112|NCT00600106|4090910|B3|College||Education||participants|Number|14|14.0||||||
4266113|NCT00600106|4090911|B2|College||Education||participants|Number|6|6.0||||||
4266114|NCT00600106|4090912|B1|College||Education||participants|Number|8|8.0||||||
4266115|NCT00600106|4090910|B3|High school or less||Education||participants|Number|23|23.0||||||
4266116|NCT00600106|4090911|B2|High school or less||Education||participants|Number|13|13.0||||||
4266117|NCT00600106|4090912|B1|High school or less||Education||participants|Number|10|10.0||||||
4266118|NCT00600106|4090910|B3|White||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4266119|NCT00600106|4090911|B2|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4266120|NCT00600106|4090912|B1|White||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4266121|NCT00600106|4090910|B3|Nonwhite||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4266122|NCT00600106|4090911|B2|Nonwhite||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4266123|NCT00600106|4090912|B1|Nonwhite||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4266124|NCT00600106|4090910|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4266125|NCT00600106|4090911|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4266126|NCT00600106|4090912|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4266127|NCT00600106|4090910|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4266128|NCT00600106|4090911|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4266129|NCT00600106|4090912|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4266130|NCT00600106|4090910|B3|||Age||years|Mean|57.5|57.5|Standard Deviation|8|8.0|||
4266131|NCT00600106|4090911|B2|||Age||years|Mean|59|59.0|Standard Deviation|7|7.0|||
4266132|NCT00600106|4090912|B1|||Age||years|Mean|56|56.0|Standard Deviation|9|9.0|||
4266133|NCT00600080|4090945|B1|United Kingdom||Region of Enrollment||participants|Number|60|60.0||||||
4266134|NCT00600080|4090945|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4266135|NCT00600080|4090945|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4266136|NCT00600080|4090945|B1|||Age||years|Mean|29.6|29.6|Standard Deviation|8.6|8.6|||
4266137|NCT00600067|4090958|B3|United States||Region of Enrollment||participants|Number|130|130.0||||||
4266138|NCT00600067|4090959|B2|United States||Region of Enrollment||participants|Number|75|75.0||||||
4266139|NCT00600067|4090960|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4266140|NCT00600067|4090958|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4266141|NCT00600067|4090959|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4266142|NCT00600067|4090960|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4266143|NCT00600067|4090958|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4266144|NCT00600067|4090959|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4266145|NCT00600067|4090960|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4266146|NCT00600067|4090958|B3|||Age||years|Mean|49.6|49.6|Standard Deviation|7.95|7.95|||
4266147|NCT00600067|4090959|B2|||Age||years|Mean|49.7|49.7|Standard Deviation|7.51|7.51|||
4266148|NCT00600067|4090960|B1|||Age||years|Mean|49.5|49.5|Standard Deviation|8.58|8.58|||
4266149|NCT00600028|4090969|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4266150|NCT00600028|4090970|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4266151|NCT00600028|4090971|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4266152|NCT00600028|4090969|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4266153|NCT00600028|4090970|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4266154|NCT00600028|4090971|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4266155|NCT00600028|4090969|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4266156|NCT00600028|4090970|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4266157|NCT00600028|4090971|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4266158|NCT00600028|4090969|B3|||Age||years|Mean|67.8|67.8|Standard Deviation|7.8|7.8|||
4266159|NCT00600028|4090970|B2|||Age||years|Mean|65.55|65.55|Standard Deviation|7.38|7.38|||
4266160|NCT00600028|4090971|B1|||Age||years|Mean|70.5|70.5|Standard Deviation|7.11|7.11|||
4266161|NCT00600028|4090969|B3||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4266162|NCT00600028|4090970|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4266163|NCT00600028|4090971|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4266164|NCT00600028|4090969|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4266165|NCT00600028|4090970|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4266166|NCT00600028|4090971|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4266167|NCT00600028|4090969|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266168|NCT00600028|4090970|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266169|NCT00600028|4090971|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266170|NCT00600015|4090984|B3|United States||Region of Enrollment||participants|Number|166|166.0||||||
4266171|NCT00600015|4090985|B2|United States||Region of Enrollment||participants|Number|55|55.0||||||
4266172|NCT00600015|4090986|B1|United States||Region of Enrollment||participants|Number|111|111.0||||||
4266173|NCT00600015|4090984|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4266174|NCT00600015|4090985|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4266175|NCT00600015|4090986|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4266176|NCT00600015|4090984|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4266177|NCT00600015|4090985|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4266178|NCT00600015|4090986|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4266179|NCT00600015|4090984|B3|||Age||years|Median|65|65.0|Full Range|||44.0|88.0|
4266180|NCT00600015|4090985|B2|||Age||years|Median|65|65.0|Full Range|||45.0|83.0|
4266181|NCT00600015|4090986|B1|||Age||years|Median|65|65.0|Full Range|||44.0|88.0|
4266182|NCT00599924|4090995|B8||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4266183|NCT00599924|4090996|B7||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4266184|NCT00599924|4090997|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4266185|NCT00599924|4090998|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4266186|NCT00599924|4090999|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4266187|NCT00599924|4091000|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4266188|NCT00599924|4091001|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4266189|NCT00599924|4091002|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4266190|NCT00599924|4090995|B8||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4266191|NCT00599924|4090996|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4266192|NCT00599924|4090997|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4266193|NCT00599924|4090998|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4266194|NCT00599924|4090999|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4266195|NCT00599924|4091000|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4266196|NCT00599924|4091001|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4266197|NCT00599924|4091002|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4266198|NCT00599924|4090995|B8|> = 65 years||Age, Customized||participants|Number|16|16.0||||||
4266199|NCT00599924|4090996|B7|> = 65 years||Age, Customized||participants|Number|3|3.0||||||
4266200|NCT00599924|4090997|B6|> = 65 years||Age, Customized||participants|Number|0|0.0||||||
4266201|NCT00599924|4090998|B5|> = 65 years||Age, Customized||participants|Number|3|3.0||||||
4266202|NCT00599924|4090999|B4|> = 65 years||Age, Customized||participants|Number|5|5.0||||||
4266203|NCT00599924|4091000|B3|> = 65 years||Age, Customized||participants|Number|0|0.0||||||
4266204|NCT00599924|4091001|B2|> = 65 years||Age, Customized||participants|Number|3|3.0||||||
4266205|NCT00599924|4091002|B1|> = 65 years||Age, Customized||participants|Number|2|2.0||||||
4266206|NCT00599924|4090995|B8|< 65 years||Age, Customized||participants|Number|37|37.0||||||
4266207|NCT00599924|4090996|B7|< 65 years||Age, Customized||participants|Number|5|5.0||||||
4266208|NCT00599924|4090997|B6|< 65 years||Age, Customized||participants|Number|6|6.0||||||
4266209|NCT00599924|4090998|B5|< 65 years||Age, Customized||participants|Number|6|6.0||||||
4266210|NCT00599924|4090999|B4|< 65 years||Age, Customized||participants|Number|7|7.0||||||
4266211|NCT00599924|4091000|B3|< 65 years||Age, Customized||participants|Number|5|5.0||||||
4266212|NCT00599924|4091001|B2|< 65 years||Age, Customized||participants|Number|6|6.0||||||
4266213|NCT00599924|4091002|B1|< 65 years||Age, Customized||participants|Number|2|2.0||||||
4266214|NCT00599872|4091093|B3|United States||Region of Enrollment||participants|Number|430|430.0||||||
4266215|NCT00599872|4091094|B2|United States||Region of Enrollment||participants|Number|214|214.0||||||
4266216|NCT00599872|4091095|B1|United States||Region of Enrollment||participants|Number|216|216.0||||||
4266217|NCT00599872|4091093|B3||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4266218|NCT00599872|4091094|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4266219|NCT00599872|4091095|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4266220|NCT00599872|4091093|B3||Female|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
4266221|NCT00599872|4091094|B2||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4266222|NCT00599872|4091095|B1||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4266223|NCT00599872|4091093|B3|||Age||years|Mean|35.6|35.6|Standard Deviation|9.38|9.38|||
4266224|NCT00599872|4091094|B2|||Age||years|Mean|35.5|35.5|Standard Deviation|9.24|9.24|||
4266225|NCT00599872|4091095|B1|||Age||years|Mean|35.8|35.8|Standard Deviation|9.54|9.54|||
4266226|NCT00599872|4091093|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4266227|NCT00599872|4091094|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4266228|NCT00599872|4091095|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4266229|NCT00599872|4091093|B3||Between 18 and 65 years|Age||Participants|Count of Participants|430|430.0||||||
4266230|NCT00599872|4091094|B2||Between 18 and 65 years|Age||Participants|Count of Participants|214|214.0||||||
4266231|NCT00599872|4091095|B1||Between 18 and 65 years|Age||Participants|Count of Participants|216|216.0||||||
4266232|NCT00599872|4091093|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266233|NCT00599872|4091094|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266234|NCT00599872|4091095|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266235|NCT00599755|4091112|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4266236|NCT00599755|4091112|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4266237|NCT00599755|4091112|B1|||Age||years|Mean|62.9|62.9|Standard Deviation|8.6|8.6|||
4266238|NCT00599521|4091121|B3|Canada||Region of Enrollment||participants|Number|95|95.0||||||
4266239|NCT00599521|4091122|B2|Canada||Region of Enrollment||participants|Number|47|47.0||||||
4266240|NCT00599521|4091123|B1|Canada||Region of Enrollment||participants|Number|48|48.0||||||
4266241|NCT00599521|4091121|B3|United States||Region of Enrollment||participants|Number|971|971.0||||||
4266242|NCT00599521|4091122|B2|United States||Region of Enrollment||participants|Number|484|484.0||||||
4266243|NCT00599521|4091123|B1|United States||Region of Enrollment||participants|Number|487|487.0||||||
4266244|NCT00599521|4091121|B3||Male|Sex: Female, Male||Participants|Count of Participants|494|494.0||||||
4266245|NCT00599521|4091122|B2||Male|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
4266246|NCT00599521|4091123|B1||Male|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4266247|NCT00599521|4091121|B3||Female|Sex: Female, Male||Participants|Count of Participants|572|572.0||||||
4266248|NCT00599521|4091122|B2||Female|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
4266249|NCT00599521|4091123|B1||Female|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
4266250|NCT00599521|4091121|B3|||Age||years|Mean|19.15|19.15|Standard Deviation|7.05|7.05|||
4266251|NCT00599521|4091122|B2|||Age||years|Mean|19.2|19.2|Standard Deviation|7.3|7.3|||
4266252|NCT00599521|4091123|B1|||Age||years|Mean|19.1|19.1|Standard Deviation|6.8|6.8|||
4266253|NCT00599521|4091121|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4266254|NCT00599521|4091122|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4266255|NCT00599521|4091123|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4266256|NCT00599521|4091121|B3||Between 18 and 65 years|Age||Participants|Count of Participants|392|392.0||||||
4266257|NCT00599521|4091122|B2||Between 18 and 65 years|Age||Participants|Count of Participants|195|195.0||||||
4266258|NCT00599521|4091123|B1||Between 18 and 65 years|Age||Participants|Count of Participants|197|197.0||||||
4266259|NCT00599521|4091121|B3||<=18 years|Age||Participants|Count of Participants|674|674.0||||||
4266260|NCT00599521|4091122|B2||<=18 years|Age||Participants|Count of Participants|336|336.0||||||
4266261|NCT00599521|4091123|B1||<=18 years|Age||Participants|Count of Participants|338|338.0||||||
4266262|NCT00599339|4091138|B1||Male|Sex: Female, Male||Participants|Count of Participants|1203|1203.0||||||
4266263|NCT00599339|4091138|B1||Female|Sex: Female, Male||Participants|Count of Participants|956|956.0||||||
4266264|NCT00599339|4091138|B1|||Age||years|Mean|67.7|67.7|Standard Deviation|9.4|9.4|||
4266265|NCT00599339|4091138|B1||>=65 years|Age||Participants|Count of Participants|1435|1435.0||||||
4266266|NCT00599339|4091138|B1||Between 18 and 65 years|Age||Participants|Count of Participants|724|724.0||||||
4266267|NCT00599339|4091138|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266268|NCT00599326|4091240|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4266269|NCT00599326|4091240|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4266270|NCT00599326|4091240|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4266271|NCT00599326|4091240|B1|||Age||years|Mean|53.7|53.7|Standard Deviation|5.907622195|5.907622195|||
4266272|NCT00599326|4091240|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4266273|NCT00599326|4091240|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4266274|NCT00599326|4091240|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266275|NCT00599313|4091245|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4266276|NCT00599313|4091245|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4266277|NCT00599313|4091245|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4266278|NCT00599313|4091245|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4266279|NCT00599313|4091245|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4266280|NCT00599313|4091245|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4266281|NCT00599313|4091245|B1|||Age||years|Mean|70.0|70.0|Standard Deviation|9.34|9.34|||
4266282|NCT00599248|4091254|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4266283|NCT00599248|4091255|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4266284|NCT00599248|4091256|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4266285|NCT00599248|4091254|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4266286|NCT00599248|4091255|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4266287|NCT00599248|4091256|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4266288|NCT00599248|4091254|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4266289|NCT00599248|4091255|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4266290|NCT00599248|4091256|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4266291|NCT00599248|4091254|B3|||Age||Years|Median|60.5|60.5|Full Range|||36.0|67.0|
4266292|NCT00599248|4091255|B2|||Age||Years|Median|60.0|60.0|Full Range|||36.0|61.0|
4266293|NCT00599248|4091256|B1|||Age||Years|Median|61.0|61.0|Full Range|||39.0|67.0|
4266294|NCT00599248|4091254|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4266295|NCT00599248|4091255|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4266296|NCT00599248|4091256|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4266297|NCT00599248|4091254|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4266298|NCT00599248|4091255|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4266299|NCT00599248|4091256|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4266300|NCT00599248|4091254|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266301|NCT00599248|4091255|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266302|NCT00599248|4091256|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266303|NCT00599196|4091287|B1|Sweden||Region of Enrollment||participants|Number|12|12.0||||||
4266304|NCT00599196|4091287|B1|New Zealand||Region of Enrollment||participants|Number|19|19.0||||||
4266305|NCT00599196|4091287|B1|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
4266306|NCT00599196|4091287|B1|Norway||Region of Enrollment||participants|Number|4|4.0||||||
4266307|NCT00599196|4091287|B1|Germany||Region of Enrollment||participants|Number|7|7.0||||||
4266308|NCT00599196|4091287|B1|South Africa||Region of Enrollment||participants|Number|42|42.0||||||
4266309|NCT00599196|4091287|B1|Australia||Region of Enrollment||participants|Number|7|7.0||||||
4266310|NCT00599196|4091287|B1|Croatia||Region of Enrollment||participants|Number|17|17.0||||||
4266311|NCT00599196|4091287|B1|Belgium||Region of Enrollment||participants|Number|12|12.0||||||
4266312|NCT00599196|4091287|B1|Poland||Region of Enrollment||participants|Number|65|65.0||||||
4266313|NCT00599196|4091287|B1|Hungary||Region of Enrollment||participants|Number|17|17.0||||||
4266314|NCT00599196|4091287|B1|Czech Republic||Region of Enrollment||participants|Number|44|44.0||||||
4266315|NCT00599196|4091287|B1|France||Region of Enrollment||participants|Number|10|10.0||||||
4266316|NCT00599196|4091287|B1|Switzerland||Region of Enrollment||participants|Number|4|4.0||||||
4266317|NCT00599196|4091287|B1|Italy||Region of Enrollment||participants|Number|9|9.0||||||
4266318|NCT00599196|4091287|B1|United Kingdom||Region of Enrollment||participants|Number|38|38.0||||||
4266319|NCT00599196|4091287|B1|Israel||Region of Enrollment||participants|Number|30|30.0||||||
4266320|NCT00599196|4091287|B1|Austria||Region of Enrollment||participants|Number|12|12.0||||||
4266321|NCT00599196|4091287|B1|Spain||Region of Enrollment||participants|Number|10|10.0||||||
4266322|NCT00599196|4091287|B1|Finland||Region of Enrollment||participants|Number|16|16.0||||||
4266323|NCT00599196|4091287|B1||Male|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4266324|NCT00599196|4091287|B1||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4266325|NCT00599196|4091287|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|10.0|10.0|||
4266326|NCT00599196|4091287|B1||>=65 years|Age|Of the 381 subjects who entered the study, 380 are included in this summary based on the Safety Set (SS). One subject was excluded from the Safety Set because he withdrew consent prior to receiving any Open Label study medication.|Participants|Count of Participants|165|165.0||||||
4266327|NCT00599196|4091287|B1||Between 18 and 65 years|Age|Of the 381 subjects who entered the study, 380 are included in this summary based on the Safety Set (SS). One subject was excluded from the Safety Set because he withdrew consent prior to receiving any Open Label study medication.|Participants|Count of Participants|215|215.0||||||
4266328|NCT00599196|4091287|B1||<=18 years|Age|Of the 381 subjects who entered the study, 380 are included in this summary based on the Safety Set (SS). One subject was excluded from the Safety Set because he withdrew consent prior to receiving any Open Label study medication.|Participants|Count of Participants|0|0.0||||||
4266329|NCT00599131|4091293|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4266330|NCT00599131|4091293|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4266331|NCT00599131|4091293|B1|||Age||years|Mean|54|54.0|Full Range|||37.0|74.0|
4266332|NCT00599053|4091301|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4266333|NCT00599053|4091302|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4266334|NCT00599053|4091303|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4266335|NCT00599053|4091301|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4266336|NCT00599053|4091302|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4266337|NCT00599053|4091303|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4266338|NCT00599053|4091301|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4266339|NCT00599053|4091302|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4266340|NCT00599053|4091303|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4266341|NCT00599053|4091301|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4266342|NCT00599053|4091302|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4266343|NCT00599053|4091303|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4266344|NCT00599053|4091301|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4266345|NCT00599053|4091302|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4266346|NCT00599053|4091303|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4266347|NCT00599053|4091301|B3||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4266348|NCT00599053|4091302|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4266349|NCT00599053|4091303|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4266350|NCT00599027|4091316|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4266351|NCT00599027|4091317|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4266352|NCT00599027|4091318|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4266353|NCT00599027|4091316|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4266354|NCT00599027|4091317|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4266355|NCT00599027|4091318|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4266356|NCT00599027|4091316|B3|||Age||years|Mean|41.7|41.7|Standard Deviation|14.97|14.97|||
4266357|NCT00599027|4091317|B2|||Age||years|Mean|43.0|43.0|Standard Deviation|16.62|16.62|||
4266358|NCT00599027|4091318|B1|||Age||years|Mean|40.5|40.5|Standard Deviation|13.42|13.42|||
4266359|NCT00599014|4091325|B1|United States||Region of Enrollment||participants|Number|335|335.0||||||
4266360|NCT00599014|4091325|B1||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4266361|NCT00599014|4091325|B1||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4266362|NCT00599014|4091325|B1|||Age||years|Mean|57.3|57.3|Standard Deviation|11.2|11.2|||
4266363|NCT00599014|4091325|B1||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
4266364|NCT00599014|4091325|B1||Between 18 and 65 years|Age||Participants|Count of Participants|300|300.0||||||
4266365|NCT00599014|4091325|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266366|NCT00598871|4091330|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4266367|NCT00598871|4091331|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4266368|NCT00598871|4091332|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4266369|NCT00598871|4091330|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4266370|NCT00598871|4091331|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4266371|NCT00598871|4091332|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4266372|NCT00598871|4091330|B3|||Age||years|Mean|49.4|49.4|Standard Deviation|13.4|13.4|||
4266373|NCT00598871|4091331|B2|||Age||years|Mean|51.4|51.4|Standard Deviation|15.0|15.0|||
4266374|NCT00598871|4091332|B1|||Age||years|Mean|43.3|43.3|Standard Deviation|3.1|3.1|||
4266375|NCT00598832|4091341|B3|Canada||Region of Enrollment||participants|Number|144|144.0||||||
4266376|NCT00598832|4091342|B2|Canada||Region of Enrollment||participants|Number|74|74.0||||||
4266377|NCT00598832|4091343|B1|Canada||Region of Enrollment||participants|Number|70|70.0||||||
4266378|NCT00598832|4091341|B3|United States||Region of Enrollment||participants|Number|931|931.0||||||
4266379|NCT00598832|4091342|B2|United States||Region of Enrollment||participants|Number|468|468.0||||||
4266380|NCT00598832|4091343|B1|United States||Region of Enrollment||participants|Number|463|463.0||||||
4266381|NCT00598832|4091341|B3||Male|Sex: Female, Male||Participants|Count of Participants|502|502.0||||||
4266382|NCT00598832|4091342|B2||Male|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
4266383|NCT00598832|4091343|B1||Male|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
4266384|NCT00598832|4091341|B3||Female|Sex: Female, Male||Participants|Count of Participants|573|573.0||||||
4266385|NCT00598832|4091342|B2||Female|Sex: Female, Male||Participants|Count of Participants|290|290.0||||||
4266386|NCT00598832|4091343|B1||Female|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
4266387|NCT00598832|4091341|B3|||Age||years|Mean|19.2|19.2|Standard Deviation|6.8|6.8|||
4266388|NCT00598832|4091342|B2|||Age||years|Mean|18.9|18.9|Standard Deviation|6.5|6.5|||
4266389|NCT00598832|4091343|B1|||Age||years|Mean|19.5|19.5|Standard Deviation|7.1|7.1|||
4266390|NCT00598832|4091341|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4266391|NCT00598832|4091342|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4266392|NCT00598832|4091343|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4266393|NCT00598832|4091341|B3||Between 18 and 65 years|Age||Participants|Count of Participants|405|405.0||||||
4266394|NCT00598832|4091342|B2||Between 18 and 65 years|Age||Participants|Count of Participants|199|199.0||||||
4266395|NCT00598832|4091343|B1||Between 18 and 65 years|Age||Participants|Count of Participants|206|206.0||||||
4266396|NCT00598832|4091341|B3||<=18 years|Age||Participants|Count of Participants|670|670.0||||||
4266397|NCT00598832|4091342|B2||<=18 years|Age||Participants|Count of Participants|343|343.0||||||
4266398|NCT00598832|4091343|B1||<=18 years|Age||Participants|Count of Participants|327|327.0||||||
4266399|NCT00598819|4091358|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4266400|NCT00598819|4091358|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4266401|NCT00598819|4091358|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4266402|NCT00598819|4091358|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4266403|NCT00598819|4091358|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4266404|NCT00598819|4091358|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266405|NCT00598806|4091366|B3|Poland||Region of Enrollment||participants|Number|207|207.0||||||
4266406|NCT00598806|4091367|B2|Poland||Region of Enrollment||participants|Number|102|102.0||||||
4266407|NCT00598806|4091368|B1|Poland||Region of Enrollment||participants|Number|105|105.0||||||
4266408|NCT00598806|4091366|B3|United States||Region of Enrollment||participants|Number|167|167.0||||||
4266409|NCT00598806|4091367|B2|United States||Region of Enrollment||participants|Number|85|85.0||||||
4266410|NCT00598806|4091368|B1|United States||Region of Enrollment||participants|Number|82|82.0||||||
4266411|NCT00598806|4091366|B3|Canada||Region of Enrollment||participants|Number|438|438.0||||||
4266412|NCT00598806|4091367|B2|Canada||Region of Enrollment||participants|Number|223|223.0||||||
4266413|NCT00598806|4091368|B1|Canada||Region of Enrollment||participants|Number|215|215.0||||||
4266414|NCT00598806|4091366|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266415|NCT00598806|4091367|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266416|NCT00598806|4091368|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266417|NCT00598806|4091366|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4266418|NCT00598806|4091367|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4266419|NCT00598806|4091368|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266420|NCT00598806|4091366|B3||White|Race (NIH/OMB)||Participants|Count of Participants|792|792.0||||||
4266421|NCT00598806|4091367|B2||White|Race (NIH/OMB)||Participants|Count of Participants|400|400.0||||||
4266422|NCT00598806|4091368|B1||White|Race (NIH/OMB)||Participants|Count of Participants|392|392.0||||||
4266423|NCT00598806|4091366|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4266424|NCT00598806|4091367|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4266425|NCT00598806|4091368|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4266426|NCT00598806|4091366|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266427|NCT00598806|4091367|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266428|NCT00598806|4091368|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266429|NCT00598806|4091366|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4266430|NCT00598806|4091367|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4266431|NCT00598806|4091368|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4266432|NCT00598806|4091366|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266433|NCT00598806|4091367|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266434|NCT00598806|4091368|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266435|NCT00598806|4091366|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266436|NCT00598806|4091367|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266437|NCT00598806|4091368|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266438|NCT00598806|4091366|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|787|787.0||||||
4266439|NCT00598806|4091367|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|398|398.0||||||
4266440|NCT00598806|4091368|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|389|389.0||||||
4266441|NCT00598806|4091366|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4266442|NCT00598806|4091367|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4266443|NCT00598806|4091368|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4266444|NCT00598806|4091366|B3||Male|Sex: Female, Male||Participants|Count of Participants|599|599.0||||||
4266445|NCT00598806|4091367|B2||Male|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
4266446|NCT00598806|4091368|B1||Male|Sex: Female, Male||Participants|Count of Participants|297|297.0||||||
4266447|NCT00598806|4091366|B3||Female|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
4266448|NCT00598806|4091367|B2||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4266449|NCT00598806|4091368|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4266450|NCT00598806|4091366|B3|>75||Age, Customized||Participants|Count of Participants|201|201.0||||||
4266451|NCT00598806|4091367|B2|>75||Age, Customized||Participants|Count of Participants|100|100.0||||||
4266452|NCT00598806|4091368|B1|>75||Age, Customized||Participants|Count of Participants|101|101.0||||||
4266453|NCT00598806|4091366|B3|65-75||Age, Customized||Participants|Count of Participants|290|290.0||||||
4266454|NCT00598806|4091367|B2|65-75||Age, Customized||Participants|Count of Participants|146|146.0||||||
4266455|NCT00598806|4091368|B1|65-75||Age, Customized||Participants|Count of Participants|144|144.0||||||
4266456|NCT00598806|4091366|B3|<65||Age, Customized||Participants|Count of Participants|321|321.0||||||
4266457|NCT00598806|4091367|B2|<65||Age, Customized||Participants|Count of Participants|164|164.0||||||
4266458|NCT00598806|4091368|B1|<65||Age, Customized||Participants|Count of Participants|157|157.0||||||
4266459|NCT00598806|4091366|B3|||Age||years|Mean|66.7|66.7|Standard Deviation|11.71|11.71|||
4266460|NCT00598806|4091367|B2|||Age||years|Mean|66.5|66.5|Standard Deviation|11.83|11.83|||
4266461|NCT00598806|4091368|B1|||Age||years|Mean|66.9|66.9|Standard Deviation|11.60|11.6|||
4266462|NCT00598702|4091389|B9||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4266463|NCT00598702|4091390|B8||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4266464|NCT00598702|4091391|B7||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4266465|NCT00598702|4091392|B6||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4266466|NCT00598702|4091393|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4266467|NCT00598702|4091394|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4266468|NCT00598702|4091395|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4266469|NCT00598702|4091396|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4266470|NCT00598702|4091397|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4266471|NCT00598702|4091389|B9||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4266472|NCT00598702|4091390|B8||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4266473|NCT00598702|4091391|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4266474|NCT00598702|4091392|B6||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4266475|NCT00598702|4091393|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4266476|NCT00598702|4091394|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4266477|NCT00598702|4091395|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4266478|NCT00598702|4091396|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4266479|NCT00598702|4091397|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4266480|NCT00598702|4091389|B9||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4266481|NCT00598702|4091390|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4266482|NCT00598702|4091391|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4266483|NCT00598702|4091392|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4266484|NCT00598702|4091393|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4266485|NCT00598702|4091394|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4266486|NCT00598702|4091395|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4266487|NCT00598702|4091396|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4266488|NCT00598702|4091397|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4266489|NCT00598702|4091389|B9||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4266490|NCT00598702|4091390|B8||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4266491|NCT00598702|4091391|B7||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4266492|NCT00598702|4091392|B6||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4266493|NCT00598702|4091393|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4266494|NCT00598702|4091394|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4266495|NCT00598702|4091395|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4266496|NCT00598702|4091396|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4266497|NCT00598702|4091397|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4266498|NCT00598702|4091389|B9||<=18 years|Age||Participants|Count of Participants|100|100.0||||||
4266499|NCT00598702|4091390|B8||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4266500|NCT00598702|4091391|B7||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4266501|NCT00598702|4091392|B6||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
4266502|NCT00598702|4091393|B5||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4266503|NCT00598702|4091394|B4||<=18 years|Age||Participants|Count of Participants|33|33.0||||||
4266504|NCT00598702|4091395|B3||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4266505|NCT00598702|4091396|B2||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4266506|NCT00598702|4091397|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4266507|NCT00598689|4091446|B3|||Number of subjects with best corrected visual acuity of 20/40 or better in each eye||participants|Number|80|80.0||||||
4266508|NCT00598689|4091447|B2|||Number of subjects with best corrected visual acuity of 20/40 or better in each eye||participants|Number|40|40.0||||||
4266509|NCT00598689|4091448|B1|||Number of subjects with best corrected visual acuity of 20/40 or better in each eye||participants|Number|40|40.0||||||
4266510|NCT00598689|4091446|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
4266511|NCT00598689|4091447|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4266512|NCT00598689|4091448|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4266513|NCT00598689|4091446|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4266514|NCT00598689|4091447|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4266515|NCT00598689|4091448|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4266516|NCT00598689|4091446|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4266517|NCT00598689|4091447|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4266518|NCT00598689|4091448|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4266519|NCT00598689|4091446|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4266520|NCT00598689|4091447|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4266521|NCT00598689|4091448|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4266522|NCT00598689|4091446|B3||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4266523|NCT00598689|4091447|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4266524|NCT00598689|4091448|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4266525|NCT00598689|4091446|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266526|NCT00598689|4091447|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266527|NCT00598689|4091448|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266528|NCT00598650|4091459|B1|||Weight||kg|Mean|49|49.0|Standard Deviation|9.24|9.24|||
4266529|NCT00598650|4091459|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4266530|NCT00598650|4091459|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4266531|NCT00598650|4091459|B1|||Age||Years|Mean|78.9|78.9|Standard Deviation|5.7|5.7|||
4266532|NCT00598585|4091466|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266533|NCT00598585|4091467|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266534|NCT00598585|4091468|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266535|NCT00598585|4091466|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266536|NCT00598585|4091467|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266537|NCT00598585|4091468|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266538|NCT00598585|4091466|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4266539|NCT00598585|4091467|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4266540|NCT00598585|4091468|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4266541|NCT00598585|4091466|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266542|NCT00598585|4091467|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266543|NCT00598585|4091468|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266544|NCT00598585|4091466|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266545|NCT00598585|4091467|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266546|NCT00598585|4091468|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266547|NCT00598585|4091466|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266548|NCT00598585|4091467|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266549|NCT00598585|4091468|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266550|NCT00598585|4091466|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266551|NCT00598585|4091467|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266552|NCT00598585|4091468|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266553|NCT00598585|4091466|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266554|NCT00598585|4091467|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266555|NCT00598585|4091468|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266556|NCT00598585|4091466|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4266557|NCT00598585|4091467|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4266558|NCT00598585|4091468|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4266559|NCT00598585|4091466|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4266560|NCT00598585|4091467|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4266561|NCT00598585|4091468|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4266562|NCT00598585|4091466|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4266563|NCT00598585|4091467|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4266564|NCT00598585|4091468|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4266565|NCT00598585|4091466|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4266566|NCT00598585|4091467|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4266567|NCT00598585|4091468|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4266568|NCT00598585|4091466|B3|||Age||years|Mean|38|38.0|Standard Deviation|5|5.0|||
4266569|NCT00598585|4091467|B2|||Age||years|Mean|38|38.0|Standard Deviation|9|9.0|||
4266570|NCT00598585|4091468|B1|||Age||years|Mean|39|39.0|Standard Deviation|6|6.0|||
4266571|NCT00598559|4091475|B4||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4266572|NCT00598559|4091476|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4266573|NCT00598559|4091477|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4266574|NCT00598559|4091478|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4266575|NCT00598559|4091475|B4||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4266576|NCT00598559|4091476|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4266577|NCT00598559|4091477|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4266578|NCT00598559|4091478|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4266579|NCT00598559|4091475|B4||>=65 years|Age||Participants|Count of Participants|94|94.0||||||
4266580|NCT00598559|4091476|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4266581|NCT00598559|4091477|B2||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
4266582|NCT00598559|4091478|B1||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
4266583|NCT00598559|4091475|B4||Between 18 and 65 years|Age||Participants|Count of Participants|119|119.0||||||
4266584|NCT00598559|4091476|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4266585|NCT00598559|4091477|B2||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4266586|NCT00598559|4091478|B1||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4266587|NCT00598559|4091475|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266588|NCT00598559|4091476|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266589|NCT00598559|4091477|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266590|NCT00598559|4091478|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266591|NCT00598507|4091497|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4266592|NCT00598507|4091497|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4266593|NCT00598507|4091497|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4266594|NCT00598507|4091497|B1|||Age||years|Median|68.7|68.7|Standard Deviation|1.7|1.7|37.0|88.0|
4266595|NCT00598507|4091497|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4266596|NCT00598507|4091497|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4266597|NCT00598507|4091497|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266598|NCT00598442|4091504|B4||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4266599|NCT00598442|4091505|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4266600|NCT00598442|4091506|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4266601|NCT00598442|4091507|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4266602|NCT00598442|4091504|B4||Female|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
4266603|NCT00598442|4091505|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4266604|NCT00598442|4091506|B2||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4266605|NCT00598442|4091507|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4266606|NCT00598442|4091504|B4|||Age||years|Mean|67.9|67.9|Standard Deviation|13.83|13.83|||
4266607|NCT00598442|4091505|B3|||Age||years|Mean|67.2|67.2|Standard Deviation|15.03|15.03|||
4266608|NCT00598442|4091506|B2|||Age||years|Mean|68.3|68.3|Standard Deviation|13.53|13.53|||
4266609|NCT00598442|4091507|B1|||Age||years|Mean|68.1|68.1|Standard Deviation|12.93|12.93|||
4266610|NCT00598442|4091504|B4||>=65 years|Age||Participants|Count of Participants|311|311.0||||||
4266611|NCT00598442|4091505|B3||>=65 years|Age||Participants|Count of Participants|101|101.0||||||
4266612|NCT00598442|4091506|B2||>=65 years|Age||Participants|Count of Participants|106|106.0||||||
4266613|NCT00598442|4091507|B1||>=65 years|Age||Participants|Count of Participants|104|104.0||||||
4266614|NCT00598442|4091504|B4||Between 18 and 65 years|Age||Participants|Count of Participants|182|182.0||||||
4266615|NCT00598442|4091505|B3||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4266616|NCT00598442|4091506|B2||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4266617|NCT00598442|4091507|B1||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4266618|NCT00598442|4091504|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266619|NCT00598442|4091505|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266620|NCT00598442|4091506|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266621|NCT00598442|4091507|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266622|NCT00598273|4091523|B4||Male|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4266623|NCT00598273|4091524|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4266624|NCT00598273|4091525|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4266625|NCT00598273|4091526|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4266626|NCT00598273|4091523|B4||Female|Sex: Female, Male||Participants|Count of Participants|279|279.0||||||
4266627|NCT00598273|4091524|B3||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4266628|NCT00598273|4091525|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4266629|NCT00598273|4091526|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4266630|NCT00598273|4091523|B4|||Age||years|Mean|66.9|66.9|Standard Deviation|13.49|13.49|||
4266631|NCT00598273|4091524|B3|||Age||years|Mean|66.4|66.4|Standard Deviation|14.25|14.25|||
4266632|NCT00598273|4091525|B2|||Age||years|Mean|67.1|67.1|Standard Deviation|12.73|12.73|||
4266633|NCT00598273|4091526|B1|||Age||years|Mean|67.1|67.1|Standard Deviation|13.51|13.51|||
4266634|NCT00598273|4091523|B4||>=65 years|Age||Participants|Count of Participants|292|292.0||||||
4266635|NCT00598273|4091524|B3||>=65 years|Age||Participants|Count of Participants|99|99.0||||||
4266636|NCT00598273|4091525|B2||>=65 years|Age||Participants|Count of Participants|102|102.0||||||
4266637|NCT00598273|4091526|B1||>=65 years|Age||Participants|Count of Participants|91|91.0||||||
4266638|NCT00598273|4091523|B4||Between 18 and 65 years|Age||Participants|Count of Participants|198|198.0||||||
4266639|NCT00598273|4091524|B3||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4266640|NCT00598273|4091525|B2||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4266641|NCT00598273|4091526|B1||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4266642|NCT00598273|4091523|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266643|NCT00598273|4091524|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266644|NCT00598273|4091525|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266645|NCT00598273|4091526|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266646|NCT00598078|4091542|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4266647|NCT00598078|4091542|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266648|NCT00598078|4091542|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266649|NCT00598078|4091542|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4266650|NCT00598078|4091542|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266651|NCT00598078|4091542|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266652|NCT00598078|4091542|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4266653|NCT00598078|4091542|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266654|NCT00598078|4091542|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4266655|NCT00598078|4091542|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4266656|NCT00598078|4091542|B1|||Age||years|Mean|60.0|60.0|Standard Deviation|8.72|8.72|||
4266657|NCT00597896|4091564|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
4266658|NCT00597896|4091565|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4266659|NCT00597896|4091566|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4266660|NCT00597896|4091564|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4266661|NCT00597896|4091565|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4266662|NCT00597896|4091566|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4266663|NCT00597896|4091564|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4266664|NCT00597896|4091565|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4266665|NCT00597896|4091566|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4266666|NCT00597896|4091564|B3|||Age||years|Mean|44.14|44.14|Standard Deviation|10.9|10.9|||
4266667|NCT00597896|4091565|B2|||Age||years|Mean|44.42|44.42|Standard Deviation|12.2|12.2|||
4266668|NCT00597896|4091566|B1|||Age||years|Mean|43.81|43.81|Standard Deviation|9.4|9.4|||
4266669|NCT00597896|4091564|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4266670|NCT00597896|4091565|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4266671|NCT00597896|4091566|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4266672|NCT00597896|4091564|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4266673|NCT00597896|4091565|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4266674|NCT00597896|4091566|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4266675|NCT00597896|4091564|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266676|NCT00597896|4091565|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266677|NCT00597896|4091566|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266678|NCT00597766|4091593|B4|United States||Region of Enrollment||participants|Number|28|28.0||||||
4266679|NCT00597766|4091594|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4266680|NCT00597766|4091595|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4266681|NCT00597766|4091596|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4266682|NCT00597766|4091593|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4266683|NCT00597766|4091594|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4266684|NCT00597766|4091595|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4266685|NCT00597766|4091596|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4266686|NCT00597766|4091593|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4266687|NCT00597766|4091594|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4266688|NCT00597766|4091595|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4266689|NCT00597766|4091596|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4266690|NCT00597766|4091593|B4|||Age||years|Mean|55.6|55.6|Standard Deviation|9.1|9.1|||
4266691|NCT00597766|4091594|B3|||Age||years|Mean|54.0|54.0|Standard Deviation|9.9|9.9|||
4266692|NCT00597766|4091595|B2|||Age||years|Mean|54.7|54.7|Standard Deviation|10.2|10.2|||
4266693|NCT00597766|4091596|B1|||Age||years|Mean|58.3|58.3|Standard Deviation|7.1|7.1|||
4266694|NCT00597766|4091593|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4266695|NCT00597766|4091594|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4266696|NCT00597766|4091595|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4266697|NCT00597766|4091596|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4266698|NCT00597766|4091593|B4||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4266699|NCT00597766|4091594|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4266700|NCT00597766|4091595|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4266701|NCT00597766|4091596|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4266702|NCT00597766|4091593|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266703|NCT00597766|4091594|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266704|NCT00597766|4091595|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266705|NCT00597766|4091596|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266706|NCT00597753|4091615|B3||Male|Sex: Female, Male||Participants|Count of Participants|437|437.0||||||
4266707|NCT00597753|4091616|B2||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4266708|NCT00597753|4091617|B1||Male|Sex: Female, Male||Participants|Count of Participants|293|293.0||||||
4266709|NCT00597753|4091615|B3||Female|Sex: Female, Male||Participants|Count of Participants|356|356.0||||||
4266710|NCT00597753|4091616|B2||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4266711|NCT00597753|4091617|B1||Female|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
4266712|NCT00597753|4091615|B3|||Age||years|Mean|57.4|57.4|Standard Deviation|13.86|13.86|||
4266713|NCT00597753|4091616|B2|||Age||years|Mean|57.5|57.5|Standard Deviation|13.68|13.68|||
4266714|NCT00597753|4091617|B1|||Age||years|Mean|57.3|57.3|Standard Deviation|13.96|13.96|||
4266715|NCT00597753|4091615|B3||>=65 years|Age|Ten participants were excluded from the full analysis population: 8 participants in the Peginesatide group and 2 participants in the Epoetin Alfa groups. These 10 participants did not receive study medication.|Participants|Count of Participants|233|233.0||||||
4266716|NCT00597753|4091616|B2||>=65 years|Age|Ten participants were excluded from the full analysis population: 8 participants in the Peginesatide group and 2 participants in the Epoetin Alfa groups. These 10 participants did not receive study medication.|Participants|Count of Participants|79|79.0||||||
4266717|NCT00597753|4091617|B1||>=65 years|Age|Ten participants were excluded from the full analysis population: 8 participants in the Peginesatide group and 2 participants in the Epoetin Alfa groups. These 10 participants did not receive study medication.|Participants|Count of Participants|154|154.0||||||
4266718|NCT00597753|4091615|B3||Between 18 and 65 years|Age|Ten participants were excluded from the full analysis population: 8 participants in the Peginesatide group and 2 participants in the Epoetin Alfa groups. These 10 participants did not receive study medication.|Participants|Count of Participants|560|560.0||||||
4266719|NCT00597753|4091616|B2||Between 18 and 65 years|Age|Ten participants were excluded from the full analysis population: 8 participants in the Peginesatide group and 2 participants in the Epoetin Alfa groups. These 10 participants did not receive study medication.|Participants|Count of Participants|190|190.0||||||
4266720|NCT00597753|4091617|B1||Between 18 and 65 years|Age|Ten participants were excluded from the full analysis population: 8 participants in the Peginesatide group and 2 participants in the Epoetin Alfa groups. These 10 participants did not receive study medication.|Participants|Count of Participants|370|370.0||||||
4266721|NCT00597753|4091615|B3||<=18 years|Age|Ten participants were excluded from the full analysis population: 8 participants in the Peginesatide group and 2 participants in the Epoetin Alfa groups. These 10 participants did not receive study medication.|Participants|Count of Participants|0|0.0||||||
4266722|NCT00597753|4091616|B2||<=18 years|Age|Ten participants were excluded from the full analysis population: 8 participants in the Peginesatide group and 2 participants in the Epoetin Alfa groups. These 10 participants did not receive study medication.|Participants|Count of Participants|0|0.0||||||
4266723|NCT00597753|4091617|B1||<=18 years|Age|Ten participants were excluded from the full analysis population: 8 participants in the Peginesatide group and 2 participants in the Epoetin Alfa groups. These 10 participants did not receive study medication.|Participants|Count of Participants|0|0.0||||||
4266724|NCT00597727|4091628|B5|United States||Region of Enrollment||participants|Number|60|60.0||||||
4266725|NCT00597727|4091629|B4|United States||Region of Enrollment||participants|Number|4|4.0||||||
4266726|NCT00597727|4091630|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
4266727|NCT00597727|4091631|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4266728|NCT00597727|4091632|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4266729|NCT00597727|4091628|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266730|NCT00597727|4091629|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266731|NCT00597727|4091630|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266788|NCT00597727|4091632|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4266732|NCT00597727|4091631|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266733|NCT00597727|4091632|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266734|NCT00597727|4091628|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4266735|NCT00597727|4091629|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4266736|NCT00597727|4091630|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266737|NCT00597727|4091631|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266738|NCT00597727|4091632|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266739|NCT00597727|4091628|B5||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4266740|NCT00597727|4091629|B4||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4266741|NCT00597727|4091630|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4266742|NCT00597727|4091631|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4266743|NCT00597727|4091632|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4266744|NCT00597727|4091628|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4266745|NCT00597727|4091629|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266746|NCT00597727|4091630|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4266747|NCT00597727|4091631|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266748|NCT00597727|4091632|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266749|NCT00597727|4091628|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266750|NCT00597727|4091629|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266751|NCT00597727|4091630|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266752|NCT00597727|4091631|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266753|NCT00597727|4091632|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266754|NCT00597727|4091628|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4266755|NCT00597727|4091629|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266756|NCT00597727|4091630|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4266757|NCT00597727|4091631|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4266758|NCT00597727|4091632|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4266759|NCT00597727|4091628|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266760|NCT00597727|4091629|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266761|NCT00597727|4091630|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266762|NCT00597727|4091631|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266763|NCT00597727|4091632|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266764|NCT00597727|4091628|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266765|NCT00597727|4091629|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266766|NCT00597727|4091630|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266767|NCT00597727|4091631|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266768|NCT00597727|4091632|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266769|NCT00597727|4091628|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4266770|NCT00597727|4091629|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4266771|NCT00597727|4091630|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4266772|NCT00597727|4091631|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4266773|NCT00597727|4091632|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4266774|NCT00597727|4091628|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266775|NCT00597727|4091629|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266776|NCT00597727|4091630|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266777|NCT00597727|4091631|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266778|NCT00597727|4091632|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266779|NCT00597727|4091628|B5||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4266780|NCT00597727|4091629|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4266781|NCT00597727|4091630|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4266782|NCT00597727|4091631|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4266783|NCT00597727|4091632|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4266784|NCT00597727|4091628|B5||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4266785|NCT00597727|4091629|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4266786|NCT00597727|4091630|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4266787|NCT00597727|4091631|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4266789|NCT00597727|4091628|B5|||Age||years|Median|6.4|6.4|Full Range|||1.6|20.8|
4266790|NCT00597727|4091629|B4|||Age||years|Median|15.6|15.6|Full Range|||8.9|20.8|
4266791|NCT00597727|4091630|B3|||Age||years|Median|6.0|6.0|Full Range|||1.5|11.8|
4266792|NCT00597727|4091631|B2|||Age||years|Median|6.6|6.6|Full Range|||1.6|11.9|
4266793|NCT00597727|4091632|B1|||Age||years|Median|6.0|6.0|Full Range|||2.8|10.9|
4266794|NCT00597714|4091650|B3|United States||Region of Enrollment||participants|Number|137|137.0||||||
4266795|NCT00597714|4091651|B2|United States||Region of Enrollment||participants|Number|57|57.0||||||
4266796|NCT00597714|4091652|B1|United States||Region of Enrollment||participants|Number|80|80.0||||||
4266797|NCT00597714|4091650|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266798|NCT00597714|4091651|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266799|NCT00597714|4091652|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266800|NCT00597714|4091650|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|137|137.0||||||
4266801|NCT00597714|4091651|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4266802|NCT00597714|4091652|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
4266803|NCT00597714|4091650|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266804|NCT00597714|4091651|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266805|NCT00597714|4091652|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266806|NCT00597714|4091650|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266807|NCT00597714|4091651|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266808|NCT00597714|4091652|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266809|NCT00597714|4091650|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266810|NCT00597714|4091651|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266811|NCT00597714|4091652|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266812|NCT00597714|4091650|B3||White|Race (NIH/OMB)||Participants|Count of Participants|121|121.0||||||
4266813|NCT00597714|4091651|B2||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4266814|NCT00597714|4091652|B1||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4266815|NCT00597714|4091650|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4266816|NCT00597714|4091651|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4266817|NCT00597714|4091652|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4266818|NCT00597714|4091650|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266819|NCT00597714|4091651|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266820|NCT00597714|4091652|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266821|NCT00597714|4091650|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4266822|NCT00597714|4091651|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266823|NCT00597714|4091652|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4266824|NCT00597714|4091650|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266825|NCT00597714|4091651|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266826|NCT00597714|4091652|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4266827|NCT00597714|4091650|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4266828|NCT00597714|4091651|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4266829|NCT00597714|4091652|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4266830|NCT00597714|4091650|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4266831|NCT00597714|4091651|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4266832|NCT00597714|4091652|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4266833|NCT00597714|4091650|B3||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4266834|NCT00597714|4091651|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4266835|NCT00597714|4091652|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4266836|NCT00597714|4091650|B3||Between 18 and 65 years|Age||Participants|Count of Participants|113|113.0||||||
4266837|NCT00597714|4091651|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4266838|NCT00597714|4091652|B1||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4266839|NCT00597714|4091650|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266840|NCT00597714|4091651|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266841|NCT00597714|4091652|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266842|NCT00597701|4091664|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
4266843|NCT00597701|4091665|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4266844|NCT00597701|4091666|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4266845|NCT00597701|4091664|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4266846|NCT00597701|4091665|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4266847|NCT00597701|4091666|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4266848|NCT00597701|4091664|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4266849|NCT00597701|4091665|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4266850|NCT00597701|4091666|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4266851|NCT00597701|4091664|B3|||Age||years|Mean|46.9|46.9|Standard Deviation|10.9|10.9|||
4266852|NCT00597701|4091665|B2|||Age||years|Mean|46.1|46.1|Standard Deviation|11.9|11.9|||
4266853|NCT00597701|4091666|B1|||Age||years|Mean|47.5|47.5|Standard Deviation|10.3|10.3|||
4266854|NCT00597701|4091664|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4266855|NCT00597701|4091665|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4266856|NCT00597701|4091666|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4266857|NCT00597701|4091664|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4266858|NCT00597701|4091665|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4266859|NCT00597701|4091666|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4266860|NCT00597701|4091664|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266861|NCT00597701|4091665|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266862|NCT00597701|4091666|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266863|NCT00597675|4091673|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4266864|NCT00597675|4091674|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4266865|NCT00597675|4091675|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4266866|NCT00597675|4091673|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4266867|NCT00597675|4091674|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4266868|NCT00597675|4091675|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4266869|NCT00597675|4091673|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4266870|NCT00597675|4091674|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4266871|NCT00597675|4091675|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4266872|NCT00597675|4091673|B3|||Age||years|Mean|5.4|5.4|Full Range|||3.6|7.0|
4266873|NCT00597675|4091674|B2|||Age||years|Mean|5.2|5.2|Full Range|||3.6|7.0|
4266874|NCT00597675|4091675|B1|||Age||years|Mean|5.8|5.8|Full Range|||4.8|6.9|
4266875|NCT00597584|4091687|B3||Male|Sex: Female, Male||Participants|Count of Participants|484|484.0||||||
4266876|NCT00597584|4091688|B2||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4266877|NCT00597584|4091689|B1||Male|Sex: Female, Male||Participants|Count of Participants|331|331.0||||||
4266878|NCT00597584|4091687|B3||Female|Sex: Female, Male||Participants|Count of Participants|331|331.0||||||
4266879|NCT00597584|4091688|B2||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4266880|NCT00597584|4091689|B1||Female|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4266881|NCT00597584|4091687|B3|||Age||years|Mean|58.8|58.8|Standard Deviation|14.22|14.22|||
4266882|NCT00597584|4091688|B2|||Age||years|Mean|58.6|58.6|Standard Deviation|13.73|13.73|||
4266883|NCT00597584|4091689|B1|||Age||years|Mean|58.8|58.8|Standard Deviation|14.47|14.47|||
4266884|NCT00597584|4091687|B3||>=65 years|Age|Eight participants were excluded from the full analysis population: 7 participants in the Peginesatide group and 1 participant in the Epoetin group. These 8 participants did not receive study medication.|Participants|Count of Participants|292|292.0||||||
4266885|NCT00597584|4091688|B2||>=65 years|Age|Eight participants were excluded from the full analysis population: 7 participants in the Peginesatide group and 1 participant in the Epoetin group. These 8 participants did not receive study medication.|Participants|Count of Participants|100|100.0||||||
4266886|NCT00597584|4091689|B1||>=65 years|Age|Eight participants were excluded from the full analysis population: 7 participants in the Peginesatide group and 1 participant in the Epoetin group. These 8 participants did not receive study medication.|Participants|Count of Participants|192|192.0||||||
4266887|NCT00597584|4091687|B3||Between 18 and 65 years|Age|Eight participants were excluded from the full analysis population: 7 participants in the Peginesatide group and 1 participant in the Epoetin group. These 8 participants did not receive study medication.|Participants|Count of Participants|523|523.0||||||
4266888|NCT00597584|4091688|B2||Between 18 and 65 years|Age|Eight participants were excluded from the full analysis population: 7 participants in the Peginesatide group and 1 participant in the Epoetin group. These 8 participants did not receive study medication.|Participants|Count of Participants|173|173.0||||||
4266889|NCT00597584|4091689|B1||Between 18 and 65 years|Age|Eight participants were excluded from the full analysis population: 7 participants in the Peginesatide group and 1 participant in the Epoetin group. These 8 participants did not receive study medication.|Participants|Count of Participants|350|350.0||||||
4266890|NCT00597584|4091687|B3||<=18 years|Age|Eight participants were excluded from the full analysis population: 7 participants in the Peginesatide group and 1 participant in the Epoetin group. These 8 participants did not receive study medication.|Participants|Count of Participants|0|0.0||||||
4266891|NCT00597584|4091688|B2||<=18 years|Age|Eight participants were excluded from the full analysis population: 7 participants in the Peginesatide group and 1 participant in the Epoetin group. These 8 participants did not receive study medication.|Participants|Count of Participants|0|0.0||||||
4266892|NCT00597584|4091689|B1||<=18 years|Age|Eight participants were excluded from the full analysis population: 7 participants in the Peginesatide group and 1 participant in the Epoetin group. These 8 participants did not receive study medication.|Participants|Count of Participants|0|0.0||||||
4266893|NCT00597558|4091700|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4266894|NCT00597558|4091700|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4266895|NCT00597558|4091700|B1|||Age||years|Mean|6.6|6.6|Full Range|||3.6|13.6|
4266896|NCT00597545|4091706|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4266897|NCT00597545|4091707|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4266898|NCT00597545|4091708|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4266899|NCT00597545|4091706|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4266900|NCT00597545|4091707|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4266901|NCT00597545|4091708|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4266902|NCT00597545|4091706|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4266903|NCT00597545|4091707|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4266904|NCT00597545|4091708|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4266905|NCT00597545|4091706|B3|||Age||years|Mean|68.7|68.7|Full Range|||64.0|79.0|
4266906|NCT00597545|4091707|B2|||Age||years|Mean|69|69.0|Full Range|||65.0|79.0|
4266907|NCT00597545|4091708|B1|||Age||years|Mean|68|68.0|Full Range|||64.0|78.0|
4266908|NCT00597545|4091706|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4266909|NCT00597545|4091707|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4266910|NCT00597545|4091708|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4266911|NCT00597545|4091706|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4266912|NCT00597545|4091707|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4266913|NCT00597545|4091708|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4266914|NCT00597545|4091706|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266915|NCT00597545|4091707|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266916|NCT00597545|4091708|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266917|NCT00597519|4091715|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4266918|NCT00597519|4091715|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4266919|NCT00597519|4091715|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4266920|NCT00597519|4091715|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4266921|NCT00597519|4091715|B1||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4266922|NCT00597506|4091719|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4266923|NCT00597506|4091719|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4266924|NCT00597506|4091719|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4266925|NCT00597506|4091719|B1|||Age||years|Mean|56|56.0|Standard Deviation|10.8|10.8|||
4266926|NCT00597506|4091719|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4266927|NCT00597506|4091719|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4266928|NCT00597506|4091719|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4266929|NCT00597493|4091724|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4266930|NCT00597493|4091724|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4266931|NCT00597493|4091724|B1|||Age||years|Median|53.6|53.6|Full Range|||30.4|72.5|
4266932|NCT00597428|4091741|B3|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4266933|NCT00597428|4091742|B2|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4266934|NCT00597428|4091743|B1|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4266935|NCT00597428|4091741|B3|United States||Region of Enrollment||participants|Number|426|426.0||||||
4266936|NCT00597428|4091742|B2|United States||Region of Enrollment||participants|Number|219|219.0||||||
4266937|NCT00597428|4091743|B1|United States||Region of Enrollment||participants|Number|207|207.0||||||
4266938|NCT00597428|4091741|B3||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4266939|NCT00597428|4091742|B2||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4266940|NCT00597428|4091743|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4266941|NCT00597428|4091741|B3||Female|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
4266942|NCT00597428|4091742|B2||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4266943|NCT00597428|4091743|B1||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4266944|NCT00597428|4091741|B3|||Age||years|Mean|49.4|49.4|Standard Deviation|10.14|10.14|||
4266945|NCT00597428|4091742|B2|||Age||years|Mean|48.9|48.9|Standard Deviation|9.85|9.85|||
4266946|NCT00597428|4091743|B1|||Age||years|Mean|49.8|49.8|Standard Deviation|10.44|10.44|||
4266947|NCT00597402|4091760|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4266948|NCT00597402|4091760|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4266949|NCT00597402|4091760|B1|||Age||years|Mean|54.6|54.6|Standard Deviation|12.5|12.5|||
4266950|NCT00597376|4091767|B3|||potential anti-oxidant (PAO)|Potential anti-oxidant (PAO) measures the antioxidant capacity of a serum sample to reduce cupric ions from Cu++ to Cu+.|micromol/L|Geometric Mean|997|997.0|Standard Deviation|2|2.0|||
4266951|NCT00597376|4091768|B2|||potential anti-oxidant (PAO)|Potential anti-oxidant (PAO) measures the antioxidant capacity of a serum sample to reduce cupric ions from Cu++ to Cu+.|micromol/L|Geometric Mean|1016|1016.0|Standard Deviation|2|2.0|||
4266952|NCT00597376|4091769|B1|||potential anti-oxidant (PAO)|Potential anti-oxidant (PAO) measures the antioxidant capacity of a serum sample to reduce cupric ions from Cu++ to Cu+.|micromol/L|Geometric Mean|979|979.0|Standard Deviation|2|2.0|||
4266953|NCT00597376|4091767|B3|||malondialdehyde||micromol/L|Geometric Mean|0.92|0.92|Standard Deviation|1.71|1.71|||
4266954|NCT00597376|4091768|B2|||malondialdehyde||micromol/L|Geometric Mean|0.93|0.93|Standard Deviation|1.75|1.75|||
4266955|NCT00597376|4091769|B1|||malondialdehyde||micromol/L|Geometric Mean|0.90|0.9|Standard Deviation|1.67|1.67|||
4266956|NCT00597376|4091767|B3|||interleukin-6||pg/mL|Geometric Mean|2.12|2.12|Standard Deviation|2.17|2.17|||
4266957|NCT00597376|4091768|B2|||interleukin-6||pg/mL|Geometric Mean|2.12|2.12|Standard Deviation|2.35|2.35|||
4266958|NCT00597376|4091769|B1|||interleukin-6||pg/mL|Geometric Mean|2.12|2.12|Standard Deviation|1.98|1.98|||
4266959|NCT00597376|4091767|B3|||tumor necrosis factor alpha||pg/mL|Geometric Mean|1.41|1.41|Standard Deviation|1.57|1.57|||
4266960|NCT00597376|4091768|B2|||tumor necrosis factor alpha||pg/mL|Geometric Mean|1.37|1.37|Standard Deviation|1.53|1.53|||
4266961|NCT00597376|4091769|B1|||tumor necrosis factor alpha||pg/mL|Geometric Mean|1.45|1.45|Standard Deviation|1.61|1.61|||
4266962|NCT00597376|4091767|B3|||highly sensitive c-Reactive Protein||mg/mL|Geometric Mean|0.22|0.22|Standard Deviation|20.68|20.68|||
4266963|NCT00597376|4091768|B2|||highly sensitive c-Reactive Protein||mg/mL|Geometric Mean|0.23|0.23|Standard Deviation|22.37|22.37|||
4266964|NCT00597376|4091769|B1|||highly sensitive c-Reactive Protein||mg/mL|Geometric Mean|0.20|0.2|Standard Deviation|18.93|18.93|||
4266965|NCT00597376|4091767|B3|||ratio of amyloid beta 1-42 to 1-40||pmol/L:pmol/L|Geometric Mean|0.031|0.031|Standard Deviation|1.77|1.77|||
4266966|NCT00597376|4091768|B2|||ratio of amyloid beta 1-42 to 1-40||pmol/L:pmol/L|Geometric Mean|0.034|0.034|Standard Deviation|1.81|1.81|||
4266967|NCT00597376|4091769|B1|||ratio of amyloid beta 1-42 to 1-40||pmol/L:pmol/L|Geometric Mean|0.027|0.027|Standard Deviation|1.73|1.73|||
4266968|NCT00597376|4091767|B3|||glutathione||micromol/L|Geometric Mean|4.02|4.02|Standard Deviation|1.63|1.63|||
4266969|NCT00597376|4091768|B2|||glutathione||micromol/L|Geometric Mean|4.02|4.02|Standard Deviation|1.59|1.59|||
4266970|NCT00597376|4091769|B1|||glutathione||micromol/L|Geometric Mean|4.01|4.01|Standard Deviation|1.67|1.67|||
4266971|NCT00597376|4091767|B3|||total plasma homocysteine||micromol/L|Geometric Mean|8.22|8.22|Standard Deviation|1.33|1.33|||
4266972|NCT00597376|4091768|B2|||total plasma homocysteine||micromol/L|Geometric Mean|8.10|8.1|Standard Deviation|1.33|1.33|||
4266973|NCT00597376|4091769|B1|||total plasma homocysteine||micromol/L|Geometric Mean|8.35|8.35|Standard Deviation|1.32|1.32|||
4266974|NCT00597376|4091767|B3|||Education Level||years|Mean|15|15.0|Standard Deviation|3|3.0|||
4266975|NCT00597376|4091768|B2|||Education Level||years|Mean|15|15.0|Standard Deviation|3|3.0|||
4266976|NCT00597376|4091769|B1|||Education Level||years|Mean|15|15.0|Standard Deviation|3|3.0|||
4266977|NCT00597376|4091767|B3|United States||Region of Enrollment||participants|Number|104|104.0||||||
4266978|NCT00597376|4091768|B2|United States||Region of Enrollment||participants|Number|53|53.0||||||
4266979|NCT00597376|4091769|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4266980|NCT00597376|4091767|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4266981|NCT00597376|4091768|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4266982|NCT00597376|4091769|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4266983|NCT00597376|4091767|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4266984|NCT00597376|4091768|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4266985|NCT00597376|4091769|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4266986|NCT00597376|4091767|B3|||Age||years|Mean|80.1|80.1|Standard Deviation|7.7|7.7|||
4266987|NCT00597376|4091768|B2|||Age||years|Mean|79.4|79.4|Standard Deviation|8.7|8.7|||
4266988|NCT00597376|4091769|B1|||Age||years|Mean|80.9|80.9|Standard Deviation|6.6|6.6|||
4266989|NCT00597272|4091780|B8|United States||Region of Enrollment||participants|Number|34|34.0||||||
4266990|NCT00597272|4091781|B7|United States||Region of Enrollment||participants|Number|10|10.0||||||
4266991|NCT00597272|4091782|B6|United States||Region of Enrollment||participants|Number|10|10.0||||||
4266992|NCT00597272|4091783|B5|United States||Region of Enrollment||participants|Number|1|1.0||||||
4266993|NCT00597272|4091784|B4|United States||Region of Enrollment||participants|Number|1|1.0||||||
4266994|NCT00597272|4091785|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4266995|NCT00597272|4091786|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4266996|NCT00597272|4091787|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4266997|NCT00597272|4091780|B8||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4266998|NCT00597272|4091781|B7||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4266999|NCT00597272|4091782|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4267000|NCT00597272|4091783|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4267001|NCT00597272|4091784|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4267002|NCT00597272|4091785|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4267003|NCT00597272|4091786|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4267004|NCT00597272|4091787|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4267005|NCT00597272|4091780|B8||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4267006|NCT00597272|4091781|B7||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4267007|NCT00597272|4091782|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4267008|NCT00597272|4091783|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4267009|NCT00597272|4091784|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4267010|NCT00597272|4091785|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4267011|NCT00597272|4091786|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4267012|NCT00597272|4091787|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4267013|NCT00597272|4091780|B8||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4267014|NCT00597272|4091781|B7||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4267015|NCT00597272|4091782|B6||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4267016|NCT00597272|4091783|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4267017|NCT00597272|4091784|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4267018|NCT00597272|4091785|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4267019|NCT00597272|4091786|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4267020|NCT00597272|4091787|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4267021|NCT00597272|4091780|B8||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4267022|NCT00597272|4091781|B7||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4267023|NCT00597272|4091782|B6||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4267024|NCT00597272|4091783|B5||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4267025|NCT00597272|4091784|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4267026|NCT00597272|4091785|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4267027|NCT00597272|4091786|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4267028|NCT00597272|4091787|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4267029|NCT00597272|4091780|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267030|NCT00597272|4091781|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267031|NCT00597272|4091782|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267032|NCT00597272|4091783|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267033|NCT00597272|4091784|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267034|NCT00597272|4091785|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267035|NCT00597272|4091786|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267036|NCT00597272|4091787|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267037|NCT00597207|4091809|B3||Male|Sex: Female, Male||Participants|Count of Participants|2610|2610.0||||||
4267038|NCT00597207|4091810|B2||Male|Sex: Female, Male||Participants|Count of Participants|1295|1295.0||||||
4267039|NCT00597207|4091811|B1||Male|Sex: Female, Male||Participants|Count of Participants|1315|1315.0||||||
4267040|NCT00597207|4091809|B3||Female|Sex: Female, Male||Participants|Count of Participants|1621|1621.0||||||
4267041|NCT00597207|4091810|B2||Female|Sex: Female, Male||Participants|Count of Participants|837|837.0||||||
4267042|NCT00597207|4091811|B1||Female|Sex: Female, Male||Participants|Count of Participants|784|784.0||||||
4267043|NCT00597207|4091809|B3|75+ years||Age, Customized||participants|Number|1431|1431.0||||||
4267044|NCT00597207|4091810|B2|75+ years||Age, Customized||participants|Number|709|709.0||||||
4267045|NCT00597207|4091811|B1|75+ years||Age, Customized||participants|Number|722|722.0||||||
4267046|NCT00597207|4091809|B3|60-74 years||Age, Customized||participants|Number|1360|1360.0||||||
4267047|NCT00597207|4091810|B2|60-74 years||Age, Customized||participants|Number|689|689.0||||||
4267048|NCT00597207|4091811|B1|60-74 years||Age, Customized||participants|Number|671|671.0||||||
4267049|NCT00597207|4091809|B3|18-59 years||Age, Customized||participants|Number|1440|1440.0||||||
4267050|NCT00597207|4091810|B2|18-59 years||Age, Customized||participants|Number|734|734.0||||||
4267051|NCT00597207|4091811|B1|18-59 years||Age, Customized||participants|Number|706|706.0||||||
4267052|NCT00597116|4091818|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4267053|NCT00597116|4091819|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4267054|NCT00597116|4091820|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4267055|NCT00597116|4091818|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4267056|NCT00597116|4091819|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4267057|NCT00597116|4091820|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4267058|NCT00597116|4091818|B3|||Age||Years|Median|65.5|65.5|Full Range|||27.0|77.0|
4267059|NCT00597116|4091819|B2|||Age||Years|Median|64|64.0|Full Range|||27.0|76.0|
4267060|NCT00597116|4091820|B1|||Age||Years|Median|67|67.0|Full Range|||54.0|77.0|
4267061|NCT00597038|4091833|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4267062|NCT00597038|4091834|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
4267063|NCT00597038|4091835|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4267064|NCT00597038|4091833|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4267065|NCT00597038|4091834|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4267066|NCT00597038|4091835|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4267067|NCT00597038|4091833|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4267068|NCT00597038|4091834|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4267069|NCT00597038|4091835|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4267070|NCT00597038|4091833|B3|||Age||years|Mean|62.3|62.3|Full Range|||34.0|81.0|
4267071|NCT00597038|4091834|B2|||Age||years|Mean|60.3|60.3|Full Range|||34.0|80.0|
4267072|NCT00597038|4091835|B1|||Age||years|Mean|68.1|68.1|Full Range|||47.0|81.0|
4267073|NCT00597038|4091833|B3||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4267074|NCT00597038|4091834|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4267075|NCT00597038|4091835|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4267076|NCT00597038|4091833|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4267077|NCT00597038|4091834|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4267078|NCT00597038|4091835|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4267079|NCT00597038|4091833|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267080|NCT00597038|4091834|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267081|NCT00597038|4091835|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267082|NCT00597012|4091845|B3|3||Kellgren-Lawrence grade|"A Kellgren–Lawrence grade of 0 (no osteophytes or joint-space narrowing) indicates no osteoarthritis, a grade of 1 (questionable osteophyte) indicates possible osteoarthritis; a grade of 2 (definite osteophyte, no joint-space narrowing) indicates mild osteoarthritis, a grade of 3 (less than or equal to 50% joint-space narrowing) indicates moderate osteoarthritis, and a grade of 4 (greater than 50% joint-space narrowing) indicates severe osteoarthritis.~Total number of participants analyzed does not equal the total number of participants due to missing data."|participants|Number|84|84.0||||||
4267083|NCT00597012|4091846|B2|3||Kellgren-Lawrence grade|"A Kellgren–Lawrence grade of 0 (no osteophytes or joint-space narrowing) indicates no osteoarthritis, a grade of 1 (questionable osteophyte) indicates possible osteoarthritis; a grade of 2 (definite osteophyte, no joint-space narrowing) indicates mild osteoarthritis, a grade of 3 (less than or equal to 50% joint-space narrowing) indicates moderate osteoarthritis, and a grade of 4 (greater than 50% joint-space narrowing) indicates severe osteoarthritis.~Total number of participants analyzed does not equal the total number of participants due to missing data."|participants|Number|39|39.0||||||
4267084|NCT00597012|4091847|B1|3||Kellgren-Lawrence grade|"A Kellgren–Lawrence grade of 0 (no osteophytes or joint-space narrowing) indicates no osteoarthritis, a grade of 1 (questionable osteophyte) indicates possible osteoarthritis; a grade of 2 (definite osteophyte, no joint-space narrowing) indicates mild osteoarthritis, a grade of 3 (less than or equal to 50% joint-space narrowing) indicates moderate osteoarthritis, and a grade of 4 (greater than 50% joint-space narrowing) indicates severe osteoarthritis.~Total number of participants analyzed does not equal the total number of participants due to missing data."|participants|Number|45|45.0||||||
4267085|NCT00597012|4091845|B3|2||Kellgren-Lawrence grade|"A Kellgren–Lawrence grade of 0 (no osteophytes or joint-space narrowing) indicates no osteoarthritis, a grade of 1 (questionable osteophyte) indicates possible osteoarthritis; a grade of 2 (definite osteophyte, no joint-space narrowing) indicates mild osteoarthritis, a grade of 3 (less than or equal to 50% joint-space narrowing) indicates moderate osteoarthritis, and a grade of 4 (greater than 50% joint-space narrowing) indicates severe osteoarthritis.~Total number of participants analyzed does not equal the total number of participants due to missing data."|participants|Number|76|76.0||||||
4267086|NCT00597012|4091846|B2|2||Kellgren-Lawrence grade|"A Kellgren–Lawrence grade of 0 (no osteophytes or joint-space narrowing) indicates no osteoarthritis, a grade of 1 (questionable osteophyte) indicates possible osteoarthritis; a grade of 2 (definite osteophyte, no joint-space narrowing) indicates mild osteoarthritis, a grade of 3 (less than or equal to 50% joint-space narrowing) indicates moderate osteoarthritis, and a grade of 4 (greater than 50% joint-space narrowing) indicates severe osteoarthritis.~Total number of participants analyzed does not equal the total number of participants due to missing data."|participants|Number|39|39.0||||||
4267087|NCT00597012|4091847|B1|2||Kellgren-Lawrence grade|"A Kellgren–Lawrence grade of 0 (no osteophytes or joint-space narrowing) indicates no osteoarthritis, a grade of 1 (questionable osteophyte) indicates possible osteoarthritis; a grade of 2 (definite osteophyte, no joint-space narrowing) indicates mild osteoarthritis, a grade of 3 (less than or equal to 50% joint-space narrowing) indicates moderate osteoarthritis, and a grade of 4 (greater than 50% joint-space narrowing) indicates severe osteoarthritis.~Total number of participants analyzed does not equal the total number of participants due to missing data."|participants|Number|37|37.0||||||
4267088|NCT00597012|4091845|B3|1||Kellgren-Lawrence grade|"A Kellgren–Lawrence grade of 0 (no osteophytes or joint-space narrowing) indicates no osteoarthritis, a grade of 1 (questionable osteophyte) indicates possible osteoarthritis; a grade of 2 (definite osteophyte, no joint-space narrowing) indicates mild osteoarthritis, a grade of 3 (less than or equal to 50% joint-space narrowing) indicates moderate osteoarthritis, and a grade of 4 (greater than 50% joint-space narrowing) indicates severe osteoarthritis.~Total number of participants analyzed does not equal the total number of participants due to missing data."|participants|Number|61|61.0||||||
4267089|NCT00597012|4091846|B2|1||Kellgren-Lawrence grade|"A Kellgren–Lawrence grade of 0 (no osteophytes or joint-space narrowing) indicates no osteoarthritis, a grade of 1 (questionable osteophyte) indicates possible osteoarthritis; a grade of 2 (definite osteophyte, no joint-space narrowing) indicates mild osteoarthritis, a grade of 3 (less than or equal to 50% joint-space narrowing) indicates moderate osteoarthritis, and a grade of 4 (greater than 50% joint-space narrowing) indicates severe osteoarthritis.~Total number of participants analyzed does not equal the total number of participants due to missing data."|participants|Number|35|35.0||||||
4267090|NCT00597012|4091847|B1|1||Kellgren-Lawrence grade|"A Kellgren–Lawrence grade of 0 (no osteophytes or joint-space narrowing) indicates no osteoarthritis, a grade of 1 (questionable osteophyte) indicates possible osteoarthritis; a grade of 2 (definite osteophyte, no joint-space narrowing) indicates mild osteoarthritis, a grade of 3 (less than or equal to 50% joint-space narrowing) indicates moderate osteoarthritis, and a grade of 4 (greater than 50% joint-space narrowing) indicates severe osteoarthritis.~Total number of participants analyzed does not equal the total number of participants due to missing data."|participants|Number|26|26.0||||||
4267091|NCT00597012|4091845|B3|0||Kellgren-Lawrence grade|"A Kellgren–Lawrence grade of 0 (no osteophytes or joint-space narrowing) indicates no osteoarthritis, a grade of 1 (questionable osteophyte) indicates possible osteoarthritis; a grade of 2 (definite osteophyte, no joint-space narrowing) indicates mild osteoarthritis, a grade of 3 (less than or equal to 50% joint-space narrowing) indicates moderate osteoarthritis, and a grade of 4 (greater than 50% joint-space narrowing) indicates severe osteoarthritis.~Total number of participants analyzed does not equal the total number of participants due to missing data."|participants|Number|70|70.0||||||
4267126|NCT00597012|4091847|B1|White||Race/Ethnicity, Customized||participants|Number|138|138.0||||||
4267127|NCT00597012|4091845|B3||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4267128|NCT00597012|4091846|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4267092|NCT00597012|4091846|B2|0||Kellgren-Lawrence grade|"A Kellgren–Lawrence grade of 0 (no osteophytes or joint-space narrowing) indicates no osteoarthritis, a grade of 1 (questionable osteophyte) indicates possible osteoarthritis; a grade of 2 (definite osteophyte, no joint-space narrowing) indicates mild osteoarthritis, a grade of 3 (less than or equal to 50% joint-space narrowing) indicates moderate osteoarthritis, and a grade of 4 (greater than 50% joint-space narrowing) indicates severe osteoarthritis.~Total number of participants analyzed does not equal the total number of participants due to missing data."|participants|Number|36|36.0||||||
4267093|NCT00597012|4091847|B1|0||Kellgren-Lawrence grade|"A Kellgren–Lawrence grade of 0 (no osteophytes or joint-space narrowing) indicates no osteoarthritis, a grade of 1 (questionable osteophyte) indicates possible osteoarthritis; a grade of 2 (definite osteophyte, no joint-space narrowing) indicates mild osteoarthritis, a grade of 3 (less than or equal to 50% joint-space narrowing) indicates moderate osteoarthritis, and a grade of 4 (greater than 50% joint-space narrowing) indicates severe osteoarthritis.~Total number of participants analyzed does not equal the total number of participants due to missing data."|participants|Number|34|34.0||||||
4267094|NCT00597012|4091845|B3|||SF-36 Physical Activity score|Scores on the physical-activity scale of the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) range from 0 to 100, with higher scores indicating greater physical activity.|Units on a scale|Mean|43.8|43.8|Standard Deviation|23.5|23.5|||
4267095|NCT00597012|4091846|B2|||SF-36 Physical Activity score|Scores on the physical-activity scale of the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) range from 0 to 100, with higher scores indicating greater physical activity.|Units on a scale|Mean|43.3|43.3|Standard Deviation|23.3|23.3|||
4267096|NCT00597012|4091847|B1|||SF-36 Physical Activity score|Scores on the physical-activity scale of the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) range from 0 to 100, with higher scores indicating greater physical activity.|Units on a scale|Mean|44.3|44.3|Standard Deviation|23.7|23.7|||
4267097|NCT00597012|4091845|B3|||Mental Health Index 5 score|Scores on the Mental Health Index 5 range from 0 to 100, with higher scores indicating better mental health.|Units on a scale|Mean|74.4|74.4|Standard Deviation|13.5|13.5|||
4267098|NCT00597012|4091846|B2|||Mental Health Index 5 score|Scores on the Mental Health Index 5 range from 0 to 100, with higher scores indicating better mental health.|Units on a scale|Mean|74.0|74.0|Standard Deviation|13.9|13.9|||
4267099|NCT00597012|4091847|B1|||Mental Health Index 5 score|Scores on the Mental Health Index 5 range from 0 to 100, with higher scores indicating better mental health.|Units on a scale|Mean|74.8|74.8|Standard Deviation|12.9|12.9|||
4267100|NCT00597012|4091845|B3|||KOOS pain score|Scores on the pain scale of the Knee Injury and Osteoarthritis Outcome Scale (KOOS) range from 0 to 100, with higher scores indicating more pain.|Units on a scale|Mean|46.6|46.6|Standard Deviation|16.0|16.0|||
4267101|NCT00597012|4091846|B2|||KOOS pain score|Scores on the pain scale of the Knee Injury and Osteoarthritis Outcome Scale (KOOS) range from 0 to 100, with higher scores indicating more pain.|Units on a scale|Mean|47.2|47.2|Standard Deviation|16.4|16.4|||
4267102|NCT00597012|4091847|B1|||KOOS pain score|Scores on the pain scale of the Knee Injury and Osteoarthritis Outcome Scale (KOOS) range from 0 to 100, with higher scores indicating more pain.|Units on a scale|Mean|46.0|46.0|Standard Deviation|15.5|15.5|||
4267103|NCT00597012|4091845|B3|||WOMAC physical-function score|Scores on the physical-function subscale of the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) range from 0 to 100, with higher scores indicating more limitation of physical function.|Units on a scale|Mean|37.3|37.3|Standard Deviation|18.1|18.1|||
4267104|NCT00597012|4091846|B2|||WOMAC physical-function score|Scores on the physical-function subscale of the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) range from 0 to 100, with higher scores indicating more limitation of physical function.|Units on a scale|Mean|37.5|37.5|Standard Deviation|18.3|18.3|||
4267105|NCT00597012|4091847|B1|||WOMAC physical-function score|Scores on the physical-function subscale of the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) range from 0 to 100, with higher scores indicating more limitation of physical function.|Units on a scale|Mean|37.1|37.1|Standard Deviation|17.9|17.9|||
4267106|NCT00597012|4091845|B3|||Mean Body-Mass Index|The body-mass index is the weight in kilograms divided by the square of the height in meters.|kg/m^2|Mean|30.0|30.0|Standard Deviation|6.1|6.1|||
4267107|NCT00597012|4091846|B2|||Mean Body-Mass Index|The body-mass index is the weight in kilograms divided by the square of the height in meters.|kg/m^2|Mean|30.0|30.0|Standard Deviation|6.1|6.1|||
4267108|NCT00597012|4091847|B1|||Mean Body-Mass Index|The body-mass index is the weight in kilograms divided by the square of the height in meters.|kg/m^2|Mean|30.0|30.0|Standard Deviation|6.1|6.1|||
4267109|NCT00597012|4091845|B3|Left||Index Knee||participants|Number|192|192.0||||||
4267110|NCT00597012|4091846|B2|Left||Index Knee||participants|Number|101|101.0||||||
4267111|NCT00597012|4091847|B1|Left||Index Knee||participants|Number|91|91.0||||||
4267112|NCT00597012|4091845|B3|Right||Index Knee||participants|Number|138|138.0||||||
4267113|NCT00597012|4091846|B2|Right||Index Knee||participants|Number|68|68.0||||||
4267114|NCT00597012|4091847|B1|Right||Index Knee||participants|Number|70|70.0||||||
4267115|NCT00597012|4091845|B3|Other||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4267116|NCT00597012|4091846|B2|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4267117|NCT00597012|4091847|B1|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4267118|NCT00597012|4091845|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4267119|NCT00597012|4091846|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4267120|NCT00597012|4091847|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4267121|NCT00597012|4091845|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4267122|NCT00597012|4091846|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4267123|NCT00597012|4091847|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4267124|NCT00597012|4091845|B3|White||Race/Ethnicity, Customized||participants|Number|280|280.0||||||
4267125|NCT00597012|4091846|B2|White||Race/Ethnicity, Customized||participants|Number|142|142.0||||||
4267129|NCT00597012|4091847|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4267130|NCT00597012|4091845|B3||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4267131|NCT00597012|4091846|B2||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4267132|NCT00597012|4091847|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4267133|NCT00597012|4091845|B3|||Age, Customized||years|Mean|58.4|58.4|Standard Deviation|7.3|7.3|||
4267134|NCT00597012|4091846|B2|||Age, Customized||years|Mean|57.8|57.8|Standard Deviation|6.8|6.8|||
4267135|NCT00597012|4091847|B1|||Age, Customized||years|Mean|59.0|59.0|Standard Deviation|7.9|7.9|||
4267136|NCT00596960|4091858|B3|||Posttraumatic stress disorder checklist - Civilian (PCL-C)|The PCL-C is a standardized self-report rating scale for Posttraumatic Stress disorder symptoms (PTSD). The maximum score is 85 with a range of 17 to 85. Higher scores indicate increased PTSD symptoms. A cut-off of 50 has good sesnitivity and specificty for PTSD.|units on a scale|Mean|39.28|39.28|Standard Deviation|15.62|15.62|||
4267137|NCT00596960|4091859|B2|||Posttraumatic stress disorder checklist - Civilian (PCL-C)|The PCL-C is a standardized self-report rating scale for Posttraumatic Stress disorder symptoms (PTSD). The maximum score is 85 with a range of 17 to 85. Higher scores indicate increased PTSD symptoms. A cut-off of 50 has good sesnitivity and specificty for PTSD.|units on a scale|Mean|40.61|40.61|Standard Deviation|16.04|16.04|||
4267138|NCT00596960|4091860|B1|||Posttraumatic stress disorder checklist - Civilian (PCL-C)|The PCL-C is a standardized self-report rating scale for Posttraumatic Stress disorder symptoms (PTSD). The maximum score is 85 with a range of 17 to 85. Higher scores indicate increased PTSD symptoms. A cut-off of 50 has good sesnitivity and specificty for PTSD.|units on a scale|Mean|38.01|38.01|Standard Deviation|15.21|15.21|||
4267139|NCT00596960|4091858|B3|||Brief Symptom Inventory|The Brief Symptom Inventory (BSI) is a 53 item self-report instrument that reflects 9 symptom dimensions: Somatization (SOM), Obsessive-compulsive (0-C), Interpersonal sensitivity (I-S), Depression (DEP), Anxiety (ANX), Hostility (HOS), Phobic anxiety (PHOB), Paranoid ideation (PAR) and Psychotics (PSY). For this study we used a total BSI score as a measure of distress. The maximum score is 159 and a range of 0 to 159 with higher scores indicating more psychological distress.|units on a scale|Mean|54.05|54.05|Standard Deviation|42.66|42.66|||
4267140|NCT00596960|4091859|B2|||Brief Symptom Inventory|The Brief Symptom Inventory (BSI) is a 53 item self-report instrument that reflects 9 symptom dimensions: Somatization (SOM), Obsessive-compulsive (0-C), Interpersonal sensitivity (I-S), Depression (DEP), Anxiety (ANX), Hostility (HOS), Phobic anxiety (PHOB), Paranoid ideation (PAR) and Psychotics (PSY). For this study we used a total BSI score as a measure of distress. The maximum score is 159 and a range of 0 to 159 with higher scores indicating more psychological distress.|units on a scale|Mean|56.91|56.91|Standard Deviation|44.18|44.18|||
4267141|NCT00596960|4091860|B1|||Brief Symptom Inventory|The Brief Symptom Inventory (BSI) is a 53 item self-report instrument that reflects 9 symptom dimensions: Somatization (SOM), Obsessive-compulsive (0-C), Interpersonal sensitivity (I-S), Depression (DEP), Anxiety (ANX), Hostility (HOS), Phobic anxiety (PHOB), Paranoid ideation (PAR) and Psychotics (PSY). For this study we used a total BSI score as a measure of distress. The maximum score is 159 and a range of 0 to 159 with higher scores indicating more psychological distress.|units on a scale|Mean|51.23|51.23|Standard Deviation|41.23|41.23|||
4267142|NCT00596960|4091858|B3|||Beck Depression Inventory-II|The Beck Depression Inventory-II is a continuous measure of depressive symptoms. Maximum score is 63 with a range of 0 to 63. Higher scores indicate more severe depressive symptoms.|units on a scale|Mean|17.36|17.36|Standard Deviation|11.16|11.16|||
4267143|NCT00596960|4091859|B2|||Beck Depression Inventory-II|The Beck Depression Inventory-II is a continuous measure of depressive symptoms. Maximum score is 63 with a range of 0 to 63. Higher scores indicate more severe depressive symptoms.|units on a scale|Mean|17.31|17.31|Standard Deviation|10.79|10.79|||
4267144|NCT00596960|4091860|B1|||Beck Depression Inventory-II|The Beck Depression Inventory-II is a continuous measure of depressive symptoms. Maximum score is 63 with a range of 0 to 63. Higher scores indicate more severe depressive symptoms.|units on a scale|Mean|17.40|17.4|Standard Deviation|11.58|11.58|||
4267145|NCT00596960|4091858|B3|||Mean standard drinks per week||Standard drinks of alcohol|Mean|37.13|37.13|Standard Deviation|37.03|37.03|||
4267146|NCT00596960|4091859|B2|||Mean standard drinks per week||Standard drinks of alcohol|Mean|38.86|38.86|Standard Deviation|46.19|46.19|||
4267147|NCT00596960|4091860|B1|||Mean standard drinks per week||Standard drinks of alcohol|Mean|35.45|35.45|Standard Deviation|25.42|25.42|||
4267148|NCT00596960|4091858|B3|||Percentage of days abstinent|Percentage of days abstinent from alcohol as measured by the time line follow back method in the past 30 days.|percentage of days abstinent|Mean|34.81|34.81|Standard Deviation|26.8|26.8|||
4267149|NCT00596960|4091859|B2|||Percentage of days abstinent|Percentage of days abstinent from alcohol as measured by the time line follow back method in the past 30 days.|percentage of days abstinent|Mean|34.63|34.63|Standard Deviation|27.0|27.0|||
4267150|NCT00596960|4091860|B1|||Percentage of days abstinent|Percentage of days abstinent from alcohol as measured by the time line follow back method in the past 30 days.|percentage of days abstinent|Mean|34.98|34.98|Standard Deviation|26.7|26.7|||
4267151|NCT00596960|4091858|B3|United States||Region of Enrollment||participants|Number|139|139.0||||||
4267152|NCT00596960|4091859|B2|United States||Region of Enrollment||participants|Number|69|69.0||||||
4267153|NCT00596960|4091860|B1|United States||Region of Enrollment||participants|Number|70|70.0||||||
4267154|NCT00596960|4091858|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4267155|NCT00596960|4091859|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4267156|NCT00596960|4091860|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4267157|NCT00596960|4091858|B3|Native American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4267158|NCT00596960|4091859|B2|Native American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4267159|NCT00596960|4091860|B1|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4267160|NCT00596960|4091858|B3|African American||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4267161|NCT00596960|4091859|B2|African American||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4267162|NCT00596960|4091860|B1|African American||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4267163|NCT00596960|4091858|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|94|94.0||||||
4267164|NCT00596960|4091859|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4267165|NCT00596960|4091860|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
4267166|NCT00596960|4091858|B3||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4267167|NCT00596960|4091859|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4267168|NCT00596960|4091860|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4267169|NCT00596960|4091858|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4267170|NCT00596960|4091859|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4267171|NCT00596960|4091860|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4267172|NCT00596960|4091858|B3|||Age||years|Mean|55.5|55.5|Standard Deviation|6.6|6.6|||
4267173|NCT00596960|4091859|B2|||Age||years|Mean|55.2|55.2|Standard Deviation|6.3|6.3|||
4267174|NCT00596960|4091860|B1|||Age||years|Mean|55.8|55.8|Standard Deviation|6.8|6.8|||
4267175|NCT00596947|4091871|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4267176|NCT00596947|4091872|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4267177|NCT00596947|4091873|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4267178|NCT00596947|4091871|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4267179|NCT00596947|4091872|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4267180|NCT00596947|4091873|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4267181|NCT00596947|4091871|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4267182|NCT00596947|4091872|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4267183|NCT00596947|4091873|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4267184|NCT00596947|4091871|B3|||Age||years|Mean|49.2|49.2|Standard Deviation|12.5|12.5|||
4267185|NCT00596947|4091872|B2|||Age||years|Mean|50.6|50.6|Standard Deviation|13.2|13.2|||
4267186|NCT00596947|4091873|B1|||Age||years|Mean|47.5|47.5|Standard Deviation|12.3|12.3|||
4267187|NCT00596947|4091871|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4267188|NCT00596947|4091872|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4267189|NCT00596947|4091873|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4267190|NCT00596947|4091871|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4267191|NCT00596947|4091872|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4267192|NCT00596947|4091873|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4267193|NCT00596947|4091871|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267194|NCT00596947|4091872|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267195|NCT00596947|4091873|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267196|NCT00596934|4091914|B1|||Fasting triglycerides|Normal range for laboratory values: <150 mg/dL|mg/dL|Mean|129.4|129.4|Standard Deviation|66.2|66.2|||
4267197|NCT00596934|4091914|B1|||Insulin Resistance: homeostatic model assessment (HOMA)|HOMA values are based on fasting insulin and glucose concentrations and calculated as fasting insulin concentration (mU/L) x fasting glucose concentration (mg/dL)/405|mU/L x mg/dL|Mean|7.4|7.4|Standard Deviation|3.2|3.2|||
4267198|NCT00596934|4091914|B1|||Fasting glucose|Normal range for laboratory values: 73 - 100 mg/dL|mg/dL|Mean|98.1|98.1|Standard Deviation|7.2|7.2|||
4267199|NCT00596934|4091914|B1|||Liver function test: Aspartate aminotransferase (AST)|Normal range for laboratory values: 8 - 30 IU/L|IU/L|Mean|33.5|33.5|Standard Deviation|13.3|13.3|||
4267200|NCT00596934|4091914|B1|||Liver function test: Alanine aminotransferase (ALT)|Normal range for laboratory values: <=35 IU/L|IU/L|Mean|50.9|50.9|Standard Deviation|19.4|19.4|||
4267201|NCT00596934|4091914|B1|||Liver fat percentage by Magnetic Resonance Imaging (MRI - Dixon method)|For determination of hepatic fat content by MRI and MR spectroscopy in patients, a series of out-phase and in-phase MRI at multiple flip angles are used. By combination of out-phase and in-phase MRI at multiple flip-angles and TE times, relaxation-time effects can be removed to yield quantitative intra-hepatic (and other organs’) fractional fat content throughout the liver in a few breath-hold intervals.|liver fat percentage|Mean|19.0|19.0|Standard Deviation|7.7|7.7|||
4267202|NCT00596934|4091914|B1|||Body Weight||kg|Mean|90.9|90.9|Standard Deviation|9.0|9.0|||
4267203|NCT00596934|4091914|B1|||Non-alcoholic steatohepatitis (NASH) score|NASH scale: 0 - 14. The higher the NASH score the more severe the liver disease.|units on a scale|Mean|8.1|8.1|Standard Deviation|3.3|3.3|||
4267204|NCT00596934|4091914|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4267205|NCT00596934|4091914|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4267206|NCT00596934|4091914|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4267207|NCT00596934|4091914|B1|||Age||years|Mean|44.3|44.3|Full Range|||32.0|53.0|
4267208|NCT00596830|4091925|B3||Male|Sex: Female, Male||Participants|Count of Participants|521|521.0||||||
4267209|NCT00596830|4091926|B2||Male|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
4267210|NCT00596830|4091927|B1||Male|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
4267211|NCT00596830|4091925|B3||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4267212|NCT00596830|4091926|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4267213|NCT00596830|4091927|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4267214|NCT00596830|4091925|B3|||Age||years|Mean|61.8|61.8|Standard Deviation|9.0|9.0|||
4267215|NCT00596830|4091926|B2|||Age||years|Mean|61.8|61.8|Standard Deviation|9.1|9.1|||
4267216|NCT00596830|4091927|B1|||Age||years|Mean|61.8|61.8|Standard Deviation|9.0|9.0|||
4267217|NCT00596817|4091951|B4|||SDS|The Sheehan Disability Scale (SDS) comprises self-rated items designed to measure impairment. The patient rates the extent to which his or her (1) work, (2) social life or leisure activities and (3) home life or family responsibilities are impaired on a 10-point visual analogue scales, on which 0 = normal functioning and 10 = severe functional impairment. The three items may be summed into a single dimensional measure of global functional impairment that ranges from 0 (unimpaired) to 30 (highly impaired). The higher the score, the more severe.|units on a scale|Mean|8.66|8.66|Standard Deviation|7.27|7.27|||
4267218|NCT00596817|4091952|B3|||SDS|The Sheehan Disability Scale (SDS) comprises self-rated items designed to measure impairment. The patient rates the extent to which his or her (1) work, (2) social life or leisure activities and (3) home life or family responsibilities are impaired on a 10-point visual analogue scales, on which 0 = normal functioning and 10 = severe functional impairment. The three items may be summed into a single dimensional measure of global functional impairment that ranges from 0 (unimpaired) to 30 (highly impaired). The higher the score, the more severe.|units on a scale|Mean|8.95|8.95|Standard Deviation|7.09|7.09|||
4267219|NCT00596817|4091953|B2|||SDS|The Sheehan Disability Scale (SDS) comprises self-rated items designed to measure impairment. The patient rates the extent to which his or her (1) work, (2) social life or leisure activities and (3) home life or family responsibilities are impaired on a 10-point visual analogue scales, on which 0 = normal functioning and 10 = severe functional impairment. The three items may be summed into a single dimensional measure of global functional impairment that ranges from 0 (unimpaired) to 30 (highly impaired). The higher the score, the more severe.|units on a scale|Mean|8.37|8.37|Standard Deviation|7.44|7.44|||
4267220|NCT00596817|4091954|B1|||SDS|The Sheehan Disability Scale (SDS) comprises self-rated items designed to measure impairment. The patient rates the extent to which his or her (1) work, (2) social life or leisure activities and (3) home life or family responsibilities are impaired on a 10-point visual analogue scales, on which 0 = normal functioning and 10 = severe functional impairment. The three items may be summed into a single dimensional measure of global functional impairment that ranges from 0 (unimpaired) to 30 (highly impaired). The higher the score, the more severe.|units on a scale|Mean|20.8|20.8|Standard Deviation|5.7|5.7|||
4267221|NCT00596817|4091951|B4|||CGI-S|The Clinical Global Impression - Severity of Illness (CGI-S) is a 7-point scale rated from 1 (normal, not at all ill) to 7 (among the most extremely ill patients). The investigator should use his/her total clinical experience with this patient population to judge how mentally ill the patient is at the time of rating.|units on a scale|Mean|1.55|1.55|Standard Deviation|0.69|0.69|||
4267222|NCT00596817|4091952|B3|||CGI-S|The Clinical Global Impression - Severity of Illness (CGI-S) is a 7-point scale rated from 1 (normal, not at all ill) to 7 (among the most extremely ill patients). The investigator should use his/her total clinical experience with this patient population to judge how mentally ill the patient is at the time of rating.|units on a scale|Mean|1.56|1.56|Standard Deviation|0.68|0.68|||
4267223|NCT00596817|4091953|B2|||CGI-S|The Clinical Global Impression - Severity of Illness (CGI-S) is a 7-point scale rated from 1 (normal, not at all ill) to 7 (among the most extremely ill patients). The investigator should use his/her total clinical experience with this patient population to judge how mentally ill the patient is at the time of rating.|units on a scale|Mean|1.54|1.54|Standard Deviation|0.69|0.69|||
4267224|NCT00596817|4091954|B1|||CGI-S|The Clinical Global Impression - Severity of Illness (CGI-S) is a 7-point scale rated from 1 (normal, not at all ill) to 7 (among the most extremely ill patients). The investigator should use his/her total clinical experience with this patient population to judge how mentally ill the patient is at the time of rating.|units on a scale|Mean|4.8|4.8|Standard Deviation|0.7|0.7|||
4267225|NCT00596817|4091951|B4|||HAM-A|The Hamilton Anxiety Rating Scale (HAM-A) consists of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behaviour at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic, and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total score from 0 to 56. The higher the score, the more severe.|units on a scale|Mean|4.85|4.85|Standard Deviation|3.72|3.72|||
4267226|NCT00596817|4091952|B3|||HAM-A|The Hamilton Anxiety Rating Scale (HAM-A) consists of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behaviour at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic, and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total score from 0 to 56. The higher the score, the more severe.|units on a scale|Mean|5.09|5.09|Standard Deviation|3.83|3.83|||
4267227|NCT00596817|4091953|B2|||HAM-A|The Hamilton Anxiety Rating Scale (HAM-A) consists of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behaviour at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic, and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total score from 0 to 56. The higher the score, the more severe.|units on a scale|Mean|4.60|4.6|Standard Deviation|3.60|3.6|||
4267228|NCT00596817|4091954|B1|||HAM-A|The Hamilton Anxiety Rating Scale (HAM-A) consists of 14 items that assess anxious mood, tension, fear, insomnia, intellectual (cognitive) symptoms, depressed mood, behaviour at interview, somatic (sensory), cardiovascular, respiratory, gastrointestinal, genitourinary, autonomic, and somatic (muscular) symptoms. Each symptom is rated from 0 (absent) to 4 (maximum severity). Total score from 0 to 56. The higher the score, the more severe.|units on a scale|Mean|22.6|22.6|Standard Deviation|6.6|6.6|||
4267229|NCT00596817|4091951|B4|||HAM-D-17|The Hamilton Depression Scale – 17 items (HAM-D-17) measures depression severity. Items are rated on a scale from 0 (symptoms not present) to a maximum of 2 to 4 (symptom extremely severe) for a total score range of 0 to 52. The higher the score, the more severe.|units on a scale|Mean|4.21|4.21|Standard Deviation|3.21|3.21|||
4267230|NCT00596817|4091952|B3|||HAM-D-17|The Hamilton Depression Scale – 17 items (HAM-D-17) measures depression severity. Items are rated on a scale from 0 (symptoms not present) to a maximum of 2 to 4 (symptom extremely severe) for a total score range of 0 to 52. The higher the score, the more severe.|units on a scale|Mean|4.46|4.46|Standard Deviation|3.27|3.27|||
4267270|NCT00596752|4091979|B2||>=65 years|Age||Participants|Count of Participants|253|253.0||||||
4267271|NCT00596752|4091980|B1||>=65 years|Age||Participants|Count of Participants|263|263.0||||||
4267231|NCT00596817|4091953|B2|||HAM-D-17|The Hamilton Depression Scale – 17 items (HAM-D-17) measures depression severity. Items are rated on a scale from 0 (symptoms not present) to a maximum of 2 to 4 (symptom extremely severe) for a total score range of 0 to 52. The higher the score, the more severe.|units on a scale|Mean|3.96|3.96|Standard Deviation|3.15|3.15|||
4267232|NCT00596817|4091954|B1|||HAM-D-17|The Hamilton Depression Scale – 17 items (HAM-D-17) measures depression severity. Items are rated on a scale from 0 (symptoms not present) to a maximum of 2 to 4 (symptom extremely severe) for a total score range of 0 to 52. The higher the score, the more severe.|units on a scale|Mean|22.8|22.8|Standard Deviation|4.5|4.5|||
4267233|NCT00596817|4091951|B4|||MADRS|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 (no symptom) to 6 (severe symptom). The 10 items represent the core symptoms of depressive illness. The rating should be based on a clinical interview with the patient, moving from broadly phrased questions about symptoms to more detailed ones, which allow a precise rating of severity, covering the last 7 days. Total score from 0 to 60. The higher the score, the more severe.|units on a scale|Mean|4.78|4.78|Standard Deviation|3.08|3.08|||
4267234|NCT00596817|4091952|B3|||MADRS|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 (no symptom) to 6 (severe symptom). The 10 items represent the core symptoms of depressive illness. The rating should be based on a clinical interview with the patient, moving from broadly phrased questions about symptoms to more detailed ones, which allow a precise rating of severity, covering the last 7 days. Total score from 0 to 60. The higher the score, the more severe.|units on a scale|Mean|4.89|4.89|Standard Deviation|3.00|3.0|||
4267235|NCT00596817|4091953|B2|||MADRS|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 (no symptom) to 6 (severe symptom). The 10 items represent the core symptoms of depressive illness. The rating should be based on a clinical interview with the patient, moving from broadly phrased questions about symptoms to more detailed ones, which allow a precise rating of severity, covering the last 7 days. Total score from 0 to 60. The higher the score, the more severe.|units on a scale|Mean|4.66|4.66|Standard Deviation|3.16|3.16|||
4267236|NCT00596817|4091954|B1|||MADRS|The Montgomery Åsberg Depression Rating Scale (MADRS) is a depression rating scale consisting of 10 items, each rated 0 (no symptom) to 6 (severe symptom). The 10 items represent the core symptoms of depressive illness. The rating should be based on a clinical interview with the patient, moving from broadly phrased questions about symptoms to more detailed ones, which allow a precise rating of severity, covering the last 7 days. Total score from 0 to 60. The higher the score, the more severe.|units on a scale|Mean|32.3|32.3|Standard Deviation|4.1|4.1|||
4267237|NCT00596817|4091951|B4|Male (Double-blind Period)||Sex/Gender, Customized||participants|Number|146|146.0||||||
4267238|NCT00596817|4091952|B3|Male (Double-blind Period)||Sex/Gender, Customized||participants|Number|74|74.0||||||
4267239|NCT00596817|4091953|B2|Male (Double-blind Period)||Sex/Gender, Customized||participants|Number|72|72.0||||||
4267240|NCT00596817|4091954|B1|Male (Double-blind Period)||Sex/Gender, Customized||participants|Number|0|0.0||||||
4267241|NCT00596817|4091951|B4|Female (Double-blind Period)||Sex/Gender, Customized||participants|Number|250|250.0||||||
4267242|NCT00596817|4091952|B3|Female (Double-blind Period)||Sex/Gender, Customized||participants|Number|130|130.0||||||
4267243|NCT00596817|4091953|B2|Female (Double-blind Period)||Sex/Gender, Customized||participants|Number|120|120.0||||||
4267244|NCT00596817|4091954|B1|Female (Double-blind Period)||Sex/Gender, Customized||participants|Number|0|0.0||||||
4267245|NCT00596817|4091951|B4|Male (Open-label Period)||Sex/Gender, Customized||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4267246|NCT00596817|4091952|B3|Male (Open-label Period)||Sex/Gender, Customized||participants|Number|NA|||||||Only data for Open-label Period
4267247|NCT00596817|4091953|B2|Male (Open-label Period)||Sex/Gender, Customized||participants|Number|NA|||||||Only data for Open-label Period
4267248|NCT00596817|4091954|B1|Male (Open-label Period)||Sex/Gender, Customized||participants|Number|242|242.0||||||
4267249|NCT00596817|4091951|B4|Female (Open-label Period)||Sex/Gender, Customized||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4267250|NCT00596817|4091952|B3|Female (Open-label Period)||Sex/Gender, Customized||participants|Number|NA|||||||Only data for Open-label Period
4267251|NCT00596817|4091953|B2|Female (Open-label Period)||Sex/Gender, Customized||participants|Number|NA|||||||Only data for Open-label Period
4267252|NCT00596817|4091954|B1|Female (Open-label Period)||Sex/Gender, Customized||participants|Number|397|397.0||||||
4267253|NCT00596817|4091951|B4|||Age||years|Mean|45.0|45.0|Standard Deviation|12.3|12.3|||
4267254|NCT00596817|4091952|B3|||Age||years|Mean|44.8|44.8|Standard Deviation|12.4|12.4|||
4267255|NCT00596817|4091953|B2|||Age||years|Mean|45.1|45.1|Standard Deviation|12.1|12.1|||
4267256|NCT00596817|4091954|B1|||Age||years|Mean|44.6|44.6|Standard Deviation|12.4|12.4|||
4267257|NCT00596752|4091978|B3|||Weight||kilogram (kg)|Mean|76.0|76.0|Standard Deviation|12.2|12.2|||
4267258|NCT00596752|4091979|B2|||Weight||kilogram (kg)|Mean|76.6|76.6|Standard Deviation|12.6|12.6|||
4267259|NCT00596752|4091980|B1|||Weight||kilogram (kg)|Mean|75.4|75.4|Standard Deviation|11.9|11.9|||
4267260|NCT00596752|4091978|B3||Male|Sex: Female, Male||Participants|Count of Participants|599|599.0||||||
4267261|NCT00596752|4091979|B2||Male|Sex: Female, Male||Participants|Count of Participants|306|306.0||||||
4267262|NCT00596752|4091980|B1||Male|Sex: Female, Male||Participants|Count of Participants|293|293.0||||||
4267263|NCT00596752|4091978|B3||Female|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
4267264|NCT00596752|4091979|B2||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4267265|NCT00596752|4091980|B1||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4267266|NCT00596752|4091978|B3|||Age||years|Mean|66.6|66.6|Standard Deviation|8.9|8.9|||
4267267|NCT00596752|4091979|B2|||Age||years|Mean|66.4|66.4|Standard Deviation|9.3|9.3|||
4267268|NCT00596752|4091980|B1|||Age||years|Mean|66.8|66.8|Standard Deviation|8.5|8.5|||
4267269|NCT00596752|4091978|B3||>=65 years|Age||Participants|Count of Participants|516|516.0||||||
4267272|NCT00596752|4091978|B3||Between 18 and 65 years|Age||Participants|Count of Participants|323|323.0||||||
4267273|NCT00596752|4091979|B2||Between 18 and 65 years|Age||Participants|Count of Participants|170|170.0||||||
4267274|NCT00596752|4091980|B1||Between 18 and 65 years|Age||Participants|Count of Participants|153|153.0||||||
4267275|NCT00596752|4091978|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267276|NCT00596752|4091979|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267277|NCT00596752|4091980|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267278|NCT00596687|4092009|B3|United States||Region of Enrollment||participants|Number|211|211.0||||||
4267279|NCT00596687|4092010|B2|United States||Region of Enrollment||participants|Number|107|107.0||||||
4267280|NCT00596687|4092011|B1|United States||Region of Enrollment||participants|Number|104|104.0||||||
4267281|NCT00596687|4092009|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4267282|NCT00596687|4092010|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4267283|NCT00596687|4092011|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4267284|NCT00596687|4092009|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4267285|NCT00596687|4092010|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4267286|NCT00596687|4092011|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4267287|NCT00596687|4092009|B3|||Age||years|Mean|58|58.0|Standard Deviation|11|11.0|||
4267288|NCT00596687|4092010|B2|||Age||years|Mean|57|57.0|Standard Deviation|10|10.0|||
4267289|NCT00596687|4092011|B1|||Age||years|Mean|58|58.0|Standard Deviation|12|12.0|||
4267290|NCT00596687|4092009|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4267291|NCT00596687|4092010|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4267292|NCT00596687|4092011|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4267293|NCT00596687|4092009|B3||Between 18 and 65 years|Age||Participants|Count of Participants|203|203.0||||||
4267294|NCT00596687|4092010|B2||Between 18 and 65 years|Age||Participants|Count of Participants|102|102.0||||||
4267295|NCT00596687|4092011|B1||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
4267296|NCT00596687|4092009|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267297|NCT00596687|4092010|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267298|NCT00596687|4092011|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267299|NCT00596635|4092020|B4|United States||Region of Enrollment||participants|Number|56|56.0||||||
4267300|NCT00596635|4092021|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4267301|NCT00596635|4092022|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4267302|NCT00596635|4092023|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4267303|NCT00596635|4092020|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4267304|NCT00596635|4092021|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4267305|NCT00596635|4092022|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4267306|NCT00596635|4092023|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4267307|NCT00596635|4092020|B4||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4267308|NCT00596635|4092021|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4267309|NCT00596635|4092022|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4267310|NCT00596635|4092023|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4267311|NCT00596635|4092020|B4|||Age||years|Mean|86.82|86.82|Standard Deviation|7.97|7.97|||
4267312|NCT00596635|4092021|B3|||Age||years|Mean|86.68|86.68|Standard Deviation|5.16|5.16|||
4267313|NCT00596635|4092022|B2|||Age||years|Mean|88.30|88.3|Standard Deviation|6.16|6.16|||
4267314|NCT00596635|4092023|B1|||Age||years|Mean|85.76|85.76|Standard Deviation|11.76|11.76|||
4267315|NCT00596635|4092020|B4||>=65 years|Age||Participants|Count of Participants|55|55.0||||||
4267316|NCT00596635|4092021|B3||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4267317|NCT00596635|4092022|B2||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4267318|NCT00596635|4092023|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4267319|NCT00596635|4092020|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4267320|NCT00596635|4092021|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4267321|NCT00596635|4092022|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4267322|NCT00596635|4092023|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4267323|NCT00596635|4092020|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267324|NCT00596635|4092021|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267325|NCT00596635|4092022|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267326|NCT00596635|4092023|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267327|NCT00596622|4092039|B4|United States||Region of Enrollment||participants|Number|46|46.0||||||
4267328|NCT00596622|4092040|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4267329|NCT00596622|4092041|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4267330|NCT00596622|4092042|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4267331|NCT00596622|4092039|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4267332|NCT00596622|4092040|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4267333|NCT00596622|4092041|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4267334|NCT00596622|4092042|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4267335|NCT00596622|4092039|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4267336|NCT00596622|4092040|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4267337|NCT00596622|4092041|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4267338|NCT00596622|4092042|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4267339|NCT00596622|4092039|B4|||Age||years|Mean|33|33.0|Standard Deviation|10|10.0|||
4267340|NCT00596622|4092040|B3|||Age||years|Mean|26|26.0|Standard Deviation|4|4.0|||
4267341|NCT00596622|4092041|B2|||Age||years|Mean|34|34.0|Standard Deviation|11|11.0|||
4267342|NCT00596622|4092042|B1|||Age||years|Mean|34|34.0|Standard Deviation|10|10.0|||
4267343|NCT00596466|4092051|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4267344|NCT00596466|4092051|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4267345|NCT00596466|4092051|B1|Greater than or equal to (≥) 65 years||Age, Customized||Participants|Number|4|4.0||||||
4267346|NCT00596466|4092051|B1|45-64 years||Age, Customized||Participants|Number|23|23.0||||||
4267347|NCT00596466|4092051|B1|18-44 years||Age, Customized||Participants|Number|48|48.0||||||
4267348|NCT00596453|4092057|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
4267349|NCT00596453|4092058|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4267350|NCT00596453|4092059|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4267351|NCT00596453|4092057|B3||Male|Gender||Participants|Count of Participants|28|28.0||||||
4267352|NCT00596453|4092058|B2||Male|Gender||Participants|Count of Participants|15|15.0||||||
4267353|NCT00596453|4092059|B1||Male|Gender||Participants|Count of Participants|13|13.0||||||
4267354|NCT00596453|4092057|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
4267355|NCT00596453|4092058|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
4267356|NCT00596453|4092059|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
4267357|NCT00596453|4092057|B3|||Age||years|Mean|60.75|60.75|Full Range|||44.0|72.0|
4267358|NCT00596453|4092058|B2|||Age||years|Mean|62.73|62.73|Full Range|||47.0|71.0|
4267359|NCT00596453|4092059|B1|||Age||years|Mean|58.46|58.46|Full Range|||44.0|72.0|
4267360|NCT00596453|4092057|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4267361|NCT00596453|4092058|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4267362|NCT00596453|4092059|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4267363|NCT00596453|4092057|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4267364|NCT00596453|4092058|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4267365|NCT00596453|4092059|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4267366|NCT00596453|4092057|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267367|NCT00596453|4092058|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267368|NCT00596453|4092059|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267369|NCT00596440|4092066|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4267370|NCT00596440|4092067|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4267371|NCT00596440|4092068|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4267372|NCT00596440|4092066|B3||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4267373|NCT00596440|4092067|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4267374|NCT00596440|4092068|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4267375|NCT00596440|4092066|B3|||Age||years|Mean|47.0|47.0|Standard Deviation|11.9|11.9|||
4267376|NCT00596440|4092067|B2|||Age||years|Mean|49.2|49.2|Standard Deviation|11.7|11.7|||
4267377|NCT00596440|4092068|B1|||Age||years|Mean|44.7|44.7|Standard Deviation|11.7|11.7|||
4267378|NCT00596427|4092079|B3|||Triacylglycerol||mmol/l|Mean|2.1|2.1|Standard Deviation|0.9|0.9|||
4267379|NCT00596427|4092080|B2|||Triacylglycerol||mmol/l|Mean|2.0|2.0|Standard Deviation|0.9|0.9|||
4267380|NCT00596427|4092081|B1|||Triacylglycerol||mmol/l|Mean|2.2|2.2|Standard Deviation|0.8|0.8|||
4267381|NCT00596427|4092079|B3|||HDL-cholesterol||mmol/l|Mean|1.0|1.0|Standard Deviation|0.2|0.2|||
4267382|NCT00596427|4092080|B2|||HDL-cholesterol||mmol/l|Mean|1.0|1.0|Standard Deviation|0.2|0.2|||
4267383|NCT00596427|4092081|B1|||HDL-cholesterol||mmol/l|Mean|0.9|0.9|Standard Deviation|0.2|0.2|||
4267384|NCT00596427|4092079|B3|||LDL-cholesterol||mmol/l|Mean|2.8|2.8|Standard Deviation|0.9|0.9|||
4267385|NCT00596427|4092080|B2|||LDL-cholesterol||mmol/l|Mean|2.8|2.8|Standard Deviation|1.0|1.0|||
4267386|NCT00596427|4092081|B1|||LDL-cholesterol||mmol/l|Mean|2.8|2.8|Standard Deviation|0.8|0.8|||
4267387|NCT00596427|4092079|B3|||Total cholesterol||mmol/l|Mean|4.6|4.6|Standard Deviation|1.3|1.3|||
4267388|NCT00596427|4092080|B2|||Total cholesterol||mmol/l|Mean|4.6|4.6|Standard Deviation|1.3|1.3|||
4267389|NCT00596427|4092081|B1|||Total cholesterol||mmol/l|Mean|4.6|4.6|Standard Deviation|1.2|1.2|||
4267390|NCT00596427|4092079|B3|||Insulin||pmol/l|Mean|87|87.0|Standard Deviation|42|42.0|||
4267391|NCT00596427|4092080|B2|||Insulin||pmol/l|Mean|97|97.0|Standard Deviation|42|42.0|||
4267392|NCT00596427|4092081|B1|||Insulin||pmol/l|Mean|76|76.0|Standard Deviation|42|42.0|||
4267393|NCT00596427|4092079|B3|||Glucose||mmol/l|Mean|8.8|8.8|Standard Deviation|2.3|2.3|||
4267394|NCT00596427|4092080|B2|||Glucose||mmol/l|Mean|8.4|8.4|Standard Deviation|2.4|2.4|||
4267395|NCT00596427|4092081|B1|||Glucose||mmol/l|Mean|9.2|9.2|Standard Deviation|2.3|2.3|||
4267396|NCT00596427|4092079|B3|||HbA 1c||percentage|Mean|8.25|8.25|Standard Deviation|1.05|1.05|||
4267397|NCT00596427|4092080|B2|||HbA 1c||percentage|Mean|8.0|8.0|Standard Deviation|0.9|0.9|||
4267398|NCT00596427|4092081|B1|||HbA 1c||percentage|Mean|8.5|8.5|Standard Deviation|1.2|1.2|||
4267399|NCT00596427|4092079|B3|||Weight|Baseline participant characteristics.|kg|Mean|86|86.0|Standard Deviation|18|18.0|||
4267400|NCT00596427|4092080|B2|||Weight|Baseline participant characteristics.|kg|Mean|88|88.0|Standard Deviation|19|19.0|||
4267401|NCT00596427|4092081|B1|||Weight|Baseline participant characteristics.|kg|Mean|84|84.0|Standard Deviation|16|16.0|||
4267402|NCT00596427|4092079|B3|||BMI|Baseline participant characteristics.|kg/m2|Mean|30.5|30.5|Standard Deviation|5|5.0|||
4267403|NCT00596427|4092080|B2|||BMI|Baseline participant characteristics.|kg/m2|Mean|31|31.0|Standard Deviation|5|5.0|||
4267404|NCT00596427|4092081|B1|||BMI|Baseline participant characteristics.|kg/m2|Mean|30|30.0|Standard Deviation|5|5.0|||
4267405|NCT00596427|4092079|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4267406|NCT00596427|4092080|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4267407|NCT00596427|4092081|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4267408|NCT00596427|4092079|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4267409|NCT00596427|4092080|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4267410|NCT00596427|4092081|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4267411|NCT00596427|4092079|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4267412|NCT00596427|4092080|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4267413|NCT00596427|4092081|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4267414|NCT00596427|4092079|B3|||Age||years|Mean|57.5|57.5|Standard Deviation|9|9.0|||
4267415|NCT00596427|4092080|B2|||Age||years|Mean|56|56.0|Standard Deviation|9|9.0|||
4267416|NCT00596427|4092081|B1|||Age||years|Mean|59|59.0|Standard Deviation|9|9.0|||
4267417|NCT00596427|4092079|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4267418|NCT00596427|4092080|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4267419|NCT00596427|4092081|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4267420|NCT00596427|4092079|B3||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4267421|NCT00596427|4092080|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4267422|NCT00596427|4092081|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4267423|NCT00596427|4092079|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267424|NCT00596427|4092080|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267425|NCT00596427|4092081|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267426|NCT00596362|4092110|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4267427|NCT00596362|4092110|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4267428|NCT00596362|4092110|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4267429|NCT00596362|4092110|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4267430|NCT00596362|4092110|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4267431|NCT00596362|4092110|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267432|NCT00596271|4092114|B4|Europe||Region of Enrollment||participants|Number|192|192.0||||||
4267433|NCT00596271|4092115|B3|Europe||Region of Enrollment||participants|Number|62|62.0||||||
4267434|NCT00596271|4092116|B2|Europe||Region of Enrollment||participants|Number|65|65.0||||||
4267435|NCT00596271|4092117|B1|Europe||Region of Enrollment||participants|Number|65|65.0||||||
4267436|NCT00596271|4092114|B4||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4267437|NCT00596271|4092115|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4267438|NCT00596271|4092116|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4267439|NCT00596271|4092117|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4267440|NCT00596271|4092114|B4||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4267441|NCT00596271|4092115|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4267442|NCT00596271|4092116|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4267443|NCT00596271|4092117|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4267444|NCT00596271|4092114|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4267445|NCT00596271|4092115|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4267446|NCT00596271|4092116|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4267447|NCT00596271|4092117|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4267448|NCT00596271|4092114|B4||Between 18 and 65 years|Age||Participants|Count of Participants|192|192.0||||||
4267449|NCT00596271|4092115|B3||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4267450|NCT00596271|4092116|B2||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4267451|NCT00596271|4092117|B1||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4267452|NCT00596271|4092114|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267453|NCT00596271|4092115|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267454|NCT00596271|4092116|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267455|NCT00596271|4092117|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267456|NCT00596167|4092128|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4267457|NCT00596167|4092128|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4267458|NCT00596167|4092128|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4267459|NCT00596167|4092128|B1|||Age||years|Mean|40|40.0|Standard Deviation|2|2.0|||
4267460|NCT00596167|4092128|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4267461|NCT00596167|4092128|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4267462|NCT00596167|4092128|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267463|NCT00596102|4092132|B4|Other||Race/Ethnicity, Customized||participants|Number|104|104.0||||||
4267464|NCT00596102|4092133|B3|Other||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4267465|NCT00596102|4092134|B2|Other||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4267466|NCT00596102|4092135|B1|Other||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
4267467|NCT00596102|4092132|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|2938|2938.0||||||
4267468|NCT00596102|4092133|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|574|574.0||||||
4267469|NCT00596102|4092134|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|288|288.0||||||
4267470|NCT00596102|4092135|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|2076|2076.0||||||
4267471|NCT00596102|4092132|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|161|161.0||||||
4267472|NCT00596102|4092133|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4267473|NCT00596102|4092134|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4267474|NCT00596102|4092135|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|101|101.0||||||
4267475|NCT00596102|4092132|B4|Asian||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
4267476|NCT00596102|4092133|B3|Asian||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4267477|NCT00596102|4092134|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4267478|NCT00596102|4092135|B1|Asian||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4267479|NCT00596102|4092132|B4||Male|Sex: Female, Male||Participants|Count of Participants|1418|1418.0||||||
4267480|NCT00596102|4092133|B3||Male|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
4267481|NCT00596102|4092134|B2||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4267482|NCT00596102|4092135|B1||Male|Sex: Female, Male||Participants|Count of Participants|1009|1009.0||||||
4267483|NCT00596102|4092132|B4||Female|Sex: Female, Male||Participants|Count of Participants|1840|1840.0||||||
4267484|NCT00596102|4092133|B3||Female|Sex: Female, Male||Participants|Count of Participants|365|365.0||||||
4267485|NCT00596102|4092134|B2||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4267486|NCT00596102|4092135|B1||Female|Sex: Female, Male||Participants|Count of Participants|1274|1274.0||||||
4267487|NCT00596102|4092132|B4|||Age||years|Mean|35.6|35.6|Standard Deviation|13.9|13.9|||
4267488|NCT00596102|4092133|B3|||Age||years|Mean|33.5|33.5|Standard Deviation|13.0|13.0|||
4267489|NCT00596102|4092134|B2|||Age||years|Mean|42.3|42.3|Standard Deviation|14.1|14.1|||
4267490|NCT00596102|4092135|B1|||Age||years|Mean|35.3|35.3|Standard Deviation|13.8|13.8|||
4267491|NCT00596011|4092144|B3|United States||Region of Enrollment||Participants|Count of Participants|97|97.0||||||
4267492|NCT00596011|4092145|B2|United States||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
4267493|NCT00596011|4092146|B1|United States||Region of Enrollment||Participants|Count of Participants|49|49.0||||||
4267494|NCT00596011|4092144|B3||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4267495|NCT00596011|4092145|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4267496|NCT00596011|4092146|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4267497|NCT00596011|4092144|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4267498|NCT00596011|4092145|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4267499|NCT00596011|4092146|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4267500|NCT00596011|4092144|B3||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
4267501|NCT00596011|4092145|B2||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4267502|NCT00596011|4092146|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4267503|NCT00596011|4092144|B3||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4267504|NCT00596011|4092145|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4267505|NCT00596011|4092146|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4267506|NCT00596011|4092144|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267507|NCT00596011|4092145|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267508|NCT00596011|4092146|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267509|NCT00596011|4092144|B3|||Age||years|Mean|63.02|63.02|Full Range|||45.0|79.0|
4267510|NCT00596011|4092145|B2|||Age||years|Mean|64.10|64.1|Full Range|||45.0|78.0|
4267511|NCT00596011|4092146|B1|||Age||years|Mean|62|62.0|Full Range|||45.0|79.0|
4267512|NCT00595959|4092163|B1|African American||Race/Ethnicity||participants|Number|11|11.0||||||
4267513|NCT00595959|4092163|B1|Not Hispanic or Latino||Race/Ethnicity||participants|Number|49|49.0||||||
4267514|NCT00595959|4092163|B1|Hispanic or Latino||Race/Ethnicity||participants|Number|5|5.0||||||
4267515|NCT00595959|4092163|B1|United States||Region of Enrollment||participants|Number|65|65.0||||||
4267516|NCT00595959|4092163|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4267517|NCT00595959|4092163|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4267518|NCT00595959|4092163|B1|||Age||years|Mean|68.3|68.3|Standard Deviation|10.1|10.1|||
4267519|NCT00595946|4092178|B3|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4267520|NCT00595946|4092179|B2|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4267521|NCT00595946|4092180|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4267522|NCT00595946|4092178|B3|United States||Region of Enrollment||participants|Number|434|434.0||||||
4267523|NCT00595946|4092179|B2|United States||Region of Enrollment||participants|Number|218|218.0||||||
4267524|NCT00595946|4092180|B1|United States||Region of Enrollment||participants|Number|216|216.0||||||
4267525|NCT00595946|4092178|B3||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4267526|NCT00595946|4092179|B2||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4267527|NCT00595946|4092180|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4267528|NCT00595946|4092178|B3||Female|Sex: Female, Male||Participants|Count of Participants|280|280.0||||||
4267529|NCT00595946|4092179|B2||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4267530|NCT00595946|4092180|B1||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4267531|NCT00595946|4092178|B3|||Age||years|Mean|50.0|50.0|Standard Deviation|10.94|10.94|||
4267532|NCT00595946|4092179|B2|||Age||years|Mean|50.1|50.1|Standard Deviation|9.89|9.89|||
4267533|NCT00595946|4092180|B1|||Age||years|Mean|49.9|49.9|Standard Deviation|11.94|11.94|||
4267534|NCT00595920|4092197|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4267535|NCT00595920|4092197|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4267536|NCT00595920|4092197|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4267537|NCT00595920|4092197|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4267538|NCT00595920|4092197|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4267539|NCT00595920|4092197|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267540|NCT00595920|4092197|B1|||Age||years|Mean|39.98|39.98|Full Range|||21.0|57.0|
4267541|NCT00595881|4092201|B1|United States||Region of Enrollment||participants|Number|420|420.0||||||
4267542|NCT00595881|4092201|B1||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4267543|NCT00595881|4092201|B1||Female|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4267544|NCT00595881|4092201|B1|||Age||years|Mean|7.8|7.8|Standard Deviation|6|6.0|||
4267545|NCT00595881|4092201|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4267546|NCT00595881|4092201|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4267547|NCT00595881|4092201|B1||<=18 years|Age||Participants|Count of Participants|420|420.0||||||
4267548|NCT00595868|4092206|B3|United States||Region of Enrollment||participants|Number|218|218.0||||||
4267549|NCT00595868|4092207|B2|United States||Region of Enrollment||participants|Number|111|111.0||||||
4267550|NCT00595868|4092208|B1|United States||Region of Enrollment||participants|Number|107|107.0||||||
4267551|NCT00595868|4092206|B3|Missing||Sex/Gender, Customized||participants|Number|2|2.0||||||
4267552|NCT00595868|4092207|B2|Missing||Sex/Gender, Customized||participants|Number|1|1.0||||||
4267553|NCT00595868|4092208|B1|Missing||Sex/Gender, Customized||participants|Number|1|1.0||||||
4267554|NCT00595868|4092206|B3|Male||Sex/Gender, Customized||participants|Number|127|127.0||||||
4267555|NCT00595868|4092207|B2|Male||Sex/Gender, Customized||participants|Number|63|63.0||||||
4267556|NCT00595868|4092208|B1|Male||Sex/Gender, Customized||participants|Number|64|64.0||||||
4267557|NCT00595868|4092206|B3|Female||Sex/Gender, Customized||participants|Number|89|89.0||||||
4267558|NCT00595868|4092207|B2|Female||Sex/Gender, Customized||participants|Number|47|47.0||||||
4267559|NCT00595868|4092208|B1|Female||Sex/Gender, Customized||participants|Number|42|42.0||||||
4267560|NCT00595868|4092206|B3|||Age||years|Mean|42|42.0|Standard Deviation|15|15.0|||
4267561|NCT00595868|4092207|B2|||Age||years|Mean|41|41.0|Standard Deviation|15|15.0|||
4267562|NCT00595868|4092208|B1|||Age||years|Mean|44|44.0|Standard Deviation|14|14.0|||
4267563|NCT00595868|4092206|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4267564|NCT00595868|4092207|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4267565|NCT00595868|4092208|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4267566|NCT00595868|4092206|B3||Between 18 and 65 years|Age||Participants|Count of Participants|205|205.0||||||
4267567|NCT00595868|4092207|B2||Between 18 and 65 years|Age||Participants|Count of Participants|106|106.0||||||
4267568|NCT00595868|4092208|B1||Between 18 and 65 years|Age||Participants|Count of Participants|99|99.0||||||
4267569|NCT00595868|4092206|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267570|NCT00595868|4092207|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267571|NCT00595868|4092208|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267572|NCT00595790|4092217|B4|Germany||Region of Enrollment||participants|Number|201|201.0||||||
4267573|NCT00595790|4092218|B3|Germany||Region of Enrollment||participants|Number|67|67.0||||||
4267574|NCT00595790|4092219|B2|Germany||Region of Enrollment||participants|Number|67|67.0||||||
4267575|NCT00595790|4092220|B1|Germany||Region of Enrollment||participants|Number|67|67.0||||||
4267576|NCT00595790|4092217|B4|United Kingdom||Region of Enrollment||participants|Number|173|173.0||||||
4267577|NCT00595790|4092218|B3|United Kingdom||Region of Enrollment||participants|Number|57|57.0||||||
4267578|NCT00595790|4092219|B2|United Kingdom||Region of Enrollment||participants|Number|58|58.0||||||
4267579|NCT00595790|4092220|B1|United Kingdom||Region of Enrollment||participants|Number|58|58.0||||||
4267580|NCT00595790|4092217|B4||Male|Sex: Female, Male|Baseline Characteristics are based on Safety Population: all randomized subjects who received at least one vaccination, analysed using the treatment actually received.|Participants|Count of Participants|177|177.0||||||
4267581|NCT00595790|4092218|B3||Male|Sex: Female, Male|Baseline Characteristics are based on Safety Population: all randomized subjects who received at least one vaccination, analysed using the treatment actually received.|Participants|Count of Participants|63|63.0||||||
4267747|NCT00595465|4092303|B4|||Age||years|Mean|29.5|29.5|Standard Deviation|9.5|9.5|||
4267582|NCT00595790|4092219|B2||Male|Sex: Female, Male|Baseline Characteristics are based on Safety Population: all randomized subjects who received at least one vaccination, analysed using the treatment actually received.|Participants|Count of Participants|60|60.0||||||
4267583|NCT00595790|4092220|B1||Male|Sex: Female, Male|Baseline Characteristics are based on Safety Population: all randomized subjects who received at least one vaccination, analysed using the treatment actually received.|Participants|Count of Participants|54|54.0||||||
4267584|NCT00595790|4092217|B4||Female|Sex: Female, Male|Baseline Characteristics are based on Safety Population: all randomized subjects who received at least one vaccination, analysed using the treatment actually received.|Participants|Count of Participants|197|197.0||||||
4267585|NCT00595790|4092218|B3||Female|Sex: Female, Male|Baseline Characteristics are based on Safety Population: all randomized subjects who received at least one vaccination, analysed using the treatment actually received.|Participants|Count of Participants|61|61.0||||||
4267586|NCT00595790|4092219|B2||Female|Sex: Female, Male|Baseline Characteristics are based on Safety Population: all randomized subjects who received at least one vaccination, analysed using the treatment actually received.|Participants|Count of Participants|65|65.0||||||
4267587|NCT00595790|4092220|B1||Female|Sex: Female, Male|Baseline Characteristics are based on Safety Population: all randomized subjects who received at least one vaccination, analysed using the treatment actually received.|Participants|Count of Participants|71|71.0||||||
4267588|NCT00595790|4092217|B4|||Age||years|Mean|40.8|40.8|Standard Deviation|14.7|14.7|||
4267589|NCT00595790|4092218|B3|||Age||years|Mean|41.6|41.6|Standard Deviation|14.8|14.8|||
4267590|NCT00595790|4092219|B2|||Age||years|Mean|41.2|41.2|Standard Deviation|15.0|15.0|||
4267591|NCT00595790|4092220|B1|||Age||years|Mean|39.6|39.6|Standard Deviation|14.2|14.2|||
4267592|NCT00595764|4092230|B3|United States||Region of Enrollment||participants|Number|141|141.0||||||
4267593|NCT00595764|4092231|B2|United States||Region of Enrollment||participants|Number|70|70.0||||||
4267594|NCT00595764|4092232|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
4267595|NCT00595764|4092230|B3||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4267596|NCT00595764|4092231|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4267597|NCT00595764|4092232|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4267598|NCT00595764|4092230|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4267599|NCT00595764|4092231|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4267600|NCT00595764|4092232|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4267601|NCT00595764|4092230|B3|||Age||years|Mean|33.6|33.6|Standard Deviation|9.5|9.5|||
4267602|NCT00595764|4092231|B2|||Age||years|Mean|32.8|32.8|Standard Deviation|8.6|8.6|||
4267603|NCT00595764|4092232|B1|||Age||years|Mean|34.5|34.5|Standard Deviation|10.3|10.3|||
4267604|NCT00595764|4092230|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4267605|NCT00595764|4092231|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4267606|NCT00595764|4092232|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4267607|NCT00595764|4092230|B3||Between 18 and 65 years|Age||Participants|Count of Participants|141|141.0||||||
4267608|NCT00595764|4092231|B2||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4267609|NCT00595764|4092232|B1||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4267610|NCT00595764|4092230|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267611|NCT00595764|4092231|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267612|NCT00595764|4092232|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267613|NCT00595582|4092247|B1|United States||Region of Enrollment||participants|Number|10.0|10.0||||||
4267614|NCT00595582|4092247|B1||Male|Sex: Female, Male||Participants|Count of Participants|3.0|3.0||||||
4267615|NCT00595582|4092247|B1||Female|Sex: Female, Male||Participants|Count of Participants|7.0|7.0||||||
4267616|NCT00595582|4092247|B1|||Age||years|Mean|77.6|77.6|Standard Deviation|5.83476|5.83476|||
4267617|NCT00595582|4092247|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4267618|NCT00595582|4092247|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4267619|NCT00595582|4092247|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267620|NCT00595556|4092251|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4267621|NCT00595556|4092252|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4267622|NCT00595556|4092253|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4267623|NCT00595556|4092251|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4267624|NCT00595556|4092252|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4267625|NCT00595556|4092253|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4267626|NCT00595556|4092251|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4267627|NCT00595556|4092252|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4267628|NCT00595556|4092253|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4267629|NCT00595556|4092251|B3|||Age||years|Mean|49.1|49.1|Standard Deviation|10|10.0|||
4267630|NCT00595556|4092252|B2|||Age||years|Mean|50.4|50.4|Standard Deviation|11|11.0|||
4267631|NCT00595556|4092253|B1|||Age||years|Mean|47.8|47.8|Standard Deviation|9.9|9.9|||
4267632|NCT00595556|4092251|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4267633|NCT00595556|4092252|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4267634|NCT00595556|4092253|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4267635|NCT00595556|4092251|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4267748|NCT00595465|4092304|B3|||Age||years|Mean|30.2|30.2|Standard Deviation|10.5|10.5|||
4267636|NCT00595556|4092252|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4267637|NCT00595556|4092253|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4267638|NCT00595556|4092251|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267639|NCT00595556|4092252|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267640|NCT00595556|4092253|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267641|NCT00595530|4092268|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4267642|NCT00595530|4092268|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267643|NCT00595530|4092268|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4267644|NCT00595530|4092268|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4267645|NCT00595530|4092268|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267646|NCT00595530|4092268|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267647|NCT00595530|4092268|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4267648|NCT00595530|4092268|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4267649|NCT00595530|4092268|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267650|NCT00595530|4092268|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267651|NCT00595530|4092268|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267652|NCT00595530|4092268|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4267653|NCT00595530|4092268|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4267654|NCT00595530|4092268|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4267655|NCT00595530|4092268|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4267656|NCT00595530|4092268|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4267657|NCT00595530|4092268|B1|||Age||years|Mean|19|19.0|Standard Deviation|3|3.0|||
4267658|NCT00595517|4092272|B1|Female||Sex/Gender, Customized||Participants|Number|95|95.0||||95.0|0.0|
4267659|NCT00595517|4092272|B1|Male||Sex/Gender, Customized||Participants|Number|35|35.0||||35.0|0.0|
4267660|NCT00595517|4092272|B1|>= 75 years||Age, Customized||Participants|Number|24|24.0||||24.0|0.0|
4267661|NCT00595517|4092272|B1|65 - 74 years||Age, Customized||Participants|Number|43|43.0||||43.0|0.0|
4267662|NCT00595517|4092272|B1|< 65 years||Age, Customized||Participants|Number|63|63.0||||63.0|0.0|
4267663|NCT00595504|4092279|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4267664|NCT00595504|4092280|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4267665|NCT00595504|4092281|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4267666|NCT00595504|4092279|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4267667|NCT00595504|4092280|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4267668|NCT00595504|4092281|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4267669|NCT00595504|4092279|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4267670|NCT00595504|4092280|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4267671|NCT00595504|4092281|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4267672|NCT00595504|4092279|B3|||Age||years|Mean|53|53.0|Standard Deviation|8|8.0|||
4267673|NCT00595504|4092280|B2|||Age||years|Mean|56|56.0|Standard Deviation|9|9.0|||
4267674|NCT00595504|4092281|B1|||Age||years|Mean|49|49.0|Standard Deviation|7|7.0|||
4267675|NCT00595504|4092279|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4267676|NCT00595504|4092280|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4267677|NCT00595504|4092281|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4267678|NCT00595504|4092279|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4267679|NCT00595504|4092280|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4267680|NCT00595504|4092281|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4267681|NCT00595504|4092279|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267682|NCT00595504|4092280|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267683|NCT00595504|4092281|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267684|NCT00595478|4092292|B3||None|DSM Alcohol Use Disorder||Participants|Count of Participants|35|35.0||||||
4267685|NCT00595478|4092293|B2||None|DSM Alcohol Use Disorder||Participants|Count of Participants|17|17.0||||||
4267686|NCT00595478|4092294|B1||None|DSM Alcohol Use Disorder||Participants|Count of Participants|18|18.0||||||
4267687|NCT00595478|4092292|B3||Abuse only|DSM Alcohol Use Disorder||Participants|Count of Participants|26|26.0||||||
4267688|NCT00595478|4092293|B2||Abuse only|DSM Alcohol Use Disorder||Participants|Count of Participants|14|14.0||||||
4267689|NCT00595478|4092294|B1||Abuse only|DSM Alcohol Use Disorder||Participants|Count of Participants|12|12.0||||||
4267690|NCT00595478|4092292|B3||Dependence|DSM Alcohol Use Disorder||Participants|Count of Participants|14|14.0||||||
4267691|NCT00595478|4092293|B2||Dependence|DSM Alcohol Use Disorder||Participants|Count of Participants|7|7.0||||||
4267692|NCT00595478|4092294|B1||Dependence|DSM Alcohol Use Disorder||Participants|Count of Participants|7|7.0||||||
4267693|NCT00595478|4092292|B3|||Mean drinks per drinking day||Drinks|Mean|6.0|6.0|Standard Deviation|4.7|4.7|||
4267694|NCT00595478|4092293|B2|||Mean drinks per drinking day||Drinks|Mean|6.4|6.4|Standard Deviation|4.5|4.5|||
4267695|NCT00595478|4092294|B1|||Mean drinks per drinking day||Drinks|Mean|5.7|5.7|Standard Deviation|4.9|4.9|||
4267696|NCT00595478|4092292|B3|||Mean intake proportion of days used alcohol in past 30 days|We report the proportion of days used because not all participants provided data for the identical number of days at each assessment. Therefore the denominator differs across participants, and the proportion of days on which use was reported is the more appropriate measure of use frequency.|proportion of days used alcohol|Mean|0.12|0.12|Standard Deviation|0.15|0.15|||
4267697|NCT00595478|4092293|B2|||Mean intake proportion of days used alcohol in past 30 days|We report the proportion of days used because not all participants provided data for the identical number of days at each assessment. Therefore the denominator differs across participants, and the proportion of days on which use was reported is the more appropriate measure of use frequency.|proportion of days used alcohol|Mean|0.12|0.12|Standard Deviation|0.14|0.14|||
4267698|NCT00595478|4092294|B1|||Mean intake proportion of days used alcohol in past 30 days|We report the proportion of days used because not all participants provided data for the identical number of days at each assessment. Therefore the denominator differs across participants, and the proportion of days on which use was reported is the more appropriate measure of use frequency.|proportion of days used alcohol|Mean|0.12|0.12|Standard Deviation|0.16|0.16|||
4267699|NCT00595478|4092292|B3|||Tobacco user||Participants|Count of Participants|60|60.0||||||
4267700|NCT00595478|4092293|B2|||Tobacco user||Participants|Count of Participants|30|30.0||||||
4267701|NCT00595478|4092294|B1|||Tobacco user||Participants|Count of Participants|30|30.0||||||
4267702|NCT00595478|4092292|B3|United States||Region of Enrollment||Participants|Count of Participants|75|75.0||||||
4267703|NCT00595478|4092293|B2|United States||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
4267704|NCT00595478|4092294|B1|United States||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
4267705|NCT00595478|4092292|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4267706|NCT00595478|4092293|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4267707|NCT00595478|4092294|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4267708|NCT00595478|4092292|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4267709|NCT00595478|4092293|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4267710|NCT00595478|4092294|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267711|NCT00595478|4092292|B3||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4267712|NCT00595478|4092293|B2||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4267713|NCT00595478|4092294|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4267714|NCT00595478|4092292|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4267715|NCT00595478|4092293|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4267716|NCT00595478|4092294|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4267717|NCT00595478|4092292|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267718|NCT00595478|4092293|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267719|NCT00595478|4092294|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267720|NCT00595478|4092292|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267721|NCT00595478|4092293|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267722|NCT00595478|4092294|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267723|NCT00595478|4092292|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267724|NCT00595478|4092293|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267725|NCT00595478|4092294|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267726|NCT00595478|4092292|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4267727|NCT00595478|4092293|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4267728|NCT00595478|4092294|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4267729|NCT00595478|4092292|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4267730|NCT00595478|4092293|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4267731|NCT00595478|4092294|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4267732|NCT00595478|4092292|B3|||Age||years|Mean|16.1|16.1|Standard Deviation|1.2|1.2|||
4267733|NCT00595478|4092293|B2|||Age||years|Mean|16.2|16.2|Standard Deviation|1.2|1.2|||
4267734|NCT00595478|4092294|B1|||Age||years|Mean|16.1|16.1|Standard Deviation|1.2|1.2|||
4267735|NCT00595465|4092303|B4|Europe||Region of Enrollment||participants|Number|387|387.0||||||
4267736|NCT00595465|4092304|B3|Europe||Region of Enrollment||participants|Number|128|128.0||||||
4267737|NCT00595465|4092305|B2|Europe||Region of Enrollment||participants|Number|129|129.0||||||
4267738|NCT00595465|4092306|B1|Europe||Region of Enrollment||participants|Number|130|130.0||||||
4267739|NCT00595465|4092303|B4||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4267740|NCT00595465|4092304|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4267741|NCT00595465|4092305|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4267742|NCT00595465|4092306|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4267743|NCT00595465|4092303|B4||Female|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
4267744|NCT00595465|4092304|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4267745|NCT00595465|4092305|B2||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4267746|NCT00595465|4092306|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4267749|NCT00595465|4092305|B2|||Age||years|Mean|28.9|28.9|Standard Deviation|9.4|9.4|||
4267750|NCT00595465|4092306|B1|||Age||years|Mean|29.3|29.3|Standard Deviation|8.6|8.6|||
4267751|NCT00595465|4092303|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4267752|NCT00595465|4092304|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4267753|NCT00595465|4092305|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4267754|NCT00595465|4092306|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4267755|NCT00595465|4092303|B4||Between 18 and 65 years|Age||Participants|Count of Participants|385|385.0||||||
4267756|NCT00595465|4092304|B3||Between 18 and 65 years|Age||Participants|Count of Participants|127|127.0||||||
4267757|NCT00595465|4092305|B2||Between 18 and 65 years|Age||Participants|Count of Participants|128|128.0||||||
4267758|NCT00595465|4092306|B1||Between 18 and 65 years|Age||Participants|Count of Participants|130|130.0||||||
4267759|NCT00595465|4092303|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267760|NCT00595465|4092304|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267761|NCT00595465|4092305|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267762|NCT00595465|4092306|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267763|NCT00595413|4092316|B5||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4267764|NCT00595413|4092317|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4267765|NCT00595413|4092318|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4267766|NCT00595413|4092319|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4267767|NCT00595413|4092320|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4267768|NCT00595413|4092316|B5||Female|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
4267769|NCT00595413|4092317|B4||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4267770|NCT00595413|4092318|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4267771|NCT00595413|4092319|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4267772|NCT00595413|4092320|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4267773|NCT00595413|4092316|B5|||Age||years|Mean|53.4|53.4|Standard Deviation|11.6|11.6|||
4267774|NCT00595413|4092317|B4|||Age||years|Mean|53.3|53.3|Standard Deviation|11.5|11.5|||
4267775|NCT00595413|4092318|B3|||Age||years|Mean|53.3|53.3|Standard Deviation|13.2|13.2|||
4267776|NCT00595413|4092319|B2|||Age||years|Mean|53.0|53.0|Standard Deviation|11.3|11.3|||
4267777|NCT00595413|4092320|B1|||Age||years|Mean|54.0|54.0|Standard Deviation|10.3|10.3|||
4267778|NCT00595361|4092349|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4267779|NCT00595361|4092350|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4267780|NCT00595361|4092351|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4267781|NCT00595361|4092349|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4267782|NCT00595361|4092350|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4267783|NCT00595361|4092351|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4267784|NCT00595361|4092349|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4267785|NCT00595361|4092350|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4267786|NCT00595361|4092351|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4267787|NCT00595361|4092349|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4267788|NCT00595361|4092350|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4267789|NCT00595361|4092351|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4267790|NCT00595361|4092349|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4267791|NCT00595361|4092350|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4267792|NCT00595361|4092351|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4267793|NCT00595361|4092349|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267794|NCT00595361|4092350|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267795|NCT00595361|4092351|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267796|NCT00595361|4092349|B3|||Age||years|Mean|26.6|26.6|Standard Deviation|1.3|1.3|||
4267797|NCT00595361|4092350|B2|||Age||years|Mean|27.2|27.2|Standard Deviation|1.4|1.4|||
4267798|NCT00595361|4092351|B1|||Age||years|Mean|25.8|25.8|Standard Deviation|2.4|2.4|||
4267799|NCT00595335|4092362|B3|||Clinical Activity Score|The CAS, which is based on classical signs of inflammation (pain, redness, and swelling), consists of 7 equally weighted items. The total CAS (as used in this study) may range from 0 to 7. The higher the CAS, the greater degree of inflammation is present. A drop in CAS of 2 or more points suggests an improvement in the inflammatory components of the disease. A CAS ≥3 implies active disease.|units on a scale|Mean|5.1|5.1|Standard Deviation|1.0|1.0|||
4267800|NCT00595335|4092363|B2|||Clinical Activity Score|The CAS, which is based on classical signs of inflammation (pain, redness, and swelling), consists of 7 equally weighted items. The total CAS (as used in this study) may range from 0 to 7. The higher the CAS, the greater degree of inflammation is present. A drop in CAS of 2 or more points suggests an improvement in the inflammatory components of the disease. A CAS ≥3 implies active disease.|units on a scale|Mean|5.3|5.3|Standard Deviation|1.0|1.0|||
4267801|NCT00595335|4092364|B1|||Clinical Activity Score|The CAS, which is based on classical signs of inflammation (pain, redness, and swelling), consists of 7 equally weighted items. The total CAS (as used in this study) may range from 0 to 7. The higher the CAS, the greater degree of inflammation is present. A drop in CAS of 2 or more points suggests an improvement in the inflammatory components of the disease. A CAS ≥3 implies active disease.|units on a scale|Mean|4.9|4.9|Standard Deviation|1.0|1.0|||
4267802|NCT00595335|4092362|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4267803|NCT00595335|4092363|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4267804|NCT00595335|4092364|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4267805|NCT00595335|4092362|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4267806|NCT00595335|4092363|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4267807|NCT00595335|4092364|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4267808|NCT00595335|4092362|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4267809|NCT00595335|4092363|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4267810|NCT00595335|4092364|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4267811|NCT00595335|4092362|B3|||Age||years|Mean|58.6|58.6|Standard Deviation|11.8|11.8|||
4267812|NCT00595335|4092363|B2|||Age||years|Mean|61.8|61.8|Standard Deviation|11.0|11.0|||
4267813|NCT00595335|4092364|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|12.7|12.7|||
4267814|NCT00595309|4092385|B1|Germany||Region of Enrollment||participants|Number|95|95.0||||||
4267815|NCT00595309|4092385|B1|Austria||Region of Enrollment||participants|Number|103|103.0||||||
4267816|NCT00595309|4092385|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4267817|NCT00595309|4092385|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4267818|NCT00595309|4092385|B1|||Age||years|Mean|31.2|31.2|Standard Deviation|9.9|9.9|||
4267819|NCT00595309|4092385|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4267820|NCT00595309|4092385|B1||Between 18 and 65 years|Age||Participants|Count of Participants|197|197.0||||||
4267821|NCT00595309|4092385|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267822|NCT00595270|4092389|B4|Europe||Region of Enrollment||participants|Number|349|349.0||||||
4267823|NCT00595270|4092390|B3|Europe||Region of Enrollment||participants|Number|116|116.0||||||
4267824|NCT00595270|4092391|B2|Europe||Region of Enrollment||participants|Number|117|117.0||||||
4267825|NCT00595270|4092392|B1|Europe||Region of Enrollment||participants|Number|116|116.0||||||
4267826|NCT00595270|4092389|B4||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4267827|NCT00595270|4092390|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4267828|NCT00595270|4092391|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4267829|NCT00595270|4092392|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4267830|NCT00595270|4092389|B4||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4267831|NCT00595270|4092390|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4267832|NCT00595270|4092391|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4267833|NCT00595270|4092392|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4267834|NCT00595270|4092389|B4||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4267835|NCT00595270|4092390|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4267836|NCT00595270|4092391|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4267837|NCT00595270|4092392|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4267838|NCT00595270|4092389|B4||Between 18 and 65 years|Age||Participants|Count of Participants|323|323.0||||||
4267839|NCT00595270|4092390|B3||Between 18 and 65 years|Age||Participants|Count of Participants|106|106.0||||||
4267840|NCT00595270|4092391|B2||Between 18 and 65 years|Age||Participants|Count of Participants|108|108.0||||||
4267841|NCT00595270|4092392|B1||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
4267842|NCT00595270|4092389|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267843|NCT00595270|4092390|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267844|NCT00595270|4092391|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267845|NCT00595270|4092392|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267846|NCT00595153|4092402|B4|United States||Region of Enrollment||participants|Number|127|127.0||||||
4267847|NCT00595153|4092403|B3|United States||Region of Enrollment||participants|Number|61|61.0||||||
4267848|NCT00595153|4092404|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
4267849|NCT00595153|4092405|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4267850|NCT00595153|4092402|B4||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4267851|NCT00595153|4092403|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4267852|NCT00595153|4092404|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4267853|NCT00595153|4092405|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4267854|NCT00595153|4092402|B4||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4267855|NCT00595153|4092403|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4267856|NCT00595153|4092404|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4267857|NCT00595153|4092405|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4267858|NCT00595153|4092402|B4|||Age||years|Mean|35.9|35.9|Standard Deviation|11.7|11.7|||
4267859|NCT00595153|4092403|B3|||Age||years|Mean|39.0|39.0|Standard Deviation|11.9|11.9|||
4267860|NCT00595153|4092404|B2|||Age||years|Mean|32.0|32.0|Standard Deviation|11.6|11.6|||
4267861|NCT00595153|4092405|B1|||Age||years|Mean|34.5|34.5|Standard Deviation|9.0|9.0|||
4267862|NCT00595153|4092402|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4267863|NCT00595153|4092403|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4267864|NCT00595153|4092404|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4267865|NCT00595153|4092405|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4267866|NCT00595153|4092402|B4||Between 18 and 65 years|Age||Participants|Count of Participants|127|127.0||||||
4267867|NCT00595153|4092403|B3||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4267868|NCT00595153|4092404|B2||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4267869|NCT00595153|4092405|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4267870|NCT00595153|4092402|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267871|NCT00595153|4092403|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267872|NCT00595153|4092404|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267873|NCT00595153|4092405|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267874|NCT00595127|4092415|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4267875|NCT00595127|4092415|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4267876|NCT00595127|4092415|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4267877|NCT00595127|4092415|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4267878|NCT00595127|4092415|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4267879|NCT00595127|4092415|B1||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4267880|NCT00595114|4092419|B3|United States||Region of Enrollment||participants|Number|43|43.0||||||
4267881|NCT00595114|4092420|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4267882|NCT00595114|4092421|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4267883|NCT00595114|4092419|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267884|NCT00595114|4092420|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267885|NCT00595114|4092421|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267886|NCT00595114|4092419|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267887|NCT00595114|4092420|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267888|NCT00595114|4092421|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267889|NCT00595114|4092419|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4267890|NCT00595114|4092420|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4267891|NCT00595114|4092421|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4267892|NCT00595114|4092419|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4267893|NCT00595114|4092420|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4267894|NCT00595114|4092421|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4267895|NCT00595114|4092419|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267896|NCT00595114|4092420|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267897|NCT00595114|4092421|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267898|NCT00595114|4092419|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267899|NCT00595114|4092420|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267900|NCT00595114|4092421|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267901|NCT00595114|4092419|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267902|NCT00595114|4092420|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267903|NCT00595114|4092421|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267904|NCT00595114|4092419|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267905|NCT00595114|4092420|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267906|NCT00595114|4092421|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267907|NCT00595114|4092419|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4267908|NCT00595114|4092420|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4267909|NCT00595114|4092421|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4267910|NCT00595114|4092419|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4267911|NCT00595114|4092420|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4267912|NCT00595114|4092421|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4267913|NCT00595114|4092419|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4267914|NCT00595114|4092420|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4267915|NCT00595114|4092421|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4267916|NCT00595114|4092419|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4267917|NCT00595114|4092420|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4267918|NCT00595114|4092421|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4267919|NCT00595114|4092419|B3|||Age||years|Mean|38|38.0|Standard Deviation|10|10.0|||
4267920|NCT00595114|4092420|B2|||Age||years|Mean|40|40.0|Standard Deviation|11|11.0|||
4267921|NCT00595114|4092421|B1|||Age||years|Mean|37|37.0|Standard Deviation|10|10.0|||
4267922|NCT00595088|4092428|B1|Israel||Region of Enrollment||participants|Number|39|39.0||||||
4267923|NCT00595088|4092428|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4267924|NCT00595088|4092428|B1||Male|Sex: Female, Male|36 males and 11 females|Participants|Count of Participants|36|36.0||||||
4267925|NCT00595088|4092428|B1||Female|Sex: Female, Male|36 males and 11 females|Participants|Count of Participants|11|11.0||||||
4267926|NCT00595088|4092428|B1||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4267927|NCT00595088|4092428|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4267928|NCT00595088|4092428|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267929|NCT00595075|4092435|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4267930|NCT00595075|4092436|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4267931|NCT00595075|4092437|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4267932|NCT00595075|4092435|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4267933|NCT00595075|4092436|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4267934|NCT00595075|4092437|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4267935|NCT00595075|4092435|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4267936|NCT00595075|4092436|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4267937|NCT00595075|4092437|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4267938|NCT00595075|4092435|B3|||Age||years|Mean|24.5|24.5|Standard Deviation|4.1|4.1|||
4267939|NCT00595075|4092436|B2|||Age||years|Mean|26.8|26.8|Standard Deviation|3.2|3.2|||
4267940|NCT00595075|4092437|B1|||Age||years|Mean|22.7|22.7|Standard Deviation|4.1|4.1|||
4267941|NCT00595075|4092435|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4267942|NCT00595075|4092436|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4267943|NCT00595075|4092437|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4267944|NCT00595075|4092435|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4267945|NCT00595075|4092436|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4267946|NCT00595075|4092437|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4267947|NCT00595075|4092435|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267948|NCT00595075|4092436|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267949|NCT00595075|4092437|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4267950|NCT00594958|4092456|B4|Europe||Region of Enrollment||participants|Number|636|636.0||||||
4267951|NCT00594958|4092457|B3|Europe||Region of Enrollment||participants|Number|211|211.0||||||
4267952|NCT00594958|4092458|B2|Europe||Region of Enrollment||participants|Number|213|213.0||||||
4267953|NCT00594958|4092459|B1|Europe||Region of Enrollment||participants|Number|212|212.0||||||
4267954|NCT00594958|4092456|B4||Male|Sex: Female, Male|numbers based on Safety Population: subjects with at least one vaccination|Participants|Count of Participants|286|286.0||||||
4267955|NCT00594958|4092457|B3||Male|Sex: Female, Male|numbers based on Safety Population: subjects with at least one vaccination|Participants|Count of Participants|92|92.0||||||
4267956|NCT00594958|4092458|B2||Male|Sex: Female, Male|numbers based on Safety Population: subjects with at least one vaccination|Participants|Count of Participants|90|90.0||||||
4267957|NCT00594958|4092459|B1||Male|Sex: Female, Male|numbers based on Safety Population: subjects with at least one vaccination|Participants|Count of Participants|104|104.0||||||
4267958|NCT00594958|4092456|B4||Female|Sex: Female, Male|numbers based on Safety Population: subjects with at least one vaccination|Participants|Count of Participants|350|350.0||||||
4267959|NCT00594958|4092457|B3||Female|Sex: Female, Male|numbers based on Safety Population: subjects with at least one vaccination|Participants|Count of Participants|119|119.0||||||
4267960|NCT00594958|4092458|B2||Female|Sex: Female, Male|numbers based on Safety Population: subjects with at least one vaccination|Participants|Count of Participants|123|123.0||||||
4267961|NCT00594958|4092459|B1||Female|Sex: Female, Male|numbers based on Safety Population: subjects with at least one vaccination|Participants|Count of Participants|108|108.0||||||
4267962|NCT00594958|4092456|B4|||Age|numbers based on Safety Population: subjects with at least one vaccination|years|Mean|31.3|31.3|Standard Deviation|10.7|10.7|||
4267963|NCT00594958|4092457|B3|||Age|numbers based on Safety Population: subjects with at least one vaccination|years|Mean|30.7|30.7|Standard Deviation|10.3|10.3|||
4267964|NCT00594958|4092458|B2|||Age|numbers based on Safety Population: subjects with at least one vaccination|years|Mean|31.3|31.3|Standard Deviation|11.0|11.0|||
4267965|NCT00594958|4092459|B1|||Age|numbers based on Safety Population: subjects with at least one vaccination|years|Mean|31.7|31.7|Standard Deviation|10.8|10.8|||
4267966|NCT00594945|4092469|B4|Finland||Region of Enrollment||participants|Number|5|5.0||||||
4267967|NCT00594945|4092470|B3|Finland||Region of Enrollment||participants|Number|1|1.0||||||
4267968|NCT00594945|4092471|B2|Finland||Region of Enrollment||participants|Number|2|2.0||||||
4267969|NCT00594945|4092472|B1|Finland||Region of Enrollment||participants|Number|2|2.0||||||
4267970|NCT00594945|4092469|B4|United States||Region of Enrollment||participants|Number|4|4.0||||||
4267971|NCT00594945|4092470|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4267972|NCT00594945|4092471|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4267973|NCT00594945|4092472|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4267974|NCT00594945|4092469|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267975|NCT00594945|4092470|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267976|NCT00594945|4092471|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267977|NCT00594945|4092472|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267978|NCT00594945|4092469|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267979|NCT00594945|4092470|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267980|NCT00594945|4092471|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267981|NCT00594945|4092472|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267982|NCT00594945|4092469|B4||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4267983|NCT00594945|4092470|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4267984|NCT00594945|4092471|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4267985|NCT00594945|4092472|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4267986|NCT00594945|4092469|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267987|NCT00594945|4092470|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267988|NCT00594945|4092471|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267989|NCT00594945|4092472|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267990|NCT00594945|4092469|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267991|NCT00594945|4092470|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267992|NCT00594945|4092471|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267993|NCT00594945|4092472|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267994|NCT00594945|4092469|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267995|NCT00594945|4092470|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267996|NCT00594945|4092471|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267997|NCT00594945|4092472|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267998|NCT00594945|4092469|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4267999|NCT00594945|4092470|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268000|NCT00594945|4092471|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268001|NCT00594945|4092472|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268002|NCT00594945|4092469|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4268003|NCT00594945|4092470|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4268004|NCT00594945|4092471|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4268005|NCT00594945|4092472|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4268006|NCT00594945|4092469|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4268007|NCT00594945|4092470|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4268008|NCT00594945|4092471|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4268009|NCT00594945|4092472|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4268010|NCT00594945|4092469|B4|||Age||years|Mean|33.4|33.4|Standard Deviation|9.25|9.25|||
4268011|NCT00594945|4092470|B3|||Age||years|Mean|45.0|45.0|Standard Deviation|1.41|1.41|||
4268012|NCT00594945|4092471|B2|||Age||years|Mean|29.7|29.7|Standard Deviation|7.37|7.37|||
4268013|NCT00594945|4092472|B1|||Age||years|Mean|30.5|30.5|Standard Deviation|8.74|8.74|||
4268014|NCT00594906|4092480|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4268015|NCT00594906|4092481|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4268016|NCT00594906|4092482|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4268017|NCT00594906|4092480|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4268018|NCT00594906|4092481|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4268019|NCT00594906|4092482|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4268020|NCT00594906|4092480|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4268021|NCT00594906|4092481|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4268022|NCT00594906|4092482|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4268023|NCT00594906|4092480|B3|||Age||years|Mean|75|75.0|Standard Deviation|13|13.0|||
4268024|NCT00594906|4092481|B2|||Age||years|Mean|66|66.0|Standard Deviation|5|5.0|||
4268025|NCT00594906|4092482|B1|||Age||years|Mean|78|78.0|Standard Deviation|14|14.0|||
4268026|NCT00594906|4092480|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4268027|NCT00594906|4092481|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4268028|NCT00594906|4092482|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4268029|NCT00594906|4092480|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4268030|NCT00594906|4092481|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4268031|NCT00594906|4092482|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4268032|NCT00594906|4092480|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4268033|NCT00594906|4092481|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4268034|NCT00594906|4092482|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4268035|NCT00594880|4092489|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4268036|NCT00594880|4092490|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4268037|NCT00594880|4092491|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4268038|NCT00594880|4092489|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4268039|NCT00594880|4092490|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4268040|NCT00594880|4092491|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4268041|NCT00594880|4092489|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4268042|NCT00594880|4092490|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4268043|NCT00594880|4092491|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4268044|NCT00594880|4092489|B3|Age||Age||years|Median|45|45.0|Inter-Quartile Range|||40.5|49.5|
4268045|NCT00594880|4092490|B2|Age||Age||years|Median|44|44.0|Inter-Quartile Range|||32.0|49.5|
4268046|NCT00594880|4092491|B1|Age||Age||years|Median|45.5|45.5|Inter-Quartile Range|||42.8|48.5|
4268047|NCT00594880|4092489|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4268048|NCT00594880|4092490|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4268049|NCT00594880|4092491|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4268050|NCT00594880|4092489|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4268051|NCT00594880|4092490|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4268052|NCT00594880|4092491|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4268053|NCT00594880|4092489|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4268054|NCT00594880|4092490|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4268055|NCT00594880|4092491|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4268056|NCT00594854|4092502|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4268057|NCT00594854|4092503|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4268058|NCT00594854|4092504|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4268059|NCT00594854|4092502|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4268060|NCT00594854|4092503|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4268061|NCT00594854|4092504|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4268062|NCT00594854|4092502|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4268063|NCT00594854|4092503|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4268064|NCT00594854|4092504|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4268065|NCT00594854|4092502|B3|||Age||years|Mean|58.4|58.4|Standard Deviation|14.6|14.6|||
4268066|NCT00594854|4092503|B2|||Age||years|Mean|54.4|54.4|Standard Deviation|17.2|17.2|||
4268067|NCT00594854|4092504|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|9.5|9.5|||
4268068|NCT00594854|4092502|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4268069|NCT00594854|4092503|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4268070|NCT00594854|4092504|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4268071|NCT00594854|4092502|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4268072|NCT00594854|4092503|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4268073|NCT00594854|4092504|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4268074|NCT00594854|4092502|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4268075|NCT00594854|4092503|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4268076|NCT00594854|4092504|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4268077|NCT00594815|4092515|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4268078|NCT00594815|4092515|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4268079|NCT00594815|4092515|B1|||Age||Years|Median|60|60.0|Full Range|||30.0|79.0|
4268080|NCT00594815|4092515|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4268081|NCT00594815|4092515|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4268082|NCT00594815|4092515|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4268083|NCT00594685|4092520|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4268084|NCT00594685|4092520|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4268085|NCT00594685|4092520|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4268086|NCT00594685|4092520|B1|||Age||years|Mean|54.5|54.5|Standard Deviation|13.9|13.9|||
4268087|NCT00594685|4092520|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4268088|NCT00594685|4092520|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4268089|NCT00594685|4092520|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4268090|NCT00594659|4092537|B4|||Point prevalence abstinence|Total percentage column is not accurate because it is automatically summed, which results in an invalid number.|percentage of participants|Number|25.5|25.5||||||
4268091|NCT00594659|4092538|B3|||Point prevalence abstinence|Total percentage column is not accurate because it is automatically summed, which results in an invalid number.|percentage of participants|Number|12.5|12.5||||||
4268092|NCT00594659|4092539|B2|||Point prevalence abstinence|Total percentage column is not accurate because it is automatically summed, which results in an invalid number.|percentage of participants|Number|13|13.0||||||
4268093|NCT00594659|4092540|B1|||Point prevalence abstinence|Total percentage column is not accurate because it is automatically summed, which results in an invalid number.|percentage of participants|Number|0|0.0||||||
4268094|NCT00594659|4092537|B4|United States||Region of Enrollment||participants|Number|75|75.0||||||
4268095|NCT00594659|4092538|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4268096|NCT00594659|4092539|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4268097|NCT00594659|4092540|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4268098|NCT00594659|4092537|B4||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4268099|NCT00594659|4092538|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4268100|NCT00594659|4092539|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4268101|NCT00594659|4092540|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4268102|NCT00594659|4092537|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4268103|NCT00594659|4092538|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4268104|NCT00594659|4092539|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4268105|NCT00594659|4092540|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4268106|NCT00594659|4092537|B4|||Age||years|Mean|34.85|34.85|Standard Deviation|10.52|10.52|||
4268107|NCT00594659|4092538|B3|||Age||years|Mean|35|35.0|Standard Deviation|8.95|8.95|||
4268108|NCT00594659|4092539|B2|||Age||years|Mean|34.87|34.87|Standard Deviation|11.07|11.07|||
4268109|NCT00594659|4092540|B1|||Age||years|Mean|34.7|34.7|Standard Deviation|11.06|11.06|||
4268110|NCT00594659|4092537|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4268111|NCT00594659|4092538|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4268112|NCT00594659|4092539|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4268113|NCT00594659|4092540|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4268114|NCT00594659|4092537|B4||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4268115|NCT00594659|4092538|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4268116|NCT00594659|4092539|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4268117|NCT00594659|4092540|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4268118|NCT00594659|4092537|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4268119|NCT00594659|4092538|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4268120|NCT00594659|4092539|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4268121|NCT00594659|4092540|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4268122|NCT00594646|4092553|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
4268123|NCT00594646|4092553|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268124|NCT00594646|4092553|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4268125|NCT00594646|4092553|B1||White|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
4268126|NCT00594646|4092553|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4268127|NCT00594646|4092553|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4268128|NCT00594646|4092553|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4268129|NCT00594646|4092553|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268130|NCT00594646|4092553|B1||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4268131|NCT00594646|4092553|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4268132|NCT00594646|4092553|B1|||Age||years|Mean|33.3|33.3|Full Range|||18.0|61.0|
4268133|NCT00594646|4092553|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4268134|NCT00594646|4092553|B1||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4268135|NCT00594646|4092553|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4268136|NCT00594568|4092558|B4|||Alzheimer's Disease Cooperative Study Activities of Daily Living (ADCS-ADL) Inventory Score|The ADCS-ADL Inventory Score is a 23-item inventory developed as a Rater-administered questionnaire answered by the participant’s caregiver. It measures performance of basic and instrumental activities of daily living by participants. The total ADCS-ADL score ranges from 0 to 78, with lower scores indicating greater disease severity.|units on a scale|Mean|61.1|61.1|Standard Deviation|12.4|12.4|||
4268137|NCT00594568|4092559|B3|||Alzheimer's Disease Cooperative Study Activities of Daily Living (ADCS-ADL) Inventory Score|The ADCS-ADL Inventory Score is a 23-item inventory developed as a Rater-administered questionnaire answered by the participant’s caregiver. It measures performance of basic and instrumental activities of daily living by participants. The total ADCS-ADL score ranges from 0 to 78, with lower scores indicating greater disease severity.|units on a scale|Mean|60.5|60.5|Standard Deviation|12.4|12.4|||
4268138|NCT00594568|4092560|B2|||Alzheimer's Disease Cooperative Study Activities of Daily Living (ADCS-ADL) Inventory Score|The ADCS-ADL Inventory Score is a 23-item inventory developed as a Rater-administered questionnaire answered by the participant’s caregiver. It measures performance of basic and instrumental activities of daily living by participants. The total ADCS-ADL score ranges from 0 to 78, with lower scores indicating greater disease severity.|units on a scale|Mean|62.3|62.3|Standard Deviation|11.6|11.6|||
4268139|NCT00594568|4092561|B1|||Alzheimer's Disease Cooperative Study Activities of Daily Living (ADCS-ADL) Inventory Score|The ADCS-ADL Inventory Score is a 23-item inventory developed as a Rater-administered questionnaire answered by the participant’s caregiver. It measures performance of basic and instrumental activities of daily living by participants. The total ADCS-ADL score ranges from 0 to 78, with lower scores indicating greater disease severity.|units on a scale|Mean|60.5|60.5|Standard Deviation|13.0|13.0|||
4268140|NCT00594568|4092558|B4|||Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog11) Score|ADAS‑Cog11 consists of 11 items assessing areas of function most typically impaired in AD: orientation, verbal memory, language, and praxis. The scale ranges from 0 to 70, with higher scores indicating greater disease severity.|units on a scale|Mean|22.8|22.8|Standard Deviation|8.9|8.9|||
4268141|NCT00594568|4092559|B3|||Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog11) Score|ADAS‑Cog11 consists of 11 items assessing areas of function most typically impaired in AD: orientation, verbal memory, language, and praxis. The scale ranges from 0 to 70, with higher scores indicating greater disease severity.|units on a scale|Mean|23.1|23.1|Standard Deviation|8.8|8.8|||
4268142|NCT00594568|4092560|B2|||Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog11) Score|ADAS‑Cog11 consists of 11 items assessing areas of function most typically impaired in AD: orientation, verbal memory, language, and praxis. The scale ranges from 0 to 70, with higher scores indicating greater disease severity.|units on a scale|Mean|22.5|22.5|Standard Deviation|8.9|8.9|||
4268143|NCT00594568|4092561|B1|||Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog11) Score|ADAS‑Cog11 consists of 11 items assessing areas of function most typically impaired in AD: orientation, verbal memory, language, and praxis. The scale ranges from 0 to 70, with higher scores indicating greater disease severity.|units on a scale|Mean|22.8|22.8|Standard Deviation|9.1|9.1|||
4268144|NCT00594568|4092558|B4|Sweden||Region of Enrollment||participants|Number|42|42.0||||||
4268145|NCT00594568|4092559|B3|Sweden||Region of Enrollment||participants|Number|15|15.0||||||
4268146|NCT00594568|4092560|B2|Sweden||Region of Enrollment||participants|Number|17|17.0||||||
4268147|NCT00594568|4092561|B1|Sweden||Region of Enrollment||participants|Number|10|10.0||||||
4268148|NCT00594568|4092558|B4|Japan||Region of Enrollment||participants|Number|121|121.0||||||
4268149|NCT00594568|4092559|B3|Japan||Region of Enrollment||participants|Number|43|43.0||||||
4268150|NCT00594568|4092560|B2|Japan||Region of Enrollment||participants|Number|37|37.0||||||
4268151|NCT00594568|4092561|B1|Japan||Region of Enrollment||participants|Number|41|41.0||||||
4268152|NCT00594568|4092558|B4|Germany||Region of Enrollment||participants|Number|77|77.0||||||
4268153|NCT00594568|4092559|B3|Germany||Region of Enrollment||participants|Number|27|27.0||||||
4268154|NCT00594568|4092560|B2|Germany||Region of Enrollment||participants|Number|21|21.0||||||
4268155|NCT00594568|4092561|B1|Germany||Region of Enrollment||participants|Number|29|29.0||||||
4268156|NCT00594568|4092558|B4|South Africa||Region of Enrollment||participants|Number|84|84.0||||||
4268157|NCT00594568|4092559|B3|South Africa||Region of Enrollment||participants|Number|30|30.0||||||
4268158|NCT00594568|4092560|B2|South Africa||Region of Enrollment||participants|Number|28|28.0||||||
4268159|NCT00594568|4092561|B1|South Africa||Region of Enrollment||participants|Number|26|26.0||||||
4268160|NCT00594568|4092558|B4|Denmark||Region of Enrollment||participants|Number|14|14.0||||||
4268161|NCT00594568|4092559|B3|Denmark||Region of Enrollment||participants|Number|4|4.0||||||
4268162|NCT00594568|4092560|B2|Denmark||Region of Enrollment||participants|Number|5|5.0||||||
4268163|NCT00594568|4092561|B1|Denmark||Region of Enrollment||participants|Number|5|5.0||||||
4268164|NCT00594568|4092558|B4|Australia||Region of Enrollment||participants|Number|69|69.0||||||
4268165|NCT00594568|4092559|B3|Australia||Region of Enrollment||participants|Number|24|24.0||||||
4268166|NCT00594568|4092560|B2|Australia||Region of Enrollment||participants|Number|25|25.0||||||
4268167|NCT00594568|4092561|B1|Australia||Region of Enrollment||participants|Number|20|20.0||||||
4268168|NCT00594568|4092558|B4|Belgium||Region of Enrollment||participants|Number|18|18.0||||||
4268169|NCT00594568|4092559|B3|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
4268170|NCT00594568|4092560|B2|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
4268171|NCT00594568|4092561|B1|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
4268172|NCT00594568|4092558|B4|Poland||Region of Enrollment||participants|Number|45|45.0||||||
4268173|NCT00594568|4092559|B3|Poland||Region of Enrollment||participants|Number|18|18.0||||||
4268174|NCT00594568|4092560|B2|Poland||Region of Enrollment||participants|Number|15|15.0||||||
4268175|NCT00594568|4092561|B1|Poland||Region of Enrollment||participants|Number|12|12.0||||||
4268176|NCT00594568|4092558|B4|Argentina||Region of Enrollment||participants|Number|73|73.0||||||
4268177|NCT00594568|4092559|B3|Argentina||Region of Enrollment||participants|Number|26|26.0||||||
4268178|NCT00594568|4092560|B2|Argentina||Region of Enrollment||participants|Number|23|23.0||||||
4268179|NCT00594568|4092561|B1|Argentina||Region of Enrollment||participants|Number|24|24.0||||||
4268180|NCT00594568|4092558|B4|Canada||Region of Enrollment||participants|Number|59|59.0||||||
4268181|NCT00594568|4092559|B3|Canada||Region of Enrollment||participants|Number|18|18.0||||||
4268182|NCT00594568|4092560|B2|Canada||Region of Enrollment||participants|Number|21|21.0||||||
4268183|NCT00594568|4092561|B1|Canada||Region of Enrollment||participants|Number|20|20.0||||||
4268184|NCT00594568|4092558|B4|France||Region of Enrollment||participants|Number|43|43.0||||||
4268185|NCT00594568|4092559|B3|France||Region of Enrollment||participants|Number|14|14.0||||||
4268186|NCT00594568|4092560|B2|France||Region of Enrollment||participants|Number|14|14.0||||||
4268187|NCT00594568|4092561|B1|France||Region of Enrollment||participants|Number|15|15.0||||||
4268188|NCT00594568|4092558|B4|India||Region of Enrollment||participants|Number|30|30.0||||||
4268189|NCT00594568|4092559|B3|India||Region of Enrollment||participants|Number|11|11.0||||||
4268190|NCT00594568|4092560|B2|India||Region of Enrollment||participants|Number|9|9.0||||||
4268191|NCT00594568|4092561|B1|India||Region of Enrollment||participants|Number|10|10.0||||||
4268192|NCT00594568|4092558|B4|United Kingdom||Region of Enrollment||participants|Number|55|55.0||||||
4268193|NCT00594568|4092559|B3|United Kingdom||Region of Enrollment||participants|Number|21|21.0||||||
4268194|NCT00594568|4092560|B2|United Kingdom||Region of Enrollment||participants|Number|20|20.0||||||
4268195|NCT00594568|4092561|B1|United Kingdom||Region of Enrollment||participants|Number|14|14.0||||||
4268196|NCT00594568|4092558|B4|Italy||Region of Enrollment||participants|Number|17|17.0||||||
4268197|NCT00594568|4092559|B3|Italy||Region of Enrollment||participants|Number|6|6.0||||||
4268198|NCT00594568|4092560|B2|Italy||Region of Enrollment||participants|Number|5|5.0||||||
4268199|NCT00594568|4092561|B1|Italy||Region of Enrollment||participants|Number|6|6.0||||||
4268200|NCT00594568|4092558|B4|Israel||Region of Enrollment||participants|Number|64|64.0||||||
4268201|NCT00594568|4092559|B3|Israel||Region of Enrollment||participants|Number|21|21.0||||||
4268202|NCT00594568|4092560|B2|Israel||Region of Enrollment||participants|Number|21|21.0||||||
4268203|NCT00594568|4092561|B1|Israel||Region of Enrollment||participants|Number|22|22.0||||||
4268204|NCT00594568|4092558|B4|Chile||Region of Enrollment||participants|Number|43|43.0||||||
4268205|NCT00594568|4092559|B3|Chile||Region of Enrollment||participants|Number|12|12.0||||||
4268206|NCT00594568|4092560|B2|Chile||Region of Enrollment||participants|Number|14|14.0||||||
4268207|NCT00594568|4092561|B1|Chile||Region of Enrollment||participants|Number|17|17.0||||||
4268208|NCT00594568|4092558|B4|Spain||Region of Enrollment||participants|Number|73|73.0||||||
4268209|NCT00594568|4092559|B3|Spain||Region of Enrollment||participants|Number|25|25.0||||||
4268210|NCT00594568|4092560|B2|Spain||Region of Enrollment||participants|Number|24|24.0||||||
4268211|NCT00594568|4092561|B1|Spain||Region of Enrollment||participants|Number|24|24.0||||||
4268212|NCT00594568|4092558|B4|Finland||Region of Enrollment||participants|Number|22|22.0||||||
4268213|NCT00594568|4092559|B3|Finland||Region of Enrollment||participants|Number|8|8.0||||||
4268214|NCT00594568|4092560|B2|Finland||Region of Enrollment||participants|Number|8|8.0||||||
4268215|NCT00594568|4092561|B1|Finland||Region of Enrollment||participants|Number|6|6.0||||||
4268216|NCT00594568|4092558|B4|United States||Region of Enrollment||participants|Number|585|585.0||||||
4268217|NCT00594568|4092559|B3|United States||Region of Enrollment||participants|Number|199|199.0||||||
4268218|NCT00594568|4092560|B2|United States||Region of Enrollment||participants|Number|194|194.0||||||
4268219|NCT00594568|4092561|B1|United States||Region of Enrollment||participants|Number|192|192.0||||||
4268220|NCT00594568|4092558|B4|West Asian||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4268221|NCT00594568|4092559|B3|West Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4268222|NCT00594568|4092560|B2|West Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4268223|NCT00594568|4092561|B1|West Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4268224|NCT00594568|4092558|B4|East Asian||Race/Ethnicity, Customized||participants|Number|143|143.0||||||
4268225|NCT00594568|4092559|B3|East Asian||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4268226|NCT00594568|4092560|B2|East Asian||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4268227|NCT00594568|4092561|B1|East Asian||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4268228|NCT00594568|4092558|B4|Native American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4268229|NCT00594568|4092559|B3|Native American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4268230|NCT00594568|4092560|B2|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4268231|NCT00594568|4092561|B1|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4268232|NCT00594568|4092558|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
4268233|NCT00594568|4092559|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4268234|NCT00594568|4092560|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4268235|NCT00594568|4092561|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4268236|NCT00594568|4092558|B4|African||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4268237|NCT00594568|4092559|B3|African||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4268238|NCT00594568|4092560|B2|African||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4268239|NCT00594568|4092561|B1|African||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4268240|NCT00594568|4092558|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|1282|1282.0||||||
4268241|NCT00594568|4092559|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|441|441.0||||||
4268242|NCT00594568|4092560|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|428|428.0||||||
4268243|NCT00594568|4092561|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|413|413.0||||||
4268244|NCT00594568|4092558|B4||Male|Sex: Female, Male||Participants|Count of Participants|714|714.0||||||
4268245|NCT00594568|4092559|B3||Male|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
4268246|NCT00594568|4092560|B2||Male|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
4268247|NCT00594568|4092561|B1||Male|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4268248|NCT00594568|4092558|B4||Female|Sex: Female, Male||Participants|Count of Participants|820|820.0||||||
4268249|NCT00594568|4092559|B3||Female|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
4268250|NCT00594568|4092560|B2||Female|Sex: Female, Male||Participants|Count of Participants|279|279.0||||||
4268251|NCT00594568|4092561|B1||Female|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
4268252|NCT00594568|4092558|B4|||Age||years|Mean|73.8|73.8|Standard Deviation|8.2|8.2|||
4268253|NCT00594568|4092559|B3|||Age||years|Mean|73.9|73.9|Standard Deviation|8.5|8.5|||
4268254|NCT00594568|4092560|B2|||Age||years|Mean|73.6|73.6|Standard Deviation|8.0|8.0|||
4268255|NCT00594568|4092561|B1|||Age||years|Mean|73.9|73.9|Standard Deviation|8.1|8.1|||
4268256|NCT00594516|4092651|B1|Other||Race/Ethnicity, Customized|Race/ethnicity|participants|Number|0|0.0||||||
4268257|NCT00594516|4092651|B1|Hispanic or Latino||Race/Ethnicity, Customized|Race/ethnicity|participants|Number|12|12.0||||||
4268258|NCT00594516|4092651|B1|White||Race/Ethnicity, Customized|Race/ethnicity|participants|Number|90|90.0||||||
4268259|NCT00594516|4092651|B1|Black or African American||Race/Ethnicity, Customized|Race/ethnicity|participants|Number|14|14.0||||||
4268260|NCT00594516|4092651|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Race/ethnicity|participants|Number|0|0.0||||||
4268261|NCT00594516|4092651|B1|Asian||Race/Ethnicity, Customized|Race/ethnicity|participants|Number|0|0.0||||||
4268262|NCT00594516|4092651|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Race/ethnicity|participants|Number|0|0.0||||||
4268263|NCT00594516|4092651|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4268264|NCT00594516|4092651|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4268265|NCT00594516|4092651|B1|||Age||years|Mean|53.6|53.6|Standard Deviation|15.46|15.46|||
4268266|NCT00594516|4092651|B1||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4268267|NCT00594516|4092651|B1||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
4268268|NCT00594516|4092651|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4268269|NCT00594464|4092661|B1|Germany||Region of Enrollment||participants|Number|14|14.0||||||
4268270|NCT00594464|4092661|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4268271|NCT00594464|4092661|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4268272|NCT00594464|4092661|B1|||Age||years|Mean|68.7|68.7|Standard Deviation|5.9|5.9|||
4268273|NCT00594464|4092661|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4268274|NCT00594464|4092661|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4268275|NCT00594464|4092661|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4268276|NCT00594425|4092673|B4|Fitzpatrick skin type score IV||Fitzpatrick Skin type|"The patients is scored according to a predefined description of 4 different skin types.~I White; very fair; red or blond hair; blue eyes; freckles Always burns, never tans~II White; fair; red or blond hair; blue, hazel or green eyes Usually burns, tans with difficulty~III Cream white; fair with any eye or hair color; very common Sometimes mild burn, gradually tans~IV Brown; typical Mediterranean Caucasian skin Rarely burns, tans with ease"|participants|Number|36|36.0||||||
4268277|NCT00594425|4092674|B3|Fitzpatrick skin type score IV||Fitzpatrick Skin type|"The patients is scored according to a predefined description of 4 different skin types.~I White; very fair; red or blond hair; blue eyes; freckles Always burns, never tans~II White; fair; red or blond hair; blue, hazel or green eyes Usually burns, tans with difficulty~III Cream white; fair with any eye or hair color; very common Sometimes mild burn, gradually tans~IV Brown; typical Mediterranean Caucasian skin Rarely burns, tans with ease"|participants|Number|13|13.0||||||
4268278|NCT00594425|4092675|B2|Fitzpatrick skin type score IV||Fitzpatrick Skin type|"The patients is scored according to a predefined description of 4 different skin types.~I White; very fair; red or blond hair; blue eyes; freckles Always burns, never tans~II White; fair; red or blond hair; blue, hazel or green eyes Usually burns, tans with difficulty~III Cream white; fair with any eye or hair color; very common Sometimes mild burn, gradually tans~IV Brown; typical Mediterranean Caucasian skin Rarely burns, tans with ease"|participants|Number|9|9.0||||||
4268279|NCT00594425|4092676|B1|Fitzpatrick skin type score IV||Fitzpatrick Skin type|"The patients is scored according to a predefined description of 4 different skin types.~I White; very fair; red or blond hair; blue eyes; freckles Always burns, never tans~II White; fair; red or blond hair; blue, hazel or green eyes Usually burns, tans with difficulty~III Cream white; fair with any eye or hair color; very common Sometimes mild burn, gradually tans~IV Brown; typical Mediterranean Caucasian skin Rarely burns, tans with ease"|participants|Number|14|14.0||||||
4268280|NCT00594425|4092673|B4|Fitzpatrick skin type score III||Fitzpatrick Skin type|"The patients is scored according to a predefined description of 4 different skin types.~I White; very fair; red or blond hair; blue eyes; freckles Always burns, never tans~II White; fair; red or blond hair; blue, hazel or green eyes Usually burns, tans with difficulty~III Cream white; fair with any eye or hair color; very common Sometimes mild burn, gradually tans~IV Brown; typical Mediterranean Caucasian skin Rarely burns, tans with ease"|participants|Number|68|68.0||||||
4268281|NCT00594425|4092674|B3|Fitzpatrick skin type score III||Fitzpatrick Skin type|"The patients is scored according to a predefined description of 4 different skin types.~I White; very fair; red or blond hair; blue eyes; freckles Always burns, never tans~II White; fair; red or blond hair; blue, hazel or green eyes Usually burns, tans with difficulty~III Cream white; fair with any eye or hair color; very common Sometimes mild burn, gradually tans~IV Brown; typical Mediterranean Caucasian skin Rarely burns, tans with ease"|participants|Number|23|23.0||||||
4268282|NCT00594425|4092675|B2|Fitzpatrick skin type score III||Fitzpatrick Skin type|"The patients is scored according to a predefined description of 4 different skin types.~I White; very fair; red or blond hair; blue eyes; freckles Always burns, never tans~II White; fair; red or blond hair; blue, hazel or green eyes Usually burns, tans with difficulty~III Cream white; fair with any eye or hair color; very common Sometimes mild burn, gradually tans~IV Brown; typical Mediterranean Caucasian skin Rarely burns, tans with ease"|participants|Number|24|24.0||||||
4268283|NCT00594425|4092676|B1|Fitzpatrick skin type score III||Fitzpatrick Skin type|"The patients is scored according to a predefined description of 4 different skin types.~I White; very fair; red or blond hair; blue eyes; freckles Always burns, never tans~II White; fair; red or blond hair; blue, hazel or green eyes Usually burns, tans with difficulty~III Cream white; fair with any eye or hair color; very common Sometimes mild burn, gradually tans~IV Brown; typical Mediterranean Caucasian skin Rarely burns, tans with ease"|participants|Number|21|21.0||||||
4268284|NCT00594425|4092673|B4|Fitzpatrick skin type score II||Fitzpatrick Skin type|"The patients is scored according to a predefined description of 4 different skin types.~I White; very fair; red or blond hair; blue eyes; freckles Always burns, never tans~II White; fair; red or blond hair; blue, hazel or green eyes Usually burns, tans with difficulty~III Cream white; fair with any eye or hair color; very common Sometimes mild burn, gradually tans~IV Brown; typical Mediterranean Caucasian skin Rarely burns, tans with ease"|participants|Number|37|37.0||||||
4268285|NCT00594425|4092674|B3|Fitzpatrick skin type score II||Fitzpatrick Skin type|"The patients is scored according to a predefined description of 4 different skin types.~I White; very fair; red or blond hair; blue eyes; freckles Always burns, never tans~II White; fair; red or blond hair; blue, hazel or green eyes Usually burns, tans with difficulty~III Cream white; fair with any eye or hair color; very common Sometimes mild burn, gradually tans~IV Brown; typical Mediterranean Caucasian skin Rarely burns, tans with ease"|participants|Number|15|15.0||||||
4268324|NCT00594425|4092673|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4268325|NCT00594425|4092674|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4268326|NCT00594425|4092675|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4268327|NCT00594425|4092676|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4268286|NCT00594425|4092675|B2|Fitzpatrick skin type score II||Fitzpatrick Skin type|"The patients is scored according to a predefined description of 4 different skin types.~I White; very fair; red or blond hair; blue eyes; freckles Always burns, never tans~II White; fair; red or blond hair; blue, hazel or green eyes Usually burns, tans with difficulty~III Cream white; fair with any eye or hair color; very common Sometimes mild burn, gradually tans~IV Brown; typical Mediterranean Caucasian skin Rarely burns, tans with ease"|participants|Number|11|11.0||||||
4268287|NCT00594425|4092676|B1|Fitzpatrick skin type score II||Fitzpatrick Skin type|"The patients is scored according to a predefined description of 4 different skin types.~I White; very fair; red or blond hair; blue eyes; freckles Always burns, never tans~II White; fair; red or blond hair; blue, hazel or green eyes Usually burns, tans with difficulty~III Cream white; fair with any eye or hair color; very common Sometimes mild burn, gradually tans~IV Brown; typical Mediterranean Caucasian skin Rarely burns, tans with ease"|participants|Number|11|11.0||||||
4268288|NCT00594425|4092673|B4|Fitzpatrick skin type score I||Fitzpatrick Skin type|"The patients is scored according to a predefined description of 4 different skin types.~I White; very fair; red or blond hair; blue eyes; freckles Always burns, never tans~II White; fair; red or blond hair; blue, hazel or green eyes Usually burns, tans with difficulty~III Cream white; fair with any eye or hair color; very common Sometimes mild burn, gradually tans~IV Brown; typical Mediterranean Caucasian skin Rarely burns, tans with ease"|participants|Number|9|9.0||||||
4268289|NCT00594425|4092674|B3|Fitzpatrick skin type score I||Fitzpatrick Skin type|"The patients is scored according to a predefined description of 4 different skin types.~I White; very fair; red or blond hair; blue eyes; freckles Always burns, never tans~II White; fair; red or blond hair; blue, hazel or green eyes Usually burns, tans with difficulty~III Cream white; fair with any eye or hair color; very common Sometimes mild burn, gradually tans~IV Brown; typical Mediterranean Caucasian skin Rarely burns, tans with ease"|participants|Number|1|1.0||||||
4268290|NCT00594425|4092675|B2|Fitzpatrick skin type score I||Fitzpatrick Skin type|"The patients is scored according to a predefined description of 4 different skin types.~I White; very fair; red or blond hair; blue eyes; freckles Always burns, never tans~II White; fair; red or blond hair; blue, hazel or green eyes Usually burns, tans with difficulty~III Cream white; fair with any eye or hair color; very common Sometimes mild burn, gradually tans~IV Brown; typical Mediterranean Caucasian skin Rarely burns, tans with ease"|participants|Number|4|4.0||||||
4268291|NCT00594425|4092676|B1|Fitzpatrick skin type score I||Fitzpatrick Skin type|"The patients is scored according to a predefined description of 4 different skin types.~I White; very fair; red or blond hair; blue eyes; freckles Always burns, never tans~II White; fair; red or blond hair; blue, hazel or green eyes Usually burns, tans with difficulty~III Cream white; fair with any eye or hair color; very common Sometimes mild burn, gradually tans~IV Brown; typical Mediterranean Caucasian skin Rarely burns, tans with ease"|participants|Number|4|4.0||||||
4268292|NCT00594425|4092673|B4|IGA SCORE 4 (SEVERE ACNE)||Investigator's Global Assessment (IGA) Score||participants|Number|30|30.0||||||
4268293|NCT00594425|4092674|B3|IGA SCORE 4 (SEVERE ACNE)||Investigator's Global Assessment (IGA) Score||participants|Number|8|8.0||||||
4268294|NCT00594425|4092675|B2|IGA SCORE 4 (SEVERE ACNE)||Investigator's Global Assessment (IGA) Score||participants|Number|7|7.0||||||
4268295|NCT00594425|4092676|B1|IGA SCORE 4 (SEVERE ACNE)||Investigator's Global Assessment (IGA) Score||participants|Number|15|15.0||||||
4268296|NCT00594425|4092673|B4|IGA SCORE 3 (MODERATE ACNE)||Investigator's Global Assessment (IGA) Score||participants|Number|120|120.0||||||
4268297|NCT00594425|4092674|B3|IGA SCORE 3 (MODERATE ACNE)||Investigator's Global Assessment (IGA) Score||participants|Number|44|44.0||||||
4268298|NCT00594425|4092675|B2|IGA SCORE 3 (MODERATE ACNE)||Investigator's Global Assessment (IGA) Score||participants|Number|41|41.0||||||
4268299|NCT00594425|4092676|B1|IGA SCORE 3 (MODERATE ACNE)||Investigator's Global Assessment (IGA) Score||participants|Number|35|35.0||||||
4268300|NCT00594425|4092673|B4|||Non inflammatory lesion count||lesions|Mean|36.7|36.7|Full Range|||4.0|111.0|
4268301|NCT00594425|4092674|B3|||Non inflammatory lesion count||lesions|Mean|35.2|35.2|Full Range|||7.0|94.0|
4268302|NCT00594425|4092675|B2|||Non inflammatory lesion count||lesions|Mean|35.9|35.9|Full Range|||5.0|111.0|
4268303|NCT00594425|4092676|B1|||Non inflammatory lesion count||lesions|Mean|39.1|39.1|Full Range|||4.0|99.0|
4268304|NCT00594425|4092673|B4|||Inflammatory lesion count||lesions|Mean|32.5|32.5|Full Range|||19.0|81.0|
4268305|NCT00594425|4092674|B3|||Inflammatory lesion count||lesions|Mean|31.2|31.2|Full Range|||20.0|74.0|
4268306|NCT00594425|4092675|B2|||Inflammatory lesion count||lesions|Mean|32.1|32.1|Full Range|||19.0|60.0|
4268307|NCT00594425|4092676|B1|||Inflammatory lesion count||lesions|Mean|34.2|34.2|Full Range|||20.0|81.0|
4268308|NCT00594425|4092673|B4|United States||Region of Enrollment||participants|Number|150|150.0||||||
4268309|NCT00594425|4092674|B3|United States||Region of Enrollment||participants|Number|52|52.0||||||
4268310|NCT00594425|4092675|B2|United States||Region of Enrollment||participants|Number|48|48.0||||||
4268311|NCT00594425|4092676|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4268312|NCT00594425|4092673|B4||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4268313|NCT00594425|4092674|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4268314|NCT00594425|4092675|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4268315|NCT00594425|4092676|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4268316|NCT00594425|4092673|B4||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4268317|NCT00594425|4092674|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4268318|NCT00594425|4092675|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4268319|NCT00594425|4092676|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4268320|NCT00594425|4092673|B4|||Age||years|Mean|21.3|21.3|Standard Deviation|5.05|5.05|||
4268321|NCT00594425|4092674|B3|||Age||years|Mean|22.0|22.0|Standard Deviation|5.00|5.0|||
4268322|NCT00594425|4092675|B2|||Age||years|Mean|20.2|20.2|Standard Deviation|4.81|4.81|||
4268323|NCT00594425|4092676|B1|||Age||years|Mean|21.6|21.6|Standard Deviation|5.24|5.24|||
4268328|NCT00594425|4092673|B4||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
4268329|NCT00594425|4092674|B3||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4268330|NCT00594425|4092675|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4268331|NCT00594425|4092676|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4268332|NCT00594425|4092673|B4||<=18 years|Age||Participants|Count of Participants|39|39.0||||||
4268333|NCT00594425|4092674|B3||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4268334|NCT00594425|4092675|B2||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
4268335|NCT00594425|4092676|B1||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4268336|NCT00594399|4092788|B3|||Physical Function|Physical function was measured by self report using the physical function subscale of the SF-36. Scores range from 0 to 100 with a higher score indicating better functioning.|points|Mean|62.98|62.98|Standard Deviation|21.0|21.0|||
4268337|NCT00594399|4092789|B2|||Physical Function|Physical function was measured by self report using the physical function subscale of the SF-36. Scores range from 0 to 100 with a higher score indicating better functioning.|points|Mean|63.97|63.97|Standard Deviation|21.79|21.79|||
4268338|NCT00594399|4092790|B1|||Physical Function|Physical function was measured by self report using the physical function subscale of the SF-36. Scores range from 0 to 100 with a higher score indicating better functioning.|points|Mean|62.94|62.94|Standard Deviation|20.97|20.97|||
4268339|NCT00594399|4092788|B3|||usual gait speed|Normal walking speed over 4 meters|meters/second|Mean|1.24|1.24|Standard Deviation|0.3|0.3|||
4268340|NCT00594399|4092789|B2|||usual gait speed|Normal walking speed over 4 meters|meters/second|Mean|1.25|1.25|Standard Deviation|0.3|0.3|||
4268341|NCT00594399|4092790|B1|||usual gait speed|Normal walking speed over 4 meters|meters/second|Mean|1.24|1.24|Standard Deviation|0.3|0.3|||
4268342|NCT00594399|4092788|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268343|NCT00594399|4092789|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268344|NCT00594399|4092790|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268345|NCT00594399|4092788|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268346|NCT00594399|4092789|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268347|NCT00594399|4092790|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268348|NCT00594399|4092788|B3||White|Race (NIH/OMB)||Participants|Count of Participants|212|212.0||||||
4268349|NCT00594399|4092789|B2||White|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
4268350|NCT00594399|4092790|B1||White|Race (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
4268351|NCT00594399|4092788|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
4268352|NCT00594399|4092789|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4268353|NCT00594399|4092790|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4268354|NCT00594399|4092788|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268355|NCT00594399|4092789|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268356|NCT00594399|4092790|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268357|NCT00594399|4092788|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268358|NCT00594399|4092789|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268359|NCT00594399|4092790|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268360|NCT00594399|4092788|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4268361|NCT00594399|4092789|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268362|NCT00594399|4092790|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4268363|NCT00594399|4092788|B3||Male|Sex: Female, Male||Participants|Count of Participants|292|292.0||||||
4268364|NCT00594399|4092789|B2||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4268365|NCT00594399|4092790|B1||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4268366|NCT00594399|4092788|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4268367|NCT00594399|4092789|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4268368|NCT00594399|4092790|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4268369|NCT00594399|4092788|B3|||Age||years|Mean|67.2|67.2|Standard Deviation|6.1|6.1|||
4268370|NCT00594399|4092789|B2|||Age||years|Mean|67.7|67.7|Standard Deviation|6.2|6.2|||
4268371|NCT00594399|4092790|B1|||Age||years|Mean|67.1|67.1|Standard Deviation|6.3|6.3|||
4268372|NCT00594386|4092814|B1|Canada||Region of Enrollment||participants|Number|15|15.0||||||
4268373|NCT00594386|4092814|B1|United States||Region of Enrollment||participants|Number|243|243.0||||||
4268374|NCT00594386|4092814|B1||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4268375|NCT00594386|4092814|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4268376|NCT00594386|4092814|B1|||Age||years|Mean|66.4|66.4|Standard Deviation|9.6|9.6|||
4268377|NCT00594386|4092814|B1||>=65 years|Age||Participants|Count of Participants|160|160.0||||||
4268378|NCT00594386|4092814|B1||Between 18 and 65 years|Age||Participants|Count of Participants|98|98.0||||||
4268379|NCT00594386|4092814|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4268380|NCT00594308|4092820|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4268381|NCT00594308|4092820|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4268382|NCT00594308|4092820|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4268383|NCT00594308|4092820|B1|||Age||years|Mean|52.80|52.8|Standard Deviation|11.29|11.29|||
4268384|NCT00594308|4092820|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4268385|NCT00594308|4092820|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4268386|NCT00594308|4092820|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4268387|NCT00594256|4092828|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4268388|NCT00594256|4092828|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4268389|NCT00594256|4092828|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4268390|NCT00594256|4092828|B1|||Age||years|Mean|41.8|41.8|Standard Deviation|10|10.0|||
4268391|NCT00594256|4092828|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4268392|NCT00594256|4092828|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4268393|NCT00594256|4092828|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4268394|NCT00594230|4092836|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4268395|NCT00594230|4092837|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4268396|NCT00594230|4092838|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4268397|NCT00594230|4092836|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4268398|NCT00594230|4092837|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4268399|NCT00594230|4092838|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4268400|NCT00594230|4092836|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4268401|NCT00594230|4092837|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4268402|NCT00594230|4092838|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4268403|NCT00594230|4092836|B3|||Age||years|Median|75|75.0|Full Range|||59.0|86.0|
4268404|NCT00594230|4092837|B2|||Age||years|Median|74|74.0|Full Range|||64.0|84.0|
4268405|NCT00594230|4092838|B1|||Age||years|Median|75|75.0|Full Range|||59.0|86.0|
4268406|NCT00594204|4092845|B3||Male|Sex: Female, Male||Participants|Count of Participants|355|355.0||||||
4268407|NCT00594204|4092846|B2||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4268408|NCT00594204|4092847|B1||Male|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
4268409|NCT00594204|4092845|B3||Female|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
4268410|NCT00594204|4092846|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4268411|NCT00594204|4092847|B1||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4268412|NCT00594204|4092845|B3|> 65||Age, Customized||years|Number|13|13.0||||||
4268413|NCT00594204|4092846|B2|> 65||Age, Customized||years|Number|6|6.0||||||
4268414|NCT00594204|4092847|B1|> 65||Age, Customized||years|Number|7|7.0||||||
4268415|NCT00594204|4092845|B3|55 - 65||Age, Customized||years|Number|77|77.0||||||
4268416|NCT00594204|4092846|B2|55 - 65||Age, Customized||years|Number|28|28.0||||||
4268417|NCT00594204|4092847|B1|55 - 65||Age, Customized||years|Number|49|49.0||||||
4268418|NCT00594204|4092845|B3|< 55||Age, Customized||years|Number|498|498.0||||||
4268419|NCT00594204|4092846|B2|< 55||Age, Customized||years|Number|164|164.0||||||
4268420|NCT00594204|4092847|B1|< 55||Age, Customized||years|Number|334|334.0||||||
4268421|NCT00594178|4092858|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4268422|NCT00594178|4092858|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4268423|NCT00594178|4092858|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4268424|NCT00594178|4092858|B1|||Age||years|Mean|35.38|35.38|Standard Deviation|14.4314|14.4314|||
4268425|NCT00594178|4092858|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4268426|NCT00594178|4092858|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4268427|NCT00594178|4092858|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4268428|NCT00594165|4092863|B1|Canada||Region of Enrollment||participants|Number|30|30.0||||||
4268429|NCT00594165|4092863|B1|United States||Region of Enrollment||participants|Number|186|186.0||||||
4268430|NCT00594165|4092863|B1||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4268431|NCT00594165|4092863|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4268432|NCT00594165|4092863|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|10.3|10.3|||
4268433|NCT00594165|4092863|B1||>=65 years|Age||Participants|Count of Participants|97|97.0||||||
4268434|NCT00594165|4092863|B1||Between 18 and 65 years|Age||Participants|Count of Participants|119|119.0||||||
4268435|NCT00594165|4092863|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4268436|NCT00594100|4092869|B1|Asymptomatic||Symptomatic|Presence of baseline neurological symptoms within 6 months prior to study enrollment|participants|Number|167|167.0||||||
4268437|NCT00594100|4092869|B1|Symptomatic||Symptomatic|Presence of baseline neurological symptoms within 6 months prior to study enrollment|participants|Number|78|78.0||||||
4268438|NCT00594100|4092869|B1|Greater than 1 Year||Previous Endarterectomy|Timing of previous endarterectomy (CEA)|participants|Number|79|79.0||||||
4268439|NCT00594100|4092869|B1|Less than 1 Year||Previous Endarterectomy|Timing of previous endarterectomy (CEA)|participants|Number|23|23.0||||||
4268440|NCT00594100|4092869|B1|None||Previous Endarterectomy|Timing of previous endarterectomy (CEA)|participants|Number|143|143.0||||||
4268441|NCT00594100|4092869|B1|Two or More||History of Ischemic Stroke|Number of prior ischemic strokes prior to enrollment|participants|Number|11|11.0||||||
4268442|NCT00594100|4092869|B1|One||History of Ischemic Stroke|Number of prior ischemic strokes prior to enrollment|participants|Number|42|42.0||||||
4268443|NCT00594100|4092869|B1|None||History of Ischemic Stroke|Number of prior ischemic strokes prior to enrollment|participants|Number|192|192.0||||||
4268444|NCT00594100|4092869|B1|No||History of Hypertension|Patient has history of hypertension prior to study enrollment|participants|Number|33|33.0||||||
4268445|NCT00594100|4092869|B1|Yes||History of Hypertension|Patient has history of hypertension prior to study enrollment|participants|Number|212|212.0||||||
4268446|NCT00594100|4092869|B1|No||History of Diabetes|Patient has a history of Diabetes prior to enrollment|participants|Number|159|159.0||||||
4268447|NCT00594100|4092869|B1|Yes||History of Diabetes|Patient has a history of Diabetes prior to enrollment|participants|Number|86|86.0||||||
4268448|NCT00594100|4092869|B1||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4268449|NCT00594100|4092869|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4268450|NCT00594100|4092869|B1|>= 80 years||Age, Customized||participants|Number|38|38.0||||||
4268451|NCT00594100|4092869|B1|< 80 years||Age, Customized||participants|Number|207|207.0||||||
4268452|NCT00594100|4092869|B1|||Age||years|Median|71.0|71.0|Full Range|||46.0|89.8|
4268453|NCT00594100|4092869|B1|||Age||years|Mean|70.2|70.2|Standard Deviation|9.6|9.6|||
4268454|NCT00594061|4092878|B1|||Preschool Language Scale-3|Assesses global language skills using toys and pictures. This test assess auditory comprehension and expressive communication and a total language score is calculated. A higher total score indicates better performance. The standard score ranges from 50 to 150. A raw score for total language is calculated and converted into a standard score.|units on a scale|Mean|74.2|74.2|Standard Deviation|8.1|8.1|||
4268455|NCT00594061|4092878|B1|||Minnesota Child Development Inventory|This parent inventory consists of 54 statements describing the behaviors of infants and preschool-age children and provides measures of the child's expressive language development. The parent is asked yes/no questions and indicates whether the child is able to do what the statement says. Raw scores are converted into age-equivalent scores. The maximum range of age equivalent scores is 1 month to 63 months. Higher age-equivalent scores indicates better performance.|months|Mean|11.3|11.3|Standard Deviation|2.6|2.6|||
4268456|NCT00594061|4092878|B1|||MacArthur Communicative Developmental Inventories (CDI)|The CDI is a parent report measure evaluating children's communicative development. The CDI Words and Gestures (WG) tests children aged 8- to 16-months. WG assesses the child's production of language by their responses to familiar words and phases. Raw scores are converted into age-equivalent scores.The maximum range of age equivalent scores is <8 months to 18 months. Higher age-equivalent scores indicate better outcomes.|months|Mean|10.4|10.4|Standard Deviation|2.19|2.19|||
4268457|NCT00594061|4092878|B1|||Infant-Toddler Meaningful Auditory Integration Scale (IT-MAIS)|The IT-MAIS is a structured interview schedule used to assess the child’s spontaneous responses to sound in his/her everyday environment. It consists of 10 questions with a total scale range of 0-40. Performance is scored in terms of the total number of points accrued out of 40 possible points. Higher score indicates better performance. Each question has a potential of 0 (lowest) to 4 (highest) points.|units on a scale|Mean|2.6|2.6|Standard Deviation|5.5|5.5|||
4268458|NCT00594061|4092878|B1|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4268459|NCT00594061|4092878|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4268460|NCT00594061|4092878|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4268461|NCT00594061|4092878|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4268462|NCT00594061|4092878|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4268463|NCT00594061|4092878|B1||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4268464|NCT00594035|4092883|B3|United States||Region of Enrollment||participants|Number|158|158.0||||||
4268465|NCT00594035|4092884|B2|United States||Region of Enrollment||participants|Number|56|56.0||||||
4268466|NCT00594035|4092885|B1|United States||Region of Enrollment||participants|Number|102|102.0||||||
4268467|NCT00594035|4092883|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4268468|NCT00594035|4092884|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4268469|NCT00594035|4092885|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4268470|NCT00594035|4092883|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4268471|NCT00594035|4092884|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4268472|NCT00594035|4092885|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4268473|NCT00594035|4092883|B3|||Age||years|Mean|45.8|45.8|Standard Deviation|14.1|14.1|||
4268474|NCT00594035|4092884|B2|||Age||years|Mean|42.3|42.3|Standard Deviation|14.5|14.5|||
4268475|NCT00594035|4092885|B1|||Age||years|Mean|47.7|47.7|Standard Deviation|13.6|13.6|||
4268476|NCT00594035|4092883|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4268477|NCT00594035|4092884|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4268478|NCT00594035|4092885|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4268479|NCT00594035|4092883|B3||Between 18 and 65 years|Age||Participants|Count of Participants|141|141.0||||||
4268480|NCT00594035|4092884|B2||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4268481|NCT00594035|4092885|B1||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
4268482|NCT00594035|4092883|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4268483|NCT00594035|4092884|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4268484|NCT00594035|4092885|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4268485|NCT00594022|4092892|B3|||Sleep Onset Latency on Multiple Sleep Latency Test||minutes|Mean|17.86|17.86|Standard Deviation|1.86|1.86|||
4268486|NCT00594022|4092893|B2|||Sleep Onset Latency on Multiple Sleep Latency Test||minutes|Mean|17.93|17.93|Standard Deviation|1.81|1.81|||
4268487|NCT00594022|4092894|B1|||Sleep Onset Latency on Multiple Sleep Latency Test||minutes|Mean|17.79|17.79|Standard Deviation|1.90|1.9|||
4268488|NCT00594022|4092892|B3|||Pulse||beats per minute|Mean|69.79|69.79|Standard Deviation|9.79|9.79|||
4268489|NCT00594022|4092893|B2|||Pulse||beats per minute|Mean|69.43|69.43|Standard Deviation|9.60|9.6|||
4268490|NCT00594022|4092894|B1|||Pulse||beats per minute|Mean|70.14|70.14|Standard Deviation|9.99|9.99|||
4268491|NCT00594022|4092892|B3|||Respiration||breaths per minute|Mean|16.65|16.65|Standard Deviation|2.05|2.05|||
4268492|NCT00594022|4092893|B2|||Respiration||breaths per minute|Mean|16.82|16.82|Standard Deviation|1.88|1.88|||
4268493|NCT00594022|4092894|B1|||Respiration||breaths per minute|Mean|16.49|16.49|Standard Deviation|2.19|2.19|||
4268494|NCT00594022|4092892|B3|||Systolic Blood Pressure||mmHg|Mean|114.60|114.6|Standard Deviation|12.18|12.18|||
4268495|NCT00594022|4092893|B2|||Systolic Blood Pressure||mmHg|Mean|115.64|115.64|Standard Deviation|11.91|11.91|||
4268496|NCT00594022|4092894|B1|||Systolic Blood Pressure||mmHg|Mean|113.57|113.57|Standard Deviation|12.39|12.39|||
4268497|NCT00594022|4092892|B3|||Diastolic Blood Pressure||mmHg|Mean|72.23|72.23|Standard Deviation|8.94|8.94|||
4268498|NCT00594022|4092893|B2|||Diastolic Blood Pressure||mmHg|Mean|72.84|72.84|Standard Deviation|9.00|9.0|||
4268499|NCT00594022|4092894|B1|||Diastolic Blood Pressure||mmHg|Mean|71.62|71.62|Standard Deviation|8.86|8.86|||
4268500|NCT00594022|4092892|B3|||Body Mass Index||kg/m^2|Mean|25.71|25.71|Standard Deviation|5.23|5.23|||
4268501|NCT00594022|4092893|B2|||Body Mass Index||kg/m^2|Mean|26.00|26.0|Standard Deviation|5.42|5.42|||
4268502|NCT00594022|4092894|B1|||Body Mass Index||kg/m^2|Mean|25.42|25.42|Standard Deviation|5.04|5.04|||
4268503|NCT00594022|4092892|B3|United States||Region of Enrollment||participants|Number|349|349.0||||||
4268504|NCT00594022|4092893|B2|United States||Region of Enrollment||participants|Number|173|173.0||||||
4268505|NCT00594022|4092894|B1|United States||Region of Enrollment||participants|Number|176|176.0||||||
4268506|NCT00594022|4092892|B3||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4268507|NCT00594022|4092893|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4268508|NCT00594022|4092894|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4268509|NCT00594022|4092892|B3||Female|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
4268510|NCT00594022|4092893|B2||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4268511|NCT00594022|4092894|B1||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4268512|NCT00594022|4092892|B3|||Age||years|Mean|31.76|31.76|Standard Deviation|7.63|7.63|||
4268513|NCT00594022|4092893|B2|||Age||years|Mean|31.91|31.91|Standard Deviation|7.74|7.74|||
4268514|NCT00594022|4092894|B1|||Age||years|Mean|31.53|31.53|Standard Deviation|7.56|7.56|||
4268515|NCT00593957|4092909|B4|United States||Region of Enrollment||participants|Number|38|38.0||||||
4268516|NCT00593957|4092910|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4268517|NCT00593957|4092911|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4268518|NCT00593957|4092912|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4268519|NCT00593957|4092909|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4268520|NCT00593957|4092910|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4268521|NCT00593957|4092911|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4268522|NCT00593957|4092912|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4268523|NCT00593957|4092909|B4||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4268524|NCT00593957|4092910|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4268525|NCT00593957|4092911|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4268526|NCT00593957|4092912|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4268527|NCT00593957|4092909|B4|||Age||years|Mean|6.32|6.32|Standard Deviation|3.02|3.02|||
4268528|NCT00593957|4092910|B3|||Age||years|Mean|6.08|6.08|Standard Deviation|3.06|3.06|||
4268529|NCT00593957|4092911|B2|||Age||years|Mean|6.31|6.31|Standard Deviation|3.50|3.5|||
4268530|NCT00593957|4092912|B1|||Age||years|Mean|6.54|6.54|Standard Deviation|2.70|2.7|||
4268531|NCT00593957|4092909|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4268532|NCT00593957|4092910|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4268533|NCT00593957|4092911|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4268534|NCT00593957|4092912|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4268535|NCT00593957|4092909|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4268536|NCT00593957|4092910|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4268537|NCT00593957|4092911|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4268538|NCT00593957|4092912|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4268539|NCT00593957|4092909|B4||<=18 years|Age||Participants|Count of Participants|38|38.0||||||
4268540|NCT00593957|4092910|B3||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4268541|NCT00593957|4092911|B2||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4268542|NCT00593957|4092912|B1||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4268543|NCT00593918|4092936|B3|United States||Region of Enrollment||participants|Number|91|91.0||||||
4268544|NCT00593918|4092937|B2|United States||Region of Enrollment||participants|Number|74|74.0||||||
4268545|NCT00593918|4092938|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4268546|NCT00593918|4092936|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4268547|NCT00593918|4092937|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4268548|NCT00593918|4092938|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4268549|NCT00593918|4092936|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4268550|NCT00593918|4092937|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4268551|NCT00593918|4092938|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4268552|NCT00593918|4092936|B3|||Age||years|Mean|0.82|0.82|Standard Deviation|0.55|0.55|||
4268553|NCT00593918|4092937|B2|||Age||years|Mean|0.82|0.82|Standard Deviation|0.54|0.54|||
4268554|NCT00593918|4092938|B1|||Age||years|Mean|0.78|0.78|Standard Deviation|0.56|0.56|||
4268555|NCT00593918|4092936|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4268556|NCT00593918|4092937|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4268557|NCT00593918|4092938|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4268558|NCT00593918|4092936|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4268559|NCT00593918|4092937|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4268560|NCT00593918|4092938|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4268561|NCT00593918|4092936|B3||<=18 years|Age||Participants|Count of Participants|91|91.0||||||
4268562|NCT00593918|4092937|B2||<=18 years|Age||Participants|Count of Participants|74|74.0||||||
4268563|NCT00593918|4092938|B1||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
4268564|NCT00593866|4092947|B1|||Baseline CA 19-9|The CA 19-9 is a simple blood test that measures the level of antigens in the blood serum of a person with pancreatic cancer.|Units Per Millilitre (U/mL)|Median|102|102.0|Full Range|||11.0|5028.0|
4268565|NCT00593866|4092947|B1|||Tumor Volume||Cubic Centimeter (cc)|Median|47.9|47.9|Full Range|||17.0|170.0|
4268566|NCT00593866|4092947|B1|||Tumor Size||centimeters (cm)|Median|3.25|3.25|Full Range|||1.6|7.1|
4268567|NCT00593866|4092947|B1|Body/Tail||Tumor Location|Location of tumor within the pancreas|participants|Number|7|7.0||||||
4268568|NCT00593866|4092947|B1|Neck||Tumor Location|Location of tumor within the pancreas|participants|Number|10|10.0||||||
4268569|NCT00593866|4092947|B1|Head||Tumor Location|Location of tumor within the pancreas|participants|Number|33|33.0||||||
4268570|NCT00593866|4092947|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4268571|NCT00593866|4092947|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268572|NCT00593866|4092947|B1||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4268573|NCT00593866|4092947|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4268574|NCT00593866|4092947|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268575|NCT00593866|4092947|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268576|NCT00593866|4092947|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268577|NCT00593866|4092947|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4268578|NCT00593866|4092947|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4268579|NCT00593866|4092947|B1|||Age||years|Median|63|63.0|Full Range|||48.0|83.0|
4268580|NCT00593840|4092952|B1|No||Tobacco abuse||participants|Number|26|26.0||||||
4268581|NCT00593840|4092952|B1|Yes||Tobacco abuse||participants|Number|47|47.0||||||
4268582|NCT00593840|4092952|B1|Unknown||Primary tumor type||participants|Number|1|1.0||||||
4268583|NCT00593840|4092952|B1|Hypopharynx||Primary tumor type||participants|Number|4|4.0||||||
4268584|NCT00593840|4092952|B1|Oral cavity||Primary tumor type||participants|Number|14|14.0||||||
4268585|NCT00593840|4092952|B1|Larynx||Primary tumor type||participants|Number|17|17.0||||||
4268586|NCT00593840|4092952|B1|Oropharynx||Primary tumor type||participants|Number|37|37.0||||||
4268587|NCT00593840|4092952|B1|United States||Region of Enrollment||participants|Number|73|73.0||||||
4268588|NCT00593840|4092952|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4268589|NCT00593840|4092952|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4268590|NCT00593840|4092952|B1|||Age||years|Median|56|56.0|Full Range|||31.0|81.0|
4268591|NCT00593827|4092962|B3|2=symptomatic, but in bed < 50% of the day||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is normal activity; 1 is symptoms, but fully ambulatory; 2 is symptomatic, but in bed < 50% of the day; 3 is needs to be in bed > 50% of the day, but not bedridden; 4 is unable to get out of bed; 5 is dead.|Participants|Number|11|11.0||||||
4268592|NCT00593827|4092963|B2|2=symptomatic, but in bed < 50% of the day||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is normal activity; 1 is symptoms, but fully ambulatory; 2 is symptomatic, but in bed < 50% of the day; 3 is needs to be in bed > 50% of the day, but not bedridden; 4 is unable to get out of bed; 5 is dead.|Participants|Number|5|5.0||||||
4268593|NCT00593827|4092964|B1|2=symptomatic, but in bed < 50% of the day||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is normal activity; 1 is symptoms, but fully ambulatory; 2 is symptomatic, but in bed < 50% of the day; 3 is needs to be in bed > 50% of the day, but not bedridden; 4 is unable to get out of bed; 5 is dead.|Participants|Number|6|6.0||||||
4268594|NCT00593827|4092962|B3|1=symptoms, but fully ambulatory||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is normal activity; 1 is symptoms, but fully ambulatory; 2 is symptomatic, but in bed < 50% of the day; 3 is needs to be in bed > 50% of the day, but not bedridden; 4 is unable to get out of bed; 5 is dead.|Participants|Number|83|83.0||||||
4268595|NCT00593827|4092963|B2|1=symptoms, but fully ambulatory||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is normal activity; 1 is symptoms, but fully ambulatory; 2 is symptomatic, but in bed < 50% of the day; 3 is needs to be in bed > 50% of the day, but not bedridden; 4 is unable to get out of bed; 5 is dead.|Participants|Number|43|43.0||||||
4268692|NCT00593736|4092999|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268750|NCT00593736|4093002|B1|||Age||years|Mean|29.6|29.6|Standard Deviation|9.36|9.36|||
4268596|NCT00593827|4092964|B1|1=symptoms, but fully ambulatory||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is normal activity; 1 is symptoms, but fully ambulatory; 2 is symptomatic, but in bed < 50% of the day; 3 is needs to be in bed > 50% of the day, but not bedridden; 4 is unable to get out of bed; 5 is dead.|Participants|Number|40|40.0||||||
4268597|NCT00593827|4092962|B3|0=normal activity||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is normal activity; 1 is symptoms, but fully ambulatory; 2 is symptomatic, but in bed < 50% of the day; 3 is needs to be in bed > 50% of the day, but not bedridden; 4 is unable to get out of bed; 5 is dead.|Participants|Number|82|82.0||||||
4268598|NCT00593827|4092963|B2|0=normal activity||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is normal activity; 1 is symptoms, but fully ambulatory; 2 is symptomatic, but in bed < 50% of the day; 3 is needs to be in bed > 50% of the day, but not bedridden; 4 is unable to get out of bed; 5 is dead.|Participants|Number|43|43.0||||||
4268599|NCT00593827|4092964|B1|0=normal activity||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is normal activity; 1 is symptoms, but fully ambulatory; 2 is symptomatic, but in bed < 50% of the day; 3 is needs to be in bed > 50% of the day, but not bedridden; 4 is unable to get out of bed; 5 is dead.|Participants|Number|39|39.0||||||
4268600|NCT00593827|4092962|B3|United States||Region of Enrollment||Participants|Number|176|176.0||||||
4268601|NCT00593827|4092963|B2|United States||Region of Enrollment||Participants|Number|91|91.0||||||
4268602|NCT00593827|4092964|B1|United States||Region of Enrollment||Participants|Number|85|85.0||||||
4268603|NCT00593827|4092962|B3|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4268604|NCT00593827|4092963|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4268605|NCT00593827|4092964|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4268606|NCT00593827|4092962|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4268607|NCT00593827|4092963|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4268608|NCT00593827|4092964|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4268609|NCT00593827|4092962|B3|African American||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4268610|NCT00593827|4092963|B2|African American||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4268611|NCT00593827|4092964|B1|African American||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4268612|NCT00593827|4092962|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|139|139.0||||||
4268613|NCT00593827|4092963|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|70|70.0||||||
4268614|NCT00593827|4092964|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|69|69.0||||||
4268615|NCT00593827|4092962|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4268616|NCT00593827|4092963|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4268617|NCT00593827|4092964|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4268618|NCT00593827|4092962|B3||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4268619|NCT00593827|4092963|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4268620|NCT00593827|4092964|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4268621|NCT00593827|4092962|B3|||Age||Years|Mean|59.5|59.5|Standard Deviation|10.9|10.9|||
4268622|NCT00593827|4092963|B2|||Age||Years|Mean|58.7|58.7|Standard Deviation|10.4|10.4|||
4268623|NCT00593827|4092964|B1|||Age||Years|Mean|60.3|60.3|Standard Deviation|11.4|11.4|||
4268624|NCT00593814|4092987|B3|United States||Region of Enrollment||participants|Number|259|259.0||||||
4268625|NCT00593814|4092988|B2|United States||Region of Enrollment||participants|Number|120|120.0||||||
4268626|NCT00593814|4092989|B1|United States||Region of Enrollment||participants|Number|139|139.0||||||
4268627|NCT00593814|4092987|B3||Male|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4268628|NCT00593814|4092988|B2||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4268629|NCT00593814|4092989|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4268630|NCT00593814|4092987|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4268631|NCT00593814|4092988|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4268632|NCT00593814|4092989|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4268633|NCT00593814|4092987|B3|||Age||years|Mean|73.3|73.3|Standard Deviation|7.6|7.6|||
4268634|NCT00593814|4092988|B2|||Age||years|Mean|72.6|72.6|Standard Deviation|7.7|7.7|||
4268635|NCT00593814|4092989|B1|||Age||years|Mean|73.9|73.9|Standard Deviation|7.5|7.5|||
4268636|NCT00593736|4092998|B5|Desired||Time to fall asleep (habitual and desired)|Habitual sleep time defined as the time it takes to fall asleep starting at subject’s usual, later sleep time. Desired sleep time defined as the time it takes to fall asleep at subject’s preferred, earlier sleep time.|minutes|Mean|163.0|163.0|Standard Deviation|51.89|51.89|||
4268637|NCT00593736|4092999|B4|Desired||Time to fall asleep (habitual and desired)|Habitual sleep time defined as the time it takes to fall asleep starting at subject’s usual, later sleep time. Desired sleep time defined as the time it takes to fall asleep at subject’s preferred, earlier sleep time.|minutes|Mean|155.0|155.0|Standard Deviation|55.61|55.61|||
4268638|NCT00593736|4093000|B3|Desired||Time to fall asleep (habitual and desired)|Habitual sleep time defined as the time it takes to fall asleep starting at subject’s usual, later sleep time. Desired sleep time defined as the time it takes to fall asleep at subject’s preferred, earlier sleep time.|minutes|Mean|165.0|165.0|Standard Deviation|48.94|48.94|||
4268639|NCT00593736|4093001|B2|Desired||Time to fall asleep (habitual and desired)|Habitual sleep time defined as the time it takes to fall asleep starting at subject’s usual, later sleep time. Desired sleep time defined as the time it takes to fall asleep at subject’s preferred, earlier sleep time.|minutes|Mean|164.4|164.4|Standard Deviation|51.43|51.43|||
4268640|NCT00593736|4093002|B1|Desired||Time to fall asleep (habitual and desired)|Habitual sleep time defined as the time it takes to fall asleep starting at subject’s usual, later sleep time. Desired sleep time defined as the time it takes to fall asleep at subject’s preferred, earlier sleep time.|minutes|Mean|167.5|167.5|Standard Deviation|53.25|53.25|||
4268641|NCT00593736|4092998|B5|Habitual||Time to fall asleep (habitual and desired)|Habitual sleep time defined as the time it takes to fall asleep starting at subject’s usual, later sleep time. Desired sleep time defined as the time it takes to fall asleep at subject’s preferred, earlier sleep time.|minutes|Mean|80.2|80.2|Standard Deviation|65.66|65.66|||
4268642|NCT00593736|4092999|B4|Habitual||Time to fall asleep (habitual and desired)|Habitual sleep time defined as the time it takes to fall asleep starting at subject’s usual, later sleep time. Desired sleep time defined as the time it takes to fall asleep at subject’s preferred, earlier sleep time.|minutes|Mean|69.8|69.8|Standard Deviation|58.72|58.72|||
4268643|NCT00593736|4093000|B3|Habitual||Time to fall asleep (habitual and desired)|Habitual sleep time defined as the time it takes to fall asleep starting at subject’s usual, later sleep time. Desired sleep time defined as the time it takes to fall asleep at subject’s preferred, earlier sleep time.|minutes|Mean|90.4|90.4|Standard Deviation|64.79|64.79|||
4268644|NCT00593736|4093001|B2|Habitual||Time to fall asleep (habitual and desired)|Habitual sleep time defined as the time it takes to fall asleep starting at subject’s usual, later sleep time. Desired sleep time defined as the time it takes to fall asleep at subject’s preferred, earlier sleep time.|minutes|Mean|76.8|76.8|Standard Deviation|59.89|59.89|||
4268645|NCT00593736|4093002|B1|Habitual||Time to fall asleep (habitual and desired)|Habitual sleep time defined as the time it takes to fall asleep starting at subject’s usual, later sleep time. Desired sleep time defined as the time it takes to fall asleep at subject’s preferred, earlier sleep time.|minutes|Mean|83.0|83.0|Standard Deviation|78.85|78.85|||
4268646|NCT00593736|4092998|B5|Desired||Time asleep (habitual and desired)||minutes|Mean|337.8|337.8|Standard Deviation|72.06|72.06|||
4268647|NCT00593736|4092999|B4|Desired||Time asleep (habitual and desired)||minutes|Mean|330.9|330.9|Standard Deviation|64.43|64.43|||
4268648|NCT00593736|4093000|B3|Desired||Time asleep (habitual and desired)||minutes|Mean|331.3|331.3|Standard Deviation|75.30|75.3|||
4268649|NCT00593736|4093001|B2|Desired||Time asleep (habitual and desired)||minutes|Mean|347.7|347.7|Standard Deviation|72.05|72.05|||
4268650|NCT00593736|4093002|B1|Desired||Time asleep (habitual and desired)||minutes|Mean|341.7|341.7|Standard Deviation|76.46|76.46|||
4268651|NCT00593736|4092998|B5|Habitual||Time asleep (habitual and desired)||minutes|Mean|382.6|382.6|Standard Deviation|93.01|93.01|||
4268652|NCT00593736|4092999|B4|Habitual||Time asleep (habitual and desired)||minutes|Mean|384.8|384.8|Standard Deviation|78.88|78.88|||
4268653|NCT00593736|4093000|B3|Habitual||Time asleep (habitual and desired)||minutes|Mean|371.6|371.6|Standard Deviation|95.29|95.29|||
4268654|NCT00593736|4093001|B2|Habitual||Time asleep (habitual and desired)||minutes|Mean|406.4|406.4|Standard Deviation|105.29|105.29|||
4268655|NCT00593736|4093002|B1|Habitual||Time asleep (habitual and desired)||minutes|Mean|368.0|368.0|Standard Deviation|89.27|89.27|||
4268656|NCT00593736|4092998|B5|>4||Pharmacologic sleep aid needed to sleep|"For the question, Do you use of pharmacological assistance to sleep, an answer of 'no'=0 and 'yes' resulted in the question, If yes, how often per week? 1=1 day/week; 2=2 days/week; 3=3 days/week; 4=4 days/week; >4=more than 4 days/week."|subjects|Number|0|0.0||||||
4268657|NCT00593736|4092999|B4|>4||Pharmacologic sleep aid needed to sleep|"For the question, Do you use of pharmacological assistance to sleep, an answer of 'no'=0 and 'yes' resulted in the question, If yes, how often per week? 1=1 day/week; 2=2 days/week; 3=3 days/week; 4=4 days/week; >4=more than 4 days/week."|subjects|Number|0|0.0||||||
4268658|NCT00593736|4093000|B3|>4||Pharmacologic sleep aid needed to sleep|"For the question, Do you use of pharmacological assistance to sleep, an answer of 'no'=0 and 'yes' resulted in the question, If yes, how often per week? 1=1 day/week; 2=2 days/week; 3=3 days/week; 4=4 days/week; >4=more than 4 days/week."|subjects|Number|0|0.0||||||
4268659|NCT00593736|4093001|B2|>4||Pharmacologic sleep aid needed to sleep|"For the question, Do you use of pharmacological assistance to sleep, an answer of 'no'=0 and 'yes' resulted in the question, If yes, how often per week? 1=1 day/week; 2=2 days/week; 3=3 days/week; 4=4 days/week; >4=more than 4 days/week."|subjects|Number|0|0.0||||||
4268660|NCT00593736|4093002|B1|>4||Pharmacologic sleep aid needed to sleep|"For the question, Do you use of pharmacological assistance to sleep, an answer of 'no'=0 and 'yes' resulted in the question, If yes, how often per week? 1=1 day/week; 2=2 days/week; 3=3 days/week; 4=4 days/week; >4=more than 4 days/week."|subjects|Number|0|0.0||||||
4268661|NCT00593736|4092998|B5|4||Pharmacologic sleep aid needed to sleep|"For the question, Do you use of pharmacological assistance to sleep, an answer of 'no'=0 and 'yes' resulted in the question, If yes, how often per week? 1=1 day/week; 2=2 days/week; 3=3 days/week; 4=4 days/week; >4=more than 4 days/week."|subjects|Number|0|0.0||||||
4268662|NCT00593736|4092999|B4|4||Pharmacologic sleep aid needed to sleep|"For the question, Do you use of pharmacological assistance to sleep, an answer of 'no'=0 and 'yes' resulted in the question, If yes, how often per week? 1=1 day/week; 2=2 days/week; 3=3 days/week; 4=4 days/week; >4=more than 4 days/week."|subjects|Number|0|0.0||||||
4268663|NCT00593736|4093000|B3|4||Pharmacologic sleep aid needed to sleep|"For the question, Do you use of pharmacological assistance to sleep, an answer of 'no'=0 and 'yes' resulted in the question, If yes, how often per week? 1=1 day/week; 2=2 days/week; 3=3 days/week; 4=4 days/week; >4=more than 4 days/week."|subjects|Number|0|0.0||||||
4268664|NCT00593736|4093001|B2|4||Pharmacologic sleep aid needed to sleep|"For the question, Do you use of pharmacological assistance to sleep, an answer of 'no'=0 and 'yes' resulted in the question, If yes, how often per week? 1=1 day/week; 2=2 days/week; 3=3 days/week; 4=4 days/week; >4=more than 4 days/week."|subjects|Number|0|0.0||||||
4268665|NCT00593736|4093002|B1|4||Pharmacologic sleep aid needed to sleep|"For the question, Do you use of pharmacological assistance to sleep, an answer of 'no'=0 and 'yes' resulted in the question, If yes, how often per week? 1=1 day/week; 2=2 days/week; 3=3 days/week; 4=4 days/week; >4=more than 4 days/week."|subjects|Number|0|0.0||||||
4268666|NCT00593736|4092998|B5|3||Pharmacologic sleep aid needed to sleep|"For the question, Do you use of pharmacological assistance to sleep, an answer of 'no'=0 and 'yes' resulted in the question, If yes, how often per week? 1=1 day/week; 2=2 days/week; 3=3 days/week; 4=4 days/week; >4=more than 4 days/week."|subjects|Number|2|2.0||||||
4268667|NCT00593736|4092999|B4|3||Pharmacologic sleep aid needed to sleep|"For the question, Do you use of pharmacological assistance to sleep, an answer of 'no'=0 and 'yes' resulted in the question, If yes, how often per week? 1=1 day/week; 2=2 days/week; 3=3 days/week; 4=4 days/week; >4=more than 4 days/week."|subjects|Number|0|0.0||||||
4268668|NCT00593736|4093000|B3|3||Pharmacologic sleep aid needed to sleep|"For the question, Do you use of pharmacological assistance to sleep, an answer of 'no'=0 and 'yes' resulted in the question, If yes, how often per week? 1=1 day/week; 2=2 days/week; 3=3 days/week; 4=4 days/week; >4=more than 4 days/week."|subjects|Number|0|0.0||||||
4268669|NCT00593736|4093001|B2|3||Pharmacologic sleep aid needed to sleep|"For the question, Do you use of pharmacological assistance to sleep, an answer of 'no'=0 and 'yes' resulted in the question, If yes, how often per week? 1=1 day/week; 2=2 days/week; 3=3 days/week; 4=4 days/week; >4=more than 4 days/week."|subjects|Number|1|1.0||||||
4268670|NCT00593736|4093002|B1|3||Pharmacologic sleep aid needed to sleep|"For the question, Do you use of pharmacological assistance to sleep, an answer of 'no'=0 and 'yes' resulted in the question, If yes, how often per week? 1=1 day/week; 2=2 days/week; 3=3 days/week; 4=4 days/week; >4=more than 4 days/week."|subjects|Number|1|1.0||||||
4268671|NCT00593736|4092998|B5|2||Pharmacologic sleep aid needed to sleep|"For the question, Do you use of pharmacological assistance to sleep, an answer of 'no'=0 and 'yes' resulted in the question, If yes, how often per week? 1=1 day/week; 2=2 days/week; 3=3 days/week; 4=4 days/week; >4=more than 4 days/week."|subjects|Number|3|3.0||||||
4268672|NCT00593736|4092999|B4|2||Pharmacologic sleep aid needed to sleep|"For the question, Do you use of pharmacological assistance to sleep, an answer of 'no'=0 and 'yes' resulted in the question, If yes, how often per week? 1=1 day/week; 2=2 days/week; 3=3 days/week; 4=4 days/week; >4=more than 4 days/week."|subjects|Number|0|0.0||||||
4268673|NCT00593736|4093000|B3|2||Pharmacologic sleep aid needed to sleep|"For the question, Do you use of pharmacological assistance to sleep, an answer of 'no'=0 and 'yes' resulted in the question, If yes, how often per week? 1=1 day/week; 2=2 days/week; 3=3 days/week; 4=4 days/week; >4=more than 4 days/week."|subjects|Number|1|1.0||||||
4268674|NCT00593736|4093001|B2|2||Pharmacologic sleep aid needed to sleep|"For the question, Do you use of pharmacological assistance to sleep, an answer of 'no'=0 and 'yes' resulted in the question, If yes, how often per week? 1=1 day/week; 2=2 days/week; 3=3 days/week; 4=4 days/week; >4=more than 4 days/week."|subjects|Number|2|2.0||||||
4268675|NCT00593736|4093002|B1|2||Pharmacologic sleep aid needed to sleep|"For the question, Do you use of pharmacological assistance to sleep, an answer of 'no'=0 and 'yes' resulted in the question, If yes, how often per week? 1=1 day/week; 2=2 days/week; 3=3 days/week; 4=4 days/week; >4=more than 4 days/week."|subjects|Number|0|0.0||||||
4268676|NCT00593736|4092998|B5|1||Pharmacologic sleep aid needed to sleep|"For the question, Do you use of pharmacological assistance to sleep, an answer of 'no'=0 and 'yes' resulted in the question, If yes, how often per week? 1=1 day/week; 2=2 days/week; 3=3 days/week; 4=4 days/week; >4=more than 4 days/week."|subjects|Number|1|1.0||||||
4268677|NCT00593736|4092999|B4|1||Pharmacologic sleep aid needed to sleep|"For the question, Do you use of pharmacological assistance to sleep, an answer of 'no'=0 and 'yes' resulted in the question, If yes, how often per week? 1=1 day/week; 2=2 days/week; 3=3 days/week; 4=4 days/week; >4=more than 4 days/week."|subjects|Number|0|0.0||||||
4268678|NCT00593736|4093000|B3|1||Pharmacologic sleep aid needed to sleep|"For the question, Do you use of pharmacological assistance to sleep, an answer of 'no'=0 and 'yes' resulted in the question, If yes, how often per week? 1=1 day/week; 2=2 days/week; 3=3 days/week; 4=4 days/week; >4=more than 4 days/week."|subjects|Number|1|1.0||||||
4268679|NCT00593736|4093001|B2|1||Pharmacologic sleep aid needed to sleep|"For the question, Do you use of pharmacological assistance to sleep, an answer of 'no'=0 and 'yes' resulted in the question, If yes, how often per week? 1=1 day/week; 2=2 days/week; 3=3 days/week; 4=4 days/week; >4=more than 4 days/week."|subjects|Number|0|0.0||||||
4268680|NCT00593736|4093002|B1|1||Pharmacologic sleep aid needed to sleep|"For the question, Do you use of pharmacological assistance to sleep, an answer of 'no'=0 and 'yes' resulted in the question, If yes, how often per week? 1=1 day/week; 2=2 days/week; 3=3 days/week; 4=4 days/week; >4=more than 4 days/week."|subjects|Number|0|0.0||||||
4268681|NCT00593736|4092998|B5|0||Pharmacologic sleep aid needed to sleep|"For the question, Do you use of pharmacological assistance to sleep, an answer of 'no'=0 and 'yes' resulted in the question, If yes, how often per week? 1=1 day/week; 2=2 days/week; 3=3 days/week; 4=4 days/week; >4=more than 4 days/week."|subjects|Number|126|126.0||||||
4268682|NCT00593736|4092999|B4|0||Pharmacologic sleep aid needed to sleep|"For the question, Do you use of pharmacological assistance to sleep, an answer of 'no'=0 and 'yes' resulted in the question, If yes, how often per week? 1=1 day/week; 2=2 days/week; 3=3 days/week; 4=4 days/week; >4=more than 4 days/week."|subjects|Number|32|32.0||||||
4268683|NCT00593736|4093000|B3|0||Pharmacologic sleep aid needed to sleep|"For the question, Do you use of pharmacological assistance to sleep, an answer of 'no'=0 and 'yes' resulted in the question, If yes, how often per week? 1=1 day/week; 2=2 days/week; 3=3 days/week; 4=4 days/week; >4=more than 4 days/week."|subjects|Number|33|33.0||||||
4268684|NCT00593736|4093001|B2|0||Pharmacologic sleep aid needed to sleep|"For the question, Do you use of pharmacological assistance to sleep, an answer of 'no'=0 and 'yes' resulted in the question, If yes, how often per week? 1=1 day/week; 2=2 days/week; 3=3 days/week; 4=4 days/week; >4=more than 4 days/week."|subjects|Number|30|30.0||||||
4268685|NCT00593736|4093002|B1|0||Pharmacologic sleep aid needed to sleep|"For the question, Do you use of pharmacological assistance to sleep, an answer of 'no'=0 and 'yes' resulted in the question, If yes, how often per week? 1=1 day/week; 2=2 days/week; 3=3 days/week; 4=4 days/week; >4=more than 4 days/week."|subjects|Number|31|31.0||||||
4268686|NCT00593736|4092998|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4268687|NCT00593736|4092999|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268688|NCT00593736|4093000|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268689|NCT00593736|4093001|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268690|NCT00593736|4093002|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4268691|NCT00593736|4092998|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268693|NCT00593736|4093000|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268694|NCT00593736|4093001|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268695|NCT00593736|4093002|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268696|NCT00593736|4092998|B5||White|Race (NIH/OMB)||Participants|Count of Participants|114|114.0||||||
4268697|NCT00593736|4092999|B4||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4268698|NCT00593736|4093000|B3||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4268699|NCT00593736|4093001|B2||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4268700|NCT00593736|4093002|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4268701|NCT00593736|4092998|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4268702|NCT00593736|4092999|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4268703|NCT00593736|4093000|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4268704|NCT00593736|4093001|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4268705|NCT00593736|4093002|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4268706|NCT00593736|4092998|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4268707|NCT00593736|4092999|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4268708|NCT00593736|4093000|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268709|NCT00593736|4093001|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268710|NCT00593736|4093002|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268711|NCT00593736|4092998|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4268712|NCT00593736|4092999|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268713|NCT00593736|4093000|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268714|NCT00593736|4093001|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268715|NCT00593736|4093002|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4268716|NCT00593736|4092998|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4268717|NCT00593736|4092999|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268718|NCT00593736|4093000|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268719|NCT00593736|4093001|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268720|NCT00593736|4093002|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4268721|NCT00593736|4092998|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268722|NCT00593736|4092999|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268723|NCT00593736|4093000|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268724|NCT00593736|4093001|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268725|NCT00593736|4093002|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268726|NCT00593736|4092998|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4268727|NCT00593736|4092999|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4268728|NCT00593736|4093000|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4268729|NCT00593736|4093001|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4268730|NCT00593736|4093002|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4268731|NCT00593736|4092998|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4268732|NCT00593736|4092999|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4268733|NCT00593736|4093000|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4268734|NCT00593736|4093001|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4268735|NCT00593736|4093002|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4268736|NCT00593736|4092998|B5||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4268737|NCT00593736|4092999|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4268738|NCT00593736|4093000|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4268739|NCT00593736|4093001|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4268740|NCT00593736|4093002|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4268741|NCT00593736|4092998|B5||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4268742|NCT00593736|4092999|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4268743|NCT00593736|4093000|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4268744|NCT00593736|4093001|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4268745|NCT00593736|4093002|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4268746|NCT00593736|4092998|B5|||Age||years|Mean|31.4|31.4|Standard Deviation|11.19|11.19|||
4268747|NCT00593736|4092999|B4|||Age||years|Mean|33.1|33.1|Standard Deviation|13.08|13.08|||
4268748|NCT00593736|4093000|B3|||Age||years|Mean|29.3|29.3|Standard Deviation|9.40|9.4|||
4268749|NCT00593736|4093001|B2|||Age||years|Mean|33.7|33.7|Standard Deviation|12.31|12.31|||
4268751|NCT00593684|4093251|B3|||Average Line Days|umbilical arterial line, umbilical venous line, peripheral arterial line, peripheral long line, and central venous line calculated per 1,000 days.|line days|Mean|18.5|18.5|Standard Deviation|9.35|9.35|||
4268752|NCT00593684|4093252|B2|||Average Line Days|umbilical arterial line, umbilical venous line, peripheral arterial line, peripheral long line, and central venous line calculated per 1,000 days.|line days|Mean|19|19.0|Standard Deviation|9.9|9.9|||
4268753|NCT00593684|4093253|B1|||Average Line Days|umbilical arterial line, umbilical venous line, peripheral arterial line, peripheral long line, and central venous line calculated per 1,000 days.|line days|Mean|17.95|17.95|Standard Deviation|8.8|8.8|||
4268754|NCT00593684|4093251|B3|||Birth Weight (grams)||Grams|Mean|934|934.0|Standard Deviation|229|229.0|||
4268755|NCT00593684|4093252|B2|||Birth Weight (grams)||Grams|Mean|913|913.0|Standard Deviation|209|209.0|||
4268756|NCT00593684|4093253|B1|||Birth Weight (grams)||Grams|Mean|955|955.0|Standard Deviation|250|250.0|||
4268757|NCT00593684|4093251|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4268758|NCT00593684|4093252|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4268759|NCT00593684|4093253|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4268760|NCT00593684|4093251|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268761|NCT00593684|4093252|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268762|NCT00593684|4093253|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268763|NCT00593684|4093251|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4268764|NCT00593684|4093252|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4268765|NCT00593684|4093253|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4268766|NCT00593684|4093251|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4268767|NCT00593684|4093252|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4268768|NCT00593684|4093253|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4268769|NCT00593684|4093251|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268770|NCT00593684|4093252|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268771|NCT00593684|4093253|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268772|NCT00593684|4093251|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4268773|NCT00593684|4093252|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268774|NCT00593684|4093253|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4268775|NCT00593684|4093251|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4268776|NCT00593684|4093252|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268777|NCT00593684|4093253|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4268778|NCT00593684|4093251|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4268779|NCT00593684|4093252|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4268780|NCT00593684|4093253|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4268781|NCT00593684|4093251|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4268782|NCT00593684|4093252|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4268783|NCT00593684|4093253|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4268784|NCT00593684|4093251|B3|||Age|weeks of gestation|weeks|Mean|27.25|27.25|Standard Deviation|2|2.0|||
4268785|NCT00593684|4093252|B2|||Age|weeks of gestation|weeks|Mean|27.2|27.2|Standard Deviation|1.85|1.85|||
4268786|NCT00593684|4093253|B1|||Age|weeks of gestation|weeks|Mean|27.3|27.3|Standard Deviation|2.03|2.03|||
4268787|NCT00593645|4093266|B1|Acute myeloid leukemia||Diagnosis||participants|Number|4|4.0||||||
4268788|NCT00593645|4093266|B1|Myelodysplastic syndrome||Diagnosis||participants|Number|3|3.0||||||
4268789|NCT00593645|4093266|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4268790|NCT00593645|4093266|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4268791|NCT00593645|4093266|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4268792|NCT00593645|4093266|B1|||Age||years|Median|54|54.0|Full Range|||24.0|68.0|
4268793|NCT00593606|4093280|B1|Korea, Republic of||Region of Enrollment||participants|Number|116|116.0||||||
4268794|NCT00593606|4093280|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4268795|NCT00593606|4093280|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4268796|NCT00593606|4093280|B1|||Age||years|Mean|60.0|60.0|Standard Deviation|10.1|10.1|||
4268797|NCT00593606|4093280|B1||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
4268798|NCT00593606|4093280|B1||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4268799|NCT00593606|4093280|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4268800|NCT00593554|4093376|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268801|NCT00593554|4093377|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268802|NCT00593554|4093378|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268803|NCT00593554|4093376|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268804|NCT00593554|4093377|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268805|NCT00593554|4093378|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268806|NCT00593554|4093376|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4268807|NCT00593554|4093377|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4268808|NCT00593554|4093378|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4268809|NCT00593554|4093376|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4268810|NCT00593554|4093377|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4268811|NCT00593554|4093378|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4268812|NCT00593554|4093376|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268813|NCT00593554|4093377|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268814|NCT00593554|4093378|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268815|NCT00593554|4093376|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268816|NCT00593554|4093377|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268817|NCT00593554|4093378|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268818|NCT00593554|4093376|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268819|NCT00593554|4093377|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268820|NCT00593554|4093378|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268821|NCT00593554|4093376|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268822|NCT00593554|4093377|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268823|NCT00593554|4093378|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268824|NCT00593554|4093376|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4268825|NCT00593554|4093377|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4268826|NCT00593554|4093378|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4268827|NCT00593554|4093376|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268828|NCT00593554|4093377|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268829|NCT00593554|4093378|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4268830|NCT00593554|4093376|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4268831|NCT00593554|4093377|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4268832|NCT00593554|4093378|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4268833|NCT00593554|4093376|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4268834|NCT00593554|4093377|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4268835|NCT00593554|4093378|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4268836|NCT00593554|4093376|B3|||Age||years|Mean|44.6|44.6|Standard Deviation|11.91|11.91|||
4268837|NCT00593554|4093377|B2|||Age||years|Mean|45.9|45.9|Standard Deviation|12.21|12.21|||
4268838|NCT00593554|4093378|B1|||Age||years|Mean|42.6|42.6|Standard Deviation|13.73|13.73|||
4268839|NCT00593554|4093376|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4268840|NCT00593554|4093377|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4268841|NCT00593554|4093378|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4268842|NCT00593554|4093376|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4268843|NCT00593554|4093377|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4268844|NCT00593554|4093378|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4268845|NCT00593554|4093376|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4268846|NCT00593554|4093377|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4268847|NCT00593554|4093378|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4268848|NCT00593450|4093397|B5|No choroidal neovascularization or can't grade||Foveal center involvement||Participants|Number|18|18.0||||||
4268849|NCT00593450|4093398|B4|No choroidal neovascularization or can't grade||Foveal center involvement||Participants|Number|2|2.0||||||
4268850|NCT00593450|4093399|B3|No choroidal neovascularization or can't grade||Foveal center involvement||Participants|Number|6|6.0||||||
4268851|NCT00593450|4093400|B2|No choroidal neovascularization or can't grade||Foveal center involvement||Participants|Number|8|8.0||||||
4268852|NCT00593450|4093401|B1|No choroidal neovascularization or can't grade||Foveal center involvement||Participants|Number|2|2.0||||||
4268853|NCT00593450|4093397|B5|Other||Foveal center involvement||Participants|Number|71|71.0||||||
4268854|NCT00593450|4093398|B4|Other||Foveal center involvement||Participants|Number|18|18.0||||||
4268855|NCT00593450|4093399|B3|Other||Foveal center involvement||Participants|Number|15|15.0||||||
4268856|NCT00593450|4093400|B2|Other||Foveal center involvement||Participants|Number|20|20.0||||||
4268857|NCT00593450|4093401|B1|Other||Foveal center involvement||Participants|Number|18|18.0||||||
4268858|NCT00593450|4093397|B5|Hemorrhage||Foveal center involvement||Participants|Number|93|93.0||||||
4268859|NCT00593450|4093398|B4|Hemorrhage||Foveal center involvement||Participants|Number|25|25.0||||||
4268860|NCT00593450|4093399|B3|Hemorrhage||Foveal center involvement||Participants|Number|24|24.0||||||
4268861|NCT00593450|4093400|B2|Hemorrhage||Foveal center involvement||Participants|Number|24|24.0||||||
4268862|NCT00593450|4093401|B1|Hemorrhage||Foveal center involvement||Participants|Number|20|20.0||||||
4268863|NCT00593450|4093397|B5|Fluid||Foveal center involvement||Participants|Number|315|315.0||||||
4268864|NCT00593450|4093398|B4|Fluid||Foveal center involvement||Participants|Number|72|72.0||||||
4268865|NCT00593450|4093399|B3|Fluid||Foveal center involvement||Participants|Number|77|77.0||||||
4268866|NCT00593450|4093400|B2|Fluid||Foveal center involvement||Participants|Number|81|81.0||||||
4268867|NCT00593450|4093401|B1|Fluid||Foveal center involvement||Participants|Number|85|85.0||||||
4268868|NCT00593450|4093397|B5|Choroidal neovacularization||Foveal center involvement||Participants|Number|688|688.0||||||
4268869|NCT00593450|4093398|B4|Choroidal neovacularization||Foveal center involvement||Participants|Number|183|183.0||||||
4268870|NCT00593450|4093399|B3|Choroidal neovacularization||Foveal center involvement||Participants|Number|176|176.0||||||
4268871|NCT00593450|4093400|B2|Choroidal neovacularization||Foveal center involvement||Participants|Number|153|153.0||||||
4268872|NCT00593450|4093401|B1|Choroidal neovacularization||Foveal center involvement||Participants|Number|176|176.0||||||
4268873|NCT00593450|4093397|B5|||Retinal thickness plus subfoveal-fluid thickness at fovea||microns|Mean|251|251.0|Standard Deviation|120|120.0|||
4268874|NCT00593450|4093398|B4|||Retinal thickness plus subfoveal-fluid thickness at fovea||microns|Mean|252|252.0|Standard Deviation|115|115.0|||
4268875|NCT00593450|4093399|B3|||Retinal thickness plus subfoveal-fluid thickness at fovea||microns|Mean|247|247.0|Standard Deviation|122|122.0|||
4268876|NCT00593450|4093400|B2|||Retinal thickness plus subfoveal-fluid thickness at fovea||microns|Mean|254|254.0|Standard Deviation|121|121.0|||
4268877|NCT00593450|4093401|B1|||Retinal thickness plus subfoveal-fluid thickness at fovea||microns|Mean|251|251.0|Standard Deviation|122|122.0|||
4268878|NCT00593450|4093397|B5|||Total thickness at fovea||μm|Mean|460|460.0|Standard Deviation|187|187.0|||
4268879|NCT00593450|4093398|B4|||Total thickness at fovea||μm|Mean|461|461.0|Standard Deviation|175|175.0|||
4268880|NCT00593450|4093399|B3|||Total thickness at fovea||μm|Mean|458|458.0|Standard Deviation|193|193.0|||
4268881|NCT00593450|4093400|B2|||Total thickness at fovea||μm|Mean|463|463.0|Standard Deviation|196|196.0|||
4268882|NCT00593450|4093401|B1|||Total thickness at fovea||μm|Mean|458|458.0|Standard Deviation|184|184.0|||
4268883|NCT00593450|4093397|B5|||Visual-acuity score and Snellen equivalent|"Visual acuity testing was performed with the Electronic Visual Tester (EVA) following the ETDRS protocol. VA score is measured as number of letters read correctly.~In this study, the visual acuity letter score is ranged from 23 to 82, with the higher score the better visual acuity."|Letters|Mean|60.5|60.5|Standard Deviation|13.5|13.5|||
4268884|NCT00593450|4093398|B4|||Visual-acuity score and Snellen equivalent|"Visual acuity testing was performed with the Electronic Visual Tester (EVA) following the ETDRS protocol. VA score is measured as number of letters read correctly.~In this study, the visual acuity letter score is ranged from 23 to 82, with the higher score the better visual acuity."|Letters|Mean|60.4|60.4|Standard Deviation|13.4|13.4|||
4268885|NCT00593450|4093399|B3|||Visual-acuity score and Snellen equivalent|"Visual acuity testing was performed with the Electronic Visual Tester (EVA) following the ETDRS protocol. VA score is measured as number of letters read correctly.~In this study, the visual acuity letter score is ranged from 23 to 82, with the higher score the better visual acuity."|Letters|Mean|61.5|61.5|Standard Deviation|13.2|13.2|||
4268886|NCT00593450|4093400|B2|||Visual-acuity score and Snellen equivalent|"Visual acuity testing was performed with the Electronic Visual Tester (EVA) following the ETDRS protocol. VA score is measured as number of letters read correctly.~In this study, the visual acuity letter score is ranged from 23 to 82, with the higher score the better visual acuity."|Letters|Mean|60.2|60.2|Standard Deviation|13.1|13.1|||
4268887|NCT00593450|4093401|B1|||Visual-acuity score and Snellen equivalent|"Visual acuity testing was performed with the Electronic Visual Tester (EVA) following the ETDRS protocol. VA score is measured as number of letters read correctly.~In this study, the visual acuity letter score is ranged from 23 to 82, with the higher score the better visual acuity."|Letters|Mean|60.1|60.1|Standard Deviation|14.3|14.3|||
4268888|NCT00593450|4093397|B5|23-37 letters, 20/200-320||Visual-acuity score and Snellen equivalent||Participants|Number|82|82.0||||||
4268889|NCT00593450|4093398|B4|23-37 letters, 20/200-320||Visual-acuity score and Snellen equivalent||Participants|Number|20|20.0||||||
4268890|NCT00593450|4093399|B3|23-37 letters, 20/200-320||Visual-acuity score and Snellen equivalent||Participants|Number|16|16.0||||||
4268891|NCT00593450|4093400|B2|23-37 letters, 20/200-320||Visual-acuity score and Snellen equivalent||Participants|Number|21|21.0||||||
4268892|NCT00593450|4093401|B1|23-37 letters, 20/200-320||Visual-acuity score and Snellen equivalent||Participants|Number|25|25.0||||||
4268893|NCT00593450|4093397|B5|38-52 letters, 20/100-160||Visual-acuity score and Snellen equivalent||Participants|Number|236|236.0||||||
4268894|NCT00593450|4093398|B4|38-52 letters, 20/100-160||Visual-acuity score and Snellen equivalent||Participants|Number|58|58.0||||||
4268895|NCT00593450|4093399|B3|38-52 letters, 20/100-160||Visual-acuity score and Snellen equivalent||Participants|Number|58|58.0||||||
4268896|NCT00593450|4093400|B2|38-52 letters, 20/100-160||Visual-acuity score and Snellen equivalent||Participants|Number|53|53.0||||||
4268897|NCT00593450|4093401|B1|38-52 letters, 20/100-160||Visual-acuity score and Snellen equivalent||Participants|Number|67|67.0||||||
4268898|NCT00593450|4093397|B5|53-67 letters, 20/50-80||Visual-acuity score and Snellen equivalent||Participants|Number|443|443.0||||||
4268899|NCT00593450|4093398|B4|53-67 letters, 20/50-80||Visual-acuity score and Snellen equivalent||Participants|Number|119|119.0||||||
4268900|NCT00593450|4093399|B3|53-67 letters, 20/50-80||Visual-acuity score and Snellen equivalent||Participants|Number|108|108.0||||||
4268901|NCT00593450|4093400|B2|53-67 letters, 20/50-80||Visual-acuity score and Snellen equivalent||Participants|Number|118|118.0||||||
4268902|NCT00593450|4093401|B1|53-67 letters, 20/50-80||Visual-acuity score and Snellen equivalent||Participants|Number|98|98.0||||||
4268903|NCT00593450|4093397|B5|68-82 letters, 20/25-40||Visual-acuity score and Snellen equivalent||Participants|Number|424|424.0||||||
4268904|NCT00593450|4093398|B4|68-82 letters, 20/25-40||Visual-acuity score and Snellen equivalent||Participants|Number|103|103.0||||||
4268905|NCT00593450|4093399|B3|68-82 letters, 20/25-40||Visual-acuity score and Snellen equivalent||Participants|Number|116|116.0||||||
4268968|NCT00593450|4093397|B5|>=90 years||Age, Customized||participants|Number|84|84.0||||||
4268906|NCT00593450|4093400|B2|68-82 letters, 20/25-40||Visual-acuity score and Snellen equivalent||Participants|Number|94|94.0||||||
4268907|NCT00593450|4093401|B1|68-82 letters, 20/25-40||Visual-acuity score and Snellen equivalent||Participants|Number|111|111.0||||||
4268908|NCT00593450|4093397|B5|||Diastolic blood pressure||mm Hg|Mean|75|75.0|Standard Deviation|10|10.0|||
4268909|NCT00593450|4093398|B4|||Diastolic blood pressure||mm Hg|Mean|75|75.0|Standard Deviation|10|10.0|||
4268910|NCT00593450|4093399|B3|||Diastolic blood pressure||mm Hg|Mean|76|76.0|Standard Deviation|9|9.0|||
4268911|NCT00593450|4093400|B2|||Diastolic blood pressure||mm Hg|Mean|75|75.0|Standard Deviation|10|10.0|||
4268912|NCT00593450|4093401|B1|||Diastolic blood pressure||mm Hg|Mean|75|75.0|Standard Deviation|10|10.0|||
4268913|NCT00593450|4093397|B5|||Systolic blood pressure||mm Hg|Mean|135|135.0|Standard Deviation|18|18.0|||
4268914|NCT00593450|4093398|B4|||Systolic blood pressure||mm Hg|Mean|135|135.0|Standard Deviation|17|17.0|||
4268915|NCT00593450|4093399|B3|||Systolic blood pressure||mm Hg|Mean|136|136.0|Standard Deviation|17|17.0|||
4268916|NCT00593450|4093400|B2|||Systolic blood pressure||mm Hg|Mean|135|135.0|Standard Deviation|19|19.0|||
4268917|NCT00593450|4093401|B1|||Systolic blood pressure||mm Hg|Mean|134|134.0|Standard Deviation|18|18.0|||
4268918|NCT00593450|4093397|B5|No||History of transient ischemic attack||Participants|Number|1117|1117.0||||||
4268919|NCT00593450|4093398|B4|No||History of transient ischemic attack||Participants|Number|281|281.0||||||
4268920|NCT00593450|4093399|B3|No||History of transient ischemic attack||Participants|Number|286|286.0||||||
4268921|NCT00593450|4093400|B2|No||History of transient ischemic attack||Participants|Number|261|261.0||||||
4268922|NCT00593450|4093401|B1|No||History of transient ischemic attack||Participants|Number|289|289.0||||||
4268923|NCT00593450|4093397|B5|Yes||History of transient ischemic attack||Participants|Number|68|68.0||||||
4268924|NCT00593450|4093398|B4|Yes||History of transient ischemic attack||Participants|Number|19|19.0||||||
4268925|NCT00593450|4093399|B3|Yes||History of transient ischemic attack||Participants|Number|12|12.0||||||
4268926|NCT00593450|4093400|B2|Yes||History of transient ischemic attack||Participants|Number|25|25.0||||||
4268927|NCT00593450|4093401|B1|Yes||History of transient ischemic attack||Participants|Number|12|12.0||||||
4268928|NCT00593450|4093397|B5|No||History of stroke||Participants|Number|1115|1115.0||||||
4268929|NCT00593450|4093398|B4|No||History of stroke||Participants|Number|284|284.0||||||
4268930|NCT00593450|4093399|B3|No||History of stroke||Participants|Number|276|276.0||||||
4268931|NCT00593450|4093400|B2|No||History of stroke||Participants|Number|268|268.0||||||
4268932|NCT00593450|4093401|B1|No||History of stroke||Participants|Number|287|287.0||||||
4268933|NCT00593450|4093397|B5|Yes||History of stroke||Participants|Number|70|70.0||||||
4268934|NCT00593450|4093398|B4|Yes||History of stroke||Participants|Number|16|16.0||||||
4268935|NCT00593450|4093399|B3|Yes||History of stroke||Participants|Number|22|22.0||||||
4268936|NCT00593450|4093400|B2|Yes||History of stroke||Participants|Number|18|18.0||||||
4268937|NCT00593450|4093401|B1|Yes||History of stroke||Participants|Number|14|14.0||||||
4268938|NCT00593450|4093397|B5|No||History of myocardial infarction||Participants|Number|1045|1045.0||||||
4268939|NCT00593450|4093398|B4|No||History of myocardial infarction||Participants|Number|264|264.0||||||
4268940|NCT00593450|4093399|B3|No||History of myocardial infarction||Participants|Number|268|268.0||||||
4268941|NCT00593450|4093400|B2|No||History of myocardial infarction||Participants|Number|246|246.0||||||
4268942|NCT00593450|4093401|B1|No||History of myocardial infarction||Participants|Number|267|267.0||||||
4268943|NCT00593450|4093397|B5|Yes||History of myocardial infarction||Participants|Number|140|140.0||||||
4268944|NCT00593450|4093398|B4|Yes||History of myocardial infarction||Participants|Number|36|36.0||||||
4268945|NCT00593450|4093399|B3|Yes||History of myocardial infarction||Participants|Number|30|30.0||||||
4268946|NCT00593450|4093400|B2|Yes||History of myocardial infarction||Participants|Number|40|40.0||||||
4268947|NCT00593450|4093401|B1|Yes||History of myocardial infarction||Participants|Number|34|34.0||||||
4268948|NCT00593450|4093397|B5|Other||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4268949|NCT00593450|4093398|B4|Other||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4268950|NCT00593450|4093399|B3|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4268951|NCT00593450|4093400|B2|Other||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4268952|NCT00593450|4093401|B1|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4268953|NCT00593450|4093397|B5|White||Race/Ethnicity, Customized||Participants|Number|1168|1168.0||||||
4268954|NCT00593450|4093398|B4|White||Race/Ethnicity, Customized||Participants|Number|294|294.0||||||
4268955|NCT00593450|4093399|B3|White||Race/Ethnicity, Customized||Participants|Number|296|296.0||||||
4268956|NCT00593450|4093400|B2|White||Race/Ethnicity, Customized||Participants|Number|281|281.0||||||
4268957|NCT00593450|4093401|B1|White||Race/Ethnicity, Customized||Participants|Number|297|297.0||||||
4268958|NCT00593450|4093397|B5||Male|Sex: Female, Male||Participants|Count of Participants|453|453.0||||||
4268959|NCT00593450|4093398|B4||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4268960|NCT00593450|4093399|B3||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4268961|NCT00593450|4093400|B2||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4268962|NCT00593450|4093401|B1||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4268963|NCT00593450|4093397|B5||Female|Sex: Female, Male||Participants|Count of Participants|732|732.0||||||
4268964|NCT00593450|4093398|B4||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4268965|NCT00593450|4093399|B3||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4268966|NCT00593450|4093400|B2||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4268967|NCT00593450|4093401|B1||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4268969|NCT00593450|4093398|B4|>=90 years||Age, Customized||participants|Number|19|19.0||||||
4268970|NCT00593450|4093399|B3|>=90 years||Age, Customized||participants|Number|20|20.0||||||
4268971|NCT00593450|4093400|B2|>=90 years||Age, Customized||participants|Number|23|23.0||||||
4268972|NCT00593450|4093401|B1|>=90 years||Age, Customized||participants|Number|22|22.0||||||
4268973|NCT00593450|4093397|B5|80-89 years||Age, Customized||participants|Number|560|560.0||||||
4268974|NCT00593450|4093398|B4|80-89 years||Age, Customized||participants|Number|142|142.0||||||
4268975|NCT00593450|4093399|B3|80-89 years||Age, Customized||participants|Number|126|126.0||||||
4268976|NCT00593450|4093400|B2|80-89 years||Age, Customized||participants|Number|150|150.0||||||
4268977|NCT00593450|4093401|B1|80-89 years||Age, Customized||participants|Number|142|142.0||||||
4268978|NCT00593450|4093397|B5|70-79 years||Age, Customized||participants|Number|404|404.0||||||
4268979|NCT00593450|4093398|B4|70-79 years||Age, Customized||participants|Number|103|103.0||||||
4268980|NCT00593450|4093399|B3|70-79 years||Age, Customized||participants|Number|115|115.0||||||
4268981|NCT00593450|4093400|B2|70-79 years||Age, Customized||participants|Number|84|84.0||||||
4268982|NCT00593450|4093401|B1|70-79 years||Age, Customized||participants|Number|102|102.0||||||
4268983|NCT00593450|4093397|B5|60-69 years||Age, Customized||participants|Number|126|126.0||||||
4268984|NCT00593450|4093398|B4|60-69 years||Age, Customized||participants|Number|34|34.0||||||
4268985|NCT00593450|4093399|B3|60-69 years||Age, Customized||participants|Number|31|31.0||||||
4268986|NCT00593450|4093400|B2|60-69 years||Age, Customized||participants|Number|28|28.0||||||
4268987|NCT00593450|4093401|B1|60-69 years||Age, Customized||participants|Number|33|33.0||||||
4268988|NCT00593450|4093397|B5|50-59 years||Age, Customized||participants|Number|11|11.0||||||
4268989|NCT00593450|4093398|B4|50-59 years||Age, Customized||participants|Number|2|2.0||||||
4268990|NCT00593450|4093399|B3|50-59 years||Age, Customized||participants|Number|6|6.0||||||
4268991|NCT00593450|4093400|B2|50-59 years||Age, Customized||participants|Number|1|1.0||||||
4268992|NCT00593450|4093401|B1|50-59 years||Age, Customized||participants|Number|2|2.0||||||
4268993|NCT00593450|4093397|B5|||Age||years|Mean|79.3|79.3|Standard Deviation|7.5|7.5|||
4268994|NCT00593450|4093398|B4|||Age||years|Mean|79.3|79.3|Standard Deviation|7.6|7.6|||
4268995|NCT00593450|4093399|B3|||Age||years|Mean|78.4|78.4|Standard Deviation|7.8|7.8|||
4268996|NCT00593450|4093400|B2|||Age||years|Mean|80.1|80.1|Standard Deviation|7.3|7.3|||
4268997|NCT00593450|4093401|B1|||Age||years|Mean|79.2|79.2|Standard Deviation|7.4|7.4|||
4268998|NCT00593385|4093474|B1|||Renal Insufficiency||Participants|Count of Participants|19|19.0||||||
4268999|NCT00593385|4093474|B1|||Hypercholesterolemia||Participants|Count of Participants|130|130.0||||||
4269000|NCT00593385|4093474|B1|||Hypertension||Participants|Count of Participants|129|129.0||||||
4269001|NCT00593385|4093474|B1|||Diabetes Mellitus||Participants|Count of Participants|56|56.0||||||
4269002|NCT00593385|4093474|B1|||Transient Ischemic Attack||Participants|Count of Participants|7|7.0||||||
4269003|NCT00593385|4093474|B1|||Previous Amputation||Participants|Count of Participants|2|2.0||||||
4269004|NCT00593385|4093474|B1|||Cerebrovascular Accident||Participants|Count of Participants|11|11.0||||||
4269005|NCT00593385|4093474|B1|||Coronary Artery Bypass Graft Surgery||Participants|Count of Participants|34|34.0||||||
4269006|NCT00593385|4093474|B1|||Previous percutaneous coronary revascularization||Participants|Count of Participants|39|39.0||||||
4269007|NCT00593385|4093474|B1|||Previous Myocardial Infarction (MI)||Participants|Count of Participants|35|35.0||||||
4269008|NCT00593385|4093474|B1|||Coronary Artery Disease||Participants|Count of Participants|77|77.0||||||
4269009|NCT00593385|4093474|B1|||Previous Peripheral Artery Revascularization/Surgery||Participants|Count of Participants|25|25.0||||||
4269010|NCT00593385|4093474|B1||Unknown|Cigarette Smoking Status||Participants|Count of Participants|0|0.0||||||
4269011|NCT00593385|4093474|B1||Non-smoker|Cigarette Smoking Status||Participants|Count of Participants|13|13.0||||||
4269012|NCT00593385|4093474|B1||Former smoker|Cigarette Smoking Status||Participants|Count of Participants|62|62.0||||||
4269013|NCT00593385|4093474|B1||Current smoker|Cigarette Smoking Status||Participants|Count of Participants|76|76.0||||||
4269014|NCT00593385|4093474|B1|Germany||Region of Enrollment||participants|Number|20|20.0||||||
4269015|NCT00593385|4093474|B1|United States||Region of Enrollment||participants|Number|132|132.0||||||
4269016|NCT00593385|4093474|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269017|NCT00593385|4093474|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4269018|NCT00593385|4093474|B1||White|Race (NIH/OMB)||Participants|Count of Participants|142|142.0||||||
4269019|NCT00593385|4093474|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4269020|NCT00593385|4093474|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269021|NCT00593385|4093474|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269022|NCT00593385|4093474|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269023|NCT00593385|4093474|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269024|NCT00593385|4093474|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|149|149.0||||||
4269025|NCT00593385|4093474|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4269026|NCT00593385|4093474|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4269027|NCT00593385|4093474|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4269028|NCT00593385|4093474|B1|||Age||years|Mean|65.23|65.23|Standard Deviation|9.96|9.96|||
4269029|NCT00593372|4093509|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4269030|NCT00593372|4093510|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4269031|NCT00593372|4093511|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4269032|NCT00593372|4093509|B3||Male|Gender||Participants|Count of Participants|7|7.0||||||
4269033|NCT00593372|4093510|B2||Male|Gender||Participants|Count of Participants|1|1.0||||||
4269034|NCT00593372|4093511|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
4269035|NCT00593372|4093509|B3||Female|Gender||Participants|Count of Participants|4|4.0||||||
4269036|NCT00593372|4093510|B2||Female|Gender||Participants|Count of Participants|2|2.0||||||
4269037|NCT00593372|4093511|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
4269038|NCT00593372|4093509|B3|||Age||years|Mean|72|72.0|Standard Deviation|6|6.0|||
4269039|NCT00593372|4093510|B2|||Age||years|Mean|72|72.0|Standard Deviation|3|3.0|||
4269040|NCT00593372|4093511|B1|||Age||years|Mean|74|74.0|Standard Deviation|5|5.0|||
4269041|NCT00593372|4093509|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4269042|NCT00593372|4093510|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4269043|NCT00593372|4093511|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4269044|NCT00593372|4093509|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4269045|NCT00593372|4093510|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4269046|NCT00593372|4093511|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4269047|NCT00593372|4093509|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269048|NCT00593372|4093510|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269049|NCT00593372|4093511|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269050|NCT00593346|4093518|B1|No||Sentinel lymph node biopsy|Only for patients with invasive cancer|participants|Number|1|1.0||||||
4269051|NCT00593346|4093518|B1|Yes||Sentinel lymph node biopsy|Only for patients with invasive cancer|participants|Number|122|122.0||||||
4269052|NCT00593346|4093518|B1|T2||Pathologic tumor stage|Tis: Carcinoma in situ. T1mic: Microinvasive ductal carcinoma T1a: Tumor >1 mm but ≤5 mm in greatest dimension. T1b: Tumor >5 mm but ≤10 mm in greatest dimension. T1c: Tumor >10 mm but ≤20 mm in greatest dimension. T2: Tumor >20 mm but ≤50 mm in greatest dimension.|participants|Number|13|13.0||||||
4269053|NCT00593346|4093518|B1|T1c||Pathologic tumor stage|Tis: Carcinoma in situ. T1mic: Microinvasive ductal carcinoma T1a: Tumor >1 mm but ≤5 mm in greatest dimension. T1b: Tumor >5 mm but ≤10 mm in greatest dimension. T1c: Tumor >10 mm but ≤20 mm in greatest dimension. T2: Tumor >20 mm but ≤50 mm in greatest dimension.|participants|Number|38|38.0||||||
4269054|NCT00593346|4093518|B1|T1b||Pathologic tumor stage|Tis: Carcinoma in situ. T1mic: Microinvasive ductal carcinoma T1a: Tumor >1 mm but ≤5 mm in greatest dimension. T1b: Tumor >5 mm but ≤10 mm in greatest dimension. T1c: Tumor >10 mm but ≤20 mm in greatest dimension. T2: Tumor >20 mm but ≤50 mm in greatest dimension.|participants|Number|52|52.0||||||
4269055|NCT00593346|4093518|B1|T1a||Pathologic tumor stage|Tis: Carcinoma in situ. T1mic: Microinvasive ductal carcinoma T1a: Tumor >1 mm but ≤5 mm in greatest dimension. T1b: Tumor >5 mm but ≤10 mm in greatest dimension. T1c: Tumor >10 mm but ≤20 mm in greatest dimension. T2: Tumor >20 mm but ≤50 mm in greatest dimension.|participants|Number|19|19.0||||||
4269056|NCT00593346|4093518|B1|T1mic||Pathologic tumor stage|Tis: Carcinoma in situ. T1mic: Microinvasive ductal carcinoma T1a: Tumor >1 mm but ≤5 mm in greatest dimension. T1b: Tumor >5 mm but ≤10 mm in greatest dimension. T1c: Tumor >10 mm but ≤20 mm in greatest dimension. T2: Tumor >20 mm but ≤50 mm in greatest dimension.|participants|Number|1|1.0||||||
4269057|NCT00593346|4093518|B1|Tis||Pathologic tumor stage|Tis: Carcinoma in situ. T1mic: Microinvasive ductal carcinoma T1a: Tumor >1 mm but ≤5 mm in greatest dimension. T1b: Tumor >5 mm but ≤10 mm in greatest dimension. T1c: Tumor >10 mm but ≤20 mm in greatest dimension. T2: Tumor >20 mm but ≤50 mm in greatest dimension.|participants|Number|28|28.0||||||
4269058|NCT00593346|4093518|B1|Lower inner quadrant||Tumor location||participants|Number|21|21.0||||||
4269059|NCT00593346|4093518|B1|Lower outer quadrant||Tumor location||participants|Number|30|30.0||||||
4269060|NCT00593346|4093518|B1|Upper inner quadrant||Tumor location||participants|Number|46|46.0||||||
4269061|NCT00593346|4093518|B1|Upper outer quadrant||Tumor location||participants|Number|54|54.0||||||
4269062|NCT00593346|4093518|B1|Rural||Residence at diagnosis||participants|Number|15|15.0||||||
4269063|NCT00593346|4093518|B1|Urban cluster||Residence at diagnosis||participants|Number|25|25.0||||||
4269064|NCT00593346|4093518|B1|Urban area||Residence at diagnosis||participants|Number|111|111.0||||||
4269065|NCT00593346|4093518|B1|African-American||Race||participants|Number|23|23.0||||||
4269066|NCT00593346|4093518|B1|Caucasian||Race||participants|Number|128|128.0||||||
4269067|NCT00593346|4093518|B1|United States||Region of Enrollment||participants|Number|151|151.0||||||
4269068|NCT00593346|4093518|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4269069|NCT00593346|4093518|B1||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4269070|NCT00593346|4093518|B1|||Age||years|Mean|60|60.0|Full Range|||40.0|85.0|
4269071|NCT00593333|4093533|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4269072|NCT00593333|4093534|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4269073|NCT00593333|4093535|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4269074|NCT00593333|4093533|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4269075|NCT00593333|4093534|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4269076|NCT00593333|4093535|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4269077|NCT00593333|4093533|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4269078|NCT00593333|4093534|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4269079|NCT00593333|4093535|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4269142|NCT00592943|4093572|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269080|NCT00593333|4093533|B3||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
4269081|NCT00593333|4093534|B2||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4269082|NCT00593333|4093535|B1||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4269083|NCT00593333|4093533|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269084|NCT00593333|4093534|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269085|NCT00593333|4093535|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269086|NCT00593320|4093542|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4269087|NCT00593320|4093543|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4269088|NCT00593320|4093544|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4269089|NCT00593320|4093542|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4269090|NCT00593320|4093543|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4269091|NCT00593320|4093544|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4269092|NCT00593320|4093542|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4269093|NCT00593320|4093543|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4269094|NCT00593320|4093544|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4269095|NCT00593320|4093542|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4269096|NCT00593320|4093543|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4269097|NCT00593320|4093544|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4269098|NCT00593320|4093542|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4269099|NCT00593320|4093543|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4269100|NCT00593320|4093544|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4269101|NCT00593320|4093542|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269102|NCT00593320|4093543|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269103|NCT00593320|4093544|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269104|NCT00593112|4093557|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
4269105|NCT00593112|4093558|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4269106|NCT00593112|4093559|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4269107|NCT00593112|4093557|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4269108|NCT00593112|4093558|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4269109|NCT00593112|4093559|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4269110|NCT00593112|4093557|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4269111|NCT00593112|4093558|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4269112|NCT00593112|4093559|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4269113|NCT00593112|4093557|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4269114|NCT00593112|4093558|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4269115|NCT00593112|4093559|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4269116|NCT00593112|4093557|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4269117|NCT00593112|4093558|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4269118|NCT00593112|4093559|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4269119|NCT00593112|4093557|B3||<=18 years|Age||Participants|Count of Participants|39|39.0||||||
4269120|NCT00593112|4093558|B2||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4269121|NCT00593112|4093559|B1||<=18 years|Age||Participants|Count of Participants|27|27.0||||||
4269122|NCT00592943|4093570|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4269123|NCT00592943|4093571|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4269124|NCT00592943|4093572|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4269125|NCT00592943|4093570|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4269126|NCT00592943|4093571|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4269127|NCT00592943|4093572|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4269128|NCT00592943|4093570|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4269129|NCT00592943|4093571|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4269130|NCT00592943|4093572|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4269131|NCT00592943|4093570|B3|||Age||Years|Mean|23.29|23.29|Full Range|||18.75|34.5|
4269132|NCT00592943|4093571|B2|||Age||Years|Mean|21.44|21.44|Full Range|2.5|2.5|18.75|22.92|
4269133|NCT00592943|4093572|B1|||Age||Years|Mean|25.13|25.13|Full Range|1.1|1.1|22.83|34.5|
4269134|NCT00592943|4093570|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4269135|NCT00592943|4093571|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4269136|NCT00592943|4093572|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4269137|NCT00592943|4093570|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4269138|NCT00592943|4093571|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4269139|NCT00592943|4093572|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4269140|NCT00592943|4093570|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269141|NCT00592943|4093571|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269143|NCT00592904|4093583|B5|Other||Race/Ethnicity, Customized|Race|Participants|Number|16|16.0||||||
4269144|NCT00592904|4093584|B4|Other||Race/Ethnicity, Customized|Race|Participants|Number|3|3.0||||||
4269145|NCT00592904|4093585|B3|Other||Race/Ethnicity, Customized|Race|Participants|Number|1|1.0||||||
4269146|NCT00592904|4093586|B2|Other||Race/Ethnicity, Customized|Race|Participants|Number|9|9.0||||||
4269147|NCT00592904|4093587|B1|Other||Race/Ethnicity, Customized|Race|Participants|Number|3|3.0||||||
4269148|NCT00592904|4093583|B5|White||Race/Ethnicity, Customized|Race|Participants|Number|225|225.0||||||
4269149|NCT00592904|4093584|B4|White||Race/Ethnicity, Customized|Race|Participants|Number|24|24.0||||||
4269150|NCT00592904|4093585|B3|White||Race/Ethnicity, Customized|Race|Participants|Number|26|26.0||||||
4269151|NCT00592904|4093586|B2|White||Race/Ethnicity, Customized|Race|Participants|Number|127|127.0||||||
4269152|NCT00592904|4093587|B1|White||Race/Ethnicity, Customized|Race|Participants|Number|48|48.0||||||
4269153|NCT00592904|4093583|B5|Black||Race/Ethnicity, Customized|Race|Participants|Number|18|18.0||||||
4269154|NCT00592904|4093584|B4|Black||Race/Ethnicity, Customized|Race|Participants|Number|3|3.0||||||
4269155|NCT00592904|4093585|B3|Black||Race/Ethnicity, Customized|Race|Participants|Number|0|0.0||||||
4269156|NCT00592904|4093586|B2|Black||Race/Ethnicity, Customized|Race|Participants|Number|11|11.0||||||
4269157|NCT00592904|4093587|B1|Black||Race/Ethnicity, Customized|Race|Participants|Number|4|4.0||||||
4269158|NCT00592904|4093583|B5|Asian||Race/Ethnicity, Customized|Race|Participants|Number|3|3.0||||||
4269159|NCT00592904|4093584|B4|Asian||Race/Ethnicity, Customized|Race|Participants|Number|0|0.0||||||
4269160|NCT00592904|4093585|B3|Asian||Race/Ethnicity, Customized|Race|Participants|Number|0|0.0||||||
4269161|NCT00592904|4093586|B2|Asian||Race/Ethnicity, Customized|Race|Participants|Number|1|1.0||||||
4269162|NCT00592904|4093587|B1|Asian||Race/Ethnicity, Customized|Race|Participants|Number|2|2.0||||||
4269163|NCT00592904|4093583|B5||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4269164|NCT00592904|4093584|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4269165|NCT00592904|4093585|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4269166|NCT00592904|4093586|B2||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4269167|NCT00592904|4093587|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4269168|NCT00592904|4093583|B5||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4269169|NCT00592904|4093584|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4269170|NCT00592904|4093585|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4269171|NCT00592904|4093586|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4269172|NCT00592904|4093587|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4269173|NCT00592904|4093583|B5|≥65||Age, Customized||Participants|Number|107|107.0||||||
4269174|NCT00592904|4093584|B4|≥65||Age, Customized||Participants|Number|21|21.0||||||
4269175|NCT00592904|4093585|B3|≥65||Age, Customized||Participants|Number|18|18.0||||||
4269176|NCT00592904|4093586|B2|≥65||Age, Customized||Participants|Number|51|51.0||||||
4269177|NCT00592904|4093587|B1|≥65||Age, Customized||Participants|Number|17|17.0||||||
4269178|NCT00592904|4093583|B5|<65||Age, Customized||Participants|Number|155|155.0||||||
4269179|NCT00592904|4093584|B4|<65||Age, Customized||Participants|Number|9|9.0||||||
4269180|NCT00592904|4093585|B3|<65||Age, Customized||Participants|Number|9|9.0||||||
4269181|NCT00592904|4093586|B2|<65||Age, Customized||Participants|Number|97|97.0||||||
4269182|NCT00592904|4093587|B1|<65||Age, Customized||Participants|Number|40|40.0||||||
4269183|NCT00592852|4093616|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4269184|NCT00592852|4093616|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4269185|NCT00592852|4093616|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4269186|NCT00592852|4093616|B1|||Age||years|Mean|12.46|12.46|Standard Deviation|3.91|3.91|||
4269187|NCT00592852|4093616|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4269188|NCT00592852|4093616|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4269189|NCT00592852|4093616|B1||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4269190|NCT00592839|4093621|B4|United States||Region of Enrollment||participants|Number|157|157.0||||||
4269191|NCT00592839|4093622|B3|United States||Region of Enrollment||participants|Number|52|52.0||||||
4269192|NCT00592839|4093623|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
4269193|NCT00592839|4093624|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
4269194|NCT00592839|4093621|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4269195|NCT00592839|4093622|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4269196|NCT00592839|4093623|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4269197|NCT00592839|4093624|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4269198|NCT00592839|4093621|B4||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4269199|NCT00592839|4093622|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4269200|NCT00592839|4093623|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4269201|NCT00592839|4093624|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4269202|NCT00592839|4093621|B4|||Age||years|Mean|54.1|54.1|Standard Deviation|5.87|5.87|||
4269203|NCT00592839|4093622|B3|||Age||years|Mean|53.8|53.8|Standard Deviation|6.27|6.27|||
4269204|NCT00592839|4093623|B2|||Age||years|Mean|54.6|54.6|Standard Deviation|5.38|5.38|||
4269205|NCT00592839|4093624|B1|||Age||years|Mean|53.9|53.9|Standard Deviation|6.00|6.0|||
4269206|NCT00592839|4093621|B4|Between 30 and 65 years||Age, Customized||participants|Number|157|157.0||||||
4269207|NCT00592839|4093622|B3|Between 30 and 65 years||Age, Customized||participants|Number|52|52.0||||||
4269208|NCT00592839|4093623|B2|Between 30 and 65 years||Age, Customized||participants|Number|52|52.0||||||
4269209|NCT00592839|4093624|B1|Between 30 and 65 years||Age, Customized||participants|Number|53|53.0||||||
4269210|NCT00592774|4093649|B6|Other||Race/Ethnicity, Customized|Race (Safety population)|Participants|Number|7|7.0||||||
4269211|NCT00592774|4093650|B5|Other||Race/Ethnicity, Customized|Race (Safety population)|Participants|Number|1|1.0||||||
4269212|NCT00592774|4093651|B4|Other||Race/Ethnicity, Customized|Race (Safety population)|Participants|Number|1|1.0||||||
4269213|NCT00592774|4093652|B3|Other||Race/Ethnicity, Customized|Race (Safety population)|Participants|Number|2|2.0||||||
4269214|NCT00592774|4093653|B2|Other||Race/Ethnicity, Customized|Race (Safety population)|Participants|Number|3|3.0||||||
4269215|NCT00592774|4093654|B1|Other||Race/Ethnicity, Customized|Race (Safety population)|Participants|Number|0|0.0||||||
4269216|NCT00592774|4093649|B6|Asian||Race/Ethnicity, Customized|Race (Safety population)|Participants|Number|3|3.0||||||
4269217|NCT00592774|4093650|B5|Asian||Race/Ethnicity, Customized|Race (Safety population)|Participants|Number|3|3.0||||||
4269218|NCT00592774|4093651|B4|Asian||Race/Ethnicity, Customized|Race (Safety population)|Participants|Number|0|0.0||||||
4269219|NCT00592774|4093652|B3|Asian||Race/Ethnicity, Customized|Race (Safety population)|Participants|Number|0|0.0||||||
4269220|NCT00592774|4093653|B2|Asian||Race/Ethnicity, Customized|Race (Safety population)|Participants|Number|0|0.0||||||
4269221|NCT00592774|4093654|B1|Asian||Race/Ethnicity, Customized|Race (Safety population)|Participants|Number|0|0.0||||||
4269222|NCT00592774|4093649|B6|Black||Race/Ethnicity, Customized|Race (Safety population)|Participants|Number|9|9.0||||||
4269223|NCT00592774|4093650|B5|Black||Race/Ethnicity, Customized|Race (Safety population)|Participants|Number|1|1.0||||||
4269224|NCT00592774|4093651|B4|Black||Race/Ethnicity, Customized|Race (Safety population)|Participants|Number|0|0.0||||||
4269225|NCT00592774|4093652|B3|Black||Race/Ethnicity, Customized|Race (Safety population)|Participants|Number|0|0.0||||||
4269226|NCT00592774|4093653|B2|Black||Race/Ethnicity, Customized|Race (Safety population)|Participants|Number|7|7.0||||||
4269227|NCT00592774|4093654|B1|Black||Race/Ethnicity, Customized|Race (Safety population)|Participants|Number|1|1.0||||||
4269228|NCT00592774|4093649|B6|White||Race/Ethnicity, Customized|Race (Safety population)|Participants|Number|127|127.0||||||
4269229|NCT00592774|4093650|B5|White||Race/Ethnicity, Customized|Race (Safety population)|Participants|Number|18|18.0||||||
4269230|NCT00592774|4093651|B4|White||Race/Ethnicity, Customized|Race (Safety population)|Participants|Number|21|21.0||||||
4269231|NCT00592774|4093652|B3|White||Race/Ethnicity, Customized|Race (Safety population)|Participants|Number|20|20.0||||||
4269232|NCT00592774|4093653|B2|White||Race/Ethnicity, Customized|Race (Safety population)|Participants|Number|43|43.0||||||
4269233|NCT00592774|4093654|B1|White||Race/Ethnicity, Customized|Race (Safety population)|Participants|Number|25|25.0||||||
4269234|NCT00592774|4093649|B6||Male|Sex: Female, Male|Safety population-subjects who were randomized, took at least 1 dose of study drug, and had at least 1 post-baseline assessment|Participants|Count of Participants|71|71.0||||||
4269235|NCT00592774|4093650|B5||Male|Sex: Female, Male|Safety population-subjects who were randomized, took at least 1 dose of study drug, and had at least 1 post-baseline assessment|Participants|Count of Participants|9|9.0||||||
4269236|NCT00592774|4093651|B4||Male|Sex: Female, Male|Safety population-subjects who were randomized, took at least 1 dose of study drug, and had at least 1 post-baseline assessment|Participants|Count of Participants|11|11.0||||||
4269237|NCT00592774|4093652|B3||Male|Sex: Female, Male|Safety population-subjects who were randomized, took at least 1 dose of study drug, and had at least 1 post-baseline assessment|Participants|Count of Participants|14|14.0||||||
4269238|NCT00592774|4093653|B2||Male|Sex: Female, Male|Safety population-subjects who were randomized, took at least 1 dose of study drug, and had at least 1 post-baseline assessment|Participants|Count of Participants|22|22.0||||||
4269239|NCT00592774|4093654|B1||Male|Sex: Female, Male|Safety population-subjects who were randomized, took at least 1 dose of study drug, and had at least 1 post-baseline assessment|Participants|Count of Participants|15|15.0||||||
4269240|NCT00592774|4093649|B6||Female|Sex: Female, Male|Safety population-subjects who were randomized, took at least 1 dose of study drug, and had at least 1 post-baseline assessment|Participants|Count of Participants|75|75.0||||||
4269241|NCT00592774|4093650|B5||Female|Sex: Female, Male|Safety population-subjects who were randomized, took at least 1 dose of study drug, and had at least 1 post-baseline assessment|Participants|Count of Participants|14|14.0||||||
4269242|NCT00592774|4093651|B4||Female|Sex: Female, Male|Safety population-subjects who were randomized, took at least 1 dose of study drug, and had at least 1 post-baseline assessment|Participants|Count of Participants|11|11.0||||||
4269243|NCT00592774|4093652|B3||Female|Sex: Female, Male|Safety population-subjects who were randomized, took at least 1 dose of study drug, and had at least 1 post-baseline assessment|Participants|Count of Participants|8|8.0||||||
4269244|NCT00592774|4093653|B2||Female|Sex: Female, Male|Safety population-subjects who were randomized, took at least 1 dose of study drug, and had at least 1 post-baseline assessment|Participants|Count of Participants|31|31.0||||||
4269245|NCT00592774|4093654|B1||Female|Sex: Female, Male|Safety population-subjects who were randomized, took at least 1 dose of study drug, and had at least 1 post-baseline assessment|Participants|Count of Participants|11|11.0||||||
4269246|NCT00592774|4093649|B6|≥75 years||Age, Customized|Safety population|Participants|Number|69|69.0||||||
4269247|NCT00592774|4093650|B5|≥75 years||Age, Customized|Safety population|Participants|Number|11|11.0||||||
4269248|NCT00592774|4093651|B4|≥75 years||Age, Customized|Safety population|Participants|Number|16|16.0||||||
4269249|NCT00592774|4093652|B3|≥75 years||Age, Customized|Safety population|Participants|Number|11|11.0||||||
4269250|NCT00592774|4093653|B2|≥75 years||Age, Customized|Safety population|Participants|Number|23|23.0||||||
4269251|NCT00592774|4093654|B1|≥75 years||Age, Customized|Safety population|Participants|Number|8|8.0||||||
4269252|NCT00592774|4093649|B6|≥65 to <75 years||Age, Customized|Safety population|Participants|Number|35|35.0||||||
4269253|NCT00592774|4093650|B5|≥65 to <75 years||Age, Customized|Safety population|Participants|Number|3|3.0||||||
4269254|NCT00592774|4093651|B4|≥65 to <75 years||Age, Customized|Safety population|Participants|Number|4|4.0||||||
4269255|NCT00592774|4093652|B3|≥65 to <75 years||Age, Customized|Safety population|Participants|Number|5|5.0||||||
4269256|NCT00592774|4093653|B2|≥65 to <75 years||Age, Customized|Safety population|Participants|Number|15|15.0||||||
4269257|NCT00592774|4093654|B1|≥65 to <75 years||Age, Customized|Safety population|Participants|Number|8|8.0||||||
4269258|NCT00592774|4093649|B6|<65 years||Age, Customized|Safety population|Participants|Number|42|42.0||||||
4269259|NCT00592774|4093650|B5|<65 years||Age, Customized|Safety population|Participants|Number|9|9.0||||||
4269260|NCT00592774|4093651|B4|<65 years||Age, Customized|Safety population|Participants|Number|2|2.0||||||
4269261|NCT00592774|4093652|B3|<65 years||Age, Customized|Safety population|Participants|Number|6|6.0||||||
4269262|NCT00592774|4093653|B2|<65 years||Age, Customized|Safety population|Participants|Number|15|15.0||||||
4269263|NCT00592774|4093654|B1|<65 years||Age, Customized|Safety population|Participants|Number|10|10.0||||||
4269264|NCT00592761|4093715|B1||Male|Sex: Female, Male|Gender effects were analyzed within the analysis of variance.|Participants|Count of Participants|11|11.0||||||
4269265|NCT00592761|4093715|B1||Female|Sex: Female, Male|Gender effects were analyzed within the analysis of variance.|Participants|Count of Participants|7|7.0||||||
4269266|NCT00592761|4093715|B1||>=65 years|Age|Participants were analyzed for age effects within analysis of variance.|Participants|Count of Participants|11|11.0||||||
4269267|NCT00592761|4093715|B1||Between 18 and 65 years|Age|Participants were analyzed for age effects within analysis of variance.|Participants|Count of Participants|7|7.0||||||
4269268|NCT00592761|4093715|B1||<=18 years|Age|Participants were analyzed for age effects within analysis of variance.|Participants|Count of Participants|0|0.0||||||
4269269|NCT00592683|4093728|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4269270|NCT00592683|4093729|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4269271|NCT00592683|4093730|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4269272|NCT00592683|4093728|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4269273|NCT00592683|4093729|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4269274|NCT00592683|4093730|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4269275|NCT00592683|4093728|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4269276|NCT00592683|4093729|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4269277|NCT00592683|4093730|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4269278|NCT00592683|4093728|B3|||Age||years|Mean|10.9|10.9|Standard Deviation|3.58|3.58|||
4269279|NCT00592683|4093729|B2|||Age||years|Mean|11|11.0|Standard Deviation|3.71|3.71|||
4269280|NCT00592683|4093730|B1|||Age||years|Mean|10.8|10.8|Standard Deviation|3.65|3.65|||
4269281|NCT00592683|4093728|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4269282|NCT00592683|4093729|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4269283|NCT00592683|4093730|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4269284|NCT00592683|4093728|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4269285|NCT00592683|4093729|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4269286|NCT00592683|4093730|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4269287|NCT00592683|4093728|B3||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
4269288|NCT00592683|4093729|B2||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4269289|NCT00592683|4093730|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4269290|NCT00592631|4093739|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4269291|NCT00592631|4093740|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4269292|NCT00592631|4093741|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4269293|NCT00592631|4093739|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4269294|NCT00592631|4093740|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4269295|NCT00592631|4093741|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4269296|NCT00592631|4093739|B3|||Age||years|Mean|29|29.0|Standard Deviation|7|7.0|||
4269297|NCT00592631|4093740|B2|||Age||years|Mean|32|32.0|Standard Deviation|9|9.0|||
4269298|NCT00592631|4093741|B1|||Age||years|Mean|27|27.0|Standard Deviation|6|6.0|||
4269299|NCT00592488|4093748|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4269300|NCT00592488|4093749|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4269301|NCT00592488|4093750|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4269302|NCT00592488|4093748|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4269303|NCT00592488|4093749|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4269304|NCT00592488|4093750|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4269305|NCT00592488|4093748|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4269306|NCT00592488|4093749|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4269307|NCT00592488|4093750|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4269308|NCT00592488|4093748|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4269309|NCT00592488|4093749|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4269310|NCT00592488|4093750|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4269311|NCT00592488|4093748|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4269312|NCT00592488|4093749|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4269313|NCT00592488|4093750|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4269314|NCT00592488|4093748|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269315|NCT00592488|4093749|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269316|NCT00592488|4093750|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269317|NCT00592475|4093761|B4|Hypervolemic - Other||Underlying Cause of Hyponatremia|"Patients in the “Not hyponatremia” categories had serum sodium levels of 135-140mEq/L.~Patients in the “Other” categories had Diuretic treatment."|Participants|Number|1|1.0||||||
4269318|NCT00592475|4093762|B3|Hypervolemic - Other||Underlying Cause of Hyponatremia|"Patients in the “Not hyponatremia” categories had serum sodium levels of 135-140mEq/L.~Patients in the “Other” categories had Diuretic treatment."|Participants|Number|0|0.0||||||
4269319|NCT00592475|4093763|B2|Hypervolemic - Other||Underlying Cause of Hyponatremia|"Patients in the “Not hyponatremia” categories had serum sodium levels of 135-140mEq/L.~Patients in the “Other” categories had Diuretic treatment."|Participants|Number|1|1.0||||||
4269320|NCT00592475|4093764|B1|Hypervolemic - Other||Underlying Cause of Hyponatremia|"Patients in the “Not hyponatremia” categories had serum sodium levels of 135-140mEq/L.~Patients in the “Other” categories had Diuretic treatment."|Participants|Number|0|0.0||||||
4269321|NCT00592475|4093761|B4|Hypervolemic - Not Hyponatremia||Underlying Cause of Hyponatremia|"Patients in the “Not hyponatremia” categories had serum sodium levels of 135-140mEq/L.~Patients in the “Other” categories had Diuretic treatment."|Participants|Number|3|3.0||||||
4269322|NCT00592475|4093762|B3|Hypervolemic - Not Hyponatremia||Underlying Cause of Hyponatremia|"Patients in the “Not hyponatremia” categories had serum sodium levels of 135-140mEq/L.~Patients in the “Other” categories had Diuretic treatment."|Participants|Number|0|0.0||||||
4269323|NCT00592475|4093763|B2|Hypervolemic - Not Hyponatremia||Underlying Cause of Hyponatremia|"Patients in the “Not hyponatremia” categories had serum sodium levels of 135-140mEq/L.~Patients in the “Other” categories had Diuretic treatment."|Participants|Number|3|3.0||||||
4269324|NCT00592475|4093764|B1|Hypervolemic - Not Hyponatremia||Underlying Cause of Hyponatremia|"Patients in the “Not hyponatremia” categories had serum sodium levels of 135-140mEq/L.~Patients in the “Other” categories had Diuretic treatment."|Participants|Number|0|0.0||||||
4269325|NCT00592475|4093761|B4|Hypervolemic - Cirrhosis||Underlying Cause of Hyponatremia|"Patients in the “Not hyponatremia” categories had serum sodium levels of 135-140mEq/L.~Patients in the “Other” categories had Diuretic treatment."|Participants|Number|8|8.0||||||
4269326|NCT00592475|4093762|B3|Hypervolemic - Cirrhosis||Underlying Cause of Hyponatremia|"Patients in the “Not hyponatremia” categories had serum sodium levels of 135-140mEq/L.~Patients in the “Other” categories had Diuretic treatment."|Participants|Number|3|3.0||||||
4269327|NCT00592475|4093763|B2|Hypervolemic - Cirrhosis||Underlying Cause of Hyponatremia|"Patients in the “Not hyponatremia” categories had serum sodium levels of 135-140mEq/L.~Patients in the “Other” categories had Diuretic treatment."|Participants|Number|3|3.0||||||
4269328|NCT00592475|4093764|B1|Hypervolemic - Cirrhosis||Underlying Cause of Hyponatremia|"Patients in the “Not hyponatremia” categories had serum sodium levels of 135-140mEq/L.~Patients in the “Other” categories had Diuretic treatment."|Participants|Number|2|2.0||||||
4269329|NCT00592475|4093761|B4|Euvolemic - Other||Underlying Cause of Hyponatremia|"Patients in the “Not hyponatremia” categories had serum sodium levels of 135-140mEq/L.~Patients in the “Other” categories had Diuretic treatment."|Participants|Number|1|1.0||||||
4269330|NCT00592475|4093762|B3|Euvolemic - Other||Underlying Cause of Hyponatremia|"Patients in the “Not hyponatremia” categories had serum sodium levels of 135-140mEq/L.~Patients in the “Other” categories had Diuretic treatment."|Participants|Number|0|0.0||||||
4269331|NCT00592475|4093763|B2|Euvolemic - Other||Underlying Cause of Hyponatremia|"Patients in the “Not hyponatremia” categories had serum sodium levels of 135-140mEq/L.~Patients in the “Other” categories had Diuretic treatment."|Participants|Number|0|0.0||||||
4269332|NCT00592475|4093764|B1|Euvolemic - Other||Underlying Cause of Hyponatremia|"Patients in the “Not hyponatremia” categories had serum sodium levels of 135-140mEq/L.~Patients in the “Other” categories had Diuretic treatment."|Participants|Number|1|1.0||||||
4269333|NCT00592475|4093761|B4|Euvolemic - Not Hyponatremia||Underlying Cause of Hyponatremia|"Patients in the “Not hyponatremia” categories had serum sodium levels of 135-140mEq/L.~Patients in the “Other” categories had Diuretic treatment."|Participants|Number|4|4.0||||||
4269334|NCT00592475|4093762|B3|Euvolemic - Not Hyponatremia||Underlying Cause of Hyponatremia|"Patients in the “Not hyponatremia” categories had serum sodium levels of 135-140mEq/L.~Patients in the “Other” categories had Diuretic treatment."|Participants|Number|1|1.0||||||
4269335|NCT00592475|4093763|B2|Euvolemic - Not Hyponatremia||Underlying Cause of Hyponatremia|"Patients in the “Not hyponatremia” categories had serum sodium levels of 135-140mEq/L.~Patients in the “Other” categories had Diuretic treatment."|Participants|Number|1|1.0||||||
4269336|NCT00592475|4093764|B1|Euvolemic - Not Hyponatremia||Underlying Cause of Hyponatremia|"Patients in the “Not hyponatremia” categories had serum sodium levels of 135-140mEq/L.~Patients in the “Other” categories had Diuretic treatment."|Participants|Number|2|2.0||||||
4269337|NCT00592475|4093761|B4|Euvolemic - Cirrhosis||Underlying Cause of Hyponatremia|"Patients in the “Not hyponatremia” categories had serum sodium levels of 135-140mEq/L.~Patients in the “Other” categories had Diuretic treatment."|Participants|Number|3|3.0||||||
4269338|NCT00592475|4093762|B3|Euvolemic - Cirrhosis||Underlying Cause of Hyponatremia|"Patients in the “Not hyponatremia” categories had serum sodium levels of 135-140mEq/L.~Patients in the “Other” categories had Diuretic treatment."|Participants|Number|1|1.0||||||
4269339|NCT00592475|4093763|B2|Euvolemic - Cirrhosis||Underlying Cause of Hyponatremia|"Patients in the “Not hyponatremia” categories had serum sodium levels of 135-140mEq/L.~Patients in the “Other” categories had Diuretic treatment."|Participants|Number|1|1.0||||||
4269397|NCT00592384|4093790|B2||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
4269619|NCT00592124|4093824|B4|||Age||years|Mean|31.3|31.3|Standard Deviation|6.4|6.4|||
4269340|NCT00592475|4093764|B1|Euvolemic - Cirrhosis||Underlying Cause of Hyponatremia|"Patients in the “Not hyponatremia” categories had serum sodium levels of 135-140mEq/L.~Patients in the “Other” categories had Diuretic treatment."|Participants|Number|1|1.0||||||
4269341|NCT00592475|4093761|B4|White||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
4269342|NCT00592475|4093762|B3|White||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4269343|NCT00592475|4093763|B2|White||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4269344|NCT00592475|4093764|B1|White||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4269345|NCT00592475|4093761|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4269346|NCT00592475|4093762|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4269347|NCT00592475|4093763|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4269348|NCT00592475|4093764|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4269349|NCT00592475|4093761|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4269350|NCT00592475|4093762|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4269351|NCT00592475|4093763|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4269352|NCT00592475|4093764|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4269353|NCT00592475|4093761|B4|||Age||years|Mean|59.9|59.9|Standard Deviation|8.95|8.95|||
4269354|NCT00592475|4093762|B3|||Age||years|Mean|55.2|55.2|Standard Deviation|7.19|7.19|||
4269355|NCT00592475|4093763|B2|||Age||years|Mean|60.0|60.0|Standard Deviation|9.72|9.72|||
4269356|NCT00592475|4093764|B1|||Age||years|Mean|63.7|63.7|Standard Deviation|8.52|8.52|||
4269357|NCT00592384|4093789|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4269358|NCT00592384|4093790|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4269359|NCT00592384|4093791|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4269360|NCT00592384|4093789|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
4269361|NCT00592384|4093790|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4269362|NCT00592384|4093791|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4269363|NCT00592384|4093789|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4269364|NCT00592384|4093790|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4269365|NCT00592384|4093791|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4269366|NCT00592384|4093789|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4269367|NCT00592384|4093790|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4269368|NCT00592384|4093791|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4269369|NCT00592384|4093789|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269370|NCT00592384|4093790|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269371|NCT00592384|4093791|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269372|NCT00592384|4093789|B3||White|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4269373|NCT00592384|4093790|B2||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4269374|NCT00592384|4093791|B1||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4269375|NCT00592384|4093789|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4269376|NCT00592384|4093790|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4269377|NCT00592384|4093791|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4269378|NCT00592384|4093789|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269379|NCT00592384|4093790|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269380|NCT00592384|4093791|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269381|NCT00592384|4093789|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4269382|NCT00592384|4093790|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269383|NCT00592384|4093791|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4269384|NCT00592384|4093789|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269385|NCT00592384|4093790|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269386|NCT00592384|4093791|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269387|NCT00592384|4093789|B3||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4269388|NCT00592384|4093790|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4269389|NCT00592384|4093791|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4269390|NCT00592384|4093789|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4269391|NCT00592384|4093790|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4269392|NCT00592384|4093791|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4269393|NCT00592384|4093789|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4269394|NCT00592384|4093790|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4269395|NCT00592384|4093791|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4269396|NCT00592384|4093789|B3||Between 18 and 65 years|Age||Participants|Count of Participants|133|133.0||||||
4269398|NCT00592384|4093791|B1||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4269399|NCT00592384|4093789|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269400|NCT00592384|4093790|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269401|NCT00592384|4093791|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269402|NCT00592384|4093789|B3|||Age||years|Mean|40|40.0|Standard Deviation|12|12.0|||
4269403|NCT00592384|4093790|B2|||Age||years|Mean|39|39.0|Standard Deviation|11|11.0|||
4269404|NCT00592384|4093791|B1|||Age||years|Mean|41|41.0|Standard Deviation|12|12.0|||
4269405|NCT00592358|4093800|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4269406|NCT00592358|4093800|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4269407|NCT00592358|4093800|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4269408|NCT00592358|4093800|B1|||Age||years|Mean|9.88|9.88|Standard Deviation|2.39|2.39|||
4269409|NCT00592358|4093800|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4269410|NCT00592358|4093800|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4269411|NCT00592358|4093800|B1||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
4269412|NCT00592319|4093805|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4269413|NCT00592319|4093806|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4269414|NCT00592319|4093807|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4269415|NCT00592319|4093805|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4269416|NCT00592319|4093806|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4269417|NCT00592319|4093807|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4269418|NCT00592319|4093805|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4269419|NCT00592319|4093806|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4269420|NCT00592319|4093807|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4269421|NCT00592319|4093805|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4269422|NCT00592319|4093806|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4269423|NCT00592319|4093807|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4269424|NCT00592319|4093805|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269425|NCT00592319|4093806|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269426|NCT00592319|4093807|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269427|NCT00592176|4093816|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4269428|NCT00592176|4093816|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4269429|NCT00592176|4093816|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4269430|NCT00592176|4093816|B1|||Age||years|Mean|51.5|51.5|Standard Deviation|10.1|10.1|||
4269431|NCT00592176|4093816|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4269432|NCT00592176|4093816|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4269433|NCT00592176|4093816|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269434|NCT00592124|4093821|B7||Attended College or University|What is your highest education level?||Participants|Count of Participants|62|62.0||||||
4269435|NCT00592124|4093822|B6||Attended College or University|What is your highest education level?||Participants|Count of Participants|11|11.0||||||
4269436|NCT00592124|4093823|B5||Attended College or University|What is your highest education level?||Participants|Count of Participants|9|9.0||||||
4269437|NCT00592124|4093824|B4||Attended College or University|What is your highest education level?||Participants|Count of Participants|11|11.0||||||
4269438|NCT00592124|4093825|B3||Attended College or University|What is your highest education level?||Participants|Count of Participants|11|11.0||||||
4269439|NCT00592124|4093826|B2||Attended College or University|What is your highest education level?||Participants|Count of Participants|12|12.0||||||
4269440|NCT00592124|4093827|B1||Attended College or University|What is your highest education level?||Participants|Count of Participants|8|8.0||||||
4269441|NCT00592124|4093821|B7||Secondary School, Complete|What is your highest education level?||Participants|Count of Participants|29|29.0||||||
4269442|NCT00592124|4093822|B6||Secondary School, Complete|What is your highest education level?||Participants|Count of Participants|2|2.0||||||
4269443|NCT00592124|4093823|B5||Secondary School, Complete|What is your highest education level?||Participants|Count of Participants|6|6.0||||||
4269444|NCT00592124|4093824|B4||Secondary School, Complete|What is your highest education level?||Participants|Count of Participants|4|4.0||||||
4269445|NCT00592124|4093825|B3||Secondary School, Complete|What is your highest education level?||Participants|Count of Participants|6|6.0||||||
4269446|NCT00592124|4093826|B2||Secondary School, Complete|What is your highest education level?||Participants|Count of Participants|3|3.0||||||
4269447|NCT00592124|4093827|B1||Secondary School, Complete|What is your highest education level?||Participants|Count of Participants|8|8.0||||||
4269448|NCT00592124|4093821|B7||Secondary School, Not Complete|What is your highest education level?||Participants|Count of Participants|37|37.0||||||
4269449|NCT00592124|4093822|B6||Secondary School, Not Complete|What is your highest education level?||Participants|Count of Participants|8|8.0||||||
4269450|NCT00592124|4093823|B5||Secondary School, Not Complete|What is your highest education level?||Participants|Count of Participants|7|7.0||||||
4269451|NCT00592124|4093824|B4||Secondary School, Not Complete|What is your highest education level?||Participants|Count of Participants|6|6.0||||||
4269452|NCT00592124|4093825|B3||Secondary School, Not Complete|What is your highest education level?||Participants|Count of Participants|4|4.0||||||
4269453|NCT00592124|4093826|B2||Secondary School, Not Complete|What is your highest education level?||Participants|Count of Participants|5|5.0||||||
4269454|NCT00592124|4093827|B1||Secondary School, Not Complete|What is your highest education level?||Participants|Count of Participants|7|7.0||||||
4269455|NCT00592124|4093821|B7||Primary School, Complete|What is your highest education level?||Participants|Count of Participants|7|7.0||||||
4269456|NCT00592124|4093822|B6||Primary School, Complete|What is your highest education level?||Participants|Count of Participants|2|2.0||||||
4269457|NCT00592124|4093823|B5||Primary School, Complete|What is your highest education level?||Participants|Count of Participants|1|1.0||||||
4269458|NCT00592124|4093824|B4||Primary School, Complete|What is your highest education level?||Participants|Count of Participants|1|1.0||||||
4269459|NCT00592124|4093825|B3||Primary School, Complete|What is your highest education level?||Participants|Count of Participants|2|2.0||||||
4269460|NCT00592124|4093826|B2||Primary School, Complete|What is your highest education level?||Participants|Count of Participants|1|1.0||||||
4269461|NCT00592124|4093827|B1||Primary School, Complete|What is your highest education level?||Participants|Count of Participants|0|0.0||||||
4269462|NCT00592124|4093821|B7||Primary School, Not Complete|What is your highest education level?||Participants|Count of Participants|8|8.0||||||
4269463|NCT00592124|4093822|B6||Primary School, Not Complete|What is your highest education level?||Participants|Count of Participants|1|1.0||||||
4269464|NCT00592124|4093823|B5||Primary School, Not Complete|What is your highest education level?||Participants|Count of Participants|0|0.0||||||
4269465|NCT00592124|4093824|B4||Primary School, Not Complete|What is your highest education level?||Participants|Count of Participants|2|2.0||||||
4269466|NCT00592124|4093825|B3||Primary School, Not Complete|What is your highest education level?||Participants|Count of Participants|1|1.0||||||
4269467|NCT00592124|4093826|B2||Primary School, Not Complete|What is your highest education level?||Participants|Count of Participants|3|3.0||||||
4269468|NCT00592124|4093827|B1||Primary School, Not Complete|What is your highest education level?||Participants|Count of Participants|1|1.0||||||
4269469|NCT00592124|4093821|B7||No Schooling|What is your highest education level?||Participants|Count of Participants|1|1.0||||||
4269470|NCT00592124|4093822|B6||No Schooling|What is your highest education level?||Participants|Count of Participants|0|0.0||||||
4269471|NCT00592124|4093823|B5||No Schooling|What is your highest education level?||Participants|Count of Participants|1|1.0||||||
4269472|NCT00592124|4093824|B4||No Schooling|What is your highest education level?||Participants|Count of Participants|0|0.0||||||
4269473|NCT00592124|4093825|B3||No Schooling|What is your highest education level?||Participants|Count of Participants|0|0.0||||||
4269474|NCT00592124|4093826|B2||No Schooling|What is your highest education level?||Participants|Count of Participants|0|0.0||||||
4269475|NCT00592124|4093827|B1||No Schooling|What is your highest education level?||Participants|Count of Participants|0|0.0||||||
4269476|NCT00592124|4093821|B7|||What is your household(s) average monthly income?||US Dollars|Median|495.40|495.4|Inter-Quartile Range|||134.99|1900.0|
4269477|NCT00592124|4093822|B6|||What is your household(s) average monthly income?||US Dollars|Median|306.75|306.75|Inter-Quartile Range|||98.16|2500.0|
4269478|NCT00592124|4093823|B5|||What is your household(s) average monthly income?||US Dollars|Median|368.10|368.1|Inter-Quartile Range|||98.16|1500.0|
4269479|NCT00592124|4093824|B4|||What is your household(s) average monthly income?||US Dollars|Median|490.80|490.8|Inter-Quartile Range|||147.24|2400.0|
4269480|NCT00592124|4093825|B3|||What is your household(s) average monthly income?||US Dollars|Median|417.18|417.18|Inter-Quartile Range|||141.75|940.8|
4269481|NCT00592124|4093826|B2|||What is your household(s) average monthly income?||US Dollars|Median|773.01|773.01|Inter-Quartile Range|||122.7|3200.0|
4269482|NCT00592124|4093827|B1|||What is your household(s) average monthly income?||US Dollars|Median|495.40|495.4|Inter-Quartile Range|||227.0|1250.0|
4269483|NCT00592124|4093821|B7|No||Do you currently have a male sex partner?||Participants|Count of Participants|59|59.0||||||
4269484|NCT00592124|4093822|B6|No||Do you currently have a male sex partner?||Participants|Count of Participants|12|12.0||||||
4269485|NCT00592124|4093823|B5|No||Do you currently have a male sex partner?||Participants|Count of Participants|10|10.0||||||
4269486|NCT00592124|4093824|B4|No||Do you currently have a male sex partner?||Participants|Count of Participants|11|11.0||||||
4269487|NCT00592124|4093825|B3|No||Do you currently have a male sex partner?||Participants|Count of Participants|8|8.0||||||
4269488|NCT00592124|4093826|B2|No||Do you currently have a male sex partner?||Participants|Count of Participants|9|9.0||||||
4269489|NCT00592124|4093827|B1|No||Do you currently have a male sex partner?||Participants|Count of Participants|9|9.0||||||
4269490|NCT00592124|4093821|B7|Yes||Do you currently have a male sex partner?||Participants|Count of Participants|85|85.0||||||
4269491|NCT00592124|4093822|B6|Yes||Do you currently have a male sex partner?||Participants|Count of Participants|12|12.0||||||
4269492|NCT00592124|4093823|B5|Yes||Do you currently have a male sex partner?||Participants|Count of Participants|14|14.0||||||
4269493|NCT00592124|4093824|B4|Yes||Do you currently have a male sex partner?||Participants|Count of Participants|13|13.0||||||
4269494|NCT00592124|4093825|B3|Yes||Do you currently have a male sex partner?||Participants|Count of Participants|16|16.0||||||
4269495|NCT00592124|4093826|B2|Yes||Do you currently have a male sex partner?||Participants|Count of Participants|15|15.0||||||
4269496|NCT00592124|4093827|B1|Yes||Do you currently have a male sex partner?||Participants|Count of Participants|15|15.0||||||
4269497|NCT00592124|4093821|B7||No|Are you currently married?||Participants|Count of Participants|87|87.0||||||
4269498|NCT00592124|4093822|B6||No|Are you currently married?||Participants|Count of Participants|12|12.0||||||
4269499|NCT00592124|4093823|B5||No|Are you currently married?||Participants|Count of Participants|15|15.0||||||
4269500|NCT00592124|4093824|B4||No|Are you currently married?||Participants|Count of Participants|14|14.0||||||
4269501|NCT00592124|4093825|B3||No|Are you currently married?||Participants|Count of Participants|16|16.0||||||
4269502|NCT00592124|4093826|B2||No|Are you currently married?||Participants|Count of Participants|15|15.0||||||
4269503|NCT00592124|4093827|B1||No|Are you currently married?||Participants|Count of Participants|15|15.0||||||
4269504|NCT00592124|4093821|B7||Yes|Are you currently married?||Participants|Count of Participants|57|57.0||||||
4269505|NCT00592124|4093822|B6||Yes|Are you currently married?||Participants|Count of Participants|12|12.0||||||
4269506|NCT00592124|4093823|B5||Yes|Are you currently married?||Participants|Count of Participants|9|9.0||||||
4269507|NCT00592124|4093824|B4||Yes|Are you currently married?||Participants|Count of Participants|10|10.0||||||
4269508|NCT00592124|4093825|B3||Yes|Are you currently married?||Participants|Count of Participants|8|8.0||||||
4269509|NCT00592124|4093826|B2||Yes|Are you currently married?||Participants|Count of Participants|9|9.0||||||
4269510|NCT00592124|4093827|B1||Yes|Are you currently married?||Participants|Count of Participants|9|9.0||||||
4269511|NCT00592124|4093821|B7|Uganda||Region of Enrollment||participants|Number|24|24.0||||||
4269512|NCT00592124|4093822|B6|Uganda||Region of Enrollment||participants|Number|4|4.0||||||
4269513|NCT00592124|4093823|B5|Uganda||Region of Enrollment||participants|Number|4|4.0||||||
4269514|NCT00592124|4093824|B4|Uganda||Region of Enrollment||participants|Number|4|4.0||||||
4269515|NCT00592124|4093825|B3|Uganda||Region of Enrollment||participants|Number|4|4.0||||||
4269516|NCT00592124|4093826|B2|Uganda||Region of Enrollment||participants|Number|4|4.0||||||
4269517|NCT00592124|4093827|B1|Uganda||Region of Enrollment||participants|Number|4|4.0||||||
4269518|NCT00592124|4093821|B7|South Africa||Region of Enrollment||participants|Number|48|48.0||||||
4269519|NCT00592124|4093822|B6|South Africa||Region of Enrollment||participants|Number|8|8.0||||||
4269520|NCT00592124|4093823|B5|South Africa||Region of Enrollment||participants|Number|8|8.0||||||
4269521|NCT00592124|4093824|B4|South Africa||Region of Enrollment||participants|Number|8|8.0||||||
4269522|NCT00592124|4093825|B3|South Africa||Region of Enrollment||participants|Number|8|8.0||||||
4269523|NCT00592124|4093826|B2|South Africa||Region of Enrollment||participants|Number|8|8.0||||||
4269524|NCT00592124|4093827|B1|South Africa||Region of Enrollment||participants|Number|8|8.0||||||
4269525|NCT00592124|4093821|B7|United States||Region of Enrollment||participants|Number|72|72.0||||||
4269526|NCT00592124|4093822|B6|United States||Region of Enrollment||participants|Number|12|12.0||||||
4269527|NCT00592124|4093823|B5|United States||Region of Enrollment||participants|Number|12|12.0||||||
4269528|NCT00592124|4093824|B4|United States||Region of Enrollment||participants|Number|12|12.0||||||
4269529|NCT00592124|4093825|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4269530|NCT00592124|4093826|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4269531|NCT00592124|4093827|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4269532|NCT00592124|4093821|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4269533|NCT00592124|4093822|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269534|NCT00592124|4093823|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269535|NCT00592124|4093824|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4269536|NCT00592124|4093825|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269537|NCT00592124|4093826|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269538|NCT00592124|4093827|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269539|NCT00592124|4093821|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269540|NCT00592124|4093822|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269541|NCT00592124|4093823|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269542|NCT00592124|4093824|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269543|NCT00592124|4093825|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269544|NCT00592124|4093826|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269545|NCT00592124|4093827|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269546|NCT00592124|4093821|B7||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4269547|NCT00592124|4093822|B6||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4269548|NCT00592124|4093823|B5||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4269549|NCT00592124|4093824|B4||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4269550|NCT00592124|4093825|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4269551|NCT00592124|4093826|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4269552|NCT00592124|4093827|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4269553|NCT00592124|4093821|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4269554|NCT00592124|4093822|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4269555|NCT00592124|4093823|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4269556|NCT00592124|4093824|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4269557|NCT00592124|4093825|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4269558|NCT00592124|4093826|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4269559|NCT00592124|4093827|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4269560|NCT00592124|4093821|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269561|NCT00592124|4093822|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269562|NCT00592124|4093823|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269563|NCT00592124|4093824|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269564|NCT00592124|4093825|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269565|NCT00592124|4093826|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269566|NCT00592124|4093827|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269567|NCT00592124|4093821|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4269568|NCT00592124|4093822|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269569|NCT00592124|4093823|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269570|NCT00592124|4093824|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4269571|NCT00592124|4093825|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269572|NCT00592124|4093826|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4269573|NCT00592124|4093827|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269574|NCT00592124|4093821|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4269575|NCT00592124|4093822|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269576|NCT00592124|4093823|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4269577|NCT00592124|4093824|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269578|NCT00592124|4093825|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269579|NCT00592124|4093826|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269580|NCT00592124|4093827|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269581|NCT00592124|4093821|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
4269582|NCT00592124|4093822|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4269583|NCT00592124|4093823|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4269584|NCT00592124|4093824|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4269585|NCT00592124|4093825|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4269586|NCT00592124|4093826|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4269587|NCT00592124|4093827|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4269588|NCT00592124|4093821|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4269589|NCT00592124|4093822|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4269590|NCT00592124|4093823|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4269591|NCT00592124|4093824|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4269592|NCT00592124|4093825|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4269593|NCT00592124|4093826|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4269594|NCT00592124|4093827|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4269595|NCT00592124|4093821|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4269596|NCT00592124|4093822|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4269597|NCT00592124|4093823|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269598|NCT00592124|4093824|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4269599|NCT00592124|4093825|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269600|NCT00592124|4093826|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4269601|NCT00592124|4093827|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4269602|NCT00592124|4093821|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4269603|NCT00592124|4093822|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4269604|NCT00592124|4093823|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4269605|NCT00592124|4093824|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4269606|NCT00592124|4093825|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4269607|NCT00592124|4093826|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4269608|NCT00592124|4093827|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4269609|NCT00592124|4093821|B7||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4269610|NCT00592124|4093822|B6||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4269611|NCT00592124|4093823|B5||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4269612|NCT00592124|4093824|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4269613|NCT00592124|4093825|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4269614|NCT00592124|4093826|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4269615|NCT00592124|4093827|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4269616|NCT00592124|4093821|B7|||Age||years|Mean|30.8|30.8|Standard Deviation|7.1|7.1|||
4269617|NCT00592124|4093822|B6|||Age||years|Mean|31.3|31.3|Standard Deviation|8.2|8.2|||
4269618|NCT00592124|4093823|B5|||Age||years|Mean|31.1|31.1|Standard Deviation|7.5|7.5|||
4269620|NCT00592124|4093825|B3|||Age||years|Mean|29.8|29.8|Standard Deviation|6.5|6.5|||
4269621|NCT00592124|4093826|B2|||Age||years|Mean|29.1|29.1|Standard Deviation|6.3|6.3|||
4269622|NCT00592124|4093827|B1|||Age||years|Mean|32.3|32.3|Standard Deviation|7.6|7.6|||
4269623|NCT00592072|4093883|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4269624|NCT00592072|4093883|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4269625|NCT00592072|4093883|B1|||Age||years|Mean|34.8|34.8|Standard Deviation|8.9|8.9|||
4269626|NCT00592007|4093906|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4269627|NCT00592007|4093906|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4269628|NCT00592007|4093906|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4269629|NCT00592007|4093906|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4269630|NCT00592007|4093906|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4269631|NCT00592007|4093906|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269632|NCT00591942|4093911|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4269633|NCT00591942|4093911|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4269634|NCT00591942|4093911|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4269635|NCT00591942|4093911|B1|||Age||years|Mean|56|56.0|Standard Deviation|10|10.0|||
4269636|NCT00591942|4093911|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4269637|NCT00591942|4093911|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4269638|NCT00591942|4093911|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269639|NCT00591864|4093918|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4269640|NCT00591864|4093918|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4269641|NCT00591864|4093918|B1|||Age||Years|Mean|53|53.0|Full Range|||35.0|91.0|
4269642|NCT00591851|4093924|B1|United States||Region of Enrollment||participants|Number|70|70.0||||||
4269643|NCT00591851|4093924|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4269644|NCT00591851|4093924|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4269645|NCT00591851|4093924|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4269646|NCT00591851|4093924|B1||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4269647|NCT00591851|4093924|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269648|NCT00591851|4093924|B1|||Age||years|Median|49|49.0|Full Range|||27.0|72.0|
4269649|NCT00591825|4093928|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4269650|NCT00591825|4093929|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4269651|NCT00591825|4093930|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4269652|NCT00591825|4093931|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4269653|NCT00591825|4093932|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4269654|NCT00591825|4093928|B5||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4269655|NCT00591825|4093929|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4269656|NCT00591825|4093930|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4269657|NCT00591825|4093931|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4269658|NCT00591825|4093932|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4269659|NCT00591825|4093928|B5|||Age||years|Mean|25.65|25.65|Standard Deviation|7.78|7.78|||
4269660|NCT00591825|4093929|B4|||Age||years|Mean|24.73|24.73|Standard Deviation|6.65|6.65|||
4269661|NCT00591825|4093930|B3|||Age||years|Mean|26.00|26.0|Standard Deviation|8.06|8.06|||
4269662|NCT00591825|4093931|B2|||Age||years|Mean|26.75|26.75|Standard Deviation|9.09|9.09|||
4269663|NCT00591825|4093932|B1|||Age||years|Mean|23.09|23.09|Standard Deviation|3.70|3.7|||
4269664|NCT00591773|4093961|B4||Male|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
4269665|NCT00591773|4093962|B3||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4269666|NCT00591773|4093963|B2||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4269667|NCT00591773|4093964|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4269668|NCT00591773|4093961|B4||Female|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
4269669|NCT00591773|4093962|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4269670|NCT00591773|4093963|B2||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4269671|NCT00591773|4093964|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4269672|NCT00591773|4093961|B4|≥65 years||Age||participants|Number|162|162.0||||||
4269673|NCT00591773|4093962|B3|≥65 years||Age||participants|Number|55|55.0||||||
4269674|NCT00591773|4093963|B2|≥65 years||Age||participants|Number|57|57.0||||||
4269675|NCT00591773|4093964|B1|≥65 years||Age||participants|Number|50|50.0||||||
4269676|NCT00591773|4093961|B4|Between 45 and 64 years||Age||participants|Number|337|337.0||||||
4269677|NCT00591773|4093962|B3|Between 45 and 64 years||Age||participants|Number|113|113.0||||||
4269678|NCT00591773|4093963|B2|Between 45 and 64 years||Age||participants|Number|110|110.0||||||
4269679|NCT00591773|4093964|B1|Between 45 and 64 years||Age||participants|Number|114|114.0||||||
4269680|NCT00591773|4093961|B4|<45 years||Age||participants|Number|52|52.0||||||
4269681|NCT00591773|4093962|B3|<45 years||Age||participants|Number|16|16.0||||||
4269682|NCT00591773|4093963|B2|<45 years||Age||participants|Number|15|15.0||||||
4269683|NCT00591773|4093964|B1|<45 years||Age||participants|Number|21|21.0||||||
4269684|NCT00591760|4094016|B3|||echocardiography||% of ejection fraction|Mean|35|35.0|Full Range|||20.0|70.0|
4269685|NCT00591760|4094017|B2|||echocardiography||% of ejection fraction|Mean|40|40.0|Full Range|||20.0|70.0|
4269686|NCT00591760|4094018|B1|||echocardiography||% of ejection fraction|Mean|30|30.0|Full Range|||20.0|70.0|
4269687|NCT00591760|4094016|B3||Male|Sex: Female, Male||Participants|Count of Participants|47.0|47.0||||||
4269688|NCT00591760|4094017|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4269689|NCT00591760|4094018|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4269690|NCT00591760|4094016|B3||Female|Sex: Female, Male||Participants|Count of Participants|9.0|9.0||||||
4269691|NCT00591760|4094017|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4269692|NCT00591760|4094018|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4269693|NCT00591760|4094016|B3|||Age||years|Mean|62|62.0|Standard Deviation|4|4.0|||
4269694|NCT00591760|4094017|B2|||Age||years|Mean|62|62.0|Standard Deviation|8|8.0|||
4269695|NCT00591760|4094018|B1|||Age||years|Mean|62|62.0|Standard Deviation|6|6.0|||
4269696|NCT00591760|4094016|B3||>=65 years|Age||Participants|Count of Participants|24.0|24.0||||||
4269697|NCT00591760|4094017|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4269698|NCT00591760|4094018|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4269699|NCT00591760|4094016|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32.0|32.0||||||
4269700|NCT00591760|4094017|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4269701|NCT00591760|4094018|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4269702|NCT00591760|4094016|B3||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4269703|NCT00591760|4094017|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269704|NCT00591760|4094018|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269705|NCT00591734|4094025|B1|United States||Region of Enrollment||participants|Number|57|57.0||||||
4269706|NCT00591734|4094025|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4269707|NCT00591734|4094025|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4269708|NCT00591734|4094025|B1|||Age||years|Median|70|70.0|Full Range|||36.0|88.0|
4269709|NCT00591721|4094029|B3|United States||Region of Enrollment||participants|Number|181|181.0||||||
4269710|NCT00591721|4094030|B2|United States||Region of Enrollment||participants|Number|92|92.0||||||
4269711|NCT00591721|4094031|B1|United States||Region of Enrollment||participants|Number|89|89.0||||||
4269712|NCT00591721|4094029|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4269713|NCT00591721|4094030|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4269714|NCT00591721|4094031|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4269715|NCT00591721|4094029|B3||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4269716|NCT00591721|4094030|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4269717|NCT00591721|4094031|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4269718|NCT00591721|4094029|B3|||Age||years|Mean|53.5|53.5|Standard Deviation|8.9|8.9|||
4269719|NCT00591721|4094030|B2|||Age||years|Mean|53.5|53.5|Standard Deviation|9.7|9.7|||
4269720|NCT00591721|4094031|B1|||Age||years|Mean|53.5|53.5|Standard Deviation|9.1|9.1|||
4269721|NCT00591721|4094029|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4269722|NCT00591721|4094030|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4269723|NCT00591721|4094031|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4269724|NCT00591721|4094029|B3||Between 18 and 65 years|Age||Participants|Count of Participants|165|165.0||||||
4269725|NCT00591721|4094030|B2||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
4269726|NCT00591721|4094031|B1||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
4269727|NCT00591721|4094029|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269728|NCT00591721|4094030|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269729|NCT00591721|4094031|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269730|NCT00591591|4094038|B3|United States||Region of Enrollment||participants|Number|309|309.0||||||
4269731|NCT00591591|4094039|B2|United States||Region of Enrollment||participants|Number|133|133.0||||||
4269732|NCT00591591|4094040|B1|United States||Region of Enrollment||participants|Number|176|176.0||||||
4269733|NCT00591591|4094038|B3||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4269734|NCT00591591|4094039|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4269735|NCT00591591|4094040|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4269736|NCT00591591|4094038|B3||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4269737|NCT00591591|4094039|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4269738|NCT00591591|4094040|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4269739|NCT00591591|4094038|B3|||Age||years|Mean|38.3|38.3|Standard Deviation|9.52|9.52|||
4269740|NCT00591591|4094039|B2|||Age||years|Mean|41.7|41.7|Standard Deviation|8.9|8.9|||
4269741|NCT00591591|4094040|B1|||Age||years|Mean|34.9|34.9|Standard Deviation|10.15|10.15|||
4269742|NCT00591591|4094038|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4269743|NCT00591591|4094039|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4269744|NCT00591591|4094040|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4269745|NCT00591591|4094038|B3||Between 18 and 65 years|Age||Participants|Count of Participants|309|309.0||||||
4269804|NCT00591344|4094122|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4269746|NCT00591591|4094039|B2||Between 18 and 65 years|Age||Participants|Count of Participants|133|133.0||||||
4269747|NCT00591591|4094040|B1||Between 18 and 65 years|Age||Participants|Count of Participants|176|176.0||||||
4269748|NCT00591591|4094038|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269749|NCT00591591|4094039|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269750|NCT00591591|4094040|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269751|NCT00591578|4094055|B4|Male (Open Label Phase)||Sex/Gender, Customized||participants|Number|79|79.0||||||
4269752|NCT00591578|4094056|B3|Male (Open Label Phase)||Sex/Gender, Customized||participants|Number|0|0.0||||||
4269753|NCT00591578|4094057|B2|Male (Open Label Phase)||Sex/Gender, Customized||participants|Number|58|58.0||||||
4269754|NCT00591578|4094058|B1|Male (Open Label Phase)||Sex/Gender, Customized||participants|Number|21|21.0||||||
4269755|NCT00591578|4094055|B4|Female (Open Label Phase)||Sex/Gender, Customized||participants|Number|91|91.0||||||
4269756|NCT00591578|4094056|B3|Female (Open Label Phase)||Sex/Gender, Customized||participants|Number|0|0.0||||||
4269757|NCT00591578|4094057|B2|Female (Open Label Phase)||Sex/Gender, Customized||participants|Number|57|57.0||||||
4269758|NCT00591578|4094058|B1|Female (Open Label Phase)||Sex/Gender, Customized||participants|Number|34|34.0||||||
4269759|NCT00591578|4094055|B4|Male (Double Blind Phase)||Sex/Gender, Customized||participants|Number|509|509.0||||||
4269760|NCT00591578|4094056|B3|Male (Double Blind Phase)||Sex/Gender, Customized||participants|Number|176|176.0||||||
4269761|NCT00591578|4094057|B2|Male (Double Blind Phase)||Sex/Gender, Customized||participants|Number|169|169.0||||||
4269762|NCT00591578|4094058|B1|Male (Double Blind Phase)||Sex/Gender, Customized||participants|Number|164|164.0||||||
4269763|NCT00591578|4094055|B4|Female (Double Blind Phase)||Sex/Gender, Customized||participants|Number|475|475.0||||||
4269764|NCT00591578|4094056|B3|Female (Double Blind Phase)||Sex/Gender, Customized||participants|Number|152|152.0||||||
4269765|NCT00591578|4094057|B2|Female (Double Blind Phase)||Sex/Gender, Customized||participants|Number|160|160.0||||||
4269766|NCT00591578|4094058|B1|Female (Double Blind Phase)||Sex/Gender, Customized||participants|Number|163|163.0||||||
4269767|NCT00591578|4094055|B4|≥65 years (Open Label Phase)||Age, Customized||participants|Number|59|59.0||||||
4269768|NCT00591578|4094056|B3|≥65 years (Open Label Phase)||Age, Customized||participants|Number|0|0.0||||||
4269769|NCT00591578|4094057|B2|≥65 years (Open Label Phase)||Age, Customized||participants|Number|39|39.0||||||
4269770|NCT00591578|4094058|B1|≥65 years (Open Label Phase)||Age, Customized||participants|Number|20|20.0||||||
4269771|NCT00591578|4094055|B4|Between 45 and 64 years (Open Label Phase)||Age, Customized||participants|Number|93|93.0||||||
4269772|NCT00591578|4094056|B3|Between 45 and 64 years (Open Label Phase)||Age, Customized||participants|Number|0|0.0||||||
4269773|NCT00591578|4094057|B2|Between 45 and 64 years (Open Label Phase)||Age, Customized||participants|Number|68|68.0||||||
4269774|NCT00591578|4094058|B1|Between 45 and 64 years (Open Label Phase)||Age, Customized||participants|Number|25|25.0||||||
4269775|NCT00591578|4094055|B4|<45 years (Open Label Phase)||Age, Customized||participants|Number|18|18.0||||||
4269776|NCT00591578|4094056|B3|<45 years (Open Label Phase)||Age, Customized||participants|Number|0|0.0||||||
4269777|NCT00591578|4094057|B2|<45 years (Open Label Phase)||Age, Customized||participants|Number|8|8.0||||||
4269778|NCT00591578|4094058|B1|<45 years (Open Label Phase)||Age, Customized||participants|Number|10|10.0||||||
4269779|NCT00591578|4094055|B4|≥65 years (Double Blind Phase)||Age, Customized||participants|Number|283|283.0||||||
4269780|NCT00591578|4094056|B3|≥65 years (Double Blind Phase)||Age, Customized||participants|Number|98|98.0||||||
4269781|NCT00591578|4094057|B2|≥65 years (Double Blind Phase)||Age, Customized||participants|Number|82|82.0||||||
4269782|NCT00591578|4094058|B1|≥65 years (Double Blind Phase)||Age, Customized||participants|Number|103|103.0||||||
4269783|NCT00591578|4094055|B4|Between 45 and 64 years (Double Blind Phase)||Age, Customized||participants|Number|588|588.0||||||
4269784|NCT00591578|4094056|B3|Between 45 and 64 years (Double Blind Phase)||Age, Customized||participants|Number|199|199.0||||||
4269785|NCT00591578|4094057|B2|Between 45 and 64 years (Double Blind Phase)||Age, Customized||participants|Number|208|208.0||||||
4269786|NCT00591578|4094058|B1|Between 45 and 64 years (Double Blind Phase)||Age, Customized||participants|Number|181|181.0||||||
4269787|NCT00591578|4094055|B4|<45 years (Double Blind Phase)||Age, Customized||participants|Number|113|113.0||||||
4269788|NCT00591578|4094056|B3|<45 years (Double Blind Phase)||Age, Customized||participants|Number|31|31.0||||||
4269789|NCT00591578|4094057|B2|<45 years (Double Blind Phase)||Age, Customized||participants|Number|39|39.0||||||
4269790|NCT00591578|4094058|B1|<45 years (Double Blind Phase)||Age, Customized||participants|Number|43|43.0||||||
4269791|NCT00591565|4094111|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4269792|NCT00591565|4094111|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4269793|NCT00591565|4094111|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4269794|NCT00591565|4094111|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4269795|NCT00591565|4094111|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4269796|NCT00591565|4094111|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269797|NCT00591370|4094115|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4269798|NCT00591370|4094115|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4269799|NCT00591370|4094115|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4269800|NCT00591370|4094115|B1||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4269801|NCT00591370|4094115|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4269802|NCT00591370|4094115|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4269803|NCT00591344|4094121|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4269805|NCT00591344|4094123|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4269806|NCT00591344|4094121|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4269807|NCT00591344|4094122|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4269808|NCT00591344|4094123|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4269809|NCT00591344|4094121|B3|||Age||years|Mean|58.8|58.8|Standard Deviation|5.1|5.1|||
4269810|NCT00591344|4094122|B2|||Age||years|Mean|59.0|59.0|Standard Deviation|4.6|4.6|||
4269811|NCT00591344|4094123|B1|||Age||years|Mean|58.6|58.6|Standard Deviation|5.6|5.6|||
4269812|NCT00591305|4094134|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4269813|NCT00591305|4094136|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4269814|NCT00591305|4094134|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4269815|NCT00591305|4094135|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4269816|NCT00591305|4094136|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4269817|NCT00591305|4094134|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4269818|NCT00591305|4094135|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4269819|NCT00591305|4094136|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4269820|NCT00591305|4094134|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4269821|NCT00591305|4094135|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4269822|NCT00591305|4094136|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4269823|NCT00591305|4094134|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4269824|NCT00591305|4094135|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4269825|NCT00591305|4094136|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4269826|NCT00591305|4094134|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4269827|NCT00591305|4094135|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269828|NCT00591305|4094136|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4269829|NCT00591266|4094147|B4||Male|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
4269830|NCT00591266|4094148|B3||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4269831|NCT00591266|4094149|B2||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4269832|NCT00591266|4094150|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4269833|NCT00591266|4094147|B4||Female|Sex: Female, Male||Participants|Count of Participants|279|279.0||||||
4269834|NCT00591266|4094148|B3||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4269835|NCT00591266|4094149|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4269836|NCT00591266|4094150|B1||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4269837|NCT00591266|4094147|B4|≥65 years||Age||participants|Number|177|177.0||||||
4269838|NCT00591266|4094148|B3|≥65 years||Age||participants|Number|59|59.0||||||
4269839|NCT00591266|4094149|B2|≥65 years||Age||participants|Number|54|54.0||||||
4269840|NCT00591266|4094150|B1|≥65 years||Age||participants|Number|64|64.0||||||
4269841|NCT00591266|4094147|B4|Between 45 and 64 years||Age||participants|Number|323|323.0||||||
4269842|NCT00591266|4094148|B3|Between 45 and 64 years||Age||participants|Number|115|115.0||||||
4269843|NCT00591266|4094149|B2|Between 45 and 64 years||Age||participants|Number|111|111.0||||||
4269844|NCT00591266|4094150|B1|Between 45 and 64 years||Age||participants|Number|97|97.0||||||
4269845|NCT00591266|4094147|B4|<45 years||Age||participants|Number|66|66.0||||||
4269846|NCT00591266|4094148|B3|<45 years||Age||participants|Number|15|15.0||||||
4269847|NCT00591266|4094149|B2|<45 years||Age||participants|Number|23|23.0||||||
4269848|NCT00591266|4094150|B1|<45 years||Age||participants|Number|28|28.0||||||
4269849|NCT00591253|4094202|B4||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4269850|NCT00591253|4094203|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4269851|NCT00591253|4094204|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4269852|NCT00591253|4094205|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4269853|NCT00591253|4094202|B4||Female|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
4269854|NCT00591253|4094203|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4269855|NCT00591253|4094204|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4269856|NCT00591253|4094205|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4269857|NCT00591253|4094202|B4|≥65 years||Age||participants|Number|46|46.0||||||
4269858|NCT00591253|4094203|B3|≥65 years||Age||participants|Number|17|17.0||||||
4269859|NCT00591253|4094204|B2|≥65 years||Age||participants|Number|14|14.0||||||
4269860|NCT00591253|4094205|B1|≥65 years||Age||participants|Number|15|15.0||||||
4269861|NCT00591253|4094202|B4|Between 45 and 64 years||Age||participants|Number|265|265.0||||||
4269862|NCT00591253|4094203|B3|Between 45 and 64 years||Age||participants|Number|85|85.0||||||
4269863|NCT00591253|4094204|B2|Between 45 and 64 years||Age||participants|Number|86|86.0||||||
4269864|NCT00591253|4094205|B1|Between 45 and 64 years||Age||participants|Number|94|94.0||||||
4269865|NCT00591253|4094202|B4|<45 years||Age||participants|Number|102|102.0||||||
4269866|NCT00591253|4094203|B3|<45 years||Age||participants|Number|36|36.0||||||
4269867|NCT00591253|4094204|B2|<45 years||Age||participants|Number|37|37.0||||||
4269868|NCT00591253|4094205|B1|<45 years||Age||participants|Number|29|29.0||||||
4269869|NCT00591240|4094257|B3||Male|Sex: Female, Male||Participants|Count of Participants|327|327.0||||||
4269870|NCT00591240|4094258|B2||Male|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
4269871|NCT00591240|4094259|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4269872|NCT00591240|4094257|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4269873|NCT00591240|4094258|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4269874|NCT00591240|4094259|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4269875|NCT00591240|4094257|B3||>=65 years|Age||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4269876|NCT00591240|4094258|B2||>=65 years|Age||Participants|Count of Participants|NA|||||||Age information was not collected for Group 2: Antimicrobial susceptibility testing.
4269877|NCT00591240|4094259|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4269878|NCT00591240|4094257|B3||Between 18 and 65 years|Age||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4269879|NCT00591240|4094258|B2||Between 18 and 65 years|Age||Participants|Count of Participants|NA|||||||Age information was not collected for Group 2: Antimicrobial susceptibility testing.
4269880|NCT00591240|4094259|B1||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4269881|NCT00591240|4094257|B3||<=18 years|Age||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4269882|NCT00591240|4094258|B2||<=18 years|Age||Participants|Count of Participants|NA|||||||Age information was not collected for Group 2: Antimicrobial susceptibility testing.
4269883|NCT00591240|4094259|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269884|NCT00591227|4094266|B3|United States||Region of Enrollment||participants|Number|176|176.0||||||
4269885|NCT00591227|4094267|B2|United States||Region of Enrollment||participants|Number|87|87.0||||||
4269886|NCT00591227|4094268|B1|United States||Region of Enrollment||participants|Number|89|89.0||||||
4269887|NCT00591227|4094266|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4269888|NCT00591227|4094267|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4269889|NCT00591227|4094268|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4269890|NCT00591227|4094266|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4269891|NCT00591227|4094267|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4269892|NCT00591227|4094268|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4269893|NCT00591227|4094266|B3|||Age||years|Mean|55|55.0|Standard Deviation|15|15.0|||
4269894|NCT00591227|4094267|B2|||Age||years|Mean|55|55.0|Standard Deviation|15|15.0|||
4269895|NCT00591227|4094268|B1|||Age||years|Mean|55|55.0|Standard Deviation|15|15.0|||
4269896|NCT00591227|4094266|B3||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
4269897|NCT00591227|4094267|B2||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4269898|NCT00591227|4094268|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4269899|NCT00591227|4094266|B3||Between 18 and 65 years|Age||Participants|Count of Participants|136|136.0||||||
4269900|NCT00591227|4094267|B2||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
4269901|NCT00591227|4094268|B1||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
4269902|NCT00591227|4094266|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269903|NCT00591227|4094267|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269904|NCT00591227|4094268|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269905|NCT00591214|4094275|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4269906|NCT00591214|4094275|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4269907|NCT00591214|4094275|B1|||Age||years|Mean|54|54.0|Standard Deviation|10.2|10.2|||
4269908|NCT00591149|4094284|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4269909|NCT00591149|4094284|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4269910|NCT00591149|4094284|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4269911|NCT00591149|4094284|B1|||Age||years|Median|66|66.0|Full Range|||51.0|71.0|
4269912|NCT00591019|4094288|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4269913|NCT00591019|4094288|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4269914|NCT00591019|4094288|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4269915|NCT00591019|4094288|B1|||Age||years|Mean|55|55.0|Standard Deviation|2|2.0|||
4269916|NCT00591019|4094288|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4269917|NCT00591019|4094288|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4269918|NCT00591019|4094288|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269919|NCT00591006|4094300|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4269920|NCT00591006|4094300|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4269921|NCT00591006|4094300|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4269922|NCT00591006|4094300|B1|||Age||years|Mean|27.1|27.1|Standard Deviation|9.6|9.6|||
4269923|NCT00591006|4094300|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4269924|NCT00591006|4094300|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4269925|NCT00591006|4094300|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4269926|NCT00590980|4094341|B1|United States||Region of Enrollment||participants|Number|66|66.0||||||
4269927|NCT00590980|4094341|B1|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4269928|NCT00590980|4094341|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4269929|NCT00590980|4094341|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269930|NCT00590980|4094341|B1||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4269931|NCT00590980|4094341|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4269932|NCT00590980|4094341|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269933|NCT00590980|4094341|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4269934|NCT00590980|4094341|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269935|NCT00590980|4094341|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4269936|NCT00590980|4094341|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4269937|NCT00590980|4094341|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4269938|NCT00590980|4094341|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4269939|NCT00590980|4094341|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4269940|NCT00590980|4094341|B1|||Age||years|Mean|65.6|65.6|Full Range|||39.0|89.0|
4269941|NCT00590967|4094345|B3|United States||Region of Enrollment||participants|Number|61|61.0||||||
4269942|NCT00590967|4094346|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4269943|NCT00590967|4094347|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4269944|NCT00590967|4094345|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4269945|NCT00590967|4094346|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4269946|NCT00590967|4094347|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4269947|NCT00590967|4094345|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4269948|NCT00590967|4094346|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4269949|NCT00590967|4094347|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4269950|NCT00590967|4094345|B3|||Age||years|Median|45|45.0|Full Range|||26.0|77.0|
4269951|NCT00590967|4094346|B2|||Age||years|Median|52|52.0|Full Range|||39.0|62.0|
4269952|NCT00590967|4094347|B1|||Age||years|Median|45|45.0|Full Range|||26.0|77.0|
4269953|NCT00590902|4094360|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4269954|NCT00590902|4094360|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4269955|NCT00590902|4094360|B1||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
4269956|NCT00590902|4094360|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4269957|NCT00590902|4094360|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269958|NCT00590889|4094364|B3||Male|Sex: Female, Male||Participants|Count of Participants|474|474.0||||||
4269959|NCT00590889|4094365|B2||Male|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
4269960|NCT00590889|4094366|B1||Male|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
4269961|NCT00590889|4094364|B3||Female|Sex: Female, Male||Participants|Count of Participants|333|333.0||||||
4269962|NCT00590889|4094365|B2||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4269963|NCT00590889|4094366|B1||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4269964|NCT00590889|4094364|B3|>=65 years||Age|We are missing 1 person's age in the Conventional group which would make the total 404|participants|Number|344|344.0||||||
4269965|NCT00590889|4094365|B2|>=65 years||Age|We are missing 1 person's age in the Conventional group which would make the total 404|participants|Number|185|185.0||||||
4269966|NCT00590889|4094366|B1|>=65 years||Age|We are missing 1 person's age in the Conventional group which would make the total 404|participants|Number|159|159.0||||||
4269967|NCT00590889|4094364|B3|Between 18 and 65 years||Age|We are missing 1 person's age in the Conventional group which would make the total 404|participants|Number|462|462.0||||||
4269968|NCT00590889|4094365|B2|Between 18 and 65 years||Age|We are missing 1 person's age in the Conventional group which would make the total 404|participants|Number|218|218.0||||||
4269969|NCT00590889|4094366|B1|Between 18 and 65 years||Age|We are missing 1 person's age in the Conventional group which would make the total 404|participants|Number|244|244.0||||||
4269970|NCT00590889|4094364|B3|<=18 years||Age|We are missing 1 person's age in the Conventional group which would make the total 404|participants|Number|0|0.0||||||
4269971|NCT00590889|4094365|B2|<=18 years||Age|We are missing 1 person's age in the Conventional group which would make the total 404|participants|Number|0|0.0||||||
4269972|NCT00590889|4094366|B1|<=18 years||Age|We are missing 1 person's age in the Conventional group which would make the total 404|participants|Number|0|0.0||||||
4269973|NCT00590863|4094373|B4|United States||Region of Enrollment||participants|Number|665|665.0||||||
4269974|NCT00590863|4094374|B3|United States||Region of Enrollment||participants|Number|224|224.0||||||
4269975|NCT00590863|4094375|B2|United States||Region of Enrollment||participants|Number|220|220.0||||||
4269976|NCT00590863|4094376|B1|United States||Region of Enrollment||participants|Number|221|221.0||||||
4269977|NCT00590863|4094373|B4||Male|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
4269978|NCT00590863|4094374|B3||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4269979|NCT00590863|4094375|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4269980|NCT00590863|4094376|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4269981|NCT00590863|4094373|B4||Female|Sex: Female, Male||Participants|Count of Participants|452|452.0||||||
4269982|NCT00590863|4094374|B3||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4269983|NCT00590863|4094375|B2||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4269984|NCT00590863|4094376|B1||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4269985|NCT00590863|4094373|B4|||Age||years|Mean|42.7|42.7|Standard Deviation|13.0|13.0|||
4269986|NCT00590863|4094374|B3|||Age||years|Mean|43.6|43.6|Standard Deviation|13.1|13.1|||
4269987|NCT00590863|4094375|B2|||Age||years|Mean|42.0|42.0|Standard Deviation|12.4|12.4|||
4269988|NCT00590863|4094376|B1|||Age||years|Mean|42.4|42.4|Standard Deviation|13.5|13.5|||
4269989|NCT00590863|4094373|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4269990|NCT00590863|4094374|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4269991|NCT00590863|4094375|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4269992|NCT00590863|4094376|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4269993|NCT00590863|4094373|B4||Between 18 and 65 years|Age||Participants|Count of Participants|665|665.0||||||
4269994|NCT00590863|4094374|B3||Between 18 and 65 years|Age||Participants|Count of Participants|224|224.0||||||
4269995|NCT00590863|4094375|B2||Between 18 and 65 years|Age||Participants|Count of Participants|220|220.0||||||
4269996|NCT00590863|4094376|B1||Between 18 and 65 years|Age||Participants|Count of Participants|221|221.0||||||
4269997|NCT00590863|4094373|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269998|NCT00590863|4094374|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4269999|NCT00590863|4094375|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270000|NCT00590863|4094376|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270001|NCT00590772|4094389|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4270002|NCT00590772|4094389|B1||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||data are not available at this time
4270003|NCT00590772|4094389|B1||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||data are not available at this time
4270004|NCT00590772|4094389|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4270005|NCT00590772|4094389|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4270006|NCT00590772|4094389|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270007|NCT00590759|4094395|B1|United States||Region of Enrollment||participants|Number|150|150.0||||||
4270008|NCT00590759|4094395|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4270009|NCT00590759|4094395|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4270010|NCT00590759|4094395|B1|||Age||years|Mean|72.1|72.1|Standard Deviation|10.5|10.5|||
4270011|NCT00590720|4094400|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4270012|NCT00590720|4094401|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4270013|NCT00590720|4094402|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4270014|NCT00590720|4094400|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4270015|NCT00590720|4094401|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4270016|NCT00590720|4094402|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4270017|NCT00590720|4094400|B3|||Age||Years|Mean|32.0|32.0|Standard Deviation|9.7|9.7|||
4270018|NCT00590720|4094401|B2|||Age||Years|Mean|32.1|32.1|Standard Deviation|8.2|8.2|||
4270019|NCT00590720|4094402|B1|||Age||Years|Mean|31.8|31.8|Standard Deviation|13.5|13.5|||
4270020|NCT00590707|4094445|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4270021|NCT00590707|4094446|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4270022|NCT00590707|4094447|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4270023|NCT00590707|4094445|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4270024|NCT00590707|4094446|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4270025|NCT00590707|4094447|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4270026|NCT00590707|4094445|B3||White|Race (NIH/OMB)||Participants|Count of Participants|194|194.0||||||
4270027|NCT00590707|4094446|B2||White|Race (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
4270028|NCT00590707|4094447|B1||White|Race (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
4270029|NCT00590707|4094445|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4270030|NCT00590707|4094446|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4270031|NCT00590707|4094447|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4270032|NCT00590707|4094445|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4270033|NCT00590707|4094446|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4270034|NCT00590707|4094447|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4270035|NCT00590707|4094445|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4270036|NCT00590707|4094446|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4270037|NCT00590707|4094447|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4270038|NCT00590707|4094445|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4270039|NCT00590707|4094446|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4270040|NCT00590707|4094447|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4270041|NCT00590707|4094445|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4270042|NCT00590707|4094446|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4270043|NCT00590707|4094447|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4270044|NCT00590707|4094445|B3||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4270045|NCT00590707|4094446|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4270046|NCT00590707|4094447|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4270047|NCT00590707|4094445|B3|||Age||years|Mean|82|82.0|Standard Deviation|8|8.0|||
4270048|NCT00590707|4094446|B2|||Age||years|Mean|82|82.0|Standard Deviation|8|8.0|||
4270049|NCT00590707|4094447|B1|||Age||years|Mean|82|82.0|Standard Deviation|7|7.0|||
4270050|NCT00590707|4094445|B3||>=65 years|Age||Participants|Count of Participants|200|200.0||||||
4270051|NCT00590707|4094446|B2||>=65 years|Age||Participants|Count of Participants|100|100.0||||||
4270052|NCT00590707|4094447|B1||>=65 years|Age||Participants|Count of Participants|100|100.0||||||
4270053|NCT00590707|4094445|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4270054|NCT00590707|4094446|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4270055|NCT00590707|4094447|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4270056|NCT00590707|4094445|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270057|NCT00590707|4094446|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270058|NCT00590707|4094447|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270059|NCT00590590|4094462|B4|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4270060|NCT00590590|4094463|B3|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4270061|NCT00590590|4094464|B2|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4270062|NCT00590590|4094465|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4270063|NCT00590590|4094462|B4|United States||Region of Enrollment||participants|Number|100|100.0||||||
4270064|NCT00590590|4094463|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4270065|NCT00590590|4094464|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
4270066|NCT00590590|4094465|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4270067|NCT00590590|4094462|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4270068|NCT00590590|4094463|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4270069|NCT00590590|4094464|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4270070|NCT00590590|4094465|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4270071|NCT00590590|4094462|B4||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4270072|NCT00590590|4094463|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4270073|NCT00590590|4094464|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4270074|NCT00590590|4094465|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4270075|NCT00590590|4094462|B4|||Age||years|Mean|31|31.0|Standard Deviation|8.5|8.5|||
4270076|NCT00590590|4094463|B3|||Age||years|Mean|32|32.0|Standard Deviation|9.5|9.5|||
4270077|NCT00590590|4094464|B2|||Age||years|Mean|32|32.0|Standard Deviation|9.0|9.0|||
4270078|NCT00590590|4094465|B1|||Age||years|Mean|30|30.0|Standard Deviation|7.4|7.4|||
4270079|NCT00590590|4094462|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4270080|NCT00590590|4094463|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4270081|NCT00590590|4094464|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4270082|NCT00590590|4094465|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4270083|NCT00590590|4094462|B4||Between 18 and 65 years|Age||Participants|Count of Participants|105|105.0||||||
4270084|NCT00590590|4094463|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4270085|NCT00590590|4094464|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4270086|NCT00590590|4094465|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4270087|NCT00590590|4094462|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270088|NCT00590590|4094463|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270089|NCT00590590|4094464|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270090|NCT00590590|4094465|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270091|NCT00590577|4094490|B5|Serbia||Region of Enrollment||participants|Number|9|9.0||||||
4270092|NCT00590577|4094491|B4|Serbia||Region of Enrollment||participants|Number|2|2.0||||||
4270093|NCT00590577|4094492|B3|Serbia||Region of Enrollment||participants|Number|2|2.0||||||
4270094|NCT00590577|4094493|B2|Serbia||Region of Enrollment||participants|Number|3|3.0||||||
4270095|NCT00590577|4094494|B1|Serbia||Region of Enrollment||participants|Number|2|2.0||||||
4270096|NCT00590577|4094490|B5|Korea, Republic of||Region of Enrollment||participants|Number|24|24.0||||||
4270097|NCT00590577|4094491|B4|Korea, Republic of||Region of Enrollment||participants|Number|6|6.0||||||
4270098|NCT00590577|4094492|B3|Korea, Republic of||Region of Enrollment||participants|Number|6|6.0||||||
4270099|NCT00590577|4094493|B2|Korea, Republic of||Region of Enrollment||participants|Number|5|5.0||||||
4270100|NCT00590577|4094494|B1|Korea, Republic of||Region of Enrollment||participants|Number|7|7.0||||||
4270101|NCT00590577|4094490|B5|Malaysia||Region of Enrollment||participants|Number|29|29.0||||||
4270102|NCT00590577|4094491|B4|Malaysia||Region of Enrollment||participants|Number|7|7.0||||||
4270103|NCT00590577|4094492|B3|Malaysia||Region of Enrollment||participants|Number|7|7.0||||||
4270104|NCT00590577|4094493|B2|Malaysia||Region of Enrollment||participants|Number|8|8.0||||||
4270105|NCT00590577|4094494|B1|Malaysia||Region of Enrollment||participants|Number|7|7.0||||||
4270106|NCT00590577|4094490|B5|Taiwan||Region of Enrollment||participants|Number|39|39.0||||||
4270107|NCT00590577|4094491|B4|Taiwan||Region of Enrollment||participants|Number|10|10.0||||||
4270108|NCT00590577|4094492|B3|Taiwan||Region of Enrollment||participants|Number|9|9.0||||||
4270109|NCT00590577|4094493|B2|Taiwan||Region of Enrollment||participants|Number|10|10.0||||||
4270110|NCT00590577|4094494|B1|Taiwan||Region of Enrollment||participants|Number|10|10.0||||||
4270111|NCT00590577|4094490|B5|Romania||Region of Enrollment||participants|Number|39|39.0||||||
4270112|NCT00590577|4094491|B4|Romania||Region of Enrollment||participants|Number|10|10.0||||||
4270113|NCT00590577|4094492|B3|Romania||Region of Enrollment||participants|Number|8|8.0||||||
4270114|NCT00590577|4094493|B2|Romania||Region of Enrollment||participants|Number|10|10.0||||||
4270115|NCT00590577|4094494|B1|Romania||Region of Enrollment||participants|Number|11|11.0||||||
4270116|NCT00590577|4094490|B5|Ukraine||Region of Enrollment||participants|Number|53|53.0||||||
4270117|NCT00590577|4094491|B4|Ukraine||Region of Enrollment||participants|Number|13|13.0||||||
4270118|NCT00590577|4094492|B3|Ukraine||Region of Enrollment||participants|Number|13|13.0||||||
4270119|NCT00590577|4094493|B2|Ukraine||Region of Enrollment||participants|Number|14|14.0||||||
4270120|NCT00590577|4094494|B1|Ukraine||Region of Enrollment||participants|Number|13|13.0||||||
4270121|NCT00590577|4094490|B5|Russian Federation||Region of Enrollment||participants|Number|130|130.0||||||
4270122|NCT00590577|4094491|B4|Russian Federation||Region of Enrollment||participants|Number|32|32.0||||||
4270123|NCT00590577|4094492|B3|Russian Federation||Region of Enrollment||participants|Number|33|33.0||||||
4270124|NCT00590577|4094493|B2|Russian Federation||Region of Enrollment||participants|Number|33|33.0||||||
4270125|NCT00590577|4094494|B1|Russian Federation||Region of Enrollment||participants|Number|32|32.0||||||
4270126|NCT00590577|4094490|B5|United States||Region of Enrollment||participants|Number|329|329.0||||||
4270127|NCT00590577|4094491|B4|United States||Region of Enrollment||participants|Number|84|84.0||||||
4270128|NCT00590577|4094492|B3|United States||Region of Enrollment||participants|Number|85|85.0||||||
4270129|NCT00590577|4094493|B2|United States||Region of Enrollment||participants|Number|82|82.0||||||
4270130|NCT00590577|4094494|B1|United States||Region of Enrollment||participants|Number|78|78.0||||||
4270131|NCT00590577|4094490|B5||Male|Sex: Female, Male||Participants|Count of Participants|440|440.0||||||
4270132|NCT00590577|4094491|B4||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4270133|NCT00590577|4094492|B3||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4270134|NCT00590577|4094493|B2||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4270135|NCT00590577|4094494|B1||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4270136|NCT00590577|4094490|B5||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4270137|NCT00590577|4094491|B4||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4270138|NCT00590577|4094492|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4270139|NCT00590577|4094493|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4270140|NCT00590577|4094494|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4270141|NCT00590577|4094490|B5|||Age||years|Mean|39.3|39.3|Standard Deviation|10.55|10.55|||
4270142|NCT00590577|4094491|B4|||Age||years|Mean|39.9|39.9|Standard Deviation|10.96|10.96|||
4270143|NCT00590577|4094492|B3|||Age||years|Mean|39.4|39.4|Standard Deviation|10.69|10.69|||
4270144|NCT00590577|4094493|B2|||Age||years|Mean|38.7|38.7|Standard Deviation|10.27|10.27|||
4270145|NCT00590577|4094494|B1|||Age||years|Mean|39.2|39.2|Standard Deviation|10.33|10.33|||
4270146|NCT00590577|4094490|B5||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4270147|NCT00590577|4094491|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4270148|NCT00590577|4094492|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4270149|NCT00590577|4094493|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4270150|NCT00590577|4094494|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4270151|NCT00590577|4094490|B5||Between 18 and 65 years|Age||Participants|Count of Participants|646|646.0||||||
4270152|NCT00590577|4094491|B4||Between 18 and 65 years|Age||Participants|Count of Participants|163|163.0||||||
4270153|NCT00590577|4094492|B3||Between 18 and 65 years|Age||Participants|Count of Participants|160|160.0||||||
4270154|NCT00590577|4094493|B2||Between 18 and 65 years|Age||Participants|Count of Participants|163|163.0||||||
4270155|NCT00590577|4094494|B1||Between 18 and 65 years|Age||Participants|Count of Participants|160|160.0||||||
4270156|NCT00590577|4094490|B5||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4270157|NCT00590577|4094491|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270158|NCT00590577|4094492|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4270159|NCT00590577|4094493|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4270160|NCT00590577|4094494|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270161|NCT00590564|4094515|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4270162|NCT00590564|4094515|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4270163|NCT00590564|4094515|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4270164|NCT00590564|4094515|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4270165|NCT00590564|4094515|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270166|NCT00590538|4094519|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4270167|NCT00590538|4094519|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4270168|NCT00590538|4094519|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4270169|NCT00590538|4094519|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4270170|NCT00590538|4094519|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4270171|NCT00590538|4094519|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270172|NCT00590460|4094527|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4270173|NCT00590460|4094527|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4270174|NCT00590460|4094527|B1|Between 10 and 15 years||Age, Customized||participants|Number|2|2.0||||||
4270175|NCT00590460|4094527|B1|Between 5 and 9 years||Age, Customized||participants|Number|2|2.0||||||
4270176|NCT00590460|4094527|B1|<=5 years||Age, Customized||participants|Number|1|1.0||||||
4270177|NCT00590369|4094540|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4270178|NCT00590369|4094541|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4270179|NCT00590369|4094542|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4270180|NCT00590369|4094540|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4270181|NCT00590369|4094541|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4270182|NCT00590369|4094542|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4270183|NCT00590369|4094540|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4270184|NCT00590369|4094541|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4270185|NCT00590369|4094542|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4270186|NCT00590369|4094540|B3|median||Age||years|Median|50|50.0|Inter-Quartile Range|42, 58|42.0|42.0|58.0|
4270187|NCT00590369|4094541|B2|median||Age||years|Median|49|49.0|Inter-Quartile Range|47, 50|47.0|47.0|50.0|
4270188|NCT00590369|4094542|B1|median||Age||years|Median|57|57.0|Inter-Quartile Range|42, 58|42.0|35.0|58.0|
4270189|NCT00590369|4094540|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4270190|NCT00590369|4094541|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4270191|NCT00590369|4094542|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4270192|NCT00590369|4094540|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4270193|NCT00590369|4094541|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4270194|NCT00590369|4094542|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4270195|NCT00590369|4094540|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270196|NCT00590369|4094541|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270197|NCT00590369|4094542|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270198|NCT00590317|4094559|B3|United States||Region of Enrollment||participants|Number|64|64.0||||||
4270199|NCT00590317|4094560|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
4270200|NCT00590317|4094561|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4270201|NCT00590317|4094559|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4270202|NCT00590317|4094560|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4270203|NCT00590317|4094561|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4270204|NCT00590317|4094559|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4270205|NCT00590317|4094560|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4270206|NCT00590317|4094561|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4270207|NCT00590317|4094559|B3|||Age||years|Mean|40|40.0|Standard Deviation|12|12.0|||
4270208|NCT00590317|4094560|B2|||Age||years|Mean|40|40.0|Standard Deviation|11|11.0|||
4270209|NCT00590317|4094561|B1|||Age||years|Mean|41|41.0|Standard Deviation|12|12.0|||
4270210|NCT00590317|4094559|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4270211|NCT00590317|4094560|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4270212|NCT00590317|4094561|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4270213|NCT00590317|4094559|B3||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4270214|NCT00590317|4094560|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4270215|NCT00590317|4094561|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4270216|NCT00590317|4094559|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270217|NCT00590317|4094560|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270218|NCT00590317|4094561|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270219|NCT00590226|4094572|B3|United States||Region of Enrollment||participants|Number|130|130.0||||||
4270220|NCT00590226|4094573|B2|United States||Region of Enrollment||participants|Number|63|63.0||||||
4270221|NCT00590226|4094574|B1|United States||Region of Enrollment||participants|Number|67|67.0||||||
4270222|NCT00590226|4094572|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4270223|NCT00590226|4094573|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4270224|NCT00590226|4094574|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4270225|NCT00590226|4094572|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4270226|NCT00590226|4094573|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4270227|NCT00590226|4094574|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4270228|NCT00590226|4094572|B3|||Age||years|Mean|58|58.0|Standard Deviation|10|10.0|||
4270229|NCT00590226|4094573|B2|||Age||years|Mean|58|58.0|Standard Deviation|10|10.0|||
4270230|NCT00590226|4094574|B1|||Age||years|Mean|59|59.0|Standard Deviation|10|10.0|||
4270231|NCT00590226|4094572|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4270232|NCT00590226|4094573|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4270233|NCT00590226|4094574|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4270234|NCT00590226|4094572|B3||Between 18 and 65 years|Age||Participants|Count of Participants|117|117.0||||||
4270235|NCT00590226|4094573|B2||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4270236|NCT00590226|4094574|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4270237|NCT00590226|4094572|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270238|NCT00590226|4094573|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270239|NCT00590226|4094574|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270240|NCT00590161|4094583|B3|United States||Region of Enrollment||participants|Number|55|55.0||||||
4270241|NCT00590161|4094584|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4270242|NCT00590161|4094585|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4270243|NCT00590161|4094583|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4270244|NCT00590161|4094584|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4270245|NCT00590161|4094585|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4270246|NCT00590161|4094583|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4270247|NCT00590161|4094584|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4270248|NCT00590161|4094585|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4270249|NCT00590161|4094583|B3|||Age||years|Mean|50|50.0|Standard Deviation|11.1|11.1|||
4270250|NCT00590161|4094584|B2|||Age||years|Mean|49.6|49.6|Standard Deviation|9.6|9.6|||
4270251|NCT00590161|4094585|B1|||Age||years|Mean|50.5|50.5|Standard Deviation|12.7|12.7|||
4270252|NCT00590161|4094583|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4270253|NCT00590161|4094584|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4270254|NCT00590161|4094585|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4270255|NCT00590161|4094583|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4270256|NCT00590161|4094584|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4270257|NCT00590161|4094585|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4270258|NCT00590161|4094583|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270259|NCT00590161|4094584|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270260|NCT00590161|4094585|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270261|NCT00590135|4094592|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4270262|NCT00590135|4094592|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4270263|NCT00590135|4094592|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4270264|NCT00590135|4094592|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4270265|NCT00590135|4094592|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270266|NCT00590044|4094600|B3|United States||Region of Enrollment||participants|Number|74|74.0||||||
4270267|NCT00590044|4094601|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
4270268|NCT00590044|4094602|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4270269|NCT00590044|4094600|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4270270|NCT00590044|4094601|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4270271|NCT00590044|4094602|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4270272|NCT00590044|4094600|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4270273|NCT00590044|4094601|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4270274|NCT00590044|4094602|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4270275|NCT00590044|4094600|B3|||Age||years|Mean|38.5|38.5|Standard Deviation|12|12.0|||
4270276|NCT00590044|4094601|B2|||Age||years|Mean|38|38.0|Standard Deviation|12|12.0|||
4270277|NCT00590044|4094602|B1|||Age||years|Mean|39|39.0|Standard Deviation|12|12.0|||
4270278|NCT00590044|4094600|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4270279|NCT00590044|4094601|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4270280|NCT00590044|4094602|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4270281|NCT00590044|4094600|B3||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
4270282|NCT00590044|4094601|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4270283|NCT00590044|4094602|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4270284|NCT00590044|4094600|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270285|NCT00590044|4094601|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270286|NCT00590044|4094602|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270287|NCT00590031|4094615|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4270288|NCT00590031|4094615|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4270289|NCT00590031|4094615|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4270290|NCT00590031|4094615|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4270291|NCT00590031|4094615|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4270292|NCT00590031|4094615|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270293|NCT00590018|4094620|B3|||Inotrope score|Inotrope score: epinephrine (mcg/kg/min x 100) + norepinephrine (mcg/kg/min x 100) + phenylephrine (mcg/kg/min x 100) + dopamine (mcg/kg/min x1) + dobutamine (mcg/kg/min x 1) + milrinone (mcg/kg/min x15). The higher the score the higher the inotrope requirements and generally the sicker the patient. Minimum would be 0. Maximum would be 85.|units on a scale|Mean|22.78|22.78|Standard Deviation|3.12|3.12|||
4270550|NCT00589693|4094773|B1||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
4270294|NCT00590018|4094621|B2|||Inotrope score|Inotrope score: epinephrine (mcg/kg/min x 100) + norepinephrine (mcg/kg/min x 100) + phenylephrine (mcg/kg/min x 100) + dopamine (mcg/kg/min x1) + dobutamine (mcg/kg/min x 1) + milrinone (mcg/kg/min x15). The higher the score the higher the inotrope requirements and generally the sicker the patient. Minimum would be 0. Maximum would be 85.|units on a scale|Mean|22.11|22.11|Standard Deviation|2.31|2.31|||
4270295|NCT00590018|4094622|B1|||Inotrope score|Inotrope score: epinephrine (mcg/kg/min x 100) + norepinephrine (mcg/kg/min x 100) + phenylephrine (mcg/kg/min x 100) + dopamine (mcg/kg/min x1) + dobutamine (mcg/kg/min x 1) + milrinone (mcg/kg/min x15). The higher the score the higher the inotrope requirements and generally the sicker the patient. Minimum would be 0. Maximum would be 85.|units on a scale|Mean|23.46|23.46|Standard Deviation|3.79|3.79|||
4270296|NCT00590018|4094620|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4270297|NCT00590018|4094621|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4270298|NCT00590018|4094622|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4270299|NCT00590018|4094620|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4270300|NCT00590018|4094621|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4270301|NCT00590018|4094622|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4270302|NCT00590018|4094620|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4270303|NCT00590018|4094621|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4270304|NCT00590018|4094622|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4270305|NCT00590018|4094620|B3|||Age||days|Mean|8.5|8.5|Standard Deviation|7.94|7.94|||
4270306|NCT00590018|4094621|B2|||Age||days|Mean|7|7.0|Standard Deviation|4.12|4.12|||
4270307|NCT00590018|4094622|B1|||Age||days|Mean|10|10.0|Standard Deviation|10.58|10.58|||
4270308|NCT00590018|4094620|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4270309|NCT00590018|4094621|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4270310|NCT00590018|4094622|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4270311|NCT00590018|4094620|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4270312|NCT00590018|4094621|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4270313|NCT00590018|4094622|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4270314|NCT00590018|4094620|B3||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
4270315|NCT00590018|4094621|B2||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4270316|NCT00590018|4094622|B1||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4270317|NCT00590005|4094631|B1|United States||Region of Enrollment||participants|Number|225|225.0||||||
4270318|NCT00590005|4094631|B1||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4270319|NCT00590005|4094631|B1||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4270320|NCT00590005|4094631|B1|||Age||years|Mean|11.8|11.8|Standard Deviation|3.6|3.6|||
4270321|NCT00590005|4094631|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4270322|NCT00590005|4094631|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4270323|NCT00590005|4094631|B1||<=18 years|Age||Participants|Count of Participants|225|225.0||||||
4270324|NCT00589979|4094640|B3|United States||Region of Enrollment||participants|Number|93|93.0||||||
4270325|NCT00589979|4094641|B2|United States||Region of Enrollment||participants|Number|43|43.0||||||
4270326|NCT00589979|4094642|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4270327|NCT00589979|4094640|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4270328|NCT00589979|4094641|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4270329|NCT00589979|4094642|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4270330|NCT00589979|4094640|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4270331|NCT00589979|4094641|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4270332|NCT00589979|4094642|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4270333|NCT00589979|4094640|B3|||Age||years|Mean|61.1|61.1|Standard Deviation|10.4|10.4|||
4270334|NCT00589979|4094641|B2|||Age||years|Mean|61.1|61.1|Standard Deviation|10.9|10.9|||
4270335|NCT00589979|4094642|B1|||Age||years|Mean|61.1|61.1|Standard Deviation|10.0|10.0|||
4270336|NCT00589914|4094681|B3|<18 years||AgeCategorical||participants|Number|0|0.0||||||
4270337|NCT00589914|4094682|B2|<18 years||AgeCategorical||participants|Number|0|0.0||||||
4270338|NCT00589914|4094683|B1|<18 years||AgeCategorical||participants|Number|0|0.0||||||
4270339|NCT00589914|4094681|B3|>65 years||AgeCategorical||participants|Number|13|13.0||||||
4270340|NCT00589914|4094682|B2|>65 years||AgeCategorical||participants|Number|6|6.0||||||
4270341|NCT00589914|4094683|B1|>65 years||AgeCategorical||participants|Number|7|7.0||||||
4270342|NCT00589914|4094681|B3|51-65 years||AgeCategorical||participants|Number|228|228.0||||||
4270343|NCT00589914|4094682|B2|51-65 years||AgeCategorical||participants|Number|113|113.0||||||
4270344|NCT00589914|4094683|B1|51-65 years||AgeCategorical||participants|Number|115|115.0||||||
4270345|NCT00589914|4094681|B3|26-50 years||AgeCategorical||participants|Number|778|778.0||||||
4270346|NCT00589914|4094682|B2|26-50 years||AgeCategorical||participants|Number|397|397.0||||||
4270347|NCT00589914|4094683|B1|26-50 years||AgeCategorical||participants|Number|381|381.0||||||
4270348|NCT00589914|4094681|B3|18-25 years||AgeCategorical||participants|Number|195|195.0||||||
4270349|NCT00589914|4094682|B2|18-25 years||AgeCategorical||participants|Number|92|92.0||||||
4270350|NCT00589914|4094683|B1|18-25 years||AgeCategorical||participants|Number|103|103.0||||||
4270351|NCT00589914|4094681|B3|United States of America||Region of Enrollment||participants|Number|269|269.0||||||
4270352|NCT00589914|4094682|B2|United States of America||Region of Enrollment||participants|Number|137|137.0||||||
4270353|NCT00589914|4094683|B1|United States of America||Region of Enrollment||participants|Number|132|132.0||||||
4270354|NCT00589914|4094681|B3|Ukraine||Region of Enrollment||participants|Number|168|168.0||||||
4270355|NCT00589914|4094682|B2|Ukraine||Region of Enrollment||participants|Number|84|84.0||||||
4270356|NCT00589914|4094683|B1|Ukraine||Region of Enrollment||participants|Number|84|84.0||||||
4270357|NCT00589914|4094681|B3|Spain||Region of Enrollment||participants|Number|34|34.0||||||
4270358|NCT00589914|4094682|B2|Spain||Region of Enrollment||participants|Number|17|17.0||||||
4270359|NCT00589914|4094683|B1|Spain||Region of Enrollment||participants|Number|17|17.0||||||
4270360|NCT00589914|4094681|B3|Russia||Region of Enrollment||participants|Number|318|318.0||||||
4270361|NCT00589914|4094682|B2|Russia||Region of Enrollment||participants|Number|159|159.0||||||
4270362|NCT00589914|4094683|B1|Russia||Region of Enrollment||participants|Number|159|159.0||||||
4270363|NCT00589914|4094681|B3|Poland||Region of Enrollment||participants|Number|44|44.0||||||
4270364|NCT00589914|4094682|B2|Poland||Region of Enrollment||participants|Number|20|20.0||||||
4270365|NCT00589914|4094683|B1|Poland||Region of Enrollment||participants|Number|24|24.0||||||
4270366|NCT00589914|4094681|B3|Lithuania||Region of Enrollment||participants|Number|37|37.0||||||
4270367|NCT00589914|4094682|B2|Lithuania||Region of Enrollment||participants|Number|20|20.0||||||
4270368|NCT00589914|4094683|B1|Lithuania||Region of Enrollment||participants|Number|17|17.0||||||
4270369|NCT00589914|4094681|B3|India||Region of Enrollment||participants|Number|62|62.0||||||
4270370|NCT00589914|4094682|B2|India||Region of Enrollment||participants|Number|31|31.0||||||
4270371|NCT00589914|4094683|B1|India||Region of Enrollment||participants|Number|31|31.0||||||
4270372|NCT00589914|4094681|B3|Hungary||Region of Enrollment||participants|Number|65|65.0||||||
4270373|NCT00589914|4094682|B2|Hungary||Region of Enrollment||participants|Number|34|34.0||||||
4270374|NCT00589914|4094683|B1|Hungary||Region of Enrollment||participants|Number|31|31.0||||||
4270375|NCT00589914|4094681|B3|Germany||Region of Enrollment||participants|Number|8|8.0||||||
4270376|NCT00589914|4094682|B2|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4270377|NCT00589914|4094683|B1|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4270378|NCT00589914|4094681|B3|France||Region of Enrollment||participants|Number|10|10.0||||||
4270379|NCT00589914|4094682|B2|France||Region of Enrollment||participants|Number|3|3.0||||||
4270380|NCT00589914|4094683|B1|France||Region of Enrollment||participants|Number|7|7.0||||||
4270381|NCT00589914|4094681|B3|Estonia||Region of Enrollment||participants|Number|66|66.0||||||
4270382|NCT00589914|4094682|B2|Estonia||Region of Enrollment||participants|Number|34|34.0||||||
4270383|NCT00589914|4094683|B1|Estonia||Region of Enrollment||participants|Number|32|32.0||||||
4270384|NCT00589914|4094681|B3|Czech Republic||Region of Enrollment||participants|Number|98|98.0||||||
4270385|NCT00589914|4094682|B2|Czech Republic||Region of Enrollment||participants|Number|48|48.0||||||
4270386|NCT00589914|4094683|B1|Czech Republic||Region of Enrollment||participants|Number|50|50.0||||||
4270387|NCT00589914|4094681|B3|Bulgaria||Region of Enrollment||participants|Number|29|29.0||||||
4270388|NCT00589914|4094682|B2|Bulgaria||Region of Enrollment||participants|Number|14|14.0||||||
4270389|NCT00589914|4094683|B1|Bulgaria||Region of Enrollment||participants|Number|15|15.0||||||
4270390|NCT00589914|4094681|B3|Austria||Region of Enrollment||participants|Number|6|6.0||||||
4270391|NCT00589914|4094682|B2|Austria||Region of Enrollment||participants|Number|3|3.0||||||
4270392|NCT00589914|4094683|B1|Austria||Region of Enrollment||participants|Number|3|3.0||||||
4270393|NCT00589914|4094681|B3||Male|Sex: Female, Male||Participants|Count of Participants|701|701.0||||||
4270394|NCT00589914|4094682|B2||Male|Sex: Female, Male||Participants|Count of Participants|340|340.0||||||
4270395|NCT00589914|4094683|B1||Male|Sex: Female, Male||Participants|Count of Participants|361|361.0||||||
4270396|NCT00589914|4094681|B3||Female|Sex: Female, Male||Participants|Count of Participants|513|513.0||||||
4270397|NCT00589914|4094682|B2||Female|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
4270398|NCT00589914|4094683|B1||Female|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4270399|NCT00589914|4094681|B3|||Age||years|Mean|38.9|38.9|Standard Deviation|11.98|11.98|||
4270400|NCT00589914|4094682|B2|||Age||years|Mean|38.7|38.7|Standard Deviation|11.83|11.83|||
4270401|NCT00589914|4094683|B1|||Age||years|Mean|39|39.0|Standard Deviation|12.13|12.13|||
4270402|NCT00589914|4094681|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4270403|NCT00589914|4094682|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4270404|NCT00589914|4094683|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4270405|NCT00589914|4094681|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1195|1195.0||||||
4270406|NCT00589914|4094682|B2||Between 18 and 65 years|Age||Participants|Count of Participants|599|599.0||||||
4270407|NCT00589914|4094683|B1||Between 18 and 65 years|Age||Participants|Count of Participants|596|596.0||||||
4270408|NCT00589914|4094681|B3||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4270409|NCT00589914|4094682|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4270410|NCT00589914|4094683|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4270452|NCT00589797|4094738|B3|SF-36 PCS||Short-Form (36) Health Questionnaire (SF-36) Scores|Scores on a scale from 0 (maximum disability) to 100 (no disability) for mental component summary (MCS) and physical component summary (PCS)|units on a scale|Mean|29.2|29.2|Standard Deviation|6.2|6.2|||
4270453|NCT00589797|4094739|B2|SF-36 PCS||Short-Form (36) Health Questionnaire (SF-36) Scores|Scores on a scale from 0 (maximum disability) to 100 (no disability) for mental component summary (MCS) and physical component summary (PCS)|units on a scale|Mean|28.4|28.4|Standard Deviation|6.2|6.2|||
4270411|NCT00589888|4094694|B1|||Baseline Flow-mediated dilatation (FMD) of Brachial Artery|FMD was assessed as a measurement of endothelial function. Ultrasound images of the brachial artery were obtained at baseline under standardized conditions and 60 s after induction of reactive hyperemia by 5-min cuff occlusion of the forearm. All images were digitized online, and arterial diameters were measured with customized software by individuals blinded to the clinical and laboratory status of the subjects. Flow-mediated dilatation (FMD) was expressed as the percentage increase in diameter from baseline. Itis measured in percentage|percentage|Mean|9.4|9.4|Standard Deviation|2.7|2.7|||
4270412|NCT00589888|4094694|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4270413|NCT00589888|4094694|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4270414|NCT00589888|4094694|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4270415|NCT00589888|4094694|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4270416|NCT00589888|4094694|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4270417|NCT00589888|4094694|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4270418|NCT00589888|4094694|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4270419|NCT00589888|4094694|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4270420|NCT00589888|4094694|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4270421|NCT00589888|4094694|B1|||Age||years|Mean|32.2|32.2|Standard Deviation|9.8|9.8|||
4270422|NCT00589849|4094730|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4270423|NCT00589849|4094730|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4270424|NCT00589849|4094730|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4270425|NCT00589849|4094730|B1|||Age||years|Mean|58|58.0|Standard Deviation|13.04|13.04|||
4270426|NCT00589849|4094730|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4270427|NCT00589849|4094730|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4270428|NCT00589849|4094730|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270429|NCT00589836|4094734|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4270430|NCT00589836|4094734|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4270431|NCT00589836|4094734|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4270432|NCT00589836|4094734|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4270433|NCT00589836|4094734|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270434|NCT00589797|4094738|B3|Reflexes||Normal Neurological Status|Number of subjects meeting the following criteria for normal status: Motor - Grade 5 (active movement vs. full resistance); Sensory - Grade 2 (normal); Reflexes - Grade 2 (normal)|participants|Number|133|133.0||||||
4270435|NCT00589797|4094739|B2|Reflexes||Normal Neurological Status|Number of subjects meeting the following criteria for normal status: Motor - Grade 5 (active movement vs. full resistance); Sensory - Grade 2 (normal); Reflexes - Grade 2 (normal)|participants|Number|42|42.0||||||
4270436|NCT00589797|4094740|B1|Reflexes||Normal Neurological Status|Number of subjects meeting the following criteria for normal status: Motor - Grade 5 (active movement vs. full resistance); Sensory - Grade 2 (normal); Reflexes - Grade 2 (normal)|participants|Number|91|91.0||||||
4270437|NCT00589797|4094738|B3|Sensory||Normal Neurological Status|Number of subjects meeting the following criteria for normal status: Motor - Grade 5 (active movement vs. full resistance); Sensory - Grade 2 (normal); Reflexes - Grade 2 (normal)|participants|Number|111|111.0||||||
4270438|NCT00589797|4094739|B2|Sensory||Normal Neurological Status|Number of subjects meeting the following criteria for normal status: Motor - Grade 5 (active movement vs. full resistance); Sensory - Grade 2 (normal); Reflexes - Grade 2 (normal)|participants|Number|33|33.0||||||
4270439|NCT00589797|4094740|B1|Sensory||Normal Neurological Status|Number of subjects meeting the following criteria for normal status: Motor - Grade 5 (active movement vs. full resistance); Sensory - Grade 2 (normal); Reflexes - Grade 2 (normal)|participants|Number|78|78.0||||||
4270440|NCT00589797|4094738|B3|Motor||Normal Neurological Status|Number of subjects meeting the following criteria for normal status: Motor - Grade 5 (active movement vs. full resistance); Sensory - Grade 2 (normal); Reflexes - Grade 2 (normal)|participants|Number|137|137.0||||||
4270441|NCT00589797|4094739|B2|Motor||Normal Neurological Status|Number of subjects meeting the following criteria for normal status: Motor - Grade 5 (active movement vs. full resistance); Sensory - Grade 2 (normal); Reflexes - Grade 2 (normal)|participants|Number|40|40.0||||||
4270442|NCT00589797|4094740|B1|Motor||Normal Neurological Status|Number of subjects meeting the following criteria for normal status: Motor - Grade 5 (active movement vs. full resistance); Sensory - Grade 2 (normal); Reflexes - Grade 2 (normal)|participants|Number|97|97.0||||||
4270443|NCT00589797|4094738|B3|||Translational Range of Motion||millimeters|Mean|0.6|0.6|Standard Deviation|0.6|0.6|||
4270444|NCT00589797|4094739|B2|||Translational Range of Motion||millimeters|Mean|0.6|0.6|Standard Deviation|0.6|0.6|||
4270445|NCT00589797|4094740|B1|||Translational Range of Motion||millimeters|Mean|0.5|0.5|Standard Deviation|0.7|0.7|||
4270446|NCT00589797|4094738|B3|Lateral Bending AP||Rotational Range of Motion||degrees|Mean|1.0|1.0|Standard Deviation|1.9|1.9|||
4270447|NCT00589797|4094739|B2|Lateral Bending AP||Rotational Range of Motion||degrees|Mean|1.0|1.0|Standard Deviation|1.8|1.8|||
4270448|NCT00589797|4094740|B1|Lateral Bending AP||Rotational Range of Motion||degrees|Mean|1.0|1.0|Standard Deviation|2.0|2.0|||
4270449|NCT00589797|4094738|B3|Flexion/Extension||Rotational Range of Motion||degrees|Mean|6.6|6.6|Standard Deviation|4.8|4.8|||
4270450|NCT00589797|4094739|B2|Flexion/Extension||Rotational Range of Motion||degrees|Mean|6.6|6.6|Standard Deviation|4.6|4.6|||
4270451|NCT00589797|4094740|B1|Flexion/Extension||Rotational Range of Motion||degrees|Mean|6.6|6.6|Standard Deviation|5.1|5.1|||
4270491|NCT00589797|4094738|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)|All enrolled subjects|Participants|Count of Participants|0|0.0||||||
4270454|NCT00589797|4094740|B1|SF-36 PCS||Short-Form (36) Health Questionnaire (SF-36) Scores|Scores on a scale from 0 (maximum disability) to 100 (no disability) for mental component summary (MCS) and physical component summary (PCS)|units on a scale|Mean|29.9|29.9|Standard Deviation|6.2|6.2|||
4270455|NCT00589797|4094738|B3|SF-36 MCS||Short-Form (36) Health Questionnaire (SF-36) Scores|Scores on a scale from 0 (maximum disability) to 100 (no disability) for mental component summary (MCS) and physical component summary (PCS)|units on a scale|Mean|39.4|39.4|Standard Deviation|14.4|14.4|||
4270456|NCT00589797|4094739|B2|SF-36 MCS||Short-Form (36) Health Questionnaire (SF-36) Scores|Scores on a scale from 0 (maximum disability) to 100 (no disability) for mental component summary (MCS) and physical component summary (PCS)|units on a scale|Mean|39.6|39.6|Standard Deviation|14.9|14.9|||
4270457|NCT00589797|4094740|B1|SF-36 MCS||Short-Form (36) Health Questionnaire (SF-36) Scores|Scores on a scale from 0 (maximum disability) to 100 (no disability) for mental component summary (MCS) and physical component summary (PCS)|units on a scale|Mean|39.1|39.1|Standard Deviation|13.9|13.9|||
4270458|NCT00589797|4094738|B3|VAS Left Leg Pain||Visual Analog Scale (VAS) Ratings for Back and Leg Pain|Ratings on a scale from 0 (no pain) to 100 (worst possible pain)|units on a scale|Mean|30.4|30.4|Standard Deviation|29.6|29.6|||
4270459|NCT00589797|4094739|B2|VAS Left Leg Pain||Visual Analog Scale (VAS) Ratings for Back and Leg Pain|Ratings on a scale from 0 (no pain) to 100 (worst possible pain)|units on a scale|Mean|30.7|30.7|Standard Deviation|29.5|29.5|||
4270460|NCT00589797|4094740|B1|VAS Left Leg Pain||Visual Analog Scale (VAS) Ratings for Back and Leg Pain|Ratings on a scale from 0 (no pain) to 100 (worst possible pain)|units on a scale|Mean|29.6|29.6|Standard Deviation|29.4|29.4|||
4270461|NCT00589797|4094738|B3|VAS Right Leg Pain||Visual Analog Scale (VAS) Ratings for Back and Leg Pain|Ratings on a scale from 0 (no pain) to 100 (worst possible pain)|units on a scale|Mean|30.6|30.6|Standard Deviation|30.0|30.0|||
4270462|NCT00589797|4094739|B2|VAS Right Leg Pain||Visual Analog Scale (VAS) Ratings for Back and Leg Pain|Ratings on a scale from 0 (no pain) to 100 (worst possible pain)|units on a scale|Mean|32.9|32.9|Standard Deviation|29.6|29.6|||
4270463|NCT00589797|4094740|B1|VAS Right Leg Pain||Visual Analog Scale (VAS) Ratings for Back and Leg Pain|Ratings on a scale from 0 (no pain) to 100 (worst possible pain)|units on a scale|Mean|28.7|28.7|Standard Deviation|29.8|29.8|||
4270464|NCT00589797|4094738|B3|VAS Back Pain||Visual Analog Scale (VAS) Ratings for Back and Leg Pain|Ratings on a scale from 0 (no pain) to 100 (worst possible pain)|units on a scale|Mean|79.1|79.1|Standard Deviation|14.8|14.8|||
4270465|NCT00589797|4094739|B2|VAS Back Pain||Visual Analog Scale (VAS) Ratings for Back and Leg Pain|Ratings on a scale from 0 (no pain) to 100 (worst possible pain)|units on a scale|Mean|79.1|79.1|Standard Deviation|14.8|14.8|||
4270466|NCT00589797|4094740|B1|VAS Back Pain||Visual Analog Scale (VAS) Ratings for Back and Leg Pain|Ratings on a scale from 0 (no pain) to 100 (worst possible pain)|units on a scale|Mean|79.0|79.0|Standard Deviation|14.9|14.9|||
4270467|NCT00589797|4094738|B3|||Oswestry Disability Index (ODI) Scores for Low Back Pain|Scores on a scale from 0 (minimal disability) to 100 (bed-bound)|units on a scale|Mean|57.9|57.9|Standard Deviation|13.9|13.9|||
4270468|NCT00589797|4094739|B2|||Oswestry Disability Index (ODI) Scores for Low Back Pain|Scores on a scale from 0 (minimal disability) to 100 (bed-bound)|units on a scale|Mean|58.6|58.6|Standard Deviation|14.1|14.1|||
4270469|NCT00589797|4094740|B1|||Oswestry Disability Index (ODI) Scores for Low Back Pain|Scores on a scale from 0 (minimal disability) to 100 (bed-bound)|units on a scale|Mean|57.1|57.1|Standard Deviation|13.9|13.9|||
4270470|NCT00589797|4094738|B3||Unknown or Not Reported|Race (NIH/OMB)|All enrolled subjects|Participants|Count of Participants|8|8.0||||||
4270471|NCT00589797|4094739|B2||Unknown or Not Reported|Race (NIH/OMB)|All enrolled subjects|Participants|Count of Participants|1|1.0||||||
4270472|NCT00589797|4094740|B1||Unknown or Not Reported|Race (NIH/OMB)|All enrolled subjects|Participants|Count of Participants|7|7.0||||||
4270473|NCT00589797|4094738|B3||More than one race|Race (NIH/OMB)|All enrolled subjects|Participants|Count of Participants|0|0.0||||||
4270474|NCT00589797|4094739|B2||More than one race|Race (NIH/OMB)|All enrolled subjects|Participants|Count of Participants|0|0.0||||||
4270475|NCT00589797|4094740|B1||More than one race|Race (NIH/OMB)|All enrolled subjects|Participants|Count of Participants|0|0.0||||||
4270476|NCT00589797|4094738|B3||White|Race (NIH/OMB)|All enrolled subjects|Participants|Count of Participants|339|339.0||||||
4270477|NCT00589797|4094739|B2||White|Race (NIH/OMB)|All enrolled subjects|Participants|Count of Participants|106|106.0||||||
4270478|NCT00589797|4094740|B1||White|Race (NIH/OMB)|All enrolled subjects|Participants|Count of Participants|233|233.0||||||
4270479|NCT00589797|4094738|B3||Black or African American|Race (NIH/OMB)|All enrolled subjects|Participants|Count of Participants|23|23.0||||||
4270480|NCT00589797|4094739|B2||Black or African American|Race (NIH/OMB)|All enrolled subjects|Participants|Count of Participants|5|5.0||||||
4270481|NCT00589797|4094740|B1||Black or African American|Race (NIH/OMB)|All enrolled subjects|Participants|Count of Participants|18|18.0||||||
4270482|NCT00589797|4094738|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|All enrolled subjects|Participants|Count of Participants|0|0.0||||||
4270483|NCT00589797|4094739|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|All enrolled subjects|Participants|Count of Participants|0|0.0||||||
4270484|NCT00589797|4094740|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|All enrolled subjects|Participants|Count of Participants|0|0.0||||||
4270485|NCT00589797|4094738|B3||Asian|Race (NIH/OMB)|All enrolled subjects|Participants|Count of Participants|3|3.0||||||
4270486|NCT00589797|4094739|B2||Asian|Race (NIH/OMB)|All enrolled subjects|Participants|Count of Participants|0|0.0||||||
4270487|NCT00589797|4094740|B1||Asian|Race (NIH/OMB)|All enrolled subjects|Participants|Count of Participants|3|3.0||||||
4270488|NCT00589797|4094738|B3||American Indian or Alaska Native|Race (NIH/OMB)|All enrolled subjects|Participants|Count of Participants|3|3.0||||||
4270489|NCT00589797|4094739|B2||American Indian or Alaska Native|Race (NIH/OMB)|All enrolled subjects|Participants|Count of Participants|0|0.0||||||
4270490|NCT00589797|4094740|B1||American Indian or Alaska Native|Race (NIH/OMB)|All enrolled subjects|Participants|Count of Participants|3|3.0||||||
4270492|NCT00589797|4094739|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)|All enrolled subjects|Participants|Count of Participants|0|0.0||||||
4270493|NCT00589797|4094740|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|All enrolled subjects|Participants|Count of Participants|0|0.0||||||
4270494|NCT00589797|4094738|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)|All enrolled subjects|Participants|Count of Participants|335|335.0||||||
4270495|NCT00589797|4094739|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)|All enrolled subjects|Participants|Count of Participants|100|100.0||||||
4270496|NCT00589797|4094740|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|All enrolled subjects|Participants|Count of Participants|235|235.0||||||
4270497|NCT00589797|4094738|B3||Hispanic or Latino|Ethnicity (NIH/OMB)|All enrolled subjects|Participants|Count of Participants|41|41.0||||||
4270498|NCT00589797|4094739|B2||Hispanic or Latino|Ethnicity (NIH/OMB)|All enrolled subjects|Participants|Count of Participants|12|12.0||||||
4270499|NCT00589797|4094740|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|All enrolled subjects|Participants|Count of Participants|29|29.0||||||
4270500|NCT00589797|4094738|B3||Male|Sex: Female, Male|All enrolled subjects|Participants|Count of Participants|196|196.0||||||
4270501|NCT00589797|4094739|B2||Male|Sex: Female, Male|All enrolled subjects|Participants|Count of Participants|56|56.0||||||
4270502|NCT00589797|4094740|B1||Male|Sex: Female, Male|All enrolled subjects|Participants|Count of Participants|140|140.0||||||
4270503|NCT00589797|4094738|B3||Female|Sex: Female, Male|All enrolled subjects|Participants|Count of Participants|180|180.0||||||
4270504|NCT00589797|4094739|B2||Female|Sex: Female, Male|All enrolled subjects|Participants|Count of Participants|56|56.0||||||
4270505|NCT00589797|4094740|B1||Female|Sex: Female, Male|All enrolled subjects|Participants|Count of Participants|124|124.0||||||
4270506|NCT00589797|4094738|B3|||Age|All enrolled subjects|years|Mean|39.6|39.6|Standard Deviation|8.6|8.6|||
4270507|NCT00589797|4094739|B2|||Age|All enrolled subjects|years|Mean|40.0|40.0|Standard Deviation|8.6|8.6|||
4270508|NCT00589797|4094740|B1|||Age|All enrolled subjects|years|Mean|39.1|39.1|Standard Deviation|8.6|8.6|||
4270509|NCT00589797|4094738|B3||>=65 years|Age|All enrolled subjects|Participants|Count of Participants|0|0.0||||||
4270510|NCT00589797|4094739|B2||>=65 years|Age|All enrolled subjects|Participants|Count of Participants|0|0.0||||||
4270511|NCT00589797|4094740|B1||>=65 years|Age|All enrolled subjects|Participants|Count of Participants|0|0.0||||||
4270512|NCT00589797|4094738|B3||Between 18 and 65 years|Age|All enrolled subjects|Participants|Count of Participants|376|376.0||||||
4270513|NCT00589797|4094739|B2||Between 18 and 65 years|Age|All enrolled subjects|Participants|Count of Participants|112|112.0||||||
4270514|NCT00589797|4094740|B1||Between 18 and 65 years|Age|All enrolled subjects|Participants|Count of Participants|264|264.0||||||
4270515|NCT00589797|4094738|B3||<=18 years|Age|All enrolled subjects|Participants|Count of Participants|0|0.0||||||
4270516|NCT00589797|4094739|B2||<=18 years|Age|All enrolled subjects|Participants|Count of Participants|0|0.0||||||
4270517|NCT00589797|4094740|B1||<=18 years|Age|All enrolled subjects|Participants|Count of Participants|0|0.0||||||
4270518|NCT00589784|4094763|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4270519|NCT00589784|4094764|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4270520|NCT00589784|4094765|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4270521|NCT00589784|4094763|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4270522|NCT00589784|4094764|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4270523|NCT00589784|4094765|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4270524|NCT00589784|4094763|B3|Median Age||Age, Customized||years|Median|59|59.0|Full Range|||27.0|85.0|
4270525|NCT00589784|4094764|B2|Median Age||Age, Customized||years|Median|48|48.0|Full Range|||32.0|79.0|
4270526|NCT00589784|4094765|B1|Median Age||Age, Customized||years|Median|61|61.0|Full Range|||27.0|85.0|
4270527|NCT00589693|4094771|B3|SOUTH AMERICA||Region Enroll||participants|Number|44|44.0||||||
4270528|NCT00589693|4094772|B2|SOUTH AMERICA||Region Enroll||participants|Number|23|23.0||||||
4270529|NCT00589693|4094773|B1|SOUTH AMERICA||Region Enroll||participants|Number|21|21.0||||||
4270530|NCT00589693|4094771|B3|REST OF WORLD||Region Enroll||participants|Number|15|15.0||||||
4270531|NCT00589693|4094772|B2|REST OF WORLD||Region Enroll||participants|Number|6|6.0||||||
4270532|NCT00589693|4094773|B1|REST OF WORLD||Region Enroll||participants|Number|9|9.0||||||
4270533|NCT00589693|4094771|B3|NORTH AMERICA||Region Enroll||participants|Number|28|28.0||||||
4270534|NCT00589693|4094772|B2|NORTH AMERICA||Region Enroll||participants|Number|12|12.0||||||
4270535|NCT00589693|4094773|B1|NORTH AMERICA||Region Enroll||participants|Number|16|16.0||||||
4270536|NCT00589693|4094771|B3|EUROPE||Region Enroll||participants|Number|140|140.0||||||
4270537|NCT00589693|4094772|B2|EUROPE||Region Enroll||participants|Number|71|71.0||||||
4270538|NCT00589693|4094773|B1|EUROPE||Region Enroll||participants|Number|69|69.0||||||
4270539|NCT00589693|4094771|B3||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4270540|NCT00589693|4094772|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4270541|NCT00589693|4094773|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4270542|NCT00589693|4094771|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4270543|NCT00589693|4094772|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4270544|NCT00589693|4094773|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4270545|NCT00589693|4094771|B3|||Age||years|Mean|56.1|56.1|Standard Deviation|17.53|17.53|||
4270546|NCT00589693|4094772|B2|||Age||years|Mean|54.6|54.6|Standard Deviation|18.46|18.46|||
4270547|NCT00589693|4094773|B1|||Age||years|Mean|57.5|57.5|Standard Deviation|16.53|16.53|||
4270548|NCT00589693|4094771|B3||>=65 years|Age||Participants|Count of Participants|82|82.0||||||
4270549|NCT00589693|4094772|B2||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4270551|NCT00589693|4094771|B3||Between 18 and 65 years|Age||Participants|Count of Participants|144|144.0||||||
4270552|NCT00589693|4094772|B2||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
4270553|NCT00589693|4094773|B1||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
4270554|NCT00589693|4094771|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4270555|NCT00589693|4094772|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4270556|NCT00589693|4094773|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270557|NCT00589667|4094788|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4270558|NCT00589667|4094788|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4270559|NCT00589667|4094788|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4270560|NCT00589667|4094788|B1|||Age||years|Mean|52.5|52.5|Standard Deviation|43.13351365|43.13351365|||
4270561|NCT00589667|4094788|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4270562|NCT00589667|4094788|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4270563|NCT00589667|4094788|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270564|NCT00589628|4094793|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4270565|NCT00589628|4094794|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4270566|NCT00589628|4094795|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4270567|NCT00589628|4094793|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4270568|NCT00589628|4094794|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4270569|NCT00589628|4094795|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4270570|NCT00589628|4094793|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4270571|NCT00589628|4094794|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4270572|NCT00589628|4094795|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4270573|NCT00589628|4094793|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4270574|NCT00589628|4094794|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4270575|NCT00589628|4094795|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4270576|NCT00589628|4094793|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4270577|NCT00589628|4094794|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4270578|NCT00589628|4094795|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4270579|NCT00589628|4094793|B3||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4270580|NCT00589628|4094794|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4270581|NCT00589628|4094795|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4270582|NCT00589602|4094802|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4270583|NCT00589602|4094802|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4270584|NCT00589602|4094802|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4270585|NCT00589602|4094802|B1|||Age||years|Median|46|46.0|Full Range|||18.0|58.0|
4270586|NCT00589602|4094802|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4270587|NCT00589602|4094802|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4270588|NCT00589602|4094802|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4270589|NCT00589563|4094810|B1|Others||Patient/donor sex match||participants|Number|29|29.0||||||
4270590|NCT00589563|4094810|B1|Male patient/Female donor||Patient/donor sex match||participants|Number|3|3.0||||||
4270591|NCT00589563|4094810|B1|Fractionated Total Body Irradiation/Etoposide||Conditioning Regimen||participants|Number|5|5.0||||||
4270592|NCT00589563|4094810|B1|Fractionated Total Body Irradiation/Cytoxan||Conditioning Regimen||participants|Number|4|4.0||||||
4270593|NCT00589563|4094810|B1|Fludarabine/Melphalan||Conditioning Regimen||participants|Number|23|23.0||||||
4270594|NCT00589563|4094810|B1|3 Mismatches||Human Leukocyte Antigen (HLA) Match Type|All mismatches occur at A, B, C, or DR.|participants|Number|1|1.0||||||
4270595|NCT00589563|4094810|B1|2 Mismatches||Human Leukocyte Antigen (HLA) Match Type|All mismatches occur at A, B, C, or DR.|participants|Number|1|1.0||||||
4270596|NCT00589563|4094810|B1|1 Mismatch||Human Leukocyte Antigen (HLA) Match Type|All mismatches occur at A, B, C, or DR.|participants|Number|12|12.0||||||
4270597|NCT00589563|4094810|B1|10/10 Matched||Human Leukocyte Antigen (HLA) Match Type|All mismatches occur at A, B, C, or DR.|participants|Number|18|18.0||||||
4270598|NCT00589563|4094810|B1|Negative/Positive||Patient/Donor Cytomegalovirus (CMV) infection status|Patient CMV status listed first followed by Donor CMV status. Both are determined at time of transplant.|participants|Number|5|5.0||||||
4270599|NCT00589563|4094810|B1|Negative/Negative||Patient/Donor Cytomegalovirus (CMV) infection status|Patient CMV status listed first followed by Donor CMV status. Both are determined at time of transplant.|participants|Number|3|3.0||||||
4270600|NCT00589563|4094810|B1|Positive/Positive||Patient/Donor Cytomegalovirus (CMV) infection status|Patient CMV status listed first followed by Donor CMV status. Both are determined at time of transplant.|participants|Number|12|12.0||||||
4270601|NCT00589563|4094810|B1|Positive/Negative||Patient/Donor Cytomegalovirus (CMV) infection status|Patient CMV status listed first followed by Donor CMV status. Both are determined at time of transplant.|participants|Number|12|12.0||||||
4270602|NCT00589563|4094810|B1|High/Intermediate Risk||Disease Status (American Society for Blood and Marrow Transplantation Guidelines)|Disease status at time of transplant.|participants|Number|18|18.0||||||
4270603|NCT00589563|4094810|B1|Standard Risk||Disease Status (American Society for Blood and Marrow Transplantation Guidelines)|Disease status at time of transplant.|participants|Number|14|14.0||||||
4270604|NCT00589563|4094810|B1|Chronic Lymphocytic Leukemia||Diagnosis|Diagnosis at time of transplant.|participants|Number|1|1.0||||||
4270605|NCT00589563|4094810|B1|Myeloproliferative Disorder||Diagnosis|Diagnosis at time of transplant.|participants|Number|2|2.0||||||
4270606|NCT00589563|4094810|B1|Non-Hodgkin Lymphoma||Diagnosis|Diagnosis at time of transplant.|participants|Number|3|3.0||||||
4270607|NCT00589563|4094810|B1|Chronic Myeloid Leukemia||Diagnosis|Diagnosis at time of transplant.|participants|Number|3|3.0||||||
4270608|NCT00589563|4094810|B1|Acute Lymphoblastic Leukemia||Diagnosis|Diagnosis at time of transplant.|participants|Number|3|3.0||||||
4270609|NCT00589563|4094810|B1|Myelodysplastic Syndrome||Diagnosis|Diagnosis at time of transplant.|participants|Number|6|6.0||||||
4270610|NCT00589563|4094810|B1|Acute Myeloid Leukemia||Diagnosis|Diagnosis at time of transplant.|participants|Number|14|14.0||||||
4270611|NCT00589563|4094810|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4270612|NCT00589563|4094810|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4270613|NCT00589563|4094810|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4270614|NCT00589563|4094810|B1|||Age||years|Median|59.5|59.5|Full Range|||19.0|71.0|
4270615|NCT00589550|4094827|B1|United States||Region of Enrollment||patients|Number|1|1.0||||||
4270616|NCT00589550|4094827|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4270617|NCT00589550|4094827|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4270618|NCT00589550|4094827|B1|Age18-60||Age, Customized||patient|Number|1|1.0||||||
4270619|NCT00589472|4094837|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4270620|NCT00589472|4094837|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4270621|NCT00589472|4094837|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4270622|NCT00589472|4094837|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4270623|NCT00589472|4094837|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270624|NCT00589303|4094847|B3|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4270625|NCT00589303|4094848|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4270626|NCT00589303|4094849|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4270627|NCT00589303|4094847|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4270628|NCT00589303|4094848|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4270629|NCT00589303|4094849|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4270630|NCT00589303|4094847|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4270631|NCT00589303|4094848|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4270632|NCT00589303|4094849|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4270633|NCT00589303|4094847|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4270634|NCT00589303|4094848|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4270635|NCT00589303|4094849|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4270636|NCT00589303|4094847|B3||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4270637|NCT00589303|4094848|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4270638|NCT00589303|4094849|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4270639|NCT00589303|4094847|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4270640|NCT00589303|4094848|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4270641|NCT00589303|4094849|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4270642|NCT00589303|4094847|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270643|NCT00589303|4094848|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270644|NCT00589303|4094849|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270645|NCT00589290|4094856|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4270646|NCT00589290|4094856|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4270647|NCT00589290|4094856|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4270648|NCT00589290|4094856|B1|||Age||years|Mean|54.53|54.53|Standard Deviation|13.13|13.13|||
4270649|NCT00589290|4094856|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4270650|NCT00589290|4094856|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4270651|NCT00589290|4094856|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270652|NCT00589277|4094864|B3||Male|Sex: Female, Male||Participants|Count of Participants|879|879.0||||||
4270653|NCT00589277|4094865|B2||Male|Sex: Female, Male||Participants|Count of Participants|332|332.0||||||
4270654|NCT00589277|4094866|B1||Male|Sex: Female, Male||Participants|Count of Participants|547|547.0||||||
4270655|NCT00589277|4094864|B3||Female|Sex: Female, Male||Participants|Count of Participants|1153|1153.0||||||
4270656|NCT00589277|4094865|B2||Female|Sex: Female, Male||Participants|Count of Participants|478|478.0||||||
4270657|NCT00589277|4094866|B1||Female|Sex: Female, Male||Participants|Count of Participants|675|675.0||||||
4270658|NCT00589277|4094864|B3|||Age||years|Mean|46.5|46.5|Standard Deviation|13.7|13.7|||
4270659|NCT00589277|4094865|B2|||Age||years|Mean|47.2|47.2|Standard Deviation|13.4|13.4|||
4270660|NCT00589277|4094866|B1|||Age||years|Mean|46.4|46.4|Standard Deviation|13.9|13.9|||
4270661|NCT00589121|4094877|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4270662|NCT00589121|4094878|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4270663|NCT00589121|4094879|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4270664|NCT00589121|4094877|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4270665|NCT00589121|4094878|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4270666|NCT00589121|4094879|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4270667|NCT00589121|4094877|B3|||Age||years|Median|61|61.0|Full Range|||24.0|88.0|
4270668|NCT00589121|4094878|B2|||Age||years|Median|61|61.0|Full Range|||24.0|88.0|
4270669|NCT00589121|4094879|B1|||Age||years|Median|52|52.0|Full Range|||30.0|71.0|
4270670|NCT00589108|4094897|B4|United States||Region of Enrollment||participants|Number|240|240.0||||||
4270671|NCT00589108|4094898|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
4270672|NCT00589108|4094899|B2|United States||Region of Enrollment||participants|Number|80|80.0||||||
4270673|NCT00589108|4094900|B1|United States||Region of Enrollment||participants|Number|80|80.0||||||
4270674|NCT00589108|4094897|B4||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4270675|NCT00589108|4094898|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4270676|NCT00589108|4094899|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4270677|NCT00589108|4094900|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4270678|NCT00589108|4094897|B4||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4270679|NCT00589108|4094898|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4270680|NCT00589108|4094899|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4270681|NCT00589108|4094900|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4270682|NCT00589108|4094897|B4|||Age||years|Median|68.5|68.5|Full Range|||41.0|81.0|
4270683|NCT00589108|4094898|B3|||Age||years|Median|69.0|69.0|Full Range|||41.0|81.0|
4270684|NCT00589108|4094899|B2|||Age||years|Median|68.5|68.5|Full Range|||41.0|81.0|
4270685|NCT00589108|4094900|B1|||Age||years|Median|69.0|69.0|Full Range|||41.0|81.0|
4270686|NCT00588965|4094922|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4270687|NCT00588965|4094922|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4270688|NCT00588965|4094922|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4270689|NCT00588965|4094922|B1|||Age||years|Mean|32|32.0|Standard Deviation|12|12.0|||
4270690|NCT00588965|4094922|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4270691|NCT00588965|4094922|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4270692|NCT00588965|4094922|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270693|NCT00588952|4094930|B3|United States||Region of Enrollment||participants|Number|99|99.0||||||
4270694|NCT00588952|4094931|B2|United States||Region of Enrollment||participants|Number|70|70.0||||||
4270695|NCT00588952|4094932|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4270696|NCT00588952|4094930|B3||Male|Gender||Participants|Count of Participants|50|50.0||||||
4270697|NCT00588952|4094931|B2||Male|Gender||Participants|Count of Participants|34|34.0||||||
4270698|NCT00588952|4094932|B1||Male|Gender||Participants|Count of Participants|16|16.0||||||
4270699|NCT00588952|4094930|B3||Female|Gender||Participants|Count of Participants|49|49.0||||||
4270700|NCT00588952|4094931|B2||Female|Gender||Participants|Count of Participants|36|36.0||||||
4270701|NCT00588952|4094932|B1||Female|Gender||Participants|Count of Participants|13|13.0||||||
4270702|NCT00588952|4094930|B3|||Age||years|Mean|24.37|24.37|Standard Deviation|2.57|2.57|||
4270703|NCT00588952|4094931|B2|||Age||years|Mean|24.13|24.13|Standard Deviation|2.34|2.34|||
4270704|NCT00588952|4094932|B1|||Age||years|Mean|24.97|24.97|Standard Deviation|3.02|3.02|||
4270705|NCT00588952|4094930|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4270706|NCT00588952|4094931|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4270707|NCT00588952|4094932|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4270708|NCT00588952|4094930|B3||Between 18 and 65 years|Age||Participants|Count of Participants|99|99.0||||||
4270709|NCT00588952|4094931|B2||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4270710|NCT00588952|4094932|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4270711|NCT00588952|4094930|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270712|NCT00588952|4094931|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270713|NCT00588952|4094932|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270714|NCT00588900|4094953|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4270715|NCT00588900|4094953|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4270716|NCT00588900|4094953|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4270717|NCT00588900|4094953|B1|||Age||years|Median|69.9|69.9|Full Range|||52.3|80.9|
4270718|NCT00588861|4094959|B3||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4270719|NCT00588861|4094960|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4270720|NCT00588861|4094961|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4270721|NCT00588861|4094959|B3||Female|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
4270722|NCT00588861|4094960|B2||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4270723|NCT00588861|4094961|B1||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4270724|NCT00588861|4094959|B3|||Age||years|Mean|75|75.0|Full Range|||46.0|95.0|
4270725|NCT00588861|4094960|B2|||Age||years|Mean|76|76.0|Full Range|||54.0|95.0|
4270726|NCT00588861|4094961|B1|||Age||years|Mean|73|73.0|Full Range|||46.0|93.0|
4270727|NCT00588848|4094970|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4270728|NCT00588848|4094971|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4270729|NCT00588848|4094972|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4270730|NCT00588848|4094970|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4270731|NCT00588848|4094971|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4270732|NCT00588848|4094972|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4270733|NCT00588848|4094970|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4270734|NCT00588848|4094971|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4270735|NCT00588848|4094972|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4270736|NCT00588848|4094970|B3|||Age||years|Mean|51.2|51.2|Standard Deviation|8.2|8.2|||
4270737|NCT00588848|4094971|B2|||Age||years|Mean|52.5|52.5|Standard Deviation|7.5|7.5|||
4270738|NCT00588848|4094972|B1|||Age||years|Mean|50.3|50.3|Standard Deviation|9.0|9.0|||
4270739|NCT00588848|4094970|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4270740|NCT00588848|4094971|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4270741|NCT00588848|4094972|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4270742|NCT00588848|4094970|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4270743|NCT00588848|4094971|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4270744|NCT00588848|4094972|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4270745|NCT00588848|4094970|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270746|NCT00588848|4094971|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270747|NCT00588848|4094972|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270748|NCT00588822|4094983|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4270749|NCT00588822|4094983|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4270750|NCT00588822|4094983|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4270751|NCT00588822|4094983|B1|||Age||years|Mean|67.4|67.4|Standard Deviation|7.7|7.7|||
4270752|NCT00588809|4094992|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4270753|NCT00588809|4094992|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4270754|NCT00588809|4094992|B1|||Age||years|Median|69|69.0|Full Range|||26.0|83.0|
4270755|NCT00588731|4095001|B3|Benzodiazepine||Medications||participants|Number|5|5.0||||||
4270756|NCT00588731|4095002|B2|Benzodiazepine||Medications||participants|Number|3|3.0||||||
4270757|NCT00588731|4095003|B1|Benzodiazepine||Medications||participants|Number|2|2.0||||||
4270758|NCT00588731|4095001|B3|Anticonvulsants/Mood Stabilizers||Medications||participants|Number|9|9.0||||||
4270759|NCT00588731|4095002|B2|Anticonvulsants/Mood Stabilizers||Medications||participants|Number|6|6.0||||||
4270760|NCT00588731|4095003|B1|Anticonvulsants/Mood Stabilizers||Medications||participants|Number|3|3.0||||||
4270761|NCT00588731|4095001|B3|Anticholinergic||Medications||participants|Number|14|14.0||||||
4270762|NCT00588731|4095002|B2|Anticholinergic||Medications||participants|Number|7|7.0||||||
4270763|NCT00588731|4095003|B1|Anticholinergic||Medications||participants|Number|7|7.0||||||
4270764|NCT00588731|4095001|B3|Antidepressant||Medications||participants|Number|7|7.0||||||
4270765|NCT00588731|4095002|B2|Antidepressant||Medications||participants|Number|4|4.0||||||
4270766|NCT00588731|4095003|B1|Antidepressant||Medications||participants|Number|3|3.0||||||
4270767|NCT00588731|4095001|B3|Long Acting Injectable Antipsychotics||Medications||participants|Number|9|9.0||||||
4270768|NCT00588731|4095002|B2|Long Acting Injectable Antipsychotics||Medications||participants|Number|6|6.0||||||
4270769|NCT00588731|4095003|B1|Long Acting Injectable Antipsychotics||Medications||participants|Number|3|3.0||||||
4270770|NCT00588731|4095001|B3|Multiple Antipsychotics||Medications||participants|Number|9|9.0||||||
4270771|NCT00588731|4095002|B2|Multiple Antipsychotics||Medications||participants|Number|7|7.0||||||
4270772|NCT00588731|4095003|B1|Multiple Antipsychotics||Medications||participants|Number|2|2.0||||||
4270773|NCT00588731|4095001|B3|Second Generation Antipsychotics||Medications||participants|Number|23|23.0||||||
4270774|NCT00588731|4095002|B2|Second Generation Antipsychotics||Medications||participants|Number|13|13.0||||||
4270775|NCT00588731|4095003|B1|Second Generation Antipsychotics||Medications||participants|Number|10|10.0||||||
4270776|NCT00588731|4095001|B3|First Generation Antipsychotics||Medications||participants|Number|14|14.0||||||
4270777|NCT00588731|4095002|B2|First Generation Antipsychotics||Medications||participants|Number|5|5.0||||||
4270778|NCT00588731|4095003|B1|First Generation Antipsychotics||Medications||participants|Number|9|9.0||||||
4270779|NCT00588731|4095001|B3|PANSS General Subscale||Positive And Negative Syndrome Scale|The PANSS is a scale used for measuring symptoms severity of patients with schizophrenia. Of the 30 items included: 7 constitute a Positive Scale, 7 a Negative Scale, and 16 a General Psychopathology Scale. The scores for these scales are arrived at by summation of ratings across component items (each item scored between 1-7). Therefore, the potential ranges are 7-49 for the Positive and Negative Scales, and 16-112 for the General Psychopathology Scale. The PANSS Total Score is the summation of these subscales and can range from a score of 30-210. A higher score indicates more severe symptoms.|T-score|Mean|39.15|39.15|Standard Deviation|7.95|7.95|||
4270780|NCT00588731|4095002|B2|PANSS General Subscale||Positive And Negative Syndrome Scale|The PANSS is a scale used for measuring symptoms severity of patients with schizophrenia. Of the 30 items included: 7 constitute a Positive Scale, 7 a Negative Scale, and 16 a General Psychopathology Scale. The scores for these scales are arrived at by summation of ratings across component items (each item scored between 1-7). Therefore, the potential ranges are 7-49 for the Positive and Negative Scales, and 16-112 for the General Psychopathology Scale. The PANSS Total Score is the summation of these subscales and can range from a score of 30-210. A higher score indicates more severe symptoms.|T-score|Mean|41.2|41.2|Standard Deviation|5.6|5.6|||
4270841|NCT00588731|4095003|B1|||Age||years|Mean|48.4|48.4|Standard Deviation|9.3|9.3|||
4270781|NCT00588731|4095003|B1|PANSS General Subscale||Positive And Negative Syndrome Scale|The PANSS is a scale used for measuring symptoms severity of patients with schizophrenia. Of the 30 items included: 7 constitute a Positive Scale, 7 a Negative Scale, and 16 a General Psychopathology Scale. The scores for these scales are arrived at by summation of ratings across component items (each item scored between 1-7). Therefore, the potential ranges are 7-49 for the Positive and Negative Scales, and 16-112 for the General Psychopathology Scale. The PANSS Total Score is the summation of these subscales and can range from a score of 30-210. A higher score indicates more severe symptoms.|T-score|Mean|37.1|37.1|Standard Deviation|10.3|10.3|||
4270782|NCT00588731|4095001|B3|PANSS Negative Subscale||Positive And Negative Syndrome Scale|The PANSS is a scale used for measuring symptoms severity of patients with schizophrenia. Of the 30 items included: 7 constitute a Positive Scale, 7 a Negative Scale, and 16 a General Psychopathology Scale. The scores for these scales are arrived at by summation of ratings across component items (each item scored between 1-7). Therefore, the potential ranges are 7-49 for the Positive and Negative Scales, and 16-112 for the General Psychopathology Scale. The PANSS Total Score is the summation of these subscales and can range from a score of 30-210. A higher score indicates more severe symptoms.|T-score|Mean|20.8|20.8|Standard Deviation|4.65|4.65|||
4270783|NCT00588731|4095002|B2|PANSS Negative Subscale||Positive And Negative Syndrome Scale|The PANSS is a scale used for measuring symptoms severity of patients with schizophrenia. Of the 30 items included: 7 constitute a Positive Scale, 7 a Negative Scale, and 16 a General Psychopathology Scale. The scores for these scales are arrived at by summation of ratings across component items (each item scored between 1-7). Therefore, the potential ranges are 7-49 for the Positive and Negative Scales, and 16-112 for the General Psychopathology Scale. The PANSS Total Score is the summation of these subscales and can range from a score of 30-210. A higher score indicates more severe symptoms.|T-score|Mean|20.9|20.9|Standard Deviation|4.7|4.7|||
4270784|NCT00588731|4095003|B1|PANSS Negative Subscale||Positive And Negative Syndrome Scale|The PANSS is a scale used for measuring symptoms severity of patients with schizophrenia. Of the 30 items included: 7 constitute a Positive Scale, 7 a Negative Scale, and 16 a General Psychopathology Scale. The scores for these scales are arrived at by summation of ratings across component items (each item scored between 1-7). Therefore, the potential ranges are 7-49 for the Positive and Negative Scales, and 16-112 for the General Psychopathology Scale. The PANSS Total Score is the summation of these subscales and can range from a score of 30-210. A higher score indicates more severe symptoms.|T-score|Mean|20.7|20.7|Standard Deviation|4.6|4.6|||
4270785|NCT00588731|4095001|B3|PANSS Positive Subscale||Positive And Negative Syndrome Scale|The PANSS is a scale used for measuring symptoms severity of patients with schizophrenia. Of the 30 items included: 7 constitute a Positive Scale, 7 a Negative Scale, and 16 a General Psychopathology Scale. The scores for these scales are arrived at by summation of ratings across component items (each item scored between 1-7). Therefore, the potential ranges are 7-49 for the Positive and Negative Scales, and 16-112 for the General Psychopathology Scale. The PANSS Total Score is the summation of these subscales and can range from a score of 30-210. A higher score indicates more severe symptoms.|T-score|Mean|19.7|19.7|Standard Deviation|4.25|4.25|||
4270786|NCT00588731|4095002|B2|PANSS Positive Subscale||Positive And Negative Syndrome Scale|The PANSS is a scale used for measuring symptoms severity of patients with schizophrenia. Of the 30 items included: 7 constitute a Positive Scale, 7 a Negative Scale, and 16 a General Psychopathology Scale. The scores for these scales are arrived at by summation of ratings across component items (each item scored between 1-7). Therefore, the potential ranges are 7-49 for the Positive and Negative Scales, and 16-112 for the General Psychopathology Scale. The PANSS Total Score is the summation of these subscales and can range from a score of 30-210. A higher score indicates more severe symptoms.|T-score|Mean|20.6|20.6|Standard Deviation|3.8|3.8|||
4270787|NCT00588731|4095003|B1|PANSS Positive Subscale||Positive And Negative Syndrome Scale|The PANSS is a scale used for measuring symptoms severity of patients with schizophrenia. Of the 30 items included: 7 constitute a Positive Scale, 7 a Negative Scale, and 16 a General Psychopathology Scale. The scores for these scales are arrived at by summation of ratings across component items (each item scored between 1-7). Therefore, the potential ranges are 7-49 for the Positive and Negative Scales, and 16-112 for the General Psychopathology Scale. The PANSS Total Score is the summation of these subscales and can range from a score of 30-210. A higher score indicates more severe symptoms.|T-score|Mean|18.8|18.8|Standard Deviation|4.7|4.7|||
4270788|NCT00588731|4095001|B3|PANSS Total Score||Positive And Negative Syndrome Scale|The PANSS is a scale used for measuring symptoms severity of patients with schizophrenia. Of the 30 items included: 7 constitute a Positive Scale, 7 a Negative Scale, and 16 a General Psychopathology Scale. The scores for these scales are arrived at by summation of ratings across component items (each item scored between 1-7). Therefore, the potential ranges are 7-49 for the Positive and Negative Scales, and 16-112 for the General Psychopathology Scale. The PANSS Total Score is the summation of these subscales and can range from a score of 30-210. A higher score indicates more severe symptoms.|T-score|Mean|79.65|79.65|Standard Deviation|12.9|12.9|||
4270789|NCT00588731|4095002|B2|PANSS Total Score||Positive And Negative Syndrome Scale|The PANSS is a scale used for measuring symptoms severity of patients with schizophrenia. Of the 30 items included: 7 constitute a Positive Scale, 7 a Negative Scale, and 16 a General Psychopathology Scale. The scores for these scales are arrived at by summation of ratings across component items (each item scored between 1-7). Therefore, the potential ranges are 7-49 for the Positive and Negative Scales, and 16-112 for the General Psychopathology Scale. The PANSS Total Score is the summation of these subscales and can range from a score of 30-210. A higher score indicates more severe symptoms.|T-score|Mean|82.7|82.7|Standard Deviation|8.8|8.8|||
4270790|NCT00588731|4095003|B1|PANSS Total Score||Positive And Negative Syndrome Scale|The PANSS is a scale used for measuring symptoms severity of patients with schizophrenia. Of the 30 items included: 7 constitute a Positive Scale, 7 a Negative Scale, and 16 a General Psychopathology Scale. The scores for these scales are arrived at by summation of ratings across component items (each item scored between 1-7). Therefore, the potential ranges are 7-49 for the Positive and Negative Scales, and 16-112 for the General Psychopathology Scale. The PANSS Total Score is the summation of these subscales and can range from a score of 30-210. A higher score indicates more severe symptoms.|T-score|Mean|76.6|76.6|Standard Deviation|17|17.0|||
4270842|NCT00588692|4095012|B3|Not Obese at Baseline||Obesity||participants|Number|26|26.0||||||
4270843|NCT00588692|4095013|B2|Not Obese at Baseline||Obesity||participants|Number|13|13.0||||||
4270791|NCT00588731|4095001|B3|||Hopkins Verbal Learning Test T-Score|The Hopkins Verbal Learning Test is a measure of verbal short term memory. Each trial has a max total score of 12 (range of 0-12), and the max total score for all three trials is 36 (range of 0-36). The data listed is reported in the form of a t-score, with a higher score representing better verbal learning. These t-score values are normalizing the scores to populations, comparing them to a representative sample.|T-Score|Mean|33.5|33.5|Standard Deviation|6.15|6.15|||
4270792|NCT00588731|4095002|B2|||Hopkins Verbal Learning Test T-Score|The Hopkins Verbal Learning Test is a measure of verbal short term memory. Each trial has a max total score of 12 (range of 0-12), and the max total score for all three trials is 36 (range of 0-36). The data listed is reported in the form of a t-score, with a higher score representing better verbal learning. These t-score values are normalizing the scores to populations, comparing them to a representative sample.|T-Score|Mean|34.5|34.5|Standard Deviation|6|6.0|||
4270793|NCT00588731|4095003|B1|||Hopkins Verbal Learning Test T-Score|The Hopkins Verbal Learning Test is a measure of verbal short term memory. Each trial has a max total score of 12 (range of 0-12), and the max total score for all three trials is 36 (range of 0-36). The data listed is reported in the form of a t-score, with a higher score representing better verbal learning. These t-score values are normalizing the scores to populations, comparing them to a representative sample.|T-Score|Mean|32.5|32.5|Standard Deviation|6.3|6.3|||
4270794|NCT00588731|4095001|B3|Non-Smokers||Smoking Status||participants|Number|17|17.0||||||
4270795|NCT00588731|4095002|B2|Non-Smokers||Smoking Status||participants|Number|8|8.0||||||
4270796|NCT00588731|4095003|B1|Non-Smokers||Smoking Status||participants|Number|9|9.0||||||
4270797|NCT00588731|4095001|B3|Smokers||Smoking Status||participants|Number|19|19.0||||||
4270798|NCT00588731|4095002|B2|Smokers||Smoking Status||participants|Number|10|10.0||||||
4270799|NCT00588731|4095003|B1|Smokers||Smoking Status||participants|Number|9|9.0||||||
4270800|NCT00588731|4095001|B3|||Education||years|Mean|13|13.0|Standard Deviation|1.8|1.8|||
4270801|NCT00588731|4095002|B2|||Education||years|Mean|12.8|12.8|Standard Deviation|2|2.0|||
4270802|NCT00588731|4095003|B1|||Education||years|Mean|13.2|13.2|Standard Deviation|1.6|1.6|||
4270803|NCT00588731|4095001|B3|||Intelligence Quotient (IQ)||IQ|Mean|86.6|86.6|Standard Deviation|17.3|17.3|||
4270804|NCT00588731|4095002|B2|||Intelligence Quotient (IQ)||IQ|Mean|82.3|82.3|Standard Deviation|15.4|15.4|||
4270805|NCT00588731|4095003|B1|||Intelligence Quotient (IQ)||IQ|Mean|91.6|91.6|Standard Deviation|18.4|18.4|||
4270806|NCT00588731|4095001|B3|||Length of Diagnosis||years|Mean|26.9|26.9|Standard Deviation|10.6|10.6|||
4270807|NCT00588731|4095002|B2|||Length of Diagnosis||years|Mean|28.2|28.2|Standard Deviation|8.5|8.5|||
4270808|NCT00588731|4095003|B1|||Length of Diagnosis||years|Mean|25.6|25.6|Standard Deviation|12.7|12.7|||
4270809|NCT00588731|4095001|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4270810|NCT00588731|4095002|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4270811|NCT00588731|4095003|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4270812|NCT00588731|4095001|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4270813|NCT00588731|4095002|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4270814|NCT00588731|4095003|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4270815|NCT00588731|4095001|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4270816|NCT00588731|4095002|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4270817|NCT00588731|4095003|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4270818|NCT00588731|4095001|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4270819|NCT00588731|4095002|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4270820|NCT00588731|4095003|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4270821|NCT00588731|4095001|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4270822|NCT00588731|4095002|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4270823|NCT00588731|4095003|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4270824|NCT00588731|4095001|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4270825|NCT00588731|4095002|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4270826|NCT00588731|4095003|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4270827|NCT00588731|4095001|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4270828|NCT00588731|4095002|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4270829|NCT00588731|4095003|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4270830|NCT00588731|4095001|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4270831|NCT00588731|4095002|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4270832|NCT00588731|4095003|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4270833|NCT00588731|4095001|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4270834|NCT00588731|4095002|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4270835|NCT00588731|4095003|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4270836|NCT00588731|4095001|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4270837|NCT00588731|4095002|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4270838|NCT00588731|4095003|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4270839|NCT00588731|4095001|B3|||Age||years|Mean|47.4|47.4|Standard Deviation|9.3|9.3|||
4270840|NCT00588731|4095002|B2|||Age||years|Mean|46.4|46.4|Standard Deviation|9.5|9.5|||
4270844|NCT00588692|4095014|B1|Not Obese at Baseline||Obesity||participants|Number|13|13.0||||||
4270845|NCT00588692|4095012|B3|Obese at Baseline||Obesity||participants|Number|24|24.0||||||
4270846|NCT00588692|4095013|B2|Obese at Baseline||Obesity||participants|Number|14|14.0||||||
4270847|NCT00588692|4095014|B1|Obese at Baseline||Obesity||participants|Number|10|10.0||||||
4270848|NCT00588692|4095012|B3|No History of Diabetes||Diabetes||participants|Number|26|26.0||||||
4270849|NCT00588692|4095013|B2|No History of Diabetes||Diabetes||participants|Number|15|15.0||||||
4270850|NCT00588692|4095014|B1|No History of Diabetes||Diabetes||participants|Number|11|11.0||||||
4270851|NCT00588692|4095012|B3|Prior History of Diabetes||Diabetes||participants|Number|24|24.0||||||
4270852|NCT00588692|4095013|B2|Prior History of Diabetes||Diabetes||participants|Number|12|12.0||||||
4270853|NCT00588692|4095014|B1|Prior History of Diabetes||Diabetes||participants|Number|12|12.0||||||
4270854|NCT00588692|4095012|B3|No Prior Hypertension||History of Hypertension||participants|Number|4|4.0||||||
4270855|NCT00588692|4095013|B2|No Prior Hypertension||History of Hypertension||participants|Number|1|1.0||||||
4270856|NCT00588692|4095014|B1|No Prior Hypertension||History of Hypertension||participants|Number|3|3.0||||||
4270857|NCT00588692|4095012|B3|Prior Hypertension||History of Hypertension||participants|Number|46|46.0||||||
4270858|NCT00588692|4095013|B2|Prior Hypertension||History of Hypertension||participants|Number|26|26.0||||||
4270859|NCT00588692|4095014|B1|Prior Hypertension||History of Hypertension||participants|Number|20|20.0||||||
4270860|NCT00588692|4095012|B3|||Body Mass Index|Body Mass Index (BMI) is a health index for comparing weight to height. BMI is a person's weight in kilograms (kg) divided by his or her height in meters squared. The body mass index is an indication if a person is at a suitable weight for his height on an approximation of body fat. A body mass index of under 20 is considered to be underweight, while a body mass index between 20 to 25 is considered healthy. A body mass index in the range of 25 to 30 is regarded as overweight. A body mass index over 30 is regarded as obese.|kg/m^2|Mean|29.6|29.6|Standard Deviation|4.6|4.6|||
4270861|NCT00588692|4095013|B2|||Body Mass Index|Body Mass Index (BMI) is a health index for comparing weight to height. BMI is a person's weight in kilograms (kg) divided by his or her height in meters squared. The body mass index is an indication if a person is at a suitable weight for his height on an approximation of body fat. A body mass index of under 20 is considered to be underweight, while a body mass index between 20 to 25 is considered healthy. A body mass index in the range of 25 to 30 is regarded as overweight. A body mass index over 30 is regarded as obese.|kg/m^2|Mean|29.9|29.9|Standard Deviation|4.6|4.6|||
4270862|NCT00588692|4095014|B1|||Body Mass Index|Body Mass Index (BMI) is a health index for comparing weight to height. BMI is a person's weight in kilograms (kg) divided by his or her height in meters squared. The body mass index is an indication if a person is at a suitable weight for his height on an approximation of body fat. A body mass index of under 20 is considered to be underweight, while a body mass index between 20 to 25 is considered healthy. A body mass index in the range of 25 to 30 is regarded as overweight. A body mass index over 30 is regarded as obese.|kg/m^2|Mean|29.2|29.2|Standard Deviation|4.5|4.5|||
4270863|NCT00588692|4095012|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4270864|NCT00588692|4095013|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4270865|NCT00588692|4095014|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4270866|NCT00588692|4095012|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4270867|NCT00588692|4095013|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4270868|NCT00588692|4095014|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4270869|NCT00588692|4095012|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4270870|NCT00588692|4095013|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4270871|NCT00588692|4095014|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4270872|NCT00588692|4095012|B3|||Age||years|Mean|73|73.0|Standard Deviation|8|8.0|||
4270873|NCT00588692|4095013|B2|||Age||years|Mean|72|72.0|Standard Deviation|8|8.0|||
4270874|NCT00588692|4095014|B1|||Age||years|Mean|74|74.0|Standard Deviation|8|8.0|||
4270875|NCT00588666|4095051|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4270876|NCT00588666|4095051|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4270877|NCT00588666|4095051|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4270878|NCT00588666|4095051|B1||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4270879|NCT00588666|4095051|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4270880|NCT00588666|4095051|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270881|NCT00588640|4095056|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4270882|NCT00588640|4095056|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4270883|NCT00588640|4095056|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4270884|NCT00588640|4095056|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4270885|NCT00588640|4095056|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270886|NCT00588536|4095060|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4270887|NCT00588536|4095060|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4270888|NCT00588536|4095060|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4270889|NCT00588536|4095060|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4270890|NCT00588536|4095060|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4270891|NCT00588536|4095060|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4270892|NCT00588471|4095064|B3|United States||Region of Enrollment||participants|Number|57|57.0||||||
4270893|NCT00588471|4095065|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4270894|NCT00588471|4095066|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4270895|NCT00588471|4095064|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4270896|NCT00588471|4095065|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4270897|NCT00588471|4095066|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4270898|NCT00588471|4095064|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4270899|NCT00588471|4095065|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4270900|NCT00588471|4095066|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4270901|NCT00588471|4095064|B3||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4270902|NCT00588471|4095065|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4270903|NCT00588471|4095066|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4270904|NCT00588471|4095064|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4270905|NCT00588471|4095065|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4270906|NCT00588471|4095066|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4270907|NCT00588471|4095064|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270908|NCT00588471|4095065|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270909|NCT00588471|4095066|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270910|NCT00588445|4095075|B1|United States||Region of Enrollment||participants|Number|65|65.0||||||
4270911|NCT00588445|4095075|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4270912|NCT00588445|4095075|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4270913|NCT00588445|4095075|B1||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4270914|NCT00588445|4095075|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4270915|NCT00588445|4095075|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270916|NCT00588406|4095081|B3|||Forced expiratory volume at one second (FEV1) % predicted||percent predicted of FEV1|Mean|29.2|29.2|Standard Deviation|8.7|8.7|||
4270917|NCT00588406|4095082|B2|||Forced expiratory volume at one second (FEV1) % predicted||percent predicted of FEV1|Mean|29|29.0|Standard Deviation|8.1|8.1|||
4270918|NCT00588406|4095083|B1|||Forced expiratory volume at one second (FEV1) % predicted||percent predicted of FEV1|Mean|29.5|29.5|Standard Deviation|9.5|9.5|||
4270919|NCT00588406|4095081|B3|United States||Region of Enrollment||participants|Number|95|95.0||||||
4270920|NCT00588406|4095082|B2|United States||Region of Enrollment||participants|Number|49|49.0||||||
4270921|NCT00588406|4095083|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4270922|NCT00588406|4095081|B3|Unknown||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4270923|NCT00588406|4095082|B2|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4270924|NCT00588406|4095083|B1|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4270925|NCT00588406|4095081|B3|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4270926|NCT00588406|4095082|B2|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4270927|NCT00588406|4095083|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4270928|NCT00588406|4095081|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4270929|NCT00588406|4095082|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4270930|NCT00588406|4095083|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4270931|NCT00588406|4095081|B3|Black||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4270932|NCT00588406|4095082|B2|Black||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4270933|NCT00588406|4095083|B1|Black||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4270934|NCT00588406|4095081|B3|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4270935|NCT00588406|4095082|B2|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4270936|NCT00588406|4095083|B1|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4270937|NCT00588406|4095081|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4270938|NCT00588406|4095082|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4270939|NCT00588406|4095083|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4270940|NCT00588406|4095081|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4270941|NCT00588406|4095082|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4270942|NCT00588406|4095083|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4270943|NCT00588406|4095081|B3|||Age||years|Mean|40|40.0|Standard Deviation|11.7|11.7|||
4270944|NCT00588406|4095082|B2|||Age||years|Mean|42.6|42.6|Standard Deviation|11.4|11.4|||
4270945|NCT00588406|4095083|B1|||Age||years|Mean|37.2|37.2|Standard Deviation|11.4|11.4|||
4270946|NCT00588380|4095092|B1|United States||Region of Enrollment||participants|Number|88|88.0||||||
4270947|NCT00588380|4095092|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4270948|NCT00588380|4095092|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4270949|NCT00588380|4095092|B1|||Age||years|Mean|26.3|26.3|Standard Deviation|5.6|5.6|||
4270950|NCT00588354|4095097|B3|||Pain Intensity Score|Pain Intensity Score as measured by Pain Intensity Numerical Rating Scale (PI-NRS). This is an 11-point ordinal scale measuring patient pain, ranging from 0 (no pain) to 10 (most severe/disabling pain).|Units on a scale|Mean|7.0|7.0|Standard Deviation|1.9|1.9|||
4270951|NCT00588354|4095098|B2|||Pain Intensity Score|Pain Intensity Score as measured by Pain Intensity Numerical Rating Scale (PI-NRS). This is an 11-point ordinal scale measuring patient pain, ranging from 0 (no pain) to 10 (most severe/disabling pain).|Units on a scale|Mean|7.0|7.0|Standard Deviation|2.0|2.0|||
4270952|NCT00588354|4095099|B1|||Pain Intensity Score|Pain Intensity Score as measured by Pain Intensity Numerical Rating Scale (PI-NRS). This is an 11-point ordinal scale measuring patient pain, ranging from 0 (no pain) to 10 (most severe/disabling pain).|Units on a scale|Mean|7.0|7.0|Standard Deviation|1.9|1.9|||
4270953|NCT00588354|4095097|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4270954|NCT00588354|4095098|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4270955|NCT00588354|4095099|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4270956|NCT00588354|4095097|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4270957|NCT00588354|4095098|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4270958|NCT00588354|4095099|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4270959|NCT00588354|4095097|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4270960|NCT00588354|4095098|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4270961|NCT00588354|4095099|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4270962|NCT00588354|4095097|B3|||Age||years|Mean|47.7|47.7|Standard Deviation|11.9|11.9|||
4270963|NCT00588354|4095098|B2|||Age||years|Mean|50.3|50.3|Standard Deviation|11.0|11.0|||
4270964|NCT00588354|4095099|B1|||Age||years|Mean|44.1|44.1|Standard Deviation|12.4|12.4|||
4270965|NCT00588341|4095120|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4270966|NCT00588341|4095120|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4270967|NCT00588341|4095120|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4270968|NCT00588341|4095120|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4270969|NCT00588341|4095120|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270970|NCT00588237|4095124|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4270971|NCT00588237|4095124|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4270972|NCT00588237|4095124|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4270973|NCT00588237|4095124|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4270974|NCT00588237|4095124|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270975|NCT00588159|4095128|B3|United States||Region of Enrollment||participants|Number|146|146.0||||||
4270976|NCT00588159|4095129|B2|United States||Region of Enrollment||participants|Number|74|74.0||||||
4270977|NCT00588159|4095130|B1|United States||Region of Enrollment||participants|Number|72|72.0||||||
4270978|NCT00588159|4095128|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4270979|NCT00588159|4095129|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4270980|NCT00588159|4095130|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4270981|NCT00588159|4095128|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4270982|NCT00588159|4095129|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4270983|NCT00588159|4095130|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4270984|NCT00588159|4095128|B3|||Age||years|Mean|64|64.0|Standard Deviation|7|7.0|||
4270985|NCT00588159|4095129|B2|||Age||years|Mean|64|64.0|Standard Deviation|7|7.0|||
4270986|NCT00588159|4095130|B1|||Age||years|Mean|64|64.0|Standard Deviation|7|7.0|||
4270987|NCT00588159|4095128|B3||>=65 years|Age||Participants|Count of Participants|75|75.0||||||
4270988|NCT00588159|4095129|B2||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4270989|NCT00588159|4095130|B1||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4270990|NCT00588159|4095128|B3||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4270991|NCT00588159|4095129|B2||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4270992|NCT00588159|4095130|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4270993|NCT00588159|4095128|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270994|NCT00588159|4095129|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270995|NCT00588159|4095130|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4270996|NCT00588146|4095147|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4270997|NCT00588146|4095147|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4270998|NCT00588146|4095147|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4270999|NCT00588146|4095147|B1|||Age||years|Mean|56|56.0|Standard Deviation|15.8|15.8|||
4271000|NCT00588146|4095147|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4271001|NCT00588146|4095147|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4271002|NCT00588146|4095147|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271003|NCT00588094|4095154|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4271004|NCT00588094|4095154|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4271005|NCT00588094|4095154|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4271006|NCT00588094|4095154|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4271007|NCT00588094|4095154|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4271008|NCT00588094|4095154|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271009|NCT00587990|4095158|B4|United States||Region of Enrollment||participants|Number|9|9.0||||||
4271010|NCT00587990|4095159|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4271011|NCT00587990|4095160|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4271012|NCT00587990|4095161|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4271013|NCT00587990|4095158|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4271014|NCT00587990|4095159|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4271015|NCT00587990|4095160|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4271016|NCT00587990|4095161|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4271017|NCT00587990|4095158|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4271018|NCT00587990|4095159|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4271019|NCT00587990|4095160|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4271020|NCT00587990|4095161|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4271021|NCT00587990|4095158|B4|||Age||years|Mean|57.7014222|57.7014222|Standard Deviation|9.3869460|9.386946|||
4271022|NCT00587990|4095159|B3|||Age||years|Mean|63.6276523|63.6276523|Standard Deviation|2.9733072|2.9733072|||
4271023|NCT00587990|4095160|B2|||Age||years|Mean|51.9240246|51.9240246|Standard Deviation|9.1760352|9.1760352|||
4271024|NCT00587990|4095161|B1|||Age||years|Mean|60.3668720|60.366872|Standard Deviation|13.4742319|13.4742319|||
4271025|NCT00587990|4095158|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4271026|NCT00587990|4095159|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4271027|NCT00587990|4095160|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4271028|NCT00587990|4095161|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4271029|NCT00587990|4095158|B4||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4271030|NCT00587990|4095159|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4271031|NCT00587990|4095160|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4271032|NCT00587990|4095161|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4271033|NCT00587990|4095158|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271034|NCT00587990|4095159|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271035|NCT00587990|4095160|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271036|NCT00587990|4095161|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271037|NCT00587964|4095177|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4271038|NCT00587964|4095177|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4271039|NCT00587964|4095177|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4271040|NCT00587964|4095177|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4271041|NCT00587964|4095177|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271042|NCT00587860|4095181|B3|||Irritable Bowel Syndrome - Quality of Life (IBS-QoL)|The IBS-QOL is a self-report quality-of-life measure specific to Irritable Bowel Syndrome (IBS) that can be used to assess the impact of IBS and its treatment. The IBS-QOL was measured at baseline, week 12 and week 24. The individual responses to the 34 items are summed and averaged for a total score and then transformed to a 0-100 scale for ease of interpretation with higher scores indicating better IBS specific quality of life.|Units on a scale|Median|21.5|21.5|Full Range|||0.0|79.0|
4271043|NCT00587860|4095182|B2|||Irritable Bowel Syndrome - Quality of Life (IBS-QoL)|The IBS-QOL is a self-report quality-of-life measure specific to Irritable Bowel Syndrome (IBS) that can be used to assess the impact of IBS and its treatment. The IBS-QOL was measured at baseline, week 12 and week 24. The individual responses to the 34 items are summed and averaged for a total score and then transformed to a 0-100 scale for ease of interpretation with higher scores indicating better IBS specific quality of life.|Units on a scale|Median|20|20.0|Full Range|||0.0|79.0|
4271044|NCT00587860|4095183|B1|||Irritable Bowel Syndrome - Quality of Life (IBS-QoL)|The IBS-QOL is a self-report quality-of-life measure specific to Irritable Bowel Syndrome (IBS) that can be used to assess the impact of IBS and its treatment. The IBS-QOL was measured at baseline, week 12 and week 24. The individual responses to the 34 items are summed and averaged for a total score and then transformed to a 0-100 scale for ease of interpretation with higher scores indicating better IBS specific quality of life.|Units on a scale|Median|23|23.0|Full Range|||4.0|62.0|
4271045|NCT00587860|4095181|B3|||Center for Epidemiologic Studies Depression Scale (CES-D) score|We measured CES-D Score at baseline as well as bi-weekly throughout the study. The CES-D is a self-reported 20 question survey designed to measure depressive symptomatology in the general population. The possible range of scores is zero to 60, with the higher scores indicating the presence of more symptomatology.|Units on a scale|Median|5.5|5.5|Full Range|||0.0|32.0|
4271046|NCT00587860|4095182|B2|||Center for Epidemiologic Studies Depression Scale (CES-D) score|We measured CES-D Score at baseline as well as bi-weekly throughout the study. The CES-D is a self-reported 20 question survey designed to measure depressive symptomatology in the general population. The possible range of scores is zero to 60, with the higher scores indicating the presence of more symptomatology.|Units on a scale|Median|5|5.0|Full Range|||0.0|32.0|
4271047|NCT00587860|4095183|B1|||Center for Epidemiologic Studies Depression Scale (CES-D) score|We measured CES-D Score at baseline as well as bi-weekly throughout the study. The CES-D is a self-reported 20 question survey designed to measure depressive symptomatology in the general population. The possible range of scores is zero to 60, with the higher scores indicating the presence of more symptomatology.|Units on a scale|Median|6|6.0|Full Range|||0.0|26.0|
4271048|NCT00587860|4095181|B3|||Bowel Symptom Score (BSS)|The BSS is a five question, 100-mm visual analog scale of four IBS symptoms (pain/discomfort, bloating, constipation, and diarrhea), and an overall severity scale. The best possible value would be 0 (no symptoms) and the worst is 500 (severe symptoms). BSS was assessed on a bi-weekly basis.|Units on a scale|Median|169|169.0|Full Range|||36.0|314.0|
4271049|NCT00587860|4095182|B2|||Bowel Symptom Score (BSS)|The BSS is a five question, 100-mm visual analog scale of four IBS symptoms (pain/discomfort, bloating, constipation, and diarrhea), and an overall severity scale. The best possible value would be 0 (no symptoms) and the worst is 500 (severe symptoms). BSS was assessed on a bi-weekly basis.|Units on a scale|Median|165|165.0|Full Range|||73.0|290.0|
4271050|NCT00587860|4095183|B1|||Bowel Symptom Score (BSS)|The BSS is a five question, 100-mm visual analog scale of four IBS symptoms (pain/discomfort, bloating, constipation, and diarrhea), and an overall severity scale. The best possible value would be 0 (no symptoms) and the worst is 500 (severe symptoms). BSS was assessed on a bi-weekly basis.|Units on a scale|Median|173|173.0|Full Range|||36.0|314.0|
4271051|NCT00587860|4095181|B3|United States||Region of Enrollment||participants|Number|70|70.0||||||
4271052|NCT00587860|4095182|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
4271053|NCT00587860|4095183|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4271054|NCT00587860|4095181|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4271055|NCT00587860|4095182|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4271056|NCT00587860|4095183|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4271057|NCT00587860|4095181|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4271058|NCT00587860|4095182|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4271059|NCT00587860|4095183|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4271060|NCT00587860|4095181|B3|||Age||years|Mean|40.81|40.81|Standard Deviation|12.87|12.87|||
4271061|NCT00587860|4095182|B2|||Age||years|Mean|39.43|39.43|Standard Deviation|11.26|11.26|||
4271062|NCT00587860|4095183|B1|||Age||years|Mean|42.2|42.2|Standard Deviation|14.34|14.34|||
4271063|NCT00587860|4095181|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4271064|NCT00587860|4095182|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4271065|NCT00587860|4095183|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4271066|NCT00587860|4095181|B3||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
4271067|NCT00587860|4095182|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4271068|NCT00587860|4095183|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4271069|NCT00587860|4095181|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271070|NCT00587860|4095182|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271071|NCT00587860|4095183|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271072|NCT00587847|4095204|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4271073|NCT00587847|4095204|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4271074|NCT00587847|4095204|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4271075|NCT00587847|4095204|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4271076|NCT00587847|4095204|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4271077|NCT00587847|4095204|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271078|NCT00587834|4095209|B1|United States||Region of Enrollment||participants|Number|96|96.0||||||
4271079|NCT00587834|4095209|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4271080|NCT00587834|4095209|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271081|NCT00587834|4095209|B1||White|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
4271082|NCT00587834|4095209|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4271083|NCT00587834|4095209|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271084|NCT00587834|4095209|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4271085|NCT00587834|4095209|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271086|NCT00587834|4095209|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4271087|NCT00587834|4095209|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
4271088|NCT00587834|4095209|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4271089|NCT00587834|4095209|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4271090|NCT00587834|4095209|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4271091|NCT00587834|4095209|B1|||Age||years|Mean|47.14|47.14|Standard Deviation|13.13|13.13|||
4271092|NCT00587834|4095209|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4271093|NCT00587834|4095209|B1||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
4271094|NCT00587834|4095209|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271095|NCT00587795|4095225|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4271096|NCT00587795|4095227|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4271097|NCT00587795|4095225|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4271098|NCT00587795|4095227|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4271099|NCT00587795|4095225|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4271100|NCT00587795|4095227|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4271101|NCT00587795|4095225|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4271102|NCT00587795|4095226|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4271103|NCT00587795|4095227|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4271104|NCT00587795|4095225|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4271105|NCT00587795|4095226|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4271106|NCT00587795|4095227|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4271107|NCT00587795|4095225|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271108|NCT00587795|4095226|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271109|NCT00587795|4095227|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271110|NCT00587769|4095234|B1|||Cigarettes per day||cigarettes per day|Mean|19.9|19.9|Standard Deviation|7.8|7.8|||
4271111|NCT00587769|4095234|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4271112|NCT00587769|4095234|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4271113|NCT00587769|4095234|B1|||Age||years|Median|49.1|49.1|Standard Deviation|12.4|12.4|||
4271114|NCT00587678|4095239|B4|||V02 max - maximal oxygen consumption|Measured during treadmill exercise|ml/kg/min|Mean|12.8|12.8|Standard Deviation|4.0|4.0|||
4271115|NCT00587678|4095240|B3|||V02 max - maximal oxygen consumption|Measured during treadmill exercise|ml/kg/min|Mean|12.1|12.1|Standard Deviation|3.8|3.8|||
4271116|NCT00587678|4095241|B2|||V02 max - maximal oxygen consumption|Measured during treadmill exercise|ml/kg/min|Mean|12.4|12.4|Standard Deviation|3.2|3.2|||
4271117|NCT00587678|4095242|B1|||V02 max - maximal oxygen consumption|Measured during treadmill exercise|ml/kg/min|Mean|14.6|14.6|Standard Deviation|4.6|4.6|||
4271118|NCT00587678|4095239|B4|||6-minute walk distance||feet|Mean|1024|1024.0|Standard Deviation|397|397.0|||
4271119|NCT00587678|4095240|B3|||6-minute walk distance||feet|Mean|1007|1007.0|Standard Deviation|435|435.0|||
4271120|NCT00587678|4095241|B2|||6-minute walk distance||feet|Mean|976|976.0|Standard Deviation|324|324.0|||
4271121|NCT00587678|4095242|B1|||6-minute walk distance||feet|Mean|1103|1103.0|Standard Deviation|407|407.0|||
4271122|NCT00587678|4095239|B4|||Log of Treadmill Exercise Time||log of time in seconds|Mean|5.95|5.95|Standard Deviation|0.76|0.76|||
4271123|NCT00587678|4095240|B3|||Log of Treadmill Exercise Time||log of time in seconds|Mean|5.94|5.94|Standard Deviation|0.78|0.78|||
4271124|NCT00587678|4095241|B2|||Log of Treadmill Exercise Time||log of time in seconds|Mean|5.82|5.82|Standard Deviation|0.67|0.67|||
4271125|NCT00587678|4095242|B1|||Log of Treadmill Exercise Time||log of time in seconds|Mean|6.08|6.08|Standard Deviation|0.84|0.84|||
4271126|NCT00587678|4095239|B4|||Magnetic resonance angiographic index|Index of stenoses based on MR angiogram (0=normal, 4=worst possible)|units on a scale (0-4). 0 = normal.|Mean|0.81|0.81|Standard Deviation|0.64|0.64|||
4271127|NCT00587678|4095240|B3|||Magnetic resonance angiographic index|Index of stenoses based on MR angiogram (0=normal, 4=worst possible)|units on a scale (0-4). 0 = normal.|Mean|0.65|0.65|Standard Deviation|0.62|0.62|||
4271128|NCT00587678|4095241|B2|||Magnetic resonance angiographic index|Index of stenoses based on MR angiogram (0=normal, 4=worst possible)|units on a scale (0-4). 0 = normal.|Mean|1.10|1.1|Standard Deviation|0.72|0.72|||
4271129|NCT00587678|4095242|B1|||Magnetic resonance angiographic index|Index of stenoses based on MR angiogram (0=normal, 4=worst possible)|units on a scale (0-4). 0 = normal.|Mean|0.73|0.73|Standard Deviation|0.50|0.5|||
4271130|NCT00587678|4095239|B4|||Phosphocreatine recovery time constant|Phosphocreatine recovery time constant measured at peak exercise with 31P magnetic resonance spectroscopy. The range is from 20 to 1000 seconds with 20-40 being normal and higher than 40 abnormal.|seconds|Mean|92|92.0|Standard Deviation|64|64.0|||
4271131|NCT00587678|4095240|B3|||Phosphocreatine recovery time constant|Phosphocreatine recovery time constant measured at peak exercise with 31P magnetic resonance spectroscopy. The range is from 20 to 1000 seconds with 20-40 being normal and higher than 40 abnormal.|seconds|Mean|83|83.0|Standard Deviation|62|62.0|||
4271132|NCT00587678|4095241|B2|||Phosphocreatine recovery time constant|Phosphocreatine recovery time constant measured at peak exercise with 31P magnetic resonance spectroscopy. The range is from 20 to 1000 seconds with 20-40 being normal and higher than 40 abnormal.|seconds|Mean|104|104.0|Standard Deviation|56|56.0|||
4271133|NCT00587678|4095242|B1|||Phosphocreatine recovery time constant|Phosphocreatine recovery time constant measured at peak exercise with 31P magnetic resonance spectroscopy. The range is from 20 to 1000 seconds with 20-40 being normal and higher than 40 abnormal.|seconds|Mean|94|94.0|Standard Deviation|77|77.0|||
4271134|NCT00587678|4095239|B4|||Perfusion index|First pass contrast-enhanced MRI measure of exercise calf muscle perfusion|Units on a scale (0 = worst, 1 = best).|Mean|0.48|0.48|Standard Deviation|0.16|0.16|||
4271135|NCT00587678|4095240|B3|||Perfusion index|First pass contrast-enhanced MRI measure of exercise calf muscle perfusion|Units on a scale (0 = worst, 1 = best).|Mean|0.51|0.51|Standard Deviation|0.16|0.16|||
4271136|NCT00587678|4095241|B2|||Perfusion index|First pass contrast-enhanced MRI measure of exercise calf muscle perfusion|Units on a scale (0 = worst, 1 = best).|Mean|0.42|0.42|Standard Deviation|0.13|0.13|||
4271137|NCT00587678|4095242|B1|||Perfusion index|First pass contrast-enhanced MRI measure of exercise calf muscle perfusion|Units on a scale (0 = worst, 1 = best).|Mean|0.48|0.48|Standard Deviation|0.18|0.18|||
4271138|NCT00587678|4095239|B4|||Lumen volume||cm3|Mean|6.0|6.0|Standard Deviation|3.8|3.8|||
4271139|NCT00587678|4095240|B3|||Lumen volume||cm3|Mean|5.7|5.7|Standard Deviation|0.5|0.5|||
4271140|NCT00587678|4095241|B2|||Lumen volume||cm3|Mean|5.9|5.9|Standard Deviation|1.1|1.1|||
4271141|NCT00587678|4095242|B1|||Lumen volume||cm3|Mean|6.7|6.7|Standard Deviation|1.2|1.2|||
4271142|NCT00587678|4095239|B4|||Total vessel volume||cm^3|Mean|16.6|16.6|Standard Deviation|8.7|8.7|||
4271143|NCT00587678|4095240|B3|||Total vessel volume||cm^3|Mean|15.7|15.7|Standard Deviation|1.2|1.2|||
4271144|NCT00587678|4095241|B2|||Total vessel volume||cm^3|Mean|17.5|17.5|Standard Deviation|2.4|2.4|||
4271145|NCT00587678|4095242|B1|||Total vessel volume||cm^3|Mean|17.7|17.7|Standard Deviation|2.5|2.5|||
4271146|NCT00587678|4095239|B4|||Plaque volume||cm^3|Mean|10.6|10.6|Standard Deviation|5.4|5.4|||
4271147|NCT00587678|4095240|B3|||Plaque volume||cm^3|Mean|10.0|10.0|Standard Deviation|0.8|0.8|||
4271148|NCT00587678|4095241|B2|||Plaque volume||cm^3|Mean|11.5|11.5|Standard Deviation|1.4|1.4|||
4271149|NCT00587678|4095242|B1|||Plaque volume||cm^3|Mean|11.0|11.0|Standard Deviation|1.5|1.5|||
4271150|NCT00587678|4095239|B4|||Triglycerides||mg/dl|Mean|159|159.0|Standard Deviation|104|104.0|||
4271151|NCT00587678|4095240|B3|||Triglycerides||mg/dl|Mean|157|157.0|Standard Deviation|20|20.0|||
4271152|NCT00587678|4095241|B2|||Triglycerides||mg/dl|Mean|130|130.0|Standard Deviation|21|21.0|||
4271153|NCT00587678|4095242|B1|||Triglycerides||mg/dl|Mean|227|227.0|Standard Deviation|47|47.0|||
4271154|NCT00587678|4095239|B4|||High density lipoprotein cholesterol||mg/dl|Mean|43|43.0|Standard Deviation|13|13.0|||
4271155|NCT00587678|4095240|B3|||High density lipoprotein cholesterol||mg/dl|Mean|42|42.0|Standard Deviation|2|2.0|||
4271156|NCT00587678|4095241|B2|||High density lipoprotein cholesterol||mg/dl|Mean|48|48.0|Standard Deviation|4|4.0|||
4271157|NCT00587678|4095242|B1|||High density lipoprotein cholesterol||mg/dl|Mean|45|45.0|Standard Deviation|4|4.0|||
4271158|NCT00587678|4095239|B4|||Low density lipoprotein cholesterol||mg/dl|Mean|111|111.0|Standard Deviation|35|35.0|||
4271159|NCT00587678|4095240|B3|||Low density lipoprotein cholesterol||mg/dl|Mean|100|100.0|Standard Deviation|4|4.0|||
4271160|NCT00587678|4095241|B2|||Low density lipoprotein cholesterol||mg/dl|Mean|118|118.0|Standard Deviation|9|9.0|||
4271161|NCT00587678|4095242|B1|||Low density lipoprotein cholesterol||mg/dl|Mean|118|118.0|Standard Deviation|10|10.0|||
4271162|NCT00587678|4095239|B4|||Total cholesterol||mg/dl|Mean|182|182.0|Standard Deviation|45|45.0|||
4271163|NCT00587678|4095240|B3|||Total cholesterol||mg/dl|Mean|170|170.0|Standard Deviation|6|6.0|||
4271164|NCT00587678|4095241|B2|||Total cholesterol||mg/dl|Mean|189|189.0|Standard Deviation|10|10.0|||
4271165|NCT00587678|4095242|B1|||Total cholesterol||mg/dl|Mean|194|194.0|Standard Deviation|11|11.0|||
4271166|NCT00587678|4095239|B4|United States||Region of Enrollment||participants|Number|85|85.0||||||
4271167|NCT00587678|4095240|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
4271168|NCT00587678|4095241|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4271169|NCT00587678|4095242|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4271170|NCT00587678|4095239|B4||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4271171|NCT00587678|4095240|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4271172|NCT00587678|4095241|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4271173|NCT00587678|4095242|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4271174|NCT00587678|4095239|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4271175|NCT00587678|4095240|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4271176|NCT00587678|4095241|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4271177|NCT00587678|4095242|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4271178|NCT00587678|4095239|B4|||Age||years|Mean|63|63.0|Standard Deviation|11|11.0|||
4271179|NCT00587678|4095240|B3|||Age||years|Mean|66|66.0|Standard Deviation|11|11.0|||
4271180|NCT00587678|4095241|B2|||Age||years|Mean|64|64.0|Standard Deviation|9|9.0|||
4271181|NCT00587678|4095242|B1|||Age||years|Mean|59|59.0|Standard Deviation|12|12.0|||
4271182|NCT00587678|4095239|B4||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4271183|NCT00587678|4095240|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4271184|NCT00587678|4095241|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4271185|NCT00587678|4095242|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4271186|NCT00587678|4095239|B4||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4271187|NCT00587678|4095240|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4271188|NCT00587678|4095241|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4271189|NCT00587678|4095242|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4271190|NCT00587678|4095239|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271191|NCT00587678|4095240|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271192|NCT00587678|4095241|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271193|NCT00587678|4095242|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271194|NCT00587639|4095282|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4271195|NCT00587639|4095282|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4271196|NCT00587639|4095282|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4271197|NCT00587639|4095282|B1|||Age||years|Mean|16.5|16.5|Standard Deviation|1.18|1.18|||
4271198|NCT00587639|4095282|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4271199|NCT00587639|4095282|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4271200|NCT00587639|4095282|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4271201|NCT00587587|4095287|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271202|NCT00587587|4095288|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271203|NCT00587587|4095289|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271204|NCT00587587|4095287|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271205|NCT00587587|4095288|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271206|NCT00587587|4095289|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271207|NCT00587587|4095287|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4271208|NCT00587587|4095288|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4271209|NCT00587587|4095289|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4271210|NCT00587587|4095287|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4271211|NCT00587587|4095288|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4271212|NCT00587587|4095289|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4271213|NCT00587587|4095287|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271214|NCT00587587|4095288|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271215|NCT00587587|4095289|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271216|NCT00587587|4095287|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271217|NCT00587587|4095288|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271218|NCT00587587|4095289|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271219|NCT00587587|4095287|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271220|NCT00587587|4095288|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271221|NCT00587587|4095289|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271222|NCT00587587|4095287|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271223|NCT00587587|4095288|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271224|NCT00587587|4095289|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271225|NCT00587587|4095287|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4271226|NCT00587587|4095288|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4271227|NCT00587587|4095289|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4271228|NCT00587587|4095287|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4271229|NCT00587587|4095288|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4271230|NCT00587587|4095289|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4271231|NCT00587587|4095287|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4271232|NCT00587587|4095288|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4271233|NCT00587587|4095289|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4271234|NCT00587587|4095287|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4271235|NCT00587587|4095288|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4271236|NCT00587587|4095289|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4271237|NCT00587587|4095287|B3|||Age||years|Mean|34.4|34.4|Standard Deviation|13.1|13.1|||
4271238|NCT00587587|4095288|B2|||Age||years|Mean|36.7|36.7|Standard Deviation|13.5|13.5|||
4271239|NCT00587587|4095289|B1|||Age||years|Mean|32.7|32.7|Standard Deviation|12.9|12.9|||
4271240|NCT00587587|4095287|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4271241|NCT00587587|4095288|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4271242|NCT00587587|4095289|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4271243|NCT00587587|4095287|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4271244|NCT00587587|4095288|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4271245|NCT00587587|4095289|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4271246|NCT00587587|4095287|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271247|NCT00587587|4095288|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271248|NCT00587587|4095289|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271249|NCT00587483|4095310|B4|Unknown or Not Reported||Medical History/Comorbidities|Participants could have had more than one pre-existing condition, therefore the totals may be greater or less than the total number of participants in each group.|Participants|Number|143|143.0||||||
4271250|NCT00587483|4095311|B3|Unknown or Not Reported||Medical History/Comorbidities|Participants could have had more than one pre-existing condition, therefore the totals may be greater or less than the total number of participants in each group.|Participants|Number|45|45.0||||||
4271251|NCT00587483|4095312|B2|Unknown or Not Reported||Medical History/Comorbidities|Participants could have had more than one pre-existing condition, therefore the totals may be greater or less than the total number of participants in each group.|Participants|Number|41|41.0||||||
4271252|NCT00587483|4095313|B1|Unknown or Not Reported||Medical History/Comorbidities|Participants could have had more than one pre-existing condition, therefore the totals may be greater or less than the total number of participants in each group.|Participants|Number|57|57.0||||||
4271253|NCT00587483|4095310|B4|Hypertension||Medical History/Comorbidities|Participants could have had more than one pre-existing condition, therefore the totals may be greater or less than the total number of participants in each group.|Participants|Number|140|140.0||||||
4271254|NCT00587483|4095311|B3|Hypertension||Medical History/Comorbidities|Participants could have had more than one pre-existing condition, therefore the totals may be greater or less than the total number of participants in each group.|Participants|Number|48|48.0||||||
4271255|NCT00587483|4095312|B2|Hypertension||Medical History/Comorbidities|Participants could have had more than one pre-existing condition, therefore the totals may be greater or less than the total number of participants in each group.|Participants|Number|55|55.0||||||
4271256|NCT00587483|4095313|B1|Hypertension||Medical History/Comorbidities|Participants could have had more than one pre-existing condition, therefore the totals may be greater or less than the total number of participants in each group.|Participants|Number|37|37.0||||||
4271257|NCT00587483|4095310|B4|Chronic Obstructive Pulmonary Disease (COPD)||Medical History/Comorbidities|Participants could have had more than one pre-existing condition, therefore the totals may be greater or less than the total number of participants in each group.|Participants|Number|15|15.0||||||
4271258|NCT00587483|4095311|B3|Chronic Obstructive Pulmonary Disease (COPD)||Medical History/Comorbidities|Participants could have had more than one pre-existing condition, therefore the totals may be greater or less than the total number of participants in each group.|Participants|Number|5|5.0||||||
4271259|NCT00587483|4095312|B2|Chronic Obstructive Pulmonary Disease (COPD)||Medical History/Comorbidities|Participants could have had more than one pre-existing condition, therefore the totals may be greater or less than the total number of participants in each group.|Participants|Number|3|3.0||||||
4271260|NCT00587483|4095313|B1|Chronic Obstructive Pulmonary Disease (COPD)||Medical History/Comorbidities|Participants could have had more than one pre-existing condition, therefore the totals may be greater or less than the total number of participants in each group.|Participants|Number|7|7.0||||||
4271261|NCT00587483|4095310|B4|Diabetes Mellitus||Medical History/Comorbidities|Participants could have had more than one pre-existing condition, therefore the totals may be greater or less than the total number of participants in each group.|Participants|Number|44|44.0||||||
4271262|NCT00587483|4095311|B3|Diabetes Mellitus||Medical History/Comorbidities|Participants could have had more than one pre-existing condition, therefore the totals may be greater or less than the total number of participants in each group.|Participants|Number|14|14.0||||||
4271263|NCT00587483|4095312|B2|Diabetes Mellitus||Medical History/Comorbidities|Participants could have had more than one pre-existing condition, therefore the totals may be greater or less than the total number of participants in each group.|Participants|Number|16|16.0||||||
4271264|NCT00587483|4095313|B1|Diabetes Mellitus||Medical History/Comorbidities|Participants could have had more than one pre-existing condition, therefore the totals may be greater or less than the total number of participants in each group.|Participants|Number|14|14.0||||||
4271265|NCT00587483|4095310|B4|||Left Ventricular Ejection Fraction (%)||Percentage|Mean|62.75|62.75|Standard Deviation|11|11.0|||
4271266|NCT00587483|4095311|B3|||Left Ventricular Ejection Fraction (%)||Percentage|Mean|62.8|62.8|Standard Deviation|11.7|11.7|||
4271267|NCT00587483|4095312|B2|||Left Ventricular Ejection Fraction (%)||Percentage|Mean|62.7|62.7|Standard Deviation|10.8|10.8|||
4271268|NCT00587483|4095313|B1|||Left Ventricular Ejection Fraction (%)||Percentage|Mean|62.7|62.7|Standard Deviation|11.5|11.5|||
4271269|NCT00587483|4095310|B4|Unknown or Not Reported||History of Dysrhythmias||Participants|Number|267|267.0||||||
4271270|NCT00587483|4095311|B3|Unknown or Not Reported||History of Dysrhythmias||Participants|Number|91|91.0||||||
4271271|NCT00587483|4095312|B2|Unknown or Not Reported||History of Dysrhythmias||Participants|Number|88|88.0||||||
4271272|NCT00587483|4095313|B1|Unknown or Not Reported||History of Dysrhythmias||Participants|Number|88|88.0||||||
4271273|NCT00587483|4095310|B4|Ventricular||History of Dysrhythmias||Participants|Number|6|6.0||||||
4271274|NCT00587483|4095311|B3|Ventricular||History of Dysrhythmias||Participants|Number|3|3.0||||||
4271275|NCT00587483|4095312|B2|Ventricular||History of Dysrhythmias||Participants|Number|0|0.0||||||
4271276|NCT00587483|4095313|B1|Ventricular||History of Dysrhythmias||Participants|Number|3|3.0||||||
4271277|NCT00587483|4095310|B4|Atrial Flutter||History of Dysrhythmias||Participants|Number|7|7.0||||||
4271278|NCT00587483|4095311|B3|Atrial Flutter||History of Dysrhythmias||Participants|Number|1|1.0||||||
4271279|NCT00587483|4095312|B2|Atrial Flutter||History of Dysrhythmias||Participants|Number|4|4.0||||||
4271280|NCT00587483|4095313|B1|Atrial Flutter||History of Dysrhythmias||Participants|Number|2|2.0||||||
4271281|NCT00587483|4095310|B4|Atrial Fibrillation||History of Dysrhythmias||Participants|Number|62|62.0||||||
4271282|NCT00587483|4095311|B3|Atrial Fibrillation||History of Dysrhythmias||Participants|Number|17|17.0||||||
4271283|NCT00587483|4095312|B2|Atrial Fibrillation||History of Dysrhythmias||Participants|Number|23|23.0||||||
4271284|NCT00587483|4095313|B1|Atrial Fibrillation||History of Dysrhythmias||Participants|Number|22|22.0||||||
4271285|NCT00587483|4095310|B4|Amiodarone||Preoperative Medications|Participants could have received more than one preoperative medication, therefore the totals of all the medications are greater than the number of participants.|Participants|Number|14|14.0||||||
4271286|NCT00587483|4095311|B3|Amiodarone||Preoperative Medications|Participants could have received more than one preoperative medication, therefore the totals of all the medications are greater than the number of participants.|Participants|Number|2|2.0||||||
4271287|NCT00587483|4095312|B2|Amiodarone||Preoperative Medications|Participants could have received more than one preoperative medication, therefore the totals of all the medications are greater than the number of participants.|Participants|Number|5|5.0||||||
4271288|NCT00587483|4095313|B1|Amiodarone||Preoperative Medications|Participants could have received more than one preoperative medication, therefore the totals of all the medications are greater than the number of participants.|Participants|Number|7|7.0||||||
4271289|NCT00587483|4095310|B4|Digoxin||Preoperative Medications|Participants could have received more than one preoperative medication, therefore the totals of all the medications are greater than the number of participants.|Participants|Number|18|18.0||||||
4271290|NCT00587483|4095311|B3|Digoxin||Preoperative Medications|Participants could have received more than one preoperative medication, therefore the totals of all the medications are greater than the number of participants.|Participants|Number|7|7.0||||||
4271291|NCT00587483|4095312|B2|Digoxin||Preoperative Medications|Participants could have received more than one preoperative medication, therefore the totals of all the medications are greater than the number of participants.|Participants|Number|7|7.0||||||
4271292|NCT00587483|4095313|B1|Digoxin||Preoperative Medications|Participants could have received more than one preoperative medication, therefore the totals of all the medications are greater than the number of participants.|Participants|Number|4|4.0||||||
4271293|NCT00587483|4095310|B4|Statin||Preoperative Medications|Participants could have received more than one preoperative medication, therefore the totals of all the medications are greater than the number of participants.|Participants|Number|148|148.0||||||
4271294|NCT00587483|4095311|B3|Statin||Preoperative Medications|Participants could have received more than one preoperative medication, therefore the totals of all the medications are greater than the number of participants.|Participants|Number|60|60.0||||||
4271295|NCT00587483|4095312|B2|Statin||Preoperative Medications|Participants could have received more than one preoperative medication, therefore the totals of all the medications are greater than the number of participants.|Participants|Number|46|46.0||||||
4271334|NCT00587457|4095342|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4271296|NCT00587483|4095313|B1|Statin||Preoperative Medications|Participants could have received more than one preoperative medication, therefore the totals of all the medications are greater than the number of participants.|Participants|Number|42|42.0||||||
4271297|NCT00587483|4095310|B4|ACE Inhibitor/Angiotensin Receptor Blocker (ARB)||Preoperative Medications|Participants could have received more than one preoperative medication, therefore the totals of all the medications are greater than the number of participants.|Participants|Number|103|103.0||||||
4271298|NCT00587483|4095311|B3|ACE Inhibitor/Angiotensin Receptor Blocker (ARB)||Preoperative Medications|Participants could have received more than one preoperative medication, therefore the totals of all the medications are greater than the number of participants.|Participants|Number|29|29.0||||||
4271299|NCT00587483|4095312|B2|ACE Inhibitor/Angiotensin Receptor Blocker (ARB)||Preoperative Medications|Participants could have received more than one preoperative medication, therefore the totals of all the medications are greater than the number of participants.|Participants|Number|43|43.0||||||
4271300|NCT00587483|4095313|B1|ACE Inhibitor/Angiotensin Receptor Blocker (ARB)||Preoperative Medications|Participants could have received more than one preoperative medication, therefore the totals of all the medications are greater than the number of participants.|Participants|Number|31|31.0||||||
4271301|NCT00587483|4095310|B4|Beta blocker||Preoperative Medications|Participants could have received more than one preoperative medication, therefore the totals of all the medications are greater than the number of participants.|Participants|Number|213|213.0||||||
4271302|NCT00587483|4095311|B3|Beta blocker||Preoperative Medications|Participants could have received more than one preoperative medication, therefore the totals of all the medications are greater than the number of participants.|Participants|Number|73|73.0||||||
4271303|NCT00587483|4095312|B2|Beta blocker||Preoperative Medications|Participants could have received more than one preoperative medication, therefore the totals of all the medications are greater than the number of participants.|Participants|Number|67|67.0||||||
4271304|NCT00587483|4095313|B1|Beta blocker||Preoperative Medications|Participants could have received more than one preoperative medication, therefore the totals of all the medications are greater than the number of participants.|Participants|Number|73|73.0||||||
4271305|NCT00587483|4095310|B4|Multiple Procedures||Type of Operation|The planned operative procedure requiring cardiopulmonary bypass with aortic cross clamping.|Participants|Number|85|85.0||||||
4271306|NCT00587483|4095311|B3|Multiple Procedures||Type of Operation|The planned operative procedure requiring cardiopulmonary bypass with aortic cross clamping.|Participants|Number|27|27.0||||||
4271307|NCT00587483|4095312|B2|Multiple Procedures||Type of Operation|The planned operative procedure requiring cardiopulmonary bypass with aortic cross clamping.|Participants|Number|25|25.0||||||
4271308|NCT00587483|4095313|B1|Multiple Procedures||Type of Operation|The planned operative procedure requiring cardiopulmonary bypass with aortic cross clamping.|Participants|Number|33|33.0||||||
4271309|NCT00587483|4095310|B4|Septal Myectomy||Type of Operation|The planned operative procedure requiring cardiopulmonary bypass with aortic cross clamping.|Participants|Number|98|98.0||||||
4271310|NCT00587483|4095311|B3|Septal Myectomy||Type of Operation|The planned operative procedure requiring cardiopulmonary bypass with aortic cross clamping.|Participants|Number|34|34.0||||||
4271311|NCT00587483|4095312|B2|Septal Myectomy||Type of Operation|The planned operative procedure requiring cardiopulmonary bypass with aortic cross clamping.|Participants|Number|34|34.0||||||
4271312|NCT00587483|4095313|B1|Septal Myectomy||Type of Operation|The planned operative procedure requiring cardiopulmonary bypass with aortic cross clamping.|Participants|Number|30|30.0||||||
4271313|NCT00587483|4095310|B4|Valve only||Type of Operation|The planned operative procedure requiring cardiopulmonary bypass with aortic cross clamping.|Participants|Number|106|106.0||||||
4271314|NCT00587483|4095311|B3|Valve only||Type of Operation|The planned operative procedure requiring cardiopulmonary bypass with aortic cross clamping.|Participants|Number|31|31.0||||||
4271315|NCT00587483|4095312|B2|Valve only||Type of Operation|The planned operative procedure requiring cardiopulmonary bypass with aortic cross clamping.|Participants|Number|38|38.0||||||
4271316|NCT00587483|4095313|B1|Valve only||Type of Operation|The planned operative procedure requiring cardiopulmonary bypass with aortic cross clamping.|Participants|Number|37|37.0||||||
4271317|NCT00587483|4095310|B4|Coronary Artery Bypass Grafting only||Type of Operation|The planned operative procedure requiring cardiopulmonary bypass with aortic cross clamping.|Participants|Number|53|53.0||||||
4271318|NCT00587483|4095311|B3|Coronary Artery Bypass Grafting only||Type of Operation|The planned operative procedure requiring cardiopulmonary bypass with aortic cross clamping.|Participants|Number|20|20.0||||||
4271319|NCT00587483|4095312|B2|Coronary Artery Bypass Grafting only||Type of Operation|The planned operative procedure requiring cardiopulmonary bypass with aortic cross clamping.|Participants|Number|18|18.0||||||
4271320|NCT00587483|4095313|B1|Coronary Artery Bypass Grafting only||Type of Operation|The planned operative procedure requiring cardiopulmonary bypass with aortic cross clamping.|Participants|Number|15|15.0||||||
4271321|NCT00587483|4095310|B4||Male|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
4271322|NCT00587483|4095311|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4271323|NCT00587483|4095312|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4271324|NCT00587483|4095313|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4271325|NCT00587483|4095310|B4||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4271326|NCT00587483|4095311|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4271327|NCT00587483|4095312|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4271328|NCT00587483|4095313|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4271329|NCT00587483|4095310|B4|||Age||years|Mean|63.2|63.2|Standard Deviation|13.0|13.0|||
4271330|NCT00587483|4095311|B3|||Age||years|Mean|63.6|63.6|Standard Deviation|13.0|13.0|||
4271331|NCT00587483|4095312|B2|||Age||years|Mean|63.3|63.3|Standard Deviation|13.6|13.6|||
4271332|NCT00587483|4095313|B1|||Age||years|Mean|62.7|62.7|Standard Deviation|13.9|13.9|||
4271333|NCT00587457|4095341|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4271335|NCT00587457|4095343|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4271336|NCT00587457|4095344|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4271337|NCT00587457|4095341|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4271338|NCT00587457|4095342|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4271339|NCT00587457|4095343|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4271340|NCT00587457|4095344|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4271341|NCT00587457|4095341|B4|||Age||Years|Mean|60.9|60.9|Standard Deviation|5.4|5.4|||
4271342|NCT00587457|4095342|B3|||Age||Years|Mean|61.6|61.6|Standard Deviation|7.5|7.5|||
4271343|NCT00587457|4095343|B2|||Age||Years|Mean|62.0|62.0|Standard Deviation|4.4|4.4|||
4271344|NCT00587457|4095344|B1|||Age||Years|Mean|58.7|58.7|Standard Deviation|2.3|2.3|||
4271345|NCT00587431|4095381|B3|United States||Region of Enrollment||participants|Number|102|102.0||||||
4271346|NCT00587431|4095382|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
4271347|NCT00587431|4095383|B1|United States||Region of Enrollment||participants|Number|63|63.0||||||
4271348|NCT00587431|4095381|B3||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4271349|NCT00587431|4095382|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4271350|NCT00587431|4095383|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4271351|NCT00587431|4095381|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4271352|NCT00587431|4095382|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4271353|NCT00587431|4095383|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4271354|NCT00587431|4095381|B3||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
4271355|NCT00587431|4095382|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4271356|NCT00587431|4095383|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4271357|NCT00587431|4095381|B3||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
4271358|NCT00587431|4095382|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4271359|NCT00587431|4095383|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4271360|NCT00587431|4095381|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271361|NCT00587431|4095382|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271362|NCT00587431|4095383|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271363|NCT00587431|4095381|B3|||Age||years|Median|61.5|61.5|Standard Deviation|30.40559159|30.40559159|||
4271364|NCT00587431|4095382|B2|||Age||years|Median|58.5|58.5|Standard Deviation|26.1629509|26.1629509|||
4271365|NCT00587431|4095383|B1|||Age||years|Median|65|65.0|Standard Deviation|25.45584412|25.45584412|||
4271366|NCT00587288|4095393|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4271367|NCT00587288|4095394|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4271368|NCT00587288|4095395|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4271369|NCT00587288|4095393|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4271370|NCT00587288|4095394|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4271371|NCT00587288|4095395|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4271372|NCT00587288|4095393|B3|>/= 65 years||Age, Customized||participants|Number|7|7.0||||||
4271373|NCT00587288|4095394|B2|>/= 65 years||Age, Customized||participants|Number|1|1.0||||||
4271374|NCT00587288|4095395|B1|>/= 65 years||Age, Customized||participants|Number|6|6.0||||||
4271375|NCT00587288|4095393|B3|45 to < 65 years||Age, Customized||participants|Number|51|51.0||||||
4271376|NCT00587288|4095394|B2|45 to < 65 years||Age, Customized||participants|Number|32|32.0||||||
4271377|NCT00587288|4095395|B1|45 to < 65 years||Age, Customized||participants|Number|19|19.0||||||
4271378|NCT00587288|4095393|B3|18 to < 45 years||Age, Customized||participants|Number|48|48.0||||||
4271379|NCT00587288|4095394|B2|18 to < 45 years||Age, Customized||participants|Number|20|20.0||||||
4271380|NCT00587288|4095395|B1|18 to < 45 years||Age, Customized||participants|Number|28|28.0||||||
4271381|NCT00587288|4095393|B3|||Age||years|Mean|45.4|45.4|Standard Deviation|12.83|12.83|||
4271382|NCT00587288|4095394|B2|||Age||years|Mean|45.8|45.8|Standard Deviation|11.74|11.74|||
4271383|NCT00587288|4095395|B1|||Age||years|Mean|44.9|44.9|Standard Deviation|13.94|13.94|||
4271384|NCT00587223|4095414|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4271385|NCT00587223|4095414|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271386|NCT00587223|4095414|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271387|NCT00587223|4095414|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4271388|NCT00587223|4095414|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271389|NCT00587223|4095414|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271390|NCT00587223|4095414|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271391|NCT00587223|4095414|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271392|NCT00587223|4095414|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4271393|NCT00587223|4095414|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4271394|NCT00587223|4095414|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4271395|NCT00587223|4095414|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4271396|NCT00587223|4095414|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4271397|NCT00587171|4095429|B3|Failed pretest||Randot Preschool stereoacuity|The Randot Preschool Stereotest measures stereopsis from 800 to 40 seconds of arc on patients as young as 2 years of age. This Stereotest is designed as a matching game in which the patient matches pictures in a test booklet wearing special glasses. A subject can fail the pretest (not see any pictures) or can score >800 (the worst), 800, 400, 200, 100, 60, or 40 (the best) seconds of arc. If two shapes are identified correctly the patient progresses to the next lower stereoacuity level. A failed test occurs when the patient cannot identify any shapes.|participants|Number|0|0.0||||||
4271398|NCT00587171|4095430|B2|Failed pretest||Randot Preschool stereoacuity|The Randot Preschool Stereotest measures stereopsis from 800 to 40 seconds of arc on patients as young as 2 years of age. This Stereotest is designed as a matching game in which the patient matches pictures in a test booklet wearing special glasses. A subject can fail the pretest (not see any pictures) or can score >800 (the worst), 800, 400, 200, 100, 60, or 40 (the best) seconds of arc. If two shapes are identified correctly the patient progresses to the next lower stereoacuity level. A failed test occurs when the patient cannot identify any shapes.|participants|Number|0|0.0||||||
4271399|NCT00587171|4095431|B1|Failed pretest||Randot Preschool stereoacuity|The Randot Preschool Stereotest measures stereopsis from 800 to 40 seconds of arc on patients as young as 2 years of age. This Stereotest is designed as a matching game in which the patient matches pictures in a test booklet wearing special glasses. A subject can fail the pretest (not see any pictures) or can score >800 (the worst), 800, 400, 200, 100, 60, or 40 (the best) seconds of arc. If two shapes are identified correctly the patient progresses to the next lower stereoacuity level. A failed test occurs when the patient cannot identify any shapes.|participants|Number|0|0.0||||||
4271400|NCT00587171|4095429|B3|>800 arcsec||Randot Preschool stereoacuity|The Randot Preschool Stereotest measures stereopsis from 800 to 40 seconds of arc on patients as young as 2 years of age. This Stereotest is designed as a matching game in which the patient matches pictures in a test booklet wearing special glasses. A subject can fail the pretest (not see any pictures) or can score >800 (the worst), 800, 400, 200, 100, 60, or 40 (the best) seconds of arc. If two shapes are identified correctly the patient progresses to the next lower stereoacuity level. A failed test occurs when the patient cannot identify any shapes.|participants|Number|0|0.0||||||
4271401|NCT00587171|4095430|B2|>800 arcsec||Randot Preschool stereoacuity|The Randot Preschool Stereotest measures stereopsis from 800 to 40 seconds of arc on patients as young as 2 years of age. This Stereotest is designed as a matching game in which the patient matches pictures in a test booklet wearing special glasses. A subject can fail the pretest (not see any pictures) or can score >800 (the worst), 800, 400, 200, 100, 60, or 40 (the best) seconds of arc. If two shapes are identified correctly the patient progresses to the next lower stereoacuity level. A failed test occurs when the patient cannot identify any shapes.|participants|Number|0|0.0||||||
4271402|NCT00587171|4095431|B1|>800 arcsec||Randot Preschool stereoacuity|The Randot Preschool Stereotest measures stereopsis from 800 to 40 seconds of arc on patients as young as 2 years of age. This Stereotest is designed as a matching game in which the patient matches pictures in a test booklet wearing special glasses. A subject can fail the pretest (not see any pictures) or can score >800 (the worst), 800, 400, 200, 100, 60, or 40 (the best) seconds of arc. If two shapes are identified correctly the patient progresses to the next lower stereoacuity level. A failed test occurs when the patient cannot identify any shapes.|participants|Number|0|0.0||||||
4271403|NCT00587171|4095429|B3|800 arcsec||Randot Preschool stereoacuity|The Randot Preschool Stereotest measures stereopsis from 800 to 40 seconds of arc on patients as young as 2 years of age. This Stereotest is designed as a matching game in which the patient matches pictures in a test booklet wearing special glasses. A subject can fail the pretest (not see any pictures) or can score >800 (the worst), 800, 400, 200, 100, 60, or 40 (the best) seconds of arc. If two shapes are identified correctly the patient progresses to the next lower stereoacuity level. A failed test occurs when the patient cannot identify any shapes.|participants|Number|5|5.0||||||
4271404|NCT00587171|4095430|B2|800 arcsec||Randot Preschool stereoacuity|The Randot Preschool Stereotest measures stereopsis from 800 to 40 seconds of arc on patients as young as 2 years of age. This Stereotest is designed as a matching game in which the patient matches pictures in a test booklet wearing special glasses. A subject can fail the pretest (not see any pictures) or can score >800 (the worst), 800, 400, 200, 100, 60, or 40 (the best) seconds of arc. If two shapes are identified correctly the patient progresses to the next lower stereoacuity level. A failed test occurs when the patient cannot identify any shapes.|participants|Number|2|2.0||||||
4271405|NCT00587171|4095431|B1|800 arcsec||Randot Preschool stereoacuity|The Randot Preschool Stereotest measures stereopsis from 800 to 40 seconds of arc on patients as young as 2 years of age. This Stereotest is designed as a matching game in which the patient matches pictures in a test booklet wearing special glasses. A subject can fail the pretest (not see any pictures) or can score >800 (the worst), 800, 400, 200, 100, 60, or 40 (the best) seconds of arc. If two shapes are identified correctly the patient progresses to the next lower stereoacuity level. A failed test occurs when the patient cannot identify any shapes.|participants|Number|3|3.0||||||
4271406|NCT00587171|4095429|B3|400 arcsec||Randot Preschool stereoacuity|The Randot Preschool Stereotest measures stereopsis from 800 to 40 seconds of arc on patients as young as 2 years of age. This Stereotest is designed as a matching game in which the patient matches pictures in a test booklet wearing special glasses. A subject can fail the pretest (not see any pictures) or can score >800 (the worst), 800, 400, 200, 100, 60, or 40 (the best) seconds of arc. If two shapes are identified correctly the patient progresses to the next lower stereoacuity level. A failed test occurs when the patient cannot identify any shapes.|participants|Number|3|3.0||||||
4271407|NCT00587171|4095430|B2|400 arcsec||Randot Preschool stereoacuity|The Randot Preschool Stereotest measures stereopsis from 800 to 40 seconds of arc on patients as young as 2 years of age. This Stereotest is designed as a matching game in which the patient matches pictures in a test booklet wearing special glasses. A subject can fail the pretest (not see any pictures) or can score >800 (the worst), 800, 400, 200, 100, 60, or 40 (the best) seconds of arc. If two shapes are identified correctly the patient progresses to the next lower stereoacuity level. A failed test occurs when the patient cannot identify any shapes.|participants|Number|2|2.0||||||
4271439|NCT00587171|4095429|B3|20/40 (68 to 72 letters) (worse)||Distance visual acuity in fellow eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|0|0.0||||||
4271408|NCT00587171|4095431|B1|400 arcsec||Randot Preschool stereoacuity|The Randot Preschool Stereotest measures stereopsis from 800 to 40 seconds of arc on patients as young as 2 years of age. This Stereotest is designed as a matching game in which the patient matches pictures in a test booklet wearing special glasses. A subject can fail the pretest (not see any pictures) or can score >800 (the worst), 800, 400, 200, 100, 60, or 40 (the best) seconds of arc. If two shapes are identified correctly the patient progresses to the next lower stereoacuity level. A failed test occurs when the patient cannot identify any shapes.|participants|Number|1|1.0||||||
4271409|NCT00587171|4095429|B3|200 arcsec||Randot Preschool stereoacuity|The Randot Preschool Stereotest measures stereopsis from 800 to 40 seconds of arc on patients as young as 2 years of age. This Stereotest is designed as a matching game in which the patient matches pictures in a test booklet wearing special glasses. A subject can fail the pretest (not see any pictures) or can score >800 (the worst), 800, 400, 200, 100, 60, or 40 (the best) seconds of arc. If two shapes are identified correctly the patient progresses to the next lower stereoacuity level. A failed test occurs when the patient cannot identify any shapes.|participants|Number|5|5.0||||||
4271410|NCT00587171|4095430|B2|200 arcsec||Randot Preschool stereoacuity|The Randot Preschool Stereotest measures stereopsis from 800 to 40 seconds of arc on patients as young as 2 years of age. This Stereotest is designed as a matching game in which the patient matches pictures in a test booklet wearing special glasses. A subject can fail the pretest (not see any pictures) or can score >800 (the worst), 800, 400, 200, 100, 60, or 40 (the best) seconds of arc. If two shapes are identified correctly the patient progresses to the next lower stereoacuity level. A failed test occurs when the patient cannot identify any shapes.|participants|Number|2|2.0||||||
4271411|NCT00587171|4095431|B1|200 arcsec||Randot Preschool stereoacuity|The Randot Preschool Stereotest measures stereopsis from 800 to 40 seconds of arc on patients as young as 2 years of age. This Stereotest is designed as a matching game in which the patient matches pictures in a test booklet wearing special glasses. A subject can fail the pretest (not see any pictures) or can score >800 (the worst), 800, 400, 200, 100, 60, or 40 (the best) seconds of arc. If two shapes are identified correctly the patient progresses to the next lower stereoacuity level. A failed test occurs when the patient cannot identify any shapes.|participants|Number|3|3.0||||||
4271412|NCT00587171|4095429|B3|100 arcsec||Randot Preschool stereoacuity|The Randot Preschool Stereotest measures stereopsis from 800 to 40 seconds of arc on patients as young as 2 years of age. This Stereotest is designed as a matching game in which the patient matches pictures in a test booklet wearing special glasses. A subject can fail the pretest (not see any pictures) or can score >800 (the worst), 800, 400, 200, 100, 60, or 40 (the best) seconds of arc. If two shapes are identified correctly the patient progresses to the next lower stereoacuity level. A failed test occurs when the patient cannot identify any shapes.|participants|Number|6|6.0||||||
4271413|NCT00587171|4095430|B2|100 arcsec||Randot Preschool stereoacuity|The Randot Preschool Stereotest measures stereopsis from 800 to 40 seconds of arc on patients as young as 2 years of age. This Stereotest is designed as a matching game in which the patient matches pictures in a test booklet wearing special glasses. A subject can fail the pretest (not see any pictures) or can score >800 (the worst), 800, 400, 200, 100, 60, or 40 (the best) seconds of arc. If two shapes are identified correctly the patient progresses to the next lower stereoacuity level. A failed test occurs when the patient cannot identify any shapes.|participants|Number|4|4.0||||||
4271414|NCT00587171|4095431|B1|100 arcsec||Randot Preschool stereoacuity|The Randot Preschool Stereotest measures stereopsis from 800 to 40 seconds of arc on patients as young as 2 years of age. This Stereotest is designed as a matching game in which the patient matches pictures in a test booklet wearing special glasses. A subject can fail the pretest (not see any pictures) or can score >800 (the worst), 800, 400, 200, 100, 60, or 40 (the best) seconds of arc. If two shapes are identified correctly the patient progresses to the next lower stereoacuity level. A failed test occurs when the patient cannot identify any shapes.|participants|Number|2|2.0||||||
4271415|NCT00587171|4095429|B3|60 arcsec||Randot Preschool stereoacuity|The Randot Preschool Stereotest measures stereopsis from 800 to 40 seconds of arc on patients as young as 2 years of age. This Stereotest is designed as a matching game in which the patient matches pictures in a test booklet wearing special glasses. A subject can fail the pretest (not see any pictures) or can score >800 (the worst), 800, 400, 200, 100, 60, or 40 (the best) seconds of arc. If two shapes are identified correctly the patient progresses to the next lower stereoacuity level. A failed test occurs when the patient cannot identify any shapes.|participants|Number|0|0.0||||||
4271416|NCT00587171|4095430|B2|60 arcsec||Randot Preschool stereoacuity|The Randot Preschool Stereotest measures stereopsis from 800 to 40 seconds of arc on patients as young as 2 years of age. This Stereotest is designed as a matching game in which the patient matches pictures in a test booklet wearing special glasses. A subject can fail the pretest (not see any pictures) or can score >800 (the worst), 800, 400, 200, 100, 60, or 40 (the best) seconds of arc. If two shapes are identified correctly the patient progresses to the next lower stereoacuity level. A failed test occurs when the patient cannot identify any shapes.|participants|Number|0|0.0||||||
4271417|NCT00587171|4095431|B1|60 arcsec||Randot Preschool stereoacuity|The Randot Preschool Stereotest measures stereopsis from 800 to 40 seconds of arc on patients as young as 2 years of age. This Stereotest is designed as a matching game in which the patient matches pictures in a test booklet wearing special glasses. A subject can fail the pretest (not see any pictures) or can score >800 (the worst), 800, 400, 200, 100, 60, or 40 (the best) seconds of arc. If two shapes are identified correctly the patient progresses to the next lower stereoacuity level. A failed test occurs when the patient cannot identify any shapes.|participants|Number|0|0.0||||||
4271418|NCT00587171|4095429|B3|40 arcsec||Randot Preschool stereoacuity|The Randot Preschool Stereotest measures stereopsis from 800 to 40 seconds of arc on patients as young as 2 years of age. This Stereotest is designed as a matching game in which the patient matches pictures in a test booklet wearing special glasses. A subject can fail the pretest (not see any pictures) or can score >800 (the worst), 800, 400, 200, 100, 60, or 40 (the best) seconds of arc. If two shapes are identified correctly the patient progresses to the next lower stereoacuity level. A failed test occurs when the patient cannot identify any shapes.|participants|Number|0|0.0||||||
4271440|NCT00587171|4095430|B2|20/40 (68 to 72 letters) (worse)||Distance visual acuity in fellow eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|0|0.0||||||
4271419|NCT00587171|4095430|B2|40 arcsec||Randot Preschool stereoacuity|The Randot Preschool Stereotest measures stereopsis from 800 to 40 seconds of arc on patients as young as 2 years of age. This Stereotest is designed as a matching game in which the patient matches pictures in a test booklet wearing special glasses. A subject can fail the pretest (not see any pictures) or can score >800 (the worst), 800, 400, 200, 100, 60, or 40 (the best) seconds of arc. If two shapes are identified correctly the patient progresses to the next lower stereoacuity level. A failed test occurs when the patient cannot identify any shapes.|participants|Number|0|0.0||||||
4271420|NCT00587171|4095431|B1|40 arcsec||Randot Preschool stereoacuity|The Randot Preschool Stereotest measures stereopsis from 800 to 40 seconds of arc on patients as young as 2 years of age. This Stereotest is designed as a matching game in which the patient matches pictures in a test booklet wearing special glasses. A subject can fail the pretest (not see any pictures) or can score >800 (the worst), 800, 400, 200, 100, 60, or 40 (the best) seconds of arc. If two shapes are identified correctly the patient progresses to the next lower stereoacuity level. A failed test occurs when the patient cannot identify any shapes.|participants|Number|0|0.0||||||
4271421|NCT00587171|4095429|B3|||Mean (SD) Intereye Acuity Difference|The difference between eyes in letters was calculated with positive values indicating sound eye better.|letters|Mean|23.7|23.7|Standard Deviation|7.6|7.6|||
4271422|NCT00587171|4095430|B2|||Mean (SD) Intereye Acuity Difference|The difference between eyes in letters was calculated with positive values indicating sound eye better.|letters|Mean|24.3|24.3|Standard Deviation|8.8|8.8|||
4271423|NCT00587171|4095431|B1|||Mean (SD) Intereye Acuity Difference|The difference between eyes in letters was calculated with positive values indicating sound eye better.|letters|Mean|23.0|23.0|Standard Deviation|6.5|6.5|||
4271424|NCT00587171|4095429|B3|||Mean (SD) Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|letters|Mean|85.8|85.8|Standard Deviation|3.8|3.8|||
4271425|NCT00587171|4095430|B2|||Mean (SD) Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|letters|Mean|86.2|86.2|Standard Deviation|4.0|4.0|||
4271426|NCT00587171|4095431|B1|||Mean (SD) Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|letters|Mean|85.3|85.3|Standard Deviation|3.6|3.6|||
4271427|NCT00587171|4095429|B3|20/16 (88 to 92 letters) (best)||Distance visual acuity in fellow eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|6|6.0||||||
4271428|NCT00587171|4095430|B2|20/16 (88 to 92 letters) (best)||Distance visual acuity in fellow eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|3|3.0||||||
4271429|NCT00587171|4095431|B1|20/16 (88 to 92 letters) (best)||Distance visual acuity in fellow eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|3|3.0||||||
4271430|NCT00587171|4095429|B3|20/20 (83 to 87 letters)||Distance visual acuity in fellow eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|9|9.0||||||
4271431|NCT00587171|4095430|B2|20/20 (83 to 87 letters)||Distance visual acuity in fellow eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|5|5.0||||||
4271432|NCT00587171|4095431|B1|20/20 (83 to 87 letters)||Distance visual acuity in fellow eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|4|4.0||||||
4271433|NCT00587171|4095429|B3|20/25 (78 to 82 letters)||Distance visual acuity in fellow eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|4|4.0||||||
4271434|NCT00587171|4095430|B2|20/25 (78 to 82 letters)||Distance visual acuity in fellow eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|2|2.0||||||
4271435|NCT00587171|4095431|B1|20/25 (78 to 82 letters)||Distance visual acuity in fellow eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|2|2.0||||||
4271436|NCT00587171|4095429|B3|20/32 (73 to 77 letters)||Distance visual acuity in fellow eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|0|0.0||||||
4271437|NCT00587171|4095430|B2|20/32 (73 to 77 letters)||Distance visual acuity in fellow eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|0|0.0||||||
4271438|NCT00587171|4095431|B1|20/32 (73 to 77 letters)||Distance visual acuity in fellow eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|0|0.0||||||
4271441|NCT00587171|4095431|B1|20/40 (68 to 72 letters) (worse)||Distance visual acuity in fellow eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|0|0.0||||||
4271442|NCT00587171|4095429|B3|||Mean (SD) Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|letters|Mean|62.1|62.1|Standard Deviation|7.2|7.2|||
4271443|NCT00587171|4095430|B2|||Mean (SD) Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|letters|Mean|61.9|61.9|Standard Deviation|7.9|7.9|||
4271444|NCT00587171|4095431|B1|||Mean (SD) Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|letters|Mean|62.3|62.3|Standard Deviation|6.8|6.8|||
4271445|NCT00587171|4095429|B3|20/40 (68 to 72 letters) (best)||Distance visual acuity in amblyopic eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|6|6.0||||||
4271446|NCT00587171|4095430|B2|20/40 (68 to 72 letters) (best)||Distance visual acuity in amblyopic eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|4|4.0||||||
4271447|NCT00587171|4095431|B1|20/40 (68 to 72 letters) (best)||Distance visual acuity in amblyopic eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|2|2.0||||||
4271448|NCT00587171|4095429|B3|20/50 (63 to 67 letters)||Distance visual acuity in amblyopic eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|6|6.0||||||
4271449|NCT00587171|4095430|B2|20/50 (63 to 67 letters)||Distance visual acuity in amblyopic eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|2|2.0||||||
4271450|NCT00587171|4095431|B1|20/50 (63 to 67 letters)||Distance visual acuity in amblyopic eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|4|4.0||||||
4271451|NCT00587171|4095429|B3|20/63 (58 to 62 letters)||Distance visual acuity in amblyopic eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|2|2.0||||||
4271452|NCT00587171|4095430|B2|20/63 (58 to 62 letters)||Distance visual acuity in amblyopic eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|1|1.0||||||
4271453|NCT00587171|4095431|B1|20/63 (58 to 62 letters)||Distance visual acuity in amblyopic eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|1|1.0||||||
4271454|NCT00587171|4095429|B3|20/80 (53 to 57 letters)||Distance visual acuity in amblyopic eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|1|1.0||||||
4271455|NCT00587171|4095430|B2|20/80 (53 to 57 letters)||Distance visual acuity in amblyopic eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|1|1.0||||||
4271456|NCT00587171|4095431|B1|20/80 (53 to 57 letters)||Distance visual acuity in amblyopic eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|0|0.0||||||
4271457|NCT00587171|4095429|B3|20/100 (48 to 52 letters) (worse)||Distance visual acuity in amblyopic eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|4|4.0||||||
4271458|NCT00587171|4095430|B2|20/100 (48 to 52 letters) (worse)||Distance visual acuity in amblyopic eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|2|2.0||||||
4271459|NCT00587171|4095431|B1|20/100 (48 to 52 letters) (worse)||Distance visual acuity in amblyopic eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|2|2.0||||||
4271460|NCT00587171|4095429|B3|Strabismus and anisometropia||Cause of Amblyopia||participants|Number|8|8.0||||||
4271461|NCT00587171|4095430|B2|Strabismus and anisometropia||Cause of Amblyopia||participants|Number|3|3.0||||||
4271462|NCT00587171|4095431|B1|Strabismus and anisometropia||Cause of Amblyopia||participants|Number|5|5.0||||||
4271463|NCT00587171|4095429|B3|Strabismus||Cause of Amblyopia||participants|Number|2|2.0||||||
4271464|NCT00587171|4095430|B2|Strabismus||Cause of Amblyopia||participants|Number|2|2.0||||||
4271465|NCT00587171|4095431|B1|Strabismus||Cause of Amblyopia||participants|Number|0|0.0||||||
4271466|NCT00587171|4095429|B3|Anisometropia||Cause of Amblyopia||participants|Number|9|9.0||||||
4271467|NCT00587171|4095430|B2|Anisometropia||Cause of Amblyopia||participants|Number|5|5.0||||||
4271468|NCT00587171|4095431|B1|Anisometropia||Cause of Amblyopia||participants|Number|4|4.0||||||
4271469|NCT00587171|4095429|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4271470|NCT00587171|4095430|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4271471|NCT00587171|4095431|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4271472|NCT00587171|4095429|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4271473|NCT00587171|4095430|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4271474|NCT00587171|4095431|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4271475|NCT00587171|4095429|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4271476|NCT00587171|4095430|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4271477|NCT00587171|4095431|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4271478|NCT00587171|4095429|B3|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4271479|NCT00587171|4095430|B2|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4271480|NCT00587171|4095431|B1|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4271481|NCT00587171|4095429|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4271482|NCT00587171|4095430|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4271483|NCT00587171|4095431|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4271484|NCT00587171|4095429|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4271485|NCT00587171|4095430|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4271486|NCT00587171|4095431|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4271487|NCT00587171|4095429|B3|12 years old||Age, Customized|Age at enrollment in years|participants|Number|4|4.0||||||
4271488|NCT00587171|4095430|B2|12 years old||Age, Customized|Age at enrollment in years|participants|Number|1|1.0||||||
4271489|NCT00587171|4095431|B1|12 years old||Age, Customized|Age at enrollment in years|participants|Number|3|3.0||||||
4271490|NCT00587171|4095429|B3|11 years old||Age, Customized|Age at enrollment in years|participants|Number|4|4.0||||||
4271491|NCT00587171|4095430|B2|11 years old||Age, Customized|Age at enrollment in years|participants|Number|4|4.0||||||
4271492|NCT00587171|4095431|B1|11 years old||Age, Customized|Age at enrollment in years|participants|Number|0|0.0||||||
4271493|NCT00587171|4095429|B3|10 years old||Age, Customized|Age at enrollment in years|participants|Number|1|1.0||||||
4271494|NCT00587171|4095430|B2|10 years old||Age, Customized|Age at enrollment in years|participants|Number|0|0.0||||||
4271495|NCT00587171|4095431|B1|10 years old||Age, Customized|Age at enrollment in years|participants|Number|1|1.0||||||
4271496|NCT00587171|4095429|B3|9 years old||Age, Customized|Age at enrollment in years|participants|Number|4|4.0||||||
4271497|NCT00587171|4095430|B2|9 years old||Age, Customized|Age at enrollment in years|participants|Number|2|2.0||||||
4271498|NCT00587171|4095431|B1|9 years old||Age, Customized|Age at enrollment in years|participants|Number|2|2.0||||||
4271499|NCT00587171|4095429|B3|8 years old||Age, Customized|Age at enrollment in years|participants|Number|3|3.0||||||
4271500|NCT00587171|4095430|B2|8 years old||Age, Customized|Age at enrollment in years|participants|Number|1|1.0||||||
4271501|NCT00587171|4095431|B1|8 years old||Age, Customized|Age at enrollment in years|participants|Number|2|2.0||||||
4271502|NCT00587171|4095429|B3|7 years old||Age, Customized|Age at enrollment in years|participants|Number|3|3.0||||||
4271503|NCT00587171|4095430|B2|7 years old||Age, Customized|Age at enrollment in years|participants|Number|2|2.0||||||
4271504|NCT00587171|4095431|B1|7 years old||Age, Customized|Age at enrollment in years|participants|Number|1|1.0||||||
4271505|NCT00587171|4095429|B3|||Age|Age at enrollment in years|years|Mean|10.0|10.0|Standard Deviation|1.9|1.9|||
4271506|NCT00587171|4095430|B2|||Age|Age at enrollment in years|years|Mean|10.0|10.0|Standard Deviation|1.8|1.8|||
4271507|NCT00587171|4095431|B1|||Age|Age at enrollment in years|years|Mean|10.1|10.1|Standard Deviation|2.1|2.1|||
4271508|NCT00587158|4095460|B3|Moderate to severe fibrosis at baseline||Degree of interstitial fibrosis|"Interstitial fibrosis refers to degree of scarring or fibrous tissue formed in the kidney. Renal pathologists reviewed biopsies of the subject's kidney grafts for fibrosis, with results expressed according to the Banff schema. The degree of fibrosis was reported using Banff scores (ci) as mild (ci greater than 0 and less than 2) or moderate to severe (ci greater than or equal to 2). Because not all subjects had interstitial fibrosis in their kidneys, the number with fibrosis will differ from the overall number of subjects in each treatment group."|Participants|Number|0|0.0||||||
4271509|NCT00587158|4095461|B2|Moderate to severe fibrosis at baseline||Degree of interstitial fibrosis|"Interstitial fibrosis refers to degree of scarring or fibrous tissue formed in the kidney. Renal pathologists reviewed biopsies of the subject's kidney grafts for fibrosis, with results expressed according to the Banff schema. The degree of fibrosis was reported using Banff scores (ci) as mild (ci greater than 0 and less than 2) or moderate to severe (ci greater than or equal to 2). Because not all subjects had interstitial fibrosis in their kidneys, the number with fibrosis will differ from the overall number of subjects in each treatment group."|Participants|Number|0|0.0||||||
4271542|NCT00587158|4095461|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4271543|NCT00587158|4095462|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4271544|NCT00587158|4095460|B3|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4271510|NCT00587158|4095462|B1|Moderate to severe fibrosis at baseline||Degree of interstitial fibrosis|"Interstitial fibrosis refers to degree of scarring or fibrous tissue formed in the kidney. Renal pathologists reviewed biopsies of the subject's kidney grafts for fibrosis, with results expressed according to the Banff schema. The degree of fibrosis was reported using Banff scores (ci) as mild (ci greater than 0 and less than 2) or moderate to severe (ci greater than or equal to 2). Because not all subjects had interstitial fibrosis in their kidneys, the number with fibrosis will differ from the overall number of subjects in each treatment group."|Participants|Number|0|0.0||||||
4271511|NCT00587158|4095460|B3|Mild fibrosis at baseline||Degree of interstitial fibrosis|"Interstitial fibrosis refers to degree of scarring or fibrous tissue formed in the kidney. Renal pathologists reviewed biopsies of the subject's kidney grafts for fibrosis, with results expressed according to the Banff schema. The degree of fibrosis was reported using Banff scores (ci) as mild (ci greater than 0 and less than 2) or moderate to severe (ci greater than or equal to 2). Because not all subjects had interstitial fibrosis in their kidneys, the number with fibrosis will differ from the overall number of subjects in each treatment group."|Participants|Number|5|5.0||||||
4271512|NCT00587158|4095461|B2|Mild fibrosis at baseline||Degree of interstitial fibrosis|"Interstitial fibrosis refers to degree of scarring or fibrous tissue formed in the kidney. Renal pathologists reviewed biopsies of the subject's kidney grafts for fibrosis, with results expressed according to the Banff schema. The degree of fibrosis was reported using Banff scores (ci) as mild (ci greater than 0 and less than 2) or moderate to severe (ci greater than or equal to 2). Because not all subjects had interstitial fibrosis in their kidneys, the number with fibrosis will differ from the overall number of subjects in each treatment group."|Participants|Number|3|3.0||||||
4271513|NCT00587158|4095462|B1|Mild fibrosis at baseline||Degree of interstitial fibrosis|"Interstitial fibrosis refers to degree of scarring or fibrous tissue formed in the kidney. Renal pathologists reviewed biopsies of the subject's kidney grafts for fibrosis, with results expressed according to the Banff schema. The degree of fibrosis was reported using Banff scores (ci) as mild (ci greater than 0 and less than 2) or moderate to severe (ci greater than or equal to 2). Because not all subjects had interstitial fibrosis in their kidneys, the number with fibrosis will differ from the overall number of subjects in each treatment group."|Participants|Number|2|2.0||||||
4271514|NCT00587158|4095460|B3|||Living kidney donor|Because some of the donor kidneys were from cadaver donors, the number of subjects receiving a kidney from living donors will not match the total number of subjects in each arm.|participants|Number|96|96.0||||||
4271515|NCT00587158|4095461|B2|||Living kidney donor|Because some of the donor kidneys were from cadaver donors, the number of subjects receiving a kidney from living donors will not match the total number of subjects in each arm.|participants|Number|48|48.0||||||
4271516|NCT00587158|4095462|B1|||Living kidney donor|Because some of the donor kidneys were from cadaver donors, the number of subjects receiving a kidney from living donors will not match the total number of subjects in each arm.|participants|Number|48|48.0||||||
4271517|NCT00587158|4095460|B3|Other||Cause of End-Stage Renal Disease||participants|Number|15|15.0||||||
4271518|NCT00587158|4095461|B2|Other||Cause of End-Stage Renal Disease||participants|Number|8|8.0||||||
4271519|NCT00587158|4095462|B1|Other||Cause of End-Stage Renal Disease||participants|Number|7|7.0||||||
4271520|NCT00587158|4095460|B3|Hypertension||Cause of End-Stage Renal Disease||participants|Number|4|4.0||||||
4271521|NCT00587158|4095461|B2|Hypertension||Cause of End-Stage Renal Disease||participants|Number|3|3.0||||||
4271522|NCT00587158|4095462|B1|Hypertension||Cause of End-Stage Renal Disease||participants|Number|1|1.0||||||
4271523|NCT00587158|4095460|B3|Glomerulonephritis||Cause of End-Stage Renal Disease||participants|Number|33|33.0||||||
4271524|NCT00587158|4095461|B2|Glomerulonephritis||Cause of End-Stage Renal Disease||participants|Number|16|16.0||||||
4271525|NCT00587158|4095462|B1|Glomerulonephritis||Cause of End-Stage Renal Disease||participants|Number|17|17.0||||||
4271526|NCT00587158|4095460|B3|Diabetic||Cause of End-Stage Renal Disease||participants|Number|18|18.0||||||
4271527|NCT00587158|4095461|B2|Diabetic||Cause of End-Stage Renal Disease||participants|Number|8|8.0||||||
4271528|NCT00587158|4095462|B1|Diabetic||Cause of End-Stage Renal Disease||participants|Number|10|10.0||||||
4271529|NCT00587158|4095460|B3|Adult Polycystic Kidney Disease||Cause of End-Stage Renal Disease||participants|Number|30|30.0||||||
4271530|NCT00587158|4095461|B2|Adult Polycystic Kidney Disease||Cause of End-Stage Renal Disease||participants|Number|16|16.0||||||
4271531|NCT00587158|4095462|B1|Adult Polycystic Kidney Disease||Cause of End-Stage Renal Disease||participants|Number|14|14.0||||||
4271532|NCT00587158|4095460|B3|||First transplant|Because this was not the first transplant for some subjects, the number of subjects having their first transplant will not match the total number of subjects in each arm.|participants|Number|97|97.0||||||
4271533|NCT00587158|4095461|B2|||First transplant|Because this was not the first transplant for some subjects, the number of subjects having their first transplant will not match the total number of subjects in each arm.|participants|Number|50|50.0||||||
4271534|NCT00587158|4095462|B1|||First transplant|Because this was not the first transplant for some subjects, the number of subjects having their first transplant will not match the total number of subjects in each arm.|participants|Number|47|47.0||||||
4271535|NCT00587158|4095460|B3|||Diabetes|Not all subjects were diabetic, so the total number of subjects within each arm will not match the number of subjects with diabetes within each arm.|participants|Number|22|22.0||||||
4271536|NCT00587158|4095461|B2|||Diabetes|Not all subjects were diabetic, so the total number of subjects within each arm will not match the number of subjects with diabetes within each arm.|participants|Number|10|10.0||||||
4271537|NCT00587158|4095462|B1|||Diabetes|Not all subjects were diabetic, so the total number of subjects within each arm will not match the number of subjects with diabetes within each arm.|participants|Number|12|12.0||||||
4271538|NCT00587158|4095460|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
4271539|NCT00587158|4095461|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
4271540|NCT00587158|4095462|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
4271541|NCT00587158|4095460|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4271545|NCT00587158|4095461|B2|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4271546|NCT00587158|4095462|B1|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4271547|NCT00587158|4095460|B3|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4271548|NCT00587158|4095461|B2|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4271549|NCT00587158|4095462|B1|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4271550|NCT00587158|4095460|B3|White||Race/Ethnicity, Customized||Participants|Number|91|91.0||||||
4271551|NCT00587158|4095461|B2|White||Race/Ethnicity, Customized||Participants|Number|49|49.0||||||
4271552|NCT00587158|4095462|B1|White||Race/Ethnicity, Customized||Participants|Number|42|42.0||||||
4271553|NCT00587158|4095460|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4271554|NCT00587158|4095461|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4271555|NCT00587158|4095462|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4271556|NCT00587158|4095460|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4271557|NCT00587158|4095461|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4271558|NCT00587158|4095462|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4271559|NCT00587158|4095460|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4271560|NCT00587158|4095461|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4271561|NCT00587158|4095462|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4271562|NCT00587158|4095460|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4271563|NCT00587158|4095461|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4271564|NCT00587158|4095462|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4271565|NCT00587158|4095460|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4271566|NCT00587158|4095461|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4271567|NCT00587158|4095462|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4271568|NCT00587158|4095460|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4271569|NCT00587158|4095461|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4271570|NCT00587158|4095462|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4271571|NCT00587158|4095460|B3|||Age||years|Mean|48.1|48.1|Standard Deviation|10.1|10.1|||
4271572|NCT00587158|4095461|B2|||Age||years|Mean|48.5|48.5|Standard Deviation|10.3|10.3|||
4271573|NCT00587158|4095462|B1|||Age||years|Mean|47.7|47.7|Standard Deviation|10.0|10.0|||
4271574|NCT00587132|4095493|B5|United States||Region of Enrollment||participants|Number|4|4.0||||||
4271575|NCT00587132|4095497|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4271576|NCT00587132|4095493|B5|Male||Gender||participants|Number|1|1.0||||||
4271577|NCT00587132|4095497|B1|Male||Gender||participants|Number|1|1.0||||||
4271578|NCT00587132|4095493|B5|Female||Gender||participants|Number|3|3.0||||||
4271579|NCT00587132|4095497|B1|Female||Gender||participants|Number|3|3.0||||||
4271580|NCT00587132|4095493|B5|>=65 years||Age||participants|Number|2|2.0||||||
4271581|NCT00587132|4095497|B1|>=65 years||Age||participants|Number|2|2.0||||||
4271582|NCT00587132|4095493|B5|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
4271583|NCT00587132|4095497|B1|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
4271584|NCT00587132|4095493|B5|<=18 years||Age||participants|Number|0|0.0||||||
4271585|NCT00587132|4095497|B1|<=18 years||Age||participants|Number|0|0.0||||||
4271586|NCT00587067|4095510|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4271587|NCT00587067|4095510|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4271588|NCT00587067|4095510|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271589|NCT00587067|4095510|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4271590|NCT00587067|4095510|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271591|NCT00587067|4095510|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271592|NCT00587067|4095510|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4271593|NCT00587067|4095510|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271594|NCT00587067|4095510|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4271595|NCT00587067|4095510|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4271596|NCT00587067|4095510|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4271597|NCT00587067|4095510|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4271598|NCT00587067|4095510|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4271599|NCT00587067|4095510|B1|||Age||years|Mean|56.5|56.5|Full Range|||30.0|85.0|
4271600|NCT00587054|4095516|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4271601|NCT00587054|4095516|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4271602|NCT00587054|4095516|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4271603|NCT00587054|4095516|B1||Between 18 and 65 years|Age||Participants|Count of Participants|127|127.0||||||
4271604|NCT00587054|4095516|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4271665|NCT00586729|4095555|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4271605|NCT00587041|4095520|B4|||Total Kidney Stones Passed|Mean number of kidney stones passed prior to study entry|Number of Stones|Mean|2.25|2.25|Standard Deviation|1.86|1.86|||
4271606|NCT00587041|4095521|B3|||Total Kidney Stones Passed|Mean number of kidney stones passed prior to study entry|Number of Stones|Mean|2.77|2.77|Standard Deviation|2.35|2.35|||
4271607|NCT00587041|4095522|B2|||Total Kidney Stones Passed|Mean number of kidney stones passed prior to study entry|Number of Stones|Mean|1.75|1.75|Standard Deviation|0.93|0.93|||
4271608|NCT00587041|4095523|B1|||Total Kidney Stones Passed|Mean number of kidney stones passed prior to study entry|Number of Stones|Mean|2.36|2.36|Standard Deviation|2.2|2.2|||
4271609|NCT00587041|4095520|B4|United States||Region of Enrollment||participants|Number|40|40.0||||||
4271610|NCT00587041|4095521|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4271611|NCT00587041|4095522|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4271612|NCT00587041|4095523|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4271613|NCT00587041|4095520|B4||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4271614|NCT00587041|4095521|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4271615|NCT00587041|4095522|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4271616|NCT00587041|4095523|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4271617|NCT00587041|4095520|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4271618|NCT00587041|4095521|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4271619|NCT00587041|4095522|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4271620|NCT00587041|4095523|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4271621|NCT00587041|4095520|B4|||Age||years|Mean|52.79|52.79|Standard Deviation|14.64|14.64|||
4271622|NCT00587041|4095521|B3|||Age||years|Mean|50.22|50.22|Standard Deviation|12.79|12.79|||
4271623|NCT00587041|4095522|B2|||Age||years|Mean|54.22|54.22|Standard Deviation|14.12|14.12|||
4271624|NCT00587041|4095523|B1|||Age||years|Mean|53.65|53.65|Standard Deviation|17.80|17.8|||
4271625|NCT00586898|4095536|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4271626|NCT00586898|4095536|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4271627|NCT00586898|4095536|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4271628|NCT00586898|4095536|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4271629|NCT00586898|4095536|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271630|NCT00586846|4095540|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4271631|NCT00586846|4095540|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4271632|NCT00586846|4095540|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4271633|NCT00586846|4095540|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4271634|NCT00586846|4095540|B1||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
4271635|NCT00586820|4095544|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4271636|NCT00586820|4095545|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4271637|NCT00586820|4095546|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4271638|NCT00586820|4095544|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4271639|NCT00586820|4095545|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4271640|NCT00586820|4095546|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4271641|NCT00586820|4095544|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4271642|NCT00586820|4095545|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4271643|NCT00586820|4095546|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4271644|NCT00586820|4095544|B3|||Age||years|Mean|64.27|64.27|Standard Deviation|11.6|11.6|||
4271645|NCT00586820|4095545|B2|||Age||years|Mean|64|64.0|Standard Deviation|12.5|12.5|||
4271646|NCT00586820|4095546|B1|||Age||years|Mean|64.5|64.5|Standard Deviation|11.2|11.2|||
4271647|NCT00586729|4095555|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4271648|NCT00586729|4095556|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4271649|NCT00586729|4095557|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4271650|NCT00586729|4095555|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4271651|NCT00586729|4095556|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4271652|NCT00586729|4095557|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4271653|NCT00586729|4095555|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4271654|NCT00586729|4095556|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4271655|NCT00586729|4095557|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4271656|NCT00586729|4095555|B3|||Age||years|Mean|47.6|47.6|Standard Deviation|17.8|17.8|||
4271657|NCT00586729|4095556|B2|||Age||years|Mean|52.7|52.7|Standard Deviation|16.1|16.1|||
4271658|NCT00586729|4095557|B1|||Age||years|Mean|47.0|47.0|Standard Deviation|17.9|17.9|||
4271659|NCT00586729|4095555|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4271660|NCT00586729|4095556|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4271661|NCT00586729|4095557|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4271662|NCT00586729|4095555|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4271663|NCT00586729|4095556|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4271664|NCT00586729|4095557|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4271666|NCT00586729|4095556|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271667|NCT00586729|4095557|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4271668|NCT00586716|4095568|B3|Unknown||Sex/Gender, Customized||participants|Number|22|22.0||||||
4271669|NCT00586716|4095569|B2|Unknown||Sex/Gender, Customized||participants|Number|8|8.0||||||
4271670|NCT00586716|4095570|B1|Unknown||Sex/Gender, Customized||participants|Number|14|14.0||||||
4271671|NCT00586716|4095568|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4271672|NCT00586716|4095569|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4271673|NCT00586716|4095570|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4271674|NCT00586716|4095568|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4271675|NCT00586716|4095569|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4271676|NCT00586716|4095570|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4271677|NCT00586716|4095568|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271678|NCT00586716|4095569|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271679|NCT00586716|4095570|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271680|NCT00586703|4095578|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4271681|NCT00586703|4095578|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271682|NCT00586703|4095578|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4271683|NCT00586703|4095578|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271684|NCT00586703|4095578|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4271685|NCT00586703|4095578|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271686|NCT00586703|4095578|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4271687|NCT00586703|4095578|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4271688|NCT00586703|4095578|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271689|NCT00586703|4095578|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271690|NCT00586703|4095578|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271691|NCT00586703|4095578|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4271692|NCT00586703|4095578|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4271693|NCT00586703|4095578|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4271694|NCT00586703|4095578|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4271695|NCT00586703|4095578|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271696|NCT00586690|4095583|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
4271697|NCT00586690|4095584|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4271698|NCT00586690|4095585|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4271699|NCT00586690|4095583|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271700|NCT00586690|4095584|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271701|NCT00586690|4095585|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271702|NCT00586690|4095583|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4271703|NCT00586690|4095584|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4271704|NCT00586690|4095585|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4271705|NCT00586690|4095583|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271706|NCT00586690|4095584|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271707|NCT00586690|4095585|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271708|NCT00586690|4095583|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271709|NCT00586690|4095584|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271710|NCT00586690|4095585|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271711|NCT00586690|4095583|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271712|NCT00586690|4095584|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271713|NCT00586690|4095585|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271714|NCT00586690|4095583|B3||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4271715|NCT00586690|4095584|B2||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4271716|NCT00586690|4095585|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4271717|NCT00586690|4095583|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4271718|NCT00586690|4095584|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4271719|NCT00586690|4095585|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4271720|NCT00586690|4095583|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271721|NCT00586690|4095584|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271722|NCT00586690|4095585|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271723|NCT00586690|4095583|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271724|NCT00586690|4095584|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271725|NCT00586690|4095585|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271726|NCT00586690|4095583|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271727|NCT00586690|4095584|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271728|NCT00586690|4095585|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4271729|NCT00586690|4095583|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4271730|NCT00586690|4095584|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4271731|NCT00586690|4095585|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4271732|NCT00586690|4095583|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4271733|NCT00586690|4095584|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4271734|NCT00586690|4095585|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4271735|NCT00586690|4095583|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4271736|NCT00586690|4095584|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4271737|NCT00586690|4095585|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4271738|NCT00586690|4095583|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4271739|NCT00586690|4095584|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4271740|NCT00586690|4095585|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4271741|NCT00586690|4095583|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271742|NCT00586690|4095584|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271743|NCT00586690|4095585|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271744|NCT00586664|4095593|B4||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4271745|NCT00586664|4095594|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4271746|NCT00586664|4095595|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4271747|NCT00586664|4095596|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4271748|NCT00586664|4095593|B4||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4271749|NCT00586664|4095594|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4271750|NCT00586664|4095595|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4271751|NCT00586664|4095596|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4271752|NCT00586664|4095593|B4|||Age||years|Mean|33.8|33.8|Standard Deviation|14.3|14.3|||
4271753|NCT00586664|4095594|B3|||Age||years|Mean|34.8|34.8|Standard Deviation|14.0|14.0|||
4271754|NCT00586664|4095595|B2|||Age||years|Mean|33.3|33.3|Standard Deviation|14.1|14.1|||
4271755|NCT00586664|4095596|B1|||Age||years|Mean|33.3|33.3|Standard Deviation|15.1|15.1|||
4271756|NCT00586625|4095642|B3||Male|Sex: Female, Male||Participants|Count of Participants|316|316.0||||||
4271757|NCT00586625|4095643|B2||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4271758|NCT00586625|4095644|B1||Male|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4271759|NCT00586625|4095642|B3||Female|Sex: Female, Male||Participants|Count of Participants|545|545.0||||||
4271760|NCT00586625|4095643|B2||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4271761|NCT00586625|4095644|B1||Female|Sex: Female, Male||Participants|Count of Participants|367|367.0||||||
4271762|NCT00586625|4095642|B3|||Age||years|Mean|34.4|34.4|Standard Deviation|16.4|16.4|||
4271763|NCT00586625|4095643|B2|||Age||years|Mean|34.2|34.2|Standard Deviation|16.3|16.3|||
4271764|NCT00586625|4095644|B1|||Age||years|Mean|34.5|34.5|Standard Deviation|16.5|16.5|||
4271765|NCT00586625|4095642|B3|>=18 years||Age, Customized||participants|Number|734|734.0||||||
4271766|NCT00586625|4095643|B2|>=18 years||Age, Customized||participants|Number|246|246.0||||||
4271767|NCT00586625|4095644|B1|>=18 years||Age, Customized||participants|Number|488|488.0||||||
4271768|NCT00586625|4095642|B3|10-17 years||Age, Customized||participants|Number|55|55.0||||||
4271769|NCT00586625|4095643|B2|10-17 years||Age, Customized||participants|Number|15|15.0||||||
4271770|NCT00586625|4095644|B1|10-17 years||Age, Customized||participants|Number|40|40.0||||||
4271771|NCT00586625|4095642|B3|3-9 years||Age, Customized||participants|Number|72|72.0||||||
4271772|NCT00586625|4095643|B2|3-9 years||Age, Customized||participants|Number|25|25.0||||||
4271773|NCT00586625|4095644|B1|3-9 years||Age, Customized||participants|Number|47|47.0||||||
4271774|NCT00586612|4095651|B3||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4271775|NCT00586612|4095652|B2||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4271776|NCT00586612|4095653|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4271777|NCT00586612|4095651|B3||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4271778|NCT00586612|4095652|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4271779|NCT00586612|4095653|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4271780|NCT00586612|4095651|B3|||Age||weeks|Mean|8.9|8.9|Standard Deviation|0.99|0.99|||
4271781|NCT00586612|4095652|B2|||Age||weeks|Mean|8.8|8.8|Standard Deviation|0.79|0.79|||
4271782|NCT00586612|4095653|B1|||Age||weeks|Mean|8.9|8.9|Standard Deviation|1.15|1.15|||
4271783|NCT00586573|4095720|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4271784|NCT00586573|4095720|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4271785|NCT00586573|4095720|B1|||Age||years|Mean|41.8|41.8|Standard Deviation|10.8|10.8|||
4271786|NCT00586573|4095720|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4271787|NCT00586573|4095720|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4271788|NCT00586573|4095720|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271789|NCT00586521|4095724|B1|Number participants without target joints presence||Target joints presence|16 (80%) subjects had at least 1 target joint; in most elbow(s) and/or ankles(s) were affected|participants|Number|4|4.0||||||
4271790|NCT00586521|4095724|B1|Number participants with target joints presence||Target joints presence|16 (80%) subjects had at least 1 target joint; in most elbow(s) and/or ankles(s) were affected|participants|Number|16|16.0||||||
4271791|NCT00586521|4095724|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4271792|NCT00586521|4095724|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4271793|NCT00586521|4095724|B1|||Age||years|Mean|36.4|36.4|Standard Deviation|3.5|3.5|||
4271794|NCT00586521|4095724|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4271795|NCT00586521|4095724|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4271796|NCT00586521|4095724|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271797|NCT00586495|4095731|B1|1||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG performance status is a rating of daily living abilities, from 0 to 5. 0=Fully active without restriction. 1= Restricted in physically strenuous activity. 2= Ambulatory, capable of all selfcare. 3=Capable of limited selfcare. 4= Completely disabled. 5= Dead.|participants|Number|15|15.0||||||
4271798|NCT00586495|4095731|B1|0||Eastern Cooperative Oncology Group (ECOG) performance status|ECOG performance status is a rating of daily living abilities, from 0 to 5. 0=Fully active without restriction. 1= Restricted in physically strenuous activity. 2= Ambulatory, capable of all selfcare. 3=Capable of limited selfcare. 4= Completely disabled. 5= Dead.|participants|Number|80|80.0||||||
4271799|NCT00586495|4095731|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4271800|NCT00586495|4095731|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4271801|NCT00586495|4095731|B1|>=65 years||Age, Customized||participants|Number|41|41.0||||||
4271802|NCT00586495|4095731|B1|<65 years||Age, Customized||participants|Number|54|54.0||||||
4271803|NCT00586495|4095731|B1|||Age||years|Mean|62.0|62.0|Standard Deviation|10.5|10.5|||
4271804|NCT00586482|4095741|B3|Did not intend to abstain prior to surgery||Pre-operative Abstinence Intention||participants|Number|9|9.0||||||
4271805|NCT00586482|4095742|B2|Did not intend to abstain prior to surgery||Pre-operative Abstinence Intention||participants|Number|5|5.0||||||
4271806|NCT00586482|4095743|B1|Did not intend to abstain prior to surgery||Pre-operative Abstinence Intention||participants|Number|4|4.0||||||
4271807|NCT00586482|4095741|B3|Intended to abstain prior to surgery||Pre-operative Abstinence Intention||participants|Number|37|37.0||||||
4271808|NCT00586482|4095742|B2|Intended to abstain prior to surgery||Pre-operative Abstinence Intention||participants|Number|19|19.0||||||
4271809|NCT00586482|4095743|B1|Intended to abstain prior to surgery||Pre-operative Abstinence Intention||participants|Number|18|18.0||||||
4271810|NCT00586482|4095741|B3|||Minnesota Nicotine Withdrawal Score|This item was measured using the Minnesota Nicotine Withdrawal Questionnaire, self-reported for the prior 24 hour period. This questionnaire consists of 15 items, each rated from 0 to 4, with a possible score of 0 to 60. A lower score indicates lesser withdrawal symptoms, and a higher score indicates greater withdrawal symptoms.|units on a scale|Mean|1.5|1.5|Standard Deviation|1.0|1.0|||
4271811|NCT00586482|4095742|B2|||Minnesota Nicotine Withdrawal Score|This item was measured using the Minnesota Nicotine Withdrawal Questionnaire, self-reported for the prior 24 hour period. This questionnaire consists of 15 items, each rated from 0 to 4, with a possible score of 0 to 60. A lower score indicates lesser withdrawal symptoms, and a higher score indicates greater withdrawal symptoms.|units on a scale|Mean|1.5|1.5|Standard Deviation|1.0|1.0|||
4271812|NCT00586482|4095743|B1|||Minnesota Nicotine Withdrawal Score|This item was measured using the Minnesota Nicotine Withdrawal Questionnaire, self-reported for the prior 24 hour period. This questionnaire consists of 15 items, each rated from 0 to 4, with a possible score of 0 to 60. A lower score indicates lesser withdrawal symptoms, and a higher score indicates greater withdrawal symptoms.|units on a scale|Mean|1.5|1.5|Standard Deviation|0.9|0.9|||
4271813|NCT00586482|4095741|B3|||Fagerstrom Test for Nicotine Dependence|This instrument consists of 6 questions related to cigarette smoking and nicotine dependency. Scores can range from 0 to 10. A score of 5 or less suggests low to moderate nicotine dependency. A score of 6 or higher indicates high nicotine dependency.|Units on a scale|Mean|6.4|6.4|Standard Deviation|1.3|1.3|||
4271814|NCT00586482|4095742|B2|||Fagerstrom Test for Nicotine Dependence|This instrument consists of 6 questions related to cigarette smoking and nicotine dependency. Scores can range from 0 to 10. A score of 5 or less suggests low to moderate nicotine dependency. A score of 6 or higher indicates high nicotine dependency.|Units on a scale|Mean|6.1|6.1|Standard Deviation|1.4|1.4|||
4271815|NCT00586482|4095743|B1|||Fagerstrom Test for Nicotine Dependence|This instrument consists of 6 questions related to cigarette smoking and nicotine dependency. Scores can range from 0 to 10. A score of 5 or less suggests low to moderate nicotine dependency. A score of 6 or higher indicates high nicotine dependency.|Units on a scale|Mean|6.7|6.7|Standard Deviation|1.2|1.2|||
4271816|NCT00586482|4095741|B3|||Number of cigarettes per day||Cigarettes per day|Mean|17.2|17.2|Standard Deviation|7.0|7.0|||
4271817|NCT00586482|4095742|B2|||Number of cigarettes per day||Cigarettes per day|Mean|17.9|17.9|Standard Deviation|7.2|7.2|||
4271818|NCT00586482|4095743|B1|||Number of cigarettes per day||Cigarettes per day|Mean|16.8|16.8|Standard Deviation|6.7|6.7|||
4271819|NCT00586482|4095741|B3|Out-Patient Elective Surgery||In-patient surgery||participants|Number|21|21.0||||||
4271820|NCT00586482|4095742|B2|Out-Patient Elective Surgery||In-patient surgery||participants|Number|11|11.0||||||
4271821|NCT00586482|4095743|B1|Out-Patient Elective Surgery||In-patient surgery||participants|Number|10|10.0||||||
4271822|NCT00586482|4095741|B3|In-Patient Elective Surgery||In-patient surgery||participants|Number|25|25.0||||||
4271823|NCT00586482|4095742|B2|In-Patient Elective Surgery||In-patient surgery||participants|Number|13|13.0||||||
4271824|NCT00586482|4095743|B1|In-Patient Elective Surgery||In-patient surgery||participants|Number|12|12.0||||||
4271825|NCT00586482|4095741|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
4271826|NCT00586482|4095742|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4271827|NCT00586482|4095743|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4271828|NCT00586482|4095741|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4271829|NCT00586482|4095742|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4271830|NCT00586482|4095743|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4271831|NCT00586482|4095741|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4271832|NCT00586482|4095742|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4271833|NCT00586482|4095743|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4271834|NCT00586482|4095741|B3|||Age||years|Mean|52.7|52.7|Standard Deviation|13.2|13.2|||
4271835|NCT00586482|4095742|B2|||Age||years|Mean|49.8|49.8|Standard Deviation|12.8|12.8|||
4271836|NCT00586482|4095743|B1|||Age||years|Mean|54.7|54.7|Standard Deviation|14.0|14.0|||
4271837|NCT00586469|4095758|B3||Male|Gender||Participants|Count of Participants|424|424.0||||||
4271838|NCT00586469|4095759|B2||Male|Gender||Participants|Count of Participants|220|220.0||||||
4271839|NCT00586469|4095760|B1||Male|Gender||Participants|Count of Participants|204|204.0||||||
4271840|NCT00586469|4095758|B3||Female|Gender||Participants|Count of Participants|576|576.0||||||
4271841|NCT00586469|4095759|B2||Female|Gender||Participants|Count of Participants|280|280.0||||||
4271842|NCT00586469|4095760|B1||Female|Gender||Participants|Count of Participants|296|296.0||||||
4271843|NCT00586469|4095758|B3|||Age||years|Mean|40.1|40.1|Standard Deviation|12.04|12.04|||
4271844|NCT00586469|4095759|B2|||Age||years|Mean|40.1|40.1|Standard Deviation|12.01|12.01|||
4271845|NCT00586469|4095760|B1|||Age||years|Mean|40.0|40.0|Standard Deviation|12.08|12.08|||
4271846|NCT00586339|4095785|B4|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|150|150.0||||||
4271847|NCT00586339|4095786|B3|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
4271848|NCT00586339|4095787|B2|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|59|59.0||||||
4271849|NCT00586339|4095788|B1|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|61|61.0||||||
4271850|NCT00586339|4095785|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4271851|NCT00586339|4095786|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4271852|NCT00586339|4095787|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4271853|NCT00586339|4095788|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4271854|NCT00586339|4095785|B4||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4271855|NCT00586339|4095786|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4271856|NCT00586339|4095787|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4271857|NCT00586339|4095788|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4271858|NCT00586339|4095785|B4|||Age||Years|Mean|21.9|21.9|Standard Deviation|1.85|1.85|||
4271859|NCT00586339|4095786|B3|||Age||Years|Mean|21.3|21.3|Standard Deviation|1.65|1.65|||
4271860|NCT00586339|4095787|B2|||Age||Years|Mean|22.7|22.7|Standard Deviation|1.70|1.7|||
4271861|NCT00586339|4095788|B1|||Age||Years|Mean|21.6|21.6|Standard Deviation|2.21|2.21|||
4271862|NCT00586326|4095888|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
4271863|NCT00586326|4095888|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4271864|NCT00586326|4095888|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4271865|NCT00586326|4095888|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|10.5|10.5|||
4271866|NCT00586326|4095888|B1||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4271867|NCT00586326|4095888|B1||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
4271868|NCT00586326|4095888|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271869|NCT00586313|4095899|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4271870|NCT00586313|4095899|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4271871|NCT00586313|4095899|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4271872|NCT00586313|4095899|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4271873|NCT00586313|4095899|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4271874|NCT00586313|4095899|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271875|NCT00586261|4095904|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4271876|NCT00586261|4095905|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4271877|NCT00586261|4095906|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4271878|NCT00586261|4095904|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4271879|NCT00586261|4095905|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4271880|NCT00586261|4095906|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4271881|NCT00586261|4095904|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4271882|NCT00586261|4095905|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4271883|NCT00586261|4095906|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4271884|NCT00586261|4095904|B3|||Age||years|Mean|73.1|73.1|Standard Deviation|7.9|7.9|||
4271885|NCT00586261|4095905|B2|||Age||years|Mean|72.1|72.1|Standard Deviation|8.3|8.3|||
4271886|NCT00586261|4095906|B1|||Age||years|Mean|74.2|74.2|Standard Deviation|7.4|7.4|||
4271887|NCT00586261|4095904|B3||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4271888|NCT00586261|4095905|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4271889|NCT00586261|4095906|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4271890|NCT00586261|4095904|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4271891|NCT00586261|4095905|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4271892|NCT00586261|4095906|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4271893|NCT00586261|4095904|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271894|NCT00586261|4095905|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271895|NCT00586261|4095906|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271896|NCT00586196|4095913|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4271897|NCT00586196|4095914|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4271898|NCT00586196|4095915|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4271899|NCT00586196|4095913|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4271900|NCT00586196|4095914|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4271901|NCT00586196|4095915|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4271902|NCT00586196|4095913|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4271903|NCT00586196|4095914|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4271904|NCT00586196|4095915|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4271905|NCT00586196|4095913|B3|||Age||years|Mean|87|87.0|Standard Deviation|4.5|4.5|||
4271906|NCT00586196|4095914|B2|||Age||years|Mean|87|87.0|Standard Deviation|3.7|3.7|||
4271907|NCT00586196|4095915|B1|||Age||years|Mean|88|88.0|Standard Deviation|5.2|5.2|||
4271908|NCT00586196|4095913|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4271909|NCT00586196|4095914|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4271910|NCT00586196|4095915|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4271911|NCT00586196|4095913|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4271912|NCT00586196|4095914|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4271913|NCT00586196|4095915|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4271914|NCT00586196|4095913|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271915|NCT00586196|4095914|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271916|NCT00586196|4095915|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271917|NCT00586170|4095924|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4271918|NCT00586170|4095925|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4271919|NCT00586170|4095926|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4271920|NCT00586170|4095924|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4271921|NCT00586170|4095925|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4271922|NCT00586170|4095926|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4271923|NCT00586170|4095924|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4271924|NCT00586170|4095925|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4271925|NCT00586170|4095926|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4271926|NCT00586170|4095924|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4271927|NCT00586170|4095925|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4271928|NCT00586170|4095926|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4271929|NCT00586170|4095924|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4271930|NCT00586170|4095925|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4271931|NCT00586170|4095926|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4271932|NCT00586170|4095924|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271933|NCT00586170|4095925|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271934|NCT00586170|4095926|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271935|NCT00586157|4095935|B1|||Before-School Functioning Questionnaire|"The questionnaire includes two a sections, a clinician rated 20-item scale and a 14-item self-report section completed collaboratively by child and parent/guardian.~Units on the clinician rated scale range from 0-3 on a scale of severity, with 0 being the least severe item score and 3 being the most severe. Units on the self-report section ranged from 0-2 on a scale of severity, with 0 being the least severe item score and 2 being the most severe. The possible range of scores for the questionnaire is 88"|Units on a Scale|Mean|40.50|40.5|Standard Deviation|11.64|11.64|||
4271936|NCT00586157|4095935|B1|||Attention Deficit Hyperactivity Disorder Rating Scale - AM|"Units on a scale range from 0-3 on a scale of severity, with 0 being the least severe item score and 3 being the most severe. The possible range of scores for the scale is 0 (least severe) to 54 (most severe).~This measure looked at the morning only."|Units on a scale|Mean|30.83|30.83|Standard Deviation|11.53|11.53|||
4271937|NCT00586157|4095935|B1|||Attention Deficit Hyperactivity Disorder Rating Scale|Units on a scale range from 0-3 on a scale of severity, with 0 being the least severe item score and 3 being the most severe. The possible range of scores for the scale is 0 (least severe) to 54 (most severe).|Units on a scale|Mean|37.80|37.8|Standard Deviation|9.08|9.08|||
4271938|NCT00586157|4095935|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4271939|NCT00586157|4095935|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4271940|NCT00586157|4095935|B1|||Age||years|Mean|9.17|9.17|Standard Deviation|1.84|1.84|||
4271941|NCT00586157|4095935|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4271942|NCT00586157|4095935|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4271943|NCT00586157|4095935|B1||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4271944|NCT00586105|4095946|B1|||Time since initial diagnosis|Time since initial diagnosis was the mean time from initial diagnosis to randomization into the study.|years|Mean|1.7|1.7|Standard Deviation|2.5|2.5|||
4271945|NCT00586105|4095946|B1|||Time since first progression|Time since first progression was defined as the time from the first progression of the patient’s disease after initial diagnosis until randomization into this study.|years|Mean|0.4|0.4|Standard Deviation|0.6|0.6|||
4271946|NCT00586105|4095946|B1|Predominantly clear cell||Renal Cell Carcinoma subtype|Patients were categorized into 1 or 2 subgroups depending on the tumor histology: Clear cell or predominantly clear cell.|participants|Number|5|5.0||||||
4271947|NCT00586105|4095946|B1|Clear cell||Renal Cell Carcinoma subtype|Patients were categorized into 1 or 2 subgroups depending on the tumor histology: Clear cell or predominantly clear cell.|participants|Number|34|34.0||||||
4271948|NCT00586105|4095946|B1|Intermediate-risk (1 or 2 risk factors)||Motzer risk factors|The 5 Motzer risk factors correlate with overall survival in metastatic RCC. Patients with no factors (low-risk) have a favorable survival risk, patients with 1 or 2 risk factors survive a shorter time and constitute an intermediate-risk group, and those with 3 or more risk factors have the poorest survival and represent a poor-risk group.|participants|Number|18|18.0||||||
4271949|NCT00586105|4095946|B1|Low-risk (no risk factors)||Motzer risk factors|The 5 Motzer risk factors correlate with overall survival in metastatic RCC. Patients with no factors (low-risk) have a favorable survival risk, patients with 1 or 2 risk factors survive a shorter time and constitute an intermediate-risk group, and those with 3 or more risk factors have the poorest survival and represent a poor-risk group.|participants|Number|21|21.0||||||
4271950|NCT00586105|4095946|B1|ECOG 1||Eastern Cooperative Oncology Group (ECOG) Scale|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. The scale ranges from 0 (fully active) to 5 (dead). Subjects entering this study must have had an ECOG score of 0 or 1 (restricted in physically strenuous activity but ambulatory).|participants|Number|19|19.0||||||
4271951|NCT00586105|4095946|B1|ECOG 0||Eastern Cooperative Oncology Group (ECOG) Scale|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. The scale ranges from 0 (fully active) to 5 (dead). Subjects entering this study must have had an ECOG score of 0 or 1 (restricted in physically strenuous activity but ambulatory).|participants|Number|20|20.0||||||
4271952|NCT00586105|4095946|B1|China||Region of Enrollment||participants|Number|20|20.0||||||
4271953|NCT00586105|4095946|B1|Taiwan||Region of Enrollment||participants|Number|19|19.0||||||
4271954|NCT00586105|4095946|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4271955|NCT00586105|4095946|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4271956|NCT00586105|4095946|B1|||Age||years|Mean|58|58.0|Standard Deviation|14.5|14.5|||
4271957|NCT00586066|4095959|B3|United States||Region of Enrollment||Participants|Count of Participants|72|72.0||||||
4271958|NCT00586066|4095960|B2|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
4271959|NCT00586066|4095961|B1|United States||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
4271960|NCT00586066|4095959|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4271961|NCT00586066|4095960|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4271962|NCT00586066|4095961|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4271963|NCT00586066|4095959|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4271964|NCT00586066|4095960|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4271965|NCT00586066|4095961|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4271966|NCT00586066|4095959|B3|||Age||years|Mean|46.70|46.7|Standard Deviation|9.54|9.54|||
4271967|NCT00586066|4095960|B2|||Age||years|Mean|47.33|47.33|Standard Deviation|7.98|7.98|||
4271968|NCT00586066|4095961|B1|||Age||years|Mean|46.29|46.29|Standard Deviation|10.48|10.48|||
4271969|NCT00586001|4095972|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
4271970|NCT00586001|4095973|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4271971|NCT00586001|4095974|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4271972|NCT00586001|4095972|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4271973|NCT00586001|4095973|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4271974|NCT00586001|4095974|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4271975|NCT00586001|4095972|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4271976|NCT00586001|4095973|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4271977|NCT00586001|4095974|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4271978|NCT00586001|4095972|B3|||Age||years|Mean|30.01|30.01|Full Range|||19.0|43.0|
4271979|NCT00586001|4095973|B2|||Age||years|Mean|30.64|30.64|Full Range|||19.0|43.0|
4271980|NCT00586001|4095974|B1|||Age||years|Mean|29.38|29.38|Full Range|||19.0|52.0|
4271981|NCT00586001|4095972|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4271982|NCT00586001|4095973|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4271983|NCT00586001|4095974|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4271984|NCT00586001|4095972|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4271985|NCT00586001|4095973|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4271986|NCT00586001|4095974|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4271987|NCT00586001|4095972|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271988|NCT00586001|4095973|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271989|NCT00586001|4095974|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4271990|NCT00585975|4096017|B3||Male|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4271991|NCT00585975|4096018|B2||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4271992|NCT00585975|4096019|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4271993|NCT00585975|4096017|B3||Female|Sex: Female, Male||Participants|Count of Participants|323|323.0||||||
4271994|NCT00585975|4096018|B2||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4271995|NCT00585975|4096019|B1||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4271996|NCT00585975|4096017|B3|||Age||years|Mean|68.7|68.7|Full Range|||37.0|90.0|
4271997|NCT00585975|4096018|B2|||Age||years|Mean|68.6|68.6|Full Range|||41.0|90.0|
4271998|NCT00585975|4096019|B1|||Age||years|Mean|68.8|68.8|Full Range|||37.0|90.0|
4271999|NCT00585923|4096028|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4272000|NCT00585923|4096029|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4272001|NCT00585923|4096030|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4272002|NCT00585923|4096028|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4272003|NCT00585923|4096029|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4272004|NCT00585923|4096030|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4272005|NCT00585923|4096028|B3|||Age||years|Mean|49.76|49.76|Standard Deviation|10.10|10.1|||
4272006|NCT00585923|4096029|B2|||Age||years|Mean|50.03|50.03|Standard Deviation|10.04|10.04|||
4272007|NCT00585923|4096030|B1|||Age||years|Mean|49.46|49.46|Standard Deviation|10.26|10.26|||
4272008|NCT00585923|4096028|B3|>=65 years||Age|There were 5 patients in the fixed hole group and 2 patients in the slotted hole group who do not have calculated age due to missing information that we were unable to obtain from the clinical site|participants|Number|12|12.0||||||
4272009|NCT00585923|4096029|B2|>=65 years||Age|There were 5 patients in the fixed hole group and 2 patients in the slotted hole group who do not have calculated age due to missing information that we were unable to obtain from the clinical site|participants|Number|7|7.0||||||
4272010|NCT00585923|4096030|B1|>=65 years||Age|There were 5 patients in the fixed hole group and 2 patients in the slotted hole group who do not have calculated age due to missing information that we were unable to obtain from the clinical site|participants|Number|5|5.0||||||
4272011|NCT00585923|4096028|B3|Between 18 and 65 years||Age|There were 5 patients in the fixed hole group and 2 patients in the slotted hole group who do not have calculated age due to missing information that we were unable to obtain from the clinical site|participants|Number|96|96.0||||||
4272012|NCT00585923|4096029|B2|Between 18 and 65 years||Age|There were 5 patients in the fixed hole group and 2 patients in the slotted hole group who do not have calculated age due to missing information that we were unable to obtain from the clinical site|participants|Number|50|50.0||||||
4272013|NCT00585923|4096030|B1|Between 18 and 65 years||Age|There were 5 patients in the fixed hole group and 2 patients in the slotted hole group who do not have calculated age due to missing information that we were unable to obtain from the clinical site|participants|Number|46|46.0||||||
4272014|NCT00585923|4096028|B3|<=18 years||Age|There were 5 patients in the fixed hole group and 2 patients in the slotted hole group who do not have calculated age due to missing information that we were unable to obtain from the clinical site|participants|Number|0|0.0||||||
4272015|NCT00585923|4096029|B2|<=18 years||Age|There were 5 patients in the fixed hole group and 2 patients in the slotted hole group who do not have calculated age due to missing information that we were unable to obtain from the clinical site|participants|Number|0|0.0||||||
4272016|NCT00585923|4096030|B1|<=18 years||Age|There were 5 patients in the fixed hole group and 2 patients in the slotted hole group who do not have calculated age due to missing information that we were unable to obtain from the clinical site|participants|Number|0|0.0||||||
4272017|NCT00585910|4096045|B1|United States||Region of Enrollment||participants|Number|72|72.0||||||
4272018|NCT00585910|4096045|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4272019|NCT00585910|4096045|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4272020|NCT00585910|4096045|B1|||Age||years|Mean|9.1|9.1|Standard Deviation|2.7|2.7|||
4272021|NCT00585910|4096045|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272022|NCT00585910|4096045|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4272023|NCT00585910|4096045|B1||<=18 years|Age||Participants|Count of Participants|72|72.0||||||
4272024|NCT00585715|4096051|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4272025|NCT00585715|4096052|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4272026|NCT00585715|4096053|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4272027|NCT00585715|4096051|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4272028|NCT00585715|4096052|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4272029|NCT00585715|4096053|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4272030|NCT00585715|4096051|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4272031|NCT00585715|4096052|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4272032|NCT00585715|4096053|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4272033|NCT00585715|4096051|B3|||Age||years|Mean|37|37.0|Standard Deviation|8.77225062|8.77225062|||
4272034|NCT00585715|4096052|B2|||Age||years|Mean|36|36.0|Standard Deviation|8.40346249|8.40346249|||
4272035|NCT00585715|4096053|B1|||Age||years|Mean|38|38.0|Standard Deviation|9.47724547|9.47724547|||
4272036|NCT00585715|4096051|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272037|NCT00585715|4096052|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272038|NCT00585715|4096053|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272039|NCT00585715|4096051|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4272040|NCT00585715|4096052|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4272041|NCT00585715|4096053|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4272042|NCT00585715|4096051|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272043|NCT00585715|4096052|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272044|NCT00585715|4096053|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272045|NCT00585689|4096062|B1|None||Mixed Histological Features Present||participants|Number|19|19.0||||||
4272046|NCT00585689|4096062|B1|Micropapillary and Nested||Mixed Histological Features Present||participants|Number|1|1.0||||||
4272047|NCT00585689|4096062|B1|Micropapillary||Mixed Histological Features Present||participants|Number|1|1.0||||||
4272048|NCT00585689|4096062|B1|Nested||Mixed Histological Features Present||participants|Number|3|3.0||||||
4272049|NCT00585689|4096062|B1|20% Glandular||Mixed Histological Features Present||participants|Number|1|1.0||||||
4272050|NCT00585689|4096062|B1|10% Spindle||Mixed Histological Features Present||participants|Number|1|1.0||||||
4272051|NCT00585689|4096062|B1|5% Squamous||Mixed Histological Features Present||participants|Number|1|1.0||||||
4272052|NCT00585689|4096062|B1|10% Plasmacytoid, 10% Signet Ring||Mixed Histological Features Present||participants|Number|1|1.0||||||
4272053|NCT00585689|4096062|B1|70% Plasmacytoid, 5% Sarcomatoid||Mixed Histological Features Present||participants|Number|1|1.0||||||
4272054|NCT00585689|4096062|B1|No||Adjacent Carcinoma in Situ Present||participants|Number|13|13.0||||||
4272055|NCT00585689|4096062|B1|Yes||Adjacent Carcinoma in Situ Present||participants|Number|16|16.0||||||
4272056|NCT00585689|4096062|B1|No||Angiolymphatic Invasion Present||participants|Number|20|20.0||||||
4272057|NCT00585689|4096062|B1|Yes||Angiolymphatic Invasion Present||participants|Number|9|9.0||||||
4272058|NCT00585689|4096062|B1|No||Hydronephrosis Present||participants|Number|21|21.0||||||
4272059|NCT00585689|4096062|B1|Yes||Hydronephrosis Present||participants|Number|8|8.0||||||
4272060|NCT00585689|4096062|B1|T4N0||Clinical Disease Stage||participants|Number|2|2.0||||||
4272061|NCT00585689|4096062|B1|T3N0||Clinical Disease Stage||participants|Number|6|6.0||||||
4272062|NCT00585689|4096062|B1|T2N2||Clinical Disease Stage||participants|Number|1|1.0||||||
4272063|NCT00585689|4096062|B1|T2N1||Clinical Disease Stage||participants|Number|2|2.0||||||
4272064|NCT00585689|4096062|B1|T2N0||Clinical Disease Stage||participants|Number|18|18.0||||||
4272065|NCT00585689|4096062|B1|1||Performance Status (ECOG)|Eastern Cooperative Oncology Group (ECOG) Performance Status is an attempt to quantify cancer patients' general well-being and activities of daily life. The score runs from 0 to 5, with 0 denoting perfect health and 5 death.|participants|Number|12|12.0||||||
4272066|NCT00585689|4096062|B1|0||Performance Status (ECOG)|Eastern Cooperative Oncology Group (ECOG) Performance Status is an attempt to quantify cancer patients' general well-being and activities of daily life. The score runs from 0 to 5, with 0 denoting perfect health and 5 death.|participants|Number|17|17.0||||||
4272067|NCT00585689|4096062|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4272068|NCT00585689|4096062|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4272069|NCT00585689|4096062|B1|||Age||years|Median|66|66.0|Full Range|||38.0|82.0|
4272070|NCT00585650|4096066|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4272071|NCT00585650|4096067|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4272072|NCT00585650|4096068|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4272073|NCT00585650|4096066|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4272074|NCT00585650|4096067|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4272075|NCT00585650|4096068|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4272076|NCT00585650|4096066|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4272077|NCT00585650|4096067|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4272078|NCT00585650|4096068|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4272079|NCT00585650|4096066|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272080|NCT00585650|4096067|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272081|NCT00585650|4096068|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272082|NCT00585650|4096066|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4272083|NCT00585650|4096067|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4272084|NCT00585650|4096068|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4272085|NCT00585650|4096066|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272086|NCT00585650|4096067|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272087|NCT00585650|4096068|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272088|NCT00585637|4096075|B5|United States||Region of Enrollment||participants|Number|328|328.0||||||
4272089|NCT00585637|4096076|B4|United States||Region of Enrollment||participants|Number|83|83.0||||||
4272090|NCT00585637|4096077|B3|United States||Region of Enrollment||participants|Number|83|83.0||||||
4272091|NCT00585637|4096078|B2|United States||Region of Enrollment||participants|Number|81|81.0||||||
4272092|NCT00585637|4096079|B1|United States||Region of Enrollment||participants|Number|81|81.0||||||
4272093|NCT00585637|4096075|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272094|NCT00585637|4096076|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272095|NCT00585637|4096077|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272096|NCT00585637|4096078|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272097|NCT00585637|4096079|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272098|NCT00585637|4096075|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272099|NCT00585637|4096076|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272100|NCT00585637|4096077|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272101|NCT00585637|4096078|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272102|NCT00585637|4096079|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272103|NCT00585637|4096075|B5||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272104|NCT00585637|4096076|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272105|NCT00585637|4096077|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272106|NCT00585637|4096078|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272107|NCT00585637|4096079|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272108|NCT00585637|4096075|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|328|328.0||||||
4272109|NCT00585637|4096076|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
4272110|NCT00585637|4096077|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
4272111|NCT00585637|4096078|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
4272112|NCT00585637|4096079|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
4272113|NCT00585637|4096075|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272114|NCT00585637|4096076|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272115|NCT00585637|4096077|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272116|NCT00585637|4096078|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272117|NCT00585637|4096079|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272118|NCT00585637|4096075|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272119|NCT00585637|4096076|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272120|NCT00585637|4096077|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272121|NCT00585637|4096078|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272122|NCT00585637|4096079|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272123|NCT00585637|4096075|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272124|NCT00585637|4096076|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272125|NCT00585637|4096077|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272126|NCT00585637|4096078|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272127|NCT00585637|4096079|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272128|NCT00585637|4096075|B5||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4272129|NCT00585637|4096076|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4272130|NCT00585637|4096077|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4272131|NCT00585637|4096078|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4272132|NCT00585637|4096079|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4272133|NCT00585637|4096075|B5||Female|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4272134|NCT00585637|4096076|B4||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4272135|NCT00585637|4096077|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4272136|NCT00585637|4096078|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4272137|NCT00585637|4096079|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4272138|NCT00585637|4096075|B5|||Age||years|Median|51.0|51.0|Inter-Quartile Range|||43.6|59.4|
4272139|NCT00585637|4096076|B4|||Age||years|Median|51.3|51.3|Inter-Quartile Range|||44.1|59.7|
4272140|NCT00585637|4096077|B3|||Age||years|Median|50.3|50.3|Inter-Quartile Range|||43.4|58.2|
4272141|NCT00585637|4096078|B2|||Age||years|Median|51.1|51.1|Inter-Quartile Range|||43.4|60.1|
4272142|NCT00585637|4096079|B1|||Age||years|Median|50.7|50.7|Inter-Quartile Range|||44.2|58.0|
4272143|NCT00585585|4096108|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4272144|NCT00585585|4096108|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4272145|NCT00585585|4096108|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4272146|NCT00585585|4096108|B1|||Age||years|Mean|54|54.0|Standard Deviation|0|0.0|||
4272147|NCT00585585|4096108|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272148|NCT00585585|4096108|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4272149|NCT00585585|4096108|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272150|NCT00585546|4096112|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4272151|NCT00585546|4096112|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4272152|NCT00585546|4096112|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4272153|NCT00585546|4096112|B1|||Age||years|Median|57|57.0|Inter-Quartile Range|||54.0|62.0|
4272154|NCT00585533|4096126|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4272155|NCT00585533|4096126|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4272156|NCT00585533|4096126|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4272157|NCT00585533|4096126|B1|||Age||years|Mean|65|65.0|Standard Deviation|10.09443|10.09443|||
4272158|NCT00585533|4096126|B1||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4272159|NCT00585533|4096126|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4272160|NCT00585533|4096126|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272161|NCT00585494|4096131|B1|United States||Region of Enrollment||participants|Number|302|302.0||||||
4272162|NCT00585494|4096131|B1||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4272163|NCT00585494|4096131|B1||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4272164|NCT00585494|4096131|B1|||Age||years|Mean|59.5|59.5|Standard Deviation|1.4|1.4|||
4272165|NCT00585494|4096131|B1||>=65 years|Age||Participants|Count of Participants|105|105.0||||||
4272166|NCT00585494|4096131|B1||Between 18 and 65 years|Age||Participants|Count of Participants|197|197.0||||||
4272167|NCT00585494|4096131|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272168|NCT00585468|4096135|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4272169|NCT00585468|4096135|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4272170|NCT00585468|4096135|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4272171|NCT00585468|4096135|B1|||Age||years|Mean|43.6|43.6|Standard Deviation|9.8|9.8|||
4272172|NCT00585468|4096135|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272173|NCT00585468|4096135|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4272174|NCT00585468|4096135|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272175|NCT00585377|4096156|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4272176|NCT00585377|4096156|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4272177|NCT00585377|4096156|B1|||Age||years|Median|65|65.0|Full Range|||45.0|90.0|
4272178|NCT00585351|4096162|B7|United States||Region of Enrollment||participants|Number|52|52.0||||||
4272179|NCT00585351|4096163|B6|United States||Region of Enrollment||participants|Number|3|3.0||||||
4272180|NCT00585351|4096164|B5|United States||Region of Enrollment||participants|Number|7|7.0||||||
4272181|NCT00585351|4096165|B4|United States||Region of Enrollment||participants|Number|7|7.0||||||
4272182|NCT00585351|4096166|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4272183|NCT00585351|4096167|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4272184|NCT00585351|4096168|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4272185|NCT00585351|4096162|B7||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4272186|NCT00585351|4096163|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4272187|NCT00585351|4096164|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4272188|NCT00585351|4096165|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4272189|NCT00585351|4096166|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4272190|NCT00585351|4096167|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4272191|NCT00585351|4096168|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4272192|NCT00585351|4096162|B7||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4272193|NCT00585351|4096163|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4272194|NCT00585351|4096164|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4272195|NCT00585351|4096165|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4272196|NCT00585351|4096166|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4272197|NCT00585351|4096167|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4272198|NCT00585351|4096168|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4272199|NCT00585351|4096162|B7|||Age||years|Mean|64|64.0|Standard Deviation|13|13.0|||
4272200|NCT00585351|4096163|B6|||Age||years|Mean|68|68.0|Standard Deviation|12|12.0|||
4272201|NCT00585351|4096164|B5|||Age||years|Mean|62|62.0|Standard Deviation|8|8.0|||
4272202|NCT00585351|4096165|B4|||Age||years|Mean|62|62.0|Standard Deviation|12|12.0|||
4272203|NCT00585351|4096166|B3|||Age||years|Mean|67|67.0|Standard Deviation|13|13.0|||
4272204|NCT00585351|4096167|B2|||Age||years|Mean|62|62.0|Standard Deviation|16|16.0|||
4272205|NCT00585351|4096168|B1|||Age||years|Mean|66|66.0|Standard Deviation|14|14.0|||
4272206|NCT00585351|4096162|B7||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4272207|NCT00585351|4096163|B6||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4272208|NCT00585351|4096164|B5||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4272209|NCT00585351|4096165|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4272210|NCT00585351|4096166|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4272211|NCT00585351|4096167|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4272212|NCT00585351|4096168|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4272213|NCT00585351|4096162|B7||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4272214|NCT00585351|4096163|B6||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4272215|NCT00585351|4096164|B5||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4272216|NCT00585351|4096165|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4272217|NCT00585351|4096166|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4272218|NCT00585351|4096167|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4272219|NCT00585351|4096168|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4272220|NCT00585351|4096162|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272221|NCT00585351|4096163|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272222|NCT00585351|4096164|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272223|NCT00585351|4096165|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272224|NCT00585351|4096166|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272225|NCT00585351|4096167|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272226|NCT00585351|4096168|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272227|NCT00585325|4096189|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4272228|NCT00585325|4096190|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4272229|NCT00585325|4096191|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4272230|NCT00585325|4096189|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4272231|NCT00585325|4096190|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4272232|NCT00585325|4096191|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4272233|NCT00585325|4096189|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4272234|NCT00585325|4096190|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4272235|NCT00585325|4096191|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4272236|NCT00585325|4096189|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4272237|NCT00585325|4096190|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4272238|NCT00585325|4096191|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4272239|NCT00585325|4096189|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4272240|NCT00585325|4096190|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4272241|NCT00585325|4096191|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4272242|NCT00585325|4096189|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272243|NCT00585325|4096190|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272244|NCT00585325|4096191|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272245|NCT00585312|4096198|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4272246|NCT00585312|4096199|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4272247|NCT00585312|4096200|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4272248|NCT00585312|4096198|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4272249|NCT00585312|4096199|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4272250|NCT00585312|4096200|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4272251|NCT00585312|4096198|B3|||Age||years|Mean|12.4|12.4|Standard Deviation|2.0|2.0|||
4272252|NCT00585312|4096199|B2|||Age||years|Mean|12.2|12.2|Standard Deviation|1.8|1.8|||
4272253|NCT00585312|4096200|B1|||Age||years|Mean|12.6|12.6|Standard Deviation|2.2|2.2|||
4272254|NCT00585286|4096213|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4272255|NCT00585286|4096213|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4272256|NCT00585286|4096213|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4272257|NCT00585286|4096213|B1|||Age||years|Mean|36|36.0|Standard Deviation|13|13.0|||
4272258|NCT00585286|4096213|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272259|NCT00585286|4096213|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4272260|NCT00585286|4096213|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272261|NCT00585247|4096220|B3|United States||Region of Enrollment||Participants|Number|27|27.0||||||
4272262|NCT00585247|4096221|B2|United States||Region of Enrollment||Participants|Number|13|13.0||||||
4272263|NCT00585247|4096222|B1|United States||Region of Enrollment||Participants|Number|14|14.0||||||
4272264|NCT00585247|4096220|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4272265|NCT00585247|4096221|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4272266|NCT00585247|4096222|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4272267|NCT00585247|4096220|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4272268|NCT00585247|4096221|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4272269|NCT00585247|4096222|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4272270|NCT00585247|4096220|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4272271|NCT00585247|4096221|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272272|NCT00585247|4096222|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4272273|NCT00585247|4096220|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4272274|NCT00585247|4096221|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4272275|NCT00585247|4096222|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4272276|NCT00585247|4096220|B3||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4272277|NCT00585247|4096221|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272278|NCT00585247|4096222|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4272279|NCT00585221|4096229|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4272280|NCT00585221|4096229|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
4272281|NCT00585221|4096229|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
4272282|NCT00585221|4096229|B1|||Age||years|Mean|64.875|64.875|Standard Deviation|17.97|17.97|||
4272283|NCT00585221|4096229|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4272284|NCT00585221|4096229|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4272285|NCT00585221|4096229|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272286|NCT00585182|4096234|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4272287|NCT00585182|4096234|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4272288|NCT00585182|4096234|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4272289|NCT00585182|4096234|B1|||Age||years|Mean|54|54.0|Standard Deviation|11|11.0|||
4272290|NCT00585182|4096234|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4272291|NCT00585182|4096234|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4272292|NCT00585182|4096234|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272293|NCT00585169|4096239|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4272294|NCT00585169|4096239|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4272295|NCT00585169|4096239|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272296|NCT00585169|4096239|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4272297|NCT00585169|4096239|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4272298|NCT00585169|4096239|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272299|NCT00585169|4096239|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4272300|NCT00585169|4096239|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4272301|NCT00585169|4096239|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4272302|NCT00585169|4096239|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4272303|NCT00585169|4096239|B1|||Age||years|Mean|50.4|50.4|Standard Deviation|13|13.0|||
4272304|NCT00585169|4096239|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4272305|NCT00585169|4096239|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4272306|NCT00585169|4096239|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272307|NCT00585104|4096245|B1|||Left Ventricular End Diastolic Pressure (LVEDP)||mmHg|Mean|18|18.0|Standard Deviation|7|7.0|||
4272308|NCT00585104|4096245|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4272309|NCT00585104|4096245|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4272310|NCT00585104|4096245|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4272311|NCT00585104|4096245|B1|||Age||years|Mean|59|59.0|Standard Deviation|13.6|13.6|||
4272312|NCT00585104|4096245|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272313|NCT00585104|4096245|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4272314|NCT00585104|4096245|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272315|NCT00585078|4096249|B1|Metastatic||Stage||Participants|Count of Participants|38|38.0||||||
4272316|NCT00585078|4096249|B1|Locally Advanced||Stage||Participants|Count of Participants|2|2.0||||||
4272317|NCT00585078|4096249|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4272318|NCT00585078|4096249|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4272319|NCT00585078|4096249|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4272320|NCT00585078|4096249|B1|||Age||years|Median|61|61.0|Full Range|||40.0|78.0|
4272321|NCT00585052|4096256|B1|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4272322|NCT00585052|4096256|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272323|NCT00585052|4096256|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272324|NCT00585052|4096256|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4272325|NCT00585052|4096256|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272326|NCT00585052|4096256|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272327|NCT00585052|4096256|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272328|NCT00585052|4096256|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272329|NCT00585052|4096256|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4272330|NCT00585052|4096256|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4272331|NCT00585052|4096256|B1|||Age||years|Mean|61.6|61.6|Full Range|||51.0|78.0|
4272332|NCT00585052|4096256|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4272333|NCT00585052|4096256|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4272334|NCT00585052|4096256|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272335|NCT00585039|4096261|B3|United States||Region of Enrollment||participants|Number|101|101.0||||||
4272336|NCT00585039|4096262|B2|United States||Region of Enrollment||participants|Number|44|44.0||||||
4272337|NCT00585039|4096263|B1|United States||Region of Enrollment||participants|Number|57|57.0||||||
4272338|NCT00585039|4096261|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4272339|NCT00585039|4096262|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4272340|NCT00585039|4096263|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4272341|NCT00585039|4096261|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4272342|NCT00585039|4096262|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4272343|NCT00585039|4096263|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4272344|NCT00585039|4096261|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272345|NCT00585039|4096262|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272346|NCT00585039|4096263|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272347|NCT00585039|4096261|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4272348|NCT00585039|4096262|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4272349|NCT00585039|4096263|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4272350|NCT00585039|4096261|B3||<=18 years|Age||Participants|Count of Participants|101|101.0||||||
4272351|NCT00585039|4096262|B2||<=18 years|Age||Participants|Count of Participants|44|44.0||||||
4272352|NCT00585039|4096263|B1||<=18 years|Age||Participants|Count of Participants|57|57.0||||||
4272353|NCT00585013|4096272|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4272354|NCT00585013|4096273|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4272355|NCT00585013|4096274|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4272356|NCT00585013|4096272|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4272357|NCT00585013|4096273|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4272358|NCT00585013|4096274|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4272359|NCT00585013|4096272|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4272360|NCT00585013|4096273|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4272361|NCT00585013|4096274|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4272362|NCT00585013|4096272|B3|||Age||years|Mean|.4|0.4|Standard Deviation|.1|0.1|||
4272363|NCT00585013|4096273|B2|||Age||years|Mean|.4|0.4|Standard Deviation|.1|0.1|||
4272364|NCT00585013|4096274|B1|||Age||years|Mean|.4|0.4|Standard Deviation|.1|0.1|||
4272365|NCT00585013|4096272|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272366|NCT00585013|4096273|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272367|NCT00585013|4096274|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272368|NCT00585013|4096272|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4272369|NCT00585013|4096273|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4272370|NCT00585013|4096274|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4272371|NCT00585013|4096272|B3||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4272372|NCT00585013|4096273|B2||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4272373|NCT00585013|4096274|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4272374|NCT00584987|4096289|B5||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4272375|NCT00584987|4096290|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4272376|NCT00584987|4096291|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4272377|NCT00584987|4096292|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4272378|NCT00584987|4096293|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4272379|NCT00584987|4096289|B5||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4272380|NCT00584987|4096290|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4272381|NCT00584987|4096291|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4272382|NCT00584987|4096292|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4272383|NCT00584987|4096293|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4272384|NCT00584987|4096289|B5|||Age||years|Mean|28.8|28.8|Standard Deviation|8.5|8.5|||
4272385|NCT00584987|4096290|B4|||Age||years|Mean|28.6|28.6|Standard Deviation|8.7|8.7|||
4272386|NCT00584987|4096291|B3|||Age||years|Mean|26.6|26.6|Standard Deviation|5.2|5.2|||
4272387|NCT00584987|4096292|B2|||Age||years|Mean|31.7|31.7|Standard Deviation|9.5|9.5|||
4272388|NCT00584987|4096293|B1|||Age||years|Mean|29.6|29.6|Standard Deviation|11|11.0|||
4272389|NCT00584948|4096326|B3|United States||Region of Enrollment||participants|Number|94|94.0||||||
4272390|NCT00584948|4096327|B2|United States||Region of Enrollment||participants|Number|47|47.0||||||
4272391|NCT00584948|4096328|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
4272392|NCT00584948|4096326|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272393|NCT00584948|4096327|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272394|NCT00584948|4096328|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272395|NCT00584948|4096326|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
4272396|NCT00584948|4096327|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4272397|NCT00584948|4096328|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4272398|NCT00584948|4096326|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4272399|NCT00584948|4096327|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4272400|NCT00584948|4096328|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4272401|NCT00584948|4096326|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272402|NCT00584948|4096327|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272403|NCT00584948|4096328|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272404|NCT00584948|4096326|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272405|NCT00584948|4096327|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272406|NCT00584948|4096328|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272407|NCT00584948|4096326|B3||White|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
4272408|NCT00584948|4096327|B2||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4272409|NCT00584948|4096328|B1||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4272410|NCT00584948|4096326|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272411|NCT00584948|4096327|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272412|NCT00584948|4096328|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272413|NCT00584948|4096326|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272414|NCT00584948|4096327|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272415|NCT00584948|4096328|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272416|NCT00584948|4096326|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272417|NCT00584948|4096327|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272418|NCT00584948|4096328|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272419|NCT00584948|4096326|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272420|NCT00584948|4096327|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272421|NCT00584948|4096328|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272422|NCT00584948|4096326|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4272423|NCT00584948|4096327|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4272424|NCT00584948|4096328|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4272425|NCT00584948|4096326|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4272426|NCT00584948|4096327|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4272427|NCT00584948|4096328|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4272428|NCT00584948|4096326|B3|||Age||years|Mean|65.5|65.5|Standard Deviation|8.4|8.4|||
4272429|NCT00584948|4096327|B2|||Age||years|Mean|66.3|66.3|Standard Deviation|7.0|7.0|||
4272430|NCT00584948|4096328|B1|||Age||years|Mean|64.7|64.7|Standard Deviation|9.7|9.7|||
4272431|NCT00584935|4096337|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4272432|NCT00584935|4096337|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4272433|NCT00584935|4096337|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4272434|NCT00584935|4096337|B1|||Age||years|Mean|61|61.0|Standard Deviation|28|28.0|||
4272435|NCT00584935|4096337|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4272436|NCT00584935|4096337|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4272437|NCT00584935|4096337|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272438|NCT00584909|4096344|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4272439|NCT00584909|4096344|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4272440|NCT00584909|4096344|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4272441|NCT00584909|4096344|B1|||Age||years|Mean|63|63.0|Standard Deviation|6|6.0|||
4272442|NCT00584909|4096344|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4272443|NCT00584909|4096344|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4272444|NCT00584909|4096344|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272445|NCT00584857|4096349|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4272446|NCT00584857|4096349|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4272447|NCT00584857|4096349|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4272448|NCT00584857|4096349|B1|||Age||years|Mean|60.4|60.4|Standard Deviation|12.2|12.2|||
4272449|NCT00584857|4096349|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4272450|NCT00584857|4096349|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4272451|NCT00584857|4096349|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272452|NCT00584844|4096354|B1|United States||Region of Enrollment||participants|Number|405|405.0||||||
4272453|NCT00584844|4096354|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272454|NCT00584844|4096354|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4272455|NCT00584844|4096354|B1||White|Race (NIH/OMB)||Participants|Count of Participants|357|357.0||||||
4272456|NCT00584844|4096354|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4272457|NCT00584844|4096354|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4272458|NCT00584844|4096354|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4272459|NCT00584844|4096354|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4272460|NCT00584844|4096354|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272461|NCT00584844|4096354|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|382|382.0||||||
4272462|NCT00584844|4096354|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4272463|NCT00584844|4096354|B1||Male|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
4272464|NCT00584844|4096354|B1||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4272465|NCT00584844|4096354|B1|60-69 years||Age, Customized||Participants|Count of Participants|9|9.0||||||
4272466|NCT00584844|4096354|B1|50-59 years||Age, Customized||Participants|Count of Participants|54|54.0||||||
4272467|NCT00584844|4096354|B1|40-49 years||Age, Customized||Participants|Count of Participants|106|106.0||||||
4272468|NCT00584844|4096354|B1|30-39 years||Age, Customized||Participants|Count of Participants|126|126.0||||||
4272469|NCT00584844|4096354|B1|20-29 years||Age, Customized||Participants|Count of Participants|108|108.0||||||
4272470|NCT00584844|4096354|B1|<20 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
4272471|NCT00584831|4096364|B1|United Kingdom||Region of Enrollment||participants|Number|40|40.0||||||
4272472|NCT00584831|4096364|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4272473|NCT00584831|4096364|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4272474|NCT00584831|4096364|B1|||Age||years|Mean|28.3|28.3|Standard Deviation|7.9|7.9|||
4272475|NCT00584740|4096404|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4272476|NCT00584740|4096405|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4272477|NCT00584740|4096406|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4272478|NCT00584740|4096404|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4272479|NCT00584740|4096405|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4272480|NCT00584740|4096406|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4272481|NCT00584740|4096404|B3|||Age||Years|Mean|37.6|37.6|Standard Deviation|12.68|12.68|||
4272482|NCT00584740|4096405|B2|||Age||Years|Mean|38.3|38.3|Standard Deviation|14.29|14.29|||
4272483|NCT00584740|4096406|B1|||Age||Years|Mean|37.3|37.3|Standard Deviation|11.96|11.96|||
4272484|NCT00584727|4096425|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4272485|NCT00584727|4096425|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4272486|NCT00584727|4096425|B1|||Age||years|Mean|28.0|28.0|Standard Deviation|5.96|5.96|||
4272487|NCT00584701|4096454|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
4272488|NCT00584701|4096454|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4272489|NCT00584701|4096454|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4272490|NCT00584701|4096454|B1|||Age||years|Mean|9.4|9.4|Standard Deviation|4.3|4.3|||
4272491|NCT00584701|4096454|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272492|NCT00584701|4096454|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4272493|NCT00584701|4096454|B1||<=18 years|Age||Participants|Count of Participants|49|49.0||||||
4272494|NCT00584558|4096459|B1|United States||Region of Enrollment||participants|Number|2420|2420.0||||||
4272495|NCT00584558|4096459|B1||Male|Sex: Female, Male||Participants|Count of Participants|1428|1428.0||||||
4272496|NCT00584558|4096459|B1||Female|Sex: Female, Male||Participants|Count of Participants|992|992.0||||||
4272497|NCT00584558|4096459|B1||>=65 years|Age||Participants|Count of Participants|436|436.0||||||
4272498|NCT00584558|4096459|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1306|1306.0||||||
4272499|NCT00584558|4096459|B1||<=18 years|Age||Participants|Count of Participants|678|678.0||||||
4272500|NCT00584480|4096464|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4272501|NCT00584480|4096464|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4272502|NCT00584480|4096464|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4272503|NCT00584480|4096464|B1|||Age||years|Mean|5.3|5.3|Standard Deviation|1.8|1.8|||
4272504|NCT00584480|4096464|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272505|NCT00584480|4096464|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4272506|NCT00584480|4096464|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4272507|NCT00584454|4096468|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4272508|NCT00584454|4096468|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272509|NCT00584454|4096468|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272510|NCT00584454|4096468|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4272511|NCT00584454|4096468|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4272512|NCT00584454|4096468|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272513|NCT00584454|4096468|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272514|NCT00584454|4096468|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272515|NCT00584454|4096468|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272516|NCT00584454|4096468|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4272517|NCT00584454|4096468|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272518|NCT00584454|4096468|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4272519|NCT00584454|4096468|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4272520|NCT00584454|4096468|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272521|NCT00584454|4096468|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4272522|NCT00584454|4096468|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272523|NCT00584415|4096472|B1|United States||Region of Enrollment||participants|Number|119|119.0||||||
4272524|NCT00584415|4096472|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4272525|NCT00584415|4096472|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4272526|NCT00584415|4096472|B1|||Age||years|Mean|57|57.0|Standard Deviation|1|1.0|||
4272527|NCT00584415|4096472|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4272528|NCT00584415|4096472|B1||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
4272529|NCT00584415|4096472|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272530|NCT00584402|4096477|B1|Female||Sex/Gender, Customized||Participants|Count of Participants|3|3.0||||||
4272531|NCT00584402|4096477|B1|Male||Sex/Gender, Customized||Participants|Count of Participants|5|5.0||||||
4272532|NCT00584402|4096477|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272533|NCT00584402|4096477|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4272534|NCT00584402|4096477|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272535|NCT00584285|4096482|B1|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4272536|NCT00584285|4096482|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4272537|NCT00584285|4096482|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4272538|NCT00584285|4096482|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272539|NCT00584285|4096482|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4272540|NCT00584285|4096482|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272541|NCT00584220|4096486|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4272542|NCT00584220|4096486|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4272543|NCT00584220|4096486|B1|||Age||years|Mean|28.0|28.0|Standard Deviation|5.98|5.98|||
4272544|NCT00584194|4096495|B1|United States||Region of Enrollment||participants|Number|153|153.0||||||
4272545|NCT00584194|4096495|B1||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4272546|NCT00584194|4096495|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4272547|NCT00584194|4096495|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272548|NCT00584194|4096495|B1||Between 18 and 65 years|Age||Participants|Count of Participants|153|153.0||||||
4272549|NCT00584194|4096495|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272550|NCT00584077|4096503|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4272551|NCT00584077|4096503|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4272552|NCT00584077|4096503|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4272553|NCT00584077|4096503|B1|Age||Age||years|Mean|49|49.0|Standard Deviation|8|8.0|||
4272554|NCT00584077|4096503|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272555|NCT00584077|4096503|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4272556|NCT00584077|4096503|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272557|NCT00584012|4096508|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4272558|NCT00584012|4096508|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272559|NCT00584012|4096508|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272560|NCT00584012|4096508|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4272561|NCT00584012|4096508|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272562|NCT00584012|4096508|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272563|NCT00584012|4096508|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272564|NCT00584012|4096508|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272565|NCT00584012|4096508|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4272566|NCT00584012|4096508|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4272567|NCT00584012|4096508|B1|||Age||years|Mean|56.1|56.1|Full Range|||29.5|71.7|
4272568|NCT00584012|4096508|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4272569|NCT00584012|4096508|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4272570|NCT00584012|4096508|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272571|NCT00583947|4096512|B3|||Weight||kilograms|Mean|32.12|32.12|Standard Deviation|12.345|12.345|||
4272572|NCT00583947|4096513|B2|||Weight||kilograms|Mean|32.68|32.68|Standard Deviation|12.802|12.802|||
4272573|NCT00583947|4096514|B1|||Weight||kilograms|Mean|31.57|31.57|Standard Deviation|12.106|12.106|||
4272574|NCT00583947|4096512|B3|||Height||centimeters|Mean|131.03|131.03|Standard Deviation|15.174|15.174|||
4272575|NCT00583947|4096513|B2|||Height||centimeters|Mean|130.42|130.42|Standard Deviation|15.377|15.377|||
4272576|NCT00583947|4096514|B1|||Height||centimeters|Mean|131.62|131.62|Standard Deviation|15.244|15.244|||
4272577|NCT00583947|4096512|B3|United States||Region of Enrollment||participants|Number|53|53.0||||||
4272578|NCT00583947|4096513|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4272579|NCT00583947|4096514|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4272580|NCT00583947|4096512|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4272581|NCT00583947|4096513|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4272582|NCT00583947|4096514|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4272583|NCT00583947|4096512|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4272584|NCT00583947|4096513|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4272585|NCT00583947|4096514|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4272586|NCT00583947|4096512|B3|White/Caucasian||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4272587|NCT00583947|4096513|B2|White/Caucasian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4272588|NCT00583947|4096514|B1|White/Caucasian||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4272589|NCT00583947|4096512|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4272590|NCT00583947|4096513|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4272591|NCT00583947|4096514|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4272592|NCT00583947|4096512|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4272593|NCT00583947|4096513|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4272594|NCT00583947|4096514|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4272595|NCT00583947|4096512|B3|Age 6-11 years||Age||years|Mean|8.8|8.8|Standard Deviation|1.35|1.35|||
4272596|NCT00583947|4096513|B2|Age 6-11 years||Age||years|Mean|8.5|8.5|Standard Deviation|1.43|1.43|||
4272597|NCT00583947|4096514|B1|Age 6-11 years||Age||years|Mean|9.0|9.0|Standard Deviation|1.26|1.26|||
4272598|NCT00583947|4096512|B3|Age 2-5 years||Age||years|Mean|4.4|4.4|Standard Deviation|0.76|0.76|||
4272599|NCT00583947|4096513|B2|Age 2-5 years||Age||years|Mean|4.4|4.4|Standard Deviation|0.79|0.79|||
4272600|NCT00583947|4096514|B1|Age 2-5 years||Age||years|Mean|4.4|4.4|Standard Deviation|0.79|0.79|||
4272601|NCT00583947|4096512|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272602|NCT00583947|4096513|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272603|NCT00583947|4096514|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272604|NCT00583947|4096512|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4272605|NCT00583947|4096513|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4272606|NCT00583947|4096514|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4272607|NCT00583947|4096512|B3||<=18 years|Age||Participants|Count of Participants|53|53.0||||||
4272608|NCT00583947|4096513|B2||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
4272609|NCT00583947|4096514|B1||<=18 years|Age||Participants|Count of Participants|27|27.0||||||
4272610|NCT00583908|4096565|B1|United Kingdom||Region of Enrollment||participants|Number|14|14.0||||||
4272611|NCT00583908|4096565|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4272612|NCT00583908|4096565|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4272613|NCT00583908|4096565|B1|||Age||years|Mean|42.1|42.1|Standard Deviation|6.0|6.0|||
4272614|NCT00583804|4096630|B1|||Grasp-Release Test - Baseline|The Grasp-Release tests consists of six standard objects requiring different grasp patterns and forces to pick up and move. The subjects have a fixed period of time to attempt to acquire the object and move it from one location on the test board to a second location. The outcome is measured as the number of objects that they can successfully pick up and move. The minimum score is 0 and the maximum score is 6.|Objects|Median|2|2.0|Full Range|||0.0|4.0|
4272615|NCT00583804|4096630|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272616|NCT00583804|4096630|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272617|NCT00583804|4096630|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4272618|NCT00583804|4096630|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272619|NCT00583804|4096630|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272620|NCT00583804|4096630|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272621|NCT00583804|4096630|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272622|NCT00583804|4096630|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272623|NCT00583804|4096630|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4272624|NCT00583804|4096630|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4272625|NCT00583804|4096630|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4272626|NCT00583804|4096630|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4272627|NCT00583804|4096630|B1|||Age||years|Median|37|37.0|Full Range|||26.0|56.0|
4272628|NCT00583713|4096636|B4|United States||Region of Enrollment||participants|Number|18|18.0||||||
4272629|NCT00583713|4096637|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4272630|NCT00583713|4096638|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4272631|NCT00583713|4096639|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4272632|NCT00583713|4096636|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4272633|NCT00583713|4096637|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4272634|NCT00583713|4096638|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4272635|NCT00583713|4096639|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4272636|NCT00583713|4096636|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4272637|NCT00583713|4096637|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4272638|NCT00583713|4096638|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4272639|NCT00583713|4096639|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4272640|NCT00583713|4096636|B4|||Age||years|Mean|51.3|51.3|Standard Deviation|6.83|6.83|||
4272641|NCT00583713|4096637|B3|||Age||years|Mean|51.2|51.2|Standard Deviation|5.74|5.74|||
4272642|NCT00583713|4096638|B2|||Age||years|Mean|49.0|49.0|Standard Deviation|6.93|6.93|||
4272643|NCT00583713|4096639|B1|||Age||years|Mean|53.8|53.8|Standard Deviation|7.96|7.96|||
4272644|NCT00583713|4096636|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4272645|NCT00583713|4096637|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272646|NCT00583713|4096638|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272647|NCT00583713|4096639|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4272648|NCT00583713|4096636|B4||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4272649|NCT00583713|4096637|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4272650|NCT00583713|4096638|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4272651|NCT00583713|4096639|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4272652|NCT00583713|4096636|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272653|NCT00583713|4096637|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272654|NCT00583713|4096638|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272655|NCT00583713|4096639|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272656|NCT00583700|4096664|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
4272657|NCT00583700|4096665|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4272658|NCT00583700|4096666|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4272659|NCT00583700|4096664|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4272660|NCT00583700|4096665|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4272661|NCT00583700|4096666|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4272662|NCT00583700|4096664|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4272663|NCT00583700|4096665|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4272664|NCT00583700|4096666|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4272665|NCT00583700|4096664|B3|||Age||years|Mean|56.81|56.81|Standard Deviation|11.54|11.54|||
4272666|NCT00583700|4096665|B2|||Age||years|Mean|59.65|59.65|Standard Deviation|11.74|11.74|||
4272667|NCT00583700|4096666|B1|||Age||years|Mean|54.7|54.7|Standard Deviation|10.81|10.81|||
4272668|NCT00583700|4096664|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4272669|NCT00583700|4096665|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4272670|NCT00583700|4096666|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4272671|NCT00583700|4096664|B3||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4272672|NCT00583700|4096665|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4272673|NCT00583700|4096666|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4272674|NCT00583700|4096664|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272675|NCT00583700|4096665|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272676|NCT00583700|4096666|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272677|NCT00583661|4096675|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4272678|NCT00583661|4096675|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
4272679|NCT00583661|4096675|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4272680|NCT00583661|4096675|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4272681|NCT00583661|4096675|B1|||Age||Months|Median|64.3|64.3|Full Range|||2.6|191.8|
4272682|NCT00583661|4096675|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272683|NCT00583661|4096675|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4272684|NCT00583661|4096675|B1||<=18 years|Age||Participants|Count of Participants|48|48.0||||||
4272685|NCT00583622|4096682|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4272686|NCT00583622|4096682|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4272687|NCT00583622|4096682|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4272688|NCT00583622|4096682|B1|||Age||years|Median|47|47.0|Full Range|||33.0|56.0|
4272689|NCT00583596|4096687|B1|United States||Region of Enrollment||participants|Number|436|436.0||||||
4272690|NCT00583596|4096687|B1||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4272691|NCT00583596|4096687|B1||Female|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
4272692|NCT00583596|4096687|B1|||Age||years|Mean|6.14|6.14|Standard Deviation|11.14|11.14|||
4272693|NCT00583557|4096692|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4272694|NCT00583557|4096692|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4272695|NCT00583557|4096692|B1|||Age||years|Mean|51.1|51.1|Standard Deviation|8.9|8.9|||
4272696|NCT00583492|4096696|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
4272697|NCT00583492|4096697|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4272698|NCT00583492|4096698|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4272699|NCT00583492|4096696|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4272700|NCT00583492|4096697|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4272701|NCT00583492|4096698|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4272702|NCT00583492|4096696|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4272703|NCT00583492|4096697|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4272704|NCT00583492|4096698|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4272705|NCT00583492|4096696|B3||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4272706|NCT00583492|4096697|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4272707|NCT00583492|4096698|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4272708|NCT00583492|4096696|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4272709|NCT00583492|4096697|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4272710|NCT00583492|4096698|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4272711|NCT00583492|4096696|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272712|NCT00583492|4096697|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272713|NCT00583492|4096698|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272714|NCT00583466|4096715|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4272715|NCT00583466|4096715|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4272716|NCT00583466|4096715|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4272717|NCT00583466|4096715|B1|>= 18, <= 90||Age, Customized||Participants|Count of Participants|18|18.0||||||
4272718|NCT00583453|4096721|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4272719|NCT00583453|4096722|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4272720|NCT00583453|4096723|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4272721|NCT00583453|4096721|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4272722|NCT00583453|4096722|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4272723|NCT00583453|4096723|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4272724|NCT00583453|4096721|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4272725|NCT00583453|4096722|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4272726|NCT00583453|4096723|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4272727|NCT00583453|4096721|B3|||Age||years|Mean|25.0|25.0|Standard Deviation|3.2|3.2|||
4272728|NCT00583453|4096722|B2|||Age||years|Mean|25.0|25.0|Standard Deviation|3.3|3.3|||
4272729|NCT00583453|4096723|B1|||Age||years|Mean|25.1|25.1|Standard Deviation|4.1|4.1|||
4272730|NCT00583453|4096721|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272731|NCT00583453|4096722|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272732|NCT00583453|4096723|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272733|NCT00583453|4096721|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4272734|NCT00583453|4096722|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4272735|NCT00583453|4096723|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4272736|NCT00583453|4096721|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272737|NCT00583453|4096722|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272738|NCT00583453|4096723|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272739|NCT00583375|4096738|B3|United States||Region of Enrollment||Participants|Count of Participants|315|315.0||||||
4272740|NCT00583375|4096739|B2|United States||Region of Enrollment||Participants|Count of Participants|205|205.0||||||
4272741|NCT00583375|4096740|B1|United States||Region of Enrollment||Participants|Count of Participants|110|110.0||||||
4272742|NCT00583375|4096738|B3|Canada||Region of Enrollment||Participants|Count of Participants|99|99.0||||||
4272743|NCT00583375|4096739|B2|Canada||Region of Enrollment||Participants|Count of Participants|67|67.0||||||
4272744|NCT00583375|4096740|B1|Canada||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
4272745|NCT00583375|4096738|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4272746|NCT00583375|4096739|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4272747|NCT00583375|4096740|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4272748|NCT00583375|4096738|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272749|NCT00583375|4096739|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272750|NCT00583375|4096740|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272751|NCT00583375|4096738|B3||White|Race (NIH/OMB)||Participants|Count of Participants|378|378.0||||||
4272752|NCT00583375|4096739|B2||White|Race (NIH/OMB)||Participants|Count of Participants|247|247.0||||||
4272753|NCT00583375|4096740|B1||White|Race (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
4272754|NCT00583375|4096738|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4272755|NCT00583375|4096739|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4272756|NCT00583375|4096740|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4272757|NCT00583375|4096738|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272758|NCT00583375|4096739|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272759|NCT00583375|4096740|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272760|NCT00583375|4096738|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4272761|NCT00583375|4096739|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4272762|NCT00583375|4096740|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272763|NCT00583375|4096738|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272764|NCT00583375|4096739|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272765|NCT00583375|4096740|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272766|NCT00583375|4096738|B3||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4272767|NCT00583375|4096739|B2||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4272768|NCT00583375|4096740|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4272769|NCT00583375|4096738|B3||Female|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4272770|NCT00583375|4096739|B2||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4272771|NCT00583375|4096740|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4272772|NCT00583375|4096738|B3|||Age||years|Mean|56.47|56.47|Standard Deviation|14.14|14.14|||
4272773|NCT00583375|4096739|B2|||Age||years|Mean|55.9|55.9|Standard Deviation|14.5|14.5|||
4272774|NCT00583375|4096740|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|13.4|13.4|||
4272775|NCT00583362|4096757|B1|White||Race/Ethnicity, Customized|MITT Population|Participants|Number|215|215.0||||||
4272776|NCT00583362|4096757|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|MITT Population|Participants|Number|1|1.0||||||
4272777|NCT00583362|4096757|B1|Black or African American||Race/Ethnicity, Customized|MITT Population|Participants|Number|68|68.0||||||
4272778|NCT00583362|4096757|B1|Asian||Race/Ethnicity, Customized|MITT Population|Participants|Number|6|6.0||||||
4272779|NCT00583362|4096757|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|MITT Population|Participants|Number|6|6.0||||||
4272780|NCT00583362|4096757|B1||Male|Sex: Female, Male|MITT Population|Participants|Count of Participants|20|20.0||||||
4272781|NCT00583362|4096757|B1||Female|Sex: Female, Male|MITT Population|Participants|Count of Participants|276|276.0||||||
4272782|NCT00583362|4096757|B1|||Age|Modified Intent to Treat (MITT) Population: All participants who were enrolled in the study and were treated with at least one dose of belimumab in the study.|Years|Mean|43|43.0|Standard Deviation|11.58|11.58|||
4272783|NCT00583219|4096781|B1|||Body Mass Index||kg/m^2|Median|26.6|26.6|Full Range|||18.4|40.0|
4272784|NCT00583219|4096781|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4272785|NCT00583219|4096781|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4272786|NCT00583219|4096781|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4272787|NCT00583219|4096781|B1|||Age||years|Median|74|74.0|Full Range|||37.0|86.0|
4272788|NCT00583115|4096798|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4272789|NCT00583115|4096798|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4272790|NCT00583115|4096798|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4272791|NCT00583115|4096798|B1|Age 8-18 years||Age, Customized||years|Number|1|1.0||||||
4272792|NCT00583102|4096803|B1|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4272793|NCT00583102|4096803|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4272794|NCT00583102|4096803|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4272795|NCT00583102|4096803|B1|||Age||years|Mean|64.3|64.3|Full Range|||45.6|81.9|
4272796|NCT00583102|4096803|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4272797|NCT00583102|4096803|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4272798|NCT00583102|4096803|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272799|NCT00582972|4096807|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4272800|NCT00582972|4096807|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4272801|NCT00582972|4096807|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4272802|NCT00582972|4096807|B1|||Age||years|Mean|58|58.0|Standard Deviation|7|7.0|||
4272803|NCT00582972|4096807|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272804|NCT00582972|4096807|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4272805|NCT00582972|4096807|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272806|NCT00582946|4096812|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4272807|NCT00582946|4096812|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4272808|NCT00582946|4096812|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4272809|NCT00582946|4096812|B1|||Age||years|Mean|65|65.0|Standard Deviation|8|8.0|||
4272810|NCT00582946|4096812|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4272811|NCT00582946|4096812|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4272812|NCT00582946|4096812|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272813|NCT00582933|4096816|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4272814|NCT00582933|4096816|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4272815|NCT00582933|4096816|B1|||Age||years|Median|54.5|54.5|Full Range|||0.6|71.3|
4272816|NCT00582907|4096820|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4272817|NCT00582907|4096820|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4272818|NCT00582907|4096820|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4272819|NCT00582907|4096820|B1|||Age||years|Mean|24.4|24.4|Standard Deviation|11.8|11.8|||
4272820|NCT00582907|4096820|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272821|NCT00582907|4096820|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4272822|NCT00582907|4096820|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4272823|NCT00582894|4096855|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4272824|NCT00582894|4096855|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4272825|NCT00582894|4096855|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4272826|NCT00582894|4096855|B1|||Age||years|Mean|51.8|51.8|Standard Deviation|9.08|9.08|||
4272827|NCT00582894|4096855|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272828|NCT00582894|4096855|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4272829|NCT00582894|4096855|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272830|NCT00582816|4096862|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4272831|NCT00582816|4096862|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4272832|NCT00582816|4096862|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272833|NCT00582816|4096862|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4272834|NCT00582816|4096862|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272835|NCT00582816|4096862|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272836|NCT00582816|4096862|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272837|NCT00582816|4096862|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272838|NCT00582816|4096862|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272839|NCT00582816|4096862|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4272840|NCT00582816|4096862|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4272841|NCT00582816|4096862|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4272842|NCT00582816|4096862|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4272843|NCT00582816|4096862|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272844|NCT00582816|4096862|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4272845|NCT00582816|4096862|B1||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4272846|NCT00582790|4096872|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4272847|NCT00582790|4096872|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4272848|NCT00582790|4096872|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4272849|NCT00582790|4096872|B1|||Age||Years|Mean|56.2|56.2|Standard Deviation|10.6|10.6|||
4272850|NCT00582738|4096879|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4272851|NCT00582738|4096880|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4272852|NCT00582738|4096881|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4272853|NCT00582738|4096879|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4272854|NCT00582738|4096880|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4272855|NCT00582738|4096881|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4272856|NCT00582738|4096879|B3|||Age||years|Median|57|57.0|Full Range|||41.0|70.0|
4272857|NCT00582738|4096880|B2|||Age||years|Median|56.5|56.5|Full Range|8.01|8.01|41.0|69.0|
4272858|NCT00582738|4096881|B1|||Age||years|Median|60.0|60.0|Full Range|6.79|6.79|43.0|70.0|
4272859|NCT00582712|4096906|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4272860|NCT00582712|4096906|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272861|NCT00582712|4096906|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272862|NCT00582712|4096906|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4272863|NCT00582712|4096906|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272864|NCT00582712|4096906|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272865|NCT00582712|4096906|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272866|NCT00582712|4096906|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272867|NCT00582712|4096906|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272868|NCT00582712|4096906|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4272869|NCT00582712|4096906|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4272870|NCT00582712|4096906|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4272871|NCT00582712|4096906|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4272872|NCT00582712|4096906|B1|> 69 years of age||Age, Customized||participants|Number|1|1.0||||||
4272873|NCT00582712|4096906|B1|60-69 years of age||Age, Customized||participants|Number|1|1.0||||||
4272874|NCT00582712|4096906|B1|50-59 years of age||Age, Customized||participants|Number|2|2.0||||||
4272875|NCT00582712|4096906|B1|< 50 years of age||Age, Customized||participants|Number|1|1.0||||||
4272876|NCT00582660|4096910|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4272877|NCT00582660|4096911|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4272878|NCT00582660|4096912|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4272879|NCT00582660|4096910|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4272880|NCT00582660|4096911|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4272881|NCT00582660|4096912|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4272882|NCT00582660|4096910|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4272883|NCT00582660|4096911|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4272884|NCT00582660|4096912|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4272885|NCT00582660|4096910|B3|||Age||years|Mean|62|62.0|Standard Deviation|1|1.0|||
4272886|NCT00582660|4096911|B2|||Age||years|Mean|62|62.0|Standard Deviation|1|1.0|||
4272887|NCT00582660|4096912|B1|||Age||years|Mean|62|62.0|Standard Deviation|1|1.0|||
4272888|NCT00582660|4096910|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272889|NCT00582660|4096911|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272890|NCT00582660|4096912|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272891|NCT00582660|4096910|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4272892|NCT00582660|4096911|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4272893|NCT00582660|4096912|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4272894|NCT00582660|4096910|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272895|NCT00582660|4096911|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272896|NCT00582660|4096912|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272897|NCT00582608|4096921|B1||Male|Gender||Participants|Count of Participants|7|7.0||||||
4272898|NCT00582608|4096921|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
4272899|NCT00582608|4096921|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272900|NCT00582608|4096921|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4272901|NCT00582608|4096921|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4272902|NCT00582556|4096925|B4|||Participants with evidence of osteopenia/osteoporosis||participants|Number|15|15.0||||||
4272903|NCT00582556|4096926|B3|||Participants with evidence of osteopenia/osteoporosis||participants|Number|5|5.0||||||
4272904|NCT00582556|4096927|B2|||Participants with evidence of osteopenia/osteoporosis||participants|Number|4|4.0||||||
4272905|NCT00582556|4096928|B1|||Participants with evidence of osteopenia/osteoporosis||participants|Number|6|6.0||||||
4272906|NCT00582556|4096925|B4|||Gleason Score of 8 or more|The Gleason score is a sum of two scores--each ranging between 1 and 5--provided by the pathologist who examines the cancer under the microscope. When you add the 2 scores you get the Gleason sum which ranges from 2-10: 2 looking basically like a normal prostate and 10 looking extremely aggressive.|participants|Number|15|15.0||||||
4272907|NCT00582556|4096926|B3|||Gleason Score of 8 or more|The Gleason score is a sum of two scores--each ranging between 1 and 5--provided by the pathologist who examines the cancer under the microscope. When you add the 2 scores you get the Gleason sum which ranges from 2-10: 2 looking basically like a normal prostate and 10 looking extremely aggressive.|participants|Number|8|8.0||||||
4272908|NCT00582556|4096927|B2|||Gleason Score of 8 or more|The Gleason score is a sum of two scores--each ranging between 1 and 5--provided by the pathologist who examines the cancer under the microscope. When you add the 2 scores you get the Gleason sum which ranges from 2-10: 2 looking basically like a normal prostate and 10 looking extremely aggressive.|participants|Number|4|4.0||||||
4272909|NCT00582556|4096928|B1|||Gleason Score of 8 or more|The Gleason score is a sum of two scores--each ranging between 1 and 5--provided by the pathologist who examines the cancer under the microscope. When you add the 2 scores you get the Gleason sum which ranges from 2-10: 2 looking basically like a normal prostate and 10 looking extremely aggressive.|participants|Number|3|3.0||||||
4272910|NCT00582556|4096925|B4||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4272911|NCT00582556|4096926|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4272912|NCT00582556|4096927|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4272913|NCT00582556|4096928|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4272914|NCT00582556|4096925|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4272915|NCT00582556|4096926|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4272916|NCT00582556|4096927|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4272917|NCT00582556|4096928|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4272918|NCT00582556|4096925|B4||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4272919|NCT00582556|4096926|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4272920|NCT00582556|4096927|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4272921|NCT00582556|4096928|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4272922|NCT00582556|4096925|B4||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4272923|NCT00582556|4096926|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4272924|NCT00582556|4096927|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4272925|NCT00582556|4096928|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4272926|NCT00582556|4096925|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272927|NCT00582556|4096926|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272928|NCT00582556|4096927|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272929|NCT00582556|4096928|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272930|NCT00582517|4096947|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
4272931|NCT00582517|4096948|B2|United States||Region of Enrollment||participants|Number|55|55.0||||||
4272932|NCT00582517|4096949|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4272933|NCT00582517|4096947|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4272934|NCT00582517|4096948|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4272935|NCT00582517|4096949|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4272936|NCT00582517|4096947|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4272937|NCT00582517|4096948|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4272938|NCT00582517|4096949|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4272939|NCT00582517|4096947|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4272940|NCT00582517|4096948|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4272941|NCT00582517|4096949|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272942|NCT00582517|4096947|B3||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
4272943|NCT00582517|4096948|B2||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4272944|NCT00582517|4096949|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4272945|NCT00582517|4096947|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272946|NCT00582517|4096948|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272947|NCT00582517|4096949|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272948|NCT00582491|4096956|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4272949|NCT00582491|4096957|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4272950|NCT00582491|4096958|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4272951|NCT00582491|4096956|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4272952|NCT00582491|4096957|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4272953|NCT00582491|4096958|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4272954|NCT00582491|4096956|B3|||Age||years|Mean|42.9|42.9|Standard Deviation|6.4|6.4|||
4272955|NCT00582491|4096957|B2|||Age||years|Mean|43.9|43.9|Standard Deviation|8.4|8.4|||
4272956|NCT00582491|4096958|B1|||Age||years|Mean|41.9|41.9|Standard Deviation|3.7|3.7|||
4272957|NCT00582426|4096981|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4272958|NCT00582426|4096982|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4272959|NCT00582426|4096983|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4272960|NCT00582426|4096981|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4272961|NCT00582426|4096982|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4272962|NCT00582426|4096983|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4272963|NCT00582426|4096981|B3|||Age||years|Mean|55.85|55.85|Standard Deviation|12.1|12.1|||
4272964|NCT00582426|4096982|B2|||Age||years|Mean|55.5|55.5|Standard Deviation|11.4|11.4|||
4272965|NCT00582426|4096983|B1|||Age||years|Mean|56.2|56.2|Standard Deviation|12.8|12.8|||
4272966|NCT00582400|4097010|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4272967|NCT00582400|4097010|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4272968|NCT00582400|4097010|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4272969|NCT00582400|4097010|B1|||Age||years|Median|57|57.0|Full Range|||50.0|62.0|
4272970|NCT00582400|4097010|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4272971|NCT00582400|4097010|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4272972|NCT00582400|4097010|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272973|NCT00582361|4097017|B3|United States||Region of Enrollment||participants|Number|63|63.0||||||
4272974|NCT00582361|4097018|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
4272975|NCT00582361|4097019|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4272976|NCT00582361|4097017|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4272977|NCT00582361|4097018|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4272978|NCT00582361|4097019|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4272979|NCT00582361|4097017|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4272980|NCT00582361|4097018|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4272981|NCT00582361|4097019|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4272982|NCT00582361|4097017|B3|||Age||years|Mean|41|41.0|Standard Deviation|15|15.0|||
4272983|NCT00582361|4097018|B2|||Age||years|Mean|38|38.0|Standard Deviation|15|15.0|||
4272984|NCT00582361|4097019|B1|||Age||years|Mean|44|44.0|Standard Deviation|16|16.0|||
4272985|NCT00582361|4097017|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4272986|NCT00582361|4097018|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4272987|NCT00582361|4097019|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4272988|NCT00582361|4097017|B3||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4272989|NCT00582361|4097018|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4272990|NCT00582361|4097019|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4272991|NCT00582361|4097017|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272992|NCT00582361|4097018|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272993|NCT00582361|4097019|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4272994|NCT00582309|4097028|B4|United States||Region of Enrollment||participants|Number|151|151.0||||||
4272995|NCT00582309|4097029|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
4272996|NCT00582309|4097030|B2|United States||Region of Enrollment||participants|Number|49|49.0||||||
4272997|NCT00582309|4097031|B1|United States||Region of Enrollment||participants|Number|56|56.0||||||
4272998|NCT00582309|4097028|B4||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4272999|NCT00582309|4097029|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4273000|NCT00582309|4097030|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4273001|NCT00582309|4097031|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4273002|NCT00582309|4097028|B4||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4273003|NCT00582309|4097029|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4273004|NCT00582309|4097030|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4273005|NCT00582309|4097031|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4273006|NCT00582309|4097028|B4|||Age||years|Mean|61.2|61.2|Standard Deviation|11.3|11.3|||
4273007|NCT00582309|4097029|B3|||Age||years|Mean|61.4|61.4|Standard Deviation|13.6|13.6|||
4273008|NCT00582309|4097030|B2|||Age||years|Mean|60.6|60.6|Standard Deviation|12.3|12.3|||
4273009|NCT00582309|4097031|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|10.6|10.6|||
4273010|NCT00582309|4097028|B4||>=65 years|Age||Participants|Count of Participants|56|56.0||||||
4273011|NCT00582309|4097029|B3||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4273012|NCT00582309|4097030|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4273013|NCT00582309|4097031|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4273014|NCT00582309|4097028|B4||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
4273015|NCT00582309|4097029|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4273016|NCT00582309|4097030|B2||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4273017|NCT00582309|4097031|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4273018|NCT00582309|4097028|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273019|NCT00582309|4097029|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273020|NCT00582309|4097030|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273021|NCT00582309|4097031|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273022|NCT00582205|4097041|B1|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
4273023|NCT00582205|4097041|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4273024|NCT00582205|4097041|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4273025|NCT00582205|4097041|B1|||Age||years|Median|61|61.0|Full Range|||29.0|76.0|
4273026|NCT00582205|4097041|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4273027|NCT00582205|4097041|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4273028|NCT00582205|4097041|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273029|NCT00582166|4097046|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4273030|NCT00582166|4097046|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4273031|NCT00582166|4097046|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4273032|NCT00582166|4097046|B1|||Age||years|Mean|55|55.0|Full Range|||37.0|75.0|
4273033|NCT00582114|4097054|B3|||Creatinine||mg/dL|Mean|10.1|10.1|Standard Deviation|3.6|3.6|||
4273034|NCT00582114|4097055|B2|||Creatinine||mg/dL|Mean|10|10.0|Standard Deviation|3.6|3.6|||
4273035|NCT00582114|4097056|B1|||Creatinine||mg/dL|Mean|10.3|10.3|Standard Deviation|3.5|3.5|||
4273036|NCT00582114|4097054|B3|||Hemoglobin||g/dL|Mean|11.3|11.3|Standard Deviation|1.3|1.3|||
4273037|NCT00582114|4097055|B2|||Hemoglobin||g/dL|Mean|11.3|11.3|Standard Deviation|1.4|1.4|||
4273038|NCT00582114|4097056|B1|||Hemoglobin||g/dL|Mean|11.3|11.3|Standard Deviation|1.2|1.2|||
4273039|NCT00582114|4097054|B3|||Albumin||g/dL|Mean|3.6|3.6|Standard Deviation|0.5|0.5|||
4273040|NCT00582114|4097055|B2|||Albumin||g/dL|Mean|3.6|3.6|Standard Deviation|0.5|0.5|||
4273041|NCT00582114|4097056|B1|||Albumin||g/dL|Mean|3.6|3.6|Standard Deviation|0.5|0.5|||
4273042|NCT00582114|4097054|B3|||Urea reduction ratio||%|Mean|75|75.0|Standard Deviation|8|8.0|||
4273043|NCT00582114|4097055|B2|||Urea reduction ratio||%|Mean|76|76.0|Standard Deviation|8|8.0|||
4273044|NCT00582114|4097056|B1|||Urea reduction ratio||%|Mean|74|74.0|Standard Deviation|8|8.0|||
4273045|NCT00582114|4097054|B3|Delivered dialysis duration||Dialysis duration||minutes|Mean|222|222.0|Standard Deviation|34.2|34.2|||
4273046|NCT00582114|4097055|B2|Delivered dialysis duration||Dialysis duration||minutes|Mean|219.8|219.8|Standard Deviation|33.7|33.7|||
4273047|NCT00582114|4097056|B1|Delivered dialysis duration||Dialysis duration||minutes|Mean|224.1|224.1|Standard Deviation|34.7|34.7|||
4273048|NCT00582114|4097054|B3|Prescribed dialysis duration||Dialysis duration||minutes|Mean|239.4|239.4|Standard Deviation|22.7|22.7|||
4273049|NCT00582114|4097055|B2|Prescribed dialysis duration||Dialysis duration||minutes|Mean|239.4|239.4|Standard Deviation|25.9|25.9|||
4273050|NCT00582114|4097056|B1|Prescribed dialysis duration||Dialysis duration||minutes|Mean|239.4|239.4|Standard Deviation|19|19.0|||
4273051|NCT00582114|4097054|B3|||Dialysate flow rate||mL/min|Mean|770.4|770.4|Standard Deviation|73|73.0|||
4273052|NCT00582114|4097055|B2|||Dialysate flow rate||mL/min|Mean|761.3|761.3|Standard Deviation|82|82.0|||
4273053|NCT00582114|4097056|B1|||Dialysate flow rate||mL/min|Mean|779.6|779.6|Standard Deviation|61.9|61.9|||
4273054|NCT00582114|4097054|B3|||Blood flow rate||mL/min|Mean|393.4|393.4|Standard Deviation|33.7|33.7|||
4273055|NCT00582114|4097055|B2|||Blood flow rate||mL/min|Mean|392.4|392.4|Standard Deviation|36.4|36.4|||
4273056|NCT00582114|4097056|B1|||Blood flow rate||mL/min|Mean|394.3|394.3|Standard Deviation|30.9|30.9|||
4273057|NCT00582114|4097054|B3|Catheter||Access type||participants|Number|52|52.0||||||
4273058|NCT00582114|4097055|B2|Catheter||Access type||participants|Number|27|27.0||||||
4273059|NCT00582114|4097056|B1|Catheter||Access type||participants|Number|25|25.0||||||
4273060|NCT00582114|4097054|B3|Graft||Access type||participants|Number|30|30.0||||||
4273061|NCT00582114|4097055|B2|Graft||Access type||participants|Number|14|14.0||||||
4273062|NCT00582114|4097056|B1|Graft||Access type||participants|Number|16|16.0||||||
4273063|NCT00582114|4097054|B3|Fistula||Access type||participants|Number|118|118.0||||||
4273064|NCT00582114|4097055|B2|Fistula||Access type||participants|Number|59|59.0||||||
4273065|NCT00582114|4097056|B1|Fistula||Access type||participants|Number|59|59.0||||||
4273066|NCT00582114|4097054|B3|||Body mass index||kg/m^2|Mean|27.9|27.9|Standard Deviation|7.7|7.7|||
4273067|NCT00582114|4097055|B2|||Body mass index||kg/m^2|Mean|27.5|27.5|Standard Deviation|8.3|8.3|||
4273068|NCT00582114|4097056|B1|||Body mass index||kg/m^2|Mean|28.4|28.4|Standard Deviation|7|7.0|||
4273069|NCT00582114|4097054|B3|||Weight||kg|Mean|83|83.0|Standard Deviation|23.1|23.1|||
4273070|NCT00582114|4097055|B2|||Weight||kg|Mean|80.9|80.9|Standard Deviation|24.3|24.3|||
4273071|NCT00582114|4097056|B1|||Weight||kg|Mean|85.1|85.1|Standard Deviation|21.7|21.7|||
4273072|NCT00582114|4097054|B3|||Height||inches|Mean|67.9|67.9|Standard Deviation|3.9|3.9|||
4273073|NCT00582114|4097055|B2|||Height||inches|Mean|67.6|67.6|Standard Deviation|3.7|3.7|||
4273074|NCT00582114|4097056|B1|||Height||inches|Mean|68.3|68.3|Standard Deviation|4.1|4.1|||
4273075|NCT00582114|4097054|B3|Does not drink alcohol||Alcohol||participants|Number|154|154.0||||||
4273076|NCT00582114|4097055|B2|Does not drink alcohol||Alcohol||participants|Number|81|81.0||||||
4273077|NCT00582114|4097056|B1|Does not drink alcohol||Alcohol||participants|Number|73|73.0||||||
4273078|NCT00582114|4097054|B3|Drinks alcohol||Alcohol||participants|Number|46|46.0||||||
4273079|NCT00582114|4097055|B2|Drinks alcohol||Alcohol||participants|Number|19|19.0||||||
4273080|NCT00582114|4097056|B1|Drinks alcohol||Alcohol||participants|Number|27|27.0||||||
4273081|NCT00582114|4097054|B3|Non-smoker||Smoking||participants|Number|114|114.0||||||
4273082|NCT00582114|4097055|B2|Non-smoker||Smoking||participants|Number|57|57.0||||||
4273083|NCT00582114|4097056|B1|Non-smoker||Smoking||participants|Number|57|57.0||||||
4273084|NCT00582114|4097054|B3|Current smoker||Smoking||participants|Number|86|86.0||||||
4273085|NCT00582114|4097055|B2|Current smoker||Smoking||participants|Number|43|43.0||||||
4273086|NCT00582114|4097056|B1|Current smoker||Smoking||participants|Number|43|43.0||||||
4273087|NCT00582114|4097054|B3|Refused||Income||participants|Number|19|19.0||||||
4273088|NCT00582114|4097055|B2|Refused||Income||participants|Number|13|13.0||||||
4273089|NCT00582114|4097056|B1|Refused||Income||participants|Number|6|6.0||||||
4273090|NCT00582114|4097054|B3|>= $25,000||Income||participants|Number|17|17.0||||||
4273091|NCT00582114|4097055|B2|>= $25,000||Income||participants|Number|7|7.0||||||
4273092|NCT00582114|4097056|B1|>= $25,000||Income||participants|Number|10|10.0||||||
4273093|NCT00582114|4097054|B3|< $25,000||Income||participants|Number|164|164.0||||||
4273094|NCT00582114|4097055|B2|< $25,000||Income||participants|Number|80|80.0||||||
4273095|NCT00582114|4097056|B1|< $25,000||Income||participants|Number|84|84.0||||||
4273096|NCT00582114|4097054|B3|Retired||Employed||participants|Number|45|45.0||||||
4273097|NCT00582114|4097055|B2|Retired||Employed||participants|Number|23|23.0||||||
4273098|NCT00582114|4097056|B1|Retired||Employed||participants|Number|22|22.0||||||
4273099|NCT00582114|4097054|B3|Not working||Employed||participants|Number|137|137.0||||||
4273100|NCT00582114|4097055|B2|Not working||Employed||participants|Number|70|70.0||||||
4273101|NCT00582114|4097056|B1|Not working||Employed||participants|Number|67|67.0||||||
4273102|NCT00582114|4097054|B3|Working||Employed||participants|Number|18|18.0||||||
4273103|NCT00582114|4097055|B2|Working||Employed||participants|Number|7|7.0||||||
4273104|NCT00582114|4097056|B1|Working||Employed||participants|Number|11|11.0||||||
4273105|NCT00582114|4097054|B3|Widowed||Marital status||participants|Number|16|16.0||||||
4273106|NCT00582114|4097055|B2|Widowed||Marital status||participants|Number|10|10.0||||||
4273107|NCT00582114|4097056|B1|Widowed||Marital status||participants|Number|6|6.0||||||
4273108|NCT00582114|4097054|B3|Divorced/separated||Marital status||participants|Number|33|33.0||||||
4273109|NCT00582114|4097055|B2|Divorced/separated||Marital status||participants|Number|15|15.0||||||
4273110|NCT00582114|4097056|B1|Divorced/separated||Marital status||participants|Number|18|18.0||||||
4273111|NCT00582114|4097054|B3|Married||Marital status||participants|Number|42|42.0||||||
4273112|NCT00582114|4097055|B2|Married||Marital status||participants|Number|19|19.0||||||
4273113|NCT00582114|4097056|B1|Married||Marital status||participants|Number|23|23.0||||||
4273114|NCT00582114|4097054|B3|Single||Marital status||participants|Number|109|109.0||||||
4273115|NCT00582114|4097055|B2|Single||Marital status||participants|Number|56|56.0||||||
4273116|NCT00582114|4097056|B1|Single||Marital status||participants|Number|53|53.0||||||
4273117|NCT00582114|4097054|B3|Peripheral vascular disease||Comorbid conditions||participants|Number|21|21.0||||||
4273118|NCT00582114|4097055|B2|Peripheral vascular disease||Comorbid conditions||participants|Number|11|11.0||||||
4273119|NCT00582114|4097056|B1|Peripheral vascular disease||Comorbid conditions||participants|Number|10|10.0||||||
4273120|NCT00582114|4097054|B3|Cerebrovascular disease||Comorbid conditions||participants|Number|33|33.0||||||
4273121|NCT00582114|4097055|B2|Cerebrovascular disease||Comorbid conditions||participants|Number|20|20.0||||||
4273122|NCT00582114|4097056|B1|Cerebrovascular disease||Comorbid conditions||participants|Number|13|13.0||||||
4273123|NCT00582114|4097054|B3|Coronary revascularization||Comorbid conditions||participants|Number|19|19.0||||||
4273124|NCT00582114|4097055|B2|Coronary revascularization||Comorbid conditions||participants|Number|15|15.0||||||
4273125|NCT00582114|4097056|B1|Coronary revascularization||Comorbid conditions||participants|Number|4|4.0||||||
4273126|NCT00582114|4097054|B3|Coronary artery disease||Comorbid conditions||participants|Number|53|53.0||||||
4273127|NCT00582114|4097055|B2|Coronary artery disease||Comorbid conditions||participants|Number|31|31.0||||||
4273128|NCT00582114|4097056|B1|Coronary artery disease||Comorbid conditions||participants|Number|22|22.0||||||
4273129|NCT00582114|4097054|B3|Hospitalized heart failure||Comorbid conditions||participants|Number|62|62.0||||||
4273130|NCT00582114|4097055|B2|Hospitalized heart failure||Comorbid conditions||participants|Number|37|37.0||||||
4273131|NCT00582114|4097056|B1|Hospitalized heart failure||Comorbid conditions||participants|Number|25|25.0||||||
4273132|NCT00582114|4097054|B3|Diabetes mellitus||Comorbid conditions||participants|Number|86|86.0||||||
4273133|NCT00582114|4097055|B2|Diabetes mellitus||Comorbid conditions||participants|Number|43|43.0||||||
4273134|NCT00582114|4097056|B1|Diabetes mellitus||Comorbid conditions||participants|Number|43|43.0||||||
4273135|NCT00582114|4097054|B3|||Education||years|Mean|12|12.0|Standard Deviation|2|2.0|||
4273136|NCT00582114|4097055|B2|||Education||years|Mean|12|12.0|Standard Deviation|2|2.0|||
4273137|NCT00582114|4097056|B1|||Education||years|Mean|12|12.0|Standard Deviation|2|2.0|||
4273138|NCT00582114|4097054|B3|||Anuric||participants|Number|134|134.0||||||
4273139|NCT00582114|4097055|B2|||Anuric||participants|Number|66|66.0||||||
4273140|NCT00582114|4097056|B1|||Anuric||participants|Number|68|68.0||||||
4273141|NCT00582114|4097054|B3|||Dialysis vintage||years|Mean|4.1|4.1|Standard Deviation|4.3|4.3|||
4273142|NCT00582114|4097055|B2|||Dialysis vintage||years|Mean|3.9|3.9|Standard Deviation|4.2|4.2|||
4273143|NCT00582114|4097056|B1|||Dialysis vintage||years|Mean|4.2|4.2|Standard Deviation|4.4|4.4|||
4273144|NCT00582114|4097054|B3|Other etiologies||Etiology of chronic kidney disease||participants|Number|34|34.0||||||
4273145|NCT00582114|4097055|B2|Other etiologies||Etiology of chronic kidney disease||participants|Number|21|21.0||||||
4273146|NCT00582114|4097056|B1|Other etiologies||Etiology of chronic kidney disease||participants|Number|13|13.0||||||
4273147|NCT00582114|4097054|B3|Polycystic kidney disease||Etiology of chronic kidney disease||participants|Number|1|1.0||||||
4273148|NCT00582114|4097055|B2|Polycystic kidney disease||Etiology of chronic kidney disease||participants|Number|1|1.0||||||
4273149|NCT00582114|4097056|B1|Polycystic kidney disease||Etiology of chronic kidney disease||participants|Number|0|0.0||||||
4273150|NCT00582114|4097054|B3|Glomerulonephritis||Etiology of chronic kidney disease||participants|Number|9|9.0||||||
4273151|NCT00582114|4097055|B2|Glomerulonephritis||Etiology of chronic kidney disease||participants|Number|5|5.0||||||
4273152|NCT00582114|4097056|B1|Glomerulonephritis||Etiology of chronic kidney disease||participants|Number|4|4.0||||||
4273153|NCT00582114|4097054|B3|Hypertension||Etiology of chronic kidney disease||participants|Number|100|100.0||||||
4273154|NCT00582114|4097055|B2|Hypertension||Etiology of chronic kidney disease||participants|Number|46|46.0||||||
4273155|NCT00582114|4097056|B1|Hypertension||Etiology of chronic kidney disease||participants|Number|54|54.0||||||
4273156|NCT00582114|4097054|B3|Diabetes mellitus||Etiology of chronic kidney disease||participants|Number|56|56.0||||||
4273157|NCT00582114|4097055|B2|Diabetes mellitus||Etiology of chronic kidney disease||participants|Number|27|27.0||||||
4273158|NCT00582114|4097056|B1|Diabetes mellitus||Etiology of chronic kidney disease||participants|Number|29|29.0||||||
4273159|NCT00582114|4097054|B3|United States||Region of Enrollment||participants|Number|200|200.0||||||
4273160|NCT00582114|4097055|B2|United States||Region of Enrollment||participants|Number|100|100.0||||||
4273161|NCT00582114|4097056|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
4273162|NCT00582114|4097054|B3|Non-blacks||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4273163|NCT00582114|4097055|B2|Non-blacks||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4273164|NCT00582114|4097056|B1|Non-blacks||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4273165|NCT00582114|4097054|B3|Blacks||Race/Ethnicity, Customized||participants|Number|172|172.0||||||
4273166|NCT00582114|4097055|B2|Blacks||Race/Ethnicity, Customized||participants|Number|86|86.0||||||
4273167|NCT00582114|4097056|B1|Blacks||Race/Ethnicity, Customized||participants|Number|86|86.0||||||
4273168|NCT00582114|4097054|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273169|NCT00582114|4097055|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273170|NCT00582114|4097056|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273171|NCT00582114|4097054|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|199|199.0||||||
4273172|NCT00582114|4097055|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
4273173|NCT00582114|4097056|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
4273174|NCT00582114|4097054|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4273175|NCT00582114|4097055|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273176|NCT00582114|4097056|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4273177|NCT00582114|4097054|B3||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4273178|NCT00582114|4097055|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4273179|NCT00582114|4097056|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4273180|NCT00582114|4097054|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4273181|NCT00582114|4097055|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4273182|NCT00582114|4097056|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4273183|NCT00582114|4097054|B3|||Age||years|Mean|52.7|52.7|Standard Deviation|12.6|12.6|||
4273184|NCT00582114|4097055|B2|||Age||years|Mean|53.1|53.1|Standard Deviation|13.5|13.5|||
4273185|NCT00582114|4097056|B1|||Age||years|Mean|52.5|52.5|Standard Deviation|11.7|11.7|||
4273186|NCT00582075|4097065|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4273187|NCT00582075|4097065|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4273188|NCT00582075|4097065|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4273189|NCT00582075|4097065|B1|||Age||years|Mean|56|56.0|Full Range|||23.0|80.0|
4273190|NCT00582075|4097065|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4273191|NCT00582075|4097065|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4273192|NCT00582075|4097065|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273193|NCT00582036|4097070|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4273194|NCT00582036|4097071|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4273195|NCT00582036|4097072|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4273196|NCT00582036|4097070|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4273197|NCT00582036|4097071|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4273198|NCT00582036|4097072|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4273199|NCT00582036|4097070|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4273200|NCT00582036|4097071|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4273201|NCT00582036|4097072|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4273202|NCT00582036|4097070|B3|||Age||years|Mean|59|59.0|Standard Deviation|2|2.0|||
4273203|NCT00582036|4097071|B2|||Age||years|Mean|58|58.0|Standard Deviation|2|2.0|||
4273204|NCT00582036|4097072|B1|||Age||years|Mean|60|60.0|Standard Deviation|1|1.0|||
4273205|NCT00582036|4097070|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4273206|NCT00582036|4097071|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4273207|NCT00582036|4097072|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4273208|NCT00582036|4097070|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4273209|NCT00582036|4097071|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4273210|NCT00582036|4097072|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4273211|NCT00582036|4097070|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273212|NCT00582036|4097071|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273213|NCT00582036|4097072|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273214|NCT00582010|4097079|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
4273215|NCT00582010|4097080|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4273216|NCT00582010|4097081|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4273217|NCT00582010|4097079|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4273218|NCT00582010|4097080|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4273219|NCT00582010|4097081|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4273220|NCT00582010|4097079|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4273221|NCT00582010|4097080|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4273222|NCT00582010|4097081|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4273223|NCT00582010|4097079|B3|||Age||years|Mean|60|60.0|Full Range|||24.0|72.0|
4273224|NCT00582010|4097080|B2|||Age||years|Mean|61|61.0|Full Range|||24.0|70.0|
4273225|NCT00582010|4097081|B1|||Age||years|Mean|59|59.0|Full Range|4|4.0|30.0|72.0|
4273226|NCT00581971|4097104|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4273227|NCT00581971|4097104|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4273228|NCT00581971|4097104|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4273229|NCT00581971|4097104|B1|||Age||years|Mean|53.83|53.83|Standard Deviation|8.06|8.06|||
4273230|NCT00581971|4097104|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4273231|NCT00581971|4097104|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4273232|NCT00581971|4097104|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273233|NCT00581945|4097109|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4273234|NCT00581945|4097110|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4273235|NCT00581945|4097111|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4273236|NCT00581945|4097109|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4273237|NCT00581945|4097110|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4273238|NCT00581945|4097111|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4273239|NCT00581945|4097109|B3|||Age||years|Mean|63.7|63.7|Standard Deviation|7.78|7.78|||
4273240|NCT00581945|4097110|B2|||Age||years|Mean|63.6|63.6|Standard Deviation|7.92|7.92|||
4273241|NCT00581945|4097111|B1|||Age||years|Mean|63.9|63.9|Standard Deviation|7.70|7.7|||
4273242|NCT00581919|4097128|B1||Male|Gender||Participants|Count of Participants|21|21.0||||||
4273243|NCT00581919|4097128|B1||Female|Gender||Participants|Count of Participants|11|11.0||||||
4273244|NCT00581919|4097128|B1|80-89||Age, Customized||participants|Number|2|2.0||||||
4273245|NCT00581919|4097128|B1|70-79||Age, Customized||participants|Number|7|7.0||||||
4273246|NCT00581919|4097128|B1|60-69||Age, Customized||participants|Number|12|12.0||||||
4273247|NCT00581919|4097128|B1|50-59||Age, Customized||participants|Number|6|6.0||||||
4273248|NCT00581919|4097128|B1|40-49||Age, Customized||participants|Number|4|4.0||||||
4273249|NCT00581919|4097128|B1|30-39||Age, Customized||participants|Number|1|1.0||||||
4273250|NCT00581867|4097134|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4273251|NCT00581867|4097134|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4273252|NCT00581867|4097134|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4273253|NCT00581867|4097134|B1|||Age||years|Mean|72.9|72.9|Standard Deviation|7.1|7.1|||
4273254|NCT00581854|4097143|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4273255|NCT00581854|4097143|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4273256|NCT00581854|4097143|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4273257|NCT00581854|4097143|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4273258|NCT00581854|4097143|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4273259|NCT00581854|4097143|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273260|NCT00581828|4097147|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4273261|NCT00581828|4097147|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4273262|NCT00581828|4097147|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4273263|NCT00581828|4097147|B1|||Age||years|Mean|58|58.0|Standard Deviation|8|8.0|||
4273264|NCT00581828|4097147|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4273265|NCT00581828|4097147|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4273266|NCT00581828|4097147|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273267|NCT00581776|4097151|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4273268|NCT00581776|4097151|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4273269|NCT00581776|4097151|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4273270|NCT00581776|4097151|B1|||Age||years|Mean|61|61.0|Standard Deviation|26|26.0|||
4273271|NCT00581776|4097151|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4273272|NCT00581776|4097151|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4273273|NCT00581776|4097151|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273274|NCT00581581|4097158|B3|New Zealand||Region of Enrollment||participants|Number|4|4.0||||||
4273275|NCT00581581|4097159|B2|New Zealand||Region of Enrollment||participants|Number|2|2.0||||||
4273276|NCT00581581|4097160|B1|New Zealand||Region of Enrollment||participants|Number|2|2.0||||||
4273277|NCT00581581|4097158|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
4273278|NCT00581581|4097159|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4273279|NCT00581581|4097160|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4273280|NCT00581581|4097158|B3|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
4273281|NCT00581581|4097159|B2|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4273282|NCT00581581|4097160|B1|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4273283|NCT00581581|4097158|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4273284|NCT00581581|4097159|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4273285|NCT00581581|4097160|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4273286|NCT00581581|4097158|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4273287|NCT00581581|4097159|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4273288|NCT00581581|4097160|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4273289|NCT00581581|4097158|B3|||Age||years|Mean|7.67|7.67|Standard Deviation|0.62|0.62|||
4273290|NCT00581581|4097159|B2|||Age||years|Mean|7.66|7.66|Standard Deviation|0.63|0.63|||
4273291|NCT00581581|4097160|B1|||Age||years|Mean|7.68|7.68|Standard Deviation|0.62|0.62|||
4273292|NCT00581581|4097158|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4273293|NCT00581581|4097159|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4273294|NCT00581581|4097160|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4273295|NCT00581581|4097158|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4273296|NCT00581581|4097159|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4273297|NCT00581581|4097160|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4273298|NCT00581581|4097158|B3||<=18 years|Age||Participants|Count of Participants|62|62.0||||||
4273299|NCT00581581|4097159|B2||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4273300|NCT00581581|4097160|B1||<=18 years|Age||Participants|Count of Participants|32|32.0||||||
4273301|NCT00581555|4097167|B3|||DLQI score|Dermatology Life Quality Index (DLQI) is the dermatology-specific quality of life measure used for psoriatic population. The 10 item questionnaire has a score range of 0 to 30 with higher scores indicating poor quality of life. An estimate of the minimal clinically important difference of the DLQI total score is a 5 point improvement. Total score range: 0 (best) to 30 (worst).|units on scale|Mean|11.23|11.23|Standard Deviation|6.72|6.72|||
4273302|NCT00581555|4097168|B2|||DLQI score|Dermatology Life Quality Index (DLQI) is the dermatology-specific quality of life measure used for psoriatic population. The 10 item questionnaire has a score range of 0 to 30 with higher scores indicating poor quality of life. An estimate of the minimal clinically important difference of the DLQI total score is a 5 point improvement. Total score range: 0 (best) to 30 (worst).|units on scale|Mean|11.20|11.2|Standard Deviation|7.22|7.22|||
4273337|NCT00581529|4097203|B1|IDC||Histology|Breast cancer histology: Ductal carcinoma in situ (DCIS) or Invasive ductal carcinoma (IDC).|participants|Number|14|14.0||||||
4273303|NCT00581555|4097169|B1|||DLQI score|Dermatology Life Quality Index (DLQI) is the dermatology-specific quality of life measure used for psoriatic population. The 10 item questionnaire has a score range of 0 to 30 with higher scores indicating poor quality of life. An estimate of the minimal clinically important difference of the DLQI total score is a 5 point improvement. Total score range: 0 (best) to 30 (worst).|units on scale|Mean|11.26|11.26|Standard Deviation|6.30|6.3|||
4273304|NCT00581555|4097167|B3|||PGA|Physician Global Assessment (PGA) score is based on dermatologist's assessment of disease averaged over all lesions. Overall lesions were graded for individual scores of induration, erythema, and scaling; range: 0 (no evidence) to 5 (severe). The sum of the 3 scores was divided by 3 to obtain a final PGA score. Higher scores indicate greater severity of disease.|units on scale|Mean|4.15|4.15|Standard Deviation|0.78|0.78|||
4273305|NCT00581555|4097168|B2|||PGA|Physician Global Assessment (PGA) score is based on dermatologist's assessment of disease averaged over all lesions. Overall lesions were graded for individual scores of induration, erythema, and scaling; range: 0 (no evidence) to 5 (severe). The sum of the 3 scores was divided by 3 to obtain a final PGA score. Higher scores indicate greater severity of disease.|units on scale|Mean|4.25|4.25|Standard Deviation|0.85|0.85|||
4273306|NCT00581555|4097169|B1|||PGA|Physician Global Assessment (PGA) score is based on dermatologist's assessment of disease averaged over all lesions. Overall lesions were graded for individual scores of induration, erythema, and scaling; range: 0 (no evidence) to 5 (severe). The sum of the 3 scores was divided by 3 to obtain a final PGA score. Higher scores indicate greater severity of disease.|units on scale|Mean|4.07|4.07|Standard Deviation|0.73|0.73|||
4273307|NCT00581555|4097167|B3|||PASI score|Psoriasis Area and Severity Index (PASI) score: range: 0 (none) to 72 (maximum). Body was divided into head, upper extremities, trunk and lower extremities; each area score was combined for final PASI. For each section, percent area of skin involved was estimated: 0 (0%) to 6 (90 - 100%), and severity was estimated by clinical signs: (erythema, induration, and desquamation); scale: 0 (none) to 4 (maximum). Final PASI= sum of severity parameters for each section times area score times weight of section (head: 0.1, upper extremities: 0.2, trunk: 0.3, lower extremities: 0.4).|units on scale|Mean|19.74|19.74|Standard Deviation|7.26|7.26|||
4273308|NCT00581555|4097168|B2|||PASI score|Psoriasis Area and Severity Index (PASI) score: range: 0 (none) to 72 (maximum). Body was divided into head, upper extremities, trunk and lower extremities; each area score was combined for final PASI. For each section, percent area of skin involved was estimated: 0 (0%) to 6 (90 - 100%), and severity was estimated by clinical signs: (erythema, induration, and desquamation); scale: 0 (none) to 4 (maximum). Final PASI= sum of severity parameters for each section times area score times weight of section (head: 0.1, upper extremities: 0.2, trunk: 0.3, lower extremities: 0.4).|units on scale|Mean|20.19|20.19|Standard Deviation|7.76|7.76|||
4273309|NCT00581555|4097169|B1|||PASI score|Psoriasis Area and Severity Index (PASI) score: range: 0 (none) to 72 (maximum). Body was divided into head, upper extremities, trunk and lower extremities; each area score was combined for final PASI. For each section, percent area of skin involved was estimated: 0 (0%) to 6 (90 - 100%), and severity was estimated by clinical signs: (erythema, induration, and desquamation); scale: 0 (none) to 4 (maximum). Final PASI= sum of severity parameters for each section times area score times weight of section (head: 0.1, upper extremities: 0.2, trunk: 0.3, lower extremities: 0.4).|units on scale|Mean|19.35|19.35|Standard Deviation|6.98|6.98|||
4273310|NCT00581555|4097167|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4273311|NCT00581555|4097168|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4273312|NCT00581555|4097169|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4273313|NCT00581555|4097167|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4273314|NCT00581555|4097168|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4273315|NCT00581555|4097169|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4273316|NCT00581555|4097167|B3|||Age||years|Mean|41.63|41.63|Standard Deviation|11.52|11.52|||
4273317|NCT00581555|4097168|B2|||Age||years|Mean|41.78|41.78|Standard Deviation|9.86|9.86|||
4273318|NCT00581555|4097169|B1|||Age||years|Mean|41.50|41.5|Standard Deviation|12.97|12.97|||
4273319|NCT00581542|4097192|B3|United States||Region of Enrollment||participants|Number|124|124.0||||||
4273320|NCT00581542|4097193|B2|United States||Region of Enrollment||participants|Number|62|62.0||||||
4273321|NCT00581542|4097194|B1|United States||Region of Enrollment||participants|Number|62|62.0||||||
4273322|NCT00581542|4097192|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4273323|NCT00581542|4097193|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4273324|NCT00581542|4097194|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4273325|NCT00581542|4097192|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4273326|NCT00581542|4097193|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4273327|NCT00581542|4097194|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4273328|NCT00581542|4097192|B3|||Age||months|Mean|71.3|71.3|Standard Deviation|49|49.0|||
4273329|NCT00581542|4097193|B2|||Age||months|Mean|70.3|70.3|Standard Deviation|48|48.0|||
4273330|NCT00581542|4097194|B1|||Age||months|Mean|73.4|73.4|Standard Deviation|50|50.0|||
4273331|NCT00581529|4097203|B1|No||Re-excision|Did patients required a second surgical excision to achieve final negative margins?|participants|Number|15|15.0||||||
4273332|NCT00581529|4097203|B1|Yes||Re-excision|Did patients required a second surgical excision to achieve final negative margins?|participants|Number|15|15.0||||||
4273333|NCT00581529|4097203|B1|No||Endocrine Therapy|Did participant receive endocrine therapy following APBI (Accelerated partial breast irradiation)?|participants|Number|11|11.0||||||
4273334|NCT00581529|4097203|B1|Yes||Endocrine Therapy|Did participant receive endocrine therapy following APBI (Accelerated partial breast irradiation)?|participants|Number|19|19.0||||||
4273335|NCT00581529|4097203|B1|No||Chemotherapy|Did participant receive chemotherapy following APBI (Accelerated partial breast irradiation)?|participants|Number|25|25.0||||||
4273336|NCT00581529|4097203|B1|Yes||Chemotherapy|Did participant receive chemotherapy following APBI (Accelerated partial breast irradiation)?|participants|Number|5|5.0||||||
4273338|NCT00581529|4097203|B1|DCIS||Histology|Breast cancer histology: Ductal carcinoma in situ (DCIS) or Invasive ductal carcinoma (IDC).|participants|Number|16|16.0||||||
4273339|NCT00581529|4097203|B1|Right Breast||Laterality|Left or right breast|participants|Number|21|21.0||||||
4273340|NCT00581529|4097203|B1|Left Breast||Laterality|Left or right breast|participants|Number|9|9.0||||||
4273341|NCT00581529|4097203|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4273342|NCT00581529|4097203|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4273343|NCT00581529|4097203|B1|||Age||years|Median|56|56.0|Full Range|||40.0|80.0|
4273344|NCT00581399|4097210|B3|United States||Region of Enrollment||participants|Number|94|94.0||||||
4273345|NCT00581399|4097211|B2|United States||Region of Enrollment||participants|Number|48|48.0||||||
4273346|NCT00581399|4097212|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4273347|NCT00581399|4097210|B3||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4273348|NCT00581399|4097211|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4273349|NCT00581399|4097212|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4273350|NCT00581399|4097210|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4273351|NCT00581399|4097211|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4273352|NCT00581399|4097212|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4273353|NCT00581399|4097210|B3||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4273354|NCT00581399|4097211|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4273355|NCT00581399|4097212|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4273356|NCT00581399|4097210|B3||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4273357|NCT00581399|4097211|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4273358|NCT00581399|4097212|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4273359|NCT00581399|4097210|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273360|NCT00581399|4097211|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273361|NCT00581399|4097212|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273362|NCT00581386|4097221|B4|United States||Region of Enrollment||participants|Number|218|218.0||||||
4273363|NCT00581386|4097222|B3|United States||Region of Enrollment||participants|Number|72|72.0||||||
4273364|NCT00581386|4097223|B2|United States||Region of Enrollment||participants|Number|73|73.0||||||
4273365|NCT00581386|4097224|B1|United States||Region of Enrollment||participants|Number|73|73.0||||||
4273366|NCT00581386|4097221|B4||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4273367|NCT00581386|4097222|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4273368|NCT00581386|4097223|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4273369|NCT00581386|4097224|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4273370|NCT00581386|4097221|B4||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4273371|NCT00581386|4097222|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4273372|NCT00581386|4097223|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4273373|NCT00581386|4097224|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4273374|NCT00581386|4097221|B4|||Age||years|Mean|40.47|40.47|Standard Deviation|14.12|14.12|||
4273375|NCT00581386|4097222|B3|||Age||years|Mean|40.08|40.08|Standard Deviation|13.68|13.68|||
4273376|NCT00581386|4097223|B2|||Age||years|Mean|39.45|39.45|Standard Deviation|13.73|13.73|||
4273377|NCT00581386|4097224|B1|||Age||years|Mean|41.84|41.84|Standard Deviation|14.95|14.95|||
4273378|NCT00581386|4097221|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4273379|NCT00581386|4097222|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4273380|NCT00581386|4097223|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4273381|NCT00581386|4097224|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4273382|NCT00581386|4097221|B4||Between 18 and 65 years|Age||Participants|Count of Participants|218|218.0||||||
4273383|NCT00581386|4097222|B3||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
4273384|NCT00581386|4097223|B2||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4273385|NCT00581386|4097224|B1||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4273386|NCT00581386|4097221|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273387|NCT00581386|4097222|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273388|NCT00581386|4097223|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273389|NCT00581386|4097224|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273390|NCT00581360|4097249|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4273391|NCT00581360|4097249|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4273392|NCT00581360|4097249|B1|||Age||years|Median|56|56.0|Full Range|||44.0|74.0|
4273393|NCT00581347|4097257|B3||Male|Sex: Female, Male||Participants|Count of Participants|3794|3794.0||||||
4273394|NCT00581347|4097258|B2||Male|Sex: Female, Male||Participants|Count of Participants|1858|1858.0||||||
4273395|NCT00581347|4097259|B1||Male|Sex: Female, Male||Participants|Count of Participants|1936|1936.0||||||
4273396|NCT00581347|4097257|B3||Female|Sex: Female, Male||Participants|Count of Participants|3752|3752.0||||||
4273397|NCT00581347|4097258|B2||Female|Sex: Female, Male||Participants|Count of Participants|1849|1849.0||||||
4273398|NCT00581347|4097259|B1||Female|Sex: Female, Male||Participants|Count of Participants|1903|1903.0||||||
4273399|NCT00581347|4097257|B3|15 years old||Age, Customized||participants|Number|1622|1622.0||||||
4273400|NCT00581347|4097258|B2|15 years old||Age, Customized||participants|Number|805|805.0||||||
4273401|NCT00581347|4097259|B1|15 years old||Age, Customized||participants|Number|817|817.0||||||
4273402|NCT00581347|4097257|B3|14 years old||Age, Customized||participants|Number|1539|1539.0||||||
4273403|NCT00581347|4097258|B2|14 years old||Age, Customized||participants|Number|758|758.0||||||
4273404|NCT00581347|4097259|B1|14 years old||Age, Customized||participants|Number|781|781.0||||||
4273405|NCT00581347|4097257|B3|13 years old||Age, Customized||participants|Number|1400|1400.0||||||
4273406|NCT00581347|4097258|B2|13 years old||Age, Customized||participants|Number|686|686.0||||||
4273407|NCT00581347|4097259|B1|13 years old||Age, Customized||participants|Number|714|714.0||||||
4273408|NCT00581347|4097257|B3|12 years old||Age, Customized||participants|Number|1444|1444.0||||||
4273409|NCT00581347|4097258|B2|12 years old||Age, Customized||participants|Number|701|701.0||||||
4273410|NCT00581347|4097259|B1|12 years old||Age, Customized||participants|Number|743|743.0||||||
4273411|NCT00581347|4097257|B3|11 years old||Age, Customized||participants|Number|1541|1541.0||||||
4273412|NCT00581347|4097258|B2|11 years old||Age, Customized||participants|Number|757|757.0||||||
4273413|NCT00581347|4097259|B1|11 years old||Age, Customized||participants|Number|784|784.0||||||
4273414|NCT00581308|4097268|B1|No||General Medical History: Other (non-ASD) Cardiac Disease||Participants|Number|187|187.0||||||
4273415|NCT00581308|4097268|B1|Yes||General Medical History: Other (non-ASD) Cardiac Disease||Participants|Number|28|28.0||||||
4273416|NCT00581308|4097268|B1|No||General Medical History: Cardiac Arrhythmia(s)||Participants|Number|199|199.0||||||
4273417|NCT00581308|4097268|B1|Yes||General Medical History: Cardiac Arrhythmia(s)||Participants|Number|16|16.0||||||
4273418|NCT00581308|4097268|B1|No||General Medical History: ECG Abnormalities||Participants|Number|118|118.0||||||
4273419|NCT00581308|4097268|B1|Yes||General Medical History: ECG Abnormalities||Participants|Number|97|97.0||||||
4273420|NCT00581308|4097268|B1|No||General Medical History: Previous Cardiac Surgery||Participants|Number|203|203.0||||||
4273421|NCT00581308|4097268|B1|Yes||General Medical History: Previous Cardiac Surgery||Participants|Number|12|12.0||||||
4273422|NCT00581308|4097268|B1|No||Multiple Fenestrations Noted||Participants|Number|176|176.0||||||
4273423|NCT00581308|4097268|B1|Yes||Multiple Fenestrations Noted||Participants|Number|39|39.0||||||
4273424|NCT00581308|4097268|B1|||Defect Size by Direct Balloon Sizing||(mm)|Median|13|13.0|Full Range|||5.0|20.0|
4273425|NCT00581308|4097268|B1|||Defect Size by Direct Balloon Sizing||(mm)|Mean|12|12.0|Standard Deviation|3|3.0|||
4273426|NCT00581308|4097268|B1|Missing Value||Defect Size by Direct Balloon Sizing||Participants|Number|6|6.0||||||
4273427|NCT00581308|4097268|B1|With Value||Defect Size by Direct Balloon Sizing||Participants|Number|209|209.0||||||
4273428|NCT00581308|4097268|B1|Unknown||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4273429|NCT00581308|4097268|B1|Other||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4273430|NCT00581308|4097268|B1|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4273431|NCT00581308|4097268|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4273432|NCT00581308|4097268|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4273433|NCT00581308|4097268|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|141|141.0||||||
4273434|NCT00581308|4097268|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4273435|NCT00581308|4097268|B1||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4273436|NCT00581308|4097268|B1|||Age, Customized||years|Median|6.5|6.5|Full Range|||0.8|88.5|
4273437|NCT00581308|4097268|B1|Mean (Standard Deviation)||Age||years|Mean|11.3|11.3|Standard Deviation|12.9|12.9|||
4273438|NCT00581308|4097268|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4273439|NCT00581308|4097268|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4273440|NCT00581308|4097268|B1||<=18 years|Age||Participants|Count of Participants|188|188.0||||||
4273441|NCT00581256|4097275|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4273442|NCT00581256|4097276|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4273443|NCT00581256|4097277|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4273444|NCT00581256|4097275|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4273445|NCT00581256|4097276|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4273446|NCT00581256|4097277|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4273447|NCT00581256|4097275|B3|||Age||years|Mean|50.6|50.6|Full Range|||25.0|74.0|
4273448|NCT00581256|4097276|B2|||Age||years|Mean|51.7|51.7|Full Range|||25.0|74.0|
4273449|NCT00581256|4097277|B1|||Age||years|Mean|47.8|47.8|Full Range|||30.0|69.0|
4273450|NCT00581230|4097290|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4273451|NCT00581230|4097290|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4273452|NCT00581230|4097290|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4273453|NCT00581230|4097290|B1|||Age||years|Mean|42.76|42.76|Standard Deviation|10.94|10.94|||
4273454|NCT00581230|4097290|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4273455|NCT00581230|4097290|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4273456|NCT00581230|4097290|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273457|NCT00581113|4097297|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4273458|NCT00581113|4097298|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4273459|NCT00581113|4097299|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4273460|NCT00581113|4097297|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4273461|NCT00581113|4097298|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4273462|NCT00581113|4097299|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4273463|NCT00581113|4097297|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4273464|NCT00581113|4097298|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4273465|NCT00581113|4097299|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4273466|NCT00581113|4097297|B3|||Age||years|Mean|59.6|59.6|Standard Deviation|0.6|0.6|||
4273467|NCT00581113|4097298|B2|||Age||years|Mean|52.0|52.0|Standard Deviation|0.0|0.0|||
4273468|NCT00581113|4097299|B1|||Age||years|Mean|67.2|67.2|Standard Deviation|9.7|9.7|||
4273469|NCT00581113|4097297|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4273470|NCT00581113|4097298|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4273471|NCT00581113|4097299|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4273472|NCT00581113|4097297|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4273473|NCT00581113|4097298|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4273474|NCT00581113|4097299|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4273475|NCT00581113|4097297|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273476|NCT00581113|4097298|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273477|NCT00581113|4097299|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273478|NCT00581100|4097308|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4273479|NCT00581100|4097309|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4273480|NCT00581100|4097310|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4273481|NCT00581100|4097308|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4273482|NCT00581100|4097309|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4273483|NCT00581100|4097310|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4273484|NCT00581100|4097308|B3|||Age, Customized||years|Mean|45.84|45.84|Standard Deviation|11.57|11.57|||
4273485|NCT00581100|4097309|B2|||Age, Customized||years|Mean|45.36|45.36|Standard Deviation|9.19|9.19|||
4273486|NCT00581100|4097310|B1|||Age, Customized||years|Mean|46.28|46.28|Standard Deviation|13.51|13.51|||
4273487|NCT00581061|4097347|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4273488|NCT00581061|4097347|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4273489|NCT00581061|4097347|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4273490|NCT00581061|4097347|B1|||Age||years|Mean|62.9|62.9|Standard Deviation|6.9|6.9|||
4273491|NCT00581061|4097347|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4273492|NCT00581061|4097347|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4273493|NCT00581061|4097347|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273494|NCT00581048|4097353|B1|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
4273495|NCT00581048|4097353|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273496|NCT00581048|4097353|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273497|NCT00581048|4097353|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4273498|NCT00581048|4097353|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4273499|NCT00581048|4097353|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273500|NCT00581048|4097353|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273501|NCT00581048|4097353|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273502|NCT00581048|4097353|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4273503|NCT00581048|4097353|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4273504|NCT00581048|4097353|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4273505|NCT00581048|4097353|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4273506|NCT00581048|4097353|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273507|NCT00580983|4097364|B1|Current Smoker||Smoking Status||participants|Number|16|16.0||||||
4273508|NCT00580983|4097364|B1|Previous Smoker||Smoking Status||participants|Number|31|31.0||||||
4273509|NCT00580983|4097364|B1|Never Smoked||Smoking Status||participants|Number|26|26.0||||||
4273510|NCT00580983|4097364|B1|Stage IVB||AJCC Stage|"The AJCC staging system is a classification system developed by the American Joint Committee on Cancer (AJCC) for describing the extent of disease progression in cancer patients.~The TNM (Tumor, Lymph Node, Metastasis) classifications for cancers of the head and neck vary with location. Once the T, N, and M are determined, they are combined, and an overall stage of 0, I, II, III, IV is assigned."|participants|Number|6|6.0||||||
4273511|NCT00580983|4097364|B1|Stage IVA||AJCC Stage|"The AJCC staging system is a classification system developed by the American Joint Committee on Cancer (AJCC) for describing the extent of disease progression in cancer patients.~The TNM (Tumor, Lymph Node, Metastasis) classifications for cancers of the head and neck vary with location. Once the T, N, and M are determined, they are combined, and an overall stage of 0, I, II, III, IV is assigned."|participants|Number|58|58.0||||||
4273512|NCT00580983|4097364|B1|Stage III||AJCC Stage|"The AJCC staging system is a classification system developed by the American Joint Committee on Cancer (AJCC) for describing the extent of disease progression in cancer patients.~The TNM (Tumor, Lymph Node, Metastasis) classifications for cancers of the head and neck vary with location. Once the T, N, and M are determined, they are combined, and an overall stage of 0, I, II, III, IV is assigned."|participants|Number|9|9.0||||||
4273513|NCT00580983|4097364|B1|Stage 3||N Stage|The TNM staging system is a standard system used to describe and summarize how far a patient's cancer has spread. The T describes the extent of spread to nearby lymph nodes. The numbers 0 through 4 indicate increasing severity.|participants|Number|6|6.0||||||
4273514|NCT00580983|4097364|B1|Stage 2||N Stage|The TNM staging system is a standard system used to describe and summarize how far a patient's cancer has spread. The T describes the extent of spread to nearby lymph nodes. The numbers 0 through 4 indicate increasing severity.|participants|Number|55|55.0||||||
4273515|NCT00580983|4097364|B1|Stage 1||N Stage|The TNM staging system is a standard system used to describe and summarize how far a patient's cancer has spread. The T describes the extent of spread to nearby lymph nodes. The numbers 0 through 4 indicate increasing severity.|participants|Number|6|6.0||||||
4273516|NCT00580983|4097364|B1|Stage 0||N Stage|The TNM staging system is a standard system used to describe and summarize how far a patient's cancer has spread. The T describes the extent of spread to nearby lymph nodes. The numbers 0 through 4 indicate increasing severity.|participants|Number|6|6.0||||||
4273517|NCT00580983|4097364|B1|Stage 4||T Stage|The TNM (Classification of Malignant Tumours) staging system is a standard system used to describe and summarize how far a patient's cancer has spread. The T indicates the size of the primary tumor. The numbers 0 through 4 indicate increasing severity.|participants|Number|18|18.0||||||
4273518|NCT00580983|4097364|B1|Stage 3||T Stage|The TNM (Classification of Malignant Tumours) staging system is a standard system used to describe and summarize how far a patient's cancer has spread. The T indicates the size of the primary tumor. The numbers 0 through 4 indicate increasing severity.|participants|Number|17|17.0||||||
4273519|NCT00580983|4097364|B1|Stage 2||T Stage|The TNM (Classification of Malignant Tumours) staging system is a standard system used to describe and summarize how far a patient's cancer has spread. The T indicates the size of the primary tumor. The numbers 0 through 4 indicate increasing severity.|participants|Number|29|29.0||||||
4273520|NCT00580983|4097364|B1|Stage 1||T Stage|The TNM (Classification of Malignant Tumours) staging system is a standard system used to describe and summarize how far a patient's cancer has spread. The T indicates the size of the primary tumor. The numbers 0 through 4 indicate increasing severity.|participants|Number|9|9.0||||||
4273521|NCT00580983|4097364|B1|||Gross Tumor Volume||mL|Median|110|110.0|Full Range|||19.0|378.0|
4273522|NCT00580983|4097364|B1|Base of Tongue||Tumor Location||participants|Number|38|38.0||||||
4273523|NCT00580983|4097364|B1|Tonsil||Tumor Location||participants|Number|35|35.0||||||
4273524|NCT00580983|4097364|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4273525|NCT00580983|4097364|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4273526|NCT00580983|4097364|B1|||Age||years|Median|55|55.0|Full Range|||50.0|78.0|
4273527|NCT00580970|4097369|B3|United States||Region of Enrollment||participants|Number|73|73.0||||||
4273528|NCT00580970|4097370|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4273529|NCT00580970|4097371|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
4273530|NCT00580970|4097369|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273531|NCT00580970|4097370|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273532|NCT00580970|4097371|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273533|NCT00580970|4097369|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273534|NCT00580970|4097370|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273535|NCT00580970|4097371|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273536|NCT00580970|4097369|B3||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4273537|NCT00580970|4097370|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4273538|NCT00580970|4097371|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4273539|NCT00580970|4097369|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4273540|NCT00580970|4097370|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4273541|NCT00580970|4097371|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4273542|NCT00580970|4097369|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273543|NCT00580970|4097370|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273544|NCT00580970|4097371|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273545|NCT00580970|4097369|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273546|NCT00580970|4097370|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273547|NCT00580970|4097371|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273548|NCT00580970|4097369|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273549|NCT00580970|4097370|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273550|NCT00580970|4097371|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273551|NCT00580970|4097369|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4273552|NCT00580970|4097370|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4273553|NCT00580970|4097371|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4273554|NCT00580970|4097369|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4273555|NCT00580970|4097370|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4273556|NCT00580970|4097371|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4273557|NCT00580970|4097369|B3|||Age||years|Median|62|62.0|Full Range|||47.0|80.0|
4273558|NCT00580970|4097370|B2|||Age||years|Median|58.5|58.5|Full Range|||50.0|69.0|
4273559|NCT00580970|4097371|B1|||Age||years|Median|63|63.0|Full Range|||47.0|80.0|
4273560|NCT00580957|4097375|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4273561|NCT00580957|4097376|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4273562|NCT00580957|4097377|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4273563|NCT00580957|4097375|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4273564|NCT00580957|4097376|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4273565|NCT00580957|4097377|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4273566|NCT00580957|4097375|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4273567|NCT00580957|4097376|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4273568|NCT00580957|4097377|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4273569|NCT00580957|4097375|B3|||Age||years|Mean|43|43.0|Standard Deviation|5.5|5.5|||
4273570|NCT00580957|4097376|B2|||Age||years|Mean|43|43.0|Standard Deviation|5|5.0|||
4273571|NCT00580957|4097377|B1|||Age||years|Mean|44|44.0|Standard Deviation|6|6.0|||
4273572|NCT00580957|4097375|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4273573|NCT00580957|4097376|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4273574|NCT00580957|4097377|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4273575|NCT00580957|4097375|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4273576|NCT00580957|4097376|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4273577|NCT00580957|4097377|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4273578|NCT00580957|4097375|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273579|NCT00580957|4097376|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273580|NCT00580957|4097377|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273581|NCT00580866|4097384|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4273582|NCT00580866|4097385|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4273583|NCT00580866|4097386|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4273584|NCT00580866|4097384|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4273585|NCT00580866|4097385|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4273586|NCT00580866|4097386|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4273587|NCT00580866|4097384|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4273588|NCT00580866|4097385|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4273589|NCT00580866|4097386|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4273590|NCT00580866|4097384|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4273591|NCT00580866|4097385|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4273592|NCT00580866|4097386|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4273593|NCT00580866|4097384|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4273594|NCT00580866|4097385|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4273595|NCT00580866|4097386|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4273596|NCT00580866|4097384|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273597|NCT00580866|4097385|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273598|NCT00580866|4097386|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273599|NCT00580853|4097395|B4||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4273600|NCT00580853|4097396|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4273601|NCT00580853|4097397|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4273602|NCT00580853|4097398|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4273603|NCT00580853|4097395|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4273604|NCT00580853|4097396|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4273605|NCT00580853|4097397|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4273606|NCT00580853|4097398|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4273607|NCT00580853|4097395|B4|||Age||years|Mean|35.47|35.47|Standard Deviation|6.95|6.95|||
4273608|NCT00580853|4097396|B3|||Age||years|Mean|36.47|36.47|Standard Deviation|10.95|10.95|||
4273609|NCT00580853|4097397|B2|||Age||years|Mean|34.95|34.95|Standard Deviation|9.70|9.7|||
4273610|NCT00580853|4097398|B1|||Age||years|Mean|34.95|34.95|Standard Deviation|11.36|11.36|||
4273611|NCT00580840|4097411|B1|Canada||Region of Enrollment||participants|Number|20|20.0||||||
4273612|NCT00580840|4097411|B1|United States||Region of Enrollment||participants|Number|306|306.0||||||
4273613|NCT00580840|4097411|B1|France||Region of Enrollment||participants|Number|7|7.0||||||
4273614|NCT00580840|4097411|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4273615|NCT00580840|4097411|B1||Female|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
4273616|NCT00580840|4097411|B1|||Age||years|Mean|54.2|54.2|Standard Deviation|12.75|12.75|||
4273617|NCT00580840|4097411|B1||>=65 years|Age||Participants|Count of Participants|69|69.0||||||
4273618|NCT00580840|4097411|B1||Between 18 and 65 years|Age||Participants|Count of Participants|264|264.0||||||
4273619|NCT00580840|4097411|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273620|NCT00580801|4097519|B4|France||Region of Enrollment|All Participants enrolled were from France.|Participants|Number|24|24.0||||||
4273621|NCT00580801|4097520|B3|France||Region of Enrollment|All Participants enrolled were from France.|Participants|Number|8|8.0||||||
4273622|NCT00580801|4097521|B2|France||Region of Enrollment|All Participants enrolled were from France.|Participants|Number|8|8.0||||||
4273623|NCT00580801|4097522|B1|France||Region of Enrollment|All Participants enrolled were from France.|Participants|Number|8|8.0||||||
4273624|NCT00580801|4097519|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4273625|NCT00580801|4097520|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4273626|NCT00580801|4097521|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4273627|NCT00580801|4097522|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4273628|NCT00580801|4097519|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4273629|NCT00580801|4097520|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4273630|NCT00580801|4097521|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4273631|NCT00580801|4097522|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4273632|NCT00580801|4097519|B4|||Age||Years|Median|45.5|45.5|Inter-Quartile Range|||28.0|61.0|
4273633|NCT00580801|4097520|B3|||Age||Years|Median|46|46.0|Inter-Quartile Range|||30.0|56.0|
4273634|NCT00580801|4097521|B2|||Age||Years|Median|41|41.0|Inter-Quartile Range|||28.0|52.0|
4273635|NCT00580801|4097522|B1|||Age||Years|Median|43|43.0|Inter-Quartile Range|||36.0|61.0|
4273636|NCT00580801|4097519|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4273637|NCT00580801|4097520|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4273638|NCT00580801|4097521|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4273639|NCT00580801|4097522|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4273640|NCT00580801|4097519|B4||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4273641|NCT00580801|4097520|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4273642|NCT00580801|4097521|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4273643|NCT00580801|4097522|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4273644|NCT00580801|4097519|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273645|NCT00580801|4097520|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273646|NCT00580801|4097521|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273647|NCT00580801|4097522|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273648|NCT00580788|4097559|B5|United States||Region of Enrollment||participants|Number|14|14.0||||||
4273649|NCT00580788|4097560|B4|United States||Region of Enrollment||participants|Number|2|2.0||||||
4273650|NCT00580788|4097561|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4273651|NCT00580788|4097562|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4273652|NCT00580788|4097563|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4273653|NCT00580788|4097559|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4273654|NCT00580788|4097560|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4273655|NCT00580788|4097561|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4273656|NCT00580788|4097562|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4273657|NCT00580788|4097563|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4273658|NCT00580788|4097559|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4273659|NCT00580788|4097560|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4273660|NCT00580788|4097561|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4273661|NCT00580788|4097562|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4273662|NCT00580788|4097563|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4273663|NCT00580788|4097559|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4273664|NCT00580788|4097560|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4273665|NCT00580788|4097561|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4273666|NCT00580788|4097562|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4273667|NCT00580788|4097563|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4273668|NCT00580788|4097559|B5||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4273669|NCT00580788|4097560|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4273670|NCT00580788|4097561|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4273671|NCT00580788|4097562|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4273672|NCT00580788|4097563|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4273673|NCT00580788|4097559|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273674|NCT00580788|4097560|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273675|NCT00580788|4097561|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273676|NCT00580788|4097562|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273677|NCT00580788|4097563|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273678|NCT00580723|4097624|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4273679|NCT00580723|4097624|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4273680|NCT00580723|4097624|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4273681|NCT00580723|4097624|B1|||Age||years|Mean|51|51.0|Standard Deviation|11|11.0|||
4273682|NCT00580723|4097624|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4273683|NCT00580723|4097624|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4273684|NCT00580723|4097624|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273685|NCT00580671|4097630|B4|United States||Region of Enrollment||participants|Number|153|153.0||||||
4273686|NCT00580671|4097631|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
4273687|NCT00580671|4097632|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
4273688|NCT00580671|4097633|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4273689|NCT00580671|4097630|B4||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4273690|NCT00580671|4097631|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4273691|NCT00580671|4097632|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4273692|NCT00580671|4097633|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4273693|NCT00580671|4097630|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4273694|NCT00580671|4097631|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4273695|NCT00580671|4097632|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4273696|NCT00580671|4097633|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4273697|NCT00580671|4097630|B4|||Age||years|Mean|15.8|15.8|Standard Deviation|1.4|1.4|||
4273698|NCT00580671|4097631|B3|||Age||years|Mean|15.7|15.7|Standard Deviation|1.3|1.3|||
4273699|NCT00580671|4097632|B2|||Age||years|Mean|15.9|15.9|Standard Deviation|1.3|1.3|||
4273700|NCT00580671|4097633|B1|||Age||years|Mean|15.8|15.8|Standard Deviation|1.4|1.4|||
4273701|NCT00580671|4097630|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4273702|NCT00580671|4097631|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4273703|NCT00580671|4097632|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4273704|NCT00580671|4097633|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4273705|NCT00580671|4097630|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4273706|NCT00580671|4097631|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4273707|NCT00580671|4097632|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4273708|NCT00580671|4097633|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4273709|NCT00580671|4097630|B4||<=18 years|Age||Participants|Count of Participants|153|153.0||||||
4273710|NCT00580671|4097631|B3||<=18 years|Age||Participants|Count of Participants|51|51.0||||||
4273711|NCT00580671|4097632|B2||<=18 years|Age||Participants|Count of Participants|51|51.0||||||
4273712|NCT00580671|4097633|B1||<=18 years|Age||Participants|Count of Participants|51|51.0||||||
4273713|NCT00580645|4097649|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4273714|NCT00580645|4097650|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4273715|NCT00580645|4097651|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4273716|NCT00580645|4097652|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4273717|NCT00580645|4097649|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
4273718|NCT00580645|4097650|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
4273719|NCT00580645|4097651|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4273720|NCT00580645|4097652|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4273721|NCT00580645|4097649|B4|African American||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4273722|NCT00580645|4097650|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4273723|NCT00580645|4097651|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4273724|NCT00580645|4097652|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4273725|NCT00580645|4097649|B4|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4273726|NCT00580645|4097650|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4273727|NCT00580645|4097651|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4273728|NCT00580645|4097652|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4273729|NCT00580645|4097649|B4||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4273730|NCT00580645|4097650|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4273731|NCT00580645|4097651|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4273732|NCT00580645|4097652|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4273733|NCT00580645|4097649|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4273734|NCT00580645|4097650|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4273735|NCT00580645|4097651|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4273736|NCT00580645|4097652|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4273737|NCT00580645|4097649|B4|||Age||years|Mean|33.90|33.9|Standard Deviation|9.80|9.8|||
4273738|NCT00580645|4097650|B3|||Age||years|Mean|34.15|34.15|Standard Deviation|11.6|11.6|||
4273739|NCT00580645|4097651|B2|||Age||years|Mean|33.35|33.35|Standard Deviation|8.51|8.51|||
4273740|NCT00580645|4097652|B1|||Age||years|Mean|34.2|34.2|Standard Deviation|9.52|9.52|||
4273741|NCT00580606|4097665|B3|||Age at Initial Peanut Allergic Reaction|Two subjects in the Placebo group did not have a value for this measure.|years|Mean|3.3|3.3|Standard Deviation|5.2|5.2|||
4273742|NCT00580606|4097666|B2|||Age at Initial Peanut Allergic Reaction|Two subjects in the Placebo group did not have a value for this measure.|years|Mean|1.9|1.9|Standard Deviation|1.5|1.5|||
4273743|NCT00580606|4097667|B1|||Age at Initial Peanut Allergic Reaction|Two subjects in the Placebo group did not have a value for this measure.|years|Mean|4.6|4.6|Standard Deviation|6.9|6.9|||
4273744|NCT00580606|4097665|B3|||Peanut Skin Prick Test Score|This score is calculated by subtracting the size of the saline wheal (in mm) from the size of the peanut wheal (in mm) observed for a skin prick test. Individuals with a peanut skin prick test score of < 3 mm are considered to have a negative result. 1 subject in the Placebo group did not have a value for this measure.|mm|Mean|13.2|13.2|Standard Deviation|5.9|5.9|||
4273745|NCT00580606|4097666|B2|||Peanut Skin Prick Test Score|This score is calculated by subtracting the size of the saline wheal (in mm) from the size of the peanut wheal (in mm) observed for a skin prick test. Individuals with a peanut skin prick test score of < 3 mm are considered to have a negative result. 1 subject in the Placebo group did not have a value for this measure.|mm|Mean|12.4|12.4|Standard Deviation|4.6|4.6|||
4273746|NCT00580606|4097667|B1|||Peanut Skin Prick Test Score|This score is calculated by subtracting the size of the saline wheal (in mm) from the size of the peanut wheal (in mm) observed for a skin prick test. Individuals with a peanut skin prick test score of < 3 mm are considered to have a negative result. 1 subject in the Placebo group did not have a value for this measure.|mm|Mean|14.0|14.0|Standard Deviation|6.9|6.9|||
4273747|NCT00580606|4097665|B3|||Peanut IgE|Amount of serum peanut-specific immunoglobulin E. Individuals with a peanut IgE of <0.35 kUA/L are considered not to be sensitized to peanut.|kUA/L|Mean|40.4|40.4|Standard Deviation|48.9|48.9|||
4273748|NCT00580606|4097666|B2|||Peanut IgE|Amount of serum peanut-specific immunoglobulin E. Individuals with a peanut IgE of <0.35 kUA/L are considered not to be sensitized to peanut.|kUA/L|Mean|47.1|47.1|Standard Deviation|58.0|58.0|||
4273749|NCT00580606|4097667|B1|||Peanut IgE|Amount of serum peanut-specific immunoglobulin E. Individuals with a peanut IgE of <0.35 kUA/L are considered not to be sensitized to peanut.|kUA/L|Mean|33.6|33.6|Standard Deviation|38.1|38.1|||
4273750|NCT00580606|4097665|B3|||Total IgE|Total amount of serum immunoglobulin E. Individuals who are not allergic may have a total IgE as high as 304 kU/L.|kU/L|Mean|369.1|369.1|Standard Deviation|279.9|279.9|||
4273751|NCT00580606|4097666|B2|||Total IgE|Total amount of serum immunoglobulin E. Individuals who are not allergic may have a total IgE as high as 304 kU/L.|kU/L|Mean|330.5|330.5|Standard Deviation|305.0|305.0|||
4273752|NCT00580606|4097667|B1|||Total IgE|Total amount of serum immunoglobulin E. Individuals who are not allergic may have a total IgE as high as 304 kU/L.|kU/L|Mean|407.8|407.8|Standard Deviation|254.1|254.1|||
4273753|NCT00580606|4097665|B3|||Atopic Dermatitis Total Score|The Atopic Dermatitis Total Score is scored on a 10 point scale of 0 to 9 where a higher score indicates increasing severity of atopic dermatitis. This score is a combination of three scores that range from 0 to 3 in the following areas: body surface area score, disease course, and disease intensity.|Scores on a scale|Mean|1.0|1.0|Standard Deviation|1.6|1.6|||
4273754|NCT00580606|4097666|B2|||Atopic Dermatitis Total Score|The Atopic Dermatitis Total Score is scored on a 10 point scale of 0 to 9 where a higher score indicates increasing severity of atopic dermatitis. This score is a combination of three scores that range from 0 to 3 in the following areas: body surface area score, disease course, and disease intensity.|Scores on a scale|Mean|0.9|0.9|Standard Deviation|1.6|1.6|||
4273755|NCT00580606|4097667|B1|||Atopic Dermatitis Total Score|The Atopic Dermatitis Total Score is scored on a 10 point scale of 0 to 9 where a higher score indicates increasing severity of atopic dermatitis. This score is a combination of three scores that range from 0 to 3 in the following areas: body surface area score, disease course, and disease intensity.|Scores on a scale|Mean|1.1|1.1|Standard Deviation|1.7|1.7|||
4273756|NCT00580606|4097665|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4273757|NCT00580606|4097666|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4273758|NCT00580606|4097667|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4273759|NCT00580606|4097665|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273760|NCT00580606|4097666|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273761|NCT00580606|4097667|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273762|NCT00580606|4097665|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273763|NCT00580606|4097666|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273764|NCT00580606|4097667|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273765|NCT00580606|4097665|B3||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4273766|NCT00580606|4097666|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4273767|NCT00580606|4097667|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4273768|NCT00580606|4097665|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4273769|NCT00580606|4097666|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273770|NCT00580606|4097667|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4273771|NCT00580606|4097665|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273772|NCT00580606|4097666|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273773|NCT00580606|4097667|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273774|NCT00580606|4097665|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4273775|NCT00580606|4097666|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4273776|NCT00580606|4097667|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4273777|NCT00580606|4097665|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273778|NCT00580606|4097666|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273779|NCT00580606|4097667|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273901|NCT00580073|4097740|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4273780|NCT00580606|4097665|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273781|NCT00580606|4097666|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273782|NCT00580606|4097667|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273783|NCT00580606|4097665|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4273784|NCT00580606|4097666|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4273785|NCT00580606|4097667|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4273786|NCT00580606|4097665|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273787|NCT00580606|4097666|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273788|NCT00580606|4097667|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273789|NCT00580606|4097665|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4273790|NCT00580606|4097666|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4273791|NCT00580606|4097667|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4273792|NCT00580606|4097665|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4273793|NCT00580606|4097666|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4273794|NCT00580606|4097667|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4273795|NCT00580606|4097665|B3|||Age||years|Mean|16.8|16.8|Standard Deviation|5.8|5.8|||
4273796|NCT00580606|4097666|B2|||Age||years|Mean|16.5|16.5|Standard Deviation|3.5|3.5|||
4273797|NCT00580606|4097667|B1|||Age||years|Mean|17.2|17.2|Standard Deviation|7.6|7.6|||
4273798|NCT00580606|4097665|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4273799|NCT00580606|4097666|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4273800|NCT00580606|4097667|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4273801|NCT00580606|4097665|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4273802|NCT00580606|4097666|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4273803|NCT00580606|4097667|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4273804|NCT00580606|4097665|B3||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4273805|NCT00580606|4097666|B2||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4273806|NCT00580606|4097667|B1||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4273807|NCT00580502|4097686|B1|||BMI||kg/m2|Mean|35.1|35.1|Standard Deviation|2.6|2.6|||
4273808|NCT00580502|4097686|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4273809|NCT00580502|4097686|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4273810|NCT00580502|4097686|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4273811|NCT00580502|4097686|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4273812|NCT00580502|4097686|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273813|NCT00580398|4097693|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4273814|NCT00580398|4097694|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4273815|NCT00580398|4097695|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273816|NCT00580398|4097693|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4273817|NCT00580398|4097694|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4273818|NCT00580398|4097695|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273819|NCT00580398|4097693|B3||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4273820|NCT00580398|4097694|B2||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4273821|NCT00580398|4097695|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4273822|NCT00580398|4097693|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4273823|NCT00580398|4097694|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4273824|NCT00580398|4097695|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273825|NCT00580398|4097693|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273826|NCT00580398|4097694|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273827|NCT00580398|4097695|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273828|NCT00580398|4097693|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273829|NCT00580398|4097694|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273830|NCT00580398|4097695|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273831|NCT00580398|4097693|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273832|NCT00580398|4097694|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273833|NCT00580398|4097695|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273834|NCT00580398|4097693|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273835|NCT00580398|4097694|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273836|NCT00580398|4097695|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273837|NCT00580398|4097693|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4273838|NCT00580398|4097694|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4273839|NCT00580398|4097695|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4273840|NCT00580398|4097693|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4273841|NCT00580398|4097694|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4273842|NCT00580398|4097695|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4273843|NCT00580398|4097693|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4273844|NCT00580398|4097694|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4273845|NCT00580398|4097695|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4273846|NCT00580398|4097693|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4273847|NCT00580398|4097694|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4273848|NCT00580398|4097695|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4273849|NCT00580398|4097693|B3|||Age||years|Mean|57.7|57.7|Standard Deviation|12.4|12.4|||
4273850|NCT00580398|4097694|B2|||Age||years|Mean|57.5|57.5|Standard Deviation|13.4|13.4|||
4273851|NCT00580398|4097695|B1|||Age||years|Mean|58.0|58.0|Standard Deviation|10.5|10.5|||
4273852|NCT00580372|4097704|B1|United States||Region of Enrollment||participants|Number|231|231.0||||||
4273853|NCT00580372|4097704|B1||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4273854|NCT00580372|4097704|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4273855|NCT00580372|4097704|B1|||Age||years|Median|51.6|51.6|Full Range|||26.5|71.5|
4273856|NCT00580372|4097704|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4273857|NCT00580372|4097704|B1||Between 18 and 65 years|Age||Participants|Count of Participants|211|211.0||||||
4273858|NCT00580372|4097704|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273859|NCT00580333|4097708|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4273860|NCT00580333|4097708|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4273861|NCT00580333|4097708|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4273862|NCT00580333|4097708|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4273863|NCT00580333|4097708|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4273864|NCT00580333|4097708|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273865|NCT00580333|4097708|B1|||Age||years|Median|50|50.0|Full Range|||30.0|66.0|
4273866|NCT00580294|4097715|B1|||Average Pain Intensity|Brief Pain Inventory average daily pain (0= no pain, 10=worst imaginable pain)|units on a scale|Mean|7.34|7.34|Standard Deviation|1.18|1.18|||
4273867|NCT00580294|4097715|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4273868|NCT00580294|4097715|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4273869|NCT00580294|4097715|B1|||Age||years|Mean|50.4|50.4|Standard Deviation|12.4|12.4|||
4273870|NCT00580229|4097719|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4273871|NCT00580229|4097719|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4273872|NCT00580229|4097719|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4273873|NCT00580229|4097719|B1|||Age||years|Mean|27|27.0|Standard Deviation|28|28.0|||
4273874|NCT00580229|4097719|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4273875|NCT00580229|4097719|B1||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4273876|NCT00580229|4097719|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273877|NCT00580151|4097725|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4273878|NCT00580151|4097727|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4273879|NCT00580151|4097725|B3|Male||Gender||participants|Number|8|8.0||||||
4273880|NCT00580151|4097727|B1|Male||Gender||participants|Number|8|8.0||||||
4273881|NCT00580151|4097725|B3|Female||Gender||participants|Number|1|1.0||||||
4273882|NCT00580151|4097727|B1|Female||Gender||participants|Number|1|1.0||||||
4273883|NCT00580151|4097725|B3|||Age||years|Mean|7.8|7.8|Standard Deviation|3.2|3.2|||
4273884|NCT00580151|4097727|B1|||Age||years|Mean|7.8|7.8|Standard Deviation|3.2|3.2|||
4273885|NCT00580151|4097725|B3|>=65 years||Age||participants|Number|0|0.0||||||
4273886|NCT00580151|4097727|B1|>=65 years||Age||participants|Number|0|0.0||||||
4273887|NCT00580151|4097725|B3|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
4273888|NCT00580151|4097727|B1|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
4273889|NCT00580151|4097725|B3|<=18 years||Age||participants|Number|9|9.0||||||
4273890|NCT00580151|4097727|B1|<=18 years||Age||participants|Number|9|9.0||||||
4273891|NCT00580138|4097736|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4273892|NCT00580138|4097736|B1||Male|Gender||Participants|Count of Participants|17|17.0||||||
4273893|NCT00580138|4097736|B1||Female|Gender||Participants|Count of Participants|13|13.0||||||
4273894|NCT00580138|4097736|B1|||Age||years|Mean|62|62.0|Standard Deviation|4|4.0|||
4273895|NCT00580138|4097736|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4273896|NCT00580138|4097736|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4273897|NCT00580138|4097736|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273898|NCT00580073|4097740|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4273899|NCT00580073|4097740|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4273900|NCT00580073|4097740|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4273902|NCT00580073|4097740|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4273903|NCT00580073|4097740|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273904|NCT00580047|4097746|B4|||Spine bone density|mean spine bone density in g/cm2|grams/cm2|Mean|1.3|1.3|Standard Deviation|.05|0.05|||
4273905|NCT00580047|4097747|B3|||Spine bone density|mean spine bone density in g/cm2|grams/cm2|Mean|1.12|1.12|Standard Deviation|0.05|0.05|||
4273906|NCT00580047|4097748|B2|||Spine bone density|mean spine bone density in g/cm2|grams/cm2|Mean|1.28|1.28|Standard Deviation|0.046|0.046|||
4273907|NCT00580047|4097749|B1|||Spine bone density|mean spine bone density in g/cm2|grams/cm2|Mean|1.5|1.5|Standard Deviation|0.03|0.03|||
4273908|NCT00580047|4097746|B4|United States||Region of Enrollment||Participants|Count of Participants|59|59.0||||||
4273909|NCT00580047|4097747|B3|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4273910|NCT00580047|4097748|B2|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4273911|NCT00580047|4097749|B1|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
4273912|NCT00580047|4097746|B4||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4273913|NCT00580047|4097747|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4273914|NCT00580047|4097748|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4273915|NCT00580047|4097749|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4273916|NCT00580047|4097746|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4273917|NCT00580047|4097747|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4273918|NCT00580047|4097748|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4273919|NCT00580047|4097749|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4273920|NCT00580047|4097746|B4|||Age||years|Mean|47|47.0|Standard Deviation|12|12.0|||
4273921|NCT00580047|4097747|B3|||Age||years|Mean|46|46.0|Standard Deviation|12|12.0|||
4273922|NCT00580047|4097748|B2|||Age||years|Mean|50|50.0|Standard Deviation|15|15.0|||
4273923|NCT00580047|4097749|B1|||Age||years|Mean|47|47.0|Standard Deviation|11|11.0|||
4273924|NCT00580034|4097762|B1|United States||Region of Enrollment||participants|Number|88|88.0||||||
4273925|NCT00580034|4097762|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4273926|NCT00580034|4097762|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4273927|NCT00580034|4097762|B1|||Age||years|Mean|49|49.0|Standard Deviation|24|24.0|||
4273928|NCT00580034|4097762|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4273929|NCT00580034|4097762|B1||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4273930|NCT00580034|4097762|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4273931|NCT00579982|4097769|B1|Mixed race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4273932|NCT00579982|4097769|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4273933|NCT00579982|4097769|B1|White||Race/Ethnicity, Customized||participants|Number|94|94.0||||||
4273934|NCT00579982|4097769|B1||Male|Gender||Participants|Count of Participants|14|14.0||||||
4273935|NCT00579982|4097769|B1||Female|Gender||Participants|Count of Participants|83|83.0||||||
4273936|NCT00579982|4097769|B1|||Age||years|Mean|41.0|41.0|Standard Deviation|12.07|12.07|||
4273937|NCT00579826|4097788|B3|||Masood Score|Semi-quantitative cytology index score reflecting increasing abnormality, thus higher scores are worse. Range 6 to 24.|units on a scale|Mean|15|15.0|Standard Deviation|1.0|1.0|||
4273938|NCT00579826|4097789|B2|||Masood Score|Semi-quantitative cytology index score reflecting increasing abnormality, thus higher scores are worse. Range 6 to 24.|units on a scale|Mean|15|15.0|Standard Deviation|1.1|1.1|||
4273939|NCT00579826|4097790|B1|||Masood Score|Semi-quantitative cytology index score reflecting increasing abnormality, thus higher scores are worse. Range 6 to 24.|units on a scale|Mean|15|15.0|Standard Deviation|0.9|0.9|||
4273940|NCT00579826|4097788|B3|Hyperplasia with Atypia||Cytology||participants|Number|37|37.0||||||
4273941|NCT00579826|4097789|B2|Hyperplasia with Atypia||Cytology||participants|Number|17|17.0||||||
4273942|NCT00579826|4097790|B1|Hyperplasia with Atypia||Cytology||participants|Number|20|20.0||||||
4273943|NCT00579826|4097788|B3|Hyperplasia with borderline atypia||Cytology||participants|Number|10|10.0||||||
4273944|NCT00579826|4097789|B2|Hyperplasia with borderline atypia||Cytology||participants|Number|5|5.0||||||
4273945|NCT00579826|4097790|B1|Hyperplasia with borderline atypia||Cytology||participants|Number|5|5.0||||||
4273946|NCT00579826|4097788|B3|Hyperplasia||Cytology||participants|Number|8|8.0||||||
4273947|NCT00579826|4097789|B2|Hyperplasia||Cytology||participants|Number|4|4.0||||||
4273948|NCT00579826|4097790|B1|Hyperplasia||Cytology||participants|Number|4|4.0||||||
4273949|NCT00579826|4097788|B3|||Immunocytochemical expression of Ki-67|Percent of breast epithelial cells staining positive for Ki-67 by immunocytochemistry.|percent|Mean|4.2|4.2|Standard Deviation|3.0|3.0|||
4273950|NCT00579826|4097789|B2|||Immunocytochemical expression of Ki-67|Percent of breast epithelial cells staining positive for Ki-67 by immunocytochemistry.|percent|Mean|4.0|4.0|Standard Deviation|2.8|2.8|||
4273951|NCT00579826|4097790|B1|||Immunocytochemical expression of Ki-67|Percent of breast epithelial cells staining positive for Ki-67 by immunocytochemistry.|percent|Mean|4.5|4.5|Standard Deviation|3.1|3.1|||
4273952|NCT00579826|4097788|B3|||Gail risk of developing breast cancer within 5 years||percent|Mean|3.8|3.8|Standard Deviation|3.1|3.1|||
4273953|NCT00579826|4097789|B2|||Gail risk of developing breast cancer within 5 years||percent|Mean|3.4|3.4|Standard Deviation|1.8|1.8|||
4273954|NCT00579826|4097790|B1|||Gail risk of developing breast cancer within 5 years||percent|Mean|4.2|4.2|Standard Deviation|3.9|3.9|||
4273955|NCT00579826|4097788|B3|No relatives||Number of relatives with breast cancer||participants|Number|17|17.0||||||
4273956|NCT00579826|4097789|B2|No relatives||Number of relatives with breast cancer||participants|Number|6|6.0||||||
4273957|NCT00579826|4097790|B1|No relatives||Number of relatives with breast cancer||participants|Number|11|11.0||||||
4273958|NCT00579826|4097788|B3|With relatives||Number of relatives with breast cancer||participants|Number|38|38.0||||||
4273959|NCT00579826|4097789|B2|With relatives||Number of relatives with breast cancer||participants|Number|20|20.0||||||
4273960|NCT00579826|4097790|B1|With relatives||Number of relatives with breast cancer||participants|Number|18|18.0||||||
4273961|NCT00579826|4097788|B3|No History||History of prior Ductal Carcinoma In Situ (DCIS) or Lobular Carcinoma in Situ (LCIS)||participants|Number|51|51.0||||||
4273962|NCT00579826|4097789|B2|No History||History of prior Ductal Carcinoma In Situ (DCIS) or Lobular Carcinoma in Situ (LCIS)||participants|Number|25|25.0||||||
4273963|NCT00579826|4097790|B1|No History||History of prior Ductal Carcinoma In Situ (DCIS) or Lobular Carcinoma in Situ (LCIS)||participants|Number|26|26.0||||||
4273964|NCT00579826|4097788|B3|History||History of prior Ductal Carcinoma In Situ (DCIS) or Lobular Carcinoma in Situ (LCIS)||participants|Number|4|4.0||||||
4273965|NCT00579826|4097789|B2|History||History of prior Ductal Carcinoma In Situ (DCIS) or Lobular Carcinoma in Situ (LCIS)||participants|Number|1|1.0||||||
4273966|NCT00579826|4097790|B1|History||History of prior Ductal Carcinoma In Situ (DCIS) or Lobular Carcinoma in Situ (LCIS)||participants|Number|3|3.0||||||
4273967|NCT00579826|4097788|B3|No history of biopsy||History of prior breast biopsy||participants|Number|20|20.0||||||
4273968|NCT00579826|4097789|B2|No history of biopsy||History of prior breast biopsy||participants|Number|10|10.0||||||
4273969|NCT00579826|4097790|B1|No history of biopsy||History of prior breast biopsy||participants|Number|10|10.0||||||
4273970|NCT00579826|4097788|B3|History of biopsy||History of prior breast biopsy||participants|Number|35|35.0||||||
4273971|NCT00579826|4097789|B2|History of biopsy||History of prior breast biopsy||participants|Number|16|16.0||||||
4273972|NCT00579826|4097790|B1|History of biopsy||History of prior breast biopsy||participants|Number|19|19.0||||||
4273973|NCT00579826|4097788|B3|||Age at first live birth||years|Mean|21.4|21.4|Standard Deviation|10.2|10.2|||
4273974|NCT00579826|4097789|B2|||Age at first live birth||years|Mean|21.7|21.7|Standard Deviation|11.1|11.1|||
4273975|NCT00579826|4097790|B1|||Age at first live birth||years|Mean|20.5|20.5|Standard Deviation|10.1|10.1|||
4273976|NCT00579826|4097788|B3|||Age at menarche||years|Mean|12.6|12.6|Standard Deviation|1.2|1.2|||
4273977|NCT00579826|4097789|B2|||Age at menarche||years|Mean|12.6|12.6|Standard Deviation|1.2|1.2|||
4273978|NCT00579826|4097790|B1|||Age at menarche||years|Mean|12.6|12.6|Standard Deviation|1.3|1.3|||
4273979|NCT00579826|4097788|B3|||Body Mass Index||kg/m^2|Mean|27.0|27.0|Standard Deviation|7.2|7.2|||
4273980|NCT00579826|4097789|B2|||Body Mass Index||kg/m^2|Mean|27.9|27.9|Standard Deviation|9.1|9.1|||
4273981|NCT00579826|4097790|B1|||Body Mass Index||kg/m^2|Mean|26.3|26.3|Standard Deviation|5.0|5.0|||
4273982|NCT00579826|4097788|B3|||Weight||kg|Mean|71.2|71.2|Standard Deviation|13.7|13.7|||
4273983|NCT00579826|4097789|B2|||Weight||kg|Mean|73.6|73.6|Standard Deviation|15.9|15.9|||
4273984|NCT00579826|4097790|B1|||Weight||kg|Mean|69.0|69.0|Standard Deviation|11.2|11.2|||
4273985|NCT00579826|4097788|B3|||Height||m|Mean|1.63|1.63|Standard Deviation|0.08|0.08|||
4273986|NCT00579826|4097789|B2|||Height||m|Mean|1.64|1.64|Standard Deviation|0.08|0.08|||
4273987|NCT00579826|4097790|B1|||Height||m|Mean|1.63|1.63|Standard Deviation|0.09|0.09|||
4273988|NCT00579826|4097788|B3|United States||Region of Enrollment||participants|Number|55|55.0||||||
4273989|NCT00579826|4097789|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4273990|NCT00579826|4097790|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4273991|NCT00579826|4097788|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273992|NCT00579826|4097789|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273993|NCT00579826|4097790|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273994|NCT00579826|4097788|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273995|NCT00579826|4097789|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273996|NCT00579826|4097790|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4273997|NCT00579826|4097788|B3||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4273998|NCT00579826|4097789|B2||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4273999|NCT00579826|4097790|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4274000|NCT00579826|4097788|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4274001|NCT00579826|4097789|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4274002|NCT00579826|4097790|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4274003|NCT00579826|4097788|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4274004|NCT00579826|4097789|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4274005|NCT00579826|4097790|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4274006|NCT00579826|4097788|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4274007|NCT00579826|4097789|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4274008|NCT00579826|4097790|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4274009|NCT00579826|4097788|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4274010|NCT00579826|4097789|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4274011|NCT00579826|4097790|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4274012|NCT00579826|4097788|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4274013|NCT00579826|4097789|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4274014|NCT00579826|4097790|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4274015|NCT00579826|4097788|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4274016|NCT00579826|4097789|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4274017|NCT00579826|4097790|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4274018|NCT00579826|4097788|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4274019|NCT00579826|4097789|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4274020|NCT00579826|4097790|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4274021|NCT00579826|4097788|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4274022|NCT00579826|4097789|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4274023|NCT00579826|4097790|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4274024|NCT00579826|4097788|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4274025|NCT00579826|4097789|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4274026|NCT00579826|4097790|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4274027|NCT00579826|4097788|B3|||Age||years|Mean|57.0|57.0|Standard Deviation|7.9|7.9|||
4274028|NCT00579826|4097789|B2|||Age||years|Mean|44.7|44.7|Standard Deviation|7.4|7.4|||
4274029|NCT00579826|4097790|B1|||Age||years|Mean|58.2|58.2|Standard Deviation|8.3|8.3|||
4274030|NCT00579813|4097801|B3|United States||Region of Enrollment||participants|Number|70|70.0||||||
4274031|NCT00579813|4097802|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4274032|NCT00579813|4097803|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4274033|NCT00579813|4097801|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4274034|NCT00579813|4097802|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4274035|NCT00579813|4097803|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4274036|NCT00579813|4097801|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4274037|NCT00579813|4097802|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4274038|NCT00579813|4097803|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4274039|NCT00579813|4097801|B3|||Age||years|Mean|55|55.0|Standard Deviation|5|5.0|||
4274040|NCT00579813|4097802|B2|||Age||years|Mean|57|57.0|Standard Deviation|2|2.0|||
4274041|NCT00579813|4097803|B1|||Age||years|Mean|53|53.0|Standard Deviation|6|6.0|||
4274042|NCT00579813|4097801|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4274043|NCT00579813|4097802|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4274044|NCT00579813|4097803|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4274045|NCT00579813|4097801|B3||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4274046|NCT00579813|4097802|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4274047|NCT00579813|4097803|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4274048|NCT00579813|4097801|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4274049|NCT00579813|4097802|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4274050|NCT00579813|4097803|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4274051|NCT00579670|4097820|B6|||Schizophrenia Duration||Years|Mean|15.4|15.4|Full Range|||0.0|63.1|
4274052|NCT00579670|4097821|B5|||Schizophrenia Duration||Years|Mean|15.6|15.6|Full Range|||0.0|41.4|
4274053|NCT00579670|4097822|B4|||Schizophrenia Duration||Years|Mean|12.8|12.8|Full Range|||0.0|50.3|
4274054|NCT00579670|4097823|B3|||Schizophrenia Duration||Years|Mean|16.9|16.9|Full Range|||0.0|52.4|
4274055|NCT00579670|4097824|B2|||Schizophrenia Duration||Years|Mean|21.4|21.4|Full Range|||0.0|58.5|
4274056|NCT00579670|4097825|B1|||Schizophrenia Duration||Years|Mean|33.9|33.9|Full Range|||0.0|63.1|
4274057|NCT00579670|4097820|B6|Unspecified||Sex/Gender, Customized||Participants|Number|3|3.0||||||
4274058|NCT00579670|4097821|B5|Unspecified||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4274059|NCT00579670|4097822|B4|Unspecified||Sex/Gender, Customized||Participants|Number|2|2.0||||||
4274060|NCT00579670|4097823|B3|Unspecified||Sex/Gender, Customized||Participants|Number|1|1.0||||||
4274061|NCT00579670|4097824|B2|Unspecified||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4274062|NCT00579670|4097825|B1|Unspecified||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4274063|NCT00579670|4097820|B6|Female||Sex/Gender, Customized||Participants|Number|185|185.0||||||
4274064|NCT00579670|4097821|B5|Female||Sex/Gender, Customized||Participants|Number|2|2.0||||||
4274065|NCT00579670|4097822|B4|Female||Sex/Gender, Customized||Participants|Number|110|110.0||||||
4274066|NCT00579670|4097823|B3|Female||Sex/Gender, Customized||Participants|Number|45|45.0||||||
4274067|NCT00579670|4097824|B2|Female||Sex/Gender, Customized||Participants|Number|22|22.0||||||
4274068|NCT00579670|4097825|B1|Female||Sex/Gender, Customized||Participants|Number|6|6.0||||||
4274069|NCT00579670|4097820|B6|Male||Sex/Gender, Customized||Participants|Number|262|262.0||||||
4274070|NCT00579670|4097821|B5|Male||Sex/Gender, Customized||Participants|Number|3|3.0||||||
4274071|NCT00579670|4097822|B4|Male||Sex/Gender, Customized||Participants|Number|173|173.0||||||
4274072|NCT00579670|4097823|B3|Male||Sex/Gender, Customized||Participants|Number|42|42.0||||||
4274073|NCT00579670|4097824|B2|Male||Sex/Gender, Customized||Participants|Number|35|35.0||||||
4274074|NCT00579670|4097825|B1|Male||Sex/Gender, Customized||Participants|Number|9|9.0||||||
4274075|NCT00579670|4097820|B6|>= 65 years||Age, Customized||Participants|Number|54|54.0||||||
4274076|NCT00579670|4097821|B5|>= 65 years||Age, Customized||Participants|Number|1|1.0||||||
4274077|NCT00579670|4097822|B4|>= 65 years||Age, Customized||Participants|Number|20|20.0||||||
4274078|NCT00579670|4097823|B3|>= 65 years||Age, Customized||Participants|Number|9|9.0||||||
4274079|NCT00579670|4097824|B2|>= 65 years||Age, Customized||Participants|Number|16|16.0||||||
4274080|NCT00579670|4097825|B1|>= 65 years||Age, Customized||Participants|Number|8|8.0||||||
4274081|NCT00579670|4097820|B6|45 years through 64 years||Age, Customized||Participants|Number|157|157.0||||||
4274082|NCT00579670|4097821|B5|45 years through 64 years||Age, Customized||Participants|Number|2|2.0||||||
4274083|NCT00579670|4097822|B4|45 years through 64 years||Age, Customized||Participants|Number|96|96.0||||||
4274084|NCT00579670|4097823|B3|45 years through 64 years||Age, Customized||Participants|Number|36|36.0||||||
4274085|NCT00579670|4097824|B2|45 years through 64 years||Age, Customized||Participants|Number|19|19.0||||||
4274086|NCT00579670|4097825|B1|45 years through 64 years||Age, Customized||Participants|Number|4|4.0||||||
4274087|NCT00579670|4097820|B6|18 years through 44 years||Age, Customized||Participants|Number|238|238.0||||||
4274088|NCT00579670|4097821|B5|18 years through 44 years||Age, Customized||Participants|Number|2|2.0||||||
4274089|NCT00579670|4097822|B4|18 years through 44 years||Age, Customized||Participants|Number|169|169.0||||||
4274090|NCT00579670|4097823|B3|18 years through 44 years||Age, Customized||Participants|Number|42|42.0||||||
4274091|NCT00579670|4097824|B2|18 years through 44 years||Age, Customized||Participants|Number|22|22.0||||||
4274092|NCT00579670|4097825|B1|18 years through 44 years||Age, Customized||Participants|Number|3|3.0||||||
4274093|NCT00579670|4097820|B6|< 18 years||Age, Customized||Participants|Number|1|1.0||||||
4274094|NCT00579670|4097821|B5|< 18 years||Age, Customized||Participants|Number|0|0.0||||||
4274095|NCT00579670|4097822|B4|< 18 years||Age, Customized||Participants|Number|0|0.0||||||
4274096|NCT00579670|4097823|B3|< 18 years||Age, Customized||Participants|Number|1|1.0||||||
4274097|NCT00579670|4097824|B2|< 18 years||Age, Customized||Participants|Number|0|0.0||||||
4274098|NCT00579670|4097825|B1|< 18 years||Age, Customized||Participants|Number|0|0.0||||||
4274099|NCT00579501|4098041|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4274100|NCT00579501|4098041|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4274101|NCT00579501|4098041|B1|greater than or equal to 70 years||Age, Customized||participants|Number|4|4.0||||||
4274102|NCT00579501|4098041|B1|50-69 years||Age, Customized||participants|Number|10|10.0||||||
4274103|NCT00579501|4098041|B1|18-49 years||Age, Customized||participants|Number|15|15.0||||||
4274104|NCT00579436|4098046|B3|||HbA1c||percent|Mean|5.8|5.8|Standard Deviation|.4|0.4|||
4274105|NCT00579436|4098047|B2|||HbA1c||percent|Mean|5.6|5.6|Standard Deviation|0.4|0.4|||
4274106|NCT00579436|4098048|B1|||HbA1c||percent|Mean|6.0|6.0|Standard Deviation|.3|0.3|||
4274107|NCT00579436|4098046|B3|||2 hour Glucose||mg/dl|Mean|163.1|163.1|Standard Deviation|37.6|37.6|||
4274108|NCT00579436|4098047|B2|||2 hour Glucose||mg/dl|Mean|157.8|157.8|Standard Deviation|29.0|29.0|||
4274109|NCT00579436|4098048|B1|||2 hour Glucose||mg/dl|Mean|167.8|167.8|Standard Deviation|43.3|43.3|||
4274110|NCT00579436|4098046|B3|||Low density lipoprotein||mg/dl|Mean|125.5|125.5|Standard Deviation|37.5|37.5|||
4274111|NCT00579436|4098047|B2|||Low density lipoprotein||mg/dl|Mean|122.4|122.4|Standard Deviation|40.8|40.8|||
4274112|NCT00579436|4098048|B1|||Low density lipoprotein||mg/dl|Mean|125.9|125.9|Standard Deviation|36.8|36.8|||
4274113|NCT00579436|4098046|B3|||High density lipoprotein||mg/dl|Mean|49.50|49.5|Standard Deviation|13.63|13.63|||
4274114|NCT00579436|4098047|B2|||High density lipoprotein||mg/dl|Mean|47.7|47.7|Standard Deviation|12.2|12.2|||
4274115|NCT00579436|4098048|B1|||High density lipoprotein||mg/dl|Mean|53.5|53.5|Standard Deviation|15.21|15.21|||
4274116|NCT00579436|4098046|B3|||Cholesterol||mg/dl|Mean|206|206.0|Standard Deviation|42.3|42.3|||
4274117|NCT00579436|4098047|B2|||Cholesterol||mg/dl|Mean|204.7|204.7|Standard Deviation|44.5|44.5|||
4274118|NCT00579436|4098048|B1|||Cholesterol||mg/dl|Mean|207.1|207.1|Standard Deviation|41.6|41.6|||
4274119|NCT00579436|4098046|B3|||Triglycerides||mg/dl|Mean|155.7|155.7|Standard Deviation|69|69.0|||
4274120|NCT00579436|4098047|B2|||Triglycerides||mg/dl|Mean|163.0|163.0|Standard Deviation|82.8|82.8|||
4274121|NCT00579436|4098048|B1|||Triglycerides||mg/dl|Mean|150|150.0|Standard Deviation|57.92|57.92|||
4274122|NCT00579436|4098046|B3|||BMI||kg/m^2|Mean|33.4|33.4|Standard Deviation|4.9|4.9|||
4274123|NCT00579436|4098047|B2|||BMI||kg/m^2|Mean|33.8|33.8|Standard Deviation|4.3|4.3|||
4274124|NCT00579436|4098048|B1|||BMI||kg/m^2|Mean|33.4|33.4|Standard Deviation|5.4|5.4|||
4274125|NCT00579436|4098046|B3|||Body fat||percent|Mean|44.9|44.9|Standard Deviation|8.64|8.64|||
4274126|NCT00579436|4098047|B2|||Body fat||percent|Mean|46.2|46.2|Standard Deviation|10.1|10.1|||
4274127|NCT00579436|4098048|B1|||Body fat||percent|Mean|44.4|44.4|Standard Deviation|7.4|7.4|||
4274128|NCT00579436|4098046|B3|||Weight||kilograms|Mean|96.8|96.8|Standard Deviation|14.9|14.9|||
4274129|NCT00579436|4098047|B2|||Weight||kilograms|Mean|92.1|92.1|Standard Deviation|16.9|16.9|||
4274130|NCT00579436|4098048|B1|||Weight||kilograms|Mean|99.8|99.8|Standard Deviation|12.5|12.5|||
4274131|NCT00579436|4098046|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
4274132|NCT00579436|4098047|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4274133|NCT00579436|4098048|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4274134|NCT00579436|4098046|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4274135|NCT00579436|4098047|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4274136|NCT00579436|4098048|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4274137|NCT00579436|4098046|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4274138|NCT00579436|4098047|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4274139|NCT00579436|4098048|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4274140|NCT00579436|4098046|B3|||Age||years|Mean|50.8|50.8|Standard Deviation|9.3|9.3|||
4274141|NCT00579436|4098047|B2|||Age||years|Mean|53.3|53.3|Standard Deviation|8.3|8.3|||
4274142|NCT00579436|4098048|B1|||Age||years|Mean|48.8|48.8|Standard Deviation|9.8|9.8|||
4274143|NCT00579345|4098061|B9||Male|Gender||Participants|Count of Participants|631|631.0||||||
4274144|NCT00579345|4098062|B8||Male|Gender||Participants|Count of Participants|19|19.0||||||
4274145|NCT00579345|4098063|B7||Male|Gender||Participants|Count of Participants|19|19.0||||||
4274146|NCT00579345|4098064|B6||Male|Gender||Participants|Count of Participants|38|38.0||||||
4274147|NCT00579345|4098065|B5||Male|Gender||Participants|Count of Participants|44|44.0||||||
4274148|NCT00579345|4098066|B4||Male|Gender||Participants|Count of Participants|54|54.0||||||
4274149|NCT00579345|4098067|B3||Male|Gender||Participants|Count of Participants|159|159.0||||||
4274150|NCT00579345|4098068|B2||Male|Gender||Participants|Count of Participants|67|67.0||||||
4274151|NCT00579345|4098069|B1||Male|Gender||Participants|Count of Participants|231|231.0||||||
4274152|NCT00579345|4098061|B9||Female|Gender||Participants|Count of Participants|891|891.0||||||
4274153|NCT00579345|4098062|B8||Female|Gender||Participants|Count of Participants|25|25.0||||||
4274154|NCT00579345|4098063|B7||Female|Gender||Participants|Count of Participants|38|38.0||||||
4274155|NCT00579345|4098064|B6||Female|Gender||Participants|Count of Participants|40|40.0||||||
4274156|NCT00579345|4098065|B5||Female|Gender||Participants|Count of Participants|46|46.0||||||
4274157|NCT00579345|4098066|B4||Female|Gender||Participants|Count of Participants|90|90.0||||||
4274158|NCT00579345|4098067|B3||Female|Gender||Participants|Count of Participants|232|232.0||||||
4274159|NCT00579345|4098068|B2||Female|Gender||Participants|Count of Participants|102|102.0||||||
4274160|NCT00579345|4098069|B1||Female|Gender||Participants|Count of Participants|318|318.0||||||
4274161|NCT00579345|4098061|B9|Randomized elderly||Age||years|Mean|71.4|71.4|Standard Deviation|5.5|5.5|||
4274162|NCT00579345|4098062|B8|Randomized elderly||Age||years|Mean|71.1|71.1|Standard Deviation|5.2|5.2|||
4274163|NCT00579345|4098063|B7|Randomized elderly||Age||years|Mean|71.2|71.2|Standard Deviation|4.9|4.9|||
4274164|NCT00579345|4098064|B6|Randomized elderly||Age||years|Mean|71.5|71.5|Standard Deviation|5.5|5.5|||
4274165|NCT00579345|4098065|B5|Randomized elderly||Age||years|Mean|71.6|71.6|Standard Deviation|5.9|5.9|||
4274166|NCT00579345|4098066|B4|Randomized elderly||Age||years|Mean|NA||Standard Deviation|NA||||This category does not belong to randomized elderly
4274167|NCT00579345|4098067|B3|Randomized elderly||Age||years|Mean|NA||Standard Deviation|NA||||This category does not belong to randomized elderly
4274168|NCT00579345|4098068|B2|Randomized elderly||Age||years|Mean|NA||Standard Deviation|NA||||This category does not belong to randomized elderly
4274169|NCT00579345|4098069|B1|Randomized elderly||Age||years|Mean|NA||Standard Deviation|NA||||This category does not belong to randomized elderly
4274170|NCT00579345|4098061|B9|Unrandomized elderly||Age||years|Mean|71.7|71.7|Standard Deviation|5.6|5.6|||
4274171|NCT00579345|4098062|B8|Unrandomized elderly||Age||years|Mean|NA||Standard Deviation|NA||||This category does not belong to unrandomized elderly
4274172|NCT00579345|4098063|B7|Unrandomized elderly||Age||years|Mean|NA||Standard Deviation|NA||||This category does not belong to unrandomized elderly
4274173|NCT00579345|4098064|B6|Unrandomized elderly||Age||years|Mean|NA||Standard Deviation|NA||||This category does not belong to unrandomized elderly
4274174|NCT00579345|4098065|B5|Unrandomized elderly||Age||years|Mean|NA||Standard Deviation|NA||||This category does not belong to unrandomized elderly
4274175|NCT00579345|4098066|B4|Unrandomized elderly||Age||years|Mean|72.4|72.4|Standard Deviation|5.7|5.7|||
4274176|NCT00579345|4098067|B3|Unrandomized elderly||Age||years|Mean|71.5|71.5|Standard Deviation|5.5|5.5|||
4274177|NCT00579345|4098068|B2|Unrandomized elderly||Age||years|Mean|NA||Standard Deviation|NA||||This category does not belong to unrandomized elderly
4274178|NCT00579345|4098069|B1|Unrandomized elderly||Age||years|Mean|NA||Standard Deviation|NA||||This category does not belong to unrandomized elderly
4274179|NCT00579345|4098061|B9|Unrandomized adults||Age||years|Mean|43.9|43.9|Standard Deviation|12.3|12.3|||
4274180|NCT00579345|4098062|B8|Unrandomized adults||Age||years|Mean|NA||Standard Deviation|NA||||This category does not belong to unrandomized adults
4274181|NCT00579345|4098063|B7|Unrandomized adults||Age||years|Mean|NA||Standard Deviation|NA||||This category does not belong to unrandomized adults
4274182|NCT00579345|4098064|B6|Unrandomized adults||Age||years|Mean|NA||Standard Deviation|NA||||This category does not belong to unrandomized adults
4274183|NCT00579345|4098065|B5|Unrandomized adults||Age||years|Mean|NA||Standard Deviation|NA||||This category does not belong to unrandomized adults
4274184|NCT00579345|4098066|B4|Unrandomized adults||Age||years|Mean|NA||Standard Deviation|NA||||This category does not belong to unrandomized adults
4274185|NCT00579345|4098067|B3|Unrandomized adults||Age||years|Mean|NA||Standard Deviation|NA||||This category does not belong to unrandomized adults
4274186|NCT00579345|4098068|B2|Unrandomized adults||Age||years|Mean|43.3|43.3|Standard Deviation|12.4|12.4|||
4274187|NCT00579345|4098069|B1|Unrandomized adults||Age||years|Mean|44|44.0|Standard Deviation|12.3|12.3|||
4274188|NCT00579254|4098108|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4274189|NCT00579254|4098108|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4274190|NCT00579254|4098108|B1|||Age||years|Mean|54.7|54.7|Standard Deviation|9.6|9.6|||
4274191|NCT00579137|4098112|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4274192|NCT00579137|4098112|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4274193|NCT00579137|4098112|B1|<=1 years||Age, Customized||participants|Number|3|3.0||||||
4274194|NCT00579111|4098119|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4274195|NCT00579111|4098120|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4274196|NCT00579111|4098121|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4274197|NCT00579111|4098119|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4274198|NCT00579111|4098120|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4274199|NCT00579111|4098121|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4274200|NCT00579111|4098119|B3|>=65 years||Age, Customized||participants|Number|1|1.0||||||
4274201|NCT00579111|4098120|B2|>=65 years||Age, Customized||participants|Number|1|1.0||||||
4274202|NCT00579111|4098121|B1|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4274203|NCT00579111|4098119|B3|Between 50 and 65 years||Age, Customized||participants|Number|3|3.0||||||
4274204|NCT00579111|4098120|B2|Between 50 and 65 years||Age, Customized||participants|Number|0|0.0||||||
4274205|NCT00579111|4098121|B1|Between 50 and 65 years||Age, Customized||participants|Number|3|3.0||||||
4274206|NCT00579098|4098130|B3|Nonpulmonary vein foci||Anatomical area of ablation|The catheter ablation procedure involves intentional destruction of left atrial (LA) tissue via radiofrequency energy and is used to treat atrial fibrillation (AF). Lesions often extend to the pericardium and pericardiac tissues, therefore the total number of various anatomical ablation locations reported will not total the overall number of subjects in a treatment group.|Participants|Number|13|13.0||||||
4274207|NCT00579098|4098131|B2|Nonpulmonary vein foci||Anatomical area of ablation|The catheter ablation procedure involves intentional destruction of left atrial (LA) tissue via radiofrequency energy and is used to treat atrial fibrillation (AF). Lesions often extend to the pericardium and pericardiac tissues, therefore the total number of various anatomical ablation locations reported will not total the overall number of subjects in a treatment group.|Participants|Number|6|6.0||||||
4274208|NCT00579098|4098132|B1|Nonpulmonary vein foci||Anatomical area of ablation|The catheter ablation procedure involves intentional destruction of left atrial (LA) tissue via radiofrequency energy and is used to treat atrial fibrillation (AF). Lesions often extend to the pericardium and pericardiac tissues, therefore the total number of various anatomical ablation locations reported will not total the overall number of subjects in a treatment group.|Participants|Number|7|7.0||||||
4274209|NCT00579098|4098130|B3|Cavotricuspid isthmus line||Anatomical area of ablation|The catheter ablation procedure involves intentional destruction of left atrial (LA) tissue via radiofrequency energy and is used to treat atrial fibrillation (AF). Lesions often extend to the pericardium and pericardiac tissues, therefore the total number of various anatomical ablation locations reported will not total the overall number of subjects in a treatment group.|Participants|Number|100|100.0||||||
4274210|NCT00579098|4098131|B2|Cavotricuspid isthmus line||Anatomical area of ablation|The catheter ablation procedure involves intentional destruction of left atrial (LA) tissue via radiofrequency energy and is used to treat atrial fibrillation (AF). Lesions often extend to the pericardium and pericardiac tissues, therefore the total number of various anatomical ablation locations reported will not total the overall number of subjects in a treatment group.|Participants|Number|51|51.0||||||
4274211|NCT00579098|4098132|B1|Cavotricuspid isthmus line||Anatomical area of ablation|The catheter ablation procedure involves intentional destruction of left atrial (LA) tissue via radiofrequency energy and is used to treat atrial fibrillation (AF). Lesions often extend to the pericardium and pericardiac tissues, therefore the total number of various anatomical ablation locations reported will not total the overall number of subjects in a treatment group.|Participants|Number|49|49.0||||||
4274212|NCT00579098|4098130|B3|Roof line||Anatomical area of ablation|The catheter ablation procedure involves intentional destruction of left atrial (LA) tissue via radiofrequency energy and is used to treat atrial fibrillation (AF). Lesions often extend to the pericardium and pericardiac tissues, therefore the total number of various anatomical ablation locations reported will not total the overall number of subjects in a treatment group.|Participants|Number|20|20.0||||||
4274213|NCT00579098|4098131|B2|Roof line||Anatomical area of ablation|The catheter ablation procedure involves intentional destruction of left atrial (LA) tissue via radiofrequency energy and is used to treat atrial fibrillation (AF). Lesions often extend to the pericardium and pericardiac tissues, therefore the total number of various anatomical ablation locations reported will not total the overall number of subjects in a treatment group.|Participants|Number|8|8.0||||||
4274214|NCT00579098|4098132|B1|Roof line||Anatomical area of ablation|The catheter ablation procedure involves intentional destruction of left atrial (LA) tissue via radiofrequency energy and is used to treat atrial fibrillation (AF). Lesions often extend to the pericardium and pericardiac tissues, therefore the total number of various anatomical ablation locations reported will not total the overall number of subjects in a treatment group.|Participants|Number|12|12.0||||||
4274215|NCT00579098|4098130|B3|LA isthmus||Anatomical area of ablation|The catheter ablation procedure involves intentional destruction of left atrial (LA) tissue via radiofrequency energy and is used to treat atrial fibrillation (AF). Lesions often extend to the pericardium and pericardiac tissues, therefore the total number of various anatomical ablation locations reported will not total the overall number of subjects in a treatment group.|Participants|Number|19|19.0||||||
4274216|NCT00579098|4098131|B2|LA isthmus||Anatomical area of ablation|The catheter ablation procedure involves intentional destruction of left atrial (LA) tissue via radiofrequency energy and is used to treat atrial fibrillation (AF). Lesions often extend to the pericardium and pericardiac tissues, therefore the total number of various anatomical ablation locations reported will not total the overall number of subjects in a treatment group.|Participants|Number|7|7.0||||||
4274217|NCT00579098|4098132|B1|LA isthmus||Anatomical area of ablation|The catheter ablation procedure involves intentional destruction of left atrial (LA) tissue via radiofrequency energy and is used to treat atrial fibrillation (AF). Lesions often extend to the pericardium and pericardiac tissues, therefore the total number of various anatomical ablation locations reported will not total the overall number of subjects in a treatment group.|Participants|Number|12|12.0||||||
4274352|NCT00578968|4098159|B3|||Age||years|Mean|58.4|58.4|Standard Deviation|10.6|10.6|||
4274218|NCT00579098|4098130|B3|Wide-area circumferential ablation||Anatomical area of ablation|The catheter ablation procedure involves intentional destruction of left atrial (LA) tissue via radiofrequency energy and is used to treat atrial fibrillation (AF). Lesions often extend to the pericardium and pericardiac tissues, therefore the total number of various anatomical ablation locations reported will not total the overall number of subjects in a treatment group.|Participants|Number|90|90.0||||||
4274219|NCT00579098|4098131|B2|Wide-area circumferential ablation||Anatomical area of ablation|The catheter ablation procedure involves intentional destruction of left atrial (LA) tissue via radiofrequency energy and is used to treat atrial fibrillation (AF). Lesions often extend to the pericardium and pericardiac tissues, therefore the total number of various anatomical ablation locations reported will not total the overall number of subjects in a treatment group.|Participants|Number|46|46.0||||||
4274220|NCT00579098|4098132|B1|Wide-area circumferential ablation||Anatomical area of ablation|The catheter ablation procedure involves intentional destruction of left atrial (LA) tissue via radiofrequency energy and is used to treat atrial fibrillation (AF). Lesions often extend to the pericardium and pericardiac tissues, therefore the total number of various anatomical ablation locations reported will not total the overall number of subjects in a treatment group.|Participants|Number|44|44.0||||||
4274221|NCT00579098|4098130|B3|||Procedural time||Minutes|Mean|111|111.0|Standard Deviation|42|42.0|||
4274222|NCT00579098|4098131|B2|||Procedural time||Minutes|Mean|113|113.0|Standard Deviation|47|47.0|||
4274223|NCT00579098|4098132|B1|||Procedural time||Minutes|Mean|110|110.0|Standard Deviation|39|39.0|||
4274224|NCT00579098|4098130|B3|||Echocardiographic parameter-LVEF|LVEF= left ventricular ejection fraction, which is the volume of blood pumped out of the heart with each heartbeat. A normal LVEF ranges from 55-70%. A LVEF of 65, for example, means that 65% of the total amount of blood in the left ventricle is pumped out with each heartbeat.|Percentage|Mean|60|60.0|Standard Deviation|10|10.0|||
4274225|NCT00579098|4098131|B2|||Echocardiographic parameter-LVEF|LVEF= left ventricular ejection fraction, which is the volume of blood pumped out of the heart with each heartbeat. A normal LVEF ranges from 55-70%. A LVEF of 65, for example, means that 65% of the total amount of blood in the left ventricle is pumped out with each heartbeat.|Percentage|Mean|60|60.0|Standard Deviation|9|9.0|||
4274226|NCT00579098|4098132|B1|||Echocardiographic parameter-LVEF|LVEF= left ventricular ejection fraction, which is the volume of blood pumped out of the heart with each heartbeat. A normal LVEF ranges from 55-70%. A LVEF of 65, for example, means that 65% of the total amount of blood in the left ventricle is pumped out with each heartbeat.|Percentage|Mean|60|60.0|Standard Deviation|10|10.0|||
4274227|NCT00579098|4098130|B3|||Echocardiographic parameter-LA volume index||cc/m^2|Mean|39.9|39.9|Standard Deviation|13.8|13.8|||
4274228|NCT00579098|4098131|B2|||Echocardiographic parameter-LA volume index||cc/m^2|Mean|39.4|39.4|Standard Deviation|13.1|13.1|||
4274229|NCT00579098|4098132|B1|||Echocardiographic parameter-LA volume index||cc/m^2|Mean|40.4|40.4|Standard Deviation|0.7|0.7|||
4274230|NCT00579098|4098130|B3|||Echocardiographic parameter-LA diameter, long axis|LA = left atrium (chamber of heart)|millimeters|Mean|57.9|57.9|Standard Deviation|7.2|7.2|||
4274231|NCT00579098|4098131|B2|||Echocardiographic parameter-LA diameter, long axis|LA = left atrium (chamber of heart)|millimeters|Mean|57.5|57.5|Standard Deviation|7.7|7.7|||
4274232|NCT00579098|4098132|B1|||Echocardiographic parameter-LA diameter, long axis|LA = left atrium (chamber of heart)|millimeters|Mean|58.4|58.4|Standard Deviation|6.7|6.7|||
4274233|NCT00579098|4098130|B3|Sodium Channel Blocker Class IC||Antiarrhythmic drugs|Not all subjects were taking antiarrhythmic drugs upon admission, therefore the numbers reported will differ from the number of overall subjects in each treatment group.|Participants|Number|33|33.0||||||
4274234|NCT00579098|4098131|B2|Sodium Channel Blocker Class IC||Antiarrhythmic drugs|Not all subjects were taking antiarrhythmic drugs upon admission, therefore the numbers reported will differ from the number of overall subjects in each treatment group.|Participants|Number|20|20.0||||||
4274235|NCT00579098|4098132|B1|Sodium Channel Blocker Class IC||Antiarrhythmic drugs|Not all subjects were taking antiarrhythmic drugs upon admission, therefore the numbers reported will differ from the number of overall subjects in each treatment group.|Participants|Number|13|13.0||||||
4274236|NCT00579098|4098130|B3|Amiodarone||Antiarrhythmic drugs|Not all subjects were taking antiarrhythmic drugs upon admission, therefore the numbers reported will differ from the number of overall subjects in each treatment group.|Participants|Number|5|5.0||||||
4274237|NCT00579098|4098131|B2|Amiodarone||Antiarrhythmic drugs|Not all subjects were taking antiarrhythmic drugs upon admission, therefore the numbers reported will differ from the number of overall subjects in each treatment group.|Participants|Number|4|4.0||||||
4274238|NCT00579098|4098132|B1|Amiodarone||Antiarrhythmic drugs|Not all subjects were taking antiarrhythmic drugs upon admission, therefore the numbers reported will differ from the number of overall subjects in each treatment group.|Participants|Number|1|1.0||||||
4274239|NCT00579098|4098130|B3|Sotalol/dofetilide||Antiarrhythmic drugs|Not all subjects were taking antiarrhythmic drugs upon admission, therefore the numbers reported will differ from the number of overall subjects in each treatment group.|Participants|Number|23|23.0||||||
4274240|NCT00579098|4098131|B2|Sotalol/dofetilide||Antiarrhythmic drugs|Not all subjects were taking antiarrhythmic drugs upon admission, therefore the numbers reported will differ from the number of overall subjects in each treatment group.|Participants|Number|9|9.0||||||
4274241|NCT00579098|4098132|B1|Sotalol/dofetilide||Antiarrhythmic drugs|Not all subjects were taking antiarrhythmic drugs upon admission, therefore the numbers reported will differ from the number of overall subjects in each treatment group.|Participants|Number|14|14.0||||||
4274242|NCT00579098|4098130|B3|Total on any antiarrhythmic drug||Antiarrhythmic drugs|Not all subjects were taking antiarrhythmic drugs upon admission, therefore the numbers reported will differ from the number of overall subjects in each treatment group.|Participants|Number|61|61.0||||||
4274243|NCT00579098|4098131|B2|Total on any antiarrhythmic drug||Antiarrhythmic drugs|Not all subjects were taking antiarrhythmic drugs upon admission, therefore the numbers reported will differ from the number of overall subjects in each treatment group.|Participants|Number|33|33.0||||||
4274353|NCT00578968|4098160|B2|||Age||years|Mean|56.3|56.3|Standard Deviation|9.4|9.4|||
4274354|NCT00578968|4098161|B1|||Age||years|Mean|61.2|61.2|Standard Deviation|5.7|5.7|||
4274244|NCT00579098|4098132|B1|Total on any antiarrhythmic drug||Antiarrhythmic drugs|Not all subjects were taking antiarrhythmic drugs upon admission, therefore the numbers reported will differ from the number of overall subjects in each treatment group.|Participants|Number|28|28.0||||||
4274245|NCT00579098|4098130|B3|ACE inhibitors/Angiotensin Receptor Blockers||Medication on admission|Not all subjects were taking all medications upon admission, therefore the number reported for each medication class will not match the overall/total number of subjects per treatment group.|Participants|Number|19|19.0||||||
4274246|NCT00579098|4098131|B2|ACE inhibitors/Angiotensin Receptor Blockers||Medication on admission|Not all subjects were taking all medications upon admission, therefore the number reported for each medication class will not match the overall/total number of subjects per treatment group.|Participants|Number|7|7.0||||||
4274247|NCT00579098|4098132|B1|ACE inhibitors/Angiotensin Receptor Blockers||Medication on admission|Not all subjects were taking all medications upon admission, therefore the number reported for each medication class will not match the overall/total number of subjects per treatment group.|Participants|Number|12|12.0||||||
4274248|NCT00579098|4098130|B3|Beta blocker||Medication on admission|Not all subjects were taking all medications upon admission, therefore the number reported for each medication class will not match the overall/total number of subjects per treatment group.|Participants|Number|65|65.0||||||
4274249|NCT00579098|4098131|B2|Beta blocker||Medication on admission|Not all subjects were taking all medications upon admission, therefore the number reported for each medication class will not match the overall/total number of subjects per treatment group.|Participants|Number|30|30.0||||||
4274250|NCT00579098|4098132|B1|Beta blocker||Medication on admission|Not all subjects were taking all medications upon admission, therefore the number reported for each medication class will not match the overall/total number of subjects per treatment group.|Participants|Number|35|35.0||||||
4274251|NCT00579098|4098130|B3|Oral anticoagulation||Medication on admission|Not all subjects were taking all medications upon admission, therefore the number reported for each medication class will not match the overall/total number of subjects per treatment group.|Participants|Number|87|87.0||||||
4274252|NCT00579098|4098131|B2|Oral anticoagulation||Medication on admission|Not all subjects were taking all medications upon admission, therefore the number reported for each medication class will not match the overall/total number of subjects per treatment group.|Participants|Number|41|41.0||||||
4274253|NCT00579098|4098132|B1|Oral anticoagulation||Medication on admission|Not all subjects were taking all medications upon admission, therefore the number reported for each medication class will not match the overall/total number of subjects per treatment group.|Participants|Number|46|46.0||||||
4274254|NCT00579098|4098130|B3|Aspirin||Medication on admission|Not all subjects were taking all medications upon admission, therefore the number reported for each medication class will not match the overall/total number of subjects per treatment group.|Participants|Number|58|58.0||||||
4274255|NCT00579098|4098131|B2|Aspirin||Medication on admission|Not all subjects were taking all medications upon admission, therefore the number reported for each medication class will not match the overall/total number of subjects per treatment group.|Participants|Number|30|30.0||||||
4274256|NCT00579098|4098132|B1|Aspirin||Medication on admission|Not all subjects were taking all medications upon admission, therefore the number reported for each medication class will not match the overall/total number of subjects per treatment group.|Participants|Number|28|28.0||||||
4274257|NCT00579098|4098130|B3|Sleep apnea||Concomitant Conditions|Not all subjects had all concomitant medical conditions, therefore the number reported for each condition will not match the overall/total number of subjects per treatment group.|Participants|Number|26|26.0||||||
4274258|NCT00579098|4098131|B2|Sleep apnea||Concomitant Conditions|Not all subjects had all concomitant medical conditions, therefore the number reported for each condition will not match the overall/total number of subjects per treatment group.|Participants|Number|12|12.0||||||
4274259|NCT00579098|4098132|B1|Sleep apnea||Concomitant Conditions|Not all subjects had all concomitant medical conditions, therefore the number reported for each condition will not match the overall/total number of subjects per treatment group.|Participants|Number|14|14.0||||||
4274260|NCT00579098|4098130|B3|Chronic lung disease||Concomitant Conditions|Not all subjects had all concomitant medical conditions, therefore the number reported for each condition will not match the overall/total number of subjects per treatment group.|Participants|Number|3|3.0||||||
4274261|NCT00579098|4098131|B2|Chronic lung disease||Concomitant Conditions|Not all subjects had all concomitant medical conditions, therefore the number reported for each condition will not match the overall/total number of subjects per treatment group.|Participants|Number|2|2.0||||||
4274262|NCT00579098|4098132|B1|Chronic lung disease||Concomitant Conditions|Not all subjects had all concomitant medical conditions, therefore the number reported for each condition will not match the overall/total number of subjects per treatment group.|Participants|Number|1|1.0||||||
4274263|NCT00579098|4098130|B3|Chronic kidney disease||Concomitant Conditions|Not all subjects had all concomitant medical conditions, therefore the number reported for each condition will not match the overall/total number of subjects per treatment group.|Participants|Number|3|3.0||||||
4274264|NCT00579098|4098131|B2|Chronic kidney disease||Concomitant Conditions|Not all subjects had all concomitant medical conditions, therefore the number reported for each condition will not match the overall/total number of subjects per treatment group.|Participants|Number|2|2.0||||||
4274265|NCT00579098|4098132|B1|Chronic kidney disease||Concomitant Conditions|Not all subjects had all concomitant medical conditions, therefore the number reported for each condition will not match the overall/total number of subjects per treatment group.|Participants|Number|1|1.0||||||
4274266|NCT00579098|4098130|B3|Old Cardiovascular Accident/Transient Ischemic Att||Concomitant Conditions|Not all subjects had all concomitant medical conditions, therefore the number reported for each condition will not match the overall/total number of subjects per treatment group.|Participants|Number|0|0.0||||||
4274267|NCT00579098|4098131|B2|Old Cardiovascular Accident/Transient Ischemic Att||Concomitant Conditions|Not all subjects had all concomitant medical conditions, therefore the number reported for each condition will not match the overall/total number of subjects per treatment group.|Participants|Number|0|0.0||||||
4274355|NCT00578942|4098224|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4274356|NCT00578942|4098224|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4274268|NCT00579098|4098132|B1|Old Cardiovascular Accident/Transient Ischemic Att||Concomitant Conditions|Not all subjects had all concomitant medical conditions, therefore the number reported for each condition will not match the overall/total number of subjects per treatment group.|Participants|Number|0|0.0||||||
4274269|NCT00579098|4098130|B3|Valvular heart disease||Concomitant Conditions|Not all subjects had all concomitant medical conditions, therefore the number reported for each condition will not match the overall/total number of subjects per treatment group.|Participants|Number|11|11.0||||||
4274270|NCT00579098|4098131|B2|Valvular heart disease||Concomitant Conditions|Not all subjects had all concomitant medical conditions, therefore the number reported for each condition will not match the overall/total number of subjects per treatment group.|Participants|Number|5|5.0||||||
4274271|NCT00579098|4098132|B1|Valvular heart disease||Concomitant Conditions|Not all subjects had all concomitant medical conditions, therefore the number reported for each condition will not match the overall/total number of subjects per treatment group.|Participants|Number|6|6.0||||||
4274272|NCT00579098|4098130|B3|Hypertrophic cardiomyopathy||Concomitant Conditions|Not all subjects had all concomitant medical conditions, therefore the number reported for each condition will not match the overall/total number of subjects per treatment group.|Participants|Number|0|0.0||||||
4274273|NCT00579098|4098131|B2|Hypertrophic cardiomyopathy||Concomitant Conditions|Not all subjects had all concomitant medical conditions, therefore the number reported for each condition will not match the overall/total number of subjects per treatment group.|Participants|Number|0|0.0||||||
4274274|NCT00579098|4098132|B1|Hypertrophic cardiomyopathy||Concomitant Conditions|Not all subjects had all concomitant medical conditions, therefore the number reported for each condition will not match the overall/total number of subjects per treatment group.|Participants|Number|0|0.0||||||
4274275|NCT00579098|4098130|B3|Dilated cardiomyopathy||Concomitant Conditions|Not all subjects had all concomitant medical conditions, therefore the number reported for each condition will not match the overall/total number of subjects per treatment group.|Participants|Number|1|1.0||||||
4274276|NCT00579098|4098131|B2|Dilated cardiomyopathy||Concomitant Conditions|Not all subjects had all concomitant medical conditions, therefore the number reported for each condition will not match the overall/total number of subjects per treatment group.|Participants|Number|0|0.0||||||
4274277|NCT00579098|4098132|B1|Dilated cardiomyopathy||Concomitant Conditions|Not all subjects had all concomitant medical conditions, therefore the number reported for each condition will not match the overall/total number of subjects per treatment group.|Participants|Number|1|1.0||||||
4274278|NCT00579098|4098130|B3|Congestive Heart Failure||Concomitant Conditions|Not all subjects had all concomitant medical conditions, therefore the number reported for each condition will not match the overall/total number of subjects per treatment group.|Participants|Number|3|3.0||||||
4274279|NCT00579098|4098131|B2|Congestive Heart Failure||Concomitant Conditions|Not all subjects had all concomitant medical conditions, therefore the number reported for each condition will not match the overall/total number of subjects per treatment group.|Participants|Number|3|3.0||||||
4274280|NCT00579098|4098132|B1|Congestive Heart Failure||Concomitant Conditions|Not all subjects had all concomitant medical conditions, therefore the number reported for each condition will not match the overall/total number of subjects per treatment group.|Participants|Number|0|0.0||||||
4274281|NCT00579098|4098130|B3|Coronary Artery Disease||Concomitant Conditions|Not all subjects had all concomitant medical conditions, therefore the number reported for each condition will not match the overall/total number of subjects per treatment group.|Participants|Number|0|0.0||||||
4274282|NCT00579098|4098131|B2|Coronary Artery Disease||Concomitant Conditions|Not all subjects had all concomitant medical conditions, therefore the number reported for each condition will not match the overall/total number of subjects per treatment group.|Participants|Number|0|0.0||||||
4274283|NCT00579098|4098132|B1|Coronary Artery Disease||Concomitant Conditions|Not all subjects had all concomitant medical conditions, therefore the number reported for each condition will not match the overall/total number of subjects per treatment group.|Participants|Number|0|0.0||||||
4274284|NCT00579098|4098130|B3|Diabetes Mellitus||Concomitant Conditions|Not all subjects had all concomitant medical conditions, therefore the number reported for each condition will not match the overall/total number of subjects per treatment group.|Participants|Number|1|1.0||||||
4274285|NCT00579098|4098131|B2|Diabetes Mellitus||Concomitant Conditions|Not all subjects had all concomitant medical conditions, therefore the number reported for each condition will not match the overall/total number of subjects per treatment group.|Participants|Number|0|0.0||||||
4274286|NCT00579098|4098132|B1|Diabetes Mellitus||Concomitant Conditions|Not all subjects had all concomitant medical conditions, therefore the number reported for each condition will not match the overall/total number of subjects per treatment group.|Participants|Number|1|1.0||||||
4274287|NCT00579098|4098130|B3|Hypertension||Concomitant Conditions|Not all subjects had all concomitant medical conditions, therefore the number reported for each condition will not match the overall/total number of subjects per treatment group.|Participants|Number|36|36.0||||||
4274288|NCT00579098|4098131|B2|Hypertension||Concomitant Conditions|Not all subjects had all concomitant medical conditions, therefore the number reported for each condition will not match the overall/total number of subjects per treatment group.|Participants|Number|16|16.0||||||
4274289|NCT00579098|4098132|B1|Hypertension||Concomitant Conditions|Not all subjects had all concomitant medical conditions, therefore the number reported for each condition will not match the overall/total number of subjects per treatment group.|Participants|Number|20|20.0||||||
4274290|NCT00579098|4098130|B3|||Years of Atrial Fibrillation||Years|Mean|5.3|5.3|Standard Deviation|4.45|4.45|||
4274291|NCT00579098|4098131|B2|||Years of Atrial Fibrillation||Years|Mean|4.9|4.9|Standard Deviation|3.96|3.96|||
4274292|NCT00579098|4098132|B1|||Years of Atrial Fibrillation||Years|Mean|5.7|5.7|Standard Deviation|4.90|4.9|||
4274293|NCT00579098|4098130|B3|||Duration of Atrial Fibrillation||Months|Median|4|4.0|Full Range|||1.0|24.0|
4274294|NCT00579098|4098131|B2|||Duration of Atrial Fibrillation||Months|Median|4|4.0|Full Range|||1.0|18.0|
4274295|NCT00579098|4098132|B1|||Duration of Atrial Fibrillation||Months|Median|4|4.0|Full Range|||1.0|24.0|
4274357|NCT00578942|4098224|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4274296|NCT00579098|4098130|B3|||Paroxysmal Atrial Fibrillation|Paroxysmal atrial fibrillation is atrial fibrillation that comes and goes, starting and stopping suddenly. Not all patients experience this type of atrial fibrillation, therefore, the number reported for each group will differ from the number of overall participants per group.|Participants|Number|90|90.0||||||
4274297|NCT00579098|4098131|B2|||Paroxysmal Atrial Fibrillation|Paroxysmal atrial fibrillation is atrial fibrillation that comes and goes, starting and stopping suddenly. Not all patients experience this type of atrial fibrillation, therefore, the number reported for each group will differ from the number of overall participants per group.|Participants|Number|46|46.0||||||
4274298|NCT00579098|4098132|B1|||Paroxysmal Atrial Fibrillation|Paroxysmal atrial fibrillation is atrial fibrillation that comes and goes, starting and stopping suddenly. Not all patients experience this type of atrial fibrillation, therefore, the number reported for each group will differ from the number of overall participants per group.|Participants|Number|44|44.0||||||
4274299|NCT00579098|4098130|B3|United States||Region of Enrollment||participants|Number|125|125.0||||||
4274300|NCT00579098|4098131|B2|United States||Region of Enrollment||participants|Number|63|63.0||||||
4274301|NCT00579098|4098132|B1|United States||Region of Enrollment||participants|Number|62|62.0||||||
4274302|NCT00579098|4098130|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4274303|NCT00579098|4098131|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4274304|NCT00579098|4098132|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4274305|NCT00579098|4098130|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4274306|NCT00579098|4098131|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4274307|NCT00579098|4098132|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4274308|NCT00579098|4098130|B3|||Age||years|Mean|57|57.0|Standard Deviation|10|10.0|||
4274309|NCT00579098|4098131|B2|||Age||years|Mean|57|57.0|Standard Deviation|10|10.0|||
4274310|NCT00579098|4098132|B1|||Age||years|Mean|56|56.0|Standard Deviation|10|10.0|||
4274311|NCT00579059|4098147|B3|United States||Region of Enrollment||participants|Number|31.0|31.0||||||
4274312|NCT00579059|4098148|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4274313|NCT00579059|4098149|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4274314|NCT00579059|4098147|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4274315|NCT00579059|4098148|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4274316|NCT00579059|4098149|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4274317|NCT00579059|4098147|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4274318|NCT00579059|4098148|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4274319|NCT00579059|4098149|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4274320|NCT00579059|4098147|B3|||Age||years|Mean|65|65.0|Full Range|||53.0|82.0|
4274321|NCT00579059|4098148|B2|||Age||years|Mean|62|62.0|Full Range|6|6.0|54.0|75.0|
4274322|NCT00579059|4098149|B1|||Age||years|Mean|68|68.0|Full Range|8|8.0|53.0|82.0|
4274323|NCT00578968|4098158|B4|||Body Surface Area (BSA)||m^2|Mean|2.02|2.02|Standard Deviation|0.26|0.26|||
4274324|NCT00578968|4098159|B3|||Body Surface Area (BSA)||m^2|Mean|1.96|1.96|Standard Deviation|0.17|0.17|||
4274325|NCT00578968|4098160|B2|||Body Surface Area (BSA)||m^2|Mean|2.07|2.07|Standard Deviation|0.25|0.25|||
4274326|NCT00578968|4098161|B1|||Body Surface Area (BSA)||m^2|Mean|2.06|2.06|Standard Deviation|0.35|0.35|||
4274327|NCT00578968|4098158|B4|||Body Mass Index (BMI)||kg/m^2|Mean|29.4|29.4|Standard Deviation|7.0|7.0|||
4274328|NCT00578968|4098159|B3|||Body Mass Index (BMI)||kg/m^2|Mean|26.8|26.8|Standard Deviation|3.1|3.1|||
4274329|NCT00578968|4098160|B2|||Body Mass Index (BMI)||kg/m^2|Mean|29.9|29.9|Standard Deviation|4.4|4.4|||
4274330|NCT00578968|4098161|B1|||Body Mass Index (BMI)||kg/m^2|Mean|32.1|32.1|Standard Deviation|10.4|10.4|||
4274331|NCT00578968|4098158|B4|||Weight||kg|Mean|86.7|86.7|Standard Deviation|21.2|21.2|||
4274332|NCT00578968|4098159|B3|||Weight||kg|Mean|80.4|80.4|Standard Deviation|11.3|11.3|||
4274333|NCT00578968|4098160|B2|||Weight||kg|Mean|89.6|89.6|Standard Deviation|17.9|17.9|||
4274334|NCT00578968|4098161|B1|||Weight||kg|Mean|91.9|91.9|Standard Deviation|30.2|30.2|||
4274335|NCT00578968|4098158|B4|||Height||cm|Mean|171.3|171.3|Standard Deviation|8.7|8.7|||
4274336|NCT00578968|4098159|B3|||Height||cm|Mean|173.0|173.0|Standard Deviation|7.7|7.7|||
4274337|NCT00578968|4098160|B2|||Height||cm|Mean|172.5|172.5|Standard Deviation|8.0|8.0|||
4274338|NCT00578968|4098161|B1|||Height||cm|Mean|169.1|169.1|Standard Deviation|10.3|10.3|||
4274339|NCT00578968|4098158|B4|United States||Region of Enrollment||participants|Number|36|36.0||||||
4274340|NCT00578968|4098159|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4274341|NCT00578968|4098160|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4274342|NCT00578968|4098161|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4274343|NCT00578968|4098158|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4274344|NCT00578968|4098159|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4274345|NCT00578968|4098160|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4274346|NCT00578968|4098161|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4274347|NCT00578968|4098158|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4274348|NCT00578968|4098159|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4274349|NCT00578968|4098160|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4274350|NCT00578968|4098161|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4274351|NCT00578968|4098158|B4|||Age||years|Mean|58.6|58.6|Standard Deviation|9.0|9.0|||
4274358|NCT00578942|4098224|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4274359|NCT00578942|4098224|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4274360|NCT00578942|4098224|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4274361|NCT00578942|4098224|B1||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4274362|NCT00578942|4098224|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4274363|NCT00578942|4098224|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4274364|NCT00578942|4098224|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4274365|NCT00578942|4098224|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4274366|NCT00578942|4098224|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4274367|NCT00578942|4098224|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4274368|NCT00578942|4098224|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4274369|NCT00578942|4098224|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4274370|NCT00578942|4098224|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4274371|NCT00578929|4098230|B5||Male|Sex: Female, Male||Participants|Count of Participants|687|687.0||||||
4274372|NCT00578929|4098231|B4||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4274373|NCT00578929|4098232|B3||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4274374|NCT00578929|4098233|B2||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4274375|NCT00578929|4098234|B1||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4274376|NCT00578929|4098230|B5||Female|Sex: Female, Male||Participants|Count of Participants|501|501.0||||||
4274377|NCT00578929|4098231|B4||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4274378|NCT00578929|4098232|B3||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4274379|NCT00578929|4098233|B2||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4274380|NCT00578929|4098234|B1||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4274381|NCT00578929|4098230|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4274382|NCT00578929|4098231|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4274383|NCT00578929|4098232|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4274384|NCT00578929|4098233|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4274385|NCT00578929|4098234|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4274386|NCT00578929|4098230|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4274387|NCT00578929|4098231|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4274388|NCT00578929|4098232|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4274389|NCT00578929|4098233|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4274390|NCT00578929|4098234|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4274391|NCT00578929|4098230|B5||<=18 years|Age||Participants|Count of Participants|1188|1188.0||||||
4274392|NCT00578929|4098231|B4||<=18 years|Age||Participants|Count of Participants|297|297.0||||||
4274393|NCT00578929|4098232|B3||<=18 years|Age||Participants|Count of Participants|296|296.0||||||
4274394|NCT00578929|4098233|B2||<=18 years|Age||Participants|Count of Participants|297|297.0||||||
4274395|NCT00578929|4098234|B1||<=18 years|Age||Participants|Count of Participants|298|298.0||||||
4274396|NCT00578903|4098252|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4274397|NCT00578903|4098252|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4274398|NCT00578903|4098252|B1|41-50 years||Age, Customized||participants|Number|1|1.0||||||
4274399|NCT00578903|4098252|B1|31-40 years||Age, Customized||participants|Number|0|0.0||||||
4274400|NCT00578903|4098252|B1|21-30 years||Age, Customized||participants|Number|0|0.0||||||
4274401|NCT00578903|4098252|B1|11-20 years||Age, Customized||participants|Number|12|12.0||||||
4274402|NCT00578903|4098252|B1|0-10 years||Age, Customized||participants|Number|9|9.0||||||
4274403|NCT00578877|4098261|B3|United States||Region of Enrollment||participants|Number|421|421.0||||||
4274404|NCT00578877|4098262|B2|United States||Region of Enrollment||participants|Number|283|283.0||||||
4274405|NCT00578877|4098263|B1|United States||Region of Enrollment||participants|Number|138|138.0||||||
4274406|NCT00578877|4098261|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4274407|NCT00578877|4098262|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4274408|NCT00578877|4098263|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4274409|NCT00578877|4098261|B3||Female|Sex: Female, Male||Participants|Count of Participants|421|421.0||||||
4274410|NCT00578877|4098262|B2||Female|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
4274411|NCT00578877|4098263|B1||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4274412|NCT00578877|4098261|B3|||Age||years|Mean|28.9|28.9|Standard Deviation|6.0|6.0|||
4274413|NCT00578877|4098262|B2|||Age||years|Mean|28.7|28.7|Standard Deviation|6.0|6.0|||
4274414|NCT00578877|4098263|B1|||Age||years|Mean|29.2|29.2|Standard Deviation|6|6.0|||
4274415|NCT00578877|4098261|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4274416|NCT00578877|4098262|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4274417|NCT00578877|4098263|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4274418|NCT00578877|4098261|B3||Between 18 and 65 years|Age||Participants|Count of Participants|421|421.0||||||
4274419|NCT00578877|4098262|B2||Between 18 and 65 years|Age||Participants|Count of Participants|283|283.0||||||
4274420|NCT00578877|4098263|B1||Between 18 and 65 years|Age||Participants|Count of Participants|138|138.0||||||
4274421|NCT00578877|4098261|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4274422|NCT00578877|4098262|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4274423|NCT00578877|4098263|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4274424|NCT00578864|4098270|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4274425|NCT00578864|4098271|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4274426|NCT00578864|4098272|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4274427|NCT00578864|4098270|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4274428|NCT00578864|4098271|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4274429|NCT00578864|4098272|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4274430|NCT00578864|4098270|B3|||Age||month|Median|26.9|26.9|Full Range|||8.4|130.8|
4274431|NCT00578864|4098271|B2|||Age||month|Median|25.3|25.3|Full Range|||8.4|34.3|
4274432|NCT00578864|4098272|B1|||Age||month|Median|26.9|26.9|Full Range|||17.7|130.8|
4274433|NCT00578812|4098287|B3|United States||Region of Enrollment||participants|Number|403|403.0||||||
4274434|NCT00578812|4098288|B2|United States||Region of Enrollment||participants|Number|185|185.0||||||
4274435|NCT00578812|4098289|B1|United States||Region of Enrollment||participants|Number|218|218.0||||||
4274436|NCT00578812|4098287|B3|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4274437|NCT00578812|4098288|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4274438|NCT00578812|4098289|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4274439|NCT00578812|4098287|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4274440|NCT00578812|4098288|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4274441|NCT00578812|4098289|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4274442|NCT00578812|4098287|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4274443|NCT00578812|4098288|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4274444|NCT00578812|4098289|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4274445|NCT00578812|4098287|B3|Black||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4274446|NCT00578812|4098288|B2|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4274447|NCT00578812|4098289|B1|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4274448|NCT00578812|4098287|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|372|372.0||||||
4274449|NCT00578812|4098288|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|170|170.0||||||
4274450|NCT00578812|4098289|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|202|202.0||||||
4274451|NCT00578812|4098287|B3||Male|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4274452|NCT00578812|4098288|B2||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4274453|NCT00578812|4098289|B1||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4274454|NCT00578812|4098287|B3||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4274455|NCT00578812|4098288|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4274456|NCT00578812|4098289|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4274457|NCT00578812|4098287|B3|||Age||years|Mean|44.5|44.5|Standard Deviation|8.7|8.7|||
4274458|NCT00578812|4098288|B2|||Age||years|Mean|43.7|43.7|Standard Deviation|8.3|8.3|||
4274459|NCT00578812|4098289|B1|||Age||years|Mean|45.3|45.3|Standard Deviation|9.0|9.0|||
4274460|NCT00578786|4098326|B4|||Body Mass Index (BMI)|Adult body mass index (BMI) is calculated by dividing weight in kg by height in meters squared.BMI below 18.5 = underweight; BMI 18.5 to 24.9 = normal; BMI 25.0 to 29.9 = overweight; BMI 30.0 and above = obese. Note that 1 subject was not included in the denominator for the Ambrisentan 5 mg group (N=189) and the combined group (N=382). Baseline was defined as previously described.|kg/m^2|Mean|27.17|27.17|Standard Deviation|5.958|5.958|||
4274461|NCT00578786|4098327|B3|||Body Mass Index (BMI)|Adult body mass index (BMI) is calculated by dividing weight in kg by height in meters squared.BMI below 18.5 = underweight; BMI 18.5 to 24.9 = normal; BMI 25.0 to 29.9 = overweight; BMI 30.0 and above = obese. Note that 1 subject was not included in the denominator for the Ambrisentan 5 mg group (N=189) and the combined group (N=382). Baseline was defined as previously described.|kg/m^2|Mean|28.26|28.26|Standard Deviation|7.212|7.212|||
4274462|NCT00578786|4098328|B2|||Body Mass Index (BMI)|Adult body mass index (BMI) is calculated by dividing weight in kg by height in meters squared.BMI below 18.5 = underweight; BMI 18.5 to 24.9 = normal; BMI 25.0 to 29.9 = overweight; BMI 30.0 and above = obese. Note that 1 subject was not included in the denominator for the Ambrisentan 5 mg group (N=189) and the combined group (N=382). Baseline was defined as previously described.|kg/m^2|Mean|26.86|26.86|Standard Deviation|5.632|5.632|||
4274463|NCT00578786|4098329|B1|||Body Mass Index (BMI)|Adult body mass index (BMI) is calculated by dividing weight in kg by height in meters squared.BMI below 18.5 = underweight; BMI 18.5 to 24.9 = normal; BMI 25.0 to 29.9 = overweight; BMI 30.0 and above = obese. Note that 1 subject was not included in the denominator for the Ambrisentan 5 mg group (N=189) and the combined group (N=382). Baseline was defined as previously described.|kg/m^2|Mean|26.68|26.68|Standard Deviation|5.038|5.038|||
4274464|NCT00578786|4098326|B4|||Borg Dyspnea Index (BDI)|Borg Dyspnea Index is a measure of perceived shortness of breath: 0 units on a scale (none) to 10 units on a scale (maximum breathlessness). Baseline data values established at the screening/randomization visit of the 2 prior (parent) studies defined the baseline of this long-term analysis for subjects who first received 2.5, 5, or 10 mg ambrisentan in the prior studies. The Screening/Randomization Visit of the present extension study defined the baseline for subjects who received placebo in the 2 prior studies.|units on a scale|Mean|3.88|3.88|Standard Deviation|2.377|2.377|||
4274516|NCT00578786|4098326|B4||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4274465|NCT00578786|4098327|B3|||Borg Dyspnea Index (BDI)|Borg Dyspnea Index is a measure of perceived shortness of breath: 0 units on a scale (none) to 10 units on a scale (maximum breathlessness). Baseline data values established at the screening/randomization visit of the 2 prior (parent) studies defined the baseline of this long-term analysis for subjects who first received 2.5, 5, or 10 mg ambrisentan in the prior studies. The Screening/Randomization Visit of the present extension study defined the baseline for subjects who received placebo in the 2 prior studies.|units on a scale|Mean|3.78|3.78|Standard Deviation|2.133|2.133|||
4274466|NCT00578786|4098328|B2|||Borg Dyspnea Index (BDI)|Borg Dyspnea Index is a measure of perceived shortness of breath: 0 units on a scale (none) to 10 units on a scale (maximum breathlessness). Baseline data values established at the screening/randomization visit of the 2 prior (parent) studies defined the baseline of this long-term analysis for subjects who first received 2.5, 5, or 10 mg ambrisentan in the prior studies. The Screening/Randomization Visit of the present extension study defined the baseline for subjects who received placebo in the 2 prior studies.|units on a scale|Mean|3.80|3.8|Standard Deviation|2.332|2.332|||
4274467|NCT00578786|4098329|B1|||Borg Dyspnea Index (BDI)|Borg Dyspnea Index is a measure of perceived shortness of breath: 0 units on a scale (none) to 10 units on a scale (maximum breathlessness). Baseline data values established at the screening/randomization visit of the 2 prior (parent) studies defined the baseline of this long-term analysis for subjects who first received 2.5, 5, or 10 mg ambrisentan in the prior studies. The Screening/Randomization Visit of the present extension study defined the baseline for subjects who received placebo in the 2 prior studies.|units on a scale|Mean|4.14|4.14|Standard Deviation|2.684|2.684|||
4274468|NCT00578786|4098326|B4|WHO Class IV||World Heath Organization (WHO) Class|WHO Classes: I) pulmonary hypertension (PH); ordinary physical activity not limited or causes increased dyspnea, fatigue, chest pain, or presyncope. II) PH; ordinary physical activity mildly limits/causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. III) PH; physical activity markedly limited and less than ordinary physical activity causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. IV) PH; physical activity causes symptoms; signs of right heart failure; dyspnea/fatigue possible at rest. Baseline defined as previously described.|participants|Number|30|30.0||||||
4274469|NCT00578786|4098327|B3|WHO Class IV||World Heath Organization (WHO) Class|WHO Classes: I) pulmonary hypertension (PH); ordinary physical activity not limited or causes increased dyspnea, fatigue, chest pain, or presyncope. II) PH; ordinary physical activity mildly limits/causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. III) PH; physical activity markedly limited and less than ordinary physical activity causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. IV) PH; physical activity causes symptoms; signs of right heart failure; dyspnea/fatigue possible at rest. Baseline defined as previously described.|participants|Number|10|10.0||||||
4274470|NCT00578786|4098328|B2|WHO Class IV||World Heath Organization (WHO) Class|WHO Classes: I) pulmonary hypertension (PH); ordinary physical activity not limited or causes increased dyspnea, fatigue, chest pain, or presyncope. II) PH; ordinary physical activity mildly limits/causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. III) PH; physical activity markedly limited and less than ordinary physical activity causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. IV) PH; physical activity causes symptoms; signs of right heart failure; dyspnea/fatigue possible at rest. Baseline defined as previously described.|participants|Number|15|15.0||||||
4274471|NCT00578786|4098329|B1|WHO Class IV||World Heath Organization (WHO) Class|WHO Classes: I) pulmonary hypertension (PH); ordinary physical activity not limited or causes increased dyspnea, fatigue, chest pain, or presyncope. II) PH; ordinary physical activity mildly limits/causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. III) PH; physical activity markedly limited and less than ordinary physical activity causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. IV) PH; physical activity causes symptoms; signs of right heart failure; dyspnea/fatigue possible at rest. Baseline defined as previously described.|participants|Number|5|5.0||||||
4274472|NCT00578786|4098326|B4|WHO Class III||World Heath Organization (WHO) Class|WHO Classes: I) pulmonary hypertension (PH); ordinary physical activity not limited or causes increased dyspnea, fatigue, chest pain, or presyncope. II) PH; ordinary physical activity mildly limits/causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. III) PH; physical activity markedly limited and less than ordinary physical activity causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. IV) PH; physical activity causes symptoms; signs of right heart failure; dyspnea/fatigue possible at rest. Baseline defined as previously described.|participants|Number|178|178.0||||||
4274473|NCT00578786|4098327|B3|WHO Class III||World Heath Organization (WHO) Class|WHO Classes: I) pulmonary hypertension (PH); ordinary physical activity not limited or causes increased dyspnea, fatigue, chest pain, or presyncope. II) PH; ordinary physical activity mildly limits/causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. III) PH; physical activity markedly limited and less than ordinary physical activity causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. IV) PH; physical activity causes symptoms; signs of right heart failure; dyspnea/fatigue possible at rest. Baseline defined as previously described.|participants|Number|48|48.0||||||
4274474|NCT00578786|4098328|B2|WHO Class III||World Heath Organization (WHO) Class|WHO Classes: I) pulmonary hypertension (PH); ordinary physical activity not limited or causes increased dyspnea, fatigue, chest pain, or presyncope. II) PH; ordinary physical activity mildly limits/causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. III) PH; physical activity markedly limited and less than ordinary physical activity causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. IV) PH; physical activity causes symptoms; signs of right heart failure; dyspnea/fatigue possible at rest. Baseline defined as previously described.|participants|Number|91|91.0||||||
4274475|NCT00578786|4098329|B1|WHO Class III||World Heath Organization (WHO) Class|WHO Classes: I) pulmonary hypertension (PH); ordinary physical activity not limited or causes increased dyspnea, fatigue, chest pain, or presyncope. II) PH; ordinary physical activity mildly limits/causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. III) PH; physical activity markedly limited and less than ordinary physical activity causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. IV) PH; physical activity causes symptoms; signs of right heart failure; dyspnea/fatigue possible at rest. Baseline defined as previously described.|participants|Number|39|39.0||||||
4274517|NCT00578786|4098327|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4274476|NCT00578786|4098326|B4|WHO Class II||World Heath Organization (WHO) Class|WHO Classes: I) pulmonary hypertension (PH); ordinary physical activity not limited or causes increased dyspnea, fatigue, chest pain, or presyncope. II) PH; ordinary physical activity mildly limits/causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. III) PH; physical activity markedly limited and less than ordinary physical activity causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. IV) PH; physical activity causes symptoms; signs of right heart failure; dyspnea/fatigue possible at rest. Baseline defined as previously described.|participants|Number|163|163.0||||||
4274477|NCT00578786|4098327|B3|WHO Class II||World Heath Organization (WHO) Class|WHO Classes: I) pulmonary hypertension (PH); ordinary physical activity not limited or causes increased dyspnea, fatigue, chest pain, or presyncope. II) PH; ordinary physical activity mildly limits/causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. III) PH; physical activity markedly limited and less than ordinary physical activity causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. IV) PH; physical activity causes symptoms; signs of right heart failure; dyspnea/fatigue possible at rest. Baseline defined as previously described.|participants|Number|35|35.0||||||
4274478|NCT00578786|4098328|B2|WHO Class II||World Heath Organization (WHO) Class|WHO Classes: I) pulmonary hypertension (PH); ordinary physical activity not limited or causes increased dyspnea, fatigue, chest pain, or presyncope. II) PH; ordinary physical activity mildly limits/causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. III) PH; physical activity markedly limited and less than ordinary physical activity causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. IV) PH; physical activity causes symptoms; signs of right heart failure; dyspnea/fatigue possible at rest. Baseline defined as previously described.|participants|Number|77|77.0||||||
4274479|NCT00578786|4098329|B1|WHO Class II||World Heath Organization (WHO) Class|WHO Classes: I) pulmonary hypertension (PH); ordinary physical activity not limited or causes increased dyspnea, fatigue, chest pain, or presyncope. II) PH; ordinary physical activity mildly limits/causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. III) PH; physical activity markedly limited and less than ordinary physical activity causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. IV) PH; physical activity causes symptoms; signs of right heart failure; dyspnea/fatigue possible at rest. Baseline defined as previously described.|participants|Number|51|51.0||||||
4274480|NCT00578786|4098326|B4|WHO Class I||World Heath Organization (WHO) Class|WHO Classes: I) pulmonary hypertension (PH); ordinary physical activity not limited or causes increased dyspnea, fatigue, chest pain, or presyncope. II) PH; ordinary physical activity mildly limits/causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. III) PH; physical activity markedly limited and less than ordinary physical activity causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. IV) PH; physical activity causes symptoms; signs of right heart failure; dyspnea/fatigue possible at rest. Baseline defined as previously described.|participants|Number|12|12.0||||||
4274481|NCT00578786|4098327|B3|WHO Class I||World Heath Organization (WHO) Class|WHO Classes: I) pulmonary hypertension (PH); ordinary physical activity not limited or causes increased dyspnea, fatigue, chest pain, or presyncope. II) PH; ordinary physical activity mildly limits/causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. III) PH; physical activity markedly limited and less than ordinary physical activity causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. IV) PH; physical activity causes symptoms; signs of right heart failure; dyspnea/fatigue possible at rest. Baseline defined as previously described.|participants|Number|4|4.0||||||
4274482|NCT00578786|4098328|B2|WHO Class I||World Heath Organization (WHO) Class|WHO Classes: I) pulmonary hypertension (PH); ordinary physical activity not limited or causes increased dyspnea, fatigue, chest pain, or presyncope. II) PH; ordinary physical activity mildly limits/causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. III) PH; physical activity markedly limited and less than ordinary physical activity causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. IV) PH; physical activity causes symptoms; signs of right heart failure; dyspnea/fatigue possible at rest. Baseline defined as previously described.|participants|Number|7|7.0||||||
4274483|NCT00578786|4098329|B1|WHO Class I||World Heath Organization (WHO) Class|WHO Classes: I) pulmonary hypertension (PH); ordinary physical activity not limited or causes increased dyspnea, fatigue, chest pain, or presyncope. II) PH; ordinary physical activity mildly limits/causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. III) PH; physical activity markedly limited and less than ordinary physical activity causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. IV) PH; physical activity causes symptoms; signs of right heart failure; dyspnea/fatigue possible at rest. Baseline defined as previously described.|participants|Number|1|1.0||||||
4274484|NCT00578786|4098326|B4|||6-Minute Walk Distance (6MWD)|A measure of the distance participants could walk in 6 minutes. Baseline data values established at the screening/randomization visit of the 2 prior (parent) studies defined the baseline of this long-term analysis for subjects who first received 2.5, 5, or 10 mg ambrisentan in the prior studies. The Screening/Randomization Visit of the present extension study defined the baseline for subjects who received placebo in the 2 prior studies.|meters|Mean|347.0|347.0|Standard Deviation|85.389|85.389|||
4274485|NCT00578786|4098327|B3|||6-Minute Walk Distance (6MWD)|A measure of the distance participants could walk in 6 minutes. Baseline data values established at the screening/randomization visit of the 2 prior (parent) studies defined the baseline of this long-term analysis for subjects who first received 2.5, 5, or 10 mg ambrisentan in the prior studies. The Screening/Randomization Visit of the present extension study defined the baseline for subjects who received placebo in the 2 prior studies.|meters|Mean|342.3|342.3|Standard Deviation|80.840|80.84|||
4274486|NCT00578786|4098328|B2|||6-Minute Walk Distance (6MWD)|A measure of the distance participants could walk in 6 minutes. Baseline data values established at the screening/randomization visit of the 2 prior (parent) studies defined the baseline of this long-term analysis for subjects who first received 2.5, 5, or 10 mg ambrisentan in the prior studies. The Screening/Randomization Visit of the present extension study defined the baseline for subjects who received placebo in the 2 prior studies.|meters|Mean|347.7|347.7|Standard Deviation|87.333|87.333|||
4274518|NCT00578786|4098328|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4274519|NCT00578786|4098329|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4274520|NCT00578786|4098326|B4||Female|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
4274487|NCT00578786|4098329|B1|||6-Minute Walk Distance (6MWD)|A measure of the distance participants could walk in 6 minutes. Baseline data values established at the screening/randomization visit of the 2 prior (parent) studies defined the baseline of this long-term analysis for subjects who first received 2.5, 5, or 10 mg ambrisentan in the prior studies. The Screening/Randomization Visit of the present extension study defined the baseline for subjects who received placebo in the 2 prior studies.|meters|Mean|350.3|350.3|Standard Deviation|86.640|86.64|||
4274488|NCT00578786|4098326|B4|Non-IPAH||Pulmonary Arterial Hypertension Stratification|Participants were classified as diagnosed with idiopathic pulmonary arterial hypertension (IPAH) or non-idiopathic PAH (non-IPAH). Baseline data values established at the screening/randomization visit of the 2 prior (parent) studies defined the baseline of this long-term analysis for subjects who first received 2.5, 5, or 10 mg ambrisentan in the prior studies. The Screening/Randomization Visit of the present extension study defined the baseline for subjects who received placebo in the 2 prior studies.|participants|Number|142|142.0||||||
4274489|NCT00578786|4098327|B3|Non-IPAH||Pulmonary Arterial Hypertension Stratification|Participants were classified as diagnosed with idiopathic pulmonary arterial hypertension (IPAH) or non-idiopathic PAH (non-IPAH). Baseline data values established at the screening/randomization visit of the 2 prior (parent) studies defined the baseline of this long-term analysis for subjects who first received 2.5, 5, or 10 mg ambrisentan in the prior studies. The Screening/Randomization Visit of the present extension study defined the baseline for subjects who received placebo in the 2 prior studies.|participants|Number|38|38.0||||||
4274490|NCT00578786|4098328|B2|Non-IPAH||Pulmonary Arterial Hypertension Stratification|Participants were classified as diagnosed with idiopathic pulmonary arterial hypertension (IPAH) or non-idiopathic PAH (non-IPAH). Baseline data values established at the screening/randomization visit of the 2 prior (parent) studies defined the baseline of this long-term analysis for subjects who first received 2.5, 5, or 10 mg ambrisentan in the prior studies. The Screening/Randomization Visit of the present extension study defined the baseline for subjects who received placebo in the 2 prior studies.|participants|Number|71|71.0||||||
4274491|NCT00578786|4098329|B1|Non-IPAH||Pulmonary Arterial Hypertension Stratification|Participants were classified as diagnosed with idiopathic pulmonary arterial hypertension (IPAH) or non-idiopathic PAH (non-IPAH). Baseline data values established at the screening/randomization visit of the 2 prior (parent) studies defined the baseline of this long-term analysis for subjects who first received 2.5, 5, or 10 mg ambrisentan in the prior studies. The Screening/Randomization Visit of the present extension study defined the baseline for subjects who received placebo in the 2 prior studies.|participants|Number|33|33.0||||||
4274492|NCT00578786|4098326|B4|Idiopathic PAH (IPAH)||Pulmonary Arterial Hypertension Stratification|Participants were classified as diagnosed with idiopathic pulmonary arterial hypertension (IPAH) or non-idiopathic PAH (non-IPAH). Baseline data values established at the screening/randomization visit of the 2 prior (parent) studies defined the baseline of this long-term analysis for subjects who first received 2.5, 5, or 10 mg ambrisentan in the prior studies. The Screening/Randomization Visit of the present extension study defined the baseline for subjects who received placebo in the 2 prior studies.|participants|Number|241|241.0||||||
4274493|NCT00578786|4098327|B3|Idiopathic PAH (IPAH)||Pulmonary Arterial Hypertension Stratification|Participants were classified as diagnosed with idiopathic pulmonary arterial hypertension (IPAH) or non-idiopathic PAH (non-IPAH). Baseline data values established at the screening/randomization visit of the 2 prior (parent) studies defined the baseline of this long-term analysis for subjects who first received 2.5, 5, or 10 mg ambrisentan in the prior studies. The Screening/Randomization Visit of the present extension study defined the baseline for subjects who received placebo in the 2 prior studies.|participants|Number|59|59.0||||||
4274494|NCT00578786|4098328|B2|Idiopathic PAH (IPAH)||Pulmonary Arterial Hypertension Stratification|Participants were classified as diagnosed with idiopathic pulmonary arterial hypertension (IPAH) or non-idiopathic PAH (non-IPAH). Baseline data values established at the screening/randomization visit of the 2 prior (parent) studies defined the baseline of this long-term analysis for subjects who first received 2.5, 5, or 10 mg ambrisentan in the prior studies. The Screening/Randomization Visit of the present extension study defined the baseline for subjects who received placebo in the 2 prior studies.|participants|Number|119|119.0||||||
4274495|NCT00578786|4098329|B1|Idiopathic PAH (IPAH)||Pulmonary Arterial Hypertension Stratification|Participants were classified as diagnosed with idiopathic pulmonary arterial hypertension (IPAH) or non-idiopathic PAH (non-IPAH). Baseline data values established at the screening/randomization visit of the 2 prior (parent) studies defined the baseline of this long-term analysis for subjects who first received 2.5, 5, or 10 mg ambrisentan in the prior studies. The Screening/Randomization Visit of the present extension study defined the baseline for subjects who received placebo in the 2 prior studies.|participants|Number|63|63.0||||||
4274496|NCT00578786|4098326|B4|Other||Race/Ethnicity, Customized|Baseline data values established at the screening/randomization visit of the 2 prior (parent) studies defined the baseline of this long-term analysis for subjects who first received 2.5, 5, or 10 mg ambrisentan in the prior studies. The Screening/Randomization Visit of the present extension study defined the baseline for subjects who received placebo in the 2 prior studies.|participants|Number|4|4.0||||||
4274497|NCT00578786|4098327|B3|Other||Race/Ethnicity, Customized|Baseline data values established at the screening/randomization visit of the 2 prior (parent) studies defined the baseline of this long-term analysis for subjects who first received 2.5, 5, or 10 mg ambrisentan in the prior studies. The Screening/Randomization Visit of the present extension study defined the baseline for subjects who received placebo in the 2 prior studies.|participants|Number|2|2.0||||||
4274498|NCT00578786|4098328|B2|Other||Race/Ethnicity, Customized|Baseline data values established at the screening/randomization visit of the 2 prior (parent) studies defined the baseline of this long-term analysis for subjects who first received 2.5, 5, or 10 mg ambrisentan in the prior studies. The Screening/Randomization Visit of the present extension study defined the baseline for subjects who received placebo in the 2 prior studies.|participants|Number|2|2.0||||||
4274499|NCT00578786|4098329|B1|Other||Race/Ethnicity, Customized|Baseline data values established at the screening/randomization visit of the 2 prior (parent) studies defined the baseline of this long-term analysis for subjects who first received 2.5, 5, or 10 mg ambrisentan in the prior studies. The Screening/Randomization Visit of the present extension study defined the baseline for subjects who received placebo in the 2 prior studies.|participants|Number|0|0.0||||||
4274521|NCT00578786|4098327|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4274500|NCT00578786|4098326|B4|Hispanic||Race/Ethnicity, Customized|Baseline data values established at the screening/randomization visit of the 2 prior (parent) studies defined the baseline of this long-term analysis for subjects who first received 2.5, 5, or 10 mg ambrisentan in the prior studies. The Screening/Randomization Visit of the present extension study defined the baseline for subjects who received placebo in the 2 prior studies.|participants|Number|65|65.0||||||
4274501|NCT00578786|4098327|B3|Hispanic||Race/Ethnicity, Customized|Baseline data values established at the screening/randomization visit of the 2 prior (parent) studies defined the baseline of this long-term analysis for subjects who first received 2.5, 5, or 10 mg ambrisentan in the prior studies. The Screening/Randomization Visit of the present extension study defined the baseline for subjects who received placebo in the 2 prior studies.|participants|Number|22|22.0||||||
4274502|NCT00578786|4098328|B2|Hispanic||Race/Ethnicity, Customized|Baseline data values established at the screening/randomization visit of the 2 prior (parent) studies defined the baseline of this long-term analysis for subjects who first received 2.5, 5, or 10 mg ambrisentan in the prior studies. The Screening/Randomization Visit of the present extension study defined the baseline for subjects who received placebo in the 2 prior studies.|participants|Number|29|29.0||||||
4274503|NCT00578786|4098329|B1|Hispanic||Race/Ethnicity, Customized|Baseline data values established at the screening/randomization visit of the 2 prior (parent) studies defined the baseline of this long-term analysis for subjects who first received 2.5, 5, or 10 mg ambrisentan in the prior studies. The Screening/Randomization Visit of the present extension study defined the baseline for subjects who received placebo in the 2 prior studies.|participants|Number|14|14.0||||||
4274504|NCT00578786|4098326|B4|Asian||Race/Ethnicity, Customized|Baseline data values established at the screening/randomization visit of the 2 prior (parent) studies defined the baseline of this long-term analysis for subjects who first received 2.5, 5, or 10 mg ambrisentan in the prior studies. The Screening/Randomization Visit of the present extension study defined the baseline for subjects who received placebo in the 2 prior studies.|participants|Number|9|9.0||||||
4274505|NCT00578786|4098327|B3|Asian||Race/Ethnicity, Customized|Baseline data values established at the screening/randomization visit of the 2 prior (parent) studies defined the baseline of this long-term analysis for subjects who first received 2.5, 5, or 10 mg ambrisentan in the prior studies. The Screening/Randomization Visit of the present extension study defined the baseline for subjects who received placebo in the 2 prior studies.|participants|Number|2|2.0||||||
4274506|NCT00578786|4098328|B2|Asian||Race/Ethnicity, Customized|Baseline data values established at the screening/randomization visit of the 2 prior (parent) studies defined the baseline of this long-term analysis for subjects who first received 2.5, 5, or 10 mg ambrisentan in the prior studies. The Screening/Randomization Visit of the present extension study defined the baseline for subjects who received placebo in the 2 prior studies.|participants|Number|6|6.0||||||
4274507|NCT00578786|4098329|B1|Asian||Race/Ethnicity, Customized|Baseline data values established at the screening/randomization visit of the 2 prior (parent) studies defined the baseline of this long-term analysis for subjects who first received 2.5, 5, or 10 mg ambrisentan in the prior studies. The Screening/Randomization Visit of the present extension study defined the baseline for subjects who received placebo in the 2 prior studies.|participants|Number|1|1.0||||||
4274508|NCT00578786|4098326|B4|Black||Race/Ethnicity, Customized|Baseline data values established at the screening/randomization visit of the 2 prior (parent) studies defined the baseline of this long-term analysis for subjects who first received 2.5, 5, or 10 mg ambrisentan in the prior studies. The Screening/Randomization Visit of the present extension study defined the baseline for subjects who received placebo in the 2 prior studies.|participants|Number|11|11.0||||||
4274509|NCT00578786|4098327|B3|Black||Race/Ethnicity, Customized|Baseline data values established at the screening/randomization visit of the 2 prior (parent) studies defined the baseline of this long-term analysis for subjects who first received 2.5, 5, or 10 mg ambrisentan in the prior studies. The Screening/Randomization Visit of the present extension study defined the baseline for subjects who received placebo in the 2 prior studies.|participants|Number|6|6.0||||||
4274510|NCT00578786|4098328|B2|Black||Race/Ethnicity, Customized|Baseline data values established at the screening/randomization visit of the 2 prior (parent) studies defined the baseline of this long-term analysis for subjects who first received 2.5, 5, or 10 mg ambrisentan in the prior studies. The Screening/Randomization Visit of the present extension study defined the baseline for subjects who received placebo in the 2 prior studies.|participants|Number|5|5.0||||||
4274511|NCT00578786|4098329|B1|Black||Race/Ethnicity, Customized|Baseline data values established at the screening/randomization visit of the 2 prior (parent) studies defined the baseline of this long-term analysis for subjects who first received 2.5, 5, or 10 mg ambrisentan in the prior studies. The Screening/Randomization Visit of the present extension study defined the baseline for subjects who received placebo in the 2 prior studies.|participants|Number|0|0.0||||||
4274512|NCT00578786|4098326|B4|Caucasian||Race/Ethnicity, Customized|Baseline data values established at the screening/randomization visit of the 2 prior (parent) studies defined the baseline of this long-term analysis for subjects who first received 2.5, 5, or 10 mg ambrisentan in the prior studies. The Screening/Randomization Visit of the present extension study defined the baseline for subjects who received placebo in the 2 prior studies.|participants|Number|294|294.0||||||
4274513|NCT00578786|4098327|B3|Caucasian||Race/Ethnicity, Customized|Baseline data values established at the screening/randomization visit of the 2 prior (parent) studies defined the baseline of this long-term analysis for subjects who first received 2.5, 5, or 10 mg ambrisentan in the prior studies. The Screening/Randomization Visit of the present extension study defined the baseline for subjects who received placebo in the 2 prior studies.|participants|Number|65|65.0||||||
4274514|NCT00578786|4098328|B2|Caucasian||Race/Ethnicity, Customized|Baseline data values established at the screening/randomization visit of the 2 prior (parent) studies defined the baseline of this long-term analysis for subjects who first received 2.5, 5, or 10 mg ambrisentan in the prior studies. The Screening/Randomization Visit of the present extension study defined the baseline for subjects who received placebo in the 2 prior studies.|participants|Number|148|148.0||||||
4274515|NCT00578786|4098329|B1|Caucasian||Race/Ethnicity, Customized|Baseline data values established at the screening/randomization visit of the 2 prior (parent) studies defined the baseline of this long-term analysis for subjects who first received 2.5, 5, or 10 mg ambrisentan in the prior studies. The Screening/Randomization Visit of the present extension study defined the baseline for subjects who received placebo in the 2 prior studies.|participants|Number|81|81.0||||||
4274522|NCT00578786|4098328|B2||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4274523|NCT00578786|4098329|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4274524|NCT00578786|4098326|B4|||Age|Baseline data values established at the screening/randomization visit of the 2 prior (parent) studies defined the baseline of this long-term analysis for subjects who first received 2.5, 5, or 10 mg ambrisentan in the prior studies. The Screening/Randomization Visit of the present extension study defined the baseline for subjects who received placebo in the 2 prior studies.|years|Mean|51.06|51.06|Standard Deviation|15.139|15.139|||
4274525|NCT00578786|4098327|B3|||Age|Baseline data values established at the screening/randomization visit of the 2 prior (parent) studies defined the baseline of this long-term analysis for subjects who first received 2.5, 5, or 10 mg ambrisentan in the prior studies. The Screening/Randomization Visit of the present extension study defined the baseline for subjects who received placebo in the 2 prior studies.|years|Mean|49.09|49.09|Standard Deviation|16.572|16.572|||
4274526|NCT00578786|4098328|B2|||Age|Baseline data values established at the screening/randomization visit of the 2 prior (parent) studies defined the baseline of this long-term analysis for subjects who first received 2.5, 5, or 10 mg ambrisentan in the prior studies. The Screening/Randomization Visit of the present extension study defined the baseline for subjects who received placebo in the 2 prior studies.|years|Mean|51.46|51.46|Standard Deviation|14.429|14.429|||
4274527|NCT00578786|4098329|B1|||Age|Baseline data values established at the screening/randomization visit of the 2 prior (parent) studies defined the baseline of this long-term analysis for subjects who first received 2.5, 5, or 10 mg ambrisentan in the prior studies. The Screening/Randomization Visit of the present extension study defined the baseline for subjects who received placebo in the 2 prior studies.|years|Mean|52.27|52.27|Standard Deviation|14.968|14.968|||
4274528|NCT00578734|4098410|B3|Chile||Region of Enrollment||participants|Number|110|110.0||||||
4274529|NCT00578734|4098411|B2|Chile||Region of Enrollment||participants|Number|54|54.0||||||
4274530|NCT00578734|4098412|B1|Chile||Region of Enrollment||participants|Number|56|56.0||||||
4274531|NCT00578734|4098410|B3|United States||Region of Enrollment||participants|Number|55|55.0||||||
4274532|NCT00578734|4098411|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4274533|NCT00578734|4098412|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4274534|NCT00578734|4098410|B3||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4274535|NCT00578734|4098411|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4274536|NCT00578734|4098412|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4274537|NCT00578734|4098410|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4274538|NCT00578734|4098411|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4274539|NCT00578734|4098412|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4274540|NCT00578734|4098410|B3|||Age||years|Mean|0.45|0.45|Standard Deviation|0.43|0.43|||
4274541|NCT00578734|4098411|B2|||Age||years|Mean|0.45|0.45|Standard Deviation|0.43|0.43|||
4274542|NCT00578734|4098412|B1|||Age||years|Mean|0.44|0.44|Standard Deviation|0.43|0.43|||
4274543|NCT00578734|4098410|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4274544|NCT00578734|4098411|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4274545|NCT00578734|4098412|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4274546|NCT00578734|4098410|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4274547|NCT00578734|4098411|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4274548|NCT00578734|4098412|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4274549|NCT00578734|4098410|B3||<=18 years|Age||Participants|Count of Participants|165|165.0||||||
4274550|NCT00578734|4098411|B2||<=18 years|Age||Participants|Count of Participants|81|81.0||||||
4274551|NCT00578734|4098412|B1||<=18 years|Age||Participants|Count of Participants|84|84.0||||||
4274552|NCT00578669|4098421|B3|||Single major depressive disorder (MDD) episode||Participants|Count of Participants|14|14.0||||||
4274553|NCT00578669|4098422|B2|||Single major depressive disorder (MDD) episode||Participants|Count of Participants|7|7.0||||||
4274554|NCT00578669|4098423|B1|||Single major depressive disorder (MDD) episode||Participants|Count of Participants|7|7.0||||||
4274555|NCT00578669|4098421|B3|||Recurrent major depressive disorder (MDD)||Participants|Count of Participants|34|34.0||||||
4274556|NCT00578669|4098422|B2|||Recurrent major depressive disorder (MDD)||Participants|Count of Participants|16|16.0||||||
4274557|NCT00578669|4098423|B1|||Recurrent major depressive disorder (MDD)||Participants|Count of Participants|18|18.0||||||
4274558|NCT00578669|4098421|B3|||Center for Epidemiologic Studies - Depression (CES-D) > 16|CES-D consists of 20 items, with total scores on the scale ranging from 0 - 60. Higher scores are indicative of greater levels of depressive symptoms.|Participants|Count of Participants|36|36.0||||||
4274559|NCT00578669|4098422|B2|||Center for Epidemiologic Studies - Depression (CES-D) > 16|CES-D consists of 20 items, with total scores on the scale ranging from 0 - 60. Higher scores are indicative of greater levels of depressive symptoms.|Participants|Count of Participants|21|21.0||||||
4274560|NCT00578669|4098423|B1|||Center for Epidemiologic Studies - Depression (CES-D) > 16|CES-D consists of 20 items, with total scores on the scale ranging from 0 - 60. Higher scores are indicative of greater levels of depressive symptoms.|Participants|Count of Participants|15|15.0||||||
4274561|NCT00578669|4098421|B3|||Center for Epidemiologic Studies - Depression (CES-D) scale|CES-D consists of 20 items, with total scores on the scale ranging from 0 - 60. Higher scores are indicative of greater levels of depressive symptoms.|units on a scale|Mean|9.77|9.77|Standard Deviation|8.31|8.31|||
4274562|NCT00578669|4098422|B2|||Center for Epidemiologic Studies - Depression (CES-D) scale|CES-D consists of 20 items, with total scores on the scale ranging from 0 - 60. Higher scores are indicative of greater levels of depressive symptoms.|units on a scale|Mean|9.90|9.9|Standard Deviation|8.14|8.14|||
4274615|NCT00578643|4098432|B1|Race/Ethnicity|Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4274563|NCT00578669|4098423|B1|||Center for Epidemiologic Studies - Depression (CES-D) scale|CES-D consists of 20 items, with total scores on the scale ranging from 0 - 60. Higher scores are indicative of greater levels of depressive symptoms.|units on a scale|Mean|9.64|9.64|Standard Deviation|8.53|8.53|||
4274564|NCT00578669|4098421|B3|||Fagerstrom Test for Nicotine Dependence (FTND)|Scale can be scored on a range of 0 - 10. Higher scores signify greater levels of nicotine dependence.|units on a scale|Mean|5.66|5.66|Standard Deviation|2.08|2.08|||
4274565|NCT00578669|4098422|B2|||Fagerstrom Test for Nicotine Dependence (FTND)|Scale can be scored on a range of 0 - 10. Higher scores signify greater levels of nicotine dependence.|units on a scale|Mean|5.90|5.9|Standard Deviation|1.74|1.74|||
4274566|NCT00578669|4098423|B1|||Fagerstrom Test for Nicotine Dependence (FTND)|Scale can be scored on a range of 0 - 10. Higher scores signify greater levels of nicotine dependence.|units on a scale|Mean|5.40|5.4|Standard Deviation|2.37|2.37|||
4274567|NCT00578669|4098421|B3|||Cigarettes smoked per day (past month)||cigarettes|Mean|21.01|21.01|Standard Deviation|9.7|9.7|||
4274568|NCT00578669|4098422|B2|||Cigarettes smoked per day (past month)||cigarettes|Mean|20.96|20.96|Standard Deviation|10.33|10.33|||
4274569|NCT00578669|4098423|B1|||Cigarettes smoked per day (past month)||cigarettes|Mean|21.07|21.07|Standard Deviation|9.03|9.03|||
4274570|NCT00578669|4098421|B3|United States||Region of Enrollment||participants|Number|206|206.0||||||
4274571|NCT00578669|4098422|B2|United States||Region of Enrollment||participants|Number|107|107.0||||||
4274572|NCT00578669|4098423|B1|United States||Region of Enrollment||participants|Number|99|99.0||||||
4274573|NCT00578669|4098421|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4274574|NCT00578669|4098422|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4274575|NCT00578669|4098423|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4274576|NCT00578669|4098421|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4274577|NCT00578669|4098422|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4274578|NCT00578669|4098423|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4274579|NCT00578669|4098421|B3||White|Race (NIH/OMB)||Participants|Count of Participants|188|188.0||||||
4274580|NCT00578669|4098422|B2||White|Race (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
4274581|NCT00578669|4098423|B1||White|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
4274582|NCT00578669|4098421|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4274583|NCT00578669|4098422|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4274584|NCT00578669|4098423|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4274585|NCT00578669|4098421|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4274586|NCT00578669|4098422|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4274587|NCT00578669|4098423|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4274588|NCT00578669|4098421|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4274589|NCT00578669|4098422|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4274590|NCT00578669|4098423|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4274591|NCT00578669|4098421|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4274592|NCT00578669|4098422|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4274593|NCT00578669|4098423|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4274594|NCT00578669|4098421|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4274595|NCT00578669|4098422|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4274596|NCT00578669|4098423|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4274597|NCT00578669|4098421|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|203|203.0||||||
4274598|NCT00578669|4098422|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
4274599|NCT00578669|4098423|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
4274600|NCT00578669|4098421|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4274601|NCT00578669|4098422|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4274602|NCT00578669|4098423|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4274603|NCT00578669|4098421|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4274604|NCT00578669|4098422|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4274605|NCT00578669|4098423|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4274606|NCT00578669|4098421|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4274607|NCT00578669|4098422|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4274608|NCT00578669|4098423|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4274609|NCT00578669|4098421|B3|||Age||years|Mean|43.54|43.54|Standard Deviation|11.16|11.16|||
4274610|NCT00578669|4098422|B2|||Age||years|Mean|43.07|43.07|Standard Deviation|10.97|10.97|||
4274611|NCT00578669|4098423|B1|||Age||years|Mean|44.05|44.05|Standard Deviation|11.40|11.4|||
4274612|NCT00578643|4098432|B1|Race/Ethnicity|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4274613|NCT00578643|4098432|B1|Race/Ethnicity|Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4274614|NCT00578643|4098432|B1|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4274616|NCT00578643|4098432|B1|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4274617|NCT00578643|4098432|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4274618|NCT00578643|4098432|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4274619|NCT00578643|4098432|B1|||Age||years|Median|6|6.0|Inter-Quartile Range|||2.0|10.0|
4274620|NCT00578617|4098439|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4274621|NCT00578617|4098440|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4274622|NCT00578617|4098441|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4274623|NCT00578617|4098439|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4274624|NCT00578617|4098440|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4274625|NCT00578617|4098441|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4274626|NCT00578617|4098439|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4274627|NCT00578617|4098440|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4274628|NCT00578617|4098441|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4274629|NCT00578617|4098439|B3|||Age||years|Mean|61.2|61.2|Standard Deviation|10.47|10.47|||
4274630|NCT00578617|4098440|B2|||Age||years|Mean|60.3|60.3|Standard Deviation|11.46|11.46|||
4274631|NCT00578617|4098441|B1|||Age||years|Mean|62.1|62.1|Standard Deviation|9.57|9.57|||
4274632|NCT00578617|4098439|B3||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4274633|NCT00578617|4098440|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4274634|NCT00578617|4098441|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4274635|NCT00578617|4098439|B3||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4274636|NCT00578617|4098440|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4274637|NCT00578617|4098441|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4274638|NCT00578617|4098439|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4274639|NCT00578617|4098440|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4274640|NCT00578617|4098441|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4274641|NCT00578565|4098448|B1|Usual Interstitial Pneumonia (UIP)||Histological subtypes of RA-ILD||participants|Number|4|4.0||||||
4274642|NCT00578565|4098448|B1|Nonspecific Interstitial Pneumonia (NSIP)||Histological subtypes of RA-ILD||participants|Number|6|6.0||||||
4274643|NCT00578565|4098448|B1|||Duration of Interstitial Lung Disease (ILD)||Years|Mean|3.2|3.2|Full Range|||0.0|7.5|
4274644|NCT00578565|4098448|B1|||Duration of Rheumatoid Arthritis (RA)||Years|Mean|13.8|13.8|Full Range|||0.4|44.0|
4274645|NCT00578565|4098448|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4274646|NCT00578565|4098448|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4274647|NCT00578565|4098448|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4274648|NCT00578565|4098448|B1|||Age||years|Mean|64.7|64.7|Full Range|||43.0|80.0|
4274649|NCT00578552|4098457|B4|||Cigarettes per day|Self Reported average number of cigarettes smoked per day in the preceeding 6 months prior to study enrollment.|cigarettes per day|Mean|21.5|21.5|Standard Deviation|7.2|7.2|||
4274650|NCT00578552|4098458|B3|||Cigarettes per day|Self Reported average number of cigarettes smoked per day in the preceeding 6 months prior to study enrollment.|cigarettes per day|Mean|20.9|20.9|Standard Deviation|7.9|7.9|||
4274651|NCT00578552|4098459|B2|||Cigarettes per day|Self Reported average number of cigarettes smoked per day in the preceeding 6 months prior to study enrollment.|cigarettes per day|Mean|23.7|23.7|Standard Deviation|6.9|6.9|||
4274652|NCT00578552|4098460|B1|||Cigarettes per day|Self Reported average number of cigarettes smoked per day in the preceeding 6 months prior to study enrollment.|cigarettes per day|Mean|20.0|20.0|Standard Deviation|6.6|6.6|||
4274653|NCT00578552|4098457|B4||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4274654|NCT00578552|4098458|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4274655|NCT00578552|4098459|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4274656|NCT00578552|4098460|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4274657|NCT00578552|4098457|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4274658|NCT00578552|4098458|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4274659|NCT00578552|4098459|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4274660|NCT00578552|4098460|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4274661|NCT00578552|4098457|B4|||Age||years|Mean|40.9|40.9|Standard Deviation|11.3|11.3|||
4274662|NCT00578552|4098458|B3|||Age||years|Mean|40.7|40.7|Standard Deviation|13.5|13.5|||
4274663|NCT00578552|4098459|B2|||Age||years|Mean|41.1|41.1|Standard Deviation|9.5|9.5|||
4274664|NCT00578552|4098460|B1|||Age||years|Mean|41.0|41.0|Standard Deviation|11.1|11.1|||
4274665|NCT00578552|4098457|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4274666|NCT00578552|4098458|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4274667|NCT00578552|4098459|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4274668|NCT00578552|4098460|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4274669|NCT00578552|4098457|B4||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4274670|NCT00578552|4098458|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4274671|NCT00578552|4098459|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4274672|NCT00578552|4098460|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4274673|NCT00578552|4098457|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4274674|NCT00578552|4098458|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4274675|NCT00578552|4098459|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4274676|NCT00578552|4098460|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4274677|NCT00578539|4098470|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4274678|NCT00578539|4098470|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4274679|NCT00578539|4098470|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4274680|NCT00578539|4098470|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4274681|NCT00578539|4098470|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4274682|NCT00578539|4098470|B1||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
4274683|NCT00578539|4098470|B1|||Age||years|Mean|10.0|10.0|Standard Deviation|4.9|4.9|||
4274684|NCT00578461|4098474|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4274685|NCT00578461|4098474|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4274686|NCT00578461|4098474|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4274687|NCT00578461|4098474|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4274688|NCT00578461|4098474|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4274689|NCT00578461|4098474|B1||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
4274690|NCT00578461|4098474|B1|||Age||years|Mean|9.7|9.7|Standard Deviation|4.5|4.5|||
4274691|NCT00578448|4098478|B1|||Weight||kilograms|Mean|74.90|74.9|Standard Deviation|17.735|17.735|||
4274692|NCT00578448|4098478|B1|Argentina||Region of Enrollment||participants|Number|2|2.0||||||
4274693|NCT00578448|4098478|B1|Mexico||Region of Enrollment||participants|Number|6|6.0||||||
4274694|NCT00578448|4098478|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4274695|NCT00578448|4098478|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4274696|NCT00578448|4098478|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4274697|NCT00578448|4098478|B1|||Age||years|Mean|48.7|48.7|Standard Deviation|19.05|19.05|||
4274698|NCT00578448|4098478|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4274699|NCT00578448|4098478|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4274700|NCT00578448|4098478|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4274701|NCT00578383|4098492|B5|United States||Region of Enrollment||participants|Number|107|107.0||||||
4274702|NCT00578383|4098493|B4|United States||Region of Enrollment||participants|Number|15|15.0||||||
4274703|NCT00578383|4098494|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4274704|NCT00578383|4098495|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
4274705|NCT00578383|4098496|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4274706|NCT00578383|4098492|B5||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4274707|NCT00578383|4098493|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4274708|NCT00578383|4098494|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4274709|NCT00578383|4098495|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4274710|NCT00578383|4098496|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4274711|NCT00578383|4098492|B5||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4274712|NCT00578383|4098493|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4274713|NCT00578383|4098494|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4274714|NCT00578383|4098495|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4274715|NCT00578383|4098496|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4274716|NCT00578383|4098492|B5|||Age||years|Mean|42.9|42.9|Standard Deviation|13.3|13.3|||
4274717|NCT00578383|4098493|B4|||Age||years|Mean|43.5|43.5|Standard Deviation|14.9|14.9|||
4274718|NCT00578383|4098494|B3|||Age||years|Mean|43.1|43.1|Standard Deviation|15.5|15.5|||
4274719|NCT00578383|4098495|B2|||Age||years|Mean|42.2|42.2|Standard Deviation|12.2|12.2|||
4274720|NCT00578383|4098496|B1|||Age||years|Mean|42.6|42.6|Standard Deviation|13.0|13.0|||
4274721|NCT00578383|4098492|B5||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4274722|NCT00578383|4098493|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4274723|NCT00578383|4098494|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4274724|NCT00578383|4098495|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4274725|NCT00578383|4098496|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4274726|NCT00578383|4098492|B5||Between 18 and 65 years|Age||Participants|Count of Participants|106|106.0||||||
4274727|NCT00578383|4098493|B4||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4274728|NCT00578383|4098494|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4274729|NCT00578383|4098495|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4274730|NCT00578383|4098496|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4274731|NCT00578383|4098492|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4274732|NCT00578383|4098493|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4274733|NCT00578383|4098494|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4274734|NCT00578383|4098495|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4274735|NCT00578383|4098496|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4274736|NCT00578331|4098529|B3||Male|Sex: Female, Male||Participants|Count of Participants|312|312.0||||||
4274737|NCT00578331|4098530|B2||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4274738|NCT00578331|4098531|B1||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4274739|NCT00578331|4098529|B3||Female|Sex: Female, Male||Participants|Count of Participants|578|578.0||||||
4274740|NCT00578331|4098530|B2||Female|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
4274741|NCT00578331|4098531|B1||Female|Sex: Female, Male||Participants|Count of Participants|296|296.0||||||
4274742|NCT00578331|4098529|B3||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4274743|NCT00578331|4098530|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4274744|NCT00578331|4098531|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4274745|NCT00578331|4098529|B3||Between 18 and 65 years|Age||Participants|Count of Participants|771|771.0||||||
4274746|NCT00578331|4098530|B2||Between 18 and 65 years|Age||Participants|Count of Participants|388|388.0||||||
4274747|NCT00578331|4098531|B1||Between 18 and 65 years|Age||Participants|Count of Participants|383|383.0||||||
4274748|NCT00578331|4098529|B3||<=18 years|Age||Participants|Count of Participants|99|99.0||||||
4274749|NCT00578331|4098530|B2||<=18 years|Age||Participants|Count of Participants|46|46.0||||||
4274750|NCT00578331|4098531|B1||<=18 years|Age||Participants|Count of Participants|53|53.0||||||
4274751|NCT00578318|4098540|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4274752|NCT00578318|4098541|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4274753|NCT00578318|4098542|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4274754|NCT00578318|4098540|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4274755|NCT00578318|4098541|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4274756|NCT00578318|4098542|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4274757|NCT00578318|4098540|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4274758|NCT00578318|4098541|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4274759|NCT00578318|4098542|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4274760|NCT00578318|4098540|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4274761|NCT00578318|4098541|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4274762|NCT00578318|4098542|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4274763|NCT00578318|4098540|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4274764|NCT00578318|4098541|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4274765|NCT00578318|4098542|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4274766|NCT00578318|4098540|B3||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4274767|NCT00578318|4098541|B2||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4274768|NCT00578318|4098542|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4274769|NCT00578305|4098549|B4||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4274770|NCT00578305|4098550|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4274771|NCT00578305|4098551|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4274772|NCT00578305|4098552|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4274773|NCT00578305|4098549|B4||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4274774|NCT00578305|4098550|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4274775|NCT00578305|4098551|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4274776|NCT00578305|4098552|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4274777|NCT00578305|4098549|B4|||Age||years|Mean|49.9|49.9|Standard Deviation|11.54|11.54|||
4274778|NCT00578305|4098550|B3|||Age||years|Mean|50.3|50.3|Standard Deviation|11.94|11.94|||
4274779|NCT00578305|4098551|B2|||Age||years|Mean|50.7|50.7|Standard Deviation|11.65|11.65|||
4274780|NCT00578305|4098552|B1|||Age||years|Mean|48.7|48.7|Standard Deviation|11.10|11.1|||
4274781|NCT00578279|4098613|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4274782|NCT00578279|4098614|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4274783|NCT00578279|4098615|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4274784|NCT00578279|4098613|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4274785|NCT00578279|4098614|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4274786|NCT00578279|4098615|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4274787|NCT00578279|4098613|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4274788|NCT00578279|4098614|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4274789|NCT00578279|4098615|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4274790|NCT00578279|4098613|B3|||Age||years|Mean|64|64.0|Standard Deviation|12|12.0|||
4274791|NCT00578279|4098614|B2|||Age||years|Mean|63|63.0|Standard Deviation|10|10.0|||
4274792|NCT00578279|4098615|B1|||Age||years|Mean|66|66.0|Standard Deviation|14|14.0|||
4274793|NCT00578227|4098622|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4274794|NCT00578227|4098623|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4274795|NCT00578227|4098624|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4274796|NCT00578227|4098625|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4274797|NCT00578227|4098622|B4||Female|Sex: Female, Male||Participants|Count of Participants|813|813.0||||||
4274798|NCT00578227|4098623|B3||Female|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
4274799|NCT00578227|4098624|B2||Female|Sex: Female, Male||Participants|Count of Participants|270|270.0||||||
4274800|NCT00578227|4098625|B1||Female|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
4274801|NCT00578227|4098622|B4|||Age||years|Mean|11.2|11.2|Standard Deviation|2.01|2.01|||
4274802|NCT00578227|4098623|B3|||Age||years|Mean|11.2|11.2|Standard Deviation|1.99|1.99|||
4274803|NCT00578227|4098624|B2|||Age||years|Mean|11.2|11.2|Standard Deviation|2.02|2.02|||
4274804|NCT00578227|4098625|B1|||Age||years|Mean|11.2|11.2|Standard Deviation|2.04|2.04|||
4274805|NCT00578214|4098697|B4|Basal Cell and Squamous Cell Carcinomas||Type of Non-melanoma Skin Cancer||participants|Number|2|2.0||||||
4274806|NCT00578214|4098698|B3|Basal Cell and Squamous Cell Carcinomas||Type of Non-melanoma Skin Cancer||participants|Number|1|1.0||||||
4274807|NCT00578214|4098699|B2|Basal Cell and Squamous Cell Carcinomas||Type of Non-melanoma Skin Cancer||participants|Number|1|1.0||||||
4274808|NCT00578214|4098700|B1|Basal Cell and Squamous Cell Carcinomas||Type of Non-melanoma Skin Cancer||participants|Number|0|0.0||||||
4274809|NCT00578214|4098697|B4|Squamous Cell Carcinoma||Type of Non-melanoma Skin Cancer||participants|Number|27|27.0||||||
4274810|NCT00578214|4098698|B3|Squamous Cell Carcinoma||Type of Non-melanoma Skin Cancer||participants|Number|8|8.0||||||
4274811|NCT00578214|4098699|B2|Squamous Cell Carcinoma||Type of Non-melanoma Skin Cancer||participants|Number|10|10.0||||||
4274812|NCT00578214|4098700|B1|Squamous Cell Carcinoma||Type of Non-melanoma Skin Cancer||participants|Number|9|9.0||||||
4274813|NCT00578214|4098697|B4|Basal Cell Carcinoma||Type of Non-melanoma Skin Cancer||participants|Number|46|46.0||||||
4274814|NCT00578214|4098698|B3|Basal Cell Carcinoma||Type of Non-melanoma Skin Cancer||participants|Number|22|22.0||||||
4274815|NCT00578214|4098699|B2|Basal Cell Carcinoma||Type of Non-melanoma Skin Cancer||participants|Number|11|11.0||||||
4274816|NCT00578214|4098700|B1|Basal Cell Carcinoma||Type of Non-melanoma Skin Cancer||participants|Number|13|13.0||||||
4274817|NCT00578214|4098697|B4|Unknown||Prior Mohs Micrographic Surgery||participants|Number|3|3.0||||||
4274818|NCT00578214|4098698|B3|Unknown||Prior Mohs Micrographic Surgery||participants|Number|1|1.0||||||
4274819|NCT00578214|4098699|B2|Unknown||Prior Mohs Micrographic Surgery||participants|Number|1|1.0||||||
4274820|NCT00578214|4098700|B1|Unknown||Prior Mohs Micrographic Surgery||participants|Number|1|1.0||||||
4274821|NCT00578214|4098697|B4|Yes||Prior Mohs Micrographic Surgery||participants|Number|18|18.0||||||
4274822|NCT00578214|4098698|B3|Yes||Prior Mohs Micrographic Surgery||participants|Number|9|9.0||||||
4274823|NCT00578214|4098699|B2|Yes||Prior Mohs Micrographic Surgery||participants|Number|4|4.0||||||
4274824|NCT00578214|4098700|B1|Yes||Prior Mohs Micrographic Surgery||participants|Number|5|5.0||||||
4274825|NCT00578214|4098697|B4|No||Prior Mohs Micrographic Surgery||participants|Number|54|54.0||||||
4274826|NCT00578214|4098698|B3|No||Prior Mohs Micrographic Surgery||participants|Number|21|21.0||||||
4274827|NCT00578214|4098699|B2|No||Prior Mohs Micrographic Surgery||participants|Number|17|17.0||||||
4274828|NCT00578214|4098700|B1|No||Prior Mohs Micrographic Surgery||participants|Number|16|16.0||||||
4274829|NCT00578214|4098697|B4|||Weight at study entry||kg|Mean|84.3|84.3|Standard Deviation|16.2|16.2|||
4274830|NCT00578214|4098698|B3|||Weight at study entry||kg|Mean|87.8|87.8|Standard Deviation|20.16|20.16|||
4274831|NCT00578214|4098699|B2|||Weight at study entry||kg|Mean|80.6|80.6|Standard Deviation|11.82|11.82|||
4274832|NCT00578214|4098700|B1|||Weight at study entry||kg|Mean|83.1|83.1|Standard Deviation|13.23|13.23|||
4274833|NCT00578214|4098697|B4|United States||Region of Enrollment||participants|Number|75|75.0||||||
4274834|NCT00578214|4098698|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4274835|NCT00578214|4098699|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4274836|NCT00578214|4098700|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4274837|NCT00578214|4098697|B4||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4274838|NCT00578214|4098698|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4274839|NCT00578214|4098699|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4274840|NCT00578214|4098700|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4274841|NCT00578214|4098697|B4||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4274842|NCT00578214|4098698|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4274843|NCT00578214|4098699|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4274844|NCT00578214|4098700|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4274845|NCT00578214|4098697|B4|||Age||years|Mean|67.7|67.7|Standard Deviation|13.4|13.4|||
4274846|NCT00578214|4098698|B3|||Age||years|Mean|62.9|62.9|Standard Deviation|14.1|14.1|||
4274847|NCT00578214|4098699|B2|||Age||years|Mean|70.1|70.1|Standard Deviation|12.8|12.8|||
4274848|NCT00578214|4098700|B1|||Age||years|Mean|71.9|71.9|Standard Deviation|11.5|11.5|||
4274849|NCT00578175|4098749|B4||Male|Sex: Female, Male||Participants|Count of Participants|895|895.0||||||
4274850|NCT00578175|4098750|B3||Male|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4274851|NCT00578175|4098751|B2||Male|Sex: Female, Male||Participants|Count of Participants|343|343.0||||||
4274852|NCT00578175|4098752|B1||Male|Sex: Female, Male||Participants|Count of Participants|349|349.0||||||
4274853|NCT00578175|4098749|B4||Female|Sex: Female, Male||Participants|Count of Participants|888|888.0||||||
4274854|NCT00578175|4098750|B3||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4274855|NCT00578175|4098751|B2||Female|Sex: Female, Male||Participants|Count of Participants|346|346.0||||||
4274856|NCT00578175|4098752|B1||Female|Sex: Female, Male||Participants|Count of Participants|356|356.0||||||
4274857|NCT00578175|4098749|B4|||Age||months|Mean|12.3|12.3|Standard Deviation|0.59|0.59|||
4274858|NCT00578175|4098750|B3|||Age||months|Mean|12.3|12.3|Standard Deviation|0.61|0.61|||
4274859|NCT00578175|4098751|B2|||Age||months|Mean|12.3|12.3|Standard Deviation|0.59|0.59|||
4274860|NCT00578175|4098752|B1|||Age||months|Mean|12.3|12.3|Standard Deviation|0.58|0.58|||
4274861|NCT00578136|4098831|B3|United States||Region of Enrollment||participants|Number|52|52.0||||||
4274862|NCT00578136|4098832|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4274863|NCT00578136|4098833|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4274864|NCT00578136|4098831|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4274865|NCT00578136|4098832|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4274866|NCT00578136|4098833|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4274867|NCT00578136|4098831|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4274868|NCT00578136|4098832|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4274869|NCT00578136|4098833|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4274870|NCT00578136|4098831|B3|||Age||years|Mean|7.8|7.8|Standard Deviation|.88|0.88|||
4274871|NCT00578136|4098832|B2|||Age||years|Mean|7.9|7.9|Standard Deviation|.88|0.88|||
4274872|NCT00578136|4098833|B1|||Age||years|Mean|7.7|7.7|Standard Deviation|.88|0.88|||
4274873|NCT00578136|4098831|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4274874|NCT00578136|4098832|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4274875|NCT00578136|4098833|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4274876|NCT00578136|4098831|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4274877|NCT00578136|4098832|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4274878|NCT00578136|4098833|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4274879|NCT00578136|4098831|B3||<=18 years|Age||Participants|Count of Participants|52|52.0||||||
4274880|NCT00578136|4098832|B2||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
4274881|NCT00578136|4098833|B1||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
4274882|NCT00578071|4098842|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4274883|NCT00578071|4098842|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4274884|NCT00578071|4098842|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4274885|NCT00578071|4098842|B1|||Age||years|Mean|58.97|58.97|Standard Deviation|10.32|10.32|||
4274886|NCT00578071|4098842|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4274887|NCT00578071|4098842|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4274888|NCT00578071|4098842|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4274889|NCT00577889|4098849|B4|United States||Region of Enrollment||participants|Number|20|20.0||||||
4274890|NCT00577889|4098850|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4274891|NCT00577889|4098851|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4274892|NCT00577889|4098852|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4274893|NCT00577889|4098849|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4274894|NCT00577889|4098850|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4274895|NCT00577889|4098851|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4274896|NCT00577889|4098852|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4274897|NCT00577889|4098849|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4274898|NCT00577889|4098850|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4274899|NCT00577889|4098851|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4274900|NCT00577889|4098852|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4274901|NCT00577889|4098849|B4|||Age||years|Median|61.5|61.5|Full Range|||51.0|81.0|
4274902|NCT00577889|4098850|B3|||Age||years|Median|67|67.0|Full Range|||55.0|75.0|
4274903|NCT00577889|4098851|B2|||Age||years|Median|71|71.0|Full Range|||51.0|81.0|
4274904|NCT00577889|4098852|B1|||Age||years|Median|59|59.0|Full Range|||51.0|77.0|
4274905|NCT00577863|4098871|B3|||Duration of Prior Forteo 1.1 Pen Experience||weeks|Mean|31.2|31.2|Standard Deviation|23.78|23.78|||
4274906|NCT00577863|4098872|B2|||Duration of Prior Forteo 1.1 Pen Experience||weeks|Mean|12.9|12.9|Standard Deviation|16.33|16.33|||
4274907|NCT00577863|4098873|B1|||Duration of Prior Forteo 1.1 Pen Experience||weeks|Mean|36.5|36.5|Standard Deviation|23.01|23.01|||
4274908|NCT00577863|4098871|B3|East Asian||Race/Ethnicity||participants|Number|4|4.0||||||
4274909|NCT00577863|4098872|B2|East Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4274910|NCT00577863|4098873|B1|East Asian||Race/Ethnicity||participants|Number|3|3.0||||||
4274911|NCT00577863|4098871|B3|Hispanic||Race/Ethnicity||participants|Number|3|3.0||||||
4274912|NCT00577863|4098872|B2|Hispanic||Race/Ethnicity||participants|Number|1|1.0||||||
4274913|NCT00577863|4098873|B1|Hispanic||Race/Ethnicity||participants|Number|2|2.0||||||
4274914|NCT00577863|4098871|B3|African||Race/Ethnicity||participants|Number|1|1.0||||||
4274915|NCT00577863|4098872|B2|African||Race/Ethnicity||participants|Number|1|1.0||||||
4274916|NCT00577863|4098873|B1|African||Race/Ethnicity||participants|Number|0|0.0||||||
4274917|NCT00577863|4098871|B3|Caucasian||Race/Ethnicity||participants|Number|191|191.0||||||
4274918|NCT00577863|4098872|B2|Caucasian||Race/Ethnicity||participants|Number|104|104.0||||||
4274919|NCT00577863|4098873|B1|Caucasian||Race/Ethnicity||participants|Number|87|87.0||||||
4274920|NCT00577863|4098871|B3|No||Previous Teriparatide Use||participants|Number|80|80.0||||||
4274921|NCT00577863|4098872|B2|No||Previous Teriparatide Use||participants|Number|80|80.0||||||
4274922|NCT00577863|4098873|B1|No||Previous Teriparatide Use||participants|Number|0|0.0||||||
4274923|NCT00577863|4098871|B3|Yes||Previous Teriparatide Use||participants|Number|119|119.0||||||
4274924|NCT00577863|4098872|B2|Yes||Previous Teriparatide Use||participants|Number|27|27.0||||||
4274925|NCT00577863|4098873|B1|Yes||Previous Teriparatide Use||participants|Number|92|92.0||||||
4274926|NCT00577863|4098871|B3|United States||Region of Enrollment||participants|Number|199|199.0||||||
4274927|NCT00577863|4098872|B2|United States||Region of Enrollment||participants|Number|107|107.0||||||
4274928|NCT00577863|4098873|B1|United States||Region of Enrollment||participants|Number|92|92.0||||||
4274929|NCT00577863|4098871|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4274930|NCT00577863|4098872|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4274931|NCT00577863|4098873|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4274932|NCT00577863|4098871|B3||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4274933|NCT00577863|4098872|B2||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4274934|NCT00577863|4098873|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4274935|NCT00577863|4098871|B3|||Age||years|Mean|67.9|67.9|Standard Deviation|11.30|11.3|||
4274936|NCT00577863|4098872|B2|||Age||years|Mean|68.5|68.5|Standard Deviation|11.54|11.54|||
4274937|NCT00577863|4098873|B1|||Age||years|Mean|67.1|67.1|Standard Deviation|11.01|11.01|||
4274938|NCT00577824|4098913|B4||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4274939|NCT00577824|4098914|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4274940|NCT00577824|4098915|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4274941|NCT00577824|4098916|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4274942|NCT00577824|4098913|B4||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4274943|NCT00577824|4098914|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4274944|NCT00577824|4098915|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4274945|NCT00577824|4098916|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4274946|NCT00577824|4098913|B4|||Age||years|Mean|58.4|58.4|Standard Deviation|9.94|9.94|||
4274947|NCT00577824|4098914|B3|||Age||years|Mean|56.3|56.3|Standard Deviation|11.41|11.41|||
4274948|NCT00577824|4098915|B2|||Age||years|Mean|59.4|59.4|Standard Deviation|9.75|9.75|||
4274949|NCT00577824|4098916|B1|||Age||years|Mean|58.5|58.5|Standard Deviation|9.33|9.33|||
4274950|NCT00577824|4098913|B4||>=65 years|Age||Participants|Count of Participants|53|53.0||||||
4274951|NCT00577824|4098914|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4274952|NCT00577824|4098915|B2||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4274953|NCT00577824|4098916|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4274954|NCT00577824|4098913|B4||Between 18 and 65 years|Age||Participants|Count of Participants|126|126.0||||||
4274955|NCT00577824|4098914|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4274956|NCT00577824|4098915|B2||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4274957|NCT00577824|4098916|B1||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4274958|NCT00577824|4098913|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4274959|NCT00577824|4098914|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4274960|NCT00577824|4098915|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4274961|NCT00577824|4098916|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4274962|NCT00577772|4098974|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4274963|NCT00577772|4098975|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4274964|NCT00577772|4098976|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4274965|NCT00577772|4098974|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4274966|NCT00577772|4098975|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4274967|NCT00577772|4098976|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4274968|NCT00577772|4098974|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4274969|NCT00577772|4098975|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4274970|NCT00577772|4098976|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4274971|NCT00577772|4098974|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4274972|NCT00577772|4098975|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4274973|NCT00577772|4098976|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4274974|NCT00577772|4098974|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4274975|NCT00577772|4098975|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4274976|NCT00577772|4098976|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4274977|NCT00577772|4098974|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4274978|NCT00577772|4098975|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4274979|NCT00577772|4098976|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4274980|NCT00577720|4098983|B5|United States||Region of Enrollment||participants|Number|181|181.0||||||
4274981|NCT00577720|4098984|B4|United States||Region of Enrollment||participants|Number|72|72.0||||||
4274982|NCT00577720|4098985|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4274983|NCT00577720|4098986|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
4274984|NCT00577720|4098987|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4274985|NCT00577720|4098983|B5|Hawaiian/Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4274986|NCT00577720|4098984|B4|Hawaiian/Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4274987|NCT00577720|4098985|B3|Hawaiian/Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4274988|NCT00577720|4098986|B2|Hawaiian/Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4274989|NCT00577720|4098987|B1|Hawaiian/Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4274990|NCT00577720|4098983|B5|Other||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4274991|NCT00577720|4098984|B4|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4274992|NCT00577720|4098985|B3|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4274993|NCT00577720|4098986|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4274994|NCT00577720|4098987|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4274995|NCT00577720|4098983|B5|Multi-Racial||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4274996|NCT00577720|4098984|B4|Multi-Racial||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4274997|NCT00577720|4098985|B3|Multi-Racial||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4274998|NCT00577720|4098986|B2|Multi-Racial||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4274999|NCT00577720|4098987|B1|Multi-Racial||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4275000|NCT00577720|4098983|B5|Caucasian||Race/Ethnicity, Customized||Participants|Number|141|141.0||||||
4275001|NCT00577720|4098984|B4|Caucasian||Race/Ethnicity, Customized||Participants|Number|56|56.0||||||
4275002|NCT00577720|4098985|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|26|26.0||||||
4275003|NCT00577720|4098986|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
4275004|NCT00577720|4098987|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
4275005|NCT00577720|4098983|B5|Black||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4275006|NCT00577720|4098984|B4|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4275007|NCT00577720|4098985|B3|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4275008|NCT00577720|4098986|B2|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4275009|NCT00577720|4098987|B1|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4275010|NCT00577720|4098983|B5|Asian (Oriental)||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
4275011|NCT00577720|4098984|B4|Asian (Oriental)||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4275012|NCT00577720|4098985|B3|Asian (Oriental)||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4275013|NCT00577720|4098986|B2|Asian (Oriental)||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4275014|NCT00577720|4098987|B1|Asian (Oriental)||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4275015|NCT00577720|4098983|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275016|NCT00577720|4098984|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275017|NCT00577720|4098985|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275018|NCT00577720|4098986|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275019|NCT00577720|4098987|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275020|NCT00577720|4098983|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
4275021|NCT00577720|4098984|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4275022|NCT00577720|4098985|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4275023|NCT00577720|4098986|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4275024|NCT00577720|4098987|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4275025|NCT00577720|4098983|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4275026|NCT00577720|4098984|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4275027|NCT00577720|4098985|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4275028|NCT00577720|4098986|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4275029|NCT00577720|4098987|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4275030|NCT00577720|4098983|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4275031|NCT00577720|4098984|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4275032|NCT00577720|4098985|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4275033|NCT00577720|4098986|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4275034|NCT00577720|4098987|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4275035|NCT00577720|4098983|B5||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4275036|NCT00577720|4098984|B4||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4275037|NCT00577720|4098985|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4275038|NCT00577720|4098986|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4275039|NCT00577720|4098987|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4275040|NCT00577720|4098983|B5|||Age||years|Mean|59.9|59.9|Standard Deviation|7.0|7.0|||
4275041|NCT00577720|4098984|B4|||Age||years|Mean|59.7|59.7|Standard Deviation|7.8|7.8|||
4275042|NCT00577720|4098985|B3|||Age||years|Mean|60.0|60.0|Standard Deviation|6.1|6.1|||
4275043|NCT00577720|4098986|B2|||Age||years|Mean|58.9|58.9|Standard Deviation|6.7|6.7|||
4275044|NCT00577720|4098987|B1|||Age||years|Mean|61.1|61.1|Standard Deviation|6.2|6.2|||
4275045|NCT00577707|4099008|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4275046|NCT00577707|4099008|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4275047|NCT00577707|4099008|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4275048|NCT00577707|4099008|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4275049|NCT00577707|4099008|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4275050|NCT00577655|4099014|B3|||Forced Expiratory Volume in One Second (FEV1) on Day 1|Baseline measurement is the average of two Day 1 pre-dose FEV1 values. n=51, 51, 103|liters|Mean|1.50|1.5|Standard Deviation|0.42|0.42|||
4275051|NCT00577655|4099015|B2|||Forced Expiratory Volume in One Second (FEV1) on Day 1|Baseline measurement is the average of two Day 1 pre-dose FEV1 values. n=51, 51, 103|liters|Mean|1.49|1.49|Standard Deviation|0.46|0.46|||
4275052|NCT00577655|4099016|B1|||Forced Expiratory Volume in One Second (FEV1) on Day 1|Baseline measurement is the average of two Day 1 pre-dose FEV1 values. n=51, 51, 103|liters|Mean|1.52|1.52|Standard Deviation|0.38|0.38|||
4275053|NCT00577655|4099014|B3|United States||Region of Enrollment||participants|Number|103|103.0||||||
4275054|NCT00577655|4099015|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
4275055|NCT00577655|4099016|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
4275056|NCT00577655|4099014|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4275057|NCT00577655|4099015|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4275058|NCT00577655|4099016|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4275059|NCT00577655|4099014|B3|North American Indian or Alaska native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4275060|NCT00577655|4099015|B2|North American Indian or Alaska native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4275061|NCT00577655|4099016|B1|North American Indian or Alaska native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4275062|NCT00577655|4099014|B3|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4275063|NCT00577655|4099015|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4275064|NCT00577655|4099016|B1|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4275065|NCT00577655|4099014|B3|Black||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4275066|NCT00577655|4099015|B2|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4275067|NCT00577655|4099016|B1|Black||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4275068|NCT00577655|4099014|B3|White||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
4275069|NCT00577655|4099015|B2|White||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4275070|NCT00577655|4099016|B1|White||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4275071|NCT00577655|4099014|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4275072|NCT00577655|4099015|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4275073|NCT00577655|4099016|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4275074|NCT00577655|4099014|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4275075|NCT00577655|4099015|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4275076|NCT00577655|4099016|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4275077|NCT00577655|4099014|B3|||Age||Years|Mean|8.2|8.2|Standard Deviation|1.95|1.95|||
4275078|NCT00577655|4099015|B2|||Age||Years|Mean|8.2|8.2|Standard Deviation|2.09|2.09|||
4275079|NCT00577655|4099016|B1|||Age||Years|Mean|8.3|8.3|Standard Deviation|1.82|1.82|||
4275080|NCT00577642|4099055|B1|≤ 3 bone lesions||Bone Lesions||participants|Number|9|9.0||||||
4275081|NCT00577642|4099055|B1|> 3 bone lesions||Bone Lesions||participants|Number|20|20.0||||||
4275082|NCT00577642|4099055|B1|No||Autologous Transplant||Participants|Count of Participants|16|16.0||||||
4275083|NCT00577642|4099055|B1|Yes||Autologous Transplant||Participants|Count of Participants|13|13.0||||||
4275084|NCT00577642|4099055|B1|Other||Therapy||participants|Number|5|5.0||||||
4275085|NCT00577642|4099055|B1|Bortezomib + Other||Therapy||participants|Number|10|10.0||||||
4275086|NCT00577642|4099055|B1|Bortezomib + lenalidomide||Therapy||participants|Number|14|14.0||||||
4275087|NCT00577642|4099055|B1|Stage III||ISS Stage|International Staging System (ISS) stage|participants|Number|9|9.0||||||
4275088|NCT00577642|4099055|B1|Stage II||ISS Stage|International Staging System (ISS) stage|participants|Number|9|9.0||||||
4275089|NCT00577642|4099055|B1|Stage I||ISS Stage|International Staging System (ISS) stage|participants|Number|11|11.0||||||
4275090|NCT00577642|4099055|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4275091|NCT00577642|4099055|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4275092|NCT00577642|4099055|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4275093|NCT00577642|4099055|B1|||Age||years|Median|60|60.0|Full Range|||46.0|85.0|
4275094|NCT00577642|4099055|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4275095|NCT00577642|4099055|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4275096|NCT00577642|4099055|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4275097|NCT00577629|4099059|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4275098|NCT00577629|4099059|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4275099|NCT00577629|4099059|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4275100|NCT00577629|4099059|B1|||Age, Customized||Years|Mean|60|60.0|Full Range|||21.0|80.0|
4275101|NCT00577629|4099059|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4275102|NCT00577629|4099059|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4275103|NCT00577629|4099059|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4275104|NCT00577590|4099067|B4|United States||Region of Enrollment||Participants|Count of Participants|78|78.0||||||
4275105|NCT00577590|4099068|B3|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4275106|NCT00577590|4099069|B2|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
4275107|NCT00577590|4099070|B1|United States||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
4275108|NCT00577590|4099067|B4|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4275109|NCT00577590|4099067|B4||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4275110|NCT00577590|4099068|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4275111|NCT00577590|4099069|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4275112|NCT00577590|4099070|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4275113|NCT00577590|4099067|B4||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4275114|NCT00577590|4099068|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4275115|NCT00577590|4099069|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4275116|NCT00577590|4099070|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4275117|NCT00577590|4099067|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4275118|NCT00577590|4099068|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4275119|NCT00577590|4099069|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4275120|NCT00577590|4099070|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4275121|NCT00577590|4099067|B4||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
4275122|NCT00577590|4099068|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4275123|NCT00577590|4099069|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4275124|NCT00577590|4099070|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4275125|NCT00577590|4099067|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4275126|NCT00577590|4099068|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4275127|NCT00577590|4099069|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4275128|NCT00577590|4099070|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4275129|NCT00577512|4099080|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4275130|NCT00577512|4099080|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4275131|NCT00577512|4099080|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4275132|NCT00577512|4099080|B1|||Age||years|Mean|54.3|54.3|Standard Deviation|6.24|6.24|||
4275133|NCT00577512|4099080|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4275134|NCT00577512|4099080|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4275135|NCT00577512|4099080|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4275136|NCT00577473|4099084|B3|Multi-racial/other||Race/Ethnicity, Customized||Partcipants|Number|3|3.0||||||
4275137|NCT00577473|4099085|B2|Multi-racial/other||Race/Ethnicity, Customized||Partcipants|Number|2|2.0||||||
4275138|NCT00577473|4099086|B1|Multi-racial/other||Race/Ethnicity, Customized||Partcipants|Number|1|1.0||||||
4275139|NCT00577473|4099084|B3|Hispanic||Race/Ethnicity, Customized||Partcipants|Number|19|19.0||||||
4275140|NCT00577473|4099085|B2|Hispanic||Race/Ethnicity, Customized||Partcipants|Number|9|9.0||||||
4275141|NCT00577473|4099086|B1|Hispanic||Race/Ethnicity, Customized||Partcipants|Number|10|10.0||||||
4275142|NCT00577473|4099084|B3|Asian (Oriental)||Race/Ethnicity, Customized||Partcipants|Number|1|1.0||||||
4275143|NCT00577473|4099085|B2|Asian (Oriental)||Race/Ethnicity, Customized||Partcipants|Number|0|0.0||||||
4275144|NCT00577473|4099086|B1|Asian (Oriental)||Race/Ethnicity, Customized||Partcipants|Number|1|1.0||||||
4275145|NCT00577473|4099084|B3|Asian (Indian)||Race/Ethnicity, Customized||Partcipants|Number|4|4.0||||||
4275146|NCT00577473|4099085|B2|Asian (Indian)||Race/Ethnicity, Customized||Partcipants|Number|2|2.0||||||
4275147|NCT00577473|4099086|B1|Asian (Indian)||Race/Ethnicity, Customized||Partcipants|Number|2|2.0||||||
4275148|NCT00577473|4099084|B3|Black or African American||Race/Ethnicity, Customized||Partcipants|Number|36|36.0||||||
4275149|NCT00577473|4099085|B2|Black or African American||Race/Ethnicity, Customized||Partcipants|Number|18|18.0||||||
4275150|NCT00577473|4099086|B1|Black or African American||Race/Ethnicity, Customized||Partcipants|Number|18|18.0||||||
4275151|NCT00577473|4099084|B3|Caucasian||Race/Ethnicity, Customized||Partcipants|Number|238|238.0||||||
4275152|NCT00577473|4099085|B2|Caucasian||Race/Ethnicity, Customized||Partcipants|Number|116|116.0||||||
4275153|NCT00577473|4099086|B1|Caucasian||Race/Ethnicity, Customized||Partcipants|Number|122|122.0||||||
4275154|NCT00577473|4099084|B3||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4275155|NCT00577473|4099085|B2||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4275156|NCT00577473|4099086|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4275157|NCT00577473|4099084|B3||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4275158|NCT00577473|4099085|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4275159|NCT00577473|4099086|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4275160|NCT00577473|4099084|B3|>= 65 years||Age, Customized||Participants|Number|27|27.0||||||
4275161|NCT00577473|4099085|B2|>= 65 years||Age, Customized||Participants|Number|14|14.0||||||
4275162|NCT00577473|4099086|B1|>= 65 years||Age, Customized||Participants|Number|13|13.0||||||
4275163|NCT00577473|4099084|B3|18 - 64 years||Age, Customized||Participants|Number|274|274.0||||||
4275164|NCT00577473|4099085|B2|18 - 64 years||Age, Customized||Participants|Number|133|133.0||||||
4275165|NCT00577473|4099086|B1|18 - 64 years||Age, Customized||Participants|Number|141|141.0||||||
4275166|NCT00577460|4099115|B4||Male|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
4275167|NCT00577460|4099116|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4275168|NCT00577460|4099117|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4275169|NCT00577460|4099118|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4275170|NCT00577460|4099115|B4||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4275171|NCT00577460|4099116|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4275172|NCT00577460|4099117|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4275173|NCT00577460|4099118|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4275174|NCT00577460|4099115|B4|||Age||Years|Mean|61.6|61.6|Standard Deviation|9.7|9.7|||
4275175|NCT00577460|4099116|B3|||Age||Years|Mean|61.8|61.8|Standard Deviation|9.7|9.7|||
4275176|NCT00577460|4099117|B2|||Age||Years|Mean|61.7|61.7|Standard Deviation|9.8|9.8|||
4275177|NCT00577460|4099118|B1|||Age||Years|Mean|61.3|61.3|Standard Deviation|9.7|9.7|||
4275178|NCT00577408|4099227|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4275179|NCT00577408|4099228|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
4275180|NCT00577408|4099229|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4275181|NCT00577408|4099227|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4275182|NCT00577408|4099228|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4275183|NCT00577408|4099229|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4275184|NCT00577408|4099227|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4275185|NCT00577408|4099228|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4275186|NCT00577408|4099229|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4275187|NCT00577408|4099227|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4275188|NCT00577408|4099228|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4275189|NCT00577408|4099229|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4275190|NCT00577408|4099227|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4275191|NCT00577408|4099228|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4275192|NCT00577408|4099229|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4275193|NCT00577408|4099227|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
4275194|NCT00577408|4099228|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
4275195|NCT00577408|4099229|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4275196|NCT00577408|4099227|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4275197|NCT00577408|4099228|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4275198|NCT00577408|4099229|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4275199|NCT00577408|4099227|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4275200|NCT00577408|4099228|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4275201|NCT00577408|4099229|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4275202|NCT00577408|4099227|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4275203|NCT00577408|4099228|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4275204|NCT00577408|4099229|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4275205|NCT00577408|4099227|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4275206|NCT00577408|4099228|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4275207|NCT00577408|4099229|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4275208|NCT00577408|4099227|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4275209|NCT00577408|4099228|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4275210|NCT00577408|4099229|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4275211|NCT00577395|4099236|B3|Argentina||Region of Enrollment||participants|Number|5|5.0||||||
4275212|NCT00577395|4099237|B2|Argentina||Region of Enrollment||participants|Number|3|3.0||||||
4275213|NCT00577395|4099238|B1|Argentina||Region of Enrollment||participants|Number|2|2.0||||||
4275214|NCT00577395|4099236|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4275215|NCT00577395|4099237|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4275216|NCT00577395|4099238|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4275217|NCT00577395|4099236|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4275218|NCT00577395|4099237|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4275219|NCT00577395|4099238|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4275220|NCT00577395|4099236|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4275221|NCT00577395|4099237|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4275222|NCT00577395|4099238|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4275223|NCT00577395|4099236|B3|||Age||years|Mean|52.53|52.53|Standard Deviation|2.75|2.75|||
4275224|NCT00577395|4099237|B2|||Age||years|Mean|53.83|53.83|Standard Deviation|2.63|2.63|||
4275225|NCT00577395|4099238|B1|||Age||years|Mean|51.42|51.42|Standard Deviation|2.50|2.5|||
4275226|NCT00577395|4099236|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4275227|NCT00577395|4099237|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4275228|NCT00577395|4099238|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4275229|NCT00577395|4099236|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4275230|NCT00577395|4099237|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4275231|NCT00577395|4099238|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4275232|NCT00577395|4099236|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4275233|NCT00577395|4099237|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4275234|NCT00577395|4099238|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4275235|NCT00577382|4099247|B3|United States||Region of Enrollment||participants|Number|52|52.0||||||
4275236|NCT00577382|4099248|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
4275237|NCT00577382|4099249|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4275238|NCT00577382|4099247|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275239|NCT00577382|4099248|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275240|NCT00577382|4099249|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275241|NCT00577382|4099247|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275242|NCT00577382|4099248|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275243|NCT00577382|4099249|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275244|NCT00577382|4099247|B3||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4275245|NCT00577382|4099248|B2||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4275246|NCT00577382|4099249|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4275247|NCT00577382|4099247|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4275248|NCT00577382|4099248|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4275249|NCT00577382|4099249|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275250|NCT00577382|4099247|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275251|NCT00577382|4099248|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275252|NCT00577382|4099249|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275253|NCT00577382|4099247|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275254|NCT00577382|4099248|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275255|NCT00577382|4099249|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275256|NCT00577382|4099247|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275257|NCT00577382|4099248|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275258|NCT00577382|4099249|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275259|NCT00577382|4099247|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4275260|NCT00577382|4099248|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4275261|NCT00577382|4099249|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4275262|NCT00577382|4099247|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4275263|NCT00577382|4099248|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4275264|NCT00577382|4099249|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4275265|NCT00577382|4099247|B3|||Age||years|Median|63|63.0|Full Range|||38.0|86.0|
4275266|NCT00577382|4099248|B2|||Age||years|Median|63|63.0|Full Range|||40.0|86.0|
4275267|NCT00577382|4099249|B1|||Age||years|Median|63|63.0|Full Range|||38.0|80.0|
4275268|NCT00577356|4099262|B1|||Prostate Cancer||participants|Number|6|6.0||||||
4275269|NCT00577356|4099262|B1|||adenocarcinoma of the prostate and no radiographic evidence of metastatic disease||years|Mean|2|2.0|Standard Deviation|7.1|7.1|||
4275270|NCT00577356|4099262|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4275271|NCT00577356|4099262|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4275272|NCT00577356|4099262|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4275273|NCT00577356|4099262|B1|<55 years||Age, Customized||participants|Number|6|6.0||||||
4275274|NCT00577135|4099266|B5||Male|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
4275275|NCT00577135|4099267|B4||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4275276|NCT00577135|4099268|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4275277|NCT00577135|4099269|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4275278|NCT00577135|4099270|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4275279|NCT00577135|4099266|B5||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4275280|NCT00577135|4099267|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4275281|NCT00577135|4099268|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4275282|NCT00577135|4099269|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4275283|NCT00577135|4099270|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4275284|NCT00577135|4099266|B5|||Age||years|Mean|66.0|66.0|Standard Deviation|13.6|13.6|||
4275285|NCT00577135|4099267|B4|||Age||years|Mean|67.2|67.2|Standard Deviation|14.0|14.0|||
4275286|NCT00577135|4099268|B3|||Age||years|Mean|64.5|64.5|Standard Deviation|14.1|14.1|||
4275287|NCT00577135|4099269|B2|||Age||years|Mean|65.2|65.2|Standard Deviation|13.8|13.8|||
4275288|NCT00577135|4099270|B1|||Age||years|Mean|67.4|67.4|Standard Deviation|12.4|12.4|||
4275289|NCT00577122|4099391|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275290|NCT00577122|4099392|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275291|NCT00577122|4099393|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275292|NCT00577122|4099391|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275293|NCT00577122|4099392|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275294|NCT00577122|4099393|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275295|NCT00577122|4099391|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4275296|NCT00577122|4099392|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4275297|NCT00577122|4099393|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4275298|NCT00577122|4099391|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4275299|NCT00577122|4099392|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4275300|NCT00577122|4099393|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4275301|NCT00577122|4099391|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275302|NCT00577122|4099392|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275303|NCT00577122|4099393|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275304|NCT00577122|4099391|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4275305|NCT00577122|4099392|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4275306|NCT00577122|4099393|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275307|NCT00577122|4099391|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275308|NCT00577122|4099392|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275309|NCT00577122|4099393|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275310|NCT00577122|4099391|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275311|NCT00577122|4099392|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275312|NCT00577122|4099393|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275313|NCT00577122|4099391|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4275314|NCT00577122|4099392|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4275315|NCT00577122|4099393|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4275316|NCT00577122|4099391|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275317|NCT00577122|4099392|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275318|NCT00577122|4099393|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275319|NCT00577122|4099391|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4275320|NCT00577122|4099392|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4275321|NCT00577122|4099393|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4275322|NCT00577122|4099391|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4275323|NCT00577122|4099392|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4275324|NCT00577122|4099393|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4275325|NCT00577122|4099391|B3|||Age||Years|Mean|57.5|57.5|Standard Deviation|12.36|12.36|0.0|0.0|
4275326|NCT00577122|4099392|B2|||Age||Years|Mean|56.2|56.2|Standard Deviation|12.24|12.24|||
4275327|NCT00577122|4099393|B1|||Age||Years|Mean|59.0|59.0|Standard Deviation|12.78|12.78|||
4275328|NCT00577122|4099391|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4275329|NCT00577122|4099392|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4275330|NCT00577122|4099393|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4275331|NCT00577122|4099391|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4275332|NCT00577122|4099392|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4275333|NCT00577122|4099393|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4275334|NCT00577122|4099391|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4275335|NCT00577122|4099392|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4275336|NCT00577122|4099393|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4275337|NCT00577096|4099406|B3|United States||Region of Enrollment||participants|Number|135|135.0||||||
4275338|NCT00577096|4099407|B2|United States||Region of Enrollment||participants|Number|66|66.0||||||
4275339|NCT00577096|4099408|B1|United States||Region of Enrollment||participants|Number|69|69.0||||||
4275340|NCT00577096|4099406|B3|Other (long term study)||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4275341|NCT00577096|4099407|B2|Other (long term study)||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4275342|NCT00577096|4099408|B1|Other (long term study)||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4275343|NCT00577096|4099406|B3|Caucasian (long term study)||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
4275344|NCT00577096|4099407|B2|Caucasian (long term study)||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4275345|NCT00577096|4099408|B1|Caucasian (long term study)||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4275346|NCT00577096|4099406|B3|Other (short term study)||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4275347|NCT00577096|4099407|B2|Other (short term study)||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4275348|NCT00577096|4099408|B1|Other (short term study)||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4275349|NCT00577096|4099406|B3|Caucasian (short term study)||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
4275350|NCT00577096|4099407|B2|Caucasian (short term study)||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4275351|NCT00577096|4099408|B1|Caucasian (short term study)||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4275352|NCT00577096|4099406|B3|Female (long term study)||Sex/Gender, Customized||participants|Number|22|22.0||||||
4275353|NCT00577096|4099407|B2|Female (long term study)||Sex/Gender, Customized||participants|Number|12|12.0||||||
4275354|NCT00577096|4099408|B1|Female (long term study)||Sex/Gender, Customized||participants|Number|10|10.0||||||
4275355|NCT00577096|4099406|B3|Male (long term study)||Sex/Gender, Customized||participants|Number|47|47.0||||||
4275356|NCT00577096|4099407|B2|Male (long term study)||Sex/Gender, Customized||participants|Number|23|23.0||||||
4275357|NCT00577096|4099408|B1|Male (long term study)||Sex/Gender, Customized||participants|Number|24|24.0||||||
4275358|NCT00577096|4099406|B3|Female (short term study)||Sex/Gender, Customized||participants|Number|41|41.0||||||
4275359|NCT00577096|4099407|B2|Female (short term study)||Sex/Gender, Customized||participants|Number|19|19.0||||||
4275360|NCT00577096|4099408|B1|Female (short term study)||Sex/Gender, Customized||participants|Number|22|22.0||||||
4275361|NCT00577096|4099406|B3|Male (short term study)||Sex/Gender, Customized||participants|Number|25|25.0||||||
4275362|NCT00577096|4099407|B2|Male (short term study)||Sex/Gender, Customized||participants|Number|12|12.0||||||
4275363|NCT00577096|4099408|B1|Male (short term study)||Sex/Gender, Customized||participants|Number|13|13.0||||||
4275364|NCT00577096|4099406|B3|Long Term Participants||Age||years|Mean|55|55.0|Standard Deviation|10.6|10.6|||
4275365|NCT00577096|4099407|B2|Long Term Participants||Age||years|Mean|55.4|55.4|Standard Deviation|11.4|11.4|||
4275366|NCT00577096|4099408|B1|Long Term Participants||Age||years|Mean|54.4|54.4|Standard Deviation|9.7|9.7|||
4275367|NCT00577096|4099406|B3|Short Term Participants||Age||years|Mean|55|55.0|Standard Deviation|10|10.0|||
4275368|NCT00577096|4099407|B2|Short Term Participants||Age||years|Mean|54.5|54.5|Standard Deviation|10.4|10.4|||
4275369|NCT00577096|4099408|B1|Short Term Participants||Age||years|Mean|58|58.0|Standard Deviation|9.2|9.2|||
4275370|NCT00577083|4099433|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
4275371|NCT00577083|4099434|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
4275372|NCT00577083|4099435|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4275373|NCT00577083|4099433|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4275374|NCT00577083|4099434|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4275375|NCT00577083|4099435|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4275376|NCT00577083|4099433|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4275377|NCT00577083|4099434|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4275378|NCT00577083|4099435|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4275379|NCT00577083|4099433|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4275380|NCT00577083|4099434|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4275381|NCT00577083|4099435|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4275382|NCT00577083|4099433|B3||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4275383|NCT00577083|4099434|B2||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4275384|NCT00577083|4099435|B1||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4275385|NCT00577083|4099433|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4275386|NCT00577083|4099434|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4275387|NCT00577083|4099435|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4275388|NCT00577031|4099448|B1||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4275389|NCT00577031|4099448|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4275390|NCT00577031|4099448|B1|||Age||years|Mean|62.25|62.25|Standard Deviation|9.94|9.94|||
4275391|NCT00577005|4099467|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4275392|NCT00577005|4099468|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4275393|NCT00577005|4099469|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4275394|NCT00577005|4099467|B3|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4275395|NCT00577005|4099468|B2|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4275396|NCT00577005|4099469|B1|African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4275397|NCT00577005|4099467|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4275398|NCT00577005|4099468|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4275399|NCT00577005|4099469|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4275400|NCT00577005|4099467|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4275401|NCT00577005|4099468|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4275402|NCT00577005|4099469|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4275403|NCT00577005|4099467|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4275404|NCT00577005|4099468|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4275405|NCT00577005|4099469|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4275406|NCT00577005|4099467|B3|||Age||years|Mean|34.4|34.4|Standard Deviation|10.1|10.1|||
4275407|NCT00577005|4099468|B2|||Age||years|Mean|33.6|33.6|Standard Deviation|9.6|9.6|||
4275408|NCT00577005|4099469|B1|||Age||years|Mean|35.1|35.1|Standard Deviation|10.7|10.7|||
4275409|NCT00576927|4099482|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4275410|NCT00576927|4099483|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4275411|NCT00576927|4099484|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4275412|NCT00576927|4099482|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4275413|NCT00576927|4099483|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4275414|NCT00576927|4099484|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4275415|NCT00576927|4099482|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4275416|NCT00576927|4099483|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4275417|NCT00576927|4099484|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4275418|NCT00576927|4099482|B3|||Age||years|Mean|85.0|85.0|Standard Deviation|7.5|7.5|||
4275419|NCT00576927|4099483|B2|||Age||years|Mean|85.0|85.0|Standard Deviation|8.9|8.9|||
4275420|NCT00576927|4099484|B1|||Age||years|Mean|83.9|83.9|Standard Deviation|6.8|6.8|||
4275421|NCT00576927|4099482|B3||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4275422|NCT00576927|4099483|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4275423|NCT00576927|4099484|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4275424|NCT00576927|4099482|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4275425|NCT00576927|4099483|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4275426|NCT00576927|4099484|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4275427|NCT00576927|4099482|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4275428|NCT00576927|4099483|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4275429|NCT00576927|4099484|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4275430|NCT00576901|4099496|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4275431|NCT00576901|4099496|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4275432|NCT00576901|4099496|B1|||Age||years|Mean|51.96|51.96|Standard Deviation|11.51|11.51|||
4275433|NCT00576823|4099504|B4|Two UTI episodes||Urinary Tract Infection (UTI) history within the last 3 months||participants|Number|1|1.0||||||
4275434|NCT00576823|4099505|B3|Two UTI episodes||Urinary Tract Infection (UTI) history within the last 3 months||participants|Number|0|0.0||||||
4275435|NCT00576823|4099506|B2|Two UTI episodes||Urinary Tract Infection (UTI) history within the last 3 months||participants|Number|0|0.0||||||
4275436|NCT00576823|4099507|B1|Two UTI episodes||Urinary Tract Infection (UTI) history within the last 3 months||participants|Number|1|1.0||||||
4275437|NCT00576823|4099504|B4|One UTI episode||Urinary Tract Infection (UTI) history within the last 3 months||participants|Number|5|5.0||||||
4275438|NCT00576823|4099505|B3|One UTI episode||Urinary Tract Infection (UTI) history within the last 3 months||participants|Number|1|1.0||||||
4275439|NCT00576823|4099506|B2|One UTI episode||Urinary Tract Infection (UTI) history within the last 3 months||participants|Number|2|2.0||||||
4275440|NCT00576823|4099507|B1|One UTI episode||Urinary Tract Infection (UTI) history within the last 3 months||participants|Number|2|2.0||||||
4275441|NCT00576823|4099504|B4|No UTI episode||Urinary Tract Infection (UTI) history within the last 3 months||participants|Number|19|19.0||||||
4275442|NCT00576823|4099505|B3|No UTI episode||Urinary Tract Infection (UTI) history within the last 3 months||participants|Number|6|6.0||||||
4275443|NCT00576823|4099506|B2|No UTI episode||Urinary Tract Infection (UTI) history within the last 3 months||participants|Number|4|4.0||||||
4275444|NCT00576823|4099507|B1|No UTI episode||Urinary Tract Infection (UTI) history within the last 3 months||participants|Number|9|9.0||||||
4275445|NCT00576823|4099504|B4|||Duration of diagnosis for hydronephrosis||years|Mean|3.12|3.12|Standard Deviation|3.26|3.26|||
4275446|NCT00576823|4099505|B3|||Duration of diagnosis for hydronephrosis||years|Mean|3.35|3.35|Standard Deviation|3.05|3.05|||
4275447|NCT00576823|4099506|B2|||Duration of diagnosis for hydronephrosis||years|Mean|5.45|5.45|Standard Deviation|4.20|4.2|||
4275448|NCT00576823|4099507|B1|||Duration of diagnosis for hydronephrosis||years|Mean|1.83|1.83|Standard Deviation|2.30|2.3|||
4275449|NCT00576823|4099504|B4|Right kidney||Grade of hydronephrosis|Hydronephrosis was investigated by ultrasound of the kidneys, and graded using the Society of Fetal Urology (SFU) classification [5-point ordinal scale grading hydronephrosis from 0 (No hydronephrosis) to 4 (worst condition)].|grade|Median|1|1.0|Full Range|||0.0|3.0|
4275450|NCT00576823|4099505|B3|Right kidney||Grade of hydronephrosis|Hydronephrosis was investigated by ultrasound of the kidneys, and graded using the Society of Fetal Urology (SFU) classification [5-point ordinal scale grading hydronephrosis from 0 (No hydronephrosis) to 4 (worst condition)].|grade|Median|1|1.0|Full Range|||0.0|3.0|
4275451|NCT00576823|4099506|B2|Right kidney||Grade of hydronephrosis|Hydronephrosis was investigated by ultrasound of the kidneys, and graded using the Society of Fetal Urology (SFU) classification [5-point ordinal scale grading hydronephrosis from 0 (No hydronephrosis) to 4 (worst condition)].|grade|Median|2|2.0|Full Range|||0.0|3.0|
4275504|NCT00576823|4099507|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4275452|NCT00576823|4099507|B1|Right kidney||Grade of hydronephrosis|Hydronephrosis was investigated by ultrasound of the kidneys, and graded using the Society of Fetal Urology (SFU) classification [5-point ordinal scale grading hydronephrosis from 0 (No hydronephrosis) to 4 (worst condition)].|grade|Median|1|1.0|Full Range|||0.0|3.0|
4275453|NCT00576823|4099504|B4|Left kidney||Grade of hydronephrosis|Hydronephrosis was investigated by ultrasound of the kidneys, and graded using the Society of Fetal Urology (SFU) classification [5-point ordinal scale grading hydronephrosis from 0 (No hydronephrosis) to 4 (worst condition)].|grade|Median|2|2.0|Full Range|||1.0|3.0|
4275454|NCT00576823|4099505|B3|Left kidney||Grade of hydronephrosis|Hydronephrosis was investigated by ultrasound of the kidneys, and graded using the Society of Fetal Urology (SFU) classification [5-point ordinal scale grading hydronephrosis from 0 (No hydronephrosis) to 4 (worst condition)].|grade|Median|2|2.0|Full Range|||1.0|3.0|
4275455|NCT00576823|4099506|B2|Left kidney||Grade of hydronephrosis|Hydronephrosis was investigated by ultrasound of the kidneys, and graded using the Society of Fetal Urology (SFU) classification [5-point ordinal scale grading hydronephrosis from 0 (No hydronephrosis) to 4 (worst condition)].|grade|Median|1.5|1.5|Full Range|||1.0|3.0|
4275456|NCT00576823|4099507|B1|Left kidney||Grade of hydronephrosis|Hydronephrosis was investigated by ultrasound of the kidneys, and graded using the Society of Fetal Urology (SFU) classification [5-point ordinal scale grading hydronephrosis from 0 (No hydronephrosis) to 4 (worst condition)].|grade|Median|2|2.0|Full Range|||1.0|3.0|
4275457|NCT00576823|4099504|B4|Unilateral hydronephrosis (one kidney affected)||Type of hydronephrosis||participants|Number|5|5.0||||||
4275458|NCT00576823|4099505|B3|Unilateral hydronephrosis (one kidney affected)||Type of hydronephrosis||participants|Number|2|2.0||||||
4275459|NCT00576823|4099506|B2|Unilateral hydronephrosis (one kidney affected)||Type of hydronephrosis||participants|Number|2|2.0||||||
4275460|NCT00576823|4099507|B1|Unilateral hydronephrosis (one kidney affected)||Type of hydronephrosis||participants|Number|1|1.0||||||
4275461|NCT00576823|4099504|B4|Bilateral hydronephrosis (both kidneys affected)||Type of hydronephrosis||participants|Number|20|20.0||||||
4275462|NCT00576823|4099505|B3|Bilateral hydronephrosis (both kidneys affected)||Type of hydronephrosis||participants|Number|5|5.0||||||
4275463|NCT00576823|4099506|B2|Bilateral hydronephrosis (both kidneys affected)||Type of hydronephrosis||participants|Number|4|4.0||||||
4275464|NCT00576823|4099507|B1|Bilateral hydronephrosis (both kidneys affected)||Type of hydronephrosis||participants|Number|11|11.0||||||
4275465|NCT00576823|4099504|B4|India||Region of Enrollment||participants|Number|3|3.0||||||
4275466|NCT00576823|4099505|B3|India||Region of Enrollment||participants|Number|0|0.0||||||
4275467|NCT00576823|4099506|B2|India||Region of Enrollment||participants|Number|1|1.0||||||
4275468|NCT00576823|4099507|B1|India||Region of Enrollment||participants|Number|2|2.0||||||
4275469|NCT00576823|4099504|B4|Russian Federation||Region of Enrollment||participants|Number|7|7.0||||||
4275470|NCT00576823|4099505|B3|Russian Federation||Region of Enrollment||participants|Number|2|2.0||||||
4275471|NCT00576823|4099506|B2|Russian Federation||Region of Enrollment||participants|Number|2|2.0||||||
4275472|NCT00576823|4099507|B1|Russian Federation||Region of Enrollment||participants|Number|3|3.0||||||
4275473|NCT00576823|4099504|B4|Turkey||Region of Enrollment||participants|Number|1|1.0||||||
4275474|NCT00576823|4099505|B3|Turkey||Region of Enrollment||participants|Number|0|0.0||||||
4275475|NCT00576823|4099506|B2|Turkey||Region of Enrollment||participants|Number|0|0.0||||||
4275476|NCT00576823|4099507|B1|Turkey||Region of Enrollment||participants|Number|1|1.0||||||
4275477|NCT00576823|4099504|B4|Singapore||Region of Enrollment||participants|Number|1|1.0||||||
4275478|NCT00576823|4099505|B3|Singapore||Region of Enrollment||participants|Number|0|0.0||||||
4275479|NCT00576823|4099506|B2|Singapore||Region of Enrollment||participants|Number|0|0.0||||||
4275480|NCT00576823|4099507|B1|Singapore||Region of Enrollment||participants|Number|1|1.0||||||
4275481|NCT00576823|4099504|B4|Malaysia||Region of Enrollment||participants|Number|1|1.0||||||
4275482|NCT00576823|4099505|B3|Malaysia||Region of Enrollment||participants|Number|1|1.0||||||
4275483|NCT00576823|4099506|B2|Malaysia||Region of Enrollment||participants|Number|0|0.0||||||
4275484|NCT00576823|4099507|B1|Malaysia||Region of Enrollment||participants|Number|0|0.0||||||
4275485|NCT00576823|4099504|B4|Poland||Region of Enrollment||participants|Number|8|8.0||||||
4275486|NCT00576823|4099505|B3|Poland||Region of Enrollment||participants|Number|2|2.0||||||
4275487|NCT00576823|4099506|B2|Poland||Region of Enrollment||participants|Number|2|2.0||||||
4275488|NCT00576823|4099507|B1|Poland||Region of Enrollment||participants|Number|4|4.0||||||
4275489|NCT00576823|4099504|B4|Slovakia||Region of Enrollment||participants|Number|2|2.0||||||
4275490|NCT00576823|4099505|B3|Slovakia||Region of Enrollment||participants|Number|1|1.0||||||
4275491|NCT00576823|4099506|B2|Slovakia||Region of Enrollment||participants|Number|0|0.0||||||
4275492|NCT00576823|4099507|B1|Slovakia||Region of Enrollment||participants|Number|1|1.0||||||
4275493|NCT00576823|4099504|B4|Taiwan||Region of Enrollment||participants|Number|2|2.0||||||
4275494|NCT00576823|4099505|B3|Taiwan||Region of Enrollment||participants|Number|1|1.0||||||
4275495|NCT00576823|4099506|B2|Taiwan||Region of Enrollment||participants|Number|1|1.0||||||
4275496|NCT00576823|4099507|B1|Taiwan||Region of Enrollment||participants|Number|0|0.0||||||
4275497|NCT00576823|4099504|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4275498|NCT00576823|4099505|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4275499|NCT00576823|4099506|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4275500|NCT00576823|4099507|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4275501|NCT00576823|4099504|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4275502|NCT00576823|4099505|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4275503|NCT00576823|4099506|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4275505|NCT00576823|4099504|B4|||Age||years|Mean|7.9|7.9|Standard Deviation|4.0|4.0|||
4275506|NCT00576823|4099505|B3|||Age||years|Mean|11.2|11.2|Standard Deviation|2.3|2.3|||
4275507|NCT00576823|4099506|B2|||Age||years|Mean|10.0|10.0|Standard Deviation|1.7|1.7|||
4275508|NCT00576823|4099507|B1|||Age||years|Mean|4.3|4.3|Standard Deviation|1.5|1.5|||
4275509|NCT00576758|4099523|B3||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4275510|NCT00576758|4099524|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4275511|NCT00576758|4099525|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4275512|NCT00576758|4099523|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4275513|NCT00576758|4099524|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4275514|NCT00576758|4099525|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4275515|NCT00576758|4099523|B3|>70 years||Age, Customized||participants|Number|35|35.0||||||
4275516|NCT00576758|4099524|B2|>70 years||Age, Customized||participants|Number|19|19.0||||||
4275517|NCT00576758|4099525|B1|>70 years||Age, Customized||participants|Number|16|16.0||||||
4275518|NCT00576758|4099523|B3|65-70 years||Age, Customized||participants|Number|44|44.0||||||
4275519|NCT00576758|4099524|B2|65-70 years||Age, Customized||participants|Number|22|22.0||||||
4275520|NCT00576758|4099525|B1|65-70 years||Age, Customized||participants|Number|22|22.0||||||
4275521|NCT00576758|4099523|B3|<65 years||Age, Customized||participants|Number|96|96.0||||||
4275522|NCT00576758|4099524|B2|<65 years||Age, Customized||participants|Number|47|47.0||||||
4275523|NCT00576758|4099525|B1|<65 years||Age, Customized||participants|Number|49|49.0||||||
4275524|NCT00576732|4099569|B4|>=12 years||Age||participants|Number|22|22.0||||||
4275525|NCT00576732|4099570|B3|>=12 years||Age||participants|Number|7|7.0||||||
4275526|NCT00576732|4099571|B2|>=12 years||Age||participants|Number|10|10.0||||||
4275527|NCT00576732|4099572|B1|>=12 years||Age||participants|Number|5|5.0||||||
4275528|NCT00576732|4099569|B4|<12 years||Age||participants|Number|74|74.0||||||
4275529|NCT00576732|4099570|B3|<12 years||Age||participants|Number|24|24.0||||||
4275530|NCT00576732|4099571|B2|<12 years||Age||participants|Number|20|20.0||||||
4275531|NCT00576732|4099572|B1|<12 years||Age||participants|Number|30|30.0||||||
4275532|NCT00576732|4099569|B4|United States of America||Region of Enrollment||participants|Number|96|96.0||||||
4275533|NCT00576732|4099570|B3|United States of America||Region of Enrollment||participants|Number|31|31.0||||||
4275534|NCT00576732|4099571|B2|United States of America||Region of Enrollment||participants|Number|30|30.0||||||
4275535|NCT00576732|4099572|B1|United States of America||Region of Enrollment||participants|Number|35|35.0||||||
4275536|NCT00576732|4099569|B4||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4275537|NCT00576732|4099570|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4275538|NCT00576732|4099571|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4275539|NCT00576732|4099572|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4275540|NCT00576732|4099569|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4275541|NCT00576732|4099570|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4275542|NCT00576732|4099571|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4275543|NCT00576732|4099572|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4275544|NCT00576732|4099569|B4|||Age||years|Mean|9.3|9.3|Standard Deviation|3.07|3.07|||
4275545|NCT00576732|4099570|B3|||Age||years|Mean|9.3|9.3|Standard Deviation|3.11|3.11|||
4275546|NCT00576732|4099571|B2|||Age||years|Mean|10.2|10.2|Standard Deviation|3.42|3.42|||
4275547|NCT00576732|4099572|B1|||Age||years|Mean|8.6|8.6|Standard Deviation|2.57|2.57|||
4275548|NCT00576732|4099569|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4275549|NCT00576732|4099570|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4275550|NCT00576732|4099571|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4275551|NCT00576732|4099572|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4275552|NCT00576732|4099569|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4275553|NCT00576732|4099570|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4275554|NCT00576732|4099571|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4275555|NCT00576732|4099572|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4275556|NCT00576732|4099569|B4||<=18 years|Age||Participants|Count of Participants|96|96.0||||||
4275557|NCT00576732|4099570|B3||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
4275558|NCT00576732|4099571|B2||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4275559|NCT00576732|4099572|B1||<=18 years|Age||Participants|Count of Participants|35|35.0||||||
4275560|NCT00576693|4099607|B3|||Percent Stenosis of Symptomatic Qualifying Artery|According to a reading of the cerebral angiogram by the site interventionist.|% of the diameter the artery|Mean|81|81.0|Standard Deviation|7|7.0|||
4275561|NCT00576693|4099608|B2|||Percent Stenosis of Symptomatic Qualifying Artery|According to a reading of the cerebral angiogram by the site interventionist.|% of the diameter the artery|Mean|81|81.0|Standard Deviation|7|7.0|||
4275562|NCT00576693|4099609|B1|||Percent Stenosis of Symptomatic Qualifying Artery|According to a reading of the cerebral angiogram by the site interventionist.|% of the diameter the artery|Mean|80|80.0|Standard Deviation|7|7.0|||
4275563|NCT00576693|4099607|B3|Basilar Artery||Symptomatic Qualifying Artery||participants|Number|100|100.0||||||
4275564|NCT00576693|4099608|B2|Basilar Artery||Symptomatic Qualifying Artery||participants|Number|51|51.0||||||
4275565|NCT00576693|4099609|B1|Basilar Artery||Symptomatic Qualifying Artery||participants|Number|49|49.0||||||
4275566|NCT00576693|4099607|B3|Vertebral Artery||Symptomatic Qualifying Artery||participants|Number|60|60.0||||||
4275567|NCT00576693|4099608|B2|Vertebral Artery||Symptomatic Qualifying Artery||participants|Number|22|22.0||||||
4275568|NCT00576693|4099609|B1|Vertebral Artery||Symptomatic Qualifying Artery||participants|Number|38|38.0||||||
4275569|NCT00576693|4099607|B3|Middle Cerebral Artery||Symptomatic Qualifying Artery||participants|Number|197|197.0||||||
4275570|NCT00576693|4099608|B2|Middle Cerebral Artery||Symptomatic Qualifying Artery||participants|Number|105|105.0||||||
4275571|NCT00576693|4099609|B1|Middle Cerebral Artery||Symptomatic Qualifying Artery||participants|Number|92|92.0||||||
4275572|NCT00576693|4099607|B3|Internal Carotid Artery||Symptomatic Qualifying Artery||participants|Number|94|94.0||||||
4275573|NCT00576693|4099608|B2|Internal Carotid Artery||Symptomatic Qualifying Artery||participants|Number|49|49.0||||||
4275574|NCT00576693|4099609|B1|Internal Carotid Artery||Symptomatic Qualifying Artery||participants|Number|45|45.0||||||
4275575|NCT00576693|4099607|B3|||Time from Qualifying Event to Randomization||days|Median|7|7.0|Inter-Quartile Range|||4.0|17.5|
4275576|NCT00576693|4099608|B2|||Time from Qualifying Event to Randomization||days|Median|7|7.0|Inter-Quartile Range|||4.0|19.0|
4275577|NCT00576693|4099609|B1|||Time from Qualifying Event to Randomization||days|Median|7|7.0|Inter-Quartile Range|||4.0|16.0|
4275578|NCT00576693|4099607|B3|No||On Antithrombotic Therapy at Qualifying Event||participants|Number|167|167.0||||||
4275579|NCT00576693|4099608|B2|No||On Antithrombotic Therapy at Qualifying Event||participants|Number|87|87.0||||||
4275580|NCT00576693|4099609|B1|No||On Antithrombotic Therapy at Qualifying Event||participants|Number|80|80.0||||||
4275581|NCT00576693|4099607|B3|Yes||On Antithrombotic Therapy at Qualifying Event||participants|Number|284|284.0||||||
4275582|NCT00576693|4099608|B2|Yes||On Antithrombotic Therapy at Qualifying Event||participants|Number|140|140.0||||||
4275583|NCT00576693|4099609|B1|Yes||On Antithrombotic Therapy at Qualifying Event||participants|Number|144|144.0||||||
4275584|NCT00576693|4099607|B3|TIA||Qualifying Event||participants|Number|157|157.0||||||
4275585|NCT00576693|4099608|B2|TIA||Qualifying Event||participants|Number|75|75.0||||||
4275586|NCT00576693|4099609|B1|TIA||Qualifying Event||participants|Number|82|82.0||||||
4275587|NCT00576693|4099607|B3|Stroke||Qualifying Event||participants|Number|294|294.0||||||
4275588|NCT00576693|4099608|B2|Stroke||Qualifying Event||participants|Number|152|152.0||||||
4275589|NCT00576693|4099609|B1|Stroke||Qualifying Event||participants|Number|142|142.0||||||
4275590|NCT00576693|4099607|B3|No||History of Stroke (Not Qualifying Event)||participants|Number|333|333.0||||||
4275591|NCT00576693|4099608|B2|No||History of Stroke (Not Qualifying Event)||participants|Number|169|169.0||||||
4275592|NCT00576693|4099609|B1|No||History of Stroke (Not Qualifying Event)||participants|Number|164|164.0||||||
4275593|NCT00576693|4099607|B3|Yes||History of Stroke (Not Qualifying Event)||participants|Number|118|118.0||||||
4275594|NCT00576693|4099608|B2|Yes||History of Stroke (Not Qualifying Event)||participants|Number|58|58.0||||||
4275595|NCT00576693|4099609|B1|Yes||History of Stroke (Not Qualifying Event)||participants|Number|60|60.0||||||
4275596|NCT00576693|4099607|B3|No||History of Coronary Artery Disease||participants|Number|345|345.0||||||
4275597|NCT00576693|4099608|B2|No||History of Coronary Artery Disease||participants|Number|168|168.0||||||
4275598|NCT00576693|4099609|B1|No||History of Coronary Artery Disease||participants|Number|177|177.0||||||
4275599|NCT00576693|4099607|B3|Yes||History of Coronary Artery Disease||participants|Number|106|106.0||||||
4275600|NCT00576693|4099608|B2|Yes||History of Coronary Artery Disease||participants|Number|59|59.0||||||
4275601|NCT00576693|4099609|B1|Yes||History of Coronary Artery Disease||participants|Number|47|47.0||||||
4275602|NCT00576693|4099607|B3|||Body Mass Index||kg/m^2|Mean|30.5|30.5|Standard Deviation|6.3|6.3|||
4275603|NCT00576693|4099608|B2|||Body Mass Index||kg/m^2|Mean|30.7|30.7|Standard Deviation|6.3|6.3|||
4275604|NCT00576693|4099609|B1|||Body Mass Index||kg/m^2|Mean|30.3|30.3|Standard Deviation|6.2|6.2|||
4275605|NCT00576693|4099607|B3|||Low Density Lipoprotein Cholesterol||mg/dl|Mean|97.0|97.0|Standard Deviation|37.5|37.5|||
4275606|NCT00576693|4099608|B2|||Low Density Lipoprotein Cholesterol||mg/dl|Mean|97.7|97.7|Standard Deviation|36.6|36.6|||
4275607|NCT00576693|4099609|B1|||Low Density Lipoprotein Cholesterol||mg/dl|Mean|96.2|96.2|Standard Deviation|38.4|38.4|||
4275608|NCT00576693|4099607|B3|||Systolic Blood Pressure||mmHg|Mean|145.4|145.4|Standard Deviation|21.3|21.3|||
4275609|NCT00576693|4099608|B2|||Systolic Blood Pressure||mmHg|Mean|146.8|146.8|Standard Deviation|21.8|21.8|||
4275610|NCT00576693|4099609|B1|||Systolic Blood Pressure||mmHg|Mean|143.9|143.9|Standard Deviation|20.6|20.6|||
4275611|NCT00576693|4099607|B3|No||Diabetes|A patient is considered diabetic at baseline if there is a history of diabetes or if the baseline hemoglobin A1c > 6.5%.|participants|Number|243|243.0||||||
4275612|NCT00576693|4099608|B2|No||Diabetes|A patient is considered diabetic at baseline if there is a history of diabetes or if the baseline hemoglobin A1c > 6.5%.|participants|Number|124|124.0||||||
4275613|NCT00576693|4099609|B1|No||Diabetes|A patient is considered diabetic at baseline if there is a history of diabetes or if the baseline hemoglobin A1c > 6.5%.|participants|Number|119|119.0||||||
4275614|NCT00576693|4099607|B3|Yes||Diabetes|A patient is considered diabetic at baseline if there is a history of diabetes or if the baseline hemoglobin A1c > 6.5%.|participants|Number|208|208.0||||||
4275615|NCT00576693|4099608|B2|Yes||Diabetes|A patient is considered diabetic at baseline if there is a history of diabetes or if the baseline hemoglobin A1c > 6.5%.|participants|Number|103|103.0||||||
4275616|NCT00576693|4099609|B1|Yes||Diabetes|A patient is considered diabetic at baseline if there is a history of diabetes or if the baseline hemoglobin A1c > 6.5%.|participants|Number|105|105.0||||||
4275617|NCT00576693|4099607|B3|Currently||Smoking|"Based on the Physician-based Assessment and Counseling for Exercise (PACE) Smoking Score.~The data value for smoking status was missing for 1 patient in the intensive medical management plus stenting group."|participants|Number|123|123.0||||||
4275731|NCT00576251|4099963|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4275618|NCT00576693|4099608|B2|Currently||Smoking|"Based on the Physician-based Assessment and Counseling for Exercise (PACE) Smoking Score.~The data value for smoking status was missing for 1 patient in the intensive medical management plus stenting group."|participants|Number|69|69.0||||||
4275619|NCT00576693|4099609|B1|Currently||Smoking|"Based on the Physician-based Assessment and Counseling for Exercise (PACE) Smoking Score.~The data value for smoking status was missing for 1 patient in the intensive medical management plus stenting group."|participants|Number|54|54.0||||||
4275620|NCT00576693|4099607|B3|Previously||Smoking|"Based on the Physician-based Assessment and Counseling for Exercise (PACE) Smoking Score.~The data value for smoking status was missing for 1 patient in the intensive medical management plus stenting group."|participants|Number|159|159.0||||||
4275621|NCT00576693|4099608|B2|Previously||Smoking|"Based on the Physician-based Assessment and Counseling for Exercise (PACE) Smoking Score.~The data value for smoking status was missing for 1 patient in the intensive medical management plus stenting group."|participants|Number|80|80.0||||||
4275622|NCT00576693|4099609|B1|Previously||Smoking|"Based on the Physician-based Assessment and Counseling for Exercise (PACE) Smoking Score.~The data value for smoking status was missing for 1 patient in the intensive medical management plus stenting group."|participants|Number|79|79.0||||||
4275623|NCT00576693|4099607|B3|Never||Smoking|"Based on the Physician-based Assessment and Counseling for Exercise (PACE) Smoking Score.~The data value for smoking status was missing for 1 patient in the intensive medical management plus stenting group."|participants|Number|168|168.0||||||
4275624|NCT00576693|4099608|B2|Never||Smoking|"Based on the Physician-based Assessment and Counseling for Exercise (PACE) Smoking Score.~The data value for smoking status was missing for 1 patient in the intensive medical management plus stenting group."|participants|Number|78|78.0||||||
4275625|NCT00576693|4099609|B1|Never||Smoking|"Based on the Physician-based Assessment and Counseling for Exercise (PACE) Smoking Score.~The data value for smoking status was missing for 1 patient in the intensive medical management plus stenting group."|participants|Number|90|90.0||||||
4275626|NCT00576693|4099607|B3|No||History of Lipid Disorder||participants|Number|54|54.0||||||
4275627|NCT00576693|4099608|B2|No||History of Lipid Disorder||participants|Number|25|25.0||||||
4275628|NCT00576693|4099609|B1|No||History of Lipid Disorder||participants|Number|29|29.0||||||
4275629|NCT00576693|4099607|B3|Yes||History of Lipid Disorder||participants|Number|397|397.0||||||
4275630|NCT00576693|4099608|B2|Yes||History of Lipid Disorder||participants|Number|202|202.0||||||
4275631|NCT00576693|4099609|B1|Yes||History of Lipid Disorder||participants|Number|195|195.0||||||
4275632|NCT00576693|4099607|B3|No||History of Hypertension||participants|Number|48|48.0||||||
4275633|NCT00576693|4099608|B2|No||History of Hypertension||participants|Number|24|24.0||||||
4275634|NCT00576693|4099609|B1|No||History of Hypertension||participants|Number|24|24.0||||||
4275635|NCT00576693|4099607|B3|Yes||History of Hypertension||participants|Number|403|403.0||||||
4275636|NCT00576693|4099608|B2|Yes||History of Hypertension||participants|Number|203|203.0||||||
4275637|NCT00576693|4099609|B1|Yes||History of Hypertension||participants|Number|200|200.0||||||
4275638|NCT00576693|4099607|B3|Other||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4275639|NCT00576693|4099608|B2|Other||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4275640|NCT00576693|4099609|B1|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4275641|NCT00576693|4099607|B3|White||Race/Ethnicity, Customized||participants|Number|322|322.0||||||
4275642|NCT00576693|4099608|B2|White||Race/Ethnicity, Customized||participants|Number|162|162.0||||||
4275643|NCT00576693|4099609|B1|White||Race/Ethnicity, Customized||participants|Number|160|160.0||||||
4275644|NCT00576693|4099607|B3|Black||Race/Ethnicity, Customized||participants|Number|104|104.0||||||
4275645|NCT00576693|4099608|B2|Black||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4275646|NCT00576693|4099609|B1|Black||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
4275647|NCT00576693|4099607|B3||Male|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
4275648|NCT00576693|4099608|B2||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4275649|NCT00576693|4099609|B1||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4275650|NCT00576693|4099607|B3||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4275651|NCT00576693|4099608|B2||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4275652|NCT00576693|4099609|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4275653|NCT00576693|4099607|B3|||Age||years|Mean|60.2|60.2|Standard Deviation|11.3|11.3|||
4275654|NCT00576693|4099608|B2|||Age||years|Mean|59.5|59.5|Standard Deviation|11.8|11.8|||
4275655|NCT00576693|4099609|B1|||Age||years|Mean|61.0|61.0|Standard Deviation|10.7|10.7|||
4275656|NCT00576628|4099616|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4275657|NCT00576628|4099616|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4275658|NCT00576628|4099616|B1|||Age||years|Mean|46.8|46.8|Standard Deviation|15.41|15.41|||
4275659|NCT00576576|4099636|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4275660|NCT00576576|4099636|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4275661|NCT00576576|4099636|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4275662|NCT00576576|4099636|B1|||Age||years|Median|54|54.0|Inter-Quartile Range|46-68|46.0|46.0|68.0|
4275663|NCT00576576|4099636|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4275664|NCT00576576|4099636|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4275665|NCT00576576|4099636|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4275666|NCT00576524|4099642|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4275667|NCT00576524|4099644|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4275668|NCT00576524|4099642|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4275669|NCT00576524|4099644|B1||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Data not analyzed- study closed due to lack of recruitment
4275670|NCT00576524|4099642|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4275671|NCT00576524|4099644|B1||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Data not analyzed- study closed due to lack of recruitment
4275672|NCT00576524|4099642|B3|>=65 years||Age||participants|Number|0|0.0||||||
4275673|NCT00576524|4099644|B1|>=65 years||Age||participants|Number|0|0.0||||||
4275674|NCT00576524|4099642|B3|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
4275675|NCT00576524|4099644|B1|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
4275676|NCT00576524|4099642|B3|<=18 years||Age||participants|Number|2|2.0||||||
4275677|NCT00576524|4099644|B1|<=18 years||Age||participants|Number|2|2.0||||||
4275678|NCT00576472|4099655|B16|Brain Tumors (BT)||Disease Group||Participants|Number|211|211.0||||||
4275679|NCT00576472|4099668|B3|Brain Tumors (BT)||Disease Group||Participants|Number|196|196.0||||||
4275680|NCT00576472|4099669|B2|Brain Tumors (BT)||Disease Group||Participants|Number|1|1.0||||||
4275681|NCT00576472|4099670|B1|Brain Tumors (BT)||Disease Group||Participants|Number|14|14.0||||||
4275682|NCT00576472|4099655|B16|Acute Lymphoblastic Leukemia (ALL)||Disease Group||Participants|Number|258|258.0||||||
4275683|NCT00576472|4099668|B3|Acute Lymphoblastic Leukemia (ALL)||Disease Group||Participants|Number|3|3.0||||||
4275684|NCT00576472|4099669|B2|Acute Lymphoblastic Leukemia (ALL)||Disease Group||Participants|Number|39|39.0||||||
4275685|NCT00576472|4099670|B1|Acute Lymphoblastic Leukemia (ALL)||Disease Group||Participants|Number|216|216.0||||||
4275686|NCT00576472|4099655|B16||Male|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
4275687|NCT00576472|4099668|B3||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4275688|NCT00576472|4099669|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4275689|NCT00576472|4099670|B1||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4275690|NCT00576472|4099655|B16||Female|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4275691|NCT00576472|4099668|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4275692|NCT00576472|4099669|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4275693|NCT00576472|4099670|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4275694|NCT00576472|4099655|B16|≥ 4 years of age||Age, Customized||Participants|Number|282|282.0||||||
4275695|NCT00576472|4099668|B3|≥ 4 years of age||Age, Customized||Participants|Number|148|148.0||||||
4275696|NCT00576472|4099669|B2|≥ 4 years of age||Age, Customized||Participants|Number|17|17.0||||||
4275697|NCT00576472|4099670|B1|≥ 4 years of age||Age, Customized||Participants|Number|117|117.0||||||
4275698|NCT00576472|4099655|B16|< 4 years of age||Age, Customized||Participants|Number|187|187.0||||||
4275699|NCT00576472|4099668|B3|< 4 years of age||Age, Customized||Participants|Number|51|51.0||||||
4275700|NCT00576472|4099669|B2|< 4 years of age||Age, Customized||Participants|Number|23|23.0||||||
4275701|NCT00576472|4099670|B1|< 4 years of age||Age, Customized||Participants|Number|113|113.0||||||
4275702|NCT00576420|4099774|B4|United States||Region of Enrollment||participants|Number|73|73.0||||||
4275703|NCT00576420|4099775|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4275704|NCT00576420|4099776|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4275705|NCT00576420|4099777|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4275706|NCT00576420|4099774|B4||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4275707|NCT00576420|4099775|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4275708|NCT00576420|4099776|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4275709|NCT00576420|4099777|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4275710|NCT00576420|4099774|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4275711|NCT00576420|4099775|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4275712|NCT00576420|4099776|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4275713|NCT00576420|4099777|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4275714|NCT00576420|4099774|B4|||Age||years|Median|63|63.0|Full Range|||24.0|86.0|
4275715|NCT00576420|4099775|B3|||Age||years|Median|63.0|63.0|Full Range|14.4|14.4|38.0|86.0|
4275716|NCT00576420|4099776|B2|||Age||years|Median|67.0|67.0|Full Range|14.6|14.6|24.0|84.0|
4275717|NCT00576420|4099777|B1|||Age||years|Median|63.0|63.0|Full Range|12.7|12.7|33.0|85.0|
4275718|NCT00576381|4099944|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4275719|NCT00576381|4099944|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4275720|NCT00576381|4099944|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4275721|NCT00576381|4099944|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4275722|NCT00576381|4099944|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4275723|NCT00576381|4099944|B1||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4275724|NCT00576316|4099948|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4275725|NCT00576316|4099948|B1||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4275726|NCT00576316|4099948|B1|Mean Age||Age||years|Mean|46.73|46.73|Standard Deviation|12.31|12.31|||
4275727|NCT00576303|4099953|B1||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4275728|NCT00576303|4099953|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4275729|NCT00576303|4099953|B1|||Age||years|Mean|51.0|51.0|Standard Deviation|12.98|12.98|||
4275730|NCT00576251|4099962|B3||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4275732|NCT00576251|4099964|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4275733|NCT00576251|4099962|B3||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4275734|NCT00576251|4099963|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4275735|NCT00576251|4099964|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4275736|NCT00576251|4099962|B3||>=65 years|Age||Participants|Count of Participants|88|88.0||||||
4275737|NCT00576251|4099963|B2||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4275738|NCT00576251|4099964|B1||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
4275739|NCT00576251|4099962|B3||Between 18 and 65 years|Age||Participants|Count of Participants|127|127.0||||||
4275740|NCT00576251|4099963|B2||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4275741|NCT00576251|4099964|B1||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4275742|NCT00576251|4099962|B3||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4275743|NCT00576251|4099963|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4275744|NCT00576251|4099964|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4275745|NCT00576199|4099971|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4275746|NCT00576199|4099971|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4275747|NCT00576199|4099971|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|10.43|10.43|||
4275748|NCT00576147|4099980|B1|India||Region of Enrollment||participants|Number|125|125.0||||||
4275749|NCT00576147|4099980|B1|United States||Region of Enrollment||participants|Number|306|306.0||||||
4275750|NCT00576147|4099980|B1||Male|Sex: Female, Male||Participants|Count of Participants|323|323.0||||||
4275751|NCT00576147|4099980|B1||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4275752|NCT00576147|4099980|B1|||Age||years|Mean|36.7|36.7|Standard Deviation|26|26.0|||
4275753|NCT00576147|4099980|B1||>=65 years|Age||Participants|Count of Participants|52|52.0||||||
4275754|NCT00576147|4099980|B1||Between 18 and 65 years|Age||Participants|Count of Participants|333|333.0||||||
4275755|NCT00576147|4099980|B1||<=18 years|Age||Participants|Count of Participants|46|46.0||||||
4275756|NCT00576056|4099984|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4275757|NCT00576056|4099984|B1||Male|Gender||Participants|Count of Participants|15|15.0||||||
4275758|NCT00576056|4099984|B1||Female|Gender||Participants|Count of Participants|4|4.0||||||
4275759|NCT00576056|4099984|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4275760|NCT00576056|4099984|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4275761|NCT00576056|4099984|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4275762|NCT00575965|4099989|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4275763|NCT00575965|4099989|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4275764|NCT00575965|4099989|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4275765|NCT00575965|4099989|B1|||Age||years|Mean|66|66.0|Standard Deviation|13|13.0|||
4275766|NCT00575965|4099989|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4275767|NCT00575965|4099989|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4275768|NCT00575965|4099989|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4275769|NCT00575887|4099994|B1|Turkey||Region of Enrollment||participants|Number|25|25.0||||||
4275770|NCT00575887|4099994|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4275771|NCT00575887|4099994|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4275772|NCT00575887|4099994|B1|||Age||years|Mean|50|50.0|Standard Deviation|14|14.0|||
4275773|NCT00575887|4099994|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4275774|NCT00575887|4099994|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4275775|NCT00575887|4099994|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4275776|NCT00575666|4099998|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
4275777|NCT00575666|4099999|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4275778|NCT00575666|4100000|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4275779|NCT00575666|4099998|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4275780|NCT00575666|4099999|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4275781|NCT00575666|4100000|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4275782|NCT00575666|4099998|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4275783|NCT00575666|4099999|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4275784|NCT00575666|4100000|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4275785|NCT00575666|4099998|B3|||Age||years|Mean|46.0|46.0|Standard Deviation|9.0|9.0|||
4275786|NCT00575666|4099999|B2|||Age||years|Mean|43.8|43.8|Standard Deviation|9.2|9.2|||
4275787|NCT00575666|4100000|B1|||Age||years|Mean|49.2|49.2|Standard Deviation|9.3|9.3|||
4275788|NCT00575666|4099998|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4275789|NCT00575666|4099999|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4275790|NCT00575666|4100000|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4275791|NCT00575666|4099998|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4275792|NCT00575666|4099999|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4275793|NCT00575666|4100000|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4275794|NCT00575666|4099998|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4275795|NCT00575666|4099999|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4275796|NCT00575666|4100000|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4275797|NCT00575588|4100039|B3||Male|Sex: Female, Male||Participants|Count of Participants|444|444.0||||||
4275798|NCT00575588|4100040|B2||Male|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
4275799|NCT00575588|4100041|B1||Male|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4275800|NCT00575588|4100039|B3||Female|Sex: Female, Male||Participants|Count of Participants|414|414.0||||||
4275801|NCT00575588|4100040|B2||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4275802|NCT00575588|4100041|B1||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4275803|NCT00575588|4100039|B3|||Age||years|Mean|57.55|57.55|Standard Deviation|10.31|10.31|||
4275804|NCT00575588|4100040|B2|||Age||years|Mean|57.59|57.59|Standard Deviation|10.37|10.37|||
4275805|NCT00575588|4100041|B1|||Age||years|Mean|57.50|57.5|Standard Deviation|10.26|10.26|||
4275806|NCT00575510|4100062|B4|United States||Region of Enrollment||participants|Number|341|341.0||||||
4275807|NCT00575510|4100063|B3|United States||Region of Enrollment||participants|Number|113|113.0||||||
4275808|NCT00575510|4100064|B2|United States||Region of Enrollment||participants|Number|114|114.0||||||
4275809|NCT00575510|4100065|B1|United States||Region of Enrollment||participants|Number|114|114.0||||||
4275810|NCT00575510|4100062|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4275811|NCT00575510|4100063|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4275812|NCT00575510|4100064|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4275813|NCT00575510|4100065|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4275814|NCT00575510|4100062|B4||Female|Sex: Female, Male||Participants|Count of Participants|341|341.0||||||
4275815|NCT00575510|4100063|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4275816|NCT00575510|4100064|B2||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4275817|NCT00575510|4100065|B1||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4275818|NCT00575510|4100062|B4|||Age||years|Mean|28|28.0|Standard Deviation|7|7.0|||
4275819|NCT00575510|4100063|B3|||Age||years|Mean|29|29.0|Standard Deviation|8|8.0|||
4275820|NCT00575510|4100064|B2|||Age||years|Mean|28|28.0|Standard Deviation|8|8.0|||
4275821|NCT00575510|4100065|B1|||Age||years|Mean|27|27.0|Standard Deviation|7|7.0|||
4275822|NCT00575380|4100078|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4275823|NCT00575380|4100079|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4275824|NCT00575380|4100080|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4275825|NCT00575380|4100078|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4275826|NCT00575380|4100079|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4275827|NCT00575380|4100080|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4275828|NCT00575380|4100078|B3|||Age||years|Mean|68.6|68.6|Standard Deviation|9.15|9.15|||
4275829|NCT00575380|4100079|B2|||Age||years|Mean|66.3|66.3|Standard Deviation|10.02|10.02|||
4275830|NCT00575380|4100080|B1|||Age||years|Mean|71.0|71.0|Standard Deviation|7.57|7.57|||
4275831|NCT00575367|4100089|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4275832|NCT00575367|4100090|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4275833|NCT00575367|4100091|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4275834|NCT00575367|4100089|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4275835|NCT00575367|4100090|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4275836|NCT00575367|4100091|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4275837|NCT00575367|4100089|B3|||Age|Baseline measures for two subjects were not included in this analysis due to missing data on too many data points. Although the total number of baseline participants was 37, the actual number included in the analysis was 35 subjects, 18 subjects in the Azasite group and 17 in the Vigamox group.|years|Mean|36.0|36.0|Standard Deviation|12.92|12.92|||
4275838|NCT00575367|4100090|B2|||Age|Baseline measures for two subjects were not included in this analysis due to missing data on too many data points. Although the total number of baseline participants was 37, the actual number included in the analysis was 35 subjects, 18 subjects in the Azasite group and 17 in the Vigamox group.|years|Mean|38.1|38.1|Standard Deviation|13.29|13.29|||
4275839|NCT00575367|4100091|B1|||Age|Baseline measures for two subjects were not included in this analysis due to missing data on too many data points. Although the total number of baseline participants was 37, the actual number included in the analysis was 35 subjects, 18 subjects in the Azasite group and 17 in the Vigamox group.|years|Mean|33.9|33.9|Standard Deviation|12.59|12.59|||
4275840|NCT00575185|4100098|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4275841|NCT00575185|4100099|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4275842|NCT00575185|4100100|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4275843|NCT00575185|4100098|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4275844|NCT00575185|4100099|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4275845|NCT00575185|4100100|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4275846|NCT00575185|4100098|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4275847|NCT00575185|4100099|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4275848|NCT00575185|4100100|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4275849|NCT00575185|4100098|B3|>=65 years||Age, Customized||particpants|Number|0|0.0||||||
4275850|NCT00575185|4100099|B2|>=65 years||Age, Customized||particpants|Number|0|0.0||||||
4275851|NCT00575185|4100100|B1|>=65 years||Age, Customized||particpants|Number|0|0.0||||||
4275852|NCT00575185|4100098|B3|Between 18 and 65 years||Age, Customized||particpants|Number|23|23.0||||||
4275853|NCT00575185|4100099|B2|Between 18 and 65 years||Age, Customized||particpants|Number|11|11.0||||||
4275854|NCT00575185|4100100|B1|Between 18 and 65 years||Age, Customized||particpants|Number|12|12.0||||||
4275855|NCT00575185|4100098|B3|<=18 years||Age, Customized||particpants|Number|0|0.0||||||
4275856|NCT00575185|4100099|B2|<=18 years||Age, Customized||particpants|Number|0|0.0||||||
4275857|NCT00575185|4100100|B1|<=18 years||Age, Customized||particpants|Number|0|0.0||||||
4275858|NCT00575159|4100109|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275859|NCT00575159|4100109|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275860|NCT00575159|4100109|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4275861|NCT00575159|4100109|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275862|NCT00575159|4100109|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275863|NCT00575159|4100109|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275864|NCT00575159|4100109|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275865|NCT00575159|4100109|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4275866|NCT00575159|4100109|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4275867|NCT00575159|4100109|B1|||Age||Years|Mean|42.9|42.9|Standard Deviation|8.08|8.08|||
4275868|NCT00575146|4100217|B1|Germany||Region of Enrollment||participants|Number|20|20.0||||||
4275869|NCT00575146|4100217|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4275870|NCT00575146|4100217|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4275871|NCT00575146|4100217|B1|||Age||years|Mean|55|55.0|Standard Deviation|12.2|12.2|||
4275872|NCT00575146|4100217|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4275873|NCT00575146|4100217|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4275874|NCT00575146|4100217|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4275875|NCT00575094|4100223|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4275876|NCT00575094|4100223|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4275877|NCT00575094|4100223|B1|||Age||years|Mean|62.78|62.78|Standard Deviation|18.27|18.27|||
4275878|NCT00575042|4100227|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4275879|NCT00575042|4100227|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4275880|NCT00575042|4100227|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4275881|NCT00575042|4100227|B1|||Age||years|Mean|54|54.0|Standard Deviation|8.9|8.9|||
4275882|NCT00575042|4100227|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4275883|NCT00575042|4100227|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4275884|NCT00575042|4100227|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4275885|NCT00575029|4100232|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4275886|NCT00575029|4100232|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4275887|NCT00575029|4100232|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4275888|NCT00575029|4100232|B1|||Age||years|Mean|68|68.0|Standard Deviation|5.3|5.3|||
4275889|NCT00575029|4100232|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4275890|NCT00575029|4100232|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4275891|NCT00575029|4100232|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4275892|NCT00575016|4100237|B5||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4275893|NCT00575016|4100238|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4275894|NCT00575016|4100239|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4275895|NCT00575016|4100240|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4275896|NCT00575016|4100241|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4275897|NCT00575016|4100237|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4275898|NCT00575016|4100238|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4275899|NCT00575016|4100239|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4275900|NCT00575016|4100240|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4275901|NCT00575016|4100241|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4275902|NCT00575016|4100237|B5|>= 75 years||Age, Customized||participants|Number|0|0.0||||||
4275903|NCT00575016|4100238|B4|>= 75 years||Age, Customized||participants|Number|0|0.0||||||
4275904|NCT00575016|4100239|B3|>= 75 years||Age, Customized||participants|Number|0|0.0||||||
4275905|NCT00575016|4100240|B2|>= 75 years||Age, Customized||participants|Number|0|0.0||||||
4275906|NCT00575016|4100241|B1|>= 75 years||Age, Customized||participants|Number|0|0.0||||||
4275907|NCT00575016|4100237|B5|Between 65 and 74 years||Age, Customized||participants|Number|0|0.0||||||
4275908|NCT00575016|4100238|B4|Between 65 and 74 years||Age, Customized||participants|Number|0|0.0||||||
4275909|NCT00575016|4100239|B3|Between 65 and 74 years||Age, Customized||participants|Number|0|0.0||||||
4275910|NCT00575016|4100240|B2|Between 65 and 74 years||Age, Customized||participants|Number|0|0.0||||||
4275911|NCT00575016|4100241|B1|Between 65 and 74 years||Age, Customized||participants|Number|0|0.0||||||
4275912|NCT00575016|4100237|B5|Between 40 and 64 years||Age, Customized||participants|Number|21|21.0||||||
4275913|NCT00575016|4100238|B4|Between 40 and 64 years||Age, Customized||participants|Number|6|6.0||||||
4275914|NCT00575016|4100239|B3|Between 40 and 64 years||Age, Customized||participants|Number|3|3.0||||||
4275915|NCT00575016|4100240|B2|Between 40 and 64 years||Age, Customized||participants|Number|8|8.0||||||
4275916|NCT00575016|4100241|B1|Between 40 and 64 years||Age, Customized||participants|Number|4|4.0||||||
4275917|NCT00575016|4100237|B5|< 40 years||Age, Customized||participants|Number|53|53.0||||||
4275918|NCT00575016|4100238|B4|< 40 years||Age, Customized||participants|Number|11|11.0||||||
4275919|NCT00575016|4100239|B3|< 40 years||Age, Customized||participants|Number|16|16.0||||||
4275920|NCT00575016|4100240|B2|< 40 years||Age, Customized||participants|Number|13|13.0||||||
4275921|NCT00575016|4100241|B1|< 40 years||Age, Customized||participants|Number|13|13.0||||||
4275922|NCT00574990|4100262|B4|United States||Region of Enrollment||participants|Number|39|39.0||||||
4275923|NCT00574990|4100263|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4275924|NCT00574990|4100264|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4275925|NCT00574990|4100265|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4275926|NCT00574990|4100262|B4||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4275927|NCT00574990|4100263|B3||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||No demographics were collected including gender.
4275928|NCT00574990|4100264|B2||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||No demographics were collected including gender.
4275929|NCT00574990|4100265|B1||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||No demographics were collected including gender.
4275930|NCT00574990|4100262|B4||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4275931|NCT00574990|4100263|B3||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||No demographics were collected including gender.
4275932|NCT00574990|4100264|B2||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||No demographics were collected including gender.
4275933|NCT00574990|4100265|B1||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||No demographics were collected including gender.
4275934|NCT00574990|4100262|B4|18 to 75 years||Age, Customized||participants|Number|39|39.0||||||
4275935|NCT00574990|4100263|B3|18 to 75 years||Age, Customized||participants|Number|8|8.0||||||
4275936|NCT00574990|4100264|B2|18 to 75 years||Age, Customized||participants|Number|19|19.0||||||
4275937|NCT00574990|4100265|B1|18 to 75 years||Age, Customized||participants|Number|12|12.0||||||
4275938|NCT00574951|4100278|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4275939|NCT00574951|4100278|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4275940|NCT00574951|4100278|B1|Age at study entry|80-89 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
4275941|NCT00574951|4100278|B1|Age at study entry|70-79 years|Age, Customized||Participants|Count of Participants|5|5.0||||||
4275942|NCT00574951|4100278|B1|Age at study entry|60-69 years|Age, Customized||Participants|Count of Participants|9|9.0||||||
4275943|NCT00574951|4100278|B1|Age at study entry|50-59 years|Age, Customized||Participants|Count of Participants|7|7.0||||||
4275944|NCT00574951|4100278|B1|||Age||years|Mean|64.4|64.4|Standard Deviation|9.6|9.6|||
4275945|NCT00574912|4100286|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4275946|NCT00574912|4100286|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4275947|NCT00574912|4100286|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4275948|NCT00574912|4100286|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4275949|NCT00574912|4100286|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4275950|NCT00574912|4100286|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4275951|NCT00574873|4100298|B3||Male|Sex: Female, Male||Participants|Count of Participants|284|284.0||||||
4275952|NCT00574873|4100299|B2||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4275953|NCT00574873|4100300|B1||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4275954|NCT00574873|4100298|B3||Female|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4275955|NCT00574873|4100299|B2||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4275956|NCT00574873|4100300|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4275957|NCT00574873|4100298|B3|||Age||years|Mean|46.5|46.5|Standard Deviation|14.61|14.61|||
4275958|NCT00574873|4100299|B2|||Age||years|Mean|45.6|45.6|Standard Deviation|14.80|14.8|||
4275959|NCT00574873|4100300|B1|||Age||years|Mean|47.4|47.4|Standard Deviation|14.39|14.39|||
4275960|NCT00574847|4100317|B3|||History of Depression||participants|Number|21|21.0||||||
4275961|NCT00574847|4100318|B2|||History of Depression||participants|Number|10|10.0||||||
4275962|NCT00574847|4100319|B1|||History of Depression||participants|Number|11|11.0||||||
4275963|NCT00574847|4100317|B3||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4275964|NCT00574847|4100318|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4275965|NCT00574847|4100319|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4275966|NCT00574847|4100317|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4275967|NCT00574847|4100318|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4275968|NCT00574847|4100319|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4275969|NCT00574847|4100317|B3|||Age||years|Mean|64.0|64.0|Standard Deviation|10.7|10.7|||
4275970|NCT00574847|4100318|B2|||Age||years|Mean|61.4|61.4|Standard Deviation|11.5|11.5|||
4275971|NCT00574847|4100319|B1|||Age||years|Mean|66.5|66.5|Standard Deviation|9.3|9.3|||
4275972|NCT00574834|4100352|B4|United States||Region of Enrollment||participants|Number|17|17.0||||||
4275973|NCT00574834|4100353|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4275974|NCT00574834|4100354|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4275975|NCT00574834|4100355|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4275976|NCT00574834|4100352|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275977|NCT00574834|4100353|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275978|NCT00574834|4100354|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275979|NCT00574834|4100355|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275980|NCT00574834|4100352|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275981|NCT00574834|4100353|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275982|NCT00574834|4100354|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275983|NCT00574834|4100355|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275984|NCT00574834|4100352|B4||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4275985|NCT00574834|4100353|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4275986|NCT00574834|4100354|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4275987|NCT00574834|4100355|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4275988|NCT00574834|4100352|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4275989|NCT00574834|4100353|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4275990|NCT00574834|4100354|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4275991|NCT00574834|4100355|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4275992|NCT00574834|4100352|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275993|NCT00574834|4100353|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275994|NCT00574834|4100354|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275995|NCT00574834|4100355|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275996|NCT00574834|4100352|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275997|NCT00574834|4100353|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275998|NCT00574834|4100354|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4275999|NCT00574834|4100355|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276000|NCT00574834|4100352|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276001|NCT00574834|4100353|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276002|NCT00574834|4100354|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276003|NCT00574834|4100355|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276004|NCT00574834|4100352|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4276005|NCT00574834|4100353|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4276006|NCT00574834|4100354|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4276007|NCT00574834|4100355|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4276008|NCT00574834|4100352|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4276009|NCT00574834|4100353|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4276010|NCT00574834|4100354|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4276011|NCT00574834|4100355|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4276012|NCT00574834|4100352|B4|||Age||years|Mean|46|46.0|Standard Deviation|10|10.0|||
4276013|NCT00574834|4100353|B3|||Age||years|Mean|41|41.0|Standard Deviation|13|13.0|||
4276014|NCT00574834|4100354|B2|||Age||years|Mean|46|46.0|Standard Deviation|9|9.0|||
4276015|NCT00574834|4100355|B1|||Age||years|Mean|49|49.0|Standard Deviation|8.5|8.5|||
4276016|NCT00574834|4100352|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4276017|NCT00574834|4100353|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4276018|NCT00574834|4100354|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4276019|NCT00574834|4100355|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4276020|NCT00574834|4100352|B4||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4276021|NCT00574834|4100353|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4276022|NCT00574834|4100354|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4276023|NCT00574834|4100355|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4276024|NCT00574834|4100352|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276025|NCT00574834|4100353|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276026|NCT00574834|4100354|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276027|NCT00574834|4100355|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276028|NCT00574795|4100365|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4276029|NCT00574795|4100365|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4276030|NCT00574795|4100365|B1|||Age||months|Mean|3.7|3.7|Standard Deviation|1.5|1.5|||
4276031|NCT00574704|4100382|B5|Europe||Region of Enrollment||participants|Number|40|40.0||||||
4276032|NCT00574704|4100383|B4|Europe||Region of Enrollment||participants|Number|10|10.0||||||
4276033|NCT00574704|4100384|B3|Europe||Region of Enrollment||participants|Number|10|10.0||||||
4276034|NCT00574704|4100385|B2|Europe||Region of Enrollment||participants|Number|10|10.0||||||
4276035|NCT00574704|4100386|B1|Europe||Region of Enrollment||participants|Number|10|10.0||||||
4276036|NCT00574704|4100382|B5||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4276037|NCT00574704|4100383|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4276038|NCT00574704|4100384|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4276039|NCT00574704|4100385|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4276040|NCT00574704|4100386|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4276041|NCT00574704|4100382|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4276042|NCT00574704|4100383|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4276043|NCT00574704|4100384|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4276044|NCT00574704|4100385|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4276045|NCT00574704|4100386|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4276046|NCT00574704|4100382|B5|||Age||years|Mean|34.6|34.6|Standard Deviation|11.5|11.5|||
4276047|NCT00574704|4100383|B4|||Age||years|Mean|31.0|31.0|Standard Deviation|15.9|15.9|||
4276048|NCT00574704|4100384|B3|||Age||years|Mean|36.8|36.8|Standard Deviation|11.0|11.0|||
4276049|NCT00574704|4100385|B2|||Age||years|Mean|36.5|36.5|Standard Deviation|9.8|9.8|||
4276050|NCT00574704|4100386|B1|||Age||years|Mean|34.2|34.2|Standard Deviation|8.6|8.6|||
4276051|NCT00574704|4100382|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4276052|NCT00574704|4100383|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4276053|NCT00574704|4100384|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4276054|NCT00574704|4100385|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4276055|NCT00574704|4100386|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4276056|NCT00574704|4100382|B5||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4276057|NCT00574704|4100383|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4276058|NCT00574704|4100384|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4276059|NCT00574704|4100385|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4276060|NCT00574704|4100386|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4276061|NCT00574704|4100382|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276062|NCT00574704|4100383|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276063|NCT00574704|4100384|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276064|NCT00574704|4100385|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276065|NCT00574704|4100386|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276066|NCT00574548|4100399|B3||Male|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
4276067|NCT00574548|4100400|B2||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4276068|NCT00574548|4100401|B1||Male|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4276069|NCT00574548|4100399|B3||Female|Sex: Female, Male||Participants|Count of Participants|415|415.0||||||
4276070|NCT00574548|4100400|B2||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4276071|NCT00574548|4100401|B1||Female|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
4276072|NCT00574548|4100399|B3|||Age||years|Mean|61.7|61.7|Standard Deviation|1.4|1.4|||
4276073|NCT00574548|4100400|B2|||Age||years|Mean|61.7|61.7|Standard Deviation|1.4|1.4|||
4276074|NCT00574548|4100401|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|1.4|1.4|||
4276075|NCT00574405|4100446|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4276076|NCT00574405|4100447|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4276077|NCT00574405|4100448|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4276078|NCT00574405|4100446|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4276079|NCT00574405|4100447|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4276080|NCT00574405|4100448|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4276081|NCT00574405|4100446|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4276082|NCT00574405|4100447|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4276083|NCT00574405|4100448|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4276084|NCT00574405|4100446|B3|||Age||years|Mean|12.1|12.1|Standard Deviation|2.8|2.8|||
4276085|NCT00574405|4100447|B2|||Age||years|Mean|12.1|12.1|Standard Deviation|3.6|3.6|||
4276086|NCT00574405|4100448|B1|||Age||years|Mean|12.1|12.1|Standard Deviation|2.5|2.5|||
4276087|NCT00574405|4100446|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4276088|NCT00574405|4100447|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4276089|NCT00574405|4100448|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4276090|NCT00574405|4100446|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4276091|NCT00574405|4100447|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4276092|NCT00574405|4100448|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4276093|NCT00574405|4100446|B3||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
4276094|NCT00574405|4100447|B2||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4276095|NCT00574405|4100448|B1||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4276096|NCT00574340|4100455|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4276097|NCT00574340|4100455|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276098|NCT00574340|4100455|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4276099|NCT00574340|4100455|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276100|NCT00574340|4100455|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4276101|NCT00574340|4100455|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4276102|NCT00574340|4100455|B1|||Age||years|Mean|35|35.0|Standard Deviation|1|1.0|||
4276103|NCT00574340|4100455|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4276104|NCT00574340|4100455|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4276105|NCT00574340|4100455|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276106|NCT00574288|4100462|B8||None|Refractory to proteasome inhibitor (PI)/immunomodulatory agent (IMiD)||Participants|Count of Participants|32|32.0||||||
4276107|NCT00574288|4100463|B7||None|Refractory to proteasome inhibitor (PI)/immunomodulatory agent (IMiD)||Participants|Count of Participants|8|8.0||||||
4276108|NCT00574288|4100464|B6||None|Refractory to proteasome inhibitor (PI)/immunomodulatory agent (IMiD)||Participants|Count of Participants|3|3.0||||||
4276109|NCT00574288|4100465|B5||None|Refractory to proteasome inhibitor (PI)/immunomodulatory agent (IMiD)||Participants|Count of Participants|0|0.0||||||
4276110|NCT00574288|4100466|B4||None|Refractory to proteasome inhibitor (PI)/immunomodulatory agent (IMiD)||Participants|Count of Participants|1|1.0||||||
4276111|NCT00574288|4100467|B3||None|Refractory to proteasome inhibitor (PI)/immunomodulatory agent (IMiD)||Participants|Count of Participants|0|0.0||||||
4276112|NCT00574288|4100468|B2||None|Refractory to proteasome inhibitor (PI)/immunomodulatory agent (IMiD)||Participants|Count of Participants|0|0.0||||||
4276113|NCT00574288|4100469|B1||None|Refractory to proteasome inhibitor (PI)/immunomodulatory agent (IMiD)||Participants|Count of Participants|20|20.0||||||
4276114|NCT00574288|4100462|B8||IMiD only|Refractory to proteasome inhibitor (PI)/immunomodulatory agent (IMiD)||Participants|Count of Participants|12|12.0||||||
4276115|NCT00574288|4100463|B7||IMiD only|Refractory to proteasome inhibitor (PI)/immunomodulatory agent (IMiD)||Participants|Count of Participants|4|4.0||||||
4276116|NCT00574288|4100464|B6||IMiD only|Refractory to proteasome inhibitor (PI)/immunomodulatory agent (IMiD)||Participants|Count of Participants|6|6.0||||||
4276117|NCT00574288|4100465|B5||IMiD only|Refractory to proteasome inhibitor (PI)/immunomodulatory agent (IMiD)||Participants|Count of Participants|1|1.0||||||
4276118|NCT00574288|4100466|B4||IMiD only|Refractory to proteasome inhibitor (PI)/immunomodulatory agent (IMiD)||Participants|Count of Participants|1|1.0||||||
4276119|NCT00574288|4100467|B3||IMiD only|Refractory to proteasome inhibitor (PI)/immunomodulatory agent (IMiD)||Participants|Count of Participants|0|0.0||||||
4276120|NCT00574288|4100468|B2||IMiD only|Refractory to proteasome inhibitor (PI)/immunomodulatory agent (IMiD)||Participants|Count of Participants|0|0.0||||||
4276121|NCT00574288|4100469|B1||IMiD only|Refractory to proteasome inhibitor (PI)/immunomodulatory agent (IMiD)||Participants|Count of Participants|0|0.0||||||
4276122|NCT00574288|4100462|B8||PI only|Refractory to proteasome inhibitor (PI)/immunomodulatory agent (IMiD)||Participants|Count of Participants|6|6.0||||||
4276123|NCT00574288|4100463|B7||PI only|Refractory to proteasome inhibitor (PI)/immunomodulatory agent (IMiD)||Participants|Count of Participants|3|3.0||||||
4276124|NCT00574288|4100464|B6||PI only|Refractory to proteasome inhibitor (PI)/immunomodulatory agent (IMiD)||Participants|Count of Participants|2|2.0||||||
4276125|NCT00574288|4100465|B5||PI only|Refractory to proteasome inhibitor (PI)/immunomodulatory agent (IMiD)||Participants|Count of Participants|0|0.0||||||
4276126|NCT00574288|4100466|B4||PI only|Refractory to proteasome inhibitor (PI)/immunomodulatory agent (IMiD)||Participants|Count of Participants|0|0.0||||||
4276127|NCT00574288|4100467|B3||PI only|Refractory to proteasome inhibitor (PI)/immunomodulatory agent (IMiD)||Participants|Count of Participants|0|0.0||||||
4276128|NCT00574288|4100468|B2||PI only|Refractory to proteasome inhibitor (PI)/immunomodulatory agent (IMiD)||Participants|Count of Participants|1|1.0||||||
4276129|NCT00574288|4100469|B1||PI only|Refractory to proteasome inhibitor (PI)/immunomodulatory agent (IMiD)||Participants|Count of Participants|0|0.0||||||
4276130|NCT00574288|4100462|B8||Both a PI and IMiD|Refractory to proteasome inhibitor (PI)/immunomodulatory agent (IMiD)||Participants|Count of Participants|54|54.0||||||
4276131|NCT00574288|4100463|B7||Both a PI and IMiD|Refractory to proteasome inhibitor (PI)/immunomodulatory agent (IMiD)||Participants|Count of Participants|27|27.0||||||
4276132|NCT00574288|4100464|B6||Both a PI and IMiD|Refractory to proteasome inhibitor (PI)/immunomodulatory agent (IMiD)||Participants|Count of Participants|19|19.0||||||
4276133|NCT00574288|4100465|B5||Both a PI and IMiD|Refractory to proteasome inhibitor (PI)/immunomodulatory agent (IMiD)||Participants|Count of Participants|2|2.0||||||
4276134|NCT00574288|4100466|B4||Both a PI and IMiD|Refractory to proteasome inhibitor (PI)/immunomodulatory agent (IMiD)||Participants|Count of Participants|1|1.0||||||
4276135|NCT00574288|4100467|B3||Both a PI and IMiD|Refractory to proteasome inhibitor (PI)/immunomodulatory agent (IMiD)||Participants|Count of Participants|3|3.0||||||
4276136|NCT00574288|4100468|B2||Both a PI and IMiD|Refractory to proteasome inhibitor (PI)/immunomodulatory agent (IMiD)||Participants|Count of Participants|2|2.0||||||
4276137|NCT00574288|4100469|B1||Both a PI and IMiD|Refractory to proteasome inhibitor (PI)/immunomodulatory agent (IMiD)||Participants|Count of Participants|0|0.0||||||
4276138|NCT00574288|4100462|B8||> 3 Lines|No. of Prior Lines of Therapy||Participants|Count of Participants|78|78.0||||||
4276139|NCT00574288|4100463|B7||> 3 Lines|No. of Prior Lines of Therapy||Participants|Count of Participants|26|26.0||||||
4276140|NCT00574288|4100464|B6||> 3 Lines|No. of Prior Lines of Therapy||Participants|Count of Participants|24|24.0||||||
4276141|NCT00574288|4100465|B5||> 3 Lines|No. of Prior Lines of Therapy||Participants|Count of Participants|3|3.0||||||
4276142|NCT00574288|4100466|B4||> 3 Lines|No. of Prior Lines of Therapy||Participants|Count of Participants|3|3.0||||||
4276143|NCT00574288|4100467|B3||> 3 Lines|No. of Prior Lines of Therapy||Participants|Count of Participants|3|3.0||||||
4276144|NCT00574288|4100468|B2||> 3 Lines|No. of Prior Lines of Therapy||Participants|Count of Participants|1|1.0||||||
4276145|NCT00574288|4100469|B1||> 3 Lines|No. of Prior Lines of Therapy||Participants|Count of Participants|18|18.0||||||
4276146|NCT00574288|4100462|B8||<= 3 Lines|No. of Prior Lines of Therapy||Participants|Count of Participants|26|26.0||||||
4276147|NCT00574288|4100463|B7||<= 3 Lines|No. of Prior Lines of Therapy||Participants|Count of Participants|16|16.0||||||
4276148|NCT00574288|4100464|B6||<= 3 Lines|No. of Prior Lines of Therapy||Participants|Count of Participants|6|6.0||||||
4276149|NCT00574288|4100465|B5||<= 3 Lines|No. of Prior Lines of Therapy||Participants|Count of Participants|0|0.0||||||
4276150|NCT00574288|4100466|B4||<= 3 Lines|No. of Prior Lines of Therapy||Participants|Count of Participants|0|0.0||||||
4276151|NCT00574288|4100467|B3||<= 3 Lines|No. of Prior Lines of Therapy||Participants|Count of Participants|0|0.0||||||
4276152|NCT00574288|4100468|B2||<= 3 Lines|No. of Prior Lines of Therapy||Participants|Count of Participants|2|2.0||||||
4276153|NCT00574288|4100469|B1||<= 3 Lines|No. of Prior Lines of Therapy||Participants|Count of Participants|2|2.0||||||
4276154|NCT00574288|4100462|B8|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4276155|NCT00574288|4100463|B7|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4276156|NCT00574288|4100464|B6|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4276157|NCT00574288|4100465|B5|United States||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4276158|NCT00574288|4100466|B4|United States||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4276159|NCT00574288|4100467|B3|United States||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4276160|NCT00574288|4100468|B2|United States||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4276161|NCT00574288|4100469|B1|United States||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4276162|NCT00574288|4100462|B8|Sweden||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4276163|NCT00574288|4100463|B7|Sweden||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4276164|NCT00574288|4100464|B6|Sweden||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4276165|NCT00574288|4100465|B5|Sweden||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4276166|NCT00574288|4100466|B4|Sweden||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4276167|NCT00574288|4100467|B3|Sweden||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4276168|NCT00574288|4100468|B2|Sweden||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4276169|NCT00574288|4100469|B1|Sweden||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4276170|NCT00574288|4100462|B8|Netherlands||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
4276171|NCT00574288|4100463|B7|Netherlands||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4276172|NCT00574288|4100464|B6|Netherlands||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4276173|NCT00574288|4100465|B5|Netherlands||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4276174|NCT00574288|4100466|B4|Netherlands||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4276175|NCT00574288|4100467|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4276176|NCT00574288|4100468|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4276177|NCT00574288|4100469|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4276178|NCT00574288|4100462|B8|Denmark||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4276179|NCT00574288|4100463|B7|Denmark||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4276180|NCT00574288|4100464|B6|Denmark||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4276181|NCT00574288|4100465|B5|Denmark||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4276182|NCT00574288|4100466|B4|Denmark||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4276183|NCT00574288|4100467|B3|Denmark||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4276184|NCT00574288|4100468|B2|Denmark||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4276185|NCT00574288|4100469|B1|Denmark||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4276186|NCT00574288|4100462|B8||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4276187|NCT00574288|4100463|B7||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4276188|NCT00574288|4100464|B6||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4276189|NCT00574288|4100465|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4276190|NCT00574288|4100466|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4276191|NCT00574288|4100467|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4276192|NCT00574288|4100468|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4276193|NCT00574288|4100469|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4276194|NCT00574288|4100462|B8||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4276195|NCT00574288|4100463|B7||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4276196|NCT00574288|4100464|B6||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4276197|NCT00574288|4100465|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4276198|NCT00574288|4100466|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4276199|NCT00574288|4100467|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4276200|NCT00574288|4100468|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4276201|NCT00574288|4100469|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4276202|NCT00574288|4100462|B8|||Age||years|Mean|61.4|61.4|Standard Deviation|9|9.0|||
4276203|NCT00574288|4100463|B7|||Age||years|Mean|63.8|63.8|Standard Deviation|8.27|8.27|||
4276204|NCT00574288|4100464|B6|||Age||years|Mean|58.6|58.6|Standard Deviation|10.05|10.05|||
4276205|NCT00574288|4100465|B5|||Age||years|Mean|59|59.0|Standard Deviation|9.54|9.54|||
4276206|NCT00574288|4100466|B4|||Age||years|Mean|53|53.0|Standard Deviation|1.73|1.73|||
4276207|NCT00574288|4100467|B3|||Age||years|Mean|61.3|61.3|Standard Deviation|6.11|6.11|||
4276208|NCT00574288|4100468|B2|||Age||years|Mean|64|64.0|Standard Deviation|2|2.0|||
4276209|NCT00574288|4100469|B1|||Age||years|Mean|61.8|61.8|Standard Deviation|9.24|9.24|||
4276210|NCT00574288|4100462|B8||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
4276211|NCT00574288|4100463|B7||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4276212|NCT00574288|4100464|B6||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4276213|NCT00574288|4100465|B5||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4276214|NCT00574288|4100466|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4276215|NCT00574288|4100467|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4276216|NCT00574288|4100468|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4276217|NCT00574288|4100469|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4276218|NCT00574288|4100462|B8||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4276219|NCT00574288|4100463|B7||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4276220|NCT00574288|4100464|B6||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4276221|NCT00574288|4100465|B5||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4276222|NCT00574288|4100466|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4276223|NCT00574288|4100467|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4276224|NCT00574288|4100468|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4276225|NCT00574288|4100469|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4276226|NCT00574288|4100462|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276227|NCT00574288|4100463|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276228|NCT00574288|4100464|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276229|NCT00574288|4100465|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276230|NCT00574288|4100466|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276231|NCT00574288|4100467|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276232|NCT00574288|4100468|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276233|NCT00574288|4100469|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276234|NCT00574275|4100511|B3|No||Primary tumor resection|Whether the participant had prior pancreatectomy.|participants|Number|467|467.0||||||
4276235|NCT00574275|4100512|B2|No||Primary tumor resection|Whether the participant had prior pancreatectomy.|participants|Number|232|232.0||||||
4276236|NCT00574275|4100513|B1|No||Primary tumor resection|Whether the participant had prior pancreatectomy.|participants|Number|235|235.0||||||
4276237|NCT00574275|4100511|B3|Yes||Primary tumor resection|Whether the participant had prior pancreatectomy.|participants|Number|79|79.0||||||
4276238|NCT00574275|4100512|B2|Yes||Primary tumor resection|Whether the participant had prior pancreatectomy.|participants|Number|39|39.0||||||
4276239|NCT00574275|4100513|B1|Yes||Primary tumor resection|Whether the participant had prior pancreatectomy.|participants|Number|40|40.0||||||
4276240|NCT00574275|4100511|B3|Participants with ECOG Score = 2||Eastern Cooperative Oncology Group (ECOG) Performance Status Score|"The ECOG score assesses how the disease affects a participant's daily living abilities. It ranges from 0-5, with 0 being the best and 5 being the worst outcome. 0 reflects a fully active participant, able to carry on all pre-disease performance without restriction. 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. 2 reflects an ambulatory participant, who is up and about more than 50% of waking hours, and capable of all self-care but unable to carry out any work activities."|participants|Number|36|36.0||||||
4276241|NCT00574275|4100512|B2|Participants with ECOG Score = 2||Eastern Cooperative Oncology Group (ECOG) Performance Status Score|"The ECOG score assesses how the disease affects a participant's daily living abilities. It ranges from 0-5, with 0 being the best and 5 being the worst outcome. 0 reflects a fully active participant, able to carry on all pre-disease performance without restriction. 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. 2 reflects an ambulatory participant, who is up and about more than 50% of waking hours, and capable of all self-care but unable to carry out any work activities."|participants|Number|17|17.0||||||
4276242|NCT00574275|4100513|B1|Participants with ECOG Score = 2||Eastern Cooperative Oncology Group (ECOG) Performance Status Score|"The ECOG score assesses how the disease affects a participant's daily living abilities. It ranges from 0-5, with 0 being the best and 5 being the worst outcome. 0 reflects a fully active participant, able to carry on all pre-disease performance without restriction. 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. 2 reflects an ambulatory participant, who is up and about more than 50% of waking hours, and capable of all self-care but unable to carry out any work activities."|participants|Number|19|19.0||||||
4276277|NCT00574275|4100512|B2|ITALY||Region of Enrollment||participants|Number|24|24.0||||||
4276278|NCT00574275|4100513|B1|ITALY||Region of Enrollment||participants|Number|17|17.0||||||
4276279|NCT00574275|4100511|B3|INDIA||Region of Enrollment||participants|Number|6|6.0||||||
4276280|NCT00574275|4100512|B2|INDIA||Region of Enrollment||participants|Number|3|3.0||||||
4276243|NCT00574275|4100511|B3|Participants with ECOG Score = 1||Eastern Cooperative Oncology Group (ECOG) Performance Status Score|"The ECOG score assesses how the disease affects a participant's daily living abilities. It ranges from 0-5, with 0 being the best and 5 being the worst outcome. 0 reflects a fully active participant, able to carry on all pre-disease performance without restriction. 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. 2 reflects an ambulatory participant, who is up and about more than 50% of waking hours, and capable of all self-care but unable to carry out any work activities."|participants|Number|306|306.0||||||
4276244|NCT00574275|4100512|B2|Participants with ECOG Score = 1||Eastern Cooperative Oncology Group (ECOG) Performance Status Score|"The ECOG score assesses how the disease affects a participant's daily living abilities. It ranges from 0-5, with 0 being the best and 5 being the worst outcome. 0 reflects a fully active participant, able to carry on all pre-disease performance without restriction. 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. 2 reflects an ambulatory participant, who is up and about more than 50% of waking hours, and capable of all self-care but unable to carry out any work activities."|participants|Number|152|152.0||||||
4276245|NCT00574275|4100513|B1|Participants with ECOG Score = 1||Eastern Cooperative Oncology Group (ECOG) Performance Status Score|"The ECOG score assesses how the disease affects a participant's daily living abilities. It ranges from 0-5, with 0 being the best and 5 being the worst outcome. 0 reflects a fully active participant, able to carry on all pre-disease performance without restriction. 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. 2 reflects an ambulatory participant, who is up and about more than 50% of waking hours, and capable of all self-care but unable to carry out any work activities."|participants|Number|154|154.0||||||
4276246|NCT00574275|4100511|B3|Participants with ECOG Score = 0||Eastern Cooperative Oncology Group (ECOG) Performance Status Score|"The ECOG score assesses how the disease affects a participant's daily living abilities. It ranges from 0-5, with 0 being the best and 5 being the worst outcome. 0 reflects a fully active participant, able to carry on all pre-disease performance without restriction. 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. 2 reflects an ambulatory participant, who is up and about more than 50% of waking hours, and capable of all self-care but unable to carry out any work activities."|participants|Number|204|204.0||||||
4276247|NCT00574275|4100512|B2|Participants with ECOG Score = 0||Eastern Cooperative Oncology Group (ECOG) Performance Status Score|"The ECOG score assesses how the disease affects a participant's daily living abilities. It ranges from 0-5, with 0 being the best and 5 being the worst outcome. 0 reflects a fully active participant, able to carry on all pre-disease performance without restriction. 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. 2 reflects an ambulatory participant, who is up and about more than 50% of waking hours, and capable of all self-care but unable to carry out any work activities."|participants|Number|102|102.0||||||
4276248|NCT00574275|4100513|B1|Participants with ECOG Score = 0||Eastern Cooperative Oncology Group (ECOG) Performance Status Score|"The ECOG score assesses how the disease affects a participant's daily living abilities. It ranges from 0-5, with 0 being the best and 5 being the worst outcome. 0 reflects a fully active participant, able to carry on all pre-disease performance without restriction. 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. 2 reflects an ambulatory participant, who is up and about more than 50% of waking hours, and capable of all self-care but unable to carry out any work activities."|participants|Number|102|102.0||||||
4276249|NCT00574275|4100511|B3|UNITED STATES||Region of Enrollment||participants|Number|138|138.0||||||
4276250|NCT00574275|4100512|B2|UNITED STATES||Region of Enrollment||participants|Number|68|68.0||||||
4276251|NCT00574275|4100513|B1|UNITED STATES||Region of Enrollment||participants|Number|70|70.0||||||
4276252|NCT00574275|4100511|B3|SWITZERLAND||Region of Enrollment||participants|Number|17|17.0||||||
4276253|NCT00574275|4100512|B2|SWITZERLAND||Region of Enrollment||participants|Number|9|9.0||||||
4276254|NCT00574275|4100513|B1|SWITZERLAND||Region of Enrollment||participants|Number|8|8.0||||||
4276255|NCT00574275|4100511|B3|SPAIN||Region of Enrollment||participants|Number|27|27.0||||||
4276256|NCT00574275|4100512|B2|SPAIN||Region of Enrollment||participants|Number|14|14.0||||||
4276257|NCT00574275|4100513|B1|SPAIN||Region of Enrollment||participants|Number|13|13.0||||||
4276258|NCT00574275|4100511|B3|SLOVAKIA||Region of Enrollment||participants|Number|8|8.0||||||
4276259|NCT00574275|4100512|B2|SLOVAKIA||Region of Enrollment||participants|Number|3|3.0||||||
4276260|NCT00574275|4100513|B1|SLOVAKIA||Region of Enrollment||participants|Number|5|5.0||||||
4276261|NCT00574275|4100511|B3|RUSSIAN FEDERATION||Region of Enrollment||participants|Number|38|38.0||||||
4276262|NCT00574275|4100512|B2|RUSSIAN FEDERATION||Region of Enrollment||participants|Number|19|19.0||||||
4276263|NCT00574275|4100513|B1|RUSSIAN FEDERATION||Region of Enrollment||participants|Number|19|19.0||||||
4276264|NCT00574275|4100511|B3|ROMANIA||Region of Enrollment||participants|Number|21|21.0||||||
4276265|NCT00574275|4100512|B2|ROMANIA||Region of Enrollment||participants|Number|8|8.0||||||
4276266|NCT00574275|4100513|B1|ROMANIA||Region of Enrollment||participants|Number|13|13.0||||||
4276267|NCT00574275|4100511|B3|PUERTO RICO||Region of Enrollment||participants|Number|1|1.0||||||
4276268|NCT00574275|4100512|B2|PUERTO RICO||Region of Enrollment||participants|Number|0|0.0||||||
4276269|NCT00574275|4100513|B1|PUERTO RICO||Region of Enrollment||participants|Number|1|1.0||||||
4276270|NCT00574275|4100511|B3|POLAND||Region of Enrollment||participants|Number|23|23.0||||||
4276271|NCT00574275|4100512|B2|POLAND||Region of Enrollment||participants|Number|11|11.0||||||
4276272|NCT00574275|4100513|B1|POLAND||Region of Enrollment||participants|Number|12|12.0||||||
4276273|NCT00574275|4100511|B3|MEXICO||Region of Enrollment||participants|Number|3|3.0||||||
4276274|NCT00574275|4100512|B2|MEXICO||Region of Enrollment||participants|Number|2|2.0||||||
4276275|NCT00574275|4100513|B1|MEXICO||Region of Enrollment||participants|Number|1|1.0||||||
4276276|NCT00574275|4100511|B3|ITALY||Region of Enrollment||participants|Number|41|41.0||||||
4276281|NCT00574275|4100513|B1|INDIA||Region of Enrollment||participants|Number|3|3.0||||||
4276282|NCT00574275|4100511|B3|HUNGARY||Region of Enrollment||participants|Number|17|17.0||||||
4276283|NCT00574275|4100512|B2|HUNGARY||Region of Enrollment||participants|Number|10|10.0||||||
4276284|NCT00574275|4100513|B1|HUNGARY||Region of Enrollment||participants|Number|7|7.0||||||
4276285|NCT00574275|4100511|B3|GREECE||Region of Enrollment||participants|Number|12|12.0||||||
4276286|NCT00574275|4100512|B2|GREECE||Region of Enrollment||participants|Number|7|7.0||||||
4276287|NCT00574275|4100513|B1|GREECE||Region of Enrollment||participants|Number|5|5.0||||||
4276288|NCT00574275|4100511|B3|GERMANY||Region of Enrollment||participants|Number|25|25.0||||||
4276289|NCT00574275|4100512|B2|GERMANY||Region of Enrollment||participants|Number|10|10.0||||||
4276290|NCT00574275|4100513|B1|GERMANY||Region of Enrollment||participants|Number|15|15.0||||||
4276291|NCT00574275|4100511|B3|FRANCE||Region of Enrollment||participants|Number|24|24.0||||||
4276292|NCT00574275|4100512|B2|FRANCE||Region of Enrollment||participants|Number|13|13.0||||||
4276293|NCT00574275|4100513|B1|FRANCE||Region of Enrollment||participants|Number|11|11.0||||||
4276294|NCT00574275|4100511|B3|CZECH REPUBLIC||Region of Enrollment||participants|Number|24|24.0||||||
4276295|NCT00574275|4100512|B2|CZECH REPUBLIC||Region of Enrollment||participants|Number|14|14.0||||||
4276296|NCT00574275|4100513|B1|CZECH REPUBLIC||Region of Enrollment||participants|Number|10|10.0||||||
4276297|NCT00574275|4100511|B3|CYPRUS||Region of Enrollment||participants|Number|6|6.0||||||
4276298|NCT00574275|4100512|B2|CYPRUS||Region of Enrollment||participants|Number|3|3.0||||||
4276299|NCT00574275|4100513|B1|CYPRUS||Region of Enrollment||participants|Number|3|3.0||||||
4276300|NCT00574275|4100511|B3|CHILE||Region of Enrollment||participants|Number|16|16.0||||||
4276301|NCT00574275|4100512|B2|CHILE||Region of Enrollment||participants|Number|8|8.0||||||
4276302|NCT00574275|4100513|B1|CHILE||Region of Enrollment||participants|Number|8|8.0||||||
4276303|NCT00574275|4100511|B3|CANADA||Region of Enrollment||participants|Number|31|31.0||||||
4276304|NCT00574275|4100512|B2|CANADA||Region of Enrollment||participants|Number|16|16.0||||||
4276305|NCT00574275|4100513|B1|CANADA||Region of Enrollment||participants|Number|15|15.0||||||
4276306|NCT00574275|4100511|B3|BULGARIA||Region of Enrollment||participants|Number|23|23.0||||||
4276307|NCT00574275|4100512|B2|BULGARIA||Region of Enrollment||participants|Number|11|11.0||||||
4276308|NCT00574275|4100513|B1|BULGARIA||Region of Enrollment||participants|Number|12|12.0||||||
4276309|NCT00574275|4100511|B3|BELGIUM||Region of Enrollment||participants|Number|34|34.0||||||
4276310|NCT00574275|4100512|B2|BELGIUM||Region of Enrollment||participants|Number|16|16.0||||||
4276311|NCT00574275|4100513|B1|BELGIUM||Region of Enrollment||participants|Number|18|18.0||||||
4276312|NCT00574275|4100511|B3|AUSTRIA||Region of Enrollment||participants|Number|8|8.0||||||
4276313|NCT00574275|4100512|B2|AUSTRIA||Region of Enrollment||participants|Number|2|2.0||||||
4276314|NCT00574275|4100513|B1|AUSTRIA||Region of Enrollment||participants|Number|6|6.0||||||
4276315|NCT00574275|4100511|B3|ARGENTINA||Region of Enrollment||participants|Number|3|3.0||||||
4276316|NCT00574275|4100512|B2|ARGENTINA||Region of Enrollment||participants|Number|0|0.0||||||
4276317|NCT00574275|4100513|B1|ARGENTINA||Region of Enrollment||participants|Number|3|3.0||||||
4276318|NCT00574275|4100511|B3|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4276319|NCT00574275|4100512|B2|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4276320|NCT00574275|4100513|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4276321|NCT00574275|4100511|B3|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4276322|NCT00574275|4100512|B2|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4276323|NCT00574275|4100513|B1|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4276324|NCT00574275|4100511|B3|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4276325|NCT00574275|4100512|B2|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4276326|NCT00574275|4100513|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4276327|NCT00574275|4100511|B3|Caucasian/White||Race/Ethnicity, Customized||participants|Number|523|523.0||||||
4276328|NCT00574275|4100512|B2|Caucasian/White||Race/Ethnicity, Customized||participants|Number|256|256.0||||||
4276329|NCT00574275|4100513|B1|Caucasian/White||Race/Ethnicity, Customized||participants|Number|267|267.0||||||
4276330|NCT00574275|4100511|B3|Female||Sex/Gender, Customized||participants|Number|229|229.0||||||
4276331|NCT00574275|4100512|B2|Female||Sex/Gender, Customized||participants|Number|111|111.0||||||
4276332|NCT00574275|4100513|B1|Female||Sex/Gender, Customized||participants|Number|118|118.0||||||
4276333|NCT00574275|4100511|B3|Male||Sex/Gender, Customized||participants|Number|317|317.0||||||
4276334|NCT00574275|4100512|B2|Male||Sex/Gender, Customized||participants|Number|160|160.0||||||
4276335|NCT00574275|4100513|B1|Male||Sex/Gender, Customized||participants|Number|157|157.0||||||
4276336|NCT00574275|4100511|B3|>=75 years||Age, Customized||participants|Number|39|39.0||||||
4276337|NCT00574275|4100512|B2|>=75 years||Age, Customized||participants|Number|20|20.0||||||
4276338|NCT00574275|4100513|B1|>=75 years||Age, Customized||participants|Number|19|19.0||||||
4276339|NCT00574275|4100511|B3|>=65 but <75 years||Age, Customized||participants|Number|167|167.0||||||
4276340|NCT00574275|4100512|B2|>=65 but <75 years||Age, Customized||participants|Number|90|90.0||||||
4276341|NCT00574275|4100513|B1|>=65 but <75 years||Age, Customized||participants|Number|77|77.0||||||
4276342|NCT00574275|4100511|B3|<65 years||Age, Customized||participants|Number|340|340.0||||||
4276343|NCT00574275|4100512|B2|<65 years||Age, Customized||participants|Number|161|161.0||||||
4276344|NCT00574275|4100513|B1|<65 years||Age, Customized||participants|Number|179|179.0||||||
4276345|NCT00574275|4100511|B3|||Age||Years|Mean|61.2|61.2|Standard Deviation|9.7|9.7|||
4276346|NCT00574275|4100512|B2|||Age||Years|Mean|62.0|62.0|Standard Deviation|9.4|9.4|||
4276347|NCT00574275|4100513|B1|||Age||Years|Mean|60.4|60.4|Standard Deviation|10.0|10.0|||
4276348|NCT00574249|4100530|B3|United Kingdom||Region of Enrollment||participants|Number|39|39.0||||||
4276349|NCT00574249|4100531|B2|United Kingdom||Region of Enrollment||participants|Number|21|21.0||||||
4276350|NCT00574249|4100532|B1|United Kingdom||Region of Enrollment||participants|Number|18|18.0||||||
4276351|NCT00574249|4100530|B3|Turkey||Region of Enrollment||participants|Number|28|28.0||||||
4276352|NCT00574249|4100531|B2|Turkey||Region of Enrollment||participants|Number|14|14.0||||||
4276353|NCT00574249|4100532|B1|Turkey||Region of Enrollment||participants|Number|14|14.0||||||
4276354|NCT00574249|4100530|B3|Switzerland||Region of Enrollment||participants|Number|22|22.0||||||
4276355|NCT00574249|4100531|B2|Switzerland||Region of Enrollment||participants|Number|10|10.0||||||
4276356|NCT00574249|4100532|B1|Switzerland||Region of Enrollment||participants|Number|12|12.0||||||
4276357|NCT00574249|4100530|B3|Sweden||Region of Enrollment||participants|Number|17|17.0||||||
4276358|NCT00574249|4100531|B2|Sweden||Region of Enrollment||participants|Number|8|8.0||||||
4276359|NCT00574249|4100532|B1|Sweden||Region of Enrollment||participants|Number|9|9.0||||||
4276360|NCT00574249|4100530|B3|Spain||Region of Enrollment||participants|Number|59|59.0||||||
4276361|NCT00574249|4100531|B2|Spain||Region of Enrollment||participants|Number|26|26.0||||||
4276362|NCT00574249|4100532|B1|Spain||Region of Enrollment||participants|Number|33|33.0||||||
4276363|NCT00574249|4100530|B3|Netherlands||Region of Enrollment||participants|Number|35|35.0||||||
4276364|NCT00574249|4100531|B2|Netherlands||Region of Enrollment||participants|Number|18|18.0||||||
4276365|NCT00574249|4100532|B1|Netherlands||Region of Enrollment||participants|Number|17|17.0||||||
4276366|NCT00574249|4100530|B3|Italy||Region of Enrollment||participants|Number|66|66.0||||||
4276367|NCT00574249|4100531|B2|Italy||Region of Enrollment||participants|Number|34|34.0||||||
4276368|NCT00574249|4100532|B1|Italy||Region of Enrollment||participants|Number|32|32.0||||||
4276369|NCT00574249|4100530|B3|Greece||Region of Enrollment||participants|Number|24|24.0||||||
4276370|NCT00574249|4100531|B2|Greece||Region of Enrollment||participants|Number|12|12.0||||||
4276371|NCT00574249|4100532|B1|Greece||Region of Enrollment||participants|Number|12|12.0||||||
4276372|NCT00574249|4100530|B3|Germany||Region of Enrollment||participants|Number|162|162.0||||||
4276373|NCT00574249|4100531|B2|Germany||Region of Enrollment||participants|Number|83|83.0||||||
4276374|NCT00574249|4100532|B1|Germany||Region of Enrollment||participants|Number|79|79.0||||||
4276375|NCT00574249|4100530|B3|France||Region of Enrollment||participants|Number|119|119.0||||||
4276376|NCT00574249|4100531|B2|France||Region of Enrollment||participants|Number|61|61.0||||||
4276377|NCT00574249|4100532|B1|France||Region of Enrollment||participants|Number|58|58.0||||||
4276378|NCT00574249|4100530|B3|Finland||Region of Enrollment||participants|Number|11|11.0||||||
4276379|NCT00574249|4100531|B2|Finland||Region of Enrollment||participants|Number|6|6.0||||||
4276380|NCT00574249|4100532|B1|Finland||Region of Enrollment||participants|Number|5|5.0||||||
4276381|NCT00574249|4100530|B3|Denmark||Region of Enrollment||participants|Number|30|30.0||||||
4276382|NCT00574249|4100531|B2|Denmark||Region of Enrollment||participants|Number|15|15.0||||||
4276383|NCT00574249|4100532|B1|Denmark||Region of Enrollment||participants|Number|15|15.0||||||
4276384|NCT00574249|4100530|B3|Czech Republic||Region of Enrollment||participants|Number|18|18.0||||||
4276385|NCT00574249|4100531|B2|Czech Republic||Region of Enrollment||participants|Number|10|10.0||||||
4276386|NCT00574249|4100532|B1|Czech Republic||Region of Enrollment||participants|Number|8|8.0||||||
4276387|NCT00574249|4100530|B3|Belgium||Region of Enrollment||participants|Number|76|76.0||||||
4276388|NCT00574249|4100531|B2|Belgium||Region of Enrollment||participants|Number|36|36.0||||||
4276389|NCT00574249|4100532|B1|Belgium||Region of Enrollment||participants|Number|40|40.0||||||
4276390|NCT00574249|4100530|B3|Austria||Region of Enrollment||participants|Number|24|24.0||||||
4276391|NCT00574249|4100531|B2|Austria||Region of Enrollment||participants|Number|12|12.0||||||
4276392|NCT00574249|4100532|B1|Austria||Region of Enrollment||participants|Number|12|12.0||||||
4276393|NCT00574249|4100530|B3||Male|Sex: Female, Male||Participants|Count of Participants|501|501.0||||||
4276394|NCT00574249|4100531|B2||Male|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
4276395|NCT00574249|4100532|B1||Male|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4276396|NCT00574249|4100530|B3||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4276397|NCT00574249|4100531|B2||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4276398|NCT00574249|4100532|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4276399|NCT00574249|4100530|B3|||Age||years|Mean|45.1|45.1|Standard Deviation|12.28|12.28|||
4276400|NCT00574249|4100531|B2|||Age||years|Mean|45.3|45.3|Standard Deviation|11.95|11.95|||
4276401|NCT00574249|4100532|B1|||Age||years|Mean|44.8|44.8|Standard Deviation|12.61|12.61|||
4276402|NCT00574249|4100530|B3||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4276403|NCT00574249|4100531|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4276404|NCT00574249|4100532|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4276405|NCT00574249|4100530|B3||Between 18 and 65 years|Age||Participants|Count of Participants|693|693.0||||||
4276406|NCT00574249|4100531|B2||Between 18 and 65 years|Age||Participants|Count of Participants|350|350.0||||||
4276407|NCT00574249|4100532|B1||Between 18 and 65 years|Age||Participants|Count of Participants|343|343.0||||||
4276408|NCT00574249|4100530|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4276409|NCT00574249|4100531|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4276410|NCT00574249|4100532|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276411|NCT00574236|4100573|B1|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4276412|NCT00574236|4100573|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276413|NCT00574236|4100573|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276414|NCT00574236|4100573|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4276415|NCT00574236|4100573|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276416|NCT00574236|4100573|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276417|NCT00574236|4100573|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276418|NCT00574236|4100573|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276419|NCT00574236|4100573|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4276420|NCT00574236|4100573|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4276421|NCT00574236|4100573|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276422|NCT00574236|4100573|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4276423|NCT00574236|4100573|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4276424|NCT00574236|4100573|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4276425|NCT00574236|4100573|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4276426|NCT00574236|4100573|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276427|NCT00574171|4100578|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4276428|NCT00574171|4100578|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4276429|NCT00574171|4100578|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4276430|NCT00574171|4100578|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4276431|NCT00574171|4100578|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276432|NCT00574145|4100582|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
4276433|NCT00574145|4100583|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4276434|NCT00574145|4100584|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4276435|NCT00574145|4100582|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4276436|NCT00574145|4100583|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4276437|NCT00574145|4100584|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4276438|NCT00574145|4100582|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4276439|NCT00574145|4100583|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4276440|NCT00574145|4100584|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4276441|NCT00574145|4100582|B3|||Age||years|Mean|51|51.0|Standard Deviation|1|1.0|||
4276442|NCT00574145|4100583|B2|||Age||years|Mean|51|51.0|Standard Deviation|1|1.0|||
4276443|NCT00574145|4100584|B1|||Age||years|Mean|50|50.0|Standard Deviation|1|1.0|||
4276444|NCT00574145|4100582|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4276445|NCT00574145|4100583|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4276446|NCT00574145|4100584|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4276447|NCT00574145|4100582|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4276448|NCT00574145|4100583|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4276449|NCT00574145|4100584|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4276450|NCT00574145|4100582|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276451|NCT00574145|4100583|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276452|NCT00574145|4100584|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276453|NCT00574080|4100595|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4276454|NCT00574080|4100596|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4276455|NCT00574080|4100597|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4276456|NCT00574080|4100595|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4276457|NCT00574080|4100596|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4276458|NCT00574080|4100597|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4276459|NCT00574080|4100595|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4276460|NCT00574080|4100596|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4276461|NCT00574080|4100597|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4276462|NCT00574080|4100595|B3|||Age||years|Mean|57.6|57.6|Standard Deviation|7.04|7.04|||
4276463|NCT00574080|4100596|B2|||Age||years|Mean|59|59.0|Standard Deviation|8.67|8.67|||
4276464|NCT00574080|4100597|B1|||Age||years|Mean|56.2|56.2|Standard Deviation|5.01|5.01|||
4276465|NCT00574080|4100595|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4276466|NCT00574080|4100596|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4276467|NCT00574080|4100597|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4276468|NCT00574080|4100595|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4276469|NCT00574080|4100596|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4276470|NCT00574080|4100597|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4276471|NCT00574080|4100595|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276472|NCT00574080|4100596|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276473|NCT00574080|4100597|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276474|NCT00574067|4100604|B5||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4276475|NCT00574067|4100605|B4||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4276476|NCT00574067|4100606|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4276477|NCT00574067|4100607|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4276478|NCT00574067|4100608|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4276479|NCT00574067|4100604|B5||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4276480|NCT00574067|4100605|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4276481|NCT00574067|4100606|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4276482|NCT00574067|4100607|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4276483|NCT00574067|4100608|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4276484|NCT00574067|4100604|B5|||Age||years|Mean|39.08|39.08|Standard Deviation|8.8|8.8|||
4276485|NCT00574067|4100605|B4|||Age||years|Mean|38.42|38.42|Standard Deviation|9.1|9.1|||
4276486|NCT00574067|4100606|B3|||Age||years|Mean|39.55|39.55|Standard Deviation|10.0|10.0|||
4276487|NCT00574067|4100607|B2|||Age||years|Mean|39.18|39.18|Standard Deviation|8.7|8.7|||
4276488|NCT00574067|4100608|B1|||Age||years|Mean|39.15|39.15|Standard Deviation|7.5|7.5|||
4276489|NCT00573989|4100645|B1|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
4276490|NCT00573989|4100645|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276491|NCT00573989|4100645|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276492|NCT00573989|4100645|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4276493|NCT00573989|4100645|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4276494|NCT00573989|4100645|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276495|NCT00573989|4100645|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276496|NCT00573989|4100645|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4276497|NCT00573989|4100645|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4276498|NCT00573989|4100645|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4276499|NCT00573989|4100645|B1|||Age||years|Mean|62.96|62.96|Standard Deviation|7.87|7.87|||
4276500|NCT00573989|4100645|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4276501|NCT00573989|4100645|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4276502|NCT00573989|4100645|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276503|NCT00573937|4100665|B3|Male||Gender||participants|Number|0|0.0||||||
4276504|NCT00573937|4100666|B2|Male||Gender||participants|Number|0|0.0||||||
4276505|NCT00573937|4100665|B3|Female||Gender||participants|Number|1|1.0||||||
4276506|NCT00573937|4100666|B2|Female||Gender||participants|Number|1|1.0||||||
4276507|NCT00573937|4100665|B3|||Age||years|Mean|48|48.0|Standard Deviation|||||
4276508|NCT00573937|4100666|B2|||Age||years|Mean|48|48.0|Standard Deviation|||||
4276509|NCT00573872|4100676|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276510|NCT00573872|4100676|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276511|NCT00573872|4100676|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4276512|NCT00573872|4100676|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4276513|NCT00573872|4100676|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276514|NCT00573872|4100676|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276515|NCT00573872|4100676|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276516|NCT00573872|4100676|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4276517|NCT00573872|4100676|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4276518|NCT00573872|4100676|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4276519|NCT00573872|4100676|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4276520|NCT00573872|4100676|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276521|NCT00573859|4100682|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4276522|NCT00573859|4100682|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4276523|NCT00573859|4100682|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4276524|NCT00573859|4100682|B1|||Age||years|Mean|27.2|27.2|Standard Deviation|8.9|8.9|||
4276525|NCT00573859|4100682|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4276526|NCT00573859|4100682|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4276527|NCT00573859|4100682|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276528|NCT00573833|4100688|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4276529|NCT00573833|4100688|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4276530|NCT00573833|4100688|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4276531|NCT00573833|4100688|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4276532|NCT00573833|4100688|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4276533|NCT00573833|4100688|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276534|NCT00573794|4100695|B1||Male|Sex: Female, Male||Participants|Count of Participants|371|371.0||||||
4276535|NCT00573794|4100695|B1||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4276536|NCT00573794|4100695|B1|||Age||years|Mean|41.6|41.6|Standard Deviation|12.85|12.85|||
4276537|NCT00573768|4100723|B4|Germany||Region of Enrollment||participants|Number|271|271.0||||||
4276538|NCT00573768|4100724|B3|Germany||Region of Enrollment||participants|Number|91|91.0||||||
4276539|NCT00573768|4100725|B2|Germany||Region of Enrollment||participants|Number|91|91.0||||||
4276540|NCT00573768|4100726|B1|Germany||Region of Enrollment||participants|Number|89|89.0||||||
4276541|NCT00573768|4100723|B4||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4276542|NCT00573768|4100724|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4276543|NCT00573768|4100725|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4276544|NCT00573768|4100726|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4276545|NCT00573768|4100723|B4||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4276546|NCT00573768|4100724|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4276547|NCT00573768|4100725|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4276548|NCT00573768|4100726|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4276549|NCT00573768|4100723|B4|||Age||years|Mean|38.6|38.6|Standard Deviation|14.1|14.1|||
4276550|NCT00573768|4100724|B3|||Age||years|Mean|38.9|38.9|Standard Deviation|14.1|14.1|||
4276551|NCT00573768|4100725|B2|||Age||years|Mean|38.2|38.2|Standard Deviation|14.6|14.6|||
4276552|NCT00573768|4100726|B1|||Age||years|Mean|38.8|38.8|Standard Deviation|13.7|13.7|||
4276553|NCT00573755|4100736|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4276554|NCT00573755|4100737|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4276555|NCT00573755|4100738|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4276556|NCT00573755|4100736|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276557|NCT00573755|4100737|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276558|NCT00573755|4100738|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276559|NCT00573755|4100736|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276560|NCT00573755|4100737|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276561|NCT00573755|4100738|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276562|NCT00573755|4100736|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4276563|NCT00573755|4100737|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4276564|NCT00573755|4100738|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4276565|NCT00573755|4100736|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276566|NCT00573755|4100737|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276567|NCT00573755|4100738|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276568|NCT00573755|4100736|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276569|NCT00573755|4100737|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276570|NCT00573755|4100738|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276571|NCT00573755|4100736|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276572|NCT00573755|4100737|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276573|NCT00573755|4100738|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276574|NCT00573755|4100736|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276575|NCT00573755|4100737|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276576|NCT00573755|4100738|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4276577|NCT00573755|4100736|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4276578|NCT00573755|4100737|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4276579|NCT00573755|4100738|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4276580|NCT00573755|4100736|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4276581|NCT00573755|4100737|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4276582|NCT00573755|4100738|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4276583|NCT00573755|4100736|B3|||Age||years|Mean|61.3|61.3|Standard Deviation|10.1|10.1|||
4276584|NCT00573755|4100737|B2|||Age||years|Mean|54.5|54.5|Standard Deviation|4.9|4.9|||
4276585|NCT00573755|4100738|B1|||Age||years|Mean|68.0|68.0|Standard Deviation|9.9|9.9|||
4276586|NCT00573534|4100755|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4276587|NCT00573534|4100755|B1||Male|Gender||Participants|Count of Participants|7|7.0||||||
4276588|NCT00573534|4100755|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
4276589|NCT00573534|4100755|B1|||Age||years|Mean|14.2|14.2|Standard Deviation|2|2.0|||
4276590|NCT00573534|4100755|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4276591|NCT00573534|4100755|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4276592|NCT00573534|4100755|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4276593|NCT00573508|4100760|B3|Other||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4276594|NCT00573508|4100761|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4276595|NCT00573508|4100762|B1|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4276596|NCT00573508|4100760|B3|Native Hawaiian-Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4276597|NCT00573508|4100761|B2|Native Hawaiian-Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4276598|NCT00573508|4100762|B1|Native Hawaiian-Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4276599|NCT00573508|4100760|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4276600|NCT00573508|4100761|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4276601|NCT00573508|4100762|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4276602|NCT00573508|4100760|B3|Asian||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4276603|NCT00573508|4100761|B2|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4276604|NCT00573508|4100762|B1|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4276605|NCT00573508|4100760|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
4276606|NCT00573508|4100761|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4276607|NCT00573508|4100762|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4276608|NCT00573508|4100760|B3|White||Race/Ethnicity, Customized||participants|Number|680|680.0||||||
4276609|NCT00573508|4100761|B2|White||Race/Ethnicity, Customized||participants|Number|347|347.0||||||
4276610|NCT00573508|4100762|B1|White||Race/Ethnicity, Customized||participants|Number|333|333.0||||||
4276611|NCT00573508|4100760|B3||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4276612|NCT00573508|4100761|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4276613|NCT00573508|4100762|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4276614|NCT00573508|4100760|B3||Female|Sex: Female, Male||Participants|Count of Participants|632|632.0||||||
4276615|NCT00573508|4100761|B2||Female|Sex: Female, Male||Participants|Count of Participants|311|311.0||||||
4276616|NCT00573508|4100762|B1||Female|Sex: Female, Male||Participants|Count of Participants|321|321.0||||||
4276617|NCT00573508|4100760|B3|||Age||years|Mean|59.4|59.4|Standard Deviation|12.90|12.9|||
4276618|NCT00573508|4100761|B2|||Age||years|Mean|59.4|59.4|Standard Deviation|13.44|13.44|||
4276619|NCT00573508|4100762|B1|||Age||years|Mean|59.4|59.4|Standard Deviation|12.36|12.36|||
4276620|NCT00573469|4100793|B4||Male|Sex: Female, Male|Gender|Participants|Count of Participants|55.0|55.0||||||
4276621|NCT00573469|4100794|B3||Male|Sex: Female, Male|Gender|Participants|Count of Participants|20|20.0||||||
4276622|NCT00573469|4100795|B2||Male|Sex: Female, Male|Gender|Participants|Count of Participants|18|18.0||||||
4276623|NCT00573469|4100796|B1||Male|Sex: Female, Male|Gender|Participants|Count of Participants|17|17.0||||||
4276624|NCT00573469|4100793|B4||Female|Sex: Female, Male|Gender|Participants|Count of Participants|22.0|22.0||||||
4276625|NCT00573469|4100794|B3||Female|Sex: Female, Male|Gender|Participants|Count of Participants|6|6.0||||||
4276626|NCT00573469|4100795|B2||Female|Sex: Female, Male|Gender|Participants|Count of Participants|7|7.0||||||
4276627|NCT00573469|4100796|B1||Female|Sex: Female, Male|Gender|Participants|Count of Participants|9|9.0||||||
4276628|NCT00573469|4100793|B4|>=30 years||Age, Customized|Age in Years|Participants|Number|58.0|58.0||||||
4276629|NCT00573469|4100794|B3|>=30 years||Age, Customized|Age in Years|Participants|Number|22|22.0||||||
4276630|NCT00573469|4100795|B2|>=30 years||Age, Customized|Age in Years|Participants|Number|18|18.0||||||
4276631|NCT00573469|4100796|B1|>=30 years||Age, Customized|Age in Years|Participants|Number|18|18.0||||||
4276632|NCT00573469|4100793|B4|<30 years||Age, Customized|Age in Years|Participants|Number|19.0|19.0||||||
4276633|NCT00573469|4100794|B3|<30 years||Age, Customized|Age in Years|Participants|Number|4|4.0||||||
4276634|NCT00573469|4100795|B2|<30 years||Age, Customized|Age in Years|Participants|Number|7|7.0||||||
4276635|NCT00573469|4100796|B1|<30 years||Age, Customized|Age in Years|Participants|Number|8|8.0||||||
4276636|NCT00573443|4100818|B4||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4276637|NCT00573443|4100819|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4276638|NCT00573443|4100820|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4276639|NCT00573443|4100821|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4276640|NCT00573443|4100818|B4||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4276641|NCT00573443|4100819|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4276642|NCT00573443|4100820|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4276643|NCT00573443|4100821|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4276644|NCT00573443|4100818|B4|||Age||Years|Mean|51.39|51.39|Standard Deviation|11.356|11.356|||
4276645|NCT00573443|4100819|B3|||Age||Years|Mean|50.27|50.27|Standard Deviation|11.939|11.939|||
4276646|NCT00573443|4100820|B2|||Age||Years|Mean|50.81|50.81|Standard Deviation|11.114|11.114|||
4276647|NCT00573443|4100821|B1|||Age||Years|Mean|53.08|53.08|Standard Deviation|11.016|11.016|||
4276648|NCT00573430|4100850|B4|Male||Gender|Analyzed efficacy data and demography data based on Intended to Treat (ITT) set. The discrepancy of “Total” and “Started Period 1” is who is excluded to the ITT set.|Participants|Number|66|66.0||||||
4276649|NCT00573430|4100851|B3|Male||Gender|Analyzed efficacy data and demography data based on Intended to Treat (ITT) set. The discrepancy of “Total” and “Started Period 1” is who is excluded to the ITT set.|Participants|Number|19|19.0||||||
4276650|NCT00573430|4100852|B2|Male||Gender|Analyzed efficacy data and demography data based on Intended to Treat (ITT) set. The discrepancy of “Total” and “Started Period 1” is who is excluded to the ITT set.|Participants|Number|28|28.0||||||
4276651|NCT00573430|4100853|B1|Male||Gender|Analyzed efficacy data and demography data based on Intended to Treat (ITT) set. The discrepancy of “Total” and “Started Period 1” is who is excluded to the ITT set.|Participants|Number|19|19.0||||||
4276652|NCT00573430|4100850|B4|Female||Gender|Analyzed efficacy data and demography data based on Intended to Treat (ITT) set. The discrepancy of “Total” and “Started Period 1” is who is excluded to the ITT set.|Participants|Number|53|53.0||||||
4276653|NCT00573430|4100851|B3|Female||Gender|Analyzed efficacy data and demography data based on Intended to Treat (ITT) set. The discrepancy of “Total” and “Started Period 1” is who is excluded to the ITT set.|Participants|Number|17|17.0||||||
4276654|NCT00573430|4100852|B2|Female||Gender|Analyzed efficacy data and demography data based on Intended to Treat (ITT) set. The discrepancy of “Total” and “Started Period 1” is who is excluded to the ITT set.|Participants|Number|16|16.0||||||
4276655|NCT00573430|4100853|B1|Female||Gender|Analyzed efficacy data and demography data based on Intended to Treat (ITT) set. The discrepancy of “Total” and “Started Period 1” is who is excluded to the ITT set.|Participants|Number|20|20.0||||||
4276656|NCT00573430|4100850|B4|19 to 70||Age||years|Mean|47.3|47.3|Standard Deviation|13.4|13.4|||
4276657|NCT00573430|4100851|B3|19 to 70||Age||years|Mean|49.50|49.5|Standard Deviation|11|11.0|||
4276658|NCT00573430|4100852|B2|19 to 70||Age||years|Mean|46.80|46.8|Standard Deviation|16|16.0|||
4276659|NCT00573430|4100853|B1|19 to 70||Age||years|Mean|45.70|45.7|Standard Deviation|11|11.0|||
4276660|NCT00573391|4100875|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4276661|NCT00573391|4100876|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4276662|NCT00573391|4100877|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4276663|NCT00573391|4100875|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4276664|NCT00573391|4100876|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4276665|NCT00573391|4100877|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4276666|NCT00573391|4100875|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4276667|NCT00573391|4100876|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4276668|NCT00573391|4100877|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4276669|NCT00573391|4100875|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4276670|NCT00573391|4100876|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4276671|NCT00573391|4100877|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4276672|NCT00573391|4100875|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276673|NCT00573391|4100876|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276674|NCT00573391|4100877|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276675|NCT00573313|4100884|B5|United States||Region of Enrollment||participants|Number|91|91.0||||||
4276676|NCT00573313|4100885|B4|United States||Region of Enrollment||participants|Number|19|19.0||||||
4276677|NCT00573313|4100886|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4276678|NCT00573313|4100887|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4276679|NCT00573313|4100888|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4276680|NCT00573313|4100884|B5||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4276681|NCT00573313|4100885|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4276682|NCT00573313|4100886|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4276683|NCT00573313|4100887|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4276684|NCT00573313|4100888|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4276685|NCT00573313|4100884|B5||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4276686|NCT00573313|4100885|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4276687|NCT00573313|4100886|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4276688|NCT00573313|4100887|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4276689|NCT00573313|4100888|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4276690|NCT00573313|4100884|B5||>=65 years|Age|Baseline age measure|Participants|Count of Participants|2|2.0||||||
4276691|NCT00573313|4100885|B4||>=65 years|Age|Baseline age measure|Participants|Count of Participants|0|0.0||||||
4276692|NCT00573313|4100886|B3||>=65 years|Age|Baseline age measure|Participants|Count of Participants|1|1.0||||||
4276693|NCT00573313|4100887|B2||>=65 years|Age|Baseline age measure|Participants|Count of Participants|0|0.0||||||
4276694|NCT00573313|4100888|B1||>=65 years|Age|Baseline age measure|Participants|Count of Participants|1|1.0||||||
4276695|NCT00573313|4100884|B5||Between 18 and 65 years|Age|Baseline age measure|Participants|Count of Participants|89|89.0||||||
4276696|NCT00573313|4100885|B4||Between 18 and 65 years|Age|Baseline age measure|Participants|Count of Participants|19|19.0||||||
4276697|NCT00573313|4100886|B3||Between 18 and 65 years|Age|Baseline age measure|Participants|Count of Participants|25|25.0||||||
4276698|NCT00573313|4100887|B2||Between 18 and 65 years|Age|Baseline age measure|Participants|Count of Participants|28|28.0||||||
4276699|NCT00573313|4100888|B1||Between 18 and 65 years|Age|Baseline age measure|Participants|Count of Participants|17|17.0||||||
4276700|NCT00573313|4100884|B5||<=18 years|Age|Baseline age measure|Participants|Count of Participants|0|0.0||||||
4276701|NCT00573313|4100885|B4||<=18 years|Age|Baseline age measure|Participants|Count of Participants|0|0.0||||||
4276702|NCT00573313|4100886|B3||<=18 years|Age|Baseline age measure|Participants|Count of Participants|0|0.0||||||
4276703|NCT00573313|4100887|B2||<=18 years|Age|Baseline age measure|Participants|Count of Participants|0|0.0||||||
4276704|NCT00573313|4100888|B1||<=18 years|Age|Baseline age measure|Participants|Count of Participants|0|0.0||||||
4276705|NCT00573287|4100899|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4276706|NCT00573287|4100900|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4276707|NCT00573287|4100901|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4276708|NCT00573287|4100899|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4276709|NCT00573287|4100900|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4276710|NCT00573287|4100901|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4276711|NCT00573287|4100899|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4276712|NCT00573287|4100900|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4276713|NCT00573287|4100901|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4276714|NCT00573287|4100899|B3|||Age||years|Mean|22.4|22.4|Standard Deviation|5.9|5.9|||
4276715|NCT00573287|4100900|B2|||Age||years|Mean|22.0|22.0|Standard Deviation|6.4|6.4|||
4276716|NCT00573287|4100901|B1|||Age||years|Mean|22.9|22.9|Standard Deviation|5.8|5.8|||
4276717|NCT00573287|4100899|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4276718|NCT00573287|4100900|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4276719|NCT00573287|4100901|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4276720|NCT00573287|4100899|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4276721|NCT00573287|4100900|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4276722|NCT00573287|4100901|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4276723|NCT00573287|4100899|B3||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4276724|NCT00573287|4100900|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4276725|NCT00573287|4100901|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4276726|NCT00573261|4100910|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4276727|NCT00573261|4100911|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4276728|NCT00573261|4100912|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4276729|NCT00573261|4100910|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4276730|NCT00573261|4100911|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4276731|NCT00573261|4100912|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4276732|NCT00573261|4100910|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4276733|NCT00573261|4100911|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4276734|NCT00573261|4100912|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4276735|NCT00573261|4100910|B3|||Age||years|Mean|57.4|57.4|Standard Deviation|13.5|13.5|||
4276736|NCT00573261|4100911|B2|||Age||years|Mean|59.65|59.65|Standard Deviation|12.5|12.5|||
4276737|NCT00573261|4100912|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|14.36|14.36|||
4276738|NCT00573261|4100910|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4276739|NCT00573261|4100911|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4276740|NCT00573261|4100912|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4276741|NCT00573261|4100910|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4276742|NCT00573261|4100911|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4276743|NCT00573261|4100912|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4276744|NCT00573261|4100910|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276745|NCT00573261|4100911|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276746|NCT00573261|4100912|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276747|NCT00573248|4100939|B3|United States||Region of Enrollment||participants|Number|78|78.0||||||
4276748|NCT00573248|4100940|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
4276749|NCT00573248|4100941|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4276750|NCT00573248|4100939|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4276751|NCT00573248|4100940|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4276752|NCT00573248|4100941|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4276753|NCT00573248|4100939|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4276754|NCT00573248|4100940|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4276755|NCT00573248|4100941|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4276756|NCT00573248|4100939|B3|||Age||years|Mean|27|27.0|Standard Deviation|8|8.0|||
4276757|NCT00573248|4100940|B2|||Age||years|Mean|28|28.0|Standard Deviation|8|8.0|||
4276758|NCT00573248|4100941|B1|||Age||years|Mean|25|25.0|Standard Deviation|7|7.0|||
4276759|NCT00573248|4100939|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4276760|NCT00573248|4100940|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4276761|NCT00573248|4100941|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4276762|NCT00573248|4100939|B3||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
4276763|NCT00573248|4100940|B2||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4276764|NCT00573248|4100941|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4276765|NCT00573248|4100939|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276766|NCT00573248|4100940|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276767|NCT00573248|4100941|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276768|NCT00573183|4100954|B3|United States||Region of Enrollment||participants|Number|471|471.0||||||
4276769|NCT00573183|4100955|B2|United States||Region of Enrollment||participants|Number|237|237.0||||||
4276770|NCT00573183|4100956|B1|United States||Region of Enrollment||participants|Number|234|234.0||||||
4276771|NCT00573183|4100954|B3||Male|Gender||Participants|Count of Participants|194|194.0||||||
4276772|NCT00573183|4100955|B2||Male|Gender||Participants|Count of Participants|105|105.0||||||
4276773|NCT00573183|4100956|B1||Male|Gender||Participants|Count of Participants|89|89.0||||||
4276774|NCT00573183|4100954|B3||Female|Gender||Participants|Count of Participants|277|277.0||||||
4276775|NCT00573183|4100955|B2||Female|Gender||Participants|Count of Participants|132|132.0||||||
4276776|NCT00573183|4100956|B1||Female|Gender||Participants|Count of Participants|145|145.0||||||
4276777|NCT00573183|4100954|B3|||Age||years|Mean|38.35|38.35|Standard Deviation|9.71|9.71|||
4276778|NCT00573183|4100955|B2|||Age||years|Mean|38.45|38.45|Standard Deviation|9.40|9.4|||
4276779|NCT00573183|4100956|B1|||Age||years|Mean|38.24|38.24|Standard Deviation|10.04|10.04|||
4276780|NCT00573183|4100954|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4276781|NCT00573183|4100955|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4276782|NCT00573183|4100956|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4276783|NCT00573183|4100954|B3||Between 18 and 65 years|Age||Participants|Count of Participants|471|471.0||||||
4276784|NCT00573183|4100955|B2||Between 18 and 65 years|Age||Participants|Count of Participants|237|237.0||||||
4276785|NCT00573183|4100956|B1||Between 18 and 65 years|Age||Participants|Count of Participants|234|234.0||||||
4276786|NCT00573183|4100954|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276787|NCT00573183|4100955|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276788|NCT00573183|4100956|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276789|NCT00573170|4100965|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4276790|NCT00573170|4100965|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4276791|NCT00573170|4100965|B1|American Indian or Native Alaskan||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4276792|NCT00573170|4100965|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4276793|NCT00573170|4100965|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4276794|NCT00573170|4100965|B1|Asian - Central/South||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4276795|NCT00573170|4100965|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4276796|NCT00573170|4100965|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
4276797|NCT00573170|4100965|B1|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|368|368.0||||||
4276798|NCT00573170|4100965|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4276799|NCT00573170|4100965|B1||Female|Sex: Female, Male||Participants|Count of Participants|391|391.0||||||
4276800|NCT00573170|4100965|B1|||Age|Baseline data are reported for the Safety Population, comprised of all participants who were treated at least once with study medication. . All randomized participants are accounted for in the Participant Flow module. Only a portion of the participants who were randomized comprise the Safety Population.|Years|Mean|42.6|42.6|Standard Deviation|11.23|11.23|||
4276801|NCT00573157|4101044|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4276802|NCT00573157|4101045|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4276803|NCT00573157|4101046|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4276804|NCT00573157|4101044|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4276805|NCT00573157|4101045|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4276806|NCT00573157|4101046|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4276807|NCT00573157|4101044|B3|||Age||years|Mean|36.5|36.5|Standard Deviation|14.4|14.4|||
4276808|NCT00573157|4101045|B2|||Age||years|Mean|36.0|36.0|Standard Deviation|25.5|25.5|||
4276809|NCT00573157|4101046|B1|||Age||years|Mean|36.8|36.8|Standard Deviation|11.3|11.3|||
4276810|NCT00573144|4101057|B3|United States||Region of Enrollment||participants|Number|53|53.0||||||
4276811|NCT00573144|4101058|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4276812|NCT00573144|4101059|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4276813|NCT00573144|4101057|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4276814|NCT00573144|4101058|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4276815|NCT00573144|4101059|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4276816|NCT00573144|4101057|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4276817|NCT00573144|4101058|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4276818|NCT00573144|4101059|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4276819|NCT00573144|4101057|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4276820|NCT00573144|4101058|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4276821|NCT00573144|4101059|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4276822|NCT00573144|4101057|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4276823|NCT00573144|4101058|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4276824|NCT00573144|4101059|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4276825|NCT00573144|4101057|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276826|NCT00573144|4101058|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276827|NCT00573144|4101059|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276828|NCT00573144|4101057|B3|||Age||years|Mean|58.0|58.0|Standard Deviation|11.26|11.26|||
4276829|NCT00573144|4101058|B2|||Age||years|Mean|60.4|60.4|Standard Deviation|11.15|11.15|||
4276830|NCT00573144|4101059|B1|||Age||years|Mean|55.85|55.85|Standard Deviation|11.12|11.12|||
4276831|NCT00573131|4101070|B3|India||Region of Enrollment||participants|Number|72|72.0||||||
4276832|NCT00573131|4101071|B2|India||Region of Enrollment||participants|Number|35|35.0||||||
4276833|NCT00573131|4101072|B1|India||Region of Enrollment||participants|Number|37|37.0||||||
4276834|NCT00573131|4101070|B3|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4276835|NCT00573131|4101071|B2|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4276836|NCT00573131|4101072|B1|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
4276837|NCT00573131|4101070|B3|Poland||Region of Enrollment||participants|Number|17|17.0||||||
4276838|NCT00573131|4101071|B2|Poland||Region of Enrollment||participants|Number|9|9.0||||||
4276839|NCT00573131|4101072|B1|Poland||Region of Enrollment||participants|Number|8|8.0||||||
4276840|NCT00573131|4101070|B3|Czech Republic||Region of Enrollment||participants|Number|25|25.0||||||
4276841|NCT00573131|4101071|B2|Czech Republic||Region of Enrollment||participants|Number|11|11.0||||||
4276842|NCT00573131|4101072|B1|Czech Republic||Region of Enrollment||participants|Number|14|14.0||||||
4276843|NCT00573131|4101070|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4276844|NCT00573131|4101071|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4276845|NCT00573131|4101072|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4276846|NCT00573131|4101070|B3||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4276847|NCT00573131|4101071|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4276848|NCT00573131|4101072|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4276849|NCT00573131|4101070|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4276850|NCT00573131|4101071|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4276851|NCT00573131|4101072|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4276852|NCT00573131|4101070|B3|||Age||years|Mean|58.0|58.0|Standard Deviation|9.1|9.1|||
4276853|NCT00573131|4101071|B2|||Age||years|Mean|57.6|57.6|Standard Deviation|10.9|10.9|||
4276854|NCT00573131|4101072|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|7.2|7.2|||
4276855|NCT00573131|4101070|B3||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
4276856|NCT00573131|4101071|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4276857|NCT00573131|4101072|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4276858|NCT00573131|4101070|B3||Between 18 and 65 years|Age||Participants|Count of Participants|103|103.0||||||
4276859|NCT00573131|4101071|B2||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4276860|NCT00573131|4101072|B1||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4276861|NCT00573131|4101070|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276862|NCT00573131|4101071|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276863|NCT00573131|4101072|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4276864|NCT00573066|4101079|B1|United States||Region of Enrollment||participants|Number|56|56.0||||||
4276865|NCT00573066|4101079|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4276866|NCT00573066|4101079|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4276867|NCT00573066|4101079|B1|||Age||years|Mean|0.74|0.74|Standard Deviation|0.42|0.42|||
4276868|NCT00573066|4101079|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4276869|NCT00573066|4101079|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4276870|NCT00573066|4101079|B1||<=18 years|Age||Participants|Count of Participants|56|56.0||||||
4276871|NCT00572936|4101083|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4276872|NCT00572936|4101083|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4276873|NCT00572936|4101083|B1|||Age||years|Mean|59|59.0|Standard Deviation|11|11.0|||
4276874|NCT00572910|4101117|B7||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4276875|NCT00572910|4101118|B6||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4276876|NCT00572910|4101119|B5||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4276877|NCT00572910|4101120|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4276878|NCT00572910|4101121|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4276879|NCT00572910|4101122|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4276880|NCT00572910|4101123|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4276881|NCT00572910|4101117|B7||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4276882|NCT00572910|4101118|B6||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4276883|NCT00572910|4101119|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4276884|NCT00572910|4101120|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4276885|NCT00572910|4101121|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4276886|NCT00572910|4101122|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4276887|NCT00572910|4101123|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4276888|NCT00572910|4101117|B7|>=50 years of age||Age, Customized||Participants|Number|143|143.0||||||
4276889|NCT00572910|4101118|B6|>=50 years of age||Age, Customized||Participants|Number|12|12.0||||||
4276890|NCT00572910|4101119|B5|>=50 years of age||Age, Customized||Participants|Number|24|24.0||||||
4276891|NCT00572910|4101120|B4|>=50 years of age||Age, Customized||Participants|Number|33|33.0||||||
4276892|NCT00572910|4101121|B3|>=50 years of age||Age, Customized||Participants|Number|24|24.0||||||
4276893|NCT00572910|4101122|B2|>=50 years of age||Age, Customized||Participants|Number|23|23.0||||||
4276894|NCT00572910|4101123|B1|>=50 years of age||Age, Customized||Participants|Number|27|27.0||||||
4276895|NCT00572910|4101117|B7|<50 years of age||Age, Customized||Participants|Number|63|63.0||||||
4276896|NCT00572910|4101118|B6|<50 years of age||Age, Customized||Participants|Number|6|6.0||||||
4276897|NCT00572910|4101119|B5|<50 years of age||Age, Customized||Participants|Number|14|14.0||||||
4276898|NCT00572910|4101120|B4|<50 years of age||Age, Customized||Participants|Number|5|5.0||||||
4276899|NCT00572910|4101121|B3|<50 years of age||Age, Customized||Participants|Number|14|14.0||||||
4276900|NCT00572910|4101122|B2|<50 years of age||Age, Customized||Participants|Number|14|14.0||||||
4276901|NCT00572910|4101123|B1|<50 years of age||Age, Customized||Participants|Number|10|10.0||||||
4276902|NCT00572897|4101179|B3|HLA Ag matched, 1 0r 2 alleles mismatched||HLA match||participants|Number|5|5.0||||||
4276903|NCT00572897|4101180|B2|HLA Ag matched, 1 0r 2 alleles mismatched||HLA match||participants|Number|5|5.0||||||
4276904|NCT00572897|4101181|B1|HLA Ag matched, 1 0r 2 alleles mismatched||HLA match||participants|Number|0|0.0||||||
4276905|NCT00572897|4101179|B3|HLA 1 Ag mismatched, no allele mismatched||HLA match||participants|Number|6|6.0||||||
4276906|NCT00572897|4101180|B2|HLA 1 Ag mismatched, no allele mismatched||HLA match||participants|Number|4|4.0||||||
4276907|NCT00572897|4101181|B1|HLA 1 Ag mismatched, no allele mismatched||HLA match||participants|Number|2|2.0||||||
4276908|NCT00572897|4101179|B3|Full HLA matched||HLA match||participants|Number|55|55.0||||||
4276909|NCT00572897|4101180|B2|Full HLA matched||HLA match||participants|Number|25|25.0||||||
4276910|NCT00572897|4101181|B1|Full HLA matched||HLA match||participants|Number|30|30.0||||||
4276911|NCT00572897|4101179|B3|Bone Marrow||Stem cell source||participants|Number|9|9.0||||||
4276912|NCT00572897|4101180|B2|Bone Marrow||Stem cell source||participants|Number|3|3.0||||||
4276913|NCT00572897|4101181|B1|Bone Marrow||Stem cell source||participants|Number|6|6.0||||||
4276914|NCT00572897|4101179|B3|Peripheral blood||Stem cell source||participants|Number|57|57.0||||||
4276915|NCT00572897|4101180|B2|Peripheral blood||Stem cell source||participants|Number|31|31.0||||||
4276916|NCT00572897|4101181|B1|Peripheral blood||Stem cell source||participants|Number|26|26.0||||||
4276917|NCT00572897|4101179|B3|Unknown||Karyotype||participants|Number|17|17.0||||||
4276918|NCT00572897|4101180|B2|Unknown||Karyotype||participants|Number|11|11.0||||||
4276919|NCT00572897|4101181|B1|Unknown||Karyotype||participants|Number|6|6.0||||||
4276920|NCT00572897|4101179|B3|Complex abnormality||Karyotype||participants|Number|5|5.0||||||
4276921|NCT00572897|4101180|B2|Complex abnormality||Karyotype||participants|Number|0|0.0||||||
4276922|NCT00572897|4101181|B1|Complex abnormality||Karyotype||participants|Number|5|5.0||||||
4276923|NCT00572897|4101179|B3|One abnormality||Karyotype||participants|Number|16|16.0||||||
4276924|NCT00572897|4101180|B2|One abnormality||Karyotype||participants|Number|9|9.0||||||
4276925|NCT00572897|4101181|B1|One abnormality||Karyotype||participants|Number|7|7.0||||||
4276926|NCT00572897|4101179|B3|Normal||Karyotype||participants|Number|28|28.0||||||
4276927|NCT00572897|4101180|B2|Normal||Karyotype||participants|Number|14|14.0||||||
4276928|NCT00572897|4101181|B1|Normal||Karyotype||participants|Number|14|14.0||||||
4276929|NCT00572897|4101179|B3|Splenectomy||Splenomegaly||participants|Number|10|10.0||||||
4276930|NCT00572897|4101180|B2|Splenectomy||Splenomegaly||participants|Number|5|5.0||||||
4276931|NCT00572897|4101181|B1|Splenectomy||Splenomegaly||participants|Number|5|5.0||||||
4276932|NCT00572897|4101179|B3|No||Splenomegaly||participants|Number|4|4.0||||||
4276933|NCT00572897|4101180|B2|No||Splenomegaly||participants|Number|1|1.0||||||
4276934|NCT00572897|4101181|B1|No||Splenomegaly||participants|Number|3|3.0||||||
4276935|NCT00572897|4101179|B3|Yes||Splenomegaly||participants|Number|52|52.0||||||
4276936|NCT00572897|4101180|B2|Yes||Splenomegaly||participants|Number|28|28.0||||||
4276937|NCT00572897|4101181|B1|Yes||Splenomegaly||participants|Number|24|24.0||||||
4276938|NCT00572897|4101179|B3|Unknown||Bone Marrow Fibrosis|"European consensus on grading bone marrow fibrosis:~MF - 0 Scattered linear reticulin with no intersections (cross-overs) corresponding to normal bone marrow; MF - 1 Loose network of reticulin with many intersections, especially in perivascular areas; MF - 2 Diffuse and dense increase in reticulin with extensive intersections,occasionally with only focal bundles of collagen and/or focal osteosclerosis; MF - 3 Diffuse and dense increase in reticulin with extensive intersections with coarse bundles of collagen, often associated with significant osteosclerosis"|participants|Number|15|15.0||||||
4276939|NCT00572897|4101180|B2|Unknown||Bone Marrow Fibrosis|"European consensus on grading bone marrow fibrosis:~MF - 0 Scattered linear reticulin with no intersections (cross-overs) corresponding to normal bone marrow; MF - 1 Loose network of reticulin with many intersections, especially in perivascular areas; MF - 2 Diffuse and dense increase in reticulin with extensive intersections,occasionally with only focal bundles of collagen and/or focal osteosclerosis; MF - 3 Diffuse and dense increase in reticulin with extensive intersections with coarse bundles of collagen, often associated with significant osteosclerosis"|participants|Number|3|3.0||||||
4276960|NCT00572897|4101180|B2|Female:Male||Patient: donor gender||participants|Number|13|13.0||||||
4276961|NCT00572897|4101181|B1|Female:Male||Patient: donor gender||participants|Number|9|9.0||||||
4276962|NCT00572897|4101179|B3|Male:Female||Patient: donor gender||participants|Number|16|16.0||||||
4276940|NCT00572897|4101181|B1|Unknown||Bone Marrow Fibrosis|"European consensus on grading bone marrow fibrosis:~MF - 0 Scattered linear reticulin with no intersections (cross-overs) corresponding to normal bone marrow; MF - 1 Loose network of reticulin with many intersections, especially in perivascular areas; MF - 2 Diffuse and dense increase in reticulin with extensive intersections,occasionally with only focal bundles of collagen and/or focal osteosclerosis; MF - 3 Diffuse and dense increase in reticulin with extensive intersections with coarse bundles of collagen, often associated with significant osteosclerosis"|participants|Number|12|12.0||||||
4276941|NCT00572897|4101179|B3|Grade 3||Bone Marrow Fibrosis|"European consensus on grading bone marrow fibrosis:~MF - 0 Scattered linear reticulin with no intersections (cross-overs) corresponding to normal bone marrow; MF - 1 Loose network of reticulin with many intersections, especially in perivascular areas; MF - 2 Diffuse and dense increase in reticulin with extensive intersections,occasionally with only focal bundles of collagen and/or focal osteosclerosis; MF - 3 Diffuse and dense increase in reticulin with extensive intersections with coarse bundles of collagen, often associated with significant osteosclerosis"|participants|Number|41|41.0||||||
4276942|NCT00572897|4101180|B2|Grade 3||Bone Marrow Fibrosis|"European consensus on grading bone marrow fibrosis:~MF - 0 Scattered linear reticulin with no intersections (cross-overs) corresponding to normal bone marrow; MF - 1 Loose network of reticulin with many intersections, especially in perivascular areas; MF - 2 Diffuse and dense increase in reticulin with extensive intersections,occasionally with only focal bundles of collagen and/or focal osteosclerosis; MF - 3 Diffuse and dense increase in reticulin with extensive intersections with coarse bundles of collagen, often associated with significant osteosclerosis"|participants|Number|23|23.0||||||
4276943|NCT00572897|4101181|B1|Grade 3||Bone Marrow Fibrosis|"European consensus on grading bone marrow fibrosis:~MF - 0 Scattered linear reticulin with no intersections (cross-overs) corresponding to normal bone marrow; MF - 1 Loose network of reticulin with many intersections, especially in perivascular areas; MF - 2 Diffuse and dense increase in reticulin with extensive intersections,occasionally with only focal bundles of collagen and/or focal osteosclerosis; MF - 3 Diffuse and dense increase in reticulin with extensive intersections with coarse bundles of collagen, often associated with significant osteosclerosis"|participants|Number|18|18.0||||||
4276944|NCT00572897|4101179|B3|Grade 2||Bone Marrow Fibrosis|"European consensus on grading bone marrow fibrosis:~MF - 0 Scattered linear reticulin with no intersections (cross-overs) corresponding to normal bone marrow; MF - 1 Loose network of reticulin with many intersections, especially in perivascular areas; MF - 2 Diffuse and dense increase in reticulin with extensive intersections,occasionally with only focal bundles of collagen and/or focal osteosclerosis; MF - 3 Diffuse and dense increase in reticulin with extensive intersections with coarse bundles of collagen, often associated with significant osteosclerosis"|participants|Number|8|8.0||||||
4276945|NCT00572897|4101180|B2|Grade 2||Bone Marrow Fibrosis|"European consensus on grading bone marrow fibrosis:~MF - 0 Scattered linear reticulin with no intersections (cross-overs) corresponding to normal bone marrow; MF - 1 Loose network of reticulin with many intersections, especially in perivascular areas; MF - 2 Diffuse and dense increase in reticulin with extensive intersections,occasionally with only focal bundles of collagen and/or focal osteosclerosis; MF - 3 Diffuse and dense increase in reticulin with extensive intersections with coarse bundles of collagen, often associated with significant osteosclerosis"|participants|Number|6|6.0||||||
4276946|NCT00572897|4101181|B1|Grade 2||Bone Marrow Fibrosis|"European consensus on grading bone marrow fibrosis:~MF - 0 Scattered linear reticulin with no intersections (cross-overs) corresponding to normal bone marrow; MF - 1 Loose network of reticulin with many intersections, especially in perivascular areas; MF - 2 Diffuse and dense increase in reticulin with extensive intersections,occasionally with only focal bundles of collagen and/or focal osteosclerosis; MF - 3 Diffuse and dense increase in reticulin with extensive intersections with coarse bundles of collagen, often associated with significant osteosclerosis"|participants|Number|2|2.0||||||
4276947|NCT00572897|4101179|B3|Grade 1||Bone Marrow Fibrosis|"European consensus on grading bone marrow fibrosis:~MF - 0 Scattered linear reticulin with no intersections (cross-overs) corresponding to normal bone marrow; MF - 1 Loose network of reticulin with many intersections, especially in perivascular areas; MF - 2 Diffuse and dense increase in reticulin with extensive intersections,occasionally with only focal bundles of collagen and/or focal osteosclerosis; MF - 3 Diffuse and dense increase in reticulin with extensive intersections with coarse bundles of collagen, often associated with significant osteosclerosis"|participants|Number|2|2.0||||||
4276948|NCT00572897|4101180|B2|Grade 1||Bone Marrow Fibrosis|"European consensus on grading bone marrow fibrosis:~MF - 0 Scattered linear reticulin with no intersections (cross-overs) corresponding to normal bone marrow; MF - 1 Loose network of reticulin with many intersections, especially in perivascular areas; MF - 2 Diffuse and dense increase in reticulin with extensive intersections,occasionally with only focal bundles of collagen and/or focal osteosclerosis; MF - 3 Diffuse and dense increase in reticulin with extensive intersections with coarse bundles of collagen, often associated with significant osteosclerosis"|participants|Number|2|2.0||||||
4276949|NCT00572897|4101181|B1|Grade 1||Bone Marrow Fibrosis|"European consensus on grading bone marrow fibrosis:~MF - 0 Scattered linear reticulin with no intersections (cross-overs) corresponding to normal bone marrow; MF - 1 Loose network of reticulin with many intersections, especially in perivascular areas; MF - 2 Diffuse and dense increase in reticulin with extensive intersections,occasionally with only focal bundles of collagen and/or focal osteosclerosis; MF - 3 Diffuse and dense increase in reticulin with extensive intersections with coarse bundles of collagen, often associated with significant osteosclerosis"|participants|Number|0|0.0||||||
4276950|NCT00572897|4101179|B3|Unknown||JAK-2V617F||participants|Number|3|3.0||||||
4276951|NCT00572897|4101180|B2|Unknown||JAK-2V617F||participants|Number|0|0.0||||||
4276952|NCT00572897|4101181|B1|Unknown||JAK-2V617F||participants|Number|3|3.0||||||
4276953|NCT00572897|4101179|B3|Negative||JAK-2V617F||participants|Number|33|33.0||||||
4276954|NCT00572897|4101180|B2|Negative||JAK-2V617F||participants|Number|16|16.0||||||
4276955|NCT00572897|4101181|B1|Negative||JAK-2V617F||participants|Number|17|17.0||||||
4276956|NCT00572897|4101179|B3|Positive||JAK-2V617F||participants|Number|30|30.0||||||
4276957|NCT00572897|4101180|B2|Positive||JAK-2V617F||participants|Number|18|18.0||||||
4276958|NCT00572897|4101181|B1|Positive||JAK-2V617F||participants|Number|12|12.0||||||
4276959|NCT00572897|4101179|B3|Female:Male||Patient: donor gender||participants|Number|22|22.0||||||
4276963|NCT00572897|4101180|B2|Male:Female||Patient: donor gender||participants|Number|6|6.0||||||
4276964|NCT00572897|4101181|B1|Male:Female||Patient: donor gender||participants|Number|10|10.0||||||
4276965|NCT00572897|4101179|B3|Male:Male||Patient: donor gender||participants|Number|15|15.0||||||
4276966|NCT00572897|4101180|B2|Male:Male||Patient: donor gender||participants|Number|8|8.0||||||
4276967|NCT00572897|4101181|B1|Male:Male||Patient: donor gender||participants|Number|7|7.0||||||
4276968|NCT00572897|4101179|B3|Female:Female||Patient: donor gender||participants|Number|13|13.0||||||
4276969|NCT00572897|4101180|B2|Female:Female||Patient: donor gender||participants|Number|7|7.0||||||
4276970|NCT00572897|4101181|B1|Female:Female||Patient: donor gender||participants|Number|6|6.0||||||
4276971|NCT00572897|4101179|B3|2||Lille score|The Lille scoring system was created by Dupriez and coworkers and used in selecting intermediate- and higher-risk patients as candidates for Autologous Stem Cell Transplant (ASCT). A platelet count of >100 × 109/L in patients with IM was associated with an adverse outcome and created a complete blood count scoring system using three parameters: Hgb < 10 gm/dL; WBC < 4 or > 30 × 109/L; and platelet count <100 × 109/L. Each event was given a score of 1. Higher scores indicate lower median survival.|participants|Number|20|20.0||||||
4276972|NCT00572897|4101180|B2|2||Lille score|The Lille scoring system was created by Dupriez and coworkers and used in selecting intermediate- and higher-risk patients as candidates for Autologous Stem Cell Transplant (ASCT). A platelet count of >100 × 109/L in patients with IM was associated with an adverse outcome and created a complete blood count scoring system using three parameters: Hgb < 10 gm/dL; WBC < 4 or > 30 × 109/L; and platelet count <100 × 109/L. Each event was given a score of 1. Higher scores indicate lower median survival.|participants|Number|11|11.0||||||
4276973|NCT00572897|4101181|B1|2||Lille score|The Lille scoring system was created by Dupriez and coworkers and used in selecting intermediate- and higher-risk patients as candidates for Autologous Stem Cell Transplant (ASCT). A platelet count of >100 × 109/L in patients with IM was associated with an adverse outcome and created a complete blood count scoring system using three parameters: Hgb < 10 gm/dL; WBC < 4 or > 30 × 109/L; and platelet count <100 × 109/L. Each event was given a score of 1. Higher scores indicate lower median survival.|participants|Number|9|9.0||||||
4276974|NCT00572897|4101179|B3|1||Lille score|The Lille scoring system was created by Dupriez and coworkers and used in selecting intermediate- and higher-risk patients as candidates for Autologous Stem Cell Transplant (ASCT). A platelet count of >100 × 109/L in patients with IM was associated with an adverse outcome and created a complete blood count scoring system using three parameters: Hgb < 10 gm/dL; WBC < 4 or > 30 × 109/L; and platelet count <100 × 109/L. Each event was given a score of 1. Higher scores indicate lower median survival.|participants|Number|43|43.0||||||
4276975|NCT00572897|4101180|B2|1||Lille score|The Lille scoring system was created by Dupriez and coworkers and used in selecting intermediate- and higher-risk patients as candidates for Autologous Stem Cell Transplant (ASCT). A platelet count of >100 × 109/L in patients with IM was associated with an adverse outcome and created a complete blood count scoring system using three parameters: Hgb < 10 gm/dL; WBC < 4 or > 30 × 109/L; and platelet count <100 × 109/L. Each event was given a score of 1. Higher scores indicate lower median survival.|participants|Number|23|23.0||||||
4276976|NCT00572897|4101181|B1|1||Lille score|The Lille scoring system was created by Dupriez and coworkers and used in selecting intermediate- and higher-risk patients as candidates for Autologous Stem Cell Transplant (ASCT). A platelet count of >100 × 109/L in patients with IM was associated with an adverse outcome and created a complete blood count scoring system using three parameters: Hgb < 10 gm/dL; WBC < 4 or > 30 × 109/L; and platelet count <100 × 109/L. Each event was given a score of 1. Higher scores indicate lower median survival.|participants|Number|20|20.0||||||
4276977|NCT00572897|4101179|B3|0||Lille score|The Lille scoring system was created by Dupriez and coworkers and used in selecting intermediate- and higher-risk patients as candidates for Autologous Stem Cell Transplant (ASCT). A platelet count of >100 × 109/L in patients with IM was associated with an adverse outcome and created a complete blood count scoring system using three parameters: Hgb < 10 gm/dL; WBC < 4 or > 30 × 109/L; and platelet count <100 × 109/L. Each event was given a score of 1. Higher scores indicate lower median survival.|participants|Number|3|3.0||||||
4276978|NCT00572897|4101180|B2|0||Lille score|The Lille scoring system was created by Dupriez and coworkers and used in selecting intermediate- and higher-risk patients as candidates for Autologous Stem Cell Transplant (ASCT). A platelet count of >100 × 109/L in patients with IM was associated with an adverse outcome and created a complete blood count scoring system using three parameters: Hgb < 10 gm/dL; WBC < 4 or > 30 × 109/L; and platelet count <100 × 109/L. Each event was given a score of 1. Higher scores indicate lower median survival.|participants|Number|0|0.0||||||
4276979|NCT00572897|4101181|B1|0||Lille score|The Lille scoring system was created by Dupriez and coworkers and used in selecting intermediate- and higher-risk patients as candidates for Autologous Stem Cell Transplant (ASCT). A platelet count of >100 × 109/L in patients with IM was associated with an adverse outcome and created a complete blood count scoring system using three parameters: Hgb < 10 gm/dL; WBC < 4 or > 30 × 109/L; and platelet count <100 × 109/L. Each event was given a score of 1. Higher scores indicate lower median survival.|participants|Number|3|3.0||||||
4276980|NCT00572897|4101179|B3|ET-MF||Diagnosis|Primary Myelofibrosis (PMF); Post-Polycythemia vera (PV-MF); Post-Essential Thrombocythemia (ET-MF)|participants|Number|19|19.0||||||
4276981|NCT00572897|4101180|B2|ET-MF||Diagnosis|Primary Myelofibrosis (PMF); Post-Polycythemia vera (PV-MF); Post-Essential Thrombocythemia (ET-MF)|participants|Number|4|4.0||||||
4276982|NCT00572897|4101181|B1|ET-MF||Diagnosis|Primary Myelofibrosis (PMF); Post-Polycythemia vera (PV-MF); Post-Essential Thrombocythemia (ET-MF)|participants|Number|15|15.0||||||
4276983|NCT00572897|4101179|B3|PV-MF||Diagnosis|Primary Myelofibrosis (PMF); Post-Polycythemia vera (PV-MF); Post-Essential Thrombocythemia (ET-MF)|participants|Number|8|8.0||||||
4276984|NCT00572897|4101180|B2|PV-MF||Diagnosis|Primary Myelofibrosis (PMF); Post-Polycythemia vera (PV-MF); Post-Essential Thrombocythemia (ET-MF)|participants|Number|5|5.0||||||
4276985|NCT00572897|4101181|B1|PV-MF||Diagnosis|Primary Myelofibrosis (PMF); Post-Polycythemia vera (PV-MF); Post-Essential Thrombocythemia (ET-MF)|participants|Number|3|3.0||||||
4276986|NCT00572897|4101179|B3|PMF||Diagnosis|Primary Myelofibrosis (PMF); Post-Polycythemia vera (PV-MF); Post-Essential Thrombocythemia (ET-MF)|participants|Number|39|39.0||||||
4276987|NCT00572897|4101180|B2|PMF||Diagnosis|Primary Myelofibrosis (PMF); Post-Polycythemia vera (PV-MF); Post-Essential Thrombocythemia (ET-MF)|participants|Number|25|25.0||||||
4276988|NCT00572897|4101181|B1|PMF||Diagnosis|Primary Myelofibrosis (PMF); Post-Polycythemia vera (PV-MF); Post-Essential Thrombocythemia (ET-MF)|participants|Number|14|14.0||||||
4276989|NCT00572897|4101179|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4276990|NCT00572897|4101180|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4276991|NCT00572897|4101181|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4276992|NCT00572897|4101179|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4276993|NCT00572897|4101180|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4276994|NCT00572897|4101181|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4276995|NCT00572897|4101179|B3|||Age|Median age at the time of transplant|years|Median|55|55.0|Full Range|||30.0|65.0|
4276996|NCT00572897|4101180|B2|||Age|Median age at the time of transplant|years|Median|56|56.0|Full Range|||30.0|65.0|
4276997|NCT00572897|4101181|B1|||Age|Median age at the time of transplant|years|Median|55|55.0|Full Range|||40.0|65.0|
4276998|NCT00572832|4101198|B3|||Body Mass Index||kg/m^2|Mean|24.3|24.3|Standard Deviation|4.9|4.9|||
4276999|NCT00572832|4101199|B2|||Body Mass Index||kg/m^2|Mean|24.5|24.5|Standard Deviation|5.1|5.1|||
4277000|NCT00572832|4101200|B1|||Body Mass Index||kg/m^2|Mean|24.2|24.2|Standard Deviation|4.7|4.7|||
4277001|NCT00572832|4101198|B3|United States||Region of Enrollment||participants|Number|200|200.0||||||
4277002|NCT00572832|4101199|B2|United States||Region of Enrollment||participants|Number|100|100.0||||||
4277003|NCT00572832|4101200|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
4277004|NCT00572832|4101198|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4277005|NCT00572832|4101199|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4277006|NCT00572832|4101200|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4277007|NCT00572832|4101198|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277008|NCT00572832|4101199|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277009|NCT00572832|4101200|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277010|NCT00572832|4101198|B3||White|Race (NIH/OMB)||Participants|Count of Participants|172|172.0||||||
4277011|NCT00572832|4101199|B2||White|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
4277012|NCT00572832|4101200|B1||White|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
4277013|NCT00572832|4101198|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4277014|NCT00572832|4101199|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4277015|NCT00572832|4101200|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4277016|NCT00572832|4101198|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277017|NCT00572832|4101199|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277018|NCT00572832|4101200|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277019|NCT00572832|4101198|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4277020|NCT00572832|4101199|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4277021|NCT00572832|4101200|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4277022|NCT00572832|4101198|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277023|NCT00572832|4101199|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277024|NCT00572832|4101200|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277025|NCT00572832|4101198|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4277026|NCT00572832|4101199|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4277027|NCT00572832|4101200|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4277028|NCT00572832|4101198|B3||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4277029|NCT00572832|4101199|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4277030|NCT00572832|4101200|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4277031|NCT00572832|4101198|B3|||Age||years|Mean|20.2|20.2|Standard Deviation|1.3|1.3|||
4277032|NCT00572832|4101199|B2|||Age||years|Mean|20.1|20.1|Standard Deviation|1.4|1.4|||
4277033|NCT00572832|4101200|B1|||Age||years|Mean|20.3|20.3|Standard Deviation|1.3|1.3|||
4277034|NCT00572832|4101198|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4277035|NCT00572832|4101199|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4277036|NCT00572832|4101200|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4277037|NCT00572832|4101198|B3||Between 18 and 65 years|Age||Participants|Count of Participants|200|200.0||||||
4277038|NCT00572832|4101199|B2||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4277039|NCT00572832|4101200|B1||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4277040|NCT00572832|4101198|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4277041|NCT00572832|4101199|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4277042|NCT00572832|4101200|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4277043|NCT00572728|4101207|B1|United States||Region of Enrollment||participants|Number|90|90.0||||||
4277044|NCT00572728|4101207|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4277045|NCT00572728|4101207|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277046|NCT00572728|4101207|B1||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4277047|NCT00572728|4101207|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4277048|NCT00572728|4101207|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277049|NCT00572728|4101207|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4277050|NCT00572728|4101207|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4277051|NCT00572728|4101207|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4277052|NCT00572728|4101207|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4277053|NCT00572728|4101207|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4277054|NCT00572728|4101207|B1||Male|Gender|Overall Number of Baseline Participants|Participants|Count of Participants|0|0.0||||||
4277055|NCT00572728|4101207|B1||Female|Gender|Overall Number of Baseline Participants|Participants|Count of Participants|90|90.0||||||
4277056|NCT00572728|4101207|B1|||Age||years|Mean|51|51.0|Full Range|||22.0|83.0|
4277057|NCT00572624|4101219|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4277058|NCT00572624|4101220|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4277059|NCT00572624|4101221|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4277060|NCT00572624|4101219|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277061|NCT00572624|4101220|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277062|NCT00572624|4101221|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277063|NCT00572624|4101219|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277064|NCT00572624|4101220|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277065|NCT00572624|4101221|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277066|NCT00572624|4101219|B3||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4277067|NCT00572624|4101220|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4277068|NCT00572624|4101221|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4277069|NCT00572624|4101219|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4277070|NCT00572624|4101220|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277071|NCT00572624|4101221|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4277072|NCT00572624|4101219|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277073|NCT00572624|4101220|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277074|NCT00572624|4101221|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277075|NCT00572624|4101219|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277076|NCT00572624|4101220|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277077|NCT00572624|4101221|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277078|NCT00572624|4101219|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277079|NCT00572624|4101220|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277080|NCT00572624|4101221|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277081|NCT00572624|4101219|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277082|NCT00572624|4101220|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277083|NCT00572624|4101221|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277084|NCT00572624|4101219|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4277085|NCT00572624|4101220|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4277086|NCT00572624|4101221|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4277087|NCT00572624|4101219|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277088|NCT00572624|4101220|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277089|NCT00572624|4101221|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277090|NCT00572624|4101219|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4277091|NCT00572624|4101220|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4277092|NCT00572624|4101221|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4277093|NCT00572624|4101219|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4277094|NCT00572624|4101220|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4277095|NCT00572624|4101221|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4277096|NCT00572624|4101219|B3|≥ 21 and ≤ 50 years of age||Age, Customized||Participants|Count of Participants|30|30.0||||||
4277097|NCT00572624|4101220|B2|≥ 21 and ≤ 50 years of age||Age, Customized||Participants|Count of Participants|10|10.0||||||
4277098|NCT00572624|4101221|B1|≥ 21 and ≤ 50 years of age||Age, Customized||Participants|Count of Participants|20|20.0||||||
4277099|NCT00572572|4101248|B3|CMAS and Surgery||Prior Therapies||participants|Number|2|2.0||||||
4277100|NCT00572572|4101249|B2|CMAS and Surgery||Prior Therapies||participants|Number|1|1.0||||||
4277101|NCT00572572|4101250|B1|CMAS and Surgery||Prior Therapies||participants|Number|1|1.0||||||
4277102|NCT00572572|4101248|B3|Chemotherapy Multiple Agent Systemic (CMAS)||Prior Therapies||participants|Number|10|10.0||||||
4277103|NCT00572572|4101249|B2|Chemotherapy Multiple Agent Systemic (CMAS)||Prior Therapies||participants|Number|5|5.0||||||
4277104|NCT00572572|4101250|B1|Chemotherapy Multiple Agent Systemic (CMAS)||Prior Therapies||participants|Number|5|5.0||||||
4277105|NCT00572572|4101248|B3|No Prior Therapy||Prior Therapies||participants|Number|57|57.0||||||
4277106|NCT00572572|4101249|B2|No Prior Therapy||Prior Therapies||participants|Number|28|28.0||||||
4277107|NCT00572572|4101250|B1|No Prior Therapy||Prior Therapies||participants|Number|29|29.0||||||
4277108|NCT00572572|4101248|B3|United States||Region of Enrollment||participants|Number|69|69.0||||||
4277109|NCT00572572|4101249|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
4277110|NCT00572572|4101250|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4277111|NCT00572572|4101248|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277112|NCT00572572|4101249|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277113|NCT00572572|4101250|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277114|NCT00572572|4101248|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277115|NCT00572572|4101249|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277116|NCT00572572|4101250|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277117|NCT00572572|4101248|B3||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4277118|NCT00572572|4101249|B2||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4277119|NCT00572572|4101250|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4277120|NCT00572572|4101248|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4277121|NCT00572572|4101249|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4277122|NCT00572572|4101250|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277123|NCT00572572|4101248|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277124|NCT00572572|4101249|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277125|NCT00572572|4101250|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277126|NCT00572572|4101248|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4277127|NCT00572572|4101249|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4277128|NCT00572572|4101250|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277129|NCT00572572|4101248|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277130|NCT00572572|4101249|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277131|NCT00572572|4101250|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277132|NCT00572572|4101248|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4277133|NCT00572572|4101249|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277134|NCT00572572|4101250|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4277135|NCT00572572|4101248|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4277136|NCT00572572|4101249|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4277137|NCT00572572|4101250|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4277138|NCT00572572|4101248|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4277139|NCT00572572|4101249|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4277140|NCT00572572|4101250|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277141|NCT00572572|4101248|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4277142|NCT00572572|4101249|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4277143|NCT00572572|4101250|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4277144|NCT00572572|4101248|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4277145|NCT00572572|4101249|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4277146|NCT00572572|4101250|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4277147|NCT00572572|4101248|B3|||Age|Median age was specifically reported by the investigator.|years|Median|31|31.0|Standard Deviation|10.16|10.16|||
4277148|NCT00572572|4101249|B2|||Age|Median age was specifically reported by the investigator.|years|Median|30|30.0|Standard Deviation|8.6|8.6|||
4277149|NCT00572572|4101250|B1|||Age|Median age was specifically reported by the investigator.|years|Median|34|34.0|Standard Deviation|11.2|11.2|||
4277150|NCT00572533|4101267|B3|||ESA dose|ESA dose across group in March 2011|IU/week/subject|Mean|4,968|4.0|Standard Deviation|7,555|7.0|||
4277151|NCT00572533|4101268|B2|||ESA dose|ESA dose across group in March 2011|IU/week/subject|Mean|5,290|5.0|Standard Deviation|7,751|7.0|||
4277152|NCT00572533|4101269|B1|||ESA dose|ESA dose across group in March 2011|IU/week/subject|Mean|4,645|4.0|Standard Deviation|7,468|7.0|||
4277153|NCT00572533|4101267|B3|||Hemoglobin (g/dL)|Hemoglobin concentration in March 2011|g/dL|Mean|11.3|11.3|Standard Deviation|1.2|1.2|||
4277154|NCT00572533|4101268|B2|||Hemoglobin (g/dL)|Hemoglobin concentration in March 2011|g/dL|Mean|11.3|11.3|Standard Deviation|1.0|1.0|||
4277155|NCT00572533|4101269|B1|||Hemoglobin (g/dL)|Hemoglobin concentration in March 2011|g/dL|Mean|11.2|11.2|Standard Deviation|1.4|1.4|||
4277156|NCT00572533|4101267|B3|Graft||Vascular Access Type|Number of patients with specific vascular access type|Participants|Number|12|12.0||||||
4277157|NCT00572533|4101268|B2|Graft||Vascular Access Type|Number of patients with specific vascular access type|Participants|Number|7|7.0||||||
4277158|NCT00572533|4101269|B1|Graft||Vascular Access Type|Number of patients with specific vascular access type|Participants|Number|5|5.0||||||
4277159|NCT00572533|4101267|B3|Catheter||Vascular Access Type|Number of patients with specific vascular access type|Participants|Number|9|9.0||||||
4277160|NCT00572533|4101268|B2|Catheter||Vascular Access Type|Number of patients with specific vascular access type|Participants|Number|3|3.0||||||
4277161|NCT00572533|4101269|B1|Catheter||Vascular Access Type|Number of patients with specific vascular access type|Participants|Number|6|6.0||||||
4277162|NCT00572533|4101267|B3|Fistula||Vascular Access Type|Number of patients with specific vascular access type|Participants|Number|41|41.0||||||
4277163|NCT00572533|4101268|B2|Fistula||Vascular Access Type|Number of patients with specific vascular access type|Participants|Number|21|21.0||||||
4277164|NCT00572533|4101269|B1|Fistula||Vascular Access Type|Number of patients with specific vascular access type|Participants|Number|20|20.0||||||
4277165|NCT00572533|4101267|B3|No CHF||Congestive Heart Failure (CHF)|Number of subjects with diagnosed CHF|Subjects|Number|48|48.0||||||
4277166|NCT00572533|4101268|B2|No CHF||Congestive Heart Failure (CHF)|Number of subjects with diagnosed CHF|Subjects|Number|23|23.0||||||
4277167|NCT00572533|4101269|B1|No CHF||Congestive Heart Failure (CHF)|Number of subjects with diagnosed CHF|Subjects|Number|25|25.0||||||
4277168|NCT00572533|4101267|B3|CHF||Congestive Heart Failure (CHF)|Number of subjects with diagnosed CHF|Subjects|Number|14|14.0||||||
4277169|NCT00572533|4101268|B2|CHF||Congestive Heart Failure (CHF)|Number of subjects with diagnosed CHF|Subjects|Number|8|8.0||||||
4277170|NCT00572533|4101269|B1|CHF||Congestive Heart Failure (CHF)|Number of subjects with diagnosed CHF|Subjects|Number|6|6.0||||||
4277171|NCT00572533|4101267|B3|No Diabetes||Diabetes|Number of subjects with diagnosed diabetes|Participants|Number|27|27.0||||||
4277172|NCT00572533|4101268|B2|No Diabetes||Diabetes|Number of subjects with diagnosed diabetes|Participants|Number|13|13.0||||||
4277173|NCT00572533|4101269|B1|No Diabetes||Diabetes|Number of subjects with diagnosed diabetes|Participants|Number|14|14.0||||||
4277174|NCT00572533|4101267|B3|Diabetes||Diabetes|Number of subjects with diagnosed diabetes|Participants|Number|35|35.0||||||
4277175|NCT00572533|4101268|B2|Diabetes||Diabetes|Number of subjects with diagnosed diabetes|Participants|Number|18|18.0||||||
4277176|NCT00572533|4101269|B1|Diabetes||Diabetes|Number of subjects with diagnosed diabetes|Participants|Number|17|17.0||||||
4277177|NCT00572533|4101267|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
4277178|NCT00572533|4101268|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
4277179|NCT00572533|4101269|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4277180|NCT00572533|4101267|B3|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4277181|NCT00572533|4101268|B2|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4277182|NCT00572533|4101269|B1|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4277183|NCT00572533|4101267|B3|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4277184|NCT00572533|4101268|B2|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4277185|NCT00572533|4101269|B1|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4277186|NCT00572533|4101267|B3|White||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
4277187|NCT00572533|4101268|B2|White||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4277188|NCT00572533|4101269|B1|White||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4277189|NCT00572533|4101267|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|41|41.0||||||
4277190|NCT00572533|4101268|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
4277191|NCT00572533|4101269|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
4277192|NCT00572533|4101267|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4277193|NCT00572533|4101268|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4277194|NCT00572533|4101269|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4277195|NCT00572533|4101267|B3|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4277196|NCT00572533|4101268|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4277197|NCT00572533|4101269|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4277198|NCT00572533|4101267|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4277199|NCT00572533|4101268|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4277200|NCT00572533|4101269|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4277201|NCT00572533|4101267|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4277202|NCT00572533|4101268|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4277203|NCT00572533|4101269|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4277204|NCT00572533|4101267|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4277205|NCT00572533|4101268|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4277206|NCT00572533|4101269|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4277207|NCT00572533|4101267|B3|||Age||years|Mean|57|57.0|Standard Deviation|9|9.0|||
4277208|NCT00572533|4101268|B2|||Age||years|Mean|57|57.0|Standard Deviation|9|9.0|||
4277209|NCT00572533|4101269|B1|||Age||years|Mean|57|57.0|Standard Deviation|10|10.0|||
4277210|NCT00572533|4101267|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4277211|NCT00572533|4101268|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4277212|NCT00572533|4101269|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4277213|NCT00572533|4101267|B3||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4277214|NCT00572533|4101268|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4277215|NCT00572533|4101269|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4277216|NCT00572533|4101267|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4277217|NCT00572533|4101268|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4277218|NCT00572533|4101269|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4277219|NCT00572468|4101290|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4277220|NCT00572468|4101291|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4277221|NCT00572468|4101292|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4277222|NCT00572468|4101290|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4277223|NCT00572468|4101291|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4277224|NCT00572468|4101292|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4277225|NCT00572468|4101290|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4277226|NCT00572468|4101291|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4277227|NCT00572468|4101292|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4277228|NCT00572468|4101290|B3|||Age||Years|Mean|60.56|60.56|Full Range|||46.0|73.0|
4277229|NCT00572468|4101291|B2|||Age||Years|Mean|60.75|60.75|Full Range|||53.0|73.0|
4277230|NCT00572468|4101292|B1|||Age||Years|Mean|60.4|60.4|Full Range|||46.0|71.0|
4277231|NCT00572468|4101290|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4277232|NCT00572468|4101291|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4277233|NCT00572468|4101292|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4277234|NCT00572468|4101290|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4277235|NCT00572468|4101291|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4277236|NCT00572468|4101292|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4277237|NCT00572468|4101290|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4277238|NCT00572468|4101291|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4277239|NCT00572468|4101292|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4277240|NCT00572260|4101301|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4277241|NCT00572260|4101301|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4277242|NCT00572260|4101301|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4277243|NCT00572260|4101301|B1|||Age||years|Mean|60|60.0|Standard Deviation|17|17.0|||
4277244|NCT00572260|4101301|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4277245|NCT00572260|4101301|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4277246|NCT00572260|4101301|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4277247|NCT00572156|4101305|B5|||Father height|Number of subjects analysed= 18,20,22,21 (Total = 81)|cm|Mean|172|172.0|Standard Deviation|6|6.0|||
4277248|NCT00572156|4101306|B4|||Father height|Number of subjects analysed= 18,20,22,21 (Total = 81)|cm|Mean|172|172.0|Standard Deviation|6|6.0|||
4277249|NCT00572156|4101307|B3|||Father height|Number of subjects analysed= 18,20,22,21 (Total = 81)|cm|Mean|173|173.0|Standard Deviation|7|7.0|||
4277250|NCT00572156|4101308|B2|||Father height|Number of subjects analysed= 18,20,22,21 (Total = 81)|cm|Mean|169|169.0|Standard Deviation|5|5.0|||
4277251|NCT00572156|4101309|B1|||Father height|Number of subjects analysed= 18,20,22,21 (Total = 81)|cm|Mean|172|172.0|Standard Deviation|4|4.0|||
4277252|NCT00572156|4101305|B5|||Mother height|Number of subjects analysed= 24,23,25,25 (Total 97)|cm|Mean|158|158.0|Standard Deviation|6|6.0|||
4277253|NCT00572156|4101306|B4|||Mother height|Number of subjects analysed= 24,23,25,25 (Total 97)|cm|Mean|159|159.0|Standard Deviation|7|7.0|||
4277254|NCT00572156|4101307|B3|||Mother height|Number of subjects analysed= 24,23,25,25 (Total 97)|cm|Mean|157|157.0|Standard Deviation|6|6.0|||
4277255|NCT00572156|4101308|B2|||Mother height|Number of subjects analysed= 24,23,25,25 (Total 97)|cm|Mean|157|157.0|Standard Deviation|5|5.0|||
4277256|NCT00572156|4101309|B1|||Mother height|Number of subjects analysed= 24,23,25,25 (Total 97)|cm|Mean|157|157.0|Standard Deviation|5|5.0|||
4277257|NCT00572156|4101305|B5|||IGFBP-3 SDS|"Number of subjects analysed= 26,26,27,26 (Total 105)~IGFBP-3 SDS was computed based on actual value of IGFBP-3, the mean reference value of IGFBP-3 and the SD reference value of IGFBP-3 as defined in the International Congress of Endocrinology, Lisbon, 2004"|SDS|Mean|-1.1|-1.1|Standard Deviation|0.8|0.8|||
4277258|NCT00572156|4101306|B4|||IGFBP-3 SDS|"Number of subjects analysed= 26,26,27,26 (Total 105)~IGFBP-3 SDS was computed based on actual value of IGFBP-3, the mean reference value of IGFBP-3 and the SD reference value of IGFBP-3 as defined in the International Congress of Endocrinology, Lisbon, 2004"|SDS|Mean|-1.3|-1.3|Standard Deviation|0.8|0.8|||
4277259|NCT00572156|4101307|B3|||IGFBP-3 SDS|"Number of subjects analysed= 26,26,27,26 (Total 105)~IGFBP-3 SDS was computed based on actual value of IGFBP-3, the mean reference value of IGFBP-3 and the SD reference value of IGFBP-3 as defined in the International Congress of Endocrinology, Lisbon, 2004"|SDS|Mean|-1.0|-1.0|Standard Deviation|0.8|0.8|||
4277260|NCT00572156|4101308|B2|||IGFBP-3 SDS|"Number of subjects analysed= 26,26,27,26 (Total 105)~IGFBP-3 SDS was computed based on actual value of IGFBP-3, the mean reference value of IGFBP-3 and the SD reference value of IGFBP-3 as defined in the International Congress of Endocrinology, Lisbon, 2004"|SDS|Mean|-1.2|-1.2|Standard Deviation|0.9|0.9|||
4277388|NCT00572039|4101383|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277261|NCT00572156|4101309|B1|||IGFBP-3 SDS|"Number of subjects analysed= 26,26,27,26 (Total 105)~IGFBP-3 SDS was computed based on actual value of IGFBP-3, the mean reference value of IGFBP-3 and the SD reference value of IGFBP-3 as defined in the International Congress of Endocrinology, Lisbon, 2004"|SDS|Mean|-1.1|-1.1|Standard Deviation|0.7|0.7|||
4277262|NCT00572156|4101305|B5|||Max stimulated GH||ng/mL|Mean|18.9|18.9|Standard Deviation|8.0|8.0|||
4277263|NCT00572156|4101306|B4|||Max stimulated GH||ng/mL|Mean|20.1|20.1|Standard Deviation|8.4|8.4|||
4277264|NCT00572156|4101307|B3|||Max stimulated GH||ng/mL|Mean|19.5|19.5|Standard Deviation|6.3|6.3|||
4277265|NCT00572156|4101308|B2|||Max stimulated GH||ng/mL|Mean|18.2|18.2|Standard Deviation|8.4|8.4|||
4277266|NCT00572156|4101309|B1|||Max stimulated GH||ng/mL|Mean|17.9|17.9|Standard Deviation|8.9|8.9|||
4277267|NCT00572156|4101305|B5|||Height Age||years|Mean|6.3|6.3|Standard Deviation|1.7|1.7|||
4277268|NCT00572156|4101306|B4|||Height Age||years|Mean|6.2|6.2|Standard Deviation|1.9|1.9|||
4277269|NCT00572156|4101307|B3|||Height Age||years|Mean|6.4|6.4|Standard Deviation|1.8|1.8|||
4277270|NCT00572156|4101308|B2|||Height Age||years|Mean|6.0|6.0|Standard Deviation|1.5|1.5|||
4277271|NCT00572156|4101309|B1|||Height Age||years|Mean|6.5|6.5|Standard Deviation|1.6|1.6|||
4277272|NCT00572156|4101305|B5|||Bone age imputed||years|Mean|7.3|7.3|Standard Deviation|1.9|1.9|||
4277273|NCT00572156|4101306|B4|||Bone age imputed||years|Mean|7.3|7.3|Standard Deviation|2.0|2.0|||
4277274|NCT00572156|4101307|B3|||Bone age imputed||years|Mean|7.2|7.2|Standard Deviation|2.0|2.0|||
4277275|NCT00572156|4101308|B2|||Bone age imputed||years|Mean|7.2|7.2|Standard Deviation|1.8|1.8|||
4277276|NCT00572156|4101309|B1|||Bone age imputed||years|Mean|7.6|7.6|Standard Deviation|1.7|1.7|||
4277277|NCT00572156|4101305|B5|||Mid-Parental target height|"The mid-parental target height SDS is defined as: 0.4*(Mother’s Height SDS+Father’s Height SDS)~The SDS was calculated as: SDS=[(value /M)^L – 1] / LS; using power (L), Mean (M) and coefficient of variation (S). The reference values were dependent on gender in addition to age and were selected at the age the closest below subject’s age. SDS scores were calculated using L, M and S as defined in the National Center for Health Statistics 2000 data as provided by the Center for Disease Control (Kuczmarski, Ogden et al. 2002)"|SDS|Mean|-0.5|-0.5|Standard Deviation|0.5|0.5|||
4277278|NCT00572156|4101306|B4|||Mid-Parental target height|"The mid-parental target height SDS is defined as: 0.4*(Mother’s Height SDS+Father’s Height SDS)~The SDS was calculated as: SDS=[(value /M)^L – 1] / LS; using power (L), Mean (M) and coefficient of variation (S). The reference values were dependent on gender in addition to age and were selected at the age the closest below subject’s age. SDS scores were calculated using L, M and S as defined in the National Center for Health Statistics 2000 data as provided by the Center for Disease Control (Kuczmarski, Ogden et al. 2002)"|SDS|Mean|-0.5|-0.5|Standard Deviation|0.5|0.5|||
4277279|NCT00572156|4101307|B3|||Mid-Parental target height|"The mid-parental target height SDS is defined as: 0.4*(Mother’s Height SDS+Father’s Height SDS)~The SDS was calculated as: SDS=[(value /M)^L – 1] / LS; using power (L), Mean (M) and coefficient of variation (S). The reference values were dependent on gender in addition to age and were selected at the age the closest below subject’s age. SDS scores were calculated using L, M and S as defined in the National Center for Health Statistics 2000 data as provided by the Center for Disease Control (Kuczmarski, Ogden et al. 2002)"|SDS|Mean|-0.5|-0.5|Standard Deviation|0.5|0.5|||
4277280|NCT00572156|4101308|B2|||Mid-Parental target height|"The mid-parental target height SDS is defined as: 0.4*(Mother’s Height SDS+Father’s Height SDS)~The SDS was calculated as: SDS=[(value /M)^L – 1] / LS; using power (L), Mean (M) and coefficient of variation (S). The reference values were dependent on gender in addition to age and were selected at the age the closest below subject’s age. SDS scores were calculated using L, M and S as defined in the National Center for Health Statistics 2000 data as provided by the Center for Disease Control (Kuczmarski, Ogden et al. 2002)"|SDS|Mean|-0.6|-0.6|Standard Deviation|0.5|0.5|||
4277281|NCT00572156|4101309|B1|||Mid-Parental target height|"The mid-parental target height SDS is defined as: 0.4*(Mother’s Height SDS+Father’s Height SDS)~The SDS was calculated as: SDS=[(value /M)^L – 1] / LS; using power (L), Mean (M) and coefficient of variation (S). The reference values were dependent on gender in addition to age and were selected at the age the closest below subject’s age. SDS scores were calculated using L, M and S as defined in the National Center for Health Statistics 2000 data as provided by the Center for Disease Control (Kuczmarski, Ogden et al. 2002)"|SDS|Mean|-0.5|-0.5|Standard Deviation|0.4|0.4|||
4277282|NCT00572156|4101305|B5|||IGF-1|IGF-1 SDS was computed based on actual value of IGF-1, the mean reference value of IGF-1 and the SD reference value of IGF-1 as defined in the International Congress of Endocrinology, Lisbon, 2004|SDS|Mean|-1.9|-1.9|Standard Deviation|0.6|0.6|||
4277283|NCT00572156|4101306|B4|||IGF-1|IGF-1 SDS was computed based on actual value of IGF-1, the mean reference value of IGF-1 and the SD reference value of IGF-1 as defined in the International Congress of Endocrinology, Lisbon, 2004|SDS|Mean|-2.0|-2.0|Standard Deviation|0.6|0.6|||
4277284|NCT00572156|4101307|B3|||IGF-1|IGF-1 SDS was computed based on actual value of IGF-1, the mean reference value of IGF-1 and the SD reference value of IGF-1 as defined in the International Congress of Endocrinology, Lisbon, 2004|SDS|Mean|-1.8|-1.8|Standard Deviation|0.6|0.6|||
4277285|NCT00572156|4101308|B2|||IGF-1|IGF-1 SDS was computed based on actual value of IGF-1, the mean reference value of IGF-1 and the SD reference value of IGF-1 as defined in the International Congress of Endocrinology, Lisbon, 2004|SDS|Mean|-2.0|-2.0|Standard Deviation|0.7|0.7|||
4277286|NCT00572156|4101309|B1|||IGF-1|IGF-1 SDS was computed based on actual value of IGF-1, the mean reference value of IGF-1 and the SD reference value of IGF-1 as defined in the International Congress of Endocrinology, Lisbon, 2004|SDS|Mean|-1.8|-1.8|Standard Deviation|0.5|0.5|||
4277287|NCT00572156|4101305|B5|||Body Mass Index (BMI)|"BMI was calculated by weight divided by height squared and measured as kilogram per square meter (kg/m^2).~The SDS was calculated as: SDS=[(value /M)^L – 1] / LS; using power (L), Mean (M) and coefficient of variation (S). The reference values were dependent on gender in addition to age and were selected at the age the closest below subject’s age. SDS scores were calculated using L, M and S as defined in the National Center for Health Statistics 2000 data as provided by the Center for Disease Control (Kuczmarski, Ogden et al. 2002)"|SDS|Mean|-0.4|-0.4|Standard Deviation|0.7|0.7|||
4277288|NCT00572156|4101306|B4|||Body Mass Index (BMI)|"BMI was calculated by weight divided by height squared and measured as kilogram per square meter (kg/m^2).~The SDS was calculated as: SDS=[(value /M)^L – 1] / LS; using power (L), Mean (M) and coefficient of variation (S). The reference values were dependent on gender in addition to age and were selected at the age the closest below subject’s age. SDS scores were calculated using L, M and S as defined in the National Center for Health Statistics 2000 data as provided by the Center for Disease Control (Kuczmarski, Ogden et al. 2002)"|SDS|Mean|-0.5|-0.5|Standard Deviation|0.8|0.8|||
4277289|NCT00572156|4101307|B3|||Body Mass Index (BMI)|"BMI was calculated by weight divided by height squared and measured as kilogram per square meter (kg/m^2).~The SDS was calculated as: SDS=[(value /M)^L – 1] / LS; using power (L), Mean (M) and coefficient of variation (S). The reference values were dependent on gender in addition to age and were selected at the age the closest below subject’s age. SDS scores were calculated using L, M and S as defined in the National Center for Health Statistics 2000 data as provided by the Center for Disease Control (Kuczmarski, Ogden et al. 2002)"|SDS|Mean|-0.4|-0.4|Standard Deviation|0.7|0.7|||
4277290|NCT00572156|4101308|B2|||Body Mass Index (BMI)|"BMI was calculated by weight divided by height squared and measured as kilogram per square meter (kg/m^2).~The SDS was calculated as: SDS=[(value /M)^L – 1] / LS; using power (L), Mean (M) and coefficient of variation (S). The reference values were dependent on gender in addition to age and were selected at the age the closest below subject’s age. SDS scores were calculated using L, M and S as defined in the National Center for Health Statistics 2000 data as provided by the Center for Disease Control (Kuczmarski, Ogden et al. 2002)"|SDS|Mean|-0.5|-0.5|Standard Deviation|0.7|0.7|||
4277291|NCT00572156|4101309|B1|||Body Mass Index (BMI)|"BMI was calculated by weight divided by height squared and measured as kilogram per square meter (kg/m^2).~The SDS was calculated as: SDS=[(value /M)^L – 1] / LS; using power (L), Mean (M) and coefficient of variation (S). The reference values were dependent on gender in addition to age and were selected at the age the closest below subject’s age. SDS scores were calculated using L, M and S as defined in the National Center for Health Statistics 2000 data as provided by the Center for Disease Control (Kuczmarski, Ogden et al. 2002)"|SDS|Mean|-0.3|-0.3|Standard Deviation|0.7|0.7|||
4277292|NCT00572156|4101305|B5|||Weight|"Weight was recorded from a single observation of the subject in light clothing or dressing gown with shoes removed.~The SDS was calculated as: SDS=[(value /M)^L – 1] / LS; using power (L), Mean (M) and coefficient of variation (S). The reference values were dependent on gender in addition to age and were selected at the age the closest below subject’s age. SDS scores were calculated using L, M and S as defined in the National Center for Health Statistics 2000 data as provided by the Center for Disease Control (Kuczmarski, Ogden et al. 2002)"|SDS|Mean|-2.1|-2.1|Standard Deviation|0.7|0.7|||
4277293|NCT00572156|4101306|B4|||Weight|"Weight was recorded from a single observation of the subject in light clothing or dressing gown with shoes removed.~The SDS was calculated as: SDS=[(value /M)^L – 1] / LS; using power (L), Mean (M) and coefficient of variation (S). The reference values were dependent on gender in addition to age and were selected at the age the closest below subject’s age. SDS scores were calculated using L, M and S as defined in the National Center for Health Statistics 2000 data as provided by the Center for Disease Control (Kuczmarski, Ogden et al. 2002)"|SDS|Mean|-2.2|-2.2|Standard Deviation|0.9|0.9|||
4277294|NCT00572156|4101307|B3|||Weight|"Weight was recorded from a single observation of the subject in light clothing or dressing gown with shoes removed.~The SDS was calculated as: SDS=[(value /M)^L – 1] / LS; using power (L), Mean (M) and coefficient of variation (S). The reference values were dependent on gender in addition to age and were selected at the age the closest below subject’s age. SDS scores were calculated using L, M and S as defined in the National Center for Health Statistics 2000 data as provided by the Center for Disease Control (Kuczmarski, Ogden et al. 2002)"|SDS|Mean|-2.0|-2.0|Standard Deviation|0.7|0.7|||
4277295|NCT00572156|4101308|B2|||Weight|"Weight was recorded from a single observation of the subject in light clothing or dressing gown with shoes removed.~The SDS was calculated as: SDS=[(value /M)^L – 1] / LS; using power (L), Mean (M) and coefficient of variation (S). The reference values were dependent on gender in addition to age and were selected at the age the closest below subject’s age. SDS scores were calculated using L, M and S as defined in the National Center for Health Statistics 2000 data as provided by the Center for Disease Control (Kuczmarski, Ogden et al. 2002)"|SDS|Mean|-2.1|-2.1|Standard Deviation|0.6|0.6|||
4277296|NCT00572156|4101309|B1|||Weight|"Weight was recorded from a single observation of the subject in light clothing or dressing gown with shoes removed.~The SDS was calculated as: SDS=[(value /M)^L – 1] / LS; using power (L), Mean (M) and coefficient of variation (S). The reference values were dependent on gender in addition to age and were selected at the age the closest below subject’s age. SDS scores were calculated using L, M and S as defined in the National Center for Health Statistics 2000 data as provided by the Center for Disease Control (Kuczmarski, Ogden et al. 2002)"|SDS|Mean|-2.0|-2.0|Standard Deviation|0.7|0.7|||
4277297|NCT00572156|4101305|B5|||Height|"Height was measured standing and without shoes, and recorded as the mean of three measurements (the subject being repositioned each time) by the same observer using a Harpenden or other wall-mounted stadiometer which was to be calibrated prior to measurement of each subject and a calibration log kept.~The SDS calculation and description is specified in baseline characteristic for parameter 'Weight'"|Standard Deviation Score (SDS)|Mean|-2.5|-2.5|Standard Deviation|0.4|0.4|||
4277298|NCT00572156|4101306|B4|||Height|"Height was measured standing and without shoes, and recorded as the mean of three measurements (the subject being repositioned each time) by the same observer using a Harpenden or other wall-mounted stadiometer which was to be calibrated prior to measurement of each subject and a calibration log kept.~The SDS calculation and description is specified in baseline characteristic for parameter 'Weight'"|Standard Deviation Score (SDS)|Mean|-2.6|-2.6|Standard Deviation|0.4|0.4|||
4277299|NCT00572156|4101307|B3|||Height|"Height was measured standing and without shoes, and recorded as the mean of three measurements (the subject being repositioned each time) by the same observer using a Harpenden or other wall-mounted stadiometer which was to be calibrated prior to measurement of each subject and a calibration log kept.~The SDS calculation and description is specified in baseline characteristic for parameter 'Weight'"|Standard Deviation Score (SDS)|Mean|-2.6|-2.6|Standard Deviation|0.4|0.4|||
4277389|NCT00572039|4101381|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277390|NCT00572039|4101382|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277300|NCT00572156|4101308|B2|||Height|"Height was measured standing and without shoes, and recorded as the mean of three measurements (the subject being repositioned each time) by the same observer using a Harpenden or other wall-mounted stadiometer which was to be calibrated prior to measurement of each subject and a calibration log kept.~The SDS calculation and description is specified in baseline characteristic for parameter 'Weight'"|Standard Deviation Score (SDS)|Mean|-2.5|-2.5|Standard Deviation|0.4|0.4|||
4277301|NCT00572156|4101309|B1|||Height|"Height was measured standing and without shoes, and recorded as the mean of three measurements (the subject being repositioned each time) by the same observer using a Harpenden or other wall-mounted stadiometer which was to be calibrated prior to measurement of each subject and a calibration log kept.~The SDS calculation and description is specified in baseline characteristic for parameter 'Weight'"|Standard Deviation Score (SDS)|Mean|-2.5|-2.5|Standard Deviation|0.5|0.5|||
4277302|NCT00572156|4101305|B5|Hawaiian or Pacific Islander/ White||Race||participants|Number|1|1.0||||||
4277303|NCT00572156|4101306|B4|Hawaiian or Pacific Islander/ White||Race||participants|Number|0|0.0||||||
4277304|NCT00572156|4101307|B3|Hawaiian or Pacific Islander/ White||Race||participants|Number|0|0.0||||||
4277305|NCT00572156|4101308|B2|Hawaiian or Pacific Islander/ White||Race||participants|Number|0|0.0||||||
4277306|NCT00572156|4101309|B1|Hawaiian or Pacific Islander/ White||Race||participants|Number|1|1.0||||||
4277307|NCT00572156|4101305|B5|Hispanic/White||Race||participants|Number|5|5.0||||||
4277308|NCT00572156|4101306|B4|Hispanic/White||Race||participants|Number|0|0.0||||||
4277309|NCT00572156|4101307|B3|Hispanic/White||Race||participants|Number|3|3.0||||||
4277310|NCT00572156|4101308|B2|Hispanic/White||Race||participants|Number|1|1.0||||||
4277311|NCT00572156|4101309|B1|Hispanic/White||Race||participants|Number|1|1.0||||||
4277312|NCT00572156|4101305|B5|White||Race||participants|Number|79|79.0||||||
4277313|NCT00572156|4101306|B4|White||Race||participants|Number|23|23.0||||||
4277314|NCT00572156|4101307|B3|White||Race||participants|Number|19|19.0||||||
4277315|NCT00572156|4101308|B2|White||Race||participants|Number|20|20.0||||||
4277316|NCT00572156|4101309|B1|White||Race||participants|Number|17|17.0||||||
4277317|NCT00572156|4101305|B5|Hispanic||Race||participants|Number|10|10.0||||||
4277318|NCT00572156|4101306|B4|Hispanic||Race||participants|Number|2|2.0||||||
4277319|NCT00572156|4101307|B3|Hispanic||Race||participants|Number|3|3.0||||||
4277320|NCT00572156|4101308|B2|Hispanic||Race||participants|Number|1|1.0||||||
4277321|NCT00572156|4101309|B1|Hispanic||Race||participants|Number|4|4.0||||||
4277322|NCT00572156|4101305|B5|Black||Race||participants|Number|3|3.0||||||
4277323|NCT00572156|4101306|B4|Black||Race||participants|Number|0|0.0||||||
4277324|NCT00572156|4101307|B3|Black||Race||participants|Number|1|1.0||||||
4277325|NCT00572156|4101308|B2|Black||Race||participants|Number|1|1.0||||||
4277326|NCT00572156|4101309|B1|Black||Race||participants|Number|1|1.0||||||
4277327|NCT00572156|4101305|B5|Asian||Race||participants|Number|8|8.0||||||
4277328|NCT00572156|4101306|B4|Asian||Race||participants|Number|1|1.0||||||
4277329|NCT00572156|4101307|B3|Asian||Race||participants|Number|1|1.0||||||
4277330|NCT00572156|4101308|B2|Asian||Race||participants|Number|4|4.0||||||
4277331|NCT00572156|4101309|B1|Asian||Race||participants|Number|2|2.0||||||
4277332|NCT00572156|4101305|B5||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4277333|NCT00572156|4101306|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4277334|NCT00572156|4101307|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4277335|NCT00572156|4101308|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4277336|NCT00572156|4101309|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4277337|NCT00572156|4101305|B5||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4277338|NCT00572156|4101306|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4277339|NCT00572156|4101307|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4277340|NCT00572156|4101308|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4277341|NCT00572156|4101309|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4277342|NCT00572156|4101305|B5|||Age||years|Mean|8.8|8.8|Standard Deviation|2.1|2.1|||
4277343|NCT00572156|4101306|B4|||Age||years|Mean|8.8|8.8|Standard Deviation|2.3|2.3|||
4277344|NCT00572156|4101307|B3|||Age||years|Mean|9.0|9.0|Standard Deviation|2.2|2.2|||
4277345|NCT00572156|4101308|B2|||Age||years|Mean|8.4|8.4|Standard Deviation|2.0|2.0|||
4277346|NCT00572156|4101309|B1|||Age||years|Mean|9.2|9.2|Standard Deviation|2.0|2.0|||
4277347|NCT00572117|4101370|B3||Male|Gender||Participants|Count of Participants|5|5.0||||||
4277348|NCT00572117|4101371|B2||Male|Gender||Participants|Count of Participants|2|2.0||||||
4277349|NCT00572117|4101372|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
4277350|NCT00572117|4101370|B3||Female|Gender||Participants|Count of Participants|7|7.0||||||
4277351|NCT00572117|4101371|B2||Female|Gender||Participants|Count of Participants|5|5.0||||||
4277352|NCT00572117|4101372|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
4277353|NCT00572117|4101370|B3|||Age||years|Mean|43.6|43.6|Standard Deviation|9.7|9.7|||
4277354|NCT00572117|4101371|B2|||Age||years|Mean|46.6|46.6|Standard Deviation|8.3|8.3|||
4277355|NCT00572117|4101372|B1|||Age||years|Mean|39.4|39.4|Standard Deviation|10.8|10.8|||
4277356|NCT00572039|4101381|B3|||Number of resources/rehabilitative devices used||number of resources/devices used|Mean|4.93|4.93|Standard Deviation|3.18|3.18|||
4277357|NCT00572039|4101382|B2|||Number of resources/rehabilitative devices used||number of resources/devices used|Mean|4.71|4.71|Standard Deviation|3.02|3.02|||
4277358|NCT00572039|4101383|B1|||Number of resources/rehabilitative devices used||number of resources/devices used|Mean|5.14|5.14|Standard Deviation|3.34|3.34|||
4277359|NCT00572039|4101381|B3|||Patient Health Questionnaire-9|To assess depression, we used the 9-item Patient Health Questionnaire, which yields a continuous measure of depression severity. Scores range from 0 to 27, with higher scores indicating worse depression.|units on a scale|Mean|1.28|1.28|Standard Deviation|2.48|2.48|||
4277360|NCT00572039|4101382|B2|||Patient Health Questionnaire-9|To assess depression, we used the 9-item Patient Health Questionnaire, which yields a continuous measure of depression severity. Scores range from 0 to 27, with higher scores indicating worse depression.|units on a scale|Mean|1.17|1.17|Standard Deviation|2.28|2.28|||
4277361|NCT00572039|4101383|B1|||Patient Health Questionnaire-9|To assess depression, we used the 9-item Patient Health Questionnaire, which yields a continuous measure of depression severity. Scores range from 0 to 27, with higher scores indicating worse depression.|units on a scale|Mean|1.39|1.39|Standard Deviation|2.67|2.67|||
4277362|NCT00572039|4101381|B3|||NEI VFQ-25 + supplement total score|We administered the 25-item National Eye Institute Vision Function Questionaire plus Supplement (NEI-VFQ).19 This version of the NEI VFQ consists of 39 items that assess self-reported vision function and vision-related QoL. The latter yields a multidimensional index of vision-related health composed of social functioning (social interactions), mental health (worry, frustration), role difficulties (accomplishing less), and dependency (relying more on others) due to vision loss. Scores range from 0 to 100, with higher scores indicating better function.|units on a scale|Mean|66.0|66.0|Standard Deviation|14.2|14.2|||
4277363|NCT00572039|4101382|B2|||NEI VFQ-25 + supplement total score|We administered the 25-item National Eye Institute Vision Function Questionaire plus Supplement (NEI-VFQ).19 This version of the NEI VFQ consists of 39 items that assess self-reported vision function and vision-related QoL. The latter yields a multidimensional index of vision-related health composed of social functioning (social interactions), mental health (worry, frustration), role difficulties (accomplishing less), and dependency (relying more on others) due to vision loss. Scores range from 0 to 100, with higher scores indicating better function.|units on a scale|Mean|65.8|65.8|Standard Deviation|14.2|14.2|||
4277364|NCT00572039|4101383|B1|||NEI VFQ-25 + supplement total score|We administered the 25-item National Eye Institute Vision Function Questionaire plus Supplement (NEI-VFQ).19 This version of the NEI VFQ consists of 39 items that assess self-reported vision function and vision-related QoL. The latter yields a multidimensional index of vision-related health composed of social functioning (social interactions), mental health (worry, frustration), role difficulties (accomplishing less), and dependency (relying more on others) due to vision loss. Scores range from 0 to 100, with higher scores indicating better function.|units on a scale|Mean|66.2|66.2|Standard Deviation|14.3|14.3|||
4277365|NCT00572039|4101381|B3|||Targeted vision function|At baseline subjects completed the Activities Inventory, a structured vision function questionnaire that asks patients to rate the value and difficulty of 48 vision function goal and the tasks that are required to achieve them. If a goal is important, the subject rates its “difficulty”. The average TVF score is the sum of the difficulty ratings of the (up to) 4 self-selected goals divided by the number of goals (from 1 to 4). Higher average scores indicate greater disability.|units on a scale|Mean|2.72|2.72|Standard Deviation|.52|0.52|||
4277366|NCT00572039|4101382|B2|||Targeted vision function|At baseline subjects completed the Activities Inventory, a structured vision function questionnaire that asks patients to rate the value and difficulty of 48 vision function goal and the tasks that are required to achieve them. If a goal is important, the subject rates its “difficulty”. The average TVF score is the sum of the difficulty ratings of the (up to) 4 self-selected goals divided by the number of goals (from 1 to 4). Higher average scores indicate greater disability.|units on a scale|Mean|2.73|2.73|Standard Deviation|.52|0.52|||
4277367|NCT00572039|4101383|B1|||Targeted vision function|At baseline subjects completed the Activities Inventory, a structured vision function questionnaire that asks patients to rate the value and difficulty of 48 vision function goal and the tasks that are required to achieve them. If a goal is important, the subject rates its “difficulty”. The average TVF score is the sum of the difficulty ratings of the (up to) 4 self-selected goals divided by the number of goals (from 1 to 4). Higher average scores indicate greater disability.|units on a scale|Mean|2.71|2.71|Standard Deviation|.52|0.52|||
4277368|NCT00572039|4101381|B3|United States||Region of Enrollment||participants|Number|241|241.0||||||
4277369|NCT00572039|4101382|B2|United States||Region of Enrollment||participants|Number|120|120.0||||||
4277370|NCT00572039|4101383|B1|United States||Region of Enrollment||participants|Number|121|121.0||||||
4277371|NCT00572039|4101381|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277372|NCT00572039|4101382|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277373|NCT00572039|4101383|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277374|NCT00572039|4101381|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277375|NCT00572039|4101382|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277376|NCT00572039|4101383|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277377|NCT00572039|4101381|B3||White|Race (NIH/OMB)||Participants|Count of Participants|239|239.0||||||
4277378|NCT00572039|4101382|B2||White|Race (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
4277379|NCT00572039|4101383|B1||White|Race (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
4277380|NCT00572039|4101381|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4277381|NCT00572039|4101382|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4277382|NCT00572039|4101383|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4277383|NCT00572039|4101381|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277384|NCT00572039|4101382|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277385|NCT00572039|4101383|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277386|NCT00572039|4101381|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277387|NCT00572039|4101382|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277391|NCT00572039|4101383|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277392|NCT00572039|4101381|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4277393|NCT00572039|4101382|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4277394|NCT00572039|4101383|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4277395|NCT00572039|4101381|B3||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4277396|NCT00572039|4101382|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4277397|NCT00572039|4101383|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4277398|NCT00572039|4101381|B3|||Age||years|Mean|82.7|82.7|Standard Deviation|6.9|6.9|||
4277399|NCT00572039|4101382|B2|||Age||years|Mean|82.8|82.8|Standard Deviation|7.3|7.3|||
4277400|NCT00572039|4101383|B1|||Age||years|Mean|82.7|82.7|Standard Deviation|6.6|6.6|||
4277401|NCT00571987|4101396|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4277402|NCT00571987|4101396|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4277403|NCT00571987|4101396|B1|||Age||years|Mean|65.02|65.02|Standard Deviation|10|10.0|||
4277404|NCT00571974|4101401|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4277405|NCT00571974|4101402|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4277406|NCT00571974|4101403|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4277407|NCT00571974|4101401|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4277408|NCT00571974|4101402|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4277409|NCT00571974|4101403|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4277410|NCT00571974|4101401|B3|>=80 years||Age, Customized||participants|Number|0|0.0||||||
4277411|NCT00571974|4101402|B2|>=80 years||Age, Customized||participants|Number|0|0.0||||||
4277412|NCT00571974|4101403|B1|>=80 years||Age, Customized||participants|Number|0|0.0||||||
4277413|NCT00571974|4101401|B3|Between 18 and 80 years||Age, Customized||participants|Number|29|29.0||||||
4277414|NCT00571974|4101402|B2|Between 18 and 80 years||Age, Customized||participants|Number|18|18.0||||||
4277415|NCT00571974|4101403|B1|Between 18 and 80 years||Age, Customized||participants|Number|11|11.0||||||
4277416|NCT00571974|4101401|B3|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4277417|NCT00571974|4101402|B2|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4277418|NCT00571974|4101403|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4277419|NCT00571961|4101410|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4277420|NCT00571961|4101410|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4277421|NCT00571961|4101410|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4277422|NCT00571961|4101410|B1|||Age||years|Median|42|42.0|Full Range|1|1.0|29.0|54.0|
4277423|NCT00571948|4101414|B3|Germany||Region of Enrollment||participants|Number|132|132.0||||||
4277424|NCT00571948|4101415|B2|Germany||Region of Enrollment||participants|Number|66|66.0||||||
4277425|NCT00571948|4101416|B1|Germany||Region of Enrollment||participants|Number|66|66.0||||||
4277426|NCT00571948|4101414|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4277427|NCT00571948|4101415|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4277428|NCT00571948|4101416|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4277429|NCT00571948|4101414|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4277430|NCT00571948|4101415|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4277431|NCT00571948|4101416|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4277432|NCT00571948|4101414|B3|<=2 months at beginning||Age, Customized||Participants|Number|132|132.0||||||
4277433|NCT00571948|4101415|B2|<=2 months at beginning||Age, Customized||Participants|Number|66|66.0||||||
4277434|NCT00571948|4101416|B1|<=2 months at beginning||Age, Customized||Participants|Number|66|66.0||||||
4277435|NCT00571922|4101423|B3||Male|Sex: Female, Male|PI passed away, and there is no access to data. Although the total number of subjects enrolled is known, information regarding baseline characteristics is unavailable.|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4277436|NCT00571922|4101424|B2||Male|Sex: Female, Male|PI passed away, and there is no access to data. Although the total number of subjects enrolled is known, information regarding baseline characteristics is unavailable.|Participants|Count of Participants|NA|||||||PI passed away, and there is no access to data. Although the total number of subjects enrolled is known, information regarding baseline characteristics is unavailable.
4277437|NCT00571922|4101425|B1||Male|Sex: Female, Male|PI passed away, and there is no access to data. Although the total number of subjects enrolled is known, information regarding baseline characteristics is unavailable.|Participants|Count of Participants|NA|||||||PI passed away, and there is no access to data. Although the total number of subjects enrolled is known, information regarding baseline characteristics is unavailable.
4277438|NCT00571922|4101423|B3||Female|Sex: Female, Male|PI passed away, and there is no access to data. Although the total number of subjects enrolled is known, information regarding baseline characteristics is unavailable.|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4277439|NCT00571922|4101424|B2||Female|Sex: Female, Male|PI passed away, and there is no access to data. Although the total number of subjects enrolled is known, information regarding baseline characteristics is unavailable.|Participants|Count of Participants|NA|||||||PI passed away, and there is no access to data. Although the total number of subjects enrolled is known, information regarding baseline characteristics is unavailable.
4277476|NCT00571701|4101436|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4277477|NCT00571701|4101434|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4277440|NCT00571922|4101425|B1||Female|Sex: Female, Male|PI passed away, and there is no access to data. Although the total number of subjects enrolled is known, information regarding baseline characteristics is unavailable.|Participants|Count of Participants|NA|||||||PI passed away, and there is no access to data. Although the total number of subjects enrolled is known, information regarding baseline characteristics is unavailable.
4277441|NCT00571922|4101423|B3||>=65 years|Age|PI passed away, and there is no access to data. Although the total number of subjects enrolled is known, information regarding baseline characteristics is unavailable.|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4277442|NCT00571922|4101424|B2||>=65 years|Age|PI passed away, and there is no access to data. Although the total number of subjects enrolled is known, information regarding baseline characteristics is unavailable.|Participants|Count of Participants|NA|||||||PI passed away, and there is no access to data. Although the total number of subjects enrolled is known, information regarding baseline characteristics is unavailable.
4277443|NCT00571922|4101425|B1||>=65 years|Age|PI passed away, and there is no access to data. Although the total number of subjects enrolled is known, information regarding baseline characteristics is unavailable.|Participants|Count of Participants|NA|||||||PI passed away, and there is no access to data. Although the total number of subjects enrolled is known, information regarding baseline characteristics is unavailable.
4277444|NCT00571922|4101423|B3||Between 18 and 65 years|Age|PI passed away, and there is no access to data. Although the total number of subjects enrolled is known, information regarding baseline characteristics is unavailable.|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4277445|NCT00571922|4101424|B2||Between 18 and 65 years|Age|PI passed away, and there is no access to data. Although the total number of subjects enrolled is known, information regarding baseline characteristics is unavailable.|Participants|Count of Participants|NA|||||||PI passed away, and there is no access to data. Although the total number of subjects enrolled is known, information regarding baseline characteristics is unavailable.
4277446|NCT00571922|4101425|B1||Between 18 and 65 years|Age|PI passed away, and there is no access to data. Although the total number of subjects enrolled is known, information regarding baseline characteristics is unavailable.|Participants|Count of Participants|NA|||||||PI passed away, and there is no access to data. Although the total number of subjects enrolled is known, information regarding baseline characteristics is unavailable.
4277447|NCT00571922|4101423|B3||<=18 years|Age|PI passed away, and there is no access to data. Although the total number of subjects enrolled is known, information regarding baseline characteristics is unavailable.|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4277448|NCT00571922|4101424|B2||<=18 years|Age|PI passed away, and there is no access to data. Although the total number of subjects enrolled is known, information regarding baseline characteristics is unavailable.|Participants|Count of Participants|NA|||||||PI passed away, and there is no access to data. Although the total number of subjects enrolled is known, information regarding baseline characteristics is unavailable.
4277449|NCT00571922|4101425|B1||<=18 years|Age|PI passed away, and there is no access to data. Although the total number of subjects enrolled is known, information regarding baseline characteristics is unavailable.|Participants|Count of Participants|NA|||||||PI passed away, and there is no access to data. Although the total number of subjects enrolled is known, information regarding baseline characteristics is unavailable.
4277450|NCT00571701|4101434|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277451|NCT00571701|4101435|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277452|NCT00571701|4101436|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277453|NCT00571701|4101434|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4277454|NCT00571701|4101435|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4277455|NCT00571701|4101436|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277456|NCT00571701|4101434|B3||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4277457|NCT00571701|4101435|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4277458|NCT00571701|4101436|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4277459|NCT00571701|4101434|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4277460|NCT00571701|4101435|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4277461|NCT00571701|4101436|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4277462|NCT00571701|4101434|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277463|NCT00571701|4101435|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277464|NCT00571701|4101436|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277465|NCT00571701|4101434|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277466|NCT00571701|4101435|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277467|NCT00571701|4101436|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277468|NCT00571701|4101434|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277469|NCT00571701|4101435|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277470|NCT00571701|4101436|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277471|NCT00571701|4101434|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277472|NCT00571701|4101435|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277473|NCT00571701|4101436|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277474|NCT00571701|4101434|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4277475|NCT00571701|4101435|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4277478|NCT00571701|4101435|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4277479|NCT00571701|4101436|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4277480|NCT00571701|4101434|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4277481|NCT00571701|4101435|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4277482|NCT00571701|4101436|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4277483|NCT00571701|4101434|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4277484|NCT00571701|4101435|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4277485|NCT00571701|4101436|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4277486|NCT00571701|4101434|B3|Age 40 and above||Age, Customized||participants|Number|9|9.0||||||
4277487|NCT00571701|4101435|B2|Age 40 and above||Age, Customized||participants|Number|2|2.0||||||
4277488|NCT00571701|4101436|B1|Age 40 and above||Age, Customized||participants|Number|7|7.0||||||
4277489|NCT00571701|4101434|B3|Age 20 - < 40||Age, Customized||participants|Number|12|12.0||||||
4277490|NCT00571701|4101435|B2|Age 20 - < 40||Age, Customized||participants|Number|9|9.0||||||
4277491|NCT00571701|4101436|B1|Age 20 - < 40||Age, Customized||participants|Number|3|3.0||||||
4277492|NCT00571701|4101434|B3|Age < 20||Age, Customized||participants|Number|20|20.0||||||
4277493|NCT00571701|4101435|B2|Age < 20||Age, Customized||participants|Number|11|11.0||||||
4277494|NCT00571701|4101436|B1|Age < 20||Age, Customized||participants|Number|9|9.0||||||
4277495|NCT00571688|4101461|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4277496|NCT00571688|4101462|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4277497|NCT00571688|4101463|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4277498|NCT00571688|4101461|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4277499|NCT00571688|4101462|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4277500|NCT00571688|4101463|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4277501|NCT00571688|4101461|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4277502|NCT00571688|4101462|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4277503|NCT00571688|4101463|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4277504|NCT00571688|4101461|B3|||Age||Years|Mean|40.5|40.5|Standard Deviation|9.45|9.45|||
4277505|NCT00571688|4101462|B2|||Age||Years|Mean|38.2|38.2|Standard Deviation|10.2|10.2|||
4277506|NCT00571688|4101463|B1|||Age||Years|Mean|42.8|42.8|Standard Deviation|8.7|8.7|||
4277507|NCT00571688|4101461|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4277508|NCT00571688|4101462|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4277509|NCT00571688|4101463|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4277510|NCT00571688|4101461|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4277511|NCT00571688|4101462|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4277512|NCT00571688|4101463|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4277513|NCT00571688|4101461|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4277514|NCT00571688|4101462|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4277515|NCT00571688|4101463|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4277516|NCT00571662|4101470|B1|United States||Region of Enrollment||participants|Number|76|76.0||||||
4277517|NCT00571662|4101470|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4277518|NCT00571662|4101470|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4277519|NCT00571662|4101470|B1|||Age||years|Median|56|56.0|Full Range|||21.0|69.0|
4277520|NCT00571662|4101470|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4277521|NCT00571662|4101470|B1||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4277522|NCT00571662|4101470|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4277523|NCT00571649|4101479|B3|Acute respiratory insufficiency||Reason for hospitalization|Participants may have more than one acute condition as hospitalization reason. Acute medical illnesses included heart failure (New York Heart Association [NYHA] Class III [marked limitation of physical activity] or NYHA Class IV [inability to carry out any physical activity without discomfort)] active cancer, acute ischemic stroke, acute infectious and inflammatory diseases (including acute rheumatic diseases), acute respiratory insufficiency.|participants|Number|2236|2236.0||||||
4277524|NCT00571649|4101480|B2|Acute respiratory insufficiency||Reason for hospitalization|Participants may have more than one acute condition as hospitalization reason. Acute medical illnesses included heart failure (New York Heart Association [NYHA] Class III [marked limitation of physical activity] or NYHA Class IV [inability to carry out any physical activity without discomfort)] active cancer, acute ischemic stroke, acute infectious and inflammatory diseases (including acute rheumatic diseases), acute respiratory insufficiency.|participants|Number|1151|1151.0||||||
4277525|NCT00571649|4101481|B1|Acute respiratory insufficiency||Reason for hospitalization|Participants may have more than one acute condition as hospitalization reason. Acute medical illnesses included heart failure (New York Heart Association [NYHA] Class III [marked limitation of physical activity] or NYHA Class IV [inability to carry out any physical activity without discomfort)] active cancer, acute ischemic stroke, acute infectious and inflammatory diseases (including acute rheumatic diseases), acute respiratory insufficiency.|participants|Number|1085|1085.0||||||
4277587|NCT00571493|4101514|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4277588|NCT00571493|4101514|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277589|NCT00571493|4101514|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4277526|NCT00571649|4101479|B3|Acute inflammatory or rheumatic disease||Reason for hospitalization|Participants may have more than one acute condition as hospitalization reason. Acute medical illnesses included heart failure (New York Heart Association [NYHA] Class III [marked limitation of physical activity] or NYHA Class IV [inability to carry out any physical activity without discomfort)] active cancer, acute ischemic stroke, acute infectious and inflammatory diseases (including acute rheumatic diseases), acute respiratory insufficiency.|participants|Number|299|299.0||||||
4277527|NCT00571649|4101480|B2|Acute inflammatory or rheumatic disease||Reason for hospitalization|Participants may have more than one acute condition as hospitalization reason. Acute medical illnesses included heart failure (New York Heart Association [NYHA] Class III [marked limitation of physical activity] or NYHA Class IV [inability to carry out any physical activity without discomfort)] active cancer, acute ischemic stroke, acute infectious and inflammatory diseases (including acute rheumatic diseases), acute respiratory insufficiency.|participants|Number|149|149.0||||||
4277528|NCT00571649|4101481|B1|Acute inflammatory or rheumatic disease||Reason for hospitalization|Participants may have more than one acute condition as hospitalization reason. Acute medical illnesses included heart failure (New York Heart Association [NYHA] Class III [marked limitation of physical activity] or NYHA Class IV [inability to carry out any physical activity without discomfort)] active cancer, acute ischemic stroke, acute infectious and inflammatory diseases (including acute rheumatic diseases), acute respiratory insufficiency.|participants|Number|150|150.0||||||
4277529|NCT00571649|4101479|B3|Acute infectious disease||Reason for hospitalization|Participants may have more than one acute condition as hospitalization reason. Acute medical illnesses included heart failure (New York Heart Association [NYHA] Class III [marked limitation of physical activity] or NYHA Class IV [inability to carry out any physical activity without discomfort)] active cancer, acute ischemic stroke, acute infectious and inflammatory diseases (including acute rheumatic diseases), acute respiratory insufficiency.|participants|Number|3627|3627.0||||||
4277530|NCT00571649|4101480|B2|Acute infectious disease||Reason for hospitalization|Participants may have more than one acute condition as hospitalization reason. Acute medical illnesses included heart failure (New York Heart Association [NYHA] Class III [marked limitation of physical activity] or NYHA Class IV [inability to carry out any physical activity without discomfort)] active cancer, acute ischemic stroke, acute infectious and inflammatory diseases (including acute rheumatic diseases), acute respiratory insufficiency.|participants|Number|1801|1801.0||||||
4277531|NCT00571649|4101481|B1|Acute infectious disease||Reason for hospitalization|Participants may have more than one acute condition as hospitalization reason. Acute medical illnesses included heart failure (New York Heart Association [NYHA] Class III [marked limitation of physical activity] or NYHA Class IV [inability to carry out any physical activity without discomfort)] active cancer, acute ischemic stroke, acute infectious and inflammatory diseases (including acute rheumatic diseases), acute respiratory insufficiency.|participants|Number|1826|1826.0||||||
4277532|NCT00571649|4101479|B3|Acute Infectious and Inflammatory Diseases||Reason for hospitalization|Participants may have more than one acute condition as hospitalization reason. Acute medical illnesses included heart failure (New York Heart Association [NYHA] Class III [marked limitation of physical activity] or NYHA Class IV [inability to carry out any physical activity without discomfort)] active cancer, acute ischemic stroke, acute infectious and inflammatory diseases (including acute rheumatic diseases), acute respiratory insufficiency.|participants|Number|3780|3780.0||||||
4277533|NCT00571649|4101480|B2|Acute Infectious and Inflammatory Diseases||Reason for hospitalization|Participants may have more than one acute condition as hospitalization reason. Acute medical illnesses included heart failure (New York Heart Association [NYHA] Class III [marked limitation of physical activity] or NYHA Class IV [inability to carry out any physical activity without discomfort)] active cancer, acute ischemic stroke, acute infectious and inflammatory diseases (including acute rheumatic diseases), acute respiratory insufficiency.|participants|Number|1876|1876.0||||||
4277534|NCT00571649|4101481|B1|Acute Infectious and Inflammatory Diseases||Reason for hospitalization|Participants may have more than one acute condition as hospitalization reason. Acute medical illnesses included heart failure (New York Heart Association [NYHA] Class III [marked limitation of physical activity] or NYHA Class IV [inability to carry out any physical activity without discomfort)] active cancer, acute ischemic stroke, acute infectious and inflammatory diseases (including acute rheumatic diseases), acute respiratory insufficiency.|participants|Number|1904|1904.0||||||
4277535|NCT00571649|4101479|B3|Acute ischemic stroke||Reason for hospitalization|Participants may have more than one acute condition as hospitalization reason. Acute medical illnesses included heart failure (New York Heart Association [NYHA] Class III [marked limitation of physical activity] or NYHA Class IV [inability to carry out any physical activity without discomfort)] active cancer, acute ischemic stroke, acute infectious and inflammatory diseases (including acute rheumatic diseases), acute respiratory insufficiency.|participants|Number|1383|1383.0||||||
4277536|NCT00571649|4101480|B2|Acute ischemic stroke||Reason for hospitalization|Participants may have more than one acute condition as hospitalization reason. Acute medical illnesses included heart failure (New York Heart Association [NYHA] Class III [marked limitation of physical activity] or NYHA Class IV [inability to carry out any physical activity without discomfort)] active cancer, acute ischemic stroke, acute infectious and inflammatory diseases (including acute rheumatic diseases), acute respiratory insufficiency.|participants|Number|692|692.0||||||
4277537|NCT00571649|4101481|B1|Acute ischemic stroke||Reason for hospitalization|Participants may have more than one acute condition as hospitalization reason. Acute medical illnesses included heart failure (New York Heart Association [NYHA] Class III [marked limitation of physical activity] or NYHA Class IV [inability to carry out any physical activity without discomfort)] active cancer, acute ischemic stroke, acute infectious and inflammatory diseases (including acute rheumatic diseases), acute respiratory insufficiency.|participants|Number|691|691.0||||||
4277538|NCT00571649|4101479|B3|Active cancer||Reason for hospitalization|Participants may have more than one acute condition as hospitalization reason. Acute medical illnesses included heart failure (New York Heart Association [NYHA] Class III [marked limitation of physical activity] or NYHA Class IV [inability to carry out any physical activity without discomfort)] active cancer, acute ischemic stroke, acute infectious and inflammatory diseases (including acute rheumatic diseases), acute respiratory insufficiency.|participants|Number|584|584.0||||||
4277590|NCT00571493|4101514|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4277591|NCT00571493|4101514|B1|||Age||years|Median|58|58.0|Full Range|||34.0|73.0|
4277539|NCT00571649|4101480|B2|Active cancer||Reason for hospitalization|Participants may have more than one acute condition as hospitalization reason. Acute medical illnesses included heart failure (New York Heart Association [NYHA] Class III [marked limitation of physical activity] or NYHA Class IV [inability to carry out any physical activity without discomfort)] active cancer, acute ischemic stroke, acute infectious and inflammatory diseases (including acute rheumatic diseases), acute respiratory insufficiency.|participants|Number|290|290.0||||||
4277540|NCT00571649|4101481|B1|Active cancer||Reason for hospitalization|Participants may have more than one acute condition as hospitalization reason. Acute medical illnesses included heart failure (New York Heart Association [NYHA] Class III [marked limitation of physical activity] or NYHA Class IV [inability to carry out any physical activity without discomfort)] active cancer, acute ischemic stroke, acute infectious and inflammatory diseases (including acute rheumatic diseases), acute respiratory insufficiency.|participants|Number|294|294.0||||||
4277541|NCT00571649|4101479|B3|Heart failure (NYHA Class III or NYHA Class IV)||Reason for hospitalization|Participants may have more than one acute condition as hospitalization reason. Acute medical illnesses included heart failure (New York Heart Association [NYHA] Class III [marked limitation of physical activity] or NYHA Class IV [inability to carry out any physical activity without discomfort)] active cancer, acute ischemic stroke, acute infectious and inflammatory diseases (including acute rheumatic diseases), acute respiratory insufficiency.|participants|Number|2593|2593.0||||||
4277542|NCT00571649|4101480|B2|Heart failure (NYHA Class III or NYHA Class IV)||Reason for hospitalization|Participants may have more than one acute condition as hospitalization reason. Acute medical illnesses included heart failure (New York Heart Association [NYHA] Class III [marked limitation of physical activity] or NYHA Class IV [inability to carry out any physical activity without discomfort)] active cancer, acute ischemic stroke, acute infectious and inflammatory diseases (including acute rheumatic diseases), acute respiratory insufficiency.|participants|Number|1301|1301.0||||||
4277543|NCT00571649|4101481|B1|Heart failure (NYHA Class III or NYHA Class IV)||Reason for hospitalization|Participants may have more than one acute condition as hospitalization reason. Acute medical illnesses included heart failure (New York Heart Association [NYHA] Class III [marked limitation of physical activity] or NYHA Class IV [inability to carry out any physical activity without discomfort)] active cancer, acute ischemic stroke, acute infectious and inflammatory diseases (including acute rheumatic diseases), acute respiratory insufficiency.|participants|Number|1292|1292.0||||||
4277544|NCT00571649|4101479|B3|Missing||Race||participants|Number|355|355.0||||||
4277545|NCT00571649|4101480|B2|Missing||Race||participants|Number|177|177.0||||||
4277546|NCT00571649|4101481|B1|Missing||Race||participants|Number|178|178.0||||||
4277547|NCT00571649|4101479|B3|Unknown||Race||participants|Number|1|1.0||||||
4277548|NCT00571649|4101480|B2|Unknown||Race||participants|Number|0|0.0||||||
4277549|NCT00571649|4101481|B1|Unknown||Race||participants|Number|1|1.0||||||
4277550|NCT00571649|4101479|B3|Uncodable||Race||participants|Number|218|218.0||||||
4277551|NCT00571649|4101480|B2|Uncodable||Race||participants|Number|112|112.0||||||
4277552|NCT00571649|4101481|B1|Uncodable||Race||participants|Number|106|106.0||||||
4277553|NCT00571649|4101479|B3|Hispanic||Race||participants|Number|139|139.0||||||
4277554|NCT00571649|4101480|B2|Hispanic||Race||participants|Number|70|70.0||||||
4277555|NCT00571649|4101481|B1|Hispanic||Race||participants|Number|69|69.0||||||
4277556|NCT00571649|4101479|B3|Native American||Race||participants|Number|24|24.0||||||
4277557|NCT00571649|4101480|B2|Native American||Race||participants|Number|12|12.0||||||
4277558|NCT00571649|4101481|B1|Native American||Race||participants|Number|12|12.0||||||
4277559|NCT00571649|4101479|B3|Asian||Race||participants|Number|1587|1587.0||||||
4277560|NCT00571649|4101480|B2|Asian||Race||participants|Number|794|794.0||||||
4277561|NCT00571649|4101481|B1|Asian||Race||participants|Number|793|793.0||||||
4277562|NCT00571649|4101479|B3|Black||Race||participants|Number|181|181.0||||||
4277563|NCT00571649|4101480|B2|Black||Race||participants|Number|92|92.0||||||
4277564|NCT00571649|4101481|B1|Black||Race||participants|Number|89|89.0||||||
4277565|NCT00571649|4101479|B3|White||Race||participants|Number|5493|5493.0||||||
4277566|NCT00571649|4101480|B2|White||Race||participants|Number|2744|2744.0||||||
4277567|NCT00571649|4101481|B1|White||Race||participants|Number|2749|2749.0||||||
4277568|NCT00571649|4101479|B3||Male|Sex: Female, Male||Participants|Count of Participants|4326|4326.0||||||
4277569|NCT00571649|4101480|B2||Male|Sex: Female, Male||Participants|Count of Participants|2103|2103.0||||||
4277570|NCT00571649|4101481|B1||Male|Sex: Female, Male||Participants|Count of Participants|2223|2223.0||||||
4277571|NCT00571649|4101479|B3||Female|Sex: Female, Male||Participants|Count of Participants|3672|3672.0||||||
4277572|NCT00571649|4101480|B2||Female|Sex: Female, Male||Participants|Count of Participants|1898|1898.0||||||
4277573|NCT00571649|4101481|B1||Female|Sex: Female, Male||Participants|Count of Participants|1774|1774.0||||||
4277574|NCT00571649|4101479|B3|>= 75 years||Age, Customized||participants|Number|3078|3078.0||||||
4277575|NCT00571649|4101480|B2|>= 75 years||Age, Customized||participants|Number|1548|1548.0||||||
4277576|NCT00571649|4101481|B1|>= 75 years||Age, Customized||participants|Number|1530|1530.0||||||
4277577|NCT00571649|4101479|B3|65 to < 75 years||Age, Customized||participants|Number|2234|2234.0||||||
4277578|NCT00571649|4101480|B2|65 to < 75 years||Age, Customized||participants|Number|1090|1090.0||||||
4277579|NCT00571649|4101481|B1|65 to < 75 years||Age, Customized||participants|Number|1144|1144.0||||||
4277580|NCT00571649|4101479|B3|< 65 years||Age, Customized||participants|Number|2686|2686.0||||||
4277581|NCT00571649|4101480|B2|< 65 years||Age, Customized||participants|Number|1363|1363.0||||||
4277582|NCT00571649|4101481|B1|< 65 years||Age, Customized||participants|Number|1323|1323.0||||||
4277583|NCT00571649|4101479|B3|||Age||years|Mean|69.2|69.2|Standard Deviation|11.8|11.8|||
4277584|NCT00571649|4101480|B2|||Age||years|Mean|69.2|69.2|Standard Deviation|11.7|11.7|||
4277585|NCT00571649|4101481|B1|||Age||years|Mean|69.2|69.2|Standard Deviation|11.9|11.9|||
4277586|NCT00571493|4101514|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277592|NCT00571428|4101528|B3|Currently does not smoke||Participants Categorized by the Number of Packs Currently Smoked per Day|This measure gives an indication of the quantity of cigarettes currently smoked per day.|participants|Number|18.0|18.0||||||
4277593|NCT00571428|4101529|B2|Currently does not smoke||Participants Categorized by the Number of Packs Currently Smoked per Day|This measure gives an indication of the quantity of cigarettes currently smoked per day.|participants|Number|11|11.0||||||
4277594|NCT00571428|4101530|B1|Currently does not smoke||Participants Categorized by the Number of Packs Currently Smoked per Day|This measure gives an indication of the quantity of cigarettes currently smoked per day.|participants|Number|7|7.0||||||
4277595|NCT00571428|4101528|B3|> 4 packs||Participants Categorized by the Number of Packs Currently Smoked per Day|This measure gives an indication of the quantity of cigarettes currently smoked per day.|participants|Number|0.0|0.0||||||
4277596|NCT00571428|4101529|B2|> 4 packs||Participants Categorized by the Number of Packs Currently Smoked per Day|This measure gives an indication of the quantity of cigarettes currently smoked per day.|participants|Number|0|0.0||||||
4277597|NCT00571428|4101530|B1|> 4 packs||Participants Categorized by the Number of Packs Currently Smoked per Day|This measure gives an indication of the quantity of cigarettes currently smoked per day.|participants|Number|0|0.0||||||
4277598|NCT00571428|4101528|B3|>2 - 4 packs||Participants Categorized by the Number of Packs Currently Smoked per Day|This measure gives an indication of the quantity of cigarettes currently smoked per day.|participants|Number|0.0|0.0||||||
4277599|NCT00571428|4101529|B2|>2 - 4 packs||Participants Categorized by the Number of Packs Currently Smoked per Day|This measure gives an indication of the quantity of cigarettes currently smoked per day.|participants|Number|0|0.0||||||
4277600|NCT00571428|4101530|B1|>2 - 4 packs||Participants Categorized by the Number of Packs Currently Smoked per Day|This measure gives an indication of the quantity of cigarettes currently smoked per day.|participants|Number|0|0.0||||||
4277601|NCT00571428|4101528|B3|>1 -2 packs||Participants Categorized by the Number of Packs Currently Smoked per Day|This measure gives an indication of the quantity of cigarettes currently smoked per day.|participants|Number|6.0|6.0||||||
4277602|NCT00571428|4101529|B2|>1 -2 packs||Participants Categorized by the Number of Packs Currently Smoked per Day|This measure gives an indication of the quantity of cigarettes currently smoked per day.|participants|Number|3|3.0||||||
4277603|NCT00571428|4101530|B1|>1 -2 packs||Participants Categorized by the Number of Packs Currently Smoked per Day|This measure gives an indication of the quantity of cigarettes currently smoked per day.|participants|Number|3|3.0||||||
4277604|NCT00571428|4101528|B3|>0 -1 pack||Participants Categorized by the Number of Packs Currently Smoked per Day|This measure gives an indication of the quantity of cigarettes currently smoked per day.|participants|Number|9.0|9.0||||||
4277605|NCT00571428|4101529|B2|>0 -1 pack||Participants Categorized by the Number of Packs Currently Smoked per Day|This measure gives an indication of the quantity of cigarettes currently smoked per day.|participants|Number|4|4.0||||||
4277606|NCT00571428|4101530|B1|>0 -1 pack||Participants Categorized by the Number of Packs Currently Smoked per Day|This measure gives an indication of the quantity of cigarettes currently smoked per day.|participants|Number|5|5.0||||||
4277607|NCT00571428|4101528|B3|>=30 years||Participants Categorized by the Number of Pack Years Smoked|Pack years smoked is a way to measure the amount a person has smoked over a long period of time. It is calculated by taking the number of cigarettes smoked per day times the the number of years smoked divided by 20 (cigarettes per pack).|participants|Number|27.0|27.0||||||
4277608|NCT00571428|4101529|B2|>=30 years||Participants Categorized by the Number of Pack Years Smoked|Pack years smoked is a way to measure the amount a person has smoked over a long period of time. It is calculated by taking the number of cigarettes smoked per day times the the number of years smoked divided by 20 (cigarettes per pack).|participants|Number|13|13.0||||||
4277609|NCT00571428|4101530|B1|>=30 years||Participants Categorized by the Number of Pack Years Smoked|Pack years smoked is a way to measure the amount a person has smoked over a long period of time. It is calculated by taking the number of cigarettes smoked per day times the the number of years smoked divided by 20 (cigarettes per pack).|participants|Number|14|14.0||||||
4277610|NCT00571428|4101528|B3|>=25 years - < 30 years||Participants Categorized by the Number of Pack Years Smoked|Pack years smoked is a way to measure the amount a person has smoked over a long period of time. It is calculated by taking the number of cigarettes smoked per day times the the number of years smoked divided by 20 (cigarettes per pack).|participants|Number|3.0|3.0||||||
4277611|NCT00571428|4101529|B2|>=25 years - < 30 years||Participants Categorized by the Number of Pack Years Smoked|Pack years smoked is a way to measure the amount a person has smoked over a long period of time. It is calculated by taking the number of cigarettes smoked per day times the the number of years smoked divided by 20 (cigarettes per pack).|participants|Number|3|3.0||||||
4277612|NCT00571428|4101530|B1|>=25 years - < 30 years||Participants Categorized by the Number of Pack Years Smoked|Pack years smoked is a way to measure the amount a person has smoked over a long period of time. It is calculated by taking the number of cigarettes smoked per day times the the number of years smoked divided by 20 (cigarettes per pack).|participants|Number|0|0.0||||||
4277613|NCT00571428|4101528|B3|>=15 years - <25 years||Participants Categorized by the Number of Pack Years Smoked|Pack years smoked is a way to measure the amount a person has smoked over a long period of time. It is calculated by taking the number of cigarettes smoked per day times the the number of years smoked divided by 20 (cigarettes per pack).|participants|Number|3.0|3.0||||||
4277614|NCT00571428|4101529|B2|>=15 years - <25 years||Participants Categorized by the Number of Pack Years Smoked|Pack years smoked is a way to measure the amount a person has smoked over a long period of time. It is calculated by taking the number of cigarettes smoked per day times the the number of years smoked divided by 20 (cigarettes per pack).|participants|Number|2|2.0||||||
4277615|NCT00571428|4101530|B1|>=15 years - <25 years||Participants Categorized by the Number of Pack Years Smoked|Pack years smoked is a way to measure the amount a person has smoked over a long period of time. It is calculated by taking the number of cigarettes smoked per day times the the number of years smoked divided by 20 (cigarettes per pack).|participants|Number|1|1.0||||||
4277616|NCT00571428|4101528|B3|No||Inhaled Corticosteroid Use at Baseline|This measure answers the question: Does the patient use a corticosteroid inhaler at the baseline visit?|participants|Number|28.0|28.0||||||
4277670|NCT00571324|4101563|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4277617|NCT00571428|4101529|B2|No||Inhaled Corticosteroid Use at Baseline|This measure answers the question: Does the patient use a corticosteroid inhaler at the baseline visit?|participants|Number|14|14.0||||||
4277618|NCT00571428|4101530|B1|No||Inhaled Corticosteroid Use at Baseline|This measure answers the question: Does the patient use a corticosteroid inhaler at the baseline visit?|participants|Number|14|14.0||||||
4277619|NCT00571428|4101528|B3|Yes||Inhaled Corticosteroid Use at Baseline|This measure answers the question: Does the patient use a corticosteroid inhaler at the baseline visit?|participants|Number|5.0|5.0||||||
4277620|NCT00571428|4101529|B2|Yes||Inhaled Corticosteroid Use at Baseline|This measure answers the question: Does the patient use a corticosteroid inhaler at the baseline visit?|participants|Number|4|4.0||||||
4277621|NCT00571428|4101530|B1|Yes||Inhaled Corticosteroid Use at Baseline|This measure answers the question: Does the patient use a corticosteroid inhaler at the baseline visit?|participants|Number|1|1.0||||||
4277622|NCT00571428|4101528|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0.0|0.0||||||
4277623|NCT00571428|4101529|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277624|NCT00571428|4101530|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277625|NCT00571428|4101528|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0.0|0.0||||||
4277626|NCT00571428|4101529|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277627|NCT00571428|4101530|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277628|NCT00571428|4101528|B3||White|Race (NIH/OMB)||Participants|Count of Participants|29.0|29.0||||||
4277629|NCT00571428|4101529|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4277630|NCT00571428|4101530|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4277631|NCT00571428|4101528|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4.0|4.0||||||
4277632|NCT00571428|4101529|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4277633|NCT00571428|4101530|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4277634|NCT00571428|4101528|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0.0|0.0||||||
4277635|NCT00571428|4101529|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277636|NCT00571428|4101530|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277637|NCT00571428|4101528|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0.0|0.0||||||
4277638|NCT00571428|4101529|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277639|NCT00571428|4101530|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277640|NCT00571428|4101528|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0.0|0.0||||||
4277641|NCT00571428|4101529|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277642|NCT00571428|4101530|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277643|NCT00571428|4101528|B3||Male|Sex: Female, Male||Participants|Count of Participants|20.0|20.0||||||
4277644|NCT00571428|4101529|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4277645|NCT00571428|4101530|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4277646|NCT00571428|4101528|B3||Female|Sex: Female, Male||Participants|Count of Participants|13.0|13.0||||||
4277647|NCT00571428|4101529|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4277648|NCT00571428|4101530|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4277649|NCT00571428|4101528|B3|||Age||Years|Mean|64.5|64.5|Standard Deviation|8.8|8.8|||
4277650|NCT00571428|4101529|B2|||Age||Years|Mean|64.9|64.9|Standard Deviation|8.7|8.7|||
4277651|NCT00571428|4101530|B1|||Age||Years|Mean|63.9|63.9|Standard Deviation|9.3|9.3|||
4277652|NCT00571428|4101528|B3||>=65 years|Age||Participants|Count of Participants|19.0|19.0||||||
4277653|NCT00571428|4101529|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4277654|NCT00571428|4101530|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4277655|NCT00571428|4101528|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14.0|14.0||||||
4277656|NCT00571428|4101529|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4277657|NCT00571428|4101530|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4277658|NCT00571428|4101528|B3||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4277659|NCT00571428|4101529|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4277660|NCT00571428|4101530|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4277661|NCT00571324|4101563|B1|95% Pancreatectomy||Pancreatectomy|Whether subject has undergone prior pancreatectomy during infancy and if so, what percent of the pancreas was removed.|participants|Number|2|2.0||||||
4277662|NCT00571324|4101563|B1|85% Pancreatectomy||Pancreatectomy|Whether subject has undergone prior pancreatectomy during infancy and if so, what percent of the pancreas was removed.|participants|Number|1|1.0||||||
4277663|NCT00571324|4101563|B1|None||Pancreatectomy|Whether subject has undergone prior pancreatectomy during infancy and if so, what percent of the pancreas was removed.|participants|Number|6|6.0||||||
4277664|NCT00571324|4101563|B1|Compound heterozygous recessive ABCC8 mutations||Mutation (ABCC8)||participants|Number|1|1.0||||||
4277665|NCT00571324|4101563|B1|Homozygous common recessive Ashkenazi mutation||Mutation (ABCC8)||participants|Number|2|2.0||||||
4277666|NCT00571324|4101563|B1|Heterozygous dominant ABCC8 mutations||Mutation (ABCC8)||participants|Number|6|6.0||||||
4277667|NCT00571324|4101563|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4277668|NCT00571324|4101563|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277669|NCT00571324|4101563|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277671|NCT00571324|4101563|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277672|NCT00571324|4101563|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277673|NCT00571324|4101563|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277674|NCT00571324|4101563|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277675|NCT00571324|4101563|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4277676|NCT00571324|4101563|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4277677|NCT00571324|4101563|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4277678|NCT00571324|4101563|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4277679|NCT00571324|4101563|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4277680|NCT00571194|4101576|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4277681|NCT00571194|4101576|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4277682|NCT00571194|4101576|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4277683|NCT00571194|4101576|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4277684|NCT00571194|4101576|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4277685|NCT00571194|4101576|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4277686|NCT00571103|4101580|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4277687|NCT00571103|4101580|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4277688|NCT00571103|4101580|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4277689|NCT00571103|4101580|B1|||Age||years|Mean|48.0|48.0|Standard Deviation|16.4|16.4|||
4277690|NCT00571103|4101580|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4277691|NCT00571103|4101580|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4277692|NCT00571103|4101580|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4277693|NCT00571064|4101585|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4277694|NCT00571064|4101585|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4277695|NCT00571064|4101585|B1|||Age||Years|Mean|81.0|81.0|Standard Deviation|10.30|10.3|||
4277696|NCT00571038|4101598|B3|United States||Region of Enrollment||participants|Number|404|404.0||||||
4277697|NCT00571038|4101599|B2|United States||Region of Enrollment||participants|Number|185|185.0||||||
4277698|NCT00571038|4101600|B1|United States||Region of Enrollment||participants|Number|219|219.0||||||
4277699|NCT00571038|4101598|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277700|NCT00571038|4101599|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277701|NCT00571038|4101600|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277702|NCT00571038|4101598|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4277703|NCT00571038|4101599|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4277704|NCT00571038|4101600|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277705|NCT00571038|4101598|B3||White|Race (NIH/OMB)||Participants|Count of Participants|389|389.0||||||
4277706|NCT00571038|4101599|B2||White|Race (NIH/OMB)||Participants|Count of Participants|175|175.0||||||
4277707|NCT00571038|4101600|B1||White|Race (NIH/OMB)||Participants|Count of Participants|214|214.0||||||
4277708|NCT00571038|4101598|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4277709|NCT00571038|4101599|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4277710|NCT00571038|4101600|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4277711|NCT00571038|4101598|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277712|NCT00571038|4101599|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277713|NCT00571038|4101600|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277714|NCT00571038|4101598|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277715|NCT00571038|4101599|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277716|NCT00571038|4101600|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277717|NCT00571038|4101598|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4277718|NCT00571038|4101599|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4277719|NCT00571038|4101600|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4277720|NCT00571038|4101598|B3||Male|Sex: Female, Male||Participants|Count of Participants|353|353.0||||||
4277721|NCT00571038|4101599|B2||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4277722|NCT00571038|4101600|B1||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4277723|NCT00571038|4101598|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4277724|NCT00571038|4101599|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4277725|NCT00571038|4101600|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4277726|NCT00571038|4101598|B3|||Age||years|Mean|68.2|68.2|Standard Deviation|10.1|10.1|||
4277727|NCT00571038|4101599|B2|||Age||years|Mean|67.4|67.4|Standard Deviation|10.3|10.3|||
4277728|NCT00571038|4101600|B1|||Age||years|Mean|68.8|68.8|Standard Deviation|9.97|9.97|||
4277729|NCT00570960|4101647|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4277730|NCT00570960|4101648|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4277731|NCT00570960|4101649|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4277732|NCT00570960|4101647|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4277733|NCT00570960|4101648|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4277734|NCT00570960|4101649|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4277735|NCT00570960|4101647|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4277736|NCT00570960|4101648|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4277737|NCT00570960|4101649|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4277738|NCT00570960|4101647|B3|||Age||years|Mean|51.6|51.6|Standard Deviation|9.2|9.2|||
4277739|NCT00570960|4101648|B2|||Age||years|Mean|51.8|51.8|Standard Deviation|12.2|12.2|||
4277740|NCT00570960|4101649|B1|||Age||years|Mean|51.5|51.5|Standard Deviation|7.0|7.0|||
4277741|NCT00570960|4101647|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4277742|NCT00570960|4101648|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4277743|NCT00570960|4101649|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4277744|NCT00570960|4101647|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4277745|NCT00570960|4101648|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4277746|NCT00570960|4101649|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4277747|NCT00570960|4101647|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4277748|NCT00570960|4101648|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4277749|NCT00570960|4101649|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4277750|NCT00570921|4101656|B1|Resistant||AI Sensitivity||participants|Number|10|10.0||||||
4277751|NCT00570921|4101656|B1|Sensitive||AI Sensitivity||participants|Number|21|21.0||||||
4277752|NCT00570921|4101656|B1|No||Two prior aromatase inhibitor therapy||participants|Number|24|24.0||||||
4277753|NCT00570921|4101656|B1|Yes||Two prior aromatase inhibitor therapy||participants|Number|7|7.0||||||
4277754|NCT00570921|4101656|B1|No||3 or more prior endocrine therapies||participants|Number|23|23.0||||||
4277755|NCT00570921|4101656|B1|Yes||3 or more prior endocrine therapies||participants|Number|8|8.0||||||
4277756|NCT00570921|4101656|B1|No||Prior Chemotherapy||participants|Number|9|9.0||||||
4277757|NCT00570921|4101656|B1|Yes||Prior Chemotherapy||participants|Number|22|22.0||||||
4277758|NCT00570921|4101656|B1|No||Prior tamoxifen therapy||participants|Number|6|6.0||||||
4277759|NCT00570921|4101656|B1|Yes||Prior tamoxifen therapy||participants|Number|25|25.0||||||
4277760|NCT00570921|4101656|B1|||Prior aromatase inhibitor (AI) therapy within 6 months of enrollment||participants|Number|31|31.0||||||
4277761|NCT00570921|4101656|B1|No||Skin Disease||participants|Number|27|27.0||||||
4277762|NCT00570921|4101656|B1|Yes||Skin Disease||participants|Number|4|4.0||||||
4277763|NCT00570921|4101656|B1|No||Intact Primary Tumor||participants|Number|25|25.0||||||
4277764|NCT00570921|4101656|B1|Yes||Intact Primary Tumor||participants|Number|6|6.0||||||
4277765|NCT00570921|4101656|B1|No||Lung Disease||participants|Number|14|14.0||||||
4277766|NCT00570921|4101656|B1|Yes||Lung Disease||participants|Number|17|17.0||||||
4277767|NCT00570921|4101656|B1|No||Liver Disease||participants|Number|12|12.0||||||
4277768|NCT00570921|4101656|B1|Yes||Liver Disease||participants|Number|19|19.0||||||
4277769|NCT00570921|4101656|B1|No||Bone Disease||participants|Number|11|11.0||||||
4277770|NCT00570921|4101656|B1|Yes||Bone Disease||participants|Number|20|20.0||||||
4277771|NCT00570921|4101656|B1|3 or more||Number of metastatic sites||participants|Number|17|17.0||||||
4277772|NCT00570921|4101656|B1|2||Number of metastatic sites||participants|Number|10|10.0||||||
4277773|NCT00570921|4101656|B1|1||Number of metastatic sites||participants|Number|4|4.0||||||
4277774|NCT00570921|4101656|B1|De novo||Relapsed versus de novo metastasis||participants|Number|7|7.0||||||
4277775|NCT00570921|4101656|B1|Relapse||Relapsed versus de novo metastasis||participants|Number|24|24.0||||||
4277776|NCT00570921|4101656|B1|Intracystic papillary||Histology||participants|Number|1|1.0||||||
4277777|NCT00570921|4101656|B1|Mixed ductal and lobular||Histology||participants|Number|1|1.0||||||
4277778|NCT00570921|4101656|B1|Lobular||Histology||participants|Number|3|3.0||||||
4277779|NCT00570921|4101656|B1|Ductal||Histology||participants|Number|26|26.0||||||
4277780|NCT00570921|4101656|B1|Positive||Human epidermal growth factor receptor 2 (HER2) Status||participants|Number|2|2.0||||||
4277781|NCT00570921|4101656|B1|Negative||Human epidermal growth factor receptor 2 (HER2) Status||participants|Number|29|29.0||||||
4277782|NCT00570921|4101656|B1|ER-positive/progesterone receptor (PgR)-negative||Hormone Receptor Status||participants|Number|5|5.0||||||
4277783|NCT00570921|4101656|B1|ER-positive/progesterone receptor (PgR)-positive||Hormone Receptor Status||participants|Number|26|26.0||||||
4277784|NCT00570921|4101656|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4277785|NCT00570921|4101656|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4277786|NCT00570921|4101656|B1|White||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4277787|NCT00570921|4101656|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4277788|NCT00570921|4101656|B1||Female|Gender||Participants|Count of Participants|31|31.0||||||
4277789|NCT00570921|4101656|B1|||Age||years|Median|54|54.0|Full Range|||45.0|85.0|
4277790|NCT00570908|4101662|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277791|NCT00570908|4101662|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277792|NCT00570908|4101662|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4277854|NCT00570739|4101706|B5|||Weight||kg|Mean|79.08|79.08|Standard Deviation|15.92|15.92|||
4277793|NCT00570908|4101662|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4277794|NCT00570908|4101662|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277795|NCT00570908|4101662|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277796|NCT00570908|4101662|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277797|NCT00570908|4101662|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4277798|NCT00570908|4101662|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4277799|NCT00570908|4101662|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4277800|NCT00570908|4101662|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4277801|NCT00570908|4101662|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4277802|NCT00570908|4101662|B1|||Age||years|Median|50|50.0|Full Range|||32.0|64.0|
4277803|NCT00570778|4101666|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4277804|NCT00570778|4101666|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4277805|NCT00570778|4101666|B1|||Age|Baseline characteristics are based on the Safety Population that consists of all participants who received study drug.|years|Mean|61.7|61.7|Standard Deviation|8.5|8.5|||
4277806|NCT00570765|4101687|B4|United Kingdom||Region of Enrollment||participants|Number|19|19.0||||||
4277807|NCT00570765|4101688|B3|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4277808|NCT00570765|4101689|B2|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4277809|NCT00570765|4101690|B1|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
4277810|NCT00570765|4101687|B4|Germany||Region of Enrollment||participants|Number|8|8.0||||||
4277811|NCT00570765|4101688|B3|Germany||Region of Enrollment||participants|Number|3|3.0||||||
4277812|NCT00570765|4101689|B2|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4277813|NCT00570765|4101690|B1|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4277814|NCT00570765|4101687|B4|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4277815|NCT00570765|4101688|B3|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4277816|NCT00570765|4101689|B2|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4277817|NCT00570765|4101690|B1|Spain||Region of Enrollment||participants|Number|0|0.0||||||
4277818|NCT00570765|4101687|B4|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4277819|NCT00570765|4101688|B3|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4277820|NCT00570765|4101689|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4277821|NCT00570765|4101690|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4277822|NCT00570765|4101687|B4|United States||Region of Enrollment||participants|Number|17|17.0||||||
4277823|NCT00570765|4101688|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4277824|NCT00570765|4101689|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4277825|NCT00570765|4101690|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4277826|NCT00570765|4101687|B4|France||Region of Enrollment||participants|Number|4|4.0||||||
4277827|NCT00570765|4101688|B3|France||Region of Enrollment||participants|Number|1|1.0||||||
4277828|NCT00570765|4101689|B2|France||Region of Enrollment||participants|Number|1|1.0||||||
4277829|NCT00570765|4101690|B1|France||Region of Enrollment||participants|Number|2|2.0||||||
4277830|NCT00570765|4101687|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4277831|NCT00570765|4101688|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4277832|NCT00570765|4101689|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4277833|NCT00570765|4101690|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4277834|NCT00570765|4101687|B4||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4277835|NCT00570765|4101688|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4277836|NCT00570765|4101689|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4277837|NCT00570765|4101690|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4277838|NCT00570765|4101687|B4|||Age||years|Mean|54.8|54.8|Standard Deviation|9.5|9.5|||
4277839|NCT00570765|4101688|B3|||Age||years|Mean|55.3|55.3|Standard Deviation|10.0|10.0|||
4277840|NCT00570765|4101689|B2|||Age||years|Mean|54.1|54.1|Standard Deviation|7.3|7.3|||
4277841|NCT00570765|4101690|B1|||Age||years|Mean|54.8|54.8|Standard Deviation|10.9|10.9|||
4277842|NCT00570765|4101687|B4||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4277843|NCT00570765|4101688|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4277844|NCT00570765|4101689|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4277845|NCT00570765|4101690|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4277846|NCT00570765|4101687|B4||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4277847|NCT00570765|4101688|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4277848|NCT00570765|4101689|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4277849|NCT00570765|4101690|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4277850|NCT00570765|4101687|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4277851|NCT00570765|4101688|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4277852|NCT00570765|4101689|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4277853|NCT00570765|4101690|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4277855|NCT00570739|4101707|B4|||Weight||kg|Mean|80.63|80.63|Standard Deviation|18.02|18.02|||
4277856|NCT00570739|4101708|B3|||Weight||kg|Mean|78.18|78.18|Standard Deviation|13.76|13.76|||
4277857|NCT00570739|4101709|B2|||Weight||kg|Mean|80.84|80.84|Standard Deviation|15.53|15.53|||
4277858|NCT00570739|4101710|B1|||Weight||kg|Mean|77.26|77.26|Standard Deviation|16.17|16.17|||
4277859|NCT00570739|4101706|B5|||Low Density Lipoprotein Cholesterol||mg/dL|Mean|132.2|132.2|Standard Deviation|25.07|25.07|||
4277860|NCT00570739|4101707|B4|||Low Density Lipoprotein Cholesterol||mg/dL|Mean|132.8|132.8|Standard Deviation|23.88|23.88|||
4277861|NCT00570739|4101708|B3|||Low Density Lipoprotein Cholesterol||mg/dL|Mean|136.8|136.8|Standard Deviation|28.48|28.48|||
4277862|NCT00570739|4101709|B2|||Low Density Lipoprotein Cholesterol||mg/dL|Mean|129.1|129.1|Standard Deviation|23.08|23.08|||
4277863|NCT00570739|4101710|B1|||Low Density Lipoprotein Cholesterol||mg/dL|Mean|135.5|135.5|Standard Deviation|26.66|26.66|||
4277864|NCT00570739|4101706|B5|||Hemoglobin A1c||Percent|Mean|7.65|7.65|Standard Deviation|1.0|1.0|||
4277865|NCT00570739|4101707|B4|||Hemoglobin A1c||Percent|Mean|6.02|6.02|Standard Deviation|0.46|0.46|||
4277866|NCT00570739|4101708|B3|||Hemoglobin A1c||Percent|Mean|6.07|6.07|Standard Deviation|0.45|0.45|||
4277867|NCT00570739|4101709|B2|||Hemoglobin A1c||Percent|Mean|7.76|7.76|Standard Deviation|1.04|1.04|||
4277868|NCT00570739|4101710|B1|||Hemoglobin A1c||Percent|Mean|7.53|7.53|Standard Deviation|0.94|0.94|||
4277869|NCT00570739|4101706|B5|||Height||cm|Mean|161.5|161.5|Standard Deviation|10.18|10.18|||
4277870|NCT00570739|4101707|B4|||Height||cm|Mean|160.8|160.8|Standard Deviation|9.96|9.96|||
4277871|NCT00570739|4101708|B3|||Height||cm|Mean|159.1|159.1|Standard Deviation|9.95|9.95|||
4277872|NCT00570739|4101709|B2|||Height||cm|Mean|162.3|162.3|Standard Deviation|9.67|9.67|||
4277873|NCT00570739|4101710|B1|||Height||cm|Mean|160.6|160.6|Standard Deviation|10.64|10.64|||
4277874|NCT00570739|4101706|B5|||Glucose 2 hours after meal||mg/dL|Mean|227.7|227.7|Standard Deviation|65.74|65.74|||
4277875|NCT00570739|4101707|B4|||Glucose 2 hours after meal||mg/dL|Mean|153.7|153.7|Standard Deviation|37.90|37.9|||
4277876|NCT00570739|4101708|B3|||Glucose 2 hours after meal||mg/dL|Mean|153.7|153.7|Standard Deviation|39.81|39.81|||
4277877|NCT00570739|4101709|B2|||Glucose 2 hours after meal||mg/dL|Mean|234.7|234.7|Standard Deviation|71.36|71.36|||
4277878|NCT00570739|4101710|B1|||Glucose 2 hours after meal||mg/dL|Mean|220.3|220.3|Standard Deviation|58.68|58.68|||
4277879|NCT00570739|4101706|B5|||Fasting insulin||uIU/mL|Mean|13.34|13.34|Standard Deviation|12.66|12.66|||
4277880|NCT00570739|4101707|B4|||Fasting insulin||uIU/mL|Mean|13.12|13.12|Standard Deviation|8.75|8.75|||
4277881|NCT00570739|4101708|B3|||Fasting insulin||uIU/mL|Mean|11.03|11.03|Standard Deviation|5.55|5.55|||
4277882|NCT00570739|4101709|B2|||Fasting insulin||uIU/mL|Mean|13.86|13.86|Standard Deviation|15.75|15.75|||
4277883|NCT00570739|4101710|B1|||Fasting insulin||uIU/mL|Mean|12.82|12.82|Standard Deviation|8.44|8.44|||
4277884|NCT00570739|4101706|B5|||Fasting glucose||mg/dL|Mean|149.6|149.6|Standard Deviation|38.43|38.43|||
4277885|NCT00570739|4101707|B4|||Fasting glucose||mg/dL|Mean|104.1|104.1|Standard Deviation|11.33|11.33|||
4277886|NCT00570739|4101708|B3|||Fasting glucose||mg/dL|Mean|106.8|106.8|Standard Deviation|14.80|14.8|||
4277887|NCT00570739|4101709|B2|||Fasting glucose||mg/dL|Mean|153.4|153.4|Standard Deviation|39.04|39.04|||
4277888|NCT00570739|4101710|B1|||Fasting glucose||mg/dL|Mean|145.7|145.7|Standard Deviation|37.54|37.54|||
4277889|NCT00570739|4101706|B5|||Body Mass Index||kg/m squared|Mean|30.19|30.19|Standard Deviation|4.57|4.57|||
4277890|NCT00570739|4101707|B4|||Body Mass Index||kg/m squared|Mean|30.93|30.93|Standard Deviation|4.89|4.89|||
4277891|NCT00570739|4101708|B3|||Body Mass Index||kg/m squared|Mean|30.82|30.82|Standard Deviation|4.18|4.18|||
4277892|NCT00570739|4101709|B2|||Body Mass Index||kg/m squared|Mean|30.58|30.58|Standard Deviation|4.669|4.669|||
4277893|NCT00570739|4101710|B1|||Body Mass Index||kg/m squared|Mean|29.78|29.78|Standard Deviation|4.44|4.44|||
4277894|NCT00570739|4101706|B5|||Previously diagnosed with type 2 diabetes||Participant|Number|221|221.0||||||
4277895|NCT00570739|4101707|B4|||Previously diagnosed with type 2 diabetes||Participant|Number|1|1.0||||||
4277896|NCT00570739|4101708|B3|||Previously diagnosed with type 2 diabetes||Participant|Number|1|1.0||||||
4277897|NCT00570739|4101709|B2|||Previously diagnosed with type 2 diabetes||Participant|Number|109|109.0||||||
4277898|NCT00570739|4101710|B1|||Previously diagnosed with type 2 diabetes||Participant|Number|110|110.0||||||
4277899|NCT00570739|4101706|B5|||Previously diagnosed with pre-diabetes||Participant|Number|204|204.0||||||
4277900|NCT00570739|4101707|B4|||Previously diagnosed with pre-diabetes||Participant|Number|85|85.0||||||
4277901|NCT00570739|4101708|B3|||Previously diagnosed with pre-diabetes||Participant|Number|81|81.0||||||
4277902|NCT00570739|4101709|B2|||Previously diagnosed with pre-diabetes||Participant|Number|21|21.0||||||
4277903|NCT00570739|4101710|B1|||Previously diagnosed with pre-diabetes||Participant|Number|17|17.0||||||
4277904|NCT00570739|4101706|B5|||Previously diagnosed with neither diabetes nor pre-diabetes||Participant|Number|77|77.0||||||
4277905|NCT00570739|4101707|B4|||Previously diagnosed with neither diabetes nor pre-diabetes||Participant|Number|22|22.0||||||
4277906|NCT00570739|4101708|B3|||Previously diagnosed with neither diabetes nor pre-diabetes||Participant|Number|26|26.0||||||
4277907|NCT00570739|4101709|B2|||Previously diagnosed with neither diabetes nor pre-diabetes||Participant|Number|15|15.0||||||
4277908|NCT00570739|4101710|B1|||Previously diagnosed with neither diabetes nor pre-diabetes||Participant|Number|14|14.0||||||
4277909|NCT00570739|4101706|B5|India||Region of Enrollment||participants|Number|90|90.0||||||
4277910|NCT00570739|4101707|B4|India||Region of Enrollment||participants|Number|14|14.0||||||
4277911|NCT00570739|4101708|B3|India||Region of Enrollment||participants|Number|15|15.0||||||
4277912|NCT00570739|4101709|B2|India||Region of Enrollment||participants|Number|31|31.0||||||
4277913|NCT00570739|4101710|B1|India||Region of Enrollment||participants|Number|30|30.0||||||
4277914|NCT00570739|4101706|B5|Colombia||Region of Enrollment||participants|Number|124|124.0||||||
4277915|NCT00570739|4101707|B4|Colombia||Region of Enrollment||participants|Number|37|37.0||||||
4277916|NCT00570739|4101708|B3|Colombia||Region of Enrollment||participants|Number|36|36.0||||||
4277917|NCT00570739|4101709|B2|Colombia||Region of Enrollment||participants|Number|26|26.0||||||
4277918|NCT00570739|4101710|B1|Colombia||Region of Enrollment||participants|Number|25|25.0||||||
4277919|NCT00570739|4101706|B5|Mexico||Region of Enrollment||participants|Number|195|195.0||||||
4277920|NCT00570739|4101707|B4|Mexico||Region of Enrollment||participants|Number|41|41.0||||||
4277921|NCT00570739|4101708|B3|Mexico||Region of Enrollment||participants|Number|40|40.0||||||
4277922|NCT00570739|4101709|B2|Mexico||Region of Enrollment||participants|Number|58|58.0||||||
4277923|NCT00570739|4101710|B1|Mexico||Region of Enrollment||participants|Number|56|56.0||||||
4277924|NCT00570739|4101706|B5|United States||Region of Enrollment||participants|Number|93|93.0||||||
4277925|NCT00570739|4101707|B4|United States||Region of Enrollment||participants|Number|16|16.0||||||
4277926|NCT00570739|4101708|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4277927|NCT00570739|4101709|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4277928|NCT00570739|4101710|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4277929|NCT00570739|4101706|B5|Hispanic||Race/Ethnicity, Customized||Participants|Number|339|339.0||||||
4277930|NCT00570739|4101707|B4|Hispanic||Race/Ethnicity, Customized||Participants|Number|82|82.0||||||
4277931|NCT00570739|4101708|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|78|78.0||||||
4277932|NCT00570739|4101709|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|89|89.0||||||
4277933|NCT00570739|4101710|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|90|90.0||||||
4277934|NCT00570739|4101706|B5|White||Race/Ethnicity, Customized||Participants|Number|66|66.0||||||
4277935|NCT00570739|4101707|B4|White||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4277936|NCT00570739|4101708|B3|White||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4277937|NCT00570739|4101709|B2|White||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
4277938|NCT00570739|4101710|B1|White||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
4277939|NCT00570739|4101706|B5|Black/African American||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4277940|NCT00570739|4101707|B4|Black/African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4277941|NCT00570739|4101708|B3|Black/African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4277942|NCT00570739|4101709|B2|Black/African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4277943|NCT00570739|4101710|B1|Black/African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4277944|NCT00570739|4101706|B5|Asian||Race/Ethnicity, Customized||Participants|Number|91|91.0||||||
4277945|NCT00570739|4101707|B4|Asian||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4277946|NCT00570739|4101708|B3|Asian||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4277947|NCT00570739|4101709|B2|Asian||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
4277948|NCT00570739|4101710|B1|Asian||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
4277949|NCT00570739|4101706|B5||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4277950|NCT00570739|4101707|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4277951|NCT00570739|4101708|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4277952|NCT00570739|4101709|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4277953|NCT00570739|4101710|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4277954|NCT00570739|4101706|B5||Female|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
4277955|NCT00570739|4101707|B4||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4277956|NCT00570739|4101708|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4277957|NCT00570739|4101709|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4277958|NCT00570739|4101710|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4277959|NCT00570739|4101706|B5|||Age||years|Mean|53.3|53.3|Standard Deviation|10.81|10.81|||
4277960|NCT00570739|4101707|B4|||Age||years|Mean|53.3|53.3|Standard Deviation|12.27|12.27|||
4277961|NCT00570739|4101708|B3|||Age||years|Mean|55.7|55.7|Standard Deviation|11.14|11.14|||
4277962|NCT00570739|4101709|B2|||Age||years|Mean|52.7|52.7|Standard Deviation|11.46|11.46|||
4277963|NCT00570739|4101710|B1|||Age||years|Mean|53.9|53.9|Standard Deviation|10.11|10.11|||
4277964|NCT00570713|4101863|B3|Europe||Region of Enrollment||participants|Number|41|41.0||||||
4277965|NCT00570713|4101864|B2|Europe||Region of Enrollment||participants|Number|20|20.0||||||
4277966|NCT00570713|4101865|B1|Europe||Region of Enrollment||participants|Number|21|21.0||||||
4277967|NCT00570713|4101863|B3|North America||Region of Enrollment||participants|Number|114|114.0||||||
4277968|NCT00570713|4101864|B2|North America||Region of Enrollment||participants|Number|57|57.0||||||
4277969|NCT00570713|4101865|B1|North America||Region of Enrollment||participants|Number|57|57.0||||||
4277970|NCT00570713|4101863|B3|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4277971|NCT00570713|4101864|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4277972|NCT00570713|4101865|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4277973|NCT00570713|4101863|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|136|136.0||||||
4277974|NCT00570713|4101864|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|67|67.0||||||
4278035|NCT00570531|4101942|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4277975|NCT00570713|4101865|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|69|69.0||||||
4277976|NCT00570713|4101863|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4277977|NCT00570713|4101864|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4277978|NCT00570713|4101865|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4277979|NCT00570713|4101863|B3|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4277980|NCT00570713|4101864|B2|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4277981|NCT00570713|4101865|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4277982|NCT00570713|4101863|B3|African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4277983|NCT00570713|4101864|B2|African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4277984|NCT00570713|4101865|B1|African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4277985|NCT00570713|4101863|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4277986|NCT00570713|4101864|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4277987|NCT00570713|4101865|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4277988|NCT00570713|4101863|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4277989|NCT00570713|4101864|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4277990|NCT00570713|4101865|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4277991|NCT00570713|4101863|B3|||Age||years|Mean|65.0|65.0|Standard Deviation|11.5|11.5|||
4277992|NCT00570713|4101864|B2|||Age||years|Mean|65.8|65.8|Standard Deviation|10.3|10.3|||
4277993|NCT00570713|4101865|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|12.7|12.7|||
4277994|NCT00570713|4101863|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4277995|NCT00570713|4101864|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4277996|NCT00570713|4101865|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4277997|NCT00570713|4101863|B3||Between 18 and 65 years|Age||Participants|Count of Participants|155|155.0||||||
4277998|NCT00570713|4101864|B2||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
4277999|NCT00570713|4101865|B1||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
4278000|NCT00570713|4101863|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4278001|NCT00570713|4101864|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4278002|NCT00570713|4101865|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4278003|NCT00570700|4101876|B1|United States||Region of Enrollment||Participants|Number|38|38.0||||||
4278004|NCT00570700|4101876|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4278005|NCT00570700|4101876|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278006|NCT00570700|4101876|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4278007|NCT00570700|4101876|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4278008|NCT00570700|4101876|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278009|NCT00570700|4101876|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4278010|NCT00570700|4101876|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278011|NCT00570700|4101876|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4278012|NCT00570700|4101876|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4278013|NCT00570700|4101876|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4278014|NCT00570700|4101876|B1|Male||Sex/Gender, Customized||participants|Number|38|38.0||||||
4278015|NCT00570700|4101876|B1|||Age||years|Median|68|68.0|Full Range|||55.0|88.0|
4278016|NCT00570687|4101882|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4278017|NCT00570687|4101883|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4278018|NCT00570687|4101884|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4278019|NCT00570687|4101882|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4278020|NCT00570687|4101883|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4278021|NCT00570687|4101884|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4278022|NCT00570687|4101882|B3|||Age||years|Mean|55.1|55.1|Standard Deviation|7.2|7.2|||
4278023|NCT00570687|4101883|B2|||Age||years|Mean|54.9|54.9|Standard Deviation|6.9|6.9|||
4278024|NCT00570687|4101884|B1|||Age||years|Mean|55.3|55.3|Standard Deviation|7.6|7.6|||
4278025|NCT00570674|4101919|B1|Other||Primary Tumor Site||Participants|Count of Participants|2|2.0||||||
4278026|NCT00570674|4101919|B1|Unknown Primary||Primary Tumor Site||Participants|Count of Participants|2|2.0||||||
4278027|NCT00570674|4101919|B1|Larynx||Primary Tumor Site||Participants|Count of Participants|4|4.0||||||
4278028|NCT00570674|4101919|B1|Oropharynx||Primary Tumor Site||Participants|Count of Participants|17|17.0||||||
4278029|NCT00570674|4101919|B1|Oral cavity||Primary Tumor Site||Participants|Count of Participants|3|3.0||||||
4278030|NCT00570674|4101919|B1|United States||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
4278031|NCT00570674|4101919|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4278032|NCT00570674|4101919|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4278033|NCT00570674|4101919|B1|||Age||years|Median|60|60.0|Full Range|||44.0|74.0|
4278034|NCT00570531|4101942|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4278036|NCT00570531|4101942|B1|||Age||years|Mean|60|60.0|Full Range|||44.0|68.0|
4278037|NCT00570505|4101948|B1|United States||Region of Enrollment||participants|Number|149|149.0||||||
4278038|NCT00570505|4101948|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4278039|NCT00570505|4101948|B1||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4278040|NCT00570505|4101948|B1|||Age||years|Mean|39.28|39.28|Standard Deviation|9.304|9.304|||
4278041|NCT00570505|4101948|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4278042|NCT00570505|4101948|B1||Between 18 and 65 years|Age||Participants|Count of Participants|147|147.0||||||
4278043|NCT00570505|4101948|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4278044|NCT00570492|4101959|B3|Native Hawaiian/ Other Pacific Islander and White||Race/Ethnicity, Customized|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all participants who had been randomized to and received at least one dose of Double-blind study medication.|participants|Number|1|1.0||||||
4278045|NCT00570492|4101960|B2|Native Hawaiian/ Other Pacific Islander and White||Race/Ethnicity, Customized|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all participants who had been randomized to and received at least one dose of Double-blind study medication.|participants|Number|0|0.0||||||
4278046|NCT00570492|4101961|B1|Native Hawaiian/ Other Pacific Islander and White||Race/Ethnicity, Customized|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all participants who had been randomized to and received at least one dose of Double-blind study medication.|participants|Number|1|1.0||||||
4278047|NCT00570492|4101959|B3|Asian and White||Race/Ethnicity, Customized|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all participants who had been randomized to and received at least one dose of Double-blind study medication.|participants|Number|2|2.0||||||
4278048|NCT00570492|4101960|B2|Asian and White||Race/Ethnicity, Customized|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all participants who had been randomized to and received at least one dose of Double-blind study medication.|participants|Number|1|1.0||||||
4278049|NCT00570492|4101961|B1|Asian and White||Race/Ethnicity, Customized|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all participants who had been randomized to and received at least one dose of Double-blind study medication.|participants|Number|1|1.0||||||
4278050|NCT00570492|4101959|B3|Amc Indian or Alk N and White||Race/Ethnicity, Customized|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all participants who had been randomized to and received at least one dose of Double-blind study medication.|participants|Number|1|1.0||||||
4278051|NCT00570492|4101960|B2|Amc Indian or Alk N and White||Race/Ethnicity, Customized|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all participants who had been randomized to and received at least one dose of Double-blind study medication.|participants|Number|0|0.0||||||
4278052|NCT00570492|4101961|B1|Amc Indian or Alk N and White||Race/Ethnicity, Customized|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all participants who had been randomized to and received at least one dose of Double-blind study medication.|participants|Number|1|1.0||||||
4278053|NCT00570492|4101959|B3|African Amc/African Heritage and White||Race/Ethnicity, Customized|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all participants who had been randomized to and received at least one dose of Double-blind study medication.|participants|Number|3|3.0||||||
4278054|NCT00570492|4101960|B2|African Amc/African Heritage and White||Race/Ethnicity, Customized|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all participants who had been randomized to and received at least one dose of Double-blind study medication.|participants|Number|2|2.0||||||
4278055|NCT00570492|4101961|B1|African Amc/African Heritage and White||Race/Ethnicity, Customized|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all participants who had been randomized to and received at least one dose of Double-blind study medication.|participants|Number|1|1.0||||||
4278056|NCT00570492|4101959|B3|African Amc/African and Amc Indian or Alk N||Race/Ethnicity, Customized|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all participants who had been randomized to and received at least one dose of Double-blind study medication.|participants|Number|1|1.0||||||
4278057|NCT00570492|4101960|B2|African Amc/African and Amc Indian or Alk N||Race/Ethnicity, Customized|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all participants who had been randomized to and received at least one dose of Double-blind study medication.|participants|Number|0|0.0||||||
4278058|NCT00570492|4101961|B1|African Amc/African and Amc Indian or Alk N||Race/Ethnicity, Customized|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all participants who had been randomized to and received at least one dose of Double-blind study medication.|participants|Number|1|1.0||||||
4278059|NCT00570492|4101959|B3|White||Race/Ethnicity, Customized|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all participants who had been randomized to and received at least one dose of Double-blind study medication.|participants|Number|388|388.0||||||
4278060|NCT00570492|4101960|B2|White||Race/Ethnicity, Customized|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all participants who had been randomized to and received at least one dose of Double-blind study medication.|participants|Number|199|199.0||||||
4278061|NCT00570492|4101961|B1|White||Race/Ethnicity, Customized|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all participants who had been randomized to and received at least one dose of Double-blind study medication.|participants|Number|189|189.0||||||
4278062|NCT00570492|4101959|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all participants who had been randomized to and received at least one dose of Double-blind study medication.|participants|Number|1|1.0||||||
4278091|NCT00570362|4102005|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4278063|NCT00570492|4101960|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all participants who had been randomized to and received at least one dose of Double-blind study medication.|participants|Number|0|0.0||||||
4278064|NCT00570492|4101961|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all participants who had been randomized to and received at least one dose of Double-blind study medication.|participants|Number|1|1.0||||||
4278065|NCT00570492|4101959|B3|Asian||Race/Ethnicity, Customized|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all participants who had been randomized to and received at least one dose of Double-blind study medication.|participants|Number|12|12.0||||||
4278066|NCT00570492|4101960|B2|Asian||Race/Ethnicity, Customized|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all participants who had been randomized to and received at least one dose of Double-blind study medication.|participants|Number|5|5.0||||||
4278067|NCT00570492|4101961|B1|Asian||Race/Ethnicity, Customized|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all participants who had been randomized to and received at least one dose of Double-blind study medication.|participants|Number|7|7.0||||||
4278068|NCT00570492|4101959|B3|Amc Indian or Alaska Native (Alk N)||Race/Ethnicity, Customized|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all participants who had been randomized to and received at least one dose of Double-blind study medication.|participants|Number|37|37.0||||||
4278069|NCT00570492|4101960|B2|Amc Indian or Alaska Native (Alk N)||Race/Ethnicity, Customized|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all participants who had been randomized to and received at least one dose of Double-blind study medication.|participants|Number|18|18.0||||||
4278070|NCT00570492|4101961|B1|Amc Indian or Alaska Native (Alk N)||Race/Ethnicity, Customized|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all participants who had been randomized to and received at least one dose of Double-blind study medication.|participants|Number|19|19.0||||||
4278071|NCT00570492|4101959|B3|African American (Amc)/African Heritage||Race/Ethnicity, Customized|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all participants who had been randomized to and received at least one dose of Double-blind study medication.|participants|Number|28|28.0||||||
4278072|NCT00570492|4101960|B2|African American (Amc)/African Heritage||Race/Ethnicity, Customized|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all participants who had been randomized to and received at least one dose of Double-blind study medication.|participants|Number|12|12.0||||||
4278073|NCT00570492|4101961|B1|African American (Amc)/African Heritage||Race/Ethnicity, Customized|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all participants who had been randomized to and received at least one dose of Double-blind study medication.|participants|Number|16|16.0||||||
4278074|NCT00570492|4101959|B3||Male|Sex: Female, Male|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all participants who had been randomized to and received at least one dose of Double-blind study medication.|Participants|Count of Participants|326|326.0||||||
4278075|NCT00570492|4101960|B2||Male|Sex: Female, Male|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all participants who had been randomized to and received at least one dose of Double-blind study medication.|Participants|Count of Participants|162|162.0||||||
4278076|NCT00570492|4101961|B1||Male|Sex: Female, Male|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all participants who had been randomized to and received at least one dose of Double-blind study medication.|Participants|Count of Participants|164|164.0||||||
4278077|NCT00570492|4101959|B3||Female|Sex: Female, Male|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all participants who had been randomized to and received at least one dose of Double-blind study medication.|Participants|Count of Participants|148|148.0||||||
4278078|NCT00570492|4101960|B2||Female|Sex: Female, Male|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all participants who had been randomized to and received at least one dose of Double-blind study medication.|Participants|Count of Participants|75|75.0||||||
4278079|NCT00570492|4101961|B1||Female|Sex: Female, Male|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all participants who had been randomized to and received at least one dose of Double-blind study medication.|Participants|Count of Participants|73|73.0||||||
4278080|NCT00570492|4101959|B3|||Age|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all participants who had been randomized to and received at least one dose of Double-blind study medication.|Years|Mean|6.63|6.63|Standard Deviation|0.950|0.95|||
4278081|NCT00570492|4101960|B2|||Age|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all participants who had been randomized to and received at least one dose of Double-blind study medication.|Years|Mean|6.64|6.64|Standard Deviation|0.933|0.933|||
4278082|NCT00570492|4101961|B1|||Age|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all participants who had been randomized to and received at least one dose of Double-blind study medication.|Years|Mean|6.61|6.61|Standard Deviation|0.969|0.969|||
4278083|NCT00570401|4102001|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4278084|NCT00570401|4102001|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4278085|NCT00570401|4102001|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4278086|NCT00570401|4102001|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4278087|NCT00570401|4102001|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4278088|NCT00570362|4102005|B3|Korea, Republic of||Region of Enrollment||participants|Number|49|49.0||||||
4278089|NCT00570362|4102006|B2|Korea, Republic of||Region of Enrollment||participants|Number|30|30.0||||||
4278090|NCT00570362|4102007|B1|Korea, Republic of||Region of Enrollment||participants|Number|19|19.0||||||
4278092|NCT00570362|4102006|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4278093|NCT00570362|4102007|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4278094|NCT00570362|4102005|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4278095|NCT00570362|4102006|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4278096|NCT00570362|4102007|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4278097|NCT00570362|4102005|B3|||Age||years|Mean|54.08|54.08|Standard Deviation|7.43|7.43|||
4278098|NCT00570362|4102006|B2|||Age||years|Mean|52.70|52.7|Standard Deviation|6.70|6.7|||
4278099|NCT00570362|4102007|B1|||Age||years|Mean|56.26|56.26|Standard Deviation|8.48|8.48|||
4278100|NCT00570362|4102005|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4278101|NCT00570362|4102006|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4278102|NCT00570362|4102007|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4278103|NCT00570362|4102005|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4278104|NCT00570362|4102006|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4278105|NCT00570362|4102007|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4278106|NCT00570362|4102005|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4278107|NCT00570362|4102006|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4278108|NCT00570362|4102007|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4278109|NCT00570349|4102014|B4|United States||Region of Enrollment||participants|Number|18|18.0||||||
4278110|NCT00570349|4102015|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4278111|NCT00570349|4102016|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4278112|NCT00570349|4102017|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4278113|NCT00570349|4102014|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4278114|NCT00570349|4102015|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4278115|NCT00570349|4102016|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4278116|NCT00570349|4102017|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4278117|NCT00570349|4102014|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4278118|NCT00570349|4102015|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4278119|NCT00570349|4102016|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4278120|NCT00570349|4102017|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4278121|NCT00570349|4102014|B4|||Age||years|Mean|16.7|16.7|Standard Deviation|3.40|3.4|||
4278122|NCT00570349|4102015|B3|||Age||years|Mean|17.7|17.7|Standard Deviation|5.14|5.14|||
4278123|NCT00570349|4102016|B2|||Age||years|Mean|15.6|15.6|Standard Deviation|2.33|2.33|||
4278124|NCT00570349|4102017|B1|||Age||years|Mean|16.9|16.9|Standard Deviation|2.14|2.14|||
4278125|NCT00570349|4102014|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4278126|NCT00570349|4102015|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4278127|NCT00570349|4102016|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4278128|NCT00570349|4102017|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4278129|NCT00570349|4102014|B4||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4278130|NCT00570349|4102015|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4278131|NCT00570349|4102016|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4278132|NCT00570349|4102017|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4278133|NCT00570349|4102014|B4||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4278134|NCT00570349|4102015|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4278135|NCT00570349|4102016|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4278136|NCT00570349|4102017|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4278137|NCT00570310|4102033|B3|||Body Mass Index||kilograms/meter^2|Mean|31.9|31.9|Full Range|||18.5|49.5|
4278138|NCT00570310|4102034|B2|||Body Mass Index||kilograms/meter^2|Mean|31.3|31.3|Full Range|||18.5|49.5|
4278139|NCT00570310|4102035|B1|||Body Mass Index||kilograms/meter^2|Mean|32.6|32.6|Full Range|||20.9|49.3|
4278140|NCT00570310|4102033|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4278141|NCT00570310|4102034|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4278142|NCT00570310|4102035|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4278143|NCT00570310|4102033|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4278144|NCT00570310|4102034|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4278145|NCT00570310|4102035|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4278146|NCT00570310|4102033|B3|||Age||years|Mean|60.5|60.5|Standard Deviation|10.9|10.9|||
4278147|NCT00570310|4102034|B2|||Age||years|Mean|59.3|59.3|Standard Deviation|11.0|11.0|||
4278148|NCT00570310|4102035|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|10.8|10.8|||
4278149|NCT00570232|4102044|B1|None||Histological features||participants|Number|13|13.0||||||
4278150|NCT00570232|4102044|B1|Positive lymph nodes||Histological features||participants|Number|4|4.0||||||
4278151|NCT00570232|4102044|B1|Lymphovascular invasion present||Histological features||participants|Number|4|4.0||||||
4278152|NCT00570232|4102044|B1|Perineural invasion present||Histological features||participants|Number|10|10.0||||||
4278153|NCT00570232|4102044|B1|Not specified||Histological tumor grade||participants|Number|9|9.0||||||
4278154|NCT00570232|4102044|B1|Poorly differentiated||Histological tumor grade||participants|Number|7|7.0||||||
4278155|NCT00570232|4102044|B1|Moderately differentiated||Histological tumor grade||participants|Number|14|14.0||||||
4278156|NCT00570232|4102044|B1|Well differentiated||Histological tumor grade||participants|Number|1|1.0||||||
4278157|NCT00570232|4102044|B1|None||Neck dissection|Number of participants who received a neck dissection (either unilateral or bilateral) during salvage surgery prior to enrollment|participants|Number|10|10.0||||||
4278158|NCT00570232|4102044|B1|Bilateral||Neck dissection|Number of participants who received a neck dissection (either unilateral or bilateral) during salvage surgery prior to enrollment|participants|Number|12|12.0||||||
4278159|NCT00570232|4102044|B1|Unilateral||Neck dissection|Number of participants who received a neck dissection (either unilateral or bilateral) during salvage surgery prior to enrollment|participants|Number|9|9.0||||||
4278160|NCT00570232|4102044|B1|No||Flap reconstruction|Number of participants who received flap reconstruction during salvage surgery prior to enrollment|participants|Number|4|4.0||||||
4278161|NCT00570232|4102044|B1|Yes||Flap reconstruction|Number of participants who received flap reconstruction during salvage surgery prior to enrollment|participants|Number|27|27.0||||||
4278162|NCT00570232|4102044|B1|None||Procedure details|Number of participants who received coincident placement of tracheostomy or PEG tube during salvage surgery prior to enrollment|participants|Number|7|7.0||||||
4278163|NCT00570232|4102044|B1|Coincident PEG||Procedure details|Number of participants who received coincident placement of tracheostomy or PEG tube during salvage surgery prior to enrollment|participants|Number|11|11.0||||||
4278164|NCT00570232|4102044|B1|Coincident tracheostomy||Procedure details|Number of participants who received coincident placement of tracheostomy or PEG tube during salvage surgery prior to enrollment|participants|Number|13|13.0||||||
4278165|NCT00570232|4102044|B1|unknown||Tumor subsite|location of primary tumor|participants|Number|1|1.0||||||
4278166|NCT00570232|4102044|B1|oropharynx||Tumor subsite|location of primary tumor|participants|Number|9|9.0||||||
4278167|NCT00570232|4102044|B1|hypopharynx||Tumor subsite|location of primary tumor|participants|Number|3|3.0||||||
4278168|NCT00570232|4102044|B1|larynx||Tumor subsite|location of primary tumor|participants|Number|7|7.0||||||
4278169|NCT00570232|4102044|B1|oral cavity||Tumor subsite|location of primary tumor|participants|Number|11|11.0||||||
4278170|NCT00570232|4102044|B1|Locoregional||Extent of recurrence||participants|Number|5|5.0||||||
4278171|NCT00570232|4102044|B1|Regional||Extent of recurrence||participants|Number|5|5.0||||||
4278172|NCT00570232|4102044|B1|Local||Extent of recurrence||participants|Number|21|21.0||||||
4278173|NCT00570232|4102044|B1|not specified||Tumor Stage at Study Start - Regional Metastasis (N)|"Classification of Malignant Tumors based on the American Joint Committee on Cancer (AJCC) staging criteria. N indicates the number of lymph nodes with cancer or the location of the cancer-involved lymph nodes.~N0 = no regional lymph node metastasis~N1 = a single ipsilateral lymph node <3 cm in greatest dimension~N2 = a single ipsilateral lymph nodes 3-6 cm in size OR multiple ipsilateral, bilateral, or contralateral lymph nodes <6 cm in greatest dimension~N3 = a lymph node >6 cm in greatest dimension"|participants|Number|8|8.0||||||
4278174|NCT00570232|4102044|B1|N3||Tumor Stage at Study Start - Regional Metastasis (N)|"Classification of Malignant Tumors based on the American Joint Committee on Cancer (AJCC) staging criteria. N indicates the number of lymph nodes with cancer or the location of the cancer-involved lymph nodes.~N0 = no regional lymph node metastasis~N1 = a single ipsilateral lymph node <3 cm in greatest dimension~N2 = a single ipsilateral lymph nodes 3-6 cm in size OR multiple ipsilateral, bilateral, or contralateral lymph nodes <6 cm in greatest dimension~N3 = a lymph node >6 cm in greatest dimension"|participants|Number|1|1.0||||||
4278175|NCT00570232|4102044|B1|N2||Tumor Stage at Study Start - Regional Metastasis (N)|"Classification of Malignant Tumors based on the American Joint Committee on Cancer (AJCC) staging criteria. N indicates the number of lymph nodes with cancer or the location of the cancer-involved lymph nodes.~N0 = no regional lymph node metastasis~N1 = a single ipsilateral lymph node <3 cm in greatest dimension~N2 = a single ipsilateral lymph nodes 3-6 cm in size OR multiple ipsilateral, bilateral, or contralateral lymph nodes <6 cm in greatest dimension~N3 = a lymph node >6 cm in greatest dimension"|participants|Number|2|2.0||||||
4278176|NCT00570232|4102044|B1|N1||Tumor Stage at Study Start - Regional Metastasis (N)|"Classification of Malignant Tumors based on the American Joint Committee on Cancer (AJCC) staging criteria. N indicates the number of lymph nodes with cancer or the location of the cancer-involved lymph nodes.~N0 = no regional lymph node metastasis~N1 = a single ipsilateral lymph node <3 cm in greatest dimension~N2 = a single ipsilateral lymph nodes 3-6 cm in size OR multiple ipsilateral, bilateral, or contralateral lymph nodes <6 cm in greatest dimension~N3 = a lymph node >6 cm in greatest dimension"|participants|Number|2|2.0||||||
4278177|NCT00570232|4102044|B1|N0||Tumor Stage at Study Start - Regional Metastasis (N)|"Classification of Malignant Tumors based on the American Joint Committee on Cancer (AJCC) staging criteria. N indicates the number of lymph nodes with cancer or the location of the cancer-involved lymph nodes.~N0 = no regional lymph node metastasis~N1 = a single ipsilateral lymph node <3 cm in greatest dimension~N2 = a single ipsilateral lymph nodes 3-6 cm in size OR multiple ipsilateral, bilateral, or contralateral lymph nodes <6 cm in greatest dimension~N3 = a lymph node >6 cm in greatest dimension"|participants|Number|18|18.0||||||
4278178|NCT00570232|4102044|B1|not specified||Tumor Stage at Study Start - Primary Tumor Stage (T)|Classification of Malignant Tumors based on the American Joint Committee on Cancer (AJCC) staging criteria. T indicates tumor size, extent, or penetration (depth) of the tumor. T1 is the smallest/least advanced,while T4 is the largest/most advanced.|participants|Number|8|8.0||||||
4278179|NCT00570232|4102044|B1|T4||Tumor Stage at Study Start - Primary Tumor Stage (T)|Classification of Malignant Tumors based on the American Joint Committee on Cancer (AJCC) staging criteria. T indicates tumor size, extent, or penetration (depth) of the tumor. T1 is the smallest/least advanced,while T4 is the largest/most advanced.|participants|Number|13|13.0||||||
4278180|NCT00570232|4102044|B1|T3||Tumor Stage at Study Start - Primary Tumor Stage (T)|Classification of Malignant Tumors based on the American Joint Committee on Cancer (AJCC) staging criteria. T indicates tumor size, extent, or penetration (depth) of the tumor. T1 is the smallest/least advanced,while T4 is the largest/most advanced.|participants|Number|6|6.0||||||
4278222|NCT00570037|4102133|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4278181|NCT00570232|4102044|B1|T2||Tumor Stage at Study Start - Primary Tumor Stage (T)|Classification of Malignant Tumors based on the American Joint Committee on Cancer (AJCC) staging criteria. T indicates tumor size, extent, or penetration (depth) of the tumor. T1 is the smallest/least advanced,while T4 is the largest/most advanced.|participants|Number|3|3.0||||||
4278182|NCT00570232|4102044|B1|T1||Tumor Stage at Study Start - Primary Tumor Stage (T)|Classification of Malignant Tumors based on the American Joint Committee on Cancer (AJCC) staging criteria. T indicates tumor size, extent, or penetration (depth) of the tumor. T1 is the smallest/least advanced,while T4 is the largest/most advanced.|participants|Number|1|1.0||||||
4278183|NCT00570232|4102044|B1|unknown||ECOG performance status|"ECOG PS 0 Fully active,able to carry on all predisease performance without restriction~Restricted in physically strenuous activity but ambulatory & able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory & capable of all selfcare but unable to carry out any work activities. Up & about more than 50% of waking hours~Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair~Dead The ECOG PS is in the public domain."|participants|Number|3|3.0||||||
4278184|NCT00570232|4102044|B1|2||ECOG performance status|"ECOG PS 0 Fully active,able to carry on all predisease performance without restriction~Restricted in physically strenuous activity but ambulatory & able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory & capable of all selfcare but unable to carry out any work activities. Up & about more than 50% of waking hours~Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair~Dead The ECOG PS is in the public domain."|participants|Number|2|2.0||||||
4278185|NCT00570232|4102044|B1|1||ECOG performance status|"ECOG PS 0 Fully active,able to carry on all predisease performance without restriction~Restricted in physically strenuous activity but ambulatory & able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory & capable of all selfcare but unable to carry out any work activities. Up & about more than 50% of waking hours~Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair~Dead The ECOG PS is in the public domain."|participants|Number|8|8.0||||||
4278186|NCT00570232|4102044|B1|0||ECOG performance status|"ECOG PS 0 Fully active,able to carry on all predisease performance without restriction~Restricted in physically strenuous activity but ambulatory & able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory & capable of all selfcare but unable to carry out any work activities. Up & about more than 50% of waking hours~Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair~Dead The ECOG PS is in the public domain."|participants|Number|18|18.0||||||
4278187|NCT00570232|4102044|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4278188|NCT00570232|4102044|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4278189|NCT00570232|4102044|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4278190|NCT00570232|4102044|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4278191|NCT00570232|4102044|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4278192|NCT00570141|4102050|B1|VSU||Wound Type||Participants|Number|6|6.0||||||
4278193|NCT00570141|4102050|B1|DFU||Wound Type||Participants|Number|7|7.0||||||
4278194|NCT00570141|4102050|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4278195|NCT00570141|4102050|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4278196|NCT00570141|4102050|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4278197|NCT00570141|4102050|B1|||Age||years|Mean|63.5|63.5|Standard Deviation|17.2|17.2|||
4278198|NCT00570141|4102050|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4278199|NCT00570141|4102050|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4278200|NCT00570141|4102050|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4278201|NCT00570089|4102055|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4278202|NCT00570089|4102055|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4278203|NCT00570089|4102055|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4278204|NCT00570089|4102055|B1|||Age||years|Mean|57|57.0|Full Range|||46.0|68.0|
4278205|NCT00570089|4102055|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4278206|NCT00570089|4102055|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4278207|NCT00570089|4102055|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4278208|NCT00570063|4102064|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4278209|NCT00570063|4102065|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4278210|NCT00570063|4102066|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4278211|NCT00570063|4102064|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4278212|NCT00570063|4102065|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4278213|NCT00570063|4102066|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4278214|NCT00570063|4102064|B3|||Age||years|Mean|42.6|42.6|Standard Deviation|9.7|9.7|||
4278215|NCT00570063|4102065|B2|||Age||years|Mean|43.1|43.1|Standard Deviation|10.8|10.8|||
4278216|NCT00570063|4102066|B1|||Age||years|Mean|42.3|42.3|Standard Deviation|9.3|9.3|||
4278217|NCT00570037|4102131|B3|United States||Region of Enrollment||participants|Number|544|544.0||||||
4278218|NCT00570037|4102132|B2|United States||Region of Enrollment||participants|Number|306|306.0||||||
4278219|NCT00570037|4102133|B1|United States||Region of Enrollment||participants|Number|238|238.0||||||
4278220|NCT00570037|4102131|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4278221|NCT00570037|4102132|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4278223|NCT00570037|4102131|B3||Female|Sex: Female, Male||Participants|Count of Participants|544|544.0||||||
4278224|NCT00570037|4102132|B2||Female|Sex: Female, Male||Participants|Count of Participants|306|306.0||||||
4278225|NCT00570037|4102133|B1||Female|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
4278226|NCT00570037|4102131|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4278227|NCT00570037|4102132|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4278228|NCT00570037|4102133|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4278229|NCT00570037|4102131|B3||Between 18 and 65 years|Age||Participants|Count of Participants|544|544.0||||||
4278230|NCT00570037|4102132|B2||Between 18 and 65 years|Age||Participants|Count of Participants|306|306.0||||||
4278231|NCT00570037|4102133|B1||Between 18 and 65 years|Age||Participants|Count of Participants|238|238.0||||||
4278232|NCT00570037|4102131|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4278233|NCT00570037|4102132|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4278234|NCT00570037|4102133|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4278235|NCT00569946|4102144|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4278236|NCT00569946|4102144|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4278237|NCT00569946|4102144|B1|>= 65||Age, Customized||participants|Number|28|28.0||||||
4278238|NCT00569946|4102144|B1|45-64||Age, Customized||participants|Number|30|30.0||||||
4278239|NCT00569946|4102144|B1|18-44||Age, Customized||participants|Number|6|6.0||||||
4278240|NCT00569946|4102144|B1|<18||Age, Customized||participants|Number|0|0.0||||||
4278241|NCT00569868|4102160|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4278242|NCT00569868|4102160|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4278243|NCT00569868|4102160|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4278244|NCT00569868|4102160|B1|||Age||years|Mean|64|64.0|Standard Deviation|7.67|7.67|||
4278245|NCT00569868|4102160|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4278246|NCT00569868|4102160|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4278247|NCT00569868|4102160|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4278248|NCT00569855|4102164|B1|United States||Region of Enrollment||participants|Number|785|785.0||||||
4278249|NCT00569855|4102164|B1||Male|Sex: Female, Male||Participants|Count of Participants|395|395.0||||||
4278250|NCT00569855|4102164|B1||Female|Sex: Female, Male||Participants|Count of Participants|390|390.0||||||
4278251|NCT00569855|4102164|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4278252|NCT00569855|4102164|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4278253|NCT00569855|4102164|B1||<=18 years|Age||Participants|Count of Participants|785|785.0||||||
4278254|NCT00569803|4102168|B9||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4278255|NCT00569803|4102169|B8||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4278256|NCT00569803|4102170|B7||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4278257|NCT00569803|4102171|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4278258|NCT00569803|4102172|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4278259|NCT00569803|4102173|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4278260|NCT00569803|4102174|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4278261|NCT00569803|4102175|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4278262|NCT00569803|4102176|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4278263|NCT00569803|4102168|B9||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4278264|NCT00569803|4102169|B8||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4278265|NCT00569803|4102170|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4278266|NCT00569803|4102171|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4278267|NCT00569803|4102172|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4278268|NCT00569803|4102173|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4278269|NCT00569803|4102174|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4278270|NCT00569803|4102175|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4278271|NCT00569803|4102176|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4278272|NCT00569803|4102168|B9|||Age||years|Mean|30|30.0|Standard Deviation|12|12.0|||
4278273|NCT00569803|4102169|B8|||Age||years|Mean|27|27.0|Standard Deviation|6|6.0|||
4278274|NCT00569803|4102170|B7|||Age||years|Mean|32|32.0|Standard Deviation|16|16.0|||
4278275|NCT00569803|4102171|B6|||Age||years|Mean|31|31.0|Standard Deviation|10|10.0|||
4278276|NCT00569803|4102172|B5|||Age||years|Mean|31|31.0|Standard Deviation|11|11.0|||
4278277|NCT00569803|4102173|B4|||Age||years|Mean|34|34.0|Standard Deviation|18|18.0|||
4278278|NCT00569803|4102174|B3|||Age||years|Mean|28|28.0|Standard Deviation|12|12.0|||
4278279|NCT00569803|4102175|B2|||Age||years|Mean|27|27.0|Standard Deviation|12|12.0|||
4278280|NCT00569803|4102176|B1|||Age||years|Mean|30|30.0|Standard Deviation|11|11.0|||
4278281|NCT00569777|4102308|B3|United States||Region of Enrollment||participants|Number|310|310.0||||||
4278282|NCT00569777|4102309|B2|United States||Region of Enrollment||participants|Number|104|104.0||||||
4278283|NCT00569777|4102310|B1|United States||Region of Enrollment||participants|Number|206|206.0||||||
4278284|NCT00569777|4102308|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4278285|NCT00569777|4102309|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4278286|NCT00569777|4102310|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4278287|NCT00569777|4102308|B3||Female|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
4278288|NCT00569777|4102309|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4278289|NCT00569777|4102310|B1||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4278290|NCT00569777|4102308|B3|||Age||years|Mean|31|31.0|Standard Deviation|11.33|11.33|||
4278291|NCT00569777|4102309|B2|||Age||years|Mean|30|30.0|Standard Deviation|10.75|10.75|||
4278292|NCT00569777|4102310|B1|||Age||years|Mean|31|31.0|Standard Deviation|11.62|11.62|||
4278293|NCT00569673|4102353|B1|Serous Adenocarcinoma||Cell Type||participants|Number|53|53.0||||||
4278294|NCT00569673|4102353|B1|Mixed Epithelial Carcinoma||Cell Type||participants|Number|2|2.0||||||
4278295|NCT00569673|4102353|B1|Endometrioid Adenocarcinoma||Cell Type||participants|Number|6|6.0||||||
4278296|NCT00569673|4102353|B1|Clear Cell Carcinoma||Cell Type||participants|Number|3|3.0||||||
4278297|NCT00569673|4102353|B1|Adenocarcinoma, Unspecified||Cell Type||participants|Number|7|7.0||||||
4278298|NCT00569673|4102353|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
4278299|NCT00569673|4102353|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4278300|NCT00569673|4102353|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4278301|NCT00569673|4102353|B1|80-89 years||Age, Customized||participants|Number|1|1.0||||||
4278302|NCT00569673|4102353|B1|70-79 years||Age, Customized||participants|Number|7|7.0||||||
4278303|NCT00569673|4102353|B1|60-69 years||Age, Customized||participants|Number|25|25.0||||||
4278304|NCT00569673|4102353|B1|50-59 years||Age, Customized||participants|Number|28|28.0||||||
4278305|NCT00569673|4102353|B1|40-49 years||Age, Customized||participants|Number|10|10.0||||||
4278306|NCT00569673|4102353|B1|||Age, Customized||years|Mean|59.3|59.3|Standard Deviation|9.2|9.2|||
4278307|NCT00569660|4102358|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4278308|NCT00569660|4102358|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4278309|NCT00569660|4102358|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4278310|NCT00569660|4102358|B1|||Age||years|Median|67|67.0|Full Range|||39.0|82.0|
4278311|NCT00569660|4102358|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4278312|NCT00569660|4102358|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4278313|NCT00569660|4102358|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4278314|NCT00569582|4102362|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4278315|NCT00569582|4102362|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4278316|NCT00569582|4102362|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4278317|NCT00569582|4102362|B1|||Age||years|Mean|45.4|45.4|Standard Deviation|11.85|11.85|||
4278318|NCT00569582|4102362|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4278319|NCT00569582|4102362|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4278320|NCT00569582|4102362|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4278321|NCT00569530|4102367|B3|||Multiple gestation|The number of infants who were a product of a multiple gestation pregnancy. Only a small number of pregnancies are multiple gestation. Multiple gestation infants will be a subset of infants enrolled.|infants|Number|18|18.0||||||
4278322|NCT00569530|4102368|B2|||Multiple gestation|The number of infants who were a product of a multiple gestation pregnancy. Only a small number of pregnancies are multiple gestation. Multiple gestation infants will be a subset of infants enrolled.|infants|Number|10|10.0||||||
4278323|NCT00569530|4102369|B1|||Multiple gestation|The number of infants who were a product of a multiple gestation pregnancy. Only a small number of pregnancies are multiple gestation. Multiple gestation infants will be a subset of infants enrolled.|infants|Number|8|8.0||||||
4278324|NCT00569530|4102367|B3|||RSS at entry|Respiratory Severity Score = Mean Airway pressure X FiO2. The higher the number, the sicker the infant.|units on a scale|Mean|3.3|3.3|Standard Deviation|1.7|1.7|||
4278325|NCT00569530|4102368|B2|||RSS at entry|Respiratory Severity Score = Mean Airway pressure X FiO2. The higher the number, the sicker the infant.|units on a scale|Mean|3.2|3.2|Standard Deviation|1.7|1.7|||
4278326|NCT00569530|4102369|B1|||RSS at entry|Respiratory Severity Score = Mean Airway pressure X FiO2. The higher the number, the sicker the infant.|units on a scale|Mean|3.4|3.4|Standard Deviation|1.7|1.7|||
4278327|NCT00569530|4102367|B3|||Prior surfactant treatment|Number of infants who received prior surfactant therapy (prior to enrollment). Not all infants receive surfactant therapy at birth. Therefore number treated will not always match number in group.|infants|Number|84|84.0||||||
4278328|NCT00569530|4102368|B2|||Prior surfactant treatment|Number of infants who received prior surfactant therapy (prior to enrollment). Not all infants receive surfactant therapy at birth. Therefore number treated will not always match number in group.|infants|Number|41|41.0||||||
4278329|NCT00569530|4102369|B1|||Prior surfactant treatment|Number of infants who received prior surfactant therapy (prior to enrollment). Not all infants receive surfactant therapy at birth. Therefore number treated will not always match number in group.|infants|Number|43|43.0||||||
4278330|NCT00569530|4102367|B3|||Antenatal Corticosteroids|Number of infants who received Antenatal Corticosteroids. Not all mothers receive antenatal steroids. Therefore number treated will not match number in group.|infants|Number|65|65.0||||||
4278331|NCT00569530|4102368|B2|||Antenatal Corticosteroids|Number of infants who received Antenatal Corticosteroids. Not all mothers receive antenatal steroids. Therefore number treated will not match number in group.|infants|Number|33|33.0||||||
4278332|NCT00569530|4102369|B1|||Antenatal Corticosteroids|Number of infants who received Antenatal Corticosteroids. Not all mothers receive antenatal steroids. Therefore number treated will not match number in group.|infants|Number|32|32.0||||||
4278333|NCT00569530|4102367|B3|United States||Region of Enrollment||infants|Number|85|85.0||||||
4278334|NCT00569530|4102368|B2|United States||Region of Enrollment||infants|Number|42|42.0||||||
4278335|NCT00569530|4102369|B1|United States||Region of Enrollment||infants|Number|43|43.0||||||
4278336|NCT00569530|4102367|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4278337|NCT00569530|4102368|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4278338|NCT00569530|4102369|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4278339|NCT00569530|4102367|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278340|NCT00569530|4102368|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278341|NCT00569530|4102369|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278342|NCT00569530|4102367|B3||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4278343|NCT00569530|4102368|B2||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4278344|NCT00569530|4102369|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4278345|NCT00569530|4102367|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4278346|NCT00569530|4102368|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4278347|NCT00569530|4102369|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4278348|NCT00569530|4102367|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278349|NCT00569530|4102368|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278350|NCT00569530|4102369|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278351|NCT00569530|4102367|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278352|NCT00569530|4102368|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278353|NCT00569530|4102369|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278354|NCT00569530|4102367|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278355|NCT00569530|4102368|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278356|NCT00569530|4102369|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278357|NCT00569530|4102367|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4278358|NCT00569530|4102368|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4278359|NCT00569530|4102369|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4278360|NCT00569530|4102367|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4278361|NCT00569530|4102368|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4278362|NCT00569530|4102369|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4278363|NCT00569530|4102367|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4278364|NCT00569530|4102368|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4278365|NCT00569530|4102369|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4278366|NCT00569530|4102367|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4278367|NCT00569530|4102368|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4278368|NCT00569530|4102369|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4278369|NCT00569530|4102367|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4278370|NCT00569530|4102368|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4278371|NCT00569530|4102369|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4278372|NCT00569530|4102367|B3|||Age|Age at enrollment: Infants were enrolled if they remained ventilated between 7 and 14 day of age.|Days|Mean|10.2|10.2|Standard Deviation|2.5|2.5|||
4278373|NCT00569530|4102368|B2|||Age|Age at enrollment: Infants were enrolled if they remained ventilated between 7 and 14 day of age.|Days|Mean|10.5|10.5|Standard Deviation|2.8|2.8|||
4278374|NCT00569530|4102369|B1|||Age|Age at enrollment: Infants were enrolled if they remained ventilated between 7 and 14 day of age.|Days|Mean|9.9|9.9|Standard Deviation|2.2|2.2|||
4278375|NCT00569374|4102378|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4278376|NCT00569374|4102378|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4278377|NCT00569374|4102378|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4278378|NCT00569374|4102378|B1|||Age||years|Mean|45.3|45.3|Standard Deviation|7.2|7.2|||
4278379|NCT00569374|4102378|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4278380|NCT00569374|4102378|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4278381|NCT00569374|4102378|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4278382|NCT00569309|4102388|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4278383|NCT00569309|4102388|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278384|NCT00569309|4102388|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278385|NCT00569309|4102388|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4278386|NCT00569309|4102388|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4278387|NCT00569309|4102388|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278388|NCT00569309|4102388|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278439|NCT00569192|4102442|B2|||Age||years|Median|4.0|4.0|Full Range|||1.0|8.0|
4278389|NCT00569309|4102388|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278390|NCT00569309|4102388|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278391|NCT00569309|4102388|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4278392|NCT00569309|4102388|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278393|NCT00569309|4102388|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4278394|NCT00569309|4102388|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4278395|NCT00569309|4102388|B1|||Age||years|Mean|51|51.0|Full Range|||18.0|71.0|
4278396|NCT00569270|4102397|B1|||D(L)CO(SB) - ml/min/mmHg % predicted|single-breath diffusing capacity - ml/min/mmHg - percent predicted|ml/min/mmHg|Mean|69|69.0|Standard Deviation|23|23.0|||
4278397|NCT00569270|4102397|B1|||D(L)CO(SB) - ml/min/mmHg observed (Single-breath diffusing capacity )|Single-breath diffusing capacity (ml/min/mmHg)observed|ml/min/mmHg|Mean|14|14.0|Standard Deviation|5|5.0|||
4278398|NCT00569270|4102397|B1|||TLC Percent of liters predicted|total lung capacity - percent of liters predicted|percentage of liters predicted|Mean|109|109.0|Standard Deviation|16|16.0|||
4278399|NCT00569270|4102397|B1|||TLC (L) (total lung capacity) observed|total lung capacity - observed|liters|Mean|5.9|5.9|Standard Deviation|1.3|1.3|||
4278400|NCT00569270|4102397|B1|||RV (L) - % predicted|residual volume (L) - percent predicted|percentage|Mean|131|131.0|Standard Deviation|37|37.0|||
4278401|NCT00569270|4102397|B1|||RV (L) (residual volume) observed|residual volume (liters) observed|liters|Mean|2.9|2.9|Standard Deviation|0.1|0.1|||
4278402|NCT00569270|4102397|B1|||FRC percent of liters predicted|functional residual capacity percent of liters predicted|percentage of liters predicted|Mean|138|138.0|Standard Deviation|29|29.0|||
4278403|NCT00569270|4102397|B1|||FRC (L) (functional residual capacity) observed|functional residual capacity - observed|liters|Mean|3.9|3.9|Standard Deviation|0.8|0.8|||
4278404|NCT00569270|4102397|B1|||SGaw (Lps/cmH2O/L) (specific airway conductance)|specific airway conductance (observed)|Lps/cmH2O/L|Mean|0.10|0.1|Standard Deviation|0.08|0.08|||
4278405|NCT00569270|4102397|B1|||FEV1/FVC percentage|forced expiratory volume in 1s/forced vital capacity - percent|percentage of liters expected|Mean|56|56.0|Standard Deviation|8|8.0|||
4278406|NCT00569270|4102397|B1|FEV1 percent liters predicted post albuterol||FEV1 (L) percent predicted|forced vital capacity (L) - percent predicted|percentage of liters expected|Mean|8|8.0|Standard Deviation|6|6.0|||
4278407|NCT00569270|4102397|B1|FEV1 percent liters predicted||FEV1 (L) percent predicted|forced vital capacity (L) - percent predicted|percentage of liters expected|Mean|61|61.0|Standard Deviation|69|69.0|||
4278408|NCT00569270|4102397|B1|FEV1(L) post 180 ug albuterol sulfate MDI||FEV1(L) (forces expiratory volume) observed|Forced expiratory volume in 1s, observed|liters|Mean|1.8|1.8|Standard Deviation|0.6|0.6|||
4278409|NCT00569270|4102397|B1|FEV1(L)||FEV1(L) (forces expiratory volume) observed|Forced expiratory volume in 1s, observed|liters|Mean|1.6|1.6|Standard Deviation|0.6|0.6|||
4278410|NCT00569270|4102397|B1|FVC post 180 µg albuterol percent of ltrs predict||FVC|Forced vital capacity - % predicted|percentage of liters expected|Mean|95|95.0|Standard Deviation|16|16.0|||
4278411|NCT00569270|4102397|B1|FVC percent of liters predicted||FVC|Forced vital capacity - % predicted|percentage of liters expected|Mean|86|86.0|Standard Deviation|17|17.0|||
4278412|NCT00569270|4102397|B1|FVC (L) post 180 µg albuterol sulfate MDI||FVC (forced vital capacity)|forced vital capacity (observed)|liters|Mean|3.3|3.3|Standard Deviation|1.2|1.2|||
4278413|NCT00569270|4102397|B1|FVC (L)||FVC (forced vital capacity)|forced vital capacity (observed)|liters|Mean|2.9|2.9|Standard Deviation|1.2|1.2|||
4278414|NCT00569270|4102397|B1|||Average participant age +/- SD|One patient was dropped due to a protocol violation.|years|Mean|70|70.0|Standard Deviation|9|9.0|||
4278415|NCT00569270|4102397|B1|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4278416|NCT00569270|4102397|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4278417|NCT00569270|4102397|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4278418|NCT00569270|4102397|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4278419|NCT00569270|4102397|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4278420|NCT00569270|4102397|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4278421|NCT00569270|4102397|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4278422|NCT00569231|4102433|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4278423|NCT00569231|4102433|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4278424|NCT00569231|4102433|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4278425|NCT00569231|4102433|B1|||Age||years|Mean|29.8|29.8|Standard Deviation|9.1|9.1|||
4278426|NCT00569231|4102433|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4278427|NCT00569231|4102433|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4278428|NCT00569231|4102433|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4278429|NCT00569192|4102440|B4||Male|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4278430|NCT00569192|4102441|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4278431|NCT00569192|4102442|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4278432|NCT00569192|4102443|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4278433|NCT00569192|4102440|B4||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4278434|NCT00569192|4102441|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4278435|NCT00569192|4102442|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4278436|NCT00569192|4102443|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4278437|NCT00569192|4102440|B4|||Age||years|Median|4.0|4.0|Full Range|||1.0|8.0|
4278438|NCT00569192|4102441|B3|||Age||years|Median|4.0|4.0|Full Range|||1.0|8.0|
4278440|NCT00569192|4102443|B1|||Age||years|Median|4.0|4.0|Full Range|||1.0|8.0|
4278441|NCT00569192|4102440|B4|||Age||years|Mean|4.4|4.4|Standard Deviation|2.26|2.26|||
4278442|NCT00569192|4102441|B3|||Age||years|Mean|4.2|4.2|Standard Deviation|2.27|2.27|||
4278443|NCT00569192|4102442|B2|||Age||years|Mean|4.4|4.4|Standard Deviation|2.33|2.33|||
4278444|NCT00569192|4102443|B1|||Age||years|Mean|4.5|4.5|Standard Deviation|2.17|2.17|||
4278445|NCT00569166|4102468|B4|No||Current tamoxifen, raloxifene, or aromatase inhibitor treatment||participants|Number|59|59.0||||||
4278446|NCT00569166|4102469|B3|No||Current tamoxifen, raloxifene, or aromatase inhibitor treatment||participants|Number|19|19.0||||||
4278447|NCT00569166|4102470|B2|No||Current tamoxifen, raloxifene, or aromatase inhibitor treatment||participants|Number|24|24.0||||||
4278448|NCT00569166|4102471|B1|No||Current tamoxifen, raloxifene, or aromatase inhibitor treatment||participants|Number|16|16.0||||||
4278449|NCT00569166|4102468|B4|Yes||Current tamoxifen, raloxifene, or aromatase inhibitor treatment||participants|Number|33|33.0||||||
4278450|NCT00569166|4102469|B3|Yes||Current tamoxifen, raloxifene, or aromatase inhibitor treatment||participants|Number|12|12.0||||||
4278451|NCT00569166|4102470|B2|Yes||Current tamoxifen, raloxifene, or aromatase inhibitor treatment||participants|Number|7|7.0||||||
4278452|NCT00569166|4102471|B1|Yes||Current tamoxifen, raloxifene, or aromatase inhibitor treatment||participants|Number|14|14.0||||||
4278453|NCT00569166|4102468|B4|>=10 Hot flashes per day||Average Frequency of Hot Flashes per day||participants|Number|44|44.0||||||
4278454|NCT00569166|4102469|B3|>=10 Hot flashes per day||Average Frequency of Hot Flashes per day||participants|Number|11|11.0||||||
4278455|NCT00569166|4102470|B2|>=10 Hot flashes per day||Average Frequency of Hot Flashes per day||participants|Number|14|14.0||||||
4278456|NCT00569166|4102471|B1|>=10 Hot flashes per day||Average Frequency of Hot Flashes per day||participants|Number|19|19.0||||||
4278457|NCT00569166|4102468|B4|4-9 Hot flashes per day||Average Frequency of Hot Flashes per day||participants|Number|39|39.0||||||
4278458|NCT00569166|4102469|B3|4-9 Hot flashes per day||Average Frequency of Hot Flashes per day||participants|Number|14|14.0||||||
4278459|NCT00569166|4102470|B2|4-9 Hot flashes per day||Average Frequency of Hot Flashes per day||participants|Number|15|15.0||||||
4278460|NCT00569166|4102471|B1|4-9 Hot flashes per day||Average Frequency of Hot Flashes per day||participants|Number|10|10.0||||||
4278461|NCT00569166|4102468|B4|<4 Hot flashes per day||Average Frequency of Hot Flashes per day||participants|Number|9|9.0||||||
4278462|NCT00569166|4102469|B3|<4 Hot flashes per day||Average Frequency of Hot Flashes per day||participants|Number|6|6.0||||||
4278463|NCT00569166|4102470|B2|<4 Hot flashes per day||Average Frequency of Hot Flashes per day||participants|Number|2|2.0||||||
4278464|NCT00569166|4102471|B1|<4 Hot flashes per day||Average Frequency of Hot Flashes per day||participants|Number|1|1.0||||||
4278465|NCT00569166|4102468|B4|No||Breast Cancer History||participants|Number|44|44.0||||||
4278466|NCT00569166|4102469|B3|No||Breast Cancer History||participants|Number|16|16.0||||||
4278467|NCT00569166|4102470|B2|No||Breast Cancer History||participants|Number|18|18.0||||||
4278468|NCT00569166|4102471|B1|No||Breast Cancer History||participants|Number|10|10.0||||||
4278469|NCT00569166|4102468|B4|Yes||Breast Cancer History||participants|Number|48|48.0||||||
4278470|NCT00569166|4102469|B3|Yes||Breast Cancer History||participants|Number|15|15.0||||||
4278471|NCT00569166|4102470|B2|Yes||Breast Cancer History||participants|Number|13|13.0||||||
4278472|NCT00569166|4102471|B1|Yes||Breast Cancer History||participants|Number|20|20.0||||||
4278473|NCT00569166|4102468|B4|United States||Region of Enrollment||participants|Number|92|92.0||||||
4278474|NCT00569166|4102469|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4278475|NCT00569166|4102470|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
4278476|NCT00569166|4102471|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4278477|NCT00569166|4102468|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278478|NCT00569166|4102469|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278479|NCT00569166|4102470|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278480|NCT00569166|4102471|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278481|NCT00569166|4102468|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278482|NCT00569166|4102469|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278483|NCT00569166|4102470|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278484|NCT00569166|4102471|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278485|NCT00569166|4102468|B4||White|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
4278486|NCT00569166|4102469|B3||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4278487|NCT00569166|4102470|B2||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4278488|NCT00569166|4102471|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4278489|NCT00569166|4102468|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278490|NCT00569166|4102469|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278491|NCT00569166|4102470|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278492|NCT00569166|4102471|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278493|NCT00569166|4102468|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278494|NCT00569166|4102469|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278495|NCT00569166|4102470|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278496|NCT00569166|4102471|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278497|NCT00569166|4102468|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278498|NCT00569166|4102469|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278499|NCT00569166|4102470|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278500|NCT00569166|4102471|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278501|NCT00569166|4102468|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278502|NCT00569166|4102469|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278503|NCT00569166|4102470|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278504|NCT00569166|4102471|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278505|NCT00569166|4102468|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4278506|NCT00569166|4102469|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4278507|NCT00569166|4102470|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4278508|NCT00569166|4102471|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4278509|NCT00569166|4102468|B4||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4278510|NCT00569166|4102469|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4278511|NCT00569166|4102470|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4278512|NCT00569166|4102471|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4278513|NCT00569166|4102468|B4|>=50 years||Age, Customized||participants|Number|60|60.0||||||
4278514|NCT00569166|4102469|B3|>=50 years||Age, Customized||participants|Number|22|22.0||||||
4278515|NCT00569166|4102470|B2|>=50 years||Age, Customized||participants|Number|23|23.0||||||
4278516|NCT00569166|4102471|B1|>=50 years||Age, Customized||participants|Number|15|15.0||||||
4278517|NCT00569166|4102468|B4|Between 18 and 49 years||Age, Customized||participants|Number|32|32.0||||||
4278518|NCT00569166|4102469|B3|Between 18 and 49 years||Age, Customized||participants|Number|9|9.0||||||
4278519|NCT00569166|4102470|B2|Between 18 and 49 years||Age, Customized||participants|Number|8|8.0||||||
4278520|NCT00569166|4102471|B1|Between 18 and 49 years||Age, Customized||participants|Number|15|15.0||||||
4278521|NCT00569166|4102468|B4|||Age||years|Mean|53.4|53.4|Standard Deviation|8.5|8.5|||
4278522|NCT00569166|4102469|B3|||Age||years|Mean|54.5|54.5|Standard Deviation|8.7|8.7|||
4278523|NCT00569166|4102470|B2|||Age||years|Mean|54.4|54.4|Standard Deviation|8.1|8.1|||
4278524|NCT00569166|4102471|B1|||Age||years|Mean|51.3|51.3|Standard Deviation|8.4|8.4|||
4278525|NCT00569127|4102505|B3|None within 2 months prior to registration||Prior Octreotide||participants|Number|173|173.0||||||
4278526|NCT00569127|4102506|B2|None within 2 months prior to registration||Prior Octreotide||participants|Number|87|87.0||||||
4278527|NCT00569127|4102507|B1|None within 2 months prior to registration||Prior Octreotide||participants|Number|86|86.0||||||
4278528|NCT00569127|4102505|B3|Within 2 months prior to registration||Prior Octreotide||participants|Number|229|229.0||||||
4278529|NCT00569127|4102506|B2|Within 2 months prior to registration||Prior Octreotide||participants|Number|115|115.0||||||
4278530|NCT00569127|4102507|B1|Within 2 months prior to registration||Prior Octreotide||participants|Number|114|114.0||||||
4278531|NCT00569127|4102505|B3|Intermediate (atypical)||Histologic Grade||participants|Number|62|62.0||||||
4278532|NCT00569127|4102506|B2|Intermediate (atypical)||Histologic Grade||participants|Number|31|31.0||||||
4278533|NCT00569127|4102507|B1|Intermediate (atypical)||Histologic Grade||participants|Number|31|31.0||||||
4278534|NCT00569127|4102505|B3|Low||Histologic Grade||participants|Number|340|340.0||||||
4278535|NCT00569127|4102506|B2|Low||Histologic Grade||participants|Number|171|171.0||||||
4278536|NCT00569127|4102507|B1|Low||Histologic Grade||participants|Number|169|169.0||||||
4278537|NCT00569127|4102505|B3|No||Progression after Initial Diagnosis||participants|Number|32|32.0||||||
4278538|NCT00569127|4102506|B2|No||Progression after Initial Diagnosis||participants|Number|14|14.0||||||
4278539|NCT00569127|4102507|B1|No||Progression after Initial Diagnosis||participants|Number|18|18.0||||||
4278540|NCT00569127|4102505|B3|Yes||Progression after Initial Diagnosis||participants|Number|370|370.0||||||
4278541|NCT00569127|4102506|B2|Yes||Progression after Initial Diagnosis||participants|Number|188|188.0||||||
4278542|NCT00569127|4102507|B1|Yes||Progression after Initial Diagnosis||participants|Number|182|182.0||||||
4278543|NCT00569127|4102505|B3|Other sites||Disease Site||participants|Number|259|259.0||||||
4278544|NCT00569127|4102506|B2|Other sites||Disease Site||participants|Number|130|130.0||||||
4278545|NCT00569127|4102507|B1|Other sites||Disease Site||participants|Number|129|129.0||||||
4278546|NCT00569127|4102505|B3|Small bowel, cecum, appendix||Disease Site||participants|Number|143|143.0||||||
4278547|NCT00569127|4102506|B2|Small bowel, cecum, appendix||Disease Site||participants|Number|72|72.0||||||
4278548|NCT00569127|4102507|B1|Small bowel, cecum, appendix||Disease Site||participants|Number|71|71.0||||||
4278549|NCT00569127|4102505|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4278550|NCT00569127|4102506|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4278551|NCT00569127|4102507|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4278552|NCT00569127|4102505|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4278553|NCT00569127|4102506|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278554|NCT00569127|4102507|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4278555|NCT00569127|4102505|B3||White|Race (NIH/OMB)||Participants|Count of Participants|336|336.0||||||
4278556|NCT00569127|4102506|B2||White|Race (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
4278557|NCT00569127|4102507|B1||White|Race (NIH/OMB)||Participants|Count of Participants|169|169.0||||||
4278558|NCT00569127|4102505|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4278559|NCT00569127|4102506|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4278560|NCT00569127|4102507|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4278561|NCT00569127|4102505|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4278562|NCT00569127|4102506|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278563|NCT00569127|4102507|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4278564|NCT00569127|4102505|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4278565|NCT00569127|4102506|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4278566|NCT00569127|4102507|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4278567|NCT00569127|4102505|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4278568|NCT00569127|4102506|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278569|NCT00569127|4102507|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4278570|NCT00569127|4102505|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4278571|NCT00569127|4102506|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4278572|NCT00569127|4102507|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4278573|NCT00569127|4102505|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|343|343.0||||||
4278574|NCT00569127|4102506|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|177|177.0||||||
4278575|NCT00569127|4102507|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|166|166.0||||||
4278576|NCT00569127|4102505|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4278577|NCT00569127|4102506|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4278578|NCT00569127|4102507|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4278579|NCT00569127|4102505|B3||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4278580|NCT00569127|4102506|B2||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4278581|NCT00569127|4102507|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4278582|NCT00569127|4102505|B3||Female|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4278583|NCT00569127|4102506|B2||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4278584|NCT00569127|4102507|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4278585|NCT00569127|4102505|B3|||Age||years|Median|60.9|60.9|Full Range|||23.1|85.4|
4278586|NCT00569127|4102506|B2|||Age||years|Median|61.1|61.1|Full Range|||23.1|85.4|
4278587|NCT00569127|4102507|B1|||Age||years|Median|60.5|60.5|Full Range|||27.2|85.3|
4278588|NCT00569010|4102524|B5|United States||Region of Enrollment||participants|Number|34|34.0||||||
4278589|NCT00569010|4102525|B4|United States||Region of Enrollment||participants|Number|11|11.0||||||
4278590|NCT00569010|4102526|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4278591|NCT00569010|4102527|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4278592|NCT00569010|4102528|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4278593|NCT00569010|4102524|B5||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4278594|NCT00569010|4102525|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4278595|NCT00569010|4102526|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4278596|NCT00569010|4102527|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4278597|NCT00569010|4102528|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4278598|NCT00569010|4102524|B5||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4278599|NCT00569010|4102525|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4278600|NCT00569010|4102526|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4278601|NCT00569010|4102527|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4278602|NCT00569010|4102528|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4278603|NCT00569010|4102524|B5|||Age||years|Mean|61|61.0|Full Range|||31.0|79.0|
4278604|NCT00569010|4102525|B4|||Age||years|Mean|62|62.0|Full Range|||38.0|69.0|
4278605|NCT00569010|4102526|B3|||Age||years|Mean|74|74.0|Full Range|||52.0|79.0|
4278606|NCT00569010|4102527|B2|||Age||years|Mean|61|61.0|Full Range|||49.0|75.0|
4278607|NCT00569010|4102528|B1|||Age||years|Mean|44|44.0|Full Range|||31.0|76.0|
4278608|NCT00568958|4102541|B3|Alcohol Dependence||Alcohol Use Diagnosis||participants|Number|76|76.0||||||
4278609|NCT00568958|4102542|B2|Alcohol Dependence||Alcohol Use Diagnosis||participants|Number|42|42.0||||||
4278610|NCT00568958|4102543|B1|Alcohol Dependence||Alcohol Use Diagnosis||participants|Number|34|34.0||||||
4278611|NCT00568958|4102541|B3|Alcohol Abuse||Alcohol Use Diagnosis||participants|Number|25|25.0||||||
4278612|NCT00568958|4102542|B2|Alcohol Abuse||Alcohol Use Diagnosis||participants|Number|14|14.0||||||
4278613|NCT00568958|4102543|B1|Alcohol Abuse||Alcohol Use Diagnosis||participants|Number|11|11.0||||||
4278614|NCT00568958|4102541|B3|No Diagnosis||Alcohol Use Diagnosis||participants|Number|27|27.0||||||
4278615|NCT00568958|4102542|B2|No Diagnosis||Alcohol Use Diagnosis||participants|Number|11|11.0||||||
4278616|NCT00568958|4102543|B1|No Diagnosis||Alcohol Use Diagnosis||participants|Number|16|16.0||||||
4278617|NCT00568958|4102541|B3|Non-Caucasian||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4278618|NCT00568958|4102542|B2|Non-Caucasian||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4278619|NCT00568958|4102543|B1|Non-Caucasian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4278620|NCT00568958|4102541|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|99|99.0||||||
4278621|NCT00568958|4102542|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
4278622|NCT00568958|4102543|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4278623|NCT00568958|4102541|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4278624|NCT00568958|4102542|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4278625|NCT00568958|4102543|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4278626|NCT00568958|4102541|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4278627|NCT00568958|4102542|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4278628|NCT00568958|4102543|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4278629|NCT00568958|4102541|B3|18-25 year olds||Age, Customized||participants|Number|128|128.0||||||
4278630|NCT00568958|4102542|B2|18-25 year olds||Age, Customized||participants|Number|67|67.0||||||
4278631|NCT00568958|4102543|B1|18-25 year olds||Age, Customized||participants|Number|61|61.0||||||
4278632|NCT00568854|4102562|B3|||Hemoglobin A1C||%|Median|6.1|6.1|Full Range|||5.6|7.5|
4278633|NCT00568854|4102563|B2|||Hemoglobin A1C||%|Median|5.65|5.65|Full Range|||5.6|5.7|
4278634|NCT00568854|4102564|B1|||Hemoglobin A1C||%|Median|6.65|6.65|Full Range|||6.1|7.5|
4278635|NCT00568854|4102562|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278636|NCT00568854|4102563|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278637|NCT00568854|4102564|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278638|NCT00568854|4102562|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278639|NCT00568854|4102563|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278640|NCT00568854|4102564|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278641|NCT00568854|4102562|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4278642|NCT00568854|4102563|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4278643|NCT00568854|4102564|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4278644|NCT00568854|4102562|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4278645|NCT00568854|4102563|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278646|NCT00568854|4102564|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4278647|NCT00568854|4102562|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278648|NCT00568854|4102563|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278649|NCT00568854|4102564|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278650|NCT00568854|4102562|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4278651|NCT00568854|4102563|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4278652|NCT00568854|4102564|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278653|NCT00568854|4102562|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278654|NCT00568854|4102563|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278655|NCT00568854|4102564|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278656|NCT00568854|4102562|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4278657|NCT00568854|4102563|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4278658|NCT00568854|4102564|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4278659|NCT00568854|4102562|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4278660|NCT00568854|4102563|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4278661|NCT00568854|4102564|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4278662|NCT00568854|4102562|B3|||Age||years|Median|54.5|54.5|Full Range|||32.0|65.0|
4278663|NCT00568854|4102563|B2|||Age||years|Median|41.5|41.5|Full Range|||32.0|46.0|
4278664|NCT00568854|4102564|B1|||Age||years|Median|59.5|59.5|Full Range|||54.0|65.0|
4278665|NCT00568776|4102573|B5|Canada||Region of Enrollment||patients|Number|62|62.0||||||
4278666|NCT00568776|4102574|B4|Canada||Region of Enrollment||patients|Number|16|16.0||||||
4278667|NCT00568776|4102575|B3|Canada||Region of Enrollment||patients|Number|18|18.0||||||
4278668|NCT00568776|4102576|B2|Canada||Region of Enrollment||patients|Number|13|13.0||||||
4278669|NCT00568776|4102577|B1|Canada||Region of Enrollment||patients|Number|15|15.0||||||
4278670|NCT00568776|4102573|B5|United States||Region of Enrollment||patients|Number|289|289.0||||||
4278671|NCT00568776|4102574|B4|United States||Region of Enrollment||patients|Number|75|75.0||||||
4278672|NCT00568776|4102575|B3|United States||Region of Enrollment||patients|Number|71|71.0||||||
4278673|NCT00568776|4102576|B2|United States||Region of Enrollment||patients|Number|75|75.0||||||
4278674|NCT00568776|4102577|B1|United States||Region of Enrollment||patients|Number|68|68.0||||||
4278675|NCT00568776|4102573|B5||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4278676|NCT00568776|4102574|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4278677|NCT00568776|4102575|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4278678|NCT00568776|4102576|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4278679|NCT00568776|4102577|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4278680|NCT00568776|4102573|B5||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4278681|NCT00568776|4102574|B4||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4278682|NCT00568776|4102575|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4278683|NCT00568776|4102576|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4278684|NCT00568776|4102577|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4278685|NCT00568776|4102573|B5|||Age||years|Mean|73.1|73.1|Standard Deviation|7.7|7.7|||
4278686|NCT00568776|4102574|B4|||Age||years|Mean|72.2|72.2|Standard Deviation|8.20|8.2|||
4278687|NCT00568776|4102575|B3|||Age||years|Mean|73.4|73.4|Standard Deviation|7.56|7.56|||
4278688|NCT00568776|4102576|B2|||Age||years|Mean|73.4|73.4|Standard Deviation|7.26|7.26|||
4278689|NCT00568776|4102577|B1|||Age||years|Mean|73.4|73.4|Standard Deviation|7.83|7.83|||
4278690|NCT00568685|4102614|B4|||Weight||kilograms|Mean|35.56|35.56|Standard Deviation|11.455|11.455|||
4278691|NCT00568685|4102615|B3|||Weight||kilograms|Mean|35.48|35.48|Standard Deviation|11.536|11.536|||
4278692|NCT00568685|4102616|B2|||Weight||kilograms|Mean|35.54|35.54|Standard Deviation|10.647|10.647|||
4278693|NCT00568685|4102617|B1|||Weight||kilograms|Mean|35.67|35.67|Standard Deviation|12.348|12.348|||
4278694|NCT00568685|4102614|B4|||Clinical Global Impressions-Attention-Deficit/Hyperactivity Disorder Severity Scale (CGI-ADHD-S)|Clinical Global Impressions-Attention-Deficit/Hyperactivity Disorder Severity Scale (CGI-ADHD-S) rates severity using a 7-point scale (1=normal, not at all ill; 7=among the most extremely ill subjects). A higher score indicates greater severity of ADHD symptoms.|units on a scale|Mean|5.27|5.27|Standard Deviation|0.728|0.728|||
4278695|NCT00568685|4102615|B3|||Clinical Global Impressions-Attention-Deficit/Hyperactivity Disorder Severity Scale (CGI-ADHD-S)|Clinical Global Impressions-Attention-Deficit/Hyperactivity Disorder Severity Scale (CGI-ADHD-S) rates severity using a 7-point scale (1=normal, not at all ill; 7=among the most extremely ill subjects). A higher score indicates greater severity of ADHD symptoms.|units on a scale|Mean|5.16|5.16|Standard Deviation|0.703|0.703|||
4278696|NCT00568685|4102616|B2|||Clinical Global Impressions-Attention-Deficit/Hyperactivity Disorder Severity Scale (CGI-ADHD-S)|Clinical Global Impressions-Attention-Deficit/Hyperactivity Disorder Severity Scale (CGI-ADHD-S) rates severity using a 7-point scale (1=normal, not at all ill; 7=among the most extremely ill subjects). A higher score indicates greater severity of ADHD symptoms.|units on a scale|Mean|5.31|5.31|Standard Deviation|0.787|0.787|||
4278697|NCT00568685|4102617|B1|||Clinical Global Impressions-Attention-Deficit/Hyperactivity Disorder Severity Scale (CGI-ADHD-S)|Clinical Global Impressions-Attention-Deficit/Hyperactivity Disorder Severity Scale (CGI-ADHD-S) rates severity using a 7-point scale (1=normal, not at all ill; 7=among the most extremely ill subjects). A higher score indicates greater severity of ADHD symptoms.|units on a scale|Mean|5.35|5.35|Standard Deviation|0.688|0.688|||
4278698|NCT00568685|4102614|B4|||ADHRS-IV-Parent: Inv. Total Scores|Attention-Deficit/Hyperactivity Disorder Rating Scale-IV-Parent Version:Investigator-Administered and Scored (ADHDRS-IV-Parent:Inv) is an 18-item scale with one item for each of 18 symptoms contained in the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) diagnosis for ADHD. Total Score consists of all 18 items. Each item is scored on a 4 point scale (0=never or rarely; 1=sometimes; 2=often; 3=very often) for total score range of 0 (no symptoms) to 54 (highly symptomatic).|units on a scale|Mean|37.63|37.63|Standard Deviation|7.489|7.489|||
4278699|NCT00568685|4102615|B3|||ADHRS-IV-Parent: Inv. Total Scores|Attention-Deficit/Hyperactivity Disorder Rating Scale-IV-Parent Version:Investigator-Administered and Scored (ADHDRS-IV-Parent:Inv) is an 18-item scale with one item for each of 18 symptoms contained in the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) diagnosis for ADHD. Total Score consists of all 18 items. Each item is scored on a 4 point scale (0=never or rarely; 1=sometimes; 2=often; 3=very often) for total score range of 0 (no symptoms) to 54 (highly symptomatic).|units on a scale|Mean|36.16|36.16|Standard Deviation|7.341|7.341|||
4278700|NCT00568685|4102616|B2|||ADHRS-IV-Parent: Inv. Total Scores|Attention-Deficit/Hyperactivity Disorder Rating Scale-IV-Parent Version:Investigator-Administered and Scored (ADHDRS-IV-Parent:Inv) is an 18-item scale with one item for each of 18 symptoms contained in the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) diagnosis for ADHD. Total Score consists of all 18 items. Each item is scored on a 4 point scale (0=never or rarely; 1=sometimes; 2=often; 3=very often) for total score range of 0 (no symptoms) to 54 (highly symptomatic).|units on a scale|Mean|37.67|37.67|Standard Deviation|7.064|7.064|||
4278701|NCT00568685|4102617|B1|||ADHRS-IV-Parent: Inv. Total Scores|Attention-Deficit/Hyperactivity Disorder Rating Scale-IV-Parent Version:Investigator-Administered and Scored (ADHDRS-IV-Parent:Inv) is an 18-item scale with one item for each of 18 symptoms contained in the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) diagnosis for ADHD. Total Score consists of all 18 items. Each item is scored on a 4 point scale (0=never or rarely; 1=sometimes; 2=often; 3=very often) for total score range of 0 (no symptoms) to 54 (highly symptomatic).|units on a scale|Mean|39.08|39.08|Standard Deviation|7.896|7.896|||
4278702|NCT00568685|4102614|B4|||ADHRS-IV-Parent: Inv. Inattention Subscale Score|Attention-Deficit/Hyperactivity Disorder Rating Scale-IV-Parent Version:Investigator-Administered and Scored (ADHDRS-IV-Parent:Inv) is an 18-item scale with one item for each of 18 symptoms contained in the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) diagnosis for ADHD. Inattention Subscale consists of 9 items. Each item is scored on a 4 point scale (0=never or rarely; 1=sometimes; 2=often; 3=very often) for total score range of 0 (no symptoms) to 27 (highly symptomatic).|units on a scale|Mean|20.94|20.94|Standard Deviation|3.499|3.499|||
4278732|NCT00568685|4102616|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4278733|NCT00568685|4102617|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4278734|NCT00568685|4102614|B4|||Age||years|Median|9.41|9.41|Inter-Quartile Range|2.382|2.382|7.87|11.22|
4278703|NCT00568685|4102615|B3|||ADHRS-IV-Parent: Inv. Inattention Subscale Score|Attention-Deficit/Hyperactivity Disorder Rating Scale-IV-Parent Version:Investigator-Administered and Scored (ADHDRS-IV-Parent:Inv) is an 18-item scale with one item for each of 18 symptoms contained in the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) diagnosis for ADHD. Inattention Subscale consists of 9 items. Each item is scored on a 4 point scale (0=never or rarely; 1=sometimes; 2=often; 3=very often) for total score range of 0 (no symptoms) to 27 (highly symptomatic).|units on a scale|Mean|20.20|20.2|Standard Deviation|3.476|3.476|||
4278704|NCT00568685|4102616|B2|||ADHRS-IV-Parent: Inv. Inattention Subscale Score|Attention-Deficit/Hyperactivity Disorder Rating Scale-IV-Parent Version:Investigator-Administered and Scored (ADHDRS-IV-Parent:Inv) is an 18-item scale with one item for each of 18 symptoms contained in the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) diagnosis for ADHD. Inattention Subscale consists of 9 items. Each item is scored on a 4 point scale (0=never or rarely; 1=sometimes; 2=often; 3=very often) for total score range of 0 (no symptoms) to 27 (highly symptomatic).|units on a scale|Mean|21.06|21.06|Standard Deviation|3.630|3.63|||
4278705|NCT00568685|4102617|B1|||ADHRS-IV-Parent: Inv. Inattention Subscale Score|Attention-Deficit/Hyperactivity Disorder Rating Scale-IV-Parent Version:Investigator-Administered and Scored (ADHDRS-IV-Parent:Inv) is an 18-item scale with one item for each of 18 symptoms contained in the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) diagnosis for ADHD. Inattention Subscale consists of 9 items. Each item is scored on a 4 point scale (0=never or rarely; 1=sometimes; 2=often; 3=very often) for total score range of 0 (no symptoms) to 27 (highly symptomatic).|units on a scale|Mean|21.57|21.57|Standard Deviation|3.312|3.312|||
4278706|NCT00568685|4102614|B4|||ADHD Rating Scale-IV-Parent:Investigator Rated Hyperactivity Subscale Score|Attention-Deficit/Hyperactivity Disorder Rating Scale-IV-Parent Version:Investigator-Administered and Scored (ADHDRS-IV-Parent:Inv) is an 18-item scale with one item for each of 18 symptoms contained in the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) diagnosis for ADHD. Hyperactive/Impulsive Subscale consists of 9 items. Each item is scored on a 4 point scale (0=never or rarely; 1=sometimes; 2=often; 3=very often) for total score range of 0 (no symptoms) to 27 (highly symptomatic).|units on a scale|Mean|16.69|16.69|Standard Deviation|5.504|5.504|||
4278707|NCT00568685|4102615|B3|||ADHD Rating Scale-IV-Parent:Investigator Rated Hyperactivity Subscale Score|Attention-Deficit/Hyperactivity Disorder Rating Scale-IV-Parent Version:Investigator-Administered and Scored (ADHDRS-IV-Parent:Inv) is an 18-item scale with one item for each of 18 symptoms contained in the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) diagnosis for ADHD. Hyperactive/Impulsive Subscale consists of 9 items. Each item is scored on a 4 point scale (0=never or rarely; 1=sometimes; 2=often; 3=very often) for total score range of 0 (no symptoms) to 27 (highly symptomatic).|units on a scale|Mean|15.96|15.96|Standard Deviation|5.553|5.553|||
4278708|NCT00568685|4102616|B2|||ADHD Rating Scale-IV-Parent:Investigator Rated Hyperactivity Subscale Score|Attention-Deficit/Hyperactivity Disorder Rating Scale-IV-Parent Version:Investigator-Administered and Scored (ADHDRS-IV-Parent:Inv) is an 18-item scale with one item for each of 18 symptoms contained in the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) diagnosis for ADHD. Hyperactive/Impulsive Subscale consists of 9 items. Each item is scored on a 4 point scale (0=never or rarely; 1=sometimes; 2=often; 3=very often) for total score range of 0 (no symptoms) to 27 (highly symptomatic).|units on a scale|Mean|16.61|16.61|Standard Deviation|5.107|5.107|||
4278709|NCT00568685|4102617|B1|||ADHD Rating Scale-IV-Parent:Investigator Rated Hyperactivity Subscale Score|Attention-Deficit/Hyperactivity Disorder Rating Scale-IV-Parent Version:Investigator-Administered and Scored (ADHDRS-IV-Parent:Inv) is an 18-item scale with one item for each of 18 symptoms contained in the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) diagnosis for ADHD. Hyperactive/Impulsive Subscale consists of 9 items. Each item is scored on a 4 point scale (0=never or rarely; 1=sometimes; 2=often; 3=very often) for total score range of 0 (no symptoms) to 27 (highly symptomatic).|units on a scale|Mean|17.51|17.51|Standard Deviation|5.825|5.825|||
4278710|NCT00568685|4102614|B4|Korean||Race/Ethnicity||participants|Number|153|153.0||||||
4278711|NCT00568685|4102615|B3|Korean||Race/Ethnicity||participants|Number|51|51.0||||||
4278712|NCT00568685|4102616|B2|Korean||Race/Ethnicity||participants|Number|51|51.0||||||
4278713|NCT00568685|4102617|B1|Korean||Race/Ethnicity||participants|Number|51|51.0||||||
4278714|NCT00568685|4102614|B4|13-18 years||Age-Categorical|Pediatric participant age categories|participants|Number|27|27.0||||||
4278715|NCT00568685|4102615|B3|13-18 years||Age-Categorical|Pediatric participant age categories|participants|Number|7|7.0||||||
4278716|NCT00568685|4102616|B2|13-18 years||Age-Categorical|Pediatric participant age categories|participants|Number|7|7.0||||||
4278717|NCT00568685|4102617|B1|13-18 years||Age-Categorical|Pediatric participant age categories|participants|Number|13|13.0||||||
4278718|NCT00568685|4102614|B4|6-12 years||Age-Categorical|Pediatric participant age categories|participants|Number|126|126.0||||||
4278719|NCT00568685|4102615|B3|6-12 years||Age-Categorical|Pediatric participant age categories|participants|Number|44|44.0||||||
4278720|NCT00568685|4102616|B2|6-12 years||Age-Categorical|Pediatric participant age categories|participants|Number|44|44.0||||||
4278721|NCT00568685|4102617|B1|6-12 years||Age-Categorical|Pediatric participant age categories|participants|Number|38|38.0||||||
4278722|NCT00568685|4102614|B4|Korea, Republic of||Region of Enrollment||participants|Number|153|153.0||||||
4278723|NCT00568685|4102615|B3|Korea, Republic of||Region of Enrollment||participants|Number|51|51.0||||||
4278724|NCT00568685|4102616|B2|Korea, Republic of||Region of Enrollment||participants|Number|51|51.0||||||
4278725|NCT00568685|4102617|B1|Korea, Republic of||Region of Enrollment||participants|Number|51|51.0||||||
4278726|NCT00568685|4102614|B4||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4278727|NCT00568685|4102615|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4278728|NCT00568685|4102616|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4278729|NCT00568685|4102617|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4278730|NCT00568685|4102614|B4||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4278731|NCT00568685|4102615|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4278735|NCT00568685|4102615|B3|||Age||years|Median|9.29|9.29|Inter-Quartile Range|2.187|2.187|8.02|11.06|
4278736|NCT00568685|4102616|B2|||Age||years|Median|10.06|10.06|Inter-Quartile Range|2.178|2.178|8.11|11.17|
4278737|NCT00568685|4102617|B1|||Age||years|Median|8.87|8.87|Inter-Quartile Range|2.774|2.774|7.63|12.09|
4278738|NCT00568555|4102651|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
4278739|NCT00568555|4102652|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4278740|NCT00568555|4102653|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4278741|NCT00568555|4102651|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4278742|NCT00568555|4102652|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4278743|NCT00568555|4102653|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4278744|NCT00568555|4102651|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4278745|NCT00568555|4102652|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4278746|NCT00568555|4102653|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4278747|NCT00568555|4102651|B3|||Age||years|Mean|42.7|42.7|Standard Deviation|12.9|12.9|||
4278748|NCT00568555|4102652|B2|||Age||years|Mean|42.3|42.3|Standard Deviation|13.0|13.0|||
4278749|NCT00568555|4102653|B1|||Age||years|Mean|43.8|43.8|Standard Deviation|13.4|13.4|||
4278750|NCT00568555|4102651|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4278751|NCT00568555|4102652|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4278752|NCT00568555|4102653|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4278753|NCT00568555|4102651|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4278754|NCT00568555|4102652|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4278755|NCT00568555|4102653|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4278756|NCT00568555|4102651|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4278757|NCT00568555|4102652|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4278758|NCT00568555|4102653|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4278759|NCT00568451|4102668|B5|||Number of Metastatic Sites||Sites|Median|2|2.0|Full Range|||1.0|5.0|
4278760|NCT00568451|4102669|B4|||Number of Metastatic Sites||Sites|Median|2|2.0|Full Range|||1.0|5.0|
4278761|NCT00568451|4102670|B3|||Number of Metastatic Sites||Sites|Median|2|2.0|Full Range|||2.0|2.0|
4278762|NCT00568451|4102668|B5|M1c (other visceral sites)||M Stage|M stage is based on whether the melanoma has metastasized (spread) to distant organs, which organs it has reached, and on blood levels of a substance called LDH.|participants|Number|6|6.0||||||
4278763|NCT00568451|4102669|B4|M1c (other visceral sites)||M Stage|M stage is based on whether the melanoma has metastasized (spread) to distant organs, which organs it has reached, and on blood levels of a substance called LDH.|participants|Number|5|5.0||||||
4278764|NCT00568451|4102670|B3|M1c (other visceral sites)||M Stage|M stage is based on whether the melanoma has metastasized (spread) to distant organs, which organs it has reached, and on blood levels of a substance called LDH.|participants|Number|1|1.0||||||
4278765|NCT00568451|4102668|B5|M1b (lung)||M Stage|M stage is based on whether the melanoma has metastasized (spread) to distant organs, which organs it has reached, and on blood levels of a substance called LDH.|participants|Number|4|4.0||||||
4278766|NCT00568451|4102669|B4|M1b (lung)||M Stage|M stage is based on whether the melanoma has metastasized (spread) to distant organs, which organs it has reached, and on blood levels of a substance called LDH.|participants|Number|3|3.0||||||
4278767|NCT00568451|4102670|B3|M1b (lung)||M Stage|M stage is based on whether the melanoma has metastasized (spread) to distant organs, which organs it has reached, and on blood levels of a substance called LDH.|participants|Number|1|1.0||||||
4278768|NCT00568451|4102668|B5|M1a (skin/subcutaneous tissue/lymph node only)||M Stage|M stage is based on whether the melanoma has metastasized (spread) to distant organs, which organs it has reached, and on blood levels of a substance called LDH.|participants|Number|1|1.0||||||
4278769|NCT00568451|4102669|B4|M1a (skin/subcutaneous tissue/lymph node only)||M Stage|M stage is based on whether the melanoma has metastasized (spread) to distant organs, which organs it has reached, and on blood levels of a substance called LDH.|participants|Number|1|1.0||||||
4278770|NCT00568451|4102670|B3|M1a (skin/subcutaneous tissue/lymph node only)||M Stage|M stage is based on whether the melanoma has metastasized (spread) to distant organs, which organs it has reached, and on blood levels of a substance called LDH.|participants|Number|0|0.0||||||
4278771|NCT00568451|4102668|B5|United States||Region of Enrollment||participants|Number|11|11.0||||||
4278772|NCT00568451|4102669|B4|United States||Region of Enrollment||participants|Number|9|9.0||||||
4278773|NCT00568451|4102670|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4278774|NCT00568451|4102668|B5|Male||Gender||participants|Number|8|8.0||||||
4278775|NCT00568451|4102669|B4|Male||Gender||participants|Number|6|6.0||||||
4278776|NCT00568451|4102670|B3|Male||Gender||participants|Number|2|2.0||||||
4278777|NCT00568451|4102668|B5|Female||Gender||participants|Number|3|3.0||||||
4278778|NCT00568451|4102669|B4|Female||Gender||participants|Number|3|3.0||||||
4278779|NCT00568451|4102670|B3|Female||Gender||participants|Number|0|0.0||||||
4278780|NCT00568451|4102668|B5|||Age||years|Mean|62.4|62.4|Standard Deviation|12.97|12.97|||
4278781|NCT00568451|4102669|B4|||Age||years|Mean|63.3|63.3|Standard Deviation|14.05|14.05|||
4278782|NCT00568451|4102670|B3|||Age||years|Mean|61.5|61.5|Standard Deviation|14.85|14.85|||
4278783|NCT00568399|4102691|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4278784|NCT00568399|4102691|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4278785|NCT00568399|4102691|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4278786|NCT00568399|4102691|B1|||Age||years|Mean|59|59.0|Standard Deviation|10|10.0|||
4278787|NCT00568399|4102691|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4278788|NCT00568399|4102691|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4278789|NCT00568399|4102691|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4278790|NCT00568386|4102695|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4278791|NCT00568386|4102696|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4278792|NCT00568386|4102697|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4278793|NCT00568386|4102695|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4278794|NCT00568386|4102696|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4278795|NCT00568386|4102697|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4278796|NCT00568386|4102695|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4278797|NCT00568386|4102696|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4278798|NCT00568386|4102697|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4278799|NCT00568386|4102695|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4278800|NCT00568386|4102696|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4278801|NCT00568386|4102697|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4278802|NCT00568386|4102695|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4278803|NCT00568386|4102696|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4278804|NCT00568386|4102697|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4278805|NCT00568386|4102695|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4278806|NCT00568386|4102696|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4278807|NCT00568386|4102697|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4278808|NCT00568334|4102704|B3|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|244|244.0||||||
4278809|NCT00568334|4102705|B2|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|122|122.0||||||
4278810|NCT00568334|4102706|B1|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|122|122.0||||||
4278811|NCT00568334|4102704|B3||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4278812|NCT00568334|4102705|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4278813|NCT00568334|4102706|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4278814|NCT00568334|4102704|B3||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4278815|NCT00568334|4102705|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4278816|NCT00568334|4102706|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4278817|NCT00568334|4102704|B3|||Age||Months|Mean|15.20|15.2|Standard Deviation|3.23|3.23|||
4278818|NCT00568334|4102705|B2|||Age||Months|Mean|14.8|14.8|Standard Deviation|3.08|3.08|||
4278819|NCT00568334|4102706|B1|||Age||Months|Mean|15.6|15.6|Standard Deviation|3.34|3.34|||
4278820|NCT00568178|4102731|B3|||Weight||Kilograms (kg)|Mean|38.0|38.0|Standard Deviation|20.3|20.3|||
4278821|NCT00568178|4102732|B2|||Weight||Kilograms (kg)|Mean|36.4|36.4|Standard Deviation|19.5|19.5|||
4278822|NCT00568178|4102733|B1|||Weight||Kilograms (kg)|Mean|39.6|39.6|Standard Deviation|21.0|21.0|||
4278823|NCT00568178|4102731|B3|||Sitting Systolic Blood Pressure||mm Hg|Mean|106.6|106.6|Standard Deviation|13.6|13.6|||
4278824|NCT00568178|4102732|B2|||Sitting Systolic Blood Pressure||mm Hg|Mean|107.2|107.2|Standard Deviation|13.8|13.8|||
4278825|NCT00568178|4102733|B1|||Sitting Systolic Blood Pressure||mm Hg|Mean|106.0|106.0|Standard Deviation|13.4|13.4|||
4278826|NCT00568178|4102731|B3|||Sitting Diastolic Blood Pressure||millimeters of mercury (mm Hg)|Mean|67.3|67.3|Standard Deviation|11.2|11.2|||
4278827|NCT00568178|4102732|B2|||Sitting Diastolic Blood Pressure||millimeters of mercury (mm Hg)|Mean|67.8|67.8|Standard Deviation|11.6|11.6|||
4278828|NCT00568178|4102733|B1|||Sitting Diastolic Blood Pressure||millimeters of mercury (mm Hg)|Mean|66.8|66.8|Standard Deviation|10.7|10.7|||
4278829|NCT00568178|4102731|B3|||Protein-to-Creatinine Ratio||grams/grams|Mean|2.5|2.5|Standard Deviation|3.3|3.3|||
4278830|NCT00568178|4102732|B2|||Protein-to-Creatinine Ratio||grams/grams|Mean|2.8|2.8|Standard Deviation|3.8|3.8|||
4278831|NCT00568178|4102733|B1|||Protein-to-Creatinine Ratio||grams/grams|Mean|2.2|2.2|Standard Deviation|2.6|2.6|||
4278832|NCT00568178|4102731|B3|||Height||Centimeters (cm)|Mean|133.9|133.9|Standard Deviation|27.9|27.9|||
4278833|NCT00568178|4102732|B2|||Height||Centimeters (cm)|Mean|132.0|132.0|Standard Deviation|28.4|28.4|||
4278834|NCT00568178|4102733|B1|||Height||Centimeters (cm)|Mean|135.8|135.8|Standard Deviation|27.3|27.3|||
4278835|NCT00568178|4102731|B3|||Duration of Hypertension||Years|Mean|5.5|5.5|Standard Deviation|4.5|4.5|||
4278836|NCT00568178|4102732|B2|||Duration of Hypertension||Years|Mean|6.1|6.1|Standard Deviation|4.8|4.8|||
4278837|NCT00568178|4102733|B1|||Duration of Hypertension||Years|Mean|4.8|4.8|Standard Deviation|4.1|4.1|||
4278838|NCT00568178|4102731|B3|||Body Mass Index (BMI)||kilograms per meter squared (kg/m2)|Mean|19.5|19.5|Standard Deviation|4.9|4.9|||
4278839|NCT00568178|4102732|B2|||Body Mass Index (BMI)||kilograms per meter squared (kg/m2)|Mean|19.2|19.2|Standard Deviation|4.2|4.2|||
4278840|NCT00568178|4102733|B1|||Body Mass Index (BMI)||kilograms per meter squared (kg/m2)|Mean|19.8|19.8|Standard Deviation|5.5|5.5|||
4278841|NCT00568178|4102731|B3|Stage V||Tanner Stage|"A scale of physical development.~The scale defines physical measurements of development based on external primary and secondary sex characteristics, such as the size of the breasts, genitalia, and development of pubic hair.~Stages range from I to V with I being the least developed."|Participants|Number|25|25.0||||||
4278842|NCT00568178|4102732|B2|Stage V||Tanner Stage|"A scale of physical development.~The scale defines physical measurements of development based on external primary and secondary sex characteristics, such as the size of the breasts, genitalia, and development of pubic hair.~Stages range from I to V with I being the least developed."|Participants|Number|13|13.0||||||
4278843|NCT00568178|4102733|B1|Stage V||Tanner Stage|"A scale of physical development.~The scale defines physical measurements of development based on external primary and secondary sex characteristics, such as the size of the breasts, genitalia, and development of pubic hair.~Stages range from I to V with I being the least developed."|Participants|Number|12|12.0||||||
4278844|NCT00568178|4102731|B3|Stage IV||Tanner Stage|"A scale of physical development.~The scale defines physical measurements of development based on external primary and secondary sex characteristics, such as the size of the breasts, genitalia, and development of pubic hair.~Stages range from I to V with I being the least developed."|Participants|Number|47|47.0||||||
4278845|NCT00568178|4102732|B2|Stage IV||Tanner Stage|"A scale of physical development.~The scale defines physical measurements of development based on external primary and secondary sex characteristics, such as the size of the breasts, genitalia, and development of pubic hair.~Stages range from I to V with I being the least developed."|Participants|Number|24|24.0||||||
4278846|NCT00568178|4102733|B1|Stage IV||Tanner Stage|"A scale of physical development.~The scale defines physical measurements of development based on external primary and secondary sex characteristics, such as the size of the breasts, genitalia, and development of pubic hair.~Stages range from I to V with I being the least developed."|Participants|Number|23|23.0||||||
4278847|NCT00568178|4102731|B3|Stage III||Tanner Stage|"A scale of physical development.~The scale defines physical measurements of development based on external primary and secondary sex characteristics, such as the size of the breasts, genitalia, and development of pubic hair.~Stages range from I to V with I being the least developed."|Participants|Number|40|40.0||||||
4278848|NCT00568178|4102732|B2|Stage III||Tanner Stage|"A scale of physical development.~The scale defines physical measurements of development based on external primary and secondary sex characteristics, such as the size of the breasts, genitalia, and development of pubic hair.~Stages range from I to V with I being the least developed."|Participants|Number|18|18.0||||||
4278849|NCT00568178|4102733|B1|Stage III||Tanner Stage|"A scale of physical development.~The scale defines physical measurements of development based on external primary and secondary sex characteristics, such as the size of the breasts, genitalia, and development of pubic hair.~Stages range from I to V with I being the least developed."|Participants|Number|22|22.0||||||
4278850|NCT00568178|4102731|B3|Stage II||Tanner Stage|"A scale of physical development.~The scale defines physical measurements of development based on external primary and secondary sex characteristics, such as the size of the breasts, genitalia, and development of pubic hair.~Stages range from I to V with I being the least developed."|Participants|Number|47|47.0||||||
4278851|NCT00568178|4102732|B2|Stage II||Tanner Stage|"A scale of physical development.~The scale defines physical measurements of development based on external primary and secondary sex characteristics, such as the size of the breasts, genitalia, and development of pubic hair.~Stages range from I to V with I being the least developed."|Participants|Number|21|21.0||||||
4278852|NCT00568178|4102733|B1|Stage II||Tanner Stage|"A scale of physical development.~The scale defines physical measurements of development based on external primary and secondary sex characteristics, such as the size of the breasts, genitalia, and development of pubic hair.~Stages range from I to V with I being the least developed."|Participants|Number|26|26.0||||||
4278853|NCT00568178|4102731|B3|Stage I||Tanner Stage|"A scale of physical development.~The scale defines physical measurements of development based on external primary and secondary sex characteristics, such as the size of the breasts, genitalia, and development of pubic hair.~Stages range from I to V with I being the least developed."|Participants|Number|147|147.0||||||
4278854|NCT00568178|4102732|B2|Stage I||Tanner Stage|"A scale of physical development.~The scale defines physical measurements of development based on external primary and secondary sex characteristics, such as the size of the breasts, genitalia, and development of pubic hair.~Stages range from I to V with I being the least developed."|Participants|Number|78|78.0||||||
4278855|NCT00568178|4102733|B1|Stage I||Tanner Stage|"A scale of physical development.~The scale defines physical measurements of development based on external primary and secondary sex characteristics, such as the size of the breasts, genitalia, and development of pubic hair.~Stages range from I to V with I being the least developed."|Participants|Number|69|69.0||||||
4278856|NCT00568178|4102731|B3|Outside of United States||Region||Participants|Number|281|281.0||||||
4278857|NCT00568178|4102732|B2|Outside of United States||Region||Participants|Number|144|144.0||||||
4278858|NCT00568178|4102733|B1|Outside of United States||Region||Participants|Number|137|137.0||||||
4278859|NCT00568178|4102731|B3|United States||Region||Participants|Number|25|25.0||||||
4278860|NCT00568178|4102732|B2|United States||Region||Participants|Number|10|10.0||||||
4278861|NCT00568178|4102733|B1|United States||Region||Participants|Number|15|15.0||||||
4278862|NCT00568178|4102731|B3|Other||Race||participants|Number|12|12.0||||||
4278863|NCT00568178|4102732|B2|Other||Race||participants|Number|4|4.0||||||
4278864|NCT00568178|4102733|B1|Other||Race||participants|Number|8|8.0||||||
4278865|NCT00568178|4102731|B3|White||Race||participants|Number|162|162.0||||||
4278866|NCT00568178|4102732|B2|White||Race||participants|Number|85|85.0||||||
4278867|NCT00568178|4102733|B1|White||Race||participants|Number|77|77.0||||||
4278868|NCT00568178|4102731|B3|Multi-Racial||Race||participants|Number|70|70.0||||||
4278869|NCT00568178|4102732|B2|Multi-Racial||Race||participants|Number|34|34.0||||||
4278870|NCT00568178|4102733|B1|Multi-Racial||Race||participants|Number|36|36.0||||||
4278871|NCT00568178|4102731|B3|Black||Race||participants|Number|10|10.0||||||
4278872|NCT00568178|4102732|B2|Black||Race||participants|Number|5|5.0||||||
4278873|NCT00568178|4102733|B1|Black||Race||participants|Number|5|5.0||||||
4278874|NCT00568178|4102731|B3|Asian||Race||participants|Number|52|52.0||||||
4278875|NCT00568178|4102732|B2|Asian||Race||participants|Number|26|26.0||||||
4278876|NCT00568178|4102733|B1|Asian||Race||participants|Number|26|26.0||||||
4278919|NCT00568087|4102754|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4278877|NCT00568178|4102731|B3|No||Prior Angiotensin Converting Enzyme Inhibitor /Angiotensin II Type I Receptor Blocker (ACE-I/ARB)Use||Participants|Number|142|142.0||||||
4278878|NCT00568178|4102732|B2|No||Prior Angiotensin Converting Enzyme Inhibitor /Angiotensin II Type I Receptor Blocker (ACE-I/ARB)Use||Participants|Number|73|73.0||||||
4278879|NCT00568178|4102733|B1|No||Prior Angiotensin Converting Enzyme Inhibitor /Angiotensin II Type I Receptor Blocker (ACE-I/ARB)Use||Participants|Number|69|69.0||||||
4278880|NCT00568178|4102731|B3|Yes||Prior Angiotensin Converting Enzyme Inhibitor /Angiotensin II Type I Receptor Blocker (ACE-I/ARB)Use||Participants|Number|164|164.0||||||
4278881|NCT00568178|4102732|B2|Yes||Prior Angiotensin Converting Enzyme Inhibitor /Angiotensin II Type I Receptor Blocker (ACE-I/ARB)Use||Participants|Number|81|81.0||||||
4278882|NCT00568178|4102733|B1|Yes||Prior Angiotensin Converting Enzyme Inhibitor /Angiotensin II Type I Receptor Blocker (ACE-I/ARB)Use||Participants|Number|83|83.0||||||
4278883|NCT00568178|4102731|B3|No||Hypertensive|Sitting systolic blood pressure (SiSBP) or diastolic blood pressure (SiDBP) ≥90th percentile AND participant on medication for proteinuria/hypertension OR SiSBP or SiDBP ≥95th percentile AND participant NOT on medication for proteinuria/hypertension OR documented hypertension and on anti-hypertensive medication, whether or not medicated for proteinuria.|Participants|Number|246|246.0||||||
4278884|NCT00568178|4102732|B2|No||Hypertensive|Sitting systolic blood pressure (SiSBP) or diastolic blood pressure (SiDBP) ≥90th percentile AND participant on medication for proteinuria/hypertension OR SiSBP or SiDBP ≥95th percentile AND participant NOT on medication for proteinuria/hypertension OR documented hypertension and on anti-hypertensive medication, whether or not medicated for proteinuria.|Participants|Number|124|124.0||||||
4278885|NCT00568178|4102733|B1|No||Hypertensive|Sitting systolic blood pressure (SiSBP) or diastolic blood pressure (SiDBP) ≥90th percentile AND participant on medication for proteinuria/hypertension OR SiSBP or SiDBP ≥95th percentile AND participant NOT on medication for proteinuria/hypertension OR documented hypertension and on anti-hypertensive medication, whether or not medicated for proteinuria.|Participants|Number|122|122.0||||||
4278886|NCT00568178|4102731|B3|Yes||Hypertensive|Sitting systolic blood pressure (SiSBP) or diastolic blood pressure (SiDBP) ≥90th percentile AND participant on medication for proteinuria/hypertension OR SiSBP or SiDBP ≥95th percentile AND participant NOT on medication for proteinuria/hypertension OR documented hypertension and on anti-hypertensive medication, whether or not medicated for proteinuria.|Participants|Number|60|60.0||||||
4278887|NCT00568178|4102732|B2|Yes||Hypertensive|Sitting systolic blood pressure (SiSBP) or diastolic blood pressure (SiDBP) ≥90th percentile AND participant on medication for proteinuria/hypertension OR SiSBP or SiDBP ≥95th percentile AND participant NOT on medication for proteinuria/hypertension OR documented hypertension and on anti-hypertensive medication, whether or not medicated for proteinuria.|Participants|Number|30|30.0||||||
4278888|NCT00568178|4102733|B1|Yes||Hypertensive|Sitting systolic blood pressure (SiSBP) or diastolic blood pressure (SiDBP) ≥90th percentile AND participant on medication for proteinuria/hypertension OR SiSBP or SiDBP ≥95th percentile AND participant NOT on medication for proteinuria/hypertension OR documented hypertension and on anti-hypertensive medication, whether or not medicated for proteinuria.|Participants|Number|30|30.0||||||
4278889|NCT00568178|4102731|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278890|NCT00568178|4102732|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278891|NCT00568178|4102733|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4278892|NCT00568178|4102731|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|145|145.0||||||
4278893|NCT00568178|4102732|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4278894|NCT00568178|4102733|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
4278895|NCT00568178|4102731|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|161|161.0||||||
4278896|NCT00568178|4102732|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
4278897|NCT00568178|4102733|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
4278898|NCT00568178|4102731|B3||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4278899|NCT00568178|4102732|B2||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4278900|NCT00568178|4102733|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4278901|NCT00568178|4102731|B3||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4278902|NCT00568178|4102732|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4278903|NCT00568178|4102733|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4278904|NCT00568178|4102731|B3|13-17 Years of Age||Age, Customized||participants|Number|117|117.0||||||
4278905|NCT00568178|4102732|B2|13-17 Years of Age||Age, Customized||participants|Number|55|55.0||||||
4278906|NCT00568178|4102733|B1|13-17 Years of Age||Age, Customized||participants|Number|62|62.0||||||
4278907|NCT00568178|4102731|B3|7-12 Years of Age||Age, Customized||participants|Number|114|114.0||||||
4278908|NCT00568178|4102732|B2|7-12 Years of Age||Age, Customized||participants|Number|57|57.0||||||
4278909|NCT00568178|4102733|B1|7-12 Years of Age||Age, Customized||participants|Number|57|57.0||||||
4278910|NCT00568178|4102731|B3|≤6 Years of Age||Age, Customized||participants|Number|75|75.0||||||
4278911|NCT00568178|4102732|B2|≤6 Years of Age||Age, Customized||participants|Number|42|42.0||||||
4278912|NCT00568178|4102733|B1|≤6 Years of Age||Age, Customized||participants|Number|33|33.0||||||
4278913|NCT00568178|4102731|B3|||Age||years|Mean|10.1|10.1|Standard Deviation|4.7|4.7|||
4278914|NCT00568178|4102732|B2|||Age||years|Mean|9.7|9.7|Standard Deviation|4.6|4.6|||
4278915|NCT00568178|4102733|B1|||Age||years|Mean|10.4|10.4|Standard Deviation|4.7|4.7|||
4278916|NCT00568087|4102754|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
4278917|NCT00568087|4102755|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4278918|NCT00568087|4102756|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4278920|NCT00568087|4102755|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4278921|NCT00568087|4102756|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4278922|NCT00568087|4102754|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4278923|NCT00568087|4102755|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4278924|NCT00568087|4102756|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4278925|NCT00568087|4102754|B3|||Age||years|Mean|53.5|53.5|Standard Deviation|9.8|9.8|||
4278926|NCT00568087|4102755|B2|||Age||years|Mean|56.5|56.5|Standard Deviation|7.0|7.0|||
4278927|NCT00568087|4102756|B1|||Age||years|Mean|50.1|50.1|Standard Deviation|11.3|11.3|||
4278928|NCT00568087|4102754|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4278929|NCT00568087|4102755|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4278930|NCT00568087|4102756|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4278931|NCT00568087|4102754|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4278932|NCT00568087|4102755|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4278933|NCT00568087|4102756|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4278934|NCT00568087|4102754|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4278935|NCT00568087|4102755|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4278936|NCT00568087|4102756|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4278937|NCT00568061|4102767|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
4278938|NCT00568061|4102768|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4278939|NCT00568061|4102769|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4278940|NCT00568061|4102767|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4278941|NCT00568061|4102768|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4278942|NCT00568061|4102769|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4278943|NCT00568061|4102767|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4278944|NCT00568061|4102768|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4278945|NCT00568061|4102769|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4278946|NCT00568061|4102767|B3|||Age||years|Mean|63.1|63.1|Standard Deviation|11.91|11.91|||
4278947|NCT00568061|4102768|B2|||Age||years|Mean|63.8|63.8|Standard Deviation|12.41|12.41|||
4278948|NCT00568061|4102769|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|11.71|11.71|||
4278949|NCT00568061|4102767|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4278950|NCT00568061|4102768|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4278951|NCT00568061|4102769|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4278952|NCT00568061|4102767|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4278953|NCT00568061|4102768|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4278954|NCT00568061|4102769|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4278955|NCT00568061|4102767|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4278956|NCT00568061|4102768|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4278957|NCT00568061|4102769|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4278958|NCT00568022|4102776|B4|Japan||Region of Enrollment||participants|Number|9|9.0||||||
4278959|NCT00568022|4102777|B3|Japan||Region of Enrollment||participants|Number|3|3.0||||||
4278960|NCT00568022|4102778|B2|Japan||Region of Enrollment||participants|Number|3|3.0||||||
4278961|NCT00568022|4102779|B1|Japan||Region of Enrollment||participants|Number|3|3.0||||||
4278962|NCT00568022|4102776|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4278963|NCT00568022|4102777|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4278964|NCT00568022|4102778|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4278965|NCT00568022|4102779|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4278966|NCT00568022|4102776|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4278967|NCT00568022|4102777|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4278968|NCT00568022|4102778|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4278969|NCT00568022|4102779|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4278970|NCT00568022|4102776|B4|||Age||years|Mean|53.1|53.1|Standard Deviation|12.28|12.28|||
4278971|NCT00568022|4102777|B3|||Age||years|Mean|52.7|52.7|Standard Deviation|20.26|20.26|||
4278972|NCT00568022|4102778|B2|||Age||years|Mean|52.7|52.7|Standard Deviation|4.73|4.73|||
4278973|NCT00568022|4102779|B1|||Age||years|Mean|54.0|54.0|Standard Deviation|13.00|13.0|||
4278974|NCT00568022|4102776|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4278975|NCT00568022|4102777|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4278976|NCT00568022|4102778|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4278977|NCT00568022|4102779|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4278978|NCT00568022|4102776|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4278979|NCT00568022|4102777|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4278980|NCT00568022|4102778|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4278981|NCT00568022|4102779|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4278982|NCT00568022|4102776|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4278983|NCT00568022|4102777|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4278984|NCT00568022|4102778|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4278985|NCT00568022|4102779|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4278986|NCT00567996|4102811|B4||Male|Sex: Female, Male||Participants|Count of Participants|745|745.0||||||
4278987|NCT00567996|4102812|B3||Male|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
4278988|NCT00567996|4102813|B2||Male|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
4278989|NCT00567996|4102814|B1||Male|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
4278990|NCT00567996|4102811|B4||Female|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
4278991|NCT00567996|4102812|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4278992|NCT00567996|4102813|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4278993|NCT00567996|4102814|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4278994|NCT00567996|4102811|B4|||Age|All baseline measures are based on the intent-to-treat population that included all randomized participants who received at least one dose of study medication.|years|Mean|63.5|63.5|Standard Deviation|8.81|8.81|||
4278995|NCT00567996|4102812|B3|||Age|All baseline measures are based on the intent-to-treat population that included all randomized participants who received at least one dose of study medication.|years|Mean|63.9|63.9|Standard Deviation|8.56|8.56|||
4278996|NCT00567996|4102813|B2|||Age|All baseline measures are based on the intent-to-treat population that included all randomized participants who received at least one dose of study medication.|years|Mean|63.4|63.4|Standard Deviation|9.19|9.19|||
4278997|NCT00567996|4102814|B1|||Age|All baseline measures are based on the intent-to-treat population that included all randomized participants who received at least one dose of study medication.|years|Mean|63.2|63.2|Standard Deviation|8.67|8.67|||
4278998|NCT00567892|4102830|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
4278999|NCT00567892|4102831|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4279000|NCT00567892|4102832|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4279001|NCT00567892|4102830|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4279002|NCT00567892|4102831|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4279003|NCT00567892|4102832|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4279004|NCT00567892|4102830|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4279005|NCT00567892|4102831|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4279006|NCT00567892|4102832|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4279007|NCT00567892|4102830|B3|||Age||years|Mean|50|50.0|Full Range|||22.0|59.0|
4279008|NCT00567892|4102831|B2|||Age||years|Mean|42|42.0|Full Range|||22.0|59.0|
4279009|NCT00567892|4102832|B1|||Age||years|Mean|52|52.0|Full Range|5.1|5.1|42.0|59.0|
4279010|NCT00567892|4102830|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4279011|NCT00567892|4102831|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4279012|NCT00567892|4102832|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4279013|NCT00567892|4102830|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4279014|NCT00567892|4102831|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4279015|NCT00567892|4102832|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4279016|NCT00567892|4102830|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279017|NCT00567892|4102831|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279018|NCT00567892|4102832|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279019|NCT00567879|4102847|B7|Female||Sex/Gender, Customized||Participants|Number|56|56.0||||||
4279020|NCT00567879|4102848|B6|Female||Sex/Gender, Customized||Participants|Number|3|3.0||||||
4279021|NCT00567879|4102849|B5|Female||Sex/Gender, Customized||Participants|Number|12|12.0||||||
4279022|NCT00567879|4102850|B4|Female||Sex/Gender, Customized||Participants|Number|6|6.0||||||
4279023|NCT00567879|4102851|B3|Female||Sex/Gender, Customized||Participants|Number|21|21.0||||||
4279024|NCT00567879|4102852|B2|Female||Sex/Gender, Customized||Participants|Number|7|7.0||||||
4279025|NCT00567879|4102853|B1|Female||Sex/Gender, Customized||Participants|Number|7|7.0||||||
4279026|NCT00567879|4102847|B7|||Age||Years|Median|53.0|53.0|Full Range|||33.0|83.0|
4279027|NCT00567879|4102848|B6|||Age||Years|Median|47.0|47.0|Full Range|||38.0|60.0|
4279028|NCT00567879|4102849|B5|||Age||Years|Median|53.5|53.5|Full Range|||40.0|65.0|
4279029|NCT00567879|4102850|B4|||Age||Years|Median|54.5|54.5|Full Range|||49.0|59.0|
4279030|NCT00567879|4102851|B3|||Age||Years|Median|57.0|57.0|Full Range|||37.0|83.0|
4279031|NCT00567879|4102852|B2|||Age||Years|Median|49.0|49.0|Full Range|||33.0|60.0|
4279032|NCT00567879|4102853|B1|||Age||Years|Median|58.0|58.0|Full Range|||35.0|60.0|
4279033|NCT00567840|4102879|B6|||Body Mass Index (BMI)||kg/m^2|Mean|19.43|19.43|Standard Deviation|3.294|3.294|||
4279034|NCT00567840|4102880|B5|||Body Mass Index (BMI)||kg/m^2|Mean|17.53|17.53|Standard Deviation|1.785|1.785|||
4279035|NCT00567840|4102881|B4|||Body Mass Index (BMI)||kg/m^2|Mean|19.41|19.41|Standard Deviation|3.058|3.058|||
4279036|NCT00567840|4102882|B3|||Body Mass Index (BMI)||kg/m^2|Mean|19.09|19.09|Standard Deviation|2.562|2.562|||
4279037|NCT00567840|4102883|B2|||Body Mass Index (BMI)||kg/m^2|Mean|20.09|20.09|Standard Deviation|3.899|3.899|||
4279038|NCT00567840|4102884|B1|||Body Mass Index (BMI)||kg/m^2|Mean|20.19|20.19|Standard Deviation|4.031|4.031|||
4279039|NCT00567840|4102879|B6|||Weight||kg|Mean|53.6|53.6|Standard Deviation|9.36|9.36|||
4279040|NCT00567840|4102880|B5|||Weight||kg|Mean|48.0|48.0|Standard Deviation|8.70|8.7|||
4279041|NCT00567840|4102881|B4|||Weight||kg|Mean|53.5|53.5|Standard Deviation|8.48|8.48|||
4279042|NCT00567840|4102882|B3|||Weight||kg|Mean|52.5|52.5|Standard Deviation|9.82|9.82|||
4279043|NCT00567840|4102883|B2|||Weight||kg|Mean|55.9|55.9|Standard Deviation|10.51|10.51|||
4279044|NCT00567840|4102884|B1|||Weight||kg|Mean|55.3|55.3|Standard Deviation|8.58|8.58|||
4279045|NCT00567840|4102879|B6|Mixed Ethnic||Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
4279046|NCT00567840|4102880|B5|Mixed Ethnic||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4279047|NCT00567840|4102881|B4|Mixed Ethnic||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4279048|NCT00567840|4102882|B3|Mixed Ethnic||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4279049|NCT00567840|4102883|B2|Mixed Ethnic||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4279050|NCT00567840|4102884|B1|Mixed Ethnic||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4279051|NCT00567840|4102879|B6|Black||Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
4279052|NCT00567840|4102880|B5|Black||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4279053|NCT00567840|4102881|B4|Black||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4279054|NCT00567840|4102882|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4279055|NCT00567840|4102883|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4279056|NCT00567840|4102884|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4279057|NCT00567840|4102879|B6||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4279058|NCT00567840|4102880|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4279059|NCT00567840|4102881|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4279060|NCT00567840|4102882|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4279061|NCT00567840|4102883|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4279062|NCT00567840|4102884|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4279063|NCT00567840|4102879|B6||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4279064|NCT00567840|4102880|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4279065|NCT00567840|4102881|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4279066|NCT00567840|4102882|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4279067|NCT00567840|4102883|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4279068|NCT00567840|4102884|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4279069|NCT00567840|4102879|B6|||Age||years|Mean|30.2|30.2|Standard Deviation|9.48|9.48|||
4279070|NCT00567840|4102880|B5|||Age||years|Mean|21.9|21.9|Standard Deviation|3.44|3.44|||
4279071|NCT00567840|4102881|B4|||Age||years|Mean|32.4|32.4|Standard Deviation|11.51|11.51|||
4279072|NCT00567840|4102882|B3|||Age||years|Mean|31.7|31.7|Standard Deviation|8.86|8.86|||
4279073|NCT00567840|4102883|B2|||Age||years|Mean|30.6|30.6|Standard Deviation|9.72|9.72|||
4279074|NCT00567840|4102884|B1|||Age||years|Mean|30.5|30.5|Standard Deviation|8.50|8.5|||
4279075|NCT00567593|4102925|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4279076|NCT00567593|4102925|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279077|NCT00567593|4102925|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4279078|NCT00567593|4102925|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4279079|NCT00567593|4102925|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4279080|NCT00567593|4102925|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279081|NCT00567593|4102925|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4279082|NCT00567593|4102925|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279083|NCT00567593|4102925|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4279084|NCT00567593|4102925|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4279085|NCT00567593|4102925|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4279086|NCT00567593|4102925|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4279087|NCT00567593|4102925|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4279088|NCT00567593|4102925|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4279089|NCT00567593|4102925|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4279090|NCT00567593|4102925|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279091|NCT00567567|4102929|B4|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4279092|NCT00567567|4102930|B3|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
4279093|NCT00567567|4102931|B2|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
4279094|NCT00567567|4102932|B1|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4279095|NCT00567567|4102929|B4|Australia||Region of Enrollment||participants|Number|29|29.0||||||
4279096|NCT00567567|4102930|B3|Australia||Region of Enrollment||participants|Number|10|10.0||||||
4279097|NCT00567567|4102931|B2|Australia||Region of Enrollment||participants|Number|8|8.0||||||
4279098|NCT00567567|4102932|B1|Australia||Region of Enrollment||participants|Number|11|11.0||||||
4279099|NCT00567567|4102929|B4|United States||Region of Enrollment||participants|Number|565|565.0||||||
4279100|NCT00567567|4102930|B3|United States||Region of Enrollment||participants|Number|243|243.0||||||
4279101|NCT00567567|4102931|B2|United States||Region of Enrollment||participants|Number|146|146.0||||||
4279102|NCT00567567|4102932|B1|United States||Region of Enrollment||participants|Number|176|176.0||||||
4279103|NCT00567567|4102929|B4|Canada||Region of Enrollment||participants|Number|63|63.0||||||
4279104|NCT00567567|4102930|B3|Canada||Region of Enrollment||participants|Number|23|23.0||||||
4279105|NCT00567567|4102931|B2|Canada||Region of Enrollment||participants|Number|21|21.0||||||
4279106|NCT00567567|4102932|B1|Canada||Region of Enrollment||participants|Number|19|19.0||||||
4279107|NCT00567567|4102929|B4|New Zealand||Region of Enrollment||participants|Number|7|7.0||||||
4279108|NCT00567567|4102930|B3|New Zealand||Region of Enrollment||participants|Number|3|3.0||||||
4279109|NCT00567567|4102931|B2|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
4279110|NCT00567567|4102932|B1|New Zealand||Region of Enrollment||participants|Number|3|3.0||||||
4279111|NCT00567567|4102929|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4279112|NCT00567567|4102930|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4279113|NCT00567567|4102931|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4279114|NCT00567567|4102932|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4279115|NCT00567567|4102929|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279116|NCT00567567|4102930|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279117|NCT00567567|4102931|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279118|NCT00567567|4102932|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279119|NCT00567567|4102929|B4||White|Race (NIH/OMB)||Participants|Count of Participants|492|492.0||||||
4279120|NCT00567567|4102930|B3||White|Race (NIH/OMB)||Participants|Count of Participants|203|203.0||||||
4279121|NCT00567567|4102931|B2||White|Race (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
4279122|NCT00567567|4102932|B1||White|Race (NIH/OMB)||Participants|Count of Participants|157|157.0||||||
4279123|NCT00567567|4102929|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
4279124|NCT00567567|4102930|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4279125|NCT00567567|4102931|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4279126|NCT00567567|4102932|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4279127|NCT00567567|4102929|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4279128|NCT00567567|4102930|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4279129|NCT00567567|4102931|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279130|NCT00567567|4102932|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4279131|NCT00567567|4102929|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4279132|NCT00567567|4102930|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4279133|NCT00567567|4102931|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4279134|NCT00567567|4102932|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4279135|NCT00567567|4102929|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4279136|NCT00567567|4102930|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279137|NCT00567567|4102931|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279138|NCT00567567|4102932|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4279139|NCT00567567|4102929|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4279140|NCT00567567|4102930|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4279141|NCT00567567|4102931|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4279142|NCT00567567|4102932|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4279143|NCT00567567|4102929|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|559|559.0||||||
4279144|NCT00567567|4102930|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|233|233.0||||||
4279145|NCT00567567|4102931|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|145|145.0||||||
4279146|NCT00567567|4102932|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|181|181.0||||||
4279147|NCT00567567|4102929|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
4279148|NCT00567567|4102930|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4279149|NCT00567567|4102931|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4279150|NCT00567567|4102932|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4279151|NCT00567567|4102929|B4||Male|Sex: Female, Male||Participants|Count of Participants|374|374.0||||||
4279152|NCT00567567|4102930|B3||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4279153|NCT00567567|4102931|B2||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4279154|NCT00567567|4102932|B1||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4279155|NCT00567567|4102929|B4||Female|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
4279156|NCT00567567|4102930|B3||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4279157|NCT00567567|4102931|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4279158|NCT00567567|4102932|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4279159|NCT00567567|4102929|B4|||Age||Years|Mean|3.2|3.2|Standard Deviation|2.7|2.7|||
4279160|NCT00567567|4102930|B3|||Age||Years|Mean|3.4|3.4|Standard Deviation|2.8|2.8|||
4279161|NCT00567567|4102931|B2|||Age||Years|Mean|2.9|2.9|Standard Deviation|2.4|2.4|||
4279162|NCT00567567|4102932|B1|||Age||Years|Mean|3.2|3.2|Standard Deviation|2.9|2.9|||
4279163|NCT00567567|4102929|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4279164|NCT00567567|4102930|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4279165|NCT00567567|4102931|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4279166|NCT00567567|4102932|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4279167|NCT00567567|4102929|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4279168|NCT00567567|4102930|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4279169|NCT00567567|4102931|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4279170|NCT00567567|4102932|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4279171|NCT00567567|4102929|B4||<=18 years|Age||Participants|Count of Participants|661|661.0||||||
4279172|NCT00567567|4102930|B3||<=18 years|Age||Participants|Count of Participants|277|277.0||||||
4279173|NCT00567567|4102931|B2||<=18 years|Age||Participants|Count of Participants|176|176.0||||||
4279174|NCT00567567|4102932|B1||<=18 years|Age||Participants|Count of Participants|208|208.0||||||
4279175|NCT00567541|4102958|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4279176|NCT00567541|4102959|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4279177|NCT00567541|4102960|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4279178|NCT00567541|4102958|B3|non-white||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4279179|NCT00567541|4102959|B2|non-white||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4279180|NCT00567541|4102960|B1|non-white||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4279181|NCT00567541|4102958|B3|white||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4279182|NCT00567541|4102959|B2|white||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4279183|NCT00567541|4102960|B1|white||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4279184|NCT00567541|4102958|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4279185|NCT00567541|4102959|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4279186|NCT00567541|4102960|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4279187|NCT00567541|4102958|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4279188|NCT00567541|4102959|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4279189|NCT00567541|4102960|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4279190|NCT00567541|4102958|B3|56-80 years old||Age, Customized||participants|Number|12|12.0||||||
4279191|NCT00567541|4102959|B2|56-80 years old||Age, Customized||participants|Number|6|6.0||||||
4279192|NCT00567541|4102960|B1|56-80 years old||Age, Customized||participants|Number|6|6.0||||||
4279193|NCT00567541|4102958|B3|35-55 years old||Age, Customized||participants|Number|4|4.0||||||
4279194|NCT00567541|4102959|B2|35-55 years old||Age, Customized||participants|Number|3|3.0||||||
4279195|NCT00567541|4102960|B1|35-55 years old||Age, Customized||participants|Number|1|1.0||||||
4279196|NCT00567502|4102967|B5||Male|Sex: Female, Male||Participants|Count of Participants|1409|1409.0||||||
4279197|NCT00567502|4102968|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4279198|NCT00567502|4102969|B3||Male|Sex: Female, Male||Participants|Count of Participants|1032|1032.0||||||
4279199|NCT00567502|4102970|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4279200|NCT00567502|4102971|B1||Male|Sex: Female, Male||Participants|Count of Participants|303|303.0||||||
4279201|NCT00567502|4102967|B5||Female|Sex: Female, Male||Participants|Count of Participants|2238|2238.0||||||
4279202|NCT00567502|4102968|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4279203|NCT00567502|4102969|B3||Female|Sex: Female, Male||Participants|Count of Participants|1632|1632.0||||||
4279204|NCT00567502|4102970|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4279205|NCT00567502|4102971|B1||Female|Sex: Female, Male||Participants|Count of Participants|501|501.0||||||
4279206|NCT00567502|4102967|B5|Greater than equal to (>=)75 years||Age, Customized||participants|Number|983|983.0||||||
4279207|NCT00567502|4102968|B4|Greater than equal to (>=)75 years||Age, Customized||participants|Number|11|11.0||||||
4279208|NCT00567502|4102969|B3|Greater than equal to (>=)75 years||Age, Customized||participants|Number|854|854.0||||||
4279209|NCT00567502|4102970|B2|Greater than equal to (>=)75 years||Age, Customized||participants|Number|22|22.0||||||
4279210|NCT00567502|4102971|B1|Greater than equal to (>=)75 years||Age, Customized||participants|Number|96|96.0||||||
4279211|NCT00567502|4102967|B5|65-<75 years||Age, Customized||participants|Number|1073|1073.0||||||
4279212|NCT00567502|4102968|B4|65-<75 years||Age, Customized||participants|Number|13|13.0||||||
4279213|NCT00567502|4102969|B3|65-<75 years||Age, Customized||participants|Number|897|897.0||||||
4279214|NCT00567502|4102970|B2|65-<75 years||Age, Customized||participants|Number|30|30.0||||||
4279215|NCT00567502|4102971|B1|65-<75 years||Age, Customized||participants|Number|133|133.0||||||
4279216|NCT00567502|4102967|B5|Less than (<) 65 years||Age, Customized||participants|Number|1591|1591.0||||||
4279217|NCT00567502|4102968|B4|Less than (<) 65 years||Age, Customized||participants|Number|14|14.0||||||
4279218|NCT00567502|4102969|B3|Less than (<) 65 years||Age, Customized||participants|Number|913|913.0||||||
4279219|NCT00567502|4102970|B2|Less than (<) 65 years||Age, Customized||participants|Number|89|89.0||||||
4279220|NCT00567502|4102971|B1|Less than (<) 65 years||Age, Customized||participants|Number|575|575.0||||||
4279221|NCT00567502|4102967|B5|||Age||years|Mean|64.4|64.4|Standard Deviation|14.43|14.43|||
4279222|NCT00567502|4102968|B4|||Age||years|Mean|64.3|64.3|Standard Deviation|14.26|14.26|||
4279223|NCT00567502|4102969|B3|||Age||years|Mean|67.4|67.4|Standard Deviation|13.05|13.05|||
4279224|NCT00567502|4102970|B2|||Age||years|Mean|59.9|59.9|Standard Deviation|13.74|13.74|||
4279225|NCT00567502|4102971|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|14.99|14.99|||
4279226|NCT00567476|4103009|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4279227|NCT00567476|4103010|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4279228|NCT00567476|4103011|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4279229|NCT00567476|4103009|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4279230|NCT00567476|4103010|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4279231|NCT00567476|4103011|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4279232|NCT00567476|4103009|B3|≥ 65 and < 75 years||Age, Customized||Participants|Number|9|9.0||||||
4279233|NCT00567476|4103010|B2|≥ 65 and < 75 years||Age, Customized||Participants|Number|4|4.0||||||
4279234|NCT00567476|4103011|B1|≥ 65 and < 75 years||Age, Customized||Participants|Number|5|5.0||||||
4279235|NCT00567476|4103009|B3|≥ 55 and < 65 years||Age, Customized||Participants|Number|16|16.0||||||
4279236|NCT00567476|4103010|B2|≥ 55 and < 65 years||Age, Customized||Participants|Number|4|4.0||||||
4279237|NCT00567476|4103011|B1|≥ 55 and < 65 years||Age, Customized||Participants|Number|12|12.0||||||
4279238|NCT00567476|4103009|B3|≥ 35 and < 55 years||Age, Customized||Participants|Number|65|65.0||||||
4279239|NCT00567476|4103010|B2|≥ 35 and < 55 years||Age, Customized||Participants|Number|23|23.0||||||
4279240|NCT00567476|4103011|B1|≥ 35 and < 55 years||Age, Customized||Participants|Number|42|42.0||||||
4279241|NCT00567476|4103009|B3|≥ 25 and < 35 years||Age, Customized||Participants|Number|18|18.0||||||
4279242|NCT00567476|4103010|B2|≥ 25 and < 35 years||Age, Customized||Participants|Number|3|3.0||||||
4279243|NCT00567476|4103011|B1|≥ 25 and < 35 years||Age, Customized||Participants|Number|15|15.0||||||
4279244|NCT00567476|4103009|B3|> 12 years and < 25 years||Age, Customized||Participants|Number|8|8.0||||||
4279245|NCT00567476|4103010|B2|> 12 years and < 25 years||Age, Customized||Participants|Number|4|4.0||12.8|12.8|||
4279246|NCT00567476|4103011|B1|> 12 years and < 25 years||Age, Customized||Participants|Number|4|4.0||13.1|13.1|||
4279247|NCT00567359|4103036|B1||L861Q|EGFR Mutation|Epidermal Growth Factor Receptor (EGFR) allows healthy cells to grow and divide. A mutation in the EGFR gene can lead to cells having too many receptors. This can cause the cells to continue to grow and divide more than normal tissue, as happens in cancer.|Participants|Count of Participants|1|1.0||||||
4279248|NCT00567359|4103036|B1||G719X|EGFR Mutation|Epidermal Growth Factor Receptor (EGFR) allows healthy cells to grow and divide. A mutation in the EGFR gene can lead to cells having too many receptors. This can cause the cells to continue to grow and divide more than normal tissue, as happens in cancer.|Participants|Count of Participants|2|2.0||||||
4279249|NCT00567359|4103036|B1||L858R|EGFR Mutation|Epidermal Growth Factor Receptor (EGFR) allows healthy cells to grow and divide. A mutation in the EGFR gene can lead to cells having too many receptors. This can cause the cells to continue to grow and divide more than normal tissue, as happens in cancer.|Participants|Count of Participants|35|35.0||||||
4279250|NCT00567359|4103036|B1||Exon 19 Deletion|EGFR Mutation|Epidermal Growth Factor Receptor (EGFR) allows healthy cells to grow and divide. A mutation in the EGFR gene can lead to cells having too many receptors. This can cause the cells to continue to grow and divide more than normal tissue, as happens in cancer.|Participants|Count of Participants|62|62.0||||||
4279251|NCT00567359|4103036|B1||Stage IIIA|Stage|Cancer stage is a measure of disease progression. The later stage indicates more advanced cancer. So, the Participants with Stage II cancer have more advanced disease than stage I participants. The letters represent sub groups within a given stage, with B representing more advanced cancer than A.|Participants|Count of Participants|28|28.0||||||
4279252|NCT00567359|4103036|B1||Stage IIB|Stage|Cancer stage is a measure of disease progression. The later stage indicates more advanced cancer. So, the Participants with Stage II cancer have more advanced disease than stage I participants. The letters represent sub groups within a given stage, with B representing more advanced cancer than A.|Participants|Count of Participants|16|16.0||||||
4279253|NCT00567359|4103036|B1||Stage IIA|Stage|Cancer stage is a measure of disease progression. The later stage indicates more advanced cancer. So, the Participants with Stage II cancer have more advanced disease than stage I participants. The letters represent sub groups within a given stage, with B representing more advanced cancer than A.|Participants|Count of Participants|11|11.0||||||
4279254|NCT00567359|4103036|B1||Stage IB|Stage|Cancer stage is a measure of disease progression. The later stage indicates more advanced cancer. So, the Participants with Stage II cancer have more advanced disease than stage I participants. The letters represent sub groups within a given stage, with B representing more advanced cancer than A.|Participants|Count of Participants|31|31.0||||||
4279255|NCT00567359|4103036|B1||Stage IA|Stage|Cancer stage is a measure of disease progression. The later stage indicates more advanced cancer. So, the Participants with Stage II cancer have more advanced disease than stage I participants. The letters represent sub groups within a given stage, with B representing more advanced cancer than A.|Participants|Count of Participants|14|14.0||||||
4279256|NCT00567359|4103036|B1||>10 pack years + current|Smoking Status||Participants|Count of Participants|27|27.0||||||
4279257|NCT00567359|4103036|B1||<=10 pack years|Smoking Status||Participants|Count of Participants|14|14.0||||||
4279258|NCT00567359|4103036|B1||Never|Smoking Status||Participants|Count of Participants|59|59.0||||||
4279259|NCT00567359|4103036|B1|United States||Region of Enrollment||Participants|Count of Participants|100|100.0||||||
4279260|NCT00567359|4103036|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4279261|NCT00567359|4103036|B1||Non-Asian|Race/Ethnicity, Customized||Participants|Count of Participants|83|83.0||||||
4279262|NCT00567359|4103036|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4279263|NCT00567359|4103036|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4279264|NCT00567359|4103036|B1|||Age||years|Median|63|63.0|Full Range|||41.0|84.0|
4279265|NCT00567320|4103043|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4279266|NCT00567320|4103044|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4279267|NCT00567320|4103045|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4279268|NCT00567320|4103043|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4279269|NCT00567320|4103044|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4279270|NCT00567320|4103045|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4279271|NCT00567320|4103043|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4279272|NCT00567320|4103044|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4279273|NCT00567320|4103045|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4279274|NCT00567320|4103043|B3|||Age||years|Mean|35.45|35.45|Standard Deviation|12|12.0|||
4279275|NCT00567320|4103044|B2|||Age||years|Mean|34.4|34.4|Standard Deviation|12|12.0|||
4279276|NCT00567320|4103045|B1|||Age||years|Mean|36.5|36.5|Standard Deviation|12|12.0|||
4279277|NCT00567307|4103052|B3|||Total Cholesterol||mmol/L|Mean|5.9|5.9|Standard Deviation|1.3|1.3|||
4279278|NCT00567307|4103053|B2|||Total Cholesterol||mmol/L|Mean|6.1|6.1|Standard Deviation|1.3|1.3|||
4279279|NCT00567307|4103054|B1|||Total Cholesterol||mmol/L|Mean|5.7|5.7|Standard Deviation|1.3|1.3|||
4279280|NCT00567307|4103052|B3|||Systolic Blood Pressure||mmHG|Mean|165.2|165.2|Standard Deviation|18.2|18.2|||
4279281|NCT00567307|4103053|B2|||Systolic Blood Pressure||mmHG|Mean|165.7|165.7|Standard Deviation|19.2|19.2|||
4279282|NCT00567307|4103054|B1|||Systolic Blood Pressure||mmHG|Mean|164.7|164.7|Standard Deviation|17.3|17.3|||
4279283|NCT00567307|4103052|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4279284|NCT00567307|4103053|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4279285|NCT00567307|4103054|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4279286|NCT00567307|4103052|B3||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4279287|NCT00567307|4103053|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4279288|NCT00567307|4103054|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4279289|NCT00567307|4103052|B3|||Age||years|Mean|59.1|59.1|Standard Deviation|7.2|7.2|||
4279290|NCT00567307|4103053|B2|||Age||years|Mean|59.0|59.0|Standard Deviation|6.9|6.9|||
4279291|NCT00567307|4103054|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|7.4|7.4|||
4279292|NCT00567268|4103061|B1||Male|Sex: Female, Male|Participants taking gabapentin oral tablets 200, 300, or 400 mg according to the Japanese package insert.|Participants|Count of Participants|602|602.0||||||
4279293|NCT00567268|4103061|B1||Female|Sex: Female, Male|Participants taking gabapentin oral tablets 200, 300, or 400 mg according to the Japanese package insert.|Participants|Count of Participants|542|542.0||||||
4279294|NCT00567268|4103061|B1|>=65 years||Age, Customized|Participants taking gabapentin oral tablets 200, 300, or 400 mg according to the Japanese package insert.|participants|Number|143|143.0||||||
4279295|NCT00567268|4103061|B1|<65 years||Age, Customized|Participants taking gabapentin oral tablets 200, 300, or 400 mg according to the Japanese package insert.|participants|Number|1001|1001.0||||||
4279296|NCT00567255|4103110|B3|||BMI||kg/m^2|Mean|36.17|36.17|Standard Deviation|4.39|4.39|||
4279297|NCT00567255|4103111|B2|||BMI||kg/m^2|Mean|36.09|36.09|Standard Deviation|4.27|4.27|||
4279298|NCT00567255|4103112|B1|||BMI||kg/m^2|Mean|36.22|36.22|Standard Deviation|4.45|4.45|||
4279299|NCT00567255|4103110|B3|||Weight||kg|Mean|99.95|99.95|Standard Deviation|16.33|16.33|||
4279300|NCT00567255|4103111|B2|||Weight||kg|Mean|99.21|99.21|Standard Deviation|15.86|15.86|||
4279301|NCT00567255|4103112|B1|||Weight||kg|Mean|100.3|100.3|Standard Deviation|16.55|16.55|||
4279302|NCT00567255|4103110|B3|Other||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4279303|NCT00567255|4103111|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4279304|NCT00567255|4103112|B1|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4279305|NCT00567255|4103110|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4279306|NCT00567255|4103111|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4279307|NCT00567255|4103112|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4279308|NCT00567255|4103110|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4279309|NCT00567255|4103111|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4279310|NCT00567255|4103112|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4279311|NCT00567255|4103110|B3|Asian||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4279312|NCT00567255|4103111|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4279313|NCT00567255|4103112|B1|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4279314|NCT00567255|4103110|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|205|205.0||||||
4279315|NCT00567255|4103111|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
4279316|NCT00567255|4103112|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|133|133.0||||||
4279317|NCT00567255|4103110|B3|White||Race/Ethnicity, Customized||participants|Number|1249|1249.0||||||
4279318|NCT00567255|4103111|B2|White||Race/Ethnicity, Customized||participants|Number|414|414.0||||||
4279319|NCT00567255|4103112|B1|White||Race/Ethnicity, Customized||participants|Number|835|835.0||||||
4279320|NCT00567255|4103110|B3||Male|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4279321|NCT00567255|4103111|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4279322|NCT00567255|4103112|B1||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4279323|NCT00567255|4103110|B3||Female|Sex: Female, Male||Participants|Count of Participants|1267|1267.0||||||
4279324|NCT00567255|4103111|B2||Female|Sex: Female, Male||Participants|Count of Participants|420|420.0||||||
4279325|NCT00567255|4103112|B1||Female|Sex: Female, Male||Participants|Count of Participants|847|847.0||||||
4279326|NCT00567255|4103110|B3|||Age||years|Mean|44.32|44.32|Standard Deviation|11.23|11.23|||
4279327|NCT00567255|4103111|B2|||Age||years|Mean|44.41|44.41|Standard Deviation|11.38|11.38|||
4279328|NCT00567255|4103112|B1|||Age||years|Mean|44.27|44.27|Standard Deviation|11.16|11.16|||
4279329|NCT00567242|4103157|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4279330|NCT00567242|4103158|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4279331|NCT00567242|4103159|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4279332|NCT00567242|4103157|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4279333|NCT00567242|4103158|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4279334|NCT00567242|4103159|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4279335|NCT00567242|4103157|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4279336|NCT00567242|4103158|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4279337|NCT00567242|4103159|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4279338|NCT00567242|4103157|B3|||Age||years|Mean|66.93|66.93|Standard Deviation|11.24|11.24|||
4279339|NCT00567242|4103158|B2|||Age||years|Mean|63.00|63.0|Standard Deviation|9.22|9.22|||
4279340|NCT00567242|4103159|B1|||Age||years|Mean|70.86|70.86|Standard Deviation|12.35|12.35|||
4279341|NCT00567242|4103157|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4279342|NCT00567242|4103158|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4279343|NCT00567242|4103159|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4279344|NCT00567242|4103157|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4279345|NCT00567242|4103158|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4279346|NCT00567242|4103159|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4279347|NCT00567242|4103157|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279348|NCT00567242|4103158|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279349|NCT00567242|4103159|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279350|NCT00567229|4103170|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4279351|NCT00567229|4103170|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4279352|NCT00567229|4103170|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4279353|NCT00567229|4103170|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4279354|NCT00567229|4103170|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279355|NCT00567190|4103174|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4279356|NCT00567190|4103175|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4279357|NCT00567190|4103176|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4279358|NCT00567190|4103174|B3||Female|Sex: Female, Male||Participants|Count of Participants|806|806.0||||||
4279359|NCT00567190|4103175|B2||Female|Sex: Female, Male||Participants|Count of Participants|404|404.0||||||
4279360|NCT00567190|4103176|B1||Female|Sex: Female, Male||Participants|Count of Participants|402|402.0||||||
4279361|NCT00567190|4103174|B3|||Age||years|Mean|53.5|53.5|Standard Deviation|11.14|11.14|||
4279362|NCT00567190|4103175|B2|||Age||years|Mean|53.5|53.5|Standard Deviation|11.35|11.35|||
4279363|NCT00567190|4103176|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|10.94|10.94|||
4279364|NCT00567164|4103194|B4||Male|Sex: Female, Male|Only describes treated participants|Participants|Count of Participants|0|0.0||||||
4279365|NCT00567164|4103195|B3||Male|Sex: Female, Male|Only describes treated participants|Participants|Count of Participants|0|0.0||||||
4279366|NCT00567164|4103196|B2||Male|Sex: Female, Male|Only describes treated participants|Participants|Count of Participants|0|0.0||||||
4279367|NCT00567164|4103197|B1||Male|Sex: Female, Male|Only describes treated participants|Participants|Count of Participants|0|0.0||||||
4279368|NCT00567164|4103194|B4||Female|Sex: Female, Male|Only describes treated participants|Participants|Count of Participants|1864|1864.0||||||
4279369|NCT00567164|4103195|B3||Female|Sex: Female, Male|Only describes treated participants|Participants|Count of Participants|226|226.0||||||
4279370|NCT00567164|4103196|B2||Female|Sex: Female, Male|Only describes treated participants|Participants|Count of Participants|232|232.0||||||
4279371|NCT00567164|4103197|B1||Female|Sex: Female, Male|Only describes treated participants|Participants|Count of Participants|1406|1406.0||||||
4279372|NCT00567164|4103194|B4|||Age|Only describes treated participants|years|Mean|25.7|25.7|Standard Deviation|5.2|5.2|||
4279373|NCT00567164|4103195|B3|||Age|Only describes treated participants|years|Mean|27.3|27.3|Standard Deviation|6.4|6.4|||
4279374|NCT00567164|4103196|B2|||Age|Only describes treated participants|years|Mean|26.8|26.8|Standard Deviation|6.8|6.8|||
4279375|NCT00567164|4103197|B1|||Age|Only describes treated participants|years|Mean|25.2|25.2|Standard Deviation|4.5|4.5|||
4279376|NCT00567112|4103271|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4279377|NCT00567112|4103271|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4279378|NCT00567112|4103271|B1|≥ 35 and ≤ 69 years||Age, Customized||participants|Number|18|18.0||||||
4279379|NCT00567008|4103295|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
4279380|NCT00567008|4103296|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4279381|NCT00567008|4103297|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4279382|NCT00567008|4103295|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4279383|NCT00567008|4103296|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4279384|NCT00567008|4103297|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4279385|NCT00567008|4103295|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4279386|NCT00567008|4103296|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4279387|NCT00567008|4103297|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4279388|NCT00567008|4103295|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4279389|NCT00567008|4103296|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4279390|NCT00567008|4103297|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4279391|NCT00567008|4103295|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4279392|NCT00567008|4103296|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4279393|NCT00567008|4103297|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4279394|NCT00567008|4103295|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279395|NCT00567008|4103296|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279396|NCT00567008|4103297|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279397|NCT00566995|4103304|B1|United States||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
4279398|NCT00566995|4103304|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279399|NCT00566995|4103304|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279400|NCT00566995|4103304|B1||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4279401|NCT00566995|4103304|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4279402|NCT00566995|4103304|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279403|NCT00566995|4103304|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4279404|NCT00566995|4103304|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279405|NCT00566995|4103304|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4279406|NCT00566995|4103304|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4279407|NCT00566995|4103304|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4279408|NCT00566995|4103304|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4279409|NCT00566995|4103304|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4279410|NCT00566995|4103304|B1|||Age||years|Mean|46.65|46.65|Standard Deviation|9.96|9.96|||
4279411|NCT00566995|4103304|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4279412|NCT00566995|4103304|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4279413|NCT00566995|4103304|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279414|NCT00566982|4103317|B3|||BMI||kg/m^2|Mean|24.38|24.38|Full Range|||17.4|31.2|
4279415|NCT00566982|4103318|B2|||BMI||kg/m^2|Mean|24.11|24.11|Full Range|||17.7|29.7|
4279416|NCT00566982|4103319|B1|||BMI||kg/m^2|Mean|24.65|24.65|Full Range|||17.4|31.2|
4279417|NCT00566982|4103317|B3|||BMI||kg/m^2|Mean|24.38|24.38|Standard Deviation|2.892|2.892|||
4279418|NCT00566982|4103318|B2|||BMI||kg/m^2|Mean|24.11|24.11|Standard Deviation|2.867|2.867|||
4279419|NCT00566982|4103319|B1|||BMI||kg/m^2|Mean|24.65|24.65|Standard Deviation|2.916|2.916|||
4279420|NCT00566982|4103317|B3|||Alcohol||drinks/week|Mean|2.35|2.35|Full Range|||0.0|14.0|
4279421|NCT00566982|4103318|B2|||Alcohol||drinks/week|Mean|2.3|2.3|Full Range|||0.0|14.0|
4279422|NCT00566982|4103319|B1|||Alcohol||drinks/week|Mean|2.4|2.4|Full Range|||0.0|14.0|
4279423|NCT00566982|4103317|B3|||Alcohol||drinks/week|Mean|2.35|2.35|Standard Deviation|3.33|3.33|||
4279424|NCT00566982|4103318|B2|||Alcohol||drinks/week|Mean|2.3|2.3|Standard Deviation|3.26|3.26|||
4279425|NCT00566982|4103319|B1|||Alcohol||drinks/week|Mean|2.4|2.4|Standard Deviation|3.40|3.4|||
4279426|NCT00566982|4103317|B3|Sweden||Region of Enrollment||Participants|Number|34|34.0||||||
4279427|NCT00566982|4103318|B2|Sweden||Region of Enrollment||Participants|Number|5|5.0||||||
4279428|NCT00566982|4103319|B1|Sweden||Region of Enrollment||Participants|Number|29|29.0||||||
4279429|NCT00566982|4103317|B3|Finland||Region of Enrollment||Participants|Number|208|208.0||||||
4279430|NCT00566982|4103318|B2|Finland||Region of Enrollment||Participants|Number|31|31.0||||||
4279431|NCT00566982|4103319|B1|Finland||Region of Enrollment||Participants|Number|177|177.0||||||
4279432|NCT00566982|4103317|B3|Denmark||Region of Enrollment||Participants|Number|65|65.0||||||
4279433|NCT00566982|4103318|B2|Denmark||Region of Enrollment||Participants|Number|9|9.0||||||
4279434|NCT00566982|4103319|B1|Denmark||Region of Enrollment||Participants|Number|56|56.0||||||
4279435|NCT00566982|4103317|B3|Belgium||Region of Enrollment||Participants|Number|119|119.0||||||
4279436|NCT00566982|4103318|B2|Belgium||Region of Enrollment||Participants|Number|18|18.0||||||
4279437|NCT00566982|4103319|B1|Belgium||Region of Enrollment||Participants|Number|101|101.0||||||
4279438|NCT00566982|4103317|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4279439|NCT00566982|4103318|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4279440|NCT00566982|4103319|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4279441|NCT00566982|4103317|B3|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4279442|NCT00566982|4103318|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4279443|NCT00566982|4103319|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4279444|NCT00566982|4103317|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|424|424.0||||||
4279445|NCT00566982|4103318|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
4279446|NCT00566982|4103319|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|361|361.0||||||
4279447|NCT00566982|4103317|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4279448|NCT00566982|4103318|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4279449|NCT00566982|4103319|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4279450|NCT00566982|4103317|B3||Female|Sex: Female, Male||Participants|Count of Participants|426|426.0||||||
4279451|NCT00566982|4103318|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4279452|NCT00566982|4103319|B1||Female|Sex: Female, Male||Participants|Count of Participants|363|363.0||||||
4279453|NCT00566982|4103317|B3|||Age||years|Mean|62.3|62.3|Full Range|||49.0|79.0|
4279454|NCT00566982|4103318|B2|||Age||years|Mean|62.9|62.9|Full Range|||50.0|79.0|
4279455|NCT00566982|4103319|B1|||Age||years|Mean|61.7|61.7|Full Range|||49.0|78.0|
4279456|NCT00566982|4103317|B3|||Age||years|Mean|62.3|62.3|Standard Deviation|6.32|6.32|||
4279457|NCT00566982|4103318|B2|||Age||years|Mean|62.9|62.9|Standard Deviation|6.47|6.47|||
4279458|NCT00566982|4103319|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|6.16|6.16|||
4279459|NCT00566969|4103342|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4279460|NCT00566969|4103343|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4279461|NCT00566969|4103344|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4279462|NCT00566969|4103345|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4279463|NCT00566969|4103342|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279464|NCT00566969|4103343|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279465|NCT00566969|4103344|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279466|NCT00566969|4103345|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279467|NCT00566969|4103342|B4||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4279468|NCT00566969|4103343|B3||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4279469|NCT00566969|4103344|B2||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4279470|NCT00566969|4103345|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4279471|NCT00566969|4103342|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4279472|NCT00566969|4103343|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4279473|NCT00566969|4103344|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4279474|NCT00566969|4103345|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4279475|NCT00566969|4103342|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279476|NCT00566969|4103343|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279477|NCT00566969|4103344|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279478|NCT00566969|4103345|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279479|NCT00566969|4103342|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279480|NCT00566969|4103343|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279481|NCT00566969|4103344|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279482|NCT00566969|4103345|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279483|NCT00566969|4103342|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279484|NCT00566969|4103343|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279485|NCT00566969|4103344|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279486|NCT00566969|4103345|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279487|NCT00566969|4103342|B4||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4279488|NCT00566969|4103343|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4279489|NCT00566969|4103344|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4279490|NCT00566969|4103345|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4279491|NCT00566969|4103342|B4||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4279492|NCT00566969|4103343|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4279493|NCT00566969|4103344|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4279494|NCT00566969|4103345|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4279495|NCT00566969|4103342|B4|||Age||years|Mean|38.1|38.1|Standard Deviation|10.3|10.3|||
4279496|NCT00566969|4103343|B3|||Age||years|Mean|39.1|39.1|Standard Deviation|10.9|10.9|||
4279497|NCT00566969|4103344|B2|||Age||years|Mean|37.7|37.7|Standard Deviation|10.9|10.9|||
4279498|NCT00566969|4103345|B1|||Age||years|Mean|37.6|37.6|Standard Deviation|9.1|9.1|||
4279499|NCT00566943|4103355|B3|United States||Region of Enrollment||participants|Number|101|101.0||||||
4279500|NCT00566943|4103356|B2|United States||Region of Enrollment||participants|Number|49|49.0||||||
4279501|NCT00566943|4103357|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
4279502|NCT00566943|4103355|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4279503|NCT00566943|4103356|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4279504|NCT00566943|4103357|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4279505|NCT00566943|4103355|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4279506|NCT00566943|4103356|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4279507|NCT00566943|4103357|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4279508|NCT00566943|4103355|B3|||Age||years|Mean|45.3|45.3|Standard Deviation|9.69|9.69|||
4279509|NCT00566943|4103356|B2|||Age||years|Mean|46.61|46.61|Standard Deviation|10.2|10.2|||
4279510|NCT00566943|4103357|B1|||Age||years|Mean|42.93|42.93|Standard Deviation|9.18|9.18|||
4279511|NCT00566943|4103355|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4279512|NCT00566943|4103356|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4279513|NCT00566943|4103357|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4279514|NCT00566943|4103355|B3||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
4279515|NCT00566943|4103356|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4279516|NCT00566943|4103357|B1||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4279517|NCT00566943|4103355|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279518|NCT00566943|4103356|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279519|NCT00566943|4103357|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279520|NCT00566930|4103370|B4|Canada||Region of Enrollment||participants|Number|98|98.0||||||
4279521|NCT00566930|4103371|B3|Canada||Region of Enrollment||participants|Number|33|33.0||||||
4279522|NCT00566930|4103372|B2|Canada||Region of Enrollment||participants|Number|36|36.0||||||
4279523|NCT00566930|4103373|B1|Canada||Region of Enrollment||participants|Number|29|29.0||||||
4279524|NCT00566930|4103370|B4||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4279525|NCT00566930|4103371|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4279526|NCT00566930|4103372|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4279527|NCT00566930|4103373|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4279528|NCT00566930|4103370|B4||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4279529|NCT00566930|4103371|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4279530|NCT00566930|4103372|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4279531|NCT00566930|4103373|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4279532|NCT00566930|4103370|B4|||Age||years|Mean|39|39.0|Standard Deviation|11|11.0|||
4279533|NCT00566930|4103371|B3|||Age||years|Mean|37|37.0|Standard Deviation|11|11.0|||
4279534|NCT00566930|4103372|B2|||Age||years|Mean|37|37.0|Standard Deviation|11|11.0|||
4279535|NCT00566930|4103373|B1|||Age||years|Mean|43|43.0|Standard Deviation|11|11.0|||
4279536|NCT00566930|4103370|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4279537|NCT00566930|4103371|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4279538|NCT00566930|4103372|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4279539|NCT00566930|4103373|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4279540|NCT00566930|4103370|B4||Between 18 and 65 years|Age||Participants|Count of Participants|98|98.0||||||
4279541|NCT00566930|4103371|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4279542|NCT00566930|4103372|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4279543|NCT00566930|4103373|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4279544|NCT00566930|4103370|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279545|NCT00566930|4103371|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279546|NCT00566930|4103372|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279547|NCT00566930|4103373|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279548|NCT00566852|4103383|B3||Male|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4279549|NCT00566852|4103384|B2||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4279550|NCT00566852|4103385|B1||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4279551|NCT00566852|4103383|B3||Female|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
4279552|NCT00566852|4103384|B2||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4279553|NCT00566852|4103385|B1||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4279554|NCT00566852|4103383|B3|||Age||years|Median|59|59.0|Full Range|||29.0|86.0|
4279555|NCT00566852|4103384|B2|||Age||years|Median|59|59.0|Full Range|||29.0|86.0|
4279556|NCT00566852|4103385|B1|||Age||years|Median|60|60.0|Full Range|||31.0|84.0|
4279557|NCT00566813|4103402|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4279558|NCT00566813|4103403|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4279559|NCT00566813|4103404|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4279560|NCT00566813|4103402|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4279561|NCT00566813|4103403|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4279562|NCT00566813|4103404|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4279563|NCT00566813|4103402|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4279564|NCT00566813|4103403|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4279565|NCT00566813|4103404|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4279566|NCT00566813|4103402|B3|||Age||years|Mean|46.2|46.2|Standard Deviation|9.7|9.7|||
4279567|NCT00566813|4103403|B2|||Age||years|Mean|44.5|44.5|Standard Deviation|9.7|9.7|||
4279568|NCT00566813|4103404|B1|||Age||years|Mean|48.8|48.8|Standard Deviation|11.9|11.9|||
4279569|NCT00566813|4103402|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4279570|NCT00566813|4103403|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4279571|NCT00566813|4103404|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4279572|NCT00566813|4103402|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4279573|NCT00566813|4103403|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4279574|NCT00566813|4103404|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4279575|NCT00566813|4103402|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279576|NCT00566813|4103403|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279577|NCT00566813|4103404|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279578|NCT00566735|4103415|B3|||Modified Mini Mental Status Exam (3MSE)|The 3MSE is a rater-administered test that assesses a broad variety of cognitive functioning. Scores range from 0 to 30. Scores greater than 25 indicate a normal cognition. Below this, scores can indicate severe (≤9 points), moderate (10-20 points) or mild (21-24 points) cognitive impairment.|3MSE Score|Mean|91.20|91.2|Standard Deviation|7.02|7.02|||
4279579|NCT00566735|4103416|B2|||Modified Mini Mental Status Exam (3MSE)|The 3MSE is a rater-administered test that assesses a broad variety of cognitive functioning. Scores range from 0 to 30. Scores greater than 25 indicate a normal cognition. Below this, scores can indicate severe (≤9 points), moderate (10-20 points) or mild (21-24 points) cognitive impairment.|3MSE Score|Mean|90.41|90.41|Standard Deviation|5.48|5.48|||
4279580|NCT00566735|4103417|B1|||Modified Mini Mental Status Exam (3MSE)|The 3MSE is a rater-administered test that assesses a broad variety of cognitive functioning. Scores range from 0 to 30. Scores greater than 25 indicate a normal cognition. Below this, scores can indicate severe (≤9 points), moderate (10-20 points) or mild (21-24 points) cognitive impairment.|3MSE Score|Mean|91.72|91.72|Standard Deviation|8.05|8.05|||
4279581|NCT00566735|4103415|B3|||Clinical-Global Impressions - Severity (CGI-S)|This scale is a rater-administered assessment of severity of symptoms. 1 = Normal, not ill at all; 2 = Borderline ill; 3 = Mildly ill; 4 = Moderately ill; 5 = Markedly ill; 6 = Severely ill; 7 = Among the most extremely ill patients|CGI-S Score|Mean|4.61|4.61|Standard Deviation|.72|0.72|||
4279582|NCT00566735|4103416|B2|||Clinical-Global Impressions - Severity (CGI-S)|This scale is a rater-administered assessment of severity of symptoms. 1 = Normal, not ill at all; 2 = Borderline ill; 3 = Mildly ill; 4 = Moderately ill; 5 = Markedly ill; 6 = Severely ill; 7 = Among the most extremely ill patients|CGI-S Score|Mean|4.41|4.41|Standard Deviation|0.87|0.87|||
4279583|NCT00566735|4103417|B1|||Clinical-Global Impressions - Severity (CGI-S)|This scale is a rater-administered assessment of severity of symptoms. 1 = Normal, not ill at all; 2 = Borderline ill; 3 = Mildly ill; 4 = Moderately ill; 5 = Markedly ill; 6 = Severely ill; 7 = Among the most extremely ill patients|CGI-S Score|Mean|4.75|4.75|Standard Deviation|0.62|0.62|||
4279584|NCT00566735|4103415|B3|||Subjective Mood||Subjective Mood Score|Mean|7.95|7.95|Standard Deviation|1.70|1.7|||
4279585|NCT00566735|4103416|B2|||Subjective Mood||Subjective Mood Score|Mean|7.88|7.88|Standard Deviation|1.93|1.93|||
4279586|NCT00566735|4103417|B1|||Subjective Mood||Subjective Mood Score|Mean|8.0|8.0|Standard Deviation|1.54|1.54|||
4279587|NCT00566735|4103415|B3|||Hamilton Depression Rating Scale 17 (HAM-D-17)|This scale is a rater-administered assessment of depression severity and improvement. Scores range from 0 (not depressed) to 52 (severely depressed).|HAM-D-17 Score|Mean|26.21|26.21|Standard Deviation|4.33|4.33|||
4279588|NCT00566735|4103416|B2|||Hamilton Depression Rating Scale 17 (HAM-D-17)|This scale is a rater-administered assessment of depression severity and improvement. Scores range from 0 (not depressed) to 52 (severely depressed).|HAM-D-17 Score|Mean|24.53|24.53|Standard Deviation|4.33|4.33|||
4279589|NCT00566735|4103417|B1|||Hamilton Depression Rating Scale 17 (HAM-D-17)|This scale is a rater-administered assessment of depression severity and improvement. Scores range from 0 (not depressed) to 52 (severely depressed).|HAM-D-17 Score|Mean|27.33|27.33|Standard Deviation|4.33|4.33|||
4279590|NCT00566735|4103415|B3|||Wechsler Abbreviated Scale of Intelligence (WASI)|The WASI is a standardized measurement of intelligence quotient (IQ). Scores range from 1 to 160, with 100 signifying average intelligence, scores above 140 signifying superior intelligence, and scores below 40 signifying severe intellectual impairment.|WASI Score|Mean|103.12|103.12|Standard Deviation|15.87|15.87|||
4279591|NCT00566735|4103416|B2|||Wechsler Abbreviated Scale of Intelligence (WASI)|The WASI is a standardized measurement of intelligence quotient (IQ). Scores range from 1 to 160, with 100 signifying average intelligence, scores above 140 signifying superior intelligence, and scores below 40 signifying severe intellectual impairment.|WASI Score|Mean|104.57|104.57|Standard Deviation|12.35|12.35|||
4279592|NCT00566735|4103417|B1|||Wechsler Abbreviated Scale of Intelligence (WASI)|The WASI is a standardized measurement of intelligence quotient (IQ). Scores range from 1 to 160, with 100 signifying average intelligence, scores above 140 signifying superior intelligence, and scores below 40 signifying severe intellectual impairment.|WASI Score|Mean|102.16|102.16|Standard Deviation|18.21|18.21|||
4279593|NCT00566735|4103415|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4279594|NCT00566735|4103416|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4279595|NCT00566735|4103417|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4279596|NCT00566735|4103415|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4279597|NCT00566735|4103416|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4279598|NCT00566735|4103417|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4279599|NCT00566735|4103415|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4279600|NCT00566735|4103416|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4279601|NCT00566735|4103417|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4279602|NCT00566735|4103415|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4279603|NCT00566735|4103416|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4279604|NCT00566735|4103417|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4279605|NCT00566735|4103415|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279606|NCT00566735|4103416|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279607|NCT00566735|4103417|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279608|NCT00566722|4103428|B4|Canada||Region of Enrollment||participants|Number|46|46.0||||||
4279609|NCT00566722|4103429|B3|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4279610|NCT00566722|4103430|B2|Canada||Region of Enrollment||participants|Number|19|19.0||||||
4279611|NCT00566722|4103431|B1|Canada||Region of Enrollment||participants|Number|15|15.0||||||
4279612|NCT00566722|4103428|B4|United States||Region of Enrollment||participants|Number|106|106.0||||||
4279613|NCT00566722|4103429|B3|United States||Region of Enrollment||participants|Number|70|70.0||||||
4279614|NCT00566722|4103430|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4279615|NCT00566722|4103431|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4279616|NCT00566722|4103428|B4||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4279617|NCT00566722|4103429|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4279618|NCT00566722|4103430|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4279619|NCT00566722|4103431|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4279620|NCT00566722|4103428|B4||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4279621|NCT00566722|4103429|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4279622|NCT00566722|4103430|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4279623|NCT00566722|4103431|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4279624|NCT00566722|4103428|B4|||Age||years|Mean|47.6|47.6|Standard Deviation|13.67|13.67|||
4279625|NCT00566722|4103429|B3|||Age||years|Mean|48.3|48.3|Standard Deviation|13.70|13.7|||
4279626|NCT00566722|4103430|B2|||Age||years|Mean|45.7|45.7|Standard Deviation|14.60|14.6|||
4279627|NCT00566722|4103431|B1|||Age||years|Mean|47.4|47.4|Standard Deviation|13.11|13.11|||
4279628|NCT00566709|4103477|B3|Intra cerebral hemorrhage||Diagnosis||participants|Number|22|22.0||||||
4279629|NCT00566709|4103478|B2|Intra cerebral hemorrhage||Diagnosis||participants|Number|11|11.0||||||
4279630|NCT00566709|4103479|B1|Intra cerebral hemorrhage||Diagnosis||participants|Number|11|11.0||||||
4279631|NCT00566709|4103477|B3|Subarachnoid hemorrhage||Diagnosis||participants|Number|23|23.0||||||
4279632|NCT00566709|4103478|B2|Subarachnoid hemorrhage||Diagnosis||participants|Number|13|13.0||||||
4279633|NCT00566709|4103479|B1|Subarachnoid hemorrhage||Diagnosis||participants|Number|10|10.0||||||
4279634|NCT00566709|4103477|B3|Traumatic Brain Injury||Diagnosis||participants|Number|57|57.0||||||
4279635|NCT00566709|4103478|B2|Traumatic Brain Injury||Diagnosis||participants|Number|27|27.0||||||
4279636|NCT00566709|4103479|B1|Traumatic Brain Injury||Diagnosis||participants|Number|30|30.0||||||
4279637|NCT00566709|4103477|B3|||CPP (mm Hg) (N=17, 22)|"Cerebral perfusion pressure (CPP)~Only 39 patients monitored with a PbrO2 probe are included:~17 into rSO2 arm~22 into hemoglobin arm"|mm Hg|Mean|73.4|73.4|Standard Deviation|16.7|16.7|||
4279638|NCT00566709|4103478|B2|||CPP (mm Hg) (N=17, 22)|"Cerebral perfusion pressure (CPP)~Only 39 patients monitored with a PbrO2 probe are included:~17 into rSO2 arm~22 into hemoglobin arm"|mm Hg|Mean|72.9|72.9|Standard Deviation|15.6|15.6|||
4279639|NCT00566709|4103479|B1|||CPP (mm Hg) (N=17, 22)|"Cerebral perfusion pressure (CPP)~Only 39 patients monitored with a PbrO2 probe are included:~17 into rSO2 arm~22 into hemoglobin arm"|mm Hg|Mean|73.9|73.9|Standard Deviation|18.5|18.5|||
4279640|NCT00566709|4103477|B3|||PbrO2 (mm Hg) (N=17, 22)|"Pressure brain regional oxygen: PbrO2~Only 39 patients monitored with a PbrO2 probe are included:~17 into rSO2 arm~22 into hemoglobin arm"|mm Hg|Mean|22.4|22.4|Standard Deviation|5.6|5.6|||
4279641|NCT00566709|4103478|B2|||PbrO2 (mm Hg) (N=17, 22)|"Pressure brain regional oxygen: PbrO2~Only 39 patients monitored with a PbrO2 probe are included:~17 into rSO2 arm~22 into hemoglobin arm"|mm Hg|Mean|22.8|22.8|Standard Deviation|5.6|5.6|||
4279642|NCT00566709|4103479|B1|||PbrO2 (mm Hg) (N=17, 22)|"Pressure brain regional oxygen: PbrO2~Only 39 patients monitored with a PbrO2 probe are included:~17 into rSO2 arm~22 into hemoglobin arm"|mm Hg|Mean|21.9|21.9|Standard Deviation|5.7|5.7|||
4279643|NCT00566709|4103477|B3|||Modified Grab score (N=11, 11)|"Modified Graeb score for intra cerebral hemorrhage Minimum: 0; maximum: 42.~Higher values represent worse outcome~Only 22 patients with intra cerebral hemorrhage are included~11 into rSO2 arm.~11 into hemoglobin arm."|units on a scale|Mean|6.3|6.3|Standard Deviation|3.4|3.4|||
4279644|NCT00566709|4103478|B2|||Modified Grab score (N=11, 11)|"Modified Graeb score for intra cerebral hemorrhage Minimum: 0; maximum: 42.~Higher values represent worse outcome~Only 22 patients with intra cerebral hemorrhage are included~11 into rSO2 arm.~11 into hemoglobin arm."|units on a scale|Mean|5.9|5.9|Standard Deviation|3|3.0|||
4279645|NCT00566709|4103479|B1|||Modified Grab score (N=11, 11)|"Modified Graeb score for intra cerebral hemorrhage Minimum: 0; maximum: 42.~Higher values represent worse outcome~Only 22 patients with intra cerebral hemorrhage are included~11 into rSO2 arm.~11 into hemoglobin arm."|units on a scale|Mean|6.7|6.7|Standard Deviation|3.9|3.9|||
4279646|NCT00566709|4103477|B3|||Fisher scale (N=10, 13)|"Computer tomography Fisher Scale~Minimum: 1; Maximum: 4~Higher values represent worse outcome~Only 23 patients with subarachnoid hemorrhage are included~10 into rSO2 arm~13 into hemoglobin arm"|units on a scale|Mean|3.8|3.8|Standard Deviation|0.4|0.4|||
4279647|NCT00566709|4103478|B2|||Fisher scale (N=10, 13)|"Computer tomography Fisher Scale~Minimum: 1; Maximum: 4~Higher values represent worse outcome~Only 23 patients with subarachnoid hemorrhage are included~10 into rSO2 arm~13 into hemoglobin arm"|units on a scale|Mean|3.8|3.8|Standard Deviation|0.4|0.4|||
4279648|NCT00566709|4103479|B1|||Fisher scale (N=10, 13)|"Computer tomography Fisher Scale~Minimum: 1; Maximum: 4~Higher values represent worse outcome~Only 23 patients with subarachnoid hemorrhage are included~10 into rSO2 arm~13 into hemoglobin arm"|units on a scale|Mean|3.9|3.9|Standard Deviation|0.3|0.3|||
4279649|NCT00566709|4103477|B3|||Hunt and Hess scale (N=10, 13)|"Hunt and Hess scale for assessing the severity of patients with subarachnoid hemorrhage Minimum: 1; Maximum: 5 Higher values represent worse outcome~Only 23 patients with subarachnoid hemorrhage are included.~10 into rSO2 arm~13 into hemoglobin arm"|units on a scale|Mean|4.1|4.1|Standard Deviation|1|1.0|||
4279650|NCT00566709|4103478|B2|||Hunt and Hess scale (N=10, 13)|"Hunt and Hess scale for assessing the severity of patients with subarachnoid hemorrhage Minimum: 1; Maximum: 5 Higher values represent worse outcome~Only 23 patients with subarachnoid hemorrhage are included.~10 into rSO2 arm~13 into hemoglobin arm"|units on a scale|Mean|4.1|4.1|Standard Deviation|0.8|0.8|||
4279651|NCT00566709|4103479|B1|||Hunt and Hess scale (N=10, 13)|"Hunt and Hess scale for assessing the severity of patients with subarachnoid hemorrhage Minimum: 1; Maximum: 5 Higher values represent worse outcome~Only 23 patients with subarachnoid hemorrhage are included.~10 into rSO2 arm~13 into hemoglobin arm"|units on a scale|Mean|4.1|4.1|Standard Deviation|1.2|1.2|||
4279652|NCT00566709|4103477|B3|||ISS score (N=30, 27)|"Injury severity score (ISS) Minimum: 0; maximum: 75 Higher values represent worse outcome~ISS is only collected in patients with traumatic brain injury (N=57)~30 into rSO2 arm~27 into hemoglobin arm"|units on a scale|Mean|28.5|28.5|Standard Deviation|9.6|9.6|||
4279653|NCT00566709|4103478|B2|||ISS score (N=30, 27)|"Injury severity score (ISS) Minimum: 0; maximum: 75 Higher values represent worse outcome~ISS is only collected in patients with traumatic brain injury (N=57)~30 into rSO2 arm~27 into hemoglobin arm"|units on a scale|Mean|29.0|29.0|Standard Deviation|9.6|9.6|||
4279654|NCT00566709|4103479|B1|||ISS score (N=30, 27)|"Injury severity score (ISS) Minimum: 0; maximum: 75 Higher values represent worse outcome~ISS is only collected in patients with traumatic brain injury (N=57)~30 into rSO2 arm~27 into hemoglobin arm"|units on a scale|Mean|28.0|28.0|Standard Deviation|9.8|9.8|||
4279655|NCT00566709|4103477|B3|||GCS|Glasgow Coma Scale Minimun: 3; Maximum: 15 Higher values represent better outcome|units on a scale|Median|9|9.0|Inter-Quartile Range|||7.0|11.0|
4279656|NCT00566709|4103478|B2|||GCS|Glasgow Coma Scale Minimun: 3; Maximum: 15 Higher values represent better outcome|units on a scale|Median|9|9.0|Inter-Quartile Range|||7.0|11.0|
4279657|NCT00566709|4103479|B1|||GCS|Glasgow Coma Scale Minimun: 3; Maximum: 15 Higher values represent better outcome|units on a scale|Median|9|9.0|Inter-Quartile Range|||7.0|12.0|
4279658|NCT00566709|4103477|B3|||APACHE II score|Acute Physiology and Chronic Health Evaluation (APACHE) II score Minimun score:0, Maximum score: 71 Higher values represent worse result.|units on a scale|Mean|14.1|14.1|Standard Deviation|4.5|4.5|||
4279659|NCT00566709|4103478|B2|||APACHE II score|Acute Physiology and Chronic Health Evaluation (APACHE) II score Minimun score:0, Maximum score: 71 Higher values represent worse result.|units on a scale|Mean|13.8|13.8|Standard Deviation|4.2|4.2|||
4279660|NCT00566709|4103479|B1|||APACHE II score|Acute Physiology and Chronic Health Evaluation (APACHE) II score Minimun score:0, Maximum score: 71 Higher values represent worse result.|units on a scale|Mean|14.6|14.6|Standard Deviation|4.8|4.8|||
4279661|NCT00566709|4103477|B3|No||Diabetes mellitus (n)||participants|Number|95|95.0||||||
4279662|NCT00566709|4103478|B2|No||Diabetes mellitus (n)||participants|Number|46|46.0||||||
4279663|NCT00566709|4103479|B1|No||Diabetes mellitus (n)||participants|Number|49|49.0||||||
4279664|NCT00566709|4103477|B3|Yes||Diabetes mellitus (n)||participants|Number|7|7.0||||||
4279665|NCT00566709|4103478|B2|Yes||Diabetes mellitus (n)||participants|Number|5|5.0||||||
4279666|NCT00566709|4103479|B1|Yes||Diabetes mellitus (n)||participants|Number|2|2.0||||||
4279667|NCT00566709|4103477|B3|No||Arterial Hypertension (n)||participants|Number|73|73.0||||||
4279668|NCT00566709|4103478|B2|No||Arterial Hypertension (n)||participants|Number|36|36.0||||||
4279669|NCT00566709|4103479|B1|No||Arterial Hypertension (n)||participants|Number|37|37.0||||||
4279670|NCT00566709|4103477|B3|Yes||Arterial Hypertension (n)||participants|Number|29|29.0||||||
4279671|NCT00566709|4103478|B2|Yes||Arterial Hypertension (n)||participants|Number|15|15.0||||||
4279672|NCT00566709|4103479|B1|Yes||Arterial Hypertension (n)||participants|Number|14|14.0||||||
4279673|NCT00566709|4103477|B3|||Hemoglobin (g/L)||g/L|Mean|112.4|112.4|Standard Deviation|21.3|21.3|||
4279674|NCT00566709|4103478|B2|||Hemoglobin (g/L)||g/L|Mean|114|114.0|Standard Deviation|21.6|21.6|||
4279675|NCT00566709|4103479|B1|||Hemoglobin (g/L)||g/L|Mean|110.9|110.9|Standard Deviation|21.2|21.2|||
4279676|NCT00566709|4103477|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4279677|NCT00566709|4103478|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4279678|NCT00566709|4103479|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4279679|NCT00566709|4103477|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4279680|NCT00566709|4103478|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4279681|NCT00566709|4103479|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4279682|NCT00566709|4103477|B3|||Age||years|Mean|45.6|45.6|Standard Deviation|17.3|17.3|||
4279683|NCT00566709|4103478|B2|||Age||years|Mean|46.1|46.1|Standard Deviation|16.3|16.3|||
4279684|NCT00566709|4103479|B1|||Age||years|Mean|45.2|45.2|Standard Deviation|18.3|18.3|||
4279685|NCT00566696|4103496|B1|Alemtuzumab (Campath-1H)||Conditioning Drug Received||participants|Number|20|20.0||||||
4279686|NCT00566696|4103496|B1|Muromonab (OKT3)||Conditioning Drug Received||participants|Number|11|11.0||||||
4279687|NCT00566696|4103496|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4279688|NCT00566696|4103496|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4279689|NCT00566696|4103496|B1|||Age, Customized|Age was evaluated at the time of transplantation.|years|Median|14.2|14.2|Full Range|||3.54|20.4|
4279690|NCT00566696|4103496|B1|||Age|Age was evaluated at the time of transplantation.|years|Mean|13.3|13.3|Standard Deviation|4.69|4.69|||
4279691|NCT00566631|4103504|B1||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4279692|NCT00566631|4103504|B1||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4279693|NCT00566631|4103504|B1|||Age||Years|Mean|40.3|40.3|Standard Deviation|12.4|12.4|||
4279694|NCT00566579|4103519|B3|Thailand||Region of Enrollment||participants|Number|60|60.0||||||
4279695|NCT00566579|4103520|B2|Thailand||Region of Enrollment||participants|Number|31|31.0||||||
4279696|NCT00566579|4103521|B1|Thailand||Region of Enrollment||participants|Number|29|29.0||||||
4279697|NCT00566579|4103519|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4279698|NCT00566579|4103520|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4279699|NCT00566579|4103521|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4279700|NCT00566579|4103519|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4279701|NCT00566579|4103520|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4279702|NCT00566579|4103521|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4279703|NCT00566579|4103519|B3|||Age||years|Mean|41.42|41.42|Standard Deviation|7.65|7.65|||
4279704|NCT00566579|4103520|B2|||Age||years|Mean|40.71|40.71|Standard Deviation|7.51|7.51|||
4279705|NCT00566579|4103521|B1|||Age||years|Mean|42.17|42.17|Standard Deviation|7.86|7.86|||
4279706|NCT00566579|4103519|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4279707|NCT00566579|4103520|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4279708|NCT00566579|4103521|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4279709|NCT00566579|4103519|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4279710|NCT00566579|4103520|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4279711|NCT00566579|4103521|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4279712|NCT00566579|4103519|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279713|NCT00566579|4103520|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279714|NCT00566579|4103521|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279715|NCT00566527|4103528|B4||Male|Sex: Female, Male||Participants|Count of Participants|799|799.0||||||
4279716|NCT00566527|4103529|B3||Male|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
4279717|NCT00566527|4103530|B2||Male|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
4279718|NCT00566527|4103531|B1||Male|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
4279719|NCT00566527|4103528|B4||Female|Sex: Female, Male||Participants|Count of Participants|821|821.0||||||
4279720|NCT00566527|4103529|B3||Female|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
4279721|NCT00566527|4103530|B2||Female|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
4279722|NCT00566527|4103531|B1||Female|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
4279723|NCT00566527|4103528|B4|||Age|Age at inclusion in study.|Months|Mean|9.48|9.48|Standard Deviation|0.30|0.3|||
4279724|NCT00566527|4103529|B3|||Age|Age at inclusion in study.|Months|Mean|9.47|9.47|Standard Deviation|9.43|9.43|||
4279725|NCT00566527|4103530|B2|||Age|Age at inclusion in study.|Months|Mean|9.48|9.48|Standard Deviation|0.30|0.3|||
4279726|NCT00566527|4103531|B1|||Age|Age at inclusion in study.|Months|Mean|9.47|9.47|Standard Deviation|0.29|0.29|||
4279727|NCT00566501|4103572|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
4279728|NCT00566501|4103573|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4279729|NCT00566501|4103574|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4279730|NCT00566501|4103572|B3|Other ( not specified)||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4279731|NCT00566501|4103573|B2|Other ( not specified)||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4279732|NCT00566501|4103574|B1|Other ( not specified)||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4279733|NCT00566501|4103572|B3|White||Race/Ethnicity, Customized||participants|Number|681|681.0||||||
4279734|NCT00566501|4103573|B2|White||Race/Ethnicity, Customized||participants|Number|246|246.0||||||
4279735|NCT00566501|4103574|B1|White||Race/Ethnicity, Customized||participants|Number|435|435.0||||||
4279736|NCT00566501|4103572|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4279737|NCT00566501|4103573|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4279738|NCT00566501|4103574|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4279739|NCT00566501|4103572|B3|Asian||Race/Ethnicity, Customized||participants|Number|144|144.0||||||
4279740|NCT00566501|4103573|B2|Asian||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
4279741|NCT00566501|4103574|B1|Asian||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
4279742|NCT00566501|4103572|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4279743|NCT00566501|4103573|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4279744|NCT00566501|4103574|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4279745|NCT00566501|4103572|B3||Male|Sex: Female, Male||Participants|Count of Participants|333|333.0||||||
4279746|NCT00566501|4103573|B2||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4279747|NCT00566501|4103574|B1||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4279748|NCT00566501|4103572|B3||Female|Sex: Female, Male||Participants|Count of Participants|582|582.0||||||
4279749|NCT00566501|4103573|B2||Female|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4279750|NCT00566501|4103574|B1||Female|Sex: Female, Male||Participants|Count of Participants|378|378.0||||||
4279751|NCT00566501|4103572|B3|||Age||years|Mean|74.2|74.2|Standard Deviation|8.56|8.56|||
4279752|NCT00566501|4103573|B2|||Age||years|Mean|74.5|74.5|Standard Deviation|8.46|8.46|||
4279753|NCT00566501|4103574|B1|||Age||years|Mean|74.1|74.1|Standard Deviation|8.63|8.63|||
4279754|NCT00566462|4103581|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4279755|NCT00566462|4103583|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4279756|NCT00566462|4103581|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4279757|NCT00566462|4103582|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4279758|NCT00566462|4103583|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4279759|NCT00566462|4103581|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4279760|NCT00566462|4103582|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4279761|NCT00566462|4103583|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4279762|NCT00566462|4103581|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4279763|NCT00566462|4103582|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4279764|NCT00566462|4103583|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4279765|NCT00566462|4103581|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4279766|NCT00566462|4103582|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4279767|NCT00566462|4103583|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4279768|NCT00566462|4103581|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279769|NCT00566462|4103582|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279770|NCT00566462|4103583|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279771|NCT00566254|4103592|B3||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4279772|NCT00566254|4103593|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4279773|NCT00566254|4103594|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4279774|NCT00566254|4103592|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4279775|NCT00566254|4103593|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4279776|NCT00566254|4103594|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4279777|NCT00566254|4103592|B3|12-17 Years Old||Age, Customized||Participants|Number|97|97.0||||||
4279778|NCT00566254|4103593|B2|12-17 Years Old||Age, Customized||Participants|Number|52|52.0||||||
4279779|NCT00566254|4103594|B1|12-17 Years Old||Age, Customized||Participants|Number|45|45.0||||||
4279780|NCT00566254|4103592|B3|6-11 Years Old||Age, Customized||Participants|Number|110|110.0||||||
4279781|NCT00566254|4103593|B2|6-11 Years Old||Age, Customized||Participants|Number|55|55.0||||||
4279782|NCT00566254|4103594|B1|6-11 Years Old||Age, Customized||Participants|Number|55|55.0||||||
4279783|NCT00566228|4103607|B3|United States||Region of Enrollment||Participants|Count of Participants|121|121.0||||||
4279784|NCT00566228|4103608|B2|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
4279785|NCT00566228|4103609|B1|United States||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
4279786|NCT00566228|4103607|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4279787|NCT00566228|4103608|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4279788|NCT00566228|4103609|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4279789|NCT00566228|4103607|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4279790|NCT00566228|4103608|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4279791|NCT00566228|4103609|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4279792|NCT00566228|4103607|B3|||Age||years|Median|58|58.0|Inter-Quartile Range|||50.0|64.0|
4279793|NCT00566228|4103608|B2|||Age||years|Median|58|58.0|Inter-Quartile Range|||49.0|64.0|
4279794|NCT00566228|4103609|B1|||Age||years|Median|58|58.0|Inter-Quartile Range|||50.0|64.0|
4279795|NCT00566150|4103626|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
4279796|NCT00566150|4103627|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4279797|NCT00566150|4103628|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4279798|NCT00566150|4103626|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4279799|NCT00566150|4103627|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4279800|NCT00566150|4103628|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4279801|NCT00566150|4103626|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4279802|NCT00566150|4103627|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4279803|NCT00566150|4103628|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4279804|NCT00566150|4103626|B3|||Age||years|Mean|44.1|44.1|Standard Deviation|10.2|10.2|||
4279805|NCT00566150|4103627|B2|||Age||years|Mean|42.4|42.4|Standard Deviation|9.6|9.6|||
4279806|NCT00566150|4103628|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|10.7|10.7|||
4279807|NCT00566150|4103626|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4279808|NCT00566150|4103627|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4279809|NCT00566150|4103628|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4279810|NCT00566150|4103626|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4279811|NCT00566150|4103627|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4279812|NCT00566150|4103628|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4279813|NCT00566150|4103626|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279814|NCT00566150|4103627|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279815|NCT00566150|4103628|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279816|NCT00566111|4103641|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4279817|NCT00566111|4103642|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4279818|NCT00566111|4103643|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4279819|NCT00566111|4103641|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4279820|NCT00566111|4103642|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4279821|NCT00566111|4103643|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4279822|NCT00566111|4103641|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4279823|NCT00566111|4103642|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4279824|NCT00566111|4103643|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4279825|NCT00566111|4103641|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4279826|NCT00566111|4103642|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4279827|NCT00566111|4103643|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4279828|NCT00566111|4103641|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279829|NCT00566111|4103642|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279830|NCT00566111|4103643|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279831|NCT00566098|4103658|B1|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4279832|NCT00566098|4103658|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4279833|NCT00566098|4103658|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279834|NCT00566098|4103658|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4279835|NCT00566098|4103658|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4279836|NCT00566098|4103658|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279837|NCT00566098|4103658|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279838|NCT00566098|4103658|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279839|NCT00566098|4103658|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4279840|NCT00566098|4103658|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4279841|NCT00566098|4103658|B1|||Age||years|Median|56|56.0|Full Range|||30.0|71.0|
4279842|NCT00566020|4103668|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4279843|NCT00566020|4103668|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|91|91.0||||||
4279844|NCT00566020|4103668|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4279845|NCT00566020|4103668|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4279846|NCT00566020|4103668|B1|||Age||Years|Mean|43.5|43.5|Standard Deviation|12.11|12.11|||
4279847|NCT00565916|4103694|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4279848|NCT00565916|4103695|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4279849|NCT00565916|4103696|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4279850|NCT00565916|4103694|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4279851|NCT00565916|4103695|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4279852|NCT00565916|4103696|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4279853|NCT00565916|4103694|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4279854|NCT00565916|4103695|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4279855|NCT00565916|4103696|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4279856|NCT00565916|4103694|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4279857|NCT00565916|4103695|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4279858|NCT00565916|4103696|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4279859|NCT00565916|4103694|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279860|NCT00565916|4103695|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279861|NCT00565916|4103696|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279862|NCT00565864|4103703|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4279863|NCT00565864|4103704|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279864|NCT00565864|4103705|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4279865|NCT00565864|4103706|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4279866|NCT00565864|4103703|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4279867|NCT00565864|4103704|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4279868|NCT00565864|4103705|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4279869|NCT00565864|4103706|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279870|NCT00565864|4103703|B4||White|Race (NIH/OMB)||Participants|Count of Participants|127|127.0||||||
4279871|NCT00565864|4103704|B3||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4279872|NCT00565864|4103705|B2||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4279873|NCT00565864|4103706|B1||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4279874|NCT00565864|4103703|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4279875|NCT00565864|4103704|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4279876|NCT00565864|4103705|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279877|NCT00565864|4103706|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279878|NCT00565864|4103703|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279879|NCT00565864|4103704|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279880|NCT00565864|4103705|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279881|NCT00565864|4103706|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279882|NCT00565864|4103703|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4279883|NCT00565864|4103704|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4279884|NCT00565864|4103705|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4279885|NCT00565864|4103706|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279886|NCT00565864|4103703|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4279887|NCT00565864|4103704|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279888|NCT00565864|4103705|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279889|NCT00565864|4103706|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4279890|NCT00565864|4103703|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279891|NCT00565864|4103704|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279892|NCT00565864|4103705|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279893|NCT00565864|4103706|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279894|NCT00565864|4103703|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
4279895|NCT00565864|4103704|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4279896|NCT00565864|4103705|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4279897|NCT00565864|4103706|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4279898|NCT00565864|4103703|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4279899|NCT00565864|4103704|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4279900|NCT00565864|4103705|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4279901|NCT00565864|4103706|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4279902|NCT00565864|4103703|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4279903|NCT00565864|4103704|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4279904|NCT00565864|4103705|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4279905|NCT00565864|4103706|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4279906|NCT00565864|4103703|B4||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4279907|NCT00565864|4103704|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4279908|NCT00565864|4103705|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4279909|NCT00565864|4103706|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4279910|NCT00565864|4103703|B4|||Age||years|Mean|49.7|49.7|Standard Deviation|11.7|11.7|||
4279911|NCT00565864|4103704|B3|||Age||years|Mean|49.3|49.3|Standard Deviation|10.7|10.7|||
4279912|NCT00565864|4103705|B2|||Age||years|Mean|50.9|50.9|Standard Deviation|12.3|12.3|||
4279913|NCT00565864|4103706|B1|||Age||years|Mean|49.5|49.5|Standard Deviation|11.5|11.5|||
4279914|NCT00565812|4103755|B4||Male|Gender||Participants|Count of Participants|343|343.0||||||
4279915|NCT00565812|4103756|B3||Male|Gender||Participants|Count of Participants|122|122.0||||||
4279916|NCT00565812|4103757|B2||Male|Gender||Participants|Count of Participants|119|119.0||||||
4279917|NCT00565812|4103758|B1||Male|Gender||Participants|Count of Participants|102|102.0||||||
4279918|NCT00565812|4103755|B4||Female|Gender||Participants|Count of Participants|1114|1114.0||||||
4279919|NCT00565812|4103756|B3||Female|Gender||Participants|Count of Participants|364|364.0||||||
4279920|NCT00565812|4103757|B2||Female|Gender||Participants|Count of Participants|367|367.0||||||
4279921|NCT00565812|4103758|B1||Female|Gender||Participants|Count of Participants|383|383.0||||||
4279922|NCT00565812|4103755|B4|||Age||years|Mean|61.0|61.0|Standard Deviation|8.8|8.8|||
4279923|NCT00565812|4103756|B3|||Age||years|Mean|61.3|61.3|Standard Deviation|9.1|9.1|||
4279924|NCT00565812|4103757|B2|||Age||years|Mean|60.8|60.8|Standard Deviation|8.6|8.6|||
4279925|NCT00565812|4103758|B1|||Age||years|Mean|61.0|61.0|Standard Deviation|8.7|8.7|||
4279926|NCT00565747|4103897|B3|Sweden||Region of Enrollment||participants|Number|87|87.0||||||
4279927|NCT00565747|4103898|B2|Sweden||Region of Enrollment||participants|Number|43|43.0||||||
4279928|NCT00565747|4103899|B1|Sweden||Region of Enrollment||participants|Number|44|44.0||||||
4279929|NCT00565747|4103897|B3|Denmark||Region of Enrollment||participants|Number|1245|1245.0||||||
4279930|NCT00565747|4103898|B2|Denmark||Region of Enrollment||participants|Number|635|635.0||||||
4279931|NCT00565747|4103899|B1|Denmark||Region of Enrollment||participants|Number|610|610.0||||||
4279932|NCT00565747|4103897|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4279933|NCT00565747|4103898|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4279934|NCT00565747|4103899|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4279935|NCT00565747|4103897|B3||Female|Sex: Female, Male||Participants|Count of Participants|1332|1332.0||||||
4279936|NCT00565747|4103898|B2||Female|Sex: Female, Male||Participants|Count of Participants|678|678.0||||||
4279937|NCT00565747|4103899|B1||Female|Sex: Female, Male||Participants|Count of Participants|654|654.0||||||
4279938|NCT00565747|4103897|B3|||Age||Years|Mean|32.3|32.3|Standard Deviation|3.8|3.8|||
4279939|NCT00565747|4103898|B2|||Age||Years|Mean|32.4|32.4|Standard Deviation|3.8|3.8|||
4279940|NCT00565747|4103899|B1|||Age||Years|Mean|32.2|32.2|Standard Deviation|3.7|3.7|||
4279941|NCT00565721|4103910|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4279942|NCT00565721|4103910|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4279943|NCT00565721|4103910|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4279944|NCT00565721|4103910|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4279945|NCT00565721|4103910|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4279946|NCT00565721|4103910|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4279947|NCT00565721|4103910|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4279948|NCT00565721|4103910|B1|||Age||years|Mean|50.4|50.4|Standard Deviation|10.09|10.09|||
4279949|NCT00565669|4103929|B3|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4279950|NCT00565669|4103930|B2|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4279951|NCT00565669|4103931|B1|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4279952|NCT00565669|4103929|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279953|NCT00565669|4103930|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279954|NCT00565669|4103931|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279955|NCT00565669|4103929|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279956|NCT00565669|4103930|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279957|NCT00565669|4103931|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279958|NCT00565669|4103929|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4279959|NCT00565669|4103930|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4279960|NCT00565669|4103931|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4279961|NCT00565669|4103929|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279962|NCT00565669|4103930|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279963|NCT00565669|4103931|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279964|NCT00565669|4103929|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279965|NCT00565669|4103930|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279966|NCT00565669|4103931|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279967|NCT00565669|4103929|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279968|NCT00565669|4103930|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279969|NCT00565669|4103931|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279970|NCT00565669|4103929|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279971|NCT00565669|4103930|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279972|NCT00565669|4103931|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279973|NCT00565669|4103929|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279974|NCT00565669|4103930|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279975|NCT00565669|4103931|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279976|NCT00565669|4103929|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4279977|NCT00565669|4103930|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4279978|NCT00565669|4103931|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4279979|NCT00565669|4103929|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279980|NCT00565669|4103930|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279981|NCT00565669|4103931|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4279982|NCT00565669|4103929|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4279983|NCT00565669|4103930|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4279984|NCT00565669|4103931|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4279985|NCT00565669|4103929|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4279986|NCT00565669|4103930|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4279987|NCT00565669|4103931|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4279988|NCT00565669|4103929|B3|||Age||years|Mean|66.8|66.8|Standard Deviation|8.8|8.8|||
4279989|NCT00565669|4103930|B2|||Age||years|Mean|67.4|67.4|Standard Deviation|7.82|7.82|||
4279990|NCT00565669|4103931|B1|||Age||years|Mean|66.3|66.3|Standard Deviation|9.7|9.7|||
4279991|NCT00565643|4103938|B3|||Preoperative Maximum Temperature||degrees Fahrenheit|Mean|NA||Standard Deviation|NA||||The Totals are unable to be calculated because the analysis was not performed for the Total population and there are no means to calculate.
4279992|NCT00565643|4103939|B2|||Preoperative Maximum Temperature||degrees Fahrenheit|Mean|97.9|97.9|Standard Deviation|0.9|0.9|||
4279993|NCT00565643|4103940|B1|||Preoperative Maximum Temperature||degrees Fahrenheit|Mean|97.8|97.8|Standard Deviation|1.0|1.0|||
4279994|NCT00565643|4103938|B3|||Preoperative White Blood cell count||cells/mm^3|Mean|NA||Standard Deviation|NA||||The Totals are unable to be calculated because the analysis was not performed for the Total population and there are no means to calculate.
4279995|NCT00565643|4103939|B2|||Preoperative White Blood cell count||cells/mm^3|Mean|10.7|10.7|Standard Deviation|4.6|4.6|||
4279996|NCT00565643|4103940|B1|||Preoperative White Blood cell count||cells/mm^3|Mean|10.3|10.3|Standard Deviation|3.4|3.4|||
4279997|NCT00565643|4103938|B3|||Preoperative Hematocrit||percent|Mean|NA||Standard Deviation|NA||||The Totals are unable to be calculated because the analysis was not performed for the Total population and there are no means to calculate.
4279998|NCT00565643|4103939|B2|||Preoperative Hematocrit||percent|Mean|34.4|34.4|Standard Deviation|5.0|5.0|||
4279999|NCT00565643|4103940|B1|||Preoperative Hematocrit||percent|Mean|34.8|34.8|Standard Deviation|4.3|4.3|||
4280000|NCT00565643|4103938|B3|||# of previous cesarean births||births|Median|NA||Full Range|||0.0|0.0|The Totals are unable to be calculated because the analysis was not performed for the Total population and there are no means to calculate.
4280001|NCT00565643|4103939|B2|||# of previous cesarean births||births|Median|1|1.0|Full Range|||0.0|3.0|
4280002|NCT00565643|4103940|B1|||# of previous cesarean births||births|Median|1|1.0|Full Range|||0.0|3.0|
4280003|NCT00565643|4103938|B3|||Body Mass Index (BMI), kg/m^2||kg/m^2|Mean|NA||Standard Deviation|NA||||The Totals are unable to be calculated because the analysis was not performed for the Total population and there are no means to calculate.
4280004|NCT00565643|4103939|B2|||Body Mass Index (BMI), kg/m^2||kg/m^2|Mean|33.2|33.2|Standard Deviation|7.8|7.8|||
4280005|NCT00565643|4103940|B1|||Body Mass Index (BMI), kg/m^2||kg/m^2|Mean|33.3|33.3|Standard Deviation|6.6|6.6|||
4280006|NCT00565643|4103938|B3|||Gestational age (weeks)||weeks|Mean|NA||Standard Deviation|NA||||The Totals are unable to be calculated because the analysis was not performed for the Total population and there are no means to calculate.
4280007|NCT00565643|4103939|B2|||Gestational age (weeks)||weeks|Mean|38.1|38.1|Standard Deviation|3.9|3.9|||
4280008|NCT00565643|4103940|B1|||Gestational age (weeks)||weeks|Mean|38.7|38.7|Standard Deviation|1.9|1.9|||
4280009|NCT00565643|4103938|B3|||Parity||pregnancies|Median|NA||Full Range|||0.0|0.0|The Totals are unable to be calculated because the analysis was not performed for the Total population and there are no means to calculate.
4280010|NCT00565643|4103939|B2|||Parity||pregnancies|Median|1|1.0|Full Range|||0.0|4.0|
4280011|NCT00565643|4103940|B1|||Parity||pregnancies|Median|1|1.0|Full Range|||0.0|4.0|
4280012|NCT00565643|4103938|B3|||Gravid||pregnancies|Mean|NA||Full Range|||0.0|0.0|The Totals are unable to be calculated because the analysis was not performed for the Total population and there are no means to calculate.
4280013|NCT00565643|4103939|B2|||Gravid||pregnancies|Mean|2|2.0|Full Range|||1.0|11.0|
4280014|NCT00565643|4103940|B1|||Gravid||pregnancies|Mean|2|2.0|Full Range|||1.0|20.0|
4280015|NCT00565643|4103938|B3|United States||Region of Enrollment||participants|Number|753|753.0||||||
4280016|NCT00565643|4103939|B2|United States||Region of Enrollment||participants|Number|373|373.0||||||
4280017|NCT00565643|4103940|B1|United States||Region of Enrollment||participants|Number|380|380.0||||||
4280018|NCT00565643|4103938|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4280019|NCT00565643|4103939|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4280020|NCT00565643|4103940|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4280021|NCT00565643|4103938|B3||Female|Sex: Female, Male||Participants|Count of Participants|753|753.0||||||
4280022|NCT00565643|4103939|B2||Female|Sex: Female, Male||Participants|Count of Participants|373|373.0||||||
4280023|NCT00565643|4103940|B1||Female|Sex: Female, Male||Participants|Count of Participants|380|380.0||||||
4280024|NCT00565643|4103938|B3|||Age||years|Mean|NA||Standard Deviation|NA||||The Totals are unable to be calculated because the analysis was not performed for the Total population and there are no means to calculate.
4280025|NCT00565643|4103939|B2|||Age||years|Mean|30.9|30.9|Standard Deviation|5.3|5.3|||
4280026|NCT00565643|4103940|B1|||Age||years|Mean|30.4|30.4|Standard Deviation|5.1|5.1|||
4280027|NCT00565617|4103959|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4280028|NCT00565617|4103959|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4280029|NCT00565617|4103959|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4280030|NCT00565617|4103959|B1|||Age||years|Mean|44.2|44.2|Standard Deviation|9.7|9.7|||
4280031|NCT00565617|4103959|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4280032|NCT00565617|4103959|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4280033|NCT00565617|4103959|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280034|NCT00565604|4103963|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4280035|NCT00565604|4103963|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4280036|NCT00565604|4103963|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4280037|NCT00565604|4103963|B1|||Age||years|Mean|54.1|54.1|Standard Deviation|14.4|14.4|||
4280038|NCT00565461|4103970|B5|United States||Region of Enrollment||participants|Number|160|160.0||||||
4280039|NCT00565461|4103971|B4|United States||Region of Enrollment||participants|Number|40|40.0||||||
4280040|NCT00565461|4103972|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4280041|NCT00565461|4103973|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4280042|NCT00565461|4103974|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4280043|NCT00565461|4103970|B5||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4280044|NCT00565461|4103971|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4280045|NCT00565461|4103972|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4280046|NCT00565461|4103973|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4280047|NCT00565461|4103974|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4280048|NCT00565461|4103970|B5||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4280049|NCT00565461|4103971|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4280050|NCT00565461|4103972|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4280051|NCT00565461|4103973|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4280052|NCT00565461|4103974|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4280053|NCT00565461|4103970|B5|||Age||years|Mean|36.0|36.0|Standard Deviation|11.02|11.02|||
4280054|NCT00565461|4103971|B4|||Age||years|Mean|34.1|34.1|Standard Deviation|11.18|11.18|||
4280055|NCT00565461|4103972|B3|||Age||years|Mean|38.1|38.1|Standard Deviation|11.18|11.18|||
4280056|NCT00565461|4103973|B2|||Age||years|Mean|35.0|35.0|Standard Deviation|11.10|11.1|||
4280057|NCT00565461|4103974|B1|||Age||years|Mean|36.8|36.8|Standard Deviation|12.21|12.21|||
4280058|NCT00565448|4103989|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4280059|NCT00565448|4103990|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4280060|NCT00565448|4103991|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4280061|NCT00565448|4103989|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4280062|NCT00565448|4103990|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4280063|NCT00565448|4103991|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4280064|NCT00565448|4103989|B3|Adolescents >=16||Age, Customized||participants|Number|40|40.0||||||
4280065|NCT00565448|4103990|B2|Adolescents >=16||Age, Customized||participants|Number|14|14.0||||||
4280066|NCT00565448|4103991|B1|Adolescents >=16||Age, Customized||participants|Number|26|26.0||||||
4280067|NCT00565448|4103989|B3|Adolescents from 12 years to <16 years||Age, Customized||participants|Number|30|30.0||||||
4280068|NCT00565448|4103990|B2|Adolescents from 12 years to <16 years||Age, Customized||participants|Number|10|10.0||||||
4280069|NCT00565448|4103991|B1|Adolescents from 12 years to <16 years||Age, Customized||participants|Number|20|20.0||||||
4280070|NCT00565448|4103989|B3|Children from 2 years to <12 years||Age, Customized||participants|Number|5|5.0||||||
4280071|NCT00565448|4103990|B2|Children from 2 years to <12 years||Age, Customized||participants|Number|1|1.0||||||
4280072|NCT00565448|4103991|B1|Children from 2 years to <12 years||Age, Customized||participants|Number|4|4.0||||||
4280073|NCT00565448|4103989|B3|Infants from 28 days to 23 months||Age, Customized||participants|Number|0|0.0||||||
4280074|NCT00565448|4103990|B2|Infants from 28 days to 23 months||Age, Customized||participants|Number|0|0.0||||||
4280075|NCT00565448|4103991|B1|Infants from 28 days to 23 months||Age, Customized||participants|Number|0|0.0||||||
4280076|NCT00565448|4103989|B3|||Age||years|Median|16|16.0|Full Range|||9.0|21.0|
4280077|NCT00565448|4103990|B2|||Age||years|Median|16|16.0|Full Range|||9.0|21.0|
4280078|NCT00565448|4103991|B1|||Age||years|Median|16|16.0|Full Range|||9.0|21.0|
4280079|NCT00565409|4104003|B1||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4280080|NCT00565409|4104003|B1||Female|Sex: Female, Male||Participants|Count of Participants|694|694.0||||||
4280081|NCT00565409|4104003|B1|||Age||years|Mean|48.36|48.36|Standard Deviation|11.94|11.94|||
4280082|NCT00565370|4104108|B1|Korea, Republic of||Region of Enrollment||participants|Number|21|21.0||||||
4280083|NCT00565370|4104108|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4280084|NCT00565370|4104108|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4280085|NCT00565370|4104108|B1|||Age||years|Mean|53.7|53.7|Standard Deviation|11.8|11.8|||
4280086|NCT00565370|4104108|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4280087|NCT00565370|4104108|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4280088|NCT00565370|4104108|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280089|NCT00565266|4104116|B1|United States||Region of Enrollment||participants|Number|210|210.0||||||
4280090|NCT00565266|4104116|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4280091|NCT00565266|4104116|B1||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4280092|NCT00565266|4104116|B1|||Age||years|Mean|42.2|42.2|Standard Deviation|12.3|12.3|||
4280093|NCT00565266|4104116|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4280094|NCT00565266|4104116|B1||Between 18 and 65 years|Age||Participants|Count of Participants|207|207.0||||||
4280095|NCT00565266|4104116|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280096|NCT00565136|4104142|B1|||Endoanal Ultrasound/Magnetic Resonance Imaging - Extent of Sphincter Defect|Data from 10 subjects who had a sphincter defect. Defects are measured on 0-360 degree scale.|degrees|Mean|95.0|95.0|Standard Deviation|50.2|50.2|||
4280097|NCT00565136|4104142|B1|No||Endoanal Ultrasound/Magnetic Resonance Imaging - Sphincter Defect||participants|Number|19|19.0||||||
4280098|NCT00565136|4104142|B1|Yes||Endoanal Ultrasound/Magnetic Resonance Imaging - Sphincter Defect||participants|Number|10|10.0||||||
4280099|NCT00565136|4104142|B1|MRI||Endoanal Ultrasound or Magnetic Resonance Imaging Completed||participants|Number|6|6.0||||||
4280100|NCT00565136|4104142|B1|Endoanal Ultrasound||Endoanal Ultrasound or Magnetic Resonance Imaging Completed||participants|Number|23|23.0||||||
4280101|NCT00565136|4104142|B1|No||Digital Rectal Exam - Anal Resting Tone||participants|Number|2|2.0||||||
4280102|NCT00565136|4104142|B1|Yes||Digital Rectal Exam - Anal Resting Tone||participants|Number|27|27.0||||||
4280103|NCT00565136|4104142|B1|No||Digital Rectal Exam - Hemorrhoids||participants|Number|27|27.0||||||
4280104|NCT00565136|4104142|B1|Yes||Digital Rectal Exam - Hemorrhoids||participants|Number|2|2.0||||||
4280105|NCT00565136|4104142|B1|No||Digital Rectal Exam - Soft Tissue Scarring||participants|Number|24|24.0||||||
4280106|NCT00565136|4104142|B1|Yes||Digital Rectal Exam - Soft Tissue Scarring||participants|Number|5|5.0||||||
4280107|NCT00565136|4104142|B1|Other||Colonoscopy Results||participants|Number|0|0.0||||||
4280108|NCT00565136|4104142|B1|Unknown||Colonoscopy Results||participants|Number|6|6.0||||||
4280109|NCT00565136|4104142|B1|Abnormal||Colonoscopy Results||participants|Number|8|8.0||||||
4280110|NCT00565136|4104142|B1|Normal||Colonoscopy Results||participants|Number|15|15.0||||||
4280111|NCT00565136|4104142|B1|No||Colonoscopy within past 10 years||participants|Number|5|5.0||||||
4280112|NCT00565136|4104142|B1|Yes||Colonoscopy within past 10 years||participants|Number|24|24.0||||||
4280113|NCT00565136|4104142|B1|Other||Etiology of Fecal Incontinence|Participants can have multiple etiologies|participants|Number|0|0.0||||||
4280114|NCT00565136|4104142|B1|Congenital abnormality||Etiology of Fecal Incontinence|Participants can have multiple etiologies|participants|Number|0|0.0||||||
4280115|NCT00565136|4104142|B1|Idiopathic/Unknown||Etiology of Fecal Incontinence|Participants can have multiple etiologies|participants|Number|15|15.0||||||
4280116|NCT00565136|4104142|B1|Obstetric trauma||Etiology of Fecal Incontinence|Participants can have multiple etiologies|participants|Number|10|10.0||||||
4280117|NCT00565136|4104142|B1|Anorectal trauma||Etiology of Fecal Incontinence|Participants can have multiple etiologies|participants|Number|4|4.0||||||
4280118|NCT00565136|4104142|B1|Neurological||Etiology of Fecal Incontinence|Participants can have multiple etiologies|participants|Number|2|2.0||||||
4280119|NCT00565136|4104142|B1|Other||Fecal Incontinence Treatment History (failed modalities)|Participants can have multiple failed modalities|participants|Number|6|6.0||||||
4280120|NCT00565136|4104142|B1|Pelvic surgery||Fecal Incontinence Treatment History (failed modalities)|Participants can have multiple failed modalities|participants|Number|3|3.0||||||
4280121|NCT00565136|4104142|B1|Biofeedback||Fecal Incontinence Treatment History (failed modalities)|Participants can have multiple failed modalities|participants|Number|11|11.0||||||
4280122|NCT00565136|4104142|B1|FI medication||Fecal Incontinence Treatment History (failed modalities)|Participants can have multiple failed modalities|participants|Number|9|9.0||||||
4280123|NCT00565136|4104142|B1|Diet modification||Fecal Incontinence Treatment History (failed modalities)|Participants can have multiple failed modalities|participants|Number|25|25.0||||||
4280124|NCT00565136|4104142|B1|Post-menopausal||Menopausal Status||participants|Number|22|22.0||||||
4280125|NCT00565136|4104142|B1|Pre-menopausal||Menopausal Status||participants|Number|7|7.0||||||
4280126|NCT00565136|4104142|B1|||Number of Vaginal Births||deliveries|Mean|2.8|2.8|Standard Deviation|1.1|1.1|||
4280127|NCT00565136|4104142|B1|||Number Cesarean Births||deliveries|Mean|0.1|0.1|Standard Deviation|0.3|0.3|||
4280128|NCT00565136|4104142|B1|||Parity|Parity is defined as the number of times a female has given birth.|births|Mean|2.9|2.9|Standard Deviation|1.1|1.1|||
4280129|NCT00565136|4104142|B1|||Gravidity|Gravidity is defined as the number of times a female has been pregnant.|pregnancies|Mean|3.6|3.6|Standard Deviation|2.1|2.1|||
4280130|NCT00565136|4104142|B1|||Body Mass Index|Body Mass Index is calculated as by the formula: weight (kg) / [height (m)]^2|kg/[m]^2|Mean|28.1|28.1|Standard Deviation|7.1|7.1|||
4280131|NCT00565136|4104142|B1|||Weight||kg|Mean|76.3|76.3|Standard Deviation|19.6|19.6|||
4280132|NCT00565136|4104142|B1|||Height||cm|Mean|164.8|164.8|Standard Deviation|5.9|5.9|||
4280133|NCT00565136|4104142|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4280134|NCT00565136|4104142|B1|White / Caucasian||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4280135|NCT00565136|4104142|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4280136|NCT00565136|4104142|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4280137|NCT00565136|4104142|B1|||Age||years|Mean|60.6|60.6|Standard Deviation|13.9|13.9|||
4280138|NCT00565110|4104160|B3|United States||Region of Enrollment||participants|Number|472|472.0||||||
4280139|NCT00565110|4104161|B2|United States||Region of Enrollment||participants|Number|242|242.0||||||
4280140|NCT00565110|4104162|B1|United States||Region of Enrollment||participants|Number|230|230.0||||||
4280141|NCT00565110|4104160|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280142|NCT00565110|4104161|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280143|NCT00565110|4104162|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280144|NCT00565110|4104160|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4280145|NCT00565110|4104161|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4280146|NCT00565110|4104162|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4280147|NCT00565110|4104160|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|415|415.0||||||
4280148|NCT00565110|4104161|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|219|219.0||||||
4280149|NCT00565110|4104162|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|196|196.0||||||
4280150|NCT00565110|4104160|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4280151|NCT00565110|4104161|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4280152|NCT00565110|4104162|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4280153|NCT00565110|4104160|B3||Female|Sex: Female, Male||Participants|Count of Participants|399|399.0||||||
4280154|NCT00565110|4104161|B2||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4280155|NCT00565110|4104162|B1||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4280156|NCT00565110|4104160|B3|||Age||years|Mean|48.65|48.65|Standard Deviation|12.94|12.94|||
4280157|NCT00565110|4104161|B2|||Age||years|Mean|47.59|47.59|Standard Deviation|12.88|12.88|||
4280158|NCT00565110|4104162|B1|||Age||years|Mean|49.77|49.77|Standard Deviation|12.93|12.93|||
4280159|NCT00565084|4104171|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4280160|NCT00565084|4104171|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4280161|NCT00565084|4104171|B1|||Age||years|Mean|60.78|60.78|Full Range|||47.0|80.0|
4280162|NCT00565058|4104181|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
4280163|NCT00565058|4104182|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4280164|NCT00565058|4104183|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4280165|NCT00565058|4104181|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4280166|NCT00565058|4104182|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4280167|NCT00565058|4104183|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4280168|NCT00565058|4104181|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4280169|NCT00565058|4104182|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4280170|NCT00565058|4104183|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4280171|NCT00565058|4104181|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4280172|NCT00565058|4104182|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4280173|NCT00565058|4104183|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4280174|NCT00565058|4104181|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4280175|NCT00565058|4104182|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4280176|NCT00565058|4104183|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4280177|NCT00565058|4104181|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280178|NCT00565058|4104182|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280179|NCT00565058|4104183|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280180|NCT00565045|4104192|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4280181|NCT00565045|4104193|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4280182|NCT00565045|4104194|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4280183|NCT00565045|4104192|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4280184|NCT00565045|4104193|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4280185|NCT00565045|4104194|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4280186|NCT00565045|4104192|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4280187|NCT00565045|4104193|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4280188|NCT00565045|4104194|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4280189|NCT00565045|4104192|B3|||Age||years|Mean|48.6|48.6|Standard Deviation|14.7|14.7|||
4280190|NCT00565045|4104193|B2|||Age||years|Mean|43.9|43.9|Standard Deviation|15.2|15.2|||
4280191|NCT00565045|4104194|B1|||Age||years|Mean|53.8|53.8|Standard Deviation|12.9|12.9|||
4280192|NCT00565045|4104192|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4280193|NCT00565045|4104193|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4280194|NCT00565045|4104194|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4280195|NCT00565045|4104192|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4280196|NCT00565045|4104193|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4280197|NCT00565045|4104194|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4280198|NCT00565045|4104192|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280199|NCT00565045|4104193|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280200|NCT00565045|4104194|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280201|NCT00564954|4104209|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4280202|NCT00564954|4104210|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4280203|NCT00564954|4104211|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4280204|NCT00564954|4104209|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4280205|NCT00564954|4104210|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4280206|NCT00564954|4104211|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4280207|NCT00564954|4104209|B3|||Age||years|Mean|9.5|9.5|Standard Deviation|1.7|1.7|||
4280208|NCT00564954|4104210|B2|||Age||years|Mean|9.4|9.4|Standard Deviation|1.4|1.4|||
4280209|NCT00564954|4104211|B1|||Age||years|Mean|9.5|9.5|Standard Deviation|2.0|2.0|||
4280275|NCT00564876|4104273|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4280276|NCT00564876|4104273|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4280277|NCT00564876|4104273|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280278|NCT00564850|4104280|B1|||Weight||Kg|Mean|32.76|32.76|Standard Deviation|7.36|7.36|||
4280279|NCT00564850|4104280|B1|France||Region of Enrollment||participants|Number|37|37.0||||||
4280210|NCT00564902|4104228|B4|||100% Kinetic Field|Scotomas within the central 20 degree central macula visual field sensitivity were assessed at 5 contrast levels (20, 40, 60, 80, and full contrast). A yellow wavelength stimulus avoided confounding by the lens. Subjects outline the boundaries of their scotoma(s) on an area-integrating and recording touch flat- screen RGB monitor displaying a central fixation point and movable horizontal/vertical raster lines. The computer calculates summed area of the scotoma(s) with arbitrary scaling from 6000 (dense scotoma) to 0 relative units (absence of scotoma).|Units on a scale (0 to 6000)|Mean|2738|2738.0|Standard Deviation|4471|4471.0|||
4280211|NCT00564902|4104229|B3|||100% Kinetic Field|Scotomas within the central 20 degree central macula visual field sensitivity were assessed at 5 contrast levels (20, 40, 60, 80, and full contrast). A yellow wavelength stimulus avoided confounding by the lens. Subjects outline the boundaries of their scotoma(s) on an area-integrating and recording touch flat- screen RGB monitor displaying a central fixation point and movable horizontal/vertical raster lines. The computer calculates summed area of the scotoma(s) with arbitrary scaling from 6000 (dense scotoma) to 0 relative units (absence of scotoma).|Units on a scale (0 to 6000)|Mean|2649|2649.0|Standard Deviation|750|750.0|||
4280212|NCT00564902|4104230|B2|||100% Kinetic Field|Scotomas within the central 20 degree central macula visual field sensitivity were assessed at 5 contrast levels (20, 40, 60, 80, and full contrast). A yellow wavelength stimulus avoided confounding by the lens. Subjects outline the boundaries of their scotoma(s) on an area-integrating and recording touch flat- screen RGB monitor displaying a central fixation point and movable horizontal/vertical raster lines. The computer calculates summed area of the scotoma(s) with arbitrary scaling from 6000 (dense scotoma) to 0 relative units (absence of scotoma).|Units on a scale (0 to 6000)|Mean|1717|1717.0|Standard Deviation|765|765.0|||
4280213|NCT00564902|4104231|B1|||100% Kinetic Field|Scotomas within the central 20 degree central macula visual field sensitivity were assessed at 5 contrast levels (20, 40, 60, 80, and full contrast). A yellow wavelength stimulus avoided confounding by the lens. Subjects outline the boundaries of their scotoma(s) on an area-integrating and recording touch flat- screen RGB monitor displaying a central fixation point and movable horizontal/vertical raster lines. The computer calculates summed area of the scotoma(s) with arbitrary scaling from 6000 (dense scotoma) to 0 relative units (absence of scotoma).|Units on a scale (0 to 6000)|Mean|5514|5514.0|Standard Deviation|2074|2074.0|||
4280214|NCT00564902|4104228|B4|||6.5 degrees Tritan threshold|The ChromaTest© is a computerized psychophysical test of protan and tritan color thresholds against age-corrected data. The computer finds the endpoint of the test by a Modified Binary Search method; if response is correct, on the next presentation the color difference between letter and background is halved. If response is incorrect, the color -contrast is doubled. Incorrect responses prolong the test, but do not influence the final threshold. This method of determining thresholds leads to finite steps which reach a plateau at the color contrast sensitivity threshold.|(dB)|Mean|6.9|6.9|Standard Deviation|10|10.0|||
4280215|NCT00564902|4104229|B3|||6.5 degrees Tritan threshold|The ChromaTest© is a computerized psychophysical test of protan and tritan color thresholds against age-corrected data. The computer finds the endpoint of the test by a Modified Binary Search method; if response is correct, on the next presentation the color difference between letter and background is halved. If response is incorrect, the color -contrast is doubled. Incorrect responses prolong the test, but do not influence the final threshold. This method of determining thresholds leads to finite steps which reach a plateau at the color contrast sensitivity threshold.|(dB)|Mean|6|6.0|Standard Deviation|9|9.0|||
4280216|NCT00564902|4104230|B2|||6.5 degrees Tritan threshold|The ChromaTest© is a computerized psychophysical test of protan and tritan color thresholds against age-corrected data. The computer finds the endpoint of the test by a Modified Binary Search method; if response is correct, on the next presentation the color difference between letter and background is halved. If response is incorrect, the color -contrast is doubled. Incorrect responses prolong the test, but do not influence the final threshold. This method of determining thresholds leads to finite steps which reach a plateau at the color contrast sensitivity threshold.|(dB)|Mean|8.6|8.6|Standard Deviation|12|12.0|||
4280217|NCT00564902|4104231|B1|||6.5 degrees Tritan threshold|The ChromaTest© is a computerized psychophysical test of protan and tritan color thresholds against age-corrected data. The computer finds the endpoint of the test by a Modified Binary Search method; if response is correct, on the next presentation the color difference between letter and background is halved. If response is incorrect, the color -contrast is doubled. Incorrect responses prolong the test, but do not influence the final threshold. This method of determining thresholds leads to finite steps which reach a plateau at the color contrast sensitivity threshold.|(dB)|Mean|4.9|4.9|Standard Deviation|4|4.0|||
4280218|NCT00564902|4104228|B4|||Shape Discrimination|We determined the target deformation detection thresholds, or amplitude of the minimum detectable distortion of a 1 degree foveal circular target. The peak spatial frequency of RF (radial frequency) patterns was 5 cyc/deg; the radial modulation frequency was 8 cyc/360°; mean radii were 0.5°, 1°, 2.0°, or 2.5°; and stimulus contrast was 80%. The highest % modulation score possible is 0.13 while the easiest (lowest score) was 10% modulation.|% modulation|Mean|0.8|0.8|Standard Deviation|0.8|0.8|||
4280219|NCT00564902|4104229|B3|||Shape Discrimination|We determined the target deformation detection thresholds, or amplitude of the minimum detectable distortion of a 1 degree foveal circular target. The peak spatial frequency of RF (radial frequency) patterns was 5 cyc/deg; the radial modulation frequency was 8 cyc/360°; mean radii were 0.5°, 1°, 2.0°, or 2.5°; and stimulus contrast was 80%. The highest % modulation score possible is 0.13 while the easiest (lowest score) was 10% modulation.|% modulation|Mean|1|1.0|Standard Deviation|0.2|0.2|||
4280220|NCT00564902|4104230|B2|||Shape Discrimination|We determined the target deformation detection thresholds, or amplitude of the minimum detectable distortion of a 1 degree foveal circular target. The peak spatial frequency of RF (radial frequency) patterns was 5 cyc/deg; the radial modulation frequency was 8 cyc/360°; mean radii were 0.5°, 1°, 2.0°, or 2.5°; and stimulus contrast was 80%. The highest % modulation score possible is 0.13 while the easiest (lowest score) was 10% modulation.|% modulation|Mean|0.7|0.7|Standard Deviation|0.1|0.1|||
4280221|NCT00564902|4104231|B1|||Shape Discrimination|We determined the target deformation detection thresholds, or amplitude of the minimum detectable distortion of a 1 degree foveal circular target. The peak spatial frequency of RF (radial frequency) patterns was 5 cyc/deg; the radial modulation frequency was 8 cyc/360°; mean radii were 0.5°, 1°, 2.0°, or 2.5°; and stimulus contrast was 80%. The highest % modulation score possible is 0.13 while the easiest (lowest score) was 10% modulation.|% modulation|Mean|0.7|0.7|Standard Deviation|0.2|0.2|||
4280222|NCT00564902|4104228|B4|||Contrast Sensitivity Function Photopic Distance|Distance photopic contrast sensitivity function (CSF) at 5 spatial frequencies (1.5, 3, 6, 12 & 20 cc/deg) was determined with the Functional Vision Analyzer® (Stereo Optical Co, Inc, Chicago, IL). Contrast sensitivity readings are shown as a curve. Visual acuity is plotted along the horizontal axis and contrast sensitivity along the vertical axis. Among the normally sighted people, both visual acuity and contrast sensitivity have a wide range of variation.Low population CSF is 0-200 units; normal population CSF is 200-300 units and suprathreshold CSF is 300+ units.|units on a scale|Mean|204|204.0|Standard Deviation|125|125.0|||
4280223|NCT00564902|4104229|B3|||Contrast Sensitivity Function Photopic Distance|Distance photopic contrast sensitivity function (CSF) at 5 spatial frequencies (1.5, 3, 6, 12 & 20 cc/deg) was determined with the Functional Vision Analyzer® (Stereo Optical Co, Inc, Chicago, IL). Contrast sensitivity readings are shown as a curve. Visual acuity is plotted along the horizontal axis and contrast sensitivity along the vertical axis. Among the normally sighted people, both visual acuity and contrast sensitivity have a wide range of variation.Low population CSF is 0-200 units; normal population CSF is 200-300 units and suprathreshold CSF is 300+ units.|units on a scale|Mean|201|201.0|Standard Deviation|22|22.0|||
4280224|NCT00564902|4104230|B2|||Contrast Sensitivity Function Photopic Distance|Distance photopic contrast sensitivity function (CSF) at 5 spatial frequencies (1.5, 3, 6, 12 & 20 cc/deg) was determined with the Functional Vision Analyzer® (Stereo Optical Co, Inc, Chicago, IL). Contrast sensitivity readings are shown as a curve. Visual acuity is plotted along the horizontal axis and contrast sensitivity along the vertical axis. Among the normally sighted people, both visual acuity and contrast sensitivity have a wide range of variation.Low population CSF is 0-200 units; normal population CSF is 200-300 units and suprathreshold CSF is 300+ units.|units on a scale|Mean|204|204.0|Standard Deviation|30|30.0|||
4280225|NCT00564902|4104231|B1|||Contrast Sensitivity Function Photopic Distance|Distance photopic contrast sensitivity function (CSF) at 5 spatial frequencies (1.5, 3, 6, 12 & 20 cc/deg) was determined with the Functional Vision Analyzer® (Stereo Optical Co, Inc, Chicago, IL). Contrast sensitivity readings are shown as a curve. Visual acuity is plotted along the horizontal axis and contrast sensitivity along the vertical axis. Among the normally sighted people, both visual acuity and contrast sensitivity have a wide range of variation.Low population CSF is 0-200 units; normal population CSF is 200-300 units and suprathreshold CSF is 300+ units.|units on a scale|Mean|212|212.0|Standard Deviation|34|34.0|||
4280226|NCT00564902|4104228|B4|||Glare Recovery|Photostress glare recovery test involves exposing an individual eye to intense light, or retinal bleach, for a set duration of time and measuring the time taken for visual acuity to recover to a predetermined level. (Margrain 2002) Glare photo-stress recovery (in seconds) following 30 seconds of continuous retinal bleach, was assessed using 2 line supra-threshold low contrast randomly presented Landolt Cs using the KOWA AS14B Night Vision Tester (KOWA Optimed, Tokyo, Japan).|Seconds|Mean|34.1|34.1|Standard Deviation|30|30.0|||
4280227|NCT00564902|4104229|B3|||Glare Recovery|Photostress glare recovery test involves exposing an individual eye to intense light, or retinal bleach, for a set duration of time and measuring the time taken for visual acuity to recover to a predetermined level. (Margrain 2002) Glare photo-stress recovery (in seconds) following 30 seconds of continuous retinal bleach, was assessed using 2 line supra-threshold low contrast randomly presented Landolt Cs using the KOWA AS14B Night Vision Tester (KOWA Optimed, Tokyo, Japan).|Seconds|Mean|26.7|26.7|Standard Deviation|5|5.0|||
4280228|NCT00564902|4104230|B2|||Glare Recovery|Photostress glare recovery test involves exposing an individual eye to intense light, or retinal bleach, for a set duration of time and measuring the time taken for visual acuity to recover to a predetermined level. (Margrain 2002) Glare photo-stress recovery (in seconds) following 30 seconds of continuous retinal bleach, was assessed using 2 line supra-threshold low contrast randomly presented Landolt Cs using the KOWA AS14B Night Vision Tester (KOWA Optimed, Tokyo, Japan).|Seconds|Mean|35.6|35.6|Standard Deviation|6|6.0|||
4280229|NCT00564902|4104231|B1|||Glare Recovery|Photostress glare recovery test involves exposing an individual eye to intense light, or retinal bleach, for a set duration of time and measuring the time taken for visual acuity to recover to a predetermined level. (Margrain 2002) Glare photo-stress recovery (in seconds) following 30 seconds of continuous retinal bleach, was assessed using 2 line supra-threshold low contrast randomly presented Landolt Cs using the KOWA AS14B Night Vision Tester (KOWA Optimed, Tokyo, Japan).|Seconds|Mean|52.9|52.9|Standard Deviation|16|16.0|||
4280230|NCT00564902|4104228|B4|||Early Treatment Diabetic Retinopathy Study distance visual acuity|Black and 10% contrast near reading visual acuity was assessed with a Colenbrander Mixed Contrast Reading Card with LogMAR letters (#4031, Precision Vision, LaSalle, Illinois). We determined single letter acuity on an ordinal VAS (Visual Acuity Scale). The largest letters were 0.05 LogMAR with a VAS = 35 while the most difficult smallest letters were LogMar 1.25 or VAS 105. The test card was held at 40 cm with best monocular refraction, and both low and high contrast letter acuity were assessed.|units on a scale|Mean|88.7|88.7|Standard Deviation|13|13.0|||
4280231|NCT00564902|4104229|B3|||Early Treatment Diabetic Retinopathy Study distance visual acuity|Black and 10% contrast near reading visual acuity was assessed with a Colenbrander Mixed Contrast Reading Card with LogMAR letters (#4031, Precision Vision, LaSalle, Illinois). We determined single letter acuity on an ordinal VAS (Visual Acuity Scale). The largest letters were 0.05 LogMAR with a VAS = 35 while the most difficult smallest letters were LogMar 1.25 or VAS 105. The test card was held at 40 cm with best monocular refraction, and both low and high contrast letter acuity were assessed.|units on a scale|Mean|88.3|88.3|Standard Deviation|10|10.0|||
4280232|NCT00564902|4104230|B2|||Early Treatment Diabetic Retinopathy Study distance visual acuity|Black and 10% contrast near reading visual acuity was assessed with a Colenbrander Mixed Contrast Reading Card with LogMAR letters (#4031, Precision Vision, LaSalle, Illinois). We determined single letter acuity on an ordinal VAS (Visual Acuity Scale). The largest letters were 0.05 LogMAR with a VAS = 35 while the most difficult smallest letters were LogMar 1.25 or VAS 105. The test card was held at 40 cm with best monocular refraction, and both low and high contrast letter acuity were assessed.|units on a scale|Mean|86.8|86.8|Standard Deviation|12|12.0|||
4280280|NCT00564850|4104280|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4280281|NCT00564850|4104280|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4280282|NCT00564850|4104280|B1|||Age||years|Mean|8.2|8.2|Standard Deviation|1.1|1.1|||
4280283|NCT00564850|4104280|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4280233|NCT00564902|4104231|B1|||Early Treatment Diabetic Retinopathy Study distance visual acuity|Black and 10% contrast near reading visual acuity was assessed with a Colenbrander Mixed Contrast Reading Card with LogMAR letters (#4031, Precision Vision, LaSalle, Illinois). We determined single letter acuity on an ordinal VAS (Visual Acuity Scale). The largest letters were 0.05 LogMAR with a VAS = 35 while the most difficult smallest letters were LogMar 1.25 or VAS 105. The test card was held at 40 cm with best monocular refraction, and both low and high contrast letter acuity were assessed.|units on a scale|Mean|93.3|93.3|Standard Deviation|8|8.0|||
4280234|NCT00564902|4104228|B4|||Macular Pigment Optical Density|Foveal 1 degree estimated central macular pigment density evaluated with the QuantifEye (ZeaVision, Inc., Chesterfield, Missouri),a modified heterochromic flicker photometer (HFP). The MPOD value is derived by taking the logarithm of the ratio between blue and green luminance measured centrally and peripherally. MPOD varies widely between individuals. Low MPOD is 0 – 0.20 density units (du), normal MPOD is 0.20 – 0.50 du and high MPOD is any value above 0.50 du.|Density units of macular pigment|Mean|0.33|0.33|Standard Deviation|0.05|0.05|||
4280235|NCT00564902|4104229|B3|||Macular Pigment Optical Density|Foveal 1 degree estimated central macular pigment density evaluated with the QuantifEye (ZeaVision, Inc., Chesterfield, Missouri),a modified heterochromic flicker photometer (HFP). The MPOD value is derived by taking the logarithm of the ratio between blue and green luminance measured centrally and peripherally. MPOD varies widely between individuals. Low MPOD is 0 – 0.20 density units (du), normal MPOD is 0.20 – 0.50 du and high MPOD is any value above 0.50 du.|Density units of macular pigment|Mean|0.35|0.35|Standard Deviation|0.04|0.04|||
4280236|NCT00564902|4104230|B2|||Macular Pigment Optical Density|Foveal 1 degree estimated central macular pigment density evaluated with the QuantifEye (ZeaVision, Inc., Chesterfield, Missouri),a modified heterochromic flicker photometer (HFP). The MPOD value is derived by taking the logarithm of the ratio between blue and green luminance measured centrally and peripherally. MPOD varies widely between individuals. Low MPOD is 0 – 0.20 density units (du), normal MPOD is 0.20 – 0.50 du and high MPOD is any value above 0.50 du.|Density units of macular pigment|Mean|0.29|0.29|Standard Deviation|0.06|0.06|||
4280237|NCT00564902|4104231|B1|||Macular Pigment Optical Density|Foveal 1 degree estimated central macular pigment density evaluated with the QuantifEye (ZeaVision, Inc., Chesterfield, Missouri),a modified heterochromic flicker photometer (HFP). The MPOD value is derived by taking the logarithm of the ratio between blue and green luminance measured centrally and peripherally. MPOD varies widely between individuals. Low MPOD is 0 – 0.20 density units (du), normal MPOD is 0.20 – 0.50 du and high MPOD is any value above 0.50 du.|Density units of macular pigment|Mean|0.37|0.37|Standard Deviation|0.05|0.05|||
4280238|NCT00564902|4104228|B4||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4280239|NCT00564902|4104229|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4280240|NCT00564902|4104230|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4280241|NCT00564902|4104231|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4280242|NCT00564902|4104228|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4280243|NCT00564902|4104229|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4280244|NCT00564902|4104230|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4280245|NCT00564902|4104231|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4280246|NCT00564902|4104228|B4|||Age||years|Mean|74.9|74.9|Standard Deviation|10|10.0|||
4280247|NCT00564902|4104229|B3|||Age||years|Mean|74.4|74.4|Standard Deviation|11|11.0|||
4280248|NCT00564902|4104230|B2|||Age||years|Mean|75.8|75.8|Standard Deviation|9|9.0|||
4280249|NCT00564902|4104231|B1|||Age||years|Mean|73.9|73.9|Standard Deviation|9|9.0|||
4280250|NCT00564902|4104228|B4||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4280251|NCT00564902|4104229|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4280252|NCT00564902|4104230|B2||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4280253|NCT00564902|4104231|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4280254|NCT00564902|4104228|B4||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4280255|NCT00564902|4104229|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4280256|NCT00564902|4104230|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4280257|NCT00564902|4104231|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4280258|NCT00564902|4104228|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280259|NCT00564902|4104229|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280260|NCT00564902|4104230|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280261|NCT00564902|4104231|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280262|NCT00564889|4104265|B1|No||Had a Prior Stem Cell Transplant||participants|Number|28|28.0||||||
4280263|NCT00564889|4104265|B1|Yes||Had a Prior Stem Cell Transplant||participants|Number|7|7.0||||||
4280264|NCT00564889|4104265|B1|No||Received Previous Treatment||participants|Number|24|24.0||||||
4280265|NCT00564889|4104265|B1|Yes||Received Previous Treatment||participants|Number|11|11.0||||||
4280266|NCT00564889|4104265|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4280267|NCT00564889|4104265|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4280268|NCT00564889|4104265|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4280269|NCT00564889|4104265|B1|||Age||years|Median|64|64.0|Full Range|||44.0|82.0|
4280270|NCT00564876|4104273|B1|||Dasatinib|70 mg dasatinib orally twice daily for 3 weeks|participants|Number|2|2.0||||||
4280271|NCT00564876|4104273|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4280272|NCT00564876|4104273|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4280273|NCT00564876|4104273|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4280274|NCT00564876|4104273|B1|||Age||years|Mean|61|61.0|Standard Deviation|2|2.0|||
4280284|NCT00564850|4104280|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4280285|NCT00564850|4104280|B1||<=18 years|Age||Participants|Count of Participants|37|37.0||||||
4280286|NCT00564733|4104298|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4280287|NCT00564733|4104298|B1||Male|Gender||Participants|Count of Participants|24|24.0||||||
4280288|NCT00564733|4104298|B1||Female|Gender||Participants|Count of Participants|22|22.0||||||
4280289|NCT00564733|4104298|B1|||Age||years|Mean|60|60.0|Full Range|||48.0|78.0|
4280290|NCT00564733|4104298|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4280291|NCT00564733|4104298|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4280292|NCT00564733|4104298|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280293|NCT00564681|4104302|B5||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4280294|NCT00564681|4104303|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4280295|NCT00564681|4104304|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4280296|NCT00564681|4104305|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4280297|NCT00564681|4104306|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4280298|NCT00564681|4104302|B5||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4280299|NCT00564681|4104303|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4280300|NCT00564681|4104304|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4280301|NCT00564681|4104305|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4280302|NCT00564681|4104306|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4280303|NCT00564681|4104302|B5|>65 years||Age, Customized||Participants|Number|27|27.0||||||
4280304|NCT00564681|4104303|B4|>65 years||Age, Customized||Participants|Number|2|2.0||||||
4280305|NCT00564681|4104304|B3|>65 years||Age, Customized||Participants|Number|6|6.0||||||
4280306|NCT00564681|4104305|B2|>65 years||Age, Customized||Participants|Number|11|11.0||||||
4280307|NCT00564681|4104306|B1|>65 years||Age, Customized||Participants|Number|8|8.0||||||
4280308|NCT00564681|4104302|B5|Between 45 and 65 years||Age, Customized||Participants|Number|131|131.0||||||
4280309|NCT00564681|4104303|B4|Between 45 and 65 years||Age, Customized||Participants|Number|8|8.0||||||
4280310|NCT00564681|4104304|B3|Between 45 and 65 years||Age, Customized||Participants|Number|24|24.0||||||
4280311|NCT00564681|4104305|B2|Between 45 and 65 years||Age, Customized||Participants|Number|28|28.0||||||
4280312|NCT00564681|4104306|B1|Between 45 and 65 years||Age, Customized||Participants|Number|71|71.0||||||
4280313|NCT00564681|4104302|B5|<45 years||Age, Customized||Participants|Number|84|84.0||||||
4280314|NCT00564681|4104303|B4|<45 years||Age, Customized||Participants|Number|11|11.0||||||
4280315|NCT00564681|4104304|B3|<45 years||Age, Customized||Participants|Number|13|13.0||||||
4280316|NCT00564681|4104305|B2|<45 years||Age, Customized||Participants|Number|22|22.0||||||
4280317|NCT00564681|4104306|B1|<45 years||Age, Customized||Participants|Number|38|38.0||||||
4280318|NCT00564629|4104330|B3|United States||Region of Enrollment||participants|Number|105|105.0||||||
4280319|NCT00564629|4104331|B2|United States||Region of Enrollment||participants|Number|54|54.0||||||
4280320|NCT00564629|4104332|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4280321|NCT00564629|4104330|B3||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4280322|NCT00564629|4104331|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4280323|NCT00564629|4104332|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4280324|NCT00564629|4104330|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4280325|NCT00564629|4104331|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4280326|NCT00564629|4104332|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4280327|NCT00564629|4104330|B3|||Age|"mITT(modified intent to treat) population was used for age continuous baseline measure. mITT is defined as the all randomized subjects who received at least one full dose of oral or intravenous study medication without vomiting less than 2 hours after the oral study medication dose.~81 subjects were included in the mITT group with 36 subjects in the oral acetaminophen arm and 45 subjects in the IV acetaminophen arm."|years|Mean|33|33.0|Standard Deviation|10.52|10.52|||
4280328|NCT00564629|4104331|B2|||Age|"mITT(modified intent to treat) population was used for age continuous baseline measure. mITT is defined as the all randomized subjects who received at least one full dose of oral or intravenous study medication without vomiting less than 2 hours after the oral study medication dose.~81 subjects were included in the mITT group with 36 subjects in the oral acetaminophen arm and 45 subjects in the IV acetaminophen arm."|years|Mean|33.8|33.8|Standard Deviation|11.6|11.6|||
4280329|NCT00564629|4104332|B1|||Age|"mITT(modified intent to treat) population was used for age continuous baseline measure. mITT is defined as the all randomized subjects who received at least one full dose of oral or intravenous study medication without vomiting less than 2 hours after the oral study medication dose.~81 subjects were included in the mITT group with 36 subjects in the oral acetaminophen arm and 45 subjects in the IV acetaminophen arm."|years|Mean|32.1|32.1|Standard Deviation|9.07|9.07|||
4280330|NCT00564629|4104330|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4280331|NCT00564629|4104331|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4280332|NCT00564629|4104332|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4280333|NCT00564629|4104330|B3||Between 18 and 65 years|Age||Participants|Count of Participants|105|105.0||||||
4280334|NCT00564629|4104331|B2||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4280335|NCT00564629|4104332|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4280336|NCT00564629|4104330|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280337|NCT00564629|4104331|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280338|NCT00564629|4104332|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280339|NCT00564486|4104355|B4||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4280340|NCT00564486|4104356|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4280341|NCT00564486|4104357|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4280342|NCT00564486|4104358|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4280343|NCT00564486|4104355|B4||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4280344|NCT00564486|4104356|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4280345|NCT00564486|4104357|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4280346|NCT00564486|4104358|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4280347|NCT00564486|4104355|B4||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4280348|NCT00564486|4104356|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4280349|NCT00564486|4104357|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4280350|NCT00564486|4104358|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4280351|NCT00564486|4104355|B4||Between 18 and 65 years|Age||Participants|Count of Participants|224|224.0||||||
4280352|NCT00564486|4104356|B3||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4280353|NCT00564486|4104357|B2||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
4280354|NCT00564486|4104358|B1||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4280355|NCT00564486|4104355|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280356|NCT00564486|4104356|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280357|NCT00564486|4104357|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280358|NCT00564486|4104358|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280359|NCT00564447|4104377|B9|United States||Region of Enrollment||participants|Number|48|48.0||||||
4280360|NCT00564447|4104378|B8|United States||Region of Enrollment||participants|Number|6|6.0||||||
4280361|NCT00564447|4104379|B7|United States||Region of Enrollment||participants|Number|6|6.0||||||
4280362|NCT00564447|4104380|B6|United States||Region of Enrollment||participants|Number|6|6.0||||||
4280363|NCT00564447|4104381|B5|United States||Region of Enrollment||participants|Number|6|6.0||||||
4280364|NCT00564447|4104382|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
4280365|NCT00564447|4104383|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4280366|NCT00564447|4104384|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4280367|NCT00564447|4104385|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4280368|NCT00564447|4104377|B9||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4280369|NCT00564447|4104378|B8||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4280370|NCT00564447|4104379|B7||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4280371|NCT00564447|4104380|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4280372|NCT00564447|4104381|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4280373|NCT00564447|4104382|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4280374|NCT00564447|4104383|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4280375|NCT00564447|4104384|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4280376|NCT00564447|4104385|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4280377|NCT00564447|4104377|B9||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4280378|NCT00564447|4104378|B8||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4280379|NCT00564447|4104379|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4280380|NCT00564447|4104380|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4280381|NCT00564447|4104381|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4280382|NCT00564447|4104382|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4280383|NCT00564447|4104383|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4280384|NCT00564447|4104384|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4280385|NCT00564447|4104385|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4280386|NCT00564447|4104377|B9|||Age||years|Mean|40.0|40.0|Standard Deviation|12.8|12.8|||
4280387|NCT00564447|4104378|B8|||Age||years|Mean|36.7|36.7|Standard Deviation|11.7|11.7|||
4280388|NCT00564447|4104379|B7|||Age||years|Mean|33.3|33.3|Standard Deviation|8.2|8.2|||
4280389|NCT00564447|4104380|B6|||Age||years|Mean|43.5|43.5|Standard Deviation|13.2|13.2|||
4280390|NCT00564447|4104381|B5|||Age||years|Mean|43.0|43.0|Standard Deviation|13.7|13.7|||
4280391|NCT00564447|4104382|B4|||Age||years|Mean|33.7|33.7|Standard Deviation|16.8|16.8|||
4280392|NCT00564447|4104383|B3|||Age||years|Mean|38.2|38.2|Standard Deviation|13.2|13.2|||
4280393|NCT00564447|4104384|B2|||Age||years|Mean|46.8|46.8|Standard Deviation|13.1|13.1|||
4280394|NCT00564447|4104385|B1|||Age||years|Mean|44.5|44.5|Standard Deviation|11.1|11.1|||
4280395|NCT00564395|4104410|B1|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4280396|NCT00564395|4104410|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4280397|NCT00564395|4104410|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4280398|NCT00564395|4104410|B1|||Age||years|Mean|14.8|14.8|Standard Deviation|2.7|2.7|||
4280399|NCT00564395|4104410|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4280400|NCT00564395|4104410|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4280401|NCT00564395|4104410|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4280402|NCT00564278|4104417|B3|United States||Region of Enrollment||participants|Number|195|195.0||||||
4280403|NCT00564278|4104418|B2|United States||Region of Enrollment||participants|Number|98|98.0||||||
4280404|NCT00564278|4104419|B1|United States||Region of Enrollment||participants|Number|97|97.0||||||
4280405|NCT00564278|4104417|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280406|NCT00564278|4104418|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280407|NCT00564278|4104419|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280408|NCT00564278|4104417|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280409|NCT00564278|4104418|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280410|NCT00564278|4104419|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280411|NCT00564278|4104417|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|195|195.0||||||
4280412|NCT00564278|4104418|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
4280413|NCT00564278|4104419|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
4280414|NCT00564278|4104417|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4280415|NCT00564278|4104418|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4280416|NCT00564278|4104419|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4280417|NCT00564278|4104417|B3||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4280418|NCT00564278|4104418|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4280419|NCT00564278|4104419|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4280420|NCT00564278|4104417|B3|||Age||years|Mean|43.8|43.8|Standard Deviation|12.7|12.7|||
4280421|NCT00564278|4104418|B2|||Age||years|Mean|44.1|44.1|Standard Deviation|12.3|12.3|||
4280422|NCT00564278|4104419|B1|||Age||years|Mean|43.4|43.4|Standard Deviation|13.2|13.2|||
4280423|NCT00564278|4104417|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4280424|NCT00564278|4104418|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4280425|NCT00564278|4104419|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4280426|NCT00564278|4104417|B3||Between 18 and 65 years|Age||Participants|Count of Participants|185|185.0||||||
4280427|NCT00564278|4104418|B2||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
4280428|NCT00564278|4104419|B1||Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
4280429|NCT00564278|4104417|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280430|NCT00564278|4104418|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280431|NCT00564278|4104419|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280432|NCT00564265|4104436|B1|Chile||Region of Enrollment||participants|Number|24|24.0||||||
4280433|NCT00564265|4104436|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4280434|NCT00564265|4104436|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4280435|NCT00564265|4104436|B1|||Age||years|Mean|49|49.0|Standard Deviation|15.4|15.4|||
4280436|NCT00564265|4104436|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4280437|NCT00564265|4104436|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4280438|NCT00564265|4104436|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280439|NCT00564070|4104440|B3|||HbA1C|Hemoglobin A1C value at acute outcome. HbA1c is the number of hemoglobin in red blood cells that is glycosylated (attached to sugar) and is reported here as a percentage.|percentage of glycosylated hemoglobin|Mean|8.78|8.78|Standard Deviation|1.60|1.6|||
4280440|NCT00564070|4104441|B2|||HbA1C|Hemoglobin A1C value at acute outcome. HbA1c is the number of hemoglobin in red blood cells that is glycosylated (attached to sugar) and is reported here as a percentage.|percentage of glycosylated hemoglobin|Mean|8.81|8.81|Standard Deviation|1.78|1.78|||
4280441|NCT00564070|4104442|B1|||HbA1C|Hemoglobin A1C value at acute outcome. HbA1c is the number of hemoglobin in red blood cells that is glycosylated (attached to sugar) and is reported here as a percentage.|percentage of glycosylated hemoglobin|Mean|8.74|8.74|Standard Deviation|1.41|1.41|||
4280442|NCT00564070|4104440|B3|||Clinician-Rated Depression|Depression as assessed by the Montgomery Asberg Depression Rating Scale (MADRS). This scale has a range of 0-60 with higher scores indicating greater depression severity.|units on a scale|Mean|24.46|24.46|Standard Deviation|8.10|8.1|||
4280443|NCT00564070|4104441|B2|||Clinician-Rated Depression|Depression as assessed by the Montgomery Asberg Depression Rating Scale (MADRS). This scale has a range of 0-60 with higher scores indicating greater depression severity.|units on a scale|Mean|25.60|25.6|Standard Deviation|8.99|8.99|||
4280444|NCT00564070|4104442|B1|||Clinician-Rated Depression|Depression as assessed by the Montgomery Asberg Depression Rating Scale (MADRS). This scale has a range of 0-60 with higher scores indicating greater depression severity.|units on a scale|Mean|23.31|23.31|Standard Deviation|7.20|7.2|||
4280445|NCT00564070|4104440|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280446|NCT00564070|4104441|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280447|NCT00564070|4104442|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280448|NCT00564070|4104440|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
4280449|NCT00564070|4104441|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4280450|NCT00564070|4104442|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4280451|NCT00564070|4104440|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4280452|NCT00564070|4104441|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280453|NCT00564070|4104442|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4280454|NCT00564070|4104440|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4280455|NCT00564070|4104441|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4280456|NCT00564070|4104442|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4280457|NCT00564070|4104440|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4280458|NCT00564070|4104441|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280459|NCT00564070|4104442|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4280460|NCT00564070|4104440|B3||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4280461|NCT00564070|4104441|B2||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4280462|NCT00564070|4104442|B1||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4280463|NCT00564070|4104440|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4280464|NCT00564070|4104441|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4280465|NCT00564070|4104442|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4280466|NCT00564070|4104440|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280467|NCT00564070|4104441|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280468|NCT00564070|4104442|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280469|NCT00564070|4104440|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4280470|NCT00564070|4104441|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280471|NCT00564070|4104442|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4280472|NCT00564070|4104440|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280473|NCT00564070|4104441|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280474|NCT00564070|4104442|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280475|NCT00564070|4104440|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4280476|NCT00564070|4104441|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4280477|NCT00564070|4104442|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4280478|NCT00564070|4104440|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4280479|NCT00564070|4104441|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4280480|NCT00564070|4104442|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4280481|NCT00564070|4104440|B3|||Age||years|Mean|56.87|56.87|Standard Deviation|8.07|8.07|||
4280482|NCT00564070|4104441|B2|||Age||years|Mean|55.44|55.44|Standard Deviation|8.72|8.72|||
4280483|NCT00564070|4104442|B1|||Age||years|Mean|58.31|58.31|Standard Deviation|7.41|7.41|||
4280484|NCT00563797|4104467|B3|Non-Smokers||Smoking Status||participants|Number|9|9.0||||||
4280485|NCT00563797|4104468|B2|Non-Smokers||Smoking Status||participants|Number|5|5.0||||||
4280486|NCT00563797|4104469|B1|Non-Smokers||Smoking Status||participants|Number|4|4.0||||||
4280487|NCT00563797|4104467|B3|Smokers||Smoking Status||participants|Number|12|12.0||||||
4280488|NCT00563797|4104468|B2|Smokers||Smoking Status||participants|Number|5|5.0||||||
4280489|NCT00563797|4104469|B1|Smokers||Smoking Status||participants|Number|7|7.0||||||
4280490|NCT00563797|4104467|B3|||Depression HAMD|"The Hamilton Depression Rating Scale (HAM-D) has proven useful for many years as a way of determining a patient’s level of depression before, during, and after treatment. It should be administered by a clinician experienced in working with psychiatric patients.~Although the HAM-D form lists 21 items, the scoring is based on the first 17. It generally takes 15-20 minutes to complete the interview and score the results. The Scale ranges from 0 (normal) to >23 (Very Severe Depression)"|units on a scale|Mean|13.29|13.29|Standard Deviation|4.32|4.32|||
4280491|NCT00563797|4104468|B2|||Depression HAMD|"The Hamilton Depression Rating Scale (HAM-D) has proven useful for many years as a way of determining a patient’s level of depression before, during, and after treatment. It should be administered by a clinician experienced in working with psychiatric patients.~Although the HAM-D form lists 21 items, the scoring is based on the first 17. It generally takes 15-20 minutes to complete the interview and score the results. The Scale ranges from 0 (normal) to >23 (Very Severe Depression)"|units on a scale|Mean|12.90|12.9|Standard Deviation|2.93|2.93|||
4280492|NCT00563797|4104469|B1|||Depression HAMD|"The Hamilton Depression Rating Scale (HAM-D) has proven useful for many years as a way of determining a patient’s level of depression before, during, and after treatment. It should be administered by a clinician experienced in working with psychiatric patients.~Although the HAM-D form lists 21 items, the scoring is based on the first 17. It generally takes 15-20 minutes to complete the interview and score the results. The Scale ranges from 0 (normal) to >23 (Very Severe Depression)"|units on a scale|Mean|13.64|13.64|Standard Deviation|5.43|5.43|||
4280537|NCT00563706|4104486|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4280538|NCT00563706|4104487|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4280539|NCT00563706|4104488|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4280540|NCT00563706|4104489|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4280541|NCT00563706|4104490|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4280493|NCT00563797|4104467|B3|||Total Alcohol Dependence Scale (ADS) score|The Alcohol Dependence Scale is made of 25 items that cover alcohol withdrawal symptoms, impaired control over drinking, awareness of a compulsion to drink, increased tolerance to alcohol, and salience of drink-seeking behavior. The scale can range from 0 to 47. The higher the value the greater the dependence. A score of 9 or more is highly predictive of DSM diagnosis of alcohol dependence. More specifically, a score from 1-13 indicates low dependence, 14-21 indicates intermediate, 22-30 indicates substantial, and 31-47 severe level of alcohol dependence.|units on a scale|Mean|19.70|19.7|Standard Deviation|9.98|9.98|||
4280494|NCT00563797|4104468|B2|||Total Alcohol Dependence Scale (ADS) score|The Alcohol Dependence Scale is made of 25 items that cover alcohol withdrawal symptoms, impaired control over drinking, awareness of a compulsion to drink, increased tolerance to alcohol, and salience of drink-seeking behavior. The scale can range from 0 to 47. The higher the value the greater the dependence. A score of 9 or more is highly predictive of DSM diagnosis of alcohol dependence. More specifically, a score from 1-13 indicates low dependence, 14-21 indicates intermediate, 22-30 indicates substantial, and 31-47 severe level of alcohol dependence.|units on a scale|Mean|21.7|21.7|Standard Deviation|9.72|9.72|||
4280495|NCT00563797|4104469|B1|||Total Alcohol Dependence Scale (ADS) score|The Alcohol Dependence Scale is made of 25 items that cover alcohol withdrawal symptoms, impaired control over drinking, awareness of a compulsion to drink, increased tolerance to alcohol, and salience of drink-seeking behavior. The scale can range from 0 to 47. The higher the value the greater the dependence. A score of 9 or more is highly predictive of DSM diagnosis of alcohol dependence. More specifically, a score from 1-13 indicates low dependence, 14-21 indicates intermediate, 22-30 indicates substantial, and 31-47 severe level of alcohol dependence.|units on a scale|Mean|17.70|17.7|Standard Deviation|10.34|10.34|||
4280496|NCT00563797|4104467|B3|||Cigarettes per day||cigarettes|Mean|14.9|14.9|Standard Deviation|6.60|6.6|||
4280497|NCT00563797|4104468|B2|||Cigarettes per day||cigarettes|Mean|16.6|16.6|Standard Deviation|4.50|4.5|||
4280498|NCT00563797|4104469|B1|||Cigarettes per day||cigarettes|Mean|13.6|13.6|Standard Deviation|7.8|7.8|||
4280499|NCT00563797|4104467|B3|||Heavy drinking days, past 30|Heavy drinking days is defined as 5 drinks on a single occasion for men and 4 for women|days|Mean|19.95|19.95|Standard Deviation|9.57|9.57|||
4280500|NCT00563797|4104468|B2|||Heavy drinking days, past 30|Heavy drinking days is defined as 5 drinks on a single occasion for men and 4 for women|days|Mean|18.00|18.0|Standard Deviation|11.62|11.62|||
4280501|NCT00563797|4104469|B1|||Heavy drinking days, past 30|Heavy drinking days is defined as 5 drinks on a single occasion for men and 4 for women|days|Mean|21.73|21.73|Standard Deviation|7.38|7.38|||
4280502|NCT00563797|4104467|B3|||Drinking days, past 30||drinking days|Mean|22.33|22.33|Standard Deviation|7.83|7.83|||
4280503|NCT00563797|4104468|B2|||Drinking days, past 30||drinking days|Mean|22.10|22.1|Standard Deviation|8.57|8.57|||
4280504|NCT00563797|4104469|B1|||Drinking days, past 30||drinking days|Mean|22.55|22.55|Standard Deviation|7.50|7.5|||
4280505|NCT00563797|4104467|B3|||Drinks per drinking day||drinks per day|Mean|11.54|11.54|Standard Deviation|8.68|8.68|||
4280506|NCT00563797|4104468|B2|||Drinks per drinking day||drinks per day|Mean|9.32|9.32|Standard Deviation|8.99|8.99|||
4280507|NCT00563797|4104469|B1|||Drinks per drinking day||drinks per day|Mean|13.56|13.56|Standard Deviation|8.27|8.27|||
4280508|NCT00563797|4104467|B3|African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4280509|NCT00563797|4104468|B2|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4280510|NCT00563797|4104469|B1|African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4280511|NCT00563797|4104467|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4280512|NCT00563797|4104468|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4280513|NCT00563797|4104469|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4280514|NCT00563797|4104467|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4280515|NCT00563797|4104468|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4280516|NCT00563797|4104469|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4280517|NCT00563797|4104467|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4280518|NCT00563797|4104468|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4280519|NCT00563797|4104469|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4280520|NCT00563797|4104467|B3|||Age||years|Mean|49.62|49.62|Standard Deviation|9.00|9.0|||
4280521|NCT00563797|4104468|B2|||Age||years|Mean|48.20|48.2|Standard Deviation|9.84|9.84|||
4280522|NCT00563797|4104469|B1|||Age||years|Mean|50.91|50.91|Standard Deviation|8.43|8.43|||
4280523|NCT00563706|4104482|B10||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4280524|NCT00563706|4104483|B9||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4280525|NCT00563706|4104484|B8||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4280526|NCT00563706|4104485|B7||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4280527|NCT00563706|4104486|B6||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4280528|NCT00563706|4104487|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4280529|NCT00563706|4104488|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4280530|NCT00563706|4104489|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4280531|NCT00563706|4104490|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4280532|NCT00563706|4104491|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4280533|NCT00563706|4104482|B10||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4280534|NCT00563706|4104483|B9||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4280535|NCT00563706|4104484|B8||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4280536|NCT00563706|4104485|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4280542|NCT00563706|4104491|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4280543|NCT00563706|4104482|B10|||Age||years|Mean|42.07|42.07|Standard Deviation|9.67|9.67|||
4280544|NCT00563706|4104483|B9|||Age||years|Mean|42.72|42.72|Standard Deviation|9.93|9.93|||
4280545|NCT00563706|4104484|B8|||Age||years|Mean|43.60|43.6|Standard Deviation|9.25|9.25|||
4280546|NCT00563706|4104485|B7|||Age||years|Mean|38.17|38.17|Standard Deviation|9.73|9.73|||
4280547|NCT00563706|4104486|B6|||Age||years|Mean|40.74|40.74|Standard Deviation|10.29|10.29|||
4280548|NCT00563706|4104487|B5|||Age||years|Mean|42.94|42.94|Standard Deviation|8.27|8.27|||
4280549|NCT00563706|4104488|B4|||Age||years|Mean|40.53|40.53|Standard Deviation|11.43|11.43|||
4280550|NCT00563706|4104489|B3|||Age||years|Mean|41.25|41.25|Standard Deviation|4.89|4.89|||
4280551|NCT00563706|4104490|B2|||Age||years|Mean|43.22|43.22|Standard Deviation|10.17|10.17|||
4280552|NCT00563706|4104491|B1|||Age||years|Mean|42.05|42.05|Standard Deviation|9.88|9.88|||
4280553|NCT00563576|4104600|B3|United States||Region of Enrollment||participants|Number|71|71.0||||||
4280554|NCT00563576|4104601|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
4280555|NCT00563576|4104602|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4280556|NCT00563576|4104600|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4280557|NCT00563576|4104601|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4280558|NCT00563576|4104602|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4280559|NCT00563576|4104600|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4280560|NCT00563576|4104601|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4280561|NCT00563576|4104602|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4280562|NCT00563576|4104600|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4280563|NCT00563576|4104601|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4280564|NCT00563576|4104602|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4280565|NCT00563576|4104600|B3||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4280566|NCT00563576|4104601|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4280567|NCT00563576|4104602|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4280568|NCT00563576|4104600|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280569|NCT00563576|4104601|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280570|NCT00563576|4104602|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280571|NCT00563381|4104613|B3|White||Race/Ethnicity, Customized||Participants|Number|7350|7350.0||||||
4280572|NCT00563381|4104614|B2|White||Race/Ethnicity, Customized||Participants|Number|3657|3657.0||||||
4280573|NCT00563381|4104615|B1|White||Race/Ethnicity, Customized||Participants|Number|3693|3693.0||||||
4280574|NCT00563381|4104613|B3|Black||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4280575|NCT00563381|4104614|B2|Black||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4280576|NCT00563381|4104615|B1|Black||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4280577|NCT00563381|4104613|B3|Asian||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4280578|NCT00563381|4104614|B2|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4280579|NCT00563381|4104615|B1|Asian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4280580|NCT00563381|4104613|B3||Male|Sex: Female, Male||Participants|Count of Participants|5506|5506.0||||||
4280581|NCT00563381|4104614|B2||Male|Sex: Female, Male||Participants|Count of Participants|2747|2747.0||||||
4280582|NCT00563381|4104615|B1||Male|Sex: Female, Male||Participants|Count of Participants|2759|2759.0||||||
4280583|NCT00563381|4104613|B3||Female|Sex: Female, Male||Participants|Count of Participants|1870|1870.0||||||
4280584|NCT00563381|4104614|B2||Female|Sex: Female, Male||Participants|Count of Participants|922|922.0||||||
4280585|NCT00563381|4104615|B1||Female|Sex: Female, Male||Participants|Count of Participants|948|948.0||||||
4280586|NCT00563381|4104613|B3|||Age||Years|Mean|62.9|62.9|Standard Deviation|9.0|9.0|||
4280587|NCT00563381|4104614|B2|||Age||Years|Mean|62.8|62.8|Standard Deviation|9.0|9.0|||
4280588|NCT00563381|4104615|B1|||Age||Years|Mean|62.9|62.9|Standard Deviation|9.0|9.0|||
4280589|NCT00563368|4104682|B8|United States||Region of Enrollment||participants|Number|756|756.0||||||
4280590|NCT00563368|4104683|B7|United States||Region of Enrollment||participants|Number|108|108.0||||||
4280591|NCT00563368|4104684|B6|United States||Region of Enrollment||participants|Number|107|107.0||||||
4280592|NCT00563368|4104685|B5|United States||Region of Enrollment||participants|Number|108|108.0||||||
4280593|NCT00563368|4104686|B4|United States||Region of Enrollment||participants|Number|107|107.0||||||
4280594|NCT00563368|4104687|B3|United States||Region of Enrollment||participants|Number|108|108.0||||||
4280595|NCT00563368|4104688|B2|United States||Region of Enrollment||participants|Number|109|109.0||||||
4280596|NCT00563368|4104689|B1|United States||Region of Enrollment||participants|Number|109|109.0||||||
4280597|NCT00563368|4104682|B8||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4280598|NCT00563368|4104683|B7||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4280599|NCT00563368|4104684|B6||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4280600|NCT00563368|4104685|B5||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4280601|NCT00563368|4104686|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4280602|NCT00563368|4104687|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4280603|NCT00563368|4104688|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4280604|NCT00563368|4104689|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4280605|NCT00563368|4104682|B8||Female|Sex: Female, Male||Participants|Count of Participants|599|599.0||||||
4280606|NCT00563368|4104683|B7||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4280607|NCT00563368|4104684|B6||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4280608|NCT00563368|4104685|B5||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4280609|NCT00563368|4104686|B4||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4280610|NCT00563368|4104687|B3||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4280611|NCT00563368|4104688|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4280612|NCT00563368|4104689|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4280613|NCT00563368|4104682|B8|||Age||years|Mean|45.6|45.6|Standard Deviation|11.88|11.88|||
4280614|NCT00563368|4104683|B7|||Age||years|Mean|44.6|44.6|Standard Deviation|12.84|12.84|||
4280615|NCT00563368|4104684|B6|||Age||years|Mean|45.8|45.8|Standard Deviation|11.21|11.21|||
4280616|NCT00563368|4104685|B5|||Age||years|Mean|45.7|45.7|Standard Deviation|12.38|12.38|||
4280617|NCT00563368|4104686|B4|||Age||years|Mean|44.6|44.6|Standard Deviation|11.07|11.07|||
4280618|NCT00563368|4104687|B3|||Age||years|Mean|46.9|46.9|Standard Deviation|12.62|12.62|||
4280619|NCT00563368|4104688|B2|||Age||years|Mean|46.4|46.4|Standard Deviation|11.57|11.57|||
4280620|NCT00563368|4104689|B1|||Age||years|Mean|45|45.0|Standard Deviation|11.43|11.43|||
4280621|NCT00563316|4104718|B1|Rectal Cancer||Primary Tumor Type||participants|Number|10|10.0||||||
4280622|NCT00563316|4104718|B1|Colon Cancer||Primary Tumor Type||participants|Number|17|17.0||||||
4280623|NCT00563316|4104718|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4280624|NCT00563316|4104718|B1|Aborigine||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4280625|NCT00563316|4104718|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4280626|NCT00563316|4104718|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4280627|NCT00563316|4104718|B1|Japanese||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4280628|NCT00563316|4104718|B1|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4280629|NCT00563316|4104718|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4280630|NCT00563316|4104718|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4280631|NCT00563316|4104718|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4280632|NCT00563316|4104718|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4280633|NCT00563316|4104718|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4280634|NCT00563316|4104718|B1|||Age||years|Mean|58.1|58.1|Standard Deviation|10.7|10.7|||
4280635|NCT00563290|4104729|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280636|NCT00563290|4104730|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280637|NCT00563290|4104731|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280638|NCT00563290|4104729|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280639|NCT00563290|4104730|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280640|NCT00563290|4104731|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280641|NCT00563290|4104729|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4280642|NCT00563290|4104730|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4280643|NCT00563290|4104731|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4280644|NCT00563290|4104729|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280645|NCT00563290|4104730|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280646|NCT00563290|4104731|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280647|NCT00563290|4104729|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280648|NCT00563290|4104730|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280649|NCT00563290|4104731|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280650|NCT00563290|4104729|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280651|NCT00563290|4104730|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280652|NCT00563290|4104731|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280653|NCT00563290|4104729|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280654|NCT00563290|4104730|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280655|NCT00563290|4104731|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280656|NCT00563290|4104729|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4280657|NCT00563290|4104730|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4280658|NCT00563290|4104731|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4280659|NCT00563290|4104729|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4280660|NCT00563290|4104730|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4280661|NCT00563290|4104731|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4280662|NCT00563290|4104729|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4280663|NCT00563290|4104730|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4280664|NCT00563290|4104731|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4280665|NCT00563290|4104729|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4280666|NCT00563290|4104730|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4280667|NCT00563290|4104731|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4280668|NCT00563290|4104729|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280669|NCT00563290|4104730|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280670|NCT00563290|4104731|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280671|NCT00563186|4104741|B3|Canada||Region of Enrollment||participants|Number|1514|1514.0||||||
4280672|NCT00563186|4104742|B2|Canada||Region of Enrollment||participants|Number|604|604.0||||||
4280673|NCT00563186|4104743|B1|Canada||Region of Enrollment||participants|Number|910|910.0||||||
4280674|NCT00563186|4104741|B3||Male|Sex: Female, Male||Participants|Count of Participants|829|829.0||||||
4280675|NCT00563186|4104742|B2||Male|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
4280676|NCT00563186|4104743|B1||Male|Sex: Female, Male||Participants|Count of Participants|503|503.0||||||
4280677|NCT00563186|4104741|B3||Female|Sex: Female, Male||Participants|Count of Participants|685|685.0||||||
4280678|NCT00563186|4104742|B2||Female|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
4280679|NCT00563186|4104743|B1||Female|Sex: Female, Male||Participants|Count of Participants|407|407.0||||||
4280680|NCT00563186|4104741|B3|||Age||years|Mean|61.66|61.66|Standard Deviation|18.61|18.61|||
4280681|NCT00563186|4104742|B2|||Age||years|Mean|63.22|63.22|Standard Deviation|18.78|18.78|||
4280682|NCT00563186|4104743|B1|||Age||years|Mean|60.62|60.62|Standard Deviation|18.44|18.44|||
4280683|NCT00563186|4104741|B3||>=65 years|Age||Participants|Count of Participants|809|809.0||||||
4280684|NCT00563186|4104742|B2||>=65 years|Age||Participants|Count of Participants|299|299.0||||||
4280685|NCT00563186|4104743|B1||>=65 years|Age||Participants|Count of Participants|510|510.0||||||
4280686|NCT00563186|4104741|B3||Between 18 and 65 years|Age||Participants|Count of Participants|705|705.0||||||
4280687|NCT00563186|4104742|B2||Between 18 and 65 years|Age||Participants|Count of Participants|305|305.0||||||
4280688|NCT00563186|4104743|B1||Between 18 and 65 years|Age||Participants|Count of Participants|400|400.0||||||
4280689|NCT00563186|4104741|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280690|NCT00563186|4104742|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280691|NCT00563186|4104743|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280692|NCT00562965|4104753|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4280693|NCT00562965|4104754|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4280694|NCT00562965|4104755|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4280695|NCT00562965|4104753|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4280696|NCT00562965|4104754|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4280697|NCT00562965|4104755|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4280698|NCT00562965|4104753|B3|||Age||years|Mean|61.7|61.7|Standard Deviation|11.7|11.7|||
4280699|NCT00562965|4104754|B2|||Age||years|Mean|60.9|60.9|Standard Deviation|12.4|12.4|||
4280700|NCT00562965|4104755|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|11.4|11.4|||
4280701|NCT00562861|4104775|B3|United States||Region of Enrollment||participants|Number|119|119.0||||||
4280702|NCT00562861|4104776|B2|United States||Region of Enrollment||participants|Number|59|59.0||||||
4280703|NCT00562861|4104777|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4280704|NCT00562861|4104775|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280705|NCT00562861|4104776|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280706|NCT00562861|4104777|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280707|NCT00562861|4104775|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4280708|NCT00562861|4104776|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4280709|NCT00562861|4104777|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4280710|NCT00562861|4104775|B3||White|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
4280711|NCT00562861|4104776|B2||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4280712|NCT00562861|4104777|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4280713|NCT00562861|4104775|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4280714|NCT00562861|4104776|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4280715|NCT00562861|4104777|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4280716|NCT00562861|4104775|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280717|NCT00562861|4104776|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280718|NCT00562861|4104777|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280719|NCT00562861|4104775|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4280720|NCT00562861|4104776|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280721|NCT00562861|4104777|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4280722|NCT00562861|4104775|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280723|NCT00562861|4104776|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280724|NCT00562861|4104777|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4280725|NCT00562861|4104775|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4280726|NCT00562861|4104776|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4280727|NCT00562861|4104777|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4280728|NCT00562861|4104775|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4280729|NCT00562861|4104776|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4280730|NCT00562861|4104777|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4280731|NCT00562861|4104775|B3|||Age||years|Mean|41.5|41.5|Standard Deviation|11.7|11.7|||
4280732|NCT00562861|4104776|B2|||Age||years|Mean|42.1|42.1|Standard Deviation|11.3|11.3|||
4280733|NCT00562861|4104777|B1|||Age||years|Mean|40.9|40.9|Standard Deviation|12.6|12.6|||
4280734|NCT00562627|4104784|B4|Norway||Region of Enrollment||participants|Number|102|102.0||||||
4280735|NCT00562627|4104785|B3|Norway||Region of Enrollment||participants|Number|34|34.0||||||
4280736|NCT00562627|4104786|B2|Norway||Region of Enrollment||participants|Number|34|34.0||||||
4280737|NCT00562627|4104787|B1|Norway||Region of Enrollment||participants|Number|34|34.0||||||
4280738|NCT00562627|4104784|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4280739|NCT00562627|4104785|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4280740|NCT00562627|4104786|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4280741|NCT00562627|4104787|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4280742|NCT00562627|4104784|B4||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4280743|NCT00562627|4104785|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4280744|NCT00562627|4104786|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4280745|NCT00562627|4104787|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4280746|NCT00562627|4104784|B4|||Age||years|Mean|66.5|66.5|Standard Deviation|9.9|9.9|||
4280747|NCT00562627|4104785|B3|||Age||years|Mean|65.8|65.8|Standard Deviation|10.7|10.7|||
4280748|NCT00562627|4104786|B2|||Age||years|Mean|67.2|67.2|Standard Deviation|8.9|8.9|||
4280749|NCT00562627|4104787|B1|||Age||years|Mean|66.5|66.5|Standard Deviation|11|11.0|||
4280750|NCT00562627|4104784|B4||>=65 years|Age||Participants|Count of Participants|55|55.0||||||
4280751|NCT00562627|4104785|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4280752|NCT00562627|4104786|B2||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4280753|NCT00562627|4104787|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4280754|NCT00562627|4104784|B4||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4280755|NCT00562627|4104785|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4280756|NCT00562627|4104786|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4280757|NCT00562627|4104787|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4280758|NCT00562627|4104784|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280759|NCT00562627|4104785|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280760|NCT00562627|4104786|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280761|NCT00562627|4104787|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280762|NCT00562588|4104803|B3||Male|Sex: Female, Male||Participants|Count of Participants|339|339.0||||||
4280763|NCT00562588|4104804|B2||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4280764|NCT00562588|4104805|B1||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4280765|NCT00562588|4104803|B3||Female|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4280766|NCT00562588|4104804|B2||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4280767|NCT00562588|4104805|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4280768|NCT00562588|4104803|B3|||Age||Years|Mean|67.3|67.3|Standard Deviation|11.5|11.5|||
4280769|NCT00562588|4104804|B2|||Age||Years|Mean|66.5|66.5|Standard Deviation|11.4|11.4|||
4280770|NCT00562588|4104805|B1|||Age||Years|Mean|68.3|68.3|Standard Deviation|11.5|11.5|||
4280771|NCT00562484|4104834|B3|New Zealand||Region of Enrollment||participants|Number|2753|2753.0||||||
4280772|NCT00562484|4104835|B2|New Zealand||Region of Enrollment||participants|Number|921|921.0||||||
4280773|NCT00562484|4104836|B1|New Zealand||Region of Enrollment||participants|Number|1832|1832.0||||||
4280774|NCT00562484|4104834|B3|Australia||Region of Enrollment||participants|Number|12291|12291.0||||||
4280775|NCT00562484|4104835|B2|Australia||Region of Enrollment||participants|Number|4090|4090.0||||||
4280776|NCT00562484|4104836|B1|Australia||Region of Enrollment||participants|Number|8201|8201.0||||||
4280777|NCT00562484|4104834|B3||Male|Sex: Female, Male||Participants|Count of Participants|6854|6854.0||||||
4280778|NCT00562484|4104835|B2||Male|Sex: Female, Male||Participants|Count of Participants|2344|2344.0||||||
4280779|NCT00562484|4104836|B1||Male|Sex: Female, Male||Participants|Count of Participants|4510|4510.0||||||
4280780|NCT00562484|4104834|B3||Female|Sex: Female, Male||Participants|Count of Participants|8190|8190.0||||||
4280781|NCT00562484|4104835|B2||Female|Sex: Female, Male||Participants|Count of Participants|2667|2667.0||||||
4280782|NCT00562484|4104836|B1||Female|Sex: Female, Male||Participants|Count of Participants|5523|5523.0||||||
4280783|NCT00562484|4104834|B3|||Age||years|Mean|35.5|35.5|Standard Deviation|14.69|14.69|||
4280784|NCT00562484|4104835|B2|||Age||years|Mean|35.4|35.4|Standard Deviation|14.69|14.69|||
4280785|NCT00562484|4104836|B1|||Age||years|Mean|35.5|35.5|Standard Deviation|14.69|14.69|||
4280786|NCT00562484|4104834|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4280787|NCT00562484|4104835|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4280788|NCT00562484|4104836|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4280789|NCT00562484|4104834|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15044|15044.0||||||
4280790|NCT00562484|4104835|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5011|5011.0||||||
4280791|NCT00562484|4104836|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10033|10033.0||||||
4280792|NCT00562484|4104834|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280793|NCT00562484|4104835|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280794|NCT00562484|4104836|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280795|NCT00562354|4104867|B3||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4280796|NCT00562354|4104868|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4280797|NCT00562354|4104869|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4280798|NCT00562354|4104867|B3||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4280799|NCT00562354|4104868|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4280800|NCT00562354|4104869|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4280801|NCT00562354|4104867|B3|||Age||years|Mean|64.0|64.0|Standard Deviation|7.7|7.7|||
4280802|NCT00562354|4104868|B2|||Age||years|Mean|70.5|70.5|Standard Deviation|4.4|4.4|||
4280803|NCT00562354|4104869|B1|||Age||years|Mean|57.5|57.5|Standard Deviation|4.0|4.0|||
4280804|NCT00562328|4104911|B1|Unknown||ZAP-70 Expression|This test is used to predict the rate of progression from diagnosis to need for treatment in CLL. Participants with positive ZAP-70 (>=20%) tend to experience a more aggressive course of CLL.|participants|Number|1|1.0||||||
4280805|NCT00562328|4104911|B1|Negative (<20%)||ZAP-70 Expression|This test is used to predict the rate of progression from diagnosis to need for treatment in CLL. Participants with positive ZAP-70 (>=20%) tend to experience a more aggressive course of CLL.|participants|Number|7|7.0||||||
4280806|NCT00562328|4104911|B1|Positive (>=20%)||ZAP-70 Expression|This test is used to predict the rate of progression from diagnosis to need for treatment in CLL. Participants with positive ZAP-70 (>=20%) tend to experience a more aggressive course of CLL.|participants|Number|25|25.0||||||
4280807|NCT00562328|4104911|B1|Unmutated||Immunoglobulin Variable Heavy Chain (IGVH) Mutation Status|IGVH testing helps predict which patients will experience a more aggressive (if the gene is unmutated, <=2%) or less aggressive (if the gene is mutated, >2%) course of CLL. This technically complex test is only available at select medical institutions.|participants|Number|30|30.0||||||
4280808|NCT00562328|4104911|B1|Mutated||Immunoglobulin Variable Heavy Chain (IGVH) Mutation Status|IGVH testing helps predict which patients will experience a more aggressive (if the gene is unmutated, <=2%) or less aggressive (if the gene is mutated, >2%) course of CLL. This technically complex test is only available at select medical institutions.|participants|Number|3|3.0||||||
4280809|NCT00562328|4104911|B1|Negative (<30%)||CD38 Expression Status|This test is used to predict the rate of progression from diagnosis to need for treatment in CLL. Participants with positive CD38 (>=30%) tend to experience a more aggressive course of CLL.|participants|Number|18|18.0||||||
4280810|NCT00562328|4104911|B1|Positive (>=30%)||CD38 Expression Status|This test is used to predict the rate of progression from diagnosis to need for treatment in CLL. Participants with positive CD38 (>=30%) tend to experience a more aggressive course of CLL.|participants|Number|15|15.0||||||
4280811|NCT00562328|4104911|B1|Stage 2||Rai Stage|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL); higher stages reflect increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis and lymphadenopathy, Rai Stage II: Lymphocytosis and hepatomegaly +/- splenomegaly, Rai Stage III: Lymphocytosis and anemia, Rai Stage IV: Lymphocytosis and thrombocytopenia"|participants|Number|4|4.0||||||
4280812|NCT00562328|4104911|B1|Stage 1||Rai Stage|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL); higher stages reflect increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis and lymphadenopathy, Rai Stage II: Lymphocytosis and hepatomegaly +/- splenomegaly, Rai Stage III: Lymphocytosis and anemia, Rai Stage IV: Lymphocytosis and thrombocytopenia"|participants|Number|27|27.0||||||
4280813|NCT00562328|4104911|B1|Stage 0||Rai Stage|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL); higher stages reflect increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis and lymphadenopathy, Rai Stage II: Lymphocytosis and hepatomegaly +/- splenomegaly, Rai Stage III: Lymphocytosis and anemia, Rai Stage IV: Lymphocytosis and thrombocytopenia"|participants|Number|2|2.0||||||
4280814|NCT00562328|4104911|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4280815|NCT00562328|4104911|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4280816|NCT00562328|4104911|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4280817|NCT00562328|4104911|B1|||Age||years|Median|60|60.0|Full Range|||42.0|77.0|
4280818|NCT00562315|4104915|B1|United States||Region of Enrollment||participants|Number|93|93.0||||||
4280819|NCT00562315|4104915|B1||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4280820|NCT00562315|4104915|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4280821|NCT00562315|4104915|B1|||Age||years|Mean|68.0|68.0|Standard Deviation|7.6|7.6|||
4280822|NCT00562302|4104930|B3|No||History of Smoking||Participants|Number|48|48.0||||||
4280823|NCT00562302|4104931|B2|No||History of Smoking||Participants|Number|23|23.0||||||
4280824|NCT00562302|4104932|B1|No||History of Smoking||Participants|Number|25|25.0||||||
4280825|NCT00562302|4104930|B3|Yes||History of Smoking||Participants|Number|291|291.0||||||
4280826|NCT00562302|4104931|B2|Yes||History of Smoking||Participants|Number|146|146.0||||||
4280827|NCT00562302|4104932|B1|Yes||History of Smoking||Participants|Number|145|145.0||||||
4280828|NCT00562302|4104930|B3||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4280829|NCT00562302|4104931|B2||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4280830|NCT00562302|4104932|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4280831|NCT00562302|4104930|B3||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4280832|NCT00562302|4104931|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4280833|NCT00562302|4104932|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4280834|NCT00562302|4104930|B3|||Age||Years|Mean|66.7|66.7|Standard Deviation|11.93|11.93|||
4280835|NCT00562302|4104931|B2|||Age||Years|Mean|67.2|67.2|Standard Deviation|12.38|12.38|||
4280836|NCT00562302|4104932|B1|||Age||Years|Mean|66.1|66.1|Standard Deviation|11.47|11.47|||
4280837|NCT00562159|4104953|B3||Male|Gender||Participants|Count of Participants|217|217.0||||||
4280838|NCT00562159|4104954|B2||Male|Gender||Participants|Count of Participants|113|113.0||||||
4280839|NCT00562159|4104955|B1||Male|Gender||Participants|Count of Participants|104|104.0||||||
4280840|NCT00562159|4104953|B3||Female|Gender||Participants|Count of Participants|221|221.0||||||
4280841|NCT00562159|4104954|B2||Female|Gender||Participants|Count of Participants|112|112.0||||||
4280842|NCT00562159|4104955|B1||Female|Gender||Participants|Count of Participants|109|109.0||||||
4280843|NCT00562159|4104953|B3|||Age||years|Mean|35.9|35.9|Standard Deviation|10.5|10.5|||
4280844|NCT00562159|4104954|B2|||Age||years|Mean|35.9|35.9|Standard Deviation|9.8|9.8|||
4280845|NCT00562159|4104955|B1|||Age||years|Mean|35.9|35.9|Standard Deviation|11.1|11.1|||
4280846|NCT00562120|4104968|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4280847|NCT00562120|4104968|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4280848|NCT00562120|4104968|B1|45 to 64 years||Age, Customized||participants|Number|5|5.0||||||
4280849|NCT00562120|4104968|B1|18 to 44 years||Age, Customized||participants|Number|15|15.0||||||
4280850|NCT00562094|4105003|B1|Missing data||Indication for prescription of pantoprazole||percentage of participants|Number|0.4|0.4||||||
4280851|NCT00562094|4105003|B1|Acute reflux oesophagitis||Indication for prescription of pantoprazole||percentage of participants|Number|49.1|49.1||||||
4280852|NCT00562094|4105003|B1|long-term therapy and/or relapse prophylaxis||Indication for prescription of pantoprazole||percentage of participants|Number|50.5|50.5||||||
4280853|NCT00562094|4105003|B1|Missing data||Drug abuse||percentage of participants|Number|1.1|1.1||||||
4280854|NCT00562094|4105003|B1|No drug abuse||Drug abuse||percentage of participants|Number|96.0|96.0||||||
4280855|NCT00562094|4105003|B1|Drug abuse||Drug abuse||percentage of participants|Number|2.9|2.9||||||
4280856|NCT00562094|4105003|B1|Missing data||Alcohol use||percentage of participants|Number|0.8|0.8||||||
4280857|NCT00562094|4105003|B1|Not daily||Alcohol use||percentage of participants|Number|77.2|77.2||||||
4280858|NCT00562094|4105003|B1|Daily||Alcohol use||percentage of participants|Number|22.1|22.1||||||
4280859|NCT00562094|4105003|B1|Missing data||Nicotine use||percentage of participants|Number|0.7|0.7||||||
4280860|NCT00562094|4105003|B1|Non-smoker||Nicotine use||percentage of participants|Number|64.1|64.1||||||
4280861|NCT00562094|4105003|B1|Smoker||Nicotine use||percentage of participants|Number|35.2|35.2||||||
4280862|NCT00562094|4105003|B1|Missing data||Sex/Gender, Customized||percentage of participants|Number|0.5|0.5||||||
4280863|NCT00562094|4105003|B1|Male||Sex/Gender, Customized||percentage of participants|Number|51.7|51.7||||||
4280864|NCT00562094|4105003|B1|Female||Sex/Gender, Customized||percentage of participants|Number|47.8|47.8||||||
4280865|NCT00562094|4105003|B1|||Age|The measured value is related to the number of 8502 subjects (= valid cases). This number differs from the overall number of baseline participants due to missing data for 114 subjects.|years|Mean|55.7|55.7|Standard Deviation|14.51|14.51|||
4280866|NCT00561977|4105015|B4|United States||Region of Enrollment||participants|Number|36|36.0||||||
4280867|NCT00561977|4105016|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4280868|NCT00561977|4105017|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4280869|NCT00561977|4105018|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4280870|NCT00561977|4105015|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4280871|NCT00561977|4105016|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4280872|NCT00561977|4105017|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4280873|NCT00561977|4105018|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4280874|NCT00561977|4105015|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4280875|NCT00561977|4105016|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4280876|NCT00561977|4105017|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4280877|NCT00561977|4105018|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4280878|NCT00561977|4105015|B4|||Age||years|Mean|47.58|47.58|Standard Deviation|13.48|13.48|||
4280879|NCT00561977|4105016|B3|||Age||years|Mean|41.33|41.33|Standard Deviation|15.89|15.89|||
4280880|NCT00561977|4105017|B2|||Age||years|Mean|53.00|53.0|Standard Deviation|12.5|12.5|||
4280881|NCT00561977|4105018|B1|||Age||years|Mean|48.42|48.42|Standard Deviation|9.77|9.77|||
4280882|NCT00561977|4105015|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4280883|NCT00561977|4105016|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4280884|NCT00561977|4105017|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4280885|NCT00561977|4105018|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4280886|NCT00561977|4105015|B4||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4280887|NCT00561977|4105016|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4280888|NCT00561977|4105017|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4280889|NCT00561977|4105018|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4280890|NCT00561977|4105015|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280891|NCT00561977|4105016|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280892|NCT00561977|4105017|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280893|NCT00561977|4105018|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280894|NCT00561951|4105043|B4||Male|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4280895|NCT00561951|4105044|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4280896|NCT00561951|4105045|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4280897|NCT00561951|4105046|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4280898|NCT00561951|4105043|B4||Female|Sex: Female, Male||Participants|Count of Participants|757|757.0||||||
4280899|NCT00561951|4105044|B3||Female|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
4280900|NCT00561951|4105045|B2||Female|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4280901|NCT00561951|4105046|B1||Female|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4280902|NCT00561951|4105043|B4|||Age||years|Mean|57.6|57.6|Standard Deviation|13.7|13.7|||
4280903|NCT00561951|4105044|B3|||Age||years|Mean|58.8|58.8|Standard Deviation|13.4|13.4|||
4280904|NCT00561951|4105045|B2|||Age||years|Mean|57.2|57.2|Standard Deviation|14.2|14.2|||
4280905|NCT00561951|4105046|B1|||Age||years|Mean|56.7|56.7|Standard Deviation|13.5|13.5|||
4280906|NCT00561951|4105043|B4||>=65 years|Age||Participants|Count of Participants|311|311.0||||||
4280907|NCT00561951|4105044|B3||>=65 years|Age||Participants|Count of Participants|117|117.0||||||
4280908|NCT00561951|4105045|B2||>=65 years|Age||Participants|Count of Participants|103|103.0||||||
4280909|NCT00561951|4105046|B1||>=65 years|Age||Participants|Count of Participants|91|91.0||||||
4280910|NCT00561951|4105043|B4||Between 18 and 65 years|Age||Participants|Count of Participants|640|640.0||||||
4280911|NCT00561951|4105044|B3||Between 18 and 65 years|Age||Participants|Count of Participants|196|196.0||||||
4280912|NCT00561951|4105045|B2||Between 18 and 65 years|Age||Participants|Count of Participants|217|217.0||||||
4280913|NCT00561951|4105046|B1||Between 18 and 65 years|Age||Participants|Count of Participants|227|227.0||||||
4280914|NCT00561951|4105043|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280915|NCT00561951|4105044|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280916|NCT00561951|4105045|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280917|NCT00561951|4105046|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4280918|NCT00561925|4105101|B4|Drinks - could interfere with trial||Alcohol Status||participants|Number|5|5.0||||||
4280919|NCT00561925|4105102|B3|Drinks - could interfere with trial||Alcohol Status||participants|Number|2|2.0||||||
4280920|NCT00561925|4105103|B2|Drinks - could interfere with trial||Alcohol Status||participants|Number|3|3.0||||||
4280921|NCT00561925|4105101|B4|Drinks - no interfere with trial||Alcohol Status||participants|Number|689|689.0||||||
4280922|NCT00561925|4105102|B3|Drinks - no interfere with trial||Alcohol Status||participants|Number|335|335.0||||||
4280923|NCT00561925|4105103|B2|Drinks - no interfere with trial||Alcohol Status||participants|Number|354|354.0||||||
4280924|NCT00561925|4105101|B4|Non drinker||Alcohol Status||participants|Number|319|319.0||||||
4280925|NCT00561925|4105102|B3|Non drinker||Alcohol Status||participants|Number|168|168.0||||||
4280926|NCT00561925|4105103|B2|Non drinker||Alcohol Status||participants|Number|151|151.0||||||
4280927|NCT00561925|4105101|B4|Current smoker||Smoking History||participants|Number|372|372.0||||||
4280928|NCT00561925|4105102|B3|Current smoker||Smoking History||participants|Number|195|195.0||||||
4280929|NCT00561925|4105103|B2|Current smoker||Smoking History||participants|Number|177|177.0||||||
4280930|NCT00561925|4105101|B4|Ex-smoker||Smoking History||participants|Number|167|167.0||||||
4280931|NCT00561925|4105102|B3|Ex-smoker||Smoking History||participants|Number|86|86.0||||||
4280932|NCT00561925|4105103|B2|Ex-smoker||Smoking History||participants|Number|81|81.0||||||
4280933|NCT00561925|4105101|B4|Never smoked||Smoking History||participants|Number|474|474.0||||||
4280934|NCT00561925|4105102|B3|Never smoked||Smoking History||participants|Number|224|224.0||||||
4280935|NCT00561925|4105103|B2|Never smoked||Smoking History||participants|Number|250|250.0||||||
4280936|NCT00561925|4105101|B4|Africa||Region of Enrollment||participants|Number|106|106.0||||||
4280937|NCT00561925|4105102|B3|Africa||Region of Enrollment||participants|Number|49|49.0||||||
4280938|NCT00561925|4105103|B2|Africa||Region of Enrollment||participants|Number|57|57.0||||||
4280939|NCT00561925|4105101|B4|Latin America||Region of Enrollment||participants|Number|107|107.0||||||
4280940|NCT00561925|4105102|B3|Latin America||Region of Enrollment||participants|Number|58|58.0||||||
4280941|NCT00561925|4105103|B2|Latin America||Region of Enrollment||participants|Number|49|49.0||||||
4280942|NCT00561925|4105101|B4|Europe||Region of Enrollment||participants|Number|510|510.0||||||
4280943|NCT00561925|4105102|B3|Europe||Region of Enrollment||participants|Number|257|257.0||||||
4280944|NCT00561925|4105103|B2|Europe||Region of Enrollment||participants|Number|253|253.0||||||
4280945|NCT00561925|4105101|B4|North America / Australia||Region of Enrollment||participants|Number|290|290.0||||||
4280946|NCT00561925|4105102|B3|North America / Australia||Region of Enrollment||participants|Number|141|141.0||||||
4280947|NCT00561925|4105103|B2|North America / Australia||Region of Enrollment||participants|Number|149|149.0||||||
4280948|NCT00561925|4105101|B4|Not Hispanic / Latino||Race/Ethnicity, Customized||Participants|Number|789|789.0||||||
4280949|NCT00561925|4105102|B3|Not Hispanic / Latino||Race/Ethnicity, Customized||Participants|Number|390|390.0||||||
4280950|NCT00561925|4105103|B2|Not Hispanic / Latino||Race/Ethnicity, Customized||Participants|Number|399|399.0||||||
4280951|NCT00561925|4105101|B4|Hispanic / Latino||Race/Ethnicity, Customized||Participants|Number|224|224.0||||||
4280952|NCT00561925|4105102|B3|Hispanic / Latino||Race/Ethnicity, Customized||Participants|Number|115|115.0||||||
4280953|NCT00561925|4105103|B2|Hispanic / Latino||Race/Ethnicity, Customized||Participants|Number|109|109.0||||||
4280954|NCT00561925|4105101|B4|White||Race/Ethnicity, Customized||participants|Number|763|763.0||||||
4280955|NCT00561925|4105102|B3|White||Race/Ethnicity, Customized||participants|Number|387|387.0||||||
4280956|NCT00561925|4105103|B2|White||Race/Ethnicity, Customized||participants|Number|376|376.0||||||
4280957|NCT00561925|4105101|B4|Hawaiian / Pacific Isle.||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4280958|NCT00561925|4105102|B3|Hawaiian / Pacific Isle.||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4280959|NCT00561925|4105103|B2|Hawaiian / Pacific Isle.||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4280960|NCT00561925|4105101|B4|Black||Race/Ethnicity, Customized||participants|Number|207|207.0||||||
4280961|NCT00561925|4105102|B3|Black||Race/Ethnicity, Customized||participants|Number|94|94.0||||||
4280962|NCT00561925|4105103|B2|Black||Race/Ethnicity, Customized||participants|Number|113|113.0||||||
4280963|NCT00561925|4105101|B4|Asian||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4280964|NCT00561925|4105102|B3|Asian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4280965|NCT00561925|4105103|B2|Asian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4280966|NCT00561925|4105101|B4|American Indian / Alaskan Native||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4280967|NCT00561925|4105102|B3|American Indian / Alaskan Native||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4280968|NCT00561925|4105103|B2|American Indian / Alaskan Native||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4280969|NCT00561925|4105101|B4|Male||Gender||participants|Number|864|864.0||||||
4280970|NCT00561925|4105102|B3|Male||Gender||participants|Number|431|431.0||||||
4280971|NCT00561925|4105103|B2|Male||Gender||participants|Number|433|433.0||||||
4280972|NCT00561925|4105101|B4|Female||Gender||participants|Number|149|149.0||||||
4280973|NCT00561925|4105102|B3|Female||Gender||participants|Number|74|74.0||||||
4280974|NCT00561925|4105103|B2|Female||Gender||participants|Number|75|75.0||||||
4280975|NCT00561925|4105101|B4|65 years or more||Age, Customized||participants|Number|7|7.0||||||
4280976|NCT00561925|4105102|B3|65 years or more||Age, Customized||participants|Number|5|5.0||||||
4280977|NCT00561925|4105103|B2|65 years or more||Age, Customized||participants|Number|2|2.0||||||
4280978|NCT00561925|4105101|B4|56 to < 65 years||Age, Customized||participants|Number|44|44.0||||||
4280979|NCT00561925|4105102|B3|56 to < 65 years||Age, Customized||participants|Number|19|19.0||||||
4280980|NCT00561925|4105103|B2|56 to < 65 years||Age, Customized||participants|Number|25|25.0||||||
4280981|NCT00561925|4105101|B4|41 to < 56 years||Age, Customized||participants|Number|347|347.0||||||
4280982|NCT00561925|4105102|B3|41 to < 56 years||Age, Customized||participants|Number|182|182.0||||||
4280983|NCT00561925|4105103|B2|41 to < 56 years||Age, Customized||participants|Number|165|165.0||||||
4280984|NCT00561925|4105101|B4|18 to < 41 years||Age, Customized||participants|Number|615|615.0||||||
4280985|NCT00561925|4105102|B3|18 to < 41 years||Age, Customized||participants|Number|299|299.0||||||
4280986|NCT00561925|4105103|B2|18 to < 41 years||Age, Customized||participants|Number|316|316.0||||||
4280987|NCT00561925|4105101|B4|||Age||years|Mean|38.1|38.1|Standard Deviation|9.7|9.7|||
4280988|NCT00561925|4105102|B3|||Age||years|Mean|38.3|38.3|Standard Deviation|9.7|9.7|||
4280989|NCT00561925|4105103|B2|||Age||years|Mean|38.0|38.0|Standard Deviation|9.7|9.7|||
4280990|NCT00561912|4105157|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4280991|NCT00561912|4105157|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4280992|NCT00561912|4105157|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4280993|NCT00561912|4105157|B1|||Age||years|Mean|53|53.0|Full Range|||47.0|58.0|
4280994|NCT00561834|4105161|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4280995|NCT00561834|4105161|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4280996|NCT00561834|4105161|B1|||Age||years|Mean|63.5|63.5|Standard Deviation|4.95|4.95|||
4280997|NCT00561821|4105165|B5||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4280998|NCT00561821|4105166|B4||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4280999|NCT00561821|4105167|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4281000|NCT00561821|4105168|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4281001|NCT00561821|4105169|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4281002|NCT00561821|4105165|B5||Female|Sex: Female, Male||Participants|Count of Participants|336|336.0||||||
4281003|NCT00561821|4105166|B4||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4281004|NCT00561821|4105167|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4281005|NCT00561821|4105168|B2||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4281006|NCT00561821|4105169|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4281007|NCT00561821|4105165|B5|||Age||Years|Mean|70.4|70.4|Standard Deviation|4.5|4.5|||
4281008|NCT00561821|4105166|B4|||Age||Years|Mean|70.3|70.3|Standard Deviation|4.3|4.3|||
4281009|NCT00561821|4105167|B3|||Age||Years|Mean|71.1|71.1|Standard Deviation|4.6|4.6|||
4281010|NCT00561821|4105168|B2|||Age||Years|Mean|70.0|70.0|Standard Deviation|4.4|4.4|||
4281011|NCT00561821|4105169|B1|||Age||Years|Mean|70.1|70.1|Standard Deviation|4.4|4.4|||
4281012|NCT00561795|4105246|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4281013|NCT00561795|4105247|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4281014|NCT00561795|4105248|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4281015|NCT00561795|4105246|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4281016|NCT00561795|4105247|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4281017|NCT00561795|4105248|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4281018|NCT00561795|4105246|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4281019|NCT00561795|4105247|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4281020|NCT00561795|4105248|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4281021|NCT00561795|4105246|B3|||Age||years|Mean|53.7|53.7|Standard Deviation|9.49|9.49|||
4281022|NCT00561795|4105247|B2|||Age||years|Mean|52.3|52.3|Standard Deviation|9.85|9.85|||
4281023|NCT00561795|4105248|B1|||Age||years|Mean|55.0|55.0|Standard Deviation|9.84|9.84|||
4281024|NCT00561730|4105271|B1|Missing data||Diagnosis: reflux disease||Percentage of participants|Number|0.9|0.9||||||
4281025|NCT00561730|4105271|B1|Erosive Gastroesophageal Reflux Disease (eGERD)||Diagnosis: reflux disease||Percentage of participants|Number|64.1|64.1||||||
4281026|NCT00561730|4105271|B1|Non-Erosive Reflux Disease (NERD)||Diagnosis: reflux disease||Percentage of participants|Number|35.1|35.1||||||
4281027|NCT00561730|4105271|B1|Missing data||Drug abuse||Percentage of participants|Number|1.0|1.0||||||
4281028|NCT00561730|4105271|B1|No drug abuse||Drug abuse||Percentage of participants|Number|98.0|98.0||||||
4281029|NCT00561730|4105271|B1|Drug abuse||Drug abuse||Percentage of participants|Number|1.0|1.0||||||
4281030|NCT00561730|4105271|B1|Missing data||Alcohol use||Percentage of participants|Number|0.5|0.5||||||
4281031|NCT00561730|4105271|B1|Not daily||Alcohol use||Percentage of participants|Number|82.2|82.2||||||
4281032|NCT00561730|4105271|B1|Daily||Alcohol use||Percentage of participants|Number|17.3|17.3||||||
4281033|NCT00561730|4105271|B1|Missing data||Nicotine use||Percentage of participants|Number|0.7|0.7||||||
4281034|NCT00561730|4105271|B1|Non-smoker||Nicotine use||Percentage of participants|Number|66.8|66.8||||||
4281035|NCT00561730|4105271|B1|Smoker||Nicotine use||Percentage of participants|Number|32.5|32.5||||||
4281036|NCT00561730|4105271|B1|Missing data||Sex/Gender, Customized||Percentage of participants|Number|0.3|0.3||||||
4281037|NCT00561730|4105271|B1|Male||Sex/Gender, Customized||Percentage of participants|Number|53.4|53.4||||||
4281038|NCT00561730|4105271|B1|Female||Sex/Gender, Customized||Percentage of participants|Number|46.3|46.3||||||
4281039|NCT00561730|4105271|B1|||Age|The measured value is related to the number of 1977 subjects (= valid cases). This number differs from the overall number of baseline participants due to missing data for 18 subjects.|Years|Mean|54.1|54.1|Standard Deviation|15.0|15.0|||
4281040|NCT00561678|4105285|B3|||Propofol|amount of general anesthesia given|mg/kg|Median|165.0|165.0|Inter-Quartile Range|||120.0|300.0|
4281041|NCT00561678|4105286|B2|||Propofol|amount of general anesthesia given|mg/kg|Median|160.0|160.0|Inter-Quartile Range|||120.0|220.0|
4281042|NCT00561678|4105287|B1|||Propofol|amount of general anesthesia given|mg/kg|Median|170.0|170.0|Inter-Quartile Range|||120.0|360.0|
4281043|NCT00561678|4105285|B3|||Dosage of Fentanyl used prior to this study|amount of general anesthesia given|µg/h|Median|250.0|250.0|Inter-Quartile Range|||175.0|375.0|
4281044|NCT00561678|4105286|B2|||Dosage of Fentanyl used prior to this study|amount of general anesthesia given|µg/h|Median|250.0|250.0|Inter-Quartile Range|||200.0|400.0|
4281045|NCT00561678|4105287|B1|||Dosage of Fentanyl used prior to this study|amount of general anesthesia given|µg/h|Median|250.0|250.0|Inter-Quartile Range|||150.0|350.0|
4281046|NCT00561678|4105285|B3|General||Surgical Procedure||Participants|Count of Participants|93|93.0||||||
4281047|NCT00561678|4105286|B2|General||Surgical Procedure||Participants|Count of Participants|53|53.0||||||
4281048|NCT00561678|4105287|B1|General||Surgical Procedure||Participants|Count of Participants|40|40.0||||||
4281049|NCT00561678|4105285|B3|Urologic||Surgical Procedure||Participants|Count of Participants|49|49.0||||||
4281050|NCT00561678|4105286|B2|Urologic||Surgical Procedure||Participants|Count of Participants|29|29.0||||||
4281051|NCT00561678|4105287|B1|Urologic||Surgical Procedure||Participants|Count of Participants|20|20.0||||||
4281052|NCT00561678|4105285|B3|Orthopedic||Surgical Procedure||Participants|Count of Participants|90|90.0||||||
4281053|NCT00561678|4105286|B2|Orthopedic||Surgical Procedure||Participants|Count of Participants|36|36.0||||||
4281054|NCT00561678|4105287|B1|Orthopedic||Surgical Procedure||Participants|Count of Participants|54|54.0||||||
4281055|NCT00561678|4105285|B3|Thoracic||Surgical Procedure||Participants|Count of Participants|11|11.0||||||
4281056|NCT00561678|4105286|B2|Thoracic||Surgical Procedure||Participants|Count of Participants|6|6.0||||||
4281057|NCT00561678|4105287|B1|Thoracic||Surgical Procedure||Participants|Count of Participants|5|5.0||||||
4281058|NCT00561678|4105285|B3|Spine||Surgical Procedure||Participants|Count of Participants|147|147.0||||||
4281059|NCT00561678|4105286|B2|Spine||Surgical Procedure||Participants|Count of Participants|77|77.0||||||
4281060|NCT00561678|4105287|B1|Spine||Surgical Procedure||Participants|Count of Participants|70|70.0||||||
4281061|NCT00561678|4105285|B3|||Cancer (CA)||Participants|Count of Participants|158|158.0||||||
4281062|NCT00561678|4105286|B2|||Cancer (CA)||Participants|Count of Participants|77|77.0||||||
4281063|NCT00561678|4105287|B1|||Cancer (CA)||Participants|Count of Participants|81|81.0||||||
4281064|NCT00561678|4105285|B3|||Diabetes (DM)||Participants|Count of Participants|79|79.0||||||
4281065|NCT00561678|4105286|B2|||Diabetes (DM)||Participants|Count of Participants|40|40.0||||||
4281066|NCT00561678|4105287|B1|||Diabetes (DM)||Participants|Count of Participants|39|39.0||||||
4281067|NCT00561678|4105285|B3|||Congestive Heart Failure (CHF)||Participants|Count of Participants|1|1.0||||||
4281068|NCT00561678|4105286|B2|||Congestive Heart Failure (CHF)||Participants|Count of Participants|1|1.0||||||
4281069|NCT00561678|4105287|B1|||Congestive Heart Failure (CHF)||Participants|Count of Participants|0|0.0||||||
4281070|NCT00561678|4105285|B3|||Hypertension (HTN)||Participants|Count of Participants|240|240.0||||||
4281071|NCT00561678|4105286|B2|||Hypertension (HTN)||Participants|Count of Participants|116|116.0||||||
4281072|NCT00561678|4105287|B1|||Hypertension (HTN)||Participants|Count of Participants|124|124.0||||||
4281073|NCT00561678|4105285|B3|||Coronary Artery Disease (CAD)||Participants|Count of Participants|32|32.0||||||
4281074|NCT00561678|4105286|B2|||Coronary Artery Disease (CAD)||Participants|Count of Participants|18|18.0||||||
4281075|NCT00561678|4105287|B1|||Coronary Artery Disease (CAD)||Participants|Count of Participants|14|14.0||||||
4281076|NCT00561678|4105285|B3|4||ASA Status|"The American Society of Anesthesiologists (ASA) Physical Status classification:~- normal healthy patient~- patients with mild systemic disease~- patients with severe systemic disease~- patients with severe systemic disease that is a constant threat to life"|Participants|Count of Participants|13|13.0||||||
4281077|NCT00561678|4105286|B2|4||ASA Status|"The American Society of Anesthesiologists (ASA) Physical Status classification:~- normal healthy patient~- patients with mild systemic disease~- patients with severe systemic disease~- patients with severe systemic disease that is a constant threat to life"|Participants|Count of Participants|5|5.0||||||
4281078|NCT00561678|4105287|B1|4||ASA Status|"The American Society of Anesthesiologists (ASA) Physical Status classification:~- normal healthy patient~- patients with mild systemic disease~- patients with severe systemic disease~- patients with severe systemic disease that is a constant threat to life"|Participants|Count of Participants|8|8.0||||||
4281079|NCT00561678|4105285|B3|3||ASA Status|"The American Society of Anesthesiologists (ASA) Physical Status classification:~- normal healthy patient~- patients with mild systemic disease~- patients with severe systemic disease~- patients with severe systemic disease that is a constant threat to life"|Participants|Count of Participants|241|241.0||||||
4281080|NCT00561678|4105286|B2|3||ASA Status|"The American Society of Anesthesiologists (ASA) Physical Status classification:~- normal healthy patient~- patients with mild systemic disease~- patients with severe systemic disease~- patients with severe systemic disease that is a constant threat to life"|Participants|Count of Participants|133|133.0||||||
4281081|NCT00561678|4105287|B1|3||ASA Status|"The American Society of Anesthesiologists (ASA) Physical Status classification:~- normal healthy patient~- patients with mild systemic disease~- patients with severe systemic disease~- patients with severe systemic disease that is a constant threat to life"|Participants|Count of Participants|108|108.0||||||
4281082|NCT00561678|4105285|B3|1 or 2||ASA Status|"The American Society of Anesthesiologists (ASA) Physical Status classification:~- normal healthy patient~- patients with mild systemic disease~- patients with severe systemic disease~- patients with severe systemic disease that is a constant threat to life"|Participants|Count of Participants|136|136.0||||||
4281083|NCT00561678|4105286|B2|1 or 2||ASA Status|"The American Society of Anesthesiologists (ASA) Physical Status classification:~- normal healthy patient~- patients with mild systemic disease~- patients with severe systemic disease~- patients with severe systemic disease that is a constant threat to life"|Participants|Count of Participants|63|63.0||||||
4281084|NCT00561678|4105287|B1|1 or 2||ASA Status|"The American Society of Anesthesiologists (ASA) Physical Status classification:~- normal healthy patient~- patients with mild systemic disease~- patients with severe systemic disease~- patients with severe systemic disease that is a constant threat to life"|Participants|Count of Participants|73|73.0||||||
4281085|NCT00561678|4105285|B3|||Mild Cognitive Impairment (MCI)||Participants|Count of Participants|246|246.0||||||
4281086|NCT00561678|4105286|B2|||Mild Cognitive Impairment (MCI)||Participants|Count of Participants|122|122.0||||||
4281087|NCT00561678|4105287|B1|||Mild Cognitive Impairment (MCI)||Participants|Count of Participants|124|124.0||||||
4281088|NCT00561678|4105285|B3|||Surgical Time||minutes|Median|177.0|177.0|Inter-Quartile Range|||121.0|238.0|
4281089|NCT00561678|4105286|B2|||Surgical Time||minutes|Median|180.0|180.0|Inter-Quartile Range|||123.0|249.0|
4281090|NCT00561678|4105287|B1|||Surgical Time||minutes|Median|174.0|174.0|Inter-Quartile Range|||119.0|233.0|
4281091|NCT00561678|4105285|B3|||Anesthesia Time||minutes|Median|253.0|253.0|Inter-Quartile Range|||185.0|345.0|
4281092|NCT00561678|4105286|B2|||Anesthesia Time||minutes|Median|254.0|254.0|Inter-Quartile Range|||191.0|339.0|
4281093|NCT00561678|4105287|B1|||Anesthesia Time||minutes|Median|252.0|252.0|Inter-Quartile Range|||173.0|348.0|
4281094|NCT00561678|4105285|B3|||Body Mass Index (BMI)||kg/m^2|Median|28.0|28.0|Inter-Quartile Range|||24.1|31.9|
4281095|NCT00561678|4105286|B2|||Body Mass Index (BMI)||kg/m^2|Median|27.7|27.7|Inter-Quartile Range|||24.0|32.3|
4281096|NCT00561678|4105287|B1|||Body Mass Index (BMI)||kg/m^2|Median|28.1|28.1|Inter-Quartile Range|||24.3|31.7|
4281097|NCT00561678|4105285|B3|||Education||years|Median|16.0|16.0|Inter-Quartile Range|||12.0|18.0|
4281098|NCT00561678|4105286|B2|||Education||years|Median|15.0|15.0|Inter-Quartile Range|||12.0|17.0|
4281099|NCT00561678|4105287|B1|||Education||years|Median|16.0|16.0|Inter-Quartile Range|||12.0|18.0|
4281100|NCT00561678|4105285|B3||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4281101|NCT00561678|4105286|B2||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4281102|NCT00561678|4105287|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4281103|NCT00561678|4105285|B3||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4281104|NCT00561678|4105286|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4281105|NCT00561678|4105287|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4281106|NCT00561678|4105285|B3|||Age||years|Median|74.0|74.0|Inter-Quartile Range|||71.0|78.0|
4281107|NCT00561678|4105286|B2|||Age||years|Median|74.0|74.0|Inter-Quartile Range|||71.0|78.0|
4281108|NCT00561678|4105287|B1|||Age||years|Median|74.0|74.0|Inter-Quartile Range|||71.0|78.0|
4281109|NCT00561652|4105304|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4281110|NCT00561652|4105305|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4281111|NCT00561652|4105306|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4281112|NCT00561652|4105304|B3|Nonhispanic White||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4281113|NCT00561652|4105305|B2|Nonhispanic White||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4281114|NCT00561652|4105306|B1|Nonhispanic White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4281115|NCT00561652|4105304|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4281116|NCT00561652|4105305|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4281117|NCT00561652|4105306|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4281118|NCT00561652|4105304|B3|Nonhispanic Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4281119|NCT00561652|4105305|B2|Nonhispanic Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4281120|NCT00561652|4105306|B1|Nonhispanic Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4281121|NCT00561652|4105304|B3|Asian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4281122|NCT00561652|4105305|B2|Asian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4281123|NCT00561652|4105306|B1|Asian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4281124|NCT00561652|4105304|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4281125|NCT00561652|4105305|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4281126|NCT00561652|4105306|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4281127|NCT00561652|4105304|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4281128|NCT00561652|4105305|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4281129|NCT00561652|4105306|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4281130|NCT00561652|4105304|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4281131|NCT00561652|4105305|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4281132|NCT00561652|4105306|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4281133|NCT00561652|4105304|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4281134|NCT00561652|4105305|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4281135|NCT00561652|4105306|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4281136|NCT00561652|4105304|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4281137|NCT00561652|4105305|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4281138|NCT00561652|4105306|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4281139|NCT00561652|4105304|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4281140|NCT00561652|4105305|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4281141|NCT00561652|4105306|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4281142|NCT00561600|4105325|B3|||BMI|Body mass index|lb/in^2|Mean|29.9|29.9|Standard Deviation|6.5|6.5|||
4281143|NCT00561600|4105326|B2|||BMI|Body mass index|lb/in^2|Mean|30.1|30.1|Standard Deviation|6.0|6.0|||
4281144|NCT00561600|4105327|B1|||BMI|Body mass index|lb/in^2|Mean|29.7|29.7|Standard Deviation|7.0|7.0|||
4281145|NCT00561600|4105325|B3|United States||Region of Enrollment||participants|Number|265|265.0||||||
4281146|NCT00561600|4105326|B2|United States||Region of Enrollment||participants|Number|135|135.0||||||
4281147|NCT00561600|4105327|B1|United States||Region of Enrollment||participants|Number|130|130.0||||||
4281148|NCT00561600|4105325|B3||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4281149|NCT00561600|4105326|B2||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4281150|NCT00561600|4105327|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4281151|NCT00561600|4105325|B3||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4281152|NCT00561600|4105326|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4281153|NCT00561600|4105327|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4281154|NCT00561600|4105325|B3|||Age||years|Mean|59.6|59.6|Standard Deviation|9.0|9.0|||
4281155|NCT00561600|4105326|B2|||Age||years|Mean|59.4|59.4|Standard Deviation|9.4|9.4|||
4281156|NCT00561600|4105327|B1|||Age||years|Mean|59.7|59.7|Standard Deviation|8.6|8.6|||
4281157|NCT00561574|4105388|B3||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4281158|NCT00561574|4105389|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4281159|NCT00561574|4105390|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4281160|NCT00561574|4105388|B3||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4281161|NCT00561574|4105389|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4281162|NCT00561574|4105390|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4281163|NCT00561574|4105388|B3|||Age||Years|Mean|70.9|70.9|Standard Deviation|5.2|5.2|||
4281164|NCT00561574|4105389|B2|||Age||Years|Mean|71.1|71.1|Standard Deviation|5.1|5.1|||
4281165|NCT00561574|4105390|B1|||Age||Years|Mean|70.7|70.7|Standard Deviation|5.2|5.2|||
4281166|NCT00561470|4105415|B3|No||Prior Bevacizumab|Number of participants randomized in the prior bevacizumab stratum as per the interactive voice response system (IVRS).|participants|Number|853|853.0||||||
4281167|NCT00561470|4105416|B2|No||Prior Bevacizumab|Number of participants randomized in the prior bevacizumab stratum as per the interactive voice response system (IVRS).|participants|Number|426|426.0||||||
4281168|NCT00561470|4105417|B1|No||Prior Bevacizumab|Number of participants randomized in the prior bevacizumab stratum as per the interactive voice response system (IVRS).|participants|Number|427|427.0||||||
4281169|NCT00561470|4105415|B3|Yes||Prior Bevacizumab|Number of participants randomized in the prior bevacizumab stratum as per the interactive voice response system (IVRS).|participants|Number|373|373.0||||||
4281170|NCT00561470|4105416|B2|Yes||Prior Bevacizumab|Number of participants randomized in the prior bevacizumab stratum as per the interactive voice response system (IVRS).|participants|Number|186|186.0||||||
4281171|NCT00561470|4105417|B1|Yes||Prior Bevacizumab|Number of participants randomized in the prior bevacizumab stratum as per the interactive voice response system (IVRS).|participants|Number|187|187.0||||||
4281172|NCT00561470|4105415|B3|Participants with ECOG Score = 2||Eastern Cooperative Oncology Group (ECOG) performance status score|"The ECOG score assesses how the disease affects a participant's daily living abilities. It ranges from 0-5, with 0 being the best and 5 being the worst outcome. 0 reflects a fully active participant, able to carry on all pre-disease performance without restriction. 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. 2 reflects an ambulatory participant, who is up and about more than 50% of waking hours, and capable of all self-care but unable to carry out any work activities."|participants|Number|27|27.0||||||
4281173|NCT00561470|4105416|B2|Participants with ECOG Score = 2||Eastern Cooperative Oncology Group (ECOG) performance status score|"The ECOG score assesses how the disease affects a participant's daily living abilities. It ranges from 0-5, with 0 being the best and 5 being the worst outcome. 0 reflects a fully active participant, able to carry on all pre-disease performance without restriction. 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. 2 reflects an ambulatory participant, who is up and about more than 50% of waking hours, and capable of all self-care but unable to carry out any work activities."|participants|Number|13|13.0||||||
4281174|NCT00561470|4105417|B1|Participants with ECOG Score = 2||Eastern Cooperative Oncology Group (ECOG) performance status score|"The ECOG score assesses how the disease affects a participant's daily living abilities. It ranges from 0-5, with 0 being the best and 5 being the worst outcome. 0 reflects a fully active participant, able to carry on all pre-disease performance without restriction. 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. 2 reflects an ambulatory participant, who is up and about more than 50% of waking hours, and capable of all self-care but unable to carry out any work activities."|participants|Number|14|14.0||||||
4281175|NCT00561470|4105415|B3|Participants with ECOG Score = 1||Eastern Cooperative Oncology Group (ECOG) performance status score|"The ECOG score assesses how the disease affects a participant's daily living abilities. It ranges from 0-5, with 0 being the best and 5 being the worst outcome. 0 reflects a fully active participant, able to carry on all pre-disease performance without restriction. 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. 2 reflects an ambulatory participant, who is up and about more than 50% of waking hours, and capable of all self-care but unable to carry out any work activities."|participants|Number|500|500.0||||||
4281176|NCT00561470|4105416|B2|Participants with ECOG Score = 1||Eastern Cooperative Oncology Group (ECOG) performance status score|"The ECOG score assesses how the disease affects a participant's daily living abilities. It ranges from 0-5, with 0 being the best and 5 being the worst outcome. 0 reflects a fully active participant, able to carry on all pre-disease performance without restriction. 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. 2 reflects an ambulatory participant, who is up and about more than 50% of waking hours, and capable of all self-care but unable to carry out any work activities."|participants|Number|250|250.0||||||
4281177|NCT00561470|4105417|B1|Participants with ECOG Score = 1||Eastern Cooperative Oncology Group (ECOG) performance status score|"The ECOG score assesses how the disease affects a participant's daily living abilities. It ranges from 0-5, with 0 being the best and 5 being the worst outcome. 0 reflects a fully active participant, able to carry on all pre-disease performance without restriction. 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. 2 reflects an ambulatory participant, who is up and about more than 50% of waking hours, and capable of all self-care but unable to carry out any work activities."|participants|Number|250|250.0||||||
4281178|NCT00561470|4105415|B3|Participants with ECOG Score = 0||Eastern Cooperative Oncology Group (ECOG) performance status score|"The ECOG score assesses how the disease affects a participant's daily living abilities. It ranges from 0-5, with 0 being the best and 5 being the worst outcome. 0 reflects a fully active participant, able to carry on all pre-disease performance without restriction. 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. 2 reflects an ambulatory participant, who is up and about more than 50% of waking hours, and capable of all self-care but unable to carry out any work activities."|participants|Number|699|699.0||||||
4281179|NCT00561470|4105416|B2|Participants with ECOG Score = 0||Eastern Cooperative Oncology Group (ECOG) performance status score|"The ECOG score assesses how the disease affects a participant's daily living abilities. It ranges from 0-5, with 0 being the best and 5 being the worst outcome. 0 reflects a fully active participant, able to carry on all pre-disease performance without restriction. 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. 2 reflects an ambulatory participant, who is up and about more than 50% of waking hours, and capable of all self-care but unable to carry out any work activities."|participants|Number|349|349.0||||||
4281180|NCT00561470|4105417|B1|Participants with ECOG Score = 0||Eastern Cooperative Oncology Group (ECOG) performance status score|"The ECOG score assesses how the disease affects a participant's daily living abilities. It ranges from 0-5, with 0 being the best and 5 being the worst outcome. 0 reflects a fully active participant, able to carry on all pre-disease performance without restriction. 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. 2 reflects an ambulatory participant, who is up and about more than 50% of waking hours, and capable of all self-care but unable to carry out any work activities."|participants|Number|350|350.0||||||
4281181|NCT00561470|4105415|B3|UNITED STATES||Region of Enrollment||participants|Number|132|132.0||||||
4281182|NCT00561470|4105416|B2|UNITED STATES||Region of Enrollment||participants|Number|61|61.0||||||
4281183|NCT00561470|4105417|B1|UNITED STATES||Region of Enrollment||participants|Number|71|71.0||||||
4281184|NCT00561470|4105415|B3|UNITED KINGDOM||Region of Enrollment||participants|Number|99|99.0||||||
4281185|NCT00561470|4105416|B2|UNITED KINGDOM||Region of Enrollment||participants|Number|52|52.0||||||
4281186|NCT00561470|4105417|B1|UNITED KINGDOM||Region of Enrollment||participants|Number|47|47.0||||||
4281187|NCT00561470|4105415|B3|UKRAINE||Region of Enrollment||participants|Number|22|22.0||||||
4281188|NCT00561470|4105416|B2|UKRAINE||Region of Enrollment||participants|Number|11|11.0||||||
4281189|NCT00561470|4105417|B1|UKRAINE||Region of Enrollment||participants|Number|11|11.0||||||
4281190|NCT00561470|4105415|B3|TURKEY||Region of Enrollment||participants|Number|6|6.0||||||
4281191|NCT00561470|4105416|B2|TURKEY||Region of Enrollment||participants|Number|2|2.0||||||
4281192|NCT00561470|4105417|B1|TURKEY||Region of Enrollment||participants|Number|4|4.0||||||
4281193|NCT00561470|4105415|B3|SWEDEN||Region of Enrollment||participants|Number|14|14.0||||||
4281194|NCT00561470|4105416|B2|SWEDEN||Region of Enrollment||participants|Number|4|4.0||||||
4281195|NCT00561470|4105417|B1|SWEDEN||Region of Enrollment||participants|Number|10|10.0||||||
4281196|NCT00561470|4105415|B3|SPAIN||Region of Enrollment||participants|Number|55|55.0||||||
4281197|NCT00561470|4105416|B2|SPAIN||Region of Enrollment||participants|Number|28|28.0||||||
4281198|NCT00561470|4105417|B1|SPAIN||Region of Enrollment||participants|Number|27|27.0||||||
4281199|NCT00561470|4105415|B3|SOUTH AFRICA||Region of Enrollment||participants|Number|67|67.0||||||
4281200|NCT00561470|4105416|B2|SOUTH AFRICA||Region of Enrollment||participants|Number|31|31.0||||||
4281201|NCT00561470|4105417|B1|SOUTH AFRICA||Region of Enrollment||participants|Number|36|36.0||||||
4281202|NCT00561470|4105415|B3|RUSSIAN FEDERATION||Region of Enrollment||participants|Number|75|75.0||||||
4281203|NCT00561470|4105416|B2|RUSSIAN FEDERATION||Region of Enrollment||participants|Number|40|40.0||||||
4281204|NCT00561470|4105417|B1|RUSSIAN FEDERATION||Region of Enrollment||participants|Number|35|35.0||||||
4281205|NCT00561470|4105415|B3|ROMANIA||Region of Enrollment||participants|Number|32|32.0||||||
4281206|NCT00561470|4105416|B2|ROMANIA||Region of Enrollment||participants|Number|16|16.0||||||
4281207|NCT00561470|4105417|B1|ROMANIA||Region of Enrollment||participants|Number|16|16.0||||||
4281208|NCT00561470|4105415|B3|PUERTO RICO||Region of Enrollment||participants|Number|6|6.0||||||
4281209|NCT00561470|4105416|B2|PUERTO RICO||Region of Enrollment||participants|Number|2|2.0||||||
4281210|NCT00561470|4105417|B1|PUERTO RICO||Region of Enrollment||participants|Number|4|4.0||||||
4281211|NCT00561470|4105415|B3|POLAND||Region of Enrollment||participants|Number|56|56.0||||||
4281212|NCT00561470|4105416|B2|POLAND||Region of Enrollment||participants|Number|32|32.0||||||
4281213|NCT00561470|4105417|B1|POLAND||Region of Enrollment||participants|Number|24|24.0||||||
4281214|NCT00561470|4105415|B3|NORWAY||Region of Enrollment||participants|Number|33|33.0||||||
4281215|NCT00561470|4105416|B2|NORWAY||Region of Enrollment||participants|Number|19|19.0||||||
4281216|NCT00561470|4105417|B1|NORWAY||Region of Enrollment||participants|Number|14|14.0||||||
4281217|NCT00561470|4105415|B3|NEW ZEALAND||Region of Enrollment||participants|Number|20|20.0||||||
4281218|NCT00561470|4105416|B2|NEW ZEALAND||Region of Enrollment||participants|Number|7|7.0||||||
4281219|NCT00561470|4105417|B1|NEW ZEALAND||Region of Enrollment||participants|Number|13|13.0||||||
4281220|NCT00561470|4105415|B3|NETHERLANDS||Region of Enrollment||participants|Number|34|34.0||||||
4281221|NCT00561470|4105416|B2|NETHERLANDS||Region of Enrollment||participants|Number|14|14.0||||||
4281222|NCT00561470|4105417|B1|NETHERLANDS||Region of Enrollment||participants|Number|20|20.0||||||
4281223|NCT00561470|4105415|B3|KOREA, REPUBLIC OF||Region of Enrollment||participants|Number|65|65.0||||||
4281224|NCT00561470|4105416|B2|KOREA, REPUBLIC OF||Region of Enrollment||participants|Number|26|26.0||||||
4281225|NCT00561470|4105417|B1|KOREA, REPUBLIC OF||Region of Enrollment||participants|Number|39|39.0||||||
4281226|NCT00561470|4105415|B3|ITALY||Region of Enrollment||participants|Number|49|49.0||||||
4281227|NCT00561470|4105416|B2|ITALY||Region of Enrollment||participants|Number|23|23.0||||||
4281228|NCT00561470|4105417|B1|ITALY||Region of Enrollment||participants|Number|26|26.0||||||
4281229|NCT00561470|4105415|B3|GREECE||Region of Enrollment||participants|Number|19|19.0||||||
4281230|NCT00561470|4105416|B2|GREECE||Region of Enrollment||participants|Number|10|10.0||||||
4281231|NCT00561470|4105417|B1|GREECE||Region of Enrollment||participants|Number|9|9.0||||||
4281232|NCT00561470|4105415|B3|GERMANY||Region of Enrollment||participants|Number|35|35.0||||||
4281233|NCT00561470|4105416|B2|GERMANY||Region of Enrollment||participants|Number|12|12.0||||||
4281234|NCT00561470|4105417|B1|GERMANY||Region of Enrollment||participants|Number|23|23.0||||||
4281235|NCT00561470|4105415|B3|FRANCE||Region of Enrollment||participants|Number|2|2.0||||||
4281236|NCT00561470|4105416|B2|FRANCE||Region of Enrollment||participants|Number|1|1.0||||||
4281237|NCT00561470|4105417|B1|FRANCE||Region of Enrollment||participants|Number|1|1.0||||||
4281238|NCT00561470|4105415|B3|ESTONIA||Region of Enrollment||participants|Number|10|10.0||||||
4281239|NCT00561470|4105416|B2|ESTONIA||Region of Enrollment||participants|Number|3|3.0||||||
4281240|NCT00561470|4105417|B1|ESTONIA||Region of Enrollment||participants|Number|7|7.0||||||
4281241|NCT00561470|4105415|B3|DENMARK||Region of Enrollment||participants|Number|15|15.0||||||
4281242|NCT00561470|4105416|B2|DENMARK||Region of Enrollment||participants|Number|6|6.0||||||
4281243|NCT00561470|4105417|B1|DENMARK||Region of Enrollment||participants|Number|9|9.0||||||
4281244|NCT00561470|4105415|B3|CZECH REPUBLIC||Region of Enrollment||participants|Number|77|77.0||||||
4281245|NCT00561470|4105416|B2|CZECH REPUBLIC||Region of Enrollment||participants|Number|47|47.0||||||
4281246|NCT00561470|4105417|B1|CZECH REPUBLIC||Region of Enrollment||participants|Number|30|30.0||||||
4281247|NCT00561470|4105415|B3|CHILE||Region of Enrollment||participants|Number|64|64.0||||||
4281248|NCT00561470|4105416|B2|CHILE||Region of Enrollment||participants|Number|33|33.0||||||
4281249|NCT00561470|4105417|B1|CHILE||Region of Enrollment||participants|Number|31|31.0||||||
4281250|NCT00561470|4105415|B3|BRAZIL||Region of Enrollment||participants|Number|48|48.0||||||
4281251|NCT00561470|4105416|B2|BRAZIL||Region of Enrollment||participants|Number|27|27.0||||||
4281252|NCT00561470|4105417|B1|BRAZIL||Region of Enrollment||participants|Number|21|21.0||||||
4281253|NCT00561470|4105415|B3|BELGIUM||Region of Enrollment||participants|Number|82|82.0||||||
4281254|NCT00561470|4105416|B2|BELGIUM||Region of Enrollment||participants|Number|45|45.0||||||
4281255|NCT00561470|4105417|B1|BELGIUM||Region of Enrollment||participants|Number|37|37.0||||||
4281256|NCT00561470|4105415|B3|AUSTRIA||Region of Enrollment||participants|Number|7|7.0||||||
4281257|NCT00561470|4105416|B2|AUSTRIA||Region of Enrollment||participants|Number|4|4.0||||||
4281258|NCT00561470|4105417|B1|AUSTRIA||Region of Enrollment||participants|Number|3|3.0||||||
4281259|NCT00561470|4105415|B3|AUSTRALIA||Region of Enrollment||participants|Number|96|96.0||||||
4281260|NCT00561470|4105416|B2|AUSTRALIA||Region of Enrollment||participants|Number|54|54.0||||||
4281261|NCT00561470|4105417|B1|AUSTRALIA||Region of Enrollment||participants|Number|42|42.0||||||
4281262|NCT00561470|4105415|B3|ARGENTINA||Region of Enrollment||participants|Number|6|6.0||||||
4281263|NCT00561470|4105416|B2|ARGENTINA||Region of Enrollment||participants|Number|2|2.0||||||
4281264|NCT00561470|4105417|B1|ARGENTINA||Region of Enrollment||participants|Number|4|4.0||||||
4281265|NCT00561470|4105415|B3|Other||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4281266|NCT00561470|4105416|B2|Other||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4281267|NCT00561470|4105417|B1|Other||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4281268|NCT00561470|4105415|B3|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|86|86.0||||||
4281269|NCT00561470|4105416|B2|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4281270|NCT00561470|4105417|B1|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4281271|NCT00561470|4105415|B3|Black||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4281272|NCT00561470|4105416|B2|Black||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4281273|NCT00561470|4105417|B1|Black||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4281274|NCT00561470|4105415|B3|Caucasian/White||Race/Ethnicity, Customized||participants|Number|1071|1071.0||||||
4281275|NCT00561470|4105416|B2|Caucasian/White||Race/Ethnicity, Customized||participants|Number|548|548.0||||||
4281276|NCT00561470|4105417|B1|Caucasian/White||Race/Ethnicity, Customized||participants|Number|523|523.0||||||
4281277|NCT00561470|4105415|B3|Female||Sex/Gender, Customized||participants|Number|508|508.0||||||
4281278|NCT00561470|4105416|B2|Female||Sex/Gender, Customized||participants|Number|247|247.0||||||
4281279|NCT00561470|4105417|B1|Female||Sex/Gender, Customized||participants|Number|261|261.0||||||
4281280|NCT00561470|4105415|B3|Male||Sex/Gender, Customized||participants|Number|718|718.0||||||
4281281|NCT00561470|4105416|B2|Male||Sex/Gender, Customized||participants|Number|365|365.0||||||
4281282|NCT00561470|4105417|B1|Male||Sex/Gender, Customized||participants|Number|353|353.0||||||
4281283|NCT00561470|4105415|B3|>=75 years||Age, Customized||participants|Number|72|72.0||||||
4281284|NCT00561470|4105416|B2|>=75 years||Age, Customized||participants|Number|33|33.0||||||
4281285|NCT00561470|4105417|B1|>=75 years||Age, Customized||participants|Number|39|39.0||||||
4281286|NCT00561470|4105415|B3|>=65 but <75 years||Age, Customized||participants|Number|371|371.0||||||
4281287|NCT00561470|4105416|B2|>=65 but <75 years||Age, Customized||participants|Number|172|172.0||||||
4281288|NCT00561470|4105417|B1|>=65 but <75 years||Age, Customized||participants|Number|199|199.0||||||
4281289|NCT00561470|4105415|B3|<65 years||Age, Customized||participants|Number|783|783.0||||||
4281290|NCT00561470|4105416|B2|<65 years||Age, Customized||participants|Number|407|407.0||||||
4281291|NCT00561470|4105417|B1|<65 years||Age, Customized||participants|Number|376|376.0||||||
4281292|NCT00561470|4105415|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|10.7|10.7|||
4281293|NCT00561470|4105416|B2|||Age||years|Mean|59.5|59.5|Standard Deviation|10.5|10.5|||
4281294|NCT00561470|4105417|B1|||Age||years|Mean|60.2|60.2|Standard Deviation|10.8|10.8|||
4281295|NCT00561457|4105432|B1|United States||Region of Enrollment||participants|Number|134|134.0||||||
4281296|NCT00561457|4105432|B1||Male|Gender||Participants|Count of Participants|73|73.0||||||
4281297|NCT00561457|4105432|B1||Female|Gender||Participants|Count of Participants|61|61.0||||||
4281298|NCT00561457|4105432|B1|||Age||years|Mean|67.31|67.31|Standard Deviation|10.31|10.31|||
4281299|NCT00561431|4105436|B3|United States||Region of Enrollment||participants|Number|200|200.0||||||
4281300|NCT00561431|4105437|B2|United States||Region of Enrollment||participants|Number|100|100.0||||||
4281301|NCT00561431|4105438|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
4281302|NCT00561431|4105436|B3||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4281303|NCT00561431|4105437|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4281304|NCT00561431|4105438|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4281305|NCT00561431|4105436|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4281306|NCT00561431|4105437|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4281307|NCT00561431|4105438|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4281308|NCT00561431|4105436|B3|||Age||years|Mean|60|60.0|Standard Deviation|15|15.0|||
4281309|NCT00561431|4105437|B2|||Age||years|Mean|58|58.0|Standard Deviation|16|16.0|||
4281310|NCT00561431|4105438|B1|||Age||years|Mean|62|62.0|Standard Deviation|15|15.0|||
4281311|NCT00561431|4105436|B3||>=65 years|Age||Participants|Count of Participants|79|79.0||||||
4281312|NCT00561431|4105437|B2||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4281313|NCT00561431|4105438|B1||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
4281314|NCT00561431|4105436|B3||Between 18 and 65 years|Age||Participants|Count of Participants|121|121.0||||||
4281315|NCT00561431|4105437|B2||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4281316|NCT00561431|4105438|B1||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4281317|NCT00561431|4105436|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4281318|NCT00561431|4105437|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4281319|NCT00561431|4105438|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4281320|NCT00561418|4105447|B1|United States||Region of Enrollment||patients|Number|23|23.0||||||
4281321|NCT00561418|4105447|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4281322|NCT00561418|4105447|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4281323|NCT00561418|4105447|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4281324|NCT00561418|4105447|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4281325|NCT00561418|4105447|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4281326|NCT00561418|4105447|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4281327|NCT00561418|4105447|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4281328|NCT00561418|4105447|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4281329|NCT00561418|4105447|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4281330|NCT00561418|4105447|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4281331|NCT00561418|4105447|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4281332|NCT00561418|4105447|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4281333|NCT00561418|4105447|B1|||Age||years|Median|55|55.0|Full Range|||25.0|75.0|
4281334|NCT00561392|4105454|B1|Germany||Region of Enrollment||participants|Number|208|208.0||||||
4281335|NCT00561392|4105454|B1||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4281336|NCT00561392|4105454|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4281337|NCT00561392|4105454|B1|||Age||years|Mean|74|74.0|Standard Deviation|7.7|7.7|||
4281338|NCT00561353|4105466|B11|Panel D||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|5|5.0||||||
4281339|NCT00561353|4105467|B10|Panel D||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|5|5.0||||||
4281340|NCT00561353|4105468|B9|Panel D||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|0|0.0||||||
4281341|NCT00561353|4105469|B8|Panel D||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|0|0.0||||||
4281342|NCT00561353|4105470|B7|Panel D||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|0|0.0||||||
4281343|NCT00561353|4105471|B6|Panel D||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|0|0.0||||||
4281344|NCT00561353|4105472|B5|Panel D||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|0|0.0||||||
4281345|NCT00561353|4105473|B4|Panel D||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|0|0.0||||||
4281346|NCT00561353|4105474|B3|Panel D||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|0|0.0||||||
4281347|NCT00561353|4105475|B2|Panel D||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|0|0.0||||||
4281348|NCT00561353|4105476|B1|Panel D||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|0|0.0||||||
4281349|NCT00561353|4105466|B11|Panel C||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|37|37.0||||||
4281350|NCT00561353|4105467|B10|Panel C||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|0|0.0||||||
4281351|NCT00561353|4105468|B9|Panel C||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|9|9.0||||||
4281352|NCT00561353|4105469|B8|Panel C||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|10|10.0||||||
4281353|NCT00561353|4105470|B7|Panel C||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|9|9.0||||||
4281354|NCT00561353|4105471|B6|Panel C||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|9|9.0||||||
4281382|NCT00561353|4105466|B11||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4281355|NCT00561353|4105472|B5|Panel C||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|0|0.0||||||
4281356|NCT00561353|4105473|B4|Panel C||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|0|0.0||||||
4281357|NCT00561353|4105474|B3|Panel C||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|0|0.0||||||
4281358|NCT00561353|4105475|B2|Panel C||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|0|0.0||||||
4281359|NCT00561353|4105476|B1|Panel C||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|0|0.0||||||
4281360|NCT00561353|4105466|B11|Panel B||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|37|37.0||||||
4281361|NCT00561353|4105467|B10|Panel B||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|0|0.0||||||
4281362|NCT00561353|4105468|B9|Panel B||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|0|0.0||||||
4281363|NCT00561353|4105469|B8|Panel B||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|0|0.0||||||
4281364|NCT00561353|4105470|B7|Panel B||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|0|0.0||||||
4281365|NCT00561353|4105471|B6|Panel B||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|0|0.0||||||
4281366|NCT00561353|4105472|B5|Panel B||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|3|3.0||||||
4281367|NCT00561353|4105473|B4|Panel B||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|9|9.0||||||
4281368|NCT00561353|4105474|B3|Panel B||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|7|7.0||||||
4281369|NCT00561353|4105475|B2|Panel B||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|9|9.0||||||
4281370|NCT00561353|4105476|B1|Panel B||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|9|9.0||||||
4281371|NCT00561353|4105466|B11|Panel A||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|37|37.0||||||
4281372|NCT00561353|4105467|B10|Panel A||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|0|0.0||||||
4281373|NCT00561353|4105468|B9|Panel A||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|0|0.0||||||
4281374|NCT00561353|4105469|B8|Panel A||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|0|0.0||||||
4281375|NCT00561353|4105470|B7|Panel A||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|0|0.0||||||
4281376|NCT00561353|4105471|B6|Panel A||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|0|0.0||||||
4281377|NCT00561353|4105472|B5|Panel A||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|3|3.0||||||
4281378|NCT00561353|4105473|B4|Panel A||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|9|9.0||||||
4281379|NCT00561353|4105474|B3|Panel A||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|6|6.0||||||
4281380|NCT00561353|4105475|B2|Panel A||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|10|10.0||||||
4281381|NCT00561353|4105476|B1|Panel A||The Number of Participants Randomized to each Treatment Panel|The table below shows the number of participants in Cohorts 1, 2, 4 and 5 that were randomized to treatment Panels A, B, C, and D.|participants|Number|9|9.0||||||
4281383|NCT00561353|4105467|B10||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4281384|NCT00561353|4105468|B9||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4281385|NCT00561353|4105469|B8||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4281386|NCT00561353|4105470|B7||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4281387|NCT00561353|4105471|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4281388|NCT00561353|4105472|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4281389|NCT00561353|4105473|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4281390|NCT00561353|4105474|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4281391|NCT00561353|4105475|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4281392|NCT00561353|4105476|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4281393|NCT00561353|4105466|B11||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4281394|NCT00561353|4105467|B10||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4281395|NCT00561353|4105468|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4281396|NCT00561353|4105469|B8||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4281397|NCT00561353|4105470|B7||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4281398|NCT00561353|4105471|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4281399|NCT00561353|4105472|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4281400|NCT00561353|4105473|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4281401|NCT00561353|4105474|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4281402|NCT00561353|4105475|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4281403|NCT00561353|4105476|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4281404|NCT00561353|4105466|B11|||Age||years|Median|49|49.0|Full Range|||19.0|70.0|
4281405|NCT00561353|4105467|B10|||Age||years|Median|56|56.0|Full Range|||33.0|66.0|
4281406|NCT00561353|4105468|B9|||Age||years|Median|47|47.0|Full Range|||21.0|57.0|
4281407|NCT00561353|4105469|B8|||Age||years|Median|55.5|55.5|Full Range|||28.0|69.0|
4281408|NCT00561353|4105470|B7|||Age||years|Median|56|56.0|Full Range|||32.0|67.0|
4281409|NCT00561353|4105471|B6|||Age||years|Median|53|53.0|Full Range|||38.0|62.0|
4281410|NCT00561353|4105472|B5|||Age||years|Median|44.5|44.5|Full Range|||19.0|50.0|
4281411|NCT00561353|4105473|B4|||Age||years|Median|46.5|46.5|Full Range|||19.0|68.0|
4281412|NCT00561353|4105474|B3|||Age||years|Median|45|45.0|Full Range|||19.0|60.0|
4281413|NCT00561353|4105475|B2|||Age||years|Median|47|47.0|Full Range|||22.0|70.0|
4281414|NCT00561353|4105476|B1|||Age||years|Median|52|52.0|Full Range|||22.0|64.0|
4281415|NCT00561340|4105638|B3|Prior Placebo Treatment||ADHD treatment status||participants|Number|15|15.0||||||
4281416|NCT00561340|4105639|B2|Prior Placebo Treatment||ADHD treatment status||participants|Number|10|10.0||||||
4281417|NCT00561340|4105640|B1|Prior Placebo Treatment||ADHD treatment status||participants|Number|5|5.0||||||
4281418|NCT00561340|4105638|B3|Prior Active ADHD Treatment||ADHD treatment status||participants|Number|14|14.0||||||
4281419|NCT00561340|4105639|B2|Prior Active ADHD Treatment||ADHD treatment status||participants|Number|6|6.0||||||
4281420|NCT00561340|4105640|B1|Prior Active ADHD Treatment||ADHD treatment status||participants|Number|8|8.0||||||
4281421|NCT00561340|4105638|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
4281422|NCT00561340|4105639|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4281423|NCT00561340|4105640|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4281424|NCT00561340|4105638|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4281425|NCT00561340|4105639|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4281426|NCT00561340|4105640|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4281427|NCT00561340|4105638|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4281428|NCT00561340|4105639|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4281429|NCT00561340|4105640|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4281430|NCT00561340|4105638|B3||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4281431|NCT00561340|4105639|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4281432|NCT00561340|4105640|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4281433|NCT00561340|4105638|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4281434|NCT00561340|4105639|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4281435|NCT00561340|4105640|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4281436|NCT00561340|4105638|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4281437|NCT00561340|4105639|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4281438|NCT00561340|4105640|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4281439|NCT00561340|4105638|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4281440|NCT00561340|4105639|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4281441|NCT00561340|4105640|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4281442|NCT00561340|4105638|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4281504|NCT00561015|4105736|B5|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4281443|NCT00561340|4105639|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4281444|NCT00561340|4105640|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4281445|NCT00561340|4105638|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4281446|NCT00561340|4105639|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4281447|NCT00561340|4105640|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4281448|NCT00561340|4105638|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4281449|NCT00561340|4105639|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4281450|NCT00561340|4105640|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4281451|NCT00561340|4105638|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4281452|NCT00561340|4105639|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4281453|NCT00561340|4105640|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4281454|NCT00561340|4105638|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4281455|NCT00561340|4105639|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4281456|NCT00561340|4105640|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4281457|NCT00561340|4105638|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4281458|NCT00561340|4105639|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4281459|NCT00561340|4105640|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4281460|NCT00561340|4105638|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4281461|NCT00561340|4105639|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4281462|NCT00561340|4105640|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4281463|NCT00561340|4105638|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4281464|NCT00561340|4105639|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4281465|NCT00561340|4105640|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4281466|NCT00561340|4105638|B3||<=18 years|Age||Participants|Count of Participants|29|29.0||||||
4281467|NCT00561340|4105639|B2||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4281468|NCT00561340|4105640|B1||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4281469|NCT00561145|4105649|B3|Netherlands||Region of Enrollment||participants|Number|32|32.0||||||
4281470|NCT00561145|4105650|B2|Netherlands||Region of Enrollment||participants|Number|17|17.0||||||
4281471|NCT00561145|4105651|B1|Netherlands||Region of Enrollment||participants|Number|15|15.0||||||
4281472|NCT00561145|4105649|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4281473|NCT00561145|4105650|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4281474|NCT00561145|4105651|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4281475|NCT00561145|4105649|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4281476|NCT00561145|4105650|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4281477|NCT00561145|4105651|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4281478|NCT00561145|4105649|B3|||Age||years|Median|50|50.0|Inter-Quartile Range|1|1.0|20.0|85.0|
4281479|NCT00561145|4105650|B2|||Age||years|Median|68|68.0|Inter-Quartile Range|1|1.0|64.0|85.0|
4281480|NCT00561145|4105651|B1|||Age||years|Median|24|24.0|Inter-Quartile Range|1|1.0|20.0|34.0|
4281481|NCT00561145|4105649|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4281482|NCT00561145|4105650|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4281483|NCT00561145|4105651|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4281484|NCT00561145|4105649|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4281485|NCT00561145|4105650|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4281486|NCT00561145|4105651|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4281487|NCT00561145|4105649|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4281488|NCT00561145|4105650|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4281489|NCT00561145|4105651|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4281490|NCT00561080|4105658|B4||Male|Sex: Female, Male||Participants|Count of Participants|338|338.0||||||
4281491|NCT00561080|4105659|B3||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4281492|NCT00561080|4105660|B2||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4281493|NCT00561080|4105661|B1||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4281494|NCT00561080|4105658|B4||Female|Sex: Female, Male||Participants|Count of Participants|421|421.0||||||
4281495|NCT00561080|4105659|B3||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4281496|NCT00561080|4105660|B2||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4281497|NCT00561080|4105661|B1||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4281498|NCT00561080|4105658|B4|||Age||years|Mean|76.1|76.1|Standard Deviation|5.4|5.4|||
4281499|NCT00561080|4105659|B3|||Age||years|Mean|76.1|76.1|Standard Deviation|5.3|5.3|||
4281500|NCT00561080|4105660|B2|||Age||years|Mean|76.0|76.0|Standard Deviation|5.4|5.4|||
4281501|NCT00561080|4105661|B1|||Age||years|Mean|76.2|76.2|Standard Deviation|5.5|5.5|||
4281502|NCT00561015|4105734|B7|United Kingdom||Region of Enrollment||participants|Number|16|16.0||||||
4281503|NCT00561015|4105735|B6|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4281505|NCT00561015|4105737|B4|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4281506|NCT00561015|4105738|B3|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4281507|NCT00561015|4105739|B2|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4281508|NCT00561015|4105740|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4281509|NCT00561015|4105734|B7|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
4281510|NCT00561015|4105735|B6|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
4281511|NCT00561015|4105736|B5|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
4281512|NCT00561015|4105737|B4|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
4281513|NCT00561015|4105738|B3|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
4281514|NCT00561015|4105739|B2|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
4281515|NCT00561015|4105740|B1|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
4281516|NCT00561015|4105734|B7|Italy||Region of Enrollment||participants|Number|4|4.0||||||
4281517|NCT00561015|4105735|B6|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4281518|NCT00561015|4105736|B5|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4281519|NCT00561015|4105737|B4|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4281520|NCT00561015|4105738|B3|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4281521|NCT00561015|4105739|B2|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4281522|NCT00561015|4105740|B1|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4281523|NCT00561015|4105734|B7|France||Region of Enrollment||participants|Number|28|28.0||||||
4281524|NCT00561015|4105735|B6|France||Region of Enrollment||participants|Number|3|3.0||||||
4281525|NCT00561015|4105736|B5|France||Region of Enrollment||participants|Number|4|4.0||||||
4281526|NCT00561015|4105737|B4|France||Region of Enrollment||participants|Number|3|3.0||||||
4281527|NCT00561015|4105738|B3|France||Region of Enrollment||participants|Number|6|6.0||||||
4281528|NCT00561015|4105739|B2|France||Region of Enrollment||participants|Number|5|5.0||||||
4281529|NCT00561015|4105740|B1|France||Region of Enrollment||participants|Number|7|7.0||||||
4281530|NCT00561015|4105734|B7||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4281531|NCT00561015|4105735|B6||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4281532|NCT00561015|4105736|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4281533|NCT00561015|4105737|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4281534|NCT00561015|4105738|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4281535|NCT00561015|4105739|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4281536|NCT00561015|4105740|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4281537|NCT00561015|4105734|B7||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4281538|NCT00561015|4105735|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4281539|NCT00561015|4105736|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4281540|NCT00561015|4105737|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4281541|NCT00561015|4105738|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4281542|NCT00561015|4105739|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4281543|NCT00561015|4105740|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4281544|NCT00561015|4105734|B7|||Age||years|Mean|44.9|44.9|Standard Deviation|10.97|10.97|||
4281545|NCT00561015|4105735|B6|||Age||years|Mean|39.8|39.8|Standard Deviation|13.76|13.76|||
4281546|NCT00561015|4105736|B5|||Age||years|Mean|42.4|42.4|Standard Deviation|7.75|7.75|||
4281547|NCT00561015|4105737|B4|||Age||years|Mean|43.4|43.4|Standard Deviation|9.62|9.62|||
4281548|NCT00561015|4105738|B3|||Age||years|Mean|49.8|49.8|Standard Deviation|10.33|10.33|||
4281549|NCT00561015|4105739|B2|||Age||years|Mean|56.6|56.6|Standard Deviation|5.13|5.13|||
4281550|NCT00561015|4105740|B1|||Age||years|Mean|42.3|42.3|Standard Deviation|10.63|10.63|||
4281551|NCT00561015|4105734|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4281552|NCT00561015|4105735|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4281553|NCT00561015|4105736|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4281554|NCT00561015|4105737|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4281555|NCT00561015|4105738|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4281556|NCT00561015|4105739|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4281557|NCT00561015|4105740|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4281558|NCT00561015|4105734|B7||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4281559|NCT00561015|4105735|B6||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4281560|NCT00561015|4105736|B5||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4281561|NCT00561015|4105737|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4281562|NCT00561015|4105738|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4281563|NCT00561015|4105739|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4281564|NCT00561015|4105740|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4281565|NCT00561015|4105734|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4281566|NCT00561015|4105735|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4281567|NCT00561015|4105736|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4281568|NCT00561015|4105737|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4281569|NCT00561015|4105738|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4281570|NCT00561015|4105739|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4281571|NCT00561015|4105740|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4281572|NCT00561002|4105819|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4281573|NCT00561002|4105820|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4281574|NCT00561002|4105821|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4281575|NCT00561002|4105819|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4281576|NCT00561002|4105820|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4281577|NCT00561002|4105821|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4281578|NCT00561002|4105819|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4281579|NCT00561002|4105820|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4281580|NCT00561002|4105821|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4281581|NCT00561002|4105819|B3|Age Continuous||Age||Months|Mean|21.2|21.2|Standard Deviation|8.11|8.11|||
4281582|NCT00561002|4105820|B2|Age Continuous||Age||Months|Mean|24.5|24.5|Standard Deviation|5.10|5.1|||
4281583|NCT00561002|4105821|B1|Age Continuous||Age||Months|Mean|19.8|19.8|Standard Deviation|8.76|8.76|||
4281584|NCT00561002|4105819|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4281585|NCT00561002|4105820|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4281586|NCT00561002|4105821|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4281587|NCT00561002|4105819|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4281588|NCT00561002|4105820|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4281589|NCT00561002|4105821|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4281590|NCT00561002|4105819|B3||<=18 years|Age||Participants|Count of Participants|32|32.0||||||
4281591|NCT00561002|4105820|B2||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4281592|NCT00561002|4105821|B1||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
4281593|NCT00560950|4105834|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4281594|NCT00560950|4105835|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4281595|NCT00560950|4105836|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4281596|NCT00560950|4105834|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4281597|NCT00560950|4105835|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4281598|NCT00560950|4105836|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4281599|NCT00560950|4105834|B3|||Age||years|Mean|75.8|75.8|Full Range|||60.0|93.0|
4281600|NCT00560950|4105835|B2|||Age||years|Mean|77.1|77.1|Full Range|||60.0|88.0|
4281601|NCT00560950|4105836|B1|||Age||years|Mean|74.6|74.6|Full Range|||60.0|93.0|
4281602|NCT00560937|4105873|B3|United States||Region of Enrollment||participants|Number|21.0|21.0||||||
4281603|NCT00560937|4105874|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4281604|NCT00560937|4105875|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4281605|NCT00560937|4105873|B3||Male|Sex: Female, Male||Participants|Count of Participants|19.0|19.0||||||
4281606|NCT00560937|4105874|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4281607|NCT00560937|4105875|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4281608|NCT00560937|4105873|B3||Female|Sex: Female, Male||Participants|Count of Participants|2.0|2.0||||||
4281609|NCT00560937|4105874|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4281610|NCT00560937|4105875|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4281611|NCT00560937|4105873|B3|||Age||years|Mean|51|51.0|Standard Deviation|9|9.0|||
4281612|NCT00560937|4105874|B2|||Age||years|Mean|49|49.0|Standard Deviation|12|12.0|||
4281613|NCT00560937|4105875|B1|||Age||years|Mean|53|53.0|Standard Deviation|6|6.0|||
4281614|NCT00560937|4105873|B3||>=65 years|Age||Participants|Count of Participants|0.0|0.0||||||
4281615|NCT00560937|4105874|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4281616|NCT00560937|4105875|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4281617|NCT00560937|4105873|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21.0|21.0||||||
4281618|NCT00560937|4105874|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4281619|NCT00560937|4105875|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4281620|NCT00560937|4105873|B3||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4281621|NCT00560937|4105874|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4281622|NCT00560937|4105875|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4281623|NCT00560885|4105892|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4281624|NCT00560885|4105892|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4281625|NCT00560885|4105892|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4281626|NCT00560885|4105892|B1|||Age||years|Mean|70.5|70.5|Standard Deviation|9.3|9.3|||
4281627|NCT00560885|4105892|B1||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
4281628|NCT00560885|4105892|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4281629|NCT00560885|4105892|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4281630|NCT00560859|4105899|B3|United States||Region of Enrollment||participants|Number|453|453.0||||||
4281631|NCT00560859|4105900|B2|United States||Region of Enrollment||participants|Number|227|227.0||||||
4281632|NCT00560859|4105901|B1|United States||Region of Enrollment||participants|Number|226|226.0||||||
4281633|NCT00560859|4105899|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4281634|NCT00560859|4105900|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4281635|NCT00560859|4105901|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4281636|NCT00560859|4105899|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|416|416.0||||||
4281637|NCT00560859|4105900|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|206|206.0||||||
4281638|NCT00560859|4105901|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|210|210.0||||||
4281639|NCT00560859|4105899|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4281640|NCT00560859|4105900|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4281641|NCT00560859|4105901|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4281642|NCT00560859|4105899|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4281643|NCT00560859|4105900|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4281644|NCT00560859|4105901|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4281645|NCT00560859|4105899|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4281646|NCT00560859|4105900|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4281647|NCT00560859|4105901|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4281648|NCT00560859|4105899|B3||White|Race (NIH/OMB)||Participants|Count of Participants|155|155.0||||||
4281649|NCT00560859|4105900|B2||White|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
4281650|NCT00560859|4105901|B1||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4281651|NCT00560859|4105899|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|249|249.0||||||
4281652|NCT00560859|4105900|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
4281653|NCT00560859|4105901|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
4281654|NCT00560859|4105899|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4281655|NCT00560859|4105900|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4281656|NCT00560859|4105901|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4281657|NCT00560859|4105899|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4281658|NCT00560859|4105900|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4281659|NCT00560859|4105901|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4281660|NCT00560859|4105899|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4281661|NCT00560859|4105900|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4281662|NCT00560859|4105901|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4281663|NCT00560859|4105899|B3||Male|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
4281664|NCT00560859|4105900|B2||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4281665|NCT00560859|4105901|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4281666|NCT00560859|4105899|B3||Female|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
4281667|NCT00560859|4105900|B2||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4281668|NCT00560859|4105901|B1||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4281669|NCT00560859|4105899|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4281670|NCT00560859|4105900|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4281671|NCT00560859|4105901|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4281672|NCT00560859|4105899|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4281673|NCT00560859|4105900|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4281674|NCT00560859|4105901|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4281675|NCT00560859|4105899|B3||<=18 years|Age||Participants|Count of Participants|453|453.0||||||
4281676|NCT00560859|4105900|B2||<=18 years|Age||Participants|Count of Participants|227|227.0||||||
4281677|NCT00560859|4105901|B1||<=18 years|Age||Participants|Count of Participants|226|226.0||||||
4281678|NCT00560859|4105899|B3|||Age||Years|Mean|6.6|6.6|Standard Deviation|1.4|1.4|||
4281679|NCT00560859|4105900|B2|||Age||Years|Mean|6.5|6.5|Standard Deviation|1.4|1.4|||
4281680|NCT00560859|4105901|B1|||Age||Years|Mean|6.6|6.6|Standard Deviation|1.4|1.4|||
4281681|NCT00560833|4105912|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4281682|NCT00560833|4105913|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4281683|NCT00560833|4105914|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4281684|NCT00560833|4105915|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4281685|NCT00560833|4105916|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4281686|NCT00560833|4105917|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4281687|NCT00560833|4105912|B6||Female|Sex: Female, Male||Participants|Count of Participants|941|941.0||||||
4281688|NCT00560833|4105913|B5||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4281689|NCT00560833|4105914|B4||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4281690|NCT00560833|4105915|B3||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4281691|NCT00560833|4105916|B2||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4281692|NCT00560833|4105917|B1||Female|Sex: Female, Male||Participants|Count of Participants|317|317.0||||||
4281693|NCT00560833|4105912|B6|||Age||Years|Mean|54.1|54.1|Standard Deviation|4.4|4.4|||
4281694|NCT00560833|4105913|B5|||Age||Years|Mean|54.1|54.1|Standard Deviation|4.5|4.5|||
4281695|NCT00560833|4105914|B4|||Age||Years|Mean|54.9|54.9|Standard Deviation|4.8|4.8|||
4281696|NCT00560833|4105915|B3|||Age||Years|Mean|54.1|54.1|Standard Deviation|4.2|4.2|||
4281697|NCT00560833|4105916|B2|||Age||Years|Mean|53.4|53.4|Standard Deviation|4.4|4.4|||
4281698|NCT00560833|4105917|B1|||Age||Years|Mean|54.0|54.0|Standard Deviation|4.4|4.4|||
4281699|NCT00560794|4105953|B1|Rearrangements of Ig / TCR genes & translocations||Genetic Alterations|"bcr/abl: breakpoint cluster region; Ig: immunoglobulin; TCR: T-cell receptor. For bcr/abl above detection limit and t(4;11) translocation above detection limit participants may have rearrangements in addition to translocations.~For Rearrangements of immunoglobulin / TCR genes participants did not show any translocation."|participants|Number|3|3.0||||||
4281700|NCT00560794|4105953|B1|Rearrangements of Ig / TCR genes only||Genetic Alterations|"bcr/abl: breakpoint cluster region; Ig: immunoglobulin; TCR: T-cell receptor. For bcr/abl above detection limit and t(4;11) translocation above detection limit participants may have rearrangements in addition to translocations.~For Rearrangements of immunoglobulin / TCR genes participants did not show any translocation."|participants|Number|13|13.0||||||
4281701|NCT00560794|4105953|B1|t(4;11) translocation above detection limit||Genetic Alterations|"bcr/abl: breakpoint cluster region; Ig: immunoglobulin; TCR: T-cell receptor. For bcr/abl above detection limit and t(4;11) translocation above detection limit participants may have rearrangements in addition to translocations.~For Rearrangements of immunoglobulin / TCR genes participants did not show any translocation."|participants|Number|2|2.0||||||
4281702|NCT00560794|4105953|B1|bcr/abl translocation above detection limit||Genetic Alterations|"bcr/abl: breakpoint cluster region; Ig: immunoglobulin; TCR: T-cell receptor. For bcr/abl above detection limit and t(4;11) translocation above detection limit participants may have rearrangements in addition to translocations.~For Rearrangements of immunoglobulin / TCR genes participants did not show any translocation."|participants|Number|5|5.0||||||
4281703|NCT00560794|4105953|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4281704|NCT00560794|4105953|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4281705|NCT00560794|4105953|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4281706|NCT00560794|4105953|B1|> 70 years||Age, Customized||participants|Number|2|2.0||||||
4281707|NCT00560794|4105953|B1|61-70 years||Age, Customized||participants|Number|7|7.0||||||
4281708|NCT00560794|4105953|B1|51-60 years||Age, Customized||participants|Number|1|1.0||||||
4281709|NCT00560794|4105953|B1|41-50 years||Age, Customized||participants|Number|2|2.0||||||
4281710|NCT00560794|4105953|B1|31-40 years||Age, Customized||participants|Number|5|5.0||||||
4281711|NCT00560794|4105953|B1|20-30 years||Age, Customized||participants|Number|3|3.0||||||
4281712|NCT00560794|4105953|B1|||Age||years|Mean|49.8|49.8|Standard Deviation|18.3|18.3|||
4281713|NCT00560755|4105970|B1||Male|Sex: Female, Male||Participants|Count of Participants|1738|1738.0||||||
4281714|NCT00560755|4105970|B1||Female|Sex: Female, Male||Participants|Count of Participants|1650|1650.0||||||
4281715|NCT00560755|4105970|B1|||Age||Months|Mean|14.6|14.6|Standard Deviation|2.3|2.3|||
4281716|NCT00560703|4105989|B3|United States||Region of Enrollment||participants|Number|70|70.0||||||
4281717|NCT00560703|4105990|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4281718|NCT00560703|4105991|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4281719|NCT00560703|4105989|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4281720|NCT00560703|4105990|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4281721|NCT00560703|4105991|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4281722|NCT00560703|4105989|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4281723|NCT00560703|4105990|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4281724|NCT00560703|4105991|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4281725|NCT00560703|4105989|B3|||Age||years|Mean|55.7|55.7|Standard Deviation|13.76|13.76|||
4281726|NCT00560703|4105990|B2|||Age||years|Mean|58.2|58.2|Standard Deviation|14.27|14.27|||
4281727|NCT00560703|4105991|B1|||Age||years|Mean|54.5|54.5|Standard Deviation|13.46|13.46|||
4281728|NCT00560703|4105989|B3||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4281729|NCT00560703|4105990|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4281730|NCT00560703|4105991|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4281731|NCT00560703|4105989|B3||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4281732|NCT00560703|4105990|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4281733|NCT00560703|4105991|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4281734|NCT00560703|4105989|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4281735|NCT00560703|4105990|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4281736|NCT00560703|4105991|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4281737|NCT00560612|4106000|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4281738|NCT00560612|4106001|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4281739|NCT00560612|4106002|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4281740|NCT00560612|4106000|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4281741|NCT00560612|4106001|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4281742|NCT00560612|4106002|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4281743|NCT00560612|4106000|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4281744|NCT00560612|4106001|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4281745|NCT00560612|4106002|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4281746|NCT00560612|4106000|B3|||Age||years|Mean|37.3|37.3|Standard Deviation|7.9|7.9|||
4281747|NCT00560612|4106001|B2|||Age||years|Mean|35.9|35.9|Standard Deviation|9.69|9.69|||
4281748|NCT00560612|4106002|B1|||Age||years|Mean|39.3|39.3|Standard Deviation|4.73|4.73|||
4281749|NCT00560612|4106000|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4281750|NCT00560612|4106001|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4281751|NCT00560612|4106002|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4281752|NCT00560612|4106000|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4281753|NCT00560612|4106001|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4281754|NCT00560612|4106002|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4281755|NCT00560612|4106000|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4281756|NCT00560612|4106001|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4281757|NCT00560612|4106002|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4281758|NCT00560573|4106009|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4281759|NCT00560573|4106009|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4281760|NCT00560573|4106009|B1|||Age||Years|Mean|59.2|59.2|Standard Deviation|8.0|8.0|||
4281761|NCT00560560|4106066|B3||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4281762|NCT00560560|4106067|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4281763|NCT00560560|4106068|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4281764|NCT00560560|4106066|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4281765|NCT00560560|4106067|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4281766|NCT00560560|4106068|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4281767|NCT00560560|4106066|B3|>=65 years||Age, Customized||participants|Number|53|53.0||||||
4281768|NCT00560560|4106067|B2|>=65 years||Age, Customized||participants|Number|24|24.0||||||
4281769|NCT00560560|4106068|B1|>=65 years||Age, Customized||participants|Number|29|29.0||||||
4281770|NCT00560560|4106066|B3|<65 years||Age, Customized||participants|Number|115|115.0||||||
4281771|NCT00560560|4106067|B2|<65 years||Age, Customized||participants|Number|59|59.0||||||
4281772|NCT00560560|4106068|B1|<65 years||Age, Customized||participants|Number|56|56.0||||||
4281773|NCT00560508|4106089|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4281774|NCT00560508|4106090|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4281775|NCT00560508|4106091|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4281776|NCT00560508|4106089|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4281777|NCT00560508|4106090|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4281778|NCT00560508|4106091|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4281779|NCT00560508|4106089|B3|||Age||years|Mean|67.5|67.5|Standard Deviation|7.8|7.8|||
4281780|NCT00560508|4106090|B2|||Age||years|Mean|66.1|66.1|Standard Deviation|7.5|7.5|||
4281781|NCT00560508|4106091|B1|||Age||years|Mean|68.8|68.8|Standard Deviation|8.0|8.0|||
4281782|NCT00560417|4106149|B3|||Duration of Diabetes||years|Mean|9.91|9.91|Standard Deviation|6.31|6.31|||
4281783|NCT00560417|4106150|B2|||Duration of Diabetes||years|Mean|10.31|10.31|Standard Deviation|6.63|6.63|||
4281784|NCT00560417|4106151|B1|||Duration of Diabetes||years|Mean|9.51|9.51|Standard Deviation|5.98|5.98|||
4281785|NCT00560417|4106149|B3|No||Sulfonylurea Group|Participants taking a sulfonylurea at baseline.|participants|Number|121|121.0||||||
4281786|NCT00560417|4106150|B2|No||Sulfonylurea Group|Participants taking a sulfonylurea at baseline.|participants|Number|58|58.0||||||
4281787|NCT00560417|4106151|B1|No||Sulfonylurea Group|Participants taking a sulfonylurea at baseline.|participants|Number|63|63.0||||||
4281788|NCT00560417|4106149|B3|Yes||Sulfonylurea Group|Participants taking a sulfonylurea at baseline.|participants|Number|218|218.0||||||
4281789|NCT00560417|4106150|B2|Yes||Sulfonylurea Group|Participants taking a sulfonylurea at baseline.|participants|Number|110|110.0||||||
4281790|NCT00560417|4106151|B1|Yes||Sulfonylurea Group|Participants taking a sulfonylurea at baseline.|participants|Number|108|108.0||||||
4281791|NCT00560417|4106149|B3|||Hemoglobin A1C||percent of glycosylated hemoglobin|Mean|8.22|8.22|Standard Deviation|0.79|0.79|||
4281792|NCT00560417|4106150|B2|||Hemoglobin A1C||percent of glycosylated hemoglobin|Mean|8.22|8.22|Standard Deviation|0.80|0.8|||
4281793|NCT00560417|4106151|B1|||Hemoglobin A1C||percent of glycosylated hemoglobin|Mean|8.21|8.21|Standard Deviation|0.79|0.79|||
4281794|NCT00560417|4106149|B3|||Body Weight||Kilograms|Mean|101.95|101.95|Standard Deviation|19.18|19.18|||
4281795|NCT00560417|4106150|B2|||Body Weight||Kilograms|Mean|102.33|102.33|Standard Deviation|19.73|19.73|||
4281796|NCT00560417|4106151|B1|||Body Weight||Kilograms|Mean|101.57|101.57|Standard Deviation|18.67|18.67|||
4281797|NCT00560417|4106149|B3|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters (kg/m^2)|Mean|34.85|34.85|Standard Deviation|5.18|5.18|||
4281798|NCT00560417|4106150|B2|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters (kg/m^2)|Mean|34.78|34.78|Standard Deviation|5.17|5.17|||
4281950|NCT00560391|4106223|B6|46 - 65 years||Age, Customized||participants|Number|20|20.0||||||
4281799|NCT00560417|4106151|B1|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters (kg/m^2)|Mean|34.92|34.92|Standard Deviation|5.21|5.21|||
4281800|NCT00560417|4106149|B3|Puerto Rico||Region of Enrollment||participants|Number|9|9.0||||||
4281801|NCT00560417|4106150|B2|Puerto Rico||Region of Enrollment||participants|Number|3|3.0||||||
4281802|NCT00560417|4106151|B1|Puerto Rico||Region of Enrollment||participants|Number|6|6.0||||||
4281803|NCT00560417|4106149|B3|United States||Region of Enrollment||participants|Number|330|330.0||||||
4281804|NCT00560417|4106150|B2|United States||Region of Enrollment||participants|Number|165|165.0||||||
4281805|NCT00560417|4106151|B1|United States||Region of Enrollment||participants|Number|165|165.0||||||
4281806|NCT00560417|4106149|B3|White||Race/Ethnicity, Customized||participants|Number|260|260.0||||||
4281807|NCT00560417|4106150|B2|White||Race/Ethnicity, Customized||participants|Number|130|130.0||||||
4281808|NCT00560417|4106151|B1|White||Race/Ethnicity, Customized||participants|Number|130|130.0||||||
4281809|NCT00560417|4106149|B3|West Asian (Indian sub-continent)||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4281810|NCT00560417|4106150|B2|West Asian (Indian sub-continent)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4281811|NCT00560417|4106151|B1|West Asian (Indian sub-continent)||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4281812|NCT00560417|4106149|B3|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4281813|NCT00560417|4106150|B2|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4281814|NCT00560417|4106151|B1|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4281815|NCT00560417|4106149|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4281816|NCT00560417|4106150|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4281817|NCT00560417|4106151|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4281818|NCT00560417|4106149|B3|East Asian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4281819|NCT00560417|4106150|B2|East Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4281820|NCT00560417|4106151|B1|East Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4281821|NCT00560417|4106149|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4281822|NCT00560417|4106150|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4281823|NCT00560417|4106151|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4281824|NCT00560417|4106149|B3||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4281825|NCT00560417|4106150|B2||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4281826|NCT00560417|4106151|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4281827|NCT00560417|4106149|B3||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4281828|NCT00560417|4106150|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4281829|NCT00560417|4106151|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4281830|NCT00560417|4106149|B3|||Age||years|Mean|56.38|56.38|Standard Deviation|9.52|9.52|||
4281831|NCT00560417|4106150|B2|||Age||years|Mean|56.24|56.24|Standard Deviation|9.33|9.33|||
4281832|NCT00560417|4106151|B1|||Age||years|Mean|56.51|56.51|Standard Deviation|9.73|9.73|||
4281833|NCT00560404|4106178|B3||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4281834|NCT00560404|4106179|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4281835|NCT00560404|4106180|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4281836|NCT00560404|4106178|B3||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4281837|NCT00560404|4106179|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4281838|NCT00560404|4106180|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4281839|NCT00560404|4106178|B3|||Age||years|Median|54.0|54.0|Full Range|||19.0|84.0|
4281840|NCT00560404|4106179|B2|||Age||years|Median|53.0|53.0|Full Range|||19.0|84.0|
4281841|NCT00560404|4106180|B1|||Age||years|Median|54.5|54.5|Full Range|||22.0|81.0|
4281842|NCT00560391|4106223|B6|||Time from diagnosis to first dosing||years|Median|4.4|4.4|Full Range|||1.0|18.0|
4281843|NCT00560391|4106224|B5|||Time from diagnosis to first dosing||years|Median|3.7|3.7|Full Range|||1.0|16.0|
4281844|NCT00560391|4106225|B4|||Time from diagnosis to first dosing||years|Median|5.2|5.2|Full Range|||1.0|6.0|
4281845|NCT00560391|4106226|B3|||Time from diagnosis to first dosing||years|Median|7.5|7.5|Full Range|||7.0|11.0|
4281846|NCT00560391|4106227|B2|||Time from diagnosis to first dosing||years|Median|4.0|4.0|Full Range|||1.0|5.0|
4281847|NCT00560391|4106228|B1|||Time from diagnosis to first dosing||years|Median|4.9|4.9|Full Range|||2.0|18.0|
4281848|NCT00560391|4106223|B6|Not Assessed||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|8|8.0||||||
4281893|NCT00560391|4106226|B3|Not assessed||International Staging System (ISS)|The ISS is an updated staging system for multiple myeloma. ISS divides multiple myeloma into three stages, which indicate the effect the disease is having on the body and how quickly or slowly it may develop. The ISS is based on the levels of blood proteins beta-2 microglobulin (β2M) and albumin. Stage I= β2M: <3.5 mg/L, albumin: >=3.5 g/dL; Stage II= β2M level: < 3.5 mg/L and albumin: < 3.5 g/dL, or β2M =3.5 to 5.5 mg/dL; Stage III: β2M level: >=5.5 mg/L.|participants|Number|2|2.0||||||
4281849|NCT00560391|4106224|B5|Not Assessed||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|6|6.0||||||
4281850|NCT00560391|4106225|B4|Not Assessed||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|2|2.0||||||
4281851|NCT00560391|4106226|B3|Not Assessed||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|0|0.0||||||
4281852|NCT00560391|4106227|B2|Not Assessed||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|0|0.0||||||
4281853|NCT00560391|4106228|B1|Not Assessed||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|0|0.0||||||
4281854|NCT00560391|4106223|B6|Stage IIIB||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|0|0.0||||||
4281855|NCT00560391|4106224|B5|Stage IIIB||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|0|0.0||||||
4281856|NCT00560391|4106225|B4|Stage IIIB||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|0|0.0||||||
4281857|NCT00560391|4106226|B3|Stage IIIB||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|0|0.0||||||
4281858|NCT00560391|4106227|B2|Stage IIIB||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|0|0.0||||||
4281859|NCT00560391|4106228|B1|Stage IIIB||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|0|0.0||||||
4281860|NCT00560391|4106223|B6|Stage IIIA||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|11|11.0||||||
4281861|NCT00560391|4106224|B5|Stage IIIA||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|6|6.0||||||
4281862|NCT00560391|4106225|B4|Stage IIIA||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|0|0.0||||||
4281863|NCT00560391|4106226|B3|Stage IIIA||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|0|0.0||||||
4281864|NCT00560391|4106227|B2|Stage IIIA||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|2|2.0||||||
4281865|NCT00560391|4106228|B1|Stage IIIA||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|3|3.0||||||
4281866|NCT00560391|4106223|B6|Stage IIB||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|0|0.0||||||
4281867|NCT00560391|4106224|B5|Stage IIB||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|0|0.0||||||
4281868|NCT00560391|4106225|B4|Stage IIB||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|0|0.0||||||
4281869|NCT00560391|4106226|B3|Stage IIB||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|0|0.0||||||
4281870|NCT00560391|4106227|B2|Stage IIB||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|0|0.0||||||
4281871|NCT00560391|4106228|B1|Stage IIB||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|0|0.0||||||
4281872|NCT00560391|4106223|B6|Stage IIA||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|7|7.0||||||
4281873|NCT00560391|4106224|B5|Stage IIA||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|3|3.0||||||
4281874|NCT00560391|4106225|B4|Stage IIA||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|3|3.0||||||
4281875|NCT00560391|4106226|B3|Stage IIA||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|1|1.0||||||
4281876|NCT00560391|4106227|B2|Stage IIA||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|0|0.0||||||
4281877|NCT00560391|4106228|B1|Stage IIA||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|0|0.0||||||
4281878|NCT00560391|4106223|B6|Stage IB||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|0|0.0||||||
4281879|NCT00560391|4106224|B5|Stage IB||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|0|0.0||||||
4281880|NCT00560391|4106225|B4|Stage IB||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|0|0.0||||||
4281881|NCT00560391|4106226|B3|Stage IB||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|0|0.0||||||
4281882|NCT00560391|4106227|B2|Stage IB||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|0|0.0||||||
4281883|NCT00560391|4106228|B1|Stage IB||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|0|0.0||||||
4281884|NCT00560391|4106223|B6|Stage IA||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|9|9.0||||||
4281885|NCT00560391|4106224|B5|Stage IA||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|2|2.0||||||
4281886|NCT00560391|4106225|B4|Stage IA||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|1|1.0||||||
4281887|NCT00560391|4106226|B3|Stage IA||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|2|2.0||||||
4281888|NCT00560391|4106227|B2|Stage IA||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|1|1.0||||||
4281889|NCT00560391|4106228|B1|Stage IA||Durie-Salmon Staging System|Myeloma is classified into 3 stages. Stage I: hemoglobin (Hb) >10g/dL, normal calcium levels, normal skeletal survey or single plasmacytoma or osteoporosis, serum paraprotein level<5g/dL if immunoglobulin G(IgG), <3g/dL if IgA, urinary light chain excretion<4g/24h. Stage II: fulfilling the criteria of neither I nor III. Stage III: Hb<8.5g/dL, high calcium >12mg/dL, Skeletal survey of 3 or more lytic bone lesions, serum paraprotein >7g/dL if IgG,>5g/dL if IgA, urinary light chain excretion >12g/24h. Each stage further subdivided: A= serum creatinine <2mg/dL and B= serum creatinine >2mg/dL.|participants|Number|3|3.0||||||
4281890|NCT00560391|4106223|B6|Not assessed||International Staging System (ISS)|The ISS is an updated staging system for multiple myeloma. ISS divides multiple myeloma into three stages, which indicate the effect the disease is having on the body and how quickly or slowly it may develop. The ISS is based on the levels of blood proteins beta-2 microglobulin (β2M) and albumin. Stage I= β2M: <3.5 mg/L, albumin: >=3.5 g/dL; Stage II= β2M level: < 3.5 mg/L and albumin: < 3.5 g/dL, or β2M =3.5 to 5.5 mg/dL; Stage III: β2M level: >=5.5 mg/L.|participants|Number|18|18.0||||||
4281891|NCT00560391|4106224|B5|Not assessed||International Staging System (ISS)|The ISS is an updated staging system for multiple myeloma. ISS divides multiple myeloma into three stages, which indicate the effect the disease is having on the body and how quickly or slowly it may develop. The ISS is based on the levels of blood proteins beta-2 microglobulin (β2M) and albumin. Stage I= β2M: <3.5 mg/L, albumin: >=3.5 g/dL; Stage II= β2M level: < 3.5 mg/L and albumin: < 3.5 g/dL, or β2M =3.5 to 5.5 mg/dL; Stage III: β2M level: >=5.5 mg/L.|participants|Number|10|10.0||||||
4281892|NCT00560391|4106225|B4|Not assessed||International Staging System (ISS)|The ISS is an updated staging system for multiple myeloma. ISS divides multiple myeloma into three stages, which indicate the effect the disease is having on the body and how quickly or slowly it may develop. The ISS is based on the levels of blood proteins beta-2 microglobulin (β2M) and albumin. Stage I= β2M: <3.5 mg/L, albumin: >=3.5 g/dL; Stage II= β2M level: < 3.5 mg/L and albumin: < 3.5 g/dL, or β2M =3.5 to 5.5 mg/dL; Stage III: β2M level: >=5.5 mg/L.|participants|Number|2|2.0||||||
4281945|NCT00560391|4106224|B5|66 - 75 years||Age, Customized||participants|Number|3|3.0||||||
4281946|NCT00560391|4106225|B4|66 - 75 years||Age, Customized||participants|Number|5|5.0||||||
4281947|NCT00560391|4106226|B3|66 - 75 years||Age, Customized||participants|Number|1|1.0||||||
4281894|NCT00560391|4106227|B2|Not assessed||International Staging System (ISS)|The ISS is an updated staging system for multiple myeloma. ISS divides multiple myeloma into three stages, which indicate the effect the disease is having on the body and how quickly or slowly it may develop. The ISS is based on the levels of blood proteins beta-2 microglobulin (β2M) and albumin. Stage I= β2M: <3.5 mg/L, albumin: >=3.5 g/dL; Stage II= β2M level: < 3.5 mg/L and albumin: < 3.5 g/dL, or β2M =3.5 to 5.5 mg/dL; Stage III: β2M level: >=5.5 mg/L.|participants|Number|1|1.0||||||
4281895|NCT00560391|4106228|B1|Not assessed||International Staging System (ISS)|The ISS is an updated staging system for multiple myeloma. ISS divides multiple myeloma into three stages, which indicate the effect the disease is having on the body and how quickly or slowly it may develop. The ISS is based on the levels of blood proteins beta-2 microglobulin (β2M) and albumin. Stage I= β2M: <3.5 mg/L, albumin: >=3.5 g/dL; Stage II= β2M level: < 3.5 mg/L and albumin: < 3.5 g/dL, or β2M =3.5 to 5.5 mg/dL; Stage III: β2M level: >=5.5 mg/L.|participants|Number|3|3.0||||||
4281896|NCT00560391|4106223|B6|Stage III||International Staging System (ISS)|The ISS is an updated staging system for multiple myeloma. ISS divides multiple myeloma into three stages, which indicate the effect the disease is having on the body and how quickly or slowly it may develop. The ISS is based on the levels of blood proteins beta-2 microglobulin (β2M) and albumin. Stage I= β2M: <3.5 mg/L, albumin: >=3.5 g/dL; Stage II= β2M level: < 3.5 mg/L and albumin: < 3.5 g/dL, or β2M =3.5 to 5.5 mg/dL; Stage III: β2M level: >=5.5 mg/L.|participants|Number|5|5.0||||||
4281897|NCT00560391|4106224|B5|Stage III||International Staging System (ISS)|The ISS is an updated staging system for multiple myeloma. ISS divides multiple myeloma into three stages, which indicate the effect the disease is having on the body and how quickly or slowly it may develop. The ISS is based on the levels of blood proteins beta-2 microglobulin (β2M) and albumin. Stage I= β2M: <3.5 mg/L, albumin: >=3.5 g/dL; Stage II= β2M level: < 3.5 mg/L and albumin: < 3.5 g/dL, or β2M =3.5 to 5.5 mg/dL; Stage III: β2M level: >=5.5 mg/L.|participants|Number|1|1.0||||||
4281898|NCT00560391|4106225|B4|Stage III||International Staging System (ISS)|The ISS is an updated staging system for multiple myeloma. ISS divides multiple myeloma into three stages, which indicate the effect the disease is having on the body and how quickly or slowly it may develop. The ISS is based on the levels of blood proteins beta-2 microglobulin (β2M) and albumin. Stage I= β2M: <3.5 mg/L, albumin: >=3.5 g/dL; Stage II= β2M level: < 3.5 mg/L and albumin: < 3.5 g/dL, or β2M =3.5 to 5.5 mg/dL; Stage III: β2M level: >=5.5 mg/L.|participants|Number|1|1.0||||||
4281899|NCT00560391|4106226|B3|Stage III||International Staging System (ISS)|The ISS is an updated staging system for multiple myeloma. ISS divides multiple myeloma into three stages, which indicate the effect the disease is having on the body and how quickly or slowly it may develop. The ISS is based on the levels of blood proteins beta-2 microglobulin (β2M) and albumin. Stage I= β2M: <3.5 mg/L, albumin: >=3.5 g/dL; Stage II= β2M level: < 3.5 mg/L and albumin: < 3.5 g/dL, or β2M =3.5 to 5.5 mg/dL; Stage III: β2M level: >=5.5 mg/L.|participants|Number|0|0.0||||||
4281900|NCT00560391|4106227|B2|Stage III||International Staging System (ISS)|The ISS is an updated staging system for multiple myeloma. ISS divides multiple myeloma into three stages, which indicate the effect the disease is having on the body and how quickly or slowly it may develop. The ISS is based on the levels of blood proteins beta-2 microglobulin (β2M) and albumin. Stage I= β2M: <3.5 mg/L, albumin: >=3.5 g/dL; Stage II= β2M level: < 3.5 mg/L and albumin: < 3.5 g/dL, or β2M =3.5 to 5.5 mg/dL; Stage III: β2M level: >=5.5 mg/L.|participants|Number|2|2.0||||||
4281901|NCT00560391|4106228|B1|Stage III||International Staging System (ISS)|The ISS is an updated staging system for multiple myeloma. ISS divides multiple myeloma into three stages, which indicate the effect the disease is having on the body and how quickly or slowly it may develop. The ISS is based on the levels of blood proteins beta-2 microglobulin (β2M) and albumin. Stage I= β2M: <3.5 mg/L, albumin: >=3.5 g/dL; Stage II= β2M level: < 3.5 mg/L and albumin: < 3.5 g/dL, or β2M =3.5 to 5.5 mg/dL; Stage III: β2M level: >=5.5 mg/L.|participants|Number|1|1.0||||||
4281902|NCT00560391|4106223|B6|Stage II||International Staging System (ISS)|The ISS is an updated staging system for multiple myeloma. ISS divides multiple myeloma into three stages, which indicate the effect the disease is having on the body and how quickly or slowly it may develop. The ISS is based on the levels of blood proteins beta-2 microglobulin (β2M) and albumin. Stage I= β2M: <3.5 mg/L, albumin: >=3.5 g/dL; Stage II= β2M level: < 3.5 mg/L and albumin: < 3.5 g/dL, or β2M =3.5 to 5.5 mg/dL; Stage III: β2M level: >=5.5 mg/L.|participants|Number|6|6.0||||||
4281903|NCT00560391|4106224|B5|Stage II||International Staging System (ISS)|The ISS is an updated staging system for multiple myeloma. ISS divides multiple myeloma into three stages, which indicate the effect the disease is having on the body and how quickly or slowly it may develop. The ISS is based on the levels of blood proteins beta-2 microglobulin (β2M) and albumin. Stage I= β2M: <3.5 mg/L, albumin: >=3.5 g/dL; Stage II= β2M level: < 3.5 mg/L and albumin: < 3.5 g/dL, or β2M =3.5 to 5.5 mg/dL; Stage III: β2M level: >=5.5 mg/L.|participants|Number|2|2.0||||||
4281904|NCT00560391|4106225|B4|Stage II||International Staging System (ISS)|The ISS is an updated staging system for multiple myeloma. ISS divides multiple myeloma into three stages, which indicate the effect the disease is having on the body and how quickly or slowly it may develop. The ISS is based on the levels of blood proteins beta-2 microglobulin (β2M) and albumin. Stage I= β2M: <3.5 mg/L, albumin: >=3.5 g/dL; Stage II= β2M level: < 3.5 mg/L and albumin: < 3.5 g/dL, or β2M =3.5 to 5.5 mg/dL; Stage III: β2M level: >=5.5 mg/L.|participants|Number|3|3.0||||||
4281905|NCT00560391|4106226|B3|Stage II||International Staging System (ISS)|The ISS is an updated staging system for multiple myeloma. ISS divides multiple myeloma into three stages, which indicate the effect the disease is having on the body and how quickly or slowly it may develop. The ISS is based on the levels of blood proteins beta-2 microglobulin (β2M) and albumin. Stage I= β2M: <3.5 mg/L, albumin: >=3.5 g/dL; Stage II= β2M level: < 3.5 mg/L and albumin: < 3.5 g/dL, or β2M =3.5 to 5.5 mg/dL; Stage III: β2M level: >=5.5 mg/L.|participants|Number|0|0.0||||||
4281906|NCT00560391|4106227|B2|Stage II||International Staging System (ISS)|The ISS is an updated staging system for multiple myeloma. ISS divides multiple myeloma into three stages, which indicate the effect the disease is having on the body and how quickly or slowly it may develop. The ISS is based on the levels of blood proteins beta-2 microglobulin (β2M) and albumin. Stage I= β2M: <3.5 mg/L, albumin: >=3.5 g/dL; Stage II= β2M level: < 3.5 mg/L and albumin: < 3.5 g/dL, or β2M =3.5 to 5.5 mg/dL; Stage III: β2M level: >=5.5 mg/L.|participants|Number|0|0.0||||||
4281948|NCT00560391|4106227|B2|66 - 75 years||Age, Customized||participants|Number|2|2.0||||||
4281949|NCT00560391|4106228|B1|66 - 75 years||Age, Customized||participants|Number|1|1.0||||||
4281907|NCT00560391|4106228|B1|Stage II||International Staging System (ISS)|The ISS is an updated staging system for multiple myeloma. ISS divides multiple myeloma into three stages, which indicate the effect the disease is having on the body and how quickly or slowly it may develop. The ISS is based on the levels of blood proteins beta-2 microglobulin (β2M) and albumin. Stage I= β2M: <3.5 mg/L, albumin: >=3.5 g/dL; Stage II= β2M level: < 3.5 mg/L and albumin: < 3.5 g/dL, or β2M =3.5 to 5.5 mg/dL; Stage III: β2M level: >=5.5 mg/L.|participants|Number|1|1.0||||||
4281908|NCT00560391|4106223|B6|Stage I||International Staging System (ISS)|The ISS is an updated staging system for multiple myeloma. ISS divides multiple myeloma into three stages, which indicate the effect the disease is having on the body and how quickly or slowly it may develop. The ISS is based on the levels of blood proteins beta-2 microglobulin (β2M) and albumin. Stage I= β2M: <3.5 mg/L, albumin: >=3.5 g/dL; Stage II= β2M level: < 3.5 mg/L and albumin: < 3.5 g/dL, or β2M =3.5 to 5.5 mg/dL; Stage III: β2M level: >=5.5 mg/L.|participants|Number|6|6.0||||||
4281909|NCT00560391|4106224|B5|Stage I||International Staging System (ISS)|The ISS is an updated staging system for multiple myeloma. ISS divides multiple myeloma into three stages, which indicate the effect the disease is having on the body and how quickly or slowly it may develop. The ISS is based on the levels of blood proteins beta-2 microglobulin (β2M) and albumin. Stage I= β2M: <3.5 mg/L, albumin: >=3.5 g/dL; Stage II= β2M level: < 3.5 mg/L and albumin: < 3.5 g/dL, or β2M =3.5 to 5.5 mg/dL; Stage III: β2M level: >=5.5 mg/L.|participants|Number|4|4.0||||||
4281910|NCT00560391|4106225|B4|Stage I||International Staging System (ISS)|The ISS is an updated staging system for multiple myeloma. ISS divides multiple myeloma into three stages, which indicate the effect the disease is having on the body and how quickly or slowly it may develop. The ISS is based on the levels of blood proteins beta-2 microglobulin (β2M) and albumin. Stage I= β2M: <3.5 mg/L, albumin: >=3.5 g/dL; Stage II= β2M level: < 3.5 mg/L and albumin: < 3.5 g/dL, or β2M =3.5 to 5.5 mg/dL; Stage III: β2M level: >=5.5 mg/L.|participants|Number|0|0.0||||||
4281911|NCT00560391|4106226|B3|Stage I||International Staging System (ISS)|The ISS is an updated staging system for multiple myeloma. ISS divides multiple myeloma into three stages, which indicate the effect the disease is having on the body and how quickly or slowly it may develop. The ISS is based on the levels of blood proteins beta-2 microglobulin (β2M) and albumin. Stage I= β2M: <3.5 mg/L, albumin: >=3.5 g/dL; Stage II= β2M level: < 3.5 mg/L and albumin: < 3.5 g/dL, or β2M =3.5 to 5.5 mg/dL; Stage III: β2M level: >=5.5 mg/L.|participants|Number|1|1.0||||||
4281912|NCT00560391|4106227|B2|Stage I||International Staging System (ISS)|The ISS is an updated staging system for multiple myeloma. ISS divides multiple myeloma into three stages, which indicate the effect the disease is having on the body and how quickly or slowly it may develop. The ISS is based on the levels of blood proteins beta-2 microglobulin (β2M) and albumin. Stage I= β2M: <3.5 mg/L, albumin: >=3.5 g/dL; Stage II= β2M level: < 3.5 mg/L and albumin: < 3.5 g/dL, or β2M =3.5 to 5.5 mg/dL; Stage III: β2M level: >=5.5 mg/L.|participants|Number|0|0.0||||||
4281913|NCT00560391|4106228|B1|Stage I||International Staging System (ISS)|The ISS is an updated staging system for multiple myeloma. ISS divides multiple myeloma into three stages, which indicate the effect the disease is having on the body and how quickly or slowly it may develop. The ISS is based on the levels of blood proteins beta-2 microglobulin (β2M) and albumin. Stage I= β2M: <3.5 mg/L, albumin: >=3.5 g/dL; Stage II= β2M level: < 3.5 mg/L and albumin: < 3.5 g/dL, or β2M =3.5 to 5.5 mg/dL; Stage III: β2M level: >=5.5 mg/L.|participants|Number|1|1.0||||||
4281914|NCT00560391|4106223|B6|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4281915|NCT00560391|4106224|B5|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4281916|NCT00560391|4106225|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4281917|NCT00560391|4106226|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4281918|NCT00560391|4106227|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4281919|NCT00560391|4106228|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4281920|NCT00560391|4106223|B6|White||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4281921|NCT00560391|4106224|B5|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4281922|NCT00560391|4106225|B4|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4281923|NCT00560391|4106226|B3|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4281924|NCT00560391|4106227|B2|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4281925|NCT00560391|4106228|B1|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4281926|NCT00560391|4106223|B6||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4281927|NCT00560391|4106224|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4281928|NCT00560391|4106225|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4281929|NCT00560391|4106226|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4281930|NCT00560391|4106227|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4281931|NCT00560391|4106228|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4281932|NCT00560391|4106223|B6||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4281933|NCT00560391|4106224|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4281934|NCT00560391|4106225|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4281935|NCT00560391|4106226|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4281936|NCT00560391|4106227|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4281937|NCT00560391|4106228|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4281938|NCT00560391|4106223|B6|>75 years||Age, Customized||participants|Number|2|2.0||||||
4281939|NCT00560391|4106224|B5|>75 years||Age, Customized||participants|Number|0|0.0||||||
4281940|NCT00560391|4106225|B4|>75 years||Age, Customized||participants|Number|0|0.0||||||
4281941|NCT00560391|4106226|B3|>75 years||Age, Customized||participants|Number|0|0.0||||||
4281942|NCT00560391|4106227|B2|>75 years||Age, Customized||participants|Number|0|0.0||||||
4281943|NCT00560391|4106228|B1|>75 years||Age, Customized||participants|Number|2|2.0||||||
4281944|NCT00560391|4106223|B6|66 - 75 years||Age, Customized||participants|Number|12|12.0||||||
4281951|NCT00560391|4106224|B5|46 - 65 years||Age, Customized||participants|Number|13|13.0||||||
4281952|NCT00560391|4106225|B4|46 - 65 years||Age, Customized||participants|Number|1|1.0||||||
4281953|NCT00560391|4106226|B3|46 - 65 years||Age, Customized||participants|Number|2|2.0||||||
4281954|NCT00560391|4106227|B2|46 - 65 years||Age, Customized||participants|Number|1|1.0||||||
4281955|NCT00560391|4106228|B1|46 - 65 years||Age, Customized||participants|Number|3|3.0||||||
4281956|NCT00560391|4106223|B6|21 - 45 years||Age, Customized||participants|Number|1|1.0||||||
4281957|NCT00560391|4106224|B5|21 - 45 years||Age, Customized||participants|Number|1|1.0||||||
4281958|NCT00560391|4106225|B4|21 - 45 years||Age, Customized||participants|Number|0|0.0||||||
4281959|NCT00560391|4106226|B3|21 - 45 years||Age, Customized||participants|Number|0|0.0||||||
4281960|NCT00560391|4106227|B2|21 - 45 years||Age, Customized||participants|Number|0|0.0||||||
4281961|NCT00560391|4106228|B1|21 - 45 years||Age, Customized||participants|Number|0|0.0||||||
4281962|NCT00560391|4106223|B6|||Age||years|Mean|63.4|63.4|Standard Deviation|9.19|9.19|||
4281963|NCT00560391|4106224|B5|||Age||years|Mean|59.3|59.3|Standard Deviation|8.06|8.06|||
4281964|NCT00560391|4106225|B4|||Age||years|Mean|69.7|69.7|Standard Deviation|5.92|5.92|||
4281965|NCT00560391|4106226|B3|||Age||years|Mean|63.0|63.0|Standard Deviation|11.14|11.14|||
4281966|NCT00560391|4106227|B2|||Age||years|Mean|69.3|69.3|Standard Deviation|4.73|4.73|||
4281967|NCT00560391|4106228|B1|||Age||years|Mean|66.2|66.2|Standard Deviation|11.75|11.75|||
4281968|NCT00560352|4106285|B4|Not reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4281969|NCT00560352|4106286|B3|Not reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4281970|NCT00560352|4106287|B2|Not reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4281971|NCT00560352|4106288|B1|Not reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4281972|NCT00560352|4106285|B4|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4281973|NCT00560352|4106286|B3|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4281974|NCT00560352|4106287|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4281975|NCT00560352|4106288|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4281976|NCT00560352|4106285|B4|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4281977|NCT00560352|4106286|B3|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4281978|NCT00560352|4106287|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4281979|NCT00560352|4106288|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4281980|NCT00560352|4106285|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4281981|NCT00560352|4106286|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4281982|NCT00560352|4106287|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4281983|NCT00560352|4106288|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4281984|NCT00560352|4106285|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4281985|NCT00560352|4106286|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4281986|NCT00560352|4106287|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4281987|NCT00560352|4106288|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4281988|NCT00560352|4106285|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4281989|NCT00560352|4106286|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4281990|NCT00560352|4106287|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4281991|NCT00560352|4106288|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4281992|NCT00560352|4106285|B4|White||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4281993|NCT00560352|4106286|B3|White||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4281994|NCT00560352|4106287|B2|White||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4281995|NCT00560352|4106288|B1|White||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4281996|NCT00560352|4106285|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4281997|NCT00560352|4106286|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4281998|NCT00560352|4106287|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4281999|NCT00560352|4106288|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4282000|NCT00560352|4106285|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4282001|NCT00560352|4106286|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4282002|NCT00560352|4106287|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4282003|NCT00560352|4106288|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4282004|NCT00560352|4106285|B4|Older than 75 years||Age, Customized||Participants|Number|0|0.0||||||
4282005|NCT00560352|4106286|B3|Older than 75 years||Age, Customized||Participants|Number|0|0.0||||||
4282006|NCT00560352|4106287|B2|Older than 75 years||Age, Customized||Participants|Number|0|0.0||||||
4282007|NCT00560352|4106288|B1|Older than 75 years||Age, Customized||Participants|Number|0|0.0||||||
4282008|NCT00560352|4106285|B4|66 to 75 years||Age, Customized||Participants|Number|9|9.0||||||
4282009|NCT00560352|4106286|B3|66 to 75 years||Age, Customized||Participants|Number|1|1.0||||||
4282010|NCT00560352|4106287|B2|66 to 75 years||Age, Customized||Participants|Number|2|2.0||||||
4282011|NCT00560352|4106288|B1|66 to 75 years||Age, Customized||Participants|Number|6|6.0||||||
4282012|NCT00560352|4106285|B4|46 to 65 years||Age, Customized||Participants|Number|5|5.0||||||
4282013|NCT00560352|4106286|B3|46 to 65 years||Age, Customized||Participants|Number|3|3.0||||||
4282014|NCT00560352|4106287|B2|46 to 65 years||Age, Customized||Participants|Number|1|1.0||||||
4282015|NCT00560352|4106288|B1|46 to 65 years||Age, Customized||Participants|Number|1|1.0||||||
4282016|NCT00560352|4106285|B4|||Age||Years|Mean|71|71.0|Full Range|||53.0|75.0|
4282017|NCT00560352|4106286|B3|||Age||Years|Mean|59.5|59.5|Full Range|||53.0|75.0|
4282018|NCT00560352|4106287|B2|||Age||Years|Mean|74|74.0|Full Range|||57.0|75.0|
4282019|NCT00560352|4106288|B1|||Age||Years|Mean|72|72.0|Full Range|||64.0|74.0|
4282020|NCT00560313|4106307|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4282021|NCT00560313|4106307|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4282022|NCT00560313|4106307|B1|||Age||years|Mean|31.8|31.8|Standard Deviation|6.1|6.1|||
4282023|NCT00560235|4106331|B4||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4282024|NCT00560235|4106332|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4282025|NCT00560235|4106333|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4282026|NCT00560235|4106334|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4282027|NCT00560235|4106331|B4||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4282028|NCT00560235|4106332|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4282029|NCT00560235|4106333|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4282030|NCT00560235|4106334|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4282031|NCT00560235|4106331|B4|>=41 years||Age, Customized||participants|Number|7|7.0||||||
4282032|NCT00560235|4106332|B3|>=41 years||Age, Customized||participants|Number|7|7.0||||||
4282033|NCT00560235|4106333|B2|>=41 years||Age, Customized||participants|Number|0|0.0||||||
4282034|NCT00560235|4106334|B1|>=41 years||Age, Customized||participants|Number|0|0.0||||||
4282035|NCT00560235|4106331|B4|30 to <41 years||Age, Customized||participants|Number|10|10.0||||||
4282036|NCT00560235|4106332|B3|30 to <41 years||Age, Customized||participants|Number|10|10.0||||||
4282037|NCT00560235|4106333|B2|30 to <41 years||Age, Customized||participants|Number|0|0.0||||||
4282038|NCT00560235|4106334|B1|30 to <41 years||Age, Customized||participants|Number|0|0.0||||||
4282039|NCT00560235|4106331|B4|18 to <30 years||Age, Customized||participants|Number|43|43.0||||||
4282040|NCT00560235|4106332|B3|18 to <30 years||Age, Customized||participants|Number|43|43.0||||||
4282041|NCT00560235|4106333|B2|18 to <30 years||Age, Customized||participants|Number|0|0.0||||||
4282042|NCT00560235|4106334|B1|18 to <30 years||Age, Customized||participants|Number|0|0.0||||||
4282043|NCT00560235|4106331|B4|13 to <=18 years||Age, Customized||participants|Number|56|56.0||||||
4282044|NCT00560235|4106332|B3|13 to <=18 years||Age, Customized||participants|Number|30|30.0||||||
4282045|NCT00560235|4106333|B2|13 to <=18 years||Age, Customized||participants|Number|18|18.0||||||
4282046|NCT00560235|4106334|B1|13 to <=18 years||Age, Customized||participants|Number|8|8.0||||||
4282047|NCT00560235|4106331|B4|10 to <13 years||Age, Customized||participants|Number|22|22.0||||||
4282048|NCT00560235|4106332|B3|10 to <13 years||Age, Customized||participants|Number|17|17.0||||||
4282049|NCT00560235|4106333|B2|10 to <13 years||Age, Customized||participants|Number|3|3.0||||||
4282050|NCT00560235|4106334|B1|10 to <13 years||Age, Customized||participants|Number|2|2.0||||||
4282051|NCT00560105|4106365|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4282052|NCT00560105|4106366|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4282053|NCT00560105|4106367|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4282054|NCT00560105|4106365|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4282055|NCT00560105|4106366|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4282056|NCT00560105|4106367|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4282057|NCT00560105|4106365|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4282058|NCT00560105|4106366|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4282059|NCT00560105|4106367|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4282060|NCT00560105|4106365|B3|||Age||years|Mean|62.5|62.5|Standard Deviation|2.0|2.0|||
4282061|NCT00560105|4106366|B2|||Age||years|Mean|64.0|64.0|Standard Deviation|2.4|2.4|||
4282062|NCT00560105|4106367|B1|||Age||years|Mean|60.9|60.9|Standard Deviation|1.6|1.6|||
4282063|NCT00560105|4106365|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4282064|NCT00560105|4106366|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4282065|NCT00560105|4106367|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4282066|NCT00560105|4106365|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4282067|NCT00560105|4106366|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4282068|NCT00560105|4106367|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4282069|NCT00560105|4106365|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4282070|NCT00560105|4106366|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4282071|NCT00560105|4106367|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4282072|NCT00560066|4106380|B3||Male|Sex: Female, Male||Participants|Count of Participants|659|659.0||||||
4282073|NCT00560066|4106381|B2||Male|Sex: Female, Male||Participants|Count of Participants|469|469.0||||||
4282074|NCT00560066|4106382|B1||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4282075|NCT00560066|4106380|B3||Female|Sex: Female, Male||Participants|Count of Participants|739|739.0||||||
4282076|NCT00560066|4106381|B2||Female|Sex: Female, Male||Participants|Count of Participants|533|533.0||||||
4282077|NCT00560066|4106382|B1||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
4282078|NCT00560066|4106380|B3|||Age||years|Mean|48.3|48.3|Standard Deviation|16.6|16.6|||
4282079|NCT00560066|4106381|B2|||Age||years|Mean|48.7|48.7|Standard Deviation|16.3|16.3|||
4282080|NCT00560066|4106382|B1|||Age||years|Mean|47.6|47.6|Standard Deviation|17.3|17.3|||
4282081|NCT00559988|4106413|B3||Male|Sex: Female, Male||Participants|Count of Participants|2003|2003.0||||||
4282082|NCT00559988|4106414|B2||Male|Sex: Female, Male||Participants|Count of Participants|993|993.0||||||
4282083|NCT00559988|4106415|B1||Male|Sex: Female, Male||Participants|Count of Participants|1010|1010.0||||||
4282084|NCT00559988|4106413|B3||Female|Sex: Female, Male||Participants|Count of Participants|715|715.0||||||
4282085|NCT00559988|4106414|B2||Female|Sex: Female, Male||Participants|Count of Participants|368|368.0||||||
4282086|NCT00559988|4106415|B1||Female|Sex: Female, Male||Participants|Count of Participants|347|347.0||||||
4282087|NCT00559988|4106413|B3|||Age||years|Mean|64.4|64.4|Standard Deviation|11.2|11.2|||
4282088|NCT00559988|4106414|B2|||Age||years|Mean|64.2|64.2|Standard Deviation|11.5|11.5|||
4282089|NCT00559988|4106415|B1|||Age||years|Mean|64.7|64.7|Standard Deviation|10.8|10.8|||
4282090|NCT00559962|4106438|B9|United States||Region of Enrollment||participants|Number|260|260.0||||||
4282091|NCT00559962|4106439|B8|United States||Region of Enrollment||participants|Number|29|29.0||||||
4282092|NCT00559962|4106440|B7|United States||Region of Enrollment||participants|Number|33|33.0||||||
4282093|NCT00559962|4106441|B6|United States||Region of Enrollment||participants|Number|28|28.0||||||
4282094|NCT00559962|4106442|B5|United States||Region of Enrollment||participants|Number|35|35.0||||||
4282095|NCT00559962|4106443|B4|United States||Region of Enrollment||participants|Number|34|34.0||||||
4282096|NCT00559962|4106444|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
4282097|NCT00559962|4106445|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
4282098|NCT00559962|4106446|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4282099|NCT00559962|4106438|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4282100|NCT00559962|4106439|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4282101|NCT00559962|4106440|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4282102|NCT00559962|4106441|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4282103|NCT00559962|4106442|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4282104|NCT00559962|4106443|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4282105|NCT00559962|4106444|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4282106|NCT00559962|4106445|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4282107|NCT00559962|4106446|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4282108|NCT00559962|4106438|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282109|NCT00559962|4106439|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282110|NCT00559962|4106440|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282111|NCT00559962|4106441|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282112|NCT00559962|4106442|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282113|NCT00559962|4106443|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282114|NCT00559962|4106444|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282115|NCT00559962|4106445|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282116|NCT00559962|4106446|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282117|NCT00559962|4106438|B9||White|Race (NIH/OMB)||Participants|Count of Participants|182|182.0||||||
4282118|NCT00559962|4106439|B8||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4282119|NCT00559962|4106440|B7||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4282120|NCT00559962|4106441|B6||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4282121|NCT00559962|4106442|B5||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4282122|NCT00559962|4106443|B4||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4282123|NCT00559962|4106444|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4282124|NCT00559962|4106445|B2||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4282125|NCT00559962|4106446|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4282126|NCT00559962|4106438|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4282127|NCT00559962|4106439|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4282128|NCT00559962|4106440|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4282129|NCT00559962|4106441|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4282130|NCT00559962|4106442|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4282131|NCT00559962|4106443|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4282132|NCT00559962|4106444|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4282133|NCT00559962|4106445|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4282134|NCT00559962|4106446|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4282135|NCT00559962|4106438|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282136|NCT00559962|4106439|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282137|NCT00559962|4106440|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282138|NCT00559962|4106441|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282139|NCT00559962|4106442|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282140|NCT00559962|4106443|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282141|NCT00559962|4106444|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282142|NCT00559962|4106445|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282143|NCT00559962|4106446|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282144|NCT00559962|4106438|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4282145|NCT00559962|4106439|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282146|NCT00559962|4106440|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4282147|NCT00559962|4106441|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282148|NCT00559962|4106442|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282149|NCT00559962|4106443|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4282150|NCT00559962|4106444|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282151|NCT00559962|4106445|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282152|NCT00559962|4106446|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4282153|NCT00559962|4106438|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282154|NCT00559962|4106439|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282155|NCT00559962|4106440|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282156|NCT00559962|4106441|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282157|NCT00559962|4106442|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282158|NCT00559962|4106443|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282159|NCT00559962|4106444|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282160|NCT00559962|4106445|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282161|NCT00559962|4106446|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282162|NCT00559962|4106438|B9||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4282163|NCT00559962|4106439|B8||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4282164|NCT00559962|4106440|B7||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4282165|NCT00559962|4106441|B6||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4282166|NCT00559962|4106442|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4282167|NCT00559962|4106443|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4282168|NCT00559962|4106444|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4282169|NCT00559962|4106445|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4282170|NCT00559962|4106446|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4282171|NCT00559962|4106438|B9||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4282172|NCT00559962|4106439|B8||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4282173|NCT00559962|4106440|B7||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4282174|NCT00559962|4106441|B6||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4282175|NCT00559962|4106442|B5||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4282176|NCT00559962|4106443|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4282177|NCT00559962|4106444|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4282178|NCT00559962|4106445|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4282179|NCT00559962|4106446|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4282180|NCT00559962|4106438|B9|||Age||years|Mean|51.3|51.3|Standard Deviation|11.44|11.44|||
4282181|NCT00559962|4106439|B8|||Age||years|Mean|52.7|52.7|Standard Deviation|9.36|9.36|||
4282182|NCT00559962|4106440|B7|||Age||years|Mean|54.0|54.0|Standard Deviation|11.95|11.95|||
4282183|NCT00559962|4106441|B6|||Age||years|Mean|53.9|53.9|Standard Deviation|8.92|8.92|||
4282184|NCT00559962|4106442|B5|||Age||years|Mean|52.9|52.9|Standard Deviation|11.97|11.97|||
4282185|NCT00559962|4106443|B4|||Age||years|Mean|49.0|49.0|Standard Deviation|10.24|10.24|||
4282186|NCT00559962|4106444|B3|||Age||years|Mean|48.6|48.6|Standard Deviation|11.3|11.3|||
4282187|NCT00559962|4106445|B2|||Age||years|Mean|51.5|51.5|Standard Deviation|12.99|12.99|||
4282188|NCT00559962|4106446|B1|||Age||years|Mean|47.8|47.8|Standard Deviation|12.53|12.53|||
4282189|NCT00559949|4106473|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4282190|NCT00559949|4106473|B1|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4282191|NCT00559949|4106473|B1||Male|Gender||Participants|Count of Participants|26|26.0||||||
4282192|NCT00559949|4106473|B1||Female|Gender||Participants|Count of Participants|13|13.0||||||
4282193|NCT00559949|4106473|B1|||Age||years|Median|64|64.0|Full Range|||37.0|86.0|
4282194|NCT00559949|4106473|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4282195|NCT00559949|4106473|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4282196|NCT00559949|4106473|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4282197|NCT00559936|4106480|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4282198|NCT00559936|4106480|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4282199|NCT00559936|4106480|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4282200|NCT00559936|4106480|B1|||Age||years|Mean|52.5|52.5|Standard Deviation|3.3|3.3|||
4282201|NCT00559936|4106480|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4282202|NCT00559936|4106480|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4282203|NCT00559936|4106480|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4282204|NCT00559897|4106485|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4282205|NCT00559897|4106485|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4282206|NCT00559897|4106485|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4282207|NCT00559897|4106485|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4282208|NCT00559897|4106485|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4282209|NCT00559897|4106485|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4282210|NCT00559845|4106489|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4282211|NCT00559845|4106489|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4282212|NCT00559845|4106489|B1|||Age||years|Mean|50.00|50.0|Standard Deviation|9.279|9.279|||
4282213|NCT00559754|4106498|B1|Female||Sex/Gender, Customized||participants|Number|72|72.0||||||
4282214|NCT00559754|4106498|B1|||Age||years|Mean|47.22|47.22|Standard Deviation|9.85|9.85|||
4282215|NCT00559637|4106522|B1||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4282216|NCT00559637|4106522|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4282217|NCT00559637|4106522|B1|||Age||years|Mean|66.4|66.4|Standard Deviation|15.77|15.77|||
4282218|NCT00559585|4106533|B3|||Weight||kg|Mean|71.8|71.8|Standard Deviation|17.8|17.8|||
4282219|NCT00559585|4106534|B2|||Weight||kg|Mean|71.5|71.5|Standard Deviation|17.5|17.5|||
4282220|NCT00559585|4106535|B1|||Weight||kg|Mean|72.1|72.1|Standard Deviation|18.1|18.1|||
4282221|NCT00559585|4106533|B3|||Baseline Methotrexate (MTX) Dose||mg/wk|Mean|16.4|16.4|Standard Deviation|3.6|3.6|||
4282222|NCT00559585|4106534|B2|||Baseline Methotrexate (MTX) Dose||mg/wk|Mean|16.5|16.5|Standard Deviation|3.7|3.7|||
4282223|NCT00559585|4106535|B1|||Baseline Methotrexate (MTX) Dose||mg/wk|Mean|16.3|16.3|Standard Deviation|3.6|3.6|||
4282224|NCT00559585|4106533|B3|Unknown||Rheumatoid Factor Status|Rheumatoid factor (RF or RhF) is an autoantibody (antibody directed against an organism's own tissues) most relevant in rheumatoid arthritis. It is an antibody against the Fc portion of Immunoglobulin (Ig)G, which is itself an antibody. RF and IgG join to form immune complexes which contribute to the disease process. A positive value for RF was >20 IU/mL; a negative value for RF was ≤ 20 IU/mL.|participants|Number|21|21.0||||||
4282225|NCT00559585|4106534|B2|Unknown||Rheumatoid Factor Status|Rheumatoid factor (RF or RhF) is an autoantibody (antibody directed against an organism's own tissues) most relevant in rheumatoid arthritis. It is an antibody against the Fc portion of Immunoglobulin (Ig)G, which is itself an antibody. RF and IgG join to form immune complexes which contribute to the disease process. A positive value for RF was >20 IU/mL; a negative value for RF was ≤ 20 IU/mL.|participants|Number|9|9.0||||||
4282226|NCT00559585|4106535|B1|Unknown||Rheumatoid Factor Status|Rheumatoid factor (RF or RhF) is an autoantibody (antibody directed against an organism's own tissues) most relevant in rheumatoid arthritis. It is an antibody against the Fc portion of Immunoglobulin (Ig)G, which is itself an antibody. RF and IgG join to form immune complexes which contribute to the disease process. A positive value for RF was >20 IU/mL; a negative value for RF was ≤ 20 IU/mL.|participants|Number|12|12.0||||||
4282227|NCT00559585|4106533|B3|Positive||Rheumatoid Factor Status|Rheumatoid factor (RF or RhF) is an autoantibody (antibody directed against an organism's own tissues) most relevant in rheumatoid arthritis. It is an antibody against the Fc portion of Immunoglobulin (Ig)G, which is itself an antibody. RF and IgG join to form immune complexes which contribute to the disease process. A positive value for RF was >20 IU/mL; a negative value for RF was ≤ 20 IU/mL.|participants|Number|1165|1165.0||||||
4282228|NCT00559585|4106534|B2|Positive||Rheumatoid Factor Status|Rheumatoid factor (RF or RhF) is an autoantibody (antibody directed against an organism's own tissues) most relevant in rheumatoid arthritis. It is an antibody against the Fc portion of Immunoglobulin (Ig)G, which is itself an antibody. RF and IgG join to form immune complexes which contribute to the disease process. A positive value for RF was >20 IU/mL; a negative value for RF was ≤ 20 IU/mL.|participants|Number|583|583.0||||||
4282229|NCT00559585|4106535|B1|Positive||Rheumatoid Factor Status|Rheumatoid factor (RF or RhF) is an autoantibody (antibody directed against an organism's own tissues) most relevant in rheumatoid arthritis. It is an antibody against the Fc portion of Immunoglobulin (Ig)G, which is itself an antibody. RF and IgG join to form immune complexes which contribute to the disease process. A positive value for RF was >20 IU/mL; a negative value for RF was ≤ 20 IU/mL.|participants|Number|582|582.0||||||
4282230|NCT00559585|4106533|B3|Negative||Rheumatoid Factor Status|Rheumatoid factor (RF or RhF) is an autoantibody (antibody directed against an organism's own tissues) most relevant in rheumatoid arthritis. It is an antibody against the Fc portion of Immunoglobulin (Ig)G, which is itself an antibody. RF and IgG join to form immune complexes which contribute to the disease process. A positive value for RF was >20 IU/mL; a negative value for RF was ≤ 20 IU/mL.|participants|Number|193|193.0||||||
4282231|NCT00559585|4106534|B2|Negative||Rheumatoid Factor Status|Rheumatoid factor (RF or RhF) is an autoantibody (antibody directed against an organism's own tissues) most relevant in rheumatoid arthritis. It is an antibody against the Fc portion of Immunoglobulin (Ig)G, which is itself an antibody. RF and IgG join to form immune complexes which contribute to the disease process. A positive value for RF was >20 IU/mL; a negative value for RF was ≤ 20 IU/mL.|participants|Number|91|91.0||||||
4282232|NCT00559585|4106535|B1|Negative||Rheumatoid Factor Status|Rheumatoid factor (RF or RhF) is an autoantibody (antibody directed against an organism's own tissues) most relevant in rheumatoid arthritis. It is an antibody against the Fc portion of Immunoglobulin (Ig)G, which is itself an antibody. RF and IgG join to form immune complexes which contribute to the disease process. A positive value for RF was >20 IU/mL; a negative value for RF was ≤ 20 IU/mL.|participants|Number|102|102.0||||||
4282233|NCT00559585|4106533|B3|||Disease Activity Score (CRP)|"The DAS28 index measures disease activity in rheumatoid arthritis and is a composite derived from the number of swollen/tender joints, laboratory tests of inflammation (C-reactive protein measured in mg/L), and participant assessment of global health (by marking a 100 mm line from very good to very bad). A higher DAS28 score indicates worse control of disease. High disease activity is > 5.1, low disease activity is < 3.2 and remission is < 2.6."|units on a scale|Mean|6.24|6.24|Standard Deviation|0.83|0.83|||
4282234|NCT00559585|4106534|B2|||Disease Activity Score (CRP)|"The DAS28 index measures disease activity in rheumatoid arthritis and is a composite derived from the number of swollen/tender joints, laboratory tests of inflammation (C-reactive protein measured in mg/L), and participant assessment of global health (by marking a 100 mm line from very good to very bad). A higher DAS28 score indicates worse control of disease. High disease activity is > 5.1, low disease activity is < 3.2 and remission is < 2.6."|units on a scale|Mean|6.22|6.22|Standard Deviation|0.83|0.83|||
4282235|NCT00559585|4106535|B1|||Disease Activity Score (CRP)|"The DAS28 index measures disease activity in rheumatoid arthritis and is a composite derived from the number of swollen/tender joints, laboratory tests of inflammation (C-reactive protein measured in mg/L), and participant assessment of global health (by marking a 100 mm line from very good to very bad). A higher DAS28 score indicates worse control of disease. High disease activity is > 5.1, low disease activity is < 3.2 and remission is < 2.6."|units on a scale|Mean|6.25|6.25|Standard Deviation|0.84|0.84|||
4282236|NCT00559585|4106533|B3|||High Sensitivity C-Reactive Protein (hsCRP) Level|hs-CRP is a acute phase reactant protein that is a clinical marker for Rheumatoid Arthritis (RA). Levels of hs-CRP can be used to determine DAS28.|mg/dL|Mean|2.69|2.69|Standard Deviation|2.91|2.91|||
4282237|NCT00559585|4106534|B2|||High Sensitivity C-Reactive Protein (hsCRP) Level|hs-CRP is a acute phase reactant protein that is a clinical marker for Rheumatoid Arthritis (RA). Levels of hs-CRP can be used to determine DAS28.|mg/dL|Mean|2.72|2.72|Standard Deviation|2.91|2.91|||
4282238|NCT00559585|4106535|B1|||High Sensitivity C-Reactive Protein (hsCRP) Level|hs-CRP is a acute phase reactant protein that is a clinical marker for Rheumatoid Arthritis (RA). Levels of hs-CRP can be used to determine DAS28.|mg/dL|Mean|2.65|2.65|Standard Deviation|2.91|2.91|||
4282239|NCT00559585|4106533|B3|||Physician Global Assessment|Physician global rheumatoid arthritis assessment core component of the ACR scoring system where increasing score indicates increasing level of severity as indicated on a 100 mm Visual Analog Scale, with 0 mm representing no pain and 100 mm representing the most pain possible.|units on a scale|Mean|63.9|63.9|Standard Deviation|16.4|16.4|||
4282240|NCT00559585|4106534|B2|||Physician Global Assessment|Physician global rheumatoid arthritis assessment core component of the ACR scoring system where increasing score indicates increasing level of severity as indicated on a 100 mm Visual Analog Scale, with 0 mm representing no pain and 100 mm representing the most pain possible.|units on a scale|Mean|63.4|63.4|Standard Deviation|16.3|16.3|||
4282241|NCT00559585|4106535|B1|||Physician Global Assessment|Physician global rheumatoid arthritis assessment core component of the ACR scoring system where increasing score indicates increasing level of severity as indicated on a 100 mm Visual Analog Scale, with 0 mm representing no pain and 100 mm representing the most pain possible.|units on a scale|Mean|64.3|64.3|Standard Deviation|16.5|16.5|||
4282242|NCT00559585|4106533|B3|||Participant Global Assessment|"Participants used a horizontal VAS of 100 mm for overall assessment of rheumatoid arthritis. Scale ranged from 0 (very well) to 100 (very poor). Participants were instructed to draw a vertical through a horizontal line to indicate state of rheumatoid arthritis. Distance from the very well end of the horizontal line to the vertical line drawn by the participant was the global disease assessment score on a scale of 1-10, where 1=controlled or equivocal rheumatoid arthritis activity, 1.1-4=mild activity, 4-8=moderate activity, and 8.1-10=high activity."|units on a scale|Mean|66.2|66.2|Standard Deviation|20.0|20.0|||
4282243|NCT00559585|4106534|B2|||Participant Global Assessment|"Participants used a horizontal VAS of 100 mm for overall assessment of rheumatoid arthritis. Scale ranged from 0 (very well) to 100 (very poor). Participants were instructed to draw a vertical through a horizontal line to indicate state of rheumatoid arthritis. Distance from the very well end of the horizontal line to the vertical line drawn by the participant was the global disease assessment score on a scale of 1-10, where 1=controlled or equivocal rheumatoid arthritis activity, 1.1-4=mild activity, 4-8=moderate activity, and 8.1-10=high activity."|units on a scale|Mean|65.2|65.2|Standard Deviation|19.9|19.9|||
4282244|NCT00559585|4106535|B1|||Participant Global Assessment|"Participants used a horizontal VAS of 100 mm for overall assessment of rheumatoid arthritis. Scale ranged from 0 (very well) to 100 (very poor). Participants were instructed to draw a vertical through a horizontal line to indicate state of rheumatoid arthritis. Distance from the very well end of the horizontal line to the vertical line drawn by the participant was the global disease assessment score on a scale of 1-10, where 1=controlled or equivocal rheumatoid arthritis activity, 1.1-4=mild activity, 4-8=moderate activity, and 8.1-10=high activity."|units on a scale|Mean|67.2|67.2|Standard Deviation|20.1|20.1|||
4282245|NCT00559585|4106533|B3|||Physical Function (Health Assessment Questionnaire Disability Index [HAQ-DI])|The disability section of the full HAQ includes 20 questions to assess physical The HAQ-DI includes 20 questions to assess physical function in 8 domains: dressing, arising, eating, walking, hygiene, reach, grip, and common activities. The domain questions are evaluated on a 4-point scale: 0=without any difficulty, 1=with some difficulty, 2=with much difficulty, 3=unable to do. HAQ-DI=sum of worst scores in each domain divided by the number of domains answered. HAQ-DI overall score ranges from a minimum of 0 to a maximum of 3.0.|units on a scale|Mean|1.71|1.71|Standard Deviation|0.67|0.67|||
4282271|NCT00559585|4106535|B1|||Duration of RA Disease||years|Mean|7.6|7.6|Standard Deviation|8.0|8.0|||
4282272|NCT00559585|4106533|B3|>100 kg||Baseline Weight Category||participants|Number|104|104.0||||||
4282273|NCT00559585|4106534|B2|>100 kg||Baseline Weight Category||participants|Number|47|47.0||||||
4282274|NCT00559585|4106535|B1|>100 kg||Baseline Weight Category||participants|Number|57|57.0||||||
4282246|NCT00559585|4106534|B2|||Physical Function (Health Assessment Questionnaire Disability Index [HAQ-DI])|The disability section of the full HAQ includes 20 questions to assess physical The HAQ-DI includes 20 questions to assess physical function in 8 domains: dressing, arising, eating, walking, hygiene, reach, grip, and common activities. The domain questions are evaluated on a 4-point scale: 0=without any difficulty, 1=with some difficulty, 2=with much difficulty, 3=unable to do. HAQ-DI=sum of worst scores in each domain divided by the number of domains answered. HAQ-DI overall score ranges from a minimum of 0 to a maximum of 3.0.|units on a scale|Mean|1.69|1.69|Standard Deviation|0.67|0.67|||
4282247|NCT00559585|4106535|B1|||Physical Function (Health Assessment Questionnaire Disability Index [HAQ-DI])|The disability section of the full HAQ includes 20 questions to assess physical The HAQ-DI includes 20 questions to assess physical function in 8 domains: dressing, arising, eating, walking, hygiene, reach, grip, and common activities. The domain questions are evaluated on a 4-point scale: 0=without any difficulty, 1=with some difficulty, 2=with much difficulty, 3=unable to do. HAQ-DI=sum of worst scores in each domain divided by the number of domains answered. HAQ-DI overall score ranges from a minimum of 0 to a maximum of 3.0.|units on a scale|Mean|1.73|1.73|Standard Deviation|0.68|0.68|||
4282248|NCT00559585|4106533|B3|||Participant Pain Assessment|The participant self-reported pain assessment is a core component of the ACR scoring system where increasing score indicates increasing level of severity as indicated on a 100 mm Visual Analog Scale (VAS) with 0 mm representing no pain and 100 mm representing the most pain possible. For each post-baseline visit in the DB, time-matched baseline Participant Pain Assessment values were presented and represent the mean baseline value for only that cohort of participants with assessments available at that visit.|units on a scale|Mean|67.5|67.5|Standard Deviation|20.3|20.3|||
4282249|NCT00559585|4106534|B2|||Participant Pain Assessment|The participant self-reported pain assessment is a core component of the ACR scoring system where increasing score indicates increasing level of severity as indicated on a 100 mm Visual Analog Scale (VAS) with 0 mm representing no pain and 100 mm representing the most pain possible. For each post-baseline visit in the DB, time-matched baseline Participant Pain Assessment values were presented and represent the mean baseline value for only that cohort of participants with assessments available at that visit.|units on a scale|Mean|66.9|66.9|Standard Deviation|20.5|20.5|||
4282250|NCT00559585|4106535|B1|||Participant Pain Assessment|The participant self-reported pain assessment is a core component of the ACR scoring system where increasing score indicates increasing level of severity as indicated on a 100 mm Visual Analog Scale (VAS) with 0 mm representing no pain and 100 mm representing the most pain possible. For each post-baseline visit in the DB, time-matched baseline Participant Pain Assessment values were presented and represent the mean baseline value for only that cohort of participants with assessments available at that visit.|units on a scale|Mean|68.0|68.0|Standard Deviation|20.0|20.0|||
4282251|NCT00559585|4106533|B3|||Number of Swollen Joints|Swollen joints are an indicator of Rheumatoid Arthritis. The number of swollen joints in a standard 66 joint count was evaluated. The number of swollen joints ranges from 0 swollen joints to 66, where an increased number of swollen joints indicates increasing level of disease severity.|swollen joints|Mean|20.0|20.0|Standard Deviation|9.0|9.0|||
4282252|NCT00559585|4106534|B2|||Number of Swollen Joints|Swollen joints are an indicator of Rheumatoid Arthritis. The number of swollen joints in a standard 66 joint count was evaluated. The number of swollen joints ranges from 0 swollen joints to 66, where an increased number of swollen joints indicates increasing level of disease severity.|swollen joints|Mean|19.6|19.6|Standard Deviation|8.5|8.5|||
4282253|NCT00559585|4106535|B1|||Number of Swollen Joints|Swollen joints are an indicator of Rheumatoid Arthritis. The number of swollen joints in a standard 66 joint count was evaluated. The number of swollen joints ranges from 0 swollen joints to 66, where an increased number of swollen joints indicates increasing level of disease severity.|swollen joints|Mean|20.5|20.5|Standard Deviation|9.4|9.4|||
4282254|NCT00559585|4106533|B3|||Number of Tender Joints|Tender joints are an indicator of Rheumatoid Arthritis. The number of tender joints in a standard 68 joint count was evaluated. The number of tender joints ranges from 0 tender joints to 68, where an increased number of tender joints indicates increasing level of disease severity.|tender joints|Mean|29.6|29.6|Standard Deviation|13.6|13.6|||
4282255|NCT00559585|4106534|B2|||Number of Tender Joints|Tender joints are an indicator of Rheumatoid Arthritis. The number of tender joints in a standard 68 joint count was evaluated. The number of tender joints ranges from 0 tender joints to 68, where an increased number of tender joints indicates increasing level of disease severity.|tender joints|Mean|29.2|29.2|Standard Deviation|13.1|13.1|||
4282256|NCT00559585|4106535|B1|||Number of Tender Joints|Tender joints are an indicator of Rheumatoid Arthritis. The number of tender joints in a standard 68 joint count was evaluated. The number of tender joints ranges from 0 tender joints to 68, where an increased number of tender joints indicates increasing level of disease severity.|tender joints|Mean|30|30.0|Standard Deviation|14.1|14.1|||
4282257|NCT00559585|4106533|B3|> 10 yrs||Duration of Disease Category||participants|Number|366|366.0||||||
4282258|NCT00559585|4106534|B2|> 10 yrs||Duration of Disease Category||participants|Number|177|177.0||||||
4282259|NCT00559585|4106535|B1|> 10 yrs||Duration of Disease Category||participants|Number|189|189.0||||||
4282260|NCT00559585|4106533|B3|5 - ≤10 yrs||Duration of Disease Category||participants|Number|289|289.0||||||
4282261|NCT00559585|4106534|B2|5 - ≤10 yrs||Duration of Disease Category||participants|Number|155|155.0||||||
4282262|NCT00559585|4106535|B1|5 - ≤10 yrs||Duration of Disease Category||participants|Number|134|134.0||||||
4282263|NCT00559585|4106533|B3|2 - ≤5 yrs||Duration of Disease Category||participants|Number|289|289.0||||||
4282264|NCT00559585|4106534|B2|2 - ≤5 yrs||Duration of Disease Category||participants|Number|145|145.0||||||
4282265|NCT00559585|4106535|B1|2 - ≤5 yrs||Duration of Disease Category||participants|Number|144|144.0||||||
4282266|NCT00559585|4106533|B3|≤2 Years||Duration of Disease Category||participants|Number|435|435.0||||||
4282267|NCT00559585|4106534|B2|≤2 Years||Duration of Disease Category||participants|Number|206|206.0||||||
4282268|NCT00559585|4106535|B1|≤2 Years||Duration of Disease Category||participants|Number|229|229.0||||||
4282269|NCT00559585|4106533|B3|||Duration of RA Disease||years|Mean|7.7|7.7|Standard Deviation|7.9|7.9|||
4282270|NCT00559585|4106534|B2|||Duration of RA Disease||years|Mean|7.7|7.7|Standard Deviation|7.9|7.9|||
4282275|NCT00559585|4106533|B3|60 to 100 kg||Baseline Weight Category||participants|Number|929|929.0||||||
4282276|NCT00559585|4106534|B2|60 to 100 kg||Baseline Weight Category||participants|Number|465|465.0||||||
4282277|NCT00559585|4106535|B1|60 to 100 kg||Baseline Weight Category||participants|Number|464|464.0||||||
4282278|NCT00559585|4106533|B3|<60 kg||Baseline Weight Category||participants|Number|346|346.0||||||
4282279|NCT00559585|4106534|B2|<60 kg||Baseline Weight Category||participants|Number|171|171.0||||||
4282280|NCT00559585|4106535|B1|<60 kg||Baseline Weight Category||participants|Number|175|175.0||||||
4282281|NCT00559585|4106533|B3|Rest of the World||Region Of Enrollment||participants|Number|215|215.0||||||
4282282|NCT00559585|4106534|B2|Rest of the World||Region Of Enrollment||participants|Number|109|109.0||||||
4282283|NCT00559585|4106535|B1|Rest of the World||Region Of Enrollment||participants|Number|106|106.0||||||
4282284|NCT00559585|4106533|B3|Europe||Region Of Enrollment||participants|Number|246|246.0||||||
4282285|NCT00559585|4106534|B2|Europe||Region Of Enrollment||participants|Number|123|123.0||||||
4282286|NCT00559585|4106535|B1|Europe||Region Of Enrollment||participants|Number|123|123.0||||||
4282287|NCT00559585|4106533|B3|South America||Region Of Enrollment||participants|Number|678|678.0||||||
4282288|NCT00559585|4106534|B2|South America||Region Of Enrollment||participants|Number|340|340.0||||||
4282289|NCT00559585|4106535|B1|South America||Region Of Enrollment||participants|Number|338|338.0||||||
4282290|NCT00559585|4106533|B3|North America||Region Of Enrollment||participants|Number|240|240.0||||||
4282291|NCT00559585|4106534|B2|North America||Region Of Enrollment||participants|Number|111|111.0||||||
4282292|NCT00559585|4106535|B1|North America||Region Of Enrollment||participants|Number|129|129.0||||||
4282293|NCT00559585|4106533|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
4282294|NCT00559585|4106534|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
4282295|NCT00559585|4106535|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4282296|NCT00559585|4106533|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282297|NCT00559585|4106534|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282298|NCT00559585|4106535|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282299|NCT00559585|4106533|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1021|1021.0||||||
4282300|NCT00559585|4106534|B2||White|Race (NIH/OMB)||Participants|Count of Participants|505|505.0||||||
4282301|NCT00559585|4106535|B1||White|Race (NIH/OMB)||Participants|Count of Participants|516|516.0||||||
4282302|NCT00559585|4106533|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4282303|NCT00559585|4106534|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4282304|NCT00559585|4106535|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4282305|NCT00559585|4106533|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282306|NCT00559585|4106534|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282307|NCT00559585|4106535|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282308|NCT00559585|4106533|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|135|135.0||||||
4282309|NCT00559585|4106534|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4282310|NCT00559585|4106535|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4282311|NCT00559585|4106533|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4282312|NCT00559585|4106534|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4282313|NCT00559585|4106535|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4282314|NCT00559585|4106533|B3||Male|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
4282315|NCT00559585|4106534|B2||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4282316|NCT00559585|4106535|B1||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4282317|NCT00559585|4106533|B3||Female|Sex: Female, Male||Participants|Count of Participants|1135|1135.0||||||
4282318|NCT00559585|4106534|B2||Female|Sex: Female, Male||Participants|Count of Participants|549|549.0||||||
4282319|NCT00559585|4106535|B1||Female|Sex: Female, Male||Participants|Count of Participants|586|586.0||||||
4282320|NCT00559585|4106533|B3|||Age|Since regulatory guidelines indicate use of the Per Protocol (PP) Analysis Population (instead of the Intent-To-Treat Population) for non-inferiority studies, this population was used to perform primary and key secondary efficacy analyses. Thus, Baseline continuous age data are presented for the PP Analysis Population.|years|Mean|49.9|49.9|Standard Deviation|12.8|12.8|||
4282321|NCT00559585|4106534|B2|||Age|Since regulatory guidelines indicate use of the Per Protocol (PP) Analysis Population (instead of the Intent-To-Treat Population) for non-inferiority studies, this population was used to perform primary and key secondary efficacy analyses. Thus, Baseline continuous age data are presented for the PP Analysis Population.|years|Mean|49.9|49.9|Standard Deviation|12.7|12.7|||
4282322|NCT00559585|4106535|B1|||Age|Since regulatory guidelines indicate use of the Per Protocol (PP) Analysis Population (instead of the Intent-To-Treat Population) for non-inferiority studies, this population was used to perform primary and key secondary efficacy analyses. Thus, Baseline continuous age data are presented for the PP Analysis Population.|years|Mean|49.9|49.9|Standard Deviation|13.0|13.0|||
4282323|NCT00559507|4106596|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4282324|NCT00559507|4106596|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4282325|NCT00559507|4106596|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4282326|NCT00559507|4106596|B1|||Age||years|Mean|57|57.0|Standard Deviation|38.18376618|38.18376618|||
4282327|NCT00559507|4106596|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4282328|NCT00559507|4106596|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4282329|NCT00559507|4106596|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4282330|NCT00559377|4106602|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4282331|NCT00559377|4106602|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4282332|NCT00559377|4106602|B1||Female|Gender||Participants|Count of Participants|16|16.0||||||
4282333|NCT00559377|4106602|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4282334|NCT00559377|4106602|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4282335|NCT00559377|4106602|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4282336|NCT00559364|4106610|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4282337|NCT00559364|4106611|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4282338|NCT00559364|4106612|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4282339|NCT00559364|4106610|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4282340|NCT00559364|4106611|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4282341|NCT00559364|4106612|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4282342|NCT00559364|4106610|B3|||Age||years|Mean|50.8|50.8|Standard Deviation|8.98|8.98|||
4282343|NCT00559364|4106611|B2|||Age||years|Mean|50.6|50.6|Standard Deviation|7.63|7.63|||
4282344|NCT00559364|4106612|B1|||Age||years|Mean|50.9|50.9|Standard Deviation|9.91|9.91|||
4282345|NCT00559273|4106623|B3||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4282346|NCT00559273|4106624|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4282347|NCT00559273|4106625|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4282348|NCT00559273|4106623|B3||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4282349|NCT00559273|4106624|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4282350|NCT00559273|4106625|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4282351|NCT00559273|4106623|B3|||Age||years|Mean|66.3|66.3|Standard Deviation|13.91|13.91|||
4282352|NCT00559273|4106624|B2|||Age||years|Mean|67.4|67.4|Standard Deviation|13.40|13.4|||
4282353|NCT00559273|4106625|B1|||Age||years|Mean|65.2|65.2|Standard Deviation|14.37|14.37|||
4282354|NCT00559104|4106646|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4282355|NCT00559104|4106647|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4282356|NCT00559104|4106648|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4282357|NCT00559104|4106646|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4282358|NCT00559104|4106647|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4282359|NCT00559104|4106648|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4282360|NCT00559104|4106646|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4282361|NCT00559104|4106647|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4282362|NCT00559104|4106648|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4282363|NCT00559104|4106646|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4282364|NCT00559104|4106647|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4282365|NCT00559104|4106648|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4282366|NCT00559104|4106646|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4282367|NCT00559104|4106647|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4282368|NCT00559104|4106648|B1||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4282369|NCT00559104|4106646|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4282370|NCT00559104|4106647|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4282371|NCT00559104|4106648|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4282372|NCT00559104|4106646|B3|||Age||years|Median|42.5|42.5|Full Range|||19.0|59.6|
4282373|NCT00559104|4106647|B2|||Age||years|Median|32.4|32.4|Full Range|||21.7|59.6|
4282374|NCT00559104|4106648|B1|||Age||years|Median|44.2|44.2|Full Range|||19.0|57.7|
4282375|NCT00559013|4106659|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4282376|NCT00559013|4106659|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4282377|NCT00559013|4106659|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4282378|NCT00559013|4106659|B1|||Age||years|Mean|57.26|57.26|Standard Deviation|11.44|11.44|||
4282379|NCT00559013|4106659|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4282380|NCT00559013|4106659|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4282381|NCT00559013|4106659|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4282382|NCT00558896|4106663|B8|United States||Region of Enrollment||participants|Number|377|377.0||||||
4282383|NCT00558896|4106664|B7|United States||Region of Enrollment||participants|Number|33|33.0||||||
4282384|NCT00558896|4106665|B6|United States||Region of Enrollment||participants|Number|120|120.0||||||
4282385|NCT00558896|4106666|B5|United States||Region of Enrollment||participants|Number|60|60.0||||||
4282386|NCT00558896|4106667|B4|United States||Region of Enrollment||participants|Number|35|35.0||||||
4282387|NCT00558896|4106668|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
4282388|NCT00558896|4106669|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
4282389|NCT00558896|4106670|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4282390|NCT00558896|4106663|B8||Male|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
4282391|NCT00558896|4106664|B7||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4282392|NCT00558896|4106665|B6||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4282393|NCT00558896|4106666|B5||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4282394|NCT00558896|4106667|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4282395|NCT00558896|4106668|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4282396|NCT00558896|4106669|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4282397|NCT00558896|4106670|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4282398|NCT00558896|4106663|B8||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4282399|NCT00558896|4106664|B7||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4282400|NCT00558896|4106665|B6||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4282401|NCT00558896|4106666|B5||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4282402|NCT00558896|4106667|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4282403|NCT00558896|4106668|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4282404|NCT00558896|4106669|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4282405|NCT00558896|4106670|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4282406|NCT00558896|4106663|B8|||Age||years|Median|64|64.0|Full Range|||32.0|88.0|
4282407|NCT00558896|4106664|B7|||Age||years|Median|66|66.0|Full Range|||52.0|82.0|
4282408|NCT00558896|4106665|B6|||Age||years|Median|65|65.0|Full Range|||36.0|85.0|
4282409|NCT00558896|4106666|B5|||Age||years|Median|65.5|65.5|Full Range|||32.0|82.0|
4282410|NCT00558896|4106667|B4|||Age||years|Median|61|61.0|Full Range|||45.0|77.0|
4282411|NCT00558896|4106668|B3|||Age||years|Median|62|62.0|Full Range|||39.0|77.0|
4282412|NCT00558896|4106669|B2|||Age||years|Median|61.5|61.5|Full Range|||39.0|77.0|
4282413|NCT00558896|4106670|B1|||Age||years|Median|65.5|65.5|Full Range|||35.0|88.0|
4282414|NCT00558870|4106706|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4282415|NCT00558870|4106707|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4282416|NCT00558870|4106708|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4282417|NCT00558870|4106706|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282418|NCT00558870|4106707|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282419|NCT00558870|4106708|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282420|NCT00558870|4106706|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282421|NCT00558870|4106707|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282422|NCT00558870|4106708|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282423|NCT00558870|4106706|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4282424|NCT00558870|4106707|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4282425|NCT00558870|4106708|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4282426|NCT00558870|4106706|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4282427|NCT00558870|4106707|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4282428|NCT00558870|4106708|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282429|NCT00558870|4106706|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282430|NCT00558870|4106707|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282431|NCT00558870|4106708|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282432|NCT00558870|4106706|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282433|NCT00558870|4106707|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282434|NCT00558870|4106708|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282435|NCT00558870|4106706|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282436|NCT00558870|4106707|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282437|NCT00558870|4106708|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4282438|NCT00558870|4106706|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4282439|NCT00558870|4106707|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4282440|NCT00558870|4106708|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4282441|NCT00558870|4106706|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4282442|NCT00558870|4106707|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4282443|NCT00558870|4106708|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4282444|NCT00558870|4106706|B3|||Age||years|Median|42|42.0|Full Range|||28.0|48.0|
4282445|NCT00558870|4106707|B2|||Age||years|Median|35|35.0|Full Range|||28.0|42.0|
4282446|NCT00558870|4106708|B1|||Age||years|Median|45|45.0|Full Range|||42.0|48.0|
4282447|NCT00558831|4106717|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4282448|NCT00558831|4106717|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4282449|NCT00558831|4106717|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4282450|NCT00558831|4106717|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4282451|NCT00558831|4106717|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4282452|NCT00558831|4106717|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4282453|NCT00558792|4106723|B4|Italy||Region of Enrollment||participants|Number|7|7.0||||||
4282454|NCT00558792|4106724|B3|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4282455|NCT00558792|4106725|B2|Italy||Region of Enrollment||participants|Number|3|3.0||||||
4282456|NCT00558792|4106726|B1|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4282457|NCT00558792|4106723|B4|Canada||Region of Enrollment||participants|Number|31|31.0||||||
4282458|NCT00558792|4106724|B3|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4282459|NCT00558792|4106725|B2|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4282460|NCT00558792|4106726|B1|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4282461|NCT00558792|4106723|B4|United States||Region of Enrollment||participants|Number|153|153.0||||||
4282462|NCT00558792|4106724|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
4282463|NCT00558792|4106725|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
4282464|NCT00558792|4106726|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4282465|NCT00558792|4106723|B4||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4282466|NCT00558792|4106724|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4282467|NCT00558792|4106725|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4282468|NCT00558792|4106726|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4282469|NCT00558792|4106723|B4||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4282470|NCT00558792|4106724|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4282471|NCT00558792|4106725|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4282472|NCT00558792|4106726|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4282473|NCT00558792|4106723|B4|||Age||years|Mean|58.0|58.0|Standard Deviation|8.85|8.85|||
4282474|NCT00558792|4106724|B3|||Age||years|Mean|58.7|58.7|Standard Deviation|9.25|9.25|||
4282475|NCT00558792|4106725|B2|||Age||years|Mean|57.7|57.7|Standard Deviation|8.54|8.54|||
4282476|NCT00558792|4106726|B1|||Age||years|Mean|57.7|57.7|Standard Deviation|8.85|8.85|||
4282477|NCT00558792|4106723|B4||>=65 years|Age||Participants|Count of Participants|47|47.0||||||
4282478|NCT00558792|4106724|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4282479|NCT00558792|4106725|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4282480|NCT00558792|4106726|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4282481|NCT00558792|4106723|B4||Between 18 and 65 years|Age||Participants|Count of Participants|144|144.0||||||
4282482|NCT00558792|4106724|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4282483|NCT00558792|4106725|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4282484|NCT00558792|4106726|B1||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4282485|NCT00558792|4106723|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4282486|NCT00558792|4106724|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4282487|NCT00558792|4106725|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4282488|NCT00558792|4106726|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4282489|NCT00558753|4106772|B3|||BMI|Body Mass Index...........................................|kg/m^2|Mean|34.4|34.4|Standard Deviation|8|8.0|||
4282490|NCT00558753|4106773|B2|||BMI|Body Mass Index...........................................|kg/m^2|Mean|34.2|34.2|Standard Deviation|8.4|8.4|||
4282491|NCT00558753|4106774|B1|||BMI|Body Mass Index...........................................|kg/m^2|Mean|34.6|34.6|Standard Deviation|7.7|7.7|||
4282492|NCT00558753|4106772|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4282493|NCT00558753|4106773|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4282494|NCT00558753|4106774|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4282495|NCT00558753|4106772|B3||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4282496|NCT00558753|4106773|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4282497|NCT00558753|4106774|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4282498|NCT00558753|4106772|B3|||Age||years|Mean|63.7|63.7|Standard Deviation|8.6|8.6|||
4282499|NCT00558753|4106773|B2|||Age||years|Mean|64.0|64.0|Standard Deviation|8.3|8.3|||
4282500|NCT00558753|4106774|B1|||Age||years|Mean|63.3|63.3|Standard Deviation|8.9|8.9|||
4282501|NCT00558701|4106785|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4282502|NCT00558701|4106786|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4282503|NCT00558701|4106787|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4282504|NCT00558701|4106785|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4282505|NCT00558701|4106786|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4282506|NCT00558701|4106787|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4282507|NCT00558701|4106785|B3|||Age||years|Mean|33.8|33.8|Standard Deviation|9.5|9.5|||
4282508|NCT00558701|4106786|B2|||Age||years|Mean|33.8|33.8|Standard Deviation|9.5|9.5|||
4282509|NCT00558701|4106787|B1|||Age||years|Mean|33.8|33.8|Standard Deviation|9.5|9.5|||
4282510|NCT00558636|4106794|B3|Stage IV||Stage at study entry|Subjects in the study were stratified by the stage of their disease: Stage IIIB (with cytologically confirmed malignant pleural or pericardial effusion) or Stage IV histological or cytological confirmation of Non-Small Cell Lung Cancer (NSCLC).|Participants|Number|77|77.0||||||
4282511|NCT00558636|4106795|B2|Stage IV||Stage at study entry|Subjects in the study were stratified by the stage of their disease: Stage IIIB (with cytologically confirmed malignant pleural or pericardial effusion) or Stage IV histological or cytological confirmation of Non-Small Cell Lung Cancer (NSCLC).|Participants|Number|40|40.0||||||
4282512|NCT00558636|4106796|B1|Stage IV||Stage at study entry|Subjects in the study were stratified by the stage of their disease: Stage IIIB (with cytologically confirmed malignant pleural or pericardial effusion) or Stage IV histological or cytological confirmation of Non-Small Cell Lung Cancer (NSCLC).|Participants|Number|37|37.0||||||
4282513|NCT00558636|4106794|B3|Stage IIIB||Stage at study entry|Subjects in the study were stratified by the stage of their disease: Stage IIIB (with cytologically confirmed malignant pleural or pericardial effusion) or Stage IV histological or cytological confirmation of Non-Small Cell Lung Cancer (NSCLC).|Participants|Number|10|10.0||||||
4282514|NCT00558636|4106795|B2|Stage IIIB||Stage at study entry|Subjects in the study were stratified by the stage of their disease: Stage IIIB (with cytologically confirmed malignant pleural or pericardial effusion) or Stage IV histological or cytological confirmation of Non-Small Cell Lung Cancer (NSCLC).|Participants|Number|3|3.0||||||
4282515|NCT00558636|4106796|B1|Stage IIIB||Stage at study entry|Subjects in the study were stratified by the stage of their disease: Stage IIIB (with cytologically confirmed malignant pleural or pericardial effusion) or Stage IV histological or cytological confirmation of Non-Small Cell Lung Cancer (NSCLC).|Participants|Number|7|7.0||||||
4282516|NCT00558636|4106794|B3|Missing||Stage at study entry|Subjects in the study were stratified by the stage of their disease: Stage IIIB (with cytologically confirmed malignant pleural or pericardial effusion) or Stage IV histological or cytological confirmation of Non-Small Cell Lung Cancer (NSCLC).|Participants|Number|4|4.0||||||
4282517|NCT00558636|4106795|B2|Missing||Stage at study entry|Subjects in the study were stratified by the stage of their disease: Stage IIIB (with cytologically confirmed malignant pleural or pericardial effusion) or Stage IV histological or cytological confirmation of Non-Small Cell Lung Cancer (NSCLC).|Participants|Number|1|1.0||||||
4282518|NCT00558636|4106796|B1|Missing||Stage at study entry|Subjects in the study were stratified by the stage of their disease: Stage IIIB (with cytologically confirmed malignant pleural or pericardial effusion) or Stage IV histological or cytological confirmation of Non-Small Cell Lung Cancer (NSCLC).|Participants|Number|3|3.0||||||
4282519|NCT00558636|4106794|B3|Missing histology||Histology|Subjects in the study were stratified by the histology of their non-small cell lung cancer into non-squamous vs squamous.|Participants|Number|1|1.0||||||
4282520|NCT00558636|4106795|B2|Missing histology||Histology|Subjects in the study were stratified by the histology of their non-small cell lung cancer into non-squamous vs squamous.|Participants|Number|0|0.0||||||
4282521|NCT00558636|4106796|B1|Missing histology||Histology|Subjects in the study were stratified by the histology of their non-small cell lung cancer into non-squamous vs squamous.|Participants|Number|1|1.0||||||
4282522|NCT00558636|4106794|B3|Other||Histology|Subjects in the study were stratified by the histology of their non-small cell lung cancer into non-squamous vs squamous.|Participants|Number|63|63.0||||||
4282523|NCT00558636|4106795|B2|Other||Histology|Subjects in the study were stratified by the histology of their non-small cell lung cancer into non-squamous vs squamous.|Participants|Number|30|30.0||||||
4282524|NCT00558636|4106796|B1|Other||Histology|Subjects in the study were stratified by the histology of their non-small cell lung cancer into non-squamous vs squamous.|Participants|Number|33|33.0||||||
4282525|NCT00558636|4106794|B3|Squamous cell (epidermoid) carcinoma||Histology|Subjects in the study were stratified by the histology of their non-small cell lung cancer into non-squamous vs squamous.|Participants|Number|27|27.0||||||
4282526|NCT00558636|4106795|B2|Squamous cell (epidermoid) carcinoma||Histology|Subjects in the study were stratified by the histology of their non-small cell lung cancer into non-squamous vs squamous.|Participants|Number|14|14.0||||||
4282527|NCT00558636|4106796|B1|Squamous cell (epidermoid) carcinoma||Histology|Subjects in the study were stratified by the histology of their non-small cell lung cancer into non-squamous vs squamous.|Participants|Number|13|13.0||||||
4282528|NCT00558636|4106794|B3|Non-China||Geographic region|Subjects in the study were stratified as to whether they were from China or not from China.|Participants|Number|20|20.0||||||
4282529|NCT00558636|4106795|B2|Non-China||Geographic region|Subjects in the study were stratified as to whether they were from China or not from China.|Participants|Number|8|8.0||||||
4282530|NCT00558636|4106796|B1|Non-China||Geographic region|Subjects in the study were stratified as to whether they were from China or not from China.|Participants|Number|12|12.0||||||
4282531|NCT00558636|4106794|B3|China||Geographic region|Subjects in the study were stratified as to whether they were from China or not from China.|Participants|Number|71|71.0||||||
4282532|NCT00558636|4106795|B2|China||Geographic region|Subjects in the study were stratified as to whether they were from China or not from China.|Participants|Number|36|36.0||||||
4282533|NCT00558636|4106796|B1|China||Geographic region|Subjects in the study were stratified as to whether they were from China or not from China.|Participants|Number|35|35.0||||||
4282534|NCT00558636|4106794|B3|Grade 1: Restricted strenuous activity, ambulatory||Eastern Cooperative Oncology Group (ECOG) performance status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. The scale ranges from 0 (fully active) to 5 (dead). Subjects entering this study must have had an ECOG score of 0 or 1(restricted in physically strenuous activity but ambulatory).|Participants|Number|78|78.0||||||
4282535|NCT00558636|4106795|B2|Grade 1: Restricted strenuous activity, ambulatory||Eastern Cooperative Oncology Group (ECOG) performance status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. The scale ranges from 0 (fully active) to 5 (dead). Subjects entering this study must have had an ECOG score of 0 or 1(restricted in physically strenuous activity but ambulatory).|Participants|Number|39|39.0||||||
4282536|NCT00558636|4106796|B1|Grade 1: Restricted strenuous activity, ambulatory||Eastern Cooperative Oncology Group (ECOG) performance status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. The scale ranges from 0 (fully active) to 5 (dead). Subjects entering this study must have had an ECOG score of 0 or 1(restricted in physically strenuous activity but ambulatory).|Participants|Number|39|39.0||||||
4282591|NCT00558467|4106903|B1|Black/African American||Race, Customized||participants|Number|2|2.0||||||
4282537|NCT00558636|4106794|B3|Grade 0: Fully active||Eastern Cooperative Oncology Group (ECOG) performance status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. The scale ranges from 0 (fully active) to 5 (dead). Subjects entering this study must have had an ECOG score of 0 or 1(restricted in physically strenuous activity but ambulatory).|Participants|Number|13|13.0||||||
4282538|NCT00558636|4106795|B2|Grade 0: Fully active||Eastern Cooperative Oncology Group (ECOG) performance status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. The scale ranges from 0 (fully active) to 5 (dead). Subjects entering this study must have had an ECOG score of 0 or 1(restricted in physically strenuous activity but ambulatory).|Participants|Number|5|5.0||||||
4282539|NCT00558636|4106796|B1|Grade 0: Fully active||Eastern Cooperative Oncology Group (ECOG) performance status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. The scale ranges from 0 (fully active) to 5 (dead). Subjects entering this study must have had an ECOG score of 0 or 1(restricted in physically strenuous activity but ambulatory).|Participants|Number|8|8.0||||||
4282540|NCT00558636|4106794|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4282541|NCT00558636|4106795|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4282542|NCT00558636|4106796|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4282543|NCT00558636|4106794|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4282544|NCT00558636|4106795|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4282545|NCT00558636|4106796|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4282546|NCT00558636|4106794|B3|||Age||years|Mean|55.8|55.8|Standard Deviation|11.0|11.0|||
4282547|NCT00558636|4106795|B2|||Age||years|Mean|55.4|55.4|Standard Deviation|12.6|12.6|||
4282548|NCT00558636|4106796|B1|||Age||years|Mean|56.2|56.2|Standard Deviation|9.3|9.3|||
4282549|NCT00558636|4106794|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4282550|NCT00558636|4106795|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4282551|NCT00558636|4106796|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4282552|NCT00558636|4106794|B3||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4282553|NCT00558636|4106795|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4282554|NCT00558636|4106796|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4282555|NCT00558636|4106794|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4282556|NCT00558636|4106795|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4282557|NCT00558636|4106796|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4282558|NCT00558571|4106815|B5||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4282559|NCT00558571|4106816|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4282560|NCT00558571|4106817|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4282561|NCT00558571|4106818|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4282562|NCT00558571|4106819|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4282563|NCT00558571|4106815|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4282564|NCT00558571|4106816|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4282565|NCT00558571|4106817|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4282566|NCT00558571|4106818|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4282567|NCT00558571|4106819|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4282568|NCT00558571|4106815|B5|||Age||years|Mean|56.7|56.7|Standard Deviation|8.7|8.7|||
4282569|NCT00558571|4106816|B4|||Age||years|Mean|56.5|56.5|Standard Deviation|8.2|8.2|||
4282570|NCT00558571|4106817|B3|||Age||years|Mean|56.1|56.1|Standard Deviation|8.5|8.5|||
4282571|NCT00558571|4106818|B2|||Age||years|Mean|56.8|56.8|Standard Deviation|8.7|8.7|||
4282572|NCT00558571|4106819|B1|||Age||years|Mean|57.7|57.7|Standard Deviation|10.4|10.4|||
4282573|NCT00558558|4106897|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4282574|NCT00558558|4106897|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4282575|NCT00558558|4106897|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4282576|NCT00558558|4106897|B1|||Age||years|Mean|59|59.0|Full Range|||50.0|61.0|
4282577|NCT00558467|4106901|B3|||Weight||kilograms|Mean|53.21|53.21|Standard Deviation|21.05|21.05|||
4282578|NCT00558467|4106902|B2|||Weight||kilograms|Mean|55.87|55.87|Standard Deviation|20.64|20.64|||
4282579|NCT00558467|4106903|B1|||Weight||kilograms|Mean|47.48|47.48|Standard Deviation|21.29|21.29|||
4282580|NCT00558467|4106901|B3|||Height||centimeters|Mean|153.8|153.8|Standard Deviation|18|18.0|||
4282581|NCT00558467|4106902|B2|||Height||centimeters|Mean|155.3|155.3|Standard Deviation|16.2|16.2|||
4282582|NCT00558467|4106903|B1|||Height||centimeters|Mean|150.7|150.7|Standard Deviation|21.6|21.6|||
4282583|NCT00558467|4106901|B3|||Body Mass Index||kilograms/(meters squared)|Mean|21.784|21.784|Standard Deviation|5.632|5.632|||
4282584|NCT00558467|4106902|B2|||Body Mass Index||kilograms/(meters squared)|Mean|22.575|22.575|Standard Deviation|5.656|5.656|||
4282585|NCT00558467|4106903|B1|||Body Mass Index||kilograms/(meters squared)|Mean|20.085|20.085|Standard Deviation|5.324|5.324|||
4282586|NCT00558467|4106901|B3|White||Race, Customized||participants|Number|57|57.0||||||
4282587|NCT00558467|4106902|B2|White||Race, Customized||participants|Number|39|39.0||||||
4282588|NCT00558467|4106903|B1|White||Race, Customized||participants|Number|18|18.0||||||
4282589|NCT00558467|4106901|B3|Black/African American||Race, Customized||participants|Number|6|6.0||||||
4282590|NCT00558467|4106902|B2|Black/African American||Race, Customized||participants|Number|4|4.0||||||
4282592|NCT00558467|4106901|B3|Positive||Obsessive Compulsive Disorder|Diagnosis of disorder was performed using National Institute of Mental Health Diagnostic Interview Schedule for Children (NIMH DISC IV) and resulted in patients being classified as negative, intermediate and positive for disorder.|participants|Number|6|6.0||||||
4282593|NCT00558467|4106902|B2|Positive||Obsessive Compulsive Disorder|Diagnosis of disorder was performed using National Institute of Mental Health Diagnostic Interview Schedule for Children (NIMH DISC IV) and resulted in patients being classified as negative, intermediate and positive for disorder.|participants|Number|3|3.0||||||
4282594|NCT00558467|4106903|B1|Positive||Obsessive Compulsive Disorder|Diagnosis of disorder was performed using National Institute of Mental Health Diagnostic Interview Schedule for Children (NIMH DISC IV) and resulted in patients being classified as negative, intermediate and positive for disorder.|participants|Number|3|3.0||||||
4282595|NCT00558467|4106901|B3|Negative||Obsessive Compulsive Disorder|Diagnosis of disorder was performed using National Institute of Mental Health Diagnostic Interview Schedule for Children (NIMH DISC IV) and resulted in patients being classified as negative, intermediate and positive for disorder.|participants|Number|53|53.0||||||
4282596|NCT00558467|4106902|B2|Negative||Obsessive Compulsive Disorder|Diagnosis of disorder was performed using National Institute of Mental Health Diagnostic Interview Schedule for Children (NIMH DISC IV) and resulted in patients being classified as negative, intermediate and positive for disorder.|participants|Number|37|37.0||||||
4282597|NCT00558467|4106903|B1|Negative||Obsessive Compulsive Disorder|Diagnosis of disorder was performed using National Institute of Mental Health Diagnostic Interview Schedule for Children (NIMH DISC IV) and resulted in patients being classified as negative, intermediate and positive for disorder.|participants|Number|16|16.0||||||
4282598|NCT00558467|4106901|B3|Intermediate||Obsessive Compulsive Disorder|Diagnosis of disorder was performed using National Institute of Mental Health Diagnostic Interview Schedule for Children (NIMH DISC IV) and resulted in patients being classified as negative, intermediate and positive for disorder.|participants|Number|4|4.0||||||
4282599|NCT00558467|4106902|B2|Intermediate||Obsessive Compulsive Disorder|Diagnosis of disorder was performed using National Institute of Mental Health Diagnostic Interview Schedule for Children (NIMH DISC IV) and resulted in patients being classified as negative, intermediate and positive for disorder.|participants|Number|3|3.0||||||
4282600|NCT00558467|4106903|B1|Intermediate||Obsessive Compulsive Disorder|Diagnosis of disorder was performed using National Institute of Mental Health Diagnostic Interview Schedule for Children (NIMH DISC IV) and resulted in patients being classified as negative, intermediate and positive for disorder.|participants|Number|1|1.0||||||
4282601|NCT00558467|4106901|B3|Not Hispanic/Latino||Ethnicity, Customized||Number of Patients|Number|56|56.0||||||
4282602|NCT00558467|4106902|B2|Not Hispanic/Latino||Ethnicity, Customized||Number of Patients|Number|38|38.0||||||
4282603|NCT00558467|4106903|B1|Not Hispanic/Latino||Ethnicity, Customized||Number of Patients|Number|18|18.0||||||
4282604|NCT00558467|4106901|B3|Hispanic/Latino||Ethnicity, Customized||Number of Patients|Number|7|7.0||||||
4282605|NCT00558467|4106902|B2|Hispanic/Latino||Ethnicity, Customized||Number of Patients|Number|5|5.0||||||
4282606|NCT00558467|4106903|B1|Hispanic/Latino||Ethnicity, Customized||Number of Patients|Number|2|2.0||||||
4282607|NCT00558467|4106901|B3|More than 5 years||Duration of Tourettes syndrome||participants|Number|16|16.0||||||
4282608|NCT00558467|4106902|B2|More than 5 years||Duration of Tourettes syndrome||participants|Number|12|12.0||||||
4282609|NCT00558467|4106903|B1|More than 5 years||Duration of Tourettes syndrome||participants|Number|4|4.0||||||
4282610|NCT00558467|4106901|B3|Less than 1 years||Duration of Tourettes syndrome||participants|Number|18|18.0||||||
4282611|NCT00558467|4106902|B2|Less than 1 years||Duration of Tourettes syndrome||participants|Number|12|12.0||||||
4282612|NCT00558467|4106903|B1|Less than 1 years||Duration of Tourettes syndrome||participants|Number|6|6.0||||||
4282613|NCT00558467|4106901|B3|1-5 years||Duration of Tourettes syndrome||participants|Number|29|29.0||||||
4282614|NCT00558467|4106902|B2|1-5 years||Duration of Tourettes syndrome||participants|Number|19|19.0||||||
4282615|NCT00558467|4106903|B1|1-5 years||Duration of Tourettes syndrome||participants|Number|10|10.0||||||
4282616|NCT00558467|4106901|B3|Positive||Attention Deficit Hyperactive Disorder|Diagnosis of disorder was performed using National Institute of Mental Health Diagnostic Interview Schedule for Children (NIMH DISC IV) and resulted in patients being classified as negative diagnosis, intermediate diagnosis and positive diagnosis for disorder.|Number of Patients|Number|23|23.0||||||
4282617|NCT00558467|4106902|B2|Positive||Attention Deficit Hyperactive Disorder|Diagnosis of disorder was performed using National Institute of Mental Health Diagnostic Interview Schedule for Children (NIMH DISC IV) and resulted in patients being classified as negative diagnosis, intermediate diagnosis and positive diagnosis for disorder.|Number of Patients|Number|15|15.0||||||
4282618|NCT00558467|4106903|B1|Positive||Attention Deficit Hyperactive Disorder|Diagnosis of disorder was performed using National Institute of Mental Health Diagnostic Interview Schedule for Children (NIMH DISC IV) and resulted in patients being classified as negative diagnosis, intermediate diagnosis and positive diagnosis for disorder.|Number of Patients|Number|8|8.0||||||
4282619|NCT00558467|4106901|B3|Negative||Attention Deficit Hyperactive Disorder|Diagnosis of disorder was performed using National Institute of Mental Health Diagnostic Interview Schedule for Children (NIMH DISC IV) and resulted in patients being classified as negative diagnosis, intermediate diagnosis and positive diagnosis for disorder.|Number of Patients|Number|31|31.0||||||
4282620|NCT00558467|4106902|B2|Negative||Attention Deficit Hyperactive Disorder|Diagnosis of disorder was performed using National Institute of Mental Health Diagnostic Interview Schedule for Children (NIMH DISC IV) and resulted in patients being classified as negative diagnosis, intermediate diagnosis and positive diagnosis for disorder.|Number of Patients|Number|22|22.0||||||
4282621|NCT00558467|4106903|B1|Negative||Attention Deficit Hyperactive Disorder|Diagnosis of disorder was performed using National Institute of Mental Health Diagnostic Interview Schedule for Children (NIMH DISC IV) and resulted in patients being classified as negative diagnosis, intermediate diagnosis and positive diagnosis for disorder.|Number of Patients|Number|9|9.0||||||
4282676|NCT00558285|4107061|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4282677|NCT00558285|4107062|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4282622|NCT00558467|4106901|B3|Intermediate||Attention Deficit Hyperactive Disorder|Diagnosis of disorder was performed using National Institute of Mental Health Diagnostic Interview Schedule for Children (NIMH DISC IV) and resulted in patients being classified as negative diagnosis, intermediate diagnosis and positive diagnosis for disorder.|Number of Patients|Number|9|9.0||||||
4282623|NCT00558467|4106902|B2|Intermediate||Attention Deficit Hyperactive Disorder|Diagnosis of disorder was performed using National Institute of Mental Health Diagnostic Interview Schedule for Children (NIMH DISC IV) and resulted in patients being classified as negative diagnosis, intermediate diagnosis and positive diagnosis for disorder.|Number of Patients|Number|6|6.0||||||
4282624|NCT00558467|4106903|B1|Intermediate||Attention Deficit Hyperactive Disorder|Diagnosis of disorder was performed using National Institute of Mental Health Diagnostic Interview Schedule for Children (NIMH DISC IV) and resulted in patients being classified as negative diagnosis, intermediate diagnosis and positive diagnosis for disorder.|Number of Patients|Number|3|3.0||||||
4282625|NCT00558467|4106901|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4282626|NCT00558467|4106902|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4282627|NCT00558467|4106903|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4282628|NCT00558467|4106901|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4282629|NCT00558467|4106902|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4282630|NCT00558467|4106903|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4282631|NCT00558467|4106901|B3|||Age||Years|Mean|11.8|11.8|Standard Deviation|2.7|2.7|||
4282632|NCT00558467|4106902|B2|||Age||Years|Mean|12.2|12.2|Standard Deviation|2.4|2.4|||
4282633|NCT00558467|4106903|B1|||Age||Years|Mean|11.1|11.1|Standard Deviation|3.2|3.2|||
4282634|NCT00558428|4106960|B5||Male|Sex: Female, Male||Participants|Count of Participants|682|682.0||||||
4282635|NCT00558428|4106961|B4||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4282636|NCT00558428|4106962|B3||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4282637|NCT00558428|4106963|B2||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4282638|NCT00558428|4106964|B1||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4282639|NCT00558428|4106960|B5||Female|Sex: Female, Male||Participants|Count of Participants|415|415.0||||||
4282640|NCT00558428|4106961|B4||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4282641|NCT00558428|4106962|B3||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4282642|NCT00558428|4106963|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4282643|NCT00558428|4106964|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4282644|NCT00558428|4106960|B5|||Age||Years|Mean|54.2|54.2|Standard Deviation|10.6|10.6|||
4282645|NCT00558428|4106961|B4|||Age||Years|Mean|54.5|54.5|Standard Deviation|10.2|10.2|||
4282646|NCT00558428|4106962|B3|||Age||Years|Mean|53.9|53.9|Standard Deviation|11|11.0|||
4282647|NCT00558428|4106963|B2|||Age||Years|Mean|54.3|54.3|Standard Deviation|10.6|10.6|||
4282648|NCT00558428|4106964|B1|||Age||Years|Mean|54|54.0|Standard Deviation|10.6|10.6|||
4282649|NCT00558363|4107005|B3|Asian – Central/Soth Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4282650|NCT00558363|4107006|B2|Asian – Central/Soth Asian Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4282651|NCT00558363|4107007|B1|Asian – Central/Soth Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4282652|NCT00558363|4107005|B3|White – Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4282653|NCT00558363|4107006|B2|White – Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4282654|NCT00558363|4107007|B1|White – Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4282655|NCT00558363|4107005|B3|White – Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|292|292.0||||||
4282656|NCT00558363|4107006|B2|White – Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|147|147.0||||||
4282657|NCT00558363|4107007|B1|White – Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|145|145.0||||||
4282658|NCT00558363|4107005|B3||Male|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
4282659|NCT00558363|4107006|B2||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4282660|NCT00558363|4107007|B1||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4282661|NCT00558363|4107005|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4282662|NCT00558363|4107006|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4282663|NCT00558363|4107007|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4282664|NCT00558363|4107005|B3|||Age||Years|Mean|69.1|69.1|Standard Deviation|6.17|6.17|||
4282665|NCT00558363|4107006|B2|||Age||Years|Mean|69.7|69.7|Standard Deviation|5.76|5.76|||
4282666|NCT00558363|4107007|B1|||Age||Years|Mean|68.6|68.6|Standard Deviation|6.53|6.53|||
4282667|NCT00558285|4107058|B6||Male|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4282668|NCT00558285|4107059|B5||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4282669|NCT00558285|4107060|B4||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4282670|NCT00558285|4107061|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4282671|NCT00558285|4107062|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4282672|NCT00558285|4107063|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4282673|NCT00558285|4107058|B6||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4282674|NCT00558285|4107059|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4282675|NCT00558285|4107060|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4282678|NCT00558285|4107063|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4282679|NCT00558285|4107058|B6|||Age|Overall Number of Baseline Participants is based on the Safety Population|years|Mean|63.8|63.8|Standard Deviation|9.19|9.19|||
4282680|NCT00558285|4107059|B5|||Age|Overall Number of Baseline Participants is based on the Safety Population|years|Mean|64.3|64.3|Standard Deviation|8.95|8.95|||
4282681|NCT00558285|4107060|B4|||Age|Overall Number of Baseline Participants is based on the Safety Population|years|Mean|64.5|64.5|Standard Deviation|9.75|9.75|||
4282682|NCT00558285|4107061|B3|||Age|Overall Number of Baseline Participants is based on the Safety Population|years|Mean|60.9|60.9|Standard Deviation|8.58|8.58|||
4282683|NCT00558285|4107062|B2|||Age|Overall Number of Baseline Participants is based on the Safety Population|years|Mean|63.7|63.7|Standard Deviation|8.94|8.94|||
4282684|NCT00558285|4107063|B1|||Age|Overall Number of Baseline Participants is based on the Safety Population|years|Mean|65.7|65.7|Standard Deviation|9.34|9.34|||
4282685|NCT00558272|4107109|B3||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4282686|NCT00558272|4107110|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4282687|NCT00558272|4107111|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4282688|NCT00558272|4107109|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4282689|NCT00558272|4107110|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4282690|NCT00558272|4107111|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4282691|NCT00558272|4107109|B3|||Age||Years|Mean|67.4|67.4|Standard Deviation|10.07|10.07|||
4282692|NCT00558272|4107110|B2|||Age||Years|Mean|67.3|67.3|Standard Deviation|11.58|11.58|||
4282693|NCT00558272|4107111|B1|||Age||Years|Mean|67.6|67.6|Standard Deviation|8.35|8.35|||
4282694|NCT00558259|4107150|B3|||Body mass index (BMI) continuous||kg/m^2|Mean|28.43|28.43|Standard Deviation|5.50|5.5|||
4282695|NCT00558259|4107151|B2|||Body mass index (BMI) continuous||kg/m^2|Mean|28.41|28.41|Standard Deviation|5.56|5.56|||
4282696|NCT00558259|4107152|B1|||Body mass index (BMI) continuous||kg/m^2|Mean|28.45|28.45|Standard Deviation|5.44|5.44|||
4282697|NCT00558259|4107150|B3||Male|Sex: Female, Male||Participants|Count of Participants|745|745.0||||||
4282698|NCT00558259|4107151|B2||Male|Sex: Female, Male||Participants|Count of Participants|364|364.0||||||
4282699|NCT00558259|4107152|B1||Male|Sex: Female, Male||Participants|Count of Participants|381|381.0||||||
4282700|NCT00558259|4107150|B3||Female|Sex: Female, Male||Participants|Count of Participants|598|598.0||||||
4282701|NCT00558259|4107151|B2||Female|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
4282702|NCT00558259|4107152|B1||Female|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
4282703|NCT00558259|4107150|B3|||Age||Years|Mean|55.8|55.8|Standard Deviation|15.3|15.3|||
4282704|NCT00558259|4107151|B2|||Age||Years|Mean|55.5|55.5|Standard Deviation|15.1|15.1|||
4282705|NCT00558259|4107152|B1|||Age||Years|Mean|56.1|56.1|Standard Deviation|15.5|15.5|||
4282706|NCT00558246|4107173|B1|Sweden||Region of Enrollment||participants|Number|16|16.0||||||
4282707|NCT00558246|4107173|B1|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4282708|NCT00558246|4107173|B1|Germany||Region of Enrollment||participants|Number|47|47.0||||||
4282709|NCT00558246|4107173|B1|Belgium||Region of Enrollment||participants|Number|10|10.0||||||
4282710|NCT00558246|4107173|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4282711|NCT00558246|4107173|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4282712|NCT00558246|4107173|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4282713|NCT00558246|4107173|B1||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
4282714|NCT00558246|4107173|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4282715|NCT00558103|4107188|B6|American Indian or Alaska Native and Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4282716|NCT00558103|4107189|B5|American Indian or Alaska Native and Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4282717|NCT00558103|4107190|B4|American Indian or Alaska Native and Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4282718|NCT00558103|4107191|B3|American Indian or Alaska Native and Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4282719|NCT00558103|4107192|B2|American Indian or Alaska Native and Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4282720|NCT00558103|4107193|B1|American Indian or Alaska Native and Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4282721|NCT00558103|4107188|B6|White||Race/Ethnicity, Customized||participants|Number|97|97.0||||||
4282722|NCT00558103|4107189|B5|White||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4282723|NCT00558103|4107190|B4|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4282724|NCT00558103|4107191|B3|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4282725|NCT00558103|4107192|B2|White||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4282726|NCT00558103|4107193|B1|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4282727|NCT00558103|4107188|B6|Japanese/East Asian /South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4282728|NCT00558103|4107189|B5|Japanese/East Asian /South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4282729|NCT00558103|4107190|B4|Japanese/East Asian /South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4282730|NCT00558103|4107191|B3|Japanese/East Asian /South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4282731|NCT00558103|4107192|B2|Japanese/East Asian /South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4282732|NCT00558103|4107193|B1|Japanese/East Asian /South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4282733|NCT00558103|4107188|B6|Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4282734|NCT00558103|4107189|B5|Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4282735|NCT00558103|4107190|B4|Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4282736|NCT00558103|4107191|B3|Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4282737|NCT00558103|4107192|B2|Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4282738|NCT00558103|4107193|B1|Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4282739|NCT00558103|4107188|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4282740|NCT00558103|4107189|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4282741|NCT00558103|4107190|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4282742|NCT00558103|4107191|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4282743|NCT00558103|4107192|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4282744|NCT00558103|4107193|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4282745|NCT00558103|4107188|B6|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4282746|NCT00558103|4107189|B5|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4282747|NCT00558103|4107190|B4|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4282748|NCT00558103|4107191|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4282749|NCT00558103|4107192|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4282750|NCT00558103|4107193|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4282751|NCT00558103|4107188|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4282752|NCT00558103|4107189|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4282753|NCT00558103|4107190|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4282754|NCT00558103|4107191|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4282755|NCT00558103|4107192|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4282756|NCT00558103|4107193|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4282757|NCT00558103|4107188|B6||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4282758|NCT00558103|4107189|B5||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4282759|NCT00558103|4107190|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4282760|NCT00558103|4107191|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4282761|NCT00558103|4107192|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4282762|NCT00558103|4107193|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4282763|NCT00558103|4107188|B6|Years||Age||Years|Mean|53.0|53.0|Standard Deviation|11.31|11.31|||
4282764|NCT00558103|4107189|B5|Years||Age||Years|Mean|53.9|53.9|Standard Deviation|12.65|12.65|||
4282765|NCT00558103|4107190|B4|Years||Age||Years|Mean|54.7|54.7|Standard Deviation|12.26|12.26|||
4282766|NCT00558103|4107191|B3|Years||Age||Years|Mean|53.0|53.0|Standard Deviation|10.39|10.39|||
4282767|NCT00558103|4107192|B2|Years||Age||Years|Mean|52.4|52.4|Standard Deviation|12.84|12.84|||
4282768|NCT00558103|4107193|B1|Years||Age||Years|Mean|51.9|51.9|Standard Deviation|9.00|9.0|||
4282769|NCT00558064|4107226|B3||Male|Sex: Female, Male||Participants|Count of Participants|383|383.0||||||
4282770|NCT00558064|4107227|B2||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4282771|NCT00558064|4107228|B1||Male|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4282772|NCT00558064|4107226|B3||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4282773|NCT00558064|4107227|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4282774|NCT00558064|4107228|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4282775|NCT00558064|4107226|B3|||Age||years|Mean|56.5|56.5|Standard Deviation|9.7|9.7|||
4282776|NCT00558064|4107227|B2|||Age||years|Mean|56|56.0|Standard Deviation|9.9|9.9|||
4282777|NCT00558064|4107228|B1|||Age||years|Mean|57|57.0|Standard Deviation|9.6|9.6|||
4282778|NCT00558025|4107249|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4282779|NCT00558025|4107250|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4282780|NCT00558025|4107251|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4282781|NCT00558025|4107249|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4282782|NCT00558025|4107250|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4282783|NCT00558025|4107251|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4282784|NCT00558025|4107249|B3|||Age||Years|Mean|63.7|63.7|Standard Deviation|9.1|9.1|||
4282785|NCT00558025|4107250|B2|||Age||Years|Mean|63.5|63.5|Standard Deviation|9.7|9.7|||
4282786|NCT00558025|4107251|B1|||Age||Years|Mean|63.8|63.8|Standard Deviation|8.8|8.8|||
4282787|NCT00558012|4107274|B3|United States||Region of Enrollment||participants|Number|181|181.0||||||
4282788|NCT00558012|4107275|B2|United States||Region of Enrollment||participants|Number|92|92.0||||||
4282789|NCT00558012|4107276|B1|United States||Region of Enrollment||participants|Number|89|89.0||||||
4282790|NCT00558012|4107274|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4282791|NCT00558012|4107275|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4282792|NCT00558012|4107276|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4282793|NCT00558012|4107274|B3||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4282794|NCT00558012|4107275|B2||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4282795|NCT00558012|4107276|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4282796|NCT00558012|4107274|B3||>=65 years|Age||Participants|Count of Participants|181|181.0||||||
4282797|NCT00558012|4107275|B2||>=65 years|Age||Participants|Count of Participants|92|92.0||||||
4282798|NCT00558012|4107276|B1||>=65 years|Age||Participants|Count of Participants|89|89.0||||||
4282799|NCT00558012|4107274|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4282800|NCT00558012|4107275|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4282801|NCT00558012|4107276|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4282802|NCT00558012|4107274|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4282803|NCT00558012|4107275|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4282804|NCT00558012|4107276|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4282805|NCT00557947|4107283|B1|Sweden||Region of Enrollment||participants|Number|5|5.0||||||
4282806|NCT00557947|4107283|B1|United Kingdom||Region of Enrollment||participants|Number|20|20.0||||||
4282807|NCT00557947|4107283|B1|Germany||Region of Enrollment||participants|Number|36|36.0||||||
4282808|NCT00557947|4107283|B1|Belgium||Region of Enrollment||participants|Number|22|22.0||||||
4282809|NCT00557947|4107283|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4282810|NCT00557947|4107283|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4282811|NCT00557947|4107283|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4282812|NCT00557947|4107283|B1||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
4282813|NCT00557947|4107283|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4282814|NCT00557856|4107299|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4282815|NCT00557856|4107299|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4282816|NCT00557856|4107299|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|11.5|11.5|||
4282817|NCT00557830|4107503|B4|United States (Randomization Phase)||Region of Enrollment, Customized||participants|Number|6|6.0||||||
4282818|NCT00557830|4107504|B3|United States (Randomization Phase)||Region of Enrollment, Customized||participants|Number|2|2.0||||||
4282819|NCT00557830|4107505|B2|United States (Randomization Phase)||Region of Enrollment, Customized||participants|Number|4|4.0||||||
4282820|NCT00557830|4107506|B1|United States (Randomization Phase)||Region of Enrollment, Customized||participants|Number|NA|||||||Region for screening population only
4282821|NCT00557830|4107503|B4|United States (Screening Treatment Phase)||Region of Enrollment, Customized||participants|Number|12|12.0||||||
4282822|NCT00557830|4107504|B3|United States (Screening Treatment Phase)||Region of Enrollment, Customized||participants|Number|NA|||||||Region for randomization population only
4282823|NCT00557830|4107505|B2|United States (Screening Treatment Phase)||Region of Enrollment, Customized||participants|Number|NA|||||||Region for randomization population only
4282824|NCT00557830|4107506|B1|United States (Screening Treatment Phase)||Region of Enrollment, Customized||participants|Number|12|12.0||||||
4282825|NCT00557830|4107503|B4|United States||Region of Enrollment||participants|Number|0|0.0||||||
4282826|NCT00557830|4107504|B3|United States||Region of Enrollment||participants|Number|NA|||||||See Customized Region of Enrollment Table
4282827|NCT00557830|4107505|B2|United States||Region of Enrollment||participants|Number|NA|||||||See Customized Region of Enrollment Table
4282828|NCT00557830|4107506|B1|United States||Region of Enrollment||participants|Number|NA|||||||See Customized Region of Enrollment Table
4282829|NCT00557830|4107503|B4|Male (Randomization Phase)||Sex/Gender, Customized||Participants|Number|4|4.0||||||
4282830|NCT00557830|4107504|B3|Male (Randomization Phase)||Sex/Gender, Customized||Participants|Number|2|2.0||||||
4282831|NCT00557830|4107505|B2|Male (Randomization Phase)||Sex/Gender, Customized||Participants|Number|2|2.0||||||
4282832|NCT00557830|4107506|B1|Male (Randomization Phase)||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4282833|NCT00557830|4107503|B4|Female (Randomization Phase)||Sex/Gender, Customized||Participants|Number|2|2.0||||||
4282834|NCT00557830|4107504|B3|Female (Randomization Phase)||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4282835|NCT00557830|4107505|B2|Female (Randomization Phase)||Sex/Gender, Customized||Participants|Number|2|2.0||||||
4282836|NCT00557830|4107506|B1|Female (Randomization Phase)||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4282837|NCT00557830|4107503|B4|Male (Screening Treatment Phase)||Sex/Gender, Customized||Participants|Number|9|9.0||||||
4282838|NCT00557830|4107504|B3|Male (Screening Treatment Phase)||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4282839|NCT00557830|4107505|B2|Male (Screening Treatment Phase)||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4282840|NCT00557830|4107506|B1|Male (Screening Treatment Phase)||Sex/Gender, Customized||Participants|Number|9|9.0||||||
4282841|NCT00557830|4107503|B4|Female (Screening Treatment Phase)||Sex/Gender, Customized||Participants|Number|3|3.0||||||
4282842|NCT00557830|4107504|B3|Female (Screening Treatment Phase)||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4282843|NCT00557830|4107505|B2|Female (Screening Treatment Phase)||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4282844|NCT00557830|4107506|B1|Female (Screening Treatment Phase)||Sex/Gender, Customized||Participants|Number|3|3.0||||||
4282845|NCT00557830|4107503|B4|Randomization Phase||Age||years|Mean|63.5|63.5|Standard Deviation|7.18|7.18|||
4282846|NCT00557830|4107504|B3|Randomization Phase||Age||years|Mean|58.5|58.5|Standard Deviation|7.78|7.78|||
4282847|NCT00557830|4107505|B2|Randomization Phase||Age||years|Mean|66.0|66.0|Standard Deviation|6.38|6.38|||
4282848|NCT00557830|4107506|B1|Randomization Phase||Age||years|Mean|NA||Standard Deviation|NA||||Age for randomization population only.
4282849|NCT00557830|4107503|B4|Screening Treatment Phase||Age||years|Mean|62.2|62.2|Standard Deviation|10.99|10.99|||
4282850|NCT00557830|4107504|B3|Screening Treatment Phase||Age||years|Mean|NA||Standard Deviation|NA||||Age for screening population only.
4282851|NCT00557830|4107505|B2|Screening Treatment Phase||Age||years|Mean|NA||Standard Deviation|NA||||Age for screening population only
4282852|NCT00557830|4107506|B1|Screening Treatment Phase||Age||years|Mean|62.2|62.2|Standard Deviation|10.99|10.99|||
4282853|NCT00557622|4107528|B3|54 weeks||The number of participants with an MVA(Motor Vehicle Accident) of a particular duration|The number of participants who experienced a MVA of various durations with severe or potentially severe physical injury more than 3 months ago|participants|Number|1|1.0||||||
4282854|NCT00557622|4107529|B2|54 weeks||The number of participants with an MVA(Motor Vehicle Accident) of a particular duration|The number of participants who experienced a MVA of various durations with severe or potentially severe physical injury more than 3 months ago|participants|Number|0|0.0||||||
4282855|NCT00557622|4107530|B1|54 weeks||The number of participants with an MVA(Motor Vehicle Accident) of a particular duration|The number of participants who experienced a MVA of various durations with severe or potentially severe physical injury more than 3 months ago|participants|Number|1|1.0||||||
4282856|NCT00557622|4107528|B3|25 weeks||The number of participants with an MVA(Motor Vehicle Accident) of a particular duration|The number of participants who experienced a MVA of various durations with severe or potentially severe physical injury more than 3 months ago|participants|Number|1|1.0||||||
4282857|NCT00557622|4107529|B2|25 weeks||The number of participants with an MVA(Motor Vehicle Accident) of a particular duration|The number of participants who experienced a MVA of various durations with severe or potentially severe physical injury more than 3 months ago|participants|Number|1|1.0||||||
4282858|NCT00557622|4107530|B1|25 weeks||The number of participants with an MVA(Motor Vehicle Accident) of a particular duration|The number of participants who experienced a MVA of various durations with severe or potentially severe physical injury more than 3 months ago|participants|Number|0|0.0||||||
4282859|NCT00557622|4107528|B3|23 weeks||The number of participants with an MVA(Motor Vehicle Accident) of a particular duration|The number of participants who experienced a MVA of various durations with severe or potentially severe physical injury more than 3 months ago|participants|Number|1|1.0||||||
4282860|NCT00557622|4107529|B2|23 weeks||The number of participants with an MVA(Motor Vehicle Accident) of a particular duration|The number of participants who experienced a MVA of various durations with severe or potentially severe physical injury more than 3 months ago|participants|Number|1|1.0||||||
4282861|NCT00557622|4107530|B1|23 weeks||The number of participants with an MVA(Motor Vehicle Accident) of a particular duration|The number of participants who experienced a MVA of various durations with severe or potentially severe physical injury more than 3 months ago|participants|Number|0|0.0||||||
4282862|NCT00557622|4107528|B3|Asian-Japanese Heritage||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4282863|NCT00557622|4107529|B2|Asian-Japanese Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4282864|NCT00557622|4107530|B1|Asian-Japanese Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4282865|NCT00557622|4107528|B3||Male|Gender||Participants|Count of Participants|2|2.0||||||
4282866|NCT00557622|4107529|B2||Male|Gender||Participants|Count of Participants|1|1.0||||||
4282867|NCT00557622|4107530|B1||Male|Gender||Participants|Count of Participants|1|1.0||||||
4282868|NCT00557622|4107528|B3||Female|Gender||Participants|Count of Participants|1|1.0||||||
4282869|NCT00557622|4107529|B2||Female|Gender||Participants|Count of Participants|1|1.0||||||
4282870|NCT00557622|4107530|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
4282871|NCT00557622|4107528|B3|48 years old||Age, Customized||participants|Number|1|1.0||||||
4282872|NCT00557622|4107529|B2|48 years old||Age, Customized||participants|Number|1|1.0||||||
4282873|NCT00557622|4107530|B1|48 years old||Age, Customized||participants|Number|0|0.0||||||
4282874|NCT00557622|4107528|B3|43 years old||Age, Customized||participants|Number|1|1.0||||||
4282875|NCT00557622|4107529|B2|43 years old||Age, Customized||participants|Number|1|1.0||||||
4282876|NCT00557622|4107530|B1|43 years old||Age, Customized||participants|Number|0|0.0||||||
4282877|NCT00557622|4107528|B3|39 years old||Age, Customized||participants|Number|1|1.0||||||
4282878|NCT00557622|4107529|B2|39 years old||Age, Customized||participants|Number|0|0.0||||||
4282879|NCT00557622|4107530|B1|39 years old||Age, Customized||participants|Number|1|1.0||||||
4282880|NCT00557505|4107551|B10||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4282881|NCT00557505|4107552|B9||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4282882|NCT00557505|4107553|B8||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4282883|NCT00557505|4107554|B7||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4282884|NCT00557505|4107555|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4282885|NCT00557505|4107556|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4282886|NCT00557505|4107557|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4282887|NCT00557505|4107558|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4282888|NCT00557505|4107559|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4282889|NCT00557505|4107560|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4282890|NCT00557505|4107551|B10||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4282891|NCT00557505|4107552|B9||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4282892|NCT00557505|4107553|B8||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4282893|NCT00557505|4107554|B7||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4282894|NCT00557505|4107555|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4282895|NCT00557505|4107556|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4282896|NCT00557505|4107557|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4282897|NCT00557505|4107558|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4282898|NCT00557505|4107559|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4282899|NCT00557505|4107560|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4282900|NCT00557505|4107551|B10|Equal to or greater than 65 years||Age, Customized||participants|Number|11|11.0||||||
4282901|NCT00557505|4107552|B9|Equal to or greater than 65 years||Age, Customized||participants|Number|3|3.0||||||
4282902|NCT00557505|4107553|B8|Equal to or greater than 65 years||Age, Customized||participants|Number|1|1.0||||||
4282903|NCT00557505|4107554|B7|Equal to or greater than 65 years||Age, Customized||participants|Number|2|2.0||||||
4282904|NCT00557505|4107555|B6|Equal to or greater than 65 years||Age, Customized||participants|Number|1|1.0||||||
4282905|NCT00557505|4107556|B5|Equal to or greater than 65 years||Age, Customized||participants|Number|0|0.0||||||
4282906|NCT00557505|4107557|B4|Equal to or greater than 65 years||Age, Customized||participants|Number|0|0.0||||||
4282907|NCT00557505|4107558|B3|Equal to or greater than 65 years||Age, Customized||participants|Number|1|1.0||||||
4282908|NCT00557505|4107559|B2|Equal to or greater than 65 years||Age, Customized||participants|Number|1|1.0||||||
4282909|NCT00557505|4107560|B1|Equal to or greater than 65 years||Age, Customized||participants|Number|2|2.0||||||
4282910|NCT00557505|4107551|B10|45 to 64 years||Age, Customized||participants|Number|27|27.0||||||
4282911|NCT00557505|4107552|B9|45 to 64 years||Age, Customized||participants|Number|13|13.0||||||
4282912|NCT00557505|4107553|B8|45 to 64 years||Age, Customized||participants|Number|3|3.0||||||
4282913|NCT00557505|4107554|B7|45 to 64 years||Age, Customized||participants|Number|1|1.0||||||
4282914|NCT00557505|4107555|B6|45 to 64 years||Age, Customized||participants|Number|1|1.0||||||
4282915|NCT00557505|4107556|B5|45 to 64 years||Age, Customized||participants|Number|2|2.0||||||
4282916|NCT00557505|4107557|B4|45 to 64 years||Age, Customized||participants|Number|2|2.0||||||
4282917|NCT00557505|4107558|B3|45 to 64 years||Age, Customized||participants|Number|3|3.0||||||
4282918|NCT00557505|4107559|B2|45 to 64 years||Age, Customized||participants|Number|1|1.0||||||
4282919|NCT00557505|4107560|B1|45 to 64 years||Age, Customized||participants|Number|1|1.0||||||
4282920|NCT00557505|4107551|B10|18 to 44 years||Age, Customized||participants|Number|5|5.0||||||
4282921|NCT00557505|4107552|B9|18 to 44 years||Age, Customized||participants|Number|1|1.0||||||
4282922|NCT00557505|4107553|B8|18 to 44 years||Age, Customized||participants|Number|1|1.0||||||
4282923|NCT00557505|4107554|B7|18 to 44 years||Age, Customized||participants|Number|0|0.0||||||
4282924|NCT00557505|4107555|B6|18 to 44 years||Age, Customized||participants|Number|1|1.0||||||
4282925|NCT00557505|4107556|B5|18 to 44 years||Age, Customized||participants|Number|0|0.0||||||
4282926|NCT00557505|4107557|B4|18 to 44 years||Age, Customized||participants|Number|1|1.0||||||
4282927|NCT00557505|4107558|B3|18 to 44 years||Age, Customized||participants|Number|0|0.0||||||
4282928|NCT00557505|4107559|B2|18 to 44 years||Age, Customized||participants|Number|1|1.0||||||
4282929|NCT00557505|4107560|B1|18 to 44 years||Age, Customized||participants|Number|0|0.0||||||
4282930|NCT00557492|4107732|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4282931|NCT00557492|4107732|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4282932|NCT00557492|4107732|B1|||Age||years|Median|60|60.0|Full Range|||37.0|74.0|
4282933|NCT00557466|4107744|B7||Male|Sex: Female, Male||Participants|Count of Participants|399|399.0||||||
4282934|NCT00557466|4107745|B6||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4282935|NCT00557466|4107746|B5||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4282936|NCT00557466|4107747|B4||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4282937|NCT00557466|4107748|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4282938|NCT00557466|4107749|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4282939|NCT00557466|4107750|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4282940|NCT00557466|4107744|B7||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4282941|NCT00557466|4107745|B6||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4282942|NCT00557466|4107746|B5||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4282943|NCT00557466|4107747|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4282944|NCT00557466|4107748|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4282945|NCT00557466|4107749|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4282946|NCT00557466|4107750|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4282947|NCT00557466|4107744|B7|||Age|Total number of baseline participants is based on the Intent to Treat Population|years|Mean|62.1|62.1|Standard Deviation|8.58|8.58|||
4282948|NCT00557466|4107745|B6|||Age|Total number of baseline participants is based on the Intent to Treat Population|years|Mean|62.2|62.2|Standard Deviation|8.84|8.84|||
4282949|NCT00557466|4107746|B5|||Age|Total number of baseline participants is based on the Intent to Treat Population|years|Mean|63.3|63.3|Standard Deviation|8.36|8.36|||
4282950|NCT00557466|4107747|B4|||Age|Total number of baseline participants is based on the Intent to Treat Population|years|Mean|61.9|61.9|Standard Deviation|8.48|8.48|||
4282951|NCT00557466|4107748|B3|||Age|Total number of baseline participants is based on the Intent to Treat Population|years|Mean|61.6|61.6|Standard Deviation|8.68|8.68|||
4282952|NCT00557466|4107749|B2|||Age|Total number of baseline participants is based on the Intent to Treat Population|years|Mean|61.6|61.6|Standard Deviation|9.51|9.51|||
4282953|NCT00557466|4107750|B1|||Age|Total number of baseline participants is based on the Intent to Treat Population|years|Mean|62.1|62.1|Standard Deviation|7.69|7.69|||
4282954|NCT00557440|4107805|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4282955|NCT00557440|4107806|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4282956|NCT00557440|4107807|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4282957|NCT00557440|4107808|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4282958|NCT00557440|4107805|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4282959|NCT00557440|4107806|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4282960|NCT00557440|4107807|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4282961|NCT00557440|4107808|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4282962|NCT00557440|4107805|B4|||Age||years|Mean|47.9|47.9|Standard Deviation|13.51|13.51|||
4282963|NCT00557440|4107806|B3|||Age||years|Mean|52.5|52.5|Standard Deviation|10.46|10.46|||
4282964|NCT00557440|4107807|B2|||Age||years|Mean|50.5|50.5|Standard Deviation|12.00|12.0|||
4282965|NCT00557440|4107808|B1|||Age||years|Mean|40.2|40.2|Standard Deviation|15.37|15.37|||
4282966|NCT00557362|4107830|B5|||Enrollment logMAR BSCVA|Best spectacle-corrected visual acuity at time of enrollment measured in logMAR|logMAR|Mean|0.93|0.93|Standard Deviation|0.64|0.64|||
4282967|NCT00557362|4107831|B4|||Enrollment logMAR BSCVA|Best spectacle-corrected visual acuity at time of enrollment measured in logMAR|logMAR|Mean|0.94|0.94|Standard Deviation|0.61|0.61|||
4282968|NCT00557362|4107832|B3|||Enrollment logMAR BSCVA|Best spectacle-corrected visual acuity at time of enrollment measured in logMAR|logMAR|Mean|0.87|0.87|Standard Deviation|0.67|0.67|||
4282969|NCT00557362|4107833|B2|||Enrollment logMAR BSCVA|Best spectacle-corrected visual acuity at time of enrollment measured in logMAR|logMAR|Mean|0.96|0.96|Standard Deviation|0.66|0.66|||
4282970|NCT00557362|4107834|B1|||Enrollment logMAR BSCVA|Best spectacle-corrected visual acuity at time of enrollment measured in logMAR|logMAR|Mean|0.94|0.94|Standard Deviation|0.66|0.66|||
4282971|NCT00557362|4107830|B5|India||Region of Enrollment||participants|Number|120|120.0||||||
4282972|NCT00557362|4107831|B4|India||Region of Enrollment||participants|Number|30|30.0||||||
4282973|NCT00557362|4107832|B3|India||Region of Enrollment||participants|Number|30|30.0||||||
4282974|NCT00557362|4107833|B2|India||Region of Enrollment||participants|Number|30|30.0||||||
4282975|NCT00557362|4107834|B1|India||Region of Enrollment||participants|Number|30|30.0||||||
4282976|NCT00557362|4107830|B5||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4282977|NCT00557362|4107831|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4282978|NCT00557362|4107832|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4282979|NCT00557362|4107833|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4282980|NCT00557362|4107834|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4282981|NCT00557362|4107830|B5||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4282982|NCT00557362|4107831|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4282983|NCT00557362|4107832|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4282984|NCT00557362|4107833|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4282985|NCT00557362|4107834|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4282986|NCT00557362|4107830|B5|||Age||years|Mean|46.93|46.93|Standard Deviation|13.72|13.72|||
4282987|NCT00557362|4107831|B4|||Age||years|Mean|45.9|45.9|Standard Deviation|13.1|13.1|||
4282988|NCT00557362|4107832|B3|||Age||years|Mean|49.8|49.8|Standard Deviation|11.9|11.9|||
4282989|NCT00557362|4107833|B2|||Age||years|Mean|45.0|45.0|Standard Deviation|14.5|14.5|||
4282990|NCT00557362|4107834|B1|||Age||years|Mean|47.0|47.0|Standard Deviation|14.5|14.5|||
4282991|NCT00557349|4107853|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4282992|NCT00557349|4107854|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4282993|NCT00557349|4107855|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4282994|NCT00557349|4107853|B3|Female||Sex/Gender, Customized|Gender information is missing for the Famotidine arm.|participants|Number|14|14.0||||||
4282995|NCT00557349|4107854|B2|Female||Sex/Gender, Customized|Gender information is missing for the Famotidine arm.|participants|Number|0|0.0||||||
4282996|NCT00557349|4107855|B1|Female||Sex/Gender, Customized|Gender information is missing for the Famotidine arm.|participants|Number|14|14.0||||||
4282997|NCT00557349|4107853|B3|Male||Sex/Gender, Customized|Gender information is missing for the Famotidine arm.|participants|Number|8|8.0||||||
4282998|NCT00557349|4107854|B2|Male||Sex/Gender, Customized|Gender information is missing for the Famotidine arm.|participants|Number|0|0.0||||||
4282999|NCT00557349|4107855|B1|Male||Sex/Gender, Customized|Gender information is missing for the Famotidine arm.|participants|Number|8|8.0||||||
4283000|NCT00557349|4107853|B3|Unknown||Sex/Gender, Customized|Gender information is missing for the Famotidine arm.|participants|Number|18|18.0||||||
4283001|NCT00557349|4107854|B2|Unknown||Sex/Gender, Customized|Gender information is missing for the Famotidine arm.|participants|Number|18|18.0||||||
4283002|NCT00557349|4107855|B1|Unknown||Sex/Gender, Customized|Gender information is missing for the Famotidine arm.|participants|Number|0|0.0||||||
4283003|NCT00557349|4107853|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4283004|NCT00557349|4107854|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4283005|NCT00557349|4107855|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4283006|NCT00557349|4107853|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4283007|NCT00557349|4107854|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4283008|NCT00557349|4107855|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4283009|NCT00557349|4107853|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4283010|NCT00557349|4107854|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4283011|NCT00557349|4107855|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4283012|NCT00557323|4107864|B1|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4283013|NCT00557323|4107864|B1|Germany||Region of Enrollment||participants|Number|18|18.0||||||
4283014|NCT00557323|4107864|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4283015|NCT00557323|4107864|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4283016|NCT00557323|4107864|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4283017|NCT00557323|4107864|B1|||Age||participants|Mean|54.1|54.1|Standard Deviation|13.3|13.3|||
4283018|NCT00557310|4107869|B1|||Total Hip T-Score||units on a scale|Mean|-1.80|-1.8|Standard Deviation|0.81|0.81|||
4283019|NCT00557310|4107869|B1|||Femoral Neck T-Score||units on a scale|Mean|-2.38|-2.38|Standard Deviation|0.67|0.67|||
4283020|NCT00557310|4107869|B1|||Lumbar Spine T-Score|The T-score is a comparison of a patient's bone mineral density (BMD) to that of the mean BMD for a healthy population of women at peak bone mass (30 years). A normal T-score has a value of -1.0 or higher. Osteoporosis is defined as a T-score of -2.5 or lower, meaning a bone mineral density that is two and a half standard deviations below the mean BMD of a healthy population of women at peak bone mass (30 years).|units on a scale|Mean|-2.91|-2.91|Standard Deviation|1.04|1.04|||
4283021|NCT00557310|4107869|B1|No||Prior Bisphosphonate Use||participants|Number|13|13.0||||||
4283022|NCT00557310|4107869|B1|Yes||Prior Bisphosphonate Use||participants|Number|21|21.0||||||
4283023|NCT00557310|4107869|B1|||Years Postmenopausal||years|Mean|16.97|16.97|Standard Deviation|12.10|12.1|||
4283024|NCT00557310|4107869|B1|Any non-vertebral fracture||Prevalent Fractures|A prevalent fracture is defined as a fracture that a participant already had at the time of study entry. One participant had both a vertebral and non-vertebral fracture and therefore the total number of participants is higher than the baseline population number.|participants|Number|17|17.0||||||
4283025|NCT00557310|4107869|B1|Any vertebral fracture||Prevalent Fractures|A prevalent fracture is defined as a fracture that a participant already had at the time of study entry. One participant had both a vertebral and non-vertebral fracture and therefore the total number of participants is higher than the baseline population number.|participants|Number|4|4.0||||||
4283026|NCT00557310|4107869|B1|None||Prevalent Fractures|A prevalent fracture is defined as a fracture that a participant already had at the time of study entry. One participant had both a vertebral and non-vertebral fracture and therefore the total number of participants is higher than the baseline population number.|participants|Number|14|14.0||||||
4283027|NCT00557310|4107869|B1|Right||Dominant Hand||participants|Number|33|33.0||||||
4283028|NCT00557310|4107869|B1|Left||Dominant Hand||participants|Number|1|1.0||||||
4283029|NCT00557310|4107869|B1|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4283030|NCT00557310|4107869|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4283031|NCT00557310|4107869|B1|West Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4283032|NCT00557310|4107869|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4283033|NCT00557310|4107869|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4283034|NCT00557310|4107869|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4283035|NCT00557310|4107869|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4283036|NCT00557310|4107869|B1|||Age||years|Mean|61.96|61.96|Standard Deviation|8.14|8.14|||
4283037|NCT00557284|4107889|B3|||GSRS|GI symptoms will be recorded weekly on *GSRS validated scale adjusted for pediatrics (*Gastrointestinal Symptoms in Patients with Irritable Bowel Syndrome and Peptic Ulcer Disease). This scale measures 7 different GI symptoms (1. abdominal pain; 2. nausea and vomiting; 3. abdominal dissention; 4. decreased passage of stools; 5. increased passage of stools; 6. loose stools; 7. hard stools) with severity ranges from 0 - 3 (maximum total of 21 - most severe). Measurement is the mean for all subjects in each arm.|Scores on a scale|Mean|4.83|4.83|Standard Deviation|2.45|2.45|||
4283038|NCT00557284|4107890|B2|||GSRS|GI symptoms will be recorded weekly on *GSRS validated scale adjusted for pediatrics (*Gastrointestinal Symptoms in Patients with Irritable Bowel Syndrome and Peptic Ulcer Disease). This scale measures 7 different GI symptoms (1. abdominal pain; 2. nausea and vomiting; 3. abdominal dissention; 4. decreased passage of stools; 5. increased passage of stools; 6. loose stools; 7. hard stools) with severity ranges from 0 - 3 (maximum total of 21 - most severe). Measurement is the mean for all subjects in each arm.|Scores on a scale|Mean|5.0|5.0|Standard Deviation|2.4|2.4|||
4283039|NCT00557284|4107891|B1|||GSRS|GI symptoms will be recorded weekly on *GSRS validated scale adjusted for pediatrics (*Gastrointestinal Symptoms in Patients with Irritable Bowel Syndrome and Peptic Ulcer Disease). This scale measures 7 different GI symptoms (1. abdominal pain; 2. nausea and vomiting; 3. abdominal dissention; 4. decreased passage of stools; 5. increased passage of stools; 6. loose stools; 7. hard stools) with severity ranges from 0 - 3 (maximum total of 21 - most severe). Measurement is the mean for all subjects in each arm.|Scores on a scale|Mean|4.67|4.67|Standard Deviation|2.5|2.5|||
4283040|NCT00557284|4107889|B3|||IgE|Serum Immunoglobulin E levels. Measurement is the mean for all subjects in each arm.|kU/L|Mean|412.30|412.3|Standard Deviation|664.45|664.45|||
4283041|NCT00557284|4107890|B2|||IgE|Serum Immunoglobulin E levels. Measurement is the mean for all subjects in each arm.|kU/L|Mean|392.40|392.4|Standard Deviation|441.00|441.0|||
4283042|NCT00557284|4107891|B1|||IgE|Serum Immunoglobulin E levels. Measurement is the mean for all subjects in each arm.|kU/L|Mean|432.20|432.2|Standard Deviation|887.90|887.9|||
4283043|NCT00557284|4107889|B3|||Urine LTE4|Urine Cysteinyl leukotriene 4 levels. Measurement is the mean for all subjects in each arm.|pg/ml|Mean|59.77|59.77|Standard Deviation|51.55|51.55|||
4283044|NCT00557284|4107890|B2|||Urine LTE4|Urine Cysteinyl leukotriene 4 levels. Measurement is the mean for all subjects in each arm.|pg/ml|Mean|66.65|66.65|Standard Deviation|62.90|62.9|||
4283045|NCT00557284|4107891|B1|||Urine LTE4|Urine Cysteinyl leukotriene 4 levels. Measurement is the mean for all subjects in each arm.|pg/ml|Mean|52.90|52.9|Standard Deviation|40.20|40.2|||
4283046|NCT00557284|4107889|B3|||NGF|Serum Nerve Growth Factor levels. Measurement is the mean for all subjects in each arm.|pg/ml|Mean|104.24|104.24|Standard Deviation|179.86|179.86|||
4283047|NCT00557284|4107890|B2|||NGF|Serum Nerve Growth Factor levels. Measurement is the mean for all subjects in each arm.|pg/ml|Mean|108.70|108.7|Standard Deviation|192.35|192.35|||
4283048|NCT00557284|4107891|B1|||NGF|Serum Nerve Growth Factor levels. Measurement is the mean for all subjects in each arm.|pg/ml|Mean|99.78|99.78|Standard Deviation|167.38|167.38|||
4283049|NCT00557284|4107889|B3|||TNF alpha|Serum Tumor Necrosis Factor levels. Measurement is the mean for all subjects in each arm.|pg/ml|Mean|3.78|3.78|Standard Deviation|5.95|5.95|||
4283050|NCT00557284|4107890|B2|||TNF alpha|Serum Tumor Necrosis Factor levels. Measurement is the mean for all subjects in each arm.|pg/ml|Mean|5.70|5.7|Standard Deviation|11.03|11.03|||
4283051|NCT00557284|4107891|B1|||TNF alpha|Serum Tumor Necrosis Factor levels. Measurement is the mean for all subjects in each arm.|pg/ml|Mean|1.87|1.87|Standard Deviation|0.87|0.87|||
4283052|NCT00557284|4107889|B3|||IL-13|Serum interleukin 13 levels. Measurement is the mean for all subjects in each arm.|pg/ml|Mean|34.18|34.18|Standard Deviation|33.60|33.6|||
4283053|NCT00557284|4107890|B2|||IL-13|Serum interleukin 13 levels. Measurement is the mean for all subjects in each arm.|pg/ml|Mean|34.70|34.7|Standard Deviation|37.0|37.0|||
4283054|NCT00557284|4107891|B1|||IL-13|Serum interleukin 13 levels. Measurement is the mean for all subjects in each arm.|pg/ml|Mean|33.67|33.67|Standard Deviation|30.20|30.2|||
4283055|NCT00557284|4107889|B3|||Pruritus score|Pruritus assessments (“itch”) will be recorded for the previous 24 hours using a 4 point-scale, ranging from none (0) to severe (3). Measurement is mean of all subjects in each arm.|units on a scale|Mean|1.36|1.36|Standard Deviation|0.30|0.3|||
4283056|NCT00557284|4107890|B2|||Pruritus score|Pruritus assessments (“itch”) will be recorded for the previous 24 hours using a 4 point-scale, ranging from none (0) to severe (3). Measurement is mean of all subjects in each arm.|units on a scale|Mean|1.17|1.17|Standard Deviation|0.72|0.72|||
4283057|NCT00557284|4107891|B1|||Pruritus score|Pruritus assessments (“itch”) will be recorded for the previous 24 hours using a 4 point-scale, ranging from none (0) to severe (3). Measurement is mean of all subjects in each arm.|units on a scale|Mean|1.60|1.6|Standard Deviation|0.79|0.79|||
4283058|NCT00557284|4107889|B3|||PADC (caregivers assessment of disease control)|Caregiver’s evaluation of disease control over the previous 7 days and will consist of a four-point scale ranging from complete control (0) to uncontrolled disease (3). Measurement is the mean for all subjects in each arm.|Scores on a scale|Mean|1.79|1.79|Standard Deviation|0.80|0.8|||
4283059|NCT00557284|4107890|B2|||PADC (caregivers assessment of disease control)|Caregiver’s evaluation of disease control over the previous 7 days and will consist of a four-point scale ranging from complete control (0) to uncontrolled disease (3). Measurement is the mean for all subjects in each arm.|Scores on a scale|Mean|1.80|1.8|Standard Deviation|0.92|0.92|||
4283060|NCT00557284|4107891|B1|||PADC (caregivers assessment of disease control)|Caregiver’s evaluation of disease control over the previous 7 days and will consist of a four-point scale ranging from complete control (0) to uncontrolled disease (3). Measurement is the mean for all subjects in each arm.|Scores on a scale|Mean|1.78|1.78|Standard Deviation|0.67|0.67|||
4283061|NCT00557284|4107889|B3|||Investigator Global Assessment (IGA)|The IGA is a six-point measure of disease severity are evaluated by the study doctor based on the overall assessment of skin lesions: 0=clear, 1=almost clear, 2=mild, 3=moderate, 4=severe, 5= very severe. Measurement is the mean for all subjects in each arm.|Scores on a scale|Mean|2.20|2.2|Standard Deviation|0.40|0.4|||
4283062|NCT00557284|4107890|B2|||Investigator Global Assessment (IGA)|The IGA is a six-point measure of disease severity are evaluated by the study doctor based on the overall assessment of skin lesions: 0=clear, 1=almost clear, 2=mild, 3=moderate, 4=severe, 5= very severe. Measurement is the mean for all subjects in each arm.|Scores on a scale|Mean|2.30|2.3|Standard Deviation|0.48|0.48|||
4283063|NCT00557284|4107891|B1|||Investigator Global Assessment (IGA)|The IGA is a six-point measure of disease severity are evaluated by the study doctor based on the overall assessment of skin lesions: 0=clear, 1=almost clear, 2=mild, 3=moderate, 4=severe, 5= very severe. Measurement is the mean for all subjects in each arm.|Scores on a scale|Mean|2.11|2.11|Standard Deviation|0.33|0.33|||
4283064|NCT00557284|4107889|B3|||Percentage of Body Involvement|Percentage of body surface as calculated by investigator. Measurement is mean for all subjects in each arm.|percentage|Mean|20.86|20.86|Standard Deviation|8.5|8.5|||
4283065|NCT00557284|4107890|B2|||Percentage of Body Involvement|Percentage of body surface as calculated by investigator. Measurement is mean for all subjects in each arm.|percentage|Mean|20.05|20.05|Standard Deviation|8.1|8.1|||
4283066|NCT00557284|4107891|B1|||Percentage of Body Involvement|Percentage of body surface as calculated by investigator. Measurement is mean for all subjects in each arm.|percentage|Mean|21.67|21.67|Standard Deviation|8.9|8.9|||
4283067|NCT00557284|4107889|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4283068|NCT00557284|4107890|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4283069|NCT00557284|4107891|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4283070|NCT00557284|4107889|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4283071|NCT00557284|4107890|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4283072|NCT00557284|4107891|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4283073|NCT00557284|4107889|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4283074|NCT00557284|4107890|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4283075|NCT00557284|4107891|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4283076|NCT00557284|4107889|B3|||Age||years|Mean|5.5|5.5|Standard Deviation|2.0|2.0|||
4283077|NCT00557284|4107890|B2|||Age||years|Mean|5.6|5.6|Standard Deviation|1.7|1.7|||
4283078|NCT00557284|4107891|B1|||Age||years|Mean|5.5|5.5|Standard Deviation|2.3|2.3|||
4283079|NCT00557284|4107889|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4283080|NCT00557284|4107890|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4283081|NCT00557284|4107891|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4283082|NCT00557284|4107889|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4283083|NCT00557284|4107890|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4283084|NCT00557284|4107891|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4283085|NCT00557284|4107889|B3||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
4283086|NCT00557284|4107890|B2||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4283087|NCT00557284|4107891|B1||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4283088|NCT00557245|4107912|B4|||Percentage of participants who had unprotected sex in the past month|The percentage of participants who had any unprotected sex acts in the prior month.|percentage of participants|Number|80|80.0||||||
4283089|NCT00557245|4107913|B3|||Percentage of participants who had unprotected sex in the past month|The percentage of participants who had any unprotected sex acts in the prior month.|percentage of participants|Number|26|26.0||||||
4283090|NCT00557245|4107914|B2|||Percentage of participants who had unprotected sex in the past month|The percentage of participants who had any unprotected sex acts in the prior month.|percentage of participants|Number|26|26.0||||||
4283091|NCT00557245|4107915|B1|||Percentage of participants who had unprotected sex in the past month|The percentage of participants who had any unprotected sex acts in the prior month.|percentage of participants|Number|28|28.0||||||
4283092|NCT00557245|4107912|B4|Uganda||Region of Enrollment||participants|Number|2652|2652.0||||||
4283093|NCT00557245|4107913|B3|Uganda||Region of Enrollment||participants|Number|887|887.0||||||
4283094|NCT00557245|4107914|B2|Uganda||Region of Enrollment||participants|Number|881|881.0||||||
4283095|NCT00557245|4107915|B1|Uganda||Region of Enrollment||participants|Number|884|884.0||||||
4283096|NCT00557245|4107912|B4|Kenya||Region of Enrollment||participants|Number|2095|2095.0||||||
4283097|NCT00557245|4107913|B3|Kenya||Region of Enrollment||participants|Number|697|697.0||||||
4283098|NCT00557245|4107914|B2|Kenya||Region of Enrollment||participants|Number|698|698.0||||||
4283099|NCT00557245|4107915|B1|Kenya||Region of Enrollment||participants|Number|700|700.0||||||
4283100|NCT00557245|4107912|B4||Male|Sex: Female, Male||Participants|Count of Participants|2962|2962.0||||||
4283101|NCT00557245|4107913|B3||Male|Sex: Female, Male||Participants|Count of Participants|963|963.0||||||
4283102|NCT00557245|4107914|B2||Male|Sex: Female, Male||Participants|Count of Participants|1013|1013.0||||||
4283103|NCT00557245|4107915|B1||Male|Sex: Female, Male||Participants|Count of Participants|986|986.0||||||
4283104|NCT00557245|4107912|B4||Female|Sex: Female, Male||Participants|Count of Participants|1785|1785.0||||||
4283105|NCT00557245|4107913|B3||Female|Sex: Female, Male||Participants|Count of Participants|621|621.0||||||
4283106|NCT00557245|4107914|B2||Female|Sex: Female, Male||Participants|Count of Participants|566|566.0||||||
4283107|NCT00557245|4107915|B1||Female|Sex: Female, Male||Participants|Count of Participants|598|598.0||||||
4283108|NCT00557245|4107912|B4|45 years and older||Age, Customized||participants|Number|624|624.0||||||
4283109|NCT00557245|4107913|B3|45 years and older||Age, Customized||participants|Number|211|211.0||||||
4283110|NCT00557245|4107914|B2|45 years and older||Age, Customized||participants|Number|214|214.0||||||
4283111|NCT00557245|4107915|B1|45 years and older||Age, Customized||participants|Number|199|199.0||||||
4283112|NCT00557245|4107912|B4|35-44 years||Age, Customized||participants|Number|1491|1491.0||||||
4283113|NCT00557245|4107913|B3|35-44 years||Age, Customized||participants|Number|513|513.0||||||
4283114|NCT00557245|4107914|B2|35-44 years||Age, Customized||participants|Number|498|498.0||||||
4283115|NCT00557245|4107915|B1|35-44 years||Age, Customized||participants|Number|480|480.0||||||
4283116|NCT00557245|4107912|B4|25-34 years||Age, Customized||participants|Number|2099|2099.0||||||
4283117|NCT00557245|4107913|B3|25-34 years||Age, Customized||participants|Number|688|688.0||||||
4283118|NCT00557245|4107914|B2|25-34 years||Age, Customized||participants|Number|690|690.0||||||
4283119|NCT00557245|4107915|B1|25-34 years||Age, Customized||participants|Number|721|721.0||||||
4283120|NCT00557245|4107912|B4|18-24 years||Age, Customized||participants|Number|533|533.0||||||
4283121|NCT00557245|4107913|B3|18-24 years||Age, Customized||participants|Number|172|172.0||||||
4283122|NCT00557245|4107914|B2|18-24 years||Age, Customized||participants|Number|177|177.0||||||
4283123|NCT00557245|4107915|B1|18-24 years||Age, Customized||participants|Number|184|184.0||||||
4283124|NCT00557193|4107955|B1|Australia||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4283125|NCT00557193|4107955|B1|New Zealand||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4283126|NCT00557193|4107955|B1|Canada||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4283127|NCT00557193|4107955|B1|United States||Region of Enrollment||Participants|Count of Participants|201|201.0||||||
4283128|NCT00557193|4107955|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4283129|NCT00557193|4107955|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283130|NCT00557193|4107955|B1||White|Race (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
4283131|NCT00557193|4107955|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4283132|NCT00557193|4107955|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283133|NCT00557193|4107955|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4283134|NCT00557193|4107955|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4283135|NCT00557193|4107955|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4283136|NCT00557193|4107955|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|160|160.0||||||
4283137|NCT00557193|4107955|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4283138|NCT00557193|4107955|B1||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4283139|NCT00557193|4107955|B1||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4283140|NCT00557193|4107955|B1|||Age||Years|Mean|0.54|0.54|Standard Deviation|0.28|0.28|||
4283141|NCT00557193|4107955|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4283142|NCT00557193|4107955|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4283143|NCT00557193|4107955|B1||<=18 years|Age||Participants|Count of Participants|218|218.0||||||
4283144|NCT00557076|4107983|B3|Graduate or Professional Degree||Education Achieved at Injury||participants|Number|2|2.0||||||
4283145|NCT00557076|4107984|B2|Graduate or Professional Degree||Education Achieved at Injury||participants|Number|1|1.0||||||
4283146|NCT00557076|4107985|B1|Graduate or Professional Degree||Education Achieved at Injury||participants|Number|1|1.0||||||
4283147|NCT00557076|4107983|B3|Bachelor Degree||Education Achieved at Injury||participants|Number|4|4.0||||||
4283148|NCT00557076|4107984|B2|Bachelor Degree||Education Achieved at Injury||participants|Number|2|2.0||||||
4283149|NCT00557076|4107985|B1|Bachelor Degree||Education Achieved at Injury||participants|Number|2|2.0||||||
4283150|NCT00557076|4107983|B3|Some College, No Degree||Education Achieved at Injury||participants|Number|4|4.0||||||
4283151|NCT00557076|4107984|B2|Some College, No Degree||Education Achieved at Injury||participants|Number|3|3.0||||||
4283152|NCT00557076|4107985|B1|Some College, No Degree||Education Achieved at Injury||participants|Number|1|1.0||||||
4283153|NCT00557076|4107983|B3|High School Graduate or GED||Education Achieved at Injury||participants|Number|5|5.0||||||
4283154|NCT00557076|4107984|B2|High School Graduate or GED||Education Achieved at Injury||participants|Number|1|1.0||||||
4283155|NCT00557076|4107985|B1|High School Graduate or GED||Education Achieved at Injury||participants|Number|4|4.0||||||
4283156|NCT00557076|4107983|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283157|NCT00557076|4107984|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283158|NCT00557076|4107985|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283159|NCT00557076|4107983|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4283160|NCT00557076|4107984|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4283161|NCT00557076|4107985|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4283162|NCT00557076|4107983|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4283163|NCT00557076|4107984|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4283164|NCT00557076|4107985|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4283165|NCT00557076|4107983|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283166|NCT00557076|4107984|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283167|NCT00557076|4107985|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283168|NCT00557076|4107983|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283169|NCT00557076|4107984|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283170|NCT00557076|4107985|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283171|NCT00557076|4107983|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4283172|NCT00557076|4107984|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4283173|NCT00557076|4107985|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4283174|NCT00557076|4107983|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4283175|NCT00557076|4107984|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4283176|NCT00557076|4107985|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4283177|NCT00557076|4107983|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283178|NCT00557076|4107984|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283179|NCT00557076|4107985|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283180|NCT00557076|4107983|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4283181|NCT00557076|4107984|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4283182|NCT00557076|4107985|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4283183|NCT00557076|4107983|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283184|NCT00557076|4107984|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283185|NCT00557076|4107985|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283186|NCT00557076|4107983|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4283187|NCT00557076|4107984|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4283188|NCT00557076|4107985|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4283189|NCT00557076|4107983|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4283190|NCT00557076|4107984|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4283191|NCT00557076|4107985|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4283192|NCT00557076|4107983|B3|||Age||years|Mean|35.1|35.1|Standard Deviation|11.0|11.0|||
4283193|NCT00557076|4107984|B2|||Age||years|Mean|34.4|34.4|Standard Deviation|12.0|12.0|||
4283194|NCT00557076|4107985|B1|||Age||years|Mean|35.6|35.6|Standard Deviation|11.0|11.0|||
4283195|NCT00556998|4107994|B1|Male||Sex/Gender, Customized||Participants|Number|17|17.0||||||
4283196|NCT00556998|4107994|B1|Female||Sex/Gender, Customized||Participants|Number|9|9.0||||||
4283197|NCT00556998|4107994|B1|>13 to <17||Age, Customized||Years|Number|12|12.0||||||
4283198|NCT00556998|4107994|B1|13||Age, Customized||Years|Number|10|10.0||||||
4283199|NCT00556998|4107994|B1|12||Age, Customized||Years|Number|4|4.0||||||
4283200|NCT00556972|4108014|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4283201|NCT00556972|4108014|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4283202|NCT00556972|4108014|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4283203|NCT00556972|4108014|B1|||Age||years|Mean|62.0|62.0|Standard Deviation|14.2|14.2|||
4283204|NCT00556972|4108014|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4283205|NCT00556972|4108014|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4283206|NCT00556972|4108014|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4283207|NCT00556946|4108021|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4283208|NCT00556946|4108021|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4283209|NCT00556946|4108021|B1|Adult over 18||Age, Customized||participants|Number|17|17.0||||||
4283210|NCT00556933|4108025|B5|CMV Low-risk||Donor/Recipient High-Risk CMV Serostatus|"Donor/Recipient High-Risk CMV Serostatus = Donor CMV Positive/Recipient CMV Positive or Negative~Donor/Recipient Low-Risk CMV Serostatus = Donor CMV Negative/Recipient CMV Positive or Negative"|participants|Number|70|70.0||||||
4283211|NCT00556933|4108026|B4|CMV Low-risk||Donor/Recipient High-Risk CMV Serostatus|"Donor/Recipient High-Risk CMV Serostatus = Donor CMV Positive/Recipient CMV Positive or Negative~Donor/Recipient Low-Risk CMV Serostatus = Donor CMV Negative/Recipient CMV Positive or Negative"|participants|Number|12|12.0||||||
4283212|NCT00556933|4108027|B3|CMV Low-risk||Donor/Recipient High-Risk CMV Serostatus|"Donor/Recipient High-Risk CMV Serostatus = Donor CMV Positive/Recipient CMV Positive or Negative~Donor/Recipient Low-Risk CMV Serostatus = Donor CMV Negative/Recipient CMV Positive or Negative"|participants|Number|20|20.0||||||
4283213|NCT00556933|4108028|B2|CMV Low-risk||Donor/Recipient High-Risk CMV Serostatus|"Donor/Recipient High-Risk CMV Serostatus = Donor CMV Positive/Recipient CMV Positive or Negative~Donor/Recipient Low-Risk CMV Serostatus = Donor CMV Negative/Recipient CMV Positive or Negative"|participants|Number|17|17.0||||||
4283214|NCT00556933|4108029|B1|CMV Low-risk||Donor/Recipient High-Risk CMV Serostatus|"Donor/Recipient High-Risk CMV Serostatus = Donor CMV Positive/Recipient CMV Positive or Negative~Donor/Recipient Low-Risk CMV Serostatus = Donor CMV Negative/Recipient CMV Positive or Negative"|participants|Number|21|21.0||||||
4283215|NCT00556933|4108025|B5|CMV High-risk||Donor/Recipient High-Risk CMV Serostatus|"Donor/Recipient High-Risk CMV Serostatus = Donor CMV Positive/Recipient CMV Positive or Negative~Donor/Recipient Low-Risk CMV Serostatus = Donor CMV Negative/Recipient CMV Positive or Negative"|participants|Number|108|108.0||||||
4283216|NCT00556933|4108026|B4|CMV High-risk||Donor/Recipient High-Risk CMV Serostatus|"Donor/Recipient High-Risk CMV Serostatus = Donor CMV Positive/Recipient CMV Positive or Negative~Donor/Recipient Low-Risk CMV Serostatus = Donor CMV Negative/Recipient CMV Positive or Negative"|participants|Number|33|33.0||||||
4283217|NCT00556933|4108027|B3|CMV High-risk||Donor/Recipient High-Risk CMV Serostatus|"Donor/Recipient High-Risk CMV Serostatus = Donor CMV Positive/Recipient CMV Positive or Negative~Donor/Recipient Low-Risk CMV Serostatus = Donor CMV Negative/Recipient CMV Positive or Negative"|participants|Number|25|25.0||||||
4283218|NCT00556933|4108028|B2|CMV High-risk||Donor/Recipient High-Risk CMV Serostatus|"Donor/Recipient High-Risk CMV Serostatus = Donor CMV Positive/Recipient CMV Positive or Negative~Donor/Recipient Low-Risk CMV Serostatus = Donor CMV Negative/Recipient CMV Positive or Negative"|participants|Number|27|27.0||||||
4283219|NCT00556933|4108029|B1|CMV High-risk||Donor/Recipient High-Risk CMV Serostatus|"Donor/Recipient High-Risk CMV Serostatus = Donor CMV Positive/Recipient CMV Positive or Negative~Donor/Recipient Low-Risk CMV Serostatus = Donor CMV Negative/Recipient CMV Positive or Negative"|participants|Number|23|23.0||||||
4283220|NCT00556933|4108025|B5|Adult donor||Pediatric vs. Adult Donor||participants|Number|168|168.0||||||
4283221|NCT00556933|4108026|B4|Adult donor||Pediatric vs. Adult Donor||participants|Number|42|42.0||||||
4283222|NCT00556933|4108027|B3|Adult donor||Pediatric vs. Adult Donor||participants|Number|42|42.0||||||
4283223|NCT00556933|4108028|B2|Adult donor||Pediatric vs. Adult Donor||participants|Number|43|43.0||||||
4283224|NCT00556933|4108029|B1|Adult donor||Pediatric vs. Adult Donor||participants|Number|41|41.0||||||
4283225|NCT00556933|4108025|B5|Pediatric donor||Pediatric vs. Adult Donor||participants|Number|10|10.0||||||
4283226|NCT00556933|4108026|B4|Pediatric donor||Pediatric vs. Adult Donor||participants|Number|3|3.0||||||
4283227|NCT00556933|4108027|B3|Pediatric donor||Pediatric vs. Adult Donor||participants|Number|3|3.0||||||
4283228|NCT00556933|4108028|B2|Pediatric donor||Pediatric vs. Adult Donor||participants|Number|1|1.0||||||
4283229|NCT00556933|4108029|B1|Pediatric donor||Pediatric vs. Adult Donor||participants|Number|3|3.0||||||
4283230|NCT00556933|4108025|B5|||Adult Cadaver Donor Nyberg Grade|Nyberg et al (AmJourTrans 2001; 1: 162–170) developed a deceased-donor kidney grading system to predict early graft dysfunction and failure; developed from seven donor variables (cause of death, 0–6 points; history of hypertension, 0–6; final creatinine clearance before procurement, 0–6; age, 0–6; history of diabetes mellitus, 0–3; cold ischemia time, 0–3; and severity of renal artery plaque, 0–3). It stratifies deceased-donor kidneys by score: grade A, 0–5 points; grade B, 6– 10; grade C, 11–15; and grade D, 16–32. Risk of delayed graft function was 17% in Group A and 62% in group D.|units on a scale|Mean|13.1|13.1|Standard Deviation|7.4|7.4|||
4283231|NCT00556933|4108026|B4|||Adult Cadaver Donor Nyberg Grade|Nyberg et al (AmJourTrans 2001; 1: 162–170) developed a deceased-donor kidney grading system to predict early graft dysfunction and failure; developed from seven donor variables (cause of death, 0–6 points; history of hypertension, 0–6; final creatinine clearance before procurement, 0–6; age, 0–6; history of diabetes mellitus, 0–3; cold ischemia time, 0–3; and severity of renal artery plaque, 0–3). It stratifies deceased-donor kidneys by score: grade A, 0–5 points; grade B, 6– 10; grade C, 11–15; and grade D, 16–32. Risk of delayed graft function was 17% in Group A and 62% in group D.|units on a scale|Mean|15.4|15.4|Standard Deviation|7.8|7.8|||
4283232|NCT00556933|4108027|B3|||Adult Cadaver Donor Nyberg Grade|Nyberg et al (AmJourTrans 2001; 1: 162–170) developed a deceased-donor kidney grading system to predict early graft dysfunction and failure; developed from seven donor variables (cause of death, 0–6 points; history of hypertension, 0–6; final creatinine clearance before procurement, 0–6; age, 0–6; history of diabetes mellitus, 0–3; cold ischemia time, 0–3; and severity of renal artery plaque, 0–3). It stratifies deceased-donor kidneys by score: grade A, 0–5 points; grade B, 6– 10; grade C, 11–15; and grade D, 16–32. Risk of delayed graft function was 17% in Group A and 62% in group D.|units on a scale|Mean|11.8|11.8|Standard Deviation|6.9|6.9|||
4283233|NCT00556933|4108028|B2|||Adult Cadaver Donor Nyberg Grade|Nyberg et al (AmJourTrans 2001; 1: 162–170) developed a deceased-donor kidney grading system to predict early graft dysfunction and failure; developed from seven donor variables (cause of death, 0–6 points; history of hypertension, 0–6; final creatinine clearance before procurement, 0–6; age, 0–6; history of diabetes mellitus, 0–3; cold ischemia time, 0–3; and severity of renal artery plaque, 0–3). It stratifies deceased-donor kidneys by score: grade A, 0–5 points; grade B, 6– 10; grade C, 11–15; and grade D, 16–32. Risk of delayed graft function was 17% in Group A and 62% in group D.|units on a scale|Mean|14.6|14.6|Standard Deviation|7.0|7.0|||
4283234|NCT00556933|4108029|B1|||Adult Cadaver Donor Nyberg Grade|Nyberg et al (AmJourTrans 2001; 1: 162–170) developed a deceased-donor kidney grading system to predict early graft dysfunction and failure; developed from seven donor variables (cause of death, 0–6 points; history of hypertension, 0–6; final creatinine clearance before procurement, 0–6; age, 0–6; history of diabetes mellitus, 0–3; cold ischemia time, 0–3; and severity of renal artery plaque, 0–3). It stratifies deceased-donor kidneys by score: grade A, 0–5 points; grade B, 6– 10; grade C, 11–15; and grade D, 16–32. Risk of delayed graft function was 17% in Group A and 62% in group D.|units on a scale|Mean|10.5|10.5|Standard Deviation|7.5|7.5|||
4283235|NCT00556933|4108025|B5|||Donor final serum creatinine||mg/dl|Mean|1.0|1.0|Standard Deviation|0.5|0.5|||
4283236|NCT00556933|4108026|B4|||Donor final serum creatinine||mg/dl|Mean|1.0|1.0|Standard Deviation|0.5|0.5|||
4283237|NCT00556933|4108027|B3|||Donor final serum creatinine||mg/dl|Mean|1.0|1.0|Standard Deviation|0.5|0.5|||
4283238|NCT00556933|4108028|B2|||Donor final serum creatinine||mg/dl|Mean|1.1|1.1|Standard Deviation|0.6|0.6|||
4283239|NCT00556933|4108029|B1|||Donor final serum creatinine||mg/dl|Mean|1.0|1.0|Standard Deviation|0.3|0.3|||
4283240|NCT00556933|4108025|B5|||Donor BMI||kg/m^2|Mean|27.6|27.6|Standard Deviation|4.8|4.8|||
4283241|NCT00556933|4108026|B4|||Donor BMI||kg/m^2|Mean|28.3|28.3|Standard Deviation|5.1|5.1|||
4283242|NCT00556933|4108027|B3|||Donor BMI||kg/m^2|Mean|27.1|27.1|Standard Deviation|4.2|4.2|||
4283243|NCT00556933|4108028|B2|||Donor BMI||kg/m^2|Mean|27.3|27.3|Standard Deviation|4.0|4.0|||
4283244|NCT00556933|4108029|B1|||Donor BMI||kg/m^2|Mean|27.7|27.7|Standard Deviation|5.7|5.7|||
4283245|NCT00556933|4108025|B5|Female||Donor gender||participants|Number|100|100.0||||||
4283246|NCT00556933|4108026|B4|Female||Donor gender||participants|Number|25|25.0||||||
4283247|NCT00556933|4108027|B3|Female||Donor gender||participants|Number|28|28.0||||||
4283248|NCT00556933|4108028|B2|Female||Donor gender||participants|Number|21|21.0||||||
4283249|NCT00556933|4108029|B1|Female||Donor gender||participants|Number|26|26.0||||||
4283250|NCT00556933|4108025|B5|Male||Donor gender||participants|Number|78|78.0||||||
4283251|NCT00556933|4108026|B4|Male||Donor gender||participants|Number|20|20.0||||||
4283252|NCT00556933|4108027|B3|Male||Donor gender||participants|Number|17|17.0||||||
4283253|NCT00556933|4108028|B2|Male||Donor gender||participants|Number|23|23.0||||||
4283254|NCT00556933|4108029|B1|Male||Donor gender||participants|Number|18|18.0||||||
4283255|NCT00556933|4108025|B5|||Donor age||years|Mean|40.9|40.9|Standard Deviation|12.7|12.7|||
4283256|NCT00556933|4108026|B4|||Donor age||years|Mean|41.2|41.2|Standard Deviation|14.0|14.0|||
4283257|NCT00556933|4108027|B3|||Donor age||years|Mean|37.4|37.4|Standard Deviation|12.1|12.1|||
4283258|NCT00556933|4108028|B2|||Donor age||years|Mean|44.7|44.7|Standard Deviation|10.0|10.0|||
4283259|NCT00556933|4108029|B1|||Donor age||years|Mean|40.4|40.4|Standard Deviation|13.1|13.1|||
4283260|NCT00556933|4108025|B5|||Donor/recipient height ratio||ratio|Mean|0.99|0.99|Standard Deviation|0.1|0.1|||
4283261|NCT00556933|4108026|B4|||Donor/recipient height ratio||ratio|Mean|1.00|1.0|Standard Deviation|0.16|0.16|||
4283262|NCT00556933|4108027|B3|||Donor/recipient height ratio||ratio|Mean|0.98|0.98|Standard Deviation|0.16|0.16|||
4283263|NCT00556933|4108028|B2|||Donor/recipient height ratio||ratio|Mean|1.00|1.0|Standard Deviation|0.17|0.17|||
4283264|NCT00556933|4108029|B1|||Donor/recipient height ratio||ratio|Mean|0.98|0.98|Standard Deviation|0.07|0.07|||
4283265|NCT00556933|4108025|B5|||Patient Panel Reactive Antibody (PRA)(%)||% reactive|Mean|1.0|1.0|Standard Deviation|5.6|5.6|||
4283266|NCT00556933|4108026|B4|||Patient Panel Reactive Antibody (PRA)(%)||% reactive|Mean|1.3|1.3|Standard Deviation|7.8|7.8|||
4283267|NCT00556933|4108027|B3|||Patient Panel Reactive Antibody (PRA)(%)||% reactive|Mean|1.1|1.1|Standard Deviation|6.3|6.3|||
4283268|NCT00556933|4108028|B2|||Patient Panel Reactive Antibody (PRA)(%)||% reactive|Mean|1.0|1.0|Standard Deviation|4.8|4.8|||
4283269|NCT00556933|4108029|B1|||Patient Panel Reactive Antibody (PRA)(%)||% reactive|Mean|0.6|0.6|Standard Deviation|2.3|2.3|||
4283270|NCT00556933|4108025|B5|||Deceased-donor Cold Ischemia Time||Hours|Mean|14.5|14.5|Standard Deviation|7.2|7.2|||
4283271|NCT00556933|4108026|B4|||Deceased-donor Cold Ischemia Time||Hours|Mean|15.4|15.4|Standard Deviation|11|11.0|||
4283272|NCT00556933|4108027|B3|||Deceased-donor Cold Ischemia Time||Hours|Mean|14.7|14.7|Standard Deviation|5.7|5.7|||
4283273|NCT00556933|4108028|B2|||Deceased-donor Cold Ischemia Time||Hours|Mean|13.7|13.7|Standard Deviation|4.1|4.1|||
4283274|NCT00556933|4108029|B1|||Deceased-donor Cold Ischemia Time||Hours|Mean|14.3|14.3|Standard Deviation|7|7.0|||
4283275|NCT00556933|4108025|B5|Living donor||Donor type||participants|Number|108|108.0||||||
4283276|NCT00556933|4108026|B4|Living donor||Donor type||participants|Number|28|28.0||||||
4283277|NCT00556933|4108027|B3|Living donor||Donor type||participants|Number|27|27.0||||||
4283278|NCT00556933|4108028|B2|Living donor||Donor type||participants|Number|27|27.0||||||
4283279|NCT00556933|4108029|B1|Living donor||Donor type||participants|Number|26|26.0||||||
4283280|NCT00556933|4108025|B5|Deceased donor||Donor type||participants|Number|70|70.0||||||
4283281|NCT00556933|4108026|B4|Deceased donor||Donor type||participants|Number|17|17.0||||||
4283282|NCT00556933|4108027|B3|Deceased donor||Donor type||participants|Number|18|18.0||||||
4283283|NCT00556933|4108028|B2|Deceased donor||Donor type||participants|Number|17|17.0||||||
4283284|NCT00556933|4108029|B1|Deceased donor||Donor type||participants|Number|18|18.0||||||
4283285|NCT00556933|4108025|B5|||Patient Body Mass Index (BMI)||kg/m^2|Mean|28.5|28.5|Standard Deviation|5.7|5.7|||
4283286|NCT00556933|4108026|B4|||Patient Body Mass Index (BMI)||kg/m^2|Mean|28.9|28.9|Standard Deviation|6.9|6.9|||
4283287|NCT00556933|4108027|B3|||Patient Body Mass Index (BMI)||kg/m^2|Mean|28.8|28.8|Standard Deviation|7.0|7.0|||
4283288|NCT00556933|4108028|B2|||Patient Body Mass Index (BMI)||kg/m^2|Mean|27.9|27.9|Standard Deviation|6.6|6.6|||
4283289|NCT00556933|4108029|B1|||Patient Body Mass Index (BMI)||kg/m^2|Mean|28.5|28.5|Standard Deviation|5.0|5.0|||
4283290|NCT00556933|4108025|B5|Non Caucasian/Asian||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4283291|NCT00556933|4108026|B4|Non Caucasian/Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4283292|NCT00556933|4108027|B3|Non Caucasian/Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4283293|NCT00556933|4108028|B2|Non Caucasian/Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4283294|NCT00556933|4108029|B1|Non Caucasian/Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4283295|NCT00556933|4108025|B5|Caucasian/Asian||Race/Ethnicity, Customized||participants|Number|157|157.0||||||
4283296|NCT00556933|4108026|B4|Caucasian/Asian||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4283297|NCT00556933|4108027|B3|Caucasian/Asian||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4283298|NCT00556933|4108028|B2|Caucasian/Asian||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4283299|NCT00556933|4108029|B1|Caucasian/Asian||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4283300|NCT00556933|4108025|B5||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4283301|NCT00556933|4108026|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4283302|NCT00556933|4108027|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4283303|NCT00556933|4108028|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4283304|NCT00556933|4108029|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4283305|NCT00556933|4108025|B5||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4283306|NCT00556933|4108026|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4283307|NCT00556933|4108027|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4283308|NCT00556933|4108028|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4283309|NCT00556933|4108029|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4283310|NCT00556933|4108025|B5|||Age||years|Mean|47.2|47.2|Standard Deviation|11.8|11.8|||
4283311|NCT00556933|4108026|B4|||Age||years|Mean|51.6|51.6|Standard Deviation|9.7|9.7|||
4283312|NCT00556933|4108027|B3|||Age||years|Mean|44.1|44.1|Standard Deviation|13.2|13.2|||
4283313|NCT00556933|4108028|B2|||Age||years|Mean|47.1|47.1|Standard Deviation|11.2|11.2|||
4283314|NCT00556933|4108029|B1|||Age||years|Mean|45.8|45.8|Standard Deviation|12|12.0|||
4283315|NCT00556894|4108086|B4|Bulgaria||Region of Enrollment||participants|Number|91|91.0||||||
4283316|NCT00556894|4108087|B3|Bulgaria||Region of Enrollment||participants|Number|30|30.0||||||
4283317|NCT00556894|4108088|B2|Bulgaria||Region of Enrollment||participants|Number|32|32.0||||||
4283318|NCT00556894|4108089|B1|Bulgaria||Region of Enrollment||participants|Number|29|29.0||||||
4283319|NCT00556894|4108086|B4|Israel||Region of Enrollment||participants|Number|26|26.0||||||
4283320|NCT00556894|4108087|B3|Israel||Region of Enrollment||participants|Number|8|8.0||||||
4283321|NCT00556894|4108088|B2|Israel||Region of Enrollment||participants|Number|9|9.0||||||
4283322|NCT00556894|4108089|B1|Israel||Region of Enrollment||participants|Number|9|9.0||||||
4283323|NCT00556894|4108086|B4|Ukraine||Region of Enrollment||participants|Number|74|74.0||||||
4283324|NCT00556894|4108087|B3|Ukraine||Region of Enrollment||participants|Number|26|26.0||||||
4283325|NCT00556894|4108088|B2|Ukraine||Region of Enrollment||participants|Number|26|26.0||||||
4283326|NCT00556894|4108089|B1|Ukraine||Region of Enrollment||participants|Number|22|22.0||||||
4283327|NCT00556894|4108086|B4|Serbia||Region of Enrollment||participants|Number|62|62.0||||||
4283328|NCT00556894|4108087|B3|Serbia||Region of Enrollment||participants|Number|20|20.0||||||
4283329|NCT00556894|4108088|B2|Serbia||Region of Enrollment||participants|Number|20|20.0||||||
4283330|NCT00556894|4108089|B1|Serbia||Region of Enrollment||participants|Number|22|22.0||||||
4283331|NCT00556894|4108086|B4||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4283332|NCT00556894|4108087|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4283333|NCT00556894|4108088|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4283334|NCT00556894|4108089|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4283335|NCT00556894|4108086|B4||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4283336|NCT00556894|4108087|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4283337|NCT00556894|4108088|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4283338|NCT00556894|4108089|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4283339|NCT00556894|4108086|B4|||Age||years|Median|54|54.0|Full Range|||24.0|75.0|
4283340|NCT00556894|4108087|B3|||Age||years|Median|54|54.0|Full Range|||33.0|73.0|
4283341|NCT00556894|4108088|B2|||Age||years|Median|54|54.0|Full Range|||25.0|75.0|
4283342|NCT00556894|4108089|B1|||Age||years|Median|55|55.0|Full Range|||24.0|75.0|
4283343|NCT00556894|4108086|B4||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
4283344|NCT00556894|4108087|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4283345|NCT00556894|4108088|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4283346|NCT00556894|4108089|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4283347|NCT00556894|4108086|B4||Between 18 and 65 years|Age||Participants|Count of Participants|204|204.0||||||
4283348|NCT00556894|4108087|B3||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
4283349|NCT00556894|4108088|B2||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
4283350|NCT00556894|4108089|B1||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4283351|NCT00556894|4108086|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4283352|NCT00556894|4108087|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4283353|NCT00556894|4108088|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4283354|NCT00556894|4108089|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4283355|NCT00556712|4108099|B3||Male|Sex: Female, Male||Participants|Count of Participants|659|659.0||||||
4283356|NCT00556712|4108100|B2||Male|Sex: Female, Male||Participants|Count of Participants|321|321.0||||||
4283357|NCT00556712|4108101|B1||Male|Sex: Female, Male||Participants|Count of Participants|338|338.0||||||
4283358|NCT00556712|4108099|B3||Female|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4283359|NCT00556712|4108100|B2||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4283360|NCT00556712|4108101|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4283361|NCT00556712|4108099|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|9.44|9.44|||
4283362|NCT00556712|4108100|B2|||Age||years|Mean|59.8|59.8|Standard Deviation|9.52|9.52|||
4283363|NCT00556712|4108101|B1|||Age||years|Mean|59.7|59.7|Standard Deviation|9.39|9.39|||
4283364|NCT00556673|4108178|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4283365|NCT00556673|4108179|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4283366|NCT00556673|4108180|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4283367|NCT00556673|4108178|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4283368|NCT00556673|4108179|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4283369|NCT00556673|4108180|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4283370|NCT00556673|4108178|B3|||Age||years|Mean|40.3|40.3|Standard Deviation|9.85|9.85|||
4283371|NCT00556673|4108179|B2|||Age||years|Mean|41.5|41.5|Standard Deviation|7.23|7.23|||
4283372|NCT00556673|4108180|B1|||Age||years|Mean|39.1|39.1|Standard Deviation|11.93|11.93|||
4283373|NCT00556543|4108217|B1|Rib Fracture, Chronic Non-Union||Rib Fracture|"Acute Rib Fracture: Subjects with 1. multiple rib fractures and flail chest injury with failure to wean from ventilator (>5 days post-injury, 2. painful, displaced rib fractures who do not receive adequate pain control from usual care, and 3. chest wall defect (visible deformity) / severely displaced rib fractures will be included. Subjects who have sustained a severe head injury or those with extensive associated injuries will not be included.~Chronic Rib Fracture Non-Union: Subjects with CT evidence of non-healed rib fractures > 2 months from time of injury, with rib pain."|Participants|Number|4|4.0||||||
4283374|NCT00556543|4108217|B1|Rib Fracture, Acute||Rib Fracture|"Acute Rib Fracture: Subjects with 1. multiple rib fractures and flail chest injury with failure to wean from ventilator (>5 days post-injury, 2. painful, displaced rib fractures who do not receive adequate pain control from usual care, and 3. chest wall defect (visible deformity) / severely displaced rib fractures will be included. Subjects who have sustained a severe head injury or those with extensive associated injuries will not be included.~Chronic Rib Fracture Non-Union: Subjects with CT evidence of non-healed rib fractures > 2 months from time of injury, with rib pain."|Participants|Number|6|6.0||||||
4283375|NCT00556543|4108217|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4283376|NCT00556543|4108217|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4283377|NCT00556543|4108217|B1|||Age||years|Mean|46.5|46.5|Standard Deviation|22.5|22.5|||
4283378|NCT00556543|4108217|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4283379|NCT00556543|4108217|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4283380|NCT00556543|4108217|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4283381|NCT00556504|4108233|B3|Fibrosis score 2||Fibrosis score|"Liver biopsy within 12 months prior to study entry showed liver cirrhosis with METAVIR system fibrosis score~0 No fibrosis~Stellate enlargement of portal tract but without septa formation~Enlargement of portal tract with rare septa formation"|participants|Number|50|50.0||||||
4283382|NCT00556504|4108234|B2|Fibrosis score 2||Fibrosis score|"Liver biopsy within 12 months prior to study entry showed liver cirrhosis with METAVIR system fibrosis score~0 No fibrosis~Stellate enlargement of portal tract but without septa formation~Enlargement of portal tract with rare septa formation"|participants|Number|19|19.0||||||
4283383|NCT00556504|4108235|B1|Fibrosis score 2||Fibrosis score|"Liver biopsy within 12 months prior to study entry showed liver cirrhosis with METAVIR system fibrosis score~0 No fibrosis~Stellate enlargement of portal tract but without septa formation~Enlargement of portal tract with rare septa formation"|participants|Number|31|31.0||||||
4283384|NCT00556504|4108233|B3|Fibrosis score 1||Fibrosis score|"Liver biopsy within 12 months prior to study entry showed liver cirrhosis with METAVIR system fibrosis score~0 No fibrosis~Stellate enlargement of portal tract but without septa formation~Enlargement of portal tract with rare septa formation"|participants|Number|32|32.0||||||
4283385|NCT00556504|4108234|B2|Fibrosis score 1||Fibrosis score|"Liver biopsy within 12 months prior to study entry showed liver cirrhosis with METAVIR system fibrosis score~0 No fibrosis~Stellate enlargement of portal tract but without septa formation~Enlargement of portal tract with rare septa formation"|participants|Number|21|21.0||||||
4283386|NCT00556504|4108235|B1|Fibrosis score 1||Fibrosis score|"Liver biopsy within 12 months prior to study entry showed liver cirrhosis with METAVIR system fibrosis score~0 No fibrosis~Stellate enlargement of portal tract but without septa formation~Enlargement of portal tract with rare septa formation"|participants|Number|11|11.0||||||
4283387|NCT00556504|4108233|B3|Fibrosis score 0||Fibrosis score|"Liver biopsy within 12 months prior to study entry showed liver cirrhosis with METAVIR system fibrosis score~0 No fibrosis~Stellate enlargement of portal tract but without septa formation~Enlargement of portal tract with rare septa formation"|participants|Number|2|2.0||||||
4283388|NCT00556504|4108234|B2|Fibrosis score 0||Fibrosis score|"Liver biopsy within 12 months prior to study entry showed liver cirrhosis with METAVIR system fibrosis score~0 No fibrosis~Stellate enlargement of portal tract but without septa formation~Enlargement of portal tract with rare septa formation"|participants|Number|2|2.0||||||
4283389|NCT00556504|4108235|B1|Fibrosis score 0||Fibrosis score|"Liver biopsy within 12 months prior to study entry showed liver cirrhosis with METAVIR system fibrosis score~0 No fibrosis~Stellate enlargement of portal tract but without septa formation~Enlargement of portal tract with rare septa formation"|participants|Number|0|0.0||||||
4283390|NCT00556504|4108233|B3|Taiwan||Region of Enrollment||participants|Number|84|84.0||||||
4283391|NCT00556504|4108234|B2|Taiwan||Region of Enrollment||participants|Number|42|42.0||||||
4283392|NCT00556504|4108235|B1|Taiwan||Region of Enrollment||participants|Number|42|42.0||||||
4283393|NCT00556504|4108233|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4283394|NCT00556504|4108234|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4283395|NCT00556504|4108235|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4283396|NCT00556504|4108233|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4283397|NCT00556504|4108234|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4283398|NCT00556504|4108235|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4283399|NCT00556504|4108233|B3|||Age||years|Mean|48.67|48.67|Standard Deviation|10.53|10.53|||
4283400|NCT00556504|4108234|B2|||Age||years|Mean|48.74|48.74|Standard Deviation|11.52|11.52|||
4283401|NCT00556504|4108235|B1|||Age||years|Mean|48.6|48.6|Standard Deviation|9.58|9.58|||
4283402|NCT00556504|4108233|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4283403|NCT00556504|4108234|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4283404|NCT00556504|4108235|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4283405|NCT00556504|4108233|B3||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
4283406|NCT00556504|4108234|B2||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4283407|NCT00556504|4108235|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4283408|NCT00556504|4108233|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4283409|NCT00556504|4108234|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4283410|NCT00556504|4108235|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4283411|NCT00556491|4108254|B3|||kidney function|Estimated GFR (MDRD)|ml/min|Mean|74.3|74.3|Standard Deviation|26.9|26.9|||
4283412|NCT00556491|4108255|B2|||kidney function|Estimated GFR (MDRD)|ml/min|Mean|77.3|77.3|Standard Deviation|27.4|27.4|||
4283413|NCT00556491|4108256|B1|||kidney function|Estimated GFR (MDRD)|ml/min|Mean|71.9|71.9|Standard Deviation|26.4|26.4|||
4283414|NCT00556491|4108254|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4283415|NCT00556491|4108255|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4283416|NCT00556491|4108256|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4283417|NCT00556491|4108254|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283418|NCT00556491|4108255|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283419|NCT00556491|4108256|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283420|NCT00556491|4108254|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283421|NCT00556491|4108255|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283422|NCT00556491|4108256|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283423|NCT00556491|4108254|B3||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4283424|NCT00556491|4108255|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4283425|NCT00556491|4108256|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4283426|NCT00556491|4108254|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4283427|NCT00556491|4108255|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4283428|NCT00556491|4108256|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4283429|NCT00556491|4108254|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283430|NCT00556491|4108255|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283431|NCT00556491|4108256|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283432|NCT00556491|4108254|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283433|NCT00556491|4108255|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283434|NCT00556491|4108256|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283435|NCT00556491|4108254|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283436|NCT00556491|4108255|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283437|NCT00556491|4108256|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283438|NCT00556491|4108254|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4283439|NCT00556491|4108255|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4283440|NCT00556491|4108256|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4283441|NCT00556491|4108254|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4283442|NCT00556491|4108255|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4283443|NCT00556491|4108256|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4283444|NCT00556491|4108254|B3|||Age||years|Mean|62|62.0|Standard Deviation|10.4|10.4|||
4283445|NCT00556491|4108255|B2|||Age||years|Mean|60.8|60.8|Standard Deviation|11.5|11.5|||
4283446|NCT00556491|4108256|B1|||Age||years|Mean|64.1|64.1|Standard Deviation|9.9|9.9|||
4283447|NCT00556491|4108254|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4283448|NCT00556491|4108255|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4283449|NCT00556491|4108256|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4283450|NCT00556491|4108254|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4283451|NCT00556491|4108255|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4283452|NCT00556491|4108256|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4283453|NCT00556491|4108254|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4283454|NCT00556491|4108255|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4283455|NCT00556491|4108256|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4283456|NCT00556478|4108273|B3|United States||Region of Enrollment||participants|Number|128|128.0||||||
4283457|NCT00556478|4108274|B2|United States||Region of Enrollment||participants|Number|43|43.0||||||
4283458|NCT00556478|4108275|B1|United States||Region of Enrollment||participants|Number|85|85.0||||||
4283459|NCT00556478|4108273|B3|Canada||Region of Enrollment||participants|Number|21|21.0||||||
4283460|NCT00556478|4108274|B2|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4283461|NCT00556478|4108275|B1|Canada||Region of Enrollment||participants|Number|14|14.0||||||
4283462|NCT00556478|4108273|B3|Poland||Region of Enrollment||participants|Number|100|100.0||||||
4283463|NCT00556478|4108274|B2|Poland||Region of Enrollment||participants|Number|32|32.0||||||
4283464|NCT00556478|4108275|B1|Poland||Region of Enrollment||participants|Number|68|68.0||||||
4283465|NCT00556478|4108273|B3||Male|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
4283466|NCT00556478|4108274|B2||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4283467|NCT00556478|4108275|B1||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4283468|NCT00556478|4108273|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4283469|NCT00556478|4108274|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4283470|NCT00556478|4108275|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4283471|NCT00556478|4108273|B3|||Age||years|Mean|38.7|38.7|Standard Deviation|11.78|11.78|||
4283472|NCT00556478|4108274|B2|||Age||years|Mean|37.9|37.9|Standard Deviation|11.97|11.97|||
4283473|NCT00556478|4108275|B1|||Age||years|Mean|39.1|39.1|Standard Deviation|11.71|11.71|||
4283474|NCT00556478|4108273|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4283475|NCT00556478|4108274|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4283476|NCT00556478|4108275|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4283477|NCT00556478|4108273|B3||Between 18 and 65 years|Age||Participants|Count of Participants|244|244.0||||||
4283478|NCT00556478|4108274|B2||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
4283479|NCT00556478|4108275|B1||Between 18 and 65 years|Age||Participants|Count of Participants|163|163.0||||||
4283480|NCT00556478|4108273|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4283481|NCT00556478|4108274|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4283482|NCT00556478|4108275|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4283483|NCT00556452|4108301|B4|Multiple Myeloma (MM)||Disease|The number of patients with each disease type.|participants|Number|1|1.0||||||
4283484|NCT00556452|4108302|B3|Multiple Myeloma (MM)||Disease|The number of patients with each disease type.|participants|Number|0|0.0||||||
4283485|NCT00556452|4108303|B2|Multiple Myeloma (MM)||Disease|The number of patients with each disease type.|participants|Number|1|1.0||||||
4283486|NCT00556452|4108304|B1|Multiple Myeloma (MM)||Disease|The number of patients with each disease type.|participants|Number|0|0.0||||||
4283487|NCT00556452|4108301|B4|Myelodysplastic Syndromes (MDS)||Disease|The number of patients with each disease type.|participants|Number|1|1.0||||||
4283488|NCT00556452|4108302|B3|Myelodysplastic Syndromes (MDS)||Disease|The number of patients with each disease type.|participants|Number|1|1.0||||||
4283489|NCT00556452|4108303|B2|Myelodysplastic Syndromes (MDS)||Disease|The number of patients with each disease type.|participants|Number|0|0.0||||||
4283490|NCT00556452|4108304|B1|Myelodysplastic Syndromes (MDS)||Disease|The number of patients with each disease type.|participants|Number|0|0.0||||||
4283491|NCT00556452|4108301|B4|Non-Hodgkin Lymphoma (NHL)||Disease|The number of patients with each disease type.|participants|Number|3|3.0||||||
4283492|NCT00556452|4108302|B3|Non-Hodgkin Lymphoma (NHL)||Disease|The number of patients with each disease type.|participants|Number|1|1.0||||||
4283493|NCT00556452|4108303|B2|Non-Hodgkin Lymphoma (NHL)||Disease|The number of patients with each disease type.|participants|Number|2|2.0||||||
4283549|NCT00556439|4108315|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4283494|NCT00556452|4108304|B1|Non-Hodgkin Lymphoma (NHL)||Disease|The number of patients with each disease type.|participants|Number|0|0.0||||||
4283495|NCT00556452|4108301|B4|Chronic Lymphocytic Leukemia (CLL)||Disease|The number of patients with each disease type.|participants|Number|4|4.0||||||
4283496|NCT00556452|4108302|B3|Chronic Lymphocytic Leukemia (CLL)||Disease|The number of patients with each disease type.|participants|Number|1|1.0||||||
4283497|NCT00556452|4108303|B2|Chronic Lymphocytic Leukemia (CLL)||Disease|The number of patients with each disease type.|participants|Number|3|3.0||||||
4283498|NCT00556452|4108304|B1|Chronic Lymphocytic Leukemia (CLL)||Disease|The number of patients with each disease type.|participants|Number|0|0.0||||||
4283499|NCT00556452|4108301|B4|Acute Lymphoblastic Leukemia (ALL)||Disease|The number of patients with each disease type.|participants|Number|4|4.0||||||
4283500|NCT00556452|4108302|B3|Acute Lymphoblastic Leukemia (ALL)||Disease|The number of patients with each disease type.|participants|Number|2|2.0||||||
4283501|NCT00556452|4108303|B2|Acute Lymphoblastic Leukemia (ALL)||Disease|The number of patients with each disease type.|participants|Number|1|1.0||||||
4283502|NCT00556452|4108304|B1|Acute Lymphoblastic Leukemia (ALL)||Disease|The number of patients with each disease type.|participants|Number|1|1.0||||||
4283503|NCT00556452|4108301|B4|Chronic Myeloid Leukemia (CML)||Disease|The number of patients with each disease type.|participants|Number|2|2.0||||||
4283504|NCT00556452|4108302|B3|Chronic Myeloid Leukemia (CML)||Disease|The number of patients with each disease type.|participants|Number|0|0.0||||||
4283505|NCT00556452|4108303|B2|Chronic Myeloid Leukemia (CML)||Disease|The number of patients with each disease type.|participants|Number|1|1.0||||||
4283506|NCT00556452|4108304|B1|Chronic Myeloid Leukemia (CML)||Disease|The number of patients with each disease type.|participants|Number|1|1.0||||||
4283507|NCT00556452|4108301|B4|Acute Myeloid Leukemia (AML)||Disease|The number of patients with each disease type.|participants|Number|31|31.0||||||
4283508|NCT00556452|4108302|B3|Acute Myeloid Leukemia (AML)||Disease|The number of patients with each disease type.|participants|Number|14|14.0||||||
4283509|NCT00556452|4108303|B2|Acute Myeloid Leukemia (AML)||Disease|The number of patients with each disease type.|participants|Number|13|13.0||||||
4283510|NCT00556452|4108304|B1|Acute Myeloid Leukemia (AML)||Disease|The number of patients with each disease type.|participants|Number|4|4.0||||||
4283511|NCT00556452|4108301|B4|United States||Region of Enrollment||participants|Number|46|46.0||||||
4283512|NCT00556452|4108302|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4283513|NCT00556452|4108303|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4283514|NCT00556452|4108304|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4283515|NCT00556452|4108301|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4283516|NCT00556452|4108302|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4283517|NCT00556452|4108303|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4283518|NCT00556452|4108304|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4283519|NCT00556452|4108301|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4283520|NCT00556452|4108302|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4283521|NCT00556452|4108303|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4283522|NCT00556452|4108304|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4283523|NCT00556452|4108301|B4|||Age||years|Median|53|53.0|Full Range|||1.0|68.0|
4283524|NCT00556452|4108302|B3|||Age||years|Median|51|51.0|Full Range|||1.0|67.0|
4283525|NCT00556452|4108303|B2|||Age||years|Median|54|54.0|Full Range|||18.0|68.0|
4283526|NCT00556452|4108304|B1|||Age||years|Median|48.5|48.5|Full Range|||14.0|61.0|
4283527|NCT00556439|4108313|B5|United States||Region of Enrollment||participants|Number|50|50.0||||||
4283528|NCT00556439|4108314|B4|United States||Region of Enrollment||participants|Number|12|12.0||||||
4283529|NCT00556439|4108315|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4283530|NCT00556439|4108316|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4283531|NCT00556439|4108317|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4283532|NCT00556439|4108313|B5|Canada||Region of Enrollment||participants|Number|17|17.0||||||
4283533|NCT00556439|4108314|B4|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4283534|NCT00556439|4108315|B3|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4283535|NCT00556439|4108316|B2|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4283536|NCT00556439|4108317|B1|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4283537|NCT00556439|4108313|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4283538|NCT00556439|4108314|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283539|NCT00556439|4108315|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4283540|NCT00556439|4108316|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283541|NCT00556439|4108317|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283542|NCT00556439|4108313|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283543|NCT00556439|4108314|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283544|NCT00556439|4108315|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283545|NCT00556439|4108316|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283546|NCT00556439|4108317|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283547|NCT00556439|4108313|B5||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4283548|NCT00556439|4108314|B4||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4283550|NCT00556439|4108316|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4283551|NCT00556439|4108317|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4283552|NCT00556439|4108313|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4283553|NCT00556439|4108314|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283554|NCT00556439|4108315|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4283555|NCT00556439|4108316|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4283556|NCT00556439|4108317|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4283557|NCT00556439|4108313|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283558|NCT00556439|4108314|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283559|NCT00556439|4108315|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283560|NCT00556439|4108316|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283561|NCT00556439|4108317|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283562|NCT00556439|4108313|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4283563|NCT00556439|4108314|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4283564|NCT00556439|4108315|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4283565|NCT00556439|4108316|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4283566|NCT00556439|4108317|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283567|NCT00556439|4108313|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283568|NCT00556439|4108314|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283569|NCT00556439|4108315|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283570|NCT00556439|4108316|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283571|NCT00556439|4108317|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283572|NCT00556439|4108313|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4283573|NCT00556439|4108314|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4283574|NCT00556439|4108315|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283575|NCT00556439|4108316|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283576|NCT00556439|4108317|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4283577|NCT00556439|4108313|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4283578|NCT00556439|4108314|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4283579|NCT00556439|4108315|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4283580|NCT00556439|4108316|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4283581|NCT00556439|4108317|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4283582|NCT00556439|4108313|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4283583|NCT00556439|4108314|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283584|NCT00556439|4108315|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4283585|NCT00556439|4108316|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283586|NCT00556439|4108317|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283587|NCT00556439|4108313|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4283588|NCT00556439|4108314|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4283589|NCT00556439|4108315|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4283590|NCT00556439|4108316|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4283591|NCT00556439|4108317|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4283592|NCT00556439|4108313|B5||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4283593|NCT00556439|4108314|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4283594|NCT00556439|4108315|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4283595|NCT00556439|4108316|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4283596|NCT00556439|4108317|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4283597|NCT00556439|4108313|B5|||Age||Years|Median|48.74|48.74|Full Range|||19.93|86.63|
4283598|NCT00556439|4108314|B4|||Age||Years|Median|28.61|28.61|Full Range|||19.54|56.97|
4283599|NCT00556439|4108315|B3|||Age||Years|Median|30.17|30.17|Full Range|||18.93|58.94|
4283600|NCT00556439|4108316|B2|||Age||Years|Median|71.48|71.48|Full Range|||54.26|86.63|
4283601|NCT00556439|4108317|B1|||Age||Years|Median|63.47|63.47|Full Range|||57.27|80.13|
4283602|NCT00556439|4108313|B5||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4283603|NCT00556439|4108314|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4283604|NCT00556439|4108315|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4283605|NCT00556439|4108316|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4283606|NCT00556439|4108317|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4283607|NCT00556439|4108313|B5||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4283608|NCT00556439|4108314|B4||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4283609|NCT00556439|4108315|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4283610|NCT00556439|4108316|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4283611|NCT00556439|4108317|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4283612|NCT00556439|4108313|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4283613|NCT00556439|4108314|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4283614|NCT00556439|4108315|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4283615|NCT00556439|4108316|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4283616|NCT00556439|4108317|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4283617|NCT00556426|4108330|B1|no active thromboembolic disease||Indication for Placement|Patients with active thromboembolic disease (the presence of Deep Vein Thrombosis (DVT) or pulmonary embolism (PE) within 3 months of study enrollment).|Number of Participants|Number|57|57.0||||||
4283618|NCT00556426|4108330|B1|active thromboembolic disease||Indication for Placement|Patients with active thromboembolic disease (the presence of Deep Vein Thrombosis (DVT) or pulmonary embolism (PE) within 3 months of study enrollment).|Number of Participants|Number|43|43.0||||||
4283619|NCT00556426|4108330|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
4283620|NCT00556426|4108330|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4283621|NCT00556426|4108330|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4283622|NCT00556426|4108330|B1|||Age||years|Mean|52.1|52.1|Standard Deviation|16.7|16.7|||
4283623|NCT00556400|4108338|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4283624|NCT00556400|4108340|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4283625|NCT00556400|4108338|B3|Male||Gender||participants|Number|0|0.0||||||
4283626|NCT00556400|4108340|B1|Male||Gender||participants|Number|0|0.0||||||
4283627|NCT00556400|4108338|B3|Female||Gender||participants|Number|1|1.0||||||
4283628|NCT00556400|4108340|B1|Female||Gender||participants|Number|1|1.0||||||
4283629|NCT00556400|4108338|B3|>=65 years||Age||participants|Number|0|0.0||||||
4283630|NCT00556400|4108340|B1|>=65 years||Age||participants|Number|0|0.0||||||
4283631|NCT00556400|4108338|B3|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
4283632|NCT00556400|4108340|B1|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
4283633|NCT00556400|4108338|B3|<=18 years||Age||participants|Number|1|1.0||||||
4283634|NCT00556400|4108340|B1|<=18 years||Age||participants|Number|1|1.0||||||
4283635|NCT00556374|4108350|B3|T-score ≥ -1.0||Stratification Factor: Total Lumbar Spine Bone Mineral Density T-score||participants|Number|1872|1872.0||||||
4283636|NCT00556374|4108351|B2|T-score ≥ -1.0||Stratification Factor: Total Lumbar Spine Bone Mineral Density T-score||participants|Number|938|938.0||||||
4283637|NCT00556374|4108352|B1|T-score ≥ -1.0||Stratification Factor: Total Lumbar Spine Bone Mineral Density T-score||participants|Number|934|934.0||||||
4283638|NCT00556374|4108350|B3|T-score < -1.0||Stratification Factor: Total Lumbar Spine Bone Mineral Density T-score||participants|Number|1548|1548.0||||||
4283639|NCT00556374|4108351|B2|T-score < -1.0||Stratification Factor: Total Lumbar Spine Bone Mineral Density T-score||participants|Number|773|773.0||||||
4283640|NCT00556374|4108352|B1|T-score < -1.0||Stratification Factor: Total Lumbar Spine Bone Mineral Density T-score||participants|Number|775|775.0||||||
4283641|NCT00556374|4108350|B3|Yes||Stratification Factor: Prior Aromatase inhibitor Use||participants|Number|2881|2881.0||||||
4283642|NCT00556374|4108351|B2|Yes||Stratification Factor: Prior Aromatase inhibitor Use||participants|Number|1441|1441.0||||||
4283643|NCT00556374|4108352|B1|Yes||Stratification Factor: Prior Aromatase inhibitor Use||participants|Number|1440|1440.0||||||
4283644|NCT00556374|4108350|B3|No||Stratification Factor: Prior Aromatase inhibitor Use||participants|Number|539|539.0||||||
4283645|NCT00556374|4108351|B2|No||Stratification Factor: Prior Aromatase inhibitor Use||participants|Number|270|270.0||||||
4283646|NCT00556374|4108352|B1|No||Stratification Factor: Prior Aromatase inhibitor Use||participants|Number|269|269.0||||||
4283647|NCT00556374|4108350|B3|Other Center||Stratification Factor: Type of Hospital||particpants|Number|2155|2155.0||||||
4283648|NCT00556374|4108351|B2|Other Center||Stratification Factor: Type of Hospital||particpants|Number|1078|1078.0||||||
4283649|NCT00556374|4108352|B1|Other Center||Stratification Factor: Type of Hospital||particpants|Number|1077|1077.0||||||
4283650|NCT00556374|4108350|B3|Major Academic Center||Stratification Factor: Type of Hospital||particpants|Number|1265|1265.0||||||
4283651|NCT00556374|4108351|B2|Major Academic Center||Stratification Factor: Type of Hospital||particpants|Number|633|633.0||||||
4283652|NCT00556374|4108352|B1|Major Academic Center||Stratification Factor: Type of Hospital||particpants|Number|632|632.0||||||
4283653|NCT00556374|4108350|B3|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4283654|NCT00556374|4108351|B2|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4283655|NCT00556374|4108352|B1|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4283656|NCT00556374|4108350|B3|Black/Afro-Caribbean||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4283657|NCT00556374|4108351|B2|Black/Afro-Caribbean||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4283658|NCT00556374|4108352|B1|Black/Afro-Caribbean||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4283659|NCT00556374|4108350|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4283660|NCT00556374|4108351|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4283661|NCT00556374|4108352|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4283662|NCT00556374|4108350|B3|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4283663|NCT00556374|4108351|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4283664|NCT00556374|4108352|B1|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4283665|NCT00556374|4108350|B3|White/Caucasian||Race/Ethnicity, Customized||participants|Number|3402|3402.0||||||
4283666|NCT00556374|4108351|B2|White/Caucasian||Race/Ethnicity, Customized||participants|Number|1702|1702.0||||||
4283667|NCT00556374|4108352|B1|White/Caucasian||Race/Ethnicity, Customized||participants|Number|1700|1700.0||||||
4283668|NCT00556374|4108350|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4283669|NCT00556374|4108351|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4283670|NCT00556374|4108352|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4283671|NCT00556374|4108350|B3||Female|Sex: Female, Male||Participants|Count of Participants|3420|3420.0||||||
4283672|NCT00556374|4108351|B2||Female|Sex: Female, Male||Participants|Count of Participants|1711|1711.0||||||
4283673|NCT00556374|4108352|B1||Female|Sex: Female, Male||Participants|Count of Participants|1709|1709.0||||||
4283674|NCT00556374|4108350|B3|||Age||years|Mean|64.3|64.3|Standard Deviation|8.0|8.0|||
4283675|NCT00556374|4108351|B2|||Age||years|Mean|64.0|64.0|Standard Deviation|7.9|7.9|||
4283676|NCT00556374|4108352|B1|||Age||years|Mean|64.6|64.6|Standard Deviation|8.0|8.0|||
4283677|NCT00556322|4108369|B3||Male|Sex: Female, Male||Participants|Count of Participants|321|321.0||||||
4283678|NCT00556322|4108370|B2||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4283679|NCT00556322|4108371|B1||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4283680|NCT00556322|4108369|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4283681|NCT00556322|4108370|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4283682|NCT00556322|4108371|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4283683|NCT00556322|4108369|B3|||Age||years|Mean|58.4|58.4|Standard Deviation|9.76|9.76|||
4283684|NCT00556322|4108370|B2|||Age||years|Mean|58.6|58.6|Standard Deviation|9.64|9.64|||
4283685|NCT00556322|4108371|B1|||Age||years|Mean|58.3|58.3|Standard Deviation|9.90|9.9|||
4283686|NCT00556166|4108420|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283687|NCT00556166|4108420|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4283688|NCT00556166|4108420|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4283689|NCT00556166|4108420|B1|Non-specific gender count||Sex/Gender, Customized||participants|Number|4|4.0||||||
4283690|NCT00556166|4108420|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4283691|NCT00556166|4108420|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4283692|NCT00556166|4108420|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4283693|NCT00556140|4108425|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4283694|NCT00556140|4108425|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4283695|NCT00556140|4108425|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4283696|NCT00556140|4108425|B1|||Age||years|Mean|41.8|41.8|Standard Deviation|12.9|12.9|||
4283697|NCT00556140|4108425|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4283698|NCT00556140|4108425|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4283699|NCT00556140|4108425|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4283700|NCT00556075|4108430|B4|United States||Region of Enrollment||participants|Number|67|67.0||||||
4283701|NCT00556075|4108431|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4283702|NCT00556075|4108432|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4283703|NCT00556075|4108433|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4283704|NCT00556075|4108430|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4283705|NCT00556075|4108431|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4283706|NCT00556075|4108432|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4283707|NCT00556075|4108433|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4283708|NCT00556075|4108430|B4||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4283709|NCT00556075|4108431|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4283710|NCT00556075|4108432|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4283711|NCT00556075|4108433|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4283712|NCT00556075|4108430|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4283713|NCT00556075|4108431|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4283714|NCT00556075|4108432|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4283715|NCT00556075|4108433|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4283716|NCT00556075|4108430|B4||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
4283717|NCT00556075|4108431|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4283718|NCT00556075|4108432|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4283719|NCT00556075|4108433|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4283720|NCT00556075|4108430|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4283721|NCT00556075|4108431|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4283722|NCT00556075|4108432|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4283723|NCT00556075|4108433|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4283724|NCT00556049|4108458|B1|United States||Region of Enrollment||participants|Number|72|72.0||||||
4283725|NCT00556049|4108458|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4283726|NCT00556049|4108458|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4283727|NCT00556049|4108458|B1|||Age||years|Median|58|58.0|Full Range|||45.0|75.0|
4283728|NCT00556049|4108458|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4283729|NCT00556049|4108458|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4283730|NCT00556049|4108458|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4283731|NCT00555997|4108462|B4|United States||Region of Enrollment||participants|Number|120|120.0||||||
4283732|NCT00555997|4108463|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
4283733|NCT00555997|4108464|B2|United States||Region of Enrollment||participants|Number|44|44.0||||||
4283734|NCT00555997|4108465|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
4283735|NCT00555997|4108462|B4||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4283736|NCT00555997|4108463|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4283737|NCT00555997|4108464|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4283738|NCT00555997|4108465|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4283739|NCT00555997|4108462|B4||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4283740|NCT00555997|4108463|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4283741|NCT00555997|4108464|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4283742|NCT00555997|4108465|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4283743|NCT00555997|4108462|B4|||Age||years|Mean|43.7|43.7|Standard Deviation|11.0|11.0|||
4283744|NCT00555997|4108463|B3|||Age||years|Mean|41.5|41.5|Standard Deviation|10.6|10.6|||
4283745|NCT00555997|4108464|B2|||Age||years|Mean|44.6|44.6|Standard Deviation|11.0|11.0|||
4283746|NCT00555997|4108465|B1|||Age||years|Mean|44.1|44.1|Standard Deviation|11.1|11.1|||
4283747|NCT00555997|4108462|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4283748|NCT00555997|4108463|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4283749|NCT00555997|4108464|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4283750|NCT00555997|4108465|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4283751|NCT00555997|4108462|B4||Between 18 and 65 years|Age||Participants|Count of Participants|118|118.0||||||
4283752|NCT00555997|4108463|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4283753|NCT00555997|4108464|B2||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4283754|NCT00555997|4108465|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4283755|NCT00555997|4108462|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4283756|NCT00555997|4108463|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4283757|NCT00555997|4108464|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4283758|NCT00555997|4108465|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4283759|NCT00555906|4108484|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4283760|NCT00555906|4108485|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4283761|NCT00555906|4108486|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4283762|NCT00555906|4108487|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4283763|NCT00555906|4108484|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4283764|NCT00555906|4108485|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4283765|NCT00555906|4108486|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4283766|NCT00555906|4108487|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4283767|NCT00555906|4108484|B4|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|26|26.0||||||
4283768|NCT00555906|4108485|B3|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|19|19.0||||||
4283769|NCT00555906|4108486|B2|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|4|4.0||||||
4283770|NCT00555906|4108487|B1|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|3|3.0||||||
4283771|NCT00555906|4108484|B4|45 to 64 years||Age, Customized||participants|Number|24|24.0||||||
4283772|NCT00555906|4108485|B3|45 to 64 years||Age, Customized||participants|Number|13|13.0||||||
4283773|NCT00555906|4108486|B2|45 to 64 years||Age, Customized||participants|Number|7|7.0||||||
4283774|NCT00555906|4108487|B1|45 to 64 years||Age, Customized||participants|Number|4|4.0||||||
4283775|NCT00555906|4108484|B4|18 to 44 years||Age, Customized||participants|Number|3|3.0||||||
4283776|NCT00555906|4108485|B3|18 to 44 years||Age, Customized||participants|Number|0|0.0||||||
4283777|NCT00555906|4108486|B2|18 to 44 years||Age, Customized||participants|Number|1|1.0||||||
4283778|NCT00555906|4108487|B1|18 to 44 years||Age, Customized||participants|Number|2|2.0||||||
4283779|NCT00555893|4108521|B3|Type B||Influenza Type|Number of individuals positive by polymerase chain reaction (PCR) assay by flu type; 1 excluded who was positive for both A & B|participants|Number|41|41.0||||||
4283780|NCT00555893|4108522|B2|Type B||Influenza Type|Number of individuals positive by polymerase chain reaction (PCR) assay by flu type; 1 excluded who was positive for both A & B|participants|Number|13|13.0||||||
4283781|NCT00555893|4108523|B1|Type B||Influenza Type|Number of individuals positive by polymerase chain reaction (PCR) assay by flu type; 1 excluded who was positive for both A & B|participants|Number|28|28.0||||||
4283782|NCT00555893|4108521|B3|Type A||Influenza Type|Number of individuals positive by polymerase chain reaction (PCR) assay by flu type; 1 excluded who was positive for both A & B|participants|Number|123|123.0||||||
4283783|NCT00555893|4108522|B2|Type A||Influenza Type|Number of individuals positive by polymerase chain reaction (PCR) assay by flu type; 1 excluded who was positive for both A & B|participants|Number|38|38.0||||||
4283784|NCT00555893|4108523|B1|Type A||Influenza Type|Number of individuals positive by polymerase chain reaction (PCR) assay by flu type; 1 excluded who was positive for both A & B|participants|Number|85|85.0||||||
4283785|NCT00555893|4108521|B3|United States||Region of Enrollment||participants|Number|165|165.0||||||
4283786|NCT00555893|4108522|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
4283787|NCT00555893|4108523|B1|United States||Region of Enrollment||participants|Number|114|114.0||||||
4283788|NCT00555893|4108521|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4283789|NCT00555893|4108522|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4283790|NCT00555893|4108523|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4283791|NCT00555893|4108521|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4283792|NCT00555893|4108522|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4283793|NCT00555893|4108523|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4283794|NCT00555893|4108521|B3|>18 years||Age, Customized||years|Number|78|78.0||||||
4283795|NCT00555893|4108522|B2|>18 years||Age, Customized||years|Number|22|22.0||||||
4283796|NCT00555893|4108523|B1|>18 years||Age, Customized||years|Number|56|56.0||||||
4283797|NCT00555893|4108521|B3|2-18 years||Age, Customized||years|Number|82|82.0||||||
4283798|NCT00555893|4108522|B2|2-18 years||Age, Customized||years|Number|28|28.0||||||
4283799|NCT00555893|4108523|B1|2-18 years||Age, Customized||years|Number|54|54.0||||||
4283800|NCT00555893|4108521|B3|<2 years||Age, Customized||years|Number|5|5.0||||||
4283801|NCT00555893|4108522|B2|<2 years||Age, Customized||years|Number|1|1.0||||||
4283802|NCT00555893|4108523|B1|<2 years||Age, Customized||years|Number|4|4.0||||||
4283803|NCT00555880|4108538|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283804|NCT00555880|4108539|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283805|NCT00555880|4108540|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283806|NCT00555880|4108538|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283807|NCT00555880|4108539|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283808|NCT00555880|4108540|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283809|NCT00555880|4108538|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4283810|NCT00555880|4108539|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4283811|NCT00555880|4108540|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4283812|NCT00555880|4108538|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4283813|NCT00555880|4108539|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4283814|NCT00555880|4108540|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4283815|NCT00555880|4108538|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283816|NCT00555880|4108539|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283817|NCT00555880|4108540|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283818|NCT00555880|4108538|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283819|NCT00555880|4108539|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283820|NCT00555880|4108540|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283821|NCT00555880|4108538|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283822|NCT00555880|4108539|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283823|NCT00555880|4108540|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283824|NCT00555880|4108538|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283825|NCT00555880|4108539|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283826|NCT00555880|4108540|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283827|NCT00555880|4108538|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4283828|NCT00555880|4108539|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4283829|NCT00555880|4108540|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4283830|NCT00555880|4108538|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283831|NCT00555880|4108539|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283832|NCT00555880|4108540|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283833|NCT00555880|4108538|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4283834|NCT00555880|4108539|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4283835|NCT00555880|4108540|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4283836|NCT00555880|4108538|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4283837|NCT00555880|4108539|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4283838|NCT00555880|4108540|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4283839|NCT00555880|4108538|B3|||Age||years|Mean|60.0|60.0|Standard Deviation|15.46|15.46|||
4283840|NCT00555880|4108539|B2|||Age||years|Mean|60.8|60.8|Standard Deviation|12.91|12.91|||
4283841|NCT00555880|4108540|B1|||Age||years|Mean|59.4|59.4|Standard Deviation|17.84|17.84|||
4283842|NCT00555750|4108578|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4283843|NCT00555750|4108579|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4283844|NCT00555750|4108580|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4283845|NCT00555750|4108578|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4283846|NCT00555750|4108579|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4283847|NCT00555750|4108580|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4283848|NCT00555750|4108578|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4283849|NCT00555750|4108579|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4283850|NCT00555750|4108580|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4283851|NCT00555750|4108578|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4283852|NCT00555750|4108579|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4283853|NCT00555750|4108580|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4283854|NCT00555750|4108578|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4283855|NCT00555750|4108579|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4283856|NCT00555750|4108580|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4283857|NCT00555750|4108578|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4283858|NCT00555750|4108579|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4283859|NCT00555750|4108580|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4283860|NCT00555672|4108611|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4283861|NCT00555672|4108612|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4283862|NCT00555672|4108613|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4283863|NCT00555672|4108611|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4283864|NCT00555672|4108612|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4283865|NCT00555672|4108613|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4283866|NCT00555672|4108611|B3|||Age||years|Mean|59.0|59.0|Standard Deviation|11.5|11.5|||
4283867|NCT00555672|4108612|B2|||Age||years|Mean|56.4|56.4|Standard Deviation|10.4|10.4|||
4283868|NCT00555672|4108613|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|12.0|12.0|||
4283869|NCT00555620|4108633|B7||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4283870|NCT00555620|4108634|B6||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4283871|NCT00555620|4108635|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4283872|NCT00555620|4108636|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4283873|NCT00555620|4108637|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4283874|NCT00555620|4108638|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4283875|NCT00555620|4108639|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4283876|NCT00555620|4108633|B7||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4283877|NCT00555620|4108634|B6||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4283878|NCT00555620|4108635|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4283879|NCT00555620|4108636|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4283880|NCT00555620|4108637|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4283881|NCT00555620|4108638|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4283882|NCT00555620|4108639|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4283883|NCT00555620|4108633|B7|||Age||years|Mean|52.4|52.4|Standard Deviation|10.9|10.9|||
4283884|NCT00555620|4108634|B6|||Age||years|Mean|50.1|50.1|Standard Deviation|11.5|11.5|||
4283885|NCT00555620|4108635|B5|||Age||years|Mean|63.3|63.3|Standard Deviation|11.6|11.6|||
4283886|NCT00555620|4108636|B4|||Age||years|Mean|54.3|54.3|Standard Deviation|10.1|10.1|||
4283887|NCT00555620|4108637|B3|||Age||years|Mean|50.9|50.9|Standard Deviation|11.3|11.3|||
4283888|NCT00555620|4108638|B2|||Age||years|Mean|50.0|50.0|Standard Deviation|12.4|12.4|||
4283889|NCT00555620|4108639|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|5.8|5.8|||
4283890|NCT00555581|4108756|B1|||MRSS at baseline|The Modified Rodnan Skin Score (MRSS) measures dermal skin thickness through the examination of 17 body areas: fingers, hands, forearms, arms, feet, legs, and thighs (in pairs), and face, chest, and abdomen. In each of these areas, the skin score is evaluated by manual palpation. The skin score is 0 for uninvolved skin, 1 for mild thickening, 2 for moderate thickening, and 3 for severe thickening (hidebound skin). The total skin score is the sum of the skin scores of the individual areas. The minimum score is 0 and the maximum score is 51. A higher score indicates greater severity of disease.|units on a scale|Mean|30.3|30.3|Standard Deviation|8.7|8.7|||
4283891|NCT00555581|4108756|B1|||Anti-Scl70 positive||Participants|Count of Participants|9|9.0||||||
4283892|NCT00555581|4108756|B1|Late||Disease Duration||years|Mean|6.1|6.1|Standard Deviation|1.6|1.6|||
4283893|NCT00555581|4108756|B1|Early||Disease Duration||years|Mean|2.1|2.1|Standard Deviation|1.2|1.2|||
4283894|NCT00555581|4108756|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4283895|NCT00555581|4108756|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283896|NCT00555581|4108756|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283897|NCT00555581|4108756|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4283898|NCT00555581|4108756|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4283899|NCT00555581|4108756|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283900|NCT00555581|4108756|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283901|NCT00555581|4108756|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283902|NCT00555581|4108756|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283903|NCT00555581|4108756|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4283904|NCT00555581|4108756|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4283905|NCT00555581|4108756|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4283906|NCT00555581|4108756|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4283907|NCT00555581|4108756|B1|||Age||years|Mean|48|48.0|Full Range|||18.0|71.0|
4283908|NCT00555581|4108756|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4283909|NCT00555581|4108756|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4283910|NCT00555581|4108756|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4283911|NCT00555568|4108765|B4|United States||Region of Enrollment||participants|Number|298|298.0||||||
4283912|NCT00555568|4108766|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
4283913|NCT00555568|4108767|B2|United States||Region of Enrollment||participants|Number|98|98.0||||||
4283914|NCT00555568|4108768|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
4283915|NCT00555568|4108765|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4283916|NCT00555568|4108766|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4283917|NCT00555568|4108767|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4283918|NCT00555568|4108768|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4283919|NCT00555568|4108765|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283920|NCT00555568|4108766|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283921|NCT00555568|4108767|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283922|NCT00555568|4108768|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283923|NCT00555568|4108765|B4||White|Race (NIH/OMB)||Participants|Count of Participants|190|190.0||||||
4283924|NCT00555568|4108766|B3||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4283925|NCT00555568|4108767|B2||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4283926|NCT00555568|4108768|B1||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4283927|NCT00555568|4108765|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
4283928|NCT00555568|4108766|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4283929|NCT00555568|4108767|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4283930|NCT00555568|4108768|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4283931|NCT00555568|4108765|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283932|NCT00555568|4108766|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283933|NCT00555568|4108767|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283934|NCT00555568|4108768|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283935|NCT00555568|4108765|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283936|NCT00555568|4108766|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283937|NCT00555568|4108767|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283938|NCT00555568|4108768|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283939|NCT00555568|4108765|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283940|NCT00555568|4108766|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283941|NCT00555568|4108767|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283942|NCT00555568|4108768|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283943|NCT00555568|4108765|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283944|NCT00555568|4108766|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283945|NCT00555568|4108767|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283946|NCT00555568|4108768|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4283947|NCT00555568|4108765|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|270|270.0||||||
4283948|NCT00555568|4108766|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
4283949|NCT00555568|4108767|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4283950|NCT00555568|4108768|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
4283951|NCT00555568|4108765|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4283952|NCT00555568|4108766|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4283953|NCT00555568|4108767|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4283954|NCT00555568|4108768|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4283955|NCT00555568|4108765|B4||Male|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
4283956|NCT00555568|4108766|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4283957|NCT00555568|4108767|B2||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4283958|NCT00555568|4108768|B1||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4283959|NCT00555568|4108765|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4283960|NCT00555568|4108766|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4283961|NCT00555568|4108767|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4283962|NCT00555568|4108768|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4283963|NCT00555568|4108765|B4|>60 years||Age, Customized||participants|Number|55|55.0||||||
4283964|NCT00555568|4108766|B3|>60 years||Age, Customized||participants|Number|21|21.0||||||
4283965|NCT00555568|4108767|B2|>60 years||Age, Customized||participants|Number|16|16.0||||||
4283966|NCT00555568|4108768|B1|>60 years||Age, Customized||participants|Number|18|18.0||||||
4283967|NCT00555568|4108765|B4|51-60 years||Age, Customized||participants|Number|132|132.0||||||
4283968|NCT00555568|4108766|B3|51-60 years||Age, Customized||participants|Number|52|52.0||||||
4283969|NCT00555568|4108767|B2|51-60 years||Age, Customized||participants|Number|36|36.0||||||
4283970|NCT00555568|4108768|B1|51-60 years||Age, Customized||participants|Number|44|44.0||||||
4283971|NCT00555568|4108765|B4|35-50 years||Age, Customized||participants|Number|93|93.0||||||
4283972|NCT00555568|4108766|B3|35-50 years||Age, Customized||participants|Number|24|24.0||||||
4283973|NCT00555568|4108767|B2|35-50 years||Age, Customized||participants|Number|38|38.0||||||
4283974|NCT00555568|4108768|B1|35-50 years||Age, Customized||participants|Number|31|31.0||||||
4283975|NCT00555568|4108765|B4|< 35 years||Age, Customized||participants|Number|18|18.0||||||
4283976|NCT00555568|4108766|B3|< 35 years||Age, Customized||participants|Number|3|3.0||||||
4283977|NCT00555568|4108767|B2|< 35 years||Age, Customized||participants|Number|8|8.0||||||
4283978|NCT00555568|4108768|B1|< 35 years||Age, Customized||participants|Number|7|7.0||||||
4283979|NCT00555477|4108790|B3|United States||Region of Enrollment||participants|Number|59|59.0||||||
4283980|NCT00555477|4108791|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
4283981|NCT00555477|4108792|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4283982|NCT00555477|4108790|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4283983|NCT00555477|4108791|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4283984|NCT00555477|4108792|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4283985|NCT00555477|4108790|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4283986|NCT00555477|4108791|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4283987|NCT00555477|4108792|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4283988|NCT00555477|4108790|B3|||Age||years|Median|50|50.0|Full Range|||40.0|56.0|
4283989|NCT00555477|4108791|B2|||Age||years|Median|50|50.0|Full Range|||40.0|56.0|
4283990|NCT00555477|4108792|B1|||Age||years|Median|46|46.0|Full Range|||44.0|52.0|
4283991|NCT00555464|4108798|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4283992|NCT00555464|4108799|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4283993|NCT00555464|4108800|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4283994|NCT00555464|4108798|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4283995|NCT00555464|4108799|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4283996|NCT00555464|4108800|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4283997|NCT00555464|4108798|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4283998|NCT00555464|4108799|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4283999|NCT00555464|4108800|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4284000|NCT00555464|4108798|B3|||Age||years|Mean|0.15|0.15|Standard Deviation|0.06|0.06|||
4284001|NCT00555464|4108799|B2|||Age||years|Mean|0.11|0.11|Standard Deviation|0.05|0.05|||
4284002|NCT00555464|4108800|B1|||Age||years|Mean|0.18|0.18|Standard Deviation|0.05|0.05|||
4284003|NCT00555464|4108798|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4284004|NCT00555464|4108799|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4284005|NCT00555464|4108800|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4284006|NCT00555464|4108798|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4284007|NCT00555464|4108799|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4284008|NCT00555464|4108800|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4284009|NCT00555464|4108798|B3||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4284010|NCT00555464|4108799|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4284011|NCT00555464|4108800|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4284012|NCT00555438|4108809|B1|France||Region of Enrollment||participants|Number|442|442.0||||||
4284013|NCT00555438|4108809|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4284014|NCT00555438|4108809|B1||Female|Sex: Female, Male||Participants|Count of Participants|353|353.0||||||
4284015|NCT00555438|4108809|B1|||Age||years|Mean|81.4|81.4|Standard Deviation|6.64|6.64|||
4284016|NCT00555438|4108809|B1||>=65 years|Age||Participants|Count of Participants|437|437.0||||||
4284017|NCT00555438|4108809|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4284018|NCT00555438|4108809|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4284019|NCT00555425|4108817|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4284020|NCT00555425|4108818|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4284021|NCT00555425|4108819|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284022|NCT00555425|4108817|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284023|NCT00555425|4108818|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284024|NCT00555425|4108819|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284025|NCT00555425|4108817|B3||White|Race (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
4284026|NCT00555425|4108818|B2||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4284027|NCT00555425|4108819|B1||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4284028|NCT00555425|4108817|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4284029|NCT00555425|4108818|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4284030|NCT00555425|4108819|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284031|NCT00555425|4108817|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284032|NCT00555425|4108818|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284033|NCT00555425|4108819|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284034|NCT00555425|4108817|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284035|NCT00555425|4108818|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284036|NCT00555425|4108819|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284037|NCT00555425|4108817|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4284038|NCT00555425|4108818|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284039|NCT00555425|4108819|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4284040|NCT00555425|4108817|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284041|NCT00555425|4108818|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284042|NCT00555425|4108819|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284043|NCT00555425|4108817|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
4284044|NCT00555425|4108818|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4284045|NCT00555425|4108819|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4284046|NCT00555425|4108817|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4284047|NCT00555425|4108818|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4284048|NCT00555425|4108819|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4284049|NCT00555425|4108817|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4284050|NCT00555425|4108818|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4284051|NCT00555425|4108819|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4284052|NCT00555425|4108817|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4284053|NCT00555425|4108818|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4284054|NCT00555425|4108819|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4284055|NCT00555425|4108817|B3|||Age||years|Mean|30.4|30.4|Standard Deviation|9.3|9.3|||
4284056|NCT00555425|4108818|B2|||Age||years|Mean|30.5|30.5|Standard Deviation|9.8|9.8|||
4284057|NCT00555425|4108819|B1|||Age||years|Mean|30.3|30.3|Standard Deviation|8.8|8.8|||
4284058|NCT00555360|4108838|B3|||Adherent to Heart Failure Medication|Number of patients with perfect Heart Failure medication adherence over the prior month as measured by the four Heart Failure Self-Care Behavior items focused on adherence.|participants|Number|165|165.0||||||
4284059|NCT00555360|4108839|B2|||Adherent to Heart Failure Medication|Number of patients with perfect Heart Failure medication adherence over the prior month as measured by the four Heart Failure Self-Care Behavior items focused on adherence.|participants|Number|84|84.0||||||
4284060|NCT00555360|4108840|B1|||Adherent to Heart Failure Medication|Number of patients with perfect Heart Failure medication adherence over the prior month as measured by the four Heart Failure Self-Care Behavior items focused on adherence.|participants|Number|81|81.0||||||
4284061|NCT00555360|4108838|B3|||Revised Heart Failure Self-Care Behavior Scale (HFSCB)|Higher scores indicate better Heart Failure self-care. The HFSCB contains 29 items with answer choices ranging from 0 to 5. The total score ranges from 0 to 145.|units on a scale|Mean|83.0|83.0|Standard Deviation|17.8|17.8|||
4284062|NCT00555360|4108839|B2|||Revised Heart Failure Self-Care Behavior Scale (HFSCB)|Higher scores indicate better Heart Failure self-care. The HFSCB contains 29 items with answer choices ranging from 0 to 5. The total score ranges from 0 to 145.|units on a scale|Mean|83.1|83.1|Standard Deviation|16.3|16.3|||
4284063|NCT00555360|4108840|B1|||Revised Heart Failure Self-Care Behavior Scale (HFSCB)|Higher scores indicate better Heart Failure self-care. The HFSCB contains 29 items with answer choices ranging from 0 to 5. The total score ranges from 0 to 145.|units on a scale|Mean|82.9|82.9|Standard Deviation|19.3|19.3|||
4284117|NCT00555321|4108856|B1|Yes||Participants on Anti-Hypertensive Medications||participants|Number|9|9.0||||||
4284118|NCT00555321|4108851|B6|No||Participants on Anti-Hypertensive Medications||participants|Number|203|203.0||||||
4284064|NCT00555360|4108838|B3|||Heart Failure-specific Quality of Life|Measured by the Minnesota Living with heart Failure Questionnaire (MLHFQ). Lower scores indicate better functioning. MLHFQ contains 21 items with answer choices ranging from 0 to 5. Overall scores on the instrument range from 0 to 105.|units on a scale|Mean|40.8|40.8|Standard Deviation|24.4|24.4|||
4284065|NCT00555360|4108839|B2|||Heart Failure-specific Quality of Life|Measured by the Minnesota Living with heart Failure Questionnaire (MLHFQ). Lower scores indicate better functioning. MLHFQ contains 21 items with answer choices ranging from 0 to 5. Overall scores on the instrument range from 0 to 105.|units on a scale|Mean|41.2|41.2|Standard Deviation|23.7|23.7|||
4284066|NCT00555360|4108840|B1|||Heart Failure-specific Quality of Life|Measured by the Minnesota Living with heart Failure Questionnaire (MLHFQ). Lower scores indicate better functioning. MLHFQ contains 21 items with answer choices ranging from 0 to 5. Overall scores on the instrument range from 0 to 105.|units on a scale|Mean|40.4|40.4|Standard Deviation|25.1|25.1|||
4284067|NCT00555360|4108838|B3|United States||Region of Enrollment||participants|Number|309|309.0||||||
4284068|NCT00555360|4108839|B2|United States||Region of Enrollment||participants|Number|153|153.0||||||
4284069|NCT00555360|4108840|B1|United States||Region of Enrollment||participants|Number|156|156.0||||||
4284070|NCT00555360|4108838|B3||Male|Sex: Female, Male||Participants|Count of Participants|307|307.0||||||
4284071|NCT00555360|4108839|B2||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4284072|NCT00555360|4108840|B1||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4284073|NCT00555360|4108838|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4284074|NCT00555360|4108839|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4284075|NCT00555360|4108840|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4284076|NCT00555360|4108838|B3|||Age||years|Mean|68.1|68.1|Standard Deviation|10.6|10.6|||
4284077|NCT00555360|4108839|B2|||Age||years|Mean|67.8|67.8|Standard Deviation|10.6|10.6|||
4284078|NCT00555360|4108840|B1|||Age||years|Mean|68.3|68.3|Standard Deviation|10.6|10.6|||
4284079|NCT00555360|4108838|B3||>=65 years|Age||Participants|Count of Participants|165|165.0||||||
4284080|NCT00555360|4108839|B2||>=65 years|Age||Participants|Count of Participants|79|79.0||||||
4284081|NCT00555360|4108840|B1||>=65 years|Age||Participants|Count of Participants|86|86.0||||||
4284082|NCT00555360|4108838|B3||Between 18 and 65 years|Age||Participants|Count of Participants|144|144.0||||||
4284083|NCT00555360|4108839|B2||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
4284084|NCT00555360|4108840|B1||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4284085|NCT00555360|4108838|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4284086|NCT00555360|4108839|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4284087|NCT00555360|4108840|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4284088|NCT00555321|4108851|B6|Yes||Participants on Anti-diabetic Medications||participants|Number|61|61.0||||||
4284089|NCT00555321|4108852|B5|Yes||Participants on Anti-diabetic Medications||participants|Number|12|12.0||||||
4284090|NCT00555321|4108853|B4|Yes||Participants on Anti-diabetic Medications||participants|Number|12|12.0||||||
4284091|NCT00555321|4108854|B3|Yes||Participants on Anti-diabetic Medications||participants|Number|9|9.0||||||
4284092|NCT00555321|4108855|B2|Yes||Participants on Anti-diabetic Medications||participants|Number|13|13.0||||||
4284093|NCT00555321|4108856|B1|Yes||Participants on Anti-diabetic Medications||participants|Number|15|15.0||||||
4284094|NCT00555321|4108851|B6|No||Participants on Anti-diabetic Medications||participants|Number|189|189.0||||||
4284095|NCT00555321|4108852|B5|No||Participants on Anti-diabetic Medications||participants|Number|38|38.0||||||
4284096|NCT00555321|4108853|B4|No||Participants on Anti-diabetic Medications||participants|Number|41|41.0||||||
4284097|NCT00555321|4108854|B3|No||Participants on Anti-diabetic Medications||participants|Number|40|40.0||||||
4284098|NCT00555321|4108855|B2|No||Participants on Anti-diabetic Medications||participants|Number|35|35.0||||||
4284099|NCT00555321|4108856|B1|No||Participants on Anti-diabetic Medications||participants|Number|35|35.0||||||
4284100|NCT00555321|4108851|B6|Yes||Participants on Lipid Lowering Medications||participants|Number|18|18.0||||||
4284101|NCT00555321|4108852|B5|Yes||Participants on Lipid Lowering Medications||participants|Number|6|6.0||||||
4284102|NCT00555321|4108853|B4|Yes||Participants on Lipid Lowering Medications||participants|Number|2|2.0||||||
4284103|NCT00555321|4108854|B3|Yes||Participants on Lipid Lowering Medications||participants|Number|1|1.0||||||
4284104|NCT00555321|4108855|B2|Yes||Participants on Lipid Lowering Medications||participants|Number|5|5.0||||||
4284105|NCT00555321|4108856|B1|Yes||Participants on Lipid Lowering Medications||participants|Number|4|4.0||||||
4284106|NCT00555321|4108851|B6|No||Participants on Lipid Lowering Medications||participants|Number|232|232.0||||||
4284107|NCT00555321|4108852|B5|No||Participants on Lipid Lowering Medications||participants|Number|44|44.0||||||
4284108|NCT00555321|4108853|B4|No||Participants on Lipid Lowering Medications||participants|Number|51|51.0||||||
4284109|NCT00555321|4108854|B3|No||Participants on Lipid Lowering Medications||participants|Number|48|48.0||||||
4284110|NCT00555321|4108855|B2|No||Participants on Lipid Lowering Medications||participants|Number|43|43.0||||||
4284111|NCT00555321|4108856|B1|No||Participants on Lipid Lowering Medications||participants|Number|46|46.0||||||
4284112|NCT00555321|4108851|B6|Yes||Participants on Anti-Hypertensive Medications||participants|Number|47|47.0||||||
4284113|NCT00555321|4108852|B5|Yes||Participants on Anti-Hypertensive Medications||participants|Number|10|10.0||||||
4284114|NCT00555321|4108853|B4|Yes||Participants on Anti-Hypertensive Medications||participants|Number|11|11.0||||||
4284115|NCT00555321|4108854|B3|Yes||Participants on Anti-Hypertensive Medications||participants|Number|8|8.0||||||
4284116|NCT00555321|4108855|B2|Yes||Participants on Anti-Hypertensive Medications||participants|Number|9|9.0||||||
4284119|NCT00555321|4108852|B5|No||Participants on Anti-Hypertensive Medications||participants|Number|40|40.0||||||
4284120|NCT00555321|4108853|B4|No||Participants on Anti-Hypertensive Medications||participants|Number|42|42.0||||||
4284121|NCT00555321|4108854|B3|No||Participants on Anti-Hypertensive Medications||participants|Number|41|41.0||||||
4284122|NCT00555321|4108855|B2|No||Participants on Anti-Hypertensive Medications||participants|Number|39|39.0||||||
4284123|NCT00555321|4108856|B1|No||Participants on Anti-Hypertensive Medications||participants|Number|41|41.0||||||
4284124|NCT00555321|4108851|B6|Not available||United Network for Organ Sharing (UNOS) Status|Participant's status category is determined by a point system, using objective and subjective factors. Status 1: critical, sudden liver failure, or newly transplanted liver not functioning; Status 2A: with chronic liver disease and are in the hospital's critical care unit. Status 1 and 2A have a life expectancy of less than 7 days without a liver transplant; Status 2B: with chronic liver disease, but do not meet the criteria for Status 2A; Status 3: with chronic liver disease, under continuous medical care, but not hospitalized, not meet the criteria for Status 2B.|participants|Number|221|221.0||||||
4284125|NCT00555321|4108852|B5|Not available||United Network for Organ Sharing (UNOS) Status|Participant's status category is determined by a point system, using objective and subjective factors. Status 1: critical, sudden liver failure, or newly transplanted liver not functioning; Status 2A: with chronic liver disease and are in the hospital's critical care unit. Status 1 and 2A have a life expectancy of less than 7 days without a liver transplant; Status 2B: with chronic liver disease, but do not meet the criteria for Status 2A; Status 3: with chronic liver disease, under continuous medical care, but not hospitalized, not meet the criteria for Status 2B.|participants|Number|47|47.0||||||
4284126|NCT00555321|4108853|B4|Not available||United Network for Organ Sharing (UNOS) Status|Participant's status category is determined by a point system, using objective and subjective factors. Status 1: critical, sudden liver failure, or newly transplanted liver not functioning; Status 2A: with chronic liver disease and are in the hospital's critical care unit. Status 1 and 2A have a life expectancy of less than 7 days without a liver transplant; Status 2B: with chronic liver disease, but do not meet the criteria for Status 2A; Status 3: with chronic liver disease, under continuous medical care, but not hospitalized, not meet the criteria for Status 2B.|participants|Number|48|48.0||||||
4284127|NCT00555321|4108854|B3|Not available||United Network for Organ Sharing (UNOS) Status|Participant's status category is determined by a point system, using objective and subjective factors. Status 1: critical, sudden liver failure, or newly transplanted liver not functioning; Status 2A: with chronic liver disease and are in the hospital's critical care unit. Status 1 and 2A have a life expectancy of less than 7 days without a liver transplant; Status 2B: with chronic liver disease, but do not meet the criteria for Status 2A; Status 3: with chronic liver disease, under continuous medical care, but not hospitalized, not meet the criteria for Status 2B.|participants|Number|40|40.0||||||
4284128|NCT00555321|4108855|B2|Not available||United Network for Organ Sharing (UNOS) Status|Participant's status category is determined by a point system, using objective and subjective factors. Status 1: critical, sudden liver failure, or newly transplanted liver not functioning; Status 2A: with chronic liver disease and are in the hospital's critical care unit. Status 1 and 2A have a life expectancy of less than 7 days without a liver transplant; Status 2B: with chronic liver disease, but do not meet the criteria for Status 2A; Status 3: with chronic liver disease, under continuous medical care, but not hospitalized, not meet the criteria for Status 2B.|participants|Number|42|42.0||||||
4284129|NCT00555321|4108856|B1|Not available||United Network for Organ Sharing (UNOS) Status|Participant's status category is determined by a point system, using objective and subjective factors. Status 1: critical, sudden liver failure, or newly transplanted liver not functioning; Status 2A: with chronic liver disease and are in the hospital's critical care unit. Status 1 and 2A have a life expectancy of less than 7 days without a liver transplant; Status 2B: with chronic liver disease, but do not meet the criteria for Status 2A; Status 3: with chronic liver disease, under continuous medical care, but not hospitalized, not meet the criteria for Status 2B.|participants|Number|44|44.0||||||
4284130|NCT00555321|4108851|B6|Status 3||United Network for Organ Sharing (UNOS) Status|Participant's status category is determined by a point system, using objective and subjective factors. Status 1: critical, sudden liver failure, or newly transplanted liver not functioning; Status 2A: with chronic liver disease and are in the hospital's critical care unit. Status 1 and 2A have a life expectancy of less than 7 days without a liver transplant; Status 2B: with chronic liver disease, but do not meet the criteria for Status 2A; Status 3: with chronic liver disease, under continuous medical care, but not hospitalized, not meet the criteria for Status 2B.|participants|Number|8|8.0||||||
4284131|NCT00555321|4108852|B5|Status 3||United Network for Organ Sharing (UNOS) Status|Participant's status category is determined by a point system, using objective and subjective factors. Status 1: critical, sudden liver failure, or newly transplanted liver not functioning; Status 2A: with chronic liver disease and are in the hospital's critical care unit. Status 1 and 2A have a life expectancy of less than 7 days without a liver transplant; Status 2B: with chronic liver disease, but do not meet the criteria for Status 2A; Status 3: with chronic liver disease, under continuous medical care, but not hospitalized, not meet the criteria for Status 2B.|participants|Number|1|1.0||||||
4284132|NCT00555321|4108853|B4|Status 3||United Network for Organ Sharing (UNOS) Status|Participant's status category is determined by a point system, using objective and subjective factors. Status 1: critical, sudden liver failure, or newly transplanted liver not functioning; Status 2A: with chronic liver disease and are in the hospital's critical care unit. Status 1 and 2A have a life expectancy of less than 7 days without a liver transplant; Status 2B: with chronic liver disease, but do not meet the criteria for Status 2A; Status 3: with chronic liver disease, under continuous medical care, but not hospitalized, not meet the criteria for Status 2B.|participants|Number|1|1.0||||||
4284133|NCT00555321|4108854|B3|Status 3||United Network for Organ Sharing (UNOS) Status|Participant's status category is determined by a point system, using objective and subjective factors. Status 1: critical, sudden liver failure, or newly transplanted liver not functioning; Status 2A: with chronic liver disease and are in the hospital's critical care unit. Status 1 and 2A have a life expectancy of less than 7 days without a liver transplant; Status 2B: with chronic liver disease, but do not meet the criteria for Status 2A; Status 3: with chronic liver disease, under continuous medical care, but not hospitalized, not meet the criteria for Status 2B.|participants|Number|2|2.0||||||
4284164|NCT00555321|4108855|B2|Malignant neoplasms||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|7|7.0||||||
4284134|NCT00555321|4108855|B2|Status 3||United Network for Organ Sharing (UNOS) Status|Participant's status category is determined by a point system, using objective and subjective factors. Status 1: critical, sudden liver failure, or newly transplanted liver not functioning; Status 2A: with chronic liver disease and are in the hospital's critical care unit. Status 1 and 2A have a life expectancy of less than 7 days without a liver transplant; Status 2B: with chronic liver disease, but do not meet the criteria for Status 2A; Status 3: with chronic liver disease, under continuous medical care, but not hospitalized, not meet the criteria for Status 2B.|participants|Number|2|2.0||||||
4284135|NCT00555321|4108856|B1|Status 3||United Network for Organ Sharing (UNOS) Status|Participant's status category is determined by a point system, using objective and subjective factors. Status 1: critical, sudden liver failure, or newly transplanted liver not functioning; Status 2A: with chronic liver disease and are in the hospital's critical care unit. Status 1 and 2A have a life expectancy of less than 7 days without a liver transplant; Status 2B: with chronic liver disease, but do not meet the criteria for Status 2A; Status 3: with chronic liver disease, under continuous medical care, but not hospitalized, not meet the criteria for Status 2B.|participants|Number|2|2.0||||||
4284136|NCT00555321|4108851|B6|Status 2B||United Network for Organ Sharing (UNOS) Status|Participant's status category is determined by a point system, using objective and subjective factors. Status 1: critical, sudden liver failure, or newly transplanted liver not functioning; Status 2A: with chronic liver disease and are in the hospital's critical care unit. Status 1 and 2A have a life expectancy of less than 7 days without a liver transplant; Status 2B: with chronic liver disease, but do not meet the criteria for Status 2A; Status 3: with chronic liver disease, under continuous medical care, but not hospitalized, not meet the criteria for Status 2B.|participants|Number|13|13.0||||||
4284137|NCT00555321|4108852|B5|Status 2B||United Network for Organ Sharing (UNOS) Status|Participant's status category is determined by a point system, using objective and subjective factors. Status 1: critical, sudden liver failure, or newly transplanted liver not functioning; Status 2A: with chronic liver disease and are in the hospital's critical care unit. Status 1 and 2A have a life expectancy of less than 7 days without a liver transplant; Status 2B: with chronic liver disease, but do not meet the criteria for Status 2A; Status 3: with chronic liver disease, under continuous medical care, but not hospitalized, not meet the criteria for Status 2B.|participants|Number|2|2.0||||||
4284138|NCT00555321|4108853|B4|Status 2B||United Network for Organ Sharing (UNOS) Status|Participant's status category is determined by a point system, using objective and subjective factors. Status 1: critical, sudden liver failure, or newly transplanted liver not functioning; Status 2A: with chronic liver disease and are in the hospital's critical care unit. Status 1 and 2A have a life expectancy of less than 7 days without a liver transplant; Status 2B: with chronic liver disease, but do not meet the criteria for Status 2A; Status 3: with chronic liver disease, under continuous medical care, but not hospitalized, not meet the criteria for Status 2B.|participants|Number|1|1.0||||||
4284139|NCT00555321|4108854|B3|Status 2B||United Network for Organ Sharing (UNOS) Status|Participant's status category is determined by a point system, using objective and subjective factors. Status 1: critical, sudden liver failure, or newly transplanted liver not functioning; Status 2A: with chronic liver disease and are in the hospital's critical care unit. Status 1 and 2A have a life expectancy of less than 7 days without a liver transplant; Status 2B: with chronic liver disease, but do not meet the criteria for Status 2A; Status 3: with chronic liver disease, under continuous medical care, but not hospitalized, not meet the criteria for Status 2B.|participants|Number|5|5.0||||||
4284140|NCT00555321|4108855|B2|Status 2B||United Network for Organ Sharing (UNOS) Status|Participant's status category is determined by a point system, using objective and subjective factors. Status 1: critical, sudden liver failure, or newly transplanted liver not functioning; Status 2A: with chronic liver disease and are in the hospital's critical care unit. Status 1 and 2A have a life expectancy of less than 7 days without a liver transplant; Status 2B: with chronic liver disease, but do not meet the criteria for Status 2A; Status 3: with chronic liver disease, under continuous medical care, but not hospitalized, not meet the criteria for Status 2B.|participants|Number|2|2.0||||||
4284141|NCT00555321|4108856|B1|Status 2B||United Network for Organ Sharing (UNOS) Status|Participant's status category is determined by a point system, using objective and subjective factors. Status 1: critical, sudden liver failure, or newly transplanted liver not functioning; Status 2A: with chronic liver disease and are in the hospital's critical care unit. Status 1 and 2A have a life expectancy of less than 7 days without a liver transplant; Status 2B: with chronic liver disease, but do not meet the criteria for Status 2A; Status 3: with chronic liver disease, under continuous medical care, but not hospitalized, not meet the criteria for Status 2B.|participants|Number|3|3.0||||||
4284142|NCT00555321|4108851|B6|Status 2A||United Network for Organ Sharing (UNOS) Status|Participant's status category is determined by a point system, using objective and subjective factors. Status 1: critical, sudden liver failure, or newly transplanted liver not functioning; Status 2A: with chronic liver disease and are in the hospital's critical care unit. Status 1 and 2A have a life expectancy of less than 7 days without a liver transplant; Status 2B: with chronic liver disease, but do not meet the criteria for Status 2A; Status 3: with chronic liver disease, under continuous medical care, but not hospitalized, not meet the criteria for Status 2B.|participants|Number|7|7.0||||||
4284143|NCT00555321|4108852|B5|Status 2A||United Network for Organ Sharing (UNOS) Status|Participant's status category is determined by a point system, using objective and subjective factors. Status 1: critical, sudden liver failure, or newly transplanted liver not functioning; Status 2A: with chronic liver disease and are in the hospital's critical care unit. Status 1 and 2A have a life expectancy of less than 7 days without a liver transplant; Status 2B: with chronic liver disease, but do not meet the criteria for Status 2A; Status 3: with chronic liver disease, under continuous medical care, but not hospitalized, not meet the criteria for Status 2B.|participants|Number|0|0.0||||||
4284144|NCT00555321|4108853|B4|Status 2A||United Network for Organ Sharing (UNOS) Status|Participant's status category is determined by a point system, using objective and subjective factors. Status 1: critical, sudden liver failure, or newly transplanted liver not functioning; Status 2A: with chronic liver disease and are in the hospital's critical care unit. Status 1 and 2A have a life expectancy of less than 7 days without a liver transplant; Status 2B: with chronic liver disease, but do not meet the criteria for Status 2A; Status 3: with chronic liver disease, under continuous medical care, but not hospitalized, not meet the criteria for Status 2B.|participants|Number|3|3.0||||||
4284165|NCT00555321|4108856|B1|Malignant neoplasms||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|4|4.0||||||
4284145|NCT00555321|4108854|B3|Status 2A||United Network for Organ Sharing (UNOS) Status|Participant's status category is determined by a point system, using objective and subjective factors. Status 1: critical, sudden liver failure, or newly transplanted liver not functioning; Status 2A: with chronic liver disease and are in the hospital's critical care unit. Status 1 and 2A have a life expectancy of less than 7 days without a liver transplant; Status 2B: with chronic liver disease, but do not meet the criteria for Status 2A; Status 3: with chronic liver disease, under continuous medical care, but not hospitalized, not meet the criteria for Status 2B.|participants|Number|2|2.0||||||
4284146|NCT00555321|4108855|B2|Status 2A||United Network for Organ Sharing (UNOS) Status|Participant's status category is determined by a point system, using objective and subjective factors. Status 1: critical, sudden liver failure, or newly transplanted liver not functioning; Status 2A: with chronic liver disease and are in the hospital's critical care unit. Status 1 and 2A have a life expectancy of less than 7 days without a liver transplant; Status 2B: with chronic liver disease, but do not meet the criteria for Status 2A; Status 3: with chronic liver disease, under continuous medical care, but not hospitalized, not meet the criteria for Status 2B.|participants|Number|1|1.0||||||
4284147|NCT00555321|4108856|B1|Status 2A||United Network for Organ Sharing (UNOS) Status|Participant's status category is determined by a point system, using objective and subjective factors. Status 1: critical, sudden liver failure, or newly transplanted liver not functioning; Status 2A: with chronic liver disease and are in the hospital's critical care unit. Status 1 and 2A have a life expectancy of less than 7 days without a liver transplant; Status 2B: with chronic liver disease, but do not meet the criteria for Status 2A; Status 3: with chronic liver disease, under continuous medical care, but not hospitalized, not meet the criteria for Status 2B.|participants|Number|1|1.0||||||
4284148|NCT00555321|4108851|B6|Status 1||United Network for Organ Sharing (UNOS) Status|Participant's status category is determined by a point system, using objective and subjective factors. Status 1: critical, sudden liver failure, or newly transplanted liver not functioning; Status 2A: with chronic liver disease and are in the hospital's critical care unit. Status 1 and 2A have a life expectancy of less than 7 days without a liver transplant; Status 2B: with chronic liver disease, but do not meet the criteria for Status 2A; Status 3: with chronic liver disease, under continuous medical care, but not hospitalized, not meet the criteria for Status 2B.|participants|Number|1|1.0||||||
4284149|NCT00555321|4108852|B5|Status 1||United Network for Organ Sharing (UNOS) Status|Participant's status category is determined by a point system, using objective and subjective factors. Status 1: critical, sudden liver failure, or newly transplanted liver not functioning; Status 2A: with chronic liver disease and are in the hospital's critical care unit. Status 1 and 2A have a life expectancy of less than 7 days without a liver transplant; Status 2B: with chronic liver disease, but do not meet the criteria for Status 2A; Status 3: with chronic liver disease, under continuous medical care, but not hospitalized, not meet the criteria for Status 2B.|participants|Number|0|0.0||||||
4284150|NCT00555321|4108853|B4|Status 1||United Network for Organ Sharing (UNOS) Status|Participant's status category is determined by a point system, using objective and subjective factors. Status 1: critical, sudden liver failure, or newly transplanted liver not functioning; Status 2A: with chronic liver disease and are in the hospital's critical care unit. Status 1 and 2A have a life expectancy of less than 7 days without a liver transplant; Status 2B: with chronic liver disease, but do not meet the criteria for Status 2A; Status 3: with chronic liver disease, under continuous medical care, but not hospitalized, not meet the criteria for Status 2B.|participants|Number|0|0.0||||||
4284151|NCT00555321|4108854|B3|Status 1||United Network for Organ Sharing (UNOS) Status|Participant's status category is determined by a point system, using objective and subjective factors. Status 1: critical, sudden liver failure, or newly transplanted liver not functioning; Status 2A: with chronic liver disease and are in the hospital's critical care unit. Status 1 and 2A have a life expectancy of less than 7 days without a liver transplant; Status 2B: with chronic liver disease, but do not meet the criteria for Status 2A; Status 3: with chronic liver disease, under continuous medical care, but not hospitalized, not meet the criteria for Status 2B.|participants|Number|0|0.0||||||
4284152|NCT00555321|4108855|B2|Status 1||United Network for Organ Sharing (UNOS) Status|Participant's status category is determined by a point system, using objective and subjective factors. Status 1: critical, sudden liver failure, or newly transplanted liver not functioning; Status 2A: with chronic liver disease and are in the hospital's critical care unit. Status 1 and 2A have a life expectancy of less than 7 days without a liver transplant; Status 2B: with chronic liver disease, but do not meet the criteria for Status 2A; Status 3: with chronic liver disease, under continuous medical care, but not hospitalized, not meet the criteria for Status 2B.|participants|Number|1|1.0||||||
4284153|NCT00555321|4108856|B1|Status 1||United Network for Organ Sharing (UNOS) Status|Participant's status category is determined by a point system, using objective and subjective factors. Status 1: critical, sudden liver failure, or newly transplanted liver not functioning; Status 2A: with chronic liver disease and are in the hospital's critical care unit. Status 1 and 2A have a life expectancy of less than 7 days without a liver transplant; Status 2B: with chronic liver disease, but do not meet the criteria for Status 2A; Status 3: with chronic liver disease, under continuous medical care, but not hospitalized, not meet the criteria for Status 2B.|participants|Number|0|0.0||||||
4284154|NCT00555321|4108851|B6|Other||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|20|20.0||||||
4284155|NCT00555321|4108852|B5|Other||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|4|4.0||||||
4284156|NCT00555321|4108853|B4|Other||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|4|4.0||||||
4284157|NCT00555321|4108854|B3|Other||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|5|5.0||||||
4284158|NCT00555321|4108855|B2|Other||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|3|3.0||||||
4284159|NCT00555321|4108856|B1|Other||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|4|4.0||||||
4284160|NCT00555321|4108851|B6|Malignant neoplasms||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|25|25.0||||||
4284161|NCT00555321|4108852|B5|Malignant neoplasms||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|3|3.0||||||
4284162|NCT00555321|4108853|B4|Malignant neoplasms||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|6|6.0||||||
4284163|NCT00555321|4108854|B3|Malignant neoplasms||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|5|5.0||||||
4284166|NCT00555321|4108851|B6|Metabolic disease||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|3|3.0||||||
4284167|NCT00555321|4108852|B5|Metabolic disease||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|0|0.0||||||
4284168|NCT00555321|4108853|B4|Metabolic disease||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|1|1.0||||||
4284169|NCT00555321|4108854|B3|Metabolic disease||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|0|0.0||||||
4284170|NCT00555321|4108855|B2|Metabolic disease||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|2|2.0||||||
4284171|NCT00555321|4108856|B1|Metabolic disease||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|0|0.0||||||
4284172|NCT00555321|4108851|B6|Acute hepatic necrosis||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|8|8.0||||||
4284173|NCT00555321|4108852|B5|Acute hepatic necrosis||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|0|0.0||||||
4284174|NCT00555321|4108853|B4|Acute hepatic necrosis||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|1|1.0||||||
4284175|NCT00555321|4108854|B3|Acute hepatic necrosis||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|3|3.0||||||
4284176|NCT00555321|4108855|B2|Acute hepatic necrosis||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|0|0.0||||||
4284177|NCT00555321|4108856|B1|Acute hepatic necrosis||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|4|4.0||||||
4284178|NCT00555321|4108851|B6|Biliary atresia||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|1|1.0||||||
4284179|NCT00555321|4108852|B5|Biliary atresia||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|0|0.0||||||
4284180|NCT00555321|4108853|B4|Biliary atresia||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|1|1.0||||||
4284181|NCT00555321|4108854|B3|Biliary atresia||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|0|0.0||||||
4284182|NCT00555321|4108855|B2|Biliary atresia||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|0|0.0||||||
4284183|NCT00555321|4108856|B1|Biliary atresia||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|0|0.0||||||
4284184|NCT00555321|4108851|B6|Cholestatic liver disease cirrhosis||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|9|9.0||||||
4284185|NCT00555321|4108852|B5|Cholestatic liver disease cirrhosis||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|2|2.0||||||
4284186|NCT00555321|4108853|B4|Cholestatic liver disease cirrhosis||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|1|1.0||||||
4284187|NCT00555321|4108854|B3|Cholestatic liver disease cirrhosis||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|3|3.0||||||
4284188|NCT00555321|4108855|B2|Cholestatic liver disease cirrhosis||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|3|3.0||||||
4284189|NCT00555321|4108856|B1|Cholestatic liver disease cirrhosis||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|0|0.0||||||
4284190|NCT00555321|4108851|B6|Non-cholestatic cirrhosis||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|184|184.0||||||
4284191|NCT00555321|4108852|B5|Non-cholestatic cirrhosis||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|41|41.0||||||
4284192|NCT00555321|4108853|B4|Non-cholestatic cirrhosis||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|39|39.0||||||
4284193|NCT00555321|4108854|B3|Non-cholestatic cirrhosis||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|33|33.0||||||
4284194|NCT00555321|4108855|B2|Non-cholestatic cirrhosis||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|33|33.0||||||
4284195|NCT00555321|4108856|B1|Non-cholestatic cirrhosis||Primary cause of End Stage Liver Disease (ESLD)||participants|Number|38|38.0||||||
4284196|NCT00555321|4108851|B6|||Model for End-Stage Liver Disease (MELD) score|The Model for End-Stage Liver Disease (MELD) is a scoring system for assessing the severity of chronic liver disease. MELD uses the participant's values for serum bilirubin, serum creatinine, and the international normalized ratio (INR) for prothrombin time to predict survival. 100% mortality= 3 month mortality is ≥ 40; 83% mortality= 3 month mortality 30-39; 76% mortality= 3 month mortality 20-29; 27% mortality= 3 month mortality 10-19; 4% mortality= 3 month mortality <10.|units on a scale|Median|22.0|22.0|Full Range|||6.0|42.0|
4284197|NCT00555321|4108852|B5|||Model for End-Stage Liver Disease (MELD) score|The Model for End-Stage Liver Disease (MELD) is a scoring system for assessing the severity of chronic liver disease. MELD uses the participant's values for serum bilirubin, serum creatinine, and the international normalized ratio (INR) for prothrombin time to predict survival. 100% mortality= 3 month mortality is ≥ 40; 83% mortality= 3 month mortality 30-39; 76% mortality= 3 month mortality 20-29; 27% mortality= 3 month mortality 10-19; 4% mortality= 3 month mortality <10.|units on a scale|Median|22.0|22.0|Full Range|5.48|5.48|9.0|40.0|
4284198|NCT00555321|4108853|B4|||Model for End-Stage Liver Disease (MELD) score|The Model for End-Stage Liver Disease (MELD) is a scoring system for assessing the severity of chronic liver disease. MELD uses the participant's values for serum bilirubin, serum creatinine, and the international normalized ratio (INR) for prothrombin time to predict survival. 100% mortality= 3 month mortality is ≥ 40; 83% mortality= 3 month mortality 30-39; 76% mortality= 3 month mortality 20-29; 27% mortality= 3 month mortality 10-19; 4% mortality= 3 month mortality <10.|units on a scale|Median|24.0|24.0|Full Range|7.48|7.48|9.0|40.0|
4284199|NCT00555321|4108854|B3|||Model for End-Stage Liver Disease (MELD) score|The Model for End-Stage Liver Disease (MELD) is a scoring system for assessing the severity of chronic liver disease. MELD uses the participant's values for serum bilirubin, serum creatinine, and the international normalized ratio (INR) for prothrombin time to predict survival. 100% mortality= 3 month mortality is ≥ 40; 83% mortality= 3 month mortality 30-39; 76% mortality= 3 month mortality 20-29; 27% mortality= 3 month mortality 10-19; 4% mortality= 3 month mortality <10.|units on a scale|Median|22.0|22.0|Full Range|6.05|6.05|7.0|31.0|
4284229|NCT00555321|4108854|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4284230|NCT00555321|4108855|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4284231|NCT00555321|4108856|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4284232|NCT00555321|4108851|B6|American Indian / Alaska native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4284200|NCT00555321|4108855|B2|||Model for End-Stage Liver Disease (MELD) score|The Model for End-Stage Liver Disease (MELD) is a scoring system for assessing the severity of chronic liver disease. MELD uses the participant's values for serum bilirubin, serum creatinine, and the international normalized ratio (INR) for prothrombin time to predict survival. 100% mortality= 3 month mortality is ≥ 40; 83% mortality= 3 month mortality 30-39; 76% mortality= 3 month mortality 20-29; 27% mortality= 3 month mortality 10-19; 4% mortality= 3 month mortality <10.|units on a scale|Median|22.0|22.0|Full Range|8.29|8.29|8.0|42.0|
4284201|NCT00555321|4108856|B1|||Model for End-Stage Liver Disease (MELD) score|The Model for End-Stage Liver Disease (MELD) is a scoring system for assessing the severity of chronic liver disease. MELD uses the participant's values for serum bilirubin, serum creatinine, and the international normalized ratio (INR) for prothrombin time to predict survival. 100% mortality= 3 month mortality is ≥ 40; 83% mortality= 3 month mortality 30-39; 76% mortality= 3 month mortality 20-29; 27% mortality= 3 month mortality 10-19; 4% mortality= 3 month mortality <10.|units on a scale|Median|22.0|22.0|Full Range|8.19|8.19|6.0|40.0|
4284202|NCT00555321|4108851|B6|Unknown (Non- US sites)||Race/Ethnicity, Customized|Ethnicity data collected in compliance with the 2005 Food and Drug Administration (FDA) Guidance for Industry for subjects enrolled in the United States (US) only.|participants|Number|128|128.0||||||
4284203|NCT00555321|4108852|B5|Unknown (Non- US sites)||Race/Ethnicity, Customized|Ethnicity data collected in compliance with the 2005 Food and Drug Administration (FDA) Guidance for Industry for subjects enrolled in the United States (US) only.|participants|Number|23|23.0||||||
4284204|NCT00555321|4108853|B4|Unknown (Non- US sites)||Race/Ethnicity, Customized|Ethnicity data collected in compliance with the 2005 Food and Drug Administration (FDA) Guidance for Industry for subjects enrolled in the United States (US) only.|participants|Number|28|28.0||||||
4284205|NCT00555321|4108854|B3|Unknown (Non- US sites)||Race/Ethnicity, Customized|Ethnicity data collected in compliance with the 2005 Food and Drug Administration (FDA) Guidance for Industry for subjects enrolled in the United States (US) only.|participants|Number|35|35.0||||||
4284206|NCT00555321|4108855|B2|Unknown (Non- US sites)||Race/Ethnicity, Customized|Ethnicity data collected in compliance with the 2005 Food and Drug Administration (FDA) Guidance for Industry for subjects enrolled in the United States (US) only.|participants|Number|25|25.0||||||
4284207|NCT00555321|4108856|B1|Unknown (Non- US sites)||Race/Ethnicity, Customized|Ethnicity data collected in compliance with the 2005 Food and Drug Administration (FDA) Guidance for Industry for subjects enrolled in the United States (US) only.|participants|Number|17|17.0||||||
4284208|NCT00555321|4108851|B6|Not Hispanic or Latino (US sites)||Race/Ethnicity, Customized|Ethnicity data collected in compliance with the 2005 Food and Drug Administration (FDA) Guidance for Industry for subjects enrolled in the United States (US) only.|participants|Number|100|100.0||||||
4284209|NCT00555321|4108852|B5|Not Hispanic or Latino (US sites)||Race/Ethnicity, Customized|Ethnicity data collected in compliance with the 2005 Food and Drug Administration (FDA) Guidance for Industry for subjects enrolled in the United States (US) only.|participants|Number|23|23.0||||||
4284210|NCT00555321|4108853|B4|Not Hispanic or Latino (US sites)||Race/Ethnicity, Customized|Ethnicity data collected in compliance with the 2005 Food and Drug Administration (FDA) Guidance for Industry for subjects enrolled in the United States (US) only.|participants|Number|22|22.0||||||
4284211|NCT00555321|4108854|B3|Not Hispanic or Latino (US sites)||Race/Ethnicity, Customized|Ethnicity data collected in compliance with the 2005 Food and Drug Administration (FDA) Guidance for Industry for subjects enrolled in the United States (US) only.|participants|Number|11|11.0||||||
4284212|NCT00555321|4108855|B2|Not Hispanic or Latino (US sites)||Race/Ethnicity, Customized|Ethnicity data collected in compliance with the 2005 Food and Drug Administration (FDA) Guidance for Industry for subjects enrolled in the United States (US) only.|participants|Number|16|16.0||||||
4284213|NCT00555321|4108856|B1|Not Hispanic or Latino (US sites)||Race/Ethnicity, Customized|Ethnicity data collected in compliance with the 2005 Food and Drug Administration (FDA) Guidance for Industry for subjects enrolled in the United States (US) only.|participants|Number|28|28.0||||||
4284214|NCT00555321|4108851|B6|Hispanic or Latino (US sites)||Race/Ethnicity, Customized|Ethnicity data collected in compliance with the 2005 Food and Drug Administration (FDA) Guidance for Industry for subjects enrolled in the United States (US) only.|participants|Number|22|22.0||||||
4284215|NCT00555321|4108852|B5|Hispanic or Latino (US sites)||Race/Ethnicity, Customized|Ethnicity data collected in compliance with the 2005 Food and Drug Administration (FDA) Guidance for Industry for subjects enrolled in the United States (US) only.|participants|Number|4|4.0||||||
4284216|NCT00555321|4108853|B4|Hispanic or Latino (US sites)||Race/Ethnicity, Customized|Ethnicity data collected in compliance with the 2005 Food and Drug Administration (FDA) Guidance for Industry for subjects enrolled in the United States (US) only.|participants|Number|3|3.0||||||
4284217|NCT00555321|4108854|B3|Hispanic or Latino (US sites)||Race/Ethnicity, Customized|Ethnicity data collected in compliance with the 2005 Food and Drug Administration (FDA) Guidance for Industry for subjects enrolled in the United States (US) only.|participants|Number|3|3.0||||||
4284218|NCT00555321|4108855|B2|Hispanic or Latino (US sites)||Race/Ethnicity, Customized|Ethnicity data collected in compliance with the 2005 Food and Drug Administration (FDA) Guidance for Industry for subjects enrolled in the United States (US) only.|participants|Number|7|7.0||||||
4284219|NCT00555321|4108856|B1|Hispanic or Latino (US sites)||Race/Ethnicity, Customized|Ethnicity data collected in compliance with the 2005 Food and Drug Administration (FDA) Guidance for Industry for subjects enrolled in the United States (US) only.|participants|Number|5|5.0||||||
4284220|NCT00555321|4108851|B6|Other||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4284221|NCT00555321|4108852|B5|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4284222|NCT00555321|4108853|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4284223|NCT00555321|4108854|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4284224|NCT00555321|4108855|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4284225|NCT00555321|4108856|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4284226|NCT00555321|4108851|B6|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4284227|NCT00555321|4108852|B5|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4284228|NCT00555321|4108853|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4284233|NCT00555321|4108852|B5|American Indian / Alaska native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4284234|NCT00555321|4108853|B4|American Indian / Alaska native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4284235|NCT00555321|4108854|B3|American Indian / Alaska native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4284236|NCT00555321|4108855|B2|American Indian / Alaska native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4284237|NCT00555321|4108856|B1|American Indian / Alaska native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4284238|NCT00555321|4108851|B6|Black / African American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4284239|NCT00555321|4108852|B5|Black / African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4284240|NCT00555321|4108853|B4|Black / African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4284241|NCT00555321|4108854|B3|Black / African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4284242|NCT00555321|4108855|B2|Black / African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4284243|NCT00555321|4108856|B1|Black / African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4284244|NCT00555321|4108851|B6|White||Race/Ethnicity, Customized||participants|Number|222|222.0||||||
4284245|NCT00555321|4108852|B5|White||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4284246|NCT00555321|4108853|B4|White||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4284247|NCT00555321|4108854|B3|White||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4284248|NCT00555321|4108855|B2|White||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4284249|NCT00555321|4108856|B1|White||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4284250|NCT00555321|4108851|B6||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4284251|NCT00555321|4108852|B5||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4284252|NCT00555321|4108853|B4||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4284253|NCT00555321|4108854|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4284254|NCT00555321|4108855|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4284255|NCT00555321|4108856|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4284256|NCT00555321|4108851|B6||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4284257|NCT00555321|4108852|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4284258|NCT00555321|4108853|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4284259|NCT00555321|4108854|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4284260|NCT00555321|4108855|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4284261|NCT00555321|4108856|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4284262|NCT00555321|4108851|B6|Above 65 years||Age, Customized||participants|Number|14|14.0||||||
4284263|NCT00555321|4108852|B5|Above 65 years||Age, Customized||participants|Number|4|4.0||||||
4284264|NCT00555321|4108853|B4|Above 65 years||Age, Customized||participants|Number|5|5.0||||||
4284265|NCT00555321|4108854|B3|Above 65 years||Age, Customized||participants|Number|2|2.0||||||
4284266|NCT00555321|4108855|B2|Above 65 years||Age, Customized||participants|Number|1|1.0||||||
4284267|NCT00555321|4108856|B1|Above 65 years||Age, Customized||participants|Number|2|2.0||||||
4284268|NCT00555321|4108851|B6|46 to 65 years||Age, Customized||participants|Number|203|203.0||||||
4284269|NCT00555321|4108852|B5|46 to 65 years||Age, Customized||participants|Number|42|42.0||||||
4284270|NCT00555321|4108853|B4|46 to 65 years||Age, Customized||participants|Number|37|37.0||||||
4284271|NCT00555321|4108854|B3|46 to 65 years||Age, Customized||participants|Number|43|43.0||||||
4284272|NCT00555321|4108855|B2|46 to 65 years||Age, Customized||participants|Number|40|40.0||||||
4284273|NCT00555321|4108856|B1|46 to 65 years||Age, Customized||participants|Number|41|41.0||||||
4284274|NCT00555321|4108851|B6|18 to 45 years||Age, Customized||participants|Number|33|33.0||||||
4284275|NCT00555321|4108852|B5|18 to 45 years||Age, Customized||participants|Number|4|4.0||||||
4284276|NCT00555321|4108853|B4|18 to 45 years||Age, Customized||participants|Number|11|11.0||||||
4284277|NCT00555321|4108854|B3|18 to 45 years||Age, Customized||participants|Number|4|4.0||||||
4284278|NCT00555321|4108855|B2|18 to 45 years||Age, Customized||participants|Number|7|7.0||||||
4284279|NCT00555321|4108856|B1|18 to 45 years||Age, Customized||participants|Number|7|7.0||||||
4284280|NCT00555217|4109162|B3|||urine albumin/creatinine at enrollment||mg/g|Median|851.0|851.0|Inter-Quartile Range|||490.0|1752.0|
4284281|NCT00555217|4109163|B2|||urine albumin/creatinine at enrollment||mg/g|Median|861.5|861.5|Inter-Quartile Range|||487.5|1789.0|
4284282|NCT00555217|4109164|B1|||urine albumin/creatinine at enrollment||mg/g|Median|841.5|841.5|Inter-Quartile Range|||495.0|1698.0|
4284283|NCT00555217|4109162|B3|||eGFR at enrollment||ml/min/1.73m^2|Mean|53.7|53.7|Standard Deviation|15.9|15.9|||
4284284|NCT00555217|4109163|B2|||eGFR at enrollment||ml/min/1.73m^2|Mean|53.7|53.7|Standard Deviation|16.2|16.2|||
4284285|NCT00555217|4109164|B1|||eGFR at enrollment||ml/min/1.73m^2|Mean|53.6|53.6|Standard Deviation|15.5|15.5|||
4284286|NCT00555217|4109162|B3|||Potassium||meq/L|Mean|4.3|4.3|Standard Deviation|0.5|0.5|||
4284287|NCT00555217|4109163|B2|||Potassium||meq/L|Mean|4.3|4.3|Standard Deviation|0.5|0.5|||
4284288|NCT00555217|4109164|B1|||Potassium||meq/L|Mean|4.3|4.3|Standard Deviation|0.5|0.5|||
4284289|NCT00555217|4109162|B3|||serum Creatinine at enrollment||mg/dl|Mean|1.5|1.5|Standard Deviation|0.4|0.4|||
4284290|NCT00555217|4109163|B2|||serum Creatinine at enrollment||mg/dl|Mean|1.5|1.5|Standard Deviation|0.4|0.4|||
4284291|NCT00555217|4109164|B1|||serum Creatinine at enrollment||mg/dl|Mean|1.5|1.5|Standard Deviation|0.4|0.4|||
4284292|NCT00555217|4109162|B3|||HbA1c||%|Mean|7.8|7.8|Standard Deviation|1.3|1.3|||
4284293|NCT00555217|4109163|B2|||HbA1c||%|Mean|7.8|7.8|Standard Deviation|1.3|1.3|||
4284294|NCT00555217|4109164|B1|||HbA1c||%|Mean|7.8|7.8|Standard Deviation|1.2|1.2|||
4284295|NCT00555217|4109162|B3|||Triglycerides||mg/dl|Median|163|163.0|Inter-Quartile Range|||111.0|249.0|
4284296|NCT00555217|4109163|B2|||Triglycerides||mg/dl|Median|162|162.0|Inter-Quartile Range|||111.0|235.0|
4284297|NCT00555217|4109164|B1|||Triglycerides||mg/dl|Median|165|165.0|Inter-Quartile Range|||111.0|260.0|
4284298|NCT00555217|4109162|B3|||HDL cholesterol||mg/dl|Mean|38.2|38.2|Standard Deviation|11.2|11.2|||
4284299|NCT00555217|4109163|B2|||HDL cholesterol||mg/dl|Mean|38.7|38.7|Standard Deviation|11.3|11.3|||
4284300|NCT00555217|4109164|B1|||HDL cholesterol||mg/dl|Mean|37.7|37.7|Standard Deviation|11.0|11.0|||
4284301|NCT00555217|4109162|B3|||LDL cholesterol||mg/dl|Mean|82.9|82.9|Standard Deviation|33.7|33.7|||
4284302|NCT00555217|4109163|B2|||LDL cholesterol||mg/dl|Mean|84.3|84.3|Standard Deviation|35.0|35.0|||
4284303|NCT00555217|4109164|B1|||LDL cholesterol||mg/dl|Mean|81.6|81.6|Standard Deviation|32.4|32.4|||
4284304|NCT00555217|4109162|B3|||Total Cholesterol||mg/dl|Mean|158.4|158.4|Standard Deviation|42.1|42.1|||
4284305|NCT00555217|4109163|B2|||Total Cholesterol||mg/dl|Mean|159.0|159.0|Standard Deviation|40.5|40.5|||
4284306|NCT00555217|4109164|B1|||Total Cholesterol||mg/dl|Mean|157.9|157.9|Standard Deviation|43.6|43.6|||
4284307|NCT00555217|4109162|B3|||DBP||mmHg|Mean|72.7|72.7|Standard Deviation|10.2|10.2|||
4284308|NCT00555217|4109163|B2|||DBP||mmHg|Mean|72.8|72.8|Standard Deviation|9.9|9.9|||
4284309|NCT00555217|4109164|B1|||DBP||mmHg|Mean|72.5|72.5|Standard Deviation|10.6|10.6|||
4284310|NCT00555217|4109162|B3|||SBP||mmHg|Mean|136.9|136.9|Standard Deviation|16.3|16.3|||
4284311|NCT00555217|4109163|B2|||SBP||mmHg|Mean|137.0|137.0|Standard Deviation|16.0|16.0|||
4284312|NCT00555217|4109164|B1|||SBP||mmHg|Mean|136.9|136.9|Standard Deviation|16.5|16.5|||
4284313|NCT00555217|4109162|B3|No||Retinopathy||participants|Number|829|829.0||||||
4284314|NCT00555217|4109163|B2|No||Retinopathy||participants|Number|414|414.0||||||
4284315|NCT00555217|4109164|B1|No||Retinopathy||participants|Number|415|415.0||||||
4284316|NCT00555217|4109162|B3|Yes||Retinopathy||participants|Number|619|619.0||||||
4284317|NCT00555217|4109163|B2|Yes||Retinopathy||participants|Number|310|310.0||||||
4284318|NCT00555217|4109164|B1|Yes||Retinopathy||participants|Number|309|309.0||||||
4284319|NCT00555217|4109162|B3|No||Congestive Heart Failure||participants|Number|1222|1222.0||||||
4284320|NCT00555217|4109163|B2|No||Congestive Heart Failure||participants|Number|614|614.0||||||
4284321|NCT00555217|4109164|B1|No||Congestive Heart Failure||participants|Number|608|608.0||||||
4284322|NCT00555217|4109162|B3|Yes||Congestive Heart Failure||participants|Number|226|226.0||||||
4284323|NCT00555217|4109163|B2|Yes||Congestive Heart Failure||participants|Number|110|110.0||||||
4284324|NCT00555217|4109164|B1|Yes||Congestive Heart Failure||participants|Number|116|116.0||||||
4284325|NCT00555217|4109162|B3|No||Coronary Artery Disease||participants|Number|1122|1122.0||||||
4284326|NCT00555217|4109163|B2|No||Coronary Artery Disease||participants|Number|557|557.0||||||
4284327|NCT00555217|4109164|B1|No||Coronary Artery Disease||participants|Number|565|565.0||||||
4284328|NCT00555217|4109162|B3|Yes||Coronary Artery Disease||participants|Number|326|326.0||||||
4284329|NCT00555217|4109163|B2|Yes||Coronary Artery Disease||participants|Number|167|167.0||||||
4284330|NCT00555217|4109164|B1|Yes||Coronary Artery Disease||participants|Number|159|159.0||||||
4284331|NCT00555217|4109162|B3|||Body Mass Index||kg/m^2|Mean|34.6|34.6|Standard Deviation|6.8|6.8|||
4284332|NCT00555217|4109163|B2|||Body Mass Index||kg/m^2|Mean|34.3|34.3|Standard Deviation|6.9|6.9|||
4284333|NCT00555217|4109164|B1|||Body Mass Index||kg/m^2|Mean|34.9|34.9|Standard Deviation|6.7|6.7|||
4284334|NCT00555217|4109162|B3|United States||Region of Enrollment||participants|Number|1448|1448.0||||||
4284335|NCT00555217|4109163|B2|United States||Region of Enrollment||participants|Number|724|724.0||||||
4284336|NCT00555217|4109164|B1|United States||Region of Enrollment||participants|Number|724|724.0||||||
4284337|NCT00555217|4109162|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4284338|NCT00555217|4109163|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284339|NCT00555217|4109164|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4284340|NCT00555217|4109162|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4284341|NCT00555217|4109163|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4284342|NCT00555217|4109164|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284343|NCT00555217|4109162|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1037|1037.0||||||
4284344|NCT00555217|4109163|B2||White|Race (NIH/OMB)||Participants|Count of Participants|514|514.0||||||
4284345|NCT00555217|4109164|B1||White|Race (NIH/OMB)||Participants|Count of Participants|523|523.0||||||
4284346|NCT00555217|4109162|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|332|332.0||||||
4284347|NCT00555217|4109163|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|160|160.0||||||
4284348|NCT00555217|4109164|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|172|172.0||||||
4284349|NCT00555217|4109162|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4284350|NCT00555217|4109163|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4284351|NCT00555217|4109164|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4284352|NCT00555217|4109162|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4284353|NCT00555217|4109163|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4284354|NCT00555217|4109164|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4284355|NCT00555217|4109162|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4284356|NCT00555217|4109163|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4284357|NCT00555217|4109164|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4284358|NCT00555217|4109162|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284359|NCT00555217|4109163|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284360|NCT00555217|4109164|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284361|NCT00555217|4109162|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1302|1302.0||||||
4284362|NCT00555217|4109163|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|649|649.0||||||
4284363|NCT00555217|4109164|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|653|653.0||||||
4284364|NCT00555217|4109162|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
4284365|NCT00555217|4109163|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4284366|NCT00555217|4109164|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
4284367|NCT00555217|4109162|B3||Male|Sex: Female, Male||Participants|Count of Participants|1436|1436.0||||||
4284368|NCT00555217|4109163|B2||Male|Sex: Female, Male||Participants|Count of Participants|721|721.0||||||
4284369|NCT00555217|4109164|B1||Male|Sex: Female, Male||Participants|Count of Participants|715|715.0||||||
4284370|NCT00555217|4109162|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4284371|NCT00555217|4109163|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4284372|NCT00555217|4109164|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4284373|NCT00555217|4109162|B3|||Age||years|Mean|64.6|64.6|Standard Deviation|7.8|7.8|||
4284374|NCT00555217|4109163|B2|||Age||years|Mean|64.7|64.7|Standard Deviation|7.7|7.7|||
4284375|NCT00555217|4109164|B1|||Age||years|Mean|64.5|64.5|Standard Deviation|7.9|7.9|||
4284376|NCT00555152|4109173|B5|United States||Region of Enrollment||participants|Number|22|22.0||||||
4284377|NCT00555152|4109174|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
4284378|NCT00555152|4109176|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4284379|NCT00555152|4109177|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4284380|NCT00555152|4109173|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4284381|NCT00555152|4109174|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4284382|NCT00555152|4109176|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284383|NCT00555152|4109177|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284384|NCT00555152|4109173|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284385|NCT00555152|4109174|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284386|NCT00555152|4109176|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284387|NCT00555152|4109177|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284388|NCT00555152|4109173|B5||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4284389|NCT00555152|4109174|B4||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4284390|NCT00555152|4109176|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4284391|NCT00555152|4109177|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4284392|NCT00555152|4109173|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284393|NCT00555152|4109174|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284394|NCT00555152|4109176|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284395|NCT00555152|4109177|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284396|NCT00555152|4109173|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284397|NCT00555152|4109174|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284398|NCT00555152|4109176|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284399|NCT00555152|4109177|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284400|NCT00555152|4109173|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4284401|NCT00555152|4109174|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284402|NCT00555152|4109176|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4284403|NCT00555152|4109177|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284404|NCT00555152|4109173|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284405|NCT00555152|4109174|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284406|NCT00555152|4109176|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284407|NCT00555152|4109177|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284408|NCT00555152|4109173|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284409|NCT00555152|4109174|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284410|NCT00555152|4109176|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284411|NCT00555152|4109177|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284412|NCT00555152|4109173|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4284413|NCT00555152|4109174|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4284414|NCT00555152|4109176|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4284415|NCT00555152|4109177|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4284416|NCT00555152|4109173|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4284417|NCT00555152|4109174|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4284418|NCT00555152|4109176|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4284419|NCT00555152|4109177|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284420|NCT00555152|4109173|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4284421|NCT00555152|4109174|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4284422|NCT00555152|4109176|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4284423|NCT00555152|4109177|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4284424|NCT00555152|4109173|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4284425|NCT00555152|4109174|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4284426|NCT00555152|4109176|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4284427|NCT00555152|4109177|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4284428|NCT00555152|4109173|B5|||Age||years|Mean|51.3|51.3|Standard Deviation|9.3|9.3|||
4284429|NCT00555152|4109174|B4|||Age||years|Mean|52|52.0|Standard Deviation|8.4|8.4|||
4284430|NCT00555152|4109176|B2|||Age||years|Mean|51.7|51.7|Standard Deviation|10.7|10.7|||
4284431|NCT00555152|4109177|B1|||Age||years|Mean|46|46.0|Standard Deviation|9.5|9.5|||
4284432|NCT00555061|4109202|B1|Missing||Race/Ethnicity, Customized|One participant was enrolled, but was withdrawn prior to assessments and did not receive study medication; therefore, this participant was not included in the study population.|participants|Number|1|1.0||||||
4284433|NCT00555061|4109202|B1|East Asian||Race/Ethnicity, Customized|One participant was enrolled, but was withdrawn prior to assessments and did not receive study medication; therefore, this participant was not included in the study population.|participants|Number|1|1.0||||||
4284434|NCT00555061|4109202|B1|Central/South Asian||Race/Ethnicity, Customized|One participant was enrolled, but was withdrawn prior to assessments and did not receive study medication; therefore, this participant was not included in the study population.|participants|Number|1|1.0||||||
4284435|NCT00555061|4109202|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|One participant was enrolled, but was withdrawn prior to assessments and did not receive study medication; therefore, this participant was not included in the study population.|participants|Number|1|1.0||||||
4284436|NCT00555061|4109202|B1|White/Caucasian||Race/Ethnicity, Customized|One participant was enrolled, but was withdrawn prior to assessments and did not receive study medication; therefore, this participant was not included in the study population.|participants|Number|36|36.0||||||
4284437|NCT00555061|4109202|B1|African American/African Heritage||Race/Ethnicity, Customized|One participant was enrolled, but was withdrawn prior to assessments and did not receive study medication; therefore, this participant was not included in the study population.|participants|Number|46|46.0||||||
4284438|NCT00555061|4109202|B1||Male|Gender|One participant was enrolled, but was withdrawn prior to assessments and did not receive study medication; therefore, this participant was not included in the study population.|Participants|Count of Participants|54|54.0||||||
4284439|NCT00555061|4109202|B1||Female|Gender|One participant was enrolled, but was withdrawn prior to assessments and did not receive study medication; therefore, this participant was not included in the study population.|Participants|Count of Participants|32|32.0||||||
4284440|NCT00555061|4109202|B1|||Age|One participant was enrolled, but was withdrawn prior to assessments and did not receive study medication; therefore, this participant was not included in the study population.|months|Mean|10.6|10.6|Standard Deviation|6.89|6.89|||
4284441|NCT00555048|4109209|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4284442|NCT00555048|4109209|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4284443|NCT00555048|4109209|B1|||Age||years|Median|47|47.0|Full Range|||47.0|47.0|
4284444|NCT00555009|4109219|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4284445|NCT00555009|4109220|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4284446|NCT00555009|4109221|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4284447|NCT00555009|4109219|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4284448|NCT00555009|4109220|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4284449|NCT00555009|4109221|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4284450|NCT00555009|4109219|B3|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4284451|NCT00555009|4109220|B2|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4284452|NCT00555009|4109221|B1|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4284453|NCT00555009|4109219|B3|45-64 years||Age, Customized||participants|Number|2|2.0||||||
4284454|NCT00555009|4109220|B2|45-64 years||Age, Customized||participants|Number|2|2.0||||||
4284455|NCT00555009|4109221|B1|45-64 years||Age, Customized||participants|Number|0|0.0||||||
4284456|NCT00555009|4109219|B3|18 - 44 years||Age, Customized||participants|Number|8|8.0||||||
4284457|NCT00555009|4109220|B2|18 - 44 years||Age, Customized||participants|Number|4|4.0||||||
4284458|NCT00555009|4109221|B1|18 - 44 years||Age, Customized||participants|Number|4|4.0||||||
4284459|NCT00555009|4109219|B3|<18 years||Age, Customized||participants|Number|0|0.0||||||
4284460|NCT00555009|4109220|B2|<18 years||Age, Customized||participants|Number|0|0.0||||||
4284461|NCT00555009|4109221|B1|<18 years||Age, Customized||participants|Number|0|0.0||||||
4284462|NCT00554996|4109244|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4284463|NCT00554996|4109244|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4284464|NCT00554996|4109244|B1|||Age||years|Mean|70.9|70.9|Full Range|||58.0|88.0|
4284465|NCT00554970|4109248|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4284466|NCT00554970|4109249|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4284467|NCT00554970|4109250|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4284468|NCT00554970|4109251|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4284469|NCT00554970|4109252|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4284470|NCT00554970|4109248|B5||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4284471|NCT00554970|4109249|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4284472|NCT00554970|4109250|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4284473|NCT00554970|4109251|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4284474|NCT00554970|4109252|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4284475|NCT00554970|4109248|B5|||Age||years|Mean|29.2|29.2|Standard Deviation|7.6|7.6|||
4284476|NCT00554970|4109249|B4|||Age||years|Mean|29.1|29.1|Standard Deviation|6.9|6.9|||
4284477|NCT00554970|4109250|B3|||Age||years|Mean|30.0|30.0|Standard Deviation|8.3|8.3|||
4284478|NCT00554970|4109251|B2|||Age||years|Mean|30.4|30.4|Standard Deviation|7.2|7.2|||
4284479|NCT00554970|4109252|B1|||Age||years|Mean|27.4|27.4|Standard Deviation|8.9|8.9|||
4284480|NCT00554853|4109285|B3|United States||Region of Enrollment||participants|Number|143|143.0||||||
4284481|NCT00554853|4109286|B2|United States||Region of Enrollment||participants|Number|71|71.0||||||
4284482|NCT00554853|4109287|B1|United States||Region of Enrollment||participants|Number|72|72.0||||||
4284483|NCT00554853|4109285|B3||Male|Gender||Participants|Count of Participants|34|34.0||||||
4284484|NCT00554853|4109286|B2||Male|Gender||Participants|Count of Participants|18|18.0||||||
4284485|NCT00554853|4109287|B1||Male|Gender||Participants|Count of Participants|16|16.0||||||
4284486|NCT00554853|4109285|B3||Female|Gender||Participants|Count of Participants|109|109.0||||||
4284487|NCT00554853|4109286|B2||Female|Gender||Participants|Count of Participants|53|53.0||||||
4284488|NCT00554853|4109287|B1||Female|Gender||Participants|Count of Participants|56|56.0||||||
4284489|NCT00554853|4109285|B3|||Age||years|Mean|55.2|55.2|Standard Deviation|12.1|12.1|||
4284490|NCT00554853|4109286|B2|||Age||years|Mean|56.0|56.0|Standard Deviation|12.0|12.0|||
4284491|NCT00554853|4109287|B1|||Age||years|Mean|54.5|54.5|Standard Deviation|12.3|12.3|||
4284492|NCT00554853|4109285|B3||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4284493|NCT00554853|4109286|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4284494|NCT00554853|4109287|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4284495|NCT00554853|4109285|B3||Between 18 and 65 years|Age||Participants|Count of Participants|116|116.0||||||
4284496|NCT00554853|4109286|B2||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4284497|NCT00554853|4109287|B1||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4284498|NCT00554853|4109285|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4284499|NCT00554853|4109286|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4284500|NCT00554853|4109287|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4284501|NCT00554840|4109300|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4284502|NCT00554840|4109301|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4284503|NCT00554840|4109302|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4284504|NCT00554840|4109300|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284505|NCT00554840|4109301|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284506|NCT00554840|4109302|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284507|NCT00554840|4109300|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4284508|NCT00554840|4109301|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284509|NCT00554840|4109302|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4284510|NCT00554840|4109300|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4284511|NCT00554840|4109301|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4284512|NCT00554840|4109302|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4284513|NCT00554840|4109300|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4284514|NCT00554840|4109301|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4284515|NCT00554840|4109302|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284516|NCT00554840|4109300|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284517|NCT00554840|4109301|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284518|NCT00554840|4109302|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284519|NCT00554840|4109300|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284520|NCT00554840|4109301|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284521|NCT00554840|4109302|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284522|NCT00554840|4109300|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284523|NCT00554840|4109301|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284524|NCT00554840|4109302|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284525|NCT00554840|4109300|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4284526|NCT00554840|4109301|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4284527|NCT00554840|4109302|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4284528|NCT00554840|4109300|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4284529|NCT00554840|4109301|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4284530|NCT00554840|4109302|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4284531|NCT00554840|4109300|B3|||Age||years|Mean|45.97|45.97|Standard Deviation|6.87|6.87|||
4284532|NCT00554840|4109301|B2|||Age||years|Mean|44.3|44.3|Standard Deviation|5.1|5.1|||
4284533|NCT00554840|4109302|B1|||Age||years|Mean|46.3|46.3|Standard Deviation|9.0|9.0|||
4284534|NCT00554840|4109300|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4284535|NCT00554840|4109301|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4284536|NCT00554840|4109302|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4284537|NCT00554840|4109300|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4284538|NCT00554840|4109301|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4284539|NCT00554840|4109302|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4284540|NCT00554840|4109300|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4284541|NCT00554840|4109301|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4284542|NCT00554840|4109302|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4284543|NCT00554801|4109319|B3|United States||Region of Enrollment||participants|Number|65|65.0||||||
4284544|NCT00554801|4109320|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4284545|NCT00554801|4109321|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4284546|NCT00554801|4109319|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4284547|NCT00554801|4109320|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4284548|NCT00554801|4109321|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4284549|NCT00554801|4109319|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4284550|NCT00554801|4109320|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4284551|NCT00554801|4109321|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4284552|NCT00554801|4109319|B3|||Age||years|Mean|32.5|32.5|Full Range|||19.0|54.0|
4284553|NCT00554801|4109320|B2|||Age||years|Mean|32.1|32.1|Full Range|||19.0|54.0|
4284554|NCT00554801|4109321|B1|||Age||years|Mean|32.8|32.8|Full Range|||20.0|54.0|
4284555|NCT00554749|4109330|B1|||School speech questionnaire (SSQ)|SSQ is a teacher-report measure assessing the frequency of the child's speaking behaviour at school. It is a 9-item questionnaire and each item has four possible responses, ranging 0 (never), 1 (seldom), 2 (often) and (3 always). The standard sum score is added up from the six questions(as defined by its author L. Bergman) and then divided by 6 to make up a corresponding factor score ranging from 0-3(worst value=0,best value=3).|units on a scale|Mean|0.59|0.59|Standard Deviation|0.51|0.51|||
4284556|NCT00554749|4109330|B1|Norway||Region of Enrollment||participants|Number|7|7.0||||||
4284557|NCT00554749|4109330|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4284558|NCT00554749|4109330|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4284559|NCT00554749|4109330|B1|||Age||years|Mean|4.30|4.3|Standard Deviation|0.75|0.75|||
4284560|NCT00554749|4109330|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4284561|NCT00554749|4109330|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4284562|NCT00554749|4109330|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4284563|NCT00554671|4109335|B3|||LDL cholesterol||mg/dL|Mean|91.0|91.0|Standard Deviation|32.1|32.1|||
4284564|NCT00554671|4109336|B2|||LDL cholesterol||mg/dL|Mean|93.7|93.7|Standard Deviation|33.7|33.7|||
4284565|NCT00554671|4109337|B1|||LDL cholesterol||mg/dL|Mean|87.6|87.6|Standard Deviation|29.8|29.8|||
4284566|NCT00554671|4109335|B3|||Systolic Blood Pressure||mmHg|Mean|136.3|136.3|Standard Deviation|18.1|18.1|||
4284567|NCT00554671|4109336|B2|||Systolic Blood Pressure||mmHg|Mean|136.2|136.2|Standard Deviation|17.4|17.4|||
4284568|NCT00554671|4109337|B1|||Systolic Blood Pressure||mmHg|Mean|136.5|136.5|Standard Deviation|19.0|19.0|||
4284569|NCT00554671|4109335|B3|||Hemoglobin A1c||percent Hemoglobin A1c|Mean|8.2|8.2|Standard Deviation|1.4|1.4|||
4284570|NCT00554671|4109336|B2|||Hemoglobin A1c||percent Hemoglobin A1c|Mean|8.2|8.2|Standard Deviation|1.3|1.3|||
4284571|NCT00554671|4109337|B1|||Hemoglobin A1c||percent Hemoglobin A1c|Mean|8.2|8.2|Standard Deviation|1.5|1.5|||
4284572|NCT00554671|4109335|B3|Unknown||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4284573|NCT00554671|4109336|B2|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4284574|NCT00554671|4109337|B1|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4284575|NCT00554671|4109335|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4284576|NCT00554671|4109336|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4284577|NCT00554671|4109337|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4284578|NCT00554671|4109335|B3|Asian Pacific Islander||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4284579|NCT00554671|4109336|B2|Asian Pacific Islander||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4284580|NCT00554671|4109337|B1|Asian Pacific Islander||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4284581|NCT00554671|4109335|B3|African American||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4284582|NCT00554671|4109336|B2|African American||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4284583|NCT00554671|4109337|B1|African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4284584|NCT00554671|4109335|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|192|192.0||||||
4284585|NCT00554671|4109336|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|104|104.0||||||
4284586|NCT00554671|4109337|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|88|88.0||||||
4284587|NCT00554671|4109335|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4284588|NCT00554671|4109336|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4284589|NCT00554671|4109337|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4284590|NCT00554671|4109335|B3||Female|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
4284591|NCT00554671|4109336|B2||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4284592|NCT00554671|4109337|B1||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4284593|NCT00554671|4109335|B3|||Age||years|Mean|65.4|65.4|Standard Deviation|9.3|9.3|||
4284594|NCT00554671|4109336|B2|||Age||years|Mean|65.0|65.0|Standard Deviation|9.8|9.8|||
4284595|NCT00554671|4109337|B1|||Age||years|Mean|65.8|65.8|Standard Deviation|8.7|8.7|||
4284596|NCT00554619|4109350|B1|Asian – Japanese Heritage||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4284597|NCT00554619|4109350|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4284598|NCT00554619|4109350|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4284599|NCT00554619|4109350|B1|||Age||Years|Mean|45.6|45.6|Standard Deviation|12.62|12.62|||
4284600|NCT00554515|4109362|B1|Unknown||ISM Risk Group|"ISM [Atkins et al CCR 2005] Pathology [Upton et al. J Immunother 2005] CAIX (carbonic anhydrase IX) [Bui et al. CCR 2003]~Poor: Poor predictive pathology OR the combination of intermediate predictive pathology and low CAIX staining Good: Good predictive pathology OR the combination of intermediate predictive pathology and high CAIX staining"|Participants|Count of Participants|3|3.0||||||
4284601|NCT00554515|4109362|B1|Poor||ISM Risk Group|"ISM [Atkins et al CCR 2005] Pathology [Upton et al. J Immunother 2005] CAIX (carbonic anhydrase IX) [Bui et al. CCR 2003]~Poor: Poor predictive pathology OR the combination of intermediate predictive pathology and low CAIX staining Good: Good predictive pathology OR the combination of intermediate predictive pathology and high CAIX staining"|Participants|Count of Participants|43|43.0||||||
4284602|NCT00554515|4109362|B1|Good||ISM Risk Group|"ISM [Atkins et al CCR 2005] Pathology [Upton et al. J Immunother 2005] CAIX (carbonic anhydrase IX) [Bui et al. CCR 2003]~Poor: Poor predictive pathology OR the combination of intermediate predictive pathology and low CAIX staining Good: Good predictive pathology OR the combination of intermediate predictive pathology and high CAIX staining"|Participants|Count of Participants|74|74.0||||||
4284603|NCT00554515|4109362|B1|High||UCLA SANI Score|University of California Los Angeles (UCLA) Survival After Nephrectomy and Immunotherapy (SANI) score: This tool also predicts RCC patient’s survival based on lymph node status, metastases, sarcomatoid feature, and TSH level. Patients are classified into 3 groups (low, intermediate, and high). [Leibovich et al. Cancer 2003]|Participants|Count of Participants|8|8.0||||||
4284604|NCT00554515|4109362|B1|Intermediate||UCLA SANI Score|University of California Los Angeles (UCLA) Survival After Nephrectomy and Immunotherapy (SANI) score: This tool also predicts RCC patient’s survival based on lymph node status, metastases, sarcomatoid feature, and TSH level. Patients are classified into 3 groups (low, intermediate, and high). [Leibovich et al. Cancer 2003]|Participants|Count of Participants|102|102.0||||||
4284605|NCT00554515|4109362|B1|Low||UCLA SANI Score|University of California Los Angeles (UCLA) Survival After Nephrectomy and Immunotherapy (SANI) score: This tool also predicts RCC patient’s survival based on lymph node status, metastases, sarcomatoid feature, and TSH level. Patients are classified into 3 groups (low, intermediate, and high). [Leibovich et al. Cancer 2003]|Participants|Count of Participants|10|10.0||||||
4284606|NCT00554515|4109362|B1|Poor||MSKCC Risk Group|Memorial Sloan Kettering Cancer Center (MSKCC) Risk Group: MSKCC developed a nomogram that is used to classify patients into 3 renal cell carcinoma (RCC) 5-year disease recurrence risk groups (low, intermediate, and high) using data from patients treated at MSKCC. The components of the nomogram include RCC histology, disease symptoms, pT stage, and tumor size.|Participants|Count of Participants|13|13.0||||||
4284607|NCT00554515|4109362|B1|Intermediate||MSKCC Risk Group|Memorial Sloan Kettering Cancer Center (MSKCC) Risk Group: MSKCC developed a nomogram that is used to classify patients into 3 renal cell carcinoma (RCC) 5-year disease recurrence risk groups (low, intermediate, and high) using data from patients treated at MSKCC. The components of the nomogram include RCC histology, disease symptoms, pT stage, and tumor size.|Participants|Count of Participants|84|84.0||||||
4284608|NCT00554515|4109362|B1|Favorable||MSKCC Risk Group|Memorial Sloan Kettering Cancer Center (MSKCC) Risk Group: MSKCC developed a nomogram that is used to classify patients into 3 renal cell carcinoma (RCC) 5-year disease recurrence risk groups (low, intermediate, and high) using data from patients treated at MSKCC. The components of the nomogram include RCC histology, disease symptoms, pT stage, and tumor size.|Participants|Count of Participants|23|23.0||||||
4284609|NCT00554515|4109362|B1|United States||Region of Enrollment||participants|Number|120|120.0||||||
4284610|NCT00554515|4109362|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4284611|NCT00554515|4109362|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4284612|NCT00554515|4109362|B1|||Age||years|Median|56|56.0|Full Range|||28.0|70.0|
4284613|NCT00554463|4109391|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4284614|NCT00554463|4109391|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4284615|NCT00554463|4109391|B1|||Age||years|Median|67|67.0|Full Range|||60.0|74.0|
4284616|NCT00554372|4109395|B3|Korea, Republic of||Region of Enrollment||participants|Number|13|13.0||||||
4284617|NCT00554372|4109396|B2|Korea, Republic of||Region of Enrollment||participants|Number|7|7.0||||||
4284618|NCT00554372|4109397|B1|Korea, Republic of||Region of Enrollment||participants|Number|6|6.0||||||
4284619|NCT00554372|4109395|B3|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4284620|NCT00554372|4109396|B2|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4284621|NCT00554372|4109397|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4284622|NCT00554372|4109395|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4284623|NCT00554372|4109396|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4284624|NCT00554372|4109397|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4284625|NCT00554372|4109395|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4284626|NCT00554372|4109396|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4284627|NCT00554372|4109397|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4284628|NCT00554372|4109395|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4284629|NCT00554372|4109396|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4284630|NCT00554372|4109397|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4284631|NCT00554372|4109395|B3|||Age||years|Mean|64.9|64.9|Standard Deviation|12.2|12.2|||
4284632|NCT00554372|4109396|B2|||Age||years|Mean|62.9|62.9|Standard Deviation|12.7|12.7|||
4284633|NCT00554372|4109397|B1|||Age||years|Mean|67.1|67.1|Standard Deviation|11.5|11.5|||
4284634|NCT00554294|4109410|B3|non-overweight||Prevalence of overweight|Overweight was defined according to the standard of the International Obesity Task Force|participants|Number|2408|2408.0||||||
4284635|NCT00554294|4109411|B2|non-overweight||Prevalence of overweight|Overweight was defined according to the standard of the International Obesity Task Force|participants|Number|1317|1317.0||||||
4284636|NCT00554294|4109412|B1|non-overweight||Prevalence of overweight|Overweight was defined according to the standard of the International Obesity Task Force|participants|Number|1091|1091.0||||||
4284637|NCT00554294|4109410|B3|overweight||Prevalence of overweight|Overweight was defined according to the standard of the International Obesity Task Force|participants|Number|782|782.0||||||
4284638|NCT00554294|4109411|B2|overweight||Prevalence of overweight|Overweight was defined according to the standard of the International Obesity Task Force|participants|Number|404|404.0||||||
4284639|NCT00554294|4109412|B1|overweight||Prevalence of overweight|Overweight was defined according to the standard of the International Obesity Task Force|participants|Number|378|378.0||||||
4284640|NCT00554294|4109410|B3||Male|Sex: Female, Male||Participants|Count of Participants|1603|1603.0||||||
4284641|NCT00554294|4109411|B2||Male|Sex: Female, Male||Participants|Count of Participants|868|868.0||||||
4284642|NCT00554294|4109412|B1||Male|Sex: Female, Male||Participants|Count of Participants|735|735.0||||||
4284643|NCT00554294|4109410|B3||Female|Sex: Female, Male||Participants|Count of Participants|1587|1587.0||||||
4284644|NCT00554294|4109411|B2||Female|Sex: Female, Male||Participants|Count of Participants|853|853.0||||||
4284645|NCT00554294|4109412|B1||Female|Sex: Female, Male||Participants|Count of Participants|734|734.0||||||
4284646|NCT00554294|4109410|B3|||Age||years|Mean|8.3|8.3|Standard Deviation|0.7|0.7|||
4284647|NCT00554294|4109411|B2|||Age||years|Mean|8.3|8.3|Standard Deviation|0.7|0.7|||
4284648|NCT00554294|4109412|B1|||Age||years|Mean|8.3|8.3|Standard Deviation|0.7|0.7|||
4284649|NCT00554229|4109417|B3||Male|Sex: Female, Male||Participants|Count of Participants|594|594.0||||||
4284650|NCT00554229|4109418|B2||Male|Sex: Female, Male||Participants|Count of Participants|295|295.0||||||
4284651|NCT00554229|4109419|B1||Male|Sex: Female, Male||Participants|Count of Participants|299|299.0||||||
4284652|NCT00554229|4109417|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4284653|NCT00554229|4109418|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4284654|NCT00554229|4109419|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4284655|NCT00554229|4109417|B3|Overall||Age||Years|Mean|70.5|70.5|Standard Deviation|8.2|8.2|||
4284656|NCT00554229|4109418|B2|Overall||Age||Years|Mean|70.9|70.9|Standard Deviation|8.6|8.6|||
4284657|NCT00554229|4109419|B1|Overall||Age||Years|Mean|70.2|70.2|Standard Deviation|7.8|7.8|||
4284658|NCT00554216|4109442|B4|United States||Region of Enrollment||participants|Number|1267|1267.0||||||
4284659|NCT00554216|4109443|B3|United States||Region of Enrollment||participants|Number|512|512.0||||||
4284660|NCT00554216|4109444|B2|United States||Region of Enrollment||participants|Number|241|241.0||||||
4284661|NCT00554216|4109445|B1|United States||Region of Enrollment||participants|Number|514|514.0||||||
4284662|NCT00554216|4109442|B4||Male|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
4284663|NCT00554216|4109443|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4284664|NCT00554216|4109444|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4284665|NCT00554216|4109445|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4284666|NCT00554216|4109442|B4||Female|Sex: Female, Male||Participants|Count of Participants|1050|1050.0||||||
4284667|NCT00554216|4109443|B3||Female|Sex: Female, Male||Participants|Count of Participants|424|424.0||||||
4284668|NCT00554216|4109444|B2||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4284669|NCT00554216|4109445|B1||Female|Sex: Female, Male||Participants|Count of Participants|425|425.0||||||
4284670|NCT00554216|4109442|B4|||Age||years|Mean|42.6|42.6|Standard Deviation|11.80|11.8|||
4284671|NCT00554216|4109443|B3|||Age||years|Mean|42.0|42.0|Standard Deviation|12.21|12.21|||
4284672|NCT00554216|4109444|B2|||Age||years|Mean|43.0|43.0|Standard Deviation|10.96|10.96|||
4284673|NCT00554216|4109445|B1|||Age||years|Mean|43.0|43.0|Standard Deviation|11.76|11.76|||
4284674|NCT00554190|4109458|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4284675|NCT00554190|4109458|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4284676|NCT00554190|4109458|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4284677|NCT00554190|4109458|B1|||Age||years|Mean|42|42.0|Standard Deviation|14.5|14.5|||
4284678|NCT00554190|4109458|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4284679|NCT00554190|4109458|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4284680|NCT00554190|4109458|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4284681|NCT00554099|4109464|B4|United States||Region of Enrollment||participants|Number|117|117.0||||||
4284682|NCT00554099|4109465|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4284683|NCT00554099|4109466|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4284684|NCT00554099|4109467|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4284685|NCT00554099|4109464|B4|Multi-racial||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4284686|NCT00554099|4109465|B3|Multi-racial||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4284687|NCT00554099|4109466|B2|Multi-racial||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4284688|NCT00554099|4109467|B1|Multi-racial||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4284689|NCT00554099|4109464|B4|Asian (Oriental)||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4284690|NCT00554099|4109465|B3|Asian (Oriental)||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4284691|NCT00554099|4109466|B2|Asian (Oriental)||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4284692|NCT00554099|4109467|B1|Asian (Oriental)||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4284693|NCT00554099|4109464|B4|Black||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4284694|NCT00554099|4109465|B3|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4284695|NCT00554099|4109466|B2|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4284696|NCT00554099|4109467|B1|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4284697|NCT00554099|4109464|B4|Caucasian||Race/Ethnicity, Customized||Participants|Number|111|111.0||||||
4284698|NCT00554099|4109465|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|33|33.0||||||
4284699|NCT00554099|4109466|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|39|39.0||||||
4284700|NCT00554099|4109467|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|39|39.0||||||
4284701|NCT00554099|4109464|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284702|NCT00554099|4109465|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284703|NCT00554099|4109466|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284704|NCT00554099|4109467|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284705|NCT00554099|4109464|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
4284706|NCT00554099|4109465|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4284707|NCT00554099|4109466|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4284708|NCT00554099|4109467|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4284709|NCT00554099|4109464|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4284710|NCT00554099|4109465|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4284711|NCT00554099|4109466|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4284712|NCT00554099|4109467|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4284713|NCT00554099|4109464|B4||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4284714|NCT00554099|4109465|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4284715|NCT00554099|4109466|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4284716|NCT00554099|4109467|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4284717|NCT00554099|4109464|B4||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4284718|NCT00554099|4109465|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4284719|NCT00554099|4109466|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4284720|NCT00554099|4109467|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4284721|NCT00554099|4109464|B4|>= 65 years||Age, Customized||Participants|Number|33|33.0||||||
4284722|NCT00554099|4109465|B3|>= 65 years||Age, Customized||Participants|Number|11|11.0||||||
4284723|NCT00554099|4109466|B2|>= 65 years||Age, Customized||Participants|Number|12|12.0||||||
4284724|NCT00554099|4109467|B1|>= 65 years||Age, Customized||Participants|Number|10|10.0||||||
4284725|NCT00554099|4109464|B4|< 65 years||Age, Customized||Participants|Number|84|84.0||||||
4284726|NCT00554099|4109465|B3|< 65 years||Age, Customized||Participants|Number|25|25.0||||||
4284727|NCT00554099|4109466|B2|< 65 years||Age, Customized||Participants|Number|28|28.0||||||
4284728|NCT00554099|4109467|B1|< 65 years||Age, Customized||Participants|Number|31|31.0||||||
4284729|NCT00553969|4109498|B5|United States||Region of Enrollment||participants|Number|91|91.0||||||
4284730|NCT00553969|4109499|B4|United States||Region of Enrollment||participants|Number|23|23.0||||||
4284731|NCT00553969|4109500|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4284732|NCT00553969|4109501|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4284733|NCT00553969|4109502|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4284734|NCT00553969|4109498|B5||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4284735|NCT00553969|4109499|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4284736|NCT00553969|4109500|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4284737|NCT00553969|4109501|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4284738|NCT00553969|4109502|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4284739|NCT00553969|4109498|B5||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4284740|NCT00553969|4109499|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4284741|NCT00553969|4109500|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4284742|NCT00553969|4109501|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4284743|NCT00553969|4109502|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4284744|NCT00553969|4109498|B5|||Age||years|Mean|52.25|52.25|Standard Deviation|11.5|11.5|||
4284745|NCT00553969|4109499|B4|||Age||years|Mean|51|51.0|Standard Deviation|13|13.0|||
4284746|NCT00553969|4109500|B3|||Age||years|Mean|53|53.0|Standard Deviation|10|10.0|||
4284747|NCT00553969|4109501|B2|||Age||years|Mean|53|53.0|Standard Deviation|10|10.0|||
4284748|NCT00553969|4109502|B1|||Age||years|Mean|52|52.0|Standard Deviation|13|13.0|||
4284749|NCT00553969|4109498|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4284750|NCT00553969|4109499|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4284751|NCT00553969|4109500|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4284752|NCT00553969|4109501|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4284753|NCT00553969|4109502|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4284754|NCT00553969|4109498|B5||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
4284755|NCT00553969|4109499|B4||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4284756|NCT00553969|4109500|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4284757|NCT00553969|4109501|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4284758|NCT00553969|4109502|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4284759|NCT00553969|4109498|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4284760|NCT00553969|4109499|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4284761|NCT00553969|4109500|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4284762|NCT00553969|4109501|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4284763|NCT00553969|4109502|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4284764|NCT00553839|4109515|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4284765|NCT00553839|4109515|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4284766|NCT00553839|4109515|B1|||Age||years|Mean|6.44|6.44|Standard Deviation|4.59|4.59|||
4284767|NCT00553787|4109521|B4|United States||Region of Enrollment||participants|Number|2487|2487.0||||||
4284768|NCT00553787|4109522|B3|United States||Region of Enrollment||participants|Number|995|995.0||||||
4284769|NCT00553787|4109523|B2|United States||Region of Enrollment||participants|Number|498|498.0||||||
4284770|NCT00553787|4109524|B1|United States||Region of Enrollment||participants|Number|994|994.0||||||
4284771|NCT00553787|4109521|B4||Male|Sex: Female, Male||Participants|Count of Participants|750|750.0||||||
4284772|NCT00553787|4109522|B3||Male|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
4284773|NCT00553787|4109523|B2||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4284774|NCT00553787|4109524|B1||Male|Sex: Female, Male||Participants|Count of Participants|299|299.0||||||
4284775|NCT00553787|4109521|B4||Female|Sex: Female, Male||Participants|Count of Participants|1737|1737.0||||||
4284776|NCT00553787|4109522|B3||Female|Sex: Female, Male||Participants|Count of Participants|693|693.0||||||
4284777|NCT00553787|4109523|B2||Female|Sex: Female, Male||Participants|Count of Participants|349|349.0||||||
4284778|NCT00553787|4109524|B1||Female|Sex: Female, Male||Participants|Count of Participants|695|695.0||||||
4284779|NCT00553787|4109521|B4|||Age||years|Mean|51.1|51.1|Standard Deviation|10.4|10.4|||
4284780|NCT00553787|4109522|B3|||Age||years|Mean|51|51.0|Standard Deviation|10.7|10.7|||
4284781|NCT00553787|4109523|B2|||Age||years|Mean|51.1|51.1|Standard Deviation|10.4|10.4|||
4284782|NCT00553787|4109524|B1|||Age||years|Mean|51.2|51.2|Standard Deviation|10.3|10.3|||
4284783|NCT00553735|4109537|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4284784|NCT00553735|4109537|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4284785|NCT00553735|4109537|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4284786|NCT00553735|4109537|B1|||Age||years|Mean|43|43.0|Standard Deviation|17|17.0|||
4284787|NCT00553735|4109537|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4284788|NCT00553735|4109537|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4284789|NCT00553735|4109537|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4284790|NCT00553696|4109554|B5||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4284791|NCT00553696|4109555|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4284792|NCT00553696|4109556|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4284793|NCT00553696|4109557|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4284794|NCT00553696|4109558|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4284795|NCT00553696|4109554|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4284796|NCT00553696|4109555|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4284797|NCT00553696|4109556|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4284798|NCT00553696|4109557|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4284799|NCT00553696|4109558|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4284800|NCT00553696|4109554|B5|||Age||years|Mean|57.2|57.2|Standard Deviation|12.3|12.3|||
4284801|NCT00553696|4109555|B4|||Age||years|Mean|64|64.0|Standard Deviation|0|0.0|||
4284802|NCT00553696|4109556|B3|||Age||years|Mean|54.8|54.8|Standard Deviation|16.6|16.6|||
4284803|NCT00553696|4109557|B2|||Age||years|Mean|56.8|56.8|Standard Deviation|11.4|11.4|||
4284804|NCT00553696|4109558|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|12.8|12.8|||
4284805|NCT00553644|4109599|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
4284806|NCT00553644|4109599|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4284807|NCT00553644|4109599|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4284808|NCT00553644|4109599|B1|||Age||years|Median|67|67.0|Full Range|||39.0|83.0|
4284809|NCT00553631|4109606|B3|India||Region of Enrollment||participants|Number|8|8.0||||||
4284810|NCT00553631|4109607|B2|India||Region of Enrollment||participants|Number|4|4.0||||||
4284811|NCT00553631|4109608|B1|India||Region of Enrollment||participants|Number|4|4.0||||||
4284812|NCT00553631|4109606|B3|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4284813|NCT00553631|4109607|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4284814|NCT00553631|4109608|B1|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4284815|NCT00553631|4109606|B3|Tunisia||Region of Enrollment||participants|Number|6|6.0||||||
4284816|NCT00553631|4109607|B2|Tunisia||Region of Enrollment||participants|Number|2|2.0||||||
4284817|NCT00553631|4109608|B1|Tunisia||Region of Enrollment||participants|Number|4|4.0||||||
4284818|NCT00553631|4109606|B3|Russian Federation||Region of Enrollment||participants|Number|4|4.0||||||
4284819|NCT00553631|4109607|B2|Russian Federation||Region of Enrollment||participants|Number|2|2.0||||||
4284820|NCT00553631|4109608|B1|Russian Federation||Region of Enrollment||participants|Number|2|2.0||||||
4284821|NCT00553631|4109606|B3|Israel||Region of Enrollment||participants|Number|3|3.0||||||
4284822|NCT00553631|4109607|B2|Israel||Region of Enrollment||participants|Number|2|2.0||||||
4284823|NCT00553631|4109608|B1|Israel||Region of Enrollment||participants|Number|1|1.0||||||
4284824|NCT00553631|4109606|B3|Spain||Region of Enrollment||participants|Number|3|3.0||||||
4284825|NCT00553631|4109607|B2|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4284826|NCT00553631|4109608|B1|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4284827|NCT00553631|4109606|B3|Argentina||Region of Enrollment||participants|Number|3|3.0||||||
4284828|NCT00553631|4109607|B2|Argentina||Region of Enrollment||participants|Number|1|1.0||||||
4284829|NCT00553631|4109608|B1|Argentina||Region of Enrollment||participants|Number|2|2.0||||||
4284830|NCT00553631|4109606|B3|Paraguay||Region of Enrollment||participants|Number|5|5.0||||||
4284831|NCT00553631|4109607|B2|Paraguay||Region of Enrollment||participants|Number|2|2.0||||||
4284832|NCT00553631|4109608|B1|Paraguay||Region of Enrollment||participants|Number|3|3.0||||||
4284833|NCT00553631|4109606|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4284834|NCT00553631|4109607|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4284835|NCT00553631|4109608|B1|United States||Region of Enrollment||participants|Number|0|0.0||||||
4284836|NCT00553631|4109606|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4284837|NCT00553631|4109607|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4284838|NCT00553631|4109608|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4284839|NCT00553631|4109606|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4284840|NCT00553631|4109607|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4284841|NCT00553631|4109608|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4284842|NCT00553631|4109606|B3|||Age||years|Median|30.5|30.5|Full Range|||3.0|73.0|
4284843|NCT00553631|4109607|B2|||Age||years|Median|27|27.0|Full Range|||3.0|73.0|
4284844|NCT00553631|4109608|B1|||Age||years|Median|36|36.0|Full Range|||7.0|60.0|
4284845|NCT00553631|4109606|B3||>=65 years|Age|Age at time of consent|Participants|Count of Participants|1|1.0||||||
4284846|NCT00553631|4109607|B2||>=65 years|Age|Age at time of consent|Participants|Count of Participants|1|1.0||||||
4284847|NCT00553631|4109608|B1||>=65 years|Age|Age at time of consent|Participants|Count of Participants|0|0.0||||||
4284848|NCT00553631|4109606|B3||Between 18 and 65 years|Age|Age at time of consent|Participants|Count of Participants|24|24.0||||||
4284849|NCT00553631|4109607|B2||Between 18 and 65 years|Age|Age at time of consent|Participants|Count of Participants|11|11.0||||||
4284850|NCT00553631|4109608|B1||Between 18 and 65 years|Age|Age at time of consent|Participants|Count of Participants|13|13.0||||||
4284851|NCT00553631|4109606|B3||<=18 years|Age|Age at time of consent|Participants|Count of Participants|9|9.0||||||
4284852|NCT00553631|4109607|B2||<=18 years|Age|Age at time of consent|Participants|Count of Participants|5|5.0||||||
4284853|NCT00553631|4109608|B1||<=18 years|Age|Age at time of consent|Participants|Count of Participants|4|4.0||||||
4284854|NCT00553605|4109629|B3||Male|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
4284855|NCT00553605|4109630|B2||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4284856|NCT00553605|4109631|B1||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4284857|NCT00553605|4109629|B3||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4284858|NCT00553605|4109630|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4284859|NCT00553605|4109631|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4284860|NCT00553605|4109629|B3|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|2|2.0||||||
4284861|NCT00553605|4109630|B2|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|1|1.0||||||
4284862|NCT00553605|4109631|B1|Greater than or equal to (>=) 65 years||Age, Customized||participants|Number|1|1.0||||||
4284863|NCT00553605|4109629|B3|45 to 64 years||Age, Customized||participants|Number|95|95.0||||||
4284864|NCT00553605|4109630|B2|45 to 64 years||Age, Customized||participants|Number|54|54.0||||||
4284865|NCT00553605|4109631|B1|45 to 64 years||Age, Customized||participants|Number|41|41.0||||||
4284866|NCT00553605|4109629|B3|18 to 44 years||Age, Customized||participants|Number|240|240.0||||||
4284867|NCT00553605|4109630|B2|18 to 44 years||Age, Customized||participants|Number|109|109.0||||||
4284868|NCT00553605|4109631|B1|18 to 44 years||Age, Customized||participants|Number|131|131.0||||||
4284869|NCT00553605|4109629|B3|Less than (<) 18 years||Age, Customized||participants|Number|1|1.0||||||
4284870|NCT00553605|4109630|B2|Less than (<) 18 years||Age, Customized||participants|Number|0|0.0||||||
4284871|NCT00553605|4109631|B1|Less than (<) 18 years||Age, Customized||participants|Number|1|1.0||||||
4284872|NCT00553514|4109656|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4284873|NCT00553514|4109657|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4284874|NCT00553514|4109658|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4284875|NCT00553514|4109659|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4284876|NCT00553514|4109660|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4284877|NCT00553514|4109661|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4284878|NCT00553514|4109656|B6||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4284879|NCT00553514|4109657|B5||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4284880|NCT00553514|4109658|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4284881|NCT00553514|4109659|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4284882|NCT00553514|4109660|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4284883|NCT00553514|4109661|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4284884|NCT00553514|4109656|B6|||Age||years|Median|30|30.0|Full Range|||23.0|36.0|
4284885|NCT00553514|4109657|B5|||Age||years|Median|30.0|30.0|Full Range|||23.0|34.0|
4284886|NCT00553514|4109658|B4|||Age||years|Median|30.0|30.0|Full Range|||23.0|36.0|
4284887|NCT00553514|4109659|B3|||Age||years|Median|28.0|28.0|Full Range|||26.0|35.0|
4284888|NCT00553514|4109660|B2|||Age||years|Median|31.5|31.5|Full Range|||23.0|36.0|
4284889|NCT00553514|4109661|B1|||Age||years|Median|29.5|29.5|Full Range|||23.0|36.0|
4284890|NCT00553501|4109702|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
4284891|NCT00553501|4109702|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4284892|NCT00553501|4109702|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284893|NCT00553501|4109702|B1||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4284894|NCT00553501|4109702|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4284895|NCT00553501|4109702|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284896|NCT00553501|4109702|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4284897|NCT00553501|4109702|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284898|NCT00553501|4109702|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4284899|NCT00553501|4109702|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4284900|NCT00553501|4109702|B1|||Age||years|Median|54|54.0|Full Range|||32.0|90.0|
4284901|NCT00553475|4109708|B4|Japan||Region of Enrollment||participants|Number|314|314.0||||||
4284902|NCT00553475|4109709|B3|Japan||Region of Enrollment||participants|Number|45|45.0||||||
4284903|NCT00553475|4109710|B2|Japan||Region of Enrollment||participants|Number|134|134.0||||||
4284904|NCT00553475|4109711|B1|Japan||Region of Enrollment||participants|Number|135|135.0||||||
4284905|NCT00553475|4109708|B4||Male|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
4284906|NCT00553475|4109709|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4284907|NCT00553475|4109710|B2||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4284908|NCT00553475|4109711|B1||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4284909|NCT00553475|4109708|B4||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4284910|NCT00553475|4109709|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4284911|NCT00553475|4109710|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4284912|NCT00553475|4109711|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4284913|NCT00553475|4109708|B4|||Age||years|Mean|61.4|61.4|Standard Deviation|10.0|10.0|||
4284914|NCT00553475|4109709|B3|||Age||years|Mean|62.2|62.2|Standard Deviation|10.3|10.3|||
4284915|NCT00553475|4109710|B2|||Age||years|Mean|61.3|61.3|Standard Deviation|10.3|10.3|||
4284916|NCT00553475|4109711|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|9.6|9.6|||
4284917|NCT00553475|4109708|B4|>= 65 years||Age, Customized||participants|Number|119|119.0||||||
4284918|NCT00553475|4109709|B3|>= 65 years||Age, Customized||participants|Number|19|19.0||||||
4284919|NCT00553475|4109710|B2|>= 65 years||Age, Customized||participants|Number|48|48.0||||||
4284920|NCT00553475|4109711|B1|>= 65 years||Age, Customized||participants|Number|52|52.0||||||
4284921|NCT00553475|4109708|B4|45 - 64 years||Age, Customized||participants|Number|179|179.0||||||
4284922|NCT00553475|4109709|B3|45 - 64 years||Age, Customized||participants|Number|25|25.0||||||
4284923|NCT00553475|4109710|B2|45 - 64 years||Age, Customized||participants|Number|78|78.0||||||
4284924|NCT00553475|4109711|B1|45 - 64 years||Age, Customized||participants|Number|76|76.0||||||
4284925|NCT00553475|4109708|B4|18 - 44 years||Age, Customized||participants|Number|16|16.0||||||
4284926|NCT00553475|4109709|B3|18 - 44 years||Age, Customized||participants|Number|1|1.0||||||
4284927|NCT00553475|4109710|B2|18 - 44 years||Age, Customized||participants|Number|8|8.0||||||
4284928|NCT00553475|4109711|B1|18 - 44 years||Age, Customized||participants|Number|7|7.0||||||
4284929|NCT00553475|4109708|B4|< 18 years||Age, Customized||participants|Number|0|0.0||||||
4284930|NCT00553475|4109709|B3|< 18 years||Age, Customized||participants|Number|0|0.0||||||
4284931|NCT00553475|4109710|B2|< 18 years||Age, Customized||participants|Number|0|0.0||||||
4284932|NCT00553475|4109711|B1|< 18 years||Age, Customized||participants|Number|0|0.0||||||
4284933|NCT00553462|4109835|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
4284934|NCT00553462|4109835|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284935|NCT00553462|4109835|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4284936|NCT00553462|4109835|B1||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4284937|NCT00553462|4109835|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4284938|NCT00553462|4109835|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284939|NCT00553462|4109835|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4284940|NCT00553462|4109835|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4284941|NCT00553462|4109835|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4284942|NCT00553462|4109835|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
4284943|NCT00553462|4109835|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4284944|NCT00553462|4109835|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4284945|NCT00553462|4109835|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4284946|NCT00553462|4109835|B1|||Age||years|Median|68|68.0|Full Range|||39.0|88.0|
4284947|NCT00553436|4109841|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4284948|NCT00553436|4109841|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4284949|NCT00553436|4109841|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4284950|NCT00553436|4109841|B1|||Age||years|Mean|65|65.0|Standard Deviation|8.36|8.36|||
4284951|NCT00553436|4109841|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4284952|NCT00553436|4109841|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4284953|NCT00553436|4109841|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4284954|NCT00553358|4109847|B4|Not interpretable||Number of participants with the indicated FISH results|The Fluorescent In Situ Hybridization (FISH) assay was used to determine the overexpression and/or amplification of HER2 in the invasive component of the primary tumor. Amplified indicates that the cell is overexpressing copies of the HER2 gene. Not amplified indicates that there is no overexpression of copies of the HER2 gene. “Not applicable” refers to the number of participants who did not have the FISH assay performed.|participants|Number|1|1.0||||||
4284955|NCT00553358|4109848|B3|Not interpretable||Number of participants with the indicated FISH results|The Fluorescent In Situ Hybridization (FISH) assay was used to determine the overexpression and/or amplification of HER2 in the invasive component of the primary tumor. Amplified indicates that the cell is overexpressing copies of the HER2 gene. Not amplified indicates that there is no overexpression of copies of the HER2 gene. “Not applicable” refers to the number of participants who did not have the FISH assay performed.|participants|Number|1|1.0||||||
4284956|NCT00553358|4109849|B2|Not interpretable||Number of participants with the indicated FISH results|The Fluorescent In Situ Hybridization (FISH) assay was used to determine the overexpression and/or amplification of HER2 in the invasive component of the primary tumor. Amplified indicates that the cell is overexpressing copies of the HER2 gene. Not amplified indicates that there is no overexpression of copies of the HER2 gene. “Not applicable” refers to the number of participants who did not have the FISH assay performed.|participants|Number|0|0.0||||||
4284957|NCT00553358|4109850|B1|Not interpretable||Number of participants with the indicated FISH results|The Fluorescent In Situ Hybridization (FISH) assay was used to determine the overexpression and/or amplification of HER2 in the invasive component of the primary tumor. Amplified indicates that the cell is overexpressing copies of the HER2 gene. Not amplified indicates that there is no overexpression of copies of the HER2 gene. “Not applicable” refers to the number of participants who did not have the FISH assay performed.|participants|Number|0|0.0||||||
4284958|NCT00553358|4109847|B4|Not amplified||Number of participants with the indicated FISH results|The Fluorescent In Situ Hybridization (FISH) assay was used to determine the overexpression and/or amplification of HER2 in the invasive component of the primary tumor. Amplified indicates that the cell is overexpressing copies of the HER2 gene. Not amplified indicates that there is no overexpression of copies of the HER2 gene. “Not applicable” refers to the number of participants who did not have the FISH assay performed.|participants|Number|4|4.0||||||
4284959|NCT00553358|4109848|B3|Not amplified||Number of participants with the indicated FISH results|The Fluorescent In Situ Hybridization (FISH) assay was used to determine the overexpression and/or amplification of HER2 in the invasive component of the primary tumor. Amplified indicates that the cell is overexpressing copies of the HER2 gene. Not amplified indicates that there is no overexpression of copies of the HER2 gene. “Not applicable” refers to the number of participants who did not have the FISH assay performed.|participants|Number|1|1.0||||||
4285022|NCT00553358|4109847|B4|Moderately differentiated||Number of participants with tumor cells of the indicated histologic grade|Histologic grade, also called differentiation, refers to how much the tumor cells resemble normal cells of the same tissue type.|participants|Number|172|172.0||||||
4284960|NCT00553358|4109849|B2|Not amplified||Number of participants with the indicated FISH results|The Fluorescent In Situ Hybridization (FISH) assay was used to determine the overexpression and/or amplification of HER2 in the invasive component of the primary tumor. Amplified indicates that the cell is overexpressing copies of the HER2 gene. Not amplified indicates that there is no overexpression of copies of the HER2 gene. “Not applicable” refers to the number of participants who did not have the FISH assay performed.|participants|Number|2|2.0||||||
4284961|NCT00553358|4109850|B1|Not amplified||Number of participants with the indicated FISH results|The Fluorescent In Situ Hybridization (FISH) assay was used to determine the overexpression and/or amplification of HER2 in the invasive component of the primary tumor. Amplified indicates that the cell is overexpressing copies of the HER2 gene. Not amplified indicates that there is no overexpression of copies of the HER2 gene. “Not applicable” refers to the number of participants who did not have the FISH assay performed.|participants|Number|1|1.0||||||
4284962|NCT00553358|4109847|B4|Amplified||Number of participants with the indicated FISH results|The Fluorescent In Situ Hybridization (FISH) assay was used to determine the overexpression and/or amplification of HER2 in the invasive component of the primary tumor. Amplified indicates that the cell is overexpressing copies of the HER2 gene. Not amplified indicates that there is no overexpression of copies of the HER2 gene. “Not applicable” refers to the number of participants who did not have the FISH assay performed.|participants|Number|329|329.0||||||
4284963|NCT00553358|4109848|B3|Amplified||Number of participants with the indicated FISH results|The Fluorescent In Situ Hybridization (FISH) assay was used to determine the overexpression and/or amplification of HER2 in the invasive component of the primary tumor. Amplified indicates that the cell is overexpressing copies of the HER2 gene. Not amplified indicates that there is no overexpression of copies of the HER2 gene. “Not applicable” refers to the number of participants who did not have the FISH assay performed.|participants|Number|109|109.0||||||
4284964|NCT00553358|4109849|B2|Amplified||Number of participants with the indicated FISH results|The Fluorescent In Situ Hybridization (FISH) assay was used to determine the overexpression and/or amplification of HER2 in the invasive component of the primary tumor. Amplified indicates that the cell is overexpressing copies of the HER2 gene. Not amplified indicates that there is no overexpression of copies of the HER2 gene. “Not applicable” refers to the number of participants who did not have the FISH assay performed.|participants|Number|105|105.0||||||
4284965|NCT00553358|4109850|B1|Amplified||Number of participants with the indicated FISH results|The Fluorescent In Situ Hybridization (FISH) assay was used to determine the overexpression and/or amplification of HER2 in the invasive component of the primary tumor. Amplified indicates that the cell is overexpressing copies of the HER2 gene. Not amplified indicates that there is no overexpression of copies of the HER2 gene. “Not applicable” refers to the number of participants who did not have the FISH assay performed.|participants|Number|115|115.0||||||
4284966|NCT00553358|4109847|B4|Not applicable||Number of participants with the indicated FISH results|The Fluorescent In Situ Hybridization (FISH) assay was used to determine the overexpression and/or amplification of HER2 in the invasive component of the primary tumor. Amplified indicates that the cell is overexpressing copies of the HER2 gene. Not amplified indicates that there is no overexpression of copies of the HER2 gene. “Not applicable” refers to the number of participants who did not have the FISH assay performed.|participants|Number|121|121.0||||||
4284967|NCT00553358|4109848|B3|Not applicable||Number of participants with the indicated FISH results|The Fluorescent In Situ Hybridization (FISH) assay was used to determine the overexpression and/or amplification of HER2 in the invasive component of the primary tumor. Amplified indicates that the cell is overexpressing copies of the HER2 gene. Not amplified indicates that there is no overexpression of copies of the HER2 gene. “Not applicable” refers to the number of participants who did not have the FISH assay performed.|participants|Number|41|41.0||||||
4284968|NCT00553358|4109849|B2|Not applicable||Number of participants with the indicated FISH results|The Fluorescent In Situ Hybridization (FISH) assay was used to determine the overexpression and/or amplification of HER2 in the invasive component of the primary tumor. Amplified indicates that the cell is overexpressing copies of the HER2 gene. Not amplified indicates that there is no overexpression of copies of the HER2 gene. “Not applicable” refers to the number of participants who did not have the FISH assay performed.|participants|Number|42|42.0||||||
4284969|NCT00553358|4109850|B1|Not applicable||Number of participants with the indicated FISH results|The Fluorescent In Situ Hybridization (FISH) assay was used to determine the overexpression and/or amplification of HER2 in the invasive component of the primary tumor. Amplified indicates that the cell is overexpressing copies of the HER2 gene. Not amplified indicates that there is no overexpression of copies of the HER2 gene. “Not applicable” refers to the number of participants who did not have the FISH assay performed.|participants|Number|38|38.0||||||
4284970|NCT00553358|4109847|B4|Non interpretable||Number of participants with the indicated IHC results|An Immunohistochemistry (IHC) test gives a score of 0 to 3+, which indicates the amount of Human Epidermal Growth Factor (HER2) receptor proteins on the cancer cells in the sample tissue. A positive score (3+) indicates that HER2 receptor protein is present, a negative score (0-1+) indicates that no HER2 receptor protein is present, and an equivocal score (2+) indicates uncertainty and a result that is open for interpretation. Equivocal results require additional testing. “Not applicable” refers to the number of participants who did not have IHC testing done.|participants|Number|9|9.0||||||
4284971|NCT00553358|4109848|B3|Non interpretable||Number of participants with the indicated IHC results|An Immunohistochemistry (IHC) test gives a score of 0 to 3+, which indicates the amount of Human Epidermal Growth Factor (HER2) receptor proteins on the cancer cells in the sample tissue. A positive score (3+) indicates that HER2 receptor protein is present, a negative score (0-1+) indicates that no HER2 receptor protein is present, and an equivocal score (2+) indicates uncertainty and a result that is open for interpretation. Equivocal results require additional testing. “Not applicable” refers to the number of participants who did not have IHC testing done.|participants|Number|4|4.0||||||
4285016|NCT00553358|4109849|B2|Differentiation cannot be assessed||Number of participants with tumor cells of the indicated histologic grade|Histologic grade, also called differentiation, refers to how much the tumor cells resemble normal cells of the same tissue type.|participants|Number|23|23.0||||||
4285017|NCT00553358|4109850|B1|Differentiation cannot be assessed||Number of participants with tumor cells of the indicated histologic grade|Histologic grade, also called differentiation, refers to how much the tumor cells resemble normal cells of the same tissue type.|participants|Number|22|22.0||||||
4284972|NCT00553358|4109849|B2|Non interpretable||Number of participants with the indicated IHC results|An Immunohistochemistry (IHC) test gives a score of 0 to 3+, which indicates the amount of Human Epidermal Growth Factor (HER2) receptor proteins on the cancer cells in the sample tissue. A positive score (3+) indicates that HER2 receptor protein is present, a negative score (0-1+) indicates that no HER2 receptor protein is present, and an equivocal score (2+) indicates uncertainty and a result that is open for interpretation. Equivocal results require additional testing. “Not applicable” refers to the number of participants who did not have IHC testing done.|participants|Number|1|1.0||||||
4284973|NCT00553358|4109850|B1|Non interpretable||Number of participants with the indicated IHC results|An Immunohistochemistry (IHC) test gives a score of 0 to 3+, which indicates the amount of Human Epidermal Growth Factor (HER2) receptor proteins on the cancer cells in the sample tissue. A positive score (3+) indicates that HER2 receptor protein is present, a negative score (0-1+) indicates that no HER2 receptor protein is present, and an equivocal score (2+) indicates uncertainty and a result that is open for interpretation. Equivocal results require additional testing. “Not applicable” refers to the number of participants who did not have IHC testing done.|participants|Number|4|4.0||||||
4284974|NCT00553358|4109847|B4|Negative: Score of 0-1+||Number of participants with the indicated IHC results|An Immunohistochemistry (IHC) test gives a score of 0 to 3+, which indicates the amount of Human Epidermal Growth Factor (HER2) receptor proteins on the cancer cells in the sample tissue. A positive score (3+) indicates that HER2 receptor protein is present, a negative score (0-1+) indicates that no HER2 receptor protein is present, and an equivocal score (2+) indicates uncertainty and a result that is open for interpretation. Equivocal results require additional testing. “Not applicable” refers to the number of participants who did not have IHC testing done.|participants|Number|4|4.0||||||
4284975|NCT00553358|4109848|B3|Negative: Score of 0-1+||Number of participants with the indicated IHC results|An Immunohistochemistry (IHC) test gives a score of 0 to 3+, which indicates the amount of Human Epidermal Growth Factor (HER2) receptor proteins on the cancer cells in the sample tissue. A positive score (3+) indicates that HER2 receptor protein is present, a negative score (0-1+) indicates that no HER2 receptor protein is present, and an equivocal score (2+) indicates uncertainty and a result that is open for interpretation. Equivocal results require additional testing. “Not applicable” refers to the number of participants who did not have IHC testing done.|participants|Number|3|3.0||||||
4284976|NCT00553358|4109849|B2|Negative: Score of 0-1+||Number of participants with the indicated IHC results|An Immunohistochemistry (IHC) test gives a score of 0 to 3+, which indicates the amount of Human Epidermal Growth Factor (HER2) receptor proteins on the cancer cells in the sample tissue. A positive score (3+) indicates that HER2 receptor protein is present, a negative score (0-1+) indicates that no HER2 receptor protein is present, and an equivocal score (2+) indicates uncertainty and a result that is open for interpretation. Equivocal results require additional testing. “Not applicable” refers to the number of participants who did not have IHC testing done.|participants|Number|1|1.0||||||
4284977|NCT00553358|4109850|B1|Negative: Score of 0-1+||Number of participants with the indicated IHC results|An Immunohistochemistry (IHC) test gives a score of 0 to 3+, which indicates the amount of Human Epidermal Growth Factor (HER2) receptor proteins on the cancer cells in the sample tissue. A positive score (3+) indicates that HER2 receptor protein is present, a negative score (0-1+) indicates that no HER2 receptor protein is present, and an equivocal score (2+) indicates uncertainty and a result that is open for interpretation. Equivocal results require additional testing. “Not applicable” refers to the number of participants who did not have IHC testing done.|participants|Number|0|0.0||||||
4284978|NCT00553358|4109847|B4|Positive: Score of 3+||Number of participants with the indicated IHC results|An Immunohistochemistry (IHC) test gives a score of 0 to 3+, which indicates the amount of Human Epidermal Growth Factor (HER2) receptor proteins on the cancer cells in the sample tissue. A positive score (3+) indicates that HER2 receptor protein is present, a negative score (0-1+) indicates that no HER2 receptor protein is present, and an equivocal score (2+) indicates uncertainty and a result that is open for interpretation. Equivocal results require additional testing. “Not applicable” refers to the number of participants who did not have IHC testing done.|participants|Number|246|246.0||||||
4284979|NCT00553358|4109848|B3|Positive: Score of 3+||Number of participants with the indicated IHC results|An Immunohistochemistry (IHC) test gives a score of 0 to 3+, which indicates the amount of Human Epidermal Growth Factor (HER2) receptor proteins on the cancer cells in the sample tissue. A positive score (3+) indicates that HER2 receptor protein is present, a negative score (0-1+) indicates that no HER2 receptor protein is present, and an equivocal score (2+) indicates uncertainty and a result that is open for interpretation. Equivocal results require additional testing. “Not applicable” refers to the number of participants who did not have IHC testing done.|participants|Number|76|76.0||||||
4284980|NCT00553358|4109849|B2|Positive: Score of 3+||Number of participants with the indicated IHC results|An Immunohistochemistry (IHC) test gives a score of 0 to 3+, which indicates the amount of Human Epidermal Growth Factor (HER2) receptor proteins on the cancer cells in the sample tissue. A positive score (3+) indicates that HER2 receptor protein is present, a negative score (0-1+) indicates that no HER2 receptor protein is present, and an equivocal score (2+) indicates uncertainty and a result that is open for interpretation. Equivocal results require additional testing. “Not applicable” refers to the number of participants who did not have IHC testing done.|participants|Number|89|89.0||||||
4284981|NCT00553358|4109850|B1|Positive: Score of 3+||Number of participants with the indicated IHC results|An Immunohistochemistry (IHC) test gives a score of 0 to 3+, which indicates the amount of Human Epidermal Growth Factor (HER2) receptor proteins on the cancer cells in the sample tissue. A positive score (3+) indicates that HER2 receptor protein is present, a negative score (0-1+) indicates that no HER2 receptor protein is present, and an equivocal score (2+) indicates uncertainty and a result that is open for interpretation. Equivocal results require additional testing. “Not applicable” refers to the number of participants who did not have IHC testing done.|participants|Number|81|81.0||||||
4285018|NCT00553358|4109847|B4|Poorly differentiated||Number of participants with tumor cells of the indicated histologic grade|Histologic grade, also called differentiation, refers to how much the tumor cells resemble normal cells of the same tissue type.|participants|Number|205|205.0||||||
4285019|NCT00553358|4109848|B3|Poorly differentiated||Number of participants with tumor cells of the indicated histologic grade|Histologic grade, also called differentiation, refers to how much the tumor cells resemble normal cells of the same tissue type.|participants|Number|64|64.0||||||
4284982|NCT00553358|4109847|B4|Equivocal: Score of 2+||Number of participants with the indicated IHC results|An Immunohistochemistry (IHC) test gives a score of 0 to 3+, which indicates the amount of Human Epidermal Growth Factor (HER2) receptor proteins on the cancer cells in the sample tissue. A positive score (3+) indicates that HER2 receptor protein is present, a negative score (0-1+) indicates that no HER2 receptor protein is present, and an equivocal score (2+) indicates uncertainty and a result that is open for interpretation. Equivocal results require additional testing. “Not applicable” refers to the number of participants who did not have IHC testing done.|participants|Number|22|22.0||||||
4284983|NCT00553358|4109848|B3|Equivocal: Score of 2+||Number of participants with the indicated IHC results|An Immunohistochemistry (IHC) test gives a score of 0 to 3+, which indicates the amount of Human Epidermal Growth Factor (HER2) receptor proteins on the cancer cells in the sample tissue. A positive score (3+) indicates that HER2 receptor protein is present, a negative score (0-1+) indicates that no HER2 receptor protein is present, and an equivocal score (2+) indicates uncertainty and a result that is open for interpretation. Equivocal results require additional testing. “Not applicable” refers to the number of participants who did not have IHC testing done.|participants|Number|8|8.0||||||
4284984|NCT00553358|4109849|B2|Equivocal: Score of 2+||Number of participants with the indicated IHC results|An Immunohistochemistry (IHC) test gives a score of 0 to 3+, which indicates the amount of Human Epidermal Growth Factor (HER2) receptor proteins on the cancer cells in the sample tissue. A positive score (3+) indicates that HER2 receptor protein is present, a negative score (0-1+) indicates that no HER2 receptor protein is present, and an equivocal score (2+) indicates uncertainty and a result that is open for interpretation. Equivocal results require additional testing. “Not applicable” refers to the number of participants who did not have IHC testing done.|participants|Number|5|5.0||||||
4284985|NCT00553358|4109850|B1|Equivocal: Score of 2+||Number of participants with the indicated IHC results|An Immunohistochemistry (IHC) test gives a score of 0 to 3+, which indicates the amount of Human Epidermal Growth Factor (HER2) receptor proteins on the cancer cells in the sample tissue. A positive score (3+) indicates that HER2 receptor protein is present, a negative score (0-1+) indicates that no HER2 receptor protein is present, and an equivocal score (2+) indicates uncertainty and a result that is open for interpretation. Equivocal results require additional testing. “Not applicable” refers to the number of participants who did not have IHC testing done.|participants|Number|9|9.0||||||
4284986|NCT00553358|4109847|B4|Not applicable||Number of participants with the indicated IHC results|An Immunohistochemistry (IHC) test gives a score of 0 to 3+, which indicates the amount of Human Epidermal Growth Factor (HER2) receptor proteins on the cancer cells in the sample tissue. A positive score (3+) indicates that HER2 receptor protein is present, a negative score (0-1+) indicates that no HER2 receptor protein is present, and an equivocal score (2+) indicates uncertainty and a result that is open for interpretation. Equivocal results require additional testing. “Not applicable” refers to the number of participants who did not have IHC testing done.|participants|Number|174|174.0||||||
4284987|NCT00553358|4109848|B3|Not applicable||Number of participants with the indicated IHC results|An Immunohistochemistry (IHC) test gives a score of 0 to 3+, which indicates the amount of Human Epidermal Growth Factor (HER2) receptor proteins on the cancer cells in the sample tissue. A positive score (3+) indicates that HER2 receptor protein is present, a negative score (0-1+) indicates that no HER2 receptor protein is present, and an equivocal score (2+) indicates uncertainty and a result that is open for interpretation. Equivocal results require additional testing. “Not applicable” refers to the number of participants who did not have IHC testing done.|participants|Number|61|61.0||||||
4284988|NCT00553358|4109849|B2|Not applicable||Number of participants with the indicated IHC results|An Immunohistochemistry (IHC) test gives a score of 0 to 3+, which indicates the amount of Human Epidermal Growth Factor (HER2) receptor proteins on the cancer cells in the sample tissue. A positive score (3+) indicates that HER2 receptor protein is present, a negative score (0-1+) indicates that no HER2 receptor protein is present, and an equivocal score (2+) indicates uncertainty and a result that is open for interpretation. Equivocal results require additional testing. “Not applicable” refers to the number of participants who did not have IHC testing done.|participants|Number|53|53.0||||||
4284989|NCT00553358|4109850|B1|Not applicable||Number of participants with the indicated IHC results|An Immunohistochemistry (IHC) test gives a score of 0 to 3+, which indicates the amount of Human Epidermal Growth Factor (HER2) receptor proteins on the cancer cells in the sample tissue. A positive score (3+) indicates that HER2 receptor protein is present, a negative score (0-1+) indicates that no HER2 receptor protein is present, and an equivocal score (2+) indicates uncertainty and a result that is open for interpretation. Equivocal results require additional testing. “Not applicable” refers to the number of participants who did not have IHC testing done.|participants|Number|60|60.0||||||
4284990|NCT00553358|4109847|B4|Nx||Number of participants with lymph nodes (LNs) of the indicated clinical N stage|Clinical N stage is an evaluation/staging of LN status through physical examination. N0, no regional LN metastasis; N1, metastasis to movable ipsilateral axillary LNs (IALNs); N2a, metastasis in IALNs fixed to one another (matted) or the other structures; N2b, metastasis only in clinically apparent ipsilateral internal mammary nodes and in the absence of clinically evident axillary LN metastasis; N3a, metastasis in ipsilateral infraclavicular LNs; N3b, metastasis in ipsilateral internal mammary LNs fixed and axillary LN; N3c, metastasis in ipsilateral subclavicar LNs; Nx, not assessed.|participants|Number|6|6.0||||||
4284991|NCT00553358|4109848|B3|Nx||Number of participants with lymph nodes (LNs) of the indicated clinical N stage|Clinical N stage is an evaluation/staging of LN status through physical examination. N0, no regional LN metastasis; N1, metastasis to movable ipsilateral axillary LNs (IALNs); N2a, metastasis in IALNs fixed to one another (matted) or the other structures; N2b, metastasis only in clinically apparent ipsilateral internal mammary nodes and in the absence of clinically evident axillary LN metastasis; N3a, metastasis in ipsilateral infraclavicular LNs; N3b, metastasis in ipsilateral internal mammary LNs fixed and axillary LN; N3c, metastasis in ipsilateral subclavicar LNs; Nx, not assessed.|participants|Number|3|3.0||||||
4285020|NCT00553358|4109849|B2|Poorly differentiated||Number of participants with tumor cells of the indicated histologic grade|Histologic grade, also called differentiation, refers to how much the tumor cells resemble normal cells of the same tissue type.|participants|Number|68|68.0||||||
4285021|NCT00553358|4109850|B1|Poorly differentiated||Number of participants with tumor cells of the indicated histologic grade|Histologic grade, also called differentiation, refers to how much the tumor cells resemble normal cells of the same tissue type.|participants|Number|73|73.0||||||
4284992|NCT00553358|4109849|B2|Nx||Number of participants with lymph nodes (LNs) of the indicated clinical N stage|Clinical N stage is an evaluation/staging of LN status through physical examination. N0, no regional LN metastasis; N1, metastasis to movable ipsilateral axillary LNs (IALNs); N2a, metastasis in IALNs fixed to one another (matted) or the other structures; N2b, metastasis only in clinically apparent ipsilateral internal mammary nodes and in the absence of clinically evident axillary LN metastasis; N3a, metastasis in ipsilateral infraclavicular LNs; N3b, metastasis in ipsilateral internal mammary LNs fixed and axillary LN; N3c, metastasis in ipsilateral subclavicar LNs; Nx, not assessed.|participants|Number|3|3.0||||||
4284993|NCT00553358|4109850|B1|Nx||Number of participants with lymph nodes (LNs) of the indicated clinical N stage|Clinical N stage is an evaluation/staging of LN status through physical examination. N0, no regional LN metastasis; N1, metastasis to movable ipsilateral axillary LNs (IALNs); N2a, metastasis in IALNs fixed to one another (matted) or the other structures; N2b, metastasis only in clinically apparent ipsilateral internal mammary nodes and in the absence of clinically evident axillary LN metastasis; N3a, metastasis in ipsilateral infraclavicular LNs; N3b, metastasis in ipsilateral internal mammary LNs fixed and axillary LN; N3c, metastasis in ipsilateral subclavicar LNs; Nx, not assessed.|participants|Number|0|0.0||||||
4284994|NCT00553358|4109847|B4|N3 (including N3a, N3b, and N3c)||Number of participants with lymph nodes (LNs) of the indicated clinical N stage|Clinical N stage is an evaluation/staging of LN status through physical examination. N0, no regional LN metastasis; N1, metastasis to movable ipsilateral axillary LNs (IALNs); N2a, metastasis in IALNs fixed to one another (matted) or the other structures; N2b, metastasis only in clinically apparent ipsilateral internal mammary nodes and in the absence of clinically evident axillary LN metastasis; N3a, metastasis in ipsilateral infraclavicular LNs; N3b, metastasis in ipsilateral internal mammary LNs fixed and axillary LN; N3c, metastasis in ipsilateral subclavicar LNs; Nx, not assessed.|participants|Number|19|19.0||||||
4284995|NCT00553358|4109848|B3|N3 (including N3a, N3b, and N3c)||Number of participants with lymph nodes (LNs) of the indicated clinical N stage|Clinical N stage is an evaluation/staging of LN status through physical examination. N0, no regional LN metastasis; N1, metastasis to movable ipsilateral axillary LNs (IALNs); N2a, metastasis in IALNs fixed to one another (matted) or the other structures; N2b, metastasis only in clinically apparent ipsilateral internal mammary nodes and in the absence of clinically evident axillary LN metastasis; N3a, metastasis in ipsilateral infraclavicular LNs; N3b, metastasis in ipsilateral internal mammary LNs fixed and axillary LN; N3c, metastasis in ipsilateral subclavicar LNs; Nx, not assessed.|participants|Number|6|6.0||||||
4284996|NCT00553358|4109849|B2|N3 (including N3a, N3b, and N3c)||Number of participants with lymph nodes (LNs) of the indicated clinical N stage|Clinical N stage is an evaluation/staging of LN status through physical examination. N0, no regional LN metastasis; N1, metastasis to movable ipsilateral axillary LNs (IALNs); N2a, metastasis in IALNs fixed to one another (matted) or the other structures; N2b, metastasis only in clinically apparent ipsilateral internal mammary nodes and in the absence of clinically evident axillary LN metastasis; N3a, metastasis in ipsilateral infraclavicular LNs; N3b, metastasis in ipsilateral internal mammary LNs fixed and axillary LN; N3c, metastasis in ipsilateral subclavicar LNs; Nx, not assessed.|participants|Number|7|7.0||||||
4284997|NCT00553358|4109850|B1|N3 (including N3a, N3b, and N3c)||Number of participants with lymph nodes (LNs) of the indicated clinical N stage|Clinical N stage is an evaluation/staging of LN status through physical examination. N0, no regional LN metastasis; N1, metastasis to movable ipsilateral axillary LNs (IALNs); N2a, metastasis in IALNs fixed to one another (matted) or the other structures; N2b, metastasis only in clinically apparent ipsilateral internal mammary nodes and in the absence of clinically evident axillary LN metastasis; N3a, metastasis in ipsilateral infraclavicular LNs; N3b, metastasis in ipsilateral internal mammary LNs fixed and axillary LN; N3c, metastasis in ipsilateral subclavicar LNs; Nx, not assessed.|participants|Number|6|6.0||||||
4284998|NCT00553358|4109847|B4|N2 (including N2a and N2b)||Number of participants with lymph nodes (LNs) of the indicated clinical N stage|Clinical N stage is an evaluation/staging of LN status through physical examination. N0, no regional LN metastasis; N1, metastasis to movable ipsilateral axillary LNs (IALNs); N2a, metastasis in IALNs fixed to one another (matted) or the other structures; N2b, metastasis only in clinically apparent ipsilateral internal mammary nodes and in the absence of clinically evident axillary LN metastasis; N3a, metastasis in ipsilateral infraclavicular LNs; N3b, metastasis in ipsilateral internal mammary LNs fixed and axillary LN; N3c, metastasis in ipsilateral subclavicar LNs; Nx, not assessed.|participants|Number|47|47.0||||||
4284999|NCT00553358|4109848|B3|N2 (including N2a and N2b)||Number of participants with lymph nodes (LNs) of the indicated clinical N stage|Clinical N stage is an evaluation/staging of LN status through physical examination. N0, no regional LN metastasis; N1, metastasis to movable ipsilateral axillary LNs (IALNs); N2a, metastasis in IALNs fixed to one another (matted) or the other structures; N2b, metastasis only in clinically apparent ipsilateral internal mammary nodes and in the absence of clinically evident axillary LN metastasis; N3a, metastasis in ipsilateral infraclavicular LNs; N3b, metastasis in ipsilateral internal mammary LNs fixed and axillary LN; N3c, metastasis in ipsilateral subclavicar LNs; Nx, not assessed.|participants|Number|15|15.0||||||
4285000|NCT00553358|4109849|B2|N2 (including N2a and N2b)||Number of participants with lymph nodes (LNs) of the indicated clinical N stage|Clinical N stage is an evaluation/staging of LN status through physical examination. N0, no regional LN metastasis; N1, metastasis to movable ipsilateral axillary LNs (IALNs); N2a, metastasis in IALNs fixed to one another (matted) or the other structures; N2b, metastasis only in clinically apparent ipsilateral internal mammary nodes and in the absence of clinically evident axillary LN metastasis; N3a, metastasis in ipsilateral infraclavicular LNs; N3b, metastasis in ipsilateral internal mammary LNs fixed and axillary LN; N3c, metastasis in ipsilateral subclavicar LNs; Nx, not assessed.|participants|Number|13|13.0||||||
4285001|NCT00553358|4109850|B1|N2 (including N2a and N2b)||Number of participants with lymph nodes (LNs) of the indicated clinical N stage|Clinical N stage is an evaluation/staging of LN status through physical examination. N0, no regional LN metastasis; N1, metastasis to movable ipsilateral axillary LNs (IALNs); N2a, metastasis in IALNs fixed to one another (matted) or the other structures; N2b, metastasis only in clinically apparent ipsilateral internal mammary nodes and in the absence of clinically evident axillary LN metastasis; N3a, metastasis in ipsilateral infraclavicular LNs; N3b, metastasis in ipsilateral internal mammary LNs fixed and axillary LN; N3c, metastasis in ipsilateral subclavicar LNs; Nx, not assessed.|participants|Number|19|19.0||||||
4285071|NCT00553358|4109848|B3|||Age||Years|Median|50.0|50.0|Full Range|||25.0|80.0|
4285002|NCT00553358|4109847|B4|N1||Number of participants with lymph nodes (LNs) of the indicated clinical N stage|Clinical N stage is an evaluation/staging of LN status through physical examination. N0, no regional LN metastasis; N1, metastasis to movable ipsilateral axillary LNs (IALNs); N2a, metastasis in IALNs fixed to one another (matted) or the other structures; N2b, metastasis only in clinically apparent ipsilateral internal mammary nodes and in the absence of clinically evident axillary LN metastasis; N3a, metastasis in ipsilateral infraclavicular LNs; N3b, metastasis in ipsilateral internal mammary LNs fixed and axillary LN; N3c, metastasis in ipsilateral subclavicar LNs; Nx, not assessed.|participants|Number|260|260.0||||||
4285003|NCT00553358|4109848|B3|N1||Number of participants with lymph nodes (LNs) of the indicated clinical N stage|Clinical N stage is an evaluation/staging of LN status through physical examination. N0, no regional LN metastasis; N1, metastasis to movable ipsilateral axillary LNs (IALNs); N2a, metastasis in IALNs fixed to one another (matted) or the other structures; N2b, metastasis only in clinically apparent ipsilateral internal mammary nodes and in the absence of clinically evident axillary LN metastasis; N3a, metastasis in ipsilateral infraclavicular LNs; N3b, metastasis in ipsilateral internal mammary LNs fixed and axillary LN; N3c, metastasis in ipsilateral subclavicar LNs; Nx, not assessed.|participants|Number|80|80.0||||||
4285004|NCT00553358|4109849|B2|N1||Number of participants with lymph nodes (LNs) of the indicated clinical N stage|Clinical N stage is an evaluation/staging of LN status through physical examination. N0, no regional LN metastasis; N1, metastasis to movable ipsilateral axillary LNs (IALNs); N2a, metastasis in IALNs fixed to one another (matted) or the other structures; N2b, metastasis only in clinically apparent ipsilateral internal mammary nodes and in the absence of clinically evident axillary LN metastasis; N3a, metastasis in ipsilateral infraclavicular LNs; N3b, metastasis in ipsilateral internal mammary LNs fixed and axillary LN; N3c, metastasis in ipsilateral subclavicar LNs; Nx, not assessed.|participants|Number|85|85.0||||||
4285005|NCT00553358|4109850|B1|N1||Number of participants with lymph nodes (LNs) of the indicated clinical N stage|Clinical N stage is an evaluation/staging of LN status through physical examination. N0, no regional LN metastasis; N1, metastasis to movable ipsilateral axillary LNs (IALNs); N2a, metastasis in IALNs fixed to one another (matted) or the other structures; N2b, metastasis only in clinically apparent ipsilateral internal mammary nodes and in the absence of clinically evident axillary LN metastasis; N3a, metastasis in ipsilateral infraclavicular LNs; N3b, metastasis in ipsilateral internal mammary LNs fixed and axillary LN; N3c, metastasis in ipsilateral subclavicar LNs; Nx, not assessed.|participants|Number|95|95.0||||||
4285006|NCT00553358|4109847|B4|N0||Number of participants with lymph nodes (LNs) of the indicated clinical N stage|Clinical N stage is an evaluation/staging of LN status through physical examination. N0, no regional LN metastasis; N1, metastasis to movable ipsilateral axillary LNs (IALNs); N2a, metastasis in IALNs fixed to one another (matted) or the other structures; N2b, metastasis only in clinically apparent ipsilateral internal mammary nodes and in the absence of clinically evident axillary LN metastasis; N3a, metastasis in ipsilateral infraclavicular LNs; N3b, metastasis in ipsilateral internal mammary LNs fixed and axillary LN; N3c, metastasis in ipsilateral subclavicar LNs; Nx, not assessed.|participants|Number|123|123.0||||||
4285007|NCT00553358|4109848|B3|N0||Number of participants with lymph nodes (LNs) of the indicated clinical N stage|Clinical N stage is an evaluation/staging of LN status through physical examination. N0, no regional LN metastasis; N1, metastasis to movable ipsilateral axillary LNs (IALNs); N2a, metastasis in IALNs fixed to one another (matted) or the other structures; N2b, metastasis only in clinically apparent ipsilateral internal mammary nodes and in the absence of clinically evident axillary LN metastasis; N3a, metastasis in ipsilateral infraclavicular LNs; N3b, metastasis in ipsilateral internal mammary LNs fixed and axillary LN; N3c, metastasis in ipsilateral subclavicar LNs; Nx, not assessed.|participants|Number|48|48.0||||||
4285008|NCT00553358|4109849|B2|N0||Number of participants with lymph nodes (LNs) of the indicated clinical N stage|Clinical N stage is an evaluation/staging of LN status through physical examination. N0, no regional LN metastasis; N1, metastasis to movable ipsilateral axillary LNs (IALNs); N2a, metastasis in IALNs fixed to one another (matted) or the other structures; N2b, metastasis only in clinically apparent ipsilateral internal mammary nodes and in the absence of clinically evident axillary LN metastasis; N3a, metastasis in ipsilateral infraclavicular LNs; N3b, metastasis in ipsilateral internal mammary LNs fixed and axillary LN; N3c, metastasis in ipsilateral subclavicar LNs; Nx, not assessed.|participants|Number|41|41.0||||||
4285009|NCT00553358|4109850|B1|N0||Number of participants with lymph nodes (LNs) of the indicated clinical N stage|Clinical N stage is an evaluation/staging of LN status through physical examination. N0, no regional LN metastasis; N1, metastasis to movable ipsilateral axillary LNs (IALNs); N2a, metastasis in IALNs fixed to one another (matted) or the other structures; N2b, metastasis only in clinically apparent ipsilateral internal mammary nodes and in the absence of clinically evident axillary LN metastasis; N3a, metastasis in ipsilateral infraclavicular LNs; N3b, metastasis in ipsilateral internal mammary LNs fixed and axillary LN; N3c, metastasis in ipsilateral subclavicar LNs; Nx, not assessed.|participants|Number|34|34.0||||||
4285010|NCT00553358|4109847|B4|Missing||Number of participants with tumor cells of the indicated histologic grade|Histologic grade, also called differentiation, refers to how much the tumor cells resemble normal cells of the same tissue type.|participants|Number|1|1.0||||||
4285011|NCT00553358|4109848|B3|Missing||Number of participants with tumor cells of the indicated histologic grade|Histologic grade, also called differentiation, refers to how much the tumor cells resemble normal cells of the same tissue type.|participants|Number|0|0.0||||||
4285012|NCT00553358|4109849|B2|Missing||Number of participants with tumor cells of the indicated histologic grade|Histologic grade, also called differentiation, refers to how much the tumor cells resemble normal cells of the same tissue type.|participants|Number|0|0.0||||||
4285013|NCT00553358|4109850|B1|Missing||Number of participants with tumor cells of the indicated histologic grade|Histologic grade, also called differentiation, refers to how much the tumor cells resemble normal cells of the same tissue type.|participants|Number|1|1.0||||||
4285014|NCT00553358|4109847|B4|Differentiation cannot be assessed||Number of participants with tumor cells of the indicated histologic grade|Histologic grade, also called differentiation, refers to how much the tumor cells resemble normal cells of the same tissue type.|participants|Number|65|65.0||||||
4285015|NCT00553358|4109848|B3|Differentiation cannot be assessed||Number of participants with tumor cells of the indicated histologic grade|Histologic grade, also called differentiation, refers to how much the tumor cells resemble normal cells of the same tissue type.|participants|Number|20|20.0||||||
4285023|NCT00553358|4109848|B3|Moderately differentiated||Number of participants with tumor cells of the indicated histologic grade|Histologic grade, also called differentiation, refers to how much the tumor cells resemble normal cells of the same tissue type.|participants|Number|63|63.0||||||
4285024|NCT00553358|4109849|B2|Moderately differentiated||Number of participants with tumor cells of the indicated histologic grade|Histologic grade, also called differentiation, refers to how much the tumor cells resemble normal cells of the same tissue type.|participants|Number|53|53.0||||||
4285025|NCT00553358|4109850|B1|Moderately differentiated||Number of participants with tumor cells of the indicated histologic grade|Histologic grade, also called differentiation, refers to how much the tumor cells resemble normal cells of the same tissue type.|participants|Number|56|56.0||||||
4285026|NCT00553358|4109847|B4|Well differentiated||Number of participants with tumor cells of the indicated histologic grade|Histologic grade, also called differentiation, refers to how much the tumor cells resemble normal cells of the same tissue type.|participants|Number|12|12.0||||||
4285027|NCT00553358|4109848|B3|Well differentiated||Number of participants with tumor cells of the indicated histologic grade|Histologic grade, also called differentiation, refers to how much the tumor cells resemble normal cells of the same tissue type.|participants|Number|5|5.0||||||
4285028|NCT00553358|4109849|B2|Well differentiated||Number of participants with tumor cells of the indicated histologic grade|Histologic grade, also called differentiation, refers to how much the tumor cells resemble normal cells of the same tissue type.|participants|Number|5|5.0||||||
4285029|NCT00553358|4109850|B1|Well differentiated||Number of participants with tumor cells of the indicated histologic grade|Histologic grade, also called differentiation, refers to how much the tumor cells resemble normal cells of the same tissue type.|participants|Number|2|2.0||||||
4285030|NCT00553358|4109847|B4|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4285031|NCT00553358|4109848|B3|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4285032|NCT00553358|4109849|B2|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4285033|NCT00553358|4109850|B1|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4285034|NCT00553358|4109847|B4|White - Caucasian European Heritage||Race/Ethnicity, Customized||participants|Number|282|282.0||||||
4285035|NCT00553358|4109848|B3|White - Caucasian European Heritage||Race/Ethnicity, Customized||participants|Number|92|92.0||||||
4285036|NCT00553358|4109849|B2|White - Caucasian European Heritage||Race/Ethnicity, Customized||participants|Number|93|93.0||||||
4285037|NCT00553358|4109850|B1|White - Caucasian European Heritage||Race/Ethnicity, Customized||participants|Number|97|97.0||||||
4285038|NCT00553358|4109847|B4|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4285039|NCT00553358|4109848|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4285040|NCT00553358|4109849|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4285041|NCT00553358|4109850|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4285042|NCT00553358|4109847|B4|Black or African American/African Heritage||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4285043|NCT00553358|4109848|B3|Black or African American/African Heritage||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4285044|NCT00553358|4109849|B2|Black or African American/African Heritage||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4285045|NCT00553358|4109850|B1|Black or African American/African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4285046|NCT00553358|4109847|B4|Asian - South East||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4285047|NCT00553358|4109848|B3|Asian - South East||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4285048|NCT00553358|4109849|B2|Asian - South East||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4285049|NCT00553358|4109850|B1|Asian - South East||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4285050|NCT00553358|4109847|B4|Asian - East||Race/Ethnicity, Customized||participants|Number|89|89.0||||||
4285051|NCT00553358|4109848|B3|Asian - East||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4285052|NCT00553358|4109849|B2|Asian - East||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4285053|NCT00553358|4109850|B1|Asian - East||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4285054|NCT00553358|4109847|B4|Asian - Central/South||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4285055|NCT00553358|4109848|B3|Asian - Central/South||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4285056|NCT00553358|4109849|B2|Asian - Central/South||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4285057|NCT00553358|4109850|B1|Asian - Central/South||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4285058|NCT00553358|4109847|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4285059|NCT00553358|4109848|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4285060|NCT00553358|4109849|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4285061|NCT00553358|4109850|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4285062|NCT00553358|4109847|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4285063|NCT00553358|4109848|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4285064|NCT00553358|4109849|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4285065|NCT00553358|4109850|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4285066|NCT00553358|4109847|B4||Female|Sex: Female, Male||Participants|Count of Participants|455|455.0||||||
4285067|NCT00553358|4109848|B3||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4285068|NCT00553358|4109849|B2||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4285069|NCT00553358|4109850|B1||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4285070|NCT00553358|4109847|B4|||Age||Years|Median|50.0|50.0|Full Range|||23.0|80.0|
4285072|NCT00553358|4109849|B2|||Age||Years|Median|49.0|49.0|Full Range|||23.0|77.0|
4285073|NCT00553358|4109850|B1|||Age||Years|Median|50.0|50.0|Full Range|||28.0|79.0|
4285074|NCT00553332|4109878|B1|||Number of target lesions||lesions|Median|4|4.0|Full Range|||1.0|13.0|
4285075|NCT00553332|4109878|B1|Other (soft tissue, lymph nodes and lung)||Metastasis site||patients|Number|5|5.0||||||
4285076|NCT00553332|4109878|B1|Liver and other sites||Metastasis site||patients|Number|16|16.0||||||
4285077|NCT00553332|4109878|B1|Liver only||Metastasis site||patients|Number|7|7.0||||||
4285078|NCT00553332|4109878|B1|Extrahepatic||Disease site||patients|Number|4|4.0||||||
4285079|NCT00553332|4109878|B1|Gallbladder||Disease site||patients|Number|7|7.0||||||
4285080|NCT00553332|4109878|B1|Intrahepatic||Disease site||patients|Number|17|17.0||||||
4285081|NCT00553332|4109878|B1|1 (Restricted activity)||Eastern Cooperative Oncology Group (ECOG)||patients|Number|17|17.0||||||
4285082|NCT00553332|4109878|B1|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG)||patients|Number|11|11.0||||||
4285083|NCT00553332|4109878|B1|United States||Region of Enrollment||patients|Number|28|28.0||||||
4285084|NCT00553332|4109878|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4285085|NCT00553332|4109878|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4285086|NCT00553332|4109878|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4285087|NCT00553332|4109878|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4285088|NCT00553332|4109878|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4285089|NCT00553332|4109878|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4285090|NCT00553332|4109878|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4285091|NCT00553332|4109878|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4285092|NCT00553332|4109878|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4285093|NCT00553332|4109878|B1|||Age||years|Median|55.6|55.6|Full Range|||26.0|79.0|
4285094|NCT00553319|4109887|B4|||Days of cocaine use (prior 28 days)||DAYS|Mean|11.7|11.7|Standard Deviation|7.4|7.4|||
4285095|NCT00553319|4109888|B3|||Days of cocaine use (prior 28 days)||DAYS|Mean|11.3|11.3|Standard Deviation|7.0|7.0|||
4285096|NCT00553319|4109889|B2|||Days of cocaine use (prior 28 days)||DAYS|Mean|12.4|12.4|Standard Deviation|7.8|7.8|||
4285097|NCT00553319|4109890|B1|||Days of cocaine use (prior 28 days)||DAYS|Mean|11.3|11.3|Standard Deviation|7.5|7.5|||
4285098|NCT00553319|4109887|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4285099|NCT00553319|4109888|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4285100|NCT00553319|4109889|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4285101|NCT00553319|4109890|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4285102|NCT00553319|4109887|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4285103|NCT00553319|4109888|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4285104|NCT00553319|4109889|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4285105|NCT00553319|4109890|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4285106|NCT00553319|4109887|B4||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4285107|NCT00553319|4109888|B3||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4285108|NCT00553319|4109889|B2||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4285109|NCT00553319|4109890|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4285110|NCT00553319|4109887|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4285111|NCT00553319|4109888|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4285112|NCT00553319|4109889|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4285113|NCT00553319|4109890|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4285114|NCT00553319|4109887|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4285115|NCT00553319|4109888|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4285116|NCT00553319|4109889|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4285117|NCT00553319|4109890|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4285118|NCT00553319|4109887|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4285119|NCT00553319|4109888|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4285120|NCT00553319|4109889|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4285121|NCT00553319|4109890|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4285122|NCT00553319|4109887|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4285123|NCT00553319|4109888|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4285124|NCT00553319|4109889|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4285125|NCT00553319|4109890|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4285126|NCT00553319|4109887|B4||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4285127|NCT00553319|4109888|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4285128|NCT00553319|4109889|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4285129|NCT00553319|4109890|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4285130|NCT00553319|4109887|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4285131|NCT00553319|4109888|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4285132|NCT00553319|4109889|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4285133|NCT00553319|4109890|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4285134|NCT00553319|4109887|B4|||Age||YEARS|Mean|40.4|40.4|Standard Deviation|8.1|8.1|||
4285135|NCT00553319|4109888|B3|||Age||YEARS|Mean|38.4|38.4|Standard Deviation|8.6|8.6|||
4285136|NCT00553319|4109889|B2|||Age||YEARS|Mean|43.9|43.9|Standard Deviation|7.5|7.5|||
4285137|NCT00553319|4109890|B1|||Age||YEARS|Mean|39.3|39.3|Standard Deviation|7.4|7.4|||
4285138|NCT00553280|4109903|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4285139|NCT00553280|4109903|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4285140|NCT00553280|4109903|B1|||Age, Customized||years|Mean|61.7|61.7|Standard Deviation|10.0|10.0|||
4285141|NCT00553280|4109903|B1|>= 65 years||Age, Customized||participants|Number|46|46.0||||||
4285142|NCT00553280|4109903|B1|45 - 64 years||Age, Customized||participants|Number|71|71.0||||||
4285143|NCT00553280|4109903|B1|18 - 44 years||Age, Customized||participants|Number|6|6.0||||||
4285144|NCT00553280|4109903|B1|< 18 years||Age, Customized||participants|Number|0|0.0||||||
4285145|NCT00553267|4109912|B4||Male|Sex: Female, Male||Participants|Count of Participants|528|528.0||||||
4285146|NCT00553267|4109913|B3||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4285147|NCT00553267|4109914|B2||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4285148|NCT00553267|4109915|B1||Male|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4285149|NCT00553267|4109912|B4||Female|Sex: Female, Male||Participants|Count of Participants|419|419.0||||||
4285150|NCT00553267|4109913|B3||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4285151|NCT00553267|4109914|B2||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4285152|NCT00553267|4109915|B1||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4285153|NCT00553267|4109912|B4|||Age||Years|Mean|56.5|56.5|Standard Deviation|9.9|9.9|||
4285154|NCT00553267|4109913|B3|||Age||Years|Mean|55.5|55.5|Standard Deviation|9.8|9.8|||
4285155|NCT00553267|4109914|B2|||Age||Years|Mean|57.6|57.6|Standard Deviation|9.4|9.4|||
4285156|NCT00553267|4109915|B1|||Age||Years|Mean|56.4|56.4|Standard Deviation|10.4|10.4|||
4285157|NCT00553202|4109952|B1|United States||Region of Enrollment||participants|Number|147|147.0||||||
4285158|NCT00553202|4109952|B1|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4285159|NCT00553202|4109952|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4285160|NCT00553202|4109952|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4285161|NCT00553202|4109952|B1||White|Race (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
4285162|NCT00553202|4109952|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4285163|NCT00553202|4109952|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4285164|NCT00553202|4109952|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4285165|NCT00553202|4109952|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4285166|NCT00553202|4109952|B1||Male|Gender||Participants|Count of Participants|83|83.0||||||
4285167|NCT00553202|4109952|B1||Female|Gender||Participants|Count of Participants|75|75.0||||||
4285168|NCT00553202|4109952|B1|||Age||Days|Mean|3215.34|3215.34|Standard Deviation|2240.48|2240.48|||
4285169|NCT00553202|4109952|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4285170|NCT00553202|4109952|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4285171|NCT00553202|4109952|B1||<=18 years|Age||Participants|Count of Participants|149|149.0||||||
4285172|NCT00553150|4109960|B3|United States||Region of Enrollment||participants|Number|122|122.0||||||
4285173|NCT00553150|4109961|B2|United States||Region of Enrollment||participants|Number|104|104.0||||||
4285174|NCT00553150|4109962|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4285175|NCT00553150|4109960|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4285176|NCT00553150|4109961|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4285177|NCT00553150|4109962|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4285178|NCT00553150|4109960|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4285179|NCT00553150|4109961|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4285180|NCT00553150|4109962|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4285181|NCT00553150|4109960|B3|||Age||years|Median|60.5|60.5|Full Range|||23.0|81.0|
4285182|NCT00553150|4109961|B2|||Age||years|Median|61|61.0|Full Range|||23.0|81.0|
4285183|NCT00553150|4109962|B1|||Age||years|Median|57.5|57.5|Full Range|||23.0|74.0|
4285184|NCT00553098|4109977|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4285185|NCT00553098|4109977|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4285186|NCT00553098|4109977|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4285187|NCT00553098|4109977|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4285188|NCT00553098|4109977|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4285189|NCT00553098|4109977|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4285190|NCT00553098|4109977|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4285253|NCT00552695|4110026|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4285191|NCT00553098|4109977|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4285192|NCT00553098|4109977|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4285193|NCT00553098|4109977|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4285194|NCT00553098|4109977|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4285195|NCT00553098|4109977|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4285196|NCT00553098|4109977|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4285197|NCT00553098|4109977|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4285198|NCT00553098|4109977|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4285199|NCT00553098|4109977|B1||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
4285200|NCT00552812|4109991|B1|United States||Region of Enrollment||participants|Number|105|105.0||||||
4285201|NCT00552812|4109991|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4285202|NCT00552812|4109991|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4285203|NCT00552812|4109991|B1|||Age||years|Median|16|16.0|Full Range|||8.0|52.0|
4285204|NCT00552812|4109991|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4285205|NCT00552812|4109991|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4285206|NCT00552812|4109991|B1||<=18 years|Age||Participants|Count of Participants|67|67.0||||||
4285207|NCT00552786|4109997|B3|Taiwan||Region of Enrollment||participants|Number|53.0|53.0||||||
4285208|NCT00552786|4109998|B2|Taiwan||Region of Enrollment||participants|Number|28|28.0||||||
4285209|NCT00552786|4109999|B1|Taiwan||Region of Enrollment||participants|Number|25|25.0||||||
4285210|NCT00552786|4109997|B3||Male|Sex: Female, Male||Participants|Count of Participants|53.0|53.0||||||
4285211|NCT00552786|4109998|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4285212|NCT00552786|4109999|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4285213|NCT00552786|4109997|B3||Female|Sex: Female, Male||Participants|Count of Participants|0.0|0.0||||||
4285214|NCT00552786|4109998|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4285215|NCT00552786|4109999|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4285216|NCT00552786|4109997|B3|||Age||years|Mean|41.1|41.1|Standard Deviation|10.5|10.5|||
4285217|NCT00552786|4109998|B2|||Age||years|Mean|42.1|42.1|Standard Deviation|9.6|9.6|||
4285218|NCT00552786|4109999|B1|||Age||years|Mean|40.0|40.0|Standard Deviation|11.6|11.6|||
4285219|NCT00552786|4109997|B3||>=65 years|Age||Participants|Count of Participants|0.0|0.0||||||
4285220|NCT00552786|4109998|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4285221|NCT00552786|4109999|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4285222|NCT00552786|4109997|B3||Between 18 and 65 years|Age||Participants|Count of Participants|53.0|53.0||||||
4285223|NCT00552786|4109998|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4285224|NCT00552786|4109999|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4285225|NCT00552786|4109997|B3||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4285226|NCT00552786|4109998|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4285227|NCT00552786|4109999|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4285228|NCT00552760|4110008|B3|United States||Region of Enrollment||participants|Number|83|83.0||||||
4285229|NCT00552760|4110009|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
4285230|NCT00552760|4110010|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4285231|NCT00552760|4110008|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4285232|NCT00552760|4110009|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4285233|NCT00552760|4110010|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4285234|NCT00552760|4110008|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4285235|NCT00552760|4110009|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4285236|NCT00552760|4110010|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4285237|NCT00552760|4110008|B3|||Age||years|Mean|45.9|45.9|Standard Deviation|10.9|10.9|||
4285238|NCT00552760|4110009|B2|||Age||years|Mean|45.2|45.2|Standard Deviation|10.8|10.8|||
4285239|NCT00552760|4110010|B1|||Age||years|Mean|46.6|46.6|Standard Deviation|11.0|11.0|||
4285240|NCT00552760|4110008|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4285241|NCT00552760|4110009|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4285242|NCT00552760|4110010|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4285243|NCT00552760|4110008|B3||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
4285244|NCT00552760|4110009|B2||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4285245|NCT00552760|4110010|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4285246|NCT00552760|4110008|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4285247|NCT00552760|4110009|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4285248|NCT00552760|4110010|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4285249|NCT00552695|4110025|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
4285250|NCT00552695|4110026|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4285251|NCT00552695|4110027|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4285252|NCT00552695|4110025|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4285254|NCT00552695|4110027|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4285255|NCT00552695|4110025|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4285256|NCT00552695|4110026|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4285257|NCT00552695|4110027|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4285258|NCT00552695|4110025|B3|||Age||years|Mean|10|10.0|Standard Deviation|4.3|4.3|||
4285259|NCT00552695|4110026|B2|||Age||years|Mean|10.8|10.8|Standard Deviation|4.5|4.5|||
4285260|NCT00552695|4110027|B1|||Age||years|Mean|9.3|9.3|Standard Deviation|4.3|4.3|||
4285261|NCT00552695|4110025|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4285262|NCT00552695|4110026|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4285263|NCT00552695|4110027|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4285264|NCT00552695|4110025|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4285265|NCT00552695|4110026|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4285266|NCT00552695|4110027|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4285267|NCT00552695|4110025|B3||<=18 years|Age||Participants|Count of Participants|45|45.0||||||
4285268|NCT00552695|4110026|B2||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
4285269|NCT00552695|4110027|B1||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
4285270|NCT00552669|4110036|B3|Argentina||Region of Enrollment||participants|Number|200|200.0||||||
4285271|NCT00552669|4110037|B2|Argentina||Region of Enrollment||participants|Number|100|100.0||||||
4285272|NCT00552669|4110038|B1|Argentina||Region of Enrollment||participants|Number|100|100.0||||||
4285273|NCT00552669|4110036|B3||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4285274|NCT00552669|4110037|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4285275|NCT00552669|4110038|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4285276|NCT00552669|4110036|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4285277|NCT00552669|4110037|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4285278|NCT00552669|4110038|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4285279|NCT00552669|4110036|B3|||Age||years|Mean|63.2|63.2|Standard Deviation|10.4|10.4|||
4285280|NCT00552669|4110037|B2|||Age||years|Mean|63.4|63.4|Standard Deviation|10.6|10.6|||
4285281|NCT00552669|4110038|B1|||Age||years|Mean|62.1|62.1|Standard Deviation|10.1|10.1|||
4285282|NCT00552669|4110036|B3||>=65 years|Age||Participants|Count of Participants|81|81.0||||||
4285283|NCT00552669|4110037|B2||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
4285284|NCT00552669|4110038|B1||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4285285|NCT00552669|4110036|B3||Between 18 and 65 years|Age||Participants|Count of Participants|119|119.0||||||
4285286|NCT00552669|4110037|B2||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4285287|NCT00552669|4110038|B1||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4285288|NCT00552669|4110036|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4285289|NCT00552669|4110037|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4285290|NCT00552669|4110038|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4285291|NCT00552578|4110049|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4285292|NCT00552578|4110050|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4285293|NCT00552578|4110051|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4285294|NCT00552578|4110049|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4285295|NCT00552578|4110050|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4285296|NCT00552578|4110051|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4285297|NCT00552578|4110049|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4285298|NCT00552578|4110050|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4285299|NCT00552578|4110051|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4285300|NCT00552578|4110049|B3|||Age||years|Mean|45|45.0|Standard Deviation|11|11.0|||
4285301|NCT00552578|4110050|B2|||Age||years|Mean|46|46.0|Standard Deviation|15|15.0|||
4285302|NCT00552578|4110051|B1|||Age||years|Mean|44|44.0|Standard Deviation|6|6.0|||
4285303|NCT00552578|4110049|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4285304|NCT00552578|4110050|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4285305|NCT00552578|4110051|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4285306|NCT00552578|4110049|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4285307|NCT00552578|4110050|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4285308|NCT00552578|4110051|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4285309|NCT00552578|4110049|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4285310|NCT00552578|4110050|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4285311|NCT00552578|4110051|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4285312|NCT00552513|4110062|B3||Male|Sex: Female, Male||Participants|Count of Participants|1979|1979.0||||||
4285313|NCT00552513|4110063|B2||Male|Sex: Female, Male||Participants|Count of Participants|940|940.0||||||
4285314|NCT00552513|4110064|B1||Male|Sex: Female, Male||Participants|Count of Participants|1039|1039.0||||||
4285315|NCT00552513|4110062|B3||Female|Sex: Female, Male||Participants|Count of Participants|1052|1052.0||||||
4285316|NCT00552513|4110063|B2||Female|Sex: Female, Male||Participants|Count of Participants|498|498.0||||||
4285317|NCT00552513|4110064|B1||Female|Sex: Female, Male||Participants|Count of Participants|554|554.0||||||
4285318|NCT00552513|4110062|B3|Age||Age, Customized||years|Mean|65.5|65.5|Standard Deviation|0|0.0|||
4285319|NCT00552513|4110063|B2|Age||Age, Customized||years|Mean|65.8|65.8|Standard Deviation|0|0.0|||
4285320|NCT00552513|4110064|B1|Age||Age, Customized||years|Mean|65.1|65.1|Standard Deviation|0|0.0|||
4285321|NCT00552448|4110075|B3|||Modified Pulmonary Index Score (Initial)|"Modified Pulmonary Index Score (MPIS): a validated asthma severity score in pediatric population (Carroll CL et al. A modified pulmonary index score with predictive value for pediatric asthma exacerbations, Ann Allergy Asthma Immunol 2005) Consists of: 1) oxygen saturation on room air 2) accessory muscle use 3) inspiratory to expiratory ratio 4) degree of wheezing 5) heart rate 6) respiratory rate. Scored observations 0, 1, 2 or 3. Total score range 0-18.~Mild exacerbation total less than 6, moderate exacerbation 6 – 10, severe exacerbation higher than 10"|units on a scale|Mean|6.03|6.03|Standard Deviation|2.87|2.87|||
4285322|NCT00552448|4110076|B2|||Modified Pulmonary Index Score (Initial)|"Modified Pulmonary Index Score (MPIS): a validated asthma severity score in pediatric population (Carroll CL et al. A modified pulmonary index score with predictive value for pediatric asthma exacerbations, Ann Allergy Asthma Immunol 2005) Consists of: 1) oxygen saturation on room air 2) accessory muscle use 3) inspiratory to expiratory ratio 4) degree of wheezing 5) heart rate 6) respiratory rate. Scored observations 0, 1, 2 or 3. Total score range 0-18.~Mild exacerbation total less than 6, moderate exacerbation 6 – 10, severe exacerbation higher than 10"|units on a scale|Mean|6.42|6.42|Standard Deviation|2.91|2.91|||
4285323|NCT00552448|4110077|B1|||Modified Pulmonary Index Score (Initial)|"Modified Pulmonary Index Score (MPIS): a validated asthma severity score in pediatric population (Carroll CL et al. A modified pulmonary index score with predictive value for pediatric asthma exacerbations, Ann Allergy Asthma Immunol 2005) Consists of: 1) oxygen saturation on room air 2) accessory muscle use 3) inspiratory to expiratory ratio 4) degree of wheezing 5) heart rate 6) respiratory rate. Scored observations 0, 1, 2 or 3. Total score range 0-18.~Mild exacerbation total less than 6, moderate exacerbation 6 – 10, severe exacerbation higher than 10"|units on a scale|Mean|5.76|5.76|Standard Deviation|2.91|2.91|||
4285324|NCT00552448|4110075|B3|Systemic steroid||Home asthma medication|Please note that because one subject may be on multiple classes of medication so the numbers will not add up|participants|Number|2|2.0||||||
4285325|NCT00552448|4110076|B2|Systemic steroid||Home asthma medication|Please note that because one subject may be on multiple classes of medication so the numbers will not add up|participants|Number|0|0.0||||||
4285326|NCT00552448|4110077|B1|Systemic steroid||Home asthma medication|Please note that because one subject may be on multiple classes of medication so the numbers will not add up|participants|Number|2|2.0||||||
4285327|NCT00552448|4110075|B3|Antihistamine||Home asthma medication|Please note that because one subject may be on multiple classes of medication so the numbers will not add up|participants|Number|5|5.0||||||
4285328|NCT00552448|4110076|B2|Antihistamine||Home asthma medication|Please note that because one subject may be on multiple classes of medication so the numbers will not add up|participants|Number|2|2.0||||||
4285329|NCT00552448|4110077|B1|Antihistamine||Home asthma medication|Please note that because one subject may be on multiple classes of medication so the numbers will not add up|participants|Number|3|3.0||||||
4285330|NCT00552448|4110075|B3|leukotriene receptor antagonist||Home asthma medication|Please note that because one subject may be on multiple classes of medication so the numbers will not add up|participants|Number|11|11.0||||||
4285331|NCT00552448|4110076|B2|leukotriene receptor antagonist||Home asthma medication|Please note that because one subject may be on multiple classes of medication so the numbers will not add up|participants|Number|5|5.0||||||
4285332|NCT00552448|4110077|B1|leukotriene receptor antagonist||Home asthma medication|Please note that because one subject may be on multiple classes of medication so the numbers will not add up|participants|Number|6|6.0||||||
4285333|NCT00552448|4110075|B3|Inhaled steroid-long acting bronchodilator||Home asthma medication|Please note that because one subject may be on multiple classes of medication so the numbers will not add up|participants|Number|5|5.0||||||
4285334|NCT00552448|4110076|B2|Inhaled steroid-long acting bronchodilator||Home asthma medication|Please note that because one subject may be on multiple classes of medication so the numbers will not add up|participants|Number|1|1.0||||||
4285335|NCT00552448|4110077|B1|Inhaled steroid-long acting bronchodilator||Home asthma medication|Please note that because one subject may be on multiple classes of medication so the numbers will not add up|participants|Number|4|4.0||||||
4285336|NCT00552448|4110075|B3|Inhaled steroid||Home asthma medication|Please note that because one subject may be on multiple classes of medication so the numbers will not add up|participants|Number|8|8.0||||||
4285337|NCT00552448|4110076|B2|Inhaled steroid||Home asthma medication|Please note that because one subject may be on multiple classes of medication so the numbers will not add up|participants|Number|3|3.0||||||
4285338|NCT00552448|4110077|B1|Inhaled steroid||Home asthma medication|Please note that because one subject may be on multiple classes of medication so the numbers will not add up|participants|Number|5|5.0||||||
4285339|NCT00552448|4110075|B3|Bronchodilator alone||Home asthma medication|Please note that because one subject may be on multiple classes of medication so the numbers will not add up|participants|Number|15|15.0||||||
4285340|NCT00552448|4110076|B2|Bronchodilator alone||Home asthma medication|Please note that because one subject may be on multiple classes of medication so the numbers will not add up|participants|Number|7|7.0||||||
4285341|NCT00552448|4110077|B1|Bronchodilator alone||Home asthma medication|Please note that because one subject may be on multiple classes of medication so the numbers will not add up|participants|Number|8|8.0||||||
4285342|NCT00552448|4110075|B3|None||Home asthma medication|Please note that because one subject may be on multiple classes of medication so the numbers will not add up|participants|Number|3|3.0||||||
4285343|NCT00552448|4110076|B2|None||Home asthma medication|Please note that because one subject may be on multiple classes of medication so the numbers will not add up|participants|Number|2|2.0||||||
4285344|NCT00552448|4110077|B1|None||Home asthma medication|Please note that because one subject may be on multiple classes of medication so the numbers will not add up|participants|Number|1|1.0||||||
4285345|NCT00552448|4110075|B3|Unknown||Prior Hospitalizations||participants|Number|1|1.0||||||
4285346|NCT00552448|4110076|B2|Unknown||Prior Hospitalizations||participants|Number|0|0.0||||||
4285347|NCT00552448|4110077|B1|Unknown||Prior Hospitalizations||participants|Number|1|1.0||||||
4285348|NCT00552448|4110075|B3|None||Prior Hospitalizations||participants|Number|16|16.0||||||
4285349|NCT00552448|4110076|B2|None||Prior Hospitalizations||participants|Number|8|8.0||||||
4285350|NCT00552448|4110077|B1|None||Prior Hospitalizations||participants|Number|8|8.0||||||
4285351|NCT00552448|4110075|B3|Yes||Prior Hospitalizations||participants|Number|19|19.0||||||
4285352|NCT00552448|4110076|B2|Yes||Prior Hospitalizations||participants|Number|8|8.0||||||
4285353|NCT00552448|4110077|B1|Yes||Prior Hospitalizations||participants|Number|11|11.0||||||
4285354|NCT00552448|4110075|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4285355|NCT00552448|4110076|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4285356|NCT00552448|4110077|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4285357|NCT00552448|4110075|B3|Ethnicity/Race Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4285358|NCT00552448|4110076|B2|Ethnicity/Race Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4285359|NCT00552448|4110077|B1|Ethnicity/Race Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4285360|NCT00552448|4110075|B3|Two or more Ethnicity/Races||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4285361|NCT00552448|4110076|B2|Two or more Ethnicity/Races||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4285362|NCT00552448|4110077|B1|Two or more Ethnicity/Races||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4285363|NCT00552448|4110075|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4285364|NCT00552448|4110076|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4285365|NCT00552448|4110077|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4285366|NCT00552448|4110075|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4285367|NCT00552448|4110076|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4285368|NCT00552448|4110077|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4285369|NCT00552448|4110075|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4285370|NCT00552448|4110076|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4285371|NCT00552448|4110077|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4285372|NCT00552448|4110075|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4285373|NCT00552448|4110076|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4285374|NCT00552448|4110077|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4285375|NCT00552448|4110075|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4285376|NCT00552448|4110076|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4285377|NCT00552448|4110077|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4285378|NCT00552448|4110075|B3|||Age||years|Mean|6.28|6.28|Standard Deviation|3.68|3.68|||
4285379|NCT00552448|4110076|B2|||Age||years|Mean|6.69|6.69|Standard Deviation|3.93|3.93|||
4285380|NCT00552448|4110077|B1|||Age||years|Mean|5.95|5.95|Standard Deviation|3.53|3.53|||
4285381|NCT00552422|4110090|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4285382|NCT00552422|4110090|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4285383|NCT00552422|4110090|B1|18-65||Age, Customized||participants|Number|6|6.0||||||
4285384|NCT00552409|4110094|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4285385|NCT00552409|4110095|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4285386|NCT00552409|4110096|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4285387|NCT00552409|4110094|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4285388|NCT00552409|4110095|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4285389|NCT00552409|4110096|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4285390|NCT00552409|4110094|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4285391|NCT00552409|4110095|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4285392|NCT00552409|4110096|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4285393|NCT00552409|4110094|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4285394|NCT00552409|4110095|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4285395|NCT00552409|4110096|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4285396|NCT00552409|4110094|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4285397|NCT00552409|4110095|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4285398|NCT00552409|4110096|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4285399|NCT00552409|4110094|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4285400|NCT00552409|4110095|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4285401|NCT00552409|4110096|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4285402|NCT00552409|4110094|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4285403|NCT00552409|4110095|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4285404|NCT00552409|4110096|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4285405|NCT00552409|4110094|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4285406|NCT00552409|4110095|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4285407|NCT00552409|4110096|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4285408|NCT00552409|4110094|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4285409|NCT00552409|4110095|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4285410|NCT00552409|4110096|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4285411|NCT00552409|4110094|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4285412|NCT00552409|4110095|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4285413|NCT00552409|4110096|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4285414|NCT00552409|4110094|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4285415|NCT00552409|4110095|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4285416|NCT00552409|4110096|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4285417|NCT00552409|4110094|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4285418|NCT00552409|4110095|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4285419|NCT00552409|4110096|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4285420|NCT00552409|4110094|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4285421|NCT00552409|4110095|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4285422|NCT00552409|4110096|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4285423|NCT00552409|4110094|B3|||Age||years|Mean|60|60.0|Standard Deviation|11|11.0|||
4285424|NCT00552409|4110095|B2|||Age||years|Mean|61|61.0|Standard Deviation|13|13.0|||
4285425|NCT00552409|4110096|B1|||Age||years|Mean|60|60.0|Standard Deviation|10|10.0|||
4285426|NCT00552409|4110094|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4285427|NCT00552409|4110095|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4285428|NCT00552409|4110096|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4285429|NCT00552409|4110094|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4285430|NCT00552409|4110095|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4285431|NCT00552409|4110096|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4285432|NCT00552409|4110094|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4285433|NCT00552409|4110095|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4285434|NCT00552409|4110096|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4285435|NCT00552396|4110103|B8|United States||Region of Enrollment||participants|Number|32|32.0||||||
4285436|NCT00552396|4110104|B7|United States||Region of Enrollment||participants|Number|10|10.0||||||
4285437|NCT00552396|4110105|B6|United States||Region of Enrollment||participants|Number|3|3.0||||||
4285438|NCT00552396|4110106|B5|United States||Region of Enrollment||participants|Number|3|3.0||||||
4285439|NCT00552396|4110107|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
4285440|NCT00552396|4110108|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4285441|NCT00552396|4110109|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4285442|NCT00552396|4110110|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4285443|NCT00552396|4110103|B8||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4285444|NCT00552396|4110104|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4285445|NCT00552396|4110105|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4285446|NCT00552396|4110106|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4285447|NCT00552396|4110107|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4285448|NCT00552396|4110108|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4285449|NCT00552396|4110109|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4285450|NCT00552396|4110110|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4285451|NCT00552396|4110103|B8||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4285452|NCT00552396|4110104|B7||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4285453|NCT00552396|4110105|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4285454|NCT00552396|4110106|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4285455|NCT00552396|4110107|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4285456|NCT00552396|4110108|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4285457|NCT00552396|4110109|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4285458|NCT00552396|4110110|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4285459|NCT00552396|4110103|B8|||Age||years|Mean|61.1|61.1|Standard Deviation|10.78|10.78|||
4285460|NCT00552396|4110104|B7|||Age||years|Mean|60.6|60.6|Standard Deviation|18.68|18.68|||
4285461|NCT00552396|4110105|B6|||Age||years|Mean|60.3|60.3|Standard Deviation|7.57|7.57|||
4285462|NCT00552396|4110106|B5|||Age||years|Mean|62.7|62.7|Standard Deviation|11.02|11.02|||
4285463|NCT00552396|4110107|B4|||Age||years|Mean|64|64.0|Standard Deviation|5.51|5.51|||
4285464|NCT00552396|4110108|B3|||Age||years|Mean|66|66.0|Standard Deviation|11.53|11.53|||
4285465|NCT00552396|4110109|B2|||Age||years|Mean|49.7|49.7|Standard Deviation|2.52|2.52|||
4285466|NCT00552396|4110110|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|4.03|4.03|||
4285467|NCT00552396|4110103|B8||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4285468|NCT00552396|4110104|B7||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4285469|NCT00552396|4110105|B6||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4285470|NCT00552396|4110106|B5||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4285471|NCT00552396|4110107|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4285472|NCT00552396|4110108|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4285473|NCT00552396|4110109|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4285474|NCT00552396|4110110|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4285475|NCT00552396|4110103|B8||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4285476|NCT00552396|4110104|B7||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4285477|NCT00552396|4110105|B6||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4285478|NCT00552396|4110106|B5||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4285479|NCT00552396|4110107|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4285480|NCT00552396|4110108|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4285481|NCT00552396|4110109|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4285482|NCT00552396|4110110|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4285483|NCT00552396|4110103|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4285484|NCT00552396|4110104|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4285485|NCT00552396|4110105|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4285486|NCT00552396|4110106|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4285487|NCT00552396|4110107|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4285488|NCT00552396|4110108|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4285489|NCT00552396|4110109|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4285490|NCT00552396|4110110|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4285491|NCT00552344|4110153|B1||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4285492|NCT00552344|4110153|B1||Female|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
4285493|NCT00552344|4110153|B1|||Age||years|Mean|37.3|37.3|Standard Deviation|12.68|12.68|||
4285494|NCT00552344|4110153|B1|>= 85 years||Age, Customized||Participants|Number|0|0.0||||||
4285495|NCT00552344|4110153|B1|65 - < 85 years||Age, Customized||Participants|Number|9|9.0||||||
4285496|NCT00552344|4110153|B1|18 - < 65 years||Age, Customized||Participants|Number|393|393.0||||||
4285497|NCT00552305|4110162|B1|Sweden||Region of Enrollment||participants|Number|24|24.0||||||
4285498|NCT00552305|4110162|B1|Switzerland||Region of Enrollment||participants|Number|2|2.0||||||
4285499|NCT00552305|4110162|B1|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
4285500|NCT00552305|4110162|B1|Germany||Region of Enrollment||participants|Number|21|21.0||||||
4285501|NCT00552305|4110162|B1|Lithuania||Region of Enrollment||participants|Number|46|46.0||||||
4285502|NCT00552305|4110162|B1|Poland||Region of Enrollment||participants|Number|4|4.0||||||
4285503|NCT00552305|4110162|B1|Hungary||Region of Enrollment||participants|Number|13|13.0||||||
4285504|NCT00552305|4110162|B1|United States||Region of Enrollment||participants|Number|248|248.0||||||
4285505|NCT00552305|4110162|B1||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4285506|NCT00552305|4110162|B1||Female|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4285507|NCT00552305|4110162|B1|||Age||years|Mean|40.8|40.8|Standard Deviation|11.01|11.01|||
4285508|NCT00552305|4110162|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4285509|NCT00552305|4110162|B1||Between 18 and 65 years|Age||Participants|Count of Participants|364|364.0||||||
4285510|NCT00552305|4110162|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4285511|NCT00552279|4110170|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4285512|NCT00552279|4110171|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4285513|NCT00552279|4110172|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4285514|NCT00552279|4110170|B3||Female|Sex: Female, Male||Participants|Count of Participants|804|804.0||||||
4285515|NCT00552279|4110171|B2||Female|Sex: Female, Male||Participants|Count of Participants|401|401.0||||||
4285516|NCT00552279|4110172|B1||Female|Sex: Female, Male||Participants|Count of Participants|403|403.0||||||
4285517|NCT00552279|4110170|B3|||Age||years|Mean|18.6|18.6|Standard Deviation|3.05|3.05|||
4285518|NCT00552279|4110171|B2|||Age||years|Mean|18.7|18.7|Standard Deviation|3.13|3.13|||
4285519|NCT00552279|4110172|B1|||Age||years|Mean|18.6|18.6|Standard Deviation|2.98|2.98|||
4285520|NCT00552240|4110197|B3|||CD4+ count||cells/mm^3|Mean|181.2|181.2|Standard Deviation|108.0|108.0|||
4285521|NCT00552240|4110198|B2|||CD4+ count||cells/mm^3|Mean|183.5|183.5|Standard Deviation|111.3|111.3|||
4285522|NCT00552240|4110199|B1|||CD4+ count||cells/mm^3|Mean|178.9|178.9|Standard Deviation|105.3|105.3|||
4285523|NCT00552240|4110197|B3|||Log10 HIV viral load||copies/mL|Mean|4.9|4.9|Standard Deviation|0.8|0.8|||
4285524|NCT00552240|4110198|B2|||Log10 HIV viral load||copies/mL|Mean|4.9|4.9|Standard Deviation|0.7|0.7|||
4285525|NCT00552240|4110199|B1|||Log10 HIV viral load||copies/mL|Mean|4.9|4.9|Standard Deviation|0.8|0.8|||
4285526|NCT00552240|4110197|B3||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4285527|NCT00552240|4110198|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4285528|NCT00552240|4110199|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4285529|NCT00552240|4110197|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4285530|NCT00552240|4110198|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4285531|NCT00552240|4110199|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4285532|NCT00552240|4110197|B3|||Age||years|Mean|36.8|36.8|Standard Deviation|10.1|10.1|||
4285533|NCT00552240|4110198|B2|||Age||years|Mean|35.9|35.9|Standard Deviation|9.7|9.7|||
4285534|NCT00552240|4110199|B1|||Age||years|Mean|37.7|37.7|Standard Deviation|10.4|10.4|||
4285535|NCT00552188|4110300|B3|Canada||Region of Enrollment||participants|Number|21|21.0||||||
4285536|NCT00552188|4110301|B2|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4285537|NCT00552188|4110302|B1|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4285538|NCT00552188|4110300|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4285539|NCT00552188|4110301|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4285540|NCT00552188|4110302|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4285541|NCT00552188|4110300|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4285542|NCT00552188|4110301|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4285543|NCT00552188|4110302|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4285544|NCT00552188|4110300|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4285545|NCT00552188|4110301|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4285546|NCT00552188|4110302|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4285547|NCT00552188|4110300|B3|||Age||years|Mean|57.4|57.4|Standard Deviation|8.79|8.79|||
4285548|NCT00552188|4110301|B2|||Age||years|Mean|58.7|58.7|Standard Deviation|8.00|8.0|||
4285549|NCT00552188|4110302|B1|||Age||years|Mean|56.2|56.2|Standard Deviation|9.50|9.5|||
4285550|NCT00552188|4110300|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4285551|NCT00552188|4110301|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4285552|NCT00552188|4110302|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4285553|NCT00552188|4110300|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4285554|NCT00552188|4110301|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4285555|NCT00552188|4110302|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4285556|NCT00552188|4110300|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4285557|NCT00552188|4110301|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4285558|NCT00552188|4110302|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4285559|NCT00552175|4110311|B4|||Weight||kilograms (kg)|Mean|64.21|64.21|Standard Deviation|11.9|11.9|||
4285560|NCT00552175|4110312|B3|||Weight||kilograms (kg)|Mean|65.08|65.08|Standard Deviation|10.23|10.23|||
4285561|NCT00552175|4110313|B2|||Weight||kilograms (kg)|Mean|62.72|62.72|Standard Deviation|13.35|13.35|||
4285562|NCT00552175|4110314|B1|||Weight||kilograms (kg)|Mean|64.52|64.52|Standard Deviation|11.93|11.93|||
4285563|NCT00552175|4110311|B4|Night Pain Score||Weekly Means of 24-Hour Average Pain, Worst Pain, and Night Pain Diary Scores|24-hour average pain severity scores recorded in a diary daily on an 11-point numerical rating scale, an ordinal scale ranging from 0 (no pain) to 10 (worst possible pain). The 11-point numerical rating scale was also used for assessment of night pain and worst pain each day, and evaluated as weekly means. Total scores for each pain assessment (average, worst, night) range from 0 to 10.|units on a scale|Mean|5.56|5.56|Standard Deviation|1.54|1.54|||
4285564|NCT00552175|4110312|B3|Night Pain Score||Weekly Means of 24-Hour Average Pain, Worst Pain, and Night Pain Diary Scores|24-hour average pain severity scores recorded in a diary daily on an 11-point numerical rating scale, an ordinal scale ranging from 0 (no pain) to 10 (worst possible pain). The 11-point numerical rating scale was also used for assessment of night pain and worst pain each day, and evaluated as weekly means. Total scores for each pain assessment (average, worst, night) range from 0 to 10.|units on a scale|Mean|5.69|5.69|Standard Deviation|1.54|1.54|||
4285565|NCT00552175|4110313|B2|Night Pain Score||Weekly Means of 24-Hour Average Pain, Worst Pain, and Night Pain Diary Scores|24-hour average pain severity scores recorded in a diary daily on an 11-point numerical rating scale, an ordinal scale ranging from 0 (no pain) to 10 (worst possible pain). The 11-point numerical rating scale was also used for assessment of night pain and worst pain each day, and evaluated as weekly means. Total scores for each pain assessment (average, worst, night) range from 0 to 10.|units on a scale|Mean|5.55|5.55|Standard Deviation|1.64|1.64|||
4285566|NCT00552175|4110314|B1|Night Pain Score||Weekly Means of 24-Hour Average Pain, Worst Pain, and Night Pain Diary Scores|24-hour average pain severity scores recorded in a diary daily on an 11-point numerical rating scale, an ordinal scale ranging from 0 (no pain) to 10 (worst possible pain). The 11-point numerical rating scale was also used for assessment of night pain and worst pain each day, and evaluated as weekly means. Total scores for each pain assessment (average, worst, night) range from 0 to 10.|units on a scale|Mean|5.5|5.5|Standard Deviation|1.49|1.49|||
4285567|NCT00552175|4110311|B4|Worst Pain Score||Weekly Means of 24-Hour Average Pain, Worst Pain, and Night Pain Diary Scores|24-hour average pain severity scores recorded in a diary daily on an 11-point numerical rating scale, an ordinal scale ranging from 0 (no pain) to 10 (worst possible pain). The 11-point numerical rating scale was also used for assessment of night pain and worst pain each day, and evaluated as weekly means. Total scores for each pain assessment (average, worst, night) range from 0 to 10.|units on a scale|Mean|6.62|6.62|Standard Deviation|1.29|1.29|||
4285568|NCT00552175|4110312|B3|Worst Pain Score||Weekly Means of 24-Hour Average Pain, Worst Pain, and Night Pain Diary Scores|24-hour average pain severity scores recorded in a diary daily on an 11-point numerical rating scale, an ordinal scale ranging from 0 (no pain) to 10 (worst possible pain). The 11-point numerical rating scale was also used for assessment of night pain and worst pain each day, and evaluated as weekly means. Total scores for each pain assessment (average, worst, night) range from 0 to 10.|units on a scale|Mean|6.61|6.61|Standard Deviation|1.33|1.33|||
4285569|NCT00552175|4110313|B2|Worst Pain Score||Weekly Means of 24-Hour Average Pain, Worst Pain, and Night Pain Diary Scores|24-hour average pain severity scores recorded in a diary daily on an 11-point numerical rating scale, an ordinal scale ranging from 0 (no pain) to 10 (worst possible pain). The 11-point numerical rating scale was also used for assessment of night pain and worst pain each day, and evaluated as weekly means. Total scores for each pain assessment (average, worst, night) range from 0 to 10.|units on a scale|Mean|6.54|6.54|Standard Deviation|1.33|1.33|||
4285570|NCT00552175|4110314|B1|Worst Pain Score||Weekly Means of 24-Hour Average Pain, Worst Pain, and Night Pain Diary Scores|24-hour average pain severity scores recorded in a diary daily on an 11-point numerical rating scale, an ordinal scale ranging from 0 (no pain) to 10 (worst possible pain). The 11-point numerical rating scale was also used for assessment of night pain and worst pain each day, and evaluated as weekly means. Total scores for each pain assessment (average, worst, night) range from 0 to 10.|units on a scale|Mean|6.66|6.66|Standard Deviation|1.25|1.25|||
4285571|NCT00552175|4110311|B4|Average Pain Score||Weekly Means of 24-Hour Average Pain, Worst Pain, and Night Pain Diary Scores|24-hour average pain severity scores recorded in a diary daily on an 11-point numerical rating scale, an ordinal scale ranging from 0 (no pain) to 10 (worst possible pain). The 11-point numerical rating scale was also used for assessment of night pain and worst pain each day, and evaluated as weekly means. Total scores for each pain assessment (average, worst, night) range from 0 to 10.|units on a scale|Mean|5.78|5.78|Standard Deviation|1.18|1.18|||
4285572|NCT00552175|4110312|B3|Average Pain Score||Weekly Means of 24-Hour Average Pain, Worst Pain, and Night Pain Diary Scores|24-hour average pain severity scores recorded in a diary daily on an 11-point numerical rating scale, an ordinal scale ranging from 0 (no pain) to 10 (worst possible pain). The 11-point numerical rating scale was also used for assessment of night pain and worst pain each day, and evaluated as weekly means. Total scores for each pain assessment (average, worst, night) range from 0 to 10.|units on a scale|Mean|5.76|5.76|Standard Deviation|1.17|1.17|||
4285573|NCT00552175|4110313|B2|Average Pain Score||Weekly Means of 24-Hour Average Pain, Worst Pain, and Night Pain Diary Scores|24-hour average pain severity scores recorded in a diary daily on an 11-point numerical rating scale, an ordinal scale ranging from 0 (no pain) to 10 (worst possible pain). The 11-point numerical rating scale was also used for assessment of night pain and worst pain each day, and evaluated as weekly means. Total scores for each pain assessment (average, worst, night) range from 0 to 10.|units on a scale|Mean|5.79|5.79|Standard Deviation|1.23|1.23|||
4285574|NCT00552175|4110314|B1|Average Pain Score||Weekly Means of 24-Hour Average Pain, Worst Pain, and Night Pain Diary Scores|24-hour average pain severity scores recorded in a diary daily on an 11-point numerical rating scale, an ordinal scale ranging from 0 (no pain) to 10 (worst possible pain). The 11-point numerical rating scale was also used for assessment of night pain and worst pain each day, and evaluated as weekly means. Total scores for each pain assessment (average, worst, night) range from 0 to 10.|units on a scale|Mean|5.78|5.78|Standard Deviation|1.17|1.17|||
4285575|NCT00552175|4110311|B4|||Height||centimeters (cm)|Mean|163.98|163.98|Standard Deviation|8.34|8.34|||
4285576|NCT00552175|4110312|B3|||Height||centimeters (cm)|Mean|164.02|164.02|Standard Deviation|7.32|7.32|||
4285577|NCT00552175|4110313|B2|||Height||centimeters (cm)|Mean|163.63|163.63|Standard Deviation|8.78|8.78|||
4285578|NCT00552175|4110314|B1|||Height||centimeters (cm)|Mean|164.13|164.13|Standard Deviation|8.65|8.65|||
4285579|NCT00552175|4110311|B4|||Duration of Diabetic Neuropathy||years|Mean|4.29|4.29|Standard Deviation|4.11|4.11|||
4285580|NCT00552175|4110312|B3|||Duration of Diabetic Neuropathy||years|Mean|4.16|4.16|Standard Deviation|3.67|3.67|||
4285581|NCT00552175|4110313|B2|||Duration of Diabetic Neuropathy||years|Mean|4.58|4.58|Standard Deviation|3.90|3.9|||
4285582|NCT00552175|4110314|B1|||Duration of Diabetic Neuropathy||years|Mean|4.21|4.21|Standard Deviation|4.44|4.44|||
4285583|NCT00552175|4110311|B4|Pain Right Now||Brief Pain Inventory (BPI) Severity Scores|A self-reported scale that measures the severity of pain and the interference of pain on function. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine). There are 4 questions assessing worst pain, least pain, and average pain in the past 24 hours, and the pain right now. Each question has a total range of scores from 0 to 10.|units on a scale|Mean|5.2|5.2|Standard Deviation|1.7|1.7|||
4285584|NCT00552175|4110312|B3|Pain Right Now||Brief Pain Inventory (BPI) Severity Scores|A self-reported scale that measures the severity of pain and the interference of pain on function. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine). There are 4 questions assessing worst pain, least pain, and average pain in the past 24 hours, and the pain right now. Each question has a total range of scores from 0 to 10.|units on a scale|Mean|5.3|5.3|Standard Deviation|1.4|1.4|||
4285585|NCT00552175|4110313|B2|Pain Right Now||Brief Pain Inventory (BPI) Severity Scores|A self-reported scale that measures the severity of pain and the interference of pain on function. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine). There are 4 questions assessing worst pain, least pain, and average pain in the past 24 hours, and the pain right now. Each question has a total range of scores from 0 to 10.|units on a scale|Mean|5.2|5.2|Standard Deviation|1.8|1.8|||
4285586|NCT00552175|4110314|B1|Pain Right Now||Brief Pain Inventory (BPI) Severity Scores|A self-reported scale that measures the severity of pain and the interference of pain on function. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine). There are 4 questions assessing worst pain, least pain, and average pain in the past 24 hours, and the pain right now. Each question has a total range of scores from 0 to 10.|units on a scale|Mean|5.1|5.1|Standard Deviation|1.7|1.7|||
4285587|NCT00552175|4110311|B4|Average Pain||Brief Pain Inventory (BPI) Severity Scores|A self-reported scale that measures the severity of pain and the interference of pain on function. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine). There are 4 questions assessing worst pain, least pain, and average pain in the past 24 hours, and the pain right now. Each question has a total range of scores from 0 to 10.|units on a scale|Mean|5.6|5.6|Standard Deviation|1.3|1.3|||
4285634|NCT00552175|4110314|B1|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters (kg/m^2)|Mean|23.90|23.9|Standard Deviation|3.70|3.7|||
4285687|NCT00552110|4110355|B2||Male|Sex: Female, Male|Intention to treat population: all randomized subjects who had taken at least one dose of study drug|Participants|Count of Participants|46|46.0||||||
4285588|NCT00552175|4110312|B3|Average Pain||Brief Pain Inventory (BPI) Severity Scores|A self-reported scale that measures the severity of pain and the interference of pain on function. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine). There are 4 questions assessing worst pain, least pain, and average pain in the past 24 hours, and the pain right now. Each question has a total range of scores from 0 to 10.|units on a scale|Mean|5.7|5.7|Standard Deviation|1.3|1.3|||
4285589|NCT00552175|4110313|B2|Average Pain||Brief Pain Inventory (BPI) Severity Scores|A self-reported scale that measures the severity of pain and the interference of pain on function. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine). There are 4 questions assessing worst pain, least pain, and average pain in the past 24 hours, and the pain right now. Each question has a total range of scores from 0 to 10.|units on a scale|Mean|5.6|5.6|Standard Deviation|1.3|1.3|||
4285590|NCT00552175|4110314|B1|Average Pain||Brief Pain Inventory (BPI) Severity Scores|A self-reported scale that measures the severity of pain and the interference of pain on function. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine). There are 4 questions assessing worst pain, least pain, and average pain in the past 24 hours, and the pain right now. Each question has a total range of scores from 0 to 10.|units on a scale|Mean|5.6|5.6|Standard Deviation|1.3|1.3|||
4285591|NCT00552175|4110311|B4|Least Pain||Brief Pain Inventory (BPI) Severity Scores|A self-reported scale that measures the severity of pain and the interference of pain on function. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine). There are 4 questions assessing worst pain, least pain, and average pain in the past 24 hours, and the pain right now. Each question has a total range of scores from 0 to 10.|units on a scale|Mean|4.1|4.1|Standard Deviation|1.8|1.8|||
4285592|NCT00552175|4110312|B3|Least Pain||Brief Pain Inventory (BPI) Severity Scores|A self-reported scale that measures the severity of pain and the interference of pain on function. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine). There are 4 questions assessing worst pain, least pain, and average pain in the past 24 hours, and the pain right now. Each question has a total range of scores from 0 to 10.|units on a scale|Mean|4.2|4.2|Standard Deviation|1.6|1.6|||
4285593|NCT00552175|4110313|B2|Least Pain||Brief Pain Inventory (BPI) Severity Scores|A self-reported scale that measures the severity of pain and the interference of pain on function. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine). There are 4 questions assessing worst pain, least pain, and average pain in the past 24 hours, and the pain right now. Each question has a total range of scores from 0 to 10.|units on a scale|Mean|4.0|4.0|Standard Deviation|1.8|1.8|||
4285594|NCT00552175|4110314|B1|Least Pain||Brief Pain Inventory (BPI) Severity Scores|A self-reported scale that measures the severity of pain and the interference of pain on function. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine). There are 4 questions assessing worst pain, least pain, and average pain in the past 24 hours, and the pain right now. Each question has a total range of scores from 0 to 10.|units on a scale|Mean|4.1|4.1|Standard Deviation|1.8|1.8|||
4285595|NCT00552175|4110311|B4|Worst Pain||Brief Pain Inventory (BPI) Severity Scores|A self-reported scale that measures the severity of pain and the interference of pain on function. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine). There are 4 questions assessing worst pain, least pain, and average pain in the past 24 hours, and the pain right now. Each question has a total range of scores from 0 to 10.|units on a scale|Mean|6.6|6.6|Standard Deviation|1.4|1.4|||
4285596|NCT00552175|4110312|B3|Worst Pain||Brief Pain Inventory (BPI) Severity Scores|A self-reported scale that measures the severity of pain and the interference of pain on function. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine). There are 4 questions assessing worst pain, least pain, and average pain in the past 24 hours, and the pain right now. Each question has a total range of scores from 0 to 10.|units on a scale|Mean|6.6|6.6|Standard Deviation|1.5|1.5|||
4285597|NCT00552175|4110313|B2|Worst Pain||Brief Pain Inventory (BPI) Severity Scores|A self-reported scale that measures the severity of pain and the interference of pain on function. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine). There are 4 questions assessing worst pain, least pain, and average pain in the past 24 hours, and the pain right now. Each question has a total range of scores from 0 to 10.|units on a scale|Mean|6.5|6.5|Standard Deviation|1.4|1.4|||
4285598|NCT00552175|4110314|B1|Worst Pain||Brief Pain Inventory (BPI) Severity Scores|A self-reported scale that measures the severity of pain and the interference of pain on function. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine). There are 4 questions assessing worst pain, least pain, and average pain in the past 24 hours, and the pain right now. Each question has a total range of scores from 0 to 10.|units on a scale|Mean|6.7|6.7|Standard Deviation|1.4|1.4|||
4285599|NCT00552175|4110311|B4|Average of Interference Scores||Brief Pain Inventory (BPI) Interference Scores|The Interference scores range from 0 (does not interfere) to 10 (completely interferes). There are 7 questions assessing the interference of pain in the past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. Each question has total scores ranging from 0 to 10.|units on a scale|Mean|3.87|3.87|Standard Deviation|2.17|2.17|||
4285600|NCT00552175|4110312|B3|Average of Interference Scores||Brief Pain Inventory (BPI) Interference Scores|The Interference scores range from 0 (does not interfere) to 10 (completely interferes). There are 7 questions assessing the interference of pain in the past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. Each question has total scores ranging from 0 to 10.|units on a scale|Mean|4.09|4.09|Standard Deviation|2.13|2.13|||
4285601|NCT00552175|4110313|B2|Average of Interference Scores||Brief Pain Inventory (BPI) Interference Scores|The Interference scores range from 0 (does not interfere) to 10 (completely interferes). There are 7 questions assessing the interference of pain in the past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. Each question has total scores ranging from 0 to 10.|units on a scale|Mean|3.88|3.88|Standard Deviation|2.25|2.25|||
4285635|NCT00552175|4110311|B4|||Beck Depression Inventory-II (BDI-II)|A 21-item, patient-completed questionnaire to assess characteristics of depression. Each of the 21 items corresponding to a symptom of depression is summed to give a single score. There is a four-point scale for each item ranging from 0 to 3. Total score ranges from 0 (no depression) to 63 (severe depression).|units on a scale|Mean|9.1|9.1|Standard Deviation|7.4|7.4|||
4285602|NCT00552175|4110314|B1|Average of Interference Scores||Brief Pain Inventory (BPI) Interference Scores|The Interference scores range from 0 (does not interfere) to 10 (completely interferes). There are 7 questions assessing the interference of pain in the past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. Each question has total scores ranging from 0 to 10.|units on a scale|Mean|3.75|3.75|Standard Deviation|2.15|2.15|||
4285603|NCT00552175|4110311|B4|Enjoyment of Life||Brief Pain Inventory (BPI) Interference Scores|The Interference scores range from 0 (does not interfere) to 10 (completely interferes). There are 7 questions assessing the interference of pain in the past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. Each question has total scores ranging from 0 to 10.|units on a scale|Mean|3.7|3.7|Standard Deviation|2.6|2.6|||
4285604|NCT00552175|4110312|B3|Enjoyment of Life||Brief Pain Inventory (BPI) Interference Scores|The Interference scores range from 0 (does not interfere) to 10 (completely interferes). There are 7 questions assessing the interference of pain in the past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. Each question has total scores ranging from 0 to 10.|units on a scale|Mean|4.0|4.0|Standard Deviation|2.5|2.5|||
4285605|NCT00552175|4110313|B2|Enjoyment of Life||Brief Pain Inventory (BPI) Interference Scores|The Interference scores range from 0 (does not interfere) to 10 (completely interferes). There are 7 questions assessing the interference of pain in the past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. Each question has total scores ranging from 0 to 10.|units on a scale|Mean|3.7|3.7|Standard Deviation|2.7|2.7|||
4285606|NCT00552175|4110314|B1|Enjoyment of Life||Brief Pain Inventory (BPI) Interference Scores|The Interference scores range from 0 (does not interfere) to 10 (completely interferes). There are 7 questions assessing the interference of pain in the past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. Each question has total scores ranging from 0 to 10.|units on a scale|Mean|3.5|3.5|Standard Deviation|2.5|2.5|||
4285607|NCT00552175|4110311|B4|Sleep||Brief Pain Inventory (BPI) Interference Scores|The Interference scores range from 0 (does not interfere) to 10 (completely interferes). There are 7 questions assessing the interference of pain in the past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. Each question has total scores ranging from 0 to 10.|units on a scale|Mean|4.0|4.0|Standard Deviation|2.7|2.7|||
4285608|NCT00552175|4110312|B3|Sleep||Brief Pain Inventory (BPI) Interference Scores|The Interference scores range from 0 (does not interfere) to 10 (completely interferes). There are 7 questions assessing the interference of pain in the past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. Each question has total scores ranging from 0 to 10.|units on a scale|Mean|4.3|4.3|Standard Deviation|2.7|2.7|||
4285609|NCT00552175|4110313|B2|Sleep||Brief Pain Inventory (BPI) Interference Scores|The Interference scores range from 0 (does not interfere) to 10 (completely interferes). There are 7 questions assessing the interference of pain in the past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. Each question has total scores ranging from 0 to 10.|units on a scale|Mean|4.0|4.0|Standard Deviation|2.8|2.8|||
4285610|NCT00552175|4110314|B1|Sleep||Brief Pain Inventory (BPI) Interference Scores|The Interference scores range from 0 (does not interfere) to 10 (completely interferes). There are 7 questions assessing the interference of pain in the past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. Each question has total scores ranging from 0 to 10.|units on a scale|Mean|3.9|3.9|Standard Deviation|2.7|2.7|||
4285611|NCT00552175|4110311|B4|Relation to People||Brief Pain Inventory (BPI) Interference Scores|The Interference scores range from 0 (does not interfere) to 10 (completely interferes). There are 7 questions assessing the interference of pain in the past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. Each question has total scores ranging from 0 to 10.|units on a scale|Mean|2.7|2.7|Standard Deviation|2.5|2.5|||
4285612|NCT00552175|4110312|B3|Relation to People||Brief Pain Inventory (BPI) Interference Scores|The Interference scores range from 0 (does not interfere) to 10 (completely interferes). There are 7 questions assessing the interference of pain in the past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. Each question has total scores ranging from 0 to 10.|units on a scale|Mean|2.9|2.9|Standard Deviation|2.4|2.4|||
4285613|NCT00552175|4110313|B2|Relation to People||Brief Pain Inventory (BPI) Interference Scores|The Interference scores range from 0 (does not interfere) to 10 (completely interferes). There are 7 questions assessing the interference of pain in the past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. Each question has total scores ranging from 0 to 10.|units on a scale|Mean|2.7|2.7|Standard Deviation|2.7|2.7|||
4285614|NCT00552175|4110314|B1|Relation to People||Brief Pain Inventory (BPI) Interference Scores|The Interference scores range from 0 (does not interfere) to 10 (completely interferes). There are 7 questions assessing the interference of pain in the past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. Each question has total scores ranging from 0 to 10.|units on a scale|Mean|2.6|2.6|Standard Deviation|2.5|2.5|||
4285615|NCT00552175|4110311|B4|Normal Work||Brief Pain Inventory (BPI) Interference Scores|The Interference scores range from 0 (does not interfere) to 10 (completely interferes). There are 7 questions assessing the interference of pain in the past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. Each question has total scores ranging from 0 to 10.|units on a scale|Mean|3.9|3.9|Standard Deviation|2.6|2.6|||
4285616|NCT00552175|4110312|B3|Normal Work||Brief Pain Inventory (BPI) Interference Scores|The Interference scores range from 0 (does not interfere) to 10 (completely interferes). There are 7 questions assessing the interference of pain in the past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. Each question has total scores ranging from 0 to 10.|units on a scale|Mean|4.3|4.3|Standard Deviation|2.5|2.5|||
4285731|NCT00552084|4110377|B3|||Age||years|Mean|61.7|61.7|Full Range|||21.0|82.0|
4285617|NCT00552175|4110313|B2|Normal Work||Brief Pain Inventory (BPI) Interference Scores|The Interference scores range from 0 (does not interfere) to 10 (completely interferes). There are 7 questions assessing the interference of pain in the past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. Each question has total scores ranging from 0 to 10.|units on a scale|Mean|3.9|3.9|Standard Deviation|2.6|2.6|||
4285618|NCT00552175|4110314|B1|Normal Work||Brief Pain Inventory (BPI) Interference Scores|The Interference scores range from 0 (does not interfere) to 10 (completely interferes). There are 7 questions assessing the interference of pain in the past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. Each question has total scores ranging from 0 to 10.|units on a scale|Mean|3.7|3.7|Standard Deviation|2.7|2.7|||
4285619|NCT00552175|4110311|B4|Walking Ability||Brief Pain Inventory (BPI) Interference Scores|The Interference scores range from 0 (does not interfere) to 10 (completely interferes). There are 7 questions assessing the interference of pain in the past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. Each question has total scores ranging from 0 to 10.|units on a scale|Mean|4.2|4.2|Standard Deviation|2.6|2.6|||
4285620|NCT00552175|4110312|B3|Walking Ability||Brief Pain Inventory (BPI) Interference Scores|The Interference scores range from 0 (does not interfere) to 10 (completely interferes). There are 7 questions assessing the interference of pain in the past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. Each question has total scores ranging from 0 to 10.|units on a scale|Mean|4.3|4.3|Standard Deviation|2.5|2.5|||
4285621|NCT00552175|4110313|B2|Walking Ability||Brief Pain Inventory (BPI) Interference Scores|The Interference scores range from 0 (does not interfere) to 10 (completely interferes). There are 7 questions assessing the interference of pain in the past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. Each question has total scores ranging from 0 to 10.|units on a scale|Mean|4.4|4.4|Standard Deviation|2.8|2.8|||
4285622|NCT00552175|4110314|B1|Walking Ability||Brief Pain Inventory (BPI) Interference Scores|The Interference scores range from 0 (does not interfere) to 10 (completely interferes). There are 7 questions assessing the interference of pain in the past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. Each question has total scores ranging from 0 to 10.|units on a scale|Mean|4.0|4.0|Standard Deviation|2.6|2.6|||
4285623|NCT00552175|4110311|B4|Mood||Brief Pain Inventory (BPI) Interference Scores|The Interference scores range from 0 (does not interfere) to 10 (completely interferes). There are 7 questions assessing the interference of pain in the past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. Each question has total scores ranging from 0 to 10.|units on a scale|Mean|4.1|4.1|Standard Deviation|2.5|2.5|||
4285624|NCT00552175|4110312|B3|Mood||Brief Pain Inventory (BPI) Interference Scores|The Interference scores range from 0 (does not interfere) to 10 (completely interferes). There are 7 questions assessing the interference of pain in the past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. Each question has total scores ranging from 0 to 10.|units on a scale|Mean|4.2|4.2|Standard Deviation|2.5|2.5|||
4285625|NCT00552175|4110313|B2|Mood||Brief Pain Inventory (BPI) Interference Scores|The Interference scores range from 0 (does not interfere) to 10 (completely interferes). There are 7 questions assessing the interference of pain in the past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. Each question has total scores ranging from 0 to 10.|units on a scale|Mean|3.9|3.9|Standard Deviation|2.5|2.5|||
4285626|NCT00552175|4110314|B1|Mood||Brief Pain Inventory (BPI) Interference Scores|The Interference scores range from 0 (does not interfere) to 10 (completely interferes). There are 7 questions assessing the interference of pain in the past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. Each question has total scores ranging from 0 to 10.|units on a scale|Mean|4.2|4.2|Standard Deviation|2.4|2.4|||
4285627|NCT00552175|4110311|B4|General Activity||Brief Pain Inventory (BPI) Interference Scores|The Interference scores range from 0 (does not interfere) to 10 (completely interferes). There are 7 questions assessing the interference of pain in the past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. Each question has total scores ranging from 0 to 10.|units on a scale|Mean|4.5|4.5|Standard Deviation|2.5|2.5|||
4285628|NCT00552175|4110312|B3|General Activity||Brief Pain Inventory (BPI) Interference Scores|The Interference scores range from 0 (does not interfere) to 10 (completely interferes). There are 7 questions assessing the interference of pain in the past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. Each question has total scores ranging from 0 to 10.|units on a scale|Mean|4.5|4.5|Standard Deviation|2.4|2.4|||
4285629|NCT00552175|4110313|B2|General Activity||Brief Pain Inventory (BPI) Interference Scores|The Interference scores range from 0 (does not interfere) to 10 (completely interferes). There are 7 questions assessing the interference of pain in the past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. Each question has total scores ranging from 0 to 10.|units on a scale|Mean|4.5|4.5|Standard Deviation|2.7|2.7|||
4285630|NCT00552175|4110314|B1|General Activity||Brief Pain Inventory (BPI) Interference Scores|The Interference scores range from 0 (does not interfere) to 10 (completely interferes). There are 7 questions assessing the interference of pain in the past 24 hours for general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. Each question has total scores ranging from 0 to 10.|units on a scale|Mean|4.4|4.4|Standard Deviation|2.4|2.4|||
4285631|NCT00552175|4110311|B4|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters (kg/m^2)|Mean|23.82|23.82|Standard Deviation|3.65|3.65|||
4285632|NCT00552175|4110312|B3|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters (kg/m^2)|Mean|24.20|24.2|Standard Deviation|3.50|3.5|||
4285633|NCT00552175|4110313|B2|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters (kg/m^2)|Mean|23.27|23.27|Standard Deviation|3.67|3.67|||
4285636|NCT00552175|4110312|B3|||Beck Depression Inventory-II (BDI-II)|A 21-item, patient-completed questionnaire to assess characteristics of depression. Each of the 21 items corresponding to a symptom of depression is summed to give a single score. There is a four-point scale for each item ranging from 0 to 3. Total score ranges from 0 (no depression) to 63 (severe depression).|units on a scale|Mean|9.4|9.4|Standard Deviation|7.2|7.2|||
4285637|NCT00552175|4110313|B2|||Beck Depression Inventory-II (BDI-II)|A 21-item, patient-completed questionnaire to assess characteristics of depression. Each of the 21 items corresponding to a symptom of depression is summed to give a single score. There is a four-point scale for each item ranging from 0 to 3. Total score ranges from 0 (no depression) to 63 (severe depression).|units on a scale|Mean|9.4|9.4|Standard Deviation|8.8|8.8|||
4285638|NCT00552175|4110314|B1|||Beck Depression Inventory-II (BDI-II)|A 21-item, patient-completed questionnaire to assess characteristics of depression. Each of the 21 items corresponding to a symptom of depression is summed to give a single score. There is a four-point scale for each item ranging from 0 to 3. Total score ranges from 0 (no depression) to 63 (severe depression).|units on a scale|Mean|8.8|8.8|Standard Deviation|6.8|6.8|||
4285639|NCT00552175|4110311|B4|Type II||Type of Diabetes||participants|Number|321|321.0||||||
4285640|NCT00552175|4110312|B3|Type II||Type of Diabetes||participants|Number|82|82.0||||||
4285641|NCT00552175|4110313|B2|Type II||Type of Diabetes||participants|Number|80|80.0||||||
4285642|NCT00552175|4110314|B1|Type II||Type of Diabetes||participants|Number|159|159.0||||||
4285643|NCT00552175|4110311|B4|Type I||Type of Diabetes||participants|Number|17|17.0||||||
4285644|NCT00552175|4110312|B3|Type I||Type of Diabetes||participants|Number|4|4.0||||||
4285645|NCT00552175|4110313|B2|Type I||Type of Diabetes||participants|Number|5|5.0||||||
4285646|NCT00552175|4110314|B1|Type I||Type of Diabetes||participants|Number|8|8.0||||||
4285647|NCT00552175|4110311|B4|Unknown||Duration of Diabetes||participants|Number|5|5.0||||||
4285648|NCT00552175|4110312|B3|Unknown||Duration of Diabetes||participants|Number|0|0.0||||||
4285649|NCT00552175|4110313|B2|Unknown||Duration of Diabetes||participants|Number|0|0.0||||||
4285650|NCT00552175|4110314|B1|Unknown||Duration of Diabetes||participants|Number|5|5.0||||||
4285651|NCT00552175|4110311|B4|>= 10 years||Duration of Diabetes||participants|Number|200|200.0||||||
4285652|NCT00552175|4110312|B3|>= 10 years||Duration of Diabetes||participants|Number|56|56.0||||||
4285653|NCT00552175|4110313|B2|>= 10 years||Duration of Diabetes||participants|Number|47|47.0||||||
4285654|NCT00552175|4110314|B1|>= 10 years||Duration of Diabetes||participants|Number|97|97.0||||||
4285655|NCT00552175|4110311|B4|5 - 10 years||Duration of Diabetes||participants|Number|64|64.0||||||
4285656|NCT00552175|4110312|B3|5 - 10 years||Duration of Diabetes||participants|Number|14|14.0||||||
4285657|NCT00552175|4110313|B2|5 - 10 years||Duration of Diabetes||participants|Number|18|18.0||||||
4285658|NCT00552175|4110314|B1|5 - 10 years||Duration of Diabetes||participants|Number|32|32.0||||||
4285659|NCT00552175|4110311|B4|<5 years||Duration of Diabetes||participants|Number|69|69.0||||||
4285660|NCT00552175|4110312|B3|<5 years||Duration of Diabetes||participants|Number|16|16.0||||||
4285661|NCT00552175|4110313|B2|<5 years||Duration of Diabetes||participants|Number|20|20.0||||||
4285662|NCT00552175|4110314|B1|<5 years||Duration of Diabetes||participants|Number|33|33.0||||||
4285663|NCT00552175|4110311|B4|Japan||Region of Enrollment||participants|Number|338|338.0||||||
4285664|NCT00552175|4110312|B3|Japan||Region of Enrollment||participants|Number|86|86.0||||||
4285665|NCT00552175|4110313|B2|Japan||Region of Enrollment||participants|Number|85|85.0||||||
4285666|NCT00552175|4110314|B1|Japan||Region of Enrollment||participants|Number|167|167.0||||||
4285667|NCT00552175|4110311|B4|Japanese||Race/Ethnicity, Customized||participants|Number|338|338.0||||||
4285668|NCT00552175|4110312|B3|Japanese||Race/Ethnicity, Customized||participants|Number|86|86.0||||||
4285669|NCT00552175|4110313|B2|Japanese||Race/Ethnicity, Customized||participants|Number|85|85.0||||||
4285670|NCT00552175|4110314|B1|Japanese||Race/Ethnicity, Customized||participants|Number|167|167.0||||||
4285671|NCT00552175|4110311|B4||Male|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
4285672|NCT00552175|4110312|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4285673|NCT00552175|4110313|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4285674|NCT00552175|4110314|B1||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4285675|NCT00552175|4110311|B4||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4285676|NCT00552175|4110312|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4285677|NCT00552175|4110313|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4285678|NCT00552175|4110314|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4285679|NCT00552175|4110311|B4|||Age||years|Mean|60.8|60.8|Standard Deviation|10|10.0|||
4285680|NCT00552175|4110312|B3|||Age||years|Mean|59.7|59.7|Standard Deviation|12.1|12.1|||
4285681|NCT00552175|4110313|B2|||Age||years|Mean|62.1|62.1|Standard Deviation|9.3|9.3|||
4285682|NCT00552175|4110314|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|9.2|9.2|||
4285683|NCT00552110|4110351|B6||Male|Sex: Female, Male|Intention to treat population: all randomized subjects who had taken at least one dose of study drug|Participants|Count of Participants|234|234.0||||||
4285684|NCT00552110|4110352|B5||Male|Sex: Female, Male|Intention to treat population: all randomized subjects who had taken at least one dose of study drug|Participants|Count of Participants|53|53.0||||||
4285685|NCT00552110|4110353|B4||Male|Sex: Female, Male|Intention to treat population: all randomized subjects who had taken at least one dose of study drug|Participants|Count of Participants|45|45.0||||||
4285686|NCT00552110|4110354|B3||Male|Sex: Female, Male|Intention to treat population: all randomized subjects who had taken at least one dose of study drug|Participants|Count of Participants|38|38.0||||||
4285732|NCT00552084|4110378|B2|||Age||years|Mean|61.5|61.5|Full Range|||28.0|82.0|
4285688|NCT00552110|4110356|B1||Male|Sex: Female, Male|Intention to treat population: all randomized subjects who had taken at least one dose of study drug|Participants|Count of Participants|52|52.0||||||
4285689|NCT00552110|4110351|B6||Female|Sex: Female, Male|Intention to treat population: all randomized subjects who had taken at least one dose of study drug|Participants|Count of Participants|471|471.0||||||
4285690|NCT00552110|4110352|B5||Female|Sex: Female, Male|Intention to treat population: all randomized subjects who had taken at least one dose of study drug|Participants|Count of Participants|89|89.0||||||
4285691|NCT00552110|4110353|B4||Female|Sex: Female, Male|Intention to treat population: all randomized subjects who had taken at least one dose of study drug|Participants|Count of Participants|95|95.0||||||
4285692|NCT00552110|4110354|B3||Female|Sex: Female, Male|Intention to treat population: all randomized subjects who had taken at least one dose of study drug|Participants|Count of Participants|101|101.0||||||
4285693|NCT00552110|4110355|B2||Female|Sex: Female, Male|Intention to treat population: all randomized subjects who had taken at least one dose of study drug|Participants|Count of Participants|93|93.0||||||
4285694|NCT00552110|4110356|B1||Female|Sex: Female, Male|Intention to treat population: all randomized subjects who had taken at least one dose of study drug|Participants|Count of Participants|93|93.0||||||
4285695|NCT00552110|4110351|B6||>=65 years|Age|Intention to treat population: all randomized subjects who had taken at least one dose of study drug|Participants|Count of Participants|14|14.0||||||
4285696|NCT00552110|4110352|B5||>=65 years|Age|Intention to treat population: all randomized subjects who had taken at least one dose of study drug|Participants|Count of Participants|3|3.0||||||
4285697|NCT00552110|4110353|B4||>=65 years|Age|Intention to treat population: all randomized subjects who had taken at least one dose of study drug|Participants|Count of Participants|4|4.0||||||
4285698|NCT00552110|4110354|B3||>=65 years|Age|Intention to treat population: all randomized subjects who had taken at least one dose of study drug|Participants|Count of Participants|2|2.0||||||
4285699|NCT00552110|4110355|B2||>=65 years|Age|Intention to treat population: all randomized subjects who had taken at least one dose of study drug|Participants|Count of Participants|3|3.0||||||
4285700|NCT00552110|4110356|B1||>=65 years|Age|Intention to treat population: all randomized subjects who had taken at least one dose of study drug|Participants|Count of Participants|2|2.0||||||
4285701|NCT00552110|4110351|B6||Between 18 and 65 years|Age|Intention to treat population: all randomized subjects who had taken at least one dose of study drug|Participants|Count of Participants|649|649.0||||||
4285702|NCT00552110|4110352|B5||Between 18 and 65 years|Age|Intention to treat population: all randomized subjects who had taken at least one dose of study drug|Participants|Count of Participants|127|127.0||||||
4285703|NCT00552110|4110353|B4||Between 18 and 65 years|Age|Intention to treat population: all randomized subjects who had taken at least one dose of study drug|Participants|Count of Participants|131|131.0||||||
4285704|NCT00552110|4110354|B3||Between 18 and 65 years|Age|Intention to treat population: all randomized subjects who had taken at least one dose of study drug|Participants|Count of Participants|132|132.0||||||
4285705|NCT00552110|4110355|B2||Between 18 and 65 years|Age|Intention to treat population: all randomized subjects who had taken at least one dose of study drug|Participants|Count of Participants|124|124.0||||||
4285706|NCT00552110|4110356|B1||Between 18 and 65 years|Age|Intention to treat population: all randomized subjects who had taken at least one dose of study drug|Participants|Count of Participants|135|135.0||||||
4285707|NCT00552110|4110351|B6||<=18 years|Age|Intention to treat population: all randomized subjects who had taken at least one dose of study drug|Participants|Count of Participants|42|42.0||||||
4285708|NCT00552110|4110352|B5||<=18 years|Age|Intention to treat population: all randomized subjects who had taken at least one dose of study drug|Participants|Count of Participants|12|12.0||||||
4285709|NCT00552110|4110353|B4||<=18 years|Age|Intention to treat population: all randomized subjects who had taken at least one dose of study drug|Participants|Count of Participants|5|5.0||||||
4285710|NCT00552110|4110354|B3||<=18 years|Age|Intention to treat population: all randomized subjects who had taken at least one dose of study drug|Participants|Count of Participants|5|5.0||||||
4285711|NCT00552110|4110355|B2||<=18 years|Age|Intention to treat population: all randomized subjects who had taken at least one dose of study drug|Participants|Count of Participants|12|12.0||||||
4285712|NCT00552110|4110356|B1||<=18 years|Age|Intention to treat population: all randomized subjects who had taken at least one dose of study drug|Participants|Count of Participants|8|8.0||||||
4285713|NCT00552084|4110377|B3|United States||Region of Enrollment||participants|Number|190|190.0||||||
4285714|NCT00552084|4110378|B2|United States||Region of Enrollment||participants|Number|64|64.0||||||
4285715|NCT00552084|4110379|B1|United States||Region of Enrollment||participants|Number|126|126.0||||||
4285716|NCT00552084|4110377|B3||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4285717|NCT00552084|4110378|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4285718|NCT00552084|4110379|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4285719|NCT00552084|4110377|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4285720|NCT00552084|4110378|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4285721|NCT00552084|4110379|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4285722|NCT00552084|4110377|B3||>=65 years|Age||Participants|Count of Participants|90|90.0||||||
4285723|NCT00552084|4110378|B2||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4285724|NCT00552084|4110379|B1||>=65 years|Age||Participants|Count of Participants|64|64.0||||||
4285725|NCT00552084|4110377|B3||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4285726|NCT00552084|4110378|B2||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4285727|NCT00552084|4110379|B1||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4285728|NCT00552084|4110377|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4285729|NCT00552084|4110378|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4285730|NCT00552084|4110379|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4285733|NCT00552084|4110379|B1|||Age||years|Mean|61.9|61.9|Full Range|||21.0|82.0|
4285734|NCT00552071|4110386|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4285735|NCT00552071|4110387|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4285736|NCT00552071|4110388|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4285737|NCT00552071|4110386|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4285738|NCT00552071|4110386|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4285739|NCT00552071|4110387|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4285740|NCT00552071|4110388|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4285741|NCT00552071|4110386|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4285742|NCT00552071|4110387|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4285743|NCT00552071|4110388|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4285744|NCT00552071|4110386|B3|||Age||years|Mean|53|53.0|Standard Deviation|15|15.0|||
4285745|NCT00552071|4110387|B2|||Age||years|Mean|53|53.0|Standard Deviation|16|16.0|||
4285746|NCT00552071|4110388|B1|||Age||years|Mean|56|56.0|Standard Deviation|14|14.0|||
4285747|NCT00552058|4110397|B3|New Zealand||Region of Enrollment||participants|Number|19|19.0||||||
4285748|NCT00552058|4110398|B2|New Zealand||Region of Enrollment||participants|Number|9|9.0||||||
4285749|NCT00552058|4110399|B1|New Zealand||Region of Enrollment||participants|Number|10|10.0||||||
4285750|NCT00552058|4110397|B3|Germany||Region of Enrollment||participants|Number|8|8.0||||||
4285751|NCT00552058|4110398|B2|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4285752|NCT00552058|4110399|B1|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4285753|NCT00552058|4110397|B3|Latvia||Region of Enrollment||participants|Number|8|8.0||||||
4285754|NCT00552058|4110398|B2|Latvia||Region of Enrollment||participants|Number|5|5.0||||||
4285755|NCT00552058|4110399|B1|Latvia||Region of Enrollment||participants|Number|3|3.0||||||
4285756|NCT00552058|4110397|B3|Australia||Region of Enrollment||participants|Number|20|20.0||||||
4285757|NCT00552058|4110398|B2|Australia||Region of Enrollment||participants|Number|12|12.0||||||
4285758|NCT00552058|4110399|B1|Australia||Region of Enrollment||participants|Number|8|8.0||||||
4285759|NCT00552058|4110397|B3|Romania||Region of Enrollment||participants|Number|7|7.0||||||
4285760|NCT00552058|4110398|B2|Romania||Region of Enrollment||participants|Number|3|3.0||||||
4285761|NCT00552058|4110399|B1|Romania||Region of Enrollment||participants|Number|4|4.0||||||
4285762|NCT00552058|4110397|B3|Brazil||Region of Enrollment||participants|Number|26|26.0||||||
4285763|NCT00552058|4110398|B2|Brazil||Region of Enrollment||participants|Number|10|10.0||||||
4285764|NCT00552058|4110399|B1|Brazil||Region of Enrollment||participants|Number|16|16.0||||||
4285765|NCT00552058|4110397|B3|Belgium||Region of Enrollment||participants|Number|14|14.0||||||
4285766|NCT00552058|4110398|B2|Belgium||Region of Enrollment||participants|Number|7|7.0||||||
4285767|NCT00552058|4110399|B1|Belgium||Region of Enrollment||participants|Number|7|7.0||||||
4285768|NCT00552058|4110397|B3|Poland||Region of Enrollment||participants|Number|30|30.0||||||
4285769|NCT00552058|4110398|B2|Poland||Region of Enrollment||participants|Number|15|15.0||||||
4285770|NCT00552058|4110399|B1|Poland||Region of Enrollment||participants|Number|15|15.0||||||
4285771|NCT00552058|4110397|B3|Canada||Region of Enrollment||participants|Number|66|66.0||||||
4285772|NCT00552058|4110398|B2|Canada||Region of Enrollment||participants|Number|32|32.0||||||
4285773|NCT00552058|4110399|B1|Canada||Region of Enrollment||participants|Number|34|34.0||||||
4285774|NCT00552058|4110397|B3|Hungary||Region of Enrollment||participants|Number|50|50.0||||||
4285775|NCT00552058|4110398|B2|Hungary||Region of Enrollment||participants|Number|25|25.0||||||
4285776|NCT00552058|4110399|B1|Hungary||Region of Enrollment||participants|Number|25|25.0||||||
4285777|NCT00552058|4110397|B3|Czech Republic||Region of Enrollment||participants|Number|22|22.0||||||
4285778|NCT00552058|4110398|B2|Czech Republic||Region of Enrollment||participants|Number|9|9.0||||||
4285779|NCT00552058|4110399|B1|Czech Republic||Region of Enrollment||participants|Number|13|13.0||||||
4285780|NCT00552058|4110397|B3|Italy||Region of Enrollment||participants|Number|13|13.0||||||
4285781|NCT00552058|4110398|B2|Italy||Region of Enrollment||participants|Number|8|8.0||||||
4285782|NCT00552058|4110399|B1|Italy||Region of Enrollment||participants|Number|5|5.0||||||
4285783|NCT00552058|4110397|B3|Israel||Region of Enrollment||participants|Number|22|22.0||||||
4285784|NCT00552058|4110398|B2|Israel||Region of Enrollment||participants|Number|10|10.0||||||
4285785|NCT00552058|4110399|B1|Israel||Region of Enrollment||participants|Number|12|12.0||||||
4285786|NCT00552058|4110397|B3|Russian Federation||Region of Enrollment||participants|Number|15|15.0||||||
4285787|NCT00552058|4110398|B2|Russian Federation||Region of Enrollment||participants|Number|7|7.0||||||
4285788|NCT00552058|4110399|B1|Russian Federation||Region of Enrollment||participants|Number|8|8.0||||||
4285789|NCT00552058|4110397|B3|Austria||Region of Enrollment||participants|Number|8|8.0||||||
4285790|NCT00552058|4110398|B2|Austria||Region of Enrollment||participants|Number|3|3.0||||||
4285791|NCT00552058|4110399|B1|Austria||Region of Enrollment||participants|Number|5|5.0||||||
4285792|NCT00552058|4110397|B3|Ukraine||Region of Enrollment||participants|Number|23|23.0||||||
4285793|NCT00552058|4110398|B2|Ukraine||Region of Enrollment||participants|Number|13|13.0||||||
4285794|NCT00552058|4110399|B1|Ukraine||Region of Enrollment||participants|Number|10|10.0||||||
4285795|NCT00552058|4110397|B3|Estonia||Region of Enrollment||participants|Number|4|4.0||||||
4285796|NCT00552058|4110398|B2|Estonia||Region of Enrollment||participants|Number|2|2.0||||||
4285797|NCT00552058|4110399|B1|Estonia||Region of Enrollment||participants|Number|2|2.0||||||
4285798|NCT00552058|4110397|B3|United States||Region of Enrollment||participants|Number|83|83.0||||||
4285799|NCT00552058|4110398|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
4285800|NCT00552058|4110399|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4285801|NCT00552058|4110397|B3||Male|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4285802|NCT00552058|4110398|B2||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4285803|NCT00552058|4110399|B1||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4285804|NCT00552058|4110397|B3||Female|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
4285805|NCT00552058|4110398|B2||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4285806|NCT00552058|4110399|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4285807|NCT00552058|4110397|B3|||Age||years|Mean|37.5|37.5|Standard Deviation|12.74|12.74|||
4285808|NCT00552058|4110398|B2|||Age||years|Mean|38.8|38.8|Standard Deviation|12.76|12.76|||
4285809|NCT00552058|4110399|B1|||Age||years|Mean|36.3|36.3|Standard Deviation|12.63|12.63|||
4285810|NCT00552058|4110397|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4285811|NCT00552058|4110398|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4285812|NCT00552058|4110399|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4285813|NCT00552058|4110397|B3||Between 18 and 65 years|Age||Participants|Count of Participants|418|418.0||||||
4285814|NCT00552058|4110398|B2||Between 18 and 65 years|Age||Participants|Count of Participants|205|205.0||||||
4285815|NCT00552058|4110399|B1||Between 18 and 65 years|Age||Participants|Count of Participants|213|213.0||||||
4285816|NCT00552058|4110397|B3||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4285817|NCT00552058|4110398|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4285818|NCT00552058|4110399|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4285819|NCT00552032|4110438|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4285820|NCT00552032|4110439|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4285821|NCT00552032|4110440|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4285822|NCT00552032|4110438|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4285823|NCT00552032|4110439|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4285824|NCT00552032|4110440|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4285825|NCT00552032|4110438|B3|||Age||years|Mean|5.46|5.46|Standard Deviation|2.38|2.38|||
4285826|NCT00552032|4110439|B2|||Age||years|Mean|5.36|5.36|Standard Deviation|2.50|2.5|||
4285827|NCT00552032|4110440|B1|||Age||years|Mean|5.56|5.56|Standard Deviation|2.27|2.27|||
4285828|NCT00551759|4110485|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4285829|NCT00551759|4110485|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4285830|NCT00551759|4110485|B1|||Age||years|Median|62|62.0|Full Range|||45.0|79.0|
4285831|NCT00551746|4110489|B3|United States||Region of Enrollment||participants|Number|70|70.0||||||
4285832|NCT00551746|4110490|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
4285833|NCT00551746|4110491|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4285834|NCT00551746|4110489|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4285835|NCT00551746|4110490|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4285836|NCT00551746|4110491|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4285837|NCT00551746|4110489|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4285838|NCT00551746|4110490|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4285839|NCT00551746|4110491|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4285840|NCT00551746|4110489|B3|||Age||years|Mean|41.6|41.6|Standard Deviation|12.8|12.8|||
4285841|NCT00551746|4110490|B2|||Age||years|Mean|42.3|42.3|Standard Deviation|11.4|11.4|||
4285842|NCT00551746|4110491|B1|||Age||years|Mean|40.8|40.8|Standard Deviation|14.1|14.1|||
4285843|NCT00551746|4110489|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4285844|NCT00551746|4110490|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4285845|NCT00551746|4110491|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4285846|NCT00551746|4110489|B3||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
4285847|NCT00551746|4110490|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4285848|NCT00551746|4110491|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4285849|NCT00551746|4110489|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4285850|NCT00551746|4110490|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4285851|NCT00551746|4110491|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4285852|NCT00551707|4110498|B6||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4285853|NCT00551707|4110499|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4285854|NCT00551707|4110500|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4285855|NCT00551707|4110501|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4285856|NCT00551707|4110502|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4285857|NCT00551707|4110503|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4285858|NCT00551707|4110498|B6||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4285859|NCT00551707|4110499|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4285860|NCT00551707|4110500|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4285861|NCT00551707|4110501|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4285862|NCT00551707|4110502|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4285863|NCT00551707|4110503|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4285864|NCT00551707|4110498|B6|||Age||years|Mean|56.0|56.0|Standard Deviation|11.09|11.09|||
4285865|NCT00551707|4110499|B5|||Age||years|Mean|58.8|58.8|Standard Deviation|9.54|9.54|||
4285866|NCT00551707|4110500|B4|||Age||years|Mean|56.5|56.5|Standard Deviation|12.76|12.76|||
4285867|NCT00551707|4110501|B3|||Age||years|Mean|55.8|55.8|Standard Deviation|11.32|11.32|||
4285868|NCT00551707|4110502|B2|||Age||years|Mean|56.2|56.2|Standard Deviation|11.96|11.96|||
4285869|NCT00551707|4110503|B1|||Age||years|Mean|51.8|51.8|Standard Deviation|5.50|5.5|||
4285870|NCT00551642|4110524|B3|Sweden||Region of Enrollment||participants|Number|44|44.0||||||
4285871|NCT00551642|4110525|B2|Sweden||Region of Enrollment||participants|Number|22|22.0||||||
4285872|NCT00551642|4110526|B1|Sweden||Region of Enrollment||participants|Number|22|22.0||||||
4285873|NCT00551642|4110524|B3|Italy||Region of Enrollment||participants|Number|78|78.0||||||
4285874|NCT00551642|4110525|B2|Italy||Region of Enrollment||participants|Number|34|34.0||||||
4285875|NCT00551642|4110526|B1|Italy||Region of Enrollment||participants|Number|44|44.0||||||
4285876|NCT00551642|4110524|B3|United Kingdom||Region of Enrollment||participants|Number|63|63.0||||||
4285877|NCT00551642|4110525|B2|United Kingdom||Region of Enrollment||participants|Number|33|33.0||||||
4285878|NCT00551642|4110526|B1|United Kingdom||Region of Enrollment||participants|Number|30|30.0||||||
4285879|NCT00551642|4110524|B3|Germany||Region of Enrollment||participants|Number|231|231.0||||||
4285880|NCT00551642|4110525|B2|Germany||Region of Enrollment||participants|Number|117|117.0||||||
4285881|NCT00551642|4110526|B1|Germany||Region of Enrollment||participants|Number|114|114.0||||||
4285882|NCT00551642|4110524|B3|Netherlands||Region of Enrollment||participants|Number|40|40.0||||||
4285883|NCT00551642|4110525|B2|Netherlands||Region of Enrollment||participants|Number|20|20.0||||||
4285884|NCT00551642|4110526|B1|Netherlands||Region of Enrollment||participants|Number|20|20.0||||||
4285885|NCT00551642|4110524|B3|Belgium||Region of Enrollment||participants|Number|74|74.0||||||
4285886|NCT00551642|4110525|B2|Belgium||Region of Enrollment||participants|Number|37|37.0||||||
4285887|NCT00551642|4110526|B1|Belgium||Region of Enrollment||participants|Number|37|37.0||||||
4285888|NCT00551642|4110524|B3|Spain||Region of Enrollment||participants|Number|155|155.0||||||
4285889|NCT00551642|4110525|B2|Spain||Region of Enrollment||participants|Number|79|79.0||||||
4285890|NCT00551642|4110526|B1|Spain||Region of Enrollment||participants|Number|76|76.0||||||
4285891|NCT00551642|4110524|B3|Finland||Region of Enrollment||participants|Number|8|8.0||||||
4285892|NCT00551642|4110525|B2|Finland||Region of Enrollment||participants|Number|4|4.0||||||
4285893|NCT00551642|4110526|B1|Finland||Region of Enrollment||participants|Number|4|4.0||||||
4285894|NCT00551642|4110524|B3|France||Region of Enrollment||participants|Number|107|107.0||||||
4285895|NCT00551642|4110525|B2|France||Region of Enrollment||participants|Number|55|55.0||||||
4285896|NCT00551642|4110526|B1|France||Region of Enrollment||participants|Number|52|52.0||||||
4285897|NCT00551642|4110524|B3||Male|Gender||Participants|Count of Participants|427|427.0||||||
4285898|NCT00551642|4110525|B2||Male|Gender||Participants|Count of Participants|220|220.0||||||
4285899|NCT00551642|4110526|B1||Male|Gender||Participants|Count of Participants|207|207.0||||||
4285900|NCT00551642|4110524|B3||Female|Gender||Participants|Count of Participants|373|373.0||||||
4285901|NCT00551642|4110525|B2||Female|Gender||Participants|Count of Participants|181|181.0||||||
4285902|NCT00551642|4110526|B1||Female|Gender||Participants|Count of Participants|192|192.0||||||
4285903|NCT00551642|4110524|B3|||Age||weeks|Mean|26.5|26.5|Standard Deviation|1.3|1.3|||
4285904|NCT00551642|4110525|B2|||Age||weeks|Mean|26.6|26.6|Standard Deviation|1.3|1.3|||
4285905|NCT00551642|4110526|B1|||Age||weeks|Mean|26.4|26.4|Standard Deviation|1.3|1.3|||
4285906|NCT00551642|4110524|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4285907|NCT00551642|4110525|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4285908|NCT00551642|4110526|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4285909|NCT00551642|4110524|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4285910|NCT00551642|4110525|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4285911|NCT00551642|4110526|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4285912|NCT00551642|4110524|B3||<=18 years|Age||Participants|Count of Participants|800|800.0||||||
4285913|NCT00551642|4110525|B2||<=18 years|Age||Participants|Count of Participants|401|401.0||||||
4285914|NCT00551642|4110526|B1||<=18 years|Age||Participants|Count of Participants|399|399.0||||||
4285915|NCT00551525|4110533|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4285916|NCT00551525|4110533|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4285917|NCT00551525|4110533|B1|||Age||years|Median|65|65.0|Full Range|||49.0|83.0|
4285918|NCT00551460|4110542|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4285919|NCT00551460|4110542|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4285920|NCT00551460|4110542|B1||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4285921|NCT00551460|4110542|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4285922|NCT00551460|4110542|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4285923|NCT00551460|4110542|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4285924|NCT00551460|4110542|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4285925|NCT00551460|4110542|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4285926|NCT00551460|4110542|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4285927|NCT00551460|4110542|B1|||Age||years|Median|46.5|46.5|Full Range|||19.2|86.4|
4285928|NCT00551421|4110548|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4285929|NCT00551421|4110548|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4285930|NCT00551421|4110548|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4285931|NCT00551421|4110548|B1|||Age||years|Median|60|60.0|Full Range|||46.0|73.0|
4285932|NCT00551369|4110555|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4285933|NCT00551369|4110555|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4285934|NCT00551369|4110555|B1|||Age||years|Median|73|73.0|Full Range|||54.0|88.0|
4285935|NCT00551291|4110563|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4285936|NCT00551291|4110563|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4285937|NCT00551291|4110563|B1|||Age||years|Mean|75.00|75.0|Standard Deviation|5.17|5.17|||
4285938|NCT00551213|4110569|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4285939|NCT00551213|4110570|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4285940|NCT00551213|4110571|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4285941|NCT00551213|4110569|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4285942|NCT00551213|4110570|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4285943|NCT00551213|4110571|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4285944|NCT00551213|4110569|B3|||Age||Years|Mean|64.0|64.0|Standard Deviation|10.7|10.7|||
4285945|NCT00551213|4110570|B2|||Age||Years|Mean|61.9|61.9|Standard Deviation|10.6|10.6|||
4285946|NCT00551213|4110571|B1|||Age||Years|Mean|64.7|64.7|Standard Deviation|10.8|10.8|||
4285947|NCT00551200|4110588|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4285948|NCT00551200|4110588|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
4285949|NCT00551200|4110588|B1||Female|Gender||Participants|Count of Participants|9|9.0||||||
4285950|NCT00551200|4110588|B1|||Age||years|Mean|35.7|35.7|Standard Deviation|16.3|16.3|||
4285951|NCT00551200|4110588|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4285952|NCT00551200|4110588|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4285953|NCT00551200|4110588|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4285954|NCT00551174|4110601|B3|||BMI||kg/m*2|Mean|25.76|25.76|Standard Deviation|4.3460|4.346|||
4285955|NCT00551174|4110602|B2|||BMI||kg/m*2|Mean|25.89|25.89|Standard Deviation|4.394|4.394|||
4285956|NCT00551174|4110603|B1|||BMI||kg/m*2|Mean|25.63|25.63|Standard Deviation|4.295|4.295|||
4285957|NCT00551174|4110601|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4285958|NCT00551174|4110602|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4285959|NCT00551174|4110603|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4285960|NCT00551174|4110601|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4285961|NCT00551174|4110602|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4285962|NCT00551174|4110603|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4285963|NCT00551174|4110601|B3|Oriental||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4285964|NCT00551174|4110602|B2|Oriental||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4285965|NCT00551174|4110603|B1|Oriental||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4285966|NCT00551174|4110601|B3|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4285967|NCT00551174|4110602|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4285968|NCT00551174|4110603|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4285969|NCT00551174|4110601|B3|Caucasian/White||Race/Ethnicity, Customized||participants|Number|751|751.0||||||
4285970|NCT00551174|4110602|B2|Caucasian/White||Race/Ethnicity, Customized||participants|Number|388|388.0||||||
4285971|NCT00551174|4110603|B1|Caucasian/White||Race/Ethnicity, Customized||participants|Number|363|363.0||||||
4285972|NCT00551174|4110601|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4285973|NCT00551174|4110602|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4285974|NCT00551174|4110603|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4285975|NCT00551174|4110601|B3||Female|Sex: Female, Male||Participants|Count of Participants|781|781.0||||||
4285976|NCT00551174|4110602|B2||Female|Sex: Female, Male||Participants|Count of Participants|400|400.0||||||
4285977|NCT00551174|4110603|B1||Female|Sex: Female, Male||Participants|Count of Participants|381|381.0||||||
4285978|NCT00551174|4110601|B3|||Age||years|Mean|68.0|68.0|Standard Deviation|6.0|6.0|||
4285979|NCT00551174|4110602|B2|||Age||years|Mean|67.9|67.9|Standard Deviation|6.0|6.0|||
4285980|NCT00551174|4110603|B1|||Age||years|Mean|68.2|68.2|Standard Deviation|6.1|6.1|||
4285981|NCT00551161|4110616|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4285982|NCT00551161|4110616|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4285983|NCT00551161|4110616|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4285984|NCT00551161|4110616|B1|||Age||years|Mean|76.1|76.1|Standard Deviation|7.5|7.5|||
4285985|NCT00551161|4110616|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4285986|NCT00551161|4110616|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4285987|NCT00551161|4110616|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4285988|NCT00551135|4110620|B5|||Sex/Gender, Customized|Number of male subjects|participants|Number|425|425.0||||||
4285989|NCT00551135|4110621|B4|||Sex/Gender, Customized|Number of male subjects|participants|Number|108|108.0||||||
4285990|NCT00551135|4110622|B3|||Sex/Gender, Customized|Number of male subjects|participants|Number|103|103.0||||||
4285991|NCT00551135|4110623|B2|||Sex/Gender, Customized|Number of male subjects|participants|Number|106|106.0||||||
4285992|NCT00551135|4110624|B1|||Sex/Gender, Customized|Number of male subjects|participants|Number|108|108.0||||||
4285993|NCT00551135|4110620|B5|>=65 years||Age, Customized||participants|Number|54|54.0||||||
4285994|NCT00551135|4110621|B4|>=65 years||Age, Customized||participants|Number|15|15.0||||||
4285995|NCT00551135|4110622|B3|>=65 years||Age, Customized||participants|Number|11|11.0||||||
4285996|NCT00551135|4110623|B2|>=65 years||Age, Customized||participants|Number|11|11.0||||||
4285997|NCT00551135|4110624|B1|>=65 years||Age, Customized||participants|Number|17|17.0||||||
4285998|NCT00551135|4110620|B5|Between 45 and 64 years||Age, Customized||participants|Number|205|205.0||||||
4285999|NCT00551135|4110621|B4|Between 45 and 64 years||Age, Customized||participants|Number|47|47.0||||||
4286000|NCT00551135|4110622|B3|Between 45 and 64 years||Age, Customized||participants|Number|52|52.0||||||
4286001|NCT00551135|4110623|B2|Between 45 and 64 years||Age, Customized||participants|Number|58|58.0||||||
4286002|NCT00551135|4110624|B1|Between 45 and 64 years||Age, Customized||participants|Number|48|48.0||||||
4286003|NCT00551135|4110620|B5|Between 18 and 44 years||Age, Customized||participants|Number|166|166.0||||||
4286004|NCT00551135|4110621|B4|Between 18 and 44 years||Age, Customized||participants|Number|46|46.0||||||
4286005|NCT00551135|4110622|B3|Between 18 and 44 years||Age, Customized||participants|Number|40|40.0||||||
4286006|NCT00551135|4110623|B2|Between 18 and 44 years||Age, Customized||participants|Number|37|37.0||||||
4286007|NCT00551135|4110624|B1|Between 18 and 44 years||Age, Customized||participants|Number|43|43.0||||||
4286008|NCT00551070|4110741|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4286009|NCT00551070|4110741|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4286010|NCT00551070|4110741|B1|80-89 years||Age, Customized||participants|Number|0|0.0||||||
4286011|NCT00551070|4110741|B1|70-79 years||Age, Customized||participants|Number|4|4.0||||||
4286012|NCT00551070|4110741|B1|60-69 years||Age, Customized||participants|Number|9|9.0||||||
4286013|NCT00551070|4110741|B1|50-59 years||Age, Customized||participants|Number|17|17.0||||||
4286014|NCT00551070|4110741|B1|40-49 years||Age, Customized||participants|Number|8|8.0||||||
4286015|NCT00551070|4110741|B1|30-39 years||Age, Customized||participants|Number|11|11.0||||||
4286016|NCT00551070|4110741|B1|20-29 years||Age, Customized||participants|Number|3|3.0||||||
4286017|NCT00551031|4110751|B6|United States||Region of Enrollment||Participants|Number|2095|2095.0||||||
4286018|NCT00551031|4110752|B5|United States||Region of Enrollment||Participants|Number|186|186.0||||||
4286019|NCT00551031|4110753|B4|United States||Region of Enrollment||Participants|Number|320|320.0||||||
4286020|NCT00551031|4110754|B3|United States||Region of Enrollment||Participants|Number|319|319.0||||||
4286021|NCT00551031|4110755|B2|United States||Region of Enrollment||Participants|Number|635|635.0||||||
4286022|NCT00551031|4110756|B1|United States||Region of Enrollment||Participants|Number|635|635.0||||||
4286023|NCT00551031|4110751|B6||Male|Sex: Female, Male||Participants|Count of Participants|905|905.0||||||
4286024|NCT00551031|4110752|B5||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4286025|NCT00551031|4110753|B4||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4286026|NCT00551031|4110754|B3||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4286027|NCT00551031|4110755|B2||Male|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
4286028|NCT00551031|4110756|B1||Male|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
4286029|NCT00551031|4110751|B6||Female|Sex: Female, Male||Participants|Count of Participants|1190|1190.0||||||
4286030|NCT00551031|4110752|B5||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4286031|NCT00551031|4110753|B4||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4286032|NCT00551031|4110754|B3||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4286033|NCT00551031|4110755|B2||Female|Sex: Female, Male||Participants|Count of Participants|347|347.0||||||
4286034|NCT00551031|4110756|B1||Female|Sex: Female, Male||Participants|Count of Participants|363|363.0||||||
4286035|NCT00551031|4110751|B6|||Age||Years|Mean|64.8|64.8|Standard Deviation|6.458|6.458|||
4286036|NCT00551031|4110752|B5|||Age||Years|Mean|32.2|32.2|Standard Deviation|8.49|8.49|||
4286037|NCT00551031|4110753|B4|||Age||Years|Mean|73.0|73.0|Standard Deviation|6.00|6.0|||
4286038|NCT00551031|4110754|B3|||Age||Years|Mean|73.4|73.4|Standard Deviation|5.91|5.91|||
4286039|NCT00551031|4110755|B2|||Age||Years|Mean|72.9|72.9|Standard Deviation|5.86|5.86|||
4286040|NCT00551031|4110756|B1|||Age||Years|Mean|73.1|73.1|Standard Deviation|6.03|6.03|||
4286041|NCT00551031|4110751|B6||>=65 years|Age||Participants|Count of Participants|1909|1909.0||||||
4286042|NCT00551031|4110752|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4286043|NCT00551031|4110753|B4||>=65 years|Age||Participants|Count of Participants|320|320.0||||||
4286044|NCT00551031|4110754|B3||>=65 years|Age||Participants|Count of Participants|319|319.0||||||
4286045|NCT00551031|4110755|B2||>=65 years|Age||Participants|Count of Participants|635|635.0||||||
4286046|NCT00551031|4110756|B1||>=65 years|Age||Participants|Count of Participants|635|635.0||||||
4286047|NCT00551031|4110751|B6||Between 18 and 65 years|Age||Participants|Count of Participants|186|186.0||||||
4286048|NCT00551031|4110752|B5||Between 18 and 65 years|Age||Participants|Count of Participants|186|186.0||||||
4286049|NCT00551031|4110753|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4286050|NCT00551031|4110754|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4286051|NCT00551031|4110755|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4286052|NCT00551031|4110756|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4286053|NCT00551031|4110751|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4286054|NCT00551031|4110752|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4286055|NCT00551031|4110753|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4286056|NCT00551031|4110754|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4286057|NCT00551031|4110755|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4286058|NCT00551031|4110756|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4286059|NCT00550953|4110787|B3||Male|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
4286060|NCT00550953|4110788|B2||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4286061|NCT00550953|4110789|B1||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4286062|NCT00550953|4110787|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4286063|NCT00550953|4110788|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4286064|NCT00550953|4110789|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4286065|NCT00550953|4110787|B3|||Age||years|Mean|55.5|55.5|Standard Deviation|9.6|9.6|||
4286066|NCT00550953|4110788|B2|||Age||years|Mean|55.5|55.5|Standard Deviation|10.2|10.2|||
4286067|NCT00550953|4110789|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|9.1|9.1|||
4286068|NCT00550862|4110810|B5|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
4286069|NCT00550862|4110811|B4|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4286070|NCT00550862|4110812|B3|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4286071|NCT00550862|4110813|B2|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4286072|NCT00550862|4110814|B1|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4286073|NCT00550862|4110810|B5|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
4286074|NCT00550862|4110811|B4|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4286075|NCT00550862|4110812|B3|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4286076|NCT00550862|4110813|B2|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4286077|NCT00550862|4110814|B1|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4286078|NCT00550862|4110810|B5|Germany||Region of Enrollment||participants|Number|8|8.0||||||
4286079|NCT00550862|4110811|B4|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4286080|NCT00550862|4110812|B3|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4286081|NCT00550862|4110813|B2|Germany||Region of Enrollment||participants|Number|3|3.0||||||
4286082|NCT00550862|4110814|B1|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4286083|NCT00550862|4110810|B5|Austria||Region of Enrollment||participants|Number|6|6.0||||||
4286084|NCT00550862|4110811|B4|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4286085|NCT00550862|4110812|B3|Austria||Region of Enrollment||participants|Number|2|2.0||||||
4286086|NCT00550862|4110813|B2|Austria||Region of Enrollment||participants|Number|2|2.0||||||
4286087|NCT00550862|4110814|B1|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4286088|NCT00550862|4110810|B5|Spain||Region of Enrollment||participants|Number|6|6.0||||||
4286089|NCT00550862|4110811|B4|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4286090|NCT00550862|4110812|B3|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4286091|NCT00550862|4110813|B2|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4286092|NCT00550862|4110814|B1|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4286093|NCT00550862|4110810|B5|Canada||Region of Enrollment||participants|Number|55|55.0||||||
4286094|NCT00550862|4110811|B4|Canada||Region of Enrollment||participants|Number|13|13.0||||||
4286095|NCT00550862|4110812|B3|Canada||Region of Enrollment||participants|Number|14|14.0||||||
4286096|NCT00550862|4110813|B2|Canada||Region of Enrollment||participants|Number|15|15.0||||||
4286097|NCT00550862|4110814|B1|Canada||Region of Enrollment||participants|Number|13|13.0||||||
4286098|NCT00550862|4110810|B5|United States||Region of Enrollment||participants|Number|72|72.0||||||
4286099|NCT00550862|4110811|B4|United States||Region of Enrollment||participants|Number|17|17.0||||||
4286100|NCT00550862|4110812|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4286101|NCT00550862|4110813|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4286102|NCT00550862|4110814|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4286103|NCT00550862|4110810|B5|France||Region of Enrollment||participants|Number|2|2.0||||||
4286104|NCT00550862|4110811|B4|France||Region of Enrollment||participants|Number|0|0.0||||||
4286105|NCT00550862|4110812|B3|France||Region of Enrollment||participants|Number|0|0.0||||||
4286106|NCT00550862|4110813|B2|France||Region of Enrollment||participants|Number|1|1.0||||||
4286107|NCT00550862|4110814|B1|France||Region of Enrollment||participants|Number|1|1.0||||||
4286108|NCT00550862|4110810|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4286109|NCT00550862|4110811|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4286110|NCT00550862|4110812|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4286111|NCT00550862|4110813|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4286112|NCT00550862|4110814|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4286113|NCT00550862|4110810|B5||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4286114|NCT00550862|4110811|B4||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4286115|NCT00550862|4110812|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4286116|NCT00550862|4110813|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4286117|NCT00550862|4110814|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4286118|NCT00550862|4110810|B5|||Age||years|Mean|55.1|55.1|Standard Deviation|8.8|8.8|||
4286119|NCT00550862|4110811|B4|||Age||years|Mean|54.8|54.8|Standard Deviation|8.5|8.5|||
4286120|NCT00550862|4110812|B3|||Age||years|Mean|54.0|54.0|Standard Deviation|9.7|9.7|||
4286121|NCT00550862|4110813|B2|||Age||years|Mean|55.9|55.9|Standard Deviation|8.0|8.0|||
4286122|NCT00550862|4110814|B1|||Age||years|Mean|55.6|55.6|Standard Deviation|9.3|9.3|||
4286123|NCT00550862|4110810|B5||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4286124|NCT00550862|4110811|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4286125|NCT00550862|4110812|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4286126|NCT00550862|4110813|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4286127|NCT00550862|4110814|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4286128|NCT00550862|4110810|B5||Between 18 and 65 years|Age||Participants|Count of Participants|147|147.0||||||
4286129|NCT00550862|4110811|B4||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4286130|NCT00550862|4110812|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4286131|NCT00550862|4110813|B2||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4286132|NCT00550862|4110814|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4286133|NCT00550862|4110810|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4286134|NCT00550862|4110811|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4286135|NCT00550862|4110812|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4286136|NCT00550862|4110813|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4286137|NCT00550862|4110814|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4286138|NCT00550836|4110835|B3|United States||Region of Enrollment||participants|Number|92|92.0||||||
4286139|NCT00550836|4110836|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
4286140|NCT00550836|4110837|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4286141|NCT00550836|4110835|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4286142|NCT00550836|4110836|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4286143|NCT00550836|4110837|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4286144|NCT00550836|4110835|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4286145|NCT00550836|4110836|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4286146|NCT00550836|4110837|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4286147|NCT00550836|4110835|B3|||Age||years|Median|61.5|61.5|Full Range|||37.0|81.0|
4286148|NCT00550836|4110836|B2|||Age||years|Median|62|62.0|Full Range|||37.0|79.0|
4286149|NCT00550836|4110837|B1|||Age||years|Median|60.5|60.5|Full Range|||37.0|81.0|
4286150|NCT00550771|4110852|B3||Male|Sex: Female, Male|ITT population.|Participants|Count of Participants|0|0.0||||||
4286151|NCT00550771|4110853|B2||Male|Sex: Female, Male|ITT population.|Participants|Count of Participants|0|0.0||||||
4286152|NCT00550771|4110854|B1||Male|Sex: Female, Male|ITT population.|Participants|Count of Participants|0|0.0||||||
4286153|NCT00550771|4110852|B3||Female|Sex: Female, Male|ITT population.|Participants|Count of Participants|179|179.0||||||
4286154|NCT00550771|4110853|B2||Female|Sex: Female, Male|ITT population.|Participants|Count of Participants|59|59.0||||||
4286155|NCT00550771|4110854|B1||Female|Sex: Female, Male|ITT population.|Participants|Count of Participants|120|120.0||||||
4286156|NCT00550771|4110852|B3|||Age|Age information was for the intent-to-treat (ITT) population (n=59 for doxorubicin arm, n=120 for PLD arm). ITT was defined as all participants who were randomized and received at least 1 dose of any study medication.|years|Mean|50.9|50.9|Standard Deviation|10.49|10.49|||
4286157|NCT00550771|4110853|B2|||Age|Age information was for the intent-to-treat (ITT) population (n=59 for doxorubicin arm, n=120 for PLD arm). ITT was defined as all participants who were randomized and received at least 1 dose of any study medication.|years|Mean|52.5|52.5|Standard Deviation|9.32|9.32|||
4286158|NCT00550771|4110854|B1|||Age|Age information was for the intent-to-treat (ITT) population (n=59 for doxorubicin arm, n=120 for PLD arm). ITT was defined as all participants who were randomized and received at least 1 dose of any study medication.|years|Mean|50.2|50.2|Standard Deviation|10.97|10.97|||
4286159|NCT00550745|4110867|B3|Nursing Home||Type of Residence||Participants|Number|31|31.0||||||
4286160|NCT00550745|4110868|B2|Nursing Home||Type of Residence||Participants|Number|14|14.0||||||
4286161|NCT00550745|4110869|B1|Nursing Home||Type of Residence||Participants|Number|17|17.0||||||
4286162|NCT00550745|4110867|B3|Independent Residential||Type of Residence||Participants|Number|11611|11611.0||||||
4286163|NCT00550745|4110868|B2|Independent Residential||Type of Residence||Participants|Number|5821|5821.0||||||
4286164|NCT00550745|4110869|B1|Independent Residential||Type of Residence||Participants|Number|5790|5790.0||||||
4286165|NCT00550745|4110867|B3|Assisted Living||Type of Residence||Participants|Number|338|338.0||||||
4286166|NCT00550745|4110868|B2|Assisted Living||Type of Residence||Participants|Number|162|162.0||||||
4286167|NCT00550745|4110869|B1|Assisted Living||Type of Residence||Participants|Number|176|176.0||||||
4286168|NCT00550745|4110867|B3|Non-U.S.||Region||Participants|Number|1359|1359.0||||||
4286169|NCT00550745|4110868|B2|Non-U.S.||Region||Participants|Number|685|685.0||||||
4286170|NCT00550745|4110869|B1|Non-U.S.||Region||Participants|Number|674|674.0||||||
4286171|NCT00550745|4110867|B3|U.S.||Region||Participants|Number|10621|10621.0||||||
4286172|NCT00550745|4110868|B2|U.S.||Region||Participants|Number|5312|5312.0||||||
4286173|NCT00550745|4110869|B1|U.S.||Region||Participants|Number|5309|5309.0||||||
4286174|NCT00550745|4110867|B3|Other||Race/Ethnicity, Customized||participants|Number|257|257.0||||||
4286175|NCT00550745|4110868|B2|Other||Race/Ethnicity, Customized||participants|Number|142|142.0||||||
4286176|NCT00550745|4110869|B1|Other||Race/Ethnicity, Customized||participants|Number|115|115.0||||||
4286177|NCT00550745|4110867|B3|White||Race/Ethnicity, Customized||participants|Number|11529|11529.0||||||
4286178|NCT00550745|4110868|B2|White||Race/Ethnicity, Customized||participants|Number|5770|5770.0||||||
4286179|NCT00550745|4110869|B1|White||Race/Ethnicity, Customized||participants|Number|5759|5759.0||||||
4286180|NCT00550745|4110867|B3|Black||Race/Ethnicity, Customized||participants|Number|194|194.0||||||
4286181|NCT00550745|4110868|B2|Black||Race/Ethnicity, Customized||participants|Number|85|85.0||||||
4286182|NCT00550745|4110869|B1|Black||Race/Ethnicity, Customized||participants|Number|109|109.0||||||
4286183|NCT00550745|4110867|B3||Male|Sex: Female, Male||Participants|Count of Participants|4940|4940.0||||||
4286184|NCT00550745|4110868|B2||Male|Sex: Female, Male||Participants|Count of Participants|2472|2472.0||||||
4286185|NCT00550745|4110869|B1||Male|Sex: Female, Male||Participants|Count of Participants|2468|2468.0||||||
4286186|NCT00550745|4110867|B3||Female|Sex: Female, Male||Participants|Count of Participants|7040|7040.0||||||
4286187|NCT00550745|4110868|B2||Female|Sex: Female, Male||Participants|Count of Participants|3525|3525.0||||||
4286188|NCT00550745|4110869|B1||Female|Sex: Female, Male||Participants|Count of Participants|3515|3515.0||||||
4286189|NCT00550745|4110867|B3|≥ 80 Years of Age||Age, Customized|Age Group (years)|participants|Number|1795|1795.0||||||
4286190|NCT00550745|4110868|B2|≥ 80 Years of Age||Age, Customized|Age Group (years)|participants|Number|898|898.0||||||
4286191|NCT00550745|4110869|B1|≥ 80 Years of Age||Age, Customized|Age Group (years)|participants|Number|897|897.0||||||
4286192|NCT00550745|4110867|B3|70 to 79 Years of Age||Age, Customized|Age Group (years)|participants|Number|3980|3980.0||||||
4286193|NCT00550745|4110868|B2|70 to 79 Years of Age||Age, Customized|Age Group (years)|participants|Number|1986|1986.0||||||
4286194|NCT00550745|4110869|B1|70 to 79 Years of Age||Age, Customized|Age Group (years)|participants|Number|1994|1994.0||||||
4286195|NCT00550745|4110867|B3|60 to 69 Years of Age||Age, Customized|Age Group (years)|participants|Number|6205|6205.0||||||
4286196|NCT00550745|4110868|B2|60 to 69 Years of Age||Age, Customized|Age Group (years)|participants|Number|3113|3113.0||||||
4286197|NCT00550745|4110869|B1|60 to 69 Years of Age||Age, Customized|Age Group (years)|participants|Number|3092|3092.0||||||
4286198|NCT00550745|4110867|B3|||Age||years|Mean|70.5|70.5|Standard Deviation|7.5|7.5|||
4286199|NCT00550745|4110868|B2|||Age||years|Mean|70.4|70.4|Standard Deviation|7.6|7.6|||
4286200|NCT00550745|4110869|B1|||Age||years|Mean|70.5|70.5|Standard Deviation|7.5|7.5|||
4286201|NCT00550732|4110878|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4286202|NCT00550732|4110878|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4286203|NCT00550732|4110878|B1|||Age, Customized||Years|Median|48|48.0|Full Range|||17.0|78.0|
4286204|NCT00550680|4110889|B1||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4286205|NCT00550680|4110889|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4286206|NCT00550680|4110889|B1|||Age||years|Mean|62.6|62.6|Standard Deviation|14.49|14.49|||
4286207|NCT00550654|4110898|B1|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4286208|NCT00550654|4110898|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286209|NCT00550654|4110898|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286210|NCT00550654|4110898|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4286211|NCT00550654|4110898|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286212|NCT00550654|4110898|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286213|NCT00550654|4110898|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286214|NCT00550654|4110898|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286215|NCT00550654|4110898|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286216|NCT00550654|4110898|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4286217|NCT00550654|4110898|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286218|NCT00550654|4110898|B1||Male|Gender||Participants|Count of Participants|1|1.0||||||
4286219|NCT00550654|4110898|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
4286220|NCT00550654|4110898|B1|||Age||years|Mean|71.6|71.6|Standard Deviation|NA||||It wasn't possible to calculate a standard deviation since there was only one participant.
4286221|NCT00550654|4110898|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4286222|NCT00550654|4110898|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4286223|NCT00550654|4110898|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4286224|NCT00550589|4110908|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4286225|NCT00550589|4110908|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4286226|NCT00550589|4110908|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4286227|NCT00550589|4110908|B1|||Age||years|Mean|44|44.0|Standard Deviation|8.9|8.9|||
4286228|NCT00550589|4110908|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4286229|NCT00550589|4110908|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4286230|NCT00550589|4110908|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4286231|NCT00550550|4110919|B3||Male|Gender||Participants|Count of Participants|223|223.0||||||
4286232|NCT00550550|4110920|B2||Male|Gender||Participants|Count of Participants|105|105.0||||||
4286233|NCT00550550|4110921|B1||Male|Gender||Participants|Count of Participants|118|118.0||||||
4286234|NCT00550550|4110919|B3||Female|Gender||Participants|Count of Participants|121|121.0||||||
4286235|NCT00550550|4110920|B2||Female|Gender||Participants|Count of Participants|64|64.0||||||
4286236|NCT00550550|4110921|B1||Female|Gender||Participants|Count of Participants|57|57.0||||||
4286237|NCT00550550|4110919|B3|||Age||years|Mean|12.3|12.3|Standard Deviation|3.0|3.0|||
4286238|NCT00550550|4110920|B2|||Age||years|Mean|12.6|12.6|Standard Deviation|3.0|3.0|||
4286239|NCT00550550|4110921|B1|||Age||years|Mean|12.1|12.1|Standard Deviation|3.0|3.0|||
4286240|NCT00550537|4110934|B1|United States||Region of Enrollment||participants|Number|116|116.0||||||
4286241|NCT00550537|4110934|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4286242|NCT00550537|4110934|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4286243|NCT00550537|4110934|B1||White|Race (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
4286244|NCT00550537|4110934|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4286245|NCT00550537|4110934|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286246|NCT00550537|4110934|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4286247|NCT00550537|4110934|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286248|NCT00550537|4110934|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4286249|NCT00550537|4110934|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|112|112.0||||||
4286250|NCT00550537|4110934|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4286251|NCT00550537|4110934|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4286252|NCT00550537|4110934|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4286253|NCT00550537|4110934|B1|||Age||years|Mean|70.9|70.9|Standard Deviation|11.3|11.3|||
4286254|NCT00550459|4110949|B3|United States||Region of Enrollment||participants|Number|57|57.0||||||
4286255|NCT00550459|4110950|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4286256|NCT00550459|4110951|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4286257|NCT00550459|4110949|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4286258|NCT00550459|4110950|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4286259|NCT00550459|4110951|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4286260|NCT00550459|4110949|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4286261|NCT00550459|4110950|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4286262|NCT00550459|4110951|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4286263|NCT00550459|4110949|B3|||Age||years|Mean|71.2|71.2|Standard Deviation|9.9|9.9|||
4286264|NCT00550459|4110950|B2|||Age||years|Mean|71.1|71.1|Standard Deviation|10.2|10.2|||
4286265|NCT00550459|4110951|B1|||Age||years|Mean|71.3|71.3|Standard Deviation|9.7|9.7|||
4286266|NCT00550459|4110949|B3||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
4286267|NCT00550459|4110950|B2||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4286268|NCT00550459|4110951|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4286269|NCT00550459|4110949|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4286270|NCT00550459|4110950|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4286271|NCT00550459|4110951|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4286272|NCT00550459|4110949|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4286273|NCT00550459|4110950|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4286274|NCT00550459|4110951|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4286275|NCT00550446|4111014|B8||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4286276|NCT00550446|4111015|B7||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4286277|NCT00550446|4111016|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4286278|NCT00550446|4111017|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4286279|NCT00550446|4111018|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4286280|NCT00550446|4111019|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4286281|NCT00550446|4111020|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4286282|NCT00550446|4111021|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4286283|NCT00550446|4111014|B8||Female|Sex: Female, Male||Participants|Count of Participants|333|333.0||||||
4286284|NCT00550446|4111015|B7||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4286285|NCT00550446|4111016|B6||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4286286|NCT00550446|4111017|B5||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4286287|NCT00550446|4111018|B4||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4286288|NCT00550446|4111019|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4286289|NCT00550446|4111020|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4286290|NCT00550446|4111021|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4286291|NCT00550446|4111014|B8|||Age||years|Mean|53.3|53.3|Standard Deviation|12.6|12.6|||
4286292|NCT00550446|4111015|B7|||Age||years|Mean|52.5|52.5|Standard Deviation|13.7|13.7|||
4286293|NCT00550446|4111016|B6|||Age||years|Mean|53.5|53.5|Standard Deviation|11.9|11.9|||
4286294|NCT00550446|4111017|B5|||Age||years|Mean|53.2|53.2|Standard Deviation|13.0|13.0|||
4286295|NCT00550446|4111018|B4|||Age||years|Mean|52.4|52.4|Standard Deviation|10.9|10.9|||
4286296|NCT00550446|4111019|B3|||Age||years|Mean|53.7|53.7|Standard Deviation|13.5|13.5|||
4286297|NCT00550446|4111020|B2|||Age||years|Mean|53.4|53.4|Standard Deviation|12.2|12.2|||
4286298|NCT00550446|4111021|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|13.3|13.3|||
4286299|NCT00550420|4111463|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286300|NCT00550420|4111463|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4286301|NCT00550420|4111463|B1||White|Race (NIH/OMB)||Participants|Count of Participants|242|242.0||||||
4286302|NCT00550420|4111463|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286303|NCT00550420|4111463|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286304|NCT00550420|4111463|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
4286305|NCT00550420|4111463|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4286306|NCT00550420|4111463|B1||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4286307|NCT00550420|4111463|B1||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
4286308|NCT00550420|4111463|B1|||Age||Years|Mean|72.8|72.8|Standard Deviation|7.95|7.95|||
4286309|NCT00550407|4111484|B3|Asian－East Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4286310|NCT00550407|4111485|B2|Asian－East Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4286311|NCT00550407|4111486|B1|Asian－East Asian Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4286312|NCT00550407|4111484|B3|Asian－Japanese Heritage||Race/Ethnicity, Customized||participants|Number|102|102.0||||||
4286313|NCT00550407|4111485|B2|Asian－Japanese Heritage||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4286314|NCT00550407|4111486|B1|Asian－Japanese Heritage||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
4286315|NCT00550407|4111484|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4286316|NCT00550407|4111485|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4286317|NCT00550407|4111486|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4286318|NCT00550407|4111484|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4286319|NCT00550407|4111485|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4286320|NCT00550407|4111486|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4286321|NCT00550407|4111484|B3|||Age||years|Mean|42.8|42.8|Standard Deviation|12.25|12.25|||
4286322|NCT00550407|4111485|B2|||Age||years|Mean|42.4|42.4|Standard Deviation|11.79|11.79|||
4286323|NCT00550407|4111486|B1|||Age||years|Mean|43.1|43.1|Standard Deviation|12.68|12.68|||
4286324|NCT00550394|4111521|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
4286325|NCT00550394|4111522|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4286326|NCT00550394|4111523|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4286327|NCT00550394|4111521|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4286328|NCT00550394|4111522|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4286329|NCT00550394|4111523|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4286330|NCT00550394|4111521|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4286331|NCT00550394|4111522|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4286332|NCT00550394|4111523|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4286333|NCT00550394|4111521|B3|||Age||years|Mean|17.9|17.9|Standard Deviation|2.7|2.7|||
4286334|NCT00550394|4111522|B2|||Age||years|Mean|17.7|17.7|Standard Deviation|2.4|2.4|||
4286335|NCT00550394|4111523|B1|||Age||years|Mean|18|18.0|Standard Deviation|3.1|3.1|||
4286336|NCT00550394|4111521|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4286337|NCT00550394|4111522|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4286338|NCT00550394|4111523|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4286339|NCT00550394|4111521|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4286340|NCT00550394|4111522|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4286341|NCT00550394|4111523|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4286342|NCT00550394|4111521|B3||<=18 years|Age||Participants|Count of Participants|39|39.0||||||
4286343|NCT00550394|4111522|B2||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
4286344|NCT00550394|4111523|B1||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
4286345|NCT00550368|4111536|B3|||Hypochlorhydric||participants|Number|9|9.0||||||
4286346|NCT00550368|4111537|B2|||Hypochlorhydric||participants|Number|7|7.0||||||
4286347|NCT00550368|4111538|B1|||Hypochlorhydric||participants|Number|2|2.0||||||
4286348|NCT00550368|4111536|B3|||Gastric pH, Median||units on a scale|Median|1.5|1.5|Full Range|||1.1|7.5|
4286349|NCT00550368|4111537|B2|||Gastric pH, Median||units on a scale|Median|1.6|1.6|Full Range|||1.2|7.5|
4286350|NCT00550368|4111538|B1|||Gastric pH, Median||units on a scale|Median|1.5|1.5|Full Range|||1.1|6.8|
4286351|NCT00550368|4111536|B3|||BMI||kg/m2|Mean|27.7|27.7|Standard Deviation|4.3|4.3|||
4286352|NCT00550368|4111537|B2|||BMI||kg/m2|Mean|28.7|28.7|Standard Deviation|3.8|3.8|||
4286353|NCT00550368|4111538|B1|||BMI||kg/m2|Mean|27|27.0|Standard Deviation|4.5|4.5|||
4286354|NCT00550368|4111536|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286355|NCT00550368|4111537|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286356|NCT00550368|4111538|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286357|NCT00550368|4111536|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4286358|NCT00550368|4111537|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4286359|NCT00550368|4111538|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4286360|NCT00550368|4111536|B3||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4286361|NCT00550368|4111537|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4286362|NCT00550368|4111538|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4286363|NCT00550368|4111536|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4286364|NCT00550368|4111537|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4286365|NCT00550368|4111538|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4286366|NCT00550368|4111536|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286367|NCT00550368|4111537|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286368|NCT00550368|4111538|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286369|NCT00550368|4111536|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4286370|NCT00550368|4111537|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4286371|NCT00550368|4111538|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4286372|NCT00550368|4111536|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286373|NCT00550368|4111537|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286374|NCT00550368|4111538|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286375|NCT00550368|4111536|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286376|NCT00550368|4111537|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286377|NCT00550368|4111538|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286378|NCT00550368|4111536|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4286379|NCT00550368|4111537|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4286380|NCT00550368|4111538|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4286381|NCT00550368|4111536|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4286382|NCT00550368|4111537|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4286383|NCT00550368|4111538|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4286384|NCT00550368|4111536|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4286385|NCT00550368|4111537|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4286386|NCT00550368|4111538|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4286387|NCT00550368|4111536|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4286388|NCT00550368|4111537|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4286389|NCT00550368|4111538|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4286390|NCT00550368|4111536|B3|||Age||years|Mean|48.6|48.6|Standard Deviation|7|7.0|||
4286391|NCT00550368|4111537|B2|||Age||years|Mean|49.4|49.4|Standard Deviation|6.7|6.7|||
4286392|NCT00550368|4111538|B1|||Age||years|Mean|48.1|48.1|Standard Deviation|7.3|7.3|||
4286393|NCT00550290|4111547|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4286394|NCT00550290|4111548|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4286395|NCT00550290|4111549|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4286396|NCT00550290|4111547|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4286397|NCT00550290|4111548|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4286398|NCT00550290|4111549|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4286399|NCT00550290|4111547|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4286400|NCT00550290|4111548|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4286401|NCT00550290|4111549|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4286402|NCT00550290|4111547|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4286403|NCT00550290|4111548|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4286404|NCT00550290|4111549|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4286405|NCT00550290|4111547|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4286406|NCT00550290|4111548|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4286407|NCT00550290|4111549|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4286408|NCT00550277|4111556|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4286409|NCT00550277|4111556|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4286410|NCT00550277|4111556|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4286411|NCT00550277|4111556|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4286412|NCT00550277|4111556|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4286413|NCT00550277|4111556|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4286414|NCT00550173|4111560|B4|Non-adenocarcinoma (non-adeno)||Histological Subtype||participants|Number|15|15.0||||||
4286415|NCT00550173|4111561|B3|Non-adenocarcinoma (non-adeno)||Histological Subtype||participants|Number|3|3.0||||||
4286416|NCT00550173|4111562|B2|Non-adenocarcinoma (non-adeno)||Histological Subtype||participants|Number|6|6.0||||||
4286417|NCT00550173|4111563|B1|Non-adenocarcinoma (non-adeno)||Histological Subtype||participants|Number|6|6.0||||||
4286418|NCT00550173|4111560|B4|Adenocarcinoma (adeno)||Histological Subtype||participants|Number|225|225.0||||||
4286419|NCT00550173|4111561|B3|Adenocarcinoma (adeno)||Histological Subtype||participants|Number|77|77.0||||||
4286420|NCT00550173|4111562|B2|Adenocarcinoma (adeno)||Histological Subtype||participants|Number|76|76.0||||||
4286421|NCT00550173|4111563|B1|Adenocarcinoma (adeno)||Histological Subtype||participants|Number|72|72.0||||||
4286422|NCT00550173|4111560|B4|3||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|ECOG PS Scale: 0 = fully active, able to perform all pre-disease activities unrestricted; 1 = restricted in physically strenuous activity but ambulatory, able to carry out light or sedentary activities; 2 = ambulatory, capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3 = capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4 = completely disabled, cannot carry on any self-care, totally confined to bed or chair; 5 = Dead.|participant|Number|1|1.0||||||
4286423|NCT00550173|4111561|B3|3||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|ECOG PS Scale: 0 = fully active, able to perform all pre-disease activities unrestricted; 1 = restricted in physically strenuous activity but ambulatory, able to carry out light or sedentary activities; 2 = ambulatory, capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3 = capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4 = completely disabled, cannot carry on any self-care, totally confined to bed or chair; 5 = Dead.|participant|Number|0|0.0||||||
4286424|NCT00550173|4111562|B2|3||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|ECOG PS Scale: 0 = fully active, able to perform all pre-disease activities unrestricted; 1 = restricted in physically strenuous activity but ambulatory, able to carry out light or sedentary activities; 2 = ambulatory, capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3 = capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4 = completely disabled, cannot carry on any self-care, totally confined to bed or chair; 5 = Dead.|participant|Number|0|0.0||||||
4286425|NCT00550173|4111563|B1|3||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|ECOG PS Scale: 0 = fully active, able to perform all pre-disease activities unrestricted; 1 = restricted in physically strenuous activity but ambulatory, able to carry out light or sedentary activities; 2 = ambulatory, capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3 = capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4 = completely disabled, cannot carry on any self-care, totally confined to bed or chair; 5 = Dead.|participant|Number|1|1.0||||||
4286426|NCT00550173|4111560|B4|2||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|ECOG PS Scale: 0 = fully active, able to perform all pre-disease activities unrestricted; 1 = restricted in physically strenuous activity but ambulatory, able to carry out light or sedentary activities; 2 = ambulatory, capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3 = capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4 = completely disabled, cannot carry on any self-care, totally confined to bed or chair; 5 = Dead.|participant|Number|16|16.0||||||
4286427|NCT00550173|4111561|B3|2||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|ECOG PS Scale: 0 = fully active, able to perform all pre-disease activities unrestricted; 1 = restricted in physically strenuous activity but ambulatory, able to carry out light or sedentary activities; 2 = ambulatory, capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3 = capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4 = completely disabled, cannot carry on any self-care, totally confined to bed or chair; 5 = Dead.|participant|Number|4|4.0||||||
4286428|NCT00550173|4111562|B2|2||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|ECOG PS Scale: 0 = fully active, able to perform all pre-disease activities unrestricted; 1 = restricted in physically strenuous activity but ambulatory, able to carry out light or sedentary activities; 2 = ambulatory, capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3 = capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4 = completely disabled, cannot carry on any self-care, totally confined to bed or chair; 5 = Dead.|participant|Number|6|6.0||||||
4286429|NCT00550173|4111563|B1|2||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|ECOG PS Scale: 0 = fully active, able to perform all pre-disease activities unrestricted; 1 = restricted in physically strenuous activity but ambulatory, able to carry out light or sedentary activities; 2 = ambulatory, capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3 = capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4 = completely disabled, cannot carry on any self-care, totally confined to bed or chair; 5 = Dead.|participant|Number|6|6.0||||||
4286430|NCT00550173|4111560|B4|1||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|ECOG PS Scale: 0 = fully active, able to perform all pre-disease activities unrestricted; 1 = restricted in physically strenuous activity but ambulatory, able to carry out light or sedentary activities; 2 = ambulatory, capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3 = capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4 = completely disabled, cannot carry on any self-care, totally confined to bed or chair; 5 = Dead.|participant|Number|177|177.0||||||
4286457|NCT00550173|4111563|B1|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4286458|NCT00550173|4111560|B4|Taiwan||Region of Enrollment||participants|Number|29|29.0||||||
4286459|NCT00550173|4111561|B3|Taiwan||Region of Enrollment||participants|Number|13|13.0||||||
4286460|NCT00550173|4111562|B2|Taiwan||Region of Enrollment||participants|Number|9|9.0||||||
4286431|NCT00550173|4111561|B3|1||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|ECOG PS Scale: 0 = fully active, able to perform all pre-disease activities unrestricted; 1 = restricted in physically strenuous activity but ambulatory, able to carry out light or sedentary activities; 2 = ambulatory, capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3 = capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4 = completely disabled, cannot carry on any self-care, totally confined to bed or chair; 5 = Dead.|participant|Number|60|60.0||||||
4286432|NCT00550173|4111562|B2|1||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|ECOG PS Scale: 0 = fully active, able to perform all pre-disease activities unrestricted; 1 = restricted in physically strenuous activity but ambulatory, able to carry out light or sedentary activities; 2 = ambulatory, capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3 = capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4 = completely disabled, cannot carry on any self-care, totally confined to bed or chair; 5 = Dead.|participant|Number|56|56.0||||||
4286433|NCT00550173|4111563|B1|1||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|ECOG PS Scale: 0 = fully active, able to perform all pre-disease activities unrestricted; 1 = restricted in physically strenuous activity but ambulatory, able to carry out light or sedentary activities; 2 = ambulatory, capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3 = capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4 = completely disabled, cannot carry on any self-care, totally confined to bed or chair; 5 = Dead.|participant|Number|61|61.0||||||
4286434|NCT00550173|4111560|B4|0||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|ECOG PS Scale: 0 = fully active, able to perform all pre-disease activities unrestricted; 1 = restricted in physically strenuous activity but ambulatory, able to carry out light or sedentary activities; 2 = ambulatory, capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3 = capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4 = completely disabled, cannot carry on any self-care, totally confined to bed or chair; 5 = Dead.|participant|Number|46|46.0||||||
4286435|NCT00550173|4111561|B3|0||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|ECOG PS Scale: 0 = fully active, able to perform all pre-disease activities unrestricted; 1 = restricted in physically strenuous activity but ambulatory, able to carry out light or sedentary activities; 2 = ambulatory, capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3 = capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4 = completely disabled, cannot carry on any self-care, totally confined to bed or chair; 5 = Dead.|participant|Number|16|16.0||||||
4286436|NCT00550173|4111562|B2|0||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|ECOG PS Scale: 0 = fully active, able to perform all pre-disease activities unrestricted; 1 = restricted in physically strenuous activity but ambulatory, able to carry out light or sedentary activities; 2 = ambulatory, capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3 = capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4 = completely disabled, cannot carry on any self-care, totally confined to bed or chair; 5 = Dead.|participant|Number|20|20.0||||||
4286437|NCT00550173|4111563|B1|0||Eastern Cooperative Oncology Group Performance Status (ECOG PS)|ECOG PS Scale: 0 = fully active, able to perform all pre-disease activities unrestricted; 1 = restricted in physically strenuous activity but ambulatory, able to carry out light or sedentary activities; 2 = ambulatory, capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3 = capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4 = completely disabled, cannot carry on any self-care, totally confined to bed or chair; 5 = Dead.|participant|Number|10|10.0||||||
4286438|NCT00550173|4111560|B4|||Body Surface Area (BSA)||meter squared (m^2)|Mean|1.6|1.6|Standard Deviation|0.17|0.17|||
4286439|NCT00550173|4111561|B3|||Body Surface Area (BSA)||meter squared (m^2)|Mean|1.6|1.6|Standard Deviation|0.17|0.17|||
4286440|NCT00550173|4111562|B2|||Body Surface Area (BSA)||meter squared (m^2)|Mean|1.6|1.6|Standard Deviation|0.18|0.18|||
4286441|NCT00550173|4111563|B1|||Body Surface Area (BSA)||meter squared (m^2)|Mean|1.6|1.6|Standard Deviation|0.17|0.17|||
4286442|NCT00550173|4111560|B4|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilogram per meter squared (kg/m^2)|Mean|23.2|23.2|Standard Deviation|4.09|4.09|||
4286443|NCT00550173|4111561|B3|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilogram per meter squared (kg/m^2)|Mean|23.0|23.0|Standard Deviation|3.87|3.87|||
4286444|NCT00550173|4111562|B2|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilogram per meter squared (kg/m^2)|Mean|23.3|23.3|Standard Deviation|3.87|3.87|||
4286445|NCT00550173|4111563|B1|||Body Mass Index (BMI)|BMI is an estimate of body fat based on body weight divided by height squared.|kilogram per meter squared (kg/m^2)|Mean|23.5|23.5|Standard Deviation|4.54|4.54|||
4286446|NCT00550173|4111560|B4|||Weight at Baseline||kilogram (kg)|Mean|59.5|59.5|Standard Deviation|11.56|11.56|||
4286447|NCT00550173|4111561|B3|||Weight at Baseline||kilogram (kg)|Mean|58.9|58.9|Standard Deviation|10.82|10.82|||
4286448|NCT00550173|4111562|B2|||Weight at Baseline||kilogram (kg)|Mean|59.9|59.9|Standard Deviation|12.17|12.17|||
4286449|NCT00550173|4111563|B1|||Weight at Baseline||kilogram (kg)|Mean|59.6|59.6|Standard Deviation|11.76|11.76|||
4286450|NCT00550173|4111560|B4|||Height at Baseline||centimeter (cm)|Mean|159.9|159.9|Standard Deviation|8.61|8.61|||
4286451|NCT00550173|4111561|B3|||Height at Baseline||centimeter (cm)|Mean|160.1|160.1|Standard Deviation|8.84|8.84|||
4286452|NCT00550173|4111562|B2|||Height at Baseline||centimeter (cm)|Mean|160.3|160.3|Standard Deviation|8.38|8.38|||
4286453|NCT00550173|4111563|B1|||Height at Baseline||centimeter (cm)|Mean|159.3|159.3|Standard Deviation|8.70|8.7|||
4286454|NCT00550173|4111560|B4|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
4286455|NCT00550173|4111561|B3|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4286456|NCT00550173|4111562|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4286461|NCT00550173|4111563|B1|Taiwan||Region of Enrollment||participants|Number|7|7.0||||||
4286462|NCT00550173|4111560|B4|Korea, Republic of||Region of Enrollment||participants|Number|53|53.0||||||
4286463|NCT00550173|4111561|B3|Korea, Republic of||Region of Enrollment||participants|Number|13|13.0||||||
4286464|NCT00550173|4111562|B2|Korea, Republic of||Region of Enrollment||participants|Number|20|20.0||||||
4286465|NCT00550173|4111563|B1|Korea, Republic of||Region of Enrollment||participants|Number|20|20.0||||||
4286466|NCT00550173|4111560|B4|India||Region of Enrollment||participants|Number|67|67.0||||||
4286467|NCT00550173|4111561|B3|India||Region of Enrollment||participants|Number|25|25.0||||||
4286468|NCT00550173|4111562|B2|India||Region of Enrollment||participants|Number|27|27.0||||||
4286469|NCT00550173|4111563|B1|India||Region of Enrollment||participants|Number|15|15.0||||||
4286470|NCT00550173|4111560|B4|Hong Kong||Region of Enrollment||participants|Number|5|5.0||||||
4286471|NCT00550173|4111561|B3|Hong Kong||Region of Enrollment||participants|Number|2|2.0||||||
4286472|NCT00550173|4111562|B2|Hong Kong||Region of Enrollment||participants|Number|3|3.0||||||
4286473|NCT00550173|4111563|B1|Hong Kong||Region of Enrollment||participants|Number|0|0.0||||||
4286474|NCT00550173|4111560|B4|China||Region of Enrollment||participants|Number|46|46.0||||||
4286475|NCT00550173|4111561|B3|China||Region of Enrollment||participants|Number|15|15.0||||||
4286476|NCT00550173|4111562|B2|China||Region of Enrollment||participants|Number|17|17.0||||||
4286477|NCT00550173|4111563|B1|China||Region of Enrollment||participants|Number|14|14.0||||||
4286478|NCT00550173|4111560|B4|Brazil||Region of Enrollment||participants|Number|28|28.0||||||
4286479|NCT00550173|4111561|B3|Brazil||Region of Enrollment||participants|Number|8|8.0||||||
4286480|NCT00550173|4111562|B2|Brazil||Region of Enrollment||participants|Number|5|5.0||||||
4286481|NCT00550173|4111563|B1|Brazil||Region of Enrollment||participants|Number|15|15.0||||||
4286482|NCT00550173|4111560|B4|Australia||Region of Enrollment||participants|Number|3|3.0||||||
4286483|NCT00550173|4111561|B3|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4286484|NCT00550173|4111562|B2|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4286485|NCT00550173|4111563|B1|Australia||Region of Enrollment||participants|Number|3|3.0||||||
4286486|NCT00550173|4111560|B4|West Asian||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
4286487|NCT00550173|4111561|B3|West Asian||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4286488|NCT00550173|4111562|B2|West Asian||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4286489|NCT00550173|4111563|B1|West Asian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4286490|NCT00550173|4111560|B4|East Asian (enrolled in non-East Asian Country)||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4286491|NCT00550173|4111561|B3|East Asian (enrolled in non-East Asian Country)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4286492|NCT00550173|4111562|B2|East Asian (enrolled in non-East Asian Country)||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4286493|NCT00550173|4111563|B1|East Asian (enrolled in non-East Asian Country)||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4286494|NCT00550173|4111560|B4|East Asian (enrolled in an East Asian country)||Race/Ethnicity, Customized||participants|Number|133|133.0||||||
4286495|NCT00550173|4111561|B3|East Asian (enrolled in an East Asian country)||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4286496|NCT00550173|4111562|B2|East Asian (enrolled in an East Asian country)||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4286497|NCT00550173|4111563|B1|East Asian (enrolled in an East Asian country)||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4286498|NCT00550173|4111560|B4|African||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4286499|NCT00550173|4111561|B3|African||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4286500|NCT00550173|4111562|B2|African||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4286501|NCT00550173|4111563|B1|African||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4286502|NCT00550173|4111560|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4286503|NCT00550173|4111561|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4286504|NCT00550173|4111562|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4286505|NCT00550173|4111563|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4286506|NCT00550173|4111560|B4||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4286507|NCT00550173|4111561|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4286508|NCT00550173|4111562|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4286509|NCT00550173|4111563|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4286510|NCT00550173|4111560|B4||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4286511|NCT00550173|4111561|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4286512|NCT00550173|4111562|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4286513|NCT00550173|4111563|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4286514|NCT00550173|4111560|B4|||Age||years|Mean|55.3|55.3|Standard Deviation|11.78|11.78|||
4286515|NCT00550173|4111561|B3|||Age||years|Mean|56.1|56.1|Standard Deviation|13.04|13.04|||
4286516|NCT00550173|4111562|B2|||Age||years|Mean|53.9|53.9|Standard Deviation|10.49|10.49|||
4286517|NCT00550173|4111563|B1|||Age||years|Mean|56.0|56.0|Standard Deviation|11.72|11.72|||
4286518|NCT00550147|4111594|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4286519|NCT00550147|4111594|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4286520|NCT00550147|4111594|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4286521|NCT00550147|4111594|B1|||Age||years|Mean|13.2|13.2|Standard Deviation|1.2|1.2|||
4286522|NCT00550147|4111594|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4286523|NCT00550147|4111594|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4286524|NCT00550147|4111594|B1||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4286525|NCT00550043|4111612|B6||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4286526|NCT00550043|4111613|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4286527|NCT00550043|4111614|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4286528|NCT00550043|4111615|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4286529|NCT00550043|4111616|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4286530|NCT00550043|4111617|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4286531|NCT00550043|4111612|B6||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4286532|NCT00550043|4111613|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4286533|NCT00550043|4111614|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4286534|NCT00550043|4111615|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4286535|NCT00550043|4111616|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4286536|NCT00550043|4111617|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4286537|NCT00550043|4111612|B6|||Age||years|Mean|54.9|54.9|Standard Deviation|11.23|11.23|||
4286538|NCT00550043|4111613|B5|||Age||years|Mean|54.5|54.5|Standard Deviation|14.14|14.14|||
4286539|NCT00550043|4111614|B4|||Age||years|Mean|57.5|57.5|Standard Deviation|11.29|11.29|||
4286540|NCT00550043|4111615|B3|||Age||years|Mean|49.6|49.6|Standard Deviation|10.69|10.69|||
4286541|NCT00550043|4111616|B2|||Age||years|Mean|56.9|56.9|Standard Deviation|8.44|8.44|||
4286542|NCT00550043|4111617|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|12.04|12.04|||
4286543|NCT00549939|4111673|B4|Tablets (8-16 years)||Study drug formulation||participants|Number|61|61.0||||||
4286544|NCT00549939|4111674|B3|Tablets (8-16 years)||Study drug formulation||participants|Number|21|21.0||||||
4286545|NCT00549939|4111675|B2|Tablets (8-16 years)||Study drug formulation||participants|Number|19|19.0||||||
4286546|NCT00549939|4111676|B1|Tablets (8-16 years)||Study drug formulation||participants|Number|21|21.0||||||
4286547|NCT00549939|4111673|B4|Solution (8-16 years)||Study drug formulation||participants|Number|27|27.0||||||
4286548|NCT00549939|4111674|B3|Solution (8-16 years)||Study drug formulation||participants|Number|9|9.0||||||
4286549|NCT00549939|4111675|B2|Solution (8-16 years)||Study drug formulation||participants|Number|10|10.0||||||
4286550|NCT00549939|4111676|B1|Solution (8-16 years)||Study drug formulation||participants|Number|8|8.0||||||
4286551|NCT00549939|4111673|B4|Solution (2-7 years)||Study drug formulation||participants|Number|84|84.0||||||
4286552|NCT00549939|4111674|B3|Solution (2-7 years)||Study drug formulation||participants|Number|28|28.0||||||
4286553|NCT00549939|4111675|B2|Solution (2-7 years)||Study drug formulation||participants|Number|28|28.0||||||
4286554|NCT00549939|4111676|B1|Solution (2-7 years)||Study drug formulation||participants|Number|28|28.0||||||
4286555|NCT00549939|4111673|B4|Two UTI episodes||Urinary Tract Infection (UTI) history in the last 3 months||participants|Number|5|5.0||||||
4286556|NCT00549939|4111674|B3|Two UTI episodes||Urinary Tract Infection (UTI) history in the last 3 months||participants|Number|2|2.0||||||
4286557|NCT00549939|4111675|B2|Two UTI episodes||Urinary Tract Infection (UTI) history in the last 3 months||participants|Number|2|2.0||||||
4286558|NCT00549939|4111676|B1|Two UTI episodes||Urinary Tract Infection (UTI) history in the last 3 months||participants|Number|1|1.0||||||
4286559|NCT00549939|4111673|B4|One UTI episode||Urinary Tract Infection (UTI) history in the last 3 months||participants|Number|29|29.0||||||
4286560|NCT00549939|4111674|B3|One UTI episode||Urinary Tract Infection (UTI) history in the last 3 months||participants|Number|16|16.0||||||
4286561|NCT00549939|4111675|B2|One UTI episode||Urinary Tract Infection (UTI) history in the last 3 months||participants|Number|5|5.0||||||
4286562|NCT00549939|4111676|B1|One UTI episode||Urinary Tract Infection (UTI) history in the last 3 months||participants|Number|8|8.0||||||
4286563|NCT00549939|4111673|B4|No UTI episode||Urinary Tract Infection (UTI) history in the last 3 months||participants|Number|138|138.0||||||
4286564|NCT00549939|4111674|B3|No UTI episode||Urinary Tract Infection (UTI) history in the last 3 months||participants|Number|40|40.0||||||
4286565|NCT00549939|4111675|B2|No UTI episode||Urinary Tract Infection (UTI) history in the last 3 months||participants|Number|50|50.0||||||
4286566|NCT00549939|4111676|B1|No UTI episode||Urinary Tract Infection (UTI) history in the last 3 months||participants|Number|48|48.0||||||
4286567|NCT00549939|4111673|B4|Germany||Region of Enrollment||participants|Number|5|5.0||||||
4286568|NCT00549939|4111674|B3|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4286569|NCT00549939|4111675|B2|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4286570|NCT00549939|4111676|B1|Germany||Region of Enrollment||participants|Number|3|3.0||||||
4286571|NCT00549939|4111673|B4|Poland||Region of Enrollment||participants|Number|39|39.0||||||
4286572|NCT00549939|4111674|B3|Poland||Region of Enrollment||participants|Number|14|14.0||||||
4286573|NCT00549939|4111675|B2|Poland||Region of Enrollment||participants|Number|10|10.0||||||
4286574|NCT00549939|4111676|B1|Poland||Region of Enrollment||participants|Number|15|15.0||||||
4286575|NCT00549939|4111673|B4|Malaysia||Region of Enrollment||participants|Number|3|3.0||||||
4286576|NCT00549939|4111674|B3|Malaysia||Region of Enrollment||participants|Number|0|0.0||||||
4286577|NCT00549939|4111675|B2|Malaysia||Region of Enrollment||participants|Number|0|0.0||||||
4286578|NCT00549939|4111676|B1|Malaysia||Region of Enrollment||participants|Number|3|3.0||||||
4286579|NCT00549939|4111673|B4|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4286580|NCT00549939|4111674|B3|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4286581|NCT00549939|4111675|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4286582|NCT00549939|4111676|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4286583|NCT00549939|4111673|B4|France||Region of Enrollment||participants|Number|7|7.0||||||
4286584|NCT00549939|4111674|B3|France||Region of Enrollment||participants|Number|4|4.0||||||
4286585|NCT00549939|4111675|B2|France||Region of Enrollment||participants|Number|2|2.0||||||
4286586|NCT00549939|4111676|B1|France||Region of Enrollment||participants|Number|1|1.0||||||
4286587|NCT00549939|4111673|B4|India||Region of Enrollment||participants|Number|20|20.0||||||
4286588|NCT00549939|4111674|B3|India||Region of Enrollment||participants|Number|9|9.0||||||
4286589|NCT00549939|4111675|B2|India||Region of Enrollment||participants|Number|9|9.0||||||
4286590|NCT00549939|4111676|B1|India||Region of Enrollment||participants|Number|2|2.0||||||
4286591|NCT00549939|4111673|B4|Russian Federation||Region of Enrollment||participants|Number|19|19.0||||||
4286592|NCT00549939|4111674|B3|Russian Federation||Region of Enrollment||participants|Number|4|4.0||||||
4286593|NCT00549939|4111675|B2|Russian Federation||Region of Enrollment||participants|Number|7|7.0||||||
4286594|NCT00549939|4111676|B1|Russian Federation||Region of Enrollment||participants|Number|8|8.0||||||
4286595|NCT00549939|4111673|B4|Turkey||Region of Enrollment||participants|Number|6|6.0||||||
4286596|NCT00549939|4111674|B3|Turkey||Region of Enrollment||participants|Number|3|3.0||||||
4286597|NCT00549939|4111675|B2|Turkey||Region of Enrollment||participants|Number|2|2.0||||||
4286598|NCT00549939|4111676|B1|Turkey||Region of Enrollment||participants|Number|1|1.0||||||
4286599|NCT00549939|4111673|B4|Spain||Region of Enrollment||participants|Number|7|7.0||||||
4286600|NCT00549939|4111674|B3|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4286601|NCT00549939|4111675|B2|Spain||Region of Enrollment||participants|Number|3|3.0||||||
4286602|NCT00549939|4111676|B1|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4286603|NCT00549939|4111673|B4|Slovakia||Region of Enrollment||participants|Number|14|14.0||||||
4286604|NCT00549939|4111674|B3|Slovakia||Region of Enrollment||participants|Number|1|1.0||||||
4286605|NCT00549939|4111675|B2|Slovakia||Region of Enrollment||participants|Number|7|7.0||||||
4286606|NCT00549939|4111676|B1|Slovakia||Region of Enrollment||participants|Number|6|6.0||||||
4286607|NCT00549939|4111673|B4|Estonia||Region of Enrollment||participants|Number|3|3.0||||||
4286608|NCT00549939|4111674|B3|Estonia||Region of Enrollment||participants|Number|1|1.0||||||
4286609|NCT00549939|4111675|B2|Estonia||Region of Enrollment||participants|Number|1|1.0||||||
4286610|NCT00549939|4111676|B1|Estonia||Region of Enrollment||participants|Number|1|1.0||||||
4286611|NCT00549939|4111673|B4|Taiwan||Region of Enrollment||participants|Number|2|2.0||||||
4286612|NCT00549939|4111674|B3|Taiwan||Region of Enrollment||participants|Number|1|1.0||||||
4286613|NCT00549939|4111675|B2|Taiwan||Region of Enrollment||participants|Number|1|1.0||||||
4286614|NCT00549939|4111676|B1|Taiwan||Region of Enrollment||participants|Number|0|0.0||||||
4286615|NCT00549939|4111673|B4|Serbia||Region of Enrollment||participants|Number|17|17.0||||||
4286616|NCT00549939|4111674|B3|Serbia||Region of Enrollment||participants|Number|7|7.0||||||
4286617|NCT00549939|4111675|B2|Serbia||Region of Enrollment||participants|Number|6|6.0||||||
4286618|NCT00549939|4111676|B1|Serbia||Region of Enrollment||participants|Number|4|4.0||||||
4286619|NCT00549939|4111673|B4|Portugal||Region of Enrollment||participants|Number|6|6.0||||||
4286620|NCT00549939|4111674|B3|Portugal||Region of Enrollment||participants|Number|3|3.0||||||
4286621|NCT00549939|4111675|B2|Portugal||Region of Enrollment||participants|Number|1|1.0||||||
4286622|NCT00549939|4111676|B1|Portugal||Region of Enrollment||participants|Number|2|2.0||||||
4286623|NCT00549939|4111673|B4|United States||Region of Enrollment||participants|Number|18|18.0||||||
4286624|NCT00549939|4111674|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4286625|NCT00549939|4111675|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4286626|NCT00549939|4111676|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4286627|NCT00549939|4111673|B4||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4286628|NCT00549939|4111674|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4286629|NCT00549939|4111675|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4286630|NCT00549939|4111676|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4286631|NCT00549939|4111673|B4||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4286632|NCT00549939|4111674|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4286633|NCT00549939|4111675|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4286634|NCT00549939|4111676|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4286635|NCT00549939|4111673|B4|||Age||years|Mean|8.3|8.3|Standard Deviation|4.0|4.0|||
4286636|NCT00549939|4111674|B3|||Age||years|Mean|8.7|8.7|Standard Deviation|3.9|3.9|||
4286637|NCT00549939|4111675|B2|||Age||years|Mean|7.9|7.9|Standard Deviation|3.9|3.9|||
4286638|NCT00549939|4111676|B1|||Age||years|Mean|8.3|8.3|Standard Deviation|4.4|4.4|||
4286639|NCT00549900|4111705|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4286640|NCT00549900|4111705|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4286641|NCT00549900|4111705|B1|||Age||years|Mean|28.0|28.0|Standard Deviation|9.03|9.03|||
4286642|NCT00549822|4111714|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4286643|NCT00549822|4111714|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286644|NCT00549822|4111714|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286645|NCT00549822|4111714|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4286646|NCT00549822|4111714|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286647|NCT00549822|4111714|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286648|NCT00549822|4111714|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286649|NCT00549822|4111714|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286650|NCT00549822|4111714|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286651|NCT00549822|4111714|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4286652|NCT00549822|4111714|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286653|NCT00549822|4111714|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4286654|NCT00549822|4111714|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4286655|NCT00549822|4111714|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4286656|NCT00549822|4111714|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4286657|NCT00549822|4111714|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4286658|NCT00549783|4111720|B3||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4286659|NCT00549783|4111721|B2||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4286660|NCT00549783|4111722|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4286661|NCT00549783|4111720|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4286662|NCT00549783|4111721|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4286663|NCT00549783|4111722|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4286664|NCT00549783|4111720|B3|||Age||years|Median|62.60|62.6|Full Range|||22.6|82.4|
4286665|NCT00549783|4111721|B2|||Age||years|Median|61.86|61.86|Full Range|||26.8|82.4|
4286666|NCT00549783|4111722|B1|||Age||years|Median|64.11|64.11|Full Range|||22.6|81.2|
4286667|NCT00549770|4111753|B9||Male|Sex: Female, Male||Participants|Count of Participants|760|760.0||||||
4286668|NCT00549770|4111754|B8||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4286669|NCT00549770|4111755|B7||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4286670|NCT00549770|4111756|B6||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4286671|NCT00549770|4111757|B5||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4286672|NCT00549770|4111758|B4||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4286673|NCT00549770|4111759|B3||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4286674|NCT00549770|4111760|B2||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4286675|NCT00549770|4111761|B1||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4286676|NCT00549770|4111753|B9||Female|Sex: Female, Male||Participants|Count of Participants|568|568.0||||||
4286677|NCT00549770|4111754|B8||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4286678|NCT00549770|4111755|B7||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4286679|NCT00549770|4111756|B6||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4286680|NCT00549770|4111757|B5||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4286681|NCT00549770|4111758|B4||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4286682|NCT00549770|4111759|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4286683|NCT00549770|4111760|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4286684|NCT00549770|4111761|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4286685|NCT00549770|4111753|B9|||Age||years|Mean|53|53.0|Standard Deviation|10.2|10.2|||
4286686|NCT00549770|4111754|B8|||Age||years|Mean|54|54.0|Standard Deviation|10.6|10.6|||
4286687|NCT00549770|4111755|B7|||Age||years|Mean|53|53.0|Standard Deviation|10.7|10.7|||
4286688|NCT00549770|4111756|B6|||Age||years|Mean|53|53.0|Standard Deviation|10.1|10.1|||
4286689|NCT00549770|4111757|B5|||Age||years|Mean|53|53.0|Standard Deviation|9.7|9.7|||
4286690|NCT00549770|4111758|B4|||Age||years|Mean|53|53.0|Standard Deviation|9.6|9.6|||
4286691|NCT00549770|4111759|B3|||Age||years|Mean|52|52.0|Standard Deviation|10.9|10.9|||
4286692|NCT00549770|4111760|B2|||Age||years|Mean|54|54.0|Standard Deviation|9.7|9.7|||
4286693|NCT00549770|4111761|B1|||Age||years|Mean|53|53.0|Standard Deviation|10.4|10.4|||
4286694|NCT00549757|4111850|B3||Male|Sex: Female, Male||Participants|Count of Participants|5826|5826.0||||||
4286695|NCT00549757|4111851|B2||Male|Sex: Female, Male||Participants|Count of Participants|2945|2945.0||||||
4286696|NCT00549757|4111852|B1||Male|Sex: Female, Male||Participants|Count of Participants|2881|2881.0||||||
4286697|NCT00549757|4111850|B3||Female|Sex: Female, Male||Participants|Count of Participants|2735|2735.0||||||
4286698|NCT00549757|4111851|B2||Female|Sex: Female, Male||Participants|Count of Participants|1342|1342.0||||||
4286699|NCT00549757|4111852|B1||Female|Sex: Female, Male||Participants|Count of Participants|1393|1393.0||||||
4286700|NCT00549757|4111850|B3|||Age||Years|Mean|64.5|64.5|Standard Deviation|9.75|9.75|||
4286701|NCT00549757|4111851|B2|||Age||Years|Mean|64.4|64.4|Standard Deviation|9.87|9.87|||
4286702|NCT00549757|4111852|B1|||Age||Years|Mean|64.6|64.6|Standard Deviation|9.62|9.62|||
4286703|NCT00549718|4111911|B5|India||Region of Enrollment||participants|Number|63|63.0||||||
4286704|NCT00549718|4111912|B4|India||Region of Enrollment||participants|Number|16|16.0||||||
4286705|NCT00549718|4111913|B3|India||Region of Enrollment||participants|Number|17|17.0||||||
4286706|NCT00549718|4111914|B2|India||Region of Enrollment||participants|Number|16|16.0||||||
4286707|NCT00549718|4111915|B1|India||Region of Enrollment||participants|Number|14|14.0||||||
4286708|NCT00549718|4111911|B5|Russian Federation||Region of Enrollment||participants|Number|57|57.0||||||
4286709|NCT00549718|4111912|B4|Russian Federation||Region of Enrollment||participants|Number|15|15.0||||||
4286710|NCT00549718|4111913|B3|Russian Federation||Region of Enrollment||participants|Number|13|13.0||||||
4286711|NCT00549718|4111914|B2|Russian Federation||Region of Enrollment||participants|Number|15|15.0||||||
4286712|NCT00549718|4111915|B1|Russian Federation||Region of Enrollment||participants|Number|14|14.0||||||
4286713|NCT00549718|4111911|B5|Romania||Region of Enrollment||participants|Number|36|36.0||||||
4286714|NCT00549718|4111912|B4|Romania||Region of Enrollment||participants|Number|9|9.0||||||
4286715|NCT00549718|4111913|B3|Romania||Region of Enrollment||participants|Number|9|9.0||||||
4286716|NCT00549718|4111914|B2|Romania||Region of Enrollment||participants|Number|9|9.0||||||
4286717|NCT00549718|4111915|B1|Romania||Region of Enrollment||participants|Number|9|9.0||||||
4286718|NCT00549718|4111911|B5|Ukraine||Region of Enrollment||participants|Number|51|51.0||||||
4286719|NCT00549718|4111912|B4|Ukraine||Region of Enrollment||participants|Number|14|14.0||||||
4286720|NCT00549718|4111913|B3|Ukraine||Region of Enrollment||participants|Number|12|12.0||||||
4286721|NCT00549718|4111914|B2|Ukraine||Region of Enrollment||participants|Number|12|12.0||||||
4286722|NCT00549718|4111915|B1|Ukraine||Region of Enrollment||participants|Number|13|13.0||||||
4286723|NCT00549718|4111911|B5|Malaysia||Region of Enrollment||participants|Number|8|8.0||||||
4286724|NCT00549718|4111912|B4|Malaysia||Region of Enrollment||participants|Number|2|2.0||||||
4286725|NCT00549718|4111913|B3|Malaysia||Region of Enrollment||participants|Number|2|2.0||||||
4286726|NCT00549718|4111914|B2|Malaysia||Region of Enrollment||participants|Number|2|2.0||||||
4286727|NCT00549718|4111915|B1|Malaysia||Region of Enrollment||participants|Number|2|2.0||||||
4286728|NCT00549718|4111911|B5|United States||Region of Enrollment||participants|Number|271|271.0||||||
4286729|NCT00549718|4111912|B4|United States||Region of Enrollment||participants|Number|67|67.0||||||
4286730|NCT00549718|4111913|B3|United States||Region of Enrollment||participants|Number|70|70.0||||||
4286731|NCT00549718|4111914|B2|United States||Region of Enrollment||participants|Number|64|64.0||||||
4286732|NCT00549718|4111915|B1|United States||Region of Enrollment||participants|Number|70|70.0||||||
4286733|NCT00549718|4111911|B5|France||Region of Enrollment||participants|Number|3|3.0||||||
4286734|NCT00549718|4111912|B4|France||Region of Enrollment||participants|Number|1|1.0||||||
4286735|NCT00549718|4111913|B3|France||Region of Enrollment||participants|Number|1|1.0||||||
4286736|NCT00549718|4111914|B2|France||Region of Enrollment||participants|Number|1|1.0||||||
4286737|NCT00549718|4111915|B1|France||Region of Enrollment||participants|Number|0|0.0||||||
4286738|NCT00549718|4111911|B5||Male|Sex: Female, Male||Participants|Count of Participants|340|340.0||||||
4286739|NCT00549718|4111912|B4||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4286740|NCT00549718|4111913|B3||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4286741|NCT00549718|4111914|B2||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4286742|NCT00549718|4111915|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4286743|NCT00549718|4111911|B5||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4286744|NCT00549718|4111912|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4286745|NCT00549718|4111913|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4286746|NCT00549718|4111914|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4286747|NCT00549718|4111915|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4286748|NCT00549718|4111911|B5|||Age||years|Mean|38.8|38.8|Standard Deviation|10.5|10.5|||
4286749|NCT00549718|4111912|B4|||Age||years|Mean|38.2|38.2|Standard Deviation|9.9|9.9|||
4286750|NCT00549718|4111913|B3|||Age||years|Mean|37.7|37.7|Standard Deviation|11.2|11.2|||
4286751|NCT00549718|4111914|B2|||Age||years|Mean|38.6|38.6|Standard Deviation|9.5|9.5|||
4286752|NCT00549718|4111915|B1|||Age||years|Mean|40.7|40.7|Standard Deviation|11.1|11.1|||
4286753|NCT00549640|4111932|B3|||Cigarettes Per Day|Self-reported number of cigarettes smoked per day|cigarettes per day|Mean|20.2|20.2|Standard Deviation|7.8|7.8|||
4286754|NCT00549640|4111933|B2|||Cigarettes Per Day|Self-reported number of cigarettes smoked per day|cigarettes per day|Mean|20.8|20.8|Standard Deviation|8.2|8.2|||
4286755|NCT00549640|4111934|B1|||Cigarettes Per Day|Self-reported number of cigarettes smoked per day|cigarettes per day|Mean|19.7|19.7|Standard Deviation|7.4|7.4|||
4286756|NCT00549640|4111932|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
4286757|NCT00549640|4111933|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4286758|NCT00549640|4111934|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4286759|NCT00549640|4111932|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4286760|NCT00549640|4111933|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4286761|NCT00549640|4111934|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4286762|NCT00549640|4111932|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4286763|NCT00549640|4111933|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4286764|NCT00549640|4111934|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4286765|NCT00549640|4111932|B3|||Age||years|Mean|36.8|36.8|Standard Deviation|11.5|11.5|||
4286766|NCT00549640|4111933|B2|||Age||years|Mean|38.0|38.0|Standard Deviation|11.9|11.9|||
4286767|NCT00549640|4111934|B1|||Age||years|Mean|35.6|35.6|Standard Deviation|11.0|11.0|||
4286768|NCT00549640|4111932|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4286769|NCT00549640|4111933|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4286770|NCT00549640|4111934|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4286771|NCT00549640|4111932|B3||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
4286772|NCT00549640|4111933|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4286773|NCT00549640|4111934|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4286774|NCT00549640|4111932|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4286775|NCT00549640|4111933|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4286776|NCT00549640|4111934|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4286777|NCT00549601|4111945|B4||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4286778|NCT00549601|4111946|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4286779|NCT00549601|4111947|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4286780|NCT00549601|4111948|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4286781|NCT00549601|4111945|B4||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4286782|NCT00549601|4111946|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4286783|NCT00549601|4111947|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4286784|NCT00549601|4111948|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4286785|NCT00549601|4111945|B4|||Age||years|Mean|76.58|76.58|Standard Deviation|6.37|6.37|||
4286786|NCT00549601|4111946|B3|||Age||years|Mean|77.35|77.35|Standard Deviation|6.62|6.62|||
4286787|NCT00549601|4111947|B2|||Age||years|Mean|75.34|75.34|Standard Deviation|7.25|7.25|||
4286788|NCT00549601|4111948|B1|||Age||years|Mean|77.05|77.05|Standard Deviation|4.82|4.82|||
4286789|NCT00549562|4111972|B1|VABS Maladaptive Behavior Subscale Total||The Vineland Adaptive Behavior Scales (VABS) - Maladaptive Behavior Domain|The VABS Maladaptive Behavior Domain measures undesirable behaviors that may interfere with an individual's adaptive functioning. The Maladaptive Domain consists two parts. Part I contains 27 minor maladaptive items and Part II contains 9 serious maladaptive behaviors. Each item is scored from 0 (never or seldom engages in the activity) to 2(usually or habitually engages in the activity). Part 1 yields a score of 0 to 54. Part II yields a score of 0 to 18. Both parts are combined to make a Total Score of 0 to 72. High scores of maladaptive behaviors reflect more negative behavior.|units on a scale|Mean|37.4|37.4|Standard Deviation|8.2|8.2|||
4286790|NCT00549562|4111972|B1|VABS Maladaptive Behavior Subscale Part II||The Vineland Adaptive Behavior Scales (VABS) - Maladaptive Behavior Domain|The VABS Maladaptive Behavior Domain measures undesirable behaviors that may interfere with an individual's adaptive functioning. The Maladaptive Domain consists two parts. Part I contains 27 minor maladaptive items and Part II contains 9 serious maladaptive behaviors. Each item is scored from 0 (never or seldom engages in the activity) to 2(usually or habitually engages in the activity). Part 1 yields a score of 0 to 54. Part II yields a score of 0 to 18. Both parts are combined to make a Total Score of 0 to 72. High scores of maladaptive behaviors reflect more negative behavior.|units on a scale|Mean|8.8|8.8|Standard Deviation|6.4|6.4|||
4286791|NCT00549562|4111972|B1|VABS Maladaptive Behavior Subscale Part I||The Vineland Adaptive Behavior Scales (VABS) - Maladaptive Behavior Domain|The VABS Maladaptive Behavior Domain measures undesirable behaviors that may interfere with an individual's adaptive functioning. The Maladaptive Domain consists two parts. Part I contains 27 minor maladaptive items and Part II contains 9 serious maladaptive behaviors. Each item is scored from 0 (never or seldom engages in the activity) to 2(usually or habitually engages in the activity). Part 1 yields a score of 0 to 54. Part II yields a score of 0 to 18. Both parts are combined to make a Total Score of 0 to 72. High scores of maladaptive behaviors reflect more negative behavior.|units on a scale|Mean|28.9|28.9|Standard Deviation|6.3|6.3|||
4286792|NCT00549562|4111972|B1|||The Social Responsiveness Scale|The Social Responsiveness Scale (SRS) is a 65-item parent completed scale that assesses social awareness, social cognition, social communication, social motivation and autistic mannerisms. Each item is scored from 1 (not true) to 3 (almost always true). Interpretation in this study is based on a total score that is proportional to the level of impairment in reciprocal social behavior. Scores within 0-53 are within normal limits. Scores within 54-86 indicate mild to moderate impairment. Scores above 87 indicate severe impairment.|units on a scale|Mean|122.6|122.6|Standard Deviation|18.4|18.4|||
4286793|NCT00549562|4111972|B1|||Children's Yale-Brown Obsessive Compulsive Scale Modified for Pervasive Developmental Disorders|The Children's Yale-Brown Obsessive Compulsive Scale Modified for Pervasive Developmental Disorders (CY-BOCS-PDD) is semi-structured clinician rating scale designed to rate the current severity of repetitive behavior in children and adolescents with PDD. The scale consists of 5 items: Time Spent, Interference, Distress, Resistance and Control. Each item is scored from 0 (None) to 4 (Extreme). The scale yields a Total Score from 0 (least symptomatic) to 20 (most symptomatic). Higher scores indicate greater severity of repetitive behavior.|units on a scale|Mean|16|16.0|Standard Deviation|3|3.0|||
4286794|NCT00549562|4111972|B1|ABC-Inappropriate Speech||The Aberrant Behavior Checklist|The Aberrant Behavior Checklist (ABC) is a 58-item measure of maladaptive behaviors and is used as a measure of drug effects. The ABC has 5 subscales:Irritability (15 items) ranging from 0 (not at all) to 45 (severe), Hyperactivity (16 items) ranging from 0 (not at all) to 48 (severe), Social Withdrawal (16 items) ranging from 0 (not at all) to 48 (severe), Stereotypy (7 items) ranging from 0 (not at all) to 21 (severe) and Inappropriate Speech (4 items) ranging from 0 (not at all) to 12 (severe). Items are rated from 0 (not at all) to 3 (severe).|units on a scale|Mean|7.5|7.5|Standard Deviation|4.4|4.4|||
4286835|NCT00549549|4111983|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4286836|NCT00549549|4111984|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4286837|NCT00549549|4111980|B5|>=65 years||Age, Customized||Participants|Number|59|59.0||||||
4286838|NCT00549549|4111981|B4|>=65 years||Age, Customized||Participants|Number|14|14.0||||||
4286839|NCT00549549|4111982|B3|>=65 years||Age, Customized||Participants|Number|12|12.0||||||
4286795|NCT00549562|4111972|B1|ABC-Stereotypy||The Aberrant Behavior Checklist|The Aberrant Behavior Checklist (ABC) is a 58-item measure of maladaptive behaviors and is used as a measure of drug effects. The ABC has 5 subscales:Irritability (15 items) ranging from 0 (not at all) to 45 (severe), Hyperactivity (16 items) ranging from 0 (not at all) to 48 (severe), Social Withdrawal (16 items) ranging from 0 (not at all) to 48 (severe), Stereotypy (7 items) ranging from 0 (not at all) to 21 (severe) and Inappropriate Speech (4 items) ranging from 0 (not at all) to 12 (severe). Items are rated from 0 (not at all) to 3 (severe).|units on a scale|Mean|12.5|12.5|Standard Deviation|6.7|6.7|||
4286796|NCT00549562|4111972|B1|ABC-Social Withdrawal||The Aberrant Behavior Checklist|The Aberrant Behavior Checklist (ABC) is a 58-item measure of maladaptive behaviors and is used as a measure of drug effects. The ABC has 5 subscales:Irritability (15 items) ranging from 0 (not at all) to 45 (severe), Hyperactivity (16 items) ranging from 0 (not at all) to 48 (severe), Social Withdrawal (16 items) ranging from 0 (not at all) to 48 (severe), Stereotypy (7 items) ranging from 0 (not at all) to 21 (severe) and Inappropriate Speech (4 items) ranging from 0 (not at all) to 12 (severe). Items are rated from 0 (not at all) to 3 (severe).|units on a scale|Mean|17.2|17.2|Standard Deviation|12.5|12.5|||
4286797|NCT00549562|4111972|B1|ABC-Hyperactivity||The Aberrant Behavior Checklist|The Aberrant Behavior Checklist (ABC) is a 58-item measure of maladaptive behaviors and is used as a measure of drug effects. The ABC has 5 subscales:Irritability (15 items) ranging from 0 (not at all) to 45 (severe), Hyperactivity (16 items) ranging from 0 (not at all) to 48 (severe), Social Withdrawal (16 items) ranging from 0 (not at all) to 48 (severe), Stereotypy (7 items) ranging from 0 (not at all) to 21 (severe) and Inappropriate Speech (4 items) ranging from 0 (not at all) to 12 (severe). Items are rated from 0 (not at all) to 3 (severe).|units on a scale|Mean|34.7|34.7|Standard Deviation|8.9|8.9|||
4286798|NCT00549562|4111972|B1|ABC-Irritability||The Aberrant Behavior Checklist|The Aberrant Behavior Checklist (ABC) is a 58-item measure of maladaptive behaviors and is used as a measure of drug effects. The ABC has 5 subscales:Irritability (15 items) ranging from 0 (not at all) to 45 (severe), Hyperactivity (16 items) ranging from 0 (not at all) to 48 (severe), Social Withdrawal (16 items) ranging from 0 (not at all) to 48 (severe), Stereotypy (7 items) ranging from 0 (not at all) to 21 (severe) and Inappropriate Speech (4 items) ranging from 0 (not at all) to 12 (severe). Items are rated from 0 (not at all) to 3 (severe).|units on a scale|Mean|30.3|30.3|Standard Deviation|6.5|6.5|||
4286799|NCT00549562|4111972|B1|||Clinical Global Impressions-Improvement (CGI-I)|The CGI Global Improvement (CGI-I) is a clinician-rate scale designed to take into account all factors to arrive at an assessment of severity and response to treatment, including parent report, parent-rated measures, teacher-rated measures, and clinician-rated measures. The CGI-I is rated from 1 to 7 (1 = very much improved; 2 = much improved; 3 = minimally improved; 4 = no change; 5 = minimally worse; 6 = much worse; 7 = very much worse) at a single time-point.|units on a scale|Mean|4.0|4.0|Standard Deviation|0.0|0.0|||
4286800|NCT00549562|4111972|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4286801|NCT00549562|4111972|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4286802|NCT00549562|4111972|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4286803|NCT00549562|4111972|B1|||Age||Years|Mean|15.36|15.36|Full Range|||12.0|21.0|
4286804|NCT00549562|4111972|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4286805|NCT00549562|4111972|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4286806|NCT00549562|4111972|B1||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
4286807|NCT00549549|4111980|B5|Other||Race/Ethnicity, Customized||Participants|Number|63|63.0||||||
4286808|NCT00549549|4111981|B4|Other||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4286809|NCT00549549|4111982|B3|Other||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4286810|NCT00549549|4111983|B2|Other||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4286811|NCT00549549|4111984|B1|Other||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4286812|NCT00549549|4111980|B5|Asian||Race/Ethnicity, Customized||Participants|Number|78|78.0||||||
4286813|NCT00549549|4111981|B4|Asian||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4286814|NCT00549549|4111982|B3|Asian||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4286815|NCT00549549|4111983|B2|Asian||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4286816|NCT00549549|4111984|B1|Asian||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4286817|NCT00549549|4111980|B5|Black||Race/Ethnicity, Customized||Participants|Number|33|33.0||||||
4286818|NCT00549549|4111981|B4|Black||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4286819|NCT00549549|4111982|B3|Black||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4286820|NCT00549549|4111983|B2|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4286821|NCT00549549|4111984|B1|Black||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4286822|NCT00549549|4111980|B5|White||Race/Ethnicity, Customized||Participants|Number|226|226.0||||||
4286823|NCT00549549|4111981|B4|White||Race/Ethnicity, Customized||Participants|Number|55|55.0||||||
4286824|NCT00549549|4111982|B3|White||Race/Ethnicity, Customized||Participants|Number|54|54.0||||||
4286825|NCT00549549|4111983|B2|White||Race/Ethnicity, Customized||Participants|Number|64|64.0||||||
4286826|NCT00549549|4111984|B1|White||Race/Ethnicity, Customized||Participants|Number|53|53.0||||||
4286827|NCT00549549|4111980|B5||Male|Sex: Female, Male||Participants|Count of Participants|366|366.0||||||
4286828|NCT00549549|4111981|B4||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4286829|NCT00549549|4111982|B3||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4286830|NCT00549549|4111983|B2||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4286831|NCT00549549|4111984|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4286832|NCT00549549|4111980|B5||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4286833|NCT00549549|4111981|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4286834|NCT00549549|4111982|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4286840|NCT00549549|4111983|B2|>=65 years||Age, Customized||Participants|Number|16|16.0||||||
4286841|NCT00549549|4111984|B1|>=65 years||Age, Customized||Participants|Number|17|17.0||||||
4286842|NCT00549549|4111980|B5|Between 18 and 65 years||Age, Customized||Participants|Number|341|341.0||||||
4286843|NCT00549549|4111981|B4|Between 18 and 65 years||Age, Customized||Participants|Number|88|88.0||||||
4286844|NCT00549549|4111982|B3|Between 18 and 65 years||Age, Customized||Participants|Number|86|86.0||||||
4286845|NCT00549549|4111983|B2|Between 18 and 65 years||Age, Customized||Participants|Number|83|83.0||||||
4286846|NCT00549549|4111984|B1|Between 18 and 65 years||Age, Customized||Participants|Number|84|84.0||||||
4286847|NCT00549445|4112053|B3|United States||Region of Enrollment||Participants|Count of Participants|53|53.0||||||
4286848|NCT00549445|4112054|B2|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4286849|NCT00549445|4112055|B1|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4286850|NCT00549445|4112053|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286851|NCT00549445|4112054|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286852|NCT00549445|4112055|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286853|NCT00549445|4112053|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286854|NCT00549445|4112054|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286855|NCT00549445|4112055|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286856|NCT00549445|4112053|B3||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4286857|NCT00549445|4112054|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4286858|NCT00549445|4112055|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4286859|NCT00549445|4112053|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4286860|NCT00549445|4112054|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4286861|NCT00549445|4112055|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4286862|NCT00549445|4112053|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286863|NCT00549445|4112054|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286864|NCT00549445|4112055|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286865|NCT00549445|4112053|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286866|NCT00549445|4112054|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286867|NCT00549445|4112055|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286868|NCT00549445|4112053|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286869|NCT00549445|4112054|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286870|NCT00549445|4112055|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4286871|NCT00549445|4112053|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4286872|NCT00549445|4112054|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4286873|NCT00549445|4112055|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4286874|NCT00549445|4112053|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4286875|NCT00549445|4112054|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4286876|NCT00549445|4112055|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4286877|NCT00549445|4112053|B3|||Age||years|Mean|67.6|67.6|Full Range|||56.0|79.2|
4286878|NCT00549445|4112054|B2|||Age||years|Mean|70.8|70.8|Full Range|||62.4|79.2|
4286879|NCT00549445|4112055|B1|||Age||years|Mean|64.4|64.4|Full Range|||56.0|72.8|
4286880|NCT00549393|4112062|B3|||PRISM III Score|Severity score that predicts mortality. Range 0 (lowest mortality risk) to 74 (highest mortality risk)|score|Median|5|5.0|Inter-Quartile Range|||0.0|12.0|
4286881|NCT00549393|4112063|B2|||PRISM III Score|Severity score that predicts mortality. Range 0 (lowest mortality risk) to 74 (highest mortality risk)|score|Median|5|5.0|Inter-Quartile Range|||0.0|11.0|
4286882|NCT00549393|4112064|B1|||PRISM III Score|Severity score that predicts mortality. Range 0 (lowest mortality risk) to 74 (highest mortality risk)|score|Median|5|5.0|Inter-Quartile Range|||0.0|13.0|
4286883|NCT00549393|4112062|B3|non-Caucasian||Race/Ethnicity, Customized||participants|Number|2407|2407.0||||||
4286884|NCT00549393|4112063|B2|non-Caucasian||Race/Ethnicity, Customized||participants|Number|1256|1256.0||||||
4286885|NCT00549393|4112064|B1|non-Caucasian||Race/Ethnicity, Customized||participants|Number|1151|1151.0||||||
4286886|NCT00549393|4112062|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|2540|2540.0||||||
4286887|NCT00549393|4112063|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|1269|1269.0||||||
4286888|NCT00549393|4112064|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|1271|1271.0||||||
4286889|NCT00549393|4112062|B3|Female||Sex/Gender, Customized||participants|Number|2170|2170.0||||||
4286890|NCT00549393|4112063|B2|Female||Sex/Gender, Customized||participants|Number|1137|1137.0||||||
4286891|NCT00549393|4112064|B1|Female||Sex/Gender, Customized||participants|Number|1033|1033.0||||||
4286892|NCT00549393|4112062|B3|Male||Sex/Gender, Customized||participants|Number|2777|2777.0||||||
4286893|NCT00549393|4112063|B2|Male||Sex/Gender, Customized||participants|Number|1388|1388.0||||||
4286894|NCT00549393|4112064|B1|Male||Sex/Gender, Customized||participants|Number|1389|1389.0||||||
4286895|NCT00549393|4112062|B3|||Age||years|Median|4.8|4.8|Inter-Quartile Range|||1.1|12.9|
4286896|NCT00549393|4112063|B2|||Age||years|Median|4.8|4.8|Inter-Quartile Range|||1.1|12.7|
4286897|NCT00549393|4112064|B1|||Age||years|Median|4.8|4.8|Inter-Quartile Range|||1.1|12.9|
4286898|NCT00549328|4112075|B1|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4286899|NCT00549328|4112075|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4286900|NCT00549328|4112075|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4286901|NCT00549328|4112075|B1|||Age||years|Mean|63.6|63.6|Standard Deviation|7.97|7.97|||
4286902|NCT00549302|4112084|B3|No||Current Bosentan Use||participants|Number|165|165.0||||||
4286903|NCT00549302|4112085|B2|No||Current Bosentan Use||participants|Number|139|139.0||||||
4286904|NCT00549302|4112086|B1|No||Current Bosentan Use||participants|Number|26|26.0||||||
4286905|NCT00549302|4112084|B3|Yes||Current Bosentan Use||participants|Number|192|192.0||||||
4286906|NCT00549302|4112085|B2|Yes||Current Bosentan Use||participants|Number|155|155.0||||||
4286907|NCT00549302|4112086|B1|Yes||Current Bosentan Use||participants|Number|37|37.0||||||
4286908|NCT00549302|4112084|B3|Surgical Repair, of at least 1 Year Duration||Etiology||participants|Number|12|12.0||||||
4286909|NCT00549302|4112085|B2|Surgical Repair, of at least 1 Year Duration||Etiology||participants|Number|9|9.0||||||
4286910|NCT00549302|4112086|B1|Surgical Repair, of at least 1 Year Duration||Etiology||participants|Number|3|3.0||||||
4286911|NCT00549302|4112084|B3|Related to Anorexigen Use||Etiology||participants|Number|15|15.0||||||
4286912|NCT00549302|4112085|B2|Related to Anorexigen Use||Etiology||participants|Number|11|11.0||||||
4286913|NCT00549302|4112086|B1|Related to Anorexigen Use||Etiology||participants|Number|4|4.0||||||
4286914|NCT00549302|4112084|B3|Associated with Atrial Septal Defect||Etiology||participants|Number|29|29.0||||||
4286915|NCT00549302|4112085|B2|Associated with Atrial Septal Defect||Etiology||participants|Number|26|26.0||||||
4286916|NCT00549302|4112086|B1|Associated with Atrial Septal Defect||Etiology||participants|Number|3|3.0||||||
4286917|NCT00549302|4112084|B3|Related to Collagen Vascular Disease||Etiology||participants|Number|78|78.0||||||
4286918|NCT00549302|4112085|B2|Related to Collagen Vascular Disease||Etiology||participants|Number|62|62.0||||||
4286919|NCT00549302|4112086|B1|Related to Collagen Vascular Disease||Etiology||participants|Number|16|16.0||||||
4286920|NCT00549302|4112084|B3|Idiopathic||Etiology||participants|Number|223|223.0||||||
4286921|NCT00549302|4112085|B2|Idiopathic||Etiology||participants|Number|186|186.0||||||
4286922|NCT00549302|4112086|B1|Idiopathic||Etiology||participants|Number|37|37.0||||||
4286923|NCT00549302|4112084|B3|Not Hispanic or Latino||Ethnicity||participants|Number|317|317.0||||||
4286924|NCT00549302|4112085|B2|Not Hispanic or Latino||Ethnicity||participants|Number|258|258.0||||||
4286925|NCT00549302|4112086|B1|Not Hispanic or Latino||Ethnicity||participants|Number|59|59.0||||||
4286926|NCT00549302|4112084|B3|Hispanic or Latino||Ethnicity||participants|Number|40|40.0||||||
4286927|NCT00549302|4112085|B2|Hispanic or Latino||Ethnicity||participants|Number|36|36.0||||||
4286928|NCT00549302|4112086|B1|Hispanic or Latino||Ethnicity||participants|Number|4|4.0||||||
4286929|NCT00549302|4112084|B3|||Weight||kilograms (kg)|Mean|75.02|75.02|Standard Deviation|19.63|19.63|||
4286930|NCT00549302|4112085|B2|||Weight||kilograms (kg)|Mean|75.26|75.26|Standard Deviation|19.80|19.8|||
4286931|NCT00549302|4112086|B1|||Weight||kilograms (kg)|Mean|73.92|73.92|Standard Deviation|18.90|18.9|||
4286932|NCT00549302|4112084|B3|Black or African American/Native Hawaiian or Other||Race||participants|Number|1|1.0||||||
4286933|NCT00549302|4112085|B2|Black or African American/Native Hawaiian or Other||Race||participants|Number|0|0.0||||||
4286934|NCT00549302|4112086|B1|Black or African American/Native Hawaiian or Other||Race||participants|Number|1|1.0||||||
4286935|NCT00549302|4112084|B3|American Indian or Alaska Native/White||Race||participants|Number|1|1.0||||||
4286936|NCT00549302|4112085|B2|American Indian or Alaska Native/White||Race||participants|Number|1|1.0||||||
4286937|NCT00549302|4112086|B1|American Indian or Alaska Native/White||Race||participants|Number|0|0.0||||||
4286938|NCT00549302|4112084|B3|Native Hawaiian or Other Pacific Islander||Race||participants|Number|2|2.0||||||
4286939|NCT00549302|4112085|B2|Native Hawaiian or Other Pacific Islander||Race||participants|Number|2|2.0||||||
4286940|NCT00549302|4112086|B1|Native Hawaiian or Other Pacific Islander||Race||participants|Number|0|0.0||||||
4286941|NCT00549302|4112084|B3|American Indian or Alaska Native||Race||participants|Number|5|5.0||||||
4286942|NCT00549302|4112085|B2|American Indian or Alaska Native||Race||participants|Number|3|3.0||||||
4286943|NCT00549302|4112086|B1|American Indian or Alaska Native||Race||participants|Number|2|2.0||||||
4286944|NCT00549302|4112084|B3|Black or African American||Race||participants|Number|28|28.0||||||
4286945|NCT00549302|4112085|B2|Black or African American||Race||participants|Number|23|23.0||||||
4286946|NCT00549302|4112086|B1|Black or African American||Race||participants|Number|5|5.0||||||
4286947|NCT00549302|4112084|B3|Asian||Race||participants|Number|29|29.0||||||
4286948|NCT00549302|4112085|B2|Asian||Race||participants|Number|22|22.0||||||
4286949|NCT00549302|4112086|B1|Asian||Race||participants|Number|7|7.0||||||
4286950|NCT00549302|4112084|B3|White||Race||participants|Number|291|291.0||||||
4286951|NCT00549302|4112085|B2|White||Race||participants|Number|243|243.0||||||
4286952|NCT00549302|4112086|B1|White||Race||participants|Number|48|48.0||||||
4286953|NCT00549302|4112084|B3|United Kingdom||Region of Enrollment||participants|Number|13|13.0||||||
4286954|NCT00549302|4112085|B2|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
4286955|NCT00549302|4112086|B1|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4286956|NCT00549302|4112084|B3|United States||Region of Enrollment||participants|Number|172|172.0||||||
4286957|NCT00549302|4112085|B2|United States||Region of Enrollment||participants|Number|139|139.0||||||
4286958|NCT00549302|4112086|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4286959|NCT00549302|4112084|B3|Spain||Region of Enrollment||participants|Number|6|6.0||||||
4286960|NCT00549302|4112085|B2|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4286961|NCT00549302|4112086|B1|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4286962|NCT00549302|4112084|B3|Japan||Region of Enrollment||participants|Number|22|22.0||||||
4286963|NCT00549302|4112085|B2|Japan||Region of Enrollment||participants|Number|17|17.0||||||
4286964|NCT00549302|4112086|B1|Japan||Region of Enrollment||participants|Number|5|5.0||||||
4286965|NCT00549302|4112084|B3|Italy||Region of Enrollment||participants|Number|29|29.0||||||
4286966|NCT00549302|4112085|B2|Italy||Region of Enrollment||participants|Number|25|25.0||||||
4286967|NCT00549302|4112086|B1|Italy||Region of Enrollment||participants|Number|4|4.0||||||
4286968|NCT00549302|4112084|B3|Ireland||Region of Enrollment||participants|Number|1|1.0||||||
4286969|NCT00549302|4112085|B2|Ireland||Region of Enrollment||participants|Number|1|1.0||||||
4286970|NCT00549302|4112086|B1|Ireland||Region of Enrollment||participants|Number|0|0.0||||||
4286971|NCT00549302|4112084|B3|Germany||Region of Enrollment||participants|Number|40|40.0||||||
4286972|NCT00549302|4112085|B2|Germany||Region of Enrollment||participants|Number|34|34.0||||||
4286973|NCT00549302|4112086|B1|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4286974|NCT00549302|4112084|B3|France||Region of Enrollment||participants|Number|25|25.0||||||
4286975|NCT00549302|4112085|B2|France||Region of Enrollment||participants|Number|22|22.0||||||
4286976|NCT00549302|4112086|B1|France||Region of Enrollment||participants|Number|3|3.0||||||
4286977|NCT00549302|4112084|B3|Canada||Region of Enrollment||participants|Number|42|42.0||||||
4286978|NCT00549302|4112085|B2|Canada||Region of Enrollment||participants|Number|38|38.0||||||
4286979|NCT00549302|4112086|B1|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4286980|NCT00549302|4112084|B3|Belgium||Region of Enrollment||participants|Number|7|7.0||||||
4286981|NCT00549302|4112085|B2|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
4286982|NCT00549302|4112086|B1|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
4286983|NCT00549302|4112084|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4286984|NCT00549302|4112085|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4286985|NCT00549302|4112086|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4286986|NCT00549302|4112084|B3||Female|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
4286987|NCT00549302|4112085|B2||Female|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4286988|NCT00549302|4112086|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4286989|NCT00549302|4112084|B3|||Age||years|Mean|53.78|53.78|Standard Deviation|15.38|15.38|||
4286990|NCT00549302|4112085|B2|||Age||years|Mean|53.94|53.94|Standard Deviation|15.36|15.36|||
4286991|NCT00549302|4112086|B1|||Age||years|Mean|53.04|53.04|Standard Deviation|15.58|15.58|||
4286992|NCT00549198|4112098|B3|White||Race/Ethnicity, Customized|The Intent-to-Treat (ITT)-Exposed (E) Population, comprised of all randomized participants who received at least one dose of study medication, was used for all baseline characteristics.|participants|Number|304|304.0||||||
4286993|NCT00549198|4112099|B2|White||Race/Ethnicity, Customized|The Intent-to-Treat (ITT)-Exposed (E) Population, comprised of all randomized participants who received at least one dose of study medication, was used for all baseline characteristics.|participants|Number|151|151.0||||||
4286994|NCT00549198|4112100|B1|White||Race/Ethnicity, Customized|The Intent-to-Treat (ITT)-Exposed (E) Population, comprised of all randomized participants who received at least one dose of study medication, was used for all baseline characteristics.|participants|Number|153|153.0||||||
4286995|NCT00549198|4112098|B3|Asian||Race/Ethnicity, Customized|The Intent-to-Treat (ITT)-Exposed (E) Population, comprised of all randomized participants who received at least one dose of study medication, was used for all baseline characteristics.|participants|Number|7|7.0||||||
4286996|NCT00549198|4112099|B2|Asian||Race/Ethnicity, Customized|The Intent-to-Treat (ITT)-Exposed (E) Population, comprised of all randomized participants who received at least one dose of study medication, was used for all baseline characteristics.|participants|Number|5|5.0||||||
4286997|NCT00549198|4112100|B1|Asian||Race/Ethnicity, Customized|The Intent-to-Treat (ITT)-Exposed (E) Population, comprised of all randomized participants who received at least one dose of study medication, was used for all baseline characteristics.|participants|Number|2|2.0||||||
4286998|NCT00549198|4112098|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|The Intent-to-Treat (ITT)-Exposed (E) Population, comprised of all randomized participants who received at least one dose of study medication, was used for all baseline characteristics.|participants|Number|18|18.0||||||
4286999|NCT00549198|4112099|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|The Intent-to-Treat (ITT)-Exposed (E) Population, comprised of all randomized participants who received at least one dose of study medication, was used for all baseline characteristics.|participants|Number|7|7.0||||||
4287000|NCT00549198|4112100|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|The Intent-to-Treat (ITT)-Exposed (E) Population, comprised of all randomized participants who received at least one dose of study medication, was used for all baseline characteristics.|participants|Number|11|11.0||||||
4287001|NCT00549198|4112098|B3|African American/African Heritage||Race/Ethnicity, Customized|The Intent-to-Treat (ITT)-Exposed (E) Population, comprised of all randomized participants who received at least one dose of study medication, was used for all baseline characteristics.|participants|Number|56|56.0||||||
4287002|NCT00549198|4112099|B2|African American/African Heritage||Race/Ethnicity, Customized|The Intent-to-Treat (ITT)-Exposed (E) Population, comprised of all randomized participants who received at least one dose of study medication, was used for all baseline characteristics.|participants|Number|30|30.0||||||
4287003|NCT00549198|4112100|B1|African American/African Heritage||Race/Ethnicity, Customized|The Intent-to-Treat (ITT)-Exposed (E) Population, comprised of all randomized participants who received at least one dose of study medication, was used for all baseline characteristics.|participants|Number|26|26.0||||||
4287004|NCT00549198|4112098|B3||Male|Sex: Female, Male|The Intent-to-Treat (ITT)-Exposed (E) Population, comprised of all randomized participants who received at least one dose of study medication, was used for all baseline characteristics.|Participants|Count of Participants|312|312.0||||||
4287005|NCT00549198|4112099|B2||Male|Sex: Female, Male|The Intent-to-Treat (ITT)-Exposed (E) Population, comprised of all randomized participants who received at least one dose of study medication, was used for all baseline characteristics.|Participants|Count of Participants|153|153.0||||||
4287006|NCT00549198|4112100|B1||Male|Sex: Female, Male|The Intent-to-Treat (ITT)-Exposed (E) Population, comprised of all randomized participants who received at least one dose of study medication, was used for all baseline characteristics.|Participants|Count of Participants|159|159.0||||||
4287007|NCT00549198|4112098|B3||Female|Sex: Female, Male|The Intent-to-Treat (ITT)-Exposed (E) Population, comprised of all randomized participants who received at least one dose of study medication, was used for all baseline characteristics.|Participants|Count of Participants|73|73.0||||||
4287008|NCT00549198|4112099|B2||Female|Sex: Female, Male|The Intent-to-Treat (ITT)-Exposed (E) Population, comprised of all randomized participants who received at least one dose of study medication, was used for all baseline characteristics.|Participants|Count of Participants|40|40.0||||||
4287009|NCT00549198|4112100|B1||Female|Sex: Female, Male|The Intent-to-Treat (ITT)-Exposed (E) Population, comprised of all randomized participants who received at least one dose of study medication, was used for all baseline characteristics.|Participants|Count of Participants|33|33.0||||||
4287010|NCT00549198|4112098|B3|||Age|The Intent-to-Treat (ITT)-Exposed (E) Population, comprised of all randomized participants who received at least one dose of study medication, was used for all baseline characteristics.|Years|Median|37.0|37.0|Full Range|||18.0|70.0|
4287011|NCT00549198|4112099|B2|||Age|The Intent-to-Treat (ITT)-Exposed (E) Population, comprised of all randomized participants who received at least one dose of study medication, was used for all baseline characteristics.|Years|Median|36.0|36.0|Full Range|||18.0|66.0|
4287012|NCT00549198|4112100|B1|||Age|The Intent-to-Treat (ITT)-Exposed (E) Population, comprised of all randomized participants who received at least one dose of study medication, was used for all baseline characteristics.|Years|Median|38.0|38.0|Full Range|||19.0|70.0|
4287013|NCT00549172|4112221|B3|Finland||Region of Enrollment||participants|Number|146|146.0||||||
4287014|NCT00549172|4112222|B2|Finland||Region of Enrollment||participants|Number|76|76.0||||||
4287015|NCT00549172|4112223|B1|Finland||Region of Enrollment||participants|Number|70|70.0||||||
4287016|NCT00549172|4112221|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4287017|NCT00549172|4112222|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4287018|NCT00549172|4112223|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4287019|NCT00549172|4112221|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4287020|NCT00549172|4112222|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4287021|NCT00549172|4112223|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4287022|NCT00549172|4112221|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4287023|NCT00549172|4112222|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4287024|NCT00549172|4112223|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4287025|NCT00549172|4112221|B3||Between 18 and 65 years|Age||Participants|Count of Participants|146|146.0||||||
4287026|NCT00549172|4112222|B2||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
4287027|NCT00549172|4112223|B1||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4287028|NCT00549172|4112221|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4287029|NCT00549172|4112222|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4287030|NCT00549172|4112223|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4287031|NCT00549172|4112221|B3|||Age||years|Mean|52|52.0|Standard Deviation|7|7.0|||
4287032|NCT00549172|4112222|B2|||Age||years|Mean|52|52.0|Standard Deviation|7|7.0|||
4287033|NCT00549172|4112223|B1|||Age||years|Mean|52|52.0|Standard Deviation|7|7.0|||
4287034|NCT00549055|4112238|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4287035|NCT00549055|4112238|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4287036|NCT00549055|4112238|B1|>= 85 years||Age, Customized||Participants|Number|5|5.0||||||
4287037|NCT00549055|4112238|B1|75 to 84 years||Age, Customized||Participants|Number|22|22.0||||||
4287038|NCT00549055|4112238|B1|65 to 74 years||Age, Customized||Participants|Number|8|8.0||||||
4287039|NCT00549055|4112238|B1|< 65 years||Age, Customized||Participants|Number|3|3.0||||||
4287040|NCT00548886|4112248|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4287041|NCT00548886|4112248|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4287042|NCT00548886|4112248|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4287043|NCT00548886|4112248|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4287044|NCT00548886|4112248|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4287045|NCT00548860|4112253|B3|United States||Region of Enrollment||participants|Number|2018|2018.0||||||
4287046|NCT00548860|4112254|B2|United States||Region of Enrollment||participants|Number|1022|1022.0||||||
4287047|NCT00548860|4112255|B1|United States||Region of Enrollment||participants|Number|996|996.0||||||
4287048|NCT00548860|4112253|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4287049|NCT00548860|4112254|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4287050|NCT00548860|4112255|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4287051|NCT00548860|4112253|B3||Female|Sex: Female, Male||Participants|Count of Participants|2018|2018.0||||||
4287052|NCT00548860|4112254|B2||Female|Sex: Female, Male||Participants|Count of Participants|1022|1022.0||||||
4287053|NCT00548860|4112255|B1||Female|Sex: Female, Male||Participants|Count of Participants|996|996.0||||||
4287054|NCT00548860|4112253|B3|||Age||years|Mean|31.3|31.3|Standard Deviation|9.17|9.17|||
4287055|NCT00548860|4112254|B2|||Age||years|Mean|31.4|31.4|Standard Deviation|8.98|8.98|||
4287056|NCT00548860|4112255|B1|||Age||years|Mean|31.2|31.2|Standard Deviation|9.36|9.36|||
4287057|NCT00548860|4112253|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4287058|NCT00548860|4112254|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4287059|NCT00548860|4112255|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4287060|NCT00548860|4112253|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1966|1966.0||||||
4287061|NCT00548860|4112254|B2||Between 18 and 65 years|Age||Participants|Count of Participants|995|995.0||||||
4287062|NCT00548860|4112255|B1||Between 18 and 65 years|Age||Participants|Count of Participants|971|971.0||||||
4287063|NCT00548860|4112253|B3||<=18 years|Age||Participants|Count of Participants|52|52.0||||||
4287064|NCT00548860|4112254|B2||<=18 years|Age||Participants|Count of Participants|27|27.0||||||
4287065|NCT00548860|4112255|B1||<=18 years|Age||Participants|Count of Participants|25|25.0||||||
4287066|NCT00548847|4112262|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4287067|NCT00548847|4112262|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4287068|NCT00548847|4112262|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287069|NCT00548847|4112262|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4287070|NCT00548847|4112262|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4287071|NCT00548847|4112262|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287072|NCT00548847|4112262|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287073|NCT00548847|4112262|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287074|NCT00548847|4112262|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4287075|NCT00548847|4112262|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4287076|NCT00548847|4112262|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4287077|NCT00548847|4112262|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4287078|NCT00548847|4112262|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4287079|NCT00548847|4112262|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4287080|NCT00548847|4112262|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4287081|NCT00548847|4112262|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4287082|NCT00548808|4112267|B3|Mexico||Region of Enrollment||participants|Number|71|71.0||||||
4287083|NCT00548808|4112268|B2|Mexico||Region of Enrollment||participants|Number|36|36.0||||||
4287084|NCT00548808|4112269|B1|Mexico||Region of Enrollment||participants|Number|35|35.0||||||
4287085|NCT00548808|4112267|B3|Korea, Republic of||Region of Enrollment||participants|Number|30|30.0||||||
4287086|NCT00548808|4112268|B2|Korea, Republic of||Region of Enrollment||participants|Number|14|14.0||||||
4287087|NCT00548808|4112269|B1|Korea, Republic of||Region of Enrollment||participants|Number|16|16.0||||||
4287088|NCT00548808|4112267|B3|India||Region of Enrollment||participants|Number|106|106.0||||||
4287089|NCT00548808|4112268|B2|India||Region of Enrollment||participants|Number|53|53.0||||||
4287090|NCT00548808|4112269|B1|India||Region of Enrollment||participants|Number|53|53.0||||||
4287091|NCT00548808|4112267|B3|China||Region of Enrollment||participants|Number|59|59.0||||||
4287092|NCT00548808|4112268|B2|China||Region of Enrollment||participants|Number|30|30.0||||||
4287093|NCT00548808|4112269|B1|China||Region of Enrollment||participants|Number|29|29.0||||||
4287094|NCT00548808|4112267|B3|Canada||Region of Enrollment||participants|Number|56|56.0||||||
4287095|NCT00548808|4112268|B2|Canada||Region of Enrollment||participants|Number|28|28.0||||||
4287096|NCT00548808|4112269|B1|Canada||Region of Enrollment||participants|Number|28|28.0||||||
4287097|NCT00548808|4112267|B3|Brazil||Region of Enrollment||participants|Number|67|67.0||||||
4287098|NCT00548808|4112268|B2|Brazil||Region of Enrollment||participants|Number|34|34.0||||||
4287099|NCT00548808|4112269|B1|Brazil||Region of Enrollment||participants|Number|33|33.0||||||
4287100|NCT00548808|4112267|B3|Australia||Region of Enrollment||participants|Number|34|34.0||||||
4287101|NCT00548808|4112268|B2|Australia||Region of Enrollment||participants|Number|17|17.0||||||
4287102|NCT00548808|4112269|B1|Australia||Region of Enrollment||participants|Number|17|17.0||||||
4287103|NCT00548808|4112267|B3|West Asian (Indian sub-continent)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4287104|NCT00548808|4112268|B2|West Asian (Indian sub-continent)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4287105|NCT00548808|4112269|B1|West Asian (Indian sub-continent)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4287106|NCT00548808|4112267|B3|West Asian||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4287107|NCT00548808|4112268|B2|West Asian||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4287108|NCT00548808|4112269|B1|West Asian||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4287109|NCT00548808|4112267|B3|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4287110|NCT00548808|4112268|B2|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4287111|NCT00548808|4112269|B1|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4287112|NCT00548808|4112267|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|71|71.0||||||
4287113|NCT00548808|4112268|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4287114|NCT00548808|4112269|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4287115|NCT00548808|4112267|B3|East Asian||Race/Ethnicity, Customized||participants|Number|155|155.0||||||
4287116|NCT00548808|4112268|B2|East Asian||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
4287117|NCT00548808|4112269|B1|East Asian||Race/Ethnicity, Customized||participants|Number|78|78.0||||||
4287118|NCT00548808|4112267|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|130|130.0||||||
4287119|NCT00548808|4112268|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
4287120|NCT00548808|4112269|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
4287121|NCT00548808|4112267|B3|African||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4287122|NCT00548808|4112268|B2|African||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4287123|NCT00548808|4112269|B1|African||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4287124|NCT00548808|4112267|B3||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4287125|NCT00548808|4112268|B2||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4287126|NCT00548808|4112269|B1||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4287127|NCT00548808|4112267|B3||Female|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
4287128|NCT00548808|4112268|B2||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4287129|NCT00548808|4112269|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4287130|NCT00548808|4112267|B3|||Age||years|Mean|56.48|56.48|Standard Deviation|8.94|8.94|||
4287131|NCT00548808|4112268|B2|||Age||years|Mean|56.29|56.29|Standard Deviation|9.35|9.35|||
4287132|NCT00548808|4112269|B1|||Age||years|Mean|56.68|56.68|Standard Deviation|8.52|8.52|||
4287133|NCT00548717|4112292|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4287134|NCT00548717|4112293|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4287135|NCT00548717|4112294|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4287136|NCT00548717|4112292|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4287137|NCT00548717|4112293|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4287138|NCT00548717|4112294|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4287139|NCT00548717|4112292|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4287140|NCT00548717|4112293|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4287141|NCT00548717|4112294|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4287142|NCT00548717|4112292|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4287143|NCT00548717|4112293|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4287144|NCT00548717|4112294|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4287145|NCT00548717|4112292|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4287146|NCT00548717|4112293|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4287147|NCT00548717|4112294|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4287148|NCT00548717|4112292|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4287149|NCT00548717|4112293|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4287150|NCT00548717|4112294|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4287151|NCT00548691|4112312|B3|United States||Region of Enrollment||participants|Number|513|513.0||||||
4287152|NCT00548691|4112313|B2|United States||Region of Enrollment||participants|Number|259|259.0||||||
4287153|NCT00548691|4112314|B1|United States||Region of Enrollment||participants|Number|254|254.0||||||
4287154|NCT00548691|4112312|B3||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4287155|NCT00548691|4112313|B2||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4287156|NCT00548691|4112314|B1||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4287157|NCT00548691|4112312|B3||Female|Sex: Female, Male||Participants|Count of Participants|312|312.0||||||
4287158|NCT00548691|4112313|B2||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4287159|NCT00548691|4112314|B1||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4287160|NCT00548691|4112312|B3|||Age||years|Mean|62.8|62.8|Standard Deviation|12.46|12.46|||
4287161|NCT00548691|4112313|B2|||Age||years|Mean|63.1|63.1|Standard Deviation|12.11|12.11|||
4287162|NCT00548691|4112314|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|12.81|12.81|||
4287163|NCT00548691|4112312|B3||>=65 years|Age||Participants|Count of Participants|260|260.0||||||
4287164|NCT00548691|4112313|B2||>=65 years|Age||Participants|Count of Participants|133|133.0||||||
4287165|NCT00548691|4112314|B1||>=65 years|Age||Participants|Count of Participants|127|127.0||||||
4287166|NCT00548691|4112312|B3||Between 18 and 65 years|Age||Participants|Count of Participants|253|253.0||||||
4287167|NCT00548691|4112313|B2||Between 18 and 65 years|Age||Participants|Count of Participants|126|126.0||||||
4287168|NCT00548691|4112314|B1||Between 18 and 65 years|Age||Participants|Count of Participants|127|127.0||||||
4287169|NCT00548691|4112312|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4287170|NCT00548691|4112313|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4287171|NCT00548691|4112314|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4287172|NCT00548548|4112321|B3||Male|Sex: Female, Male||Participants|Count of Participants|515|515.0||||||
4287173|NCT00548548|4112322|B2||Male|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
4287174|NCT00548548|4112323|B1||Male|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
4287175|NCT00548548|4112321|B3||Female|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
4287176|NCT00548548|4112322|B2||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4287177|NCT00548548|4112323|B1||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4287178|NCT00548548|4112321|B3|≥65||Age, Customized||participants|Number|219|219.0||||||
4287179|NCT00548548|4112322|B2|≥65||Age, Customized||participants|Number|109|109.0||||||
4287180|NCT00548548|4112323|B1|≥65||Age, Customized||participants|Number|110|110.0||||||
4287181|NCT00548548|4112321|B3|40-65||Age, Customized||participants|Number|490|490.0||||||
4287182|NCT00548548|4112322|B2|40-65||Age, Customized||participants|Number|249|249.0||||||
4287183|NCT00548548|4112323|B1|40-65||Age, Customized||participants|Number|241|241.0||||||
4287184|NCT00548548|4112321|B3|<40||Age, Customized||participants|Number|65|65.0||||||
4287185|NCT00548548|4112322|B2|<40||Age, Customized||participants|Number|29|29.0||||||
4287186|NCT00548548|4112323|B1|<40||Age, Customized||participants|Number|36|36.0||||||
4287187|NCT00548470|4112344|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4287188|NCT00548470|4112344|B1|hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4287189|NCT00548470|4112344|B1|african american||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4287190|NCT00548470|4112344|B1|white||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4287191|NCT00548470|4112344|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4287192|NCT00548470|4112344|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4287193|NCT00548470|4112344|B1|||Age||years|Mean|40.1|40.1|Standard Deviation|8.4|8.4|||
4287194|NCT00548431|4112352|B1|Finland||Region of Enrollment||participants|Number|5|5.0||||||
4287195|NCT00548431|4112352|B1|Sweden||Region of Enrollment||participants|Number|21|21.0||||||
4287196|NCT00548431|4112352|B1|Denmark||Region of Enrollment||participants|Number|12|12.0||||||
4287197|NCT00548431|4112352|B1||Male|Gender||Participants|Count of Participants|17|17.0||||||
4287198|NCT00548431|4112352|B1||Female|Gender||Participants|Count of Participants|21|21.0||||||
4287199|NCT00548431|4112352|B1|||Age||years|Mean|7|7.0|Standard Deviation|3|3.0|||
4287200|NCT00548431|4112352|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4287201|NCT00548431|4112352|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4287202|NCT00548431|4112352|B1||<=18 years|Age||Participants|Count of Participants|38|38.0||||||
4287203|NCT00548418|4112356|B1|Yes||Prior hysterectomy||participants|Number|5|5.0||||||
4287204|NCT00548418|4112356|B1|No||Prior hysterectomy||participants|Number|22|22.0||||||
4287205|NCT00548418|4112356|B1|3||Grade|"well differentiated~moderately differentiated~poorly differentiated"|participants|Number|14|14.0||||||
4287206|NCT00548418|4112356|B1|2||Grade|"well differentiated~moderately differentiated~poorly differentiated"|participants|Number|11|11.0||||||
4287207|NCT00548418|4112356|B1|1||Grade|"well differentiated~moderately differentiated~poorly differentiated"|participants|Number|2|2.0||||||
4287208|NCT00548418|4112356|B1|Adenocarcinoma||Histologic type||participants|Number|9|9.0||||||
4287209|NCT00548418|4112356|B1|Squamous cell||Histologic type||participants|Number|18|18.0||||||
4287210|NCT00548418|4112356|B1|IV||Disease stage|"Stage I: The cancer has grown into the cervix, but it is not growing outside the uterus. The cancer has not spread to nearby lymph nodes or distant sites.~Stage II: The cancer has grown beyond the cervix and uterus, but hasn't spread to the walls of the pelvis or the lower part of the vagina.~Stage III: The cancer has spread to the lower part of the vagina or the walls of the pelvis. The cancer may be blocking the ureters. It has not spread to nearby lymph nodes or distant sites.~Stage IV:The cancer has spread to nearby organs or other parts of the body."|participants|Number|2|2.0||||||
4287211|NCT00548418|4112356|B1|III||Disease stage|"Stage I: The cancer has grown into the cervix, but it is not growing outside the uterus. The cancer has not spread to nearby lymph nodes or distant sites.~Stage II: The cancer has grown beyond the cervix and uterus, but hasn't spread to the walls of the pelvis or the lower part of the vagina.~Stage III: The cancer has spread to the lower part of the vagina or the walls of the pelvis. The cancer may be blocking the ureters. It has not spread to nearby lymph nodes or distant sites.~Stage IV:The cancer has spread to nearby organs or other parts of the body."|participants|Number|8|8.0||||||
4287212|NCT00548418|4112356|B1|II||Disease stage|"Stage I: The cancer has grown into the cervix, but it is not growing outside the uterus. The cancer has not spread to nearby lymph nodes or distant sites.~Stage II: The cancer has grown beyond the cervix and uterus, but hasn't spread to the walls of the pelvis or the lower part of the vagina.~Stage III: The cancer has spread to the lower part of the vagina or the walls of the pelvis. The cancer may be blocking the ureters. It has not spread to nearby lymph nodes or distant sites.~Stage IV:The cancer has spread to nearby organs or other parts of the body."|participants|Number|8|8.0||||||
4287213|NCT00548418|4112356|B1|I||Disease stage|"Stage I: The cancer has grown into the cervix, but it is not growing outside the uterus. The cancer has not spread to nearby lymph nodes or distant sites.~Stage II: The cancer has grown beyond the cervix and uterus, but hasn't spread to the walls of the pelvis or the lower part of the vagina.~Stage III: The cancer has spread to the lower part of the vagina or the walls of the pelvis. The cancer may be blocking the ureters. It has not spread to nearby lymph nodes or distant sites.~Stage IV:The cancer has spread to nearby organs or other parts of the body."|participants|Number|9|9.0||||||
4287214|NCT00548418|4112356|B1|1||Performance status|"GOG/Zubrod Description~0 = Fully active, able to carry on all pre-disease performance without restriction~= Restricted in physically strenuous activitiy but ambulatory and able to carry out work of light or sedentary nature, e.g., light housework, office work~= Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours~= Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~= Completely disabled"|participants|Number|13|13.0||||||
4287249|NCT00548405|4112364|B4||Male|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
4287250|NCT00548405|4112365|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4287251|NCT00548405|4112366|B2||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4287252|NCT00548405|4112367|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4287215|NCT00548418|4112356|B1|0||Performance status|"GOG/Zubrod Description~0 = Fully active, able to carry on all pre-disease performance without restriction~= Restricted in physically strenuous activitiy but ambulatory and able to carry out work of light or sedentary nature, e.g., light housework, office work~= Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours~= Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~= Completely disabled"|participants|Number|14|14.0||||||
4287216|NCT00548418|4112356|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4287217|NCT00548418|4112356|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287218|NCT00548418|4112356|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287219|NCT00548418|4112356|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4287220|NCT00548418|4112356|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4287221|NCT00548418|4112356|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287222|NCT00548418|4112356|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287223|NCT00548418|4112356|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287224|NCT00548418|4112356|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4287225|NCT00548418|4112356|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4287226|NCT00548418|4112356|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4287227|NCT00548418|4112356|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4287228|NCT00548418|4112356|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4287229|NCT00548405|4112364|B4|||Expanded Disability Status Scale (EDSS) Score|EDSS is an ordinal scale in half-point increments that quantifies disability in participants with multiple sclerosis (MS). It assesses the 7 functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation. EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS).|units on a scale|Mean|2.7|2.7|Standard Deviation|1.22|1.22|||
4287230|NCT00548405|4112365|B3|||Expanded Disability Status Scale (EDSS) Score|EDSS is an ordinal scale in half-point increments that quantifies disability in participants with multiple sclerosis (MS). It assesses the 7 functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation. EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS).|units on a scale|Mean|2.7|2.7|Standard Deviation|1.17|1.17|||
4287231|NCT00548405|4112366|B2|||Expanded Disability Status Scale (EDSS) Score|EDSS is an ordinal scale in half-point increments that quantifies disability in participants with multiple sclerosis (MS). It assesses the 7 functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation. EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS).|units on a scale|Mean|2.7|2.7|Standard Deviation|1.26|1.26|||
4287232|NCT00548405|4112367|B1|||Expanded Disability Status Scale (EDSS) Score|EDSS is an ordinal scale in half-point increments that quantifies disability in participants with multiple sclerosis (MS). It assesses the 7 functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation. EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS).|units on a scale|Mean|2.7|2.7|Standard Deviation|1.21|1.21|||
4287233|NCT00548405|4112364|B4|Greater than or equal to 3 Relapses||Number of Relapse Episodes in the Preceding 2 Years|Number of participants with 1, 2 or greater than or equal to 3 relapses are reported.|participants|Number|347|347.0||||||
4287234|NCT00548405|4112365|B3|Greater than or equal to 3 Relapses||Number of Relapse Episodes in the Preceding 2 Years|Number of participants with 1, 2 or greater than or equal to 3 relapses are reported.|participants|Number|65|65.0||||||
4287235|NCT00548405|4112366|B2|Greater than or equal to 3 Relapses||Number of Relapse Episodes in the Preceding 2 Years|Number of participants with 1, 2 or greater than or equal to 3 relapses are reported.|participants|Number|196|196.0||||||
4287236|NCT00548405|4112367|B1|Greater than or equal to 3 Relapses||Number of Relapse Episodes in the Preceding 2 Years|Number of participants with 1, 2 or greater than or equal to 3 relapses are reported.|participants|Number|86|86.0||||||
4287237|NCT00548405|4112364|B4|2 Relapses||Number of Relapse Episodes in the Preceding 2 Years|Number of participants with 1, 2 or greater than or equal to 3 relapses are reported.|participants|Number|418|418.0||||||
4287238|NCT00548405|4112365|B3|2 Relapses||Number of Relapse Episodes in the Preceding 2 Years|Number of participants with 1, 2 or greater than or equal to 3 relapses are reported.|participants|Number|94|94.0||||||
4287239|NCT00548405|4112366|B2|2 Relapses||Number of Relapse Episodes in the Preceding 2 Years|Number of participants with 1, 2 or greater than or equal to 3 relapses are reported.|participants|Number|215|215.0||||||
4287240|NCT00548405|4112367|B1|2 Relapses||Number of Relapse Episodes in the Preceding 2 Years|Number of participants with 1, 2 or greater than or equal to 3 relapses are reported.|participants|Number|109|109.0||||||
4287241|NCT00548405|4112364|B4|1 Relapse||Number of Relapse Episodes in the Preceding 2 Years|Number of participants with 1, 2 or greater than or equal to 3 relapses are reported.|participants|Number|33|33.0||||||
4287242|NCT00548405|4112365|B3|1 Relapse||Number of Relapse Episodes in the Preceding 2 Years|Number of participants with 1, 2 or greater than or equal to 3 relapses are reported.|participants|Number|11|11.0||||||
4287243|NCT00548405|4112366|B2|1 Relapse||Number of Relapse Episodes in the Preceding 2 Years|Number of participants with 1, 2 or greater than or equal to 3 relapses are reported.|participants|Number|15|15.0||||||
4287244|NCT00548405|4112367|B1|1 Relapse||Number of Relapse Episodes in the Preceding 2 Years|Number of participants with 1, 2 or greater than or equal to 3 relapses are reported.|participants|Number|7|7.0||||||
4287245|NCT00548405|4112364|B4|||Time Since First Relapse||years|Median|3.8|3.8|Full Range|||0.2|16.9|
4287246|NCT00548405|4112365|B3|||Time Since First Relapse||years|Median|3.7|3.7|Full Range|||0.2|16.9|
4287247|NCT00548405|4112366|B2|||Time Since First Relapse||years|Median|3.8|3.8|Full Range|||0.2|14.4|
4287248|NCT00548405|4112367|B1|||Time Since First Relapse||years|Median|4.1|4.1|Full Range|||0.4|10.1|
4287253|NCT00548405|4112364|B4||Female|Sex: Female, Male||Participants|Count of Participants|532|532.0||||||
4287254|NCT00548405|4112365|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4287255|NCT00548405|4112366|B2||Female|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
4287256|NCT00548405|4112367|B1||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4287257|NCT00548405|4112364|B4|||Age||years|Mean|35.1|35.1|Standard Deviation|8.47|8.47|||
4287258|NCT00548405|4112365|B3|||Age||years|Mean|35.1|35.1|Standard Deviation|8.40|8.4|||
4287259|NCT00548405|4112366|B2|||Age||years|Mean|34.8|34.8|Standard Deviation|8.36|8.36|||
4287260|NCT00548405|4112367|B1|||Age||years|Mean|35.8|35.8|Standard Deviation|8.77|8.77|||
4287261|NCT00548340|4112387|B4||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4287262|NCT00548340|4112388|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4287263|NCT00548340|4112389|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4287264|NCT00548340|4112390|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4287265|NCT00548340|4112387|B4||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4287266|NCT00548340|4112388|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4287267|NCT00548340|4112389|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4287268|NCT00548340|4112390|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4287269|NCT00548340|4112387|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4287270|NCT00548340|4112388|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4287271|NCT00548340|4112389|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4287272|NCT00548340|4112390|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4287273|NCT00548340|4112387|B4||Between 18 and 65 years|Age||Participants|Count of Participants|322|322.0||||||
4287274|NCT00548340|4112388|B3||Between 18 and 65 years|Age||Participants|Count of Participants|104|104.0||||||
4287275|NCT00548340|4112389|B2||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
4287276|NCT00548340|4112390|B1||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
4287277|NCT00548340|4112387|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4287278|NCT00548340|4112388|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4287279|NCT00548340|4112389|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4287280|NCT00548340|4112390|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4287281|NCT00548340|4112387|B4|||Age||years|Mean|41.8|41.8|Standard Deviation|10.9|10.9|||
4287282|NCT00548340|4112388|B3|||Age||years|Mean|41.7|41.7|Standard Deviation|11.8|11.8|||
4287283|NCT00548340|4112389|B2|||Age||years|Mean|40.7|40.7|Standard Deviation|10.4|10.4|||
4287284|NCT00548340|4112390|B1|||Age||years|Mean|42.9|42.9|Standard Deviation|10.6|10.6|||
4287285|NCT00548327|4112409|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4287286|NCT00548327|4112410|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4287287|NCT00548327|4112411|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4287288|NCT00548327|4112409|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4287289|NCT00548327|4112410|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4287290|NCT00548327|4112411|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4287291|NCT00548327|4112409|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4287292|NCT00548327|4112410|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4287293|NCT00548327|4112411|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4287294|NCT00548327|4112409|B3|>=45 years||Age, Customized||participants|Number|0|0.0||||||
4287295|NCT00548327|4112410|B2|>=45 years||Age, Customized||participants|Number|0|0.0||||||
4287296|NCT00548327|4112411|B1|>=45 years||Age, Customized||participants|Number|0|0.0||||||
4287297|NCT00548327|4112409|B3|Between 18 and 45 years||Age, Customized||participants|Number|11|11.0||||||
4287298|NCT00548327|4112410|B2|Between 18 and 45 years||Age, Customized||participants|Number|5|5.0||||||
4287299|NCT00548327|4112411|B1|Between 18 and 45 years||Age, Customized||participants|Number|6|6.0||||||
4287300|NCT00548327|4112409|B3|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4287301|NCT00548327|4112410|B2|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4287302|NCT00548327|4112411|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4287303|NCT00548262|4112430|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4287304|NCT00548262|4112430|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4287305|NCT00548262|4112430|B1|≥ 65 years||Age, Customized||participants|Number|18|18.0||||||
4287306|NCT00548262|4112430|B1|Between 45 and 64 years||Age, Customized||participants|Number|18|18.0||||||
4287307|NCT00548262|4112430|B1|Between 18 and 44 years||Age, Customized||participants|Number|18|18.0||||||
4287308|NCT00548249|4112455|B6|Canada||Region of Enrollment||participants|Number|14|14.0||||||
4287309|NCT00548249|4112456|B5|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4287310|NCT00548249|4112457|B4|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4287311|NCT00548249|4112458|B3|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4287312|NCT00548249|4112459|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4287313|NCT00548249|4112460|B1|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4287314|NCT00548249|4112455|B6|United States||Region of Enrollment||participants|Number|117|117.0||||||
4287315|NCT00548249|4112456|B5|United States||Region of Enrollment||participants|Number|25|25.0||||||
4287316|NCT00548249|4112457|B4|United States||Region of Enrollment||participants|Number|21|21.0||||||
4287317|NCT00548249|4112458|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4287318|NCT00548249|4112459|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4287319|NCT00548249|4112460|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4287320|NCT00548249|4112455|B6||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4287321|NCT00548249|4112456|B5||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4287322|NCT00548249|4112457|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4287323|NCT00548249|4112458|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4287324|NCT00548249|4112459|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4287325|NCT00548249|4112460|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4287326|NCT00548249|4112455|B6||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4287327|NCT00548249|4112456|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4287328|NCT00548249|4112457|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4287329|NCT00548249|4112458|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4287330|NCT00548249|4112459|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4287331|NCT00548249|4112460|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4287332|NCT00548249|4112455|B6|||Age||years|Mean|58|58.0|Standard Deviation|14.07|14.07|||
4287333|NCT00548249|4112456|B5|||Age||years|Mean|59.8|59.8|Standard Deviation|16.96|16.96|||
4287334|NCT00548249|4112457|B4|||Age||years|Mean|57.9|57.9|Standard Deviation|12.79|12.79|||
4287335|NCT00548249|4112458|B3|||Age||years|Mean|57.3|57.3|Standard Deviation|13.97|13.97|||
4287336|NCT00548249|4112459|B2|||Age||years|Mean|57.3|57.3|Standard Deviation|15.48|15.48|||
4287337|NCT00548249|4112460|B1|||Age||years|Mean|57.7|57.7|Standard Deviation|10.68|10.68|||
4287338|NCT00548249|4112455|B6||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
4287339|NCT00548249|4112456|B5||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4287340|NCT00548249|4112457|B4||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4287341|NCT00548249|4112458|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4287342|NCT00548249|4112459|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4287343|NCT00548249|4112460|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4287344|NCT00548249|4112455|B6||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
4287345|NCT00548249|4112456|B5||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4287346|NCT00548249|4112457|B4||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4287347|NCT00548249|4112458|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4287348|NCT00548249|4112459|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4287349|NCT00548249|4112460|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4287350|NCT00548249|4112455|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4287351|NCT00548249|4112456|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4287352|NCT00548249|4112457|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4287353|NCT00548249|4112458|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4287354|NCT00548249|4112459|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4287355|NCT00548249|4112460|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4287356|NCT00548197|4112501|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4287357|NCT00548197|4112502|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4287358|NCT00548197|4112503|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4287359|NCT00548197|4112501|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4287360|NCT00548197|4112502|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4287361|NCT00548197|4112503|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4287362|NCT00548197|4112501|B3|||Age||years|Mean|54.63|54.63|Standard Deviation|11.48|11.48|||
4287363|NCT00548197|4112502|B2|||Age||years|Mean|53.2|53.2|Standard Deviation|11.7|11.7|||
4287364|NCT00548197|4112503|B1|||Age||years|Mean|55.8|55.8|Standard Deviation|11.3|11.3|||
4287365|NCT00548184|4112512|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4287366|NCT00548184|4112512|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4287367|NCT00548184|4112512|B1|||Age||years|Median|49|49.0|Full Range|||31.0|74.0|
4287368|NCT00548145|4112516|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4287369|NCT00548145|4112517|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4287370|NCT00548145|4112518|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4287371|NCT00548145|4112516|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4287372|NCT00548145|4112517|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4287373|NCT00548145|4112518|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4287374|NCT00548145|4112516|B3|||Age||years|Mean|75.5|75.5|Standard Deviation|7.4|7.4|||
4287375|NCT00548145|4112517|B2|||Age||years|Mean|75.3|75.3|Standard Deviation|7.7|7.7|||
4287376|NCT00548145|4112518|B1|||Age||years|Mean|75.8|75.8|Standard Deviation|7.2|7.2|||
4287377|NCT00548132|4112525|B3|United States||Region of Enrollment||participants|Number|1088|1088.0||||||
4287378|NCT00548132|4112526|B2|United States||Region of Enrollment||participants|Number|554|554.0||||||
4287379|NCT00548132|4112527|B1|United States||Region of Enrollment||participants|Number|534|534.0||||||
4287380|NCT00548132|4112525|B3||Male|Sex: Female, Male||Participants|Count of Participants|459|459.0||||||
4287381|NCT00548132|4112526|B2||Male|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4287382|NCT00548132|4112527|B1||Male|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4287383|NCT00548132|4112525|B3||Female|Sex: Female, Male||Participants|Count of Participants|629|629.0||||||
4287384|NCT00548132|4112526|B2||Female|Sex: Female, Male||Participants|Count of Participants|325|325.0||||||
4287385|NCT00548132|4112527|B1||Female|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
4287386|NCT00548132|4112525|B3|||Age|Age at enrollment was collected for this measure|years|Mean|58.47|58.47|Standard Deviation|16.84|16.84|||
4287387|NCT00548132|4112526|B2|||Age|Age at enrollment was collected for this measure|years|Mean|58.70|58.7|Standard Deviation|16.83|16.83|||
4287388|NCT00548132|4112527|B1|||Age|Age at enrollment was collected for this measure|years|Mean|58.26|58.26|Standard Deviation|16.88|16.88|||
4287389|NCT00548041|4112536|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
4287390|NCT00548041|4112536|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4287391|NCT00548041|4112536|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4287392|NCT00548041|4112536|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4287393|NCT00548041|4112536|B1||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
4287394|NCT00548041|4112536|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4287395|NCT00547911|4112540|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4287396|NCT00547911|4112541|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4287397|NCT00547911|4112542|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4287398|NCT00547911|4112543|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4287399|NCT00547911|4112544|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4287400|NCT00547911|4112540|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4287401|NCT00547911|4112541|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4287402|NCT00547911|4112542|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4287403|NCT00547911|4112543|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4287404|NCT00547911|4112544|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4287405|NCT00547911|4112540|B5|||Age||years|Mean|64.0|64.0|Standard Deviation|8.8|8.8|||
4287406|NCT00547911|4112541|B4|||Age||years|Mean|65.0|65.0|Standard Deviation|7.1|7.1|||
4287407|NCT00547911|4112542|B3|||Age||years|Mean|57.0|57.0|Standard Deviation|0|0.0|||
4287408|NCT00547911|4112543|B2|||Age||years|Mean|68.6|68.6|Standard Deviation|8.1|8.1|||
4287409|NCT00547911|4112544|B1|||Age||years|Mean|53.5|53.5|Standard Deviation|1.5|1.5|||
4287410|NCT00547703|4112578|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4287411|NCT00547703|4112579|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4287412|NCT00547703|4112580|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4287413|NCT00547703|4112578|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4287414|NCT00547703|4112579|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4287415|NCT00547703|4112580|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4287416|NCT00547703|4112578|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4287417|NCT00547703|4112579|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4287418|NCT00547703|4112580|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4287419|NCT00547703|4112578|B3|||Age||years|Mean|42|42.0|Standard Deviation|4|4.0|||
4287420|NCT00547703|4112579|B2|||Age||years|Mean|43|43.0|Standard Deviation|0|0.0|||
4287421|NCT00547703|4112580|B1|||Age||years|Mean|42|42.0|Standard Deviation|4|4.0|||
4287422|NCT00547703|4112578|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4287423|NCT00547703|4112579|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4287424|NCT00547703|4112580|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4287425|NCT00547703|4112578|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4287426|NCT00547703|4112579|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4287427|NCT00547703|4112580|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4287428|NCT00547703|4112578|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4287429|NCT00547703|4112579|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4287430|NCT00547703|4112580|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4287431|NCT00547638|4112587|B3|United States||Region of Enrollment||Participants|Number|216|216.0||||||
4287432|NCT00547638|4112588|B2|United States||Region of Enrollment||Participants|Number|73|73.0||||||
4287433|NCT00547638|4112589|B1|United States||Region of Enrollment||Participants|Number|143|143.0||||||
4287434|NCT00547638|4112587|B3||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4287435|NCT00547638|4112588|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4287436|NCT00547638|4112589|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4287437|NCT00547638|4112587|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4287438|NCT00547638|4112588|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4287439|NCT00547638|4112589|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4287440|NCT00547638|4112587|B3|||Age||years|Mean|25.2|25.2|Standard Deviation|18.9|18.9|||
4287441|NCT00547638|4112588|B2|||Age||years|Mean|25.7|25.7|Standard Deviation|19.8|19.8|||
4287442|NCT00547638|4112589|B1|||Age||years|Mean|25.0|25.0|Standard Deviation|18.4|18.4|||
4287443|NCT00547638|4112587|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4287444|NCT00547638|4112588|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4287445|NCT00547638|4112589|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4287446|NCT00547638|4112587|B3||Between 18 and 65 years|Age||Participants|Count of Participants|128|128.0||||||
4287447|NCT00547638|4112588|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4287448|NCT00547638|4112589|B1||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
4287449|NCT00547638|4112587|B3||<=18 years|Age||Participants|Count of Participants|82|82.0||||||
4287450|NCT00547638|4112588|B2||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4287451|NCT00547638|4112589|B1||<=18 years|Age||Participants|Count of Participants|52|52.0||||||
4287452|NCT00547534|4112606|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4287453|NCT00547534|4112606|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4287454|NCT00547534|4112606|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4287455|NCT00547534|4112606|B1|||Age||years|Mean|64.8|64.8|Standard Deviation|20|20.0|||
4287456|NCT00547534|4112606|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4287457|NCT00547534|4112606|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4287458|NCT00547534|4112606|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4287459|NCT00547521|4112612|B3|Negative||Rheumatoid Factor (RF) Status|RF is an autoantibody that is usually present in the serum of people with rheumatoid arthritis. The cut-point value for seroconversion was 15 International Unit (IU)/mL (>= 15 IU/mL resulted in a positive result).|participants|Number|30|30.0||||||
4287460|NCT00547521|4112613|B2|Negative||Rheumatoid Factor (RF) Status|RF is an autoantibody that is usually present in the serum of people with rheumatoid arthritis. The cut-point value for seroconversion was 15 International Unit (IU)/mL (>= 15 IU/mL resulted in a positive result).|participants|Number|15|15.0||||||
4287461|NCT00547521|4112614|B1|Negative||Rheumatoid Factor (RF) Status|RF is an autoantibody that is usually present in the serum of people with rheumatoid arthritis. The cut-point value for seroconversion was 15 International Unit (IU)/mL (>= 15 IU/mL resulted in a positive result).|participants|Number|15|15.0||||||
4287462|NCT00547521|4112612|B3|Positive||Rheumatoid Factor (RF) Status|RF is an autoantibody that is usually present in the serum of people with rheumatoid arthritis. The cut-point value for seroconversion was 15 International Unit (IU)/mL (>= 15 IU/mL resulted in a positive result).|participants|Number|67|67.0||||||
4287463|NCT00547521|4112613|B2|Positive||Rheumatoid Factor (RF) Status|RF is an autoantibody that is usually present in the serum of people with rheumatoid arthritis. The cut-point value for seroconversion was 15 International Unit (IU)/mL (>= 15 IU/mL resulted in a positive result).|participants|Number|32|32.0||||||
4287464|NCT00547521|4112614|B1|Positive||Rheumatoid Factor (RF) Status|RF is an autoantibody that is usually present in the serum of people with rheumatoid arthritis. The cut-point value for seroconversion was 15 International Unit (IU)/mL (>= 15 IU/mL resulted in a positive result).|participants|Number|35|35.0||||||
4287465|NCT00547521|4112612|B3|Unknown||Rheumatoid Factor (RF) Status|RF is an autoantibody that is usually present in the serum of people with rheumatoid arthritis. The cut-point value for seroconversion was 15 International Unit (IU)/mL (>= 15 IU/mL resulted in a positive result).|participants|Number|3|3.0||||||
4287466|NCT00547521|4112613|B2|Unknown||Rheumatoid Factor (RF) Status|RF is an autoantibody that is usually present in the serum of people with rheumatoid arthritis. The cut-point value for seroconversion was 15 International Unit (IU)/mL (>= 15 IU/mL resulted in a positive result).|participants|Number|2|2.0||||||
4287467|NCT00547521|4112614|B1|Unknown||Rheumatoid Factor (RF) Status|RF is an autoantibody that is usually present in the serum of people with rheumatoid arthritis. The cut-point value for seroconversion was 15 International Unit (IU)/mL (>= 15 IU/mL resulted in a positive result).|participants|Number|1|1.0||||||
4287468|NCT00547521|4112612|B3|||Health Assessment Questionnaire - Disability Index (HAQ-DI)|HAQ-DI takes into account participant's use of aids or devices or assistance in scoring algorithm for a disability category. The questionnaire includes 20 questions assessing physical function in 8 domains: dressing, arising, eating, walking, hygiene, reach, grip, and common activities. The questions are evaluated on a 4-point scale: 0 = without any difficulty, 1 = with some difficulty, 2 = with much difficulty and 3 = unable to do. Higher scores indicate greater dysfunction. The score is calculated by summing worst scores in each domain and dividing by the number of domains answered.|Units on a scale|Mean|1.4|1.4|Standard Deviation|0.7|0.7|||
4287469|NCT00547521|4112613|B2|||Health Assessment Questionnaire - Disability Index (HAQ-DI)|HAQ-DI takes into account participant's use of aids or devices or assistance in scoring algorithm for a disability category. The questionnaire includes 20 questions assessing physical function in 8 domains: dressing, arising, eating, walking, hygiene, reach, grip, and common activities. The questions are evaluated on a 4-point scale: 0 = without any difficulty, 1 = with some difficulty, 2 = with much difficulty and 3 = unable to do. Higher scores indicate greater dysfunction. The score is calculated by summing worst scores in each domain and dividing by the number of domains answered.|Units on a scale|Mean|1.5|1.5|Standard Deviation|0.7|0.7|||
4287470|NCT00547521|4112614|B1|||Health Assessment Questionnaire - Disability Index (HAQ-DI)|HAQ-DI takes into account participant's use of aids or devices or assistance in scoring algorithm for a disability category. The questionnaire includes 20 questions assessing physical function in 8 domains: dressing, arising, eating, walking, hygiene, reach, grip, and common activities. The questions are evaluated on a 4-point scale: 0 = without any difficulty, 1 = with some difficulty, 2 = with much difficulty and 3 = unable to do. Higher scores indicate greater dysfunction. The score is calculated by summing worst scores in each domain and dividing by the number of domains answered.|Units on a scale|Mean|1.3|1.3|Standard Deviation|0.7|0.7|||
4287500|NCT00547521|4112614|B1|||Weight continuous||kilogram (Kg)|Mean|84.6|84.6|Standard Deviation|18.8|18.8|||
4287501|NCT00547521|4112612|B3|Other races||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4287471|NCT00547521|4112612|B3|||Physician global assessment per VAS|Physician Global Assessment is measured by VAS (100 mm). A Visual Analogue Scale (VAS) is a measurement instrument for characteristics that range across a continuum of values. Range is 1-100; a lower score indicates a better Physician Assessment of Global Health.|mm|Mean|57.7|57.7|Standard Deviation|19.5|19.5|||
4287472|NCT00547521|4112613|B2|||Physician global assessment per VAS|Physician Global Assessment is measured by VAS (100 mm). A Visual Analogue Scale (VAS) is a measurement instrument for characteristics that range across a continuum of values. Range is 1-100; a lower score indicates a better Physician Assessment of Global Health.|mm|Mean|63.9|63.9|Standard Deviation|20.5|20.5|||
4287473|NCT00547521|4112614|B1|||Physician global assessment per VAS|Physician Global Assessment is measured by VAS (100 mm). A Visual Analogue Scale (VAS) is a measurement instrument for characteristics that range across a continuum of values. Range is 1-100; a lower score indicates a better Physician Assessment of Global Health.|mm|Mean|51.6|51.6|Standard Deviation|16.4|16.4|||
4287474|NCT00547521|4112612|B3|||Subject global assessment per VAS|Subject Global Assessment is measured by VAS (100 mm). A Visual Analogue Scale (VAS) is a measurement instrument for characteristics that range across a continuum of values. Range is 1-100; a lower score indicates a better Subject Assessment of Global Health.|mm|Mean|65.0|65.0|Standard Deviation|21.2|21.2|||
4287475|NCT00547521|4112613|B2|||Subject global assessment per VAS|Subject Global Assessment is measured by VAS (100 mm). A Visual Analogue Scale (VAS) is a measurement instrument for characteristics that range across a continuum of values. Range is 1-100; a lower score indicates a better Subject Assessment of Global Health.|mm|Mean|69.9|69.9|Standard Deviation|22.6|22.6|||
4287476|NCT00547521|4112614|B1|||Subject global assessment per VAS|Subject Global Assessment is measured by VAS (100 mm). A Visual Analogue Scale (VAS) is a measurement instrument for characteristics that range across a continuum of values. Range is 1-100; a lower score indicates a better Subject Assessment of Global Health.|mm|Mean|60.4|60.4|Standard Deviation|18.9|18.9|||
4287477|NCT00547521|4112612|B3|||Subject pain assessment per Visual Analogue Scale(VAS)|Subject Pain Assessment measured by VAS (100 mm). A Visual Analogue Scale (VAS) is a measurement instrument for characteristics that range across a continuum of values. Range is 1-100; a lower value signifies a better Subject Pain Assessment.|millimeters (mm)|Mean|66.8|66.8|Standard Deviation|19.6|19.6|||
4287478|NCT00547521|4112613|B2|||Subject pain assessment per Visual Analogue Scale(VAS)|Subject Pain Assessment measured by VAS (100 mm). A Visual Analogue Scale (VAS) is a measurement instrument for characteristics that range across a continuum of values. Range is 1-100; a lower value signifies a better Subject Pain Assessment.|millimeters (mm)|Mean|70.5|70.5|Standard Deviation|19.6|19.6|||
4287479|NCT00547521|4112614|B1|||Subject pain assessment per Visual Analogue Scale(VAS)|Subject Pain Assessment measured by VAS (100 mm). A Visual Analogue Scale (VAS) is a measurement instrument for characteristics that range across a continuum of values. Range is 1-100; a lower value signifies a better Subject Pain Assessment.|millimeters (mm)|Mean|63.3|63.3|Standard Deviation|19.1|19.1|||
4287480|NCT00547521|4112612|B3|||Swollen joints|Total number of joints analyzed=66.|swollen joints|Mean|17.2|17.2|Standard Deviation|12.1|12.1|||
4287481|NCT00547521|4112613|B2|||Swollen joints|Total number of joints analyzed=66.|swollen joints|Mean|18.3|18.3|Standard Deviation|12.2|12.2|||
4287482|NCT00547521|4112614|B1|||Swollen joints|Total number of joints analyzed=66.|swollen joints|Mean|16.2|16.2|Standard Deviation|12.0|12.0|||
4287483|NCT00547521|4112612|B3|||Tender joints|Total number of joints analyzed=68.|tender joints|Mean|24.1|24.1|Standard Deviation|16.2|16.2|||
4287484|NCT00547521|4112613|B2|||Tender joints|Total number of joints analyzed=68.|tender joints|Mean|24.3|24.3|Standard Deviation|14.2|14.2|||
4287485|NCT00547521|4112614|B1|||Tender joints|Total number of joints analyzed=68.|tender joints|Mean|23.9|23.9|Standard Deviation|18.0|18.0|||
4287486|NCT00547521|4112612|B3|||Disease activity score C-reactive protein (DAS 28-CRP)|DAS28-CRP is a continuous variable which is a composite of 4 variables: the number of tender joint out of 28, the number of swollen joint out of 28, C-reactive protein (CRP) in milligrams/Liter (mg/L) and participant assessment of disease activity measured on a visual analogue scale (VAS) of 100 millimeters (mm). DAS 28 = 0.56 * sqrt(tender28) + 0.28 * sqrt(swollen28) + 0.36 * ln(CRP+1) + 0.014 * VAS + 0.96.|Units on a scale|Mean|5.4|5.4|Standard Deviation|1.4|1.4|||
4287487|NCT00547521|4112613|B2|||Disease activity score C-reactive protein (DAS 28-CRP)|DAS28-CRP is a continuous variable which is a composite of 4 variables: the number of tender joint out of 28, the number of swollen joint out of 28, C-reactive protein (CRP) in milligrams/Liter (mg/L) and participant assessment of disease activity measured on a visual analogue scale (VAS) of 100 millimeters (mm). DAS 28 = 0.56 * sqrt(tender28) + 0.28 * sqrt(swollen28) + 0.36 * ln(CRP+1) + 0.014 * VAS + 0.96.|Units on a scale|Mean|5.8|5.8|Standard Deviation|1.5|1.5|||
4287488|NCT00547521|4112614|B1|||Disease activity score C-reactive protein (DAS 28-CRP)|DAS28-CRP is a continuous variable which is a composite of 4 variables: the number of tender joint out of 28, the number of swollen joint out of 28, C-reactive protein (CRP) in milligrams/Liter (mg/L) and participant assessment of disease activity measured on a visual analogue scale (VAS) of 100 millimeters (mm). DAS 28 = 0.56 * sqrt(tender28) + 0.28 * sqrt(swollen28) + 0.36 * ln(CRP+1) + 0.014 * VAS + 0.96.|Units on a scale|Mean|5.1|5.1|Standard Deviation|1.2|1.2|||
4287489|NCT00547521|4112612|B3|> 100 Kg||Weight customized||participants|Number|21|21.0||||||
4287490|NCT00547521|4112613|B2|> 100 Kg||Weight customized||participants|Number|10|10.0||||||
4287491|NCT00547521|4112614|B1|> 100 Kg||Weight customized||participants|Number|11|11.0||||||
4287492|NCT00547521|4112612|B3|60 - 100 Kg||Weight customized||participants|Number|67|67.0||||||
4287493|NCT00547521|4112613|B2|60 - 100 Kg||Weight customized||participants|Number|31|31.0||||||
4287494|NCT00547521|4112614|B1|60 - 100 Kg||Weight customized||participants|Number|36|36.0||||||
4287495|NCT00547521|4112612|B3|< 60 Kg||Weight customized||participants|Number|12|12.0||||||
4287496|NCT00547521|4112613|B2|< 60 Kg||Weight customized||participants|Number|8|8.0||||||
4287497|NCT00547521|4112614|B1|< 60 Kg||Weight customized||participants|Number|4|4.0||||||
4287498|NCT00547521|4112612|B3|||Weight continuous||kilogram (Kg)|Mean|83.1|83.1|Standard Deviation|20.6|20.6|||
4287499|NCT00547521|4112613|B2|||Weight continuous||kilogram (Kg)|Mean|81.6|81.6|Standard Deviation|22.4|22.4|||
4287502|NCT00547521|4112613|B2|Other races||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4287503|NCT00547521|4112614|B1|Other races||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4287504|NCT00547521|4112612|B3|Asian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4287505|NCT00547521|4112613|B2|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4287506|NCT00547521|4112614|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4287507|NCT00547521|4112612|B3|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4287508|NCT00547521|4112613|B2|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4287509|NCT00547521|4112614|B1|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4287510|NCT00547521|4112612|B3|Black||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4287511|NCT00547521|4112613|B2|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4287512|NCT00547521|4112614|B1|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4287513|NCT00547521|4112612|B3|White||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
4287514|NCT00547521|4112613|B2|White||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4287515|NCT00547521|4112614|B1|White||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4287516|NCT00547521|4112612|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4287517|NCT00547521|4112613|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4287518|NCT00547521|4112614|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4287519|NCT00547521|4112612|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4287520|NCT00547521|4112613|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4287521|NCT00547521|4112614|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4287522|NCT00547521|4112612|B3|||Age||years|Median|54.0|54.0|Full Range|10.9|10.9|26.0|84.0|
4287523|NCT00547521|4112613|B2|||Age||years|Median|54.0|54.0|Full Range|10.2|10.2|26.0|68.0|
4287524|NCT00547521|4112614|B1|||Age||years|Median|55.0|55.0|Full Range|11.5|11.5|34.0|84.0|
4287525|NCT00547456|4112685|B1|||Number of Participants with Nocturnal and Daytime Hypoxemia in COPD||participants|Number|20|20.0||||||
4287526|NCT00547456|4112685|B1|||nocturnal hypoxemia||participants|Number|20|20.0||||||
4287527|NCT00547456|4112685|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4287528|NCT00547456|4112685|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4287529|NCT00547456|4112685|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4287530|NCT00547456|4112685|B1|||Age||years|Mean|50|50.0|Full Range|||40.0|64.0|
4287531|NCT00547456|4112685|B1||>=65 years|Age|participants between the ages of 18-65|Participants|Count of Participants|0|0.0||||||
4287532|NCT00547456|4112685|B1||Between 18 and 65 years|Age|participants between the ages of 18-65|Participants|Count of Participants|20|20.0||||||
4287533|NCT00547456|4112685|B1||<=18 years|Age|participants between the ages of 18-65|Participants|Count of Participants|0|0.0||||||
4287534|NCT00547378|4112689|B4|||Baseline Voids/Day||Voids/Day|Mean|12.5|12.5|Standard Deviation|4.5|4.5|||
4287535|NCT00547378|4112690|B3|||Baseline Voids/Day||Voids/Day|Mean|13.1|13.1|Standard Deviation|4.8|4.8|||
4287536|NCT00547378|4112691|B2|||Baseline Voids/Day||Voids/Day|Mean|11.9|11.9|Standard Deviation|4.3|4.3|||
4287537|NCT00547378|4112692|B1|||Baseline Voids/Day||Voids/Day|Mean|11.2|11.2|Standard Deviation|2.9|2.9|||
4287538|NCT00547378|4112689|B4|||Baseline Leaks/Day||Leaks/Day|Mean|3.0|3.0|Standard Deviation|2.6|2.6|||
4287539|NCT00547378|4112690|B3|||Baseline Leaks/Day||Leaks/Day|Mean|3.4|3.4|Standard Deviation|3.0|3.0|||
4287540|NCT00547378|4112691|B2|||Baseline Leaks/Day||Leaks/Day|Mean|2.7|2.7|Standard Deviation|1.9|1.9|||
4287541|NCT00547378|4112692|B1|||Baseline Leaks/Day||Leaks/Day|Mean|2.4|2.4|Standard Deviation|1.7|1.7|||
4287542|NCT00547378|4112689|B4|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4287543|NCT00547378|4112690|B3|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4287544|NCT00547378|4112691|B2|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4287545|NCT00547378|4112692|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4287546|NCT00547378|4112689|B4|Race|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4287547|NCT00547378|4112690|B3|Race|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4287548|NCT00547378|4112691|B2|Race|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4287549|NCT00547378|4112692|B1|Race|Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4287550|NCT00547378|4112689|B4|Race|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4287551|NCT00547378|4112690|B3|Race|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4287552|NCT00547378|4112691|B2|Race|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4287553|NCT00547378|4112692|B1|Race|American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4287554|NCT00547378|4112689|B4|Race|American Indian or Alaska Native/White|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4287555|NCT00547378|4112690|B3|Race|American Indian or Alaska Native/White|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4287556|NCT00547378|4112691|B2|Race|American Indian or Alaska Native/White|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4287557|NCT00547378|4112692|B1|Race|American Indian or Alaska Native/White|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4287558|NCT00547378|4112689|B4|Race|Asian/White|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4287559|NCT00547378|4112690|B3|Race|Asian/White|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4287560|NCT00547378|4112691|B2|Race|Asian/White|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4287561|NCT00547378|4112692|B1|Race|Asian/White|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4287562|NCT00547378|4112689|B4|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
4287563|NCT00547378|4112690|B3|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4287564|NCT00547378|4112691|B2|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4287565|NCT00547378|4112692|B1|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4287566|NCT00547378|4112689|B4|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|292|292.0||||||
4287567|NCT00547378|4112690|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|161|161.0||||||
4287568|NCT00547378|4112691|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|70|70.0||||||
4287569|NCT00547378|4112692|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|61|61.0||||||
4287570|NCT00547378|4112689|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287571|NCT00547378|4112690|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287572|NCT00547378|4112691|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287573|NCT00547378|4112692|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287574|NCT00547378|4112689|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|317|317.0||||||
4287575|NCT00547378|4112690|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|173|173.0||||||
4287576|NCT00547378|4112691|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
4287577|NCT00547378|4112692|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4287578|NCT00547378|4112689|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4287579|NCT00547378|4112690|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4287580|NCT00547378|4112691|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287581|NCT00547378|4112692|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4287582|NCT00547378|4112689|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4287583|NCT00547378|4112690|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4287584|NCT00547378|4112691|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4287585|NCT00547378|4112692|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4287586|NCT00547378|4112689|B4||Female|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
4287587|NCT00547378|4112690|B3||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4287588|NCT00547378|4112691|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4287589|NCT00547378|4112692|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4287590|NCT00547378|4112689|B4|Age, years||Age, Customized||years|Mean|57.9|57.9|Standard Deviation|14.5|14.5|||
4287591|NCT00547378|4112690|B3|Age, years||Age, Customized||years|Mean|57.2|57.2|Standard Deviation|14.1|14.1|||
4287592|NCT00547378|4112691|B2|Age, years||Age, Customized||years|Mean|57.1|57.1|Standard Deviation|15.3|15.3|||
4287593|NCT00547378|4112692|B1|Age, years||Age, Customized||years|Mean|60.4|60.4|Standard Deviation|14.4|14.4|||
4287594|NCT00547365|4112704|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4287595|NCT00547365|4112704|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4287596|NCT00547365|4112704|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4287597|NCT00547365|4112704|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4287598|NCT00547365|4112704|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4287599|NCT00547365|4112704|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4287600|NCT00547157|4112709|B3|T4||Tumor Stage|Tumor stage is determined according to TNM staging system. The tumor, node, and metastasis (TNM) staging system integrates clinical information, including that derived from endoscopy and radiological evaluation. Together the TNM classifications determine the overall clinical stage (I, II, III or IV).|Participants|Number|55|55.0||||||
4287601|NCT00547157|4112710|B2|T4||Tumor Stage|Tumor stage is determined according to TNM staging system. The tumor, node, and metastasis (TNM) staging system integrates clinical information, including that derived from endoscopy and radiological evaluation. Together the TNM classifications determine the overall clinical stage (I, II, III or IV).|Participants|Number|23|23.0||||||
4287602|NCT00547157|4112711|B1|T4||Tumor Stage|Tumor stage is determined according to TNM staging system. The tumor, node, and metastasis (TNM) staging system integrates clinical information, including that derived from endoscopy and radiological evaluation. Together the TNM classifications determine the overall clinical stage (I, II, III or IV).|Participants|Number|32|32.0||||||
4287603|NCT00547157|4112709|B3|T1-3||Tumor Stage|Tumor stage is determined according to TNM staging system. The tumor, node, and metastasis (TNM) staging system integrates clinical information, including that derived from endoscopy and radiological evaluation. Together the TNM classifications determine the overall clinical stage (I, II, III or IV).|Participants|Number|97|97.0||||||
4287604|NCT00547157|4112710|B2|T1-3||Tumor Stage|Tumor stage is determined according to TNM staging system. The tumor, node, and metastasis (TNM) staging system integrates clinical information, including that derived from endoscopy and radiological evaluation. Together the TNM classifications determine the overall clinical stage (I, II, III or IV).|Participants|Number|39|39.0||||||
4287661|NCT00547118|4112729|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4287605|NCT00547157|4112711|B1|T1-3||Tumor Stage|Tumor stage is determined according to TNM staging system. The tumor, node, and metastasis (TNM) staging system integrates clinical information, including that derived from endoscopy and radiological evaluation. Together the TNM classifications determine the overall clinical stage (I, II, III or IV).|Participants|Number|58|58.0||||||
4287606|NCT00547157|4112709|B3|N+||Nodal Status|N0: No regional lymph node involvement; N+: Regional lymph node involvement|Participants|Number|134|134.0||||||
4287607|NCT00547157|4112710|B2|N+||Nodal Status|N0: No regional lymph node involvement; N+: Regional lymph node involvement|Participants|Number|55|55.0||||||
4287608|NCT00547157|4112711|B1|N+||Nodal Status|N0: No regional lymph node involvement; N+: Regional lymph node involvement|Participants|Number|79|79.0||||||
4287609|NCT00547157|4112709|B3|N0||Nodal Status|N0: No regional lymph node involvement; N+: Regional lymph node involvement|Participants|Number|18|18.0||||||
4287610|NCT00547157|4112710|B2|N0||Nodal Status|N0: No regional lymph node involvement; N+: Regional lymph node involvement|Participants|Number|7|7.0||||||
4287611|NCT00547157|4112711|B1|N0||Nodal Status|N0: No regional lymph node involvement; N+: Regional lymph node involvement|Participants|Number|11|11.0||||||
4287612|NCT00547157|4112709|B3|Oral Cavity/Hypopharynx||Primary Tumor Site||Participants|Number|42|42.0||||||
4287613|NCT00547157|4112710|B2|Oral Cavity/Hypopharynx||Primary Tumor Site||Participants|Number|18|18.0||||||
4287614|NCT00547157|4112711|B1|Oral Cavity/Hypopharynx||Primary Tumor Site||Participants|Number|24|24.0||||||
4287615|NCT00547157|4112709|B3|Oropharynx/Larynx||Primary Tumor Site||Participants|Number|110|110.0||||||
4287616|NCT00547157|4112710|B2|Oropharynx/Larynx||Primary Tumor Site||Participants|Number|44|44.0||||||
4287617|NCT00547157|4112711|B1|Oropharynx/Larynx||Primary Tumor Site||Participants|Number|66|66.0||||||
4287618|NCT00547157|4112709|B3|Missing||Radiotherapy Delivery Modality||Participants|Number|1|1.0||||||
4287619|NCT00547157|4112710|B2|Missing||Radiotherapy Delivery Modality||Participants|Number|1|1.0||||||
4287620|NCT00547157|4112711|B1|Missing||Radiotherapy Delivery Modality||Participants|Number|0|0.0||||||
4287621|NCT00547157|4112709|B3|3D-CRT||Radiotherapy Delivery Modality||Participants|Number|70|70.0||||||
4287622|NCT00547157|4112710|B2|3D-CRT||Radiotherapy Delivery Modality||Participants|Number|29|29.0||||||
4287623|NCT00547157|4112711|B1|3D-CRT||Radiotherapy Delivery Modality||Participants|Number|41|41.0||||||
4287624|NCT00547157|4112709|B3|IMRT||Radiotherapy Delivery Modality||Participants|Number|81|81.0||||||
4287625|NCT00547157|4112710|B2|IMRT||Radiotherapy Delivery Modality||Participants|Number|32|32.0||||||
4287626|NCT00547157|4112711|B1|IMRT||Radiotherapy Delivery Modality||Participants|Number|49|49.0||||||
4287627|NCT00547157|4112709|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4287628|NCT00547157|4112710|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4287629|NCT00547157|4112711|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4287630|NCT00547157|4112709|B3|White||Race/Ethnicity, Customized||Participants|Number|148|148.0||||||
4287631|NCT00547157|4112710|B2|White||Race/Ethnicity, Customized||Participants|Number|60|60.0||||||
4287632|NCT00547157|4112711|B1|White||Race/Ethnicity, Customized||Participants|Number|88|88.0||||||
4287633|NCT00547157|4112709|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4287634|NCT00547157|4112710|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4287635|NCT00547157|4112711|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4287636|NCT00547157|4112709|B3|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4287637|NCT00547157|4112710|B2|Asian||Race/Ethnicity, Customized||Participants|Number|00|0.0||||||
4287638|NCT00547157|4112711|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4287639|NCT00547157|4112709|B3||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4287640|NCT00547157|4112710|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4287641|NCT00547157|4112711|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4287642|NCT00547157|4112709|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4287643|NCT00547157|4112710|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4287644|NCT00547157|4112711|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4287645|NCT00547157|4112709|B3|||Age||Years|Mean|57.1|57.1|Standard Deviation|8.1|8.1|||
4287646|NCT00547157|4112710|B2|||Age||Years|Mean|57.4|57.4|Standard Deviation|7.9|7.9|||
4287647|NCT00547157|4112711|B1|||Age||Years|Mean|56.9|56.9|Standard Deviation|8.3|8.3|||
4287648|NCT00547118|4112728|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4287649|NCT00547118|4112729|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4287650|NCT00547118|4112730|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4287651|NCT00547118|4112728|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287652|NCT00547118|4112729|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287653|NCT00547118|4112730|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287654|NCT00547118|4112728|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287655|NCT00547118|4112729|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287656|NCT00547118|4112730|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287657|NCT00547118|4112728|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4287658|NCT00547118|4112729|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4287659|NCT00547118|4112730|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4287660|NCT00547118|4112728|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4287662|NCT00547118|4112730|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4287663|NCT00547118|4112728|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287664|NCT00547118|4112729|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287665|NCT00547118|4112730|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287666|NCT00547118|4112728|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287667|NCT00547118|4112729|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287668|NCT00547118|4112730|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287669|NCT00547118|4112728|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287670|NCT00547118|4112729|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287671|NCT00547118|4112730|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287672|NCT00547118|4112728|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4287673|NCT00547118|4112729|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4287674|NCT00547118|4112730|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4287675|NCT00547118|4112728|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4287676|NCT00547118|4112729|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4287677|NCT00547118|4112730|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4287678|NCT00547118|4112728|B3|||Age||Years|Mean|45.7|45.7|Standard Deviation|8.4|8.4|||
4287679|NCT00547118|4112729|B2|||Age||Years|Mean|42.4|42.4|Standard Deviation|13.3|13.3|||
4287680|NCT00547118|4112730|B1|||Age||Years|Mean|45.9|45.9|Standard Deviation|6.9|6.9|||
4287681|NCT00547118|4112728|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4287682|NCT00547118|4112729|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4287683|NCT00547118|4112730|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4287684|NCT00547118|4112728|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4287685|NCT00547118|4112729|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4287686|NCT00547118|4112730|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4287687|NCT00547118|4112728|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4287688|NCT00547118|4112729|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4287689|NCT00547118|4112730|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4287690|NCT00547105|4112763|B1|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
4287691|NCT00547105|4112763|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4287692|NCT00547105|4112763|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4287693|NCT00547105|4112763|B1|||Age||years|Median|67|67.0|Full Range|||56.0|86.0|
4287694|NCT00546910|4112773|B3|Item 11 Subscore||Weekly Rating Of Evening & Morning Behavior-Revised-Investigator Rated, Total & Subscores|Weekly Rating Of Evening & Morning Behavior-Revised-Investigator Rated (WREMB-R-Inv) measures the level of difficulty of 11 common morning or evening behaviors (e.g. getting out of bed, doing homework, sitting through dinner). Possible scores for each item range from 0 (no difficulty) to 3 (a lot of difficulty) with a Total score (maximum score=33), Morning subscore (maximum score=9), Evening subscore (maximum score=24), and Item 11 score which pertains to degree of difficulty falling asleep (maximum score=3).|units on a scale|Mean|1.58|1.58|Standard Deviation|1.24|1.24|||
4287695|NCT00546910|4112774|B2|Item 11 Subscore||Weekly Rating Of Evening & Morning Behavior-Revised-Investigator Rated, Total & Subscores|Weekly Rating Of Evening & Morning Behavior-Revised-Investigator Rated (WREMB-R-Inv) measures the level of difficulty of 11 common morning or evening behaviors (e.g. getting out of bed, doing homework, sitting through dinner). Possible scores for each item range from 0 (no difficulty) to 3 (a lot of difficulty) with a Total score (maximum score=33), Morning subscore (maximum score=9), Evening subscore (maximum score=24), and Item 11 score which pertains to degree of difficulty falling asleep (maximum score=3).|units on a scale|Mean|1.56|1.56|Standard Deviation|1.26|1.26|||
4287696|NCT00546910|4112775|B1|Item 11 Subscore||Weekly Rating Of Evening & Morning Behavior-Revised-Investigator Rated, Total & Subscores|Weekly Rating Of Evening & Morning Behavior-Revised-Investigator Rated (WREMB-R-Inv) measures the level of difficulty of 11 common morning or evening behaviors (e.g. getting out of bed, doing homework, sitting through dinner). Possible scores for each item range from 0 (no difficulty) to 3 (a lot of difficulty) with a Total score (maximum score=33), Morning subscore (maximum score=9), Evening subscore (maximum score=24), and Item 11 score which pertains to degree of difficulty falling asleep (maximum score=3).|units on a scale|Mean|1.60|1.6|Standard Deviation|1.23|1.23|||
4287697|NCT00546910|4112773|B3|Evening Subscore||Weekly Rating Of Evening & Morning Behavior-Revised-Investigator Rated, Total & Subscores|Weekly Rating Of Evening & Morning Behavior-Revised-Investigator Rated (WREMB-R-Inv) measures the level of difficulty of 11 common morning or evening behaviors (e.g. getting out of bed, doing homework, sitting through dinner). Possible scores for each item range from 0 (no difficulty) to 3 (a lot of difficulty) with a Total score (maximum score=33), Morning subscore (maximum score=9), Evening subscore (maximum score=24), and Item 11 score which pertains to degree of difficulty falling asleep (maximum score=3).|units on a scale|Mean|14.96|14.96|Standard Deviation|4.75|4.75|||
4287698|NCT00546910|4112774|B2|Evening Subscore||Weekly Rating Of Evening & Morning Behavior-Revised-Investigator Rated, Total & Subscores|Weekly Rating Of Evening & Morning Behavior-Revised-Investigator Rated (WREMB-R-Inv) measures the level of difficulty of 11 common morning or evening behaviors (e.g. getting out of bed, doing homework, sitting through dinner). Possible scores for each item range from 0 (no difficulty) to 3 (a lot of difficulty) with a Total score (maximum score=33), Morning subscore (maximum score=9), Evening subscore (maximum score=24), and Item 11 score which pertains to degree of difficulty falling asleep (maximum score=3).|units on a scale|Mean|15.39|15.39|Standard Deviation|4.74|4.74|||
4287699|NCT00546910|4112775|B1|Evening Subscore||Weekly Rating Of Evening & Morning Behavior-Revised-Investigator Rated, Total & Subscores|Weekly Rating Of Evening & Morning Behavior-Revised-Investigator Rated (WREMB-R-Inv) measures the level of difficulty of 11 common morning or evening behaviors (e.g. getting out of bed, doing homework, sitting through dinner). Possible scores for each item range from 0 (no difficulty) to 3 (a lot of difficulty) with a Total score (maximum score=33), Morning subscore (maximum score=9), Evening subscore (maximum score=24), and Item 11 score which pertains to degree of difficulty falling asleep (maximum score=3).|units on a scale|Mean|14.54|14.54|Standard Deviation|4.76|4.76|||
4287700|NCT00546910|4112773|B3|Morning Subscore||Weekly Rating Of Evening & Morning Behavior-Revised-Investigator Rated, Total & Subscores|Weekly Rating Of Evening & Morning Behavior-Revised-Investigator Rated (WREMB-R-Inv) measures the level of difficulty of 11 common morning or evening behaviors (e.g. getting out of bed, doing homework, sitting through dinner). Possible scores for each item range from 0 (no difficulty) to 3 (a lot of difficulty) with a Total score (maximum score=33), Morning subscore (maximum score=9), Evening subscore (maximum score=24), and Item 11 score which pertains to degree of difficulty falling asleep (maximum score=3).|units on a scale|Mean|5.10|5.1|Standard Deviation|2.82|2.82|||
4287701|NCT00546910|4112774|B2|Morning Subscore||Weekly Rating Of Evening & Morning Behavior-Revised-Investigator Rated, Total & Subscores|Weekly Rating Of Evening & Morning Behavior-Revised-Investigator Rated (WREMB-R-Inv) measures the level of difficulty of 11 common morning or evening behaviors (e.g. getting out of bed, doing homework, sitting through dinner). Possible scores for each item range from 0 (no difficulty) to 3 (a lot of difficulty) with a Total score (maximum score=33), Morning subscore (maximum score=9), Evening subscore (maximum score=24), and Item 11 score which pertains to degree of difficulty falling asleep (maximum score=3).|units on a scale|Mean|4.63|4.63|Standard Deviation|2.92|2.92|||
4287702|NCT00546910|4112775|B1|Morning Subscore||Weekly Rating Of Evening & Morning Behavior-Revised-Investigator Rated, Total & Subscores|Weekly Rating Of Evening & Morning Behavior-Revised-Investigator Rated (WREMB-R-Inv) measures the level of difficulty of 11 common morning or evening behaviors (e.g. getting out of bed, doing homework, sitting through dinner). Possible scores for each item range from 0 (no difficulty) to 3 (a lot of difficulty) with a Total score (maximum score=33), Morning subscore (maximum score=9), Evening subscore (maximum score=24), and Item 11 score which pertains to degree of difficulty falling asleep (maximum score=3).|units on a scale|Mean|5.56|5.56|Standard Deviation|2.66|2.66|||
4287703|NCT00546910|4112773|B3|Total Score||Weekly Rating Of Evening & Morning Behavior-Revised-Investigator Rated, Total & Subscores|Weekly Rating Of Evening & Morning Behavior-Revised-Investigator Rated (WREMB-R-Inv) measures the level of difficulty of 11 common morning or evening behaviors (e.g. getting out of bed, doing homework, sitting through dinner). Possible scores for each item range from 0 (no difficulty) to 3 (a lot of difficulty) with a Total score (maximum score=33), Morning subscore (maximum score=9), Evening subscore (maximum score=24), and Item 11 score which pertains to degree of difficulty falling asleep (maximum score=3).|units on a scale|Mean|21.64|21.64|Standard Deviation|7.75|7.75|||
4287704|NCT00546910|4112774|B2|Total Score||Weekly Rating Of Evening & Morning Behavior-Revised-Investigator Rated, Total & Subscores|Weekly Rating Of Evening & Morning Behavior-Revised-Investigator Rated (WREMB-R-Inv) measures the level of difficulty of 11 common morning or evening behaviors (e.g. getting out of bed, doing homework, sitting through dinner). Possible scores for each item range from 0 (no difficulty) to 3 (a lot of difficulty) with a Total score (maximum score=33), Morning subscore (maximum score=9), Evening subscore (maximum score=24), and Item 11 score which pertains to degree of difficulty falling asleep (maximum score=3).|units on a scale|Mean|21.58|21.58|Standard Deviation|7.91|7.91|||
4287705|NCT00546910|4112775|B1|Total Score||Weekly Rating Of Evening & Morning Behavior-Revised-Investigator Rated, Total & Subscores|Weekly Rating Of Evening & Morning Behavior-Revised-Investigator Rated (WREMB-R-Inv) measures the level of difficulty of 11 common morning or evening behaviors (e.g. getting out of bed, doing homework, sitting through dinner). Possible scores for each item range from 0 (no difficulty) to 3 (a lot of difficulty) with a Total score (maximum score=33), Morning subscore (maximum score=9), Evening subscore (maximum score=24), and Item 11 score which pertains to degree of difficulty falling asleep (maximum score=3).|units on a scale|Mean|21.70|21.7|Standard Deviation|7.64|7.64|||
4287706|NCT00546910|4112773|B3|||Time Since Onset Of ADHD Symptoms||years|Mean|5.0|5.0|Standard Deviation|2.04|2.04|||
4287707|NCT00546910|4112774|B2|||Time Since Onset Of ADHD Symptoms||years|Mean|5.2|5.2|Standard Deviation|1.95|1.95|||
4287708|NCT00546910|4112775|B1|||Time Since Onset Of ADHD Symptoms||years|Mean|4.9|4.9|Standard Deviation|2.12|2.12|||
4287709|NCT00546910|4112773|B3|||Time Since Initial Diagnosis Of ADHD||years|Mean|1.7|1.7|Standard Deviation|2.06|2.06|||
4287710|NCT00546910|4112774|B2|||Time Since Initial Diagnosis Of ADHD||years|Mean|1.6|1.6|Standard Deviation|1.89|1.89|||
4287711|NCT00546910|4112775|B1|||Time Since Initial Diagnosis Of ADHD||years|Mean|1.8|1.8|Standard Deviation|2.23|2.23|||
4287712|NCT00546910|4112773|B3|||Clinical Global Impressions - Severity Of Attention Deficit Hyperactive Disorder Score|Clinical Global Impressions- Severity Of Attention Deficit Hyperactive Disorder (CGI-S-ADHD) measures severity of the patient's overall severity of ADHD symptoms (1=normal, not at all ill; 7=among the most extremely ill patients).|units on a scale|Mean|5.08|5.08|Standard Deviation|1.06|1.06|||
4287713|NCT00546910|4112774|B2|||Clinical Global Impressions - Severity Of Attention Deficit Hyperactive Disorder Score|Clinical Global Impressions- Severity Of Attention Deficit Hyperactive Disorder (CGI-S-ADHD) measures severity of the patient's overall severity of ADHD symptoms (1=normal, not at all ill; 7=among the most extremely ill patients).|units on a scale|Mean|5.05|5.05|Standard Deviation|1.11|1.11|||
4287714|NCT00546910|4112775|B1|||Clinical Global Impressions - Severity Of Attention Deficit Hyperactive Disorder Score|Clinical Global Impressions- Severity Of Attention Deficit Hyperactive Disorder (CGI-S-ADHD) measures severity of the patient's overall severity of ADHD symptoms (1=normal, not at all ill; 7=among the most extremely ill patients).|units on a scale|Mean|5.11|5.11|Standard Deviation|1.02|1.02|||
4287735|NCT00546910|4112775|B1|None or missing||Number of Participants with Prior Therapy For Attention-Deficit/Hyperactive Disorder (ADHD)|Summarizes number of participants who received previous medication and non-medication attention-deficit/hyperactive disorder (ADHD) therapy.|participants|Number|37|37.0||||||
4287774|NCT00546897|4112796|B1|Unknown||Cytogenetic Risk Category||participants|Number|0|0.0||||||
4287715|NCT00546910|4112773|B3|||ADHD Rating Scale-IV Parent Version: Investigator Administered & Scored, Total Score|ADHD Rating Scale-IV Parent Version: Investigator Administered & Scored (ADHD-RS-IV-PV:IR) measures the 18 symptoms contained in the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition, Text Revision (DSM-IV-TR) diagnosis of Attention-Deficit/Hyperactivity Disorder. Individual item scores range from 0 (none/never or rarely) to 3 (severe/very often). Total scores range from 0 to 54.|units on a scale|Mean|36.99|36.99|Standard Deviation|11.56|11.56|||
4287716|NCT00546910|4112774|B2|||ADHD Rating Scale-IV Parent Version: Investigator Administered & Scored, Total Score|ADHD Rating Scale-IV Parent Version: Investigator Administered & Scored (ADHD-RS-IV-PV:IR) measures the 18 symptoms contained in the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition, Text Revision (DSM-IV-TR) diagnosis of Attention-Deficit/Hyperactivity Disorder. Individual item scores range from 0 (none/never or rarely) to 3 (severe/very often). Total scores range from 0 to 54.|units on a scale|Mean|36.68|36.68|Standard Deviation|12.53|12.53|||
4287717|NCT00546910|4112775|B1|||ADHD Rating Scale-IV Parent Version: Investigator Administered & Scored, Total Score|ADHD Rating Scale-IV Parent Version: Investigator Administered & Scored (ADHD-RS-IV-PV:IR) measures the 18 symptoms contained in the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition, Text Revision (DSM-IV-TR) diagnosis of Attention-Deficit/Hyperactivity Disorder. Individual item scores range from 0 (none/never or rarely) to 3 (severe/very often). Total scores range from 0 to 54.|units on a scale|Mean|37.30|37.3|Standard Deviation|10.62|10.62|||
4287718|NCT00546910|4112773|B3|Step Parent (One Biologic and one step parent)||Summary Of Participants' Living Arrangements|Summarizes the participants' living arrangements according to where they live most of the time.|participants|Number|19|19.0||||||
4287719|NCT00546910|4112774|B2|Step Parent (One Biologic and one step parent)||Summary Of Participants' Living Arrangements|Summarizes the participants' living arrangements according to where they live most of the time.|participants|Number|9|9.0||||||
4287720|NCT00546910|4112775|B1|Step Parent (One Biologic and one step parent)||Summary Of Participants' Living Arrangements|Summarizes the participants' living arrangements according to where they live most of the time.|participants|Number|10|10.0||||||
4287721|NCT00546910|4112773|B3|Single Mother||Summary Of Participants' Living Arrangements|Summarizes the participants' living arrangements according to where they live most of the time.|participants|Number|32|32.0||||||
4287722|NCT00546910|4112774|B2|Single Mother||Summary Of Participants' Living Arrangements|Summarizes the participants' living arrangements according to where they live most of the time.|participants|Number|17|17.0||||||
4287723|NCT00546910|4112775|B1|Single Mother||Summary Of Participants' Living Arrangements|Summarizes the participants' living arrangements according to where they live most of the time.|participants|Number|15|15.0||||||
4287724|NCT00546910|4112773|B3|Nuclear Family (Biological Mother and Father)||Summary Of Participants' Living Arrangements|Summarizes the participants' living arrangements according to where they live most of the time.|participants|Number|74|74.0||||||
4287725|NCT00546910|4112774|B2|Nuclear Family (Biological Mother and Father)||Summary Of Participants' Living Arrangements|Summarizes the participants' living arrangements according to where they live most of the time.|participants|Number|36|36.0||||||
4287726|NCT00546910|4112775|B1|Nuclear Family (Biological Mother and Father)||Summary Of Participants' Living Arrangements|Summarizes the participants' living arrangements according to where they live most of the time.|participants|Number|38|38.0||||||
4287727|NCT00546910|4112773|B3|None or missing||Number of Participants with Psychiatric Comorbidities|Summarizes the psychologic comorbidities of participants. Because some participants may have one or more comorbidities while others may not, the breakdown of psychiatric comorbidities by treatment group does not equal the overall baseline number of participants in each treatment group.|participants|Number|75|75.0||||||
4287728|NCT00546910|4112774|B2|None or missing||Number of Participants with Psychiatric Comorbidities|Summarizes the psychologic comorbidities of participants. Because some participants may have one or more comorbidities while others may not, the breakdown of psychiatric comorbidities by treatment group does not equal the overall baseline number of participants in each treatment group.|participants|Number|37|37.0||||||
4287729|NCT00546910|4112775|B1|None or missing||Number of Participants with Psychiatric Comorbidities|Summarizes the psychologic comorbidities of participants. Because some participants may have one or more comorbidities while others may not, the breakdown of psychiatric comorbidities by treatment group does not equal the overall baseline number of participants in each treatment group.|participants|Number|38|38.0||||||
4287730|NCT00546910|4112773|B3|At least one psychiatric comorbidity||Number of Participants with Psychiatric Comorbidities|Summarizes the psychologic comorbidities of participants. Because some participants may have one or more comorbidities while others may not, the breakdown of psychiatric comorbidities by treatment group does not equal the overall baseline number of participants in each treatment group.|participants|Number|50|50.0||||||
4287731|NCT00546910|4112774|B2|At least one psychiatric comorbidity||Number of Participants with Psychiatric Comorbidities|Summarizes the psychologic comorbidities of participants. Because some participants may have one or more comorbidities while others may not, the breakdown of psychiatric comorbidities by treatment group does not equal the overall baseline number of participants in each treatment group.|participants|Number|25|25.0||||||
4287732|NCT00546910|4112775|B1|At least one psychiatric comorbidity||Number of Participants with Psychiatric Comorbidities|Summarizes the psychologic comorbidities of participants. Because some participants may have one or more comorbidities while others may not, the breakdown of psychiatric comorbidities by treatment group does not equal the overall baseline number of participants in each treatment group.|participants|Number|25|25.0||||||
4287733|NCT00546910|4112773|B3|None or missing||Number of Participants with Prior Therapy For Attention-Deficit/Hyperactive Disorder (ADHD)|Summarizes number of participants who received previous medication and non-medication attention-deficit/hyperactive disorder (ADHD) therapy.|participants|Number|72|72.0||||||
4287734|NCT00546910|4112774|B2|None or missing||Number of Participants with Prior Therapy For Attention-Deficit/Hyperactive Disorder (ADHD)|Summarizes number of participants who received previous medication and non-medication attention-deficit/hyperactive disorder (ADHD) therapy.|participants|Number|35|35.0||||||
4287772|NCT00546897|4112794|B3|Unknown||Cytogenetic Risk Category||participants|Number|2|2.0||||||
4287773|NCT00546897|4112795|B2|Unknown||Cytogenetic Risk Category||participants|Number|2|2.0||||||
4287736|NCT00546910|4112773|B3|Previous treatment for ADHD||Number of Participants with Prior Therapy For Attention-Deficit/Hyperactive Disorder (ADHD)|Summarizes number of participants who received previous medication and non-medication attention-deficit/hyperactive disorder (ADHD) therapy.|participants|Number|53|53.0||||||
4287737|NCT00546910|4112774|B2|Previous treatment for ADHD||Number of Participants with Prior Therapy For Attention-Deficit/Hyperactive Disorder (ADHD)|Summarizes number of participants who received previous medication and non-medication attention-deficit/hyperactive disorder (ADHD) therapy.|participants|Number|27|27.0||||||
4287738|NCT00546910|4112775|B1|Previous treatment for ADHD||Number of Participants with Prior Therapy For Attention-Deficit/Hyperactive Disorder (ADHD)|Summarizes number of participants who received previous medication and non-medication attention-deficit/hyperactive disorder (ADHD) therapy.|participants|Number|26|26.0||||||
4287739|NCT00546910|4112773|B3|None or missing||Number of Participants with Family History of ADHD|Number of participants with at least one biological relative (mother, father, sibling [brother, sister] or grandparent) with ADHD.|participants|Number|54|54.0||||||
4287740|NCT00546910|4112774|B2|None or missing||Number of Participants with Family History of ADHD|Number of participants with at least one biological relative (mother, father, sibling [brother, sister] or grandparent) with ADHD.|participants|Number|27|27.0||||||
4287741|NCT00546910|4112775|B1|None or missing||Number of Participants with Family History of ADHD|Number of participants with at least one biological relative (mother, father, sibling [brother, sister] or grandparent) with ADHD.|participants|Number|27|27.0||||||
4287742|NCT00546910|4112773|B3|At least one known relative with ADHD||Number of Participants with Family History of ADHD|Number of participants with at least one biological relative (mother, father, sibling [brother, sister] or grandparent) with ADHD.|participants|Number|71|71.0||||||
4287743|NCT00546910|4112774|B2|At least one known relative with ADHD||Number of Participants with Family History of ADHD|Number of participants with at least one biological relative (mother, father, sibling [brother, sister] or grandparent) with ADHD.|participants|Number|35|35.0||||||
4287744|NCT00546910|4112775|B1|At least one known relative with ADHD||Number of Participants with Family History of ADHD|Number of participants with at least one biological relative (mother, father, sibling [brother, sister] or grandparent) with ADHD.|participants|Number|36|36.0||||||
4287745|NCT00546910|4112773|B3|ADHD- Predominantly Hyperactive-Impulsive Type||Diagnosis|Breakdown of Attention Deficit/Hyperactivity Disorder (ADHD) diagnosis according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV)|participants|Number|9|9.0||||||
4287746|NCT00546910|4112774|B2|ADHD- Predominantly Hyperactive-Impulsive Type||Diagnosis|Breakdown of Attention Deficit/Hyperactivity Disorder (ADHD) diagnosis according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV)|participants|Number|3|3.0||||||
4287747|NCT00546910|4112775|B1|ADHD- Predominantly Hyperactive-Impulsive Type||Diagnosis|Breakdown of Attention Deficit/Hyperactivity Disorder (ADHD) diagnosis according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV)|participants|Number|6|6.0||||||
4287748|NCT00546910|4112773|B3|ADHD-Predominantly Inattentive Type||Diagnosis|Breakdown of Attention Deficit/Hyperactivity Disorder (ADHD) diagnosis according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV)|participants|Number|28|28.0||||||
4287749|NCT00546910|4112774|B2|ADHD-Predominantly Inattentive Type||Diagnosis|Breakdown of Attention Deficit/Hyperactivity Disorder (ADHD) diagnosis according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV)|participants|Number|11|11.0||||||
4287750|NCT00546910|4112775|B1|ADHD-Predominantly Inattentive Type||Diagnosis|Breakdown of Attention Deficit/Hyperactivity Disorder (ADHD) diagnosis according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV)|participants|Number|17|17.0||||||
4287751|NCT00546910|4112773|B3|ADHD-Combined Type||Diagnosis|Breakdown of Attention Deficit/Hyperactivity Disorder (ADHD) diagnosis according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV)|participants|Number|88|88.0||||||
4287752|NCT00546910|4112774|B2|ADHD-Combined Type||Diagnosis|Breakdown of Attention Deficit/Hyperactivity Disorder (ADHD) diagnosis according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV)|participants|Number|48|48.0||||||
4287753|NCT00546910|4112775|B1|ADHD-Combined Type||Diagnosis|Breakdown of Attention Deficit/Hyperactivity Disorder (ADHD) diagnosis according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV)|participants|Number|40|40.0||||||
4287754|NCT00546910|4112773|B3|Germany||Region of Enrollment||participants|Number|125|125.0||||||
4287755|NCT00546910|4112774|B2|Germany||Region of Enrollment||participants|Number|62|62.0||||||
4287756|NCT00546910|4112775|B1|Germany||Region of Enrollment||participants|Number|63|63.0||||||
4287757|NCT00546910|4112773|B3|African||Race/Ethnicity, Customized|Breakdown of participants by race|participants|Number|1|1.0||||||
4287758|NCT00546910|4112774|B2|African||Race/Ethnicity, Customized|Breakdown of participants by race|participants|Number|0|0.0||||||
4287759|NCT00546910|4112775|B1|African||Race/Ethnicity, Customized|Breakdown of participants by race|participants|Number|1|1.0||||||
4287760|NCT00546910|4112773|B3|Caucasian||Race/Ethnicity, Customized|Breakdown of participants by race|participants|Number|124|124.0||||||
4287761|NCT00546910|4112774|B2|Caucasian||Race/Ethnicity, Customized|Breakdown of participants by race|participants|Number|62|62.0||||||
4287762|NCT00546910|4112775|B1|Caucasian||Race/Ethnicity, Customized|Breakdown of participants by race|participants|Number|62|62.0||||||
4287763|NCT00546910|4112773|B3||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4287764|NCT00546910|4112774|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4287765|NCT00546910|4112775|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4287766|NCT00546910|4112773|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4287767|NCT00546910|4112774|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4287768|NCT00546910|4112775|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4287769|NCT00546910|4112773|B3|||Age||years|Mean|9.0|9.0|Standard Deviation|1.79|1.79|||
4287770|NCT00546910|4112774|B2|||Age||years|Mean|8.9|8.9|Standard Deviation|1.64|1.64|||
4287771|NCT00546910|4112775|B1|||Age||years|Mean|9.1|9.1|Standard Deviation|1.93|1.93|||
4287775|NCT00546897|4112794|B3|Unfavorable||Cytogenetic Risk Category||participants|Number|15|15.0||||||
4287776|NCT00546897|4112795|B2|Unfavorable||Cytogenetic Risk Category||participants|Number|13|13.0||||||
4287777|NCT00546897|4112796|B1|Unfavorable||Cytogenetic Risk Category||participants|Number|2|2.0||||||
4287778|NCT00546897|4112794|B3|Intermediate||Cytogenetic Risk Category||participants|Number|31|31.0||||||
4287779|NCT00546897|4112795|B2|Intermediate||Cytogenetic Risk Category||participants|Number|18|18.0||||||
4287780|NCT00546897|4112796|B1|Intermediate||Cytogenetic Risk Category||participants|Number|13|13.0||||||
4287781|NCT00546897|4112794|B3|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 Fully active, able to carry on all pre-disease performance without restriction.~1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work.~2 Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours.~3 Capable of only limited self-care, confined to bed or chair more than 50% of waking hours.~4 Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.~5 Dead"|participants|Number|5|5.0||||||
4287782|NCT00546897|4112795|B2|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 Fully active, able to carry on all pre-disease performance without restriction.~1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work.~2 Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours.~3 Capable of only limited self-care, confined to bed or chair more than 50% of waking hours.~4 Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.~5 Dead"|participants|Number|4|4.0||||||
4287783|NCT00546897|4112796|B1|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 Fully active, able to carry on all pre-disease performance without restriction.~1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work.~2 Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours.~3 Capable of only limited self-care, confined to bed or chair more than 50% of waking hours.~4 Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.~5 Dead"|participants|Number|1|1.0||||||
4287784|NCT00546897|4112794|B3|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 Fully active, able to carry on all pre-disease performance without restriction.~1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work.~2 Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours.~3 Capable of only limited self-care, confined to bed or chair more than 50% of waking hours.~4 Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.~5 Dead"|participants|Number|17|17.0||||||
4287785|NCT00546897|4112795|B2|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 Fully active, able to carry on all pre-disease performance without restriction.~1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work.~2 Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours.~3 Capable of only limited self-care, confined to bed or chair more than 50% of waking hours.~4 Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.~5 Dead"|participants|Number|13|13.0||||||
4287786|NCT00546897|4112796|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 Fully active, able to carry on all pre-disease performance without restriction.~1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work.~2 Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours.~3 Capable of only limited self-care, confined to bed or chair more than 50% of waking hours.~4 Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.~5 Dead"|participants|Number|4|4.0||||||
4287787|NCT00546897|4112794|B3|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 Fully active, able to carry on all pre-disease performance without restriction.~1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work.~2 Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours.~3 Capable of only limited self-care, confined to bed or chair more than 50% of waking hours.~4 Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.~5 Dead"|participants|Number|26|26.0||||||
4287788|NCT00546897|4112795|B2|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 Fully active, able to carry on all pre-disease performance without restriction.~1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work.~2 Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours.~3 Capable of only limited self-care, confined to bed or chair more than 50% of waking hours.~4 Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.~5 Dead"|participants|Number|16|16.0||||||
4287789|NCT00546897|4112796|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 Fully active, able to carry on all pre-disease performance without restriction.~1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work.~2 Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours.~3 Capable of only limited self-care, confined to bed or chair more than 50% of waking hours.~4 Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair.~5 Dead"|participants|Number|10|10.0||||||
4287790|NCT00546897|4112794|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
4287791|NCT00546897|4112795|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4287792|NCT00546897|4112796|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4287793|NCT00546897|4112794|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4287794|NCT00546897|4112795|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4287795|NCT00546897|4112796|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4287796|NCT00546897|4112794|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4287797|NCT00546897|4112795|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4287798|NCT00546897|4112796|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4287799|NCT00546897|4112794|B3|||Age||years|Median|71|71.0|Full Range|||60.0|88.0|
4287800|NCT00546897|4112795|B2|||Age||years|Median|71|71.0|Full Range|||60.0|88.0|
4287801|NCT00546897|4112796|B1|||Age||years|Median|71|71.0|Full Range|||60.0|86.0|
4287802|NCT00546884|4112833|B3|United States||Region of Enrollment||participants|Number|262|262.0||||||
4287803|NCT00546884|4112834|B2|United States||Region of Enrollment||participants|Number|117|117.0||||||
4287804|NCT00546884|4112835|B1|United States||Region of Enrollment||participants|Number|145|145.0||||||
4287805|NCT00546884|4112833|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287806|NCT00546884|4112834|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287807|NCT00546884|4112835|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287808|NCT00546884|4112833|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4287809|NCT00546884|4112834|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4287810|NCT00546884|4112835|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4287811|NCT00546884|4112833|B3||White|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
4287812|NCT00546884|4112834|B2||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4287813|NCT00546884|4112835|B1||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4287814|NCT00546884|4112833|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|141|141.0||||||
4287815|NCT00546884|4112834|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4287816|NCT00546884|4112835|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
4287817|NCT00546884|4112833|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287818|NCT00546884|4112834|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287819|NCT00546884|4112835|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287820|NCT00546884|4112833|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4287821|NCT00546884|4112834|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4287822|NCT00546884|4112835|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4287823|NCT00546884|4112833|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4287824|NCT00546884|4112834|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4287825|NCT00546884|4112835|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4287826|NCT00546884|4112833|B3||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4287827|NCT00546884|4112834|B2||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4287828|NCT00546884|4112835|B1||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4287829|NCT00546884|4112833|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4287830|NCT00546884|4112834|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4287831|NCT00546884|4112835|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4287832|NCT00546884|4112833|B3|||Age||years|Mean|43.1|43.1|Full Range|||19.0|70.0|
4287833|NCT00546884|4112834|B2|||Age||years|Mean|43.1|43.1|Full Range|||21.0|70.0|
4287834|NCT00546884|4112835|B1|||Age||years|Mean|43.3|43.3|Full Range|||19.0|68.0|
4287835|NCT00546884|4112833|B3||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
4287836|NCT00546884|4112834|B2||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4287837|NCT00546884|4112835|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4287838|NCT00546884|4112833|B3||Between 18 and 65 years|Age||Participants|Count of Participants|217|217.0||||||
4287839|NCT00546884|4112834|B2||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
4287840|NCT00546884|4112835|B1||Between 18 and 65 years|Age||Participants|Count of Participants|123|123.0||||||
4287841|NCT00546884|4112833|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4287842|NCT00546884|4112834|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4287843|NCT00546884|4112835|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4287844|NCT00546871|4112842|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
4287845|NCT00546871|4112842|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4287846|NCT00546871|4112842|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4287847|NCT00546871|4112842|B1|≥ 12 years||Age, Customized||Participants|Number|35|35.0||||||
4287848|NCT00546871|4112842|B1|2 to <12 years||Age, Customized||Participants|Number|14|14.0||||||
4287849|NCT00546819|4112946|B3|>10 to 20 mg of prednisone or equivalent||Daily Corticosteroid Dose Stratum||Participants|Number|39|39.0||||||
4287850|NCT00546819|4112947|B2|>10 to 20 mg of prednisone or equivalent||Daily Corticosteroid Dose Stratum||Participants|Number|14|14.0||||||
4287851|NCT00546819|4112948|B1|>10 to 20 mg of prednisone or equivalent||Daily Corticosteroid Dose Stratum||Participants|Number|25|25.0||||||
4287852|NCT00546819|4112946|B3|5 to 10 mg of prednisone or equivalent||Daily Corticosteroid Dose Stratum||Participants|Number|270|270.0||||||
4287853|NCT00546819|4112947|B2|5 to 10 mg of prednisone or equivalent||Daily Corticosteroid Dose Stratum||Participants|Number|88|88.0||||||
4287854|NCT00546819|4112948|B1|5 to 10 mg of prednisone or equivalent||Daily Corticosteroid Dose Stratum||Participants|Number|182|182.0||||||
4287855|NCT00546819|4112946|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4287856|NCT00546819|4112947|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4287857|NCT00546819|4112948|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4287858|NCT00546819|4112946|B3||Female|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
4287859|NCT00546819|4112947|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4287860|NCT00546819|4112948|B1||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4287861|NCT00546819|4112946|B3|||Age||years|Mean|69.8|69.8|Standard Deviation|7.0|7.0|||
4287862|NCT00546819|4112947|B2|||Age||years|Mean|69.9|69.9|Standard Deviation|7.2|7.2|||
4287863|NCT00546819|4112948|B1|||Age||years|Mean|69.8|69.8|Standard Deviation|6.9|6.9|||
4287864|NCT00546754|4112959|B3|Unknown||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4287865|NCT00546754|4112960|B2|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4287866|NCT00546754|4112961|B1|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4287867|NCT00546754|4112959|B3|From Middle East||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4287868|NCT00546754|4112960|B2|From Middle East||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4287869|NCT00546754|4112961|B1|From Middle East||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4287870|NCT00546754|4112959|B3|East Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4287871|NCT00546754|4112960|B2|East Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4287872|NCT00546754|4112961|B1|East Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4287873|NCT00546754|4112959|B3|Native||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4287874|NCT00546754|4112960|B2|Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4287875|NCT00546754|4112961|B1|Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4287876|NCT00546754|4112959|B3|Asian||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
4287877|NCT00546754|4112960|B2|Asian||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4287878|NCT00546754|4112961|B1|Asian||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4287879|NCT00546754|4112959|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4287880|NCT00546754|4112960|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4287881|NCT00546754|4112961|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4287882|NCT00546754|4112959|B3|Black||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4287883|NCT00546754|4112960|B2|Black||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4287884|NCT00546754|4112961|B1|Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4287885|NCT00546754|4112959|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|690|690.0||||||
4287886|NCT00546754|4112960|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|326|326.0||||||
4287887|NCT00546754|4112961|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|364|364.0||||||
4287888|NCT00546754|4112959|B3||Male|Sex: Female, Male||Participants|Count of Participants|412|412.0||||||
4287889|NCT00546754|4112960|B2||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4287890|NCT00546754|4112961|B1||Male|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
4287891|NCT00546754|4112959|B3||Female|Sex: Female, Male||Participants|Count of Participants|377|377.0||||||
4287892|NCT00546754|4112960|B2||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4287893|NCT00546754|4112961|B1||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4287894|NCT00546754|4112959|B3|||Age||years|Mean|58.5|58.5|Standard Deviation|10.71|10.71|||
4287895|NCT00546754|4112960|B2|||Age||years|Mean|58.3|58.3|Standard Deviation|10.26|10.26|||
4287896|NCT00546754|4112961|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|11.11|11.11|||
4287897|NCT00546728|4112992|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4287898|NCT00546728|4112993|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4287899|NCT00546728|4112994|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4287900|NCT00546728|4112992|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4287901|NCT00546728|4112993|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4287902|NCT00546728|4112994|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4287903|NCT00546728|4112992|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4287904|NCT00546728|4112993|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4287905|NCT00546728|4112994|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4287906|NCT00546728|4112992|B3|||Age||years|Mean|58.5|58.5|Standard Deviation|10.0|10.0|||
4287907|NCT00546728|4112993|B2|||Age||years|Mean|58.4|58.4|Standard Deviation|10.1|10.1|||
4287908|NCT00546728|4112994|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|10|10.0|||
4287909|NCT00546728|4112992|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4287910|NCT00546728|4112993|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4287911|NCT00546728|4112994|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4287912|NCT00546728|4112992|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4287913|NCT00546728|4112993|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4287914|NCT00546728|4112994|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4287915|NCT00546728|4112992|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4287916|NCT00546728|4112993|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4287917|NCT00546728|4112994|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4287918|NCT00546715|4113001|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4287919|NCT00546715|4113002|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4287920|NCT00546715|4113003|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4287921|NCT00546715|4113004|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4287922|NCT00546715|4113005|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4287923|NCT00546715|4113001|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4287924|NCT00546715|4113002|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4287925|NCT00546715|4113003|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4287926|NCT00546715|4113004|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4287927|NCT00546715|4113005|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4287928|NCT00546715|4113001|B5|||Age||years|Median|44|44.0|Full Range|||22.0|49.0|
4287929|NCT00546715|4113002|B4|||Age||years|Median|28|28.0|Full Range|||22.0|34.0|
4287930|NCT00546715|4113003|B3|||Age||years|Median|44|44.0|Full Range|||32.0|45.0|
4287931|NCT00546715|4113004|B2|||Age||years|Median|46|46.0|Full Range|||23.0|49.0|
4287932|NCT00546715|4113005|B1|||Age||years|Median|43.5|43.5|Full Range|||31.0|48.0|
4287933|NCT00546637|4113061|B3||Male|Sex: Female, Male||Participants|Count of Participants|943|943.0||||||
4287934|NCT00546637|4113062|B2||Male|Sex: Female, Male||Participants|Count of Participants|472|472.0||||||
4287935|NCT00546637|4113063|B1||Male|Sex: Female, Male||Participants|Count of Participants|471|471.0||||||
4287936|NCT00546637|4113061|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4287937|NCT00546637|4113062|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4287938|NCT00546637|4113063|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4287939|NCT00546637|4113061|B3|>=65 years||Age, Customized||participants|Number|527|527.0||||||
4287940|NCT00546637|4113062|B2|>=65 years||Age, Customized||participants|Number|274|274.0||||||
4287941|NCT00546637|4113063|B1|>=65 years||Age, Customized||participants|Number|253|253.0||||||
4287942|NCT00546637|4113061|B3|45- 64 years||Age, Customized||participants|Number|400|400.0||||||
4287943|NCT00546637|4113062|B2|45- 64 years||Age, Customized||participants|Number|189|189.0||||||
4287944|NCT00546637|4113063|B1|45- 64 years||Age, Customized||participants|Number|211|211.0||||||
4287945|NCT00546637|4113061|B3|18 - 44 years||Age, Customized||participants|Number|16|16.0||||||
4287946|NCT00546637|4113062|B2|18 - 44 years||Age, Customized||participants|Number|9|9.0||||||
4287947|NCT00546637|4113063|B1|18 - 44 years||Age, Customized||participants|Number|7|7.0||||||
4287948|NCT00546572|4113136|B3||Male|Sex: Female, Male||Participants|Count of Participants|480|480.0||||||
4287949|NCT00546572|4113137|B2||Male|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
4287950|NCT00546572|4113138|B1||Male|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
4287951|NCT00546572|4113136|B3||Female|Sex: Female, Male||Participants|Count of Participants|456|456.0||||||
4287952|NCT00546572|4113137|B2||Female|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4287953|NCT00546572|4113138|B1||Female|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
4287954|NCT00546572|4113136|B3|||Age||years|Mean|76.7|76.7|Standard Deviation|4.6|4.6|||
4287955|NCT00546572|4113137|B2|||Age||years|Mean|76.7|76.7|Standard Deviation|4.5|4.5|||
4287956|NCT00546572|4113138|B1|||Age||years|Mean|76.7|76.7|Standard Deviation|4.6|4.6|||
4287957|NCT00546481|4113181|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4287958|NCT00546481|4113182|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4287959|NCT00546481|4113183|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4287960|NCT00546481|4113181|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4287961|NCT00546481|4113182|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4287962|NCT00546481|4113183|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4287963|NCT00546481|4113181|B3|||Age||Years|Mean|54.7|54.7|Standard Deviation|14.0|14.0|||
4287964|NCT00546481|4113182|B2|||Age||Years|Mean|54.3|54.3|Standard Deviation|12.8|12.8|||
4287965|NCT00546481|4113183|B1|||Age||Years|Mean|55|55.0|Standard Deviation|15.3|15.3|||
4287966|NCT00546429|4113208|B1|United States||Region of Enrollment||participants|Number|62|62.0||||||
4287967|NCT00546429|4113208|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4287968|NCT00546429|4113208|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4287969|NCT00546429|4113208|B1|||Age||years|Mean|79.2|79.2|Standard Deviation|14.1|14.1|||
4287970|NCT00546377|4113212|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4287971|NCT00546377|4113212|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4287972|NCT00546377|4113212|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4287973|NCT00546377|4113212|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4287974|NCT00546377|4113212|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4287975|NCT00546377|4113212|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4287976|NCT00546364|4113217|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287977|NCT00546364|4113218|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287978|NCT00546364|4113219|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287979|NCT00546364|4113220|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4288041|NCT00546273|4113289|B2|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4287980|NCT00546364|4113217|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287981|NCT00546364|4113218|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287982|NCT00546364|4113219|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287983|NCT00546364|4113220|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287984|NCT00546364|4113217|B4||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4287985|NCT00546364|4113218|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4287986|NCT00546364|4113219|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4287987|NCT00546364|4113220|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4287988|NCT00546364|4113217|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4287989|NCT00546364|4113218|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4287990|NCT00546364|4113219|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4287991|NCT00546364|4113220|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4287992|NCT00546364|4113217|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287993|NCT00546364|4113218|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287994|NCT00546364|4113219|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287995|NCT00546364|4113220|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287996|NCT00546364|4113217|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287997|NCT00546364|4113218|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287998|NCT00546364|4113219|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4287999|NCT00546364|4113220|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4288000|NCT00546364|4113217|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4288001|NCT00546364|4113218|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4288002|NCT00546364|4113219|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4288003|NCT00546364|4113220|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4288004|NCT00546364|4113217|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288005|NCT00546364|4113218|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288006|NCT00546364|4113219|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288007|NCT00546364|4113220|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288008|NCT00546364|4113217|B4||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4288009|NCT00546364|4113218|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4288010|NCT00546364|4113219|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4288011|NCT00546364|4113220|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4288012|NCT00546364|4113217|B4|||Age||years|Median|57.5|57.5|Full Range|||32.0|79.0|
4288013|NCT00546364|4113218|B3|||Age||years|Median|55.5|55.5|Full Range|||33.0|65.0|
4288014|NCT00546364|4113219|B2|||Age||years|Median|59|59.0|Full Range|||39.0|79.0|
4288015|NCT00546364|4113220|B1|||Age||years|Median|55.5|55.5|Full Range|||32.0|68.0|
4288016|NCT00546351|4113257|B1|Germany||Region of Enrollment||participants|Number|117|117.0||||||
4288017|NCT00546351|4113257|B1|Bulgaria||Region of Enrollment||participants|Number|62|62.0||||||
4288018|NCT00546351|4113257|B1|Romania||Region of Enrollment||participants|Number|61|61.0||||||
4288019|NCT00546351|4113257|B1|Poland||Region of Enrollment||participants|Number|101|101.0||||||
4288020|NCT00546351|4113257|B1|Belgium||Region of Enrollment||participants|Number|19|19.0||||||
4288021|NCT00546351|4113257|B1|Hungary||Region of Enrollment||participants|Number|76|76.0||||||
4288022|NCT00546351|4113257|B1|Czech Republic||Region of Enrollment||participants|Number|57|57.0||||||
4288023|NCT00546351|4113257|B1|France||Region of Enrollment||participants|Number|6|6.0||||||
4288024|NCT00546351|4113257|B1|Italy||Region of Enrollment||participants|Number|7|7.0||||||
4288025|NCT00546351|4113257|B1|United Kingdom||Region of Enrollment||participants|Number|19|19.0||||||
4288026|NCT00546351|4113257|B1|Russian Federation||Region of Enrollment||participants|Number|30|30.0||||||
4288027|NCT00546351|4113257|B1|Austria||Region of Enrollment||participants|Number|9|9.0||||||
4288028|NCT00546351|4113257|B1|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4288029|NCT00546351|4113257|B1|Finland||Region of Enrollment||participants|Number|1|1.0||||||
4288030|NCT00546351|4113257|B1|Serbia||Region of Enrollment||participants|Number|54|54.0||||||
4288031|NCT00546351|4113257|B1||Male|Sex: Female, Male||Participants|Count of Participants|325|325.0||||||
4288032|NCT00546351|4113257|B1||Female|Sex: Female, Male||Participants|Count of Participants|296|296.0||||||
4288033|NCT00546351|4113257|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|9.51|9.51|||
4288034|NCT00546351|4113257|B1||>=65 years|Age||Participants|Count of Participants|121|121.0||||||
4288035|NCT00546351|4113257|B1||Between 18 and 65 years|Age||Participants|Count of Participants|500|500.0||||||
4288036|NCT00546351|4113257|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288037|NCT00546273|4113285|B6|Spain||Region of Enrollment||participants|Number|24|24.0||||||
4288038|NCT00546273|4113286|B5|Spain||Region of Enrollment||participants|Number|8|8.0||||||
4288039|NCT00546273|4113287|B4|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4288040|NCT00546273|4113288|B3|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4288042|NCT00546273|4113290|B1|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4288043|NCT00546273|4113285|B6||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4288044|NCT00546273|4113286|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4288045|NCT00546273|4113287|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4288046|NCT00546273|4113288|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4288047|NCT00546273|4113289|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4288048|NCT00546273|4113290|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4288049|NCT00546273|4113285|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288050|NCT00546273|4113286|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288051|NCT00546273|4113287|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288052|NCT00546273|4113288|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288053|NCT00546273|4113289|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288054|NCT00546273|4113290|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288055|NCT00546273|4113285|B6|||Age||years|Mean|24.08|24.08|Standard Deviation|3.46|3.46|||
4288056|NCT00546273|4113286|B5|||Age||years|Mean|24|24.0|Standard Deviation|4.75|4.75|||
4288057|NCT00546273|4113287|B4|||Age||years|Mean|22.25|22.25|Standard Deviation|2.22|2.22|||
4288058|NCT00546273|4113288|B3|||Age||years|Mean|23|23.0|Standard Deviation|2.16|2.16|||
4288059|NCT00546273|4113289|B2|||Age||years|Mean|26|26.0|Standard Deviation|2.94|2.94|||
4288060|NCT00546273|4113290|B1|||Age||years|Mean|25.25|25.25|Standard Deviation|2.87|2.87|||
4288061|NCT00546273|4113285|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4288062|NCT00546273|4113286|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4288063|NCT00546273|4113287|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4288064|NCT00546273|4113288|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4288065|NCT00546273|4113289|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4288066|NCT00546273|4113290|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4288067|NCT00546273|4113285|B6||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4288068|NCT00546273|4113286|B5||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4288069|NCT00546273|4113287|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4288070|NCT00546273|4113288|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4288071|NCT00546273|4113289|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4288072|NCT00546273|4113290|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4288073|NCT00546273|4113285|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288074|NCT00546273|4113286|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288075|NCT00546273|4113287|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288076|NCT00546273|4113288|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288077|NCT00546273|4113289|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288078|NCT00546273|4113290|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288079|NCT00546260|4113301|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4288080|NCT00546260|4113302|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4288081|NCT00546260|4113303|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4288082|NCT00546260|4113301|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4288083|NCT00546260|4113302|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4288084|NCT00546260|4113303|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4288085|NCT00546260|4113301|B3|||Age||years|Mean|55.6|55.6|Standard Deviation|11.5|11.5|||
4288086|NCT00546260|4113302|B2|||Age||years|Mean|57.8|57.8|Standard Deviation|10.4|10.4|||
4288087|NCT00546260|4113303|B1|||Age||years|Mean|53.6|53.6|Standard Deviation|11.9|11.9|||
4288088|NCT00546260|4113301|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4288089|NCT00546260|4113302|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4288090|NCT00546260|4113303|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4288091|NCT00546260|4113301|B3||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4288092|NCT00546260|4113302|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4288093|NCT00546260|4113303|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4288094|NCT00546260|4113301|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288095|NCT00546260|4113302|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288096|NCT00546260|4113303|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288097|NCT00546156|4113314|B3|United States||Region of Enrollment||participants|Number|104|104.0||||||
4288098|NCT00546156|4113315|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4288099|NCT00546156|4113316|B1|United States||Region of Enrollment||participants|Number|84|84.0||||||
4288100|NCT00546156|4113314|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288101|NCT00546156|4113315|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288102|NCT00546156|4113316|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288103|NCT00546156|4113314|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4288104|NCT00546156|4113315|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4288105|NCT00546156|4113316|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4288106|NCT00546156|4113314|B3|||Age||years|Median|47.5|47.5|Full Range|||22.0|66.0|
4288107|NCT00546156|4113315|B2|||Age||years|Median|47.5|47.5|Full Range|||22.0|65.0|
4288108|NCT00546156|4113316|B1|||Age||years|Median|47.5|47.5|Full Range|||24.0|66.0|
4288109|NCT00546117|4113324|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4288110|NCT00546117|4113325|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4288111|NCT00546117|4113326|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4288112|NCT00546117|4113324|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4288113|NCT00546117|4113325|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4288114|NCT00546117|4113326|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4288115|NCT00546117|4113324|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4288116|NCT00546117|4113325|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4288117|NCT00546117|4113326|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4288118|NCT00546117|4113324|B3|||Age||years|Mean|5.10|5.1|Standard Deviation|1.86|1.86|||
4288119|NCT00546117|4113325|B2|||Age||years|Mean|5.45|5.45|Standard Deviation|1.32|1.32|||
4288120|NCT00546117|4113326|B1|||Age||years|Mean|4.82|4.82|Standard Deviation|1.98|1.98|||
4288121|NCT00546117|4113324|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4288122|NCT00546117|4113325|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4288123|NCT00546117|4113326|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4288124|NCT00546117|4113324|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4288125|NCT00546117|4113325|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4288126|NCT00546117|4113326|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4288127|NCT00546117|4113324|B3||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4288128|NCT00546117|4113325|B2||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4288129|NCT00546117|4113326|B1||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4288130|NCT00546104|4113341|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4288131|NCT00546104|4113341|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288132|NCT00546104|4113341|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4288133|NCT00546104|4113341|B1|||Age||years|Mean|54.4|54.4|Standard Deviation|13.4|13.4|||
4288134|NCT00546104|4113341|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4288135|NCT00546104|4113341|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4288136|NCT00546104|4113341|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288137|NCT00546078|4113350|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288138|NCT00546078|4113351|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288139|NCT00546078|4113352|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288140|NCT00546078|4113350|B3||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4288141|NCT00546078|4113351|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4288142|NCT00546078|4113352|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4288143|NCT00546078|4113350|B3|||Age||years|Mean|27.5|27.5|Standard Deviation|2.87|2.87|||
4288144|NCT00546078|4113351|B2|||Age||years|Mean|27.0|27.0|Standard Deviation|2.89|2.89|||
4288145|NCT00546078|4113352|B1|||Age||years|Mean|27.8|27.8|Standard Deviation|2.82|2.82|||
4288146|NCT00546052|4113391|B1|||Weight||Kilograms (Kg)|Mean|92.5|92.5|Standard Deviation|18.1|18.1|||
4288147|NCT00546052|4113391|B1|||Uric Acid||mmol/L|Mean|365.8|365.8|Standard Deviation|85.4|85.4|||
4288148|NCT00546052|4113391|B1|||Triglycerides||mmol/L|Mean|2.16|2.16|Standard Deviation|1.16|1.16|||
4288149|NCT00546052|4113391|B1|||Total Cholesterol||mmol/L|Mean|5.36|5.36|Standard Deviation|1.05|1.05|||
4288150|NCT00546052|4113391|B1|||Systolic Blood Pressure||mm Hg|Mean|148.22|148.22|Standard Deviation|10.72|10.72|||
4288151|NCT00546052|4113391|B1|||Low Density Lipoprotein-C||mmol/L|Mean|3.17|3.17|Standard Deviation|0.93|0.93|||
4288152|NCT00546052|4113391|B1|||High Density Lipoprotein-C||mol/L|Mean|1.23|1.23|Standard Deviation|0.33|0.33|||
4288153|NCT00546052|4113391|B1|||Hemoglobin A1c||Percent|Mean|5.71|5.71|Standard Deviation|0.59|0.59|||
4288154|NCT00546052|4113391|B1|||Heart Rate||Beats per Minute (BPM)|Mean|75|75.0|Standard Deviation|8.0|8.0|||
4288155|NCT00546052|4113391|B1|||Fasting Blood Glucose||mmol/L|Mean|5.7|5.7|Standard Deviation|0.7|0.7|||
4288156|NCT00546052|4113391|B1|||Diastolic Blood Pressure||mm Hg|Mean|90.54|90.54|Standard Deviation|8.16|8.16|||
4288157|NCT00546052|4113391|B1|||C-Reactive Protein||mg/L|Mean|5.4|5.4|Standard Deviation|8.8|8.8|||
4288158|NCT00546052|4113391|B1|||Body Mass Index||Kg/m2|Mean|33.23|33.23|Standard Deviation|5.59|5.59|||
4288159|NCT00546052|4113391|B1|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4288160|NCT00546052|4113391|B1|Other||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4288161|NCT00546052|4113391|B1|Native American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4288162|NCT00546052|4113391|B1|Asian||Race/Ethnicity, Customized||participants|Number|200|200.0||||||
4288163|NCT00546052|4113391|B1|Black||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4288164|NCT00546052|4113391|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|1451|1451.0||||||
4288165|NCT00546052|4113391|B1||Male|Sex: Female, Male||Participants|Count of Participants|980|980.0||||||
4288166|NCT00546052|4113391|B1||Female|Sex: Female, Male||Participants|Count of Participants|734|734.0||||||
4288167|NCT00546052|4113391|B1|Missing||Age, Customized||participants|Number|1|1.0||||||
4288168|NCT00546052|4113391|B1|>=65.00||Age, Customized||participants|Number|326|326.0||||||
4288169|NCT00546052|4113391|B1|58.01 - 65.00||Age, Customized||participants|Number|346|346.0||||||
4288170|NCT00546052|4113391|B1|52.01 - 58.00||Age, Customized||participants|Number|356|356.0||||||
4288171|NCT00546052|4113391|B1|45.01 - 52.00||Age, Customized||participants|Number|359|359.0||||||
4288172|NCT00546052|4113391|B1|<=45.00||Age, Customized||participants|Number|326|326.0||||||
4288173|NCT00546052|4113391|B1|||Age||Years|Mean|54.93|54.93|Standard Deviation|11.29|11.29|||
4288174|NCT00546000|4113409|B1|United States||Region of Enrollment||participants|Number|56|56.0||||||
4288175|NCT00546000|4113409|B1|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|3|3.0||||||
4288176|NCT00546000|4113409|B1|More than one race||Race (NIH/OMB)||participants|Number|7|7.0||||||
4288177|NCT00546000|4113409|B1|White||Race (NIH/OMB)||participants|Number|19|19.0||||||
4288178|NCT00546000|4113409|B1|Black or African American||Race (NIH/OMB)||participants|Number|31|31.0||||||
4288179|NCT00546000|4113409|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4288180|NCT00546000|4113409|B1|Asian||Race (NIH/OMB)||participants|Number|7|7.0||||||
4288181|NCT00546000|4113409|B1|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|1|1.0||||||
4288182|NCT00546000|4113409|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4288183|NCT00546000|4113409|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4288184|NCT00546000|4113409|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4288185|NCT00546000|4113409|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4288186|NCT00546000|4113409|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4288187|NCT00546000|4113409|B1|||Age||Months|Mean|7.2|7.2|Standard Deviation|2.6|2.6|||
4288188|NCT00545974|4113414|B3|United States||Region of Enrollment||participants|Number|81|81.0||||||
4288189|NCT00545974|4113415|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
4288190|NCT00545974|4113416|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4288191|NCT00545974|4113414|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4288192|NCT00545974|4113415|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4288193|NCT00545974|4113416|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4288194|NCT00545974|4113414|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4288195|NCT00545974|4113415|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4288196|NCT00545974|4113416|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4288197|NCT00545974|4113414|B3|||Age||years|Mean|66.0|66.0|Standard Deviation|2.5|2.5|||
4288198|NCT00545974|4113415|B2|||Age||years|Mean|66.2|66.2|Standard Deviation|2.3|2.3|||
4288199|NCT00545974|4113416|B1|||Age||years|Mean|65.8|65.8|Standard Deviation|2.8|2.8|||
4288200|NCT00545974|4113414|B3||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4288201|NCT00545974|4113415|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4288202|NCT00545974|4113416|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4288203|NCT00545974|4113414|B3||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4288204|NCT00545974|4113415|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4288205|NCT00545974|4113416|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4288206|NCT00545974|4113414|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288207|NCT00545974|4113415|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288208|NCT00545974|4113416|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288209|NCT00545948|4113425|B4|United States||Region of Enrollment||participants|Number|31|31.0||||||
4288210|NCT00545948|4113426|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4288211|NCT00545948|4113427|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4288212|NCT00545948|4113428|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4288213|NCT00545948|4113425|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4288214|NCT00545948|4113426|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4288215|NCT00545948|4113427|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4288216|NCT00545948|4113428|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4288217|NCT00545948|4113425|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4288218|NCT00545948|4113426|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4288219|NCT00545948|4113427|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4288220|NCT00545948|4113428|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4288221|NCT00545948|4113425|B4|||Age||years|Mean|61.18|61.18|Standard Deviation|8.05|8.05|||
4288222|NCT00545948|4113426|B3|||Age||years|Mean|61.44|61.44|Standard Deviation|11.35|11.35|||
4288223|NCT00545948|4113427|B2|||Age||years|Mean|58.93|58.93|Standard Deviation|9.14|9.14|||
4288224|NCT00545948|4113428|B1|||Age||years|Mean|65.13|65.13|Standard Deviation|3.36|3.36|||
4288225|NCT00545844|4113440|B1|||Asthma Diagnosis Duration||Months|Mean|147.6|147.6|Standard Deviation|139.0|139.0|||
4288226|NCT00545844|4113440|B1|||Allergic Rhinitis Diagnosis Duration||Months|Mean|131.4|131.4|Standard Deviation|135.4|135.4|||
4288227|NCT00545844|4113440|B1|Missing||Inhaled Corticosteroids or Inhaled Corticosteroids / Long-Acting Beta 2-Agonist Use||participants|Number|6|6.0||||||
4288415|NCT00545623|4113618|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4288228|NCT00545844|4113440|B1|Inhaled Corticosteroids/Long-Acting Beta 2-Agonist||Inhaled Corticosteroids or Inhaled Corticosteroids / Long-Acting Beta 2-Agonist Use||participants|Number|153|153.0||||||
4288229|NCT00545844|4113440|B1|Inhaled Corticosteroids Only||Inhaled Corticosteroids or Inhaled Corticosteroids / Long-Acting Beta 2-Agonist Use||participants|Number|154|154.0||||||
4288230|NCT00545844|4113440|B1||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4288231|NCT00545844|4113440|B1||Female|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4288232|NCT00545844|4113440|B1|||Age||years|Mean|46.1|46.1|Standard Deviation|17.2|17.2|||
4288233|NCT00545792|4113454|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4288234|NCT00545792|4113454|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288235|NCT00545792|4113454|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4288236|NCT00545792|4113454|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|8.5|8.5|||
4288237|NCT00545792|4113454|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4288238|NCT00545792|4113454|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4288239|NCT00545792|4113454|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288240|NCT00545779|4113459|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288241|NCT00545779|4113459|B1||Female|Sex: Female, Male||Participants|Count of Participants|670|670.0||||||
4288242|NCT00545779|4113459|B1|||Age||years|Mean|62.7|62.7|Standard Deviation|8.9|8.9|||
4288243|NCT00545766|4113472|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4288244|NCT00545766|4113472|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4288245|NCT00545766|4113472|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288246|NCT00545766|4113472|B1|||Age||years|Mean|72|72.0|Standard Deviation|8.4|8.4|||
4288247|NCT00545766|4113472|B1||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
4288248|NCT00545766|4113472|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4288249|NCT00545766|4113472|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288250|NCT00545753|4113476|B4|United States||Region of Enrollment||participants|Number|558|558.0||||||
4288251|NCT00545753|4113477|B3|United States||Region of Enrollment||participants|Number|256|256.0||||||
4288252|NCT00545753|4113478|B2|United States||Region of Enrollment||participants|Number|59|59.0||||||
4288253|NCT00545753|4113479|B1|United States||Region of Enrollment||participants|Number|243|243.0||||||
4288254|NCT00545753|4113476|B4||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4288255|NCT00545753|4113477|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4288256|NCT00545753|4113478|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4288257|NCT00545753|4113479|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4288258|NCT00545753|4113476|B4||Female|Sex: Female, Male||Participants|Count of Participants|457|457.0||||||
4288259|NCT00545753|4113477|B3||Female|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4288260|NCT00545753|4113478|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4288261|NCT00545753|4113479|B1||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4288262|NCT00545753|4113476|B4|||Age||years|Mean|17|17.0|Standard Deviation|15|15.0|||
4288263|NCT00545753|4113477|B3|||Age||years|Mean|17|17.0|Standard Deviation|14|14.0|||
4288264|NCT00545753|4113478|B2|||Age||years|Mean|19|19.0|Standard Deviation|16|16.0|||
4288265|NCT00545753|4113479|B1|||Age||years|Mean|16|16.0|Standard Deviation|15|15.0|||
4288266|NCT00545753|4113476|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4288267|NCT00545753|4113477|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4288268|NCT00545753|4113478|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4288269|NCT00545753|4113479|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4288270|NCT00545753|4113476|B4||Between 18 and 65 years|Age||Participants|Count of Participants|167|167.0||||||
4288271|NCT00545753|4113477|B3||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
4288272|NCT00545753|4113478|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4288273|NCT00545753|4113479|B1||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4288274|NCT00545753|4113476|B4||<=18 years|Age||Participants|Count of Participants|389|389.0||||||
4288275|NCT00545753|4113477|B3||<=18 years|Age||Participants|Count of Participants|177|177.0||||||
4288276|NCT00545753|4113478|B2||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
4288277|NCT00545753|4113479|B1||<=18 years|Age||Participants|Count of Participants|172|172.0||||||
4288278|NCT00545740|4113490|B5|United States||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|277|277.0||||||
4288279|NCT00545740|4113491|B4|United States||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|69|69.0||||||
4288280|NCT00545740|4113492|B3|United States||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|69|69.0||||||
4288281|NCT00545740|4113493|B2|United States||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|70|70.0||||||
4288282|NCT00545740|4113494|B1|United States||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|69|69.0||||||
4288283|NCT00545740|4113490|B5|United Kingdom||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|13|13.0||||||
4288284|NCT00545740|4113491|B4|United Kingdom||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|4|4.0||||||
4288416|NCT00545623|4113619|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4288285|NCT00545740|4113492|B3|United Kingdom||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|3|3.0||||||
4288286|NCT00545740|4113493|B2|United Kingdom||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|3|3.0||||||
4288287|NCT00545740|4113494|B1|United Kingdom||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|3|3.0||||||
4288288|NCT00545740|4113490|B5|Sweden||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|38|38.0||||||
4288289|NCT00545740|4113491|B4|Sweden||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|9|9.0||||||
4288290|NCT00545740|4113492|B3|Sweden||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|11|11.0||||||
4288291|NCT00545740|4113493|B2|Sweden||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|9|9.0||||||
4288292|NCT00545740|4113494|B1|Sweden||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|9|9.0||||||
4288293|NCT00545740|4113490|B5|Spain||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|8|8.0||||||
4288294|NCT00545740|4113491|B4|Spain||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|2|2.0||||||
4288295|NCT00545740|4113492|B3|Spain||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|4|4.0||||||
4288296|NCT00545740|4113493|B2|Spain||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|1|1.0||||||
4288297|NCT00545740|4113494|B1|Spain||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|1|1.0||||||
4288298|NCT00545740|4113490|B5|New Zealand||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|15|15.0||||||
4288299|NCT00545740|4113491|B4|New Zealand||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|4|4.0||||||
4288300|NCT00545740|4113492|B3|New Zealand||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|4|4.0||||||
4288301|NCT00545740|4113493|B2|New Zealand||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|4|4.0||||||
4288302|NCT00545740|4113494|B1|New Zealand||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|3|3.0||||||
4288303|NCT00545740|4113490|B5|Israel||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|95|95.0||||||
4288304|NCT00545740|4113491|B4|Israel||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|24|24.0||||||
4288305|NCT00545740|4113492|B3|Israel||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|23|23.0||||||
4288306|NCT00545740|4113493|B2|Israel||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|24|24.0||||||
4288307|NCT00545740|4113494|B1|Israel||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|24|24.0||||||
4288308|NCT00545740|4113490|B5|India||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|13|13.0||||||
4288309|NCT00545740|4113491|B4|India||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|4|4.0||||||
4288310|NCT00545740|4113492|B3|India||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|3|3.0||||||
4288311|NCT00545740|4113493|B2|India||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|2|2.0||||||
4288312|NCT00545740|4113494|B1|India||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|4|4.0||||||
4288313|NCT00545740|4113490|B5|France||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|23|23.0||||||
4288314|NCT00545740|4113491|B4|France||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|6|6.0||||||
4288315|NCT00545740|4113492|B3|France||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|6|6.0||||||
4288316|NCT00545740|4113493|B2|France||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|6|6.0||||||
4288317|NCT00545740|4113494|B1|France||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|5|5.0||||||
4288318|NCT00545740|4113490|B5|Colombia||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|74|74.0||||||
4288319|NCT00545740|4113491|B4|Colombia||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|19|19.0||||||
4288320|NCT00545740|4113492|B3|Colombia||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|18|18.0||||||
4288321|NCT00545740|4113493|B2|Colombia||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|18|18.0||||||
4288322|NCT00545740|4113494|B1|Colombia||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|19|19.0||||||
4288323|NCT00545740|4113490|B5|Australia||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|19|19.0||||||
4288324|NCT00545740|4113491|B4|Australia||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|5|5.0||||||
4288325|NCT00545740|4113492|B3|Australia||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|6|6.0||||||
4288326|NCT00545740|4113493|B2|Australia||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|5|5.0||||||
4288417|NCT00545623|4113620|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4288327|NCT00545740|4113494|B1|Australia||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|3|3.0||||||
4288328|NCT00545740|4113490|B5|Argentina||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|15|15.0||||||
4288329|NCT00545740|4113491|B4|Argentina||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|3|3.0||||||
4288330|NCT00545740|4113492|B3|Argentina||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|4|4.0||||||
4288331|NCT00545740|4113493|B2|Argentina||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|3|3.0||||||
4288332|NCT00545740|4113494|B1|Argentina||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 590).|participants|Number|5|5.0||||||
4288333|NCT00545740|4113490|B5|Male||Gender|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 590 subjects randomized, 7 were never dosed with investigational product. Therefore, 583 subjects are in the Safety Population.|participants|Number|308|308.0||||||
4288334|NCT00545740|4113491|B4|Male||Gender|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 590 subjects randomized, 7 were never dosed with investigational product. Therefore, 583 subjects are in the Safety Population.|participants|Number|76|76.0||||||
4288335|NCT00545740|4113492|B3|Male||Gender|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 590 subjects randomized, 7 were never dosed with investigational product. Therefore, 583 subjects are in the Safety Population.|participants|Number|79|79.0||||||
4288336|NCT00545740|4113493|B2|Male||Gender|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 590 subjects randomized, 7 were never dosed with investigational product. Therefore, 583 subjects are in the Safety Population.|participants|Number|74|74.0||||||
4288337|NCT00545740|4113494|B1|Male||Gender|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 590 subjects randomized, 7 were never dosed with investigational product. Therefore, 583 subjects are in the Safety Population.|participants|Number|79|79.0||||||
4288338|NCT00545740|4113490|B5|Female||Gender|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 590 subjects randomized, 7 were never dosed with investigational product. Therefore, 583 subjects are in the Safety Population.|participants|Number|275|275.0||||||
4288339|NCT00545740|4113491|B4|Female||Gender|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 590 subjects randomized, 7 were never dosed with investigational product. Therefore, 583 subjects are in the Safety Population.|participants|Number|71|71.0||||||
4288340|NCT00545740|4113492|B3|Female||Gender|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 590 subjects randomized, 7 were never dosed with investigational product. Therefore, 583 subjects are in the Safety Population.|participants|Number|71|71.0||||||
4288341|NCT00545740|4113493|B2|Female||Gender|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 590 subjects randomized, 7 were never dosed with investigational product. Therefore, 583 subjects are in the Safety Population.|participants|Number|69|69.0||||||
4288342|NCT00545740|4113494|B1|Female||Gender|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 590 subjects randomized, 7 were never dosed with investigational product. Therefore, 583 subjects are in the Safety Population.|participants|Number|64|64.0||||||
4288343|NCT00545740|4113490|B5|>= 65 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 590 subjects randomized, 7 were never dosed with investigational product. Therefore, 583 subjects are in the Safety Population.|participants|Number|118|118.0||||||
4288344|NCT00545740|4113491|B4|>= 65 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 590 subjects randomized, 7 were never dosed with investigational product. Therefore, 583 subjects are in the Safety Population.|participants|Number|31|31.0||||||
4288345|NCT00545740|4113492|B3|>= 65 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 590 subjects randomized, 7 were never dosed with investigational product. Therefore, 583 subjects are in the Safety Population.|participants|Number|29|29.0||||||
4288346|NCT00545740|4113493|B2|>= 65 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 590 subjects randomized, 7 were never dosed with investigational product. Therefore, 583 subjects are in the Safety Population.|participants|Number|30|30.0||||||
4288347|NCT00545740|4113494|B1|>= 65 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 590 subjects randomized, 7 were never dosed with investigational product. Therefore, 583 subjects are in the Safety Population.|participants|Number|28|28.0||||||
4288348|NCT00545740|4113490|B5|55 to <65 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 590 subjects randomized, 7 were never dosed with investigational product. Therefore, 583 subjects are in the Safety Population.|participants|Number|202|202.0||||||
4288349|NCT00545740|4113491|B4|55 to <65 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 590 subjects randomized, 7 were never dosed with investigational product. Therefore, 583 subjects are in the Safety Population.|participants|Number|62|62.0||||||
4288350|NCT00545740|4113492|B3|55 to <65 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 590 subjects randomized, 7 were never dosed with investigational product. Therefore, 583 subjects are in the Safety Population.|participants|Number|51|51.0||||||
4288351|NCT00545740|4113493|B2|55 to <65 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 590 subjects randomized, 7 were never dosed with investigational product. Therefore, 583 subjects are in the Safety Population.|participants|Number|46|46.0||||||
4288352|NCT00545740|4113494|B1|55 to <65 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 590 subjects randomized, 7 were never dosed with investigational product. Therefore, 583 subjects are in the Safety Population.|participants|Number|43|43.0||||||
4288353|NCT00545740|4113490|B5|45 to <55 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 590 subjects randomized, 7 were never dosed with investigational product. Therefore, 583 subjects are in the Safety Population.|participants|Number|161|161.0||||||
4288354|NCT00545740|4113491|B4|45 to <55 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 590 subjects randomized, 7 were never dosed with investigational product. Therefore, 583 subjects are in the Safety Population.|participants|Number|37|37.0||||||
4288355|NCT00545740|4113492|B3|45 to <55 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 590 subjects randomized, 7 were never dosed with investigational product. Therefore, 583 subjects are in the Safety Population.|participants|Number|36|36.0||||||
4288356|NCT00545740|4113493|B2|45 to <55 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 590 subjects randomized, 7 were never dosed with investigational product. Therefore, 583 subjects are in the Safety Population.|participants|Number|39|39.0||||||
4288357|NCT00545740|4113494|B1|45 to <55 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 590 subjects randomized, 7 were never dosed with investigational product. Therefore, 583 subjects are in the Safety Population.|participants|Number|49|49.0||||||
4288358|NCT00545740|4113490|B5|35 to <45 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 590 subjects randomized, 7 were never dosed with investigational product. Therefore, 583 subjects are in the Safety Population.|participants|Number|77|77.0||||||
4288359|NCT00545740|4113491|B4|35 to <45 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 590 subjects randomized, 7 were never dosed with investigational product. Therefore, 583 subjects are in the Safety Population.|participants|Number|14|14.0||||||
4288360|NCT00545740|4113492|B3|35 to <45 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 590 subjects randomized, 7 were never dosed with investigational product. Therefore, 583 subjects are in the Safety Population.|participants|Number|26|26.0||||||
4288361|NCT00545740|4113493|B2|35 to <45 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 590 subjects randomized, 7 were never dosed with investigational product. Therefore, 583 subjects are in the Safety Population.|participants|Number|17|17.0||||||
4288362|NCT00545740|4113494|B1|35 to <45 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 590 subjects randomized, 7 were never dosed with investigational product. Therefore, 583 subjects are in the Safety Population.|participants|Number|20|20.0||||||
4288363|NCT00545740|4113490|B5|18 to <35 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 590 subjects randomized, 7 were never dosed with investigational product. Therefore, 583 subjects are in the Safety Population.|participants|Number|25|25.0||||||
4288364|NCT00545740|4113491|B4|18 to <35 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 590 subjects randomized, 7 were never dosed with investigational product. Therefore, 583 subjects are in the Safety Population.|participants|Number|3|3.0||||||
4288365|NCT00545740|4113492|B3|18 to <35 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 590 subjects randomized, 7 were never dosed with investigational product. Therefore, 583 subjects are in the Safety Population.|participants|Number|8|8.0||||||
4288366|NCT00545740|4113493|B2|18 to <35 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 590 subjects randomized, 7 were never dosed with investigational product. Therefore, 583 subjects are in the Safety Population.|participants|Number|11|11.0||||||
4288418|NCT00545623|4113621|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4288367|NCT00545740|4113494|B1|18 to <35 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 590 subjects randomized, 7 were never dosed with investigational product. Therefore, 583 subjects are in the Safety Population.|participants|Number|3|3.0||||||
4288368|NCT00545740|4113490|B5|||Age|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 590 subjects randomized, 7 were never dosed with investigational product. Therefore, 583 subjects are in the Safety Population.|years|Mean|55.3|55.3|Standard Deviation|11.39|11.39|||
4288369|NCT00545740|4113491|B4|||Age|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 590 subjects randomized, 7 were never dosed with investigational product. Therefore, 583 subjects are in the Safety Population.|years|Mean|57.1|57.1|Standard Deviation|10.42|10.42|||
4288370|NCT00545740|4113492|B3|||Age|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 590 subjects randomized, 7 were never dosed with investigational product. Therefore, 583 subjects are in the Safety Population.|years|Mean|54.5|54.5|Standard Deviation|11.93|11.93|||
4288371|NCT00545740|4113493|B2|||Age|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 590 subjects randomized, 7 were never dosed with investigational product. Therefore, 583 subjects are in the Safety Population.|years|Mean|54.5|54.5|Standard Deviation|11.96|11.96|||
4288372|NCT00545740|4113494|B1|||Age|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 590 subjects randomized, 7 were never dosed with investigational product. Therefore, 583 subjects are in the Safety Population.|years|Mean|55.1|55.1|Standard Deviation|11.11|11.11|||
4288373|NCT00545688|4113531|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288374|NCT00545688|4113532|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288375|NCT00545688|4113533|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288376|NCT00545688|4113534|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288377|NCT00545688|4113535|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288378|NCT00545688|4113531|B5||Female|Sex: Female, Male||Participants|Count of Participants|417|417.0||||||
4288379|NCT00545688|4113532|B4||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4288380|NCT00545688|4113533|B3||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4288381|NCT00545688|4113534|B2||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4288382|NCT00545688|4113535|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4288383|NCT00545688|4113531|B5|||Age||years|Mean|49.8|49.8|Standard Deviation|10.04|10.04|||
4288384|NCT00545688|4113532|B4|||Age||years|Mean|48.9|48.9|Standard Deviation|10.50|10.5|||
4288385|NCT00545688|4113533|B3|||Age||years|Mean|49.7|49.7|Standard Deviation|10.67|10.67|||
4288386|NCT00545688|4113534|B2|||Age||years|Mean|49.6|49.6|Standard Deviation|10.05|10.05|||
4288387|NCT00545688|4113535|B1|||Age||years|Mean|50.9|50.9|Standard Deviation|8.94|8.94|||
4288388|NCT00545662|4113608|B3|United States||Region of Enrollment||participants|Number|1213|1213.0||||||
4288389|NCT00545662|4113609|B2|United States||Region of Enrollment||participants|Number|607|607.0||||||
4288390|NCT00545662|4113610|B1|United States||Region of Enrollment||participants|Number|606|606.0||||||
4288391|NCT00545662|4113608|B3||Male|Sex: Female, Male||Participants|Count of Participants|903|903.0||||||
4288392|NCT00545662|4113609|B2||Male|Sex: Female, Male||Participants|Count of Participants|456|456.0||||||
4288393|NCT00545662|4113610|B1||Male|Sex: Female, Male||Participants|Count of Participants|447|447.0||||||
4288394|NCT00545662|4113608|B3||Female|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
4288395|NCT00545662|4113609|B2||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4288396|NCT00545662|4113610|B1||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4288397|NCT00545662|4113608|B3|||Age||years|Mean|40.4|40.4|Standard Deviation|15.9|15.9|||
4288398|NCT00545662|4113609|B2|||Age||years|Mean|39.7|39.7|Standard Deviation|16.2|16.2|||
4288399|NCT00545662|4113610|B1|||Age||years|Mean|41.1|41.1|Standard Deviation|15.5|15.5|||
4288400|NCT00545662|4113608|B3||>=65 years|Age||Participants|Count of Participants|81|81.0||||||
4288401|NCT00545662|4113609|B2||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
4288402|NCT00545662|4113610|B1||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4288403|NCT00545662|4113608|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1131|1131.0||||||
4288404|NCT00545662|4113609|B2||Between 18 and 65 years|Age||Participants|Count of Participants|563|563.0||||||
4288405|NCT00545662|4113610|B1||Between 18 and 65 years|Age||Participants|Count of Participants|568|568.0||||||
4288406|NCT00545662|4113608|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4288407|NCT00545662|4113609|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4288408|NCT00545662|4113610|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288409|NCT00545623|4113617|B5|United States||Region of Enrollment||participants|Number|115|115.0||||||
4288410|NCT00545623|4113618|B4|United States||Region of Enrollment||participants|Number|30|30.0||||||
4288411|NCT00545623|4113619|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
4288412|NCT00545623|4113620|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4288413|NCT00545623|4113621|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4288414|NCT00545623|4113617|B5||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4288419|NCT00545623|4113617|B5||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4288420|NCT00545623|4113618|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4288421|NCT00545623|4113619|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4288422|NCT00545623|4113620|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4288423|NCT00545623|4113621|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4288424|NCT00545623|4113617|B5|||Age||years|Mean|46.6|46.6|Standard Deviation|8.5|8.5|||
4288425|NCT00545623|4113618|B4|||Age||years|Mean|47.0|47.0|Standard Deviation|8.2|8.2|||
4288426|NCT00545623|4113619|B3|||Age||years|Mean|47.1|47.1|Standard Deviation|9.9|9.9|||
4288427|NCT00545623|4113620|B2|||Age||years|Mean|45.0|45.0|Standard Deviation|7.1|7.1|||
4288428|NCT00545623|4113621|B1|||Age||years|Mean|47.2|47.2|Standard Deviation|8.8|8.8|||
4288429|NCT00545584|4113634|B4||Male|Sex: Female, Male|The Full Analysis Set (FAS) population included all selected patients with at least one measured HbA1c value after Visit 2 and having received at least one dose of sitagliptin.|Participants|Count of Participants|503|503.0||||||
4288430|NCT00545584|4113635|B3||Male|Sex: Female, Male|The Full Analysis Set (FAS) population included all selected patients with at least one measured HbA1c value after Visit 2 and having received at least one dose of sitagliptin.|Participants|Count of Participants|139|139.0||||||
4288431|NCT00545584|4113636|B2||Male|Sex: Female, Male|The Full Analysis Set (FAS) population included all selected patients with at least one measured HbA1c value after Visit 2 and having received at least one dose of sitagliptin.|Participants|Count of Participants|183|183.0||||||
4288432|NCT00545584|4113637|B1||Male|Sex: Female, Male|The Full Analysis Set (FAS) population included all selected patients with at least one measured HbA1c value after Visit 2 and having received at least one dose of sitagliptin.|Participants|Count of Participants|181|181.0||||||
4288433|NCT00545584|4113634|B4||Female|Sex: Female, Male|The Full Analysis Set (FAS) population included all selected patients with at least one measured HbA1c value after Visit 2 and having received at least one dose of sitagliptin.|Participants|Count of Participants|482|482.0||||||
4288434|NCT00545584|4113635|B3||Female|Sex: Female, Male|The Full Analysis Set (FAS) population included all selected patients with at least one measured HbA1c value after Visit 2 and having received at least one dose of sitagliptin.|Participants|Count of Participants|126|126.0||||||
4288435|NCT00545584|4113636|B2||Female|Sex: Female, Male|The Full Analysis Set (FAS) population included all selected patients with at least one measured HbA1c value after Visit 2 and having received at least one dose of sitagliptin.|Participants|Count of Participants|175|175.0||||||
4288436|NCT00545584|4113637|B1||Female|Sex: Female, Male|The Full Analysis Set (FAS) population included all selected patients with at least one measured HbA1c value after Visit 2 and having received at least one dose of sitagliptin.|Participants|Count of Participants|181|181.0||||||
4288437|NCT00545584|4113634|B4|||Age|The Full Analysis Set (FAS) population included all selected patients with at least one measured HbA1c value after Visit 2 and having received at least one dose of sitagliptin.|years|Mean|57.71|57.71|Standard Deviation|9.68|9.68|||
4288438|NCT00545584|4113635|B3|||Age|The Full Analysis Set (FAS) population included all selected patients with at least one measured HbA1c value after Visit 2 and having received at least one dose of sitagliptin.|years|Mean|57.30|57.3|Standard Deviation|9.90|9.9|||
4288439|NCT00545584|4113636|B2|||Age|The Full Analysis Set (FAS) population included all selected patients with at least one measured HbA1c value after Visit 2 and having received at least one dose of sitagliptin.|years|Mean|57.47|57.47|Standard Deviation|9.12|9.12|||
4288440|NCT00545584|4113637|B1|||Age|The Full Analysis Set (FAS) population included all selected patients with at least one measured HbA1c value after Visit 2 and having received at least one dose of sitagliptin.|years|Mean|58.26|58.26|Standard Deviation|10.04|10.04|||
4288441|NCT00545571|4113650|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4288442|NCT00545571|4113650|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4288443|NCT00545571|4113650|B1|||Age||Years|Mean|67.9|67.9|Standard Deviation|13.34|13.34|||
4288444|NCT00545532|4113663|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4288445|NCT00545532|4113664|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4288446|NCT00545532|4113665|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4288447|NCT00545532|4113663|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4288448|NCT00545532|4113664|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4288449|NCT00545532|4113665|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4288450|NCT00545532|4113663|B3||White|Race (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
4288451|NCT00545532|4113664|B2||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4288452|NCT00545532|4113665|B1||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4288453|NCT00545532|4113663|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4288454|NCT00545532|4113664|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4288455|NCT00545532|4113665|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4288456|NCT00545532|4113663|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4288457|NCT00545532|4113664|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4288458|NCT00545532|4113665|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4288459|NCT00545532|4113663|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4288460|NCT00545532|4113664|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4288461|NCT00545532|4113665|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4288462|NCT00545532|4113663|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4288463|NCT00545532|4113664|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4288464|NCT00545532|4113665|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4288465|NCT00545532|4113663|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4288466|NCT00545532|4113664|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4288467|NCT00545532|4113665|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4288468|NCT00545532|4113663|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|179|179.0||||||
4288469|NCT00545532|4113664|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
4288470|NCT00545532|4113665|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4288471|NCT00545532|4113663|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4288472|NCT00545532|4113664|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4288473|NCT00545532|4113665|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4288474|NCT00545532|4113663|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4288475|NCT00545532|4113664|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4288476|NCT00545532|4113665|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4288477|NCT00545532|4113663|B3||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4288478|NCT00545532|4113664|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4288479|NCT00545532|4113665|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4288480|NCT00545532|4113663|B3|||Age||years|Mean|43.5|43.5|Standard Deviation|16.0|16.0|||
4288481|NCT00545532|4113664|B2|||Age||years|Mean|43.9|43.9|Standard Deviation|16.5|16.5|||
4288482|NCT00545532|4113665|B1|||Age||years|Mean|43.0|43.0|Standard Deviation|15.5|15.5|||
4288483|NCT00545506|4113746|B3|Austria||Region of Enrollment||participants|Number|40|40.0||||||
4288484|NCT00545506|4113747|B2|Austria||Region of Enrollment||participants|Number|20|20.0||||||
4288485|NCT00545506|4113748|B1|Austria||Region of Enrollment||participants|Number|20|20.0||||||
4288486|NCT00545506|4113746|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4288487|NCT00545506|4113747|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4288488|NCT00545506|4113748|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4288489|NCT00545506|4113746|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288490|NCT00545506|4113747|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288491|NCT00545506|4113748|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288492|NCT00545506|4113746|B3|||Age||years|Mean|55|55.0|Standard Deviation|5|5.0|||
4288493|NCT00545506|4113747|B2|||Age||years|Mean|55|55.0|Standard Deviation|5|5.0|||
4288494|NCT00545506|4113748|B1|||Age||years|Mean|55|55.0|Standard Deviation|5|5.0|||
4288495|NCT00545506|4113746|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4288496|NCT00545506|4113747|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4288497|NCT00545506|4113748|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4288498|NCT00545506|4113746|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4288499|NCT00545506|4113747|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4288500|NCT00545506|4113748|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4288501|NCT00545506|4113746|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288502|NCT00545506|4113747|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288503|NCT00545506|4113748|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288504|NCT00545441|4113755|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4288505|NCT00545441|4113756|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4288506|NCT00545441|4113757|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4288507|NCT00545441|4113755|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4288508|NCT00545441|4113756|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4288509|NCT00545441|4113757|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4288510|NCT00545441|4113755|B3|||Age|One patient in the SurgiSIS AFP arm has age missing.|years|Mean|47.2|47.2|Standard Deviation|13.3|13.3|||
4288511|NCT00545441|4113756|B2|||Age|One patient in the SurgiSIS AFP arm has age missing.|years|Mean|49.4|49.4|Standard Deviation|13.1|13.1|||
4288512|NCT00545441|4113757|B1|||Age|One patient in the SurgiSIS AFP arm has age missing.|years|Mean|45.1|45.1|Standard Deviation|13.2|13.2|||
4288513|NCT00545402|4113764|B3||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4288514|NCT00545402|4113765|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4288515|NCT00545402|4113766|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4288516|NCT00545402|4113764|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4288517|NCT00545402|4113765|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4288518|NCT00545402|4113766|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4288519|NCT00545402|4113764|B3|||Age||years|Mean|54.2|54.2|Standard Deviation|8.4|8.4|||
4288520|NCT00545402|4113765|B2|||Age||years|Mean|55.1|55.1|Standard Deviation|8.3|8.3|||
4288521|NCT00545402|4113766|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|8.5|8.5|||
4288522|NCT00545363|4113783|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288523|NCT00545363|4113784|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288524|NCT00545363|4113785|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288525|NCT00545363|4113783|B3||Female|Sex: Female, Male||Participants|Count of Participants|711|711.0||||||
4288526|NCT00545363|4113784|B2||Female|Sex: Female, Male||Participants|Count of Participants|357|357.0||||||
4288527|NCT00545363|4113785|B1||Female|Sex: Female, Male||Participants|Count of Participants|354|354.0||||||
4288528|NCT00545363|4113783|B3|||Age||years|Mean|66.2|66.2|Standard Deviation|6.90|6.9|||
4288529|NCT00545363|4113784|B2|||Age||years|Mean|65.6|65.6|Standard Deviation|6.64|6.64|||
4288530|NCT00545363|4113785|B1|||Age||years|Mean|66.7|66.7|Standard Deviation|7.12|7.12|||
4288531|NCT00545298|4113798|B4|United States||Region of Enrollment||participants|Number|4|4.0||||||
4288532|NCT00545298|4113799|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4288533|NCT00545298|4113800|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4288534|NCT00545298|4113801|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4288535|NCT00545298|4113798|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4288536|NCT00545298|4113799|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288537|NCT00545298|4113800|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288538|NCT00545298|4113801|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4288539|NCT00545298|4113798|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4288540|NCT00545298|4113799|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4288541|NCT00545298|4113800|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4288542|NCT00545298|4113801|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288543|NCT00545298|4113798|B4|||Age||years|Mean|69|69.0|Standard Deviation|5|5.0|||
4288544|NCT00545298|4113799|B3|||Age||years|Mean|65|65.0|Standard Deviation|0|0.0|||
4288545|NCT00545298|4113800|B2|||Age||years|Mean|60|60.0|Standard Deviation|0|0.0|||
4288546|NCT00545298|4113801|B1|||Age||years|Mean|76|76.0|Standard Deviation|4|4.0|||
4288547|NCT00545298|4113798|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4288548|NCT00545298|4113799|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4288549|NCT00545298|4113800|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4288550|NCT00545298|4113801|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4288551|NCT00545298|4113798|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4288552|NCT00545298|4113799|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4288553|NCT00545298|4113800|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4288554|NCT00545298|4113801|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4288555|NCT00545298|4113798|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288556|NCT00545298|4113799|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288557|NCT00545298|4113800|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288558|NCT00545298|4113801|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288559|NCT00545272|4113814|B7||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4288560|NCT00545272|4113815|B6||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4288561|NCT00545272|4113816|B5||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4288562|NCT00545272|4113817|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4288563|NCT00545272|4113818|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4288564|NCT00545272|4113819|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4288565|NCT00545272|4113820|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4288566|NCT00545272|4113814|B7||Female|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4288567|NCT00545272|4113815|B6||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4288568|NCT00545272|4113816|B5||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4288569|NCT00545272|4113817|B4||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4288570|NCT00545272|4113818|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4288571|NCT00545272|4113819|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4288572|NCT00545272|4113820|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4288573|NCT00545272|4113814|B7|||Age||years|Mean|40.0|40.0|Standard Deviation|16.50|16.5|||
4288574|NCT00545272|4113815|B6|||Age||years|Mean|39.8|39.8|Standard Deviation|15.82|15.82|||
4288575|NCT00545272|4113816|B5|||Age||years|Mean|44.0|44.0|Standard Deviation|17.98|17.98|||
4288576|NCT00545272|4113817|B4|||Age||years|Mean|40.1|40.1|Standard Deviation|15.47|15.47|||
4288577|NCT00545272|4113818|B3|||Age||years|Mean|36.6|36.6|Standard Deviation|15.76|15.76|||
4288578|NCT00545272|4113819|B2|||Age||years|Mean|38.4|38.4|Standard Deviation|17.25|17.25|||
4288579|NCT00545272|4113820|B1|||Age||years|Mean|41.3|41.3|Standard Deviation|16.27|16.27|||
4288580|NCT00545233|4113875|B3||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4288581|NCT00545233|4113876|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4288582|NCT00545233|4113877|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4288583|NCT00545233|4113875|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4288584|NCT00545233|4113876|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4288585|NCT00545233|4113877|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4288586|NCT00545233|4113875|B3|>40 years||Age, Customized|Baseline Measures are based on the Intent-to-Treat Population that includes all participants who received at least one dose of study drug.|participants|Number|136|136.0||||||
4288587|NCT00545233|4113876|B2|>40 years||Age, Customized|Baseline Measures are based on the Intent-to-Treat Population that includes all participants who received at least one dose of study drug.|participants|Number|65|65.0||||||
4288588|NCT00545233|4113877|B1|>40 years||Age, Customized|Baseline Measures are based on the Intent-to-Treat Population that includes all participants who received at least one dose of study drug.|participants|Number|71|71.0||||||
4288589|NCT00545233|4113875|B3|<=40 years||Age, Customized|Baseline Measures are based on the Intent-to-Treat Population that includes all participants who received at least one dose of study drug.|participants|Number|14|14.0||||||
4288590|NCT00545233|4113876|B2|<=40 years||Age, Customized|Baseline Measures are based on the Intent-to-Treat Population that includes all participants who received at least one dose of study drug.|participants|Number|8|8.0||||||
4288591|NCT00545233|4113877|B1|<=40 years||Age, Customized|Baseline Measures are based on the Intent-to-Treat Population that includes all participants who received at least one dose of study drug.|participants|Number|6|6.0||||||
4288592|NCT00545181|4113925|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
4288593|NCT00545181|4113926|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4288594|NCT00545181|4113927|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4288595|NCT00545181|4113925|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288596|NCT00545181|4113926|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288597|NCT00545181|4113927|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288598|NCT00545181|4113925|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4288599|NCT00545181|4113926|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4288600|NCT00545181|4113927|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4288601|NCT00545181|4113925|B3|||Age||years|Mean|31.0|31.0|Standard Deviation|6.4|6.4|||
4288602|NCT00545181|4113926|B2|||Age||years|Mean|32.4|32.4|Standard Deviation|6.9|6.9|||
4288603|NCT00545181|4113927|B1|||Age||years|Mean|29.8|29.8|Standard Deviation|5.8|5.8|||
4288604|NCT00545181|4113925|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4288605|NCT00545181|4113926|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4288606|NCT00545181|4113927|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4288607|NCT00545181|4113925|B3||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4288608|NCT00545181|4113926|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4288609|NCT00545181|4113927|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4288610|NCT00545181|4113925|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288611|NCT00545181|4113926|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288612|NCT00545181|4113927|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288613|NCT00545168|4113934|B4|United States||Region of Enrollment||participants|Number|480|480.0||||||
4288614|NCT00545168|4113935|B3|United States||Region of Enrollment||participants|Number|214|214.0||||||
4288615|NCT00545168|4113936|B2|United States||Region of Enrollment||participants|Number|63|63.0||||||
4288616|NCT00545168|4113937|B1|United States||Region of Enrollment||participants|Number|203|203.0||||||
4288617|NCT00545168|4113934|B4||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4288618|NCT00545168|4113935|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4288619|NCT00545168|4113936|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4288620|NCT00545168|4113937|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4288621|NCT00545168|4113934|B4||Female|Sex: Female, Male||Participants|Count of Participants|399|399.0||||||
4288622|NCT00545168|4113935|B3||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4288623|NCT00545168|4113936|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4288624|NCT00545168|4113937|B1||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4288625|NCT00545168|4113934|B4|||Age||years|Mean|16|16.0|Standard Deviation|14|14.0|||
4288626|NCT00545168|4113935|B3|||Age||years|Mean|16|16.0|Standard Deviation|15|15.0|||
4288627|NCT00545168|4113936|B2|||Age||years|Mean|14|14.0|Standard Deviation|13|13.0|||
4288628|NCT00545168|4113937|B1|||Age||years|Mean|15|15.0|Standard Deviation|14|14.0|||
4288629|NCT00545168|4113934|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4288630|NCT00545168|4113935|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4288631|NCT00545168|4113936|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4288632|NCT00545168|4113937|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4288633|NCT00545168|4113934|B4||Between 18 and 65 years|Age||Participants|Count of Participants|137|137.0||||||
4288634|NCT00545168|4113935|B3||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4288635|NCT00545168|4113936|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4288636|NCT00545168|4113937|B1||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4288637|NCT00545168|4113934|B4||<=18 years|Age||Participants|Count of Participants|340|340.0||||||
4288638|NCT00545168|4113935|B3||<=18 years|Age||Participants|Count of Participants|147|147.0||||||
4288639|NCT00545168|4113936|B2||<=18 years|Age||Participants|Count of Participants|46|46.0||||||
4288640|NCT00545168|4113937|B1||<=18 years|Age||Participants|Count of Participants|147|147.0||||||
4288641|NCT00545155|4113948|B1|United States||Region of Enrollment||participants|Number|187|187.0||||||
4288642|NCT00545155|4113948|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4288643|NCT00545155|4113948|B1||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4288644|NCT00545155|4113948|B1|||Age||years|Mean|75.6|75.6|Standard Deviation|9.2|9.2|||
4288645|NCT00545103|4113961|B5|Italy||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|9|9.0||||||
4288646|NCT00545103|4113962|B4|Italy||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|4|4.0||||||
4288647|NCT00545103|4113963|B3|Italy||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|2|2.0||||||
4288648|NCT00545103|4113964|B2|Italy||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|1|1.0||||||
4288649|NCT00545103|4113965|B1|Italy||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|2|2.0||||||
4288650|NCT00545103|4113961|B5|Germany||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|21|21.0||||||
4288651|NCT00545103|4113962|B4|Germany||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|4|4.0||||||
4288652|NCT00545103|4113963|B3|Germany||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|4|4.0||||||
4288653|NCT00545103|4113964|B2|Germany||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|6|6.0||||||
4288654|NCT00545103|4113965|B1|Germany||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|7|7.0||||||
4288655|NCT00545103|4113961|B5|Netherlands||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|18|18.0||||||
4288656|NCT00545103|4113962|B4|Netherlands||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|5|5.0||||||
4288657|NCT00545103|4113963|B3|Netherlands||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|5|5.0||||||
4288658|NCT00545103|4113964|B2|Netherlands||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|3|3.0||||||
4288659|NCT00545103|4113965|B1|Netherlands||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|5|5.0||||||
4288660|NCT00545103|4113961|B5|South Africa||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|60|60.0||||||
4288661|NCT00545103|4113962|B4|South Africa||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|15|15.0||||||
4288662|NCT00545103|4113963|B3|South Africa||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|15|15.0||||||
4288663|NCT00545103|4113964|B2|South Africa||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|16|16.0||||||
4288664|NCT00545103|4113965|B1|South Africa||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|14|14.0||||||
4288665|NCT00545103|4113961|B5|Romania||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|42|42.0||||||
4288666|NCT00545103|4113962|B4|Romania||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|9|9.0||||||
4288667|NCT00545103|4113963|B3|Romania||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|11|11.0||||||
4288668|NCT00545103|4113964|B2|Romania||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|12|12.0||||||
4288669|NCT00545103|4113965|B1|Romania||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|10|10.0||||||
4288670|NCT00545103|4113961|B5|Brazil||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|40|40.0||||||
4288671|NCT00545103|4113962|B4|Brazil||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|11|11.0||||||
4288672|NCT00545103|4113963|B3|Brazil||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|10|10.0||||||
4288673|NCT00545103|4113964|B2|Brazil||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|9|9.0||||||
4288674|NCT00545103|4113965|B1|Brazil||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|10|10.0||||||
4288675|NCT00545103|4113961|B5|Finland||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|18|18.0||||||
4288676|NCT00545103|4113962|B4|Finland||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|4|4.0||||||
4288677|NCT00545103|4113963|B3|Finland||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|5|5.0||||||
4288678|NCT00545103|4113964|B2|Finland||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|5|5.0||||||
4288679|NCT00545103|4113965|B1|Finland||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|4|4.0||||||
4288680|NCT00545103|4113961|B5|Canada||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|19|19.0||||||
4288681|NCT00545103|4113962|B4|Canada||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|5|5.0||||||
4288682|NCT00545103|4113963|B3|Canada||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|4|4.0||||||
4288683|NCT00545103|4113964|B2|Canada||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|5|5.0||||||
4288684|NCT00545103|4113965|B1|Canada||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|5|5.0||||||
4288685|NCT00545103|4113961|B5|Hungary||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|14|14.0||||||
4288686|NCT00545103|4113962|B4|Hungary||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|3|3.0||||||
4288687|NCT00545103|4113963|B3|Hungary||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|6|6.0||||||
4288688|NCT00545103|4113964|B2|Hungary||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|3|3.0||||||
4288689|NCT00545103|4113965|B1|Hungary||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|2|2.0||||||
4288690|NCT00545103|4113961|B5|United States||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|351|351.0||||||
4288691|NCT00545103|4113962|B4|United States||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|86|86.0||||||
4288692|NCT00545103|4113963|B3|United States||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|88|88.0||||||
4288693|NCT00545103|4113964|B2|United States||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|88|88.0||||||
4288694|NCT00545103|4113965|B1|United States||Region of Enrollment|This baseline measure consists of all randomized subjects (n = 592).|participants|Number|89|89.0||||||
4288695|NCT00545103|4113961|B5||Male|Sex: Female, Male|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 592 subjects randomized, 6 were never dosed with investigational product. Therefore, 586 subjects are in the Safety Population.|Participants|Count of Participants|272|272.0||||||
4288696|NCT00545103|4113962|B4||Male|Sex: Female, Male|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 592 subjects randomized, 6 were never dosed with investigational product. Therefore, 586 subjects are in the Safety Population.|Participants|Count of Participants|70|70.0||||||
4288697|NCT00545103|4113963|B3||Male|Sex: Female, Male|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 592 subjects randomized, 6 were never dosed with investigational product. Therefore, 586 subjects are in the Safety Population.|Participants|Count of Participants|61|61.0||||||
4288698|NCT00545103|4113964|B2||Male|Sex: Female, Male|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 592 subjects randomized, 6 were never dosed with investigational product. Therefore, 586 subjects are in the Safety Population.|Participants|Count of Participants|76|76.0||||||
4288699|NCT00545103|4113965|B1||Male|Sex: Female, Male|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 592 subjects randomized, 6 were never dosed with investigational product. Therefore, 586 subjects are in the Safety Population.|Participants|Count of Participants|65|65.0||||||
4288700|NCT00545103|4113961|B5||Female|Sex: Female, Male|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 592 subjects randomized, 6 were never dosed with investigational product. Therefore, 586 subjects are in the Safety Population.|Participants|Count of Participants|314|314.0||||||
4288701|NCT00545103|4113962|B4||Female|Sex: Female, Male|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 592 subjects randomized, 6 were never dosed with investigational product. Therefore, 586 subjects are in the Safety Population.|Participants|Count of Participants|72|72.0||||||
4288702|NCT00545103|4113963|B3||Female|Sex: Female, Male|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 592 subjects randomized, 6 were never dosed with investigational product. Therefore, 586 subjects are in the Safety Population.|Participants|Count of Participants|88|88.0||||||
4288703|NCT00545103|4113964|B2||Female|Sex: Female, Male|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 592 subjects randomized, 6 were never dosed with investigational product. Therefore, 586 subjects are in the Safety Population.|Participants|Count of Participants|71|71.0||||||
4288704|NCT00545103|4113965|B1||Female|Sex: Female, Male|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 592 subjects randomized, 6 were never dosed with investigational product. Therefore, 586 subjects are in the Safety Population.|Participants|Count of Participants|83|83.0||||||
4288705|NCT00545103|4113961|B5|>= 65 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 592 subjects randomized, 6 were never dosed with investigational product. Therefore, 586 subjects are in the Safety Population.|participants|Number|143|143.0||||||
4288706|NCT00545103|4113962|B4|>= 65 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 592 subjects randomized, 6 were never dosed with investigational product. Therefore, 586 subjects are in the Safety Population.|participants|Number|35|35.0||||||
4288707|NCT00545103|4113963|B3|>= 65 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 592 subjects randomized, 6 were never dosed with investigational product. Therefore, 586 subjects are in the Safety Population.|participants|Number|40|40.0||||||
4288708|NCT00545103|4113964|B2|>= 65 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 592 subjects randomized, 6 were never dosed with investigational product. Therefore, 586 subjects are in the Safety Population.|participants|Number|24|24.0||||||
4288771|NCT00544882|4114058|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4288709|NCT00545103|4113965|B1|>= 65 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 592 subjects randomized, 6 were never dosed with investigational product. Therefore, 586 subjects are in the Safety Population.|participants|Number|44|44.0||||||
4288710|NCT00545103|4113961|B5|55 to < 65 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 592 subjects randomized, 6 were never dosed with investigational product. Therefore, 586 subjects are in the Safety Population.|participants|Number|183|183.0||||||
4288711|NCT00545103|4113962|B4|55 to < 65 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 592 subjects randomized, 6 were never dosed with investigational product. Therefore, 586 subjects are in the Safety Population.|participants|Number|45|45.0||||||
4288712|NCT00545103|4113963|B3|55 to < 65 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 592 subjects randomized, 6 were never dosed with investigational product. Therefore, 586 subjects are in the Safety Population.|participants|Number|45|45.0||||||
4288713|NCT00545103|4113964|B2|55 to < 65 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 592 subjects randomized, 6 were never dosed with investigational product. Therefore, 586 subjects are in the Safety Population.|participants|Number|48|48.0||||||
4288714|NCT00545103|4113965|B1|55 to < 65 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 592 subjects randomized, 6 were never dosed with investigational product. Therefore, 586 subjects are in the Safety Population.|participants|Number|45|45.0||||||
4288715|NCT00545103|4113961|B5|45 to < 55 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 592 subjects randomized, 6 were never dosed with investigational product. Therefore, 586 subjects are in the Safety Population.|participants|Number|173|173.0||||||
4288716|NCT00545103|4113962|B4|45 to < 55 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 592 subjects randomized, 6 were never dosed with investigational product. Therefore, 586 subjects are in the Safety Population.|participants|Number|40|40.0||||||
4288717|NCT00545103|4113963|B3|45 to < 55 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 592 subjects randomized, 6 were never dosed with investigational product. Therefore, 586 subjects are in the Safety Population.|participants|Number|41|41.0||||||
4288718|NCT00545103|4113964|B2|45 to < 55 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 592 subjects randomized, 6 were never dosed with investigational product. Therefore, 586 subjects are in the Safety Population.|participants|Number|50|50.0||||||
4288719|NCT00545103|4113965|B1|45 to < 55 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 592 subjects randomized, 6 were never dosed with investigational product. Therefore, 586 subjects are in the Safety Population.|participants|Number|42|42.0||||||
4288720|NCT00545103|4113961|B5|35 to < 45 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 592 subjects randomized, 6 were never dosed with investigational product. Therefore, 586 subjects are in the Safety Population.|participants|Number|71|71.0||||||
4288721|NCT00545103|4113962|B4|35 to < 45 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 592 subjects randomized, 6 were never dosed with investigational product. Therefore, 586 subjects are in the Safety Population.|participants|Number|16|16.0||||||
4288722|NCT00545103|4113963|B3|35 to < 45 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 592 subjects randomized, 6 were never dosed with investigational product. Therefore, 586 subjects are in the Safety Population.|participants|Number|18|18.0||||||
4288723|NCT00545103|4113964|B2|35 to < 45 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 592 subjects randomized, 6 were never dosed with investigational product. Therefore, 586 subjects are in the Safety Population.|participants|Number|21|21.0||||||
4288724|NCT00545103|4113965|B1|35 to < 45 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 592 subjects randomized, 6 were never dosed with investigational product. Therefore, 586 subjects are in the Safety Population.|participants|Number|16|16.0||||||
4288725|NCT00545103|4113961|B5|18 to < 35 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 592 subjects randomized, 6 were never dosed with investigational product. Therefore, 586 subjects are in the Safety Population.|participants|Number|16|16.0||||||
4288726|NCT00545103|4113962|B4|18 to < 35 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 592 subjects randomized, 6 were never dosed with investigational product. Therefore, 586 subjects are in the Safety Population.|participants|Number|6|6.0||||||
4288772|NCT00544882|4114056|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4288727|NCT00545103|4113963|B3|18 to < 35 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 592 subjects randomized, 6 were never dosed with investigational product. Therefore, 586 subjects are in the Safety Population.|participants|Number|5|5.0||||||
4288728|NCT00545103|4113964|B2|18 to < 35 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 592 subjects randomized, 6 were never dosed with investigational product. Therefore, 586 subjects are in the Safety Population.|participants|Number|4|4.0||||||
4288729|NCT00545103|4113965|B1|18 to < 35 years||Age, Customized|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 592 subjects randomized, 6 were never dosed with investigational product. Therefore, 586 subjects are in the Safety Population.|participants|Number|1|1.0||||||
4288730|NCT00545103|4113961|B5|||Age|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 592 subjects randomized, 6 were never dosed with investigational product. Therefore, 586 subjects are in the Safety Population.|years|Mean|56.1|56.1|Standard Deviation|11.04|11.04|||
4288731|NCT00545103|4113962|B4|||Age|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 592 subjects randomized, 6 were never dosed with investigational product. Therefore, 586 subjects are in the Safety Population.|years|Mean|55.7|55.7|Standard Deviation|11.15|11.15|||
4288732|NCT00545103|4113963|B3|||Age|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 592 subjects randomized, 6 were never dosed with investigational product. Therefore, 586 subjects are in the Safety Population.|years|Mean|56.7|56.7|Standard Deviation|11.76|11.76|||
4288733|NCT00545103|4113964|B2|||Age|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 592 subjects randomized, 6 were never dosed with investigational product. Therefore, 586 subjects are in the Safety Population.|years|Mean|54.2|54.2|Standard Deviation|10.10|10.1|||
4288734|NCT00545103|4113965|B1|||Age|The Safety Population was used for this baseline measure. The Safety Population consists of subjects who were randomized and took at least 1 dose of investigational product. Out of the 592 subjects randomized, 6 were never dosed with investigational product. Therefore, 586 subjects are in the Safety Population.|years|Mean|57.8|57.8|Standard Deviation|10.88|10.88|||
4288735|NCT00545064|4114002|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4288736|NCT00545064|4114002|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4288737|NCT00545064|4114002|B1|||Age||years|Mean|65.6|65.6|Standard Deviation|12.1|12.1|||
4288738|NCT00545051|4114011|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288739|NCT00545051|4114012|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288740|NCT00545051|4114013|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288741|NCT00545051|4114011|B3||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4288742|NCT00545051|4114012|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4288743|NCT00545051|4114013|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4288744|NCT00545051|4114011|B3|||Age||years|Mean|63.79|63.79|Standard Deviation|7.39|7.39|||
4288745|NCT00545051|4114012|B2|||Age||years|Mean|63.2|63.2|Standard Deviation|6.83|6.83|||
4288746|NCT00545051|4114013|B1|||Age||years|Mean|64.4|64.4|Standard Deviation|7.90|7.9|||
4288747|NCT00545025|4114028|B3||Male|Gender||Participants|Count of Participants|101|101.0||||||
4288748|NCT00545025|4114029|B2||Male|Gender||Participants|Count of Participants|39|39.0||||||
4288749|NCT00545025|4114030|B1||Male|Gender||Participants|Count of Participants|62|62.0||||||
4288750|NCT00545025|4114028|B3||Female|Gender||Participants|Count of Participants|142|142.0||||||
4288751|NCT00545025|4114029|B2||Female|Gender||Participants|Count of Participants|44|44.0||||||
4288752|NCT00545025|4114030|B1||Female|Gender||Participants|Count of Participants|98|98.0||||||
4288753|NCT00545025|4114028|B3|||Age||Years|Mean|39.9|39.9|Standard Deviation|13.66|13.66|||
4288754|NCT00545025|4114029|B2|||Age||Years|Mean|40.9|40.9|Standard Deviation|13.66|13.66|||
4288755|NCT00545025|4114030|B1|||Age||Years|Mean|39.4|39.4|Standard Deviation|13.66|13.66|||
4288756|NCT00544908|4114051|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4288757|NCT00544908|4114051|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4288758|NCT00544908|4114051|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4288759|NCT00544908|4114051|B1|||Age||years|Median|61|61.0|Full Range|||41.0|83.0|
4288760|NCT00544882|4114056|B3|United States||Region of Enrollment||participants|Number|56|56.0||||||
4288761|NCT00544882|4114057|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4288762|NCT00544882|4114058|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4288763|NCT00544882|4114056|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4288764|NCT00544882|4114057|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4288765|NCT00544882|4114058|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4288766|NCT00544882|4114056|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4288767|NCT00544882|4114057|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4288768|NCT00544882|4114058|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4288769|NCT00544882|4114056|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4288770|NCT00544882|4114057|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4288773|NCT00544882|4114057|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4288774|NCT00544882|4114058|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4288775|NCT00544882|4114056|B3|African-American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4288776|NCT00544882|4114057|B2|African-American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4288777|NCT00544882|4114058|B1|African-American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4288778|NCT00544882|4114056|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288779|NCT00544882|4114057|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288780|NCT00544882|4114058|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288781|NCT00544882|4114056|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4288782|NCT00544882|4114057|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4288783|NCT00544882|4114058|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4288784|NCT00544882|4114056|B3|||Age||years|Mean|27.7|27.7|Standard Deviation|4.51|4.51|||
4288785|NCT00544882|4114057|B2|||Age||years|Mean|28.0|28.0|Standard Deviation|4.38|4.38|||
4288786|NCT00544882|4114058|B1|||Age||years|Mean|27.3|27.3|Standard Deviation|4.68|4.68|||
4288787|NCT00544869|4114082|B4|Japan||Region of Enrollment||participants|Number|51|51.0||||||
4288788|NCT00544869|4114083|B3|Japan||Region of Enrollment||participants|Number|2|2.0||||||
4288789|NCT00544869|4114084|B2|Japan||Region of Enrollment||participants|Number|13|13.0||||||
4288790|NCT00544869|4114085|B1|Japan||Region of Enrollment||participants|Number|36|36.0||||||
4288791|NCT00544869|4114082|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4288792|NCT00544869|4114083|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4288793|NCT00544869|4114084|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4288794|NCT00544869|4114085|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4288795|NCT00544869|4114082|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4288796|NCT00544869|4114083|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4288797|NCT00544869|4114084|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4288798|NCT00544869|4114085|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4288799|NCT00544869|4114082|B4|||Age||years|Mean|70.5|70.5|Standard Deviation|10.4|10.4|||
4288800|NCT00544869|4114083|B3|||Age||years|Mean|78.5|78.5|Standard Deviation|2.1|2.1|||
4288801|NCT00544869|4114084|B2|||Age||years|Mean|67.2|67.2|Standard Deviation|12.7|12.7|||
4288802|NCT00544869|4114085|B1|||Age||years|Mean|71.3|71.3|Standard Deviation|9.5|9.5|||
4288803|NCT00544869|4114082|B4||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
4288804|NCT00544869|4114083|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4288805|NCT00544869|4114084|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4288806|NCT00544869|4114085|B1||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4288807|NCT00544869|4114082|B4||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4288808|NCT00544869|4114083|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4288809|NCT00544869|4114084|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4288810|NCT00544869|4114085|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4288811|NCT00544869|4114082|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288812|NCT00544869|4114083|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288813|NCT00544869|4114084|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288814|NCT00544869|4114085|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288815|NCT00544817|4114095|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
4288816|NCT00544817|4114095|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4288817|NCT00544817|4114095|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4288818|NCT00544817|4114095|B1|||Age||years|Median|54|54.0|Full Range|||28.0|79.0|
4288819|NCT00544778|4114101|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4288820|NCT00544778|4114101|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4288821|NCT00544778|4114101|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4288822|NCT00544778|4114101|B1|||Age||years|Median|39|39.0|Full Range|||20.0|62.0|
4288823|NCT00544713|4114105|B3||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4288824|NCT00544713|4114106|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4288825|NCT00544713|4114107|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4288826|NCT00544713|4114105|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4288827|NCT00544713|4114106|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4288828|NCT00544713|4114107|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4288829|NCT00544713|4114105|B3|>= 40 Years||Age, Customized||participants|Number|48|48.0||||||
4288830|NCT00544713|4114106|B2|>= 40 Years||Age, Customized||participants|Number|22|22.0||||||
4288831|NCT00544713|4114107|B1|>= 40 Years||Age, Customized||participants|Number|26|26.0||||||
4288832|NCT00544713|4114105|B3|<40 Years||Age, Customized||participants|Number|180|180.0||||||
4288833|NCT00544713|4114106|B2|<40 Years||Age, Customized||participants|Number|92|92.0||||||
4288834|NCT00544713|4114107|B1|<40 Years||Age, Customized||participants|Number|88|88.0||||||
4288835|NCT00544674|4114138|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4288836|NCT00544674|4114138|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4288837|NCT00544674|4114138|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4288838|NCT00544674|4114138|B1|||Age||years|Mean|63|63.0|Standard Deviation|9.19|9.19|||
4288839|NCT00544674|4114138|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4288840|NCT00544674|4114138|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4288841|NCT00544674|4114138|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288842|NCT00544648|4114142|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4288843|NCT00544648|4114143|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4288844|NCT00544648|4114144|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4288845|NCT00544648|4114142|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4288846|NCT00544648|4114143|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4288847|NCT00544648|4114144|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4288848|NCT00544648|4114142|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4288849|NCT00544648|4114143|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4288850|NCT00544648|4114144|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4288851|NCT00544648|4114142|B3|||Age||years|Mean|59|59.0|Standard Deviation|16|16.0|||
4288852|NCT00544648|4114143|B2|||Age||years|Mean|56|56.0|Standard Deviation|4|4.0|||
4288853|NCT00544648|4114144|B1|||Age||years|Mean|63|63.0|Standard Deviation|9|9.0|||
4288854|NCT00544648|4114142|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4288855|NCT00544648|4114143|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4288856|NCT00544648|4114144|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4288857|NCT00544648|4114142|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4288858|NCT00544648|4114143|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4288859|NCT00544648|4114144|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4288860|NCT00544648|4114142|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288861|NCT00544648|4114143|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288862|NCT00544648|4114144|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288863|NCT00544557|4114159|B1|Missing||Sex/Gender, Customized||participants|Number|3|3.0||||||
4288864|NCT00544557|4114159|B1|Female||Sex/Gender, Customized||participants|Number|615|615.0||||||
4288865|NCT00544557|4114159|B1|Male||Sex/Gender, Customized||participants|Number|1067|1067.0||||||
4288866|NCT00544557|4114159|B1|||Age||years|Mean|43.9|43.9|Standard Deviation|12.9|12.9|||
4288867|NCT00544544|4114190|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4288868|NCT00544544|4114190|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4288869|NCT00544544|4114190|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4288870|NCT00544544|4114190|B1|||Age||years|Mean|44.5|44.5|Standard Deviation|12.0|12.0|||
4288871|NCT00544544|4114190|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4288872|NCT00544544|4114190|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4288873|NCT00544544|4114190|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288874|NCT00544440|4114197|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4288875|NCT00544440|4114197|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288876|NCT00544440|4114197|B1|||Age||years|Mean|69.1|69.1|Standard Deviation|8.93|8.93|||
4288877|NCT00544167|4114204|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4288878|NCT00544167|4114204|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288879|NCT00544167|4114204|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4288880|NCT00544167|4114204|B1|||Age||years|Median|54|54.0|Full Range|||35.0|74.0|
4288881|NCT00543985|4114208|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4288882|NCT00543985|4114208|B1||Male|Gender||Participants|Count of Participants|17|17.0||||||
4288883|NCT00543985|4114208|B1||Female|Gender||Participants|Count of Participants|15|15.0||||||
4288884|NCT00543985|4114208|B1|||Age||years|Mean|37|37.0|Standard Deviation|2|2.0|||
4288885|NCT00543985|4114208|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4288886|NCT00543985|4114208|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4288887|NCT00543985|4114208|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288888|NCT00543855|4114215|B5||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4288889|NCT00543855|4114216|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4288890|NCT00543855|4114217|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4288891|NCT00543855|4114218|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4288892|NCT00543855|4114219|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4288893|NCT00543855|4114215|B5||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4288894|NCT00543855|4114216|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4288895|NCT00543855|4114217|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4288896|NCT00543855|4114218|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4288897|NCT00543855|4114219|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4288898|NCT00543855|4114215|B5|||Age||years|Mean|78.7|78.7|Standard Deviation|5.6|5.6|||
4288899|NCT00543855|4114216|B4|||Age||years|Mean|78.7|78.7|Standard Deviation|4.9|4.9|||
4288900|NCT00543855|4114217|B3|||Age||years|Mean|78.4|78.4|Standard Deviation|6.1|6.1|||
4288901|NCT00543855|4114218|B2|||Age||years|Mean|77.9|77.9|Standard Deviation|6.7|6.7|||
4288902|NCT00543855|4114219|B1|||Age||years|Mean|79.6|79.6|Standard Deviation|4.5|4.5|||
4288903|NCT00543803|4114244|B1||Male|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
4288904|NCT00543803|4114244|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4288905|NCT00543803|4114244|B1|||Age||Years|Mean|41.8|41.8|Standard Deviation|9.8|9.8|||
4288906|NCT00543764|4114261|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288907|NCT00543764|4114262|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288908|NCT00543764|4114263|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288909|NCT00543764|4114261|B3||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4288910|NCT00543764|4114262|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4288911|NCT00543764|4114263|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4288912|NCT00543764|4114261|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4288913|NCT00543764|4114262|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4288914|NCT00543764|4114263|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4288915|NCT00543764|4114261|B3||Between 18 and 65 years|Age||Participants|Count of Participants|150|150.0||||||
4288916|NCT00543764|4114262|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4288917|NCT00543764|4114263|B1||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4288918|NCT00543764|4114261|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288919|NCT00543764|4114262|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288920|NCT00543764|4114263|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288921|NCT00543725|4114270|B3|USA, Canada, Europe, Australia||Region Enroll||participants|Number|326|326.0||||||
4288922|NCT00543725|4114271|B2|USA, Canada, Europe, Australia||Region Enroll||participants|Number|154|154.0||||||
4288923|NCT00543725|4114272|B1|USA, Canada, Europe, Australia||Region Enroll||participants|Number|172|172.0||||||
4288924|NCT00543725|4114270|B3|Latin America||Region Enroll||participants|Number|175|175.0||||||
4288925|NCT00543725|4114271|B2|Latin America||Region Enroll||participants|Number|85|85.0||||||
4288926|NCT00543725|4114272|B1|Latin America||Region Enroll||participants|Number|90|90.0||||||
4288927|NCT00543725|4114270|B3|Asia||Region Enroll||participants|Number|120|120.0||||||
4288928|NCT00543725|4114271|B2|Asia||Region Enroll||participants|Number|61|61.0||||||
4288929|NCT00543725|4114272|B1|Asia||Region Enroll||participants|Number|59|59.0||||||
4288930|NCT00543725|4114270|B3|Africa||Region Enroll||participants|Number|57|57.0||||||
4288931|NCT00543725|4114271|B2|Africa||Region Enroll||participants|Number|38|38.0||||||
4288932|NCT00543725|4114272|B1|Africa||Region Enroll||participants|Number|19|19.0||||||
4288933|NCT00543725|4114270|B3||Male|Sex: Female, Male||Participants|Count of Participants|494|494.0||||||
4288934|NCT00543725|4114271|B2||Male|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
4288935|NCT00543725|4114272|B1||Male|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
4288936|NCT00543725|4114270|B3||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4288937|NCT00543725|4114271|B2||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4288938|NCT00543725|4114272|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4288939|NCT00543725|4114270|B3|||Age||years|Mean|36.5|36.5|Standard Deviation|9.15|9.15|||
4288940|NCT00543725|4114271|B2|||Age||years|Mean|36.4|36.4|Standard Deviation|8.92|8.92|||
4288941|NCT00543725|4114272|B1|||Age||years|Mean|36.7|36.7|Standard Deviation|9.39|9.39|||
4288942|NCT00543725|4114270|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4288943|NCT00543725|4114271|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4288944|NCT00543725|4114272|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4288945|NCT00543725|4114270|B3||Between 18 and 65 years|Age||Participants|Count of Participants|676|676.0||||||
4288946|NCT00543725|4114271|B2||Between 18 and 65 years|Age||Participants|Count of Participants|337|337.0||||||
4288947|NCT00543725|4114272|B1||Between 18 and 65 years|Age||Participants|Count of Participants|339|339.0||||||
4288948|NCT00543725|4114270|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288949|NCT00543725|4114271|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288950|NCT00543725|4114272|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4288951|NCT00543569|4114295|B5||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4288952|NCT00543569|4114296|B4||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4288953|NCT00543569|4114297|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4288954|NCT00543569|4114298|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4288955|NCT00543569|4114299|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4288956|NCT00543569|4114295|B5||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4288957|NCT00543569|4114296|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4288958|NCT00543569|4114297|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4288959|NCT00543569|4114298|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4288960|NCT00543569|4114299|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4288961|NCT00543569|4114295|B5|||Age||years|Mean|48.80|48.8|Standard Deviation|13.707|13.707|||
4288962|NCT00543569|4114296|B4|||Age||years|Mean|49.68|49.68|Standard Deviation|13.749|13.749|||
4288963|NCT00543569|4114297|B3|||Age||years|Mean|47.80|47.8|Standard Deviation|12.469|12.469|||
4288964|NCT00543569|4114298|B2|||Age||years|Mean|49.26|49.26|Standard Deviation|13.532|13.532|||
4288965|NCT00543569|4114299|B1|||Age||years|Mean|48.44|48.44|Standard Deviation|15.077|15.077|||
4288966|NCT00543543|4114404|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288967|NCT00543543|4114405|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288968|NCT00543543|4114406|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288969|NCT00543543|4114407|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288970|NCT00543543|4114408|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4288971|NCT00543543|4114404|B5||Female|Sex: Female, Male||Participants|Count of Participants|14840|14840.0||||||
4288972|NCT00543543|4114405|B4||Female|Sex: Female, Male||Participants|Count of Participants|7109|7109.0||||||
4288973|NCT00543543|4114406|B3||Female|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
4288974|NCT00543543|4114407|B2||Female|Sex: Female, Male||Participants|Count of Participants|7106|7106.0||||||
4288975|NCT00543543|4114408|B1||Female|Sex: Female, Male||Participants|Count of Participants|315|315.0||||||
4288976|NCT00543543|4114404|B5|||Age||Years|Mean|21.9|21.9|Standard Deviation|2.5|2.5|||
4288977|NCT00543543|4114405|B4|||Age||Years|Mean|21.8|21.8|Standard Deviation|2.5|2.5|||
4288978|NCT00543543|4114406|B3|||Age||Years|Mean|21.9|21.9|Standard Deviation|2.4|2.4|||
4288979|NCT00543543|4114407|B2|||Age||Years|Mean|21.9|21.9|Standard Deviation|2.5|2.5|||
4288980|NCT00543543|4114408|B1|||Age||Years|Mean|21.7|21.7|Standard Deviation|2.4|2.4|||
4288981|NCT00543400|4114452|B5||Male|Sex: Female, Male||Participants|Count of Participants|364|364.0||||||
4288982|NCT00543400|4114453|B4||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4288983|NCT00543400|4114454|B3||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4288984|NCT00543400|4114455|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4288985|NCT00543400|4114456|B1||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4288986|NCT00543400|4114452|B5||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4288987|NCT00543400|4114453|B4||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4288988|NCT00543400|4114454|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4288989|NCT00543400|4114455|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4288990|NCT00543400|4114456|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4288991|NCT00543400|4114452|B5|||Age|Overall age of participants|years|Mean|63.9|63.9|Full Range|||54.1|71.6|
4288992|NCT00543400|4114453|B4|||Age|Overall age of participants|years|Mean|63.0|63.0|Full Range|||58.3|69.9|
4288993|NCT00543400|4114454|B3|||Age|Overall age of participants|years|Mean|65.3|65.3|Full Range|||57.4|71.0|
4288994|NCT00543400|4114455|B2|||Age|Overall age of participants|years|Mean|62.9|62.9|Full Range|||54.1|70.9|
4288995|NCT00543400|4114456|B1|||Age|Overall age of participants|years|Mean|63.8|63.8|Full Range|||56.8|71.6|
4288996|NCT00543387|4114469|B10||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4288997|NCT00543387|4114470|B9||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4288998|NCT00543387|4114471|B8||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4288999|NCT00543387|4114472|B7||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4289000|NCT00543387|4114473|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4289001|NCT00543387|4114474|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4289002|NCT00543387|4114475|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4289003|NCT00543387|4114476|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4289004|NCT00543387|4114477|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4289005|NCT00543387|4114478|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4289006|NCT00543387|4114469|B10||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4289007|NCT00543387|4114470|B9||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4289008|NCT00543387|4114471|B8||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4289009|NCT00543387|4114472|B7||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4289010|NCT00543387|4114473|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4289011|NCT00543387|4114474|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4289012|NCT00543387|4114475|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4289013|NCT00543387|4114476|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4289014|NCT00543387|4114477|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4289015|NCT00543387|4114478|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4289016|NCT00543387|4114469|B10|||Age||years|Mean|59.1|59.1|Standard Deviation|11.9|11.9|||
4289017|NCT00543387|4114470|B9|||Age||years|Mean|59.8|59.8|Standard Deviation|8.9|8.9|||
4289018|NCT00543387|4114471|B8|||Age||years|Mean|57.3|57.3|Standard Deviation|15.7|15.7|||
4289019|NCT00543387|4114472|B7|||Age||years|Mean|58.0|58.0|Standard Deviation|15.1|15.1|||
4289020|NCT00543387|4114473|B6|||Age||years|Mean|61.0|61.0|Standard Deviation|2.0|2.0|||
4289021|NCT00543387|4114474|B5|||Age||years|Mean|54.3|54.3|Standard Deviation|7.5|7.5|||
4289022|NCT00543387|4114475|B4|||Age||years|Mean|58.0|58.0|Standard Deviation|15.7|15.7|||
4289023|NCT00543387|4114476|B3|||Age||years|Mean|75.3|75.3|Standard Deviation|9.1|9.1|||
4289024|NCT00543387|4114477|B2|||Age||years|Mean|57.0|57.0|Standard Deviation|7.8|7.8|||
4289025|NCT00543387|4114478|B1|||Age||years|Mean|54.0|54.0|Standard Deviation|11.4|11.4|||
4289026|NCT00543309|4114523|B4|||Chromosomal abnormality or syndrome||Participants|Count of Participants|5|5.0||||||
4289027|NCT00543309|4114524|B3|||Chromosomal abnormality or syndrome||Participants|Count of Participants|1|1.0||||||
4289028|NCT00543309|4114525|B2|||Chromosomal abnormality or syndrome||Participants|Count of Participants|1|1.0||||||
4289029|NCT00543309|4114526|B1|||Chromosomal abnormality or syndrome||Participants|Count of Participants|3|3.0||||||
4289030|NCT00543309|4114523|B4|||Noncardiac congenital anomaly||Participants|Count of Participants|17|17.0||||||
4289031|NCT00543309|4114524|B3|||Noncardiac congenital anomaly||Participants|Count of Participants|6|6.0||||||
4289032|NCT00543309|4114525|B2|||Noncardiac congenital anomaly||Participants|Count of Participants|7|7.0||||||
4289033|NCT00543309|4114526|B1|||Noncardiac congenital anomaly||Participants|Count of Participants|4|4.0||||||
4289034|NCT00543309|4114523|B4|||History of Arrhythmias||Participants|Count of Participants|16|16.0||||||
4289035|NCT00543309|4114524|B3|||History of Arrhythmias||Participants|Count of Participants|2|2.0||||||
4289036|NCT00543309|4114525|B2|||History of Arrhythmias||Participants|Count of Participants|5|5.0||||||
4289037|NCT00543309|4114526|B1|||History of Arrhythmias||Participants|Count of Participants|9|9.0||||||
4289038|NCT00543309|4114523|B4|||Prior Interventional Cardiac Catheterization||Participants|Count of Participants|88|88.0||||||
4289039|NCT00543309|4114524|B3|||Prior Interventional Cardiac Catheterization||Participants|Count of Participants|30|30.0||||||
4289040|NCT00543309|4114525|B2|||Prior Interventional Cardiac Catheterization||Participants|Count of Participants|30|30.0||||||
4289041|NCT00543309|4114526|B1|||Prior Interventional Cardiac Catheterization||Participants|Count of Participants|28|28.0||||||
4289042|NCT00543309|4114523|B4|||Prior Cardiac Operations||operations|Median|2|2.0|Full Range|||0.0|4.0|
4289043|NCT00543309|4114524|B3|||Prior Cardiac Operations||operations|Median|2|2.0|Full Range|||1.0|3.0|
4289044|NCT00543309|4114525|B2|||Prior Cardiac Operations||operations|Median|2|2.0|Full Range|||0.0|4.0|
4289045|NCT00543309|4114526|B1|||Prior Cardiac Operations||operations|Median|2|2.0|Full Range|||1.0|4.0|
4289046|NCT00543309|4114523|B4||Two ventricles|Ventricular Morphology||Participants|Count of Participants|2|2.0||||||
4289047|NCT00543309|4114524|B3||Two ventricles|Ventricular Morphology||Participants|Count of Participants|1|1.0||||||
4289048|NCT00543309|4114525|B2||Two ventricles|Ventricular Morphology||Participants|Count of Participants|1|1.0||||||
4289049|NCT00543309|4114526|B1||Two ventricles|Ventricular Morphology||Participants|Count of Participants|0|0.0||||||
4289050|NCT00543309|4114523|B4||Right dominant|Ventricular Morphology||Participants|Count of Participants|67|67.0||||||
4289051|NCT00543309|4114524|B3||Right dominant|Ventricular Morphology||Participants|Count of Participants|22|22.0||||||
4289052|NCT00543309|4114525|B2||Right dominant|Ventricular Morphology||Participants|Count of Participants|25|25.0||||||
4289053|NCT00543309|4114526|B1||Right dominant|Ventricular Morphology||Participants|Count of Participants|20|20.0||||||
4289054|NCT00543309|4114523|B4||Left dominant|Ventricular Morphology||Participants|Count of Participants|37|37.0||||||
4289055|NCT00543309|4114524|B3||Left dominant|Ventricular Morphology||Participants|Count of Participants|12|12.0||||||
4289056|NCT00543309|4114525|B2||Left dominant|Ventricular Morphology||Participants|Count of Participants|10|10.0||||||
4289057|NCT00543309|4114526|B1||Left dominant|Ventricular Morphology||Participants|Count of Participants|15|15.0||||||
4289058|NCT00543309|4114523|B4|||Weight||kilograms|Median|12.6|12.6|Full Range|||9.1|65.7|
4289059|NCT00543309|4114524|B3|||Weight||kilograms|Median|12.6|12.6|Full Range|||9.8|20.4|
4289060|NCT00543309|4114525|B2|||Weight||kilograms|Median|12.8|12.8|Full Range|||9.1|40.6|
4289061|NCT00543309|4114526|B1|||Weight||kilograms|Median|12.5|12.5|Full Range|||9.9|65.7|
4289062|NCT00543309|4114523|B4|United States||Region of Enrollment||Participants|Count of Participants|106|106.0||||||
4289063|NCT00543309|4114524|B3|United States||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
4289064|NCT00543309|4114525|B2|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
4289065|NCT00543309|4114526|B1|United States||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
4289066|NCT00543309|4114523|B4|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4289067|NCT00543309|4114524|B3|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4289068|NCT00543309|4114525|B2|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4289069|NCT00543309|4114526|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4289070|NCT00543309|4114523|B4|Race|More than one race|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4289071|NCT00543309|4114524|B3|Race|More than one race|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4289072|NCT00543309|4114525|B2|Race|More than one race|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4289073|NCT00543309|4114526|B1|Race|More than one race|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4289074|NCT00543309|4114523|B4|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4289075|NCT00543309|4114524|B3|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4289076|NCT00543309|4114525|B2|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4289077|NCT00543309|4114526|B1|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4289078|NCT00543309|4114523|B4|Race|Hispanic/Latino|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
4289079|NCT00543309|4114524|B3|Race|Hispanic/Latino|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4289080|NCT00543309|4114525|B2|Race|Hispanic/Latino|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4289081|NCT00543309|4114526|B1|Race|Hispanic/Latino|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4289082|NCT00543309|4114523|B4|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4289083|NCT00543309|4114524|B3|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4289084|NCT00543309|4114525|B2|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4289085|NCT00543309|4114526|B1|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4289086|NCT00543309|4114523|B4|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|74|74.0||||||
4289087|NCT00543309|4114524|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
4289088|NCT00543309|4114525|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
4289089|NCT00543309|4114526|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
4289090|NCT00543309|4114523|B4||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4289091|NCT00543309|4114524|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4289092|NCT00543309|4114525|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4289093|NCT00543309|4114526|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4289094|NCT00543309|4114523|B4||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4289095|NCT00543309|4114524|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4289096|NCT00543309|4114525|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4289097|NCT00543309|4114526|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4289098|NCT00543309|4114523|B4|||Age||years|Median|2.7|2.7|Full Range|||1.8|15.2|
4289099|NCT00543309|4114524|B3|||Age||years|Median|2.7|2.7|Full Range|||1.9|4.5|
4289100|NCT00543309|4114525|B2|||Age||years|Median|2.6|2.6|Full Range|||1.8|14.4|
4289101|NCT00543309|4114526|B1|||Age||years|Median|2.7|2.7|Full Range|||1.9|15.2|
4289102|NCT00543296|4114578|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4289103|NCT00543296|4114578|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4289104|NCT00543296|4114578|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4289105|NCT00543296|4114578|B1|||Age||years|Mean|50.0|50.0|Standard Deviation|12.9|12.9|||
4289106|NCT00543140|4114585|B1|||Body Mass Index (kg/m^2)||kilograms per meters squared|Mean|44.1|44.1|Standard Deviation|4.76|4.76|||
4289107|NCT00543140|4114585|B1|||Weight (lbs)||pounds|Mean|272.2|272.2|Standard Deviation|40.78|40.78|||
4289108|NCT00543140|4114585|B1|United States||Region of Enrollment||participants|Number|303|303.0||||||
4289109|NCT00543140|4114585|B1|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4289110|NCT00543140|4114585|B1|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4289111|NCT00543140|4114585|B1|Black, not of Hispanic origin||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4289112|NCT00543140|4114585|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
4289113|NCT00543140|4114585|B1|Caucasian, not of Hispanic origin||Race/Ethnicity, Customized||participants|Number|205|205.0||||||
4289114|NCT00543140|4114585|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4289115|NCT00543140|4114585|B1||Female|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
4289116|NCT00543140|4114585|B1|||Age||years|Mean|40.5|40.5|Standard Deviation|9.90|9.9|||
4289117|NCT00543101|4114593|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4289118|NCT00543101|4114594|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4289119|NCT00543101|4114595|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4289120|NCT00543101|4114593|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4289121|NCT00543101|4114594|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4289122|NCT00543101|4114595|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4289123|NCT00543101|4114593|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4289124|NCT00543101|4114594|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4289125|NCT00543101|4114595|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4289126|NCT00543101|4114593|B3|||Age||years|Median|50|50.0|Full Range|||31.0|64.0|
4289127|NCT00543101|4114594|B2|||Age||years|Median|51|51.0|Full Range|||36.0|64.0|
4289128|NCT00543101|4114595|B1|||Age||years|Median|46|46.0|Full Range|||31.0|59.0|
4289129|NCT00543101|4114593|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4289130|NCT00543101|4114594|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4289131|NCT00543101|4114595|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4289132|NCT00543101|4114593|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4289133|NCT00543101|4114594|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4289134|NCT00543101|4114595|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4289135|NCT00543101|4114593|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4289136|NCT00543101|4114594|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4289137|NCT00543101|4114595|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4289138|NCT00542997|4114608|B1|Autosomal recessive agammaglobulinemia (ARAG)||Type of Primary Immunodeficiency||Participants|Number|1|1.0||||||
4289139|NCT00542997|4114608|B1|X-linked agammaglobulinemia (XLA)||Type of Primary Immunodeficiency||Participants|Number|20|20.0||||||
4289140|NCT00542997|4114608|B1|Common variable immunodeficiency (CVID)||Type of Primary Immunodeficiency||Participants|Number|30|30.0||||||
4289141|NCT00542997|4114608|B1|White||Race/Ethnicity, Customized||Participants|Number|51|51.0||||||
4289142|NCT00542997|4114608|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4289143|NCT00542997|4114608|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4289144|NCT00542997|4114608|B1|16 to < 65 years||Age, Customized||Participants|Number|28|28.0||||||
4289145|NCT00542997|4114608|B1|12 to < 16 years||Age, Customized||Participants|Number|5|5.0||||||
4289146|NCT00542997|4114608|B1|2 to < 12 years||Age, Customized||Participants|Number|18|18.0||||||
4289147|NCT00542997|4114608|B1|||Age||years|Mean|22.6|22.6|Standard Deviation|16.02|16.02|||
4289148|NCT00542971|4114623|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
4289149|NCT00542971|4114623|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4289150|NCT00542971|4114623|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4289151|NCT00542971|4114623|B1|||Age||years|Median|52|52.0|Full Range|||18.0|66.0|
4289152|NCT00542880|4114628|B3||Male|Sex: Female, Male||Participants|Count of Participants|316|316.0||||||
4289153|NCT00542880|4114629|B2||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4289154|NCT00542880|4114630|B1||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4289155|NCT00542880|4114628|B3||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4289156|NCT00542880|4114629|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4289157|NCT00542880|4114630|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4289158|NCT00542880|4114628|B3|||Age||years|Mean|63.1|63.1|Full Range|||40.0|86.0|
4289159|NCT00542880|4114629|B2|||Age||years|Mean|63.2|63.2|Full Range|||40.0|86.0|
4289160|NCT00542880|4114630|B1|||Age||years|Mean|62.9|62.9|Full Range|||41.0|82.0|
4289161|NCT00542828|4114667|B1|Not Reported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4289162|NCT00542828|4114667|B1|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4289163|NCT00542828|4114667|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4289164|NCT00542828|4114667|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4289165|NCT00542828|4114667|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4289166|NCT00542828|4114667|B1|>=60 years||Age, Customized||participants|Number|4|4.0||||||
4289167|NCT00542828|4114667|B1|<60 years||Age, Customized||participants|Number|10|10.0||||||
4289168|NCT00542828|4114667|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|7.67|7.67|||
4289169|NCT00542815|4114682|B4||Male|Sex: Female, Male||Participants|Count of Participants|351|351.0||||||
4289170|NCT00542815|4114683|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4289171|NCT00542815|4114684|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4289172|NCT00542815|4114685|B1||Male|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4289173|NCT00542815|4114682|B4||Female|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
4289174|NCT00542815|4114683|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4289175|NCT00542815|4114684|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4289176|NCT00542815|4114685|B1||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4289177|NCT00542815|4114682|B4|>=65 years||Age, Customized||participants|Number|126|126.0||||||
4289178|NCT00542815|4114683|B3|>=65 years||Age, Customized||participants|Number|47|47.0||||||
4289179|NCT00542815|4114684|B2|>=65 years||Age, Customized||participants|Number|21|21.0||||||
4289180|NCT00542815|4114685|B1|>=65 years||Age, Customized||participants|Number|58|58.0||||||
4289181|NCT00542815|4114682|B4|<65 years||Age, Customized||participants|Number|506|506.0||||||
4289182|NCT00542815|4114683|B3|<65 years||Age, Customized||participants|Number|77|77.0||||||
4289183|NCT00542815|4114684|B2|<65 years||Age, Customized||participants|Number|55|55.0||||||
4289184|NCT00542815|4114685|B1|<65 years||Age, Customized||participants|Number|374|374.0||||||
4289185|NCT00542789|4114698|B3|Missing||Sex/Gender, Customized||participants|Number|2|2.0||||||
4289186|NCT00542789|4114699|B2|Missing||Sex/Gender, Customized||participants|Number|0|0.0||||||
4289187|NCT00542789|4114700|B1|Missing||Sex/Gender, Customized||participants|Number|2|2.0||||||
4289188|NCT00542789|4114698|B3|Male||Sex/Gender, Customized||participants|Number|133|133.0||||||
4289189|NCT00542789|4114699|B2|Male||Sex/Gender, Customized||participants|Number|68|68.0||||||
4289190|NCT00542789|4114700|B1|Male||Sex/Gender, Customized||participants|Number|65|65.0||||||
4289191|NCT00542789|4114698|B3|Female||Sex/Gender, Customized||participants|Number|208|208.0||||||
4289192|NCT00542789|4114699|B2|Female||Sex/Gender, Customized||participants|Number|100|100.0||||||
4289193|NCT00542789|4114700|B1|Female||Sex/Gender, Customized||participants|Number|108|108.0||||||
4289194|NCT00542789|4114698|B3|Missing||Age, Customized||participants|Number|2|2.0||||||
4289195|NCT00542789|4114699|B2|Missing||Age, Customized||participants|Number|0|0.0||||||
4289196|NCT00542789|4114700|B1|Missing||Age, Customized||participants|Number|2|2.0||||||
4289197|NCT00542789|4114698|B3|>=75 years||Age, Customized||participants|Number|59|59.0||||||
4289198|NCT00542789|4114699|B2|>=75 years||Age, Customized||participants|Number|23|23.0||||||
4289199|NCT00542789|4114700|B1|>=75 years||Age, Customized||participants|Number|36|36.0||||||
4289200|NCT00542789|4114698|B3|Between 65 and 74 years||Age, Customized||participants|Number|113|113.0||||||
4289201|NCT00542789|4114699|B2|Between 65 and 74 years||Age, Customized||participants|Number|54|54.0||||||
4289202|NCT00542789|4114700|B1|Between 65 and 74 years||Age, Customized||participants|Number|59|59.0||||||
4289203|NCT00542789|4114698|B3|<65 years||Age, Customized||participants|Number|169|169.0||||||
4289204|NCT00542789|4114699|B2|<65 years||Age, Customized||participants|Number|91|91.0||||||
4289205|NCT00542789|4114700|B1|<65 years||Age, Customized||participants|Number|78|78.0||||||
4289206|NCT00542750|4114711|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4289207|NCT00542750|4114711|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4289208|NCT00542750|4114711|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4289209|NCT00542750|4114711|B1|||Age||years|Mean|19|19.0|Standard Deviation|0.78|0.78|||
4289210|NCT00542750|4114711|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4289211|NCT00542750|4114711|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4289212|NCT00542750|4114711|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4289213|NCT00542620|4114715|B3|||Diabetes history|Number of years since diagnosis|years|Mean|6.42|6.42|Standard Deviation|2.97|2.97|||
4289214|NCT00542620|4114716|B2|||Diabetes history|Number of years since diagnosis|years|Mean|6.13|6.13|Standard Deviation|2.38|2.38|||
4289215|NCT00542620|4114717|B1|||Diabetes history|Number of years since diagnosis|years|Mean|6.68|6.68|Standard Deviation|3.51|3.51|||
4289216|NCT00542620|4114715|B3|France||Region of Enrollment||participants|Number|25|25.0||||||
4289217|NCT00542620|4114716|B2|France||Region of Enrollment||participants|Number|12|12.0||||||
4289218|NCT00542620|4114717|B1|France||Region of Enrollment||participants|Number|13|13.0||||||
4289219|NCT00542620|4114715|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4289220|NCT00542620|4114716|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4289221|NCT00542620|4114717|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4289222|NCT00542620|4114715|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4289223|NCT00542620|4114716|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4289224|NCT00542620|4114717|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4289225|NCT00542620|4114715|B3|||Age||years|Mean|11.3|11.3|Standard Deviation|2.5|2.5|||
4289226|NCT00542620|4114716|B2|||Age||years|Mean|10.9|10.9|Standard Deviation|2.5|2.5|||
4289227|NCT00542620|4114717|B1|||Age||years|Mean|11.6|11.6|Standard Deviation|2.6|2.6|||
4289228|NCT00542542|4114782|B3|United States||Region of Enrollment||participants|Number|88|88.0||||||
4289229|NCT00542542|4114783|B2|United States||Region of Enrollment||participants|Number|44|44.0||||||
4289230|NCT00542542|4114784|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4289231|NCT00542542|4114782|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4289232|NCT00542542|4114783|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4289233|NCT00542542|4114784|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4289234|NCT00542542|4114782|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4289235|NCT00542542|4114783|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4289236|NCT00542542|4114784|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4289237|NCT00542542|4114782|B3|||Age||years|Median|51|51.0|Full Range|||27.0|81.0|
4289238|NCT00542542|4114783|B2|||Age||years|Median|51|51.0|Full Range|||27.0|81.0|
4289239|NCT00542542|4114784|B1|||Age||years|Median|49|49.0|Full Range|||27.0|75.0|
4289240|NCT00542490|4114791|B1|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4289241|NCT00542490|4114791|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4289242|NCT00542490|4114791|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4289243|NCT00542490|4114791|B1|||Age||years|Mean|69|69.0|Full Range|||46.0|81.0|
4289244|NCT00542490|4114791|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4289245|NCT00542490|4114791|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4289246|NCT00542490|4114791|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4289247|NCT00542425|4114796|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4289248|NCT00542425|4114797|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4289249|NCT00542425|4114798|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4289250|NCT00542425|4114799|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4289251|NCT00542425|4114800|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4289252|NCT00542425|4114801|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4289253|NCT00542425|4114796|B6||Female|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4289254|NCT00542425|4114797|B5||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4289255|NCT00542425|4114798|B4||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4289256|NCT00542425|4114799|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4289257|NCT00542425|4114800|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4289258|NCT00542425|4114801|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4289259|NCT00542425|4114796|B6|||Age||years|Mean|65|65.0|Standard Deviation|7.19|7.19|||
4289260|NCT00542425|4114797|B5|||Age||years|Mean|64.5|64.5|Standard Deviation|7.48|7.48|||
4289261|NCT00542425|4114798|B4|||Age||years|Mean|64.8|64.8|Standard Deviation|7.21|7.21|||
4289262|NCT00542425|4114799|B3|||Age||years|Mean|64.5|64.5|Standard Deviation|7.35|7.35|||
4289263|NCT00542425|4114800|B2|||Age||years|Mean|66.3|66.3|Standard Deviation|6.96|6.96|||
4289264|NCT00542425|4114801|B1|||Age||years|Mean|65|65.0|Standard Deviation|7.11|7.11|||
4289265|NCT00542386|4114837|B7||Male|Sex: Female, Male||Participants|Count of Participants|340|340.0||||||
4289266|NCT00542386|4114838|B6||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4289267|NCT00542386|4114839|B5||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4289268|NCT00542386|4114840|B4||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4289269|NCT00542386|4114841|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4289270|NCT00542386|4114842|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4289271|NCT00542386|4114843|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4289272|NCT00542386|4114837|B7||Female|Sex: Female, Male||Participants|Count of Participants|299|299.0||||||
4289273|NCT00542386|4114838|B6||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4289274|NCT00542386|4114839|B5||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4289275|NCT00542386|4114840|B4||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4289276|NCT00542386|4114841|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4289277|NCT00542386|4114842|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4289278|NCT00542386|4114843|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4289279|NCT00542386|4114837|B7|||Age||years|Mean|49.1|49.1|Standard Deviation|12.65|12.65|||
4289280|NCT00542386|4114838|B6|||Age||years|Mean|48.5|48.5|Standard Deviation|12.54|12.54|||
4289281|NCT00542386|4114839|B5|||Age||years|Mean|50.7|50.7|Standard Deviation|11.34|11.34|||
4289282|NCT00542386|4114840|B4|||Age||years|Mean|49.5|49.5|Standard Deviation|12.41|12.41|||
4289283|NCT00542386|4114841|B3|||Age||years|Mean|47.3|47.3|Standard Deviation|12.55|12.55|||
4289284|NCT00542386|4114842|B2|||Age||years|Mean|48.7|48.7|Standard Deviation|14.64|14.64|||
4289285|NCT00542386|4114843|B1|||Age||years|Mean|49.9|49.9|Standard Deviation|12.20|12.2|||
4289286|NCT00542321|4114868|B3|||FIO2|Fraction of inspired oxygen (FIO2) from APACHE II assessment (highest FIO2 within 24 hours of ICU admission)|Fraction|Mean|0.75|0.75|Standard Deviation|0.26|0.26|||
4289287|NCT00542321|4114869|B2|||FIO2|Fraction of inspired oxygen (FIO2) from APACHE II assessment (highest FIO2 within 24 hours of ICU admission)|Fraction|Mean|0.77|0.77|Standard Deviation|0.28|0.28|||
4289288|NCT00542321|4114870|B1|||FIO2|Fraction of inspired oxygen (FIO2) from APACHE II assessment (highest FIO2 within 24 hours of ICU admission)|Fraction|Mean|0.73|0.73|Standard Deviation|0.25|0.25|||
4289289|NCT00542321|4114868|B3|||APACHE II|Score on the Acute Physiology and Chronic Health Evaluation (APACHE) II (acuity of illness)instrument. Score ranges from 0 to 71, with higher score indicating greater severity of illness and risk for mortality.|Scores on a scale|Mean|25|25.0|Standard Deviation|6.7|6.7|||
4289290|NCT00542321|4114869|B2|||APACHE II|Score on the Acute Physiology and Chronic Health Evaluation (APACHE) II (acuity of illness)instrument. Score ranges from 0 to 71, with higher score indicating greater severity of illness and risk for mortality.|Scores on a scale|Mean|27|27.0|Standard Deviation|9|9.0|||
4289291|NCT00542321|4114870|B1|||APACHE II|Score on the Acute Physiology and Chronic Health Evaluation (APACHE) II (acuity of illness)instrument. Score ranges from 0 to 71, with higher score indicating greater severity of illness and risk for mortality.|Scores on a scale|Mean|24|24.0|Standard Deviation|5|5.0|||
4289292|NCT00542321|4114868|B3|No||Surgery||Participant|Number|11|11.0||||||
4289293|NCT00542321|4114869|B2|No||Surgery||Participant|Number|6|6.0||||||
4289294|NCT00542321|4114870|B1|No||Surgery||Participant|Number|5|5.0||||||
4289295|NCT00542321|4114868|B3|Yes||Surgery||Participant|Number|5|5.0||||||
4289296|NCT00542321|4114869|B2|Yes||Surgery||Participant|Number|2|2.0||||||
4289297|NCT00542321|4114870|B1|Yes||Surgery||Participant|Number|3|3.0||||||
4289298|NCT00542321|4114868|B3|No||COPD Diagnosis|Diagnosis of chronic obstructive pulmonary disease (COPD) in medical record|Participant|Number|12|12.0||||||
4289299|NCT00542321|4114869|B2|No||COPD Diagnosis|Diagnosis of chronic obstructive pulmonary disease (COPD) in medical record|Participant|Number|4|4.0||||||
4289300|NCT00542321|4114870|B1|No||COPD Diagnosis|Diagnosis of chronic obstructive pulmonary disease (COPD) in medical record|Participant|Number|8|8.0||||||
4289301|NCT00542321|4114868|B3|Yes||COPD Diagnosis|Diagnosis of chronic obstructive pulmonary disease (COPD) in medical record|Participant|Number|4|4.0||||||
4289302|NCT00542321|4114869|B2|Yes||COPD Diagnosis|Diagnosis of chronic obstructive pulmonary disease (COPD) in medical record|Participant|Number|4|4.0||||||
4289303|NCT00542321|4114870|B1|Yes||COPD Diagnosis|Diagnosis of chronic obstructive pulmonary disease (COPD) in medical record|Participant|Number|0|0.0||||||
4289304|NCT00542321|4114868|B3|Absence||Vasopressor Use|Use of continuous intravenous infusion of any vasopressor during study period|Participant|Number|10|10.0||||||
4289305|NCT00542321|4114869|B2|Absence||Vasopressor Use|Use of continuous intravenous infusion of any vasopressor during study period|Participant|Number|5|5.0||||||
4289306|NCT00542321|4114870|B1|Absence||Vasopressor Use|Use of continuous intravenous infusion of any vasopressor during study period|Participant|Number|5|5.0||||||
4289307|NCT00542321|4114868|B3|Presence||Vasopressor Use|Use of continuous intravenous infusion of any vasopressor during study period|Participant|Number|6|6.0||||||
4289308|NCT00542321|4114869|B2|Presence||Vasopressor Use|Use of continuous intravenous infusion of any vasopressor during study period|Participant|Number|3|3.0||||||
4289309|NCT00542321|4114870|B1|Presence||Vasopressor Use|Use of continuous intravenous infusion of any vasopressor during study period|Participant|Number|3|3.0||||||
4289310|NCT00542321|4114868|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4289311|NCT00542321|4114869|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4289312|NCT00542321|4114870|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4289313|NCT00542321|4114868|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4289314|NCT00542321|4114869|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4289315|NCT00542321|4114870|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4289316|NCT00542321|4114868|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4289317|NCT00542321|4114869|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4289318|NCT00542321|4114870|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4289319|NCT00542321|4114868|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4289320|NCT00542321|4114869|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4289321|NCT00542321|4114870|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4289322|NCT00542321|4114868|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4289323|NCT00542321|4114869|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4289324|NCT00542321|4114870|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4289325|NCT00542321|4114868|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4289326|NCT00542321|4114869|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4289327|NCT00542321|4114870|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4289328|NCT00542321|4114868|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4289329|NCT00542321|4114869|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4289330|NCT00542321|4114870|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4289331|NCT00542321|4114868|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4289332|NCT00542321|4114869|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4289333|NCT00542321|4114870|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4289334|NCT00542321|4114868|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4289335|NCT00542321|4114869|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4289336|NCT00542321|4114870|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4289337|NCT00542321|4114868|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4289338|NCT00542321|4114869|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4289339|NCT00542321|4114870|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4289340|NCT00542321|4114868|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4289341|NCT00542321|4114869|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4289342|NCT00542321|4114870|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4289343|NCT00542321|4114868|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4289344|NCT00542321|4114869|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4289345|NCT00542321|4114870|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4289346|NCT00542321|4114868|B3|||Age||years|Mean|56.3|56.3|Standard Deviation|11.5|11.5|||
4289347|NCT00542321|4114869|B2|||Age||years|Mean|54.3|54.3|Standard Deviation|12.2|12.2|||
4289348|NCT00542321|4114870|B1|||Age||years|Mean|58|58.0|Standard Deviation|11.4|11.4|||
4289349|NCT00542308|4114885|B1|Italy||Region of Enrollment||participants|Number|9|9.0||||||
4289350|NCT00542308|4114885|B1|Colombia||Region of Enrollment||participants|Number|1|1.0||||||
4289351|NCT00542308|4114885|B1|Germany||Region of Enrollment||participants|Number|11|11.0||||||
4289352|NCT00542308|4114885|B1|Chile||Region of Enrollment||participants|Number|8|8.0||||||
4289353|NCT00542308|4114885|B1|Israel||Region of Enrollment||participants|Number|12|12.0||||||
4289354|NCT00542308|4114885|B1|Austria||Region of Enrollment||participants|Number|3|3.0||||||
4289355|NCT00542308|4114885|B1|Peru||Region of Enrollment||participants|Number|4|4.0||||||
4289356|NCT00542308|4114885|B1|Slovakia||Region of Enrollment||participants|Number|4|4.0||||||
4289357|NCT00542308|4114885|B1|Czech Republic||Region of Enrollment||participants|Number|6|6.0||||||
4289358|NCT00542308|4114885|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4289359|NCT00542308|4114885|B1|Portugal||Region of Enrollment||participants|Number|10|10.0||||||
4289360|NCT00542308|4114885|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4289361|NCT00542308|4114885|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4289362|NCT00542308|4114885|B1|||Age||years|Mean|59.1|59.1|Standard Deviation|8.7|8.7|||
4289363|NCT00542308|4114885|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4289364|NCT00542308|4114885|B1||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4289365|NCT00542308|4114885|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4289366|NCT00542269|4114890|B4||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4289367|NCT00542269|4114891|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4289368|NCT00542269|4114892|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4289369|NCT00542269|4114893|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4289370|NCT00542269|4114890|B4||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4289371|NCT00542269|4114891|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4289372|NCT00542269|4114892|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4289373|NCT00542269|4114893|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4289374|NCT00542269|4114890|B4|≥ 65 years||Age, Customized||participants|Number|52|52.0||||||
4289375|NCT00542269|4114891|B3|≥ 65 years||Age, Customized||participants|Number|15|15.0||||||
4289376|NCT00542269|4114892|B2|≥ 65 years||Age, Customized||participants|Number|13|13.0||||||
4289377|NCT00542269|4114893|B1|≥ 65 years||Age, Customized||participants|Number|24|24.0||||||
4289378|NCT00542269|4114890|B4|< 65 years||Age, Customized||participants|Number|126|126.0||||||
4289379|NCT00542269|4114891|B3|< 65 years||Age, Customized||participants|Number|42|42.0||||||
4289380|NCT00542269|4114892|B2|< 65 years||Age, Customized||participants|Number|47|47.0||||||
4289381|NCT00542269|4114893|B1|< 65 years||Age, Customized||participants|Number|37|37.0||||||
4289382|NCT00542269|4114890|B4|||Age||years|Mean|59.6|59.6|Standard Deviation|8.95|8.95|||
4289383|NCT00542269|4114891|B3|||Age||years|Mean|59.1|59.1|Standard Deviation|8.86|8.86|||
4289384|NCT00542269|4114892|B2|||Age||years|Mean|58.3|58.3|Standard Deviation|8.95|8.95|||
4289385|NCT00542269|4114893|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|8.90|8.9|||
4289386|NCT00542178|4114924|B7|Blood Pressure and Lipid Studies|Missing|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|2|2.0||||||
4289387|NCT00542178|4114925|B6|Blood Pressure and Lipid Studies|Missing|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|0|0.0||||||
4289388|NCT00542178|4114926|B5|Blood Pressure and Lipid Studies|Missing|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|0|0.0||||||
4289389|NCT00542178|4114927|B4|Blood Pressure and Lipid Studies|Missing|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|0|0.0||||||
4289390|NCT00542178|4114928|B3|Blood Pressure and Lipid Studies|Missing|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|2|2.0||||||
4289391|NCT00542178|4114924|B7|Blood Pressure and Lipid Studies|Proliferative diabetic retinopathy|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|29|29.0||||||
4289392|NCT00542178|4114925|B6|Blood Pressure and Lipid Studies|Proliferative diabetic retinopathy|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|6|6.0||||||
4289393|NCT00542178|4114926|B5|Blood Pressure and Lipid Studies|Proliferative diabetic retinopathy|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|4|4.0||||||
4289394|NCT00542178|4114927|B4|Blood Pressure and Lipid Studies|Proliferative diabetic retinopathy|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|5|5.0||||||
4289395|NCT00542178|4114928|B3|Blood Pressure and Lipid Studies|Proliferative diabetic retinopathy|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|14|14.0||||||
4289471|NCT00542178|4114924|B7|Glycemic Control Study||Visual acuity|Visual acuity is defined as a mean of the acuity scores for both eyes of 74 to 78 letters (the approximate Snellen equivalent of 20/30)|letters|Mean|75.9|75.9|Standard Deviation|10.2|10.2|||
4289396|NCT00542178|4114924|B7|Blood Pressure and Lipid Studies|Severe Nonproliferative Diabetic Retinopathy|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|10|10.0||||||
4289397|NCT00542178|4114925|B6|Blood Pressure and Lipid Studies|Severe Nonproliferative Diabetic Retinopathy|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|4|4.0||||||
4289398|NCT00542178|4114926|B5|Blood Pressure and Lipid Studies|Severe Nonproliferative Diabetic Retinopathy|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|2|2.0||||||
4289399|NCT00542178|4114927|B4|Blood Pressure and Lipid Studies|Severe Nonproliferative Diabetic Retinopathy|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|1|1.0||||||
4289400|NCT00542178|4114928|B3|Blood Pressure and Lipid Studies|Severe Nonproliferative Diabetic Retinopathy|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|3|3.0||||||
4289401|NCT00542178|4114924|B7|Blood Pressure and Lipid Studies|Moderate Nonproliferative Diabetic Retinopathy|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|847|847.0||||||
4289402|NCT00542178|4114925|B6|Blood Pressure and Lipid Studies|Moderate Nonproliferative Diabetic Retinopathy|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|224|224.0||||||
4289403|NCT00542178|4114926|B5|Blood Pressure and Lipid Studies|Moderate Nonproliferative Diabetic Retinopathy|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|230|230.0||||||
4289404|NCT00542178|4114927|B4|Blood Pressure and Lipid Studies|Moderate Nonproliferative Diabetic Retinopathy|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|198|198.0||||||
4289405|NCT00542178|4114928|B3|Blood Pressure and Lipid Studies|Moderate Nonproliferative Diabetic Retinopathy|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|195|195.0||||||
4289406|NCT00542178|4114924|B7|Blood Pressure and Lipid Studies|Mild|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|518|518.0||||||
4289407|NCT00542178|4114925|B6|Blood Pressure and Lipid Studies|Mild|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|155|155.0||||||
4289408|NCT00542178|4114926|B5|Blood Pressure and Lipid Studies|Mild|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|141|141.0||||||
4289409|NCT00542178|4114927|B4|Blood Pressure and Lipid Studies|Mild|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|117|117.0||||||
4289410|NCT00542178|4114928|B3|Blood Pressure and Lipid Studies|Mild|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|105|105.0||||||
4289411|NCT00542178|4114924|B7|Blood Pressure and Lipid Studies|None|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|1450|1450.0||||||
4289412|NCT00542178|4114925|B6|Blood Pressure and Lipid Studies|None|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|398|398.0||||||
4289413|NCT00542178|4114926|B5|Blood Pressure and Lipid Studies|None|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|429|429.0||||||
4289414|NCT00542178|4114927|B4|Blood Pressure and Lipid Studies|None|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|295|295.0||||||
4289415|NCT00542178|4114928|B3|Blood Pressure and Lipid Studies|None|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|328|328.0||||||
4289416|NCT00542178|4114924|B7|Glycemic Control Study|Missing|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|2|2.0||||||
4289417|NCT00542178|4114929|B2|Glycemic Control Study|Missing|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|1|1.0||||||
4289418|NCT00542178|4114930|B1|Glycemic Control Study|Missing|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|1|1.0||||||
4289419|NCT00542178|4114924|B7|Glycemic Control Study|Proliferative diabetic retinopathy|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|29|29.0||||||
4289472|NCT00542178|4114929|B2|Glycemic Control Study||Visual acuity|Visual acuity is defined as a mean of the acuity scores for both eyes of 74 to 78 letters (the approximate Snellen equivalent of 20/30)|letters|Mean|75.9|75.9|Standard Deviation|10.0|10.0|||
4289520|NCT00542178|4114929|B2|Glycemic Control Study||Cholesterol (LDL)||mg/dl|Mean|100.7|100.7|Standard Deviation|32.1|32.1|||
4289420|NCT00542178|4114929|B2|Glycemic Control Study|Proliferative diabetic retinopathy|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|19|19.0||||||
4289421|NCT00542178|4114930|B1|Glycemic Control Study|Proliferative diabetic retinopathy|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|10|10.0||||||
4289422|NCT00542178|4114924|B7|Glycemic Control Study|Severe Nonproliferative Diabetic Retinopathy|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|10|10.0||||||
4289423|NCT00542178|4114929|B2|Glycemic Control Study|Severe Nonproliferative Diabetic Retinopathy|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|5|5.0||||||
4289424|NCT00542178|4114930|B1|Glycemic Control Study|Severe Nonproliferative Diabetic Retinopathy|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|5|5.0||||||
4289425|NCT00542178|4114924|B7|Glycemic Control Study|Moderate Nonproliferative Diabetic Retinopathy|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|847|847.0||||||
4289426|NCT00542178|4114929|B2|Glycemic Control Study|Moderate Nonproliferative Diabetic Retinopathy|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|404|404.0||||||
4289427|NCT00542178|4114930|B1|Glycemic Control Study|Moderate Nonproliferative Diabetic Retinopathy|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|443|443.0||||||
4289428|NCT00542178|4114924|B7|Glycemic Control Study|Mild|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|518|518.0||||||
4289429|NCT00542178|4114929|B2|Glycemic Control Study|Mild|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|277|277.0||||||
4289430|NCT00542178|4114930|B1|Glycemic Control Study|Mild|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|241|241.0||||||
4289431|NCT00542178|4114924|B7|Glycemic Control Study|None|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|1450|1450.0||||||
4289519|NCT00542178|4114924|B7|Glycemic Control Study||Cholesterol (LDL)||mg/dl|Mean|100.7|100.7|Standard Deviation|32.7|32.7|||
4289622|NCT00541931|4115125|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4289432|NCT00542178|4114929|B2|Glycemic Control Study|None|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|721|721.0||||||
4289433|NCT00542178|4114930|B1|Glycemic Control Study|None|Severity of Diabetic Retinopathy|Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.|Participants|Count of Participants|729|729.0||||||
4289434|NCT00542178|4114924|B7|Blood Pressure and Lipid Studies|Missing|Smoking status||Participants|Count of Participants|1|1.0||||||
4289435|NCT00542178|4114925|B6|Blood Pressure and Lipid Studies|Missing|Smoking status||Participants|Count of Participants|0|0.0||||||
4289436|NCT00542178|4114926|B5|Blood Pressure and Lipid Studies|Missing|Smoking status||Participants|Count of Participants|1|1.0||||||
4289437|NCT00542178|4114927|B4|Blood Pressure and Lipid Studies|Missing|Smoking status||Participants|Count of Participants|0|0.0||||||
4289438|NCT00542178|4114928|B3|Blood Pressure and Lipid Studies|Missing|Smoking status||Participants|Count of Participants|0|0.0||||||
4289439|NCT00542178|4114924|B7|Blood Pressure and Lipid Studies|Current Smoker|Smoking status||Participants|Count of Participants|387|387.0||||||
4289440|NCT00542178|4114925|B6|Blood Pressure and Lipid Studies|Current Smoker|Smoking status||Participants|Count of Participants|102|102.0||||||
4289441|NCT00542178|4114926|B5|Blood Pressure and Lipid Studies|Current Smoker|Smoking status||Participants|Count of Participants|119|119.0||||||
4289442|NCT00542178|4114927|B4|Blood Pressure and Lipid Studies|Current Smoker|Smoking status||Participants|Count of Participants|77|77.0||||||
4289443|NCT00542178|4114928|B3|Blood Pressure and Lipid Studies|Current Smoker|Smoking status||Participants|Count of Participants|89|89.0||||||
4289444|NCT00542178|4114924|B7|Blood Pressure and Lipid Studies|Former Smoker|Smoking status||Participants|Count of Participants|1280|1280.0||||||
4289445|NCT00542178|4114925|B6|Blood Pressure and Lipid Studies|Former Smoker|Smoking status||Participants|Count of Participants|352|352.0||||||
4289446|NCT00542178|4114926|B5|Blood Pressure and Lipid Studies|Former Smoker|Smoking status||Participants|Count of Participants|373|373.0||||||
4289447|NCT00542178|4114927|B4|Blood Pressure and Lipid Studies|Former Smoker|Smoking status||Participants|Count of Participants|276|276.0||||||
4289448|NCT00542178|4114928|B3|Blood Pressure and Lipid Studies|Former Smoker|Smoking status||Participants|Count of Participants|279|279.0||||||
4289449|NCT00542178|4114924|B7|Blood Pressure and Lipid Studies|Never smoked|Smoking status||Participants|Count of Participants|1188|1188.0||||||
4289450|NCT00542178|4114925|B6|Blood Pressure and Lipid Studies|Never smoked|Smoking status||Participants|Count of Participants|333|333.0||||||
4289451|NCT00542178|4114926|B5|Blood Pressure and Lipid Studies|Never smoked|Smoking status||Participants|Count of Participants|313|313.0||||||
4289452|NCT00542178|4114927|B4|Blood Pressure and Lipid Studies|Never smoked|Smoking status||Participants|Count of Participants|263|263.0||||||
4289453|NCT00542178|4114928|B3|Blood Pressure and Lipid Studies|Never smoked|Smoking status||Participants|Count of Participants|279|279.0||||||
4289454|NCT00542178|4114924|B7|Glycemic Control Study|Missing|Smoking status||Participants|Count of Participants|1|1.0||||||
4289455|NCT00542178|4114929|B2|Glycemic Control Study|Missing|Smoking status||Participants|Count of Participants|1|1.0||||||
4289456|NCT00542178|4114930|B1|Glycemic Control Study|Missing|Smoking status||Participants|Count of Participants|0|0.0||||||
4289457|NCT00542178|4114924|B7|Glycemic Control Study|Current Smoker|Smoking status||Participants|Count of Participants|387|387.0||||||
4289458|NCT00542178|4114929|B2|Glycemic Control Study|Current Smoker|Smoking status||Participants|Count of Participants|196|196.0||||||
4289459|NCT00542178|4114930|B1|Glycemic Control Study|Current Smoker|Smoking status||Participants|Count of Participants|191|191.0||||||
4289460|NCT00542178|4114924|B7|Glycemic Control Study|Former Smoker|Smoking status||Participants|Count of Participants|1280|1280.0||||||
4289461|NCT00542178|4114929|B2|Glycemic Control Study|Former Smoker|Smoking status||Participants|Count of Participants|623|623.0||||||
4289462|NCT00542178|4114930|B1|Glycemic Control Study|Former Smoker|Smoking status||Participants|Count of Participants|657|657.0||||||
4289463|NCT00542178|4114924|B7|Glycemic Control Study|Never smoked|Smoking status||Participants|Count of Participants|1188|1188.0||||||
4289464|NCT00542178|4114929|B2|Glycemic Control Study|Never smoked|Smoking status||Participants|Count of Participants|607|607.0||||||
4289465|NCT00542178|4114930|B1|Glycemic Control Study|Never smoked|Smoking status||Participants|Count of Participants|581|581.0||||||
4289466|NCT00542178|4114924|B7|Blood Pressure and Lipid Studies||Visual acuity|Visual acuity is defined as a mean of the acuity scores for both eyes of 74 to 78 letters (the approximate Snellen equivalent of 20/30)|letters|Mean|75.9|75.9|Standard Deviation|10.2|10.2|||
4289467|NCT00542178|4114925|B6|Blood Pressure and Lipid Studies||Visual acuity|Visual acuity is defined as a mean of the acuity scores for both eyes of 74 to 78 letters (the approximate Snellen equivalent of 20/30)|letters|Mean|76.2|76.2|Standard Deviation|10.7|10.7|||
4289468|NCT00542178|4114926|B5|Blood Pressure and Lipid Studies||Visual acuity|Visual acuity is defined as a mean of the acuity scores for both eyes of 74 to 78 letters (the approximate Snellen equivalent of 20/30)|letters|Mean|76.2|76.2|Standard Deviation|9.7|9.7|||
4289469|NCT00542178|4114927|B4|Blood Pressure and Lipid Studies||Visual acuity|Visual acuity is defined as a mean of the acuity scores for both eyes of 74 to 78 letters (the approximate Snellen equivalent of 20/30)|letters|Mean|75.5|75.5|Standard Deviation|10.2|10.2|||
4289470|NCT00542178|4114928|B3|Blood Pressure and Lipid Studies||Visual acuity|Visual acuity is defined as a mean of the acuity scores for both eyes of 74 to 78 letters (the approximate Snellen equivalent of 20/30)|letters|Mean|75.6|75.6|Standard Deviation|10.3|10.3|||
4289473|NCT00542178|4114930|B1|Glycemic Control Study||Visual acuity|Visual acuity is defined as a mean of the acuity scores for both eyes of 74 to 78 letters (the approximate Snellen equivalent of 20/30)|letters|Mean|75.9|75.9|Standard Deviation|10.4|10.4|||
4289474|NCT00542178|4114924|B7|Blood Pressure and Lipid Studies||BMI||kg/m^2|Mean|32.4|32.4|Standard Deviation|5.5|5.5|||
4289475|NCT00542178|4114925|B6|Blood Pressure and Lipid Studies||BMI||kg/m^2|Mean|32.6|32.6|Standard Deviation|5.4|5.4|||
4289476|NCT00542178|4114926|B5|Blood Pressure and Lipid Studies||BMI||kg/m^2|Mean|32.3|32.3|Standard Deviation|5.5|5.5|||
4289477|NCT00542178|4114927|B4|Blood Pressure and Lipid Studies||BMI||kg/m^2|Mean|32.2|32.2|Standard Deviation|5.3|5.3|||
4289478|NCT00542178|4114928|B3|Blood Pressure and Lipid Studies||BMI||kg/m^2|Mean|32.7|32.7|Standard Deviation|5.7|5.7|||
4289479|NCT00542178|4114924|B7|Glycemic Control Study||BMI||kg/m^2|Mean|32.4|32.4|Standard Deviation|5.5|5.5|||
4289480|NCT00542178|4114929|B2|Glycemic Control Study||BMI||kg/m^2|Mean|32.5|32.5|Standard Deviation|5.4|5.4|||
4289481|NCT00542178|4114930|B1|Glycemic Control Study||BMI||kg/m^2|Mean|32.4|32.4|Standard Deviation|5.5|5.5|||
4289482|NCT00542178|4114924|B7|Blood Pressure and Lipid Studies||Urinary albumin:creatinine ratio||albumin (mg/dL): creatinin (g/dL)|Mean|71.8|71.8|Standard Deviation|253.1|253.1|||
4289483|NCT00542178|4114925|B6|Blood Pressure and Lipid Studies||Urinary albumin:creatinine ratio||albumin (mg/dL): creatinin (g/dL)|Mean|83.2|83.2|Standard Deviation|331.5|331.5|||
4289484|NCT00542178|4114926|B5|Blood Pressure and Lipid Studies||Urinary albumin:creatinine ratio||albumin (mg/dL): creatinin (g/dL)|Mean|62.3|62.3|Standard Deviation|180.2|180.2|||
4289485|NCT00542178|4114927|B4|Blood Pressure and Lipid Studies||Urinary albumin:creatinine ratio||albumin (mg/dL): creatinin (g/dL)|Mean|79.2|79.2|Standard Deviation|269.9|269.9|||
4289486|NCT00542178|4114928|B3|Blood Pressure and Lipid Studies||Urinary albumin:creatinine ratio||albumin (mg/dL): creatinin (g/dL)|Mean|62.5|62.5|Standard Deviation|197.6|197.6|||
4289487|NCT00542178|4114924|B7|Glycemic Control Study||Urinary albumin:creatinine ratio||albumin (mg/dL): creatinin (g/dL)|Mean|71.8|71.8|Standard Deviation|253.1|253.1|||
4289488|NCT00542178|4114929|B2|Glycemic Control Study||Urinary albumin:creatinine ratio||albumin (mg/dL): creatinin (g/dL)|Mean|74.0|74.0|Standard Deviation|275.3|275.3|||
4289489|NCT00542178|4114930|B1|Glycemic Control Study||Urinary albumin:creatinine ratio||albumin (mg/dL): creatinin (g/dL)|Mean|69.5|69.5|Standard Deviation|2228.9|2228.9|||
4289490|NCT00542178|4114924|B7|Blood Pressure and Lipid Studies||Diastolic Blood Pressure||mm Hg|Mean|74.9|74.9|Standard Deviation|10.5|10.5|||
4289491|NCT00542178|4114925|B6|Blood Pressure and Lipid Studies||Diastolic Blood Pressure||mm Hg|Mean|73.6|73.6|Standard Deviation|10.5|10.5|||
4289492|NCT00542178|4114926|B5|Blood Pressure and Lipid Studies||Diastolic Blood Pressure||mm Hg|Mean|73.7|73.7|Standard Deviation|10.5|10.5|||
4289493|NCT00542178|4114927|B4|Blood Pressure and Lipid Studies||Diastolic Blood Pressure||mm Hg|Mean|76.8|76.8|Standard Deviation|9.9|9.9|||
4289494|NCT00542178|4114928|B3|Blood Pressure and Lipid Studies||Diastolic Blood Pressure||mm Hg|Mean|76.3|76.3|Standard Deviation|10.5|10.5|||
4289495|NCT00542178|4114924|B7|Glycemic Control Study||Diastolic Blood Pressure||mm Hg|Mean|74.9|74.9|Standard Deviation|10.5|10.5|||
4289496|NCT00542178|4114929|B2|Glycemic Control Study||Diastolic Blood Pressure||mm Hg|Mean|75.0|75.0|Standard Deviation|10.6|10.6|||
4289497|NCT00542178|4114930|B1|Glycemic Control Study||Diastolic Blood Pressure||mm Hg|Mean|74.9|74.9|Standard Deviation|10.3|10.3|||
4289498|NCT00542178|4114924|B7|Blood Pressure and Lipid Studies||Systolic Blood pressure||mm Hg|Mean|134.5|134.5|Standard Deviation|17.0|17.0|||
4289499|NCT00542178|4114925|B6|Blood Pressure and Lipid Studies||Systolic Blood pressure||mm Hg|Mean|131.1|131.1|Standard Deviation|17.5|17.5|||
4289500|NCT00542178|4114926|B5|Blood Pressure and Lipid Studies||Systolic Blood pressure||mm Hg|Mean|131.5|131.5|Standard Deviation|17.0|17.0|||
4289501|NCT00542178|4114927|B4|Blood Pressure and Lipid Studies||Systolic Blood pressure||mm Hg|Mean|139.0|139.0|Standard Deviation|14.7|14.7|||
4289502|NCT00542178|4114928|B3|Blood Pressure and Lipid Studies||Systolic Blood pressure||mm Hg|Mean|138.0|138.0|Standard Deviation|16.7|16.7|||
4289503|NCT00542178|4114924|B7|Glycemic Control Study||Systolic Blood pressure||mm Hg|Mean|134.5|134.5|Standard Deviation|17.0|17.0|||
4289504|NCT00542178|4114929|B2|Glycemic Control Study||Systolic Blood pressure||mm Hg|Mean|134.7|134.7|Standard Deviation|17.4|17.4|||
4289505|NCT00542178|4114930|B1|Glycemic Control Study||Systolic Blood pressure||mm Hg|Mean|134.3|134.3|Standard Deviation|16.6|16.6|||
4289506|NCT00542178|4114924|B7|Blood Pressure and Lipid Studies||Triglycerides||mg/dl|Mean|195.1|195.1|Standard Deviation|162.6|162.6|||
4289507|NCT00542178|4114925|B6|Blood Pressure and Lipid Studies||Triglycerides||mg/dl|Mean|187.9|187.9|Standard Deviation|112.4|112.4|||
4289508|NCT00542178|4114926|B5|Blood Pressure and Lipid Studies||Triglycerides||mg/dl|Mean|190.1|190.1|Standard Deviation|111.3|111.3|||
4289509|NCT00542178|4114927|B4|Blood Pressure and Lipid Studies||Triglycerides||mg/dl|Mean|204.7|204.7|Standard Deviation|240.3|240.3|||
4289510|NCT00542178|4114928|B3|Blood Pressure and Lipid Studies||Triglycerides||mg/dl|Mean|200.7|200.7|Standard Deviation|175.5|175.5|||
4289511|NCT00542178|4114924|B7|Glycemic Control Study||Triglycerides||mg/dl|Mean|195.1|195.1|Standard Deviation|162.6|162.6|||
4289512|NCT00542178|4114929|B2|Glycemic Control Study||Triglycerides||mg/dl|Mean|194|194.0|Standard Deviation|167.3|167.3|||
4289513|NCT00542178|4114930|B1|Glycemic Control Study||Triglycerides||mg/dl|Mean|196.1|196.1|Standard Deviation|157.8|157.8|||
4289514|NCT00542178|4114924|B7|Blood Pressure and Lipid Studies||Cholesterol (LDL)||mg/dl|Mean|100.7|100.7|Standard Deviation|32.7|32.7|||
4289515|NCT00542178|4114925|B6|Blood Pressure and Lipid Studies||Cholesterol (LDL)||mg/dl|Mean|97.0|97.0|Standard Deviation|30.1|30.1|||
4289516|NCT00542178|4114926|B5|Blood Pressure and Lipid Studies||Cholesterol (LDL)||mg/dl|Mean|96.5|96.5|Standard Deviation|29.7|29.7|||
4289517|NCT00542178|4114927|B4|Blood Pressure and Lipid Studies||Cholesterol (LDL)||mg/dl|Mean|104.1|104.1|Standard Deviation|33.5|33.5|||
4289518|NCT00542178|4114928|B3|Blood Pressure and Lipid Studies||Cholesterol (LDL)||mg/dl|Mean|107.4|107.4|Standard Deviation|37.0|37.0|||
4289521|NCT00542178|4114930|B1|Glycemic Control Study||Cholesterol (LDL)||mg/dl|Mean|100.8|100.8|Standard Deviation|33.4|33.4|||
4289522|NCT00542178|4114924|B7|Blood Pressure and Lipid Studies||Cholesterol (HDL)||mg/dl|Mean|41.9|41.9|Standard Deviation|11.3|11.3|||
4289523|NCT00542178|4114925|B6|Blood Pressure and Lipid Studies||Cholesterol (HDL)||mg/dl|Mean|38.5|38.5|Standard Deviation|7.9|7.9|||
4289524|NCT00542178|4114926|B5|Blood Pressure and Lipid Studies||Cholesterol (HDL)||mg/dl|Mean|38.6|38.6|Standard Deviation|7.8|7.8|||
4289525|NCT00542178|4114927|B4|Blood Pressure and Lipid Studies||Cholesterol (HDL)||mg/dl|Mean|46.31|46.31|Standard Deviation|13.8|13.8|||
4289526|NCT00542178|4114928|B3|Blood Pressure and Lipid Studies||Cholesterol (HDL)||mg/dl|Mean|46.3|46.3|Standard Deviation|12.8|12.8|||
4289527|NCT00542178|4114924|B7|Glycemic Control Study||Cholesterol (HDL)||mg/dl|Mean|41.9|41.9|Standard Deviation|11.3|11.3|||
4289528|NCT00542178|4114929|B2|Glycemic Control Study||Cholesterol (HDL)||mg/dl|Mean|41.9|41.9|Standard Deviation|11.1|11.1|||
4289529|NCT00542178|4114930|B1|Glycemic Control Study||Cholesterol (HDL)||mg/dl|Mean|42.0|42.0|Standard Deviation|11.4|11.4|||
4289530|NCT00542178|4114924|B7|Blood Pressure and Lipid Studies||Glycated hemoglobin||percent|Mean|8.2|8.2|Standard Deviation|1.0|1.0|||
4289531|NCT00542178|4114925|B6|Blood Pressure and Lipid Studies||Glycated hemoglobin||percent|Mean|8.2|8.2|Standard Deviation|1.0|1.0|||
4289532|NCT00542178|4114926|B5|Blood Pressure and Lipid Studies||Glycated hemoglobin||percent|Mean|8.2|8.2|Standard Deviation|1.0|1.0|||
4289533|NCT00542178|4114927|B4|Blood Pressure and Lipid Studies||Glycated hemoglobin||percent|Mean|8.2|8.2|Standard Deviation|1.0|1.0|||
4289534|NCT00542178|4114928|B3|Blood Pressure and Lipid Studies||Glycated hemoglobin||percent|Mean|8.4|8.4|Standard Deviation|1.1|1.1|||
4289535|NCT00542178|4114924|B7|Glycemic Control Study||Glycated hemoglobin||percent|Mean|8.2|8.2|Standard Deviation|1.0|1.0|||
4289536|NCT00542178|4114929|B2|Glycemic Control Study||Glycated hemoglobin||percent|Mean|8.3|8.3|Standard Deviation|1.0|1.0|||
4289537|NCT00542178|4114930|B1|Glycemic Control Study||Glycated hemoglobin||percent|Mean|8.2|8.2|Standard Deviation|1.0|1.0|||
4289538|NCT00542178|4114924|B7|Blood Pressure and Lipid Studies|White race|Race||Participants|Count of Participants|1996|1996.0||||||
4289539|NCT00542178|4114925|B6|Blood Pressure and Lipid Studies|White race|Race||Participants|Count of Participants|553|553.0||||||
4289540|NCT00542178|4114926|B5|Blood Pressure and Lipid Studies|White race|Race||Participants|Count of Participants|584|584.0||||||
4289541|NCT00542178|4114927|B4|Blood Pressure and Lipid Studies|White race|Race||Participants|Count of Participants|415|415.0||||||
4289542|NCT00542178|4114928|B3|Blood Pressure and Lipid Studies|White race|Race||Participants|Count of Participants|444|444.0||||||
4289543|NCT00542178|4114924|B7|Blood Pressure and Lipid Studies|Nonwhite race|Race||Participants|Count of Participants|860|860.0||||||
4289544|NCT00542178|4114925|B6|Blood Pressure and Lipid Studies|Nonwhite race|Race||Participants|Count of Participants|234|234.0||||||
4289545|NCT00542178|4114926|B5|Blood Pressure and Lipid Studies|Nonwhite race|Race||Participants|Count of Participants|222|222.0||||||
4289546|NCT00542178|4114927|B4|Blood Pressure and Lipid Studies|Nonwhite race|Race||Participants|Count of Participants|201|201.0||||||
4289547|NCT00542178|4114928|B3|Blood Pressure and Lipid Studies|Nonwhite race|Race||Participants|Count of Participants|203|203.0||||||
4289548|NCT00542178|4114924|B7|Glycemic Control Study|White race|Race||Participants|Count of Participants|1996|1996.0||||||
4289549|NCT00542178|4114929|B2|Glycemic Control Study|White race|Race||Participants|Count of Participants|994|994.0||||||
4289550|NCT00542178|4114930|B1|Glycemic Control Study|White race|Race||Participants|Count of Participants|1002|1002.0||||||
4289551|NCT00542178|4114924|B7|Glycemic Control Study|Nonwhite race|Race||Participants|Count of Participants|860|860.0||||||
4289552|NCT00542178|4114929|B2|Glycemic Control Study|Nonwhite race|Race||Participants|Count of Participants|433|433.0||||||
4289553|NCT00542178|4114930|B1|Glycemic Control Study|Nonwhite race|Race||Participants|Count of Participants|427|427.0||||||
4289554|NCT00542178|4114924|B7|Blood Pressure and Lipid Studies|No previous cardiovascular event|Previous cardiovascular event||Participants|Count of Participants|1961|1961.0||||||
4289555|NCT00542178|4114925|B6|Blood Pressure and Lipid Studies|No previous cardiovascular event|Previous cardiovascular event||Participants|Count of Participants|532|532.0||||||
4289556|NCT00542178|4114926|B5|Blood Pressure and Lipid Studies|No previous cardiovascular event|Previous cardiovascular event||Participants|Count of Participants|543|543.0||||||
4289557|NCT00542178|4114927|B4|Blood Pressure and Lipid Studies|No previous cardiovascular event|Previous cardiovascular event||Participants|Count of Participants|419|419.0||||||
4289558|NCT00542178|4114928|B3|Blood Pressure and Lipid Studies|No previous cardiovascular event|Previous cardiovascular event||Participants|Count of Participants|467|467.0||||||
4289559|NCT00542178|4114924|B7|Blood Pressure and Lipid Studies|Previous cardiovascular event|Previous cardiovascular event||Participants|Count of Participants|895|895.0||||||
4289560|NCT00542178|4114925|B6|Blood Pressure and Lipid Studies|Previous cardiovascular event|Previous cardiovascular event||Participants|Count of Participants|255|255.0||||||
4289561|NCT00542178|4114926|B5|Blood Pressure and Lipid Studies|Previous cardiovascular event|Previous cardiovascular event||Participants|Count of Participants|263|263.0||||||
4289562|NCT00542178|4114927|B4|Blood Pressure and Lipid Studies|Previous cardiovascular event|Previous cardiovascular event||Participants|Count of Participants|197|197.0||||||
4289563|NCT00542178|4114928|B3|Blood Pressure and Lipid Studies|Previous cardiovascular event|Previous cardiovascular event||Participants|Count of Participants|180|180.0||||||
4289564|NCT00542178|4114924|B7|Glycemic Control Study|No previous cardiovascular event|Previous cardiovascular event||Participants|Count of Participants|1961|1961.0||||||
4289565|NCT00542178|4114929|B2|Glycemic Control Study|No previous cardiovascular event|Previous cardiovascular event||Participants|Count of Participants|984|984.0||||||
4289566|NCT00542178|4114930|B1|Glycemic Control Study|No previous cardiovascular event|Previous cardiovascular event||Participants|Count of Participants|977|977.0||||||
4289621|NCT00541931|4115127|B1|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
4289567|NCT00542178|4114924|B7|Glycemic Control Study|Previous cardiovascular event|Previous cardiovascular event||Participants|Count of Participants|895|895.0||||||
4289568|NCT00542178|4114929|B2|Glycemic Control Study|Previous cardiovascular event|Previous cardiovascular event||Participants|Count of Participants|443|443.0||||||
4289569|NCT00542178|4114930|B1|Glycemic Control Study|Previous cardiovascular event|Previous cardiovascular event||Participants|Count of Participants|452|452.0||||||
4289570|NCT00542178|4114924|B7|Blood Pressure and Lipid Studies||Duration of diabetes||year|Mean|10.0|10.0|Standard Deviation|7.1|7.1|||
4289571|NCT00542178|4114925|B6|Blood Pressure and Lipid Studies||Duration of diabetes||year|Mean|9.8|9.8|Standard Deviation|7.2|7.2|||
4289572|NCT00542178|4114926|B5|Blood Pressure and Lipid Studies||Duration of diabetes||year|Mean|9.7|9.7|Standard Deviation|6.8|6.8|||
4289573|NCT00542178|4114927|B4|Blood Pressure and Lipid Studies||Duration of diabetes||year|Mean|10.3|10.3|Standard Deviation|7.5|7.5|||
4289574|NCT00542178|4114928|B3|Blood Pressure and Lipid Studies||Duration of diabetes||year|Mean|10.1|10.1|Standard Deviation|7.0|7.0|||
4289575|NCT00542178|4114924|B7|Glycemic Control Study||Duration of diabetes||year|Mean|10.0|10.0|Standard Deviation|7.1|7.1|||
4289576|NCT00542178|4114929|B2|Glycemic Control Study||Duration of diabetes||year|Mean|10.1|10.1|Standard Deviation|7.2|7.2|||
4289577|NCT00542178|4114930|B1|Glycemic Control Study||Duration of diabetes||year|Mean|9.8|9.8|Standard Deviation|7.1|7.1|||
4289578|NCT00542178|4114924|B7|Blood Pressure and Lipid Studies|Male|Sex: Female, Male||Participants|Count of Participants|1766|1766.0||||||
4289579|NCT00542178|4114925|B6|Blood Pressure and Lipid Studies|Male|Sex: Female, Male||Participants|Count of Participants|533|533.0||||||
4289580|NCT00542178|4114926|B5|Blood Pressure and Lipid Studies|Male|Sex: Female, Male||Participants|Count of Participants|559|559.0||||||
4289581|NCT00542178|4114927|B4|Blood Pressure and Lipid Studies|Male|Sex: Female, Male||Participants|Count of Participants|337|337.0||||||
4289582|NCT00542178|4114928|B3|Blood Pressure and Lipid Studies|Male|Sex: Female, Male||Participants|Count of Participants|337|337.0||||||
4289583|NCT00542178|4114924|B7|Blood Pressure and Lipid Studies|Female|Sex: Female, Male||Participants|Count of Participants|1090|1090.0||||||
4289584|NCT00542178|4114925|B6|Blood Pressure and Lipid Studies|Female|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
4289585|NCT00542178|4114926|B5|Blood Pressure and Lipid Studies|Female|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
4289586|NCT00542178|4114927|B4|Blood Pressure and Lipid Studies|Female|Sex: Female, Male||Participants|Count of Participants|279|279.0||||||
4289587|NCT00542178|4114928|B3|Blood Pressure and Lipid Studies|Female|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
4289588|NCT00542178|4114924|B7|Glycemic Control Study|Male|Sex: Female, Male||Participants|Count of Participants|1766|1766.0||||||
4289589|NCT00542178|4114929|B2|Glycemic Control Study|Male|Sex: Female, Male||Participants|Count of Participants|875|875.0||||||
4289590|NCT00542178|4114930|B1|Glycemic Control Study|Male|Sex: Female, Male||Participants|Count of Participants|891|891.0||||||
4289591|NCT00542178|4114924|B7|Glycemic Control Study|Female|Sex: Female, Male||Participants|Count of Participants|1090|1090.0||||||
4289592|NCT00542178|4114929|B2|Glycemic Control Study|Female|Sex: Female, Male||Participants|Count of Participants|552|552.0||||||
4289593|NCT00542178|4114930|B1|Glycemic Control Study|Female|Sex: Female, Male||Participants|Count of Participants|538|538.0||||||
4289594|NCT00542178|4114924|B7|||Age||years|Mean|61.6|61.6|Standard Deviation|6.3|6.3|||
4289595|NCT00542178|4114925|B6|||Age||years|Mean|61.5|61.5|Standard Deviation|6.5|6.5|||
4289596|NCT00542178|4114926|B5|||Age||years|Mean|61.9|61.9|Standard Deviation|6.2|6.2|||
4289597|NCT00542178|4114927|B4|||Age||years|Mean|61.5|61.5|Standard Deviation|6.6|6.6|||
4289598|NCT00542178|4114928|B3|||Age||years|Mean|61.3|61.3|Standard Deviation|6.1|6.1|||
4289599|NCT00542178|4114929|B2|||Age||years|Mean|61.5|61.5|Standard Deviation|6.3|6.3|||
4289600|NCT00542178|4114930|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|6.4|6.4|||
4289601|NCT00541970|4114969|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4289602|NCT00541970|4114970|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4289603|NCT00541970|4114971|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4289604|NCT00541970|4114972|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4289605|NCT00541970|4114973|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4289606|NCT00541970|4114969|B5||Female|Sex: Female, Male||Participants|Count of Participants|960|960.0||||||
4289607|NCT00541970|4114970|B4||Female|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
4289608|NCT00541970|4114971|B3||Female|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
4289609|NCT00541970|4114972|B2||Female|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
4289610|NCT00541970|4114973|B1||Female|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
4289611|NCT00541970|4114969|B5|||Age||Years|Mean|17.2|17.2|Standard Deviation|4.31|4.31|||
4289612|NCT00541970|4114970|B4|||Age||Years|Mean|17.2|17.2|Standard Deviation|4.38|4.38|||
4289613|NCT00541970|4114971|B3|||Age||Years|Mean|17.3|17.3|Standard Deviation|4.25|4.25|||
4289614|NCT00541970|4114972|B2|||Age||Years|Mean|17.2|17.2|Standard Deviation|4.30|4.3|||
4289615|NCT00541970|4114973|B1|||Age||Years|Mean|17.1|17.1|Standard Deviation|4.30|4.3|||
4289616|NCT00541931|4115125|B3|||Fine wrinkling as assessed by clinician||units on a scale|Mean|8.37|8.37|Standard Deviation|1.75|1.75|||
4289617|NCT00541931|4115126|B2|||Fine wrinkling as assessed by clinician||units on a scale|Mean|8.70|8.7|Standard Deviation|1.70|1.7|||
4289618|NCT00541931|4115127|B1|||Fine wrinkling as assessed by clinician||units on a scale|Mean|8.35|8.35|Standard Deviation|1.80|1.8|||
4289619|NCT00541931|4115125|B3|United States||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
4289620|NCT00541931|4115126|B2|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4289623|NCT00541931|4115126|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4289624|NCT00541931|4115127|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4289625|NCT00541931|4115125|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4289626|NCT00541931|4115126|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4289627|NCT00541931|4115127|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4289628|NCT00541931|4115125|B3|||Age||years|Mean|56.0|56.0|Standard Deviation|5.6|5.6|||
4289629|NCT00541931|4115126|B2|||Age||years|Mean|56.3|56.3|Standard Deviation|5.0|5.0|||
4289630|NCT00541931|4115127|B1|||Age||years|Mean|55.7|55.7|Standard Deviation|6.3|6.3|||
4289631|NCT00541931|4115125|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4289632|NCT00541931|4115126|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4289633|NCT00541931|4115127|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4289634|NCT00541931|4115125|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4289635|NCT00541931|4115126|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4289636|NCT00541931|4115127|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4289637|NCT00541931|4115125|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4289638|NCT00541931|4115126|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4289639|NCT00541931|4115127|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4289640|NCT00541866|4115136|B6|United States||Region of Enrollment||participants|Number|108|108.0||||||
4289641|NCT00541866|4115137|B5|United States||Region of Enrollment||participants|Number|18|18.0||||||
4289642|NCT00541866|4115138|B4|United States||Region of Enrollment||participants|Number|16|16.0||||||
4289643|NCT00541866|4115139|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4289644|NCT00541866|4115140|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4289645|NCT00541866|4115141|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4289646|NCT00541866|4115136|B6||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4289647|NCT00541866|4115137|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4289648|NCT00541866|4115138|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4289649|NCT00541866|4115139|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4289650|NCT00541866|4115140|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4289651|NCT00541866|4115141|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4289652|NCT00541866|4115136|B6||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4289653|NCT00541866|4115137|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4289654|NCT00541866|4115138|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4289655|NCT00541866|4115139|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4289656|NCT00541866|4115140|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4289657|NCT00541866|4115141|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4289658|NCT00541866|4115136|B6|||Age||Years|Mean|56.3|56.3|Standard Deviation|11.95|11.95|||
4289659|NCT00541866|4115137|B5|||Age||Years|Mean|56.3|56.3|Standard Deviation|12.09|12.09|||
4289660|NCT00541866|4115138|B4|||Age||Years|Mean|58.4|58.4|Standard Deviation|11.03|11.03|||
4289661|NCT00541866|4115139|B3|||Age||Years|Mean|59.7|59.7|Standard Deviation|9.29|9.29|||
4289662|NCT00541866|4115140|B2|||Age||Years|Mean|47.4|47.4|Standard Deviation|13.83|13.83|||
4289663|NCT00541866|4115141|B1|||Age||Years|Mean|58.0|58.0|Standard Deviation|10.90|10.9|||
4289664|NCT00541775|4115183|B4|||Hemoglobin A1C (A1C)||Percent of glycosylated hemoglobin (A1C)|Mean|7.7|7.7|Standard Deviation|0.9|0.9|||
4289665|NCT00541775|4115184|B3|||Hemoglobin A1C (A1C)||Percent of glycosylated hemoglobin (A1C)|Mean|7.7|7.7|Standard Deviation|0.9|0.9|||
4289666|NCT00541775|4115185|B2|||Hemoglobin A1C (A1C)||Percent of glycosylated hemoglobin (A1C)|Mean|7.7|7.7|Standard Deviation|0.8|0.8|||
4289667|NCT00541775|4115186|B1|||Hemoglobin A1C (A1C)||Percent of glycosylated hemoglobin (A1C)|Mean|7.8|7.8|Standard Deviation|1.0|1.0|||
4289668|NCT00541775|4115183|B4|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|158.1|158.1|Standard Deviation|33.5|33.5|||
4289669|NCT00541775|4115184|B3|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|160.0|160.0|Standard Deviation|37.4|37.4|||
4289670|NCT00541775|4115185|B2|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|156.9|156.9|Standard Deviation|31.6|31.6|||
4289671|NCT00541775|4115186|B1|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|157.5|157.5|Standard Deviation|31.4|31.4|||
4289672|NCT00541775|4115183|B4|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4289673|NCT00541775|4115184|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4289674|NCT00541775|4115185|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4289675|NCT00541775|4115186|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4289676|NCT00541775|4115183|B4|Asian||Race/Ethnicity, Customized||participants|Number|105|105.0||||||
4289677|NCT00541775|4115184|B3|Asian||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4289678|NCT00541775|4115185|B2|Asian||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4289679|NCT00541775|4115186|B1|Asian||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4289680|NCT00541775|4115183|B4|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4289681|NCT00541775|4115184|B3|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4289682|NCT00541775|4115185|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4289683|NCT00541775|4115186|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4289684|NCT00541775|4115183|B4|White||Race/Ethnicity, Customized||participants|Number|164|164.0||||||
4289685|NCT00541775|4115184|B3|White||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
4289686|NCT00541775|4115185|B2|White||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4289687|NCT00541775|4115186|B1|White||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
4289688|NCT00541775|4115183|B4||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4289689|NCT00541775|4115184|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4289690|NCT00541775|4115185|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4289691|NCT00541775|4115186|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4289692|NCT00541775|4115183|B4||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4289693|NCT00541775|4115184|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4289694|NCT00541775|4115185|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4289695|NCT00541775|4115186|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4289696|NCT00541775|4115183|B4|||Age||years|Mean|55.1|55.1|Standard Deviation|9.8|9.8|||
4289697|NCT00541775|4115184|B3|||Age||years|Mean|55.3|55.3|Standard Deviation|9.3|9.3|||
4289698|NCT00541775|4115185|B2|||Age||years|Mean|54.8|54.8|Standard Deviation|10.5|10.5|||
4289699|NCT00541775|4115186|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|9.8|9.8|||
4289700|NCT00541671|4115202|B3|||Sex/Gender, Customized||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4289701|NCT00541671|4115203|B2|||Sex/Gender, Customized||participants|Number|NA|||||||Not Collected because not relevant.
4289702|NCT00541671|4115204|B1|||Sex/Gender, Customized||participants|Number|NA|||||||Not collected because not relevant.
4289703|NCT00541671|4115202|B3|Greater than or equal to 18||Age, Customized||participants|Number|25|25.0||||||
4289704|NCT00541671|4115203|B2|Greater than or equal to 18||Age, Customized||participants|Number|13|13.0||||||
4289705|NCT00541671|4115204|B1|Greater than or equal to 18||Age, Customized||participants|Number|12|12.0||||||
4289706|NCT00541658|4115211|B4|United States||Region of Enrollment||participants|Number|140|140.0||||||
4289707|NCT00541658|4115212|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
4289708|NCT00541658|4115213|B2|United States||Region of Enrollment||participants|Number|43|43.0||||||
4289709|NCT00541658|4115214|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4289710|NCT00541658|4115211|B4|Poland||Region of Enrollment||participants|Number|171|171.0||||||
4289711|NCT00541658|4115212|B3|Poland||Region of Enrollment||participants|Number|58|58.0||||||
4289712|NCT00541658|4115213|B2|Poland||Region of Enrollment||participants|Number|57|57.0||||||
4289713|NCT00541658|4115214|B1|Poland||Region of Enrollment||participants|Number|56|56.0||||||
4289714|NCT00541658|4115211|B4|Hungary||Region of Enrollment||participants|Number|102|102.0||||||
4289715|NCT00541658|4115212|B3|Hungary||Region of Enrollment||participants|Number|33|33.0||||||
4289716|NCT00541658|4115213|B2|Hungary||Region of Enrollment||participants|Number|34|34.0||||||
4289717|NCT00541658|4115214|B1|Hungary||Region of Enrollment||participants|Number|35|35.0||||||
4289718|NCT00541658|4115211|B4|France||Region of Enrollment||participants|Number|60|60.0||||||
4289719|NCT00541658|4115212|B3|France||Region of Enrollment||participants|Number|18|18.0||||||
4289720|NCT00541658|4115213|B2|France||Region of Enrollment||participants|Number|23|23.0||||||
4289721|NCT00541658|4115214|B1|France||Region of Enrollment||participants|Number|19|19.0||||||
4289722|NCT00541658|4115211|B4|Estonia||Region of Enrollment||participants|Number|158|158.0||||||
4289723|NCT00541658|4115212|B3|Estonia||Region of Enrollment||participants|Number|52|52.0||||||
4289724|NCT00541658|4115213|B2|Estonia||Region of Enrollment||participants|Number|53|53.0||||||
4289725|NCT00541658|4115214|B1|Estonia||Region of Enrollment||participants|Number|53|53.0||||||
4289726|NCT00541658|4115211|B4|Canada||Region of Enrollment||participants|Number|23|23.0||||||
4289727|NCT00541658|4115212|B3|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4289728|NCT00541658|4115213|B2|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4289729|NCT00541658|4115214|B1|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4289730|NCT00541658|4115211|B4|Belgium||Region of Enrollment||participants|Number|12|12.0||||||
4289731|NCT00541658|4115212|B3|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
4289732|NCT00541658|4115213|B2|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
4289733|NCT00541658|4115214|B1|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
4289734|NCT00541658|4115211|B4|Argentina||Region of Enrollment||participants|Number|257|257.0||||||
4289735|NCT00541658|4115212|B3|Argentina||Region of Enrollment||participants|Number|84|84.0||||||
4289736|NCT00541658|4115213|B2|Argentina||Region of Enrollment||participants|Number|85|85.0||||||
4289737|NCT00541658|4115214|B1|Argentina||Region of Enrollment||participants|Number|88|88.0||||||
4289738|NCT00541658|4115211|B4|Male||Gender|ITT Population|participants|Number|0|0.0||||||
4289739|NCT00541658|4115212|B3|Male||Gender|ITT Population|participants|Number|0|0.0||||||
4289740|NCT00541658|4115213|B2|Male||Gender|ITT Population|participants|Number|0|0.0||||||
4289741|NCT00541658|4115214|B1|Male||Gender|ITT Population|participants|Number|0|0.0||||||
4289742|NCT00541658|4115211|B4|Female||Gender|ITT Population|participants|Number|922|922.0||||||
4289743|NCT00541658|4115212|B3|Female||Gender|ITT Population|participants|Number|308|308.0||||||
4289744|NCT00541658|4115213|B2|Female||Gender|ITT Population|participants|Number|307|307.0||||||
4289745|NCT00541658|4115214|B1|Female||Gender|ITT Population|participants|Number|307|307.0||||||
4289746|NCT00541658|4115211|B4|> = 75 years||Age, Customized|ITT Population|participants|Number|119|119.0||||||
4289747|NCT00541658|4115212|B3|> = 75 years||Age, Customized|ITT Population|participants|Number|42|42.0||||||
4289748|NCT00541658|4115213|B2|> = 75 years||Age, Customized|ITT Population|participants|Number|39|39.0||||||
4289749|NCT00541658|4115214|B1|> = 75 years||Age, Customized|ITT Population|participants|Number|38|38.0||||||
4289750|NCT00541658|4115211|B4|Between 65 and < 75 years||Age, Customized|ITT Population|participants|Number|402|402.0||||||
4289751|NCT00541658|4115212|B3|Between 65 and < 75 years||Age, Customized|ITT Population|participants|Number|133|133.0||||||
4289752|NCT00541658|4115213|B2|Between 65 and < 75 years||Age, Customized|ITT Population|participants|Number|141|141.0||||||
4289753|NCT00541658|4115214|B1|Between 65 and < 75 years||Age, Customized|ITT Population|participants|Number|128|128.0||||||
4289754|NCT00541658|4115211|B4|< 65 years||Age, Customized|ITT Population|participants|Number|401|401.0||||||
4289755|NCT00541658|4115212|B3|< 65 years||Age, Customized|ITT Population|participants|Number|133|133.0||||||
4289756|NCT00541658|4115213|B2|< 65 years||Age, Customized|ITT Population|participants|Number|127|127.0||||||
4289757|NCT00541658|4115214|B1|< 65 years||Age, Customized|ITT Population|participants|Number|141|141.0||||||
4289758|NCT00541658|4115211|B4|||Age|ITT Population|years|Mean|65.7|65.7|Standard Deviation|7.4|7.4|||
4289759|NCT00541658|4115212|B3|||Age|ITT Population|years|Mean|66.0|66.0|Standard Deviation|7.5|7.5|||
4289760|NCT00541658|4115213|B2|||Age|ITT Population|years|Mean|65.8|65.8|Standard Deviation|7.4|7.4|||
4289761|NCT00541658|4115214|B1|||Age|ITT Population|years|Mean|65.3|65.3|Standard Deviation|7.4|7.4|||
4289762|NCT00541593|4115373|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4289763|NCT00541593|4115373|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4289764|NCT00541593|4115373|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4289765|NCT00541593|4115373|B1|||Age||years|Mean|55.8|55.8|Standard Deviation|9.20|9.2|||
4289766|NCT00541593|4115373|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4289767|NCT00541593|4115373|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4289768|NCT00541593|4115373|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4289769|NCT00541450|4115377|B3||Male|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
4289770|NCT00541450|4115378|B2||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4289771|NCT00541450|4115379|B1||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4289772|NCT00541450|4115377|B3||Female|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4289773|NCT00541450|4115378|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4289774|NCT00541450|4115379|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4289775|NCT00541450|4115377|B3|||Age||years|Mean|51.1|51.1|Standard Deviation|10.5|10.5|||
4289776|NCT00541450|4115378|B2|||Age||years|Mean|51.7|51.7|Standard Deviation|10.1|10.1|||
4289777|NCT00541450|4115379|B1|||Age||years|Mean|50.5|50.5|Standard Deviation|10.9|10.9|||
4289778|NCT00541346|4115398|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4289779|NCT00541346|4115398|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4289780|NCT00541346|4115398|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4289781|NCT00541346|4115398|B1|||Age||years|Mean|7.83|7.83|Standard Deviation|1.23|1.23|||
4289782|NCT00541346|4115398|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4289783|NCT00541346|4115398|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4289784|NCT00541346|4115398|B1||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4289785|NCT00541307|4115412|B1|United States||Region of Enrollment||participants|Number|119|119.0||||||
4289786|NCT00541307|4115412|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4289787|NCT00541307|4115412|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4289788|NCT00541307|4115412|B1|||Age||years|Mean|66|66.0|Standard Deviation|9.6|9.6|||
4289789|NCT00541307|4115412|B1||>=65 years|Age||Participants|Count of Participants|61|61.0||||||
4289790|NCT00541307|4115412|B1||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4289791|NCT00541307|4115412|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4289792|NCT00541242|4115420|B3||Male|Sex: Female, Male|Intent to Treat (ITT) population used for Baseline characteristics. The ITT population included all patients who were randomized (started Treatment Period 2)|Participants|Count of Participants|241|241.0||||||
4289793|NCT00541242|4115421|B2||Male|Sex: Female, Male|Intent to Treat (ITT) population used for Baseline characteristics. The ITT population included all patients who were randomized (started Treatment Period 2)|Participants|Count of Participants|118|118.0||||||
4289794|NCT00541242|4115422|B1||Male|Sex: Female, Male|Intent to Treat (ITT) population used for Baseline characteristics. The ITT population included all patients who were randomized (started Treatment Period 2)|Participants|Count of Participants|123|123.0||||||
4289795|NCT00541242|4115420|B3||Female|Sex: Female, Male|Intent to Treat (ITT) population used for Baseline characteristics. The ITT population included all patients who were randomized (started Treatment Period 2)|Participants|Count of Participants|302|302.0||||||
4289796|NCT00541242|4115421|B2||Female|Sex: Female, Male|Intent to Treat (ITT) population used for Baseline characteristics. The ITT population included all patients who were randomized (started Treatment Period 2)|Participants|Count of Participants|155|155.0||||||
4289797|NCT00541242|4115422|B1||Female|Sex: Female, Male|Intent to Treat (ITT) population used for Baseline characteristics. The ITT population included all patients who were randomized (started Treatment Period 2)|Participants|Count of Participants|147|147.0||||||
4289798|NCT00541242|4115420|B3|> 65 years||Age, Customized|Intent to Treat (ITT) population used for Baseline characteristics. The ITT population included all patients who were randomized (started Treatment Period 2)|participants|Number|287|287.0||||||
4289799|NCT00541242|4115421|B2|> 65 years||Age, Customized|Intent to Treat (ITT) population used for Baseline characteristics. The ITT population included all patients who were randomized (started Treatment Period 2)|participants|Number|137|137.0||||||
4289800|NCT00541242|4115422|B1|> 65 years||Age, Customized|Intent to Treat (ITT) population used for Baseline characteristics. The ITT population included all patients who were randomized (started Treatment Period 2)|participants|Number|150|150.0||||||
4289801|NCT00541242|4115420|B3|Between 45 and 65 years||Age, Customized|Intent to Treat (ITT) population used for Baseline characteristics. The ITT population included all patients who were randomized (started Treatment Period 2)|participants|Number|231|231.0||||||
4289802|NCT00541242|4115421|B2|Between 45 and 65 years||Age, Customized|Intent to Treat (ITT) population used for Baseline characteristics. The ITT population included all patients who were randomized (started Treatment Period 2)|participants|Number|120|120.0||||||
4289803|NCT00541242|4115422|B1|Between 45 and 65 years||Age, Customized|Intent to Treat (ITT) population used for Baseline characteristics. The ITT population included all patients who were randomized (started Treatment Period 2)|participants|Number|111|111.0||||||
4289804|NCT00541242|4115420|B3|< 45 years||Age, Customized|Intent to Treat (ITT) population used for Baseline characteristics. The ITT population included all patients who were randomized (started Treatment Period 2)|participants|Number|25|25.0||||||
4289805|NCT00541242|4115421|B2|< 45 years||Age, Customized|Intent to Treat (ITT) population used for Baseline characteristics. The ITT population included all patients who were randomized (started Treatment Period 2)|participants|Number|16|16.0||||||
4289806|NCT00541242|4115422|B1|< 45 years||Age, Customized|Intent to Treat (ITT) population used for Baseline characteristics. The ITT population included all patients who were randomized (started Treatment Period 2)|participants|Number|9|9.0||||||
4289807|NCT00541229|4115431|B7|||Fasting Plasma Glucose||mg/dL|Mean|172.0|172.0|Standard Deviation|36.9|36.9|||
4289808|NCT00541229|4115432|B6|||Fasting Plasma Glucose||mg/dL|Mean|166.0|166.0|Standard Deviation|36.5|36.5|||
4289809|NCT00541229|4115433|B5|||Fasting Plasma Glucose||mg/dL|Mean|158.5|158.5|Standard Deviation|17.3|17.3|||
4289810|NCT00541229|4115434|B4|||Fasting Plasma Glucose||mg/dL|Mean|173.2|173.2|Standard Deviation|43.2|43.2|||
4289811|NCT00541229|4115435|B3|||Fasting Plasma Glucose||mg/dL|Mean|184.0|184.0|Standard Deviation|42.1|42.1|||
4289812|NCT00541229|4115436|B2|||Fasting Plasma Glucose||mg/dL|Mean|167.0|167.0|Standard Deviation|41.1|41.1|||
4289813|NCT00541229|4115437|B1|||Fasting Plasma Glucose||mg/dL|Mean|179.3|179.3|Standard Deviation|32.1|32.1|||
4289814|NCT00541229|4115431|B7|Other||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4289815|NCT00541229|4115432|B6|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4289816|NCT00541229|4115433|B5|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4289817|NCT00541229|4115434|B4|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4289818|NCT00541229|4115435|B3|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4289819|NCT00541229|4115436|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4289820|NCT00541229|4115437|B1|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4289821|NCT00541229|4115431|B7|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4289822|NCT00541229|4115432|B6|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4289823|NCT00541229|4115433|B5|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4289824|NCT00541229|4115434|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4289825|NCT00541229|4115435|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4289826|NCT00541229|4115436|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4289827|NCT00541229|4115437|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4289828|NCT00541229|4115431|B7|White||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
4289829|NCT00541229|4115432|B6|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4289830|NCT00541229|4115433|B5|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4289831|NCT00541229|4115434|B4|White||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4289832|NCT00541229|4115435|B3|White||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4289833|NCT00541229|4115436|B2|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4289834|NCT00541229|4115437|B1|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4289835|NCT00541229|4115431|B7||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4289836|NCT00541229|4115432|B6||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4289837|NCT00541229|4115433|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4289838|NCT00541229|4115434|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4289839|NCT00541229|4115435|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4289840|NCT00541229|4115436|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4289841|NCT00541229|4115437|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4289842|NCT00541229|4115431|B7||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4289843|NCT00541229|4115432|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4289844|NCT00541229|4115433|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4289845|NCT00541229|4115434|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4289846|NCT00541229|4115435|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4289847|NCT00541229|4115436|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4289848|NCT00541229|4115437|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4289849|NCT00541229|4115431|B7|||Age||years|Mean|53.5|53.5|Standard Deviation|8.6|8.6|||
4289850|NCT00541229|4115432|B6|||Age||years|Mean|48.6|48.6|Standard Deviation|9.6|9.6|||
4289851|NCT00541229|4115433|B5|||Age||years|Mean|50.0|50.0|Standard Deviation|10.0|10.0|||
4289852|NCT00541229|4115434|B4|||Age||years|Mean|55.3|55.3|Standard Deviation|8.3|8.3|||
4289853|NCT00541229|4115435|B3|||Age||years|Mean|55.7|55.7|Standard Deviation|7.2|7.2|||
4289854|NCT00541229|4115436|B2|||Age||years|Mean|56.6|56.6|Standard Deviation|5.8|5.8|||
4289855|NCT00541229|4115437|B1|||Age||years|Mean|54.5|54.5|Standard Deviation|8.4|8.4|||
4289856|NCT00541190|4115450|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4289857|NCT00541190|4115451|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4289858|NCT00541190|4115452|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4289859|NCT00541190|4115450|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4289860|NCT00541190|4115451|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4289861|NCT00541190|4115452|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4289862|NCT00541190|4115450|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4289863|NCT00541190|4115451|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4289864|NCT00541190|4115452|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4289865|NCT00541190|4115450|B3|||Age||years|Mean|29|29.0|Standard Deviation|9|9.0|||
4289866|NCT00541190|4115451|B2|||Age||years|Mean|29|29.0|Standard Deviation|7|7.0|||
4289867|NCT00541190|4115452|B1|||Age||years|Mean|29|29.0|Standard Deviation|11|11.0|||
4289868|NCT00541190|4115450|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4289869|NCT00541190|4115451|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4289870|NCT00541190|4115452|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4289871|NCT00541190|4115450|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4289872|NCT00541190|4115451|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4289873|NCT00541190|4115452|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4289874|NCT00541190|4115450|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4289875|NCT00541190|4115451|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4289876|NCT00541190|4115452|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4289877|NCT00541099|4115461|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4289878|NCT00541099|4115461|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4289879|NCT00541099|4115461|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4289880|NCT00541099|4115461|B1|||Age||years|Mean|79.7|79.7|Standard Deviation|4.15|4.15|||
4289881|NCT00541034|4115467|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4289882|NCT00541034|4115467|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4289883|NCT00541034|4115467|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4289884|NCT00541034|4115467|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4289885|NCT00541034|4115467|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4289886|NCT00540722|4115484|B1|Gliosarcoma||Histology||Participants|Count of Participants|2|2.0||||||
4289887|NCT00540722|4115484|B1|Glioblastoma||Histology||Participants|Count of Participants|54|54.0||||||
4289888|NCT00540722|4115484|B1|||Karnofsky Performance Status (KPS)|Karnofsky Performance Status Scale Higher score better 100 - Normal; no complaints; no evidence of disease; 90 - Able to carry on normal activity; minor signs or symptoms of disease, 80 - Normal activity with effort; some signs or symptoms of disease; 70 - Cares for self; unable to carry on normal activity or to do active work; 60 - Requires occasional assistance, but is able to care for most of his personal needs|units on a scale|Median|80|80.0|Full Range|||70.0|100.0|
4289889|NCT00540722|4115484|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4289890|NCT00540722|4115484|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4289891|NCT00540722|4115484|B1||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4289892|NCT00540722|4115484|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4289893|NCT00540722|4115484|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4289894|NCT00540722|4115484|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4289895|NCT00540722|4115484|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4289896|NCT00540722|4115484|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4289897|NCT00540722|4115484|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4289898|NCT00540722|4115484|B1|||Age||years|Median|59|59.0|Full Range|||34.0|79.0|
4289899|NCT00540644|4115492|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4289900|NCT00540644|4115493|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4289901|NCT00540644|4115494|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4289902|NCT00540644|4115492|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4289903|NCT00540644|4115493|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4289904|NCT00540644|4115494|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4289905|NCT00540644|4115492|B3||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4289906|NCT00540644|4115493|B2||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4289907|NCT00540644|4115494|B1||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4289908|NCT00540644|4115492|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4289909|NCT00540644|4115493|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4289910|NCT00540644|4115494|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4289911|NCT00540644|4115492|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4289912|NCT00540644|4115493|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4289913|NCT00540644|4115494|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4289914|NCT00540644|4115492|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4289915|NCT00540644|4115493|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4289916|NCT00540644|4115494|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4289917|NCT00540644|4115492|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4289918|NCT00540644|4115493|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4289919|NCT00540644|4115494|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4289920|NCT00540644|4115492|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4289921|NCT00540644|4115493|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4289922|NCT00540644|4115494|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4289923|NCT00540644|4115492|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4289924|NCT00540644|4115493|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4289925|NCT00540644|4115494|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4289926|NCT00540644|4115492|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4289927|NCT00540644|4115493|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4289928|NCT00540644|4115494|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4289929|NCT00540644|4115492|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4289930|NCT00540644|4115493|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4289931|NCT00540644|4115494|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4289932|NCT00540644|4115492|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4289933|NCT00540644|4115493|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4289934|NCT00540644|4115494|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4289935|NCT00540644|4115492|B3|||Age||years|Mean|61.2|61.2|Standard Deviation|9.8|9.8|||
4289936|NCT00540644|4115493|B2|||Age||years|Mean|59.9|59.9|Standard Deviation|8.0|8.0|||
4289937|NCT00540644|4115494|B1|||Age||years|Mean|61.9|61.9|Standard Deviation|10.5|10.5|||
4289938|NCT00540644|4115492|B3||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4289939|NCT00540644|4115493|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4289940|NCT00540644|4115494|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4289941|NCT00540644|4115492|B3||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4289942|NCT00540644|4115493|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4289943|NCT00540644|4115494|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4289944|NCT00540644|4115492|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4289945|NCT00540644|4115493|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4289946|NCT00540644|4115494|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4289947|NCT00540592|4115505|B11||Male|Sex: Female, Male||Participants|Count of Participants|1023|1023.0||||||
4289948|NCT00540592|4115506|B10||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4289949|NCT00540592|4115507|B9||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4289950|NCT00540592|4115508|B8||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4289951|NCT00540592|4115509|B7||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4289952|NCT00540592|4115510|B6||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4289953|NCT00540592|4115511|B5||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4289954|NCT00540592|4115512|B4||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4289955|NCT00540592|4115513|B3||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4289956|NCT00540592|4115514|B2||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4289957|NCT00540592|4115515|B1||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4289958|NCT00540592|4115505|B11||Female|Sex: Female, Male||Participants|Count of Participants|984|984.0||||||
4289959|NCT00540592|4115506|B10||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4289960|NCT00540592|4115507|B9||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4289961|NCT00540592|4115508|B8||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4289962|NCT00540592|4115509|B7||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4289963|NCT00540592|4115510|B6||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4289964|NCT00540592|4115511|B5||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4289965|NCT00540592|4115512|B4||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4289966|NCT00540592|4115513|B3||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4289967|NCT00540592|4115514|B2||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4289968|NCT00540592|4115515|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4289969|NCT00540592|4115505|B11|||Age||Years|Mean|68.11|68.11|Standard Deviation|14.81|14.81|||
4289970|NCT00540592|4115506|B10|||Age||Years|Mean|27.4|27.4|Standard Deviation|6.25|6.25|||
4289971|NCT00540592|4115507|B9|||Age||Years|Mean|72.7|72.7|Standard Deviation|5.43|5.43|||
4289972|NCT00540592|4115508|B8|||Age||Years|Mean|73.0|73.0|Standard Deviation|6.03|6.03|||
4289973|NCT00540592|4115509|B7|||Age||Years|Mean|72.6|72.6|Standard Deviation|5.67|5.67|||
4289974|NCT00540592|4115510|B6|||Age||Years|Mean|72.7|72.7|Standard Deviation|5.56|5.56|||
4289975|NCT00540592|4115511|B5|||Age||Years|Mean|72.6|72.6|Standard Deviation|5.66|5.66|||
4289976|NCT00540592|4115512|B4|||Age||Years|Mean|72.9|72.9|Standard Deviation|6.09|6.09|||
4289977|NCT00540592|4115513|B3|||Age||Years|Mean|72.4|72.4|Standard Deviation|5.62|5.62|||
4289978|NCT00540592|4115514|B2|||Age||Years|Mean|72.6|72.6|Standard Deviation|5.16|5.16|||
4289979|NCT00540592|4115515|B1|||Age||Years|Mean|72.7|72.7|Standard Deviation|5.75|5.75|||
4289980|NCT00540579|4115756|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4289981|NCT00540579|4115756|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4289982|NCT00540579|4115756|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4289983|NCT00540579|4115756|B1|||Age||years|Median|62|62.0|Full Range|||47.0|78.0|
4289984|NCT00540514|4115761|B3|IV||Stage at Randomization||participants|Number|834|834.0||||||
4289985|NCT00540514|4115762|B2|IV||Stage at Randomization||participants|Number|421|421.0||||||
4289986|NCT00540514|4115763|B1|IV||Stage at Randomization||participants|Number|413|413.0||||||
4289987|NCT00540514|4115761|B3|IIIb||Stage at Randomization||participants|Number|218|218.0||||||
4289988|NCT00540514|4115762|B2|IIIb||Stage at Randomization||participants|Number|110|110.0||||||
4289989|NCT00540514|4115763|B1|IIIb||Stage at Randomization||participants|Number|108|108.0||||||
4289990|NCT00540514|4115761|B3|||Time from 1st Documented Metastasis/Relapse to Study Entry||months|Mean|0.9|0.9|Standard Deviation|1.73|1.73|||
4289991|NCT00540514|4115762|B2|||Time from 1st Documented Metastasis/Relapse to Study Entry||months|Mean|0.8|0.8|Standard Deviation|1.25|1.25|||
4289992|NCT00540514|4115763|B1|||Time from 1st Documented Metastasis/Relapse to Study Entry||months|Mean|0.9|0.9|Standard Deviation|2.11|2.11|||
4289993|NCT00540514|4115761|B3|Other||Histology of Primary Diagnosis||participants|Number|62|62.0||||||
4289994|NCT00540514|4115762|B2|Other||Histology of Primary Diagnosis||participants|Number|33|33.0||||||
4289995|NCT00540514|4115763|B1|Other||Histology of Primary Diagnosis||participants|Number|29|29.0||||||
4289996|NCT00540514|4115761|B3|Large Cell Carcinoma||Histology of Primary Diagnosis||participants|Number|22|22.0||||||
4289997|NCT00540514|4115762|B2|Large Cell Carcinoma||Histology of Primary Diagnosis||participants|Number|13|13.0||||||
4289998|NCT00540514|4115763|B1|Large Cell Carcinoma||Histology of Primary Diagnosis||participants|Number|9|9.0||||||
4289999|NCT00540514|4115761|B3|Squamous Cell Carcinoma||Histology of Primary Diagnosis||participants|Number|450|450.0||||||
4290000|NCT00540514|4115762|B2|Squamous Cell Carcinoma||Histology of Primary Diagnosis||participants|Number|221|221.0||||||
4290001|NCT00540514|4115763|B1|Squamous Cell Carcinoma||Histology of Primary Diagnosis||participants|Number|229|229.0||||||
4290002|NCT00540514|4115761|B3|Carcinoma/ Adenocarcinoma||Histology of Primary Diagnosis||participants|Number|518|518.0||||||
4290003|NCT00540514|4115762|B2|Carcinoma/ Adenocarcinoma||Histology of Primary Diagnosis||participants|Number|264|264.0||||||
4290004|NCT00540514|4115763|B1|Carcinoma/ Adenocarcinoma||Histology of Primary Diagnosis||participants|Number|254|254.0||||||
4290005|NCT00540514|4115761|B3|Other||Anatomic Site of Primary Diagnosis||participants|Number|73|73.0||||||
4290006|NCT00540514|4115762|B2|Other||Anatomic Site of Primary Diagnosis||participants|Number|32|32.0||||||
4290007|NCT00540514|4115763|B1|Other||Anatomic Site of Primary Diagnosis||participants|Number|41|41.0||||||
4290008|NCT00540514|4115761|B3|Lung||Anatomic Site of Primary Diagnosis||participants|Number|979|979.0||||||
4290009|NCT00540514|4115762|B2|Lung||Anatomic Site of Primary Diagnosis||participants|Number|499|499.0||||||
4290010|NCT00540514|4115763|B1|Lung||Anatomic Site of Primary Diagnosis||participants|Number|480|480.0||||||
4290011|NCT00540514|4115761|B3|Unknown||Stage at Primary Diagnosis|"I: The tumor has not spread outside the chest or to the lymph nodes.~II: A tumor that may have spread to local lymph nodes, but has not spread further.~IIIa: A tumor of any size, cancer cells are found in the lymph nodes near the lungs and bronchi and in the lymph nodes between the lungs on the same side of the chest.~IIIb: Any size tumor that has spread to distant lymph nodes, or invaded other structures in the chest such as the heart or esophagus, or a tumor with a malignant pleural effusion.~IV - The cancer has spread to another part of the body, including the opposite lung."|participants|Number|8|8.0||||||
4290012|NCT00540514|4115762|B2|Unknown||Stage at Primary Diagnosis|"I: The tumor has not spread outside the chest or to the lymph nodes.~II: A tumor that may have spread to local lymph nodes, but has not spread further.~IIIa: A tumor of any size, cancer cells are found in the lymph nodes near the lungs and bronchi and in the lymph nodes between the lungs on the same side of the chest.~IIIb: Any size tumor that has spread to distant lymph nodes, or invaded other structures in the chest such as the heart or esophagus, or a tumor with a malignant pleural effusion.~IV - The cancer has spread to another part of the body, including the opposite lung."|participants|Number|3|3.0||||||
4290013|NCT00540514|4115763|B1|Unknown||Stage at Primary Diagnosis|"I: The tumor has not spread outside the chest or to the lymph nodes.~II: A tumor that may have spread to local lymph nodes, but has not spread further.~IIIa: A tumor of any size, cancer cells are found in the lymph nodes near the lungs and bronchi and in the lymph nodes between the lungs on the same side of the chest.~IIIb: Any size tumor that has spread to distant lymph nodes, or invaded other structures in the chest such as the heart or esophagus, or a tumor with a malignant pleural effusion.~IV - The cancer has spread to another part of the body, including the opposite lung."|participants|Number|5|5.0||||||
4290052|NCT00540514|4115763|B1|Never smoked||Smoking status||participants|Number|137|137.0||||||
4290053|NCT00540514|4115761|B3|Ukraine||Region of Enrollment||participants|Number|255|255.0||||||
4290014|NCT00540514|4115761|B3|IV||Stage at Primary Diagnosis|"I: The tumor has not spread outside the chest or to the lymph nodes.~II: A tumor that may have spread to local lymph nodes, but has not spread further.~IIIa: A tumor of any size, cancer cells are found in the lymph nodes near the lungs and bronchi and in the lymph nodes between the lungs on the same side of the chest.~IIIb: Any size tumor that has spread to distant lymph nodes, or invaded other structures in the chest such as the heart or esophagus, or a tumor with a malignant pleural effusion.~IV - The cancer has spread to another part of the body, including the opposite lung."|participants|Number|669|669.0||||||
4290015|NCT00540514|4115762|B2|IV||Stage at Primary Diagnosis|"I: The tumor has not spread outside the chest or to the lymph nodes.~II: A tumor that may have spread to local lymph nodes, but has not spread further.~IIIa: A tumor of any size, cancer cells are found in the lymph nodes near the lungs and bronchi and in the lymph nodes between the lungs on the same side of the chest.~IIIb: Any size tumor that has spread to distant lymph nodes, or invaded other structures in the chest such as the heart or esophagus, or a tumor with a malignant pleural effusion.~IV - The cancer has spread to another part of the body, including the opposite lung."|participants|Number|344|344.0||||||
4290016|NCT00540514|4115763|B1|IV||Stage at Primary Diagnosis|"I: The tumor has not spread outside the chest or to the lymph nodes.~II: A tumor that may have spread to local lymph nodes, but has not spread further.~IIIa: A tumor of any size, cancer cells are found in the lymph nodes near the lungs and bronchi and in the lymph nodes between the lungs on the same side of the chest.~IIIb: Any size tumor that has spread to distant lymph nodes, or invaded other structures in the chest such as the heart or esophagus, or a tumor with a malignant pleural effusion.~IV - The cancer has spread to another part of the body, including the opposite lung."|participants|Number|325|325.0||||||
4290017|NCT00540514|4115761|B3|IIIb||Stage at Primary Diagnosis|"I: The tumor has not spread outside the chest or to the lymph nodes.~II: A tumor that may have spread to local lymph nodes, but has not spread further.~IIIa: A tumor of any size, cancer cells are found in the lymph nodes near the lungs and bronchi and in the lymph nodes between the lungs on the same side of the chest.~IIIb: Any size tumor that has spread to distant lymph nodes, or invaded other structures in the chest such as the heart or esophagus, or a tumor with a malignant pleural effusion.~IV - The cancer has spread to another part of the body, including the opposite lung."|participants|Number|251|251.0||||||
4290018|NCT00540514|4115762|B2|IIIb||Stage at Primary Diagnosis|"I: The tumor has not spread outside the chest or to the lymph nodes.~II: A tumor that may have spread to local lymph nodes, but has not spread further.~IIIa: A tumor of any size, cancer cells are found in the lymph nodes near the lungs and bronchi and in the lymph nodes between the lungs on the same side of the chest.~IIIb: Any size tumor that has spread to distant lymph nodes, or invaded other structures in the chest such as the heart or esophagus, or a tumor with a malignant pleural effusion.~IV - The cancer has spread to another part of the body, including the opposite lung."|participants|Number|116|116.0||||||
4290019|NCT00540514|4115763|B1|IIIb||Stage at Primary Diagnosis|"I: The tumor has not spread outside the chest or to the lymph nodes.~II: A tumor that may have spread to local lymph nodes, but has not spread further.~IIIa: A tumor of any size, cancer cells are found in the lymph nodes near the lungs and bronchi and in the lymph nodes between the lungs on the same side of the chest.~IIIb: Any size tumor that has spread to distant lymph nodes, or invaded other structures in the chest such as the heart or esophagus, or a tumor with a malignant pleural effusion.~IV - The cancer has spread to another part of the body, including the opposite lung."|participants|Number|135|135.0||||||
4290020|NCT00540514|4115761|B3|IIIa||Stage at Primary Diagnosis|"I: The tumor has not spread outside the chest or to the lymph nodes.~II: A tumor that may have spread to local lymph nodes, but has not spread further.~IIIa: A tumor of any size, cancer cells are found in the lymph nodes near the lungs and bronchi and in the lymph nodes between the lungs on the same side of the chest.~IIIb: Any size tumor that has spread to distant lymph nodes, or invaded other structures in the chest such as the heart or esophagus, or a tumor with a malignant pleural effusion.~IV - The cancer has spread to another part of the body, including the opposite lung."|participants|Number|46|46.0||||||
4290021|NCT00540514|4115762|B2|IIIa||Stage at Primary Diagnosis|"I: The tumor has not spread outside the chest or to the lymph nodes.~II: A tumor that may have spread to local lymph nodes, but has not spread further.~IIIa: A tumor of any size, cancer cells are found in the lymph nodes near the lungs and bronchi and in the lymph nodes between the lungs on the same side of the chest.~IIIb: Any size tumor that has spread to distant lymph nodes, or invaded other structures in the chest such as the heart or esophagus, or a tumor with a malignant pleural effusion.~IV - The cancer has spread to another part of the body, including the opposite lung."|participants|Number|24|24.0||||||
4290022|NCT00540514|4115763|B1|IIIa||Stage at Primary Diagnosis|"I: The tumor has not spread outside the chest or to the lymph nodes.~II: A tumor that may have spread to local lymph nodes, but has not spread further.~IIIa: A tumor of any size, cancer cells are found in the lymph nodes near the lungs and bronchi and in the lymph nodes between the lungs on the same side of the chest.~IIIb: Any size tumor that has spread to distant lymph nodes, or invaded other structures in the chest such as the heart or esophagus, or a tumor with a malignant pleural effusion.~IV - The cancer has spread to another part of the body, including the opposite lung."|participants|Number|22|22.0||||||
4290023|NCT00540514|4115761|B3|II||Stage at Primary Diagnosis|"I: The tumor has not spread outside the chest or to the lymph nodes.~II: A tumor that may have spread to local lymph nodes, but has not spread further.~IIIa: A tumor of any size, cancer cells are found in the lymph nodes near the lungs and bronchi and in the lymph nodes between the lungs on the same side of the chest.~IIIb: Any size tumor that has spread to distant lymph nodes, or invaded other structures in the chest such as the heart or esophagus, or a tumor with a malignant pleural effusion.~IV - The cancer has spread to another part of the body, including the opposite lung."|participants|Number|42|42.0||||||
4290024|NCT00540514|4115762|B2|II||Stage at Primary Diagnosis|"I: The tumor has not spread outside the chest or to the lymph nodes.~II: A tumor that may have spread to local lymph nodes, but has not spread further.~IIIa: A tumor of any size, cancer cells are found in the lymph nodes near the lungs and bronchi and in the lymph nodes between the lungs on the same side of the chest.~IIIb: Any size tumor that has spread to distant lymph nodes, or invaded other structures in the chest such as the heart or esophagus, or a tumor with a malignant pleural effusion.~IV - The cancer has spread to another part of the body, including the opposite lung."|participants|Number|24|24.0||||||
4290054|NCT00540514|4115762|B2|Ukraine||Region of Enrollment||participants|Number|135|135.0||||||
4290055|NCT00540514|4115763|B1|Ukraine||Region of Enrollment||participants|Number|120|120.0||||||
4290025|NCT00540514|4115763|B1|II||Stage at Primary Diagnosis|"I: The tumor has not spread outside the chest or to the lymph nodes.~II: A tumor that may have spread to local lymph nodes, but has not spread further.~IIIa: A tumor of any size, cancer cells are found in the lymph nodes near the lungs and bronchi and in the lymph nodes between the lungs on the same side of the chest.~IIIb: Any size tumor that has spread to distant lymph nodes, or invaded other structures in the chest such as the heart or esophagus, or a tumor with a malignant pleural effusion.~IV - The cancer has spread to another part of the body, including the opposite lung."|participants|Number|18|18.0||||||
4290026|NCT00540514|4115761|B3|I||Stage at Primary Diagnosis|"I: The tumor has not spread outside the chest or to the lymph nodes.~II: A tumor that may have spread to local lymph nodes, but has not spread further.~IIIa: A tumor of any size, cancer cells are found in the lymph nodes near the lungs and bronchi and in the lymph nodes between the lungs on the same side of the chest.~IIIb: Any size tumor that has spread to distant lymph nodes, or invaded other structures in the chest such as the heart or esophagus, or a tumor with a malignant pleural effusion.~IV - The cancer has spread to another part of the body, including the opposite lung."|participants|Number|36|36.0||||||
4290027|NCT00540514|4115762|B2|I||Stage at Primary Diagnosis|"I: The tumor has not spread outside the chest or to the lymph nodes.~II: A tumor that may have spread to local lymph nodes, but has not spread further.~IIIa: A tumor of any size, cancer cells are found in the lymph nodes near the lungs and bronchi and in the lymph nodes between the lungs on the same side of the chest.~IIIb: Any size tumor that has spread to distant lymph nodes, or invaded other structures in the chest such as the heart or esophagus, or a tumor with a malignant pleural effusion.~IV - The cancer has spread to another part of the body, including the opposite lung."|participants|Number|20|20.0||||||
4290028|NCT00540514|4115763|B1|I||Stage at Primary Diagnosis|"I: The tumor has not spread outside the chest or to the lymph nodes.~II: A tumor that may have spread to local lymph nodes, but has not spread further.~IIIa: A tumor of any size, cancer cells are found in the lymph nodes near the lungs and bronchi and in the lymph nodes between the lungs on the same side of the chest.~IIIb: Any size tumor that has spread to distant lymph nodes, or invaded other structures in the chest such as the heart or esophagus, or a tumor with a malignant pleural effusion.~IV - The cancer has spread to another part of the body, including the opposite lung."|participants|Number|16|16.0||||||
4290029|NCT00540514|4115761|B3|||Time from Primary Diagnosis to Study Entry||months|Mean|4.3|4.3|Standard Deviation|16.60|16.6|||
4290030|NCT00540514|4115762|B2|||Time from Primary Diagnosis to Study Entry||months|Mean|4.3|4.3|Standard Deviation|16.09|16.09|||
4290031|NCT00540514|4115763|B1|||Time from Primary Diagnosis to Study Entry||months|Mean|4.3|4.3|Standard Deviation|17.12|17.12|||
4290032|NCT00540514|4115761|B3|2 (Ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|5|5.0||||||
4290033|NCT00540514|4115762|B2|2 (Ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|2|2.0||||||
4290034|NCT00540514|4115763|B1|2 (Ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|3|3.0||||||
4290035|NCT00540514|4115761|B3|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|801|801.0||||||
4290036|NCT00540514|4115762|B2|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|416|416.0||||||
4290037|NCT00540514|4115763|B1|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|385|385.0||||||
4290038|NCT00540514|4115761|B3|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|246|246.0||||||
4290039|NCT00540514|4115762|B2|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|113|113.0||||||
4290040|NCT00540514|4115763|B1|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|133|133.0||||||
4290041|NCT00540514|4115761|B3|Missing||Smoking status||participants|Number|7|7.0||||||
4290042|NCT00540514|4115762|B2|Missing||Smoking status||participants|Number|5|5.0||||||
4290043|NCT00540514|4115763|B1|Missing||Smoking status||participants|Number|2|2.0||||||
4290044|NCT00540514|4115761|B3|Smoked and currently smokes||Smoking status||participants|Number|448|448.0||||||
4290045|NCT00540514|4115762|B2|Smoked and currently smokes||Smoking status||participants|Number|234|234.0||||||
4290046|NCT00540514|4115763|B1|Smoked and currently smokes||Smoking status||participants|Number|214|214.0||||||
4290047|NCT00540514|4115761|B3|Smoked and quit smoking||Smoking status||participants|Number|316|316.0||||||
4290048|NCT00540514|4115762|B2|Smoked and quit smoking||Smoking status||participants|Number|148|148.0||||||
4290049|NCT00540514|4115763|B1|Smoked and quit smoking||Smoking status||participants|Number|168|168.0||||||
4290050|NCT00540514|4115761|B3|Never smoked||Smoking status||participants|Number|281|281.0||||||
4290051|NCT00540514|4115762|B2|Never smoked||Smoking status||participants|Number|144|144.0||||||
4290056|NCT00540514|4115761|B3|Russian Federation||Region of Enrollment||participants|Number|469|469.0||||||
4290057|NCT00540514|4115762|B2|Russian Federation||Region of Enrollment||participants|Number|231|231.0||||||
4290058|NCT00540514|4115763|B1|Russian Federation||Region of Enrollment||participants|Number|238|238.0||||||
4290059|NCT00540514|4115761|B3|Japan||Region of Enrollment||participants|Number|149|149.0||||||
4290060|NCT00540514|4115762|B2|Japan||Region of Enrollment||participants|Number|75|75.0||||||
4290061|NCT00540514|4115763|B1|Japan||Region of Enrollment||participants|Number|74|74.0||||||
4290062|NCT00540514|4115761|B3|Australia||Region of Enrollment||participants|Number|14|14.0||||||
4290063|NCT00540514|4115762|B2|Australia||Region of Enrollment||participants|Number|9|9.0||||||
4290064|NCT00540514|4115763|B1|Australia||Region of Enrollment||participants|Number|5|5.0||||||
4290065|NCT00540514|4115761|B3|Canada||Region of Enrollment||participants|Number|44|44.0||||||
4290066|NCT00540514|4115762|B2|Canada||Region of Enrollment||participants|Number|23|23.0||||||
4290067|NCT00540514|4115763|B1|Canada||Region of Enrollment||participants|Number|21|21.0||||||
4290068|NCT00540514|4115761|B3|United States||Region of Enrollment||participants|Number|121|121.0||||||
4290069|NCT00540514|4115762|B2|United States||Region of Enrollment||participants|Number|58|58.0||||||
4290070|NCT00540514|4115763|B1|United States||Region of Enrollment||participants|Number|63|63.0||||||
4290071|NCT00540514|4115761|B3|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4290072|NCT00540514|4115762|B2|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4290073|NCT00540514|4115763|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4290074|NCT00540514|4115761|B3|White, Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4290075|NCT00540514|4115762|B2|White, Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4290076|NCT00540514|4115763|B1|White, Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4290077|NCT00540514|4115761|B3|White, Non Hispanic and Non Latino||Race/Ethnicity, Customized||participants|Number|849|849.0||||||
4290078|NCT00540514|4115762|B2|White, Non Hispanic and Non Latino||Race/Ethnicity, Customized||participants|Number|433|433.0||||||
4290079|NCT00540514|4115763|B1|White, Non Hispanic and Non Latino||Race/Ethnicity, Customized||participants|Number|416|416.0||||||
4290080|NCT00540514|4115761|B3|North American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4290081|NCT00540514|4115762|B2|North American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4290082|NCT00540514|4115763|B1|North American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4290083|NCT00540514|4115761|B3|Black, of African Heritage||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4290084|NCT00540514|4115762|B2|Black, of African Heritage||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4290085|NCT00540514|4115763|B1|Black, of African Heritage||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4290086|NCT00540514|4115761|B3|Asian||Race/Ethnicity, Customized||participants|Number|159|159.0||||||
4290087|NCT00540514|4115762|B2|Asian||Race/Ethnicity, Customized||participants|Number|80|80.0||||||
4290088|NCT00540514|4115763|B1|Asian||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
4290089|NCT00540514|4115761|B3||Male|Sex: Female, Male||Participants|Count of Participants|789|789.0||||||
4290090|NCT00540514|4115762|B2||Male|Sex: Female, Male||Participants|Count of Participants|397|397.0||||||
4290091|NCT00540514|4115763|B1||Male|Sex: Female, Male||Participants|Count of Participants|392|392.0||||||
4290092|NCT00540514|4115761|B3||Female|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
4290093|NCT00540514|4115762|B2||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4290094|NCT00540514|4115763|B1||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4290095|NCT00540514|4115761|B3|||Age||years|Mean|59.6|59.6|Standard Deviation|9.33|9.33|||
4290096|NCT00540514|4115762|B2|||Age||years|Mean|59.7|59.7|Standard Deviation|9.53|9.53|||
4290097|NCT00540514|4115763|B1|||Age||years|Mean|59.5|59.5|Standard Deviation|9.14|9.14|||
4290098|NCT00540449|4115794|B3|USA, Canada, Europe, Australia||Region Enroll||participants|Number|400|400.0||||||
4290099|NCT00540449|4115795|B2|USA, Canada, Europe, Australia||Region Enroll||participants|Number|193|193.0||||||
4290100|NCT00540449|4115796|B1|USA, Canada, Europe, Australia||Region Enroll||participants|Number|207|207.0||||||
4290101|NCT00540449|4115794|B3|Latin America||Region Enroll||participants|Number|129|129.0||||||
4290102|NCT00540449|4115795|B2|Latin America||Region Enroll||participants|Number|69|69.0||||||
4290103|NCT00540449|4115796|B1|Latin America||Region Enroll||participants|Number|60|60.0||||||
4290104|NCT00540449|4115794|B3|Asia||Region Enroll||participants|Number|98|98.0||||||
4290105|NCT00540449|4115795|B2|Asia||Region Enroll||participants|Number|51|51.0||||||
4290106|NCT00540449|4115796|B1|Asia||Region Enroll||participants|Number|47|47.0||||||
4290107|NCT00540449|4115794|B3|Africa||Region Enroll||participants|Number|63|63.0||||||
4290108|NCT00540449|4115795|B2|Africa||Region Enroll||participants|Number|31|31.0||||||
4290109|NCT00540449|4115796|B1|Africa||Region Enroll||participants|Number|32|32.0||||||
4290110|NCT00540449|4115794|B3||Male|Sex: Female, Male||Participants|Count of Participants|543|543.0||||||
4290111|NCT00540449|4115795|B2||Male|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4290112|NCT00540449|4115796|B1||Male|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
4290113|NCT00540449|4115794|B3||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4290114|NCT00540449|4115795|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4290115|NCT00540449|4115796|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4290116|NCT00540449|4115794|B3|||Age||years|Mean|36.8|36.8|Standard Deviation|9.59|9.59|||
4290117|NCT00540449|4115795|B2|||Age||years|Mean|36.7|36.7|Standard Deviation|9.51|9.51|||
4290118|NCT00540449|4115796|B1|||Age||years|Mean|37|37.0|Standard Deviation|9.68|9.68|||
4290119|NCT00540449|4115794|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4290120|NCT00540449|4115795|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4290121|NCT00540449|4115796|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4290122|NCT00540449|4115794|B3||Between 18 and 65 years|Age||Participants|Count of Participants|686|686.0||||||
4290123|NCT00540449|4115795|B2||Between 18 and 65 years|Age||Participants|Count of Participants|343|343.0||||||
4290124|NCT00540449|4115796|B1||Between 18 and 65 years|Age||Participants|Count of Participants|343|343.0||||||
4290125|NCT00540449|4115794|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4290126|NCT00540449|4115795|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4290127|NCT00540449|4115796|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4290128|NCT00540436|4115819|B1|Asian-Japanese Heritage||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4290129|NCT00540436|4115819|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4290130|NCT00540436|4115819|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4290131|NCT00540436|4115819|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|13.66|13.66|||
4290132|NCT00540423|4115832|B3|Japanese Heritage||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4290133|NCT00540423|4115833|B2|Japanese Heritage||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4290134|NCT00540423|4115834|B1|Japanese Heritage||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4290135|NCT00540423|4115832|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4290136|NCT00540423|4115833|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4290137|NCT00540423|4115834|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4290138|NCT00540423|4115832|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4290139|NCT00540423|4115833|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4290140|NCT00540423|4115834|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4290141|NCT00540423|4115832|B3|||Age||years|Mean|55.3|55.3|Standard Deviation|12.98|12.98|||
4290142|NCT00540423|4115833|B2|||Age||years|Mean|58.4|58.4|Standard Deviation|11.72|11.72|||
4290143|NCT00540423|4115834|B1|||Age||years|Mean|53.7|53.7|Standard Deviation|13.72|13.72|||
4290144|NCT00540293|4115886|B1||Male|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4290145|NCT00540293|4115886|B1||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4290146|NCT00540293|4115886|B1|Males between 18 and 80 years||Age||Years|Mean|58.6|58.6|Standard Deviation|10.2|10.2|||
4290147|NCT00540293|4115886|B1|Females between 18 and 80 years||Age||Years|Mean|62.9|62.9|Standard Deviation|8.6|8.6|||
4290148|NCT00540228|4115929|B6||Male|Sex: Female, Male||Participants|Count of Participants|397|397.0||||||
4290149|NCT00540228|4115930|B5||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4290150|NCT00540228|4115931|B4||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4290151|NCT00540228|4115932|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4290152|NCT00540228|4115933|B2||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4290153|NCT00540228|4115934|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4290154|NCT00540228|4115929|B6||Female|Sex: Female, Male||Participants|Count of Participants|609|609.0||||||
4290155|NCT00540228|4115930|B5||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4290156|NCT00540228|4115931|B4||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4290157|NCT00540228|4115932|B3||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4290158|NCT00540228|4115933|B2||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4290159|NCT00540228|4115934|B1||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4290160|NCT00540228|4115929|B6|||Age||Years|Mean|40.1|40.1|Standard Deviation|14.14|14.14|||
4290161|NCT00540228|4115930|B5|||Age||Years|Mean|40.1|40.1|Standard Deviation|14.11|14.11|||
4290162|NCT00540228|4115931|B4|||Age||Years|Mean|39.7|39.7|Standard Deviation|14.31|14.31|||
4290163|NCT00540228|4115932|B3|||Age||Years|Mean|39.7|39.7|Standard Deviation|14.37|14.37|||
4290164|NCT00540228|4115933|B2|||Age||Years|Mean|40.3|40.3|Standard Deviation|13.79|13.79|||
4290165|NCT00540228|4115934|B1|||Age||Years|Mean|40.5|40.5|Standard Deviation|14.14|14.14|||
4290166|NCT00540124|4116005|B4|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/meters squared (kg/m^2)|Mean|24.6|24.6|Standard Deviation|2.2|2.2|||
4290167|NCT00540124|4116006|B3|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/meters squared (kg/m^2)|Mean|24.4|24.4|Standard Deviation|2.1|2.1|||
4290168|NCT00540124|4116007|B2|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/meters squared (kg/m^2)|Mean|24.7|24.7|Standard Deviation|2.3|2.3|||
4290169|NCT00540124|4116008|B1|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/meters squared (kg/m^2)|Mean|24.8|24.8|Standard Deviation|2.2|2.2|||
4290170|NCT00540124|4116005|B4|||Weight||kilograms|Mean|69.7|69.7|Standard Deviation|7.7|7.7|||
4290171|NCT00540124|4116006|B3|||Weight||kilograms|Mean|68.4|68.4|Standard Deviation|7.6|7.6|||
4290172|NCT00540124|4116007|B2|||Weight||kilograms|Mean|70.1|70.1|Standard Deviation|7.5|7.5|||
4290173|NCT00540124|4116008|B1|||Weight||kilograms|Mean|70.7|70.7|Standard Deviation|8.1|8.1|||
4290174|NCT00540124|4116005|B4|||Height||centimeters|Mean|168.2|168.2|Standard Deviation|5.1|5.1|||
4290175|NCT00540124|4116006|B3|||Height||centimeters|Mean|167.3|167.3|Standard Deviation|4.6|4.6|||
4290176|NCT00540124|4116007|B2|||Height||centimeters|Mean|168.6|168.6|Standard Deviation|5.5|5.5|||
4290177|NCT00540124|4116008|B1|||Height||centimeters|Mean|168.6|168.6|Standard Deviation|5.2|5.2|||
4290178|NCT00540124|4116005|B4|||Postvoid Residual Volume (PRV)||milliliters|Mean|35.7|35.7|Standard Deviation|44.3|44.3|||
4290179|NCT00540124|4116006|B3|||Postvoid Residual Volume (PRV)||milliliters|Mean|42.0|42.0|Standard Deviation|59.6|59.6|||
4290180|NCT00540124|4116007|B2|||Postvoid Residual Volume (PRV)||milliliters|Mean|30.9|30.9|Standard Deviation|33.8|33.8|||
4290181|NCT00540124|4116008|B1|||Postvoid Residual Volume (PRV)||milliliters|Mean|34.4|34.4|Standard Deviation|35.7|35.7|||
4290182|NCT00540124|4116005|B4|Severe (IPSS ≥20)||Lower Urinary Tract Symptoms Severity|Severity was assessed through the International Prostate Symptom (IPSS) Total Score. The Total Score was obtained by combining the scores of the responses to 1 through 7 component questions. Each question is scored from 0-5 for a range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|48|48.0||||||
4290183|NCT00540124|4116006|B3|Severe (IPSS ≥20)||Lower Urinary Tract Symptoms Severity|Severity was assessed through the International Prostate Symptom (IPSS) Total Score. The Total Score was obtained by combining the scores of the responses to 1 through 7 component questions. Each question is scored from 0-5 for a range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|16|16.0||||||
4290184|NCT00540124|4116007|B2|Severe (IPSS ≥20)||Lower Urinary Tract Symptoms Severity|Severity was assessed through the International Prostate Symptom (IPSS) Total Score. The Total Score was obtained by combining the scores of the responses to 1 through 7 component questions. Each question is scored from 0-5 for a range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|16|16.0||||||
4290185|NCT00540124|4116008|B1|Severe (IPSS ≥20)||Lower Urinary Tract Symptoms Severity|Severity was assessed through the International Prostate Symptom (IPSS) Total Score. The Total Score was obtained by combining the scores of the responses to 1 through 7 component questions. Each question is scored from 0-5 for a range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|16|16.0||||||
4290186|NCT00540124|4116005|B4|Moderate (IPSS < 20)||Lower Urinary Tract Symptoms Severity|Severity was assessed through the International Prostate Symptom (IPSS) Total Score. The Total Score was obtained by combining the scores of the responses to 1 through 7 component questions. Each question is scored from 0-5 for a range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|103|103.0||||||
4290187|NCT00540124|4116006|B3|Moderate (IPSS < 20)||Lower Urinary Tract Symptoms Severity|Severity was assessed through the International Prostate Symptom (IPSS) Total Score. The Total Score was obtained by combining the scores of the responses to 1 through 7 component questions. Each question is scored from 0-5 for a range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|33|33.0||||||
4290188|NCT00540124|4116007|B2|Moderate (IPSS < 20)||Lower Urinary Tract Symptoms Severity|Severity was assessed through the International Prostate Symptom (IPSS) Total Score. The Total Score was obtained by combining the scores of the responses to 1 through 7 component questions. Each question is scored from 0-5 for a range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|35|35.0||||||
4290189|NCT00540124|4116008|B1|Moderate (IPSS < 20)||Lower Urinary Tract Symptoms Severity|Severity was assessed through the International Prostate Symptom (IPSS) Total Score. The Total Score was obtained by combining the scores of the responses to 1 through 7 component questions. Each question is scored from 0-5 for a range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|35|35.0||||||
4290190|NCT00540124|4116005|B4|Severe||Severity of Erectile Dysfunction (ED)|"Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study. Severity is determined from the International Index of Erectile Function Scores. Scores range from 0 (low or no erectile function) to 5 (high erectile function) on 6 questions (1-5, 15 of the IIEF). Total Erectile Function Domain scores range from 0 to 30. Severity is determined based on scores as follows:~Severe ED ≤10 Moderate ED 11-16 Mild ED 17-25 No ED >25"|participants|Number|12|12.0||||||
4290191|NCT00540124|4116006|B3|Severe||Severity of Erectile Dysfunction (ED)|"Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study. Severity is determined from the International Index of Erectile Function Scores. Scores range from 0 (low or no erectile function) to 5 (high erectile function) on 6 questions (1-5, 15 of the IIEF). Total Erectile Function Domain scores range from 0 to 30. Severity is determined based on scores as follows:~Severe ED ≤10 Moderate ED 11-16 Mild ED 17-25 No ED >25"|participants|Number|4|4.0||||||
4290192|NCT00540124|4116007|B2|Severe||Severity of Erectile Dysfunction (ED)|"Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study. Severity is determined from the International Index of Erectile Function Scores. Scores range from 0 (low or no erectile function) to 5 (high erectile function) on 6 questions (1-5, 15 of the IIEF). Total Erectile Function Domain scores range from 0 to 30. Severity is determined based on scores as follows:~Severe ED ≤10 Moderate ED 11-16 Mild ED 17-25 No ED >25"|participants|Number|3|3.0||||||
4290193|NCT00540124|4116008|B1|Severe||Severity of Erectile Dysfunction (ED)|"Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study. Severity is determined from the International Index of Erectile Function Scores. Scores range from 0 (low or no erectile function) to 5 (high erectile function) on 6 questions (1-5, 15 of the IIEF). Total Erectile Function Domain scores range from 0 to 30. Severity is determined based on scores as follows:~Severe ED ≤10 Moderate ED 11-16 Mild ED 17-25 No ED >25"|participants|Number|5|5.0||||||
4290211|NCT00540124|4116006|B3|Organic||Etiology of Erectile Dysfunction (ED)|Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study.|participants|Number|11|11.0||||||
4290243|NCT00540124|4116006|B3|Korea, Republic of||Region of Enrollment||participants|Number|49|49.0||||||
4290194|NCT00540124|4116005|B4|Moderate||Severity of Erectile Dysfunction (ED)|"Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study. Severity is determined from the International Index of Erectile Function Scores. Scores range from 0 (low or no erectile function) to 5 (high erectile function) on 6 questions (1-5, 15 of the IIEF). Total Erectile Function Domain scores range from 0 to 30. Severity is determined based on scores as follows:~Severe ED ≤10 Moderate ED 11-16 Mild ED 17-25 No ED >25"|participants|Number|26|26.0||||||
4290195|NCT00540124|4116006|B3|Moderate||Severity of Erectile Dysfunction (ED)|"Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study. Severity is determined from the International Index of Erectile Function Scores. Scores range from 0 (low or no erectile function) to 5 (high erectile function) on 6 questions (1-5, 15 of the IIEF). Total Erectile Function Domain scores range from 0 to 30. Severity is determined based on scores as follows:~Severe ED ≤10 Moderate ED 11-16 Mild ED 17-25 No ED >25"|participants|Number|7|7.0||||||
4290196|NCT00540124|4116007|B2|Moderate||Severity of Erectile Dysfunction (ED)|"Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study. Severity is determined from the International Index of Erectile Function Scores. Scores range from 0 (low or no erectile function) to 5 (high erectile function) on 6 questions (1-5, 15 of the IIEF). Total Erectile Function Domain scores range from 0 to 30. Severity is determined based on scores as follows:~Severe ED ≤10 Moderate ED 11-16 Mild ED 17-25 No ED >25"|participants|Number|5|5.0||||||
4290197|NCT00540124|4116008|B1|Moderate||Severity of Erectile Dysfunction (ED)|"Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study. Severity is determined from the International Index of Erectile Function Scores. Scores range from 0 (low or no erectile function) to 5 (high erectile function) on 6 questions (1-5, 15 of the IIEF). Total Erectile Function Domain scores range from 0 to 30. Severity is determined based on scores as follows:~Severe ED ≤10 Moderate ED 11-16 Mild ED 17-25 No ED >25"|participants|Number|14|14.0||||||
4290198|NCT00540124|4116005|B4|Mild||Severity of Erectile Dysfunction (ED)|"Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study. Severity is determined from the International Index of Erectile Function Scores. Scores range from 0 (low or no erectile function) to 5 (high erectile function) on 6 questions (1-5, 15 of the IIEF). Total Erectile Function Domain scores range from 0 to 30. Severity is determined based on scores as follows:~Severe ED ≤10 Moderate ED 11-16 Mild ED 17-25 No ED >25"|participants|Number|52|52.0||||||
4290199|NCT00540124|4116006|B3|Mild||Severity of Erectile Dysfunction (ED)|"Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study. Severity is determined from the International Index of Erectile Function Scores. Scores range from 0 (low or no erectile function) to 5 (high erectile function) on 6 questions (1-5, 15 of the IIEF). Total Erectile Function Domain scores range from 0 to 30. Severity is determined based on scores as follows:~Severe ED ≤10 Moderate ED 11-16 Mild ED 17-25 No ED >25"|participants|Number|13|13.0||||||
4290200|NCT00540124|4116007|B2|Mild||Severity of Erectile Dysfunction (ED)|"Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study. Severity is determined from the International Index of Erectile Function Scores. Scores range from 0 (low or no erectile function) to 5 (high erectile function) on 6 questions (1-5, 15 of the IIEF). Total Erectile Function Domain scores range from 0 to 30. Severity is determined based on scores as follows:~Severe ED ≤10 Moderate ED 11-16 Mild ED 17-25 No ED >25"|participants|Number|22|22.0||||||
4290201|NCT00540124|4116008|B1|Mild||Severity of Erectile Dysfunction (ED)|"Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study. Severity is determined from the International Index of Erectile Function Scores. Scores range from 0 (low or no erectile function) to 5 (high erectile function) on 6 questions (1-5, 15 of the IIEF). Total Erectile Function Domain scores range from 0 to 30. Severity is determined based on scores as follows:~Severe ED ≤10 Moderate ED 11-16 Mild ED 17-25 No ED >25"|participants|Number|17|17.0||||||
4290202|NCT00540124|4116005|B4|Unknown||Etiology of Erectile Dysfunction (ED)|Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study.|participants|Number|7|7.0||||||
4290203|NCT00540124|4116006|B3|Unknown||Etiology of Erectile Dysfunction (ED)|Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study.|participants|Number|1|1.0||||||
4290204|NCT00540124|4116007|B2|Unknown||Etiology of Erectile Dysfunction (ED)|Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study.|participants|Number|5|5.0||||||
4290205|NCT00540124|4116008|B1|Unknown||Etiology of Erectile Dysfunction (ED)|Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study.|participants|Number|1|1.0||||||
4290206|NCT00540124|4116005|B4|Mixed||Etiology of Erectile Dysfunction (ED)|Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study.|participants|Number|44|44.0||||||
4290207|NCT00540124|4116006|B3|Mixed||Etiology of Erectile Dysfunction (ED)|Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study.|participants|Number|12|12.0||||||
4290208|NCT00540124|4116007|B2|Mixed||Etiology of Erectile Dysfunction (ED)|Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study.|participants|Number|15|15.0||||||
4290209|NCT00540124|4116008|B1|Mixed||Etiology of Erectile Dysfunction (ED)|Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study.|participants|Number|17|17.0||||||
4290210|NCT00540124|4116005|B4|Organic||Etiology of Erectile Dysfunction (ED)|Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study.|participants|Number|37|37.0||||||
4290212|NCT00540124|4116007|B2|Organic||Etiology of Erectile Dysfunction (ED)|Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study.|participants|Number|10|10.0||||||
4290213|NCT00540124|4116008|B1|Organic||Etiology of Erectile Dysfunction (ED)|Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study.|participants|Number|16|16.0||||||
4290214|NCT00540124|4116005|B4|Psychogenic||Etiology of Erectile Dysfunction (ED)|Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study.|participants|Number|2|2.0||||||
4290215|NCT00540124|4116006|B3|Psychogenic||Etiology of Erectile Dysfunction (ED)|Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study.|participants|Number|0|0.0||||||
4290216|NCT00540124|4116007|B2|Psychogenic||Etiology of Erectile Dysfunction (ED)|Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study.|participants|Number|0|0.0||||||
4290217|NCT00540124|4116008|B1|Psychogenic||Etiology of Erectile Dysfunction (ED)|Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study.|participants|Number|2|2.0||||||
4290218|NCT00540124|4116005|B4|1 Year or More||Duration of Erectile Dysfunction (ED)|Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study.|participants|Number|70|70.0||||||
4290219|NCT00540124|4116006|B3|1 Year or More||Duration of Erectile Dysfunction (ED)|Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study.|participants|Number|18|18.0||||||
4290220|NCT00540124|4116007|B2|1 Year or More||Duration of Erectile Dysfunction (ED)|Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study.|participants|Number|23|23.0||||||
4290221|NCT00540124|4116008|B1|1 Year or More||Duration of Erectile Dysfunction (ED)|Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study.|participants|Number|29|29.0||||||
4290222|NCT00540124|4116005|B4|6 Months to < 1 Year||Duration of Erectile Dysfunction (ED)|Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study.|participants|Number|13|13.0||||||
4290223|NCT00540124|4116006|B3|6 Months to < 1 Year||Duration of Erectile Dysfunction (ED)|Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study.|participants|Number|5|5.0||||||
4290224|NCT00540124|4116007|B2|6 Months to < 1 Year||Duration of Erectile Dysfunction (ED)|Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study.|participants|Number|3|3.0||||||
4290225|NCT00540124|4116008|B1|6 Months to < 1 Year||Duration of Erectile Dysfunction (ED)|Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study.|participants|Number|5|5.0||||||
4290226|NCT00540124|4116005|B4|3 Months to < 6 Months||Duration of Erectile Dysfunction (ED)|Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study.|participants|Number|6|6.0||||||
4290227|NCT00540124|4116006|B3|3 Months to < 6 Months||Duration of Erectile Dysfunction (ED)|Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study.|participants|Number|1|1.0||||||
4290228|NCT00540124|4116007|B2|3 Months to < 6 Months||Duration of Erectile Dysfunction (ED)|Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study.|participants|Number|3|3.0||||||
4290229|NCT00540124|4116008|B1|3 Months to < 6 Months||Duration of Erectile Dysfunction (ED)|Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study.|participants|Number|2|2.0||||||
4290230|NCT00540124|4116005|B4|<3 Months||Duration of Erectile Dysfunction (ED)|Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study.|participants|Number|1|1.0||||||
4290231|NCT00540124|4116006|B3|<3 Months||Duration of Erectile Dysfunction (ED)|Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study.|participants|Number|0|0.0||||||
4290232|NCT00540124|4116007|B2|<3 Months||Duration of Erectile Dysfunction (ED)|Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study.|participants|Number|1|1.0||||||
4290233|NCT00540124|4116008|B1|<3 Months||Duration of Erectile Dysfunction (ED)|Because this measure applies only to participants with ED, the number of participants reported here will be less than the total number of participants in the study.|participants|Number|0|0.0||||||
4290234|NCT00540124|4116005|B4|No||Erectile Dysfunction (ED)||participants|Number|61|61.0||||||
4290235|NCT00540124|4116006|B3|No||Erectile Dysfunction (ED)||participants|Number|25|25.0||||||
4290236|NCT00540124|4116007|B2|No||Erectile Dysfunction (ED)||participants|Number|21|21.0||||||
4290237|NCT00540124|4116008|B1|No||Erectile Dysfunction (ED)||participants|Number|15|15.0||||||
4290238|NCT00540124|4116005|B4|Yes||Erectile Dysfunction (ED)||participants|Number|90|90.0||||||
4290239|NCT00540124|4116006|B3|Yes||Erectile Dysfunction (ED)||participants|Number|24|24.0||||||
4290240|NCT00540124|4116007|B2|Yes||Erectile Dysfunction (ED)||participants|Number|30|30.0||||||
4290241|NCT00540124|4116008|B1|Yes||Erectile Dysfunction (ED)||participants|Number|36|36.0||||||
4290242|NCT00540124|4116005|B4|Korea, Republic of||Region of Enrollment||participants|Number|151|151.0||||||
4290244|NCT00540124|4116007|B2|Korea, Republic of||Region of Enrollment||participants|Number|51|51.0||||||
4290245|NCT00540124|4116008|B1|Korea, Republic of||Region of Enrollment||participants|Number|51|51.0||||||
4290246|NCT00540124|4116005|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290247|NCT00540124|4116006|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290248|NCT00540124|4116007|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290249|NCT00540124|4116008|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290250|NCT00540124|4116005|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290251|NCT00540124|4116006|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290252|NCT00540124|4116007|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290253|NCT00540124|4116008|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290254|NCT00540124|4116005|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290255|NCT00540124|4116006|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290256|NCT00540124|4116007|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290257|NCT00540124|4116008|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290258|NCT00540124|4116005|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290259|NCT00540124|4116006|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290260|NCT00540124|4116007|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290261|NCT00540124|4116008|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290262|NCT00540124|4116005|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290263|NCT00540124|4116006|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290264|NCT00540124|4116007|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290265|NCT00540124|4116008|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290266|NCT00540124|4116005|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|151|151.0||||||
4290267|NCT00540124|4116006|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4290268|NCT00540124|4116007|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4290269|NCT00540124|4116008|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4290270|NCT00540124|4116005|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290271|NCT00540124|4116006|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290272|NCT00540124|4116007|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290273|NCT00540124|4116008|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290274|NCT00540124|4116005|B4||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4290275|NCT00540124|4116006|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4290276|NCT00540124|4116007|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4290277|NCT00540124|4116008|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4290278|NCT00540124|4116005|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4290279|NCT00540124|4116006|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4290280|NCT00540124|4116007|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4290281|NCT00540124|4116008|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4290282|NCT00540124|4116005|B4|||Age||years|Mean|61.6|61.6|Standard Deviation|6.6|6.6|||
4290283|NCT00540124|4116006|B3|||Age||years|Mean|61.5|61.5|Standard Deviation|6.4|6.4|||
4290284|NCT00540124|4116007|B2|||Age||years|Mean|61.2|61.2|Standard Deviation|6.6|6.6|||
4290285|NCT00540124|4116008|B1|||Age||years|Mean|62.2|62.2|Standard Deviation|6.8|6.8|||
4290286|NCT00540046|4116054|B3|||Gestational age||weeks|Mean|19.0|19.0|Full Range|||12.0|24.0|
4290287|NCT00540046|4116055|B2|||Gestational age||weeks|Mean|18.8|18.8|Full Range|||12.0|24.0|
4290288|NCT00540046|4116056|B1|||Gestational age||weeks|Mean|19.2|19.2|Full Range|||12.0|24.0|
4290289|NCT00540046|4116054|B3|Missing||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4290290|NCT00540046|4116055|B2|Missing||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4290291|NCT00540046|4116056|B1|Missing||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4290292|NCT00540046|4116054|B3|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4290293|NCT00540046|4116055|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4290294|NCT00540046|4116056|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4290295|NCT00540046|4116054|B3|Mixed||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4290296|NCT00540046|4116055|B2|Mixed||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4290297|NCT00540046|4116056|B1|Mixed||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4290298|NCT00540046|4116054|B3|Asian or South Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4290299|NCT00540046|4116055|B2|Asian or South Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4290300|NCT00540046|4116056|B1|Asian or South Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4290301|NCT00540046|4116054|B3|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4290302|NCT00540046|4116055|B2|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4290303|NCT00540046|4116056|B1|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4290304|NCT00540046|4116054|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
4290305|NCT00540046|4116055|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4290306|NCT00540046|4116056|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4290307|NCT00540046|4116054|B3|Black||Race/Ethnicity, Customized||participants|Number|100|100.0||||||
4290308|NCT00540046|4116055|B2|Black||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
4290309|NCT00540046|4116056|B1|Black||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
4290310|NCT00540046|4116054|B3|Female||Sex/Gender, Customized||participants|Number|215|215.0||||||
4290311|NCT00540046|4116055|B2|Female||Sex/Gender, Customized||participants|Number|111|111.0||||||
4290312|NCT00540046|4116056|B1|Female||Sex/Gender, Customized||participants|Number|104|104.0||||||
4290313|NCT00540046|4116054|B3|||Age||years|Mean|23.7|23.7|Full Range|||16.0|43.0|
4290314|NCT00540046|4116055|B2|||Age||years|Mean|23.4|23.4|Full Range|||16.0|43.0|
4290315|NCT00540046|4116056|B1|||Age||years|Mean|24|24.0|Full Range|||16.0|41.0|
4290316|NCT00540007|4116065|B3|United States||Region of Enrollment||Participants|Count of Participants|80|80.0||||||
4290317|NCT00540007|4116066|B2|United States||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
4290318|NCT00540007|4116067|B1|United States||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
4290319|NCT00540007|4116065|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4290320|NCT00540007|4116066|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4290321|NCT00540007|4116067|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4290322|NCT00540007|4116065|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4290323|NCT00540007|4116066|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4290324|NCT00540007|4116067|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4290325|NCT00540007|4116065|B3|||Age||years|Median|36|36.0|Full Range|||19.0|84.0|
4290326|NCT00540007|4116066|B2|||Age||years|Median|38|38.0|Full Range|||19.0|84.0|
4290327|NCT00540007|4116067|B1|||Age||years|Median|34|34.0|Full Range|||25.0|63.0|
4290328|NCT00539994|4116090|B4|Excluded from analysis||Efficacy population by carrier type (persistent vs intermittent)||participants|Number|8|8.0||||||
4290329|NCT00539994|4116091|B3|Excluded from analysis||Efficacy population by carrier type (persistent vs intermittent)||participants|Number|2|2.0||||||
4290330|NCT00539994|4116092|B2|Excluded from analysis||Efficacy population by carrier type (persistent vs intermittent)||participants|Number|1|1.0||||||
4290331|NCT00539994|4116093|B1|Excluded from analysis||Efficacy population by carrier type (persistent vs intermittent)||participants|Number|5|5.0||||||
4290332|NCT00539994|4116090|B4|Intermittent, Intent-to-Treat||Efficacy population by carrier type (persistent vs intermittent)||participants|Number|3|3.0||||||
4290333|NCT00539994|4116091|B3|Intermittent, Intent-to-Treat||Efficacy population by carrier type (persistent vs intermittent)||participants|Number|0|0.0||||||
4290334|NCT00539994|4116092|B2|Intermittent, Intent-to-Treat||Efficacy population by carrier type (persistent vs intermittent)||participants|Number|2|2.0||||||
4290335|NCT00539994|4116093|B1|Intermittent, Intent-to-Treat||Efficacy population by carrier type (persistent vs intermittent)||participants|Number|1|1.0||||||
4290336|NCT00539994|4116090|B4|Persistent, Intent-to-Treat||Efficacy population by carrier type (persistent vs intermittent)||participants|Number|46|46.0||||||
4290337|NCT00539994|4116091|B3|Persistent, Intent-to-Treat||Efficacy population by carrier type (persistent vs intermittent)||participants|Number|13|13.0||||||
4290338|NCT00539994|4116092|B2|Persistent, Intent-to-Treat||Efficacy population by carrier type (persistent vs intermittent)||participants|Number|16|16.0||||||
4290339|NCT00539994|4116093|B1|Persistent, Intent-to-Treat||Efficacy population by carrier type (persistent vs intermittent)||participants|Number|17|17.0||||||
4290340|NCT00539994|4116090|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
4290341|NCT00539994|4116091|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4290342|NCT00539994|4116092|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4290343|NCT00539994|4116093|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4290344|NCT00539994|4116090|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4290345|NCT00539994|4116091|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4290346|NCT00539994|4116092|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4290347|NCT00539994|4116093|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4290348|NCT00539994|4116090|B4|Mixed Race||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4290349|NCT00539994|4116091|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4290350|NCT00539994|4116092|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4290351|NCT00539994|4116093|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4290352|NCT00539994|4116090|B4|White||Race/Ethnicity, Customized||Participants|Number|34|34.0||||||
4290353|NCT00539994|4116091|B3|White||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4290354|NCT00539994|4116092|B2|White||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4290355|NCT00539994|4116093|B1|White||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4290356|NCT00539994|4116090|B4|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4290357|NCT00539994|4116091|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4290358|NCT00539994|4116092|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4290359|NCT00539994|4116093|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4290360|NCT00539994|4116090|B4|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4290361|NCT00539994|4116091|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4290362|NCT00539994|4116092|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4290363|NCT00539994|4116093|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4290364|NCT00539994|4116090|B4|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4290365|NCT00539994|4116091|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4290366|NCT00539994|4116092|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4290367|NCT00539994|4116093|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4290368|NCT00539994|4116090|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4290369|NCT00539994|4116091|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4290370|NCT00539994|4116092|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4290371|NCT00539994|4116093|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4290372|NCT00539994|4116090|B4||Male|Gender||Participants|Count of Participants|43|43.0||||||
4290373|NCT00539994|4116091|B3||Male|Gender||Participants|Count of Participants|13|13.0||||||
4290374|NCT00539994|4116092|B2||Male|Gender||Participants|Count of Participants|13|13.0||||||
4290375|NCT00539994|4116093|B1||Male|Gender||Participants|Count of Participants|17|17.0||||||
4290376|NCT00539994|4116090|B4||Female|Gender||Participants|Count of Participants|14|14.0||||||
4290377|NCT00539994|4116091|B3||Female|Gender||Participants|Count of Participants|2|2.0||||||
4290378|NCT00539994|4116092|B2||Female|Gender||Participants|Count of Participants|6|6.0||||||
4290379|NCT00539994|4116093|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
4290380|NCT00539994|4116090|B4|||Age||Years|Mean|33.6|33.6|Standard Deviation|11.36|11.36|||
4290381|NCT00539994|4116091|B3|||Age||Years|Mean|33.7|33.7|Standard Deviation|12.67|12.67|||
4290382|NCT00539994|4116092|B2|||Age||Years|Mean|35.8|35.8|Standard Deviation|11.16|11.16|||
4290383|NCT00539994|4116093|B1|||Age||Years|Mean|31.8|31.8|Standard Deviation|10.80|10.8|||
4290384|NCT00539942|4116132|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4290385|NCT00539942|4116133|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4290386|NCT00539942|4116134|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4290387|NCT00539942|4116132|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4290388|NCT00539942|4116133|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4290389|NCT00539942|4116134|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4290390|NCT00539942|4116132|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4290391|NCT00539942|4116133|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4290392|NCT00539942|4116134|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4290393|NCT00539942|4116132|B3|||Age||years|Mean|54|54.0|Standard Deviation|9|9.0|||
4290394|NCT00539942|4116133|B2|||Age||years|Mean|57|57.0|Standard Deviation|7|7.0|||
4290395|NCT00539942|4116134|B1|||Age||years|Mean|52|52.0|Standard Deviation|12|12.0|||
4290396|NCT00539942|4116132|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4290397|NCT00539942|4116133|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4290398|NCT00539942|4116134|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4290399|NCT00539942|4116132|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4290400|NCT00539942|4116133|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4290401|NCT00539942|4116134|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4290402|NCT00539942|4116132|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4290403|NCT00539942|4116133|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4290404|NCT00539942|4116134|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4290405|NCT00539864|4116143|B3|United States||Region of Enrollment||participants|Number|602|602.0||||||
4290406|NCT00539864|4116144|B2|United States||Region of Enrollment||participants|Number|302|302.0||||||
4290407|NCT00539864|4116145|B1|United States||Region of Enrollment||participants|Number|300|300.0||||||
4290408|NCT00539864|4116143|B3||Male|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4290409|NCT00539864|4116144|B2||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4290410|NCT00539864|4116145|B1||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4290411|NCT00539864|4116143|B3||Female|Sex: Female, Male||Participants|Count of Participants|379|379.0||||||
4290412|NCT00539864|4116144|B2||Female|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4290413|NCT00539864|4116145|B1||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4290414|NCT00539864|4116143|B3|||Age||years|Mean|55.8|55.8|Standard Deviation|3.67|3.67|||
4290415|NCT00539864|4116144|B2|||Age||years|Mean|55.7|55.7|Standard Deviation|3.64|3.64|||
4290416|NCT00539864|4116145|B1|||Age||years|Mean|55.9|55.9|Standard Deviation|3.71|3.71|||
4290417|NCT00539864|4116143|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4290418|NCT00539864|4116144|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4290419|NCT00539864|4116145|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4290420|NCT00539864|4116143|B3||Between 18 and 65 years|Age||Participants|Count of Participants|602|602.0||||||
4290421|NCT00539864|4116144|B2||Between 18 and 65 years|Age||Participants|Count of Participants|302|302.0||||||
4290422|NCT00539864|4116145|B1||Between 18 and 65 years|Age||Participants|Count of Participants|300|300.0||||||
4290423|NCT00539864|4116143|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4290424|NCT00539864|4116144|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4290425|NCT00539864|4116145|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4290426|NCT00539734|4116158|B1|Thailand||Region of Enrollment||participants|Number|26|26.0||||||
4290427|NCT00539734|4116158|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4290428|NCT00539734|4116158|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4290429|NCT00539734|4116158|B1|||Age||years|Mean|66.5|66.5|Standard Deviation|9.22|9.22|||
4290430|NCT00539734|4116158|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4290431|NCT00539734|4116158|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4290432|NCT00539734|4116158|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4290433|NCT00539695|4116163|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4290434|NCT00539695|4116163|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4290435|NCT00539695|4116163|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4290436|NCT00539695|4116163|B1|greater and equal 20 yrs||Age||years|Median|47.5|47.5|Inter-Quartile Range|||30.5|59.5|
4290437|NCT00539695|4116163|B1|less than 20 yrs||Age||years|Median|13|13.0|Inter-Quartile Range|||9.0|15.0|
4290438|NCT00539617|4116169|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4290439|NCT00539617|4116169|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4290440|NCT00539617|4116169|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4290441|NCT00539617|4116169|B1|||Age||years|Mean|54|54.0|Standard Deviation|12|12.0|||
4290442|NCT00539617|4116169|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4290443|NCT00539617|4116169|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4290444|NCT00539617|4116169|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4290445|NCT00539591|4116174|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4290446|NCT00539591|4116175|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4290447|NCT00539591|4116176|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4290448|NCT00539591|4116177|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4290449|NCT00539591|4116174|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4290450|NCT00539591|4116175|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4290451|NCT00539591|4116176|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4290452|NCT00539591|4116177|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4290453|NCT00539591|4116174|B4|||Age||years|Median|10.77|10.77|Full Range|2.4|2.4|2.4|22.1|
4290454|NCT00539591|4116175|B3|||Age||years|Median|18.4|18.4|Full Range|3.6|3.6|3.6|22.1|
4290455|NCT00539591|4116176|B2|||Age||years|Median|11.9|11.9|Full Range|3.96|3.96|3.96|19.89|
4290456|NCT00539591|4116177|B1|||Age||years|Median|10.3|10.3|Full Range|2.4|2.4|2.4|20.0|
4290457|NCT00539539|4116287|B3|Canada||Region of Enrollment||participants|Number|43|43.0||||||
4290458|NCT00539539|4116288|B2|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4290459|NCT00539539|4116289|B1|Canada||Region of Enrollment||participants|Number|38|38.0||||||
4290460|NCT00539539|4116287|B3|United States||Region of Enrollment||participants|Number|1543|1543.0||||||
4290461|NCT00539539|4116288|B2|United States||Region of Enrollment||participants|Number|766|766.0||||||
4290462|NCT00539539|4116289|B1|United States||Region of Enrollment||participants|Number|777|777.0||||||
4290463|NCT00539539|4116287|B3||Male|Sex: Female, Male||Participants|Count of Participants|1000|1000.0||||||
4290464|NCT00539539|4116288|B2||Male|Sex: Female, Male||Participants|Count of Participants|480|480.0||||||
4290465|NCT00539539|4116289|B1||Male|Sex: Female, Male||Participants|Count of Participants|520|520.0||||||
4290466|NCT00539539|4116287|B3||Female|Sex: Female, Male||Participants|Count of Participants|586|586.0||||||
4290467|NCT00539539|4116288|B2||Female|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
4290468|NCT00539539|4116289|B1||Female|Sex: Female, Male||Participants|Count of Participants|295|295.0||||||
4290469|NCT00539539|4116287|B3|||Age|Age available for 1171 participants; 585 on feedback arm; 586 on feedback off arm|years|Mean|66|66.0|Standard Deviation|17|17.0|||
4290470|NCT00539539|4116288|B2|||Age|Age available for 1171 participants; 585 on feedback arm; 586 on feedback off arm|years|Mean|66|66.0|Standard Deviation|17|17.0|||
4290471|NCT00539539|4116289|B1|||Age|Age available for 1171 participants; 585 on feedback arm; 586 on feedback off arm|years|Mean|65|65.0|Standard Deviation|17|17.0|||
4290472|NCT00539539|4116287|B3|>=65 years||Age|Age is available on 1171 participants; 585 on feedback on arm; 586 on the feedback off arm|participants|Number|608|608.0||||||
4290473|NCT00539539|4116288|B2|>=65 years||Age|Age is available on 1171 participants; 585 on feedback on arm; 586 on the feedback off arm|participants|Number|298|298.0||||||
4290474|NCT00539539|4116289|B1|>=65 years||Age|Age is available on 1171 participants; 585 on feedback on arm; 586 on the feedback off arm|participants|Number|310|310.0||||||
4290475|NCT00539539|4116287|B3|Between 18 and 65 years||Age|Age is available on 1171 participants; 585 on feedback on arm; 586 on the feedback off arm|participants|Number|563|563.0||||||
4290476|NCT00539539|4116288|B2|Between 18 and 65 years||Age|Age is available on 1171 participants; 585 on feedback on arm; 586 on the feedback off arm|participants|Number|288|288.0||||||
4290477|NCT00539539|4116289|B1|Between 18 and 65 years||Age|Age is available on 1171 participants; 585 on feedback on arm; 586 on the feedback off arm|participants|Number|275|275.0||||||
4290478|NCT00539539|4116287|B3|<=18 years||Age|Age is available on 1171 participants; 585 on feedback on arm; 586 on the feedback off arm|participants|Number|0|0.0||||||
4290479|NCT00539539|4116288|B2|<=18 years||Age|Age is available on 1171 participants; 585 on feedback on arm; 586 on the feedback off arm|participants|Number|0|0.0||||||
4290480|NCT00539539|4116289|B1|<=18 years||Age|Age is available on 1171 participants; 585 on feedback on arm; 586 on the feedback off arm|participants|Number|0|0.0||||||
4290481|NCT00539526|4116310|B4||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4290482|NCT00539526|4116311|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4290483|NCT00539526|4116312|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4290484|NCT00539526|4116313|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4290485|NCT00539526|4116310|B4||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4290486|NCT00539526|4116311|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4290487|NCT00539526|4116312|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4290488|NCT00539526|4116313|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4290489|NCT00539526|4116310|B4|||Age||years|Mean|67.3|67.3|Full Range|||52.0|81.0|
4290490|NCT00539526|4116311|B3|||Age||years|Mean|67.3|67.3|Full Range|||57.0|77.0|
4290491|NCT00539526|4116312|B2|||Age||years|Mean|65.4|65.4|Full Range|||52.0|78.0|
4290492|NCT00539526|4116313|B1|||Age||years|Mean|69.3|69.3|Full Range|||57.0|81.0|
4290493|NCT00539513|4116329|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4290494|NCT00539513|4116330|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4290495|NCT00539513|4116331|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4290496|NCT00539513|4116329|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4290497|NCT00539513|4116330|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4290498|NCT00539513|4116331|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4290499|NCT00539513|4116329|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4290500|NCT00539513|4116330|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4290501|NCT00539513|4116331|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4290502|NCT00539513|4116329|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4290503|NCT00539513|4116330|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4290504|NCT00539513|4116331|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4290505|NCT00539513|4116329|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4290506|NCT00539513|4116330|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4290507|NCT00539513|4116331|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4290508|NCT00539305|4116344|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4290509|NCT00539305|4116345|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4290510|NCT00539305|4116346|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4290511|NCT00539305|4116344|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4290512|NCT00539305|4116345|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4290513|NCT00539305|4116346|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4290514|NCT00539305|4116344|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4290515|NCT00539305|4116345|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4290516|NCT00539305|4116346|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4290517|NCT00539305|4116344|B3|||Age||years|Mean|70.5|70.5|Standard Deviation|8.2|8.2|||
4290518|NCT00539305|4116345|B2|||Age||years|Mean|70.0|70.0|Standard Deviation|7.7|7.7|||
4290519|NCT00539305|4116346|B1|||Age||years|Mean|71.2|71.2|Standard Deviation|9.1|9.1|||
4290520|NCT00539305|4116344|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4290521|NCT00539305|4116345|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4290522|NCT00539305|4116346|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4290523|NCT00539305|4116344|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4290524|NCT00539305|4116345|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4290525|NCT00539305|4116346|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4290526|NCT00539305|4116344|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4290527|NCT00539305|4116345|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4290528|NCT00539305|4116346|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4290529|NCT00539279|4116359|B3|||Global Neuropsychological Deficits (Standardized, Composite)|Among our battery of seven neuropsychological tests, we worked with our neuropsychologist to choose 13 key scales. We used a conversion system to equally weight areas where there were large deficits, even if there were only one or two deficits, to prevent such scores from being minimized among the large range of T scores for the other scales. We converted T scores as follows: >40 = 0; 35-39 = 1; 30-34 = 2; 25-29 = 3; 20-24 = 4; < 20 = 5. Higher scores mean a higher global cognitive deficit.|standardized units on a scale|Mean|.38|0.38|Standard Deviation|.38|0.38|||
4290575|NCT00539279|4116360|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290576|NCT00539279|4116361|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290577|NCT00539279|4116359|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
4290578|NCT00539279|4116360|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4290530|NCT00539279|4116360|B2|||Global Neuropsychological Deficits (Standardized, Composite)|Among our battery of seven neuropsychological tests, we worked with our neuropsychologist to choose 13 key scales. We used a conversion system to equally weight areas where there were large deficits, even if there were only one or two deficits, to prevent such scores from being minimized among the large range of T scores for the other scales. We converted T scores as follows: >40 = 0; 35-39 = 1; 30-34 = 2; 25-29 = 3; 20-24 = 4; < 20 = 5. Higher scores mean a higher global cognitive deficit.|standardized units on a scale|Mean|.42|0.42|Standard Deviation|.41|0.41|||
4290531|NCT00539279|4116361|B1|||Global Neuropsychological Deficits (Standardized, Composite)|Among our battery of seven neuropsychological tests, we worked with our neuropsychologist to choose 13 key scales. We used a conversion system to equally weight areas where there were large deficits, even if there were only one or two deficits, to prevent such scores from being minimized among the large range of T scores for the other scales. We converted T scores as follows: >40 = 0; 35-39 = 1; 30-34 = 2; 25-29 = 3; 20-24 = 4; < 20 = 5. Higher scores mean a higher global cognitive deficit.|standardized units on a scale|Mean|.32|0.32|Standard Deviation|.33|0.33|||
4290532|NCT00539279|4116359|B3|||Sheehan Disability Scale (SDS)|The SDS is a self-report questionnaire about functioning. There are 3 scored items (Work/School; Social Life; and Family Life/Home Responsibilities), each with response categories from 0 (zero; Not at All) to 10 (Extremely). Thus, the total score ranges from 0 to 30. Higher scores reflect lower (poorer) levels of functioning.|units on a scale|Mean|18.19|18.19|Standard Deviation|8.09|8.09|||
4290533|NCT00539279|4116360|B2|||Sheehan Disability Scale (SDS)|The SDS is a self-report questionnaire about functioning. There are 3 scored items (Work/School; Social Life; and Family Life/Home Responsibilities), each with response categories from 0 (zero; Not at All) to 10 (Extremely). Thus, the total score ranges from 0 to 30. Higher scores reflect lower (poorer) levels of functioning.|units on a scale|Mean|18.83|18.83|Standard Deviation|7.95|7.95|||
4290534|NCT00539279|4116361|B1|||Sheehan Disability Scale (SDS)|The SDS is a self-report questionnaire about functioning. There are 3 scored items (Work/School; Social Life; and Family Life/Home Responsibilities), each with response categories from 0 (zero; Not at All) to 10 (Extremely). Thus, the total score ranges from 0 to 30. Higher scores reflect lower (poorer) levels of functioning.|units on a scale|Mean|18.15|18.15|Standard Deviation|8.03|8.03|||
4290535|NCT00539279|4116359|B3|||State-Trait Anxiety Inventory State Scale (STAI-S)|"The STAI-S is a self-report questionnaire about state (present state) anxiety. There are 20 scored items, each with response categories from 1 (Not at All) to 4 (Very Much So). Some items (e.g., I feel calm) are reversed scored so that the total score appropriately reflects state anxiety. Thus, the total score ranges from 20 to 80. Higher scores reflect higher levels of state anxiety."|units on a scale|Mean|43.08|43.08|Standard Deviation|5.96|5.96|||
4290536|NCT00539279|4116360|B2|||State-Trait Anxiety Inventory State Scale (STAI-S)|"The STAI-S is a self-report questionnaire about state (present state) anxiety. There are 20 scored items, each with response categories from 1 (Not at All) to 4 (Very Much So). Some items (e.g., I feel calm) are reversed scored so that the total score appropriately reflects state anxiety. Thus, the total score ranges from 20 to 80. Higher scores reflect higher levels of state anxiety."|units on a scale|Mean|41.67|41.67|Standard Deviation|6.13|6.13|||
4290537|NCT00539279|4116361|B1|||State-Trait Anxiety Inventory State Scale (STAI-S)|"The STAI-S is a self-report questionnaire about state (present state) anxiety. There are 20 scored items, each with response categories from 1 (Not at All) to 4 (Very Much So). Some items (e.g., I feel calm) are reversed scored so that the total score appropriately reflects state anxiety. Thus, the total score ranges from 20 to 80. Higher scores reflect higher levels of state anxiety."|units on a scale|Mean|44.46|44.46|Standard Deviation|5.46|5.46|||
4290538|NCT00539279|4116359|B3|||Posttraumatic Cognitions Inventory (PTCI)|The PTCI is a self-report questionnaire about thoughts following traumatic events. There are 33 scored items, each with response categories from 1 (Totally Disagree) to 7 (Totally Agree), summed to create the total score. Thus, the total score ranges from 7 to 231. Higher scores reflect higher levels of negative cognitions.|units on a scale|Mean|3.45|3.45|Standard Deviation|1.13|1.13|||
4290539|NCT00539279|4116360|B2|||Posttraumatic Cognitions Inventory (PTCI)|The PTCI is a self-report questionnaire about thoughts following traumatic events. There are 33 scored items, each with response categories from 1 (Totally Disagree) to 7 (Totally Agree), summed to create the total score. Thus, the total score ranges from 7 to 231. Higher scores reflect higher levels of negative cognitions.|units on a scale|Mean|3.78|3.78|Standard Deviation|1.07|1.07|||
4290540|NCT00539279|4116361|B1|||Posttraumatic Cognitions Inventory (PTCI)|The PTCI is a self-report questionnaire about thoughts following traumatic events. There are 33 scored items, each with response categories from 1 (Totally Disagree) to 7 (Totally Agree), summed to create the total score. Thus, the total score ranges from 7 to 231. Higher scores reflect higher levels of negative cognitions.|units on a scale|Mean|3.14|3.14|Standard Deviation|1.07|1.07|||
4290541|NCT00539279|4116359|B3|||Clinician-Administered PTSD Scale Severity Score (CAPS)|The CAPS is a clinician-administered interview about PTSD symptoms. There are 17 scored items for PTSD severity, each with response categories from 0 (zero) to 4 separately for both frequency and severity. Thus, each item can receive a score of 0 (zero) to 8, and the total severity score ranges from 0 to 136. Higher scores reflect higher levels of PTSD symptoms. Scores of 60 or above are generally considered clinically significant, and changes of 10 points or more (e.g., between pre-treatment and post-treatment) are considered clinically significant changes.|units on a scale|Mean|67.11|67.11|Standard Deviation|17.83|17.83|||
4290542|NCT00539279|4116360|B2|||Clinician-Administered PTSD Scale Severity Score (CAPS)|The CAPS is a clinician-administered interview about PTSD symptoms. There are 17 scored items for PTSD severity, each with response categories from 0 (zero) to 4 separately for both frequency and severity. Thus, each item can receive a score of 0 (zero) to 8, and the total severity score ranges from 0 to 136. Higher scores reflect higher levels of PTSD symptoms. Scores of 60 or above are generally considered clinically significant, and changes of 10 points or more (e.g., between pre-treatment and post-treatment) are considered clinically significant changes.|units on a scale|Mean|72.98|72.98|Standard Deviation|14.64|14.64|||
4290579|NCT00539279|4116361|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4290580|NCT00539279|4116359|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4290581|NCT00539279|4116360|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4290543|NCT00539279|4116361|B1|||Clinician-Administered PTSD Scale Severity Score (CAPS)|The CAPS is a clinician-administered interview about PTSD symptoms. There are 17 scored items for PTSD severity, each with response categories from 0 (zero) to 4 separately for both frequency and severity. Thus, each item can receive a score of 0 (zero) to 8, and the total severity score ranges from 0 to 136. Higher scores reflect higher levels of PTSD symptoms. Scores of 60 or above are generally considered clinically significant, and changes of 10 points or more (e.g., between pre-treatment and post-treatment) are considered clinically significant changes.|units on a scale|Mean|66.02|66.02|Standard Deviation|14.85|14.85|||
4290544|NCT00539279|4116359|B3|||Patient Health Questionnaire Depression Subscale (PHQ-9)|"The PHQ-9 is a self-report questionnaire about depressive symptoms. There are 9 scored items, each with response categories from 0 (zero) to 3. Thus, the total score ranges from 0 to 27. Higher scores reflect higher levels of depressive symptoms, with interpretation as follows:~0 (zero) No depression 1-4 Minimal depression 5-9 Mild depression 10-14 Moderate depression 15-19 Moderately severe depression 20-27 Severe depression"|units on a scale|Mean|13.28|13.28|Standard Deviation|6.20|6.2|||
4290545|NCT00539279|4116360|B2|||Patient Health Questionnaire Depression Subscale (PHQ-9)|"The PHQ-9 is a self-report questionnaire about depressive symptoms. There are 9 scored items, each with response categories from 0 (zero) to 3. Thus, the total score ranges from 0 to 27. Higher scores reflect higher levels of depressive symptoms, with interpretation as follows:~0 (zero) No depression 1-4 Minimal depression 5-9 Mild depression 10-14 Moderate depression 15-19 Moderately severe depression 20-27 Severe depression"|units on a scale|Mean|15.12|15.12|Standard Deviation|5.17|5.17|||
4290546|NCT00539279|4116361|B1|||Patient Health Questionnaire Depression Subscale (PHQ-9)|"The PHQ-9 is a self-report questionnaire about depressive symptoms. There are 9 scored items, each with response categories from 0 (zero) to 3. Thus, the total score ranges from 0 to 27. Higher scores reflect higher levels of depressive symptoms, with interpretation as follows:~0 (zero) No depression 1-4 Minimal depression 5-9 Mild depression 10-14 Moderate depression 15-19 Moderately severe depression 20-27 Severe depression"|units on a scale|Mean|12.13|12.13|Standard Deviation|6.57|6.57|||
4290547|NCT00539279|4116359|B3|||PTSD Checklist (PCL)|The PTSD Checklist is a self-report questionnaire about PTSD symptoms. The version used in this study is called the PCL-S, which denotes a specific traumatic event for subjects to respond to. There are 17 items, each with response categories from 1 to 5. Thus, the total score ranges from 17 to 85. Higher scores reflect higher levels of PTSD symptoms, and a score of 50 or above is commonly interpreted to designate clinically significant PTSD symptoms.|units on a scale|Mean|58.28|58.28|Standard Deviation|12.36|12.36|||
4290548|NCT00539279|4116360|B2|||PTSD Checklist (PCL)|The PTSD Checklist is a self-report questionnaire about PTSD symptoms. The version used in this study is called the PCL-S, which denotes a specific traumatic event for subjects to respond to. There are 17 items, each with response categories from 1 to 5. Thus, the total score ranges from 17 to 85. Higher scores reflect higher levels of PTSD symptoms, and a score of 50 or above is commonly interpreted to designate clinically significant PTSD symptoms.|units on a scale|Mean|59.98|59.98|Standard Deviation|11.80|11.8|||
4290549|NCT00539279|4116361|B1|||PTSD Checklist (PCL)|The PTSD Checklist is a self-report questionnaire about PTSD symptoms. The version used in this study is called the PCL-S, which denotes a specific traumatic event for subjects to respond to. There are 17 items, each with response categories from 1 to 5. Thus, the total score ranges from 17 to 85. Higher scores reflect higher levels of PTSD symptoms, and a score of 50 or above is commonly interpreted to designate clinically significant PTSD symptoms.|units on a scale|Mean|57.46|57.46|Standard Deviation|12.66|12.66|||
4290550|NCT00539279|4116359|B3|United States||Region of Enrollment||participants|Number|87|87.0||||||
4290551|NCT00539279|4116360|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
4290552|NCT00539279|4116361|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4290553|NCT00539279|4116359|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4290554|NCT00539279|4116360|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4290555|NCT00539279|4116361|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4290556|NCT00539279|4116359|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290557|NCT00539279|4116360|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290558|NCT00539279|4116361|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290559|NCT00539279|4116359|B3||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
4290560|NCT00539279|4116360|B2||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4290561|NCT00539279|4116361|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4290562|NCT00539279|4116359|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4290563|NCT00539279|4116360|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4290564|NCT00539279|4116361|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4290565|NCT00539279|4116359|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290566|NCT00539279|4116360|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290567|NCT00539279|4116361|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290568|NCT00539279|4116359|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4290569|NCT00539279|4116360|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4290570|NCT00539279|4116361|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4290571|NCT00539279|4116359|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4290572|NCT00539279|4116360|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4290573|NCT00539279|4116361|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290574|NCT00539279|4116359|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290582|NCT00539279|4116361|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4290583|NCT00539279|4116359|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4290584|NCT00539279|4116360|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4290585|NCT00539279|4116361|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4290586|NCT00539279|4116359|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4290587|NCT00539279|4116360|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4290588|NCT00539279|4116361|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4290589|NCT00539279|4116359|B3|||Age||Years|Mean|65.54|65.54|Standard Deviation|5.69|5.69|||
4290590|NCT00539279|4116360|B2|||Age||Years|Mean|64.44|64.44|Standard Deviation|4.49|4.49|||
4290591|NCT00539279|4116361|B1|||Age||Years|Mean|66.51|66.51|Standard Deviation|6.21|6.21|||
4290592|NCT00539253|4116380|B1|United States||Region of Enrollment|Percentage of enhancement changes observed using Triple-phase MultiHance-enhanced MRI|Participants|Count of Participants|45|45.0||||||
4290593|NCT00539253|4116380|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4290594|NCT00539253|4116380|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4290595|NCT00539253|4116380|B1|||Age||years|Mean|60.9|60.9|Full Range|||43.0|73.0|
4290596|NCT00539240|4116385|B4|||Body Mass Index||kg/meter-squared|Mean|29.5|29.5|Standard Deviation|5.9|5.9|||
4290597|NCT00539240|4116386|B3|||Body Mass Index||kg/meter-squared|Mean|29.8|29.8|Standard Deviation|4.6|4.6|||
4290598|NCT00539240|4116387|B2|||Body Mass Index||kg/meter-squared|Mean|29.3|29.3|Standard Deviation|6.5|6.5|||
4290599|NCT00539240|4116388|B1|||Body Mass Index||kg/meter-squared|Mean|29.4|29.4|Standard Deviation|6.1|6.1|||
4290600|NCT00539240|4116385|B4|United States||Region of Enrollment||participants|Number|168|168.0||||||
4290601|NCT00539240|4116386|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
4290602|NCT00539240|4116387|B2|United States||Region of Enrollment||participants|Number|55|55.0||||||
4290603|NCT00539240|4116388|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
4290604|NCT00539240|4116385|B4||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4290605|NCT00539240|4116386|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4290606|NCT00539240|4116387|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4290607|NCT00539240|4116388|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4290608|NCT00539240|4116385|B4||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4290609|NCT00539240|4116386|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4290610|NCT00539240|4116387|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4290611|NCT00539240|4116388|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4290612|NCT00539240|4116385|B4|||Age||years|Mean|55.6|55.6|Standard Deviation|13.0|13.0|||
4290613|NCT00539240|4116386|B3|||Age||years|Mean|56|56.0|Standard Deviation|11.5|11.5|||
4290614|NCT00539240|4116387|B2|||Age||years|Mean|54.8|54.8|Standard Deviation|13.4|13.4|||
4290615|NCT00539240|4116388|B1|||Age||years|Mean|56|56.0|Standard Deviation|13.8|13.8|||
4290616|NCT00539188|4116407|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4290617|NCT00539188|4116408|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4290618|NCT00539188|4116409|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4290619|NCT00539188|4116407|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4290620|NCT00539188|4116408|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4290621|NCT00539188|4116409|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4290622|NCT00539188|4116407|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4290623|NCT00539188|4116408|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4290624|NCT00539188|4116409|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4290625|NCT00539188|4116407|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4290626|NCT00539188|4116408|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4290627|NCT00539188|4116409|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4290628|NCT00539188|4116407|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4290629|NCT00539188|4116408|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4290630|NCT00539188|4116409|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4290631|NCT00539110|4116422|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4290632|NCT00539110|4116423|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4290633|NCT00539110|4116424|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4290634|NCT00539110|4116422|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4290635|NCT00539110|4116423|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4290636|NCT00539110|4116424|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4290637|NCT00539110|4116422|B3|||Age||years|Mean|7.8|7.8|Standard Deviation|1.6|1.6|||
4290638|NCT00539110|4116423|B2|||Age||years|Mean|7.8|7.8|Standard Deviation|1.6|1.6|||
4290639|NCT00539110|4116424|B1|||Age||years|Mean|7.8|7.8|Standard Deviation|1.6|1.6|||
4290640|NCT00539032|4116431|B3|Saudi Arabia||Region of Enrollment||participants|Number|238|238.0||||||
4290641|NCT00539032|4116432|B2|Saudi Arabia||Region of Enrollment||participants|Number|85|85.0||||||
4290642|NCT00539032|4116433|B1|Saudi Arabia||Region of Enrollment||participants|Number|153|153.0||||||
4290643|NCT00539032|4116431|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4290644|NCT00539032|4116432|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4290645|NCT00539032|4116433|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4290646|NCT00539032|4116431|B3||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4290647|NCT00539032|4116432|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4290648|NCT00539032|4116433|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4290649|NCT00539032|4116431|B3|||Age||Years|Mean|6.26|6.26|Standard Deviation|0.89|0.89|||
4290650|NCT00539032|4116432|B2|||Age||Years|Mean|6.52|6.52|Standard Deviation|1.22|1.22|||
4290651|NCT00539032|4116433|B1|||Age||Years|Mean|6.12|6.12|Standard Deviation|0.60|0.6|||
4290652|NCT00539032|4116431|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4290653|NCT00539032|4116432|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4290654|NCT00539032|4116433|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4290655|NCT00539032|4116431|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4290656|NCT00539032|4116432|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4290657|NCT00539032|4116433|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4290658|NCT00539032|4116431|B3||<=18 years|Age||Participants|Count of Participants|238|238.0||||||
4290659|NCT00539032|4116432|B2||<=18 years|Age||Participants|Count of Participants|85|85.0||||||
4290660|NCT00539032|4116433|B1||<=18 years|Age||Participants|Count of Participants|153|153.0||||||
4290661|NCT00539006|4116444|B5|African American/African Heritage & White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4290662|NCT00539006|4116445|B4|African American/African Heritage & White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4290663|NCT00539006|4116446|B3|African American/African Heritage & White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4290664|NCT00539006|4116447|B2|African American/African Heritage & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4290665|NCT00539006|4116448|B1|African American/African Heritage & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4290666|NCT00539006|4116444|B5|African American/African-American Indian/Alaskan||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4290667|NCT00539006|4116445|B4|African American/African-American Indian/Alaskan||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4290668|NCT00539006|4116446|B3|African American/African-American Indian/Alaskan||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4290669|NCT00539006|4116447|B2|African American/African-American Indian/Alaskan||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4290670|NCT00539006|4116448|B1|African American/African-American Indian/Alaskan||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4290671|NCT00539006|4116444|B5|White||Race/Ethnicity, Customized||participants|Number|334|334.0||||||
4290672|NCT00539006|4116445|B4|White||Race/Ethnicity, Customized||participants|Number|80|80.0||||||
4290673|NCT00539006|4116446|B3|White||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
4290674|NCT00539006|4116447|B2|White||Race/Ethnicity, Customized||participants|Number|84|84.0||||||
4290675|NCT00539006|4116448|B1|White||Race/Ethnicity, Customized||participants|Number|88|88.0||||||
4290676|NCT00539006|4116444|B5|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4290677|NCT00539006|4116445|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4290678|NCT00539006|4116446|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4290679|NCT00539006|4116447|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4290680|NCT00539006|4116448|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4290681|NCT00539006|4116444|B5|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4290682|NCT00539006|4116445|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4290683|NCT00539006|4116446|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4290684|NCT00539006|4116447|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4290685|NCT00539006|4116448|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4290686|NCT00539006|4116444|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4290687|NCT00539006|4116445|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4290688|NCT00539006|4116446|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4290689|NCT00539006|4116447|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4290690|NCT00539006|4116448|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4290691|NCT00539006|4116444|B5|American/African Heritage||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4290692|NCT00539006|4116445|B4|American/African Heritage||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4290693|NCT00539006|4116446|B3|American/African Heritage||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4290694|NCT00539006|4116447|B2|American/African Heritage||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4290695|NCT00539006|4116448|B1|American/African Heritage||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4290696|NCT00539006|4116444|B5||Male|Gender||Participants|Count of Participants|115|115.0||||||
4290697|NCT00539006|4116445|B4||Male|Gender||Participants|Count of Participants|31|31.0||||||
4290698|NCT00539006|4116446|B3||Male|Gender||Participants|Count of Participants|28|28.0||||||
4290699|NCT00539006|4116447|B2||Male|Gender||Participants|Count of Participants|22|22.0||||||
4290700|NCT00539006|4116448|B1||Male|Gender||Participants|Count of Participants|34|34.0||||||
4290701|NCT00539006|4116444|B5||Female|Gender||Participants|Count of Participants|262|262.0||||||
4290702|NCT00539006|4116445|B4||Female|Gender||Participants|Count of Participants|60|60.0||||||
4290703|NCT00539006|4116446|B3||Female|Gender||Participants|Count of Participants|67|67.0||||||
4290704|NCT00539006|4116447|B2||Female|Gender||Participants|Count of Participants|73|73.0||||||
4290705|NCT00539006|4116448|B1||Female|Gender||Participants|Count of Participants|62|62.0||||||
4290706|NCT00539006|4116444|B5|||Age||years|Mean|39.9|39.9|Standard Deviation|13.33|13.33|||
4290707|NCT00539006|4116445|B4|||Age||years|Mean|39.7|39.7|Standard Deviation|14.32|14.32|||
4290708|NCT00539006|4116446|B3|||Age||years|Mean|40.5|40.5|Standard Deviation|12.29|12.29|||
4290709|NCT00539006|4116447|B2|||Age||years|Mean|42|42.0|Standard Deviation|12.48|12.48|||
4290710|NCT00539006|4116448|B1|||Age||years|Mean|37.3|37.3|Standard Deviation|13.89|13.89|||
4290711|NCT00538980|4116481|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4290712|NCT00538980|4116481|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290713|NCT00538980|4116481|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290714|NCT00538980|4116481|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4290715|NCT00538980|4116481|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290716|NCT00538980|4116481|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290717|NCT00538980|4116481|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290718|NCT00538980|4116481|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290719|NCT00538980|4116481|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290720|NCT00538980|4116481|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4290721|NCT00538980|4116481|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290722|NCT00538980|4116481|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4290723|NCT00538980|4116481|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4290724|NCT00538980|4116481|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4290725|NCT00538980|4116481|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4290726|NCT00538980|4116481|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4290727|NCT00538915|4116489|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4290728|NCT00538915|4116489|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4290729|NCT00538915|4116489|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4290730|NCT00538915|4116489|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4290731|NCT00538915|4116489|B1||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4290732|NCT00538902|4116493|B4|China||Region of Enrollment||participants|Number|302|302.0||||||
4290733|NCT00538902|4116494|B3|China||Region of Enrollment||participants|Number|121|121.0||||||
4290734|NCT00538902|4116495|B2|China||Region of Enrollment||participants|Number|121|121.0||||||
4290735|NCT00538902|4116496|B1|China||Region of Enrollment||participants|Number|60|60.0||||||
4290736|NCT00538902|4116493|B4||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4290737|NCT00538902|4116494|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4290738|NCT00538902|4116495|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4290739|NCT00538902|4116496|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4290740|NCT00538902|4116493|B4||Female|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
4290741|NCT00538902|4116494|B3||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4290742|NCT00538902|4116495|B2||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4290743|NCT00538902|4116496|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4290744|NCT00538902|4116493|B4||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4290745|NCT00538902|4116494|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4290746|NCT00538902|4116495|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4290747|NCT00538902|4116496|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4290748|NCT00538902|4116493|B4||Between 18 and 65 years|Age||Participants|Count of Participants|284|284.0||||||
4290749|NCT00538902|4116494|B3||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
4290750|NCT00538902|4116495|B2||Between 18 and 65 years|Age||Participants|Count of Participants|115|115.0||||||
4290751|NCT00538902|4116496|B1||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4290752|NCT00538902|4116493|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4290753|NCT00538902|4116494|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4290754|NCT00538902|4116495|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4290755|NCT00538902|4116496|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4290756|NCT00538863|4116533|B1|Maintenance period - Male||Sex/Gender, Customized||Participants|Number|128|128.0||||||
4290757|NCT00538863|4116533|B1|Maintenance period - Female||Sex/Gender, Customized||Participants|Number|141|141.0||||||
4290758|NCT00538863|4116533|B1|Titration period - Male||Sex/Gender, Customized||Participants|Number|112|112.0||||||
4290759|NCT00538863|4116533|B1|Titration period - Female||Sex/Gender, Customized||Participants|Number|117|117.0||||||
4290760|NCT00538863|4116533|B1|Maintenance Period||Age||years|Mean|53.6|53.6|Standard Deviation|12.2|12.2|||
4290761|NCT00538863|4116533|B1|Titration Period||Age||years|Mean|54.1|54.1|Standard Deviation|12.5|12.5|||
4290762|NCT00538850|4116539|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4290763|NCT00538850|4116539|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4290764|NCT00538850|4116539|B1|||Age||years|Mean|55.6|55.6|Standard Deviation|12.2|12.2|||
4290765|NCT00538824|4116553|B1|Free Kappa light Chain Myeloma||Immunoglobulins||participants|Number|3|3.0||||||
4290766|NCT00538824|4116553|B1|IgG lambda Myeloma||Immunoglobulins||participants|Number|2|2.0||||||
4290767|NCT00538824|4116553|B1|III||International Staging System Classification|Stage I: β2M < 3.5 mg/l and serum albumin ≥3.5 g/100 ml (median survival 62 months); stage II, neither stage I nor stage III (median survival 44 months) and stage III β2M ≥5.5 mg/l (median survival 29 months)|participants|Number|2|2.0||||||
4290768|NCT00538824|4116553|B1|II||International Staging System Classification|Stage I: β2M < 3.5 mg/l and serum albumin ≥3.5 g/100 ml (median survival 62 months); stage II, neither stage I nor stage III (median survival 44 months) and stage III β2M ≥5.5 mg/l (median survival 29 months)|participants|Number|3|3.0||||||
4290769|NCT00538824|4116553|B1|I||International Staging System Classification|Stage I: β2M < 3.5 mg/l and serum albumin ≥3.5 g/100 ml (median survival 62 months); stage II, neither stage I nor stage III (median survival 44 months) and stage III β2M ≥5.5 mg/l (median survival 29 months)|participants|Number|0|0.0||||||
4290770|NCT00538824|4116553|B1|3b||Durie-Salmon Classification|"Subjects were staged according to the Durie salmon Staging Classification System. Criteria for the staging system can be found here: https://www.themmrf.org/multiple-myeloma/prognosis/myeloma-stages/durie-salmon-staging-system/.~Staging classification describes multiple myeloma tumor burden; stage 1 is a low tumor burden/myeloma cell mass, stage 2 is intermediate tumor burden/cell mass, and stage 3 is a high tumor burden/cell mass."|participants|Number|0|0.0||||||
4290771|NCT00538824|4116553|B1|3a||Durie-Salmon Classification|"Subjects were staged according to the Durie salmon Staging Classification System. Criteria for the staging system can be found here: https://www.themmrf.org/multiple-myeloma/prognosis/myeloma-stages/durie-salmon-staging-system/.~Staging classification describes multiple myeloma tumor burden; stage 1 is a low tumor burden/myeloma cell mass, stage 2 is intermediate tumor burden/cell mass, and stage 3 is a high tumor burden/cell mass."|participants|Number|1|1.0||||||
4290772|NCT00538824|4116553|B1|2b||Durie-Salmon Classification|"Subjects were staged according to the Durie salmon Staging Classification System. Criteria for the staging system can be found here: https://www.themmrf.org/multiple-myeloma/prognosis/myeloma-stages/durie-salmon-staging-system/.~Staging classification describes multiple myeloma tumor burden; stage 1 is a low tumor burden/myeloma cell mass, stage 2 is intermediate tumor burden/cell mass, and stage 3 is a high tumor burden/cell mass."|participants|Number|1|1.0||||||
4290773|NCT00538824|4116553|B1|2a||Durie-Salmon Classification|"Subjects were staged according to the Durie salmon Staging Classification System. Criteria for the staging system can be found here: https://www.themmrf.org/multiple-myeloma/prognosis/myeloma-stages/durie-salmon-staging-system/.~Staging classification describes multiple myeloma tumor burden; stage 1 is a low tumor burden/myeloma cell mass, stage 2 is intermediate tumor burden/cell mass, and stage 3 is a high tumor burden/cell mass."|participants|Number|3|3.0||||||
4290774|NCT00538824|4116553|B1|1 (a or b)||Durie-Salmon Classification|"Subjects were staged according to the Durie salmon Staging Classification System. Criteria for the staging system can be found here: https://www.themmrf.org/multiple-myeloma/prognosis/myeloma-stages/durie-salmon-staging-system/.~Staging classification describes multiple myeloma tumor burden; stage 1 is a low tumor burden/myeloma cell mass, stage 2 is intermediate tumor burden/cell mass, and stage 3 is a high tumor burden/cell mass."|participants|Number|0|0.0||||||
4290775|NCT00538824|4116553|B1|||lactage dehydrogenase at baseline (U/L)||U/L|Median|177|177.0|Full Range|||150.0|225.0|
4290776|NCT00538824|4116553|B1|||Beta-2 microglobulin at baseline (in mg/L)||mg/dL|Median|4.1|4.1|Full Range|||1.5|5.6|
4290777|NCT00538824|4116553|B1|||serum creatinine at baseline (in mg/dL)||mg/dL|Median|3.8|3.8|Full Range|||3.1|4.2|
4290778|NCT00538824|4116553|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290779|NCT00538824|4116553|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290780|NCT00538824|4116553|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4290781|NCT00538824|4116553|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4290782|NCT00538824|4116553|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290783|NCT00538824|4116553|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290784|NCT00538824|4116553|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290785|NCT00538824|4116553|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290786|NCT00538824|4116553|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4290787|NCT00538824|4116553|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290788|NCT00538824|4116553|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4290789|NCT00538824|4116553|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4290790|NCT00538824|4116553|B1|||Age||years|Median|65|65.0|Full Range|||50.0|80.0|
4290791|NCT00538785|4116557|B3|Sweden||Region of Enrollment||participants|Number|21|21.0||||||
4290792|NCT00538785|4116558|B2|Sweden||Region of Enrollment||participants|Number|11|11.0||||||
4290793|NCT00538785|4116559|B1|Sweden||Region of Enrollment||participants|Number|10|10.0||||||
4290794|NCT00538785|4116557|B3|Germany||Region of Enrollment||participants|Number|66|66.0||||||
4290795|NCT00538785|4116558|B2|Germany||Region of Enrollment||participants|Number|31|31.0||||||
4290796|NCT00538785|4116559|B1|Germany||Region of Enrollment||participants|Number|35|35.0||||||
4290797|NCT00538785|4116557|B3|Bulgaria||Region of Enrollment||participants|Number|36|36.0||||||
4290798|NCT00538785|4116558|B2|Bulgaria||Region of Enrollment||participants|Number|18|18.0||||||
4290799|NCT00538785|4116559|B1|Bulgaria||Region of Enrollment||participants|Number|18|18.0||||||
4290800|NCT00538785|4116557|B3|Poland||Region of Enrollment||participants|Number|99|99.0||||||
4290801|NCT00538785|4116558|B2|Poland||Region of Enrollment||participants|Number|49|49.0||||||
4290802|NCT00538785|4116559|B1|Poland||Region of Enrollment||participants|Number|50|50.0||||||
4290803|NCT00538785|4116557|B3|Belgium||Region of Enrollment||participants|Number|54|54.0||||||
4290804|NCT00538785|4116558|B2|Belgium||Region of Enrollment||participants|Number|26|26.0||||||
4290805|NCT00538785|4116559|B1|Belgium||Region of Enrollment||participants|Number|28|28.0||||||
4290806|NCT00538785|4116557|B3|Canada||Region of Enrollment||participants|Number|49|49.0||||||
4290807|NCT00538785|4116558|B2|Canada||Region of Enrollment||participants|Number|22|22.0||||||
4290808|NCT00538785|4116559|B1|Canada||Region of Enrollment||participants|Number|27|27.0||||||
4290809|NCT00538785|4116557|B3|Hungary||Region of Enrollment||participants|Number|53|53.0||||||
4290810|NCT00538785|4116558|B2|Hungary||Region of Enrollment||participants|Number|26|26.0||||||
4290811|NCT00538785|4116559|B1|Hungary||Region of Enrollment||participants|Number|27|27.0||||||
4290812|NCT00538785|4116557|B3|Czech Republic||Region of Enrollment||participants|Number|74|74.0||||||
4290813|NCT00538785|4116558|B2|Czech Republic||Region of Enrollment||participants|Number|39|39.0||||||
4290814|NCT00538785|4116559|B1|Czech Republic||Region of Enrollment||participants|Number|35|35.0||||||
4290815|NCT00538785|4116557|B3|France||Region of Enrollment||participants|Number|28|28.0||||||
4290816|NCT00538785|4116558|B2|France||Region of Enrollment||participants|Number|15|15.0||||||
4290817|NCT00538785|4116559|B1|France||Region of Enrollment||participants|Number|13|13.0||||||
4290818|NCT00538785|4116557|B3|United Kingdom||Region of Enrollment||participants|Number|57|57.0||||||
4290819|NCT00538785|4116558|B2|United Kingdom||Region of Enrollment||participants|Number|31|31.0||||||
4290820|NCT00538785|4116559|B1|United Kingdom||Region of Enrollment||participants|Number|26|26.0||||||
4290821|NCT00538785|4116557|B3|Russian Federation||Region of Enrollment||participants|Number|66|66.0||||||
4290822|NCT00538785|4116558|B2|Russian Federation||Region of Enrollment||participants|Number|34|34.0||||||
4290823|NCT00538785|4116559|B1|Russian Federation||Region of Enrollment||participants|Number|32|32.0||||||
4290824|NCT00538785|4116557|B3|Israel||Region of Enrollment||participants|Number|132|132.0||||||
4290825|NCT00538785|4116558|B2|Israel||Region of Enrollment||participants|Number|65|65.0||||||
4290826|NCT00538785|4116559|B1|Israel||Region of Enrollment||participants|Number|67|67.0||||||
4290827|NCT00538785|4116557|B3|Austria||Region of Enrollment||participants|Number|14|14.0||||||
4290828|NCT00538785|4116558|B2|Austria||Region of Enrollment||participants|Number|7|7.0||||||
4290829|NCT00538785|4116559|B1|Austria||Region of Enrollment||participants|Number|7|7.0||||||
4290830|NCT00538785|4116557|B3|Lebanon||Region of Enrollment||participants|Number|128|128.0||||||
4290831|NCT00538785|4116558|B2|Lebanon||Region of Enrollment||participants|Number|66|66.0||||||
4290832|NCT00538785|4116559|B1|Lebanon||Region of Enrollment||participants|Number|62|62.0||||||
4290833|NCT00538785|4116557|B3|Spain||Region of Enrollment||participants|Number|57|57.0||||||
4290834|NCT00538785|4116558|B2|Spain||Region of Enrollment||participants|Number|26|26.0||||||
4290835|NCT00538785|4116559|B1|Spain||Region of Enrollment||participants|Number|31|31.0||||||
4290836|NCT00538785|4116557|B3|United States||Region of Enrollment||participants|Number|301|301.0||||||
4290837|NCT00538785|4116558|B2|United States||Region of Enrollment||participants|Number|146|146.0||||||
4290838|NCT00538785|4116559|B1|United States||Region of Enrollment||participants|Number|155|155.0||||||
4290839|NCT00538785|4116557|B3|Other||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
4290840|NCT00538785|4116558|B2|Other||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4290841|NCT00538785|4116559|B1|Other||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4290842|NCT00538785|4116557|B3|Asian||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4290843|NCT00538785|4116558|B2|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4290844|NCT00538785|4116559|B1|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4290845|NCT00538785|4116557|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4290846|NCT00538785|4116558|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4290847|NCT00538785|4116559|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4290848|NCT00538785|4116557|B3|Black||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4290849|NCT00538785|4116558|B2|Black||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4290850|NCT00538785|4116559|B1|Black||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4290851|NCT00538785|4116557|B3|White/Non-hispanic||Race/Ethnicity, Customized||participants|Number|1069|1069.0||||||
4290852|NCT00538785|4116558|B2|White/Non-hispanic||Race/Ethnicity, Customized||participants|Number|529|529.0||||||
4290853|NCT00538785|4116559|B1|White/Non-hispanic||Race/Ethnicity, Customized||participants|Number|540|540.0||||||
4290854|NCT00538785|4116557|B3||Male|Sex: Female, Male||Participants|Count of Participants|655|655.0||||||
4290855|NCT00538785|4116558|B2||Male|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
4290856|NCT00538785|4116559|B1||Male|Sex: Female, Male||Participants|Count of Participants|341|341.0||||||
4290857|NCT00538785|4116557|B3||Female|Sex: Female, Male||Participants|Count of Participants|580|580.0||||||
4290858|NCT00538785|4116558|B2||Female|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
4290859|NCT00538785|4116559|B1||Female|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
4290860|NCT00538785|4116557|B3|||Age||months|Mean|8.33|8.33|Standard Deviation|6.45|6.45|||
4290861|NCT00538785|4116558|B2|||Age||months|Mean|8.18|8.18|Standard Deviation|6.51|6.51|||
4290862|NCT00538785|4116559|B1|||Age||months|Mean|8.47|8.47|Standard Deviation|6.40|6.4|||
4290863|NCT00538733|4116581|B1|||Beta-2 microglobulin at baseline (in mg/L)||mg/L|Median|2.2|2.2|Full Range|||1.2|7.6|
4290864|NCT00538733|4116581|B1|||C-reactive protein at baseline (in mg/dL)||mg/dL|Median|0.225|0.225|Full Range|||0.03|10.3|
4290865|NCT00538733|4116581|B1|||lactage dehydrogenase at baseline (U/L)||U/L|Median|151|151.0|Full Range|||92.0|280.0|
4290866|NCT00538733|4116581|B1|||albumin at baseline (in mg/dL)||mg/dL|Median|3.5|3.5|Full Range|||2.2|4.4|
4290867|NCT00538733|4116581|B1|||absolute neutrophil count at baseline (in 1000/uL)||1000/uL|Median|3|3.0|Full Range|||0.9|3.4|
4290868|NCT00538733|4116581|B1|||platelet count at baseline (in 1000/uL)||1000/uL|Median|241|241.0|Full Range|||87.0|383.0|
4290869|NCT00538733|4116581|B1|||serum creatinine at baseline (in mg/dL)||mg/dL|Median|0.85|0.85|Full Range|||0.5|1.9|
4290870|NCT00538733|4116581|B1|||Hemoglobin at baseline (in g/dL)||g/dL|Median|11.95|11.95|Full Range|||9.1|15.4|
4290871|NCT00538733|4116581|B1|Stage III||International Staging System Classification|"Stage I ß2-M < 3.5 mg/dL and albumin =3.5 g/dL~Stage II Neither stage I nor stage III~Stage III ß2-M ≥ 5.5 mg/L"|participants|Number|4|4.0||||||
4290872|NCT00538733|4116581|B1|Stage II||International Staging System Classification|"Stage I ß2-M < 3.5 mg/dL and albumin =3.5 g/dL~Stage II Neither stage I nor stage III~Stage III ß2-M ≥ 5.5 mg/L"|participants|Number|13|13.0||||||
4290873|NCT00538733|4116581|B1|Stage I||International Staging System Classification|"Stage I ß2-M < 3.5 mg/dL and albumin =3.5 g/dL~Stage II Neither stage I nor stage III~Stage III ß2-M ≥ 5.5 mg/L"|participants|Number|9|9.0||||||
4290874|NCT00538733|4116581|B1|70%||karnofsky performance status|Normal, no complaints = 100%; Able to carry on normal activities. Minor signs or symptoms of disease = 90%; Normal activity with effort = 80%; Care for self. Unable to carry on normal activity or to do active work = 70%; Requires occasional assistance, but able to care for most of his needs= 60% Requires considerable assistance & frequent medical care = 50%; Disabled. Requires special care & assistance = 40%; Severely disabled. Hospitalization indicated though death nonimminent = 30%; Very Sick, hospitalization necessary. Active supportive treatment necessary = 20%; moribund =10%; dead = 0%|participants|Number|2|2.0||||||
4290875|NCT00538733|4116581|B1|80%||karnofsky performance status|Normal, no complaints = 100%; Able to carry on normal activities. Minor signs or symptoms of disease = 90%; Normal activity with effort = 80%; Care for self. Unable to carry on normal activity or to do active work = 70%; Requires occasional assistance, but able to care for most of his needs= 60% Requires considerable assistance & frequent medical care = 50%; Disabled. Requires special care & assistance = 40%; Severely disabled. Hospitalization indicated though death nonimminent = 30%; Very Sick, hospitalization necessary. Active supportive treatment necessary = 20%; moribund =10%; dead = 0%|participants|Number|12|12.0||||||
4290876|NCT00538733|4116581|B1|90% (or better)||karnofsky performance status|Normal, no complaints = 100%; Able to carry on normal activities. Minor signs or symptoms of disease = 90%; Normal activity with effort = 80%; Care for self. Unable to carry on normal activity or to do active work = 70%; Requires occasional assistance, but able to care for most of his needs= 60% Requires considerable assistance & frequent medical care = 50%; Disabled. Requires special care & assistance = 40%; Severely disabled. Hospitalization indicated though death nonimminent = 30%; Very Sick, hospitalization necessary. Active supportive treatment necessary = 20%; moribund =10%; dead = 0%|participants|Number|12|12.0||||||
4290877|NCT00538733|4116581|B1|light chain only myeloma||Immunoglobulins||participants|Number|8|8.0||||||
4290878|NCT00538733|4116581|B1|IgG myeloma||Immunoglobulins||participants|Number|15|15.0||||||
4290879|NCT00538733|4116581|B1|IgA myeloma||Immunoglobulins||participants|Number|3|3.0||||||
4290880|NCT00538733|4116581|B1|high risk||Cytogenetics|"Cytogenetic analysis was done on all patients to determine if they were of standard or high risk. Cytogenetics were performed on bone marrow cultures.~Standard risk was defined by the presence of one or more of the following on : t(11;14); hyperdiploidy; del 13q14 detected using florescence in situ hybridization (FISH); no abnormality High risk was defined by the presence of one or more of the following: del 17p; karyotype del 13q; amp 1q/del 1p; t(14;20); t(14;16); t(4;14)"|participants|Number|8|8.0||||||
4290881|NCT00538733|4116581|B1|standard risk||Cytogenetics|"Cytogenetic analysis was done on all patients to determine if they were of standard or high risk. Cytogenetics were performed on bone marrow cultures.~Standard risk was defined by the presence of one or more of the following on : t(11;14); hyperdiploidy; del 13q14 detected using florescence in situ hybridization (FISH); no abnormality High risk was defined by the presence of one or more of the following: del 17p; karyotype del 13q; amp 1q/del 1p; t(14;20); t(14;16); t(4;14)"|participants|Number|18|18.0||||||
4290882|NCT00538733|4116581|B1|Stage 3A||Durie-Salmon Classification|"The Durie Salmon Staging System was used to assess patients clinical status. Stage 1A is associated with a better outcome and a low tumor burden, stage 2A is associated with a intermediate outcome and tumor burden, and stage 3A is associated with a worse outcome and higher tumor burden. Patients are classified into each stage based on multiple criteria including hemoglobin and calcium values, disease burden, and renal function.~The Durie Salmon Staging System can be found here: https://www.themmrf.org/multiple-myeloma/prognosis/myeloma-stages/durie-salmon-staging-system/"|participants|Number|5|5.0||||||
4290883|NCT00538733|4116581|B1|Stage 2A||Durie-Salmon Classification|"The Durie Salmon Staging System was used to assess patients clinical status. Stage 1A is associated with a better outcome and a low tumor burden, stage 2A is associated with a intermediate outcome and tumor burden, and stage 3A is associated with a worse outcome and higher tumor burden. Patients are classified into each stage based on multiple criteria including hemoglobin and calcium values, disease burden, and renal function.~The Durie Salmon Staging System can be found here: https://www.themmrf.org/multiple-myeloma/prognosis/myeloma-stages/durie-salmon-staging-system/"|participants|Number|9|9.0||||||
4290884|NCT00538733|4116581|B1|Stage 1A||Durie-Salmon Classification|"The Durie Salmon Staging System was used to assess patients clinical status. Stage 1A is associated with a better outcome and a low tumor burden, stage 2A is associated with a intermediate outcome and tumor burden, and stage 3A is associated with a worse outcome and higher tumor burden. Patients are classified into each stage based on multiple criteria including hemoglobin and calcium values, disease burden, and renal function.~The Durie Salmon Staging System can be found here: https://www.themmrf.org/multiple-myeloma/prognosis/myeloma-stages/durie-salmon-staging-system/"|participants|Number|12|12.0||||||
4290885|NCT00538733|4116581|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4290886|NCT00538733|4116581|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290887|NCT00538733|4116581|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4290888|NCT00538733|4116581|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290889|NCT00538733|4116581|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290890|NCT00538733|4116581|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4290891|NCT00538733|4116581|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290892|NCT00538733|4116581|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4290893|NCT00538733|4116581|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4290894|NCT00538733|4116581|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4290895|NCT00538733|4116581|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4290896|NCT00538733|4116581|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4290897|NCT00538733|4116581|B1|||Age||years|Median|61|61.0|Full Range|||40.0|82.0|
4290898|NCT00538642|4116588|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4290899|NCT00538642|4116589|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4290900|NCT00538642|4116590|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4290901|NCT00538642|4116588|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4290902|NCT00538642|4116589|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4290903|NCT00538642|4116590|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4290904|NCT00538642|4116588|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4290905|NCT00538642|4116589|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4290906|NCT00538642|4116590|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4290907|NCT00538642|4116588|B3|||Age||years|Mean|40.25|40.25|Standard Deviation|8.63|8.63|||
4290908|NCT00538642|4116589|B2|||Age||years|Mean|41.43|41.43|Standard Deviation|8.46|8.46|||
4290909|NCT00538642|4116590|B1|||Age||years|Mean|38.6|38.6|Standard Deviation|9.05|9.05|||
4290910|NCT00538642|4116588|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4290911|NCT00538642|4116589|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4290912|NCT00538642|4116590|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4290913|NCT00538642|4116588|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4290914|NCT00538642|4116589|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4290915|NCT00538642|4116590|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4290916|NCT00538642|4116588|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4290917|NCT00538642|4116589|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4290918|NCT00538642|4116590|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4290919|NCT00538629|4116631|B1|Unspecified||Sex/Gender, Customized||participants|Number|2|2.0||||||
4290920|NCT00538629|4116631|B1|Female||Sex/Gender, Customized||participants|Number|271|271.0||||||
4290921|NCT00538629|4116631|B1|Male||Sex/Gender, Customized||participants|Number|198|198.0||||||
4290922|NCT00538629|4116631|B1|>=65 years||Age, Customized||participants|Number|23|23.0||||||
4290923|NCT00538629|4116631|B1|45-64 years||Age, Customized||participants|Number|152|152.0||||||
4290924|NCT00538629|4116631|B1|18-44 years||Age, Customized||participants|Number|294|294.0||||||
4290925|NCT00538629|4116631|B1|<18 years||Age, Customized||participants|Number|2|2.0||||||
4290926|NCT00538616|4116676|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4290927|NCT00538616|4116677|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4290928|NCT00538616|4116678|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4290929|NCT00538616|4116676|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4290930|NCT00538616|4116677|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4290931|NCT00538616|4116678|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4290932|NCT00538616|4116676|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4290933|NCT00538616|4116677|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4290934|NCT00538616|4116678|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4290935|NCT00538616|4116676|B3|||Age||years|Mean|41.5|41.5|Standard Deviation|6.0|6.0|||
4290936|NCT00538616|4116677|B2|||Age||years|Mean|55|55.0|Standard Deviation|8.6|8.6|||
4290937|NCT00538616|4116678|B1|||Age||years|Mean|33|33.0|Standard Deviation|5.6|5.6|||
4290938|NCT00538616|4116676|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4290939|NCT00538616|4116677|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4290940|NCT00538616|4116678|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4290941|NCT00538616|4116676|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4290942|NCT00538616|4116677|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4290943|NCT00538616|4116678|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4290944|NCT00538616|4116676|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4290945|NCT00538616|4116677|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4290946|NCT00538616|4116678|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4290947|NCT00538590|4116685|B3|Germany||Region of Enrollment||participants|Number|20|20.0||||||
4290948|NCT00538590|4116686|B2|Germany||Region of Enrollment||participants|Number|10|10.0||||||
4290949|NCT00538590|4116687|B1|Germany||Region of Enrollment||participants|Number|10|10.0||||||
4290950|NCT00538590|4116685|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4290951|NCT00538590|4116686|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4290952|NCT00538590|4116687|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4290953|NCT00538590|4116685|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4290954|NCT00538590|4116686|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4290955|NCT00538590|4116687|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4290956|NCT00538590|4116685|B3|||Age||years|Mean|62.8|62.8|Standard Deviation|9.5|9.5|||
4290957|NCT00538590|4116686|B2|||Age||years|Mean|64.9|64.9|Standard Deviation|8.6|8.6|||
4290958|NCT00538590|4116687|B1|||Age||years|Mean|60.6|60.6|Standard Deviation|9.4|9.4|||
4290959|NCT00538590|4116685|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4290960|NCT00538590|4116686|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4290961|NCT00538590|4116687|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4290962|NCT00538590|4116685|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4290963|NCT00538590|4116686|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4290964|NCT00538590|4116687|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4290965|NCT00538590|4116685|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4290966|NCT00538590|4116686|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4290967|NCT00538590|4116687|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4290968|NCT00538512|4116702|B4|United States||Region of Enrollment||participants|Number|1952|1952.0||||||
4290969|NCT00538512|4116703|B3|United States||Region of Enrollment||participants|Number|325|325.0||||||
4290970|NCT00538512|4116704|B2|United States||Region of Enrollment||participants|Number|813|813.0||||||
4290971|NCT00538512|4116705|B1|United States||Region of Enrollment||participants|Number|814|814.0||||||
4290972|NCT00538512|4116702|B4||Male|Sex: Female, Male||Participants|Count of Participants|738|738.0||||||
4290973|NCT00538512|4116703|B3||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4290974|NCT00538512|4116704|B2||Male|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
4290975|NCT00538512|4116705|B1||Male|Sex: Female, Male||Participants|Count of Participants|320|320.0||||||
4290976|NCT00538512|4116702|B4||Female|Sex: Female, Male||Participants|Count of Participants|1214|1214.0||||||
4290977|NCT00538512|4116703|B3||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4290978|NCT00538512|4116704|B2||Female|Sex: Female, Male||Participants|Count of Participants|519|519.0||||||
4290979|NCT00538512|4116705|B1||Female|Sex: Female, Male||Participants|Count of Participants|494|494.0||||||
4290980|NCT00538512|4116702|B4|||Age||years|Mean|23.3|23.3|Standard Deviation|7.4|7.4|||
4290981|NCT00538512|4116703|B3|||Age||years|Mean|22.9|22.9|Standard Deviation|6.7|6.7|||
4290982|NCT00538512|4116704|B2|||Age||years|Mean|23.5|23.5|Standard Deviation|7.7|7.7|||
4290983|NCT00538512|4116705|B1|||Age||years|Mean|23.2|23.2|Standard Deviation|7.4|7.4|||
4290984|NCT00538512|4116702|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4290985|NCT00538512|4116703|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4290986|NCT00538512|4116704|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4290987|NCT00538512|4116705|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4290988|NCT00538512|4116702|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1952|1952.0||||||
4290989|NCT00538512|4116703|B3||Between 18 and 65 years|Age||Participants|Count of Participants|325|325.0||||||
4290990|NCT00538512|4116704|B2||Between 18 and 65 years|Age||Participants|Count of Participants|813|813.0||||||
4290991|NCT00538512|4116705|B1||Between 18 and 65 years|Age||Participants|Count of Participants|814|814.0||||||
4290992|NCT00538512|4116702|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4290993|NCT00538512|4116703|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4290994|NCT00538512|4116704|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4290995|NCT00538512|4116705|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4290996|NCT00538473|4116724|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4290997|NCT00538473|4116725|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4290998|NCT00538473|4116726|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4290999|NCT00538473|4116724|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4291000|NCT00538473|4116725|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4291001|NCT00538473|4116726|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4291002|NCT00538473|4116724|B3|||Age||Years|Mean|73.15|73.15|Standard Deviation|4.93|4.93|||
4291003|NCT00538473|4116725|B2|||Age||Years|Mean|73.2|73.2|Standard Deviation|5.34|5.34|||
4291004|NCT00538473|4116726|B1|||Age||Years|Mean|73.1|73.1|Standard Deviation|4.53|4.53|||
4291005|NCT00538434|4116759|B5||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4291006|NCT00538434|4116760|B4||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4291007|NCT00538434|4116761|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4291008|NCT00538434|4116762|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4291009|NCT00538434|4116763|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4291010|NCT00538434|4116759|B5||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4291011|NCT00538434|4116760|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4291012|NCT00538434|4116761|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4291013|NCT00538434|4116762|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4291014|NCT00538434|4116763|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4291015|NCT00538434|4116759|B5|12 to < 19 years||Age, Customized||participants|Number|127|127.0||||||
4291016|NCT00538434|4116760|B4|12 to < 19 years||Age, Customized||participants|Number|32|32.0||||||
4291017|NCT00538434|4116761|B3|12 to < 19 years||Age, Customized||participants|Number|30|30.0||||||
4291018|NCT00538434|4116762|B2|12 to < 19 years||Age, Customized||participants|Number|31|31.0||||||
4291019|NCT00538434|4116763|B1|12 to < 19 years||Age, Customized||participants|Number|34|34.0||||||
4291020|NCT00538434|4116759|B5|5 to < 12 years||Age, Customized||participants|Number|99|99.0||||||
4291021|NCT00538434|4116760|B4|5 to < 12 years||Age, Customized||participants|Number|25|25.0||||||
4291022|NCT00538434|4116761|B3|5 to < 12 years||Age, Customized||participants|Number|27|27.0||||||
4291023|NCT00538434|4116762|B2|5 to < 12 years||Age, Customized||participants|Number|26|26.0||||||
4291024|NCT00538434|4116763|B1|5 to < 12 years||Age, Customized||participants|Number|21|21.0||||||
4291025|NCT00538434|4116759|B5|||Age||years|Mean|11.9|11.9|Standard Deviation|3.95|3.95|||
4291026|NCT00538434|4116760|B4|||Age||years|Mean|11.9|11.9|Standard Deviation|4.17|4.17|||
4291027|NCT00538434|4116761|B3|||Age||years|Mean|11.5|11.5|Standard Deviation|4.04|4.04|||
4291028|NCT00538434|4116762|B2|||Age||years|Mean|11.8|11.8|Standard Deviation|3.82|3.82|||
4291029|NCT00538434|4116763|B1|||Age||years|Mean|12.3|12.3|Standard Deviation|3.83|3.83|||
4291030|NCT00538304|4116788|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4291031|NCT00538304|4116789|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4291032|NCT00538304|4116790|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4291033|NCT00538304|4116788|B3||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4291034|NCT00538304|4116789|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4291035|NCT00538304|4116790|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4291036|NCT00538304|4116788|B3|> 65 years||Age, Customized||participants|Number|113|113.0||||||
4291037|NCT00538304|4116789|B2|> 65 years||Age, Customized||participants|Number|37|37.0||||||
4291038|NCT00538304|4116790|B1|> 65 years||Age, Customized||participants|Number|76|76.0||||||
4291039|NCT00538304|4116788|B3|Between 45 and 65 years||Age, Customized||participants|Number|98|98.0||||||
4291040|NCT00538304|4116789|B2|Between 45 and 65 years||Age, Customized||participants|Number|32|32.0||||||
4291041|NCT00538304|4116790|B1|Between 45 and 65 years||Age, Customized||participants|Number|66|66.0||||||
4291042|NCT00538304|4116788|B3|< 45 years||Age, Customized||participants|Number|11|11.0||||||
4291043|NCT00538304|4116789|B2|< 45 years||Age, Customized||participants|Number|2|2.0||||||
4291044|NCT00538304|4116790|B1|< 45 years||Age, Customized||participants|Number|9|9.0||||||
4291045|NCT00538291|4116807|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4291046|NCT00538291|4116807|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4291047|NCT00538291|4116807|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4291048|NCT00538291|4116807|B1|||Age||years|Median|61|61.0|Full Range|||23.0|77.0|
4291049|NCT00538213|4116811|B4||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4291050|NCT00538213|4116812|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4291051|NCT00538213|4116813|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4291052|NCT00538213|4116814|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4291053|NCT00538213|4116811|B4||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4291054|NCT00538213|4116812|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4291055|NCT00538213|4116813|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4291056|NCT00538213|4116814|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4291057|NCT00538213|4116811|B4|||Age||Years|Mean|58.69|58.69|Standard Deviation|20.30|20.3|||
4291058|NCT00538213|4116812|B3|||Age||Years|Mean|27.4|27.4|Standard Deviation|6.08|6.08|||
4291059|NCT00538213|4116813|B2|||Age||Years|Mean|71.2|71.2|Standard Deviation|3.47|3.47|||
4291060|NCT00538213|4116814|B1|||Age||Years|Mean|71.2|71.2|Standard Deviation|3.07|3.07|||
4291061|NCT00537979|4116863|B3|Mexico||Region of Enrollment||participants|Number|147|147.0||||||
4291062|NCT00537979|4116864|B2|Mexico||Region of Enrollment||participants|Number|109|109.0||||||
4291063|NCT00537979|4116865|B1|Mexico||Region of Enrollment||participants|Number|38|38.0||||||
4291064|NCT00537979|4116863|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4291065|NCT00537979|4116864|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4291066|NCT00537979|4116865|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4291067|NCT00537979|4116863|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4291068|NCT00537979|4116864|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4291069|NCT00537979|4116865|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4291070|NCT00537979|4116863|B3|||Age||years|Mean|44.39|44.39|Standard Deviation|17.47|17.47|||
4291071|NCT00537979|4116864|B2|||Age||years|Mean|44.89|44.89|Standard Deviation|17.91|17.91|||
4291072|NCT00537979|4116865|B1|||Age||years|Mean|43.79|43.79|Standard Deviation|16.36|16.36|||
4291073|NCT00537940|4116880|B3||Male|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
4291074|NCT00537940|4116881|B2||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4291075|NCT00537940|4116882|B1||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4291076|NCT00537940|4116880|B3||Female|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
4291077|NCT00537940|4116881|B2||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4291078|NCT00537940|4116882|B1||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4291079|NCT00537940|4116880|B3|||Age||years|Mean|35.1|35.1|Standard Deviation|13.0|13.0|||
4291080|NCT00537940|4116881|B2|||Age||years|Mean|35.3|35.3|Standard Deviation|12.9|12.9|||
4291081|NCT00537940|4116882|B1|||Age||years|Mean|34.9|34.9|Standard Deviation|13.0|13.0|||
4291082|NCT00537823|4116905|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4291083|NCT00537823|4116906|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4291084|NCT00537823|4116907|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4291085|NCT00537823|4116905|B3||Male|Gender||Participants|Count of Participants|5|5.0||||||
4291086|NCT00537823|4116906|B2||Male|Gender||Participants|Count of Participants|1|1.0||||||
4291087|NCT00537823|4116907|B1||Male|Gender||Participants|Count of Participants|4|4.0||||||
4291088|NCT00537823|4116905|B3||Female|Gender||Participants|Count of Participants|4|4.0||||||
4291089|NCT00537823|4116906|B2||Female|Gender||Participants|Count of Participants|1|1.0||||||
4291090|NCT00537823|4116907|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
4291091|NCT00537823|4116905|B3|||Age||years|Median|62|62.0|Full Range|||44.0|77.0|
4291092|NCT00537823|4116906|B2|||Age||years|Median|62|62.0|Full Range|||47.0|77.0|
4291093|NCT00537823|4116907|B1|||Age||years|Median|62|62.0|Full Range|||44.0|70.0|
4291094|NCT00537810|4116930|B5|||Age at onset of Binge Eating Disorder (BED)||years|Mean|26.2|26.2|Standard Deviation|12.5|12.5|||
4291095|NCT00537810|4116931|B4|||Age at onset of Binge Eating Disorder (BED)||years|Mean|29.1|29.1|Standard Deviation|13.1|13.1|||
4291096|NCT00537810|4116932|B3|||Age at onset of Binge Eating Disorder (BED)||years|Mean|25.7|25.7|Standard Deviation|15.1|15.1|||
4291097|NCT00537810|4116933|B2|||Age at onset of Binge Eating Disorder (BED)||years|Mean|25.5|25.5|Standard Deviation|11.1|11.1|||
4291098|NCT00537810|4116934|B1|||Age at onset of Binge Eating Disorder (BED)||years|Mean|25.7|25.7|Standard Deviation|11.2|11.2|||
4291099|NCT00537810|4116930|B5|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4291100|NCT00537810|4116931|B4|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4291101|NCT00537810|4116932|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4291102|NCT00537810|4116933|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4291103|NCT00537810|4116934|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4291104|NCT00537810|4116930|B5|Hispanic-American||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4291105|NCT00537810|4116931|B4|Hispanic-American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4291106|NCT00537810|4116932|B3|Hispanic-American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4291107|NCT00537810|4116933|B2|Hispanic-American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4291108|NCT00537810|4116934|B1|Hispanic-American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4291109|NCT00537810|4116930|B5|African-American||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4291110|NCT00537810|4116931|B4|African-American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4291111|NCT00537810|4116932|B3|African-American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4291112|NCT00537810|4116933|B2|African-American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4291113|NCT00537810|4116934|B1|African-American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4291114|NCT00537810|4116930|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4291115|NCT00537810|4116931|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4291116|NCT00537810|4116932|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4291117|NCT00537810|4116933|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4291118|NCT00537810|4116934|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4291119|NCT00537810|4116930|B5||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4291120|NCT00537810|4116931|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4291121|NCT00537810|4116932|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4291122|NCT00537810|4116933|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4291123|NCT00537810|4116934|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4291124|NCT00537810|4116930|B5||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4291125|NCT00537810|4116931|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4291126|NCT00537810|4116932|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4291127|NCT00537810|4116933|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4291128|NCT00537810|4116934|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4291129|NCT00537810|4116930|B5|||Age||years|Mean|44.2|44.2|Standard Deviation|11.1|11.1|||
4291130|NCT00537810|4116931|B4|||Age||years|Mean|45.6|45.6|Standard Deviation|9.4|9.4|||
4291131|NCT00537810|4116932|B3|||Age||years|Mean|45.7|45.7|Standard Deviation|12.4|12.4|||
4291132|NCT00537810|4116933|B2|||Age||years|Mean|43.2|43.2|Standard Deviation|12.4|12.4|||
4291133|NCT00537810|4116934|B1|||Age||years|Mean|41.2|41.2|Standard Deviation|10.3|10.3|||
4291134|NCT00537771|4116951|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4291135|NCT00537771|4116952|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4291136|NCT00537771|4116953|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4291137|NCT00537771|4116951|B3||Female|Sex: Female, Male||Participants|Count of Participants|353|353.0||||||
4291138|NCT00537771|4116952|B2||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4291139|NCT00537771|4116953|B1||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4291140|NCT00537771|4116951|B3|||Age||years|Mean|59.6|59.6|Standard Deviation|8.31|8.31|||
4291141|NCT00537771|4116952|B2|||Age||years|Mean|59.4|59.4|Standard Deviation|8.84|8.84|||
4291142|NCT00537771|4116953|B1|||Age||years|Mean|59.7|59.7|Standard Deviation|7.77|7.77|||
4291143|NCT00537745|4116964|B1|||% days w/1+Interlock test failures|The describes the percent of days in the 90 days preceding study screening that the subject had at least 1 interlock test failure.|percent of days|Mean|3.1|3.1|Standard Deviation|4.4|4.4|||
4291144|NCT00537745|4116964|B1|||Average Drinks/day||Standard Drinks|Mean|3.0|3.0|Standard Deviation|1.8|1.8|||
4291145|NCT00537745|4116964|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4291146|NCT00537745|4116964|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4291147|NCT00537745|4116964|B1|||Age||years|Mean|43.14|43.14|Standard Deviation|11.08|11.08|||
4291148|NCT00537680|4116969|B4|United States||Region of Enrollment||participants|Number|70|70.0||||||
4291149|NCT00537680|4116970|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4291150|NCT00537680|4116971|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4291151|NCT00537680|4116972|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4291152|NCT00537680|4116969|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4291153|NCT00537680|4116970|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4291154|NCT00537680|4116971|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4291155|NCT00537680|4116972|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4291156|NCT00537680|4116969|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4291157|NCT00537680|4116970|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4291158|NCT00537680|4116971|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4291159|NCT00537680|4116972|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4291160|NCT00537680|4116969|B4|||Age||years|Mean|13.68|13.68|Standard Deviation|2.76|2.76|||
4291161|NCT00537680|4116970|B3|||Age||years|Mean|13.69|13.69|Standard Deviation|2.77|2.77|||
4291162|NCT00537680|4116971|B2|||Age||years|Mean|13.44|13.44|Standard Deviation|3.03|3.03|||
4291163|NCT00537680|4116972|B1|||Age||years|Mean|13.93|13.93|Standard Deviation|2.54|2.54|||
4291164|NCT00537680|4116969|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4291165|NCT00537680|4116970|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4291166|NCT00537680|4116971|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4291167|NCT00537680|4116972|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4291168|NCT00537680|4116969|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4291169|NCT00537680|4116970|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4291170|NCT00537680|4116971|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4291171|NCT00537680|4116972|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4291172|NCT00537680|4116969|B4||<=18 years|Age||Participants|Count of Participants|70|70.0||||||
4291173|NCT00537680|4116970|B3||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
4291174|NCT00537680|4116971|B2||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
4291175|NCT00537680|4116972|B1||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
4291176|NCT00537511|4116982|B1|Non-caucasian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4291177|NCT00537511|4116982|B1|Caucasian (White)||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4291178|NCT00537511|4116982|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4291179|NCT00537511|4116982|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4291180|NCT00537511|4116982|B1|||Age||years|Mean|63.9|63.9|Standard Deviation|8.76|8.76|||
4291181|NCT00537485|4117007|B3|Japan||Region of Enrollment||participants|Number|176|176.0||||||
4291182|NCT00537485|4117008|B2|Japan||Region of Enrollment||participants|Number|88|88.0||||||
4291183|NCT00537485|4117009|B1|Japan||Region of Enrollment||participants|Number|88|88.0||||||
4291184|NCT00537485|4117007|B3||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4291185|NCT00537485|4117008|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4291186|NCT00537485|4117009|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4291187|NCT00537485|4117007|B3||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4291188|NCT00537485|4117008|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4291189|NCT00537485|4117009|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4291190|NCT00537485|4117007|B3|||Age||years|Mean|65.6|65.6|Standard Deviation|8.0|8.0|||
4291191|NCT00537485|4117008|B2|||Age||years|Mean|66.2|66.2|Standard Deviation|7.9|7.9|||
4291192|NCT00537485|4117009|B1|||Age||years|Mean|65.1|65.1|Standard Deviation|8.1|8.1|||
4291193|NCT00537485|4117007|B3||>=65 years|Age||Participants|Count of Participants|105|105.0||||||
4291194|NCT00537485|4117008|B2||>=65 years|Age||Participants|Count of Participants|53|53.0||||||
4291195|NCT00537485|4117009|B1||>=65 years|Age||Participants|Count of Participants|52|52.0||||||
4291458|NCT00537303|4117194|B2|||Age||years|Mean|58.3|58.3|Standard Deviation|8.54|8.54|||
4291196|NCT00537485|4117007|B3||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4291197|NCT00537485|4117008|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4291198|NCT00537485|4117009|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4291199|NCT00537485|4117007|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4291200|NCT00537485|4117008|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4291201|NCT00537485|4117009|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4291202|NCT00537407|4117034|B6|United States||Region of Enrollment||participants|Number|50|50.0||||||
4291203|NCT00537407|4117035|B5|United States||Region of Enrollment||participants|Number|10|10.0||||||
4291204|NCT00537407|4117036|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
4291205|NCT00537407|4117037|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4291206|NCT00537407|4117038|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4291207|NCT00537407|4117039|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4291208|NCT00537407|4117034|B6||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4291209|NCT00537407|4117035|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4291210|NCT00537407|4117036|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4291211|NCT00537407|4117037|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4291212|NCT00537407|4117038|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4291213|NCT00537407|4117039|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4291214|NCT00537407|4117034|B6||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4291215|NCT00537407|4117035|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4291216|NCT00537407|4117036|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4291217|NCT00537407|4117037|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4291218|NCT00537407|4117038|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4291219|NCT00537407|4117039|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4291220|NCT00537407|4117034|B6|||Age||years|Mean|51.0|51.0|Standard Deviation|8.09|8.09|||
4291221|NCT00537407|4117035|B5|||Age||years|Mean|52.8|52.8|Standard Deviation|6.51|6.51|||
4291222|NCT00537407|4117036|B4|||Age||years|Mean|48.5|48.5|Standard Deviation|9.87|9.87|||
4291223|NCT00537407|4117037|B3|||Age||years|Mean|49.9|49.9|Standard Deviation|10.71|10.71|||
4291224|NCT00537407|4117038|B2|||Age||years|Mean|52.6|52.6|Standard Deviation|5.94|5.94|||
4291225|NCT00537407|4117039|B1|||Age||years|Mean|51.4|51.4|Standard Deviation|6.62|6.62|||
4291226|NCT00537407|4117034|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4291227|NCT00537407|4117035|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4291228|NCT00537407|4117036|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4291229|NCT00537407|4117037|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4291230|NCT00537407|4117038|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4291231|NCT00537407|4117039|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4291232|NCT00537407|4117034|B6||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4291233|NCT00537407|4117035|B5||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4291234|NCT00537407|4117036|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4291235|NCT00537407|4117037|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4291236|NCT00537407|4117038|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4291237|NCT00537407|4117039|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4291238|NCT00537407|4117034|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4291239|NCT00537407|4117035|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4291240|NCT00537407|4117036|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4291241|NCT00537407|4117037|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4291242|NCT00537407|4117038|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4291243|NCT00537407|4117039|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4291244|NCT00537394|4117080|B4|||Plasma HIV-1 RNA, continuous||log10 copies/mL|Median|4.2|4.2|Inter-Quartile Range|||3.6|4.6|
4291245|NCT00537394|4117081|B3|||Plasma HIV-1 RNA, continuous||log10 copies/mL|Median|4.4|4.4|Inter-Quartile Range|||4.1|4.8|
4291246|NCT00537394|4117082|B2|||Plasma HIV-1 RNA, continuous||log10 copies/mL|Median|4.2|4.2|Inter-Quartile Range|||3.6|4.6|
4291247|NCT00537394|4117083|B1|||Plasma HIV-1 RNA, continuous||log10 copies/mL|Median|4.2|4.2|Inter-Quartile Range|||3.6|4.7|
4291248|NCT00537394|4117080|B4|||CD4 count, continuous||cells/mm^3|Mean|236.9|236.9|Standard Deviation|194.2|194.2|||
4291249|NCT00537394|4117081|B3|||CD4 count, continuous||cells/mm^3|Mean|154.8|154.8|Standard Deviation|170.1|170.1|||
4291250|NCT00537394|4117082|B2|||CD4 count, continuous||cells/mm^3|Mean|245.6|245.6|Standard Deviation|195.1|195.1|||
4291251|NCT00537394|4117083|B1|||CD4 count, continuous||cells/mm^3|Mean|252.3|252.3|Standard Deviation|194.9|194.9|||
4291252|NCT00537394|4117080|B4|United States||Region of Enrollment||participants|Number|413|413.0||||||
4291253|NCT00537394|4117081|B3|United States||Region of Enrollment||participants|Number|53|53.0||||||
4291254|NCT00537394|4117082|B2|United States||Region of Enrollment||participants|Number|179|179.0||||||
4291255|NCT00537394|4117083|B1|United States||Region of Enrollment||participants|Number|181|181.0||||||
4291256|NCT00537394|4117080|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4291257|NCT00537394|4117081|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4291258|NCT00537394|4117082|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4291259|NCT00537394|4117083|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4291260|NCT00537394|4117080|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4291261|NCT00537394|4117081|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4291262|NCT00537394|4117082|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4291263|NCT00537394|4117083|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4291264|NCT00537394|4117080|B4||White|Race (NIH/OMB)||Participants|Count of Participants|204|204.0||||||
4291265|NCT00537394|4117081|B3||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4291266|NCT00537394|4117082|B2||White|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
4291267|NCT00537394|4117083|B1||White|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
4291268|NCT00537394|4117080|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|173|173.0||||||
4291269|NCT00537394|4117081|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4291270|NCT00537394|4117082|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4291271|NCT00537394|4117083|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
4291272|NCT00537394|4117080|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4291273|NCT00537394|4117081|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4291274|NCT00537394|4117082|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4291275|NCT00537394|4117083|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4291276|NCT00537394|4117080|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4291277|NCT00537394|4117081|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4291278|NCT00537394|4117082|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4291279|NCT00537394|4117083|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4291280|NCT00537394|4117080|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4291281|NCT00537394|4117081|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4291282|NCT00537394|4117082|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4291283|NCT00537394|4117083|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4291284|NCT00537394|4117080|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4291285|NCT00537394|4117081|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4291286|NCT00537394|4117082|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4291287|NCT00537394|4117083|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4291288|NCT00537394|4117080|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|311|311.0||||||
4291289|NCT00537394|4117081|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4291290|NCT00537394|4117082|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
4291291|NCT00537394|4117083|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|141|141.0||||||
4291292|NCT00537394|4117080|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
4291293|NCT00537394|4117081|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4291294|NCT00537394|4117082|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4291295|NCT00537394|4117083|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4291296|NCT00537394|4117080|B4||Male|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
4291297|NCT00537394|4117081|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4291298|NCT00537394|4117082|B2||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4291299|NCT00537394|4117083|B1||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4291300|NCT00537394|4117080|B4||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4291301|NCT00537394|4117081|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4291302|NCT00537394|4117082|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4291303|NCT00537394|4117083|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4291304|NCT00537394|4117080|B4|||Age||years|Mean|44.3|44.3|Standard Deviation|11.2|11.2|||
4291305|NCT00537394|4117081|B3|||Age||years|Mean|43.1|43.1|Standard Deviation|10.7|10.7|||
4291306|NCT00537394|4117082|B2|||Age||years|Mean|44.1|44.1|Standard Deviation|11.7|11.7|||
4291307|NCT00537394|4117083|B1|||Age||years|Mean|44.7|44.7|Standard Deviation|10.8|10.8|||
4291308|NCT00537394|4117080|B4||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4291309|NCT00537394|4117081|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4291310|NCT00537394|4117082|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4291311|NCT00537394|4117083|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4291312|NCT00537394|4117080|B4||Between 18 and 65 years|Age||Participants|Count of Participants|391|391.0||||||
4291313|NCT00537394|4117081|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4291314|NCT00537394|4117082|B2||Between 18 and 65 years|Age||Participants|Count of Participants|168|168.0||||||
4291315|NCT00537394|4117083|B1||Between 18 and 65 years|Age||Participants|Count of Participants|173|173.0||||||
4291316|NCT00537394|4117080|B4||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
4291317|NCT00537394|4117081|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4291318|NCT00537394|4117082|B2||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4291319|NCT00537394|4117083|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4291320|NCT00537381|4117119|B3|UNITED STATES||Region of Enrollment||participants|Number|4|4.0||||||
4291321|NCT00537381|4117120|B2|UNITED STATES||Region of Enrollment||participants|Number|3|3.0||||||
4291322|NCT00537381|4117121|B1|UNITED STATES||Region of Enrollment||participants|Number|1|1.0||||||
4291323|NCT00537381|4117119|B3|UNITED KINGDOM||Region of Enrollment||participants|Number|2|2.0||||||
4291324|NCT00537381|4117120|B2|UNITED KINGDOM||Region of Enrollment||participants|Number|1|1.0||||||
4291325|NCT00537381|4117121|B1|UNITED KINGDOM||Region of Enrollment||participants|Number|1|1.0||||||
4291326|NCT00537381|4117119|B3|SOUTH AFRICA||Region of Enrollment||participants|Number|1|1.0||||||
4291327|NCT00537381|4117120|B2|SOUTH AFRICA||Region of Enrollment||participants|Number|0|0.0||||||
4291328|NCT00537381|4117121|B1|SOUTH AFRICA||Region of Enrollment||participants|Number|1|1.0||||||
4291329|NCT00537381|4117119|B3|RUSSIAN FEDERATION||Region of Enrollment||participants|Number|16|16.0||||||
4291330|NCT00537381|4117120|B2|RUSSIAN FEDERATION||Region of Enrollment||participants|Number|12|12.0||||||
4291331|NCT00537381|4117121|B1|RUSSIAN FEDERATION||Region of Enrollment||participants|Number|4|4.0||||||
4291332|NCT00537381|4117119|B3|POLAND||Region of Enrollment||participants|Number|23|23.0||||||
4291333|NCT00537381|4117120|B2|POLAND||Region of Enrollment||participants|Number|10|10.0||||||
4291334|NCT00537381|4117121|B1|POLAND||Region of Enrollment||participants|Number|13|13.0||||||
4291335|NCT00537381|4117119|B3|NETHERLANDS||Region of Enrollment||participants|Number|7|7.0||||||
4291336|NCT00537381|4117120|B2|NETHERLANDS||Region of Enrollment||participants|Number|5|5.0||||||
4291337|NCT00537381|4117121|B1|NETHERLANDS||Region of Enrollment||participants|Number|2|2.0||||||
4291338|NCT00537381|4117119|B3|INDIA||Region of Enrollment||participants|Number|21|21.0||||||
4291339|NCT00537381|4117120|B2|INDIA||Region of Enrollment||participants|Number|10|10.0||||||
4291340|NCT00537381|4117121|B1|INDIA||Region of Enrollment||participants|Number|11|11.0||||||
4291341|NCT00537381|4117119|B3|GERMANY||Region of Enrollment||participants|Number|33|33.0||||||
4291342|NCT00537381|4117120|B2|GERMANY||Region of Enrollment||participants|Number|14|14.0||||||
4291343|NCT00537381|4117121|B1|GERMANY||Region of Enrollment||participants|Number|19|19.0||||||
4291344|NCT00537381|4117119|B3|BELGIUM||Region of Enrollment||participants|Number|19|19.0||||||
4291345|NCT00537381|4117120|B2|BELGIUM||Region of Enrollment||participants|Number|9|9.0||||||
4291346|NCT00537381|4117121|B1|BELGIUM||Region of Enrollment||participants|Number|10|10.0||||||
4291347|NCT00537381|4117119|B3|AUSTRIA||Region of Enrollment||participants|Number|5|5.0||||||
4291348|NCT00537381|4117120|B2|AUSTRIA||Region of Enrollment||participants|Number|2|2.0||||||
4291349|NCT00537381|4117121|B1|AUSTRIA||Region of Enrollment||participants|Number|3|3.0||||||
4291350|NCT00537381|4117119|B3||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4291351|NCT00537381|4117120|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4291352|NCT00537381|4117121|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4291353|NCT00537381|4117119|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4291354|NCT00537381|4117120|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4291355|NCT00537381|4117121|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4291356|NCT00537381|4117119|B3|||Age||Years|Mean|66.7|66.7|Standard Deviation|8.13|8.13|||
4291357|NCT00537381|4117120|B2|||Age||Years|Mean|66.3|66.3|Standard Deviation|7.51|7.51|||
4291358|NCT00537381|4117121|B1|||Age||Years|Mean|67.2|67.2|Standard Deviation|8.74|8.74|||
4291359|NCT00537329|4117142|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4291360|NCT00537329|4117142|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4291361|NCT00537329|4117142|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|18.5|18.5|||
4291362|NCT00537329|4117142|B1|≥ 65 years||Age, Customized||participants|Number|18|18.0||||||
4291363|NCT00537329|4117142|B1|Between 45 and 64 years||Age, Customized||participants|Number|15|15.0||||||
4291364|NCT00537329|4117142|B1|Between 18 and 44 years||Age, Customized||participants|Number|10|10.0||||||
4291365|NCT00537316|4117156|B7||Male|Sex: Female, Male|Baseline characteristics for Part 2 are presented for the direct entry participants only: 1 participant randomized to the maintenance IFX/AZA group, 1 participant randomized to the intermittent IFX/AZA group, and 1 participant randomized to the intermittent IFX group. No participants were directly enrolled into the maintenance IFX group in Part 2 of the study.|Participants|Count of Participants|124|124.0||||||
4291366|NCT00537316|4117157|B6||Male|Sex: Female, Male|Baseline characteristics for Part 2 are presented for the direct entry participants only: 1 participant randomized to the maintenance IFX/AZA group, 1 participant randomized to the intermittent IFX/AZA group, and 1 participant randomized to the intermittent IFX group. No participants were directly enrolled into the maintenance IFX group in Part 2 of the study.|Participants|Count of Participants|0|0.0||||||
4291367|NCT00537316|4117158|B5||Male|Sex: Female, Male|Baseline characteristics for Part 2 are presented for the direct entry participants only: 1 participant randomized to the maintenance IFX/AZA group, 1 participant randomized to the intermittent IFX/AZA group, and 1 participant randomized to the intermittent IFX group. No participants were directly enrolled into the maintenance IFX group in Part 2 of the study.|Participants|Count of Participants|0|0.0||||||
4291459|NCT00537303|4117195|B1|||Age||years|Mean|58.3|58.3|Standard Deviation|8.29|8.29|||
4291368|NCT00537316|4117159|B4||Male|Sex: Female, Male|Baseline characteristics for Part 2 are presented for the direct entry participants only: 1 participant randomized to the maintenance IFX/AZA group, 1 participant randomized to the intermittent IFX/AZA group, and 1 participant randomized to the intermittent IFX group. No participants were directly enrolled into the maintenance IFX group in Part 2 of the study.|Participants|Count of Participants|1|1.0||||||
4291369|NCT00537316|4117160|B3||Male|Sex: Female, Male|Baseline characteristics for Part 2 are presented for the direct entry participants only: 1 participant randomized to the maintenance IFX/AZA group, 1 participant randomized to the intermittent IFX/AZA group, and 1 participant randomized to the intermittent IFX group. No participants were directly enrolled into the maintenance IFX group in Part 2 of the study.|Participants|Count of Participants|48|48.0||||||
4291370|NCT00537316|4117161|B2||Male|Sex: Female, Male|Baseline characteristics for Part 2 are presented for the direct entry participants only: 1 participant randomized to the maintenance IFX/AZA group, 1 participant randomized to the intermittent IFX/AZA group, and 1 participant randomized to the intermittent IFX group. No participants were directly enrolled into the maintenance IFX group in Part 2 of the study.|Participants|Count of Participants|33|33.0||||||
4291371|NCT00537316|4117162|B1||Male|Sex: Female, Male|Baseline characteristics for Part 2 are presented for the direct entry participants only: 1 participant randomized to the maintenance IFX/AZA group, 1 participant randomized to the intermittent IFX/AZA group, and 1 participant randomized to the intermittent IFX group. No participants were directly enrolled into the maintenance IFX group in Part 2 of the study.|Participants|Count of Participants|42|42.0||||||
4291372|NCT00537316|4117156|B7||Female|Sex: Female, Male|Baseline characteristics for Part 2 are presented for the direct entry participants only: 1 participant randomized to the maintenance IFX/AZA group, 1 participant randomized to the intermittent IFX/AZA group, and 1 participant randomized to the intermittent IFX group. No participants were directly enrolled into the maintenance IFX group in Part 2 of the study.|Participants|Count of Participants|116|116.0||||||
4291373|NCT00537316|4117157|B6||Female|Sex: Female, Male|Baseline characteristics for Part 2 are presented for the direct entry participants only: 1 participant randomized to the maintenance IFX/AZA group, 1 participant randomized to the intermittent IFX/AZA group, and 1 participant randomized to the intermittent IFX group. No participants were directly enrolled into the maintenance IFX group in Part 2 of the study.|Participants|Count of Participants|1|1.0||||||
4291374|NCT00537316|4117158|B5||Female|Sex: Female, Male|Baseline characteristics for Part 2 are presented for the direct entry participants only: 1 participant randomized to the maintenance IFX/AZA group, 1 participant randomized to the intermittent IFX/AZA group, and 1 participant randomized to the intermittent IFX group. No participants were directly enrolled into the maintenance IFX group in Part 2 of the study.|Participants|Count of Participants|1|1.0||||||
4291375|NCT00537316|4117159|B4||Female|Sex: Female, Male|Baseline characteristics for Part 2 are presented for the direct entry participants only: 1 participant randomized to the maintenance IFX/AZA group, 1 participant randomized to the intermittent IFX/AZA group, and 1 participant randomized to the intermittent IFX group. No participants were directly enrolled into the maintenance IFX group in Part 2 of the study.|Participants|Count of Participants|0|0.0||||||
4291376|NCT00537316|4117160|B3||Female|Sex: Female, Male|Baseline characteristics for Part 2 are presented for the direct entry participants only: 1 participant randomized to the maintenance IFX/AZA group, 1 participant randomized to the intermittent IFX/AZA group, and 1 participant randomized to the intermittent IFX group. No participants were directly enrolled into the maintenance IFX group in Part 2 of the study.|Participants|Count of Participants|32|32.0||||||
4291377|NCT00537316|4117161|B2||Female|Sex: Female, Male|Baseline characteristics for Part 2 are presented for the direct entry participants only: 1 participant randomized to the maintenance IFX/AZA group, 1 participant randomized to the intermittent IFX/AZA group, and 1 participant randomized to the intermittent IFX group. No participants were directly enrolled into the maintenance IFX group in Part 2 of the study.|Participants|Count of Participants|46|46.0||||||
4291378|NCT00537316|4117162|B1||Female|Sex: Female, Male|Baseline characteristics for Part 2 are presented for the direct entry participants only: 1 participant randomized to the maintenance IFX/AZA group, 1 participant randomized to the intermittent IFX/AZA group, and 1 participant randomized to the intermittent IFX group. No participants were directly enrolled into the maintenance IFX group in Part 2 of the study.|Participants|Count of Participants|36|36.0||||||
4291379|NCT00537316|4117156|B7|65 years and older||Age, Customized|Baseline characteristics for Part 2 are presented for the direct entry participants only: 1 participant randomized to the maintenance IFX/AZA group, 1 participant randomized to the intermittent IFX/AZA group, and 1 participant randomized to the intermittent IFX group. No participants were directly enrolled into the maintenance IFX group in Part 2 of the study.|Participants|Number|6|6.0||||||
4291380|NCT00537316|4117157|B6|65 years and older||Age, Customized|Baseline characteristics for Part 2 are presented for the direct entry participants only: 1 participant randomized to the maintenance IFX/AZA group, 1 participant randomized to the intermittent IFX/AZA group, and 1 participant randomized to the intermittent IFX group. No participants were directly enrolled into the maintenance IFX group in Part 2 of the study.|Participants|Number|0|0.0||||||
4291381|NCT00537316|4117158|B5|65 years and older||Age, Customized|Baseline characteristics for Part 2 are presented for the direct entry participants only: 1 participant randomized to the maintenance IFX/AZA group, 1 participant randomized to the intermittent IFX/AZA group, and 1 participant randomized to the intermittent IFX group. No participants were directly enrolled into the maintenance IFX group in Part 2 of the study.|Participants|Number|0|0.0||||||
4291382|NCT00537316|4117159|B4|65 years and older||Age, Customized|Baseline characteristics for Part 2 are presented for the direct entry participants only: 1 participant randomized to the maintenance IFX/AZA group, 1 participant randomized to the intermittent IFX/AZA group, and 1 participant randomized to the intermittent IFX group. No participants were directly enrolled into the maintenance IFX group in Part 2 of the study.|Participants|Number|0|0.0||||||
4291383|NCT00537316|4117160|B3|65 years and older||Age, Customized|Baseline characteristics for Part 2 are presented for the direct entry participants only: 1 participant randomized to the maintenance IFX/AZA group, 1 participant randomized to the intermittent IFX/AZA group, and 1 participant randomized to the intermittent IFX group. No participants were directly enrolled into the maintenance IFX group in Part 2 of the study.|Participants|Number|2|2.0||||||
4291401|NCT00537303|4117194|B2|||Diabetes history|Number of years since diagnosis|years|Mean|12.68|12.68|Standard Deviation|6.68|6.68|||
4291384|NCT00537316|4117161|B2|65 years and older||Age, Customized|Baseline characteristics for Part 2 are presented for the direct entry participants only: 1 participant randomized to the maintenance IFX/AZA group, 1 participant randomized to the intermittent IFX/AZA group, and 1 participant randomized to the intermittent IFX group. No participants were directly enrolled into the maintenance IFX group in Part 2 of the study.|Participants|Number|3|3.0||||||
4291385|NCT00537316|4117162|B1|65 years and older||Age, Customized|Baseline characteristics for Part 2 are presented for the direct entry participants only: 1 participant randomized to the maintenance IFX/AZA group, 1 participant randomized to the intermittent IFX/AZA group, and 1 participant randomized to the intermittent IFX group. No participants were directly enrolled into the maintenance IFX group in Part 2 of the study.|Participants|Number|1|1.0||||||
4291386|NCT00537316|4117156|B7|18 years to <65 years||Age, Customized|Baseline characteristics for Part 2 are presented for the direct entry participants only: 1 participant randomized to the maintenance IFX/AZA group, 1 participant randomized to the intermittent IFX/AZA group, and 1 participant randomized to the intermittent IFX group. No participants were directly enrolled into the maintenance IFX group in Part 2 of the study.|Participants|Number|234|234.0||||||
4291387|NCT00537316|4117157|B6|18 years to <65 years||Age, Customized|Baseline characteristics for Part 2 are presented for the direct entry participants only: 1 participant randomized to the maintenance IFX/AZA group, 1 participant randomized to the intermittent IFX/AZA group, and 1 participant randomized to the intermittent IFX group. No participants were directly enrolled into the maintenance IFX group in Part 2 of the study.|Participants|Number|1|1.0||||||
4291388|NCT00537316|4117158|B5|18 years to <65 years||Age, Customized|Baseline characteristics for Part 2 are presented for the direct entry participants only: 1 participant randomized to the maintenance IFX/AZA group, 1 participant randomized to the intermittent IFX/AZA group, and 1 participant randomized to the intermittent IFX group. No participants were directly enrolled into the maintenance IFX group in Part 2 of the study.|Participants|Number|1|1.0||||||
4291389|NCT00537316|4117159|B4|18 years to <65 years||Age, Customized|Baseline characteristics for Part 2 are presented for the direct entry participants only: 1 participant randomized to the maintenance IFX/AZA group, 1 participant randomized to the intermittent IFX/AZA group, and 1 participant randomized to the intermittent IFX group. No participants were directly enrolled into the maintenance IFX group in Part 2 of the study.|Participants|Number|1|1.0||||||
4291390|NCT00537316|4117160|B3|18 years to <65 years||Age, Customized|Baseline characteristics for Part 2 are presented for the direct entry participants only: 1 participant randomized to the maintenance IFX/AZA group, 1 participant randomized to the intermittent IFX/AZA group, and 1 participant randomized to the intermittent IFX group. No participants were directly enrolled into the maintenance IFX group in Part 2 of the study.|Participants|Number|78|78.0||||||
4291391|NCT00537316|4117161|B2|18 years to <65 years||Age, Customized|Baseline characteristics for Part 2 are presented for the direct entry participants only: 1 participant randomized to the maintenance IFX/AZA group, 1 participant randomized to the intermittent IFX/AZA group, and 1 participant randomized to the intermittent IFX group. No participants were directly enrolled into the maintenance IFX group in Part 2 of the study.|Participants|Number|76|76.0||||||
4291392|NCT00537316|4117162|B1|18 years to <65 years||Age, Customized|Baseline characteristics for Part 2 are presented for the direct entry participants only: 1 participant randomized to the maintenance IFX/AZA group, 1 participant randomized to the intermittent IFX/AZA group, and 1 participant randomized to the intermittent IFX group. No participants were directly enrolled into the maintenance IFX group in Part 2 of the study.|Participants|Number|77|77.0||||||
4291393|NCT00537316|4117156|B7|<18 years||Age, Customized|Baseline characteristics for Part 2 are presented for the direct entry participants only: 1 participant randomized to the maintenance IFX/AZA group, 1 participant randomized to the intermittent IFX/AZA group, and 1 participant randomized to the intermittent IFX group. No participants were directly enrolled into the maintenance IFX group in Part 2 of the study.|Participants|Number|0|0.0||||||
4291394|NCT00537316|4117157|B6|<18 years||Age, Customized|Baseline characteristics for Part 2 are presented for the direct entry participants only: 1 participant randomized to the maintenance IFX/AZA group, 1 participant randomized to the intermittent IFX/AZA group, and 1 participant randomized to the intermittent IFX group. No participants were directly enrolled into the maintenance IFX group in Part 2 of the study.|Participants|Number|0|0.0||||||
4291395|NCT00537316|4117158|B5|<18 years||Age, Customized|Baseline characteristics for Part 2 are presented for the direct entry participants only: 1 participant randomized to the maintenance IFX/AZA group, 1 participant randomized to the intermittent IFX/AZA group, and 1 participant randomized to the intermittent IFX group. No participants were directly enrolled into the maintenance IFX group in Part 2 of the study.|Participants|Number|0|0.0||||||
4291396|NCT00537316|4117159|B4|<18 years||Age, Customized|Baseline characteristics for Part 2 are presented for the direct entry participants only: 1 participant randomized to the maintenance IFX/AZA group, 1 participant randomized to the intermittent IFX/AZA group, and 1 participant randomized to the intermittent IFX group. No participants were directly enrolled into the maintenance IFX group in Part 2 of the study.|Participants|Number|0|0.0||||||
4291397|NCT00537316|4117160|B3|<18 years||Age, Customized|Baseline characteristics for Part 2 are presented for the direct entry participants only: 1 participant randomized to the maintenance IFX/AZA group, 1 participant randomized to the intermittent IFX/AZA group, and 1 participant randomized to the intermittent IFX group. No participants were directly enrolled into the maintenance IFX group in Part 2 of the study.|Participants|Number|0|0.0||||||
4291398|NCT00537316|4117161|B2|<18 years||Age, Customized|Baseline characteristics for Part 2 are presented for the direct entry participants only: 1 participant randomized to the maintenance IFX/AZA group, 1 participant randomized to the intermittent IFX/AZA group, and 1 participant randomized to the intermittent IFX group. No participants were directly enrolled into the maintenance IFX group in Part 2 of the study.|Participants|Number|0|0.0||||||
4291399|NCT00537316|4117162|B1|<18 years||Age, Customized|Baseline characteristics for Part 2 are presented for the direct entry participants only: 1 participant randomized to the maintenance IFX/AZA group, 1 participant randomized to the intermittent IFX/AZA group, and 1 participant randomized to the intermittent IFX group. No participants were directly enrolled into the maintenance IFX group in Part 2 of the study.|Participants|Number|0|0.0||||||
4291400|NCT00537303|4117193|B3|||Diabetes history|Number of years since diagnosis|years|Mean|12.25|12.25|Standard Deviation|6.35|6.35|||
4291402|NCT00537303|4117195|B1|||Diabetes history|Number of years since diagnosis|years|Mean|11.82|11.82|Standard Deviation|5.99|5.99|||
4291403|NCT00537303|4117193|B3|||HbA1c (glycosylated haemoglobin A1c)||percentage (%) of total haemoglobin|Mean|8.78|8.78|Standard Deviation|1.07|1.07|||
4291404|NCT00537303|4117194|B2|||HbA1c (glycosylated haemoglobin A1c)||percentage (%) of total haemoglobin|Mean|8.67|8.67|Standard Deviation|0.97|0.97|||
4291405|NCT00537303|4117195|B1|||HbA1c (glycosylated haemoglobin A1c)||percentage (%) of total haemoglobin|Mean|8.89|8.89|Standard Deviation|1.16|1.16|||
4291406|NCT00537303|4117193|B3|Metformin + other OAD||Stratification||participants|Number|170|170.0||||||
4291407|NCT00537303|4117194|B2|Metformin + other OAD||Stratification||participants|Number|86|86.0||||||
4291408|NCT00537303|4117195|B1|Metformin + other OAD||Stratification||participants|Number|84|84.0||||||
4291409|NCT00537303|4117193|B3|Metformin alone||Stratification||participants|Number|126|126.0||||||
4291410|NCT00537303|4117194|B2|Metformin alone||Stratification||participants|Number|64|64.0||||||
4291411|NCT00537303|4117195|B1|Metformin alone||Stratification||participants|Number|62|62.0||||||
4291412|NCT00537303|4117193|B3|||BMI (Body Mass Index)||kg/m^2|Mean|31.32|31.32|Standard Deviation|4.60|4.6|||
4291413|NCT00537303|4117194|B2|||BMI (Body Mass Index)||kg/m^2|Mean|31.38|31.38|Standard Deviation|4.92|4.92|||
4291414|NCT00537303|4117195|B1|||BMI (Body Mass Index)||kg/m^2|Mean|31.26|31.26|Standard Deviation|4.26|4.26|||
4291415|NCT00537303|4117193|B3|||Body weight||kg|Mean|88.4|88.4|Standard Deviation|16.0|16.0|||
4291416|NCT00537303|4117194|B2|||Body weight||kg|Mean|88.0|88.0|Standard Deviation|16.3|16.3|||
4291417|NCT00537303|4117195|B1|||Body weight||kg|Mean|88.8|88.8|Standard Deviation|15.8|15.8|||
4291418|NCT00537303|4117193|B3|||Height||meter|Mean|1.68|1.68|Standard Deviation|0.10|0.1|||
4291419|NCT00537303|4117194|B2|||Height||meter|Mean|1.67|1.67|Standard Deviation|0.10|0.1|||
4291420|NCT00537303|4117195|B1|||Height||meter|Mean|1.68|1.68|Standard Deviation|0.10|0.1|||
4291421|NCT00537303|4117193|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4291422|NCT00537303|4117194|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4291423|NCT00537303|4117195|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4291424|NCT00537303|4117193|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4291425|NCT00537303|4117194|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4291426|NCT00537303|4117195|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4291427|NCT00537303|4117193|B3||White|Race (NIH/OMB)||Participants|Count of Participants|242|242.0||||||
4291428|NCT00537303|4117194|B2||White|Race (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
4291429|NCT00537303|4117195|B1||White|Race (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
4291430|NCT00537303|4117193|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4291431|NCT00537303|4117194|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4291432|NCT00537303|4117195|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4291433|NCT00537303|4117193|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4291434|NCT00537303|4117194|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4291435|NCT00537303|4117195|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4291436|NCT00537303|4117193|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4291437|NCT00537303|4117194|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4291438|NCT00537303|4117195|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4291439|NCT00537303|4117193|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4291440|NCT00537303|4117194|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4291441|NCT00537303|4117195|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4291442|NCT00537303|4117193|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4291443|NCT00537303|4117194|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4291444|NCT00537303|4117195|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4291445|NCT00537303|4117193|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|211|211.0||||||
4291446|NCT00537303|4117194|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
4291447|NCT00537303|4117195|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
4291448|NCT00537303|4117193|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4291449|NCT00537303|4117194|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4291450|NCT00537303|4117195|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4291451|NCT00537303|4117193|B3||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4291452|NCT00537303|4117194|B2||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4291453|NCT00537303|4117195|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4291454|NCT00537303|4117193|B3||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4291455|NCT00537303|4117194|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4291456|NCT00537303|4117195|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4291457|NCT00537303|4117193|B3|||Age||years|Mean|58.3|58.3|Standard Deviation|8.40|8.4|||
4291460|NCT00537303|4117193|B3||>=65 years|Age||Participants|Count of Participants|57|57.0||||||
4291461|NCT00537303|4117194|B2||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4291462|NCT00537303|4117195|B1||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4291463|NCT00537303|4117193|B3||Between 18 and 65 years|Age||Participants|Count of Participants|239|239.0||||||
4291464|NCT00537303|4117194|B2||Between 18 and 65 years|Age||Participants|Count of Participants|122|122.0||||||
4291465|NCT00537303|4117195|B1||Between 18 and 65 years|Age||Participants|Count of Participants|117|117.0||||||
4291466|NCT00537303|4117193|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4291467|NCT00537303|4117194|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4291468|NCT00537303|4117195|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4291469|NCT00537290|4117212|B1|United States||Region of Enrollment|Region of the patients|Participants|Count of Participants|19|19.0||||||
4291470|NCT00537290|4117212|B1||Unknown or Not Reported|Race (NIH/OMB)|Race distribution|Participants|Count of Participants|2|2.0||||||
4291471|NCT00537290|4117212|B1||More than one race|Race (NIH/OMB)|Race distribution|Participants|Count of Participants|0|0.0||||||
4291472|NCT00537290|4117212|B1||White|Race (NIH/OMB)|Race distribution|Participants|Count of Participants|17|17.0||||||
4291473|NCT00537290|4117212|B1||Black or African American|Race (NIH/OMB)|Race distribution|Participants|Count of Participants|0|0.0||||||
4291474|NCT00537290|4117212|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race distribution|Participants|Count of Participants|0|0.0||||||
4291475|NCT00537290|4117212|B1||Asian|Race (NIH/OMB)|Race distribution|Participants|Count of Participants|0|0.0||||||
4291476|NCT00537290|4117212|B1||American Indian or Alaska Native|Race (NIH/OMB)|Race distribution|Participants|Count of Participants|0|0.0||||||
4291477|NCT00537290|4117212|B1||Male|Sex: Female, Male|Gender distribution|Participants|Count of Participants|8|8.0||||||
4291478|NCT00537290|4117212|B1||Female|Sex: Female, Male|Gender distribution|Participants|Count of Participants|11|11.0||||||
4291479|NCT00537290|4117212|B1|||Age|The mean age of the patients|years|Mean|40.5|40.5|Standard Deviation|13.8|13.8|||
4291480|NCT00537290|4117212|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4291481|NCT00537290|4117212|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4291482|NCT00537290|4117212|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4291483|NCT00537277|4117217|B1|||Weight||kg|Mean|80.2|80.2|Standard Deviation|15.1|15.1|||
4291484|NCT00537277|4117217|B1|||Height||cm|Mean|161|161.0|Standard Deviation|9.00|9.0|||
4291485|NCT00537277|4117217|B1|||Diabetes Duration|Number of years since diagnosis|years|Mean|9.5|9.5|Standard Deviation|5.1|5.1|||
4291486|NCT00537277|4117217|B1|||BMI|Body mass index|kg/m^2|Mean|31.1|31.1|Standard Deviation|5.7|5.7|||
4291487|NCT00537277|4117217|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4291488|NCT00537277|4117217|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4291489|NCT00537277|4117217|B1|||Age||years|Mean|54.4|54.4|Standard Deviation|10.0|10.0|||
4291490|NCT00537238|4117226|B3||Male|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4291491|NCT00537238|4117227|B2||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4291492|NCT00537238|4117228|B1||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4291493|NCT00537238|4117226|B3||Female|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
4291494|NCT00537238|4117227|B2||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4291495|NCT00537238|4117228|B1||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4291496|NCT00537238|4117226|B3|||Age||years|Mean|34.5|34.5|Standard Deviation|11.8|11.8|||
4291497|NCT00537238|4117227|B2|||Age||years|Mean|36.3|36.3|Standard Deviation|12.2|12.2|||
4291498|NCT00537238|4117228|B1|||Age||years|Mean|32.7|32.7|Standard Deviation|11.2|11.2|||
4291499|NCT00537199|4117249|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4291500|NCT00537199|4117249|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4291501|NCT00537199|4117249|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4291502|NCT00537199|4117249|B1|||Age||years|Median|64|64.0|Full Range|||64.0|64.0|
4291503|NCT00537095|4117253|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4291504|NCT00537095|4117254|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4291505|NCT00537095|4117255|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4291506|NCT00537095|4117253|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4291507|NCT00537095|4117254|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4291508|NCT00537095|4117255|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4291509|NCT00537095|4117253|B3|||Age||year|Mean|63|63.0|Standard Deviation|11.4|11.4|||
4291510|NCT00537095|4117254|B2|||Age||year|Mean|63.8|63.8|Standard Deviation|11.59|11.59|||
4291511|NCT00537095|4117255|B1|||Age||year|Mean|62.8|62.8|Standard Deviation|11.21|11.21|||
4291512|NCT00537082|4117268|B4|Japan||Region of Enrollment||participants|Number|171|171.0||||||
4291513|NCT00537082|4117269|B3|Japan||Region of Enrollment||participants|Number|57|57.0||||||
4291514|NCT00537082|4117270|B2|Japan||Region of Enrollment||participants|Number|57|57.0||||||
4291515|NCT00537082|4117271|B1|Japan||Region of Enrollment||participants|Number|57|57.0||||||
4291516|NCT00537082|4117268|B4||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4291517|NCT00537082|4117269|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4291518|NCT00537082|4117270|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4291519|NCT00537082|4117271|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4291520|NCT00537082|4117268|B4||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4291521|NCT00537082|4117269|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4291522|NCT00537082|4117270|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4291523|NCT00537082|4117271|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4291524|NCT00537082|4117268|B4|||Age||years|Mean|35.3|35.3|Standard Deviation|9.04|9.04|||
4291525|NCT00537082|4117269|B3|||Age||years|Mean|35.0|35.0|Standard Deviation|8.93|8.93|||
4291526|NCT00537082|4117270|B2|||Age||years|Mean|35.0|35.0|Standard Deviation|9.01|9.01|||
4291527|NCT00537082|4117271|B1|||Age||years|Mean|36.0|36.0|Standard Deviation|9.31|9.31|||
4291528|NCT00537056|4117290|B1|United States||Region of Enrollment|Stanford Hospital and Clinics|participants|Number|17|17.0||||||
4291529|NCT00537056|4117290|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4291530|NCT00537056|4117290|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4291531|NCT00537056|4117290|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4291532|NCT00537056|4117290|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4291533|NCT00537056|4117290|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4291534|NCT00537030|4117302|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4291535|NCT00537030|4117302|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4291536|NCT00537030|4117302|B1||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4291537|NCT00537030|4117302|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4291538|NCT00537030|4117302|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4291539|NCT00537030|4117302|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4291540|NCT00537030|4117302|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4291541|NCT00537030|4117302|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4291542|NCT00537030|4117302|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4291543|NCT00537030|4117302|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4291544|NCT00537030|4117302|B1||Male|Gender||Participants|Count of Participants|35|35.0||||||
4291545|NCT00537030|4117302|B1||Female|Gender||Participants|Count of Participants|24|24.0||||||
4291546|NCT00537030|4117302|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4291547|NCT00537030|4117302|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4291548|NCT00537030|4117302|B1||<=18 years|Age||Participants|Count of Participants|59|59.0||||||
4291549|NCT00537017|4117306|B1||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4291550|NCT00537017|4117306|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4291551|NCT00537017|4117306|B1|||Age||Years|Mean|62.9|62.9|Standard Deviation|9.8|9.8|||
4291552|NCT00536991|4117317|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4291553|NCT00536991|4117317|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4291554|NCT00536991|4117317|B1||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4291555|NCT00536991|4117317|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4291556|NCT00536991|4117317|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4291557|NCT00536991|4117317|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4291558|NCT00536991|4117317|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4291559|NCT00536991|4117317|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4291560|NCT00536991|4117317|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4291561|NCT00536991|4117317|B1|||Age||years|Mean|68.0|68.0|Standard Deviation|8.7|8.7|||
4291562|NCT00536991|4117317|B1||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
4291563|NCT00536991|4117317|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4291564|NCT00536991|4117317|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4291565|NCT00536978|4117324|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4291566|NCT00536978|4117324|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4291567|NCT00536978|4117324|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4291568|NCT00536978|4117324|B1|||Age||years|Mean|54|54.0|Full Range|||34.0|67.0|
4291569|NCT00536913|4117328|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4291570|NCT00536913|4117329|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4291571|NCT00536913|4117330|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4291572|NCT00536913|4117328|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4291573|NCT00536913|4117329|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4291574|NCT00536913|4117330|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4291575|NCT00536913|4117328|B3|||Age||years|Mean|8.7|8.7|Full Range|||6.0|11.0|
4291576|NCT00536913|4117329|B2|||Age||years|Mean|8.9|8.9|Full Range|||6.0|11.0|
4291577|NCT00536913|4117330|B1|||Age||years|Mean|8.6|8.6|Full Range|||6.0|11.0|
4291578|NCT00536874|4117353|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4291579|NCT00536874|4117353|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4291580|NCT00536874|4117353|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4291581|NCT00536874|4117353|B1||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4291582|NCT00536874|4117353|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4291583|NCT00536874|4117353|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4291584|NCT00536874|4117353|B1|||Age||years|Median|63.5|63.5|Standard Deviation|33.23401872|33.23401872|||
4291585|NCT00536809|4117363|B1|White/Caucasian/European heritage||Race/Ethnicity, Customized|Baseline participants include the 10 participants who completed Phase I, and the 2 who were enrolled into Phase II before the study was terminated.|participants|Number|12|12.0||||||
4291586|NCT00536809|4117363|B1||Male|Sex: Female, Male|Baseline participants include the 10 participants who completed Phase I, and the 2 who were enrolled into Phase II before the study was terminated.|Participants|Count of Participants|1|1.0||||||
4291587|NCT00536809|4117363|B1||Female|Sex: Female, Male|Baseline participants include the 10 participants who completed Phase I, and the 2 who were enrolled into Phase II before the study was terminated.|Participants|Count of Participants|11|11.0||||||
4291588|NCT00536809|4117363|B1|||Age|Baseline participants include the 10 participants who completed Phase I, and the 2 who were enrolled into Phase II before the study was terminated.|years|Mean|59.9|59.9|Full Range|||36.0|78.0|
4291589|NCT00536744|4117384|B3|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4291590|NCT00536744|4117385|B2|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4291591|NCT00536744|4117386|B1|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4291592|NCT00536744|4117384|B3|Germany||Region of Enrollment||participants|Number|5|5.0||||||
4291593|NCT00536744|4117385|B2|Germany||Region of Enrollment||participants|Number|3|3.0||||||
4291594|NCT00536744|4117386|B1|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4291595|NCT00536744|4117384|B3|United States||Region of Enrollment||participants|Number|197|197.0||||||
4291596|NCT00536744|4117385|B2|United States||Region of Enrollment||participants|Number|94|94.0||||||
4291597|NCT00536744|4117386|B1|United States||Region of Enrollment||participants|Number|103|103.0||||||
4291598|NCT00536744|4117384|B3||Male|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4291599|NCT00536744|4117385|B2||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4291600|NCT00536744|4117386|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4291601|NCT00536744|4117384|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4291602|NCT00536744|4117385|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4291603|NCT00536744|4117386|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4291604|NCT00536744|4117384|B3|||Age||years|Mean|58.3|58.3|Standard Deviation|9.9|9.9|||
4291605|NCT00536744|4117385|B2|||Age||years|Mean|56.2|56.2|Standard Deviation|9.4|9.4|||
4291606|NCT00536744|4117386|B1|||Age||years|Mean|60.4|60.4|Standard Deviation|10.4|10.4|||
4291607|NCT00536731|4117393|B4||Male|Sex: Female, Male||Participants|Count of Participants|317|317.0||||||
4291608|NCT00536731|4117394|B3||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4291609|NCT00536731|4117395|B2||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4291610|NCT00536731|4117396|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4291611|NCT00536731|4117393|B4||Female|Sex: Female, Male||Participants|Count of Participants|425|425.0||||||
4291612|NCT00536731|4117394|B3||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4291613|NCT00536731|4117395|B2||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4291614|NCT00536731|4117396|B1||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4291615|NCT00536731|4117393|B4|||Age||years|Mean|41|41.0|Full Range|||12.0|78.0|
4291616|NCT00536731|4117394|B3|||Age||years|Mean|39|39.0|Full Range|||12.0|78.0|
4291617|NCT00536731|4117395|B2|||Age||years|Mean|42|42.0|Full Range|||12.0|76.0|
4291618|NCT00536731|4117396|B1|||Age||years|Mean|41|41.0|Full Range|||12.0|75.0|
4291619|NCT00536575|4117442|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4291620|NCT00536575|4117442|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4291621|NCT00536575|4117442|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4291622|NCT00536575|4117442|B1|||Age||years|Median|67|67.0|Full Range|||41.0|86.0|
4291623|NCT00536510|4117446|B3|||Low Density Lipoprotein Cholesterol (LDL-C)||mg/dL|Mean|122.9|122.9|Standard Deviation|34.2|34.2|||
4291624|NCT00536510|4117447|B2|||Low Density Lipoprotein Cholesterol (LDL-C)||mg/dL|Mean|121.8|121.8|Standard Deviation|34.0|34.0|||
4291625|NCT00536510|4117448|B1|||Low Density Lipoprotein Cholesterol (LDL-C)||mg/dL|Mean|124|124.0|Standard Deviation|34.4|34.4|||
4291626|NCT00536510|4117446|B3|||High Density Lipoprotein Cholesterol (HDL-C)||mg/dL|Mean|48.3|48.3|Standard Deviation|11.3|11.3|||
4291627|NCT00536510|4117447|B2|||High Density Lipoprotein Cholesterol (HDL-C)||mg/dL|Mean|48.5|48.5|Standard Deviation|11.8|11.8|||
4291628|NCT00536510|4117448|B1|||High Density Lipoprotein Cholesterol (HDL-C)||mg/dL|Mean|48.1|48.1|Standard Deviation|10.8|10.8|||
4291629|NCT00536510|4117446|B3|Diabetic*||Glycemic Status|"Fasting Plasma Glucose (FPG)~*Glycemic Status (Source: American Diabetes Association Guidelines)~Normal - FPG level of less than 100 mg/dL~Impaired Glucose – FPG level between 100 & 125 mg/dL~Diabetic – FPG level of 126 mg/dL or higher"|Participants|Number|312|312.0||||||
4291630|NCT00536510|4117447|B2|Diabetic*||Glycemic Status|"Fasting Plasma Glucose (FPG)~*Glycemic Status (Source: American Diabetes Association Guidelines)~Normal - FPG level of less than 100 mg/dL~Impaired Glucose – FPG level between 100 & 125 mg/dL~Diabetic – FPG level of 126 mg/dL or higher"|Participants|Number|164|164.0||||||
4291631|NCT00536510|4117448|B1|Diabetic*||Glycemic Status|"Fasting Plasma Glucose (FPG)~*Glycemic Status (Source: American Diabetes Association Guidelines)~Normal - FPG level of less than 100 mg/dL~Impaired Glucose – FPG level between 100 & 125 mg/dL~Diabetic – FPG level of 126 mg/dL or higher"|Participants|Number|148|148.0||||||
4291632|NCT00536510|4117446|B3|Impaired Glucose*||Glycemic Status|"Fasting Plasma Glucose (FPG)~*Glycemic Status (Source: American Diabetes Association Guidelines)~Normal - FPG level of less than 100 mg/dL~Impaired Glucose – FPG level between 100 & 125 mg/dL~Diabetic – FPG level of 126 mg/dL or higher"|Participants|Number|12|12.0||||||
4291633|NCT00536510|4117447|B2|Impaired Glucose*||Glycemic Status|"Fasting Plasma Glucose (FPG)~*Glycemic Status (Source: American Diabetes Association Guidelines)~Normal - FPG level of less than 100 mg/dL~Impaired Glucose – FPG level between 100 & 125 mg/dL~Diabetic – FPG level of 126 mg/dL or higher"|Participants|Number|4|4.0||||||
4291634|NCT00536510|4117448|B1|Impaired Glucose*||Glycemic Status|"Fasting Plasma Glucose (FPG)~*Glycemic Status (Source: American Diabetes Association Guidelines)~Normal - FPG level of less than 100 mg/dL~Impaired Glucose – FPG level between 100 & 125 mg/dL~Diabetic – FPG level of 126 mg/dL or higher"|Participants|Number|8|8.0||||||
4291635|NCT00536510|4117446|B3|Normal*||Glycemic Status|"Fasting Plasma Glucose (FPG)~*Glycemic Status (Source: American Diabetes Association Guidelines)~Normal - FPG level of less than 100 mg/dL~Impaired Glucose – FPG level between 100 & 125 mg/dL~Diabetic – FPG level of 126 mg/dL or higher"|Participants|Number|322|322.0||||||
4291636|NCT00536510|4117447|B2|Normal*||Glycemic Status|"Fasting Plasma Glucose (FPG)~*Glycemic Status (Source: American Diabetes Association Guidelines)~Normal - FPG level of less than 100 mg/dL~Impaired Glucose – FPG level between 100 & 125 mg/dL~Diabetic – FPG level of 126 mg/dL or higher"|Participants|Number|156|156.0||||||
4291637|NCT00536510|4117448|B1|Normal*||Glycemic Status|"Fasting Plasma Glucose (FPG)~*Glycemic Status (Source: American Diabetes Association Guidelines)~Normal - FPG level of less than 100 mg/dL~Impaired Glucose – FPG level between 100 & 125 mg/dL~Diabetic – FPG level of 126 mg/dL or higher"|Participants|Number|166|166.0||||||
4291638|NCT00536510|4117446|B3|Korea||Country||Participants|Number|168|168.0||||||
4291639|NCT00536510|4117447|B2|Korea||Country||Participants|Number|87|87.0||||||
4291640|NCT00536510|4117448|B1|Korea||Country||Participants|Number|81|81.0||||||
4291641|NCT00536510|4117446|B3|India||Country||Participants|Number|161|161.0||||||
4291642|NCT00536510|4117447|B2|India||Country||Participants|Number|79|79.0||||||
4291643|NCT00536510|4117448|B1|India||Country||Participants|Number|82|82.0||||||
4291644|NCT00536510|4117446|B3|China (includes Hong Kong)||Country||Participants|Number|317|317.0||||||
4291645|NCT00536510|4117447|B2|China (includes Hong Kong)||Country||Participants|Number|158|158.0||||||
4291646|NCT00536510|4117448|B1|China (includes Hong Kong)||Country||Participants|Number|159|159.0||||||
4291647|NCT00536510|4117446|B3|No||Concomitant Statin Use||Participants|Number|350|350.0||||||
4291648|NCT00536510|4117447|B2|No||Concomitant Statin Use||Participants|Number|178|178.0||||||
4291649|NCT00536510|4117448|B1|No||Concomitant Statin Use||Participants|Number|172|172.0||||||
4291650|NCT00536510|4117446|B3|Yes||Concomitant Statin Use||Participants|Number|296|296.0||||||
4291651|NCT00536510|4117447|B2|Yes||Concomitant Statin Use||Participants|Number|146|146.0||||||
4291652|NCT00536510|4117448|B1|Yes||Concomitant Statin Use||Participants|Number|150|150.0||||||
4291653|NCT00536510|4117446|B3||Male|Sex: Female, Male||Participants|Count of Participants|270|270.0||||||
4291654|NCT00536510|4117447|B2||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4291655|NCT00536510|4117448|B1||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4291656|NCT00536510|4117446|B3||Female|Sex: Female, Male||Participants|Count of Participants|376|376.0||||||
4291657|NCT00536510|4117447|B2||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4291658|NCT00536510|4117448|B1||Female|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4291659|NCT00536510|4117446|B3|>=65 years||Age, Customized||participants|Number|91|91.0||||||
4291660|NCT00536510|4117447|B2|>=65 years||Age, Customized||participants|Number|45|45.0||||||
4291661|NCT00536510|4117448|B1|>=65 years||Age, Customized||participants|Number|46|46.0||||||
4291662|NCT00536510|4117446|B3|<65 years||Age, Customized||participants|Number|555|555.0||||||
4291663|NCT00536510|4117447|B2|<65 years||Age, Customized||participants|Number|279|279.0||||||
4291664|NCT00536510|4117448|B1|<65 years||Age, Customized||participants|Number|276|276.0||||||
4291665|NCT00536484|4117457|B3||Male|Sex: Female, Male||Participants|Count of Participants|151.0|151.0||||||
4291666|NCT00536484|4117458|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4291667|NCT00536484|4117459|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4291668|NCT00536484|4117457|B3||Female|Sex: Female, Male||Participants|Count of Participants|732.0|732.0||||||
4291669|NCT00536484|4117458|B2||Female|Sex: Female, Male||Participants|Count of Participants|364|364.0||||||
4291670|NCT00536484|4117459|B1||Female|Sex: Female, Male||Participants|Count of Participants|368|368.0||||||
4291671|NCT00536484|4117457|B3|||Age||years|Mean|59.9|59.9|Standard Deviation|13.3|13.3|||
4291672|NCT00536484|4117458|B2|||Age||years|Mean|59.7|59.7|Standard Deviation|13.7|13.7|||
4291673|NCT00536484|4117459|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|12.9|12.9|||
4291674|NCT00536471|4117490|B5|||History - Time Since Most Recent Episode||weeks|Mean|49.8|49.8|Standard Deviation|87.3|87.3|||
4291675|NCT00536471|4117491|B4|||History - Time Since Most Recent Episode||weeks|Mean|59.2|59.2|Standard Deviation|111.2|111.2|||
4291676|NCT00536471|4117492|B3|||History - Time Since Most Recent Episode||weeks|Mean|51.4|51.4|Standard Deviation|103.3|103.3|||
4291677|NCT00536471|4117493|B2|||History - Time Since Most Recent Episode||weeks|Mean|48.8|48.8|Standard Deviation|69.5|69.5|||
4291678|NCT00536471|4117494|B1|||History - Time Since Most Recent Episode||weeks|Mean|44.0|44.0|Standard Deviation|60.2|60.2|||
4291679|NCT00536471|4117490|B5|||History - Time Since First Episode Date||years|Mean|13.2|13.2|Standard Deviation|11.7|11.7|||
4291680|NCT00536471|4117491|B4|||History - Time Since First Episode Date||years|Mean|14.0|14.0|Standard Deviation|12.0|12.0|||
4291681|NCT00536471|4117492|B3|||History - Time Since First Episode Date||years|Mean|14.0|14.0|Standard Deviation|11.5|11.5|||
4291682|NCT00536471|4117493|B2|||History - Time Since First Episode Date||years|Mean|12.5|12.5|Standard Deviation|11.6|11.6|||
4291683|NCT00536471|4117494|B1|||History - Time Since First Episode Date||years|Mean|12.3|12.3|Standard Deviation|11.6|11.6|||
4291684|NCT00536471|4117490|B5|||History - Number of Previous Episodes||number of previous episodes|Mean|4.5|4.5|Standard Deviation|5.1|5.1|||
4291685|NCT00536471|4117491|B4|||History - Number of Previous Episodes||number of previous episodes|Mean|5.2|5.2|Standard Deviation|5.4|5.4|||
4291686|NCT00536471|4117492|B3|||History - Number of Previous Episodes||number of previous episodes|Mean|4.9|4.9|Standard Deviation|5.4|5.4|||
4291687|NCT00536471|4117493|B2|||History - Number of Previous Episodes||number of previous episodes|Mean|3.8|3.8|Standard Deviation|4.3|4.3|||
4291688|NCT00536471|4117494|B1|||History - Number of Previous Episodes||number of previous episodes|Mean|4.0|4.0|Standard Deviation|4.8|4.8|||
4291689|NCT00536471|4117490|B5|||History - Interval Between Start of Current and Remission of Last MDD Episode||weeks|Mean|13.0|13.0|Standard Deviation|21.8|21.8|||
4291690|NCT00536471|4117491|B4|||History - Interval Between Start of Current and Remission of Last MDD Episode||weeks|Mean|13.1|13.1|Standard Deviation|22.2|22.2|||
4291691|NCT00536471|4117492|B3|||History - Interval Between Start of Current and Remission of Last MDD Episode||weeks|Mean|13.1|13.1|Standard Deviation|22.1|22.1|||
4291692|NCT00536471|4117493|B2|||History - Interval Between Start of Current and Remission of Last MDD Episode||weeks|Mean|12.5|12.5|Standard Deviation|24.3|24.3|||
4291693|NCT00536471|4117494|B1|||History - Interval Between Start of Current and Remission of Last MDD Episode||weeks|Mean|13.2|13.2|Standard Deviation|20.1|20.1|||
4291694|NCT00536471|4117490|B5|||History - How Long was Last Major Depressive Disorder (MDD) Episode||weeks|Mean|5.2|5.2|Standard Deviation|8.6|8.6|||
4291695|NCT00536471|4117491|B4|||History - How Long was Last Major Depressive Disorder (MDD) Episode||weeks|Mean|6.5|6.5|Standard Deviation|14.5|14.5|||
4291696|NCT00536471|4117492|B3|||History - How Long was Last Major Depressive Disorder (MDD) Episode||weeks|Mean|5.2|5.2|Standard Deviation|6.9|6.9|||
4291697|NCT00536471|4117493|B2|||History - How Long was Last Major Depressive Disorder (MDD) Episode||weeks|Mean|5.0|5.0|Standard Deviation|7.4|7.4|||
4291698|NCT00536471|4117494|B1|||History - How Long was Last Major Depressive Disorder (MDD) Episode||weeks|Mean|4.7|4.7|Standard Deviation|6.3|6.3|||
4291699|NCT00536471|4117490|B5|||History - Age at First Episode||years|Mean|30.4|30.4|Standard Deviation|13.3|13.3|||
4291700|NCT00536471|4117491|B4|||History - Age at First Episode||years|Mean|30.0|30.0|Standard Deviation|12.6|12.6|||
4291701|NCT00536471|4117492|B3|||History - Age at First Episode||years|Mean|30.7|30.7|Standard Deviation|13.6|13.6|||
4291702|NCT00536471|4117493|B2|||History - Age at First Episode||years|Mean|31.2|31.2|Standard Deviation|13.7|13.7|||
4291703|NCT00536471|4117494|B1|||History - Age at First Episode||years|Mean|30.0|30.0|Standard Deviation|13.2|13.2|||
4291704|NCT00536471|4117490|B5|||Evaluation - Social Adaptation Self-Evaluation Scale (SASS) Total|A 21-item self-rated scale that evaluates patient social motivation and behavior in depression. Each of the 21 items is scored from 0 (minimal social adjustment) to 3 (maximal social adjustment). Total score ranges from 0 to 60.|units on a scale|Mean|28.0|28.0|Standard Deviation|8.0|8.0|||
4291705|NCT00536471|4117491|B4|||Evaluation - Social Adaptation Self-Evaluation Scale (SASS) Total|A 21-item self-rated scale that evaluates patient social motivation and behavior in depression. Each of the 21 items is scored from 0 (minimal social adjustment) to 3 (maximal social adjustment). Total score ranges from 0 to 60.|units on a scale|Mean|29.3|29.3|Standard Deviation|8.2|8.2|||
4291706|NCT00536471|4117492|B3|||Evaluation - Social Adaptation Self-Evaluation Scale (SASS) Total|A 21-item self-rated scale that evaluates patient social motivation and behavior in depression. Each of the 21 items is scored from 0 (minimal social adjustment) to 3 (maximal social adjustment). Total score ranges from 0 to 60.|units on a scale|Mean|27.6|27.6|Standard Deviation|8.2|8.2|||
4291707|NCT00536471|4117493|B2|||Evaluation - Social Adaptation Self-Evaluation Scale (SASS) Total|A 21-item self-rated scale that evaluates patient social motivation and behavior in depression. Each of the 21 items is scored from 0 (minimal social adjustment) to 3 (maximal social adjustment). Total score ranges from 0 to 60.|units on a scale|Mean|29.1|29.1|Standard Deviation|8.4|8.4|||
4291708|NCT00536471|4117494|B1|||Evaluation - Social Adaptation Self-Evaluation Scale (SASS) Total|A 21-item self-rated scale that evaluates patient social motivation and behavior in depression. Each of the 21 items is scored from 0 (minimal social adjustment) to 3 (maximal social adjustment). Total score ranges from 0 to 60.|units on a scale|Mean|27.2|27.2|Standard Deviation|7.3|7.3|||
4291709|NCT00536471|4117490|B5|||Evaluation - Sheehan Disability Scale (SDS) Total Score|The SDS is completed by the patient and is used to assess the effect of the patient's symptoms on their work/social/family life. Total scores range from 0 to 30 with higher values indicating greater disruption in the patient's work/social/family life.|units on a scale|Mean|18.3|18.3|Standard Deviation|6.9|6.9|||
4291710|NCT00536471|4117491|B4|||Evaluation - Sheehan Disability Scale (SDS) Total Score|The SDS is completed by the patient and is used to assess the effect of the patient's symptoms on their work/social/family life. Total scores range from 0 to 30 with higher values indicating greater disruption in the patient's work/social/family life.|units on a scale|Mean|17.5|17.5|Standard Deviation|7.0|7.0|||
4291711|NCT00536471|4117492|B3|||Evaluation - Sheehan Disability Scale (SDS) Total Score|The SDS is completed by the patient and is used to assess the effect of the patient's symptoms on their work/social/family life. Total scores range from 0 to 30 with higher values indicating greater disruption in the patient's work/social/family life.|units on a scale|Mean|18.4|18.4|Standard Deviation|7.1|7.1|||
4291712|NCT00536471|4117493|B2|||Evaluation - Sheehan Disability Scale (SDS) Total Score|The SDS is completed by the patient and is used to assess the effect of the patient's symptoms on their work/social/family life. Total scores range from 0 to 30 with higher values indicating greater disruption in the patient's work/social/family life.|units on a scale|Mean|17.8|17.8|Standard Deviation|7.3|7.3|||
4291713|NCT00536471|4117494|B1|||Evaluation - Sheehan Disability Scale (SDS) Total Score|The SDS is completed by the patient and is used to assess the effect of the patient's symptoms on their work/social/family life. Total scores range from 0 to 30 with higher values indicating greater disruption in the patient's work/social/family life.|units on a scale|Mean|19.0|19.0|Standard Deviation|6.5|6.5|||
4291714|NCT00536471|4117490|B5|||Evaluation - Sheehan Disability Scale (SDS) Item 3|The SDS is completed by the patient and Item 3 is used to assess the effect of the patient's symptoms on their family life/home responsibilities. Scores range from 0 to 10 with higher values indicating greater disruption in the patient's family life/home responsibilities.|units on a scale|Mean|6.2|6.2|Standard Deviation|2.6|2.6|||
4291715|NCT00536471|4117491|B4|||Evaluation - Sheehan Disability Scale (SDS) Item 3|The SDS is completed by the patient and Item 3 is used to assess the effect of the patient's symptoms on their family life/home responsibilities. Scores range from 0 to 10 with higher values indicating greater disruption in the patient's family life/home responsibilities.|units on a scale|Mean|6.0|6.0|Standard Deviation|2.5|2.5|||
4291716|NCT00536471|4117492|B3|||Evaluation - Sheehan Disability Scale (SDS) Item 3|The SDS is completed by the patient and Item 3 is used to assess the effect of the patient's symptoms on their family life/home responsibilities. Scores range from 0 to 10 with higher values indicating greater disruption in the patient's family life/home responsibilities.|units on a scale|Mean|6.2|6.2|Standard Deviation|2.6|2.6|||
4291717|NCT00536471|4117493|B2|||Evaluation - Sheehan Disability Scale (SDS) Item 3|The SDS is completed by the patient and Item 3 is used to assess the effect of the patient's symptoms on their family life/home responsibilities. Scores range from 0 to 10 with higher values indicating greater disruption in the patient's family life/home responsibilities.|units on a scale|Mean|6.0|6.0|Standard Deviation|2.6|2.6|||
4291718|NCT00536471|4117494|B1|||Evaluation - Sheehan Disability Scale (SDS) Item 3|The SDS is completed by the patient and Item 3 is used to assess the effect of the patient's symptoms on their family life/home responsibilities. Scores range from 0 to 10 with higher values indicating greater disruption in the patient's family life/home responsibilities.|units on a scale|Mean|6.5|6.5|Standard Deviation|2.5|2.5|||
4291719|NCT00536471|4117490|B5|||Evaluation - Sheehan Disability Scale (SDS) Item 2|The SDS is completed by the patient and Item 2 is used to assess the effect of the patient's symptoms on their social life/leisure acitivities. Scores range from 0 to 10 with higher values indicating greater disruption in the patient's social life.|units on a scale|Mean|6.3|6.3|Standard Deviation|2.6|2.6|||
4291720|NCT00536471|4117491|B4|||Evaluation - Sheehan Disability Scale (SDS) Item 2|The SDS is completed by the patient and Item 2 is used to assess the effect of the patient's symptoms on their social life/leisure acitivities. Scores range from 0 to 10 with higher values indicating greater disruption in the patient's social life.|units on a scale|Mean|5.9|5.9|Standard Deviation|2.5|2.5|||
4291721|NCT00536471|4117492|B3|||Evaluation - Sheehan Disability Scale (SDS) Item 2|The SDS is completed by the patient and Item 2 is used to assess the effect of the patient's symptoms on their social life/leisure acitivities. Scores range from 0 to 10 with higher values indicating greater disruption in the patient's social life.|units on a scale|Mean|6.4|6.4|Standard Deviation|2.8|2.8|||
4291722|NCT00536471|4117493|B2|||Evaluation - Sheehan Disability Scale (SDS) Item 2|The SDS is completed by the patient and Item 2 is used to assess the effect of the patient's symptoms on their social life/leisure acitivities. Scores range from 0 to 10 with higher values indicating greater disruption in the patient's social life.|units on a scale|Mean|6.2|6.2|Standard Deviation|2.8|2.8|||
4291723|NCT00536471|4117494|B1|||Evaluation - Sheehan Disability Scale (SDS) Item 2|The SDS is completed by the patient and Item 2 is used to assess the effect of the patient's symptoms on their social life/leisure acitivities. Scores range from 0 to 10 with higher values indicating greater disruption in the patient's social life.|units on a scale|Mean|6.6|6.6|Standard Deviation|2.4|2.4|||
4291724|NCT00536471|4117490|B5|||Evaluation - Sheehan Disability Scale (SDS) Item 1|The SDS is completed by the patient and Item 1 is used to assess the effect of the patient's symptoms on their work/school schedule. Scores range from 0 to 10 with higher values indicating greater disruption in the patient's work/school life.|units on a scale|Mean|5.5|5.5|Standard Deviation|2.7|2.7|||
4291725|NCT00536471|4117491|B4|||Evaluation - Sheehan Disability Scale (SDS) Item 1|The SDS is completed by the patient and Item 1 is used to assess the effect of the patient's symptoms on their work/school schedule. Scores range from 0 to 10 with higher values indicating greater disruption in the patient's work/school life.|units on a scale|Mean|5.3|5.3|Standard Deviation|2.8|2.8|||
4291726|NCT00536471|4117492|B3|||Evaluation - Sheehan Disability Scale (SDS) Item 1|The SDS is completed by the patient and Item 1 is used to assess the effect of the patient's symptoms on their work/school schedule. Scores range from 0 to 10 with higher values indicating greater disruption in the patient's work/school life.|units on a scale|Mean|5.6|5.6|Standard Deviation|2.7|2.7|||
4291727|NCT00536471|4117493|B2|||Evaluation - Sheehan Disability Scale (SDS) Item 1|The SDS is completed by the patient and Item 1 is used to assess the effect of the patient's symptoms on their work/school schedule. Scores range from 0 to 10 with higher values indicating greater disruption in the patient's work/school life.|units on a scale|Mean|5.4|5.4|Standard Deviation|2.7|2.7|||
4291728|NCT00536471|4117494|B1|||Evaluation - Sheehan Disability Scale (SDS) Item 1|The SDS is completed by the patient and Item 1 is used to assess the effect of the patient's symptoms on their work/school schedule. Scores range from 0 to 10 with higher values indicating greater disruption in the patient's work/school life.|units on a scale|Mean|5.5|5.5|Standard Deviation|2.8|2.8|||
4291729|NCT00536471|4117490|B5|||Evaluation - Pain Numerical Rating Scale (NRS) Score Item 7|"Item 7=How much they have been bothered by pain over the last week, as measured by an 11-point Likert scale. A score of 0 reflects not bothered at all and a score of 10 reflects extremely bothered."|units on a scale|Mean|4.7|4.7|Standard Deviation|3.1|3.1|||
4291730|NCT00536471|4117491|B4|||Evaluation - Pain Numerical Rating Scale (NRS) Score Item 7|"Item 7=How much they have been bothered by pain over the last week, as measured by an 11-point Likert scale. A score of 0 reflects not bothered at all and a score of 10 reflects extremely bothered."|units on a scale|Mean|4.9|4.9|Standard Deviation|3.2|3.2|||
4291731|NCT00536471|4117492|B3|||Evaluation - Pain Numerical Rating Scale (NRS) Score Item 7|"Item 7=How much they have been bothered by pain over the last week, as measured by an 11-point Likert scale. A score of 0 reflects not bothered at all and a score of 10 reflects extremely bothered."|units on a scale|Mean|4.7|4.7|Standard Deviation|3.2|3.2|||
4291732|NCT00536471|4117493|B2|||Evaluation - Pain Numerical Rating Scale (NRS) Score Item 7|"Item 7=How much they have been bothered by pain over the last week, as measured by an 11-point Likert scale. A score of 0 reflects not bothered at all and a score of 10 reflects extremely bothered."|units on a scale|Mean|4.5|4.5|Standard Deviation|3.1|3.1|||
4291733|NCT00536471|4117494|B1|||Evaluation - Pain Numerical Rating Scale (NRS) Score Item 7|"Item 7=How much they have been bothered by pain over the last week, as measured by an 11-point Likert scale. A score of 0 reflects not bothered at all and a score of 10 reflects extremely bothered."|units on a scale|Mean|4.7|4.7|Standard Deviation|3.0|3.0|||
4291734|NCT00536471|4117490|B5|||Evaluation - Pain Numerical Rating Scale (NRS) Score Item 1|"Item 1=Average musculoskeletal pain severity. Participants are asked to rate their average pain over the last week as measured by an 11-point Likert scale. A score of 0 reflects no pain and a score of 10 reflects worst possible pain."|units on a scale|Mean|4.4|4.4|Standard Deviation|2.9|2.9|||
4291735|NCT00536471|4117491|B4|||Evaluation - Pain Numerical Rating Scale (NRS) Score Item 1|"Item 1=Average musculoskeletal pain severity. Participants are asked to rate their average pain over the last week as measured by an 11-point Likert scale. A score of 0 reflects no pain and a score of 10 reflects worst possible pain."|units on a scale|Mean|4.5|4.5|Standard Deviation|2.8|2.8|||
4291736|NCT00536471|4117492|B3|||Evaluation - Pain Numerical Rating Scale (NRS) Score Item 1|"Item 1=Average musculoskeletal pain severity. Participants are asked to rate their average pain over the last week as measured by an 11-point Likert scale. A score of 0 reflects no pain and a score of 10 reflects worst possible pain."|units on a scale|Mean|4.5|4.5|Standard Deviation|3.1|3.1|||
4291737|NCT00536471|4117493|B2|||Evaluation - Pain Numerical Rating Scale (NRS) Score Item 1|"Item 1=Average musculoskeletal pain severity. Participants are asked to rate their average pain over the last week as measured by an 11-point Likert scale. A score of 0 reflects no pain and a score of 10 reflects worst possible pain."|units on a scale|Mean|4.1|4.1|Standard Deviation|2.7|2.7|||
4291738|NCT00536471|4117494|B1|||Evaluation - Pain Numerical Rating Scale (NRS) Score Item 1|"Item 1=Average musculoskeletal pain severity. Participants are asked to rate their average pain over the last week as measured by an 11-point Likert scale. A score of 0 reflects no pain and a score of 10 reflects worst possible pain."|units on a scale|Mean|4.3|4.3|Standard Deviation|2.8|2.8|||
4291739|NCT00536471|4117490|B5|||Evaluation - Massachusetts General Hospital Cognitive and Physical Functioning Questionnaire|A 7-item patitent-rated questionnaire pertaining to a patient's cognitive and physical well-being. It assesses motivation, wakefulness, energy, focus, recall, word-finding difficulty, and mental acuity. Each of the 7 questions is scored on a 6-point scale ranging fom 1 (greater than normal) to 6 (totally absent). Total score ranges from 7 to 42.|units on a scale|Mean|28.2|28.2|Standard Deviation|6.0|6.0|||
4291740|NCT00536471|4117491|B4|||Evaluation - Massachusetts General Hospital Cognitive and Physical Functioning Questionnaire|A 7-item patitent-rated questionnaire pertaining to a patient's cognitive and physical well-being. It assesses motivation, wakefulness, energy, focus, recall, word-finding difficulty, and mental acuity. Each of the 7 questions is scored on a 6-point scale ranging fom 1 (greater than normal) to 6 (totally absent). Total score ranges from 7 to 42.|units on a scale|Mean|28.6|28.6|Standard Deviation|5.4|5.4|||
4291741|NCT00536471|4117492|B3|||Evaluation - Massachusetts General Hospital Cognitive and Physical Functioning Questionnaire|A 7-item patitent-rated questionnaire pertaining to a patient's cognitive and physical well-being. It assesses motivation, wakefulness, energy, focus, recall, word-finding difficulty, and mental acuity. Each of the 7 questions is scored on a 6-point scale ranging fom 1 (greater than normal) to 6 (totally absent). Total score ranges from 7 to 42.|units on a scale|Mean|28.6|28.6|Standard Deviation|6.1|6.1|||
4291742|NCT00536471|4117493|B2|||Evaluation - Massachusetts General Hospital Cognitive and Physical Functioning Questionnaire|A 7-item patitent-rated questionnaire pertaining to a patient's cognitive and physical well-being. It assesses motivation, wakefulness, energy, focus, recall, word-finding difficulty, and mental acuity. Each of the 7 questions is scored on a 6-point scale ranging fom 1 (greater than normal) to 6 (totally absent). Total score ranges from 7 to 42.|units on a scale|Mean|26.8|26.8|Standard Deviation|6.1|6.1|||
4291743|NCT00536471|4117494|B1|||Evaluation - Massachusetts General Hospital Cognitive and Physical Functioning Questionnaire|A 7-item patitent-rated questionnaire pertaining to a patient's cognitive and physical well-being. It assesses motivation, wakefulness, energy, focus, recall, word-finding difficulty, and mental acuity. Each of the 7 questions is scored on a 6-point scale ranging fom 1 (greater than normal) to 6 (totally absent). Total score ranges from 7 to 42.|units on a scale|Mean|28.4|28.4|Standard Deviation|6.0|6.0|||
4291744|NCT00536471|4117490|B5|||Evaluation - Clinical Global Impressions of Severity Scale (CGI-S) Score|Measures severity of illness at the time of assessment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill patients.|units on a scale|Mean|4.6|4.6|Standard Deviation|0.7|0.7|||
4291745|NCT00536471|4117491|B4|||Evaluation - Clinical Global Impressions of Severity Scale (CGI-S) Score|Measures severity of illness at the time of assessment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill patients.|units on a scale|Mean|4.7|4.7|Standard Deviation|0.7|0.7|||
4291746|NCT00536471|4117492|B3|||Evaluation - Clinical Global Impressions of Severity Scale (CGI-S) Score|Measures severity of illness at the time of assessment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill patients.|units on a scale|Mean|4.7|4.7|Standard Deviation|0.7|0.7|||
4291747|NCT00536471|4117493|B2|||Evaluation - Clinical Global Impressions of Severity Scale (CGI-S) Score|Measures severity of illness at the time of assessment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill patients.|units on a scale|Mean|4.5|4.5|Standard Deviation|0.6|0.6|||
4291748|NCT00536471|4117494|B1|||Evaluation - Clinical Global Impressions of Severity Scale (CGI-S) Score|Measures severity of illness at the time of assessment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill patients.|units on a scale|Mean|4.6|4.6|Standard Deviation|0.6|0.6|||
4291749|NCT00536471|4117490|B5|||Evaluation - 24-Item Hamilton Depression Rating Scale - Item 21:Obsessional and Compulsive Symptoms|Measures obsessional and compulsive symptoms on a scale of 0 (absent) to 2 (severe).|units on a scale|Mean|0.1|0.1|Standard Deviation|0.4|0.4|||
4291750|NCT00536471|4117491|B4|||Evaluation - 24-Item Hamilton Depression Rating Scale - Item 21:Obsessional and Compulsive Symptoms|Measures obsessional and compulsive symptoms on a scale of 0 (absent) to 2 (severe).|units on a scale|Mean|0.1|0.1|Standard Deviation|0.4|0.4|||
4291751|NCT00536471|4117492|B3|||Evaluation - 24-Item Hamilton Depression Rating Scale - Item 21:Obsessional and Compulsive Symptoms|Measures obsessional and compulsive symptoms on a scale of 0 (absent) to 2 (severe).|units on a scale|Mean|0.1|0.1|Standard Deviation|0.4|0.4|||
4291752|NCT00536471|4117493|B2|||Evaluation - 24-Item Hamilton Depression Rating Scale - Item 21:Obsessional and Compulsive Symptoms|Measures obsessional and compulsive symptoms on a scale of 0 (absent) to 2 (severe).|units on a scale|Mean|0.1|0.1|Standard Deviation|0.4|0.4|||
4291753|NCT00536471|4117494|B1|||Evaluation - 24-Item Hamilton Depression Rating Scale - Item 21:Obsessional and Compulsive Symptoms|Measures obsessional and compulsive symptoms on a scale of 0 (absent) to 2 (severe).|units on a scale|Mean|0.1|0.1|Standard Deviation|0.4|0.4|||
4291754|NCT00536471|4117490|B5|||Evaluation - 24-Item Hamilton Depression Rating Scale - Item 19: Depersonalization and Derealization|Measures feelings of unreality on a scale of 0 (absent) to 4 (incapacitating).|units on a scale|Mean|0.2|0.2|Standard Deviation|0.6|0.6|||
4291755|NCT00536471|4117491|B4|||Evaluation - 24-Item Hamilton Depression Rating Scale - Item 19: Depersonalization and Derealization|Measures feelings of unreality on a scale of 0 (absent) to 4 (incapacitating).|units on a scale|Mean|0.2|0.2|Standard Deviation|0.5|0.5|||
4291756|NCT00536471|4117492|B3|||Evaluation - 24-Item Hamilton Depression Rating Scale - Item 19: Depersonalization and Derealization|Measures feelings of unreality on a scale of 0 (absent) to 4 (incapacitating).|units on a scale|Mean|0.2|0.2|Standard Deviation|0.5|0.5|||
4291757|NCT00536471|4117493|B2|||Evaluation - 24-Item Hamilton Depression Rating Scale - Item 19: Depersonalization and Derealization|Measures feelings of unreality on a scale of 0 (absent) to 4 (incapacitating).|units on a scale|Mean|0.3|0.3|Standard Deviation|0.6|0.6|||
4291758|NCT00536471|4117494|B1|||Evaluation - 24-Item Hamilton Depression Rating Scale - Item 19: Depersonalization and Derealization|Measures feelings of unreality on a scale of 0 (absent) to 4 (incapacitating).|units on a scale|Mean|0.2|0.2|Standard Deviation|0.6|0.6|||
4291759|NCT00536471|4117490|B5|||Evaluation - 24-Item Hamilton Depression Rating Scale - Item 18B:Diurnal Variation-Severity|Measures the severity of the diurnal variation on a scale of 0 (none) to 2 (severe).|units on a scale|Mean|0.9|0.9|Standard Deviation|0.8|0.8|||
4291760|NCT00536471|4117491|B4|||Evaluation - 24-Item Hamilton Depression Rating Scale - Item 18B:Diurnal Variation-Severity|Measures the severity of the diurnal variation on a scale of 0 (none) to 2 (severe).|units on a scale|Mean|1.0|1.0|Standard Deviation|0.9|0.9|||
4291761|NCT00536471|4117492|B3|||Evaluation - 24-Item Hamilton Depression Rating Scale - Item 18B:Diurnal Variation-Severity|Measures the severity of the diurnal variation on a scale of 0 (none) to 2 (severe).|units on a scale|Mean|0.9|0.9|Standard Deviation|0.8|0.8|||
4291762|NCT00536471|4117493|B2|||Evaluation - 24-Item Hamilton Depression Rating Scale - Item 18B:Diurnal Variation-Severity|Measures the severity of the diurnal variation on a scale of 0 (none) to 2 (severe).|units on a scale|Mean|0.9|0.9|Standard Deviation|0.9|0.9|||
4291763|NCT00536471|4117494|B1|||Evaluation - 24-Item Hamilton Depression Rating Scale - Item 18B:Diurnal Variation-Severity|Measures the severity of the diurnal variation on a scale of 0 (none) to 2 (severe).|units on a scale|Mean|0.8|0.8|Standard Deviation|0.8|0.8|||
4291764|NCT00536471|4117490|B5|||Evaluation - 24-Item Hamilton Depression Rating Scale - Item 12:Somatic Symptoms/Gastrointestinal|Measures gastrointestical somatic symptoms on a scale of 0 (none) to 2 (difficulty eating, requires medication for symptoms).|units on a scale|Mean|0.7|0.7|Standard Deviation|0.7|0.7|||
4291765|NCT00536471|4117491|B4|||Evaluation - 24-Item Hamilton Depression Rating Scale - Item 12:Somatic Symptoms/Gastrointestinal|Measures gastrointestical somatic symptoms on a scale of 0 (none) to 2 (difficulty eating, requires medication for symptoms).|units on a scale|Mean|0.7|0.7|Standard Deviation|0.7|0.7|||
4291766|NCT00536471|4117492|B3|||Evaluation - 24-Item Hamilton Depression Rating Scale - Item 12:Somatic Symptoms/Gastrointestinal|Measures gastrointestical somatic symptoms on a scale of 0 (none) to 2 (difficulty eating, requires medication for symptoms).|units on a scale|Mean|0.6|0.6|Standard Deviation|0.7|0.7|||
4291767|NCT00536471|4117493|B2|||Evaluation - 24-Item Hamilton Depression Rating Scale - Item 12:Somatic Symptoms/Gastrointestinal|Measures gastrointestical somatic symptoms on a scale of 0 (none) to 2 (difficulty eating, requires medication for symptoms).|units on a scale|Mean|0.6|0.6|Standard Deviation|0.7|0.7|||
4291768|NCT00536471|4117494|B1|||Evaluation - 24-Item Hamilton Depression Rating Scale - Item 12:Somatic Symptoms/Gastrointestinal|Measures gastrointestical somatic symptoms on a scale of 0 (none) to 2 (difficulty eating, requires medication for symptoms).|units on a scale|Mean|0.7|0.7|Standard Deviation|0.7|0.7|||
4291769|NCT00536471|4117490|B5|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) Total Score|The 24-item HAMD measures depression severity. Items are rated on a scale from 0 (symptoms not present) to a maximum of 2 to 4 (symptom extremely severe) for a total score range of 0 to 76.|units on a scale|Mean|28.7|28.7|Standard Deviation|6.1|6.1|||
4291770|NCT00536471|4117491|B4|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) Total Score|The 24-item HAMD measures depression severity. Items are rated on a scale from 0 (symptoms not present) to a maximum of 2 to 4 (symptom extremely severe) for a total score range of 0 to 76.|units on a scale|Mean|29.0|29.0|Standard Deviation|6.7|6.7|||
4291771|NCT00536471|4117492|B3|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) Total Score|The 24-item HAMD measures depression severity. Items are rated on a scale from 0 (symptoms not present) to a maximum of 2 to 4 (symptom extremely severe) for a total score range of 0 to 76.|units on a scale|Mean|28.7|28.7|Standard Deviation|6.2|6.2|||
4291772|NCT00536471|4117493|B2|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) Total Score|The 24-item HAMD measures depression severity. Items are rated on a scale from 0 (symptoms not present) to a maximum of 2 to 4 (symptom extremely severe) for a total score range of 0 to 76.|units on a scale|Mean|28.6|28.6|Standard Deviation|5.5|5.5|||
4291773|NCT00536471|4117494|B1|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) Total Score|The 24-item HAMD measures depression severity. Items are rated on a scale from 0 (symptoms not present) to a maximum of 2 to 4 (symptom extremely severe) for a total score range of 0 to 76.|units on a scale|Mean|28.6|28.6|Standard Deviation|6.0|6.0|||
4291774|NCT00536471|4117490|B5|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) Sleep Subscale Score|The Sleep subscale (Items 4,5,6) evaluates initial, middle, and late insomnia. Total subscale scores range from 0 (no difficulty) to 6 (difficulty).|units on a scale|Mean|4.1|4.1|Standard Deviation|1.6|1.6|||
4291775|NCT00536471|4117491|B4|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) Sleep Subscale Score|The Sleep subscale (Items 4,5,6) evaluates initial, middle, and late insomnia. Total subscale scores range from 0 (no difficulty) to 6 (difficulty).|units on a scale|Mean|4.0|4.0|Standard Deviation|1.5|1.5|||
4291776|NCT00536471|4117492|B3|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) Sleep Subscale Score|The Sleep subscale (Items 4,5,6) evaluates initial, middle, and late insomnia. Total subscale scores range from 0 (no difficulty) to 6 (difficulty).|units on a scale|Mean|3.9|3.9|Standard Deviation|1.7|1.7|||
4291777|NCT00536471|4117493|B2|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) Sleep Subscale Score|The Sleep subscale (Items 4,5,6) evaluates initial, middle, and late insomnia. Total subscale scores range from 0 (no difficulty) to 6 (difficulty).|units on a scale|Mean|4.3|4.3|Standard Deviation|1.5|1.5|||
4291778|NCT00536471|4117494|B1|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) Sleep Subscale Score|The Sleep subscale (Items 4,5,6) evaluates initial, middle, and late insomnia. Total subscale scores range from 0 (no difficulty) to 6 (difficulty).|units on a scale|Mean|4.2|4.2|Standard Deviation|1.6|1.6|||
4291779|NCT00536471|4117490|B5|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) Retardation Subscale Score|The Retardation subscale (Items 1,7,8,14) evaluates dysfunction in mood, work, and sexual activity, as well as overall motor retardation. Total subscale scores range from 0 (normal) to 14 (severe).|units on a scale|Mean|8.1|8.1|Standard Deviation|1.6|1.6|||
4291780|NCT00536471|4117491|B4|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) Retardation Subscale Score|The Retardation subscale (Items 1,7,8,14) evaluates dysfunction in mood, work, and sexual activity, as well as overall motor retardation. Total subscale scores range from 0 (normal) to 14 (severe).|units on a scale|Mean|7.9|7.9|Standard Deviation|1.6|1.6|||
4291781|NCT00536471|4117492|B3|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) Retardation Subscale Score|The Retardation subscale (Items 1,7,8,14) evaluates dysfunction in mood, work, and sexual activity, as well as overall motor retardation. Total subscale scores range from 0 (normal) to 14 (severe).|units on a scale|Mean|8.0|8.0|Standard Deviation|1.6|1.6|||
4291782|NCT00536471|4117493|B2|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) Retardation Subscale Score|The Retardation subscale (Items 1,7,8,14) evaluates dysfunction in mood, work, and sexual activity, as well as overall motor retardation. Total subscale scores range from 0 (normal) to 14 (severe).|units on a scale|Mean|8.0|8.0|Standard Deviation|1.6|1.6|||
4291783|NCT00536471|4117494|B1|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) Retardation Subscale Score|The Retardation subscale (Items 1,7,8,14) evaluates dysfunction in mood, work, and sexual activity, as well as overall motor retardation. Total subscale scores range from 0 (normal) to 14 (severe).|units on a scale|Mean|8.2|8.2|Standard Deviation|1.6|1.6|||
4291784|NCT00536471|4117490|B5|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) Maier Subscale Score|"The Maier subscale (Items 1,2,7,8,9,10) represents the core symptoms of depression. Total subscale scores range from 0 (normal) to 24 (severe)."|units on a scale|Mean|11.7|11.7|Standard Deviation|2.2|2.2|||
4291785|NCT00536471|4117491|B4|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) Maier Subscale Score|"The Maier subscale (Items 1,2,7,8,9,10) represents the core symptoms of depression. Total subscale scores range from 0 (normal) to 24 (severe)."|units on a scale|Mean|11.6|11.6|Standard Deviation|2.4|2.4|||
4291786|NCT00536471|4117492|B3|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) Maier Subscale Score|"The Maier subscale (Items 1,2,7,8,9,10) represents the core symptoms of depression. Total subscale scores range from 0 (normal) to 24 (severe)."|units on a scale|Mean|11.6|11.6|Standard Deviation|2.2|2.2|||
4291787|NCT00536471|4117493|B2|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) Maier Subscale Score|"The Maier subscale (Items 1,2,7,8,9,10) represents the core symptoms of depression. Total subscale scores range from 0 (normal) to 24 (severe)."|units on a scale|Mean|11.7|11.7|Standard Deviation|1.9|1.9|||
4291788|NCT00536471|4117494|B1|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) Maier Subscale Score|"The Maier subscale (Items 1,2,7,8,9,10) represents the core symptoms of depression. Total subscale scores range from 0 (normal) to 24 (severe)."|units on a scale|Mean|11.8|11.8|Standard Deviation|2.2|2.2|||
4291789|NCT00536471|4117490|B5|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) Bech Subscale Score|"The Bech subscale (Items 1,2,7,8,10,13) evaluates core symptoms of Major Depressive Disorder (MDD). Total subscale scores range from 0 (normal) to 22 (severe)."|units on a scale|Mean|12.5|12.5|Standard Deviation|2.0|2.0|||
4291790|NCT00536471|4117491|B4|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) Bech Subscale Score|"The Bech subscale (Items 1,2,7,8,10,13) evaluates core symptoms of Major Depressive Disorder (MDD). Total subscale scores range from 0 (normal) to 22 (severe)."|units on a scale|Mean|12.3|12.3|Standard Deviation|2.2|2.2|||
4291791|NCT00536471|4117492|B3|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) Bech Subscale Score|"The Bech subscale (Items 1,2,7,8,10,13) evaluates core symptoms of Major Depressive Disorder (MDD). Total subscale scores range from 0 (normal) to 22 (severe)."|units on a scale|Mean|12.4|12.4|Standard Deviation|1.9|1.9|||
4291792|NCT00536471|4117493|B2|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) Bech Subscale Score|"The Bech subscale (Items 1,2,7,8,10,13) evaluates core symptoms of Major Depressive Disorder (MDD). Total subscale scores range from 0 (normal) to 22 (severe)."|units on a scale|Mean|12.5|12.5|Standard Deviation|1.7|1.7|||
4291793|NCT00536471|4117494|B1|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) Bech Subscale Score|"The Bech subscale (Items 1,2,7,8,10,13) evaluates core symptoms of Major Depressive Disorder (MDD). Total subscale scores range from 0 (normal) to 22 (severe)."|units on a scale|Mean|12.6|12.6|Standard Deviation|2.0|2.0|||
4291794|NCT00536471|4117490|B5|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) Anxiety/Somatization Subscale Score|The Anxiety/Somatization subscale (items 10-13, 15, 17) evaluates severity of psychic and somatic manifistations of anxiety as well as agitation. Total subscale scores range from 0 (normal) to 18 (severe).|units on a scale|Mean|7.0|7.0|Standard Deviation|2.2|2.2|||
4291795|NCT00536471|4117491|B4|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) Anxiety/Somatization Subscale Score|The Anxiety/Somatization subscale (items 10-13, 15, 17) evaluates severity of psychic and somatic manifistations of anxiety as well as agitation. Total subscale scores range from 0 (normal) to 18 (severe).|units on a scale|Mean|7.3|7.3|Standard Deviation|2.4|2.4|||
4291818|NCT00536471|4117494|B1|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 6:Insomnia Late|Measures late insomnia on a scale of 0 (no difficulty) to 2 (unable to fall asleep again if gets out of bed).|units on a scale|Mean|1.2|1.2|Standard Deviation|0.8|0.8|||
4291796|NCT00536471|4117492|B3|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) Anxiety/Somatization Subscale Score|The Anxiety/Somatization subscale (items 10-13, 15, 17) evaluates severity of psychic and somatic manifistations of anxiety as well as agitation. Total subscale scores range from 0 (normal) to 18 (severe).|units on a scale|Mean|7.1|7.1|Standard Deviation|2.3|2.3|||
4291797|NCT00536471|4117493|B2|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) Anxiety/Somatization Subscale Score|The Anxiety/Somatization subscale (items 10-13, 15, 17) evaluates severity of psychic and somatic manifistations of anxiety as well as agitation. Total subscale scores range from 0 (normal) to 18 (severe).|units on a scale|Mean|6.9|6.9|Standard Deviation|1.9|1.9|||
4291798|NCT00536471|4117494|B1|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) Anxiety/Somatization Subscale Score|The Anxiety/Somatization subscale (items 10-13, 15, 17) evaluates severity of psychic and somatic manifistations of anxiety as well as agitation. Total subscale scores range from 0 (normal) to 18 (severe).|units on a scale|Mean|6.8|6.8|Standard Deviation|2.1|2.1|||
4291799|NCT00536471|4117490|B5|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 9:Agitation|Measures agitation on a scale of 0 (none) to 4 (hand-wringing, nail-biting).|units on a scale|Mean|0.9|0.9|Standard Deviation|0.9|0.9|||
4291800|NCT00536471|4117491|B4|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 9:Agitation|Measures agitation on a scale of 0 (none) to 4 (hand-wringing, nail-biting).|units on a scale|Mean|1.0|1.0|Standard Deviation|0.9|0.9|||
4291801|NCT00536471|4117492|B3|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 9:Agitation|Measures agitation on a scale of 0 (none) to 4 (hand-wringing, nail-biting).|units on a scale|Mean|0.9|0.9|Standard Deviation|0.9|0.9|||
4291802|NCT00536471|4117493|B2|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 9:Agitation|Measures agitation on a scale of 0 (none) to 4 (hand-wringing, nail-biting).|units on a scale|Mean|0.9|0.9|Standard Deviation|0.8|0.8|||
4291803|NCT00536471|4117494|B1|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 9:Agitation|Measures agitation on a scale of 0 (none) to 4 (hand-wringing, nail-biting).|units on a scale|Mean|0.9|0.9|Standard Deviation|0.9|0.9|||
4291804|NCT00536471|4117490|B5|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 8:Retardation|Measures slowness of thought and speech; impaired ability to concentrate; decreased motor activity on a scale of 0 (normal speech and thought) to 4 (complete stupor).|units on a scale|Mean|1.1|1.1|Standard Deviation|0.8|0.8|||
4291805|NCT00536471|4117491|B4|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 8:Retardation|Measures slowness of thought and speech; impaired ability to concentrate; decreased motor activity on a scale of 0 (normal speech and thought) to 4 (complete stupor).|units on a scale|Mean|1.1|1.1|Standard Deviation|0.9|0.9|||
4291806|NCT00536471|4117492|B3|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 8:Retardation|Measures slowness of thought and speech; impaired ability to concentrate; decreased motor activity on a scale of 0 (normal speech and thought) to 4 (complete stupor).|units on a scale|Mean|1.1|1.1|Standard Deviation|0.8|0.8|||
4291807|NCT00536471|4117493|B2|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 8:Retardation|Measures slowness of thought and speech; impaired ability to concentrate; decreased motor activity on a scale of 0 (normal speech and thought) to 4 (complete stupor).|units on a scale|Mean|1.0|1.0|Standard Deviation|0.7|0.7|||
4291808|NCT00536471|4117494|B1|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 8:Retardation|Measures slowness of thought and speech; impaired ability to concentrate; decreased motor activity on a scale of 0 (normal speech and thought) to 4 (complete stupor).|units on a scale|Mean|1.1|1.1|Standard Deviation|0.7|0.7|||
4291809|NCT00536471|4117490|B5|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 7:Work and Activities|Item 7 of the HAMD-24 assesses loss of interest or pleasure in work and activities and is an essential symptom in MDD. Scores range from 0 (no difficulty/no loss) to 4 (difficulty/loss).|units on a scale|Mean|2.8|2.8|Standard Deviation|0.5|0.5|||
4291810|NCT00536471|4117491|B4|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 7:Work and Activities|Item 7 of the HAMD-24 assesses loss of interest or pleasure in work and activities and is an essential symptom in MDD. Scores range from 0 (no difficulty/no loss) to 4 (difficulty/loss).|units on a scale|Mean|2.8|2.8|Standard Deviation|0.5|0.5|||
4291811|NCT00536471|4117492|B3|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 7:Work and Activities|Item 7 of the HAMD-24 assesses loss of interest or pleasure in work and activities and is an essential symptom in MDD. Scores range from 0 (no difficulty/no loss) to 4 (difficulty/loss).|units on a scale|Mean|2.8|2.8|Standard Deviation|0.5|0.5|||
4291812|NCT00536471|4117493|B2|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 7:Work and Activities|Item 7 of the HAMD-24 assesses loss of interest or pleasure in work and activities and is an essential symptom in MDD. Scores range from 0 (no difficulty/no loss) to 4 (difficulty/loss).|units on a scale|Mean|2.8|2.8|Standard Deviation|0.6|0.6|||
4291813|NCT00536471|4117494|B1|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 7:Work and Activities|Item 7 of the HAMD-24 assesses loss of interest or pleasure in work and activities and is an essential symptom in MDD. Scores range from 0 (no difficulty/no loss) to 4 (difficulty/loss).|units on a scale|Mean|2.9|2.9|Standard Deviation|0.5|0.5|||
4291814|NCT00536471|4117490|B5|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 6:Insomnia Late|Measures late insomnia on a scale of 0 (no difficulty) to 2 (unable to fall asleep again if gets out of bed).|units on a scale|Mean|1.2|1.2|Standard Deviation|0.8|0.8|||
4291815|NCT00536471|4117491|B4|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 6:Insomnia Late|Measures late insomnia on a scale of 0 (no difficulty) to 2 (unable to fall asleep again if gets out of bed).|units on a scale|Mean|1.1|1.1|Standard Deviation|0.8|0.8|||
4291816|NCT00536471|4117492|B3|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 6:Insomnia Late|Measures late insomnia on a scale of 0 (no difficulty) to 2 (unable to fall asleep again if gets out of bed).|units on a scale|Mean|1.1|1.1|Standard Deviation|0.8|0.8|||
4291817|NCT00536471|4117493|B2|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 6:Insomnia Late|Measures late insomnia on a scale of 0 (no difficulty) to 2 (unable to fall asleep again if gets out of bed).|units on a scale|Mean|1.3|1.3|Standard Deviation|0.8|0.8|||
4292056|NCT00536380|4117742|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4291819|NCT00536471|4117490|B5|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 5:Insomnia Middle|Measures middle insomnia on a scale of 0 (no difficulty) to 2 (waking during the night).|units on a scale|Mean|1.5|1.5|Standard Deviation|0.7|0.7|||
4291820|NCT00536471|4117491|B4|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 5:Insomnia Middle|Measures middle insomnia on a scale of 0 (no difficulty) to 2 (waking during the night).|units on a scale|Mean|1.5|1.5|Standard Deviation|0.7|0.7|||
4291821|NCT00536471|4117492|B3|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 5:Insomnia Middle|Measures middle insomnia on a scale of 0 (no difficulty) to 2 (waking during the night).|units on a scale|Mean|1.4|1.4|Standard Deviation|0.8|0.8|||
4291822|NCT00536471|4117493|B2|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 5:Insomnia Middle|Measures middle insomnia on a scale of 0 (no difficulty) to 2 (waking during the night).|units on a scale|Mean|1.5|1.5|Standard Deviation|0.6|0.6|||
4291823|NCT00536471|4117494|B1|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 5:Insomnia Middle|Measures middle insomnia on a scale of 0 (no difficulty) to 2 (waking during the night).|units on a scale|Mean|1.5|1.5|Standard Deviation|0.7|0.7|||
4291824|NCT00536471|4117490|B5|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 4:Insomnia Early|Measures early insomnia on a scale of 0 (no difficulty falling asleep) to 2 (complains of nightly difficulty falling asleep).|units on a scale|Mean|1.4|1.4|Standard Deviation|0.8|0.8|||
4291825|NCT00536471|4117491|B4|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 4:Insomnia Early|Measures early insomnia on a scale of 0 (no difficulty falling asleep) to 2 (complains of nightly difficulty falling asleep).|units on a scale|Mean|1.4|1.4|Standard Deviation|0.8|0.8|||
4291826|NCT00536471|4117492|B3|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 4:Insomnia Early|Measures early insomnia on a scale of 0 (no difficulty falling asleep) to 2 (complains of nightly difficulty falling asleep).|units on a scale|Mean|1.4|1.4|Standard Deviation|0.8|0.8|||
4291827|NCT00536471|4117493|B2|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 4:Insomnia Early|Measures early insomnia on a scale of 0 (no difficulty falling asleep) to 2 (complains of nightly difficulty falling asleep).|units on a scale|Mean|1.4|1.4|Standard Deviation|0.8|0.8|||
4291828|NCT00536471|4117494|B1|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 4:Insomnia Early|Measures early insomnia on a scale of 0 (no difficulty falling asleep) to 2 (complains of nightly difficulty falling asleep).|units on a scale|Mean|1.5|1.5|Standard Deviation|0.8|0.8|||
4291829|NCT00536471|4117490|B5|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 3:Suicide|Measures thoughts of suicide on a scale of 0 (absent) to 4 (attempts suicide).|units on a scale|Mean|0.6|0.6|Standard Deviation|0.8|0.8|||
4291830|NCT00536471|4117491|B4|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 3:Suicide|Measures thoughts of suicide on a scale of 0 (absent) to 4 (attempts suicide).|units on a scale|Mean|0.6|0.6|Standard Deviation|0.8|0.8|||
4291831|NCT00536471|4117492|B3|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 3:Suicide|Measures thoughts of suicide on a scale of 0 (absent) to 4 (attempts suicide).|units on a scale|Mean|0.6|0.6|Standard Deviation|0.8|0.8|||
4291832|NCT00536471|4117493|B2|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 3:Suicide|Measures thoughts of suicide on a scale of 0 (absent) to 4 (attempts suicide).|units on a scale|Mean|0.7|0.7|Standard Deviation|0.7|0.7|||
4291833|NCT00536471|4117494|B1|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 3:Suicide|Measures thoughts of suicide on a scale of 0 (absent) to 4 (attempts suicide).|units on a scale|Mean|0.6|0.6|Standard Deviation|0.7|0.7|||
4291834|NCT00536471|4117490|B5|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 2:Feelings of Guilt|Measures feelings of guilt on a scale of 0 (absent) to 4 (very guilty).|units on a scale|Mean|1.8|1.8|Standard Deviation|0.7|0.7|||
4291835|NCT00536471|4117491|B4|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 2:Feelings of Guilt|Measures feelings of guilt on a scale of 0 (absent) to 4 (very guilty).|units on a scale|Mean|1.7|1.7|Standard Deviation|0.8|0.8|||
4291836|NCT00536471|4117492|B3|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 2:Feelings of Guilt|Measures feelings of guilt on a scale of 0 (absent) to 4 (very guilty).|units on a scale|Mean|1.8|1.8|Standard Deviation|0.6|0.6|||
4291837|NCT00536471|4117493|B2|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 2:Feelings of Guilt|Measures feelings of guilt on a scale of 0 (absent) to 4 (very guilty).|units on a scale|Mean|2.0|2.0|Standard Deviation|0.7|0.7|||
4291838|NCT00536471|4117494|B1|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 2:Feelings of Guilt|Measures feelings of guilt on a scale of 0 (absent) to 4 (very guilty).|units on a scale|Mean|1.8|1.8|Standard Deviation|0.7|0.7|||
4291839|NCT00536471|4117490|B5|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 24B:Worthlessness|Measures feelings of worthlessness on a scale of 0 (absent) to 4 (severe).|units on a scale|Mean|1.5|1.5|Standard Deviation|1.0|1.0|||
4291840|NCT00536471|4117491|B4|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 24B:Worthlessness|Measures feelings of worthlessness on a scale of 0 (absent) to 4 (severe).|units on a scale|Mean|1.6|1.6|Standard Deviation|1.1|1.1|||
4291841|NCT00536471|4117492|B3|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 24B:Worthlessness|Measures feelings of worthlessness on a scale of 0 (absent) to 4 (severe).|units on a scale|Mean|1.6|1.6|Standard Deviation|1.1|1.1|||
4291842|NCT00536471|4117493|B2|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 24B:Worthlessness|Measures feelings of worthlessness on a scale of 0 (absent) to 4 (severe).|units on a scale|Mean|1.5|1.5|Standard Deviation|1.0|1.0|||
4291843|NCT00536471|4117494|B1|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 24B:Worthlessness|Measures feelings of worthlessness on a scale of 0 (absent) to 4 (severe).|units on a scale|Mean|1.5|1.5|Standard Deviation|1.0|1.0|||
4291844|NCT00536471|4117490|B5|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 23B:Hopelessness|Measures feelings of hopelessness on a scale of 0 (absent) to 3 (expresses feelings of discouragement, despair, and/or pessimism about the future which cannot be dispelled).|units on a scale|Mean|1.3|1.3|Standard Deviation|0.8|0.8|||
4291994|NCT00536471|4117490|B5|No||History - Seasonal Pattern in Major Depressive Disorder (MDD) if ≥3 Previous MDD Episodes||participants|Number|669|669.0||||||
4291845|NCT00536471|4117491|B4|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 23B:Hopelessness|Measures feelings of hopelessness on a scale of 0 (absent) to 3 (expresses feelings of discouragement, despair, and/or pessimism about the future which cannot be dispelled).|units on a scale|Mean|1.3|1.3|Standard Deviation|0.9|0.9|||
4291846|NCT00536471|4117492|B3|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 23B:Hopelessness|Measures feelings of hopelessness on a scale of 0 (absent) to 3 (expresses feelings of discouragement, despair, and/or pessimism about the future which cannot be dispelled).|units on a scale|Mean|1.3|1.3|Standard Deviation|0.8|0.8|||
4291847|NCT00536471|4117493|B2|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 23B:Hopelessness|Measures feelings of hopelessness on a scale of 0 (absent) to 3 (expresses feelings of discouragement, despair, and/or pessimism about the future which cannot be dispelled).|units on a scale|Mean|1.3|1.3|Standard Deviation|0.9|0.9|||
4291848|NCT00536471|4117494|B1|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 23B:Hopelessness|Measures feelings of hopelessness on a scale of 0 (absent) to 3 (expresses feelings of discouragement, despair, and/or pessimism about the future which cannot be dispelled).|units on a scale|Mean|1.3|1.3|Standard Deviation|0.8|0.8|||
4291849|NCT00536471|4117490|B5|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 22B:Helplessness|Measures feelings of helplessness on a scale of 0 (absent) to 4 (severe).|units on a scale|Mean|1.5|1.5|Standard Deviation|1.0|1.0|||
4291850|NCT00536471|4117491|B4|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 22B:Helplessness|Measures feelings of helplessness on a scale of 0 (absent) to 4 (severe).|units on a scale|Mean|1.7|1.7|Standard Deviation|1.0|1.0|||
4291851|NCT00536471|4117492|B3|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 22B:Helplessness|Measures feelings of helplessness on a scale of 0 (absent) to 4 (severe).|units on a scale|Mean|1.5|1.5|Standard Deviation|1.0|1.0|||
4291852|NCT00536471|4117493|B2|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 22B:Helplessness|Measures feelings of helplessness on a scale of 0 (absent) to 4 (severe).|units on a scale|Mean|1.5|1.5|Standard Deviation|1.0|1.0|||
4291853|NCT00536471|4117494|B1|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 22B:Helplessness|Measures feelings of helplessness on a scale of 0 (absent) to 4 (severe).|units on a scale|Mean|1.4|1.4|Standard Deviation|1.0|1.0|||
4291854|NCT00536471|4117490|B5|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 20:Paranoid Symptoms|Measures paranoid symptoms on a scale of 0 (none) to 3 (delusions of reference and persecution).|units on a scale|Mean|0.2|0.2|Standard Deviation|0.5|0.5|||
4291855|NCT00536471|4117491|B4|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 20:Paranoid Symptoms|Measures paranoid symptoms on a scale of 0 (none) to 3 (delusions of reference and persecution).|units on a scale|Mean|0.2|0.2|Standard Deviation|0.4|0.4|||
4291856|NCT00536471|4117492|B3|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 20:Paranoid Symptoms|Measures paranoid symptoms on a scale of 0 (none) to 3 (delusions of reference and persecution).|units on a scale|Mean|0.2|0.2|Standard Deviation|0.5|0.5|||
4291857|NCT00536471|4117493|B2|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 20:Paranoid Symptoms|Measures paranoid symptoms on a scale of 0 (none) to 3 (delusions of reference and persecution).|units on a scale|Mean|0.2|0.2|Standard Deviation|0.5|0.5|||
4291858|NCT00536471|4117494|B1|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 20:Paranoid Symptoms|Measures paranoid symptoms on a scale of 0 (none) to 3 (delusions of reference and persecution).|units on a scale|Mean|0.2|0.2|Standard Deviation|0.5|0.5|||
4291859|NCT00536471|4117490|B5|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 1:Depressed Mood|Measures depressed mood on a scale of 0 (absent) to 4 (very depressed).|units on a scale|Mean|2.9|2.9|Standard Deviation|0.6|0.6|||
4291860|NCT00536471|4117491|B4|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 1:Depressed Mood|Measures depressed mood on a scale of 0 (absent) to 4 (very depressed).|units on a scale|Mean|2.9|2.9|Standard Deviation|0.5|0.5|||
4291861|NCT00536471|4117492|B3|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 1:Depressed Mood|Measures depressed mood on a scale of 0 (absent) to 4 (very depressed).|units on a scale|Mean|2.9|2.9|Standard Deviation|0.6|0.6|||
4291862|NCT00536471|4117493|B2|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 1:Depressed Mood|Measures depressed mood on a scale of 0 (absent) to 4 (very depressed).|units on a scale|Mean|2.9|2.9|Standard Deviation|0.6|0.6|||
4291863|NCT00536471|4117494|B1|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 1:Depressed Mood|Measures depressed mood on a scale of 0 (absent) to 4 (very depressed).|units on a scale|Mean|3.0|3.0|Standard Deviation|0.6|0.6|||
4291864|NCT00536471|4117490|B5|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 18A:Diurnal Variation|Measures whether symptoms are worse in morning or evening on a scale of 0 (no variation), 1 (worse in morning), or 2 (worse in evening).|units on a scale|Mean|0.9|0.9|Standard Deviation|0.9|0.9|||
4291865|NCT00536471|4117491|B4|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 18A:Diurnal Variation|Measures whether symptoms are worse in morning or evening on a scale of 0 (no variation), 1 (worse in morning), or 2 (worse in evening).|units on a scale|Mean|1.0|1.0|Standard Deviation|0.9|0.9|||
4291866|NCT00536471|4117492|B3|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 18A:Diurnal Variation|Measures whether symptoms are worse in morning or evening on a scale of 0 (no variation), 1 (worse in morning), or 2 (worse in evening).|units on a scale|Mean|1.0|1.0|Standard Deviation|0.9|0.9|||
4291867|NCT00536471|4117493|B2|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 18A:Diurnal Variation|Measures whether symptoms are worse in morning or evening on a scale of 0 (no variation), 1 (worse in morning), or 2 (worse in evening).|units on a scale|Mean|0.9|0.9|Standard Deviation|0.9|0.9|||
4291868|NCT00536471|4117494|B1|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 18A:Diurnal Variation|Measures whether symptoms are worse in morning or evening on a scale of 0 (no variation), 1 (worse in morning), or 2 (worse in evening).|units on a scale|Mean|0.8|0.8|Standard Deviation|0.8|0.8|||
4291869|NCT00536471|4117490|B5|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 17:Insight|Measures insight on a scale of 0 (acknowledges being depressed and ill) to 2 (denies being ill at all).|units on a scale|Mean|0.1|0.1|Standard Deviation|0.4|0.4|||
4291870|NCT00536471|4117491|B4|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 17:Insight|Measures insight on a scale of 0 (acknowledges being depressed and ill) to 2 (denies being ill at all).|units on a scale|Mean|0.0|0.0|Standard Deviation|0.2|0.2|||
4291871|NCT00536471|4117492|B3|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 17:Insight|Measures insight on a scale of 0 (acknowledges being depressed and ill) to 2 (denies being ill at all).|units on a scale|Mean|0.1|0.1|Standard Deviation|0.2|0.2|||
4291872|NCT00536471|4117493|B2|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 17:Insight|Measures insight on a scale of 0 (acknowledges being depressed and ill) to 2 (denies being ill at all).|units on a scale|Mean|0.2|0.2|Standard Deviation|0.4|0.4|||
4291873|NCT00536471|4117494|B1|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 17:Insight|Measures insight on a scale of 0 (acknowledges being depressed and ill) to 2 (denies being ill at all).|units on a scale|Mean|0.2|0.2|Standard Deviation|0.4|0.4|||
4291874|NCT00536471|4117490|B5|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 16:Loss of Weight|Measures weight loss since last visit on a scale of 0 (no weight loss) to 2 (definite weight loss caused by present illness).|units on a scale|Mean|0.3|0.3|Standard Deviation|0.6|0.6|||
4291875|NCT00536471|4117491|B4|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 16:Loss of Weight|Measures weight loss since last visit on a scale of 0 (no weight loss) to 2 (definite weight loss caused by present illness).|units on a scale|Mean|0.4|0.4|Standard Deviation|0.7|0.7|||
4291876|NCT00536471|4117492|B3|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 16:Loss of Weight|Measures weight loss since last visit on a scale of 0 (no weight loss) to 2 (definite weight loss caused by present illness).|units on a scale|Mean|0.3|0.3|Standard Deviation|0.6|0.6|||
4291877|NCT00536471|4117493|B2|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 16:Loss of Weight|Measures weight loss since last visit on a scale of 0 (no weight loss) to 2 (definite weight loss caused by present illness).|units on a scale|Mean|0.2|0.2|Standard Deviation|0.5|0.5|||
4291878|NCT00536471|4117494|B1|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 16:Loss of Weight|Measures weight loss since last visit on a scale of 0 (no weight loss) to 2 (definite weight loss caused by present illness).|units on a scale|Mean|0.3|0.3|Standard Deviation|0.6|0.6|||
4291879|NCT00536471|4117490|B5|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 15:Hypochondriasis|Measures hypochondriasis on a scale of 0 (not present) to 4 (hypochondriacal delusions).|units on a scale|Mean|0.9|0.9|Standard Deviation|0.9|0.9|||
4291880|NCT00536471|4117491|B4|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 15:Hypochondriasis|Measures hypochondriasis on a scale of 0 (not present) to 4 (hypochondriacal delusions).|units on a scale|Mean|1.1|1.1|Standard Deviation|0.9|0.9|||
4291881|NCT00536471|4117492|B3|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 15:Hypochondriasis|Measures hypochondriasis on a scale of 0 (not present) to 4 (hypochondriacal delusions).|units on a scale|Mean|1.0|1.0|Standard Deviation|0.9|0.9|||
4291882|NCT00536471|4117493|B2|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 15:Hypochondriasis|Measures hypochondriasis on a scale of 0 (not present) to 4 (hypochondriacal delusions).|units on a scale|Mean|0.7|0.7|Standard Deviation|0.8|0.8|||
4291883|NCT00536471|4117494|B1|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 15:Hypochondriasis|Measures hypochondriasis on a scale of 0 (not present) to 4 (hypochondriacal delusions).|units on a scale|Mean|0.7|0.7|Standard Deviation|0.8|0.8|||
4291884|NCT00536471|4117490|B5|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 14:Genital Symptoms|Measures genital symptoms (loss of libido, menstrual disturbances) on a scale of 0 (absent) to 2 (severe).|units on a scale|Mean|1.2|1.2|Standard Deviation|0.8|0.8|||
4291885|NCT00536471|4117491|B4|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 14:Genital Symptoms|Measures genital symptoms (loss of libido, menstrual disturbances) on a scale of 0 (absent) to 2 (severe).|units on a scale|Mean|1.1|1.1|Standard Deviation|0.9|0.9|||
4291886|NCT00536471|4117492|B3|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 14:Genital Symptoms|Measures genital symptoms (loss of libido, menstrual disturbances) on a scale of 0 (absent) to 2 (severe).|units on a scale|Mean|1.3|1.3|Standard Deviation|0.8|0.8|||
4291887|NCT00536471|4117493|B2|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 14:Genital Symptoms|Measures genital symptoms (loss of libido, menstrual disturbances) on a scale of 0 (absent) to 2 (severe).|units on a scale|Mean|1.2|1.2|Standard Deviation|0.9|0.9|||
4291888|NCT00536471|4117494|B1|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 14:Genital Symptoms|Measures genital symptoms (loss of libido, menstrual disturbances) on a scale of 0 (absent) to 2 (severe).|units on a scale|Mean|1.3|1.3|Standard Deviation|0.8|0.8|||
4291889|NCT00536471|4117490|B5|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 13:Somatic Symptoms/General|Measures general somatic symptoms on a scale of 0 (none) to 2 (any clear-cut symptoms).|units on a scale|Mean|1.7|1.7|Standard Deviation|0.5|0.5|||
4291890|NCT00536471|4117491|B4|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 13:Somatic Symptoms/General|Measures general somatic symptoms on a scale of 0 (none) to 2 (any clear-cut symptoms).|units on a scale|Mean|1.7|1.7|Standard Deviation|0.6|0.6|||
4291891|NCT00536471|4117492|B3|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 13:Somatic Symptoms/General|Measures general somatic symptoms on a scale of 0 (none) to 2 (any clear-cut symptoms).|units on a scale|Mean|1.7|1.7|Standard Deviation|0.5|0.5|||
4291892|NCT00536471|4117493|B2|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 13:Somatic Symptoms/General|Measures general somatic symptoms on a scale of 0 (none) to 2 (any clear-cut symptoms).|units on a scale|Mean|1.7|1.7|Standard Deviation|0.5|0.5|||
4291893|NCT00536471|4117494|B1|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 13:Somatic Symptoms/General|Measures general somatic symptoms on a scale of 0 (none) to 2 (any clear-cut symptoms).|units on a scale|Mean|1.6|1.6|Standard Deviation|0.6|0.6|||
4291894|NCT00536471|4117490|B5|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 11:Anxiety (Somatic)|Measures physiological concomitants of anxiety on a scale of 0 (absent) to 4 (incapacitating).|units on a scale|Mean|1.5|1.5|Standard Deviation|0.9|0.9|||
4291995|NCT00536471|4117491|B4|No||History - Seasonal Pattern in Major Depressive Disorder (MDD) if ≥3 Previous MDD Episodes||participants|Number|112|112.0||||||
4291895|NCT00536471|4117491|B4|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 11:Anxiety (Somatic)|Measures physiological concomitants of anxiety on a scale of 0 (absent) to 4 (incapacitating).|units on a scale|Mean|1.6|1.6|Standard Deviation|0.9|0.9|||
4291896|NCT00536471|4117492|B3|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 11:Anxiety (Somatic)|Measures physiological concomitants of anxiety on a scale of 0 (absent) to 4 (incapacitating).|units on a scale|Mean|1.6|1.6|Standard Deviation|0.9|0.9|||
4291897|NCT00536471|4117493|B2|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 11:Anxiety (Somatic)|Measures physiological concomitants of anxiety on a scale of 0 (absent) to 4 (incapacitating).|units on a scale|Mean|1.5|1.5|Standard Deviation|0.8|0.8|||
4291898|NCT00536471|4117494|B1|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 11:Anxiety (Somatic)|Measures physiological concomitants of anxiety on a scale of 0 (absent) to 4 (incapacitating).|units on a scale|Mean|1.4|1.4|Standard Deviation|0.8|0.8|||
4291899|NCT00536471|4117490|B5|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 10:Anxiety (Psychic)|Measures anxiety on a scale of 0 (no difficulty) to 4 (fears expressed).|units on a scale|Mean|2.1|2.1|Standard Deviation|0.8|0.8|||
4291900|NCT00536471|4117491|B4|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 10:Anxiety (Psychic)|Measures anxiety on a scale of 0 (no difficulty) to 4 (fears expressed).|units on a scale|Mean|2.2|2.2|Standard Deviation|0.8|0.8|||
4291901|NCT00536471|4117492|B3|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 10:Anxiety (Psychic)|Measures anxiety on a scale of 0 (no difficulty) to 4 (fears expressed).|units on a scale|Mean|2.1|2.1|Standard Deviation|0.8|0.8|||
4291902|NCT00536471|4117493|B2|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 10:Anxiety (Psychic)|Measures anxiety on a scale of 0 (no difficulty) to 4 (fears expressed).|units on a scale|Mean|2.1|2.1|Standard Deviation|0.7|0.7|||
4291903|NCT00536471|4117494|B1|||Evaluation - 24-Item Hamilton Depression Rating Scale (HAMD-24) - Item 10:Anxiety (Psychic)|Measures anxiety on a scale of 0 (no difficulty) to 4 (fears expressed).|units on a scale|Mean|2.1|2.1|Standard Deviation|0.8|0.8|||
4291904|NCT00536471|4117490|B5|||Evaluation - 17-Item Hamilton Depression Rating Scale (HAMD-17) Total Score|The 17-item HAMD measures depression severity. Each item was evaluated and scored using either a 5-point scale (e.g. absent, mild, moderate, severe, very severe) or a 3-point scale (e.g. absent, mild, marked). The total score of HAMD-17 may range from 0 (normal) to 52 (severe).|units on a scale|Mean|22.8|22.8|Standard Deviation|4.4|4.4|||
4291905|NCT00536471|4117491|B4|||Evaluation - 17-Item Hamilton Depression Rating Scale (HAMD-17) Total Score|The 17-item HAMD measures depression severity. Each item was evaluated and scored using either a 5-point scale (e.g. absent, mild, moderate, severe, very severe) or a 3-point scale (e.g. absent, mild, marked). The total score of HAMD-17 may range from 0 (normal) to 52 (severe).|units on a scale|Mean|22.9|22.9|Standard Deviation|4.9|4.9|||
4291906|NCT00536471|4117492|B3|||Evaluation - 17-Item Hamilton Depression Rating Scale (HAMD-17) Total Score|The 17-item HAMD measures depression severity. Each item was evaluated and scored using either a 5-point scale (e.g. absent, mild, moderate, severe, very severe) or a 3-point scale (e.g. absent, mild, marked). The total score of HAMD-17 may range from 0 (normal) to 52 (severe).|units on a scale|Mean|22.8|22.8|Standard Deviation|4.5|4.5|||
4291907|NCT00536471|4117493|B2|||Evaluation - 17-Item Hamilton Depression Rating Scale (HAMD-17) Total Score|The 17-item HAMD measures depression severity. Each item was evaluated and scored using either a 5-point scale (e.g. absent, mild, moderate, severe, very severe) or a 3-point scale (e.g. absent, mild, marked). The total score of HAMD-17 may range from 0 (normal) to 52 (severe).|units on a scale|Mean|22.8|22.8|Standard Deviation|3.7|3.7|||
4291908|NCT00536471|4117494|B1|||Evaluation - 17-Item Hamilton Depression Rating Scale (HAMD-17) Total Score|The 17-item HAMD measures depression severity. Each item was evaluated and scored using either a 5-point scale (e.g. absent, mild, moderate, severe, very severe) or a 3-point scale (e.g. absent, mild, marked). The total score of HAMD-17 may range from 0 (normal) to 52 (severe).|units on a scale|Mean|22.9|22.9|Standard Deviation|4.3|4.3|||
4291909|NCT00536471|4117490|B5|||Evaluation - 16-Item Quick Inventory of Depressive Symptomatology (QIDS16) Total Score|A 16-item patient-rated measure of depressive symptomatology. The total score ranges from 0 to 27 with higher scores indicative of greater severity.|units on a scale|Mean|14.6|14.6|Standard Deviation|4.2|4.2|||
4291910|NCT00536471|4117491|B4|||Evaluation - 16-Item Quick Inventory of Depressive Symptomatology (QIDS16) Total Score|A 16-item patient-rated measure of depressive symptomatology. The total score ranges from 0 to 27 with higher scores indicative of greater severity.|units on a scale|Mean|14.7|14.7|Standard Deviation|3.8|3.8|||
4291911|NCT00536471|4117492|B3|||Evaluation - 16-Item Quick Inventory of Depressive Symptomatology (QIDS16) Total Score|A 16-item patient-rated measure of depressive symptomatology. The total score ranges from 0 to 27 with higher scores indicative of greater severity.|units on a scale|Mean|15.0|15.0|Standard Deviation|4.4|4.4|||
4291912|NCT00536471|4117493|B2|||Evaluation - 16-Item Quick Inventory of Depressive Symptomatology (QIDS16) Total Score|A 16-item patient-rated measure of depressive symptomatology. The total score ranges from 0 to 27 with higher scores indicative of greater severity.|units on a scale|Mean|13.7|13.7|Standard Deviation|4.4|4.4|||
4291913|NCT00536471|4117494|B1|||Evaluation - 16-Item Quick Inventory of Depressive Symptomatology (QIDS16) Total Score|A 16-item patient-rated measure of depressive symptomatology. The total score ranges from 0 to 27 with higher scores indicative of greater severity.|units on a scale|Mean|14.7|14.7|Standard Deviation|4.1|4.1|||
4291914|NCT00536471|4117490|B5|Confusion-Bewilderment Score||Evaluation - Brief Profile of Mood States (BPOMS)|The 30-item BPOMS measures mood states and has 6 factors: tension-anxiety, depression-dejection, anxiety-hostility, fatigue, confusion, and vigor. Item scores: 0 (not at all) to 4 (extremely). Each factor scores range from 0 to 20. The Total score is sum of all factor scores minus the factor score for vigor (Total=Ten+Dep+Ang+Fat+Con-Vig).|units on a scale|Mean|9.8|9.8|Standard Deviation|4.0|4.0|||
4291915|NCT00536471|4117491|B4|Confusion-Bewilderment Score||Evaluation - Brief Profile of Mood States (BPOMS)|The 30-item BPOMS measures mood states and has 6 factors: tension-anxiety, depression-dejection, anxiety-hostility, fatigue, confusion, and vigor. Item scores: 0 (not at all) to 4 (extremely). Each factor scores range from 0 to 20. The Total score is sum of all factor scores minus the factor score for vigor (Total=Ten+Dep+Ang+Fat+Con-Vig).|units on a scale|Mean|10.1|10.1|Standard Deviation|3.8|3.8|||
4291916|NCT00536471|4117492|B3|Confusion-Bewilderment Score||Evaluation - Brief Profile of Mood States (BPOMS)|The 30-item BPOMS measures mood states and has 6 factors: tension-anxiety, depression-dejection, anxiety-hostility, fatigue, confusion, and vigor. Item scores: 0 (not at all) to 4 (extremely). Each factor scores range from 0 to 20. The Total score is sum of all factor scores minus the factor score for vigor (Total=Ten+Dep+Ang+Fat+Con-Vig).|units on a scale|Mean|9.8|9.8|Standard Deviation|4.1|4.1|||
4291917|NCT00536471|4117493|B2|Confusion-Bewilderment Score||Evaluation - Brief Profile of Mood States (BPOMS)|The 30-item BPOMS measures mood states and has 6 factors: tension-anxiety, depression-dejection, anxiety-hostility, fatigue, confusion, and vigor. Item scores: 0 (not at all) to 4 (extremely). Each factor scores range from 0 to 20. The Total score is sum of all factor scores minus the factor score for vigor (Total=Ten+Dep+Ang+Fat+Con-Vig).|units on a scale|Mean|9.6|9.6|Standard Deviation|3.9|3.9|||
4291918|NCT00536471|4117494|B1|Confusion-Bewilderment Score||Evaluation - Brief Profile of Mood States (BPOMS)|The 30-item BPOMS measures mood states and has 6 factors: tension-anxiety, depression-dejection, anxiety-hostility, fatigue, confusion, and vigor. Item scores: 0 (not at all) to 4 (extremely). Each factor scores range from 0 to 20. The Total score is sum of all factor scores minus the factor score for vigor (Total=Ten+Dep+Ang+Fat+Con-Vig).|units on a scale|Mean|9.7|9.7|Standard Deviation|4.0|4.0|||
4291919|NCT00536471|4117490|B5|Fatigue-Inertia Score||Evaluation - Brief Profile of Mood States (BPOMS)|The 30-item BPOMS measures mood states and has 6 factors: tension-anxiety, depression-dejection, anxiety-hostility, fatigue, confusion, and vigor. Item scores: 0 (not at all) to 4 (extremely). Each factor scores range from 0 to 20. The Total score is sum of all factor scores minus the factor score for vigor (Total=Ten+Dep+Ang+Fat+Con-Vig).|units on a scale|Mean|13.0|13.0|Standard Deviation|4.7|4.7|||
4291920|NCT00536471|4117491|B4|Fatigue-Inertia Score||Evaluation - Brief Profile of Mood States (BPOMS)|The 30-item BPOMS measures mood states and has 6 factors: tension-anxiety, depression-dejection, anxiety-hostility, fatigue, confusion, and vigor. Item scores: 0 (not at all) to 4 (extremely). Each factor scores range from 0 to 20. The Total score is sum of all factor scores minus the factor score for vigor (Total=Ten+Dep+Ang+Fat+Con-Vig).|units on a scale|Mean|13.2|13.2|Standard Deviation|4.5|4.5|||
4291921|NCT00536471|4117492|B3|Fatigue-Inertia Score||Evaluation - Brief Profile of Mood States (BPOMS)|The 30-item BPOMS measures mood states and has 6 factors: tension-anxiety, depression-dejection, anxiety-hostility, fatigue, confusion, and vigor. Item scores: 0 (not at all) to 4 (extremely). Each factor scores range from 0 to 20. The Total score is sum of all factor scores minus the factor score for vigor (Total=Ten+Dep+Ang+Fat+Con-Vig).|units on a scale|Mean|13.5|13.5|Standard Deviation|4.7|4.7|||
4291922|NCT00536471|4117493|B2|Fatigue-Inertia Score||Evaluation - Brief Profile of Mood States (BPOMS)|The 30-item BPOMS measures mood states and has 6 factors: tension-anxiety, depression-dejection, anxiety-hostility, fatigue, confusion, and vigor. Item scores: 0 (not at all) to 4 (extremely). Each factor scores range from 0 to 20. The Total score is sum of all factor scores minus the factor score for vigor (Total=Ten+Dep+Ang+Fat+Con-Vig).|units on a scale|Mean|12.3|12.3|Standard Deviation|4.8|4.8|||
4291923|NCT00536471|4117494|B1|Fatigue-Inertia Score||Evaluation - Brief Profile of Mood States (BPOMS)|The 30-item BPOMS measures mood states and has 6 factors: tension-anxiety, depression-dejection, anxiety-hostility, fatigue, confusion, and vigor. Item scores: 0 (not at all) to 4 (extremely). Each factor scores range from 0 to 20. The Total score is sum of all factor scores minus the factor score for vigor (Total=Ten+Dep+Ang+Fat+Con-Vig).|units on a scale|Mean|12.8|12.8|Standard Deviation|4.6|4.6|||
4291924|NCT00536471|4117490|B5|Vigor-Activity Score||Evaluation - Brief Profile of Mood States (BPOMS)|The 30-item BPOMS measures mood states and has 6 factors: tension-anxiety, depression-dejection, anxiety-hostility, fatigue, confusion, and vigor. Item scores: 0 (not at all) to 4 (extremely). Each factor scores range from 0 to 20. The Total score is sum of all factor scores minus the factor score for vigor (Total=Ten+Dep+Ang+Fat+Con-Vig).|units on a scale|Mean|3.5|3.5|Standard Deviation|3.2|3.2|||
4291925|NCT00536471|4117491|B4|Vigor-Activity Score||Evaluation - Brief Profile of Mood States (BPOMS)|The 30-item BPOMS measures mood states and has 6 factors: tension-anxiety, depression-dejection, anxiety-hostility, fatigue, confusion, and vigor. Item scores: 0 (not at all) to 4 (extremely). Each factor scores range from 0 to 20. The Total score is sum of all factor scores minus the factor score for vigor (Total=Ten+Dep+Ang+Fat+Con-Vig).|units on a scale|Mean|3.4|3.4|Standard Deviation|3.0|3.0|||
4291926|NCT00536471|4117492|B3|Vigor-Activity Score||Evaluation - Brief Profile of Mood States (BPOMS)|The 30-item BPOMS measures mood states and has 6 factors: tension-anxiety, depression-dejection, anxiety-hostility, fatigue, confusion, and vigor. Item scores: 0 (not at all) to 4 (extremely). Each factor scores range from 0 to 20. The Total score is sum of all factor scores minus the factor score for vigor (Total=Ten+Dep+Ang+Fat+Con-Vig).|units on a scale|Mean|3.6|3.6|Standard Deviation|3.5|3.5|||
4291927|NCT00536471|4117493|B2|Vigor-Activity Score||Evaluation - Brief Profile of Mood States (BPOMS)|The 30-item BPOMS measures mood states and has 6 factors: tension-anxiety, depression-dejection, anxiety-hostility, fatigue, confusion, and vigor. Item scores: 0 (not at all) to 4 (extremely). Each factor scores range from 0 to 20. The Total score is sum of all factor scores minus the factor score for vigor (Total=Ten+Dep+Ang+Fat+Con-Vig).|units on a scale|Mean|3.9|3.9|Standard Deviation|3.1|3.1|||
4291928|NCT00536471|4117494|B1|Vigor-Activity Score||Evaluation - Brief Profile of Mood States (BPOMS)|The 30-item BPOMS measures mood states and has 6 factors: tension-anxiety, depression-dejection, anxiety-hostility, fatigue, confusion, and vigor. Item scores: 0 (not at all) to 4 (extremely). Each factor scores range from 0 to 20. The Total score is sum of all factor scores minus the factor score for vigor (Total=Ten+Dep+Ang+Fat+Con-Vig).|units on a scale|Mean|3.4|3.4|Standard Deviation|3.1|3.1|||
4291929|NCT00536471|4117490|B5|Anger-Hostility Score||Evaluation - Brief Profile of Mood States (BPOMS)|The 30-item BPOMS measures mood states and has 6 factors: tension-anxiety, depression-dejection, anxiety-hostility, fatigue, confusion, and vigor. Item scores: 0 (not at all) to 4 (extremely). Each factor scores range from 0 to 20. The Total score is sum of all factor scores minus the factor score for vigor (Total=Ten+Dep+Ang+Fat+Con-Vig).|units on a scale|Mean|9.2|9.2|Standard Deviation|5.3|5.3|||
4291990|NCT00536471|4117491|B4|Missing Response||History - Seasonal Pattern in Major Depressive Disorder (MDD) if ≥3 Previous MDD Episodes||participants|Number|15|15.0||||||
4291991|NCT00536471|4117492|B3|Missing Response||History - Seasonal Pattern in Major Depressive Disorder (MDD) if ≥3 Previous MDD Episodes||participants|Number|20|20.0||||||
4291930|NCT00536471|4117491|B4|Anger-Hostility Score||Evaluation - Brief Profile of Mood States (BPOMS)|The 30-item BPOMS measures mood states and has 6 factors: tension-anxiety, depression-dejection, anxiety-hostility, fatigue, confusion, and vigor. Item scores: 0 (not at all) to 4 (extremely). Each factor scores range from 0 to 20. The Total score is sum of all factor scores minus the factor score for vigor (Total=Ten+Dep+Ang+Fat+Con-Vig).|units on a scale|Mean|9.5|9.5|Standard Deviation|5.4|5.4|||
4291931|NCT00536471|4117492|B3|Anger-Hostility Score||Evaluation - Brief Profile of Mood States (BPOMS)|The 30-item BPOMS measures mood states and has 6 factors: tension-anxiety, depression-dejection, anxiety-hostility, fatigue, confusion, and vigor. Item scores: 0 (not at all) to 4 (extremely). Each factor scores range from 0 to 20. The Total score is sum of all factor scores minus the factor score for vigor (Total=Ten+Dep+Ang+Fat+Con-Vig).|units on a scale|Mean|9.5|9.5|Standard Deviation|5.1|5.1|||
4291932|NCT00536471|4117493|B2|Anger-Hostility Score||Evaluation - Brief Profile of Mood States (BPOMS)|The 30-item BPOMS measures mood states and has 6 factors: tension-anxiety, depression-dejection, anxiety-hostility, fatigue, confusion, and vigor. Item scores: 0 (not at all) to 4 (extremely). Each factor scores range from 0 to 20. The Total score is sum of all factor scores minus the factor score for vigor (Total=Ten+Dep+Ang+Fat+Con-Vig).|units on a scale|Mean|9.0|9.0|Standard Deviation|5.4|5.4|||
4291933|NCT00536471|4117494|B1|Anger-Hostility Score||Evaluation - Brief Profile of Mood States (BPOMS)|The 30-item BPOMS measures mood states and has 6 factors: tension-anxiety, depression-dejection, anxiety-hostility, fatigue, confusion, and vigor. Item scores: 0 (not at all) to 4 (extremely). Each factor scores range from 0 to 20. The Total score is sum of all factor scores minus the factor score for vigor (Total=Ten+Dep+Ang+Fat+Con-Vig).|units on a scale|Mean|8.9|8.9|Standard Deviation|5.4|5.4|||
4291934|NCT00536471|4117490|B5|Depression-Dejection Score||Evaluation - Brief Profile of Mood States (BPOMS)|The 30-item BPOMS measures mood states and has 6 factors: tension-anxiety, depression-dejection, anxiety-hostility, fatigue, confusion, and vigor. Item scores: 0 (not at all) to 4 (extremely). Each factor scores range from 0 to 20. The Total score is sum of all factor scores minus the factor score for vigor (Total=Ten+Dep+Ang+Fat+Con-Vig).|units on a scale|Mean|12.0|12.0|Standard Deviation|4.7|4.7|||
4291935|NCT00536471|4117491|B4|Depression-Dejection Score||Evaluation - Brief Profile of Mood States (BPOMS)|The 30-item BPOMS measures mood states and has 6 factors: tension-anxiety, depression-dejection, anxiety-hostility, fatigue, confusion, and vigor. Item scores: 0 (not at all) to 4 (extremely). Each factor scores range from 0 to 20. The Total score is sum of all factor scores minus the factor score for vigor (Total=Ten+Dep+Ang+Fat+Con-Vig).|units on a scale|Mean|12.0|12.0|Standard Deviation|4.2|4.2|||
4291936|NCT00536471|4117492|B3|Depression-Dejection Score||Evaluation - Brief Profile of Mood States (BPOMS)|The 30-item BPOMS measures mood states and has 6 factors: tension-anxiety, depression-dejection, anxiety-hostility, fatigue, confusion, and vigor. Item scores: 0 (not at all) to 4 (extremely). Each factor scores range from 0 to 20. The Total score is sum of all factor scores minus the factor score for vigor (Total=Ten+Dep+Ang+Fat+Con-Vig).|units on a scale|Mean|12.3|12.3|Standard Deviation|4.6|4.6|||
4291937|NCT00536471|4117493|B2|Depression-Dejection Score||Evaluation - Brief Profile of Mood States (BPOMS)|The 30-item BPOMS measures mood states and has 6 factors: tension-anxiety, depression-dejection, anxiety-hostility, fatigue, confusion, and vigor. Item scores: 0 (not at all) to 4 (extremely). Each factor scores range from 0 to 20. The Total score is sum of all factor scores minus the factor score for vigor (Total=Ten+Dep+Ang+Fat+Con-Vig).|units on a scale|Mean|11.5|11.5|Standard Deviation|4.8|4.8|||
4291938|NCT00536471|4117494|B1|Depression-Dejection Score||Evaluation - Brief Profile of Mood States (BPOMS)|The 30-item BPOMS measures mood states and has 6 factors: tension-anxiety, depression-dejection, anxiety-hostility, fatigue, confusion, and vigor. Item scores: 0 (not at all) to 4 (extremely). Each factor scores range from 0 to 20. The Total score is sum of all factor scores minus the factor score for vigor (Total=Ten+Dep+Ang+Fat+Con-Vig).|units on a scale|Mean|11.8|11.8|Standard Deviation|4.8|4.8|||
4291939|NCT00536471|4117490|B5|Tension-Anxiety Score||Evaluation - Brief Profile of Mood States (BPOMS)|The 30-item BPOMS measures mood states and has 6 factors: tension-anxiety, depression-dejection, anxiety-hostility, fatigue, confusion, and vigor. Item scores: 0 (not at all) to 4 (extremely). Each factor scores range from 0 to 20. The Total score is sum of all factor scores minus the factor score for vigor (Total=Ten+Dep+Ang+Fat+Con-Vig).|units on a scale|Mean|9.8|9.8|Standard Deviation|4.7|4.7|||
4291940|NCT00536471|4117491|B4|Tension-Anxiety Score||Evaluation - Brief Profile of Mood States (BPOMS)|The 30-item BPOMS measures mood states and has 6 factors: tension-anxiety, depression-dejection, anxiety-hostility, fatigue, confusion, and vigor. Item scores: 0 (not at all) to 4 (extremely). Each factor scores range from 0 to 20. The Total score is sum of all factor scores minus the factor score for vigor (Total=Ten+Dep+Ang+Fat+Con-Vig).|units on a scale|Mean|10.4|10.4|Standard Deviation|4.6|4.6|||
4291941|NCT00536471|4117492|B3|Tension-Anxiety Score||Evaluation - Brief Profile of Mood States (BPOMS)|The 30-item BPOMS measures mood states and has 6 factors: tension-anxiety, depression-dejection, anxiety-hostility, fatigue, confusion, and vigor. Item scores: 0 (not at all) to 4 (extremely). Each factor scores range from 0 to 20. The Total score is sum of all factor scores minus the factor score for vigor (Total=Ten+Dep+Ang+Fat+Con-Vig).|units on a scale|Mean|10.0|10.0|Standard Deviation|5.0|5.0|||
4291942|NCT00536471|4117493|B2|Tension-Anxiety Score||Evaluation - Brief Profile of Mood States (BPOMS)|The 30-item BPOMS measures mood states and has 6 factors: tension-anxiety, depression-dejection, anxiety-hostility, fatigue, confusion, and vigor. Item scores: 0 (not at all) to 4 (extremely). Each factor scores range from 0 to 20. The Total score is sum of all factor scores minus the factor score for vigor (Total=Ten+Dep+Ang+Fat+Con-Vig).|units on a scale|Mean|9.2|9.2|Standard Deviation|4.6|4.6|||
4291943|NCT00536471|4117494|B1|Tension-Anxiety Score||Evaluation - Brief Profile of Mood States (BPOMS)|The 30-item BPOMS measures mood states and has 6 factors: tension-anxiety, depression-dejection, anxiety-hostility, fatigue, confusion, and vigor. Item scores: 0 (not at all) to 4 (extremely). Each factor scores range from 0 to 20. The Total score is sum of all factor scores minus the factor score for vigor (Total=Ten+Dep+Ang+Fat+Con-Vig).|units on a scale|Mean|9.5|9.5|Standard Deviation|4.6|4.6|||
4291992|NCT00536471|4117493|B2|Missing Response||History - Seasonal Pattern in Major Depressive Disorder (MDD) if ≥3 Previous MDD Episodes||participants|Number|19|19.0||||||
4291993|NCT00536471|4117494|B1|Missing Response||History - Seasonal Pattern in Major Depressive Disorder (MDD) if ≥3 Previous MDD Episodes||participants|Number|34|34.0||||||
4291944|NCT00536471|4117490|B5|Total Score||Evaluation - Brief Profile of Mood States (BPOMS)|The 30-item BPOMS measures mood states and has 6 factors: tension-anxiety, depression-dejection, anxiety-hostility, fatigue, confusion, and vigor. Item scores: 0 (not at all) to 4 (extremely). Each factor scores range from 0 to 20. The Total score is sum of all factor scores minus the factor score for vigor (Total=Ten+Dep+Ang+Fat+Con-Vig).|units on a scale|Mean|50.2|50.2|Standard Deviation|19.1|19.1|||
4291945|NCT00536471|4117491|B4|Total Score||Evaluation - Brief Profile of Mood States (BPOMS)|The 30-item BPOMS measures mood states and has 6 factors: tension-anxiety, depression-dejection, anxiety-hostility, fatigue, confusion, and vigor. Item scores: 0 (not at all) to 4 (extremely). Each factor scores range from 0 to 20. The Total score is sum of all factor scores minus the factor score for vigor (Total=Ten+Dep+Ang+Fat+Con-Vig).|units on a scale|Mean|51.8|51.8|Standard Deviation|18.7|18.7|||
4291946|NCT00536471|4117492|B3|Total Score||Evaluation - Brief Profile of Mood States (BPOMS)|The 30-item BPOMS measures mood states and has 6 factors: tension-anxiety, depression-dejection, anxiety-hostility, fatigue, confusion, and vigor. Item scores: 0 (not at all) to 4 (extremely). Each factor scores range from 0 to 20. The Total score is sum of all factor scores minus the factor score for vigor (Total=Ten+Dep+Ang+Fat+Con-Vig).|units on a scale|Mean|51.8|51.8|Standard Deviation|19.3|19.3|||
4291947|NCT00536471|4117493|B2|Total Score||Evaluation - Brief Profile of Mood States (BPOMS)|The 30-item BPOMS measures mood states and has 6 factors: tension-anxiety, depression-dejection, anxiety-hostility, fatigue, confusion, and vigor. Item scores: 0 (not at all) to 4 (extremely). Each factor scores range from 0 to 20. The Total score is sum of all factor scores minus the factor score for vigor (Total=Ten+Dep+Ang+Fat+Con-Vig).|units on a scale|Mean|47.5|47.5|Standard Deviation|18.7|18.7|||
4291948|NCT00536471|4117494|B1|Total Score||Evaluation - Brief Profile of Mood States (BPOMS)|The 30-item BPOMS measures mood states and has 6 factors: tension-anxiety, depression-dejection, anxiety-hostility, fatigue, confusion, and vigor. Item scores: 0 (not at all) to 4 (extremely). Each factor scores range from 0 to 20. The Total score is sum of all factor scores minus the factor score for vigor (Total=Ten+Dep+Ang+Fat+Con-Vig).|units on a scale|Mean|49.0|49.0|Standard Deviation|19.2|19.2|||
4291949|NCT00536471|4117490|B5|||Body Weight||kilograms|Mean|87.7|87.7|Standard Deviation|24.5|24.5|||
4291950|NCT00536471|4117491|B4|||Body Weight||kilograms|Mean|86.4|86.4|Standard Deviation|23.5|23.5|||
4291951|NCT00536471|4117492|B3|||Body Weight||kilograms|Mean|88.6|88.6|Standard Deviation|26.6|26.6|||
4291952|NCT00536471|4117493|B2|||Body Weight||kilograms|Mean|84.9|84.9|Standard Deviation|22.5|22.5|||
4291953|NCT00536471|4117494|B1|||Body Weight||kilograms|Mean|88.8|88.8|Standard Deviation|23.7|23.7|||
4291954|NCT00536471|4117490|B5|||Body Height||centimeters|Mean|168.6|168.6|Standard Deviation|9.7|9.7|||
4291955|NCT00536471|4117491|B4|||Body Height||centimeters|Mean|168.8|168.8|Standard Deviation|9.4|9.4|||
4291956|NCT00536471|4117492|B3|||Body Height||centimeters|Mean|169.0|169.0|Standard Deviation|9.7|9.7|||
4291957|NCT00536471|4117493|B2|||Body Height||centimeters|Mean|168.5|168.5|Standard Deviation|9.2|9.2|||
4291958|NCT00536471|4117494|B1|||Body Height||centimeters|Mean|168.1|168.1|Standard Deviation|10.1|10.1|||
4291959|NCT00536471|4117490|B5|Native American||Race/Ethnicity||participants|Number|1|1.0||||||
4291960|NCT00536471|4117491|B4|Native American||Race/Ethnicity||participants|Number|1|1.0||||||
4291961|NCT00536471|4117492|B3|Native American||Race/Ethnicity||participants|Number|0|0.0||||||
4291962|NCT00536471|4117493|B2|Native American||Race/Ethnicity||participants|Number|0|0.0||||||
4291963|NCT00536471|4117494|B1|Native American||Race/Ethnicity||participants|Number|0|0.0||||||
4291964|NCT00536471|4117490|B5|West Asian (Indian sub-continent)||Race/Ethnicity||participants|Number|7|7.0||||||
4291965|NCT00536471|4117491|B4|West Asian (Indian sub-continent)||Race/Ethnicity||participants|Number|2|2.0||||||
4291966|NCT00536471|4117492|B3|West Asian (Indian sub-continent)||Race/Ethnicity||participants|Number|1|1.0||||||
4291967|NCT00536471|4117493|B2|West Asian (Indian sub-continent)||Race/Ethnicity||participants|Number|2|2.0||||||
4291968|NCT00536471|4117494|B1|West Asian (Indian sub-continent)||Race/Ethnicity||participants|Number|2|2.0||||||
4291969|NCT00536471|4117490|B5|East Asian||Race/Ethnicity||participants|Number|12|12.0||||||
4291970|NCT00536471|4117491|B4|East Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4291971|NCT00536471|4117492|B3|East Asian||Race/Ethnicity||participants|Number|3|3.0||||||
4291972|NCT00536471|4117493|B2|East Asian||Race/Ethnicity||participants|Number|5|5.0||||||
4291973|NCT00536471|4117494|B1|East Asian||Race/Ethnicity||participants|Number|3|3.0||||||
4291974|NCT00536471|4117490|B5|Hispanic||Race/Ethnicity||participants|Number|125|125.0||||||
4291975|NCT00536471|4117491|B4|Hispanic||Race/Ethnicity||participants|Number|30|30.0||||||
4291976|NCT00536471|4117492|B3|Hispanic||Race/Ethnicity||participants|Number|55|55.0||||||
4291977|NCT00536471|4117493|B2|Hispanic||Race/Ethnicity||participants|Number|11|11.0||||||
4291978|NCT00536471|4117494|B1|Hispanic||Race/Ethnicity||participants|Number|29|29.0||||||
4291979|NCT00536471|4117490|B5|Caucasian||Race/Ethnicity||participants|Number|486|486.0||||||
4291980|NCT00536471|4117491|B4|Caucasian||Race/Ethnicity||participants|Number|81|81.0||||||
4291981|NCT00536471|4117492|B3|Caucasian||Race/Ethnicity||participants|Number|172|172.0||||||
4291982|NCT00536471|4117493|B2|Caucasian||Race/Ethnicity||participants|Number|73|73.0||||||
4291983|NCT00536471|4117494|B1|Caucasian||Race/Ethnicity||participants|Number|160|160.0||||||
4291984|NCT00536471|4117490|B5|African||Race/Ethnicity||participants|Number|145|145.0||||||
4291985|NCT00536471|4117491|B4|African||Race/Ethnicity||participants|Number|16|16.0||||||
4291986|NCT00536471|4117492|B3|African||Race/Ethnicity||participants|Number|30|30.0||||||
4291987|NCT00536471|4117493|B2|African||Race/Ethnicity||participants|Number|36|36.0||||||
4291988|NCT00536471|4117494|B1|African||Race/Ethnicity||participants|Number|63|63.0||||||
4291989|NCT00536471|4117490|B5|Missing Response||History - Seasonal Pattern in Major Depressive Disorder (MDD) if ≥3 Previous MDD Episodes||participants|Number|88|88.0||||||
4292055|NCT00536380|4117741|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4291996|NCT00536471|4117492|B3|No||History - Seasonal Pattern in Major Depressive Disorder (MDD) if ≥3 Previous MDD Episodes||participants|Number|232|232.0||||||
4291997|NCT00536471|4117493|B2|No||History - Seasonal Pattern in Major Depressive Disorder (MDD) if ≥3 Previous MDD Episodes||participants|Number|105|105.0||||||
4291998|NCT00536471|4117494|B1|No||History - Seasonal Pattern in Major Depressive Disorder (MDD) if ≥3 Previous MDD Episodes||participants|Number|220|220.0||||||
4291999|NCT00536471|4117490|B5|Yes||History - Seasonal Pattern in Major Depressive Disorder (MDD) if ≥3 Previous MDD Episodes||participants|Number|19|19.0||||||
4292000|NCT00536471|4117491|B4|Yes||History - Seasonal Pattern in Major Depressive Disorder (MDD) if ≥3 Previous MDD Episodes||participants|Number|4|4.0||||||
4292001|NCT00536471|4117492|B3|Yes||History - Seasonal Pattern in Major Depressive Disorder (MDD) if ≥3 Previous MDD Episodes||participants|Number|9|9.0||||||
4292002|NCT00536471|4117493|B2|Yes||History - Seasonal Pattern in Major Depressive Disorder (MDD) if ≥3 Previous MDD Episodes||participants|Number|3|3.0||||||
4292003|NCT00536471|4117494|B1|Yes||History - Seasonal Pattern in Major Depressive Disorder (MDD) if ≥3 Previous MDD Episodes||participants|Number|3|3.0||||||
4292004|NCT00536471|4117490|B5|No||History - Melancholic Depression||participants|Number|353|353.0||||||
4292005|NCT00536471|4117491|B4|No||History - Melancholic Depression||participants|Number|60|60.0||||||
4292006|NCT00536471|4117492|B3|No||History - Melancholic Depression||participants|Number|114|114.0||||||
4292007|NCT00536471|4117493|B2|No||History - Melancholic Depression||participants|Number|56|56.0||||||
4292008|NCT00536471|4117494|B1|No||History - Melancholic Depression||participants|Number|123|123.0||||||
4292009|NCT00536471|4117490|B5|Yes||History - Melancholic Depression||participants|Number|423|423.0||||||
4292010|NCT00536471|4117491|B4|Yes||History - Melancholic Depression||participants|Number|71|71.0||||||
4292011|NCT00536471|4117492|B3|Yes||History - Melancholic Depression||participants|Number|147|147.0||||||
4292012|NCT00536471|4117493|B2|Yes||History - Melancholic Depression||participants|Number|71|71.0||||||
4292013|NCT00536471|4117494|B1|Yes||History - Melancholic Depression||participants|Number|134|134.0||||||
4292014|NCT00536471|4117490|B5|No||History - Atypical Depression||participants|Number|738|738.0||||||
4292015|NCT00536471|4117491|B4|No||History - Atypical Depression||participants|Number|124|124.0||||||
4292016|NCT00536471|4117492|B3|No||History - Atypical Depression||participants|Number|242|242.0||||||
4292017|NCT00536471|4117493|B2|No||History - Atypical Depression||participants|Number|122|122.0||||||
4292018|NCT00536471|4117494|B1|No||History - Atypical Depression||participants|Number|250|250.0||||||
4292019|NCT00536471|4117490|B5|Yes||History - Atypical Depression||participants|Number|38|38.0||||||
4292020|NCT00536471|4117491|B4|Yes||History - Atypical Depression||participants|Number|7|7.0||||||
4292021|NCT00536471|4117492|B3|Yes||History - Atypical Depression||participants|Number|19|19.0||||||
4292022|NCT00536471|4117493|B2|Yes||History - Atypical Depression||participants|Number|5|5.0||||||
4292023|NCT00536471|4117494|B1|Yes||History - Atypical Depression||participants|Number|7|7.0||||||
4292024|NCT00536471|4117490|B5|Puerto Rico||Region of Enrollment||participants|Number|72|72.0||||||
4292025|NCT00536471|4117491|B4|Puerto Rico||Region of Enrollment||participants|Number|21|21.0||||||
4292026|NCT00536471|4117492|B3|Puerto Rico||Region of Enrollment||participants|Number|39|39.0||||||
4292027|NCT00536471|4117493|B2|Puerto Rico||Region of Enrollment||participants|Number|4|4.0||||||
4292028|NCT00536471|4117494|B1|Puerto Rico||Region of Enrollment||participants|Number|8|8.0||||||
4292029|NCT00536471|4117490|B5|United States||Region of Enrollment||participants|Number|704|704.0||||||
4292030|NCT00536471|4117491|B4|United States||Region of Enrollment||participants|Number|110|110.0||||||
4292031|NCT00536471|4117492|B3|United States||Region of Enrollment||participants|Number|222|222.0||||||
4292032|NCT00536471|4117493|B2|United States||Region of Enrollment||participants|Number|123|123.0||||||
4292033|NCT00536471|4117494|B1|United States||Region of Enrollment||participants|Number|249|249.0||||||
4292034|NCT00536471|4117490|B5||Male|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
4292035|NCT00536471|4117491|B4||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4292036|NCT00536471|4117492|B3||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4292037|NCT00536471|4117493|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4292038|NCT00536471|4117494|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4292039|NCT00536471|4117490|B5||Female|Sex: Female, Male||Participants|Count of Participants|489|489.0||||||
4292040|NCT00536471|4117491|B4||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4292041|NCT00536471|4117492|B3||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4292042|NCT00536471|4117493|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4292043|NCT00536471|4117494|B1||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4292044|NCT00536471|4117490|B5|||Age||years|Mean|43.6|43.6|Standard Deviation|12.2|12.2|||
4292045|NCT00536471|4117491|B4|||Age||years|Mean|43.9|43.9|Standard Deviation|11.9|11.9|||
4292046|NCT00536471|4117492|B3|||Age||years|Mean|44.7|44.7|Standard Deviation|12.2|12.2|||
4292047|NCT00536471|4117493|B2|||Age||years|Mean|43.7|43.7|Standard Deviation|12.5|12.5|||
4292048|NCT00536471|4117494|B1|||Age||years|Mean|42.2|42.2|Standard Deviation|12.2|12.2|||
4292049|NCT00536380|4117739|B4||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4292050|NCT00536380|4117740|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4292051|NCT00536380|4117741|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4292052|NCT00536380|4117742|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4292053|NCT00536380|4117739|B4||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4292054|NCT00536380|4117740|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4292057|NCT00536380|4117739|B4|||Age||years|Mean|40.6|40.6|Standard Deviation|13.4|13.4|||
4292058|NCT00536380|4117740|B3|||Age||years|Mean|40.1|40.1|Standard Deviation|14.2|14.2|||
4292059|NCT00536380|4117741|B2|||Age||years|Mean|40.4|40.4|Standard Deviation|13.3|13.3|||
4292060|NCT00536380|4117742|B1|||Age||years|Mean|41.4|41.4|Standard Deviation|12.8|12.8|||
4292061|NCT00536341|4117752|B3|United States||Region of Enrollment||participants|Number|64|64.0||||||
4292062|NCT00536341|4117753|B2|United States||Region of Enrollment||participants|Number|54|54.0||||||
4292063|NCT00536341|4117754|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4292064|NCT00536341|4117752|B3||Male|Gender||Participants|Count of Participants|37|37.0||||||
4292065|NCT00536341|4117753|B2||Male|Gender||Participants|Count of Participants|29|29.0||||||
4292066|NCT00536341|4117754|B1||Male|Gender||Participants|Count of Participants|8|8.0||||||
4292067|NCT00536341|4117752|B3||Female|Gender||Participants|Count of Participants|27|27.0||||||
4292068|NCT00536341|4117753|B2||Female|Gender||Participants|Count of Participants|25|25.0||||||
4292069|NCT00536341|4117754|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
4292070|NCT00536341|4117752|B3|||Age||years|Median|64|64.0|Full Range|||44.0|82.0|
4292071|NCT00536341|4117753|B2|||Age||years|Median|63|63.0|Full Range|||44.0|82.0|
4292072|NCT00536341|4117754|B1|||Age||years|Median|67|67.0|Full Range|||49.0|74.0|
4292073|NCT00536263|4117765|B4||Male|Sex: Female, Male|Treated Participants|Participants|Count of Participants|504|504.0||||||
4292074|NCT00536263|4117766|B3||Male|Sex: Female, Male|Treated Participants|Participants|Count of Participants|169|169.0||||||
4292075|NCT00536263|4117767|B2||Male|Sex: Female, Male|Treated Participants|Participants|Count of Participants|164|164.0||||||
4292076|NCT00536263|4117768|B1||Male|Sex: Female, Male|Treated Participants|Participants|Count of Participants|171|171.0||||||
4292077|NCT00536263|4117765|B4||Female|Sex: Female, Male|Treated Participants|Participants|Count of Participants|166|166.0||||||
4292078|NCT00536263|4117766|B3||Female|Sex: Female, Male|Treated Participants|Participants|Count of Participants|55|55.0||||||
4292079|NCT00536263|4117767|B2||Female|Sex: Female, Male|Treated Participants|Participants|Count of Participants|57|57.0||||||
4292080|NCT00536263|4117768|B1||Female|Sex: Female, Male|Treated Participants|Participants|Count of Participants|54|54.0||||||
4292081|NCT00536263|4117765|B4|||Age|Treated Participants|Years|Mean|28.0|28.0|Standard Deviation|7.3|7.3|||
4292082|NCT00536263|4117766|B3|||Age|Treated Participants|Years|Mean|28.4|28.4|Standard Deviation|7.6|7.6|||
4292083|NCT00536263|4117767|B2|||Age|Treated Participants|Years|Mean|27.5|27.5|Standard Deviation|7.1|7.1|||
4292084|NCT00536263|4117768|B1|||Age|Treated Participants|Years|Mean|28.2|28.2|Standard Deviation|7.2|7.2|||
4292085|NCT00536198|4117808|B3|||Baseline Luteal Phase Daily Rating of Severity of Problems Score|Daily Rating of Severity of Problems (DRSP), composed of 21 items reflecting 11 candidate symptoms for PMDD each scored 1-6. Min=11 (asymptomatic), Max=66 (Highly symptomatic), higher scores indicate most severe problems|units on a scale|Mean|60.8|60.8|Standard Deviation|18.7|18.7|||
4292086|NCT00536198|4117809|B2|||Baseline Luteal Phase Daily Rating of Severity of Problems Score|Daily Rating of Severity of Problems (DRSP), composed of 21 items reflecting 11 candidate symptoms for PMDD each scored 1-6. Min=11 (asymptomatic), Max=66 (Highly symptomatic), higher scores indicate most severe problems|units on a scale|Mean|60.37|60.37|Standard Deviation|17.37|17.37|||
4292087|NCT00536198|4117810|B1|||Baseline Luteal Phase Daily Rating of Severity of Problems Score|Daily Rating of Severity of Problems (DRSP), composed of 21 items reflecting 11 candidate symptoms for PMDD each scored 1-6. Min=11 (asymptomatic), Max=66 (Highly symptomatic), higher scores indicate most severe problems|units on a scale|Mean|61.20|61.2|Standard Deviation|20.09|20.09|||
4292088|NCT00536198|4117808|B3|||Baseline Length of Menstrual Cycle||days|Mean|27.4|27.4|Standard Deviation|4.9|4.9|||
4292089|NCT00536198|4117809|B2|||Baseline Length of Menstrual Cycle||days|Mean|27.02|27.02|Standard Deviation|4.58|4.58|||
4292090|NCT00536198|4117810|B1|||Baseline Length of Menstrual Cycle||days|Mean|27.92|27.92|Standard Deviation|5.26|5.26|||
4292091|NCT00536198|4117808|B3|No||Past Psychiatric Conditions: Major Depressive Disorder||participants|Number|174|174.0||||||
4292092|NCT00536198|4117809|B2|No||Past Psychiatric Conditions: Major Depressive Disorder||participants|Number|84|84.0||||||
4292093|NCT00536198|4117810|B1|No||Past Psychiatric Conditions: Major Depressive Disorder||participants|Number|90|90.0||||||
4292094|NCT00536198|4117808|B3|Yes||Past Psychiatric Conditions: Major Depressive Disorder||participants|Number|78|78.0||||||
4292095|NCT00536198|4117809|B2|Yes||Past Psychiatric Conditions: Major Depressive Disorder||participants|Number|43|43.0||||||
4292096|NCT00536198|4117810|B1|Yes||Past Psychiatric Conditions: Major Depressive Disorder||participants|Number|35|35.0||||||
4292097|NCT00536198|4117808|B3|Never married||Marital status||participants|Number|100|100.0||||||
4292098|NCT00536198|4117809|B2|Never married||Marital status||participants|Number|51|51.0||||||
4292099|NCT00536198|4117810|B1|Never married||Marital status||participants|Number|49|49.0||||||
4292100|NCT00536198|4117808|B3|Divorced/separated||Marital status||participants|Number|25|25.0||||||
4292101|NCT00536198|4117809|B2|Divorced/separated||Marital status||participants|Number|14|14.0||||||
4292102|NCT00536198|4117810|B1|Divorced/separated||Marital status||participants|Number|11|11.0||||||
4292103|NCT00536198|4117808|B3|Living with partner||Marital status||participants|Number|34|34.0||||||
4292104|NCT00536198|4117809|B2|Living with partner||Marital status||participants|Number|20|20.0||||||
4292105|NCT00536198|4117810|B1|Living with partner||Marital status||participants|Number|14|14.0||||||
4292106|NCT00536198|4117808|B3|Married||Marital status||participants|Number|93|93.0||||||
4292107|NCT00536198|4117809|B2|Married||Marital status||participants|Number|42|42.0||||||
4292108|NCT00536198|4117810|B1|Married||Marital status||participants|Number|51|51.0||||||
4292109|NCT00536198|4117808|B3|College/graduate or professional school||Education||participants|Number|167|167.0||||||
4292110|NCT00536198|4117809|B2|College/graduate or professional school||Education||participants|Number|94|94.0||||||
4292111|NCT00536198|4117810|B1|College/graduate or professional school||Education||participants|Number|73|73.0||||||
4292112|NCT00536198|4117808|B3|Some college||Education||participants|Number|62|62.0||||||
4292113|NCT00536198|4117809|B2|Some college||Education||participants|Number|22|22.0||||||
4292114|NCT00536198|4117810|B1|Some college||Education||participants|Number|40|40.0||||||
4292115|NCT00536198|4117808|B3|Some high school/high school graduate||Education||participants|Number|22|22.0||||||
4292116|NCT00536198|4117809|B2|Some high school/high school graduate||Education||participants|Number|11|11.0||||||
4292117|NCT00536198|4117810|B1|Some high school/high school graduate||Education||participants|Number|11|11.0||||||
4292118|NCT00536198|4117808|B3|Missing||Education||participants|Number|1|1.0||||||
4292119|NCT00536198|4117809|B2|Missing||Education||participants|Number|0|0.0||||||
4292120|NCT00536198|4117810|B1|Missing||Education||participants|Number|1|1.0||||||
4292121|NCT00536198|4117808|B3|United States||Region of Enrollment||participants|Number|252|252.0||||||
4292122|NCT00536198|4117809|B2|United States||Region of Enrollment||participants|Number|127|127.0||||||
4292123|NCT00536198|4117810|B1|United States||Region of Enrollment||participants|Number|125|125.0||||||
4292124|NCT00536198|4117808|B3|Asian/mixed/other||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4292125|NCT00536198|4117809|B2|Asian/mixed/other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4292126|NCT00536198|4117810|B1|Asian/mixed/other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4292127|NCT00536198|4117808|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4292128|NCT00536198|4117809|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4292129|NCT00536198|4117810|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4292130|NCT00536198|4117808|B3|Black||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4292131|NCT00536198|4117809|B2|Black||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4292132|NCT00536198|4117810|B1|Black||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4292133|NCT00536198|4117808|B3|White||Race/Ethnicity, Customized||participants|Number|175|175.0||||||
4292134|NCT00536198|4117809|B2|White||Race/Ethnicity, Customized||participants|Number|89|89.0||||||
4292135|NCT00536198|4117810|B1|White||Race/Ethnicity, Customized||participants|Number|86|86.0||||||
4292136|NCT00536198|4117808|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4292137|NCT00536198|4117809|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4292138|NCT00536198|4117810|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4292139|NCT00536198|4117808|B3||Female|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
4292140|NCT00536198|4117809|B2||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4292141|NCT00536198|4117810|B1||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4292142|NCT00536198|4117808|B3|||Age|mean age in years|years|Mean|34.17|34.17|Standard Deviation|6.82|6.82|||
4292143|NCT00536198|4117809|B2|||Age|mean age in years|years|Mean|34.6|34.6|Standard Deviation|6.90|6.9|||
4292144|NCT00536198|4117810|B1|||Age|mean age in years|years|Mean|33.7|33.7|Standard Deviation|6.71|6.71|||
4292145|NCT00536172|4117839|B3|radiation with/without chemotherapy||Initial Treatment Type (Surgery or Radiation)||participants|Number|67|67.0||||||
4292146|NCT00536172|4117840|B2|radiation with/without chemotherapy||Initial Treatment Type (Surgery or Radiation)||participants|Number|35|35.0||||||
4292147|NCT00536172|4117841|B1|radiation with/without chemotherapy||Initial Treatment Type (Surgery or Radiation)||participants|Number|32|32.0||||||
4292148|NCT00536172|4117839|B3|surgery, not biopsy||Initial Treatment Type (Surgery or Radiation)||participants|Number|81|81.0||||||
4292149|NCT00536172|4117840|B2|surgery, not biopsy||Initial Treatment Type (Surgery or Radiation)||participants|Number|39|39.0||||||
4292150|NCT00536172|4117841|B1|surgery, not biopsy||Initial Treatment Type (Surgery or Radiation)||participants|Number|42|42.0||||||
4292151|NCT00536172|4117839|B3|missing||Cancer Type||participants|Number|2|2.0||||||
4292152|NCT00536172|4117840|B2|missing||Cancer Type||participants|Number|2|2.0||||||
4292153|NCT00536172|4117841|B1|missing||Cancer Type||participants|Number|0|0.0||||||
4292154|NCT00536172|4117839|B3|skin||Cancer Type||participants|Number|4|4.0||||||
4292155|NCT00536172|4117840|B2|skin||Cancer Type||participants|Number|0|0.0||||||
4292156|NCT00536172|4117841|B1|skin||Cancer Type||participants|Number|4|4.0||||||
4292157|NCT00536172|4117839|B3|salivary gland||Cancer Type||participants|Number|10|10.0||||||
4292158|NCT00536172|4117840|B2|salivary gland||Cancer Type||participants|Number|5|5.0||||||
4292159|NCT00536172|4117841|B1|salivary gland||Cancer Type||participants|Number|5|5.0||||||
4292160|NCT00536172|4117839|B3|squamous cell||Cancer Type||participants|Number|132|132.0||||||
4292161|NCT00536172|4117840|B2|squamous cell||Cancer Type||participants|Number|67|67.0||||||
4292162|NCT00536172|4117841|B1|squamous cell||Cancer Type||participants|Number|65|65.0||||||
4292163|NCT00536172|4117839|B3|sinus||Cancer Site|anatomical location of tumor|participants|Number|6|6.0||||||
4292164|NCT00536172|4117840|B2|sinus||Cancer Site|anatomical location of tumor|participants|Number|1|1.0||||||
4292165|NCT00536172|4117841|B1|sinus||Cancer Site|anatomical location of tumor|participants|Number|5|5.0||||||
4292166|NCT00536172|4117839|B3|salivary gland||Cancer Site|anatomical location of tumor|participants|Number|11|11.0||||||
4292167|NCT00536172|4117840|B2|salivary gland||Cancer Site|anatomical location of tumor|participants|Number|5|5.0||||||
4292168|NCT00536172|4117841|B1|salivary gland||Cancer Site|anatomical location of tumor|participants|Number|6|6.0||||||
4292169|NCT00536172|4117839|B3|skin||Cancer Site|anatomical location of tumor|participants|Number|17|17.0||||||
4292170|NCT00536172|4117840|B2|skin||Cancer Site|anatomical location of tumor|participants|Number|8|8.0||||||
4292171|NCT00536172|4117841|B1|skin||Cancer Site|anatomical location of tumor|participants|Number|9|9.0||||||
4292172|NCT00536172|4117839|B3|pharynx||Cancer Site|anatomical location of tumor|participants|Number|49|49.0||||||
4292173|NCT00536172|4117840|B2|pharynx||Cancer Site|anatomical location of tumor|participants|Number|24|24.0||||||
4292174|NCT00536172|4117841|B1|pharynx||Cancer Site|anatomical location of tumor|participants|Number|25|25.0||||||
4292175|NCT00536172|4117839|B3|oral||Cancer Site|anatomical location of tumor|participants|Number|65|65.0||||||
4292176|NCT00536172|4117840|B2|oral||Cancer Site|anatomical location of tumor|participants|Number|36|36.0||||||
4292177|NCT00536172|4117841|B1|oral||Cancer Site|anatomical location of tumor|participants|Number|29|29.0||||||
4292178|NCT00536172|4117839|B3|III/IV||Clinical Stage|Clinical stage of cancer done using the AJCC manual on staging (2008 edition), based on TNM system. T stands for tumor (by size or extension into adjacent structures or subsites), N stands for nodal burden, M stands for distant metastasis (0 for none or 1 for any). Stage is assigned using all clinical material available to the surgeon at time of entry. Prognosis is dependent on stage and site of disease. Stage 1 was not allowed in the study due to very good prognosis and less treatment morbidity. Stage II is early stage disease. Late stage is III, IVA, IVB and IVC.|participants|Number|113|113.0||||||
4292179|NCT00536172|4117840|B2|III/IV||Clinical Stage|Clinical stage of cancer done using the AJCC manual on staging (2008 edition), based on TNM system. T stands for tumor (by size or extension into adjacent structures or subsites), N stands for nodal burden, M stands for distant metastasis (0 for none or 1 for any). Stage is assigned using all clinical material available to the surgeon at time of entry. Prognosis is dependent on stage and site of disease. Stage 1 was not allowed in the study due to very good prognosis and less treatment morbidity. Stage II is early stage disease. Late stage is III, IVA, IVB and IVC.|participants|Number|56|56.0||||||
4292180|NCT00536172|4117841|B1|III/IV||Clinical Stage|Clinical stage of cancer done using the AJCC manual on staging (2008 edition), based on TNM system. T stands for tumor (by size or extension into adjacent structures or subsites), N stands for nodal burden, M stands for distant metastasis (0 for none or 1 for any). Stage is assigned using all clinical material available to the surgeon at time of entry. Prognosis is dependent on stage and site of disease. Stage 1 was not allowed in the study due to very good prognosis and less treatment morbidity. Stage II is early stage disease. Late stage is III, IVA, IVB and IVC.|participants|Number|57|57.0||||||
4292181|NCT00536172|4117839|B3|II||Clinical Stage|Clinical stage of cancer done using the AJCC manual on staging (2008 edition), based on TNM system. T stands for tumor (by size or extension into adjacent structures or subsites), N stands for nodal burden, M stands for distant metastasis (0 for none or 1 for any). Stage is assigned using all clinical material available to the surgeon at time of entry. Prognosis is dependent on stage and site of disease. Stage 1 was not allowed in the study due to very good prognosis and less treatment morbidity. Stage II is early stage disease. Late stage is III, IVA, IVB and IVC.|participants|Number|35|35.0||||||
4292182|NCT00536172|4117840|B2|II||Clinical Stage|Clinical stage of cancer done using the AJCC manual on staging (2008 edition), based on TNM system. T stands for tumor (by size or extension into adjacent structures or subsites), N stands for nodal burden, M stands for distant metastasis (0 for none or 1 for any). Stage is assigned using all clinical material available to the surgeon at time of entry. Prognosis is dependent on stage and site of disease. Stage 1 was not allowed in the study due to very good prognosis and less treatment morbidity. Stage II is early stage disease. Late stage is III, IVA, IVB and IVC.|participants|Number|18|18.0||||||
4292183|NCT00536172|4117841|B1|II||Clinical Stage|Clinical stage of cancer done using the AJCC manual on staging (2008 edition), based on TNM system. T stands for tumor (by size or extension into adjacent structures or subsites), N stands for nodal burden, M stands for distant metastasis (0 for none or 1 for any). Stage is assigned using all clinical material available to the surgeon at time of entry. Prognosis is dependent on stage and site of disease. Stage 1 was not allowed in the study due to very good prognosis and less treatment morbidity. Stage II is early stage disease. Late stage is III, IVA, IVB and IVC.|participants|Number|17|17.0||||||
4292184|NCT00536172|4117839|B3|United States||Region of Enrollment||participants|Number|148|148.0||||||
4292185|NCT00536172|4117840|B2|United States||Region of Enrollment||participants|Number|74|74.0||||||
4292186|NCT00536172|4117841|B1|United States||Region of Enrollment||participants|Number|74|74.0||||||
4292187|NCT00536172|4117839|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4292188|NCT00536172|4117840|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4292189|NCT00536172|4117841|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4292190|NCT00536172|4117839|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|145|145.0||||||
4292191|NCT00536172|4117840|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
4292192|NCT00536172|4117841|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4292193|NCT00536172|4117839|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4292194|NCT00536172|4117840|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4292195|NCT00536172|4117841|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4292196|NCT00536172|4117839|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4292197|NCT00536172|4117840|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4292198|NCT00536172|4117841|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4292199|NCT00536172|4117839|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4292200|NCT00536172|4117840|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4292201|NCT00536172|4117841|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4292202|NCT00536172|4117839|B3||White|Race (NIH/OMB)||Participants|Count of Participants|143|143.0||||||
4292203|NCT00536172|4117840|B2||White|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
4292204|NCT00536172|4117841|B1||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4292205|NCT00536172|4117839|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4292206|NCT00536172|4117840|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4292207|NCT00536172|4117841|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4292208|NCT00536172|4117839|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4292209|NCT00536172|4117840|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4292210|NCT00536172|4117841|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4292211|NCT00536172|4117839|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4292212|NCT00536172|4117840|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4292213|NCT00536172|4117841|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4292214|NCT00536172|4117839|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4292215|NCT00536172|4117840|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4292216|NCT00536172|4117841|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4292217|NCT00536172|4117839|B3||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4292218|NCT00536172|4117840|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4292219|NCT00536172|4117841|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4292220|NCT00536172|4117839|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4292221|NCT00536172|4117840|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4292222|NCT00536172|4117841|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4292223|NCT00536172|4117839|B3||>=65 years|Age||Participants|Count of Participants|63|63.0||||||
4292224|NCT00536172|4117840|B2||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4292225|NCT00536172|4117841|B1||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4292226|NCT00536172|4117839|B3||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
4292227|NCT00536172|4117840|B2||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4292228|NCT00536172|4117841|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4292229|NCT00536172|4117839|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4292230|NCT00536172|4117840|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4292231|NCT00536172|4117841|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4292232|NCT00536172|4117839|B3|||Age||years|Mean|63.0|63.0|Standard Deviation|11.9|11.9|||
4292233|NCT00536172|4117840|B2|||Age||years|Mean|62.8|62.8|Standard Deviation|12.5|12.5|||
4292234|NCT00536172|4117841|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|11.3|11.3|||
4292235|NCT00536120|4117848|B3|CD19+; n=24||Circulating Lymphocyte Subsets|Circulating lymphocyte subsets (CD3+, CD4+, CD8+, CD19+, and CD56+) at Baseline|lymphocyte count/µL|Mean|269.8|269.8|Standard Deviation|123.00|123.0|||
4292236|NCT00536120|4117849|B2|CD19+; n=24||Circulating Lymphocyte Subsets|Circulating lymphocyte subsets (CD3+, CD4+, CD8+, CD19+, and CD56+) at Baseline|lymphocyte count/µL|Mean|NA||Standard Deviation|NA||||Calculated for Tysabri arm only.
4292237|NCT00536120|4117850|B1|CD19+; n=24||Circulating Lymphocyte Subsets|Circulating lymphocyte subsets (CD3+, CD4+, CD8+, CD19+, and CD56+) at Baseline|lymphocyte count/µL|Mean|269.8|269.8|Standard Deviation|123.00|123.0|||
4292238|NCT00536120|4117848|B3|CD16+; n=24||Circulating Lymphocyte Subsets|Circulating lymphocyte subsets (CD3+, CD4+, CD8+, CD19+, and CD56+) at Baseline|lymphocyte count/µL|Mean|179.2|179.2|Standard Deviation|106.12|106.12|||
4292239|NCT00536120|4117849|B2|CD16+; n=24||Circulating Lymphocyte Subsets|Circulating lymphocyte subsets (CD3+, CD4+, CD8+, CD19+, and CD56+) at Baseline|lymphocyte count/µL|Mean|NA||Standard Deviation|NA||||Calculated for Tysabri arm only.
4292240|NCT00536120|4117850|B1|CD16+; n=24||Circulating Lymphocyte Subsets|Circulating lymphocyte subsets (CD3+, CD4+, CD8+, CD19+, and CD56+) at Baseline|lymphocyte count/µL|Mean|179.2|179.2|Standard Deviation|106.12|106.12|||
4292241|NCT00536120|4117848|B3|CD8+; n=24||Circulating Lymphocyte Subsets|Circulating lymphocyte subsets (CD3+, CD4+, CD8+, CD19+, and CD56+) at Baseline|lymphocyte count/µL|Mean|344.6|344.6|Standard Deviation|123.91|123.91|||
4292242|NCT00536120|4117849|B2|CD8+; n=24||Circulating Lymphocyte Subsets|Circulating lymphocyte subsets (CD3+, CD4+, CD8+, CD19+, and CD56+) at Baseline|lymphocyte count/µL|Mean|NA||Standard Deviation|NA||||Calculated for Tysabri arm only.
4292243|NCT00536120|4117850|B1|CD8+; n=24||Circulating Lymphocyte Subsets|Circulating lymphocyte subsets (CD3+, CD4+, CD8+, CD19+, and CD56+) at Baseline|lymphocyte count/µL|Mean|344.6|344.6|Standard Deviation|123.91|123.91|||
4292244|NCT00536120|4117848|B3|CD4+; n=24||Circulating Lymphocyte Subsets|Circulating lymphocyte subsets (CD3+, CD4+, CD8+, CD19+, and CD56+) at Baseline|lymphocyte count/µL|Mean|905.2|905.2|Standard Deviation|299.51|299.51|||
4292245|NCT00536120|4117849|B2|CD4+; n=24||Circulating Lymphocyte Subsets|Circulating lymphocyte subsets (CD3+, CD4+, CD8+, CD19+, and CD56+) at Baseline|lymphocyte count/µL|Mean|NA||Standard Deviation|NA||||Calculated for Tysabri arm only.
4292246|NCT00536120|4117850|B1|CD4+; n=24||Circulating Lymphocyte Subsets|Circulating lymphocyte subsets (CD3+, CD4+, CD8+, CD19+, and CD56+) at Baseline|lymphocyte count/µL|Mean|905.2|905.2|Standard Deviation|299.51|299.51|||
4292247|NCT00536120|4117848|B3|CD3+; n=24||Circulating Lymphocyte Subsets|Circulating lymphocyte subsets (CD3+, CD4+, CD8+, CD19+, and CD56+) at Baseline|lymphocyte count/µL|Mean|1261.5|1261.5|Standard Deviation|309.47|309.47|||
4292248|NCT00536120|4117849|B2|CD3+; n=24||Circulating Lymphocyte Subsets|Circulating lymphocyte subsets (CD3+, CD4+, CD8+, CD19+, and CD56+) at Baseline|lymphocyte count/µL|Mean|NA||Standard Deviation|NA||||Calculated for Tysabri arm only.
4292249|NCT00536120|4117850|B1|CD3+; n=24||Circulating Lymphocyte Subsets|Circulating lymphocyte subsets (CD3+, CD4+, CD8+, CD19+, and CD56+) at Baseline|lymphocyte count/µL|Mean|1261.5|1261.5|Standard Deviation|309.47|309.47|||
4292250|NCT00536120|4117848|B3|||Expanded Disability Status Scale at Screening|The Expanded Disability Status Scale (EDSS) measures physical disability on a scale from 0.0 (no disability) to 10.0 (death due to disability) in 0.5-point increments.|scores on a scale|Median|3.00|3.0|Full Range|||0.0|7.0|
4292251|NCT00536120|4117849|B2|||Expanded Disability Status Scale at Screening|The Expanded Disability Status Scale (EDSS) measures physical disability on a scale from 0.0 (no disability) to 10.0 (death due to disability) in 0.5-point increments.|scores on a scale|Median|3.00|3.0|Full Range|||0.0|7.0|
4292252|NCT00536120|4117850|B1|||Expanded Disability Status Scale at Screening|The Expanded Disability Status Scale (EDSS) measures physical disability on a scale from 0.0 (no disability) to 10.0 (death due to disability) in 0.5-point increments.|scores on a scale|Median|2.75|2.75|Full Range|||1.0|6.0|
4292253|NCT00536120|4117848|B3|||Number of Relapses in 12 Months Prior to Screening||relapses|Mean|1.2|1.2|Standard Deviation|0.98|0.98|||
4292254|NCT00536120|4117849|B2|||Number of Relapses in 12 Months Prior to Screening||relapses|Mean|1.0|1.0|Standard Deviation|0.85|0.85|||
4292255|NCT00536120|4117850|B1|||Number of Relapses in 12 Months Prior to Screening||relapses|Mean|1.4|1.4|Standard Deviation|1.07|1.07|||
4292256|NCT00536120|4117848|B3|||Number of Relapses in 3 Years Prior to Screening||relapses|Mean|2.7|2.7|Standard Deviation|2.27|2.27|||
4292257|NCT00536120|4117849|B2|||Number of Relapses in 3 Years Prior to Screening||relapses|Mean|2.4|2.4|Standard Deviation|1.83|1.83|||
4292258|NCT00536120|4117850|B1|||Number of Relapses in 3 Years Prior to Screening||relapses|Mean|3.0|3.0|Standard Deviation|2.65|2.65|||
4292259|NCT00536120|4117848|B3|||Time Since First MS Diagnosis||years|Median|5.5|5.5|Full Range|||1.0|29.0|
4292260|NCT00536120|4117849|B2|||Time Since First MS Diagnosis||years|Median|5.0|5.0|Full Range|||1.0|19.0|
4292261|NCT00536120|4117850|B1|||Time Since First MS Diagnosis||years|Median|6.0|6.0|Full Range|||1.0|29.0|
4292262|NCT00536120|4117848|B3|||Time Since First MS Symptoms||years|Median|8.0|8.0|Full Range|||2.0|31.0|
4292263|NCT00536120|4117849|B2|||Time Since First MS Symptoms||years|Median|8.5|8.5|Full Range|||2.0|25.0|
4292264|NCT00536120|4117850|B1|||Time Since First MS Symptoms||years|Median|8.0|8.0|Full Range|||2.0|31.0|
4292265|NCT00536120|4117848|B3|White||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
4292266|NCT00536120|4117849|B2|White||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4292267|NCT00536120|4117850|B1|White||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4292268|NCT00536120|4117848|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4292269|NCT00536120|4117849|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4292270|NCT00536120|4117850|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4292271|NCT00536120|4117848|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4292272|NCT00536120|4117849|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4292273|NCT00536120|4117850|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4292274|NCT00536120|4117848|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4292275|NCT00536120|4117849|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4292276|NCT00536120|4117850|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4292277|NCT00536120|4117848|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
4292278|NCT00536120|4117849|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4292279|NCT00536120|4117850|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4292280|NCT00536120|4117848|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4292281|NCT00536120|4117849|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4292282|NCT00536120|4117850|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4292283|NCT00536120|4117848|B3||Male|Gender||Participants|Count of Participants|9|9.0||||||
4292284|NCT00536120|4117849|B2||Male|Gender||Participants|Count of Participants|2|2.0||||||
4292285|NCT00536120|4117850|B1||Male|Gender||Participants|Count of Participants|7|7.0||||||
4292286|NCT00536120|4117848|B3||Female|Gender||Participants|Count of Participants|51|51.0||||||
4292287|NCT00536120|4117849|B2||Female|Gender||Participants|Count of Participants|28|28.0||||||
4292288|NCT00536120|4117850|B1||Female|Gender||Participants|Count of Participants|23|23.0||||||
4292289|NCT00536120|4117848|B3|||Age||Years|Mean|41.8|41.8|Standard Deviation|9.16|9.16|||
4292290|NCT00536120|4117849|B2|||Age||Years|Mean|40.4|40.4|Standard Deviation|9.86|9.86|||
4292291|NCT00536120|4117850|B1|||Age||Years|Mean|43.1|43.1|Standard Deviation|8.34|8.34|||
4292292|NCT00536107|4117863|B3|||BMI||kg/m2|Mean|23.39|23.39|Standard Deviation|3.52|3.52|||
4292293|NCT00536107|4117864|B2|||BMI||kg/m2|Mean|22.77|22.77|Standard Deviation|3.27|3.27|||
4292294|NCT00536107|4117865|B1|||BMI||kg/m2|Mean|23.84|23.84|Standard Deviation|3.85|3.85|||
4292295|NCT00536107|4117863|B3|||Height||cm|Mean|160.79|160.79|Standard Deviation|7.22|7.22|||
4292296|NCT00536107|4117864|B2|||Height||cm|Mean|162.77|162.77|Standard Deviation|7.32|7.32|||
4292297|NCT00536107|4117865|B1|||Height||cm|Mean|159.3|159.3|Standard Deviation|7.26|7.26|||
4292298|NCT00536107|4117863|B3|||Weight||kg|Mean|60.31|60.31|Standard Deviation|8.57|8.57|||
4292299|NCT00536107|4117864|B2|||Weight||kg|Mean|60.03|60.03|Standard Deviation|6.4|6.4|||
4292300|NCT00536107|4117865|B1|||Weight||kg|Mean|60.51|60.51|Standard Deviation|10.35|10.35|||
4292301|NCT00536107|4117863|B3|100% bedridden||WHO performance status||participants|Number|0|0.0||||||
4292302|NCT00536107|4117864|B2|100% bedridden||WHO performance status||participants|Number|0|0.0||||||
4292303|NCT00536107|4117865|B1|100% bedridden||WHO performance status||participants|Number|0|0.0||||||
4292366|NCT00535847|4117919|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4292304|NCT00536107|4117863|B3|In bed more than 50% of the time||WHO performance status||participants|Number|0|0.0||||||
4292305|NCT00536107|4117864|B2|In bed more than 50% of the time||WHO performance status||participants|Number|0|0.0||||||
4292306|NCT00536107|4117865|B1|In bed more than 50% of the time||WHO performance status||participants|Number|0|0.0||||||
4292307|NCT00536107|4117863|B3|In bed less than or equal to 50% of time||WHO performance status||participants|Number|1|1.0||||||
4292308|NCT00536107|4117864|B2|In bed less than or equal to 50% of time||WHO performance status||participants|Number|1|1.0||||||
4292309|NCT00536107|4117865|B1|In bed less than or equal to 50% of time||WHO performance status||participants|Number|0|0.0||||||
4292310|NCT00536107|4117863|B3|Restricted activity||WHO performance status||participants|Number|12|12.0||||||
4292311|NCT00536107|4117864|B2|Restricted activity||WHO performance status||participants|Number|4|4.0||||||
4292312|NCT00536107|4117865|B1|Restricted activity||WHO performance status||participants|Number|8|8.0||||||
4292313|NCT00536107|4117863|B3|Normal activity||WHO performance status||participants|Number|1|1.0||||||
4292314|NCT00536107|4117864|B2|Normal activity||WHO performance status||participants|Number|1|1.0||||||
4292315|NCT00536107|4117865|B1|Normal activity||WHO performance status||participants|Number|0|0.0||||||
4292316|NCT00536107|4117863|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4292317|NCT00536107|4117864|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4292318|NCT00536107|4117865|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4292319|NCT00536107|4117863|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4292320|NCT00536107|4117864|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4292321|NCT00536107|4117865|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4292322|NCT00536107|4117863|B3|||Age||years|Mean|61.89|61.89|Standard Deviation|11.76|11.76|||
4292323|NCT00536107|4117864|B2|||Age||years|Mean|54.52|54.52|Standard Deviation|12.34|12.34|||
4292324|NCT00536107|4117865|B1|||Age||years|Mean|67.43|67.43|Standard Deviation|8.15|8.15|||
4292325|NCT00535938|4117874|B3||Male|Sex: Female, Male||Participants|Count of Participants|491|491.0||||||
4292326|NCT00535938|4117875|B2||Male|Sex: Female, Male||Participants|Count of Participants|289|289.0||||||
4292327|NCT00535938|4117876|B1||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4292328|NCT00535938|4117874|B3||Female|Sex: Female, Male||Participants|Count of Participants|881|881.0||||||
4292329|NCT00535938|4117875|B2||Female|Sex: Female, Male||Participants|Count of Participants|577|577.0||||||
4292330|NCT00535938|4117876|B1||Female|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
4292331|NCT00535938|4117874|B3|>65 years||Age, Customized||Participants|Number|307|307.0||||||
4292332|NCT00535938|4117875|B2|>65 years||Age, Customized||Participants|Number|197|197.0||||||
4292333|NCT00535938|4117876|B1|>65 years||Age, Customized||Participants|Number|110|110.0||||||
4292334|NCT00535938|4117874|B3|18 to 65 years||Age, Customized||Participants|Number|1015|1015.0||||||
4292335|NCT00535938|4117875|B2|18 to 65 years||Age, Customized||Participants|Number|641|641.0||||||
4292336|NCT00535938|4117876|B1|18 to 65 years||Age, Customized||Participants|Number|374|374.0||||||
4292337|NCT00535938|4117874|B3|14 to 17 years||Age, Customized||Participants|Number|50|50.0||||||
4292338|NCT00535938|4117875|B2|14 to 17 years||Age, Customized||Participants|Number|28|28.0||||||
4292339|NCT00535938|4117876|B1|14 to 17 years||Age, Customized||Participants|Number|22|22.0||||||
4292340|NCT00535873|4117913|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4292341|NCT00535873|4117913|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4292342|NCT00535873|4117913|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4292343|NCT00535873|4117913|B1|||Age||years|Median|71|71.0|Full Range|||66.0|85.0|
4292344|NCT00535847|4117917|B4|Europe||Region of Enrollment||participants|Number|25|25.0||||||
4292345|NCT00535847|4117918|B3|Europe||Region of Enrollment||participants|Number|0|0.0||||||
4292346|NCT00535847|4117919|B2|Europe||Region of Enrollment||participants|Number|8|8.0||||||
4292347|NCT00535847|4117920|B1|Europe||Region of Enrollment||participants|Number|17|17.0||||||
4292348|NCT00535847|4117917|B4|North America||Region of Enrollment||participants|Number|92|92.0||||||
4292349|NCT00535847|4117918|B3|North America||Region of Enrollment||participants|Number|2|2.0||||||
4292350|NCT00535847|4117919|B2|North America||Region of Enrollment||participants|Number|26|26.0||||||
4292351|NCT00535847|4117920|B1|North America||Region of Enrollment||participants|Number|64|64.0||||||
4292352|NCT00535847|4117917|B4||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4292353|NCT00535847|4117918|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4292354|NCT00535847|4117919|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4292355|NCT00535847|4117920|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4292356|NCT00535847|4117917|B4||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4292357|NCT00535847|4117918|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4292358|NCT00535847|4117919|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4292359|NCT00535847|4117920|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4292360|NCT00535847|4117917|B4|||Age||years|Mean|50.3|50.3|Standard Deviation|7.2|7.2|||
4292361|NCT00535847|4117918|B3|||Age||years|Mean|49.0|49.0|Standard Deviation|0.0|0.0|||
4292362|NCT00535847|4117919|B2|||Age||years|Mean|51.2|51.2|Standard Deviation|5.9|5.9|||
4292363|NCT00535847|4117920|B1|||Age||years|Mean|50.0|50.0|Standard Deviation|7.7|7.7|||
4292364|NCT00535847|4117917|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4292365|NCT00535847|4117918|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4292367|NCT00535847|4117920|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4292368|NCT00535847|4117917|B4||Between 18 and 65 years|Age||Participants|Count of Participants|117|117.0||||||
4292369|NCT00535847|4117918|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4292370|NCT00535847|4117919|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4292371|NCT00535847|4117920|B1||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
4292372|NCT00535847|4117917|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4292373|NCT00535847|4117918|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4292374|NCT00535847|4117919|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4292375|NCT00535847|4117920|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4292376|NCT00535821|4117946|B3|||SBP < 90 or Lactate >= 4 mmol/L||participants|Number|5|5.0||||||
4292377|NCT00535821|4117947|B2|||SBP < 90 or Lactate >= 4 mmol/L||participants|Number|3|3.0||||||
4292378|NCT00535821|4117948|B1|||SBP < 90 or Lactate >= 4 mmol/L||participants|Number|2|2.0||||||
4292379|NCT00535821|4117946|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4292380|NCT00535821|4117947|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4292381|NCT00535821|4117948|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4292382|NCT00535821|4117946|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4292383|NCT00535821|4117947|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4292384|NCT00535821|4117948|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4292385|NCT00535821|4117946|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4292386|NCT00535821|4117947|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4292387|NCT00535821|4117948|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4292388|NCT00535821|4117946|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4292389|NCT00535821|4117947|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4292390|NCT00535821|4117948|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4292391|NCT00535821|4117946|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4292392|NCT00535821|4117947|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4292393|NCT00535821|4117948|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4292394|NCT00535821|4117946|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4292395|NCT00535821|4117947|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4292396|NCT00535821|4117948|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4292397|NCT00535821|4117946|B3|||Age||years|Mean|69.0|69.0|Standard Deviation|6.1|6.1|||
4292398|NCT00535821|4117947|B2|||Age||years|Mean|60.7|60.7|Standard Deviation|1.2|1.2|||
4292399|NCT00535821|4117948|B1|||Age||years|Mean|81.5|81.5|Standard Deviation|10.5|10.5|||
4292400|NCT00535782|4117955|B3|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4292401|NCT00535782|4117956|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4292402|NCT00535782|4117957|B1|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4292403|NCT00535782|4117955|B3|Canada||Region of Enrollment||participants|Number|39|39.0||||||
4292404|NCT00535782|4117956|B2|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4292405|NCT00535782|4117957|B1|Canada||Region of Enrollment||participants|Number|23|23.0||||||
4292406|NCT00535782|4117955|B3|United States||Region of Enrollment||participants|Number|87|87.0||||||
4292407|NCT00535782|4117956|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
4292408|NCT00535782|4117957|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4292409|NCT00535782|4117955|B3|White||Race/Ethnicity, Customized||participants|Number|118|118.0||||||
4292410|NCT00535782|4117956|B2|White||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
4292411|NCT00535782|4117957|B1|White||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
4292412|NCT00535782|4117955|B3|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4292413|NCT00535782|4117956|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4292414|NCT00535782|4117957|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4292415|NCT00535782|4117955|B3|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4292416|NCT00535782|4117956|B2|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4292417|NCT00535782|4117957|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4292418|NCT00535782|4117955|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4292419|NCT00535782|4117956|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4292420|NCT00535782|4117957|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4292421|NCT00535782|4117955|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4292422|NCT00535782|4117956|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4292423|NCT00535782|4117957|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4292424|NCT00535782|4117955|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4292425|NCT00535782|4117956|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4292426|NCT00535782|4117957|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4292427|NCT00535782|4117955|B3|≥52 years||Age, Customized||participants|Number|89|89.0||||||
4292428|NCT00535782|4117956|B2|≥52 years||Age, Customized||participants|Number|43|43.0||||||
4292429|NCT00535782|4117957|B1|≥52 years||Age, Customized||participants|Number|46|46.0||||||
4292430|NCT00535782|4117955|B3|<52 years||Age, Customized||participants|Number|43|43.0||||||
4292431|NCT00535782|4117956|B2|<52 years||Age, Customized||participants|Number|20|20.0||||||
4292432|NCT00535782|4117957|B1|<52 years||Age, Customized||participants|Number|23|23.0||||||
4292433|NCT00535769|4117974|B3|United States||Region of Enrollment||participants|Number|70|70.0||||||
4292434|NCT00535769|4117975|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
4292435|NCT00535769|4117976|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4292436|NCT00535769|4117974|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4292437|NCT00535769|4117975|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4292438|NCT00535769|4117976|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4292439|NCT00535769|4117974|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4292440|NCT00535769|4117975|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4292441|NCT00535769|4117976|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4292442|NCT00535769|4117974|B3|||Age||years|Mean|33.6|33.6|Standard Deviation|13.8|13.8|||
4292443|NCT00535769|4117975|B2|||Age||years|Mean|32.9|32.9|Standard Deviation|13.4|13.4|||
4292444|NCT00535769|4117976|B1|||Age||years|Mean|34.3|34.3|Standard Deviation|14.2|14.2|||
4292445|NCT00535730|4117986|B3|White||Race/Ethnicity, Customized||participants|Number|468|468.0||||||
4292446|NCT00535730|4117987|B2|White||Race/Ethnicity, Customized||participants|Number|233|233.0||||||
4292447|NCT00535730|4117988|B1|White||Race/Ethnicity, Customized||participants|Number|235|235.0||||||
4292448|NCT00535730|4117986|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4292449|NCT00535730|4117987|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4292450|NCT00535730|4117988|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4292451|NCT00535730|4117986|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4292452|NCT00535730|4117987|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4292453|NCT00535730|4117988|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4292454|NCT00535730|4117986|B3||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4292455|NCT00535730|4117987|B2||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4292456|NCT00535730|4117988|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4292457|NCT00535730|4117986|B3||Female|Sex: Female, Male||Participants|Count of Participants|273|273.0||||||
4292458|NCT00535730|4117987|B2||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4292459|NCT00535730|4117988|B1||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4292460|NCT00535730|4117986|B3|||Age||years|Mean|66.2|66.2|Standard Deviation|5.6|5.6|||
4292461|NCT00535730|4117987|B2|||Age||years|Mean|66.3|66.3|Standard Deviation|5.6|5.6|||
4292462|NCT00535730|4117988|B1|||Age||years|Mean|66.0|66.0|Standard Deviation|5.6|5.6|||
4292463|NCT00535652|4118006|B1|Germany||Region of Enrollment||participants|Number|23|23.0||||||
4292464|NCT00535652|4118006|B1||Male|Gender||Participants|Count of Participants|19|19.0||||||
4292465|NCT00535652|4118006|B1||Female|Gender||Participants|Count of Participants|4|4.0||||||
4292466|NCT00535652|4118006|B1|||Age||years|Mean|55|55.0|Full Range|||25.0|76.0|
4292467|NCT00535652|4118006|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4292468|NCT00535652|4118006|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4292469|NCT00535652|4118006|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4292470|NCT00535626|4118010|B1|United States||Region of Enrollment||Participants|Count of Participants|190|190.0||||||
4292471|NCT00535626|4118010|B1||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4292472|NCT00535626|4118010|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4292473|NCT00535626|4118010|B1|||Age|For bilateral hip patients, the age at time of first study surgery is used.|years|Mean|63.70|63.7|Standard Deviation|11.45|11.45|||
4292474|NCT00535587|4118020|B5|United States||Region of Enrollment||participants|Number|207|207.0||||||
4292475|NCT00535587|4118021|B4|United States||Region of Enrollment||participants|Number|54|54.0||||||
4292476|NCT00535587|4118022|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
4292477|NCT00535587|4118023|B2|United States||Region of Enrollment||participants|Number|53|53.0||||||
4292478|NCT00535587|4118024|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
4292479|NCT00535587|4118020|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4292480|NCT00535587|4118021|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4292481|NCT00535587|4118022|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4292482|NCT00535587|4118023|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4292483|NCT00535587|4118024|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4292484|NCT00535587|4118020|B5||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4292485|NCT00535587|4118021|B4||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4292486|NCT00535587|4118022|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4292487|NCT00535587|4118023|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4292488|NCT00535587|4118024|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4292489|NCT00535587|4118020|B5|||Age||years|Mean|49|49.0|Standard Deviation|8|8.0|||
4292490|NCT00535587|4118021|B4|||Age||years|Mean|49|49.0|Standard Deviation|8|8.0|||
4292491|NCT00535587|4118022|B3|||Age||years|Mean|50|50.0|Standard Deviation|7|7.0|||
4292492|NCT00535587|4118023|B2|||Age||years|Mean|49|49.0|Standard Deviation|8|8.0|||
4292493|NCT00535587|4118024|B1|||Age||years|Mean|49|49.0|Standard Deviation|9|9.0|||
4292494|NCT00535587|4118020|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4292495|NCT00535587|4118021|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4292496|NCT00535587|4118022|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4292497|NCT00535587|4118023|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4292498|NCT00535587|4118024|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4292499|NCT00535587|4118020|B5||Between 18 and 65 years|Age||Participants|Count of Participants|207|207.0||||||
4292500|NCT00535587|4118021|B4||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4292501|NCT00535587|4118022|B3||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4292502|NCT00535587|4118023|B2||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4292503|NCT00535587|4118024|B1||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4292504|NCT00535587|4118020|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4292505|NCT00535587|4118021|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4292506|NCT00535587|4118022|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4292507|NCT00535587|4118023|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4292508|NCT00535587|4118024|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4292509|NCT00535496|4118035|B3||Male|Sex: Female, Male|Randomization into dominant and non-dominant forearms was aimed at preventing bias; so differences between dominant and non-dominant forearms were not analyzed.|Participants|Count of Participants|34|34.0||||||
4292510|NCT00535496|4118036|B2||Male|Sex: Female, Male|Randomization into dominant and non-dominant forearms was aimed at preventing bias; so differences between dominant and non-dominant forearms were not analyzed.|Participants|Count of Participants|21|21.0||||||
4292511|NCT00535496|4118037|B1||Male|Sex: Female, Male|Randomization into dominant and non-dominant forearms was aimed at preventing bias; so differences between dominant and non-dominant forearms were not analyzed.|Participants|Count of Participants|13|13.0||||||
4292512|NCT00535496|4118035|B3||Female|Sex: Female, Male|Randomization into dominant and non-dominant forearms was aimed at preventing bias; so differences between dominant and non-dominant forearms were not analyzed.|Participants|Count of Participants|56|56.0||||||
4292513|NCT00535496|4118036|B2||Female|Sex: Female, Male|Randomization into dominant and non-dominant forearms was aimed at preventing bias; so differences between dominant and non-dominant forearms were not analyzed.|Participants|Count of Participants|40|40.0||||||
4292514|NCT00535496|4118037|B1||Female|Sex: Female, Male|Randomization into dominant and non-dominant forearms was aimed at preventing bias; so differences between dominant and non-dominant forearms were not analyzed.|Participants|Count of Participants|16|16.0||||||
4292515|NCT00535496|4118035|B3|||Age|Randomization into dominant and non-dominant forearms was aimed at preventing bias; so differences between dominant and non-dominant forearms were not analyzed.|years|Mean|42|42.0|Standard Deviation|12|12.0|||
4292516|NCT00535496|4118036|B2|||Age|Randomization into dominant and non-dominant forearms was aimed at preventing bias; so differences between dominant and non-dominant forearms were not analyzed.|years|Mean|42|42.0|Standard Deviation|13|13.0|||
4292517|NCT00535496|4118037|B1|||Age|Randomization into dominant and non-dominant forearms was aimed at preventing bias; so differences between dominant and non-dominant forearms were not analyzed.|years|Mean|43|43.0|Standard Deviation|11|11.0|||
4292518|NCT00535405|4118055|B6|White||Race/Ethnicity, Customized||participants|Number|1081|1081.0||||||
4292519|NCT00535405|4118056|B5|White||Race/Ethnicity, Customized||participants|Number|210|210.0||||||
4292520|NCT00535405|4118057|B4|White||Race/Ethnicity, Customized||participants|Number|214|214.0||||||
4292521|NCT00535405|4118058|B3|White||Race/Ethnicity, Customized||participants|Number|209|209.0||||||
4292522|NCT00535405|4118059|B2|White||Race/Ethnicity, Customized||participants|Number|224|224.0||||||
4292523|NCT00535405|4118060|B1|White||Race/Ethnicity, Customized||participants|Number|224|224.0||||||
4292524|NCT00535405|4118055|B6|Other||Race/Ethnicity, Customized||participants|Number|135|135.0||||||
4292525|NCT00535405|4118056|B5|Other||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4292526|NCT00535405|4118057|B4|Other||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4292527|NCT00535405|4118058|B3|Other||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4292528|NCT00535405|4118059|B2|Other||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4292529|NCT00535405|4118060|B1|Other||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4292530|NCT00535405|4118055|B6|Black||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4292531|NCT00535405|4118056|B5|Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4292532|NCT00535405|4118057|B4|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4292533|NCT00535405|4118058|B3|Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4292534|NCT00535405|4118059|B2|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4292535|NCT00535405|4118060|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4292536|NCT00535405|4118055|B6|Asian||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4292537|NCT00535405|4118056|B5|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4292538|NCT00535405|4118057|B4|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4292539|NCT00535405|4118058|B3|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4292540|NCT00535405|4118059|B2|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4292541|NCT00535405|4118060|B1|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4292542|NCT00535405|4118055|B6||Male|Sex: Female, Male||Participants|Count of Participants|480|480.0||||||
4292543|NCT00535405|4118056|B5||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4292544|NCT00535405|4118057|B4||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4292545|NCT00535405|4118058|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4292546|NCT00535405|4118059|B2||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4292547|NCT00535405|4118060|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4292548|NCT00535405|4118055|B6||Female|Sex: Female, Male||Participants|Count of Participants|809|809.0||||||
4292549|NCT00535405|4118056|B5||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4292550|NCT00535405|4118057|B4||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4292551|NCT00535405|4118058|B3||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4292552|NCT00535405|4118059|B2||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4292553|NCT00535405|4118060|B1||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4292554|NCT00535405|4118055|B6|||Age||years|Mean|72.0|72.0|Full Range|||65.0|96.0|
4292555|NCT00535405|4118056|B5|||Age||years|Mean|72.1|72.1|Full Range|||65.0|88.0|
4292556|NCT00535405|4118057|B4|||Age||years|Mean|72.2|72.2|Full Range|||65.0|96.0|
4292557|NCT00535405|4118058|B3|||Age||years|Mean|71.7|71.7|Full Range|||65.0|90.0|
4292558|NCT00535405|4118059|B2|||Age||years|Mean|71.8|71.8|Full Range|||65.0|95.0|
4292559|NCT00535405|4118060|B1|||Age||years|Mean|72.1|72.1|Full Range|||65.0|94.0|
4292560|NCT00535392|4118101|B1|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4292561|NCT00535392|4118101|B1|Turkey||Region of Enrollment||participants|Number|6|6.0||||||
4292562|NCT00535392|4118101|B1|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
4292563|NCT00535392|4118101|B1|Mexico||Region of Enrollment||participants|Number|10|10.0||||||
4292564|NCT00535392|4118101|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4292565|NCT00535392|4118101|B1|France||Region of Enrollment||participants|Number|4|4.0||||||
4292566|NCT00535392|4118101|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4292567|NCT00535392|4118101|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4292568|NCT00535392|4118101|B1|||Age||years|Mean|9.71|9.71|Standard Deviation|3.38|3.38|||
4292569|NCT00535392|4118101|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4292570|NCT00535392|4118101|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4292571|NCT00535392|4118101|B1||<=18 years|Age||Participants|Count of Participants|33|33.0||||||
4292572|NCT00535301|4118107|B3|United States||Region of Enrollment||participants|Number|76|76.0||||||
4292573|NCT00535301|4118108|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
4292574|NCT00535301|4118109|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4292575|NCT00535301|4118107|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4292576|NCT00535301|4118108|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4292577|NCT00535301|4118109|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4292578|NCT00535301|4118107|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4292579|NCT00535301|4118108|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4292580|NCT00535301|4118109|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4292581|NCT00535301|4118107|B3|||Age||years|Mean|60|60.0|Standard Deviation|10.5|10.5|||
4292582|NCT00535301|4118108|B2|||Age||years|Mean|61|61.0|Standard Deviation|10.5|10.5|||
4292583|NCT00535301|4118109|B1|||Age||years|Mean|59|59.0|Standard Deviation|9.5|9.5|||
4292584|NCT00535301|4118107|B3||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4292585|NCT00535301|4118108|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4292586|NCT00535301|4118109|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4292587|NCT00535301|4118107|B3||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4292588|NCT00535301|4118108|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4292589|NCT00535301|4118109|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4292590|NCT00535301|4118107|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4292591|NCT00535301|4118108|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4292592|NCT00535301|4118109|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4292593|NCT00535288|4118120|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4292594|NCT00535288|4118121|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4292595|NCT00535288|4118122|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4292596|NCT00535288|4118123|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4292597|NCT00535288|4118124|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4292598|NCT00535288|4118125|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4292599|NCT00535288|4118120|B6||Female|Sex: Female, Male||Participants|Count of Participants|945|945.0||||||
4292600|NCT00535288|4118121|B5||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4292601|NCT00535288|4118122|B4||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4292602|NCT00535288|4118123|B3||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4292603|NCT00535288|4118124|B2||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4292604|NCT00535288|4118125|B1||Female|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
4292605|NCT00535288|4118120|B6|||Age||Years|Mean|53.8|53.8|Standard Deviation|4.8|4.8|||
4292606|NCT00535288|4118121|B5|||Age||Years|Mean|53.5|53.5|Standard Deviation|4.7|4.7|||
4292607|NCT00535288|4118122|B4|||Age||Years|Mean|54.7|54.7|Standard Deviation|4.6|4.6|||
4292608|NCT00535288|4118123|B3|||Age||Years|Mean|53.7|53.7|Standard Deviation|4.8|4.8|||
4292609|NCT00535288|4118124|B2|||Age||Years|Mean|53.8|53.8|Standard Deviation|5.0|5.0|||
4292610|NCT00535288|4118125|B1|||Age||Years|Mean|53.5|53.5|Standard Deviation|4.9|4.9|||
4292611|NCT00535262|4118206|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4292612|NCT00535262|4118206|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4292613|NCT00535262|4118206|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4292614|NCT00535262|4118206|B1||>=65 years|Age|Patients with Bipolar Depression and one prior anti-depressant treatment with HAM-D (17) score >10 will be entered into treatment.|Participants|Count of Participants|0|0.0||||||
4292615|NCT00535262|4118206|B1||Between 18 and 65 years|Age|Patients with Bipolar Depression and one prior anti-depressant treatment with HAM-D (17) score >10 will be entered into treatment.|Participants|Count of Participants|3|3.0||||||
4292616|NCT00535262|4118206|B1||<=18 years|Age|Patients with Bipolar Depression and one prior anti-depressant treatment with HAM-D (17) score >10 will be entered into treatment.|Participants|Count of Participants|0|0.0||||||
4292617|NCT00535223|4118210|B3|United States||Region of Enrollment||participants|Number|81|81.0||||||
4292618|NCT00535223|4118211|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4292619|NCT00535223|4118212|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4292620|NCT00535223|4118210|B3|Male||Sex/Gender, Customized||participants|Number|81|81.0||||||
4292621|NCT00535223|4118211|B2|Male||Sex/Gender, Customized||participants|Number|40|40.0||||||
4292622|NCT00535223|4118212|B1|Male||Sex/Gender, Customized||participants|Number|41|41.0||||||
4292623|NCT00535223|4118210|B3|||Age||years|Mean|61.40|61.4|Full Range|||55.0|69.0|
4292624|NCT00535223|4118211|B2|||Age||years|Mean|61.38|61.38|Full Range|||55.0|69.0|
4292625|NCT00535223|4118212|B1|||Age||years|Mean|61.41|61.41|Full Range|||55.0|68.0|
4292626|NCT00535223|4118210|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4292627|NCT00535223|4118211|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4292628|NCT00535223|4118212|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4292629|NCT00535223|4118210|B3||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
4292630|NCT00535223|4118211|B2||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4292631|NCT00535223|4118212|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4292632|NCT00535223|4118210|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4292633|NCT00535223|4118211|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4292634|NCT00535223|4118212|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4292635|NCT00535145|4118221|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4292636|NCT00535145|4118221|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4292637|NCT00535145|4118221|B1|||Age||years|Mean|48.9|48.9|Standard Deviation|6.73|6.73|||
4292638|NCT00535132|4118231|B3||Unknown or Not Reported|Race (NIH/OMB)|Safety Analysis Set.|Participants|Count of Participants|6|6.0||||||
4292639|NCT00535132|4118232|B2||Unknown or Not Reported|Race (NIH/OMB)|Safety Analysis Set.|Participants|Count of Participants|3|3.0||||||
4292640|NCT00535132|4118233|B1||Unknown or Not Reported|Race (NIH/OMB)|Safety Analysis Set.|Participants|Count of Participants|3|3.0||||||
4292641|NCT00535132|4118231|B3||More than one race|Race (NIH/OMB)|Safety Analysis Set.|Participants|Count of Participants|0|0.0||||||
4292642|NCT00535132|4118232|B2||More than one race|Race (NIH/OMB)|Safety Analysis Set.|Participants|Count of Participants|0|0.0||||||
4292643|NCT00535132|4118233|B1||More than one race|Race (NIH/OMB)|Safety Analysis Set.|Participants|Count of Participants|0|0.0||||||
4292644|NCT00535132|4118231|B3||White|Race (NIH/OMB)|Safety Analysis Set.|Participants|Count of Participants|130|130.0||||||
4292645|NCT00535132|4118232|B2||White|Race (NIH/OMB)|Safety Analysis Set.|Participants|Count of Participants|69|69.0||||||
4292646|NCT00535132|4118233|B1||White|Race (NIH/OMB)|Safety Analysis Set.|Participants|Count of Participants|61|61.0||||||
4292647|NCT00535132|4118231|B3||Black or African American|Race (NIH/OMB)|Safety Analysis Set.|Participants|Count of Participants|57|57.0||||||
4292648|NCT00535132|4118232|B2||Black or African American|Race (NIH/OMB)|Safety Analysis Set.|Participants|Count of Participants|26|26.0||||||
4292649|NCT00535132|4118233|B1||Black or African American|Race (NIH/OMB)|Safety Analysis Set.|Participants|Count of Participants|31|31.0||||||
4292650|NCT00535132|4118231|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Safety Analysis Set.|Participants|Count of Participants|1|1.0||||||
4292651|NCT00535132|4118232|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Safety Analysis Set.|Participants|Count of Participants|0|0.0||||||
4292652|NCT00535132|4118233|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Safety Analysis Set.|Participants|Count of Participants|1|1.0||||||
4292653|NCT00535132|4118231|B3||Asian|Race (NIH/OMB)|Safety Analysis Set.|Participants|Count of Participants|1|1.0||||||
4292654|NCT00535132|4118232|B2||Asian|Race (NIH/OMB)|Safety Analysis Set.|Participants|Count of Participants|1|1.0||||||
4292655|NCT00535132|4118233|B1||Asian|Race (NIH/OMB)|Safety Analysis Set.|Participants|Count of Participants|0|0.0||||||
4292656|NCT00535132|4118231|B3||American Indian or Alaska Native|Race (NIH/OMB)|Safety Analysis Set.|Participants|Count of Participants|2|2.0||||||
4292657|NCT00535132|4118232|B2||American Indian or Alaska Native|Race (NIH/OMB)|Safety Analysis Set.|Participants|Count of Participants|0|0.0||||||
4292658|NCT00535132|4118233|B1||American Indian or Alaska Native|Race (NIH/OMB)|Safety Analysis Set.|Participants|Count of Participants|2|2.0||||||
4292659|NCT00535132|4118231|B3|Female||Sex/Gender, Customized|Safety Analysis Set.|participants|Number|86|86.0||||||
4292660|NCT00535132|4118232|B2|Female||Sex/Gender, Customized|Safety Analysis Set.|participants|Number|46|46.0||||||
4292661|NCT00535132|4118233|B1|Female||Sex/Gender, Customized|Safety Analysis Set.|participants|Number|40|40.0||||||
4292662|NCT00535132|4118231|B3|Male||Sex/Gender, Customized|Safety Analysis Set.|participants|Number|111|111.0||||||
4292663|NCT00535132|4118232|B2|Male||Sex/Gender, Customized|Safety Analysis Set.|participants|Number|53|53.0||||||
4292664|NCT00535132|4118233|B1|Male||Sex/Gender, Customized|Safety Analysis Set.|participants|Number|58|58.0||||||
4292665|NCT00535132|4118231|B3|||Age|Safety Analysis Set.|years|Mean|40.6|40.6|Standard Deviation|11.9|11.9|||
4292666|NCT00535132|4118232|B2|||Age|Safety Analysis Set.|years|Mean|40.2|40.2|Standard Deviation|11.4|11.4|||
4292667|NCT00535132|4118233|B1|||Age|Safety Analysis Set.|years|Mean|41.1|41.1|Standard Deviation|12.5|12.5|||
4292668|NCT00535002|4118284|B9|United States||Region of Enrollment||participants|Number|112|112.0||||||
4292669|NCT00535002|4118285|B8|United States||Region of Enrollment||participants|Number|16|16.0||||||
4292670|NCT00535002|4118286|B7|United States||Region of Enrollment||participants|Number|14|14.0||||||
4292671|NCT00535002|4118287|B6|United States||Region of Enrollment||participants|Number|12|12.0||||||
4292672|NCT00535002|4118288|B5|United States||Region of Enrollment||participants|Number|13|13.0||||||
4292673|NCT00535002|4118289|B4|United States||Region of Enrollment||participants|Number|17|17.0||||||
4292674|NCT00535002|4118290|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4292675|NCT00535002|4118291|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4292676|NCT00535002|4118292|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4292677|NCT00535002|4118284|B9||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4292678|NCT00535002|4118285|B8||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4292679|NCT00535002|4118286|B7||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4292680|NCT00535002|4118287|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4292681|NCT00535002|4118288|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4292682|NCT00535002|4118289|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4292683|NCT00535002|4118290|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4292684|NCT00535002|4118291|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4292685|NCT00535002|4118292|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4292686|NCT00535002|4118284|B9||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4292687|NCT00535002|4118285|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4292688|NCT00535002|4118286|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4292689|NCT00535002|4118287|B6||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4292690|NCT00535002|4118288|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4292691|NCT00535002|4118289|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4292692|NCT00535002|4118290|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4292693|NCT00535002|4118291|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4292694|NCT00535002|4118292|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4292695|NCT00535002|4118284|B9|||Age||years|Mean|36.8|36.8|Standard Deviation|12.1|12.1|||
4292696|NCT00535002|4118285|B8|||Age||years|Mean|32.3|32.3|Standard Deviation|12.6|12.6|||
4292697|NCT00535002|4118286|B7|||Age||years|Mean|32.7|32.7|Standard Deviation|13.3|13.3|||
4292698|NCT00535002|4118287|B6|||Age||years|Mean|32.1|32.1|Standard Deviation|13.2|13.2|||
4292699|NCT00535002|4118288|B5|||Age||years|Mean|36.2|36.2|Standard Deviation|13.2|13.2|||
4292700|NCT00535002|4118289|B4|||Age||years|Mean|38.7|38.7|Standard Deviation|10.1|10.1|||
4292701|NCT00535002|4118290|B3|||Age||years|Mean|39.8|39.8|Standard Deviation|10.9|10.9|||
4292702|NCT00535002|4118291|B2|||Age||years|Mean|37.8|37.8|Standard Deviation|11.2|11.2|||
4292703|NCT00535002|4118292|B1|||Age||years|Mean|43.1|43.1|Standard Deviation|10.1|10.1|||
4292704|NCT00535002|4118284|B9||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4292705|NCT00535002|4118285|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4292706|NCT00535002|4118286|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4292707|NCT00535002|4118287|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4292708|NCT00535002|4118288|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4292709|NCT00535002|4118289|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4292710|NCT00535002|4118290|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4292711|NCT00535002|4118291|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4292712|NCT00535002|4118292|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4292713|NCT00535002|4118284|B9||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
4292714|NCT00535002|4118285|B8||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4292715|NCT00535002|4118286|B7||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4292716|NCT00535002|4118287|B6||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4292717|NCT00535002|4118288|B5||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4292718|NCT00535002|4118289|B4||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4292719|NCT00535002|4118290|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4292720|NCT00535002|4118291|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4292721|NCT00535002|4118292|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4292722|NCT00535002|4118284|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4292723|NCT00535002|4118285|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4292724|NCT00535002|4118286|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4292725|NCT00535002|4118287|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4292726|NCT00535002|4118288|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4292727|NCT00535002|4118289|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4292728|NCT00535002|4118290|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4292729|NCT00535002|4118291|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4292730|NCT00535002|4118292|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4292731|NCT00534976|4118313|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4292732|NCT00534976|4118314|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4292733|NCT00534976|4118315|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4292734|NCT00534976|4118313|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4292735|NCT00534976|4118314|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4292736|NCT00534976|4118315|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4292737|NCT00534976|4118313|B3|||Age||years|Mean|11.2|11.2|Standard Deviation|2.1|2.1|||
4292738|NCT00534976|4118314|B2|||Age||years|Mean|11.5|11.5|Standard Deviation|1.8|1.8|||
4292739|NCT00534976|4118315|B1|||Age||years|Mean|10.9|10.9|Standard Deviation|2.3|2.3|||
4292740|NCT00534937|4118336|B3|Unknown||Sex/Gender, Customized|The gender of 5 patients was unknown due to incompleted data from a site that was terminated early due to PI relocation.|participants|Number|5|5.0||||||
4292741|NCT00534937|4118337|B2|Unknown||Sex/Gender, Customized|The gender of 5 patients was unknown due to incompleted data from a site that was terminated early due to PI relocation.|participants|Number|2|2.0||||||
4292742|NCT00534937|4118338|B1|Unknown||Sex/Gender, Customized|The gender of 5 patients was unknown due to incompleted data from a site that was terminated early due to PI relocation.|participants|Number|3|3.0||||||
4292743|NCT00534937|4118336|B3|Male||Sex/Gender, Customized|The gender of 5 patients was unknown due to incompleted data from a site that was terminated early due to PI relocation.|participants|Number|61|61.0||||||
4292744|NCT00534937|4118337|B2|Male||Sex/Gender, Customized|The gender of 5 patients was unknown due to incompleted data from a site that was terminated early due to PI relocation.|participants|Number|33|33.0||||||
4292745|NCT00534937|4118338|B1|Male||Sex/Gender, Customized|The gender of 5 patients was unknown due to incompleted data from a site that was terminated early due to PI relocation.|participants|Number|28|28.0||||||
4292746|NCT00534937|4118336|B3|Female||Sex/Gender, Customized|The gender of 5 patients was unknown due to incompleted data from a site that was terminated early due to PI relocation.|participants|Number|23|23.0||||||
4292747|NCT00534937|4118337|B2|Female||Sex/Gender, Customized|The gender of 5 patients was unknown due to incompleted data from a site that was terminated early due to PI relocation.|participants|Number|12|12.0||||||
4292748|NCT00534937|4118338|B1|Female||Sex/Gender, Customized|The gender of 5 patients was unknown due to incompleted data from a site that was terminated early due to PI relocation.|participants|Number|11|11.0||||||
4292749|NCT00534937|4118336|B3|||Age||years|Mean|57.0|57.0|Standard Deviation|15.2|15.2|||
4292750|NCT00534937|4118337|B2|||Age||years|Mean|57.4|57.4|Standard Deviation|16.1|16.1|||
4292751|NCT00534937|4118338|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|14.3|14.3|||
4292752|NCT00534833|4118351|B3|Philippines||Region of Enrollment||Participants|Number|362|362.0||||||
4292753|NCT00534833|4118352|B2|Philippines||Region of Enrollment||Participants|Number|180|180.0||||||
4292754|NCT00534833|4118353|B1|Philippines||Region of Enrollment||Participants|Number|182|182.0||||||
4292755|NCT00534833|4118351|B3||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4292756|NCT00534833|4118352|B2||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4292757|NCT00534833|4118353|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4292758|NCT00534833|4118351|B3||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4292759|NCT00534833|4118352|B2||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4292760|NCT00534833|4118353|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4292761|NCT00534833|4118351|B3|||Age||Months|Mean|15.9|15.9|Standard Deviation|0.945|0.945|||
4292762|NCT00534833|4118352|B2|||Age||Months|Mean|15.9|15.9|Standard Deviation|0.942|0.942|||
4292763|NCT00534833|4118353|B1|||Age||Months|Mean|15.9|15.9|Standard Deviation|0.946|0.946|||
4292764|NCT00534833|4118351|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4292765|NCT00534833|4118352|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4292766|NCT00534833|4118353|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4292767|NCT00534833|4118351|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4292768|NCT00534833|4118352|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4292769|NCT00534833|4118353|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4292770|NCT00534833|4118351|B3||<=18 years|Age||Participants|Count of Participants|362|362.0||||||
4292771|NCT00534833|4118352|B2||<=18 years|Age||Participants|Count of Participants|180|180.0||||||
4292772|NCT00534833|4118353|B1||<=18 years|Age||Participants|Count of Participants|182|182.0||||||
4292773|NCT00534794|4118364|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4292774|NCT00534794|4118365|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4292775|NCT00534794|4118366|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4292776|NCT00534794|4118364|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4292777|NCT00534794|4118365|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4292778|NCT00534794|4118366|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4292779|NCT00534794|4118364|B3|||Age||years|Mean|40.7|40.7|Standard Deviation|12.73|12.73|||
4292780|NCT00534794|4118365|B2|||Age||years|Mean|40.1|40.1|Standard Deviation|13.41|13.41|||
4292781|NCT00534794|4118366|B1|||Age||years|Mean|41.3|41.3|Standard Deviation|12.18|12.18|||
4292782|NCT00534638|4118375|B3||Male|Sex: Female, Male||Participants|Count of Participants|11657|11657.0||||||
4292783|NCT00534638|4118376|B2||Male|Sex: Female, Male||Participants|Count of Participants|9219|9219.0||||||
4292784|NCT00534638|4118377|B1||Male|Sex: Female, Male||Participants|Count of Participants|2438|2438.0||||||
4292785|NCT00534638|4118375|B3||Female|Sex: Female, Male||Participants|Count of Participants|20518|20518.0||||||
4292786|NCT00534638|4118376|B2||Female|Sex: Female, Male||Participants|Count of Participants|8119|8119.0||||||
4292787|NCT00534638|4118377|B1||Female|Sex: Female, Male||Participants|Count of Participants|12399|12399.0||||||
4292788|NCT00534638|4118375|B3|||Age||Years|Mean|14.1|14.1|Standard Deviation|0.76|0.76|||
4292789|NCT00534638|4118376|B2|||Age||Years|Mean|14.1|14.1|Standard Deviation|0.76|0.76|||
4292790|NCT00534638|4118377|B1|||Age||Years|Mean|14.1|14.1|Standard Deviation|0.75|0.75|||
4292791|NCT00534599|4118411|B3||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4292792|NCT00534599|4118412|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4292793|NCT00534599|4118413|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4292794|NCT00534599|4118411|B3||Female|Sex: Female, Male||Participants|Count of Participants|296|296.0||||||
4292795|NCT00534599|4118412|B2||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4292796|NCT00534599|4118413|B1||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4292797|NCT00534599|4118411|B3|||Age||Years|Mean|44.4|44.4|Standard Deviation|11.5|11.5|||
4292798|NCT00534599|4118412|B2|||Age||Years|Mean|44.2|44.2|Standard Deviation|10.9|10.9|||
4292799|NCT00534599|4118413|B1|||Age||Years|Mean|46.6|46.6|Standard Deviation|12.1|12.1|||
4292800|NCT00534495|4118448|B3|Systemic JIA rash||Disease characteristics in the past||participants|Number|65|65.0||||||
4292801|NCT00534495|4118449|B2|Systemic JIA rash||Disease characteristics in the past||participants|Number|33|33.0||||||
4292802|NCT00534495|4118450|B1|Systemic JIA rash||Disease characteristics in the past||participants|Number|32|32.0||||||
4292803|NCT00534495|4118448|B3|Serositis||Disease characteristics in the past||participants|Number|17|17.0||||||
4292804|NCT00534495|4118449|B2|Serositis||Disease characteristics in the past||participants|Number|8|8.0||||||
4292805|NCT00534495|4118450|B1|Serositis||Disease characteristics in the past||participants|Number|9|9.0||||||
4292806|NCT00534495|4118448|B3|Complete Macrophage Activation Syndrome||Disease characteristics in the past||participants|Number|2|2.0||||||
4292807|NCT00534495|4118449|B2|Complete Macrophage Activation Syndrome||Disease characteristics in the past||participants|Number|1|1.0||||||
4292808|NCT00534495|4118450|B1|Complete Macrophage Activation Syndrome||Disease characteristics in the past||participants|Number|1|1.0||||||
4292809|NCT00534495|4118448|B3|Incomplete Macrophage Activation Syndrome||Disease characteristics in the past||participants|Number|4|4.0||||||
4292810|NCT00534495|4118449|B2|Incomplete Macrophage Activation Syndrome||Disease characteristics in the past||participants|Number|3|3.0||||||
4292811|NCT00534495|4118450|B1|Incomplete Macrophage Activation Syndrome||Disease characteristics in the past||participants|Number|1|1.0||||||
4292812|NCT00534495|4118448|B3|unknown Anakinra||Prior medications||participants|Number|8|8.0||||||
4292813|NCT00534495|4118449|B2|unknown Anakinra||Prior medications||participants|Number|4|4.0||||||
4292814|NCT00534495|4118450|B1|unknown Anakinra||Prior medications||participants|Number|4|4.0||||||
4292815|NCT00534495|4118448|B3|Anakinra||Prior medications||participants|Number|26|26.0||||||
4292816|NCT00534495|4118449|B2|Anakinra||Prior medications||participants|Number|13|13.0||||||
4292817|NCT00534495|4118450|B1|Anakinra||Prior medications||participants|Number|13|13.0||||||
4292818|NCT00534495|4118448|B3|Abatacept||Prior medications||participants|Number|9|9.0||||||
4292819|NCT00534495|4118449|B2|Abatacept||Prior medications||participants|Number|4|4.0||||||
4292820|NCT00534495|4118450|B1|Abatacept||Prior medications||participants|Number|5|5.0||||||
4292821|NCT00534495|4118448|B3|Etanercept||Prior medications||participants|Number|28|28.0||||||
4292822|NCT00534495|4118449|B2|Etanercept||Prior medications||participants|Number|16|16.0||||||
4292823|NCT00534495|4118450|B1|Etanercept||Prior medications||participants|Number|12|12.0||||||
4292824|NCT00534495|4118448|B3|Infliximab||Prior medications||participants|Number|11|11.0||||||
4292825|NCT00534495|4118449|B2|Infliximab||Prior medications||participants|Number|6|6.0||||||
4292826|NCT00534495|4118450|B1|Infliximab||Prior medications||participants|Number|5|5.0||||||
4292827|NCT00534495|4118448|B3|Leflunomide||Prior medications||participants|Number|3|3.0||||||
4292828|NCT00534495|4118449|B2|Leflunomide||Prior medications||participants|Number|2|2.0||||||
4292829|NCT00534495|4118450|B1|Leflunomide||Prior medications||participants|Number|1|1.0||||||
4292830|NCT00534495|4118448|B3|Methotrexate||Prior medications||participants|Number|47|47.0||||||
4292831|NCT00534495|4118449|B2|Methotrexate||Prior medications||participants|Number|26|26.0||||||
4292832|NCT00534495|4118450|B1|Methotrexate||Prior medications||participants|Number|21|21.0||||||
4292833|NCT00534495|4118448|B3|Corticosteroids||Prior medications||participants|Number|63|63.0||||||
4292834|NCT00534495|4118449|B2|Corticosteroids||Prior medications||participants|Number|33|33.0||||||
4292835|NCT00534495|4118450|B1|Corticosteroids||Prior medications||participants|Number|30|30.0||||||
4292836|NCT00534495|4118448|B3|||No.of joints with active disease||joints|Mean|11.1|11.1|Standard Deviation|8.6|8.6|||
4292837|NCT00534495|4118449|B2|||No.of joints with active disease||joints|Mean|10.5|10.5|Standard Deviation|7.6|7.6|||
4292838|NCT00534495|4118450|B1|||No.of joints with active disease||joints|Mean|11.7|11.7|Standard Deviation|9.6|9.6|||
4292839|NCT00534495|4118448|B3|||Disease Duration||years|Mean|2.6|2.6|Standard Deviation|3.4|3.4|||
4292840|NCT00534495|4118449|B2|||Disease Duration||years|Mean|2.6|2.6|Standard Deviation|3.1|3.1|||
4292841|NCT00534495|4118450|B1|||Disease Duration||years|Mean|2.6|2.6|Standard Deviation|3.6|3.6|||
4292842|NCT00534495|4118448|B3|Non-Hispanic||Race/Ethnicity, Customized|Black ,white and Other are races Hispanic and Non-Hispanic are ethnicities. All patients were counted twice.|Participants|Number|59|59.0||||||
4292843|NCT00534495|4118449|B2|Non-Hispanic||Race/Ethnicity, Customized|Black ,white and Other are races Hispanic and Non-Hispanic are ethnicities. All patients were counted twice.|Participants|Number|30|30.0||||||
4292844|NCT00534495|4118450|B1|Non-Hispanic||Race/Ethnicity, Customized|Black ,white and Other are races Hispanic and Non-Hispanic are ethnicities. All patients were counted twice.|Participants|Number|29|29.0||||||
4292845|NCT00534495|4118448|B3|Hispanic||Race/Ethnicity, Customized|Black ,white and Other are races Hispanic and Non-Hispanic are ethnicities. All patients were counted twice.|Participants|Number|12|12.0||||||
4292846|NCT00534495|4118449|B2|Hispanic||Race/Ethnicity, Customized|Black ,white and Other are races Hispanic and Non-Hispanic are ethnicities. All patients were counted twice.|Participants|Number|5|5.0||||||
4292847|NCT00534495|4118450|B1|Hispanic||Race/Ethnicity, Customized|Black ,white and Other are races Hispanic and Non-Hispanic are ethnicities. All patients were counted twice.|Participants|Number|7|7.0||||||
4292848|NCT00534495|4118448|B3|Other||Race/Ethnicity, Customized|Black ,white and Other are races Hispanic and Non-Hispanic are ethnicities. All patients were counted twice.|Participants|Number|11|11.0||||||
4292849|NCT00534495|4118449|B2|Other||Race/Ethnicity, Customized|Black ,white and Other are races Hispanic and Non-Hispanic are ethnicities. All patients were counted twice.|Participants|Number|5|5.0||||||
4292850|NCT00534495|4118450|B1|Other||Race/Ethnicity, Customized|Black ,white and Other are races Hispanic and Non-Hispanic are ethnicities. All patients were counted twice.|Participants|Number|6|6.0||||||
4292851|NCT00534495|4118448|B3|White||Race/Ethnicity, Customized|Black ,white and Other are races Hispanic and Non-Hispanic are ethnicities. All patients were counted twice.|Participants|Number|48|48.0||||||
4292852|NCT00534495|4118449|B2|White||Race/Ethnicity, Customized|Black ,white and Other are races Hispanic and Non-Hispanic are ethnicities. All patients were counted twice.|Participants|Number|23|23.0||||||
4292853|NCT00534495|4118450|B1|White||Race/Ethnicity, Customized|Black ,white and Other are races Hispanic and Non-Hispanic are ethnicities. All patients were counted twice.|Participants|Number|25|25.0||||||
4292854|NCT00534495|4118448|B3|Black||Race/Ethnicity, Customized|Black ,white and Other are races Hispanic and Non-Hispanic are ethnicities. All patients were counted twice.|Participants|Number|12|12.0||||||
4292855|NCT00534495|4118449|B2|Black||Race/Ethnicity, Customized|Black ,white and Other are races Hispanic and Non-Hispanic are ethnicities. All patients were counted twice.|Participants|Number|7|7.0||||||
4292856|NCT00534495|4118450|B1|Black||Race/Ethnicity, Customized|Black ,white and Other are races Hispanic and Non-Hispanic are ethnicities. All patients were counted twice.|Participants|Number|5|5.0||||||
4292857|NCT00534495|4118448|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4292858|NCT00534495|4118449|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4292859|NCT00534495|4118450|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4292860|NCT00534495|4118448|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4292861|NCT00534495|4118449|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4292862|NCT00534495|4118450|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4292863|NCT00534495|4118448|B3|||Age||years|Mean|10|10.0|Standard Deviation|4.5|4.5|||
4292864|NCT00534495|4118449|B2|||Age||years|Mean|10.5|10.5|Standard Deviation|4.4|4.4|||
4292865|NCT00534495|4118450|B1|||Age||years|Mean|9.5|9.5|Standard Deviation|4.6|4.6|||
4292866|NCT00534417|4118475|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4292867|NCT00534417|4118475|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4292868|NCT00534417|4118475|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4292869|NCT00534417|4118475|B1|||Age||years|Mean|64.5|64.5|Standard Deviation|10.80|10.8|||
4292870|NCT00534417|4118475|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4292871|NCT00534417|4118475|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4292872|NCT00534417|4118475|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4292873|NCT00534404|4118487|B4|College graduate||Highest education level||participants|Number|458|458.0||||||
4292874|NCT00534404|4118488|B3|College graduate||Highest education level||participants|Number|146|146.0||||||
4292875|NCT00534404|4118489|B2|College graduate||Highest education level||participants|Number|161|161.0||||||
4292876|NCT00534404|4118490|B1|College graduate||Highest education level||participants|Number|151|151.0||||||
4292877|NCT00534404|4118487|B4|Some college||Highest education level||participants|Number|1384|1384.0||||||
4292878|NCT00534404|4118488|B3|Some college||Highest education level||participants|Number|481|481.0||||||
4292879|NCT00534404|4118489|B2|Some college||Highest education level||participants|Number|463|463.0||||||
4292880|NCT00534404|4118490|B1|Some college||Highest education level||participants|Number|440|440.0||||||
4292881|NCT00534404|4118487|B4|High school or less||Highest education level||participants|Number|643|643.0||||||
4292882|NCT00534404|4118488|B3|High school or less||Highest education level||participants|Number|201|201.0||||||
4292883|NCT00534404|4118489|B2|High school or less||Highest education level||participants|Number|206|206.0||||||
4292884|NCT00534404|4118490|B1|High school or less||Highest education level||participants|Number|236|236.0||||||
4292885|NCT00534404|4118487|B4|United States||Region of Enrollment||participants|Number|2485|2485.0||||||
4292886|NCT00534404|4118488|B3|United States||Region of Enrollment||participants|Number|828|828.0||||||
4292887|NCT00534404|4118489|B2|United States||Region of Enrollment||participants|Number|830|830.0||||||
4292888|NCT00534404|4118490|B1|United States||Region of Enrollment||participants|Number|827|827.0||||||
4292889|NCT00534404|4118487|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4292890|NCT00534404|4118488|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4292891|NCT00534404|4118489|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4292892|NCT00534404|4118490|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4292893|NCT00534404|4118487|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
4292894|NCT00534404|4118488|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4292895|NCT00534404|4118489|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4292896|NCT00534404|4118490|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4292897|NCT00534404|4118487|B4||White|Race (NIH/OMB)||Participants|Count of Participants|2151|2151.0||||||
4292898|NCT00534404|4118488|B3||White|Race (NIH/OMB)||Participants|Count of Participants|712|712.0||||||
4292899|NCT00534404|4118489|B2||White|Race (NIH/OMB)||Participants|Count of Participants|725|725.0||||||
4292900|NCT00534404|4118490|B1||White|Race (NIH/OMB)||Participants|Count of Participants|714|714.0||||||
4292901|NCT00534404|4118487|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|176|176.0||||||
4292902|NCT00534404|4118488|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4292903|NCT00534404|4118489|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4292904|NCT00534404|4118490|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4292905|NCT00534404|4118487|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4292906|NCT00534404|4118488|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4292907|NCT00534404|4118489|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4292908|NCT00534404|4118490|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4292909|NCT00534404|4118487|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4292910|NCT00534404|4118488|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4292911|NCT00534404|4118489|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4292912|NCT00534404|4118490|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4292913|NCT00534404|4118487|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4292914|NCT00534404|4118488|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4292915|NCT00534404|4118489|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4292916|NCT00534404|4118490|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4292917|NCT00534404|4118487|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4292918|NCT00534404|4118488|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4292919|NCT00534404|4118489|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4292920|NCT00534404|4118490|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4292921|NCT00534404|4118487|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2389|2389.0||||||
4292922|NCT00534404|4118488|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|795|795.0||||||
4292923|NCT00534404|4118489|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|797|797.0||||||
4292924|NCT00534404|4118490|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|797|797.0||||||
4292925|NCT00534404|4118487|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4292926|NCT00534404|4118488|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4292927|NCT00534404|4118489|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4292928|NCT00534404|4118490|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4292929|NCT00534404|4118487|B4||Male|Sex: Female, Male||Participants|Count of Participants|764|764.0||||||
4292930|NCT00534404|4118488|B3||Male|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
4292931|NCT00534404|4118489|B2||Male|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
4292932|NCT00534404|4118490|B1||Male|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
4292933|NCT00534404|4118487|B4||Female|Sex: Female, Male||Participants|Count of Participants|1721|1721.0||||||
4292934|NCT00534404|4118488|B3||Female|Sex: Female, Male||Participants|Count of Participants|578|578.0||||||
4292935|NCT00534404|4118489|B2||Female|Sex: Female, Male||Participants|Count of Participants|581|581.0||||||
4292936|NCT00534404|4118490|B1||Female|Sex: Female, Male||Participants|Count of Participants|562|562.0||||||
4292937|NCT00534404|4118487|B4|||Age||Years|Mean|44.26|44.26|Standard Deviation|11.89|11.89|||
4292938|NCT00534404|4118488|B3|||Age||Years|Mean|44.20|44.2|Standard Deviation|11.64|11.64|||
4292939|NCT00534404|4118489|B2|||Age||Years|Mean|44.31|44.31|Standard Deviation|12.00|12.0|||
4292940|NCT00534404|4118490|B1|||Age||Years|Mean|44.27|44.27|Standard Deviation|12.03|12.03|||
4292941|NCT00534404|4118487|B4||>=65 years|Age||Participants|Count of Participants|98|98.0||||||
4292942|NCT00534404|4118488|B3||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4292943|NCT00534404|4118489|B2||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4292944|NCT00534404|4118490|B1||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4292945|NCT00534404|4118487|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2387|2387.0||||||
4292946|NCT00534404|4118488|B3||Between 18 and 65 years|Age||Participants|Count of Participants|800|800.0||||||
4292947|NCT00534404|4118489|B2||Between 18 and 65 years|Age||Participants|Count of Participants|791|791.0||||||
4292948|NCT00534404|4118490|B1||Between 18 and 65 years|Age||Participants|Count of Participants|796|796.0||||||
4292949|NCT00534404|4118487|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4292950|NCT00534404|4118488|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4292951|NCT00534404|4118489|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4292952|NCT00534404|4118490|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4292953|NCT00534365|4118506|B3|||Body mass index||kg/m^2|Mean|29.8|29.8|Standard Deviation|6|6.0|||
4292954|NCT00534365|4118507|B2|||Body mass index||kg/m^2|Mean|29.6|29.6|Standard Deviation|6.4|6.4|||
4292955|NCT00534365|4118508|B1|||Body mass index||kg/m^2|Mean|30.0|30.0|Standard Deviation|5.7|5.7|||
4292956|NCT00534365|4118506|B3|United States||Region of Enrollment||participants|Number|263|263.0||||||
4292957|NCT00534365|4118507|B2|United States||Region of Enrollment||participants|Number|136|136.0||||||
4292958|NCT00534365|4118508|B1|United States||Region of Enrollment||participants|Number|127|127.0||||||
4292959|NCT00534365|4118506|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4292960|NCT00534365|4118507|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4292961|NCT00534365|4118508|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4292962|NCT00534365|4118506|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
4292963|NCT00534365|4118507|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4292964|NCT00534365|4118508|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4292965|NCT00534365|4118506|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|238|238.0||||||
4292966|NCT00534365|4118507|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|118|118.0||||||
4292967|NCT00534365|4118508|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|120|120.0||||||
4292968|NCT00534365|4118506|B3|Female||Sex/Gender, Customized||participants|Number|263|263.0||||||
4292969|NCT00534365|4118507|B2|Female||Sex/Gender, Customized||participants|Number|136|136.0||||||
4292970|NCT00534365|4118508|B1|Female||Sex/Gender, Customized||participants|Number|127|127.0||||||
4292971|NCT00534365|4118506|B3|||Age||years|Mean|54.6|54.6|Standard Deviation|11.0|11.0|||
4292972|NCT00534365|4118507|B2|||Age||years|Mean|54.6|54.6|Standard Deviation|10.5|10.5|||
4292973|NCT00534365|4118508|B1|||Age||years|Mean|54.6|54.6|Standard Deviation|11.3|11.3|||
4292974|NCT00534352|4118523|B1|||Weight||kg|Mean|78.58|78.58|Standard Deviation|13.711|13.711|||
4292975|NCT00534352|4118523|B1|||Height||cm|Mean|172.73|172.73|Standard Deviation|8.405|8.405|||
4292976|NCT00534352|4118523|B1|||Body Mass Index||kg/m2|Mean|26.33|26.33|Standard Deviation|4.629|4.629|||
4292977|NCT00534352|4118523|B1|Yes||Family History Related to Skin Disease||participants|Number|5|5.0||||||
4292978|NCT00534352|4118523|B1|No||Family History Related to Skin Disease||participants|Number|18|18.0||||||
4292979|NCT00534352|4118523|B1|No data||CYP2C9 Genotyping|There are 21 participants with genotyping data.|participants|Number|2|2.0||||||
4292980|NCT00534352|4118523|B1|CYP2C9*1/CYP2C1*3 : Intermediate Phenotype||CYP2C9 Genotyping|There are 21 participants with genotyping data.|participants|Number|2|2.0||||||
4292981|NCT00534352|4118523|B1|CYP2C9*1/CYP2C1*1 : Normal Phenotype||CYP2C9 Genotyping|There are 21 participants with genotyping data.|participants|Number|19|19.0||||||
4292982|NCT00534352|4118523|B1|No data||CYP2C19 Genotyping|There are 21 participants with genotyping data.|participants|Number|2|2.0||||||
4292983|NCT00534352|4118523|B1|CYP2C19*2/CYP2C19*2 : Poor Phenotype||CYP2C19 Genotyping|There are 21 participants with genotyping data.|participants|Number|1|1.0||||||
4292984|NCT00534352|4118523|B1|CYP2C19*17/CYP2C19*2 : Normal Phenotype||CYP2C19 Genotyping|There are 21 participants with genotyping data.|participants|Number|2|2.0||||||
4292985|NCT00534352|4118523|B1|CYP2C19*17/CYP2C19*17 : Ultrarapid Phenotype||CYP2C19 Genotyping|There are 21 participants with genotyping data.|participants|Number|1|1.0||||||
4292986|NCT00534352|4118523|B1|CYP2C19*1/CYP2C19*2 : Intermediate Phenotype||CYP2C19 Genotyping|There are 21 participants with genotyping data.|participants|Number|7|7.0||||||
4292987|NCT00534352|4118523|B1|CYP2C19*1/CYP2C19*17 : Rapid Phenotype||CYP2C19 Genotyping|There are 21 participants with genotyping data.|participants|Number|5|5.0||||||
4292988|NCT00534352|4118523|B1|CYP2C19*1/CYP2C19*1 : Normal Phenotype||CYP2C19 Genotyping|There are 21 participants with genotyping data.|participants|Number|5|5.0||||||
4292989|NCT00534352|4118523|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4292990|NCT00534352|4118523|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4292991|NCT00534352|4118523|B1|Caucasian / White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4292992|NCT00534352|4118523|B1|Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4292993|NCT00534352|4118523|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4292994|NCT00534352|4118523|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4292995|NCT00534352|4118523|B1|||Age||years|Mean|35.87|35.87|Standard Deviation|13.264|13.264|||
4292996|NCT00534352|4118523|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4292997|NCT00534352|4118523|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4292998|NCT00534352|4118523|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4292999|NCT00534313|4118563|B5|||Weight||kilograms|Mean|89.7|89.7|Standard Deviation|19.9|19.9|||
4293000|NCT00534313|4118564|B4|||Weight||kilograms|Mean|96.0|96.0|Standard Deviation|19.4|19.4|||
4293001|NCT00534313|4118565|B3|||Weight||kilograms|Mean|85.0|85.0|Standard Deviation|19.1|19.1|||
4293002|NCT00534313|4118566|B2|||Weight||kilograms|Mean|85.0|85.0|Standard Deviation|17.9|17.9|||
4293003|NCT00534313|4118567|B1|||Weight||kilograms|Mean|92.9|92.9|Standard Deviation|21.3|21.3|||
4293004|NCT00534313|4118563|B5|Pacific||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4293005|NCT00534313|4118564|B4|Pacific||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4293006|NCT00534313|4118565|B3|Pacific||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4293007|NCT00534313|4118566|B2|Pacific||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4293008|NCT00534313|4118567|B1|Pacific||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4293009|NCT00534313|4118563|B5|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4293010|NCT00534313|4118564|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4293011|NCT00534313|4118565|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4293012|NCT00534313|4118566|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4293013|NCT00534313|4118567|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4293014|NCT00534313|4118563|B5|White||Race/Ethnicity, Customized||participants|Number|166|166.0||||||
4293015|NCT00534313|4118564|B4|White||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4293016|NCT00534313|4118565|B3|White||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4293017|NCT00534313|4118566|B2|White||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4293018|NCT00534313|4118567|B1|White||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4293019|NCT00534313|4118563|B5||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4293020|NCT00534313|4118564|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4293021|NCT00534313|4118565|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4293022|NCT00534313|4118566|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4293023|NCT00534313|4118567|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4293024|NCT00534313|4118563|B5||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4293025|NCT00534313|4118564|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4293026|NCT00534313|4118565|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4293027|NCT00534313|4118566|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4293028|NCT00534313|4118567|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4293029|NCT00534313|4118563|B5|||Age||years|Median|52.0|52.0|Full Range|||26.0|82.0|
4293030|NCT00534313|4118564|B4|||Age||years|Median|53.0|53.0|Full Range|||30.0|82.0|
4293031|NCT00534313|4118565|B3|||Age||years|Median|51.0|51.0|Full Range|||29.0|72.0|
4293032|NCT00534313|4118566|B2|||Age||years|Median|51.5|51.5|Full Range|||26.0|73.0|
4293033|NCT00534313|4118567|B1|||Age||years|Median|54.0|54.0|Full Range|||29.0|69.0|
4293034|NCT00534248|4118663|B3||Male|Sex: Female, Male||Participants|Count of Participants|8554|8554.0||||||
4293035|NCT00534248|4118664|B2||Male|Sex: Female, Male||Participants|Count of Participants|4256|4256.0||||||
4293036|NCT00534248|4118665|B1||Male|Sex: Female, Male||Participants|Count of Participants|4298|4298.0||||||
4293037|NCT00534248|4118663|B3||Female|Sex: Female, Male||Participants|Count of Participants|13885|13885.0||||||
4293038|NCT00534248|4118664|B2||Female|Sex: Female, Male||Participants|Count of Participants|6972|6972.0||||||
4293039|NCT00534248|4118665|B1||Female|Sex: Female, Male||Participants|Count of Participants|6913|6913.0||||||
4293040|NCT00534248|4118663|B3|||Age||years|Mean|54.8|54.8|Standard Deviation|2.8|2.8|||
4293041|NCT00534248|4118664|B2|||Age||years|Mean|54.8|54.8|Standard Deviation|2.8|2.8|||
4293042|NCT00534248|4118665|B1|||Age||years|Mean|54.9|54.9|Standard Deviation|2.8|2.8|||
4293043|NCT00534209|4118676|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4293044|NCT00534209|4118676|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4293045|NCT00534209|4118676|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4293046|NCT00534209|4118676|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4293047|NCT00534209|4118676|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4293048|NCT00534105|4118694|B3|United States||Region of Enrollment||participants|Number|106|106.0||||||
4293049|NCT00534105|4118695|B2|United States||Region of Enrollment||participants|Number|59|59.0||||||
4293050|NCT00534105|4118696|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
4293051|NCT00534105|4118694|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4293052|NCT00534105|4118695|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4293053|NCT00534105|4118696|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4293054|NCT00534105|4118694|B3||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4293055|NCT00534105|4118695|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4293056|NCT00534105|4118696|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4293057|NCT00534105|4118694|B3|Age at Recruitment||Age||years|Median|31|31.0|Inter-Quartile Range|||28.0|35.0|
4293058|NCT00534105|4118695|B2|Age at Recruitment||Age||years|Median|30|30.0|Inter-Quartile Range|||26.0|34.0|
4293059|NCT00534105|4118696|B1|Age at Recruitment||Age||years|Median|32|32.0|Inter-Quartile Range|||30.0|36.0|
4293060|NCT00534092|4118709|B3|Unknown||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4293061|NCT00534092|4118710|B2|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4293062|NCT00534092|4118711|B1|Unknown||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4293063|NCT00534092|4118709|B3|White||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
4293064|NCT00534092|4118710|B2|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4293065|NCT00534092|4118711|B1|White||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4293066|NCT00534092|4118709|B3|Native Hawaiian / Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4293067|NCT00534092|4118710|B2|Native Hawaiian / Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4293068|NCT00534092|4118711|B1|Native Hawaiian / Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4293069|NCT00534092|4118709|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4293070|NCT00534092|4118710|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4293071|NCT00534092|4118711|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4293072|NCT00534092|4118709|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4293073|NCT00534092|4118710|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4293074|NCT00534092|4118711|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4293075|NCT00534092|4118709|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4293076|NCT00534092|4118710|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4293077|NCT00534092|4118711|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4293078|NCT00534092|4118709|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4293079|NCT00534092|4118710|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4293080|NCT00534092|4118711|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4293081|NCT00534092|4118709|B3|||Age||years|Mean|72.9|72.9|Standard Deviation|10.1|10.1|||
4293082|NCT00534092|4118710|B2|||Age||years|Mean|76.0|76.0|Standard Deviation|8.9|8.9|||
4293083|NCT00534092|4118711|B1|||Age||years|Mean|72.1|72.1|Standard Deviation|10.2|10.2|||
4293084|NCT00534001|4118735|B3|||Cigarettes Smoked Per Day (CPD)||CPD|Mean|23|23.0|Standard Deviation|7|7.0|||
4293085|NCT00534001|4118736|B2|||Cigarettes Smoked Per Day (CPD)||CPD|Mean|23.4|23.4|Standard Deviation|7.9|7.9|||
4293086|NCT00534001|4118737|B1|||Cigarettes Smoked Per Day (CPD)||CPD|Mean|22.0|22.0|Standard Deviation|6.0|6.0|||
4293087|NCT00534001|4118735|B3|United States||Region of Enrollment||Participants|Count of Participants|95|95.0||||||
4293088|NCT00534001|4118736|B2|United States||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
4293089|NCT00534001|4118737|B1|United States||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
4293090|NCT00534001|4118735|B3|White/Not Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|86|86.0||||||
4293091|NCT00534001|4118736|B2|White/Not Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
4293092|NCT00534001|4118737|B1|White/Not Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
4293093|NCT00534001|4118735|B3|Racial/Ethnic Minority||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4293094|NCT00534001|4118736|B2|Racial/Ethnic Minority||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4293095|NCT00534001|4118737|B1|Racial/Ethnic Minority||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4293096|NCT00534001|4118735|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4293097|NCT00534001|4118736|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4293098|NCT00534001|4118737|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4293099|NCT00534001|4118735|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4293100|NCT00534001|4118736|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4293101|NCT00534001|4118737|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4293102|NCT00534001|4118735|B3|||Age||years|Mean|46|46.0|Standard Deviation|10|10.0|||
4293103|NCT00534001|4118736|B2|||Age||years|Mean|45.8|45.8|Standard Deviation|10.1|10.1|||
4293104|NCT00534001|4118737|B1|||Age||years|Mean|46.7|46.7|Standard Deviation|9.3|9.3|||
4293105|NCT00533949|4118746|B5||Male|Sex: Female, Male||Participants|Count of Participants|295|295.0||||||
4293106|NCT00533949|4118747|B4||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4293107|NCT00533949|4118748|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4293108|NCT00533949|4118749|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4293109|NCT00533949|4118750|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4293110|NCT00533949|4118746|B5||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4293111|NCT00533949|4118747|B4||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4293112|NCT00533949|4118748|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4293113|NCT00533949|4118749|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4293114|NCT00533949|4118750|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4293115|NCT00533949|4118746|B5|||Age||years|Median|64|64.0|Full Range|||37.0|83.0|
4293116|NCT00533949|4118747|B4|||Age||years|Median|64|64.0|Full Range|||44.0|83.0|
4293117|NCT00533949|4118748|B3|||Age||years|Median|64|64.0|Full Range|||38.0|83.0|
4293118|NCT00533949|4118749|B2|||Age||years|Median|64|64.0|Full Range|||41.0|82.0|
4293119|NCT00533949|4118750|B1|||Age||years|Median|64|64.0|Full Range|||37.0|82.0|
4293120|NCT00533897|4118781|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4293121|NCT00533897|4118782|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4293122|NCT00533897|4118783|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4293123|NCT00533897|4118784|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4293124|NCT00533897|4118781|B4||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4293125|NCT00533897|4118782|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4293126|NCT00533897|4118783|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4293127|NCT00533897|4118784|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4293128|NCT00533897|4118781|B4|||Age||years|Mean|49.8|49.8|Standard Deviation|13.1|13.1|||
4293129|NCT00533897|4118782|B3|||Age||years|Mean|49.1|49.1|Standard Deviation|12.8|12.8|||
4293130|NCT00533897|4118783|B2|||Age||years|Mean|48.9|48.9|Standard Deviation|14.2|14.2|||
4293131|NCT00533897|4118784|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|12.7|12.7|||
4293132|NCT00533702|4118929|B3|Other||Race||participants|Number|1|1.0||||||
4293133|NCT00533702|4118930|B2|Other||Race||participants|Number|0|0.0||||||
4293134|NCT00533702|4118931|B1|Other||Race||participants|Number|1|1.0||||||
4293135|NCT00533702|4118929|B3|White||Race||participants|Number|100|100.0||||||
4293136|NCT00533702|4118930|B2|White||Race||participants|Number|50|50.0||||||
4293137|NCT00533702|4118931|B1|White||Race||participants|Number|50|50.0||||||
4293138|NCT00533702|4118929|B3|Asian||Race||participants|Number|1|1.0||||||
4293139|NCT00533702|4118930|B2|Asian||Race||participants|Number|0|0.0||||||
4293140|NCT00533702|4118931|B1|Asian||Race||participants|Number|1|1.0||||||
4293141|NCT00533702|4118929|B3|United States||Region of Enrollment||participants|Number|102|102.0||||||
4293142|NCT00533702|4118930|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
4293143|NCT00533702|4118931|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
4293144|NCT00533702|4118929|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4293145|NCT00533702|4118930|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4293146|NCT00533702|4118931|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4293147|NCT00533702|4118929|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4293148|NCT00533702|4118930|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4293149|NCT00533702|4118931|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4293150|NCT00533702|4118929|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4293151|NCT00533702|4118930|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4293152|NCT00533702|4118931|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4293153|NCT00533702|4118929|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4293154|NCT00533702|4118930|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4293155|NCT00533702|4118931|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4293156|NCT00533702|4118929|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4293157|NCT00533702|4118930|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4293158|NCT00533702|4118931|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4293159|NCT00533702|4118929|B3||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
4293160|NCT00533702|4118930|B2||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4293161|NCT00533702|4118931|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4293162|NCT00533702|4118929|B3||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4293163|NCT00533702|4118930|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4293164|NCT00533702|4118931|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4293165|NCT00533702|4118929|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4293166|NCT00533702|4118930|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4293167|NCT00533702|4118931|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4293168|NCT00533546|4118956|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4293169|NCT00533546|4118956|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4293170|NCT00533546|4118956|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4293171|NCT00533546|4118956|B1|||Age||years|Mean|71.6|71.6|Standard Deviation|17.3|17.3|||
4293172|NCT00533507|4118963|B1||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4293173|NCT00533507|4118963|B1||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4293174|NCT00533507|4118963|B1|||Age||weeks|Mean|6.4|6.4|Standard Deviation|0.60|0.6|||
4293175|NCT00533442|4118982|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4293176|NCT00533442|4118983|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4293177|NCT00533442|4118984|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4293178|NCT00533442|4118982|B3|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4293179|NCT00533442|4118983|B2|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4293180|NCT00533442|4118984|B1|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4293181|NCT00533442|4118982|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
4293182|NCT00533442|4118983|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
4293183|NCT00533442|4118984|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
4293184|NCT00533442|4118982|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|102|102.0||||||
4293185|NCT00533442|4118983|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
4293186|NCT00533442|4118984|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|55|55.0||||||
4293187|NCT00533442|4118982|B3||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4293188|NCT00533442|4118983|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4293189|NCT00533442|4118984|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4293190|NCT00533442|4118982|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4293191|NCT00533442|4118983|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4293192|NCT00533442|4118984|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4293193|NCT00533442|4118982|B3|||Age||years|Mean|42.5|42.5|Standard Deviation|8.8|8.8|||
4293194|NCT00533442|4118983|B2|||Age||years|Mean|41.5|41.5|Standard Deviation|8.2|8.2|||
4293195|NCT00533442|4118984|B1|||Age||years|Mean|43.4|43.4|Standard Deviation|9.3|9.3|||
4293196|NCT00533351|4118995|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4293197|NCT00533351|4118996|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4293198|NCT00533351|4118997|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4293199|NCT00533351|4118995|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4293200|NCT00533351|4118996|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4293201|NCT00533351|4118997|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4293202|NCT00533351|4118995|B3|||Age||years|Mean|54.8|54.8|Standard Deviation|23.89|23.89|||
4293203|NCT00533351|4118996|B2|||Age||years|Mean|49|49.0|Standard Deviation|36.77|36.77|||
4293204|NCT00533351|4118997|B1|||Age||years|Mean|60.6|60.6|Standard Deviation|11.01|11.01|||
4293205|NCT00533273|4119006|B3|Australia||Region of Enrollment||participants|Number|66|66.0||||||
4293206|NCT00533273|4119007|B2|Australia||Region of Enrollment||participants|Number|21|21.0||||||
4293207|NCT00533273|4119008|B1|Australia||Region of Enrollment||participants|Number|45|45.0||||||
4293208|NCT00533273|4119006|B3|White||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
4293209|NCT00533273|4119007|B2|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4293210|NCT00533273|4119008|B1|White||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4293211|NCT00533273|4119006|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4293212|NCT00533273|4119007|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4293213|NCT00533273|4119008|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4293214|NCT00533273|4119006|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4293215|NCT00533273|4119007|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4293216|NCT00533273|4119008|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4293217|NCT00533273|4119006|B3|||Age||years|Mean|63.8|63.8|Standard Deviation|9.0|9.0|||
4293218|NCT00533273|4119007|B2|||Age||years|Mean|65.5|65.5|Standard Deviation|11.1|11.1|||
4293219|NCT00533273|4119008|B1|||Age||years|Mean|63.0|63.0|Standard Deviation|7.8|7.8|||
4293220|NCT00533273|4119006|B3||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4293221|NCT00533273|4119007|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4293222|NCT00533273|4119008|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4293223|NCT00533273|4119006|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4293224|NCT00533273|4119007|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4293225|NCT00533273|4119008|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4293226|NCT00533273|4119006|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4293227|NCT00533273|4119007|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4293228|NCT00533273|4119008|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4293229|NCT00533117|4119040|B5||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4293230|NCT00533117|4119041|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4293231|NCT00533117|4119042|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4293232|NCT00533117|4119043|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4293233|NCT00533117|4119044|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4293234|NCT00533117|4119040|B5||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4293235|NCT00533117|4119041|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4293236|NCT00533117|4119042|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4293237|NCT00533117|4119043|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4293238|NCT00533117|4119044|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4293239|NCT00533117|4119040|B5|||Age||years|Mean|30.2|30.2|Standard Deviation|8.7|8.7|||
4293240|NCT00533117|4119041|B4|||Age||years|Mean|31.8|31.8|Standard Deviation|11.2|11.2|||
4293241|NCT00533117|4119042|B3|||Age||years|Mean|32.3|32.3|Standard Deviation|8.6|8.6|||
4293242|NCT00533117|4119043|B2|||Age||years|Mean|29.1|29.1|Standard Deviation|8.3|8.3|||
4293243|NCT00533117|4119044|B1|||Age||years|Mean|28.6|28.6|Standard Deviation|6.9|6.9|||
4293244|NCT00532948|4119055|B4||Male|Gender||Participants|Count of Participants|9|9.0||||||
4293245|NCT00532948|4119056|B3||Male|Gender||Participants|Count of Participants|4|4.0||||||
4293246|NCT00532948|4119057|B2||Male|Gender||Participants|Count of Participants|2|2.0||||||
4293247|NCT00532948|4119058|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
4293248|NCT00532948|4119055|B4||Female|Gender||Participants|Count of Participants|15|15.0||||||
4293249|NCT00532948|4119056|B3||Female|Gender||Participants|Count of Participants|2|2.0||||||
4293250|NCT00532948|4119057|B2||Female|Gender||Participants|Count of Participants|12|12.0||||||
4293251|NCT00532948|4119058|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
4293252|NCT00532948|4119055|B4|||Age||years|Mean|9.37|9.37|Standard Deviation|3.39|3.39|||
4293253|NCT00532948|4119056|B3|||Age||years|Mean|13|13.0|Standard Deviation|3.41|3.41|||
4293254|NCT00532948|4119057|B2|||Age||years|Mean|8.4|8.4|Standard Deviation|2.65|2.65|||
4293255|NCT00532948|4119058|B1|||Age||years|Mean|7.5|7.5|Standard Deviation|1.73|1.73|||
4293256|NCT00532935|4119090|B3|||2-Hour Post-Meal Glucose (2-HR PMG)||mg/dL|Mean|276.2|276.2|Standard Deviation|85.5|85.5|||
4293257|NCT00532935|4119091|B2|||2-Hour Post-Meal Glucose (2-HR PMG)||mg/dL|Mean|278.8|278.8|Standard Deviation|86.4|86.4|||
4293258|NCT00532935|4119092|B1|||2-Hour Post-Meal Glucose (2-HR PMG)||mg/dL|Mean|273.7|273.7|Standard Deviation|84.8|84.8|||
4293259|NCT00532935|4119090|B3|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|189.8|189.8|Standard Deviation|55.2|55.2|||
4293260|NCT00532935|4119091|B2|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|188.9|188.9|Standard Deviation|57.1|57.1|||
4293261|NCT00532935|4119092|B1|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|190.6|190.6|Standard Deviation|53.4|53.4|||
4293262|NCT00532935|4119090|B3|||Hemoglobin A1C (A1C)||Percent of glycosylated hemoglobin (A1C)|Mean|8.9|8.9|Standard Deviation|1.3|1.3|||
4293263|NCT00532935|4119091|B2|||Hemoglobin A1C (A1C)||Percent of glycosylated hemoglobin (A1C)|Mean|8.9|8.9|Standard Deviation|1.3|1.3|||
4293264|NCT00532935|4119092|B1|||Hemoglobin A1C (A1C)||Percent of glycosylated hemoglobin (A1C)|Mean|9.0|9.0|Standard Deviation|1.3|1.3|||
4293265|NCT00532935|4119090|B3|Multi-racial||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
4293266|NCT00532935|4119091|B2|Multi-racial||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4293267|NCT00532935|4119092|B1|Multi-racial||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4293268|NCT00532935|4119090|B3|Asian||Race/Ethnicity, Customized||participants|Number|113|113.0||||||
4293269|NCT00532935|4119091|B2|Asian||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
4293270|NCT00532935|4119092|B1|Asian||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
4293271|NCT00532935|4119090|B3|American Indian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4293272|NCT00532935|4119091|B2|American Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4293273|NCT00532935|4119092|B1|American Indian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4293274|NCT00532935|4119090|B3|Black||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4293275|NCT00532935|4119091|B2|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4293276|NCT00532935|4119092|B1|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4293277|NCT00532935|4119090|B3|White||Race/Ethnicity, Customized||participants|Number|335|335.0||||||
4293278|NCT00532935|4119091|B2|White||Race/Ethnicity, Customized||participants|Number|167|167.0||||||
4293279|NCT00532935|4119092|B1|White||Race/Ethnicity, Customized||participants|Number|168|168.0||||||
4293280|NCT00532935|4119090|B3||Male|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
4293281|NCT00532935|4119091|B2||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4293282|NCT00532935|4119092|B1||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4293283|NCT00532935|4119090|B3||Female|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
4293284|NCT00532935|4119091|B2||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4293285|NCT00532935|4119092|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4293286|NCT00532935|4119090|B3|||Age||years|Mean|52.3|52.3|Standard Deviation|10.8|10.8|||
4293287|NCT00532935|4119091|B2|||Age||years|Mean|52.2|52.2|Standard Deviation|11|11.0|||
4293288|NCT00532935|4119092|B1|||Age||years|Mean|52.4|52.4|Standard Deviation|10.7|10.7|||
4293289|NCT00532883|4119107|B5|United States||Region of Enrollment||participants|Number|44|44.0||||||
4293290|NCT00532883|4119108|B4|United States||Region of Enrollment||participants|Number|11|11.0||||||
4293291|NCT00532883|4119109|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4293292|NCT00532883|4119110|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4293293|NCT00532883|4119111|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4293294|NCT00532883|4119107|B5||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4293295|NCT00532883|4119108|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4293296|NCT00532883|4119109|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4293297|NCT00532883|4119110|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4293298|NCT00532883|4119111|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4293299|NCT00532883|4119107|B5||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4293300|NCT00532883|4119108|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4293301|NCT00532883|4119109|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4293302|NCT00532883|4119110|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4293303|NCT00532883|4119111|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4293304|NCT00532883|4119107|B5|||Age||years|Mean|16.7|16.7|Standard Deviation|9.81|9.81|||
4293305|NCT00532883|4119108|B4|||Age||years|Mean|17.3|17.3|Standard Deviation|12.41|12.41|||
4293306|NCT00532883|4119109|B3|||Age||years|Mean|14.8|14.8|Standard Deviation|8.45|8.45|||
4293307|NCT00532883|4119110|B2|||Age||years|Mean|16.8|16.8|Standard Deviation|12.6|12.6|||
4293308|NCT00532883|4119111|B1|||Age||years|Mean|12.5|12.5|Standard Deviation|4.41|4.41|||
4293309|NCT00532883|4119107|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4293310|NCT00532883|4119108|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4293311|NCT00532883|4119109|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4293312|NCT00532883|4119110|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4293313|NCT00532883|4119111|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4293314|NCT00532883|4119107|B5||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4293315|NCT00532883|4119108|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4293316|NCT00532883|4119109|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4293317|NCT00532883|4119110|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4293318|NCT00532883|4119111|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4293319|NCT00532883|4119107|B5||<=18 years|Age||Participants|Count of Participants|37|37.0||||||
4293320|NCT00532883|4119108|B4||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4293321|NCT00532883|4119109|B3||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4293322|NCT00532883|4119110|B2||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4293323|NCT00532883|4119111|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4293324|NCT00532779|4119124|B4|||BMI||kg/m^2|Mean|36.17|36.17|Standard Deviation|4.21|4.21|||
4293325|NCT00532779|4119125|B3|||BMI||kg/m^2|Mean|36.18|36.18|Standard Deviation|4.00|4.0|||
4293326|NCT00532779|4119126|B2|||BMI||kg/m^2|Mean|36.10|36.1|Standard Deviation|4.35|4.35|||
4293327|NCT00532779|4119127|B1|||BMI||kg/m^2|Mean|36.22|36.22|Standard Deviation|4.28|4.28|||
4293328|NCT00532779|4119124|B4|||Weight||kg|Mean|99.55|99.55|Standard Deviation|14.99|14.99|||
4293329|NCT00532779|4119125|B3|||Weight||kg|Mean|99.45|99.45|Standard Deviation|14.31|14.31|||
4293330|NCT00532779|4119126|B2|||Weight||kg|Mean|99.70|99.7|Standard Deviation|15.88|15.88|||
4293331|NCT00532779|4119127|B1|||Weight||kg|Mean|99.49|99.49|Standard Deviation|14.76|14.76|||
4293332|NCT00532779|4119124|B4|Other||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4293333|NCT00532779|4119125|B3|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4293334|NCT00532779|4119126|B2|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4293335|NCT00532779|4119127|B1|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4293336|NCT00532779|4119124|B4|White||Race/Ethnicity, Customized||participants|Number|1307|1307.0||||||
4293337|NCT00532779|4119125|B3|White||Race/Ethnicity, Customized||participants|Number|440|440.0||||||
4293338|NCT00532779|4119126|B2|White||Race/Ethnicity, Customized||participants|Number|440|440.0||||||
4293339|NCT00532779|4119127|B1|White||Race/Ethnicity, Customized||participants|Number|427|427.0||||||
4293340|NCT00532779|4119124|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|338|338.0||||||
4293341|NCT00532779|4119125|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|110|110.0||||||
4293342|NCT00532779|4119126|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|106|106.0||||||
4293343|NCT00532779|4119127|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|122|122.0||||||
4293344|NCT00532779|4119124|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4293345|NCT00532779|4119125|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4293346|NCT00532779|4119126|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4293347|NCT00532779|4119127|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4293348|NCT00532779|4119124|B4|Asian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4293349|NCT00532779|4119125|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4293350|NCT00532779|4119126|B2|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4293351|NCT00532779|4119127|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4293352|NCT00532779|4119124|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
4293353|NCT00532779|4119125|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4293354|NCT00532779|4119126|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4293355|NCT00532779|4119127|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4293356|NCT00532779|4119124|B4||Male|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
4293357|NCT00532779|4119125|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4293358|NCT00532779|4119126|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4293359|NCT00532779|4119127|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4293360|NCT00532779|4119124|B4||Female|Sex: Female, Male||Participants|Count of Participants|1482|1482.0||||||
4293361|NCT00532779|4119125|B3||Female|Sex: Female, Male||Participants|Count of Participants|496|496.0||||||
4293362|NCT00532779|4119126|B2||Female|Sex: Female, Male||Participants|Count of Participants|496|496.0||||||
4293363|NCT00532779|4119127|B1||Female|Sex: Female, Male||Participants|Count of Participants|490|490.0||||||
4293364|NCT00532779|4119124|B4|||Age||years|Mean|44.14|44.14|Standard Deviation|11.17|11.17|||
4293365|NCT00532779|4119125|B3|||Age||years|Mean|43.66|43.66|Standard Deviation|11.14|11.14|||
4293366|NCT00532779|4119126|B2|||Age||years|Mean|44.41|44.41|Standard Deviation|11.14|11.14|||
4293367|NCT00532779|4119127|B1|||Age||years|Mean|44.35|44.35|Standard Deviation|11.25|11.25|||
4293368|NCT00532493|4119188|B3|No||Maintained on Selective Serotonin Re-uptake Inhibitors (SSRI)||participants|Number|78|78.0||||||
4293369|NCT00532493|4119189|B2|No||Maintained on Selective Serotonin Re-uptake Inhibitors (SSRI)||participants|Number|39|39.0||||||
4293370|NCT00532493|4119190|B1|No||Maintained on Selective Serotonin Re-uptake Inhibitors (SSRI)||participants|Number|39|39.0||||||
4293371|NCT00532493|4119188|B3|Yes||Maintained on Selective Serotonin Re-uptake Inhibitors (SSRI)||participants|Number|226|226.0||||||
4293372|NCT00532493|4119189|B2|Yes||Maintained on Selective Serotonin Re-uptake Inhibitors (SSRI)||participants|Number|113|113.0||||||
4293373|NCT00532493|4119190|B1|Yes||Maintained on Selective Serotonin Re-uptake Inhibitors (SSRI)||participants|Number|113|113.0||||||
4293374|NCT00532493|4119188|B3|No||Maintained on any Antidepressant||participants|Number|68|68.0||||||
4293375|NCT00532493|4119189|B2|No||Maintained on any Antidepressant||participants|Number|35|35.0||||||
4293376|NCT00532493|4119190|B1|No||Maintained on any Antidepressant||participants|Number|33|33.0||||||
4293377|NCT00532493|4119188|B3|Yes||Maintained on any Antidepressant||participants|Number|236|236.0||||||
4293378|NCT00532493|4119189|B2|Yes||Maintained on any Antidepressant||participants|Number|117|117.0||||||
4293379|NCT00532493|4119190|B1|Yes||Maintained on any Antidepressant||participants|Number|119|119.0||||||
4293380|NCT00532493|4119188|B3|No||Major Depression||participants|Number|189|189.0||||||
4293381|NCT00532493|4119189|B2|No||Major Depression||participants|Number|88|88.0||||||
4293382|NCT00532493|4119190|B1|No||Major Depression||participants|Number|101|101.0||||||
4293383|NCT00532493|4119188|B3|Yes||Major Depression||participants|Number|115|115.0||||||
4293384|NCT00532493|4119189|B2|Yes||Major Depression||participants|Number|64|64.0||||||
4293385|NCT00532493|4119190|B1|Yes||Major Depression||participants|Number|51|51.0||||||
4293386|NCT00532493|4119188|B3|Did Not Answer||Marital Status||participants|Number|4|4.0||||||
4293387|NCT00532493|4119189|B2|Did Not Answer||Marital Status||participants|Number|2|2.0||||||
4293388|NCT00532493|4119190|B1|Did Not Answer||Marital Status||participants|Number|2|2.0||||||
4293389|NCT00532493|4119188|B3|Widowed||Marital Status||participants|Number|7|7.0||||||
4293390|NCT00532493|4119189|B2|Widowed||Marital Status||participants|Number|4|4.0||||||
4293391|NCT00532493|4119190|B1|Widowed||Marital Status||participants|Number|3|3.0||||||
4293392|NCT00532493|4119188|B3|Divorced||Marital Status||participants|Number|66|66.0||||||
4293393|NCT00532493|4119189|B2|Divorced||Marital Status||participants|Number|27|27.0||||||
4293394|NCT00532493|4119190|B1|Divorced||Marital Status||participants|Number|39|39.0||||||
4293395|NCT00532493|4119188|B3|Separated||Marital Status||participants|Number|12|12.0||||||
4293396|NCT00532493|4119189|B2|Separated||Marital Status||participants|Number|6|6.0||||||
4293397|NCT00532493|4119190|B1|Separated||Marital Status||participants|Number|6|6.0||||||
4293398|NCT00532493|4119188|B3|Living Together in a Relationship||Marital Status||participants|Number|7|7.0||||||
4293399|NCT00532493|4119189|B2|Living Together in a Relationship||Marital Status||participants|Number|4|4.0||||||
4293400|NCT00532493|4119190|B1|Living Together in a Relationship||Marital Status||participants|Number|3|3.0||||||
4293401|NCT00532493|4119188|B3|Married||Marital Status||participants|Number|171|171.0||||||
4293402|NCT00532493|4119189|B2|Married||Marital Status||participants|Number|89|89.0||||||
4293403|NCT00532493|4119190|B1|Married||Marital Status||participants|Number|82|82.0||||||
4293404|NCT00532493|4119188|B3|Single||Marital Status||participants|Number|37|37.0||||||
4293405|NCT00532493|4119189|B2|Single||Marital Status||participants|Number|20|20.0||||||
4293406|NCT00532493|4119190|B1|Single||Marital Status||participants|Number|17|17.0||||||
4293407|NCT00532493|4119188|B3|Did Not Answer||Highest Educational Level||participants|Number|4|4.0||||||
4293408|NCT00532493|4119189|B2|Did Not Answer||Highest Educational Level||participants|Number|2|2.0||||||
4293409|NCT00532493|4119190|B1|Did Not Answer||Highest Educational Level||participants|Number|2|2.0||||||
4293410|NCT00532493|4119188|B3|Other||Highest Educational Level||participants|Number|3|3.0||||||
4293411|NCT00532493|4119189|B2|Other||Highest Educational Level||participants|Number|1|1.0||||||
4293412|NCT00532493|4119190|B1|Other||Highest Educational Level||participants|Number|2|2.0||||||
4293413|NCT00532493|4119188|B3|Post Graduate/Professional Degree||Highest Educational Level||participants|Number|20|20.0||||||
4293414|NCT00532493|4119189|B2|Post Graduate/Professional Degree||Highest Educational Level||participants|Number|13|13.0||||||
4293415|NCT00532493|4119190|B1|Post Graduate/Professional Degree||Highest Educational Level||participants|Number|7|7.0||||||
4293416|NCT00532493|4119188|B3|College Graduate||Highest Educational Level||participants|Number|47|47.0||||||
4293417|NCT00532493|4119189|B2|College Graduate||Highest Educational Level||participants|Number|25|25.0||||||
4293418|NCT00532493|4119190|B1|College Graduate||Highest Educational Level||participants|Number|22|22.0||||||
4293419|NCT00532493|4119188|B3|Some College/Ass.Degree/Tech.School||Highest Educational Level||participants|Number|156|156.0||||||
4293420|NCT00532493|4119189|B2|Some College/Ass.Degree/Tech.School||Highest Educational Level||participants|Number|77|77.0||||||
4293421|NCT00532493|4119190|B1|Some College/Ass.Degree/Tech.School||Highest Educational Level||participants|Number|79|79.0||||||
4293422|NCT00532493|4119188|B3|High School/GED||Highest Educational Level||participants|Number|64|64.0||||||
4293423|NCT00532493|4119189|B2|High School/GED||Highest Educational Level||participants|Number|29|29.0||||||
4293424|NCT00532493|4119190|B1|High School/GED||Highest Educational Level||participants|Number|35|35.0||||||
4293425|NCT00532493|4119188|B3|Some High School||Highest Educational Level||participants|Number|10|10.0||||||
4293426|NCT00532493|4119189|B2|Some High School||Highest Educational Level||participants|Number|5|5.0||||||
4293427|NCT00532493|4119190|B1|Some High School||Highest Educational Level||participants|Number|5|5.0||||||
4293428|NCT00532493|4119188|B3|Grade School or Less||Highest Educational Level||participants|Number|0|0.0||||||
4293429|NCT00532493|4119189|B2|Grade School or Less||Highest Educational Level||participants|Number|0|0.0||||||
4293430|NCT00532493|4119190|B1|Grade School or Less||Highest Educational Level||participants|Number|0|0.0||||||
4293431|NCT00532493|4119188|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4293432|NCT00532493|4119189|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4293433|NCT00532493|4119190|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4293434|NCT00532493|4119188|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4293435|NCT00532493|4119189|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4293436|NCT00532493|4119190|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4293437|NCT00532493|4119188|B3||White|Race (NIH/OMB)||Participants|Count of Participants|192|192.0||||||
4293438|NCT00532493|4119189|B2||White|Race (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
4293439|NCT00532493|4119190|B1||White|Race (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
4293440|NCT00532493|4119188|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4293441|NCT00532493|4119189|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4293442|NCT00532493|4119190|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4293443|NCT00532493|4119188|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4293444|NCT00532493|4119189|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4293445|NCT00532493|4119190|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4293446|NCT00532493|4119188|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4293447|NCT00532493|4119189|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4293448|NCT00532493|4119190|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4293449|NCT00532493|4119188|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4293450|NCT00532493|4119189|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4293451|NCT00532493|4119190|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4293452|NCT00532493|4119188|B3||Male|Sex: Female, Male||Participants|Count of Participants|297|297.0||||||
4293453|NCT00532493|4119189|B2||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4293454|NCT00532493|4119190|B1||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4293455|NCT00532493|4119188|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4293456|NCT00532493|4119189|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4293457|NCT00532493|4119190|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4293458|NCT00532493|4119188|B3|||Age||years|Mean|51.8|51.8|Standard Deviation|13.8|13.8|||
4293459|NCT00532493|4119189|B2|||Age||years|Mean|51.4|51.4|Standard Deviation|13.8|13.8|||
4293460|NCT00532493|4119190|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|13.8|13.8|||
4293461|NCT00532480|4119221|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4293462|NCT00532480|4119221|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4293463|NCT00532480|4119221|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4293464|NCT00532480|4119221|B1|||Age||years|Mean|39|39.0|Standard Deviation|12|12.0|||
4293465|NCT00532480|4119221|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4293466|NCT00532480|4119221|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4293467|NCT00532480|4119221|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4293468|NCT00532441|4119225|B1|Hepatocellular: >1 Prior Therapy||Number of Prior Systemic Therapies||participants|Number|2|2.0||||||
4293469|NCT00532441|4119225|B1|Hepatocellular: 1 Prior Therapy||Number of Prior Systemic Therapies||participants|Number|6|6.0||||||
4293470|NCT00532441|4119225|B1|Biliary: >1 Prior Therapy||Number of Prior Systemic Therapies||participants|Number|1|1.0||||||
4293471|NCT00532441|4119225|B1|Biliary: 1 Prior therapy||Number of Prior Systemic Therapies||participants|Number|6|6.0||||||
4293472|NCT00532441|4119225|B1|Hepatocellular:Surgery||Previous Treatment|Previous treatment regimens for subjects, broken out by disease site (Biliary or Hepatocellular)|participants|Number|3|3.0||||||
4293473|NCT00532441|4119225|B1|Hepatocellular: Y90 Radioembolization||Previous Treatment|Previous treatment regimens for subjects, broken out by disease site (Biliary or Hepatocellular)|participants|Number|2|2.0||||||
4293474|NCT00532441|4119225|B1|Hepatocellular:Radiotherapy||Previous Treatment|Previous treatment regimens for subjects, broken out by disease site (Biliary or Hepatocellular)|participants|Number|2|2.0||||||
4293475|NCT00532441|4119225|B1|Hepatocellular:Targeted therapy (sorafenib)||Previous Treatment|Previous treatment regimens for subjects, broken out by disease site (Biliary or Hepatocellular)|participants|Number|7|7.0||||||
4293476|NCT00532441|4119225|B1|Hepatocellular: Chemotherapy||Previous Treatment|Previous treatment regimens for subjects, broken out by disease site (Biliary or Hepatocellular)|participants|Number|3|3.0||||||
4293477|NCT00532441|4119225|B1|Biliary: Surgery||Previous Treatment|Previous treatment regimens for subjects, broken out by disease site (Biliary or Hepatocellular)|participants|Number|2|2.0||||||
4293478|NCT00532441|4119225|B1|Biliary: Y90 Radioembolization||Previous Treatment|Previous treatment regimens for subjects, broken out by disease site (Biliary or Hepatocellular)|participants|Number|0|0.0||||||
4293479|NCT00532441|4119225|B1|Biliary: Radiotherapy||Previous Treatment|Previous treatment regimens for subjects, broken out by disease site (Biliary or Hepatocellular)|participants|Number|3|3.0||||||
4293480|NCT00532441|4119225|B1|Biliary: Targeted therapy (sorafenib)||Previous Treatment|Previous treatment regimens for subjects, broken out by disease site (Biliary or Hepatocellular)|participants|Number|0|0.0||||||
4293481|NCT00532441|4119225|B1|Biliary: Chemotherapy||Previous Treatment|Previous treatment regimens for subjects, broken out by disease site (Biliary or Hepatocellular)|participants|Number|7|7.0||||||
4293482|NCT00532441|4119225|B1|Metastatic: Hepatocellular||Disease Status||participants|Number|10|10.0||||||
4293483|NCT00532441|4119225|B1|Metastatic: Biliary||Disease Status||participants|Number|11|11.0||||||
4293484|NCT00532441|4119225|B1|Locally Advanced: Hepatocellular||Disease Status||participants|Number|4|4.0||||||
4293485|NCT00532441|4119225|B1|Locally Advanced: Biliary||Disease Status||participants|Number|0|0.0||||||
4293486|NCT00532441|4119225|B1|N/A||Biliary Cancer Site||participants|Number|14|14.0||||||
4293487|NCT00532441|4119225|B1|Gallbladder||Biliary Cancer Site||participants|Number|5|5.0||||||
4293488|NCT00532441|4119225|B1|Cholangiocarcoma||Biliary Cancer Site||participants|Number|6|6.0||||||
4293489|NCT00532441|4119225|B1|Hepatocellular||Cancer Type or Histologic Subtype||participants|Number|14|14.0||||||
4293490|NCT00532441|4119225|B1|Biliary||Cancer Type or Histologic Subtype||participants|Number|11|11.0||||||
4293491|NCT00532441|4119225|B1|ECOG 2||ECOG Performance Status|"ECOG Assessment Sacle:~0 Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|participants|Number|2|2.0||||||
4293492|NCT00532441|4119225|B1|ECOG 1||ECOG Performance Status|"ECOG Assessment Sacle:~0 Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|participants|Number|12|12.0||||||
4293493|NCT00532441|4119225|B1|ECOG 0||ECOG Performance Status|"ECOG Assessment Sacle:~0 Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|participants|Number|11|11.0||||||
4293494|NCT00532441|4119225|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4293495|NCT00532441|4119225|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4293496|NCT00532441|4119225|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4293497|NCT00532441|4119225|B1|Age||Age, Customized||years|Median|63.5|63.5|Full Range|||41.0|76.0|
4293498|NCT00532298|4119235|B7||Male|Sex: Female, Male||Participants|Count of Participants|694|694.0||||||
4293499|NCT00532298|4119236|B6||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4293500|NCT00532298|4119237|B5||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4293501|NCT00532298|4119238|B4||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4293502|NCT00532298|4119239|B3||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4293503|NCT00532298|4119240|B2||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4293504|NCT00532298|4119241|B1||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4293505|NCT00532298|4119235|B7||Female|Sex: Female, Male||Participants|Count of Participants|900|900.0||||||
4293506|NCT00532298|4119236|B6||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4293507|NCT00532298|4119237|B5||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4293508|NCT00532298|4119238|B4||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4293509|NCT00532298|4119239|B3||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4293510|NCT00532298|4119240|B2||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4293511|NCT00532298|4119241|B1||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4293512|NCT00532298|4119235|B7|||Age||Years|Mean|73.08|73.08|Standard Deviation|5.43|5.43|||
4293513|NCT00532298|4119236|B6|||Age||Years|Mean|73.0|73.0|Standard Deviation|5.20|5.2|||
4293514|NCT00532298|4119237|B5|||Age||Years|Mean|73.2|73.2|Standard Deviation|5.72|5.72|||
4293515|NCT00532298|4119238|B4|||Age||Years|Mean|73.3|73.3|Standard Deviation|5.86|5.86|||
4293516|NCT00532298|4119239|B3|||Age||Years|Mean|72.8|72.8|Standard Deviation|5.06|5.06|||
4293517|NCT00532298|4119240|B2|||Age||Years|Mean|73.0|73.0|Standard Deviation|5.16|5.16|||
4293518|NCT00532298|4119241|B1|||Age||Years|Mean|73.2|73.2|Standard Deviation|5.56|5.56|||
4293519|NCT00532259|4119326|B1|Chile||Region of Enrollment||participants|Number|1|1.0||||||
4293520|NCT00532259|4119326|B1|India||Region of Enrollment||participants|Number|3|3.0||||||
4293521|NCT00532259|4119326|B1|Israel||Region of Enrollment||participants|Number|10|10.0||||||
4293522|NCT00532259|4119326|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
4293523|NCT00532259|4119326|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4293524|NCT00532259|4119326|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4293525|NCT00532259|4119326|B1|||Age||years|Mean|54.1|54.1|Standard Deviation|13.0|13.0|||
4293526|NCT00532259|4119326|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4293527|NCT00532259|4119326|B1||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4293528|NCT00532259|4119326|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4293529|NCT00532155|4119331|B3|Participants with ECOG Score = 2||Eastern Cooperative Oncology Group (ECOG) performance status score (as per IVRS)|"The ECOG score assesses how the disease affects a participant's daily living abilities. It ranges from 0-5, with 0 being the best and 5 being the worst outcome. 0 reflects a fully active participant, able to carry on all pre-disease performance without restriction. 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. 2 reflects an ambulatory participant, who is up and about more than 50% of waking hours, and capable of all self-care but unable to carry out any work activities."|participants|Number|44|44.0||||||
4293530|NCT00532155|4119332|B2|Participants with ECOG Score = 2||Eastern Cooperative Oncology Group (ECOG) performance status score (as per IVRS)|"The ECOG score assesses how the disease affects a participant's daily living abilities. It ranges from 0-5, with 0 being the best and 5 being the worst outcome. 0 reflects a fully active participant, able to carry on all pre-disease performance without restriction. 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. 2 reflects an ambulatory participant, who is up and about more than 50% of waking hours, and capable of all self-care but unable to carry out any work activities."|participants|Number|21|21.0||||||
4293531|NCT00532155|4119333|B1|Participants with ECOG Score = 2||Eastern Cooperative Oncology Group (ECOG) performance status score (as per IVRS)|"The ECOG score assesses how the disease affects a participant's daily living abilities. It ranges from 0-5, with 0 being the best and 5 being the worst outcome. 0 reflects a fully active participant, able to carry on all pre-disease performance without restriction. 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. 2 reflects an ambulatory participant, who is up and about more than 50% of waking hours, and capable of all self-care but unable to carry out any work activities."|participants|Number|23|23.0||||||
4293532|NCT00532155|4119331|B3|Participants with ECOG Score = 1||Eastern Cooperative Oncology Group (ECOG) performance status score (as per IVRS)|"The ECOG score assesses how the disease affects a participant's daily living abilities. It ranges from 0-5, with 0 being the best and 5 being the worst outcome. 0 reflects a fully active participant, able to carry on all pre-disease performance without restriction. 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. 2 reflects an ambulatory participant, who is up and about more than 50% of waking hours, and capable of all self-care but unable to carry out any work activities."|participants|Number|569|569.0||||||
4293533|NCT00532155|4119332|B2|Participants with ECOG Score = 1||Eastern Cooperative Oncology Group (ECOG) performance status score (as per IVRS)|"The ECOG score assesses how the disease affects a participant's daily living abilities. It ranges from 0-5, with 0 being the best and 5 being the worst outcome. 0 reflects a fully active participant, able to carry on all pre-disease performance without restriction. 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. 2 reflects an ambulatory participant, who is up and about more than 50% of waking hours, and capable of all self-care but unable to carry out any work activities."|participants|Number|286|286.0||||||
4293534|NCT00532155|4119333|B1|Participants with ECOG Score = 1||Eastern Cooperative Oncology Group (ECOG) performance status score (as per IVRS)|"The ECOG score assesses how the disease affects a participant's daily living abilities. It ranges from 0-5, with 0 being the best and 5 being the worst outcome. 0 reflects a fully active participant, able to carry on all pre-disease performance without restriction. 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. 2 reflects an ambulatory participant, who is up and about more than 50% of waking hours, and capable of all self-care but unable to carry out any work activities."|participants|Number|283|283.0||||||
4293535|NCT00532155|4119331|B3|Participants with ECOG Score = 0||Eastern Cooperative Oncology Group (ECOG) performance status score (as per IVRS)|"The ECOG score assesses how the disease affects a participant's daily living abilities. It ranges from 0-5, with 0 being the best and 5 being the worst outcome. 0 reflects a fully active participant, able to carry on all pre-disease performance without restriction. 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. 2 reflects an ambulatory participant, who is up and about more than 50% of waking hours, and capable of all self-care but unable to carry out any work activities."|participants|Number|300|300.0||||||
4293536|NCT00532155|4119332|B2|Participants with ECOG Score = 0||Eastern Cooperative Oncology Group (ECOG) performance status score (as per IVRS)|"The ECOG score assesses how the disease affects a participant's daily living abilities. It ranges from 0-5, with 0 being the best and 5 being the worst outcome. 0 reflects a fully active participant, able to carry on all pre-disease performance without restriction. 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. 2 reflects an ambulatory participant, who is up and about more than 50% of waking hours, and capable of all self-care but unable to carry out any work activities."|participants|Number|149|149.0||||||
4293537|NCT00532155|4119333|B1|Participants with ECOG Score = 0||Eastern Cooperative Oncology Group (ECOG) performance status score (as per IVRS)|"The ECOG score assesses how the disease affects a participant's daily living abilities. It ranges from 0-5, with 0 being the best and 5 being the worst outcome. 0 reflects a fully active participant, able to carry on all pre-disease performance without restriction. 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. 2 reflects an ambulatory participant, who is up and about more than 50% of waking hours, and capable of all self-care but unable to carry out any work activities."|participants|Number|151|151.0||||||
4293538|NCT00532155|4119331|B3|No||Prior Bevacizumab (as per IVRS)|Number of participants who had received prior bevacizumab as per interactive voice response system (IVRS).|participants|Number|809|809.0||||||
4293539|NCT00532155|4119332|B2|No||Prior Bevacizumab (as per IVRS)|Number of participants who had received prior bevacizumab as per interactive voice response system (IVRS).|participants|Number|405|405.0||||||
4293540|NCT00532155|4119333|B1|No||Prior Bevacizumab (as per IVRS)|Number of participants who had received prior bevacizumab as per interactive voice response system (IVRS).|participants|Number|404|404.0||||||
4293541|NCT00532155|4119331|B3|Yes||Prior Bevacizumab (as per IVRS)|Number of participants who had received prior bevacizumab as per interactive voice response system (IVRS).|participants|Number|104|104.0||||||
4293542|NCT00532155|4119332|B2|Yes||Prior Bevacizumab (as per IVRS)|Number of participants who had received prior bevacizumab as per interactive voice response system (IVRS).|participants|Number|51|51.0||||||
4293543|NCT00532155|4119333|B1|Yes||Prior Bevacizumab (as per IVRS)|Number of participants who had received prior bevacizumab as per interactive voice response system (IVRS).|participants|Number|53|53.0||||||
4293544|NCT00532155|4119331|B3|||Body Surface Area (BSA)||m²|Mean|1.8|1.8|Standard Deviation|0.2|0.2|||
4293545|NCT00532155|4119332|B2|||Body Surface Area (BSA)||m²|Mean|1.8|1.8|Standard Deviation|0.2|0.2|||
4293546|NCT00532155|4119333|B1|||Body Surface Area (BSA)||m²|Mean|1.8|1.8|Standard Deviation|0.2|0.2|||
4293547|NCT00532155|4119331|B3|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4293548|NCT00532155|4119332|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4293549|NCT00532155|4119333|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4293550|NCT00532155|4119331|B3|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
4293551|NCT00532155|4119332|B2|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4293552|NCT00532155|4119333|B1|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4293553|NCT00532155|4119331|B3|Black||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4293554|NCT00532155|4119332|B2|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4293555|NCT00532155|4119333|B1|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4293556|NCT00532155|4119331|B3|Caucasian/White||Race/Ethnicity, Customized||participants|Number|816|816.0||||||
4293557|NCT00532155|4119332|B2|Caucasian/White||Race/Ethnicity, Customized||participants|Number|411|411.0||||||
4293558|NCT00532155|4119333|B1|Caucasian/White||Race/Ethnicity, Customized||participants|Number|405|405.0||||||
4293559|NCT00532155|4119331|B3|Female||Sex/Gender, Customized||participants|Number|308|308.0||||||
4293560|NCT00532155|4119332|B2|Female||Sex/Gender, Customized||participants|Number|151|151.0||||||
4293561|NCT00532155|4119333|B1|Female||Sex/Gender, Customized||participants|Number|157|157.0||||||
4293562|NCT00532155|4119331|B3|Male||Sex/Gender, Customized||participants|Number|605|605.0||||||
4293563|NCT00532155|4119332|B2|Male||Sex/Gender, Customized||participants|Number|305|305.0||||||
4293564|NCT00532155|4119333|B1|Male||Sex/Gender, Customized||participants|Number|300|300.0||||||
4293565|NCT00532155|4119331|B3|>=75 years||Age, Customized||participants|Number|39|39.0||||||
4293566|NCT00532155|4119332|B2|>=75 years||Age, Customized||participants|Number|20|20.0||||||
4293567|NCT00532155|4119333|B1|>=75 years||Age, Customized||participants|Number|19|19.0||||||
4293568|NCT00532155|4119331|B3|>= and <75 years||Age, Customized||participants|Number|243|243.0||||||
4293569|NCT00532155|4119332|B2|>= and <75 years||Age, Customized||participants|Number|121|121.0||||||
4293570|NCT00532155|4119333|B1|>= and <75 years||Age, Customized||participants|Number|122|122.0||||||
4293571|NCT00532155|4119331|B3|<65 years||Age, Customized||participants|Number|631|631.0||||||
4293572|NCT00532155|4119332|B2|<65 years||Age, Customized||participants|Number|315|315.0||||||
4293573|NCT00532155|4119333|B1|<65 years||Age, Customized||participants|Number|316|316.0||||||
4293574|NCT00532155|4119331|B3|||Age||Years|Mean|59.6|59.6|Standard Deviation|9.4|9.4|||
4293575|NCT00532155|4119332|B2|||Age||Years|Mean|59.6|59.6|Standard Deviation|9.5|9.5|||
4293576|NCT00532155|4119333|B1|||Age||Years|Mean|59.6|59.6|Standard Deviation|9.4|9.4|||
4293577|NCT00532129|4119348|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4293578|NCT00532129|4119348|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4293579|NCT00532129|4119348|B1|||Age||years|Mean|69.5|69.5|Standard Deviation|8.3|8.3|||
4293580|NCT00531960|4119366|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4293581|NCT00531960|4119367|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4293582|NCT00531960|4119368|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4293583|NCT00531960|4119366|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4293584|NCT00531960|4119367|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4293585|NCT00531960|4119368|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4293586|NCT00531960|4119366|B3|||Age||years|Mean|59.53|59.53|Standard Deviation|10.34|10.34|||
4293587|NCT00531960|4119367|B2|||Age||years|Mean|61.0|61.0|Standard Deviation|10.94|10.94|||
4293588|NCT00531960|4119368|B1|||Age||years|Mean|58.0|58.0|Standard Deviation|9.55|9.55|||
4293589|NCT00531947|4119385|B3|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4293590|NCT00531947|4119386|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4293591|NCT00531947|4119387|B1|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4293592|NCT00531947|4119385|B3|Native American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4293593|NCT00531947|4119386|B2|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4293594|NCT00531947|4119387|B1|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4293595|NCT00531947|4119385|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4293596|NCT00531947|4119386|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4293597|NCT00531947|4119387|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4293598|NCT00531947|4119385|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
4293599|NCT00531947|4119386|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4293600|NCT00531947|4119387|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4293601|NCT00531947|4119385|B3|Black||Race/Ethnicity, Customized||participants|Number|80|80.0||||||
4293602|NCT00531947|4119386|B2|Black||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4293603|NCT00531947|4119387|B1|Black||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4293604|NCT00531947|4119385|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|146|146.0||||||
4293605|NCT00531947|4119386|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
4293606|NCT00531947|4119387|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
4293607|NCT00531947|4119385|B3||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4293608|NCT00531947|4119386|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4293609|NCT00531947|4119387|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4293610|NCT00531947|4119385|B3||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4293611|NCT00531947|4119386|B2||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4293612|NCT00531947|4119387|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4293613|NCT00531947|4119385|B3|||Age||years|Mean|14.8|14.8|Standard Deviation|1.61|1.61|||
4293614|NCT00531947|4119386|B2|||Age||years|Mean|14.8|14.8|Standard Deviation|1.62|1.62|||
4293615|NCT00531947|4119387|B1|||Age||years|Mean|14.7|14.7|Standard Deviation|1.6|1.6|||
4293616|NCT00531947|4119385|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4293617|NCT00531947|4119386|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4293618|NCT00531947|4119387|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4293619|NCT00531947|4119385|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4293620|NCT00531947|4119386|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4293621|NCT00531947|4119387|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4293622|NCT00531947|4119385|B3||<=18 years|Age||Participants|Count of Participants|308|308.0||||||
4293623|NCT00531947|4119386|B2||<=18 years|Age||Participants|Count of Participants|152|152.0||||||
4293624|NCT00531947|4119387|B1||<=18 years|Age||Participants|Count of Participants|156|156.0||||||
4293625|NCT00531934|4119430|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4293626|NCT00531934|4119431|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4293627|NCT00531934|4119432|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4293628|NCT00531934|4119430|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4293629|NCT00531934|4119431|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4293630|NCT00531934|4119432|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4293631|NCT00531934|4119430|B3|||Age||years|Mean|63.8|63.8|Standard Deviation|10.8|10.8|||
4293632|NCT00531934|4119431|B2|||Age||years|Mean|64.2|64.2|Standard Deviation|11.1|11.1|||
4293633|NCT00531934|4119432|B1|||Age||years|Mean|63.5|63.5|Standard Deviation|10.6|10.6|||
4293634|NCT00531882|4119501|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4293635|NCT00531882|4119502|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4293636|NCT00531882|4119503|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4293637|NCT00531882|4119504|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4293638|NCT00531882|4119501|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4293639|NCT00531882|4119502|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4293640|NCT00531882|4119503|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4293641|NCT00531882|4119504|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4293642|NCT00531882|4119501|B4|||Age||years|Mean|27.6|27.6|Standard Deviation|2.8|2.8|||
4293643|NCT00531882|4119502|B3|||Age||years|Mean|24.5|24.5|Standard Deviation|4.0|4.0|||
4293644|NCT00531882|4119503|B2|||Age||years|Mean|28.8|28.8|Standard Deviation|9.1|9.1|||
4293645|NCT00531882|4119504|B1|||Age||years|Mean|29.4|29.4|Standard Deviation|8.8|8.8|||
4293646|NCT00531882|4119501|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4293647|NCT00531882|4119502|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4293648|NCT00531882|4119503|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4293649|NCT00531882|4119504|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4293650|NCT00531882|4119501|B4||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4293651|NCT00531882|4119502|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4293652|NCT00531882|4119503|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4293653|NCT00531882|4119504|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4293654|NCT00531882|4119501|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4293655|NCT00531882|4119502|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4293656|NCT00531882|4119503|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4293657|NCT00531882|4119504|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4293658|NCT00531843|4119514|B3|United States||Region of Enrollment||participants|Number|87|87.0||||||
4293659|NCT00531843|4119515|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4293660|NCT00531843|4119516|B1|United States||Region of Enrollment||participants|Number|81|81.0||||||
4293661|NCT00531843|4119514|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4293662|NCT00531843|4119515|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4293663|NCT00531843|4119516|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4293664|NCT00531843|4119514|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4293665|NCT00531843|4119515|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4293666|NCT00531843|4119516|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4293667|NCT00531843|4119514|B3|||Age||years|Mean|44.3|44.3|Standard Deviation|19.7|19.7|||
4293668|NCT00531843|4119515|B2|||Age||years|Mean|56.8|56.8|Standard Deviation|20.9|20.9|||
4293669|NCT00531843|4119516|B1|||Age||years|Mean|43.1|43.1|Standard Deviation|19.3|19.3|||
4293670|NCT00531817|4119527|B3||Male|Sex: Female, Male|Intent-to-treat population: Tocilizumab 8 mg/kg + DMARDs, n = 409 and Placebo + DMARDs, n = 205|Participants|Count of Participants|117|117.0||||||
4293671|NCT00531817|4119528|B2||Male|Sex: Female, Male|Intent-to-treat population: Tocilizumab 8 mg/kg + DMARDs, n = 409 and Placebo + DMARDs, n = 205|Participants|Count of Participants|33|33.0||||||
4293672|NCT00531817|4119529|B1||Male|Sex: Female, Male|Intent-to-treat population: Tocilizumab 8 mg/kg + DMARDs, n = 409 and Placebo + DMARDs, n = 205|Participants|Count of Participants|84|84.0||||||
4293673|NCT00531817|4119527|B3||Female|Sex: Female, Male|Intent-to-treat population: Tocilizumab 8 mg/kg + DMARDs, n = 409 and Placebo + DMARDs, n = 205|Participants|Count of Participants|497|497.0||||||
4293674|NCT00531817|4119528|B2||Female|Sex: Female, Male|Intent-to-treat population: Tocilizumab 8 mg/kg + DMARDs, n = 409 and Placebo + DMARDs, n = 205|Participants|Count of Participants|172|172.0||||||
4293675|NCT00531817|4119529|B1||Female|Sex: Female, Male|Intent-to-treat population: Tocilizumab 8 mg/kg + DMARDs, n = 409 and Placebo + DMARDs, n = 205|Participants|Count of Participants|325|325.0||||||
4293676|NCT00531817|4119527|B3|||Age|Intent-to-treat population: Tocilizumab 8 mg/kg + DMARDs, n = 409 and Placebo + DMARDs, n = 205|years|Mean|55.5|55.5|Standard Deviation|12.24|12.24|||
4293677|NCT00531817|4119528|B2|||Age|Intent-to-treat population: Tocilizumab 8 mg/kg + DMARDs, n = 409 and Placebo + DMARDs, n = 205|years|Mean|55.8|55.8|Standard Deviation|12.42|12.42|||
4293678|NCT00531817|4119529|B1|||Age|Intent-to-treat population: Tocilizumab 8 mg/kg + DMARDs, n = 409 and Placebo + DMARDs, n = 205|years|Mean|55.2|55.2|Standard Deviation|12.06|12.06|||
4293679|NCT00531752|4119557|B5||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4293680|NCT00531752|4119558|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4293681|NCT00531752|4119559|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4293682|NCT00531752|4119560|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4293683|NCT00531752|4119561|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4293684|NCT00531752|4119557|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4293685|NCT00531752|4119558|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4293686|NCT00531752|4119559|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4293687|NCT00531752|4119560|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4293688|NCT00531752|4119561|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4293689|NCT00531752|4119557|B5|||Age||years|Mean|37.4|37.4|Standard Deviation|10.6|10.6|||
4293690|NCT00531752|4119558|B4|||Age||years|Mean|35.9|35.9|Standard Deviation|9.6|9.6|||
4293691|NCT00531752|4119559|B3|||Age||years|Mean|37.9|37.9|Standard Deviation|10.2|10.2|||
4293692|NCT00531752|4119560|B2|||Age||years|Mean|38.4|38.4|Standard Deviation|10.6|10.6|||
4293693|NCT00531752|4119561|B1|||Age||years|Mean|37.3|37.3|Standard Deviation|12.6|12.6|||
4293694|NCT00531661|4119641|B3|United States||Region of Enrollment||participants|Number|550|550.0||||||
4293695|NCT00531661|4119642|B2|United States||Region of Enrollment||participants|Number|280|280.0||||||
4293696|NCT00531661|4119643|B1|United States||Region of Enrollment||participants|Number|270|270.0||||||
4293697|NCT00531661|4119641|B3||Male|Sex: Female, Male||Participants|Count of Participants|399|399.0||||||
4293698|NCT00531661|4119642|B2||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4293699|NCT00531661|4119643|B1||Male|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4293700|NCT00531661|4119641|B3||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4293701|NCT00531661|4119642|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4293702|NCT00531661|4119643|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4293703|NCT00531661|4119641|B3|||Age||years|Mean|61.6|61.6|Standard Deviation|12.8|12.8|||
4293704|NCT00531661|4119642|B2|||Age||years|Mean|61.8|61.8|Standard Deviation|12.7|12.7|||
4293705|NCT00531661|4119643|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|13.0|13.0|||
4293706|NCT00531661|4119641|B3||>=65 years|Age||Participants|Count of Participants|245|245.0||||||
4293707|NCT00531661|4119642|B2||>=65 years|Age||Participants|Count of Participants|125|125.0||||||
4293708|NCT00531661|4119643|B1||>=65 years|Age||Participants|Count of Participants|120|120.0||||||
4293709|NCT00531661|4119641|B3||Between 18 and 65 years|Age||Participants|Count of Participants|305|305.0||||||
4293710|NCT00531661|4119642|B2||Between 18 and 65 years|Age||Participants|Count of Participants|155|155.0||||||
4293711|NCT00531661|4119643|B1||Between 18 and 65 years|Age||Participants|Count of Participants|150|150.0||||||
4293712|NCT00531661|4119641|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4293713|NCT00531661|4119642|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4293714|NCT00531661|4119643|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4293715|NCT00531518|4119664|B3|||Psychotic symptoms|Psychotic symptoms were assessed and scored using the Structured Interview for the Prodromal Syndrome (SIPS) and the Scale of Prodromal Symptoms (SOPS). The SOPS provides a measure of four domains of symptoms, including positive, negative, disorganized and general symptoms. The Positive Symptom sub-scale score reported is the sum of all five symptom items in the Positive Symptom sub-scale. The Positive Symptom sub-scale assesses psychotic symptoms, each item on a scale of 0-6. The sum scale score is 0-30, with 30 indicating severe psychotic symptoms, while 0 indicates no psychotic symptoms.|units on a scale|Mean|9.65|9.65|Standard Deviation|4.69|4.69|||
4293886|NCT00531284|4119731|B6|30-minute Infusion Groups||Age||years|Mean|69.9|69.9|Standard Deviation|11.10|11.1|||
4293716|NCT00531518|4119665|B2|||Psychotic symptoms|Psychotic symptoms were assessed and scored using the Structured Interview for the Prodromal Syndrome (SIPS) and the Scale of Prodromal Symptoms (SOPS). The SOPS provides a measure of four domains of symptoms, including positive, negative, disorganized and general symptoms. The Positive Symptom sub-scale score reported is the sum of all five symptom items in the Positive Symptom sub-scale. The Positive Symptom sub-scale assesses psychotic symptoms, each item on a scale of 0-6. The sum scale score is 0-30, with 30 indicating severe psychotic symptoms, while 0 indicates no psychotic symptoms.|units on a scale|Mean|11.99|11.99|Standard Deviation|3.42|3.42|||
4293717|NCT00531518|4119666|B1|||Psychotic symptoms|Psychotic symptoms were assessed and scored using the Structured Interview for the Prodromal Syndrome (SIPS) and the Scale of Prodromal Symptoms (SOPS). The SOPS provides a measure of four domains of symptoms, including positive, negative, disorganized and general symptoms. The Positive Symptom sub-scale score reported is the sum of all five symptom items in the Positive Symptom sub-scale. The Positive Symptom sub-scale assesses psychotic symptoms, each item on a scale of 0-6. The sum scale score is 0-30, with 30 indicating severe psychotic symptoms, while 0 indicates no psychotic symptoms.|units on a scale|Mean|4.15|4.15|Standard Deviation|1.76|1.76|||
4293718|NCT00531518|4119664|B3|United States||Region of Enrollment||participants|Number|292|292.0||||||
4293719|NCT00531518|4119665|B2|United States||Region of Enrollment||participants|Number|205|205.0||||||
4293720|NCT00531518|4119666|B1|United States||Region of Enrollment||participants|Number|87|87.0||||||
4293721|NCT00531518|4119664|B3||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4293722|NCT00531518|4119665|B2||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4293723|NCT00531518|4119666|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4293724|NCT00531518|4119664|B3||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4293725|NCT00531518|4119665|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4293726|NCT00531518|4119666|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4293727|NCT00531518|4119664|B3|||Age||years|Mean|16.35|16.35|Standard Deviation|3.26|3.26|||
4293728|NCT00531518|4119665|B2|||Age||years|Mean|16.40|16.4|Standard Deviation|3.30|3.3|||
4293729|NCT00531518|4119666|B1|||Age||years|Mean|16.23|16.23|Standard Deviation|3.18|3.18|||
4293730|NCT00531479|4119673|B3||Male|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
4293731|NCT00531479|4119674|B2||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4293732|NCT00531479|4119675|B1||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4293733|NCT00531479|4119673|B3||Female|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4293734|NCT00531479|4119674|B2||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4293735|NCT00531479|4119675|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4293736|NCT00531479|4119673|B3|||Age||years|Mean|51.5|51.5|Standard Deviation|15.7|15.7|||
4293737|NCT00531479|4119674|B2|||Age||years|Mean|51.0|51.0|Standard Deviation|15.9|15.9|||
4293738|NCT00531479|4119675|B1|||Age||years|Mean|52.0|52.0|Standard Deviation|15.4|15.4|||
4293739|NCT00531453|4119694|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4293740|NCT00531453|4119695|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4293741|NCT00531453|4119696|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4293742|NCT00531453|4119694|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4293743|NCT00531453|4119695|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4293744|NCT00531453|4119696|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4293745|NCT00531453|4119694|B3|||Age||years|Mean|55.4|55.4|Standard Deviation|7.65|7.65|||
4293746|NCT00531453|4119695|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|8.27|8.27|||
4293747|NCT00531453|4119696|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|7.04|7.04|||
4293748|NCT00531453|4119694|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4293749|NCT00531453|4119695|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4293750|NCT00531453|4119696|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4293751|NCT00531453|4119694|B3||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
4293752|NCT00531453|4119695|B2||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4293753|NCT00531453|4119696|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4293754|NCT00531453|4119694|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4293755|NCT00531453|4119695|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4293756|NCT00531453|4119696|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4293757|NCT00531427|4119705|B3||Male|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4293758|NCT00531427|4119706|B2||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4293759|NCT00531427|4119707|B1||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4293760|NCT00531427|4119705|B3||Female|Sex: Female, Male||Participants|Count of Participants|356|356.0||||||
4293761|NCT00531427|4119706|B2||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4293762|NCT00531427|4119707|B1||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4293763|NCT00531427|4119705|B3|||Age||years|Mean|59.1|59.1|Standard Deviation|9.75|9.75|||
4293764|NCT00531427|4119706|B2|||Age||years|Mean|59.1|59.1|Standard Deviation|9.77|9.77|||
4293765|NCT00531427|4119707|B1|||Age||years|Mean|59.1|59.1|Standard Deviation|9.75|9.75|||
4293887|NCT00531284|4119732|B5|30-minute Infusion Groups||Age||years|Mean|60.0|60.0|Standard Deviation|5.18|5.18|||
4293888|NCT00531284|4119733|B4|30-minute Infusion Groups||Age||years|Mean|NA||Standard Deviation|NA||||Not applicable for bolus arms
4293919|NCT00531050|4119932|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4293766|NCT00531284|4119719|B18|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|3|3.0||||||
4293767|NCT00531284|4119720|B17|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4293768|NCT00531284|4119721|B16|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4293769|NCT00531284|4119722|B15|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4293770|NCT00531284|4119723|B14|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4293771|NCT00531284|4119724|B13|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4293772|NCT00531284|4119725|B12|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4293773|NCT00531284|4119726|B11|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4293774|NCT00531284|4119727|B10|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4293775|NCT00531284|4119728|B9|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4293889|NCT00531284|4119734|B3|30-minute Infusion Groups||Age||years|Mean|NA||Standard Deviation|NA||||Not applicable for bolus arms
4293890|NCT00531284|4119735|B2|30-minute Infusion Groups||Age||years|Mean|NA||Standard Deviation|NA||||Not applicable for bolus arms
4293891|NCT00531284|4119736|B1|30-minute Infusion Groups||Age||years|Mean|NA||Standard Deviation|NA||||Not applicable for bolus arms
4293776|NCT00531284|4119729|B8|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4293777|NCT00531284|4119730|B7|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4293778|NCT00531284|4119731|B6|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4293779|NCT00531284|4119732|B5|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4293780|NCT00531284|4119733|B4|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|3|3.0||||||
4293781|NCT00531284|4119734|B3|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4293782|NCT00531284|4119735|B2|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4293783|NCT00531284|4119736|B1|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4293784|NCT00531284|4119719|B18|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|9|9.0||||||
4293785|NCT00531284|4119720|B17|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4293892|NCT00531284|4119719|B18|Bolus Groups||Age||years|Mean|62.20|62.2|Standard Deviation|10.43|10.43|||
4293893|NCT00531284|4119720|B17|Bolus Groups||Age||years|Mean|NA||Standard Deviation|NA||||Not applicable for infusion arms
4293894|NCT00531284|4119721|B16|Bolus Groups||Age||years|Mean|NA||Standard Deviation|NA||||Not applicable for infusion arms
4293895|NCT00531284|4119722|B15|Bolus Groups||Age||years|Mean|NA||Standard Deviation|NA||||Not applicable for infusion arms
4293786|NCT00531284|4119721|B16|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|1|1.0||||||
4293787|NCT00531284|4119722|B15|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|1|1.0||||||
4293788|NCT00531284|4119723|B14|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|1|1.0||||||
4293789|NCT00531284|4119724|B13|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|1|1.0||||||
4293790|NCT00531284|4119725|B12|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|1|1.0||||||
4293791|NCT00531284|4119726|B11|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|1|1.0||||||
4293792|NCT00531284|4119727|B10|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4293793|NCT00531284|4119728|B9|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4293794|NCT00531284|4119729|B8|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|1|1.0||||||
4293795|NCT00531284|4119730|B7|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4293896|NCT00531284|4119723|B14|Bolus Groups||Age||years|Mean|NA||Standard Deviation|NA||||Not applicable for infusion arms
4293897|NCT00531284|4119724|B13|Bolus Groups||Age||years|Mean|NA||Standard Deviation|NA||||Not applicable for infusion arms
4293898|NCT00531284|4119725|B12|Bolus Groups||Age||years|Mean|NA||Standard Deviation|NA||||Not applicable for infusion arms
4293899|NCT00531284|4119726|B11|Bolus Groups||Age||years|Mean|NA||Standard Deviation|NA||||Not applicable for infusion arms
4293796|NCT00531284|4119731|B6|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|2|2.0||||||
4293797|NCT00531284|4119732|B5|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4293798|NCT00531284|4119733|B4|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4293799|NCT00531284|4119734|B3|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4293800|NCT00531284|4119735|B2|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4293801|NCT00531284|4119736|B1|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4293802|NCT00531284|4119719|B18|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|99|99.0||||||
4293803|NCT00531284|4119720|B17|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|3|3.0||||||
4293804|NCT00531284|4119721|B16|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|6|6.0||||||
4293805|NCT00531284|4119722|B15|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|3|3.0||||||
4293900|NCT00531284|4119727|B10|Bolus Groups||Age||years|Mean|NA||Standard Deviation|NA||||Not applicable for infusion arms
4293901|NCT00531284|4119728|B9|Bolus Groups||Age||years|Mean|NA||Standard Deviation|NA||||Not applicable for infusion arms
4293902|NCT00531284|4119729|B8|Bolus Groups||Age||years|Mean|NA||Standard Deviation|NA||||Not applicable for infusion arms
4293903|NCT00531284|4119730|B7|Bolus Groups||Age||years|Mean|NA||Standard Deviation|NA||||Not applicable for infusion arms
4293806|NCT00531284|4119723|B14|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4293807|NCT00531284|4119724|B13|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|1|1.0||||||
4293808|NCT00531284|4119725|B12|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|15|15.0||||||
4293809|NCT00531284|4119726|B11|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|2|2.0||||||
4293810|NCT00531284|4119727|B10|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4293811|NCT00531284|4119728|B9|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|7|7.0||||||
4293812|NCT00531284|4119729|B8|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|7|7.0||||||
4293813|NCT00531284|4119730|B7|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|6|6.0||||||
4293814|NCT00531284|4119731|B6|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|4|4.0||||||
4293815|NCT00531284|4119732|B5|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|4|4.0||||||
4293904|NCT00531284|4119731|B6|Bolus Groups||Age||years|Mean|NA||Standard Deviation|NA||||Not applicable for infusion arms
4293905|NCT00531284|4119732|B5|Bolus Groups||Age||years|Mean|NA||Standard Deviation|NA||||Not applicable for infusion arms
4293906|NCT00531284|4119733|B4|Bolus Groups||Age||years|Mean|62.0|62.0|Standard Deviation|9.97|9.97|||
4293907|NCT00531284|4119734|B3|Bolus Groups||Age||years|Mean|60.0|60.0|Standard Deviation|11.72|11.72|||
4293816|NCT00531284|4119733|B4|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|35|35.0||||||
4293817|NCT00531284|4119734|B3|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|3|3.0||||||
4293818|NCT00531284|4119735|B2|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|1|1.0||||||
4293819|NCT00531284|4119736|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|2|2.0||||||
4293820|NCT00531284|4119719|B18|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|73|73.0||||||
4293821|NCT00531284|4119720|B17|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|5|5.0||||||
4293822|NCT00531284|4119721|B16|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|7|7.0||||||
4293823|NCT00531284|4119722|B15|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|3|3.0||||||
4293824|NCT00531284|4119723|B14|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|2|2.0||||||
4293825|NCT00531284|4119724|B13|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4293908|NCT00531284|4119735|B2|Bolus Groups||Age||years|Mean|60.8|60.8|Standard Deviation|8.81|8.81|||
4293909|NCT00531284|4119736|B1|Bolus Groups||Age||years|Mean|47.3|47.3|Standard Deviation|14.74|14.74|||
4293910|NCT00531206|4119902|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4293911|NCT00531206|4119902|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4293912|NCT00531206|4119902|B1|||Age||Years|Mean|45.9|45.9|Standard Deviation|8.8|8.8|||
4293826|NCT00531284|4119725|B12|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|8|8.0||||||
4293827|NCT00531284|4119726|B11|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4293828|NCT00531284|4119727|B10|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|4|4.0||||||
4293829|NCT00531284|4119728|B9|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|4|4.0||||||
4293830|NCT00531284|4119729|B8|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|2|2.0||||||
4293831|NCT00531284|4119730|B7|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4293832|NCT00531284|4119731|B6|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|1|1.0||||||
4293833|NCT00531284|4119732|B5|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|2|2.0||||||
4293834|NCT00531284|4119733|B4|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|27|27.0||||||
4293835|NCT00531284|4119734|B3|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|4|4.0||||||
4293913|NCT00531050|4119926|B7||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4293914|NCT00531050|4119927|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4293915|NCT00531050|4119928|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4293916|NCT00531050|4119929|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4293917|NCT00531050|4119930|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4293836|NCT00531284|4119735|B2|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|3|3.0||||||
4293837|NCT00531284|4119736|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|1|1.0||||||
4293838|NCT00531284|4119719|B18||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4293839|NCT00531284|4119720|B17||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4293840|NCT00531284|4119721|B16||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4293841|NCT00531284|4119722|B15||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4293842|NCT00531284|4119723|B14||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4293843|NCT00531284|4119724|B13||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4293844|NCT00531284|4119725|B12||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4293845|NCT00531284|4119726|B11||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4293846|NCT00531284|4119727|B10||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4293847|NCT00531284|4119728|B9||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4293848|NCT00531284|4119729|B8||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4293849|NCT00531284|4119730|B7||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4293850|NCT00531284|4119731|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4293851|NCT00531284|4119732|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4293852|NCT00531284|4119733|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4293853|NCT00531284|4119734|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4293854|NCT00531284|4119735|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4293855|NCT00531284|4119736|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4293856|NCT00531284|4119719|B18||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4293857|NCT00531284|4119720|B17||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4293858|NCT00531284|4119721|B16||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4293859|NCT00531284|4119722|B15||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4293860|NCT00531284|4119723|B14||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4293861|NCT00531284|4119724|B13||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4293862|NCT00531284|4119725|B12||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4293863|NCT00531284|4119726|B11||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4293864|NCT00531284|4119727|B10||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4293865|NCT00531284|4119728|B9||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4293866|NCT00531284|4119729|B8||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4293867|NCT00531284|4119730|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4293868|NCT00531284|4119731|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4293869|NCT00531284|4119732|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4293870|NCT00531284|4119733|B4||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4293871|NCT00531284|4119734|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4293872|NCT00531284|4119735|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4293873|NCT00531284|4119736|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4293874|NCT00531284|4119719|B18|30-minute Infusion Groups||Age||years|Mean|62.3|62.3|Standard Deviation|9.47|9.47|||
4293875|NCT00531284|4119720|B17|30-minute Infusion Groups||Age||years|Mean|58.3|58.3|Standard Deviation|6.14|6.14|||
4293876|NCT00531284|4119721|B16|30-minute Infusion Groups||Age||years|Mean|58.6|58.6|Standard Deviation|9.54|9.54|||
4293877|NCT00531284|4119722|B15|30-minute Infusion Groups||Age||years|Mean|65.4|65.4|Standard Deviation|10.31|10.31|||
4293878|NCT00531284|4119723|B14|30-minute Infusion Groups||Age||years|Mean|58.7|58.7|Standard Deviation|10.69|10.69|||
4293879|NCT00531284|4119724|B13|30-minute Infusion Groups||Age||years|Mean|69.5|69.5|Standard Deviation|12.02|12.02|||
4293880|NCT00531284|4119725|B12|30-minute Infusion Groups||Age||years|Mean|62.7|62.7|Standard Deviation|9.88|9.88|||
4293881|NCT00531284|4119726|B11|30-minute Infusion Groups||Age||years|Mean|72.0|72.0|Standard Deviation|5.57|5.57|||
4293882|NCT00531284|4119727|B10|30-minute Infusion Groups||Age||years|Mean|63.3|63.3|Standard Deviation|3.77|3.77|||
4293883|NCT00531284|4119728|B9|30-minute Infusion Groups||Age||years|Mean|61.6|61.6|Standard Deviation|11.58|11.58|||
4293884|NCT00531284|4119729|B8|30-minute Infusion Groups||Age||years|Mean|61.4|61.4|Standard Deviation|7.40|7.4|||
4293885|NCT00531284|4119730|B7|30-minute Infusion Groups||Age||years|Mean|61.2|61.2|Standard Deviation|10.38|10.38|||
4293918|NCT00531050|4119931|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4293920|NCT00531050|4119926|B7||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4293921|NCT00531050|4119927|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4293922|NCT00531050|4119928|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4293923|NCT00531050|4119929|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4293924|NCT00531050|4119930|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4293925|NCT00531050|4119931|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4293926|NCT00531050|4119932|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4293927|NCT00531050|4119926|B7|||Age||years|Mean|60.3|60.3|Standard Deviation|6.17|6.17|||
4293928|NCT00531050|4119927|B6|||Age||years|Mean|61.6|61.6|Standard Deviation|5.86|5.86|||
4293929|NCT00531050|4119928|B5|||Age||years|Mean|60.5|60.5|Standard Deviation|5.80|5.8|||
4293930|NCT00531050|4119929|B4|||Age||years|Mean|58.4|58.4|Standard Deviation|5.18|5.18|||
4293931|NCT00531050|4119930|B3|||Age||years|Mean|58.5|58.5|Standard Deviation|5.07|5.07|||
4293932|NCT00531050|4119931|B2|||Age||years|Mean|63.0|63.0|Standard Deviation|7.58|7.58|||
4293933|NCT00531050|4119932|B1|||Age||years|Mean|59.0|59.0|Standard Deviation|9.20|9.2|||
4293934|NCT00531011|4119964|B3|Italy||Region of Enrollment||participants|Number|200|200.0||||||
4293935|NCT00531011|4119965|B2|Italy||Region of Enrollment||participants|Number|97|97.0||||||
4293936|NCT00531011|4119966|B1|Italy||Region of Enrollment||participants|Number|103|103.0||||||
4293937|NCT00531011|4119964|B3||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4293938|NCT00531011|4119965|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4293939|NCT00531011|4119966|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4293940|NCT00531011|4119964|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4293941|NCT00531011|4119965|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4293942|NCT00531011|4119966|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4293943|NCT00531011|4119964|B3|||Age||years|Mean|64.2|64.2|Standard Deviation|10.2|10.2|||
4293944|NCT00531011|4119965|B2|||Age||years|Mean|63.8|63.8|Standard Deviation|10.2|10.2|||
4293945|NCT00531011|4119966|B1|||Age||years|Mean|64.7|64.7|Standard Deviation|10.1|10.1|||
4293946|NCT00531011|4119964|B3||>=65 years|Age||Participants|Count of Participants|106|106.0||||||
4293947|NCT00531011|4119965|B2||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
4293948|NCT00531011|4119966|B1||>=65 years|Age||Participants|Count of Participants|57|57.0||||||
4293949|NCT00531011|4119964|B3||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
4293950|NCT00531011|4119965|B2||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4293951|NCT00531011|4119966|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4293952|NCT00531011|4119964|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4293953|NCT00531011|4119965|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4293954|NCT00531011|4119966|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4293955|NCT00530946|4120009|B5|Japan||Region of Enrollment||participants|Number|165|165.0||||||
4293956|NCT00530946|4120010|B4|Japan||Region of Enrollment||participants|Number|40|40.0||||||
4293957|NCT00530946|4120011|B3|Japan||Region of Enrollment||participants|Number|41|41.0||||||
4293958|NCT00530946|4120012|B2|Japan||Region of Enrollment||participants|Number|41|41.0||||||
4293959|NCT00530946|4120013|B1|Japan||Region of Enrollment||participants|Number|43|43.0||||||
4293960|NCT00530946|4120009|B5||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4293961|NCT00530946|4120010|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4293962|NCT00530946|4120011|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4293963|NCT00530946|4120012|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4293964|NCT00530946|4120013|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4293965|NCT00530946|4120009|B5||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4293966|NCT00530946|4120010|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4293967|NCT00530946|4120011|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4293968|NCT00530946|4120012|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4293969|NCT00530946|4120013|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4293970|NCT00530946|4120009|B5|>=65 years||Age, Customized||participants|Number|58|58.0||||||
4293971|NCT00530946|4120010|B4|>=65 years||Age, Customized||participants|Number|12|12.0||||||
4293972|NCT00530946|4120011|B3|>=65 years||Age, Customized||participants|Number|14|14.0||||||
4293973|NCT00530946|4120012|B2|>=65 years||Age, Customized||participants|Number|17|17.0||||||
4293974|NCT00530946|4120013|B1|>=65 years||Age, Customized||participants|Number|15|15.0||||||
4293975|NCT00530946|4120009|B5|45 to 64 years||Age, Customized||participants|Number|87|87.0||||||
4293976|NCT00530946|4120010|B4|45 to 64 years||Age, Customized||participants|Number|23|23.0||||||
4293977|NCT00530946|4120011|B3|45 to 64 years||Age, Customized||participants|Number|23|23.0||||||
4293978|NCT00530946|4120012|B2|45 to 64 years||Age, Customized||participants|Number|21|21.0||||||
4293979|NCT00530946|4120013|B1|45 to 64 years||Age, Customized||participants|Number|20|20.0||||||
4293980|NCT00530946|4120009|B5|20 to 44 years||Age, Customized||participants|Number|20|20.0||||||
4293981|NCT00530946|4120010|B4|20 to 44 years||Age, Customized||participants|Number|5|5.0||||||
4293982|NCT00530946|4120011|B3|20 to 44 years||Age, Customized||participants|Number|4|4.0||||||
4293983|NCT00530946|4120012|B2|20 to 44 years||Age, Customized||participants|Number|3|3.0||||||
4293984|NCT00530946|4120013|B1|20 to 44 years||Age, Customized||participants|Number|8|8.0||||||
4293985|NCT00530946|4120009|B5|<20 years||Age, Customized||participants|Number|0|0.0||||||
4293986|NCT00530946|4120010|B4|<20 years||Age, Customized||participants|Number|0|0.0||||||
4293987|NCT00530946|4120011|B3|<20 years||Age, Customized||participants|Number|0|0.0||||||
4293988|NCT00530946|4120012|B2|<20 years||Age, Customized||participants|Number|0|0.0||||||
4293989|NCT00530946|4120013|B1|<20 years||Age, Customized||participants|Number|0|0.0||||||
4293990|NCT00530920|4120066|B4||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4293991|NCT00530920|4120067|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4293992|NCT00530920|4120068|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4293993|NCT00530920|4120069|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4293994|NCT00530920|4120066|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4293995|NCT00530920|4120067|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4293996|NCT00530920|4120068|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4293997|NCT00530920|4120069|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4293998|NCT00530920|4120066|B4|||Age||years|Mean|35.3|35.3|Standard Deviation|7.94|7.94|||
4293999|NCT00530920|4120067|B3|||Age||years|Mean|36.4|36.4|Standard Deviation|8|8.0|||
4294000|NCT00530920|4120068|B2|||Age||years|Mean|36.9|36.9|Standard Deviation|8.04|8.04|||
4294001|NCT00530920|4120069|B1|||Age||years|Mean|33|33.0|Standard Deviation|7.54|7.54|||
4294002|NCT00530894|4120127|B5|Inoperable||STS Score|The Society of Thoracic Surgeons (STS) score measures patient risk at the time of cardiovascular surgery on a scale that ranges from 0% to 100%, with higher numbers indicating greater risk.|Percentage|Mean|11.51|11.51|Standard Deviation|5.34|5.34|||
4294003|NCT00530894|4120128|B4|Inoperable||STS Score|The Society of Thoracic Surgeons (STS) score measures patient risk at the time of cardiovascular surgery on a scale that ranges from 0% to 100%, with higher numbers indicating greater risk.|Percentage|Mean|11.9|11.9|Standard Deviation|4.8|4.8|||
4294004|NCT00530894|4120129|B3|Inoperable||STS Score|The Society of Thoracic Surgeons (STS) score measures patient risk at the time of cardiovascular surgery on a scale that ranges from 0% to 100%, with higher numbers indicating greater risk.|Percentage|Mean|11.2|11.2|Standard Deviation|5.8|5.8|||
4294005|NCT00530894|4120130|B2|Inoperable||STS Score|The Society of Thoracic Surgeons (STS) score measures patient risk at the time of cardiovascular surgery on a scale that ranges from 0% to 100%, with higher numbers indicating greater risk.|Percentage|Mean|NA||Standard Deviation|NA||||The inoperable and high risk groups were not randomized against each other and were essentially two separate trials
4294006|NCT00530894|4120131|B1|Inoperable||STS Score|The Society of Thoracic Surgeons (STS) score measures patient risk at the time of cardiovascular surgery on a scale that ranges from 0% to 100%, with higher numbers indicating greater risk.|Percentage|Mean|NA||Standard Deviation|NA||||The inoperable and high risk groups were not randomized against each other and were essentially two separate trials
4294007|NCT00530894|4120127|B5|High Risk||STS Score|The Society of Thoracic Surgeons (STS) score measures patient risk at the time of cardiovascular surgery on a scale that ranges from 0% to 100%, with higher numbers indicating greater risk.|Percentage|Mean|11.75|11.75|Standard Deviation|3.40|3.4|||
4294008|NCT00530894|4120128|B4|High Risk||STS Score|The Society of Thoracic Surgeons (STS) score measures patient risk at the time of cardiovascular surgery on a scale that ranges from 0% to 100%, with higher numbers indicating greater risk.|Percentage|Mean|NA||Standard Deviation|NA||||The inoperable and high risk groups were not randomized against each other and were essentially two separate trials
4294009|NCT00530894|4120129|B3|High Risk||STS Score|The Society of Thoracic Surgeons (STS) score measures patient risk at the time of cardiovascular surgery on a scale that ranges from 0% to 100%, with higher numbers indicating greater risk.|Percentage|Mean|NA||Standard Deviation|NA||||The inoperable and high risk groups were not randomized against each other and were essentially two separate trials
4294010|NCT00530894|4120130|B2|High Risk||STS Score|The Society of Thoracic Surgeons (STS) score measures patient risk at the time of cardiovascular surgery on a scale that ranges from 0% to 100%, with higher numbers indicating greater risk.|Percentage|Mean|11.7|11.7|Standard Deviation|3.5|3.5|||
4294011|NCT00530894|4120131|B1|High Risk||STS Score|The Society of Thoracic Surgeons (STS) score measures patient risk at the time of cardiovascular surgery on a scale that ranges from 0% to 100%, with higher numbers indicating greater risk.|Percentage|Mean|11.8|11.8|Standard Deviation|3.3|3.3|||
4294012|NCT00530894|4120127|B5|Inoperable SF-12 Mental||Quality of Life|The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), EuroQOL, SF-12. The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), The Medical Outcomes Study Short-Form 12 (SF-12) - physical and metal states. KCCQ scores are on a range of 0-100, in which 100 reflects the best health status and 0 reflects the worst health status. SF-12 questionnaire was used in which 100 reflects the best health status and 0 reflects the worst health status.|Score|Mean|44.84|44.84|Standard Deviation|11.5|11.5|||
4294013|NCT00530894|4120128|B4|Inoperable SF-12 Mental||Quality of Life|The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), EuroQOL, SF-12. The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), The Medical Outcomes Study Short-Form 12 (SF-12) - physical and metal states. KCCQ scores are on a range of 0-100, in which 100 reflects the best health status and 0 reflects the worst health status. SF-12 questionnaire was used in which 100 reflects the best health status and 0 reflects the worst health status.|Score|Mean|45.23|45.23|Standard Deviation|11.03|11.03|||
4294014|NCT00530894|4120129|B3|Inoperable SF-12 Mental||Quality of Life|The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), EuroQOL, SF-12. The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), The Medical Outcomes Study Short-Form 12 (SF-12) - physical and metal states. KCCQ scores are on a range of 0-100, in which 100 reflects the best health status and 0 reflects the worst health status. SF-12 questionnaire was used in which 100 reflects the best health status and 0 reflects the worst health status.|Score|Mean|44.45|44.45|Standard Deviation|12.16|12.16|||
4294097|NCT00530894|4120127|B5|Inoperable||Age||Years|Mean|83.18|83.18|Standard Deviation|8.43|8.43|||
4294015|NCT00530894|4120130|B2|Inoperable SF-12 Mental||Quality of Life|The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), EuroQOL, SF-12. The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), The Medical Outcomes Study Short-Form 12 (SF-12) - physical and metal states. KCCQ scores are on a range of 0-100, in which 100 reflects the best health status and 0 reflects the worst health status. SF-12 questionnaire was used in which 100 reflects the best health status and 0 reflects the worst health status.|Score|Mean|NA||Standard Deviation|NA||||The inoperable and high risk groups were not randomized against each other and were essentially two separate trials
4294016|NCT00530894|4120131|B1|Inoperable SF-12 Mental||Quality of Life|The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), EuroQOL, SF-12. The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), The Medical Outcomes Study Short-Form 12 (SF-12) - physical and metal states. KCCQ scores are on a range of 0-100, in which 100 reflects the best health status and 0 reflects the worst health status. SF-12 questionnaire was used in which 100 reflects the best health status and 0 reflects the worst health status.|Score|Mean|NA||Standard Deviation|NA||||The inoperable and high risk groups were not randomized against each other and were essentially two separate trials
4294017|NCT00530894|4120127|B5|High Risk SF-12 Mental||Quality of Life|The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), EuroQOL, SF-12. The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), The Medical Outcomes Study Short-Form 12 (SF-12) - physical and metal states. KCCQ scores are on a range of 0-100, in which 100 reflects the best health status and 0 reflects the worst health status. SF-12 questionnaire was used in which 100 reflects the best health status and 0 reflects the worst health status.|Score|Mean|47.2|47.2|Standard Deviation|11.1|11.1|||
4294018|NCT00530894|4120128|B4|High Risk SF-12 Mental||Quality of Life|The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), EuroQOL, SF-12. The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), The Medical Outcomes Study Short-Form 12 (SF-12) - physical and metal states. KCCQ scores are on a range of 0-100, in which 100 reflects the best health status and 0 reflects the worst health status. SF-12 questionnaire was used in which 100 reflects the best health status and 0 reflects the worst health status.|Score|Mean|NA||Standard Deviation|NA||||The inoperable and high risk groups were not randomized against each other and were essentially two separate trials
4294019|NCT00530894|4120129|B3|High Risk SF-12 Mental||Quality of Life|The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), EuroQOL, SF-12. The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), The Medical Outcomes Study Short-Form 12 (SF-12) - physical and metal states. KCCQ scores are on a range of 0-100, in which 100 reflects the best health status and 0 reflects the worst health status. SF-12 questionnaire was used in which 100 reflects the best health status and 0 reflects the worst health status.|Score|Mean|NA||Standard Deviation|NA||||The inoperable and high risk groups were not randomized against each other and were essentially two separate trials
4294020|NCT00530894|4120130|B2|High Risk SF-12 Mental||Quality of Life|The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), EuroQOL, SF-12. The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), The Medical Outcomes Study Short-Form 12 (SF-12) - physical and metal states. KCCQ scores are on a range of 0-100, in which 100 reflects the best health status and 0 reflects the worst health status. SF-12 questionnaire was used in which 100 reflects the best health status and 0 reflects the worst health status.|Score|Mean|47.6|47.6|Standard Deviation|10.7|10.7|||
4294021|NCT00530894|4120131|B1|High Risk SF-12 Mental||Quality of Life|The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), EuroQOL, SF-12. The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), The Medical Outcomes Study Short-Form 12 (SF-12) - physical and metal states. KCCQ scores are on a range of 0-100, in which 100 reflects the best health status and 0 reflects the worst health status. SF-12 questionnaire was used in which 100 reflects the best health status and 0 reflects the worst health status.|Score|Mean|46.9|46.9|Standard Deviation|11.5|11.5|||
4294022|NCT00530894|4120127|B5|Inoperable SF-12 Physical||Quality of Life|The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), EuroQOL, SF-12. The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), The Medical Outcomes Study Short-Form 12 (SF-12) - physical and metal states. KCCQ scores are on a range of 0-100, in which 100 reflects the best health status and 0 reflects the worst health status. SF-12 questionnaire was used in which 100 reflects the best health status and 0 reflects the worst health status.|Score|Mean|28.0|28.0|Standard Deviation|7.23|7.23|||
4294023|NCT00530894|4120128|B4|Inoperable SF-12 Physical||Quality of Life|The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), EuroQOL, SF-12. The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), The Medical Outcomes Study Short-Form 12 (SF-12) - physical and metal states. KCCQ scores are on a range of 0-100, in which 100 reflects the best health status and 0 reflects the worst health status. SF-12 questionnaire was used in which 100 reflects the best health status and 0 reflects the worst health status.|Score|Mean|27.70|27.7|Standard Deviation|6.89|6.89|||
4294024|NCT00530894|4120129|B3|Inoperable SF-12 Physical||Quality of Life|The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), EuroQOL, SF-12. The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), The Medical Outcomes Study Short-Form 12 (SF-12) - physical and metal states. KCCQ scores are on a range of 0-100, in which 100 reflects the best health status and 0 reflects the worst health status. SF-12 questionnaire was used in which 100 reflects the best health status and 0 reflects the worst health status.|Score|Mean|28.23|28.23|Standard Deviation|7.73|7.73|||
4294025|NCT00530894|4120130|B2|Inoperable SF-12 Physical||Quality of Life|The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), EuroQOL, SF-12. The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), The Medical Outcomes Study Short-Form 12 (SF-12) - physical and metal states. KCCQ scores are on a range of 0-100, in which 100 reflects the best health status and 0 reflects the worst health status. SF-12 questionnaire was used in which 100 reflects the best health status and 0 reflects the worst health status.|Score|Mean|NA||Standard Deviation|NA||||The inoperable and high risk groups were not randomized against each other and were essentially two separate trials
4294053|NCT00530894|4120128|B4|Operable Class II||NYHA Class|New York Heart Association (NYHA), functional classification of heart failure based on how much a patient is limited during physical activity. The rating ranges from I - IV, with the lowest as no limitations and the highest unable to carry on any physical activity without discomfort.|Participants|Number|11|11.0||||||
4294098|NCT00530894|4120128|B4|Inoperable||Age||Years|Mean|83.18|83.18|Standard Deviation|8.29|8.29|||
4294099|NCT00530894|4120129|B3|Inoperable||Age||Years|Mean|83.12|83.12|Standard Deviation|8.60|8.6|||
4294026|NCT00530894|4120131|B1|Inoperable SF-12 Physical||Quality of Life|The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), EuroQOL, SF-12. The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), The Medical Outcomes Study Short-Form 12 (SF-12) - physical and metal states. KCCQ scores are on a range of 0-100, in which 100 reflects the best health status and 0 reflects the worst health status. SF-12 questionnaire was used in which 100 reflects the best health status and 0 reflects the worst health status.|Score|Mean|NA||Standard Deviation|NA||||The inoperable and high risk groups were not randomized against each other and were essentially two separate trials
4294027|NCT00530894|4120127|B5|High Risk SF-12 Physical||Quality of Life|The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), EuroQOL, SF-12. The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), The Medical Outcomes Study Short-Form 12 (SF-12) - physical and metal states. KCCQ scores are on a range of 0-100, in which 100 reflects the best health status and 0 reflects the worst health status. SF-12 questionnaire was used in which 100 reflects the best health status and 0 reflects the worst health status.|Score|Mean|30.2|30.2|Standard Deviation|7.9|7.9|||
4294028|NCT00530894|4120128|B4|High Risk SF-12 Physical||Quality of Life|The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), EuroQOL, SF-12. The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), The Medical Outcomes Study Short-Form 12 (SF-12) - physical and metal states. KCCQ scores are on a range of 0-100, in which 100 reflects the best health status and 0 reflects the worst health status. SF-12 questionnaire was used in which 100 reflects the best health status and 0 reflects the worst health status.|Score|Mean|NA||Standard Deviation|NA||||The inoperable and high risk groups were not randomized against each other and were essentially two separate trials
4294029|NCT00530894|4120129|B3|High Risk SF-12 Physical||Quality of Life|The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), EuroQOL, SF-12. The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), The Medical Outcomes Study Short-Form 12 (SF-12) - physical and metal states. KCCQ scores are on a range of 0-100, in which 100 reflects the best health status and 0 reflects the worst health status. SF-12 questionnaire was used in which 100 reflects the best health status and 0 reflects the worst health status.|Score|Mean|NA||Standard Deviation|NA||||The inoperable and high risk groups were not randomized against each other and were essentially two separate trials
4294030|NCT00530894|4120130|B2|High Risk SF-12 Physical||Quality of Life|The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), EuroQOL, SF-12. The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), The Medical Outcomes Study Short-Form 12 (SF-12) - physical and metal states. KCCQ scores are on a range of 0-100, in which 100 reflects the best health status and 0 reflects the worst health status. SF-12 questionnaire was used in which 100 reflects the best health status and 0 reflects the worst health status.|Score|Mean|30.9|30.9|Standard Deviation|8.2|8.2|||
4294031|NCT00530894|4120131|B1|High Risk SF-12 Physical||Quality of Life|The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), EuroQOL, SF-12. The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), The Medical Outcomes Study Short-Form 12 (SF-12) - physical and metal states. KCCQ scores are on a range of 0-100, in which 100 reflects the best health status and 0 reflects the worst health status. SF-12 questionnaire was used in which 100 reflects the best health status and 0 reflects the worst health status.|Score|Mean|29.6|29.6|Standard Deviation|7.6|7.6|||
4294032|NCT00530894|4120127|B5|Inoperable KCCQ Overall||Quality of Life|The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), EuroQOL, SF-12. The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), The Medical Outcomes Study Short-Form 12 (SF-12) - physical and metal states. KCCQ scores are on a range of 0-100, in which 100 reflects the best health status and 0 reflects the worst health status. SF-12 questionnaire was used in which 100 reflects the best health status and 0 reflects the worst health status.|Score|Mean|35.35|35.35|Standard Deviation|20.32|20.32|||
4294033|NCT00530894|4120128|B4|Inoperable KCCQ Overall||Quality of Life|The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), EuroQOL, SF-12. The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), The Medical Outcomes Study Short-Form 12 (SF-12) - physical and metal states. KCCQ scores are on a range of 0-100, in which 100 reflects the best health status and 0 reflects the worst health status. SF-12 questionnaire was used in which 100 reflects the best health status and 0 reflects the worst health status.|Score|Mean|34.44|34.44|Standard Deviation|20.14|20.14|||
4294034|NCT00530894|4120129|B3|Inoperable KCCQ Overall||Quality of Life|The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), EuroQOL, SF-12. The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), The Medical Outcomes Study Short-Form 12 (SF-12) - physical and metal states. KCCQ scores are on a range of 0-100, in which 100 reflects the best health status and 0 reflects the worst health status. SF-12 questionnaire was used in which 100 reflects the best health status and 0 reflects the worst health status.|Score|Mean|36.19|36.19|Standard Deviation|20.52|20.52|||
4294035|NCT00530894|4120130|B2|Inoperable KCCQ Overall||Quality of Life|The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), EuroQOL, SF-12. The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), The Medical Outcomes Study Short-Form 12 (SF-12) - physical and metal states. KCCQ scores are on a range of 0-100, in which 100 reflects the best health status and 0 reflects the worst health status. SF-12 questionnaire was used in which 100 reflects the best health status and 0 reflects the worst health status.|Score|Mean|NA||Standard Deviation|NA||||The inoperable and high risk groups were not randomized against each other and were essentially two separate trials
4294036|NCT00530894|4120131|B1|Inoperable KCCQ Overall||Quality of Life|The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), EuroQOL, SF-12. The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), The Medical Outcomes Study Short-Form 12 (SF-12) - physical and metal states. KCCQ scores are on a range of 0-100, in which 100 reflects the best health status and 0 reflects the worst health status. SF-12 questionnaire was used in which 100 reflects the best health status and 0 reflects the worst health status.|Score|Mean|NA||Standard Deviation|NA||||The inoperable and high risk groups were not randomized against each other and were essentially two separate trials
4294037|NCT00530894|4120127|B5|High Risk KCCQ Overall||Quality of Life|The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), EuroQOL, SF-12. The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), The Medical Outcomes Study Short-Form 12 (SF-12) - physical and metal states. KCCQ scores are on a range of 0-100, in which 100 reflects the best health status and 0 reflects the worst health status. SF-12 questionnaire was used in which 100 reflects the best health status and 0 reflects the worst health status.|Score|Mean|41.88|41.88|Standard Deviation|21.93|21.93|||
4294038|NCT00530894|4120128|B4|High Risk KCCQ Overall||Quality of Life|The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), EuroQOL, SF-12. The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), The Medical Outcomes Study Short-Form 12 (SF-12) - physical and metal states. KCCQ scores are on a range of 0-100, in which 100 reflects the best health status and 0 reflects the worst health status. SF-12 questionnaire was used in which 100 reflects the best health status and 0 reflects the worst health status.|Score|Mean|NA||Standard Deviation|NA||||The inoperable and high risk groups were not randomized against each other and were essentially two separate trials
4294039|NCT00530894|4120129|B3|High Risk KCCQ Overall||Quality of Life|The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), EuroQOL, SF-12. The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), The Medical Outcomes Study Short-Form 12 (SF-12) - physical and metal states. KCCQ scores are on a range of 0-100, in which 100 reflects the best health status and 0 reflects the worst health status. SF-12 questionnaire was used in which 100 reflects the best health status and 0 reflects the worst health status.|Score|Mean|NA||Standard Deviation|NA||||The inoperable and high risk groups were not randomized against each other and were essentially two separate trials
4294040|NCT00530894|4120130|B2|High Risk KCCQ Overall||Quality of Life|The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), EuroQOL, SF-12. The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), The Medical Outcomes Study Short-Form 12 (SF-12) - physical and metal states. KCCQ scores are on a range of 0-100, in which 100 reflects the best health status and 0 reflects the worst health status. SF-12 questionnaire was used in which 100 reflects the best health status and 0 reflects the worst health status.|Score|Mean|44.5|44.5|Standard Deviation|21.8|21.8|||
4294041|NCT00530894|4120131|B1|High Risk KCCQ Overall||Quality of Life|The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), EuroQOL, SF-12. The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), The Medical Outcomes Study Short-Form 12 (SF-12) - physical and metal states. KCCQ scores are on a range of 0-100, in which 100 reflects the best health status and 0 reflects the worst health status. SF-12 questionnaire was used in which 100 reflects the best health status and 0 reflects the worst health status.|Score|Mean|39.6|39.6|Standard Deviation|21.8|21.8|||
4294042|NCT00530894|4120127|B5|Inoperable Class III or IV||NYHA Class|New York Heart Association (NYHA), functional classification of heart failure based on how much a patient is limited during physical activity. The rating ranges from I - IV, with the lowest as no limitations and the highest unable to carry on any physical activity without discomfort.|Participants|Number|333|333.0||||||
4294043|NCT00530894|4120128|B4|Inoperable Class III or IV||NYHA Class|New York Heart Association (NYHA), functional classification of heart failure based on how much a patient is limited during physical activity. The rating ranges from I - IV, with the lowest as no limitations and the highest unable to carry on any physical activity without discomfort.|Participants|Number|168|168.0||||||
4294044|NCT00530894|4120129|B3|Inoperable Class III or IV||NYHA Class|New York Heart Association (NYHA), functional classification of heart failure based on how much a patient is limited during physical activity. The rating ranges from I - IV, with the lowest as no limitations and the highest unable to carry on any physical activity without discomfort.|Participants|Number|165|165.0||||||
4294045|NCT00530894|4120130|B2|Inoperable Class III or IV||NYHA Class|New York Heart Association (NYHA), functional classification of heart failure based on how much a patient is limited during physical activity. The rating ranges from I - IV, with the lowest as no limitations and the highest unable to carry on any physical activity without discomfort.|Participants|Number|NA|||||||The inoperable and high risk groups were not randomized against each other and were essentially two separate trials
4294046|NCT00530894|4120131|B1|Inoperable Class III or IV||NYHA Class|New York Heart Association (NYHA), functional classification of heart failure based on how much a patient is limited during physical activity. The rating ranges from I - IV, with the lowest as no limitations and the highest unable to carry on any physical activity without discomfort.|Participants|Number|NA|||||||The inoperable and high risk groups were not randomized against each other and were essentially two separate trials
4294047|NCT00530894|4120127|B5|High Risk Class III or IV||NYHA Class|New York Heart Association (NYHA), functional classification of heart failure based on how much a patient is limited during physical activity. The rating ranges from I - IV, with the lowest as no limitations and the highest unable to carry on any physical activity without discomfort.|Participants|Number|656|656.0||||||
4294048|NCT00530894|4120128|B4|High Risk Class III or IV||NYHA Class|New York Heart Association (NYHA), functional classification of heart failure based on how much a patient is limited during physical activity. The rating ranges from I - IV, with the lowest as no limitations and the highest unable to carry on any physical activity without discomfort.|Participants|Number|NA|||||||The inoperable and high risk groups were not randomized against each other and were essentially two separate trials
4294049|NCT00530894|4120129|B3|High Risk Class III or IV||NYHA Class|New York Heart Association (NYHA), functional classification of heart failure based on how much a patient is limited during physical activity. The rating ranges from I - IV, with the lowest as no limitations and the highest unable to carry on any physical activity without discomfort.|Participants|Number|NA|||||||The inoperable and high risk groups were not randomized against each other and were essentially two separate trials
4294050|NCT00530894|4120130|B2|High Risk Class III or IV||NYHA Class|New York Heart Association (NYHA), functional classification of heart failure based on how much a patient is limited during physical activity. The rating ranges from I - IV, with the lowest as no limitations and the highest unable to carry on any physical activity without discomfort.|Participants|Number|328|328.0||||||
4294051|NCT00530894|4120131|B1|High Risk Class III or IV||NYHA Class|New York Heart Association (NYHA), functional classification of heart failure based on how much a patient is limited during physical activity. The rating ranges from I - IV, with the lowest as no limitations and the highest unable to carry on any physical activity without discomfort.|Participants|Number|328|328.0||||||
4294052|NCT00530894|4120127|B5|Operable Class II||NYHA Class|New York Heart Association (NYHA), functional classification of heart failure based on how much a patient is limited during physical activity. The rating ranges from I - IV, with the lowest as no limitations and the highest unable to carry on any physical activity without discomfort.|Participants|Number|25|25.0||||||
4294095|NCT00530894|4120130|B2||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4294096|NCT00530894|4120131|B1||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4294054|NCT00530894|4120129|B3|Operable Class II||NYHA Class|New York Heart Association (NYHA), functional classification of heart failure based on how much a patient is limited during physical activity. The rating ranges from I - IV, with the lowest as no limitations and the highest unable to carry on any physical activity without discomfort.|Participants|Number|14|14.0||||||
4294055|NCT00530894|4120130|B2|Operable Class II||NYHA Class|New York Heart Association (NYHA), functional classification of heart failure based on how much a patient is limited during physical activity. The rating ranges from I - IV, with the lowest as no limitations and the highest unable to carry on any physical activity without discomfort.|Participants|Number|NA|||||||The inoperable and high risk groups were not randomized against each other and were essentially two separate trials
4294056|NCT00530894|4120131|B1|Operable Class II||NYHA Class|New York Heart Association (NYHA), functional classification of heart failure based on how much a patient is limited during physical activity. The rating ranges from I - IV, with the lowest as no limitations and the highest unable to carry on any physical activity without discomfort.|Participants|Number|NA|||||||The inoperable and high risk groups were not randomized against each other and were essentially two separate trials
4294057|NCT00530894|4120127|B5|High Risk Class II||NYHA Class|New York Heart Association (NYHA), functional classification of heart failure based on how much a patient is limited during physical activity. The rating ranges from I - IV, with the lowest as no limitations and the highest unable to carry on any physical activity without discomfort.|Participants|Number|41|41.0||||||
4294058|NCT00530894|4120128|B4|High Risk Class II||NYHA Class|New York Heart Association (NYHA), functional classification of heart failure based on how much a patient is limited during physical activity. The rating ranges from I - IV, with the lowest as no limitations and the highest unable to carry on any physical activity without discomfort.|Participants|Number|NA|||||||The inoperable and high risk groups were not randomized against each other and were essentially two separate trials
4294059|NCT00530894|4120129|B3|High Risk Class II||NYHA Class|New York Heart Association (NYHA), functional classification of heart failure based on how much a patient is limited during physical activity. The rating ranges from I - IV, with the lowest as no limitations and the highest unable to carry on any physical activity without discomfort.|Participants|Number|NA|||||||The inoperable and high risk groups were not randomized against each other and were essentially two separate trials
4294060|NCT00530894|4120130|B2|High Risk Class II||NYHA Class|New York Heart Association (NYHA), functional classification of heart failure based on how much a patient is limited during physical activity. The rating ranges from I - IV, with the lowest as no limitations and the highest unable to carry on any physical activity without discomfort.|Participants|Number|21|21.0||||||
4294061|NCT00530894|4120131|B1|High Risk Class II||NYHA Class|New York Heart Association (NYHA), functional classification of heart failure based on how much a patient is limited during physical activity. The rating ranges from I - IV, with the lowest as no limitations and the highest unable to carry on any physical activity without discomfort.|Participants|Number|20|20.0||||||
4294062|NCT00530894|4120127|B5|Other||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4294063|NCT00530894|4120128|B4|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4294064|NCT00530894|4120129|B3|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4294065|NCT00530894|4120130|B2|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4294066|NCT00530894|4120131|B1|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4294067|NCT00530894|4120127|B5|Hispanic||Race/Ethnicity, Customized||Participants|Number|31|31.0||||||
4294068|NCT00530894|4120128|B4|Hispanic||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4294069|NCT00530894|4120129|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4294070|NCT00530894|4120130|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4294071|NCT00530894|4120131|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4294072|NCT00530894|4120127|B5|White||Race/Ethnicity, Customized||Participants|Number|979|979.0||||||
4294073|NCT00530894|4120128|B4|White||Race/Ethnicity, Customized||Participants|Number|162|162.0||||||
4294074|NCT00530894|4120129|B3|White||Race/Ethnicity, Customized||Participants|Number|165|165.0||||||
4294075|NCT00530894|4120130|B2|White||Race/Ethnicity, Customized||Participants|Number|328|328.0||||||
4294076|NCT00530894|4120131|B1|White||Race/Ethnicity, Customized||Participants|Number|324|324.0||||||
4294077|NCT00530894|4120127|B5|Black/African American||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
4294078|NCT00530894|4120128|B4|Black/African American||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4294079|NCT00530894|4120129|B3|Black/African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4294080|NCT00530894|4120130|B2|Black/African American||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4294081|NCT00530894|4120131|B1|Black/African American||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4294082|NCT00530894|4120127|B5|Asian||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4294083|NCT00530894|4120128|B4|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4294084|NCT00530894|4120129|B3|Asian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4294085|NCT00530894|4120130|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4294086|NCT00530894|4120131|B1|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4294087|NCT00530894|4120127|B5||Male|Sex: Female, Male||Participants|Count of Participants|565|565.0||||||
4294088|NCT00530894|4120128|B4||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4294089|NCT00530894|4120129|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4294090|NCT00530894|4120130|B2||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4294091|NCT00530894|4120131|B1||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4294092|NCT00530894|4120127|B5||Female|Sex: Female, Male||Participants|Count of Participants|490|490.0||||||
4294093|NCT00530894|4120128|B4||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4294094|NCT00530894|4120129|B3||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4294100|NCT00530894|4120130|B2|Inoperable||Age||Years|Mean|NA||Standard Deviation|NA||||The inoperable and high risk groups were not randomized against each other and were essentially two separate trials
4294101|NCT00530894|4120131|B1|Inoperable||Age||Years|Mean|NA||Standard Deviation|NA||||The inoperable and high risk groups were not randomized against each other and were essentially two separate trials
4294102|NCT00530894|4120127|B5|High Risk||Age||Years|Mean|84.11|84.11|Standard Deviation|6.61|6.61|||
4294103|NCT00530894|4120128|B4|High Risk||Age||Years|Mean|NA||Standard Deviation|NA||||The inoperable and high risk groups were not randomized against each other and were essentially two separate trials
4294104|NCT00530894|4120129|B3|High Risk||Age||Years|Mean|NA||Standard Deviation|NA||||The inoperable and high risk groups were not randomized against each other and were essentially two separate trials
4294105|NCT00530894|4120130|B2|High Risk||Age||Years|Mean|84.52|84.52|Standard Deviation|6.37|6.37|||
4294106|NCT00530894|4120131|B1|High Risk||Age||Years|Mean|83.61|83.61|Standard Deviation|6.83|6.83|||
4294107|NCT00530855|4120162|B1|Other||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4294108|NCT00530855|4120162|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4294109|NCT00530855|4120162|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|46|46.0||||||
4294110|NCT00530855|4120162|B1|White||Race/Ethnicity, Customized||Participants|Number|258|258.0||||||
4294111|NCT00530855|4120162|B1||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4294112|NCT00530855|4120162|B1||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4294113|NCT00530855|4120162|B1|mean (standard deviation)||Age||years|Mean|40.7|40.7|Standard Deviation|13.3|13.3|||
4294114|NCT00530855|4120162|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4294115|NCT00530855|4120162|B1||Between 18 and 65 years|Age||Participants|Count of Participants|301|301.0||||||
4294116|NCT00530855|4120162|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4294117|NCT00530842|4120169|B3||Male|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
4294118|NCT00530842|4120170|B2||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4294119|NCT00530842|4120171|B1||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4294120|NCT00530842|4120169|B3||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4294121|NCT00530842|4120170|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4294122|NCT00530842|4120171|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4294123|NCT00530842|4120169|B3|||Age||Years|Mean|61.0|61.0|Standard Deviation|7.6|7.6|||
4294124|NCT00530842|4120170|B2|||Age||Years|Mean|60.6|60.6|Standard Deviation|7.6|7.6|||
4294125|NCT00530842|4120171|B1|||Age||Years|Mean|61.5|61.5|Standard Deviation|7.5|7.5|||
4294126|NCT00530816|4120296|B4|Missing||Measurable Disease Category|"Measurable disease categories defined as:~SPEP: Serum M-protein ≥ 1 g/dL by serum protein electrophoresis (SPEP);~UPEP: Urine M-protein ≥ 200 mg/24 hour by urine protein electrophoresis (UPEP);~SPEP and UPEP: M-protein levels ≥ 1 g/dL in serum and ≥ 200 mg/24 hours;~SFLC Only: Detectable using serum free light chain (SFLC) assay only (participants enrolled prior to Amendment 2);~IgA only: For patients with immunoglobulin A (IgA) myeloma for whom SPEP is considered unreliable, quantitative immunoglobulin (e.g. nephelometry or turbidometry) was performed."|participants|Number|1|1.0||||||
4294127|NCT00530816|4120297|B3|Missing||Measurable Disease Category|"Measurable disease categories defined as:~SPEP: Serum M-protein ≥ 1 g/dL by serum protein electrophoresis (SPEP);~UPEP: Urine M-protein ≥ 200 mg/24 hour by urine protein electrophoresis (UPEP);~SPEP and UPEP: M-protein levels ≥ 1 g/dL in serum and ≥ 200 mg/24 hours;~SFLC Only: Detectable using serum free light chain (SFLC) assay only (participants enrolled prior to Amendment 2);~IgA only: For patients with immunoglobulin A (IgA) myeloma for whom SPEP is considered unreliable, quantitative immunoglobulin (e.g. nephelometry or turbidometry) was performed."|participants|Number|1|1.0||||||
4294128|NCT00530816|4120298|B2|Missing||Measurable Disease Category|"Measurable disease categories defined as:~SPEP: Serum M-protein ≥ 1 g/dL by serum protein electrophoresis (SPEP);~UPEP: Urine M-protein ≥ 200 mg/24 hour by urine protein electrophoresis (UPEP);~SPEP and UPEP: M-protein levels ≥ 1 g/dL in serum and ≥ 200 mg/24 hours;~SFLC Only: Detectable using serum free light chain (SFLC) assay only (participants enrolled prior to Amendment 2);~IgA only: For patients with immunoglobulin A (IgA) myeloma for whom SPEP is considered unreliable, quantitative immunoglobulin (e.g. nephelometry or turbidometry) was performed."|participants|Number|0|0.0||||||
4294129|NCT00530816|4120299|B1|Missing||Measurable Disease Category|"Measurable disease categories defined as:~SPEP: Serum M-protein ≥ 1 g/dL by serum protein electrophoresis (SPEP);~UPEP: Urine M-protein ≥ 200 mg/24 hour by urine protein electrophoresis (UPEP);~SPEP and UPEP: M-protein levels ≥ 1 g/dL in serum and ≥ 200 mg/24 hours;~SFLC Only: Detectable using serum free light chain (SFLC) assay only (participants enrolled prior to Amendment 2);~IgA only: For patients with immunoglobulin A (IgA) myeloma for whom SPEP is considered unreliable, quantitative immunoglobulin (e.g. nephelometry or turbidometry) was performed."|participants|Number|0|0.0||||||
4294130|NCT00530816|4120296|B4|IgA, by Immunoglobulin Assay Only||Measurable Disease Category|"Measurable disease categories defined as:~SPEP: Serum M-protein ≥ 1 g/dL by serum protein electrophoresis (SPEP);~UPEP: Urine M-protein ≥ 200 mg/24 hour by urine protein electrophoresis (UPEP);~SPEP and UPEP: M-protein levels ≥ 1 g/dL in serum and ≥ 200 mg/24 hours;~SFLC Only: Detectable using serum free light chain (SFLC) assay only (participants enrolled prior to Amendment 2);~IgA only: For patients with immunoglobulin A (IgA) myeloma for whom SPEP is considered unreliable, quantitative immunoglobulin (e.g. nephelometry or turbidometry) was performed."|participants|Number|2|2.0||||||
4294131|NCT00530816|4120297|B3|IgA, by Immunoglobulin Assay Only||Measurable Disease Category|"Measurable disease categories defined as:~SPEP: Serum M-protein ≥ 1 g/dL by serum protein electrophoresis (SPEP);~UPEP: Urine M-protein ≥ 200 mg/24 hour by urine protein electrophoresis (UPEP);~SPEP and UPEP: M-protein levels ≥ 1 g/dL in serum and ≥ 200 mg/24 hours;~SFLC Only: Detectable using serum free light chain (SFLC) assay only (participants enrolled prior to Amendment 2);~IgA only: For patients with immunoglobulin A (IgA) myeloma for whom SPEP is considered unreliable, quantitative immunoglobulin (e.g. nephelometry or turbidometry) was performed."|participants|Number|0|0.0||||||
4294132|NCT00530816|4120298|B2|IgA, by Immunoglobulin Assay Only||Measurable Disease Category|"Measurable disease categories defined as:~SPEP: Serum M-protein ≥ 1 g/dL by serum protein electrophoresis (SPEP);~UPEP: Urine M-protein ≥ 200 mg/24 hour by urine protein electrophoresis (UPEP);~SPEP and UPEP: M-protein levels ≥ 1 g/dL in serum and ≥ 200 mg/24 hours;~SFLC Only: Detectable using serum free light chain (SFLC) assay only (participants enrolled prior to Amendment 2);~IgA only: For patients with immunoglobulin A (IgA) myeloma for whom SPEP is considered unreliable, quantitative immunoglobulin (e.g. nephelometry or turbidometry) was performed."|participants|Number|2|2.0||||||
4294133|NCT00530816|4120299|B1|IgA, by Immunoglobulin Assay Only||Measurable Disease Category|"Measurable disease categories defined as:~SPEP: Serum M-protein ≥ 1 g/dL by serum protein electrophoresis (SPEP);~UPEP: Urine M-protein ≥ 200 mg/24 hour by urine protein electrophoresis (UPEP);~SPEP and UPEP: M-protein levels ≥ 1 g/dL in serum and ≥ 200 mg/24 hours;~SFLC Only: Detectable using serum free light chain (SFLC) assay only (participants enrolled prior to Amendment 2);~IgA only: For patients with immunoglobulin A (IgA) myeloma for whom SPEP is considered unreliable, quantitative immunoglobulin (e.g. nephelometry or turbidometry) was performed."|participants|Number|0|0.0||||||
4294134|NCT00530816|4120296|B4|SFLC Only||Measurable Disease Category|"Measurable disease categories defined as:~SPEP: Serum M-protein ≥ 1 g/dL by serum protein electrophoresis (SPEP);~UPEP: Urine M-protein ≥ 200 mg/24 hour by urine protein electrophoresis (UPEP);~SPEP and UPEP: M-protein levels ≥ 1 g/dL in serum and ≥ 200 mg/24 hours;~SFLC Only: Detectable using serum free light chain (SFLC) assay only (participants enrolled prior to Amendment 2);~IgA only: For patients with immunoglobulin A (IgA) myeloma for whom SPEP is considered unreliable, quantitative immunoglobulin (e.g. nephelometry or turbidometry) was performed."|participants|Number|11|11.0||||||
4294135|NCT00530816|4120297|B3|SFLC Only||Measurable Disease Category|"Measurable disease categories defined as:~SPEP: Serum M-protein ≥ 1 g/dL by serum protein electrophoresis (SPEP);~UPEP: Urine M-protein ≥ 200 mg/24 hour by urine protein electrophoresis (UPEP);~SPEP and UPEP: M-protein levels ≥ 1 g/dL in serum and ≥ 200 mg/24 hours;~SFLC Only: Detectable using serum free light chain (SFLC) assay only (participants enrolled prior to Amendment 2);~IgA only: For patients with immunoglobulin A (IgA) myeloma for whom SPEP is considered unreliable, quantitative immunoglobulin (e.g. nephelometry or turbidometry) was performed."|participants|Number|1|1.0||||||
4294136|NCT00530816|4120298|B2|SFLC Only||Measurable Disease Category|"Measurable disease categories defined as:~SPEP: Serum M-protein ≥ 1 g/dL by serum protein electrophoresis (SPEP);~UPEP: Urine M-protein ≥ 200 mg/24 hour by urine protein electrophoresis (UPEP);~SPEP and UPEP: M-protein levels ≥ 1 g/dL in serum and ≥ 200 mg/24 hours;~SFLC Only: Detectable using serum free light chain (SFLC) assay only (participants enrolled prior to Amendment 2);~IgA only: For patients with immunoglobulin A (IgA) myeloma for whom SPEP is considered unreliable, quantitative immunoglobulin (e.g. nephelometry or turbidometry) was performed."|participants|Number|6|6.0||||||
4294137|NCT00530816|4120299|B1|SFLC Only||Measurable Disease Category|"Measurable disease categories defined as:~SPEP: Serum M-protein ≥ 1 g/dL by serum protein electrophoresis (SPEP);~UPEP: Urine M-protein ≥ 200 mg/24 hour by urine protein electrophoresis (UPEP);~SPEP and UPEP: M-protein levels ≥ 1 g/dL in serum and ≥ 200 mg/24 hours;~SFLC Only: Detectable using serum free light chain (SFLC) assay only (participants enrolled prior to Amendment 2);~IgA only: For patients with immunoglobulin A (IgA) myeloma for whom SPEP is considered unreliable, quantitative immunoglobulin (e.g. nephelometry or turbidometry) was performed."|participants|Number|4|4.0||||||
4294138|NCT00530816|4120296|B4|UPEP||Measurable Disease Category|"Measurable disease categories defined as:~SPEP: Serum M-protein ≥ 1 g/dL by serum protein electrophoresis (SPEP);~UPEP: Urine M-protein ≥ 200 mg/24 hour by urine protein electrophoresis (UPEP);~SPEP and UPEP: M-protein levels ≥ 1 g/dL in serum and ≥ 200 mg/24 hours;~SFLC Only: Detectable using serum free light chain (SFLC) assay only (participants enrolled prior to Amendment 2);~IgA only: For patients with immunoglobulin A (IgA) myeloma for whom SPEP is considered unreliable, quantitative immunoglobulin (e.g. nephelometry or turbidometry) was performed."|participants|Number|22|22.0||||||
4294139|NCT00530816|4120297|B3|UPEP||Measurable Disease Category|"Measurable disease categories defined as:~SPEP: Serum M-protein ≥ 1 g/dL by serum protein electrophoresis (SPEP);~UPEP: Urine M-protein ≥ 200 mg/24 hour by urine protein electrophoresis (UPEP);~SPEP and UPEP: M-protein levels ≥ 1 g/dL in serum and ≥ 200 mg/24 hours;~SFLC Only: Detectable using serum free light chain (SFLC) assay only (participants enrolled prior to Amendment 2);~IgA only: For patients with immunoglobulin A (IgA) myeloma for whom SPEP is considered unreliable, quantitative immunoglobulin (e.g. nephelometry or turbidometry) was performed."|participants|Number|10|10.0||||||
4294140|NCT00530816|4120298|B2|UPEP||Measurable Disease Category|"Measurable disease categories defined as:~SPEP: Serum M-protein ≥ 1 g/dL by serum protein electrophoresis (SPEP);~UPEP: Urine M-protein ≥ 200 mg/24 hour by urine protein electrophoresis (UPEP);~SPEP and UPEP: M-protein levels ≥ 1 g/dL in serum and ≥ 200 mg/24 hours;~SFLC Only: Detectable using serum free light chain (SFLC) assay only (participants enrolled prior to Amendment 2);~IgA only: For patients with immunoglobulin A (IgA) myeloma for whom SPEP is considered unreliable, quantitative immunoglobulin (e.g. nephelometry or turbidometry) was performed."|participants|Number|6|6.0||||||
4294141|NCT00530816|4120299|B1|UPEP||Measurable Disease Category|"Measurable disease categories defined as:~SPEP: Serum M-protein ≥ 1 g/dL by serum protein electrophoresis (SPEP);~UPEP: Urine M-protein ≥ 200 mg/24 hour by urine protein electrophoresis (UPEP);~SPEP and UPEP: M-protein levels ≥ 1 g/dL in serum and ≥ 200 mg/24 hours;~SFLC Only: Detectable using serum free light chain (SFLC) assay only (participants enrolled prior to Amendment 2);~IgA only: For patients with immunoglobulin A (IgA) myeloma for whom SPEP is considered unreliable, quantitative immunoglobulin (e.g. nephelometry or turbidometry) was performed."|participants|Number|6|6.0||||||
4294142|NCT00530816|4120296|B4|SPEP||Measurable Disease Category|"Measurable disease categories defined as:~SPEP: Serum M-protein ≥ 1 g/dL by serum protein electrophoresis (SPEP);~UPEP: Urine M-protein ≥ 200 mg/24 hour by urine protein electrophoresis (UPEP);~SPEP and UPEP: M-protein levels ≥ 1 g/dL in serum and ≥ 200 mg/24 hours;~SFLC Only: Detectable using serum free light chain (SFLC) assay only (participants enrolled prior to Amendment 2);~IgA only: For patients with immunoglobulin A (IgA) myeloma for whom SPEP is considered unreliable, quantitative immunoglobulin (e.g. nephelometry or turbidometry) was performed."|participants|Number|108|108.0||||||
4294166|NCT00530816|4120296|B4||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4294167|NCT00530816|4120297|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4294168|NCT00530816|4120298|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4294143|NCT00530816|4120297|B3|SPEP||Measurable Disease Category|"Measurable disease categories defined as:~SPEP: Serum M-protein ≥ 1 g/dL by serum protein electrophoresis (SPEP);~UPEP: Urine M-protein ≥ 200 mg/24 hour by urine protein electrophoresis (UPEP);~SPEP and UPEP: M-protein levels ≥ 1 g/dL in serum and ≥ 200 mg/24 hours;~SFLC Only: Detectable using serum free light chain (SFLC) assay only (participants enrolled prior to Amendment 2);~IgA only: For patients with immunoglobulin A (IgA) myeloma for whom SPEP is considered unreliable, quantitative immunoglobulin (e.g. nephelometry or turbidometry) was performed."|participants|Number|47|47.0||||||
4294144|NCT00530816|4120298|B2|SPEP||Measurable Disease Category|"Measurable disease categories defined as:~SPEP: Serum M-protein ≥ 1 g/dL by serum protein electrophoresis (SPEP);~UPEP: Urine M-protein ≥ 200 mg/24 hour by urine protein electrophoresis (UPEP);~SPEP and UPEP: M-protein levels ≥ 1 g/dL in serum and ≥ 200 mg/24 hours;~SFLC Only: Detectable using serum free light chain (SFLC) assay only (participants enrolled prior to Amendment 2);~IgA only: For patients with immunoglobulin A (IgA) myeloma for whom SPEP is considered unreliable, quantitative immunoglobulin (e.g. nephelometry or turbidometry) was performed."|participants|Number|39|39.0||||||
4294145|NCT00530816|4120299|B1|SPEP||Measurable Disease Category|"Measurable disease categories defined as:~SPEP: Serum M-protein ≥ 1 g/dL by serum protein electrophoresis (SPEP);~UPEP: Urine M-protein ≥ 200 mg/24 hour by urine protein electrophoresis (UPEP);~SPEP and UPEP: M-protein levels ≥ 1 g/dL in serum and ≥ 200 mg/24 hours;~SFLC Only: Detectable using serum free light chain (SFLC) assay only (participants enrolled prior to Amendment 2);~IgA only: For patients with immunoglobulin A (IgA) myeloma for whom SPEP is considered unreliable, quantitative immunoglobulin (e.g. nephelometry or turbidometry) was performed."|participants|Number|22|22.0||||||
4294146|NCT00530816|4120296|B4|SPEP and UPEP||Measurable Disease Category|"Measurable disease categories defined as:~SPEP: Serum M-protein ≥ 1 g/dL by serum protein electrophoresis (SPEP);~UPEP: Urine M-protein ≥ 200 mg/24 hour by urine protein electrophoresis (UPEP);~SPEP and UPEP: M-protein levels ≥ 1 g/dL in serum and ≥ 200 mg/24 hours;~SFLC Only: Detectable using serum free light chain (SFLC) assay only (participants enrolled prior to Amendment 2);~IgA only: For patients with immunoglobulin A (IgA) myeloma for whom SPEP is considered unreliable, quantitative immunoglobulin (e.g. nephelometry or turbidometry) was performed."|participants|Number|20|20.0||||||
4294147|NCT00530816|4120297|B3|SPEP and UPEP||Measurable Disease Category|"Measurable disease categories defined as:~SPEP: Serum M-protein ≥ 1 g/dL by serum protein electrophoresis (SPEP);~UPEP: Urine M-protein ≥ 200 mg/24 hour by urine protein electrophoresis (UPEP);~SPEP and UPEP: M-protein levels ≥ 1 g/dL in serum and ≥ 200 mg/24 hours;~SFLC Only: Detectable using serum free light chain (SFLC) assay only (participants enrolled prior to Amendment 2);~IgA only: For patients with immunoglobulin A (IgA) myeloma for whom SPEP is considered unreliable, quantitative immunoglobulin (e.g. nephelometry or turbidometry) was performed."|participants|Number|11|11.0||||||
4294148|NCT00530816|4120298|B2|SPEP and UPEP||Measurable Disease Category|"Measurable disease categories defined as:~SPEP: Serum M-protein ≥ 1 g/dL by serum protein electrophoresis (SPEP);~UPEP: Urine M-protein ≥ 200 mg/24 hour by urine protein electrophoresis (UPEP);~SPEP and UPEP: M-protein levels ≥ 1 g/dL in serum and ≥ 200 mg/24 hours;~SFLC Only: Detectable using serum free light chain (SFLC) assay only (participants enrolled prior to Amendment 2);~IgA only: For patients with immunoglobulin A (IgA) myeloma for whom SPEP is considered unreliable, quantitative immunoglobulin (e.g. nephelometry or turbidometry) was performed."|participants|Number|6|6.0||||||
4294149|NCT00530816|4120299|B1|SPEP and UPEP||Measurable Disease Category|"Measurable disease categories defined as:~SPEP: Serum M-protein ≥ 1 g/dL by serum protein electrophoresis (SPEP);~UPEP: Urine M-protein ≥ 200 mg/24 hour by urine protein electrophoresis (UPEP);~SPEP and UPEP: M-protein levels ≥ 1 g/dL in serum and ≥ 200 mg/24 hours;~SFLC Only: Detectable using serum free light chain (SFLC) assay only (participants enrolled prior to Amendment 2);~IgA only: For patients with immunoglobulin A (IgA) myeloma for whom SPEP is considered unreliable, quantitative immunoglobulin (e.g. nephelometry or turbidometry) was performed."|participants|Number|3|3.0||||||
4294150|NCT00530816|4120296|B4|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Death.|participants|Number|1|1.0||||||
4294151|NCT00530816|4120297|B3|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Death.|participants|Number|0|0.0||||||
4294152|NCT00530816|4120298|B2|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Death.|participants|Number|0|0.0||||||
4294153|NCT00530816|4120299|B1|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Death.|participants|Number|1|1.0||||||
4294169|NCT00530816|4120299|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4294170|NCT00530816|4120296|B4||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4294171|NCT00530816|4120297|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4294172|NCT00530816|4120298|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4294154|NCT00530816|4120296|B4|2 (Ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Death.|participants|Number|9|9.0||||||
4294155|NCT00530816|4120297|B3|2 (Ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Death.|participants|Number|5|5.0||||||
4294156|NCT00530816|4120298|B2|2 (Ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Death.|participants|Number|3|3.0||||||
4294157|NCT00530816|4120299|B1|2 (Ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Death.|participants|Number|1|1.0||||||
4294158|NCT00530816|4120296|B4|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Death.|participants|Number|87|87.0||||||
4294159|NCT00530816|4120297|B3|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Death.|participants|Number|42|42.0||||||
4294160|NCT00530816|4120298|B2|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Death.|participants|Number|27|27.0||||||
4294161|NCT00530816|4120299|B1|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Death.|participants|Number|18|18.0||||||
4294162|NCT00530816|4120296|B4|0 (Fully Active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Death.|participants|Number|67|67.0||||||
4294163|NCT00530816|4120297|B3|0 (Fully Active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Death.|participants|Number|23|23.0||||||
4294164|NCT00530816|4120298|B2|0 (Fully Active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Death.|participants|Number|29|29.0||||||
4294165|NCT00530816|4120299|B1|0 (Fully Active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. 0 = Fully Active; 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, no self-care, confined to bed or chair; 5 = Death.|participants|Number|15|15.0||||||
4294173|NCT00530816|4120299|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4294174|NCT00530816|4120296|B4||>=65 years|Age||Participants|Count of Participants|83|83.0||||||
4294175|NCT00530816|4120297|B3||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4294176|NCT00530816|4120298|B2||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4294177|NCT00530816|4120299|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4294178|NCT00530816|4120296|B4||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
4294179|NCT00530816|4120297|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4294180|NCT00530816|4120298|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4294181|NCT00530816|4120299|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4294182|NCT00530816|4120296|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4294183|NCT00530816|4120297|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4294184|NCT00530816|4120298|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4294185|NCT00530816|4120299|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4294186|NCT00530803|4120327|B3|||Number of participants with history of topical anesthetics use|Information about prior use of topical anesthetics was obtained from participants and participants' during initial interview.|Participants|Count of Participants|8|8.0||||||
4294187|NCT00530803|4120328|B2|||Number of participants with history of topical anesthetics use|Information about prior use of topical anesthetics was obtained from participants and participants' during initial interview.|Participants|Count of Participants|4|4.0||||||
4294188|NCT00530803|4120329|B1|||Number of participants with history of topical anesthetics use|Information about prior use of topical anesthetics was obtained from participants and participants' during initial interview.|Participants|Count of Participants|4|4.0||||||
4294189|NCT00530803|4120327|B3|More than 10 venipunctures||Number of Participants with Prior Venipunctures|Information about prior history of venipunctures was obtained from participants and participants' during initial interview.|Participants|Number|44|44.0||||||
4294190|NCT00530803|4120328|B2|More than 10 venipunctures||Number of Participants with Prior Venipunctures|Information about prior history of venipunctures was obtained from participants and participants' during initial interview.|Participants|Number|23|23.0||||||
4294191|NCT00530803|4120329|B1|More than 10 venipunctures||Number of Participants with Prior Venipunctures|Information about prior history of venipunctures was obtained from participants and participants' during initial interview.|Participants|Number|21|21.0||||||
4294192|NCT00530803|4120327|B3|Less than10 venipunctures||Number of Participants with Prior Venipunctures|Information about prior history of venipunctures was obtained from participants and participants' during initial interview.|Participants|Number|56|56.0||||||
4294193|NCT00530803|4120328|B2|Less than10 venipunctures||Number of Participants with Prior Venipunctures|Information about prior history of venipunctures was obtained from participants and participants' during initial interview.|Participants|Number|27|27.0||||||
4294194|NCT00530803|4120329|B1|Less than10 venipunctures||Number of Participants with Prior Venipunctures|Information about prior history of venipunctures was obtained from participants and participants' during initial interview.|Participants|Number|29|29.0||||||
4294195|NCT00530803|4120327|B3|United States||Region of Enrollment||Participants|Count of Participants|100|100.0||||||
4294196|NCT00530803|4120328|B2|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
4294197|NCT00530803|4120329|B1|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
4294198|NCT00530803|4120327|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4294199|NCT00530803|4120328|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4294200|NCT00530803|4120329|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4294201|NCT00530803|4120327|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4294202|NCT00530803|4120328|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4294203|NCT00530803|4120329|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4294204|NCT00530803|4120327|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4294205|NCT00530803|4120328|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4294206|NCT00530803|4120329|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4294207|NCT00530803|4120327|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4294208|NCT00530803|4120328|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4294209|NCT00530803|4120329|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4294210|NCT00530803|4120327|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294211|NCT00530803|4120328|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294212|NCT00530803|4120329|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294213|NCT00530803|4120327|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294214|NCT00530803|4120328|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294215|NCT00530803|4120329|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294216|NCT00530803|4120327|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294217|NCT00530803|4120328|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294218|NCT00530803|4120329|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294219|NCT00530803|4120327|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4294220|NCT00530803|4120328|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4294221|NCT00530803|4120329|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4294222|NCT00530803|4120327|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4294223|NCT00530803|4120328|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4294224|NCT00530803|4120329|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4294225|NCT00530803|4120327|B3|||Age||Years|Mean|8.8|8.8|Standard Deviation|2.5|2.5|||
4294226|NCT00530803|4120328|B2|||Age||Years|Mean|8.9|8.9|Standard Deviation|2.5|2.5|||
4294227|NCT00530803|4120329|B1|||Age||Years|Mean|8.7|8.7|Standard Deviation|2.5|2.5|||
4294228|NCT00530790|4120344|B1|Japan||Region of Enrollment||Number of participants|Number|35|35.0||||||
4294229|NCT00530790|4120344|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4294230|NCT00530790|4120344|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4294231|NCT00530790|4120344|B1|||Age||years|Mean|48.2|48.2|Standard Deviation|14.7|14.7|||
4294232|NCT00530777|4120364|B3|Kenya||Region of Enrollment||participants|Number|148|148.0||||||
4294233|NCT00530777|4120365|B2|Kenya||Region of Enrollment||participants|Number|74|74.0||||||
4294234|NCT00530777|4120366|B1|Kenya||Region of Enrollment||participants|Number|74|74.0||||||
4294235|NCT00530777|4120364|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4294236|NCT00530777|4120365|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4294237|NCT00530777|4120366|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4294238|NCT00530777|4120364|B3||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4294239|NCT00530777|4120365|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4294240|NCT00530777|4120366|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4294241|NCT00530777|4120364|B3|||Age||years|Mean|26.1|26.1|Standard Deviation|4.9|4.9|||
4294242|NCT00530777|4120365|B2|||Age||years|Mean|26.0|26.0|Standard Deviation|4.5|4.5|||
4294243|NCT00530777|4120366|B1|||Age||years|Mean|26.2|26.2|Standard Deviation|5.3|5.3|||
4294244|NCT00530777|4120364|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4294245|NCT00530777|4120365|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4294246|NCT00530777|4120366|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4294247|NCT00530777|4120364|B3||Between 18 and 65 years|Age||Participants|Count of Participants|141|141.0||||||
4294248|NCT00530777|4120365|B2||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4294249|NCT00530777|4120366|B1||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4294250|NCT00530777|4120364|B3||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4294251|NCT00530777|4120365|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4294252|NCT00530777|4120366|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4294253|NCT00530764|4120375|B5||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4294254|NCT00530764|4120376|B4||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4294255|NCT00530764|4120377|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4294256|NCT00530764|4120378|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4294257|NCT00530764|4120379|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4294258|NCT00530764|4120375|B5||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4294259|NCT00530764|4120376|B4||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4294260|NCT00530764|4120377|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4294261|NCT00530764|4120378|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4294262|NCT00530764|4120379|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4294263|NCT00530764|4120375|B5|||Age||years|Mean|58|58.0|Standard Deviation|12.2|12.2|||
4294264|NCT00530764|4120376|B4|||Age||years|Mean|56|56.0|Standard Deviation|12.2|12.2|||
4294265|NCT00530764|4120377|B3|||Age||years|Mean|59|59.0|Standard Deviation|12.3|12.3|||
4294266|NCT00530764|4120378|B2|||Age||years|Mean|59|59.0|Standard Deviation|31.1|31.1|||
4294267|NCT00530764|4120379|B1|||Age||years|Mean|58|58.0|Standard Deviation|11.2|11.2|||
4294268|NCT00530712|4120424|B1|Europe||Region of Enrollment||participants|Number|43|43.0||||||
4294269|NCT00530712|4120424|B1|United States||Region of Enrollment||participants|Number|244|244.0||||||
4294270|NCT00530712|4120424|B1||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4294271|NCT00530712|4120424|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4294272|NCT00530712|4120424|B1|||Age||years|Mean|67.7|67.7|Standard Deviation|10.7|10.7|||
4294273|NCT00530634|4120439|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4294274|NCT00530634|4120439|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4294275|NCT00530634|4120439|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4294276|NCT00530634|4120439|B1|||Age||years|Median|66|66.0|Full Range|||63.0|71.0|
4294277|NCT00530504|4120443|B1||Male|Sex: Female, Male||Participants|Count of Participants|923|923.0||||||
4294278|NCT00530504|4120443|B1||Female|Sex: Female, Male||Participants|Count of Participants|577|577.0||||||
4294279|NCT00530504|4120443|B1|||Age||years|Mean|72.5|72.5|Standard Deviation|9.5|9.5|||
4294280|NCT00530439|4120447|B3|Denmark||Region of Enrollment||participants|Number|360|360.0||||||
4294281|NCT00530439|4120448|B2|Denmark||Region of Enrollment||participants|Number|180|180.0||||||
4294282|NCT00530439|4120449|B1|Denmark||Region of Enrollment||participants|Number|180|180.0||||||
4294283|NCT00530439|4120447|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4294284|NCT00530439|4120448|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4294285|NCT00530439|4120449|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4294286|NCT00530439|4120447|B3||Female|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
4294287|NCT00530439|4120448|B2||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4294288|NCT00530439|4120449|B1||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4294289|NCT00530439|4120447|B3|||Age||Years|Median|29|29.0|Inter-Quartile Range|||26.0|32.0|
4294290|NCT00530439|4120448|B2|||Age||Years|Median|29|29.0|Inter-Quartile Range|||26.0|32.0|
4294291|NCT00530439|4120449|B1|||Age||Years|Median|29|29.0|Inter-Quartile Range|||27.0|32.0|
4294292|NCT00530439|4120447|B3|||Age||years|Mean|29.3|29.3|Standard Deviation|4.2|4.2|||
4294293|NCT00530439|4120448|B2|||Age||years|Mean|29.05|29.05|Standard Deviation|4.12|4.12|||
4294294|NCT00530439|4120449|B1|||Age||years|Mean|29.6|29.6|Standard Deviation|4.35|4.35|||
4294295|NCT00530439|4120447|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4294296|NCT00530439|4120448|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4294297|NCT00530439|4120449|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4294298|NCT00530439|4120447|B3||Between 18 and 65 years|Age||Participants|Count of Participants|360|360.0||||||
4294299|NCT00530439|4120448|B2||Between 18 and 65 years|Age||Participants|Count of Participants|180|180.0||||||
4294300|NCT00530439|4120449|B1||Between 18 and 65 years|Age||Participants|Count of Participants|180|180.0||||||
4294301|NCT00530439|4120447|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4294302|NCT00530439|4120448|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4294303|NCT00530439|4120449|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4294304|NCT00530348|4120456|B3|||Expanded Disability Status Scale (EDSS) Score|EDSS is an ordinal scale in half-point increments that quantifies disability in participants with multiple sclerosis (MS). It assesses the 7 functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation. EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS).|units on a scale|Mean|2.0|2.0|Standard Deviation|0.81|0.81|||
4294305|NCT00530348|4120457|B2|||Expanded Disability Status Scale (EDSS) Score|EDSS is an ordinal scale in half-point increments that quantifies disability in participants with multiple sclerosis (MS). It assesses the 7 functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation. EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS).|units on a scale|Mean|2.0|2.0|Standard Deviation|0.81|0.81|||
4294306|NCT00530348|4120458|B1|||Expanded Disability Status Scale (EDSS) Score|EDSS is an ordinal scale in half-point increments that quantifies disability in participants with multiple sclerosis (MS). It assesses the 7 functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation. EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS).|units on a scale|Mean|2.0|2.0|Standard Deviation|0.79|0.79|||
4294307|NCT00530348|4120456|B3|Greater than or equal to 3 Relapses||Number of Relapse Episodes in the Preceding 2 Years|Number of participants with 1, 2 or greater than or equal to 3 relapses are reported.|participants|Number|215|215.0||||||
4294308|NCT00530348|4120457|B2|Greater than or equal to 3 Relapses||Number of Relapse Episodes in the Preceding 2 Years|Number of participants with 1, 2 or greater than or equal to 3 relapses are reported.|participants|Number|149|149.0||||||
4294309|NCT00530348|4120458|B1|Greater than or equal to 3 Relapses||Number of Relapse Episodes in the Preceding 2 Years|Number of participants with 1, 2 or greater than or equal to 3 relapses are reported.|participants|Number|66|66.0||||||
4294310|NCT00530348|4120456|B3|2 Relapses||Number of Relapse Episodes in the Preceding 2 Years|Number of participants with 1, 2 or greater than or equal to 3 relapses are reported.|participants|Number|333|333.0||||||
4294311|NCT00530348|4120457|B2|2 Relapses||Number of Relapse Episodes in the Preceding 2 Years|Number of participants with 1, 2 or greater than or equal to 3 relapses are reported.|participants|Number|215|215.0||||||
4294312|NCT00530348|4120458|B1|2 Relapses||Number of Relapse Episodes in the Preceding 2 Years|Number of participants with 1, 2 or greater than or equal to 3 relapses are reported.|participants|Number|118|118.0||||||
4294313|NCT00530348|4120456|B3|1 Relapse||Number of Relapse Episodes in the Preceding 2 Years|Number of participants with 1, 2 or greater than or equal to 3 relapses are reported.|participants|Number|15|15.0||||||
4294314|NCT00530348|4120457|B2|1 Relapse||Number of Relapse Episodes in the Preceding 2 Years|Number of participants with 1, 2 or greater than or equal to 3 relapses are reported.|participants|Number|12|12.0||||||
4294315|NCT00530348|4120458|B1|1 Relapse||Number of Relapse Episodes in the Preceding 2 Years|Number of participants with 1, 2 or greater than or equal to 3 relapses are reported.|participants|Number|3|3.0||||||
4294316|NCT00530348|4120456|B3|||Time Since First Relapse||years|Mean|2.1|2.1|Standard Deviation|1.35|1.35|||
4294317|NCT00530348|4120457|B2|||Time Since First Relapse||years|Mean|2.1|2.1|Standard Deviation|1.36|1.36|||
4294318|NCT00530348|4120458|B1|||Time Since First Relapse||years|Mean|2.0|2.0|Standard Deviation|1.32|1.32|||
4294319|NCT00530348|4120456|B3||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4294320|NCT00530348|4120457|B2||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4294321|NCT00530348|4120458|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4294322|NCT00530348|4120456|B3||Female|Sex: Female, Male||Participants|Count of Participants|365|365.0||||||
4294323|NCT00530348|4120457|B2||Female|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
4294324|NCT00530348|4120458|B1||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4294325|NCT00530348|4120456|B3|||Age||years|Mean|33.1|33.1|Standard Deviation|8.18|8.18|||
4294326|NCT00530348|4120457|B2|||Age||years|Mean|33.0|33.0|Standard Deviation|8.03|8.03|||
4294327|NCT00530348|4120458|B1|||Age||years|Mean|33.2|33.2|Standard Deviation|8.48|8.48|||
4294502|NCT00529633|4120663|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4294328|NCT00530335|4120475|B1|||Hamilton Depression Rating Scale-17 Items Total Score|The 17-item HAMD measures depression severity. Each item was evaluated and scored using either a 5-point scale (e.g. absent, mild, moderate, severe, very severe) or a 3-point scale (e.g. absent, mild, marked). The total score of HAMD-17 may range from 0 (normal) to 52 (severe).|units on a scale|Mean|4.2|4.2|Standard Deviation|3.9|3.9|||
4294329|NCT00530335|4120475|B1|||Hamilton Anxiety Rating Scale-14 Items Total Score|The 14-item HAMA assesses the severity of anxiety. The investigator talked to the patient about their symptoms over the previous week before the study visit. Each item was scored using a 5-point scale, i.e. 0 = absent to 4 = severe. The total score of HAMA-14 may range from 0 (normal) to 56 (severe).|units on a scale|Mean|6.2|6.2|Standard Deviation|5.3|5.3|||
4294330|NCT00530335|4120475|B1|||Conners' Adult ADHD Rating Scale-S:SV-J Total Symptoms Score|Conners' Adult Attention-Deficit Hyperactivity Disorder (ADHD) Rating Scale-Subject:Screening Version-Japanese. Total ADHD symptom score consisted of 18 items (sum of inattention and hyperactivity-impulsivity subscales) using a 4-point scale (0=not at all/never to 3=very much/very frequently) for total score range of 0 to 54.|units on a scale|Mean|29.1|29.1|Standard Deviation|9.7|9.7|||
4294331|NCT00530335|4120475|B1|||Conners' Adult ADHD Rating Scale-S:SV-J Inattentive Subscale|Conners' Adult Attention-Deficit Hyperactivity Disorder (ADHD) Rating Scale-Subject:Screening Version-Japanese. Inattention subscale consisted of 9 items, using a 4-point scale (0=not at all/never to 3=very much/very frequently) for total score range of 0 to 27.|units on a scale|Mean|19.0|19.0|Standard Deviation|5.7|5.7|||
4294332|NCT00530335|4120475|B1|||Conners' Adult ADHD Rating Scale-S:SV-J Hyperactive/Impulsive Subscale|Conners' Adult Attention-Deficit Hyperactivity Disorder (ADHD) Rating Scale-Subject:Screening Version-Japanese. Hyperactive/Impulsive Subscale consisted of 9 items, using a 4-point scale (0=not at all/never to 3=very much/very frequently) for total score range of 0 to 27.|units on a scale|Mean|10.1|10.1|Standard Deviation|5.8|5.8|||
4294333|NCT00530335|4120475|B1|||Conners' Adult ADHD Rating Scale-S:SV-J ADHD Index Subscale|Conners' Adult Attention-Deficit Hyperactivity Disorder (ADHD) Rating Scale-Subject:Screening Version-Japanese. ADHD Index Subscale consisted of 12 items, using a 4-point scale (0=not at all/never to 3=very much/very frequently) for total score range of 0 to 36.|units on a scale|Mean|21.0|21.0|Standard Deviation|6.8|6.8|||
4294334|NCT00530335|4120475|B1|||Conners' Adult ADHD Rating Scale-Inv:SV-J Total Symptoms Score|Conners' Adult Attention-Deficit Hyperactivity Disorder (ADHD) Rating Scale-Investigator Rating:Screening Version-Japanese . Total ADHD symptom score consisted of 18 items (sum of inattention and hyperactivity-impulsivity subscales) using a 4-point scale (0=not at all/never to 3=very much/very frequently) for total score range of 0 to 54.|units on a scale|Mean|31.2|31.2|Standard Deviation|7.0|7.0|||
4294335|NCT00530335|4120475|B1|||Conners' Adult ADHD Rating Scale-Inv:SV-J Inattentive Subscale|Conners' Adult Attention-Deficit Hyperactivity Disorder (ADHD) Rating Scale-Investigator:Screening Version-Japanese. Inattention subscale consisted of 9 items, using a 4-point scale (0=not at all/never to 3=very much/very frequently) for total score range of 0 to 27.|units on a scale|Mean|21.5|21.5|Standard Deviation|3.0|3.0|||
4294336|NCT00530335|4120475|B1|||Conners' Adult ADHD Rating Scale-Inv:SV-J Hyperactive/Impulsive Subscale|Conners' Adult Attention-Deficit Hyperactivity Disorder (ADHD) Rating Scale-Investigator:Screening Version-Japanese. Hyperactive/Impulsive Subscale consisted of 9 items, using a 4-point scale (0=not at all/never to 3=very much/very frequently) for total score range of 0 to 27.|units on a scale|Mean|9.8|9.8|Standard Deviation|6.2|6.2|||
4294337|NCT00530335|4120475|B1|||Conners' Adult ADHD Rating Scale-Inv:SV-J ADHD Index Subscale|Conners' Adult Attention-Deficit Hyperactivity Disorder (ADHD) Rating Scale-Investigator:Screening Version-Japanese. ADHD Index Subscale consisted of 12 items, using a 4-point scale (0=not at all/never to 3=very much/very frequently) for total score range of 0 to 36.|units on a scale|Mean|22.3|22.3|Standard Deviation|5.7|5.7|||
4294338|NCT00530335|4120475|B1|||Clinical Global Impression-Attention Deficit Hyperactivity Disorder-Severity Scale|Measures severity of the patient's overall severity of attention-deficit/hyperactivity disorder (ADHD) symptoms (1=normal, not at all ill; 7=among the most extremely ill patients).|units on a scale|Mean|5.0|5.0|Standard Deviation|0.8|0.8|||
4294339|NCT00530335|4120475|B1|Japanese||Race/Ethnicity||participants|Number|45|45.0||||||
4294340|NCT00530335|4120475|B1|Japan||Region of Enrollment||participants|Number|45|45.0||||||
4294341|NCT00530335|4120475|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4294342|NCT00530335|4120475|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4294343|NCT00530335|4120475|B1|||Age||years|Mean|33.12|33.12|Standard Deviation|8.97|8.97|||
4294344|NCT00530270|4120490|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4294345|NCT00530270|4120491|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4294346|NCT00530270|4120492|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4294347|NCT00530270|4120490|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4294348|NCT00530270|4120491|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4294349|NCT00530270|4120492|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4294350|NCT00530270|4120490|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4294351|NCT00530270|4120491|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4294352|NCT00530270|4120492|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4294353|NCT00530270|4120490|B3|||Age||years|Mean|17.3|17.3|Standard Deviation|12.93|12.93|||
4294354|NCT00530270|4120491|B2|||Age||years|Mean|15.8|15.8|Standard Deviation|12.81|12.81|||
4294355|NCT00530270|4120492|B1|||Age||years|Mean|18.8|18.8|Standard Deviation|14.08|14.08|||
4294356|NCT00530270|4120490|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4294357|NCT00530270|4120491|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4294358|NCT00530270|4120492|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4294359|NCT00530270|4120490|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4294360|NCT00530270|4120491|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4294503|NCT00529633|4120664|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4294361|NCT00530270|4120492|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4294362|NCT00530270|4120490|B3||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4294363|NCT00530270|4120491|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4294364|NCT00530270|4120492|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4294365|NCT00530257|4120507|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4294366|NCT00530257|4120507|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4294367|NCT00530257|4120507|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4294368|NCT00530257|4120507|B1|||Age||years|Mean|8.5|8.5|Standard Deviation|1.9|1.9|||
4294369|NCT00530257|4120507|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4294370|NCT00530257|4120507|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4294371|NCT00530257|4120507|B1||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4294372|NCT00530218|4120535|B1|United States||Region of Enrollment||participants|Number|61|61.0||||||
4294373|NCT00530218|4120535|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4294374|NCT00530218|4120535|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4294375|NCT00530218|4120535|B1|||Age||years|Median|41|41.0|Full Range|||19.0|58.0|
4294376|NCT00530218|4120535|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4294377|NCT00530218|4120535|B1||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4294378|NCT00530218|4120535|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4294379|NCT00530088|4120542|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4294380|NCT00530088|4120542|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4294381|NCT00530088|4120542|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4294382|NCT00530088|4120542|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4294383|NCT00530088|4120542|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4294384|NCT00530088|4120542|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|10.1|10.1|||
4294385|NCT00530075|4120547|B1|Europe||Region of Enrollment||participants|Number|45|45.0||||||
4294386|NCT00530075|4120547|B1||Male|Gender||Participants|Count of Participants|29|29.0||||||
4294387|NCT00530075|4120547|B1||Female|Gender||Participants|Count of Participants|16|16.0||||||
4294388|NCT00530075|4120547|B1|||Age||Years|Median|51|51.0|Full Range|||19.0|77.0|
4294389|NCT00530023|4120558|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
4294390|NCT00530023|4120559|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4294391|NCT00530023|4120560|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4294392|NCT00530023|4120558|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4294393|NCT00530023|4120559|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4294394|NCT00530023|4120560|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4294395|NCT00530023|4120558|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4294396|NCT00530023|4120559|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4294397|NCT00530023|4120560|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4294398|NCT00530023|4120558|B3|||Age||years|Mean|47.4|47.4|Standard Deviation|13.05|13.05|||
4294399|NCT00530023|4120559|B2|||Age||years|Mean|49.7|49.7|Standard Deviation|13.51|13.51|||
4294400|NCT00530023|4120560|B1|||Age||years|Mean|45.1|45.1|Standard Deviation|12.59|12.59|||
4294401|NCT00530023|4120558|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4294402|NCT00530023|4120559|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4294403|NCT00530023|4120560|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4294404|NCT00530023|4120558|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4294405|NCT00530023|4120559|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4294406|NCT00530023|4120560|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4294407|NCT00530023|4120558|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4294408|NCT00530023|4120559|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4294409|NCT00530023|4120560|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4294410|NCT00529802|4120575|B1|High Uptake (avgSUVmax>4)||Average SUVmax|The standardized uptake value (SUV) was calculated for each FDG-PET scan. The average of the maximum SUV (SUVmax) across all lesions (aveSUVmax) on the baseline scan was used to classify patients into low- and high-uptake. Low uptake group was defined as avgSUVmax <=4, and high uptake group was defined as avgSUVmax > 4.|participants|Number|40|40.0||||||
4294411|NCT00529802|4120575|B1|Low Uptake (avgSUVmax<=4)||Average SUVmax|The standardized uptake value (SUV) was calculated for each FDG-PET scan. The average of the maximum SUV (SUVmax) across all lesions (aveSUVmax) on the baseline scan was used to classify patients into low- and high-uptake. Low uptake group was defined as avgSUVmax <=4, and high uptake group was defined as avgSUVmax > 4.|participants|Number|10|10.0||||||
4294412|NCT00529802|4120575|B1|Unclassified/Other||Tumor Type||participants|Number|6|6.0||||||
4294413|NCT00529802|4120575|B1|Chromophobe||Tumor Type||participants|Number|4|4.0||||||
4294414|NCT00529802|4120575|B1|Papillary Cell||Tumor Type||participants|Number|4|4.0||||||
4294415|NCT00529802|4120575|B1|Clear Cell||Tumor Type||participants|Number|36|36.0||||||
4294416|NCT00529802|4120575|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4294417|NCT00529802|4120575|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4294418|NCT00529802|4120575|B1|||Age||years|Median|60|60.0|Full Range|||36.0|79.0|
4294419|NCT00529789|4120581|B1|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters (kg/m^2)|Mean|23.7|23.7|Standard Deviation|6.4|6.4|||
4294420|NCT00529789|4120581|B1|Not Available||Tobacco Use|Tobacco use was based on cotinine level.|participants|Number|1|1.0||||||
4294421|NCT00529789|4120581|B1|Yes||Tobacco Use|Tobacco use was based on cotinine level.|participants|Number|1|1.0||||||
4294422|NCT00529789|4120581|B1|No||Tobacco Use|Tobacco use was based on cotinine level.|participants|Number|70|70.0||||||
4294423|NCT00529789|4120581|B1|Native American||Race/Ethnicity||participants|Number|1|1.0||||||
4294424|NCT00529789|4120581|B1|Hispanic||Race/Ethnicity||participants|Number|11|11.0||||||
4294425|NCT00529789|4120581|B1|East Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4294426|NCT00529789|4120581|B1|Caucasian||Race/Ethnicity||participants|Number|42|42.0||||||
4294427|NCT00529789|4120581|B1|African||Race/Ethnicity||participants|Number|17|17.0||||||
4294428|NCT00529789|4120581|B1|United States||Region of Enrollment||participants|Number|72|72.0||||||
4294429|NCT00529789|4120581|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4294430|NCT00529789|4120581|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4294431|NCT00529789|4120581|B1|||Age||years|Mean|12.5|12.5|Standard Deviation|2.9|2.9|||
4294432|NCT00529763|4120603|B4|Not Reported||Eastern co-operative Oncology Group Performance Status (ECOG PS)|ECOG PS, a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Death. The inclusion criteria allowed only for scores of 0 to 2.|units on a scale|Number|1|1.0||||||
4294433|NCT00529763|4120604|B3|Not Reported||Eastern co-operative Oncology Group Performance Status (ECOG PS)|ECOG PS, a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Death. The inclusion criteria allowed only for scores of 0 to 2.|units on a scale|Number|1|1.0||||||
4294434|NCT00529763|4120605|B2|Not Reported||Eastern co-operative Oncology Group Performance Status (ECOG PS)|ECOG PS, a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Death. The inclusion criteria allowed only for scores of 0 to 2.|units on a scale|Number|0|0.0||||||
4294435|NCT00529763|4120606|B1|Not Reported||Eastern co-operative Oncology Group Performance Status (ECOG PS)|ECOG PS, a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Death. The inclusion criteria allowed only for scores of 0 to 2.|units on a scale|Number|0|0.0||||||
4294436|NCT00529763|4120603|B4|ECOG PS = 2||Eastern co-operative Oncology Group Performance Status (ECOG PS)|ECOG PS, a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Death. The inclusion criteria allowed only for scores of 0 to 2.|units on a scale|Number|7|7.0||||||
4294437|NCT00529763|4120604|B3|ECOG PS = 2||Eastern co-operative Oncology Group Performance Status (ECOG PS)|ECOG PS, a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Death. The inclusion criteria allowed only for scores of 0 to 2.|units on a scale|Number|0|0.0||||||
4294438|NCT00529763|4120605|B2|ECOG PS = 2||Eastern co-operative Oncology Group Performance Status (ECOG PS)|ECOG PS, a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Death. The inclusion criteria allowed only for scores of 0 to 2.|units on a scale|Number|6|6.0||||||
4294439|NCT00529763|4120606|B1|ECOG PS = 2||Eastern co-operative Oncology Group Performance Status (ECOG PS)|ECOG PS, a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Death. The inclusion criteria allowed only for scores of 0 to 2.|units on a scale|Number|1|1.0||||||
4294440|NCT00529763|4120603|B4|ECOG PS = 1||Eastern co-operative Oncology Group Performance Status (ECOG PS)|ECOG PS, a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Death. The inclusion criteria allowed only for scores of 0 to 2.|units on a scale|Number|78|78.0||||||
4294441|NCT00529763|4120604|B3|ECOG PS = 1||Eastern co-operative Oncology Group Performance Status (ECOG PS)|ECOG PS, a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Death. The inclusion criteria allowed only for scores of 0 to 2.|units on a scale|Number|33|33.0||||||
4294442|NCT00529763|4120605|B2|ECOG PS = 1||Eastern co-operative Oncology Group Performance Status (ECOG PS)|ECOG PS, a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Death. The inclusion criteria allowed only for scores of 0 to 2.|units on a scale|Number|29|29.0||||||
4294443|NCT00529763|4120606|B1|ECOG PS = 1||Eastern co-operative Oncology Group Performance Status (ECOG PS)|ECOG PS, a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Death. The inclusion criteria allowed only for scores of 0 to 2.|units on a scale|Number|16|16.0||||||
4294444|NCT00529763|4120603|B4|ECOG PS = 0||Eastern co-operative Oncology Group Performance Status (ECOG PS)|ECOG PS, a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Death. The inclusion criteria allowed only for scores of 0 to 2.|units on a scale|Number|35|35.0||||||
4294500|NCT00529633|4120664|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294501|NCT00529633|4120665|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294445|NCT00529763|4120604|B3|ECOG PS = 0||Eastern co-operative Oncology Group Performance Status (ECOG PS)|ECOG PS, a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Death. The inclusion criteria allowed only for scores of 0 to 2.|units on a scale|Number|25|25.0||||||
4294446|NCT00529763|4120605|B2|ECOG PS = 0||Eastern co-operative Oncology Group Performance Status (ECOG PS)|ECOG PS, a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Death. The inclusion criteria allowed only for scores of 0 to 2.|units on a scale|Number|2|2.0||||||
4294447|NCT00529763|4120606|B1|ECOG PS = 0||Eastern co-operative Oncology Group Performance Status (ECOG PS)|ECOG PS, a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Death. The inclusion criteria allowed only for scores of 0 to 2.|units on a scale|Number|8|8.0||||||
4294448|NCT00529763|4120603|B4|China||Region of Enrollment||participants|Number|121|121.0||||||
4294449|NCT00529763|4120604|B3|China||Region of Enrollment||participants|Number|59|59.0||||||
4294450|NCT00529763|4120605|B2|China||Region of Enrollment||participants|Number|37|37.0||||||
4294451|NCT00529763|4120606|B1|China||Region of Enrollment||participants|Number|25|25.0||||||
4294452|NCT00529763|4120603|B4|Asian||Race/Ethnicity, Customized||participants|Number|121|121.0||||||
4294453|NCT00529763|4120604|B3|Asian||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
4294454|NCT00529763|4120605|B2|Asian||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4294455|NCT00529763|4120606|B1|Asian||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4294456|NCT00529763|4120603|B4||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4294457|NCT00529763|4120604|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4294458|NCT00529763|4120605|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4294459|NCT00529763|4120606|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4294460|NCT00529763|4120603|B4||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4294461|NCT00529763|4120604|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4294462|NCT00529763|4120605|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4294463|NCT00529763|4120606|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4294464|NCT00529763|4120603|B4|Between 66 and 75 years||Age, Customized||participants|Number|3|3.0||||||
4294465|NCT00529763|4120604|B3|Between 66 and 75 years||Age, Customized||participants|Number|1|1.0||||||
4294466|NCT00529763|4120605|B2|Between 66 and 75 years||Age, Customized||participants|Number|1|1.0||||||
4294467|NCT00529763|4120606|B1|Between 66 and 75 years||Age, Customized||participants|Number|1|1.0||||||
4294468|NCT00529763|4120603|B4|Between 46 and 65 years||Age, Customized||participants|Number|37|37.0||||||
4294469|NCT00529763|4120604|B3|Between 46 and 65 years||Age, Customized||participants|Number|23|23.0||||||
4294470|NCT00529763|4120605|B2|Between 46 and 65 years||Age, Customized||participants|Number|9|9.0||||||
4294471|NCT00529763|4120606|B1|Between 46 and 65 years||Age, Customized||participants|Number|5|5.0||||||
4294472|NCT00529763|4120603|B4|Between 21 and 45 years||Age, Customized||participants|Number|74|74.0||||||
4294473|NCT00529763|4120604|B3|Between 21 and 45 years||Age, Customized||participants|Number|33|33.0||||||
4294474|NCT00529763|4120605|B2|Between 21 and 45 years||Age, Customized||participants|Number|23|23.0||||||
4294475|NCT00529763|4120606|B1|Between 21 and 45 years||Age, Customized||participants|Number|18|18.0||||||
4294476|NCT00529763|4120603|B4|<=21 years||Age, Customized||participants|Number|7|7.0||||||
4294477|NCT00529763|4120604|B3|<=21 years||Age, Customized||participants|Number|2|2.0||||||
4294478|NCT00529763|4120605|B2|<=21 years||Age, Customized||participants|Number|4|4.0||||||
4294479|NCT00529763|4120606|B1|<=21 years||Age, Customized||participants|Number|1|1.0||||||
4294480|NCT00529763|4120603|B4|||Age||years|Mean|39.3|39.3|Standard Deviation|12.3|12.3|||
4294481|NCT00529763|4120604|B3|||Age||years|Mean|42.8|42.8|Standard Deviation|11.3|11.3|||
4294482|NCT00529763|4120605|B2|||Age||years|Mean|39.2|39.2|Standard Deviation|13.4|13.4|||
4294483|NCT00529763|4120606|B1|||Age||years|Mean|39.5|39.5|Standard Deviation|10.5|10.5|||
4294484|NCT00529659|4120644|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4294485|NCT00529659|4120645|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4294486|NCT00529659|4120646|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4294487|NCT00529659|4120644|B3||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4294488|NCT00529659|4120645|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4294489|NCT00529659|4120646|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4294490|NCT00529659|4120644|B3|||Age||years|Mean|75.9|75.9|Standard Deviation|6.9|6.9|||
4294491|NCT00529659|4120645|B2|||Age||years|Mean|76.8|76.8|Standard Deviation|7.1|7.1|||
4294492|NCT00529659|4120646|B1|||Age||years|Mean|75.0|75.0|Standard Deviation|6.7|6.7|||
4294493|NCT00529633|4120663|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4294494|NCT00529633|4120664|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4294495|NCT00529633|4120665|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4294496|NCT00529633|4120663|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294497|NCT00529633|4120664|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294498|NCT00529633|4120665|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294499|NCT00529633|4120663|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294504|NCT00529633|4120665|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4294505|NCT00529633|4120663|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4294506|NCT00529633|4120664|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4294507|NCT00529633|4120665|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294508|NCT00529633|4120663|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294509|NCT00529633|4120664|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294510|NCT00529633|4120665|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294511|NCT00529633|4120663|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294512|NCT00529633|4120664|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294513|NCT00529633|4120665|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294514|NCT00529633|4120663|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294515|NCT00529633|4120664|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294516|NCT00529633|4120665|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294517|NCT00529633|4120663|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294518|NCT00529633|4120664|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294519|NCT00529633|4120665|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294520|NCT00529633|4120663|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4294521|NCT00529633|4120664|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4294522|NCT00529633|4120665|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294523|NCT00529633|4120663|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4294524|NCT00529633|4120664|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294525|NCT00529633|4120665|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4294526|NCT00529633|4120663|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4294527|NCT00529633|4120664|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4294528|NCT00529633|4120665|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4294529|NCT00529633|4120663|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4294530|NCT00529633|4120664|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4294531|NCT00529633|4120665|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4294532|NCT00529633|4120663|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4294533|NCT00529633|4120664|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4294534|NCT00529633|4120665|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4294535|NCT00529633|4120663|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4294536|NCT00529633|4120664|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4294537|NCT00529633|4120665|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4294538|NCT00529633|4120663|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4294539|NCT00529633|4120664|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4294540|NCT00529633|4120665|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4294541|NCT00529568|4120676|B3|||Baseline Platelet Count|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. Platelet count eligibility was confirmed at the Baseline visit, prior to administration of eltrombopag, and was defined as the average of the screening and baseline counts, which must be <75 Gi/L.|Giga (10^9) cells per liter (Gi/L)|Mean|56.75|56.75|Standard Deviation|13.390|13.39|||
4294542|NCT00529568|4120677|B2|||Baseline Platelet Count|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. Platelet count eligibility was confirmed at the Baseline visit, prior to administration of eltrombopag, and was defined as the average of the screening and baseline counts, which must be <75 Gi/L.|Giga (10^9) cells per liter (Gi/L)|Mean|56.85|56.85|Standard Deviation|13.311|13.311|||
4294543|NCT00529568|4120678|B1|||Baseline Platelet Count|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. Platelet count eligibility was confirmed at the Baseline visit, prior to administration of eltrombopag, and was defined as the average of the screening and baseline counts, which must be <75 Gi/L.|Giga (10^9) cells per liter (Gi/L)|Mean|56.56|56.56|Standard Deviation|13.571|13.571|||
4294544|NCT00529568|4120676|B3|||Baseline HCV Ribonucleic Acid (RNA)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. HCV RNA was assessed at baseline of the DB Phase. Data are missing for three participants in the Eltrombopag+Antiviral Therapy treatment group.|International Units per milliliter|Mean|1687415.8|1687415.8|Standard Deviation|2907191.97|2907191.97|||
4294545|NCT00529568|4120677|B2|||Baseline HCV Ribonucleic Acid (RNA)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. HCV RNA was assessed at baseline of the DB Phase. Data are missing for three participants in the Eltrombopag+Antiviral Therapy treatment group.|International Units per milliliter|Mean|1702729.6|1702729.6|Standard Deviation|3066411.11|3066411.11|||
4294604|NCT00529568|4120676|B3|African A/African and A Indian/Alaska Native and W||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|1|1.0||||||
4294637|NCT00529555|4120731|B1|United States||Region of Enrollment||participants|Number|200|200.0||||||
4294546|NCT00529568|4120678|B1|||Baseline HCV Ribonucleic Acid (RNA)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. HCV RNA was assessed at baseline of the DB Phase. Data are missing for three participants in the Eltrombopag+Antiviral Therapy treatment group.|International Units per milliliter|Mean|1656788.0|1656788.0|Standard Deviation|2564763.45|2564763.45|||
4294547|NCT00529568|4120676|B3|Elevated||Number of participants with normal or elevated Baseline values for Alanine Aminotransferase (ALT)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The normal range of ALT is 0 to 48 International Units per Liter (IU/L).|participants|Number|597|597.0||||||
4294548|NCT00529568|4120677|B2|Elevated||Number of participants with normal or elevated Baseline values for Alanine Aminotransferase (ALT)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The normal range of ALT is 0 to 48 International Units per Liter (IU/L).|participants|Number|393|393.0||||||
4294549|NCT00529568|4120678|B1|Elevated||Number of participants with normal or elevated Baseline values for Alanine Aminotransferase (ALT)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The normal range of ALT is 0 to 48 International Units per Liter (IU/L).|participants|Number|204|204.0||||||
4294550|NCT00529568|4120676|B3|Normal||Number of participants with normal or elevated Baseline values for Alanine Aminotransferase (ALT)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The normal range of ALT is 0 to 48 International Units per Liter (IU/L).|participants|Number|162|162.0||||||
4294551|NCT00529568|4120677|B2|Normal||Number of participants with normal or elevated Baseline values for Alanine Aminotransferase (ALT)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The normal range of ALT is 0 to 48 International Units per Liter (IU/L).|participants|Number|113|113.0||||||
4294552|NCT00529568|4120678|B1|Normal||Number of participants with normal or elevated Baseline values for Alanine Aminotransferase (ALT)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The normal range of ALT is 0 to 48 International Units per Liter (IU/L).|participants|Number|49|49.0||||||
4294553|NCT00529568|4120676|B3|Missing||Number of participants with the indicated FibroTest/Acti Test (FibroSURE) score|FibroSURE is a noninvasive blood test that combines the quantitative results of 6 serum biochemical markers (α2-macroglobulin, haptoglobin, apolipoprotein A1, bilirubin, γ-glutamyl transpeptidase [GGT], and ALT) with a participant’s age and gender to generate a measure of liver fibrosis/cirrhosis and necroinflammatory activity. It provides a numerical quantitative estimate of liver fibrosis ranging from 0.00 to 1.00, corresponding to the Metavir scoring system of stages F0 to F4 (F0, no fibrosis [F]; F1, portal F; F2, bridging F with few septa; F3, bridging F with many septa; F4=cirrhosis).|participants|Number|90|90.0||||||
4294554|NCT00529568|4120677|B2|Missing||Number of participants with the indicated FibroTest/Acti Test (FibroSURE) score|FibroSURE is a noninvasive blood test that combines the quantitative results of 6 serum biochemical markers (α2-macroglobulin, haptoglobin, apolipoprotein A1, bilirubin, γ-glutamyl transpeptidase [GGT], and ALT) with a participant’s age and gender to generate a measure of liver fibrosis/cirrhosis and necroinflammatory activity. It provides a numerical quantitative estimate of liver fibrosis ranging from 0.00 to 1.00, corresponding to the Metavir scoring system of stages F0 to F4 (F0, no fibrosis [F]; F1, portal F; F2, bridging F with few septa; F3, bridging F with many septa; F4=cirrhosis).|participants|Number|55|55.0||||||
4294555|NCT00529568|4120678|B1|Missing||Number of participants with the indicated FibroTest/Acti Test (FibroSURE) score|FibroSURE is a noninvasive blood test that combines the quantitative results of 6 serum biochemical markers (α2-macroglobulin, haptoglobin, apolipoprotein A1, bilirubin, γ-glutamyl transpeptidase [GGT], and ALT) with a participant’s age and gender to generate a measure of liver fibrosis/cirrhosis and necroinflammatory activity. It provides a numerical quantitative estimate of liver fibrosis ranging from 0.00 to 1.00, corresponding to the Metavir scoring system of stages F0 to F4 (F0, no fibrosis [F]; F1, portal F; F2, bridging F with few septa; F3, bridging F with many septa; F4=cirrhosis).|participants|Number|35|35.0||||||
4294556|NCT00529568|4120676|B3|Score: F3/F4||Number of participants with the indicated FibroTest/Acti Test (FibroSURE) score|FibroSURE is a noninvasive blood test that combines the quantitative results of 6 serum biochemical markers (α2-macroglobulin, haptoglobin, apolipoprotein A1, bilirubin, γ-glutamyl transpeptidase [GGT], and ALT) with a participant’s age and gender to generate a measure of liver fibrosis/cirrhosis and necroinflammatory activity. It provides a numerical quantitative estimate of liver fibrosis ranging from 0.00 to 1.00, corresponding to the Metavir scoring system of stages F0 to F4 (F0, no fibrosis [F]; F1, portal F; F2, bridging F with few septa; F3, bridging F with many septa; F4=cirrhosis).|participants|Number|604|604.0||||||
4294557|NCT00529568|4120677|B2|Score: F3/F4||Number of participants with the indicated FibroTest/Acti Test (FibroSURE) score|FibroSURE is a noninvasive blood test that combines the quantitative results of 6 serum biochemical markers (α2-macroglobulin, haptoglobin, apolipoprotein A1, bilirubin, γ-glutamyl transpeptidase [GGT], and ALT) with a participant’s age and gender to generate a measure of liver fibrosis/cirrhosis and necroinflammatory activity. It provides a numerical quantitative estimate of liver fibrosis ranging from 0.00 to 1.00, corresponding to the Metavir scoring system of stages F0 to F4 (F0, no fibrosis [F]; F1, portal F; F2, bridging F with few septa; F3, bridging F with many septa; F4=cirrhosis).|participants|Number|405|405.0||||||
4294558|NCT00529568|4120678|B1|Score: F3/F4||Number of participants with the indicated FibroTest/Acti Test (FibroSURE) score|FibroSURE is a noninvasive blood test that combines the quantitative results of 6 serum biochemical markers (α2-macroglobulin, haptoglobin, apolipoprotein A1, bilirubin, γ-glutamyl transpeptidase [GGT], and ALT) with a participant’s age and gender to generate a measure of liver fibrosis/cirrhosis and necroinflammatory activity. It provides a numerical quantitative estimate of liver fibrosis ranging from 0.00 to 1.00, corresponding to the Metavir scoring system of stages F0 to F4 (F0, no fibrosis [F]; F1, portal F; F2, bridging F with few septa; F3, bridging F with many septa; F4=cirrhosis).|participants|Number|199|199.0||||||
4294605|NCT00529568|4120677|B2|African A/African and A Indian/Alaska Native and W||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|1|1.0||||||
4294638|NCT00529555|4120728|B4||Male|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
4294559|NCT00529568|4120676|B3|Score: F0/F1/F2||Number of participants with the indicated FibroTest/Acti Test (FibroSURE) score|FibroSURE is a noninvasive blood test that combines the quantitative results of 6 serum biochemical markers (α2-macroglobulin, haptoglobin, apolipoprotein A1, bilirubin, γ-glutamyl transpeptidase [GGT], and ALT) with a participant’s age and gender to generate a measure of liver fibrosis/cirrhosis and necroinflammatory activity. It provides a numerical quantitative estimate of liver fibrosis ranging from 0.00 to 1.00, corresponding to the Metavir scoring system of stages F0 to F4 (F0, no fibrosis [F]; F1, portal F; F2, bridging F with few septa; F3, bridging F with many septa; F4=cirrhosis).|participants|Number|65|65.0||||||
4294560|NCT00529568|4120677|B2|Score: F0/F1/F2||Number of participants with the indicated FibroTest/Acti Test (FibroSURE) score|FibroSURE is a noninvasive blood test that combines the quantitative results of 6 serum biochemical markers (α2-macroglobulin, haptoglobin, apolipoprotein A1, bilirubin, γ-glutamyl transpeptidase [GGT], and ALT) with a participant’s age and gender to generate a measure of liver fibrosis/cirrhosis and necroinflammatory activity. It provides a numerical quantitative estimate of liver fibrosis ranging from 0.00 to 1.00, corresponding to the Metavir scoring system of stages F0 to F4 (F0, no fibrosis [F]; F1, portal F; F2, bridging F with few septa; F3, bridging F with many septa; F4=cirrhosis).|participants|Number|46|46.0||||||
4294561|NCT00529568|4120678|B1|Score: F0/F1/F2||Number of participants with the indicated FibroTest/Acti Test (FibroSURE) score|FibroSURE is a noninvasive blood test that combines the quantitative results of 6 serum biochemical markers (α2-macroglobulin, haptoglobin, apolipoprotein A1, bilirubin, γ-glutamyl transpeptidase [GGT], and ALT) with a participant’s age and gender to generate a measure of liver fibrosis/cirrhosis and necroinflammatory activity. It provides a numerical quantitative estimate of liver fibrosis ranging from 0.00 to 1.00, corresponding to the Metavir scoring system of stages F0 to F4 (F0, no fibrosis [F]; F1, portal F; F2, bridging F with few septa; F3, bridging F with many septa; F4=cirrhosis).|participants|Number|19|19.0||||||
4294562|NCT00529568|4120676|B3|Experienced||Number of participants with or without previous interferon (IFN) use|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. Participants at Baseline were classified as not having used IFN previously (Naïve) or having used IFN previously (Experienced).|participants|Number|230|230.0||||||
4294563|NCT00529568|4120677|B2|Experienced||Number of participants with or without previous interferon (IFN) use|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. Participants at Baseline were classified as not having used IFN previously (Naïve) or having used IFN previously (Experienced).|participants|Number|159|159.0||||||
4294564|NCT00529568|4120678|B1|Experienced||Number of participants with or without previous interferon (IFN) use|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. Participants at Baseline were classified as not having used IFN previously (Naïve) or having used IFN previously (Experienced).|participants|Number|71|71.0||||||
4294565|NCT00529568|4120676|B3|Naïve||Number of participants with or without previous interferon (IFN) use|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. Participants at Baseline were classified as not having used IFN previously (Naïve) or having used IFN previously (Experienced).|participants|Number|529|529.0||||||
4294566|NCT00529568|4120677|B2|Naïve||Number of participants with or without previous interferon (IFN) use|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. Participants at Baseline were classified as not having used IFN previously (Naïve) or having used IFN previously (Experienced).|participants|Number|347|347.0||||||
4294567|NCT00529568|4120678|B1|Naïve||Number of participants with or without previous interferon (IFN) use|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. Participants at Baseline were classified as not having used IFN previously (Naïve) or having used IFN previously (Experienced).|participants|Number|182|182.0||||||
4294568|NCT00529568|4120676|B3|Missing||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15, with 5 being mild and 15 being severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess the severity of liver disease. A CP score of 5-6 = Class A (mild), 7-9 = Class B (moderate), and >=10 = Class C (severe).|participants|Number|2|2.0||||||
4294569|NCT00529568|4120677|B2|Missing||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15, with 5 being mild and 15 being severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess the severity of liver disease. A CP score of 5-6 = Class A (mild), 7-9 = Class B (moderate), and >=10 = Class C (severe).|participants|Number|2|2.0||||||
4294570|NCT00529568|4120678|B1|Missing||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15, with 5 being mild and 15 being severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess the severity of liver disease. A CP score of 5-6 = Class A (mild), 7-9 = Class B (moderate), and >=10 = Class C (severe).|participants|Number|0|0.0||||||
4294571|NCT00529568|4120676|B3|Class C||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15, with 5 being mild and 15 being severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess the severity of liver disease. A CP score of 5-6 = Class A (mild), 7-9 = Class B (moderate), and >=10 = Class C (severe).|participants|Number|0|0.0||||||
4294572|NCT00529568|4120677|B2|Class C||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15, with 5 being mild and 15 being severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess the severity of liver disease. A CP score of 5-6 = Class A (mild), 7-9 = Class B (moderate), and >=10 = Class C (severe).|participants|Number|0|0.0||||||
4294573|NCT00529568|4120678|B1|Class C||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15, with 5 being mild and 15 being severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess the severity of liver disease. A CP score of 5-6 = Class A (mild), 7-9 = Class B (moderate), and >=10 = Class C (severe).|participants|Number|0|0.0||||||
4294574|NCT00529568|4120676|B3|Class B||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15, with 5 being mild and 15 being severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess the severity of liver disease. A CP score of 5-6 = Class A (mild), 7-9 = Class B (moderate), and >=10 = Class C (severe).|participants|Number|28|28.0||||||
4294575|NCT00529568|4120677|B2|Class B||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15, with 5 being mild and 15 being severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess the severity of liver disease. A CP score of 5-6 = Class A (mild), 7-9 = Class B (moderate), and >=10 = Class C (severe).|participants|Number|17|17.0||||||
4294576|NCT00529568|4120678|B1|Class B||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15, with 5 being mild and 15 being severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess the severity of liver disease. A CP score of 5-6 = Class A (mild), 7-9 = Class B (moderate), and >=10 = Class C (severe).|participants|Number|11|11.0||||||
4294577|NCT00529568|4120676|B3|Class A||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15, with 5 being mild and 15 being severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess the severity of liver disease. A CP score of 5-6 = Class A (mild), 7-9 = Class B (moderate), and >=10 = Class C (severe).|participants|Number|729|729.0||||||
4294578|NCT00529568|4120677|B2|Class A||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15, with 5 being mild and 15 being severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess the severity of liver disease. A CP score of 5-6 = Class A (mild), 7-9 = Class B (moderate), and >=10 = Class C (severe).|participants|Number|487|487.0||||||
4294579|NCT00529568|4120678|B1|Class A||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15, with 5 being mild and 15 being severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess the severity of liver disease. A CP score of 5-6 = Class A (mild), 7-9 = Class B (moderate), and >=10 = Class C (severe).|participants|Number|242|242.0||||||
4294580|NCT00529568|4120676|B3|Missing||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|3|3.0||||||
4294581|NCT00529568|4120677|B2|Missing||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|2|2.0||||||
4294582|NCT00529568|4120678|B1|Missing||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|1|1.0||||||
4294583|NCT00529568|4120676|B3|Genotype 7||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|0|0.0||||||
4294584|NCT00529568|4120677|B2|Genotype 7||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|0|0.0||||||
4294585|NCT00529568|4120678|B1|Genotype 7||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|0|0.0||||||
4294586|NCT00529568|4120676|B3|Genotype 6||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|1|1.0||||||
4294587|NCT00529568|4120677|B2|Genotype 6||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|1|1.0||||||
4294588|NCT00529568|4120678|B1|Genotype 6||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|0|0.0||||||
4294606|NCT00529568|4120678|B1|African A/African and A Indian/Alaska Native and W||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|0|0.0||||||
4294589|NCT00529568|4120676|B3|Genotype 5||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|0|0.0||||||
4294590|NCT00529568|4120677|B2|Genotype 5||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|0|0.0||||||
4294591|NCT00529568|4120678|B1|Genotype 5||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|0|0.0||||||
4294592|NCT00529568|4120676|B3|Genotype 4||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|47|47.0||||||
4294593|NCT00529568|4120677|B2|Genotype 4||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|30|30.0||||||
4294594|NCT00529568|4120678|B1|Genotype 4||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|17|17.0||||||
4294595|NCT00529568|4120676|B3|Genotype 3||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|160|160.0||||||
4294596|NCT00529568|4120677|B2|Genotype 3||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|113|113.0||||||
4294597|NCT00529568|4120678|B1|Genotype 3||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|47|47.0||||||
4294598|NCT00529568|4120676|B3|Genotype 2||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|68|68.0||||||
4294599|NCT00529568|4120677|B2|Genotype 2||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|40|40.0||||||
4294600|NCT00529568|4120678|B1|Genotype 2||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|28|28.0||||||
4294601|NCT00529568|4120676|B3|Genotype 1||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|480|480.0||||||
4294602|NCT00529568|4120677|B2|Genotype 1||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|320|320.0||||||
4294603|NCT00529568|4120678|B1|Genotype 1||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|160|160.0||||||
4294635|NCT00529555|4120729|B3|United States||Region of Enrollment||participants|Number|200|200.0||||||
4294636|NCT00529555|4120730|B2|United States||Region of Enrollment||participants|Number|202|202.0||||||
4294607|NCT00529568|4120676|B3|American Indian or Alaska Native and White||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|1|1.0||||||
4294608|NCT00529568|4120677|B2|American Indian or Alaska Native and White||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|1|1.0||||||
4294609|NCT00529568|4120678|B1|American Indian or Alaska Native and White||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|0|0.0||||||
4294610|NCT00529568|4120676|B3|Japanese/East Asian /South East Asian||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|109|109.0||||||
4294611|NCT00529568|4120677|B2|Japanese/East Asian /South East Asian||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|64|64.0||||||
4294612|NCT00529568|4120678|B1|Japanese/East Asian /South East Asian||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|45|45.0||||||
4294613|NCT00529568|4120676|B3|Central/South Asian||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|59|59.0||||||
4294614|NCT00529568|4120677|B2|Central/South Asian||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|43|43.0||||||
4294615|NCT00529568|4120678|B1|Central/South Asian||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|16|16.0||||||
4294616|NCT00529568|4120676|B3|White (W)||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|576|576.0||||||
4294617|NCT00529568|4120677|B2|White (W)||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|388|388.0||||||
4294618|NCT00529568|4120678|B1|White (W)||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|188|188.0||||||
4294619|NCT00529568|4120676|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|1|1.0||||||
4294620|NCT00529568|4120677|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|1|1.0||||||
4294621|NCT00529568|4120678|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|0|0.0||||||
4294622|NCT00529568|4120676|B3|African American (A)/African||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|12|12.0||||||
4294623|NCT00529568|4120677|B2|African American (A)/African||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|8|8.0||||||
4294624|NCT00529568|4120678|B1|African American (A)/African||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|4|4.0||||||
4294625|NCT00529568|4120676|B3||Male|Sex: Female, Male|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all randomized participants in the Double-blind (DB) Phase of the study.|Participants|Count of Participants|481|481.0||||||
4294626|NCT00529568|4120677|B2||Male|Sex: Female, Male|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all randomized participants in the Double-blind (DB) Phase of the study.|Participants|Count of Participants|321|321.0||||||
4294627|NCT00529568|4120678|B1||Male|Sex: Female, Male|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all randomized participants in the Double-blind (DB) Phase of the study.|Participants|Count of Participants|160|160.0||||||
4294628|NCT00529568|4120676|B3||Female|Sex: Female, Male|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all randomized participants in the Double-blind (DB) Phase of the study.|Participants|Count of Participants|278|278.0||||||
4294629|NCT00529568|4120677|B2||Female|Sex: Female, Male|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all randomized participants in the Double-blind (DB) Phase of the study.|Participants|Count of Participants|185|185.0||||||
4294630|NCT00529568|4120678|B1||Female|Sex: Female, Male|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all randomized participants in the Double-blind (DB) Phase of the study.|Participants|Count of Participants|93|93.0||||||
4294631|NCT00529568|4120676|B3|||Age|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all randomized participants in the Double-blind (DB) Phase of the study.|Years|Mean|52.3|52.3|Standard Deviation|8.79|8.79|||
4294632|NCT00529568|4120677|B2|||Age|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all randomized participants in the Double-blind (DB) Phase of the study.|Years|Mean|52.4|52.4|Standard Deviation|8.61|8.61|||
4294633|NCT00529568|4120678|B1|||Age|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all randomized participants in the Double-blind (DB) Phase of the study.|Years|Mean|52.0|52.0|Standard Deviation|9.15|9.15|||
4294634|NCT00529555|4120728|B4|United States||Region of Enrollment||participants|Number|602|602.0||||||
4294639|NCT00529555|4120729|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4294640|NCT00529555|4120730|B2||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4294641|NCT00529555|4120731|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4294642|NCT00529555|4120728|B4||Female|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
4294643|NCT00529555|4120729|B3||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4294644|NCT00529555|4120730|B2||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4294645|NCT00529555|4120731|B1||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4294646|NCT00529555|4120728|B4|||Age||years|Mean|49.7|49.7|Standard Deviation|11.8|11.8|||
4294647|NCT00529555|4120729|B3|||Age||years|Mean|50.2|50.2|Standard Deviation|12.0|12.0|||
4294648|NCT00529555|4120730|B2|||Age||years|Mean|49.2|49.2|Standard Deviation|11.8|11.8|||
4294649|NCT00529555|4120731|B1|||Age||years|Mean|49.8|49.8|Standard Deviation|11.5|11.5|||
4294650|NCT00529555|4120728|B4||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4294651|NCT00529555|4120729|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4294652|NCT00529555|4120730|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4294653|NCT00529555|4120731|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4294654|NCT00529555|4120728|B4||Between 18 and 65 years|Age||Participants|Count of Participants|587|587.0||||||
4294655|NCT00529555|4120729|B3||Between 18 and 65 years|Age||Participants|Count of Participants|198|198.0||||||
4294656|NCT00529555|4120730|B2||Between 18 and 65 years|Age||Participants|Count of Participants|196|196.0||||||
4294657|NCT00529555|4120731|B1||Between 18 and 65 years|Age||Participants|Count of Participants|193|193.0||||||
4294658|NCT00529555|4120728|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4294659|NCT00529555|4120729|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4294660|NCT00529555|4120730|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4294661|NCT00529555|4120731|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4294662|NCT00529542|4120741|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4294663|NCT00529542|4120742|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4294664|NCT00529542|4120743|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4294665|NCT00529542|4120741|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4294666|NCT00529542|4120742|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4294667|NCT00529542|4120743|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4294668|NCT00529542|4120741|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4294669|NCT00529542|4120742|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4294670|NCT00529542|4120743|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4294671|NCT00529542|4120741|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4294672|NCT00529542|4120742|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4294673|NCT00529542|4120743|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4294674|NCT00529542|4120741|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4294675|NCT00529542|4120742|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4294676|NCT00529542|4120743|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4294677|NCT00529542|4120741|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4294678|NCT00529542|4120742|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4294679|NCT00529542|4120743|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4294680|NCT00529529|4120784|B4||Male|Sex: Female, Male||Participants|Count of Participants|315|315.0||||||
4294681|NCT00529529|4120785|B3||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4294682|NCT00529529|4120786|B2||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4294683|NCT00529529|4120787|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4294684|NCT00529529|4120784|B4||Female|Sex: Female, Male||Participants|Count of Participants|490|490.0||||||
4294685|NCT00529529|4120785|B3||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4294686|NCT00529529|4120786|B2||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4294687|NCT00529529|4120787|B1||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4294688|NCT00529529|4120784|B4|||Age||years|Mean|43.5|43.5|Standard Deviation|15.43|15.43|||
4294689|NCT00529529|4120785|B3|||Age||years|Mean|42.5|42.5|Standard Deviation|15.24|15.24|||
4294690|NCT00529529|4120786|B2|||Age||years|Mean|44.5|44.5|Standard Deviation|15.19|15.19|||
4294691|NCT00529529|4120787|B1|||Age||years|Mean|43.5|43.5|Standard Deviation|15.84|15.84|||
4294692|NCT00529516|4120845|B4||Male|Sex: Female, Male||Participants|Count of Participants|584|584.0||||||
4294693|NCT00529516|4120846|B3||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4294694|NCT00529516|4120847|B2||Male|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4294695|NCT00529516|4120848|B1||Male|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
4294696|NCT00529516|4120845|B4||Female|Sex: Female, Male||Participants|Count of Participants|668|668.0||||||
4294697|NCT00529516|4120846|B3||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4294698|NCT00529516|4120847|B2||Female|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
4294699|NCT00529516|4120848|B1||Female|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
4294700|NCT00529516|4120845|B4|||Age||Years|Mean|63.86|63.86|Standard Deviation|19.00|19.0|||
4294701|NCT00529516|4120846|B3|||Age||Years|Mean|30.9|30.9|Standard Deviation|6.64|6.64|||
4294702|NCT00529516|4120847|B2|||Age||Years|Mean|73.7|73.7|Standard Deviation|5.80|5.8|||
4294703|NCT00529516|4120848|B1|||Age||Years|Mean|73.8|73.8|Standard Deviation|5.50|5.5|||
4294704|NCT00529451|4120931|B5||Male|Sex: Female, Male||Participants|Count of Participants|731|731.0||||||
4294705|NCT00529451|4120932|B4||Male|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4294706|NCT00529451|4120933|B3||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4294707|NCT00529451|4120934|B2||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4294708|NCT00529451|4120935|B1||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4294709|NCT00529451|4120931|B5||Female|Sex: Female, Male||Participants|Count of Participants|585|585.0||||||
4294710|NCT00529451|4120932|B4||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4294711|NCT00529451|4120933|B3||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4294712|NCT00529451|4120934|B2||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4294713|NCT00529451|4120935|B1||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4294714|NCT00529451|4120931|B5|≥ 65 years||Age, Customized||Participants|Number|174|174.0||||||
4294715|NCT00529451|4120932|B4|≥ 65 years||Age, Customized||Participants|Number|34|34.0||||||
4294716|NCT00529451|4120933|B3|≥ 65 years||Age, Customized||Participants|Number|47|47.0||||||
4294717|NCT00529451|4120934|B2|≥ 65 years||Age, Customized||Participants|Number|50|50.0||||||
4294718|NCT00529451|4120935|B1|≥ 65 years||Age, Customized||Participants|Number|43|43.0||||||
4294719|NCT00529451|4120931|B5|< 65 years||Age, Customized||Participants|Number|1142|1142.0||||||
4294720|NCT00529451|4120932|B4|< 65 years||Age, Customized||Participants|Number|296|296.0||||||
4294721|NCT00529451|4120933|B3|< 65 years||Age, Customized||Participants|Number|285|285.0||||||
4294722|NCT00529451|4120934|B2|< 65 years||Age, Customized||Participants|Number|273|273.0||||||
4294723|NCT00529451|4120935|B1|< 65 years||Age, Customized||Participants|Number|288|288.0||||||
4294724|NCT00529451|4120931|B5|||Age||years|Mean|53.2|53.2|Standard Deviation|9.95|9.95|||
4294725|NCT00529451|4120932|B4|||Age||years|Mean|52.9|52.9|Standard Deviation|9.60|9.6|||
4294726|NCT00529451|4120933|B3|||Age||years|Mean|52.7|52.7|Standard Deviation|10.22|10.22|||
4294727|NCT00529451|4120934|B2|||Age||years|Mean|53.3|53.3|Standard Deviation|10.53|10.53|||
4294728|NCT00529451|4120935|B1|||Age||years|Mean|53.8|53.8|Standard Deviation|9.45|9.45|||
4294729|NCT00529399|4120962|B4||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4294730|NCT00529399|4120963|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4294731|NCT00529399|4120964|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4294732|NCT00529399|4120965|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4294733|NCT00529399|4120962|B4||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4294734|NCT00529399|4120963|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4294735|NCT00529399|4120964|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4294736|NCT00529399|4120965|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4294737|NCT00529399|4120962|B4|||Age||years|Mean|16.4|16.4|Standard Deviation|9.5|9.5|||
4294738|NCT00529399|4120963|B3|||Age||years|Mean|16.6|16.6|Standard Deviation|9.2|9.2|||
4294739|NCT00529399|4120964|B2|||Age||years|Mean|14.8|14.8|Standard Deviation|8.7|8.7|||
4294740|NCT00529399|4120965|B1|||Age||years|Mean|17.8|17.8|Standard Deviation|10.3|10.3|||
4294741|NCT00529308|4120975|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4294742|NCT00529308|4120976|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4294743|NCT00529308|4120977|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4294744|NCT00529308|4120975|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4294745|NCT00529308|4120976|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4294746|NCT00529308|4120977|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4294747|NCT00529308|4120975|B3|||Age||years|Mean|33.7|33.7|Standard Deviation|12.1|12.1|||
4294748|NCT00529308|4120976|B2|||Age||years|Mean|39.0|39.0|Standard Deviation|16.1|16.1|||
4294749|NCT00529308|4120977|B1|||Age||years|Mean|29.1|29.1|Standard Deviation|7.4|7.4|||
4294750|NCT00529282|4120992|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4294751|NCT00529282|4120993|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4294752|NCT00529282|4120992|B3|Male||Gender||participants|Number|1|1.0||||||
4294753|NCT00529282|4120993|B2|Male||Gender||participants|Number|1|1.0||||||
4294754|NCT00529282|4120992|B3|Female||Gender||participants|Number|1|1.0||||||
4294755|NCT00529282|4120993|B2|Female||Gender||participants|Number|1|1.0||||||
4294756|NCT00529282|4120992|B3|>=65 years||Age||participants|Number|0|0.0||||||
4294757|NCT00529282|4120993|B2|>=65 years||Age||participants|Number|0|0.0||||||
4294758|NCT00529282|4120992|B3|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
4294759|NCT00529282|4120993|B2|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
4294760|NCT00529282|4120992|B3|<=18 years||Age||participants|Number|0|0.0||||||
4294761|NCT00529282|4120993|B2|<=18 years||Age||participants|Number|0|0.0||||||
4294762|NCT00529243|4121007|B1|||Time on Enfuvirtide Therapy|mean length of time on enfuvirtide therapy before change to MK-0518 (raltegravir)|days|Mean|997|997.0|Full Range|||264.0|2457.0|
4294763|NCT00529243|4121007|B1|||Number of Past Antiretrovials Used||medications|Mean|15|15.0|Full Range|||4.0|22.0|
4294764|NCT00529243|4121007|B1|||Time of Prior Antiretroviral Therapy Use||years|Mean|15|15.0|Full Range|||7.0|22.0|
4294765|NCT00529243|4121007|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
4294766|NCT00529243|4121007|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4294767|NCT00529243|4121007|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4294768|NCT00529243|4121007|B1|||Age||years|Mean|53|53.0|Full Range|||40.0|71.0|
4294769|NCT00529217|4121012|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4294770|NCT00529217|4121012|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4294771|NCT00529217|4121012|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4294772|NCT00529217|4121012|B1|||Age||years|Mean|33.6|33.6|Standard Deviation|12.9|12.9|||
4294773|NCT00529217|4121012|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4294774|NCT00529217|4121012|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4294775|NCT00529217|4121012|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4294776|NCT00529204|4121017|B1|||HbA1c||%|Mean|8.1|8.1|Full Range|||||
4294777|NCT00529204|4121017|B1|||Weight||kg|Mean|72.3|72.3|Full Range|||||
4294778|NCT00529204|4121017|B1|||hsCRP||mg/L|Mean|8.2|8.2|Full Range|||||
4294779|NCT00529204|4121017|B1|||Triglyceride||mg/dL|Mean|482|482.0|Full Range|||||
4294780|NCT00529204|4121017|B1|||HDL||mg/dL|Mean|31|31.0|Full Range|||||
4294781|NCT00529204|4121017|B1|||Cholesterol||mg/dL|Mean|317|317.0|Full Range|||||
4294782|NCT00529204|4121017|B1|||Glucose||mg/dL|Mean|139|139.0|Full Range|||||
4294783|NCT00529204|4121017|B1|||Alanine aminotransferase||IU|Mean|84|84.0|Full Range|||||
4294784|NCT00529204|4121017|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4294785|NCT00529204|4121017|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4294786|NCT00529204|4121017|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4294787|NCT00529204|4121017|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4294788|NCT00529204|4121017|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4294789|NCT00529191|4121023|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4294790|NCT00529191|4121024|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4294791|NCT00529191|4121025|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4294792|NCT00529191|4121023|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4294793|NCT00529191|4121024|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4294794|NCT00529191|4121025|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4294795|NCT00529191|4121023|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4294796|NCT00529191|4121024|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4294797|NCT00529191|4121025|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4294798|NCT00529191|4121023|B3|||Age||years|Mean|13.33|13.33|Standard Deviation|2.055|2.055|||
4294799|NCT00529191|4121024|B2|||Age||years|Mean|13.30|13.3|Standard Deviation|2.03|2.03|||
4294800|NCT00529191|4121025|B1|||Age||years|Mean|13.38|13.38|Standard Deviation|1.96|1.96|||
4294801|NCT00529191|4121023|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4294802|NCT00529191|4121024|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4294803|NCT00529191|4121025|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4294804|NCT00529191|4121023|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4294805|NCT00529191|4121024|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4294806|NCT00529191|4121025|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4294807|NCT00529191|4121023|B3||<=18 years|Age||Participants|Count of Participants|38|38.0||||||
4294808|NCT00529191|4121024|B2||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4294809|NCT00529191|4121025|B1||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
4294810|NCT00529152|4121048|B1|||serum ferritin|serum ferritin measures the amount of iron in the blood|ug/L|Mean|2531.7|2531.7|Standard Deviation|1463.0|1463.0|||
4294811|NCT00529152|4121048|B1|Indonesia||Region of Enrollment||participants|Number|13|13.0||||||
4294812|NCT00529152|4121048|B1|Malaysia||Region of Enrollment||participants|Number|11|11.0||||||
4294813|NCT00529152|4121048|B1|Egypt||Region of Enrollment||participants|Number|76|76.0||||||
4294814|NCT00529152|4121048|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4294815|NCT00529152|4121048|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4294816|NCT00529152|4121048|B1|||Age||years|Mean|5.1|5.1|Standard Deviation|2.4|2.4|||
4294817|NCT00529126|4121052|B5|Georgia||Region of Enrollment||participants|Number|63|63.0||||||
4294818|NCT00529126|4121053|B4|Georgia||Region of Enrollment||participants|Number|12|12.0||||||
4294819|NCT00529126|4121054|B3|Georgia||Region of Enrollment||participants|Number|15|15.0||||||
4294820|NCT00529126|4121055|B2|Georgia||Region of Enrollment||participants|Number|16|16.0||||||
4294821|NCT00529126|4121056|B1|Georgia||Region of Enrollment||participants|Number|20|20.0||||||
4294822|NCT00529126|4121052|B5|United States||Region of Enrollment||participants|Number|37|37.0||||||
4294823|NCT00529126|4121053|B4|United States||Region of Enrollment||participants|Number|14|14.0||||||
4294824|NCT00529126|4121054|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4294825|NCT00529126|4121055|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4294826|NCT00529126|4121056|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4294827|NCT00529126|4121052|B5||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4294828|NCT00529126|4121053|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4294829|NCT00529126|4121054|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4294830|NCT00529126|4121055|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4294831|NCT00529126|4121056|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4294832|NCT00529126|4121052|B5||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4294833|NCT00529126|4121053|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4294834|NCT00529126|4121054|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4294835|NCT00529126|4121055|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4294836|NCT00529126|4121056|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4294837|NCT00529126|4121052|B5|||Age||years|Mean|43.4|43.4|Standard Deviation|11.1|11.1|||
4294838|NCT00529126|4121053|B4|||Age||years|Mean|44.2|44.2|Standard Deviation|10.6|10.6|||
4294839|NCT00529126|4121054|B3|||Age||years|Mean|42.2|42.2|Standard Deviation|11.5|11.5|||
4294840|NCT00529126|4121055|B2|||Age||years|Mean|41.7|41.7|Standard Deviation|11.2|11.2|||
4294841|NCT00529126|4121056|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|11.3|11.3|||
4294842|NCT00529126|4121052|B5||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4294843|NCT00529126|4121053|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4294844|NCT00529126|4121054|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4294845|NCT00529126|4121055|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4294846|NCT00529126|4121056|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4294847|NCT00529126|4121052|B5||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
4294848|NCT00529126|4121053|B4||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4294849|NCT00529126|4121054|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4294850|NCT00529126|4121055|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4294851|NCT00529126|4121056|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4294852|NCT00529126|4121052|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4294853|NCT00529126|4121053|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4294854|NCT00529126|4121054|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4294855|NCT00529126|4121055|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4294856|NCT00529126|4121056|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4294857|NCT00529100|4121069|B4|Canada||Region of Enrollment||participants|Number|49|49.0||||||
4294858|NCT00529100|4121070|B3|Canada||Region of Enrollment||participants|Number|33|33.0||||||
4294859|NCT00529100|4121071|B2|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4294860|NCT00529100|4121072|B1|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4294861|NCT00529100|4121069|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294862|NCT00529100|4121070|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294863|NCT00529100|4121071|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294864|NCT00529100|4121072|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294865|NCT00529100|4121069|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294866|NCT00529100|4121070|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294867|NCT00529100|4121071|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294868|NCT00529100|4121072|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294869|NCT00529100|4121069|B4||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4294870|NCT00529100|4121070|B3||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4294871|NCT00529100|4121071|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4294872|NCT00529100|4121072|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4294873|NCT00529100|4121069|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4294874|NCT00529100|4121070|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4294875|NCT00529100|4121071|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294876|NCT00529100|4121072|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294877|NCT00529100|4121069|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294878|NCT00529100|4121070|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294879|NCT00529100|4121071|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294880|NCT00529100|4121072|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294881|NCT00529100|4121069|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4294882|NCT00529100|4121070|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4294883|NCT00529100|4121071|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4294884|NCT00529100|4121072|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4294885|NCT00529100|4121069|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294886|NCT00529100|4121070|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294887|NCT00529100|4121071|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294929|NCT00529035|4121156|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4294888|NCT00529100|4121072|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294889|NCT00529100|4121069|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4294890|NCT00529100|4121070|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4294891|NCT00529100|4121071|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294892|NCT00529100|4121072|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294893|NCT00529100|4121069|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4294894|NCT00529100|4121070|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4294895|NCT00529100|4121071|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4294896|NCT00529100|4121072|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4294897|NCT00529100|4121069|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294898|NCT00529100|4121070|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294899|NCT00529100|4121071|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294900|NCT00529100|4121072|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4294901|NCT00529100|4121069|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4294902|NCT00529100|4121070|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4294903|NCT00529100|4121071|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4294904|NCT00529100|4121072|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4294905|NCT00529100|4121069|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4294906|NCT00529100|4121070|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4294907|NCT00529100|4121071|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4294908|NCT00529100|4121072|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4294909|NCT00529100|4121069|B4|||Age||years|Mean|61.4|61.4|Standard Deviation|9.7|9.7|||
4294910|NCT00529100|4121070|B3|||Age||years|Mean|61.2|61.2|Standard Deviation|10.5|10.5|||
4294911|NCT00529100|4121071|B2|||Age||years|Mean|64.3|64.3|Standard Deviation|8.1|8.1|||
4294912|NCT00529100|4121072|B1|||Age||years|Mean|60.3|60.3|Standard Deviation|8.0|8.0|||
4294913|NCT00529087|4121087|B4||Male|Sex: Female, Male|This baseline measure captures the double-blind population demographics in the arms MOA-728 QD, MOA-728 QOD and Placebo. It also captures the baseline demographics for the open-label portion of the study|Participants|Count of Participants|183|183.0||||||
4294914|NCT00529087|4121088|B3||Male|Sex: Female, Male|This baseline measure captures the double-blind population demographics in the arms MOA-728 QD, MOA-728 QOD and Placebo. It also captures the baseline demographics for the open-label portion of the study|Participants|Count of Participants|63|63.0||||||
4294915|NCT00529087|4121089|B2||Male|Sex: Female, Male|This baseline measure captures the double-blind population demographics in the arms MOA-728 QD, MOA-728 QOD and Placebo. It also captures the baseline demographics for the open-label portion of the study|Participants|Count of Participants|63|63.0||||||
4294916|NCT00529087|4121090|B1||Male|Sex: Female, Male|This baseline measure captures the double-blind population demographics in the arms MOA-728 QD, MOA-728 QOD and Placebo. It also captures the baseline demographics for the open-label portion of the study|Participants|Count of Participants|57|57.0||||||
4294917|NCT00529087|4121087|B4||Female|Sex: Female, Male|This baseline measure captures the double-blind population demographics in the arms MOA-728 QD, MOA-728 QOD and Placebo. It also captures the baseline demographics for the open-label portion of the study|Participants|Count of Participants|277|277.0||||||
4294918|NCT00529087|4121088|B3||Female|Sex: Female, Male|This baseline measure captures the double-blind population demographics in the arms MOA-728 QD, MOA-728 QOD and Placebo. It also captures the baseline demographics for the open-label portion of the study|Participants|Count of Participants|99|99.0||||||
4294919|NCT00529087|4121089|B2||Female|Sex: Female, Male|This baseline measure captures the double-blind population demographics in the arms MOA-728 QD, MOA-728 QOD and Placebo. It also captures the baseline demographics for the open-label portion of the study|Participants|Count of Participants|85|85.0||||||
4294920|NCT00529087|4121090|B1||Female|Sex: Female, Male|This baseline measure captures the double-blind population demographics in the arms MOA-728 QD, MOA-728 QOD and Placebo. It also captures the baseline demographics for the open-label portion of the study|Participants|Count of Participants|93|93.0||||||
4294921|NCT00529087|4121087|B4|||Age|This baseline measure captures the double-blind population demographics in the arms MOA-728 QD, MOA-728 QOD and Placebo. It also captures the baseline demographics for the open-label portion of the study.|years|Mean|48.79|48.79|Standard Deviation|10.85|10.85|||
4294922|NCT00529087|4121088|B3|||Age|This baseline measure captures the double-blind population demographics in the arms MOA-728 QD, MOA-728 QOD and Placebo. It also captures the baseline demographics for the open-label portion of the study.|years|Mean|49.69|49.69|Standard Deviation|10.77|10.77|||
4294923|NCT00529087|4121089|B2|||Age|This baseline measure captures the double-blind population demographics in the arms MOA-728 QD, MOA-728 QOD and Placebo. It also captures the baseline demographics for the open-label portion of the study.|years|Mean|48.64|48.64|Standard Deviation|11.05|11.05|||
4294924|NCT00529087|4121090|B1|||Age|This baseline measure captures the double-blind population demographics in the arms MOA-728 QD, MOA-728 QOD and Placebo. It also captures the baseline demographics for the open-label portion of the study.|years|Mean|47.99|47.99|Standard Deviation|10.74|10.74|||
4294925|NCT00529035|4121156|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4294926|NCT00529035|4121156|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4294927|NCT00529035|4121156|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4294928|NCT00529035|4121156|B1|||Age||years|Mean|46.5|46.5|Standard Deviation|12.7|12.7|||
4294930|NCT00529035|4121156|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4294931|NCT00529035|4121156|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4294932|NCT00528957|4121167|B3|||CD4 Percentage||percentage|Mean|33.5|33.5|Standard Deviation|7.11|7.11|||
4294933|NCT00528957|4121168|B2|||CD4 Percentage||percentage|Mean|33.0|33.0|Standard Deviation|6.82|6.82|||
4294934|NCT00528957|4121169|B1|||CD4 Percentage||percentage|Mean|33.9|33.9|Standard Deviation|7.44|7.44|||
4294935|NCT00528957|4121167|B3|||CD4 Cell Count||cells/mm^3|Mean|1167|1167.0|Standard Deviation|468.6|468.6|||
4294936|NCT00528957|4121168|B2|||CD4 Cell Count||cells/mm^3|Mean|1144|1144.0|Standard Deviation|388.4|388.4|||
4294937|NCT00528957|4121169|B1|||CD4 Cell Count||cells/mm^3|Mean|1190|1190.0|Standard Deviation|541.7|541.7|||
4294938|NCT00528957|4121167|B3||≥ 1000 copies/mL|Plasma HIV-1 RNA||Participants|Count of Participants|1|1.0||||||
4294939|NCT00528957|4121168|B2||≥ 1000 copies/mL|Plasma HIV-1 RNA||Participants|Count of Participants|1|1.0||||||
4294940|NCT00528957|4121169|B1||≥ 1000 copies/mL|Plasma HIV-1 RNA||Participants|Count of Participants|0|0.0||||||
4294941|NCT00528957|4121167|B3||400 to < 1000 copies/mL|Plasma HIV-1 RNA||Participants|Count of Participants|2|2.0||||||
4294942|NCT00528957|4121168|B2||400 to < 1000 copies/mL|Plasma HIV-1 RNA||Participants|Count of Participants|1|1.0||||||
4294943|NCT00528957|4121169|B1||400 to < 1000 copies/mL|Plasma HIV-1 RNA||Participants|Count of Participants|1|1.0||||||
4294944|NCT00528957|4121167|B3||50 to < 400 copies/mL|Plasma HIV-1 RNA||Participants|Count of Participants|17|17.0||||||
4294945|NCT00528957|4121168|B2||50 to < 400 copies/mL|Plasma HIV-1 RNA||Participants|Count of Participants|6|6.0||||||
4294946|NCT00528957|4121169|B1||50 to < 400 copies/mL|Plasma HIV-1 RNA||Participants|Count of Participants|11|11.0||||||
4294947|NCT00528957|4121167|B3||< 50 copies/mL|Plasma HIV-1 RNA||Participants|Count of Participants|77|77.0||||||
4294948|NCT00528957|4121168|B2||< 50 copies/mL|Plasma HIV-1 RNA||Participants|Count of Participants|41|41.0||||||
4294949|NCT00528957|4121169|B1||< 50 copies/mL|Plasma HIV-1 RNA||Participants|Count of Participants|36|36.0||||||
4294950|NCT00528957|4121167|B3|||Weight||kilograms|Mean|25.0|25.0|Standard Deviation|10.09|10.09|||
4294951|NCT00528957|4121168|B2|||Weight||kilograms|Mean|24.1|24.1|Standard Deviation|7.77|7.77|||
4294952|NCT00528957|4121169|B1|||Weight||kilograms|Mean|25.9|25.9|Standard Deviation|12.03|12.03|||
4294953|NCT00528957|4121167|B3|||Body Mass Index||kg/m^2|Mean|17.08|17.08|Standard Deviation|2.905|2.905|||
4294954|NCT00528957|4121168|B2|||Body Mass Index||kg/m^2|Mean|16.59|16.59|Standard Deviation|1.762|1.762|||
4294955|NCT00528957|4121169|B1|||Body Mass Index||kg/m^2|Mean|17.59|17.59|Standard Deviation|3.680|3.68|||
4294956|NCT00528957|4121167|B3|||Height||cm|Mean|119|119.0|Standard Deviation|18.2|18.2|||
4294957|NCT00528957|4121168|B2|||Height||cm|Mean|119|119.0|Standard Deviation|16.7|16.7|||
4294958|NCT00528957|4121169|B1|||Height||cm|Mean|118|118.0|Standard Deviation|19.8|19.8|||
4294959|NCT00528957|4121167|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4294960|NCT00528957|4121168|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4294961|NCT00528957|4121169|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4294962|NCT00528957|4121167|B3|Panama||Region of Enrollment||Participants|Count of Participants|72|72.0||||||
4294963|NCT00528957|4121168|B2|Panama||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
4294964|NCT00528957|4121169|B1|Panama||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
4294965|NCT00528957|4121167|B3|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4294966|NCT00528957|4121168|B2|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4294967|NCT00528957|4121169|B1|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4294968|NCT00528957|4121167|B3||Native Indian (Kuna)|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4294969|NCT00528957|4121168|B2||Native Indian (Kuna)|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4294970|NCT00528957|4121169|B1||Native Indian (Kuna)|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4294971|NCT00528957|4121167|B3||Mestizo|Race/Ethnicity, Customized||Participants|Count of Participants|65|65.0||||||
4294972|NCT00528957|4121168|B2||Mestizo|Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
4294973|NCT00528957|4121169|B1||Mestizo|Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
4294974|NCT00528957|4121167|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4294975|NCT00528957|4121168|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4294976|NCT00528957|4121169|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4294977|NCT00528957|4121167|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
4294978|NCT00528957|4121168|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4294979|NCT00528957|4121169|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4294980|NCT00528957|4121167|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4294981|NCT00528957|4121168|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4294982|NCT00528957|4121169|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4294983|NCT00528957|4121167|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4294984|NCT00528957|4121168|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4294985|NCT00528957|4121169|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4294986|NCT00528957|4121167|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4294987|NCT00528957|4121168|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4294988|NCT00528957|4121169|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4294989|NCT00528957|4121167|B3||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
4294990|NCT00528957|4121168|B2||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4294991|NCT00528957|4121169|B1||Not Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4294992|NCT00528957|4121167|B3||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|77|77.0||||||
4294993|NCT00528957|4121168|B2||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
4294994|NCT00528957|4121169|B1||Hispanic or Latino|Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
4294995|NCT00528957|4121167|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4294996|NCT00528957|4121168|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4294997|NCT00528957|4121169|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4294998|NCT00528957|4121167|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4294999|NCT00528957|4121168|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4295000|NCT00528957|4121169|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4295001|NCT00528957|4121167|B3|||Age||years|Mean|7|7.0|Standard Deviation|3.0|3.0|||
4295002|NCT00528957|4121168|B2|||Age||years|Mean|7|7.0|Standard Deviation|2.6|2.6|||
4295003|NCT00528957|4121169|B1|||Age||years|Mean|7|7.0|Standard Deviation|3.3|3.3|||
4295004|NCT00528931|4121311|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4295005|NCT00528931|4121311|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4295006|NCT00528931|4121311|B1|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4295007|NCT00528931|4121311|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4295008|NCT00528931|4121311|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4295009|NCT00528931|4121311|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4295010|NCT00528931|4121311|B1|||Age||years|Mean|60.6|60.6|Standard Deviation|11.74|11.74|||
4295011|NCT00528931|4121311|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4295012|NCT00528931|4121311|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4295013|NCT00528931|4121311|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4295014|NCT00528879|4121319|B5|≥30 kg/m^2||Body Mass Index||Participants|Number|312|312.0||||||
4295015|NCT00528879|4121320|B4|≥30 kg/m^2||Body Mass Index||Participants|Number|75|75.0||||||
4295016|NCT00528879|4121321|B3|≥30 kg/m^2||Body Mass Index||Participants|Number|81|81.0||||||
4295017|NCT00528879|4121322|B2|≥30 kg/m^2||Body Mass Index||Participants|Number|77|77.0||||||
4295018|NCT00528879|4121323|B1|≥30 kg/m^2||Body Mass Index||Participants|Number|79|79.0||||||
4295019|NCT00528879|4121319|B5|≥27 kg/m^2||Body Mass Index||Participants|Number|452|452.0||||||
4295020|NCT00528879|4121320|B4|≥27 kg/m^2||Body Mass Index||Participants|Number|106|106.0||||||
4295021|NCT00528879|4121321|B3|≥27 kg/m^2||Body Mass Index||Participants|Number|111|111.0||||||
4295022|NCT00528879|4121322|B2|≥27 kg/m^2||Body Mass Index||Participants|Number|120|120.0||||||
4295023|NCT00528879|4121323|B1|≥27 kg/m^2||Body Mass Index||Participants|Number|115|115.0||||||
4295024|NCT00528879|4121319|B5|≥25 kg/m^2||Body Mass Index||Participants|Number|509|509.0||||||
4295025|NCT00528879|4121320|B4|≥25 kg/m^2||Body Mass Index||Participants|Number|123|123.0||||||
4295026|NCT00528879|4121321|B3|≥25 kg/m^2||Body Mass Index||Participants|Number|125|125.0||||||
4295027|NCT00528879|4121322|B2|≥25 kg/m^2||Body Mass Index||Participants|Number|133|133.0||||||
4295028|NCT00528879|4121323|B1|≥25 kg/m^2||Body Mass Index||Participants|Number|128|128.0||||||
4295029|NCT00528879|4121319|B5|<25 kg/m^2||Body Mass Index||Participants|Number|37|37.0||||||
4295030|NCT00528879|4121320|B4|<25 kg/m^2||Body Mass Index||Participants|Number|12|12.0||||||
4295031|NCT00528879|4121321|B3|<25 kg/m^2||Body Mass Index||Participants|Number|12|12.0||||||
4295032|NCT00528879|4121322|B2|<25 kg/m^2||Body Mass Index||Participants|Number|4|4.0||||||
4295033|NCT00528879|4121323|B1|<25 kg/m^2||Body Mass Index||Participants|Number|9|9.0||||||
4295034|NCT00528879|4121319|B5|Older than 50 years||Female Age||Participants|Number|167|167.0||||||
4295035|NCT00528879|4121320|B4|Older than 50 years||Female Age||Participants|Number|36|36.0||||||
4295036|NCT00528879|4121321|B3|Older than 50 years||Female Age||Participants|Number|46|46.0||||||
4295037|NCT00528879|4121322|B2|Older than 50 years||Female Age||Participants|Number|49|49.0||||||
4295038|NCT00528879|4121323|B1|Older than 50 years||Female Age||Participants|Number|36|36.0||||||
4295039|NCT00528879|4121319|B5|50 Years and younger||Female Age||Participants|Number|87|87.0||||||
4295040|NCT00528879|4121320|B4|50 Years and younger||Female Age||Participants|Number|22|22.0||||||
4295041|NCT00528879|4121321|B3|50 Years and younger||Female Age||Participants|Number|22|22.0||||||
4295042|NCT00528879|4121322|B2|50 Years and younger||Female Age||Participants|Number|18|18.0||||||
4295043|NCT00528879|4121323|B1|50 Years and younger||Female Age||Participants|Number|25|25.0||||||
4295044|NCT00528879|4121319|B5|Other||Race/Ethnicity, Customized||Participants|Number|28|28.0||||||
4295045|NCT00528879|4121320|B4|Other||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4295046|NCT00528879|4121321|B3|Other||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4295047|NCT00528879|4121322|B2|Other||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4295048|NCT00528879|4121323|B1|Other||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4295049|NCT00528879|4121319|B5|American Indian/Alaskan Native||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4295050|NCT00528879|4121320|B4|American Indian/Alaskan Native||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4295051|NCT00528879|4121321|B3|American Indian/Alaskan Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4295052|NCT00528879|4121322|B2|American Indian/Alaskan Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4295053|NCT00528879|4121323|B1|American Indian/Alaskan Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4295054|NCT00528879|4121319|B5|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4295055|NCT00528879|4121320|B4|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4295056|NCT00528879|4121321|B3|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4295057|NCT00528879|4121322|B2|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4295058|NCT00528879|4121323|B1|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4295059|NCT00528879|4121319|B5|Asian||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4295060|NCT00528879|4121320|B4|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4295061|NCT00528879|4121321|B3|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4295062|NCT00528879|4121322|B2|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4295063|NCT00528879|4121323|B1|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4295064|NCT00528879|4121319|B5|Black/African American||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4295065|NCT00528879|4121320|B4|Black/African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4295066|NCT00528879|4121321|B3|Black/African American||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4295067|NCT00528879|4121322|B2|Black/African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4295068|NCT00528879|4121323|B1|Black/African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4295069|NCT00528879|4121319|B5|White||Race/Ethnicity, Customized||Participants|Number|480|480.0||||||
4295070|NCT00528879|4121320|B4|White||Race/Ethnicity, Customized||Participants|Number|121|121.0||||||
4295071|NCT00528879|4121321|B3|White||Race/Ethnicity, Customized||Participants|Number|118|118.0||||||
4295072|NCT00528879|4121322|B2|White||Race/Ethnicity, Customized||Participants|Number|117|117.0||||||
4295073|NCT00528879|4121323|B1|White||Race/Ethnicity, Customized||Participants|Number|124|124.0||||||
4295074|NCT00528879|4121319|B5||Male|Sex: Female, Male||Participants|Count of Participants|292|292.0||||||
4295075|NCT00528879|4121320|B4||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4295076|NCT00528879|4121321|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4295077|NCT00528879|4121322|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4295078|NCT00528879|4121323|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4295079|NCT00528879|4121319|B5||Female|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
4295080|NCT00528879|4121320|B4||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4295081|NCT00528879|4121321|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4295082|NCT00528879|4121322|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4295083|NCT00528879|4121323|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4295084|NCT00528879|4121319|B5|75 years and older||Age, Customized||Participants|Number|4|4.0||||||
4295085|NCT00528879|4121320|B4|75 years and older||Age, Customized||Participants|Number|1|1.0||||||
4295086|NCT00528879|4121321|B3|75 years and older||Age, Customized||Participants|Number|1|1.0||||||
4295087|NCT00528879|4121322|B2|75 years and older||Age, Customized||Participants|Number|2|2.0||||||
4295088|NCT00528879|4121323|B1|75 years and older||Age, Customized||Participants|Number|0|0.0||||||
4295089|NCT00528879|4121319|B5|65 to younger than 75 years||Age, Customized||Participants|Number|75|75.0||||||
4295090|NCT00528879|4121320|B4|65 to younger than 75 years||Age, Customized||Participants|Number|16|16.0||||||
4295091|NCT00528879|4121321|B3|65 to younger than 75 years||Age, Customized||Participants|Number|17|17.0||||||
4295092|NCT00528879|4121322|B2|65 to younger than 75 years||Age, Customized||Participants|Number|19|19.0||||||
4295093|NCT00528879|4121323|B1|65 to younger than 75 years||Age, Customized||Participants|Number|23|23.0||||||
4295094|NCT00528879|4121319|B5|Younger than 65 years||Age, Customized||Participants|Number|467|467.0||||||
4295095|NCT00528879|4121320|B4|Younger than 65 years||Age, Customized||Participants|Number|118|118.0||||||
4295096|NCT00528879|4121321|B3|Younger than 65 years||Age, Customized||Participants|Number|119|119.0||||||
4295097|NCT00528879|4121322|B2|Younger than 65 years||Age, Customized||Participants|Number|116|116.0||||||
4295098|NCT00528879|4121323|B1|Younger than 65 years||Age, Customized||Participants|Number|114|114.0||||||
4295099|NCT00528879|4121319|B5|||Age||Years|Mean|53.9|53.9|Full Range|||29.0|76.0|
4295100|NCT00528879|4121320|B4|||Age||Years|Mean|52.7|52.7|Full Range|||29.0|76.0|
4295101|NCT00528879|4121321|B3|||Age||Years|Mean|54.3|54.3|Full Range|||33.0|75.0|
4295102|NCT00528879|4121322|B2|||Age||Years|Mean|55.0|55.0|Full Range|||30.0|76.0|
4295103|NCT00528879|4121323|B1|||Age||Years|Mean|53.7|53.7|Full Range|||30.0|74.0|
4295104|NCT00528866|4121392|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4295105|NCT00528866|4121392|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4295106|NCT00528866|4121392|B1|||Age||years|Median|62|62.0|Full Range|||43.0|75.0|
4295107|NCT00528840|4121404|B1|United States||Region of Enrollment||participants|Number|201|201.0||||||
4295108|NCT00528840|4121404|B1|White||Race/Ethnicity, Customized||participants|Number|201|201.0||||||
4295109|NCT00528840|4121404|B1||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4295110|NCT00528840|4121404|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4295111|NCT00528840|4121404|B1|||Age||years|Mean|64.7|64.7|Standard Deviation|9.86|9.86|||
4295112|NCT00528840|4121404|B1||>=65 years|Age||Participants|Count of Participants|106|106.0||||||
4295113|NCT00528840|4121404|B1||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
4295114|NCT00528840|4121404|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4295115|NCT00528801|4121416|B3|United States||Region of Enrollment||participants|Number|212|212.0||||||
4295116|NCT00528801|4121417|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
4295117|NCT00528801|4121418|B1|United States||Region of Enrollment||participants|Number|160|160.0||||||
4295118|NCT00528801|4121416|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4295119|NCT00528801|4121417|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4295120|NCT00528801|4121418|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4295121|NCT00528801|4121416|B3||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4295122|NCT00528801|4121417|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4295123|NCT00528801|4121418|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4295124|NCT00528801|4121416|B3|||Age||years|Mean|31.94|31.94|Standard Deviation|9.24|9.24|||
4295125|NCT00528801|4121417|B2|||Age||years|Mean|33.10|33.1|Standard Deviation|10.06|10.06|||
4295126|NCT00528801|4121418|B1|||Age||years|Mean|31.57|31.57|Standard Deviation|8.95|8.95|||
4295127|NCT00528801|4121416|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4295128|NCT00528801|4121417|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4295129|NCT00528801|4121418|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4295130|NCT00528801|4121416|B3||Between 18 and 65 years|Age||Participants|Count of Participants|212|212.0||||||
4295131|NCT00528801|4121417|B2||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4295132|NCT00528801|4121418|B1||Between 18 and 65 years|Age||Participants|Count of Participants|160|160.0||||||
4295133|NCT00528801|4121416|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4295134|NCT00528801|4121417|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4295135|NCT00528801|4121418|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4295136|NCT00528788|4121429|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4295137|NCT00528788|4121429|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4295138|NCT00528788|4121429|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4295139|NCT00528788|4121429|B1|||Age||years|Mean|50.4|50.4|Standard Deviation|12.2|12.2|||
4295140|NCT00528788|4121429|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4295141|NCT00528788|4121429|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4295142|NCT00528788|4121429|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4295143|NCT00528775|4121433|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4295144|NCT00528775|4121433|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4295145|NCT00528775|4121433|B1|||Age||years|Mean|64|64.0|Standard Deviation|12.52|12.52|||
4295146|NCT00528645|4121441|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4295147|NCT00528645|4121441|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4295148|NCT00528645|4121441|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4295149|NCT00528645|4121441|B1|||Age||years|Median|58|58.0|Full Range|||48.0|82.0|
4295150|NCT00528606|4121448|B3|United States||Region of Enrollment||participants|Number|308|308.0||||||
4295151|NCT00528606|4121449|B2|United States||Region of Enrollment||participants|Number|104|104.0||||||
4295152|NCT00528606|4121450|B1|United States||Region of Enrollment||participants|Number|204|204.0||||||
4295153|NCT00528606|4121448|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4295154|NCT00528606|4121449|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4295155|NCT00528606|4121450|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4295156|NCT00528606|4121448|B3|White||Race/Ethnicity, Customized||participants|Number|307|307.0||||||
4295157|NCT00528606|4121449|B2|White||Race/Ethnicity, Customized||participants|Number|104|104.0||||||
4295158|NCT00528606|4121450|B1|White||Race/Ethnicity, Customized||participants|Number|203|203.0||||||
4295159|NCT00528606|4121448|B3||Male|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4295160|NCT00528606|4121449|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4295161|NCT00528606|4121450|B1||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4295162|NCT00528606|4121448|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4295163|NCT00528606|4121449|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4295164|NCT00528606|4121450|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4295165|NCT00528606|4121448|B3|||Age||years|Mean|62.7|62.7|Standard Deviation|9.5|9.5|||
4295166|NCT00528606|4121449|B2|||Age||years|Mean|63.3|63.3|Standard Deviation|9.1|9.1|||
4295167|NCT00528606|4121450|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|9.7|9.7|||
4295168|NCT00528606|4121448|B3||>=65 years|Age||Participants|Count of Participants|131|131.0||||||
4295169|NCT00528606|4121449|B2||>=65 years|Age||Participants|Count of Participants|47|47.0||||||
4295170|NCT00528606|4121450|B1||>=65 years|Age||Participants|Count of Participants|84|84.0||||||
4295171|NCT00528606|4121448|B3||Between 18 and 65 years|Age||Participants|Count of Participants|177|177.0||||||
4295172|NCT00528606|4121449|B2||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4295173|NCT00528606|4121450|B1||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
4295174|NCT00528606|4121448|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4295175|NCT00528606|4121449|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4295176|NCT00528606|4121450|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4295177|NCT00528580|4121473|B3|United States||Region of Enrollment||Participants|Count of Participants|68|68.0||||||
4295178|NCT00528580|4121474|B2|United States||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
4295179|NCT00528580|4121475|B1|United States||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
4295180|NCT00528580|4121473|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4295181|NCT00528580|4121474|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4295182|NCT00528580|4121475|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4295183|NCT00528580|4121473|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4295184|NCT00528580|4121474|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4295185|NCT00528580|4121475|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4295186|NCT00528580|4121473|B3|||Age||years|Mean|52|52.0|Standard Deviation|8|8.0|||
4295187|NCT00528580|4121474|B2|||Age||years|Mean|52|52.0|Standard Deviation|8|8.0|||
4295188|NCT00528580|4121475|B1|||Age||years|Mean|52|52.0|Standard Deviation|8|8.0|||
4295189|NCT00528580|4121473|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4295190|NCT00528580|4121474|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4295191|NCT00528580|4121475|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4295192|NCT00528580|4121473|B3||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
4295193|NCT00528580|4121474|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4295194|NCT00528580|4121475|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4295195|NCT00528580|4121473|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4295196|NCT00528580|4121474|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4295197|NCT00528580|4121475|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4295198|NCT00528567|4121482|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4295199|NCT00528567|4121483|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4295200|NCT00528567|4121484|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4295201|NCT00528567|4121482|B3||Female|Sex: Female, Male||Participants|Count of Participants|2591|2591.0||||||
4295202|NCT00528567|4121483|B2||Female|Sex: Female, Male||Participants|Count of Participants|1290|1290.0||||||
4295203|NCT00528567|4121484|B1||Female|Sex: Female, Male||Participants|Count of Participants|1301|1301.0||||||
4295204|NCT00528567|4121482|B3|>= 65 years||Age, Customized||participants|Number|239|239.0||||||
4295205|NCT00528567|4121483|B2|>= 65 years||Age, Customized||participants|Number|121|121.0||||||
4295206|NCT00528567|4121484|B1|>= 65 years||Age, Customized||participants|Number|118|118.0||||||
4295207|NCT00528567|4121482|B3|>= 40 to < 65 years||Age, Customized||participants|Number|1868|1868.0||||||
4295208|NCT00528567|4121483|B2|>= 40 to < 65 years||Age, Customized||participants|Number|916|916.0||||||
4295209|NCT00528567|4121484|B1|>= 40 to < 65 years||Age, Customized||participants|Number|952|952.0||||||
4295210|NCT00528567|4121482|B3|< 40 years||Age, Customized||participants|Number|484|484.0||||||
4295211|NCT00528567|4121483|B2|< 40 years||Age, Customized||participants|Number|253|253.0||||||
4295212|NCT00528567|4121484|B1|< 40 years||Age, Customized||participants|Number|231|231.0||||||
4295213|NCT00528541|4121523|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4295214|NCT00528541|4121524|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4295215|NCT00528541|4121525|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4295216|NCT00528541|4121523|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4295217|NCT00528541|4121524|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4295218|NCT00528541|4121525|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4295219|NCT00528541|4121523|B3|||Age||years|Mean|49.0|49.0|Standard Deviation|11.9|11.9|||
4295220|NCT00528541|4121524|B2|||Age||years|Mean|48.6|48.6|Standard Deviation|11.5|11.5|||
4295221|NCT00528541|4121525|B1|||Age||years|Mean|49.4|49.4|Standard Deviation|12.2|12.2|||
4295222|NCT00528528|4121548|B5|Spain||Region of Enrollment||Participants|Number|17|17.0||||||
4295223|NCT00528528|4121549|B4|Spain||Region of Enrollment||Participants|Number|4|4.0||||||
4295224|NCT00528528|4121550|B3|Spain||Region of Enrollment||Participants|Number|4|4.0||||||
4295225|NCT00528528|4121551|B2|Spain||Region of Enrollment||Participants|Number|4|4.0||||||
4295226|NCT00528528|4121552|B1|Spain||Region of Enrollment||Participants|Number|5|5.0||||||
4295227|NCT00528528|4121548|B5|Netherland||Region of Enrollment||Participants|Number|5|5.0||||||
4295228|NCT00528528|4121549|B4|Netherland||Region of Enrollment||Participants|Number|1|1.0||||||
4295229|NCT00528528|4121550|B3|Netherland||Region of Enrollment||Participants|Number|2|2.0||||||
4295230|NCT00528528|4121551|B2|Netherland||Region of Enrollment||Participants|Number|1|1.0||||||
4295231|NCT00528528|4121552|B1|Netherland||Region of Enrollment||Participants|Number|1|1.0||||||
4295232|NCT00528528|4121548|B5|Italy||Region of Enrollment||Participants|Number|9|9.0||||||
4295233|NCT00528528|4121549|B4|Italy||Region of Enrollment||Participants|Number|3|3.0||||||
4295234|NCT00528528|4121550|B3|Italy||Region of Enrollment||Participants|Number|2|2.0||||||
4295235|NCT00528528|4121551|B2|Italy||Region of Enrollment||Participants|Number|3|3.0||||||
4295236|NCT00528528|4121552|B1|Italy||Region of Enrollment||Participants|Number|1|1.0||||||
4295237|NCT00528528|4121548|B5|Germany||Region of Enrollment||Participants|Number|46|46.0||||||
4295238|NCT00528528|4121549|B4|Germany||Region of Enrollment||Participants|Number|11|11.0||||||
4295239|NCT00528528|4121550|B3|Germany||Region of Enrollment||Participants|Number|11|11.0||||||
4295240|NCT00528528|4121551|B2|Germany||Region of Enrollment||Participants|Number|11|11.0||||||
4295241|NCT00528528|4121552|B1|Germany||Region of Enrollment||Participants|Number|13|13.0||||||
4295242|NCT00528528|4121548|B5|France||Region of Enrollment||Participants|Number|55|55.0||||||
4295243|NCT00528528|4121549|B4|France||Region of Enrollment||Participants|Number|13|13.0||||||
4295244|NCT00528528|4121550|B3|France||Region of Enrollment||Participants|Number|12|12.0||||||
4295245|NCT00528528|4121551|B2|France||Region of Enrollment||Participants|Number|17|17.0||||||
4295246|NCT00528528|4121552|B1|France||Region of Enrollment||Participants|Number|13|13.0||||||
4295247|NCT00528528|4121548|B5|Belgium||Region of Enrollment||Participants|Number|23|23.0||||||
4295248|NCT00528528|4121549|B4|Belgium||Region of Enrollment||Participants|Number|4|4.0||||||
4295249|NCT00528528|4121550|B3|Belgium||Region of Enrollment||Participants|Number|8|8.0||||||
4295250|NCT00528528|4121551|B2|Belgium||Region of Enrollment||Participants|Number|5|5.0||||||
4295251|NCT00528528|4121552|B1|Belgium||Region of Enrollment||Participants|Number|6|6.0||||||
4295252|NCT00528528|4121548|B5|Austria||Region of Enrollment||Participants|Number|6|6.0||||||
4295253|NCT00528528|4121549|B4|Austria||Region of Enrollment||Participants|Number|3|3.0||||||
4295254|NCT00528528|4121550|B3|Austria||Region of Enrollment||Participants|Number|1|1.0||||||
4295255|NCT00528528|4121551|B2|Austria||Region of Enrollment||Participants|Number|1|1.0||||||
4295256|NCT00528528|4121552|B1|Austria||Region of Enrollment||Participants|Number|1|1.0||||||
4295257|NCT00528528|4121548|B5||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4295258|NCT00528528|4121549|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4295259|NCT00528528|4121550|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4295260|NCT00528528|4121551|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4295261|NCT00528528|4121552|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4295262|NCT00528528|4121548|B5||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4295263|NCT00528528|4121549|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4295264|NCT00528528|4121550|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4295265|NCT00528528|4121551|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4295266|NCT00528528|4121552|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4295267|NCT00528528|4121548|B5|||Age||Years|Median|46|46.0|Inter-Quartile Range|||37.0|51.0|
4295268|NCT00528528|4121549|B4|||Age||Years|Median|49|49.0|Inter-Quartile Range|||43.0|54.0|
4295269|NCT00528528|4121550|B3|||Age||Years|Median|40|40.0|Inter-Quartile Range|||34.0|47.5|
4295270|NCT00528528|4121551|B2|||Age||Years|Median|45.5|45.5|Inter-Quartile Range|||41.0|51.0|
4295271|NCT00528528|4121552|B1|||Age||Years|Median|46.5|46.5|Inter-Quartile Range|||39.5|51.0|
4295272|NCT00528528|4121548|B5||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4295273|NCT00528528|4121549|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4295274|NCT00528528|4121550|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4295275|NCT00528528|4121551|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4295276|NCT00528528|4121552|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4295277|NCT00528528|4121548|B5||Between 18 and 65 years|Age||Participants|Count of Participants|160|160.0||||||
4295278|NCT00528528|4121549|B4||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4295279|NCT00528528|4121550|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4295280|NCT00528528|4121551|B2||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4295281|NCT00528528|4121552|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4295282|NCT00528528|4121548|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4295283|NCT00528528|4121549|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4295284|NCT00528528|4121550|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4295285|NCT00528528|4121551|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4295286|NCT00528528|4121552|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4295287|NCT00528450|4121589|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4295288|NCT00528450|4121589|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4295289|NCT00528450|4121589|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4295290|NCT00528450|4121589|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4295291|NCT00528450|4121589|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4295292|NCT00528424|4121593|B1|United States||Region of Enrollment||participants|Number|286|286.0||||||
4295293|NCT00528424|4121593|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4295294|NCT00528424|4121593|B1|White||Race/Ethnicity, Customized||participants|Number|285|285.0||||||
4295295|NCT00528424|4121593|B1||Male|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
4295296|NCT00528424|4121593|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4295297|NCT00528424|4121593|B1|||Age||years|Mean|62.7|62.7|Standard Deviation|9.5|9.5|||
4295298|NCT00528424|4121593|B1||>=65 years|Age||Participants|Count of Participants|120|120.0||||||
4295299|NCT00528424|4121593|B1||Between 18 and 65 years|Age||Participants|Count of Participants|166|166.0||||||
4295300|NCT00528424|4121593|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4295301|NCT00528411|4121605|B4||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4295302|NCT00528411|4121606|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4295303|NCT00528411|4121607|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4295304|NCT00528411|4121608|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4295305|NCT00528411|4121605|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4295306|NCT00528411|4121606|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4295307|NCT00528411|4121607|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4295308|NCT00528411|4121608|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4295309|NCT00528411|4121605|B4|||Age||Year|Mean|63.8|63.8|Standard Deviation|8.62|8.62|||
4295310|NCT00528411|4121606|B3|||Age||Year|Mean|63.9|63.9|Standard Deviation|8.32|8.32|||
4295311|NCT00528411|4121607|B2|||Age||Year|Mean|65.4|65.4|Standard Deviation|7.98|7.98|||
4295312|NCT00528411|4121608|B1|||Age||Year|Mean|62.2|62.2|Standard Deviation|9.10|9.1|||
4295313|NCT00528398|4121733|B1||AML Evolved from MDS|Diagnosis||Participants|Count of Participants|25|25.0||||||
4295314|NCT00528398|4121733|B1||AML Secondary to Chemotherapy|Diagnosis||Participants|Count of Participants|6|6.0||||||
4295315|NCT00528398|4121733|B1||De Novo AML|Diagnosis||Participants|Count of Participants|80|80.0||||||
4295316|NCT00528398|4121733|B1||Male|Gender||Participants|Count of Participants|61|61.0||||||
4295317|NCT00528398|4121733|B1||Female|Gender||Participants|Count of Participants|50|50.0||||||
4295318|NCT00528398|4121733|B1|||Age||years|Median|43|43.0|Full Range|||17.0|60.0|
4295319|NCT00528372|4121738|B10|Not reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4295320|NCT00528372|4121739|B9|Not reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4295321|NCT00528372|4121740|B8|Not reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4295322|NCT00528372|4121741|B7|Not reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4295323|NCT00528372|4121742|B6|Not reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4295324|NCT00528372|4121743|B5|Not reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4295325|NCT00528372|4121744|B4|Not reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4295326|NCT00528372|4121745|B3|Not reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4295327|NCT00528372|4121746|B2|Not reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4295328|NCT00528372|4121747|B1|Not reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4295329|NCT00528372|4121738|B10|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4295330|NCT00528372|4121739|B9|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4295331|NCT00528372|4121740|B8|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4295332|NCT00528372|4121741|B7|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4295333|NCT00528372|4121742|B6|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4295334|NCT00528372|4121743|B5|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4295335|NCT00528372|4121744|B4|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4295336|NCT00528372|4121745|B3|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4295337|NCT00528372|4121746|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4295338|NCT00528372|4121747|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4295339|NCT00528372|4121738|B10|Native Hawaiian/Other Pacific Islanders||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4295340|NCT00528372|4121739|B9|Native Hawaiian/Other Pacific Islanders||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4295341|NCT00528372|4121740|B8|Native Hawaiian/Other Pacific Islanders||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4295342|NCT00528372|4121741|B7|Native Hawaiian/Other Pacific Islanders||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4295343|NCT00528372|4121742|B6|Native Hawaiian/Other Pacific Islanders||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4295344|NCT00528372|4121743|B5|Native Hawaiian/Other Pacific Islanders||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4295345|NCT00528372|4121744|B4|Native Hawaiian/Other Pacific Islanders||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4295346|NCT00528372|4121745|B3|Native Hawaiian/Other Pacific Islanders||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4295347|NCT00528372|4121746|B2|Native Hawaiian/Other Pacific Islanders||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4295348|NCT00528372|4121747|B1|Native Hawaiian/Other Pacific Islanders||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4295349|NCT00528372|4121738|B10|Asian||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4295350|NCT00528372|4121739|B9|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4295351|NCT00528372|4121740|B8|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4295352|NCT00528372|4121741|B7|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4295353|NCT00528372|4121742|B6|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4295354|NCT00528372|4121743|B5|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4295355|NCT00528372|4121744|B4|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4295356|NCT00528372|4121745|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4295357|NCT00528372|4121746|B2|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4295358|NCT00528372|4121747|B1|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4295359|NCT00528372|4121738|B10|American Indian/Alaskan Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4295360|NCT00528372|4121739|B9|American Indian/Alaskan Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4295361|NCT00528372|4121740|B8|American Indian/Alaskan Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4295362|NCT00528372|4121741|B7|American Indian/Alaskan Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4295363|NCT00528372|4121742|B6|American Indian/Alaskan Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4295364|NCT00528372|4121743|B5|American Indian/Alaskan Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4295365|NCT00528372|4121744|B4|American Indian/Alaskan Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4295366|NCT00528372|4121745|B3|American Indian/Alaskan Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4295367|NCT00528372|4121746|B2|American Indian/Alaskan Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4295368|NCT00528372|4121747|B1|American Indian/Alaskan Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4295369|NCT00528372|4121738|B10|Black/African American||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4295370|NCT00528372|4121739|B9|Black/African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4295371|NCT00528372|4121740|B8|Black/African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4295372|NCT00528372|4121741|B7|Black/African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4295373|NCT00528372|4121742|B6|Black/African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4295374|NCT00528372|4121743|B5|Black/African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4295375|NCT00528372|4121744|B4|Black/African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4295376|NCT00528372|4121745|B3|Black/African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4295377|NCT00528372|4121746|B2|Black/African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4295378|NCT00528372|4121747|B1|Black/African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4295379|NCT00528372|4121738|B10|White||Race/Ethnicity, Customized||Participants|Number|529|529.0||||||
4295380|NCT00528372|4121739|B9|White||Race/Ethnicity, Customized||Participants|Number|38|38.0||||||
4295381|NCT00528372|4121740|B8|White||Race/Ethnicity, Customized||Participants|Number|31|31.0||||||
4295382|NCT00528372|4121741|B7|White||Race/Ethnicity, Customized||Participants|Number|72|72.0||||||
4295383|NCT00528372|4121742|B6|White||Race/Ethnicity, Customized||Participants|Number|65|65.0||||||
4295384|NCT00528372|4121743|B5|White||Race/Ethnicity, Customized||Participants|Number|65|65.0||||||
4295385|NCT00528372|4121744|B4|White||Race/Ethnicity, Customized||Participants|Number|63|63.0||||||
4295386|NCT00528372|4121745|B3|White||Race/Ethnicity, Customized||Participants|Number|61|61.0||||||
4295387|NCT00528372|4121746|B2|White||Race/Ethnicity, Customized||Participants|Number|63|63.0||||||
4295388|NCT00528372|4121747|B1|White||Race/Ethnicity, Customized||Participants|Number|71|71.0||||||
4295389|NCT00528372|4121738|B10||Male|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
4295390|NCT00528372|4121739|B9||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4295391|NCT00528372|4121740|B8||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4295392|NCT00528372|4121741|B7||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4295393|NCT00528372|4121742|B6||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4295394|NCT00528372|4121743|B5||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4295395|NCT00528372|4121744|B4||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4295396|NCT00528372|4121745|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4295397|NCT00528372|4121746|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4295398|NCT00528372|4121747|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4295399|NCT00528372|4121738|B10||Female|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
4295400|NCT00528372|4121739|B9||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4295401|NCT00528372|4121740|B8||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4295402|NCT00528372|4121741|B7||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4295403|NCT00528372|4121742|B6||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4295404|NCT00528372|4121743|B5||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4295405|NCT00528372|4121744|B4||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4295406|NCT00528372|4121745|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4295407|NCT00528372|4121746|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4295408|NCT00528372|4121747|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4295409|NCT00528372|4121738|B10|≥75||Age, Customized||Participants|Number|5|5.0||||||
4295410|NCT00528372|4121739|B9|≥75||Age, Customized||Participants|Number|1|1.0||||||
4295411|NCT00528372|4121740|B8|≥75||Age, Customized||Participants|Number|0|0.0||||||
4295412|NCT00528372|4121741|B7|≥75||Age, Customized||Participants|Number|0|0.0||||||
4295413|NCT00528372|4121742|B6|≥75||Age, Customized||Participants|Number|3|3.0||||||
4295414|NCT00528372|4121743|B5|≥75||Age, Customized||Participants|Number|0|0.0||||||
4295415|NCT00528372|4121744|B4|≥75||Age, Customized||Participants|Number|0|0.0||||||
4295416|NCT00528372|4121745|B3|≥75||Age, Customized||Participants|Number|0|0.0||||||
4295417|NCT00528372|4121746|B2|≥75||Age, Customized||Participants|Number|0|0.0||||||
4295418|NCT00528372|4121747|B1|≥75||Age, Customized||Participants|Number|1|1.0||||||
4295419|NCT00528372|4121738|B10|≥65 and <75||Age, Customized||Participants|Number|66|66.0||||||
4295420|NCT00528372|4121739|B9|≥65 and <75||Age, Customized||Participants|Number|2|2.0||||||
4295421|NCT00528372|4121740|B8|≥65 and <75||Age, Customized||Participants|Number|0|0.0||||||
4295422|NCT00528372|4121741|B7|≥65 and <75||Age, Customized||Participants|Number|4|4.0||||||
4295423|NCT00528372|4121742|B6|≥65 and <75||Age, Customized||Participants|Number|12|12.0||||||
4295424|NCT00528372|4121743|B5|≥65 and <75||Age, Customized||Participants|Number|15|15.0||||||
4295425|NCT00528372|4121744|B4|≥65 and <75||Age, Customized||Participants|Number|4|4.0||||||
4295426|NCT00528372|4121745|B3|≥65 and <75||Age, Customized||Participants|Number|10|10.0||||||
4295427|NCT00528372|4121746|B2|≥65 and <75||Age, Customized||Participants|Number|11|11.0||||||
4295428|NCT00528372|4121747|B1|≥65 and <75||Age, Customized||Participants|Number|8|8.0||||||
4295429|NCT00528372|4121738|B10|<65 years||Age, Customized||Participants|Number|487|487.0||||||
4295430|NCT00528372|4121739|B9|<65 years||Age, Customized||Participants|Number|36|36.0||||||
4295431|NCT00528372|4121740|B8|<65 years||Age, Customized||Participants|Number|34|34.0||||||
4295432|NCT00528372|4121741|B7|<65 years||Age, Customized||Participants|Number|72|72.0||||||
4295433|NCT00528372|4121742|B6|<65 years||Age, Customized||Participants|Number|53|53.0||||||
4295434|NCT00528372|4121743|B5|<65 years||Age, Customized||Participants|Number|52|52.0||||||
4295435|NCT00528372|4121744|B4|<65 years||Age, Customized||Participants|Number|66|66.0||||||
4295436|NCT00528372|4121745|B3|<65 years||Age, Customized||Participants|Number|54|54.0||||||
4295437|NCT00528372|4121746|B2|<65 years||Age, Customized||Participants|Number|54|54.0||||||
4295438|NCT00528372|4121747|B1|<65 years||Age, Customized||Participants|Number|66|66.0||||||
4295439|NCT00528268|4121867|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4295440|NCT00528268|4121868|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4295441|NCT00528268|4121869|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4295442|NCT00528268|4121867|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4295443|NCT00528268|4121868|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4295444|NCT00528268|4121869|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4295445|NCT00528268|4121867|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4295446|NCT00528268|4121868|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4295447|NCT00528268|4121869|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4295448|NCT00528268|4121867|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4295449|NCT00528268|4121868|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4295450|NCT00528268|4121869|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4295451|NCT00528268|4121867|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4295452|NCT00528268|4121868|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4295453|NCT00528268|4121869|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4295454|NCT00528268|4121867|B3||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4295455|NCT00528268|4121868|B2||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4295456|NCT00528268|4121869|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4295457|NCT00528190|4121876|B3|Canada||Region of Enrollment||participants|Number|35|35.0||||||
4295458|NCT00528190|4121877|B2|Canada||Region of Enrollment||participants|Number|17|17.0||||||
4295459|NCT00528190|4121878|B1|Canada||Region of Enrollment||participants|Number|18|18.0||||||
4295460|NCT00528190|4121876|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4295461|NCT00528190|4121876|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4295462|NCT00528190|4121877|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4295463|NCT00528190|4121878|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4295464|NCT00528190|4121876|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4295465|NCT00528190|4121877|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4295466|NCT00528190|4121878|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4295467|NCT00528190|4121876|B3|||Age||years|Mean|25.3|25.3|Standard Deviation|10.5|10.5|||
4295468|NCT00528190|4121877|B2|||Age||years|Mean|25.2|25.2|Standard Deviation|9.1|9.1|||
4295469|NCT00528190|4121878|B1|||Age||years|Mean|25.3|25.3|Standard Deviation|10.5|10.5|||
4295470|NCT00528112|4121885|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
4295471|NCT00528112|4121886|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
4295472|NCT00528112|4121887|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4295473|NCT00528112|4121885|B3||Female|Gender||Participants|Count of Participants|2884|2884.0||||||
4295474|NCT00528112|4121886|B2||Female|Gender||Participants|Count of Participants|1452|1452.0||||||
4295475|NCT00528112|4121887|B1||Female|Gender||Participants|Count of Participants|1432|1432.0||||||
4295476|NCT00528112|4121885|B3|> 25 years ≤ 35 years||Age, Customized||Participants|Number|1754|1754.0||||||
4295477|NCT00528112|4121886|B2|> 25 years ≤ 35 years||Age, Customized||Participants|Number|888|888.0||||||
4295478|NCT00528112|4121887|B1|> 25 years ≤ 35 years||Age, Customized||Participants|Number|866|866.0||||||
4295479|NCT00528112|4121885|B3|≤ 25 years||Age, Customized||Participants|Number|1130|1130.0||||||
4295480|NCT00528112|4121886|B2|≤ 25 years||Age, Customized||Participants|Number|564|564.0||||||
4295481|NCT00528112|4121887|B1|≤ 25 years||Age, Customized||Participants|Number|566|566.0||||||
4295482|NCT00528112|4121885|B3|||Age||Years|Mean|27.1|27.1|Full Range|||18.0|35.0|
4295483|NCT00528112|4121886|B2|||Age||Years|Mean|27.1|27.1|Full Range|||18.0|35.0|
4295484|NCT00528112|4121887|B1|||Age||Years|Mean|27.2|27.2|Full Range|||18.0|35.0|
4295485|NCT00528021|4121942|B5|United States||Region of Enrollment||participants|Number|230.0|230.0||||||
4295486|NCT00528021|4121943|B4|United States||Region of Enrollment||participants|Number|56|56.0||||||
4295487|NCT00528021|4121944|B3|United States||Region of Enrollment||participants|Number|56|56.0||||||
4295488|NCT00528021|4121945|B2|United States||Region of Enrollment||participants|Number|59|59.0||||||
4295489|NCT00528021|4121946|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
4295490|NCT00528021|4121942|B5||Male|Sex: Female, Male||Participants|Count of Participants|24.0|24.0||||||
4295491|NCT00528021|4121943|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4295492|NCT00528021|4121944|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4295493|NCT00528021|4121945|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4295494|NCT00528021|4121946|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4295495|NCT00528021|4121942|B5||Female|Sex: Female, Male||Participants|Count of Participants|206.0|206.0||||||
4295496|NCT00528021|4121943|B4||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4295497|NCT00528021|4121944|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4295498|NCT00528021|4121945|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4295499|NCT00528021|4121946|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4295500|NCT00528021|4121942|B5|||Age||years|Mean|12.8|12.8|Standard Deviation|10.7|10.7|||
4295501|NCT00528021|4121943|B4|||Age||years|Mean|12.3|12.3|Standard Deviation|8.8|8.8|||
4295502|NCT00528021|4121944|B3|||Age||years|Mean|13|13.0|Standard Deviation|10.2|10.2|||
4295503|NCT00528021|4121945|B2|||Age||years|Mean|13.5|13.5|Standard Deviation|12.1|12.1|||
4295504|NCT00528021|4121946|B1|||Age||years|Mean|12.3|12.3|Standard Deviation|11.5|11.5|||
4295505|NCT00528021|4121942|B5||>=65 years|Age||Participants|Count of Participants|0.0|0.0||||||
4295506|NCT00528021|4121943|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4295507|NCT00528021|4121944|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4295508|NCT00528021|4121945|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4295509|NCT00528021|4121946|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4295510|NCT00528021|4121942|B5||Between 18 and 65 years|Age||Participants|Count of Participants|9.0|9.0||||||
4295511|NCT00528021|4121943|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4295512|NCT00528021|4121944|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4295513|NCT00528021|4121945|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4295514|NCT00528021|4121946|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4295515|NCT00528021|4121942|B5||<=18 years|Age||Participants|Count of Participants|221.0|221.0||||||
4295516|NCT00528021|4121943|B4||<=18 years|Age||Participants|Count of Participants|55|55.0||||||
4295517|NCT00528021|4121944|B3||<=18 years|Age||Participants|Count of Participants|55|55.0||||||
4295518|NCT00528021|4121945|B2||<=18 years|Age||Participants|Count of Participants|56|56.0||||||
4295519|NCT00528021|4121946|B1||<=18 years|Age||Participants|Count of Participants|55|55.0||||||
4295520|NCT00527982|4121959|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4295521|NCT00527982|4121961|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4295522|NCT00527982|4121959|B3|Male||Gender||participants|Number|0|0.0||||||
4295523|NCT00527982|4121961|B1|Male||Gender||participants|Number|0|0.0||||||
4295524|NCT00527982|4121959|B3|Female||Gender||participants|Number|1|1.0||||||
4295525|NCT00527982|4121961|B1|Female||Gender||participants|Number|1|1.0||||||
4295526|NCT00527982|4121959|B3|>=65 years||Age||years|Number|0|0.0||||||
4295527|NCT00527982|4121961|B1|>=65 years||Age||years|Number|0|0.0||||||
4295528|NCT00527982|4121959|B3|Between 18 and 65 years||Age||years|Number|1|1.0||||||
4295529|NCT00527982|4121961|B1|Between 18 and 65 years||Age||years|Number|1|1.0||||||
4295530|NCT00527982|4121959|B3|<=18 years||Age||years|Number|0|0.0||||||
4295531|NCT00527982|4121961|B1|<=18 years||Age||years|Number|0|0.0||||||
4295532|NCT00527943|4121968|B3||Male|Sex: Female, Male||Participants|Count of Participants|9312|9312.0||||||
4295533|NCT00527943|4121969|B2||Male|Sex: Female, Male||Participants|Count of Participants|4663|4663.0||||||
4295534|NCT00527943|4121970|B1||Male|Sex: Female, Male||Participants|Count of Participants|4649|4649.0||||||
4295535|NCT00527943|4121968|B3||Female|Sex: Female, Male||Participants|Count of Participants|3632|3632.0||||||
4295536|NCT00527943|4121969|B2||Female|Sex: Female, Male||Participants|Count of Participants|1810|1810.0||||||
4295537|NCT00527943|4121970|B1||Female|Sex: Female, Male||Participants|Count of Participants|1822|1822.0||||||
4295538|NCT00527943|4121968|B3|>= 75 years||Age, Customized||Participants|Number|2206|2206.0||||||
4295539|NCT00527943|4121969|B2|>= 75 years||Age, Customized||Participants|Number|1110|1110.0||||||
4295540|NCT00527943|4121970|B1|>= 75 years||Age, Customized||Participants|Number|1096|1096.0||||||
4295541|NCT00527943|4121968|B3|65 to <75 years||Age, Customized||Participants|Number|3979|3979.0||||||
4295542|NCT00527943|4121969|B2|65 to <75 years||Age, Customized||Participants|Number|1973|1973.0||||||
4295543|NCT00527943|4121970|B1|65 to <75 years||Age, Customized||Participants|Number|2006|2006.0||||||
4295544|NCT00527943|4121968|B3|<65 years||Age, Customized||Participants|Number|6759|6759.0||||||
4295545|NCT00527943|4121969|B2|<65 years||Age, Customized||Participants|Number|3390|3390.0||||||
4295546|NCT00527943|4121970|B1|<65 years||Age, Customized||Participants|Number|3369|3369.0||||||
4295547|NCT00527904|4122003|B1|United States||Region of Enrollment||participants|Number|239|239.0||||||
4295548|NCT00527904|4122003|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4295549|NCT00527904|4122003|B1||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4295550|NCT00527904|4122003|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|8.64|8.64|||
4295551|NCT00527904|4122003|B1||>=65 years|Age||Participants|Count of Participants|78|78.0||32.6|32.6|||
4295552|NCT00527904|4122003|B1||Between 18 and 65 years|Age||Participants|Count of Participants|161|161.0||67.4|67.4|||
4295553|NCT00527904|4122003|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||0|0.0|||
4295554|NCT00527878|4122007|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4295555|NCT00527878|4122007|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4295556|NCT00527878|4122007|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4295557|NCT00527878|4122007|B1|||Age||years|Mean|25.2|25.2|Standard Deviation|13.6|13.6|||
4295558|NCT00527878|4122007|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4295559|NCT00527878|4122007|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4295560|NCT00527878|4122007|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4295561|NCT00527826|4122020|B3|Smoker||Smoking History|The number of smokers/ex-smokers participating in the study was recorded. The ITT Population was used.|participants|Number|60|60.0||||||
4295562|NCT00527826|4122021|B2|Smoker||Smoking History|The number of smokers/ex-smokers participating in the study was recorded. The ITT Population was used.|participants|Number|27|27.0||||||
4295563|NCT00527826|4122022|B1|Smoker||Smoking History|The number of smokers/ex-smokers participating in the study was recorded. The ITT Population was used.|participants|Number|33|33.0||||||
4295564|NCT00527826|4122020|B3|Ex-smoker||Smoking History|The number of smokers/ex-smokers participating in the study was recorded. The ITT Population was used.|participants|Number|152|152.0||||||
4295565|NCT00527826|4122021|B2|Ex-smoker||Smoking History|The number of smokers/ex-smokers participating in the study was recorded. The ITT Population was used.|participants|Number|78|78.0||||||
4295566|NCT00527826|4122022|B1|Ex-smoker||Smoking History|The number of smokers/ex-smokers participating in the study was recorded. The ITT Population was used.|participants|Number|74|74.0||||||
4295567|NCT00527826|4122020|B3|Very severe COPD||Severity of Chronic Obstructive Lung Disease (COPD)|Severe COPD (stage III) is defined by the global initiative for chronic obstructive lung disease (GOLD) as baseline forced expiratory volume in one second (FEV1) >30% and <50% predicted and FEV1/inspiratory vital capacity (IVC) ratio <70%. Very severe COPD (stage IV) is defined as baseline FEV1 <30% predicted and FEV1/IVC <70%. ITT Population.|participants|Number|56|56.0||||||
4295568|NCT00527826|4122021|B2|Very severe COPD||Severity of Chronic Obstructive Lung Disease (COPD)|Severe COPD (stage III) is defined by the global initiative for chronic obstructive lung disease (GOLD) as baseline forced expiratory volume in one second (FEV1) >30% and <50% predicted and FEV1/inspiratory vital capacity (IVC) ratio <70%. Very severe COPD (stage IV) is defined as baseline FEV1 <30% predicted and FEV1/IVC <70%. ITT Population.|participants|Number|26|26.0||||||
4295569|NCT00527826|4122022|B1|Very severe COPD||Severity of Chronic Obstructive Lung Disease (COPD)|Severe COPD (stage III) is defined by the global initiative for chronic obstructive lung disease (GOLD) as baseline forced expiratory volume in one second (FEV1) >30% and <50% predicted and FEV1/inspiratory vital capacity (IVC) ratio <70%. Very severe COPD (stage IV) is defined as baseline FEV1 <30% predicted and FEV1/IVC <70%. ITT Population.|participants|Number|30|30.0||||||
4295570|NCT00527826|4122020|B3|Severe COPD||Severity of Chronic Obstructive Lung Disease (COPD)|Severe COPD (stage III) is defined by the global initiative for chronic obstructive lung disease (GOLD) as baseline forced expiratory volume in one second (FEV1) >30% and <50% predicted and FEV1/inspiratory vital capacity (IVC) ratio <70%. Very severe COPD (stage IV) is defined as baseline FEV1 <30% predicted and FEV1/IVC <70%. ITT Population.|participants|Number|156|156.0||||||
4295571|NCT00527826|4122021|B2|Severe COPD||Severity of Chronic Obstructive Lung Disease (COPD)|Severe COPD (stage III) is defined by the global initiative for chronic obstructive lung disease (GOLD) as baseline forced expiratory volume in one second (FEV1) >30% and <50% predicted and FEV1/inspiratory vital capacity (IVC) ratio <70%. Very severe COPD (stage IV) is defined as baseline FEV1 <30% predicted and FEV1/IVC <70%. ITT Population.|participants|Number|79|79.0||||||
4295572|NCT00527826|4122022|B1|Severe COPD||Severity of Chronic Obstructive Lung Disease (COPD)|Severe COPD (stage III) is defined by the global initiative for chronic obstructive lung disease (GOLD) as baseline forced expiratory volume in one second (FEV1) >30% and <50% predicted and FEV1/inspiratory vital capacity (IVC) ratio <70%. Very severe COPD (stage IV) is defined as baseline FEV1 <30% predicted and FEV1/IVC <70%. ITT Population.|participants|Number|77|77.0||||||
4295573|NCT00527826|4122020|B3||Male|Sex: Female, Male|The ITT Population was used.|Participants|Count of Participants|150|150.0||||||
4295574|NCT00527826|4122021|B2||Male|Sex: Female, Male|The ITT Population was used.|Participants|Count of Participants|76|76.0||||||
4295575|NCT00527826|4122022|B1||Male|Sex: Female, Male|The ITT Population was used.|Participants|Count of Participants|74|74.0||||||
4295576|NCT00527826|4122020|B3||Female|Sex: Female, Male|The ITT Population was used.|Participants|Count of Participants|62|62.0||||||
4295577|NCT00527826|4122021|B2||Female|Sex: Female, Male|The ITT Population was used.|Participants|Count of Participants|29|29.0||||||
4295578|NCT00527826|4122022|B1||Female|Sex: Female, Male|The ITT Population was used.|Participants|Count of Participants|33|33.0||||||
4295579|NCT00527826|4122020|B3|||Age|Age at study start (years). The Intent-to-Treat (ITT) Population (all participants receiving at least one dose of study medication and suffering from COPD) was used for all baseline characteristics.|years|Mean|64.9|64.9|Standard Deviation|8.6|8.6|||
4295580|NCT00527826|4122021|B2|||Age|Age at study start (years). The Intent-to-Treat (ITT) Population (all participants receiving at least one dose of study medication and suffering from COPD) was used for all baseline characteristics.|years|Mean|64.2|64.2|Standard Deviation|8.9|8.9|||
4295625|NCT00527735|4122099|B4|Bronchoalveolar carcinoma (NSCLC patients)||Cell Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|2|2.0||||||
4295581|NCT00527826|4122022|B1|||Age|Age at study start (years). The Intent-to-Treat (ITT) Population (all participants receiving at least one dose of study medication and suffering from COPD) was used for all baseline characteristics.|years|Mean|65.6|65.6|Standard Deviation|8.3|8.3|||
4295582|NCT00527787|4122070|B3||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4295583|NCT00527787|4122071|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4295584|NCT00527787|4122072|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4295585|NCT00527787|4122070|B3||Female|Sex: Female, Male||Participants|Count of Participants|299|299.0||||||
4295586|NCT00527787|4122071|B2||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4295587|NCT00527787|4122072|B1||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4295588|NCT00527787|4122070|B3|||Age||years|Mean|61.3|61.3|Standard Deviation|8.6|8.6|||
4295589|NCT00527787|4122071|B2|||Age||years|Mean|61.9|61.9|Standard Deviation|8.5|8.5|||
4295590|NCT00527787|4122072|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|8.8|8.8|||
4295591|NCT00527748|4122095|B1|Male and Female||Sex/Gender, Customized||Participants|Count of Participants|26|26.0||||||
4295592|NCT00527748|4122095|B1|18 years or older||Age, Customized||Participants|Count of Participants|26|26.0||||||
4295593|NCT00527735|4122099|B4|Not reported (SCLC patients)||Cell Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|1|1.0||||||
4295594|NCT00527735|4122100|B3|Not reported (SCLC patients)||Cell Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|0|0.0||||||
4295595|NCT00527735|4122101|B2|Not reported (SCLC patients)||Cell Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|1|1.0||||||
4295596|NCT00527735|4122102|B1|Not reported (SCLC patients)||Cell Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|0|0.0||||||
4295597|NCT00527735|4122099|B4|Unknown (SCLC patients)||Cell Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|1|1.0||||||
4295598|NCT00527735|4122100|B3|Unknown (SCLC patients)||Cell Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|0|0.0||||||
4295599|NCT00527735|4122101|B2|Unknown (SCLC patients)||Cell Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|1|1.0||||||
4295600|NCT00527735|4122102|B1|Unknown (SCLC patients)||Cell Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|0|0.0||||||
4295601|NCT00527735|4122099|B4|Small-cell carcinoma (SCLC patients)||Cell Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|124|124.0||||||
4295602|NCT00527735|4122100|B3|Small-cell carcinoma (SCLC patients)||Cell Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|45|45.0||||||
4295603|NCT00527735|4122101|B2|Small-cell carcinoma (SCLC patients)||Cell Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|38|38.0||||||
4295604|NCT00527735|4122102|B1|Small-cell carcinoma (SCLC patients)||Cell Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|41|41.0||||||
4295605|NCT00527735|4122099|B4|Other (SCLC patients)||Cell Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|4|4.0||||||
4295606|NCT00527735|4122100|B3|Other (SCLC patients)||Cell Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|0|0.0||||||
4295607|NCT00527735|4122101|B2|Other (SCLC patients)||Cell Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|2|2.0||||||
4295608|NCT00527735|4122102|B1|Other (SCLC patients)||Cell Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|2|2.0||||||
4295609|NCT00527735|4122099|B4|Unknown (NSCLC patients)||Cell Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|5|5.0||||||
4295610|NCT00527735|4122100|B3|Unknown (NSCLC patients)||Cell Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|3|3.0||||||
4295611|NCT00527735|4122101|B2|Unknown (NSCLC patients)||Cell Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|1|1.0||||||
4295612|NCT00527735|4122102|B1|Unknown (NSCLC patients)||Cell Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|1|1.0||||||
4295613|NCT00527735|4122099|B4|Squamous-cell carcinoma (NSCLC patients)||Cell Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|57|57.0||||||
4295614|NCT00527735|4122100|B3|Squamous-cell carcinoma (NSCLC patients)||Cell Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|15|15.0||||||
4295615|NCT00527735|4122101|B2|Squamous-cell carcinoma (NSCLC patients)||Cell Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|21|21.0||||||
4295616|NCT00527735|4122102|B1|Squamous-cell carcinoma (NSCLC patients)||Cell Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|21|21.0||||||
4295617|NCT00527735|4122099|B4|Other (NSCLC patients)||Cell Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|13|13.0||||||
4295618|NCT00527735|4122100|B3|Other (NSCLC patients)||Cell Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|3|3.0||||||
4295619|NCT00527735|4122101|B2|Other (NSCLC patients)||Cell Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|4|4.0||||||
4295620|NCT00527735|4122102|B1|Other (NSCLC patients)||Cell Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|6|6.0||||||
4295621|NCT00527735|4122099|B4|Large-cell carcinoma (NSCLC patients)||Cell Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|24|24.0||||||
4295622|NCT00527735|4122100|B3|Large-cell carcinoma (NSCLC patients)||Cell Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|7|7.0||||||
4295623|NCT00527735|4122101|B2|Large-cell carcinoma (NSCLC patients)||Cell Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|11|11.0||||||
4295624|NCT00527735|4122102|B1|Large-cell carcinoma (NSCLC patients)||Cell Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|6|6.0||||||
4295710|NCT00527644|4122185|B1|Unknown||Sex/Gender, Customized||Participants|Count of Participants|14|14.0||||||
4295626|NCT00527735|4122100|B3|Bronchoalveolar carcinoma (NSCLC patients)||Cell Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|0|0.0||||||
4295627|NCT00527735|4122101|B2|Bronchoalveolar carcinoma (NSCLC patients)||Cell Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|1|1.0||||||
4295628|NCT00527735|4122102|B1|Bronchoalveolar carcinoma (NSCLC patients)||Cell Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|1|1.0||||||
4295629|NCT00527735|4122099|B4|Adenocarcinoma (NSCLC patients)||Cell Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|103|103.0||||||
4295630|NCT00527735|4122100|B3|Adenocarcinoma (NSCLC patients)||Cell Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|38|38.0||||||
4295631|NCT00527735|4122101|B2|Adenocarcinoma (NSCLC patients)||Cell Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|30|30.0||||||
4295632|NCT00527735|4122102|B1|Adenocarcinoma (NSCLC patients)||Cell Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|35|35.0||||||
4295633|NCT00527735|4122099|B4|Recurrent disease (SCLC patients)||Disease Stage at Study Entry|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer. Staging of NSCLC is based on the findings of several clinical tests, including magnetic resonance imaging scans and fine needle biopsy. Stages range from 1 (best prognosis) to IV (worst prognosis). Stage I cancer is confined to the lung. Stages II and III cancers are locally advanced. Stage IV cancer has spread outside the lung to other organs. SCLC is staged using a 2-tiered system: Limited stage SCLC is confined to its area of origin in the lung and lumph nodes. Extensive-stage SCLC has spread beyond the lung to other organs.|Participants|Number|1|1.0||||||
4295634|NCT00527735|4122100|B3|Recurrent disease (SCLC patients)||Disease Stage at Study Entry|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer. Staging of NSCLC is based on the findings of several clinical tests, including magnetic resonance imaging scans and fine needle biopsy. Stages range from 1 (best prognosis) to IV (worst prognosis). Stage I cancer is confined to the lung. Stages II and III cancers are locally advanced. Stage IV cancer has spread outside the lung to other organs. SCLC is staged using a 2-tiered system: Limited stage SCLC is confined to its area of origin in the lung and lumph nodes. Extensive-stage SCLC has spread beyond the lung to other organs.|Participants|Number|1|1.0||||||
4295635|NCT00527735|4122101|B2|Recurrent disease (SCLC patients)||Disease Stage at Study Entry|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer. Staging of NSCLC is based on the findings of several clinical tests, including magnetic resonance imaging scans and fine needle biopsy. Stages range from 1 (best prognosis) to IV (worst prognosis). Stage I cancer is confined to the lung. Stages II and III cancers are locally advanced. Stage IV cancer has spread outside the lung to other organs. SCLC is staged using a 2-tiered system: Limited stage SCLC is confined to its area of origin in the lung and lumph nodes. Extensive-stage SCLC has spread beyond the lung to other organs.|Participants|Number|0|0.0||||||
4295636|NCT00527735|4122102|B1|Recurrent disease (SCLC patients)||Disease Stage at Study Entry|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer. Staging of NSCLC is based on the findings of several clinical tests, including magnetic resonance imaging scans and fine needle biopsy. Stages range from 1 (best prognosis) to IV (worst prognosis). Stage I cancer is confined to the lung. Stages II and III cancers are locally advanced. Stage IV cancer has spread outside the lung to other organs. SCLC is staged using a 2-tiered system: Limited stage SCLC is confined to its area of origin in the lung and lumph nodes. Extensive-stage SCLC has spread beyond the lung to other organs.|Participants|Number|0|0.0||||||
4295637|NCT00527735|4122099|B4|Extensive (SCLC patients)||Disease Stage at Study Entry|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer. Staging of NSCLC is based on the findings of several clinical tests, including magnetic resonance imaging scans and fine needle biopsy. Stages range from 1 (best prognosis) to IV (worst prognosis). Stage I cancer is confined to the lung. Stages II and III cancers are locally advanced. Stage IV cancer has spread outside the lung to other organs. SCLC is staged using a 2-tiered system: Limited stage SCLC is confined to its area of origin in the lung and lumph nodes. Extensive-stage SCLC has spread beyond the lung to other organs.|Participants|Number|129|129.0||||||
4295638|NCT00527735|4122100|B3|Extensive (SCLC patients)||Disease Stage at Study Entry|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer. Staging of NSCLC is based on the findings of several clinical tests, including magnetic resonance imaging scans and fine needle biopsy. Stages range from 1 (best prognosis) to IV (worst prognosis). Stage I cancer is confined to the lung. Stages II and III cancers are locally advanced. Stage IV cancer has spread outside the lung to other organs. SCLC is staged using a 2-tiered system: Limited stage SCLC is confined to its area of origin in the lung and lumph nodes. Extensive-stage SCLC has spread beyond the lung to other organs.|Participants|Number|44|44.0||||||
4295639|NCT00527735|4122101|B2|Extensive (SCLC patients)||Disease Stage at Study Entry|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer. Staging of NSCLC is based on the findings of several clinical tests, including magnetic resonance imaging scans and fine needle biopsy. Stages range from 1 (best prognosis) to IV (worst prognosis). Stage I cancer is confined to the lung. Stages II and III cancers are locally advanced. Stage IV cancer has spread outside the lung to other organs. SCLC is staged using a 2-tiered system: Limited stage SCLC is confined to its area of origin in the lung and lumph nodes. Extensive-stage SCLC has spread beyond the lung to other organs.|Participants|Number|42|42.0||||||
4295640|NCT00527735|4122102|B1|Extensive (SCLC patients)||Disease Stage at Study Entry|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer. Staging of NSCLC is based on the findings of several clinical tests, including magnetic resonance imaging scans and fine needle biopsy. Stages range from 1 (best prognosis) to IV (worst prognosis). Stage I cancer is confined to the lung. Stages II and III cancers are locally advanced. Stage IV cancer has spread outside the lung to other organs. SCLC is staged using a 2-tiered system: Limited stage SCLC is confined to its area of origin in the lung and lumph nodes. Extensive-stage SCLC has spread beyond the lung to other organs.|Participants|Number|43|43.0||||||
4295641|NCT00527735|4122099|B4|Stage IV (NSCLC patients)||Disease Stage at Study Entry|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer. Staging of NSCLC is based on the findings of several clinical tests, including magnetic resonance imaging scans and fine needle biopsy. Stages range from 1 (best prognosis) to IV (worst prognosis). Stage I cancer is confined to the lung. Stages II and III cancers are locally advanced. Stage IV cancer has spread outside the lung to other organs. SCLC is staged using a 2-tiered system: Limited stage SCLC is confined to its area of origin in the lung and lumph nodes. Extensive-stage SCLC has spread beyond the lung to other organs.|Participants|Number|169|169.0||||||
4295642|NCT00527735|4122100|B3|Stage IV (NSCLC patients)||Disease Stage at Study Entry|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer. Staging of NSCLC is based on the findings of several clinical tests, including magnetic resonance imaging scans and fine needle biopsy. Stages range from 1 (best prognosis) to IV (worst prognosis). Stage I cancer is confined to the lung. Stages II and III cancers are locally advanced. Stage IV cancer has spread outside the lung to other organs. SCLC is staged using a 2-tiered system: Limited stage SCLC is confined to its area of origin in the lung and lumph nodes. Extensive-stage SCLC has spread beyond the lung to other organs.|Participants|Number|49|49.0||||||
4295643|NCT00527735|4122101|B2|Stage IV (NSCLC patients)||Disease Stage at Study Entry|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer. Staging of NSCLC is based on the findings of several clinical tests, including magnetic resonance imaging scans and fine needle biopsy. Stages range from 1 (best prognosis) to IV (worst prognosis). Stage I cancer is confined to the lung. Stages II and III cancers are locally advanced. Stage IV cancer has spread outside the lung to other organs. SCLC is staged using a 2-tiered system: Limited stage SCLC is confined to its area of origin in the lung and lumph nodes. Extensive-stage SCLC has spread beyond the lung to other organs.|Participants|Number|61|61.0||||||
4295644|NCT00527735|4122102|B1|Stage IV (NSCLC patients)||Disease Stage at Study Entry|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer. Staging of NSCLC is based on the findings of several clinical tests, including magnetic resonance imaging scans and fine needle biopsy. Stages range from 1 (best prognosis) to IV (worst prognosis). Stage I cancer is confined to the lung. Stages II and III cancers are locally advanced. Stage IV cancer has spread outside the lung to other organs. SCLC is staged using a 2-tiered system: Limited stage SCLC is confined to its area of origin in the lung and lumph nodes. Extensive-stage SCLC has spread beyond the lung to other organs.|Participants|Number|59|59.0||||||
4295645|NCT00527735|4122099|B4|Stage IIIB (NSCLC patients)||Disease Stage at Study Entry|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer. Staging of NSCLC is based on the findings of several clinical tests, including magnetic resonance imaging scans and fine needle biopsy. Stages range from 1 (best prognosis) to IV (worst prognosis). Stage I cancer is confined to the lung. Stages II and III cancers are locally advanced. Stage IV cancer has spread outside the lung to other organs. SCLC is staged using a 2-tiered system: Limited stage SCLC is confined to its area of origin in the lung and lumph nodes. Extensive-stage SCLC has spread beyond the lung to other organs.|Participants|Number|35|35.0||||||
4295646|NCT00527735|4122100|B3|Stage IIIB (NSCLC patients)||Disease Stage at Study Entry|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer. Staging of NSCLC is based on the findings of several clinical tests, including magnetic resonance imaging scans and fine needle biopsy. Stages range from 1 (best prognosis) to IV (worst prognosis). Stage I cancer is confined to the lung. Stages II and III cancers are locally advanced. Stage IV cancer has spread outside the lung to other organs. SCLC is staged using a 2-tiered system: Limited stage SCLC is confined to its area of origin in the lung and lumph nodes. Extensive-stage SCLC has spread beyond the lung to other organs.|Participants|Number|17|17.0||||||
4295647|NCT00527735|4122101|B2|Stage IIIB (NSCLC patients)||Disease Stage at Study Entry|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer. Staging of NSCLC is based on the findings of several clinical tests, including magnetic resonance imaging scans and fine needle biopsy. Stages range from 1 (best prognosis) to IV (worst prognosis). Stage I cancer is confined to the lung. Stages II and III cancers are locally advanced. Stage IV cancer has spread outside the lung to other organs. SCLC is staged using a 2-tiered system: Limited stage SCLC is confined to its area of origin in the lung and lumph nodes. Extensive-stage SCLC has spread beyond the lung to other organs.|Participants|Number|7|7.0||||||
4295648|NCT00527735|4122102|B1|Stage IIIB (NSCLC patients)||Disease Stage at Study Entry|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer. Staging of NSCLC is based on the findings of several clinical tests, including magnetic resonance imaging scans and fine needle biopsy. Stages range from 1 (best prognosis) to IV (worst prognosis). Stage I cancer is confined to the lung. Stages II and III cancers are locally advanced. Stage IV cancer has spread outside the lung to other organs. SCLC is staged using a 2-tiered system: Limited stage SCLC is confined to its area of origin in the lung and lumph nodes. Extensive-stage SCLC has spread beyond the lung to other organs.|Participants|Number|11|11.0||||||
4295649|NCT00527735|4122099|B4|Male (SCLC patients)||Gender, by Disease Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|98|98.0||||||
4295650|NCT00527735|4122100|B3|Male (SCLC patients)||Gender, by Disease Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|33|33.0||||||
4295651|NCT00527735|4122101|B2|Male (SCLC patients)||Gender, by Disease Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|32|32.0||||||
4295652|NCT00527735|4122102|B1|Male (SCLC patients)||Gender, by Disease Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|33|33.0||||||
4295653|NCT00527735|4122099|B4|Female (SCLC patients)||Gender, by Disease Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|32|32.0||||||
4295654|NCT00527735|4122100|B3|Female (SCLC patients)||Gender, by Disease Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|12|12.0||||||
4295655|NCT00527735|4122101|B2|Female (SCLC patients)||Gender, by Disease Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|10|10.0||||||
4295656|NCT00527735|4122102|B1|Female (SCLC patients)||Gender, by Disease Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|10|10.0||||||
4295657|NCT00527735|4122099|B4|Male (NSCLC patients)||Gender, by Disease Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|151|151.0||||||
4295658|NCT00527735|4122100|B3|Male (NSCLC patients)||Gender, by Disease Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|49|49.0||||||
4295659|NCT00527735|4122101|B2|Male (NSCLC patients)||Gender, by Disease Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|49|49.0||||||
4295660|NCT00527735|4122102|B1|Male (NSCLC patients)||Gender, by Disease Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|53|53.0||||||
4295661|NCT00527735|4122099|B4|Female (NSCLC patients)||Gender, by Disease Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|53|53.0||||||
4295662|NCT00527735|4122100|B3|Female (NSCLC patients)||Gender, by Disease Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|17|17.0||||||
4295663|NCT00527735|4122101|B2|Female (NSCLC patients)||Gender, by Disease Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|19|19.0||||||
4295664|NCT00527735|4122102|B1|Female (NSCLC patients)||Gender, by Disease Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|17|17.0||||||
4295665|NCT00527735|4122099|B4|65 years and older (SCLC patients)||Age Customized, by Disease Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|30|30.0||||||
4295666|NCT00527735|4122100|B3|65 years and older (SCLC patients)||Age Customized, by Disease Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|9|9.0||||||
4295667|NCT00527735|4122101|B2|65 years and older (SCLC patients)||Age Customized, by Disease Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|13|13.0||||||
4295668|NCT00527735|4122102|B1|65 years and older (SCLC patients)||Age Customized, by Disease Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|8|8.0||||||
4295669|NCT00527735|4122099|B4|Younger than 65 years (SCLC patients)||Age Customized, by Disease Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|100|100.0||||||
4295670|NCT00527735|4122100|B3|Younger than 65 years (SCLC patients)||Age Customized, by Disease Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|36|36.0||||||
4295671|NCT00527735|4122101|B2|Younger than 65 years (SCLC patients)||Age Customized, by Disease Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|29|29.0||||||
4295672|NCT00527735|4122102|B1|Younger than 65 years (SCLC patients)||Age Customized, by Disease Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|35|35.0||||||
4295673|NCT00527735|4122099|B4|65 years and older (NSCLC patients)||Age Customized, by Disease Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|76|76.0||||||
4295674|NCT00527735|4122100|B3|65 years and older (NSCLC patients)||Age Customized, by Disease Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|26|26.0||||||
4295675|NCT00527735|4122101|B2|65 years and older (NSCLC patients)||Age Customized, by Disease Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|24|24.0||||||
4295676|NCT00527735|4122102|B1|65 years and older (NSCLC patients)||Age Customized, by Disease Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|26|26.0||||||
4295677|NCT00527735|4122099|B4|Younger than 65 years (NSCLC patients)||Age Customized, by Disease Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|128|128.0||||||
4295678|NCT00527735|4122100|B3|Younger than 65 years (NSCLC patients)||Age Customized, by Disease Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|40|40.0||||||
4295679|NCT00527735|4122101|B2|Younger than 65 years (NSCLC patients)||Age Customized, by Disease Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|44|44.0||||||
4295680|NCT00527735|4122102|B1|Younger than 65 years (NSCLC patients)||Age Customized, by Disease Type|NSCLC=nonsmall-cell lung cancer; SCLC=small-cell lung cancer|Participants|Number|44|44.0||||||
4295681|NCT00527735|4122099|B4||Male|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
4295682|NCT00527735|4122100|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4295683|NCT00527735|4122101|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4295684|NCT00527735|4122102|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4295685|NCT00527735|4122099|B4||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4295686|NCT00527735|4122100|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4295687|NCT00527735|4122101|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4295688|NCT00527735|4122102|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4295689|NCT00527735|4122099|B4|65 years and older||Age, Customized|Age of participants who received treatment.|Participants|Number|106|106.0||||||
4295690|NCT00527735|4122100|B3|65 years and older||Age, Customized|Age of participants who received treatment.|Participants|Number|35|35.0||||||
4295691|NCT00527735|4122101|B2|65 years and older||Age, Customized|Age of participants who received treatment.|Participants|Number|37|37.0||||||
4295692|NCT00527735|4122102|B1|65 years and older||Age, Customized|Age of participants who received treatment.|Participants|Number|34|34.0||||||
4295693|NCT00527735|4122099|B4|Younger than 65 years||Age, Customized|Age of participants who received treatment.|Participants|Number|228|228.0||||||
4295694|NCT00527735|4122100|B3|Younger than 65 years||Age, Customized|Age of participants who received treatment.|Participants|Number|76|76.0||||||
4295695|NCT00527735|4122101|B2|Younger than 65 years||Age, Customized|Age of participants who received treatment.|Participants|Number|73|73.0||||||
4295696|NCT00527735|4122102|B1|Younger than 65 years||Age, Customized|Age of participants who received treatment.|Participants|Number|79|79.0||||||
4295697|NCT00527722|4122176|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
4295698|NCT00527722|4122177|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4295699|NCT00527722|4122178|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4295700|NCT00527722|4122176|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4295701|NCT00527722|4122177|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4295702|NCT00527722|4122178|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4295703|NCT00527722|4122176|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4295704|NCT00527722|4122177|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4295705|NCT00527722|4122178|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4295706|NCT00527722|4122176|B3|||Age||years|Median|45|45.0|Full Range|||25.0|85.0|
4295707|NCT00527722|4122177|B2|||Age||years|Median|35|35.0|Full Range|||25.0|70.0|
4295708|NCT00527722|4122178|B1|||Age||years|Median|45|45.0|Full Range|||25.0|85.0|
4295709|NCT00527644|4122185|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4295711|NCT00527644|4122185|B1|> 18 years||Age, Customized||Participants|Count of Participants|14|14.0||||||
4295712|NCT00527618|4122190|B1|||Plasma HIV-1 RNA||log10 copies/mL|Mean|3.84|3.84|Full Range|||1.17|6.93|
4295713|NCT00527618|4122190|B1|||CD4 Count||cells/microliter|Mean|526|526.0|Full Range|||73.0|1094.0|
4295714|NCT00527618|4122190|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4295715|NCT00527618|4122190|B1|African-American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4295716|NCT00527618|4122190|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4295717|NCT00527618|4122190|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4295718|NCT00527618|4122190|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4295719|NCT00527618|4122190|B1|||Age||Years|Mean|43|43.0|Full Range|||24.0|66.0|
4295720|NCT00527605|4122204|B3|Chinese||Race/Ethnicity, Customized||participants|Number|253|253.0||||||
4295721|NCT00527605|4122205|B2|Chinese||Race/Ethnicity, Customized||participants|Number|127|127.0||||||
4295722|NCT00527605|4122206|B1|Chinese||Race/Ethnicity, Customized||participants|Number|126|126.0||||||
4295723|NCT00527605|4122204|B3||Male|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
4295724|NCT00527605|4122205|B2||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4295725|NCT00527605|4122206|B1||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4295726|NCT00527605|4122204|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4295727|NCT00527605|4122205|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4295728|NCT00527605|4122206|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4295729|NCT00527605|4122204|B3|||Age||years|Mean|66.4|66.4|Standard Deviation|7.9|7.9|||
4295730|NCT00527605|4122205|B2|||Age||years|Mean|66.9|66.9|Standard Deviation|8.2|8.2|||
4295731|NCT00527605|4122206|B1|||Age||years|Mean|65.8|65.8|Standard Deviation|7.7|7.7|||
4295732|NCT00527592|4122243|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4295733|NCT00527592|4122243|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4295734|NCT00527592|4122243|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4295735|NCT00527592|4122243|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4295736|NCT00527592|4122243|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4295737|NCT00527566|4122249|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4295738|NCT00527566|4122249|B1|Participants|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4295739|NCT00527566|4122249|B1|Participants|# White Participants|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4295740|NCT00527566|4122249|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4295741|NCT00527566|4122249|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4295742|NCT00527566|4122249|B1|||Age||years|Mean|48|48.0|Standard Deviation|5|5.0|||
4295743|NCT00527566|4122249|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4295744|NCT00527566|4122249|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4295745|NCT00527566|4122249|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4295746|NCT00527514|4122258|B1|||Systolic Blood Pressure|Seated cuff measurement as opposed to ambulatory measurement.|mm Hg|Mean|158.2|158.2|Standard Deviation|12.63|12.63|||
4295747|NCT00527514|4122258|B1|||Heart Rate||beats/minute|Mean|75.1|75.1|Standard Deviation|10.82|10.82|||
4295748|NCT00527514|4122258|B1|||24-hour Ambulatory Systolic Blood Pressure||mm Hg|Mean|144.6|144.6|Standard Deviation|10.88|10.88|||
4295749|NCT00527514|4122258|B1|||24-Hour Ambulatory Diastolic Blood Pressure||mm Hg|Mean|85.8|85.8|Standard Deviation|7.91|7.91|||
4295750|NCT00527514|4122258|B1|Stage 2||Stage of Hypertension|Stage I hypertension is defined as systolic blood pressure (SBP) of 140 – 159 mmHg and diastolic blood pressure (DBP) of 90 – 99 mmHg; Stage II is defined as SBP ≥ 160 mmHg or DBP ≥ 100 mm Hg.|Participants|Number|103|103.0||||||
4295751|NCT00527514|4122258|B1|Stage 1||Stage of Hypertension|Stage I hypertension is defined as systolic blood pressure (SBP) of 140 – 159 mmHg and diastolic blood pressure (DBP) of 90 – 99 mmHg; Stage II is defined as SBP ≥ 160 mmHg or DBP ≥ 100 mm Hg.|Participants|Number|82|82.0||||||
4295752|NCT00527514|4122258|B1|United States||Region of Enrollment||participants|Number|185|185.0||||||
4295753|NCT00527514|4122258|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4295754|NCT00527514|4122258|B1|White||Race/Ethnicity, Customized||Participants|Number|144|144.0||||||
4295755|NCT00527514|4122258|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|26|26.0||||||
4295756|NCT00527514|4122258|B1|Asian||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4295757|NCT00527514|4122258|B1||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4295758|NCT00527514|4122258|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4295759|NCT00527514|4122258|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|9.28|9.28|||
4295760|NCT00527488|4122270|B5|Germany||Region of Enrollment||participants|Number|52|52.0||||||
4295761|NCT00527488|4122271|B4|Germany||Region of Enrollment||participants|Number|13|13.0||||||
4295762|NCT00527488|4122272|B3|Germany||Region of Enrollment||participants|Number|13|13.0||||||
4295763|NCT00527488|4122273|B2|Germany||Region of Enrollment||participants|Number|13|13.0||||||
4295764|NCT00527488|4122274|B1|Germany||Region of Enrollment||participants|Number|13|13.0||||||
4295765|NCT00527488|4122270|B5||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4295766|NCT00527488|4122271|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4295767|NCT00527488|4122272|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4295768|NCT00527488|4122273|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4295769|NCT00527488|4122274|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4295770|NCT00527488|4122270|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4295771|NCT00527488|4122271|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4295772|NCT00527488|4122272|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4295773|NCT00527488|4122273|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4295774|NCT00527488|4122274|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4295775|NCT00527488|4122270|B5|||Age||years|Mean|63.8|63.8|Standard Deviation|6.2|6.2|||
4295776|NCT00527488|4122271|B4|||Age||years|Mean|60.4|60.4|Standard Deviation|7.8|7.8|||
4295777|NCT00527488|4122272|B3|||Age||years|Mean|66.3|66.3|Standard Deviation|4.6|4.6|||
4295778|NCT00527488|4122273|B2|||Age||years|Mean|63.0|63.0|Standard Deviation|6.1|6.1|||
4295779|NCT00527488|4122274|B1|||Age||years|Mean|65.7|65.7|Standard Deviation|4.7|4.7|||
4295780|NCT00527475|4122351|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4295781|NCT00527475|4122352|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4295782|NCT00527475|4122353|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4295783|NCT00527475|4122351|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4295784|NCT00527475|4122352|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4295785|NCT00527475|4122353|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4295786|NCT00527475|4122351|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4295787|NCT00527475|4122352|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4295788|NCT00527475|4122353|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4295789|NCT00527475|4122351|B3|||Age|Average age|years|Mean|79.2|79.2|Standard Deviation|7.72|7.72|||
4295790|NCT00527475|4122352|B2|||Age|Average age|years|Mean|79.3|79.3|Standard Deviation|7.23|7.23|||
4295791|NCT00527475|4122353|B1|||Age|Average age|years|Mean|79.1|79.1|Standard Deviation|8.35|8.35|||
4295792|NCT00527423|4122360|B1|||Baseline Intraocular Pressure|Intraocular pressure was measured in the study and fellow eyes using applanation tonometry or Tonopen at every study visit pre-dose, and 30 to 60 minutes post-injection.|mmHg|Mean|14.5|14.5|Standard Deviation|3.12|3.12|||
4295793|NCT00527423|4122360|B1|||Baseline Best Corrected Visual Acuity (BCVA)|For BCVA, tested via the 4 meter ETDRS (Early Treatment Diabetic Retinopathy Study) protocol, 83 letter or more would represent 20/20 vision or better which would be considered an excellent outcome. Although, the ETDRS charts include 100 letters as the maximum possible score. The worst outcome is 0 letters read.|scores on a scale|Mean|61.3|61.3|Standard Deviation|15.35|15.35|||
4295794|NCT00527423|4122360|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4295795|NCT00527423|4122360|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4295796|NCT00527423|4122360|B1||White|Race (NIH/OMB)||Participants|Count of Participants|156|156.0||||||
4295797|NCT00527423|4122360|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4295798|NCT00527423|4122360|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4295799|NCT00527423|4122360|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4295800|NCT00527423|4122360|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4295801|NCT00527423|4122360|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4295802|NCT00527423|4122360|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|153|153.0||||||
4295803|NCT00527423|4122360|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4295804|NCT00527423|4122360|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4295805|NCT00527423|4122360|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4295806|NCT00527423|4122360|B1|||Age||years|Mean|77.9|77.9|Standard Deviation|8.16|8.16|||
4295807|NCT00527397|4122366|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4295808|NCT00527397|4122366|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4295809|NCT00527397|4122366|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|15.0|15.0|||
4295810|NCT00527332|4122390|B3|Sweden||Region of Enrollment||participants|Number|180|180.0||||||
4295811|NCT00527332|4122391|B2|Sweden||Region of Enrollment||participants|Number|89|89.0||||||
4295812|NCT00527332|4122392|B1|Sweden||Region of Enrollment||participants|Number|91|91.0||||||
4295813|NCT00527332|4122390|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4295814|NCT00527332|4122391|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4295815|NCT00527332|4122392|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4295816|NCT00527332|4122390|B3||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4295817|NCT00527332|4122391|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4295818|NCT00527332|4122392|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4295819|NCT00527332|4122390|B3|||Age||years|Mean|45.9|45.9|Standard Deviation|5.7|5.7|||
4295820|NCT00527332|4122391|B2|||Age||years|Mean|46.0|46.0|Standard Deviation|6.0|6.0|||
4295821|NCT00527332|4122392|B1|||Age||years|Mean|45.9|45.9|Standard Deviation|5.5|5.5|||
4295822|NCT00527332|4122390|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4295823|NCT00527332|4122391|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4295824|NCT00527332|4122392|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4295825|NCT00527332|4122390|B3||Between 18 and 65 years|Age||Participants|Count of Participants|180|180.0||||||
4295826|NCT00527332|4122391|B2||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
4295827|NCT00527332|4122392|B1||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
4295828|NCT00527332|4122390|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4295829|NCT00527332|4122391|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4295830|NCT00527332|4122392|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4295831|NCT00527319|4122399|B4|India||Region of Enrollment||participants|Number|37|37.0||||||
4295832|NCT00527319|4122400|B3|India||Region of Enrollment||participants|Number|13|13.0||||||
4295833|NCT00527319|4122401|B2|India||Region of Enrollment||participants|Number|12|12.0||||||
4295834|NCT00527319|4122402|B1|India||Region of Enrollment||participants|Number|12|12.0||||||
4295835|NCT00527319|4122399|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4295836|NCT00527319|4122400|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4295837|NCT00527319|4122401|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4295838|NCT00527319|4122402|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4295839|NCT00527319|4122399|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4295840|NCT00527319|4122400|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4295841|NCT00527319|4122401|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4295842|NCT00527319|4122402|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4295843|NCT00527319|4122399|B4|||Age||years|Mean|55.7|55.7|Standard Deviation|10.1|10.1|||
4295844|NCT00527319|4122400|B3|||Age||years|Mean|57.6|57.6|Standard Deviation|10.4|10.4|||
4295845|NCT00527319|4122401|B2|||Age||years|Mean|55.1|55.1|Standard Deviation|7.6|7.6|||
4295846|NCT00527319|4122402|B1|||Age||years|Mean|54.1|54.1|Standard Deviation|12.0|12.0|||
4295847|NCT00527124|4122415|B3|United States||Region of Enrollment||participants|Number|57|57.0||||||
4295848|NCT00527124|4122416|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4295849|NCT00527124|4122417|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4295850|NCT00527124|4122415|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4295851|NCT00527124|4122416|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4295852|NCT00527124|4122417|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4295853|NCT00527124|4122415|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4295854|NCT00527124|4122416|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4295855|NCT00527124|4122417|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4295856|NCT00527124|4122415|B3|||Age||years|Mean|68.72|68.72|Standard Deviation|8.48|8.48|||
4295857|NCT00527124|4122416|B2|||Age||years|Mean|68.29|68.29|Standard Deviation|9.66|9.66|||
4295858|NCT00527124|4122417|B1|||Age||years|Mean|69.14|69.14|Standard Deviation|7.3|7.3|||
4295859|NCT00527111|4122432|B3|United States||Region of Enrollment||participants|Number|139|139.0||||||
4295860|NCT00527111|4122433|B2|United States||Region of Enrollment||participants|Number|69|69.0||||||
4295861|NCT00527111|4122434|B1|United States||Region of Enrollment||participants|Number|70|70.0||||||
4295862|NCT00527111|4122432|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4295863|NCT00527111|4122433|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4295864|NCT00527111|4122434|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4295865|NCT00527111|4122432|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4295866|NCT00527111|4122433|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4295867|NCT00527111|4122434|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4295868|NCT00527111|4122432|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4295869|NCT00527111|4122433|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4295870|NCT00527111|4122434|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4295871|NCT00527111|4122432|B3|Black||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4295872|NCT00527111|4122433|B2|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4295873|NCT00527111|4122434|B1|Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4295874|NCT00527111|4122432|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|119|119.0||||||
4295875|NCT00527111|4122433|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
4295876|NCT00527111|4122434|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
4295877|NCT00527111|4122432|B3||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4295878|NCT00527111|4122433|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4295879|NCT00527111|4122434|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4295880|NCT00527111|4122432|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4295881|NCT00527111|4122433|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4295882|NCT00527111|4122434|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4295883|NCT00527111|4122432|B3|||Age||years|Mean|58.6|58.6|Standard Deviation|11.3|11.3|||
4295884|NCT00527111|4122433|B2|||Age||years|Mean|61.4|61.4|Standard Deviation|11.7|11.7|||
4295885|NCT00527111|4122434|B1|||Age||years|Mean|55.9|55.9|Standard Deviation|11.0|11.0|||
4295886|NCT00527098|4122449|B3|United States||Region of Enrollment||participants|Number|119|119.0||||||
4295887|NCT00527098|4122450|B2|United States||Region of Enrollment||participants|Number|83|83.0||||||
4295888|NCT00527098|4122451|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4295889|NCT00527098|4122449|B3||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4295890|NCT00527098|4122450|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4295891|NCT00527098|4122451|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4295892|NCT00527098|4122449|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4295893|NCT00527098|4122450|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4295894|NCT00527098|4122451|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4295895|NCT00527098|4122449|B3|||Age||years|Mean|39|39.0|Standard Deviation|17|17.0|||
4295896|NCT00527098|4122450|B2|||Age||years|Mean|39|39.0|Standard Deviation|17|17.0|||
4295897|NCT00527098|4122451|B1|||Age||years|Mean|39|39.0|Standard Deviation|17|17.0|||
4295898|NCT00527098|4122449|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4295899|NCT00527098|4122450|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4295900|NCT00527098|4122451|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4295901|NCT00527098|4122449|B3||Between 18 and 65 years|Age||Participants|Count of Participants|119|119.0||||||
4295902|NCT00527098|4122450|B2||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
4295903|NCT00527098|4122451|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4295904|NCT00527098|4122449|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4295905|NCT00527098|4122450|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4295906|NCT00527098|4122451|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4295907|NCT00527072|4122457|B1||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4295908|NCT00527072|4122457|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4295909|NCT00527072|4122457|B1|||Age||years|Mean|44.4|44.4|Standard Deviation|13.32|13.32|||
4295910|NCT00527072|4122457|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4295911|NCT00527072|4122457|B1||Between 18 and 65 years|Age||Participants|Count of Participants|198|198.0||||||
4295912|NCT00527072|4122457|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4295913|NCT00526994|4122463|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4295914|NCT00526994|4122464|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4295915|NCT00526994|4122465|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4295916|NCT00526994|4122466|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4295917|NCT00526994|4122463|B4||Female|Sex: Female, Male||Participants|Count of Participants|2700|2700.0||||||
4295918|NCT00526994|4122464|B3||Female|Sex: Female, Male||Participants|Count of Participants|898|898.0||||||
4295919|NCT00526994|4122465|B2||Female|Sex: Female, Male||Participants|Count of Participants|893|893.0||||||
4295920|NCT00526994|4122466|B1||Female|Sex: Female, Male||Participants|Count of Participants|909|909.0||||||
4295921|NCT00526994|4122463|B4|||Age||years|Mean|38.7|38.7|Standard Deviation|14.9|14.9|||
4295922|NCT00526994|4122464|B3|||Age||years|Mean|38.7|38.7|Standard Deviation|15.1|15.1|||
4295923|NCT00526994|4122465|B2|||Age||years|Mean|38.3|38.3|Standard Deviation|14.8|14.8|||
4295924|NCT00526994|4122466|B1|||Age||years|Mean|39|39.0|Standard Deviation|15|15.0|||
4295925|NCT00526890|4122485|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4295926|NCT00526890|4122485|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4295927|NCT00526890|4122485|B1|||Age||years|Mean|63.25|63.25|Standard Deviation|9.22|9.22|||
4295928|NCT00526799|4122495|B3|||CA125 at Enrollment||U/mL|Median|744.2|744.2|Full Range|||144.7|2901.0|
4295929|NCT00526799|4122496|B2|||CA125 at Enrollment||U/mL|Median|1669.0|1669.0|Full Range|||437.0|2901.0|
4295930|NCT00526799|4122497|B1|||CA125 at Enrollment||U/mL|Median|744.2|744.2|Full Range|||144.7|2771.5|
4295931|NCT00526799|4122495|B3|Platinum allergy||Platinum Sensitivity||participants|Number|3|3.0||||||
4295932|NCT00526799|4122496|B2|Platinum allergy||Platinum Sensitivity||participants|Number|2|2.0||||||
4295933|NCT00526799|4122497|B1|Platinum allergy||Platinum Sensitivity||participants|Number|1|1.0||||||
4295934|NCT00526799|4122495|B3|Platinum Resistant||Platinum Sensitivity||participants|Number|18|18.0||||||
4295935|NCT00526799|4122496|B2|Platinum Resistant||Platinum Sensitivity||participants|Number|8|8.0||||||
4295936|NCT00526799|4122497|B1|Platinum Resistant||Platinum Sensitivity||participants|Number|10|10.0||||||
4295937|NCT00526799|4122495|B3|Platinum refractory||Platinum Sensitivity||participants|Number|9|9.0||||||
4295938|NCT00526799|4122496|B2|Platinum refractory||Platinum Sensitivity||participants|Number|4|4.0||||||
4295939|NCT00526799|4122497|B1|Platinum refractory||Platinum Sensitivity||participants|Number|5|5.0||||||
4295940|NCT00526799|4122495|B3|Detectable Disease||Response Evaluation|"Response Evaluation Criteria in Solid Tumors (RECIST):~Measurable disease is defined by the presence of at least one measureable lesion. If the measureable disease is restricted to a solitary lesion, its neoplastic nature should be confirmed by cytology/histology.~Detectable disease is defined as a patient who does not have measureable disease, but has at least one: 1)CA-125 >= 2x ULN w/in 14d prior to registration 2)Ascites and/or pleural effusion attributed to tumor; 3)solid and/or cystic abnormalities on radiographic imaging that don't meet RECIST definitions for target lesions."|participants|Number|8|8.0||||||
4295971|NCT00526799|4122496|B2|ECOG=0||Eastern Cooperative Onocology Group (ECOG) Perfomance Status|ECOG: Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0-5 that describes a patient's level of functioning where 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Dead|participants|Number|13|13.0||||||
4296022|NCT00526591|4122567|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4296023|NCT00526591|4122565|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4295941|NCT00526799|4122496|B2|Detectable Disease||Response Evaluation|"Response Evaluation Criteria in Solid Tumors (RECIST):~Measurable disease is defined by the presence of at least one measureable lesion. If the measureable disease is restricted to a solitary lesion, its neoplastic nature should be confirmed by cytology/histology.~Detectable disease is defined as a patient who does not have measureable disease, but has at least one: 1)CA-125 >= 2x ULN w/in 14d prior to registration 2)Ascites and/or pleural effusion attributed to tumor; 3)solid and/or cystic abnormalities on radiographic imaging that don't meet RECIST definitions for target lesions."|participants|Number|2|2.0||||||
4295942|NCT00526799|4122497|B1|Detectable Disease||Response Evaluation|"Response Evaluation Criteria in Solid Tumors (RECIST):~Measurable disease is defined by the presence of at least one measureable lesion. If the measureable disease is restricted to a solitary lesion, its neoplastic nature should be confirmed by cytology/histology.~Detectable disease is defined as a patient who does not have measureable disease, but has at least one: 1)CA-125 >= 2x ULN w/in 14d prior to registration 2)Ascites and/or pleural effusion attributed to tumor; 3)solid and/or cystic abnormalities on radiographic imaging that don't meet RECIST definitions for target lesions."|participants|Number|6|6.0||||||
4295943|NCT00526799|4122495|B3|Measurable Disease (RECIST)||Response Evaluation|"Response Evaluation Criteria in Solid Tumors (RECIST):~Measurable disease is defined by the presence of at least one measureable lesion. If the measureable disease is restricted to a solitary lesion, its neoplastic nature should be confirmed by cytology/histology.~Detectable disease is defined as a patient who does not have measureable disease, but has at least one: 1)CA-125 >= 2x ULN w/in 14d prior to registration 2)Ascites and/or pleural effusion attributed to tumor; 3)solid and/or cystic abnormalities on radiographic imaging that don't meet RECIST definitions for target lesions."|participants|Number|22|22.0||||||
4295944|NCT00526799|4122496|B2|Measurable Disease (RECIST)||Response Evaluation|"Response Evaluation Criteria in Solid Tumors (RECIST):~Measurable disease is defined by the presence of at least one measureable lesion. If the measureable disease is restricted to a solitary lesion, its neoplastic nature should be confirmed by cytology/histology.~Detectable disease is defined as a patient who does not have measureable disease, but has at least one: 1)CA-125 >= 2x ULN w/in 14d prior to registration 2)Ascites and/or pleural effusion attributed to tumor; 3)solid and/or cystic abnormalities on radiographic imaging that don't meet RECIST definitions for target lesions."|participants|Number|12|12.0||||||
4295945|NCT00526799|4122497|B1|Measurable Disease (RECIST)||Response Evaluation|"Response Evaluation Criteria in Solid Tumors (RECIST):~Measurable disease is defined by the presence of at least one measureable lesion. If the measureable disease is restricted to a solitary lesion, its neoplastic nature should be confirmed by cytology/histology.~Detectable disease is defined as a patient who does not have measureable disease, but has at least one: 1)CA-125 >= 2x ULN w/in 14d prior to registration 2)Ascites and/or pleural effusion attributed to tumor; 3)solid and/or cystic abnormalities on radiographic imaging that don't meet RECIST definitions for target lesions."|participants|Number|10|10.0||||||
4295946|NCT00526799|4122495|B3|||Number of Prior Therapies||Prior Therapies|Median|2|2.0|Full Range|||1.0|3.0|
4295947|NCT00526799|4122496|B2|||Number of Prior Therapies||Prior Therapies|Median|3|3.0|Full Range|||1.0|3.0|
4295948|NCT00526799|4122497|B1|||Number of Prior Therapies||Prior Therapies|Median|2|2.0|Full Range|||1.0|3.0|
4295949|NCT00526799|4122495|B3|Other||Histology||participants|Number|4|4.0||||||
4295950|NCT00526799|4122496|B2|Other||Histology||participants|Number|1|1.0||||||
4295951|NCT00526799|4122497|B1|Other||Histology||participants|Number|3|3.0||||||
4295952|NCT00526799|4122495|B3|Endometroid||Histology||participants|Number|5|5.0||||||
4295953|NCT00526799|4122496|B2|Endometroid||Histology||participants|Number|1|1.0||||||
4295954|NCT00526799|4122497|B1|Endometroid||Histology||participants|Number|4|4.0||||||
4295955|NCT00526799|4122495|B3|Clear Cell||Histology||participants|Number|1|1.0||||||
4295956|NCT00526799|4122496|B2|Clear Cell||Histology||participants|Number|0|0.0||||||
4295957|NCT00526799|4122497|B1|Clear Cell||Histology||participants|Number|1|1.0||||||
4295958|NCT00526799|4122495|B3|Serous Papillary||Histology||participants|Number|20|20.0||||||
4295959|NCT00526799|4122496|B2|Serous Papillary||Histology||participants|Number|12|12.0||||||
4295960|NCT00526799|4122497|B1|Serous Papillary||Histology||participants|Number|8|8.0||||||
4295961|NCT00526799|4122495|B3|Primary Peritoneal Carcinomatosis||Origin of Cancer||participants|Number|3|3.0||||||
4295962|NCT00526799|4122496|B2|Primary Peritoneal Carcinomatosis||Origin of Cancer||participants|Number|1|1.0||||||
4295963|NCT00526799|4122497|B1|Primary Peritoneal Carcinomatosis||Origin of Cancer||participants|Number|2|2.0||||||
4295964|NCT00526799|4122495|B3|Epithelial Ovarian Cancer||Origin of Cancer||participants|Number|27|27.0||||||
4295965|NCT00526799|4122496|B2|Epithelial Ovarian Cancer||Origin of Cancer||participants|Number|13|13.0||||||
4295966|NCT00526799|4122497|B1|Epithelial Ovarian Cancer||Origin of Cancer||participants|Number|14|14.0||||||
4295967|NCT00526799|4122495|B3|ECOG=1||Eastern Cooperative Onocology Group (ECOG) Perfomance Status|ECOG: Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0-5 that describes a patient's level of functioning where 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Dead|participants|Number|8|8.0||||||
4295968|NCT00526799|4122496|B2|ECOG=1||Eastern Cooperative Onocology Group (ECOG) Perfomance Status|ECOG: Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0-5 that describes a patient's level of functioning where 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Dead|participants|Number|1|1.0||||||
4295969|NCT00526799|4122497|B1|ECOG=1||Eastern Cooperative Onocology Group (ECOG) Perfomance Status|ECOG: Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0-5 that describes a patient's level of functioning where 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Dead|participants|Number|7|7.0||||||
4295970|NCT00526799|4122495|B3|ECOG=0||Eastern Cooperative Onocology Group (ECOG) Perfomance Status|ECOG: Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0-5 that describes a patient's level of functioning where 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Dead|participants|Number|22|22.0||||||
4296020|NCT00526591|4122565|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4296021|NCT00526591|4122566|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4295972|NCT00526799|4122497|B1|ECOG=0||Eastern Cooperative Onocology Group (ECOG) Perfomance Status|ECOG: Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0-5 that describes a patient's level of functioning where 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Dead|participants|Number|9|9.0||||||
4295973|NCT00526799|4122495|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4295974|NCT00526799|4122496|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4295975|NCT00526799|4122497|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4295976|NCT00526799|4122495|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4295977|NCT00526799|4122496|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4295978|NCT00526799|4122497|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4295979|NCT00526799|4122495|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4295980|NCT00526799|4122496|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4295981|NCT00526799|4122497|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4295982|NCT00526799|4122495|B3||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4295983|NCT00526799|4122496|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4295984|NCT00526799|4122497|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4295985|NCT00526799|4122495|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4295986|NCT00526799|4122496|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4295987|NCT00526799|4122497|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4295988|NCT00526799|4122495|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4295989|NCT00526799|4122496|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4295990|NCT00526799|4122497|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4295991|NCT00526799|4122495|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4295992|NCT00526799|4122496|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4295993|NCT00526799|4122497|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4295994|NCT00526799|4122495|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4295995|NCT00526799|4122496|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4295996|NCT00526799|4122497|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4295997|NCT00526799|4122495|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4295998|NCT00526799|4122496|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4295999|NCT00526799|4122497|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4296000|NCT00526799|4122495|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4296001|NCT00526799|4122496|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4296002|NCT00526799|4122497|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4296003|NCT00526799|4122495|B3|||Age||years|Median|52.5|52.5|Full Range|||35.0|79.0|
4296004|NCT00526799|4122496|B2|||Age||years|Median|52.5|52.5|Full Range|||35.0|79.0|
4296005|NCT00526799|4122497|B1|||Age||years|Median|52.5|52.5|Full Range|||41.0|66.0|
4296006|NCT00526669|4122506|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Baseline data were collected in members of the Intent-to-Treat Population, comprised of all participants who entered the study and received at least one dose of lapatinib.|participants|Number|1|1.0||||||
4296007|NCT00526669|4122506|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized|Baseline data were collected in members of the Intent-to-Treat Population, comprised of all participants who entered the study and received at least one dose of lapatinib.|participants|Number|2|2.0||||||
4296008|NCT00526669|4122506|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized|Baseline data were collected in members of the Intent-to-Treat Population, comprised of all participants who entered the study and received at least one dose of lapatinib.|participants|Number|30|30.0||||||
4296009|NCT00526669|4122506|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|Baseline data were collected in members of the Intent-to-Treat Population, comprised of all participants who entered the study and received at least one dose of lapatinib.|participants|Number|34|34.0||||||
4296010|NCT00526669|4122506|B1||Male|Sex: Female, Male|Baseline data were collected in members of the Intent-to-Treat Population, comprised of all participants who entered the study and received at least one dose of lapatinib.|Participants|Count of Participants|50|50.0||||||
4296011|NCT00526669|4122506|B1||Female|Sex: Female, Male|Baseline data were collected in members of the Intent-to-Treat Population, comprised of all participants who entered the study and received at least one dose of lapatinib.|Participants|Count of Participants|17|17.0||||||
4296012|NCT00526669|4122506|B1|||Age|Baseline data were collected in members of the Intent-to-Treat Population, comprised of all participants who entered the study and received at least one dose of lapatinib.|Years|Mean|61.4|61.4|Standard Deviation|12.57|12.57|||
4296013|NCT00526630|4122536|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4296014|NCT00526630|4122536|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4296015|NCT00526630|4122536|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4296016|NCT00526630|4122536|B1|||Age||years|Mean|67.6|67.6|Standard Deviation|9.6|9.6|||
4296017|NCT00526591|4122565|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4296018|NCT00526591|4122566|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4296019|NCT00526591|4122567|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4296024|NCT00526591|4122566|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4296025|NCT00526591|4122567|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4296026|NCT00526591|4122565|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4296027|NCT00526591|4122566|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4296028|NCT00526591|4122567|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4296029|NCT00526591|4122565|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4296030|NCT00526591|4122566|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4296031|NCT00526591|4122567|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4296032|NCT00526591|4122565|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4296033|NCT00526591|4122566|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4296034|NCT00526591|4122567|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4296035|NCT00526591|4122565|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4296036|NCT00526591|4122566|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4296037|NCT00526591|4122567|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4296038|NCT00526591|4122565|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4296039|NCT00526591|4122566|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4296040|NCT00526591|4122567|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4296041|NCT00526591|4122565|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4296042|NCT00526591|4122566|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4296043|NCT00526591|4122567|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4296044|NCT00526591|4122565|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4296045|NCT00526591|4122566|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4296046|NCT00526591|4122567|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4296047|NCT00526591|4122565|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4296048|NCT00526591|4122566|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4296049|NCT00526591|4122567|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4296050|NCT00526591|4122565|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4296051|NCT00526591|4122566|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4296052|NCT00526591|4122567|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4296053|NCT00526591|4122565|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4296054|NCT00526591|4122566|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4296055|NCT00526591|4122567|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4296056|NCT00526591|4122565|B3|||Age||years|Mean|59|59.0|Standard Deviation|6.2|6.2|||
4296057|NCT00526591|4122566|B2|||Age||years|Mean|59|59.0|Standard Deviation|4.5|4.5|||
4296058|NCT00526591|4122567|B1|||Age||years|Mean|58|58.0|Standard Deviation|7.9|7.9|||
4296059|NCT00526474|4122578|B3||Male|Sex: Female, Male||Participants|Count of Participants|20123|20123.0||||||
4296060|NCT00526474|4122579|B2||Male|Sex: Female, Male||Participants|Count of Participants|10071|10071.0||||||
4296061|NCT00526474|4122580|B1||Male|Sex: Female, Male||Participants|Count of Participants|10052|10052.0||||||
4296062|NCT00526474|4122578|B3||Female|Sex: Female, Male||Participants|Count of Participants|6326|6326.0||||||
4296063|NCT00526474|4122579|B2||Female|Sex: Female, Male||Participants|Count of Participants|3154|3154.0||||||
4296064|NCT00526474|4122580|B1||Female|Sex: Female, Male||Participants|Count of Participants|3172|3172.0||||||
4296065|NCT00526474|4122578|B3|>=75 years||Age, Customized||Participants|Number|3020|3020.0||||||
4296066|NCT00526474|4122579|B2|>=75 years||Age, Customized||Participants|Number|1514|1514.0||||||
4296067|NCT00526474|4122580|B1|>=75 years||Age, Customized||Participants|Number|1506|1506.0||||||
4296068|NCT00526474|4122578|B3|65-<75 years||Age, Customized||Participants|Number|6968|6968.0||||||
4296069|NCT00526474|4122579|B2|65-<75 years||Age, Customized||Participants|Number|3523|3523.0||||||
4296070|NCT00526474|4122580|B1|65-<75 years||Age, Customized||Participants|Number|3445|3445.0||||||
4296071|NCT00526474|4122578|B3|<65 years||Age, Customized||Participants|Number|16461|16461.0||||||
4296072|NCT00526474|4122579|B2|<65 years||Age, Customized||Participants|Number|8188|8188.0||||||
4296073|NCT00526474|4122580|B1|<65 years||Age, Customized||Participants|Number|8273|8273.0||||||
4296074|NCT00526331|4122649|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4296075|NCT00526331|4122649|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4296076|NCT00526331|4122649|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4296077|NCT00526331|4122649|B1|||Age||years|Median|62|62.0|Full Range|||37.0|77.0|
4296078|NCT00526292|4122653|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4296079|NCT00526292|4122653|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4296080|NCT00526292|4122653|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4296081|NCT00526292|4122653|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4296082|NCT00526292|4122653|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4296083|NCT00526227|4122657|B1|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
4296084|NCT00526227|4122657|B1|Finland||Region of Enrollment||participants|Number|3|3.0||||||
4296085|NCT00526227|4122657|B1|Saudi Arabia||Region of Enrollment||participants|Number|3|3.0||||||
4296086|NCT00526227|4122657|B1|Greece||Region of Enrollment||participants|Number|4|4.0||||||
4296087|NCT00526227|4122657|B1|Netherlands||Region of Enrollment||participants|Number|10|10.0||||||
4296088|NCT00526227|4122657|B1|Germany||Region of Enrollment||participants|Number|48|48.0||||||
4296089|NCT00526227|4122657|B1|Austria||Region of Enrollment||participants|Number|10|10.0||||||
4296090|NCT00526227|4122657|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4296091|NCT00526227|4122657|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4296092|NCT00526227|4122657|B1|||Age||years|Mean|63.4|63.4|Standard Deviation|10.45|10.45|||
4296093|NCT00526227|4122657|B1||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4296094|NCT00526227|4122657|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4296095|NCT00526227|4122657|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4296096|NCT00526188|4122662|B1|Calcification||Characterization of third liver lesion type of referral diagnosis||participants|Number|1|1.0||||||
4296097|NCT00526188|4122662|B1|Liver cyst||Characterization of third liver lesion type of referral diagnosis||participants|Number|1|1.0||||||
4296098|NCT00526188|4122662|B1|Hemangioma||Characterization of third liver lesion type of referral diagnosis||participants|Number|1|1.0||||||
4296099|NCT00526188|4122662|B1|No third liver lesion type||Characterization of third liver lesion type of referral diagnosis||participants|Number|231|231.0||||||
4296100|NCT00526188|4122662|B1|Not assessable||Characterization of second liver lesion type of referral diagnosis||participants|Number|2|2.0||||||
4296101|NCT00526188|4122662|B1|Inflammatory pseudotumor||Characterization of second liver lesion type of referral diagnosis||participants|Number|1|1.0||||||
4296102|NCT00526188|4122662|B1|Calcification||Characterization of second liver lesion type of referral diagnosis||participants|Number|1|1.0||||||
4296103|NCT00526188|4122662|B1|Liver cyst||Characterization of second liver lesion type of referral diagnosis||participants|Number|23|23.0||||||
4296104|NCT00526188|4122662|B1|Hydatid cyst||Characterization of second liver lesion type of referral diagnosis||participants|Number|1|1.0||||||
4296105|NCT00526188|4122662|B1|Hemangioma||Characterization of second liver lesion type of referral diagnosis||participants|Number|7|7.0||||||
4296106|NCT00526188|4122662|B1|Metastasis||Characterization of second liver lesion type of referral diagnosis||participants|Number|5|5.0||||||
4296107|NCT00526188|4122662|B1|Hepatocellular carcinoma||Characterization of second liver lesion type of referral diagnosis||participants|Number|3|3.0||||||
4296108|NCT00526188|4122662|B1|No second liver lesion type||Characterization of second liver lesion type of referral diagnosis||participants|Number|191|191.0||||||
4296109|NCT00526188|4122662|B1|Not assessable||Characterization of first liver lesion type of referral diagnosis||participants|Number|51|51.0||||||
4296110|NCT00526188|4122662|B1|Inflammatory pseudotumor||Characterization of first liver lesion type of referral diagnosis||participants|Number|2|2.0||||||
4296111|NCT00526188|4122662|B1|Infection||Characterization of first liver lesion type of referral diagnosis||participants|Number|1|1.0||||||
4296112|NCT00526188|4122662|B1|Harmatoma||Characterization of first liver lesion type of referral diagnosis||participants|Number|1|1.0||||||
4296113|NCT00526188|4122662|B1|Inflammation||Characterization of first liver lesion type of referral diagnosis||participants|Number|1|1.0||||||
4296114|NCT00526188|4122662|B1|Liver cyst||Characterization of first liver lesion type of referral diagnosis||participants|Number|13|13.0||||||
4296115|NCT00526188|4122662|B1|Focal fatty infiltration||Characterization of first liver lesion type of referral diagnosis||participants|Number|1|1.0||||||
4296116|NCT00526188|4122662|B1|Abscess||Characterization of first liver lesion type of referral diagnosis||participants|Number|2|2.0||||||
4296117|NCT00526188|4122662|B1|Hemangioma||Characterization of first liver lesion type of referral diagnosis||participants|Number|42|42.0||||||
4296118|NCT00526188|4122662|B1|Focal nodular hyperplasia||Characterization of first liver lesion type of referral diagnosis||participants|Number|14|14.0||||||
4296119|NCT00526188|4122662|B1|Metastasis||Characterization of first liver lesion type of referral diagnosis||participants|Number|58|58.0||||||
4296120|NCT00526188|4122662|B1|Cholangiocarcinoma||Characterization of first liver lesion type of referral diagnosis||participants|Number|1|1.0||||||
4296121|NCT00526188|4122662|B1|Hepatocellular carcinoma||Characterization of first liver lesion type of referral diagnosis||participants|Number|47|47.0||||||
4296122|NCT00526188|4122662|B1||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4296123|NCT00526188|4122662|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4296124|NCT00526188|4122662|B1|||Age||years|Mean|50.2|50.2|Standard Deviation|11.78|11.78|||
4296125|NCT00526162|4122668|B1|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
4296126|NCT00526162|4122668|B1|France||Region of Enrollment||participants|Number|3|3.0||||||
4296127|NCT00526162|4122668|B1|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4296128|NCT00526162|4122668|B1|Switzerland||Region of Enrollment||participants|Number|5|5.0||||||
4296129|NCT00526162|4122668|B1|Denmark||Region of Enrollment||participants|Number|5|5.0||||||
4296130|NCT00526162|4122668|B1|Norway||Region of Enrollment||participants|Number|6|6.0||||||
4296131|NCT00526162|4122668|B1|Netherlands||Region of Enrollment||participants|Number|7|7.0||||||
4296132|NCT00526162|4122668|B1|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
4296133|NCT00526162|4122668|B1|Israel||Region of Enrollment||participants|Number|15|15.0||||||
4296134|NCT00526162|4122668|B1|Germany||Region of Enrollment||participants|Number|23|23.0||||||
4296135|NCT00526162|4122668|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4296136|NCT00526162|4122668|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4296137|NCT00526162|4122668|B1|||Age||years|Mean|66.0|66.0|Standard Deviation|10.18|10.18|||
4296138|NCT00526162|4122668|B1||>=65 years|Age||Participants|Count of Participants|47|47.0||||||
4296139|NCT00526162|4122668|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4296140|NCT00526162|4122668|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4296141|NCT00526123|4122673|B3|United States||Region of Enrollment||participants|Number|599|599.0||||||
4296142|NCT00526123|4122674|B2|United States||Region of Enrollment||participants|Number|296|296.0||||||
4296143|NCT00526123|4122675|B1|United States||Region of Enrollment||participants|Number|303|303.0||||||
4296144|NCT00526123|4122673|B3||Male|Sex: Female, Male||Participants|Count of Participants|290|290.0||||||
4296145|NCT00526123|4122674|B2||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4296146|NCT00526123|4122675|B1||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4296147|NCT00526123|4122673|B3||Female|Sex: Female, Male||Participants|Count of Participants|309|309.0||||||
4296148|NCT00526123|4122674|B2||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4296149|NCT00526123|4122675|B1||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4296150|NCT00526123|4122673|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|14.92|14.92|||
4296151|NCT00526123|4122674|B2|||Age||years|Mean|58.9|58.9|Standard Deviation|15.34|15.34|||
4296152|NCT00526123|4122675|B1|||Age||years|Mean|60.0|60.0|Standard Deviation|14.49|14.49|||
4296153|NCT00526123|4122673|B3||>=65 years|Age||Participants|Count of Participants|229|229.0||||||
4296154|NCT00526123|4122674|B2||>=65 years|Age||Participants|Count of Participants|115|115.0||||||
4296155|NCT00526123|4122675|B1||>=65 years|Age||Participants|Count of Participants|114|114.0||||||
4296156|NCT00526123|4122673|B3||Between 18 and 65 years|Age||Participants|Count of Participants|369|369.0||||||
4296157|NCT00526123|4122674|B2||Between 18 and 65 years|Age||Participants|Count of Participants|180|180.0||||||
4296158|NCT00526123|4122675|B1||Between 18 and 65 years|Age||Participants|Count of Participants|189|189.0||||||
4296159|NCT00526123|4122673|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4296160|NCT00526123|4122674|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4296161|NCT00526123|4122675|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4296162|NCT00526110|4122696|B3|United States||Region of Enrollment||participants|Number|98|98.0||||||
4296163|NCT00526110|4122697|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
4296164|NCT00526110|4122698|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
4296165|NCT00526110|4122696|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4296166|NCT00526110|4122697|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4296167|NCT00526110|4122698|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4296168|NCT00526110|4122696|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4296169|NCT00526110|4122697|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4296170|NCT00526110|4122698|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4296171|NCT00526110|4122696|B3|||Age||years|Median|57|57.0|Full Range|||24.0|79.0|
4296172|NCT00526110|4122697|B2|||Age||years|Median|59|59.0|Full Range|||34.0|79.0|
4296173|NCT00526110|4122698|B1|||Age||years|Median|55|55.0|Full Range|||24.0|76.0|
4296174|NCT00526097|4122706|B3|||Baseline value for sodium (normalized value)|Normalized value: the reported laboratory value is converted by linear transformation to a preferred unit and then linear-transformed with respect to the standard reference range (Placebo: N=120, Bisacodyl: N=245)|mmol/L|Mean|139.4|139.4|Standard Deviation|2.24|2.24|||
4296175|NCT00526097|4122707|B2|||Baseline value for sodium (normalized value)|Normalized value: the reported laboratory value is converted by linear transformation to a preferred unit and then linear-transformed with respect to the standard reference range (Placebo: N=120, Bisacodyl: N=245)|mmol/L|Mean|139.3|139.3|Standard Deviation|2.30|2.3|||
4296176|NCT00526097|4122708|B1|||Baseline value for sodium (normalized value)|Normalized value: the reported laboratory value is converted by linear transformation to a preferred unit and then linear-transformed with respect to the standard reference range (Placebo: N=120, Bisacodyl: N=245)|mmol/L|Mean|139.5|139.5|Standard Deviation|2.13|2.13|||
4296177|NCT00526097|4122706|B3|||Baseline value for potassium (normalized value)|Normalized value: the reported laboratory value is converted by linear transformation to a preferred unit and then linear-transformed with respect to the standard reference range (Placebo: N=120, Bisacodyl: N=244)|mmol/L|Mean|4.2|4.2|Standard Deviation|0.33|0.33|||
4296178|NCT00526097|4122707|B2|||Baseline value for potassium (normalized value)|Normalized value: the reported laboratory value is converted by linear transformation to a preferred unit and then linear-transformed with respect to the standard reference range (Placebo: N=120, Bisacodyl: N=244)|mmol/L|Mean|4.2|4.2|Standard Deviation|0.33|0.33|||
4296179|NCT00526097|4122708|B1|||Baseline value for potassium (normalized value)|Normalized value: the reported laboratory value is converted by linear transformation to a preferred unit and then linear-transformed with respect to the standard reference range (Placebo: N=120, Bisacodyl: N=244)|mmol/L|Mean|4.2|4.2|Standard Deviation|0.33|0.33|||
4296180|NCT00526097|4122706|B3|||Baseline value for chloride (normalized value)|Normalized value: the reported laboratory value is converted by linear transformation to a preferred unit and then linear-transformed with respect to the standard reference range (Placebo: N=120, Bisacodyl: N=245)|mmol/L|Mean|103.8|103.8|Standard Deviation|2.69|2.69|||
4296181|NCT00526097|4122707|B2|||Baseline value for chloride (normalized value)|Normalized value: the reported laboratory value is converted by linear transformation to a preferred unit and then linear-transformed with respect to the standard reference range (Placebo: N=120, Bisacodyl: N=245)|mmol/L|Mean|103.7|103.7|Standard Deviation|2.85|2.85|||
4296362|NCT00525915|4122911|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4296430|NCT00525824|4122938|B5|||Age||years|Mean|62.0|62.0|Standard Deviation|9.66|9.66|||
4296182|NCT00526097|4122708|B1|||Baseline value for chloride (normalized value)|Normalized value: the reported laboratory value is converted by linear transformation to a preferred unit and then linear-transformed with respect to the standard reference range (Placebo: N=120, Bisacodyl: N=245)|mmol/L|Mean|104.0|104.0|Standard Deviation|2.33|2.33|||
4296183|NCT00526097|4122706|B3|||Baseline subscore'Worries and concerns (WCC)' of Patient Assessment of Constipation-QoL(PAC-QoL)|The PAC-QoL is a 28-item (5-point Likert scale ranging from 0 (none of the time or not at all) to 4 (all of the time or extremely). Single item scores are inverted, if applicable, to ensure that a lower score indicates a better QoL (Placebo: N=121, Bisacodyl: N=245)|Score on a scale|Mean|1.4|1.4|Standard Deviation|0.9|0.9|||
4296184|NCT00526097|4122707|B2|||Baseline subscore'Worries and concerns (WCC)' of Patient Assessment of Constipation-QoL(PAC-QoL)|The PAC-QoL is a 28-item (5-point Likert scale ranging from 0 (none of the time or not at all) to 4 (all of the time or extremely). Single item scores are inverted, if applicable, to ensure that a lower score indicates a better QoL (Placebo: N=121, Bisacodyl: N=245)|Score on a scale|Mean|1.5|1.5|Standard Deviation|0.9|0.9|||
4296185|NCT00526097|4122708|B1|||Baseline subscore'Worries and concerns (WCC)' of Patient Assessment of Constipation-QoL(PAC-QoL)|The PAC-QoL is a 28-item (5-point Likert scale ranging from 0 (none of the time or not at all) to 4 (all of the time or extremely). Single item scores are inverted, if applicable, to ensure that a lower score indicates a better QoL (Placebo: N=121, Bisacodyl: N=245)|Score on a scale|Mean|1.4|1.4|Standard Deviation|0.8|0.8|||
4296186|NCT00526097|4122706|B3|||Baseline subscore 'Satisfaction (SAT)' of PAC-QoL|The PAC-QoL is a 28-item (5-point Likert scale ranging from 0 (none of the time or not at all) to 4 (all of the time or extremely). Single item scores are inverted, if applicable, to ensure that a lower score indicates a better QoL (Placebo: N=120, Bisacodyl: N=245)|Score on a scale|Mean|2.9|2.9|Standard Deviation|0.8|0.8|||
4296187|NCT00526097|4122707|B2|||Baseline subscore 'Satisfaction (SAT)' of PAC-QoL|The PAC-QoL is a 28-item (5-point Likert scale ranging from 0 (none of the time or not at all) to 4 (all of the time or extremely). Single item scores are inverted, if applicable, to ensure that a lower score indicates a better QoL (Placebo: N=120, Bisacodyl: N=245)|Score on a scale|Mean|2.8|2.8|Standard Deviation|0.8|0.8|||
4296188|NCT00526097|4122708|B1|||Baseline subscore 'Satisfaction (SAT)' of PAC-QoL|The PAC-QoL is a 28-item (5-point Likert scale ranging from 0 (none of the time or not at all) to 4 (all of the time or extremely). Single item scores are inverted, if applicable, to ensure that a lower score indicates a better QoL (Placebo: N=120, Bisacodyl: N=245)|Score on a scale|Mean|3.0|3.0|Standard Deviation|0.7|0.7|||
4296189|NCT00526097|4122706|B3|||Baseline subscore 'Psychosocial discomfort (PSD)' of PAC-QoL|The PAC-QoL is a 28-item (5-point Likert scale ranging from 0 (none of the time or not at all) to 4 (all of the time or extremely). Single item scores are inverted, if applicable, to ensure that a lower score indicates a better QoL (Placebo: N=121, Bisacodyl: N=245)|Score on a scale|Mean|0.9|0.9|Standard Deviation|0.8|0.8|||
4296190|NCT00526097|4122707|B2|||Baseline subscore 'Psychosocial discomfort (PSD)' of PAC-QoL|The PAC-QoL is a 28-item (5-point Likert scale ranging from 0 (none of the time or not at all) to 4 (all of the time or extremely). Single item scores are inverted, if applicable, to ensure that a lower score indicates a better QoL (Placebo: N=121, Bisacodyl: N=245)|Score on a scale|Mean|0.9|0.9|Standard Deviation|0.8|0.8|||
4296191|NCT00526097|4122708|B1|||Baseline subscore 'Psychosocial discomfort (PSD)' of PAC-QoL|The PAC-QoL is a 28-item (5-point Likert scale ranging from 0 (none of the time or not at all) to 4 (all of the time or extremely). Single item scores are inverted, if applicable, to ensure that a lower score indicates a better QoL (Placebo: N=121, Bisacodyl: N=245)|Score on a scale|Mean|0.8|0.8|Standard Deviation|0.8|0.8|||
4296192|NCT00526097|4122706|B3|||Baseline subscore 'Physical discomfort (PHD)' of PAC-QoL|The PAC-QoL is a 28-item (5-point Likert scale ranging from 0 (none of the time or not at all) to 4 (all of the time or extremely). Single item scores are inverted, if applicable, to ensure that a lower score indicates a better QoL (Placebo: N=120, Bisacodyl: N=245)|Score on a scale|Mean|2.0|2.0|Standard Deviation|0.9|0.9|||
4296193|NCT00526097|4122707|B2|||Baseline subscore 'Physical discomfort (PHD)' of PAC-QoL|The PAC-QoL is a 28-item (5-point Likert scale ranging from 0 (none of the time or not at all) to 4 (all of the time or extremely). Single item scores are inverted, if applicable, to ensure that a lower score indicates a better QoL (Placebo: N=120, Bisacodyl: N=245)|Score on a scale|Mean|2.0|2.0|Standard Deviation|0.9|0.9|||
4296194|NCT00526097|4122708|B1|||Baseline subscore 'Physical discomfort (PHD)' of PAC-QoL|The PAC-QoL is a 28-item (5-point Likert scale ranging from 0 (none of the time or not at all) to 4 (all of the time or extremely). Single item scores are inverted, if applicable, to ensure that a lower score indicates a better QoL (Placebo: N=120, Bisacodyl: N=245)|Score on a scale|Mean|1.9|1.9|Standard Deviation|0.8|0.8|||
4296195|NCT00526097|4122706|B3|||Baseline overall score (OSC) of PAC-QoL|The PAC-QoL is a 28-item (5-point Likert scale ranging from 0 (none of the time or not at all) to 4 (all of the time or extremely). Single item scores are inverted, if applicable, to ensure that a lower score indicates a better QoL (Placebo: N=119, Bisacodyl: N=245)|Score on a scale|Mean|1.8|1.8|Standard Deviation|0.7|0.7|||
4296196|NCT00526097|4122707|B2|||Baseline overall score (OSC) of PAC-QoL|The PAC-QoL is a 28-item (5-point Likert scale ranging from 0 (none of the time or not at all) to 4 (all of the time or extremely). Single item scores are inverted, if applicable, to ensure that a lower score indicates a better QoL (Placebo: N=119, Bisacodyl: N=245)|Score on a scale|Mean|1.8|1.8|Standard Deviation|0.7|0.7|||
4296197|NCT00526097|4122708|B1|||Baseline overall score (OSC) of PAC-QoL|The PAC-QoL is a 28-item (5-point Likert scale ranging from 0 (none of the time or not at all) to 4 (all of the time or extremely). Single item scores are inverted, if applicable, to ensure that a lower score indicates a better QoL (Placebo: N=119, Bisacodyl: N=245)|Score on a scale|Mean|1.8|1.8|Standard Deviation|0.6|0.6|||
4296198|NCT00526097|4122706|B3|||Baseline number of Spontaneous Bowel Movements (SBMs)|Spontaneous BM (SBM): non-rescue medication-induced BM; Baseline number of SBMs is defined by the number of SBMs during the last week of the baseline period without study medication|SBMs per week|Mean|4.3|4.3|Standard Deviation|3.6|3.6|||
4296199|NCT00526097|4122707|B2|||Baseline number of Spontaneous Bowel Movements (SBMs)|Spontaneous BM (SBM): non-rescue medication-induced BM; Baseline number of SBMs is defined by the number of SBMs during the last week of the baseline period without study medication|SBMs per week|Mean|4.4|4.4|Standard Deviation|3.9|3.9|||
4296363|NCT00525915|4122909|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4296200|NCT00526097|4122708|B1|||Baseline number of Spontaneous Bowel Movements (SBMs)|Spontaneous BM (SBM): non-rescue medication-induced BM; Baseline number of SBMs is defined by the number of SBMs during the last week of the baseline period without study medication|SBMs per week|Mean|4.2|4.2|Standard Deviation|2.6|2.6|||
4296201|NCT00526097|4122706|B3|||Baseline number of Complete Spontaneous Bowel Movements (CSBMs)|Complete Spontaneous Bowel Movement (CSBM): complete non-rescue medication-induced BM; Baseline number of CSBMs is defined by the number of CSBMs during the last week of the baseline period without study medication|CSBMs per week|Mean|1.1|1.1|Standard Deviation|1.2|1.2|||
4296202|NCT00526097|4122707|B2|||Baseline number of Complete Spontaneous Bowel Movements (CSBMs)|Complete Spontaneous Bowel Movement (CSBM): complete non-rescue medication-induced BM; Baseline number of CSBMs is defined by the number of CSBMs during the last week of the baseline period without study medication|CSBMs per week|Mean|1.1|1.1|Standard Deviation|1.2|1.2|||
4296203|NCT00526097|4122708|B1|||Baseline number of Complete Spontaneous Bowel Movements (CSBMs)|Complete Spontaneous Bowel Movement (CSBM): complete non-rescue medication-induced BM; Baseline number of CSBMs is defined by the number of CSBMs during the last week of the baseline period without study medication|CSBMs per week|Mean|1.0|1.0|Standard Deviation|1.1|1.1|||
4296204|NCT00526097|4122706|B3|||Baseline mean score for constipation symptom 'Straining'|The score on a 5-point ordinal verbal rating scale from 0 (absent) to 4 (very severe) specifying patient's symptom assessment associated with each bowel movement was averaged over the day and then averaged over the days in the last week of the baseline period without study medication. (Placebo: N=116, Bisacodyl: N=231)|Score on a scale|Mean|1.9|1.9|Standard Deviation|0.8|0.8|||
4296205|NCT00526097|4122707|B2|||Baseline mean score for constipation symptom 'Straining'|The score on a 5-point ordinal verbal rating scale from 0 (absent) to 4 (very severe) specifying patient's symptom assessment associated with each bowel movement was averaged over the day and then averaged over the days in the last week of the baseline period without study medication. (Placebo: N=116, Bisacodyl: N=231)|Score on a scale|Mean|1.8|1.8|Standard Deviation|0.8|0.8|||
4296206|NCT00526097|4122708|B1|||Baseline mean score for constipation symptom 'Straining'|The score on a 5-point ordinal verbal rating scale from 0 (absent) to 4 (very severe) specifying patient's symptom assessment associated with each bowel movement was averaged over the day and then averaged over the days in the last week of the baseline period without study medication. (Placebo: N=116, Bisacodyl: N=231)|Score on a scale|Mean|1.9|1.9|Standard Deviation|0.9|0.9|||
4296207|NCT00526097|4122706|B3|||Baseline mean score for constipation symptom 'Stool quality'|The score on the 7-point Bristol Stool Form Scale from Type 1 (hard, lumpy stool) to Type 7 (watery stool) specifying patient's symptom assessment associated with each bowel movement was averaged over the day and then averaged over the days in the last week of the baseline period without study medication. (Placebo: N=116, Bisacodyl: N=231)|Score on a scale|Mean|2.4|2.4|Standard Deviation|1.3|1.3|||
4296208|NCT00526097|4122707|B2|||Baseline mean score for constipation symptom 'Stool quality'|The score on the 7-point Bristol Stool Form Scale from Type 1 (hard, lumpy stool) to Type 7 (watery stool) specifying patient's symptom assessment associated with each bowel movement was averaged over the day and then averaged over the days in the last week of the baseline period without study medication. (Placebo: N=116, Bisacodyl: N=231)|Score on a scale|Mean|2.5|2.5|Standard Deviation|1.3|1.3|||
4296209|NCT00526097|4122708|B1|||Baseline mean score for constipation symptom 'Stool quality'|The score on the 7-point Bristol Stool Form Scale from Type 1 (hard, lumpy stool) to Type 7 (watery stool) specifying patient's symptom assessment associated with each bowel movement was averaged over the day and then averaged over the days in the last week of the baseline period without study medication. (Placebo: N=116, Bisacodyl: N=231)|Score on a scale|Mean|2.4|2.4|Standard Deviation|1.2|1.2|||
4296210|NCT00526097|4122706|B3|||Baseline mean score for constipation symptom 'Anorectal obstructions/blockade'|The score on a 5-point ordinal verbal rating scale from 0 (absent) to 4 (very severe) specifying patient's symptom assessment associated with each bowel movement was averaged over the day and then averaged over the days in the last week of the baseline period without study medication. (Placebo: N=116, Bisacodyl: N=231)|Score on a scale|Mean|1.2|1.2|Standard Deviation|1.0|1.0|||
4296211|NCT00526097|4122707|B2|||Baseline mean score for constipation symptom 'Anorectal obstructions/blockade'|The score on a 5-point ordinal verbal rating scale from 0 (absent) to 4 (very severe) specifying patient's symptom assessment associated with each bowel movement was averaged over the day and then averaged over the days in the last week of the baseline period without study medication. (Placebo: N=116, Bisacodyl: N=231)|Score on a scale|Mean|1.2|1.2|Standard Deviation|1.0|1.0|||
4296212|NCT00526097|4122708|B1|||Baseline mean score for constipation symptom 'Anorectal obstructions/blockade'|The score on a 5-point ordinal verbal rating scale from 0 (absent) to 4 (very severe) specifying patient's symptom assessment associated with each bowel movement was averaged over the day and then averaged over the days in the last week of the baseline period without study medication. (Placebo: N=116, Bisacodyl: N=231)|Score on a scale|Mean|1.2|1.2|Standard Deviation|1.0|1.0|||
4296213|NCT00526097|4122706|B3|||Baseline mean score for constipation symptom 'Manual manoeuvre'|The score on a 2-point ordinal verbal rating scale from 0 (no) to 1 (yes) specifying patient's symptom assessment associated with each bowel movement was averaged over the day and then averaged over the days in the last week of the baseline period without study medication (Placebo: N=116, Bisacodyl: N=231).|Score on a scale|Mean|0.2|0.2|Standard Deviation|0.3|0.3|||
4296214|NCT00526097|4122707|B2|||Baseline mean score for constipation symptom 'Manual manoeuvre'|The score on a 2-point ordinal verbal rating scale from 0 (no) to 1 (yes) specifying patient's symptom assessment associated with each bowel movement was averaged over the day and then averaged over the days in the last week of the baseline period without study medication (Placebo: N=116, Bisacodyl: N=231).|Score on a scale|Mean|0.2|0.2|Standard Deviation|0.3|0.3|||
4296215|NCT00526097|4122708|B1|||Baseline mean score for constipation symptom 'Manual manoeuvre'|The score on a 2-point ordinal verbal rating scale from 0 (no) to 1 (yes) specifying patient's symptom assessment associated with each bowel movement was averaged over the day and then averaged over the days in the last week of the baseline period without study medication (Placebo: N=116, Bisacodyl: N=231).|Score on a scale|Mean|0.2|0.2|Standard Deviation|0.4|0.4|||
4296364|NCT00525915|4122910|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4296365|NCT00525915|4122911|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4296216|NCT00526097|4122706|B3|||Baseline mean score for constipation symptom 'Sensation of incomplete evacuation'|The score on a 2-point ordinal verbal rating scale from 0 (no) to 1 (yes) specifying patient's symptom assessment associated with each bowel movement was averaged over the day and then averaged over the days in the last week of the baseline period without study medication (Placebo: N=120, Bisacodyl: N=240).|Score on a scale|Mean|0.7|0.7|Standard Deviation|0.3|0.3|||
4296217|NCT00526097|4122707|B2|||Baseline mean score for constipation symptom 'Sensation of incomplete evacuation'|The score on a 2-point ordinal verbal rating scale from 0 (no) to 1 (yes) specifying patient's symptom assessment associated with each bowel movement was averaged over the day and then averaged over the days in the last week of the baseline period without study medication (Placebo: N=120, Bisacodyl: N=240).|Score on a scale|Mean|0.7|0.7|Standard Deviation|0.3|0.3|||
4296218|NCT00526097|4122708|B1|||Baseline mean score for constipation symptom 'Sensation of incomplete evacuation'|The score on a 2-point ordinal verbal rating scale from 0 (no) to 1 (yes) specifying patient's symptom assessment associated with each bowel movement was averaged over the day and then averaged over the days in the last week of the baseline period without study medication (Placebo: N=120, Bisacodyl: N=240).|Score on a scale|Mean|0.7|0.7|Standard Deviation|0.3|0.3|||
4296219|NCT00526097|4122706|B3|||Baseline for the Physical Component Scale (PCS) of the SF-36 QoL scale|The PCS is a summary scale of the subscales physical functioning, role-physical, bodily pain, and general health. The component scale is norm-based to a standard population. A higher score indicates a better health. (Placebo: N=119, Bisacodyl: N=245)|Score on a scale|Mean|48.5|48.5|Standard Deviation|9.7|9.7|||
4296220|NCT00526097|4122707|B2|||Baseline for the Physical Component Scale (PCS) of the SF-36 QoL scale|The PCS is a summary scale of the subscales physical functioning, role-physical, bodily pain, and general health. The component scale is norm-based to a standard population. A higher score indicates a better health. (Placebo: N=119, Bisacodyl: N=245)|Score on a scale|Mean|48.3|48.3|Standard Deviation|9.8|9.8|||
4296221|NCT00526097|4122708|B1|||Baseline for the Physical Component Scale (PCS) of the SF-36 QoL scale|The PCS is a summary scale of the subscales physical functioning, role-physical, bodily pain, and general health. The component scale is norm-based to a standard population. A higher score indicates a better health. (Placebo: N=119, Bisacodyl: N=245)|Score on a scale|Mean|48.7|48.7|Standard Deviation|9.4|9.4|||
4296222|NCT00526097|4122706|B3|||Baseline for the Mental Component Scale (MCS) of the SF-36 QoL scale|The MCS is a summary scale of the dimensions vitality, social functioning, role-emotional, and mental health. The component scale is norm-based to a standard population. A higher score indicates a better health. (Placebo: N=119, Bisacodyl: N=245)|Score on a scale|Mean|50.4|50.4|Standard Deviation|10.3|10.3|||
4296223|NCT00526097|4122707|B2|||Baseline for the Mental Component Scale (MCS) of the SF-36 QoL scale|The MCS is a summary scale of the dimensions vitality, social functioning, role-emotional, and mental health. The component scale is norm-based to a standard population. A higher score indicates a better health. (Placebo: N=119, Bisacodyl: N=245)|Score on a scale|Mean|51.1|51.1|Standard Deviation|9.8|9.8|||
4296224|NCT00526097|4122708|B1|||Baseline for the Mental Component Scale (MCS) of the SF-36 QoL scale|The MCS is a summary scale of the dimensions vitality, social functioning, role-emotional, and mental health. The component scale is norm-based to a standard population. A higher score indicates a better health. (Placebo: N=119, Bisacodyl: N=245)|Score on a scale|Mean|49.0|49.0|Standard Deviation|11.0|11.0|||
4296225|NCT00526097|4122706|B3|||Baseline for dimension 'Vitality (VT)' of the SF-36 QoL scale|The dimension is a sum of 4 single items and then transferred to a scale ranging from 0 to 100. Single item scores are inverted, if applicable, to ensure that a higher score indicates a better health.|Score on a scale|Mean|57.9|57.9|Standard Deviation|20.8|20.8|||
4296226|NCT00526097|4122707|B2|||Baseline for dimension 'Vitality (VT)' of the SF-36 QoL scale|The dimension is a sum of 4 single items and then transferred to a scale ranging from 0 to 100. Single item scores are inverted, if applicable, to ensure that a higher score indicates a better health.|Score on a scale|Mean|58.9|58.9|Standard Deviation|21.0|21.0|||
4296227|NCT00526097|4122708|B1|||Baseline for dimension 'Vitality (VT)' of the SF-36 QoL scale|The dimension is a sum of 4 single items and then transferred to a scale ranging from 0 to 100. Single item scores are inverted, if applicable, to ensure that a higher score indicates a better health.|Score on a scale|Mean|55.7|55.7|Standard Deviation|20.2|20.2|||
4296228|NCT00526097|4122706|B3|||Baseline for dimension 'Social functioning (SF)' of the SF-36 QoL scale|The dimension is a sum of 2 single items and then transferred to a scale ranging from 0 to 100. Single item scores are inverted, if applicable, to ensure that a higher score indicates a better health.|Score on a scale|Mean|85.1|85.1|Standard Deviation|21.2|21.2|||
4296229|NCT00526097|4122707|B2|||Baseline for dimension 'Social functioning (SF)' of the SF-36 QoL scale|The dimension is a sum of 2 single items and then transferred to a scale ranging from 0 to 100. Single item scores are inverted, if applicable, to ensure that a higher score indicates a better health.|Score on a scale|Mean|86.0|86.0|Standard Deviation|20.9|20.9|||
4296230|NCT00526097|4122708|B1|||Baseline for dimension 'Social functioning (SF)' of the SF-36 QoL scale|The dimension is a sum of 2 single items and then transferred to a scale ranging from 0 to 100. Single item scores are inverted, if applicable, to ensure that a higher score indicates a better health.|Score on a scale|Mean|83.4|83.4|Standard Deviation|21.6|21.6|||
4296231|NCT00526097|4122706|B3|||Baseline for dimension 'Role limitation due to physical problems (RP)' of the SF-36 QoL scale|The dimension is a sum of 4 single items and then transferred to a scale ranging from 0 to 100. Single item scores are inverted, if applicable, to ensure that a higher score indicates a better health.|Score on a scale|Mean|80.3|80.3|Standard Deviation|25.5|25.5|||
4296232|NCT00526097|4122707|B2|||Baseline for dimension 'Role limitation due to physical problems (RP)' of the SF-36 QoL scale|The dimension is a sum of 4 single items and then transferred to a scale ranging from 0 to 100. Single item scores are inverted, if applicable, to ensure that a higher score indicates a better health.|Score on a scale|Mean|80.6|80.6|Standard Deviation|25.6|25.6|||
4296233|NCT00526097|4122708|B1|||Baseline for dimension 'Role limitation due to physical problems (RP)' of the SF-36 QoL scale|The dimension is a sum of 4 single items and then transferred to a scale ranging from 0 to 100. Single item scores are inverted, if applicable, to ensure that a higher score indicates a better health.|Score on a scale|Mean|79.7|79.7|Standard Deviation|25.2|25.2|||
4296366|NCT00525915|4122909|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4296234|NCT00526097|4122706|B3|||Baseline for dimension 'Role limitation due to emotional problems (RE)' of the SF-36 QoL scale|The dimension is a sum of 3 single items and then transferred to a scale ranging from 0 to 100. Single item scores are inverted, if applicable, to ensure that a higher score indicates a better health.|Score on a scale|Mean|85.1|85.1|Standard Deviation|23.1|23.1|||
4296235|NCT00526097|4122707|B2|||Baseline for dimension 'Role limitation due to emotional problems (RE)' of the SF-36 QoL scale|The dimension is a sum of 3 single items and then transferred to a scale ranging from 0 to 100. Single item scores are inverted, if applicable, to ensure that a higher score indicates a better health.|Score on a scale|Mean|86.3|86.3|Standard Deviation|22.3|22.3|||
4296236|NCT00526097|4122708|B1|||Baseline for dimension 'Role limitation due to emotional problems (RE)' of the SF-36 QoL scale|The dimension is a sum of 3 single items and then transferred to a scale ranging from 0 to 100. Single item scores are inverted, if applicable, to ensure that a higher score indicates a better health.|Score on a scale|Mean|82.7|82.7|Standard Deviation|24.7|24.7|||
4296237|NCT00526097|4122706|B3|||Baseline for dimension 'Physical functioning (PF)' of the SF-36v2™ (SF-36) Quality of Life (QoL)|The dimension is a sum of 10 single items and then transferred to a scale ranging from 0 to 100. Single item scores are inverted, if applicable, to ensure that a higher score indicates a better health.|Score on a scale|Mean|79.8|79.8|Standard Deviation|24.5|24.5|||
4296238|NCT00526097|4122707|B2|||Baseline for dimension 'Physical functioning (PF)' of the SF-36v2™ (SF-36) Quality of Life (QoL)|The dimension is a sum of 10 single items and then transferred to a scale ranging from 0 to 100. Single item scores are inverted, if applicable, to ensure that a higher score indicates a better health.|Score on a scale|Mean|80.1|80.1|Standard Deviation|24.6|24.6|||
4296239|NCT00526097|4122708|B1|||Baseline for dimension 'Physical functioning (PF)' of the SF-36v2™ (SF-36) Quality of Life (QoL)|The dimension is a sum of 10 single items and then transferred to a scale ranging from 0 to 100. Single item scores are inverted, if applicable, to ensure that a higher score indicates a better health.|Score on a scale|Mean|79.2|79.2|Standard Deviation|24.3|24.3|||
4296240|NCT00526097|4122706|B3|||Baseline for dimension 'Mental health (MH)' of the SF-36 QoL scale|The dimension is a sum of 5 single items and then transferred to a scale ranging from 0 to 100. Single item scores are inverted, if applicable, to ensure that a higher score indicates a better health.|Score on a scale|Mean|76.1|76.1|Standard Deviation|17.2|17.2|||
4296241|NCT00526097|4122707|B2|||Baseline for dimension 'Mental health (MH)' of the SF-36 QoL scale|The dimension is a sum of 5 single items and then transferred to a scale ranging from 0 to 100. Single item scores are inverted, if applicable, to ensure that a higher score indicates a better health.|Score on a scale|Mean|77.0|77.0|Standard Deviation|16.8|16.8|||
4296242|NCT00526097|4122708|B1|||Baseline for dimension 'Mental health (MH)' of the SF-36 QoL scale|The dimension is a sum of 5 single items and then transferred to a scale ranging from 0 to 100. Single item scores are inverted, if applicable, to ensure that a higher score indicates a better health.|Score on a scale|Mean|74.2|74.2|Standard Deviation|18.0|18.0|||
4296243|NCT00526097|4122706|B3|||Baseline for dimension 'General health (GH)' of the SF-36 QoL scale|The dimension is a sum of 5 single items and then transferred to a scale ranging from 0 to 100. Single item scores are inverted, if applicable, to ensure that a higher score indicates a better health. (Placebo: N=119, Bisacodyl: N=245)|Score on a scale|Mean|69.3|69.3|Standard Deviation|20.7|20.7|||
4296244|NCT00526097|4122707|B2|||Baseline for dimension 'General health (GH)' of the SF-36 QoL scale|The dimension is a sum of 5 single items and then transferred to a scale ranging from 0 to 100. Single item scores are inverted, if applicable, to ensure that a higher score indicates a better health. (Placebo: N=119, Bisacodyl: N=245)|Score on a scale|Mean|69.9|69.9|Standard Deviation|20.6|20.6|||
4296245|NCT00526097|4122708|B1|||Baseline for dimension 'General health (GH)' of the SF-36 QoL scale|The dimension is a sum of 5 single items and then transferred to a scale ranging from 0 to 100. Single item scores are inverted, if applicable, to ensure that a higher score indicates a better health. (Placebo: N=119, Bisacodyl: N=245)|Score on a scale|Mean|68.0|68.0|Standard Deviation|21.1|21.1|||
4296246|NCT00526097|4122706|B3|||Baseline for dimension 'Bodily pain (BP)' of the SF-36 QoL scale|The dimension is a sum of 2 single items and then transferred to a scale ranging from 0 to 100. Single item scores are inverted, if applicable, to ensure that a higher score indicates a better health.|Score on a scale|Mean|67.8|67.8|Standard Deviation|25.4|25.4|||
4296247|NCT00526097|4122707|B2|||Baseline for dimension 'Bodily pain (BP)' of the SF-36 QoL scale|The dimension is a sum of 2 single items and then transferred to a scale ranging from 0 to 100. Single item scores are inverted, if applicable, to ensure that a higher score indicates a better health.|Score on a scale|Mean|67.5|67.5|Standard Deviation|26.0|26.0|||
4296248|NCT00526097|4122708|B1|||Baseline for dimension 'Bodily pain (BP)' of the SF-36 QoL scale|The dimension is a sum of 2 single items and then transferred to a scale ranging from 0 to 100. Single item scores are inverted, if applicable, to ensure that a higher score indicates a better health.|Score on a scale|Mean|68.5|68.5|Standard Deviation|24.3|24.3|||
4296249|NCT00526097|4122706|B3|Missing assessment||Baseline assessment regarding the overall satisfaction with bowel habits|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal verbal rating scale (VRS): 0 (A very great deal satisfied) to 4 (Not at all satisfied)|Participants|Number|2|2.0||||||
4296250|NCT00526097|4122707|B2|Missing assessment||Baseline assessment regarding the overall satisfaction with bowel habits|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal verbal rating scale (VRS): 0 (A very great deal satisfied) to 4 (Not at all satisfied)|Participants|Number|1|1.0||||||
4296251|NCT00526097|4122708|B1|Missing assessment||Baseline assessment regarding the overall satisfaction with bowel habits|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal verbal rating scale (VRS): 0 (A very great deal satisfied) to 4 (Not at all satisfied)|Participants|Number|1|1.0||||||
4296252|NCT00526097|4122706|B3|Not at all satisfied||Baseline assessment regarding the overall satisfaction with bowel habits|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal verbal rating scale (VRS): 0 (A very great deal satisfied) to 4 (Not at all satisfied)|Participants|Number|89|89.0||||||
4296367|NCT00525915|4122910|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4296253|NCT00526097|4122707|B2|Not at all satisfied||Baseline assessment regarding the overall satisfaction with bowel habits|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal verbal rating scale (VRS): 0 (A very great deal satisfied) to 4 (Not at all satisfied)|Participants|Number|60|60.0||||||
4296254|NCT00526097|4122708|B1|Not at all satisfied||Baseline assessment regarding the overall satisfaction with bowel habits|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal verbal rating scale (VRS): 0 (A very great deal satisfied) to 4 (Not at all satisfied)|Participants|Number|29|29.0||||||
4296255|NCT00526097|4122706|B3|Hardly satisfied||Baseline assessment regarding the overall satisfaction with bowel habits|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal verbal rating scale (VRS): 0 (A very great deal satisfied) to 4 (Not at all satisfied)|Participants|Number|137|137.0||||||
4296256|NCT00526097|4122707|B2|Hardly satisfied||Baseline assessment regarding the overall satisfaction with bowel habits|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal verbal rating scale (VRS): 0 (A very great deal satisfied) to 4 (Not at all satisfied)|Participants|Number|93|93.0||||||
4296257|NCT00526097|4122708|B1|Hardly satisfied||Baseline assessment regarding the overall satisfaction with bowel habits|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal verbal rating scale (VRS): 0 (A very great deal satisfied) to 4 (Not at all satisfied)|Participants|Number|44|44.0||||||
4296258|NCT00526097|4122706|B3|Moderately satisfied||Baseline assessment regarding the overall satisfaction with bowel habits|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal verbal rating scale (VRS): 0 (A very great deal satisfied) to 4 (Not at all satisfied)|Participants|Number|115|115.0||||||
4296259|NCT00526097|4122707|B2|Moderately satisfied||Baseline assessment regarding the overall satisfaction with bowel habits|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal verbal rating scale (VRS): 0 (A very great deal satisfied) to 4 (Not at all satisfied)|Participants|Number|74|74.0||||||
4296260|NCT00526097|4122708|B1|Moderately satisfied||Baseline assessment regarding the overall satisfaction with bowel habits|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal verbal rating scale (VRS): 0 (A very great deal satisfied) to 4 (Not at all satisfied)|Participants|Number|41|41.0||||||
4296261|NCT00526097|4122706|B3|A good deal satisfied||Baseline assessment regarding the overall satisfaction with bowel habits|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal verbal rating scale (VRS): 0 (A very great deal satisfied) to 4 (Not at all satisfied)|Participants|Number|12|12.0||||||
4296262|NCT00526097|4122707|B2|A good deal satisfied||Baseline assessment regarding the overall satisfaction with bowel habits|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal verbal rating scale (VRS): 0 (A very great deal satisfied) to 4 (Not at all satisfied)|Participants|Number|9|9.0||||||
4296263|NCT00526097|4122708|B1|A good deal satisfied||Baseline assessment regarding the overall satisfaction with bowel habits|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal verbal rating scale (VRS): 0 (A very great deal satisfied) to 4 (Not at all satisfied)|Participants|Number|3|3.0||||||
4296264|NCT00526097|4122706|B3|A very great deal satisfied||Baseline assessment regarding the overall satisfaction with bowel habits|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal verbal rating scale (VRS): 0 (A very great deal satisfied) to 4 (Not at all satisfied)|Participants|Number|13|13.0||||||
4296265|NCT00526097|4122707|B2|A very great deal satisfied||Baseline assessment regarding the overall satisfaction with bowel habits|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal verbal rating scale (VRS): 0 (A very great deal satisfied) to 4 (Not at all satisfied)|Participants|Number|10|10.0||||||
4296266|NCT00526097|4122708|B1|A very great deal satisfied||Baseline assessment regarding the overall satisfaction with bowel habits|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal verbal rating scale (VRS): 0 (A very great deal satisfied) to 4 (Not at all satisfied)|Participants|Number|3|3.0||||||
4296267|NCT00526097|4122706|B3|Missing assessment||Baseline assessment regarding the bothersomeness with constipation|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|2|2.0||||||
4296268|NCT00526097|4122707|B2|Missing assessment||Baseline assessment regarding the bothersomeness with constipation|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|1|1.0||||||
4296269|NCT00526097|4122708|B1|Missing assessment||Baseline assessment regarding the bothersomeness with constipation|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|1|1.0||||||
4296270|NCT00526097|4122706|B3|A very great deal bothersome||Baseline assessment regarding the bothersomeness with constipation|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|44|44.0||||||
4296271|NCT00526097|4122707|B2|A very great deal bothersome||Baseline assessment regarding the bothersomeness with constipation|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|33|33.0||||||
4296272|NCT00526097|4122708|B1|A very great deal bothersome||Baseline assessment regarding the bothersomeness with constipation|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|11|11.0||||||
4296273|NCT00526097|4122706|B3|A good deal bothersome||Baseline assessment regarding the bothersomeness with constipation|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|129|129.0||||||
4296274|NCT00526097|4122707|B2|A good deal bothersome||Baseline assessment regarding the bothersomeness with constipation|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|88|88.0||||||
4296275|NCT00526097|4122708|B1|A good deal bothersome||Baseline assessment regarding the bothersomeness with constipation|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|41|41.0||||||
4296276|NCT00526097|4122706|B3|Moderately bothersome||Baseline assessment regarding the bothersomeness with constipation|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|148|148.0||||||
4296277|NCT00526097|4122707|B2|Moderately bothersome||Baseline assessment regarding the bothersomeness with constipation|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|91|91.0||||||
4296278|NCT00526097|4122708|B1|Moderately bothersome||Baseline assessment regarding the bothersomeness with constipation|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|57|57.0||||||
4296279|NCT00526097|4122706|B3|Hardly bothersome||Baseline assessment regarding the bothersomeness with constipation|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|24|24.0||||||
4296280|NCT00526097|4122707|B2|Hardly bothersome||Baseline assessment regarding the bothersomeness with constipation|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|19|19.0||||||
4296281|NCT00526097|4122708|B1|Hardly bothersome||Baseline assessment regarding the bothersomeness with constipation|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|5|5.0||||||
4296282|NCT00526097|4122706|B3|Not at all bothersome||Baseline assessment regarding the bothersomeness with constipation|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|21|21.0||||||
4296283|NCT00526097|4122707|B2|Not at all bothersome||Baseline assessment regarding the bothersomeness with constipation|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|15|15.0||||||
4296284|NCT00526097|4122708|B1|Not at all bothersome||Baseline assessment regarding the bothersomeness with constipation|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|6|6.0||||||
4296285|NCT00526097|4122706|B3|Missing assessment||Baseline assessment regarding the bothersomeness with abdominal discomfort|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|2|2.0||||||
4296286|NCT00526097|4122707|B2|Missing assessment||Baseline assessment regarding the bothersomeness with abdominal discomfort|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|1|1.0||||||
4296287|NCT00526097|4122708|B1|Missing assessment||Baseline assessment regarding the bothersomeness with abdominal discomfort|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|1|1.0||||||
4296288|NCT00526097|4122706|B3|A very great deal bothersome||Baseline assessment regarding the bothersomeness with abdominal discomfort|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|31|31.0||||||
4296289|NCT00526097|4122707|B2|A very great deal bothersome||Baseline assessment regarding the bothersomeness with abdominal discomfort|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|25|25.0||||||
4296290|NCT00526097|4122708|B1|A very great deal bothersome||Baseline assessment regarding the bothersomeness with abdominal discomfort|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|6|6.0||||||
4296291|NCT00526097|4122706|B3|A good deal bothersome||Baseline assessment regarding the bothersomeness with abdominal discomfort|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|95|95.0||||||
4296292|NCT00526097|4122707|B2|A good deal bothersome||Baseline assessment regarding the bothersomeness with abdominal discomfort|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|64|64.0||||||
4296293|NCT00526097|4122708|B1|A good deal bothersome||Baseline assessment regarding the bothersomeness with abdominal discomfort|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|31|31.0||||||
4296294|NCT00526097|4122706|B3|Moderately bothersome||Baseline assessment regarding the bothersomeness with abdominal discomfort|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|138|138.0||||||
4296295|NCT00526097|4122707|B2|Moderately bothersome||Baseline assessment regarding the bothersomeness with abdominal discomfort|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|91|91.0||||||
4296296|NCT00526097|4122708|B1|Moderately bothersome||Baseline assessment regarding the bothersomeness with abdominal discomfort|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|47|47.0||||||
4296297|NCT00526097|4122706|B3|Hardly bothersome||Baseline assessment regarding the bothersomeness with abdominal discomfort|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|62|62.0||||||
4296298|NCT00526097|4122707|B2|Hardly bothersome||Baseline assessment regarding the bothersomeness with abdominal discomfort|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|40|40.0||||||
4296299|NCT00526097|4122708|B1|Hardly bothersome||Baseline assessment regarding the bothersomeness with abdominal discomfort|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|22|22.0||||||
4296300|NCT00526097|4122706|B3|Not at all bothersome||Baseline assessment regarding the bothersomeness with abdominal discomfort|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|40|40.0||||||
4296301|NCT00526097|4122707|B2|Not at all bothersome||Baseline assessment regarding the bothersomeness with abdominal discomfort|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|26|26.0||||||
4296302|NCT00526097|4122708|B1|Not at all bothersome||Baseline assessment regarding the bothersomeness with abdominal discomfort|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|14|14.0||||||
4296303|NCT00526097|4122706|B3|Missing assessment||Baseline assessment regarding the bothersomeness with abdominal bloating|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|2|2.0||||||
4296304|NCT00526097|4122707|B2|Missing assessment||Baseline assessment regarding the bothersomeness with abdominal bloating|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|1|1.0||||||
4296305|NCT00526097|4122708|B1|Missing assessment||Baseline assessment regarding the bothersomeness with abdominal bloating|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|1|1.0||||||
4296306|NCT00526097|4122706|B3|A very great deal bothersome||Baseline assessment regarding the bothersomeness with abdominal bloating|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|59|59.0||||||
4296307|NCT00526097|4122707|B2|A very great deal bothersome||Baseline assessment regarding the bothersomeness with abdominal bloating|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|47|47.0||||||
4296308|NCT00526097|4122708|B1|A very great deal bothersome||Baseline assessment regarding the bothersomeness with abdominal bloating|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|12|12.0||||||
4296309|NCT00526097|4122706|B3|A good deal bothersome||Baseline assessment regarding the bothersomeness with abdominal bloating|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|96|96.0||||||
4296310|NCT00526097|4122707|B2|A good deal bothersome||Baseline assessment regarding the bothersomeness with abdominal bloating|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|60|60.0||||||
4296311|NCT00526097|4122708|B1|A good deal bothersome||Baseline assessment regarding the bothersomeness with abdominal bloating|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|36|36.0||||||
4296312|NCT00526097|4122706|B3|Moderately bothersome||Baseline assessment regarding the bothersomeness with abdominal bloating|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|125|125.0||||||
4296313|NCT00526097|4122707|B2|Moderately bothersome||Baseline assessment regarding the bothersomeness with abdominal bloating|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|85|85.0||||||
4296368|NCT00525915|4122911|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4296369|NCT00525915|4122909|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4296314|NCT00526097|4122708|B1|Moderately bothersome||Baseline assessment regarding the bothersomeness with abdominal bloating|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|40|40.0||||||
4296315|NCT00526097|4122706|B3|Hardly bothersome||Baseline assessment regarding the bothersomeness with abdominal bloating|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|53|53.0||||||
4296316|NCT00526097|4122707|B2|Hardly bothersome||Baseline assessment regarding the bothersomeness with abdominal bloating|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|33|33.0||||||
4296317|NCT00526097|4122708|B1|Hardly bothersome||Baseline assessment regarding the bothersomeness with abdominal bloating|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|20|20.0||||||
4296318|NCT00526097|4122706|B3|Not at all bothersome||Baseline assessment regarding the bothersomeness with abdominal bloating|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|33|33.0||||||
4296319|NCT00526097|4122707|B2|Not at all bothersome||Baseline assessment regarding the bothersomeness with abdominal bloating|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|21|21.0||||||
4296320|NCT00526097|4122708|B1|Not at all bothersome||Baseline assessment regarding the bothersomeness with abdominal bloating|Baseline assessment was made at the end of the last week of the baseline period without study medication using a 5-point ordinal VRS: 0 (Not at all bothersome) to 4 (A very great deal bothersome)|Participants|Number|12|12.0||||||
4296321|NCT00526097|4122706|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4296322|NCT00526097|4122707|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4296323|NCT00526097|4122708|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4296324|NCT00526097|4122706|B3||Female|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4296325|NCT00526097|4122707|B2||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4296326|NCT00526097|4122708|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4296327|NCT00526097|4122706|B3|||Age||Years|Mean|55.4|55.4|Standard Deviation|15.6|15.6|||
4296328|NCT00526097|4122707|B2|||Age||Years|Mean|55.8|55.8|Standard Deviation|15.9|15.9|||
4296329|NCT00526097|4122708|B1|||Age||Years|Mean|54.7|54.7|Standard Deviation|15.1|15.1|||
4296330|NCT00526071|4122885|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4296331|NCT00526071|4122885|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4296332|NCT00526071|4122885|B1|||Age||years|Mean|43.1|43.1|Standard Deviation|11.33|11.33|||
4296333|NCT00526058|4122894|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4296334|NCT00526058|4122895|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4296335|NCT00526058|4122896|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4296336|NCT00526058|4122894|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4296337|NCT00526058|4122895|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4296338|NCT00526058|4122896|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4296339|NCT00526058|4122894|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4296340|NCT00526058|4122895|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4296341|NCT00526058|4122896|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4296342|NCT00526058|4122894|B3|||Age||years|Mean|58.3|58.3|Standard Deviation|8.35|8.35|||
4296343|NCT00526058|4122895|B2|||Age||years|Mean|59.7|59.7|Standard Deviation|9.15|9.15|||
4296344|NCT00526058|4122896|B1|||Age||years|Mean|57.0|57.0|Standard Deviation|7.76|7.76|||
4296345|NCT00526058|4122894|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4296346|NCT00526058|4122895|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4296347|NCT00526058|4122896|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4296348|NCT00526058|4122894|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4296349|NCT00526058|4122895|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4296350|NCT00526058|4122896|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4296351|NCT00526058|4122894|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4296352|NCT00526058|4122895|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4296353|NCT00526058|4122896|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4296354|NCT00525915|4122909|B3|United States||Region of Enrollment||participants|Number|126|126.0||||||
4296355|NCT00525915|4122910|B2|United States||Region of Enrollment||participants|Number|63|63.0||||||
4296356|NCT00525915|4122911|B1|United States||Region of Enrollment||participants|Number|63|63.0||||||
4296357|NCT00525915|4122909|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4296358|NCT00525915|4122910|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4296359|NCT00525915|4122911|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4296360|NCT00525915|4122909|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
4296361|NCT00525915|4122910|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4296370|NCT00525915|4122910|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4296371|NCT00525915|4122911|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4296372|NCT00525915|4122909|B3||White|Race (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
4296373|NCT00525915|4122910|B2||White|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4296374|NCT00525915|4122911|B1||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4296375|NCT00525915|4122909|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4296376|NCT00525915|4122910|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4296377|NCT00525915|4122911|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4296378|NCT00525915|4122909|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4296379|NCT00525915|4122910|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4296380|NCT00525915|4122911|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4296381|NCT00525915|4122909|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4296382|NCT00525915|4122910|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4296383|NCT00525915|4122911|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4296384|NCT00525915|4122909|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4296385|NCT00525915|4122910|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4296386|NCT00525915|4122911|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4296387|NCT00525915|4122909|B3||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4296388|NCT00525915|4122910|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4296389|NCT00525915|4122911|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4296390|NCT00525915|4122909|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4296391|NCT00525915|4122910|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4296392|NCT00525915|4122911|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4296393|NCT00525915|4122909|B3|||Age||years|Median|60|60.0|Full Range|||27.0|75.0|
4296394|NCT00525915|4122910|B2|||Age||years|Median|60|60.0|Full Range|||27.0|75.0|
4296395|NCT00525915|4122911|B1|||Age||years|Median|60|60.0|Full Range|||30.0|74.0|
4296396|NCT00525902|4122918|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4296397|NCT00525902|4122918|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4296398|NCT00525902|4122918|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4296399|NCT00525902|4122918|B1|||Age||years|Mean|40.9|40.9|Standard Deviation|11.6|11.6|||
4296400|NCT00525902|4122918|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4296401|NCT00525902|4122918|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4296402|NCT00525902|4122918|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4296403|NCT00525876|4122923|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4296404|NCT00525876|4122924|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4296405|NCT00525876|4122925|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4296406|NCT00525876|4122923|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4296407|NCT00525876|4122924|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4296408|NCT00525876|4122925|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4296409|NCT00525876|4122923|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4296410|NCT00525876|4122924|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4296411|NCT00525876|4122925|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4296412|NCT00525876|4122923|B3|||Age||years|Mean|59|59.0|Standard Deviation|6|6.0|||
4296413|NCT00525876|4122924|B2|||Age||years|Mean|59|59.0|Standard Deviation|6|6.0|||
4296414|NCT00525876|4122925|B1|||Age||years|Mean|59|59.0|Standard Deviation|7|7.0|||
4296415|NCT00525837|4122932|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4296416|NCT00525837|4122932|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4296417|NCT00525837|4122932|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4296418|NCT00525837|4122932|B1|Between 18 and 65 years||Age, Customized||participants|Number|18|18.0||||||
4296419|NCT00525837|4122932|B1|||Age||years|Mean|47.8|47.8|Standard Deviation|10.1|10.1|||
4296420|NCT00525824|4122938|B5||Male|Sex: Female, Male||Participants|Count of Participants|458.0|458.0||||||
4296421|NCT00525824|4122939|B4||Male|Sex: Female, Male||Participants|Count of Participants|113.0000|113.0||||||
4296422|NCT00525824|4122940|B3||Male|Sex: Female, Male||Participants|Count of Participants|105.0000|105.0||||||
4296423|NCT00525824|4122941|B2||Male|Sex: Female, Male||Participants|Count of Participants|117.0000|117.0||||||
4296424|NCT00525824|4122942|B1||Male|Sex: Female, Male||Participants|Count of Participants|123.0000|123.0||||||
4296425|NCT00525824|4122938|B5||Female|Sex: Female, Male||Participants|Count of Participants|375.0|375.0||||||
4296426|NCT00525824|4122939|B4||Female|Sex: Female, Male||Participants|Count of Participants|90.0000|90.0||||||
4296427|NCT00525824|4122940|B3||Female|Sex: Female, Male||Participants|Count of Participants|97.0000|97.0||||||
4296428|NCT00525824|4122941|B2||Female|Sex: Female, Male||Participants|Count of Participants|97.0000|97.0||||||
4296429|NCT00525824|4122942|B1||Female|Sex: Female, Male||Participants|Count of Participants|91.0000|91.0||||||
4296431|NCT00525824|4122939|B4|||Age||years|Mean|62.1|62.1|Standard Deviation|9.17|9.17|||
4296432|NCT00525824|4122940|B3|||Age||years|Mean|61.9|61.9|Standard Deviation|9.37|9.37|||
4296433|NCT00525824|4122941|B2|||Age||years|Mean|61.8|61.8|Standard Deviation|9.93|9.93|||
4296434|NCT00525824|4122942|B1|||Age||years|Mean|62.2|62.2|Standard Deviation|10.14|10.14|||
4296435|NCT00525798|4123007|B3|China||Region of Enrollment||participants|Number|448|448.0||||||
4296436|NCT00525798|4123008|B2|China||Region of Enrollment||participants|Number|224|224.0||||||
4296437|NCT00525798|4123009|B1|China||Region of Enrollment||participants|Number|224|224.0||||||
4296438|NCT00525798|4123007|B3|Italy||Region of Enrollment||participants|Number|35|35.0||||||
4296439|NCT00525798|4123008|B2|Italy||Region of Enrollment||participants|Number|17|17.0||||||
4296440|NCT00525798|4123009|B1|Italy||Region of Enrollment||participants|Number|18|18.0||||||
4296441|NCT00525798|4123007|B3|Denmark||Region of Enrollment||participants|Number|1197|1197.0||||||
4296442|NCT00525798|4123008|B2|Denmark||Region of Enrollment||participants|Number|598|598.0||||||
4296443|NCT00525798|4123009|B1|Denmark||Region of Enrollment||participants|Number|599|599.0||||||
4296444|NCT00525798|4123007|B3|Romania||Region of Enrollment||participants|Number|343|343.0||||||
4296445|NCT00525798|4123008|B2|Romania||Region of Enrollment||participants|Number|171|171.0||||||
4296446|NCT00525798|4123009|B1|Romania||Region of Enrollment||participants|Number|172|172.0||||||
4296447|NCT00525798|4123007|B3|Lithuania||Region of Enrollment||participants|Number|299|299.0||||||
4296448|NCT00525798|4123008|B2|Lithuania||Region of Enrollment||participants|Number|150|150.0||||||
4296449|NCT00525798|4123009|B1|Lithuania||Region of Enrollment||participants|Number|149|149.0||||||
4296450|NCT00525798|4123007|B3|Poland||Region of Enrollment||participants|Number|352|352.0||||||
4296451|NCT00525798|4123008|B2|Poland||Region of Enrollment||participants|Number|176|176.0||||||
4296452|NCT00525798|4123009|B1|Poland||Region of Enrollment||participants|Number|176|176.0||||||
4296453|NCT00525798|4123007|B3|Brazil||Region of Enrollment||participants|Number|984|984.0||||||
4296454|NCT00525798|4123008|B2|Brazil||Region of Enrollment||participants|Number|492|492.0||||||
4296455|NCT00525798|4123009|B1|Brazil||Region of Enrollment||participants|Number|492|492.0||||||
4296456|NCT00525798|4123007|B3|Estonia||Region of Enrollment||participants|Number|333|333.0||||||
4296457|NCT00525798|4123008|B2|Estonia||Region of Enrollment||participants|Number|166|166.0||||||
4296458|NCT00525798|4123009|B1|Estonia||Region of Enrollment||participants|Number|167|167.0||||||
4296459|NCT00525798|4123007|B3|Czech Republic||Region of Enrollment||participants|Number|462|462.0||||||
4296460|NCT00525798|4123008|B2|Czech Republic||Region of Enrollment||participants|Number|232|232.0||||||
4296461|NCT00525798|4123009|B1|Czech Republic||Region of Enrollment||participants|Number|230|230.0||||||
4296462|NCT00525798|4123007|B3|Hong Kong||Region of Enrollment||participants|Number|147|147.0||||||
4296463|NCT00525798|4123008|B2|Hong Kong||Region of Enrollment||participants|Number|73|73.0||||||
4296464|NCT00525798|4123009|B1|Hong Kong||Region of Enrollment||participants|Number|74|74.0||||||
4296465|NCT00525798|4123007|B3|France||Region of Enrollment||participants|Number|4|4.0||||||
4296466|NCT00525798|4123008|B2|France||Region of Enrollment||participants|Number|2|2.0||||||
4296467|NCT00525798|4123009|B1|France||Region of Enrollment||participants|Number|2|2.0||||||
4296468|NCT00525798|4123007|B3|United States||Region of Enrollment||participants|Number|61|61.0||||||
4296469|NCT00525798|4123008|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4296470|NCT00525798|4123009|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4296471|NCT00525798|4123007|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4296472|NCT00525798|4123008|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4296473|NCT00525798|4123009|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4296474|NCT00525798|4123007|B3||Female|Sex: Female, Male||Participants|Count of Participants|4665|4665.0||||||
4296475|NCT00525798|4123008|B2||Female|Sex: Female, Male||Participants|Count of Participants|2331|2331.0||||||
4296476|NCT00525798|4123009|B1||Female|Sex: Female, Male||Participants|Count of Participants|2334|2334.0||||||
4296477|NCT00525798|4123007|B3|||Age||years|Mean|66.8|66.8|Standard Deviation|6.14|6.14|||
4296478|NCT00525798|4123008|B2|||Age||years|Mean|67.0|67.0|Standard Deviation|6.16|6.16|||
4296479|NCT00525798|4123009|B1|||Age||years|Mean|66.5|66.5|Standard Deviation|6.12|6.12|||
4296480|NCT00525798|4123007|B3||>=65 years|Age||Participants|Count of Participants|2893|2893.0||||||
4296481|NCT00525798|4123008|B2||>=65 years|Age||Participants|Count of Participants|1471|1471.0||||||
4296482|NCT00525798|4123009|B1||>=65 years|Age||Participants|Count of Participants|1422|1422.0||||||
4296483|NCT00525798|4123007|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1772|1772.0||||||
4296484|NCT00525798|4123008|B2||Between 18 and 65 years|Age||Participants|Count of Participants|860|860.0||||||
4296485|NCT00525798|4123009|B1||Between 18 and 65 years|Age||Participants|Count of Participants|912|912.0||||||
4296486|NCT00525798|4123007|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4296487|NCT00525798|4123008|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4296488|NCT00525798|4123009|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4296489|NCT00525733|4123018|B3|||Mean CD4+ T-cell count||cells/mm^3|Mean|496|496.0|Full Range|||230.0|1066.0|
4296490|NCT00525733|4123019|B2|||Mean CD4+ T-cell count||cells/mm^3|Mean|405|405.0|Full Range|||305.0|524.0|
4296491|NCT00525733|4123020|B1|||Mean CD4+ T-cell count||cells/mm^3|Mean|539|539.0|Full Range|||230.0|1066.0|
4296492|NCT00525733|4123018|B3|||Mean log baseline HIV-1 RNA||log copies/mL|Mean|5.8|5.8|Full Range|||3.1|7.0|
4296493|NCT00525733|4123019|B2|||Mean log baseline HIV-1 RNA||log copies/mL|Mean|6.3|6.3|Full Range|||4.8|7.0|
4296494|NCT00525733|4123020|B1|||Mean log baseline HIV-1 RNA||log copies/mL|Mean|5.6|5.6|Full Range|||3.1|6.4|
4296495|NCT00525733|4123018|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
4296496|NCT00525733|4123019|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4296497|NCT00525733|4123020|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4296498|NCT00525733|4123018|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4296499|NCT00525733|4123019|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4296500|NCT00525733|4123020|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4296501|NCT00525733|4123018|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4296502|NCT00525733|4123019|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4296503|NCT00525733|4123020|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4296504|NCT00525733|4123018|B3|||Age||years|Mean|38|38.0|Full Range|||25.0|69.0|
4296505|NCT00525733|4123019|B2|||Age||years|Mean|41|41.0|Full Range|||29.0|69.0|
4296506|NCT00525733|4123020|B1|||Age||years|Mean|37|37.0|Full Range|||25.0|48.0|
4296507|NCT00525629|4123027|B1|||Triglycerides||mg/dL|Mean|199.2|199.2|Standard Deviation|22.5|22.5|||
4296508|NCT00525629|4123027|B1|||Total Cholesterol||mg/dL|Mean|207|207.0|Standard Deviation|11.8|11.8|||
4296509|NCT00525629|4123027|B1|||Body Mass Index||kg/m^2|Mean|37.1|37.1|Standard Deviation|1.4|1.4|||
4296510|NCT00525629|4123027|B1|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
4296511|NCT00525629|4123027|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4296512|NCT00525629|4123027|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4296513|NCT00525629|4123027|B1|||Age||years|Mean|59|59.0|Standard Deviation|2|2.0|||
4296514|NCT00525603|4123034|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4296515|NCT00525603|4123034|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4296516|NCT00525603|4123034|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4296517|NCT00525603|4123034|B1|||Age||years|Median|60|60.0|Full Range|||42.0|69.0|
4296518|NCT00525525|4123038|B3|United States||Region of Enrollment||participants|Number|74|74.0||||||
4296519|NCT00525525|4123039|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4296520|NCT00525525|4123040|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
4296521|NCT00525525|4123038|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4296522|NCT00525525|4123039|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4296523|NCT00525525|4123040|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4296524|NCT00525525|4123038|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4296525|NCT00525525|4123039|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4296526|NCT00525525|4123040|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4296527|NCT00525525|4123038|B3|||Age||years|Median|58|58.0|Full Range|||21.0|80.0|
4296528|NCT00525525|4123039|B2|||Age||years|Median|65|65.0|Full Range|||41.0|74.0|
4296529|NCT00525525|4123040|B1|||Age||years|Median|54|54.0|Full Range|||21.0|76.0|
4296530|NCT00525512|4123048|B3|Yes||Anticholinergic use at screening||participants|Number|241|241.0||||||
4296531|NCT00525512|4123049|B2|Yes||Anticholinergic use at screening||participants|Number|121|121.0||||||
4296532|NCT00525512|4123050|B1|Yes||Anticholinergic use at screening||participants|Number|120|120.0||||||
4296533|NCT00525512|4123048|B3|No||Anticholinergic use at screening||participants|Number|278|278.0||||||
4296534|NCT00525512|4123049|B2|No||Anticholinergic use at screening||participants|Number|139|139.0||||||
4296535|NCT00525512|4123050|B1|No||Anticholinergic use at screening||participants|Number|139|139.0||||||
4296536|NCT00525512|4123048|B3|Yes||LABA / ICS use at randomization||participants|Number|255|255.0||||||
4296537|NCT00525512|4123049|B2|Yes||LABA / ICS use at randomization||participants|Number|129|129.0||||||
4296538|NCT00525512|4123050|B1|Yes||LABA / ICS use at randomization||participants|Number|126|126.0||||||
4296539|NCT00525512|4123048|B3|No||LABA / ICS use at randomization||participants|Number|264|264.0||||||
4296540|NCT00525512|4123049|B2|No||LABA / ICS use at randomization||participants|Number|131|131.0||||||
4296541|NCT00525512|4123050|B1|No||LABA / ICS use at randomization||participants|Number|133|133.0||||||
4296542|NCT00525512|4123048|B3|Yes||ICS (Inhaled Cortico Steroid) use at randomization||participants|Number|310|310.0||||||
4296543|NCT00525512|4123049|B2|Yes||ICS (Inhaled Cortico Steroid) use at randomization||participants|Number|159|159.0||||||
4296544|NCT00525512|4123050|B1|Yes||ICS (Inhaled Cortico Steroid) use at randomization||participants|Number|151|151.0||||||
4296545|NCT00525512|4123048|B3|No||ICS (Inhaled Cortico Steroid) use at randomization||participants|Number|209|209.0||||||
4296546|NCT00525512|4123049|B2|No||ICS (Inhaled Cortico Steroid) use at randomization||participants|Number|101|101.0||||||
4296547|NCT00525512|4123050|B1|No||ICS (Inhaled Cortico Steroid) use at randomization||participants|Number|108|108.0||||||
4296548|NCT00525512|4123048|B3|Yes||LABA (Long Acting Beta Agonist) use at randomization||participants|Number|308|308.0||||||
4296549|NCT00525512|4123049|B2|Yes||LABA (Long Acting Beta Agonist) use at randomization||participants|Number|153|153.0||||||
4296550|NCT00525512|4123050|B1|Yes||LABA (Long Acting Beta Agonist) use at randomization||participants|Number|155|155.0||||||
4296551|NCT00525512|4123048|B3|No||LABA (Long Acting Beta Agonist) use at randomization||participants|Number|211|211.0||||||
4296552|NCT00525512|4123049|B2|No||LABA (Long Acting Beta Agonist) use at randomization||participants|Number|107|107.0||||||
4296553|NCT00525512|4123050|B1|No||LABA (Long Acting Beta Agonist) use at randomization||participants|Number|104|104.0||||||
4296613|NCT00525512|4123050|B1|> 55 to <= 65||Age, Customized||participants|Number|101|101.0||||||
4296554|NCT00525512|4123048|B3|Drinks - possible interference with study||Alcohol status||participants|Number|0|0.0||||||
4296555|NCT00525512|4123049|B2|Drinks - possible interference with study||Alcohol status||participants|Number|0|0.0||||||
4296556|NCT00525512|4123050|B1|Drinks - possible interference with study||Alcohol status||participants|Number|0|0.0||||||
4296557|NCT00525512|4123048|B3|Drinks - no interference with study||Alcohol status||participants|Number|282|282.0||||||
4296558|NCT00525512|4123049|B2|Drinks - no interference with study||Alcohol status||participants|Number|137|137.0||||||
4296559|NCT00525512|4123050|B1|Drinks - no interference with study||Alcohol status||participants|Number|145|145.0||||||
4296560|NCT00525512|4123048|B3|Non drinker||Alcohol status||participants|Number|237|237.0||||||
4296561|NCT00525512|4123049|B2|Non drinker||Alcohol status||participants|Number|123|123.0||||||
4296562|NCT00525512|4123050|B1|Non drinker||Alcohol status||participants|Number|114|114.0||||||
4296563|NCT00525512|4123048|B3|||BMI (Body Mass Index)||kilograms / square meter|Mean|26.4|26.4|Standard Deviation|4.31|4.31|||
4296564|NCT00525512|4123049|B2|||BMI (Body Mass Index)||kilograms / square meter|Mean|26.0|26.0|Standard Deviation|4.38|4.38|||
4296565|NCT00525512|4123050|B1|||BMI (Body Mass Index)||kilograms / square meter|Mean|26.8|26.8|Standard Deviation|4.23|4.23|||
4296566|NCT00525512|4123048|B3|||Weight||kilograms|Mean|76.4|76.4|Standard Deviation|15.5|15.5|||
4296567|NCT00525512|4123049|B2|||Weight||kilograms|Mean|75.4|75.4|Standard Deviation|16.0|16.0|||
4296568|NCT00525512|4123050|B1|||Weight||kilograms|Mean|77.4|77.4|Standard Deviation|15.0|15.0|||
4296569|NCT00525512|4123048|B3|||Height||centimeters|Mean|169.7|169.7|Standard Deviation|8.9|8.9|||
4296570|NCT00525512|4123049|B2|||Height||centimeters|Mean|169.7|169.7|Standard Deviation|9.2|9.2|||
4296571|NCT00525512|4123050|B1|||Height||centimeters|Mean|169.6|169.6|Standard Deviation|8.5|8.5|||
4296572|NCT00525512|4123048|B3|||Duration of COPD (Chronic Obstructive Pulmonary Disease)||years|Mean|8.75|8.75|Standard Deviation|6.63|6.63|||
4296573|NCT00525512|4123049|B2|||Duration of COPD (Chronic Obstructive Pulmonary Disease)||years|Mean|8.70|8.7|Standard Deviation|6.27|6.27|||
4296574|NCT00525512|4123050|B1|||Duration of COPD (Chronic Obstructive Pulmonary Disease)||years|Mean|8.80|8.8|Standard Deviation|6.99|6.99|||
4296575|NCT00525512|4123048|B3|||Smoking history||pack years|Mean|51.6|51.6|Standard Deviation|27.64|27.64|||
4296576|NCT00525512|4123049|B2|||Smoking history||pack years|Mean|52.15|52.15|Standard Deviation|28.95|28.95|||
4296577|NCT00525512|4123050|B1|||Smoking history||pack years|Mean|51.04|51.04|Standard Deviation|26.29|26.29|||
4296578|NCT00525512|4123048|B3|Currently smokes||Smoking Status||participants|Number|176|176.0||||||
4296579|NCT00525512|4123049|B2|Currently smokes||Smoking Status||participants|Number|91|91.0||||||
4296580|NCT00525512|4123050|B1|Currently smokes||Smoking Status||participants|Number|85|85.0||||||
4296581|NCT00525512|4123048|B3|Ex-smoker||Smoking Status||participants|Number|343|343.0||||||
4296582|NCT00525512|4123049|B2|Ex-smoker||Smoking Status||participants|Number|169|169.0||||||
4296583|NCT00525512|4123050|B1|Ex-smoker||Smoking Status||participants|Number|174|174.0||||||
4296584|NCT00525512|4123048|B3|Never smoked||Smoking Status||participants|Number|0|0.0||||||
4296585|NCT00525512|4123049|B2|Never smoked||Smoking Status||participants|Number|0|0.0||||||
4296586|NCT00525512|4123050|B1|Never smoked||Smoking Status||participants|Number|0|0.0||||||
4296587|NCT00525512|4123048|B3|White||Race/Ethnicity, Customized||participants|Number|463|463.0||||||
4296588|NCT00525512|4123049|B2|White||Race/Ethnicity, Customized||participants|Number|226|226.0||||||
4296589|NCT00525512|4123050|B1|White||Race/Ethnicity, Customized||participants|Number|237|237.0||||||
4296590|NCT00525512|4123048|B3|Hawaiian / Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4296591|NCT00525512|4123049|B2|Hawaiian / Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4296592|NCT00525512|4123050|B1|Hawaiian / Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4296593|NCT00525512|4123048|B3|Black / African American||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4296594|NCT00525512|4123049|B2|Black / African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4296595|NCT00525512|4123050|B1|Black / African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4296596|NCT00525512|4123048|B3|Asian||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4296597|NCT00525512|4123049|B2|Asian||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4296598|NCT00525512|4123050|B1|Asian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4296599|NCT00525512|4123048|B3|American Indian / Alaskan Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4296600|NCT00525512|4123049|B2|American Indian / Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4296601|NCT00525512|4123050|B1|American Indian / Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4296602|NCT00525512|4123048|B3||Male|Sex: Female, Male||Participants|Count of Participants|401|401.0||||||
4296603|NCT00525512|4123049|B2||Male|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4296604|NCT00525512|4123050|B1||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4296605|NCT00525512|4123048|B3||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4296606|NCT00525512|4123049|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4296607|NCT00525512|4123050|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4296608|NCT00525512|4123048|B3|> 65||Age, Customized||participants|Number|250|250.0||||||
4296609|NCT00525512|4123049|B2|> 65||Age, Customized||participants|Number|129|129.0||||||
4296610|NCT00525512|4123050|B1|> 65||Age, Customized||participants|Number|121|121.0||||||
4296611|NCT00525512|4123048|B3|> 55 to <= 65||Age, Customized||participants|Number|194|194.0||||||
4296612|NCT00525512|4123049|B2|> 55 to <= 65||Age, Customized||participants|Number|93|93.0||||||
4296614|NCT00525512|4123048|B3|<= 55||Age, Customized||participants|Number|75|75.0||||||
4296615|NCT00525512|4123049|B2|<= 55||Age, Customized||participants|Number|38|38.0||||||
4296616|NCT00525512|4123050|B1|<= 55||Age, Customized||participants|Number|37|37.0||||||
4296617|NCT00525512|4123048|B3|||Age||years|Mean|64.6|64.6|Standard Deviation|8.3|8.3|||
4296618|NCT00525512|4123049|B2|||Age||years|Mean|64.7|64.7|Standard Deviation|8.2|8.2|||
4296619|NCT00525512|4123050|B1|||Age||years|Mean|64.5|64.5|Standard Deviation|8.5|8.5|||
4296620|NCT00525499|4123191|B5|United States||Region of Enrollment||participants|Number|186|186.0||||||
4296621|NCT00525499|4123192|B4|United States||Region of Enrollment||participants|Number|46|46.0||||||
4296622|NCT00525499|4123193|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
4296623|NCT00525499|4123194|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
4296624|NCT00525499|4123195|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
4296625|NCT00525499|4123191|B5||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4296626|NCT00525499|4123192|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4296627|NCT00525499|4123193|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4296628|NCT00525499|4123194|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4296629|NCT00525499|4123195|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4296630|NCT00525499|4123191|B5||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4296631|NCT00525499|4123192|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4296632|NCT00525499|4123193|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4296633|NCT00525499|4123194|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4296634|NCT00525499|4123195|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4296635|NCT00525499|4123191|B5|||Age||years|Mean|17.9|17.9|Standard Deviation|5.2|5.2|||
4296636|NCT00525499|4123192|B4|||Age||years|Mean|18.3|18.3|Standard Deviation|5.3|5.3|||
4296637|NCT00525499|4123193|B3|||Age||years|Mean|17.7|17.7|Standard Deviation|5.8|5.8|||
4296638|NCT00525499|4123194|B2|||Age||years|Mean|18.0|18.0|Standard Deviation|4.9|4.9|||
4296639|NCT00525499|4123195|B1|||Age||years|Mean|17.7|17.7|Standard Deviation|4.9|4.9|||
4296640|NCT00525499|4123191|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4296641|NCT00525499|4123192|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4296642|NCT00525499|4123193|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4296643|NCT00525499|4123194|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4296644|NCT00525499|4123195|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4296645|NCT00525499|4123191|B5||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4296646|NCT00525499|4123192|B4||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4296647|NCT00525499|4123193|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4296648|NCT00525499|4123194|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4296649|NCT00525499|4123195|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4296650|NCT00525499|4123191|B5||<=18 years|Age||Participants|Count of Participants|129|129.0||||||
4296651|NCT00525499|4123192|B4||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
4296652|NCT00525499|4123193|B3||<=18 years|Age||Participants|Count of Participants|32|32.0||||||
4296653|NCT00525499|4123194|B2||<=18 years|Age||Participants|Count of Participants|33|33.0||||||
4296654|NCT00525499|4123195|B1||<=18 years|Age||Participants|Count of Participants|33|33.0||||||
4296655|NCT00525421|4123212|B3|No Prior Medication for OLP||Past medication for OLP|Subjects who used medications in the past for OLP|Participants|Number|3|3.0||||||
4296656|NCT00525421|4123213|B2|No Prior Medication for OLP||Past medication for OLP|Subjects who used medications in the past for OLP|Participants|Number|2|2.0||||||
4296657|NCT00525421|4123214|B1|No Prior Medication for OLP||Past medication for OLP|Subjects who used medications in the past for OLP|Participants|Number|1|1.0||||||
4296658|NCT00525421|4123212|B3|Any Prior Medication for OLP||Past medication for OLP|Subjects who used medications in the past for OLP|Participants|Number|17|17.0||||||
4296659|NCT00525421|4123213|B2|Any Prior Medication for OLP||Past medication for OLP|Subjects who used medications in the past for OLP|Participants|Number|8|8.0||||||
4296660|NCT00525421|4123214|B1|Any Prior Medication for OLP||Past medication for OLP|Subjects who used medications in the past for OLP|Participants|Number|9|9.0||||||
4296661|NCT00525421|4123212|B3|No Azathioprine||Past medication for OLP|Subjects who used medications in the past for OLP|Participants|Number|18|18.0||||||
4296662|NCT00525421|4123213|B2|No Azathioprine||Past medication for OLP|Subjects who used medications in the past for OLP|Participants|Number|9|9.0||||||
4296663|NCT00525421|4123214|B1|No Azathioprine||Past medication for OLP|Subjects who used medications in the past for OLP|Participants|Number|9|9.0||||||
4296664|NCT00525421|4123212|B3|Azathioprine||Past medication for OLP|Subjects who used medications in the past for OLP|Participants|Number|2|2.0||||||
4296665|NCT00525421|4123213|B2|Azathioprine||Past medication for OLP|Subjects who used medications in the past for OLP|Participants|Number|1|1.0||||||
4296666|NCT00525421|4123214|B1|Azathioprine||Past medication for OLP|Subjects who used medications in the past for OLP|Participants|Number|1|1.0||||||
4296667|NCT00525421|4123212|B3|No Prednisone||Past medication for OLP|Subjects who used medications in the past for OLP|Participants|Number|9|9.0||||||
4296668|NCT00525421|4123213|B2|No Prednisone||Past medication for OLP|Subjects who used medications in the past for OLP|Participants|Number|5|5.0||||||
4296669|NCT00525421|4123214|B1|No Prednisone||Past medication for OLP|Subjects who used medications in the past for OLP|Participants|Number|4|4.0||||||
4296670|NCT00525421|4123212|B3|Prednisone||Past medication for OLP|Subjects who used medications in the past for OLP|Participants|Number|11|11.0||||||
4296671|NCT00525421|4123213|B2|Prednisone||Past medication for OLP|Subjects who used medications in the past for OLP|Participants|Number|5|5.0||||||
4296672|NCT00525421|4123214|B1|Prednisone||Past medication for OLP|Subjects who used medications in the past for OLP|Participants|Number|6|6.0||||||
4296673|NCT00525421|4123212|B3|No Topical Steroids||Past medication for OLP|Subjects who used medications in the past for OLP|Participants|Number|5|5.0||||||
4296674|NCT00525421|4123213|B2|No Topical Steroids||Past medication for OLP|Subjects who used medications in the past for OLP|Participants|Number|3|3.0||||||
4296675|NCT00525421|4123214|B1|No Topical Steroids||Past medication for OLP|Subjects who used medications in the past for OLP|Participants|Number|2|2.0||||||
4296676|NCT00525421|4123212|B3|Topical Steroids||Past medication for OLP|Subjects who used medications in the past for OLP|Participants|Number|15|15.0||||||
4296677|NCT00525421|4123213|B2|Topical Steroids||Past medication for OLP|Subjects who used medications in the past for OLP|Participants|Number|7|7.0||||||
4296678|NCT00525421|4123214|B1|Topical Steroids||Past medication for OLP|Subjects who used medications in the past for OLP|Participants|Number|8|8.0||||||
4296679|NCT00525421|4123212|B3|No Ulcerations at Baseline||Presence of Oral Ulcerations||Participants|Number|13|13.0||||||
4296680|NCT00525421|4123213|B2|No Ulcerations at Baseline||Presence of Oral Ulcerations||Participants|Number|6|6.0||||||
4296681|NCT00525421|4123214|B1|No Ulcerations at Baseline||Presence of Oral Ulcerations||Participants|Number|7|7.0||||||
4296682|NCT00525421|4123212|B3|Ulcerations at Baseline||Presence of Oral Ulcerations||Participants|Number|7|7.0||||||
4296683|NCT00525421|4123213|B2|Ulcerations at Baseline||Presence of Oral Ulcerations||Participants|Number|4|4.0||||||
4296684|NCT00525421|4123214|B1|Ulcerations at Baseline||Presence of Oral Ulcerations||Participants|Number|3|3.0||||||
4296685|NCT00525421|4123212|B3|NRS 5.5-8||Symptom Score for OLP|Numerical Rating Scale (NRS): 0=No oral discomfort, 10=worst imaginable oral discomfort|Participants|Number|9|9.0||||||
4296686|NCT00525421|4123213|B2|NRS 5.5-8||Symptom Score for OLP|Numerical Rating Scale (NRS): 0=No oral discomfort, 10=worst imaginable oral discomfort|Participants|Number|4|4.0||||||
4296687|NCT00525421|4123214|B1|NRS 5.5-8||Symptom Score for OLP|Numerical Rating Scale (NRS): 0=No oral discomfort, 10=worst imaginable oral discomfort|Participants|Number|5|5.0||||||
4296688|NCT00525421|4123212|B3|NRS 3-5||Symptom Score for OLP|Numerical Rating Scale (NRS): 0=No oral discomfort, 10=worst imaginable oral discomfort|Participants|Number|11|11.0||||||
4296689|NCT00525421|4123213|B2|NRS 3-5||Symptom Score for OLP|Numerical Rating Scale (NRS): 0=No oral discomfort, 10=worst imaginable oral discomfort|Participants|Number|6|6.0||||||
4296690|NCT00525421|4123214|B1|NRS 3-5||Symptom Score for OLP|Numerical Rating Scale (NRS): 0=No oral discomfort, 10=worst imaginable oral discomfort|Participants|Number|5|5.0||||||
4296691|NCT00525421|4123212|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4296692|NCT00525421|4123213|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4296693|NCT00525421|4123214|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4296694|NCT00525421|4123212|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4296695|NCT00525421|4123213|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4296696|NCT00525421|4123214|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4296697|NCT00525421|4123212|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4296698|NCT00525421|4123213|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4296699|NCT00525421|4123214|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4296700|NCT00525421|4123212|B3|||Age||years|Mean|58.5|58.5|Standard Deviation|10.1|10.1|||
4296701|NCT00525421|4123213|B2|||Age||years|Mean|60.8|60.8|Standard Deviation|8.6|8.6|||
4296702|NCT00525421|4123214|B1|||Age||years|Mean|56.2|56.2|Standard Deviation|11.7|11.7|||
4296703|NCT00525265|4123223|B3|Japan||Region of Enrollment||participants|Number|20|20.0||||||
4296704|NCT00525265|4123224|B2|Japan||Region of Enrollment||participants|Number|10|10.0||||||
4296705|NCT00525265|4123225|B1|Japan||Region of Enrollment||participants|Number|10|10.0||||||
4296706|NCT00525265|4123223|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4296707|NCT00525265|4123224|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4296708|NCT00525265|4123225|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4296709|NCT00525265|4123223|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4296710|NCT00525265|4123224|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4296711|NCT00525265|4123225|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4296712|NCT00525265|4123223|B3|||Age||years|Mean|68.0|68.0|Standard Deviation|11.8|11.8|||
4296713|NCT00525265|4123224|B2|||Age||years|Mean|66.8|66.8|Standard Deviation|10.2|10.2|||
4296714|NCT00525265|4123225|B1|||Age||years|Mean|69.1|69.1|Standard Deviation|13.6|13.6|||
4296715|NCT00525265|4123223|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4296716|NCT00525265|4123224|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4296717|NCT00525265|4123225|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4296718|NCT00525265|4123223|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4296719|NCT00525265|4123224|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4296720|NCT00525265|4123225|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4296721|NCT00525265|4123223|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4296722|NCT00525265|4123224|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4296723|NCT00525265|4123225|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4296724|NCT00525174|4123232|B3|||Mean (SD) spherical equivalent in fellow eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value.|diopter|Mean|2.66|2.66|Standard Deviation|2.14|2.14|||
4296725|NCT00525174|4123233|B2|||Mean (SD) spherical equivalent in fellow eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value.|diopter|Mean|2.49|2.49|Standard Deviation|2.13|2.13|||
4296726|NCT00525174|4123234|B1|||Mean (SD) spherical equivalent in fellow eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value.|diopter|Mean|2.81|2.81|Standard Deviation|2.14|2.14|||
4296727|NCT00525174|4123232|B3|>= +4.00||Spherical equivalent in fellow eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopter|Number|54|54.0||||||
4296728|NCT00525174|4123233|B2|>= +4.00||Spherical equivalent in fellow eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopter|Number|22|22.0||||||
4296729|NCT00525174|4123234|B1|>= +4.00||Spherical equivalent in fellow eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopter|Number|32|32.0||||||
4296730|NCT00525174|4123232|B3|+3.00 to < +4.00||Spherical equivalent in fellow eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopter|Number|21|21.0||||||
4296731|NCT00525174|4123233|B2|+3.00 to < +4.00||Spherical equivalent in fellow eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopter|Number|13|13.0||||||
4296732|NCT00525174|4123234|B1|+3.00 to < +4.00||Spherical equivalent in fellow eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopter|Number|8|8.0||||||
4296733|NCT00525174|4123232|B3|+2.00 to < +3.00||Spherical equivalent in fellow eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopter|Number|25|25.0||||||
4296734|NCT00525174|4123233|B2|+2.00 to < +3.00||Spherical equivalent in fellow eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopter|Number|12|12.0||||||
4296735|NCT00525174|4123234|B1|+2.00 to < +3.00||Spherical equivalent in fellow eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopter|Number|13|13.0||||||
4296736|NCT00525174|4123232|B3|+1.00 to < +2.00||Spherical equivalent in fellow eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopter|Number|46|46.0||||||
4296737|NCT00525174|4123233|B2|+1.00 to < +2.00||Spherical equivalent in fellow eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopter|Number|21|21.0||||||
4296738|NCT00525174|4123234|B1|+1.00 to < +2.00||Spherical equivalent in fellow eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopter|Number|25|25.0||||||
4296739|NCT00525174|4123232|B3|0 to < +1.00||Spherical equivalent in fellow eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopter|Number|34|34.0||||||
4296740|NCT00525174|4123233|B2|0 to < +1.00||Spherical equivalent in fellow eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopter|Number|16|16.0||||||
4296741|NCT00525174|4123234|B1|0 to < +1.00||Spherical equivalent in fellow eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopter|Number|18|18.0||||||
4296742|NCT00525174|4123232|B3|<0.00||Spherical equivalent in fellow eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopter|Number|6|6.0||||||
4296743|NCT00525174|4123233|B2|<0.00||Spherical equivalent in fellow eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopter|Number|5|5.0||||||
4296744|NCT00525174|4123234|B1|<0.00||Spherical equivalent in fellow eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopter|Number|1|1.0||||||
4296745|NCT00525174|4123232|B3|||Mean (SD) spherical equivalent in amblyopic eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value.|diopter|Mean|4.29|4.29|Standard Deviation|2.38|2.38|||
4296746|NCT00525174|4123233|B2|||Mean (SD) spherical equivalent in amblyopic eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value.|diopter|Mean|4.15|4.15|Standard Deviation|2.57|2.57|||
4296747|NCT00525174|4123234|B1|||Mean (SD) spherical equivalent in amblyopic eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value.|diopter|Mean|4.41|4.41|Standard Deviation|2.21|2.21|||
4296748|NCT00525174|4123232|B3|>= +4.00||Spherical equivalent in amblyopic eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopter|Number|123|123.0||||||
4296749|NCT00525174|4123233|B2|>= +4.00||Spherical equivalent in amblyopic eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopter|Number|55|55.0||||||
4296750|NCT00525174|4123234|B1|>= +4.00||Spherical equivalent in amblyopic eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopter|Number|68|68.0||||||
4296751|NCT00525174|4123232|B3|+3.00 to < +4.00||Spherical equivalent in amblyopic eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopter|Number|23|23.0||||||
4296752|NCT00525174|4123233|B2|+3.00 to < +4.00||Spherical equivalent in amblyopic eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopter|Number|13|13.0||||||
4296753|NCT00525174|4123234|B1|+3.00 to < +4.00||Spherical equivalent in amblyopic eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopter|Number|10|10.0||||||
4296754|NCT00525174|4123232|B3|+2.00 to < +3.00||Spherical equivalent in amblyopic eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopter|Number|16|16.0||||||
4296755|NCT00525174|4123233|B2|+2.00 to < +3.00||Spherical equivalent in amblyopic eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopter|Number|10|10.0||||||
4296756|NCT00525174|4123234|B1|+2.00 to < +3.00||Spherical equivalent in amblyopic eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopter|Number|6|6.0||||||
4296757|NCT00525174|4123232|B3|+1.00 to < +2.00||Spherical equivalent in amblyopic eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopter|Number|9|9.0||||||
4296758|NCT00525174|4123233|B2|+1.00 to < +2.00||Spherical equivalent in amblyopic eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopter|Number|1|1.0||||||
4296759|NCT00525174|4123234|B1|+1.00 to < +2.00||Spherical equivalent in amblyopic eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopter|Number|8|8.0||||||
4296760|NCT00525174|4123232|B3|0 to < +1.00||Spherical equivalent in amblyopic eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopter|Number|4|4.0||||||
4296761|NCT00525174|4123233|B2|0 to < +1.00||Spherical equivalent in amblyopic eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopter|Number|2|2.0||||||
4296762|NCT00525174|4123234|B1|0 to < +1.00||Spherical equivalent in amblyopic eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopter|Number|2|2.0||||||
4296763|NCT00525174|4123232|B3|<0.00||Spherical equivalent in amblyopic eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopter|Number|11|11.0||||||
4296764|NCT00525174|4123233|B2|<0.00||Spherical equivalent in amblyopic eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopter|Number|8|8.0||||||
4296765|NCT00525174|4123234|B1|<0.00||Spherical equivalent in amblyopic eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopter|Number|3|3.0||||||
4296766|NCT00525174|4123232|B3|||Intereye acuity difference|The difference between eyes in logMAR acuity was calculated with positive values indicating sound eye better. One letter = .02 logMAR, .1 logMAR = 5 letters or one line of visual acuity.|logMAR line|Mean|4.1|4.1|Standard Deviation|1.1|1.1|||
4296767|NCT00525174|4123233|B2|||Intereye acuity difference|The difference between eyes in logMAR acuity was calculated with positive values indicating sound eye better. One letter = .02 logMAR, .1 logMAR = 5 letters or one line of visual acuity.|logMAR line|Mean|4.1|4.1|Standard Deviation|1.1|1.1|||
4296768|NCT00525174|4123234|B1|||Intereye acuity difference|The difference between eyes in logMAR acuity was calculated with positive values indicating sound eye better. One letter = .02 logMAR, .1 logMAR = 5 letters or one line of visual acuity.|logMAR line|Mean|4.2|4.2|Standard Deviation|1.1|1.1|||
4296769|NCT00525174|4123232|B3|||Mean (SD) Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|logMAR|Mean|0.04|0.04|Standard Deviation|0.10|0.1|||
4296770|NCT00525174|4123233|B2|||Mean (SD) Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|logMAR|Mean|0.03|0.03|Standard Deviation|0.10|0.1|||
4296771|NCT00525174|4123234|B1|||Mean (SD) Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|logMAR|Mean|0.04|0.04|Standard Deviation|0.10|0.1|||
4296772|NCT00525174|4123232|B3|20/16 (-0.06 to -0.14 logMAR) (best)||Distance visual acuity in fellow eye|Visual acuity was measured with the Amblyopia Treatment Study single-surround HOTV (ATS-HOTV) method for subjects aged 3 to <7 years or the Electronic Early Treatment Diabetic Retinopathy Study (E-ETDRS) method for subjects aged 7 to <10 years.|participants|Number|38|38.0||||||
4296773|NCT00525174|4123233|B2|20/16 (-0.06 to -0.14 logMAR) (best)||Distance visual acuity in fellow eye|Visual acuity was measured with the Amblyopia Treatment Study single-surround HOTV (ATS-HOTV) method for subjects aged 3 to <7 years or the Electronic Early Treatment Diabetic Retinopathy Study (E-ETDRS) method for subjects aged 7 to <10 years.|participants|Number|18|18.0||||||
4296774|NCT00525174|4123234|B1|20/16 (-0.06 to -0.14 logMAR) (best)||Distance visual acuity in fellow eye|Visual acuity was measured with the Amblyopia Treatment Study single-surround HOTV (ATS-HOTV) method for subjects aged 3 to <7 years or the Electronic Early Treatment Diabetic Retinopathy Study (E-ETDRS) method for subjects aged 7 to <10 years.|participants|Number|20|20.0||||||
4296775|NCT00525174|4123232|B3|20/20 (0.04 to -0.04 logMAR)||Distance visual acuity in fellow eye|Visual acuity was measured with the Amblyopia Treatment Study single-surround HOTV (ATS-HOTV) method for subjects aged 3 to <7 years or the Electronic Early Treatment Diabetic Retinopathy Study (E-ETDRS) method for subjects aged 7 to <10 years.|participants|Number|82|82.0||||||
4296776|NCT00525174|4123233|B2|20/20 (0.04 to -0.04 logMAR)||Distance visual acuity in fellow eye|Visual acuity was measured with the Amblyopia Treatment Study single-surround HOTV (ATS-HOTV) method for subjects aged 3 to <7 years or the Electronic Early Treatment Diabetic Retinopathy Study (E-ETDRS) method for subjects aged 7 to <10 years.|participants|Number|40|40.0||||||
4296808|NCT00525174|4123232|B3|Strabismus||Cause of amblyopia||participants|Number|50|50.0||||||
4296809|NCT00525174|4123233|B2|Strabismus||Cause of amblyopia||participants|Number|23|23.0||||||
4296810|NCT00525174|4123234|B1|Strabismus||Cause of amblyopia||participants|Number|27|27.0||||||
4296777|NCT00525174|4123234|B1|20/20 (0.04 to -0.04 logMAR)||Distance visual acuity in fellow eye|Visual acuity was measured with the Amblyopia Treatment Study single-surround HOTV (ATS-HOTV) method for subjects aged 3 to <7 years or the Electronic Early Treatment Diabetic Retinopathy Study (E-ETDRS) method for subjects aged 7 to <10 years.|participants|Number|42|42.0||||||
4296778|NCT00525174|4123232|B3|20/25 (0.14 to 0.06 logMAR)||Distance visual acuity in fellow eye|Visual acuity was measured with the Amblyopia Treatment Study single-surround HOTV (ATS-HOTV) method for subjects aged 3 to <7 years or the Electronic Early Treatment Diabetic Retinopathy Study (E-ETDRS) method for subjects aged 7 to <10 years.|participants|Number|36|36.0||||||
4296779|NCT00525174|4123233|B2|20/25 (0.14 to 0.06 logMAR)||Distance visual acuity in fellow eye|Visual acuity was measured with the Amblyopia Treatment Study single-surround HOTV (ATS-HOTV) method for subjects aged 3 to <7 years or the Electronic Early Treatment Diabetic Retinopathy Study (E-ETDRS) method for subjects aged 7 to <10 years.|participants|Number|19|19.0||||||
4296780|NCT00525174|4123234|B1|20/25 (0.14 to 0.06 logMAR)||Distance visual acuity in fellow eye|Visual acuity was measured with the Amblyopia Treatment Study single-surround HOTV (ATS-HOTV) method for subjects aged 3 to <7 years or the Electronic Early Treatment Diabetic Retinopathy Study (E-ETDRS) method for subjects aged 7 to <10 years.|participants|Number|17|17.0||||||
4296781|NCT00525174|4123232|B3|20/32 (0.24 to 0.16 logMAR)||Distance visual acuity in fellow eye|Visual acuity was measured with the Amblyopia Treatment Study single-surround HOTV (ATS-HOTV) method for subjects aged 3 to <7 years or the Electronic Early Treatment Diabetic Retinopathy Study (E-ETDRS) method for subjects aged 7 to <10 years.|participants|Number|25|25.0||||||
4296782|NCT00525174|4123233|B2|20/32 (0.24 to 0.16 logMAR)||Distance visual acuity in fellow eye|Visual acuity was measured with the Amblyopia Treatment Study single-surround HOTV (ATS-HOTV) method for subjects aged 3 to <7 years or the Electronic Early Treatment Diabetic Retinopathy Study (E-ETDRS) method for subjects aged 7 to <10 years.|participants|Number|9|9.0||||||
4296783|NCT00525174|4123234|B1|20/32 (0.24 to 0.16 logMAR)||Distance visual acuity in fellow eye|Visual acuity was measured with the Amblyopia Treatment Study single-surround HOTV (ATS-HOTV) method for subjects aged 3 to <7 years or the Electronic Early Treatment Diabetic Retinopathy Study (E-ETDRS) method for subjects aged 7 to <10 years.|participants|Number|16|16.0||||||
4296784|NCT00525174|4123232|B3|20/40 (0.32 to 0.26 logMAR) (worse)||Distance visual acuity in fellow eye|Visual acuity was measured with the Amblyopia Treatment Study single-surround HOTV (ATS-HOTV) method for subjects aged 3 to <7 years or the Electronic Early Treatment Diabetic Retinopathy Study (E-ETDRS) method for subjects aged 7 to <10 years.|participants|Number|5|5.0||||||
4296785|NCT00525174|4123233|B2|20/40 (0.32 to 0.26 logMAR) (worse)||Distance visual acuity in fellow eye|Visual acuity was measured with the Amblyopia Treatment Study single-surround HOTV (ATS-HOTV) method for subjects aged 3 to <7 years or the Electronic Early Treatment Diabetic Retinopathy Study (E-ETDRS) method for subjects aged 7 to <10 years.|participants|Number|3|3.0||||||
4296786|NCT00525174|4123234|B1|20/40 (0.32 to 0.26 logMAR) (worse)||Distance visual acuity in fellow eye|Visual acuity was measured with the Amblyopia Treatment Study single-surround HOTV (ATS-HOTV) method for subjects aged 3 to <7 years or the Electronic Early Treatment Diabetic Retinopathy Study (E-ETDRS) method for subjects aged 7 to <10 years.|participants|Number|2|2.0||||||
4296787|NCT00525174|4123232|B3|||Mean (SD) Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|logMAR|Mean|0.45|0.45|Standard Deviation|0.10|0.1|||
4296788|NCT00525174|4123233|B2|||Mean (SD) Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|logMAR|Mean|0.44|0.44|Standard Deviation|0.10|0.1|||
4296789|NCT00525174|4123234|B1|||Mean (SD) Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|logMAR|Mean|0.46|0.46|Standard Deviation|0.10|0.1|||
4296790|NCT00525174|4123232|B3|20/40 (0.34 - 0.28 logMAR) (best)||Distance visual acuity in amblyopic eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|participants|Number|43|43.0||||||
4296791|NCT00525174|4123233|B2|20/40 (0.34 - 0.28 logMAR) (best)||Distance visual acuity in amblyopic eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|participants|Number|22|22.0||||||
4296811|NCT00525174|4123232|B3|Patching and atropine||Prior treatment for amblyopia at enrollment||participants|Number|13|13.0||||||
4296812|NCT00525174|4123233|B2|Patching and atropine||Prior treatment for amblyopia at enrollment||participants|Number|9|9.0||||||
4296792|NCT00525174|4123234|B1|20/40 (0.34 - 0.28 logMAR) (best)||Distance visual acuity in amblyopic eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|participants|Number|21|21.0||||||
4296793|NCT00525174|4123232|B3|20/50 (0.44 - 0.36 logMAR)||Distance visual acuity in amblyopic eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|participants|Number|46|46.0||||||
4296794|NCT00525174|4123233|B2|20/50 (0.44 - 0.36 logMAR)||Distance visual acuity in amblyopic eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|participants|Number|24|24.0||||||
4296795|NCT00525174|4123234|B1|20/50 (0.44 - 0.36 logMAR)||Distance visual acuity in amblyopic eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|participants|Number|22|22.0||||||
4296796|NCT00525174|4123232|B3|20/63 (0.54 - 0.46 logMAR)||Distance visual acuity in amblyopic eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|participants|Number|58|58.0||||||
4296797|NCT00525174|4123233|B2|20/63 (0.54 - 0.46 logMAR)||Distance visual acuity in amblyopic eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|participants|Number|27|27.0||||||
4296798|NCT00525174|4123234|B1|20/63 (0.54 - 0.46 logMAR)||Distance visual acuity in amblyopic eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|participants|Number|31|31.0||||||
4296799|NCT00525174|4123232|B3|20/80 (0.62 - 0.56 logMAR) (worse)||Distance visual acuity in amblyopic eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|participants|Number|39|39.0||||||
4296800|NCT00525174|4123233|B2|20/80 (0.62 - 0.56 logMAR) (worse)||Distance visual acuity in amblyopic eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|participants|Number|16|16.0||||||
4296801|NCT00525174|4123234|B1|20/80 (0.62 - 0.56 logMAR) (worse)||Distance visual acuity in amblyopic eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|participants|Number|23|23.0||||||
4296802|NCT00525174|4123232|B3|Strabismus and anisometropia||Cause of amblyopia||participants|Number|55|55.0||||||
4296803|NCT00525174|4123233|B2|Strabismus and anisometropia||Cause of amblyopia||participants|Number|27|27.0||||||
4296804|NCT00525174|4123234|B1|Strabismus and anisometropia||Cause of amblyopia||participants|Number|28|28.0||||||
4296805|NCT00525174|4123232|B3|Anisometropia||Cause of amblyopia||participants|Number|81|81.0||||||
4296806|NCT00525174|4123233|B2|Anisometropia||Cause of amblyopia||participants|Number|39|39.0||||||
4296807|NCT00525174|4123234|B1|Anisometropia||Cause of amblyopia||participants|Number|42|42.0||||||
4296813|NCT00525174|4123234|B1|Patching and atropine||Prior treatment for amblyopia at enrollment||participants|Number|4|4.0||||||
4296814|NCT00525174|4123232|B3|Atropine||Prior treatment for amblyopia at enrollment||participants|Number|5|5.0||||||
4296815|NCT00525174|4123233|B2|Atropine||Prior treatment for amblyopia at enrollment||participants|Number|3|3.0||||||
4296816|NCT00525174|4123234|B1|Atropine||Prior treatment for amblyopia at enrollment||participants|Number|2|2.0||||||
4296817|NCT00525174|4123232|B3|Patching||Prior treatment for amblyopia at enrollment||participants|Number|13|13.0||||||
4296818|NCT00525174|4123233|B2|Patching||Prior treatment for amblyopia at enrollment||participants|Number|5|5.0||||||
4296819|NCT00525174|4123234|B1|Patching||Prior treatment for amblyopia at enrollment||participants|Number|8|8.0||||||
4296820|NCT00525174|4123232|B3|None||Prior treatment for amblyopia at enrollment||participants|Number|155|155.0||||||
4296821|NCT00525174|4123233|B2|None||Prior treatment for amblyopia at enrollment||participants|Number|72|72.0||||||
4296822|NCT00525174|4123234|B1|None||Prior treatment for amblyopia at enrollment||participants|Number|83|83.0||||||
4296823|NCT00525174|4123232|B3|United States||Region of Enrollment||participants|Number|186|186.0||||||
4296824|NCT00525174|4123233|B2|United States||Region of Enrollment||participants|Number|89|89.0||||||
4296825|NCT00525174|4123234|B1|United States||Region of Enrollment||participants|Number|97|97.0||||||
4296826|NCT00525174|4123232|B3|Unknown / not reported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4296827|NCT00525174|4123233|B2|Unknown / not reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4296828|NCT00525174|4123234|B1|Unknown / not reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4296829|NCT00525174|4123232|B3|More than 1 race||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4296830|NCT00525174|4123233|B2|More than 1 race||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4296831|NCT00525174|4123234|B1|More than 1 race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4296832|NCT00525174|4123232|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4296833|NCT00525174|4123233|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4296834|NCT00525174|4123234|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4296835|NCT00525174|4123232|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4296836|NCT00525174|4123233|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4296837|NCT00525174|4123234|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4296838|NCT00525174|4123232|B3|African-American||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4296839|NCT00525174|4123233|B2|African-American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4296840|NCT00525174|4123234|B1|African-American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4296841|NCT00525174|4123232|B3|White||Race/Ethnicity, Customized||participants|Number|136|136.0||||||
4296842|NCT00525174|4123233|B2|White||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
4296843|NCT00525174|4123234|B1|White||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
4296844|NCT00525174|4123232|B3||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4296845|NCT00525174|4123233|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4296846|NCT00525174|4123234|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4296847|NCT00525174|4123232|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4296848|NCT00525174|4123233|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4296849|NCT00525174|4123234|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4296850|NCT00525174|4123232|B3|7 to <10 years||Age, Customized|Age at enrollment in years|participants|Number|67|67.0||||||
4296851|NCT00525174|4123233|B2|7 to <10 years||Age, Customized|Age at enrollment in years|participants|Number|32|32.0||||||
4296852|NCT00525174|4123234|B1|7 to <10 years||Age, Customized|Age at enrollment in years|participants|Number|35|35.0||||||
4296853|NCT00525174|4123232|B3|3 to <7 years||Age, Customized|Age at enrollment in years|participants|Number|119|119.0||||||
4296854|NCT00525174|4123233|B2|3 to <7 years||Age, Customized|Age at enrollment in years|participants|Number|57|57.0||||||
4296855|NCT00525174|4123234|B1|3 to <7 years||Age, Customized|Age at enrollment in years|participants|Number|62|62.0||||||
4296856|NCT00525174|4123232|B3|||Age||years|Mean|6.3|6.3|Standard Deviation|1.64|1.64|||
4296857|NCT00525174|4123233|B2|||Age||years|Mean|6.3|6.3|Standard Deviation|1.67|1.67|||
4296858|NCT00525174|4123234|B1|||Age||years|Mean|6.3|6.3|Standard Deviation|1.62|1.62|||
4296859|NCT00525161|4123283|B1|No||Lung Metastases||participants|Number|6|6.0||||||
4296860|NCT00525161|4123283|B1|Yes||Lung Metastases||participants|Number|5|5.0||||||
4296861|NCT00525161|4123283|B1|No||Bone metastases||participants|Number|2|2.0||||||
4296862|NCT00525161|4123283|B1|Yes||Bone metastases||participants|Number|9|9.0||||||
4296863|NCT00525161|4123283|B1|Yes||Prior chemotherapy||participants|Number|3|3.0||||||
4296864|NCT00525161|4123283|B1|No||Prior chemotherapy||participants|Number|8|8.0||||||
4296865|NCT00525161|4123283|B1|Stable disease with maximal response||Disease status at entry||participants|Number|3|3.0||||||
4296866|NCT00525161|4123283|B1|Progressive Disease||Disease status at entry||participants|Number|8|8.0||||||
4296867|NCT00525161|4123283|B1|Second-line (Subsequent) treatment||Line of current endocrine therapy||participants|Number|2|2.0||||||
4296868|NCT00525161|4123283|B1|First-line (Primary) treatment||Line of current endocrine therapy||participants|Number|9|9.0||||||
4296869|NCT00525161|4123283|B1|Letrozole||Endocrine therapy at study entry||participants|Number|1|1.0||||||
4296870|NCT00525161|4123283|B1|Fulvestrant||Endocrine therapy at study entry||participants|Number|1|1.0||||||
4296871|NCT00525161|4123283|B1|Exemestane||Endocrine therapy at study entry||participants|Number|1|1.0||||||
4296872|NCT00525161|4123283|B1|Anastrozole||Endocrine therapy at study entry||participants|Number|1|1.0||||||
4296873|NCT00525161|4123283|B1|Tamoxifen||Endocrine therapy at study entry||participants|Number|7|7.0||||||
4296874|NCT00525161|4123283|B1|Unknown||Human epidermal growth factor receptor 2 (HER2) status||participants|Number|2|2.0||||||
4296875|NCT00525161|4123283|B1|Negative||Human epidermal growth factor receptor 2 (HER2) status||participants|Number|9|9.0||||||
4296876|NCT00525161|4123283|B1|Negative||Progesterone receptor status||participants|Number|2|2.0||||||
4296877|NCT00525161|4123283|B1|Positive||Progesterone receptor status||participants|Number|9|9.0||||||
4296878|NCT00525161|4123283|B1|Negative||Estrogen receptor status||participants|Number|0|0.0||||||
4296879|NCT00525161|4123283|B1|Positive||Estrogen receptor status||participants|Number|11|11.0||||||
4296880|NCT00525161|4123283|B1|Relapsed||Relapsed versus de novo metastasis||participants|Number|4|4.0||||||
4296881|NCT00525161|4123283|B1|de novo||Relapsed versus de novo metastasis||participants|Number|7|7.0||||||
4296882|NCT00525161|4123283|B1|No||Locally advanced||participants|Number|6|6.0||||||
4296883|NCT00525161|4123283|B1|Yes||Locally advanced||participants|Number|5|5.0||||||
4296884|NCT00525161|4123283|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4296885|NCT00525161|4123283|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4296886|NCT00525161|4123283|B1|>=70 years||Age, Customized||participants|Number|2|2.0||||||
4296887|NCT00525161|4123283|B1|60-69 years||Age, Customized||participants|Number|2|2.0||||||
4296888|NCT00525161|4123283|B1|50-59 years||Age, Customized||participants|Number|1|1.0||||||
4296889|NCT00525161|4123283|B1|40-49 years||Age, Customized||participants|Number|3|3.0||||||
4296890|NCT00525161|4123283|B1|<40 years||Age, Customized||participants|Number|3|3.0||||||
4296891|NCT00525161|4123283|B1|||Age||years|Median|45|45.0|Full Range|||39.0|72.0|
4296892|NCT00525148|4123289|B5||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4296893|NCT00525148|4123290|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4296894|NCT00525148|4123291|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4296895|NCT00525148|4123292|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4296896|NCT00525148|4123293|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4296897|NCT00525148|4123289|B5||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4296898|NCT00525148|4123290|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4296899|NCT00525148|4123291|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4296900|NCT00525148|4123292|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4296901|NCT00525148|4123293|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4296902|NCT00525148|4123289|B5|||Age||years|Mean|62|62.0|Standard Deviation|11.1|11.1|||
4296903|NCT00525148|4123290|B4|||Age||years|Mean|61|61.0|Standard Deviation|11.5|11.5|||
4296904|NCT00525148|4123291|B3|||Age||years|Mean|57|57.0|Standard Deviation|14.5|14.5|||
4296905|NCT00525148|4123292|B2|||Age||years|Mean|62|62.0|Standard Deviation|9.6|9.6|||
4296906|NCT00525148|4123293|B1|||Age||years|Mean|64|64.0|Standard Deviation|11.0|11.0|||
4296907|NCT00525135|4123314|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4296908|NCT00525135|4123314|B1||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Due to a registration error, the PI did not receive notifications to report results until after the data retention period had passed; numeric data are no longer available for analysis.
4296909|NCT00525135|4123314|B1||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Due to a registration error, the PI did not receive notifications to report results until after the data retention period had passed; numeric data are no longer available for analysis.
4296910|NCT00525135|4123314|B1|||Age||years|Mean|NA||Standard Deviation|NA||||Due to a registration error, the PI did not receive notifications to report results until after the data retention period had passed; numeric data are no longer available for analysis.
4296911|NCT00525031|4123322|B3|United States||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
4296912|NCT00525031|4123323|B2|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4296913|NCT00525031|4123324|B1|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
4296914|NCT00525031|4123322|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4296915|NCT00525031|4123323|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4296916|NCT00525031|4123324|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4296917|NCT00525031|4123322|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4296918|NCT00525031|4123323|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4296919|NCT00525031|4123324|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4296920|NCT00525031|4123322|B3|||Age||years|Median|60|60.0|Full Range|||31.0|82.0|
4296921|NCT00525031|4123323|B2|||Age||years|Median|62|62.0|Full Range|||32.0|82.0|
4296922|NCT00525031|4123324|B1|||Age||years|Median|58|58.0|Full Range|||31.0|71.0|
4296923|NCT00524940|4123332|B1|United States||Region of Enrollment||participants|Number|124|124.0||||||
4296924|NCT00524940|4123332|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4296925|NCT00524940|4123332|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4296926|NCT00524940|4123332|B1|||Age||years|Mean|59.40|59.4|Standard Deviation|19.50|19.5|||
4296927|NCT00524940|4123332|B1||>=65 years|Age||Participants|Count of Participants|56|56.0||||||
4296928|NCT00524940|4123332|B1||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
4296929|NCT00524940|4123332|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4296930|NCT00524771|4123337|B3|United States||Region of Enrollment||participants|Number|17381|17381.0||||||
4296931|NCT00524771|4123338|B2|United States||Region of Enrollment||participants|Number|8732|8732.0||||||
4296932|NCT00524771|4123339|B1|United States||Region of Enrollment||participants|Number|8649|8649.0||||||
4296933|NCT00524771|4123337|B3|Europe||Region of Enrollment||participants|Number|15914|15914.0||||||
4296934|NCT00524771|4123338|B2|Europe||Region of Enrollment||participants|Number|7699|7699.0||||||
4296935|NCT00524771|4123339|B1|Europe||Region of Enrollment||participants|Number|8215|8215.0||||||
4296936|NCT00524771|4123337|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4296937|NCT00524771|4123338|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4296938|NCT00524771|4123339|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4296939|NCT00524771|4123337|B3||Female|Sex: Female, Male||Participants|Count of Participants|33295|33295.0||||||
4296940|NCT00524771|4123338|B2||Female|Sex: Female, Male||Participants|Count of Participants|16431|16431.0||||||
4296941|NCT00524771|4123339|B1||Female|Sex: Female, Male||Participants|Count of Participants|16864|16864.0||||||
4296942|NCT00524771|4123337|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4296943|NCT00524771|4123338|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4296944|NCT00524771|4123339|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4296945|NCT00524771|4123337|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32762|32762.0||||||
4296946|NCT00524771|4123338|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16025|16025.0||||||
4296947|NCT00524771|4123339|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16737|16737.0||||||
4296948|NCT00524771|4123337|B3||<=18 years|Age||Participants|Count of Participants|533|533.0||||||
4296949|NCT00524771|4123338|B2||<=18 years|Age||Participants|Count of Participants|406|406.0||||||
4296950|NCT00524771|4123339|B1||<=18 years|Age||Participants|Count of Participants|127|127.0||||||
4296951|NCT00524771|4123337|B3|||Age||years|Mean|27.4|27.4|Standard Deviation|7.5|7.5|||
4296952|NCT00524771|4123338|B2|||Age||years|Mean|26.9|26.9|Standard Deviation|7.6|7.6|||
4296953|NCT00524771|4123339|B1|||Age||years|Mean|28.0|28.0|Standard Deviation|7.3|7.3|||
4296954|NCT00524745|4123350|B5|Vietnam||Region of Enrollment||participants|Number|903|903.0||||||
4296955|NCT00524745|4123351|B4|Vietnam||Region of Enrollment||participants|Number|227|227.0||||||
4296956|NCT00524745|4123352|B3|Vietnam||Region of Enrollment||participants|Number|241|241.0||||||
4296957|NCT00524745|4123353|B2|Vietnam||Region of Enrollment||participants|Number|206|206.0||||||
4296958|NCT00524745|4123354|B1|Vietnam||Region of Enrollment||participants|Number|229|229.0||||||
4296959|NCT00524745|4123350|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4296960|NCT00524745|4123351|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4296961|NCT00524745|4123352|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4296962|NCT00524745|4123353|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4296963|NCT00524745|4123354|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4296964|NCT00524745|4123350|B5||Female|Sex: Female, Male||Participants|Count of Participants|903|903.0||||||
4296965|NCT00524745|4123351|B4||Female|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
4296966|NCT00524745|4123352|B3||Female|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
4296967|NCT00524745|4123353|B2||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
4296968|NCT00524745|4123354|B1||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4296969|NCT00524745|4123350|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4296970|NCT00524745|4123351|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4296971|NCT00524745|4123352|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4296972|NCT00524745|4123353|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4296973|NCT00524745|4123354|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4296974|NCT00524745|4123350|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4296975|NCT00524745|4123351|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4296976|NCT00524745|4123352|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4296977|NCT00524745|4123353|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4296978|NCT00524745|4123354|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4296979|NCT00524745|4123350|B5||<=18 years|Age||Participants|Count of Participants|903|903.0||||||
4296980|NCT00524745|4123351|B4||<=18 years|Age||Participants|Count of Participants|227|227.0||||||
4296981|NCT00524745|4123352|B3||<=18 years|Age||Participants|Count of Participants|241|241.0||||||
4296982|NCT00524745|4123353|B2||<=18 years|Age||Participants|Count of Participants|206|206.0||||||
4296983|NCT00524745|4123354|B1||<=18 years|Age||Participants|Count of Participants|229|229.0||||||
4296984|NCT00524680|4123379|B5||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4296985|NCT00524680|4123380|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4296986|NCT00524680|4123381|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4296987|NCT00524680|4123382|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4296988|NCT00524680|4123383|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4296989|NCT00524680|4123379|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4296990|NCT00524680|4123380|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4296991|NCT00524680|4123381|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4296992|NCT00524680|4123382|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4296993|NCT00524680|4123383|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4296994|NCT00524680|4123379|B5|||Age||years|Median|66.5|66.5|Standard Deviation|8.7|8.7|||
4296995|NCT00524680|4123380|B4|||Age||years|Median|66.4|66.4|Standard Deviation|9.3|9.3|||
4296996|NCT00524680|4123381|B3|||Age||years|Median|67.9|67.9|Standard Deviation|8.7|8.7|||
4296997|NCT00524680|4123382|B2|||Age||years|Median|65.4|65.4|Standard Deviation|8.7|8.7|||
4296998|NCT00524680|4123383|B1|||Age||years|Median|68.2|68.2|Standard Deviation|8.1|8.1|||
4296999|NCT00524589|4123408|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4297000|NCT00524589|4123408|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4297001|NCT00524589|4123408|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4297002|NCT00524589|4123408|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4297003|NCT00524589|4123408|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297004|NCT00524589|4123408|B1|||Age||years|Mean|68.2|68.2|Standard Deviation|11.8|11.8|||
4297005|NCT00524576|4123413|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4297006|NCT00524576|4123414|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4297007|NCT00524576|4123415|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4297008|NCT00524576|4123413|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4297009|NCT00524576|4123414|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4297010|NCT00524576|4123415|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4297011|NCT00524576|4123413|B3|||Age||years|Mean|19.4|19.4|Standard Deviation|1.30|1.3|||
4297012|NCT00524576|4123414|B2|||Age||years|Mean|19.3|19.3|Standard Deviation|1.46|1.46|||
4297013|NCT00524576|4123415|B1|||Age||years|Mean|19.5|19.5|Standard Deviation|1.22|1.22|||
4297014|NCT00524537|4123434|B1||Male|Sex: Female, Male||Participants|Count of Participants|2156|2156.0||||||
4297015|NCT00524537|4123434|B1||Female|Sex: Female, Male||Participants|Count of Participants|2869|2869.0||||||
4297016|NCT00524537|4123434|B1|||Age||years|Mean|37.8|37.8|Standard Deviation|12.7|12.7|||
4297017|NCT00524511|4123448|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4297018|NCT00524511|4123449|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4297019|NCT00524511|4123450|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4297020|NCT00524511|4123448|B3||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4297021|NCT00524511|4123449|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4297022|NCT00524511|4123450|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4297023|NCT00524511|4123448|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4297024|NCT00524511|4123449|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4297025|NCT00524511|4123450|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4297026|NCT00524511|4123448|B3||Between 18 and 65 years|Age||Participants|Count of Participants|135|135.0||||||
4297027|NCT00524511|4123449|B2||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
4297028|NCT00524511|4123450|B1||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
4297029|NCT00524511|4123448|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4297030|NCT00524511|4123449|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297031|NCT00524511|4123450|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4297032|NCT00524485|4123459|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4297033|NCT00524485|4123459|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4297034|NCT00524485|4123459|B1|||Age||years|Median|62.4|62.4|Standard Deviation|15.8|15.8|||
4297035|NCT00524472|4123469|B3|United States||Region of Enrollment||Participants|Count of Participants|518|518.0||||||
4297036|NCT00524472|4123470|B2|United States||Region of Enrollment||Participants|Count of Participants|266|266.0||||||
4297037|NCT00524472|4123471|B1|United States||Region of Enrollment||Participants|Count of Participants|252|252.0||||||
4297038|NCT00524472|4123469|B3|Canada||Region of Enrollment||Participants|Count of Participants|921|921.0||||||
4297039|NCT00524472|4123470|B2|Canada||Region of Enrollment||Participants|Count of Participants|464|464.0||||||
4297040|NCT00524472|4123471|B1|Canada||Region of Enrollment||Participants|Count of Participants|457|457.0||||||
4297041|NCT00524472|4123469|B3||Male|Sex: Female, Male||Participants|Count of Participants|1066|1066.0||||||
4297042|NCT00524472|4123470|B2||Male|Sex: Female, Male||Participants|Count of Participants|546|546.0||||||
4297043|NCT00524472|4123471|B1||Male|Sex: Female, Male||Participants|Count of Participants|520|520.0||||||
4297044|NCT00524472|4123469|B3||Female|Sex: Female, Male||Participants|Count of Participants|373|373.0||||||
4297045|NCT00524472|4123470|B2||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4297046|NCT00524472|4123471|B1||Female|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4297047|NCT00524472|4123469|B3|||Age||years|Mean|66|66.0|Standard Deviation|11|11.0|||
4297048|NCT00524472|4123470|B2|||Age||years|Mean|66|66.0|Standard Deviation|11|11.0|||
4297049|NCT00524472|4123471|B1|||Age||years|Mean|66|66.0|Standard Deviation|11|11.0|||
4297050|NCT00524459|4123488|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4297051|NCT00524459|4123488|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4297052|NCT00524459|4123488|B1|||Age||years|Mean|44.5|44.5|Standard Deviation|9.4|9.4|||
4297053|NCT00524420|4123496|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4297054|NCT00524420|4123497|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4297055|NCT00524420|4123498|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4297056|NCT00524420|4123496|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4297057|NCT00524420|4123497|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4297058|NCT00524420|4123498|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4297059|NCT00524420|4123496|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4297060|NCT00524420|4123497|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4297061|NCT00524420|4123498|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4297062|NCT00524420|4123496|B3|||Age||years|Mean|53.17|53.17|Standard Deviation|9.10|9.1|||
4297063|NCT00524420|4123497|B2|||Age||years|Mean|52.09|52.09|Standard Deviation|10.02|10.02|||
4297064|NCT00524420|4123498|B1|||Age||years|Mean|54.86|54.86|Standard Deviation|7.65|7.65|||
4297065|NCT00524420|4123496|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4297066|NCT00524420|4123497|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4297067|NCT00524420|4123498|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4297068|NCT00524420|4123496|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4297069|NCT00524420|4123497|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4297070|NCT00524420|4123498|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4297071|NCT00524420|4123496|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297072|NCT00524420|4123497|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297073|NCT00524420|4123498|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297074|NCT00524394|4123511|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4297075|NCT00524394|4123511|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4297076|NCT00524394|4123511|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4297077|NCT00524394|4123511|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4297078|NCT00524394|4123511|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4297079|NCT00524394|4123511|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4297080|NCT00524368|4123515|B3|Unknown||Hepatitis B or C Co-infection Status||participants|Number|6|6.0||||||
4297081|NCT00524368|4123516|B2|Unknown||Hepatitis B or C Co-infection Status||participants|Number|4|4.0||||||
4297082|NCT00524368|4123517|B1|Unknown||Hepatitis B or C Co-infection Status||participants|Number|2|2.0||||||
4297083|NCT00524368|4123515|B3|Positive||Hepatitis B or C Co-infection Status||participants|Number|62|62.0||||||
4297084|NCT00524368|4123516|B2|Positive||Hepatitis B or C Co-infection Status||participants|Number|37|37.0||||||
4297085|NCT00524368|4123517|B1|Positive||Hepatitis B or C Co-infection Status||participants|Number|25|25.0||||||
4297086|NCT00524368|4123515|B3|Negative||Hepatitis B or C Co-infection Status||participants|Number|522|522.0||||||
4297087|NCT00524368|4123516|B2|Negative||Hepatitis B or C Co-infection Status||participants|Number|255|255.0||||||
4297088|NCT00524368|4123517|B1|Negative||Hepatitis B or C Co-infection Status||participants|Number|267|267.0||||||
4297089|NCT00524368|4123515|B3|Age > 65||Age (years) (categorical)||participants|Number|3|3.0||||||
4297090|NCT00524368|4123516|B2|Age > 65||Age (years) (categorical)||participants|Number|2|2.0||||||
4297091|NCT00524368|4123517|B1|Age > 65||Age (years) (categorical)||participants|Number|1|1.0||||||
4297092|NCT00524368|4123515|B3|55 < Age <= 65||Age (years) (categorical)||participants|Number|32|32.0||||||
4297093|NCT00524368|4123516|B2|55 < Age <= 65||Age (years) (categorical)||participants|Number|18|18.0||||||
4297094|NCT00524368|4123517|B1|55 < Age <= 65||Age (years) (categorical)||participants|Number|14|14.0||||||
4297095|NCT00524368|4123515|B3|45 < Age <= 55||Age (years) (categorical)||participants|Number|136|136.0||||||
4297096|NCT00524368|4123516|B2|45 < Age <= 55||Age (years) (categorical)||participants|Number|72|72.0||||||
4297097|NCT00524368|4123517|B1|45 < Age <= 55||Age (years) (categorical)||participants|Number|64|64.0||||||
4297098|NCT00524368|4123515|B3|30 < Age <= 45||Age (years) (categorical)||participants|Number|349|349.0||||||
4297099|NCT00524368|4123516|B2|30 < Age <= 45||Age (years) (categorical)||participants|Number|169|169.0||||||
4297100|NCT00524368|4123517|B1|30 < Age <= 45||Age (years) (categorical)||participants|Number|180|180.0||||||
4297101|NCT00524368|4123515|B3|Age <= 30||Age (years) (categorical)||participants|Number|70|70.0||||||
4297102|NCT00524368|4123516|B2|Age <= 30||Age (years) (categorical)||participants|Number|35|35.0||||||
4297103|NCT00524368|4123517|B1|Age <= 30||Age (years) (categorical)||participants|Number|35|35.0||||||
4297104|NCT00524368|4123515|B3||Male|Sex: Female, Male||Participants|Count of Participants|377|377.0||||||
4297105|NCT00524368|4123516|B2||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4297106|NCT00524368|4123517|B1||Male|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4297107|NCT00524368|4123515|B3||Female|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
4297108|NCT00524368|4123516|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4297109|NCT00524368|4123517|B1||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4297110|NCT00524368|4123515|B3|||Age||years|Mean|40.5|40.5|Standard Deviation|9.29|9.29|||
4297111|NCT00524368|4123516|B2|||Age||years|Mean|40.7|40.7|Standard Deviation|9.50|9.5|||
4297112|NCT00524368|4123517|B1|||Age||years|Mean|40.2|40.2|Standard Deviation|9.09|9.09|||
4297113|NCT00524342|4123546|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4297114|NCT00524342|4123546|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4297115|NCT00524342|4123546|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4297116|NCT00524342|4123546|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4297117|NCT00524342|4123546|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4297118|NCT00524342|4123546|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297119|NCT00524316|4123552|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4297120|NCT00524316|4123552|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4297121|NCT00524316|4123552|B1|||Age||years|Mean|63.8|63.8|Standard Deviation|13.9|13.9|||
4297122|NCT00524316|4123552|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4297123|NCT00524316|4123552|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4297124|NCT00524316|4123552|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297125|NCT00524303|4123561|B4|Mixed race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4297126|NCT00524303|4123562|B3|Mixed race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4297127|NCT00524303|4123563|B2|Mixed race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4297128|NCT00524303|4123564|B1|Mixed race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4297129|NCT00524303|4123561|B4|White - White/Caucasian/European heritage||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
4297130|NCT00524303|4123562|B3|White - White/Caucasian/European heritage||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4297131|NCT00524303|4123563|B2|White - White/Caucasian/European heritage||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4297132|NCT00524303|4123564|B1|White - White/Caucasian/European heritage||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4297133|NCT00524303|4123561|B4|White - Arabic/North African heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4297134|NCT00524303|4123562|B3|White - Arabic/North African heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4297135|NCT00524303|4123563|B2|White - Arabic/North African heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4297136|NCT00524303|4123564|B1|White - Arabic/North African heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4297137|NCT00524303|4123561|B4|Asian - South East Asian heritage||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4297138|NCT00524303|4123562|B3|Asian - South East Asian heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4297139|NCT00524303|4123563|B2|Asian - South East Asian heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4297140|NCT00524303|4123564|B1|Asian - South East Asian heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4297141|NCT00524303|4123561|B4|Asian - East Asian heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4297142|NCT00524303|4123562|B3|Asian - East Asian heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4297143|NCT00524303|4123563|B2|Asian - East Asian heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4297144|NCT00524303|4123564|B1|Asian - East Asian heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4297145|NCT00524303|4123561|B4|Asian - Central/South Asian heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4297146|NCT00524303|4123562|B3|Asian - Central/South Asian heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4297147|NCT00524303|4123563|B2|Asian - Central/South Asian heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4297148|NCT00524303|4123564|B1|Asian - Central/South Asian heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4297149|NCT00524303|4123561|B4|American Indian or Alaska native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4297150|NCT00524303|4123562|B3|American Indian or Alaska native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4297151|NCT00524303|4123563|B2|American Indian or Alaska native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4297152|NCT00524303|4123564|B1|American Indian or Alaska native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4297153|NCT00524303|4123561|B4|African American/African heritage||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4297154|NCT00524303|4123562|B3|African American/African heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4297155|NCT00524303|4123563|B2|African American/African heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4297156|NCT00524303|4123564|B1|African American/African heritage||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4297157|NCT00524303|4123561|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4297158|NCT00524303|4123562|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4297159|NCT00524303|4123563|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4297160|NCT00524303|4123564|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4297161|NCT00524303|4123561|B4||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4297162|NCT00524303|4123562|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4297163|NCT00524303|4123563|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4297164|NCT00524303|4123564|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4297165|NCT00524303|4123561|B4|||Age||Years|Mean|50.4|50.4|Standard Deviation|10.01|10.01|||
4297166|NCT00524303|4123562|B3|||Age||Years|Mean|49.2|49.2|Standard Deviation|10.47|10.47|||
4297167|NCT00524303|4123563|B2|||Age||Years|Mean|50.8|50.8|Standard Deviation|8.76|8.76|||
4297168|NCT00524303|4123564|B1|||Age||Years|Mean|51.1|51.1|Standard Deviation|10.90|10.9|||
4297169|NCT00524264|4123594|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4297170|NCT00524264|4123595|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4297171|NCT00524264|4123596|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4297172|NCT00524264|4123594|B3||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4297173|NCT00524264|4123595|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4297174|NCT00524264|4123596|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4297175|NCT00524264|4123594|B3|>65 years||Age, Customized||participants|Number|157|157.0||||||
4297176|NCT00524264|4123595|B2|>65 years||Age, Customized||participants|Number|49|49.0||||||
4297177|NCT00524264|4123596|B1|>65 years||Age, Customized||participants|Number|108|108.0||||||
4297178|NCT00524264|4123594|B3|Between 45 and 65 years||Age, Customized||participants|Number|86|86.0||||||
4297179|NCT00524264|4123595|B2|Between 45 and 65 years||Age, Customized||participants|Number|33|33.0||||||
4297180|NCT00524264|4123596|B1|Between 45 and 65 years||Age, Customized||participants|Number|53|53.0||||||
4297181|NCT00524264|4123594|B3|<45 years||Age, Customized||participants|Number|5|5.0||||||
4297182|NCT00524264|4123595|B2|<45 years||Age, Customized||participants|Number|2|2.0||||||
4297183|NCT00524264|4123596|B1|<45 years||Age, Customized||participants|Number|3|3.0||||||
4297184|NCT00524225|4123609|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4297185|NCT00524225|4123609|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4297186|NCT00524225|4123609|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4297187|NCT00524225|4123609|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4297188|NCT00524225|4123609|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297189|NCT00524173|4123616|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4297190|NCT00524173|4123617|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4297191|NCT00524173|4123618|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4297192|NCT00524173|4123616|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4297193|NCT00524173|4123617|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4297194|NCT00524173|4123618|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4297195|NCT00524173|4123616|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
4297196|NCT00524173|4123617|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4297197|NCT00524173|4123618|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4297198|NCT00524173|4123616|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4297199|NCT00524173|4123617|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4297200|NCT00524173|4123618|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4297201|NCT00524173|4123616|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4297202|NCT00524173|4123617|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4297203|NCT00524173|4123618|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4297204|NCT00524173|4123616|B3|||Age||years|Mean|39.56|39.56|Standard Deviation|14.69|14.69|||
4297205|NCT00524173|4123617|B2|||Age||years|Mean|39.47|39.47|Standard Deviation|12.67|12.67|||
4297206|NCT00524173|4123618|B1|||Age||years|Mean|39.65|39.65|Standard Deviation|16.66|16.66|||
4297207|NCT00524134|4123631|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4297208|NCT00524134|4123631|B1|Male or Female||Sex/Gender, Customized|Gender breakdown is not available. Columbia will never have access to this data.|participants|Number|6|6.0||||||
4297209|NCT00524134|4123631|B1|Between 10 and 65 years||Age, Customized||participants|Number|6|6.0||||||
4297210|NCT00524121|4123638|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4297211|NCT00524121|4123638|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4297212|NCT00524121|4123638|B1|||Age||years|Mean|79.94|79.94|Standard Deviation|6.44|6.44|||
4297213|NCT00524043|4123655|B4|United States||Region of Enrollment||participants|Number|100|100.0||||||
4297214|NCT00524043|4123656|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
4297215|NCT00524043|4123657|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4297216|NCT00524043|4123658|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4297217|NCT00524043|4123655|B4|Taiwan||Region of Enrollment||participants|Number|28|28.0||||||
4297218|NCT00524043|4123656|B3|Taiwan||Region of Enrollment||participants|Number|9|9.0||||||
4297219|NCT00524043|4123657|B2|Taiwan||Region of Enrollment||participants|Number|12|12.0||||||
4297220|NCT00524043|4123658|B1|Taiwan||Region of Enrollment||participants|Number|7|7.0||||||
4297221|NCT00524043|4123655|B4|India||Region of Enrollment||participants|Number|72|72.0||||||
4297222|NCT00524043|4123656|B3|India||Region of Enrollment||participants|Number|24|24.0||||||
4297223|NCT00524043|4123657|B2|India||Region of Enrollment||participants|Number|25|25.0||||||
4297224|NCT00524043|4123658|B1|India||Region of Enrollment||participants|Number|23|23.0||||||
4297225|NCT00524043|4123655|B4||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4297226|NCT00524043|4123656|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4297227|NCT00524043|4123657|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4297228|NCT00524043|4123658|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4297229|NCT00524043|4123655|B4||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4297230|NCT00524043|4123656|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4297231|NCT00524043|4123657|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4297232|NCT00524043|4123658|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4297233|NCT00524043|4123655|B4|||Age||years|Mean|39.4|39.4|Standard Deviation|11.95|11.95|||
4297234|NCT00524043|4123656|B3|||Age||years|Mean|41.3|41.3|Standard Deviation|10.96|10.96|||
4297235|NCT00524043|4123657|B2|||Age||years|Mean|40.3|40.3|Standard Deviation|12.84|12.84|||
4297236|NCT00524043|4123658|B1|||Age||years|Mean|36.5|36.5|Standard Deviation|11.57|11.57|||
4297237|NCT00524043|4123655|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4297238|NCT00524043|4123656|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4297239|NCT00524043|4123657|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4297240|NCT00524043|4123658|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4297241|NCT00524043|4123655|B4||Between 18 and 65 years|Age||Participants|Count of Participants|200|200.0||||||
4297242|NCT00524043|4123656|B3||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4297243|NCT00524043|4123657|B2||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4297244|NCT00524043|4123658|B1||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4297245|NCT00524043|4123655|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297246|NCT00524043|4123656|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297247|NCT00524043|4123657|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297248|NCT00524043|4123658|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297249|NCT00524030|4123680|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4297250|NCT00524030|4123681|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4297251|NCT00524030|4123682|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4297252|NCT00524030|4123680|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4297253|NCT00524030|4123681|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4297254|NCT00524030|4123682|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4297255|NCT00524030|4123680|B3|||Age||years|Mean|39.0|39.0|Standard Deviation|13.2|13.2|||
4297256|NCT00524030|4123681|B2|||Age||years|Mean|39.9|39.9|Standard Deviation|13.2|13.2|||
4297257|NCT00524030|4123682|B1|||Age||years|Mean|35.2|35.2|Standard Deviation|12.4|12.4|||
4297258|NCT00523991|4123699|B3|White||Race/Ethnicity, Customized||participants|Number|447|447.0||||||
4297259|NCT00523991|4123700|B2|White||Race/Ethnicity, Customized||participants|Number|234|234.0||||||
4297260|NCT00523991|4123701|B1|White||Race/Ethnicity, Customized||participants|Number|213|213.0||||||
4297261|NCT00523991|4123699|B3|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4297262|NCT00523991|4123700|B2|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4297263|NCT00523991|4123701|B1|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4297264|NCT00523991|4123699|B3||Male|Sex: Female, Male||Participants|Count of Participants|313|313.0||||||
4297265|NCT00523991|4123700|B2||Male|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4297266|NCT00523991|4123701|B1||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4297267|NCT00523991|4123699|B3||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4297268|NCT00523991|4123700|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4297269|NCT00523991|4123701|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4297270|NCT00523991|4123699|B3|>=65 years||Age, Customized||participants|Number|170|170.0||||||
4297271|NCT00523991|4123700|B2|>=65 years||Age, Customized||participants|Number|80|80.0||||||
4297272|NCT00523991|4123701|B1|>=65 years||Age, Customized||participants|Number|90|90.0||||||
4297273|NCT00523991|4123699|B3|45-64 years||Age, Customized||participants|Number|272|272.0||||||
4297274|NCT00523991|4123700|B2|45-64 years||Age, Customized||participants|Number|151|151.0||||||
4297275|NCT00523991|4123701|B1|45-64 years||Age, Customized||participants|Number|121|121.0||||||
4297276|NCT00523991|4123699|B3|18-44 years||Age, Customized||participants|Number|15|15.0||||||
4297277|NCT00523991|4123700|B2|18-44 years||Age, Customized||participants|Number|7|7.0||||||
4297278|NCT00523991|4123701|B1|18-44 years||Age, Customized||participants|Number|8|8.0||||||
4297279|NCT00523991|4123699|B3|||Age||years|Mean|61.7|61.7|Standard Deviation|8.4|8.4|||
4297280|NCT00523991|4123700|B2|||Age||years|Mean|61.2|61.2|Standard Deviation|8.2|8.2|||
4297281|NCT00523991|4123701|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|8.6|8.6|||
4297282|NCT00523978|4123980|B3|Canada||Region of Enrollment||participants|Number|59|59.0||||||
4297283|NCT00523978|4123981|B2|Canada||Region of Enrollment||participants|Number|19|19.0||||||
4297284|NCT00523978|4123982|B1|Canada||Region of Enrollment||participants|Number|40|40.0||||||
4297285|NCT00523978|4123980|B3|United States||Region of Enrollment||participants|Number|186|186.0||||||
4297286|NCT00523978|4123981|B2|United States||Region of Enrollment||participants|Number|63|63.0||||||
4297287|NCT00523978|4123982|B1|United States||Region of Enrollment||participants|Number|123|123.0||||||
4297288|NCT00523978|4123980|B3||Male|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4297289|NCT00523978|4123981|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4297290|NCT00523978|4123982|B1||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4297291|NCT00523978|4123980|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4297292|NCT00523978|4123981|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4297293|NCT00523978|4123982|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4297294|NCT00523978|4123980|B3|||Age||years|Mean|56.6|56.6|Standard Deviation|0.6|0.6|||
4297295|NCT00523978|4123981|B2|||Age||years|Mean|56.4|56.4|Standard Deviation|1.04|1.04|||
4297296|NCT00523978|4123982|B1|||Age||years|Mean|56.7|56.7|Standard Deviation|0.73|0.73|||
4297297|NCT00523939|4123995|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4297298|NCT00523939|4123996|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4297299|NCT00523939|4123997|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4297300|NCT00523939|4123995|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4297301|NCT00523939|4123996|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4297302|NCT00523939|4123997|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4297303|NCT00523939|4123995|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4297304|NCT00523939|4123996|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4297305|NCT00523939|4123997|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4297306|NCT00523939|4123995|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4297307|NCT00523939|4123996|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4297308|NCT00523939|4123997|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4297309|NCT00523939|4123995|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4297310|NCT00523939|4123996|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4297311|NCT00523939|4123997|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4297312|NCT00523939|4123995|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297313|NCT00523939|4123996|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297314|NCT00523939|4123997|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297315|NCT00523848|4124005|B1||Male|Gender||Participants|Count of Participants|26|26.0||||||
4297316|NCT00523848|4124005|B1||Female|Gender||Participants|Count of Participants|14|14.0||||||
4297317|NCT00523848|4124005|B1|||Age||years|Mean|60.13|60.13|Standard Deviation|9.34|9.34|||
4297318|NCT00523809|4124011|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4297319|NCT00523809|4124011|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4297320|NCT00523809|4124011|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4297321|NCT00523809|4124011|B1|||Age||years|Median|55|55.0|Full Range|||45.0|58.0|
4297322|NCT00523744|4124015|B1|Phase 3 - Amlodipine+valsartan+HCTZ||Sex/Gender, Customized||participants|Number|59|59.0||||||
4297323|NCT00523744|4124015|B1|Phase 3 - Amlodipine+valsartan+HCTZ||Sex/Gender, Customized||participants|Number|32|32.0||||||
4297324|NCT00523744|4124015|B1|Phase 2 - Amlodipine+valsartan||Sex/Gender, Customized||participants|Number|100|100.0||||||
4297325|NCT00523744|4124015|B1|Phase 2 - Amlodipine+valsartan||Sex/Gender, Customized||participants|Number|76|76.0||||||
4297326|NCT00523744|4124015|B1|Phase 1 - Amlodipine+olmesartan||Sex/Gender, Customized||participants|Number|145|145.0||||||
4297327|NCT00523744|4124015|B1|Phase 1 - Amlodipine+olmesartan||Sex/Gender, Customized||participants|Number|112|112.0||||||
4297328|NCT00523744|4124015|B1|Phase 3 - Amlodipine+valsartan+HCTZ||Age||years|Mean|60.9|60.9|Standard Deviation|10.98|10.98|||
4297329|NCT00523744|4124015|B1|Phase 2 - Amlodipine+valsartan||Age||years|Mean|59.8|59.8|Standard Deviation|11.84|11.84|||
4297330|NCT00523744|4124015|B1|Phase 1 - Amlodipine+olmesartan||Age||years|Mean|58.8|58.8|Standard Deviation|12.38|12.38|||
4297331|NCT00523718|4124032|B3|||HARS baseline score|The Hamilton Anxiety Rating Scale (HARS or HAM-A) is a psychological questionnaire used by clinicians to rate the severity of a patient's anxiety. Total score ranges from 0 to 56. A score of 17 or less indicates mild anxiety severity. A score from 18 to 24 indicates mild to moderate anxiety severity. A score of 25 to 30 indicates a moderate to severe anxiety severity. A score of 31 or greater represents very severe anxiety severity.|units on a scale|Mean|16.08|16.08|Standard Deviation|6.80|6.8|||
4297332|NCT00523718|4124033|B2|||HARS baseline score|The Hamilton Anxiety Rating Scale (HARS or HAM-A) is a psychological questionnaire used by clinicians to rate the severity of a patient's anxiety. Total score ranges from 0 to 56. A score of 17 or less indicates mild anxiety severity. A score from 18 to 24 indicates mild to moderate anxiety severity. A score of 25 to 30 indicates a moderate to severe anxiety severity. A score of 31 or greater represents very severe anxiety severity.|units on a scale|Mean|15.95|15.95|Standard Deviation|6.433|6.433|||
4297333|NCT00523718|4124034|B1|||HARS baseline score|The Hamilton Anxiety Rating Scale (HARS or HAM-A) is a psychological questionnaire used by clinicians to rate the severity of a patient's anxiety. Total score ranges from 0 to 56. A score of 17 or less indicates mild anxiety severity. A score from 18 to 24 indicates mild to moderate anxiety severity. A score of 25 to 30 indicates a moderate to severe anxiety severity. A score of 31 or greater represents very severe anxiety severity.|units on a scale|Mean|16.2|16.2|Standard Deviation|7.35|7.35|||
4297334|NCT00523718|4124032|B3|||HDRS baseline score|"The Hamilton Depression Rating Scale (HDRS; also known as the HAM-D) is the most widely used clinician-administered depression assessment scale. The HAM-D 17-item scale ranges from 0 (normal) to >23 (very severe depression), with a maximum score of 52. The 24-item scale has a maximum score of 75. Severity of depression (e.g. normal or very severe) is based upon the score in the first 17-items."|units on a scale|Mean|12.87|12.87|Standard Deviation|6.46|6.46|||
4297335|NCT00523718|4124033|B2|||HDRS baseline score|"The Hamilton Depression Rating Scale (HDRS; also known as the HAM-D) is the most widely used clinician-administered depression assessment scale. The HAM-D 17-item scale ranges from 0 (normal) to >23 (very severe depression), with a maximum score of 52. The 24-item scale has a maximum score of 75. Severity of depression (e.g. normal or very severe) is based upon the score in the first 17-items."|units on a scale|Mean|13.05|13.05|Standard Deviation|6.19|6.19|||
4297336|NCT00523718|4124034|B1|||HDRS baseline score|"The Hamilton Depression Rating Scale (HDRS; also known as the HAM-D) is the most widely used clinician-administered depression assessment scale. The HAM-D 17-item scale ranges from 0 (normal) to >23 (very severe depression), with a maximum score of 52. The 24-item scale has a maximum score of 75. Severity of depression (e.g. normal or very severe) is based upon the score in the first 17-items."|units on a scale|Mean|12.68|12.68|Standard Deviation|6.89|6.89|||
4297541|NCT00523302|4124215|B3|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4297337|NCT00523718|4124032|B3|||Y-BOCS baseline score|"The Yale–Brown Obsessive Compulsive Scale (Y-BOCS) is a test to rate the severity of obsessive–compulsive disorder (OCD) symptoms. The scale is a clinician-rated, 10-item scale, each item rated from 0 (no symptoms) to 4 (extreme symptoms), yielding a total possible score range from 0 to 40. The results can be interpreted based on the total score:~0–7 is sub-clinical; 8–15 is mild; 16–23 is moderate; 24–31 is severe; 32–40 is extreme."|units on a scale|Mean|30.37|30.37|Standard Deviation|5.41|5.41|||
4297338|NCT00523718|4124033|B2|||Y-BOCS baseline score|"The Yale–Brown Obsessive Compulsive Scale (Y-BOCS) is a test to rate the severity of obsessive–compulsive disorder (OCD) symptoms. The scale is a clinician-rated, 10-item scale, each item rated from 0 (no symptoms) to 4 (extreme symptoms), yielding a total possible score range from 0 to 40. The results can be interpreted based on the total score:~0–7 is sub-clinical; 8–15 is mild; 16–23 is moderate; 24–31 is severe; 32–40 is extreme."|units on a scale|Mean|30.73|30.73|Standard Deviation|5.81|5.81|||
4297339|NCT00523718|4124034|B1|||Y-BOCS baseline score|"The Yale–Brown Obsessive Compulsive Scale (Y-BOCS) is a test to rate the severity of obsessive–compulsive disorder (OCD) symptoms. The scale is a clinician-rated, 10-item scale, each item rated from 0 (no symptoms) to 4 (extreme symptoms), yielding a total possible score range from 0 to 40. The results can be interpreted based on the total score:~0–7 is sub-clinical; 8–15 is mild; 16–23 is moderate; 24–31 is severe; 32–40 is extreme."|units on a scale|Mean|30|30.0|Standard Deviation|5.12|5.12|||
4297340|NCT00523718|4124032|B3|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4297341|NCT00523718|4124033|B2|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4297342|NCT00523718|4124034|B1|African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4297343|NCT00523718|4124032|B3|White||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4297344|NCT00523718|4124033|B2|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4297345|NCT00523718|4124034|B1|White||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4297346|NCT00523718|4124032|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4297347|NCT00523718|4124033|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4297348|NCT00523718|4124034|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4297349|NCT00523718|4124032|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4297350|NCT00523718|4124033|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4297351|NCT00523718|4124034|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4297352|NCT00523718|4124032|B3|||Age||years|Mean|38.52|38.52|Standard Deviation|13.80|13.8|||
4297353|NCT00523718|4124033|B2|||Age||years|Mean|36.4|36.4|Standard Deviation|3.1|3.1|||
4297354|NCT00523718|4124034|B1|||Age||years|Mean|41.5|41.5|Standard Deviation|3.2|3.2|||
4297355|NCT00523705|4124047|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4297356|NCT00523705|4124048|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4297357|NCT00523705|4124049|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4297358|NCT00523705|4124047|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4297359|NCT00523705|4124048|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4297360|NCT00523705|4124049|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4297361|NCT00523705|4124047|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4297362|NCT00523705|4124048|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4297363|NCT00523705|4124049|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4297364|NCT00523705|4124047|B3|||Age||years|Mean|17.4|17.4|Standard Deviation|1.4|1.4|||
4297365|NCT00523705|4124048|B2|||Age||years|Mean|17.3|17.3|Standard Deviation|1.3|1.3|||
4297366|NCT00523705|4124049|B1|||Age||years|Mean|17.6|17.6|Standard Deviation|1.4|1.4|||
4297367|NCT00523705|4124047|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4297368|NCT00523705|4124048|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4297369|NCT00523705|4124049|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4297370|NCT00523705|4124047|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4297371|NCT00523705|4124048|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4297372|NCT00523705|4124049|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4297373|NCT00523705|4124047|B3||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4297374|NCT00523705|4124048|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4297375|NCT00523705|4124049|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4297376|NCT00523640|4124062|B1|No||Prior therapy-Oral Vascular Endothelial Growth Factor (VEGF) receptor kinase inhibitor||participants|Number|9|9.0||||||
4297377|NCT00523640|4124062|B1|Yes||Prior therapy-Oral Vascular Endothelial Growth Factor (VEGF) receptor kinase inhibitor||participants|Number|20|20.0||||||
4297378|NCT00523640|4124062|B1|No||Prior therapy-Cytokine therapy||participants|Number|21|21.0||||||
4297379|NCT00523640|4124062|B1|Yes||Prior therapy-Cytokine therapy||participants|Number|8|8.0||||||
4297380|NCT00523640|4124062|B1|No||Prior therapy-Radiotherapy||participants|Number|14|14.0||||||
4297381|NCT00523640|4124062|B1|Yes||Prior therapy-Radiotherapy||participants|Number|15|15.0||||||
4297382|NCT00523640|4124062|B1|No||Prior therapy-Nephrectomy||participants|Number|5|5.0||||||
4297383|NCT00523640|4124062|B1|Yes||Prior therapy-Nephrectomy||participants|Number|24|24.0||||||
4297384|NCT00523640|4124062|B1|Poor||Prognostic risk group||participants|Number|3|3.0||||||
4297385|NCT00523640|4124062|B1|Intermediate||Prognostic risk group||participants|Number|19|19.0||||||
4297386|NCT00523640|4124062|B1|Favorable||Prognostic risk group||participants|Number|7|7.0||||||
4297542|NCT00523302|4124216|B2|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4297387|NCT00523640|4124062|B1|Unknown||Fuhrman grade|An important factor used to assess renal cell carcinoma is its Fuhrman grade. This scale refers to how closely the cancer cells look like normal kidney cells under a microscope. The Fuhrman grading system ranks tumor cells on a scale of 1 through 4 and is a prognostic scale. 1 represents the best prognosis and 4 the worst. Grade 1 tumor cells look similar to normal kidney cells. Grade 1 cancers typically grow and spread slowly and most often have a good prognosis. Grade 4 tumor cells look quite different from normal kidney cells and have a worse prognosis.|participants|Number|6|6.0||||||
4297388|NCT00523640|4124062|B1|3-4||Fuhrman grade|An important factor used to assess renal cell carcinoma is its Fuhrman grade. This scale refers to how closely the cancer cells look like normal kidney cells under a microscope. The Fuhrman grading system ranks tumor cells on a scale of 1 through 4 and is a prognostic scale. 1 represents the best prognosis and 4 the worst. Grade 1 tumor cells look similar to normal kidney cells. Grade 1 cancers typically grow and spread slowly and most often have a good prognosis. Grade 4 tumor cells look quite different from normal kidney cells and have a worse prognosis.|participants|Number|21|21.0||||||
4297389|NCT00523640|4124062|B1|2||Fuhrman grade|An important factor used to assess renal cell carcinoma is its Fuhrman grade. This scale refers to how closely the cancer cells look like normal kidney cells under a microscope. The Fuhrman grading system ranks tumor cells on a scale of 1 through 4 and is a prognostic scale. 1 represents the best prognosis and 4 the worst. Grade 1 tumor cells look similar to normal kidney cells. Grade 1 cancers typically grow and spread slowly and most often have a good prognosis. Grade 4 tumor cells look quite different from normal kidney cells and have a worse prognosis.|participants|Number|2|2.0||||||
4297390|NCT00523640|4124062|B1|1||Fuhrman grade|An important factor used to assess renal cell carcinoma is its Fuhrman grade. This scale refers to how closely the cancer cells look like normal kidney cells under a microscope. The Fuhrman grading system ranks tumor cells on a scale of 1 through 4 and is a prognostic scale. 1 represents the best prognosis and 4 the worst. Grade 1 tumor cells look similar to normal kidney cells. Grade 1 cancers typically grow and spread slowly and most often have a good prognosis. Grade 4 tumor cells look quite different from normal kidney cells and have a worse prognosis.|participants|Number|0|0.0||||||
4297391|NCT00523640|4124062|B1|Poorly differentiated/unclassified||Tumor histology||participant|Number|6|6.0||||||
4297392|NCT00523640|4124062|B1|Clear cell||Tumor histology||participant|Number|23|23.0||||||
4297393|NCT00523640|4124062|B1|3 or more||Number of metastatic disease sites||participants|Number|21|21.0||||||
4297394|NCT00523640|4124062|B1|2||Number of metastatic disease sites||participants|Number|6|6.0||||||
4297395|NCT00523640|4124062|B1|1||Number of metastatic disease sites||participants|Number|2|2.0||||||
4297396|NCT00523640|4124062|B1|2||Performance Status|ECOG performance status Scores on a scale Range 0-5, higher is worse|participants|Number|1|1.0||||||
4297397|NCT00523640|4124062|B1|1||Performance Status|ECOG performance status Scores on a scale Range 0-5, higher is worse|participants|Number|23|23.0||||||
4297398|NCT00523640|4124062|B1|0||Performance Status|ECOG performance status Scores on a scale Range 0-5, higher is worse|participants|Number|5|5.0||||||
4297399|NCT00523640|4124062|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4297400|NCT00523640|4124062|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4297401|NCT00523640|4124062|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4297402|NCT00523640|4124062|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4297403|NCT00523640|4124062|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4297404|NCT00523640|4124062|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4297405|NCT00523640|4124062|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4297406|NCT00523640|4124062|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4297407|NCT00523640|4124062|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4297408|NCT00523640|4124062|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4297409|NCT00523640|4124062|B1|||Age||years|Median|58|58.0|Full Range|||36.0|82.0|
4297410|NCT00523614|4124068|B3|Germany||Region of Enrollment||participants|Number|3400|3400.0||||||
4297411|NCT00523614|4124069|B2|Germany||Region of Enrollment||participants|Number|2720|2720.0||||||
4297412|NCT00523614|4124070|B1|Germany||Region of Enrollment||participants|Number|680|680.0||||||
4297413|NCT00523614|4124068|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4297414|NCT00523614|4124069|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4297415|NCT00523614|4124070|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4297416|NCT00523614|4124068|B3||Female|Sex: Female, Male||Participants|Count of Participants|3400|3400.0||||||
4297417|NCT00523614|4124069|B2||Female|Sex: Female, Male||Participants|Count of Participants|2720|2720.0||||||
4297418|NCT00523614|4124070|B1||Female|Sex: Female, Male||Participants|Count of Participants|680|680.0||||||
4297419|NCT00523614|4124068|B3|||Age||years|Mean|36.1|36.1|Standard Deviation|9.0|9.0|||
4297420|NCT00523614|4124069|B2|||Age||years|Mean|36.1|36.1|Standard Deviation|9.0|9.0|||
4297421|NCT00523614|4124070|B1|||Age||years|Mean|36.1|36.1|Standard Deviation|9.0|9.0|||
4297422|NCT00523614|4124068|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4297423|NCT00523614|4124069|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4297424|NCT00523614|4124070|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4297425|NCT00523614|4124068|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3325|3325.0||||||
4297426|NCT00523614|4124069|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2660|2660.0||||||
4297427|NCT00523614|4124070|B1||Between 18 and 65 years|Age||Participants|Count of Participants|665|665.0||||||
4297428|NCT00523614|4124068|B3||<=18 years|Age||Participants|Count of Participants|75|75.0||||||
4297429|NCT00523614|4124069|B2||<=18 years|Age||Participants|Count of Participants|60|60.0||||||
4297430|NCT00523614|4124070|B1||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4297431|NCT00523549|4124077|B3||Male|Sex: Female, Male|In this study, even though the number of patients randomized to the intensive and standard treatment regimen were 114 and 115 respectively, analysis of the Baseline Measures was performed using the Safety Population. The Safety Population included all randomized patients who received at least one dose of study medication (Number of patients= 114 in both the treatment arms).|Participants|Count of Participants|113|113.0||||||
4297432|NCT00523549|4124078|B2||Male|Sex: Female, Male|In this study, even though the number of patients randomized to the intensive and standard treatment regimen were 114 and 115 respectively, analysis of the Baseline Measures was performed using the Safety Population. The Safety Population included all randomized patients who received at least one dose of study medication (Number of patients= 114 in both the treatment arms).|Participants|Count of Participants|60|60.0||||||
4297433|NCT00523549|4124079|B1||Male|Sex: Female, Male|In this study, even though the number of patients randomized to the intensive and standard treatment regimen were 114 and 115 respectively, analysis of the Baseline Measures was performed using the Safety Population. The Safety Population included all randomized patients who received at least one dose of study medication (Number of patients= 114 in both the treatment arms).|Participants|Count of Participants|53|53.0||||||
4297434|NCT00523549|4124077|B3||Female|Sex: Female, Male|In this study, even though the number of patients randomized to the intensive and standard treatment regimen were 114 and 115 respectively, analysis of the Baseline Measures was performed using the Safety Population. The Safety Population included all randomized patients who received at least one dose of study medication (Number of patients= 114 in both the treatment arms).|Participants|Count of Participants|115|115.0||||||
4297435|NCT00523549|4124078|B2||Female|Sex: Female, Male|In this study, even though the number of patients randomized to the intensive and standard treatment regimen were 114 and 115 respectively, analysis of the Baseline Measures was performed using the Safety Population. The Safety Population included all randomized patients who received at least one dose of study medication (Number of patients= 114 in both the treatment arms).|Participants|Count of Participants|54|54.0||||||
4297436|NCT00523549|4124079|B1||Female|Sex: Female, Male|In this study, even though the number of patients randomized to the intensive and standard treatment regimen were 114 and 115 respectively, analysis of the Baseline Measures was performed using the Safety Population. The Safety Population included all randomized patients who received at least one dose of study medication (Number of patients= 114 in both the treatment arms).|Participants|Count of Participants|61|61.0||||||
4297437|NCT00523549|4124077|B3|||Age|In this study, even though the number of patients randomized to the intensive and standard treatment regimen were 114 and 115 respectively, analysis of the Baseline Measures was performed using the Safety Population. The Safety Population included all randomized patients who received at least one dose of study medication (Number of patients= 114 in both the treatment arms).|years|Mean|59.6|59.6|Standard Deviation|9.74|9.74|||
4297438|NCT00523549|4124078|B2|||Age|In this study, even though the number of patients randomized to the intensive and standard treatment regimen were 114 and 115 respectively, analysis of the Baseline Measures was performed using the Safety Population. The Safety Population included all randomized patients who received at least one dose of study medication (Number of patients= 114 in both the treatment arms).|years|Mean|58.9|58.9|Standard Deviation|9.45|9.45|||
4297439|NCT00523549|4124079|B1|||Age|In this study, even though the number of patients randomized to the intensive and standard treatment regimen were 114 and 115 respectively, analysis of the Baseline Measures was performed using the Safety Population. The Safety Population included all randomized patients who received at least one dose of study medication (Number of patients= 114 in both the treatment arms).|years|Mean|60.2|60.2|Standard Deviation|10.03|10.03|||
4297440|NCT00523419|4124098|B1|||Time from last diagnosis to enrollment||days|Mean|13.3|13.3|Standard Deviation|12.10|12.1|||
4297441|NCT00523419|4124098|B1|||Pathological Diagnosis of Osteosarcoma at Study Entry||participants|Number|32|32.0||||||
4297442|NCT00523419|4124098|B1|5 Non Target Lesions||Number of non target lesions|All lesions that do not meet the criteria for target lesions, including small lesions (longest diameter <20 millimeter [mm] with conventional computed tomography [CT] scan, <10 mm with spiral CT scan) and other non-measurable lesions.|participants|Number|1|1.0||||||
4297443|NCT00523419|4124098|B1|3 Non Target Lesions||Number of non target lesions|All lesions that do not meet the criteria for target lesions, including small lesions (longest diameter <20 millimeter [mm] with conventional computed tomography [CT] scan, <10 mm with spiral CT scan) and other non-measurable lesions.|participants|Number|1|1.0||||||
4297444|NCT00523419|4124098|B1|2 Non Target Lesions||Number of non target lesions|All lesions that do not meet the criteria for target lesions, including small lesions (longest diameter <20 millimeter [mm] with conventional computed tomography [CT] scan, <10 mm with spiral CT scan) and other non-measurable lesions.|participants|Number|5|5.0||||||
4297445|NCT00523419|4124098|B1|1 Non Target Lesion||Number of non target lesions|All lesions that do not meet the criteria for target lesions, including small lesions (longest diameter <20 millimeter [mm] with conventional computed tomography [CT] scan, <10 mm with spiral CT scan) and other non-measurable lesions.|participants|Number|15|15.0||||||
4297446|NCT00523419|4124098|B1|0 Non Target Lesions||Number of non target lesions|All lesions that do not meet the criteria for target lesions, including small lesions (longest diameter <20 millimeter [mm] with conventional computed tomography [CT] scan, <10 mm with spiral CT scan) and other non-measurable lesions.|participants|Number|10|10.0||||||
4297447|NCT00523419|4124098|B1|5 Target Lesions||Number of Target Lesions|Target lesions: all measurable lesions up to a maximum of 5 lesions per organ and 10 lesions in total, representative of all involved organs; selected on the basis of size (those lesions with the longest diameter) and suitability for accurate repeated measurements (either by imaging techniques or clinically). If the measurable disease is restricted to a solitary lesion, the neoplastic nature of the lesion was confirmed by cytology/histology.|participants|Number|7|7.0||||||
4297448|NCT00523419|4124098|B1|4 Target Lesions||Number of Target Lesions|Target lesions: all measurable lesions up to a maximum of 5 lesions per organ and 10 lesions in total, representative of all involved organs; selected on the basis of size (those lesions with the longest diameter) and suitability for accurate repeated measurements (either by imaging techniques or clinically). If the measurable disease is restricted to a solitary lesion, the neoplastic nature of the lesion was confirmed by cytology/histology.|participants|Number|3|3.0||||||
4297543|NCT00523302|4124217|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4297449|NCT00523419|4124098|B1|3 Target Lesions||Number of Target Lesions|Target lesions: all measurable lesions up to a maximum of 5 lesions per organ and 10 lesions in total, representative of all involved organs; selected on the basis of size (those lesions with the longest diameter) and suitability for accurate repeated measurements (either by imaging techniques or clinically). If the measurable disease is restricted to a solitary lesion, the neoplastic nature of the lesion was confirmed by cytology/histology.|participants|Number|4|4.0||||||
4297450|NCT00523419|4124098|B1|2 Target Lesions||Number of Target Lesions|Target lesions: all measurable lesions up to a maximum of 5 lesions per organ and 10 lesions in total, representative of all involved organs; selected on the basis of size (those lesions with the longest diameter) and suitability for accurate repeated measurements (either by imaging techniques or clinically). If the measurable disease is restricted to a solitary lesion, the neoplastic nature of the lesion was confirmed by cytology/histology.|participants|Number|8|8.0||||||
4297451|NCT00523419|4124098|B1|1 Target Lesion||Number of Target Lesions|Target lesions: all measurable lesions up to a maximum of 5 lesions per organ and 10 lesions in total, representative of all involved organs; selected on the basis of size (those lesions with the longest diameter) and suitability for accurate repeated measurements (either by imaging techniques or clinically). If the measurable disease is restricted to a solitary lesion, the neoplastic nature of the lesion was confirmed by cytology/histology.|participants|Number|9|9.0||||||
4297452|NCT00523419|4124098|B1|0 Target Lesions||Number of Target Lesions|Target lesions: all measurable lesions up to a maximum of 5 lesions per organ and 10 lesions in total, representative of all involved organs; selected on the basis of size (those lesions with the longest diameter) and suitability for accurate repeated measurements (either by imaging techniques or clinically). If the measurable disease is restricted to a solitary lesion, the neoplastic nature of the lesion was confirmed by cytology/histology.|participants|Number|1|1.0||||||
4297453|NCT00523419|4124098|B1|||Histopathological Diagnosis of Osteosarcoma at Study Entry||participants|Number|32|32.0||||||
4297454|NCT00523419|4124098|B1|ECOG Performance Status Not Available||Eastern Cooperative Oncology Group (ECOG) performance status|0: fully active, able to carry on all pre-disease performance without restriction; 1: restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2: ambulatory and capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3: capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4: completely disabled, cannot carry on any self-care, totally confined to bed or chair; 5: dead.|participants|Number|1|1.0||||||
4297455|NCT00523419|4124098|B1|ECOG Performance Status 2||Eastern Cooperative Oncology Group (ECOG) performance status|0: fully active, able to carry on all pre-disease performance without restriction; 1: restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2: ambulatory and capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3: capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4: completely disabled, cannot carry on any self-care, totally confined to bed or chair; 5: dead.|participants|Number|1|1.0||||||
4297456|NCT00523419|4124098|B1|ECOG Performance Status 1||Eastern Cooperative Oncology Group (ECOG) performance status|0: fully active, able to carry on all pre-disease performance without restriction; 1: restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2: ambulatory and capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3: capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4: completely disabled, cannot carry on any self-care, totally confined to bed or chair; 5: dead.|participants|Number|14|14.0||||||
4297457|NCT00523419|4124098|B1|ECOG Performance Status 0||Eastern Cooperative Oncology Group (ECOG) performance status|0: fully active, able to carry on all pre-disease performance without restriction; 1: restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2: ambulatory and capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3: capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4: completely disabled, cannot carry on any self-care, totally confined to bed or chair; 5: dead.|participants|Number|16|16.0||||||
4297458|NCT00523419|4124098|B1|Not Applicable||Best Response of Last Prior Treatment Regimen for Osteosarcoma|Complete response (CR): all tumor lesions disappear. Partial response (PR): >=30% decrease in sum of the longest diameter (LD) of target lesions (reference: baseline sum LDs) or complete disappearance of target lesions, with persistence (but not worsening) of >=1 nontarget lesions; no appearance of new lesions. Stable disease: neither sufficient shrinkage for PR nor sufficient increase for PD; references: smallest sum LD. Progressive disease (PD): >=20% increase in the sum of LD of target lesions (references: smallest sum LD recorded since treatment started) or appearance of >=1 new lesions.|participants|Number|3|3.0||||||
4297459|NCT00523419|4124098|B1|Progressive Disease||Best Response of Last Prior Treatment Regimen for Osteosarcoma|Complete response (CR): all tumor lesions disappear. Partial response (PR): >=30% decrease in sum of the longest diameter (LD) of target lesions (reference: baseline sum LDs) or complete disappearance of target lesions, with persistence (but not worsening) of >=1 nontarget lesions; no appearance of new lesions. Stable disease: neither sufficient shrinkage for PR nor sufficient increase for PD; references: smallest sum LD. Progressive disease (PD): >=20% increase in the sum of LD of target lesions (references: smallest sum LD recorded since treatment started) or appearance of >=1 new lesions.|participants|Number|15|15.0||||||
4297460|NCT00523419|4124098|B1|Stable Disease||Best Response of Last Prior Treatment Regimen for Osteosarcoma|Complete response (CR): all tumor lesions disappear. Partial response (PR): >=30% decrease in sum of the longest diameter (LD) of target lesions (reference: baseline sum LDs) or complete disappearance of target lesions, with persistence (but not worsening) of >=1 nontarget lesions; no appearance of new lesions. Stable disease: neither sufficient shrinkage for PR nor sufficient increase for PD; references: smallest sum LD. Progressive disease (PD): >=20% increase in the sum of LD of target lesions (references: smallest sum LD recorded since treatment started) or appearance of >=1 new lesions.|participants|Number|10|10.0||||||
4297544|NCT00523302|4124215|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4297545|NCT00523302|4124216|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4297546|NCT00523302|4124217|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4297461|NCT00523419|4124098|B1|Partial Response||Best Response of Last Prior Treatment Regimen for Osteosarcoma|Complete response (CR): all tumor lesions disappear. Partial response (PR): >=30% decrease in sum of the longest diameter (LD) of target lesions (reference: baseline sum LDs) or complete disappearance of target lesions, with persistence (but not worsening) of >=1 nontarget lesions; no appearance of new lesions. Stable disease: neither sufficient shrinkage for PR nor sufficient increase for PD; references: smallest sum LD. Progressive disease (PD): >=20% increase in the sum of LD of target lesions (references: smallest sum LD recorded since treatment started) or appearance of >=1 new lesions.|participants|Number|3|3.0||||||
4297462|NCT00523419|4124098|B1|Complete Response||Best Response of Last Prior Treatment Regimen for Osteosarcoma|Complete response (CR): all tumor lesions disappear. Partial response (PR): >=30% decrease in sum of the longest diameter (LD) of target lesions (reference: baseline sum LDs) or complete disappearance of target lesions, with persistence (but not worsening) of >=1 nontarget lesions; no appearance of new lesions. Stable disease: neither sufficient shrinkage for PR nor sufficient increase for PD; references: smallest sum LD. Progressive disease (PD): >=20% increase in the sum of LD of target lesions (references: smallest sum LD recorded since treatment started) or appearance of >=1 new lesions.|participants|Number|1|1.0||||||
4297463|NCT00523419|4124098|B1|Italy||Region of Enrollment||participants|Number|9|9.0||||||
4297464|NCT00523419|4124098|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4297465|NCT00523419|4124098|B1|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4297466|NCT00523419|4124098|B1|Spain||Region of Enrollment||participants|Number|3|3.0||||||
4297467|NCT00523419|4124098|B1|France||Region of Enrollment||participants|Number|13|13.0||||||
4297468|NCT00523419|4124098|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4297469|NCT00523419|4124098|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4297470|NCT00523419|4124098|B1|||Age||years|Mean|42.1|42.1|Standard Deviation|16.28|16.28|||
4297471|NCT00523367|4124108|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4297472|NCT00523367|4124108|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4297473|NCT00523367|4124108|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4297474|NCT00523367|4124108|B1|||Age||years|Mean|59.16|59.16|Standard Deviation|11.81|11.81|||
4297475|NCT00523367|4124108|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4297476|NCT00523367|4124108|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4297477|NCT00523367|4124108|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297478|NCT00523341|4124112|B3|||Any Historical Fracture at Age ≥ 55 Years||participants|Number|2222|2222.0||||||
4297479|NCT00523341|4124113|B2|||Any Historical Fracture at Age ≥ 55 Years||participants|Number|1133|1133.0||||||
4297480|NCT00523341|4124114|B1|||Any Historical Fracture at Age ≥ 55 Years||participants|Number|1089|1089.0||||||
4297481|NCT00523341|4124112|B3|Femoral neck||Bone Mineral Density T-score at Study 20030216 Baseline||T-score|Mean|-2.11|-2.11|Standard Deviation|0.71|0.71|||
4297482|NCT00523341|4124113|B2|Femoral neck||Bone Mineral Density T-score at Study 20030216 Baseline||T-score|Mean|-2.11|-2.11|Standard Deviation|0.71|0.71|||
4297483|NCT00523341|4124114|B1|Femoral neck||Bone Mineral Density T-score at Study 20030216 Baseline||T-score|Mean|-2.11|-2.11|Standard Deviation|0.71|0.71|||
4297484|NCT00523341|4124112|B3|Total hip||Bone Mineral Density T-score at Study 20030216 Baseline||T-score|Mean|-1.85|-1.85|Standard Deviation|0.79|0.79|||
4297485|NCT00523341|4124113|B2|Total hip||Bone Mineral Density T-score at Study 20030216 Baseline||T-score|Mean|-1.85|-1.85|Standard Deviation|0.79|0.79|||
4297486|NCT00523341|4124114|B1|Total hip||Bone Mineral Density T-score at Study 20030216 Baseline||T-score|Mean|-1.85|-1.85|Standard Deviation|0.79|0.79|||
4297487|NCT00523341|4124112|B3|Lumbar spine||Bone Mineral Density T-score at Study 20030216 Baseline||T-score|Mean|-2.83|-2.83|Standard Deviation|0.68|0.68|||
4297488|NCT00523341|4124113|B2|Lumbar spine||Bone Mineral Density T-score at Study 20030216 Baseline||T-score|Mean|-2.83|-2.83|Standard Deviation|0.67|0.67|||
4297489|NCT00523341|4124114|B1|Lumbar spine||Bone Mineral Density T-score at Study 20030216 Baseline||T-score|Mean|-2.84|-2.84|Standard Deviation|0.68|0.68|||
4297490|NCT00523341|4124112|B3|Femoral neck||Bone Mineral Density T-score|"The T-score is the bone mineral density (BMD) at the site when compared to that of a healthy thirty-year-old.~Normal is a T-score of −1.0 or higher; Osteopenia is defined as between −1.0 and −2.5; Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a thirty-year-old man/woman."|T-score|Mean|-1.99|-1.99|Standard Deviation|0.75|0.75|||
4297491|NCT00523341|4124113|B2|Femoral neck||Bone Mineral Density T-score|"The T-score is the bone mineral density (BMD) at the site when compared to that of a healthy thirty-year-old.~Normal is a T-score of −1.0 or higher; Osteopenia is defined as between −1.0 and −2.5; Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a thirty-year-old man/woman."|T-score|Mean|-1.83|-1.83|Standard Deviation|0.75|0.75|||
4297492|NCT00523341|4124114|B1|Femoral neck||Bone Mineral Density T-score|"The T-score is the bone mineral density (BMD) at the site when compared to that of a healthy thirty-year-old.~Normal is a T-score of −1.0 or higher; Osteopenia is defined as between −1.0 and −2.5; Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a thirty-year-old man/woman."|T-score|Mean|-2.17|-2.17|Standard Deviation|0.72|0.72|||
4297493|NCT00523341|4124112|B3|Total hip||Bone Mineral Density T-score|"The T-score is the bone mineral density (BMD) at the site when compared to that of a healthy thirty-year-old.~Normal is a T-score of −1.0 or higher; Osteopenia is defined as between −1.0 and −2.5; Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a thirty-year-old man/woman."|T-score|Mean|-1.71|-1.71|Standard Deviation|0.83|0.83|||
4297547|NCT00523302|4124215|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4297548|NCT00523302|4124216|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4297549|NCT00523302|4124217|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4297494|NCT00523341|4124113|B2|Total hip||Bone Mineral Density T-score|"The T-score is the bone mineral density (BMD) at the site when compared to that of a healthy thirty-year-old.~Normal is a T-score of −1.0 or higher; Osteopenia is defined as between −1.0 and −2.5; Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a thirty-year-old man/woman."|T-score|Mean|-1.50|-1.5|Standard Deviation|0.79|0.79|||
4297495|NCT00523341|4124114|B1|Total hip||Bone Mineral Density T-score|"The T-score is the bone mineral density (BMD) at the site when compared to that of a healthy thirty-year-old.~Normal is a T-score of −1.0 or higher; Osteopenia is defined as between −1.0 and −2.5; Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a thirty-year-old man/woman."|T-score|Mean|-1.93|-1.93|Standard Deviation|0.80|0.8|||
4297496|NCT00523341|4124112|B3|Lumbar spine||Bone Mineral Density T-score|"The T-score is the bone mineral density (BMD) at the site when compared to that of a healthy thirty-year-old.~Normal is a T-score of −1.0 or higher; Osteopenia is defined as between −1.0 and −2.5; Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a thirty-year-old man/woman."|T-score|Mean|-2.47|-2.47|Standard Deviation|0.84|0.84|||
4297497|NCT00523341|4124113|B2|Lumbar spine||Bone Mineral Density T-score|"The T-score is the bone mineral density (BMD) at the site when compared to that of a healthy thirty-year-old.~Normal is a T-score of −1.0 or higher; Osteopenia is defined as between −1.0 and −2.5; Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a thirty-year-old man/woman."|T-score|Mean|-2.14|-2.14|Standard Deviation|0.80|0.8|||
4297498|NCT00523341|4124114|B1|Lumbar spine||Bone Mineral Density T-score|"The T-score is the bone mineral density (BMD) at the site when compared to that of a healthy thirty-year-old.~Normal is a T-score of −1.0 or higher; Osteopenia is defined as between −1.0 and −2.5; Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a thirty-year-old man/woman."|T-score|Mean|-2.81|-2.81|Standard Deviation|0.75|0.75|||
4297499|NCT00523341|4124112|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4297500|NCT00523341|4124113|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4297501|NCT00523341|4124114|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4297502|NCT00523341|4124112|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4297503|NCT00523341|4124113|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4297504|NCT00523341|4124114|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4297505|NCT00523341|4124112|B3|Japanese||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4297506|NCT00523341|4124113|B2|Japanese||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4297507|NCT00523341|4124114|B1|Japanese||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4297508|NCT00523341|4124112|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4297509|NCT00523341|4124113|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4297510|NCT00523341|4124114|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4297511|NCT00523341|4124112|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|266|266.0||||||
4297512|NCT00523341|4124113|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|145|145.0||||||
4297513|NCT00523341|4124114|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|121|121.0||||||
4297514|NCT00523341|4124112|B3|Black||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4297515|NCT00523341|4124113|B2|Black||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4297516|NCT00523341|4124114|B1|Black||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4297517|NCT00523341|4124112|B3|White||Race/Ethnicity, Customized||participants|Number|4232|4232.0||||||
4297518|NCT00523341|4124113|B2|White||Race/Ethnicity, Customized||participants|Number|2169|2169.0||||||
4297519|NCT00523341|4124114|B1|White||Race/Ethnicity, Customized||participants|Number|2063|2063.0||||||
4297520|NCT00523341|4124112|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4297521|NCT00523341|4124113|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4297522|NCT00523341|4124114|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4297523|NCT00523341|4124112|B3||Female|Sex: Female, Male||Participants|Count of Participants|4550|4550.0||||||
4297524|NCT00523341|4124113|B2||Female|Sex: Female, Male||Participants|Count of Participants|2343|2343.0||||||
4297525|NCT00523341|4124114|B1||Female|Sex: Female, Male||Participants|Count of Participants|2207|2207.0||||||
4297526|NCT00523341|4124112|B3|≥ 75 years||Age, Customized||participants|Number|2409|2409.0||||||
4297527|NCT00523341|4124113|B2|≥ 75 years||Age, Customized||participants|Number|1258|1258.0||||||
4297528|NCT00523341|4124114|B1|≥ 75 years||Age, Customized||participants|Number|1151|1151.0||||||
4297529|NCT00523341|4124112|B3|70 - 74 years||Age, Customized||participants|Number|1388|1388.0||||||
4297530|NCT00523341|4124113|B2|70 - 74 years||Age, Customized||participants|Number|716|716.0||||||
4297531|NCT00523341|4124114|B1|70 - 74 years||Age, Customized||participants|Number|672|672.0||||||
4297532|NCT00523341|4124112|B3|65 - 69 years||Age, Customized||participants|Number|646|646.0||||||
4297533|NCT00523341|4124113|B2|65 - 69 years||Age, Customized||participants|Number|320|320.0||||||
4297534|NCT00523341|4124114|B1|65 - 69 years||Age, Customized||participants|Number|326|326.0||||||
4297535|NCT00523341|4124112|B3|60 - 64 years||Age, Customized||participants|Number|107|107.0||||||
4297536|NCT00523341|4124113|B2|60 - 64 years||Age, Customized||participants|Number|49|49.0||||||
4297537|NCT00523341|4124114|B1|60 - 64 years||Age, Customized||participants|Number|58|58.0||||||
4297538|NCT00523341|4124112|B3|||Age||years|Mean|74.8|74.8|Standard Deviation|5.0|5.0|||
4297539|NCT00523341|4124113|B2|||Age||years|Mean|74.9|74.9|Standard Deviation|5.0|5.0|||
4297540|NCT00523341|4124114|B1|||Age||years|Mean|74.8|74.8|Standard Deviation|5.1|5.1|||
4297550|NCT00523302|4124215|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4297551|NCT00523302|4124216|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4297552|NCT00523302|4124217|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4297553|NCT00523302|4124215|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4297554|NCT00523302|4124216|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4297555|NCT00523302|4124217|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4297556|NCT00523302|4124215|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4297557|NCT00523302|4124216|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4297558|NCT00523302|4124217|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4297559|NCT00523302|4124215|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4297560|NCT00523302|4124216|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4297561|NCT00523302|4124217|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4297562|NCT00523302|4124215|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4297563|NCT00523302|4124216|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4297564|NCT00523302|4124217|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4297565|NCT00523302|4124215|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4297566|NCT00523302|4124216|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4297567|NCT00523302|4124217|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4297568|NCT00523302|4124215|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4297569|NCT00523302|4124216|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4297570|NCT00523302|4124217|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4297571|NCT00523302|4124215|B3|||Age||years|Mean|53|53.0|Standard Deviation|13.53|13.53|||
4297572|NCT00523302|4124216|B2|||Age||years|Mean|51.67|51.67|Standard Deviation|18.19|18.19|||
4297573|NCT00523302|4124217|B1|||Age||years|Mean|54.20|54.2|Standard Deviation|8.28|8.28|||
4297574|NCT00523302|4124215|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4297575|NCT00523302|4124216|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4297576|NCT00523302|4124217|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4297577|NCT00523302|4124215|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4297578|NCT00523302|4124216|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4297579|NCT00523302|4124217|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4297580|NCT00523302|4124215|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297581|NCT00523302|4124216|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297582|NCT00523302|4124217|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297583|NCT00523237|4124228|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4297584|NCT00523237|4124228|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4297585|NCT00523237|4124228|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4297586|NCT00523237|4124228|B1|||Age||years|Mean|56|56.0|Standard Deviation|56|56.0|||
4297587|NCT00523237|4124228|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4297588|NCT00523237|4124228|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4297589|NCT00523237|4124228|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297590|NCT00522951|4124232|B1|Others||Primary focus||participants|Number|21|21.0||||||
4297591|NCT00522951|4124232|B1|Breast cancer||Primary focus||participants|Number|20|20.0||||||
4297592|NCT00522951|4124232|B1|Lung cancer||Primary focus||participants|Number|123|123.0||||||
4297593|NCT00522951|4124232|B1|||Body weight||kg|Mean|56.7|56.7|Standard Deviation|12.2|12.2|||
4297594|NCT00522951|4124232|B1|||Height||cm|Mean|160.9|160.9|Standard Deviation|8.7|8.7|||
4297595|NCT00522951|4124232|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4297596|NCT00522951|4124232|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4297597|NCT00522951|4124232|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|11.8|11.8|||
4297598|NCT00522925|4124273|B4|United States||Region of Enrollment||participants|Number|113|113.0||||||
4297599|NCT00522925|4124274|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
4297600|NCT00522925|4124275|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
4297601|NCT00522925|4124276|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4297602|NCT00522925|4124273|B4||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4297603|NCT00522925|4124274|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4297604|NCT00522925|4124275|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4297605|NCT00522925|4124276|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4297606|NCT00522925|4124273|B4||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4297607|NCT00522925|4124274|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4297608|NCT00522925|4124275|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4297609|NCT00522925|4124276|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4297610|NCT00522925|4124273|B4|||Age||years|Mean|58.1|58.1|Standard Deviation|8.84|8.84|||
4297611|NCT00522925|4124274|B3|||Age||years|Mean|56.8|56.8|Standard Deviation|9.87|9.87|||
4297612|NCT00522925|4124275|B2|||Age||years|Mean|59.1|59.1|Standard Deviation|8.72|8.72|||
4297613|NCT00522925|4124276|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|7.94|7.94|||
4297614|NCT00522925|4124273|B4||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4297615|NCT00522925|4124274|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4297616|NCT00522925|4124275|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4297617|NCT00522925|4124276|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4297618|NCT00522925|4124273|B4||Between 18 and 65 years|Age||Participants|Count of Participants|88|88.0||||||
4297619|NCT00522925|4124274|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4297620|NCT00522925|4124275|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4297621|NCT00522925|4124276|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4297622|NCT00522925|4124273|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297623|NCT00522925|4124274|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297624|NCT00522925|4124275|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297625|NCT00522925|4124276|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297626|NCT00522873|4124286|B3|||Years since last menstruation at baseline||years|Mean|5.031|5.031|Standard Deviation|4.465|4.465|||
4297627|NCT00522873|4124287|B2|||Years since last menstruation at baseline||years|Mean|4.807|4.807|Standard Deviation|4.287|4.287|||
4297628|NCT00522873|4124288|B1|||Years since last menstruation at baseline||years|Mean|5.109|5.109|Standard Deviation|4.528|4.528|||
4297629|NCT00522873|4124286|B3|Oophorectomized||Number of participants with hysterectomy/oophorectomy||Participants|Number|30|30.0||||||
4297630|NCT00522873|4124287|B2|Oophorectomized||Number of participants with hysterectomy/oophorectomy||Participants|Number|5|5.0||||||
4297631|NCT00522873|4124288|B1|Oophorectomized||Number of participants with hysterectomy/oophorectomy||Participants|Number|25|25.0||||||
4297632|NCT00522873|4124286|B3|Hysterectomized||Number of participants with hysterectomy/oophorectomy||Participants|Number|0|0.0||||||
4297633|NCT00522873|4124287|B2|Hysterectomized||Number of participants with hysterectomy/oophorectomy||Participants|Number|0|0.0||||||
4297634|NCT00522873|4124288|B1|Hysterectomized||Number of participants with hysterectomy/oophorectomy||Participants|Number|0|0.0||||||
4297635|NCT00522873|4124286|B3|||Body Mass Index (BMI)|Body mass index was calculated with body weight and height measured at screening (BMI = body weight in kg/ body height in m^2).|kg/m^2|Mean|26.184|26.184|Standard Deviation|5.008|5.008|||
4297636|NCT00522873|4124287|B2|||Body Mass Index (BMI)|Body mass index was calculated with body weight and height measured at screening (BMI = body weight in kg/ body height in m^2).|kg/m^2|Mean|26.020|26.02|Standard Deviation|5.476|5.476|||
4297637|NCT00522873|4124288|B1|||Body Mass Index (BMI)|Body mass index was calculated with body weight and height measured at screening (BMI = body weight in kg/ body height in m^2).|kg/m^2|Mean|26.315|26.315|Standard Deviation|4.851|4.851|||
4297638|NCT00522873|4124286|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4297639|NCT00522873|4124287|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4297640|NCT00522873|4124288|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4297641|NCT00522873|4124286|B3||Female|Sex: Female, Male||Participants|Count of Participants|661|661.0||||||
4297642|NCT00522873|4124287|B2||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4297643|NCT00522873|4124288|B1||Female|Sex: Female, Male||Participants|Count of Participants|489|489.0||||||
4297644|NCT00522873|4124286|B3|||Age||Years|Mean|53.5|53.5|Standard Deviation|4.9|4.9|||
4297645|NCT00522873|4124287|B2|||Age||Years|Mean|53.5|53.5|Standard Deviation|4.5|4.5|||
4297646|NCT00522873|4124288|B1|||Age||Years|Mean|53.5|53.5|Standard Deviation|5.1|5.1|||
4297647|NCT00522795|4124298|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4297648|NCT00522795|4124298|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4297649|NCT00522795|4124298|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4297650|NCT00522795|4124298|B1|||Age||years|Mean|62|62.0|Standard Deviation|5|5.0|||
4297651|NCT00522795|4124298|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4297652|NCT00522795|4124298|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4297653|NCT00522795|4124298|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297654|NCT00522626|4124302|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4297655|NCT00522626|4124302|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4297656|NCT00522626|4124302|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4297657|NCT00522626|4124302|B1|||Age||years|Mean|30.25|30.25|Standard Deviation|7.38|7.38|||
4297658|NCT00522548|4124306|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
4297659|NCT00522548|4124307|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4297660|NCT00522548|4124308|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4297661|NCT00522548|4124306|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4297662|NCT00522548|4124307|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4297663|NCT00522548|4124308|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4297664|NCT00522548|4124306|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4297665|NCT00522548|4124307|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4297666|NCT00522548|4124308|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4297667|NCT00522548|4124306|B3|||Age||years|Mean|50.3|50.3|Standard Deviation|11.5|11.5|||
4297668|NCT00522548|4124307|B2|||Age||years|Mean|52.4|52.4|Standard Deviation|13.0|13.0|||
4297669|NCT00522548|4124308|B1|||Age||years|Mean|47.9|47.9|Standard Deviation|9.3|9.3|||
4297670|NCT00522548|4124306|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4297671|NCT00522548|4124307|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4297672|NCT00522548|4124308|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4297673|NCT00522548|4124306|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4297674|NCT00522548|4124307|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4297675|NCT00522548|4124308|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4297676|NCT00522548|4124306|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297677|NCT00522548|4124307|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297678|NCT00522548|4124308|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297679|NCT00522457|4124337|B1|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4297680|NCT00522457|4124337|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4297681|NCT00522457|4124337|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4297682|NCT00522457|4124337|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4297683|NCT00522457|4124337|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4297684|NCT00522457|4124337|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4297685|NCT00522457|4124337|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297686|NCT00522431|4124343|B1||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4297687|NCT00522431|4124343|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4297688|NCT00522431|4124343|B1|||Age||years|Mean|54.5|54.5|Standard Deviation|10.1|10.1|||
4297689|NCT00522418|4124348|B3|Unknown||Etiology of Epilepsy||participants|Number|44|44.0||||||
4297690|NCT00522418|4124349|B2|Unknown||Etiology of Epilepsy||participants|Number|22|22.0||||||
4297691|NCT00522418|4124350|B1|Unknown||Etiology of Epilepsy||participants|Number|22|22.0||||||
4297692|NCT00522418|4124348|B3|Structural/Metabolic||Etiology of Epilepsy||participants|Number|52|52.0||||||
4297693|NCT00522418|4124349|B2|Structural/Metabolic||Etiology of Epilepsy||participants|Number|26|26.0||||||
4297694|NCT00522418|4124350|B1|Structural/Metabolic||Etiology of Epilepsy||participants|Number|26|26.0||||||
4297695|NCT00522418|4124348|B3|||Age of Epilepsy Onset||years|Mean|15|15.0|Standard Deviation|14|14.0|||
4297696|NCT00522418|4124349|B2|||Age of Epilepsy Onset||years|Mean|16|16.0|Standard Deviation|14|14.0|||
4297697|NCT00522418|4124350|B1|||Age of Epilepsy Onset||years|Mean|13|13.0|Standard Deviation|14|14.0|||
4297698|NCT00522418|4124348|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4297699|NCT00522418|4124349|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4297700|NCT00522418|4124350|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4297701|NCT00522418|4124348|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4297702|NCT00522418|4124349|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4297703|NCT00522418|4124350|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4297704|NCT00522418|4124348|B3|||Age|Age at Randomization|Years|Mean|40|40.0|Standard Deviation|12|12.0|||
4297705|NCT00522418|4124349|B2|||Age|Age at Randomization|Years|Mean|41|41.0|Standard Deviation|11|11.0|||
4297706|NCT00522418|4124350|B1|||Age|Age at Randomization|Years|Mean|38|38.0|Standard Deviation|13|13.0|||
4297707|NCT00522392|4124397|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
4297708|NCT00522392|4124398|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4297709|NCT00522392|4124399|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4297710|NCT00522392|4124397|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4297711|NCT00522392|4124398|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4297712|NCT00522392|4124399|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4297713|NCT00522392|4124397|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4297714|NCT00522392|4124398|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4297715|NCT00522392|4124399|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4297716|NCT00522392|4124397|B3|||Age||years|Median|65|65.0|Full Range|||33.0|76.0|
4297717|NCT00522392|4124398|B2|||Age||years|Median|65|65.0|Full Range|||33.0|74.0|
4297718|NCT00522392|4124399|B1|||Age||years|Median|64|64.0|Full Range|||33.0|76.0|
4297719|NCT00522379|4124412|B6|India||Region of Enrollment||participants|Number|150|150.0||||||
4297720|NCT00522379|4124413|B5|India||Region of Enrollment||participants|Number|33|33.0||||||
4297721|NCT00522379|4124414|B4|India||Region of Enrollment||participants|Number|29|29.0||||||
4297722|NCT00522379|4124415|B3|India||Region of Enrollment||participants|Number|31|31.0||||||
4297723|NCT00522379|4124416|B2|India||Region of Enrollment||participants|Number|29|29.0||||||
4297724|NCT00522379|4124417|B1|India||Region of Enrollment||participants|Number|28|28.0||||||
4297725|NCT00522379|4124412|B6|Chile||Region of Enrollment||participants|Number|9|9.0||||||
4297726|NCT00522379|4124413|B5|Chile||Region of Enrollment||participants|Number|2|2.0||||||
4297727|NCT00522379|4124414|B4|Chile||Region of Enrollment||participants|Number|2|2.0||||||
4297728|NCT00522379|4124415|B3|Chile||Region of Enrollment||participants|Number|1|1.0||||||
4297729|NCT00522379|4124416|B2|Chile||Region of Enrollment||participants|Number|2|2.0||||||
4297730|NCT00522379|4124417|B1|Chile||Region of Enrollment||participants|Number|2|2.0||||||
4297731|NCT00522379|4124412|B6|Peru||Region of Enrollment||participants|Number|16|16.0||||||
4297732|NCT00522379|4124413|B5|Peru||Region of Enrollment||participants|Number|3|3.0||||||
4297733|NCT00522379|4124414|B4|Peru||Region of Enrollment||participants|Number|4|4.0||||||
4297734|NCT00522379|4124415|B3|Peru||Region of Enrollment||participants|Number|2|2.0||||||
4297735|NCT00522379|4124416|B2|Peru||Region of Enrollment||participants|Number|3|3.0||||||
4297736|NCT00522379|4124417|B1|Peru||Region of Enrollment||participants|Number|4|4.0||||||
4297737|NCT00522379|4124412|B6|Mexico||Region of Enrollment||participants|Number|5|5.0||||||
4297738|NCT00522379|4124413|B5|Mexico||Region of Enrollment||participants|Number|1|1.0||||||
4297739|NCT00522379|4124414|B4|Mexico||Region of Enrollment||participants|Number|0|0.0||||||
4297740|NCT00522379|4124415|B3|Mexico||Region of Enrollment||participants|Number|2|2.0||||||
4297741|NCT00522379|4124416|B2|Mexico||Region of Enrollment||participants|Number|1|1.0||||||
4297742|NCT00522379|4124417|B1|Mexico||Region of Enrollment||participants|Number|1|1.0||||||
4297743|NCT00522379|4124412|B6|United States||Region of Enrollment||participants|Number|334|334.0||||||
4297744|NCT00522379|4124413|B5|United States||Region of Enrollment||participants|Number|69|69.0||||||
4297745|NCT00522379|4124414|B4|United States||Region of Enrollment||participants|Number|59|59.0||||||
4297746|NCT00522379|4124415|B3|United States||Region of Enrollment||participants|Number|68|68.0||||||
4297747|NCT00522379|4124416|B2|United States||Region of Enrollment||participants|Number|72|72.0||||||
4297748|NCT00522379|4124417|B1|United States||Region of Enrollment||participants|Number|66|66.0||||||
4297749|NCT00522379|4124412|B6||Male|Sex: Female, Male||Participants|Count of Participants|359|359.0||||||
4297750|NCT00522379|4124413|B5||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4297751|NCT00522379|4124414|B4||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4297752|NCT00522379|4124415|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4297753|NCT00522379|4124416|B2||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4297754|NCT00522379|4124417|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4297755|NCT00522379|4124412|B6||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4297756|NCT00522379|4124413|B5||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4297757|NCT00522379|4124414|B4||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4297758|NCT00522379|4124415|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4297759|NCT00522379|4124416|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4297760|NCT00522379|4124417|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4297761|NCT00522379|4124412|B6|||Age||years|Mean|64.5|64.5|Standard Deviation|10.3|10.3|||
4297762|NCT00522379|4124413|B5|||Age||years|Mean|64.8|64.8|Standard Deviation|10.2|10.2|||
4297763|NCT00522379|4124414|B4|||Age||years|Mean|63.2|63.2|Standard Deviation|11.6|11.6|||
4297764|NCT00522379|4124415|B3|||Age||years|Mean|64.6|64.6|Standard Deviation|10.4|10.4|||
4297765|NCT00522379|4124416|B2|||Age||years|Mean|64.6|64.6|Standard Deviation|9.0|9.0|||
4297766|NCT00522379|4124417|B1|||Age||years|Mean|65.4|65.4|Standard Deviation|10.5|10.5|||
4297767|NCT00522379|4124412|B6||>=65 years|Age||Participants|Count of Participants|270|270.0||||||
4297768|NCT00522379|4124413|B5||>=65 years|Age||Participants|Count of Participants|60|60.0||||||
4297769|NCT00522379|4124414|B4||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
4297770|NCT00522379|4124415|B3||>=65 years|Age||Participants|Count of Participants|57|57.0||||||
4297771|NCT00522379|4124416|B2||>=65 years|Age||Participants|Count of Participants|53|53.0||||||
4297772|NCT00522379|4124417|B1||>=65 years|Age||Participants|Count of Participants|55|55.0||||||
4297773|NCT00522379|4124412|B6||Between 18 and 65 years|Age||Participants|Count of Participants|244|244.0||||||
4297774|NCT00522379|4124413|B5||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4297775|NCT00522379|4124414|B4||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4297776|NCT00522379|4124415|B3||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4297777|NCT00522379|4124416|B2||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4297778|NCT00522379|4124417|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4297779|NCT00522379|4124412|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297780|NCT00522379|4124413|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297781|NCT00522379|4124414|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297782|NCT00522379|4124415|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297783|NCT00522379|4124416|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297784|NCT00522379|4124417|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297785|NCT00522301|4124523|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4297786|NCT00522301|4124523|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4297787|NCT00522301|4124523|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4297788|NCT00522301|4124523|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4297789|NCT00522301|4124523|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297790|NCT00522275|4124527|B1|United States||Region of Enrollment||participants|Number|308|308.0||||||
4297791|NCT00522275|4124527|B1||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4297792|NCT00522275|4124527|B1||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4297793|NCT00522275|4124527|B1|||Age||years|Mean|38.2|38.2|Standard Deviation|12.46|12.46|||
4297794|NCT00522275|4124527|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4297795|NCT00522275|4124527|B1||Between 18 and 65 years|Age||Participants|Count of Participants|295|295.0||||||
4297796|NCT00522275|4124527|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4297797|NCT00522171|4124535|B3|Germany||Region of Enrollment||participants|Number|15|15.0||||||
4297798|NCT00522171|4124536|B2|Germany||Region of Enrollment||participants|Number|7|7.0||||||
4297799|NCT00522171|4124537|B1|Germany||Region of Enrollment||participants|Number|8|8.0||||||
4297800|NCT00522171|4124535|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4297801|NCT00522171|4124536|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4297802|NCT00522171|4124537|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4297803|NCT00522171|4124535|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4297804|NCT00522171|4124536|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4297805|NCT00522171|4124537|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4297806|NCT00522171|4124535|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4297807|NCT00522171|4124536|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4297808|NCT00522171|4124537|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4297809|NCT00522171|4124535|B3|||Age||years|Mean|38.63|38.63|Standard Deviation|9.088|9.088|||
4297810|NCT00522171|4124536|B2|||Age||years|Mean|38.13|38.13|Standard Deviation|8.105|8.105|||
4297811|NCT00522171|4124537|B1|||Age||years|Mean|39.13|39.13|Standard Deviation|10.239|10.239|||
4297812|NCT00522171|4124535|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4297813|NCT00522171|4124536|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4297814|NCT00522171|4124537|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4297815|NCT00522171|4124535|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4297816|NCT00522171|4124536|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4297817|NCT00522171|4124537|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4297818|NCT00522171|4124535|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297819|NCT00522171|4124536|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297820|NCT00522171|4124537|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297821|NCT00522041|4124546|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4297822|NCT00522041|4124547|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4297823|NCT00522041|4124548|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4297824|NCT00522041|4124546|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4297825|NCT00522041|4124547|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4297826|NCT00522041|4124548|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4297827|NCT00522041|4124546|B3||White|Race (NIH/OMB)||Participants|Count of Participants|195|195.0||||||
4297828|NCT00522041|4124547|B2||White|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4297829|NCT00522041|4124548|B1||White|Race (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
4297830|NCT00522041|4124546|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4297831|NCT00522041|4124547|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4297832|NCT00522041|4124548|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4297833|NCT00522041|4124546|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4297834|NCT00522041|4124547|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4297835|NCT00522041|4124548|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4297836|NCT00522041|4124546|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4297837|NCT00522041|4124547|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4297838|NCT00522041|4124548|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4297839|NCT00522041|4124546|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4297840|NCT00522041|4124547|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4297841|NCT00522041|4124548|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4297842|NCT00522041|4124546|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4297843|NCT00522041|4124547|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4297844|NCT00522041|4124548|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4297845|NCT00522041|4124546|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|193|193.0||||||
4297846|NCT00522041|4124547|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
4297847|NCT00522041|4124548|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
4297848|NCT00522041|4124546|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4297849|NCT00522041|4124547|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4297850|NCT00522041|4124548|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4297851|NCT00522041|4124546|B3||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4297852|NCT00522041|4124547|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4297853|NCT00522041|4124548|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4297854|NCT00522041|4124546|B3||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4297855|NCT00522041|4124547|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4297856|NCT00522041|4124548|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4297857|NCT00522041|4124546|B3|||Age||years|Mean|45.0|45.0|Standard Deviation|12.99|12.99|||
4297858|NCT00522041|4124547|B2|||Age||years|Mean|43.4|43.4|Standard Deviation|13.22|13.22|||
4297859|NCT00522041|4124548|B1|||Age||years|Mean|46.5|46.5|Standard Deviation|12.61|12.61|||
4297860|NCT00522041|4124546|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4297861|NCT00522041|4124547|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4297862|NCT00522041|4124548|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4297863|NCT00522041|4124546|B3||Between 18 and 65 years|Age||Participants|Count of Participants|231|231.0||||||
4297864|NCT00522041|4124547|B2||Between 18 and 65 years|Age||Participants|Count of Participants|117|117.0||||||
4297865|NCT00522041|4124548|B1||Between 18 and 65 years|Age||Participants|Count of Participants|114|114.0||||||
4297866|NCT00522041|4124546|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297867|NCT00522041|4124547|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297868|NCT00522041|4124548|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297869|NCT00521989|4124559|B6||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4297870|NCT00521989|4124560|B5||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4297871|NCT00521989|4124561|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4297872|NCT00521989|4124562|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4297873|NCT00521989|4124563|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4297874|NCT00521989|4124564|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4297875|NCT00521989|4124559|B6||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4297876|NCT00521989|4124560|B5||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4297877|NCT00521989|4124561|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4297878|NCT00521989|4124562|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4297879|NCT00521989|4124563|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4297880|NCT00521989|4124564|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4297881|NCT00521989|4124559|B6|||Age||years|Mean|59.3|59.3|Standard Deviation|8.96|8.96|||
4297882|NCT00521989|4124560|B5|||Age||years|Mean|57.9|57.9|Standard Deviation|7.46|7.46|||
4297883|NCT00521989|4124561|B4|||Age||years|Mean|60.2|60.2|Standard Deviation|8.65|8.65|||
4297884|NCT00521989|4124562|B3|||Age||years|Mean|57.7|57.7|Standard Deviation|9.03|9.03|||
4297885|NCT00521989|4124563|B2|||Age||years|Mean|59.4|59.4|Standard Deviation|10.02|10.02|||
4297886|NCT00521989|4124564|B1|||Age||years|Mean|61.1|61.1|Standard Deviation|9.35|9.35|||
4297887|NCT00521976|4124580|B1|Norway||Region of Enrollment||participants|Number|871|871.0||||||
4297888|NCT00521976|4124580|B1||Male|Sex: Female, Male||Participants|Count of Participants|531|531.0||||||
4297889|NCT00521976|4124580|B1||Female|Sex: Female, Male||Participants|Count of Participants|340|340.0||||||
4297890|NCT00521976|4124580|B1|||Age||years|Mean|69.6|69.6|Standard Deviation|14.4|14.4|||
4297891|NCT00521976|4124580|B1||>=65 years|Age||Participants|Count of Participants|571|571.0||||||
4297892|NCT00521976|4124580|B1||Between 18 and 65 years|Age||Participants|Count of Participants|300|300.0||||||
4297893|NCT00521976|4124580|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297894|NCT00521924|4124585|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4297895|NCT00521924|4124586|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4297896|NCT00521924|4124587|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4297897|NCT00521924|4124585|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4297898|NCT00521924|4124586|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4297899|NCT00521924|4124587|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4297900|NCT00521924|4124585|B3|||Age, Customized||participants|Number|8|8.0||||||
4297901|NCT00521924|4124586|B2|||Age, Customized||participants|Number|4|4.0||||||
4297902|NCT00521924|4124587|B1|||Age, Customized||participants|Number|4|4.0||||||
4297903|NCT00521599|4124605|B4||Male|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4297904|NCT00521599|4124606|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4297905|NCT00521599|4124607|B2||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4297906|NCT00521599|4124608|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4297907|NCT00521599|4124605|B4||Female|Sex: Female, Male||Participants|Count of Participants|464|464.0||||||
4297908|NCT00521599|4124606|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4297909|NCT00521599|4124607|B2||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4297910|NCT00521599|4124608|B1||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4297911|NCT00521599|4124605|B4||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4297912|NCT00521599|4124606|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4297913|NCT00521599|4124607|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4297914|NCT00521599|4124608|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4297915|NCT00521599|4124605|B4||Between 18 and 65 years|Age||Participants|Count of Participants|645|645.0||||||
4297916|NCT00521599|4124606|B3||Between 18 and 65 years|Age||Participants|Count of Participants|131|131.0||||||
4297917|NCT00521599|4124607|B2||Between 18 and 65 years|Age||Participants|Count of Participants|255|255.0||||||
4297918|NCT00521599|4124608|B1||Between 18 and 65 years|Age||Participants|Count of Participants|259|259.0||||||
4297919|NCT00521599|4124605|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297920|NCT00521599|4124606|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297921|NCT00521599|4124607|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297922|NCT00521599|4124608|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297923|NCT00521586|4124619|B3||Male|Sex: Female, Male||Participants|Count of Participants|470|470.0||||||
4297924|NCT00521586|4124620|B2||Male|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
4297925|NCT00521586|4124621|B1||Male|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
4297926|NCT00521586|4124619|B3||Female|Sex: Female, Male||Participants|Count of Participants|641|641.0||||||
4297927|NCT00521586|4124620|B2||Female|Sex: Female, Male||Participants|Count of Participants|322|322.0||||||
4297928|NCT00521586|4124621|B1||Female|Sex: Female, Male||Participants|Count of Participants|319|319.0||||||
4297929|NCT00521586|4124619|B3|||Age||years|Mean|54.6|54.6|Standard Deviation|2.8|2.8|||
4297930|NCT00521586|4124620|B2|||Age||years|Mean|54.6|54.6|Standard Deviation|2.9|2.9|||
4297931|NCT00521586|4124621|B1|||Age||years|Mean|54.6|54.6|Standard Deviation|2.8|2.8|||
4297932|NCT00521456|4124680|B3||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4297933|NCT00521456|4124681|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4297934|NCT00521456|4124682|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4297935|NCT00521456|4124680|B3||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4297936|NCT00521456|4124681|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4297937|NCT00521456|4124682|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4297938|NCT00521456|4124680|B3|>65 years||Age, Customized||participants|Number|168|168.0||||||
4297939|NCT00521456|4124681|B2|>65 years||Age, Customized||participants|Number|52|52.0||||||
4297940|NCT00521456|4124682|B1|>65 years||Age, Customized||participants|Number|116|116.0||||||
4297941|NCT00521456|4124680|B3|Between 45 and 65 years||Age, Customized||participants|Number|88|88.0||||||
4297942|NCT00521456|4124681|B2|Between 45 and 65 years||Age, Customized||participants|Number|32|32.0||||||
4297943|NCT00521456|4124682|B1|Between 45 and 65 years||Age, Customized||participants|Number|56|56.0||||||
4297944|NCT00521456|4124680|B3|<45 years||Age, Customized||participants|Number|7|7.0||||||
4297945|NCT00521456|4124681|B2|<45 years||Age, Customized||participants|Number|3|3.0||||||
4297946|NCT00521456|4124682|B1|<45 years||Age, Customized||participants|Number|4|4.0||||||
4297947|NCT00521365|4124695|B1|BARS||Safety scales|Simpson-Angus Scale (SAS) and Barnes Akathisia Rating Scale (BARS)total score at visit 1 (day 0). Simpson-Angus Scale (SAS) for evaluating drug-related extrapyramidal syndromes Questionnaire has 6 items with scale range 0 to 3 for each item.0=Normal; 3=Most abnormal. Total possible score is 0-18. Barnes Akathisia Rating Scale (BARS) Questionnaire has 4 items with scale range 0 to 3 for 3 items and 0 to 5 for 1 item. 0=Normal; 3 or 5=Most abnormal. Total possible score is 0-14.|Scores on a scale|Mean|1.78|1.78|Standard Deviation|2.40|2.4|||
4297948|NCT00521365|4124695|B1|SAS||Safety scales|Simpson-Angus Scale (SAS) and Barnes Akathisia Rating Scale (BARS)total score at visit 1 (day 0). Simpson-Angus Scale (SAS) for evaluating drug-related extrapyramidal syndromes Questionnaire has 6 items with scale range 0 to 3 for each item.0=Normal; 3=Most abnormal. Total possible score is 0-18. Barnes Akathisia Rating Scale (BARS) Questionnaire has 4 items with scale range 0 to 3 for 3 items and 0 to 5 for 1 item. 0=Normal; 3 or 5=Most abnormal. Total possible score is 0-14.|Scores on a scale|Mean|1.12|1.12|Standard Deviation|2.20|2.2|||
4297949|NCT00521365|4124695|B1|||European Quality of Life 5 Dimensions (EQ5D) Questionnaire Visual Analogue Scale (VAS)|European Quality of Life 5 Dimensions (Eq5D) Visual Analog Scale (VAS) at visit 1(day 0). European Quality of Life 5 Dimensions (EQ5D) questionnaire part 2 has 1 item with continuous scale range 0 to 100, where 0= the worst quality of life and 100 = the best quality of life.|Scores on a scale|Mean|55|55.0|Standard Deviation|27.8|27.8|||
4297950|NCT00521365|4124695|B1|||European Quality of Life 5 Dimensions (EQ5D) Questionnaire Index|European Quality of Life 5 Dimensions (EQ5D) Total possible score is 0-1 (0 = The worst quality of life; 1 = The best quality of life).|Scores on a scale|Mean|0.54|0.54|Standard Deviation|0.3|0.3|||
4297951|NCT00521365|4124695|B1|||Clinical Global Impression-Severity (CGI-S) total score|Clinical Global Impression-Severity (CGI-S) total score at visit 1( day 0). 1 item instrument with scale range 0 to 7. 0 = patients who were not assessed, 1 = Normal 7 = the most extremely ill patients.|Scores on a scale|Mean|5.00|5.0|Standard Deviation|0.80|0.8|||
4297952|NCT00521365|4124695|B1|||Young Mania Rating Scale (YMRS) total score|Young Mania Rating Scale (YMRS) total score at visit 1(day 0). 11 item instrument with scale range 0 to 4 for 7 items and 0 to 8 for 4 items. 0 = normal; 4 or 8 = most abnormal. Total possible score is 0 - 60.|Scores on a scale|Mean|32.06|32.06|Standard Deviation|9.00|9.0|||
4297953|NCT00521365|4124695|B1||Male|Sex: Female, Male|Participants were classified as male or female during V0.|Participants|Count of Participants|35|35.0||||||
4297954|NCT00521365|4124695|B1||Female|Sex: Female, Male|Participants were classified as male or female during V0.|Participants|Count of Participants|53|53.0||||||
4297955|NCT00521365|4124695|B1|||Age|Participants were asked for their age in years at V0|Years|Mean|36.51|36.51|Standard Deviation|12.70|12.7|||
4297956|NCT00521352|4124712|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4297957|NCT00521352|4124713|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4297958|NCT00521352|4124714|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4297959|NCT00521352|4124712|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4297960|NCT00521352|4124713|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4297961|NCT00521352|4124714|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4297962|NCT00521352|4124712|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4297963|NCT00521352|4124713|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4297964|NCT00521352|4124714|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4297965|NCT00521352|4124712|B3|||Age||years|Mean|40|40.0|Standard Deviation|11.6|11.6|||
4297966|NCT00521352|4124713|B2|||Age||years|Mean|39.8|39.8|Standard Deviation|13.3|13.3|||
4297967|NCT00521352|4124714|B1|||Age||years|Mean|40.2|40.2|Standard Deviation|10|10.0|||
4297968|NCT00521352|4124712|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4297969|NCT00521352|4124713|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4297970|NCT00521352|4124714|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4297971|NCT00521352|4124712|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4297972|NCT00521352|4124713|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4297973|NCT00521352|4124714|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4297974|NCT00521352|4124712|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297975|NCT00521352|4124713|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297976|NCT00521352|4124714|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4297977|NCT00521339|4124725|B1|||Mean Body Surface Area (BSA) Involvement|The BSA estimate was based on the palm area of the hand of the participant which equates to 1% of the total body surface area.|Percentage of BSA|Mean|22.4|22.4|Standard Deviation|13.85|13.85|||
4297978|NCT00521339|4124725|B1|||Mean Psoriasis Area and Severity Index (PASI) Score|PASI: Combined assessment of lesion severity and area affected into single score; range: 0(no disease) to 72(maximal disease).|units on a scale|Mean|17.0|17.0|Standard Deviation|6.77|6.77|||
4297979|NCT00521339|4124725|B1|||Recalcitrant Psoriasis History|Eligible participants had a diagnosis of plaque-type psoriasis at least 6 months prior to screening and either had an insufficient response, were unresponsive to, were intolerant of, or had medical contraindications to standard systemic therapy or biological treatment for plaque-type psoriasis. Participants also had a Static Physician Global Assessment (sPGA) score of at least 3 and psoriasis affected body surface area (BSA) involvement ≥ 10% at screening. The sPGA is a measure of psoriasis disease severity at the time of evaluation by the investigator.|years|Mean|10.9|10.9|Standard Deviation|11.36|11.36|||
4297980|NCT00521339|4124725|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4297981|NCT00521339|4124725|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4297982|NCT00521339|4124725|B1|||Age||years|Mean|46.3|46.3|Standard Deviation|11.43|11.43|||
4297983|NCT00521144|4124790|B6|United States||Region of Enrollment||participants|Number|22|22.0||||||
4297984|NCT00521144|4124791|B5|United States||Region of Enrollment||participants|Number|7|7.0||||||
4297985|NCT00521144|4124792|B4|United States||Region of Enrollment||participants|Number|1|1.0||||||
4297986|NCT00521144|4124793|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4297987|NCT00521144|4124794|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4297988|NCT00521144|4124795|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4297989|NCT00521144|4124790|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4297990|NCT00521144|4124791|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4297991|NCT00521144|4124792|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4297992|NCT00521144|4124793|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4297993|NCT00521144|4124794|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4297994|NCT00521144|4124795|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4297995|NCT00521144|4124790|B6||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4297996|NCT00521144|4124791|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4297997|NCT00521144|4124792|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4297998|NCT00521144|4124793|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4297999|NCT00521144|4124794|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4298000|NCT00521144|4124795|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4298001|NCT00521144|4124790|B6||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4298002|NCT00521144|4124791|B5||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4298003|NCT00521144|4124792|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4298004|NCT00521144|4124793|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4298005|NCT00521144|4124794|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4298006|NCT00521144|4124795|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4298007|NCT00521144|4124790|B6||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4298008|NCT00521144|4124791|B5||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4298009|NCT00521144|4124792|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4298010|NCT00521144|4124793|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4298011|NCT00521144|4124794|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4298012|NCT00521144|4124795|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4298013|NCT00521144|4124790|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4298014|NCT00521144|4124791|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4298015|NCT00521144|4124792|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4298016|NCT00521144|4124793|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4298017|NCT00521144|4124794|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4298018|NCT00521144|4124795|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4298019|NCT00521079|4124811|B3|Australia||Region of Enrollment||participants|Number|61|61.0||||||
4298020|NCT00521079|4124812|B2|Australia||Region of Enrollment||participants|Number|20|20.0||||||
4298021|NCT00521079|4124813|B1|Australia||Region of Enrollment||participants|Number|41|41.0||||||
4298022|NCT00521079|4124811|B3|United States||Region of Enrollment||participants|Number|219|219.0||||||
4298023|NCT00521079|4124812|B2|United States||Region of Enrollment||participants|Number|77|77.0||||||
4298024|NCT00521079|4124813|B1|United States||Region of Enrollment||participants|Number|142|142.0||||||
4298025|NCT00521079|4124811|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4298026|NCT00521079|4124812|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4298027|NCT00521079|4124813|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4298028|NCT00521079|4124811|B3||Female|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
4298029|NCT00521079|4124812|B2||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4298030|NCT00521079|4124813|B1||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4298031|NCT00521079|4124811|B3|||Age||years|Mean|45.7|45.7|Standard Deviation|10|10.0|||
4298032|NCT00521079|4124812|B2|||Age||years|Mean|45.6|45.6|Standard Deviation|10.6|10.6|||
4298033|NCT00521079|4124813|B1|||Age||years|Mean|45.7|45.7|Standard Deviation|9.7|9.7|||
4298034|NCT00521079|4124811|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4298035|NCT00521079|4124812|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4298036|NCT00521079|4124813|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4298037|NCT00521079|4124811|B3||Between 18 and 65 years|Age||Participants|Count of Participants|280|280.0||||||
4298038|NCT00521079|4124812|B2||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
4298039|NCT00521079|4124813|B1||Between 18 and 65 years|Age||Participants|Count of Participants|183|183.0||||||
4298040|NCT00521079|4124811|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4298041|NCT00521079|4124812|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4298042|NCT00521079|4124813|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4298043|NCT00521053|4124824|B1|All Lesions Treated||Untreated Disease Burden|Participants were categorized at baseline according to tumor burden that was not injected with PV-10.|participants|Number|28|28.0||||||
4298044|NCT00521053|4124824|B1|All Lesions Treated Except Bystanders||Untreated Disease Burden|Participants were categorized at baseline according to tumor burden that was not injected with PV-10.|participants|Number|26|26.0||||||
4298045|NCT00521053|4124824|B1|One or More Lesions Not Measured and Untreated||Untreated Disease Burden|Participants were categorized at baseline according to tumor burden that was not injected with PV-10.|participants|Number|8|8.0||||||
4298046|NCT00521053|4124824|B1|Untreated Visceral Disease||Untreated Disease Burden|Participants were categorized at baseline according to tumor burden that was not injected with PV-10.|participants|Number|18|18.0||||||
4298047|NCT00521053|4124824|B1|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Participants were staged clinically at baseline using the ECOG Performance Status scale:~GRADE 0: Fully active, able to carry on all pre-disease performance without restriction. GRADE 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work. GRADEe 2: Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours."|participants|Number|2|2.0||||||
4298048|NCT00521053|4124824|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Participants were staged clinically at baseline using the ECOG Performance Status scale:~GRADE 0: Fully active, able to carry on all pre-disease performance without restriction. GRADE 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work. GRADEe 2: Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours."|participants|Number|25|25.0||||||
4298049|NCT00521053|4124824|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Participants were staged clinically at baseline using the ECOG Performance Status scale:~GRADE 0: Fully active, able to carry on all pre-disease performance without restriction. GRADE 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work. GRADEe 2: Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours."|participants|Number|53|53.0||||||
4298050|NCT00521053|4124824|B1|||Number of Prior Interventions||prior interventions|Median|6|6.0|Full Range|||1.0|19.0|
4298051|NCT00521053|4124824|B1|Other||Prior Interventions|Participants may have had more than one prior intervention.|participants|Number|6|6.0||||||
4298052|NCT00521053|4124824|B1|Distal Amputation||Prior Interventions|Participants may have had more than one prior intervention.|participants|Number|7|7.0||||||
4298053|NCT00521053|4124824|B1|Systemic Chemotherapy||Prior Interventions|Participants may have had more than one prior intervention.|participants|Number|10|10.0||||||
4298054|NCT00521053|4124824|B1|Investigational Agents||Prior Interventions|Participants may have had more than one prior intervention.|participants|Number|11|11.0||||||
4298055|NCT00521053|4124824|B1|Radiotherapy||Prior Interventions|Participants may have had more than one prior intervention.|participants|Number|17|17.0||||||
4298056|NCT00521053|4124824|B1|Immunotherapy||Prior Interventions|Participants may have had more than one prior intervention.|participants|Number|17|17.0||||||
4298057|NCT00521053|4124824|B1|Regional Chemotherapy||Prior Interventions|Participants may have had more than one prior intervention.|participants|Number|19|19.0||||||
4298058|NCT00521053|4124824|B1|Nodal Biopsy||Prior Interventions|Participants may have had more than one prior intervention.|participants|Number|50|50.0||||||
4298059|NCT00521053|4124824|B1|Excision||Prior Interventions|Participants may have had more than one prior intervention.|participants|Number|80|80.0||||||
4298060|NCT00521053|4124824|B1|Too Numerous to Count||Tumor Burden in Skin||participants|Number|7|7.0||||||
4298061|NCT00521053|4124824|B1|10 or more Lesions||Tumor Burden in Skin||participants|Number|29|29.0||||||
4298062|NCT00521053|4124824|B1|Less than 10 Lesions||Tumor Burden in Skin||participants|Number|44|44.0||||||
4298063|NCT00521053|4124824|B1|M1c||American Joint Committee on Cancer (AJCC) Stage at Baseline|Participants were staged clinically at baseline based on cutaneous and subcutaneous, nodal and visceral tumor burden. Stage III participants had disease confined to cutaneous, subcutaneous and/or nodal sites. Stage IV participants had distant metastatic disease (i.e., distant cutaneous or subcutaneous metastases or visceral metastases).|participants|Number|10|10.0||||||
4298064|NCT00521053|4124824|B1|M1b||American Joint Committee on Cancer (AJCC) Stage at Baseline|Participants were staged clinically at baseline based on cutaneous and subcutaneous, nodal and visceral tumor burden. Stage III participants had disease confined to cutaneous, subcutaneous and/or nodal sites. Stage IV participants had distant metastatic disease (i.e., distant cutaneous or subcutaneous metastases or visceral metastases).|participants|Number|5|5.0||||||
4298065|NCT00521053|4124824|B1|M1a||American Joint Committee on Cancer (AJCC) Stage at Baseline|Participants were staged clinically at baseline based on cutaneous and subcutaneous, nodal and visceral tumor burden. Stage III participants had disease confined to cutaneous, subcutaneous and/or nodal sites. Stage IV participants had distant metastatic disease (i.e., distant cutaneous or subcutaneous metastases or visceral metastases).|participants|Number|3|3.0||||||
4298066|NCT00521053|4124824|B1|IIIC||American Joint Committee on Cancer (AJCC) Stage at Baseline|Participants were staged clinically at baseline based on cutaneous and subcutaneous, nodal and visceral tumor burden. Stage III participants had disease confined to cutaneous, subcutaneous and/or nodal sites. Stage IV participants had distant metastatic disease (i.e., distant cutaneous or subcutaneous metastases or visceral metastases).|participants|Number|24|24.0||||||
4298067|NCT00521053|4124824|B1|IIIB||American Joint Committee on Cancer (AJCC) Stage at Baseline|Participants were staged clinically at baseline based on cutaneous and subcutaneous, nodal and visceral tumor burden. Stage III participants had disease confined to cutaneous, subcutaneous and/or nodal sites. Stage IV participants had distant metastatic disease (i.e., distant cutaneous or subcutaneous metastases or visceral metastases).|participants|Number|38|38.0||||||
4298068|NCT00521053|4124824|B1|Australia||Region of Enrollment||participants|Number|53|53.0||||||
4298069|NCT00521053|4124824|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4298070|NCT00521053|4124824|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4298071|NCT00521053|4124824|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4298072|NCT00521053|4124824|B1|||Age||years|Median|70.0|70.0|Full Range|||33.0|97.0|
4298073|NCT00521014|4124834|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4298074|NCT00521014|4124834|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4298075|NCT00521014|4124834|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4298076|NCT00521014|4124834|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4298077|NCT00521014|4124834|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4298078|NCT00521001|4124838|B1|United States||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
4298079|NCT00521001|4124838|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4298080|NCT00521001|4124838|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4298081|NCT00521001|4124838|B1|||Age||years|Median|60|60.0|Full Range|||29.0|84.0|
4298082|NCT00520975|4124845|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
4298083|NCT00520975|4124846|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
4298084|NCT00520975|4124847|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4298085|NCT00520975|4124845|B3||Female|Gender||Participants|Count of Participants|96|96.0||||||
4298086|NCT00520975|4124846|B2||Female|Gender||Participants|Count of Participants|48|48.0||||||
4298087|NCT00520975|4124847|B1||Female|Gender||Participants|Count of Participants|48|48.0||||||
4298088|NCT00520975|4124845|B3|||Age||Years|Median|55|55.0|Full Range|||27.0|77.0|
4298089|NCT00520975|4124846|B2|||Age||Years|Median|55|55.0|Full Range|||33.0|76.0|
4298090|NCT00520975|4124847|B1|||Age||Years|Median|55|55.0|Full Range|||27.0|77.0|
4298091|NCT00520936|4124872|B9|Missing||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|18|18.0||||||
4298092|NCT00520936|4124873|B8|Missing||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|2|2.0||||||
4298093|NCT00520936|4124874|B7|Missing||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|3|3.0||||||
4298094|NCT00520936|4124875|B6|Missing||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|1|1.0||||||
4298095|NCT00520936|4124876|B5|Missing||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|1|1.0||||||
4298096|NCT00520936|4124877|B4|Missing||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|0|0.0||||||
4298097|NCT00520936|4124878|B3|Missing||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|0|0.0||||||
4298098|NCT00520936|4124879|B2|Missing||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|7|7.0||||||
4298099|NCT00520936|4124880|B1|Missing||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|4|4.0||||||
4298100|NCT00520936|4124872|B9|50||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|1|1.0||||||
4298101|NCT00520936|4124873|B8|50||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|0|0.0||||||
4298102|NCT00520936|4124874|B7|50||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|0|0.0||||||
4298103|NCT00520936|4124875|B6|50||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|0|0.0||||||
4298104|NCT00520936|4124876|B5|50||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|0|0.0||||||
4298267|NCT00520936|4124877|B4|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4298268|NCT00520936|4124878|B3|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4298269|NCT00520936|4124879|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4298105|NCT00520936|4124877|B4|50||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|0|0.0||||||
4298106|NCT00520936|4124878|B3|50||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|0|0.0||||||
4298107|NCT00520936|4124879|B2|50||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|0|0.0||||||
4298108|NCT00520936|4124880|B1|50||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|1|1.0||||||
4298109|NCT00520936|4124872|B9|60||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|4|4.0||||||
4298110|NCT00520936|4124873|B8|60||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|0|0.0||||||
4298111|NCT00520936|4124874|B7|60||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|1|1.0||||||
4298112|NCT00520936|4124875|B6|60||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|1|1.0||||||
4298113|NCT00520936|4124876|B5|60||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|0|0.0||||||
4298114|NCT00520936|4124877|B4|60||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|0|0.0||||||
4298115|NCT00520936|4124878|B3|60||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|1|1.0||||||
4298270|NCT00520936|4124880|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4298271|NCT00520936|4124872|B9|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4298116|NCT00520936|4124879|B2|60||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|0|0.0||||||
4298117|NCT00520936|4124880|B1|60||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|1|1.0||||||
4298118|NCT00520936|4124872|B9|70||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|2|2.0||||||
4298119|NCT00520936|4124873|B8|70||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|1|1.0||||||
4298120|NCT00520936|4124874|B7|70||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|0|0.0||||||
4298121|NCT00520936|4124875|B6|70||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|1|1.0||||||
4298122|NCT00520936|4124876|B5|70||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|0|0.0||||||
4298123|NCT00520936|4124877|B4|70||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|0|0.0||||||
4298124|NCT00520936|4124878|B3|70||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|0|0.0||||||
4298125|NCT00520936|4124879|B2|70||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|0|0.0||||||
4298126|NCT00520936|4124880|B1|70||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|0|0.0||||||
4298272|NCT00520936|4124873|B8|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4298273|NCT00520936|4124874|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4298127|NCT00520936|4124872|B9|80||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|11|11.0||||||
4298128|NCT00520936|4124873|B8|80||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|0|0.0||||||
4298129|NCT00520936|4124874|B7|80||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|2|2.0||||||
4298130|NCT00520936|4124875|B6|80||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|3|3.0||||||
4298131|NCT00520936|4124876|B5|80||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|2|2.0||||||
4298132|NCT00520936|4124877|B4|80||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|0|0.0||||||
4298133|NCT00520936|4124878|B3|80||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|2|2.0||||||
4298134|NCT00520936|4124879|B2|80||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|0|0.0||||||
4298135|NCT00520936|4124880|B1|80||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|2|2.0||||||
4298136|NCT00520936|4124872|B9|90||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|18|18.0||||||
4298137|NCT00520936|4124873|B8|90||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|4|4.0||||||
4298274|NCT00520936|4124875|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4298275|NCT00520936|4124876|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4298138|NCT00520936|4124874|B7|90||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|3|3.0||||||
4298139|NCT00520936|4124875|B6|90||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|2|2.0||||||
4298140|NCT00520936|4124876|B5|90||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|1|1.0||||||
4298141|NCT00520936|4124877|B4|90||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|1|1.0||||||
4298142|NCT00520936|4124878|B3|90||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|3|3.0||||||
4298143|NCT00520936|4124879|B2|90||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|3|3.0||||||
4298144|NCT00520936|4124880|B1|90||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|1|1.0||||||
4298145|NCT00520936|4124872|B9|100||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|18|18.0||||||
4298146|NCT00520936|4124873|B8|100||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|3|3.0||||||
4298147|NCT00520936|4124874|B7|100||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|2|2.0||||||
4298148|NCT00520936|4124875|B6|100||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|2|2.0||||||
4298276|NCT00520936|4124877|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4298277|NCT00520936|4124878|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4298149|NCT00520936|4124876|B5|100||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|2|2.0||||||
4298150|NCT00520936|4124877|B4|100||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|4|4.0||||||
4298151|NCT00520936|4124878|B3|100||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|3|3.0||||||
4298152|NCT00520936|4124879|B2|100||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|1|1.0||||||
4298153|NCT00520936|4124880|B1|100||Lansky Play Score|100=fully active, normal. 90=minor restrictions in physically strenuous activity. 80=active, but tires more quickly. 70=both greater restriction of and less time spent in play activity. 60=up and around, but minimal active play; keeps busy with quieter activities. 50=gets dressed, but lies around much of the day; no active play, able to participate in all quiet play activities. 40=mostly in bed; participates in quiet activities. 30=in bed; needs assistance even for quiet play. 20=often sleeping; play entirely limited to very passive activities. 10=No play; does not get out of bed.|Participants|Number|1|1.0||||||
4298154|NCT00520936|4124872|B9|Missing||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|54|54.0||||||
4298155|NCT00520936|4124873|B8|Missing||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|8|8.0||||||
4298156|NCT00520936|4124874|B7|Missing||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|8|8.0||||||
4298157|NCT00520936|4124875|B6|Missing||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|9|9.0||||||
4298158|NCT00520936|4124876|B5|Missing||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|5|5.0||||||
4298159|NCT00520936|4124877|B4|Missing||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|5|5.0||||||
4298160|NCT00520936|4124878|B3|Missing||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|9|9.0||||||
4298161|NCT00520936|4124879|B2|Missing||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|4|4.0||||||
4298278|NCT00520936|4124879|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4298279|NCT00520936|4124880|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4298280|NCT00520936|4124872|B9||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4298162|NCT00520936|4124880|B1|Missing||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|6|6.0||||||
4298163|NCT00520936|4124872|B9|50||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|2|2.0||||||
4298164|NCT00520936|4124873|B8|50||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|0|0.0||||||
4298165|NCT00520936|4124874|B7|50||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|1|1.0||||||
4298166|NCT00520936|4124875|B6|50||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|0|0.0||||||
4298167|NCT00520936|4124876|B5|50||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|0|0.0||||||
4298168|NCT00520936|4124877|B4|50||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|0|0.0||||||
4298169|NCT00520936|4124878|B3|50||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|0|0.0||||||
4298170|NCT00520936|4124879|B2|50||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|0|0.0||||||
4298171|NCT00520936|4124880|B1|50||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|1|1.0||||||
4298172|NCT00520936|4124872|B9|70||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|2|2.0||||||
4298173|NCT00520936|4124873|B8|70||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|0|0.0||||||
4298174|NCT00520936|4124874|B7|70||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|1|1.0||||||
4298175|NCT00520936|4124875|B6|70||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|0|0.0||||||
4298176|NCT00520936|4124876|B5|70||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|0|0.0||||||
4298281|NCT00520936|4124873|B8||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4298282|NCT00520936|4124874|B7||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4298177|NCT00520936|4124877|B4|70||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|0|0.0||||||
4298178|NCT00520936|4124878|B3|70||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|0|0.0||||||
4298179|NCT00520936|4124879|B2|70||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|1|1.0||||||
4298180|NCT00520936|4124880|B1|70||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|0|0.0||||||
4298181|NCT00520936|4124872|B9|80||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|2|2.0||||||
4298182|NCT00520936|4124873|B8|80||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|1|1.0||||||
4298183|NCT00520936|4124874|B7|80||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|0|0.0||||||
4298184|NCT00520936|4124875|B6|80||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|0|0.0||||||
4298185|NCT00520936|4124876|B5|80||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|0|0.0||||||
4298186|NCT00520936|4124877|B4|80||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|0|0.0||||||
4298187|NCT00520936|4124878|B3|80||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|0|0.0||||||
4298188|NCT00520936|4124879|B2|80||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|1|1.0||||||
4298189|NCT00520936|4124880|B1|80||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|0|0.0||||||
4298190|NCT00520936|4124872|B9|90||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|9|9.0||||||
4298191|NCT00520936|4124873|B8|90||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|1|1.0||||||
4298283|NCT00520936|4124875|B6||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4298284|NCT00520936|4124876|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4298192|NCT00520936|4124874|B7|90||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|1|1.0||||||
4298193|NCT00520936|4124875|B6|90||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|0|0.0||||||
4298194|NCT00520936|4124876|B5|90||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|1|1.0||||||
4298195|NCT00520936|4124877|B4|90||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|0|0.0||||||
4298196|NCT00520936|4124878|B3|90||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|0|0.0||||||
4298197|NCT00520936|4124879|B2|90||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|3|3.0||||||
4298198|NCT00520936|4124880|B1|90||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|3|3.0||||||
4298199|NCT00520936|4124872|B9|100||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|3|3.0||||||
4298200|NCT00520936|4124873|B8|100||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|0|0.0||||||
4298201|NCT00520936|4124874|B7|100||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|0|0.0||||||
4298202|NCT00520936|4124875|B6|100||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|1|1.0||||||
4298203|NCT00520936|4124876|B5|100||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|0|0.0||||||
4298204|NCT00520936|4124877|B4|100||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|0|0.0||||||
4298205|NCT00520936|4124878|B3|100||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|0|0.0||||||
4298206|NCT00520936|4124879|B2|100||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|2|2.0||||||
4298285|NCT00520936|4124877|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4298286|NCT00520936|4124878|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4298207|NCT00520936|4124880|B1|100||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.~100 - Normal no complaints; no evidence of disease 90 - Normal activity; minor signs of disease 80 - Activity with effort; some signs of disease 70 - Unable to carry on normal activity <=60 Needs increasing assistance up to Death (0)"|Participants|Number|0|0.0||||||
4298208|NCT00520936|4124872|B9|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4298209|NCT00520936|4124873|B8|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4298210|NCT00520936|4124874|B7|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4298211|NCT00520936|4124875|B6|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4298212|NCT00520936|4124876|B5|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4298213|NCT00520936|4124877|B4|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4298214|NCT00520936|4124878|B3|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4298215|NCT00520936|4124879|B2|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4298216|NCT00520936|4124880|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4298217|NCT00520936|4124872|B9|United States||Region of Enrollment||participants|Number|61|61.0||||||
4298218|NCT00520936|4124873|B8|United States||Region of Enrollment||participants|Number|10|10.0||||||
4298219|NCT00520936|4124874|B7|United States||Region of Enrollment||participants|Number|10|10.0||||||
4298220|NCT00520936|4124875|B6|United States||Region of Enrollment||participants|Number|9|9.0||||||
4298221|NCT00520936|4124876|B5|United States||Region of Enrollment||participants|Number|5|5.0||||||
4298222|NCT00520936|4124877|B4|United States||Region of Enrollment||participants|Number|5|5.0||||||
4298223|NCT00520936|4124878|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4298224|NCT00520936|4124879|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4298225|NCT00520936|4124880|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4298226|NCT00520936|4124872|B9|Unknown||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4298227|NCT00520936|4124873|B8|Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4298228|NCT00520936|4124874|B7|Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4298229|NCT00520936|4124875|B6|Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4298230|NCT00520936|4124876|B5|Unknown||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4298231|NCT00520936|4124877|B4|Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4298232|NCT00520936|4124878|B3|Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4298233|NCT00520936|4124879|B2|Unknown||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4298234|NCT00520936|4124880|B1|Unknown||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4298235|NCT00520936|4124872|B9|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4298236|NCT00520936|4124873|B8|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4298237|NCT00520936|4124874|B7|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4298238|NCT00520936|4124875|B6|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4298239|NCT00520936|4124876|B5|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4298240|NCT00520936|4124877|B4|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4298241|NCT00520936|4124878|B3|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4298242|NCT00520936|4124879|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4298243|NCT00520936|4124880|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4298244|NCT00520936|4124872|B9|White||Race/Ethnicity, Customized||Participants|Number|48|48.0||||||
4298245|NCT00520936|4124873|B8|White||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4298246|NCT00520936|4124874|B7|White||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4298247|NCT00520936|4124875|B6|White||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4298248|NCT00520936|4124876|B5|White||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4298249|NCT00520936|4124877|B4|White||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4298250|NCT00520936|4124878|B3|White||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4298251|NCT00520936|4124879|B2|White||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4298252|NCT00520936|4124880|B1|White||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4298253|NCT00520936|4124872|B9|Black or African American||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4298254|NCT00520936|4124873|B8|Black or African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4298255|NCT00520936|4124874|B7|Black or African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4298256|NCT00520936|4124875|B6|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4298257|NCT00520936|4124876|B5|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4298258|NCT00520936|4124877|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4298259|NCT00520936|4124878|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4298260|NCT00520936|4124879|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4298261|NCT00520936|4124880|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4298262|NCT00520936|4124872|B9|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4298263|NCT00520936|4124873|B8|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4298264|NCT00520936|4124874|B7|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4298265|NCT00520936|4124875|B6|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4298266|NCT00520936|4124876|B5|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4298287|NCT00520936|4124879|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4298288|NCT00520936|4124880|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4298289|NCT00520936|4124872|B9||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4298290|NCT00520936|4124873|B8||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4298291|NCT00520936|4124874|B7||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4298292|NCT00520936|4124875|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4298293|NCT00520936|4124876|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4298294|NCT00520936|4124877|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4298295|NCT00520936|4124878|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4298296|NCT00520936|4124879|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4298297|NCT00520936|4124880|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4298298|NCT00520936|4124872|B9|||Age||years|Mean|11.96|11.96|Standard Deviation|5.97|5.97|||
4298299|NCT00520936|4124873|B8|||Age||years|Mean|12.75|12.75|Standard Deviation|5.15|5.15|||
4298300|NCT00520936|4124874|B7|||Age||years|Mean|12.00|12.0|Standard Deviation|7.13|7.13|||
4298301|NCT00520936|4124875|B6|||Age||years|Mean|8.42|8.42|Standard Deviation|4.59|4.59|||
4298302|NCT00520936|4124876|B5|||Age||years|Mean|9.62|9.62|Standard Deviation|5.38|5.38|||
4298303|NCT00520936|4124877|B4|||Age||years|Mean|6.23|6.23|Standard Deviation|2.98|2.98|||
4298304|NCT00520936|4124878|B3|||Age||years|Mean|8.74|8.74|Standard Deviation|4.96|4.96|||
4298305|NCT00520936|4124879|B2|||Age||years|Mean|18.24|18.24|Standard Deviation|3.35|3.35|||
4298306|NCT00520936|4124880|B1|||Age||years|Mean|14.94|14.94|Standard Deviation|4.28|4.28|||
4298307|NCT00520845|4124914|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4298308|NCT00520845|4124914|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4298309|NCT00520845|4124914|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4298310|NCT00520845|4124914|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4298311|NCT00520845|4124914|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4298312|NCT00520845|4124914|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4298313|NCT00520845|4124914|B1|||Age||years|Mean|63.26|63.26|Full Range|||41.0|79.0|
4298314|NCT00520767|4124922|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4298315|NCT00520767|4124922|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4298316|NCT00520767|4124922|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4298317|NCT00520767|4124922|B1|||Age||years|Median|64|64.0|Full Range|||47.0|83.0|
4298318|NCT00520741|4124926|B3|||Average Baseline Seizure Frequency per 28 days||seizures/28 days|Mean|10.19|10.19|Standard Deviation|8.86|8.86|||
4298319|NCT00520741|4124927|B2|||Average Baseline Seizure Frequency per 28 days||seizures/28 days|Mean|10.22|10.22|Standard Deviation|8.88|8.88|||
4298320|NCT00520741|4124928|B1|||Average Baseline Seizure Frequency per 28 days||seizures/28 days|Mean|10.10|10.1|Standard Deviation|8.82|8.82|||
4298321|NCT00520741|4124926|B3|||Body Mass Index (BMI)||kg/m^2|Mean|28.56|28.56|Standard Deviation|6.42|6.42|||
4298322|NCT00520741|4124927|B2|||Body Mass Index (BMI)||kg/m^2|Mean|28.67|28.67|Standard Deviation|6.64|6.64|||
4298323|NCT00520741|4124928|B1|||Body Mass Index (BMI)||kg/m^2|Mean|28.22|28.22|Standard Deviation|5.74|5.74|||
4298324|NCT00520741|4124926|B3|||Weight||kilogram|Mean|82.00|82.0|Standard Deviation|20.85|20.85|||
4298325|NCT00520741|4124927|B2|||Weight||kilogram|Mean|82.13|82.13|Standard Deviation|21.30|21.3|||
4298326|NCT00520741|4124928|B1|||Weight||kilogram|Mean|81.62|81.62|Standard Deviation|19.53|19.53|||
4298327|NCT00520741|4124926|B3|||Height||centimeter|Mean|169.19|169.19|Standard Deviation|10.82|10.82|||
4298328|NCT00520741|4124927|B2|||Height||centimeter|Mean|169.01|169.01|Standard Deviation|10.87|10.87|||
4298329|NCT00520741|4124928|B1|||Height||centimeter|Mean|169.72|169.72|Standard Deviation|10.69|10.69|||
4298330|NCT00520741|4124926|B3|Other||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4298331|NCT00520741|4124927|B2|Other||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4298332|NCT00520741|4124928|B1|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4298333|NCT00520741|4124926|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4298334|NCT00520741|4124927|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4298335|NCT00520741|4124928|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4298336|NCT00520741|4124926|B3|Black||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
4298337|NCT00520741|4124927|B2|Black||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
4298338|NCT00520741|4124928|B1|Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4298339|NCT00520741|4124926|B3|White||Race/Ethnicity, Customized||participants|Number|337|337.0||||||
4298340|NCT00520741|4124927|B2|White||Race/Ethnicity, Customized||participants|Number|246|246.0||||||
4298341|NCT00520741|4124928|B1|White||Race/Ethnicity, Customized||participants|Number|91|91.0||||||
4298342|NCT00520741|4124926|B3||Male|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
4298343|NCT00520741|4124927|B2||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4298344|NCT00520741|4124928|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4298345|NCT00520741|4124926|B3||Female|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
4298346|NCT00520741|4124927|B2||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4298347|NCT00520741|4124928|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4298348|NCT00520741|4124926|B3|||Age||years|Mean|40.6|40.6|Standard Deviation|13.0|13.0|||
4298349|NCT00520741|4124927|B2|||Age||years|Mean|40.4|40.4|Standard Deviation|12.5|12.5|||
4298350|NCT00520741|4124928|B1|||Age||years|Mean|41.4|41.4|Standard Deviation|14.3|14.3|||
4298351|NCT00520741|4124926|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4298352|NCT00520741|4124927|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4298353|NCT00520741|4124928|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4298354|NCT00520741|4124926|B3||Between 18 and 65 years|Age||Participants|Count of Participants|402|402.0||||||
4298355|NCT00520741|4124927|B2||Between 18 and 65 years|Age||Participants|Count of Participants|303|303.0||||||
4298356|NCT00520741|4124928|B1||Between 18 and 65 years|Age||Participants|Count of Participants|99|99.0||||||
4298357|NCT00520741|4124926|B3||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4298358|NCT00520741|4124927|B2||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4298359|NCT00520741|4124928|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4298360|NCT00520676|4124945|B3|Carcinoma, lung||Histology||participants|Number|11|11.0||||||
4298361|NCT00520676|4124946|B2|Carcinoma, lung||Histology||participants|Number|5|5.0||||||
4298362|NCT00520676|4124947|B1|Carcinoma, lung||Histology||participants|Number|6|6.0||||||
4298363|NCT00520676|4124945|B3|Large cell carcinoma, lung||Histology||participants|Number|19|19.0||||||
4298364|NCT00520676|4124946|B2|Large cell carcinoma, lung||Histology||participants|Number|9|9.0||||||
4298365|NCT00520676|4124947|B1|Large cell carcinoma, lung||Histology||participants|Number|10|10.0||||||
4298366|NCT00520676|4124945|B3|Adenocarcinoma, not otherwise specified||Histology||participants|Number|160|160.0||||||
4298367|NCT00520676|4124946|B2|Adenocarcinoma, not otherwise specified||Histology||participants|Number|80|80.0||||||
4298368|NCT00520676|4124947|B1|Adenocarcinoma, not otherwise specified||Histology||participants|Number|80|80.0||||||
4298369|NCT00520676|4124945|B3|Adenocarcinoma, lung||Histology||participants|Number|21|21.0||||||
4298370|NCT00520676|4124946|B2|Adenocarcinoma, lung||Histology||participants|Number|11|11.0||||||
4298371|NCT00520676|4124947|B1|Adenocarcinoma, lung||Histology||participants|Number|10|10.0||||||
4298372|NCT00520676|4124945|B3|Currently Smoking||Smoking Status||participants|Number|22|22.0||||||
4298373|NCT00520676|4124946|B2|Currently Smoking||Smoking Status||participants|Number|11|11.0||||||
4298374|NCT00520676|4124947|B1|Currently Smoking||Smoking Status||participants|Number|11|11.0||||||
4298375|NCT00520676|4124945|B3|Ever Smoking but Quit||Smoking Status||participants|Number|114|114.0||||||
4298376|NCT00520676|4124946|B2|Ever Smoking but Quit||Smoking Status||participants|Number|53|53.0||||||
4298377|NCT00520676|4124947|B1|Ever Smoking but Quit||Smoking Status||participants|Number|61|61.0||||||
4298378|NCT00520676|4124945|B3|Never Smoking||Smoking Status||participants|Number|75|75.0||||||
4298379|NCT00520676|4124946|B2|Never Smoking||Smoking Status||participants|Number|41|41.0||||||
4298380|NCT00520676|4124947|B1|Never Smoking||Smoking Status||participants|Number|34|34.0||||||
4298381|NCT00520676|4124945|B3|Korea, Republic of||Region of Enrollment||participants|Number|39|39.0||||||
4298382|NCT00520676|4124946|B2|Korea, Republic of||Region of Enrollment||participants|Number|18|18.0||||||
4298383|NCT00520676|4124947|B1|Korea, Republic of||Region of Enrollment||participants|Number|21|21.0||||||
4298384|NCT00520676|4124945|B3|China||Region of Enrollment||participants|Number|37|37.0||||||
4298385|NCT00520676|4124946|B2|China||Region of Enrollment||participants|Number|17|17.0||||||
4298386|NCT00520676|4124947|B1|China||Region of Enrollment||participants|Number|20|20.0||||||
4298387|NCT00520676|4124945|B3|Australia||Region of Enrollment||participants|Number|24|24.0||||||
4298388|NCT00520676|4124946|B2|Australia||Region of Enrollment||participants|Number|14|14.0||||||
4298389|NCT00520676|4124947|B1|Australia||Region of Enrollment||participants|Number|10|10.0||||||
4298390|NCT00520676|4124945|B3|Brazil||Region of Enrollment||participants|Number|60|60.0||||||
4298391|NCT00520676|4124946|B2|Brazil||Region of Enrollment||participants|Number|25|25.0||||||
4298392|NCT00520676|4124947|B1|Brazil||Region of Enrollment||participants|Number|35|35.0||||||
4298393|NCT00520676|4124945|B3|Mexico||Region of Enrollment||participants|Number|39|39.0||||||
4298394|NCT00520676|4124946|B2|Mexico||Region of Enrollment||participants|Number|22|22.0||||||
4298395|NCT00520676|4124947|B1|Mexico||Region of Enrollment||participants|Number|17|17.0||||||
4298396|NCT00520676|4124945|B3|Taiwan||Region of Enrollment||participants|Number|12|12.0||||||
4298397|NCT00520676|4124946|B2|Taiwan||Region of Enrollment||participants|Number|9|9.0||||||
4298398|NCT00520676|4124947|B1|Taiwan||Region of Enrollment||participants|Number|3|3.0||||||
4298399|NCT00520676|4124945|B3||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4298400|NCT00520676|4124946|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4298401|NCT00520676|4124947|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4298402|NCT00520676|4124945|B3||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4298403|NCT00520676|4124946|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4298404|NCT00520676|4124947|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4298405|NCT00520676|4124945|B3|||Age||years|Mean|59.4|59.4|Standard Deviation|10.3|10.3|||
4298406|NCT00520676|4124946|B2|||Age||years|Mean|59.2|59.2|Standard Deviation|10.7|10.7|||
4298407|NCT00520676|4124947|B1|||Age||years|Mean|59.6|59.6|Standard Deviation|10.0|10.0|||
4298408|NCT00520572|4124968|B7||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4298409|NCT00520572|4124969|B6||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4298410|NCT00520572|4124970|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4298411|NCT00520572|4124971|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4298412|NCT00520572|4124972|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4298413|NCT00520572|4124973|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4298414|NCT00520572|4124974|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4298415|NCT00520572|4124968|B7||Female|Sex: Female, Male||Participants|Count of Participants|329|329.0||||||
4298416|NCT00520572|4124969|B6||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4298417|NCT00520572|4124970|B5||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4298418|NCT00520572|4124971|B4||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4298419|NCT00520572|4124972|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4298420|NCT00520572|4124973|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4298421|NCT00520572|4124974|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4298422|NCT00520572|4124968|B7|||Age||Years|Mean|51.7|51.7|Standard Deviation|11.76|11.76|||
4298423|NCT00520572|4124969|B6|||Age||Years|Mean|51|51.0|Standard Deviation|10.8|10.8|||
4298424|NCT00520572|4124970|B5|||Age||Years|Mean|51|51.0|Standard Deviation|11.9|11.9|||
4298425|NCT00520572|4124971|B4|||Age||Years|Mean|52|52.0|Standard Deviation|11.8|11.8|||
4298426|NCT00520572|4124972|B3|||Age||Years|Mean|50|50.0|Standard Deviation|11.9|11.9|||
4298427|NCT00520572|4124973|B2|||Age||Years|Mean|54|54.0|Standard Deviation|11.5|11.5|||
4298428|NCT00520572|4124974|B1|||Age||Years|Mean|52|52.0|Standard Deviation|12.8|12.8|||
4298429|NCT00520546|4125017|B1|Germany||Region of Enrollment||participants|Number|44|44.0||||||
4298430|NCT00520546|4125017|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4298431|NCT00520546|4125017|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4298432|NCT00520546|4125017|B1|||Age||years|Mean|65|65.0|Standard Deviation|6|6.0|||
4298433|NCT00520546|4125017|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4298434|NCT00520546|4125017|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4298435|NCT00520546|4125017|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4298436|NCT00520494|4125032|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4298437|NCT00520494|4125032|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4298438|NCT00520494|4125032|B1|≥ 65 years||Age, Customized||participants|Number|2|2.0||||||
4298439|NCT00520494|4125032|B1|> 16 to < 65 years||Age, Customized||participants|Number|8|8.0||||||
4298440|NCT00520494|4125032|B1|≥ 12 to ≤ 16 years||Age, Customized||participants|Number|2|2.0||||||
4298441|NCT00520494|4125032|B1|2 to < 12 years||Age, Customized||participants|Number|6|6.0||||||
4298442|NCT00520494|4125032|B1|||Age||years|Mean|25.9|25.9|Standard Deviation|21.85|21.85|||
4298443|NCT00520481|4125055|B3|United States||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
4298444|NCT00520481|4125056|B2|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4298445|NCT00520481|4125057|B1|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
4298446|NCT00520481|4125055|B3||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4298447|NCT00520481|4125056|B2||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4298448|NCT00520481|4125057|B1||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4298449|NCT00520481|4125055|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
4298450|NCT00520481|4125056|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4298451|NCT00520481|4125057|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
4298452|NCT00520481|4125055|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298453|NCT00520481|4125056|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298454|NCT00520481|4125057|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298455|NCT00520481|4125055|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4298456|NCT00520481|4125056|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4298457|NCT00520481|4125057|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4298458|NCT00520481|4125055|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4298459|NCT00520481|4125056|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298460|NCT00520481|4125057|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4298461|NCT00520481|4125055|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4298462|NCT00520481|4125056|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4298463|NCT00520481|4125057|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4298464|NCT00520481|4125055|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4298465|NCT00520481|4125056|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4298466|NCT00520481|4125057|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4298467|NCT00520481|4125055|B3|||Age||years|Mean|70.1|70.1|Standard Deviation|8.64|8.64|||
4298468|NCT00520481|4125056|B2|||Age||years|Mean|70.2|70.2|Standard Deviation|6.78|6.78|||
4298469|NCT00520481|4125057|B1|||Age||years|Mean|70.0|70.0|Standard Deviation|9.26|9.26|||
4298470|NCT00520468|4125078|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4298471|NCT00520468|4125078|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4298472|NCT00520468|4125078|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4298473|NCT00520468|4125078|B1|||Age||Years|Mean|65|65.0|Full Range|||47.0|79.0|
4298474|NCT00520468|4125078|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4298475|NCT00520468|4125078|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4298476|NCT00520468|4125078|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4298477|NCT00520403|4125082|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4298478|NCT00520403|4125082|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4298479|NCT00520403|4125082|B1|||Age||years|Mean|62.2|62.2|Standard Deviation|8.5|8.5|||
4298480|NCT00520351|4125089|B3|Canada||Region of Enrollment||participants|Number|30|30.0||||||
4298481|NCT00520351|4125090|B2|Canada||Region of Enrollment||participants|Number|15|15.0||||||
4298482|NCT00520351|4125091|B1|Canada||Region of Enrollment||participants|Number|15|15.0||||||
4298483|NCT00520351|4125089|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4298484|NCT00520351|4125090|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4298485|NCT00520351|4125091|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4298486|NCT00520351|4125089|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4298487|NCT00520351|4125090|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4298488|NCT00520351|4125091|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4298489|NCT00520351|4125089|B3|||Age||years|Mean|24.3|24.3|Standard Deviation|5.1|5.1|||
4298490|NCT00520351|4125090|B2|||Age||years|Mean|24.1|24.1|Standard Deviation|4.4|4.4|||
4298491|NCT00520351|4125091|B1|||Age||years|Mean|24.4|24.4|Standard Deviation|5.9|5.9|||
4298492|NCT00520351|4125089|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4298493|NCT00520351|4125090|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4298494|NCT00520351|4125091|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4298495|NCT00520351|4125089|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4298496|NCT00520351|4125090|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4298497|NCT00520351|4125091|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4298498|NCT00520351|4125089|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4298499|NCT00520351|4125090|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4298500|NCT00520351|4125091|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4298501|NCT00520299|4125104|B4|Not done||ASS Assay Result|Argininosuccinate synthetase (ASS) tumor expression, as determined by immunohistochemistry, is categorized as either negative or ≤ 5% positive tumor cells.|participants|Number|2|2.0||||||
4298502|NCT00520299|4125105|B3|Not done||ASS Assay Result|Argininosuccinate synthetase (ASS) tumor expression, as determined by immunohistochemistry, is categorized as either negative or ≤ 5% positive tumor cells.|participants|Number|2|2.0||||||
4298503|NCT00520299|4125106|B2|Not done||ASS Assay Result|Argininosuccinate synthetase (ASS) tumor expression, as determined by immunohistochemistry, is categorized as either negative or ≤ 5% positive tumor cells.|participants|Number|0|0.0||||||
4298504|NCT00520299|4125107|B1|Not done||ASS Assay Result|Argininosuccinate synthetase (ASS) tumor expression, as determined by immunohistochemistry, is categorized as either negative or ≤ 5% positive tumor cells.|participants|Number|0|0.0||||||
4298505|NCT00520299|4125104|B4|≤5% positive||ASS Assay Result|Argininosuccinate synthetase (ASS) tumor expression, as determined by immunohistochemistry, is categorized as either negative or ≤ 5% positive tumor cells.|participants|Number|5|5.0||||||
4298506|NCT00520299|4125105|B3|≤5% positive||ASS Assay Result|Argininosuccinate synthetase (ASS) tumor expression, as determined by immunohistochemistry, is categorized as either negative or ≤ 5% positive tumor cells.|participants|Number|3|3.0||||||
4298507|NCT00520299|4125106|B2|≤5% positive||ASS Assay Result|Argininosuccinate synthetase (ASS) tumor expression, as determined by immunohistochemistry, is categorized as either negative or ≤ 5% positive tumor cells.|participants|Number|0|0.0||||||
4298508|NCT00520299|4125107|B1|≤5% positive||ASS Assay Result|Argininosuccinate synthetase (ASS) tumor expression, as determined by immunohistochemistry, is categorized as either negative or ≤ 5% positive tumor cells.|participants|Number|2|2.0||||||
4298509|NCT00520299|4125104|B4|Negative||ASS Assay Result|Argininosuccinate synthetase (ASS) tumor expression, as determined by immunohistochemistry, is categorized as either negative or ≤ 5% positive tumor cells.|participants|Number|24|24.0||||||
4298510|NCT00520299|4125105|B3|Negative||ASS Assay Result|Argininosuccinate synthetase (ASS) tumor expression, as determined by immunohistochemistry, is categorized as either negative or ≤ 5% positive tumor cells.|participants|Number|14|14.0||||||
4298511|NCT00520299|4125106|B2|Negative||ASS Assay Result|Argininosuccinate synthetase (ASS) tumor expression, as determined by immunohistochemistry, is categorized as either negative or ≤ 5% positive tumor cells.|participants|Number|6|6.0||||||
4298512|NCT00520299|4125107|B1|Negative||ASS Assay Result|Argininosuccinate synthetase (ASS) tumor expression, as determined by immunohistochemistry, is categorized as either negative or ≤ 5% positive tumor cells.|participants|Number|4|4.0||||||
4298513|NCT00520299|4125104|B4|||BMI||kg/m^2|Mean|25.5|25.5|Standard Deviation|4.5|4.5|||
4298514|NCT00520299|4125105|B3|||BMI||kg/m^2|Mean|26.9|26.9|Standard Deviation|4.7|4.7|||
4298515|NCT00520299|4125106|B2|||BMI||kg/m^2|Mean|24.7|24.7|Standard Deviation|1.8|1.8|||
4298516|NCT00520299|4125107|B1|||BMI||kg/m^2|Mean|22.0|22.0|Standard Deviation|4.1|4.1|||
4298517|NCT00520299|4125104|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298518|NCT00520299|4125105|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298576|NCT00520286|4125139|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4298519|NCT00520299|4125106|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298520|NCT00520299|4125107|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298521|NCT00520299|4125104|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298522|NCT00520299|4125105|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298523|NCT00520299|4125106|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298524|NCT00520299|4125107|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298525|NCT00520299|4125104|B4||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4298526|NCT00520299|4125105|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4298527|NCT00520299|4125106|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4298528|NCT00520299|4125107|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4298529|NCT00520299|4125104|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298530|NCT00520299|4125105|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298531|NCT00520299|4125106|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298532|NCT00520299|4125107|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298533|NCT00520299|4125104|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298534|NCT00520299|4125105|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298535|NCT00520299|4125106|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298536|NCT00520299|4125107|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298537|NCT00520299|4125104|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4298538|NCT00520299|4125105|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4298539|NCT00520299|4125106|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298540|NCT00520299|4125107|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298541|NCT00520299|4125104|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298542|NCT00520299|4125105|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298543|NCT00520299|4125106|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298544|NCT00520299|4125107|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298545|NCT00520299|4125104|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4298546|NCT00520299|4125105|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4298547|NCT00520299|4125106|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298548|NCT00520299|4125107|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298549|NCT00520299|4125104|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4298550|NCT00520299|4125105|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4298551|NCT00520299|4125106|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4298552|NCT00520299|4125107|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4298553|NCT00520299|4125104|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4298554|NCT00520299|4125105|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4298555|NCT00520299|4125106|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298556|NCT00520299|4125107|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298557|NCT00520299|4125104|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4298558|NCT00520299|4125105|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4298559|NCT00520299|4125106|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4298560|NCT00520299|4125107|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4298561|NCT00520299|4125104|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4298562|NCT00520299|4125105|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4298563|NCT00520299|4125106|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4298564|NCT00520299|4125107|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4298565|NCT00520299|4125104|B4|||Age||years|Mean|64.9|64.9|Standard Deviation|13.2|13.2|||
4298566|NCT00520299|4125105|B3|||Age||years|Mean|67.2|67.2|Standard Deviation|11.2|11.2|||
4298567|NCT00520299|4125106|B2|||Age||years|Mean|61.2|61.2|Standard Deviation|14.7|14.7|||
4298568|NCT00520299|4125107|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|18.2|18.2|||
4298569|NCT00520286|4125138|B3|United States||Region of Enrollment||participants|Number|210|210.0||||||
4298570|NCT00520286|4125139|B2|United States||Region of Enrollment||participants|Number|68|68.0||||||
4298571|NCT00520286|4125140|B1|United States||Region of Enrollment||participants|Number|142|142.0||||||
4298572|NCT00520286|4125138|B3||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4298573|NCT00520286|4125139|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4298574|NCT00520286|4125140|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4298575|NCT00520286|4125138|B3||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4298577|NCT00520286|4125140|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4298578|NCT00520286|4125138|B3|||Age||years|Mean|39|39.0|Standard Deviation|8.6|8.6|||
4298579|NCT00520286|4125139|B2|||Age||years|Mean|39|39.0|Standard Deviation|8.6|8.6|||
4298580|NCT00520286|4125140|B1|||Age||years|Mean|77.6|77.6|Standard Deviation|17.3|17.3|||
4298581|NCT00520234|4125149|B3|||Acute Physiology And Chronic Health Evaluation (APACHE) II score (minimum 0, maximum 71)||Score on a scale|Mean|25.2|25.2|Standard Deviation|8.3|8.3|||
4298582|NCT00520234|4125150|B2|||Acute Physiology And Chronic Health Evaluation (APACHE) II score (minimum 0, maximum 71)||Score on a scale|Mean|25.1|25.1|Standard Deviation|8.7|8.7|||
4298583|NCT00520234|4125151|B1|||Acute Physiology And Chronic Health Evaluation (APACHE) II score (minimum 0, maximum 71)||Score on a scale|Mean|25.3|25.3|Standard Deviation|8.0|8.0|||
4298584|NCT00520234|4125149|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4298585|NCT00520234|4125150|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4298586|NCT00520234|4125151|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4298587|NCT00520234|4125149|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298588|NCT00520234|4125150|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298589|NCT00520234|4125151|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298590|NCT00520234|4125149|B3||White|Race (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
4298591|NCT00520234|4125150|B2||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4298592|NCT00520234|4125151|B1||White|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
4298593|NCT00520234|4125149|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4298594|NCT00520234|4125150|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4298595|NCT00520234|4125151|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4298596|NCT00520234|4125149|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298597|NCT00520234|4125150|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298598|NCT00520234|4125151|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298599|NCT00520234|4125149|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4298600|NCT00520234|4125150|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298601|NCT00520234|4125151|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4298602|NCT00520234|4125149|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4298603|NCT00520234|4125150|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4298604|NCT00520234|4125151|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298605|NCT00520234|4125149|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4298606|NCT00520234|4125150|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298607|NCT00520234|4125151|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4298608|NCT00520234|4125149|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|203|203.0||||||
4298609|NCT00520234|4125150|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
4298610|NCT00520234|4125151|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|109|109.0||||||
4298611|NCT00520234|4125149|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4298612|NCT00520234|4125150|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4298613|NCT00520234|4125151|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4298614|NCT00520234|4125149|B3||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4298615|NCT00520234|4125150|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4298616|NCT00520234|4125151|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4298617|NCT00520234|4125149|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4298618|NCT00520234|4125150|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4298619|NCT00520234|4125151|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4298620|NCT00520234|4125149|B3|||Age||years|Mean|57.5|57.5|Standard Deviation|17.1|17.1|||
4298621|NCT00520234|4125150|B2|||Age||years|Mean|56.7|56.7|Standard Deviation|16.6|16.6|||
4298622|NCT00520234|4125151|B1|||Age||years|Mean|58.2|58.2|Standard Deviation|17.5|17.5|||
4298623|NCT00520130|4125162|B3|Other||Histology|Acute Myeloid Leukemia (AML)/Myelodysplastic Syndrome (MDS); Cutaneous T Cell Lymphoma (CTCL)/Peripheral T Cell Lymphoma (PTCL)|Participants|Count of Participants|9|9.0||||||
4298624|NCT00520130|4125163|B2|Other||Histology|Acute Myeloid Leukemia (AML)/Myelodysplastic Syndrome (MDS); Cutaneous T Cell Lymphoma (CTCL)/Peripheral T Cell Lymphoma (PTCL)|Participants|Count of Participants|6|6.0||||||
4298625|NCT00520130|4125164|B1|Other||Histology|Acute Myeloid Leukemia (AML)/Myelodysplastic Syndrome (MDS); Cutaneous T Cell Lymphoma (CTCL)/Peripheral T Cell Lymphoma (PTCL)|Participants|Count of Participants|3|3.0||||||
4298626|NCT00520130|4125162|B3|Multiple Myeloma (MM)||Histology|Acute Myeloid Leukemia (AML)/Myelodysplastic Syndrome (MDS); Cutaneous T Cell Lymphoma (CTCL)/Peripheral T Cell Lymphoma (PTCL)|Participants|Count of Participants|2|2.0||||||
4298627|NCT00520130|4125163|B2|Multiple Myeloma (MM)||Histology|Acute Myeloid Leukemia (AML)/Myelodysplastic Syndrome (MDS); Cutaneous T Cell Lymphoma (CTCL)/Peripheral T Cell Lymphoma (PTCL)|Participants|Count of Participants|1|1.0||||||
4298723|NCT00520013|4125218|B4|Uterine papillary serous||Cancer Type||participants|Number|4|4.0||||||
4298628|NCT00520130|4125164|B1|Multiple Myeloma (MM)||Histology|Acute Myeloid Leukemia (AML)/Myelodysplastic Syndrome (MDS); Cutaneous T Cell Lymphoma (CTCL)/Peripheral T Cell Lymphoma (PTCL)|Participants|Count of Participants|1|1.0||||||
4298629|NCT00520130|4125162|B3|Acute Lymphoblastic Leukemia (ALL)||Histology|Acute Myeloid Leukemia (AML)/Myelodysplastic Syndrome (MDS); Cutaneous T Cell Lymphoma (CTCL)/Peripheral T Cell Lymphoma (PTCL)|Participants|Count of Participants|4|4.0||||||
4298630|NCT00520130|4125163|B2|Acute Lymphoblastic Leukemia (ALL)||Histology|Acute Myeloid Leukemia (AML)/Myelodysplastic Syndrome (MDS); Cutaneous T Cell Lymphoma (CTCL)/Peripheral T Cell Lymphoma (PTCL)|Participants|Count of Participants|2|2.0||||||
4298631|NCT00520130|4125164|B1|Acute Lymphoblastic Leukemia (ALL)||Histology|Acute Myeloid Leukemia (AML)/Myelodysplastic Syndrome (MDS); Cutaneous T Cell Lymphoma (CTCL)/Peripheral T Cell Lymphoma (PTCL)|Participants|Count of Participants|2|2.0||||||
4298632|NCT00520130|4125162|B3|CTCL/PTCL||Histology|Acute Myeloid Leukemia (AML)/Myelodysplastic Syndrome (MDS); Cutaneous T Cell Lymphoma (CTCL)/Peripheral T Cell Lymphoma (PTCL)|Participants|Count of Participants|5|5.0||||||
4298633|NCT00520130|4125163|B2|CTCL/PTCL||Histology|Acute Myeloid Leukemia (AML)/Myelodysplastic Syndrome (MDS); Cutaneous T Cell Lymphoma (CTCL)/Peripheral T Cell Lymphoma (PTCL)|Participants|Count of Participants|2|2.0||||||
4298634|NCT00520130|4125164|B1|CTCL/PTCL||Histology|Acute Myeloid Leukemia (AML)/Myelodysplastic Syndrome (MDS); Cutaneous T Cell Lymphoma (CTCL)/Peripheral T Cell Lymphoma (PTCL)|Participants|Count of Participants|3|3.0||||||
4298635|NCT00520130|4125162|B3|Chronic Myeloid Leukemia (CML)||Histology|Acute Myeloid Leukemia (AML)/Myelodysplastic Syndrome (MDS); Cutaneous T Cell Lymphoma (CTCL)/Peripheral T Cell Lymphoma (PTCL)|Participants|Count of Participants|5|5.0||||||
4298636|NCT00520130|4125163|B2|Chronic Myeloid Leukemia (CML)||Histology|Acute Myeloid Leukemia (AML)/Myelodysplastic Syndrome (MDS); Cutaneous T Cell Lymphoma (CTCL)/Peripheral T Cell Lymphoma (PTCL)|Participants|Count of Participants|1|1.0||||||
4298637|NCT00520130|4125164|B1|Chronic Myeloid Leukemia (CML)||Histology|Acute Myeloid Leukemia (AML)/Myelodysplastic Syndrome (MDS); Cutaneous T Cell Lymphoma (CTCL)/Peripheral T Cell Lymphoma (PTCL)|Participants|Count of Participants|4|4.0||||||
4298638|NCT00520130|4125162|B3|AML/MDS||Histology|Acute Myeloid Leukemia (AML)/Myelodysplastic Syndrome (MDS); Cutaneous T Cell Lymphoma (CTCL)/Peripheral T Cell Lymphoma (PTCL)|Participants|Count of Participants|11|11.0||||||
4298639|NCT00520130|4125163|B2|AML/MDS||Histology|Acute Myeloid Leukemia (AML)/Myelodysplastic Syndrome (MDS); Cutaneous T Cell Lymphoma (CTCL)/Peripheral T Cell Lymphoma (PTCL)|Participants|Count of Participants|5|5.0||||||
4298640|NCT00520130|4125164|B1|AML/MDS||Histology|Acute Myeloid Leukemia (AML)/Myelodysplastic Syndrome (MDS); Cutaneous T Cell Lymphoma (CTCL)/Peripheral T Cell Lymphoma (PTCL)|Participants|Count of Participants|6|6.0||||||
4298641|NCT00520130|4125162|B3|Chroni Lymphocytic Leukemia (CLL)||Histology|Acute Myeloid Leukemia (AML)/Myelodysplastic Syndrome (MDS); Cutaneous T Cell Lymphoma (CTCL)/Peripheral T Cell Lymphoma (PTCL)|Participants|Count of Participants|18|18.0||||||
4298642|NCT00520130|4125163|B2|Chroni Lymphocytic Leukemia (CLL)||Histology|Acute Myeloid Leukemia (AML)/Myelodysplastic Syndrome (MDS); Cutaneous T Cell Lymphoma (CTCL)/Peripheral T Cell Lymphoma (PTCL)|Participants|Count of Participants|9|9.0||||||
4298643|NCT00520130|4125164|B1|Chroni Lymphocytic Leukemia (CLL)||Histology|Acute Myeloid Leukemia (AML)/Myelodysplastic Syndrome (MDS); Cutaneous T Cell Lymphoma (CTCL)/Peripheral T Cell Lymphoma (PTCL)|Participants|Count of Participants|9|9.0||||||
4298644|NCT00520130|4125162|B3|Hodgkin's Lymphoma (HL)||Histology|Acute Myeloid Leukemia (AML)/Myelodysplastic Syndrome (MDS); Cutaneous T Cell Lymphoma (CTCL)/Peripheral T Cell Lymphoma (PTCL)|Participants|Count of Participants|10|10.0||||||
4298645|NCT00520130|4125163|B2|Hodgkin's Lymphoma (HL)||Histology|Acute Myeloid Leukemia (AML)/Myelodysplastic Syndrome (MDS); Cutaneous T Cell Lymphoma (CTCL)/Peripheral T Cell Lymphoma (PTCL)|Participants|Count of Participants|5|5.0||||||
4298646|NCT00520130|4125164|B1|Hodgkin's Lymphoma (HL)||Histology|Acute Myeloid Leukemia (AML)/Myelodysplastic Syndrome (MDS); Cutaneous T Cell Lymphoma (CTCL)/Peripheral T Cell Lymphoma (PTCL)|Participants|Count of Participants|5|5.0||||||
4298647|NCT00520130|4125162|B3|Non Hodgkin's Lymphoma (NHL)||Histology|Acute Myeloid Leukemia (AML)/Myelodysplastic Syndrome (MDS); Cutaneous T Cell Lymphoma (CTCL)/Peripheral T Cell Lymphoma (PTCL)|Participants|Count of Participants|25|25.0||||||
4298648|NCT00520130|4125163|B2|Non Hodgkin's Lymphoma (NHL)||Histology|Acute Myeloid Leukemia (AML)/Myelodysplastic Syndrome (MDS); Cutaneous T Cell Lymphoma (CTCL)/Peripheral T Cell Lymphoma (PTCL)|Participants|Count of Participants|14|14.0||||||
4298649|NCT00520130|4125164|B1|Non Hodgkin's Lymphoma (NHL)||Histology|Acute Myeloid Leukemia (AML)/Myelodysplastic Syndrome (MDS); Cutaneous T Cell Lymphoma (CTCL)/Peripheral T Cell Lymphoma (PTCL)|Participants|Count of Participants|11|11.0||||||
4298650|NCT00520130|4125162|B3|United States||Region of Enrollment||Participants|Count of Participants|89|89.0||||||
4298651|NCT00520130|4125163|B2|United States||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
4298652|NCT00520130|4125164|B1|United States||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
4298653|NCT00520130|4125162|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298654|NCT00520130|4125163|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298655|NCT00520130|4125164|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298656|NCT00520130|4125162|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4298657|NCT00520130|4125163|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4298658|NCT00520130|4125164|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298659|NCT00520130|4125162|B3||White|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
4298660|NCT00520130|4125163|B2||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4298661|NCT00520130|4125164|B1||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4298662|NCT00520130|4125162|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4298663|NCT00520130|4125163|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4298664|NCT00520130|4125164|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4298665|NCT00520130|4125162|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298666|NCT00520130|4125163|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298667|NCT00520130|4125164|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298668|NCT00520130|4125162|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4298669|NCT00520130|4125163|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4298670|NCT00520130|4125164|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4298671|NCT00520130|4125162|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298672|NCT00520130|4125163|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298673|NCT00520130|4125164|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298674|NCT00520130|4125162|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298675|NCT00520130|4125163|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298676|NCT00520130|4125164|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298677|NCT00520130|4125162|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
4298678|NCT00520130|4125163|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4298679|NCT00520130|4125164|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4298680|NCT00520130|4125162|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4298681|NCT00520130|4125163|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4298682|NCT00520130|4125164|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4298683|NCT00520130|4125162|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4298684|NCT00520130|4125163|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4298685|NCT00520130|4125164|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4298686|NCT00520130|4125162|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4298687|NCT00520130|4125163|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4298688|NCT00520130|4125164|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4298689|NCT00520130|4125162|B3|||Age||years|Mean|47.90|47.9|Standard Deviation|14.04|14.04|||
4298690|NCT00520130|4125163|B2|||Age||years|Mean|47.89|47.89|Standard Deviation|13.4|13.4|||
4298691|NCT00520130|4125164|B1|||Age||years|Mean|47.92|47.92|Standard Deviation|14.68|14.68|||
4298692|NCT00520130|4125162|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4298693|NCT00520130|4125163|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4298694|NCT00520130|4125164|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4298695|NCT00520130|4125162|B3||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
4298696|NCT00520130|4125163|B2||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4298697|NCT00520130|4125164|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4298698|NCT00520130|4125162|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4298699|NCT00520130|4125163|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4298700|NCT00520130|4125164|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4298701|NCT00520039|4125205|B3|United States||Region of Enrollment||participants|Number|52|52.0||||||
4298702|NCT00520039|4125206|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4298703|NCT00520039|4125207|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4298704|NCT00520039|4125205|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4298705|NCT00520039|4125206|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4298706|NCT00520039|4125207|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4298707|NCT00520039|4125205|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4298708|NCT00520039|4125206|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4298709|NCT00520039|4125207|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4298710|NCT00520039|4125205|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4298711|NCT00520039|4125206|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4298712|NCT00520039|4125207|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4298713|NCT00520039|4125205|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4298714|NCT00520039|4125206|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4298715|NCT00520039|4125207|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4298716|NCT00520039|4125205|B3||<=18 years|Age||Participants|Count of Participants|52|52.0||||||
4298717|NCT00520039|4125206|B2||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
4298718|NCT00520039|4125207|B1||<=18 years|Age||Participants|Count of Participants|28|28.0||||||
4298719|NCT00520013|4125218|B4|Other (mixed, carcinosarcoma)||Cancer Type||participants|Number|4|4.0||||||
4298720|NCT00520013|4125219|B3|Other (mixed, carcinosarcoma)||Cancer Type||participants|Number|0|0.0||||||
4298721|NCT00520013|4125220|B2|Other (mixed, carcinosarcoma)||Cancer Type||participants|Number|2|2.0||||||
4298722|NCT00520013|4125221|B1|Other (mixed, carcinosarcoma)||Cancer Type||participants|Number|2|2.0||||||
4298724|NCT00520013|4125219|B3|Uterine papillary serous||Cancer Type||participants|Number|1|1.0||||||
4298725|NCT00520013|4125220|B2|Uterine papillary serous||Cancer Type||participants|Number|1|1.0||||||
4298726|NCT00520013|4125221|B1|Uterine papillary serous||Cancer Type||participants|Number|2|2.0||||||
4298727|NCT00520013|4125218|B4|Epithelial ovarian||Cancer Type||participants|Number|35|35.0||||||
4298728|NCT00520013|4125219|B3|Epithelial ovarian||Cancer Type||participants|Number|8|8.0||||||
4298729|NCT00520013|4125220|B2|Epithelial ovarian||Cancer Type||participants|Number|17|17.0||||||
4298730|NCT00520013|4125221|B1|Epithelial ovarian||Cancer Type||participants|Number|10|10.0||||||
4298731|NCT00520013|4125218|B4|Fallopian tube||Cancer Type||participants|Number|10|10.0||||||
4298732|NCT00520013|4125219|B3|Fallopian tube||Cancer Type||participants|Number|1|1.0||||||
4298733|NCT00520013|4125220|B2|Fallopian tube||Cancer Type||participants|Number|4|4.0||||||
4298734|NCT00520013|4125221|B1|Fallopian tube||Cancer Type||participants|Number|5|5.0||||||
4298735|NCT00520013|4125218|B4|Primary peritoneal||Cancer Type||participants|Number|6|6.0||||||
4298736|NCT00520013|4125219|B3|Primary peritoneal||Cancer Type||participants|Number|1|1.0||||||
4298737|NCT00520013|4125220|B2|Primary peritoneal||Cancer Type||participants|Number|1|1.0||||||
4298738|NCT00520013|4125221|B1|Primary peritoneal||Cancer Type||participants|Number|4|4.0||||||
4298739|NCT00520013|4125218|B4|United States||Region of Enrollment||participants|Number|59|59.0||||||
4298740|NCT00520013|4125219|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4298741|NCT00520013|4125220|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4298742|NCT00520013|4125221|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4298743|NCT00520013|4125218|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4298744|NCT00520013|4125219|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4298745|NCT00520013|4125220|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4298746|NCT00520013|4125221|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4298747|NCT00520013|4125218|B4||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4298748|NCT00520013|4125219|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4298749|NCT00520013|4125220|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4298750|NCT00520013|4125221|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4298751|NCT00520013|4125218|B4|||Age||years|Median|57|57.0|Inter-Quartile Range|||49.0|61.0|
4298752|NCT00520013|4125219|B3|||Age||years|Median|54|54.0|Inter-Quartile Range|||51.0|59.0|
4298753|NCT00520013|4125220|B2|||Age||years|Median|56|56.0|Inter-Quartile Range|||49.0|61.0|
4298754|NCT00520013|4125221|B1|||Age||years|Median|58|58.0|Inter-Quartile Range|||48.0|63.0|
4298755|NCT00519896|4125233|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4298756|NCT00519896|4125233|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4298757|NCT00519896|4125233|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4298758|NCT00519896|4125233|B1|||Age||years|Median|61|61.0|Full Range|||34.0|73.0|
4298759|NCT00519896|4125233|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4298760|NCT00519896|4125233|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4298761|NCT00519896|4125233|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4298762|NCT00519831|4125239|B1|||Number of Participants who had a score of 0-1 in the The Eastern Cooperative Oncology Group (ECOG)|"Measure Description: A scale from 0-5 to describe a patient's level of functioning in terms of self care ability and activity level.~0. Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all self care but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited self care; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any self care; totally confined to bed or chair~Dead"|Participants|Count of Participants|16|16.0||||||
4298763|NCT00519831|4125239|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4298764|NCT00519831|4125239|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298765|NCT00519831|4125239|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298766|NCT00519831|4125239|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4298767|NCT00519831|4125239|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4298768|NCT00519831|4125239|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298769|NCT00519831|4125239|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298770|NCT00519831|4125239|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298771|NCT00519831|4125239|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4298772|NCT00519831|4125239|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4298773|NCT00519831|4125239|B1|||Age||years|Median|60.5|60.5|Full Range|||50.0|72.0|
4298774|NCT00519818|4125246|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4298775|NCT00519818|4125246|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4298776|NCT00519818|4125246|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4298777|NCT00519818|4125246|B1|||Age||years|Mean|26.8|26.8|Standard Deviation|3.8|3.8|||
4298778|NCT00519818|4125246|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4298779|NCT00519818|4125246|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4298780|NCT00519818|4125246|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4298781|NCT00519779|4125254|B3|United States||Region of Enrollment||participants|Number|68|68.0||||||
4298782|NCT00519779|4125255|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
4298783|NCT00519779|4125256|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4298784|NCT00519779|4125254|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4298785|NCT00519779|4125255|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4298786|NCT00519779|4125256|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4298787|NCT00519779|4125254|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4298788|NCT00519779|4125255|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4298789|NCT00519779|4125256|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4298790|NCT00519779|4125254|B3|||Age||years|Mean|23.6|23.6|Standard Deviation|1.9|1.9|||
4298791|NCT00519779|4125255|B2|||Age||years|Mean|23.9|23.9|Standard Deviation|2.0|2.0|||
4298792|NCT00519779|4125256|B1|||Age||years|Mean|23.4|23.4|Standard Deviation|1.7|1.7|||
4298793|NCT00519779|4125254|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4298794|NCT00519779|4125255|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4298795|NCT00519779|4125256|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4298796|NCT00519779|4125254|B3||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
4298797|NCT00519779|4125255|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4298798|NCT00519779|4125256|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4298799|NCT00519779|4125254|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4298800|NCT00519779|4125255|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4298801|NCT00519779|4125256|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4298802|NCT00519649|4125273|B1||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4298803|NCT00519649|4125273|B1||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4298804|NCT00519649|4125273|B1|||Age||years|Mean|7.7|7.7|Standard Deviation|0.46|0.46|||
4298805|NCT00519636|4125282|B5|Unknown||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4298806|NCT00519636|4125283|B4|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4298807|NCT00519636|4125284|B3|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4298808|NCT00519636|4125285|B2|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4298809|NCT00519636|4125286|B1|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4298810|NCT00519636|4125282|B5|African American/African Heritage & White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4298811|NCT00519636|4125283|B4|African American/African Heritage & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4298812|NCT00519636|4125284|B3|African American/African Heritage & White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4298813|NCT00519636|4125285|B2|African American/African Heritage & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4298814|NCT00519636|4125286|B1|African American/African Heritage & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4298815|NCT00519636|4125282|B5|African American/African Heritage & Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4298816|NCT00519636|4125283|B4|African American/African Heritage & Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4298817|NCT00519636|4125284|B3|African American/African Heritage & Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4298818|NCT00519636|4125285|B2|African American/African Heritage & Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4298819|NCT00519636|4125286|B1|African American/African Heritage & Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4298820|NCT00519636|4125282|B5|White||Race/Ethnicity, Customized||participants|Number|260|260.0||||||
4298821|NCT00519636|4125283|B4|White||Race/Ethnicity, Customized||participants|Number|64|64.0||||||
4298822|NCT00519636|4125284|B3|White||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
4298823|NCT00519636|4125285|B2|White||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
4298824|NCT00519636|4125286|B1|White||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
4298825|NCT00519636|4125282|B5|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4298826|NCT00519636|4125283|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4298827|NCT00519636|4125284|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4298828|NCT00519636|4125285|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4298829|NCT00519636|4125286|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4298830|NCT00519636|4125282|B5|Asian: Japanese/East-Southeast Asian Heritage||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4298831|NCT00519636|4125283|B4|Asian: Japanese/East-Southeast Asian Heritage||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4298832|NCT00519636|4125284|B3|Asian: Japanese/East-Southeast Asian Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4298833|NCT00519636|4125285|B2|Asian: Japanese/East-Southeast Asian Heritage||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4298834|NCT00519636|4125286|B1|Asian: Japanese/East-Southeast Asian Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4298835|NCT00519636|4125282|B5|Asian: Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4298836|NCT00519636|4125283|B4|Asian: Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4298837|NCT00519636|4125284|B3|Asian: Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4298838|NCT00519636|4125285|B2|Asian: Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4298839|NCT00519636|4125286|B1|Asian: Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4298840|NCT00519636|4125282|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4298841|NCT00519636|4125283|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4298842|NCT00519636|4125284|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4298843|NCT00519636|4125285|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4298844|NCT00519636|4125286|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4298845|NCT00519636|4125282|B5|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
4298846|NCT00519636|4125283|B4|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4298847|NCT00519636|4125284|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4298848|NCT00519636|4125285|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4298849|NCT00519636|4125286|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4298850|NCT00519636|4125282|B5||Male|Gender||Participants|Count of Participants|146|146.0||||||
4298851|NCT00519636|4125283|B4||Male|Gender||Participants|Count of Participants|39|39.0||||||
4298852|NCT00519636|4125284|B3||Male|Gender||Participants|Count of Participants|30|30.0||||||
4298853|NCT00519636|4125285|B2||Male|Gender||Participants|Count of Participants|35|35.0||||||
4298854|NCT00519636|4125286|B1||Male|Gender||Participants|Count of Participants|42|42.0||||||
4298855|NCT00519636|4125282|B5||Female|Gender||Participants|Count of Participants|214|214.0||||||
4298856|NCT00519636|4125283|B4||Female|Gender||Participants|Count of Participants|54|54.0||||||
4298857|NCT00519636|4125284|B3||Female|Gender||Participants|Count of Participants|60|60.0||||||
4298858|NCT00519636|4125285|B2||Female|Gender||Participants|Count of Participants|51|51.0||||||
4298859|NCT00519636|4125286|B1||Female|Gender||Participants|Count of Participants|49|49.0||||||
4298860|NCT00519636|4125282|B5|||Age||years|Mean|38.3|38.3|Standard Deviation|11.91|11.91|||
4298861|NCT00519636|4125283|B4|||Age||years|Mean|38.9|38.9|Standard Deviation|11.39|11.39|||
4298862|NCT00519636|4125284|B3|||Age||years|Mean|37.2|37.2|Standard Deviation|12.55|12.55|||
4298863|NCT00519636|4125285|B2|||Age||years|Mean|38|38.0|Standard Deviation|11.54|11.54|||
4298864|NCT00519636|4125286|B1|||Age||years|Mean|38.8|38.8|Standard Deviation|12.25|12.25|||
4298865|NCT00519623|4125319|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4298866|NCT00519623|4125319|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4298867|NCT00519623|4125319|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4298868|NCT00519623|4125319|B1|||Age||years|Mean|35.4|35.4|Standard Deviation|10.8|10.8|||
4298869|NCT00519623|4125319|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4298870|NCT00519623|4125319|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4298871|NCT00519623|4125319|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4298872|NCT00519584|4125324|B5||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4298873|NCT00519584|4125325|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4298874|NCT00519584|4125326|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4298875|NCT00519584|4125327|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4298876|NCT00519584|4125328|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4298877|NCT00519584|4125324|B5||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4298878|NCT00519584|4125325|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4298879|NCT00519584|4125326|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4298880|NCT00519584|4125327|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4298881|NCT00519584|4125328|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4298882|NCT00519584|4125324|B5|||Age||years|Median|59|59.0|Inter-Quartile Range|||50.0|60.0|
4298883|NCT00519584|4125325|B4|||Age||years|Median|60|60.0|Inter-Quartile Range|||51.0|68.0|
4298884|NCT00519584|4125326|B3|||Age||years|Median|58|58.0|Inter-Quartile Range|||53.0|64.0|
4298885|NCT00519584|4125327|B2|||Age||years|Median|59|59.0|Inter-Quartile Range|||49.0|68.0|
4298886|NCT00519584|4125328|B1|||Age||years|Median|55|55.0|Inter-Quartile Range|||44.0|55.0|
4298887|NCT00519532|4125353|B1|||Weight||kg|Mean|78.3|78.3|Standard Deviation|16.6|16.6|||
4298888|NCT00519532|4125353|B1|||Height||cm|Mean|170.1|170.1|Standard Deviation|10.58|10.58|||
4298889|NCT00519532|4125353|B1|||Body Mass Index (BMI)||kg/ m^2|Mean|26.928|26.928|Standard Deviation|4.219|4.219|||
4298890|NCT00519532|4125353|B1|Advanced||L- Dopa||participants|Number|73|73.0||||||
4298891|NCT00519532|4125353|B1|Early||L- Dopa||participants|Number|10|10.0||||||
4298892|NCT00519532|4125353|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4298893|NCT00519532|4125353|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298894|NCT00519532|4125353|B1||White|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
4298895|NCT00519532|4125353|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4298896|NCT00519532|4125353|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298897|NCT00519532|4125353|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298992|NCT00519090|4125557|B1|Korea, Republic of||Region of Enrollment||participants|Number|0|0.0||||||
4298898|NCT00519532|4125353|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4298899|NCT00519532|4125353|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4298900|NCT00519532|4125353|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4298901|NCT00519532|4125353|B1|||Age||years|Mean|66.2|66.2|Standard Deviation|10.4|10.4|||
4298902|NCT00519532|4125353|B1||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
4298903|NCT00519532|4125353|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4298904|NCT00519532|4125353|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4298905|NCT00519428|4125360|B4|Canada||Region of Enrollment||participants|Number|125|125.0||||||
4298906|NCT00519428|4125361|B3|Canada||Region of Enrollment||participants|Number|42|42.0||||||
4298907|NCT00519428|4125362|B2|Canada||Region of Enrollment||participants|Number|42|42.0||||||
4298908|NCT00519428|4125363|B1|Canada||Region of Enrollment||participants|Number|41|41.0||||||
4298909|NCT00519428|4125360|B4|United States||Region of Enrollment||participants|Number|120|120.0||||||
4298910|NCT00519428|4125361|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
4298911|NCT00519428|4125362|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
4298912|NCT00519428|4125363|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4298913|NCT00519428|4125360|B4||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4298914|NCT00519428|4125361|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4298915|NCT00519428|4125362|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4298916|NCT00519428|4125363|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4298917|NCT00519428|4125360|B4||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4298918|NCT00519428|4125361|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4298919|NCT00519428|4125362|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4298920|NCT00519428|4125363|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4298921|NCT00519428|4125360|B4|Age||Age|Patient's report of their age|years|Mean|40|40.0|Standard Deviation|11|11.0|||
4298922|NCT00519428|4125361|B3|Age||Age|Patient's report of their age|years|Mean|40|40.0|Standard Deviation|11|11.0|||
4298923|NCT00519428|4125362|B2|Age||Age|Patient's report of their age|years|Mean|41|41.0|Standard Deviation|11|11.0|||
4298924|NCT00519428|4125363|B1|Age||Age|Patient's report of their age|years|Mean|40|40.0|Standard Deviation|10|10.0|||
4298925|NCT00519376|4125385|B1|White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
4298926|NCT00519376|4125385|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4298927|NCT00519376|4125385|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4298928|NCT00519376|4125385|B1|||Age||Years|Mean|62.3|62.3|Standard Deviation|7.57|7.57|||
4298929|NCT00519285|4125522|B3|ECOG 2||Eastern Co-operative Group (ECOG) performance status|"ECOG performance status:~0 = Fully active, able to carry on all pre-disease performance without restriction~1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~2 = Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours"|participants|Number|54|54.0||||||
4298930|NCT00519285|4125523|B2|ECOG 2||Eastern Co-operative Group (ECOG) performance status|"ECOG performance status:~0 = Fully active, able to carry on all pre-disease performance without restriction~1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~2 = Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours"|participants|Number|26|26.0||||||
4298931|NCT00519285|4125524|B1|ECOG 2||Eastern Co-operative Group (ECOG) performance status|"ECOG performance status:~0 = Fully active, able to carry on all pre-disease performance without restriction~1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~2 = Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours"|participants|Number|28|28.0||||||
4298932|NCT00519285|4125522|B3|ECOG 1||Eastern Co-operative Group (ECOG) performance status|"ECOG performance status:~0 = Fully active, able to carry on all pre-disease performance without restriction~1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~2 = Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours"|participants|Number|602|602.0||||||
4298933|NCT00519285|4125523|B2|ECOG 1||Eastern Co-operative Group (ECOG) performance status|"ECOG performance status:~0 = Fully active, able to carry on all pre-disease performance without restriction~1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~2 = Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours"|participants|Number|303|303.0||||||
4298934|NCT00519285|4125524|B1|ECOG 1||Eastern Co-operative Group (ECOG) performance status|"ECOG performance status:~0 = Fully active, able to carry on all pre-disease performance without restriction~1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~2 = Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours"|participants|Number|299|299.0||||||
4298935|NCT00519285|4125522|B3|ECOG 0||Eastern Co-operative Group (ECOG) performance status|"ECOG performance status:~0 = Fully active, able to carry on all pre-disease performance without restriction~1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~2 = Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours"|participants|Number|568|568.0||||||
4298936|NCT00519285|4125523|B2|ECOG 0||Eastern Co-operative Group (ECOG) performance status|"ECOG performance status:~0 = Fully active, able to carry on all pre-disease performance without restriction~1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~2 = Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours"|participants|Number|283|283.0||||||
4298937|NCT00519285|4125524|B1|ECOG 0||Eastern Co-operative Group (ECOG) performance status|"ECOG performance status:~0 = Fully active, able to carry on all pre-disease performance without restriction~1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~2 = Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours"|participants|Number|285|285.0||||||
4298938|NCT00519285|4125522|B3|||Body Surface Area (BSA)||m²|Mean|2.0|2.0|Standard Deviation|0.2|0.2|||
4298939|NCT00519285|4125523|B2|||Body Surface Area (BSA)||m²|Mean|2.0|2.0|Standard Deviation|0.2|0.2|||
4298940|NCT00519285|4125524|B1|||Body Surface Area (BSA)||m²|Mean|2.0|2.0|Standard Deviation|0.2|0.2|||
4298941|NCT00519285|4125522|B3|Other region||Region of Enrollment||Participants|Number|180|180.0||||||
4298942|NCT00519285|4125523|B2|Other region||Region of Enrollment||Participants|Number|87|87.0||||||
4298943|NCT00519285|4125524|B1|Other region||Region of Enrollment||Participants|Number|93|93.0||||||
4298944|NCT00519285|4125522|B3|South America||Region of Enrollment||Participants|Number|159|159.0||||||
4298945|NCT00519285|4125523|B2|South America||Region of Enrollment||Participants|Number|71|71.0||||||
4298946|NCT00519285|4125524|B1|South America||Region of Enrollment||Participants|Number|88|88.0||||||
4298947|NCT00519285|4125522|B3|North America||Region of Enrollment||Participants|Number|176|176.0||||||
4298948|NCT00519285|4125523|B2|North America||Region of Enrollment||Participants|Number|95|95.0||||||
4298949|NCT00519285|4125524|B1|North America||Region of Enrollment||Participants|Number|81|81.0||||||
4298950|NCT00519285|4125522|B3|Eastern Europe||Region of Enrollment||Participants|Number|263|263.0||||||
4298951|NCT00519285|4125523|B2|Eastern Europe||Region of Enrollment||Participants|Number|132|132.0||||||
4298952|NCT00519285|4125524|B1|Eastern Europe||Region of Enrollment||Participants|Number|131|131.0||||||
4298953|NCT00519285|4125522|B3|Western Europe||Region of Enrollment||Participants|Number|446|446.0||||||
4298954|NCT00519285|4125523|B2|Western Europe||Region of Enrollment||Participants|Number|227|227.0||||||
4298955|NCT00519285|4125524|B1|Western Europe||Region of Enrollment||Participants|Number|219|219.0||||||
4298956|NCT00519285|4125522|B3|Other||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4298957|NCT00519285|4125523|B2|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4298958|NCT00519285|4125524|B1|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4298959|NCT00519285|4125522|B3|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
4298960|NCT00519285|4125523|B2|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4298961|NCT00519285|4125524|B1|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4298962|NCT00519285|4125522|B3|Black||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4298963|NCT00519285|4125523|B2|Black||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4298964|NCT00519285|4125524|B1|Black||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4298965|NCT00519285|4125522|B3|Caucasian/White||Race/Ethnicity, Customized||participants|Number|1112|1112.0||||||
4298966|NCT00519285|4125523|B2|Caucasian/White||Race/Ethnicity, Customized||participants|Number|560|560.0||||||
4298967|NCT00519285|4125524|B1|Caucasian/White||Race/Ethnicity, Customized||participants|Number|552|552.0||||||
4298968|NCT00519285|4125522|B3|Male||Sex/Gender, Customized||participants|Number|1224|1224.0||||||
4298969|NCT00519285|4125523|B2|Male||Sex/Gender, Customized||participants|Number|612|612.0||||||
4298970|NCT00519285|4125524|B1|Male||Sex/Gender, Customized||participants|Number|612|612.0||||||
4298971|NCT00519285|4125522|B3|≥75 years||Age, Customized||participants|Number|262|262.0||||||
4298972|NCT00519285|4125523|B2|≥75 years||Age, Customized||participants|Number|134|134.0||||||
4298973|NCT00519285|4125524|B1|≥75 years||Age, Customized||participants|Number|128|128.0||||||
4298974|NCT00519285|4125522|B3|65-74 years||Age, Customized||participants|Number|542|542.0||||||
4298975|NCT00519285|4125523|B2|65-74 years||Age, Customized||participants|Number|283|283.0||||||
4298976|NCT00519285|4125524|B1|65-74 years||Age, Customized||participants|Number|259|259.0||||||
4298977|NCT00519285|4125522|B3|<65 years||Age, Customized||participants|Number|420|420.0||||||
4298978|NCT00519285|4125523|B2|<65 years||Age, Customized||participants|Number|195|195.0||||||
4298979|NCT00519285|4125524|B1|<65 years||Age, Customized||participants|Number|225|225.0||||||
4298980|NCT00519285|4125522|B3|||Age||Years|Mean|67.8|67.8|Standard Deviation|7.9|7.9|||
4298981|NCT00519285|4125523|B2|||Age||Years|Mean|67.9|67.9|Standard Deviation|7.8|7.8|||
4298982|NCT00519285|4125524|B1|||Age||Years|Mean|67.6|67.6|Standard Deviation|8.0|8.0|||
4298983|NCT00519194|4125551|B1|United States||Region of Enrollment||participants|Number|112|112.0||||||
4298984|NCT00519194|4125551|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4298985|NCT00519194|4125551|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4298986|NCT00519194|4125551|B1|||Age||years|Mean|72.4|72.4|Standard Deviation|6.9|6.9|||
4298987|NCT00519090|4125555|B3|Poland||Region of Enrollment||participants|Number|2|2.0||||||
4298988|NCT00519090|4125556|B2|Poland||Region of Enrollment||participants|Number|2|2.0||||||
4298989|NCT00519090|4125557|B1|Poland||Region of Enrollment||participants|Number|0|0.0||||||
4298990|NCT00519090|4125555|B3|Korea, Republic of||Region of Enrollment||participants|Number|1|1.0||||||
4298991|NCT00519090|4125556|B2|Korea, Republic of||Region of Enrollment||participants|Number|1|1.0||||||
4298993|NCT00519090|4125555|B3|Japan||Region of Enrollment||participants|Number|1|1.0||||||
4298994|NCT00519090|4125556|B2|Japan||Region of Enrollment||participants|Number|0|0.0||||||
4298995|NCT00519090|4125557|B1|Japan||Region of Enrollment||participants|Number|1|1.0||||||
4298996|NCT00519090|4125555|B3|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4298997|NCT00519090|4125556|B2|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4298998|NCT00519090|4125557|B1|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4298999|NCT00519090|4125555|B3|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4299000|NCT00519090|4125556|B2|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
4299001|NCT00519090|4125557|B1|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4299002|NCT00519090|4125555|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4299003|NCT00519090|4125556|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4299004|NCT00519090|4125557|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4299005|NCT00519090|4125555|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4299006|NCT00519090|4125556|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4299007|NCT00519090|4125557|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4299008|NCT00519090|4125555|B3|||Age||years|Mean|54|54.0|Standard Deviation|15.6812|15.6812|||
4299009|NCT00519090|4125556|B2|||Age||years|Mean|45.5|45.5|Standard Deviation|12.06924|12.06924|||
4299010|NCT00519090|4125557|B1|||Age||years|Mean|69.5|69.5|Standard Deviation|4.949747|4.949747|||
4299011|NCT00519090|4125555|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4299012|NCT00519090|4125556|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4299013|NCT00519090|4125557|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4299014|NCT00519090|4125555|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4299015|NCT00519090|4125556|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4299016|NCT00519090|4125557|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4299017|NCT00519090|4125555|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4299018|NCT00519090|4125556|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4299019|NCT00519090|4125557|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4299020|NCT00519077|4125566|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4299021|NCT00519077|4125566|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4299022|NCT00519077|4125566|B1|> 62 years||Age, Customized||participants|Number|18|18.0||||||
4299023|NCT00519077|4125566|B1|<= 62 years||Age, Customized||participants|Number|26|26.0||||||
4299024|NCT00518986|4125571|B3|United States||Region of Enrollment||participants|Number|249|249.0||||||
4299025|NCT00518986|4125572|B2|United States||Region of Enrollment||participants|Number|124|124.0||||||
4299026|NCT00518986|4125573|B1|United States||Region of Enrollment||participants|Number|125|125.0||||||
4299027|NCT00518986|4125571|B3||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4299028|NCT00518986|4125572|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4299029|NCT00518986|4125573|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4299030|NCT00518986|4125571|B3||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4299031|NCT00518986|4125572|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4299032|NCT00518986|4125573|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4299033|NCT00518986|4125571|B3|||Age||years|Mean|49.5|49.5|Standard Deviation|9.99|9.99|||
4299034|NCT00518986|4125572|B2|||Age||years|Mean|49.5|49.5|Standard Deviation|9.69|9.69|||
4299035|NCT00518986|4125573|B1|||Age||years|Mean|49.5|49.5|Standard Deviation|10.32|10.32|||
4299036|NCT00518986|4125571|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4299037|NCT00518986|4125572|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4299038|NCT00518986|4125573|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4299039|NCT00518986|4125571|B3||Between 18 and 65 years|Age||Participants|Count of Participants|249|249.0||||||
4299040|NCT00518986|4125572|B2||Between 18 and 65 years|Age||Participants|Count of Participants|124|124.0||||||
4299041|NCT00518986|4125573|B1||Between 18 and 65 years|Age||Participants|Count of Participants|125|125.0||||||
4299042|NCT00518986|4125571|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4299043|NCT00518986|4125572|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4299044|NCT00518986|4125573|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4299045|NCT00518882|4125698|B3|||Weight||kg|Mean|93.1|93.1|Standard Deviation|19.8|19.8|||
4299046|NCT00518882|4125699|B2|||Weight||kg|Mean|93.0|93.0|Standard Deviation|19.5|19.5|||
4299047|NCT00518882|4125700|B1|||Weight||kg|Mean|93.1|93.1|Standard Deviation|20.1|20.1|||
4299048|NCT00518882|4125698|B3|||Height||m|Mean|1.68|1.68|Standard Deviation|0.10|0.1|||
4299049|NCT00518882|4125699|B2|||Height||m|Mean|1.68|1.68|Standard Deviation|0.10|0.1|||
4299050|NCT00518882|4125700|B1|||Height||m|Mean|1.68|1.68|Standard Deviation|0.10|0.1|||
4299051|NCT00518882|4125698|B3|||HbA1c|Glycosylated Haemoglobin at screening|percentage of total haemoglobin|Mean|8.3|8.3|Standard Deviation|1.0|1.0|||
4299052|NCT00518882|4125699|B2|||HbA1c|Glycosylated Haemoglobin at screening|percentage of total haemoglobin|Mean|8.2|8.2|Standard Deviation|1.0|1.0|||
4299053|NCT00518882|4125700|B1|||HbA1c|Glycosylated Haemoglobin at screening|percentage of total haemoglobin|Mean|8.4|8.4|Standard Deviation|1.0|1.0|||
4299054|NCT00518882|4125698|B3|||Duration of diabetes|Number of years since diagnosis|years|Mean|8.2|8.2|Standard Deviation|6.0|6.0|||
4299055|NCT00518882|4125699|B2|||Duration of diabetes|Number of years since diagnosis|years|Mean|7.9|7.9|Standard Deviation|5.9|5.9|||
4299056|NCT00518882|4125700|B1|||Duration of diabetes|Number of years since diagnosis|years|Mean|8.5|8.5|Standard Deviation|6.2|6.2|||
4299057|NCT00518882|4125698|B3|||BMI|Body Mass Index|kg/m2|Mean|32.9|32.9|Standard Deviation|5.6|5.6|||
4299058|NCT00518882|4125699|B2|||BMI|Body Mass Index|kg/m2|Mean|32.9|32.9|Standard Deviation|5.7|5.7|||
4299059|NCT00518882|4125700|B1|||BMI|Body Mass Index|kg/m2|Mean|32.9|32.9|Standard Deviation|5.5|5.5|||
4299060|NCT00518882|4125698|B3|Metformin||Previous OAD treatment|OAD = Oral Anti-diabetic Drug|participants|Number|127|127.0||||||
4299061|NCT00518882|4125699|B2|Metformin||Previous OAD treatment|OAD = Oral Anti-diabetic Drug|participants|Number|63|63.0||||||
4299062|NCT00518882|4125700|B1|Metformin||Previous OAD treatment|OAD = Oral Anti-diabetic Drug|participants|Number|64|64.0||||||
4299063|NCT00518882|4125698|B3|Sulphonylurea||Previous OAD treatment|OAD = Oral Anti-diabetic Drug|participants|Number|45|45.0||||||
4299064|NCT00518882|4125699|B2|Sulphonylurea||Previous OAD treatment|OAD = Oral Anti-diabetic Drug|participants|Number|21|21.0||||||
4299065|NCT00518882|4125700|B1|Sulphonylurea||Previous OAD treatment|OAD = Oral Anti-diabetic Drug|participants|Number|24|24.0||||||
4299066|NCT00518882|4125698|B3|Metformin/Sulphonylurea Combination||Previous OAD treatment|OAD = Oral Anti-diabetic Drug|participants|Number|292|292.0||||||
4299067|NCT00518882|4125699|B2|Metformin/Sulphonylurea Combination||Previous OAD treatment|OAD = Oral Anti-diabetic Drug|participants|Number|147|147.0||||||
4299068|NCT00518882|4125700|B1|Metformin/Sulphonylurea Combination||Previous OAD treatment|OAD = Oral Anti-diabetic Drug|participants|Number|145|145.0||||||
4299069|NCT00518882|4125698|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4299070|NCT00518882|4125699|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4299071|NCT00518882|4125700|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4299072|NCT00518882|4125698|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4299073|NCT00518882|4125699|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4299074|NCT00518882|4125700|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4299075|NCT00518882|4125698|B3||White|Race (NIH/OMB)||Participants|Count of Participants|426|426.0||||||
4299076|NCT00518882|4125699|B2||White|Race (NIH/OMB)||Participants|Count of Participants|210|210.0||||||
4299077|NCT00518882|4125700|B1||White|Race (NIH/OMB)||Participants|Count of Participants|216|216.0||||||
4299078|NCT00518882|4125698|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4299079|NCT00518882|4125699|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4299080|NCT00518882|4125700|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4299081|NCT00518882|4125698|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4299082|NCT00518882|4125699|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4299083|NCT00518882|4125700|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4299084|NCT00518882|4125698|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4299085|NCT00518882|4125699|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4299086|NCT00518882|4125700|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4299087|NCT00518882|4125698|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4299088|NCT00518882|4125699|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4299089|NCT00518882|4125700|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4299090|NCT00518882|4125698|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4299091|NCT00518882|4125699|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4299092|NCT00518882|4125700|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4299093|NCT00518882|4125698|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|407|407.0||||||
4299094|NCT00518882|4125699|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|206|206.0||||||
4299095|NCT00518882|4125700|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|201|201.0||||||
4299096|NCT00518882|4125698|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4299097|NCT00518882|4125699|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4299098|NCT00518882|4125700|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4299099|NCT00518882|4125698|B3||Male|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
4299100|NCT00518882|4125699|B2||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4299101|NCT00518882|4125700|B1||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4299102|NCT00518882|4125698|B3||Female|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4299103|NCT00518882|4125699|B2||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4299104|NCT00518882|4125700|B1||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4299105|NCT00518882|4125698|B3|||Age||years|Mean|56.7|56.7|Standard Deviation|10.3|10.3|||
4299106|NCT00518882|4125699|B2|||Age||years|Mean|57.1|57.1|Standard Deviation|10.8|10.8|||
4299107|NCT00518882|4125700|B1|||Age||years|Mean|56.3|56.3|Standard Deviation|9.8|9.8|||
4299108|NCT00518713|4125815|B5||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4299109|NCT00518713|4125816|B4||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4299110|NCT00518713|4125817|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4299111|NCT00518713|4125818|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4299112|NCT00518713|4125819|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4299113|NCT00518713|4125815|B5||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4299114|NCT00518713|4125816|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4299115|NCT00518713|4125817|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4299116|NCT00518713|4125818|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4299117|NCT00518713|4125819|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4299118|NCT00518713|4125815|B5|||Age||years|Mean|12.4|12.4|Standard Deviation|8.96|8.96|||
4299119|NCT00518713|4125816|B4|||Age||years|Mean|13.0|13.0|Standard Deviation|9.17|9.17|||
4299120|NCT00518713|4125817|B3|||Age||years|Mean|11.7|11.7|Standard Deviation|8.48|8.48|||
4299121|NCT00518713|4125818|B2|||Age||years|Mean|14.1|14.1|Standard Deviation|10.42|10.42|||
4299122|NCT00518713|4125819|B1|||Age||years|Mean|10.9|10.9|Standard Deviation|7.24|7.24|||
4299123|NCT00518713|4125815|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4299124|NCT00518713|4125816|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4299125|NCT00518713|4125817|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4299126|NCT00518713|4125818|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4299127|NCT00518713|4125819|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4299128|NCT00518713|4125815|B5||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4299129|NCT00518713|4125816|B4||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4299130|NCT00518713|4125817|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4299131|NCT00518713|4125818|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4299132|NCT00518713|4125819|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4299133|NCT00518713|4125815|B5||<=18 years|Age||Participants|Count of Participants|193|193.0||||||
4299134|NCT00518713|4125816|B4||<=18 years|Age||Participants|Count of Participants|48|48.0||||||
4299135|NCT00518713|4125817|B3||<=18 years|Age||Participants|Count of Participants|49|49.0||||||
4299136|NCT00518713|4125818|B2||<=18 years|Age||Participants|Count of Participants|48|48.0||||||
4299137|NCT00518713|4125819|B1||<=18 years|Age||Participants|Count of Participants|48|48.0||||||
4299138|NCT00518687|4125880|B3||Male|Sex: Female, Male||Participants|Count of Participants|5346|5346.0||||||
4299139|NCT00518687|4125881|B2||Male|Sex: Female, Male||Participants|Count of Participants|2669|2669.0||||||
4299140|NCT00518687|4125882|B1||Male|Sex: Female, Male||Participants|Count of Participants|2677|2677.0||||||
4299141|NCT00518687|4125880|B3||Female|Sex: Female, Male||Participants|Count of Participants|2664|2664.0||||||
4299142|NCT00518687|4125881|B2||Female|Sex: Female, Male||Participants|Count of Participants|1336|1336.0||||||
4299143|NCT00518687|4125882|B1||Female|Sex: Female, Male||Participants|Count of Participants|1328|1328.0||||||
4299144|NCT00518687|4125880|B3|||Age||years|Mean|63.8|63.8|Standard Deviation|12.5|12.5|||
4299145|NCT00518687|4125881|B2|||Age||years|Mean|63.9|63.9|Standard Deviation|12.5|12.5|||
4299146|NCT00518687|4125882|B1|||Age||years|Mean|63.6|63.6|Standard Deviation|12.6|12.6|||
4299147|NCT00518622|4125895|B9|||Plasma HCV RNA||Log10 IU/mL|Median|6.7|6.7|Full Range|||4.8|7.8|
4299148|NCT00518622|4125896|B8|||Plasma HCV RNA||Log10 IU/mL|Median|6.6|6.6|Full Range|||4.8|6.9|
4299149|NCT00518622|4125897|B7|||Plasma HCV RNA||Log10 IU/mL|Median|6.9|6.9|Full Range|||6.6|7.8|
4299150|NCT00518622|4125898|B6|||Plasma HCV RNA||Log10 IU/mL|Median|6.6|6.6|Full Range|||5.9|7.1|
4299151|NCT00518622|4125899|B5|||Plasma HCV RNA||Log10 IU/mL|Median|6.7|6.7|Full Range|||6.2|7.4|
4299152|NCT00518622|4125900|B4|||Plasma HCV RNA||Log10 IU/mL|Median|6.7|6.7|Full Range|||6.1|7.2|
4299153|NCT00518622|4125901|B3|||Plasma HCV RNA||Log10 IU/mL|Median|6.8|6.8|Full Range|||6.3|7.3|
4299154|NCT00518622|4125902|B2|||Plasma HCV RNA||Log10 IU/mL|Median|6.7|6.7|Full Range|||6.4|7.1|
4299155|NCT00518622|4125903|B1|||Plasma HCV RNA||Log10 IU/mL|Median|7.0|7.0|Full Range|||6.6|7.4|
4299156|NCT00518622|4125895|B9|||Plasma HCV RNA||Log10 IU/mL|Mean|6.7|6.7|Standard Deviation|0.5|0.5|||
4299157|NCT00518622|4125896|B8|||Plasma HCV RNA||Log10 IU/mL|Mean|6.3|6.3|Standard Deviation|0.9|0.9|||
4299158|NCT00518622|4125897|B7|||Plasma HCV RNA||Log10 IU/mL|Mean|7.1|7.1|Standard Deviation|0.5|0.5|||
4299159|NCT00518622|4125898|B6|||Plasma HCV RNA||Log10 IU/mL|Mean|6.6|6.6|Standard Deviation|0.5|0.5|||
4299160|NCT00518622|4125899|B5|||Plasma HCV RNA||Log10 IU/mL|Mean|6.7|6.7|Standard Deviation|0.4|0.4|||
4299161|NCT00518622|4125900|B4|||Plasma HCV RNA||Log10 IU/mL|Mean|6.6|6.6|Standard Deviation|0.4|0.4|||
4299162|NCT00518622|4125901|B3|||Plasma HCV RNA||Log10 IU/mL|Mean|6.8|6.8|Standard Deviation|0.4|0.4|||
4299163|NCT00518622|4125902|B2|||Plasma HCV RNA||Log10 IU/mL|Mean|6.7|6.7|Standard Deviation|0.2|0.2|||
4299164|NCT00518622|4125903|B1|||Plasma HCV RNA||Log10 IU/mL|Mean|7.0|7.0|Standard Deviation|0.4|0.4|||
4299165|NCT00518622|4125895|B9|Genotype 1b||Genotype||Participants|Number|6|6.0||||||
4299166|NCT00518622|4125896|B8|Genotype 1b||Genotype||Participants|Number|1|1.0||||||
4299167|NCT00518622|4125897|B7|Genotype 1b||Genotype||Participants|Number|0|0.0||||||
4299168|NCT00518622|4125898|B6|Genotype 1b||Genotype||Participants|Number|2|2.0||||||
4299169|NCT00518622|4125899|B5|Genotype 1b||Genotype||Participants|Number|1|1.0||||||
4299170|NCT00518622|4125900|B4|Genotype 1b||Genotype||Participants|Number|0|0.0||||||
4299171|NCT00518622|4125901|B3|Genotype 1b||Genotype||Participants|Number|1|1.0||||||
4299172|NCT00518622|4125902|B2|Genotype 1b||Genotype||Participants|Number|0|0.0||||||
4299173|NCT00518622|4125903|B1|Genotype 1b||Genotype||Participants|Number|1|1.0||||||
4299174|NCT00518622|4125895|B9|Genotype 1a||Genotype||Participants|Number|30|30.0||||||
4299175|NCT00518622|4125896|B8|Genotype 1a||Genotype||Participants|Number|4|4.0||||||
4299176|NCT00518622|4125897|B7|Genotype 1a||Genotype||Participants|Number|4|4.0||||||
4299177|NCT00518622|4125898|B6|Genotype 1a||Genotype||Participants|Number|2|2.0||||||
4299178|NCT00518622|4125899|B5|Genotype 1a||Genotype||Participants|Number|5|5.0||||||
4299179|NCT00518622|4125900|B4|Genotype 1a||Genotype||Participants|Number|4|4.0||||||
4299180|NCT00518622|4125901|B3|Genotype 1a||Genotype||Participants|Number|5|5.0||||||
4299181|NCT00518622|4125902|B2|Genotype 1a||Genotype||Participants|Number|5|5.0||||||
4299182|NCT00518622|4125903|B1|Genotype 1a||Genotype||Participants|Number|1|1.0||||||
4299183|NCT00518622|4125895|B9|Genotype 1||Genotype||Participants|Number|4|4.0||||||
4299184|NCT00518622|4125896|B8|Genotype 1||Genotype||Participants|Number|0|0.0||||||
4299185|NCT00518622|4125897|B7|Genotype 1||Genotype||Participants|Number|0|0.0||||||
4299186|NCT00518622|4125898|B6|Genotype 1||Genotype||Participants|Number|1|1.0||||||
4299187|NCT00518622|4125899|B5|Genotype 1||Genotype||Participants|Number|0|0.0||||||
4299188|NCT00518622|4125900|B4|Genotype 1||Genotype||Participants|Number|1|1.0||||||
4299189|NCT00518622|4125901|B3|Genotype 1||Genotype||Participants|Number|0|0.0||||||
4299190|NCT00518622|4125902|B2|Genotype 1||Genotype||Participants|Number|1|1.0||||||
4299191|NCT00518622|4125903|B1|Genotype 1||Genotype||Participants|Number|1|1.0||||||
4299192|NCT00518622|4125895|B9|Hispanic American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4299193|NCT00518622|4125896|B8|Hispanic American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4299194|NCT00518622|4125897|B7|Hispanic American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4299195|NCT00518622|4125898|B6|Hispanic American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4299196|NCT00518622|4125899|B5|Hispanic American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4299197|NCT00518622|4125900|B4|Hispanic American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4299198|NCT00518622|4125901|B3|Hispanic American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4299199|NCT00518622|4125902|B2|Hispanic American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4299200|NCT00518622|4125903|B1|Hispanic American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4299201|NCT00518622|4125895|B9|African American||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4299202|NCT00518622|4125896|B8|African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4299203|NCT00518622|4125897|B7|African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4299204|NCT00518622|4125898|B6|African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4299205|NCT00518622|4125899|B5|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4299206|NCT00518622|4125900|B4|African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4299207|NCT00518622|4125901|B3|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4299208|NCT00518622|4125902|B2|African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4299209|NCT00518622|4125903|B1|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4299210|NCT00518622|4125895|B9|Caucasian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4299211|NCT00518622|4125896|B8|Caucasian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4299212|NCT00518622|4125897|B7|Caucasian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4299213|NCT00518622|4125898|B6|Caucasian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4299214|NCT00518622|4125899|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4299215|NCT00518622|4125900|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4299216|NCT00518622|4125901|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4299217|NCT00518622|4125902|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4299218|NCT00518622|4125903|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4299219|NCT00518622|4125895|B9||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4299220|NCT00518622|4125896|B8||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4299221|NCT00518622|4125897|B7||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4299222|NCT00518622|4125898|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4299223|NCT00518622|4125899|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4299224|NCT00518622|4125900|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4299225|NCT00518622|4125901|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4299226|NCT00518622|4125902|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4299227|NCT00518622|4125903|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4299228|NCT00518622|4125895|B9||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4299229|NCT00518622|4125896|B8||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4299230|NCT00518622|4125897|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4299231|NCT00518622|4125898|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4299232|NCT00518622|4125899|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4299233|NCT00518622|4125900|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4299234|NCT00518622|4125901|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4299235|NCT00518622|4125902|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4299236|NCT00518622|4125903|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4299237|NCT00518622|4125895|B9|||Age||Years|Median|48.0|48.0|Full Range|||21.0|55.0|
4299238|NCT00518622|4125896|B8|||Age||Years|Median|46.0|46.0|Full Range|||40.0|54.0|
4299239|NCT00518622|4125897|B7|||Age||Years|Median|45.5|45.5|Full Range|||21.0|52.0|
4299240|NCT00518622|4125898|B6|||Age||Years|Median|50.0|50.0|Full Range|||38.0|52.0|
4299241|NCT00518622|4125899|B5|||Age||Years|Median|41.0|41.0|Full Range|||28.0|53.0|
4299242|NCT00518622|4125900|B4|||Age||Years|Median|48.0|48.0|Full Range|||41.0|55.0|
4299243|NCT00518622|4125901|B3|||Age||Years|Median|47.0|47.0|Full Range|||38.0|54.0|
4299244|NCT00518622|4125902|B2|||Age||Years|Median|47.5|47.5|Full Range|||40.0|51.0|
4299245|NCT00518622|4125903|B1|||Age||Years|Median|48.0|48.0|Full Range|||45.0|50.0|
4299246|NCT00518622|4125895|B9|||Age||years|Mean|45.7|45.7|Standard Deviation|7.4|7.4|||
4299247|NCT00518622|4125896|B8|||Age||years|Mean|46.2|46.2|Standard Deviation|5.9|5.9|||
4299248|NCT00518622|4125897|B7|||Age||years|Mean|41.0|41.0|Standard Deviation|14.4|14.4|||
4299249|NCT00518622|4125898|B6|||Age||years|Mean|46.4|46.4|Standard Deviation|6.8|6.8|||
4299250|NCT00518622|4125899|B5|||Age||years|Mean|42.3|42.3|Standard Deviation|9.6|9.6|||
4299251|NCT00518622|4125900|B4|||Age||years|Mean|49.2|49.2|Standard Deviation|5.6|5.6|||
4299252|NCT00518622|4125901|B3|||Age||years|Mean|46.3|46.3|Standard Deviation|7.1|7.1|||
4299253|NCT00518622|4125902|B2|||Age||years|Mean|46.8|46.8|Standard Deviation|4.0|4.0|||
4299254|NCT00518622|4125903|B1|||Age||years|Mean|47.7|47.7|Standard Deviation|2.5|2.5|||
4299255|NCT00518531|4125936|B3|Japanese||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4299256|NCT00518531|4125937|B2|Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4299257|NCT00518531|4125938|B1|Japanese||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4299258|NCT00518531|4125936|B3|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4299259|NCT00518531|4125937|B2|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4299260|NCT00518531|4125938|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4299261|NCT00518531|4125936|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4299262|NCT00518531|4125937|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4299263|NCT00518531|4125938|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4299264|NCT00518531|4125936|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4299265|NCT00518531|4125937|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4299266|NCT00518531|4125938|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4299267|NCT00518531|4125936|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|234|234.0||||||
4299268|NCT00518531|4125937|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|115|115.0||||||
4299269|NCT00518531|4125938|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|119|119.0||||||
4299270|NCT00518531|4125936|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4299271|NCT00518531|4125937|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4299272|NCT00518531|4125938|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4299273|NCT00518531|4125936|B3||Female|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
4299274|NCT00518531|4125937|B2||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4299275|NCT00518531|4125938|B1||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4299276|NCT00518531|4125936|B3|||Age||Years|Mean|65.2|65.2|Standard Deviation|7.6|7.6|||
4299277|NCT00518531|4125937|B2|||Age||Years|Mean|65.1|65.1|Standard Deviation|7.6|7.6|||
4299278|NCT00518531|4125938|B1|||Age||Years|Mean|65.3|65.3|Standard Deviation|7.7|7.7|||
4299279|NCT00518349|4125973|B3|Norway||Region of Enrollment||participants|Number|120|120.0||||||
4299280|NCT00518349|4125974|B2|Norway||Region of Enrollment||participants|Number|60|60.0||||||
4299281|NCT00518349|4125975|B1|Norway||Region of Enrollment||participants|Number|60|60.0||||||
4299282|NCT00518349|4125973|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4299283|NCT00518349|4125974|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4299284|NCT00518349|4125975|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4299285|NCT00518349|4125973|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4299286|NCT00518349|4125974|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4299287|NCT00518349|4125975|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4299288|NCT00518349|4125973|B3|||Age||years|Mean|58.8|58.8|Standard Deviation|16.5|16.5|||
4299289|NCT00518349|4125974|B2|||Age||years|Mean|58.6|58.6|Standard Deviation|17.6|17.6|||
4299290|NCT00518349|4125975|B1|||Age||years|Mean|58.9|58.9|Standard Deviation|15.4|15.4|||
4299291|NCT00518349|4125973|B3||>=65 years|Age||Participants|Count of Participants|47|47.0||||||
4299292|NCT00518349|4125974|B2||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4299293|NCT00518349|4125975|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4299294|NCT00518349|4125973|B3||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4299295|NCT00518349|4125974|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4299296|NCT00518349|4125975|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4299297|NCT00518349|4125973|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4299298|NCT00518349|4125974|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4299299|NCT00518349|4125975|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4299300|NCT00518336|4125982|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
4299301|NCT00518336|4125983|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
4299302|NCT00518336|4125984|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4299303|NCT00518336|4125982|B3||Female|Gender||Participants|Count of Participants|433|433.0||||||
4299304|NCT00518336|4125983|B2||Female|Gender||Participants|Count of Participants|211|211.0||||||
4299305|NCT00518336|4125984|B1||Female|Gender||Participants|Count of Participants|222|222.0||||||
4299306|NCT00518336|4125982|B3|||Age||years|Mean|26.5|26.5|Standard Deviation|3.05|3.05|||
4299307|NCT00518336|4125983|B2|||Age||years|Mean|26.4|26.4|Standard Deviation|2.9|2.9|||
4299308|NCT00518336|4125984|B1|||Age||years|Mean|26.5|26.5|Standard Deviation|3.2|3.2|||
4299309|NCT00518323|4126147|B5|India||Region of Enrollment||participants|Number|45|45.0||||||
4299310|NCT00518323|4126148|B4|India||Region of Enrollment||participants|Number|11|11.0||||||
4299311|NCT00518323|4126149|B3|India||Region of Enrollment||participants|Number|10|10.0||||||
4299312|NCT00518323|4126150|B2|India||Region of Enrollment||participants|Number|11|11.0||||||
4299313|NCT00518323|4126151|B1|India||Region of Enrollment||participants|Number|13|13.0||||||
4299314|NCT00518323|4126147|B5|Russian Federation||Region of Enrollment||participants|Number|82|82.0||||||
4299315|NCT00518323|4126148|B4|Russian Federation||Region of Enrollment||participants|Number|21|21.0||||||
4299316|NCT00518323|4126149|B3|Russian Federation||Region of Enrollment||participants|Number|19|19.0||||||
4299317|NCT00518323|4126150|B2|Russian Federation||Region of Enrollment||participants|Number|20|20.0||||||
4299318|NCT00518323|4126151|B1|Russian Federation||Region of Enrollment||participants|Number|22|22.0||||||
4299319|NCT00518323|4126147|B5|Romania||Region of Enrollment||participants|Number|10|10.0||||||
4299320|NCT00518323|4126148|B4|Romania||Region of Enrollment||participants|Number|2|2.0||||||
4299321|NCT00518323|4126149|B3|Romania||Region of Enrollment||participants|Number|3|3.0||||||
4299322|NCT00518323|4126150|B2|Romania||Region of Enrollment||participants|Number|3|3.0||||||
4299323|NCT00518323|4126151|B1|Romania||Region of Enrollment||participants|Number|2|2.0||||||
4299324|NCT00518323|4126147|B5|Ukraine||Region of Enrollment||participants|Number|34|34.0||||||
4299325|NCT00518323|4126148|B4|Ukraine||Region of Enrollment||participants|Number|8|8.0||||||
4299326|NCT00518323|4126149|B3|Ukraine||Region of Enrollment||participants|Number|9|9.0||||||
4299327|NCT00518323|4126150|B2|Ukraine||Region of Enrollment||participants|Number|8|8.0||||||
4299328|NCT00518323|4126151|B1|Ukraine||Region of Enrollment||participants|Number|9|9.0||||||
4299329|NCT00518323|4126147|B5|United States||Region of Enrollment||participants|Number|30|30.0||||||
4299330|NCT00518323|4126148|B4|United States||Region of Enrollment||participants|Number|9|9.0||||||
4299331|NCT00518323|4126149|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4299332|NCT00518323|4126150|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4299333|NCT00518323|4126151|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4299334|NCT00518323|4126147|B5||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4299335|NCT00518323|4126148|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4299336|NCT00518323|4126149|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4299337|NCT00518323|4126150|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4299338|NCT00518323|4126151|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4299339|NCT00518323|4126147|B5||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4299340|NCT00518323|4126148|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4299341|NCT00518323|4126149|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4299342|NCT00518323|4126150|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4299343|NCT00518323|4126151|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4299344|NCT00518323|4126147|B5|||Age||years|Mean|15.4|15.4|Standard Deviation|1.53|1.53|||
4299345|NCT00518323|4126148|B4|||Age||years|Mean|15.7|15.7|Standard Deviation|1.40|1.4|||
4299346|NCT00518323|4126149|B3|||Age||years|Mean|15.5|15.5|Standard Deviation|1.60|1.6|||
4299347|NCT00518323|4126150|B2|||Age||years|Mean|15.3|15.3|Standard Deviation|1.60|1.6|||
4299348|NCT00518323|4126151|B1|||Age||years|Mean|15.1|15.1|Standard Deviation|1.50|1.5|||
4299349|NCT00518323|4126147|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4299350|NCT00518323|4126148|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4299351|NCT00518323|4126149|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4299352|NCT00518323|4126150|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4299353|NCT00518323|4126151|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4299354|NCT00518323|4126147|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4299355|NCT00518323|4126148|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4299356|NCT00518323|4126149|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4299357|NCT00518323|4126150|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4299358|NCT00518323|4126151|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4299359|NCT00518323|4126147|B5||<=18 years|Age||Participants|Count of Participants|201|201.0||||||
4299360|NCT00518323|4126148|B4||<=18 years|Age||Participants|Count of Participants|51|51.0||||||
4299361|NCT00518323|4126149|B3||<=18 years|Age||Participants|Count of Participants|48|48.0||||||
4299362|NCT00518323|4126150|B2||<=18 years|Age||Participants|Count of Participants|48|48.0||||||
4299363|NCT00518323|4126151|B1||<=18 years|Age||Participants|Count of Participants|54|54.0||||||
4299364|NCT00518284|4126180|B5|White, Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4299365|NCT00518284|4126181|B4|White, Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4299366|NCT00518284|4126182|B3|White, Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4299367|NCT00518284|4126183|B2|White, Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4299368|NCT00518284|4126180|B5|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4299369|NCT00518284|4126181|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4299370|NCT00518284|4126182|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4299371|NCT00518284|4126183|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4299372|NCT00518284|4126180|B5|Male||Gender||participants|Number|5|5.0||||||
4299373|NCT00518284|4126181|B4|Male||Gender||participants|Number|1|1.0||||||
4299374|NCT00518284|4126182|B3|Male||Gender||participants|Number|1|1.0||||||
4299375|NCT00518284|4126183|B2|Male||Gender||participants|Number|3|3.0||||||
4299376|NCT00518284|4126180|B5|Female||Gender||participants|Number|1|1.0||||||
4299377|NCT00518284|4126181|B4|Female||Gender||participants|Number|1|1.0||||||
4299378|NCT00518284|4126182|B3|Female||Gender||participants|Number|0|0.0||||||
4299379|NCT00518284|4126183|B2|Female||Gender||participants|Number|0|0.0||||||
4299380|NCT00518284|4126180|B5|||Age||years|Mean|71.8|71.8|Standard Deviation|10.59|10.59|||
4299381|NCT00518284|4126181|B4|||Age||years|Mean|69.0|69.0|Standard Deviation|12.73|12.73|||
4299382|NCT00518284|4126182|B3|||Age||years|Mean|84.0|84.0|Standard Deviation|NA||||Standard deviation could not be calculated as only one patient was randomized to this treatment group.
4299383|NCT00518284|4126183|B2|||Age||years|Mean|69.7|69.7|Standard Deviation|10.50|10.5|||
4299384|NCT00518206|4126241|B3||100|Karnofsky Performance Status|"Karnofsky scores represent the following performance status categories:~70: Cares for self; unable to carry on normal activity or to do active work. 80: Normal activity with effort; some signs or symptoms of disease. 90: Able to carry on normal activity; minor signs or symptoms of disease. 100: Normal no complaints; no evidence of disease."|Participants|Count of Participants|28|28.0||||||
4299385|NCT00518206|4126242|B2||100|Karnofsky Performance Status|"Karnofsky scores represent the following performance status categories:~70: Cares for self; unable to carry on normal activity or to do active work. 80: Normal activity with effort; some signs or symptoms of disease. 90: Able to carry on normal activity; minor signs or symptoms of disease. 100: Normal no complaints; no evidence of disease."|Participants|Count of Participants|10|10.0||||||
4299386|NCT00518206|4126243|B1||100|Karnofsky Performance Status|"Karnofsky scores represent the following performance status categories:~70: Cares for self; unable to carry on normal activity or to do active work. 80: Normal activity with effort; some signs or symptoms of disease. 90: Able to carry on normal activity; minor signs or symptoms of disease. 100: Normal no complaints; no evidence of disease."|Participants|Count of Participants|18|18.0||||||
4299387|NCT00518206|4126241|B3||90|Karnofsky Performance Status|"Karnofsky scores represent the following performance status categories:~70: Cares for self; unable to carry on normal activity or to do active work. 80: Normal activity with effort; some signs or symptoms of disease. 90: Able to carry on normal activity; minor signs or symptoms of disease. 100: Normal no complaints; no evidence of disease."|Participants|Count of Participants|12|12.0||||||
4299388|NCT00518206|4126242|B2||90|Karnofsky Performance Status|"Karnofsky scores represent the following performance status categories:~70: Cares for self; unable to carry on normal activity or to do active work. 80: Normal activity with effort; some signs or symptoms of disease. 90: Able to carry on normal activity; minor signs or symptoms of disease. 100: Normal no complaints; no evidence of disease."|Participants|Count of Participants|8|8.0||||||
4299389|NCT00518206|4126243|B1||90|Karnofsky Performance Status|"Karnofsky scores represent the following performance status categories:~70: Cares for self; unable to carry on normal activity or to do active work. 80: Normal activity with effort; some signs or symptoms of disease. 90: Able to carry on normal activity; minor signs or symptoms of disease. 100: Normal no complaints; no evidence of disease."|Participants|Count of Participants|4|4.0||||||
4299390|NCT00518206|4126241|B3||80|Karnofsky Performance Status|"Karnofsky scores represent the following performance status categories:~70: Cares for self; unable to carry on normal activity or to do active work. 80: Normal activity with effort; some signs or symptoms of disease. 90: Able to carry on normal activity; minor signs or symptoms of disease. 100: Normal no complaints; no evidence of disease."|Participants|Count of Participants|4|4.0||||||
4299391|NCT00518206|4126242|B2||80|Karnofsky Performance Status|"Karnofsky scores represent the following performance status categories:~70: Cares for self; unable to carry on normal activity or to do active work. 80: Normal activity with effort; some signs or symptoms of disease. 90: Able to carry on normal activity; minor signs or symptoms of disease. 100: Normal no complaints; no evidence of disease."|Participants|Count of Participants|1|1.0||||||
4299392|NCT00518206|4126243|B1||80|Karnofsky Performance Status|"Karnofsky scores represent the following performance status categories:~70: Cares for self; unable to carry on normal activity or to do active work. 80: Normal activity with effort; some signs or symptoms of disease. 90: Able to carry on normal activity; minor signs or symptoms of disease. 100: Normal no complaints; no evidence of disease."|Participants|Count of Participants|3|3.0||||||
4299393|NCT00518206|4126241|B3||70|Karnofsky Performance Status|"Karnofsky scores represent the following performance status categories:~70: Cares for self; unable to carry on normal activity or to do active work. 80: Normal activity with effort; some signs or symptoms of disease. 90: Able to carry on normal activity; minor signs or symptoms of disease. 100: Normal no complaints; no evidence of disease."|Participants|Count of Participants|2|2.0||||||
4299394|NCT00518206|4126242|B2||70|Karnofsky Performance Status|"Karnofsky scores represent the following performance status categories:~70: Cares for self; unable to carry on normal activity or to do active work. 80: Normal activity with effort; some signs or symptoms of disease. 90: Able to carry on normal activity; minor signs or symptoms of disease. 100: Normal no complaints; no evidence of disease."|Participants|Count of Participants|0|0.0||||||
4299395|NCT00518206|4126243|B1||70|Karnofsky Performance Status|"Karnofsky scores represent the following performance status categories:~70: Cares for self; unable to carry on normal activity or to do active work. 80: Normal activity with effort; some signs or symptoms of disease. 90: Able to carry on normal activity; minor signs or symptoms of disease. 100: Normal no complaints; no evidence of disease."|Participants|Count of Participants|2|2.0||||||
4299396|NCT00518206|4126241|B3|Australia||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
4299397|NCT00518206|4126242|B2|Australia||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4299398|NCT00518206|4126243|B1|Australia||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
4299399|NCT00518206|4126241|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4299400|NCT00518206|4126242|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4299401|NCT00518206|4126243|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4299402|NCT00518206|4126241|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4299403|NCT00518206|4126242|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4299404|NCT00518206|4126243|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4299405|NCT00518206|4126241|B3||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4299406|NCT00518206|4126242|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4299407|NCT00518206|4126243|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4299408|NCT00518206|4126241|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4299409|NCT00518206|4126242|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4299410|NCT00518206|4126243|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4299411|NCT00518206|4126241|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4299412|NCT00518206|4126242|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4299413|NCT00518206|4126243|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4299414|NCT00518206|4126241|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4299415|NCT00518206|4126242|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4299416|NCT00518206|4126243|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4299417|NCT00518206|4126241|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4299418|NCT00518206|4126242|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4299419|NCT00518206|4126243|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4299420|NCT00518206|4126241|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4299421|NCT00518206|4126242|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4299422|NCT00518206|4126243|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4299423|NCT00518206|4126241|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4299424|NCT00518206|4126242|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4299425|NCT00518206|4126243|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4299426|NCT00518206|4126241|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4299427|NCT00518206|4126242|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4299428|NCT00518206|4126243|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4299429|NCT00518206|4126241|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4299430|NCT00518206|4126242|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4299431|NCT00518206|4126243|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4299432|NCT00518206|4126241|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4299433|NCT00518206|4126242|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4299434|NCT00518206|4126243|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4299435|NCT00518206|4126241|B3|||Age||years|Median|61.0|61.0|Full Range|||36.0|86.0|
4299436|NCT00518206|4126242|B2|||Age||years|Median|61.0|61.0|Full Range|||38.0|81.0|
4299437|NCT00518206|4126243|B1|||Age||years|Median|61.0|61.0|Full Range|||36.0|86.0|
4299438|NCT00518180|4126258|B4|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4299439|NCT00518180|4126259|B3|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4299440|NCT00518180|4126260|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4299441|NCT00518180|4126261|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4299442|NCT00518180|4126258|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|1619|1619.0||||||
4299443|NCT00518180|4126259|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|539|539.0||||||
4299444|NCT00518180|4126260|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|541|541.0||||||
4299445|NCT00518180|4126261|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|539|539.0||||||
4299446|NCT00518180|4126258|B4||Male|Sex: Female, Male||Participants|Count of Participants|696|696.0||||||
4299447|NCT00518180|4126259|B3||Male|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
4299448|NCT00518180|4126260|B2||Male|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
4299449|NCT00518180|4126261|B1||Male|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
4299450|NCT00518180|4126258|B4||Female|Sex: Female, Male||Participants|Count of Participants|924|924.0||||||
4299451|NCT00518180|4126259|B3||Female|Sex: Female, Male||Participants|Count of Participants|307|307.0||||||
4299452|NCT00518180|4126260|B2||Female|Sex: Female, Male||Participants|Count of Participants|309|309.0||||||
4299453|NCT00518180|4126261|B1||Female|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
4299454|NCT00518180|4126258|B4|||Age||years|Mean|13.9|13.9|Standard Deviation|2.1|2.1|||
4299455|NCT00518180|4126259|B3|||Age||years|Mean|13.8|13.8|Standard Deviation|2.2|2.2|||
4299456|NCT00518180|4126260|B2|||Age||years|Mean|13.9|13.9|Standard Deviation|2.2|2.2|||
4299457|NCT00518180|4126261|B1|||Age||years|Mean|13.9|13.9|Standard Deviation|2.1|2.1|||
4299458|NCT00518115|4126305|B11|Puerto Rican||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|1|1.0||||||
4299459|NCT00518115|4126306|B10|Puerto Rican||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|1|1.0||||||
4299460|NCT00518115|4126307|B9|Puerto Rican||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299461|NCT00518115|4126308|B8|Puerto Rican||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299462|NCT00518115|4126309|B7|Puerto Rican||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299463|NCT00518115|4126310|B6|Puerto Rican||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299464|NCT00518115|4126311|B5|Puerto Rican||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299465|NCT00518115|4126312|B4|Puerto Rican||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299466|NCT00518115|4126313|B3|Puerto Rican||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299467|NCT00518115|4126314|B2|Puerto Rican||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299468|NCT00518115|4126315|B1|Puerto Rican||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299469|NCT00518115|4126305|B11|Mulatto||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|3|3.0||||||
4299470|NCT00518115|4126306|B10|Mulatto||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|1|1.0||||||
4299471|NCT00518115|4126307|B9|Mulatto||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299472|NCT00518115|4126308|B8|Mulatto||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299473|NCT00518115|4126309|B7|Mulatto||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299474|NCT00518115|4126310|B6|Mulatto||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299475|NCT00518115|4126311|B5|Mulatto||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|1|1.0||||||
4299476|NCT00518115|4126312|B4|Mulatto||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299477|NCT00518115|4126313|B3|Mulatto||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299478|NCT00518115|4126314|B2|Mulatto||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299479|NCT00518115|4126315|B1|Mulatto||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|1|1.0||||||
4299480|NCT00518115|4126305|B11|Mexican||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|8|8.0||||||
4299481|NCT00518115|4126306|B10|Mexican||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299676|NCT00518011|4126499|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4299482|NCT00518115|4126307|B9|Mexican||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299483|NCT00518115|4126308|B8|Mexican||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|1|1.0||||||
4299484|NCT00518115|4126309|B7|Mexican||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|1|1.0||||||
4299485|NCT00518115|4126310|B6|Mexican||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|2|2.0||||||
4299486|NCT00518115|4126311|B5|Mexican||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|1|1.0||||||
4299487|NCT00518115|4126312|B4|Mexican||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299488|NCT00518115|4126313|B3|Mexican||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299489|NCT00518115|4126314|B2|Mexican||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299490|NCT00518115|4126315|B1|Mexican||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|3|3.0||||||
4299491|NCT00518115|4126305|B11|Mestizo||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|3|3.0||||||
4299492|NCT00518115|4126306|B10|Mestizo||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299493|NCT00518115|4126307|B9|Mestizo||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299494|NCT00518115|4126308|B8|Mestizo||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|1|1.0||||||
4299495|NCT00518115|4126309|B7|Mestizo||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299496|NCT00518115|4126310|B6|Mestizo||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|1|1.0||||||
4299497|NCT00518115|4126311|B5|Mestizo||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299498|NCT00518115|4126312|B4|Mestizo||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299499|NCT00518115|4126313|B3|Mestizo||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|1|1.0||||||
4299500|NCT00518115|4126314|B2|Mestizo||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299501|NCT00518115|4126315|B1|Mestizo||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299502|NCT00518115|4126305|B11|Hispanic, Puerto Rican||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|1|1.0||||||
4299503|NCT00518115|4126306|B10|Hispanic, Puerto Rican||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299504|NCT00518115|4126307|B9|Hispanic, Puerto Rican||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|1|1.0||||||
4299505|NCT00518115|4126308|B8|Hispanic, Puerto Rican||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299506|NCT00518115|4126309|B7|Hispanic, Puerto Rican||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299507|NCT00518115|4126310|B6|Hispanic, Puerto Rican||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299508|NCT00518115|4126311|B5|Hispanic, Puerto Rican||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299736|NCT00517751|4126614|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4299509|NCT00518115|4126312|B4|Hispanic, Puerto Rican||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299510|NCT00518115|4126313|B3|Hispanic, Puerto Rican||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299511|NCT00518115|4126314|B2|Hispanic, Puerto Rican||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299512|NCT00518115|4126315|B1|Hispanic, Puerto Rican||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299513|NCT00518115|4126305|B11|Hispanic||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|37|37.0||||||
4299514|NCT00518115|4126306|B10|Hispanic||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|4|4.0||||||
4299515|NCT00518115|4126307|B9|Hispanic||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|4|4.0||||||
4299516|NCT00518115|4126308|B8|Hispanic||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|5|5.0||||||
4299517|NCT00518115|4126309|B7|Hispanic||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|5|5.0||||||
4299518|NCT00518115|4126310|B6|Hispanic||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|3|3.0||||||
4299519|NCT00518115|4126311|B5|Hispanic||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|2|2.0||||||
4299520|NCT00518115|4126312|B4|Hispanic||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|7|7.0||||||
4299521|NCT00518115|4126313|B3|Hispanic||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|4|4.0||||||
4299522|NCT00518115|4126314|B2|Hispanic||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299523|NCT00518115|4126315|B1|Hispanic||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|3|3.0||||||
4299524|NCT00518115|4126305|B11|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|198|198.0||||||
4299525|NCT00518115|4126306|B10|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|20|20.0||||||
4299526|NCT00518115|4126307|B9|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|18|18.0||||||
4299527|NCT00518115|4126308|B8|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|19|19.0||||||
4299528|NCT00518115|4126309|B7|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|14|14.0||||||
4299529|NCT00518115|4126310|B6|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|21|21.0||||||
4299530|NCT00518115|4126311|B5|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|20|20.0||||||
4299531|NCT00518115|4126312|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|19|19.0||||||
4299532|NCT00518115|4126313|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|18|18.0||||||
4299533|NCT00518115|4126314|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|20|20.0||||||
4299534|NCT00518115|4126315|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|29|29.0||||||
4299535|NCT00518115|4126305|B11|White- Arabic/North African Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|17|17.0||||||
4299536|NCT00518115|4126306|B10|White- Arabic/North African Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299537|NCT00518115|4126307|B9|White- Arabic/North African Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|3|3.0||||||
4299538|NCT00518115|4126308|B8|White- Arabic/North African Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299539|NCT00518115|4126309|B7|White- Arabic/North African Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299540|NCT00518115|4126310|B6|White- Arabic/North African Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299541|NCT00518115|4126311|B5|White- Arabic/North African Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|2|2.0||||||
4299542|NCT00518115|4126312|B4|White- Arabic/North African Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|4|4.0||||||
4299543|NCT00518115|4126313|B3|White- Arabic/North African Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|2|2.0||||||
4299544|NCT00518115|4126314|B2|White- Arabic/North African Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|2|2.0||||||
4299545|NCT00518115|4126315|B1|White- Arabic/North African Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|4|4.0||||||
4299546|NCT00518115|4126305|B11|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|5|5.0||||||
4299547|NCT00518115|4126306|B10|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|1|1.0||||||
4299548|NCT00518115|4126307|B9|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299549|NCT00518115|4126308|B8|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299550|NCT00518115|4126309|B7|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|1|1.0||||||
4299551|NCT00518115|4126310|B6|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299552|NCT00518115|4126311|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299553|NCT00518115|4126312|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299554|NCT00518115|4126313|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|1|1.0||||||
4299555|NCT00518115|4126314|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|1|1.0||||||
4299556|NCT00518115|4126315|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|1|1.0||||||
4299557|NCT00518115|4126305|B11|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|5|5.0||||||
4299558|NCT00518115|4126306|B10|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|1|1.0||||||
4299635|NCT00518115|4126306|B10||Female|Gender|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Count of Participants|15|15.0||||||
4299559|NCT00518115|4126307|B9|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299560|NCT00518115|4126308|B8|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|2|2.0||||||
4299561|NCT00518115|4126309|B7|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299562|NCT00518115|4126310|B6|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|1|1.0||||||
4299563|NCT00518115|4126311|B5|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299564|NCT00518115|4126312|B4|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299565|NCT00518115|4126313|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|1|1.0||||||
4299566|NCT00518115|4126314|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299567|NCT00518115|4126315|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299568|NCT00518115|4126305|B11|Asian - Japanese Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|1|1.0||||||
4299569|NCT00518115|4126306|B10|Asian - Japanese Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299570|NCT00518115|4126307|B9|Asian - Japanese Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299571|NCT00518115|4126308|B8|Asian - Japanese Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299572|NCT00518115|4126309|B7|Asian - Japanese Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299573|NCT00518115|4126310|B6|Asian - Japanese Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299574|NCT00518115|4126311|B5|Asian - Japanese Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299575|NCT00518115|4126312|B4|Asian - Japanese Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299576|NCT00518115|4126313|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299577|NCT00518115|4126314|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|1|1.0||||||
4299578|NCT00518115|4126315|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299579|NCT00518115|4126305|B11|Asian - East Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|8|8.0||||||
4299580|NCT00518115|4126306|B10|Asian - East Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299581|NCT00518115|4126307|B9|Asian - East Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|1|1.0||||||
4299582|NCT00518115|4126308|B8|Asian - East Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|1|1.0||||||
4299583|NCT00518115|4126309|B7|Asian - East Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|1|1.0||||||
4299674|NCT00518011|4126497|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4299584|NCT00518115|4126310|B6|Asian - East Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|1|1.0||||||
4299585|NCT00518115|4126311|B5|Asian - East Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|1|1.0||||||
4299586|NCT00518115|4126312|B4|Asian - East Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299587|NCT00518115|4126313|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|1|1.0||||||
4299588|NCT00518115|4126314|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299589|NCT00518115|4126315|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|2|2.0||||||
4299590|NCT00518115|4126305|B11|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|9|9.0||||||
4299591|NCT00518115|4126306|B10|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|1|1.0||||||
4299592|NCT00518115|4126307|B9|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|1|1.0||||||
4299593|NCT00518115|4126308|B8|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|1|1.0||||||
4299594|NCT00518115|4126309|B7|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|4|4.0||||||
4299595|NCT00518115|4126310|B6|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299596|NCT00518115|4126311|B5|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299597|NCT00518115|4126312|B4|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|1|1.0||||||
4299598|NCT00518115|4126313|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299599|NCT00518115|4126314|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|1|1.0||||||
4299600|NCT00518115|4126315|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299601|NCT00518115|4126305|B11|American Indian or Alaskan Native||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|5|5.0||||||
4299602|NCT00518115|4126306|B10|American Indian or Alaskan Native||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299603|NCT00518115|4126307|B9|American Indian or Alaskan Native||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|1|1.0||||||
4299604|NCT00518115|4126308|B8|American Indian or Alaskan Native||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|1|1.0||||||
4299605|NCT00518115|4126309|B7|American Indian or Alaskan Native||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|1|1.0||||||
4299606|NCT00518115|4126310|B6|American Indian or Alaskan Native||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|1|1.0||||||
4299607|NCT00518115|4126311|B5|American Indian or Alaskan Native||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|1|1.0||||||
4299608|NCT00518115|4126312|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299609|NCT00518115|4126313|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299610|NCT00518115|4126314|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299611|NCT00518115|4126315|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|0|0.0||||||
4299612|NCT00518115|4126305|B11|African American/African Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|55|55.0||||||
4299613|NCT00518115|4126306|B10|African American/African Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|5|5.0||||||
4299614|NCT00518115|4126307|B9|African American/African Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|6|6.0||||||
4299615|NCT00518115|4126308|B8|African American/African Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|4|4.0||||||
4299616|NCT00518115|4126309|B7|African American/African Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|5|5.0||||||
4299617|NCT00518115|4126310|B6|African American/African Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|3|3.0||||||
4299618|NCT00518115|4126311|B5|African American/African Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|3|3.0||||||
4299619|NCT00518115|4126312|B4|African American/African Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|4|4.0||||||
4299620|NCT00518115|4126313|B3|African American/African Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|7|7.0||||||
4299621|NCT00518115|4126314|B2|African American/African Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|10|10.0||||||
4299622|NCT00518115|4126315|B1|African American/African Heritage||Race/Ethnicity, Customized|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Number|8|8.0||||||
4299623|NCT00518115|4126305|B11||Male|Gender|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Count of Participants|170|170.0||||||
4299624|NCT00518115|4126306|B10||Male|Gender|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Count of Participants|19|19.0||||||
4299625|NCT00518115|4126307|B9||Male|Gender|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Count of Participants|17|17.0||||||
4299626|NCT00518115|4126308|B8||Male|Gender|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Count of Participants|19|19.0||||||
4299627|NCT00518115|4126309|B7||Male|Gender|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Count of Participants|16|16.0||||||
4299628|NCT00518115|4126310|B6||Male|Gender|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Count of Participants|14|14.0||||||
4299629|NCT00518115|4126311|B5||Male|Gender|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Count of Participants|8|8.0||||||
4299630|NCT00518115|4126312|B4||Male|Gender|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Count of Participants|18|18.0||||||
4299631|NCT00518115|4126313|B3||Male|Gender|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Count of Participants|15|15.0||||||
4299632|NCT00518115|4126314|B2||Male|Gender|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Count of Participants|16|16.0||||||
4299633|NCT00518115|4126315|B1||Male|Gender|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Count of Participants|28|28.0||||||
4299634|NCT00518115|4126305|B11||Female|Gender|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Count of Participants|186|186.0||||||
4299675|NCT00518011|4126498|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4299636|NCT00518115|4126307|B9||Female|Gender|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Count of Participants|18|18.0||||||
4299637|NCT00518115|4126308|B8||Female|Gender|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Count of Participants|16|16.0||||||
4299638|NCT00518115|4126309|B7||Female|Gender|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Count of Participants|16|16.0||||||
4299639|NCT00518115|4126310|B6||Female|Gender|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Count of Participants|19|19.0||||||
4299640|NCT00518115|4126311|B5||Female|Gender|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Count of Participants|23|23.0||||||
4299641|NCT00518115|4126312|B4||Female|Gender|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Count of Participants|17|17.0||||||
4299642|NCT00518115|4126313|B3||Female|Gender|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Count of Participants|20|20.0||||||
4299643|NCT00518115|4126314|B2||Female|Gender|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Count of Participants|19|19.0||||||
4299644|NCT00518115|4126315|B1||Female|Gender|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Participants|Count of Participants|23|23.0||||||
4299645|NCT00518115|4126305|B11|||Age|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Years|Mean|53.5|53.5|Standard Deviation|10.17|10.17|||
4299646|NCT00518115|4126306|B10|||Age|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Years|Mean|54.4|54.4|Standard Deviation|9.89|9.89|||
4299647|NCT00518115|4126307|B9|||Age|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Years|Mean|54.1|54.1|Standard Deviation|11.30|11.3|||
4299648|NCT00518115|4126308|B8|||Age|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Years|Mean|51.1|51.1|Standard Deviation|10.25|10.25|||
4299649|NCT00518115|4126309|B7|||Age|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Years|Mean|55.5|55.5|Standard Deviation|9.87|9.87|||
4299650|NCT00518115|4126310|B6|||Age|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Years|Mean|52.5|52.5|Standard Deviation|9.55|9.55|||
4299651|NCT00518115|4126311|B5|||Age|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Years|Mean|54.2|54.2|Standard Deviation|9.66|9.66|||
4299652|NCT00518115|4126312|B4|||Age|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Years|Mean|55.5|55.5|Standard Deviation|10.48|10.48|||
4299653|NCT00518115|4126313|B3|||Age|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Years|Mean|50.4|50.4|Standard Deviation|10.25|10.25|||
4299654|NCT00518115|4126314|B2|||Age|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Years|Mean|53.7|53.7|Standard Deviation|9.38|9.38|||
4299655|NCT00518115|4126315|B1|||Age|Baseline data are reported for participants in the Safety Population, comprised of all randomly assigned participants who received at least one dose of study drug.|Years|Mean|54.0|54.0|Standard Deviation|10.62|10.62|||
4299656|NCT00518089|4126480|B3||Male|Sex: Female, Male||Participants|Count of Participants|520|520.0||||||
4299657|NCT00518089|4126481|B2||Male|Sex: Female, Male||Participants|Count of Participants|273|273.0||||||
4299658|NCT00518089|4126482|B1||Male|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
4299659|NCT00518089|4126480|B3||Female|Sex: Female, Male||Participants|Count of Participants|339|339.0||||||
4299660|NCT00518089|4126481|B2||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4299661|NCT00518089|4126482|B1||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4299662|NCT00518089|4126480|B3|>65 years||Age, Customized||participants|Number|90|90.0||||||
4299663|NCT00518089|4126481|B2|>65 years||Age, Customized||participants|Number|42|42.0||||||
4299664|NCT00518089|4126482|B1|>65 years||Age, Customized||participants|Number|48|48.0||||||
4299665|NCT00518089|4126480|B3|19-65 years||Age, Customized||participants|Number|629|629.0||||||
4299666|NCT00518089|4126481|B2|19-65 years||Age, Customized||participants|Number|313|313.0||||||
4299667|NCT00518089|4126482|B1|19-65 years||Age, Customized||participants|Number|316|316.0||||||
4299668|NCT00518089|4126480|B3|1-18 years||Age, Customized||participants|Number|140|140.0||||||
4299669|NCT00518089|4126481|B2|1-18 years||Age, Customized||participants|Number|74|74.0||||||
4299670|NCT00518089|4126482|B1|1-18 years||Age, Customized||participants|Number|66|66.0||||||
4299671|NCT00518011|4126497|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4299672|NCT00518011|4126498|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4299673|NCT00518011|4126499|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4299677|NCT00518011|4126497|B3|||Age|Baseline characteristics were analyzed using the intention-to-treat (ITT) population. ITT included all randomized participants.|years|Mean|74.0|74.0|Standard Deviation|9.92|9.92|||
4299678|NCT00518011|4126498|B2|||Age|Baseline characteristics were analyzed using the intention-to-treat (ITT) population. ITT included all randomized participants.|years|Mean|76.8|76.8|Standard Deviation|4.17|4.17|||
4299679|NCT00518011|4126499|B1|||Age|Baseline characteristics were analyzed using the intention-to-treat (ITT) population. ITT included all randomized participants.|years|Mean|71.6|71.6|Standard Deviation|12.94|12.94|||
4299680|NCT00517933|4126520|B3|United States||Region of Enrollment||participants|Number|180|180.0||||||
4299681|NCT00517933|4126521|B2|United States||Region of Enrollment||participants|Number|91|91.0||||||
4299682|NCT00517933|4126522|B1|United States||Region of Enrollment||participants|Number|89|89.0||||||
4299683|NCT00517933|4126520|B3||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4299684|NCT00517933|4126521|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4299685|NCT00517933|4126522|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4299686|NCT00517933|4126520|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4299687|NCT00517933|4126521|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4299688|NCT00517933|4126522|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4299689|NCT00517933|4126520|B3|||Age||years|Mean|69.0|69.0|Standard Deviation|8.9|8.9|||
4299690|NCT00517933|4126521|B2|||Age||years|Mean|68.2|68.2|Standard Deviation|9.3|9.3|||
4299691|NCT00517933|4126522|B1|||Age||years|Mean|69.8|69.8|Standard Deviation|8.7|8.7|||
4299692|NCT00517881|4126587|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4299693|NCT00517881|4126587|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4299694|NCT00517881|4126587|B1|||Age||years|Mean|60.6|60.6|Standard Deviation|11.29|11.29|||
4299695|NCT00517829|4126597|B3|United States||Region of Enrollment||participants|Number|150|150.0||||||
4299696|NCT00517829|4126598|B2|United States||Region of Enrollment||participants|Number|75|75.0||||||
4299697|NCT00517829|4126599|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
4299698|NCT00517829|4126597|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4299699|NCT00517829|4126598|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4299700|NCT00517829|4126599|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4299701|NCT00517829|4126597|B3|Hawaiian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4299702|NCT00517829|4126598|B2|Hawaiian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4299703|NCT00517829|4126599|B1|Hawaiian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4299704|NCT00517829|4126597|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4299705|NCT00517829|4126598|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4299706|NCT00517829|4126599|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4299707|NCT00517829|4126597|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4299708|NCT00517829|4126598|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4299709|NCT00517829|4126599|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4299710|NCT00517829|4126597|B3|Black||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4299711|NCT00517829|4126598|B2|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4299712|NCT00517829|4126599|B1|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4299713|NCT00517829|4126597|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|118|118.0||||||
4299714|NCT00517829|4126598|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
4299715|NCT00517829|4126599|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
4299716|NCT00517829|4126597|B3||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4299717|NCT00517829|4126598|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4299718|NCT00517829|4126599|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4299719|NCT00517829|4126597|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4299720|NCT00517829|4126598|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4299721|NCT00517829|4126599|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4299722|NCT00517829|4126597|B3|||Age||years|Mean|61.0|61.0|Standard Deviation|11.2|11.2|||
4299723|NCT00517829|4126598|B2|||Age||years|Mean|61.5|61.5|Standard Deviation|11.5|11.5|||
4299724|NCT00517829|4126599|B1|||Age||years|Mean|60.5|60.5|Standard Deviation|10.9|10.9|||
4299725|NCT00517751|4126614|B1|||Body Mass Index||kg/m^2|Mean|29.3|29.3|Standard Deviation|4.72|4.72|||
4299726|NCT00517751|4126614|B1|||Weight||lbs|Mean|188.0|188.0|Standard Deviation|37.40|37.4|||
4299727|NCT00517751|4126614|B1|||Height||inches|Mean|67.2|67.2|Standard Deviation|3.93|3.93|||
4299728|NCT00517751|4126614|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4299729|NCT00517751|4126614|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|152|152.0||||||
4299730|NCT00517751|4126614|B1|Native Hawaiian or other pacific islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4299731|NCT00517751|4126614|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4299732|NCT00517751|4126614|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4299733|NCT00517751|4126614|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4299734|NCT00517751|4126614|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4299735|NCT00517751|4126614|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4299737|NCT00517751|4126614|B1|||Age||years|Mean|71.5|71.5|Standard Deviation|8.40|8.4|||
4299738|NCT00517699|4126637|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4299739|NCT00517699|4126637|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4299740|NCT00517699|4126637|B1|||Age||years|Mean|59.8|59.8|Standard Deviation|8.23|8.23|47.0|68.0|
4299741|NCT00517634|4126645|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4299742|NCT00517634|4126645|B1|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4299743|NCT00517634|4126645|B1||Male|Gender||Participants|Count of Participants|14|14.0||||||
4299744|NCT00517634|4126645|B1||Female|Gender||Participants|Count of Participants|9|9.0||||||
4299745|NCT00517634|4126645|B1|||Age||years|Mean|36.6|36.6|Standard Deviation|6.63|6.63|||
4299746|NCT00517595|4126661|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4299747|NCT00517595|4126661|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4299748|NCT00517595|4126661|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4299749|NCT00517595|4126661|B1|||Age||years|Mean|72.60|72.6|Standard Deviation|5.20|5.2|||
4299750|NCT00517595|4126661|B1||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4299751|NCT00517595|4126661|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4299752|NCT00517595|4126661|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4299753|NCT00517556|4126670|B3|||BMI||kg/m^2|Mean|20.78|20.78|Standard Deviation|2.60|2.6|||
4299754|NCT00517556|4126671|B2|||BMI||kg/m^2|Mean|20.36|20.36|Standard Deviation|1.77|1.77|||
4299755|NCT00517556|4126672|B1|||BMI||kg/m^2|Mean|21.20|21.2|Standard Deviation|3.23|3.23|||
4299756|NCT00517556|4126670|B3|Croatia||Region of Enrollment||participants|Number|38|38.0||||||
4299757|NCT00517556|4126671|B2|Croatia||Region of Enrollment||participants|Number|19|19.0||||||
4299758|NCT00517556|4126672|B1|Croatia||Region of Enrollment||participants|Number|19|19.0||||||
4299759|NCT00517556|4126670|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4299760|NCT00517556|4126671|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4299761|NCT00517556|4126672|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4299762|NCT00517556|4126670|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4299763|NCT00517556|4126671|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4299764|NCT00517556|4126672|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4299765|NCT00517556|4126670|B3|||Age||years|Mean|20.74|20.74|Standard Deviation|3.92|3.92|||
4299766|NCT00517556|4126671|B2|||Age||years|Mean|21.00|21.0|Standard Deviation|4.03|4.03|||
4299767|NCT00517556|4126672|B1|||Age||years|Mean|20.47|20.47|Standard Deviation|3.91|3.91|||
4299768|NCT00517530|4126679|B8||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4299769|NCT00517530|4126680|B7||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4299770|NCT00517530|4126681|B6||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4299771|NCT00517530|4126682|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4299772|NCT00517530|4126683|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4299773|NCT00517530|4126684|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4299774|NCT00517530|4126685|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4299775|NCT00517530|4126686|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4299776|NCT00517530|4126679|B8||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4299777|NCT00517530|4126680|B7||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4299778|NCT00517530|4126681|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4299779|NCT00517530|4126682|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4299780|NCT00517530|4126683|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4299781|NCT00517530|4126684|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4299782|NCT00517530|4126685|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4299783|NCT00517530|4126686|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4299784|NCT00517530|4126679|B8||>=65 years|Age||Participants|Count of Participants|64|64.0||||||
4299785|NCT00517530|4126680|B7||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4299786|NCT00517530|4126681|B6||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4299787|NCT00517530|4126682|B5||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4299788|NCT00517530|4126683|B4||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4299789|NCT00517530|4126684|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4299790|NCT00517530|4126685|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4299791|NCT00517530|4126686|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4299792|NCT00517530|4126679|B8||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4299793|NCT00517530|4126680|B7||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4299794|NCT00517530|4126681|B6||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4299795|NCT00517530|4126682|B5||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4299796|NCT00517530|4126683|B4||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4299797|NCT00517530|4126684|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4299798|NCT00517530|4126685|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4299799|NCT00517530|4126686|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4299800|NCT00517530|4126679|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4299801|NCT00517530|4126680|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4299802|NCT00517530|4126681|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4299803|NCT00517530|4126682|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4299804|NCT00517530|4126683|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4299805|NCT00517530|4126684|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4299806|NCT00517530|4126685|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4299807|NCT00517530|4126686|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4299808|NCT00517413|4126752|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4299809|NCT00517413|4126752|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4299810|NCT00517413|4126752|B1|||Age||Years|Mean|53.7|53.7|Standard Deviation|14.95|14.95|||
4299811|NCT00517361|4126773|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4299812|NCT00517361|4126773|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4299813|NCT00517361|4126773|B1|||Age||years|Mean|47.7|47.7|Standard Deviation|12|12.0|||
4299814|NCT00517296|4126780|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4299815|NCT00517296|4126781|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4299816|NCT00517296|4126782|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4299817|NCT00517296|4126780|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4299818|NCT00517296|4126781|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4299819|NCT00517296|4126782|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4299820|NCT00517296|4126780|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4299821|NCT00517296|4126781|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4299822|NCT00517296|4126782|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4299823|NCT00517296|4126780|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4299824|NCT00517296|4126781|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4299825|NCT00517296|4126782|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4299826|NCT00517296|4126780|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4299827|NCT00517296|4126781|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4299828|NCT00517296|4126782|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4299829|NCT00517296|4126780|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4299830|NCT00517296|4126781|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4299831|NCT00517296|4126782|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4299832|NCT00517192|4126793|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4299833|NCT00517192|4126794|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4299834|NCT00517192|4126795|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4299835|NCT00517192|4126793|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4299836|NCT00517192|4126794|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4299837|NCT00517192|4126795|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4299838|NCT00517192|4126793|B3|||Age||Years|Mean|43.6|43.6|Standard Deviation|6.1|6.1|||
4299839|NCT00517192|4126794|B2|||Age||Years|Mean|43.1|43.1|Standard Deviation|6.2|6.2|||
4299840|NCT00517192|4126795|B1|||Age||Years|Mean|44.3|44.3|Standard Deviation|6.1|6.1|||
4299841|NCT00517010|4126889|B1|||Optical coherence tomography central macular thickness|Central macular thickness for quantitative measure; qualitative measure of presence or absence of intraretinal or subretinal fluid|microns|Mean|335|335.0|Standard Deviation|67|67.0|||
4299842|NCT00517010|4126889|B1|||Best corrected visual acuity|Number of letters read correctly|logMAR best corrected visual acuity|Mean|0.58|0.58|Standard Deviation|0.26|0.26|||
4299843|NCT00517010|4126889|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4299844|NCT00517010|4126889|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4299845|NCT00517010|4126889|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4299846|NCT00517010|4126889|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4299847|NCT00517010|4126889|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4299848|NCT00516919|4126894|B1|United States||Region of Enrollment||participants|Number|79|79.0||||||
4299849|NCT00516919|4126894|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4299850|NCT00516919|4126894|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4299851|NCT00516919|4126894|B1|||Age||years|Mean|46.3|46.3|Standard Deviation|9.7|9.7|||
4299852|NCT00516919|4126894|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4299853|NCT00516919|4126894|B1||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
4299854|NCT00516919|4126894|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4299855|NCT00516906|4126901|B3|United States||Region of Enrollment||participants|Number|68|68.0||||||
4299856|NCT00516906|4126902|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
4299857|NCT00516906|4126903|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4299858|NCT00516906|4126901|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4299859|NCT00516906|4126902|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4299860|NCT00516906|4126903|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4299861|NCT00516906|4126901|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4299862|NCT00516906|4126902|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4299863|NCT00516906|4126903|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4299864|NCT00516906|4126901|B3|||Age||years|Mean|56.0|56.0|Standard Deviation|17.0|17.0|||
4299865|NCT00516906|4126902|B2|||Age||years|Mean|53.4|53.4|Standard Deviation|18.5|18.5|||
4299866|NCT00516906|4126903|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|15.1|15.1|||
4299867|NCT00516906|4126901|B3||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4299868|NCT00516906|4126902|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4299869|NCT00516906|4126903|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4299870|NCT00516906|4126901|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4299871|NCT00516906|4126902|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4299872|NCT00516906|4126903|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4299873|NCT00516906|4126901|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4299874|NCT00516906|4126902|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4299875|NCT00516906|4126903|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4299876|NCT00516893|4126914|B1|||Expanded Disability Status Score (EDSS) Score|EDSS assesses disability in 8 functional systems. An overall score ranging from 0 (normal) to 10 (death due to MS) was calculated. All participants who were dosed (n=112) had an EDSS baseline score recorded.|scores on a scale|Mean|3.66|3.66|Standard Deviation|1.817|1.817|||
4299877|NCT00516893|4126914|B1|United States||Region of Enrollment||participants|Number|113|113.0||||||
4299878|NCT00516893|4126914|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4299879|NCT00516893|4126914|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4299880|NCT00516893|4126914|B1|White||Race/Ethnicity, Customized||participants|Number|91|91.0||||||
4299881|NCT00516893|4126914|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4299882|NCT00516893|4126914|B1|Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4299883|NCT00516893|4126914|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4299884|NCT00516893|4126914|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4299885|NCT00516893|4126914|B1|≥ 56 years||Age, Customized|Protocol deviations were filed for the 2 participants >=56 years.|participants|Number|2|2.0||||||
4299886|NCT00516893|4126914|B1|≥ 50 to < 56 years||Age, Customized|Protocol deviations were filed for the 2 participants >=56 years.|participants|Number|10|10.0||||||
4299887|NCT00516893|4126914|B1|≥ 40 to < 50 years||Age, Customized|Protocol deviations were filed for the 2 participants >=56 years.|participants|Number|41|41.0||||||
4299888|NCT00516893|4126914|B1|≥ 30 to < 40 years||Age, Customized|Protocol deviations were filed for the 2 participants >=56 years.|participants|Number|43|43.0||||||
4299889|NCT00516893|4126914|B1|≥ 20 to < 30 years||Age, Customized|Protocol deviations were filed for the 2 participants >=56 years.|participants|Number|15|15.0||||||
4299890|NCT00516893|4126914|B1|≥ 18 to < 20 years||Age, Customized|Protocol deviations were filed for the 2 participants >=56 years.|participants|Number|2|2.0||||||
4299891|NCT00516893|4126914|B1|||Age||years|Mean|38.9|38.9|Standard Deviation|8.64|8.64|||
4299892|NCT00516737|4126921|B3|Multi-Racial||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4299893|NCT00516737|4126922|B2|Multi-Racial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4299894|NCT00516737|4126923|B1|Multi-Racial||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4299895|NCT00516737|4126921|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4299896|NCT00516737|4126922|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4299897|NCT00516737|4126923|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4299898|NCT00516737|4126921|B3|White||Race/Ethnicity, Customized||participants|Number|195|195.0||||||
4299899|NCT00516737|4126922|B2|White||Race/Ethnicity, Customized||participants|Number|100|100.0||||||
4299900|NCT00516737|4126923|B1|White||Race/Ethnicity, Customized||participants|Number|95|95.0||||||
4299901|NCT00516737|4126921|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4299902|NCT00516737|4126922|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4299903|NCT00516737|4126923|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4299904|NCT00516737|4126921|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4299905|NCT00516737|4126922|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4299906|NCT00516737|4126923|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4299907|NCT00516737|4126921|B3||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4299908|NCT00516737|4126922|B2||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4299909|NCT00516737|4126923|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4299910|NCT00516737|4126921|B3|||Age||years|Mean|42.5|42.5|Full Range|||18.0|69.0|
4299911|NCT00516737|4126922|B2|||Age||years|Mean|44|44.0|Full Range|||18.0|66.0|
4299912|NCT00516737|4126923|B1|||Age||years|Mean|41|41.0|Full Range|||19.0|69.0|
4299913|NCT00516503|4126942|B3|United States||Region of Enrollment||participants|Number|203|203.0||||||
4299914|NCT00516503|4126943|B2|United States||Region of Enrollment||participants|Number|102|102.0||||||
4299915|NCT00516503|4126944|B1|United States||Region of Enrollment||participants|Number|101|101.0||||||
4299916|NCT00516503|4126942|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4299917|NCT00516503|4126943|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4299918|NCT00516503|4126944|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4299919|NCT00516503|4126942|B3||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4299920|NCT00516503|4126943|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4299921|NCT00516503|4126944|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4299922|NCT00516503|4126942|B3|||Age||years|Median|61|61.0|Full Range|||31.0|86.0|
4299923|NCT00516503|4126943|B2|||Age||years|Median|62|62.0|Full Range|||31.0|86.0|
4299924|NCT00516503|4126944|B1|||Age||years|Median|59.5|59.5|Full Range|||41.0|83.0|
4299925|NCT00516386|4126963|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4299926|NCT00516386|4126963|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4299927|NCT00516386|4126963|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4299928|NCT00516386|4126963|B1|||Age||years|Mean|16.2|16.2|Standard Deviation|0.5|0.5|||
4299929|NCT00516386|4126963|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4299930|NCT00516386|4126963|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4299931|NCT00516386|4126963|B1||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4299932|NCT00516321|4126968|B3|||Baseline Platelet Count|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. Platelet count eligibility was confirmed at the Baseline visit, prior to administration of eltrombopag, and was defined as the average of the screening and baseline counts, which must be <75 Gi/L.|Giga (10^9) cells per liter (Gi/L)|Mean|57.05|57.05|Standard Deviation|13.357|13.357|||
4299933|NCT00516321|4126969|B2|||Baseline Platelet Count|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. Platelet count eligibility was confirmed at the Baseline visit, prior to administration of eltrombopag, and was defined as the average of the screening and baseline counts, which must be <75 Gi/L.|Giga (10^9) cells per liter (Gi/L)|Mean|56.87|56.87|Standard Deviation|13.603|13.603|||
4299934|NCT00516321|4126970|B1|||Baseline Platelet Count|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. Platelet count eligibility was confirmed at the Baseline visit, prior to administration of eltrombopag, and was defined as the average of the screening and baseline counts, which must be <75 Gi/L.|Giga (10^9) cells per liter (Gi/L)|Mean|57.40|57.4|Standard Deviation|12.890|12.89|||
4299935|NCT00516321|4126968|B3|||Baseline HCV Ribonucleic Acid (RNA)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. HCV RNA was assessed at baseline of the DB Phase. Data are missing for one participant in the Eltrombopag+Antiviral Therapy treatment group.|International Units per milliliter|Mean|1873862.8|1873862.8|Standard Deviation|3188864.74|3188864.74|||
4299936|NCT00516321|4126969|B2|||Baseline HCV Ribonucleic Acid (RNA)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. HCV RNA was assessed at baseline of the DB Phase. Data are missing for one participant in the Eltrombopag+Antiviral Therapy treatment group.|International Units per milliliter|Mean|1870562.1|1870562.1|Standard Deviation|3080918.03|3080918.03|||
4299937|NCT00516321|4126970|B1|||Baseline HCV Ribonucleic Acid (RNA)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. HCV RNA was assessed at baseline of the DB Phase. Data are missing for one participant in the Eltrombopag+Antiviral Therapy treatment group.|International Units per milliliter|Mean|1880278.4|1880278.4|Standard Deviation|3395777.02|3395777.02|||
4299938|NCT00516321|4126968|B3|Elevated||Number of participants with normal or elevated Baseline values for Alanine Aminotransferase (ALT)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The normal range of ALT is 0 to 48 International Units per Liter (IU/L).|participants|Number|525|525.0||||||
4299939|NCT00516321|4126969|B2|Elevated||Number of participants with normal or elevated Baseline values for Alanine Aminotransferase (ALT)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The normal range of ALT is 0 to 48 International Units per Liter (IU/L).|participants|Number|347|347.0||||||
4299940|NCT00516321|4126970|B1|Elevated||Number of participants with normal or elevated Baseline values for Alanine Aminotransferase (ALT)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The normal range of ALT is 0 to 48 International Units per Liter (IU/L).|participants|Number|178|178.0||||||
4299941|NCT00516321|4126968|B3|Normal||Number of participants with normal or elevated Baseline values for Alanine Aminotransferase (ALT)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The normal range of ALT is 0 to 48 International Units per Liter (IU/L).|participants|Number|157|157.0||||||
4299942|NCT00516321|4126969|B2|Normal||Number of participants with normal or elevated Baseline values for Alanine Aminotransferase (ALT)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The normal range of ALT is 0 to 48 International Units per Liter (IU/L).|participants|Number|103|103.0||||||
4299943|NCT00516321|4126970|B1|Normal||Number of participants with normal or elevated Baseline values for Alanine Aminotransferase (ALT)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The normal range of ALT is 0 to 48 International Units per Liter (IU/L).|participants|Number|54|54.0||||||
4299944|NCT00516321|4126968|B3|Missing||Number of participants with the indicated FibroTest/Acti Test (FibroSURE) score|FibroSURE is a noninvasive blood test that combines the quantitative results of 6 serum biochemical markers (α2-macroglobulin, haptoglobin, apolipoprotein A1, bilirubin, γ-glutamyl transpeptidase [GGT], and ALT) with a participant’s age and gender to generate a measure of liver fibrosis/cirrhosis and necroinflammatory activity. It provides a numerical quantitative estimate of liver fibrosis ranging from 0.00 to 1.00, corresponding to the Metavir scoring system of stages F0 to F4 (F0, no fibrosis [F]; F1, portal F; F2, bridging F with few septa; F3, bridging F with many septa; F4=cirrhosis).|participants|Number|83|83.0||||||
4300051|NCT00516295|4127023|B1|Male||Gender||participants|Number|5|5.0||||||
4299945|NCT00516321|4126969|B2|Missing||Number of participants with the indicated FibroTest/Acti Test (FibroSURE) score|FibroSURE is a noninvasive blood test that combines the quantitative results of 6 serum biochemical markers (α2-macroglobulin, haptoglobin, apolipoprotein A1, bilirubin, γ-glutamyl transpeptidase [GGT], and ALT) with a participant’s age and gender to generate a measure of liver fibrosis/cirrhosis and necroinflammatory activity. It provides a numerical quantitative estimate of liver fibrosis ranging from 0.00 to 1.00, corresponding to the Metavir scoring system of stages F0 to F4 (F0, no fibrosis [F]; F1, portal F; F2, bridging F with few septa; F3, bridging F with many septa; F4=cirrhosis).|participants|Number|59|59.0||||||
4299946|NCT00516321|4126970|B1|Missing||Number of participants with the indicated FibroTest/Acti Test (FibroSURE) score|FibroSURE is a noninvasive blood test that combines the quantitative results of 6 serum biochemical markers (α2-macroglobulin, haptoglobin, apolipoprotein A1, bilirubin, γ-glutamyl transpeptidase [GGT], and ALT) with a participant’s age and gender to generate a measure of liver fibrosis/cirrhosis and necroinflammatory activity. It provides a numerical quantitative estimate of liver fibrosis ranging from 0.00 to 1.00, corresponding to the Metavir scoring system of stages F0 to F4 (F0, no fibrosis [F]; F1, portal F; F2, bridging F with few septa; F3, bridging F with many septa; F4=cirrhosis).|participants|Number|24|24.0||||||
4299947|NCT00516321|4126968|B3|Score: F3/F4||Number of participants with the indicated FibroTest/Acti Test (FibroSURE) score|FibroSURE is a noninvasive blood test that combines the quantitative results of 6 serum biochemical markers (α2-macroglobulin, haptoglobin, apolipoprotein A1, bilirubin, γ-glutamyl transpeptidase [GGT], and ALT) with a participant’s age and gender to generate a measure of liver fibrosis/cirrhosis and necroinflammatory activity. It provides a numerical quantitative estimate of liver fibrosis ranging from 0.00 to 1.00, corresponding to the Metavir scoring system of stages F0 to F4 (F0, no fibrosis [F]; F1, portal F; F2, bridging F with few septa; F3, bridging F with many septa; F4=cirrhosis).|participants|Number|539|539.0||||||
4299948|NCT00516321|4126969|B2|Score: F3/F4||Number of participants with the indicated FibroTest/Acti Test (FibroSURE) score|FibroSURE is a noninvasive blood test that combines the quantitative results of 6 serum biochemical markers (α2-macroglobulin, haptoglobin, apolipoprotein A1, bilirubin, γ-glutamyl transpeptidase [GGT], and ALT) with a participant’s age and gender to generate a measure of liver fibrosis/cirrhosis and necroinflammatory activity. It provides a numerical quantitative estimate of liver fibrosis ranging from 0.00 to 1.00, corresponding to the Metavir scoring system of stages F0 to F4 (F0, no fibrosis [F]; F1, portal F; F2, bridging F with few septa; F3, bridging F with many septa; F4=cirrhosis).|participants|Number|354|354.0||||||
4299949|NCT00516321|4126970|B1|Score: F3/F4||Number of participants with the indicated FibroTest/Acti Test (FibroSURE) score|FibroSURE is a noninvasive blood test that combines the quantitative results of 6 serum biochemical markers (α2-macroglobulin, haptoglobin, apolipoprotein A1, bilirubin, γ-glutamyl transpeptidase [GGT], and ALT) with a participant’s age and gender to generate a measure of liver fibrosis/cirrhosis and necroinflammatory activity. It provides a numerical quantitative estimate of liver fibrosis ranging from 0.00 to 1.00, corresponding to the Metavir scoring system of stages F0 to F4 (F0, no fibrosis [F]; F1, portal F; F2, bridging F with few septa; F3, bridging F with many septa; F4=cirrhosis).|participants|Number|185|185.0||||||
4299950|NCT00516321|4126968|B3|Score: F0/F1/F2||Number of participants with the indicated FibroTest/Acti Test (FibroSURE) score|FibroSURE is a noninvasive blood test that combines the quantitative results of 6 serum biochemical markers (α2-macroglobulin, haptoglobin, apolipoprotein A1, bilirubin, γ-glutamyl transpeptidase [GGT], and ALT) with a participant’s age and gender to generate a measure of liver fibrosis/cirrhosis and necroinflammatory activity. It provides a numerical quantitative estimate of liver fibrosis ranging from 0.00 to 1.00, corresponding to the Metavir scoring system of stages F0 to F4 (F0, no fibrosis [F]; F1, portal F; F2, bridging F with few septa; F3, bridging F with many septa; F4=cirrhosis).|participants|Number|60|60.0||||||
4299951|NCT00516321|4126969|B2|Score: F0/F1/F2||Number of participants with the indicated FibroTest/Acti Test (FibroSURE) score|FibroSURE is a noninvasive blood test that combines the quantitative results of 6 serum biochemical markers (α2-macroglobulin, haptoglobin, apolipoprotein A1, bilirubin, γ-glutamyl transpeptidase [GGT], and ALT) with a participant’s age and gender to generate a measure of liver fibrosis/cirrhosis and necroinflammatory activity. It provides a numerical quantitative estimate of liver fibrosis ranging from 0.00 to 1.00, corresponding to the Metavir scoring system of stages F0 to F4 (F0, no fibrosis [F]; F1, portal F; F2, bridging F with few septa; F3, bridging F with many septa; F4=cirrhosis).|participants|Number|37|37.0||||||
4299952|NCT00516321|4126970|B1|Score: F0/F1/F2||Number of participants with the indicated FibroTest/Acti Test (FibroSURE) score|FibroSURE is a noninvasive blood test that combines the quantitative results of 6 serum biochemical markers (α2-macroglobulin, haptoglobin, apolipoprotein A1, bilirubin, γ-glutamyl transpeptidase [GGT], and ALT) with a participant’s age and gender to generate a measure of liver fibrosis/cirrhosis and necroinflammatory activity. It provides a numerical quantitative estimate of liver fibrosis ranging from 0.00 to 1.00, corresponding to the Metavir scoring system of stages F0 to F4 (F0, no fibrosis [F]; F1, portal F; F2, bridging F with few septa; F3, bridging F with many septa; F4=cirrhosis).|participants|Number|23|23.0||||||
4299953|NCT00516321|4126968|B3|Experienced||Number of participants with or without previous interferon (IFN) use|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. Participants at Baseline were classified as not having used IFN previously (Naïve) or having used IFN previously (Experienced).|participants|Number|223|223.0||||||
4299954|NCT00516321|4126969|B2|Experienced||Number of participants with or without previous interferon (IFN) use|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. Participants at Baseline were classified as not having used IFN previously (Naïve) or having used IFN previously (Experienced).|participants|Number|143|143.0||||||
4299955|NCT00516321|4126970|B1|Experienced||Number of participants with or without previous interferon (IFN) use|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. Participants at Baseline were classified as not having used IFN previously (Naïve) or having used IFN previously (Experienced).|participants|Number|80|80.0||||||
4299956|NCT00516321|4126968|B3|Naïve||Number of participants with or without previous interferon (IFN) use|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. Participants at Baseline were classified as not having used IFN previously (Naïve) or having used IFN previously (Experienced).|participants|Number|459|459.0||||||
4299957|NCT00516321|4126969|B2|Naïve||Number of participants with or without previous interferon (IFN) use|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. Participants at Baseline were classified as not having used IFN previously (Naïve) or having used IFN previously (Experienced).|participants|Number|307|307.0||||||
4299958|NCT00516321|4126970|B1|Naïve||Number of participants with or without previous interferon (IFN) use|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. Participants at Baseline were classified as not having used IFN previously (Naïve) or having used IFN previously (Experienced).|participants|Number|152|152.0||||||
4299959|NCT00516321|4126968|B3|Missing Data||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15, with 5 being mild and 15 being severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess the severity of liver disease. A CP score of 5-6 = Class A (mild); 7-9 = Class B (moderate); >=10 = Class C (severe).|participants|Number|1|1.0||||||
4299960|NCT00516321|4126969|B2|Missing Data||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15, with 5 being mild and 15 being severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess the severity of liver disease. A CP score of 5-6 = Class A (mild); 7-9 = Class B (moderate); >=10 = Class C (severe).|participants|Number|1|1.0||||||
4299961|NCT00516321|4126970|B1|Missing Data||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15, with 5 being mild and 15 being severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess the severity of liver disease. A CP score of 5-6 = Class A (mild); 7-9 = Class B (moderate); >=10 = Class C (severe).|participants|Number|0|0.0||||||
4299962|NCT00516321|4126968|B3|Class C||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15, with 5 being mild and 15 being severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess the severity of liver disease. A CP score of 5-6 = Class A (mild); 7-9 = Class B (moderate); >=10 = Class C (severe).|participants|Number|0|0.0||||||
4299963|NCT00516321|4126969|B2|Class C||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15, with 5 being mild and 15 being severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess the severity of liver disease. A CP score of 5-6 = Class A (mild); 7-9 = Class B (moderate); >=10 = Class C (severe).|participants|Number|0|0.0||||||
4299964|NCT00516321|4126970|B1|Class C||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15, with 5 being mild and 15 being severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess the severity of liver disease. A CP score of 5-6 = Class A (mild); 7-9 = Class B (moderate); >=10 = Class C (severe).|participants|Number|0|0.0||||||
4299965|NCT00516321|4126968|B3|Class B||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15, with 5 being mild and 15 being severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess the severity of liver disease. A CP score of 5-6 = Class A (mild); 7-9 = Class B (moderate); >=10 = Class C (severe).|participants|Number|40|40.0||||||
4299966|NCT00516321|4126969|B2|Class B||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15, with 5 being mild and 15 being severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess the severity of liver disease. A CP score of 5-6 = Class A (mild); 7-9 = Class B (moderate); >=10 = Class C (severe).|participants|Number|25|25.0||||||
4299967|NCT00516321|4126970|B1|Class B||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15, with 5 being mild and 15 being severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess the severity of liver disease. A CP score of 5-6 = Class A (mild); 7-9 = Class B (moderate); >=10 = Class C (severe).|participants|Number|15|15.0||||||
4299968|NCT00516321|4126968|B3|Class A||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15, with 5 being mild and 15 being severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess the severity of liver disease. A CP score of 5-6 = Class A (mild); 7-9 = Class B (moderate); >=10 = Class C (severe).|participants|Number|641|641.0||||||
4299969|NCT00516321|4126969|B2|Class A||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15, with 5 being mild and 15 being severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess the severity of liver disease. A CP score of 5-6 = Class A (mild); 7-9 = Class B (moderate); >=10 = Class C (severe).|participants|Number|424|424.0||||||
4299970|NCT00516321|4126970|B1|Class A||Number of participants categorized into the indicated Child-Pugh (CP) Class|The CP score (ranging from 5 to 15, with 5 being mild and 15 being severe), calculated based on total bilirubin, serum albumin, international normalized ratio, ascites, and hepatic encephalopathy, is used to assess the severity of liver disease. A CP score of 5-6 = Class A (mild); 7-9 = Class B (moderate); >=10 = Class C (severe).|participants|Number|217|217.0||||||
4299971|NCT00516321|4126968|B3|Missing Data||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|1|1.0||||||
4299972|NCT00516321|4126969|B2|Missing Data||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|1|1.0||||||
4299973|NCT00516321|4126970|B1|Missing Data||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|0|0.0||||||
4299974|NCT00516321|4126968|B3|Genotype 7||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|0|0.0||||||
4299975|NCT00516321|4126969|B2|Genotype 7||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|0|0.0||||||
4299976|NCT00516321|4126970|B1|Genotype 7||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|0|0.0||||||
4299977|NCT00516321|4126968|B3|Genotype 6||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|6|6.0||||||
4299978|NCT00516321|4126969|B2|Genotype 6||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|4|4.0||||||
4299979|NCT00516321|4126970|B1|Genotype 6||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|2|2.0||||||
4299980|NCT00516321|4126968|B3|Genotype 5||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|0|0.0||||||
4299981|NCT00516321|4126969|B2|Genotype 5||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|0|0.0||||||
4299982|NCT00516321|4126970|B1|Genotype 5||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|0|0.0||||||
4299983|NCT00516321|4126968|B3|Genotype 4||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|16|16.0||||||
4299984|NCT00516321|4126969|B2|Genotype 4||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|11|11.0||||||
4299985|NCT00516321|4126970|B1|Genotype 4||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|5|5.0||||||
4299986|NCT00516321|4126968|B3|Genotype 3||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|169|169.0||||||
4299987|NCT00516321|4126969|B2|Genotype 3||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|115|115.0||||||
4300010|NCT00516321|4126968|B3|Central/South Asian Heritage||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|53|53.0||||||
4299988|NCT00516321|4126970|B1|Genotype 3||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|54|54.0||||||
4299989|NCT00516321|4126968|B3|Genotype 2||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|49|49.0||||||
4299990|NCT00516321|4126969|B2|Genotype 2||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|27|27.0||||||
4299991|NCT00516321|4126970|B1|Genotype 2||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|22|22.0||||||
4299992|NCT00516321|4126968|B3|Genotype 1||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|441|441.0||||||
4299993|NCT00516321|4126969|B2|Genotype 1||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|292|292.0||||||
4299994|NCT00516321|4126970|B1|Genotype 1||Number of participants categorized into the indicated genotype for Hepatitic C Virus (HCV)|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study. The HCV is a small, enveloped, single-stranded, positive-sense ribonucleic acid (RNA) virus. There are seven major genotypes of HCV, which are indicated numerically from Genotype 1 to 7.|participants|Number|149|149.0||||||
4299995|NCT00516321|4126968|B3|Native Hawaiian/ Other Pacific Islander and White||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|1|1.0||||||
4299996|NCT00516321|4126969|B2|Native Hawaiian/ Other Pacific Islander and White||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|1|1.0||||||
4299997|NCT00516321|4126970|B1|Native Hawaiian/ Other Pacific Islander and White||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|0|0.0||||||
4299998|NCT00516321|4126968|B3|Asian and White||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|1|1.0||||||
4299999|NCT00516321|4126969|B2|Asian and White||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|1|1.0||||||
4300000|NCT00516321|4126970|B1|Asian and White||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|0|0.0||||||
4300001|NCT00516321|4126968|B3|White||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|492|492.0||||||
4300002|NCT00516321|4126969|B2|White||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|326|326.0||||||
4300003|NCT00516321|4126970|B1|White||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|166|166.0||||||
4300004|NCT00516321|4126968|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|1|1.0||||||
4300005|NCT00516321|4126969|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|1|1.0||||||
4300006|NCT00516321|4126970|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|0|0.0||||||
4300007|NCT00516321|4126968|B3|Japanese/East Asian Heritage/South East Asian||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|111|111.0||||||
4300008|NCT00516321|4126969|B2|Japanese/East Asian Heritage/South East Asian||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|68|68.0||||||
4300009|NCT00516321|4126970|B1|Japanese/East Asian Heritage/South East Asian||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|43|43.0||||||
4300011|NCT00516321|4126969|B2|Central/South Asian Heritage||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|39|39.0||||||
4300012|NCT00516321|4126970|B1|Central/South Asian Heritage||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|14|14.0||||||
4300013|NCT00516321|4126968|B3|American Indian/Alaska Native||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|5|5.0||||||
4300014|NCT00516321|4126969|B2|American Indian/Alaska Native||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|2|2.0||||||
4300015|NCT00516321|4126970|B1|American Indian/Alaska Native||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|3|3.0||||||
4300016|NCT00516321|4126968|B3|African American/African Heritage||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|18|18.0||||||
4300017|NCT00516321|4126969|B2|African American/African Heritage||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|12|12.0||||||
4300018|NCT00516321|4126970|B1|African American/African Heritage||Race/Ethnicity, Customized|Baseline characteristics were collected for the ITT Population, which included all randomized participants in the DB Phase of the study.|participants|Number|6|6.0||||||
4300019|NCT00516321|4126968|B3||Male|Sex: Female, Male|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all randomized participants in the Double-blind (DB) Phase of the study.|Participants|Count of Participants|423|423.0||||||
4300020|NCT00516321|4126969|B2||Male|Sex: Female, Male|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all randomized participants in the Double-blind (DB) Phase of the study.|Participants|Count of Participants|264|264.0||||||
4300021|NCT00516321|4126970|B1||Male|Sex: Female, Male|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all randomized participants in the Double-blind (DB) Phase of the study.|Participants|Count of Participants|159|159.0||||||
4300022|NCT00516321|4126968|B3||Female|Sex: Female, Male|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all randomized participants in the Double-blind (DB) Phase of the study.|Participants|Count of Participants|259|259.0||||||
4300023|NCT00516321|4126969|B2||Female|Sex: Female, Male|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all randomized participants in the Double-blind (DB) Phase of the study.|Participants|Count of Participants|186|186.0||||||
4300024|NCT00516321|4126970|B1||Female|Sex: Female, Male|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all randomized participants in the Double-blind (DB) Phase of the study.|Participants|Count of Participants|73|73.0||||||
4300025|NCT00516321|4126968|B3|Years||Age|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all randomized participants in the Double-blind (DB) Phase of the study.|Years|Mean|51.9|51.9|Standard Deviation|8.41|8.41|||
4300026|NCT00516321|4126969|B2|Years||Age|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all randomized participants in the Double-blind (DB) Phase of the study.|Years|Mean|52.1|52.1|Standard Deviation|8.35|8.35|||
4300027|NCT00516321|4126970|B1|Years||Age|Baseline characteristics were collected for the Intent-to-Treat (ITT) Population, which included all randomized participants in the Double-blind (DB) Phase of the study.|Years|Mean|51.4|51.4|Standard Deviation|8.52|8.52|||
4300028|NCT00516295|4127020|B4|United States||Region of Enrollment||participants|Number|7|7.0||||||
4300029|NCT00516295|4127023|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4300030|NCT00516295|4127020|B4|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
4300031|NCT00516295|4127023|B1|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
4300032|NCT00516295|4127020|B4|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|5|5.0||||||
4300033|NCT00516295|4127023|B1|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|5|5.0||||||
4300034|NCT00516295|4127020|B4|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|2|2.0||||||
4300035|NCT00516295|4127023|B1|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|2|2.0||||||
4300036|NCT00516295|4127020|B4|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|1|1.0||||||
4300037|NCT00516295|4127023|B1|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|1|1.0||||||
4300038|NCT00516295|4127020|B4|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4300039|NCT00516295|4127023|B1|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4300040|NCT00516295|4127020|B4|White||Race (NIH/OMB)||participants|Number|6|6.0||||||
4300041|NCT00516295|4127023|B1|White||Race (NIH/OMB)||participants|Number|6|6.0||||||
4300042|NCT00516295|4127020|B4|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
4300043|NCT00516295|4127023|B1|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
4300044|NCT00516295|4127020|B4|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4300045|NCT00516295|4127023|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4300046|NCT00516295|4127020|B4|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
4300047|NCT00516295|4127023|B1|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
4300048|NCT00516295|4127020|B4|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
4300049|NCT00516295|4127023|B1|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
4300050|NCT00516295|4127020|B4|Male||Gender||participants|Number|5|5.0||||||
4300052|NCT00516295|4127020|B4|Female||Gender||participants|Number|2|2.0||||||
4300053|NCT00516295|4127023|B1|Female||Gender||participants|Number|2|2.0||||||
4300054|NCT00516295|4127020|B4|||Age||years|Median|15|15.0|Full Range|||12.0|20.0|
4300055|NCT00516295|4127023|B1|||Age||years|Median|15|15.0|Full Range|||12.0|20.0|
4300056|NCT00516269|4127036|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
4300057|NCT00516269|4127037|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4300058|NCT00516269|4127038|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4300059|NCT00516269|4127036|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4300060|NCT00516269|4127037|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4300061|NCT00516269|4127038|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4300062|NCT00516269|4127036|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4300063|NCT00516269|4127037|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4300064|NCT00516269|4127038|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4300065|NCT00516269|4127036|B3|||Age||years|Mean|52.35|52.35|Standard Deviation|9.88|9.88|||
4300066|NCT00516269|4127037|B2|||Age||years|Mean|51.52|51.52|Standard Deviation|7.83|7.83|||
4300067|NCT00516269|4127038|B1|||Age||years|Mean|53.26|53.26|Standard Deviation|11.95|11.95|||
4300068|NCT00516269|4127036|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4300069|NCT00516269|4127037|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4300070|NCT00516269|4127038|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4300071|NCT00516269|4127036|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4300072|NCT00516269|4127037|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4300073|NCT00516269|4127038|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4300074|NCT00516269|4127036|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300075|NCT00516269|4127037|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300076|NCT00516269|4127038|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300077|NCT00516217|4127045|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4300078|NCT00516217|4127045|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4300079|NCT00516217|4127045|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4300080|NCT00516217|4127045|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4300081|NCT00516217|4127045|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4300082|NCT00516217|4127045|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4300083|NCT00516217|4127045|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4300084|NCT00516217|4127045|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4300085|NCT00516217|4127045|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4300086|NCT00516217|4127045|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4300087|NCT00516217|4127045|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4300088|NCT00516217|4127045|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4300089|NCT00516217|4127045|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4300090|NCT00516217|4127045|B1|||Age||years|Median|36|36.0|Full Range|||22.0|70.0|
4300091|NCT00516165|4127051|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4300092|NCT00516165|4127051|B1||Male|Gender||Participants|Count of Participants|18|18.0||||||
4300093|NCT00516165|4127051|B1||Female|Gender||Participants|Count of Participants|10|10.0||||||
4300094|NCT00516165|4127051|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4300095|NCT00516165|4127051|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4300096|NCT00516165|4127051|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300097|NCT00516165|4127051|B1|||Age||years|Median|65|65.0|Full Range|||33.0|81.0|
4300098|NCT00516139|4127060|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|Baseline characteristics were collected for the Safety Population, which included all participants who were enrolled and took at least one dose of the study drug. One participant enrolled in the study did not take at least one dose of the study drug. Participants are allowed to select more than one race.|participants|Number|105|105.0||||||
4300099|NCT00516139|4127060|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized|Baseline characteristics were collected for the Safety Population, which included all participants who were enrolled and took at least one dose of the study drug. One participant enrolled in the study did not take at least one dose of the study drug. Participants are allowed to select more than one race.|participants|Number|1|1.0||||||
4300100|NCT00516139|4127060|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Baseline characteristics were collected for the Safety Population, which included all participants who were enrolled and took at least one dose of the study drug. One participant enrolled in the study did not take at least one dose of the study drug. Participants are allowed to select more than one race.|participants|Number|2|2.0||||||
4300101|NCT00516139|4127060|B1|African American/African Heritage||Race/Ethnicity, Customized|Baseline characteristics were collected for the Safety Population, which included all participants who were enrolled and took at least one dose of the study drug. One participant enrolled in the study did not take at least one dose of the study drug. Participants are allowed to select more than one race.|participants|Number|14|14.0||||||
4300159|NCT00515879|4127126|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300160|NCT00515879|4127127|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300102|NCT00516139|4127060|B1||Male|Gender|Baseline characteristics were collected for the Safety Population, which included all participants who were enrolled and took at least one dose of the study drug. One participant enrolled in the study did not take at least one dose of the study drug.|Participants|Count of Participants|62|62.0||||||
4300103|NCT00516139|4127060|B1||Female|Gender|Baseline characteristics were collected for the Safety Population, which included all participants who were enrolled and took at least one dose of the study drug. One participant enrolled in the study did not take at least one dose of the study drug.|Participants|Count of Participants|59|59.0||||||
4300104|NCT00516139|4127060|B1|||Age|Baseline characteristics were collected for the Safety Population, which included all participants who were enrolled and took at least one dose of the study drug. One participant enrolled in the study did not take at least one dose of the study drug.|Years|Mean|72.5|72.5|Standard Deviation|5.53|5.53|||
4300105|NCT00516074|4127089|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4300106|NCT00516074|4127090|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4300107|NCT00516074|4127091|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4300108|NCT00516074|4127089|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4300109|NCT00516074|4127090|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4300110|NCT00516074|4127091|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4300111|NCT00516074|4127089|B3|||Age||years|Mean|55.43|55.43|Standard Deviation|10.51|10.51|||
4300112|NCT00516074|4127090|B2|||Age||years|Mean|54.14|54.14|Standard Deviation|10.13|10.13|||
4300113|NCT00516074|4127091|B1|||Age||years|Mean|56.62|56.62|Standard Deviation|10.90|10.9|||
4300114|NCT00516074|4127089|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4300115|NCT00516074|4127090|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4300116|NCT00516074|4127091|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4300117|NCT00516074|4127089|B3||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4300118|NCT00516074|4127090|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4300119|NCT00516074|4127091|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4300120|NCT00516074|4127089|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300121|NCT00516074|4127090|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300122|NCT00516074|4127091|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300123|NCT00516048|4127108|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4300124|NCT00516048|4127109|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4300125|NCT00516048|4127110|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4300126|NCT00516048|4127108|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4300127|NCT00516048|4127109|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4300128|NCT00516048|4127110|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4300129|NCT00516048|4127108|B3|||Age||years|Mean|59.17|59.17|Standard Deviation|9.74|9.74|||
4300130|NCT00516048|4127109|B2|||Age||years|Mean|49.88|49.88|Standard Deviation|9.84|9.84|||
4300131|NCT00516048|4127110|B1|||Age||years|Mean|60.65|60.65|Standard Deviation|8.95|8.95|||
4300132|NCT00516048|4127108|B3||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4300133|NCT00516048|4127109|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4300134|NCT00516048|4127110|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4300135|NCT00516048|4127108|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4300136|NCT00516048|4127109|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4300137|NCT00516048|4127110|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4300138|NCT00516048|4127108|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300139|NCT00516048|4127109|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300140|NCT00516048|4127110|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300141|NCT00515879|4127126|B3|United States||Region of Enrollment||participants|Number|169|169.0||||||
4300142|NCT00515879|4127127|B2|United States||Region of Enrollment||participants|Number|82|82.0||||||
4300143|NCT00515879|4127128|B1|United States||Region of Enrollment||participants|Number|87|87.0||||||
4300144|NCT00515879|4127126|B3||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4300145|NCT00515879|4127127|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4300146|NCT00515879|4127128|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4300147|NCT00515879|4127126|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4300148|NCT00515879|4127127|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4300149|NCT00515879|4127128|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4300150|NCT00515879|4127126|B3|||Age||years|Mean|32.55|32.55|Standard Deviation|8.41|8.41|||
4300151|NCT00515879|4127127|B2|||Age||years|Mean|30.5|30.5|Standard Deviation|8.9|8.9|||
4300152|NCT00515879|4127128|B1|||Age||years|Mean|34.6|34.6|Standard Deviation|7.89|7.89|||
4300153|NCT00515879|4127126|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4300154|NCT00515879|4127127|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4300155|NCT00515879|4127128|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4300156|NCT00515879|4127126|B3||Between 18 and 65 years|Age||Participants|Count of Participants|169|169.0||||||
4300157|NCT00515879|4127127|B2||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
4300158|NCT00515879|4127128|B1||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
4300161|NCT00515879|4127128|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300162|NCT00515827|4127137|B3|United States||Region of Enrollment||participants|Number|53|53.0||||||
4300163|NCT00515827|4127138|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4300164|NCT00515827|4127139|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4300165|NCT00515827|4127137|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4300166|NCT00515827|4127138|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4300167|NCT00515827|4127139|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4300168|NCT00515827|4127137|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4300169|NCT00515827|4127138|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4300170|NCT00515827|4127139|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4300171|NCT00515827|4127137|B3|||Age||years|Mean|49|49.0|Standard Deviation|8|8.0|||
4300172|NCT00515827|4127138|B2|||Age||years|Mean|49|49.0|Standard Deviation|11|11.0|||
4300173|NCT00515827|4127139|B1|||Age||years|Mean|50|50.0|Standard Deviation|7|7.0|||
4300174|NCT00515827|4127137|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4300175|NCT00515827|4127138|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4300176|NCT00515827|4127139|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4300177|NCT00515827|4127137|B3||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4300178|NCT00515827|4127138|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4300179|NCT00515827|4127139|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4300180|NCT00515827|4127137|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300181|NCT00515827|4127138|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300182|NCT00515827|4127139|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300183|NCT00515697|4127162|B1|Not Hispanic or Latino||Ethnicity||participants|Number|38|38.0||||||
4300184|NCT00515697|4127162|B1|Hispanic or Latino||Ethnicity||participants|Number|1|1.0||||||
4300185|NCT00515697|4127162|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4300186|NCT00515697|4127162|B1|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4300187|NCT00515697|4127162|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4300188|NCT00515697|4127162|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4300189|NCT00515697|4127162|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4300190|NCT00515697|4127162|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4300191|NCT00515697|4127162|B1|White||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4300192|NCT00515697|4127162|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4300193|NCT00515697|4127162|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4300194|NCT00515697|4127162|B1|>=65 years||Age, Customized||participants|Number|12|12.0||||||
4300195|NCT00515697|4127162|B1|Between 18 and 65 years||Age, Customized||participants|Number|27|27.0||||||
4300196|NCT00515671|4127173|B3|United States||Region of Enrollment||participants|Number|118|118.0||||||
4300197|NCT00515671|4127174|B2|United States||Region of Enrollment||participants|Number|58|58.0||||||
4300198|NCT00515671|4127175|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4300199|NCT00515671|4127173|B3|More than one||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4300200|NCT00515671|4127174|B2|More than one||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4300201|NCT00515671|4127175|B1|More than one||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4300202|NCT00515671|4127173|B3|African American||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
4300203|NCT00515671|4127174|B2|African American||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4300204|NCT00515671|4127175|B1|African American||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4300205|NCT00515671|4127173|B3|white||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4300206|NCT00515671|4127174|B2|white||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4300207|NCT00515671|4127175|B1|white||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4300208|NCT00515671|4127173|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4300209|NCT00515671|4127174|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4300210|NCT00515671|4127175|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4300211|NCT00515671|4127173|B3||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4300212|NCT00515671|4127174|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4300213|NCT00515671|4127175|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4300214|NCT00515671|4127173|B3|||Age||years|Mean|47.7|47.7|Standard Deviation|8.9|8.9|||
4300215|NCT00515671|4127174|B2|||Age||years|Mean|47.6|47.6|Standard Deviation|8.5|8.5|||
4300216|NCT00515671|4127175|B1|||Age||years|Mean|47.7|47.7|Standard Deviation|9.3|9.3|||
4300217|NCT00515619|4127184|B1|Sweden||Region of Enrollment||participants|Number|16|16.0||||||
4300218|NCT00515619|4127184|B1|Germany||Region of Enrollment||participants|Number|35|35.0||||||
4300219|NCT00515619|4127184|B1|Australia||Region of Enrollment||participants|Number|31|31.0||||||
4300220|NCT00515619|4127184|B1|Croatia||Region of Enrollment||participants|Number|31|31.0||||||
4300221|NCT00515619|4127184|B1|Poland||Region of Enrollment||participants|Number|37|37.0||||||
4300222|NCT00515619|4127184|B1|Hungary||Region of Enrollment||participants|Number|31|31.0||||||
4300223|NCT00515619|4127184|B1|Czech Republic||Region of Enrollment||participants|Number|50|50.0||||||
4300224|NCT00515619|4127184|B1|France||Region of Enrollment||participants|Number|10|10.0||||||
4300225|NCT00515619|4127184|B1|United Kingdom||Region of Enrollment||participants|Number|20|20.0||||||
4300226|NCT00515619|4127184|B1|Russian Federation||Region of Enrollment||participants|Number|31|31.0||||||
4300227|NCT00515619|4127184|B1|Lithuania||Region of Enrollment||participants|Number|42|42.0||||||
4300228|NCT00515619|4127184|B1|Spain||Region of Enrollment||participants|Number|26|26.0||||||
4300229|NCT00515619|4127184|B1|Finland||Region of Enrollment||participants|Number|16|16.0||||||
4300230|NCT00515619|4127184|B1||Male|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4300231|NCT00515619|4127184|B1||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4300232|NCT00515619|4127184|B1|||Age||years|Mean|37.8|37.8|Standard Deviation|11.53|11.53|||
4300233|NCT00515619|4127184|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4300234|NCT00515619|4127184|B1||Between 18 and 65 years|Age||Participants|Count of Participants|366|366.0||||||
4300235|NCT00515619|4127184|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4300236|NCT00515541|4127192|B5|United States||Region of Enrollment||participants|Number|43|43.0||||||
4300237|NCT00515541|4127193|B4|United States||Region of Enrollment||participants|Number|11|11.0||||||
4300238|NCT00515541|4127194|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4300239|NCT00515541|4127195|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4300240|NCT00515541|4127196|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4300241|NCT00515541|4127192|B5|Male||Gender||participants|Number|20|20.0||||||
4300242|NCT00515541|4127193|B4|Male||Gender||participants|Number|NA|||||||The reporting site did not supply this information to Invitrox. We have requested information but have been informed that it is not available.Group D was not included in final report.
4300243|NCT00515541|4127194|B3|Male||Gender||participants|Number|5|5.0||||||
4300244|NCT00515541|4127195|B2|Male||Gender||participants|Number|8|8.0||||||
4300245|NCT00515541|4127196|B1|Male||Gender||participants|Number|7|7.0||||||
4300246|NCT00515541|4127192|B5|Female||Gender||participants|Number|12|12.0||||||
4300247|NCT00515541|4127193|B4|Female||Gender||participants|Number|NA|||||||The reporting site did not supply this information to Invitrox. We have requested information but have been informed that it is not available.Group D was not included in final report.
4300248|NCT00515541|4127194|B3|Female||Gender||participants|Number|5|5.0||||||
4300249|NCT00515541|4127195|B2|Female||Gender||participants|Number|4|4.0||||||
4300250|NCT00515541|4127196|B1|Female||Gender||participants|Number|3|3.0||||||
4300251|NCT00515541|4127192|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4300252|NCT00515541|4127193|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4300253|NCT00515541|4127194|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4300254|NCT00515541|4127195|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4300255|NCT00515541|4127196|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4300256|NCT00515541|4127192|B5||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4300257|NCT00515541|4127193|B4||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4300258|NCT00515541|4127194|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4300259|NCT00515541|4127195|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4300260|NCT00515541|4127196|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4300261|NCT00515541|4127192|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300262|NCT00515541|4127193|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300263|NCT00515541|4127194|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300264|NCT00515541|4127195|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300265|NCT00515541|4127196|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300266|NCT00515502|4127221|B1|White - White/Caucasian/European||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
4300267|NCT00515502|4127221|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4300268|NCT00515502|4127221|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4300269|NCT00515502|4127221|B1|||Age||Years|Mean|56.0|56.0|Standard Deviation|5.32|5.32|||
4300270|NCT00515463|4127390|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4300271|NCT00515463|4127391|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4300272|NCT00515463|4127392|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4300273|NCT00515463|4127390|B3|Japanese||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4300274|NCT00515463|4127391|B2|Japanese||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4300275|NCT00515463|4127392|B1|Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4300276|NCT00515463|4127390|B3|Asian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4300277|NCT00515463|4127391|B2|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4300278|NCT00515463|4127392|B1|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4300279|NCT00515463|4127390|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|42|42.0||||||
4300280|NCT00515463|4127391|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4300281|NCT00515463|4127392|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
4300282|NCT00515463|4127390|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4300283|NCT00515463|4127391|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4300284|NCT00515463|4127392|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4300285|NCT00515463|4127390|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|255|255.0||||||
4300286|NCT00515463|4127391|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|131|131.0||||||
4300287|NCT00515463|4127392|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|124|124.0||||||
4300288|NCT00515463|4127390|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4300289|NCT00515463|4127391|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4300290|NCT00515463|4127392|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4300291|NCT00515463|4127390|B3||Female|Sex: Female, Male||Participants|Count of Participants|311|311.0||||||
4300292|NCT00515463|4127391|B2||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4300293|NCT00515463|4127392|B1||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4300294|NCT00515463|4127390|B3|||Age||Years|Mean|62.7|62.7|Standard Deviation|8.7|8.7|||
4300295|NCT00515463|4127391|B2|||Age||Years|Mean|62.9|62.9|Standard Deviation|8.9|8.9|||
4300296|NCT00515463|4127392|B1|||Age||Years|Mean|62.5|62.5|Standard Deviation|8.5|8.5|||
4300297|NCT00515437|4127543|B5|United States||Region of Enrollment||participants|Number|54|54.0||||||
4300298|NCT00515437|4127544|B4|United States||Region of Enrollment||participants|Number|15|15.0||||||
4300299|NCT00515437|4127545|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4300300|NCT00515437|4127546|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4300301|NCT00515437|4127547|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4300302|NCT00515437|4127543|B5||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4300303|NCT00515437|4127544|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4300304|NCT00515437|4127545|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4300305|NCT00515437|4127546|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4300306|NCT00515437|4127547|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4300307|NCT00515437|4127543|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4300308|NCT00515437|4127544|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4300309|NCT00515437|4127545|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4300310|NCT00515437|4127546|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4300311|NCT00515437|4127547|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4300312|NCT00515437|4127543|B5|||Age||years|Mean|71|71.0|Standard Deviation|8|8.0|||
4300313|NCT00515437|4127544|B4|||Age||years|Mean|71|71.0|Standard Deviation|11|11.0|||
4300314|NCT00515437|4127545|B3|||Age||years|Mean|74|74.0|Standard Deviation|5|5.0|||
4300315|NCT00515437|4127546|B2|||Age||years|Mean|71|71.0|Standard Deviation|8|8.0|||
4300316|NCT00515437|4127547|B1|||Age||years|Mean|67|67.0|Standard Deviation|7|7.0|||
4300317|NCT00515437|4127543|B5||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
4300318|NCT00515437|4127544|B4||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4300319|NCT00515437|4127545|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4300320|NCT00515437|4127546|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4300321|NCT00515437|4127547|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4300322|NCT00515437|4127543|B5||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4300323|NCT00515437|4127544|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4300324|NCT00515437|4127545|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4300325|NCT00515437|4127546|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4300326|NCT00515437|4127547|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4300327|NCT00515437|4127543|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300328|NCT00515437|4127544|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300329|NCT00515437|4127545|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300330|NCT00515437|4127546|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300331|NCT00515437|4127547|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300332|NCT00515294|4127572|B5|United States||Region of Enrollment||participants|Number|127|127.0||||||
4300333|NCT00515294|4127573|B4|United States||Region of Enrollment||participants|Number|35|35.0||||||
4300334|NCT00515294|4127574|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
4300335|NCT00515294|4127575|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
4300336|NCT00515294|4127576|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4300337|NCT00515294|4127572|B5|Race|Unknown, not reported|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4300338|NCT00515294|4127573|B4|Race|Unknown, not reported|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4300339|NCT00515294|4127574|B3|Race|Unknown, not reported|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4300340|NCT00515294|4127575|B2|Race|Unknown, not reported|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4300341|NCT00515294|4127576|B1|Race|Unknown, not reported|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4300342|NCT00515294|4127572|B5|Race|More than one race|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4300343|NCT00515294|4127573|B4|Race|More than one race|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4300344|NCT00515294|4127574|B3|Race|More than one race|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4300345|NCT00515294|4127575|B2|Race|More than one race|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4300346|NCT00515294|4127576|B1|Race|More than one race|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4300347|NCT00515294|4127572|B5|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|95|95.0||||||
4300348|NCT00515294|4127573|B4|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
4300349|NCT00515294|4127574|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
4300350|NCT00515294|4127575|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
4300351|NCT00515294|4127576|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
4300352|NCT00515294|4127572|B5|Race|Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4300353|NCT00515294|4127573|B4|Race|Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4300354|NCT00515294|4127574|B3|Race|Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4300355|NCT00515294|4127575|B2|Race|Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4300356|NCT00515294|4127576|B1|Race|Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4300357|NCT00515294|4127572|B5|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
4300358|NCT00515294|4127573|B4|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4300359|NCT00515294|4127574|B3|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4300360|NCT00515294|4127575|B2|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4300361|NCT00515294|4127576|B1|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4300362|NCT00515294|4127572|B5||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4300363|NCT00515294|4127573|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4300364|NCT00515294|4127574|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4300365|NCT00515294|4127575|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4300366|NCT00515294|4127576|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4300367|NCT00515294|4127572|B5||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4300368|NCT00515294|4127573|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4300369|NCT00515294|4127574|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4300370|NCT00515294|4127575|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4300371|NCT00515294|4127576|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4300372|NCT00515294|4127572|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4300373|NCT00515294|4127573|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4300374|NCT00515294|4127574|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4300375|NCT00515294|4127575|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4300376|NCT00515294|4127576|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4300377|NCT00515294|4127572|B5||Between 18 and 65 years|Age||Participants|Count of Participants|127|127.0||||||
4300378|NCT00515294|4127573|B4||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4300379|NCT00515294|4127574|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4300380|NCT00515294|4127575|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4300381|NCT00515294|4127576|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4300382|NCT00515294|4127572|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300383|NCT00515294|4127573|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300384|NCT00515294|4127574|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300385|NCT00515294|4127575|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300386|NCT00515294|4127576|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300387|NCT00515216|4127593|B1|||Incidence of prior neoadjuvant or adjuvant therapy (>6 months)||percentage of participants|Number|8|8.0||||||
4300388|NCT00515216|4127593|B1|Gastroesophageal junction||Primary tumor type||participants|Number|7|7.0||||||
4300389|NCT00515216|4127593|B1|Gastric||Primary tumor type||participants|Number|19|19.0||||||
4300390|NCT00515216|4127593|B1|2||ECOG Performance Status|"0 Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours~Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair~Dead"|participants|Number|8|8.0||||||
4300391|NCT00515216|4127593|B1|1||ECOG Performance Status|"0 Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours~Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair~Dead"|participants|Number|13|13.0||||||
4300449|NCT00515112|4127654|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4300450|NCT00515112|4127655|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4300392|NCT00515216|4127593|B1|0||ECOG Performance Status|"0 Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours~Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair~Dead"|participants|Number|5|5.0||||||
4300393|NCT00515216|4127593|B1|TSER*2/*3||TSER genotypes||participants|Number|21|21.0||||||
4300394|NCT00515216|4127593|B1|TSER*2/*2||TSER genotypes||participants|Number|5|5.0||||||
4300395|NCT00515216|4127593|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4300396|NCT00515216|4127593|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4300397|NCT00515216|4127593|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4300398|NCT00515216|4127593|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4300399|NCT00515216|4127593|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4300400|NCT00515216|4127593|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4300401|NCT00515216|4127593|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4300402|NCT00515216|4127593|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4300403|NCT00515216|4127593|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4300404|NCT00515216|4127593|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4300405|NCT00515216|4127593|B1|||Age||years|Median|56|56.0|Full Range|||26.0|81.0|
4300406|NCT00515203|4127615|B3|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4300407|NCT00515203|4127616|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4300408|NCT00515203|4127617|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4300409|NCT00515203|4127615|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4300410|NCT00515203|4127616|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4300411|NCT00515203|4127617|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4300412|NCT00515203|4127615|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4300413|NCT00515203|4127616|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4300414|NCT00515203|4127617|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4300415|NCT00515203|4127615|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4300416|NCT00515203|4127616|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4300417|NCT00515203|4127617|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4300418|NCT00515203|4127615|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4300419|NCT00515203|4127616|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4300420|NCT00515203|4127617|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4300421|NCT00515203|4127615|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4300422|NCT00515203|4127616|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4300423|NCT00515203|4127617|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4300424|NCT00515203|4127615|B3|||Age||Years|Mean|9.5|9.5|Standard Deviation|5.1|5.1|||
4300425|NCT00515203|4127616|B2|||Age||Years|Mean|9.8|9.8|Standard Deviation|4.6|4.6|||
4300426|NCT00515203|4127617|B1|||Age||Years|Mean|9.4|9.4|Standard Deviation|5.4|5.4|||
4300427|NCT00515177|4127634|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4300428|NCT00515177|4127635|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4300429|NCT00515177|4127636|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4300430|NCT00515177|4127634|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4300431|NCT00515177|4127635|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4300432|NCT00515177|4127636|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4300433|NCT00515177|4127634|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4300434|NCT00515177|4127635|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4300435|NCT00515177|4127636|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4300436|NCT00515177|4127634|B3|||Age||years|Median|51|51.0|Full Range|||21.0|65.0|
4300437|NCT00515177|4127635|B2|||Age||years|Median|53.5|53.5|Full Range|||29.0|59.0|
4300438|NCT00515177|4127636|B1|||Age||years|Median|47|47.0|Full Range|||21.0|65.0|
4300439|NCT00515177|4127634|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4300440|NCT00515177|4127635|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4300441|NCT00515177|4127636|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4300442|NCT00515177|4127634|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4300443|NCT00515177|4127635|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4300444|NCT00515177|4127636|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4300445|NCT00515177|4127634|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300446|NCT00515177|4127635|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300447|NCT00515177|4127636|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300448|NCT00515112|4127653|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4300451|NCT00515112|4127653|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4300452|NCT00515112|4127654|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4300453|NCT00515112|4127655|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4300454|NCT00515112|4127653|B3|||Age||years|Mean|66.4|66.4|Standard Deviation|7.0|7.0|||
4300455|NCT00515112|4127654|B2|||Age||years|Mean|63.5|63.5|Standard Deviation|8.6|8.6|||
4300456|NCT00515112|4127655|B1|||Age||years|Mean|69.4|69.4|Standard Deviation|4.6|4.6|||
4300457|NCT00515099|4127664|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
4300458|NCT00515099|4127665|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4300459|NCT00515099|4127666|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4300460|NCT00515099|4127664|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4300461|NCT00515099|4127665|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4300462|NCT00515099|4127666|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4300463|NCT00515099|4127664|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4300464|NCT00515099|4127665|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4300465|NCT00515099|4127666|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4300466|NCT00515099|4127664|B3|22 - 35 Years||Age, Customized||participants|Number|20|20.0||||||
4300467|NCT00515099|4127665|B2|22 - 35 Years||Age, Customized||participants|Number|8|8.0||||||
4300468|NCT00515099|4127666|B1|22 - 35 Years||Age, Customized||participants|Number|12|12.0||||||
4300469|NCT00515099|4127664|B3|16 - 21 Years||Age, Customized||participants|Number|19|19.0||||||
4300470|NCT00515099|4127665|B2|16 - 21 Years||Age, Customized||participants|Number|6|6.0||||||
4300471|NCT00515099|4127666|B1|16 - 21 Years||Age, Customized||participants|Number|13|13.0||||||
4300472|NCT00515099|4127664|B3|12 -15 Years||Age, Customized||participants|Number|19|19.0||||||
4300473|NCT00515099|4127665|B2|12 -15 Years||Age, Customized||participants|Number|6|6.0||||||
4300474|NCT00515099|4127666|B1|12 -15 Years||Age, Customized||participants|Number|13|13.0||||||
4300475|NCT00515099|4127664|B3|||Age||years|Mean|19.8|19.8|Standard Deviation|6.7|6.7|||
4300476|NCT00515099|4127665|B2|||Age||years|Mean|20.5|20.5|Standard Deviation|7.1|7.1|||
4300477|NCT00515099|4127666|B1|||Age||years|Mean|19.4|19.4|Standard Deviation|6.6|6.6|||
4300478|NCT00515099|4127664|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4300479|NCT00515099|4127665|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4300480|NCT00515099|4127666|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4300481|NCT00515099|4127664|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4300482|NCT00515099|4127665|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4300483|NCT00515099|4127666|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4300484|NCT00515099|4127664|B3||<=18 years|Age||Participants|Count of Participants|29|29.0||||||
4300485|NCT00515099|4127665|B2||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4300486|NCT00515099|4127666|B1||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
4300487|NCT00515086|4127685|B5||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4300488|NCT00515086|4127686|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4300489|NCT00515086|4127687|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4300490|NCT00515086|4127688|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4300491|NCT00515086|4127689|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4300492|NCT00515086|4127685|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4300493|NCT00515086|4127686|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4300494|NCT00515086|4127687|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4300495|NCT00515086|4127688|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4300496|NCT00515086|4127689|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4300497|NCT00515086|4127685|B5||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4300498|NCT00515086|4127686|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4300499|NCT00515086|4127687|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4300500|NCT00515086|4127688|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4300501|NCT00515086|4127689|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4300502|NCT00515086|4127685|B5||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4300503|NCT00515086|4127686|B4||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4300504|NCT00515086|4127687|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4300505|NCT00515086|4127688|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4300506|NCT00515086|4127689|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4300507|NCT00515086|4127685|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300508|NCT00515086|4127686|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300509|NCT00515086|4127687|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300510|NCT00515086|4127688|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300511|NCT00515086|4127689|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300512|NCT00515073|4127719|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4300513|NCT00515073|4127719|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4300514|NCT00515073|4127719|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4300515|NCT00515073|4127719|B1|||Age||years|Median|63|63.0|Full Range|||36.0|77.0|
4300516|NCT00515034|4127723|B5|South America||Region of Enrollment||participants|Number|53|53.0||||||
4300517|NCT00515034|4127724|B4|South America||Region of Enrollment||participants|Number|9|9.0||||||
4300518|NCT00515034|4127725|B3|South America||Region of Enrollment||participants|Number|23|23.0||||||
4300519|NCT00515034|4127726|B2|South America||Region of Enrollment||participants|Number|5|5.0||||||
4300520|NCT00515034|4127727|B1|South America||Region of Enrollment||participants|Number|16|16.0||||||
4300521|NCT00515034|4127723|B5|Europe||Region of Enrollment||participants|Number|45|45.0||||||
4300522|NCT00515034|4127724|B4|Europe||Region of Enrollment||participants|Number|4|4.0||||||
4300523|NCT00515034|4127725|B3|Europe||Region of Enrollment||participants|Number|15|15.0||||||
4300524|NCT00515034|4127726|B2|Europe||Region of Enrollment||participants|Number|7|7.0||||||
4300525|NCT00515034|4127727|B1|Europe||Region of Enrollment||participants|Number|19|19.0||||||
4300526|NCT00515034|4127723|B5|North America||Region of Enrollment||participants|Number|48|48.0||||||
4300527|NCT00515034|4127724|B4|North America||Region of Enrollment||participants|Number|7|7.0||||||
4300528|NCT00515034|4127725|B3|North America||Region of Enrollment||participants|Number|24|24.0||||||
4300529|NCT00515034|4127726|B2|North America||Region of Enrollment||participants|Number|3|3.0||||||
4300530|NCT00515034|4127727|B1|North America||Region of Enrollment||participants|Number|14|14.0||||||
4300531|NCT00515034|4127723|B5||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4300532|NCT00515034|4127724|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4300533|NCT00515034|4127725|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4300534|NCT00515034|4127726|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4300535|NCT00515034|4127727|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4300536|NCT00515034|4127723|B5||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4300537|NCT00515034|4127724|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4300538|NCT00515034|4127725|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4300539|NCT00515034|4127726|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4300540|NCT00515034|4127727|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4300541|NCT00515034|4127723|B5|>=65 years||Age, Customized||participants|Number|36|36.0||||||
4300542|NCT00515034|4127724|B4|>=65 years||Age, Customized||participants|Number|4|4.0||||||
4300543|NCT00515034|4127725|B3|>=65 years||Age, Customized||participants|Number|14|14.0||||||
4300544|NCT00515034|4127726|B2|>=65 years||Age, Customized||participants|Number|4|4.0||||||
4300545|NCT00515034|4127727|B1|>=65 years||Age, Customized||participants|Number|14|14.0||||||
4300546|NCT00515034|4127723|B5|<65 years||Age, Customized||participants|Number|110|110.0||||||
4300547|NCT00515034|4127724|B4|<65 years||Age, Customized||participants|Number|16|16.0||||||
4300548|NCT00515034|4127725|B3|<65 years||Age, Customized||participants|Number|48|48.0||||||
4300549|NCT00515034|4127726|B2|<65 years||Age, Customized||participants|Number|11|11.0||||||
4300550|NCT00515034|4127727|B1|<65 years||Age, Customized||participants|Number|35|35.0||||||
4300551|NCT00515008|4127748|B3|||White race||participants|Number|37|37.0||||||
4300552|NCT00515008|4127749|B2|||White race||participants|Number|17|17.0||||||
4300553|NCT00515008|4127750|B1|||White race||participants|Number|20|20.0||||||
4300554|NCT00515008|4127748|B3|||Duration of fibromyalgia-related pain — yr||years|Mean|10.9|10.9|Standard Deviation|7.1|7.1|||
4300555|NCT00515008|4127749|B2|||Duration of fibromyalgia-related pain — yr||years|Mean|10.0|10.0|Standard Deviation|7.2|7.2|||
4300556|NCT00515008|4127750|B1|||Duration of fibromyalgia-related pain — yr||years|Mean|11.8|11.8|Standard Deviation|6.9|6.9|||
4300557|NCT00515008|4127748|B3|||High School or Higher Education||participants|Number|61|61.0||||||
4300558|NCT00515008|4127749|B2|||High School or Higher Education||participants|Number|30|30.0||||||
4300559|NCT00515008|4127750|B1|||High School or Higher Education||participants|Number|31|31.0||||||
4300560|NCT00515008|4127748|B3|||Outcome Expectations for Exercise score|The Outcome Expectations for Exercise Scale (range, 1 to 5, with 1 indicating no expectations for exercise and 5 the highest expectations for exercise) is a self-report measure of outcome expectations for exercise.|units on a scale|Mean|3.8|3.8|Standard Deviation|0.8|0.8|||
4300561|NCT00515008|4127749|B2|||Outcome Expectations for Exercise score|The Outcome Expectations for Exercise Scale (range, 1 to 5, with 1 indicating no expectations for exercise and 5 the highest expectations for exercise) is a self-report measure of outcome expectations for exercise.|units on a scale|Mean|3.9|3.9|Standard Deviation|0.7|0.7|||
4300562|NCT00515008|4127750|B1|||Outcome Expectations for Exercise score|The Outcome Expectations for Exercise Scale (range, 1 to 5, with 1 indicating no expectations for exercise and 5 the highest expectations for exercise) is a self-report measure of outcome expectations for exercise.|units on a scale|Mean|3.7|3.7|Standard Deviation|0.8|0.8|||
4300563|NCT00515008|4127748|B3|||CPSS score|The Chronic Pain Self-Efficacy Scale (CPSS) is a self-report score measuring self-efficacy with respect to chronic pain (range, 1 to 10, with higher scores indicating greater self-efficacy).|units on a scale|Mean|4.9|4.9|Standard Deviation|2.1|2.1|||
4300564|NCT00515008|4127749|B2|||CPSS score|The Chronic Pain Self-Efficacy Scale (CPSS) is a self-report score measuring self-efficacy with respect to chronic pain (range, 1 to 10, with higher scores indicating greater self-efficacy).|units on a scale|Mean|4.6|4.6|Standard Deviation|2.2|2.2|||
4300565|NCT00515008|4127750|B1|||CPSS score|The Chronic Pain Self-Efficacy Scale (CPSS) is a self-report score measuring self-efficacy with respect to chronic pain (range, 1 to 10, with higher scores indicating greater self-efficacy).|units on a scale|Mean|5.2|5.2|Standard Deviation|1.9|1.9|||
4300566|NCT00515008|4127748|B3|||CES-D score|The Center for Epidemiologic Studies (CES-D) Depression Scale (range, 0 to 60, with higher scores indicating more severe depression), is a self-report measure of depressive symptoms.|units on a scale|Mean|25.2|25.2|Standard Deviation|9.2|9.2|||
4300567|NCT00515008|4127749|B2|||CES-D score|The Center for Epidemiologic Studies (CES-D) Depression Scale (range, 0 to 60, with higher scores indicating more severe depression), is a self-report measure of depressive symptoms.|units on a scale|Mean|27.8|27.8|Standard Deviation|9.2|9.2|||
4300568|NCT00515008|4127750|B1|||CES-D score|The Center for Epidemiologic Studies (CES-D) Depression Scale (range, 0 to 60, with higher scores indicating more severe depression), is a self-report measure of depressive symptoms.|units on a scale|Mean|22.6|22.6|Standard Deviation|9.2|9.2|||
4300569|NCT00515008|4127748|B3|||SF-36 score- Mental component|The Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) Mental Component is the summary score for the mental quality-of-life components (range, 0 to 100, with higher scores indicating better health status)|units on a scale|Mean|40.2|40.2|Standard Deviation|11.4|11.4|||
4300570|NCT00515008|4127749|B2|||SF-36 score- Mental component|The Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) Mental Component is the summary score for the mental quality-of-life components (range, 0 to 100, with higher scores indicating better health status)|units on a scale|Mean|37.8|37.8|Standard Deviation|10.5|10.5|||
4300571|NCT00515008|4127750|B1|||SF-36 score- Mental component|The Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) Mental Component is the summary score for the mental quality-of-life components (range, 0 to 100, with higher scores indicating better health status)|units on a scale|Mean|42.6|42.6|Standard Deviation|12.2|12.2|||
4300572|NCT00515008|4127748|B3|||SF-36 score- Physical component|The Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) Physical Component is the summary score for the physical quality-of-life components (range, 0 to 100, with higher scores indicating better health status)|units on a scale|Mean|28.3|28.3|Standard Deviation|8.1|8.1|||
4300573|NCT00515008|4127749|B2|||SF-36 score- Physical component|The Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) Physical Component is the summary score for the physical quality-of-life components (range, 0 to 100, with higher scores indicating better health status)|units on a scale|Mean|28.0|28.0|Standard Deviation|7.8|7.8|||
4300574|NCT00515008|4127750|B1|||SF-36 score- Physical component|The Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) Physical Component is the summary score for the physical quality-of-life components (range, 0 to 100, with higher scores indicating better health status)|units on a scale|Mean|28.5|28.5|Standard Deviation|8.4|8.4|||
4300575|NCT00515008|4127748|B3|||Body-mass index||kg/m^2|Mean|32.7|32.7|Standard Deviation|8.2|8.2|||
4300576|NCT00515008|4127749|B2|||Body-mass index||kg/m^2|Mean|31.5|31.5|Standard Deviation|7.4|7.4|||
4300577|NCT00515008|4127750|B1|||Body-mass index||kg/m^2|Mean|33.9|33.9|Standard Deviation|8.9|8.9|||
4300578|NCT00515008|4127748|B3|||6-Minute walk test||yards|Mean|511.7|511.7|Standard Deviation|104.7|104.7|||
4300579|NCT00515008|4127749|B2|||6-Minute walk test||yards|Mean|501.2|501.2|Standard Deviation|106.6|106.6|||
4300580|NCT00515008|4127750|B1|||6-Minute walk test||yards|Mean|522.1|522.1|Standard Deviation|102.7|102.7|||
4300581|NCT00515008|4127748|B3|||PSQI score|The Pittsburgh Sleep Quality Index (PSQI) is a self-report measure of sleep quality(range, 0 to 21, with higher scores indicating worse sleep quality)|units on a scale|Mean|13.7|13.7|Standard Deviation|3.4|3.4|||
4300582|NCT00515008|4127749|B2|||PSQI score|The Pittsburgh Sleep Quality Index (PSQI) is a self-report measure of sleep quality(range, 0 to 21, with higher scores indicating worse sleep quality)|units on a scale|Mean|13.5|13.5|Standard Deviation|3.7|3.7|||
4300583|NCT00515008|4127750|B1|||PSQI score|The Pittsburgh Sleep Quality Index (PSQI) is a self-report measure of sleep quality(range, 0 to 21, with higher scores indicating worse sleep quality)|units on a scale|Mean|13.9|13.9|Standard Deviation|3.1|3.1|||
4300584|NCT00515008|4127748|B3|||Physician’s global assessment score|Physicians' global assessment score was assessed separately by the study physician, who was unaware of the group assignment, with the use of a visual-analogue scale (VAS) (range, 0 to 10,with higher scores indicating greater pain).|units on a scale|Mean|5.7|5.7|Standard Deviation|2.2|2.2|||
4300585|NCT00515008|4127749|B2|||Physician’s global assessment score|Physicians' global assessment score was assessed separately by the study physician, who was unaware of the group assignment, with the use of a visual-analogue scale (VAS) (range, 0 to 10,with higher scores indicating greater pain).|units on a scale|Mean|5.6|5.6|Standard Deviation|2.4|2.4|||
4300586|NCT00515008|4127750|B1|||Physician’s global assessment score|Physicians' global assessment score was assessed separately by the study physician, who was unaware of the group assignment, with the use of a visual-analogue scale (VAS) (range, 0 to 10,with higher scores indicating greater pain).|units on a scale|Mean|5.7|5.7|Standard Deviation|1.9|1.9|||
4300587|NCT00515008|4127748|B3|||Patient’s global assessment score|Patients' global assessment score was assessed separately by the participant, who was unaware of the group assignment, with the use of a visual-analogue scale (VAS) (range, 0 to 10,with higher scores indicating greater pain).|units on a scale|Mean|6.1|6.1|Standard Deviation|2.1|2.1|||
4300588|NCT00515008|4127749|B2|||Patient’s global assessment score|Patients' global assessment score was assessed separately by the participant, who was unaware of the group assignment, with the use of a visual-analogue scale (VAS) (range, 0 to 10,with higher scores indicating greater pain).|units on a scale|Mean|6.3|6.3|Standard Deviation|1.8|1.8|||
4300589|NCT00515008|4127750|B1|||Patient’s global assessment score|Patients' global assessment score was assessed separately by the participant, who was unaware of the group assignment, with the use of a visual-analogue scale (VAS) (range, 0 to 10,with higher scores indicating greater pain).|units on a scale|Mean|5.8|5.8|Standard Deviation|2.3|2.3|||
4300590|NCT00515008|4127748|B3|||FIQ score|Fibromyalgia Impact Questionnaire (FIQ) is a well-validated, multidimensional measure of the overall severity of fibromyalgia as rated by patients. Categories include the intensity of pain, physical functioning, fatigue, morning tiredness, stiffness, depression, anxiety, job difficulty, and overall well-being.21 The total score ranges from 0 to 100, with higher scores indicating more severe symptoms.|units on a scale|Mean|65.5|65.5|Standard Deviation|13.3|13.3|||
4300633|NCT00514917|4127833|B2|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4300591|NCT00515008|4127749|B2|||FIQ score|Fibromyalgia Impact Questionnaire (FIQ) is a well-validated, multidimensional measure of the overall severity of fibromyalgia as rated by patients. Categories include the intensity of pain, physical functioning, fatigue, morning tiredness, stiffness, depression, anxiety, job difficulty, and overall well-being.21 The total score ranges from 0 to 100, with higher scores indicating more severe symptoms.|units on a scale|Mean|68|68.0|Standard Deviation|11|11.0|||
4300592|NCT00515008|4127750|B1|||FIQ score|Fibromyalgia Impact Questionnaire (FIQ) is a well-validated, multidimensional measure of the overall severity of fibromyalgia as rated by patients. Categories include the intensity of pain, physical functioning, fatigue, morning tiredness, stiffness, depression, anxiety, job difficulty, and overall well-being.21 The total score ranges from 0 to 100, with higher scores indicating more severe symptoms.|units on a scale|Mean|62.9|62.9|Standard Deviation|15.5|15.5|||
4300593|NCT00515008|4127748|B3|United States||Region of Enrollment||participants|Number|66|66.0||||||
4300594|NCT00515008|4127749|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4300595|NCT00515008|4127750|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4300596|NCT00515008|4127748|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4300597|NCT00515008|4127749|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4300598|NCT00515008|4127750|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4300599|NCT00515008|4127748|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4300600|NCT00515008|4127749|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4300601|NCT00515008|4127750|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4300602|NCT00515008|4127748|B3|||Age||years|Mean|50|50.0|Standard Deviation|11.2|11.2|||
4300603|NCT00515008|4127749|B2|||Age||years|Mean|50.5|50.5|Standard Deviation|10.5|10.5|||
4300604|NCT00515008|4127750|B1|||Age||years|Mean|49.7|49.7|Standard Deviation|11.8|11.8|||
4300605|NCT00514943|4127773|B3|||Baseline sum of longest diameters (SLD) of target lesions by investigator assessments|Baseline measures were available for only 61 patients in the Afatinib/Cetuximab group and only 60 patients in the Cetuximab/Afatinib group|millimeters|Mean|68.4|68.4|Standard Deviation|44.3|44.3|||
4300606|NCT00514943|4127774|B2|||Baseline sum of longest diameters (SLD) of target lesions by investigator assessments|Baseline measures were available for only 61 patients in the Afatinib/Cetuximab group and only 60 patients in the Cetuximab/Afatinib group|millimeters|Mean|65.4|65.4|Standard Deviation|44.2|44.2|||
4300607|NCT00514943|4127775|B1|||Baseline sum of longest diameters (SLD) of target lesions by investigator assessments|Baseline measures were available for only 61 patients in the Afatinib/Cetuximab group and only 60 patients in the Cetuximab/Afatinib group|millimeters|Mean|71.4|71.4|Standard Deviation|44.6|44.6|||
4300608|NCT00514943|4127773|B3|No||Prior chemotherapies (CT)for recurrent/metastatic disease (R/M)||Number of participants|Number|41|41.0||||||
4300609|NCT00514943|4127774|B2|No||Prior chemotherapies (CT)for recurrent/metastatic disease (R/M)||Number of participants|Number|21|21.0||||||
4300610|NCT00514943|4127775|B1|No||Prior chemotherapies (CT)for recurrent/metastatic disease (R/M)||Number of participants|Number|20|20.0||||||
4300611|NCT00514943|4127773|B3|Yes||Prior chemotherapies (CT)for recurrent/metastatic disease (R/M)||Number of participants|Number|83|83.0||||||
4300612|NCT00514943|4127774|B2|Yes||Prior chemotherapies (CT)for recurrent/metastatic disease (R/M)||Number of participants|Number|41|41.0||||||
4300613|NCT00514943|4127775|B1|Yes||Prior chemotherapies (CT)for recurrent/metastatic disease (R/M)||Number of participants|Number|42|42.0||||||
4300614|NCT00514943|4127773|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4300615|NCT00514943|4127774|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4300616|NCT00514943|4127775|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4300617|NCT00514943|4127773|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4300618|NCT00514943|4127774|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4300619|NCT00514943|4127775|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4300620|NCT00514943|4127773|B3|||Age||years|Mean|58.3|58.3|Standard Deviation|9.0|9.0|||
4300621|NCT00514943|4127774|B2|||Age||years|Mean|58.8|58.8|Standard Deviation|8.7|8.7|||
4300622|NCT00514943|4127775|B1|||Age||years|Mean|57.9|57.9|Standard Deviation|9.4|9.4|||
4300623|NCT00514917|4127832|B3|||Prior Radiation Therapy||participants|Number|138|138.0||||||
4300624|NCT00514917|4127833|B2|||Prior Radiation Therapy||participants|Number|75|75.0||||||
4300625|NCT00514917|4127834|B1|||Prior Radiation Therapy||participants|Number|63|63.0||||||
4300626|NCT00514917|4127832|B3|||Body Surface Area (BSA)|BSA was calculated using the Dubois and Dubois formula: BSA (in square meter) = (weight^0.425* height^0.725)*0.007184; where weight is in kilogram (kg) and height is in centimeter (cm). Here “N” (number of participants analyzed) = 192, 198 for each treatment arm, respectively.|square meter (m^2)|Mean|2.06|2.06|Standard Deviation|0.186|0.186|||
4300627|NCT00514917|4127833|B2|||Body Surface Area (BSA)|BSA was calculated using the Dubois and Dubois formula: BSA (in square meter) = (weight^0.425* height^0.725)*0.007184; where weight is in kilogram (kg) and height is in centimeter (cm). Here “N” (number of participants analyzed) = 192, 198 for each treatment arm, respectively.|square meter (m^2)|Mean|2.08|2.08|Standard Deviation|0.194|0.194|||
4300628|NCT00514917|4127834|B1|||Body Surface Area (BSA)|BSA was calculated using the Dubois and Dubois formula: BSA (in square meter) = (weight^0.425* height^0.725)*0.007184; where weight is in kilogram (kg) and height is in centimeter (cm). Here “N” (number of participants analyzed) = 192, 198 for each treatment arm, respectively.|square meter (m^2)|Mean|2.05|2.05|Standard Deviation|0.176|0.176|||
4300629|NCT00514917|4127832|B3|Others||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4300630|NCT00514917|4127833|B2|Others||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4300631|NCT00514917|4127834|B1|Others||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4300632|NCT00514917|4127832|B3|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4300634|NCT00514917|4127834|B1|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4300635|NCT00514917|4127832|B3|Black||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4300636|NCT00514917|4127833|B2|Black||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4300637|NCT00514917|4127834|B1|Black||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4300638|NCT00514917|4127832|B3|Caucasian/White||Race/Ethnicity, Customized||participants|Number|359|359.0||||||
4300639|NCT00514917|4127833|B2|Caucasian/White||Race/Ethnicity, Customized||participants|Number|184|184.0||||||
4300640|NCT00514917|4127834|B1|Caucasian/White||Race/Ethnicity, Customized||participants|Number|175|175.0||||||
4300641|NCT00514917|4127832|B3||Male|Sex: Female, Male||Participants|Count of Participants|400|400.0||||||
4300642|NCT00514917|4127833|B2||Male|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4300643|NCT00514917|4127834|B1||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4300644|NCT00514917|4127832|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4300645|NCT00514917|4127833|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4300646|NCT00514917|4127834|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4300647|NCT00514917|4127832|B3|>= 75 Years||Age, Customized||participants|Number|26|26.0||||||
4300648|NCT00514917|4127833|B2|>= 75 Years||Age, Customized||participants|Number|11|11.0||5.4|5.4|||
4300649|NCT00514917|4127834|B1|>= 75 Years||Age, Customized||participants|Number|15|15.0||7.7|7.7|||
4300650|NCT00514917|4127832|B3|Greater Than or Equal to (>=) 65 to < 75 Years||Age, Customized||participants|Number|184|184.0||||||
4300651|NCT00514917|4127833|B2|Greater Than or Equal to (>=) 65 to < 75 Years||Age, Customized||participants|Number|89|89.0||43.6|43.6|||
4300652|NCT00514917|4127834|B1|Greater Than or Equal to (>=) 65 to < 75 Years||Age, Customized||participants|Number|95|95.0||48.5|48.5|||
4300653|NCT00514917|4127832|B3|Less Than (<) 65 Years||Age, Customized||participants|Number|190|190.0||||||
4300654|NCT00514917|4127833|B2|Less Than (<) 65 Years||Age, Customized||participants|Number|104|104.0||51.0|51.0|||
4300655|NCT00514917|4127834|B1|Less Than (<) 65 Years||Age, Customized||participants|Number|86|86.0||43.9|43.9|||
4300656|NCT00514917|4127832|B3|||Age||years|Mean|64.6|64.6|Standard Deviation|6.99|6.99|||
4300657|NCT00514917|4127833|B2|||Age||years|Mean|64.0|64.0|Standard Deviation|6.97|6.97|||
4300658|NCT00514917|4127834|B1|||Age||years|Mean|65.2|65.2|Standard Deviation|6.97|6.97|||
4300659|NCT00514904|4127861|B3|White - Caucasian/ European heritage, n(%)||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4300660|NCT00514904|4127862|B2|White - Caucasian/ European heritage, n(%)||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4300661|NCT00514904|4127863|B1|White - Caucasian/ European heritage, n(%)||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4300662|NCT00514904|4127861|B3|White - Arabic/ North African heritage, n(%)||Race/Ethnicity, Customized||Participants|Count of Participants|295|295.0||||||
4300663|NCT00514904|4127862|B2|White - Arabic/ North African heritage, n(%)||Race/Ethnicity, Customized||Participants|Count of Participants|74|74.0||||||
4300664|NCT00514904|4127863|B1|White - Arabic/ North African heritage, n(%)||Race/Ethnicity, Customized||Participants|Count of Participants|221|221.0||||||
4300665|NCT00514904|4127861|B3|Native Hawaiian or other Pacific Islander, n(%)||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4300666|NCT00514904|4127862|B2|Native Hawaiian or other Pacific Islander, n(%)||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4300667|NCT00514904|4127863|B1|Native Hawaiian or other Pacific Islander, n(%)||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4300668|NCT00514904|4127861|B3|Asian - South East Asian heritage, n(%)||Race/Ethnicity, Customized||Participants|Count of Participants|796|796.0||||||
4300669|NCT00514904|4127862|B2|Asian - South East Asian heritage, n(%)||Race/Ethnicity, Customized||Participants|Count of Participants|199|199.0||||||
4300670|NCT00514904|4127863|B1|Asian - South East Asian heritage, n(%)||Race/Ethnicity, Customized||Participants|Count of Participants|597|597.0||||||
4300671|NCT00514904|4127861|B3|Asian - Japanese heritage, n(%)||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4300672|NCT00514904|4127862|B2|Asian - Japanese heritage, n(%)||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4300673|NCT00514904|4127863|B1|Asian - Japanese heritage, n(%)||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4300674|NCT00514904|4127861|B3|Asian - Central/ South Asian heritage, n(%)||Race/Ethnicity, Customized||Participants|Count of Participants|401|401.0||||||
4300675|NCT00514904|4127862|B2|Asian - Central/ South Asian heritage, n(%)||Race/Ethnicity, Customized||Participants|Count of Participants|101|101.0||||||
4300676|NCT00514904|4127863|B1|Asian - Central/ South Asian heritage, n(%)||Race/Ethnicity, Customized||Participants|Count of Participants|300|300.0||||||
4300677|NCT00514904|4127861|B3|Male||Sex/Gender, Customized||Participants|Count of Participants|800|800.0||||||
4300678|NCT00514904|4127862|B2|Male||Sex/Gender, Customized||Participants|Count of Participants|201|201.0||||||
4300679|NCT00514904|4127863|B1|Male||Sex/Gender, Customized||Participants|Count of Participants|599|599.0||||||
4300680|NCT00514904|4127861|B3|Female||Sex/Gender, Customized||Participants|Count of Participants|701|701.0||||||
4300681|NCT00514904|4127862|B2|Female||Sex/Gender, Customized||Participants|Count of Participants|175|175.0||||||
4300682|NCT00514904|4127863|B1|Female||Sex/Gender, Customized||Participants|Count of Participants|526|526.0||||||
4300683|NCT00514904|4127861|B3|||Age||Years|Mean|5.57|5.57|Standard Deviation|2.48|2.48|||
4300684|NCT00514904|4127862|B2|||Age||Years|Mean|5.5|5.5|Standard Deviation|2.45|2.45|||
4300685|NCT00514904|4127863|B1|||Age||Years|Mean|5.6|5.6|Standard Deviation|2.49|2.49|||
4300686|NCT00514852|4127898|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4300687|NCT00514852|4127899|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4300688|NCT00514852|4127900|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4300689|NCT00514852|4127898|B3||Female|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4300690|NCT00514852|4127899|B2||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4300691|NCT00514852|4127900|B1||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4300692|NCT00514852|4127898|B3|>=40 years||Age, Customized||participants|Number|283|283.0||||||
4300693|NCT00514852|4127899|B2|>=40 years||Age, Customized||participants|Number|144|144.0||||||
4300694|NCT00514852|4127900|B1|>=40 years||Age, Customized||participants|Number|139|139.0||||||
4300695|NCT00514852|4127898|B3|<40 years||Age, Customized||participants|Number|33|33.0||||||
4300696|NCT00514852|4127899|B2|<40 years||Age, Customized||participants|Number|15|15.0||||||
4300697|NCT00514852|4127900|B1|<40 years||Age, Customized||participants|Number|18|18.0||||||
4300698|NCT00514813|4127925|B5|United Kingdom||Region of Enrollment||participants|Number|23|23.0||||||
4300699|NCT00514813|4127926|B4|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4300700|NCT00514813|4127927|B3|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4300701|NCT00514813|4127928|B2|United Kingdom||Region of Enrollment||participants|Number|15|15.0||||||
4300702|NCT00514813|4127929|B1|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4300703|NCT00514813|4127925|B5|Spain||Region of Enrollment||participants|Number|19|19.0||||||
4300704|NCT00514813|4127926|B4|Spain||Region of Enrollment||participants|Number|3|3.0||||||
4300705|NCT00514813|4127927|B3|Spain||Region of Enrollment||participants|Number|8|8.0||||||
4300706|NCT00514813|4127928|B2|Spain||Region of Enrollment||participants|Number|8|8.0||||||
4300707|NCT00514813|4127929|B1|Spain||Region of Enrollment||participants|Number|0|0.0||||||
4300708|NCT00514813|4127925|B5|Latvia||Region of Enrollment||participants|Number|13|13.0||||||
4300709|NCT00514813|4127926|B4|Latvia||Region of Enrollment||participants|Number|0|0.0||||||
4300710|NCT00514813|4127927|B3|Latvia||Region of Enrollment||participants|Number|3|3.0||||||
4300711|NCT00514813|4127928|B2|Latvia||Region of Enrollment||participants|Number|7|7.0||||||
4300712|NCT00514813|4127929|B1|Latvia||Region of Enrollment||participants|Number|3|3.0||||||
4300713|NCT00514813|4127925|B5|Italy||Region of Enrollment||participants|Number|42|42.0||||||
4300714|NCT00514813|4127926|B4|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4300715|NCT00514813|4127927|B3|Italy||Region of Enrollment||participants|Number|17|17.0||||||
4300716|NCT00514813|4127928|B2|Italy||Region of Enrollment||participants|Number|24|24.0||||||
4300717|NCT00514813|4127929|B1|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4300718|NCT00514813|4127925|B5|Germany||Region of Enrollment||participants|Number|31|31.0||||||
4300719|NCT00514813|4127926|B4|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4300720|NCT00514813|4127927|B3|Germany||Region of Enrollment||participants|Number|7|7.0||||||
4300721|NCT00514813|4127928|B2|Germany||Region of Enrollment||participants|Number|19|19.0||||||
4300722|NCT00514813|4127929|B1|Germany||Region of Enrollment||participants|Number|5|5.0||||||
4300723|NCT00514813|4127925|B5|France||Region of Enrollment||participants|Number|11|11.0||||||
4300724|NCT00514813|4127926|B4|France||Region of Enrollment||participants|Number|1|1.0||||||
4300725|NCT00514813|4127927|B3|France||Region of Enrollment||participants|Number|3|3.0||||||
4300726|NCT00514813|4127928|B2|France||Region of Enrollment||participants|Number|6|6.0||||||
4300727|NCT00514813|4127929|B1|France||Region of Enrollment||participants|Number|1|1.0||||||
4300728|NCT00514813|4127925|B5|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4300729|NCT00514813|4127926|B4|Austria||Region of Enrollment||participants|Number|0|0.0||||||
4300730|NCT00514813|4127927|B3|Austria||Region of Enrollment||participants|Number|0|0.0||||||
4300731|NCT00514813|4127928|B2|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4300732|NCT00514813|4127929|B1|Austria||Region of Enrollment||participants|Number|0|0.0||||||
4300733|NCT00514813|4127925|B5|Belgium||Region of Enrollment||participants|Number|12|12.0||||||
4300734|NCT00514813|4127926|B4|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
4300735|NCT00514813|4127927|B3|Belgium||Region of Enrollment||participants|Number|6|6.0||||||
4300736|NCT00514813|4127928|B2|Belgium||Region of Enrollment||participants|Number|6|6.0||||||
4300737|NCT00514813|4127929|B1|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
4300738|NCT00514813|4127925|B5||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4300739|NCT00514813|4127926|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4300740|NCT00514813|4127927|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4300741|NCT00514813|4127928|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4300742|NCT00514813|4127929|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4300743|NCT00514813|4127925|B5||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4300744|NCT00514813|4127926|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4300745|NCT00514813|4127927|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4300746|NCT00514813|4127928|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4300747|NCT00514813|4127929|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4300748|NCT00514813|4127925|B5|||Age||years|Mean|64.9|64.9|Standard Deviation|13.8|13.8|||
4300749|NCT00514813|4127926|B4|||Age||years|Mean|66.3|66.3|Standard Deviation|21.39|21.39|||
4300750|NCT00514813|4127927|B3|||Age||years|Mean|65.2|65.2|Standard Deviation|14.03|14.03|||
4300751|NCT00514813|4127928|B2|||Age||years|Mean|64.8|64.8|Standard Deviation|13.7|13.7|||
4300752|NCT00514813|4127929|B1|||Age||years|Mean|63.4|63.4|Standard Deviation|12.93|12.93|||
4300753|NCT00514813|4127925|B5||>=65 years|Age||Participants|Count of Participants|91|91.0||||||
4300754|NCT00514813|4127926|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4300755|NCT00514813|4127927|B3||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4300756|NCT00514813|4127928|B2||>=65 years|Age||Participants|Count of Participants|55|55.0||||||
4300757|NCT00514813|4127929|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4300758|NCT00514813|4127925|B5||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4300759|NCT00514813|4127926|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4300760|NCT00514813|4127927|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4300761|NCT00514813|4127928|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4300762|NCT00514813|4127929|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4300763|NCT00514813|4127925|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300764|NCT00514813|4127926|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300765|NCT00514813|4127927|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300766|NCT00514813|4127928|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300767|NCT00514813|4127929|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300768|NCT00514735|4127950|B3|||Left Ventricular Ejection Fraction||percent|Mean|54.7|54.7|Standard Deviation|7.0|7.0|||
4300769|NCT00514735|4127951|B2|||Left Ventricular Ejection Fraction||percent|Mean|54.9|54.9|Standard Deviation|6.7|6.7|||
4300770|NCT00514735|4127952|B1|||Left Ventricular Ejection Fraction||percent|Mean|54.7|54.7|Standard Deviation|7.1|7.1|||
4300771|NCT00514735|4127950|B3|||Left Atrial Diameter||centimeters|Mean|4.6|4.6|Standard Deviation|0.5|0.5|||
4300772|NCT00514735|4127951|B2|||Left Atrial Diameter||centimeters|Mean|4.6|4.6|Standard Deviation|0.5|0.5|||
4300773|NCT00514735|4127952|B1|||Left Atrial Diameter||centimeters|Mean|4.5|4.5|Standard Deviation|0.5|0.5|||
4300774|NCT00514735|4127950|B3|||Number of previously failed AADs per subject||antiarrhythmic drugs|Mean|1.3|1.3|Standard Deviation|0.6|0.6|||
4300775|NCT00514735|4127951|B2|||Number of previously failed AADs per subject||antiarrhythmic drugs|Mean|1.1|1.1|Standard Deviation|0.4|0.4|||
4300776|NCT00514735|4127952|B1|||Number of previously failed AADs per subject||antiarrhythmic drugs|Mean|1.4|1.4|Standard Deviation|0.6|0.6|||
4300777|NCT00514735|4127950|B3|||Number of DC cardioversions in past 4 years|Number of DC cardioversions in past 4 years per subject|cardioversions|Mean|2.1|2.1|Standard Deviation|2.2|2.2|||
4300778|NCT00514735|4127951|B2|||Number of DC cardioversions in past 4 years|Number of DC cardioversions in past 4 years per subject|cardioversions|Mean|2.4|2.4|Standard Deviation|3.5|3.5|||
4300779|NCT00514735|4127952|B1|||Number of DC cardioversions in past 4 years|Number of DC cardioversions in past 4 years per subject|cardioversions|Mean|2.0|2.0|Standard Deviation|1.1|1.1|||
4300780|NCT00514735|4127950|B3|Netherlands||Region of Enrollment||participants|Number|19|19.0||||||
4300781|NCT00514735|4127951|B2|Netherlands||Region of Enrollment||participants|Number|7|7.0||||||
4300782|NCT00514735|4127952|B1|Netherlands||Region of Enrollment||participants|Number|12|12.0||||||
4300783|NCT00514735|4127950|B3|United States||Region of Enrollment||participants|Number|191|191.0||||||
4300784|NCT00514735|4127951|B2|United States||Region of Enrollment||participants|Number|65|65.0||||||
4300785|NCT00514735|4127952|B1|United States||Region of Enrollment||participants|Number|126|126.0||||||
4300786|NCT00514735|4127950|B3||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4300787|NCT00514735|4127951|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4300788|NCT00514735|4127952|B1||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4300789|NCT00514735|4127950|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4300790|NCT00514735|4127951|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4300791|NCT00514735|4127952|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4300792|NCT00514735|4127950|B3|||Age||years|Mean|60.0|60.0|Standard Deviation|8.5|8.5|||
4300793|NCT00514735|4127951|B2|||Age||years|Mean|60.7|60.7|Standard Deviation|8.9|8.9|||
4300794|NCT00514735|4127952|B1|||Age||years|Mean|59.6|59.6|Standard Deviation|8.3|8.3|||
4300795|NCT00514735|4127950|B3||>=65 years|Age||Participants|Count of Participants|74|74.0||||||
4300796|NCT00514735|4127951|B2||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4300797|NCT00514735|4127952|B1||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
4300798|NCT00514735|4127950|B3||Between 18 and 65 years|Age||Participants|Count of Participants|136|136.0||||||
4300799|NCT00514735|4127951|B2||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4300800|NCT00514735|4127952|B1||Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
4300801|NCT00514735|4127950|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300802|NCT00514735|4127951|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300803|NCT00514735|4127952|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300804|NCT00514709|4127971|B3|Philippines||Region of Enrollment||Participants|Number|1843|1843.0||||||
4300805|NCT00514709|4127972|B2|Philippines||Region of Enrollment||Participants|Number|613|613.0||||||
4300806|NCT00514709|4127973|B1|Philippines||Region of Enrollment||Participants|Number|1230|1230.0||||||
4300807|NCT00514709|4127971|B3||Male|Sex: Female, Male||Participants|Count of Participants|912|912.0||||||
4300808|NCT00514709|4127972|B2||Male|Sex: Female, Male||Participants|Count of Participants|311|311.0||||||
4300809|NCT00514709|4127973|B1||Male|Sex: Female, Male||Participants|Count of Participants|601|601.0||||||
4300810|NCT00514709|4127971|B3||Female|Sex: Female, Male||Participants|Count of Participants|931|931.0||||||
4300811|NCT00514709|4127972|B2||Female|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
4300812|NCT00514709|4127973|B1||Female|Sex: Female, Male||Participants|Count of Participants|629|629.0||||||
4300813|NCT00514709|4127971|B3|||Age||Months|Mean|15.1|15.1|Standard Deviation|1.96|1.96|||
4300814|NCT00514709|4127972|B2|||Age||Months|Mean|15.1|15.1|Standard Deviation|1.95|1.95|||
4300815|NCT00514709|4127973|B1|||Age||Months|Mean|15.1|15.1|Standard Deviation|1.96|1.96|||
4300816|NCT00514709|4127971|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4300817|NCT00514709|4127972|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4300818|NCT00514709|4127973|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4300819|NCT00514709|4127971|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4300820|NCT00514709|4127972|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4300821|NCT00514709|4127973|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4300822|NCT00514709|4127971|B3||<=18 years|Age||Participants|Count of Participants|1843|1843.0||||||
4300823|NCT00514709|4127972|B2||<=18 years|Age||Participants|Count of Participants|613|613.0||||||
4300824|NCT00514709|4127973|B1||<=18 years|Age||Participants|Count of Participants|1230|1230.0||||||
4300825|NCT00514683|4127984|B6||Male|Sex: Female, Male||Participants|Count of Participants|320|320.0||||||
4300826|NCT00514683|4127985|B5||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4300827|NCT00514683|4127986|B4||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4300828|NCT00514683|4127987|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4300829|NCT00514683|4127988|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4300830|NCT00514683|4127989|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4300831|NCT00514683|4127984|B6||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4300832|NCT00514683|4127985|B5||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4300833|NCT00514683|4127986|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4300834|NCT00514683|4127987|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4300835|NCT00514683|4127988|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4300836|NCT00514683|4127989|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4300837|NCT00514683|4127984|B6|||Age||years|Mean|65.1|65.1|Standard Deviation|8.56|8.56|||
4300838|NCT00514683|4127985|B5|||Age||years|Mean|65.4|65.4|Standard Deviation|7.82|7.82|||
4300839|NCT00514683|4127986|B4|||Age||years|Mean|65.1|65.1|Standard Deviation|8.63|8.63|||
4300840|NCT00514683|4127987|B3|||Age||years|Mean|64.9|64.9|Standard Deviation|8.48|8.48|||
4300841|NCT00514683|4127988|B2|||Age||years|Mean|65.3|65.3|Standard Deviation|9.42|9.42|||
4300842|NCT00514683|4127989|B1|||Age||years|Mean|64.8|64.8|Standard Deviation|8.57|8.57|||
4300843|NCT00514592|4128184|B1||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4300844|NCT00514592|4128184|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4300845|NCT00514592|4128184|B1||>=65 years|Age||Participants|Count of Participants|175|175.0||||||
4300846|NCT00514592|4128184|B1||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4300847|NCT00514592|4128184|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300848|NCT00514514|4128189|B4||Male|Gender||Participants|Count of Participants|302|302.0||||||
4300849|NCT00514514|4128190|B3||Male|Gender||Participants|Count of Participants|100|100.0||||||
4300850|NCT00514514|4128191|B2||Male|Gender||Participants|Count of Participants|102|102.0||||||
4300851|NCT00514514|4128192|B1||Male|Gender||Participants|Count of Participants|100|100.0||||||
4300852|NCT00514514|4128189|B4||Female|Gender||Participants|Count of Participants|195|195.0||||||
4300853|NCT00514514|4128190|B3||Female|Gender||Participants|Count of Participants|61|61.0||||||
4300854|NCT00514514|4128191|B2||Female|Gender||Participants|Count of Participants|69|69.0||||||
4300855|NCT00514514|4128192|B1||Female|Gender||Participants|Count of Participants|65|65.0||||||
4300856|NCT00514514|4128189|B4|||Age||years|Mean|49.1|49.1|Standard Deviation|12.2|12.2|||
4300857|NCT00514514|4128190|B3|||Age||years|Mean|48.6|48.6|Standard Deviation|12.3|12.3|||
4300858|NCT00514514|4128191|B2|||Age||years|Mean|48.9|48.9|Standard Deviation|12.5|12.5|||
4300859|NCT00514514|4128192|B1|||Age||years|Mean|49.9|49.9|Standard Deviation|11.8|11.8|||
4300860|NCT00514501|4128238|B1||Male|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4300861|NCT00514501|4128238|B1||Female|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
4300862|NCT00514501|4128238|B1|||Age||years|Mean|59.2|59.2|Full Range|||30.0|97.0|
4300863|NCT00514449|4128244|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4300864|NCT00514449|4128245|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4300865|NCT00514449|4128246|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4300866|NCT00514449|4128244|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4300867|NCT00514449|4128245|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4300868|NCT00514449|4128246|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4300869|NCT00514449|4128244|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4300870|NCT00514449|4128245|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4300871|NCT00514449|4128246|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4300872|NCT00514449|4128244|B3|||Age||years|Mean|29.2|29.2|Standard Deviation|8.8|8.8|||
4300873|NCT00514449|4128245|B2|||Age||years|Mean|28.7|28.7|Standard Deviation|8.5|8.5|||
4300874|NCT00514449|4128246|B1|||Age||years|Mean|29.6|29.6|Standard Deviation|9.4|9.4|||
4300875|NCT00514449|4128244|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4300876|NCT00514449|4128245|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4300877|NCT00514449|4128246|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4300878|NCT00514449|4128244|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4300879|NCT00514449|4128245|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4300880|NCT00514449|4128246|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4300881|NCT00514449|4128244|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300882|NCT00514449|4128245|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300883|NCT00514449|4128246|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300884|NCT00514215|4128257|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4300885|NCT00514215|4128257|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4300886|NCT00514215|4128257|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4300887|NCT00514215|4128257|B1|||Age||years|Median|55|55.0|Full Range|||40.0|81.0|
4300888|NCT00514137|4128261|B1|Singapore||Region of Enrollment||participants|Number|1|1.0||||||
4300889|NCT00514137|4128261|B1|Hong Kong||Region of Enrollment||participants|Number|1|1.0||||||
4300890|NCT00514137|4128261|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4300891|NCT00514137|4128261|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4300892|NCT00514137|4128261|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4300893|NCT00514137|4128261|B1|||Age||years|Median|61|61.0|Full Range|||53.0|84.0|
4300894|NCT00514020|4128268|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4300895|NCT00514020|4128268|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4300896|NCT00514020|4128268|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4300897|NCT00514020|4128268|B1|||Age||years|Mean|58|58.0|Standard Deviation|1|1.0|||
4300898|NCT00514020|4128268|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4300899|NCT00514020|4128268|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4300900|NCT00514020|4128268|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300901|NCT00513799|4128272|B5||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4300902|NCT00513799|4128273|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4300903|NCT00513799|4128274|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4300904|NCT00513799|4128275|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4300905|NCT00513799|4128276|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4300906|NCT00513799|4128272|B5||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4300907|NCT00513799|4128273|B4||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4300908|NCT00513799|4128274|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4300909|NCT00513799|4128275|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4300910|NCT00513799|4128276|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4300911|NCT00513799|4128272|B5|||Age||years|Mean|17.61|17.61|Standard Deviation|16.31|16.31|||
4300912|NCT00513799|4128273|B4|||Age||years|Mean|18.67|18.67|Standard Deviation|15.29|15.29|||
4300913|NCT00513799|4128274|B3|||Age||years|Mean|18.19|18.19|Standard Deviation|17.37|17.37|||
4300914|NCT00513799|4128275|B2|||Age||years|Mean|16.52|16.52|Standard Deviation|16.12|16.12|||
4300915|NCT00513799|4128276|B1|||Age||years|Mean|17.37|17.37|Standard Deviation|16.57|16.57|||
4300916|NCT00513708|4128297|B4|United States||Region of Enrollment||participants|Number|150|150.0||||||
4300917|NCT00513708|4128298|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4300918|NCT00513708|4128299|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
4300919|NCT00513708|4128300|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4300920|NCT00513708|4128297|B4||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4300921|NCT00513708|4128298|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4300922|NCT00513708|4128299|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4300923|NCT00513708|4128300|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4300924|NCT00513708|4128297|B4||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4300925|NCT00513708|4128298|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4300926|NCT00513708|4128299|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4300927|NCT00513708|4128300|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4300928|NCT00513708|4128297|B4|||Age||years|Mean|45.34|45.34|Standard Deviation|11.02|11.02|||
4300929|NCT00513708|4128298|B3|||Age||years|Mean|44.48|44.48|Standard Deviation|12.36|12.36|||
4300930|NCT00513708|4128299|B2|||Age||years|Mean|44.96|44.96|Standard Deviation|10.75|10.75|||
4300931|NCT00513708|4128300|B1|||Age||years|Mean|46.58|46.58|Standard Deviation|9.92|9.92|||
4300932|NCT00513708|4128297|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4300933|NCT00513708|4128298|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4300934|NCT00513708|4128299|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4300935|NCT00513708|4128300|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4300936|NCT00513708|4128297|B4||Between 18 and 65 years|Age||Participants|Count of Participants|146|146.0||||||
4300937|NCT00513708|4128298|B3||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4300938|NCT00513708|4128299|B2||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4300939|NCT00513708|4128300|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4300940|NCT00513708|4128297|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300941|NCT00513708|4128298|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300942|NCT00513708|4128299|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300943|NCT00513708|4128300|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4300944|NCT00513695|4128316|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4300945|NCT00513695|4128316|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4300946|NCT00513695|4128316|B1||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4300947|NCT00513695|4128316|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4300948|NCT00513695|4128316|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4300949|NCT00513695|4128316|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4300950|NCT00513695|4128316|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4300951|NCT00513695|4128316|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4300952|NCT00513695|4128316|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4300953|NCT00513695|4128316|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4300954|NCT00513695|4128316|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4300955|NCT00513695|4128316|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4300956|NCT00513695|4128316|B1|||Age||years|Median|50|50.0|Full Range|||33.0|79.0|
4300957|NCT00513682|4128325|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4300958|NCT00513682|4128325|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4300959|NCT00513682|4128325|B1|||Age||years|Mean|9.8|9.8|Standard Deviation|1.64|1.64|||
4300960|NCT00513617|4128334|B4|Sickle cell Anemia (SS)||Genotype of SCD||participants|Number|102.0|102.0||||||
4300961|NCT00513617|4128335|B3|Sickle cell Anemia (SS)||Genotype of SCD||participants|Number|36|36.0||||||
4300962|NCT00513617|4128336|B2|Sickle cell Anemia (SS)||Genotype of SCD||participants|Number|32|32.0||||||
4300963|NCT00513617|4128337|B1|Sickle cell Anemia (SS)||Genotype of SCD||participants|Number|34|34.0||||||
4300964|NCT00513617|4128334|B4|Sickle cell S-Beta Thalassemia (SB0)||Genotype of SCD||participants|Number|7.0|7.0||||||
4300965|NCT00513617|4128335|B3|Sickle cell S-Beta Thalassemia (SB0)||Genotype of SCD||participants|Number|2|2.0||||||
4300966|NCT00513617|4128336|B2|Sickle cell S-Beta Thalassemia (SB0)||Genotype of SCD||participants|Number|3|3.0||||||
4300967|NCT00513617|4128337|B1|Sickle cell S-Beta Thalassemia (SB0)||Genotype of SCD||participants|Number|2|2.0||||||
4300968|NCT00513617|4128334|B4|United States||Region of Enrollment||participants|Number|109.0|109.0||||||
4300969|NCT00513617|4128335|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
4300970|NCT00513617|4128336|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
4300971|NCT00513617|4128337|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4300972|NCT00513617|4128334|B4||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4300973|NCT00513617|4128335|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4300974|NCT00513617|4128336|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4300975|NCT00513617|4128337|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4300976|NCT00513617|4128334|B4||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4300977|NCT00513617|4128335|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4300978|NCT00513617|4128336|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4300979|NCT00513617|4128337|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4300980|NCT00513617|4128334|B4|||Age||years|Mean|23.2|23.2|Standard Deviation|11.75|11.75|||
4300981|NCT00513617|4128335|B3|||Age||years|Mean|21.0|21.0|Standard Deviation|11.49|11.49|||
4300982|NCT00513617|4128336|B2|||Age||years|Mean|20.0|20.0|Standard Deviation|10.01|10.01|||
4300983|NCT00513617|4128337|B1|||Age||years|Mean|24.5|24.5|Standard Deviation|12.85|12.85|||
4300984|NCT00513617|4128334|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4300985|NCT00513617|4128335|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4300986|NCT00513617|4128336|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4300987|NCT00513617|4128337|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4300988|NCT00513617|4128334|B4||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4300989|NCT00513617|4128335|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4300990|NCT00513617|4128336|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4300991|NCT00513617|4128337|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4300992|NCT00513617|4128334|B4||<=18 years|Age||Participants|Count of Participants|50|50.0||||||
4300993|NCT00513617|4128335|B3||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
4300994|NCT00513617|4128336|B2||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
4300995|NCT00513617|4128337|B1||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4300996|NCT00513604|4128350|B6|United States||Region of Enrollment||participants|Number|158|158.0||||||
4300997|NCT00513604|4128351|B5|United States||Region of Enrollment||participants|Number|35|35.0||||||
4300998|NCT00513604|4128352|B4|United States||Region of Enrollment||participants|Number|34|34.0||||||
4300999|NCT00513604|4128353|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4301000|NCT00513604|4128354|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
4301001|NCT00513604|4128355|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4301002|NCT00513604|4128350|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301003|NCT00513604|4128351|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301004|NCT00513604|4128352|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301005|NCT00513604|4128353|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301006|NCT00513604|4128354|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301007|NCT00513604|4128355|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301008|NCT00513604|4128350|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301009|NCT00513604|4128351|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301010|NCT00513604|4128352|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301011|NCT00513604|4128353|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301012|NCT00513604|4128354|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301013|NCT00513604|4128355|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301014|NCT00513604|4128350|B6||White|Race (NIH/OMB)||Participants|Count of Participants|158|158.0||||||
4301015|NCT00513604|4128351|B5||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4301016|NCT00513604|4128352|B4||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4301017|NCT00513604|4128353|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4301018|NCT00513604|4128354|B2||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4301019|NCT00513604|4128355|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4301020|NCT00513604|4128350|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301021|NCT00513604|4128351|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301022|NCT00513604|4128352|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301023|NCT00513604|4128353|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301024|NCT00513604|4128354|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301025|NCT00513604|4128355|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301026|NCT00513604|4128350|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301027|NCT00513604|4128351|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301028|NCT00513604|4128352|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301029|NCT00513604|4128353|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301030|NCT00513604|4128354|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301031|NCT00513604|4128355|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301032|NCT00513604|4128350|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301033|NCT00513604|4128351|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301034|NCT00513604|4128352|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301035|NCT00513604|4128353|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301036|NCT00513604|4128354|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301037|NCT00513604|4128355|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301038|NCT00513604|4128350|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301039|NCT00513604|4128351|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301040|NCT00513604|4128352|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301041|NCT00513604|4128353|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301042|NCT00513604|4128354|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301043|NCT00513604|4128355|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301044|NCT00513604|4128350|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301045|NCT00513604|4128351|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301046|NCT00513604|4128352|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301047|NCT00513604|4128353|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301048|NCT00513604|4128354|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301049|NCT00513604|4128355|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301050|NCT00513604|4128350|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|158|158.0||||||
4301051|NCT00513604|4128351|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4301052|NCT00513604|4128352|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4301053|NCT00513604|4128353|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4301054|NCT00513604|4128354|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4301055|NCT00513604|4128355|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4301056|NCT00513604|4128350|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301057|NCT00513604|4128351|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301058|NCT00513604|4128352|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301059|NCT00513604|4128353|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301060|NCT00513604|4128354|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301061|NCT00513604|4128355|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301062|NCT00513604|4128350|B6||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4301063|NCT00513604|4128351|B5||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4301064|NCT00513604|4128352|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4301065|NCT00513604|4128353|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4301066|NCT00513604|4128354|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4301067|NCT00513604|4128355|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4301068|NCT00513604|4128350|B6||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4301069|NCT00513604|4128351|B5||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4301070|NCT00513604|4128352|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4301071|NCT00513604|4128353|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4301072|NCT00513604|4128354|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4301073|NCT00513604|4128355|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4301074|NCT00513604|4128350|B6|||Age||years|Mean|45.4|45.4|Standard Deviation|11.9|11.9|||
4301075|NCT00513604|4128351|B5|||Age||years|Mean|43.9|43.9|Standard Deviation|12.0|12.0|||
4301076|NCT00513604|4128352|B4|||Age||years|Mean|45.1|45.1|Standard Deviation|11.3|11.3|||
4301077|NCT00513604|4128353|B3|||Age||years|Mean|43.2|43.2|Standard Deviation|11.9|11.9|||
4301078|NCT00513604|4128354|B2|||Age||years|Mean|46.3|46.3|Standard Deviation|11.0|11.0|||
4301079|NCT00513604|4128355|B1|||Age||years|Mean|48.8|48.8|Standard Deviation|13.7|13.7|||
4301080|NCT00513604|4128350|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4301081|NCT00513604|4128351|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4301082|NCT00513604|4128352|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4301083|NCT00513604|4128353|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4301084|NCT00513604|4128354|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4301085|NCT00513604|4128355|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4301086|NCT00513604|4128350|B6||Between 18 and 65 years|Age||Participants|Count of Participants|157|157.0||||||
4301087|NCT00513604|4128351|B5||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4301088|NCT00513604|4128352|B4||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4301089|NCT00513604|4128353|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4301090|NCT00513604|4128354|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4301091|NCT00513604|4128355|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4301092|NCT00513604|4128350|B6||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4301093|NCT00513604|4128351|B5||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4301094|NCT00513604|4128352|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301095|NCT00513604|4128353|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301096|NCT00513604|4128354|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301097|NCT00513604|4128355|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301098|NCT00513526|4128376|B1|United States||Region of Enrollment||participants|Number|109|109.0||||||
4301099|NCT00513526|4128376|B1||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4301100|NCT00513526|4128376|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4301101|NCT00513526|4128376|B1|||Age||years|Mean|43.4|43.4|Standard Deviation|9.4|9.4|||
4301102|NCT00513526|4128376|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4301103|NCT00513526|4128376|B1||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
4301104|NCT00513526|4128376|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301105|NCT00513500|4128391|B3|Zambia||Region of Enrollment||participants|Number|3125|3125.0||||||
4301106|NCT00513500|4128392|B2|Zambia||Region of Enrollment||participants|Number|2108|2108.0||||||
4301107|NCT00513500|4128393|B1|Zambia||Region of Enrollment||participants|Number|1017|1017.0||||||
4301108|NCT00513500|4128391|B3||Male|Sex: Female, Male||Participants|Count of Participants|1613|1613.0||||||
4301109|NCT00513500|4128392|B2||Male|Sex: Female, Male||Participants|Count of Participants|1080|1080.0||||||
4301110|NCT00513500|4128393|B1||Male|Sex: Female, Male||Participants|Count of Participants|533|533.0||||||
4301111|NCT00513500|4128391|B3||Female|Sex: Female, Male||Participants|Count of Participants|1512|1512.0||||||
4301112|NCT00513500|4128392|B2||Female|Sex: Female, Male||Participants|Count of Participants|1028|1028.0||||||
4301113|NCT00513500|4128393|B1||Female|Sex: Female, Male||Participants|Count of Participants|484|484.0||||||
4301114|NCT00513500|4128391|B3|||Age||months|Mean|23.3|23.3|Standard Deviation|14.5|14.5|||
4301115|NCT00513500|4128392|B2|||Age||months|Mean|23.6|23.6|Standard Deviation|14.7|14.7|||
4301116|NCT00513500|4128393|B1|||Age||months|Mean|22.6|22.6|Standard Deviation|14.0|14.0|||
4301117|NCT00513500|4128391|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4301118|NCT00513500|4128392|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4301119|NCT00513500|4128393|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4301120|NCT00513500|4128391|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4301121|NCT00513500|4128392|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4301122|NCT00513500|4128393|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4301123|NCT00513500|4128391|B3||<=18 years|Age||Participants|Count of Participants|3125|3125.0||||||
4301124|NCT00513500|4128392|B2||<=18 years|Age||Participants|Count of Participants|2108|2108.0||||||
4301125|NCT00513500|4128393|B1||<=18 years|Age||Participants|Count of Participants|1017|1017.0||||||
4301126|NCT00513474|4128404|B3|Total Body Irradiation + Cyclophosphamide||Conditioning Protocol Interventions||Participants|Count of Participants|12|12.0||||||
4301127|NCT00513474|4128405|B2|Total Body Irradiation + Cyclophosphamide||Conditioning Protocol Interventions||Participants|Count of Participants|5|5.0||||||
4301128|NCT00513474|4128406|B1|Total Body Irradiation + Cyclophosphamide||Conditioning Protocol Interventions||Participants|Count of Participants|7|7.0||||||
4301129|NCT00513474|4128404|B3|Busulfan + Fludarabine||Conditioning Protocol Interventions||Participants|Count of Participants|2|2.0||||||
4301130|NCT00513474|4128405|B2|Busulfan + Fludarabine||Conditioning Protocol Interventions||Participants|Count of Participants|0|0.0||||||
4301131|NCT00513474|4128406|B1|Busulfan + Fludarabine||Conditioning Protocol Interventions||Participants|Count of Participants|2|2.0||||||
4301132|NCT00513474|4128404|B3|Busulfan + Cyclophosphamide||Conditioning Protocol Interventions||Participants|Count of Participants|28|28.0||||||
4301133|NCT00513474|4128405|B2|Busulfan + Cyclophosphamide||Conditioning Protocol Interventions||Participants|Count of Participants|16|16.0||||||
4301134|NCT00513474|4128406|B1|Busulfan + Cyclophosphamide||Conditioning Protocol Interventions||Participants|Count of Participants|12|12.0||||||
4301135|NCT00513474|4128404|B3|MUD: Tacrolimus + Methotrexate||Graft-Versus-Host Disease (GVHD) Prophylaxis Intervention|Participants received GVHD prophylaxis at the investigator's discretion. MRD=matched related donor. MUD=matched unrelated donor. ATG=antithymocyte globulin.|Participants|Count of Participants|3|3.0||||||
4301136|NCT00513474|4128405|B2|MUD: Tacrolimus + Methotrexate||Graft-Versus-Host Disease (GVHD) Prophylaxis Intervention|Participants received GVHD prophylaxis at the investigator's discretion. MRD=matched related donor. MUD=matched unrelated donor. ATG=antithymocyte globulin.|Participants|Count of Participants|2|2.0||||||
4301137|NCT00513474|4128406|B1|MUD: Tacrolimus + Methotrexate||Graft-Versus-Host Disease (GVHD) Prophylaxis Intervention|Participants received GVHD prophylaxis at the investigator's discretion. MRD=matched related donor. MUD=matched unrelated donor. ATG=antithymocyte globulin.|Participants|Count of Participants|1|1.0||||||
4301138|NCT00513474|4128404|B3|MUD: Tacrolimus + Methotrexate + ATG||Graft-Versus-Host Disease (GVHD) Prophylaxis Intervention|Participants received GVHD prophylaxis at the investigator's discretion. MRD=matched related donor. MUD=matched unrelated donor. ATG=antithymocyte globulin.|Participants|Count of Participants|12|12.0||||||
4301139|NCT00513474|4128405|B2|MUD: Tacrolimus + Methotrexate + ATG||Graft-Versus-Host Disease (GVHD) Prophylaxis Intervention|Participants received GVHD prophylaxis at the investigator's discretion. MRD=matched related donor. MUD=matched unrelated donor. ATG=antithymocyte globulin.|Participants|Count of Participants|8|8.0||||||
4301140|NCT00513474|4128406|B1|MUD: Tacrolimus + Methotrexate + ATG||Graft-Versus-Host Disease (GVHD) Prophylaxis Intervention|Participants received GVHD prophylaxis at the investigator's discretion. MRD=matched related donor. MUD=matched unrelated donor. ATG=antithymocyte globulin.|Participants|Count of Participants|4|4.0||||||
4301141|NCT00513474|4128404|B3|MRD: Tacrolimus + Methotrexate||Graft-Versus-Host Disease (GVHD) Prophylaxis Intervention|Participants received GVHD prophylaxis at the investigator's discretion. MRD=matched related donor. MUD=matched unrelated donor. ATG=antithymocyte globulin.|Participants|Count of Participants|4|4.0||||||
4301142|NCT00513474|4128405|B2|MRD: Tacrolimus + Methotrexate||Graft-Versus-Host Disease (GVHD) Prophylaxis Intervention|Participants received GVHD prophylaxis at the investigator's discretion. MRD=matched related donor. MUD=matched unrelated donor. ATG=antithymocyte globulin.|Participants|Count of Participants|2|2.0||||||
4301143|NCT00513474|4128406|B1|MRD: Tacrolimus + Methotrexate||Graft-Versus-Host Disease (GVHD) Prophylaxis Intervention|Participants received GVHD prophylaxis at the investigator's discretion. MRD=matched related donor. MUD=matched unrelated donor. ATG=antithymocyte globulin.|Participants|Count of Participants|2|2.0||||||
4301144|NCT00513474|4128404|B3|MRD: Cyclsporine + Methotrexate||Graft-Versus-Host Disease (GVHD) Prophylaxis Intervention|Participants received GVHD prophylaxis at the investigator's discretion. MRD=matched related donor. MUD=matched unrelated donor. ATG=antithymocyte globulin.|Participants|Count of Participants|25|25.0||||||
4301145|NCT00513474|4128405|B2|MRD: Cyclsporine + Methotrexate||Graft-Versus-Host Disease (GVHD) Prophylaxis Intervention|Participants received GVHD prophylaxis at the investigator's discretion. MRD=matched related donor. MUD=matched unrelated donor. ATG=antithymocyte globulin.|Participants|Count of Participants|11|11.0||||||
4301146|NCT00513474|4128406|B1|MRD: Cyclsporine + Methotrexate||Graft-Versus-Host Disease (GVHD) Prophylaxis Intervention|Participants received GVHD prophylaxis at the investigator's discretion. MRD=matched related donor. MUD=matched unrelated donor. ATG=antithymocyte globulin.|Participants|Count of Participants|14|14.0||||||
4301147|NCT00513474|4128404|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4301148|NCT00513474|4128405|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4301149|NCT00513474|4128406|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4301150|NCT00513474|4128404|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4301151|NCT00513474|4128405|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4301152|NCT00513474|4128406|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4301153|NCT00513474|4128404|B3|||Age||years|Mean|44|44.0|Full Range|||20.0|59.0|
4301154|NCT00513474|4128405|B2|||Age||years|Mean|45|45.0|Full Range|||21.0|55.0|
4301155|NCT00513474|4128406|B1|||Age||years|Mean|42.9|42.9|Full Range|||20.0|59.0|
4301156|NCT00513461|4128419|B3||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4301157|NCT00513461|4128420|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4301158|NCT00513461|4128421|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4301159|NCT00513461|4128419|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4301160|NCT00513461|4128420|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4301161|NCT00513461|4128421|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4301162|NCT00513461|4128419|B3|||Age||years|Mean|57.88|57.88|Standard Deviation|5.33|5.33|||
4301163|NCT00513461|4128420|B2|||Age||years|Mean|57.2|57.2|Standard Deviation|5.8|5.8|||
4301164|NCT00513461|4128421|B1|||Age||years|Mean|58.5|58.5|Standard Deviation|4.9|4.9|||
4301165|NCT00513435|4128456|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4301166|NCT00513435|4128456|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4301167|NCT00513435|4128456|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4301168|NCT00513435|4128456|B1|||Age||years|Mean|53.8|53.8|Standard Deviation|13.7|13.7|||
4301169|NCT00513435|4128456|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4301170|NCT00513435|4128456|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4301171|NCT00513435|4128456|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301172|NCT00513409|4128461|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4301173|NCT00513409|4128462|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4301174|NCT00513409|4128463|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4301175|NCT00513409|4128461|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4301176|NCT00513409|4128462|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4301177|NCT00513409|4128463|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4301178|NCT00513409|4128461|B3|||Age||Months|Mean|18.3|18.3|Standard Deviation|0.47|0.47|||
4301179|NCT00513409|4128462|B2|||Age||Months|Mean|18.3|18.3|Standard Deviation|0.50|0.5|||
4301180|NCT00513409|4128463|B1|||Age||Months|Mean|18.3|18.3|Standard Deviation|0.44|0.44|||
4301181|NCT00513370|4128490|B1|Canada||Region of Enrollment||participants|Number|203|203.0||||||
4301182|NCT00513370|4128490|B1||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4301183|NCT00513370|4128490|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4301184|NCT00513370|4128490|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|12.34|12.34|||
4301185|NCT00513370|4128490|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4301186|NCT00513370|4128490|B1||Between 18 and 65 years|Age||Participants|Count of Participants|192|192.0||||||
4301187|NCT00513370|4128490|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301188|NCT00513357|4128518|B3|United States||Region of Enrollment||participants|Number|73|73.0||||||
4301189|NCT00513357|4128519|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
4301190|NCT00513357|4128520|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4301191|NCT00513357|4128518|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4301192|NCT00513357|4128519|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4301193|NCT00513357|4128520|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4301194|NCT00513357|4128518|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4301195|NCT00513357|4128519|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4301196|NCT00513357|4128520|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4301197|NCT00513357|4128518|B3|Age range||Age||years|Mean|59|59.0|Full Range|||32.0|86.0|
4301198|NCT00513357|4128519|B2|Age range||Age||years|Mean|62|62.0|Full Range|||32.0|86.0|
4301199|NCT00513357|4128520|B1|Age range||Age||years|Mean|59|59.0|Full Range|||36.0|76.0|
4301200|NCT00513344|4128527|B1|Switzerland||Region of Enrollment||participants|Number|5|5.0||||||
4301201|NCT00513344|4128527|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4301202|NCT00513344|4128527|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4301203|NCT00513344|4128527|B1|>= 42 years||Age, Customized||participants|Number|0|0.0||||||
4301204|NCT00513344|4128527|B1|between 28 and 42 years||Age, Customized||participants|Number|5|5.0||||||
4301205|NCT00513344|4128527|B1|<= 28 years||Age, Customized||participants|Number|0|0.0||||||
4301206|NCT00513344|4128527|B1|||Age||years|Mean|34|34.0|Standard Deviation|7|7.0|||
4301207|NCT00513305|4128538|B3|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4301208|NCT00513305|4128539|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4301209|NCT00513305|4128540|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4301210|NCT00513305|4128538|B3|United States||Region of Enrollment||participants|Number|64|64.0||||||
4301211|NCT00513305|4128539|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
4301212|NCT00513305|4128540|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4301213|NCT00513305|4128538|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4301214|NCT00513305|4128539|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4301215|NCT00513305|4128540|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4301216|NCT00513305|4128538|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4301217|NCT00513305|4128539|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4301218|NCT00513305|4128540|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4301219|NCT00513305|4128538|B3|||Age||years|Mean|71.2|71.2|Standard Deviation|6.9|6.9|||
4301220|NCT00513305|4128539|B2|||Age||years|Mean|71.5|71.5|Standard Deviation|6.8|6.8|||
4301221|NCT00513305|4128540|B1|||Age||years|Mean|70.9|70.9|Standard Deviation|7.1|7.1|||
4301222|NCT00513305|4128538|B3||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
4301223|NCT00513305|4128539|B2||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4301224|NCT00513305|4128540|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4301225|NCT00513305|4128538|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4301226|NCT00513305|4128539|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4301227|NCT00513305|4128540|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4301228|NCT00513305|4128538|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301229|NCT00513305|4128539|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301230|NCT00513305|4128540|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301231|NCT00513292|4128557|B3|United States||Region of Enrollment||participants|Number|280|280.0||||||
4301232|NCT00513292|4128558|B2|United States||Region of Enrollment||participants|Number|142|142.0||||||
4301233|NCT00513292|4128559|B1|United States||Region of Enrollment||participants|Number|138|138.0||||||
4301234|NCT00513292|4128557|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
4301235|NCT00513292|4128558|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
4301236|NCT00513292|4128559|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4301237|NCT00513292|4128557|B3||Female|Gender||Participants|Count of Participants|280|280.0||||||
4301238|NCT00513292|4128558|B2||Female|Gender||Participants|Count of Participants|142|142.0||||||
4301239|NCT00513292|4128559|B1||Female|Gender||Participants|Count of Participants|138|138.0||||||
4301240|NCT00513292|4128557|B3|||Age||years|Median|50|50.0|Full Range|||28.0|76.0|
4301241|NCT00513292|4128558|B2|||Age||years|Median|48|48.0|Full Range|||28.0|73.0|
4301242|NCT00513292|4128559|B1|||Age||years|Median|51|51.0|Full Range|||32.0|76.0|
4301243|NCT00513240|4128576|B3|No Injury||New postoperative MRI injury||participants|Number|33|33.0||||||
4301244|NCT00513240|4128577|B2|No Injury||New postoperative MRI injury||participants|Number|14|14.0||||||
4301245|NCT00513240|4128578|B1|No Injury||New postoperative MRI injury||participants|Number|19|19.0||||||
4301246|NCT00513240|4128576|B3|Injury||New postoperative MRI injury||participants|Number|26|26.0||||||
4301247|NCT00513240|4128577|B2|Injury||New postoperative MRI injury||participants|Number|13|13.0||||||
4301248|NCT00513240|4128578|B1|Injury||New postoperative MRI injury||participants|Number|13|13.0||||||
4301249|NCT00513240|4128576|B3|No Injury||Any preoperative MRI injury||participants|Number|37|37.0||||||
4301250|NCT00513240|4128577|B2|No Injury||Any preoperative MRI injury||participants|Number|18|18.0||||||
4301251|NCT00513240|4128578|B1|No Injury||Any preoperative MRI injury||participants|Number|19|19.0||||||
4301252|NCT00513240|4128576|B3|Injury||Any preoperative MRI injury||participants|Number|22|22.0||||||
4301253|NCT00513240|4128577|B2|Injury||Any preoperative MRI injury||participants|Number|9|9.0||||||
4301254|NCT00513240|4128578|B1|Injury||Any preoperative MRI injury||participants|Number|13|13.0||||||
4301255|NCT00513240|4128576|B3|Aortic Arch & Ventricular Septal Defect/Other||Cardiac diagnosis||participants|Number|12|12.0||||||
4301256|NCT00513240|4128577|B2|Aortic Arch & Ventricular Septal Defect/Other||Cardiac diagnosis||participants|Number|5|5.0||||||
4301257|NCT00513240|4128578|B1|Aortic Arch & Ventricular Septal Defect/Other||Cardiac diagnosis||participants|Number|7|7.0||||||
4301258|NCT00513240|4128576|B3|(D-Transposition of the Great Arteries (D-TGA)||Cardiac diagnosis||participants|Number|21|21.0||||||
4301259|NCT00513240|4128577|B2|(D-Transposition of the Great Arteries (D-TGA)||Cardiac diagnosis||participants|Number|12|12.0||||||
4301260|NCT00513240|4128578|B1|(D-Transposition of the Great Arteries (D-TGA)||Cardiac diagnosis||participants|Number|9|9.0||||||
4301261|NCT00513240|4128576|B3|Hypoplastic Left Heart Syndrome (HLHS)||Cardiac diagnosis||participants|Number|26|26.0||||||
4301262|NCT00513240|4128577|B2|Hypoplastic Left Heart Syndrome (HLHS)||Cardiac diagnosis||participants|Number|10|10.0||||||
4301263|NCT00513240|4128578|B1|Hypoplastic Left Heart Syndrome (HLHS)||Cardiac diagnosis||participants|Number|16|16.0||||||
4301264|NCT00513240|4128576|B3||Male|Gender||Participants|Count of Participants|32|32.0||||||
4301265|NCT00513240|4128577|B2||Male|Gender||Participants|Count of Participants|16|16.0||||||
4301266|NCT00513240|4128578|B1||Male|Gender||Participants|Count of Participants|16|16.0||||||
4301267|NCT00513240|4128576|B3||Female|Gender||Participants|Count of Participants|27|27.0||||||
4301268|NCT00513240|4128577|B2||Female|Gender||Participants|Count of Participants|11|11.0||||||
4301269|NCT00513240|4128578|B1||Female|Gender||Participants|Count of Participants|16|16.0||||||
4301270|NCT00513240|4128576|B3|||Age|Age at inclusion surgery|days|Mean|8.58|8.58|Standard Deviation|4.85|4.85|||
4301271|NCT00513240|4128577|B2|||Age|Age at inclusion surgery|days|Mean|8.12|8.12|Standard Deviation|4.09|4.09|||
4301272|NCT00513240|4128578|B1|||Age|Age at inclusion surgery|days|Mean|8.94|8.94|Standard Deviation|5.35|5.35|||
4301273|NCT00513071|4128586|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4301274|NCT00513071|4128586|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4301275|NCT00513071|4128586|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4301276|NCT00513071|4128586|B1|||Age||years|Median|67|67.0|Full Range|||50.0|84.0|
4301277|NCT00513019|4128596|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
4301278|NCT00513019|4128597|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4301279|NCT00513019|4128598|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4301280|NCT00513019|4128596|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4301281|NCT00513019|4128597|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4301282|NCT00513019|4128598|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4301283|NCT00513019|4128596|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4301284|NCT00513019|4128597|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4301285|NCT00513019|4128598|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4301286|NCT00513019|4128596|B3|||Age||years|Mean|32.8|32.8|Standard Deviation|13.3|13.3|||
4301287|NCT00513019|4128597|B2|||Age||years|Mean|31.6|31.6|Standard Deviation|13.3|13.3|||
4301288|NCT00513019|4128598|B1|||Age||years|Mean|33.2|33.2|Standard Deviation|14.1|14.1|||
4301289|NCT00513019|4128596|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4301290|NCT00513019|4128597|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4301291|NCT00513019|4128598|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4301292|NCT00513019|4128596|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4301293|NCT00513019|4128597|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4301294|NCT00513019|4128598|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4301295|NCT00513019|4128596|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301296|NCT00513019|4128597|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301297|NCT00513019|4128598|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301298|NCT00512902|4128605|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4301299|NCT00512902|4128605|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4301300|NCT00512902|4128605|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4301301|NCT00512902|4128605|B1|||Age||years|Mean|46.1|46.1|Standard Deviation|14.2|14.2|||
4301302|NCT00512902|4128605|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4301303|NCT00512902|4128605|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4301304|NCT00512902|4128605|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301305|NCT00512876|4128613|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4301306|NCT00512876|4128613|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4301307|NCT00512876|4128613|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4301308|NCT00512876|4128613|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|3.3|3.3|||
4301309|NCT00512876|4128613|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4301310|NCT00512876|4128613|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4301311|NCT00512876|4128613|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301312|NCT00512798|4128618|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
4301313|NCT00512798|4128619|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4301314|NCT00512798|4128620|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4301315|NCT00512798|4128618|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4301316|NCT00512798|4128619|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4301317|NCT00512798|4128620|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4301318|NCT00512798|4128618|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4301319|NCT00512798|4128619|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4301320|NCT00512798|4128620|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4301321|NCT00512798|4128618|B3|||Age||years|Median|58|58.0|Full Range|||27.0|78.0|
4301322|NCT00512798|4128619|B2|||Age||years|Median|58|58.0|Full Range|||33.0|78.0|
4301323|NCT00512798|4128620|B1|||Age||years|Median|58|58.0|Full Range|||27.0|74.0|
4301324|NCT00512798|4128618|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4301325|NCT00512798|4128619|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4301326|NCT00512798|4128620|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4301327|NCT00512798|4128618|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4301328|NCT00512798|4128619|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4301329|NCT00512798|4128620|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4301330|NCT00512798|4128618|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301331|NCT00512798|4128619|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301332|NCT00512798|4128620|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301333|NCT00512707|4128630|B3|||Positive Affect Ratio (PAR) in Derogatis Affects Balance Scale (DABS)|The DABS measures affectivity and affects balance via 4 positive (Joy, Contentment, Vigor, and Affection) and 4 negative (Anxiety, Depression, Guilt, and Hostility) dimensions that reflect basic emotional states. Positive Affects Ratio (PAR), ranging from 0 to 1, is the proportion of total scores (sum of all 8 domains) that is positive (sum of 4 positive domains). Higher PAR represents better affectivity.|ratios|Mean|0.74|0.74|Standard Deviation|0.15|0.15|||
4301476|NCT00512707|4128632|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|8.3|8.3|||
4301334|NCT00512707|4128631|B2|||Positive Affect Ratio (PAR) in Derogatis Affects Balance Scale (DABS)|The DABS measures affectivity and affects balance via 4 positive (Joy, Contentment, Vigor, and Affection) and 4 negative (Anxiety, Depression, Guilt, and Hostility) dimensions that reflect basic emotional states. Positive Affects Ratio (PAR), ranging from 0 to 1, is the proportion of total scores (sum of all 8 domains) that is positive (sum of 4 positive domains). Higher PAR represents better affectivity.|ratios|Mean|0.74|0.74|Standard Deviation|0.16|0.16|||
4301335|NCT00512707|4128632|B1|||Positive Affect Ratio (PAR) in Derogatis Affects Balance Scale (DABS)|The DABS measures affectivity and affects balance via 4 positive (Joy, Contentment, Vigor, and Affection) and 4 negative (Anxiety, Depression, Guilt, and Hostility) dimensions that reflect basic emotional states. Positive Affects Ratio (PAR), ranging from 0 to 1, is the proportion of total scores (sum of all 8 domains) that is positive (sum of 4 positive domains). Higher PAR represents better affectivity.|ratios|Mean|0.75|0.75|Standard Deviation|0.14|0.14|||
4301336|NCT00512707|4128630|B3|Hostiity||Derogatis Affects Balance Scale (DABS)|The DABS measures affectivity and affects balance via 4 positive (Joy, Contentment, Vigor, and Affection) and 4 negative (Anxiety, Depression, Guilt, and Hostility) dimensions that reflect basic emotional states. Each domain is scored separately from 0 to 20 with higher scores representing stronger emotional feeling.|units on a scale|Mean|4.7|4.7|Standard Deviation|3.6|3.6|||
4301337|NCT00512707|4128631|B2|Hostiity||Derogatis Affects Balance Scale (DABS)|The DABS measures affectivity and affects balance via 4 positive (Joy, Contentment, Vigor, and Affection) and 4 negative (Anxiety, Depression, Guilt, and Hostility) dimensions that reflect basic emotional states. Each domain is scored separately from 0 to 20 with higher scores representing stronger emotional feeling.|units on a scale|Mean|4.8|4.8|Standard Deviation|3.7|3.7|||
4301338|NCT00512707|4128632|B1|Hostiity||Derogatis Affects Balance Scale (DABS)|The DABS measures affectivity and affects balance via 4 positive (Joy, Contentment, Vigor, and Affection) and 4 negative (Anxiety, Depression, Guilt, and Hostility) dimensions that reflect basic emotional states. Each domain is scored separately from 0 to 20 with higher scores representing stronger emotional feeling.|units on a scale|Mean|4.5|4.5|Standard Deviation|3.5|3.5|||
4301339|NCT00512707|4128630|B3|Guilt||Derogatis Affects Balance Scale (DABS)|The DABS measures affectivity and affects balance via 4 positive (Joy, Contentment, Vigor, and Affection) and 4 negative (Anxiety, Depression, Guilt, and Hostility) dimensions that reflect basic emotional states. Each domain is scored separately from 0 to 20 with higher scores representing stronger emotional feeling.|units on a scale|Mean|4.3|4.3|Standard Deviation|3.8|3.8|||
4301340|NCT00512707|4128631|B2|Guilt||Derogatis Affects Balance Scale (DABS)|The DABS measures affectivity and affects balance via 4 positive (Joy, Contentment, Vigor, and Affection) and 4 negative (Anxiety, Depression, Guilt, and Hostility) dimensions that reflect basic emotional states. Each domain is scored separately from 0 to 20 with higher scores representing stronger emotional feeling.|units on a scale|Mean|4.4|4.4|Standard Deviation|3.9|3.9|||
4301341|NCT00512707|4128632|B1|Guilt||Derogatis Affects Balance Scale (DABS)|The DABS measures affectivity and affects balance via 4 positive (Joy, Contentment, Vigor, and Affection) and 4 negative (Anxiety, Depression, Guilt, and Hostility) dimensions that reflect basic emotional states. Each domain is scored separately from 0 to 20 with higher scores representing stronger emotional feeling.|units on a scale|Mean|4.1|4.1|Standard Deviation|3.7|3.7|||
4301342|NCT00512707|4128630|B3|Anxiety||Derogatis Affects Balance Scale (DABS)|The DABS measures affectivity and affects balance via 4 positive (Joy, Contentment, Vigor, and Affection) and 4 negative (Anxiety, Depression, Guilt, and Hostility) dimensions that reflect basic emotional states. Each domain is scored separately from 0 to 20 with higher scores representing stronger emotional feeling.|units on a scale|Mean|5.8|5.8|Standard Deviation|3.4|3.4|||
4301343|NCT00512707|4128631|B2|Anxiety||Derogatis Affects Balance Scale (DABS)|The DABS measures affectivity and affects balance via 4 positive (Joy, Contentment, Vigor, and Affection) and 4 negative (Anxiety, Depression, Guilt, and Hostility) dimensions that reflect basic emotional states. Each domain is scored separately from 0 to 20 with higher scores representing stronger emotional feeling.|units on a scale|Mean|6.2|6.2|Standard Deviation|3.1|3.1|||
4301344|NCT00512707|4128632|B1|Anxiety||Derogatis Affects Balance Scale (DABS)|The DABS measures affectivity and affects balance via 4 positive (Joy, Contentment, Vigor, and Affection) and 4 negative (Anxiety, Depression, Guilt, and Hostility) dimensions that reflect basic emotional states. Each domain is scored separately from 0 to 20 with higher scores representing stronger emotional feeling.|units on a scale|Mean|5.4|5.4|Standard Deviation|3.5|3.5|||
4301345|NCT00512707|4128630|B3|Depression||Derogatis Affects Balance Scale (DABS)|The DABS measures affectivity and affects balance via 4 positive (Joy, Contentment, Vigor, and Affection) and 4 negative (Anxiety, Depression, Guilt, and Hostility) dimensions that reflect basic emotional states. Each domain is scored separately from 0 to 20 with higher scores representing stronger emotional feeling.|units on a scale|Mean|4.3|4.3|Standard Deviation|3.5|3.5|||
4301346|NCT00512707|4128631|B2|Depression||Derogatis Affects Balance Scale (DABS)|The DABS measures affectivity and affects balance via 4 positive (Joy, Contentment, Vigor, and Affection) and 4 negative (Anxiety, Depression, Guilt, and Hostility) dimensions that reflect basic emotional states. Each domain is scored separately from 0 to 20 with higher scores representing stronger emotional feeling.|units on a scale|Mean|4.7|4.7|Standard Deviation|3.7|3.7|||
4301347|NCT00512707|4128632|B1|Depression||Derogatis Affects Balance Scale (DABS)|The DABS measures affectivity and affects balance via 4 positive (Joy, Contentment, Vigor, and Affection) and 4 negative (Anxiety, Depression, Guilt, and Hostility) dimensions that reflect basic emotional states. Each domain is scored separately from 0 to 20 with higher scores representing stronger emotional feeling.|units on a scale|Mean|3.9|3.9|Standard Deviation|3.3|3.3|||
4301348|NCT00512707|4128630|B3|Affection||Derogatis Affects Balance Scale (DABS)|The DABS measures affectivity and affects balance via 4 positive (Joy, Contentment, Vigor, and Affection) and 4 negative (Anxiety, Depression, Guilt, and Hostility) dimensions that reflect basic emotional states. Each domain is scored separately from 0 to 20 with higher scores representing stronger emotional feeling.|units on a scale|Mean|14.3|14.3|Standard Deviation|3.7|3.7|||
4301477|NCT00512278|4128663|B3|United States||Region of Enrollment||participants|Number|146|146.0||||||
4301478|NCT00512278|4128664|B2|United States||Region of Enrollment||participants|Number|73|73.0||||||
4301479|NCT00512278|4128665|B1|United States||Region of Enrollment||participants|Number|73|73.0||||||
4301349|NCT00512707|4128631|B2|Affection||Derogatis Affects Balance Scale (DABS)|The DABS measures affectivity and affects balance via 4 positive (Joy, Contentment, Vigor, and Affection) and 4 negative (Anxiety, Depression, Guilt, and Hostility) dimensions that reflect basic emotional states. Each domain is scored separately from 0 to 20 with higher scores representing stronger emotional feeling.|units on a scale|Mean|14.2|14.2|Standard Deviation|3.8|3.8|||
4301350|NCT00512707|4128632|B1|Affection||Derogatis Affects Balance Scale (DABS)|The DABS measures affectivity and affects balance via 4 positive (Joy, Contentment, Vigor, and Affection) and 4 negative (Anxiety, Depression, Guilt, and Hostility) dimensions that reflect basic emotional states. Each domain is scored separately from 0 to 20 with higher scores representing stronger emotional feeling.|units on a scale|Mean|14.4|14.4|Standard Deviation|3.6|3.6|||
4301351|NCT00512707|4128630|B3|Vigor||Derogatis Affects Balance Scale (DABS)|The DABS measures affectivity and affects balance via 4 positive (Joy, Contentment, Vigor, and Affection) and 4 negative (Anxiety, Depression, Guilt, and Hostility) dimensions that reflect basic emotional states. Each domain is scored separately from 0 to 20 with higher scores representing stronger emotional feeling.|units on a scale|Mean|12.2|12.2|Standard Deviation|3.7|3.7|||
4301352|NCT00512707|4128631|B2|Vigor||Derogatis Affects Balance Scale (DABS)|The DABS measures affectivity and affects balance via 4 positive (Joy, Contentment, Vigor, and Affection) and 4 negative (Anxiety, Depression, Guilt, and Hostility) dimensions that reflect basic emotional states. Each domain is scored separately from 0 to 20 with higher scores representing stronger emotional feeling.|units on a scale|Mean|12.3|12.3|Standard Deviation|4.1|4.1|||
4301353|NCT00512707|4128632|B1|Vigor||Derogatis Affects Balance Scale (DABS)|The DABS measures affectivity and affects balance via 4 positive (Joy, Contentment, Vigor, and Affection) and 4 negative (Anxiety, Depression, Guilt, and Hostility) dimensions that reflect basic emotional states. Each domain is scored separately from 0 to 20 with higher scores representing stronger emotional feeling.|units on a scale|Mean|12.2|12.2|Standard Deviation|3.2|3.2|||
4301354|NCT00512707|4128630|B3|Contentment||Derogatis Affects Balance Scale (DABS)|The DABS measures affectivity and affects balance via 4 positive (Joy, Contentment, Vigor, and Affection) and 4 negative (Anxiety, Depression, Guilt, and Hostility) dimensions that reflect basic emotional states. Each domain is scored separately from 0 to 20 with higher scores representing stronger emotional feeling.|units on a scale|Mean|12.9|12.9|Standard Deviation|3.2|3.2|||
4301355|NCT00512707|4128631|B2|Contentment||Derogatis Affects Balance Scale (DABS)|The DABS measures affectivity and affects balance via 4 positive (Joy, Contentment, Vigor, and Affection) and 4 negative (Anxiety, Depression, Guilt, and Hostility) dimensions that reflect basic emotional states. Each domain is scored separately from 0 to 20 with higher scores representing stronger emotional feeling.|units on a scale|Mean|12.8|12.8|Standard Deviation|3.6|3.6|||
4301356|NCT00512707|4128632|B1|Contentment||Derogatis Affects Balance Scale (DABS)|The DABS measures affectivity and affects balance via 4 positive (Joy, Contentment, Vigor, and Affection) and 4 negative (Anxiety, Depression, Guilt, and Hostility) dimensions that reflect basic emotional states. Each domain is scored separately from 0 to 20 with higher scores representing stronger emotional feeling.|units on a scale|Mean|13.1|13.1|Standard Deviation|2.9|2.9|||
4301357|NCT00512707|4128630|B3|Joy||Derogatis Affects Balance Scale (DABS)|The DABS measures affectivity and affects balance via 4 positive (Joy, Contentment, Vigor, and Affection) and 4 negative (Anxiety, Depression, Guilt, and Hostility) dimensions that reflect basic emotional states. Each domain is scored separately from 0 to 20 with higher scores representing stronger emotional feeling.|units on a scale|Mean|13.0|13.0|Standard Deviation|3.8|3.8|||
4301358|NCT00512707|4128631|B2|Joy||Derogatis Affects Balance Scale (DABS)|The DABS measures affectivity and affects balance via 4 positive (Joy, Contentment, Vigor, and Affection) and 4 negative (Anxiety, Depression, Guilt, and Hostility) dimensions that reflect basic emotional states. Each domain is scored separately from 0 to 20 with higher scores representing stronger emotional feeling.|units on a scale|Mean|12.9|12.9|Standard Deviation|4.3|4.3|||
4301359|NCT00512707|4128632|B1|Joy||Derogatis Affects Balance Scale (DABS)|The DABS measures affectivity and affects balance via 4 positive (Joy, Contentment, Vigor, and Affection) and 4 negative (Anxiety, Depression, Guilt, and Hostility) dimensions that reflect basic emotional states. Each domain is scored separately from 0 to 20 with higher scores representing stronger emotional feeling.|units on a scale|Mean|13.0|13.0|Standard Deviation|3.2|3.2|||
4301360|NCT00512707|4128630|B3|Global score||Psychological Global Well-Being Index (PGWBI)|PGWBI consists of 22 items each ranges from 0 (poor) to 5 (good) measuring Quality of Life (QoL). It measures 6 dimensions of perceived well-being and distress: Anxiety (5 questions), Depressed Mood (3 questions), Positive Well-Being (4 questions), Self Control (3 questions), General Health (3 questions), and Vitality (4 questions). An global score is the sum of 6 domains, ranging from 0 (poor QoL) to 110 (good QoL). The PGWBI global score and those of its 6 dimensions are normalized to 0-100. Higher score represents better QoL.|units on a scale|Mean|73|73.0|Standard Deviation|13|13.0|||
4301361|NCT00512707|4128631|B2|Global score||Psychological Global Well-Being Index (PGWBI)|PGWBI consists of 22 items each ranges from 0 (poor) to 5 (good) measuring Quality of Life (QoL). It measures 6 dimensions of perceived well-being and distress: Anxiety (5 questions), Depressed Mood (3 questions), Positive Well-Being (4 questions), Self Control (3 questions), General Health (3 questions), and Vitality (4 questions). An global score is the sum of 6 domains, ranging from 0 (poor QoL) to 110 (good QoL). The PGWBI global score and those of its 6 dimensions are normalized to 0-100. Higher score represents better QoL.|units on a scale|Mean|72|72.0|Standard Deviation|14|14.0|||
4301362|NCT00512707|4128632|B1|Global score||Psychological Global Well-Being Index (PGWBI)|PGWBI consists of 22 items each ranges from 0 (poor) to 5 (good) measuring Quality of Life (QoL). It measures 6 dimensions of perceived well-being and distress: Anxiety (5 questions), Depressed Mood (3 questions), Positive Well-Being (4 questions), Self Control (3 questions), General Health (3 questions), and Vitality (4 questions). An global score is the sum of 6 domains, ranging from 0 (poor QoL) to 110 (good QoL). The PGWBI global score and those of its 6 dimensions are normalized to 0-100. Higher score represents better QoL.|units on a scale|Mean|73|73.0|Standard Deviation|12|12.0|||
4301480|NCT00512278|4128663|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4301481|NCT00512278|4128664|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4301482|NCT00512278|4128665|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4301483|NCT00512278|4128663|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4301363|NCT00512707|4128630|B3|Vitality||Psychological Global Well-Being Index (PGWBI)|PGWBI consists of 22 items each ranges from 0 (poor) to 5 (good) measuring Quality of Life (QoL). It measures 6 dimensions of perceived well-being and distress: Anxiety (5 questions), Depressed Mood (3 questions), Positive Well-Being (4 questions), Self Control (3 questions), General Health (3 questions), and Vitality (4 questions). An global score is the sum of 6 domains, ranging from 0 (poor QoL) to 110 (good QoL). The PGWBI global score and those of its 6 dimensions are normalized to 0-100. Higher score represents better QoL.|units on a scale|Mean|65|65.0|Standard Deviation|17|17.0|||
4301364|NCT00512707|4128631|B2|Vitality||Psychological Global Well-Being Index (PGWBI)|PGWBI consists of 22 items each ranges from 0 (poor) to 5 (good) measuring Quality of Life (QoL). It measures 6 dimensions of perceived well-being and distress: Anxiety (5 questions), Depressed Mood (3 questions), Positive Well-Being (4 questions), Self Control (3 questions), General Health (3 questions), and Vitality (4 questions). An global score is the sum of 6 domains, ranging from 0 (poor QoL) to 110 (good QoL). The PGWBI global score and those of its 6 dimensions are normalized to 0-100. Higher score represents better QoL.|units on a scale|Mean|65|65.0|Standard Deviation|19|19.0|||
4301365|NCT00512707|4128632|B1|Vitality||Psychological Global Well-Being Index (PGWBI)|PGWBI consists of 22 items each ranges from 0 (poor) to 5 (good) measuring Quality of Life (QoL). It measures 6 dimensions of perceived well-being and distress: Anxiety (5 questions), Depressed Mood (3 questions), Positive Well-Being (4 questions), Self Control (3 questions), General Health (3 questions), and Vitality (4 questions). An global score is the sum of 6 domains, ranging from 0 (poor QoL) to 110 (good QoL). The PGWBI global score and those of its 6 dimensions are normalized to 0-100. Higher score represents better QoL.|units on a scale|Mean|65|65.0|Standard Deviation|15|15.0|||
4301366|NCT00512707|4128630|B3|General health||Psychological Global Well-Being Index (PGWBI)|PGWBI consists of 22 items each ranges from 0 (poor) to 5 (good) measuring Quality of Life (QoL). It measures 6 dimensions of perceived well-being and distress: Anxiety (5 questions), Depressed Mood (3 questions), Positive Well-Being (4 questions), Self Control (3 questions), General Health (3 questions), and Vitality (4 questions). An global score is the sum of 6 domains, ranging from 0 (poor QoL) to 110 (good QoL). The PGWBI global score and those of its 6 dimensions are normalized to 0-100. Higher score represents better QoL.|units on a scale|Mean|73|73.0|Standard Deviation|17|17.0|||
4301367|NCT00512707|4128631|B2|General health||Psychological Global Well-Being Index (PGWBI)|PGWBI consists of 22 items each ranges from 0 (poor) to 5 (good) measuring Quality of Life (QoL). It measures 6 dimensions of perceived well-being and distress: Anxiety (5 questions), Depressed Mood (3 questions), Positive Well-Being (4 questions), Self Control (3 questions), General Health (3 questions), and Vitality (4 questions). An global score is the sum of 6 domains, ranging from 0 (poor QoL) to 110 (good QoL). The PGWBI global score and those of its 6 dimensions are normalized to 0-100. Higher score represents better QoL.|units on a scale|Mean|73|73.0|Standard Deviation|17|17.0|||
4301368|NCT00512707|4128632|B1|General health||Psychological Global Well-Being Index (PGWBI)|PGWBI consists of 22 items each ranges from 0 (poor) to 5 (good) measuring Quality of Life (QoL). It measures 6 dimensions of perceived well-being and distress: Anxiety (5 questions), Depressed Mood (3 questions), Positive Well-Being (4 questions), Self Control (3 questions), General Health (3 questions), and Vitality (4 questions). An global score is the sum of 6 domains, ranging from 0 (poor QoL) to 110 (good QoL). The PGWBI global score and those of its 6 dimensions are normalized to 0-100. Higher score represents better QoL.|units on a scale|Mean|73|73.0|Standard Deviation|16|16.0|||
4301369|NCT00512707|4128630|B3|Self-control||Psychological Global Well-Being Index (PGWBI)|PGWBI consists of 22 items each ranges from 0 (poor) to 5 (good) measuring Quality of Life (QoL). It measures 6 dimensions of perceived well-being and distress: Anxiety (5 questions), Depressed Mood (3 questions), Positive Well-Being (4 questions), Self Control (3 questions), General Health (3 questions), and Vitality (4 questions). An global score is the sum of 6 domains, ranging from 0 (poor QoL) to 110 (good QoL). The PGWBI global score and those of its 6 dimensions are normalized to 0-100. Higher score represents better QoL.|units on a scale|Mean|85|85.0|Standard Deviation|14|14.0|||
4301370|NCT00512707|4128631|B2|Self-control||Psychological Global Well-Being Index (PGWBI)|PGWBI consists of 22 items each ranges from 0 (poor) to 5 (good) measuring Quality of Life (QoL). It measures 6 dimensions of perceived well-being and distress: Anxiety (5 questions), Depressed Mood (3 questions), Positive Well-Being (4 questions), Self Control (3 questions), General Health (3 questions), and Vitality (4 questions). An global score is the sum of 6 domains, ranging from 0 (poor QoL) to 110 (good QoL). The PGWBI global score and those of its 6 dimensions are normalized to 0-100. Higher score represents better QoL.|units on a scale|Mean|84|84.0|Standard Deviation|14|14.0|||
4301371|NCT00512707|4128632|B1|Self-control||Psychological Global Well-Being Index (PGWBI)|PGWBI consists of 22 items each ranges from 0 (poor) to 5 (good) measuring Quality of Life (QoL). It measures 6 dimensions of perceived well-being and distress: Anxiety (5 questions), Depressed Mood (3 questions), Positive Well-Being (4 questions), Self Control (3 questions), General Health (3 questions), and Vitality (4 questions). An global score is the sum of 6 domains, ranging from 0 (poor QoL) to 110 (good QoL). The PGWBI global score and those of its 6 dimensions are normalized to 0-100. Higher score represents better QoL.|units on a scale|Mean|85|85.0|Standard Deviation|13|13.0|||
4301372|NCT00512707|4128630|B3|Positive well-being||Psychological Global Well-Being Index (PGWBI)|PGWBI consists of 22 items each ranges from 0 (poor) to 5 (good) measuring Quality of Life (QoL). It measures 6 dimensions of perceived well-being and distress: Anxiety (5 questions), Depressed Mood (3 questions), Positive Well-Being (4 questions), Self Control (3 questions), General Health (3 questions), and Vitality (4 questions). An global score is the sum of 6 domains, ranging from 0 (poor QoL) to 110 (good QoL). The PGWBI global score and those of its 6 dimensions are normalized to 0-100. Higher score represents better QoL.|units on a scale|Mean|61|61.0|Standard Deviation|18|18.0|||
4301373|NCT00512707|4128631|B2|Positive well-being||Psychological Global Well-Being Index (PGWBI)|PGWBI consists of 22 items each ranges from 0 (poor) to 5 (good) measuring Quality of Life (QoL). It measures 6 dimensions of perceived well-being and distress: Anxiety (5 questions), Depressed Mood (3 questions), Positive Well-Being (4 questions), Self Control (3 questions), General Health (3 questions), and Vitality (4 questions). An global score is the sum of 6 domains, ranging from 0 (poor QoL) to 110 (good QoL). The PGWBI global score and those of its 6 dimensions are normalized to 0-100. Higher score represents better QoL.|units on a scale|Mean|61|61.0|Standard Deviation|19|19.0|||
4301484|NCT00512278|4128664|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4301374|NCT00512707|4128632|B1|Positive well-being||Psychological Global Well-Being Index (PGWBI)|PGWBI consists of 22 items each ranges from 0 (poor) to 5 (good) measuring Quality of Life (QoL). It measures 6 dimensions of perceived well-being and distress: Anxiety (5 questions), Depressed Mood (3 questions), Positive Well-Being (4 questions), Self Control (3 questions), General Health (3 questions), and Vitality (4 questions). An global score is the sum of 6 domains, ranging from 0 (poor QoL) to 110 (good QoL). The PGWBI global score and those of its 6 dimensions are normalized to 0-100. Higher score represents better QoL.|units on a scale|Mean|62|62.0|Standard Deviation|17|17.0|||
4301375|NCT00512707|4128630|B3|Depressed mood||Psychological Global Well-Being Index (PGWBI)|PGWBI consists of 22 items each ranges from 0 (poor) to 5 (good) measuring Quality of Life (QoL). It measures 6 dimensions of perceived well-being and distress: Anxiety (5 questions), Depressed Mood (3 questions), Positive Well-Being (4 questions), Self Control (3 questions), General Health (3 questions), and Vitality (4 questions). An global score is the sum of 6 domains, ranging from 0 (poor QoL) to 110 (good QoL). The PGWBI global score and those of its 6 dimensions are normalized to 0-100. Higher score represents better QoL.|units on a scale|Mean|84|84.0|Standard Deviation|14|14.0|||
4301376|NCT00512707|4128631|B2|Depressed mood||Psychological Global Well-Being Index (PGWBI)|PGWBI consists of 22 items each ranges from 0 (poor) to 5 (good) measuring Quality of Life (QoL). It measures 6 dimensions of perceived well-being and distress: Anxiety (5 questions), Depressed Mood (3 questions), Positive Well-Being (4 questions), Self Control (3 questions), General Health (3 questions), and Vitality (4 questions). An global score is the sum of 6 domains, ranging from 0 (poor QoL) to 110 (good QoL). The PGWBI global score and those of its 6 dimensions are normalized to 0-100. Higher score represents better QoL.|units on a scale|Mean|83|83.0|Standard Deviation|15|15.0|||
4301377|NCT00512707|4128632|B1|Depressed mood||Psychological Global Well-Being Index (PGWBI)|PGWBI consists of 22 items each ranges from 0 (poor) to 5 (good) measuring Quality of Life (QoL). It measures 6 dimensions of perceived well-being and distress: Anxiety (5 questions), Depressed Mood (3 questions), Positive Well-Being (4 questions), Self Control (3 questions), General Health (3 questions), and Vitality (4 questions). An global score is the sum of 6 domains, ranging from 0 (poor QoL) to 110 (good QoL). The PGWBI global score and those of its 6 dimensions are normalized to 0-100. Higher score represents better QoL.|units on a scale|Mean|86|86.0|Standard Deviation|14|14.0|||
4301378|NCT00512707|4128630|B3|Anxiety||Psychological Global Well-Being Index (PGWBI)|PGWBI consists of 22 items each ranges from 0 (poor) to 5 (good) measuring Quality of Life (QoL). It measures 6 dimensions of perceived well-being and distress: Anxiety (5 questions), Depressed Mood (3 questions), Positive Well-Being (4 questions), Self Control (3 questions), General Health (3 questions), and Vitality (4 questions). An global score is the sum of 6 domains, ranging from 0 (poor QoL) to 110 (good QoL). The PGWBI global score and those of its 6 dimensions are normalized to 0-100. Higher score represents better QoL.|units on a scale|Mean|74|74.0|Standard Deviation|17|17.0|||
4301379|NCT00512707|4128631|B2|Anxiety||Psychological Global Well-Being Index (PGWBI)|PGWBI consists of 22 items each ranges from 0 (poor) to 5 (good) measuring Quality of Life (QoL). It measures 6 dimensions of perceived well-being and distress: Anxiety (5 questions), Depressed Mood (3 questions), Positive Well-Being (4 questions), Self Control (3 questions), General Health (3 questions), and Vitality (4 questions). An global score is the sum of 6 domains, ranging from 0 (poor QoL) to 110 (good QoL). The PGWBI global score and those of its 6 dimensions are normalized to 0-100. Higher score represents better QoL.|units on a scale|Mean|72|72.0|Standard Deviation|18|18.0|||
4301380|NCT00512707|4128632|B1|Anxiety||Psychological Global Well-Being Index (PGWBI)|PGWBI consists of 22 items each ranges from 0 (poor) to 5 (good) measuring Quality of Life (QoL). It measures 6 dimensions of perceived well-being and distress: Anxiety (5 questions), Depressed Mood (3 questions), Positive Well-Being (4 questions), Self Control (3 questions), General Health (3 questions), and Vitality (4 questions). An global score is the sum of 6 domains, ranging from 0 (poor QoL) to 110 (good QoL). The PGWBI global score and those of its 6 dimensions are normalized to 0-100. Higher score represents better QoL.|units on a scale|Mean|75|75.0|Standard Deviation|15|15.0|||
4301381|NCT00512707|4128630|B3|||Marital Interaction scale in CAncer Rehabilitation Evaluation System-Short Form (CARES-SF)|CAncer Rehabilitation Evaluation System-short form (CARES-SF) marital interaction scale consists of 6 items (range from 0 (best) to 4) and mean of these 6 questions was used to determine intimacy and partner interaction. Lower CARES-SF scores correspond with improved marital interaction.|units on a scale|Mean|0.85|0.85|Standard Deviation|0.80|0.8|||
4301382|NCT00512707|4128631|B2|||Marital Interaction scale in CAncer Rehabilitation Evaluation System-Short Form (CARES-SF)|CAncer Rehabilitation Evaluation System-short form (CARES-SF) marital interaction scale consists of 6 items (range from 0 (best) to 4) and mean of these 6 questions was used to determine intimacy and partner interaction. Lower CARES-SF scores correspond with improved marital interaction.|units on a scale|Mean|0.79|0.79|Standard Deviation|0.78|0.78|||
4301383|NCT00512707|4128632|B1|||Marital Interaction scale in CAncer Rehabilitation Evaluation System-Short Form (CARES-SF)|CAncer Rehabilitation Evaluation System-short form (CARES-SF) marital interaction scale consists of 6 items (range from 0 (best) to 4) and mean of these 6 questions was used to determine intimacy and partner interaction. Lower CARES-SF scores correspond with improved marital interaction.|units on a scale|Mean|0.91|0.91|Standard Deviation|0.82|0.82|||
4301384|NCT00512707|4128630|B3|||Quality of Life Specific to Male Erection Difficulties (QOL-MED)|The Quality of Life for men with Erection Difficulties (QOL-MED) is a cross-cultural instrument to measure quality of life specific to male erection difficulties. The 18 items for this scale were generated from interviews with men with erection difficulties by TH Wagner in 1996. Scores were standardized to 0 to 100. Higher QOL-MED scores reflect better quality of life.|units on a scale|Mean|49|49.0|Standard Deviation|26|26.0|||
4301385|NCT00512707|4128631|B2|||Quality of Life Specific to Male Erection Difficulties (QOL-MED)|The Quality of Life for men with Erection Difficulties (QOL-MED) is a cross-cultural instrument to measure quality of life specific to male erection difficulties. The 18 items for this scale were generated from interviews with men with erection difficulties by TH Wagner in 1996. Scores were standardized to 0 to 100. Higher QOL-MED scores reflect better quality of life.|units on a scale|Mean|51|51.0|Standard Deviation|26|26.0|||
4301485|NCT00512278|4128665|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4301486|NCT00512278|4128663|B3|||Age||years|Mean|46.9|46.9|Standard Deviation|9.58|9.58|||
4301487|NCT00512278|4128664|B2|||Age||years|Mean|47.2|47.2|Standard Deviation|9.38|9.38|||
4301386|NCT00512707|4128632|B1|||Quality of Life Specific to Male Erection Difficulties (QOL-MED)|The Quality of Life for men with Erection Difficulties (QOL-MED) is a cross-cultural instrument to measure quality of life specific to male erection difficulties. The 18 items for this scale were generated from interviews with men with erection difficulties by TH Wagner in 1996. Scores were standardized to 0 to 100. Higher QOL-MED scores reflect better quality of life.|units on a scale|Mean|47|47.0|Standard Deviation|25|25.0|||
4301387|NCT00512707|4128630|B3|Composite MSHQ||Male Sexual Health Questionnaire (MSHQ)|MSHQ, a 25-item questionnaire, assesses sexual function and satisfaction. It consists 5 domains: Erection (3 items, ranging from 0 to 15 (best)), Ejaculation (7 items, ranging from 1 to 35 (best)), Satisfaction (6 items, ranging from 6 to 30 (best)), Sexual desire (4 items, ranging 4-20 (best)), and Sexual activity (3 items, ranging 3-15 (best)). A composite score is the sum of Ejaculation and Satisfaction domains, ranging from 7 to 65 (best), with higher score representing better sexual function and satisfaction.|units on a scale|Mean|41.2|41.2|Standard Deviation|10.1|10.1|||
4301388|NCT00512707|4128631|B2|Composite MSHQ||Male Sexual Health Questionnaire (MSHQ)|MSHQ, a 25-item questionnaire, assesses sexual function and satisfaction. It consists 5 domains: Erection (3 items, ranging from 0 to 15 (best)), Ejaculation (7 items, ranging from 1 to 35 (best)), Satisfaction (6 items, ranging from 6 to 30 (best)), Sexual desire (4 items, ranging 4-20 (best)), and Sexual activity (3 items, ranging 3-15 (best)). A composite score is the sum of Ejaculation and Satisfaction domains, ranging from 7 to 65 (best), with higher score representing better sexual function and satisfaction.|units on a scale|Mean|40.8|40.8|Standard Deviation|10.6|10.6|||
4301389|NCT00512707|4128632|B1|Composite MSHQ||Male Sexual Health Questionnaire (MSHQ)|MSHQ, a 25-item questionnaire, assesses sexual function and satisfaction. It consists 5 domains: Erection (3 items, ranging from 0 to 15 (best)), Ejaculation (7 items, ranging from 1 to 35 (best)), Satisfaction (6 items, ranging from 6 to 30 (best)), Sexual desire (4 items, ranging 4-20 (best)), and Sexual activity (3 items, ranging 3-15 (best)). A composite score is the sum of Ejaculation and Satisfaction domains, ranging from 7 to 65 (best), with higher score representing better sexual function and satisfaction.|units on a scale|Mean|41.7|41.7|Standard Deviation|9.6|9.6|||
4301390|NCT00512707|4128630|B3|Sexual activity||Male Sexual Health Questionnaire (MSHQ)|MSHQ, a 25-item questionnaire, assesses sexual function and satisfaction. It consists 5 domains: Erection (3 items, ranging from 0 to 15 (best)), Ejaculation (7 items, ranging from 1 to 35 (best)), Satisfaction (6 items, ranging from 6 to 30 (best)), Sexual desire (4 items, ranging 4-20 (best)), and Sexual activity (3 items, ranging 3-15 (best)). A composite score is the sum of Ejaculation and Satisfaction domains, ranging from 7 to 65 (best), with higher score representing better sexual function and satisfaction.|units on a scale|Mean|5.5|5.5|Standard Deviation|1.4|1.4|||
4301391|NCT00512707|4128631|B2|Sexual activity||Male Sexual Health Questionnaire (MSHQ)|MSHQ, a 25-item questionnaire, assesses sexual function and satisfaction. It consists 5 domains: Erection (3 items, ranging from 0 to 15 (best)), Ejaculation (7 items, ranging from 1 to 35 (best)), Satisfaction (6 items, ranging from 6 to 30 (best)), Sexual desire (4 items, ranging 4-20 (best)), and Sexual activity (3 items, ranging 3-15 (best)). A composite score is the sum of Ejaculation and Satisfaction domains, ranging from 7 to 65 (best), with higher score representing better sexual function and satisfaction.|units on a scale|Mean|5.6|5.6|Standard Deviation|1.5|1.5|||
4301392|NCT00512707|4128632|B1|Sexual activity||Male Sexual Health Questionnaire (MSHQ)|MSHQ, a 25-item questionnaire, assesses sexual function and satisfaction. It consists 5 domains: Erection (3 items, ranging from 0 to 15 (best)), Ejaculation (7 items, ranging from 1 to 35 (best)), Satisfaction (6 items, ranging from 6 to 30 (best)), Sexual desire (4 items, ranging 4-20 (best)), and Sexual activity (3 items, ranging 3-15 (best)). A composite score is the sum of Ejaculation and Satisfaction domains, ranging from 7 to 65 (best), with higher score representing better sexual function and satisfaction.|units on a scale|Mean|5.5|5.5|Standard Deviation|1.4|1.4|||
4301393|NCT00512707|4128630|B3|Sexual desire||Male Sexual Health Questionnaire (MSHQ)|MSHQ, a 25-item questionnaire, assesses sexual function and satisfaction. It consists 5 domains: Erection (3 items, ranging from 0 to 15 (best)), Ejaculation (7 items, ranging from 1 to 35 (best)), Satisfaction (6 items, ranging from 6 to 30 (best)), Sexual desire (4 items, ranging 4-20 (best)), and Sexual activity (3 items, ranging 3-15 (best)). A composite score is the sum of Ejaculation and Satisfaction domains, ranging from 7 to 65 (best), with higher score representing better sexual function and satisfaction.|units on a scale|Mean|8.6|8.6|Standard Deviation|2.4|2.4|||
4301394|NCT00512707|4128631|B2|Sexual desire||Male Sexual Health Questionnaire (MSHQ)|MSHQ, a 25-item questionnaire, assesses sexual function and satisfaction. It consists 5 domains: Erection (3 items, ranging from 0 to 15 (best)), Ejaculation (7 items, ranging from 1 to 35 (best)), Satisfaction (6 items, ranging from 6 to 30 (best)), Sexual desire (4 items, ranging 4-20 (best)), and Sexual activity (3 items, ranging 3-15 (best)). A composite score is the sum of Ejaculation and Satisfaction domains, ranging from 7 to 65 (best), with higher score representing better sexual function and satisfaction.|units on a scale|Mean|8.6|8.6|Standard Deviation|2.5|2.5|||
4301395|NCT00512707|4128632|B1|Sexual desire||Male Sexual Health Questionnaire (MSHQ)|MSHQ, a 25-item questionnaire, assesses sexual function and satisfaction. It consists 5 domains: Erection (3 items, ranging from 0 to 15 (best)), Ejaculation (7 items, ranging from 1 to 35 (best)), Satisfaction (6 items, ranging from 6 to 30 (best)), Sexual desire (4 items, ranging 4-20 (best)), and Sexual activity (3 items, ranging 3-15 (best)). A composite score is the sum of Ejaculation and Satisfaction domains, ranging from 7 to 65 (best), with higher score representing better sexual function and satisfaction.|units on a scale|Mean|8.6|8.6|Standard Deviation|2.4|2.4|||
4301396|NCT00512707|4128630|B3|Sexual satisfaction||Male Sexual Health Questionnaire (MSHQ)|MSHQ, a 25-item questionnaire, assesses sexual function and satisfaction. It consists 5 domains: Erection (3 items, ranging from 0 to 15 (best)), Ejaculation (7 items, ranging from 1 to 35 (best)), Satisfaction (6 items, ranging from 6 to 30 (best)), Sexual desire (4 items, ranging 4-20 (best)), and Sexual activity (3 items, ranging 3-15 (best)). A composite score is the sum of Ejaculation and Satisfaction domains, ranging from 7 to 65 (best), with higher score representing better sexual function and satisfaction.|units on a scale|Mean|19.1|19.1|Standard Deviation|5.8|5.8|||
4301488|NCT00512278|4128665|B1|||Age||years|Mean|46.7|46.7|Standard Deviation|9.78|9.78|||
4301489|NCT00512278|4128663|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4301490|NCT00512278|4128664|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4301491|NCT00512278|4128665|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4301397|NCT00512707|4128631|B2|Sexual satisfaction||Male Sexual Health Questionnaire (MSHQ)|MSHQ, a 25-item questionnaire, assesses sexual function and satisfaction. It consists 5 domains: Erection (3 items, ranging from 0 to 15 (best)), Ejaculation (7 items, ranging from 1 to 35 (best)), Satisfaction (6 items, ranging from 6 to 30 (best)), Sexual desire (4 items, ranging 4-20 (best)), and Sexual activity (3 items, ranging 3-15 (best)). A composite score is the sum of Ejaculation and Satisfaction domains, ranging from 7 to 65 (best), with higher score representing better sexual function and satisfaction.|units on a scale|Mean|18.7|18.7|Standard Deviation|6.0|6.0|||
4301398|NCT00512707|4128632|B1|Sexual satisfaction||Male Sexual Health Questionnaire (MSHQ)|MSHQ, a 25-item questionnaire, assesses sexual function and satisfaction. It consists 5 domains: Erection (3 items, ranging from 0 to 15 (best)), Ejaculation (7 items, ranging from 1 to 35 (best)), Satisfaction (6 items, ranging from 6 to 30 (best)), Sexual desire (4 items, ranging 4-20 (best)), and Sexual activity (3 items, ranging 3-15 (best)). A composite score is the sum of Ejaculation and Satisfaction domains, ranging from 7 to 65 (best), with higher score representing better sexual function and satisfaction.|units on a scale|Mean|19.5|19.5|Standard Deviation|5.7|5.7|||
4301399|NCT00512707|4128630|B3|Ejaculation||Male Sexual Health Questionnaire (MSHQ)|MSHQ, a 25-item questionnaire, assesses sexual function and satisfaction. It consists 5 domains: Erection (3 items, ranging from 0 to 15 (best)), Ejaculation (7 items, ranging from 1 to 35 (best)), Satisfaction (6 items, ranging from 6 to 30 (best)), Sexual desire (4 items, ranging 4-20 (best)), and Sexual activity (3 items, ranging 3-15 (best)). A composite score is the sum of Ejaculation and Satisfaction domains, ranging from 7 to 65 (best), with higher score representing better sexual function and satisfaction.|units on a scale|Mean|22.2|22.2|Standard Deviation|7.0|7.0|||
4301400|NCT00512707|4128631|B2|Ejaculation||Male Sexual Health Questionnaire (MSHQ)|MSHQ, a 25-item questionnaire, assesses sexual function and satisfaction. It consists 5 domains: Erection (3 items, ranging from 0 to 15 (best)), Ejaculation (7 items, ranging from 1 to 35 (best)), Satisfaction (6 items, ranging from 6 to 30 (best)), Sexual desire (4 items, ranging 4-20 (best)), and Sexual activity (3 items, ranging 3-15 (best)). A composite score is the sum of Ejaculation and Satisfaction domains, ranging from 7 to 65 (best), with higher score representing better sexual function and satisfaction.|units on a scale|Mean|22.2|22.2|Standard Deviation|7.3|7.3|||
4301401|NCT00512707|4128632|B1|Ejaculation||Male Sexual Health Questionnaire (MSHQ)|MSHQ, a 25-item questionnaire, assesses sexual function and satisfaction. It consists 5 domains: Erection (3 items, ranging from 0 to 15 (best)), Ejaculation (7 items, ranging from 1 to 35 (best)), Satisfaction (6 items, ranging from 6 to 30 (best)), Sexual desire (4 items, ranging 4-20 (best)), and Sexual activity (3 items, ranging 3-15 (best)). A composite score is the sum of Ejaculation and Satisfaction domains, ranging from 7 to 65 (best), with higher score representing better sexual function and satisfaction.|units on a scale|Mean|22.2|22.2|Standard Deviation|6.6|6.6|||
4301402|NCT00512707|4128630|B3|Erection||Male Sexual Health Questionnaire (MSHQ)|MSHQ, a 25-item questionnaire, assesses sexual function and satisfaction. It consists 5 domains: Erection (3 items, ranging from 0 to 15 (best)), Ejaculation (7 items, ranging from 1 to 35 (best)), Satisfaction (6 items, ranging from 6 to 30 (best)), Sexual desire (4 items, ranging 4-20 (best)), and Sexual activity (3 items, ranging 3-15 (best)). A composite score is the sum of Ejaculation and Satisfaction domains, ranging from 7 to 65 (best), with higher score representing better sexual function and satisfaction.|units on a scale|Mean|6.8|6.8|Standard Deviation|1.9|1.9|||
4301403|NCT00512707|4128631|B2|Erection||Male Sexual Health Questionnaire (MSHQ)|MSHQ, a 25-item questionnaire, assesses sexual function and satisfaction. It consists 5 domains: Erection (3 items, ranging from 0 to 15 (best)), Ejaculation (7 items, ranging from 1 to 35 (best)), Satisfaction (6 items, ranging from 6 to 30 (best)), Sexual desire (4 items, ranging 4-20 (best)), and Sexual activity (3 items, ranging 3-15 (best)). A composite score is the sum of Ejaculation and Satisfaction domains, ranging from 7 to 65 (best), with higher score representing better sexual function and satisfaction.|units on a scale|Mean|6.9|6.9|Standard Deviation|1.8|1.8|||
4301404|NCT00512707|4128632|B1|Erection||Male Sexual Health Questionnaire (MSHQ)|MSHQ, a 25-item questionnaire, assesses sexual function and satisfaction. It consists 5 domains: Erection (3 items, ranging from 0 to 15 (best)), Ejaculation (7 items, ranging from 1 to 35 (best)), Satisfaction (6 items, ranging from 6 to 30 (best)), Sexual desire (4 items, ranging 4-20 (best)), and Sexual activity (3 items, ranging 3-15 (best)). A composite score is the sum of Ejaculation and Satisfaction domains, ranging from 7 to 65 (best), with higher score representing better sexual function and satisfaction.|units on a scale|Mean|6.7|6.7|Standard Deviation|1.9|1.9|||
4301405|NCT00512707|4128630|B3|Successful Sexual Intercourse (Satisfaction)||Successful sexual Intercourse in Sexual Encounter Profile (SEP)|Sexual Encounter Profile (SEP) diaries assesses frequency of sexual activity, sildenafil use, vaginal penetration, completion of intercourse with ejaculation, and overall satisfaction with sexual encounters. Higher percentage of Ejaculations or Satisfaction in successful sexual intercourse represents better sexual function.|percentage of successful intercourse|Mean|31|31.0|Standard Deviation|40|40.0|||
4301406|NCT00512707|4128631|B2|Successful Sexual Intercourse (Satisfaction)||Successful sexual Intercourse in Sexual Encounter Profile (SEP)|Sexual Encounter Profile (SEP) diaries assesses frequency of sexual activity, sildenafil use, vaginal penetration, completion of intercourse with ejaculation, and overall satisfaction with sexual encounters. Higher percentage of Ejaculations or Satisfaction in successful sexual intercourse represents better sexual function.|percentage of successful intercourse|Mean|40|40.0|Standard Deviation|45|45.0|||
4301407|NCT00512707|4128632|B1|Successful Sexual Intercourse (Satisfaction)||Successful sexual Intercourse in Sexual Encounter Profile (SEP)|Sexual Encounter Profile (SEP) diaries assesses frequency of sexual activity, sildenafil use, vaginal penetration, completion of intercourse with ejaculation, and overall satisfaction with sexual encounters. Higher percentage of Ejaculations or Satisfaction in successful sexual intercourse represents better sexual function.|percentage of successful intercourse|Mean|22|22.0|Standard Deviation|34|34.0|||
4301408|NCT00512707|4128630|B3|Successful sexual Intercourse(Ejaculations)||Successful sexual Intercourse in Sexual Encounter Profile (SEP)|Sexual Encounter Profile (SEP) diaries assesses frequency of sexual activity, sildenafil use, vaginal penetration, completion of intercourse with ejaculation, and overall satisfaction with sexual encounters. Higher percentage of Ejaculations or Satisfaction in successful sexual intercourse represents better sexual function.|percentage of successful intercourse|Mean|45|45.0|Standard Deviation|43|43.0|||
4301492|NCT00512278|4128663|B3||Between 18 and 65 years|Age||Participants|Count of Participants|146|146.0||||||
4301409|NCT00512707|4128631|B2|Successful sexual Intercourse(Ejaculations)||Successful sexual Intercourse in Sexual Encounter Profile (SEP)|Sexual Encounter Profile (SEP) diaries assesses frequency of sexual activity, sildenafil use, vaginal penetration, completion of intercourse with ejaculation, and overall satisfaction with sexual encounters. Higher percentage of Ejaculations or Satisfaction in successful sexual intercourse represents better sexual function.|percentage of successful intercourse|Mean|54|54.0|Standard Deviation|45|45.0|||
4301410|NCT00512707|4128632|B1|Successful sexual Intercourse(Ejaculations)||Successful sexual Intercourse in Sexual Encounter Profile (SEP)|Sexual Encounter Profile (SEP) diaries assesses frequency of sexual activity, sildenafil use, vaginal penetration, completion of intercourse with ejaculation, and overall satisfaction with sexual encounters. Higher percentage of Ejaculations or Satisfaction in successful sexual intercourse represents better sexual function.|percentage of successful intercourse|Mean|36|36.0|Standard Deviation|40|40.0|||
4301411|NCT00512707|4128630|B3|Overall satisfied with sexual encounters||Sexual Encounter Profile (SEP)|Sexual Encounter Profile (SEP) diaries assesses frequency of sexual activity, sildenafil use, vaginal penetration, completion of intercourse with ejaculation, and overall satisfaction with sexual encounters. Minimum value is 0 with no maximum limit, wherein higher values representing better sexual encounter.|events/week|Mean|0.76|0.76|Standard Deviation|1.12|1.12|||
4301412|NCT00512707|4128631|B2|Overall satisfied with sexual encounters||Sexual Encounter Profile (SEP)|Sexual Encounter Profile (SEP) diaries assesses frequency of sexual activity, sildenafil use, vaginal penetration, completion of intercourse with ejaculation, and overall satisfaction with sexual encounters. Minimum value is 0 with no maximum limit, wherein higher values representing better sexual encounter.|events/week|Mean|1.07|1.07|Standard Deviation|1.39|1.39|||
4301413|NCT00512707|4128632|B1|Overall satisfied with sexual encounters||Sexual Encounter Profile (SEP)|Sexual Encounter Profile (SEP) diaries assesses frequency of sexual activity, sildenafil use, vaginal penetration, completion of intercourse with ejaculation, and overall satisfaction with sexual encounters. Minimum value is 0 with no maximum limit, wherein higher values representing better sexual encounter.|events/week|Mean|0.49|0.49|Standard Deviation|0.71|0.71|||
4301414|NCT00512707|4128630|B3|Ejaculations||Sexual Encounter Profile (SEP)|Sexual Encounter Profile (SEP) diaries assesses frequency of sexual activity, sildenafil use, vaginal penetration, completion of intercourse with ejaculation, and overall satisfaction with sexual encounters. Minimum value is 0 with no maximum limit, wherein higher values representing better sexual encounter.|events/week|Mean|1.02|1.02|Standard Deviation|1.13|1.13|||
4301415|NCT00512707|4128631|B2|Ejaculations||Sexual Encounter Profile (SEP)|Sexual Encounter Profile (SEP) diaries assesses frequency of sexual activity, sildenafil use, vaginal penetration, completion of intercourse with ejaculation, and overall satisfaction with sexual encounters. Minimum value is 0 with no maximum limit, wherein higher values representing better sexual encounter.|events/week|Mean|1.14|1.14|Standard Deviation|1.15|1.15|||
4301416|NCT00512707|4128632|B1|Ejaculations||Sexual Encounter Profile (SEP)|Sexual Encounter Profile (SEP) diaries assesses frequency of sexual activity, sildenafil use, vaginal penetration, completion of intercourse with ejaculation, and overall satisfaction with sexual encounters. Minimum value is 0 with no maximum limit, wherein higher values representing better sexual encounter.|events/week|Mean|0.92|0.92|Standard Deviation|1.11|1.11|||
4301417|NCT00512707|4128630|B3|Vaginal penetrations||Sexual Encounter Profile (SEP)|Sexual Encounter Profile (SEP) diaries assesses frequency of sexual activity, sildenafil use, vaginal penetration, completion of intercourse with ejaculation, and overall satisfaction with sexual encounters. Minimum value is 0 with no maximum limit, wherein higher values representing better sexual encounter.|events/week|Mean|1.4|1.4|Standard Deviation|1.2|1.2|||
4301418|NCT00512707|4128631|B2|Vaginal penetrations||Sexual Encounter Profile (SEP)|Sexual Encounter Profile (SEP) diaries assesses frequency of sexual activity, sildenafil use, vaginal penetration, completion of intercourse with ejaculation, and overall satisfaction with sexual encounters. Minimum value is 0 with no maximum limit, wherein higher values representing better sexual encounter.|events/week|Mean|1.4|1.4|Standard Deviation|1.1|1.1|||
4301419|NCT00512707|4128632|B1|Vaginal penetrations||Sexual Encounter Profile (SEP)|Sexual Encounter Profile (SEP) diaries assesses frequency of sexual activity, sildenafil use, vaginal penetration, completion of intercourse with ejaculation, and overall satisfaction with sexual encounters. Minimum value is 0 with no maximum limit, wherein higher values representing better sexual encounter.|events/week|Mean|1.5|1.5|Standard Deviation|1.3|1.3|||
4301420|NCT00512707|4128630|B3|Sexual encounter attempts||Sexual Encounter Profile (SEP)|Sexual Encounter Profile (SEP) diaries assesses frequency of sexual activity, sildenafil use, vaginal penetration, completion of intercourse with ejaculation, and overall satisfaction with sexual encounters. Minimum value is 0 with no maximum limit, wherein higher values representing better sexual encounter.|events/week|Mean|2.4|2.4|Standard Deviation|1.3|1.3|||
4301421|NCT00512707|4128631|B2|Sexual encounter attempts||Sexual Encounter Profile (SEP)|Sexual Encounter Profile (SEP) diaries assesses frequency of sexual activity, sildenafil use, vaginal penetration, completion of intercourse with ejaculation, and overall satisfaction with sexual encounters. Minimum value is 0 with no maximum limit, wherein higher values representing better sexual encounter.|events/week|Mean|2.3|2.3|Standard Deviation|1.3|1.3|||
4301422|NCT00512707|4128632|B1|Sexual encounter attempts||Sexual Encounter Profile (SEP)|Sexual Encounter Profile (SEP) diaries assesses frequency of sexual activity, sildenafil use, vaginal penetration, completion of intercourse with ejaculation, and overall satisfaction with sexual encounters. Minimum value is 0 with no maximum limit, wherein higher values representing better sexual encounter.|events/week|Mean|2.5|2.5|Standard Deviation|1.4|1.4|||
4301423|NCT00512707|4128630|B3|Composite IIEF||International Index of Erectile Function (IIEF)|IIEF is a validated, 15-item questionnaire that assesses 5 domains of sexual function: erectile function (range 1-30), orgasmic function (range 0-10), sexual desire (range 2-10), intercourse satisfaction (range 0-15), and overall sexual satisfaction (range 2-10). Each question was answered on a 6-point or 5-point scale from 0/1 to 5 (best) with a total possible score (sum of 5 domains) range of 5 to 75 with higher scores representing better function.|units on a scale|Mean|33|33.0|Standard Deviation|13|13.0|||
4301493|NCT00512278|4128664|B2||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4301494|NCT00512278|4128665|B1||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4301495|NCT00512278|4128663|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301424|NCT00512707|4128631|B2|Composite IIEF||International Index of Erectile Function (IIEF)|IIEF is a validated, 15-item questionnaire that assesses 5 domains of sexual function: erectile function (range 1-30), orgasmic function (range 0-10), sexual desire (range 2-10), intercourse satisfaction (range 0-15), and overall sexual satisfaction (range 2-10). Each question was answered on a 6-point or 5-point scale from 0/1 to 5 (best) with a total possible score (sum of 5 domains) range of 5 to 75 with higher scores representing better function.|units on a scale|Mean|33|33.0|Standard Deviation|14|14.0|||
4301425|NCT00512707|4128632|B1|Composite IIEF||International Index of Erectile Function (IIEF)|IIEF is a validated, 15-item questionnaire that assesses 5 domains of sexual function: erectile function (range 1-30), orgasmic function (range 0-10), sexual desire (range 2-10), intercourse satisfaction (range 0-15), and overall sexual satisfaction (range 2-10). Each question was answered on a 6-point or 5-point scale from 0/1 to 5 (best) with a total possible score (sum of 5 domains) range of 5 to 75 with higher scores representing better function.|units on a scale|Mean|33|33.0|Standard Deviation|13|13.0|||
4301426|NCT00512707|4128630|B3|Overall satisfaction||International Index of Erectile Function (IIEF)|IIEF is a validated, 15-item questionnaire that assesses 5 domains of sexual function: erectile function (range 1-30), orgasmic function (range 0-10), sexual desire (range 2-10), intercourse satisfaction (range 0-15), and overall sexual satisfaction (range 2-10). Each question was answered on a 6-point or 5-point scale from 0/1 to 5 (best) with a total possible score (sum of 5 domains) range of 5 to 75 with higher scores representing better function.|units on a scale|Mean|4.4|4.4|Standard Deviation|2.0|2.0|||
4301427|NCT00512707|4128631|B2|Overall satisfaction||International Index of Erectile Function (IIEF)|IIEF is a validated, 15-item questionnaire that assesses 5 domains of sexual function: erectile function (range 1-30), orgasmic function (range 0-10), sexual desire (range 2-10), intercourse satisfaction (range 0-15), and overall sexual satisfaction (range 2-10). Each question was answered on a 6-point or 5-point scale from 0/1 to 5 (best) with a total possible score (sum of 5 domains) range of 5 to 75 with higher scores representing better function.|units on a scale|Mean|4.5|4.5|Standard Deviation|2.1|2.1|||
4301428|NCT00512707|4128632|B1|Overall satisfaction||International Index of Erectile Function (IIEF)|IIEF is a validated, 15-item questionnaire that assesses 5 domains of sexual function: erectile function (range 1-30), orgasmic function (range 0-10), sexual desire (range 2-10), intercourse satisfaction (range 0-15), and overall sexual satisfaction (range 2-10). Each question was answered on a 6-point or 5-point scale from 0/1 to 5 (best) with a total possible score (sum of 5 domains) range of 5 to 75 with higher scores representing better function.|units on a scale|Mean|4.3|4.3|Standard Deviation|1.9|1.9|||
4301429|NCT00512707|4128630|B3|Intercourse satisfaction||International Index of Erectile Function (IIEF)|IIEF is a validated, 15-item questionnaire that assesses 5 domains of sexual function: erectile function (range 1-30), orgasmic function (range 0-10), sexual desire (range 2-10), intercourse satisfaction (range 0-15), and overall sexual satisfaction (range 2-10). Each question was answered on a 6-point or 5-point scale from 0/1 to 5 (best) with a total possible score (sum of 5 domains) range of 5 to 75 with higher scores representing better function.|units on a scale|Mean|6.0|6.0|Standard Deviation|3.5|3.5|||
4301430|NCT00512707|4128631|B2|Intercourse satisfaction||International Index of Erectile Function (IIEF)|IIEF is a validated, 15-item questionnaire that assesses 5 domains of sexual function: erectile function (range 1-30), orgasmic function (range 0-10), sexual desire (range 2-10), intercourse satisfaction (range 0-15), and overall sexual satisfaction (range 2-10). Each question was answered on a 6-point or 5-point scale from 0/1 to 5 (best) with a total possible score (sum of 5 domains) range of 5 to 75 with higher scores representing better function.|units on a scale|Mean|6.0|6.0|Standard Deviation|3.6|3.6|||
4301431|NCT00512707|4128632|B1|Intercourse satisfaction||International Index of Erectile Function (IIEF)|IIEF is a validated, 15-item questionnaire that assesses 5 domains of sexual function: erectile function (range 1-30), orgasmic function (range 0-10), sexual desire (range 2-10), intercourse satisfaction (range 0-15), and overall sexual satisfaction (range 2-10). Each question was answered on a 6-point or 5-point scale from 0/1 to 5 (best) with a total possible score (sum of 5 domains) range of 5 to 75 with higher scores representing better function.|units on a scale|Mean|6.1|6.1|Standard Deviation|3.4|3.4|||
4301432|NCT00512707|4128630|B3|Sexual desire||International Index of Erectile Function (IIEF)|IIEF is a validated, 15-item questionnaire that assesses 5 domains of sexual function: erectile function (range 1-30), orgasmic function (range 0-10), sexual desire (range 2-10), intercourse satisfaction (range 0-15), and overall sexual satisfaction (range 2-10). Each question was answered on a 6-point or 5-point scale from 0/1 to 5 (best) with a total possible score (sum of 5 domains) range of 5 to 75 with higher scores representing better function.|units on a scale|Mean|5.6|5.6|Standard Deviation|1.9|1.9|||
4301433|NCT00512707|4128631|B2|Sexual desire||International Index of Erectile Function (IIEF)|IIEF is a validated, 15-item questionnaire that assesses 5 domains of sexual function: erectile function (range 1-30), orgasmic function (range 0-10), sexual desire (range 2-10), intercourse satisfaction (range 0-15), and overall sexual satisfaction (range 2-10). Each question was answered on a 6-point or 5-point scale from 0/1 to 5 (best) with a total possible score (sum of 5 domains) range of 5 to 75 with higher scores representing better function.|units on a scale|Mean|5.6|5.6|Standard Deviation|1.9|1.9|||
4301434|NCT00512707|4128632|B1|Sexual desire||International Index of Erectile Function (IIEF)|IIEF is a validated, 15-item questionnaire that assesses 5 domains of sexual function: erectile function (range 1-30), orgasmic function (range 0-10), sexual desire (range 2-10), intercourse satisfaction (range 0-15), and overall sexual satisfaction (range 2-10). Each question was answered on a 6-point or 5-point scale from 0/1 to 5 (best) with a total possible score (sum of 5 domains) range of 5 to 75 with higher scores representing better function.|units on a scale|Mean|5.6|5.6|Standard Deviation|1.9|1.9|||
4301435|NCT00512707|4128630|B3|Orgasmic function||International Index of Erectile Function (IIEF)|IIEF is a validated, 15-item questionnaire that assesses 5 domains of sexual function: erectile function (range 1-30), orgasmic function (range 0-10), sexual desire (range 2-10), intercourse satisfaction (range 0-15), and overall sexual satisfaction (range 2-10). Each question was answered on a 6-point or 5-point scale from 0/1 to 5 (best) with a total possible score (sum of 5 domains) range of 5 to 75 with higher scores representing better function.|units on a scale|Mean|5.3|5.3|Standard Deviation|3.1|3.1|||
4301496|NCT00512278|4128664|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301497|NCT00512278|4128665|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301436|NCT00512707|4128631|B2|Orgasmic function||International Index of Erectile Function (IIEF)|IIEF is a validated, 15-item questionnaire that assesses 5 domains of sexual function: erectile function (range 1-30), orgasmic function (range 0-10), sexual desire (range 2-10), intercourse satisfaction (range 0-15), and overall sexual satisfaction (range 2-10). Each question was answered on a 6-point or 5-point scale from 0/1 to 5 (best) with a total possible score (sum of 5 domains) range of 5 to 75 with higher scores representing better function.|units on a scale|Mean|5.4|5.4|Standard Deviation|3.1|3.1|||
4301437|NCT00512707|4128632|B1|Orgasmic function||International Index of Erectile Function (IIEF)|IIEF is a validated, 15-item questionnaire that assesses 5 domains of sexual function: erectile function (range 1-30), orgasmic function (range 0-10), sexual desire (range 2-10), intercourse satisfaction (range 0-15), and overall sexual satisfaction (range 2-10). Each question was answered on a 6-point or 5-point scale from 0/1 to 5 (best) with a total possible score (sum of 5 domains) range of 5 to 75 with higher scores representing better function.|units on a scale|Mean|5.1|5.1|Standard Deviation|3.0|3.0|||
4301438|NCT00512707|4128630|B3|Erectile function||International Index of Erectile Function (IIEF)|IIEF is a validated, 15-item questionnaire that assesses 5 domains of sexual function: erectile function (range 1-30), orgasmic function (range 0-10), sexual desire (range 2-10), intercourse satisfaction (range 0-15), and overall sexual satisfaction (range 2-10). Each question was answered on a 6-point or 5-point scale from 0/1 to 5 (best) with a total possible score (sum of 5 domains) range of 5 to 75 with higher scores representing better function.|units on a scale|Mean|12.1|12.1|Standard Deviation|6.2|6.2|||
4301439|NCT00512707|4128631|B2|Erectile function||International Index of Erectile Function (IIEF)|IIEF is a validated, 15-item questionnaire that assesses 5 domains of sexual function: erectile function (range 1-30), orgasmic function (range 0-10), sexual desire (range 2-10), intercourse satisfaction (range 0-15), and overall sexual satisfaction (range 2-10). Each question was answered on a 6-point or 5-point scale from 0/1 to 5 (best) with a total possible score (sum of 5 domains) range of 5 to 75 with higher scores representing better function.|units on a scale|Mean|12.0|12.0|Standard Deviation|6.5|6.5|||
4301440|NCT00512707|4128632|B1|Erectile function||International Index of Erectile Function (IIEF)|IIEF is a validated, 15-item questionnaire that assesses 5 domains of sexual function: erectile function (range 1-30), orgasmic function (range 0-10), sexual desire (range 2-10), intercourse satisfaction (range 0-15), and overall sexual satisfaction (range 2-10). Each question was answered on a 6-point or 5-point scale from 0/1 to 5 (best) with a total possible score (sum of 5 domains) range of 5 to 75 with higher scores representing better function.|units on a scale|Mean|12.2|12.2|Standard Deviation|5.9|5.9|||
4301441|NCT00512707|4128630|B3|||Free testosterone level||pg/mL|Mean|46|46.0|Standard Deviation|15|15.0|||
4301442|NCT00512707|4128631|B2|||Free testosterone level||pg/mL|Mean|47|47.0|Standard Deviation|16|16.0|||
4301443|NCT00512707|4128632|B1|||Free testosterone level||pg/mL|Mean|45|45.0|Standard Deviation|15|15.0|||
4301444|NCT00512707|4128630|B3|||Total testosterone level <250 ng/dL||Participants|Count of Participants|59|59.0||||||
4301445|NCT00512707|4128631|B2|||Total testosterone level <250 ng/dL||Participants|Count of Participants|28|28.0||||||
4301446|NCT00512707|4128632|B1|||Total testosterone level <250 ng/dL||Participants|Count of Participants|31|31.0||||||
4301447|NCT00512707|4128630|B3|||Total testosterone level||ng/dL|Mean|251|251.0|Standard Deviation|65|65.0|||
4301448|NCT00512707|4128631|B2|||Total testosterone level||ng/dL|Mean|254|254.0|Standard Deviation|68|68.0|||
4301449|NCT00512707|4128632|B1|||Total testosterone level||ng/dL|Mean|248|248.0|Standard Deviation|62|62.0|||
4301450|NCT00512707|4128630|B3|||Cardiovascular disease||Participants|Count of Participants|67|67.0||||||
4301451|NCT00512707|4128631|B2|||Cardiovascular disease||Participants|Count of Participants|32|32.0||||||
4301452|NCT00512707|4128632|B1|||Cardiovascular disease||Participants|Count of Participants|35|35.0||||||
4301453|NCT00512707|4128630|B3|||Hypertension||Participants|Count of Participants|56|56.0||||||
4301454|NCT00512707|4128631|B2|||Hypertension||Participants|Count of Participants|27|27.0||||||
4301455|NCT00512707|4128632|B1|||Hypertension||Participants|Count of Participants|29|29.0||||||
4301456|NCT00512707|4128630|B3|||Diabetes mellitus||Participants|Count of Participants|27|27.0||||||
4301457|NCT00512707|4128631|B2|||Diabetes mellitus||Participants|Count of Participants|14|14.0||||||
4301458|NCT00512707|4128632|B1|||Diabetes mellitus||Participants|Count of Participants|13|13.0||||||
4301459|NCT00512707|4128630|B3|||BMI||kg/m^2|Mean|32.1|32.1|Standard Deviation|6.2|6.2|||
4301460|NCT00512707|4128631|B2|||BMI||kg/m^2|Mean|32.7|32.7|Standard Deviation|6.0|6.0|||
4301461|NCT00512707|4128632|B1|||BMI||kg/m^2|Mean|31.5|31.5|Standard Deviation|6.4|6.4|||
4301462|NCT00512707|4128630|B3|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4301463|NCT00512707|4128631|B2|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4301464|NCT00512707|4128632|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4301465|NCT00512707|4128630|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|68|68.0||||||
4301466|NCT00512707|4128631|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
4301467|NCT00512707|4128632|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
4301468|NCT00512707|4128630|B3|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|61|61.0||||||
4301469|NCT00512707|4128631|B2|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
4301470|NCT00512707|4128632|B1|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
4301471|NCT00512707|4128630|B3|Male||Sex/Gender, Customized||Participants|Count of Participants|140|140.0||||||
4301472|NCT00512707|4128631|B2|Male||Sex/Gender, Customized||Participants|Count of Participants|70|70.0||||||
4301473|NCT00512707|4128632|B1|Male||Sex/Gender, Customized||Participants|Count of Participants|70|70.0||||||
4301474|NCT00512707|4128630|B3|||Age||years|Mean|54.9|54.9|Standard Deviation|8.4|8.4|||
4301475|NCT00512707|4128631|B2|||Age||years|Mean|54.6|54.6|Standard Deviation|8.5|8.5|||
4301498|NCT00512252|4128680|B4|>=Second relapse/salvage||Treatment Indication||participants|Number|4|4.0||||||
4301499|NCT00512252|4128681|B3|>=Second relapse/salvage||Treatment Indication||participants|Number|4|4.0||||||
4301500|NCT00512252|4128682|B2|>=Second relapse/salvage||Treatment Indication||participants|Number|0|0.0||||||
4301501|NCT00512252|4128683|B1|>=Second relapse/salvage||Treatment Indication||participants|Number|0|0.0||||||
4301502|NCT00512252|4128680|B4|Primary refractory||Treatment Indication||participants|Number|11|11.0||||||
4301503|NCT00512252|4128681|B3|Primary refractory||Treatment Indication||participants|Number|10|10.0||||||
4301504|NCT00512252|4128682|B2|Primary refractory||Treatment Indication||participants|Number|1|1.0||||||
4301505|NCT00512252|4128683|B1|Primary refractory||Treatment Indication||participants|Number|0|0.0||||||
4301506|NCT00512252|4128680|B4|First relapse, first salvage||Treatment Indication||participants|Number|37|37.0||||||
4301507|NCT00512252|4128681|B3|First relapse, first salvage||Treatment Indication||participants|Number|32|32.0||||||
4301508|NCT00512252|4128682|B2|First relapse, first salvage||Treatment Indication||participants|Number|2|2.0||||||
4301509|NCT00512252|4128683|B1|First relapse, first salvage||Treatment Indication||participants|Number|3|3.0||||||
4301510|NCT00512252|4128680|B4|Unknown||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status Grade 0 Fully active able to carry on all predisease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (light house work/office work)~Ambulatory, capable of all selfcare but unable to carry out any work activities. Up & about more than 50% of waking hours~Capable of limited selfcare, confined to bed/chair more than 50% of waking hours~Completely disabled. Cannot carry on selfcare. Totally confined to bed/chair~Dead"|participants|Number|8|8.0||||||
4301511|NCT00512252|4128681|B3|Unknown||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status Grade 0 Fully active able to carry on all predisease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (light house work/office work)~Ambulatory, capable of all selfcare but unable to carry out any work activities. Up & about more than 50% of waking hours~Capable of limited selfcare, confined to bed/chair more than 50% of waking hours~Completely disabled. Cannot carry on selfcare. Totally confined to bed/chair~Dead"|participants|Number|8|8.0||||||
4301512|NCT00512252|4128682|B2|Unknown||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status Grade 0 Fully active able to carry on all predisease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (light house work/office work)~Ambulatory, capable of all selfcare but unable to carry out any work activities. Up & about more than 50% of waking hours~Capable of limited selfcare, confined to bed/chair more than 50% of waking hours~Completely disabled. Cannot carry on selfcare. Totally confined to bed/chair~Dead"|participants|Number|0|0.0||||||
4301513|NCT00512252|4128683|B1|Unknown||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status Grade 0 Fully active able to carry on all predisease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (light house work/office work)~Ambulatory, capable of all selfcare but unable to carry out any work activities. Up & about more than 50% of waking hours~Capable of limited selfcare, confined to bed/chair more than 50% of waking hours~Completely disabled. Cannot carry on selfcare. Totally confined to bed/chair~Dead"|participants|Number|0|0.0||||||
4301514|NCT00512252|4128680|B4|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status Grade 0 Fully active able to carry on all predisease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (light house work/office work)~Ambulatory, capable of all selfcare but unable to carry out any work activities. Up & about more than 50% of waking hours~Capable of limited selfcare, confined to bed/chair more than 50% of waking hours~Completely disabled. Cannot carry on selfcare. Totally confined to bed/chair~Dead"|participants|Number|3|3.0||||||
4301515|NCT00512252|4128681|B3|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status Grade 0 Fully active able to carry on all predisease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (light house work/office work)~Ambulatory, capable of all selfcare but unable to carry out any work activities. Up & about more than 50% of waking hours~Capable of limited selfcare, confined to bed/chair more than 50% of waking hours~Completely disabled. Cannot carry on selfcare. Totally confined to bed/chair~Dead"|participants|Number|3|3.0||||||
4301516|NCT00512252|4128682|B2|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status Grade 0 Fully active able to carry on all predisease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (light house work/office work)~Ambulatory, capable of all selfcare but unable to carry out any work activities. Up & about more than 50% of waking hours~Capable of limited selfcare, confined to bed/chair more than 50% of waking hours~Completely disabled. Cannot carry on selfcare. Totally confined to bed/chair~Dead"|participants|Number|0|0.0||||||
4301517|NCT00512252|4128683|B1|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status Grade 0 Fully active able to carry on all predisease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (light house work/office work)~Ambulatory, capable of all selfcare but unable to carry out any work activities. Up & about more than 50% of waking hours~Capable of limited selfcare, confined to bed/chair more than 50% of waking hours~Completely disabled. Cannot carry on selfcare. Totally confined to bed/chair~Dead"|participants|Number|0|0.0||||||
4301541|NCT00512252|4128683|B1|Prior MDS/MPD||Acute myeloid leukemia (AML) source|MDS = myelodysplastic syndrome MPD = myeloproliferative disease|participants|Number|0|0.0||||||
4301542|NCT00512252|4128680|B4|Therapy related||Acute myeloid leukemia (AML) source|MDS = myelodysplastic syndrome MPD = myeloproliferative disease|participants|Number|5|5.0||||||
4301647|NCT00511875|4128770|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4301518|NCT00512252|4128680|B4|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status Grade 0 Fully active able to carry on all predisease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (light house work/office work)~Ambulatory, capable of all selfcare but unable to carry out any work activities. Up & about more than 50% of waking hours~Capable of limited selfcare, confined to bed/chair more than 50% of waking hours~Completely disabled. Cannot carry on selfcare. Totally confined to bed/chair~Dead"|participants|Number|12|12.0||||||
4301519|NCT00512252|4128681|B3|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status Grade 0 Fully active able to carry on all predisease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (light house work/office work)~Ambulatory, capable of all selfcare but unable to carry out any work activities. Up & about more than 50% of waking hours~Capable of limited selfcare, confined to bed/chair more than 50% of waking hours~Completely disabled. Cannot carry on selfcare. Totally confined to bed/chair~Dead"|participants|Number|10|10.0||||||
4301520|NCT00512252|4128682|B2|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status Grade 0 Fully active able to carry on all predisease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (light house work/office work)~Ambulatory, capable of all selfcare but unable to carry out any work activities. Up & about more than 50% of waking hours~Capable of limited selfcare, confined to bed/chair more than 50% of waking hours~Completely disabled. Cannot carry on selfcare. Totally confined to bed/chair~Dead"|participants|Number|1|1.0||||||
4301521|NCT00512252|4128683|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status Grade 0 Fully active able to carry on all predisease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (light house work/office work)~Ambulatory, capable of all selfcare but unable to carry out any work activities. Up & about more than 50% of waking hours~Capable of limited selfcare, confined to bed/chair more than 50% of waking hours~Completely disabled. Cannot carry on selfcare. Totally confined to bed/chair~Dead"|participants|Number|1|1.0||||||
4301522|NCT00512252|4128680|B4|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status Grade 0 Fully active able to carry on all predisease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (light house work/office work)~Ambulatory, capable of all selfcare but unable to carry out any work activities. Up & about more than 50% of waking hours~Capable of limited selfcare, confined to bed/chair more than 50% of waking hours~Completely disabled. Cannot carry on selfcare. Totally confined to bed/chair~Dead"|participants|Number|29|29.0||||||
4301523|NCT00512252|4128681|B3|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status Grade 0 Fully active able to carry on all predisease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (light house work/office work)~Ambulatory, capable of all selfcare but unable to carry out any work activities. Up & about more than 50% of waking hours~Capable of limited selfcare, confined to bed/chair more than 50% of waking hours~Completely disabled. Cannot carry on selfcare. Totally confined to bed/chair~Dead"|participants|Number|25|25.0||||||
4301524|NCT00512252|4128682|B2|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status Grade 0 Fully active able to carry on all predisease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (light house work/office work)~Ambulatory, capable of all selfcare but unable to carry out any work activities. Up & about more than 50% of waking hours~Capable of limited selfcare, confined to bed/chair more than 50% of waking hours~Completely disabled. Cannot carry on selfcare. Totally confined to bed/chair~Dead"|participants|Number|2|2.0||||||
4301525|NCT00512252|4128683|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status Grade 0 Fully active able to carry on all predisease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (light house work/office work)~Ambulatory, capable of all selfcare but unable to carry out any work activities. Up & about more than 50% of waking hours~Capable of limited selfcare, confined to bed/chair more than 50% of waking hours~Completely disabled. Cannot carry on selfcare. Totally confined to bed/chair~Dead"|participants|Number|2|2.0||||||
4301526|NCT00512252|4128680|B4|No prior transplant||Prior transplantation||participants|Number|43|43.0||||||
4301527|NCT00512252|4128681|B3|No prior transplant||Prior transplantation||participants|Number|37|37.0||||||
4301528|NCT00512252|4128682|B2|No prior transplant||Prior transplantation||participants|Number|3|3.0||||||
4301529|NCT00512252|4128683|B1|No prior transplant||Prior transplantation||participants|Number|3|3.0||||||
4301530|NCT00512252|4128680|B4|Allogeneic||Prior transplantation||participants|Number|6|6.0||||||
4301531|NCT00512252|4128681|B3|Allogeneic||Prior transplantation||participants|Number|6|6.0||||||
4301532|NCT00512252|4128682|B2|Allogeneic||Prior transplantation||participants|Number|0|0.0||||||
4301533|NCT00512252|4128683|B1|Allogeneic||Prior transplantation||participants|Number|0|0.0||||||
4301534|NCT00512252|4128680|B4|Autologous||Prior transplantation||participants|Number|3|3.0||||||
4301535|NCT00512252|4128681|B3|Autologous||Prior transplantation||participants|Number|3|3.0||||||
4301536|NCT00512252|4128682|B2|Autologous||Prior transplantation||participants|Number|0|0.0||||||
4301537|NCT00512252|4128683|B1|Autologous||Prior transplantation||participants|Number|0|0.0||||||
4301538|NCT00512252|4128680|B4|Prior MDS/MPD||Acute myeloid leukemia (AML) source|MDS = myelodysplastic syndrome MPD = myeloproliferative disease|participants|Number|6|6.0||||||
4301539|NCT00512252|4128681|B3|Prior MDS/MPD||Acute myeloid leukemia (AML) source|MDS = myelodysplastic syndrome MPD = myeloproliferative disease|participants|Number|6|6.0||||||
4301540|NCT00512252|4128682|B2|Prior MDS/MPD||Acute myeloid leukemia (AML) source|MDS = myelodysplastic syndrome MPD = myeloproliferative disease|participants|Number|0|0.0||||||
4301543|NCT00512252|4128681|B3|Therapy related||Acute myeloid leukemia (AML) source|MDS = myelodysplastic syndrome MPD = myeloproliferative disease|participants|Number|4|4.0||||||
4301544|NCT00512252|4128682|B2|Therapy related||Acute myeloid leukemia (AML) source|MDS = myelodysplastic syndrome MPD = myeloproliferative disease|participants|Number|1|1.0||||||
4301545|NCT00512252|4128683|B1|Therapy related||Acute myeloid leukemia (AML) source|MDS = myelodysplastic syndrome MPD = myeloproliferative disease|participants|Number|0|0.0||||||
4301546|NCT00512252|4128680|B4|De novo AML||Acute myeloid leukemia (AML) source|MDS = myelodysplastic syndrome MPD = myeloproliferative disease|participants|Number|41|41.0||||||
4301547|NCT00512252|4128681|B3|De novo AML||Acute myeloid leukemia (AML) source|MDS = myelodysplastic syndrome MPD = myeloproliferative disease|participants|Number|36|36.0||||||
4301548|NCT00512252|4128682|B2|De novo AML||Acute myeloid leukemia (AML) source|MDS = myelodysplastic syndrome MPD = myeloproliferative disease|participants|Number|2|2.0||||||
4301549|NCT00512252|4128683|B1|De novo AML||Acute myeloid leukemia (AML) source|MDS = myelodysplastic syndrome MPD = myeloproliferative disease|participants|Number|3|3.0||||||
4301550|NCT00512252|4128680|B4|United States||Region of Enrollment||participants|Number|52|52.0||||||
4301551|NCT00512252|4128681|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
4301552|NCT00512252|4128682|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4301553|NCT00512252|4128683|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4301554|NCT00512252|4128680|B4||Male|Gender||Participants|Count of Participants|22|22.0||||||
4301555|NCT00512252|4128681|B3||Male|Gender||Participants|Count of Participants|20|20.0||||||
4301556|NCT00512252|4128682|B2||Male|Gender||Participants|Count of Participants|1|1.0||||||
4301557|NCT00512252|4128683|B1||Male|Gender||Participants|Count of Participants|1|1.0||||||
4301558|NCT00512252|4128680|B4||Female|Gender||Participants|Count of Participants|30|30.0||||||
4301559|NCT00512252|4128681|B3||Female|Gender||Participants|Count of Participants|26|26.0||||||
4301560|NCT00512252|4128682|B2||Female|Gender||Participants|Count of Participants|2|2.0||||||
4301561|NCT00512252|4128683|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
4301562|NCT00512252|4128680|B4|||Age||years|Median|51|51.0|Full Range|||18.0|71.0|
4301563|NCT00512252|4128681|B3|||Age||years|Median|51|51.0|Full Range|||18.0|71.0|
4301564|NCT00512252|4128682|B2|||Age||years|Median|24|24.0|Full Range|||22.0|39.0|
4301565|NCT00512252|4128683|B1|||Age||years|Median|58|58.0|Full Range|||44.0|62.0|
4301566|NCT00512252|4128680|B4||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4301567|NCT00512252|4128681|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4301568|NCT00512252|4128682|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4301569|NCT00512252|4128683|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4301570|NCT00512252|4128680|B4||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4301571|NCT00512252|4128681|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4301572|NCT00512252|4128682|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4301573|NCT00512252|4128683|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4301574|NCT00512252|4128680|B4||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4301575|NCT00512252|4128681|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4301576|NCT00512252|4128682|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301577|NCT00512252|4128683|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301578|NCT00512148|4128713|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4301579|NCT00512148|4128713|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4301580|NCT00512148|4128713|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4301581|NCT00512148|4128713|B1|||Age||years|Mean|28.7|28.7|Standard Deviation|11.41|11.41|||
4301582|NCT00512148|4128713|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4301583|NCT00512148|4128713|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4301584|NCT00512148|4128713|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4301585|NCT00512096|4128719|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4301586|NCT00512096|4128719|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4301587|NCT00512096|4128719|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4301588|NCT00512096|4128719|B1|||Age||years|Median|57.5|57.5|Full Range|||24.0|78.0|
4301589|NCT00511992|4128723|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4301590|NCT00511992|4128723|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4301591|NCT00511992|4128723|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301592|NCT00511992|4128723|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4301593|NCT00511992|4128723|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301594|NCT00511992|4128723|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301595|NCT00511992|4128723|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301596|NCT00511992|4128723|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4301597|NCT00511992|4128723|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4301598|NCT00511992|4128723|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4301599|NCT00511992|4128723|B1|||Age||years|Mean|59|59.0|Full Range|||45.0|78.0|
4301600|NCT00511992|4128723|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4301601|NCT00511992|4128723|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4301602|NCT00511992|4128723|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301603|NCT00511914|4128728|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4301604|NCT00511914|4128729|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4301605|NCT00511914|4128730|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4301606|NCT00511914|4128728|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4301607|NCT00511914|4128729|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4301608|NCT00511914|4128730|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4301609|NCT00511914|4128728|B3|||Age||years|Mean|52.3|52.3|Standard Deviation|17.7|17.7|||
4301610|NCT00511914|4128729|B2|||Age||years|Mean|67.4|67.4|Standard Deviation|4.7|4.7|||
4301611|NCT00511914|4128730|B1|||Age||years|Mean|37.4|37.4|Standard Deviation|12.3|12.3|||
4301612|NCT00511901|4128745|B3|||POMS Depression-Dejection Scale|Profile of Mood States (POMS) Depression-Dejection Scale 15 item questionnaire to measure the degree of depressive thoughts. The POMS scores range from 0 to 60(most depressed).|Scores on a Scale|Median|3|3.0|Inter-Quartile Range|||1.0|8.0|
4301613|NCT00511901|4128746|B2|||POMS Depression-Dejection Scale|Profile of Mood States (POMS) Depression-Dejection Scale 15 item questionnaire to measure the degree of depressive thoughts. The POMS scores range from 0 to 60(most depressed).|Scores on a Scale|Median|3|3.0|Inter-Quartile Range|||0.0|8.0|
4301614|NCT00511901|4128747|B1|||POMS Depression-Dejection Scale|Profile of Mood States (POMS) Depression-Dejection Scale 15 item questionnaire to measure the degree of depressive thoughts. The POMS scores range from 0 to 60(most depressed).|Scores on a Scale|Median|3|3.0|Inter-Quartile Range|||1.0|13.0|
4301615|NCT00511901|4128745|B3|||FACIT Fatigue Scale|FACIT-Fatigue Scale (version 4) 13 item questionnaire to assess level of fatigue. The FACIT-Fatigue scores range from 0 to 52(most fatigue).|Scores on a Scale|Mean|30.4|30.4|Standard Deviation|10.4|10.4|||
4301616|NCT00511901|4128746|B2|||FACIT Fatigue Scale|FACIT-Fatigue Scale (version 4) 13 item questionnaire to assess level of fatigue. The FACIT-Fatigue scores range from 0 to 52(most fatigue).|Scores on a Scale|Mean|29.2|29.2|Standard Deviation|11.6|11.6|||
4301617|NCT00511901|4128747|B1|||FACIT Fatigue Scale|FACIT-Fatigue Scale (version 4) 13 item questionnaire to assess level of fatigue. The FACIT-Fatigue scores range from 0 to 52(most fatigue).|Scores on a Scale|Mean|31.6|31.6|Standard Deviation|9.5|9.5|||
4301618|NCT00511901|4128745|B3|||FIM Motor Scale|The Functional Independence Measure scale is a 7 point rating scale used as part of the Uniform Data System for Medical Rehabilitation. The FIM motor score ranges from 13 to 91 (most independent).|Scores on a Scale|Mean|71.5|71.5|Standard Deviation|8.2|8.2|||
4301619|NCT00511901|4128746|B2|||FIM Motor Scale|The Functional Independence Measure scale is a 7 point rating scale used as part of the Uniform Data System for Medical Rehabilitation. The FIM motor score ranges from 13 to 91 (most independent).|Scores on a Scale|Mean|68.8|68.8|Standard Deviation|6.9|6.9|||
4301620|NCT00511901|4128747|B1|||FIM Motor Scale|The Functional Independence Measure scale is a 7 point rating scale used as part of the Uniform Data System for Medical Rehabilitation. The FIM motor score ranges from 13 to 91 (most independent).|Scores on a Scale|Mean|74.2|74.2|Standard Deviation|8.8|8.8|||
4301621|NCT00511901|4128745|B3|||Days From Admit to Randomization|# of days from admission to the subacute rehabilitation facility to randomization into the study|Days|Mean|5.4|5.4|Standard Deviation|1.6|1.6|||
4301622|NCT00511901|4128746|B2|||Days From Admit to Randomization|# of days from admission to the subacute rehabilitation facility to randomization into the study|Days|Mean|5.3|5.3|Standard Deviation|1.8|1.8|||
4301623|NCT00511901|4128747|B1|||Days From Admit to Randomization|# of days from admission to the subacute rehabilitation facility to randomization into the study|Days|Mean|5.5|5.5|Standard Deviation|1.5|1.5|||
4301624|NCT00511901|4128745|B3|||Hemoglobin Level|Level Prior to Randomization|g/dL|Mean|9.8|9.8|Standard Deviation|0.8|0.8|||
4301625|NCT00511901|4128746|B2|||Hemoglobin Level|Level Prior to Randomization|g/dL|Mean|9.8|9.8|Standard Deviation|0.6|0.6|||
4301626|NCT00511901|4128747|B1|||Hemoglobin Level|Level Prior to Randomization|g/dL|Mean|9.8|9.8|Standard Deviation|1.0|1.0|||
4301627|NCT00511901|4128745|B3|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4301628|NCT00511901|4128746|B2|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4301629|NCT00511901|4128747|B1|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4301630|NCT00511901|4128745|B3|White||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4301631|NCT00511901|4128746|B2|White||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4301632|NCT00511901|4128747|B1|White||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4301633|NCT00511901|4128745|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4301634|NCT00511901|4128746|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4301635|NCT00511901|4128747|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4301636|NCT00511901|4128745|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4301637|NCT00511901|4128746|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4301638|NCT00511901|4128747|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4301639|NCT00511901|4128745|B3|||Age||years|Mean|75.0|75.0|Standard Deviation|8.2|8.2|||
4301640|NCT00511901|4128746|B2|||Age||years|Mean|75.5|75.5|Standard Deviation|8.4|8.4|||
4301641|NCT00511901|4128747|B1|||Age||years|Mean|74.4|74.4|Standard Deviation|8.3|8.3|||
4301642|NCT00511875|4128768|B3|Denmark||Region of Enrollment||participants|Number|16|16.0||||||
4301643|NCT00511875|4128769|B2|Denmark||Region of Enrollment||participants|Number|7|7.0||||||
4301644|NCT00511875|4128770|B1|Denmark||Region of Enrollment||participants|Number|9|9.0||||||
4301645|NCT00511875|4128768|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4301646|NCT00511875|4128769|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4301648|NCT00511875|4128768|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301649|NCT00511875|4128769|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301650|NCT00511875|4128770|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301651|NCT00511875|4128768|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301652|NCT00511875|4128769|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301653|NCT00511875|4128770|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301654|NCT00511875|4128768|B3||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4301655|NCT00511875|4128769|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4301656|NCT00511875|4128770|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4301657|NCT00511875|4128768|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4301658|NCT00511875|4128769|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4301659|NCT00511875|4128770|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301660|NCT00511875|4128768|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301661|NCT00511875|4128769|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301662|NCT00511875|4128770|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301663|NCT00511875|4128768|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301664|NCT00511875|4128769|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301665|NCT00511875|4128770|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301666|NCT00511875|4128768|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301667|NCT00511875|4128769|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301668|NCT00511875|4128770|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4301669|NCT00511875|4128768|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4301670|NCT00511875|4128769|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4301671|NCT00511875|4128770|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4301672|NCT00511875|4128768|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4301673|NCT00511875|4128769|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4301674|NCT00511875|4128770|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4301675|NCT00511875|4128768|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4301676|NCT00511875|4128769|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4301677|NCT00511875|4128770|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4301678|NCT00511875|4128768|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4301679|NCT00511875|4128769|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4301680|NCT00511875|4128770|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4301681|NCT00511875|4128768|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301682|NCT00511875|4128769|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301683|NCT00511875|4128770|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301684|NCT00511862|4128793|B4|United States||Region of Enrollment||participants|Number|151|151.0||||||
4301685|NCT00511862|4128794|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
4301686|NCT00511862|4128795|B2|United States||Region of Enrollment||participants|Number|43|43.0||||||
4301687|NCT00511862|4128796|B1|United States||Region of Enrollment||participants|Number|61|61.0||||||
4301688|NCT00511862|4128793|B4||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4301689|NCT00511862|4128794|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4301690|NCT00511862|4128795|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4301691|NCT00511862|4128796|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4301692|NCT00511862|4128793|B4||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4301693|NCT00511862|4128794|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4301694|NCT00511862|4128795|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4301695|NCT00511862|4128796|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4301696|NCT00511862|4128793|B4|||Age||years|Mean|63.7|63.7|Standard Deviation|11.21|11.21|||
4301697|NCT00511862|4128794|B3|||Age||years|Mean|66.1|66.1|Standard Deviation|8.52|8.52|||
4301698|NCT00511862|4128795|B2|||Age||years|Mean|61.8|61.8|Standard Deviation|13.71|13.71|||
4301699|NCT00511862|4128796|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|10.92|10.92|||
4301700|NCT00511862|4128793|B4||>=65 years|Age||Participants|Count of Participants|80|80.0||||||
4301701|NCT00511862|4128794|B3||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4301702|NCT00511862|4128795|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4301703|NCT00511862|4128796|B1||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4301704|NCT00511862|4128793|B4||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4301705|NCT00511862|4128794|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4301706|NCT00511862|4128795|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4301707|NCT00511862|4128796|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4301708|NCT00511862|4128793|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301709|NCT00511862|4128794|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301710|NCT00511862|4128795|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301711|NCT00511862|4128796|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301712|NCT00511836|4128809|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4301713|NCT00511836|4128810|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4301714|NCT00511836|4128811|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4301715|NCT00511836|4128809|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4301716|NCT00511836|4128810|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4301717|NCT00511836|4128811|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4301718|NCT00511836|4128809|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4301719|NCT00511836|4128810|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4301720|NCT00511836|4128811|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4301721|NCT00511836|4128809|B3|||Age||years|Mean|46.6|46.6|Standard Deviation|9.2|9.2|||
4301722|NCT00511836|4128810|B2|||Age||years|Mean|44.8|44.8|Standard Deviation|9.5|9.5|||
4301723|NCT00511836|4128811|B1|||Age||years|Mean|48.3|48.3|Standard Deviation|8.8|8.8|||
4301724|NCT00511836|4128809|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4301725|NCT00511836|4128810|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4301726|NCT00511836|4128811|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4301727|NCT00511836|4128809|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4301728|NCT00511836|4128810|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4301729|NCT00511836|4128811|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4301730|NCT00511836|4128809|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301731|NCT00511836|4128810|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301732|NCT00511836|4128811|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301733|NCT00511810|4128827|B3|||Depression Score|Patients were required to have a baseline score of >28 and <40 on the Children Depression Rating Scale-Revised (CDRS-R) despite being administered a standard therapeutic dose of an SSRI for a minimum of 6 weeks.|CDRS-R Score|Mean|32.7|32.7|Standard Deviation|4.8|4.8|||
4301734|NCT00511810|4128828|B2|||Depression Score|Patients were required to have a baseline score of >28 and <40 on the Children Depression Rating Scale-Revised (CDRS-R) despite being administered a standard therapeutic dose of an SSRI for a minimum of 6 weeks.|CDRS-R Score|Mean|31.9|31.9|Standard Deviation|6.5|6.5|||
4301735|NCT00511810|4128829|B1|||Depression Score|Patients were required to have a baseline score of >28 and <40 on the Children Depression Rating Scale-Revised (CDRS-R) despite being administered a standard therapeutic dose of an SSRI for a minimum of 6 weeks.|CDRS-R Score|Mean|33.5|33.5|Standard Deviation|3.1|3.1|||
4301736|NCT00511810|4128827|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4301737|NCT00511810|4128828|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4301738|NCT00511810|4128829|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4301739|NCT00511810|4128827|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4301740|NCT00511810|4128828|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4301741|NCT00511810|4128829|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4301742|NCT00511810|4128827|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4301743|NCT00511810|4128828|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4301744|NCT00511810|4128829|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4301745|NCT00511810|4128827|B3|||Age||years|Mean|15.0|15.0|Standard Deviation|3.05|3.05|||
4301746|NCT00511810|4128828|B2|||Age||years|Mean|16.7|16.7|Standard Deviation|2.9|2.9|||
4301747|NCT00511810|4128829|B1|||Age||years|Mean|13.3|13.3|Standard Deviation|3.2|3.2|||
4301748|NCT00511810|4128827|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4301749|NCT00511810|4128828|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4301750|NCT00511810|4128829|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4301751|NCT00511810|4128827|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4301752|NCT00511810|4128828|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4301753|NCT00511810|4128829|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4301754|NCT00511810|4128827|B3||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
4301755|NCT00511810|4128828|B2||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4301756|NCT00511810|4128829|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4301757|NCT00511797|4128836|B5|||Body mass index (BMI)||kg/m^2|Mean|20.82|20.82|Full Range|||15.6|30.0|
4301758|NCT00511797|4128837|B4|||Body mass index (BMI)||kg/m^2|Mean|21.19|21.19|Full Range|||17.2|27.7|
4301759|NCT00511797|4128838|B3|||Body mass index (BMI)||kg/m^2|Mean|20.67|20.67|Full Range|||16.4|29.9|
4301760|NCT00511797|4128839|B2|||Body mass index (BMI)||kg/m^2|Mean|20.41|20.41|Full Range|||16.6|25.8|
4301761|NCT00511797|4128840|B1|||Body mass index (BMI)||kg/m^2|Mean|21.05|21.05|Full Range|||15.6|30.0|
4301762|NCT00511797|4128836|B5|||Average length of menstrual cycle||days|Mean|28.6|28.6|Full Range|||25.0|33.0|
4301763|NCT00511797|4128837|B4|||Average length of menstrual cycle||days|Mean|28.7|28.7|Full Range|||25.0|31.0|
4301764|NCT00511797|4128838|B3|||Average length of menstrual cycle||days|Mean|28.3|28.3|Full Range|||25.0|32.0|
4301765|NCT00511797|4128839|B2|||Average length of menstrual cycle||days|Mean|28.7|28.7|Full Range|||25.0|33.0|
4301766|NCT00511797|4128840|B1|||Average length of menstrual cycle||days|Mean|28.6|28.6|Full Range|||25.0|31.0|
4301767|NCT00511797|4128836|B5|Bicornuate uterus||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|2|2.0||||||
4301768|NCT00511797|4128837|B4|Bicornuate uterus||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|0|0.0||||||
4301769|NCT00511797|4128838|B3|Bicornuate uterus||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|0|0.0||||||
4301770|NCT00511797|4128839|B2|Bicornuate uterus||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|0|0.0||||||
4301771|NCT00511797|4128840|B1|Bicornuate uterus||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|2|2.0||||||
4301772|NCT00511797|4128836|B5|Uterine adenomyosis||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|32|32.0||||||
4301773|NCT00511797|4128837|B4|Uterine adenomyosis||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|8|8.0||||||
4301774|NCT00511797|4128838|B3|Uterine adenomyosis||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|11|11.0||||||
4301775|NCT00511797|4128839|B2|Uterine adenomyosis||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|7|7.0||||||
4301776|NCT00511797|4128840|B1|Uterine adenomyosis||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|6|6.0||||||
4301777|NCT00511797|4128836|B5|Uterine fibroids||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|35|35.0||||||
4301778|NCT00511797|4128837|B4|Uterine fibroids||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|9|9.0||||||
4301779|NCT00511797|4128838|B3|Uterine fibroids||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|10|10.0||||||
4301780|NCT00511797|4128839|B2|Uterine fibroids||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|7|7.0||||||
4301781|NCT00511797|4128840|B1|Uterine fibroids||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|9|9.0||||||
4301782|NCT00511797|4128836|B5|Endometriosis||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|13|13.0||||||
4301783|NCT00511797|4128837|B4|Endometriosis||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|5|5.0||||||
4301784|NCT00511797|4128838|B3|Endometriosis||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|4|4.0||||||
4301785|NCT00511797|4128839|B2|Endometriosis||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|3|3.0||||||
4301786|NCT00511797|4128840|B1|Endometriosis||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|1|1.0||||||
4301787|NCT00511797|4128836|B5|Organic dysmenorrhea||Diagnosis type||participants|Number|64|64.0||||||
4301788|NCT00511797|4128837|B4|Organic dysmenorrhea||Diagnosis type||participants|Number|17|17.0||||||
4301789|NCT00511797|4128838|B3|Organic dysmenorrhea||Diagnosis type||participants|Number|19|19.0||||||
4301790|NCT00511797|4128839|B2|Organic dysmenorrhea||Diagnosis type||participants|Number|14|14.0||||||
4301791|NCT00511797|4128840|B1|Organic dysmenorrhea||Diagnosis type||participants|Number|14|14.0||||||
4301792|NCT00511797|4128836|B5|Functional dysmenorrhea||Diagnosis type||participants|Number|178|178.0||||||
4301793|NCT00511797|4128837|B4|Functional dysmenorrhea||Diagnosis type||participants|Number|41|41.0||||||
4301794|NCT00511797|4128838|B3|Functional dysmenorrhea||Diagnosis type||participants|Number|42|42.0||||||
4301795|NCT00511797|4128839|B2|Functional dysmenorrhea||Diagnosis type||participants|Number|48|48.0||||||
4301796|NCT00511797|4128840|B1|Functional dysmenorrhea||Diagnosis type||participants|Number|47|47.0||||||
4301797|NCT00511797|4128836|B5||Male|Gender||Participants|Count of Participants|0|0.0||||||
4301798|NCT00511797|4128837|B4||Male|Gender||Participants|Count of Participants|0|0.0||||||
4301799|NCT00511797|4128838|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
4301800|NCT00511797|4128839|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
4301801|NCT00511797|4128840|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4301802|NCT00511797|4128836|B5||Female|Gender||Participants|Count of Participants|242|242.0||||||
4301803|NCT00511797|4128837|B4||Female|Gender||Participants|Count of Participants|58|58.0||||||
4301804|NCT00511797|4128838|B3||Female|Gender||Participants|Count of Participants|61|61.0||||||
4301805|NCT00511797|4128839|B2||Female|Gender||Participants|Count of Participants|62|62.0||||||
4301806|NCT00511797|4128840|B1||Female|Gender||Participants|Count of Participants|61|61.0||||||
4301807|NCT00511797|4128836|B5|||Age||years|Mean|30.8|30.8|Full Range|||20.0|48.0|
4301808|NCT00511797|4128837|B4|||Age||years|Mean|30.8|30.8|Full Range|||20.0|44.0|
4301809|NCT00511797|4128838|B3|||Age||years|Mean|30.9|30.9|Full Range|||20.0|48.0|
4301810|NCT00511797|4128839|B2|||Age||years|Mean|30.6|30.6|Full Range|||20.0|43.0|
4301811|NCT00511797|4128840|B1|||Age||years|Mean|31.0|31.0|Full Range|||21.0|45.0|
4301812|NCT00511706|4128945|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4301813|NCT00511706|4128946|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4301814|NCT00511706|4128947|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4301815|NCT00511706|4128945|B3||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4301816|NCT00511706|4128946|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4301817|NCT00511706|4128947|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4301818|NCT00511706|4128945|B3|||Age||Years|Mean|76.1|76.1|Standard Deviation|8.65|8.65|||
4301819|NCT00511706|4128946|B2|||Age||Years|Mean|76.2|76.2|Standard Deviation|8.50|8.5|||
4301820|NCT00511706|4128947|B1|||Age||Years|Mean|76.1|76.1|Standard Deviation|8.83|8.83|||
4301821|NCT00511667|4128960|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4301822|NCT00511667|4128961|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4301823|NCT00511667|4128962|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4301824|NCT00511667|4128960|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4301825|NCT00511667|4128961|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4301826|NCT00511667|4128962|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4301827|NCT00511667|4128960|B3|29 to 70 years||Age, Customized||participants|Number|70|70.0||||||
4301828|NCT00511667|4128961|B2|29 to 70 years||Age, Customized||participants|Number|18|18.0||||||
4301829|NCT00511667|4128962|B1|29 to 70 years||Age, Customized||participants|Number|52|52.0||||||
4301830|NCT00511472|4128996|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4301831|NCT00511472|4128997|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4301832|NCT00511472|4128998|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4301833|NCT00511472|4128996|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4301834|NCT00511472|4128997|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4301835|NCT00511472|4128998|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4301836|NCT00511472|4128996|B3|>69 years||Age, Customized||participants|Number|0|0.0||||||
4301837|NCT00511472|4128997|B2|>69 years||Age, Customized||participants|Number|0|0.0||||||
4301838|NCT00511472|4128998|B1|>69 years||Age, Customized||participants|Number|0|0.0||||||
4301839|NCT00511472|4128996|B3|22 to 69 years||Age, Customized||participants|Number|70|70.0||||||
4301840|NCT00511472|4128997|B2|22 to 69 years||Age, Customized||participants|Number|23|23.0||||||
4301841|NCT00511472|4128998|B1|22 to 69 years||Age, Customized||participants|Number|47|47.0||||||
4301842|NCT00511472|4128996|B3|<22 years||Age, Customized||participants|Number|0|0.0||||||
4301843|NCT00511472|4128997|B2|<22 years||Age, Customized||participants|Number|0|0.0||||||
4301844|NCT00511472|4128998|B1|<22 years||Age, Customized||participants|Number|0|0.0||||||
4301845|NCT00511433|4129016|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4301846|NCT00511433|4129017|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4301847|NCT00511433|4129018|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4301848|NCT00511433|4129016|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4301849|NCT00511433|4129017|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4301850|NCT00511433|4129018|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4301851|NCT00511433|4129016|B3|||Age||years|Mean|22.8|22.8|Standard Deviation|3.6|3.6|||
4301852|NCT00511433|4129017|B2|||Age||years|Mean|22.9|22.9|Standard Deviation|4.3|4.3|||
4301853|NCT00511433|4129018|B1|||Age||years|Mean|22.8|22.8|Standard Deviation|3.3|3.3|||
4301854|NCT00511355|4129057|B3||Male|Sex: Female, Male|All-participants-treated group. For the LNG-EE arm, this population excludes 3 subjects who were randomized but not treated.|Participants|Count of Participants|0|0.0||||||
4301855|NCT00511355|4129058|B2||Male|Sex: Female, Male|All-participants-treated group. For the LNG-EE arm, this population excludes 3 subjects who were randomized but not treated.|Participants|Count of Participants|0|0.0||||||
4301856|NCT00511355|4129059|B1||Male|Sex: Female, Male|All-participants-treated group. For the LNG-EE arm, this population excludes 3 subjects who were randomized but not treated.|Participants|Count of Participants|0|0.0||||||
4301857|NCT00511355|4129057|B3||Female|Sex: Female, Male|All-participants-treated group. For the LNG-EE arm, this population excludes 3 subjects who were randomized but not treated.|Participants|Count of Participants|118|118.0||||||
4301858|NCT00511355|4129058|B2||Female|Sex: Female, Male|All-participants-treated group. For the LNG-EE arm, this population excludes 3 subjects who were randomized but not treated.|Participants|Count of Participants|58|58.0||||||
4301859|NCT00511355|4129059|B1||Female|Sex: Female, Male|All-participants-treated group. For the LNG-EE arm, this population excludes 3 subjects who were randomized but not treated.|Participants|Count of Participants|60|60.0||||||
4301860|NCT00511355|4129057|B3|||Age|All-participants-treated group. For the LNG-EE arm, this population excludes 3 subjects who were randomized but not treated.|years|Mean|28.7|28.7|Standard Deviation|8.0|8.0|||
4301896|NCT00511199|4129210|B3||Female|Sex: Female, Male||Participants|Count of Participants|2126|2126.0||||||
4301861|NCT00511355|4129058|B2|||Age|All-participants-treated group. For the LNG-EE arm, this population excludes 3 subjects who were randomized but not treated.|years|Mean|29.1|29.1|Standard Deviation|7.8|7.8|||
4301862|NCT00511355|4129059|B1|||Age|All-participants-treated group. For the LNG-EE arm, this population excludes 3 subjects who were randomized but not treated.|years|Mean|28.2|28.2|Standard Deviation|8.2|8.2|||
4301863|NCT00511342|4129158|B3|Femoral Neck||Baseline Z-scores of the Lumbar Spine (L2-L4) and Femoral Neck|"The Z-score measures the distance of the measured Bone Mineral Density (BMD) value from the appropriate normal age matched population mean value in units of standard deviation of this population. The following formula was used:~Z-score= BMD value minus mean (age-matched reference population)/ SD (age-matched reference population).~More negative scores indicate less BMD compared to age matched population, and more positive scores indicate higher BMD compared to age matched population."|score on a scale|Mean|0.181|0.181|Full Range|||-2.44|2.54|
4301864|NCT00511342|4129159|B2|Femoral Neck||Baseline Z-scores of the Lumbar Spine (L2-L4) and Femoral Neck|"The Z-score measures the distance of the measured Bone Mineral Density (BMD) value from the appropriate normal age matched population mean value in units of standard deviation of this population. The following formula was used:~Z-score= BMD value minus mean (age-matched reference population)/ SD (age-matched reference population).~More negative scores indicate less BMD compared to age matched population, and more positive scores indicate higher BMD compared to age matched population."|score on a scale|Mean|0.035|0.035|Full Range|||-2.44|2.2|
4301865|NCT00511342|4129160|B1|Femoral Neck||Baseline Z-scores of the Lumbar Spine (L2-L4) and Femoral Neck|"The Z-score measures the distance of the measured Bone Mineral Density (BMD) value from the appropriate normal age matched population mean value in units of standard deviation of this population. The following formula was used:~Z-score= BMD value minus mean (age-matched reference population)/ SD (age-matched reference population).~More negative scores indicate less BMD compared to age matched population, and more positive scores indicate higher BMD compared to age matched population."|score on a scale|Mean|0.321|0.321|Full Range|||-1.8|2.54|
4301866|NCT00511342|4129158|B3|Lumbar Spine||Baseline Z-scores of the Lumbar Spine (L2-L4) and Femoral Neck|"The Z-score measures the distance of the measured Bone Mineral Density (BMD) value from the appropriate normal age matched population mean value in units of standard deviation of this population. The following formula was used:~Z-score= BMD value minus mean (age-matched reference population)/ SD (age-matched reference population).~More negative scores indicate less BMD compared to age matched population, and more positive scores indicate higher BMD compared to age matched population."|score on a scale|Mean|0.127|0.127|Full Range|||-2.3|2.88|
4301867|NCT00511342|4129159|B2|Lumbar Spine||Baseline Z-scores of the Lumbar Spine (L2-L4) and Femoral Neck|"The Z-score measures the distance of the measured Bone Mineral Density (BMD) value from the appropriate normal age matched population mean value in units of standard deviation of this population. The following formula was used:~Z-score= BMD value minus mean (age-matched reference population)/ SD (age-matched reference population).~More negative scores indicate less BMD compared to age matched population, and more positive scores indicate higher BMD compared to age matched population."|score on a scale|Mean|-0.106|-0.106|Full Range|||-2.19|2.88|
4301868|NCT00511342|4129160|B1|Lumbar Spine||Baseline Z-scores of the Lumbar Spine (L2-L4) and Femoral Neck|"The Z-score measures the distance of the measured Bone Mineral Density (BMD) value from the appropriate normal age matched population mean value in units of standard deviation of this population. The following formula was used:~Z-score= BMD value minus mean (age-matched reference population)/ SD (age-matched reference population).~More negative scores indicate less BMD compared to age matched population, and more positive scores indicate higher BMD compared to age matched population."|score on a scale|Mean|0.351|0.351|Full Range|||-2.3|2.7|
4301869|NCT00511342|4129158|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4301870|NCT00511342|4129159|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4301871|NCT00511342|4129160|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4301872|NCT00511342|4129158|B3||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4301873|NCT00511342|4129159|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4301874|NCT00511342|4129160|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4301875|NCT00511342|4129158|B3|||Age||years|Mean|22.6|22.6|Standard Deviation|2.7|2.7|||
4301876|NCT00511342|4129159|B2|||Age||years|Mean|22.1|22.1|Standard Deviation|2.0|2.0|||
4301877|NCT00511342|4129160|B1|||Age||years|Mean|23.0|23.0|Standard Deviation|3.2|3.2|||
4301878|NCT00511238|4129190|B3||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4301879|NCT00511238|4129191|B2||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4301880|NCT00511238|4129192|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4301881|NCT00511238|4129190|B3||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4301882|NCT00511238|4129191|B2||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4301883|NCT00511238|4129192|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4301884|NCT00511238|4129190|B3||>=65 years|Age||Participants|Count of Participants|140|140.0||||||
4301885|NCT00511238|4129191|B2||>=65 years|Age||Participants|Count of Participants|120|120.0||||||
4301886|NCT00511238|4129192|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4301887|NCT00511238|4129190|B3||Between 18 and 65 years|Age||Participants|Count of Participants|172|172.0||||||
4301888|NCT00511238|4129191|B2||Between 18 and 65 years|Age||Participants|Count of Participants|146|146.0||||||
4301889|NCT00511238|4129192|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4301890|NCT00511238|4129190|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301891|NCT00511238|4129191|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301892|NCT00511238|4129192|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301893|NCT00511199|4129210|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4301894|NCT00511199|4129211|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4301895|NCT00511199|4129212|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4301897|NCT00511199|4129211|B2||Female|Sex: Female, Male||Participants|Count of Participants|535|535.0||||||
4301898|NCT00511199|4129212|B1||Female|Sex: Female, Male||Participants|Count of Participants|1591|1591.0||||||
4301899|NCT00511199|4129210|B3|||Age||years|Mean|28.0|28.0|Standard Deviation|7.0|7.0|||
4301900|NCT00511199|4129211|B2|||Age||years|Mean|27.6|27.6|Standard Deviation|7.0|7.0|||
4301901|NCT00511199|4129212|B1|||Age||years|Mean|28.1|28.1|Standard Deviation|7.0|7.0|||
4301902|NCT00511173|4129237|B1|||warfarin dose||mg/wk|Mean|35.4|35.4|Standard Deviation|16.4|16.4|||
4301903|NCT00511173|4129237|B1|||Baseline INR||ratio|Mean|2.6|2.6|Standard Deviation|.4|0.4|||
4301904|NCT00511173|4129237|B1|United States||Region of Enrollment||participants|Number|102|102.0||||||
4301905|NCT00511173|4129237|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4301906|NCT00511173|4129237|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4301907|NCT00511173|4129237|B1|||Age|Age greater than 40 years|years|Median|70|70.0|Full Range|||49.0|82.0|
4301908|NCT00511173|4129237|B1|||Age||years|Mean|71|71.0|Standard Deviation|12.3|12.3|||
4301909|NCT00511173|4129237|B1||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4301910|NCT00511173|4129237|B1||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4301911|NCT00511173|4129237|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301912|NCT00511147|4129242|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
4301913|NCT00511147|4129242|B1|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4301914|NCT00511147|4129242|B1|Black/African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4301915|NCT00511147|4129242|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
4301916|NCT00511147|4129242|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4301917|NCT00511147|4129242|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4301918|NCT00511147|4129242|B1|||Age||years|Mean|33.4|33.4|Standard Deviation|18.50|18.5|||
4301919|NCT00511134|4129249|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4301920|NCT00511134|4129250|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4301921|NCT00511134|4129251|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4301922|NCT00511134|4129249|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4301923|NCT00511134|4129250|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4301924|NCT00511134|4129251|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4301925|NCT00511134|4129249|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4301926|NCT00511134|4129250|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4301927|NCT00511134|4129251|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4301928|NCT00511134|4129249|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4301929|NCT00511134|4129250|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4301930|NCT00511134|4129251|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4301931|NCT00511134|4129249|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4301932|NCT00511134|4129250|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4301933|NCT00511134|4129251|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4301934|NCT00511134|4129249|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301935|NCT00511134|4129250|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301936|NCT00511134|4129251|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301937|NCT00511108|4129260|B5|||Hemoglobin A1c (HbA1c)||Percent|Mean|7.9|7.9|Standard Deviation|1.0|1.0|||
4301938|NCT00511108|4129261|B4|||Hemoglobin A1c (HbA1c)||Percent|Mean|8.0|8.0|Standard Deviation|1.1|1.1|||
4301939|NCT00511108|4129262|B3|||Hemoglobin A1c (HbA1c)||Percent|Mean|7.9|7.9|Standard Deviation|0.9|0.9|||
4301940|NCT00511108|4129263|B2|||Hemoglobin A1c (HbA1c)||Percent|Mean|7.9|7.9|Standard Deviation|0.9|0.9|||
4301941|NCT00511108|4129264|B1|||Hemoglobin A1c (HbA1c)||Percent|Mean|7.7|7.7|Standard Deviation|0.8|0.8|||
4301942|NCT00511108|4129260|B5|||Glucose 5-hour (hr) Total area under the curve (AUC)|"Glucose concentration was measured at 11 points during a Meal Tolerance Test (MTT), at times -10, 0, 10, 20, 30, 60, 90, 120, 180, 240, 300 minutes. Total AUC was calculated over 5 hours including all sample points starting from 0 minutes using the trapezoid method.~The number of participants for the Sitagliptin 100 mg + Pioglitazone 30 mg arm is 51, making the total number of participants for this measure 210."|mg*hr/dL|Mean|1240.4|1240.4|Standard Deviation|328.4|328.4|||
4301943|NCT00511108|4129261|B4|||Glucose 5-hour (hr) Total area under the curve (AUC)|"Glucose concentration was measured at 11 points during a Meal Tolerance Test (MTT), at times -10, 0, 10, 20, 30, 60, 90, 120, 180, 240, 300 minutes. Total AUC was calculated over 5 hours including all sample points starting from 0 minutes using the trapezoid method.~The number of participants for the Sitagliptin 100 mg + Pioglitazone 30 mg arm is 51, making the total number of participants for this measure 210."|mg*hr/dL|Mean|1255.1|1255.1|Standard Deviation|290.9|290.9|||
4301944|NCT00511108|4129262|B3|||Glucose 5-hour (hr) Total area under the curve (AUC)|"Glucose concentration was measured at 11 points during a Meal Tolerance Test (MTT), at times -10, 0, 10, 20, 30, 60, 90, 120, 180, 240, 300 minutes. Total AUC was calculated over 5 hours including all sample points starting from 0 minutes using the trapezoid method.~The number of participants for the Sitagliptin 100 mg + Pioglitazone 30 mg arm is 51, making the total number of participants for this measure 210."|mg*hr/dL|Mean|1276.0|1276.0|Standard Deviation|348.5|348.5|||
4302001|NCT00511004|4129295|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4302002|NCT00511004|4129296|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4301945|NCT00511108|4129263|B2|||Glucose 5-hour (hr) Total area under the curve (AUC)|"Glucose concentration was measured at 11 points during a Meal Tolerance Test (MTT), at times -10, 0, 10, 20, 30, 60, 90, 120, 180, 240, 300 minutes. Total AUC was calculated over 5 hours including all sample points starting from 0 minutes using the trapezoid method.~The number of participants for the Sitagliptin 100 mg + Pioglitazone 30 mg arm is 51, making the total number of participants for this measure 210."|mg*hr/dL|Mean|1250.6|1250.6|Standard Deviation|349.6|349.6|||
4301946|NCT00511108|4129264|B1|||Glucose 5-hour (hr) Total area under the curve (AUC)|"Glucose concentration was measured at 11 points during a Meal Tolerance Test (MTT), at times -10, 0, 10, 20, 30, 60, 90, 120, 180, 240, 300 minutes. Total AUC was calculated over 5 hours including all sample points starting from 0 minutes using the trapezoid method.~The number of participants for the Sitagliptin 100 mg + Pioglitazone 30 mg arm is 51, making the total number of participants for this measure 210."|mg*hr/dL|Mean|1179.9|1179.9|Standard Deviation|322.8|322.8|||
4301947|NCT00511108|4129260|B5|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4301948|NCT00511108|4129261|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4301949|NCT00511108|4129262|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4301950|NCT00511108|4129263|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4301951|NCT00511108|4129264|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4301952|NCT00511108|4129260|B5|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4301953|NCT00511108|4129261|B4|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4301954|NCT00511108|4129262|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4301955|NCT00511108|4129263|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4301956|NCT00511108|4129264|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4301957|NCT00511108|4129260|B5|Black||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4301958|NCT00511108|4129261|B4|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4301959|NCT00511108|4129262|B3|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4301960|NCT00511108|4129263|B2|Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4301961|NCT00511108|4129264|B1|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4301962|NCT00511108|4129260|B5|White||Race/Ethnicity, Customized||participants|Number|185|185.0||||||
4301963|NCT00511108|4129261|B4|White||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
4301964|NCT00511108|4129262|B3|White||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4301965|NCT00511108|4129263|B2|White||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4301966|NCT00511108|4129264|B1|White||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4301967|NCT00511108|4129260|B5||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4301968|NCT00511108|4129261|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4301969|NCT00511108|4129262|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4301970|NCT00511108|4129263|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4301971|NCT00511108|4129264|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4301972|NCT00511108|4129260|B5||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4301973|NCT00511108|4129261|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4301974|NCT00511108|4129262|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4301975|NCT00511108|4129263|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4301976|NCT00511108|4129264|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4301977|NCT00511108|4129260|B5|||Age||years|Mean|53.6|53.6|Standard Deviation|7.9|7.9|||
4301978|NCT00511108|4129261|B4|||Age||years|Mean|53.3|53.3|Standard Deviation|7.7|7.7|||
4301979|NCT00511108|4129262|B3|||Age||years|Mean|53.3|53.3|Standard Deviation|8.6|8.6|||
4301980|NCT00511108|4129263|B2|||Age||years|Mean|53.4|53.4|Standard Deviation|7.8|7.8|||
4301981|NCT00511108|4129264|B1|||Age||years|Mean|54.6|54.6|Standard Deviation|7.6|7.6|||
4301982|NCT00511095|4129285|B1|United States||Region of Enrollment||Participants|Count of Participants|207|207.0||||||
4301983|NCT00511095|4129285|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4301984|NCT00511095|4129285|B1||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4301985|NCT00511095|4129285|B1|||Age||years|Mean|43.0|43.0|Standard Deviation|8.36|8.36|||
4301986|NCT00511095|4129285|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4301987|NCT00511095|4129285|B1||Between 18 and 65 years|Age||Participants|Count of Participants|207|207.0||||||
4301988|NCT00511095|4129285|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4301989|NCT00511004|4129295|B4|||Blood microfilaremia (mf/ml)||MF/ML|Median|384|384.0|Full Range|||64.0|1244.0|
4301990|NCT00511004|4129296|B3|||Blood microfilaremia (mf/ml)||MF/ML|Median|384|384.0|Full Range|||108.0|748.0|
4301991|NCT00511004|4129297|B2|||Blood microfilaremia (mf/ml)||MF/ML|Median|264|264.0|Full Range|||112.0|1244.0|
4301992|NCT00511004|4129298|B1|||Blood microfilaremia (mf/ml)||MF/ML|Median|412|412.0|Full Range|||64.0|912.0|
4301993|NCT00511004|4129295|B4|India||Region of Enrollment||participants|Number|40|40.0||||||
4301994|NCT00511004|4129296|B3|India||Region of Enrollment||participants|Number|14|14.0||||||
4301995|NCT00511004|4129297|B2|India||Region of Enrollment||participants|Number|13|13.0||||||
4301996|NCT00511004|4129298|B1|India||Region of Enrollment||participants|Number|13|13.0||||||
4301997|NCT00511004|4129295|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4301998|NCT00511004|4129296|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4301999|NCT00511004|4129297|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4302000|NCT00511004|4129298|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4302003|NCT00511004|4129297|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4302004|NCT00511004|4129298|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4302005|NCT00511004|4129295|B4|||Age||Years|Median|37|37.0|Full Range|||18.0|54.0|
4302006|NCT00511004|4129296|B3|||Age||Years|Median|37|37.0|Full Range|||19.0|54.0|
4302007|NCT00511004|4129297|B2|||Age||Years|Median|39|39.0|Full Range|||18.0|50.0|
4302008|NCT00511004|4129298|B1|||Age||Years|Median|36|36.0|Full Range|||18.0|50.0|
4302009|NCT00511004|4129295|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4302010|NCT00511004|4129296|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4302011|NCT00511004|4129297|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4302012|NCT00511004|4129298|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4302013|NCT00511004|4129295|B4||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4302014|NCT00511004|4129296|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4302015|NCT00511004|4129297|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4302016|NCT00511004|4129298|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4302017|NCT00511004|4129295|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4302018|NCT00511004|4129296|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4302019|NCT00511004|4129297|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4302020|NCT00511004|4129298|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4302021|NCT00510952|4129317|B3|||Height||centimeters (cm)|Mean|165.03|165.03|Standard Deviation|10.07|10.07|||
4302022|NCT00510952|4129318|B2|||Height||centimeters (cm)|Mean|164.62|164.62|Standard Deviation|10.11|10.11|||
4302023|NCT00510952|4129319|B1|||Height||centimeters (cm)|Mean|165.45|165.45|Standard Deviation|10.04|10.04|||
4302024|NCT00510952|4129317|B3|||Duration of Diabetes||years|Mean|9.85|9.85|Standard Deviation|6.47|6.47|||
4302025|NCT00510952|4129318|B2|||Duration of Diabetes||years|Mean|9.90|9.9|Standard Deviation|6.51|6.51|||
4302026|NCT00510952|4129319|B1|||Duration of Diabetes||years|Mean|9.80|9.8|Standard Deviation|6.45|6.45|||
4302027|NCT00510952|4129317|B3|||Body Weight||kilograms (kg)|Mean|85.14|85.14|Standard Deviation|17.75|17.75|||
4302028|NCT00510952|4129318|B2|||Body Weight||kilograms (kg)|Mean|86.05|86.05|Standard Deviation|18.62|18.62|||
4302029|NCT00510952|4129319|B1|||Body Weight||kilograms (kg)|Mean|84.23|84.23|Standard Deviation|16.83|16.83|||
4302030|NCT00510952|4129317|B3|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|31.16|31.16|Standard Deviation|5.27|5.27|||
4302031|NCT00510952|4129318|B2|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|31.62|31.62|Standard Deviation|5.48|5.48|||
4302032|NCT00510952|4129319|B1|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|30.69|30.69|Standard Deviation|5.01|5.01|||
4302033|NCT00510952|4129317|B3|No||Sulfonylurea Group|Patients with previous sulfonylurea use.|participants|Number|77|77.0||||||
4302034|NCT00510952|4129318|B2|No||Sulfonylurea Group|Patients with previous sulfonylurea use.|participants|Number|39|39.0||||||
4302035|NCT00510952|4129319|B1|No||Sulfonylurea Group|Patients with previous sulfonylurea use.|participants|Number|38|38.0||||||
4302036|NCT00510952|4129317|B3|Yes||Sulfonylurea Group|Patients with previous sulfonylurea use.|participants|Number|381|381.0||||||
4302037|NCT00510952|4129318|B2|Yes||Sulfonylurea Group|Patients with previous sulfonylurea use.|participants|Number|190|190.0||||||
4302038|NCT00510952|4129319|B1|Yes||Sulfonylurea Group|Patients with previous sulfonylurea use.|participants|Number|191|191.0||||||
4302039|NCT00510952|4129317|B3|West Asian (Indian sub-continent)||Race/Ethnicity||participants|Number|59|59.0||||||
4302040|NCT00510952|4129318|B2|West Asian (Indian sub-continent)||Race/Ethnicity||participants|Number|31|31.0||||||
4302041|NCT00510952|4129319|B1|West Asian (Indian sub-continent)||Race/Ethnicity||participants|Number|28|28.0||||||
4302042|NCT00510952|4129317|B3|Native American||Race/Ethnicity||participants|Number|1|1.0||||||
4302043|NCT00510952|4129318|B2|Native American||Race/Ethnicity||participants|Number|1|1.0||||||
4302044|NCT00510952|4129319|B1|Native American||Race/Ethnicity||participants|Number|0|0.0||||||
4302045|NCT00510952|4129317|B3|Hispanic||Race/Ethnicity||participants|Number|59|59.0||||||
4302046|NCT00510952|4129318|B2|Hispanic||Race/Ethnicity||participants|Number|26|26.0||||||
4302047|NCT00510952|4129319|B1|Hispanic||Race/Ethnicity||participants|Number|33|33.0||||||
4302048|NCT00510952|4129317|B3|East Asian||Race/Ethnicity||participants|Number|25|25.0||||||
4302049|NCT00510952|4129318|B2|East Asian||Race/Ethnicity||participants|Number|15|15.0||||||
4302050|NCT00510952|4129319|B1|East Asian||Race/Ethnicity||participants|Number|10|10.0||||||
4302051|NCT00510952|4129317|B3|Caucasian||Race/Ethnicity||participants|Number|289|289.0||||||
4302052|NCT00510952|4129318|B2|Caucasian||Race/Ethnicity||participants|Number|142|142.0||||||
4302053|NCT00510952|4129319|B1|Caucasian||Race/Ethnicity||participants|Number|147|147.0||||||
4302054|NCT00510952|4129317|B3|African||Race/Ethnicity||participants|Number|25|25.0||||||
4302055|NCT00510952|4129318|B2|African||Race/Ethnicity||participants|Number|14|14.0||||||
4302056|NCT00510952|4129319|B1|African||Race/Ethnicity||participants|Number|11|11.0||||||
4302057|NCT00510952|4129317|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
4302058|NCT00510952|4129318|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4302059|NCT00510952|4129319|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4302060|NCT00510952|4129317|B3|Spain||Region of Enrollment||participants|Number|19|19.0||||||
4302061|NCT00510952|4129318|B2|Spain||Region of Enrollment||participants|Number|10|10.0||||||
4302062|NCT00510952|4129319|B1|Spain||Region of Enrollment||participants|Number|9|9.0||||||
4302063|NCT00510952|4129317|B3|Russian Federation||Region of Enrollment||participants|Number|59|59.0||||||
4302064|NCT00510952|4129318|B2|Russian Federation||Region of Enrollment||participants|Number|29|29.0||||||
4302065|NCT00510952|4129319|B1|Russian Federation||Region of Enrollment||participants|Number|30|30.0||||||
4302066|NCT00510952|4129317|B3|Poland||Region of Enrollment||participants|Number|102|102.0||||||
4302067|NCT00510952|4129318|B2|Poland||Region of Enrollment||participants|Number|50|50.0||||||
4302068|NCT00510952|4129319|B1|Poland||Region of Enrollment||participants|Number|52|52.0||||||
4302069|NCT00510952|4129317|B3|Mexico||Region of Enrollment||participants|Number|34|34.0||||||
4302070|NCT00510952|4129318|B2|Mexico||Region of Enrollment||participants|Number|16|16.0||||||
4302071|NCT00510952|4129319|B1|Mexico||Region of Enrollment||participants|Number|18|18.0||||||
4302072|NCT00510952|4129317|B3|Korea, Republic of||Region of Enrollment||participants|Number|22|22.0||||||
4302073|NCT00510952|4129318|B2|Korea, Republic of||Region of Enrollment||participants|Number|13|13.0||||||
4302074|NCT00510952|4129319|B1|Korea, Republic of||Region of Enrollment||participants|Number|9|9.0||||||
4302075|NCT00510952|4129317|B3|India||Region of Enrollment||participants|Number|58|58.0||||||
4302076|NCT00510952|4129318|B2|India||Region of Enrollment||participants|Number|31|31.0||||||
4302077|NCT00510952|4129319|B1|India||Region of Enrollment||participants|Number|27|27.0||||||
4302078|NCT00510952|4129317|B3|Canada||Region of Enrollment||participants|Number|40|40.0||||||
4302079|NCT00510952|4129318|B2|Canada||Region of Enrollment||participants|Number|20|20.0||||||
4302080|NCT00510952|4129319|B1|Canada||Region of Enrollment||participants|Number|20|20.0||||||
4302081|NCT00510952|4129317|B3|Brazil||Region of Enrollment||participants|Number|37|37.0||||||
4302082|NCT00510952|4129318|B2|Brazil||Region of Enrollment||participants|Number|19|19.0||||||
4302083|NCT00510952|4129319|B1|Brazil||Region of Enrollment||participants|Number|18|18.0||||||
4302084|NCT00510952|4129317|B3|Argentina||Region of Enrollment||participants|Number|25|25.0||||||
4302085|NCT00510952|4129318|B2|Argentina||Region of Enrollment||participants|Number|12|12.0||||||
4302086|NCT00510952|4129319|B1|Argentina||Region of Enrollment||participants|Number|13|13.0||||||
4302087|NCT00510952|4129317|B3||Male|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4302088|NCT00510952|4129318|B2||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4302089|NCT00510952|4129319|B1||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4302090|NCT00510952|4129317|B3||Female|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4302091|NCT00510952|4129318|B2||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4302092|NCT00510952|4129319|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4302093|NCT00510952|4129317|B3|||Age||years|Mean|57.67|57.67|Standard Deviation|9.17|9.17|||
4302094|NCT00510952|4129318|B2|||Age||years|Mean|57.29|57.29|Standard Deviation|8.99|8.99|||
4302095|NCT00510952|4129319|B1|||Age||years|Mean|58.05|58.05|Standard Deviation|9.35|9.35|||
4302096|NCT00510887|4129346|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4302097|NCT00510887|4129346|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4302098|NCT00510887|4129346|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4302099|NCT00510887|4129346|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4302100|NCT00510887|4129346|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4302101|NCT00510887|4129346|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4302102|NCT00510887|4129346|B1|||Age||years|Median|59|59.0|Full Range|||39.0|72.0|
4302103|NCT00510874|4129355|B8||Male|Sex: Female, Male||Participants|Count of Participants|331|331.0||||||
4302104|NCT00510874|4129356|B7||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4302105|NCT00510874|4129357|B6||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4302106|NCT00510874|4129358|B5||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4302107|NCT00510874|4129359|B4||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4302108|NCT00510874|4129360|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4302109|NCT00510874|4129361|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4302110|NCT00510874|4129362|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4302111|NCT00510874|4129355|B8||Female|Sex: Female, Male||Participants|Count of Participants|449|449.0||||||
4302112|NCT00510874|4129356|B7||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4302113|NCT00510874|4129357|B6||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4302114|NCT00510874|4129358|B5||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4302115|NCT00510874|4129359|B4||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4302116|NCT00510874|4129360|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4302117|NCT00510874|4129361|B2||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4302118|NCT00510874|4129362|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4302119|NCT00510874|4129355|B8|||Age||Years|Mean|38.8|38.8|Standard Deviation|12.22|12.22|||
4302120|NCT00510874|4129356|B7|||Age||Years|Mean|39.9|39.9|Standard Deviation|13.18|13.18|||
4302121|NCT00510874|4129357|B6|||Age||Years|Mean|39.2|39.2|Standard Deviation|12.21|12.21|||
4302122|NCT00510874|4129358|B5|||Age||Years|Mean|38.7|38.7|Standard Deviation|12.20|12.2|||
4302123|NCT00510874|4129359|B4|||Age||Years|Mean|38.7|38.7|Standard Deviation|11.25|11.25|||
4302124|NCT00510874|4129360|B3|||Age||Years|Mean|39.0|39.0|Standard Deviation|12.59|12.59|||
4302125|NCT00510874|4129361|B2|||Age||Years|Mean|38.1|38.1|Standard Deviation|12.10|12.1|||
4302126|NCT00510874|4129362|B1|||Age||Years|Mean|38.5|38.5|Standard Deviation|12.85|12.85|||
4302127|NCT00510835|4129468|B4|United States||Region of Enrollment||participants|Number|1341|1341.0||||||
4302128|NCT00510835|4129469|B3|United States||Region of Enrollment||participants|Number|456|456.0||||||
4302129|NCT00510835|4129470|B2|United States||Region of Enrollment||participants|Number|446|446.0||||||
4302130|NCT00510835|4129471|B1|United States||Region of Enrollment||participants|Number|439|439.0||||||
4302131|NCT00510835|4129468|B4||Male|Gender||Participants|Count of Participants|748|748.0||||||
4302132|NCT00510835|4129469|B3||Male|Gender||Participants|Count of Participants|264|264.0||||||
4302133|NCT00510835|4129470|B2||Male|Gender||Participants|Count of Participants|252|252.0||||||
4302134|NCT00510835|4129471|B1||Male|Gender||Participants|Count of Participants|232|232.0||||||
4302135|NCT00510835|4129468|B4||Female|Gender||Participants|Count of Participants|593|593.0||||||
4302136|NCT00510835|4129469|B3||Female|Gender||Participants|Count of Participants|192|192.0||||||
4302137|NCT00510835|4129470|B2||Female|Gender||Participants|Count of Participants|194|194.0||||||
4302138|NCT00510835|4129471|B1||Female|Gender||Participants|Count of Participants|207|207.0||||||
4302139|NCT00510835|4129468|B4|||Age||years|Mean|61|61.0|Standard Deviation|16.2|16.2|||
4302140|NCT00510835|4129469|B3|||Age||years|Mean|62|62.0|Standard Deviation|16.0|16.0|||
4302141|NCT00510835|4129470|B2|||Age||years|Mean|61|61.0|Standard Deviation|16.1|16.1|||
4302142|NCT00510835|4129471|B1|||Age||years|Mean|60|60.0|Standard Deviation|16.4|16.4|||
4302143|NCT00510809|4129481|B4|United States||Region of Enrollment||participants|Number|54|54.0||||||
4302144|NCT00510809|4129482|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4302145|NCT00510809|4129483|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4302146|NCT00510809|4129484|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4302147|NCT00510809|4129481|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4302148|NCT00510809|4129482|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4302149|NCT00510809|4129483|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302150|NCT00510809|4129484|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302151|NCT00510809|4129481|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302152|NCT00510809|4129482|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302153|NCT00510809|4129483|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302154|NCT00510809|4129484|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302155|NCT00510809|4129481|B4||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4302156|NCT00510809|4129482|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4302157|NCT00510809|4129483|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4302158|NCT00510809|4129484|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4302159|NCT00510809|4129481|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4302160|NCT00510809|4129482|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4302161|NCT00510809|4129483|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4302162|NCT00510809|4129484|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302163|NCT00510809|4129481|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302164|NCT00510809|4129482|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302165|NCT00510809|4129483|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302166|NCT00510809|4129484|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302167|NCT00510809|4129481|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302168|NCT00510809|4129482|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302169|NCT00510809|4129483|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302170|NCT00510809|4129484|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302171|NCT00510809|4129481|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302172|NCT00510809|4129482|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302173|NCT00510809|4129483|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302174|NCT00510809|4129484|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302175|NCT00510809|4129481|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4302176|NCT00510809|4129482|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4302177|NCT00510809|4129483|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4302178|NCT00510809|4129484|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4302179|NCT00510809|4129481|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4302180|NCT00510809|4129482|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4302181|NCT00510809|4129483|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4302182|NCT00510809|4129484|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4302183|NCT00510809|4129481|B4|||Age||years|Mean|51|51.0|Standard Deviation|13|13.0|||
4302184|NCT00510809|4129482|B3|||Age||years|Mean|46|46.0|Standard Deviation|13|13.0|||
4302185|NCT00510809|4129483|B2|||Age||years|Mean|54|54.0|Standard Deviation|14|14.0|||
4302186|NCT00510809|4129484|B1|||Age||years|Mean|54|54.0|Standard Deviation|12|12.0|||
4302187|NCT00510783|4129497|B3|United States||Region of Enrollment||participants|Number|158|158.0||||||
4302188|NCT00510783|4129498|B2|United States||Region of Enrollment||participants|Number|76|76.0||||||
4302189|NCT00510783|4129499|B1|United States||Region of Enrollment||participants|Number|82|82.0||||||
4302190|NCT00510783|4129497|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4302191|NCT00510783|4129498|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4302192|NCT00510783|4129499|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4302193|NCT00510783|4129497|B3||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4302194|NCT00510783|4129498|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4302195|NCT00510783|4129499|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4302196|NCT00510783|4129497|B3|||Age||years|Mean|58.53|58.53|Standard Deviation|131.651|131.651|||
4302197|NCT00510783|4129498|B2|||Age||years|Mean|65.79|65.79|Standard Deviation|154.721|154.721|||
4302198|NCT00510783|4129499|B1|||Age||years|Mean|51.80|51.8|Standard Deviation|106.459|106.459|||
4302199|NCT00510783|4129497|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4302200|NCT00510783|4129498|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4302201|NCT00510783|4129499|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4302202|NCT00510783|4129497|B3||Between 18 and 65 years|Age||Participants|Count of Participants|153|153.0||||||
4302203|NCT00510783|4129498|B2||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4302204|NCT00510783|4129499|B1||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4302205|NCT00510783|4129497|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4302206|NCT00510783|4129498|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4302207|NCT00510783|4129499|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4302208|NCT00510744|4129506|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4302209|NCT00510744|4129506|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302210|NCT00510744|4129506|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302211|NCT00510744|4129506|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4302212|NCT00510744|4129506|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4302213|NCT00510744|4129506|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302214|NCT00510744|4129506|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302215|NCT00510744|4129506|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302216|NCT00510744|4129506|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4302217|NCT00510744|4129506|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4302218|NCT00510744|4129506|B1|||Age||years|Mean|49|49.0|Full Range|||22.0|58.0|
4302219|NCT00510744|4129506|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4302220|NCT00510744|4129506|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4302221|NCT00510744|4129506|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4302222|NCT00510692|4129510|B3|United Kingdom||Region of Enrollment||participants|Number|55|55.0||||||
4302223|NCT00510692|4129511|B2|United Kingdom||Region of Enrollment||participants|Number|27|27.0||||||
4302224|NCT00510692|4129512|B1|United Kingdom||Region of Enrollment||participants|Number|28|28.0||||||
4302225|NCT00510692|4129510|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4302226|NCT00510692|4129511|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4302227|NCT00510692|4129512|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4302228|NCT00510692|4129510|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4302229|NCT00510692|4129511|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4302230|NCT00510692|4129512|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4302231|NCT00510692|4129510|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4302232|NCT00510692|4129511|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4302233|NCT00510692|4129512|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4302234|NCT00510692|4129510|B3||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4302235|NCT00510692|4129511|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4302236|NCT00510692|4129512|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4302237|NCT00510692|4129510|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4302238|NCT00510692|4129511|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4302239|NCT00510692|4129512|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4302240|NCT00510692|4129510|B3|||Age||years|Mean|40.1|40.1|Standard Deviation|12.6|12.6|||
4302241|NCT00510692|4129511|B2|||Age||years|Mean|42.5|42.5|Standard Deviation|13.8|13.8|||
4302242|NCT00510692|4129512|B1|||Age||years|Mean|39.5|39.5|Standard Deviation|11.4|11.4|||
4302243|NCT00510653|4129527|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4302244|NCT00510653|4129527|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4302245|NCT00510653|4129527|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4302246|NCT00510653|4129527|B1|||Age||years|Median|52|52.0|Full Range|||32.0|69.0|
4302247|NCT00510510|4129531|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4302248|NCT00510510|4129532|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302249|NCT00510510|4129533|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302250|NCT00510510|4129534|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4302251|NCT00510510|4129531|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302252|NCT00510510|4129532|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302253|NCT00510510|4129533|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302254|NCT00510510|4129534|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302255|NCT00510510|4129531|B4||White|Race (NIH/OMB)||Participants|Count of Participants|272|272.0||||||
4302256|NCT00510510|4129532|B3||White|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
4302257|NCT00510510|4129533|B2||White|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
4302258|NCT00510510|4129534|B1||White|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4302259|NCT00510510|4129531|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4302260|NCT00510510|4129532|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4302261|NCT00510510|4129533|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4302262|NCT00510510|4129534|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302263|NCT00510510|4129531|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4302264|NCT00510510|4129532|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302265|NCT00510510|4129533|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4302266|NCT00510510|4129534|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302267|NCT00510510|4129531|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302268|NCT00510510|4129532|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302269|NCT00510510|4129533|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302270|NCT00510510|4129534|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302271|NCT00510510|4129531|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302272|NCT00510510|4129532|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302273|NCT00510510|4129533|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302274|NCT00510510|4129534|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302275|NCT00510510|4129531|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4302276|NCT00510510|4129532|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4302277|NCT00510510|4129533|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4302278|NCT00510510|4129534|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4302279|NCT00510510|4129531|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|227|227.0||||||
4302280|NCT00510510|4129532|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
4302281|NCT00510510|4129533|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
4302282|NCT00510510|4129534|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4302283|NCT00510510|4129531|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4302284|NCT00510510|4129532|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4302285|NCT00510510|4129533|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4302286|NCT00510510|4129534|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4302287|NCT00510510|4129531|B4||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4302288|NCT00510510|4129532|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4302289|NCT00510510|4129533|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4302290|NCT00510510|4129534|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4302291|NCT00510510|4129531|B4||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4302292|NCT00510510|4129532|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4302293|NCT00510510|4129533|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4302294|NCT00510510|4129534|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4302295|NCT00510510|4129531|B4|||Age||years|Mean|63.4|63.4|Standard Deviation|8.82|8.82|||
4302296|NCT00510510|4129532|B3|||Age||years|Mean|63.4|63.4|Standard Deviation|9.44|9.44|||
4302297|NCT00510510|4129533|B2|||Age||years|Mean|62.6|62.6|Standard Deviation|9.04|9.04|||
4302298|NCT00510510|4129534|B1|||Age||years|Mean|64.2|64.2|Standard Deviation|7.93|7.93|||
4302299|NCT00510497|4129547|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4302300|NCT00510497|4129547|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4302301|NCT00510497|4129547|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4302302|NCT00510497|4129547|B1|||Age||years|Median|37.9|37.9|Full Range|||20.0|54.0|
4302303|NCT00510497|4129547|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4302304|NCT00510497|4129547|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4302305|NCT00510497|4129547|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4302306|NCT00510484|4129552|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4302307|NCT00510484|4129553|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4302308|NCT00510484|4129554|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4302309|NCT00510484|4129552|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4302310|NCT00510484|4129553|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4302311|NCT00510484|4129554|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4302312|NCT00510484|4129552|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4302313|NCT00510484|4129553|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4302314|NCT00510484|4129554|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4302315|NCT00510484|4129552|B3|||Age||years|Mean|22.5|22.5|Standard Deviation|7.1|7.1|||
4302316|NCT00510484|4129553|B2|||Age||years|Mean|22.8|22.8|Standard Deviation|6.5|6.5|||
4302317|NCT00510484|4129554|B1|||Age||years|Mean|22.2|22.2|Standard Deviation|7.8|7.8|||
4302318|NCT00510458|4129575|B1|United States||Region of Enrollment||Participants|Count of Participants|74|74.0||||||
4302319|NCT00510458|4129575|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4302320|NCT00510458|4129575|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4302321|NCT00510458|4129575|B1|||Age|For bilateral total hip replacement participants, the age at time of initial hip replacement surgery is used.|years|Mean|61.48|61.48|Standard Deviation|10.37|10.37|||
4302322|NCT00510289|4129588|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4302323|NCT00510289|4129588|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4302324|NCT00510289|4129588|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4302325|NCT00510289|4129588|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4302326|NCT00510289|4129588|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4302327|NCT00510289|4129588|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4302328|NCT00510276|4129596|B3|||Social Adaptation Self-Evaluation Scale (SASS)|The SASS is a patient completed scale that consists of 21 items that examine behavior and subjective perception, including satisfaction, self-perception and motivation in participating in and maintaining relationships with family and friends, satisfaction in work, home and leisure activities, and intellectual interests. Each item is scored from 0 to 3, corresponding to minimal and maximal social adjustment, with a total score range from 0 to 60.|units on a scale|Mean|37.14|37.14|Standard Deviation|6.04|6.04|||
4302329|NCT00510276|4129597|B2|||Social Adaptation Self-Evaluation Scale (SASS)|The SASS is a patient completed scale that consists of 21 items that examine behavior and subjective perception, including satisfaction, self-perception and motivation in participating in and maintaining relationships with family and friends, satisfaction in work, home and leisure activities, and intellectual interests. Each item is scored from 0 to 3, corresponding to minimal and maximal social adjustment, with a total score range from 0 to 60.|units on a scale|Mean|37.28|37.28|Standard Deviation|5.93|5.93|||
4302330|NCT00510276|4129598|B1|||Social Adaptation Self-Evaluation Scale (SASS)|The SASS is a patient completed scale that consists of 21 items that examine behavior and subjective perception, including satisfaction, self-perception and motivation in participating in and maintaining relationships with family and friends, satisfaction in work, home and leisure activities, and intellectual interests. Each item is scored from 0 to 3, corresponding to minimal and maximal social adjustment, with a total score range from 0 to 60.|units on a scale|Mean|36.99|36.99|Standard Deviation|6.17|6.17|||
4302331|NCT00510276|4129596|B3|||Montgomery Asberg Depression Rating Scale (MADRS)|Rating scale for severity of depressive mood symptoms, administered by the investigator. The scale consists of 10 items, each rated on a scale from 0 to 6. The MADRS total score is the sum of the 10 items and the score ranges from 0 to 60. Higher scores denote more severe depressive symptoms.|units on a scale|Mean|6.48|6.48|Standard Deviation|4.14|4.14|||
4302332|NCT00510276|4129597|B2|||Montgomery Asberg Depression Rating Scale (MADRS)|Rating scale for severity of depressive mood symptoms, administered by the investigator. The scale consists of 10 items, each rated on a scale from 0 to 6. The MADRS total score is the sum of the 10 items and the score ranges from 0 to 60. Higher scores denote more severe depressive symptoms.|units on a scale|Mean|6.29|6.29|Standard Deviation|4.01|4.01|||
4302333|NCT00510276|4129598|B1|||Montgomery Asberg Depression Rating Scale (MADRS)|Rating scale for severity of depressive mood symptoms, administered by the investigator. The scale consists of 10 items, each rated on a scale from 0 to 6. The MADRS total score is the sum of the 10 items and the score ranges from 0 to 60. Higher scores denote more severe depressive symptoms.|units on a scale|Mean|6.68|6.68|Standard Deviation|4.28|4.28|||
4302334|NCT00510276|4129596|B3|||Habits Timeline Followback (TLFB) Incidence for Use of Nicotine|Variation of the Alcohol Timeline Followback (TLFB) which is a method for assessing the quantity of alcohol consumption on a daily basis. This subscale assesses the amount of nicotine consumed by an individual. With a calendar as a guide, the interviewee provides a retrospective estimate of daily habits over a specified period of as long as the previous year. The goal is to provide a detailed record of patterns of use that can be used to guide treatment and to assess treatment outcome.|number of nicotine-products used per day|Mean|6.65|6.65|Standard Deviation|7.57|7.57|||
4302335|NCT00510276|4129597|B2|||Habits Timeline Followback (TLFB) Incidence for Use of Nicotine|Variation of the Alcohol Timeline Followback (TLFB) which is a method for assessing the quantity of alcohol consumption on a daily basis. This subscale assesses the amount of nicotine consumed by an individual. With a calendar as a guide, the interviewee provides a retrospective estimate of daily habits over a specified period of as long as the previous year. The goal is to provide a detailed record of patterns of use that can be used to guide treatment and to assess treatment outcome.|number of nicotine-products used per day|Mean|6.41|6.41|Standard Deviation|7.44|7.44|||
4302503|NCT00510068|4129781|B3|Asian||Race/Ethnicity, Customized||Participants|Number|74|74.0||||||
4302336|NCT00510276|4129598|B1|||Habits Timeline Followback (TLFB) Incidence for Use of Nicotine|Variation of the Alcohol Timeline Followback (TLFB) which is a method for assessing the quantity of alcohol consumption on a daily basis. This subscale assesses the amount of nicotine consumed by an individual. With a calendar as a guide, the interviewee provides a retrospective estimate of daily habits over a specified period of as long as the previous year. The goal is to provide a detailed record of patterns of use that can be used to guide treatment and to assess treatment outcome.|number of nicotine-products used per day|Mean|6.91|6.91|Standard Deviation|7.73|7.73|||
4302337|NCT00510276|4129596|B3|||Habits Timeline Followback (TLFB) Incidence for Use of Marijuana|Variation of the Alcohol Timeline Followback (TLFB) which is a method for assessing the quantity of alcohol consumption on a daily basis. This subscale assesses the amount of marjuana consumed by an individual. With a calendar as a guide, the interviewee provides a retrospective estimate of daily habits over a specified period of as long as the previous year. The goal is to provide a detailed record of patterns of use that can be used to guide treatment and to assess treatment outcome. Recorded is the number of joints that have been consumed.|number of joints smoked per day|Mean|0.34|0.34|Standard Deviation|0.50|0.5|||
4302338|NCT00510276|4129597|B2|||Habits Timeline Followback (TLFB) Incidence for Use of Marijuana|Variation of the Alcohol Timeline Followback (TLFB) which is a method for assessing the quantity of alcohol consumption on a daily basis. This subscale assesses the amount of marjuana consumed by an individual. With a calendar as a guide, the interviewee provides a retrospective estimate of daily habits over a specified period of as long as the previous year. The goal is to provide a detailed record of patterns of use that can be used to guide treatment and to assess treatment outcome. Recorded is the number of joints that have been consumed.|number of joints smoked per day|Mean|0.28|0.28|Standard Deviation|0.38|0.38|||
4302339|NCT00510276|4129598|B1|||Habits Timeline Followback (TLFB) Incidence for Use of Marijuana|Variation of the Alcohol Timeline Followback (TLFB) which is a method for assessing the quantity of alcohol consumption on a daily basis. This subscale assesses the amount of marjuana consumed by an individual. With a calendar as a guide, the interviewee provides a retrospective estimate of daily habits over a specified period of as long as the previous year. The goal is to provide a detailed record of patterns of use that can be used to guide treatment and to assess treatment outcome. Recorded is the number of joints that have been consumed.|number of joints smoked per day|Mean|0.39|0.39|Standard Deviation|0.59|0.59|||
4302340|NCT00510276|4129596|B3|||Habits Timeline Followback (TLFB) Incidence for Use of Drugs|Variation of the Alcohol Timeline Followback (TLFB) which is a method for assessing the quantity of alcohol consumption on a daily basis. This subscale assesses the amount of recreational drugs other than marijuana an individual consumed and is expressed as the ratio of number of days on which drugs were used over the total number of days, resulting in a total score ranging from 0 to 1. With a calendar as a guide, the interviewee provides a retrospective estimate of daily habits over a specified period of as long as the previous year.|ratio|Mean|0.18|0.18|Standard Deviation|0.24|0.24|||
4302341|NCT00510276|4129597|B2|||Habits Timeline Followback (TLFB) Incidence for Use of Drugs|Variation of the Alcohol Timeline Followback (TLFB) which is a method for assessing the quantity of alcohol consumption on a daily basis. This subscale assesses the amount of recreational drugs other than marijuana an individual consumed and is expressed as the ratio of number of days on which drugs were used over the total number of days, resulting in a total score ranging from 0 to 1. With a calendar as a guide, the interviewee provides a retrospective estimate of daily habits over a specified period of as long as the previous year.|ratio|Mean|0.27|0.27|Standard Deviation|0.37|0.37|||
4302342|NCT00510276|4129598|B1|||Habits Timeline Followback (TLFB) Incidence for Use of Drugs|Variation of the Alcohol Timeline Followback (TLFB) which is a method for assessing the quantity of alcohol consumption on a daily basis. This subscale assesses the amount of recreational drugs other than marijuana an individual consumed and is expressed as the ratio of number of days on which drugs were used over the total number of days, resulting in a total score ranging from 0 to 1. With a calendar as a guide, the interviewee provides a retrospective estimate of daily habits over a specified period of as long as the previous year.|ratio|Mean|0.13|0.13|Standard Deviation|0.15|0.15|||
4302343|NCT00510276|4129596|B3|||Habits Timeline Followback (TLFB) Incidence for Use of Caffeine|Variation of the Alcohol Timeline Followback (TLFB) which is a method for assessing the quantity of alcohol consumption on a daily basis. This subscale assesses the amount of caffeine consumed by an individual. With a calendar as a guide, the interviewee provides a retrospective estimate of daily habits over a specified period of as long as the previous year. The goal is to provide a detailed record of patterns of use that can be used to guide treatment and to assess treatment outcome.|number of caffeinated drinks per day|Mean|1.82|1.82|Standard Deviation|2.55|2.55|||
4302344|NCT00510276|4129597|B2|||Habits Timeline Followback (TLFB) Incidence for Use of Caffeine|Variation of the Alcohol Timeline Followback (TLFB) which is a method for assessing the quantity of alcohol consumption on a daily basis. This subscale assesses the amount of caffeine consumed by an individual. With a calendar as a guide, the interviewee provides a retrospective estimate of daily habits over a specified period of as long as the previous year. The goal is to provide a detailed record of patterns of use that can be used to guide treatment and to assess treatment outcome.|number of caffeinated drinks per day|Mean|1.87|1.87|Standard Deviation|3.19|3.19|||
4302345|NCT00510276|4129598|B1|||Habits Timeline Followback (TLFB) Incidence for Use of Caffeine|Variation of the Alcohol Timeline Followback (TLFB) which is a method for assessing the quantity of alcohol consumption on a daily basis. This subscale assesses the amount of caffeine consumed by an individual. With a calendar as a guide, the interviewee provides a retrospective estimate of daily habits over a specified period of as long as the previous year. The goal is to provide a detailed record of patterns of use that can be used to guide treatment and to assess treatment outcome.|number of caffeinated drinks per day|Mean|1.78|1.78|Standard Deviation|1.72|1.72|||
4302346|NCT00510276|4129596|B3|||Habits Timeline Followback (TLFB) Incidence for Use of Alcohol|Variation of the Alcohol Timeline Followback (TLFB) which is a method for assessing the quantity of alcohol consumption on a daily basis. With a calendar as a guide, the interviewee provides a retrospective estimate of daily habits over a specified period of as long as the previous year. The goal is to provide a detailed record of patterns of use that can be used to guide treatment and to assess treatment outcome. Recorded is the number of standard drinks that have been consumed.|number of alcoholic drinks per day|Mean|1.03|1.03|Standard Deviation|1.38|1.38|||
4302504|NCT00510068|4129782|B2|Asian||Race/Ethnicity, Customized||Participants|Number|34|34.0||||||
4302347|NCT00510276|4129597|B2|||Habits Timeline Followback (TLFB) Incidence for Use of Alcohol|Variation of the Alcohol Timeline Followback (TLFB) which is a method for assessing the quantity of alcohol consumption on a daily basis. With a calendar as a guide, the interviewee provides a retrospective estimate of daily habits over a specified period of as long as the previous year. The goal is to provide a detailed record of patterns of use that can be used to guide treatment and to assess treatment outcome. Recorded is the number of standard drinks that have been consumed.|number of alcoholic drinks per day|Mean|1.08|1.08|Standard Deviation|1.44|1.44|||
4302348|NCT00510276|4129598|B1|||Habits Timeline Followback (TLFB) Incidence for Use of Alcohol|Variation of the Alcohol Timeline Followback (TLFB) which is a method for assessing the quantity of alcohol consumption on a daily basis. With a calendar as a guide, the interviewee provides a retrospective estimate of daily habits over a specified period of as long as the previous year. The goal is to provide a detailed record of patterns of use that can be used to guide treatment and to assess treatment outcome. Recorded is the number of standard drinks that have been consumed.|number of alcoholic drinks per day|Mean|0.98|0.98|Standard Deviation|1.33|1.33|||
4302349|NCT00510276|4129596|B3|||Fagerstrom Test for Nicotine Dependence (FTND)|The FTND was designed to provide an ordinal measure of nicotine dependence related to cigarette smoking. It contains items that evaluate the quantity of cigarette consumption, the compulsion to use, and dependence. The FTND contains 4 yes-no and 2 multiple choice questions and can be used in a self-report format. The items on FTND are scored 0 to 3 for multiple choice items, the items are summed to yield a total score of 0-10 (0=minimum nicotine dependence; 10=maximum nicotine dependence).|units on a scale|Mean|2.20|2.2|Standard Deviation|2.16|2.16|||
4302350|NCT00510276|4129597|B2|||Fagerstrom Test for Nicotine Dependence (FTND)|The FTND was designed to provide an ordinal measure of nicotine dependence related to cigarette smoking. It contains items that evaluate the quantity of cigarette consumption, the compulsion to use, and dependence. The FTND contains 4 yes-no and 2 multiple choice questions and can be used in a self-report format. The items on FTND are scored 0 to 3 for multiple choice items, the items are summed to yield a total score of 0-10 (0=minimum nicotine dependence; 10=maximum nicotine dependence).|units on a scale|Mean|2.33|2.33|Standard Deviation|2.22|2.22|||
4302351|NCT00510276|4129598|B1|||Fagerstrom Test for Nicotine Dependence (FTND)|The FTND was designed to provide an ordinal measure of nicotine dependence related to cigarette smoking. It contains items that evaluate the quantity of cigarette consumption, the compulsion to use, and dependence. The FTND contains 4 yes-no and 2 multiple choice questions and can be used in a self-report format. The items on FTND are scored 0 to 3 for multiple choice items, the items are summed to yield a total score of 0-10 (0=minimum nicotine dependence; 10=maximum nicotine dependence).|units on a scale|Mean|2.08|2.08|Standard Deviation|2.10|2.1|||
4302352|NCT00510276|4129596|B3|||Epworth Sleepiness Scale (ESS)|Used to determine the level of daytime sleepiness. The ESS is a self-rated questionnaire with 8 items that describe normative daily situations known to vary in their soporific qualities. Subjects rate the likelihood of dozing off or falling asleep in each of these situations. Each item is rated on a 4-point scale from 0 (would never doze) to 3 (high chance of dozing). The item scores are summed to produce a total score (range of 0-24). Score >10 (95th percentile) are considered to be suggestive of significant daytime sleepiness.|units on a scale|Mean|9.71|9.71|Standard Deviation|4.72|4.72|||
4302353|NCT00510276|4129597|B2|||Epworth Sleepiness Scale (ESS)|Used to determine the level of daytime sleepiness. The ESS is a self-rated questionnaire with 8 items that describe normative daily situations known to vary in their soporific qualities. Subjects rate the likelihood of dozing off or falling asleep in each of these situations. Each item is rated on a 4-point scale from 0 (would never doze) to 3 (high chance of dozing). The item scores are summed to produce a total score (range of 0-24). Score >10 (95th percentile) are considered to be suggestive of significant daytime sleepiness.|units on a scale|Mean|9.60|9.6|Standard Deviation|4.74|4.74|||
4302354|NCT00510276|4129598|B1|||Epworth Sleepiness Scale (ESS)|Used to determine the level of daytime sleepiness. The ESS is a self-rated questionnaire with 8 items that describe normative daily situations known to vary in their soporific qualities. Subjects rate the likelihood of dozing off or falling asleep in each of these situations. Each item is rated on a 4-point scale from 0 (would never doze) to 3 (high chance of dozing). The item scores are summed to produce a total score (range of 0-24). Score >10 (95th percentile) are considered to be suggestive of significant daytime sleepiness.|units on a scale|Mean|9.82|9.82|Standard Deviation|4.71|4.71|||
4302355|NCT00510276|4129596|B3|||Driving Behavior Survey-Other Report|26-item driving survey completed by someone other than the patient/driver. Examples of driving behaviors included in the survey match those listed in the Self-Report version of the scale. Items are rated on a 4-point scale (1 = not at all or rarely, 2 = sometimes, 3 = often, 4 = very often). The total score is the sum of the 26 items and ranges from 26 to 104.|units on a scale|Mean|74.77|74.77|Standard Deviation|11.21|11.21|||
4302356|NCT00510276|4129597|B2|||Driving Behavior Survey-Other Report|26-item driving survey completed by someone other than the patient/driver. Examples of driving behaviors included in the survey match those listed in the Self-Report version of the scale. Items are rated on a 4-point scale (1 = not at all or rarely, 2 = sometimes, 3 = often, 4 = very often). The total score is the sum of the 26 items and ranges from 26 to 104.|units on a scale|Mean|78.00|78.0|Standard Deviation|11.24|11.24|||
4302357|NCT00510276|4129598|B1|||Driving Behavior Survey-Other Report|26-item driving survey completed by someone other than the patient/driver. Examples of driving behaviors included in the survey match those listed in the Self-Report version of the scale. Items are rated on a 4-point scale (1 = not at all or rarely, 2 = sometimes, 3 = often, 4 = very often). The total score is the sum of the 26 items and ranges from 26 to 104.|units on a scale|Mean|70.90|70.9|Standard Deviation|10.13|10.13|||
4302358|NCT00510276|4129596|B3|||Driving Behavior Survey Self-Report|26 item self-rated driving survey with examples of driving behaviors, e.g.: putting on seat belt, driving within speed limits, yielding the right of way to other drivers. Items are rated on a 4-point scale (1 = not at all or rarely, 2 = sometimes, 3 = often, 4 = very often). The total score is the sum of the 26 items. A driving history is completed by self-report the first time a rater completes the Driving Behavior Survey (Self-Report). The total score ranges from 26 to 104.|units on a scale|Mean|79.41|79.41|Standard Deviation|12.67|12.67|||
4302505|NCT00510068|4129783|B1|Asian||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
4302506|NCT00510068|4129781|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|322|322.0||||||
4302359|NCT00510276|4129597|B2|||Driving Behavior Survey Self-Report|26 item self-rated driving survey with examples of driving behaviors, e.g.: putting on seat belt, driving within speed limits, yielding the right of way to other drivers. Items are rated on a 4-point scale (1 = not at all or rarely, 2 = sometimes, 3 = often, 4 = very often). The total score is the sum of the 26 items. A driving history is completed by self-report the first time a rater completes the Driving Behavior Survey (Self-Report). The total score ranges from 26 to 104.|units on a scale|Mean|78.95|78.95|Standard Deviation|12.46|12.46|||
4302360|NCT00510276|4129598|B1|||Driving Behavior Survey Self-Report|26 item self-rated driving survey with examples of driving behaviors, e.g.: putting on seat belt, driving within speed limits, yielding the right of way to other drivers. Items are rated on a 4-point scale (1 = not at all or rarely, 2 = sometimes, 3 = often, 4 = very often). The total score is the sum of the 26 items. A driving history is completed by self-report the first time a rater completes the Driving Behavior Survey (Self-Report). The total score ranges from 26 to 104.|units on a scale|Mean|79.86|79.86|Standard Deviation|12.89|12.89|||
4302361|NCT00510276|4129596|B3|||Conners' Adult ADHD Rating Scale - Investigator Rated:Screening Version Total Score|CAARS-Inv:SV is a 30-item scale containing 3 subscales: the Inattention subscale, the Hyperactivity-Impulsivity subscale, and the ADHD Index. The 18-item total ADHD symptom score is the sum of the Inattention and Hyperactivity-Impulsivity subscales. Each item is scored on a 0 to 3 scale (0=not at all, never; 1=just a little, once in a while; 2=pretty much, often; 3=very much, very frequently). The scale assesses symptom severity over the past week. The total score ranges from 0 to 54.|units on a scale|Mean|39.05|39.05|Standard Deviation|7.59|7.59|||
4302362|NCT00510276|4129597|B2|||Conners' Adult ADHD Rating Scale - Investigator Rated:Screening Version Total Score|CAARS-Inv:SV is a 30-item scale containing 3 subscales: the Inattention subscale, the Hyperactivity-Impulsivity subscale, and the ADHD Index. The 18-item total ADHD symptom score is the sum of the Inattention and Hyperactivity-Impulsivity subscales. Each item is scored on a 0 to 3 scale (0=not at all, never; 1=just a little, once in a while; 2=pretty much, often; 3=very much, very frequently). The scale assesses symptom severity over the past week. The total score ranges from 0 to 54.|units on a scale|Mean|38.95|38.95|Standard Deviation|7.72|7.72|||
4302363|NCT00510276|4129598|B1|||Conners' Adult ADHD Rating Scale - Investigator Rated:Screening Version Total Score|CAARS-Inv:SV is a 30-item scale containing 3 subscales: the Inattention subscale, the Hyperactivity-Impulsivity subscale, and the ADHD Index. The 18-item total ADHD symptom score is the sum of the Inattention and Hyperactivity-Impulsivity subscales. Each item is scored on a 0 to 3 scale (0=not at all, never; 1=just a little, once in a while; 2=pretty much, often; 3=very much, very frequently). The scale assesses symptom severity over the past week. The total score ranges from 0 to 54.|units on a scale|Mean|39.15|39.15|Standard Deviation|7.48|7.48|||
4302364|NCT00510276|4129596|B3|||Conners' ADHD Rating Scale Self Report (CAARS-S:SV) Total Score|The CAARS-S:SV is a 30-item patient-reported scale with 3 subscales: Inattention subscale, Hyperactivity-Impulsivity subscale, and ADHD Index. 18-item total ADHD symptom score is the sum of the Inattention and Hyperactivity-Impulsivity subscales. Each individual item is scored on a 0 to 3 scale (0 = not at all, never; 1 = just a little, once in a while; 2 = Pretty much, often; 3 = very much, very frequently). The rating scale assesses symptom severity over the past week. The total score ranges from 0 to 54.|units on a scale|Mean|35.36|35.36|Standard Deviation|8.78|8.78|||
4302365|NCT00510276|4129597|B2|||Conners' ADHD Rating Scale Self Report (CAARS-S:SV) Total Score|The CAARS-S:SV is a 30-item patient-reported scale with 3 subscales: Inattention subscale, Hyperactivity-Impulsivity subscale, and ADHD Index. 18-item total ADHD symptom score is the sum of the Inattention and Hyperactivity-Impulsivity subscales. Each individual item is scored on a 0 to 3 scale (0 = not at all, never; 1 = just a little, once in a while; 2 = Pretty much, often; 3 = very much, very frequently). The rating scale assesses symptom severity over the past week. The total score ranges from 0 to 54.|units on a scale|Mean|35.69|35.69|Standard Deviation|8.60|8.6|||
4302366|NCT00510276|4129598|B1|||Conners' ADHD Rating Scale Self Report (CAARS-S:SV) Total Score|The CAARS-S:SV is a 30-item patient-reported scale with 3 subscales: Inattention subscale, Hyperactivity-Impulsivity subscale, and ADHD Index. 18-item total ADHD symptom score is the sum of the Inattention and Hyperactivity-Impulsivity subscales. Each individual item is scored on a 0 to 3 scale (0 = not at all, never; 1 = just a little, once in a while; 2 = Pretty much, often; 3 = very much, very frequently). The rating scale assesses symptom severity over the past week. The total score ranges from 0 to 54.|units on a scale|Mean|35.01|35.01|Standard Deviation|8.97|8.97|||
4302367|NCT00510276|4129596|B3|||Clinical Global Impression-ADHD- Severity (CGI-ADHD-S)|Single-item clinician rating of the clinician’s assessment of the patient’s severity of the ADHD symptoms in relation to the clinician’s total experience with ADHD patients. Severity is rated on a 7-point scale (1 = normal, not at all ill; 7 = among the most extremely ill patients). The total score ranges from 1 to 7.|units on a scale|Mean|4.74|4.74|Standard Deviation|0.65|0.65|||
4302368|NCT00510276|4129597|B2|||Clinical Global Impression-ADHD- Severity (CGI-ADHD-S)|Single-item clinician rating of the clinician’s assessment of the patient’s severity of the ADHD symptoms in relation to the clinician’s total experience with ADHD patients. Severity is rated on a 7-point scale (1 = normal, not at all ill; 7 = among the most extremely ill patients). The total score ranges from 1 to 7.|units on a scale|Mean|4.68|4.68|Standard Deviation|0.64|0.64|||
4302369|NCT00510276|4129598|B1|||Clinical Global Impression-ADHD- Severity (CGI-ADHD-S)|Single-item clinician rating of the clinician’s assessment of the patient’s severity of the ADHD symptoms in relation to the clinician’s total experience with ADHD patients. Severity is rated on a 7-point scale (1 = normal, not at all ill; 7 = among the most extremely ill patients). The total score ranges from 1 to 7.|units on a scale|Mean|4.79|4.79|Standard Deviation|0.66|0.66|||
4302370|NCT00510276|4129596|B3|||Behavior Rating Inventory of Executive Function-Adult Version Self Report- Organization of Materials|The BRIEF-A Organization of Materials assesses an individuals' organizing skills in his or her everyday environment. The self-report form is designed to be completed by adults 18-90 years of age, including adults with a wide variety of developmental, systemic, neurological, and psychiatric disorders. Observations are rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. The total score ranges from 8 to 24.|units on a scale|Mean|18.91|18.91|Standard Deviation|3.97|3.97|||
4302507|NCT00510068|4129782|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|166|166.0||||||
4302371|NCT00510276|4129597|B2|||Behavior Rating Inventory of Executive Function-Adult Version Self Report- Organization of Materials|The BRIEF-A Organization of Materials assesses an individuals' organizing skills in his or her everyday environment. The self-report form is designed to be completed by adults 18-90 years of age, including adults with a wide variety of developmental, systemic, neurological, and psychiatric disorders. Observations are rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. The total score ranges from 8 to 24.|units on a scale|Mean|19.00|19.0|Standard Deviation|3.87|3.87|||
4302372|NCT00510276|4129598|B1|||Behavior Rating Inventory of Executive Function-Adult Version Self Report- Organization of Materials|The BRIEF-A Organization of Materials assesses an individuals' organizing skills in his or her everyday environment. The self-report form is designed to be completed by adults 18-90 years of age, including adults with a wide variety of developmental, systemic, neurological, and psychiatric disorders. Observations are rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. The total score ranges from 8 to 24.|units on a scale|Mean|18.82|18.82|Standard Deviation|4.07|4.07|||
4302373|NCT00510276|4129596|B3|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - Working Memory|The BRIEF-A Working Memory assesses an individuals' memory function in his or her everyday environment. The self-report form is designed to be completed by adults 18-90 years of age, including adults with a wide variety of developmental, systemic, neurological, and psychiatric disorders. Observations are rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. The total score ranges from 8 to 24.|units on a scale|Mean|19.87|19.87|Standard Deviation|2.71|2.71|||
4302374|NCT00510276|4129597|B2|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - Working Memory|The BRIEF-A Working Memory assesses an individuals' memory function in his or her everyday environment. The self-report form is designed to be completed by adults 18-90 years of age, including adults with a wide variety of developmental, systemic, neurological, and psychiatric disorders. Observations are rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. The total score ranges from 8 to 24.|units on a scale|Mean|19.87|19.87|Standard Deviation|2.69|2.69|||
4302375|NCT00510276|4129598|B1|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - Working Memory|The BRIEF-A Working Memory assesses an individuals' memory function in his or her everyday environment. The self-report form is designed to be completed by adults 18-90 years of age, including adults with a wide variety of developmental, systemic, neurological, and psychiatric disorders. Observations are rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. The total score ranges from 8 to 24.|units on a scale|Mean|19.87|19.87|Standard Deviation|2.73|2.73|||
4302376|NCT00510276|4129596|B3|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - Task Monitor|The BRIEF-A Task Monitor assesses an individuals's ability to monitor a task in his or her everyday environment. The self-report form is designed to be completed by adults 18-90 years of age, including adults with a wide variety of developmental, systemic, neurological, and psychiatric disorders. Observations are rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. The total score ranges from 6 to 18.|units on a scale|Mean|14.56|14.56|Standard Deviation|2.33|2.33|||
4302377|NCT00510276|4129597|B2|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - Task Monitor|The BRIEF-A Task Monitor assesses an individuals's ability to monitor a task in his or her everyday environment. The self-report form is designed to be completed by adults 18-90 years of age, including adults with a wide variety of developmental, systemic, neurological, and psychiatric disorders. Observations are rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. The total score ranges from 6 to 18.|units on a scale|Mean|14.68|14.68|Standard Deviation|2.31|2.31|||
4302378|NCT00510276|4129598|B1|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - Task Monitor|The BRIEF-A Task Monitor assesses an individuals's ability to monitor a task in his or her everyday environment. The self-report form is designed to be completed by adults 18-90 years of age, including adults with a wide variety of developmental, systemic, neurological, and psychiatric disorders. Observations are rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. The total score ranges from 6 to 18.|units on a scale|Mean|14.44|14.44|Standard Deviation|2.36|2.36|||
4302379|NCT00510276|4129596|B3|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - Self Monitor|The BRIEF-A Self Monitor assesses an individuals' capacity to self monitor in his or her everyday environment. The self-report form is designed to be completed by adults 18-90 years of age, including adults with a wide variety of developmental, systemic, neurological, and psychiatric disorders. Observations are rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. The total score ranges from 6 to 18.|units on a scale|Mean|12.52|12.52|Standard Deviation|2.96|2.96|||
4302380|NCT00510276|4129597|B2|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - Self Monitor|The BRIEF-A Self Monitor assesses an individuals' capacity to self monitor in his or her everyday environment. The self-report form is designed to be completed by adults 18-90 years of age, including adults with a wide variety of developmental, systemic, neurological, and psychiatric disorders. Observations are rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. The total score ranges from 6 to 18.|units on a scale|Mean|12.25|12.25|Standard Deviation|2.89|2.89|||
4302508|NCT00510068|4129783|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|156|156.0||||||
4302509|NCT00510068|4129781|B3||Male|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
4302510|NCT00510068|4129782|B2||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4302381|NCT00510276|4129598|B1|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - Self Monitor|The BRIEF-A Self Monitor assesses an individuals' capacity to self monitor in his or her everyday environment. The self-report form is designed to be completed by adults 18-90 years of age, including adults with a wide variety of developmental, systemic, neurological, and psychiatric disorders. Observations are rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. The total score ranges from 6 to 18.|units on a scale|Mean|12.80|12.8|Standard Deviation|3.01|3.01|||
4302382|NCT00510276|4129596|B3|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - SHIFT|The BRIEF-A Shift assess an individuals' shifting between different behaviors in his or her everyday environment. The self-report form is designed to be completed by adults 18-90 years of age, including adults with a wide variety of developmental, systemic, neurological, and psychiatric disorders. Observations are rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. The total score ranges from 6 to 18.|units on a scale|Mean|12.46|12.46|Standard Deviation|2.73|2.73|||
4302383|NCT00510276|4129597|B2|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - SHIFT|The BRIEF-A Shift assess an individuals' shifting between different behaviors in his or her everyday environment. The self-report form is designed to be completed by adults 18-90 years of age, including adults with a wide variety of developmental, systemic, neurological, and psychiatric disorders. Observations are rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. The total score ranges from 6 to 18.|units on a scale|Mean|12.36|12.36|Standard Deviation|2.64|2.64|||
4302384|NCT00510276|4129598|B1|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - SHIFT|The BRIEF-A Shift assess an individuals' shifting between different behaviors in his or her everyday environment. The self-report form is designed to be completed by adults 18-90 years of age, including adults with a wide variety of developmental, systemic, neurological, and psychiatric disorders. Observations are rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. The total score ranges from 6 to 18.|units on a scale|Mean|12.56|12.56|Standard Deviation|2.82|2.82|||
4302385|NCT00510276|4129596|B3|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - Plan/Organize|The BRIEF-A Plan/Organize asseses an individuals' capabilities to plan and organize in his or her everyday environment. The self-report form is designed to be completed by adults 18-90 years of age, including adults with a wide variety of developmental, systemic, neurological, and psychiatric disorders. Behavior is rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. The total score ranges from 10 to 30.|units on a scale|Mean|23.28|23.28|Standard Deviation|3.96|3.96|||
4302386|NCT00510276|4129597|B2|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - Plan/Organize|The BRIEF-A Plan/Organize asseses an individuals' capabilities to plan and organize in his or her everyday environment. The self-report form is designed to be completed by adults 18-90 years of age, including adults with a wide variety of developmental, systemic, neurological, and psychiatric disorders. Behavior is rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. The total score ranges from 10 to 30.|units on a scale|Mean|23.31|23.31|Standard Deviation|3.91|3.91|||
4302387|NCT00510276|4129598|B1|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - Plan/Organize|The BRIEF-A Plan/Organize asseses an individuals' capabilities to plan and organize in his or her everyday environment. The self-report form is designed to be completed by adults 18-90 years of age, including adults with a wide variety of developmental, systemic, neurological, and psychiatric disorders. Behavior is rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. The total score ranges from 10 to 30.|units on a scale|Mean|23.25|23.25|Standard Deviation|4.02|4.02|||
4302388|NCT00510276|4129596|B3|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - Negativity|The BRIEF-A Negativity asseses an indivduals' perceived negativity in his or her everyday environment. The self-report form is designed to be completed by adults 18-90 years of age, including adults with a wide variety of developmental, systemic, neurological, and psychiatric disorders. Behavior is rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. The total score is calculated based on a weighted secondary scoring system and ranges from 0 to 10.|units on a scale|Mean|2.14|2.14|Standard Deviation|2.10|2.1|||
4302389|NCT00510276|4129597|B2|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - Negativity|The BRIEF-A Negativity asseses an indivduals' perceived negativity in his or her everyday environment. The self-report form is designed to be completed by adults 18-90 years of age, including adults with a wide variety of developmental, systemic, neurological, and psychiatric disorders. Behavior is rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. The total score is calculated based on a weighted secondary scoring system and ranges from 0 to 10.|units on a scale|Mean|2.06|2.06|Standard Deviation|2.03|2.03|||
4302390|NCT00510276|4129598|B1|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - Negativity|The BRIEF-A Negativity asseses an indivduals' perceived negativity in his or her everyday environment. The self-report form is designed to be completed by adults 18-90 years of age, including adults with a wide variety of developmental, systemic, neurological, and psychiatric disorders. Behavior is rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. The total score is calculated based on a weighted secondary scoring system and ranges from 0 to 10.|units on a scale|Mean|2.22|2.22|Standard Deviation|2.16|2.16|||
4302511|NCT00510068|4129783|B1||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4302512|NCT00510068|4129781|B3||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4302391|NCT00510276|4129596|B3|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - Metacognition Index|BRIEF-A Metacognition subscale is a standardized measure assessing individual's ability to systematically solve problems via planning and organization while sustaining these task-completion efforts in active working memory. Form is designed to be completed by adults, including adults with wide variety of developmental, systemic, neurological, and psychiatric disorders. Behavior is rated on a 3-point Likert scale, with 1=behavior never observed, 2=behavior sometimes observed, and 3=behavior often observed - higher ratings indicate greater perceived impairment. Total score ranges from 40 to 120.|units on a scale|Mean|94.95|94.95|Standard Deviation|13.22|13.22|||
4302392|NCT00510276|4129597|B2|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - Metacognition Index|BRIEF-A Metacognition subscale is a standardized measure assessing individual's ability to systematically solve problems via planning and organization while sustaining these task-completion efforts in active working memory. Form is designed to be completed by adults, including adults with wide variety of developmental, systemic, neurological, and psychiatric disorders. Behavior is rated on a 3-point Likert scale, with 1=behavior never observed, 2=behavior sometimes observed, and 3=behavior often observed - higher ratings indicate greater perceived impairment. Total score ranges from 40 to 120.|units on a scale|Mean|95.18|95.18|Standard Deviation|12.77|12.77|||
4302393|NCT00510276|4129598|B1|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - Metacognition Index|BRIEF-A Metacognition subscale is a standardized measure assessing individual's ability to systematically solve problems via planning and organization while sustaining these task-completion efforts in active working memory. Form is designed to be completed by adults, including adults with wide variety of developmental, systemic, neurological, and psychiatric disorders. Behavior is rated on a 3-point Likert scale, with 1=behavior never observed, 2=behavior sometimes observed, and 3=behavior often observed - higher ratings indicate greater perceived impairment. Total score ranges from 40 to 120.|units on a scale|Mean|94.71|94.71|Standard Deviation|13.69|13.69|||
4302394|NCT00510276|4129596|B3|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - Initiate|The BRIEF-A Initiate rates an individual's initiative behaviors in his or her everyday environment. The self-report form is designed to be completed by adults 18-90 years of age, including adults with a wide variety of developmental, systemic, neurological, and psychiatric disorders. Behavior is rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. The total score ranges from 8 to 24.|units on a scale|Mean|18.33|18.33|Standard Deviation|3.05|3.05|||
4302395|NCT00510276|4129597|B2|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - Initiate|The BRIEF-A Initiate rates an individual's initiative behaviors in his or her everyday environment. The self-report form is designed to be completed by adults 18-90 years of age, including adults with a wide variety of developmental, systemic, neurological, and psychiatric disorders. Behavior is rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. The total score ranges from 8 to 24.|units on a scale|Mean|18.32|18.32|Standard Deviation|3.00|3.0|||
4302396|NCT00510276|4129598|B1|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - Initiate|The BRIEF-A Initiate rates an individual's initiative behaviors in his or her everyday environment. The self-report form is designed to be completed by adults 18-90 years of age, including adults with a wide variety of developmental, systemic, neurological, and psychiatric disorders. Behavior is rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. The total score ranges from 8 to 24.|units on a scale|Mean|18.33|18.33|Standard Deviation|3.11|3.11|||
4302397|NCT00510276|4129596|B3|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - Inhibit|The BRIEF-A Inhibit rates an individual's inhibition in his or her everyday environment. The self-report form is designed to be completed by adults 18-90 years of age, including adults with a wide variety of developmental, systemic, neurological, and psychiatric disorders. Behavior is rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. The total score ranges from 8 to 24.|units on a scale|Mean|18.19|18.19|Standard Deviation|2.74|2.74|||
4302398|NCT00510276|4129597|B2|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - Inhibit|The BRIEF-A Inhibit rates an individual's inhibition in his or her everyday environment. The self-report form is designed to be completed by adults 18-90 years of age, including adults with a wide variety of developmental, systemic, neurological, and psychiatric disorders. Behavior is rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. The total score ranges from 8 to 24.|units on a scale|Mean|18.11|18.11|Standard Deviation|2.72|2.72|||
4302399|NCT00510276|4129598|B1|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - Inhibit|The BRIEF-A Inhibit rates an individual's inhibition in his or her everyday environment. The self-report form is designed to be completed by adults 18-90 years of age, including adults with a wide variety of developmental, systemic, neurological, and psychiatric disorders. Behavior is rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. The total score ranges from 8 to 24.|units on a scale|Mean|18.28|18.28|Standard Deviation|2.77|2.77|||
4302400|NCT00510276|4129596|B3|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - Infrequency|BRIEF-A Infrequency is a standardized measure assessing adult executive functioning/self-regulation in his/her everyday environment. Extent to which the respondent answers additional items in an unusual and infrequent direction. Self-report form is designed to be completed by adults 18-90 years of age. Behavior is rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. Total score is calculated based on weighted secondary scoring system and ranges from 0 to 5.|units on a scale|Mean|0.14|0.14|Standard Deviation|0.39|0.39|||
4302513|NCT00510068|4129782|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4302514|NCT00510068|4129783|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4302515|NCT00510068|4129781|B3|>=65 years||Age, Customized||Participants|Number|111|111.0||||||
4302401|NCT00510276|4129597|B2|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - Infrequency|BRIEF-A Infrequency is a standardized measure assessing adult executive functioning/self-regulation in his/her everyday environment. Extent to which the respondent answers additional items in an unusual and infrequent direction. Self-report form is designed to be completed by adults 18-90 years of age. Behavior is rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. Total score is calculated based on weighted secondary scoring system and ranges from 0 to 5.|units on a scale|Mean|0.15|0.15|Standard Deviation|0.38|0.38|||
4302402|NCT00510276|4129598|B1|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - Infrequency|BRIEF-A Infrequency is a standardized measure assessing adult executive functioning/self-regulation in his/her everyday environment. Extent to which the respondent answers additional items in an unusual and infrequent direction. Self-report form is designed to be completed by adults 18-90 years of age. Behavior is rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. Total score is calculated based on weighted secondary scoring system and ranges from 0 to 5.|units on a scale|Mean|0.13|0.13|Standard Deviation|0.40|0.4|||
4302403|NCT00510276|4129596|B3|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - Inconsistency|The BRIEF-A Inconsistency rates the behavioral inconsistency displayed by the patient in his or her everyday environment. The self-report form is designed to be completed by adults 18-90 years of age. Behavior is rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. The total score is calculated based on a weighted secondary scoring system and ranges from 0 to 20.|units on a scale|Mean|3.36|3.36|Standard Deviation|1.92|1.92|||
4302404|NCT00510276|4129597|B2|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - Inconsistency|The BRIEF-A Inconsistency rates the behavioral inconsistency displayed by the patient in his or her everyday environment. The self-report form is designed to be completed by adults 18-90 years of age. Behavior is rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. The total score is calculated based on a weighted secondary scoring system and ranges from 0 to 20.|units on a scale|Mean|3.50|3.5|Standard Deviation|1.97|1.97|||
4302405|NCT00510276|4129598|B1|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - Inconsistency|The BRIEF-A Inconsistency rates the behavioral inconsistency displayed by the patient in his or her everyday environment. The self-report form is designed to be completed by adults 18-90 years of age. Behavior is rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. The total score is calculated based on a weighted secondary scoring system and ranges from 0 to 20.|units on a scale|Mean|3.22|3.22|Standard Deviation|1.86|1.86|||
4302406|NCT00510276|4129596|B3|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - GEC|The BRIEF-A Global Executive Composite (GEC) rates the global executive composite of the patient in his or her everyday environment. The self-report form is designed to be completed by adults 18-90 years of age, including adults with a wide variety of developmental, systemic, neurological, and psychiatric disorders. Behavior is rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. The total score ranges from 75 to 225.|units on a scale|Mean|156.61|156.61|Standard Deviation|21.89|21.89|||
4302407|NCT00510276|4129597|B2|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - GEC|The BRIEF-A Global Executive Composite (GEC) rates the global executive composite of the patient in his or her everyday environment. The self-report form is designed to be completed by adults 18-90 years of age, including adults with a wide variety of developmental, systemic, neurological, and psychiatric disorders. Behavior is rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. The total score ranges from 75 to 225.|units on a scale|Mean|156.12|156.12|Standard Deviation|21.00|21.0|||
4302408|NCT00510276|4129598|B1|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - GEC|The BRIEF-A Global Executive Composite (GEC) rates the global executive composite of the patient in his or her everyday environment. The self-report form is designed to be completed by adults 18-90 years of age, including adults with a wide variety of developmental, systemic, neurological, and psychiatric disorders. Behavior is rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. The total score ranges from 75 to 225.|units on a scale|Mean|157.11|157.11|Standard Deviation|22.80|22.8|||
4302409|NCT00510276|4129596|B3|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - Emotional Control|The BRIEF-A emotional control subscale assesses an individuals emotional control in his or her everyday environment. The self-report form is designed to be completed by adults 18-90 years of age, including adults with a wide variety of developmental, systemic, neurological, and psychiatric disorders. Behavior is rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. The total score ranges from 10 to 30.|units on a scale|Mean|18.49|18.49|Standard Deviation|5.53|5.53|||
4302410|NCT00510276|4129597|B2|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - Emotional Control|The BRIEF-A emotional control subscale assesses an individuals emotional control in his or her everyday environment. The self-report form is designed to be completed by adults 18-90 years of age, including adults with a wide variety of developmental, systemic, neurological, and psychiatric disorders. Behavior is rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. The total score ranges from 10 to 30.|units on a scale|Mean|18.22|18.22|Standard Deviation|5.33|5.33|||
4302516|NCT00510068|4129782|B2|>=65 years||Age, Customized||Participants|Number|50|50.0||||||
4302517|NCT00510068|4129783|B1|>=65 years||Age, Customized||Participants|Number|61|61.0||||||
4302518|NCT00510068|4129781|B3|<65 years||Age, Customized||Participants|Number|299|299.0||||||
4302411|NCT00510276|4129598|B1|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - Emotional Control|The BRIEF-A emotional control subscale assesses an individuals emotional control in his or her everyday environment. The self-report form is designed to be completed by adults 18-90 years of age, including adults with a wide variety of developmental, systemic, neurological, and psychiatric disorders. Behavior is rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. The total score ranges from 10 to 30.|units on a scale|Mean|18.76|18.76|Standard Deviation|5.73|5.73|||
4302412|NCT00510276|4129596|B3|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - Behavioral Regulation|The BRIEF-A behavioral regulation subscale measures an individuals control over behavior in his or her everyday environment. The self-report form is designed to be completed by adults 18-90 years of age, including adults with a wide variety of developmental, systemic, neurological, and psychiatric disorders. Behavior is rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. The total score ranges from 30 to 90.|units on a scale|Mean|61.66|61.66|Standard Deviation|11.36|11.36|||
4302413|NCT00510276|4129597|B2|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - Behavioral Regulation|The BRIEF-A behavioral regulation subscale measures an individuals control over behavior in his or her everyday environment. The self-report form is designed to be completed by adults 18-90 years of age, including adults with a wide variety of developmental, systemic, neurological, and psychiatric disorders. Behavior is rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. The total score ranges from 30 to 90.|units on a scale|Mean|60.94|60.94|Standard Deviation|10.77|10.77|||
4302414|NCT00510276|4129598|B1|||Behavior Rating Inventory of Executive Function-Adult Version Self Report - Behavioral Regulation|The BRIEF-A behavioral regulation subscale measures an individuals control over behavior in his or her everyday environment. The self-report form is designed to be completed by adults 18-90 years of age, including adults with a wide variety of developmental, systemic, neurological, and psychiatric disorders. Behavior is rated on a 3-point Likert scale, with 1=behavior is never observed, 2=behavior is sometimes observed, and 3=behavior is often observed - higher ratings indicate greater perceived impairment. The total score ranges from 30 to 90.|units on a scale|Mean|62.40|62.4|Standard Deviation|11.91|11.91|||
4302415|NCT00510276|4129596|B3|||Beck Anxiety Inventory (BAI)|21-item self-reported screening tool for measuring anxiety severity. Each item is rated on a 4-point Likert scale ranging from 0 (not at all) to 3 (severely; I could barely stand it). Each item is descriptive of subjective, somatic, or panic-related symptoms of anxiety. Patients record how much they have been bothered by each symptom during the past week, including the day the questionnaire is administered. The total score ranges from 0 to 63.|units on a scale|Mean|10.07|10.07|Standard Deviation|9.13|9.13|||
4302416|NCT00510276|4129597|B2|||Beck Anxiety Inventory (BAI)|21-item self-reported screening tool for measuring anxiety severity. Each item is rated on a 4-point Likert scale ranging from 0 (not at all) to 3 (severely; I could barely stand it). Each item is descriptive of subjective, somatic, or panic-related symptoms of anxiety. Patients record how much they have been bothered by each symptom during the past week, including the day the questionnaire is administered. The total score ranges from 0 to 63.|units on a scale|Mean|9.18|9.18|Standard Deviation|8.47|8.47|||
4302417|NCT00510276|4129598|B1|||Beck Anxiety Inventory (BAI)|21-item self-reported screening tool for measuring anxiety severity. Each item is rated on a 4-point Likert scale ranging from 0 (not at all) to 3 (severely; I could barely stand it). Each item is descriptive of subjective, somatic, or panic-related symptoms of anxiety. Patients record how much they have been bothered by each symptom during the past week, including the day the questionnaire is administered. The total score ranges from 0 to 63.|units on a scale|Mean|10.98|10.98|Standard Deviation|9.69|9.69|||
4302418|NCT00510276|4129596|B3|||Adult Attention-Deficit/Hyperactivity Disorder Quality of Life 29 - relationship subscale|"Patient-reported outcome measure used to examine the disease-specific functional impariments and quality of life for adults with ADHD. This subscale assesses quality of relationships. Individual items are scored on a five-point Likert-like scale from not at all/never=1 to extremely/very often=5. The range of scores for this subscale is 0 to 100. Consistent with the majority of existing quality of life measures, higher scores on the AAQOL-29 indicate better functioning."|units on a scale|Mean|52.61|52.61|Standard Deviation|19.49|19.49|||
4302419|NCT00510276|4129597|B2|||Adult Attention-Deficit/Hyperactivity Disorder Quality of Life 29 - relationship subscale|"Patient-reported outcome measure used to examine the disease-specific functional impariments and quality of life for adults with ADHD. This subscale assesses quality of relationships. Individual items are scored on a five-point Likert-like scale from not at all/never=1 to extremely/very often=5. The range of scores for this subscale is 0 to 100. Consistent with the majority of existing quality of life measures, higher scores on the AAQOL-29 indicate better functioning."|units on a scale|Mean|52.47|52.47|Standard Deviation|19.67|19.67|||
4302420|NCT00510276|4129598|B1|||Adult Attention-Deficit/Hyperactivity Disorder Quality of Life 29 - relationship subscale|"Patient-reported outcome measure used to examine the disease-specific functional impariments and quality of life for adults with ADHD. This subscale assesses quality of relationships. Individual items are scored on a five-point Likert-like scale from not at all/never=1 to extremely/very often=5. The range of scores for this subscale is 0 to 100. Consistent with the majority of existing quality of life measures, higher scores on the AAQOL-29 indicate better functioning."|units on a scale|Mean|52.76|52.76|Standard Deviation|19.35|19.35|||
4302421|NCT00510276|4129596|B3|||Adult Attention-Deficit/Hyperactivity Disorder Quality of Life 29 - Total Score|"Patient-reported outcome measure used to examine the disease-specific functional impariments and quality of life for adults with ADHD. The domains included in the AAQOL are life productivity, psychological health, quality of relationships, and life outlook. Individual items are scored on a five-point Likert-like scale from not at all/never=1 to extremely/very often=5. The range of scores is 0 to 100. Consistent with the majority of existing quality of life measures, higher scores on the AAQOL-29 indicate better functioning."|units on a scale|Mean|45.62|45.62|Standard Deviation|13.62|13.62|||
4302519|NCT00510068|4129782|B2|<65 years||Age, Customized||Participants|Number|153|153.0||||||
4302520|NCT00510068|4129783|B1|<65 years||Age, Customized||Participants|Number|146|146.0||||||
4302422|NCT00510276|4129597|B2|||Adult Attention-Deficit/Hyperactivity Disorder Quality of Life 29 - Total Score|"Patient-reported outcome measure used to examine the disease-specific functional impariments and quality of life for adults with ADHD. The domains included in the AAQOL are life productivity, psychological health, quality of relationships, and life outlook. Individual items are scored on a five-point Likert-like scale from not at all/never=1 to extremely/very often=5. The range of scores is 0 to 100. Consistent with the majority of existing quality of life measures, higher scores on the AAQOL-29 indicate better functioning."|units on a scale|Mean|45.30|45.3|Standard Deviation|13.53|13.53|||
4302423|NCT00510276|4129598|B1|||Adult Attention-Deficit/Hyperactivity Disorder Quality of Life 29 - Total Score|"Patient-reported outcome measure used to examine the disease-specific functional impariments and quality of life for adults with ADHD. The domains included in the AAQOL are life productivity, psychological health, quality of relationships, and life outlook. Individual items are scored on a five-point Likert-like scale from not at all/never=1 to extremely/very often=5. The range of scores is 0 to 100. Consistent with the majority of existing quality of life measures, higher scores on the AAQOL-29 indicate better functioning."|units on a scale|Mean|45.95|45.95|Standard Deviation|13.74|13.74|||
4302424|NCT00510276|4129596|B3|||Adult Attention-Deficit/Hyperactivity Disorder Quality of Life 29 - Psychological Health Subscale|"Patient-reported outcome measure used to examine the disease specific functional impairments and quality of life for adults with ADHD. This subscale assesses the psychological health. Individual items are scored on a five-point Likert-like scale from not at all/never=1 to extremely/very often=5. The range of scores for this subscale is 0 to 100. Consistent with the majority of existing quality of life measures, higher scores on the AAQOL-29 indicate better functioning."|units on a scale|Mean|50.44|50.44|Standard Deviation|18.56|18.56|||
4302425|NCT00510276|4129597|B2|||Adult Attention-Deficit/Hyperactivity Disorder Quality of Life 29 - Psychological Health Subscale|"Patient-reported outcome measure used to examine the disease specific functional impairments and quality of life for adults with ADHD. This subscale assesses the psychological health. Individual items are scored on a five-point Likert-like scale from not at all/never=1 to extremely/very often=5. The range of scores for this subscale is 0 to 100. Consistent with the majority of existing quality of life measures, higher scores on the AAQOL-29 indicate better functioning."|units on a scale|Mean|50.98|50.98|Standard Deviation|18.20|18.2|||
4302426|NCT00510276|4129598|B1|||Adult Attention-Deficit/Hyperactivity Disorder Quality of Life 29 - Psychological Health Subscale|"Patient-reported outcome measure used to examine the disease specific functional impairments and quality of life for adults with ADHD. This subscale assesses the psychological health. Individual items are scored on a five-point Likert-like scale from not at all/never=1 to extremely/very often=5. The range of scores for this subscale is 0 to 100. Consistent with the majority of existing quality of life measures, higher scores on the AAQOL-29 indicate better functioning."|units on a scale|Mean|49.89|49.89|Standard Deviation|18.95|18.95|||
4302427|NCT00510276|4129596|B3|||Adult Attention-Deficit/Hyperactivity Disorder Quality of Life 29 - Life Outlook Subscale|"Patient-reported outcome measure used to examine the disease specific functional impairments and quality of life for adults with ADHD. This subscale assesses life outlook. Individual items are scored on a five-point Likert-like scale from not at all/never=1 to extremely/very often=5. The range of scores for this subscale is 0 to 100. Consistent with the majority of existing quality of life measures, higher scores on the AAQOL-29 indicate better functioning."|units on a scale|Mean|53.44|53.44|Standard Deviation|15.43|15.43|||
4302428|NCT00510276|4129597|B2|||Adult Attention-Deficit/Hyperactivity Disorder Quality of Life 29 - Life Outlook Subscale|"Patient-reported outcome measure used to examine the disease specific functional impairments and quality of life for adults with ADHD. This subscale assesses life outlook. Individual items are scored on a five-point Likert-like scale from not at all/never=1 to extremely/very often=5. The range of scores for this subscale is 0 to 100. Consistent with the majority of existing quality of life measures, higher scores on the AAQOL-29 indicate better functioning."|units on a scale|Mean|52.49|52.49|Standard Deviation|15.41|15.41|||
4302429|NCT00510276|4129598|B1|||Adult Attention-Deficit/Hyperactivity Disorder Quality of Life 29 - Life Outlook Subscale|"Patient-reported outcome measure used to examine the disease specific functional impairments and quality of life for adults with ADHD. This subscale assesses life outlook. Individual items are scored on a five-point Likert-like scale from not at all/never=1 to extremely/very often=5. The range of scores for this subscale is 0 to 100. Consistent with the majority of existing quality of life measures, higher scores on the AAQOL-29 indicate better functioning."|units on a scale|Mean|54.40|54.4|Standard Deviation|15.42|15.42|||
4302430|NCT00510276|4129596|B3|Puerto Rico||Region of Enrollment||participants|Number|15|15.0||||||
4302431|NCT00510276|4129597|B2|Puerto Rico||Region of Enrollment||participants|Number|5|5.0||||||
4302432|NCT00510276|4129598|B1|Puerto Rico||Region of Enrollment||participants|Number|10|10.0||||||
4302433|NCT00510276|4129596|B3|United States||Region of Enrollment||participants|Number|430|430.0||||||
4302434|NCT00510276|4129597|B2|United States||Region of Enrollment||participants|Number|220|220.0||||||
4302435|NCT00510276|4129598|B1|United States||Region of Enrollment||participants|Number|210|210.0||||||
4302436|NCT00510276|4129596|B3||Male|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
4302437|NCT00510276|4129597|B2||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4302438|NCT00510276|4129598|B1||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4302439|NCT00510276|4129596|B3||Female|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4302440|NCT00510276|4129597|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4302441|NCT00510276|4129598|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4302442|NCT00510276|4129596|B3|||Age||years|Mean|24.69|24.69|Standard Deviation|3.42|3.42|||
4302443|NCT00510276|4129597|B2|||Age||years|Mean|24.68|24.68|Standard Deviation|3.48|3.48|||
4302444|NCT00510276|4129598|B1|||Age||years|Mean|24.71|24.71|Standard Deviation|3.35|3.35|||
4302445|NCT00510224|4129684|B1|||Hemoglobin||gm/dl|Median|13.9|13.9|Full Range|||9.5|16.5|
4302521|NCT00510068|4129781|B3|||Age||years|Mean|56.6|56.6|Standard Deviation|11.8|11.8|||
4302522|NCT00510068|4129782|B2|||Age||years|Mean|56.2|56.2|Standard Deviation|11.4|11.4|||
4302523|NCT00510068|4129783|B1|||Age||years|Mean|57.1|57.1|Standard Deviation|12.2|12.2|||
4302446|NCT00510224|4129684|B1|||Gleason Score|A Gleason score is assigned by a pathologist based on the sum of two numbers: the first number is the grade of the most common tumor pattern, the second number is the grade of the second most common pattern. For example, if the most common tumor pattern was grade 3, but some cells were found to be grade 4, the Gleason Score would be 3+4 = 7. The Gleason Score ranges from 2 to 10, with 10 having the worst prognosis.|Score|Median|8|8.0|Full Range|||5.0|10.0|
4302447|NCT00510224|4129684|B1|||Median PSA|PSA was measured by chemiluminescent immunoassay on the Immulite 2000 analyzer (Siemens Healthcare Diagnostics, Deerfield, IL)|ng/ml|Median|36.2|36.2|Full Range|||5.4|342.8|
4302448|NCT00510224|4129684|B1|Androgen Deprivation||Primary therapy|Type of therapy prior to study enrollment|participants|Number|4|4.0||||||
4302449|NCT00510224|4129684|B1|Radiation Therapy||Primary therapy|Type of therapy prior to study enrollment|participants|Number|6|6.0||||||
4302450|NCT00510224|4129684|B1|Prostatectomy||Primary therapy|Type of therapy prior to study enrollment|participants|Number|3|3.0||||||
4302451|NCT00510224|4129684|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4302452|NCT00510224|4129684|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4302453|NCT00510224|4129684|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4302454|NCT00510224|4129684|B1|||Age||years|Median|75|75.0|Full Range|||63.0|87.0|
4302455|NCT00510146|4129691|B3|||Age at onset, Bipolar I Disorder||years|Mean|27.09|27.09|Standard Deviation|10.64|10.64|||
4302456|NCT00510146|4129692|B2|||Age at onset, Bipolar I Disorder||years|Mean|26.12|26.12|Standard Deviation|9.90|9.9|||
4302457|NCT00510146|4129693|B1|||Age at onset, Bipolar I Disorder||years|Mean|27.57|27.57|Standard Deviation|10.98|10.98|||
4302458|NCT00510146|4129691|B3|United States||Region of Enrollment||participants|Number|90|90.0||||||
4302459|NCT00510146|4129692|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4302460|NCT00510146|4129693|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4302461|NCT00510146|4129691|B3|Taiwan||Region of Enrollment||participants|Number|28|28.0||||||
4302462|NCT00510146|4129692|B2|Taiwan||Region of Enrollment||participants|Number|9|9.0||||||
4302463|NCT00510146|4129693|B1|Taiwan||Region of Enrollment||participants|Number|19|19.0||||||
4302464|NCT00510146|4129691|B3|Korea, Republic of||Region of Enrollment||participants|Number|30|30.0||||||
4302465|NCT00510146|4129692|B2|Korea, Republic of||Region of Enrollment||participants|Number|10|10.0||||||
4302466|NCT00510146|4129693|B1|Korea, Republic of||Region of Enrollment||participants|Number|20|20.0||||||
4302467|NCT00510146|4129691|B3|Japan||Region of Enrollment||participants|Number|156|156.0||||||
4302468|NCT00510146|4129692|B2|Japan||Region of Enrollment||participants|Number|52|52.0||||||
4302469|NCT00510146|4129693|B1|Japan||Region of Enrollment||participants|Number|104|104.0||||||
4302470|NCT00510146|4129691|B3|China||Region of Enrollment||participants|Number|210|210.0||||||
4302471|NCT00510146|4129692|B2|China||Region of Enrollment||participants|Number|70|70.0||||||
4302472|NCT00510146|4129693|B1|China||Region of Enrollment||participants|Number|140|140.0||||||
4302473|NCT00510146|4129691|B3|Native American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4302474|NCT00510146|4129692|B2|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4302475|NCT00510146|4129693|B1|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4302476|NCT00510146|4129691|B3|East Asian||Race/Ethnicity, Customized||participants|Number|423|423.0||||||
4302477|NCT00510146|4129692|B2|East Asian||Race/Ethnicity, Customized||participants|Number|141|141.0||||||
4302478|NCT00510146|4129693|B1|East Asian||Race/Ethnicity, Customized||participants|Number|282|282.0||||||
4302479|NCT00510146|4129691|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4302480|NCT00510146|4129692|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4302481|NCT00510146|4129693|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4302482|NCT00510146|4129691|B3|African||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4302483|NCT00510146|4129692|B2|African||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4302484|NCT00510146|4129693|B1|African||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4302485|NCT00510146|4129691|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
4302486|NCT00510146|4129692|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4302487|NCT00510146|4129693|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4302488|NCT00510146|4129691|B3||Male|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4302489|NCT00510146|4129692|B2||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4302490|NCT00510146|4129693|B1||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4302491|NCT00510146|4129691|B3||Female|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
4302492|NCT00510146|4129692|B2||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4302493|NCT00510146|4129693|B1||Female|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4302494|NCT00510146|4129691|B3|||Age||years|Mean|35.61|35.61|Standard Deviation|11.09|11.09|||
4302495|NCT00510146|4129692|B2|||Age||years|Mean|34.96|34.96|Standard Deviation|11.02|11.02|||
4302496|NCT00510146|4129693|B1|||Age||years|Mean|35.93|35.93|Standard Deviation|11.13|11.13|||
4302497|NCT00510068|4129781|B3|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4302498|NCT00510068|4129782|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4302499|NCT00510068|4129783|B1|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4302500|NCT00510068|4129781|B3|Black||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4302501|NCT00510068|4129782|B2|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4302502|NCT00510068|4129783|B1|Black||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4302524|NCT00509925|4129825|B1|||Weight||kg|Mean|81.9|81.9|Standard Deviation|10.6|10.6|||
4302525|NCT00509925|4129825|B1|||Waist:hip ratio|Waist:hip ratio was calculated as waist average in cm divided by hip average in cm, and multiplied by 100.|percentage of hip circumference|Mean|93.5|93.5|Standard Deviation|7.5|7.5|||
4302526|NCT00509925|4129825|B1|||Height||meters|Mean|1.7|1.7|Standard Deviation|0.1|0.1|||
4302527|NCT00509925|4129825|B1|||HbA1c|Glycosylated haemoglobin A1c (HbA1c)|percentage of total haemoglobin|Mean|8.2|8.2|Standard Deviation|1.0|1.0|||
4302528|NCT00509925|4129825|B1|||FPG|Fasting plasma glucose|mmol/L|Mean|10.4|10.4|Standard Deviation|3.6|3.6|||
4302529|NCT00509925|4129825|B1|||Body composition: Lean Body Mass||kg|Mean|60.6|60.6|Standard Deviation|10.8|10.8|||
4302530|NCT00509925|4129825|B1|||Body composition: Fat Mass||kg|Mean|21.3|21.3|Standard Deviation|9.3|9.3|||
4302531|NCT00509925|4129825|B1|||BMI|Body Mass Index|kg/m^2|Mean|28.0|28.0|Standard Deviation|3.6|3.6|||
4302532|NCT00509925|4129825|B1|United Kingdom||Region of Enrollment||participants|Number|23|23.0||||||
4302533|NCT00509925|4129825|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302534|NCT00509925|4129825|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302535|NCT00509925|4129825|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4302536|NCT00509925|4129825|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302537|NCT00509925|4129825|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302538|NCT00509925|4129825|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302539|NCT00509925|4129825|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302540|NCT00509925|4129825|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4302541|NCT00509925|4129825|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4302542|NCT00509925|4129825|B1|||Age||years|Mean|38.8|38.8|Standard Deviation|10.6|10.6|||
4302543|NCT00509925|4129825|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4302544|NCT00509925|4129825|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4302545|NCT00509925|4129825|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4302546|NCT00509899|4129866|B9|2||Eastern Cooperative Oncology Group Performance Status|The Eastern Cooperative Oncology Group (ECOG) performance status measures patients' functional status on the following scale: 0=Fully active, no restrictions 1=Restricted in physically strenuous activity but ambulatory, able to carry out light work; 2=Ambulatory and capable of all selfcare, unable to carry out any work activities; Up and about > 50% of waking hours; 3=Limited selfcare, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Totally confined to bed or chair; 5=Dead.|participants|Number|16|16.0||||||
4302547|NCT00509899|4129867|B8|2||Eastern Cooperative Oncology Group Performance Status|The Eastern Cooperative Oncology Group (ECOG) performance status measures patients' functional status on the following scale: 0=Fully active, no restrictions 1=Restricted in physically strenuous activity but ambulatory, able to carry out light work; 2=Ambulatory and capable of all selfcare, unable to carry out any work activities; Up and about > 50% of waking hours; 3=Limited selfcare, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Totally confined to bed or chair; 5=Dead.|participants|Number|0|0.0||||||
4302548|NCT00509899|4129868|B7|2||Eastern Cooperative Oncology Group Performance Status|The Eastern Cooperative Oncology Group (ECOG) performance status measures patients' functional status on the following scale: 0=Fully active, no restrictions 1=Restricted in physically strenuous activity but ambulatory, able to carry out light work; 2=Ambulatory and capable of all selfcare, unable to carry out any work activities; Up and about > 50% of waking hours; 3=Limited selfcare, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Totally confined to bed or chair; 5=Dead.|participants|Number|0|0.0||||||
4302549|NCT00509899|4129869|B6|2||Eastern Cooperative Oncology Group Performance Status|The Eastern Cooperative Oncology Group (ECOG) performance status measures patients' functional status on the following scale: 0=Fully active, no restrictions 1=Restricted in physically strenuous activity but ambulatory, able to carry out light work; 2=Ambulatory and capable of all selfcare, unable to carry out any work activities; Up and about > 50% of waking hours; 3=Limited selfcare, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Totally confined to bed or chair; 5=Dead.|participants|Number|3|3.0||||||
4302550|NCT00509899|4129870|B5|2||Eastern Cooperative Oncology Group Performance Status|The Eastern Cooperative Oncology Group (ECOG) performance status measures patients' functional status on the following scale: 0=Fully active, no restrictions 1=Restricted in physically strenuous activity but ambulatory, able to carry out light work; 2=Ambulatory and capable of all selfcare, unable to carry out any work activities; Up and about > 50% of waking hours; 3=Limited selfcare, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Totally confined to bed or chair; 5=Dead.|participants|Number|1|1.0||||||
4302551|NCT00509899|4129871|B4|2||Eastern Cooperative Oncology Group Performance Status|The Eastern Cooperative Oncology Group (ECOG) performance status measures patients' functional status on the following scale: 0=Fully active, no restrictions 1=Restricted in physically strenuous activity but ambulatory, able to carry out light work; 2=Ambulatory and capable of all selfcare, unable to carry out any work activities; Up and about > 50% of waking hours; 3=Limited selfcare, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Totally confined to bed or chair; 5=Dead.|participants|Number|0|0.0||||||
4302552|NCT00509899|4129872|B3|2||Eastern Cooperative Oncology Group Performance Status|The Eastern Cooperative Oncology Group (ECOG) performance status measures patients' functional status on the following scale: 0=Fully active, no restrictions 1=Restricted in physically strenuous activity but ambulatory, able to carry out light work; 2=Ambulatory and capable of all selfcare, unable to carry out any work activities; Up and about > 50% of waking hours; 3=Limited selfcare, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Totally confined to bed or chair; 5=Dead.|participants|Number|5|5.0||||||
4302600|NCT00509899|4129866|B9|||Palpable spleen length below the costal margin||cm|Mean|18.37|18.37|Standard Deviation|7.8|7.8|||
4302601|NCT00509899|4129867|B8|||Palpable spleen length below the costal margin||cm|Mean|18.33|18.33|Standard Deviation|3.5|3.5|||
4302553|NCT00509899|4129873|B2|2||Eastern Cooperative Oncology Group Performance Status|The Eastern Cooperative Oncology Group (ECOG) performance status measures patients' functional status on the following scale: 0=Fully active, no restrictions 1=Restricted in physically strenuous activity but ambulatory, able to carry out light work; 2=Ambulatory and capable of all selfcare, unable to carry out any work activities; Up and about > 50% of waking hours; 3=Limited selfcare, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Totally confined to bed or chair; 5=Dead.|participants|Number|3|3.0||||||
4302554|NCT00509899|4129874|B1|2||Eastern Cooperative Oncology Group Performance Status|The Eastern Cooperative Oncology Group (ECOG) performance status measures patients' functional status on the following scale: 0=Fully active, no restrictions 1=Restricted in physically strenuous activity but ambulatory, able to carry out light work; 2=Ambulatory and capable of all selfcare, unable to carry out any work activities; Up and about > 50% of waking hours; 3=Limited selfcare, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Totally confined to bed or chair; 5=Dead.|participants|Number|4|4.0||||||
4302555|NCT00509899|4129866|B9|1||Eastern Cooperative Oncology Group Performance Status|The Eastern Cooperative Oncology Group (ECOG) performance status measures patients' functional status on the following scale: 0=Fully active, no restrictions 1=Restricted in physically strenuous activity but ambulatory, able to carry out light work; 2=Ambulatory and capable of all selfcare, unable to carry out any work activities; Up and about > 50% of waking hours; 3=Limited selfcare, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Totally confined to bed or chair; 5=Dead.|participants|Number|113|113.0||||||
4302556|NCT00509899|4129867|B8|1||Eastern Cooperative Oncology Group Performance Status|The Eastern Cooperative Oncology Group (ECOG) performance status measures patients' functional status on the following scale: 0=Fully active, no restrictions 1=Restricted in physically strenuous activity but ambulatory, able to carry out light work; 2=Ambulatory and capable of all selfcare, unable to carry out any work activities; Up and about > 50% of waking hours; 3=Limited selfcare, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Totally confined to bed or chair; 5=Dead.|participants|Number|3|3.0||||||
4302557|NCT00509899|4129868|B7|1||Eastern Cooperative Oncology Group Performance Status|The Eastern Cooperative Oncology Group (ECOG) performance status measures patients' functional status on the following scale: 0=Fully active, no restrictions 1=Restricted in physically strenuous activity but ambulatory, able to carry out light work; 2=Ambulatory and capable of all selfcare, unable to carry out any work activities; Up and about > 50% of waking hours; 3=Limited selfcare, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Totally confined to bed or chair; 5=Dead.|participants|Number|5|5.0||||||
4302558|NCT00509899|4129869|B6|1||Eastern Cooperative Oncology Group Performance Status|The Eastern Cooperative Oncology Group (ECOG) performance status measures patients' functional status on the following scale: 0=Fully active, no restrictions 1=Restricted in physically strenuous activity but ambulatory, able to carry out light work; 2=Ambulatory and capable of all selfcare, unable to carry out any work activities; Up and about > 50% of waking hours; 3=Limited selfcare, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Totally confined to bed or chair; 5=Dead.|participants|Number|14|14.0||||||
4302559|NCT00509899|4129870|B5|1||Eastern Cooperative Oncology Group Performance Status|The Eastern Cooperative Oncology Group (ECOG) performance status measures patients' functional status on the following scale: 0=Fully active, no restrictions 1=Restricted in physically strenuous activity but ambulatory, able to carry out light work; 2=Ambulatory and capable of all selfcare, unable to carry out any work activities; Up and about > 50% of waking hours; 3=Limited selfcare, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Totally confined to bed or chair; 5=Dead.|participants|Number|4|4.0||||||
4302560|NCT00509899|4129871|B4|1||Eastern Cooperative Oncology Group Performance Status|The Eastern Cooperative Oncology Group (ECOG) performance status measures patients' functional status on the following scale: 0=Fully active, no restrictions 1=Restricted in physically strenuous activity but ambulatory, able to carry out light work; 2=Ambulatory and capable of all selfcare, unable to carry out any work activities; Up and about > 50% of waking hours; 3=Limited selfcare, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Totally confined to bed or chair; 5=Dead.|participants|Number|3|3.0||||||
4302561|NCT00509899|4129872|B3|1||Eastern Cooperative Oncology Group Performance Status|The Eastern Cooperative Oncology Group (ECOG) performance status measures patients' functional status on the following scale: 0=Fully active, no restrictions 1=Restricted in physically strenuous activity but ambulatory, able to carry out light work; 2=Ambulatory and capable of all selfcare, unable to carry out any work activities; Up and about > 50% of waking hours; 3=Limited selfcare, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Totally confined to bed or chair; 5=Dead.|participants|Number|33|33.0||||||
4302562|NCT00509899|4129873|B2|1||Eastern Cooperative Oncology Group Performance Status|The Eastern Cooperative Oncology Group (ECOG) performance status measures patients' functional status on the following scale: 0=Fully active, no restrictions 1=Restricted in physically strenuous activity but ambulatory, able to carry out light work; 2=Ambulatory and capable of all selfcare, unable to carry out any work activities; Up and about > 50% of waking hours; 3=Limited selfcare, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Totally confined to bed or chair; 5=Dead.|participants|Number|32|32.0||||||
4302563|NCT00509899|4129874|B1|1||Eastern Cooperative Oncology Group Performance Status|The Eastern Cooperative Oncology Group (ECOG) performance status measures patients' functional status on the following scale: 0=Fully active, no restrictions 1=Restricted in physically strenuous activity but ambulatory, able to carry out light work; 2=Ambulatory and capable of all selfcare, unable to carry out any work activities; Up and about > 50% of waking hours; 3=Limited selfcare, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Totally confined to bed or chair; 5=Dead.|participants|Number|19|19.0||||||
4302564|NCT00509899|4129866|B9|0||Eastern Cooperative Oncology Group Performance Status|The Eastern Cooperative Oncology Group (ECOG) performance status measures patients' functional status on the following scale: 0=Fully active, no restrictions 1=Restricted in physically strenuous activity but ambulatory, able to carry out light work; 2=Ambulatory and capable of all selfcare, unable to carry out any work activities; Up and about > 50% of waking hours; 3=Limited selfcare, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Totally confined to bed or chair; 5=Dead.|participants|Number|25|25.0||||||
4302602|NCT00509899|4129868|B7|||Palpable spleen length below the costal margin||cm|Mean|20.67|20.67|Standard Deviation|6.6|6.6|||
4302565|NCT00509899|4129867|B8|0||Eastern Cooperative Oncology Group Performance Status|The Eastern Cooperative Oncology Group (ECOG) performance status measures patients' functional status on the following scale: 0=Fully active, no restrictions 1=Restricted in physically strenuous activity but ambulatory, able to carry out light work; 2=Ambulatory and capable of all selfcare, unable to carry out any work activities; Up and about > 50% of waking hours; 3=Limited selfcare, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Totally confined to bed or chair; 5=Dead.|participants|Number|0|0.0||||||
4302566|NCT00509899|4129868|B7|0||Eastern Cooperative Oncology Group Performance Status|The Eastern Cooperative Oncology Group (ECOG) performance status measures patients' functional status on the following scale: 0=Fully active, no restrictions 1=Restricted in physically strenuous activity but ambulatory, able to carry out light work; 2=Ambulatory and capable of all selfcare, unable to carry out any work activities; Up and about > 50% of waking hours; 3=Limited selfcare, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Totally confined to bed or chair; 5=Dead.|participants|Number|1|1.0||||||
4302567|NCT00509899|4129869|B6|0||Eastern Cooperative Oncology Group Performance Status|The Eastern Cooperative Oncology Group (ECOG) performance status measures patients' functional status on the following scale: 0=Fully active, no restrictions 1=Restricted in physically strenuous activity but ambulatory, able to carry out light work; 2=Ambulatory and capable of all selfcare, unable to carry out any work activities; Up and about > 50% of waking hours; 3=Limited selfcare, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Totally confined to bed or chair; 5=Dead.|participants|Number|5|5.0||||||
4302568|NCT00509899|4129870|B5|0||Eastern Cooperative Oncology Group Performance Status|The Eastern Cooperative Oncology Group (ECOG) performance status measures patients' functional status on the following scale: 0=Fully active, no restrictions 1=Restricted in physically strenuous activity but ambulatory, able to carry out light work; 2=Ambulatory and capable of all selfcare, unable to carry out any work activities; Up and about > 50% of waking hours; 3=Limited selfcare, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Totally confined to bed or chair; 5=Dead.|participants|Number|1|1.0||||||
4302569|NCT00509899|4129871|B4|0||Eastern Cooperative Oncology Group Performance Status|The Eastern Cooperative Oncology Group (ECOG) performance status measures patients' functional status on the following scale: 0=Fully active, no restrictions 1=Restricted in physically strenuous activity but ambulatory, able to carry out light work; 2=Ambulatory and capable of all selfcare, unable to carry out any work activities; Up and about > 50% of waking hours; 3=Limited selfcare, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Totally confined to bed or chair; 5=Dead.|participants|Number|2|2.0||||||
4302570|NCT00509899|4129872|B3|0||Eastern Cooperative Oncology Group Performance Status|The Eastern Cooperative Oncology Group (ECOG) performance status measures patients' functional status on the following scale: 0=Fully active, no restrictions 1=Restricted in physically strenuous activity but ambulatory, able to carry out light work; 2=Ambulatory and capable of all selfcare, unable to carry out any work activities; Up and about > 50% of waking hours; 3=Limited selfcare, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Totally confined to bed or chair; 5=Dead.|participants|Number|9|9.0||||||
4302571|NCT00509899|4129873|B2|0||Eastern Cooperative Oncology Group Performance Status|The Eastern Cooperative Oncology Group (ECOG) performance status measures patients' functional status on the following scale: 0=Fully active, no restrictions 1=Restricted in physically strenuous activity but ambulatory, able to carry out light work; 2=Ambulatory and capable of all selfcare, unable to carry out any work activities; Up and about > 50% of waking hours; 3=Limited selfcare, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Totally confined to bed or chair; 5=Dead.|participants|Number|0|0.0||||||
4302572|NCT00509899|4129874|B1|0||Eastern Cooperative Oncology Group Performance Status|The Eastern Cooperative Oncology Group (ECOG) performance status measures patients' functional status on the following scale: 0=Fully active, no restrictions 1=Restricted in physically strenuous activity but ambulatory, able to carry out light work; 2=Ambulatory and capable of all selfcare, unable to carry out any work activities; Up and about > 50% of waking hours; 3=Limited selfcare, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Totally confined to bed or chair; 5=Dead.|participants|Number|7|7.0||||||
4302573|NCT00509899|4129866|B9|Unknown||JAK2 V617F mutation status|JAK2V617F is a mutation in the pseudokinase domain of Janus Kinase 2 (JAK2) (at amino acid 617, valine to phenylalanine) that results in constitutive activation of JAK2. Mutation status was determined using a validated assay on bone marrow as well as peripheral blood.|participants|Number|16|16.0||||||
4302574|NCT00509899|4129867|B8|Unknown||JAK2 V617F mutation status|JAK2V617F is a mutation in the pseudokinase domain of Janus Kinase 2 (JAK2) (at amino acid 617, valine to phenylalanine) that results in constitutive activation of JAK2. Mutation status was determined using a validated assay on bone marrow as well as peripheral blood.|participants|Number|0|0.0||||||
4302575|NCT00509899|4129868|B7|Unknown||JAK2 V617F mutation status|JAK2V617F is a mutation in the pseudokinase domain of Janus Kinase 2 (JAK2) (at amino acid 617, valine to phenylalanine) that results in constitutive activation of JAK2. Mutation status was determined using a validated assay on bone marrow as well as peripheral blood.|participants|Number|3|3.0||||||
4302576|NCT00509899|4129869|B6|Unknown||JAK2 V617F mutation status|JAK2V617F is a mutation in the pseudokinase domain of Janus Kinase 2 (JAK2) (at amino acid 617, valine to phenylalanine) that results in constitutive activation of JAK2. Mutation status was determined using a validated assay on bone marrow as well as peripheral blood.|participants|Number|0|0.0||||||
4302577|NCT00509899|4129870|B5|Unknown||JAK2 V617F mutation status|JAK2V617F is a mutation in the pseudokinase domain of Janus Kinase 2 (JAK2) (at amino acid 617, valine to phenylalanine) that results in constitutive activation of JAK2. Mutation status was determined using a validated assay on bone marrow as well as peripheral blood.|participants|Number|0|0.0||||||
4302578|NCT00509899|4129871|B4|Unknown||JAK2 V617F mutation status|JAK2V617F is a mutation in the pseudokinase domain of Janus Kinase 2 (JAK2) (at amino acid 617, valine to phenylalanine) that results in constitutive activation of JAK2. Mutation status was determined using a validated assay on bone marrow as well as peripheral blood.|participants|Number|2|2.0||||||
4302579|NCT00509899|4129872|B3|Unknown||JAK2 V617F mutation status|JAK2V617F is a mutation in the pseudokinase domain of Janus Kinase 2 (JAK2) (at amino acid 617, valine to phenylalanine) that results in constitutive activation of JAK2. Mutation status was determined using a validated assay on bone marrow as well as peripheral blood.|participants|Number|3|3.0||||||
4302580|NCT00509899|4129873|B2|Unknown||JAK2 V617F mutation status|JAK2V617F is a mutation in the pseudokinase domain of Janus Kinase 2 (JAK2) (at amino acid 617, valine to phenylalanine) that results in constitutive activation of JAK2. Mutation status was determined using a validated assay on bone marrow as well as peripheral blood.|participants|Number|1|1.0||||||
4302581|NCT00509899|4129874|B1|Unknown||JAK2 V617F mutation status|JAK2V617F is a mutation in the pseudokinase domain of Janus Kinase 2 (JAK2) (at amino acid 617, valine to phenylalanine) that results in constitutive activation of JAK2. Mutation status was determined using a validated assay on bone marrow as well as peripheral blood.|participants|Number|7|7.0||||||
4302582|NCT00509899|4129866|B9|Positive||JAK2 V617F mutation status|JAK2V617F is a mutation in the pseudokinase domain of Janus Kinase 2 (JAK2) (at amino acid 617, valine to phenylalanine) that results in constitutive activation of JAK2. Mutation status was determined using a validated assay on bone marrow as well as peripheral blood.|participants|Number|114|114.0||||||
4302583|NCT00509899|4129867|B8|Positive||JAK2 V617F mutation status|JAK2V617F is a mutation in the pseudokinase domain of Janus Kinase 2 (JAK2) (at amino acid 617, valine to phenylalanine) that results in constitutive activation of JAK2. Mutation status was determined using a validated assay on bone marrow as well as peripheral blood.|participants|Number|3|3.0||||||
4302584|NCT00509899|4129868|B7|Positive||JAK2 V617F mutation status|JAK2V617F is a mutation in the pseudokinase domain of Janus Kinase 2 (JAK2) (at amino acid 617, valine to phenylalanine) that results in constitutive activation of JAK2. Mutation status was determined using a validated assay on bone marrow as well as peripheral blood.|participants|Number|2|2.0||||||
4302585|NCT00509899|4129869|B6|Positive||JAK2 V617F mutation status|JAK2V617F is a mutation in the pseudokinase domain of Janus Kinase 2 (JAK2) (at amino acid 617, valine to phenylalanine) that results in constitutive activation of JAK2. Mutation status was determined using a validated assay on bone marrow as well as peripheral blood.|participants|Number|15|15.0||||||
4302586|NCT00509899|4129870|B5|Positive||JAK2 V617F mutation status|JAK2V617F is a mutation in the pseudokinase domain of Janus Kinase 2 (JAK2) (at amino acid 617, valine to phenylalanine) that results in constitutive activation of JAK2. Mutation status was determined using a validated assay on bone marrow as well as peripheral blood.|participants|Number|2|2.0||||||
4302587|NCT00509899|4129871|B4|Positive||JAK2 V617F mutation status|JAK2V617F is a mutation in the pseudokinase domain of Janus Kinase 2 (JAK2) (at amino acid 617, valine to phenylalanine) that results in constitutive activation of JAK2. Mutation status was determined using a validated assay on bone marrow as well as peripheral blood.|participants|Number|2|2.0||||||
4302588|NCT00509899|4129872|B3|Positive||JAK2 V617F mutation status|JAK2V617F is a mutation in the pseudokinase domain of Janus Kinase 2 (JAK2) (at amino acid 617, valine to phenylalanine) that results in constitutive activation of JAK2. Mutation status was determined using a validated assay on bone marrow as well as peripheral blood.|participants|Number|39|39.0||||||
4302589|NCT00509899|4129873|B2|Positive||JAK2 V617F mutation status|JAK2V617F is a mutation in the pseudokinase domain of Janus Kinase 2 (JAK2) (at amino acid 617, valine to phenylalanine) that results in constitutive activation of JAK2. Mutation status was determined using a validated assay on bone marrow as well as peripheral blood.|participants|Number|29|29.0||||||
4302590|NCT00509899|4129874|B1|Positive||JAK2 V617F mutation status|JAK2V617F is a mutation in the pseudokinase domain of Janus Kinase 2 (JAK2) (at amino acid 617, valine to phenylalanine) that results in constitutive activation of JAK2. Mutation status was determined using a validated assay on bone marrow as well as peripheral blood.|participants|Number|22|22.0||||||
4302591|NCT00509899|4129866|B9|Negative||JAK2 V617F mutation status|JAK2V617F is a mutation in the pseudokinase domain of Janus Kinase 2 (JAK2) (at amino acid 617, valine to phenylalanine) that results in constitutive activation of JAK2. Mutation status was determined using a validated assay on bone marrow as well as peripheral blood.|participants|Number|24|24.0||||||
4302592|NCT00509899|4129867|B8|Negative||JAK2 V617F mutation status|JAK2V617F is a mutation in the pseudokinase domain of Janus Kinase 2 (JAK2) (at amino acid 617, valine to phenylalanine) that results in constitutive activation of JAK2. Mutation status was determined using a validated assay on bone marrow as well as peripheral blood.|participants|Number|0|0.0||||||
4302593|NCT00509899|4129868|B7|Negative||JAK2 V617F mutation status|JAK2V617F is a mutation in the pseudokinase domain of Janus Kinase 2 (JAK2) (at amino acid 617, valine to phenylalanine) that results in constitutive activation of JAK2. Mutation status was determined using a validated assay on bone marrow as well as peripheral blood.|participants|Number|1|1.0||||||
4302594|NCT00509899|4129869|B6|Negative||JAK2 V617F mutation status|JAK2V617F is a mutation in the pseudokinase domain of Janus Kinase 2 (JAK2) (at amino acid 617, valine to phenylalanine) that results in constitutive activation of JAK2. Mutation status was determined using a validated assay on bone marrow as well as peripheral blood.|participants|Number|7|7.0||||||
4302595|NCT00509899|4129870|B5|Negative||JAK2 V617F mutation status|JAK2V617F is a mutation in the pseudokinase domain of Janus Kinase 2 (JAK2) (at amino acid 617, valine to phenylalanine) that results in constitutive activation of JAK2. Mutation status was determined using a validated assay on bone marrow as well as peripheral blood.|participants|Number|4|4.0||||||
4302596|NCT00509899|4129871|B4|Negative||JAK2 V617F mutation status|JAK2V617F is a mutation in the pseudokinase domain of Janus Kinase 2 (JAK2) (at amino acid 617, valine to phenylalanine) that results in constitutive activation of JAK2. Mutation status was determined using a validated assay on bone marrow as well as peripheral blood.|participants|Number|1|1.0||||||
4302597|NCT00509899|4129872|B3|Negative||JAK2 V617F mutation status|JAK2V617F is a mutation in the pseudokinase domain of Janus Kinase 2 (JAK2) (at amino acid 617, valine to phenylalanine) that results in constitutive activation of JAK2. Mutation status was determined using a validated assay on bone marrow as well as peripheral blood.|participants|Number|5|5.0||||||
4302598|NCT00509899|4129873|B2|Negative||JAK2 V617F mutation status|JAK2V617F is a mutation in the pseudokinase domain of Janus Kinase 2 (JAK2) (at amino acid 617, valine to phenylalanine) that results in constitutive activation of JAK2. Mutation status was determined using a validated assay on bone marrow as well as peripheral blood.|participants|Number|5|5.0||||||
4302599|NCT00509899|4129874|B1|Negative||JAK2 V617F mutation status|JAK2V617F is a mutation in the pseudokinase domain of Janus Kinase 2 (JAK2) (at amino acid 617, valine to phenylalanine) that results in constitutive activation of JAK2. Mutation status was determined using a validated assay on bone marrow as well as peripheral blood.|participants|Number|1|1.0||||||
4302603|NCT00509899|4129869|B6|||Palpable spleen length below the costal margin||cm|Mean|20.0|20.0|Standard Deviation|7.3|7.3|||
4302604|NCT00509899|4129870|B5|||Palpable spleen length below the costal margin||cm|Mean|19.58|19.58|Standard Deviation|10.5|10.5|||
4302605|NCT00509899|4129871|B4|||Palpable spleen length below the costal margin||cm|Mean|13.0|13.0|Standard Deviation|10.1|10.1|||
4302606|NCT00509899|4129872|B3|||Palpable spleen length below the costal margin||cm|Mean|17.13|17.13|Standard Deviation|8.9|8.9|||
4302607|NCT00509899|4129873|B2|||Palpable spleen length below the costal margin||cm|Mean|18.47|18.47|Standard Deviation|5.7|5.7|||
4302608|NCT00509899|4129874|B1|||Palpable spleen length below the costal margin||cm|Mean|19.11|19.11|Standard Deviation|8.2|8.2|||
4302609|NCT00509899|4129866|B9|||Body Mass Index (BMI)||kg/m^2|Mean|25.7|25.7|Standard Deviation|4.7|4.7|||
4302610|NCT00509899|4129867|B8|||Body Mass Index (BMI)||kg/m^2|Mean|26.3|26.3|Standard Deviation|3.8|3.8|||
4302611|NCT00509899|4129868|B7|||Body Mass Index (BMI)||kg/m^2|Mean|25.8|25.8|Standard Deviation|6.3|6.3|||
4302612|NCT00509899|4129869|B6|||Body Mass Index (BMI)||kg/m^2|Mean|25.3|25.3|Standard Deviation|4.5|4.5|||
4302613|NCT00509899|4129870|B5|||Body Mass Index (BMI)||kg/m^2|Mean|24.7|24.7|Standard Deviation|2.9|2.9|||
4302614|NCT00509899|4129871|B4|||Body Mass Index (BMI)||kg/m^2|Mean|24.8|24.8|Standard Deviation|2.9|2.9|||
4302615|NCT00509899|4129872|B3|||Body Mass Index (BMI)||kg/m^2|Mean|26.2|26.2|Standard Deviation|5.9|5.9|||
4302616|NCT00509899|4129873|B2|||Body Mass Index (BMI)||kg/m^2|Mean|25.3|25.3|Standard Deviation|4.4|4.4|||
4302617|NCT00509899|4129874|B1|||Body Mass Index (BMI)||kg/m^2|Mean|25.8|25.8|Standard Deviation|3.8|3.8|||
4302618|NCT00509899|4129866|B9|Post-essential thrombocythemia-myelofibrosis||Disease sub-type||Participants|Number|24|24.0||||||
4302619|NCT00509899|4129867|B8|Post-essential thrombocythemia-myelofibrosis||Disease sub-type||Participants|Number|0|0.0||||||
4302620|NCT00509899|4129868|B7|Post-essential thrombocythemia-myelofibrosis||Disease sub-type||Participants|Number|0|0.0||||||
4302621|NCT00509899|4129869|B6|Post-essential thrombocythemia-myelofibrosis||Disease sub-type||Participants|Number|4|4.0||||||
4302622|NCT00509899|4129870|B5|Post-essential thrombocythemia-myelofibrosis||Disease sub-type||Participants|Number|0|0.0||||||
4302623|NCT00509899|4129871|B4|Post-essential thrombocythemia-myelofibrosis||Disease sub-type||Participants|Number|0|0.0||||||
4302624|NCT00509899|4129872|B3|Post-essential thrombocythemia-myelofibrosis||Disease sub-type||Participants|Number|9|9.0||||||
4302625|NCT00509899|4129873|B2|Post-essential thrombocythemia-myelofibrosis||Disease sub-type||Participants|Number|6|6.0||||||
4302626|NCT00509899|4129874|B1|Post-essential thrombocythemia-myelofibrosis||Disease sub-type||Participants|Number|5|5.0||||||
4302627|NCT00509899|4129866|B9|Post-polycythemia vera-myelofibrosis||Disease sub-type||Participants|Number|49|49.0||||||
4302628|NCT00509899|4129867|B8|Post-polycythemia vera-myelofibrosis||Disease sub-type||Participants|Number|3|3.0||||||
4302629|NCT00509899|4129868|B7|Post-polycythemia vera-myelofibrosis||Disease sub-type||Participants|Number|1|1.0||||||
4302630|NCT00509899|4129869|B6|Post-polycythemia vera-myelofibrosis||Disease sub-type||Participants|Number|4|4.0||||||
4302631|NCT00509899|4129870|B5|Post-polycythemia vera-myelofibrosis||Disease sub-type||Participants|Number|1|1.0||||||
4302632|NCT00509899|4129871|B4|Post-polycythemia vera-myelofibrosis||Disease sub-type||Participants|Number|2|2.0||||||
4302633|NCT00509899|4129872|B3|Post-polycythemia vera-myelofibrosis||Disease sub-type||Participants|Number|15|15.0||||||
4302634|NCT00509899|4129873|B2|Post-polycythemia vera-myelofibrosis||Disease sub-type||Participants|Number|10|10.0||||||
4302635|NCT00509899|4129874|B1|Post-polycythemia vera-myelofibrosis||Disease sub-type||Participants|Number|13|13.0||||||
4302636|NCT00509899|4129866|B9|Primary myelofibrosis||Disease sub-type||Participants|Number|81|81.0||||||
4302637|NCT00509899|4129867|B8|Primary myelofibrosis||Disease sub-type||Participants|Number|0|0.0||||||
4302638|NCT00509899|4129868|B7|Primary myelofibrosis||Disease sub-type||Participants|Number|5|5.0||||||
4302639|NCT00509899|4129869|B6|Primary myelofibrosis||Disease sub-type||Participants|Number|14|14.0||||||
4302640|NCT00509899|4129870|B5|Primary myelofibrosis||Disease sub-type||Participants|Number|5|5.0||||||
4302641|NCT00509899|4129871|B4|Primary myelofibrosis||Disease sub-type||Participants|Number|3|3.0||||||
4302642|NCT00509899|4129872|B3|Primary myelofibrosis||Disease sub-type||Participants|Number|23|23.0||||||
4302643|NCT00509899|4129873|B2|Primary myelofibrosis||Disease sub-type||Participants|Number|19|19.0||||||
4302644|NCT00509899|4129874|B1|Primary myelofibrosis||Disease sub-type||Participants|Number|12|12.0||||||
4302645|NCT00509899|4129866|B9|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4302646|NCT00509899|4129867|B8|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4302647|NCT00509899|4129868|B7|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4302648|NCT00509899|4129869|B6|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4302649|NCT00509899|4129870|B5|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4302650|NCT00509899|4129871|B4|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4302651|NCT00509899|4129872|B3|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4302652|NCT00509899|4129873|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4302653|NCT00509899|4129874|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4302654|NCT00509899|4129866|B9|White||Race/Ethnicity, Customized||Participants|Number|147|147.0||||||
4302655|NCT00509899|4129867|B8|White||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4302656|NCT00509899|4129868|B7|White||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4302657|NCT00509899|4129869|B6|White||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
4302658|NCT00509899|4129870|B5|White||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4302659|NCT00509899|4129871|B4|White||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4302660|NCT00509899|4129872|B3|White||Race/Ethnicity, Customized||Participants|Number|45|45.0||||||
4302661|NCT00509899|4129873|B2|White||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
4302662|NCT00509899|4129874|B1|White||Race/Ethnicity, Customized||Participants|Number|28|28.0||||||
4302663|NCT00509899|4129866|B9|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4302664|NCT00509899|4129867|B8|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4302665|NCT00509899|4129868|B7|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4302666|NCT00509899|4129869|B6|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4302667|NCT00509899|4129870|B5|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4302668|NCT00509899|4129871|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4302669|NCT00509899|4129872|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4302670|NCT00509899|4129873|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4302671|NCT00509899|4129874|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4302672|NCT00509899|4129866|B9|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4302673|NCT00509899|4129867|B8|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4302674|NCT00509899|4129868|B7|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4302675|NCT00509899|4129869|B6|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4302676|NCT00509899|4129870|B5|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4302677|NCT00509899|4129871|B4|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4302678|NCT00509899|4129872|B3|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4302679|NCT00509899|4129873|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4302680|NCT00509899|4129874|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4302681|NCT00509899|4129866|B9||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4302682|NCT00509899|4129867|B8||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4302683|NCT00509899|4129868|B7||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4302684|NCT00509899|4129869|B6||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4302685|NCT00509899|4129870|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4302686|NCT00509899|4129871|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4302687|NCT00509899|4129872|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4302688|NCT00509899|4129873|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4302689|NCT00509899|4129874|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4302690|NCT00509899|4129866|B9||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4302691|NCT00509899|4129867|B8||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4302692|NCT00509899|4129868|B7||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4302693|NCT00509899|4129869|B6||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4302694|NCT00509899|4129870|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4302695|NCT00509899|4129871|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4302696|NCT00509899|4129872|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4302697|NCT00509899|4129873|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4302698|NCT00509899|4129874|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4302699|NCT00509899|4129866|B9|||Age||years|Mean|63.9|63.9|Standard Deviation|8.86|8.86|||
4302700|NCT00509899|4129867|B8|||Age||years|Mean|72.3|72.3|Standard Deviation|6.43|6.43|||
4302701|NCT00509899|4129868|B7|||Age||years|Mean|71.5|71.5|Standard Deviation|6.89|6.89|||
4302702|NCT00509899|4129869|B6|||Age||years|Mean|66.3|66.3|Standard Deviation|6.66|6.66|||
4302703|NCT00509899|4129870|B5|||Age||years|Mean|57.3|57.3|Standard Deviation|9.89|9.89|||
4302704|NCT00509899|4129871|B4|||Age||years|Mean|63.0|63.0|Standard Deviation|8.37|8.37|||
4302705|NCT00509899|4129872|B3|||Age||years|Mean|63.9|63.9|Standard Deviation|9.06|9.06|||
4302706|NCT00509899|4129873|B2|||Age||years|Mean|63.8|63.8|Standard Deviation|9.57|9.57|||
4302707|NCT00509899|4129874|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|8.29|8.29|||
4302708|NCT00509873|4129919|B3||Male|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4302709|NCT00509873|4129920|B2||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4302710|NCT00509873|4129921|B1||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4302711|NCT00509873|4129919|B3||Female|Sex: Female, Male||Participants|Count of Participants|333|333.0||||||
4302712|NCT00509873|4129920|B2||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4302713|NCT00509873|4129921|B1||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4302714|NCT00509873|4129919|B3|>65 years||Age, Customized||participants|Number|65|65.0||||||
4302715|NCT00509873|4129920|B2|>65 years||Age, Customized||participants|Number|27|27.0||||||
4302716|NCT00509873|4129921|B1|>65 years||Age, Customized||participants|Number|38|38.0||||||
4302717|NCT00509873|4129919|B3|19-65 years||Age, Customized||participants|Number|267|267.0||||||
4302718|NCT00509873|4129920|B2|19-65 years||Age, Customized||participants|Number|141|141.0||||||
4302719|NCT00509873|4129921|B1|19-65 years||Age, Customized||participants|Number|126|126.0||||||
4302720|NCT00509873|4129919|B3|1-18 years||Age, Customized||participants|Number|246|246.0||||||
4302721|NCT00509873|4129920|B2|1-18 years||Age, Customized||participants|Number|123|123.0||||||
4302722|NCT00509873|4129921|B1|1-18 years||Age, Customized||participants|Number|123|123.0||||||
4302723|NCT00509795|4129936|B5|||Baseline Best Corrected Visual Acuity (BCVA)|SAF population used for analysis. BCVA assessed by Early Treatment Diabetic Retinopathy Study (ETDRS) chart. For BCVA tested via the 4 meter ETDRS protocol, 83 letters or more would represent 20/20 vision or better which would be considered an excellent outcome. Although, the ETDRS charts include 100 letters as the maximum possible score. The worst outcome is 0 letters read.|letters read|Mean|55.1|55.1|Standard Deviation|13.14|13.14|||
4302724|NCT00509795|4129937|B4|||Baseline Best Corrected Visual Acuity (BCVA)|SAF population used for analysis. BCVA assessed by Early Treatment Diabetic Retinopathy Study (ETDRS) chart. For BCVA tested via the 4 meter ETDRS protocol, 83 letters or more would represent 20/20 vision or better which would be considered an excellent outcome. Although, the ETDRS charts include 100 letters as the maximum possible score. The worst outcome is 0 letters read.|letters read|Mean|55.7|55.7|Standard Deviation|12.84|12.84|0.0|0.0|
4302725|NCT00509795|4129938|B3|||Baseline Best Corrected Visual Acuity (BCVA)|SAF population used for analysis. BCVA assessed by Early Treatment Diabetic Retinopathy Study (ETDRS) chart. For BCVA tested via the 4 meter ETDRS protocol, 83 letters or more would represent 20/20 vision or better which would be considered an excellent outcome. Although, the ETDRS charts include 100 letters as the maximum possible score. The worst outcome is 0 letters read.|letters read|Mean|55.5|55.5|Standard Deviation|13.12|13.12|0.0|0.0|
4302726|NCT00509795|4129939|B2|||Baseline Best Corrected Visual Acuity (BCVA)|SAF population used for analysis. BCVA assessed by Early Treatment Diabetic Retinopathy Study (ETDRS) chart. For BCVA tested via the 4 meter ETDRS protocol, 83 letters or more would represent 20/20 vision or better which would be considered an excellent outcome. Although, the ETDRS charts include 100 letters as the maximum possible score. The worst outcome is 0 letters read.|letters read|Mean|55.2|55.2|Standard Deviation|13.15|13.15|0.0|0.0|
4302727|NCT00509795|4129940|B1|||Baseline Best Corrected Visual Acuity (BCVA)|SAF population used for analysis. BCVA assessed by Early Treatment Diabetic Retinopathy Study (ETDRS) chart. For BCVA tested via the 4 meter ETDRS protocol, 83 letters or more would represent 20/20 vision or better which would be considered an excellent outcome. Although, the ETDRS charts include 100 letters as the maximum possible score. The worst outcome is 0 letters read.|letters read|Mean|54.0|54.0|Standard Deviation|13.43|13.43|0.0|0.0|
4302728|NCT00509795|4129936|B5|||Baseline Total Lesion Size|SAF population used for analysis.|mm^2|Mean|6.95|6.95|Standard Deviation|5.202|5.202|||
4302729|NCT00509795|4129937|B4|||Baseline Total Lesion Size|SAF population used for analysis.|mm^2|Mean|6.88|6.88|Standard Deviation|5.214|5.214|0.0|0.0|
4302730|NCT00509795|4129938|B3|||Baseline Total Lesion Size|SAF population used for analysis.|mm^2|Mean|6.96|6.96|Standard Deviation|4.711|4.711|0.0|0.0|
4302731|NCT00509795|4129939|B2|||Baseline Total Lesion Size|SAF population used for analysis.|mm^2|Mean|6.98|6.98|Standard Deviation|5.388|5.388|0.0|0.0|
4302732|NCT00509795|4129940|B1|||Baseline Total Lesion Size|SAF population used for analysis.|mm^2|Mean|6.99|6.99|Standard Deviation|5.491|5.491|0.0|0.0|
4302733|NCT00509795|4129936|B5|Missing||Baseline Lesion Type|SAF population used for analysis.|patients|Number|12|12.0||||||
4302734|NCT00509795|4129937|B4|Missing||Baseline Lesion Type|SAF population used for analysis.|patients|Number|2|2.0||0|0.0|0.0|0.0|
4302735|NCT00509795|4129938|B3|Missing||Baseline Lesion Type|SAF population used for analysis.|patients|Number|2|2.0||0|0.0|0.0|0.0|
4302736|NCT00509795|4129939|B2|Missing||Baseline Lesion Type|SAF population used for analysis.|patients|Number|2|2.0||0|0.0|0.0|0.0|
4302737|NCT00509795|4129940|B1|Missing||Baseline Lesion Type|SAF population used for analysis.|patients|Number|6|6.0||0|0.0|0.0|0.0|
4302738|NCT00509795|4129936|B5|Predominantly Classic||Baseline Lesion Type|SAF population used for analysis.|patients|Number|322|322.0||||||
4302739|NCT00509795|4129937|B4|Predominantly Classic||Baseline Lesion Type|SAF population used for analysis.|patients|Number|71|71.0||0|0.0|0.0|0.0|
4302740|NCT00509795|4129938|B3|Predominantly Classic||Baseline Lesion Type|SAF population used for analysis.|patients|Number|82|82.0||0|0.0|0.0|0.0|
4302741|NCT00509795|4129939|B2|Predominantly Classic||Baseline Lesion Type|SAF population used for analysis.|patients|Number|87|87.0||0|0.0|0.0|0.0|
4302742|NCT00509795|4129940|B1|Predominantly Classic||Baseline Lesion Type|SAF population used for analysis.|patients|Number|82|82.0||0|0.0|0.0|0.0|
4302743|NCT00509795|4129936|B5|Minimally Classic||Baseline Lesion Type|SAF population used for analysis.|patients|Number|415|415.0||||||
4302744|NCT00509795|4129937|B4|Minimally Classic||Baseline Lesion Type|SAF population used for analysis.|patients|Number|112|112.0||0|0.0|0.0|0.0|
4302745|NCT00509795|4129938|B3|Minimally Classic||Baseline Lesion Type|SAF population used for analysis.|patients|Number|97|97.0||0|0.0|0.0|0.0|
4302746|NCT00509795|4129939|B2|Minimally Classic||Baseline Lesion Type|SAF population used for analysis.|patients|Number|105|105.0||0|0.0|0.0|0.0|
4302747|NCT00509795|4129940|B1|Minimally Classic||Baseline Lesion Type|SAF population used for analysis.|patients|Number|101|101.0||0|0.0|0.0|0.0|
4302748|NCT00509795|4129936|B5|Occult||Baseline Lesion Type|SAF population used for analysis.|patients|Number|466|466.0||||||
4302749|NCT00509795|4129937|B4|Occult||Baseline Lesion Type|SAF population used for analysis.|patients|Number|118|118.0||0|0.0|0.0|0.0|
4302750|NCT00509795|4129938|B3|Occult||Baseline Lesion Type|SAF population used for analysis.|patients|Number|123|123.0||0|0.0|0.0|0.0|
4302751|NCT00509795|4129939|B2|Occult||Baseline Lesion Type|SAF population used for analysis.|patients|Number|110|110.0||0|0.0|0.0|0.0|
4302752|NCT00509795|4129940|B1|Occult||Baseline Lesion Type|SAF population used for analysis.|patients|Number|115|115.0||0|0.0|0.0|0.0|
4302753|NCT00509795|4129936|B5|||Baseline Area of Choroidal Neovascularization (CNV)|SAF population used for analysis.|mm^2|Mean|6.54|6.54|Standard Deviation|4.968|4.968|||
4302754|NCT00509795|4129937|B4|||Baseline Area of Choroidal Neovascularization (CNV)|SAF population used for analysis.|mm^2|Mean|6.56|6.56|Standard Deviation|5.129|5.129|0.0|0.0|
4302755|NCT00509795|4129938|B3|||Baseline Area of Choroidal Neovascularization (CNV)|SAF population used for analysis.|mm^2|Mean|6.49|6.49|Standard Deviation|4.437|4.437|0.0|0.0|
4302756|NCT00509795|4129939|B2|||Baseline Area of Choroidal Neovascularization (CNV)|SAF population used for analysis.|mm^2|Mean|6.59|6.59|Standard Deviation|5.052|5.052|0.0|0.0|
4302757|NCT00509795|4129940|B1|||Baseline Area of Choroidal Neovascularization (CNV)|SAF population used for analysis.|mm^2|Mean|6.52|6.52|Standard Deviation|5.245|5.245|0.0|0.0|
4302791|NCT00509795|4129939|B2||Asian|Race (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|3|3.0||0|0.0|0.0|0.0|
4302758|NCT00509795|4129936|B5|||Baseline National Eye Institute 25-item Visual Function Questionnaire (NEI VFQ-25) total score|SAF population used for analysis. The NEI VFQ-25 total score ranges from 0-100 with a score of 0 being the worst outcome and 100 being the best outcome. The NEI VFQ questionnaire is organized as a collection of subscales which are all scored from 0-100. To reach the overall composite score, each sub-scale score is averaged in order to give each sub-scale equal weight.|scores on a scale|Mean|70.7|70.7|Standard Deviation|17.11|17.11|||
4302759|NCT00509795|4129937|B4|||Baseline National Eye Institute 25-item Visual Function Questionnaire (NEI VFQ-25) total score|SAF population used for analysis. The NEI VFQ-25 total score ranges from 0-100 with a score of 0 being the worst outcome and 100 being the best outcome. The NEI VFQ questionnaire is organized as a collection of subscales which are all scored from 0-100. To reach the overall composite score, each sub-scale score is averaged in order to give each sub-scale equal weight.|scores on a scale|Mean|69.5|69.5|Standard Deviation|16.82|16.82|0.0|0.0|
4302760|NCT00509795|4129938|B3|||Baseline National Eye Institute 25-item Visual Function Questionnaire (NEI VFQ-25) total score|SAF population used for analysis. The NEI VFQ-25 total score ranges from 0-100 with a score of 0 being the worst outcome and 100 being the best outcome. The NEI VFQ questionnaire is organized as a collection of subscales which are all scored from 0-100. To reach the overall composite score, each sub-scale score is averaged in order to give each sub-scale equal weight.|scores on a scale|Mean|71.1|71.1|Standard Deviation|17.72|17.72|0.0|0.0|
4302761|NCT00509795|4129939|B2|||Baseline National Eye Institute 25-item Visual Function Questionnaire (NEI VFQ-25) total score|SAF population used for analysis. The NEI VFQ-25 total score ranges from 0-100 with a score of 0 being the worst outcome and 100 being the best outcome. The NEI VFQ questionnaire is organized as a collection of subscales which are all scored from 0-100. To reach the overall composite score, each sub-scale score is averaged in order to give each sub-scale equal weight.|scores on a scale|Mean|70.4|70.4|Standard Deviation|16.60|16.6|0.0|0.0|
4302762|NCT00509795|4129940|B1|||Baseline National Eye Institute 25-item Visual Function Questionnaire (NEI VFQ-25) total score|SAF population used for analysis. The NEI VFQ-25 total score ranges from 0-100 with a score of 0 being the worst outcome and 100 being the best outcome. The NEI VFQ questionnaire is organized as a collection of subscales which are all scored from 0-100. To reach the overall composite score, each sub-scale score is averaged in order to give each sub-scale equal weight.|scores on a scale|Mean|71.7|71.7|Standard Deviation|17.29|17.29|0.0|0.0|
4302763|NCT00509795|4129936|B5||Unknown or Not Reported|Race (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|18|18.0||||||
4302764|NCT00509795|4129937|B4||Unknown or Not Reported|Race (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|6|6.0||0|0.0|0.0|0.0|
4302765|NCT00509795|4129938|B3||Unknown or Not Reported|Race (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|3|3.0||0|0.0|0.0|0.0|
4302766|NCT00509795|4129939|B2||Unknown or Not Reported|Race (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|5|5.0||0|0.0|0.0|0.0|
4302767|NCT00509795|4129940|B1||Unknown or Not Reported|Race (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|4|4.0||0|0.0|0.0|0.0|
4302768|NCT00509795|4129936|B5||More than one race|Race (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|1|1.0||||||
4302769|NCT00509795|4129937|B4||More than one race|Race (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|1|1.0||0|0.0|0.0|0.0|
4302770|NCT00509795|4129938|B3||More than one race|Race (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4302771|NCT00509795|4129939|B2||More than one race|Race (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4302772|NCT00509795|4129940|B1||More than one race|Race (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4302773|NCT00509795|4129936|B5||White|Race (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|1174|1174.0||||||
4302774|NCT00509795|4129937|B4||White|Race (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|289|289.0||0|0.0|0.0|0.0|
4302775|NCT00509795|4129938|B3||White|Race (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|294|294.0||0|0.0|0.0|0.0|
4302776|NCT00509795|4129939|B2||White|Race (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|295|295.0||0|0.0|0.0|0.0|
4302777|NCT00509795|4129940|B1||White|Race (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|296|296.0||0|0.0|0.0|0.0|
4302778|NCT00509795|4129936|B5||Black or African American|Race (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|3|3.0||||||
4302779|NCT00509795|4129937|B4||Black or African American|Race (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|1|1.0||0|0.0|0.0|0.0|
4302780|NCT00509795|4129938|B3||Black or African American|Race (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4302781|NCT00509795|4129939|B2||Black or African American|Race (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|1|1.0||0|0.0|0.0|0.0|
4302782|NCT00509795|4129940|B1||Black or African American|Race (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|1|1.0||0|0.0|0.0|0.0|
4302783|NCT00509795|4129936|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|2|2.0||||||
4302784|NCT00509795|4129937|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|1|1.0||0|0.0|0.0|0.0|
4302785|NCT00509795|4129938|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4302786|NCT00509795|4129939|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4302787|NCT00509795|4129940|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|1|1.0||0|0.0|0.0|0.0|
4302788|NCT00509795|4129936|B5||Asian|Race (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|12|12.0||||||
4302789|NCT00509795|4129937|B4||Asian|Race (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|4|4.0||0|0.0|0.0|0.0|
4302790|NCT00509795|4129938|B3||Asian|Race (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|5|5.0||0|0.0|0.0|0.0|
4302844|NCT00509600|4129993|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4302792|NCT00509795|4129940|B1||Asian|Race (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4302793|NCT00509795|4129936|B5||American Indian or Alaska Native|Race (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|5|5.0||||||
4302794|NCT00509795|4129937|B4||American Indian or Alaska Native|Race (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|1|1.0||0|0.0|0.0|0.0|
4302795|NCT00509795|4129938|B3||American Indian or Alaska Native|Race (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|2|2.0||0|0.0|0.0|0.0|
4302796|NCT00509795|4129939|B2||American Indian or Alaska Native|Race (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4302797|NCT00509795|4129940|B1||American Indian or Alaska Native|Race (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|2|2.0||0|0.0|0.0|0.0|
4302798|NCT00509795|4129936|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|0|0.0||||||
4302799|NCT00509795|4129937|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|0|0.0||||||
4302800|NCT00509795|4129938|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|0|0.0||||||
4302801|NCT00509795|4129939|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|0|0.0||||||
4302802|NCT00509795|4129940|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|0|0.0||||||
4302803|NCT00509795|4129936|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|1174|1174.0||||||
4302804|NCT00509795|4129937|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|291|291.0||||||
4302805|NCT00509795|4129938|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|293|293.0||||||
4302806|NCT00509795|4129939|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|293|293.0||||||
4302807|NCT00509795|4129940|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|297|297.0||||||
4302808|NCT00509795|4129936|B5||Hispanic or Latino|Ethnicity (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|41|41.0||||||
4302809|NCT00509795|4129937|B4||Hispanic or Latino|Ethnicity (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|12|12.0||0|0.0|0.0|0.0|
4302810|NCT00509795|4129938|B3||Hispanic or Latino|Ethnicity (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|11|11.0||0|0.0|0.0|0.0|
4302811|NCT00509795|4129939|B2||Hispanic or Latino|Ethnicity (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|11|11.0||0|0.0|0.0|0.0|
4302812|NCT00509795|4129940|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|SAF population used for analysis.|Participants|Count of Participants|7|7.0||0|0.0|0.0|0.0|
4302813|NCT00509795|4129936|B5||Male|Sex: Female, Male||Participants|Count of Participants|501|501.0||||||
4302814|NCT00509795|4129937|B4||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4302815|NCT00509795|4129938|B3||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4302816|NCT00509795|4129939|B2||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4302817|NCT00509795|4129940|B1||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4302818|NCT00509795|4129936|B5||Female|Sex: Female, Male||Participants|Count of Participants|714|714.0||||||
4302819|NCT00509795|4129937|B4||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4302820|NCT00509795|4129938|B3||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4302821|NCT00509795|4129939|B2||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4302822|NCT00509795|4129940|B1||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4302823|NCT00509795|4129936|B5|||Age|SAF population used for analysis.|years|Mean|78.0|78.0|Standard Deviation|8.00|8.0|||
4302824|NCT00509795|4129937|B4|||Age|SAF population used for analysis.|years|Mean|77.9|77.9|Standard Deviation|8.39|8.39|0.0|0.0|
4302825|NCT00509795|4129938|B3|||Age|SAF population used for analysis.|years|Mean|78.3|78.3|Standard Deviation|8.10|8.1|0.0|0.0|
4302826|NCT00509795|4129939|B2|||Age|SAF population used for analysis.|years|Mean|77.7|77.7|Standard Deviation|7.93|7.93|0.0|0.0|
4302827|NCT00509795|4129940|B1|||Age|SAF population used for analysis.|years|Mean|78.2|78.2|Standard Deviation|7.59|7.59|0.0|0.0|
4302828|NCT00509769|4129974|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4302829|NCT00509769|4129974|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4302830|NCT00509769|4129974|B1|||Age||years|Mean|55.0|55.0|Standard Deviation|10.3|10.3|||
4302831|NCT00509665|4129983|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4302832|NCT00509665|4129983|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302833|NCT00509665|4129983|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302834|NCT00509665|4129983|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4302835|NCT00509665|4129983|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4302836|NCT00509665|4129983|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302837|NCT00509665|4129983|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302838|NCT00509665|4129983|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302839|NCT00509665|4129983|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4302840|NCT00509665|4129983|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4302841|NCT00509665|4129983|B1|||Age||years|Median|57|57.0|Full Range|||45.0|77.0|
4302842|NCT00509600|4129993|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4302843|NCT00509600|4129993|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4302845|NCT00509600|4129993|B1|||Age||years|Mean|3|3.0|Full Range|||3.0|3.0|
4302846|NCT00509587|4129997|B1|Canada||Region of Enrollment||participants|Number|21|21.0||||||
4302847|NCT00509587|4129997|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4302848|NCT00509587|4129997|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4302849|NCT00509587|4129997|B1|||Age||years|Median|54|54.0|Full Range|||33.0|80.0|
4302850|NCT00509587|4129997|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4302851|NCT00509587|4129997|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4302852|NCT00509587|4129997|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4302853|NCT00509496|4130006|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4302854|NCT00509496|4130007|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4302855|NCT00509496|4130008|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4302856|NCT00509496|4130006|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302857|NCT00509496|4130007|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302858|NCT00509496|4130008|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302859|NCT00509496|4130006|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302860|NCT00509496|4130007|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302861|NCT00509496|4130008|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302862|NCT00509496|4130006|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4302863|NCT00509496|4130007|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4302864|NCT00509496|4130008|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4302865|NCT00509496|4130006|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302866|NCT00509496|4130007|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302867|NCT00509496|4130008|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302868|NCT00509496|4130006|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302869|NCT00509496|4130007|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302870|NCT00509496|4130008|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302871|NCT00509496|4130006|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302872|NCT00509496|4130007|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302873|NCT00509496|4130008|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302874|NCT00509496|4130006|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302875|NCT00509496|4130007|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302876|NCT00509496|4130008|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302877|NCT00509496|4130006|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302878|NCT00509496|4130007|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302879|NCT00509496|4130008|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302880|NCT00509496|4130006|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4302881|NCT00509496|4130007|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4302882|NCT00509496|4130008|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4302883|NCT00509496|4130006|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302884|NCT00509496|4130007|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302885|NCT00509496|4130008|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302886|NCT00509496|4130006|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4302887|NCT00509496|4130007|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4302888|NCT00509496|4130008|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4302889|NCT00509496|4130006|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4302890|NCT00509496|4130007|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4302891|NCT00509496|4130008|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4302892|NCT00509496|4130006|B3|||Age||years|Mean|44.4|44.4|Standard Deviation|11.3|11.3|||
4302893|NCT00509496|4130007|B2|||Age||years|Mean|28.0|28.0|Standard Deviation|2.8|2.8|||
4302894|NCT00509496|4130008|B1|||Age||years|Mean|46.1|46.1|Standard Deviation|10.5|10.5|||
4302895|NCT00509496|4130006|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4302896|NCT00509496|4130007|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4302897|NCT00509496|4130008|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4302898|NCT00509496|4130006|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4302899|NCT00509496|4130007|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4302900|NCT00509496|4130008|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4302901|NCT00509496|4130006|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4302902|NCT00509496|4130007|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4302903|NCT00509496|4130008|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4302904|NCT00509392|4130017|B3|||CIVIQ|"Chronic Venous Insufficiency Questionnaire(CIVIQ) for Quality of Life (QOL). (Min 20- Max 100).~Global index and an outline of 4 quality-of-life dimensions—“pain” (4 items), “physical” (4 items), “psychological” (9 items), and “social” (3 items). A low global (total) score corresponds to greater patient comfort."|Score on a questionnaire|Mean|40.3|40.3|Standard Deviation|15.9|15.9|||
4302905|NCT00509392|4130018|B2|||CIVIQ|"Chronic Venous Insufficiency Questionnaire(CIVIQ) for Quality of Life (QOL). (Min 20- Max 100).~Global index and an outline of 4 quality-of-life dimensions—“pain” (4 items), “physical” (4 items), “psychological” (9 items), and “social” (3 items). A low global (total) score corresponds to greater patient comfort."|Score on a questionnaire|Mean|40|40.0|Standard Deviation|14.5|14.5|||
4302906|NCT00509392|4130019|B1|||CIVIQ|"Chronic Venous Insufficiency Questionnaire(CIVIQ) for Quality of Life (QOL). (Min 20- Max 100).~Global index and an outline of 4 quality-of-life dimensions—“pain” (4 items), “physical” (4 items), “psychological” (9 items), and “social” (3 items). A low global (total) score corresponds to greater patient comfort."|Score on a questionnaire|Mean|40.6|40.6|Standard Deviation|17.2|17.2|||
4302907|NCT00509392|4130017|B3|Not CEAP Class 2||CEAP|"Clinical/Etiology/Anatomy/Pathophysiology Score~CEAP Class 2: Clinical classification for individuals with varicose veins"|limbs|Number|8|8.0||||||
4302908|NCT00509392|4130018|B2|Not CEAP Class 2||CEAP|"Clinical/Etiology/Anatomy/Pathophysiology Score~CEAP Class 2: Clinical classification for individuals with varicose veins"|limbs|Number|5|5.0||||||
4302909|NCT00509392|4130019|B1|Not CEAP Class 2||CEAP|"Clinical/Etiology/Anatomy/Pathophysiology Score~CEAP Class 2: Clinical classification for individuals with varicose veins"|limbs|Number|3|3.0||||||
4302910|NCT00509392|4130017|B3|CEAP Class 2||CEAP|"Clinical/Etiology/Anatomy/Pathophysiology Score~CEAP Class 2: Clinical classification for individuals with varicose veins"|limbs|Number|79|79.0||||||
4302911|NCT00509392|4130018|B2|CEAP Class 2||CEAP|"Clinical/Etiology/Anatomy/Pathophysiology Score~CEAP Class 2: Clinical classification for individuals with varicose veins"|limbs|Number|36|36.0||||||
4302912|NCT00509392|4130019|B1|CEAP Class 2||CEAP|"Clinical/Etiology/Anatomy/Pathophysiology Score~CEAP Class 2: Clinical classification for individuals with varicose veins"|limbs|Number|43|43.0||||||
4302913|NCT00509392|4130017|B3|||VCSS|"Venous Clinical Severity Score (0-30 total overall score):~0(minimum)- No evidence of venous disease 30(maximum)- Severe venous disease"|Scores on a scale|Mean|4.8|4.8|Standard Deviation|3.0|3.0|||
4302914|NCT00509392|4130018|B2|||VCSS|"Venous Clinical Severity Score (0-30 total overall score):~0(minimum)- No evidence of venous disease 30(maximum)- Severe venous disease"|Scores on a scale|Mean|4.9|4.9|Standard Deviation|2.8|2.8|||
4302915|NCT00509392|4130019|B1|||VCSS|"Venous Clinical Severity Score (0-30 total overall score):~0(minimum)- No evidence of venous disease 30(maximum)- Severe venous disease"|Scores on a scale|Mean|4.7|4.7|Standard Deviation|3.1|3.1|||
4302916|NCT00509392|4130017|B3|Germany||Region of Enrollment||limbs|Number|39|39.0||||||
4302917|NCT00509392|4130018|B2|Germany||Region of Enrollment||limbs|Number|18|18.0||||||
4302918|NCT00509392|4130019|B1|Germany||Region of Enrollment||limbs|Number|21|21.0||||||
4302919|NCT00509392|4130017|B3|United States||Region of Enrollment||limbs|Number|48|48.0||||||
4302920|NCT00509392|4130018|B2|United States||Region of Enrollment||limbs|Number|23|23.0||||||
4302921|NCT00509392|4130019|B1|United States||Region of Enrollment||limbs|Number|25|25.0||||||
4302922|NCT00509392|4130017|B3||Male|Sex: Female, Male||limbs|Count of Units|18|18.0||||||
4302923|NCT00509392|4130018|B2||Male|Sex: Female, Male||limbs|Count of Units|10|10.0||||||
4302924|NCT00509392|4130019|B1||Male|Sex: Female, Male||limbs|Count of Units|8|8.0||||||
4302925|NCT00509392|4130017|B3||Female|Sex: Female, Male||limbs|Count of Units|69|69.0||||||
4302926|NCT00509392|4130018|B2||Female|Sex: Female, Male||limbs|Count of Units|31|31.0||||||
4302927|NCT00509392|4130019|B1||Female|Sex: Female, Male||limbs|Count of Units|38|38.0||||||
4302928|NCT00509392|4130017|B3|||Age||Years|Mean|52.37|52.37|Standard Deviation|15.3|15.3|||
4302929|NCT00509392|4130018|B2|||Age||Years|Mean|52.4|52.4|Standard Deviation|15.3|15.3|||
4302930|NCT00509392|4130019|B1|||Age||Years|Mean|51.6|51.6|Standard Deviation|12.8|12.8|||
4302931|NCT00509392|4130017|B3||>=65 years|Age||limbs|Count of Units|17|17.0||||||
4302932|NCT00509392|4130018|B2||>=65 years|Age||limbs|Count of Units|11|11.0||||||
4302933|NCT00509392|4130019|B1||>=65 years|Age||limbs|Count of Units|6|6.0||||||
4302934|NCT00509392|4130017|B3||Between 18 and 65 years|Age||limbs|Count of Units|70|70.0||||||
4302935|NCT00509392|4130018|B2||Between 18 and 65 years|Age||limbs|Count of Units|30|30.0||||||
4302936|NCT00509392|4130019|B1||Between 18 and 65 years|Age||limbs|Count of Units|40|40.0||||||
4302937|NCT00509392|4130017|B3||<=18 years|Age||limbs|Count of Units|0|0.0||||||
4302938|NCT00509392|4130018|B2||<=18 years|Age||limbs|Count of Units|0|0.0||||||
4302939|NCT00509392|4130019|B1||<=18 years|Age||limbs|Count of Units|0|0.0||||||
4302940|NCT00509366|4130067|B6|United States||Region of Enrollment||participants|Number|101|101.0||||||
4302941|NCT00509366|4130068|B5|United States||Region of Enrollment||participants|Number|54|54.0||||||
4302942|NCT00509366|4130069|B4|United States||Region of Enrollment||participants|Number|2|2.0||||||
4302943|NCT00509366|4130070|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4302944|NCT00509366|4130071|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4302945|NCT00509366|4130072|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4302946|NCT00509366|4130067|B6||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4302947|NCT00509366|4130068|B5||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4302948|NCT00509366|4130069|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4302949|NCT00509366|4130070|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4302950|NCT00509366|4130071|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4302951|NCT00509366|4130072|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4302952|NCT00509366|4130067|B6||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4302953|NCT00509366|4130068|B5||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4302954|NCT00509366|4130069|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4302955|NCT00509366|4130070|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4302956|NCT00509366|4130071|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4302957|NCT00509366|4130072|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4302958|NCT00509366|4130067|B6|||Age||years|Mean|61.61|61.61|Standard Deviation|9.29|9.29|||
4302959|NCT00509366|4130068|B5|||Age||years|Mean|61.24|61.24|Standard Deviation|10.10|10.1|||
4302960|NCT00509366|4130069|B4|||Age||years|Mean|59.00|59.0|Standard Deviation|7.07|7.07|||
4302961|NCT00509366|4130070|B3|||Age||years|Mean|62.14|62.14|Standard Deviation|9.72|9.72|||
4302962|NCT00509366|4130071|B2|||Age||years|Mean|61.43|61.43|Standard Deviation|9.78|9.78|||
4302963|NCT00509366|4130072|B1|||Age||years|Mean|62.53|62.53|Standard Deviation|6.51|6.51|||
4302964|NCT00509288|4130087|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4302965|NCT00509288|4130088|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4302966|NCT00509288|4130089|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4302967|NCT00509288|4130087|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302968|NCT00509288|4130088|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302969|NCT00509288|4130089|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302970|NCT00509288|4130087|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302971|NCT00509288|4130088|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302972|NCT00509288|4130089|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302973|NCT00509288|4130087|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4302974|NCT00509288|4130088|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4302975|NCT00509288|4130089|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4302976|NCT00509288|4130087|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302977|NCT00509288|4130088|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302978|NCT00509288|4130089|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302979|NCT00509288|4130087|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302980|NCT00509288|4130088|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302981|NCT00509288|4130089|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302982|NCT00509288|4130087|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302983|NCT00509288|4130088|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302984|NCT00509288|4130089|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302985|NCT00509288|4130087|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302986|NCT00509288|4130088|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302987|NCT00509288|4130089|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302988|NCT00509288|4130087|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302989|NCT00509288|4130088|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302990|NCT00509288|4130089|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302991|NCT00509288|4130087|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4302992|NCT00509288|4130088|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4302993|NCT00509288|4130089|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4302994|NCT00509288|4130087|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302995|NCT00509288|4130088|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302996|NCT00509288|4130089|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4302997|NCT00509288|4130087|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4302998|NCT00509288|4130088|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4302999|NCT00509288|4130089|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4303000|NCT00509288|4130087|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4303001|NCT00509288|4130088|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4303002|NCT00509288|4130089|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4303003|NCT00509288|4130087|B3|||Age||years|Mean|46.2|46.2|Standard Deviation|11.9|11.9|||
4303004|NCT00509288|4130088|B2|||Age||years|Mean|48.0|48.0|Standard Deviation|21.7|21.7|||
4303005|NCT00509288|4130089|B1|||Age||years|Mean|45.9|45.9|Standard Deviation|11.0|11.0|||
4303006|NCT00509288|4130087|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4303007|NCT00509288|4130088|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4303008|NCT00509288|4130089|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4303009|NCT00509288|4130087|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4303010|NCT00509288|4130088|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4303011|NCT00509288|4130089|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4303012|NCT00509288|4130087|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303013|NCT00509288|4130088|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303014|NCT00509288|4130089|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303015|NCT00509262|4130098|B3||Male|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
4303016|NCT00509262|4130099|B2||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4303017|NCT00509262|4130100|B1||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4303018|NCT00509262|4130098|B3||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4303019|NCT00509262|4130099|B2||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4303020|NCT00509262|4130100|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4303021|NCT00509262|4130098|B3|||Age||years|Mean|64.2|64.2|Standard Deviation|10.1|10.1|||
4303022|NCT00509262|4130099|B2|||Age||years|Mean|64.2|64.2|Standard Deviation|9.4|9.4|||
4303023|NCT00509262|4130100|B1|||Age||years|Mean|64.2|64.2|Standard Deviation|10.7|10.7|||
4303024|NCT00509249|4130113|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4303025|NCT00509249|4130113|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4303026|NCT00509249|4130113|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4303027|NCT00509249|4130113|B1|||Age||years|Median|71|71.0|Full Range|||51.0|79.0|
4303028|NCT00509236|4130117|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4303029|NCT00509236|4130118|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4303030|NCT00509236|4130119|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4303031|NCT00509236|4130117|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4303032|NCT00509236|4130118|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4303033|NCT00509236|4130119|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4303034|NCT00509236|4130117|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|9.5|9.5|||
4303035|NCT00509236|4130118|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|9.9|9.9|||
4303036|NCT00509236|4130119|B1|||Age||years|Mean|60.5|60.5|Standard Deviation|9.1|9.1|||
4303037|NCT00509223|4130133|B3|Australia||Region of Enrollment||participants|Number|185|185.0||||||
4303038|NCT00509223|4130134|B2|Australia||Region of Enrollment||participants|Number|88|88.0||||||
4303039|NCT00509223|4130135|B1|Australia||Region of Enrollment||participants|Number|97|97.0||||||
4303040|NCT00509223|4130133|B3|United States||Region of Enrollment||participants|Number|113|113.0||||||
4303041|NCT00509223|4130134|B2|United States||Region of Enrollment||participants|Number|59|59.0||||||
4303042|NCT00509223|4130135|B1|United States||Region of Enrollment||participants|Number|54|54.0||||||
4303043|NCT00509223|4130133|B3||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4303044|NCT00509223|4130134|B2||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4303045|NCT00509223|4130135|B1||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4303046|NCT00509223|4130133|B3||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4303047|NCT00509223|4130134|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4303048|NCT00509223|4130135|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4303049|NCT00509223|4130133|B3|||Age||years|Mean|62.3|62.3|Standard Deviation|9.0|9.0|||
4303050|NCT00509223|4130134|B2|||Age||years|Mean|62.1|62.1|Standard Deviation|9.0|9.0|||
4303051|NCT00509223|4130135|B1|||Age||years|Mean|62.4|62.4|Standard Deviation|9.1|9.1|||
4303052|NCT00509223|4130133|B3||>=65 years|Age||Participants|Count of Participants|124|124.0||||||
4303053|NCT00509223|4130134|B2||>=65 years|Age||Participants|Count of Participants|57|57.0||||||
4303054|NCT00509223|4130135|B1||>=65 years|Age||Participants|Count of Participants|67|67.0||||||
4303055|NCT00509223|4130133|B3||Between 18 and 65 years|Age||Participants|Count of Participants|174|174.0||||||
4303056|NCT00509223|4130134|B2||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
4303057|NCT00509223|4130135|B1||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
4303058|NCT00509223|4130133|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303059|NCT00509223|4130134|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303060|NCT00509223|4130135|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303061|NCT00509197|4130142|B3|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4303062|NCT00509197|4130143|B2|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4303063|NCT00509197|4130144|B1|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4303064|NCT00509197|4130142|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4303065|NCT00509197|4130143|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4303066|NCT00509197|4130144|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4303067|NCT00509197|4130142|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4303068|NCT00509197|4130143|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4303069|NCT00509197|4130144|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4303070|NCT00509197|4130142|B3|||Age||years|Mean|40.5|40.5|Standard Deviation|13.2|13.2|||
4303071|NCT00509197|4130143|B2|||Age||years|Mean|43|43.0|Standard Deviation|11.7|11.7|||
4303072|NCT00509197|4130144|B1|||Age||years|Mean|38|38.0|Standard Deviation|15.3|15.3|||
4303073|NCT00509197|4130142|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4303074|NCT00509197|4130143|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4303075|NCT00509197|4130144|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4303076|NCT00509197|4130142|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4303077|NCT00509197|4130143|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4303078|NCT00509197|4130144|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4303079|NCT00509197|4130142|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303080|NCT00509197|4130143|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303081|NCT00509197|4130144|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303082|NCT00509106|4130157|B3||Male|Sex: Female, Male||Participants|Count of Participants|391|391.0||||||
4303083|NCT00509106|4130158|B2||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4303084|NCT00509106|4130159|B1||Male|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4303085|NCT00509106|4130157|B3||Female|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
4303086|NCT00509106|4130158|B2||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4303087|NCT00509106|4130159|B1||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4303088|NCT00509106|4130157|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|16.3|16.3|||
4303089|NCT00509106|4130158|B2|||Age||years|Mean|60.0|60.0|Standard Deviation|15.5|15.5|||
4303090|NCT00509106|4130159|B1|||Age||years|Mean|59.0|59.0|Standard Deviation|17.0|17.0|||
4303091|NCT00509106|4130157|B3|>=65 years||Age, Customized||participants|Number|266|266.0||||||
4303092|NCT00509106|4130158|B2|>=65 years||Age, Customized||participants|Number|134|134.0||||||
4303093|NCT00509106|4130159|B1|>=65 years||Age, Customized||participants|Number|132|132.0||||||
4303094|NCT00509106|4130157|B3|<65 years||Age, Customized||participants|Number|356|356.0||||||
4303095|NCT00509106|4130158|B2|<65 years||Age, Customized||participants|Number|173|173.0||||||
4303096|NCT00509106|4130159|B1|<65 years||Age, Customized||participants|Number|183|183.0||||||
4303097|NCT00509067|4130166|B3|United States||Region of Enrollment||participants|Number|43|43.0||||||
4303098|NCT00509067|4130167|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4303099|NCT00509067|4130168|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4303100|NCT00509067|4130166|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4303101|NCT00509067|4130167|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4303102|NCT00509067|4130168|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4303103|NCT00509067|4130166|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4303104|NCT00509067|4130167|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4303105|NCT00509067|4130168|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4303106|NCT00509067|4130166|B3|||Age||years|Mean|53.28|53.28|Standard Deviation|9.94|9.94|||
4303107|NCT00509067|4130167|B2|||Age||years|Mean|52.38|52.38|Standard Deviation|11.04|11.04|||
4303108|NCT00509067|4130168|B1|||Age||years|Mean|54.37|54.37|Standard Deviation|8.50|8.5|||
4303109|NCT00509067|4130166|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4303110|NCT00509067|4130167|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4303111|NCT00509067|4130168|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4303112|NCT00509067|4130166|B3||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4303113|NCT00509067|4130167|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4303114|NCT00509067|4130168|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4303115|NCT00509067|4130166|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303116|NCT00509067|4130167|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303117|NCT00509067|4130168|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303118|NCT00509041|4130179|B1|No||Prior surgery||participants|Number|20|20.0||||||
4303119|NCT00509041|4130179|B1|Yes||Prior surgery||participants|Number|23|23.0||||||
4303120|NCT00509041|4130179|B1|No||Prior radiation||participants|Number|37|37.0||||||
4303121|NCT00509041|4130179|B1|Yes||Prior radiation||participants|Number|6|6.0||||||
4303122|NCT00509041|4130179|B1|No||Prior chemotherapy||participants|Number|0|0.0||||||
4303123|NCT00509041|4130179|B1|Yes||Prior chemotherapy||participants|Number|43|43.0||||||
4303124|NCT00509041|4130179|B1|Not reported||Histology||participants|Number|3|3.0||||||
4303125|NCT00509041|4130179|B1|Sarcomatoid||Histology||participants|Number|2|2.0||||||
4303126|NCT00509041|4130179|B1|Biphasic||Histology||participants|Number|5|5.0||||||
4303127|NCT00509041|4130179|B1|Epithelial||Histology||participants|Number|33|33.0||||||
4303128|NCT00509041|4130179|B1|Other||Site of origin||participants|Number|1|1.0||||||
4303129|NCT00509041|4130179|B1|Peritoneum||Site of origin||participants|Number|6|6.0||||||
4303130|NCT00509041|4130179|B1|Pleura||Site of origin||participants|Number|36|36.0||||||
4303131|NCT00509041|4130179|B1|1 - Ambulatory, restricted strenuous activity||ECOG Performance Score|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|24|24.0||||||
4303132|NCT00509041|4130179|B1|0 - Fully Active||ECOG Performance Score|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|19|19.0||||||
4303133|NCT00509041|4130179|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4303134|NCT00509041|4130179|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4303135|NCT00509041|4130179|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4303136|NCT00509041|4130179|B1|||Age||years|Median|68|68.0|Full Range|||35.0|81.0|
4303137|NCT00509028|4130186|B3||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4303138|NCT00509028|4130187|B2||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4303139|NCT00509028|4130188|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4303140|NCT00509028|4130186|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4303141|NCT00509028|4130187|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4303142|NCT00509028|4130188|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4303143|NCT00509028|4130186|B3|||Age||Years|Mean|8.8|8.8|Standard Deviation|2.5|2.5|||
4303144|NCT00509028|4130187|B2|||Age||Years|Mean|8.6|8.6|Standard Deviation|2.3|2.3|||
4303145|NCT00509028|4130188|B1|||Age||Years|Mean|8.9|8.9|Standard Deviation|2.6|2.6|||
4303146|NCT00509002|4130221|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4303147|NCT00509002|4130221|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4303148|NCT00509002|4130221|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4303149|NCT00509002|4130221|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4303150|NCT00509002|4130221|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4303151|NCT00509002|4130221|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4303152|NCT00509002|4130221|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4303153|NCT00509002|4130221|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4303154|NCT00509002|4130221|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4303155|NCT00509002|4130221|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4303156|NCT00509002|4130221|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4303157|NCT00509002|4130221|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4303158|NCT00509002|4130221|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4303159|NCT00509002|4130221|B1|||Age||years|Median|55|55.0|Full Range|||26.0|80.0|
4303160|NCT00508924|4130225|B5||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4303161|NCT00508924|4130226|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4303162|NCT00508924|4130227|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4303163|NCT00508924|4130228|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4303164|NCT00508924|4130229|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4303165|NCT00508924|4130225|B5||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4303166|NCT00508924|4130226|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4303167|NCT00508924|4130227|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4303168|NCT00508924|4130228|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4303169|NCT00508924|4130229|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4303170|NCT00508924|4130225|B5|||Age||years|Mean|65.7|65.7|Standard Deviation|9.2|9.2|||
4303171|NCT00508924|4130226|B4|||Age||years|Mean|65.9|65.9|Standard Deviation|9.8|9.8|||
4303172|NCT00508924|4130227|B3|||Age||years|Mean|68.3|68.3|Standard Deviation|7.9|7.9|||
4303173|NCT00508924|4130228|B2|||Age||years|Mean|65.5|65.5|Standard Deviation|9.5|9.5|||
4303174|NCT00508924|4130229|B1|||Age||years|Mean|63.4|63.4|Standard Deviation|8.9|8.9|||
4303175|NCT00508872|4130246|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4303176|NCT00508872|4130246|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4303177|NCT00508872|4130246|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4303178|NCT00508872|4130246|B1|||Age||years|Mean|46|46.0|Full Range|||36.0|55.0|
4303179|NCT00508820|4130250|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4303180|NCT00508820|4130251|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4303181|NCT00508820|4130252|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4303182|NCT00508820|4130250|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4303183|NCT00508820|4130251|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4303184|NCT00508820|4130252|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4303185|NCT00508820|4130250|B3|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4303186|NCT00508820|4130251|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4303187|NCT00508820|4130252|B1|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4303188|NCT00508820|4130250|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4303189|NCT00508820|4130251|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4303190|NCT00508820|4130252|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4303191|NCT00508820|4130250|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4303192|NCT00508820|4130251|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4303193|NCT00508820|4130252|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4303194|NCT00508820|4130250|B3|White or Caucasian||Race/Ethnicity, Customized||participants|Number|381|381.0||||||
4303195|NCT00508820|4130251|B2|White or Caucasian||Race/Ethnicity, Customized||participants|Number|232|232.0||||||
4303196|NCT00508820|4130252|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|149|149.0||||||
4303197|NCT00508820|4130250|B3||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4303198|NCT00508820|4130251|B2||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4303199|NCT00508820|4130252|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4303200|NCT00508820|4130250|B3||Female|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
4303201|NCT00508820|4130251|B2||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4303202|NCT00508820|4130252|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4303203|NCT00508820|4130250|B3|||Age||years|Mean|53.9|53.9|Standard Deviation|17.6|17.6|||
4303204|NCT00508820|4130251|B2|||Age||years|Mean|54.1|54.1|Standard Deviation|18|18.0|||
4303205|NCT00508820|4130252|B1|||Age||years|Mean|53.6|53.6|Standard Deviation|17|17.0|||
4303206|NCT00508755|4130263|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4303207|NCT00508755|4130263|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4303208|NCT00508755|4130263|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4303209|NCT00508755|4130263|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4303210|NCT00508755|4130263|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4303211|NCT00508755|4130263|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303212|NCT00508742|4130269|B3||Male|Sex: Female, Male||Participants|Count of Participants|921|921.0||||||
4303213|NCT00508742|4130270|B2||Male|Sex: Female, Male||Participants|Count of Participants|463|463.0||||||
4303214|NCT00508742|4130271|B1||Male|Sex: Female, Male||Participants|Count of Participants|458|458.0||||||
4303215|NCT00508742|4130269|B3||Female|Sex: Female, Male||Participants|Count of Participants|945|945.0||||||
4303216|NCT00508742|4130270|B2||Female|Sex: Female, Male||Participants|Count of Participants|471|471.0||||||
4303217|NCT00508742|4130271|B1||Female|Sex: Female, Male||Participants|Count of Participants|474|474.0||||||
4303218|NCT00508742|4130269|B3|||Age||years|Mean|2.2|2.2|Standard Deviation|0.3|0.3|||
4303219|NCT00508742|4130270|B2|||Age||years|Mean|2.2|2.2|Standard Deviation|0.3|0.3|||
4303220|NCT00508742|4130271|B1|||Age||years|Mean|2.2|2.2|Standard Deviation|0.3|0.3|||
4303221|NCT00508716|4130286|B3|United States||Region of Enrollment||participants|Number|124|124.0||||||
4303222|NCT00508716|4130287|B2|United States||Region of Enrollment||participants|Number|63|63.0||||||
4303223|NCT00508716|4130288|B1|United States||Region of Enrollment||participants|Number|61|61.0||||||
4303224|NCT00508716|4130286|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4303225|NCT00508716|4130287|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4303226|NCT00508716|4130288|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4303227|NCT00508716|4130286|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4303228|NCT00508716|4130287|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4303229|NCT00508716|4130288|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4303230|NCT00508716|4130286|B3||>=65 years|Age||Participants|Count of Participants|87|87.0||||||
4303231|NCT00508716|4130287|B2||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
4303232|NCT00508716|4130288|B1||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
4303233|NCT00508716|4130286|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4303234|NCT00508716|4130287|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4303235|NCT00508716|4130288|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4303236|NCT00508716|4130286|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303237|NCT00508716|4130287|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303238|NCT00508716|4130288|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303239|NCT00508651|4130295|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4303240|NCT00508651|4130296|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4303241|NCT00508651|4130297|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4303242|NCT00508651|4130295|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4303243|NCT00508651|4130296|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4303244|NCT00508651|4130297|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4303245|NCT00508651|4130295|B3|||Age||Months|Mean|8.77|8.77|Standard Deviation|1.66|1.66|||
4303246|NCT00508651|4130296|B2|||Age||Months|Mean|8.44|8.44|Standard Deviation|1.20|1.2|||
4303247|NCT00508651|4130297|B1|||Age||Months|Mean|8.94|8.94|Standard Deviation|1.85|1.85|||
4303248|NCT00508521|4130372|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4303249|NCT00508521|4130372|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4303250|NCT00508521|4130372|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4303251|NCT00508521|4130372|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4303252|NCT00508521|4130372|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4303253|NCT00508521|4130372|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303254|NCT00508482|4130376|B4|||Cleveland Clinic Score|A scale about constipation symptoms, assessed by the doctor. There are eight items(the score was summed up by the 8 items). It ranges from '0' to '30'. '0' means none of symptoms and '30' means very severe symptoms.|units on a scale|Median|13|13.0|Inter-Quartile Range|||10.0|15.25|
4303286|NCT00508482|4130376|B4|Han||Race/Ethnicity, Customized||participants|Number|458|458.0||||||
4303255|NCT00508482|4130377|B3|||Cleveland Clinic Score|A scale about constipation symptoms, assessed by the doctor. There are eight items(the score was summed up by the 8 items). It ranges from '0' to '30'. '0' means none of symptoms and '30' means very severe symptoms.|units on a scale|Median|13|13.0|Inter-Quartile Range|||10.0|15.0|
4303256|NCT00508482|4130378|B2|||Cleveland Clinic Score|A scale about constipation symptoms, assessed by the doctor. There are eight items(the score was summed up by the 8 items). It ranges from '0' to '30'. '0' means none of symptoms and '30' means very severe symptoms.|units on a scale|Median|13|13.0|Inter-Quartile Range|||11.0|16.0|
4303257|NCT00508482|4130379|B1|||Cleveland Clinic Score|A scale about constipation symptoms, assessed by the doctor. There are eight items(the score was summed up by the 8 items). It ranges from '0' to '30'. '0' means none of symptoms and '30' means very severe symptoms.|units on a scale|Median|13|13.0|Inter-Quartile Range|||11.0|16.0|
4303258|NCT00508482|4130376|B4|||abdominal distention|one of symptoms assessed by patients (including four symptoms) at baseline. It ranges from 0 to 4. '0' means no such symptom and '4' means very severe symptom.|units on a scale|Median|1|1.0|Inter-Quartile Range|||0.0|2.0|
4303259|NCT00508482|4130377|B3|||abdominal distention|one of symptoms assessed by patients (including four symptoms) at baseline. It ranges from 0 to 4. '0' means no such symptom and '4' means very severe symptom.|units on a scale|Median|1|1.0|Inter-Quartile Range|||0.0|2.0|
4303260|NCT00508482|4130378|B2|||abdominal distention|one of symptoms assessed by patients (including four symptoms) at baseline. It ranges from 0 to 4. '0' means no such symptom and '4' means very severe symptom.|units on a scale|Median|2|2.0|Inter-Quartile Range|||1.0|2.0|
4303261|NCT00508482|4130379|B1|||abdominal distention|one of symptoms assessed by patients (including four symptoms) at baseline. It ranges from 0 to 4. '0' means no such symptom and '4' means very severe symptom.|units on a scale|Median|1|1.0|Inter-Quartile Range|||1.0|2.0|
4303262|NCT00508482|4130376|B4|||Stool consistency|one of symptoms assessed by patients (including four symptoms) at baseline. It ranges from 0 to 4,among them '0' means normal faeces and '4' means very hard faeces.|units on a scale|Median|3|3.0|Inter-Quartile Range|||2.0|3.0|
4303263|NCT00508482|4130377|B3|||Stool consistency|one of symptoms assessed by patients (including four symptoms) at baseline. It ranges from 0 to 4,among them '0' means normal faeces and '4' means very hard faeces.|units on a scale|Median|3|3.0|Inter-Quartile Range|||2.0|3.0|
4303264|NCT00508482|4130378|B2|||Stool consistency|one of symptoms assessed by patients (including four symptoms) at baseline. It ranges from 0 to 4,among them '0' means normal faeces and '4' means very hard faeces.|units on a scale|Median|3|3.0|Inter-Quartile Range|||2.0|3.0|
4303265|NCT00508482|4130379|B1|||Stool consistency|one of symptoms assessed by patients (including four symptoms) at baseline. It ranges from 0 to 4,among them '0' means normal faeces and '4' means very hard faeces.|units on a scale|Median|3|3.0|Inter-Quartile Range|||2.0|3.0|
4303266|NCT00508482|4130376|B4|||Incomplete evacuation|one of symptoms assessed by patients (including four symptoms) at baseline. It ranges from 0 to 4. '0' means no such symptom and '4' means very severe symptom.|units on a scale|Median|2|2.0|Inter-Quartile Range|||2.0|3.0|
4303267|NCT00508482|4130377|B3|||Incomplete evacuation|one of symptoms assessed by patients (including four symptoms) at baseline. It ranges from 0 to 4. '0' means no such symptom and '4' means very severe symptom.|units on a scale|Median|2|2.0|Inter-Quartile Range|||1.0|3.0|
4303268|NCT00508482|4130378|B2|||Incomplete evacuation|one of symptoms assessed by patients (including four symptoms) at baseline. It ranges from 0 to 4. '0' means no such symptom and '4' means very severe symptom.|units on a scale|Median|2|2.0|Inter-Quartile Range|||2.0|3.0|
4303269|NCT00508482|4130379|B1|||Incomplete evacuation|one of symptoms assessed by patients (including four symptoms) at baseline. It ranges from 0 to 4. '0' means no such symptom and '4' means very severe symptom.|units on a scale|Median|2|2.0|Inter-Quartile Range|||2.0|3.0|
4303270|NCT00508482|4130376|B4|||straining during defecation|one of symptoms assessed by patients (including four symptoms) at baseline.It ranges from 0 to 4. '0' means no such symptom and '4' means very severe symptom.|units on a scale|Median|3|3.0|Inter-Quartile Range|||2.0|3.0|
4303271|NCT00508482|4130377|B3|||straining during defecation|one of symptoms assessed by patients (including four symptoms) at baseline.It ranges from 0 to 4. '0' means no such symptom and '4' means very severe symptom.|units on a scale|Median|3|3.0|Inter-Quartile Range|||2.0|3.0|
4303272|NCT00508482|4130378|B2|||straining during defecation|one of symptoms assessed by patients (including four symptoms) at baseline.It ranges from 0 to 4. '0' means no such symptom and '4' means very severe symptom.|units on a scale|Median|3|3.0|Inter-Quartile Range|||2.0|3.0|
4303273|NCT00508482|4130379|B1|||straining during defecation|one of symptoms assessed by patients (including four symptoms) at baseline.It ranges from 0 to 4. '0' means no such symptom and '4' means very severe symptom.|units on a scale|Median|3|3.0|Inter-Quartile Range|||2.0|3.0|
4303274|NCT00508482|4130376|B4|||mean spontaneous bowel movements|defecation times in one week without help of medication or hands|stools/week|Median|2|2.0|Inter-Quartile Range|||1.0|3.0|
4303275|NCT00508482|4130377|B3|||mean spontaneous bowel movements|defecation times in one week without help of medication or hands|stools/week|Median|2|2.0|Inter-Quartile Range|||1.0|3.0|
4303276|NCT00508482|4130378|B2|||mean spontaneous bowel movements|defecation times in one week without help of medication or hands|stools/week|Median|2|2.0|Inter-Quartile Range|||1.0|3.0|
4303277|NCT00508482|4130379|B1|||mean spontaneous bowel movements|defecation times in one week without help of medication or hands|stools/week|Median|2|2.0|Inter-Quartile Range|||1.0|3.0|
4303278|NCT00508482|4130376|B4|China||Region of Enrollment||participants|Number|475|475.0||||||
4303279|NCT00508482|4130377|B3|China||Region of Enrollment||participants|Number|119|119.0||||||
4303280|NCT00508482|4130378|B2|China||Region of Enrollment||participants|Number|119|119.0||||||
4303281|NCT00508482|4130379|B1|China||Region of Enrollment||participants|Number|237|237.0||||||
4303282|NCT00508482|4130376|B4|Minority||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4303283|NCT00508482|4130377|B3|Minority||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4303284|NCT00508482|4130378|B2|Minority||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4303285|NCT00508482|4130379|B1|Minority||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4303287|NCT00508482|4130377|B3|Han||Race/Ethnicity, Customized||participants|Number|114|114.0||||||
4303288|NCT00508482|4130378|B2|Han||Race/Ethnicity, Customized||participants|Number|115|115.0||||||
4303289|NCT00508482|4130379|B1|Han||Race/Ethnicity, Customized||participants|Number|229|229.0||||||
4303290|NCT00508482|4130376|B4||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4303291|NCT00508482|4130377|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4303292|NCT00508482|4130378|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4303293|NCT00508482|4130379|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4303294|NCT00508482|4130376|B4||Female|Sex: Female, Male||Participants|Count of Participants|372|372.0||||||
4303295|NCT00508482|4130377|B3||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4303296|NCT00508482|4130378|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4303297|NCT00508482|4130379|B1||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4303298|NCT00508482|4130376|B4|||Age||years|Mean|44.87|44.87|Standard Deviation|17.29|17.29|||
4303299|NCT00508482|4130377|B3|||Age||years|Mean|43.71|43.71|Standard Deviation|17.23|17.23|||
4303300|NCT00508482|4130378|B2|||Age||years|Mean|45.21|45.21|Standard Deviation|17.40|17.4|||
4303301|NCT00508482|4130379|B1|||Age||years|Mean|45.18|45.18|Standard Deviation|17.28|17.28|||
4303302|NCT00508482|4130376|B4||>=65 years|Age||Participants|Count of Participants|70|70.0||||||
4303303|NCT00508482|4130377|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4303304|NCT00508482|4130378|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4303305|NCT00508482|4130379|B1||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
4303306|NCT00508482|4130376|B4||Between 18 and 65 years|Age||Participants|Count of Participants|401|401.0||||||
4303307|NCT00508482|4130377|B3||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
4303308|NCT00508482|4130378|B2||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
4303309|NCT00508482|4130379|B1||Between 18 and 65 years|Age||Participants|Count of Participants|199|199.0||||||
4303310|NCT00508482|4130376|B4||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4303311|NCT00508482|4130377|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303312|NCT00508482|4130378|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4303313|NCT00508482|4130379|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4303314|NCT00508469|4130416|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4303315|NCT00508469|4130417|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4303316|NCT00508469|4130418|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4303317|NCT00508469|4130416|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4303318|NCT00508469|4130417|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4303319|NCT00508469|4130418|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4303320|NCT00508469|4130416|B3|||Age||years|Mean|66.2|66.2|Standard Deviation|11.6|11.6|||
4303321|NCT00508469|4130417|B2|||Age||years|Mean|68.6|68.6|Standard Deviation|11.8|11.8|||
4303322|NCT00508469|4130418|B1|||Age||years|Mean|63.8|63.8|Standard Deviation|11.1|11.1|||
4303323|NCT00508404|4130425|B1|Unevaluable KRAS||Kirsten Rat Sarcoma-2 Virus (KRAS) Mutation Status||participants|Number|9|9.0||||||
4303324|NCT00508404|4130425|B1|Mutant KRAS||Kirsten Rat Sarcoma-2 Virus (KRAS) Mutation Status||participants|Number|59|59.0||||||
4303325|NCT00508404|4130425|B1|Wild-type KRAS||Kirsten Rat Sarcoma-2 Virus (KRAS) Mutation Status||participants|Number|86|86.0||||||
4303326|NCT00508404|4130425|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|150|150.0||||||
4303327|NCT00508404|4130425|B1|Japanese||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4303328|NCT00508404|4130425|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4303329|NCT00508404|4130425|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4303330|NCT00508404|4130425|B1||Male|Gender||Participants|Count of Participants|105|105.0||||||
4303331|NCT00508404|4130425|B1||Female|Gender||Participants|Count of Participants|49|49.0||||||
4303332|NCT00508404|4130425|B1|||Age||years|Mean|62.7|62.7|Standard Deviation|10.6|10.6|||
4303333|NCT00508391|4130450|B3|Switzerland||Region of Enrollment||participants|Number|5|5.0||||||
4303334|NCT00508391|4130451|B2|Switzerland||Region of Enrollment||participants|Number|3|3.0||||||
4303335|NCT00508391|4130452|B1|Switzerland||Region of Enrollment||participants|Number|2|2.0||||||
4303336|NCT00508391|4130450|B3|United States||Region of Enrollment||participants|Number|117|117.0||||||
4303337|NCT00508391|4130451|B2|United States||Region of Enrollment||participants|Number|59|59.0||||||
4303338|NCT00508391|4130452|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
4303339|NCT00508391|4130450|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4303340|NCT00508391|4130451|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4303341|NCT00508391|4130452|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4303342|NCT00508391|4130450|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4303343|NCT00508391|4130451|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4303344|NCT00508391|4130452|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4303345|NCT00508391|4130450|B3|||Age||years|Mean|67.1|67.1|Standard Deviation|13.1|13.1|||
4303346|NCT00508391|4130451|B2|||Age||years|Mean|66.1|66.1|Standard Deviation|12.0|12.0|||
4303347|NCT00508391|4130452|B1|||Age||years|Mean|68.2|68.2|Standard Deviation|14.1|14.1|||
4303348|NCT00508391|4130450|B3||>=65 years|Age||Participants|Count of Participants|74|74.0||||||
4303349|NCT00508391|4130451|B2||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
4303350|NCT00508391|4130452|B1||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4303351|NCT00508391|4130450|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4303352|NCT00508391|4130451|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4303353|NCT00508391|4130452|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4303354|NCT00508391|4130450|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303355|NCT00508391|4130451|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303356|NCT00508391|4130452|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303357|NCT00508274|4130464|B1|Chinese||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
4303358|NCT00508274|4130464|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4303359|NCT00508274|4130464|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4303360|NCT00508274|4130464|B1|||Age||years|Mean|48.8|48.8|Standard Deviation|10.61|10.61|||
4303361|NCT00508183|4130473|B3|Canada||Region of Enrollment|Ottawa,Ontario Winnipeg, Manitoba|participants|Number|90|90.0||||||
4303362|NCT00508183|4130474|B2|Canada||Region of Enrollment|Ottawa,Ontario Winnipeg, Manitoba|participants|Number|42|42.0||||||
4303363|NCT00508183|4130475|B1|Canada||Region of Enrollment|Ottawa,Ontario Winnipeg, Manitoba|participants|Number|48|48.0||||||
4303364|NCT00508183|4130473|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4303365|NCT00508183|4130474|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4303366|NCT00508183|4130475|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4303367|NCT00508183|4130473|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4303368|NCT00508183|4130474|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4303369|NCT00508183|4130475|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4303370|NCT00508183|4130473|B3|||Age||years|Mean|56.8|56.8|Standard Deviation|8.1|8.1|||
4303371|NCT00508183|4130474|B2|||Age||years|Mean|57.8|57.8|Standard Deviation|7|7.0|||
4303372|NCT00508183|4130475|B1|||Age||years|Mean|56|56.0|Standard Deviation|8.9|8.9|||
4303373|NCT00508157|4130490|B3|||Weight||kg|Mean|90.3|90.3|Standard Deviation|16.93|16.93|||
4303374|NCT00508157|4130491|B2|||Weight||kg|Mean|91.6|91.6|Standard Deviation|18.83|18.83|||
4303375|NCT00508157|4130492|B1|||Weight||kg|Mean|89.1|89.1|Standard Deviation|15.06|15.06|||
4303376|NCT00508157|4130490|B3|||Waist Circumference||cm|Mean|107.1|107.1|Full Range|||90.0|136.0|
4303377|NCT00508157|4130491|B2|||Waist Circumference||cm|Mean|107.1|107.1|Full Range|||91.0|134.0|
4303378|NCT00508157|4130492|B1|||Waist Circumference||cm|Mean|107.1|107.1|Full Range|||90.0|136.0|
4303379|NCT00508157|4130490|B3|||Fasting Non-High Density Lipoprotein (HDL) Cholesterol|Non-HDL cholesterol was calculated as fasting Total Cholesterol minus fasting HDL Cholesterol.|mg/dL|Mean|171.0|171.0|Full Range|||110.0|268.0|
4303380|NCT00508157|4130491|B2|||Fasting Non-High Density Lipoprotein (HDL) Cholesterol|Non-HDL cholesterol was calculated as fasting Total Cholesterol minus fasting HDL Cholesterol.|mg/dL|Mean|169.0|169.0|Full Range|||110.0|268.0|
4303381|NCT00508157|4130492|B1|||Fasting Non-High Density Lipoprotein (HDL) Cholesterol|Non-HDL cholesterol was calculated as fasting Total Cholesterol minus fasting HDL Cholesterol.|mg/dL|Mean|173.1|173.1|Full Range|||118.0|267.0|
4303382|NCT00508157|4130490|B3|||Body Mass Index (BMI)||kg/m2|Mean|31.38|31.38|Full Range|||19.0|49.1|
4303383|NCT00508157|4130491|B2|||Body Mass Index (BMI)||kg/m2|Mean|31.31|31.31|Full Range|||25.1|49.1|
4303384|NCT00508157|4130492|B1|||Body Mass Index (BMI)||kg/m2|Mean|31.45|31.45|Full Range|||19.0|42.8|
4303385|NCT00508157|4130490|B3|> 102 cm for Men/ > 88 cm for Women||Waist Circumference Category||participants|Number|49|49.0||||||
4303386|NCT00508157|4130491|B2|> 102 cm for Men/ > 88 cm for Women||Waist Circumference Category||participants|Number|24|24.0||||||
4303387|NCT00508157|4130492|B1|> 102 cm for Men/ > 88 cm for Women||Waist Circumference Category||participants|Number|25|25.0||||||
4303388|NCT00508157|4130490|B3|≤ 102 cm for Men/ ≤ 88 cm for Women||Waist Circumference Category||participants|Number|3|3.0||||||
4303389|NCT00508157|4130491|B2|≤ 102 cm for Men/ ≤ 88 cm for Women||Waist Circumference Category||participants|Number|2|2.0||||||
4303390|NCT00508157|4130492|B1|≤ 102 cm for Men/ ≤ 88 cm for Women||Waist Circumference Category||participants|Number|1|1.0||||||
4303391|NCT00508157|4130490|B3|>=30 kg/m2||Body Mass Index (BMI) category||Participants|Number|32|32.0||||||
4303392|NCT00508157|4130491|B2|>=30 kg/m2||Body Mass Index (BMI) category||Participants|Number|13|13.0||||||
4303393|NCT00508157|4130492|B1|>=30 kg/m2||Body Mass Index (BMI) category||Participants|Number|19|19.0||||||
4303394|NCT00508157|4130490|B3|< 30 kg/m2||Body Mass Index (BMI) category||Participants|Number|20|20.0||||||
4303395|NCT00508157|4130491|B2|< 30 kg/m2||Body Mass Index (BMI) category||Participants|Number|13|13.0||||||
4303396|NCT00508157|4130492|B1|< 30 kg/m2||Body Mass Index (BMI) category||Participants|Number|7|7.0||||||
4303397|NCT00508157|4130490|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4303398|NCT00508157|4130491|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4303399|NCT00508157|4130492|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4303400|NCT00508157|4130490|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4303401|NCT00508157|4130491|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4303402|NCT00508157|4130492|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4303403|NCT00508157|4130490|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4303404|NCT00508157|4130491|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4303405|NCT00508157|4130492|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4303406|NCT00508157|4130490|B3|White||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4303407|NCT00508157|4130491|B2|White||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4303408|NCT00508157|4130492|B1|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4303409|NCT00508157|4130490|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4303410|NCT00508157|4130491|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4303411|NCT00508157|4130492|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4303412|NCT00508157|4130490|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4303413|NCT00508157|4130491|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4303414|NCT00508157|4130492|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4303415|NCT00508157|4130490|B3|||Age||years|Mean|42.3|42.3|Standard Deviation|10.84|10.84|||
4303416|NCT00508157|4130491|B2|||Age||years|Mean|43.9|43.9|Standard Deviation|11.16|11.16|||
4303417|NCT00508157|4130492|B1|||Age||years|Mean|40.7|40.7|Standard Deviation|10.47|10.47|||
4303418|NCT00508144|4130515|B1|United States||Region of Enrollment||participants|Number|64|64.0||||||
4303419|NCT00508144|4130515|B1||Male|Gender||Participants|Count of Participants|40|40.0||||||
4303420|NCT00508144|4130515|B1||Female|Gender||Participants|Count of Participants|24|24.0||||||
4303421|NCT00508144|4130515|B1|||Age||years|Median|68|68.0|Full Range|||45.0|88.0|
4303422|NCT00508118|4130519|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4303423|NCT00508118|4130521|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4303424|NCT00508118|4130519|B3|Male||Gender||participants|Number|2|2.0||||||
4303425|NCT00508118|4130521|B1|Male||Gender||participants|Number|2|2.0||||||
4303426|NCT00508118|4130519|B3|Female||Gender||participants|Number|1|1.0||||||
4303427|NCT00508118|4130521|B1|Female||Gender||participants|Number|1|1.0||||||
4303428|NCT00508118|4130519|B3|||Age||years|Mean|50|50.0|Standard Deviation|5|5.0|||
4303429|NCT00508118|4130521|B1|||Age||years|Mean|50|50.0|Standard Deviation|5|5.0|||
4303430|NCT00508118|4130519|B3|>=65 years||Age||participants|Number|0|0.0||||||
4303431|NCT00508118|4130521|B1|>=65 years||Age||participants|Number|0|0.0||||||
4303432|NCT00508118|4130519|B3|Between 18 and 65 years||Age||participants|Number|3|3.0||||||
4303433|NCT00508118|4130521|B1|Between 18 and 65 years||Age||participants|Number|3|3.0||||||
4303434|NCT00508118|4130519|B3|<=18 years||Age||participants|Number|0|0.0||||||
4303435|NCT00508118|4130521|B1|<=18 years||Age||participants|Number|0|0.0||||||
4303436|NCT00508027|4130541|B1|Compound heterozygous Hb S and Hb C (SC)||Sickle cell genotype||participants|Number|10|10.0||||||
4303437|NCT00508027|4130541|B1|Homozygous Hb S (SS or S/beta0 thalassemia)||Sickle cell genotype||participants|Number|20|20.0||||||
4303438|NCT00508027|4130541|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4303439|NCT00508027|4130541|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4303440|NCT00508027|4130541|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4303441|NCT00508027|4130541|B1|||Age||years|Mean|25|25.0|Standard Deviation|11.5|11.5|||
4303442|NCT00508001|4130579|B4|CLIP 4||CLIP Score|"Cancer of the Liver Italian Programme (CLIP) is used to evaluate both tumour extension and remnant liver function with a score of min 0 to max 4. The CLIP score consists of 4 variables: Child-Pugh stage, tumour morphology, alpa-fetoprotein (AFP), and portal vein thrombosis. The higher the CLIP score the worse the survival.~The number of patients with CLIP Total score of 0, 1, 2, 3 and 4 is presented."|Participants|Number|18|18.0||||||
4303443|NCT00508001|4130580|B3|CLIP 4||CLIP Score|"Cancer of the Liver Italian Programme (CLIP) is used to evaluate both tumour extension and remnant liver function with a score of min 0 to max 4. The CLIP score consists of 4 variables: Child-Pugh stage, tumour morphology, alpa-fetoprotein (AFP), and portal vein thrombosis. The higher the CLIP score the worse the survival.~The number of patients with CLIP Total score of 0, 1, 2, 3 and 4 is presented."|Participants|Number|6|6.0||||||
4303444|NCT00508001|4130581|B2|CLIP 4||CLIP Score|"Cancer of the Liver Italian Programme (CLIP) is used to evaluate both tumour extension and remnant liver function with a score of min 0 to max 4. The CLIP score consists of 4 variables: Child-Pugh stage, tumour morphology, alpa-fetoprotein (AFP), and portal vein thrombosis. The higher the CLIP score the worse the survival.~The number of patients with CLIP Total score of 0, 1, 2, 3 and 4 is presented."|Participants|Number|6|6.0||||||
4303445|NCT00508001|4130582|B1|CLIP 4||CLIP Score|"Cancer of the Liver Italian Programme (CLIP) is used to evaluate both tumour extension and remnant liver function with a score of min 0 to max 4. The CLIP score consists of 4 variables: Child-Pugh stage, tumour morphology, alpa-fetoprotein (AFP), and portal vein thrombosis. The higher the CLIP score the worse the survival.~The number of patients with CLIP Total score of 0, 1, 2, 3 and 4 is presented."|Participants|Number|6|6.0||||||
4303446|NCT00508001|4130579|B4|CLIP 3||CLIP Score|"Cancer of the Liver Italian Programme (CLIP) is used to evaluate both tumour extension and remnant liver function with a score of min 0 to max 4. The CLIP score consists of 4 variables: Child-Pugh stage, tumour morphology, alpa-fetoprotein (AFP), and portal vein thrombosis. The higher the CLIP score the worse the survival.~The number of patients with CLIP Total score of 0, 1, 2, 3 and 4 is presented."|Participants|Number|18|18.0||||||
4303447|NCT00508001|4130580|B3|CLIP 3||CLIP Score|"Cancer of the Liver Italian Programme (CLIP) is used to evaluate both tumour extension and remnant liver function with a score of min 0 to max 4. The CLIP score consists of 4 variables: Child-Pugh stage, tumour morphology, alpa-fetoprotein (AFP), and portal vein thrombosis. The higher the CLIP score the worse the survival.~The number of patients with CLIP Total score of 0, 1, 2, 3 and 4 is presented."|Participants|Number|6|6.0||||||
4303448|NCT00508001|4130581|B2|CLIP 3||CLIP Score|"Cancer of the Liver Italian Programme (CLIP) is used to evaluate both tumour extension and remnant liver function with a score of min 0 to max 4. The CLIP score consists of 4 variables: Child-Pugh stage, tumour morphology, alpa-fetoprotein (AFP), and portal vein thrombosis. The higher the CLIP score the worse the survival.~The number of patients with CLIP Total score of 0, 1, 2, 3 and 4 is presented."|Participants|Number|8|8.0||||||
4303449|NCT00508001|4130582|B1|CLIP 3||CLIP Score|"Cancer of the Liver Italian Programme (CLIP) is used to evaluate both tumour extension and remnant liver function with a score of min 0 to max 4. The CLIP score consists of 4 variables: Child-Pugh stage, tumour morphology, alpa-fetoprotein (AFP), and portal vein thrombosis. The higher the CLIP score the worse the survival.~The number of patients with CLIP Total score of 0, 1, 2, 3 and 4 is presented."|Participants|Number|4|4.0||||||
4303450|NCT00508001|4130579|B4|CLIP 2||CLIP Score|"Cancer of the Liver Italian Programme (CLIP) is used to evaluate both tumour extension and remnant liver function with a score of min 0 to max 4. The CLIP score consists of 4 variables: Child-Pugh stage, tumour morphology, alpa-fetoprotein (AFP), and portal vein thrombosis. The higher the CLIP score the worse the survival.~The number of patients with CLIP Total score of 0, 1, 2, 3 and 4 is presented."|Participants|Number|15|15.0||||||
4303451|NCT00508001|4130580|B3|CLIP 2||CLIP Score|"Cancer of the Liver Italian Programme (CLIP) is used to evaluate both tumour extension and remnant liver function with a score of min 0 to max 4. The CLIP score consists of 4 variables: Child-Pugh stage, tumour morphology, alpa-fetoprotein (AFP), and portal vein thrombosis. The higher the CLIP score the worse the survival.~The number of patients with CLIP Total score of 0, 1, 2, 3 and 4 is presented."|Participants|Number|8|8.0||||||
4303452|NCT00508001|4130581|B2|CLIP 2||CLIP Score|"Cancer of the Liver Italian Programme (CLIP) is used to evaluate both tumour extension and remnant liver function with a score of min 0 to max 4. The CLIP score consists of 4 variables: Child-Pugh stage, tumour morphology, alpa-fetoprotein (AFP), and portal vein thrombosis. The higher the CLIP score the worse the survival.~The number of patients with CLIP Total score of 0, 1, 2, 3 and 4 is presented."|Participants|Number|5|5.0||||||
4303453|NCT00508001|4130582|B1|CLIP 2||CLIP Score|"Cancer of the Liver Italian Programme (CLIP) is used to evaluate both tumour extension and remnant liver function with a score of min 0 to max 4. The CLIP score consists of 4 variables: Child-Pugh stage, tumour morphology, alpa-fetoprotein (AFP), and portal vein thrombosis. The higher the CLIP score the worse the survival.~The number of patients with CLIP Total score of 0, 1, 2, 3 and 4 is presented."|Participants|Number|2|2.0||||||
4303454|NCT00508001|4130579|B4|CLIP 1||CLIP Score|"Cancer of the Liver Italian Programme (CLIP) is used to evaluate both tumour extension and remnant liver function with a score of min 0 to max 4. The CLIP score consists of 4 variables: Child-Pugh stage, tumour morphology, alpa-fetoprotein (AFP), and portal vein thrombosis. The higher the CLIP score the worse the survival.~The number of patients with CLIP Total score of 0, 1, 2, 3 and 4 is presented."|Participants|Number|13|13.0||||||
4303455|NCT00508001|4130580|B3|CLIP 1||CLIP Score|"Cancer of the Liver Italian Programme (CLIP) is used to evaluate both tumour extension and remnant liver function with a score of min 0 to max 4. The CLIP score consists of 4 variables: Child-Pugh stage, tumour morphology, alpa-fetoprotein (AFP), and portal vein thrombosis. The higher the CLIP score the worse the survival.~The number of patients with CLIP Total score of 0, 1, 2, 3 and 4 is presented."|Participants|Number|3|3.0||||||
4303456|NCT00508001|4130581|B2|CLIP 1||CLIP Score|"Cancer of the Liver Italian Programme (CLIP) is used to evaluate both tumour extension and remnant liver function with a score of min 0 to max 4. The CLIP score consists of 4 variables: Child-Pugh stage, tumour morphology, alpa-fetoprotein (AFP), and portal vein thrombosis. The higher the CLIP score the worse the survival.~The number of patients with CLIP Total score of 0, 1, 2, 3 and 4 is presented."|Participants|Number|5|5.0||||||
4303457|NCT00508001|4130582|B1|CLIP 1||CLIP Score|"Cancer of the Liver Italian Programme (CLIP) is used to evaluate both tumour extension and remnant liver function with a score of min 0 to max 4. The CLIP score consists of 4 variables: Child-Pugh stage, tumour morphology, alpa-fetoprotein (AFP), and portal vein thrombosis. The higher the CLIP score the worse the survival.~The number of patients with CLIP Total score of 0, 1, 2, 3 and 4 is presented."|Participants|Number|5|5.0||||||
4303458|NCT00508001|4130579|B4|CLIP 0||CLIP Score|"Cancer of the Liver Italian Programme (CLIP) is used to evaluate both tumour extension and remnant liver function with a score of min 0 to max 4. The CLIP score consists of 4 variables: Child-Pugh stage, tumour morphology, alpa-fetoprotein (AFP), and portal vein thrombosis. The higher the CLIP score the worse the survival.~The number of patients with CLIP Total score of 0, 1, 2, 3 and 4 is presented."|Participants|Number|3|3.0||||||
4303459|NCT00508001|4130580|B3|CLIP 0||CLIP Score|"Cancer of the Liver Italian Programme (CLIP) is used to evaluate both tumour extension and remnant liver function with a score of min 0 to max 4. The CLIP score consists of 4 variables: Child-Pugh stage, tumour morphology, alpa-fetoprotein (AFP), and portal vein thrombosis. The higher the CLIP score the worse the survival.~The number of patients with CLIP Total score of 0, 1, 2, 3 and 4 is presented."|Participants|Number|0|0.0||||||
4303460|NCT00508001|4130581|B2|CLIP 0||CLIP Score|"Cancer of the Liver Italian Programme (CLIP) is used to evaluate both tumour extension and remnant liver function with a score of min 0 to max 4. The CLIP score consists of 4 variables: Child-Pugh stage, tumour morphology, alpa-fetoprotein (AFP), and portal vein thrombosis. The higher the CLIP score the worse the survival.~The number of patients with CLIP Total score of 0, 1, 2, 3 and 4 is presented."|Participants|Number|1|1.0||||||
4303461|NCT00508001|4130582|B1|CLIP 0||CLIP Score|"Cancer of the Liver Italian Programme (CLIP) is used to evaluate both tumour extension and remnant liver function with a score of min 0 to max 4. The CLIP score consists of 4 variables: Child-Pugh stage, tumour morphology, alpa-fetoprotein (AFP), and portal vein thrombosis. The higher the CLIP score the worse the survival.~The number of patients with CLIP Total score of 0, 1, 2, 3 and 4 is presented."|Participants|Number|2|2.0||||||
4303462|NCT00508001|4130579|B4|Child-Pugh of 6||Child-Pugh Score|"Child-Pugh Scale is used to assess the prognosis of chronic liver disease. The total score employs five clinical measures of liver disease: severity of ascites and of encephalopathy, abnormality in the serum bilirubin, serum albumin and clotting times. Each measure is scored 1-3, with 3 indicating most severe derangement.~The Total score ranges between 5 min to 15 max where lower score = less liver disease and higher score = chronic liver disease.~The number of patients with Child-PughTotal score of 5 and 6 is presented."|Participants|Number|18|18.0||||||
4303463|NCT00508001|4130580|B3|Child-Pugh of 6||Child-Pugh Score|"Child-Pugh Scale is used to assess the prognosis of chronic liver disease. The total score employs five clinical measures of liver disease: severity of ascites and of encephalopathy, abnormality in the serum bilirubin, serum albumin and clotting times. Each measure is scored 1-3, with 3 indicating most severe derangement.~The Total score ranges between 5 min to 15 max where lower score = less liver disease and higher score = chronic liver disease.~The number of patients with Child-PughTotal score of 5 and 6 is presented."|Participants|Number|6|6.0||||||
4303464|NCT00508001|4130581|B2|Child-Pugh of 6||Child-Pugh Score|"Child-Pugh Scale is used to assess the prognosis of chronic liver disease. The total score employs five clinical measures of liver disease: severity of ascites and of encephalopathy, abnormality in the serum bilirubin, serum albumin and clotting times. Each measure is scored 1-3, with 3 indicating most severe derangement.~The Total score ranges between 5 min to 15 max where lower score = less liver disease and higher score = chronic liver disease.~The number of patients with Child-PughTotal score of 5 and 6 is presented."|Participants|Number|6|6.0||||||
4303465|NCT00508001|4130582|B1|Child-Pugh of 6||Child-Pugh Score|"Child-Pugh Scale is used to assess the prognosis of chronic liver disease. The total score employs five clinical measures of liver disease: severity of ascites and of encephalopathy, abnormality in the serum bilirubin, serum albumin and clotting times. Each measure is scored 1-3, with 3 indicating most severe derangement.~The Total score ranges between 5 min to 15 max where lower score = less liver disease and higher score = chronic liver disease.~The number of patients with Child-PughTotal score of 5 and 6 is presented."|Participants|Number|6|6.0||||||
4303466|NCT00508001|4130579|B4|Child-Pugh of 5||Child-Pugh Score|"Child-Pugh Scale is used to assess the prognosis of chronic liver disease. The total score employs five clinical measures of liver disease: severity of ascites and of encephalopathy, abnormality in the serum bilirubin, serum albumin and clotting times. Each measure is scored 1-3, with 3 indicating most severe derangement.~The Total score ranges between 5 min to 15 max where lower score = less liver disease and higher score = chronic liver disease.~The number of patients with Child-PughTotal score of 5 and 6 is presented."|Participants|Number|49|49.0||||||
4303467|NCT00508001|4130580|B3|Child-Pugh of 5||Child-Pugh Score|"Child-Pugh Scale is used to assess the prognosis of chronic liver disease. The total score employs five clinical measures of liver disease: severity of ascites and of encephalopathy, abnormality in the serum bilirubin, serum albumin and clotting times. Each measure is scored 1-3, with 3 indicating most severe derangement.~The Total score ranges between 5 min to 15 max where lower score = less liver disease and higher score = chronic liver disease.~The number of patients with Child-PughTotal score of 5 and 6 is presented."|Participants|Number|17|17.0||||||
4303468|NCT00508001|4130581|B2|Child-Pugh of 5||Child-Pugh Score|"Child-Pugh Scale is used to assess the prognosis of chronic liver disease. The total score employs five clinical measures of liver disease: severity of ascites and of encephalopathy, abnormality in the serum bilirubin, serum albumin and clotting times. Each measure is scored 1-3, with 3 indicating most severe derangement.~The Total score ranges between 5 min to 15 max where lower score = less liver disease and higher score = chronic liver disease.~The number of patients with Child-PughTotal score of 5 and 6 is presented."|Participants|Number|19|19.0||||||
4303469|NCT00508001|4130582|B1|Child-Pugh of 5||Child-Pugh Score|"Child-Pugh Scale is used to assess the prognosis of chronic liver disease. The total score employs five clinical measures of liver disease: severity of ascites and of encephalopathy, abnormality in the serum bilirubin, serum albumin and clotting times. Each measure is scored 1-3, with 3 indicating most severe derangement.~The Total score ranges between 5 min to 15 max where lower score = less liver disease and higher score = chronic liver disease.~The number of patients with Child-PughTotal score of 5 and 6 is presented."|Participants|Number|13|13.0||||||
4303470|NCT00508001|4130579|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4303471|NCT00508001|4130580|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4303472|NCT00508001|4130581|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4303473|NCT00508001|4130582|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4303474|NCT00508001|4130579|B4||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4303475|NCT00508001|4130580|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4303476|NCT00508001|4130581|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4303477|NCT00508001|4130582|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4303478|NCT00508001|4130579|B4|||Age||years|Mean|58.37|58.37|Standard Deviation|13.27|13.27|||
4303479|NCT00508001|4130580|B3|||Age||years|Mean|57.3|57.3|Standard Deviation|12.62|12.62|||
4303480|NCT00508001|4130581|B2|||Age||years|Mean|61.2|61.2|Standard Deviation|13.36|13.36|||
4303481|NCT00508001|4130582|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|13.48|13.48|||
4303482|NCT00507819|4130601|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4303483|NCT00507819|4130601|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4303484|NCT00507819|4130601|B1|||Age||Years|Mean|14.9|14.9|Standard Deviation|5.1|5.1|||
4303485|NCT00507767|4130614|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4303486|NCT00507767|4130614|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4303487|NCT00507767|4130614|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4303488|NCT00507767|4130614|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4303489|NCT00507767|4130614|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4303490|NCT00507767|4130614|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4303491|NCT00507767|4130614|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4303492|NCT00507767|4130614|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4303493|NCT00507767|4130614|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4303494|NCT00507767|4130614|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4303495|NCT00507767|4130614|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4303496|NCT00507767|4130614|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4303497|NCT00507767|4130614|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4303498|NCT00507767|4130614|B1|||Age||years|Median|54|54.0|Full Range|10|10.0|46.0|78.0|
4303499|NCT00507767|4130614|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4303500|NCT00507767|4130614|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4303501|NCT00507767|4130614|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303502|NCT00507689|4130618|B4|≤ ULN||Baseline alanine aminotransferase (ALT) above the upper limit of the normal range (ULN)|The upper limit of the normal range (ULN) for ALT was 34 U/L for females 18-69 years of age, and 32 U/L for females over age 69; the ULN was 43 U/L for males 18-69 years of age, and 35 U/L for males over age 69.|participants|Number|38|38.0||||||
4303503|NCT00507689|4130619|B3|≤ ULN||Baseline alanine aminotransferase (ALT) above the upper limit of the normal range (ULN)|The upper limit of the normal range (ULN) for ALT was 34 U/L for females 18-69 years of age, and 32 U/L for females over age 69; the ULN was 43 U/L for males 18-69 years of age, and 35 U/L for males over age 69.|participants|Number|3|3.0||||||
4303504|NCT00507689|4130620|B2|≤ ULN||Baseline alanine aminotransferase (ALT) above the upper limit of the normal range (ULN)|The upper limit of the normal range (ULN) for ALT was 34 U/L for females 18-69 years of age, and 32 U/L for females over age 69; the ULN was 43 U/L for males 18-69 years of age, and 35 U/L for males over age 69.|participants|Number|16|16.0||||||
4303505|NCT00507689|4130621|B1|≤ ULN||Baseline alanine aminotransferase (ALT) above the upper limit of the normal range (ULN)|The upper limit of the normal range (ULN) for ALT was 34 U/L for females 18-69 years of age, and 32 U/L for females over age 69; the ULN was 43 U/L for males 18-69 years of age, and 35 U/L for males over age 69.|participants|Number|19|19.0||||||
4303506|NCT00507689|4130618|B4|> ULN||Baseline alanine aminotransferase (ALT) above the upper limit of the normal range (ULN)|The upper limit of the normal range (ULN) for ALT was 34 U/L for females 18-69 years of age, and 32 U/L for females over age 69; the ULN was 43 U/L for males 18-69 years of age, and 35 U/L for males over age 69.|participants|Number|2|2.0||||||
4303507|NCT00507689|4130619|B3|> ULN||Baseline alanine aminotransferase (ALT) above the upper limit of the normal range (ULN)|The upper limit of the normal range (ULN) for ALT was 34 U/L for females 18-69 years of age, and 32 U/L for females over age 69; the ULN was 43 U/L for males 18-69 years of age, and 35 U/L for males over age 69.|participants|Number|0|0.0||||||
4303508|NCT00507689|4130620|B2|> ULN||Baseline alanine aminotransferase (ALT) above the upper limit of the normal range (ULN)|The upper limit of the normal range (ULN) for ALT was 34 U/L for females 18-69 years of age, and 32 U/L for females over age 69; the ULN was 43 U/L for males 18-69 years of age, and 35 U/L for males over age 69.|participants|Number|2|2.0||||||
4303509|NCT00507689|4130621|B1|> ULN||Baseline alanine aminotransferase (ALT) above the upper limit of the normal range (ULN)|The upper limit of the normal range (ULN) for ALT was 34 U/L for females 18-69 years of age, and 32 U/L for females over age 69; the ULN was 43 U/L for males 18-69 years of age, and 35 U/L for males over age 69.|participants|Number|0|0.0||||||
4303510|NCT00507689|4130618|B4|≥ 169 copies/mL||Baseline hepatitis B virus (HBV) DNA Below 169 copies/mL||participants|Number|0|0.0||||||
4303511|NCT00507689|4130619|B3|≥ 169 copies/mL||Baseline hepatitis B virus (HBV) DNA Below 169 copies/mL||participants|Number|0|0.0||||||
4303512|NCT00507689|4130620|B2|≥ 169 copies/mL||Baseline hepatitis B virus (HBV) DNA Below 169 copies/mL||participants|Number|0|0.0||||||
4303513|NCT00507689|4130621|B1|≥ 169 copies/mL||Baseline hepatitis B virus (HBV) DNA Below 169 copies/mL||participants|Number|0|0.0||||||
4303514|NCT00507689|4130618|B4|< 169 copies/mL||Baseline hepatitis B virus (HBV) DNA Below 169 copies/mL||participants|Number|40|40.0||||||
4303515|NCT00507689|4130619|B3|< 169 copies/mL||Baseline hepatitis B virus (HBV) DNA Below 169 copies/mL||participants|Number|3|3.0||||||
4303516|NCT00507689|4130620|B2|< 169 copies/mL||Baseline hepatitis B virus (HBV) DNA Below 169 copies/mL||participants|Number|18|18.0||||||
4303517|NCT00507689|4130621|B1|< 169 copies/mL||Baseline hepatitis B virus (HBV) DNA Below 169 copies/mL||participants|Number|19|19.0||||||
4303518|NCT00507689|4130618|B4|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4303519|NCT00507689|4130619|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4303520|NCT00507689|4130620|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4303521|NCT00507689|4130621|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4303522|NCT00507689|4130618|B4|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4303523|NCT00507689|4130619|B3|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4303524|NCT00507689|4130620|B2|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4303525|NCT00507689|4130621|B1|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4303526|NCT00507689|4130618|B4|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4303527|NCT00507689|4130619|B3|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4303528|NCT00507689|4130620|B2|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4303529|NCT00507689|4130621|B1|White||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4303530|NCT00507689|4130618|B4|Asian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4303531|NCT00507689|4130619|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4303532|NCT00507689|4130620|B2|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4303533|NCT00507689|4130621|B1|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4303534|NCT00507689|4130618|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4303535|NCT00507689|4130619|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4303536|NCT00507689|4130620|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4303537|NCT00507689|4130621|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4303538|NCT00507689|4130618|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4303539|NCT00507689|4130619|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4303540|NCT00507689|4130620|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4303541|NCT00507689|4130621|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4303542|NCT00507689|4130618|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4303639|NCT00507507|4130665|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4303543|NCT00507689|4130619|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4303544|NCT00507689|4130620|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4303545|NCT00507689|4130621|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4303546|NCT00507689|4130618|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4303547|NCT00507689|4130619|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4303548|NCT00507689|4130620|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4303549|NCT00507689|4130621|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4303550|NCT00507689|4130618|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4303551|NCT00507689|4130619|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4303552|NCT00507689|4130620|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4303553|NCT00507689|4130621|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4303554|NCT00507689|4130618|B4|||Age||years|Mean|57|57.0|Standard Deviation|9.6|9.6|||
4303555|NCT00507689|4130619|B3|||Age||years|Mean|64|64.0|Standard Deviation|6.0|6.0|||
4303556|NCT00507689|4130620|B2|||Age||years|Mean|59|59.0|Standard Deviation|9.1|9.1|||
4303557|NCT00507689|4130621|B1|||Age||years|Mean|54|54.0|Standard Deviation|9.7|9.7|||
4303558|NCT00507559|4130639|B1|United States||Region of Enrollment||participants|Number|155|155.0||||||
4303559|NCT00507559|4130639|B1||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4303560|NCT00507559|4130639|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4303561|NCT00507559|4130639|B1|||Age||years|Mean|73|73.0|Standard Deviation|8|8.0|||
4303562|NCT00507546|4130652|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4303563|NCT00507546|4130653|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4303564|NCT00507546|4130654|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4303565|NCT00507546|4130652|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4303566|NCT00507546|4130653|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4303567|NCT00507546|4130654|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4303568|NCT00507546|4130652|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4303569|NCT00507546|4130653|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4303570|NCT00507546|4130654|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4303571|NCT00507546|4130652|B3|||Age||years|Mean|53|53.0|Standard Deviation|12|12.0|||
4303572|NCT00507546|4130653|B2|||Age||years|Mean|55.5|55.5|Standard Deviation|15.5|15.5|||
4303573|NCT00507546|4130654|B1|||Age||years|Mean|51.25|51.25|Standard Deviation|9.74|9.74|||
4303574|NCT00507546|4130652|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4303575|NCT00507546|4130653|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4303576|NCT00507546|4130654|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4303577|NCT00507546|4130652|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4303578|NCT00507546|4130653|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4303579|NCT00507546|4130654|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4303580|NCT00507546|4130652|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303581|NCT00507546|4130653|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303582|NCT00507546|4130654|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303583|NCT00507507|4130663|B3|Missing/Unevaluable||Antibody to HBeAg (Anti-HBe)||participants|Number|124|124.0||||||
4303584|NCT00507507|4130664|B2|Missing/Unevaluable||Antibody to HBeAg (Anti-HBe)||participants|Number|61|61.0||||||
4303585|NCT00507507|4130665|B1|Missing/Unevaluable||Antibody to HBeAg (Anti-HBe)||participants|Number|63|63.0||||||
4303586|NCT00507507|4130663|B3|Positive||Antibody to HBeAg (Anti-HBe)||participants|Number|1|1.0||||||
4303587|NCT00507507|4130664|B2|Positive||Antibody to HBeAg (Anti-HBe)||participants|Number|0|0.0||||||
4303588|NCT00507507|4130665|B1|Positive||Antibody to HBeAg (Anti-HBe)||participants|Number|1|1.0||||||
4303589|NCT00507507|4130663|B3|Negative||Antibody to HBeAg (Anti-HBe)||participants|Number|1|1.0||||||
4303590|NCT00507507|4130664|B2|Negative||Antibody to HBeAg (Anti-HBe)||participants|Number|1|1.0||||||
4303591|NCT00507507|4130665|B1|Negative||Antibody to HBeAg (Anti-HBe)||participants|Number|0|0.0||||||
4303592|NCT00507507|4130663|B3|Positive||Hepatitis B e Antigen (HBeAg)||participants|Number|125|125.0||||||
4303593|NCT00507507|4130664|B2|Positive||Hepatitis B e Antigen (HBeAg)||participants|Number|62|62.0||||||
4303594|NCT00507507|4130665|B1|Positive||Hepatitis B e Antigen (HBeAg)||participants|Number|63|63.0||||||
4303595|NCT00507507|4130663|B3|Negative||Hepatitis B e Antigen (HBeAg)||participants|Number|1|1.0||||||
4303596|NCT00507507|4130664|B2|Negative||Hepatitis B e Antigen (HBeAg)||participants|Number|0|0.0||||||
4303597|NCT00507507|4130665|B1|Negative||Hepatitis B e Antigen (HBeAg)||participants|Number|1|1.0||||||
4303598|NCT00507507|4130663|B3|||Alanine Aminotransferase (ALT)||U/L|Mean|26.6|26.6|Standard Deviation|12.13|12.13|||
4303599|NCT00507507|4130664|B2|||Alanine Aminotransferase (ALT)||U/L|Mean|26.2|26.2|Standard Deviation|9.88|9.88|||
4303600|NCT00507507|4130665|B1|||Alanine Aminotransferase (ALT)||U/L|Mean|26.9|26.9|Standard Deviation|14.05|14.05|||
4303601|NCT00507507|4130663|B3|||Hepatitis B Virus (HBV) DNA||log_10 copies/mL|Mean|9.17|9.17|Standard Deviation|0.397|0.397|||
4303602|NCT00507507|4130664|B2|||Hepatitis B Virus (HBV) DNA||log_10 copies/mL|Mean|9.16|9.16|Standard Deviation|0.395|0.395|||
4303603|NCT00507507|4130665|B1|||Hepatitis B Virus (HBV) DNA||log_10 copies/mL|Mean|9.18|9.18|Standard Deviation|0.402|0.402|||
4303604|NCT00507507|4130663|B3|United States||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment. (Tenofovir DF, n = 65; FTC+tenofovir DF, n = 64.)|participants|Number|22|22.0||||||
4303605|NCT00507507|4130664|B2|United States||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment. (Tenofovir DF, n = 65; FTC+tenofovir DF, n = 64.)|participants|Number|8|8.0||||||
4303606|NCT00507507|4130665|B1|United States||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment. (Tenofovir DF, n = 65; FTC+tenofovir DF, n = 64.)|participants|Number|14|14.0||||||
4303607|NCT00507507|4130663|B3|United Kingdom||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment. (Tenofovir DF, n = 65; FTC+tenofovir DF, n = 64.)|participants|Number|2|2.0||||||
4303608|NCT00507507|4130664|B2|United Kingdom||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment. (Tenofovir DF, n = 65; FTC+tenofovir DF, n = 64.)|participants|Number|2|2.0||||||
4303609|NCT00507507|4130665|B1|United Kingdom||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment. (Tenofovir DF, n = 65; FTC+tenofovir DF, n = 64.)|participants|Number|0|0.0||||||
4303610|NCT00507507|4130663|B3|Taiwan||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment. (Tenofovir DF, n = 65; FTC+tenofovir DF, n = 64.)|participants|Number|12|12.0||||||
4303611|NCT00507507|4130664|B2|Taiwan||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment. (Tenofovir DF, n = 65; FTC+tenofovir DF, n = 64.)|participants|Number|6|6.0||||||
4303612|NCT00507507|4130665|B1|Taiwan||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment. (Tenofovir DF, n = 65; FTC+tenofovir DF, n = 64.)|participants|Number|6|6.0||||||
4303613|NCT00507507|4130663|B3|Singapore||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment. (Tenofovir DF, n = 65; FTC+tenofovir DF, n = 64.)|participants|Number|2|2.0||||||
4303614|NCT00507507|4130664|B2|Singapore||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment. (Tenofovir DF, n = 65; FTC+tenofovir DF, n = 64.)|participants|Number|0|0.0||||||
4303615|NCT00507507|4130665|B1|Singapore||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment. (Tenofovir DF, n = 65; FTC+tenofovir DF, n = 64.)|participants|Number|2|2.0||||||
4303616|NCT00507507|4130663|B3|Poland||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment. (Tenofovir DF, n = 65; FTC+tenofovir DF, n = 64.)|participants|Number|2|2.0||||||
4303617|NCT00507507|4130664|B2|Poland||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment. (Tenofovir DF, n = 65; FTC+tenofovir DF, n = 64.)|participants|Number|0|0.0||||||
4303618|NCT00507507|4130665|B1|Poland||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment. (Tenofovir DF, n = 65; FTC+tenofovir DF, n = 64.)|participants|Number|2|2.0||||||
4303619|NCT00507507|4130663|B3|New Zealand||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment. (Tenofovir DF, n = 65; FTC+tenofovir DF, n = 64.)|participants|Number|6|6.0||||||
4303620|NCT00507507|4130664|B2|New Zealand||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment. (Tenofovir DF, n = 65; FTC+tenofovir DF, n = 64.)|participants|Number|4|4.0||||||
4303621|NCT00507507|4130665|B1|New Zealand||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment. (Tenofovir DF, n = 65; FTC+tenofovir DF, n = 64.)|participants|Number|2|2.0||||||
4303622|NCT00507507|4130663|B3|Hong Kong||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment. (Tenofovir DF, n = 65; FTC+tenofovir DF, n = 64.)|participants|Number|61|61.0||||||
4303623|NCT00507507|4130664|B2|Hong Kong||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment. (Tenofovir DF, n = 65; FTC+tenofovir DF, n = 64.)|participants|Number|33|33.0||||||
4303624|NCT00507507|4130665|B1|Hong Kong||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment. (Tenofovir DF, n = 65; FTC+tenofovir DF, n = 64.)|participants|Number|28|28.0||||||
4303625|NCT00507507|4130663|B3|Germany||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment. (Tenofovir DF, n = 65; FTC+tenofovir DF, n = 64.)|participants|Number|6|6.0||||||
4303626|NCT00507507|4130664|B2|Germany||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment. (Tenofovir DF, n = 65; FTC+tenofovir DF, n = 64.)|participants|Number|3|3.0||||||
4303627|NCT00507507|4130665|B1|Germany||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment. (Tenofovir DF, n = 65; FTC+tenofovir DF, n = 64.)|participants|Number|3|3.0||||||
4303628|NCT00507507|4130663|B3|France||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment. (Tenofovir DF, n = 65; FTC+tenofovir DF, n = 64.)|participants|Number|7|7.0||||||
4303629|NCT00507507|4130664|B2|France||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment. (Tenofovir DF, n = 65; FTC+tenofovir DF, n = 64.)|participants|Number|3|3.0||||||
4303630|NCT00507507|4130665|B1|France||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment. (Tenofovir DF, n = 65; FTC+tenofovir DF, n = 64.)|participants|Number|4|4.0||||||
4303631|NCT00507507|4130663|B3|Canada||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment. (Tenofovir DF, n = 65; FTC+tenofovir DF, n = 64.)|participants|Number|7|7.0||||||
4303632|NCT00507507|4130664|B2|Canada||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment. (Tenofovir DF, n = 65; FTC+tenofovir DF, n = 64.)|participants|Number|3|3.0||||||
4303633|NCT00507507|4130665|B1|Canada||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment. (Tenofovir DF, n = 65; FTC+tenofovir DF, n = 64.)|participants|Number|4|4.0||||||
4303634|NCT00507507|4130663|B3|Australia||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment. (Tenofovir DF, n = 65; FTC+tenofovir DF, n = 64.)|participants|Number|2|2.0||||||
4303635|NCT00507507|4130664|B2|Australia||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment. (Tenofovir DF, n = 65; FTC+tenofovir DF, n = 64.)|participants|Number|2|2.0||||||
4303636|NCT00507507|4130665|B1|Australia||Region of Enrollment|All randomized participants were analyzed for Region of Enrollment. (Tenofovir DF, n = 65; FTC+tenofovir DF, n = 64.)|participants|Number|0|0.0||||||
4303637|NCT00507507|4130663|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4303638|NCT00507507|4130664|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4303640|NCT00507507|4130663|B3|Pacific Islander||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4303641|NCT00507507|4130664|B2|Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4303642|NCT00507507|4130665|B1|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4303643|NCT00507507|4130663|B3|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4303644|NCT00507507|4130664|B2|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4303645|NCT00507507|4130665|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4303646|NCT00507507|4130663|B3|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4303647|NCT00507507|4130664|B2|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4303648|NCT00507507|4130665|B1|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4303649|NCT00507507|4130663|B3|Asian||Race/Ethnicity, Customized||participants|Number|112|112.0||||||
4303650|NCT00507507|4130664|B2|Asian||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
4303651|NCT00507507|4130665|B1|Asian||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
4303652|NCT00507507|4130663|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4303653|NCT00507507|4130664|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4303654|NCT00507507|4130665|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4303655|NCT00507507|4130663|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
4303656|NCT00507507|4130664|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4303657|NCT00507507|4130665|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4303658|NCT00507507|4130663|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4303659|NCT00507507|4130664|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4303660|NCT00507507|4130665|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4303661|NCT00507507|4130663|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4303662|NCT00507507|4130664|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4303663|NCT00507507|4130665|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4303664|NCT00507507|4130663|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4303665|NCT00507507|4130664|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4303666|NCT00507507|4130665|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4303667|NCT00507507|4130663|B3|||Age||years|Mean|33|33.0|Standard Deviation|10.3|10.3|||
4303668|NCT00507507|4130664|B2|||Age||years|Mean|33|33.0|Standard Deviation|11.2|11.2|||
4303669|NCT00507507|4130665|B1|||Age||years|Mean|33|33.0|Standard Deviation|9.5|9.5|||
4303670|NCT00507455|4130698|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4303671|NCT00507455|4130699|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4303672|NCT00507455|4130700|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4303673|NCT00507455|4130701|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4303674|NCT00507455|4130698|B4|Non Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|212|212.0||||||
4303675|NCT00507455|4130699|B3|Non Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
4303676|NCT00507455|4130700|B2|Non Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|71|71.0||||||
4303677|NCT00507455|4130701|B1|Non Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
4303678|NCT00507455|4130698|B4|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4303679|NCT00507455|4130699|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4303680|NCT00507455|4130700|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4303681|NCT00507455|4130701|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4303682|NCT00507455|4130698|B4|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4303683|NCT00507455|4130699|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4303684|NCT00507455|4130700|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4303685|NCT00507455|4130701|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4303686|NCT00507455|4130698|B4|Black or African-American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4303687|NCT00507455|4130699|B3|Black or African-American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4303688|NCT00507455|4130700|B2|Black or African-American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4303689|NCT00507455|4130701|B1|Black or African-American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4303690|NCT00507455|4130698|B4|White||Race/Ethnicity, Customized||participants|Number|214|214.0||||||
4303691|NCT00507455|4130699|B3|White||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
4303692|NCT00507455|4130700|B2|White||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
4303693|NCT00507455|4130701|B1|White||Race/Ethnicity, Customized||participants|Number|71|71.0||||||
4303694|NCT00507455|4130698|B4||Male|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4303695|NCT00507455|4130699|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4303696|NCT00507455|4130700|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4303697|NCT00507455|4130701|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4303698|NCT00507455|4130698|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4303699|NCT00507455|4130699|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4303700|NCT00507455|4130700|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4303701|NCT00507455|4130701|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4303702|NCT00507455|4130698|B4|||Age||years|Mean|64.6|64.6|Standard Deviation|8.11|8.11|||
4303703|NCT00507455|4130699|B3|||Age||years|Mean|65.6|65.6|Standard Deviation|8.26|8.26|||
4303704|NCT00507455|4130700|B2|||Age||years|Mean|63.8|63.8|Standard Deviation|8.43|8.43|||
4303705|NCT00507455|4130701|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|7.60|7.6|||
4303706|NCT00507442|4130762|B5|United States||Region of Enrollment||participants|Number|158|158.0||||||
4303707|NCT00507442|4130763|B4|United States||Region of Enrollment||participants|Number|17|17.0||||||
4303708|NCT00507442|4130764|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
4303709|NCT00507442|4130765|B2|United States||Region of Enrollment||participants|Number|66|66.0||||||
4303710|NCT00507442|4130766|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4303711|NCT00507442|4130762|B5||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4303712|NCT00507442|4130763|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4303713|NCT00507442|4130764|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4303714|NCT00507442|4130765|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4303715|NCT00507442|4130766|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4303716|NCT00507442|4130762|B5||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4303717|NCT00507442|4130763|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4303718|NCT00507442|4130764|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4303719|NCT00507442|4130765|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4303720|NCT00507442|4130766|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4303721|NCT00507442|4130762|B5|||Age||years|Mean|60.5|60.5|Standard Deviation|8.75|8.75|||
4303722|NCT00507442|4130763|B4|||Age||years|Mean|59.6|59.6|Standard Deviation|9.16|9.16|||
4303723|NCT00507442|4130764|B3|||Age||years|Mean|61.4|61.4|Standard Deviation|8.32|8.32|||
4303724|NCT00507442|4130765|B2|||Age||years|Mean|60.9|60.9|Standard Deviation|8.97|8.97|||
4303725|NCT00507442|4130766|B1|||Age||years|Mean|59.5|59.5|Standard Deviation|8.76|8.76|||
4303726|NCT00507442|4130762|B5||>=65 years|Age||Participants|Count of Participants|57|57.0||||||
4303727|NCT00507442|4130763|B4||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4303728|NCT00507442|4130764|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4303729|NCT00507442|4130765|B2||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4303730|NCT00507442|4130766|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4303731|NCT00507442|4130762|B5||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
4303732|NCT00507442|4130763|B4||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4303733|NCT00507442|4130764|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4303734|NCT00507442|4130765|B2||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4303735|NCT00507442|4130766|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4303736|NCT00507442|4130762|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303737|NCT00507442|4130763|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303738|NCT00507442|4130764|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303739|NCT00507442|4130765|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303740|NCT00507442|4130766|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303741|NCT00507429|4130819|B3|India||Region of Enrollment||participants|Number|11|11.0||||||
4303742|NCT00507429|4130820|B2|India||Region of Enrollment||participants|Number|6|6.0||||||
4303743|NCT00507429|4130821|B1|India||Region of Enrollment||participants|Number|5|5.0||||||
4303744|NCT00507429|4130819|B3|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4303745|NCT00507429|4130820|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4303746|NCT00507429|4130821|B1|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4303747|NCT00507429|4130819|B3|Italy||Region of Enrollment||participants|Number|21|21.0||||||
4303748|NCT00507429|4130820|B2|Italy||Region of Enrollment||participants|Number|8|8.0||||||
4303749|NCT00507429|4130821|B1|Italy||Region of Enrollment||participants|Number|13|13.0||||||
4303750|NCT00507429|4130819|B3|Israel||Region of Enrollment||participants|Number|3|3.0||||||
4303751|NCT00507429|4130820|B2|Israel||Region of Enrollment||participants|Number|1|1.0||||||
4303752|NCT00507429|4130821|B1|Israel||Region of Enrollment||participants|Number|2|2.0||||||
4303753|NCT00507429|4130819|B3|Bulgaria||Region of Enrollment||participants|Number|3|3.0||||||
4303754|NCT00507429|4130820|B2|Bulgaria||Region of Enrollment||participants|Number|0|0.0||||||
4303755|NCT00507429|4130821|B1|Bulgaria||Region of Enrollment||participants|Number|3|3.0||||||
4303756|NCT00507429|4130819|B3|Russian Federation||Region of Enrollment||participants|Number|3|3.0||||||
4303757|NCT00507429|4130820|B2|Russian Federation||Region of Enrollment||participants|Number|1|1.0||||||
4303758|NCT00507429|4130821|B1|Russian Federation||Region of Enrollment||participants|Number|2|2.0||||||
4303759|NCT00507429|4130819|B3|Romania||Region of Enrollment||participants|Number|1|1.0||||||
4303760|NCT00507429|4130820|B2|Romania||Region of Enrollment||participants|Number|0|0.0||||||
4303761|NCT00507429|4130821|B1|Romania||Region of Enrollment||participants|Number|1|1.0||||||
4303762|NCT00507429|4130819|B3|Ukraine||Region of Enrollment||participants|Number|2|2.0||||||
4303763|NCT00507429|4130820|B2|Ukraine||Region of Enrollment||participants|Number|1|1.0||||||
4303764|NCT00507429|4130821|B1|Ukraine||Region of Enrollment||participants|Number|1|1.0||||||
4303765|NCT00507429|4130819|B3|Poland||Region of Enrollment||participants|Number|6|6.0||||||
4303766|NCT00507429|4130820|B2|Poland||Region of Enrollment||participants|Number|1|1.0||||||
4303767|NCT00507429|4130821|B1|Poland||Region of Enrollment||participants|Number|5|5.0||||||
4303768|NCT00507429|4130819|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4303769|NCT00507429|4130820|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4303770|NCT00507429|4130821|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4303771|NCT00507429|4130819|B3|Belarus||Region of Enrollment||participants|Number|2|2.0||||||
4303772|NCT00507429|4130820|B2|Belarus||Region of Enrollment||participants|Number|1|1.0||||||
4303773|NCT00507429|4130821|B1|Belarus||Region of Enrollment||participants|Number|1|1.0||||||
4303774|NCT00507429|4130819|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4303775|NCT00507429|4130820|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4303776|NCT00507429|4130821|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4303777|NCT00507429|4130819|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4303778|NCT00507429|4130820|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4303779|NCT00507429|4130821|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4303780|NCT00507429|4130819|B3|||Age||years|Mean|61.4|61.4|Standard Deviation|10.60|10.6|||
4303781|NCT00507429|4130820|B2|||Age||years|Mean|61.2|61.2|Standard Deviation|10.54|10.54|||
4303782|NCT00507429|4130821|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|10.72|10.72|||
4303783|NCT00507429|4130819|B3||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
4303784|NCT00507429|4130820|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4303785|NCT00507429|4130821|B1||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4303786|NCT00507429|4130819|B3||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4303787|NCT00507429|4130820|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4303788|NCT00507429|4130821|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4303789|NCT00507429|4130819|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303790|NCT00507429|4130820|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303791|NCT00507429|4130821|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303792|NCT00507416|4130830|B4|United States||Region of Enrollment||participants|Number|502|502.0||||||
4303793|NCT00507416|4130831|B3|United States||Region of Enrollment||participants|Number|167|167.0||||||
4303794|NCT00507416|4130832|B2|United States||Region of Enrollment||participants|Number|167|167.0||||||
4303795|NCT00507416|4130833|B1|United States||Region of Enrollment||participants|Number|168|168.0||||||
4303796|NCT00507416|4130830|B4|Not Reported||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4303797|NCT00507416|4130831|B3|Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4303798|NCT00507416|4130832|B2|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4303799|NCT00507416|4130833|B1|Not Reported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4303800|NCT00507416|4130830|B4|Other||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4303801|NCT00507416|4130831|B3|Other||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4303802|NCT00507416|4130832|B2|Other||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4303803|NCT00507416|4130833|B1|Other||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4303804|NCT00507416|4130830|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4303805|NCT00507416|4130831|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4303806|NCT00507416|4130832|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4303807|NCT00507416|4130833|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4303808|NCT00507416|4130830|B4|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4303809|NCT00507416|4130831|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4303810|NCT00507416|4130832|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4303811|NCT00507416|4130833|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4303812|NCT00507416|4130830|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4303813|NCT00507416|4130831|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4303814|NCT00507416|4130832|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4303815|NCT00507416|4130833|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4303816|NCT00507416|4130830|B4|Black||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
4303817|NCT00507416|4130831|B3|Black||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4303818|NCT00507416|4130832|B2|Black||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4303819|NCT00507416|4130833|B1|Black||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4303820|NCT00507416|4130830|B4|White||Race/Ethnicity, Customized||participants|Number|373|373.0||||||
4303821|NCT00507416|4130831|B3|White||Race/Ethnicity, Customized||participants|Number|118|118.0||||||
4303822|NCT00507416|4130832|B2|White||Race/Ethnicity, Customized||participants|Number|124|124.0||||||
4303823|NCT00507416|4130833|B1|White||Race/Ethnicity, Customized||participants|Number|131|131.0||||||
4303824|NCT00507416|4130830|B4||Male|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
4303825|NCT00507416|4130831|B3||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4303826|NCT00507416|4130832|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4303827|NCT00507416|4130833|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4303828|NCT00507416|4130830|B4||Female|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
4303829|NCT00507416|4130831|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4303830|NCT00507416|4130832|B2||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4303831|NCT00507416|4130833|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4303832|NCT00507416|4130830|B4|≥ 80 years||Age, Customized||participants|Number|90|90.0||||||
4303833|NCT00507416|4130831|B3|≥ 80 years||Age, Customized||participants|Number|23|23.0||||||
4303834|NCT00507416|4130832|B2|≥ 80 years||Age, Customized||participants|Number|27|27.0||||||
4303835|NCT00507416|4130833|B1|≥ 80 years||Age, Customized||participants|Number|40|40.0||||||
4303836|NCT00507416|4130830|B4|≥ 75 years||Age, Customized||participants|Number|210|210.0||||||
4303837|NCT00507416|4130831|B3|≥ 75 years||Age, Customized||participants|Number|62|62.0||||||
4303838|NCT00507416|4130832|B2|≥ 75 years||Age, Customized||participants|Number|64|64.0||||||
4303839|NCT00507416|4130833|B1|≥ 75 years||Age, Customized||participants|Number|84|84.0||||||
4303840|NCT00507416|4130830|B4|≥ 65 years||Age, Customized||participants|Number|414|414.0||||||
4303841|NCT00507416|4130831|B3|≥ 65 years||Age, Customized||participants|Number|139|139.0||||||
4303842|NCT00507416|4130832|B2|≥ 65 years||Age, Customized||participants|Number|135|135.0||||||
4303843|NCT00507416|4130833|B1|≥ 65 years||Age, Customized||participants|Number|140|140.0||||||
4303844|NCT00507416|4130830|B4|||Age||years|Mean|71.7|71.7|Standard Deviation|8.92|8.92|||
4303845|NCT00507416|4130831|B3|||Age||years|Mean|71.3|71.3|Standard Deviation|8.67|8.67|||
4303846|NCT00507416|4130832|B2|||Age||years|Mean|71.3|71.3|Standard Deviation|8.73|8.73|||
4303847|NCT00507416|4130833|B1|||Age||years|Mean|72.6|72.6|Standard Deviation|9.35|9.35|||
4303848|NCT00507208|4130864|B3|Surgery only||Prior Treatment|Type of treatment completed prior to enrollment in the study|participants|Number|8|8.0||||||
4303849|NCT00507208|4130865|B2|Surgery only||Prior Treatment|Type of treatment completed prior to enrollment in the study|participants|Number|4|4.0||||||
4303850|NCT00507208|4130866|B1|Surgery only||Prior Treatment|Type of treatment completed prior to enrollment in the study|participants|Number|4|4.0||||||
4303851|NCT00507208|4130864|B3|Chemoradiation & Surgery||Prior Treatment|Type of treatment completed prior to enrollment in the study|participants|Number|45|45.0||||||
4303852|NCT00507208|4130865|B2|Chemoradiation & Surgery||Prior Treatment|Type of treatment completed prior to enrollment in the study|participants|Number|22|22.0||||||
4303853|NCT00507208|4130866|B1|Chemoradiation & Surgery||Prior Treatment|Type of treatment completed prior to enrollment in the study|participants|Number|23|23.0||||||
4303854|NCT00507208|4130864|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4303855|NCT00507208|4130865|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4303856|NCT00507208|4130866|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4303857|NCT00507208|4130864|B3|African-American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4303858|NCT00507208|4130865|B2|African-American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4303859|NCT00507208|4130866|B1|African-American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4303860|NCT00507208|4130864|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4303861|NCT00507208|4130865|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4303862|NCT00507208|4130866|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4303863|NCT00507208|4130864|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4303864|NCT00507208|4130865|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4303865|NCT00507208|4130866|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4303866|NCT00507208|4130864|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4303867|NCT00507208|4130865|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4303868|NCT00507208|4130866|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4303869|NCT00507208|4130864|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4303870|NCT00507208|4130865|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4303871|NCT00507208|4130866|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4303872|NCT00507208|4130864|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4303873|NCT00507208|4130865|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4303874|NCT00507208|4130866|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4303875|NCT00507208|4130864|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303876|NCT00507208|4130865|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303877|NCT00507208|4130866|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303878|NCT00507130|4130873|B5||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4303879|NCT00507130|4130874|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4303880|NCT00507130|4130875|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4303881|NCT00507130|4130876|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4303882|NCT00507130|4130877|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4303883|NCT00507130|4130873|B5||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4303884|NCT00507130|4130874|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4303885|NCT00507130|4130875|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4303886|NCT00507130|4130876|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4303887|NCT00507130|4130877|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4303888|NCT00507130|4130873|B5|||Age||Years|Mean|34.7|34.7|Standard Deviation|13.2|13.2|||
4303889|NCT00507130|4130874|B4|||Age||Years|Mean|28.9|28.9|Standard Deviation|10.7|10.7|||
4303890|NCT00507130|4130875|B3|||Age||Years|Mean|33.2|33.2|Standard Deviation|11.9|11.9|||
4303891|NCT00507130|4130876|B2|||Age||Years|Mean|38.2|38.2|Standard Deviation|16.3|16.3|||
4303892|NCT00507130|4130877|B1|||Age||Years|Mean|38.6|38.6|Standard Deviation|13.2|13.2|||
4303893|NCT00506948|4130922|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4303894|NCT00506948|4130922|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4303895|NCT00506948|4130922|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4303896|NCT00506948|4130922|B1|||Age||years|Median|55|55.0|Full Range|||26.0|63.0|
4303897|NCT00506922|4130926|B6|United States||Region of Enrollment||participants|Number|150|150.0||||||
4303898|NCT00506922|4130927|B5|United States||Region of Enrollment||participants|Number|11|11.0||||||
4303899|NCT00506922|4130928|B4|United States||Region of Enrollment||participants|Number|63|63.0||||||
4303900|NCT00506922|4130929|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
4303901|NCT00506922|4130930|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4303902|NCT00506922|4130931|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4303903|NCT00506922|4130926|B6||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4303904|NCT00506922|4130927|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4303905|NCT00506922|4130928|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4303906|NCT00506922|4130929|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4303907|NCT00506922|4130930|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4303908|NCT00506922|4130931|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4303909|NCT00506922|4130926|B6||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4303910|NCT00506922|4130927|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4303911|NCT00506922|4130928|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4303912|NCT00506922|4130929|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4303913|NCT00506922|4130930|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4303914|NCT00506922|4130931|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4303915|NCT00506922|4130926|B6|||Age||years|Mean|46.8|46.8|Standard Deviation|23.2|23.2|||
4303916|NCT00506922|4130927|B5|||Age||years|Mean|45|45.0|Standard Deviation|32|32.0|||
4303917|NCT00506922|4130928|B4|||Age||years|Mean|50|50.0|Standard Deviation|22|22.0|||
4303918|NCT00506922|4130929|B3|||Age||years|Mean|47|47.0|Standard Deviation|20|20.0|||
4303919|NCT00506922|4130930|B2|||Age||years|Mean|42|42.0|Standard Deviation|23|23.0|||
4303920|NCT00506922|4130931|B1|||Age||years|Mean|50|50.0|Standard Deviation|19|19.0|||
4303921|NCT00506922|4130926|B6||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4303922|NCT00506922|4130927|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4303923|NCT00506922|4130928|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4303924|NCT00506922|4130929|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4303925|NCT00506922|4130930|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4303926|NCT00506922|4130931|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4303927|NCT00506922|4130926|B6||Between 18 and 65 years|Age||Participants|Count of Participants|146|146.0||||||
4303928|NCT00506922|4130927|B5||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4303929|NCT00506922|4130928|B4||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4303930|NCT00506922|4130929|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4303931|NCT00506922|4130930|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4303932|NCT00506922|4130931|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4303933|NCT00506922|4130926|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303934|NCT00506922|4130927|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303935|NCT00506922|4130928|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303936|NCT00506922|4130929|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303937|NCT00506922|4130930|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303938|NCT00506922|4130931|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303939|NCT00506883|4130943|B4||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4303940|NCT00506883|4130944|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4303941|NCT00506883|4130945|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4303942|NCT00506883|4130946|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4303943|NCT00506883|4130943|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4303944|NCT00506883|4130944|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4303945|NCT00506883|4130945|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4303946|NCT00506883|4130946|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4303947|NCT00506883|4130943|B4|||Age||years|Mean|51.5|51.5|Standard Deviation|11.12|11.12|||
4303948|NCT00506883|4130944|B3|||Age||years|Mean|51.2|51.2|Standard Deviation|11.36|11.36|||
4303949|NCT00506883|4130945|B2|||Age||years|Mean|51.4|51.4|Standard Deviation|11.79|11.79|||
4303950|NCT00506883|4130946|B1|||Age||years|Mean|51.9|51.9|Standard Deviation|10.02|10.02|||
4303951|NCT00506883|4130943|B4||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4303952|NCT00506883|4130944|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4303953|NCT00506883|4130945|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4303954|NCT00506883|4130946|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4303955|NCT00506883|4130943|B4||Between 18 and 65 years|Age||Participants|Count of Participants|160|160.0||||||
4303956|NCT00506883|4130944|B3||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4303957|NCT00506883|4130945|B2||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4303958|NCT00506883|4130946|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4303959|NCT00506883|4130943|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303960|NCT00506883|4130944|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303961|NCT00506883|4130945|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303962|NCT00506883|4130946|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303963|NCT00506857|4130956|B1|United States||Region of Enrollment||participants|Number|80|80.0||||||
4303964|NCT00506857|4130956|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4303965|NCT00506857|4130956|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4303966|NCT00506857|4130956|B1|||Age||years|Median|56|56.0|Full Range|||10.0|71.0|
4303967|NCT00506831|4130961|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4303968|NCT00506831|4130961|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4303969|NCT00506831|4130961|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4303970|NCT00506831|4130961|B1|||Age||years|Mean|56|56.0|Standard Deviation|13|13.0|||
4303971|NCT00506831|4130961|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4303972|NCT00506831|4130961|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4303973|NCT00506831|4130961|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303974|NCT00506714|4130972|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4303975|NCT00506714|4130973|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4303976|NCT00506714|4130974|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4303977|NCT00506714|4130972|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4303978|NCT00506714|4130973|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4303979|NCT00506714|4130974|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4303980|NCT00506714|4130972|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4303981|NCT00506714|4130973|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4303982|NCT00506714|4130974|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4303983|NCT00506714|4130972|B3|||Age||years|Mean|66|66.0|Standard Deviation|5.2|5.2|||
4303984|NCT00506714|4130973|B2|||Age||years|Mean|67|67.0|Standard Deviation|5.9|5.9|||
4303985|NCT00506714|4130974|B1|||Age||years|Mean|65|65.0|Standard Deviation|4.4|4.4|||
4303986|NCT00506714|4130972|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4303987|NCT00506714|4130973|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4303988|NCT00506714|4130974|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4303989|NCT00506714|4130972|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4303990|NCT00506714|4130973|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4303991|NCT00506714|4130974|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4303992|NCT00506714|4130972|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303993|NCT00506714|4130973|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303994|NCT00506714|4130974|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4303995|NCT00506675|4130983|B3|||Mean (SD) Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|logMAR|Mean|0.35|0.35|Standard Deviation|0.09|0.09|||
4303996|NCT00506675|4130984|B2|||Mean (SD) Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|logMAR|Mean|0.34|0.34|Standard Deviation|0.08|0.08|||
4304019|NCT00506675|4130983|B3|+1.00 to < +2.00D||Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|10|10.0||||||
4304020|NCT00506675|4130984|B2|+1.00 to < +2.00D||Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|5|5.0||||||
4303997|NCT00506675|4130985|B1|||Mean (SD) Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|logMAR|Mean|0.35|0.35|Standard Deviation|0.09|0.09|||
4303998|NCT00506675|4130983|B3|||Mean (SD) Spherical Equivalent Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopters|Mean|3.37|3.37|Standard Deviation|2.13|2.13|||
4303999|NCT00506675|4130984|B2|||Mean (SD) Spherical Equivalent Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopters|Mean|3.29|3.29|Standard Deviation|1.90|1.9|||
4304000|NCT00506675|4130985|B1|||Mean (SD) Spherical Equivalent Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopters|Mean|3.46|3.46|Standard Deviation|2.38|2.38|||
4304001|NCT00506675|4130983|B3|||Mean (SD) Spherical Equivalent Refractive Error in Amblyopic Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopters|Mean|4.81|4.81|Standard Deviation|2.29|2.29|||
4304002|NCT00506675|4130984|B2|||Mean (SD) Spherical Equivalent Refractive Error in Amblyopic Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopters|Mean|4.24|4.24|Standard Deviation|2.15|2.15|||
4304003|NCT00506675|4130985|B1|||Mean (SD) Spherical Equivalent Refractive Error in Amblyopic Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|diopters|Mean|5.39|5.39|Standard Deviation|2.33|2.33|||
4304004|NCT00506675|4130983|B3|||Mean (SD) Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|logMAR|Mean|0.03|0.03|Standard Deviation|0.09|0.09|||
4304005|NCT00506675|4130984|B2|||Mean (SD) Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|logMAR|Mean|0.03|0.03|Standard Deviation|0.10|0.1|||
4304006|NCT00506675|4130985|B1|||Mean (SD) Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|logMAR|Mean|0.02|0.02|Standard Deviation|0.09|0.09|||
4304007|NCT00506675|4130983|B3|||Mean (SD) Intereye Acuity Difference|The difference between eyes in logMAR acuity was calculated with positive values indicating sound eye better. One letter = .02 logMAR, .1 logMAR = 5 letters or one line of visual acuity.|logMAR|Mean|0.32|0.32|Standard Deviation|0.11|0.11|||
4304008|NCT00506675|4130984|B2|||Mean (SD) Intereye Acuity Difference|The difference between eyes in logMAR acuity was calculated with positive values indicating sound eye better. One letter = .02 logMAR, .1 logMAR = 5 letters or one line of visual acuity.|logMAR|Mean|0.31|0.31|Standard Deviation|0.10|0.1|||
4304009|NCT00506675|4130985|B1|||Mean (SD) Intereye Acuity Difference|The difference between eyes in logMAR acuity was calculated with positive values indicating sound eye better. One letter = .02 logMAR, .1 logMAR = 5 letters or one line of visual acuity.|logMAR|Mean|0.33|0.33|Standard Deviation|0.11|0.11|||
4304010|NCT00506675|4130983|B3|greater than or equal to +4.00D||Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|19|19.0||||||
4304011|NCT00506675|4130984|B2|greater than or equal to +4.00D||Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|10|10.0||||||
4304012|NCT00506675|4130985|B1|greater than or equal to +4.00D||Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|9|9.0||||||
4304013|NCT00506675|4130983|B3|+3.00 to < +4.00D||Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|13|13.0||||||
4304014|NCT00506675|4130984|B2|+3.00 to < +4.00D||Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|7|7.0||||||
4304015|NCT00506675|4130985|B1|+3.00 to < +4.00D||Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|6|6.0||||||
4304016|NCT00506675|4130983|B3|+2.00 to < +3.00D||Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|8|8.0||||||
4304017|NCT00506675|4130984|B2|+2.00 to < +3.00D||Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|4|4.0||||||
4304018|NCT00506675|4130985|B1|+2.00 to < +3.00D||Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|4|4.0||||||
4304021|NCT00506675|4130985|B1|+1.00 to < +2.00D||Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|5|5.0||||||
4304022|NCT00506675|4130983|B3|0 to < +1.00D||Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|4|4.0||||||
4304023|NCT00506675|4130984|B2|0 to < +1.00D||Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|2|2.0||||||
4304024|NCT00506675|4130985|B1|0 to < +1.00D||Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|2|2.0||||||
4304025|NCT00506675|4130983|B3|< 0.00D||Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|1|1.0||||||
4304026|NCT00506675|4130984|B2|< 0.00D||Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|0|0.0||||||
4304027|NCT00506675|4130985|B1|< 0.00D||Refractive Error in Fellow Eye|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|1|1.0||||||
4304028|NCT00506675|4130983|B3|greater than or equal to +4.00D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|39|39.0||||||
4304029|NCT00506675|4130984|B2|greater than or equal to +4.00D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|17|17.0||||||
4304030|NCT00506675|4130985|B1|greater than or equal to +4.00D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|22|22.0||||||
4304031|NCT00506675|4130983|B3|+3.00 to < +4.00D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|6|6.0||||||
4304032|NCT00506675|4130984|B2|+3.00 to < +4.00D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|5|5.0||||||
4304033|NCT00506675|4130985|B1|+3.00 to < +4.00D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|1|1.0||||||
4304034|NCT00506675|4130983|B3|+2.00 to < +3.00D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|2|2.0||||||
4304035|NCT00506675|4130984|B2|+2.00 to < +3.00D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|2|2.0||||||
4304036|NCT00506675|4130985|B1|+2.00 to < +3.00D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|0|0.0||||||
4304037|NCT00506675|4130983|B3|+1.00 to < +2.00D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|4|4.0||||||
4304038|NCT00506675|4130984|B2|+1.00 to < +2.00D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|1|1.0||||||
4304039|NCT00506675|4130985|B1|+1.00 to < +2.00D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|3|3.0||||||
4304040|NCT00506675|4130983|B3|0 to < +1.00 D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|1|1.0||||||
4304041|NCT00506675|4130984|B2|0 to < +1.00 D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|0|0.0||||||
4304042|NCT00506675|4130985|B1|0 to < +1.00 D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|1|1.0||||||
4304043|NCT00506675|4130983|B3|< 0.00D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|3|3.0||||||
4304044|NCT00506675|4130984|B2|< 0.00D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|3|3.0||||||
4304045|NCT00506675|4130985|B1|< 0.00D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value|participants|Number|0|0.0||||||
4304046|NCT00506675|4130983|B3|20/16 (-0.06 to -0.14 logMAR)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|Participants|Number|13|13.0||||||
4304124|NCT00506662|4130998|B3|||Glycosylated Haemoglobin (HbA1c)||percentage of total haemoglobin|Mean|9.19|9.19|Standard Deviation|0.82|0.82|||
4304125|NCT00506662|4130999|B2|||Glycosylated Haemoglobin (HbA1c)||percentage of total haemoglobin|Mean|9.12|9.12|Standard Deviation|0.78|0.78|||
4304126|NCT00506662|4131000|B1|||Glycosylated Haemoglobin (HbA1c)||percentage of total haemoglobin|Mean|9.26|9.26|Standard Deviation|0.87|0.87|||
4304047|NCT00506675|4130984|B2|20/16 (-0.06 to -0.14 logMAR)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|Participants|Number|6|6.0||||||
4304048|NCT00506675|4130985|B1|20/16 (-0.06 to -0.14 logMAR)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|Participants|Number|7|7.0||||||
4304049|NCT00506675|4130983|B3|20/20 (0.04 to -0.04 logMAR)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|Participants|Number|19|19.0||||||
4304050|NCT00506675|4130984|B2|20/20 (0.04 to -0.04 logMAR)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|Participants|Number|11|11.0||||||
4304051|NCT00506675|4130985|B1|20/20 (0.04 to -0.04 logMAR)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|Participants|Number|8|8.0||||||
4304052|NCT00506675|4130983|B3|20/25 (0.14 to 0.06 logMAR)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|Participants|Number|17|17.0||||||
4304053|NCT00506675|4130984|B2|20/25 (0.14 to 0.06 logMAR)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|Participants|Number|7|7.0||||||
4304054|NCT00506675|4130985|B1|20/25 (0.14 to 0.06 logMAR)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|Participants|Number|10|10.0||||||
4304055|NCT00506675|4130983|B3|20/32 (0.24 to 0.16 logMAR)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|Participants|Number|6|6.0||||||
4304056|NCT00506675|4130984|B2|20/32 (0.24 to 0.16 logMAR)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|Participants|Number|4|4.0||||||
4304057|NCT00506675|4130985|B1|20/32 (0.24 to 0.16 logMAR)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|Participants|Number|2|2.0||||||
4304058|NCT00506675|4130983|B3|20/32 (0.24 to 0.16 logMAR)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|Participants|Number|8|8.0||||||
4304059|NCT00506675|4130984|B2|20/32 (0.24 to 0.16 logMAR)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|Participants|Number|4|4.0||||||
4304060|NCT00506675|4130985|B1|20/32 (0.24 to 0.16 logMAR)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|Participants|Number|4|4.0||||||
4304061|NCT00506675|4130983|B3|20/40 (0.34 to 0.26 logMAR)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|Participants|Number|17|17.0||||||
4304062|NCT00506675|4130984|B2|20/40 (0.34 to 0.26 logMAR)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|Participants|Number|10|10.0||||||
4304063|NCT00506675|4130985|B1|20/40 (0.34 to 0.26 logMAR)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|Participants|Number|7|7.0||||||
4304064|NCT00506675|4130983|B3|20/50 (0.44 to 0.36 logMAR)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|Participants|Number|25|25.0||||||
4304065|NCT00506675|4130984|B2|20/50 (0.44 to 0.36 logMAR)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|Participants|Number|12|12.0||||||
4304066|NCT00506675|4130985|B1|20/50 (0.44 to 0.36 logMAR)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|Participants|Number|13|13.0||||||
4304067|NCT00506675|4130983|B3|20/63 (0.54 to 0.46 logMAR)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|Participants|Number|5|5.0||||||
4304068|NCT00506675|4130984|B2|20/63 (0.54 to 0.46 logMAR)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|Participants|Number|2|2.0||||||
4304069|NCT00506675|4130985|B1|20/63 (0.54 to 0.46 logMAR)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 to 20/800 for ages 3 to <7; or with the electronic early treatment diabetic retinopathy study (E-ETDRS) method for 7 to <10 year olds which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).|Participants|Number|3|3.0||||||
4304070|NCT00506675|4130983|B3|Atropine||Current Treatment for Amblyopia at Enrollment||participants|Number|16|16.0||||||
4304071|NCT00506675|4130984|B2|Atropine||Current Treatment for Amblyopia at Enrollment||participants|Number|7|7.0||||||
4304072|NCT00506675|4130985|B1|Atropine||Current Treatment for Amblyopia at Enrollment||participants|Number|9|9.0||||||
4304073|NCT00506675|4130983|B3|Patching||Current Treatment for Amblyopia at Enrollment||participants|Number|39|39.0||||||
4304074|NCT00506675|4130984|B2|Patching||Current Treatment for Amblyopia at Enrollment||participants|Number|21|21.0||||||
4304075|NCT00506675|4130985|B1|Patching||Current Treatment for Amblyopia at Enrollment||participants|Number|18|18.0||||||
4304076|NCT00506675|4130983|B3|Strabismus and Anisometropia||Cause of Amblyopia||participants|Number|20|20.0||||||
4304077|NCT00506675|4130984|B2|Strabismus and Anisometropia||Cause of Amblyopia||participants|Number|9|9.0||||||
4304078|NCT00506675|4130985|B1|Strabismus and Anisometropia||Cause of Amblyopia||participants|Number|11|11.0||||||
4304079|NCT00506675|4130983|B3|Anisometropia||Cause of Amblyopia||participants|Number|9|9.0||||||
4304080|NCT00506675|4130984|B2|Anisometropia||Cause of Amblyopia||participants|Number|3|3.0||||||
4304081|NCT00506675|4130985|B1|Anisometropia||Cause of Amblyopia||participants|Number|6|6.0||||||
4304082|NCT00506675|4130983|B3|Strabismus||Cause of Amblyopia||participants|Number|26|26.0||||||
4304083|NCT00506675|4130984|B2|Strabismus||Cause of Amblyopia||participants|Number|16|16.0||||||
4304084|NCT00506675|4130985|B1|Strabismus||Cause of Amblyopia||participants|Number|10|10.0||||||
4304085|NCT00506675|4130983|B3|United States||Region of Enrollment||participants|Number|55|55.0||||||
4304086|NCT00506675|4130984|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4304087|NCT00506675|4130985|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4304088|NCT00506675|4130983|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4304089|NCT00506675|4130984|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4304090|NCT00506675|4130985|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4304091|NCT00506675|4130983|B3|More than one race||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4304092|NCT00506675|4130984|B2|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4304093|NCT00506675|4130985|B1|More than one race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4304094|NCT00506675|4130983|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4304095|NCT00506675|4130984|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4304096|NCT00506675|4130985|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4304097|NCT00506675|4130983|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4304098|NCT00506675|4130984|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4304099|NCT00506675|4130985|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4304100|NCT00506675|4130983|B3|African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4304101|NCT00506675|4130984|B2|African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4304102|NCT00506675|4130985|B1|African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4304103|NCT00506675|4130983|B3|White||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4304104|NCT00506675|4130984|B2|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4304105|NCT00506675|4130985|B1|White||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4304106|NCT00506675|4130983|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4304107|NCT00506675|4130984|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4304108|NCT00506675|4130985|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4304109|NCT00506675|4130983|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4304110|NCT00506675|4130984|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4304111|NCT00506675|4130985|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4304112|NCT00506675|4130983|B3|7 to < 10 years||Age, Customized|Age at Enrollment in Years|participants|Number|27|27.0||||||
4304113|NCT00506675|4130984|B2|7 to < 10 years||Age, Customized|Age at Enrollment in Years|participants|Number|15|15.0||||||
4304114|NCT00506675|4130985|B1|7 to < 10 years||Age, Customized|Age at Enrollment in Years|participants|Number|12|12.0||||||
4304115|NCT00506675|4130983|B3|3 to < 7 years||Age, Customized|Age at Enrollment in Years|participants|Number|28|28.0||||||
4304116|NCT00506675|4130984|B2|3 to < 7 years||Age, Customized|Age at Enrollment in Years|participants|Number|13|13.0||||||
4304117|NCT00506675|4130985|B1|3 to < 7 years||Age, Customized|Age at Enrollment in Years|participants|Number|15|15.0||||||
4304118|NCT00506675|4130983|B3|||Age||years|Mean|6.9|6.9|Standard Deviation|1.2|1.2|||
4304119|NCT00506675|4130984|B2|||Age||years|Mean|6.9|6.9|Standard Deviation|1.3|1.3|||
4304120|NCT00506675|4130985|B1|||Age||years|Mean|6.9|6.9|Standard Deviation|1.1|1.1|||
4304121|NCT00506662|4130998|B3|||Weight||kg|Mean|79.0|79.0|Standard Deviation|16.2|16.2|||
4304122|NCT00506662|4130999|B2|||Weight||kg|Mean|80.4|80.4|Standard Deviation|16.4|16.4|||
4304123|NCT00506662|4131000|B1|||Weight||kg|Mean|77.4|77.4|Standard Deviation|15.9|15.9|||
4304242|NCT00506350|4131110|B7|||Age||Years|Mean|38.3|38.3|Standard Deviation|14.61|14.61|||
4304127|NCT00506662|4130998|B3|||Duration of diabetes|Number of years since diagnosis|years|Mean|14.6|14.6|Standard Deviation|9.8|9.8|||
4304128|NCT00506662|4130999|B2|||Duration of diabetes|Number of years since diagnosis|years|Mean|15.2|15.2|Standard Deviation|9.4|9.4|||
4304129|NCT00506662|4131000|B1|||Duration of diabetes|Number of years since diagnosis|years|Mean|13.3|13.3|Standard Deviation|10.3|10.3|||
4304130|NCT00506662|4130998|B3|||Body Mass Index (BMI)||kg/m^2|Mean|29.5|29.5|Standard Deviation|5.1|5.1|||
4304131|NCT00506662|4130999|B2|||Body Mass Index (BMI)||kg/m^2|Mean|29.8|29.8|Standard Deviation|5.5|5.5|||
4304132|NCT00506662|4131000|B1|||Body Mass Index (BMI)||kg/m^2|Mean|29.1|29.1|Standard Deviation|4.6|4.6|||
4304133|NCT00506662|4130998|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4304134|NCT00506662|4130999|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4304135|NCT00506662|4131000|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4304136|NCT00506662|4130998|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4304137|NCT00506662|4130999|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4304138|NCT00506662|4131000|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4304139|NCT00506662|4130998|B3|||Age||years|Mean|76.8|76.8|Standard Deviation|5.2|5.2|||
4304140|NCT00506662|4130999|B2|||Age||years|Mean|76.1|76.1|Standard Deviation|4.9|4.9|||
4304141|NCT00506662|4131000|B1|||Age||years|Mean|77.6|77.6|Standard Deviation|5.5|5.5|||
4304142|NCT00506662|4130998|B3||>=65 years|Age||Participants|Count of Participants|86|86.0||||||
4304143|NCT00506662|4130999|B2||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4304144|NCT00506662|4131000|B1||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4304145|NCT00506662|4130998|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4304146|NCT00506662|4130999|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4304147|NCT00506662|4131000|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4304148|NCT00506662|4130998|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4304149|NCT00506662|4130999|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4304150|NCT00506662|4131000|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4304151|NCT00506597|4131031|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4304152|NCT00506597|4131031|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4304153|NCT00506597|4131031|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4304154|NCT00506597|4131031|B1|||Age||years|Median|15|15.0|Full Range|||2.0|54.0|
4304155|NCT00506493|4131035|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
4304156|NCT00506493|4131035|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4304157|NCT00506493|4131035|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4304158|NCT00506493|4131035|B1|||Age||years|Mean|70.1|70.1|Standard Deviation|10.1|10.1|||
4304159|NCT00506493|4131035|B1||>=65 years|Age||Participants|Count of Participants|57|57.0||||||
4304160|NCT00506493|4131035|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4304161|NCT00506493|4131035|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4304162|NCT00506454|4131042|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4304163|NCT00506454|4131043|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4304164|NCT00506454|4131044|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4304165|NCT00506454|4131042|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4304166|NCT00506454|4131043|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4304167|NCT00506454|4131044|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4304168|NCT00506454|4131042|B3|||Age||years|Mean|52.4|52.4|Standard Deviation|12.83|12.83|||
4304169|NCT00506454|4131043|B2|||Age||years|Mean|55.5|55.5|Standard Deviation|7.88|7.88|||
4304170|NCT00506454|4131044|B1|||Age||years|Mean|49.3|49.3|Standard Deviation|11.57|11.57|||
4304171|NCT00506441|4131051|B1||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4304172|NCT00506441|4131051|B1||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4304173|NCT00506441|4131051|B1|||Age||years|Mean|55.8|55.8|Standard Deviation|12.9|12.9|||
4304174|NCT00506415|4131060|B1||Male|Sex: Female, Male||Participants|Count of Participants|592|592.0||||||
4304175|NCT00506415|4131060|B1||Female|Sex: Female, Male||Participants|Count of Participants|992|992.0||||||
4304176|NCT00506415|4131060|B1|||Age||years|Mean|74.93|74.93|Standard Deviation|7.131|7.131|||
4304177|NCT00506389|4131085|B4||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4304178|NCT00506389|4131086|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4304179|NCT00506389|4131087|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4304180|NCT00506389|4131088|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4304181|NCT00506389|4131085|B4||Female|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
4304182|NCT00506389|4131086|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4304183|NCT00506389|4131087|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4304184|NCT00506389|4131088|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4304185|NCT00506389|4131085|B4|||Age||Years|Mean|44.9|44.9|Standard Deviation|11.2|11.2|||
4304186|NCT00506389|4131086|B3|||Age||Years|Mean|46.6|46.6|Standard Deviation|10.5|10.5|||
4304187|NCT00506389|4131087|B2|||Age||Years|Mean|44.5|44.5|Standard Deviation|11.5|11.5|||
4304188|NCT00506389|4131088|B1|||Age||Years|Mean|43.5|43.5|Standard Deviation|11.3|11.3|||
4304189|NCT00506350|4131107|B10|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4304190|NCT00506350|4131108|B9|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4304191|NCT00506350|4131109|B8|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4304192|NCT00506350|4131110|B7|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4304193|NCT00506350|4131111|B6|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4304194|NCT00506350|4131112|B5|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4304195|NCT00506350|4131113|B4|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4304196|NCT00506350|4131114|B3|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4304197|NCT00506350|4131115|B2|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4304198|NCT00506350|4131116|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4304199|NCT00506350|4131107|B10|Race|White - Caucasian / European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|345|345.0||||||
4304200|NCT00506350|4131108|B9|Race|White - Caucasian / European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
4304201|NCT00506350|4131109|B8|Race|White - Caucasian / European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
4304202|NCT00506350|4131110|B7|Race|White - Caucasian / European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
4304203|NCT00506350|4131111|B6|Race|White - Caucasian / European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
4304204|NCT00506350|4131112|B5|Race|White - Caucasian / European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
4304205|NCT00506350|4131113|B4|Race|White - Caucasian / European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
4304206|NCT00506350|4131114|B3|Race|White - Caucasian / European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
4304207|NCT00506350|4131115|B2|Race|White - Caucasian / European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
4304208|NCT00506350|4131116|B1|Race|White - Caucasian / European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
4304209|NCT00506350|4131107|B10|Race|White - Arabic / North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4304210|NCT00506350|4131108|B9|Race|White - Arabic / North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4304211|NCT00506350|4131109|B8|Race|White - Arabic / North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4304212|NCT00506350|4131110|B7|Race|White - Arabic / North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4304213|NCT00506350|4131111|B6|Race|White - Arabic / North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4304214|NCT00506350|4131112|B5|Race|White - Arabic / North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4304215|NCT00506350|4131113|B4|Race|White - Arabic / North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4304216|NCT00506350|4131114|B3|Race|White - Arabic / North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4304217|NCT00506350|4131115|B2|Race|White - Arabic / North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4304218|NCT00506350|4131116|B1|Race|White - Arabic / North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4304219|NCT00506350|4131107|B10||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4304220|NCT00506350|4131108|B9||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4304221|NCT00506350|4131109|B8||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4304222|NCT00506350|4131110|B7||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4304223|NCT00506350|4131111|B6||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4304224|NCT00506350|4131112|B5||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4304225|NCT00506350|4131113|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4304226|NCT00506350|4131114|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4304227|NCT00506350|4131115|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4304228|NCT00506350|4131116|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4304229|NCT00506350|4131107|B10||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4304230|NCT00506350|4131108|B9||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4304231|NCT00506350|4131109|B8||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4304232|NCT00506350|4131110|B7||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4304233|NCT00506350|4131111|B6||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4304234|NCT00506350|4131112|B5||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4304235|NCT00506350|4131113|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4304236|NCT00506350|4131114|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4304237|NCT00506350|4131115|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4304238|NCT00506350|4131116|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4304239|NCT00506350|4131107|B10|||Age||Years|Mean|36.32|36.32|Standard Deviation|12.97|12.97|||
4304240|NCT00506350|4131108|B9|||Age||Years|Mean|35.9|35.9|Standard Deviation|12.78|12.78|||
4304241|NCT00506350|4131109|B8|||Age||Years|Mean|34.8|34.8|Standard Deviation|14.57|14.57|||
4304243|NCT00506350|4131111|B6|||Age||Years|Mean|38.5|38.5|Standard Deviation|13.43|13.43|||
4304244|NCT00506350|4131112|B5|||Age||Years|Mean|32.1|32.1|Standard Deviation|9.96|9.96|||
4304245|NCT00506350|4131113|B4|||Age||Years|Mean|39.5|39.5|Standard Deviation|13.27|13.27|||
4304246|NCT00506350|4131114|B3|||Age||Years|Mean|36.8|36.8|Standard Deviation|12.87|12.87|||
4304247|NCT00506350|4131115|B2|||Age||Years|Mean|36.3|36.3|Standard Deviation|12.36|12.36|||
4304248|NCT00506350|4131116|B1|||Age||Years|Mean|36.3|36.3|Standard Deviation|12.80|12.8|||
4304249|NCT00506285|4131269|B3|||Wender-Reimherr Adult Attention Deficit Disorder Scale|This is a investigator rated scale of ADHD symptoms. It assessed the 7 domains of the Utah Criteria using scores of 0 (none) to 4 (highly symptomatic). Total possible scores range from 0 (no symptoms) to 28 (worst possible score).|units on a scale|Mean|21.4|21.4|Standard Deviation|4.2|4.2|||
4304250|NCT00506285|4131270|B2|||Wender-Reimherr Adult Attention Deficit Disorder Scale|This is a investigator rated scale of ADHD symptoms. It assessed the 7 domains of the Utah Criteria using scores of 0 (none) to 4 (highly symptomatic). Total possible scores range from 0 (no symptoms) to 28 (worst possible score).|units on a scale|Mean|21.3|21.3|Standard Deviation|4.1|4.1|||
4304251|NCT00506285|4131271|B1|||Wender-Reimherr Adult Attention Deficit Disorder Scale|This is a investigator rated scale of ADHD symptoms. It assessed the 7 domains of the Utah Criteria using scores of 0 (none) to 4 (highly symptomatic). Total possible scores range from 0 (no symptoms) to 28 (worst possible score).|units on a scale|Mean|21.5|21.5|Standard Deviation|4.2|4.2|||
4304252|NCT00506285|4131269|B3|United States||Region of Enrollment||participants|Number|65|65.0||||||
4304253|NCT00506285|4131270|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
4304254|NCT00506285|4131271|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4304255|NCT00506285|4131269|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4304256|NCT00506285|4131270|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4304257|NCT00506285|4131271|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4304258|NCT00506285|4131269|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4304259|NCT00506285|4131270|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4304260|NCT00506285|4131271|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4304261|NCT00506285|4131269|B3|||Age||years|Mean|35.2|35.2|Standard Deviation|11.8|11.8|||
4304262|NCT00506285|4131270|B2|||Age||years|Mean|40.4|40.4|Standard Deviation|11.8|11.8|||
4304263|NCT00506285|4131271|B1|||Age||years|Mean|30.4|30.4|Standard Deviation|9.5|9.5|||
4304264|NCT00506285|4131269|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4304265|NCT00506285|4131270|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4304266|NCT00506285|4131271|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4304267|NCT00506285|4131269|B3||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4304268|NCT00506285|4131270|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4304269|NCT00506285|4131271|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4304270|NCT00506285|4131269|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4304271|NCT00506285|4131270|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4304272|NCT00506285|4131271|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4304273|NCT00506155|4131280|B1|Three-dimensional mass on exam under anesthesia||High risk feature|Low risk or high risk are based upon likelihood of cancer recurrence, including size, number, and appearance of tumor(s), if it recurs, and how deeply it invades into the bladder. A person whose cancer is low risk may be able to have less aggressive treatment and follow up, whereas a person with high risk bladder cancer may require more aggressive treatment and more frequent follow up. Participants may have more than one high-risk feature, so numbers exceed total number of participants.|participants|Number|27|27.0||||||
4304274|NCT00506155|4131280|B1|High-grade upper tract tumor||High risk feature|Low risk or high risk are based upon likelihood of cancer recurrence, including size, number, and appearance of tumor(s), if it recurs, and how deeply it invades into the bladder. A person whose cancer is low risk may be able to have less aggressive treatment and follow up, whereas a person with high risk bladder cancer may require more aggressive treatment and more frequent follow up. Participants may have more than one high-risk feature, so numbers exceed total number of participants.|participants|Number|16|16.0||||||
4304275|NCT00506155|4131280|B1|Diverticula||High risk feature|Low risk or high risk are based upon likelihood of cancer recurrence, including size, number, and appearance of tumor(s), if it recurs, and how deeply it invades into the bladder. A person whose cancer is low risk may be able to have less aggressive treatment and follow up, whereas a person with high risk bladder cancer may require more aggressive treatment and more frequent follow up. Participants may have more than one high-risk feature, so numbers exceed total number of participants.|participants|Number|1|1.0||||||
4304276|NCT00506155|4131280|B1|Hydronephrosis||High risk feature|Low risk or high risk are based upon likelihood of cancer recurrence, including size, number, and appearance of tumor(s), if it recurs, and how deeply it invades into the bladder. A person whose cancer is low risk may be able to have less aggressive treatment and follow up, whereas a person with high risk bladder cancer may require more aggressive treatment and more frequent follow up. Participants may have more than one high-risk feature, so numbers exceed total number of participants.|participants|Number|20|20.0||||||
4304277|NCT00506155|4131280|B1|Lymphovascular invasion||High risk feature|Low risk or high risk are based upon likelihood of cancer recurrence, including size, number, and appearance of tumor(s), if it recurs, and how deeply it invades into the bladder. A person whose cancer is low risk may be able to have less aggressive treatment and follow up, whereas a person with high risk bladder cancer may require more aggressive treatment and more frequent follow up. Participants may have more than one high-risk feature, so numbers exceed total number of participants.|participants|Number|23|23.0||||||
4304317|NCT00506025|4131319|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4304278|NCT00506155|4131280|B1|T3-4a N0M0||Clinical Stage|"Clinical cancer stage based on available information obtained before tumor removal surgery using TNM; T describes size of tumor and any spread of cancer into nearby tissue; N describes spread of cancer to nearby lymph nodes; & M describes metastasis (spread of cancer to other parts of body). Numbers after T (such as T1, T2, T3, and T4) describe tumor size and/or amount of spread into nearby structures, higher the T number, the larger the tumor and/or more it has grown into nearby tissues. All patients with T1 or T2 disease had high risk factor present to be eligible for trial."|participants|Number|27|27.0||||||
4304279|NCT00506155|4131280|B1|T2N0M0||Clinical Stage|"Clinical cancer stage based on available information obtained before tumor removal surgery using TNM; T describes size of tumor and any spread of cancer into nearby tissue; N describes spread of cancer to nearby lymph nodes; & M describes metastasis (spread of cancer to other parts of body). Numbers after T (such as T1, T2, T3, and T4) describe tumor size and/or amount of spread into nearby structures, higher the T number, the larger the tumor and/or more it has grown into nearby tissues. All patients with T1 or T2 disease had high risk factor present to be eligible for trial."|participants|Number|13|13.0||||||
4304280|NCT00506155|4131280|B1|T1N0M0||Clinical Stage|"Clinical cancer stage based on available information obtained before tumor removal surgery using TNM; T describes size of tumor and any spread of cancer into nearby tissue; N describes spread of cancer to nearby lymph nodes; & M describes metastasis (spread of cancer to other parts of body). Numbers after T (such as T1, T2, T3, and T4) describe tumor size and/or amount of spread into nearby structures, higher the T number, the larger the tumor and/or more it has grown into nearby tissues. All patients with T1 or T2 disease had high risk factor present to be eligible for trial."|participants|Number|4|4.0||||||
4304281|NCT00506155|4131280|B1|Bladder/Urethra||Primary Site|Primary cancer site is location cancer starts in body. All participants with upper tract disease had high-grade disease and were N0M0. Since resection to the muscularis is not possible owing to the inherent risk of perforation in upper tract disease, cancer stage is not available in these participants.|participants|Number|44|44.0||||||
4304282|NCT00506155|4131280|B1|Renal Pelvis/Ureter||Primary Site|Primary cancer site is location cancer starts in body. All participants with upper tract disease had high-grade disease and were N0M0. Since resection to the muscularis is not possible owing to the inherent risk of perforation in upper tract disease, cancer stage is not available in these participants.|participants|Number|16|16.0||||||
4304283|NCT00506155|4131280|B1|Mixed, Micropapillary||Histology of Urothelial Cancer|Histological variants of urothelial tumors classified according to World Health Organization (WHO)/International Society of Urologic Pathologists (ISUP) 2004 guidelines; analysis by histologic types identified as TCC or divergent histologic differentiation (mixed histologic features).|participants|Number|8|8.0||||||
4304284|NCT00506155|4131280|B1|Mixed||Histology of Urothelial Cancer|Histological variants of urothelial tumors classified according to World Health Organization (WHO)/International Society of Urologic Pathologists (ISUP) 2004 guidelines; analysis by histologic types identified as TCC or divergent histologic differentiation (mixed histologic features).|participants|Number|12|12.0||||||
4304285|NCT00506155|4131280|B1|Transitional cell carcinoma (TCC)||Histology of Urothelial Cancer|Histological variants of urothelial tumors classified according to World Health Organization (WHO)/International Society of Urologic Pathologists (ISUP) 2004 guidelines; analysis by histologic types identified as TCC or divergent histologic differentiation (mixed histologic features).|participants|Number|48|48.0||||||
4304286|NCT00506155|4131280|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4304287|NCT00506155|4131280|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4304288|NCT00506155|4131280|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4304289|NCT00506155|4131280|B1|||Age||years|Median|64|64.0|Full Range|||42.0|79.6|
4304290|NCT00506077|4131285|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4304291|NCT00506077|4131286|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4304292|NCT00506077|4131287|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4304293|NCT00506077|4131285|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4304294|NCT00506077|4131286|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4304295|NCT00506077|4131287|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4304296|NCT00506077|4131285|B3|||Age||years|Mean|31.6|31.6|Standard Deviation|7.9|7.9|||
4304297|NCT00506077|4131286|B2|||Age||years|Mean|32.5|32.5|Standard Deviation|8.4|8.4|||
4304298|NCT00506077|4131287|B1|||Age||years|Mean|30.7|30.7|Standard Deviation|7.5|7.5|||
4304299|NCT00506064|4131308|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4304300|NCT00506064|4131310|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4304301|NCT00506064|4131308|B3|Male||Gender||participants|Number|0|0.0||||||
4304302|NCT00506064|4131310|B1|Male||Gender||participants|Number|0|0.0||||||
4304303|NCT00506064|4131308|B3|Female||Gender||participants|Number|1|1.0||||||
4304304|NCT00506064|4131310|B1|Female||Gender||participants|Number|1|1.0||||||
4304305|NCT00506064|4131308|B3|>=65 years||Age||years|Number|0|0.0||||0.0|0.0|
4304306|NCT00506064|4131310|B1|>=65 years||Age||years|Number|0|0.0||||||
4304307|NCT00506064|4131308|B3|Between 18 and 65 years||Age||years|Number|1|1.0||||49.0|49.0|
4304308|NCT00506064|4131310|B1|Between 18 and 65 years||Age||years|Number|1|1.0||||49.0|49.0|
4304309|NCT00506064|4131308|B3|<=18 years||Age||years|Number|0|0.0||||0.0|0.0|
4304310|NCT00506064|4131310|B1|<=18 years||Age||years|Number|0|0.0||||||
4304311|NCT00506025|4131317|B4|United States||Region of Enrollment||participants|Number|27|27.0||||||
4304312|NCT00506025|4131318|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4304313|NCT00506025|4131319|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4304314|NCT00506025|4131320|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4304315|NCT00506025|4131317|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4304316|NCT00506025|4131318|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4304318|NCT00506025|4131320|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4304319|NCT00506025|4131317|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4304320|NCT00506025|4131318|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4304321|NCT00506025|4131319|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4304322|NCT00506025|4131320|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4304323|NCT00506025|4131317|B4|||Age||years|Mean|26.83|26.83|Standard Deviation|5.263|5.263|||
4304324|NCT00506025|4131318|B3|||Age||years|Mean|24.5|24.5|Standard Deviation|5.26|5.26|||
4304325|NCT00506025|4131319|B2|||Age||years|Mean|27|27.0|Standard Deviation|5.26|5.26|||
4304326|NCT00506025|4131320|B1|||Age||years|Mean|29|29.0|Standard Deviation|5.26|5.26|||
4304327|NCT00506025|4131317|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4304328|NCT00506025|4131318|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4304329|NCT00506025|4131319|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4304330|NCT00506025|4131320|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4304331|NCT00506025|4131317|B4||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4304332|NCT00506025|4131318|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4304333|NCT00506025|4131319|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4304334|NCT00506025|4131320|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4304335|NCT00506025|4131317|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4304336|NCT00506025|4131318|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4304337|NCT00506025|4131319|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4304338|NCT00506025|4131320|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4304339|NCT00505934|4131330|B1|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4304340|NCT00505934|4131330|B1|Turkey||Region of Enrollment||participants|Number|2|2.0||||||
4304341|NCT00505934|4131330|B1|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4304342|NCT00505934|4131330|B1|Mexico||Region of Enrollment||participants|Number|8|8.0||||||
4304343|NCT00505934|4131330|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4304344|NCT00505934|4131330|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4304345|NCT00505934|4131330|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4304346|NCT00505934|4131330|B1|||Age||years|Mean|1.59|1.59|Standard Deviation|1.24|1.24|||
4304347|NCT00505934|4131330|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4304348|NCT00505934|4131330|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4304349|NCT00505934|4131330|B1||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
4304350|NCT00505921|4131336|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4304351|NCT00505921|4131336|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4304352|NCT00505921|4131336|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4304353|NCT00505921|4131336|B1|||Age||years|Mean|44|44.0|Full Range|0|0.0|22.0|62.0|
4304354|NCT00505921|4131336|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4304355|NCT00505921|4131336|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4304356|NCT00505921|4131336|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4304357|NCT00505895|4131340|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4304358|NCT00505895|4131341|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4304359|NCT00505895|4131342|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4304360|NCT00505895|4131340|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4304361|NCT00505895|4131341|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4304362|NCT00505895|4131342|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4304363|NCT00505895|4131340|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4304364|NCT00505895|4131341|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4304365|NCT00505895|4131342|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4304366|NCT00505895|4131340|B3|||Age||years|Median|53|53.0|Full Range|||32.0|64.0|
4304367|NCT00505895|4131341|B2|||Age||years|Median|53|53.0|Full Range|||36.0|64.0|
4304368|NCT00505895|4131342|B1|||Age||years|Median|52|52.0|Full Range|||32.0|64.0|
4304369|NCT00505778|4131351|B3|United States||Region of Enrollment|ITT Population|participants|Number|1009|1009.0||||||
4304370|NCT00505778|4131352|B2|United States||Region of Enrollment|ITT Population|participants|Number|503|503.0||||||
4304371|NCT00505778|4131353|B1|United States||Region of Enrollment|ITT Population|participants|Number|506|506.0||||||
4304372|NCT00505778|4131351|B3|Canada||Region of Enrollment|ITT Population|participants|Number|14|14.0||||||
4304373|NCT00505778|4131352|B2|Canada||Region of Enrollment|ITT Population|participants|Number|8|8.0||||||
4304374|NCT00505778|4131353|B1|Canada||Region of Enrollment|ITT Population|participants|Number|6|6.0||||||
4304375|NCT00505778|4131351|B3|Male||Gender|ITT Population|participants|Number|494|494.0||||||
4304376|NCT00505778|4131352|B2|Male||Gender|ITT Population|participants|Number|243|243.0||||||
4304377|NCT00505778|4131353|B1|Male||Gender|ITT Population|participants|Number|251|251.0||||||
4304378|NCT00505778|4131351|B3|Female||Gender|ITT Population|participants|Number|529|529.0||||||
4304379|NCT00505778|4131352|B2|Female||Gender|ITT Population|participants|Number|268|268.0||||||
4304380|NCT00505778|4131353|B1|Female||Gender|ITT Population|participants|Number|261|261.0||||||
4304381|NCT00505778|4131351|B3|> = 65 years old||Age, Customized|ITT Population|Participants|Number|200|200.0||||||
4304382|NCT00505778|4131352|B2|> = 65 years old||Age, Customized|ITT Population|Participants|Number|97|97.0||||||
4304383|NCT00505778|4131353|B1|> = 65 years old||Age, Customized|ITT Population|Participants|Number|103|103.0||||||
4304384|NCT00505778|4131351|B3|< 65 years old||Age, Customized|ITT Population|Participants|Number|823|823.0||||||
4304385|NCT00505778|4131352|B2|< 65 years old||Age, Customized|ITT Population|Participants|Number|414|414.0||||||
4304386|NCT00505778|4131353|B1|< 65 years old||Age, Customized|ITT Population|Participants|Number|409|409.0||||||
4304387|NCT00505765|4131370|B4|Non-Hispanic||Race/Ethnicity, Customized|Ethnicity|Participants|Count of Participants|59|59.0||||||
4304388|NCT00505765|4131371|B3|Non-Hispanic||Race/Ethnicity, Customized|Ethnicity|Participants|Count of Participants|21|21.0||||||
4304389|NCT00505765|4131372|B2|Non-Hispanic||Race/Ethnicity, Customized|Ethnicity|Participants|Count of Participants|17|17.0||||||
4304390|NCT00505765|4131373|B1|Non-Hispanic||Race/Ethnicity, Customized|Ethnicity|Participants|Count of Participants|21|21.0||||||
4304391|NCT00505765|4131370|B4|Hispanic||Race/Ethnicity, Customized|Ethnicity|Participants|Count of Participants|4|4.0||||||
4304392|NCT00505765|4131371|B3|Hispanic||Race/Ethnicity, Customized|Ethnicity|Participants|Count of Participants|1|1.0||||||
4304393|NCT00505765|4131372|B2|Hispanic||Race/Ethnicity, Customized|Ethnicity|Participants|Count of Participants|3|3.0||||||
4304394|NCT00505765|4131373|B1|Hispanic||Race/Ethnicity, Customized|Ethnicity|Participants|Count of Participants|0|0.0||||||
4304395|NCT00505765|4131370|B4||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4304396|NCT00505765|4131371|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4304397|NCT00505765|4131372|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4304398|NCT00505765|4131373|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4304399|NCT00505765|4131370|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4304400|NCT00505765|4131371|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4304401|NCT00505765|4131372|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4304402|NCT00505765|4131373|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4304403|NCT00505765|4131370|B4|Male||Sex/Gender, Customized||participants|Number|41|41.0||||||
4304404|NCT00505765|4131371|B3|Male||Sex/Gender, Customized||participants|Number|14|14.0||||||
4304405|NCT00505765|4131372|B2|Male||Sex/Gender, Customized||participants|Number|13|13.0||||||
4304406|NCT00505765|4131373|B1|Male||Sex/Gender, Customized||participants|Number|14|14.0||||||
4304407|NCT00505765|4131370|B4|Female||Sex/Gender, Customized||participants|Number|22|22.0||||||
4304408|NCT00505765|4131371|B3|Female||Sex/Gender, Customized||participants|Number|8|8.0||||||
4304409|NCT00505765|4131372|B2|Female||Sex/Gender, Customized||participants|Number|7|7.0||||||
4304410|NCT00505765|4131373|B1|Female||Sex/Gender, Customized||participants|Number|7|7.0||||||
4304411|NCT00505765|4131370|B4|||Age||years|Mean|43.4|43.4|Standard Deviation|10.2|10.2|||
4304412|NCT00505765|4131371|B3|||Age||years|Mean|41.4|41.4|Standard Deviation|10.4|10.4|||
4304413|NCT00505765|4131372|B2|||Age||years|Mean|43.2|43.2|Standard Deviation|10.5|10.5|||
4304414|NCT00505765|4131373|B1|||Age||years|Mean|45.2|45.2|Standard Deviation|8.2|8.2|||
4304415|NCT00505752|4131398|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4304416|NCT00505752|4131399|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4304417|NCT00505752|4131400|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4304418|NCT00505752|4131401|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4304419|NCT00505752|4131402|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4304420|NCT00505752|4131398|B5||Female|Sex: Female, Male||Participants|Count of Participants|520|520.0||||||
4304421|NCT00505752|4131399|B4||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4304422|NCT00505752|4131400|B3||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4304423|NCT00505752|4131401|B2||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4304424|NCT00505752|4131402|B1||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4304425|NCT00505752|4131398|B5|||Age||years|Median|32.0|32.0|Full Range|||21.0|38.0|
4304426|NCT00505752|4131399|B4|||Age||years|Median|32.0|32.0|Full Range|||24.0|36.0|
4304427|NCT00505752|4131400|B3|||Age||years|Median|32.0|32.0|Full Range|||21.0|38.0|
4304428|NCT00505752|4131401|B2|||Age||years|Median|32.0|32.0|Full Range|||22.0|36.0|
4304429|NCT00505752|4131402|B1|||Age||years|Median|32.0|32.0|Full Range|||22.0|36.0|
4304430|NCT00505687|4131419|B1|Italy||Region of Enrollment||participants|Number|9|9.0||||||
4304431|NCT00505687|4131419|B1|United Kingdom||Region of Enrollment||participants|Number|20|20.0||||||
4304432|NCT00505687|4131419|B1|Germany||Region of Enrollment||participants|Number|22|22.0||||||
4304433|NCT00505687|4131419|B1|Israel||Region of Enrollment||participants|Number|20|20.0||||||
4304434|NCT00505687|4131419|B1|South Africa||Region of Enrollment||participants|Number|22|22.0||||||
4304435|NCT00505687|4131419|B1|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4304436|NCT00505687|4131419|B1|Spain||Region of Enrollment||participants|Number|9|9.0||||||
4304437|NCT00505687|4131419|B1|United States||Region of Enrollment||participants|Number|80|80.0||||||
4304438|NCT00505687|4131419|B1||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4304439|NCT00505687|4131419|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4304440|NCT00505687|4131419|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|10.4|10.4|||
4304441|NCT00505687|4131419|B1||>=65 years|Age||Participants|Count of Participants|92|92.0||||||
4304442|NCT00505687|4131419|B1||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
4304443|NCT00505687|4131419|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4304444|NCT00505661|4131425|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4304445|NCT00505661|4131425|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4304446|NCT00505661|4131425|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4304447|NCT00505661|4131425|B1|||Age||years|Median|54|54.0|Full Range|||43.0|77.0|
4304448|NCT00505635|4131429|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4304449|NCT00505635|4131429|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4304450|NCT00505635|4131429|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4304451|NCT00505635|4131429|B1|||Age||years|Median|43|43.0|Full Range|||35.0|49.0|
4304452|NCT00505622|4131433|B4|Asian||Race/Ethnicity, Customized|This baseline characteristic is for Race. Data comes from previous double-blind core study (E2007-G000-309). Safety Population.|participants|Number|93|93.0||||||
4304453|NCT00505622|4131434|B3|Asian||Race/Ethnicity, Customized|This baseline characteristic is for Race. Data comes from previous double-blind core study (E2007-G000-309). Safety Population.|participants|Number|31|31.0||||||
4304454|NCT00505622|4131435|B2|Asian||Race/Ethnicity, Customized|This baseline characteristic is for Race. Data comes from previous double-blind core study (E2007-G000-309). Safety Population.|participants|Number|33|33.0||||||
4304455|NCT00505622|4131436|B1|Asian||Race/Ethnicity, Customized|This baseline characteristic is for Race. Data comes from previous double-blind core study (E2007-G000-309). Safety Population.|participants|Number|29|29.0||||||
4304456|NCT00505622|4131433|B4|White||Race/Ethnicity, Customized|This baseline characteristic is for Race. Data comes from previous double-blind core study (E2007-G000-309). Safety Population.|participants|Number|232|232.0||||||
4304457|NCT00505622|4131434|B3|White||Race/Ethnicity, Customized|This baseline characteristic is for Race. Data comes from previous double-blind core study (E2007-G000-309). Safety Population.|participants|Number|65|65.0||||||
4304458|NCT00505622|4131435|B2|White||Race/Ethnicity, Customized|This baseline characteristic is for Race. Data comes from previous double-blind core study (E2007-G000-309). Safety Population.|participants|Number|75|75.0||||||
4304459|NCT00505622|4131436|B1|White||Race/Ethnicity, Customized|This baseline characteristic is for Race. Data comes from previous double-blind core study (E2007-G000-309). Safety Population.|participants|Number|92|92.0||||||
4304460|NCT00505622|4131433|B4||Male|Sex: Female, Male|Data comes from previous double-blind core study (E2007-G000-309). Safety Population - All subjects entering the open-label extension study who took at least 1 dose of perampanel.|Participants|Count of Participants|205|205.0||||||
4304461|NCT00505622|4131434|B3||Male|Sex: Female, Male|Data comes from previous double-blind core study (E2007-G000-309). Safety Population - All subjects entering the open-label extension study who took at least 1 dose of perampanel.|Participants|Count of Participants|66|66.0||||||
4304462|NCT00505622|4131435|B2||Male|Sex: Female, Male|Data comes from previous double-blind core study (E2007-G000-309). Safety Population - All subjects entering the open-label extension study who took at least 1 dose of perampanel.|Participants|Count of Participants|64|64.0||||||
4304463|NCT00505622|4131436|B1||Male|Sex: Female, Male|Data comes from previous double-blind core study (E2007-G000-309). Safety Population - All subjects entering the open-label extension study who took at least 1 dose of perampanel.|Participants|Count of Participants|75|75.0||||||
4304464|NCT00505622|4131433|B4||Female|Sex: Female, Male|Data comes from previous double-blind core study (E2007-G000-309). Safety Population - All subjects entering the open-label extension study who took at least 1 dose of perampanel.|Participants|Count of Participants|120|120.0||||||
4304465|NCT00505622|4131434|B3||Female|Sex: Female, Male|Data comes from previous double-blind core study (E2007-G000-309). Safety Population - All subjects entering the open-label extension study who took at least 1 dose of perampanel.|Participants|Count of Participants|30|30.0||||||
4304466|NCT00505622|4131435|B2||Female|Sex: Female, Male|Data comes from previous double-blind core study (E2007-G000-309). Safety Population - All subjects entering the open-label extension study who took at least 1 dose of perampanel.|Participants|Count of Participants|44|44.0||||||
4304467|NCT00505622|4131436|B1||Female|Sex: Female, Male|Data comes from previous double-blind core study (E2007-G000-309). Safety Population - All subjects entering the open-label extension study who took at least 1 dose of perampanel.|Participants|Count of Participants|46|46.0||||||
4304468|NCT00505622|4131433|B4|>= 65||Age, Customized|Data comes from previous double-blind core study (E2007-G000-309). Safety Population.|Particpants|Number|162|162.0||||||
4304469|NCT00505622|4131434|B3|>= 65||Age, Customized|Data comes from previous double-blind core study (E2007-G000-309). Safety Population.|Particpants|Number|50|50.0||||||
4304470|NCT00505622|4131435|B2|>= 65||Age, Customized|Data comes from previous double-blind core study (E2007-G000-309). Safety Population.|Particpants|Number|56|56.0||||||
4304471|NCT00505622|4131436|B1|>= 65||Age, Customized|Data comes from previous double-blind core study (E2007-G000-309). Safety Population.|Particpants|Number|56|56.0||||||
4304472|NCT00505622|4131433|B4|<65||Age, Customized|Data comes from previous double-blind core study (E2007-G000-309). Safety Population.|Particpants|Number|163|163.0||||||
4304473|NCT00505622|4131434|B3|<65||Age, Customized|Data comes from previous double-blind core study (E2007-G000-309). Safety Population.|Particpants|Number|46|46.0||||||
4304474|NCT00505622|4131435|B2|<65||Age, Customized|Data comes from previous double-blind core study (E2007-G000-309). Safety Population.|Particpants|Number|52|52.0||||||
4304475|NCT00505622|4131436|B1|<65||Age, Customized|Data comes from previous double-blind core study (E2007-G000-309). Safety Population.|Particpants|Number|65|65.0||||||
4304476|NCT00505518|4131455|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4304477|NCT00505518|4131455|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4304478|NCT00505518|4131455|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4304479|NCT00505518|4131455|B1|||Age||years|Mean|77.33|77.33|Standard Deviation|11|11.0|||
4304480|NCT00505518|4131455|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4304481|NCT00505518|4131455|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4304482|NCT00505518|4131455|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4304483|NCT00505414|4131461|B3|Latvia||Region of Enrollment||participants|Number|12|12.0||||||
4304484|NCT00505414|4131462|B2|Latvia||Region of Enrollment||participants|Number|6|6.0||||||
4304485|NCT00505414|4131463|B1|Latvia||Region of Enrollment||participants|Number|6|6.0||||||
4304486|NCT00505414|4131461|B3|Chile||Region of Enrollment||participants|Number|27|27.0||||||
4304487|NCT00505414|4131462|B2|Chile||Region of Enrollment||participants|Number|9|9.0||||||
4304488|NCT00505414|4131463|B1|Chile||Region of Enrollment||participants|Number|18|18.0||||||
4304489|NCT00505414|4131461|B3|Ukraine||Region of Enrollment||participants|Number|21|21.0||||||
4304490|NCT00505414|4131462|B2|Ukraine||Region of Enrollment||participants|Number|5|5.0||||||
4304491|NCT00505414|4131463|B1|Ukraine||Region of Enrollment||participants|Number|16|16.0||||||
4304492|NCT00505414|4131461|B3|Argentina||Region of Enrollment||participants|Number|21|21.0||||||
4304493|NCT00505414|4131462|B2|Argentina||Region of Enrollment||participants|Number|7|7.0||||||
4304494|NCT00505414|4131463|B1|Argentina||Region of Enrollment||participants|Number|14|14.0||||||
4304495|NCT00505414|4131461|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4304496|NCT00505414|4131462|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4304497|NCT00505414|4131463|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4304498|NCT00505414|4131461|B3|France||Region of Enrollment||participants|Number|5|5.0||||||
4304499|NCT00505414|4131462|B2|France||Region of Enrollment||participants|Number|0|0.0||||||
4304500|NCT00505414|4131463|B1|France||Region of Enrollment||participants|Number|5|5.0||||||
4304501|NCT00505414|4131461|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4304502|NCT00505414|4131462|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4304503|NCT00505414|4131463|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4304504|NCT00505414|4131461|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304505|NCT00505414|4131462|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304506|NCT00505414|4131463|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304507|NCT00505414|4131461|B3||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4304508|NCT00505414|4131462|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4304509|NCT00505414|4131463|B1||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4304510|NCT00505414|4131461|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4304511|NCT00505414|4131462|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4304512|NCT00505414|4131463|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304513|NCT00505414|4131461|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304514|NCT00505414|4131462|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304515|NCT00505414|4131463|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304516|NCT00505414|4131461|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304517|NCT00505414|4131462|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304518|NCT00505414|4131463|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304519|NCT00505414|4131461|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304520|NCT00505414|4131462|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304521|NCT00505414|4131463|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304522|NCT00505414|4131461|B3|Male (Placebo Maintenance)||Sex/Gender, Customized||participants|Number|6|6.0||||||
4304523|NCT00505414|4131462|B2|Male (Placebo Maintenance)||Sex/Gender, Customized||participants|Number|0|0.0||||||
4304524|NCT00505414|4131463|B1|Male (Placebo Maintenance)||Sex/Gender, Customized||participants|Number|6|6.0||||||
4304525|NCT00505414|4131461|B3|Female (Placebo Maintenance)||Sex/Gender, Customized||participants|Number|8|8.0||||||
4304526|NCT00505414|4131462|B2|Female (Placebo Maintenance)||Sex/Gender, Customized||participants|Number|0|0.0||||||
4304527|NCT00505414|4131463|B1|Female (Placebo Maintenance)||Sex/Gender, Customized||participants|Number|8|8.0||||||
4304528|NCT00505414|4131461|B3|Male (Tapentadol Maintenance)||Sex/Gender, Customized||participants|Number|6|6.0||||||
4304529|NCT00505414|4131462|B2|Male (Tapentadol Maintenance)||Sex/Gender, Customized||participants|Number|0|0.0||||||
4304530|NCT00505414|4131463|B1|Male (Tapentadol Maintenance)||Sex/Gender, Customized||participants|Number|6|6.0||||||
4304531|NCT00505414|4131461|B3|Female (Tapentadol Maintenance)||Sex/Gender, Customized||participants|Number|9|9.0||||||
4304532|NCT00505414|4131462|B2|Female (Tapentadol Maintenance)||Sex/Gender, Customized||participants|Number|0|0.0||||||
4304533|NCT00505414|4131463|B1|Female (Tapentadol Maintenance)||Sex/Gender, Customized||participants|Number|9|9.0||||||
4304534|NCT00505414|4131461|B3|Male (Morphine Maintenance)||Sex/Gender, Customized||participants|Number|10|10.0||||||
4304535|NCT00505414|4131462|B2|Male (Morphine Maintenance)||Sex/Gender, Customized||participants|Number|10|10.0||||||
4304536|NCT00505414|4131463|B1|Male (Morphine Maintenance)||Sex/Gender, Customized||participants|Number|0|0.0||||||
4304537|NCT00505414|4131461|B3|Female (Morphine (Maintenance)||Sex/Gender, Customized||participants|Number|8|8.0||||||
4304538|NCT00505414|4131462|B2|Female (Morphine (Maintenance)||Sex/Gender, Customized||participants|Number|8|8.0||||||
4304637|NCT00505076|4131581|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4304539|NCT00505414|4131463|B1|Female (Morphine (Maintenance)||Sex/Gender, Customized||participants|Number|0|0.0||||||
4304540|NCT00505414|4131461|B3|Male (Titration)||Sex/Gender, Customized||participants|Number|46|46.0||||||
4304541|NCT00505414|4131462|B2|Male (Titration)||Sex/Gender, Customized||participants|Number|19|19.0||||||
4304542|NCT00505414|4131463|B1|Male (Titration)||Sex/Gender, Customized||participants|Number|27|27.0||||||
4304543|NCT00505414|4131461|B3|Female (Titration)||Sex/Gender, Customized||participants|Number|47|47.0||||||
4304544|NCT00505414|4131462|B2|Female (Titration)||Sex/Gender, Customized||participants|Number|12|12.0||||||
4304545|NCT00505414|4131463|B1|Female (Titration)||Sex/Gender, Customized||participants|Number|35|35.0||||||
4304546|NCT00505414|4131461|B3|Placebo Maintenance (n=14, 0)||Age||years|Mean|61.0|61.0|Standard Deviation|12.93|12.93|||
4304547|NCT00505414|4131462|B2|Placebo Maintenance (n=14, 0)||Age||years|Mean|NA||Standard Deviation|NA||||No participants from the Morphine Titration in this Arm.
4304548|NCT00505414|4131463|B1|Placebo Maintenance (n=14, 0)||Age||years|Mean|61.0|61.0|Standard Deviation|12.93|12.93|||
4304549|NCT00505414|4131461|B3|Tapentadol Maintenance (n=15, 0)||Age||years|Mean|63.5|63.5|Standard Deviation|9.34|9.34|||
4304550|NCT00505414|4131462|B2|Tapentadol Maintenance (n=15, 0)||Age||years|Mean|NA||Standard Deviation|NA||||No participants from the Morphine Titration in this Arm.
4304551|NCT00505414|4131463|B1|Tapentadol Maintenance (n=15, 0)||Age||years|Mean|63.5|63.5|Standard Deviation|9.34|9.34|||
4304552|NCT00505414|4131461|B3|Morphine Maintenance (n=0, 18)||Age||years|Mean|58.4|58.4|Standard Deviation|12.65|12.65|||
4304553|NCT00505414|4131462|B2|Morphine Maintenance (n=0, 18)||Age||years|Mean|58.4|58.4|Standard Deviation|12.65|12.65|||
4304554|NCT00505414|4131463|B1|Morphine Maintenance (n=0, 18)||Age||years|Mean|NA||Standard Deviation|NA||||No participants from the Tapentadol Titration in this Arm.
4304555|NCT00505414|4131461|B3|Titration Phase (n=62, 31)||Age||years|Mean|61.8|61.8|Standard Deviation|12.23|12.23|||
4304556|NCT00505414|4131462|B2|Titration Phase (n=62, 31)||Age||years|Mean|60.6|60.6|Standard Deviation|11.77|11.77|||
4304557|NCT00505414|4131463|B1|Titration Phase (n=62, 31)||Age||years|Mean|62.4|62.4|Standard Deviation|12.51|12.51|||
4304558|NCT00505375|4131482|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4304559|NCT00505375|4131483|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4304560|NCT00505375|4131484|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4304561|NCT00505375|4131482|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4304562|NCT00505375|4131483|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4304563|NCT00505375|4131484|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4304564|NCT00505375|4131482|B3|||Age||years|Mean|13.9|13.9|Standard Deviation|6.4|6.4|||
4304565|NCT00505375|4131483|B2|||Age||years|Mean|13.7|13.7|Standard Deviation|5.3|5.3|||
4304566|NCT00505375|4131484|B1|||Age||years|Mean|13.9|13.9|Standard Deviation|6.9|6.9|||
4304567|NCT00505362|4131491|B3|||Gestational age at delivery||weeks|Median|39|39.0|Inter-Quartile Range|||37.0|39.0|
4304568|NCT00505362|4131492|B2|||Gestational age at delivery||weeks|Median|38|38.0|Inter-Quartile Range|||37.0|39.0|
4304569|NCT00505362|4131493|B1|||Gestational age at delivery||weeks|Median|39|39.0|Inter-Quartile Range|||37.0|39.0|
4304570|NCT00505362|4131491|B3|United States||Region of Enrollment||Participants|Count of Participants|63|63.0||||||
4304571|NCT00505362|4131492|B2|United States||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
4304572|NCT00505362|4131493|B1|United States||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
4304573|NCT00505362|4131491|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4304574|NCT00505362|4131492|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4304575|NCT00505362|4131493|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4304576|NCT00505362|4131491|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4304577|NCT00505362|4131492|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4304578|NCT00505362|4131493|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4304579|NCT00505362|4131491|B3|||Age||years|Mean|32|32.0|Standard Deviation|7|7.0|||
4304580|NCT00505362|4131492|B2|||Age||years|Mean|33|33.0|Standard Deviation|7|7.0|||
4304581|NCT00505362|4131493|B1|||Age||years|Mean|31|31.0|Standard Deviation|7|7.0|||
4304582|NCT00505284|4131502|B6|Other||Race/Ethnicity, Customized|This baseline characteristic is for Race.|participants|Number|17|17.0||||||
4304583|NCT00505284|4131503|B5|Other||Race/Ethnicity, Customized|This baseline characteristic is for Race.|participants|Number|2|2.0||||||
4304584|NCT00505284|4131504|B4|Other||Race/Ethnicity, Customized|This baseline characteristic is for Race.|participants|Number|3|3.0||||||
4304585|NCT00505284|4131505|B3|Other||Race/Ethnicity, Customized|This baseline characteristic is for Race.|participants|Number|6|6.0||||||
4304586|NCT00505284|4131506|B2|Other||Race/Ethnicity, Customized|This baseline characteristic is for Race.|participants|Number|3|3.0||||||
4304587|NCT00505284|4131507|B1|Other||Race/Ethnicity, Customized|This baseline characteristic is for Race.|participants|Number|3|3.0||||||
4304588|NCT00505284|4131502|B6|Asian||Race/Ethnicity, Customized|This baseline characteristic is for Race.|participants|Number|7|7.0||||||
4304589|NCT00505284|4131503|B5|Asian||Race/Ethnicity, Customized|This baseline characteristic is for Race.|participants|Number|0|0.0||||||
4304590|NCT00505284|4131504|B4|Asian||Race/Ethnicity, Customized|This baseline characteristic is for Race.|participants|Number|0|0.0||||||
4304591|NCT00505284|4131505|B3|Asian||Race/Ethnicity, Customized|This baseline characteristic is for Race.|participants|Number|2|2.0||||||
4304592|NCT00505284|4131506|B2|Asian||Race/Ethnicity, Customized|This baseline characteristic is for Race.|participants|Number|1|1.0||||||
4304593|NCT00505284|4131507|B1|Asian||Race/Ethnicity, Customized|This baseline characteristic is for Race.|participants|Number|4|4.0||||||
4304594|NCT00505284|4131502|B6|Black||Race/Ethnicity, Customized|This baseline characteristic is for Race.|participants|Number|33|33.0||||||
4304595|NCT00505284|4131503|B5|Black||Race/Ethnicity, Customized|This baseline characteristic is for Race.|participants|Number|6|6.0||||||
4304596|NCT00505284|4131504|B4|Black||Race/Ethnicity, Customized|This baseline characteristic is for Race.|participants|Number|4|4.0||||||
4304597|NCT00505284|4131505|B3|Black||Race/Ethnicity, Customized|This baseline characteristic is for Race.|participants|Number|4|4.0||||||
4304598|NCT00505284|4131506|B2|Black||Race/Ethnicity, Customized|This baseline characteristic is for Race.|participants|Number|11|11.0||||||
4304599|NCT00505284|4131507|B1|Black||Race/Ethnicity, Customized|This baseline characteristic is for Race.|participants|Number|8|8.0||||||
4304600|NCT00505284|4131502|B6|White||Race/Ethnicity, Customized|This baseline characteristic is for Race.|participants|Number|288|288.0||||||
4304601|NCT00505284|4131503|B5|White||Race/Ethnicity, Customized|This baseline characteristic is for Race.|participants|Number|60|60.0||||||
4304602|NCT00505284|4131504|B4|White||Race/Ethnicity, Customized|This baseline characteristic is for Race.|participants|Number|60|60.0||||||
4304603|NCT00505284|4131505|B3|White||Race/Ethnicity, Customized|This baseline characteristic is for Race.|participants|Number|56|56.0||||||
4304604|NCT00505284|4131506|B2|White||Race/Ethnicity, Customized|This baseline characteristic is for Race.|participants|Number|56|56.0||||||
4304605|NCT00505284|4131507|B1|White||Race/Ethnicity, Customized|This baseline characteristic is for Race.|participants|Number|56|56.0||||||
4304606|NCT00505284|4131502|B6||Male|Sex: Female, Male|Baseline characteristics look at Safety Population (subjects who were randomized, took at least 1 dose of study drug, and had at least 1 post-baseline assessment).|Participants|Count of Participants|194|194.0||||||
4304607|NCT00505284|4131503|B5||Male|Sex: Female, Male|Baseline characteristics look at Safety Population (subjects who were randomized, took at least 1 dose of study drug, and had at least 1 post-baseline assessment).|Participants|Count of Participants|43|43.0||||||
4304608|NCT00505284|4131504|B4||Male|Sex: Female, Male|Baseline characteristics look at Safety Population (subjects who were randomized, took at least 1 dose of study drug, and had at least 1 post-baseline assessment).|Participants|Count of Participants|33|33.0||||||
4304609|NCT00505284|4131505|B3||Male|Sex: Female, Male|Baseline characteristics look at Safety Population (subjects who were randomized, took at least 1 dose of study drug, and had at least 1 post-baseline assessment).|Participants|Count of Participants|40|40.0||||||
4304610|NCT00505284|4131506|B2||Male|Sex: Female, Male|Baseline characteristics look at Safety Population (subjects who were randomized, took at least 1 dose of study drug, and had at least 1 post-baseline assessment).|Participants|Count of Participants|44|44.0||||||
4304611|NCT00505284|4131507|B1||Male|Sex: Female, Male|Baseline characteristics look at Safety Population (subjects who were randomized, took at least 1 dose of study drug, and had at least 1 post-baseline assessment).|Participants|Count of Participants|34|34.0||||||
4304612|NCT00505284|4131502|B6||Female|Sex: Female, Male|Baseline characteristics look at Safety Population (subjects who were randomized, took at least 1 dose of study drug, and had at least 1 post-baseline assessment).|Participants|Count of Participants|151|151.0||||||
4304613|NCT00505284|4131503|B5||Female|Sex: Female, Male|Baseline characteristics look at Safety Population (subjects who were randomized, took at least 1 dose of study drug, and had at least 1 post-baseline assessment).|Participants|Count of Participants|25|25.0||||||
4304614|NCT00505284|4131504|B4||Female|Sex: Female, Male|Baseline characteristics look at Safety Population (subjects who were randomized, took at least 1 dose of study drug, and had at least 1 post-baseline assessment).|Participants|Count of Participants|34|34.0||||||
4304615|NCT00505284|4131505|B3||Female|Sex: Female, Male|Baseline characteristics look at Safety Population (subjects who were randomized, took at least 1 dose of study drug, and had at least 1 post-baseline assessment).|Participants|Count of Participants|28|28.0||||||
4304616|NCT00505284|4131506|B2||Female|Sex: Female, Male|Baseline characteristics look at Safety Population (subjects who were randomized, took at least 1 dose of study drug, and had at least 1 post-baseline assessment).|Participants|Count of Participants|27|27.0||||||
4304617|NCT00505284|4131507|B1||Female|Sex: Female, Male|Baseline characteristics look at Safety Population (subjects who were randomized, took at least 1 dose of study drug, and had at least 1 post-baseline assessment).|Participants|Count of Participants|37|37.0||||||
4304618|NCT00505284|4131502|B6|>=65 years||Age, Customized||Participants|Number|130|130.0||||||
4304619|NCT00505284|4131503|B5|>=65 years||Age, Customized||Participants|Number|27|27.0||||||
4304620|NCT00505284|4131504|B4|>=65 years||Age, Customized||Participants|Number|33|33.0||||||
4304621|NCT00505284|4131505|B3|>=65 years||Age, Customized||Participants|Number|28|28.0||||||
4304622|NCT00505284|4131506|B2|>=65 years||Age, Customized||Participants|Number|21|21.0||||||
4304623|NCT00505284|4131507|B1|>=65 years||Age, Customized||Participants|Number|21|21.0||||||
4304624|NCT00505284|4131502|B6|<65 years||Age, Customized||Participants|Number|215|215.0||||||
4304625|NCT00505284|4131503|B5|<65 years||Age, Customized||Participants|Number|41|41.0||||||
4304626|NCT00505284|4131504|B4|<65 years||Age, Customized||Participants|Number|34|34.0||||||
4304627|NCT00505284|4131505|B3|<65 years||Age, Customized||Participants|Number|40|40.0||||||
4304628|NCT00505284|4131506|B2|<65 years||Age, Customized||Participants|Number|50|50.0||||||
4304629|NCT00505284|4131507|B1|<65 years||Age, Customized||Participants|Number|50|50.0||||||
4304630|NCT00505076|4131578|B4|United States||Region of Enrollment||participants|Number|63|63.0||||||
4304631|NCT00505076|4131579|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4304632|NCT00505076|4131580|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4304633|NCT00505076|4131581|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4304634|NCT00505076|4131578|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4304635|NCT00505076|4131579|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4304636|NCT00505076|4131580|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4304638|NCT00505076|4131578|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4304639|NCT00505076|4131579|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4304640|NCT00505076|4131580|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4304641|NCT00505076|4131581|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4304642|NCT00505076|4131578|B4|||Age||years|Mean|42.7|42.7|Standard Deviation|9.8|9.8|||
4304643|NCT00505076|4131579|B3|||Age||years|Mean|40.0|40.0|Standard Deviation|10.9|10.9|||
4304644|NCT00505076|4131580|B2|||Age||years|Mean|43.3|43.3|Standard Deviation|9.3|9.3|||
4304645|NCT00505076|4131581|B1|||Age||years|Mean|44.9|44.9|Standard Deviation|8.7|8.7|||
4304646|NCT00505076|4131578|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4304647|NCT00505076|4131579|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4304648|NCT00505076|4131580|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4304649|NCT00505076|4131581|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4304650|NCT00505076|4131578|B4||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4304651|NCT00505076|4131579|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4304652|NCT00505076|4131580|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4304653|NCT00505076|4131581|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4304654|NCT00505076|4131578|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4304655|NCT00505076|4131579|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4304656|NCT00505076|4131580|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4304657|NCT00505076|4131581|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4304658|NCT00504985|4131597|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4304659|NCT00504985|4131597|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4304660|NCT00504985|4131597|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4304661|NCT00504985|4131597|B1|||Age||years|Median|66|66.0|Full Range|||28.0|74.0|
4304662|NCT00504894|4131601|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4304663|NCT00504894|4131602|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4304664|NCT00504894|4131603|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4304665|NCT00504894|4131601|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4304666|NCT00504894|4131602|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4304667|NCT00504894|4131603|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4304668|NCT00504894|4131601|B3|||Age||years|Median|25|25.0|Inter-Quartile Range|||22.0|28.0|
4304669|NCT00504894|4131602|B2|||Age||years|Median|25|25.0|Inter-Quartile Range|||22.75|26.25|
4304670|NCT00504894|4131603|B1|||Age||years|Median|25|25.0|Inter-Quartile Range|||22.0|29.5|
4304671|NCT00504881|4131610|B3||Male|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
4304672|NCT00504881|4131611|B2||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4304673|NCT00504881|4131612|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4304674|NCT00504881|4131610|B3||Female|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4304675|NCT00504881|4131611|B2||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4304676|NCT00504881|4131612|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4304677|NCT00504881|4131610|B3|||Age||years|Mean|35.85|35.85|Standard Deviation|11.52|11.52|||
4304678|NCT00504881|4131611|B2|||Age||years|Mean|35.6|35.6|Standard Deviation|11.5|11.5|||
4304679|NCT00504881|4131612|B1|||Age||years|Mean|36.5|36.5|Standard Deviation|11.5|11.5|||
4304680|NCT00504881|4131610|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4304681|NCT00504881|4131611|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4304682|NCT00504881|4131612|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4304683|NCT00504881|4131610|B3||Between 18 and 65 years|Age||Participants|Count of Participants|468|468.0||||||
4304684|NCT00504881|4131611|B2||Between 18 and 65 years|Age||Participants|Count of Participants|352|352.0||||||
4304685|NCT00504881|4131612|B1||Between 18 and 65 years|Age||Participants|Count of Participants|116|116.0||||||
4304686|NCT00504881|4131610|B3||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4304687|NCT00504881|4131611|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4304688|NCT00504881|4131612|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4304689|NCT00504777|4131663|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4304690|NCT00504777|4131663|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4304691|NCT00504777|4131663|B1|||Age||years|Mean|50.72|50.72|Standard Deviation|13.42|13.42|||
4304692|NCT00504751|4131670|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4304693|NCT00504751|4131670|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4304694|NCT00504751|4131670|B1|||Age||years|Median|64|64.0|Full Range|||29.0|77.0|
4304695|NCT00504725|4131674|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
4304696|NCT00504725|4131675|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4304697|NCT00504725|4131676|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4304698|NCT00504725|4131674|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4304699|NCT00504725|4131675|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4304700|NCT00504725|4131676|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4304701|NCT00504725|4131674|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4304702|NCT00504725|4131675|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4304703|NCT00504725|4131676|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4304704|NCT00504725|4131674|B3|AGE||Age||Years|Mean|63|63.0|Standard Deviation|11|11.0|||
4304705|NCT00504725|4131675|B2|AGE||Age||Years|Mean|66|66.0|Standard Deviation|10|10.0|||
4304706|NCT00504725|4131676|B1|AGE||Age||Years|Mean|61|61.0|Standard Deviation|12|12.0|||
4304707|NCT00504660|4131687|B3|United States||Region of Enrollment||participants|Number|74|74.0||||||
4304708|NCT00504660|4131688|B2|United States||Region of Enrollment||participants|Number|43|43.0||||||
4304709|NCT00504660|4131689|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4304710|NCT00504660|4131687|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4304711|NCT00504660|4131688|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4304712|NCT00504660|4131689|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4304713|NCT00504660|4131687|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4304714|NCT00504660|4131688|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4304715|NCT00504660|4131689|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4304716|NCT00504660|4131687|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4304717|NCT00504660|4131688|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4304718|NCT00504660|4131689|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4304719|NCT00504660|4131687|B3||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4304720|NCT00504660|4131688|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4304721|NCT00504660|4131689|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4304722|NCT00504660|4131687|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4304723|NCT00504660|4131688|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4304724|NCT00504660|4131689|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4304725|NCT00504595|4131696|B5||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4304726|NCT00504595|4131697|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4304727|NCT00504595|4131698|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4304728|NCT00504595|4131699|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4304729|NCT00504595|4131700|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4304730|NCT00504595|4131696|B5||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4304731|NCT00504595|4131697|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4304732|NCT00504595|4131698|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4304733|NCT00504595|4131699|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4304734|NCT00504595|4131700|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4304735|NCT00504595|4131696|B5|||Age||Years|Mean|46.9|46.9|Standard Deviation|16.22|16.22|||
4304736|NCT00504595|4131697|B4|||Age||Years|Mean|28.0|28.0|Standard Deviation|5.52|5.52|||
4304737|NCT00504595|4131698|B3|||Age||Years|Mean|46.2|46.2|Standard Deviation|12.83|12.83|||
4304738|NCT00504595|4131699|B2|||Age||Years|Mean|28.8|28.8|Standard Deviation|7.42|7.42|||
4304739|NCT00504595|4131700|B1|||Age||Years|Mean|54.4|54.4|Standard Deviation|13.42|13.42|||
4304740|NCT00504556|4131715|B6|Bosnia and Herzegovina||Region of Enrollment||participants|Number|55|55.0||||||
4304741|NCT00504556|4131716|B5|Bosnia and Herzegovina||Region of Enrollment||participants|Number|12|12.0||||||
4304742|NCT00504556|4131717|B4|Bosnia and Herzegovina||Region of Enrollment||participants|Number|8|8.0||||||
4304743|NCT00504556|4131718|B3|Bosnia and Herzegovina||Region of Enrollment||participants|Number|11|11.0||||||
4304744|NCT00504556|4131719|B2|Bosnia and Herzegovina||Region of Enrollment||participants|Number|11|11.0||||||
4304745|NCT00504556|4131720|B1|Bosnia and Herzegovina||Region of Enrollment||participants|Number|13|13.0||||||
4304746|NCT00504556|4131715|B6|Moldova, Republic of||Region of Enrollment||participants|Number|57|57.0||||||
4304747|NCT00504556|4131716|B5|Moldova, Republic of||Region of Enrollment||participants|Number|12|12.0||||||
4304748|NCT00504556|4131717|B4|Moldova, Republic of||Region of Enrollment||participants|Number|11|11.0||||||
4304749|NCT00504556|4131718|B3|Moldova, Republic of||Region of Enrollment||participants|Number|11|11.0||||||
4304750|NCT00504556|4131719|B2|Moldova, Republic of||Region of Enrollment||participants|Number|12|12.0||||||
4304751|NCT00504556|4131720|B1|Moldova, Republic of||Region of Enrollment||participants|Number|11|11.0||||||
4304752|NCT00504556|4131715|B6|Latvia||Region of Enrollment||participants|Number|27|27.0||||||
4304753|NCT00504556|4131716|B5|Latvia||Region of Enrollment||participants|Number|6|6.0||||||
4304754|NCT00504556|4131717|B4|Latvia||Region of Enrollment||participants|Number|4|4.0||||||
4304755|NCT00504556|4131718|B3|Latvia||Region of Enrollment||participants|Number|6|6.0||||||
4304756|NCT00504556|4131719|B2|Latvia||Region of Enrollment||participants|Number|6|6.0||||||
4304757|NCT00504556|4131720|B1|Latvia||Region of Enrollment||participants|Number|5|5.0||||||
4304758|NCT00504556|4131715|B6|Chile||Region of Enrollment||participants|Number|23|23.0||||||
4304759|NCT00504556|4131716|B5|Chile||Region of Enrollment||participants|Number|5|5.0||||||
4304760|NCT00504556|4131717|B4|Chile||Region of Enrollment||participants|Number|2|2.0||||||
4304761|NCT00504556|4131718|B3|Chile||Region of Enrollment||participants|Number|6|6.0||||||
4304762|NCT00504556|4131719|B2|Chile||Region of Enrollment||participants|Number|4|4.0||||||
4304763|NCT00504556|4131720|B1|Chile||Region of Enrollment||participants|Number|6|6.0||||||
4304764|NCT00504556|4131715|B6|Russian Federation||Region of Enrollment||participants|Number|432|432.0||||||
4304765|NCT00504556|4131716|B5|Russian Federation||Region of Enrollment||participants|Number|97|97.0||||||
4304766|NCT00504556|4131717|B4|Russian Federation||Region of Enrollment||participants|Number|64|64.0||||||
4304767|NCT00504556|4131718|B3|Russian Federation||Region of Enrollment||participants|Number|87|87.0||||||
4304768|NCT00504556|4131719|B2|Russian Federation||Region of Enrollment||participants|Number|93|93.0||||||
4304769|NCT00504556|4131720|B1|Russian Federation||Region of Enrollment||participants|Number|91|91.0||||||
4304770|NCT00504556|4131715|B6|Ukraine||Region of Enrollment||participants|Number|391|391.0||||||
4304771|NCT00504556|4131716|B5|Ukraine||Region of Enrollment||participants|Number|83|83.0||||||
4304772|NCT00504556|4131717|B4|Ukraine||Region of Enrollment||participants|Number|70|70.0||||||
4304773|NCT00504556|4131718|B3|Ukraine||Region of Enrollment||participants|Number|81|81.0||||||
4304774|NCT00504556|4131719|B2|Ukraine||Region of Enrollment||participants|Number|80|80.0||||||
4304775|NCT00504556|4131720|B1|Ukraine||Region of Enrollment||participants|Number|77|77.0||||||
4304776|NCT00504556|4131715|B6|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4304777|NCT00504556|4131716|B5|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4304778|NCT00504556|4131717|B4|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4304779|NCT00504556|4131718|B3|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4304780|NCT00504556|4131719|B2|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4304781|NCT00504556|4131720|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4304782|NCT00504556|4131715|B6|Mexico||Region of Enrollment||participants|Number|15|15.0||||||
4304783|NCT00504556|4131716|B5|Mexico||Region of Enrollment||participants|Number|4|4.0||||||
4304784|NCT00504556|4131717|B4|Mexico||Region of Enrollment||participants|Number|3|3.0||||||
4304785|NCT00504556|4131718|B3|Mexico||Region of Enrollment||participants|Number|3|3.0||||||
4304786|NCT00504556|4131719|B2|Mexico||Region of Enrollment||participants|Number|3|3.0||||||
4304787|NCT00504556|4131720|B1|Mexico||Region of Enrollment||participants|Number|2|2.0||||||
4304788|NCT00504556|4131715|B6|Slovakia||Region of Enrollment||participants|Number|64|64.0||||||
4304789|NCT00504556|4131716|B5|Slovakia||Region of Enrollment||participants|Number|15|15.0||||||
4304790|NCT00504556|4131717|B4|Slovakia||Region of Enrollment||participants|Number|10|10.0||||||
4304791|NCT00504556|4131718|B3|Slovakia||Region of Enrollment||participants|Number|12|12.0||||||
4304792|NCT00504556|4131719|B2|Slovakia||Region of Enrollment||participants|Number|14|14.0||||||
4304793|NCT00504556|4131720|B1|Slovakia||Region of Enrollment||participants|Number|13|13.0||||||
4304794|NCT00504556|4131715|B6|United States||Region of Enrollment||participants|Number|46|46.0||||||
4304795|NCT00504556|4131716|B5|United States||Region of Enrollment||participants|Number|9|9.0||||||
4304796|NCT00504556|4131717|B4|United States||Region of Enrollment||participants|Number|5|5.0||||||
4304797|NCT00504556|4131718|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4304798|NCT00504556|4131719|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4304799|NCT00504556|4131720|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4304800|NCT00504556|4131715|B6|Belarus||Region of Enrollment||participants|Number|22|22.0||||||
4304801|NCT00504556|4131716|B5|Belarus||Region of Enrollment||participants|Number|5|5.0||||||
4304802|NCT00504556|4131717|B4|Belarus||Region of Enrollment||participants|Number|1|1.0||||||
4304803|NCT00504556|4131718|B3|Belarus||Region of Enrollment||participants|Number|6|6.0||||||
4304804|NCT00504556|4131719|B2|Belarus||Region of Enrollment||participants|Number|5|5.0||||||
4304805|NCT00504556|4131720|B1|Belarus||Region of Enrollment||participants|Number|5|5.0||||||
4304806|NCT00504556|4131715|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4304807|NCT00504556|4131716|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4304808|NCT00504556|4131717|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4304809|NCT00504556|4131718|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4304810|NCT00504556|4131719|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4304811|NCT00504556|4131720|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4304812|NCT00504556|4131715|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304813|NCT00504556|4131716|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304814|NCT00504556|4131717|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304815|NCT00504556|4131718|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304816|NCT00504556|4131719|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304817|NCT00504556|4131720|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304818|NCT00504556|4131715|B6||White|Race (NIH/OMB)||Participants|Count of Participants|1116|1116.0||||||
4304819|NCT00504556|4131716|B5||White|Race (NIH/OMB)||Participants|Count of Participants|243|243.0||||||
4304820|NCT00504556|4131717|B4||White|Race (NIH/OMB)||Participants|Count of Participants|176|176.0||||||
4304821|NCT00504556|4131718|B3||White|Race (NIH/OMB)||Participants|Count of Participants|228|228.0||||||
4304822|NCT00504556|4131719|B2||White|Race (NIH/OMB)||Participants|Count of Participants|239|239.0||||||
4304823|NCT00504556|4131720|B1||White|Race (NIH/OMB)||Participants|Count of Participants|230|230.0||||||
4304824|NCT00504556|4131715|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4304825|NCT00504556|4131716|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304826|NCT00504556|4131717|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304827|NCT00504556|4131718|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4304828|NCT00504556|4131719|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304829|NCT00504556|4131720|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4304830|NCT00504556|4131715|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4304831|NCT00504556|4131716|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304832|NCT00504556|4131717|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304833|NCT00504556|4131718|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304834|NCT00504556|4131719|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304835|NCT00504556|4131720|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4304836|NCT00504556|4131715|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4304837|NCT00504556|4131716|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304838|NCT00504556|4131717|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304839|NCT00504556|4131718|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304840|NCT00504556|4131719|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4304841|NCT00504556|4131720|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304842|NCT00504556|4131715|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304843|NCT00504556|4131716|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304844|NCT00504556|4131717|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304845|NCT00504556|4131718|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304846|NCT00504556|4131719|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304847|NCT00504556|4131720|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304848|NCT00504556|4131715|B6||Male|Sex: Female, Male||Participants|Count of Participants|710|710.0||||||
4304849|NCT00504556|4131716|B5||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4304850|NCT00504556|4131717|B4||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4304851|NCT00504556|4131718|B3||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4304852|NCT00504556|4131719|B2||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4304853|NCT00504556|4131720|B1||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4304854|NCT00504556|4131715|B6||Female|Sex: Female, Male||Participants|Count of Participants|433|433.0||||||
4304855|NCT00504556|4131716|B5||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4304856|NCT00504556|4131717|B4||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4304857|NCT00504556|4131718|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4304858|NCT00504556|4131719|B2||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4304859|NCT00504556|4131720|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4304860|NCT00504556|4131715|B6|||Age||years|Mean|64.9|64.9|Standard Deviation|8.71|8.71|||
4304861|NCT00504556|4131716|B5|||Age||years|Mean|66.0|66.0|Standard Deviation|8.49|8.49|||
4304862|NCT00504556|4131717|B4|||Age||years|Mean|64.7|64.7|Standard Deviation|8.96|8.96|||
4304863|NCT00504556|4131718|B3|||Age||years|Mean|64.9|64.9|Standard Deviation|8.81|8.81|||
4304864|NCT00504556|4131719|B2|||Age||years|Mean|64.8|64.8|Standard Deviation|8.83|8.83|||
4304865|NCT00504556|4131720|B1|||Age||years|Mean|65.2|65.2|Standard Deviation|8.34|8.34|||
4304866|NCT00504556|4131715|B6||>=65 years|Age||Participants|Count of Participants|630|630.0||||||
4304867|NCT00504556|4131716|B5||>=65 years|Age||Participants|Count of Participants|153|153.0||||||
4304868|NCT00504556|4131717|B4||>=65 years|Age||Participants|Count of Participants|97|97.0||||||
4304869|NCT00504556|4131718|B3||>=65 years|Age||Participants|Count of Participants|129|129.0||||||
4304870|NCT00504556|4131719|B2||>=65 years|Age||Participants|Count of Participants|125|125.0||||||
4304871|NCT00504556|4131720|B1||>=65 years|Age||Participants|Count of Participants|126|126.0||||||
4304872|NCT00504556|4131715|B6||Between 18 and 65 years|Age||Participants|Count of Participants|513|513.0||||||
4304873|NCT00504556|4131716|B5||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
4304874|NCT00504556|4131717|B4||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
4304875|NCT00504556|4131718|B3||Between 18 and 65 years|Age||Participants|Count of Participants|105|105.0||||||
4304876|NCT00504556|4131719|B2||Between 18 and 65 years|Age||Participants|Count of Participants|119|119.0||||||
4304877|NCT00504556|4131720|B1||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
4304878|NCT00504556|4131715|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4304879|NCT00504556|4131716|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4304880|NCT00504556|4131717|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4304881|NCT00504556|4131718|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4304882|NCT00504556|4131719|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4304883|NCT00504556|4131720|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4304884|NCT00504504|4131784|B1|United States||Region of Enrollment||participants|Number|82|82.0||||||
4304885|NCT00504504|4131784|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4304886|NCT00504504|4131784|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4304887|NCT00504504|4131784|B1|||Age||years|Median|32|32.0|Full Range|||18.0|72.0|
4304888|NCT00504426|4131788|B5|Japan||Region of Enrollment||participants|Number|101|101.0||||||
4304889|NCT00504426|4131789|B4|Japan||Region of Enrollment||participants|Number|24|24.0||||||
4304890|NCT00504426|4131790|B3|Japan||Region of Enrollment||participants|Number|22|22.0||||||
4304891|NCT00504426|4131791|B2|Japan||Region of Enrollment||participants|Number|23|23.0||||||
4304892|NCT00504426|4131792|B1|Japan||Region of Enrollment||participants|Number|32|32.0||||||
4304893|NCT00504426|4131788|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4304894|NCT00504426|4131789|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4304895|NCT00504426|4131790|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4304896|NCT00504426|4131791|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4304897|NCT00504426|4131792|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4304898|NCT00504426|4131788|B5||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4304899|NCT00504426|4131789|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4304900|NCT00504426|4131790|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4304901|NCT00504426|4131791|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4304902|NCT00504426|4131792|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4304903|NCT00504426|4131788|B5|||Age||years|Mean|72.6|72.6|Standard Deviation|5.9|5.9|||
4304904|NCT00504426|4131789|B4|||Age||years|Mean|72.3|72.3|Standard Deviation|5.9|5.9|||
4304905|NCT00504426|4131790|B3|||Age||years|Mean|73.4|73.4|Standard Deviation|5.9|5.9|||
4304906|NCT00504426|4131791|B2|||Age||years|Mean|73.0|73.0|Standard Deviation|5.1|5.1|||
4304907|NCT00504426|4131792|B1|||Age||years|Mean|71.9|71.9|Standard Deviation|6.0|6.0|||
4304908|NCT00504426|4131788|B5||>=65 years|Age||Participants|Count of Participants|91|91.0||||||
4304909|NCT00504426|4131789|B4||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4304910|NCT00504426|4131790|B3||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4304911|NCT00504426|4131791|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4304912|NCT00504426|4131792|B1||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4304913|NCT00504426|4131788|B5||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4304914|NCT00504426|4131789|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4304915|NCT00504426|4131790|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4304916|NCT00504426|4131791|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4304917|NCT00504426|4131792|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4304918|NCT00504426|4131788|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4304919|NCT00504426|4131789|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4304920|NCT00504426|4131790|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4304921|NCT00504426|4131791|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4304922|NCT00504426|4131792|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4304923|NCT00504309|4131809|B7|United States||Region of Enrollment||participants|Number|26|26.0||||||
4304924|NCT00504309|4131810|B6|United States||Region of Enrollment||participants|Number|3|3.0||||||
4304925|NCT00504309|4131811|B5|United States||Region of Enrollment||participants|Number|7|7.0||||||
4304926|NCT00504309|4131812|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
4304927|NCT00504309|4131813|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4304928|NCT00504309|4131814|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4304929|NCT00504309|4131815|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4304930|NCT00504309|4131809|B7||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4304931|NCT00504309|4131810|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4304932|NCT00504309|4131811|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4304933|NCT00504309|4131812|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4304934|NCT00504309|4131813|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4304935|NCT00504309|4131814|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4304936|NCT00504309|4131815|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4304937|NCT00504309|4131809|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4304938|NCT00504309|4131810|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4304939|NCT00504309|4131811|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4304940|NCT00504309|4131812|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4304941|NCT00504309|4131813|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4304942|NCT00504309|4131814|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4304943|NCT00504309|4131815|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4304944|NCT00504309|4131809|B7||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4304945|NCT00504309|4131810|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4304946|NCT00504309|4131811|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4304947|NCT00504309|4131812|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4304948|NCT00504309|4131813|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4304949|NCT00504309|4131814|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4304950|NCT00504309|4131815|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4304951|NCT00504309|4131809|B7||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4304952|NCT00504309|4131810|B6||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4304953|NCT00504309|4131811|B5||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4304954|NCT00504309|4131812|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4304955|NCT00504309|4131813|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4304956|NCT00504309|4131814|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4304957|NCT00504309|4131815|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4304958|NCT00504309|4131809|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4304959|NCT00504309|4131810|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4304960|NCT00504309|4131811|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4304961|NCT00504309|4131812|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4304962|NCT00504309|4131813|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4304963|NCT00504309|4131814|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4304964|NCT00504309|4131815|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4304965|NCT00504257|4131858|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4304966|NCT00504257|4131858|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4304967|NCT00504257|4131858|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4304968|NCT00504257|4131858|B1|||Age||years|Mean|58.2|58.2|Full Range|||34.0|84.0|
4304969|NCT00504257|4131858|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4304970|NCT00504257|4131858|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4304971|NCT00504257|4131858|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4304972|NCT00504231|4131866|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4304973|NCT00504231|4131867|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4304974|NCT00504231|4131868|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4304975|NCT00504231|4131869|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4304976|NCT00504231|4131870|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4304977|NCT00504231|4131866|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304978|NCT00504231|4131867|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304979|NCT00504231|4131868|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304980|NCT00504231|4131869|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304981|NCT00504231|4131870|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304982|NCT00504231|4131866|B5||White|Race (NIH/OMB)||Participants|Count of Participants|224|224.0||||||
4304983|NCT00504231|4131867|B4||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4304984|NCT00504231|4131868|B3||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4304985|NCT00504231|4131869|B2||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4304986|NCT00504231|4131870|B1||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4304987|NCT00504231|4131866|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4304988|NCT00504231|4131867|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4304989|NCT00504231|4131868|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4304990|NCT00504231|4131869|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4304991|NCT00504231|4131870|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4304992|NCT00504231|4131866|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304993|NCT00504231|4131867|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304994|NCT00504231|4131868|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304995|NCT00504231|4131869|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304996|NCT00504231|4131870|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4304997|NCT00504231|4131866|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4304998|NCT00504231|4131867|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4304999|NCT00504231|4131868|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4305000|NCT00504231|4131869|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305001|NCT00504231|4131870|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4305002|NCT00504231|4131866|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305003|NCT00504231|4131867|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305004|NCT00504231|4131868|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305065|NCT00504166|4131892|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4305005|NCT00504231|4131869|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305006|NCT00504231|4131870|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305007|NCT00504231|4131866|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305008|NCT00504231|4131867|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305009|NCT00504231|4131868|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305010|NCT00504231|4131869|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305011|NCT00504231|4131870|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305012|NCT00504231|4131866|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|254|254.0||||||
4305013|NCT00504231|4131867|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4305014|NCT00504231|4131868|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4305015|NCT00504231|4131869|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4305016|NCT00504231|4131870|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4305017|NCT00504231|4131866|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4305018|NCT00504231|4131867|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4305019|NCT00504231|4131868|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4305020|NCT00504231|4131869|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4305021|NCT00504231|4131870|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305022|NCT00504231|4131866|B5||Male|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
4305023|NCT00504231|4131867|B4||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4305024|NCT00504231|4131868|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4305025|NCT00504231|4131869|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4305026|NCT00504231|4131870|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4305027|NCT00504231|4131866|B5||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4305028|NCT00504231|4131867|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4305029|NCT00504231|4131868|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4305030|NCT00504231|4131869|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4305031|NCT00504231|4131870|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4305032|NCT00504231|4131866|B5|||Age||years|Mean|74.8|74.8|Standard Deviation|6.8|6.8|||
4305033|NCT00504231|4131867|B4|||Age||years|Mean|74.7|74.7|Standard Deviation|6.3|6.3|||
4305034|NCT00504231|4131868|B3|||Age||years|Mean|73.6|73.6|Standard Deviation|6.3|6.3|||
4305035|NCT00504231|4131869|B2|||Age||years|Mean|75.2|75.2|Standard Deviation|7.7|7.7|||
4305036|NCT00504231|4131870|B1|||Age||years|Mean|75.6|75.6|Standard Deviation|6.8|6.8|||
4305037|NCT00504231|4131866|B5||>=65 years|Age||Participants|Count of Participants|257|257.0||||||
4305038|NCT00504231|4131867|B4||>=65 years|Age||Participants|Count of Participants|65|65.0||||||
4305039|NCT00504231|4131868|B3||>=65 years|Age||Participants|Count of Participants|63|63.0||||||
4305040|NCT00504231|4131869|B2||>=65 years|Age||Participants|Count of Participants|64|64.0||||||
4305041|NCT00504231|4131870|B1||>=65 years|Age||Participants|Count of Participants|65|65.0||||||
4305042|NCT00504231|4131866|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4305043|NCT00504231|4131867|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4305044|NCT00504231|4131868|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4305045|NCT00504231|4131869|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4305046|NCT00504231|4131870|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4305047|NCT00504231|4131866|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4305048|NCT00504231|4131867|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4305049|NCT00504231|4131868|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4305050|NCT00504231|4131869|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4305051|NCT00504231|4131870|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4305052|NCT00504166|4131891|B3|United States||Region of Enrollment||participants|Number|53|53.0||||||
4305053|NCT00504166|4131892|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4305054|NCT00504166|4131893|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4305055|NCT00504166|4131891|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4305056|NCT00504166|4131892|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4305057|NCT00504166|4131893|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4305058|NCT00504166|4131891|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4305059|NCT00504166|4131892|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4305060|NCT00504166|4131893|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4305061|NCT00504166|4131891|B3|||Age||years|Mean|55.6|55.6|Standard Deviation|3.6|3.6|||
4305062|NCT00504166|4131892|B2|||Age||years|Mean|55.4|55.4|Standard Deviation|3.3|3.3|||
4305063|NCT00504166|4131893|B1|||Age||years|Mean|55.8|55.8|Standard Deviation|3.9|3.9|||
4305064|NCT00504166|4131891|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4305066|NCT00504166|4131893|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4305067|NCT00504166|4131891|B3||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4305068|NCT00504166|4131892|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4305069|NCT00504166|4131893|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4305070|NCT00504166|4131891|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4305071|NCT00504166|4131892|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4305072|NCT00504166|4131893|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4305073|NCT00504153|4131900|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4305074|NCT00504153|4131900|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4305075|NCT00504153|4131900|B1|||Age||years|Median|64|64.0|Full Range|||34.0|83.0|
4305076|NCT00504075|4131908|B1|India||Region of Enrollment||participants|Number|21|21.0||||||
4305077|NCT00504075|4131908|B1|Argentina||Region of Enrollment||participants|Number|5|5.0||||||
4305078|NCT00504075|4131908|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4305079|NCT00504075|4131908|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4305080|NCT00504075|4131908|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4305081|NCT00504075|4131908|B1|||Age||years|Mean|36|36.0|Standard Deviation|18|18.0|||
4305082|NCT00504075|4131908|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4305083|NCT00504075|4131908|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4305084|NCT00504075|4131908|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4305085|NCT00504023|4131914|B1|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4305086|NCT00504023|4131914|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305087|NCT00504023|4131914|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305088|NCT00504023|4131914|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4305089|NCT00504023|4131914|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305090|NCT00504023|4131914|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305091|NCT00504023|4131914|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4305092|NCT00504023|4131914|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305093|NCT00504023|4131914|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305094|NCT00504023|4131914|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4305095|NCT00504023|4131914|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305096|NCT00504023|4131914|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4305097|NCT00504023|4131914|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4305098|NCT00504023|4131914|B1|||Age||years|Median|72|72.0|Full Range|||47.0|84.0|
4305099|NCT00503997|4131918|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4305100|NCT00503997|4131918|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4305101|NCT00503997|4131918|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4305102|NCT00503997|4131918|B1|||Age||years|Mean|56|56.0|Standard Deviation|1|1.0|||
4305103|NCT00503997|4131918|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4305104|NCT00503997|4131918|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4305105|NCT00503997|4131918|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4305106|NCT00503984|4131922|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4305107|NCT00503984|4131923|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4305108|NCT00503984|4131924|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4305109|NCT00503984|4131922|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305110|NCT00503984|4131923|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305111|NCT00503984|4131924|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305112|NCT00503984|4131922|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305113|NCT00503984|4131923|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305114|NCT00503984|4131924|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305115|NCT00503984|4131922|B3||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4305116|NCT00503984|4131923|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4305117|NCT00503984|4131924|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4305118|NCT00503984|4131922|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4305119|NCT00503984|4131923|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4305120|NCT00503984|4131924|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4305121|NCT00503984|4131922|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305122|NCT00503984|4131923|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305123|NCT00503984|4131924|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305124|NCT00503984|4131922|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305125|NCT00503984|4131923|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305126|NCT00503984|4131924|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305127|NCT00503984|4131922|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305128|NCT00503984|4131923|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305129|NCT00503984|4131924|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305130|NCT00503984|4131922|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305131|NCT00503984|4131923|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305132|NCT00503984|4131924|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305133|NCT00503984|4131922|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4305134|NCT00503984|4131923|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4305135|NCT00503984|4131924|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4305136|NCT00503984|4131922|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4305137|NCT00503984|4131923|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4305138|NCT00503984|4131924|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4305139|NCT00503984|4131922|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4305140|NCT00503984|4131923|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4305141|NCT00503984|4131924|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4305142|NCT00503984|4131922|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4305143|NCT00503984|4131923|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4305144|NCT00503984|4131924|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4305145|NCT00503984|4131922|B3|>= 70 years||Age, Customized||participants|Number|7|7.0||||||
4305146|NCT00503984|4131923|B2|>= 70 years||Age, Customized||participants|Number|3|3.0||||||
4305147|NCT00503984|4131924|B1|>= 70 years||Age, Customized||participants|Number|4|4.0||||||
4305148|NCT00503984|4131922|B3|60 - 69 years||Age, Customized||participants|Number|11|11.0||||||
4305149|NCT00503984|4131923|B2|60 - 69 years||Age, Customized||participants|Number|3|3.0||||||
4305150|NCT00503984|4131924|B1|60 - 69 years||Age, Customized||participants|Number|8|8.0||||||
4305151|NCT00503984|4131922|B3|< 60 years||Age, Customized||participants|Number|4|4.0||||||
4305152|NCT00503984|4131923|B2|< 60 years||Age, Customized||participants|Number|1|1.0||||||
4305153|NCT00503984|4131924|B1|< 60 years||Age, Customized||participants|Number|3|3.0||||||
4305154|NCT00503906|4131955|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4305155|NCT00503906|4131955|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4305156|NCT00503906|4131955|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305157|NCT00503906|4131955|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4305158|NCT00503906|4131955|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4305159|NCT00503906|4131955|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305160|NCT00503906|4131955|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4305161|NCT00503906|4131955|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305162|NCT00503906|4131955|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4305163|NCT00503906|4131955|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4305164|NCT00503906|4131955|B1|||Age||years|Median|53.8|53.8|Full Range|||34.0|69.0|
4305165|NCT00503906|4131955|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|9.2|9.2|||
4305166|NCT00503906|4131955|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4305167|NCT00503906|4131955|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4305168|NCT00503906|4131955|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4305169|NCT00503880|4131964|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4305170|NCT00503880|4131964|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4305171|NCT00503880|4131964|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4305172|NCT00503880|4131964|B1|||Age||years|Mean|69|69.0|Full Range|||68.0|69.0|
4305173|NCT00503841|4131977|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4305174|NCT00503841|4131977|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4305175|NCT00503841|4131977|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4305176|NCT00503841|4131977|B1|||Age||years|Mean|52|52.0|Standard Deviation|12.52769|12.52769|||
4305177|NCT00503841|4131977|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4305178|NCT00503841|4131977|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4305179|NCT00503841|4131977|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4305180|NCT00503776|4131981|B5|United States||Region of Enrollment||participants|Number|42|42.0||||||
4305181|NCT00503776|4131982|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
4305182|NCT00503776|4131983|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4305183|NCT00503776|4131984|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4305184|NCT00503776|4131985|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4305185|NCT00503776|4131981|B5||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4305186|NCT00503776|4131982|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4305187|NCT00503776|4131983|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4305188|NCT00503776|4131984|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4305189|NCT00503776|4131985|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4305190|NCT00503776|4131981|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4305191|NCT00503776|4131982|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4305192|NCT00503776|4131983|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4305193|NCT00503776|4131984|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4305194|NCT00503776|4131985|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4305195|NCT00503776|4131981|B5|||Age||years|Mean|54|54.0|Standard Deviation|1|1.0|||
4305196|NCT00503776|4131982|B4|||Age||years|Mean|55|55.0|Standard Deviation|1|1.0|||
4305197|NCT00503776|4131983|B3|||Age||years|Mean|54|54.0|Standard Deviation|1|1.0|||
4305198|NCT00503776|4131984|B2|||Age||years|Mean|55|55.0|Standard Deviation|1|1.0|||
4305199|NCT00503776|4131985|B1|||Age||years|Mean|51|51.0|Standard Deviation|1|1.0|||
4305200|NCT00503776|4131981|B5||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4305201|NCT00503776|4131982|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4305202|NCT00503776|4131983|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4305203|NCT00503776|4131984|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4305204|NCT00503776|4131985|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4305205|NCT00503776|4131981|B5||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4305206|NCT00503776|4131982|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4305207|NCT00503776|4131983|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4305208|NCT00503776|4131984|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4305209|NCT00503776|4131985|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4305210|NCT00503776|4131981|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4305211|NCT00503776|4131982|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4305212|NCT00503776|4131983|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4305213|NCT00503776|4131984|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4305214|NCT00503776|4131985|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4305215|NCT00503750|4132014|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4305216|NCT00503750|4132014|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4305217|NCT00503750|4132014|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4305218|NCT00503750|4132014|B1|||Age||years|Median|49|49.0|Full Range|||34.0|64.0|
4305219|NCT00503750|4132014|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4305220|NCT00503750|4132014|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4305221|NCT00503750|4132014|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4305222|NCT00503698|4132019|B3|||Weight||kg|Mean|80.6|80.6|Standard Deviation|24.6|24.6|||
4305223|NCT00503698|4132020|B2|||Weight||kg|Mean|80.6|80.6|Standard Deviation|25.0|25.0|||
4305224|NCT00503698|4132021|B1|||Weight||kg|Mean|80.6|80.6|Standard Deviation|24.3|24.3|||
4305225|NCT00503698|4132019|B3|||Height||cm|Mean|167.6|167.6|Standard Deviation|10.8|10.8|||
4305226|NCT00503698|4132020|B2|||Height||cm|Mean|168.1|168.1|Standard Deviation|10.4|10.4|||
4305227|NCT00503698|4132021|B1|||Height||cm|Mean|167.1|167.1|Standard Deviation|11.2|11.2|||
4305228|NCT00503698|4132019|B3|||Duration of Dialysis|Number of years in dialysis|years|Median|2.9|2.9|Full Range|||0.2|34.6|
4305229|NCT00503698|4132020|B2|||Duration of Dialysis|Number of years in dialysis|years|Median|2.9|2.9|Full Range|||0.3|34.6|
4305230|NCT00503698|4132021|B1|||Duration of Dialysis|Number of years in dialysis|years|Median|2.9|2.9|Full Range|||0.2|27.1|
4305231|NCT00503698|4132019|B3|||Duration of Diabetes|Number of years since diagnosis|years|Median|18.4|18.4|Full Range|||1.2|63.6|
4305232|NCT00503698|4132020|B2|||Duration of Diabetes|Number of years since diagnosis|years|Median|20.3|20.3|Full Range|||1.2|58.5|
4305233|NCT00503698|4132021|B1|||Duration of Diabetes|Number of years since diagnosis|years|Median|17.5|17.5|Full Range|||1.6|63.6|
4305234|NCT00503698|4132019|B3|||BMI|BMI = Body Mass Index|kg/m2|Mean|28.7|28.7|Standard Deviation|8.3|8.3|||
4305235|NCT00503698|4132020|B2|||BMI|BMI = Body Mass Index|kg/m2|Mean|28.4|28.4|Standard Deviation|8.0|8.0|||
4305236|NCT00503698|4132021|B1|||BMI|BMI = Body Mass Index|kg/m2|Mean|28.9|28.9|Standard Deviation|8.6|8.6|||
4305237|NCT00503698|4132019|B3|Not Diabetic||Diabetes||participants|Number|356|356.0||||||
4305238|NCT00503698|4132020|B2|Not Diabetic||Diabetes||participants|Number|183|183.0||||||
4305239|NCT00503698|4132021|B1|Not Diabetic||Diabetes||participants|Number|173|173.0||||||
4305240|NCT00503698|4132019|B3|Type 2 diabetes mellitus||Diabetes||participants|Number|311|311.0||||||
4305241|NCT00503698|4132020|B2|Type 2 diabetes mellitus||Diabetes||participants|Number|150|150.0||||||
4305242|NCT00503698|4132021|B1|Type 2 diabetes mellitus||Diabetes||participants|Number|161|161.0||||||
4305243|NCT00503698|4132019|B3|Type 1 diabetes mellitus||Diabetes||participants|Number|28|28.0||||||
4305244|NCT00503698|4132020|B2|Type 1 diabetes mellitus||Diabetes||participants|Number|16|16.0||||||
4305245|NCT00503698|4132021|B1|Type 1 diabetes mellitus||Diabetes||participants|Number|12|12.0||||||
4305246|NCT00503698|4132019|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4305247|NCT00503698|4132020|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305248|NCT00503698|4132021|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4305249|NCT00503698|4132019|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4305250|NCT00503698|4132020|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4305251|NCT00503698|4132021|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4305252|NCT00503698|4132019|B3||White|Race (NIH/OMB)||Participants|Count of Participants|418|418.0||||||
4305253|NCT00503698|4132020|B2||White|Race (NIH/OMB)||Participants|Count of Participants|213|213.0||||||
4305254|NCT00503698|4132021|B1||White|Race (NIH/OMB)||Participants|Count of Participants|205|205.0||||||
4305255|NCT00503698|4132019|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|227|227.0||||||
4305256|NCT00503698|4132020|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
4305257|NCT00503698|4132021|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|114|114.0||||||
4305258|NCT00503698|4132019|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4305259|NCT00503698|4132020|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4305260|NCT00503698|4132021|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305261|NCT00503698|4132019|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4305262|NCT00503698|4132020|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4305263|NCT00503698|4132021|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4305264|NCT00503698|4132019|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4305265|NCT00503698|4132020|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4305266|NCT00503698|4132021|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4305267|NCT00503698|4132019|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4305268|NCT00503698|4132020|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4305269|NCT00503698|4132021|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4305270|NCT00503698|4132019|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|565|565.0||||||
4305271|NCT00503698|4132020|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|279|279.0||||||
4305272|NCT00503698|4132021|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|286|286.0||||||
4305273|NCT00503698|4132019|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|121|121.0||||||
4305274|NCT00503698|4132020|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4305275|NCT00503698|4132021|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4305276|NCT00503698|4132019|B3||Male|Sex: Female, Male||Participants|Count of Participants|381|381.0||||||
4305277|NCT00503698|4132020|B2||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4305278|NCT00503698|4132021|B1||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4305279|NCT00503698|4132019|B3||Female|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
4305280|NCT00503698|4132020|B2||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4305281|NCT00503698|4132021|B1||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4305282|NCT00503698|4132019|B3|||Age||years|Mean|61.6|61.6|Standard Deviation|13.8|13.8|||
4305283|NCT00503698|4132020|B2|||Age||years|Mean|61.0|61.0|Standard Deviation|14.2|14.2|||
4305284|NCT00503698|4132021|B1|||Age||years|Mean|62.2|62.2|Standard Deviation|13.5|13.5|||
4305285|NCT00503685|4132036|B4|United States||Region of Enrollment||Participants|Count of Participants|64|64.0||||||
4305286|NCT00503685|4132037|B3|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4305287|NCT00503685|4132038|B2|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
4305288|NCT00503685|4132039|B1|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4305289|NCT00503685|4132036|B4||Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4305290|NCT00503685|4132037|B3||Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4305291|NCT00503685|4132038|B2||Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4305292|NCT00503685|4132039|B1||Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4305293|NCT00503685|4132036|B4||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4305294|NCT00503685|4132037|B3||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4305295|NCT00503685|4132038|B2||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4305296|NCT00503685|4132039|B1||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4305297|NCT00503685|4132036|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4305298|NCT00503685|4132037|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4305299|NCT00503685|4132038|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4305300|NCT00503685|4132039|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4305301|NCT00503685|4132036|B4||Black|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4305302|NCT00503685|4132037|B3||Black|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4305303|NCT00503685|4132038|B2||Black|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4305304|NCT00503685|4132039|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4305305|NCT00503685|4132036|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
4305306|NCT00503685|4132037|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4305307|NCT00503685|4132038|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4305308|NCT00503685|4132039|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4305309|NCT00503685|4132036|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305310|NCT00503685|4132037|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305311|NCT00503685|4132038|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305312|NCT00503685|4132039|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305313|NCT00503685|4132036|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4305314|NCT00503685|4132037|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4305315|NCT00503685|4132038|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4305316|NCT00503685|4132039|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4305317|NCT00503685|4132036|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4305318|NCT00503685|4132037|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4305319|NCT00503685|4132038|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4305320|NCT00503685|4132039|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4305321|NCT00503685|4132036|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4305322|NCT00503685|4132037|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4305323|NCT00503685|4132038|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4305324|NCT00503685|4132039|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4305325|NCT00503685|4132036|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4305326|NCT00503685|4132037|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4305327|NCT00503685|4132038|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4305328|NCT00503685|4132039|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4305329|NCT00503685|4132036|B4|||Age||years|Median|60.5|60.5|Full Range|9.84|9.84|40.0|84.0|
4305330|NCT00503685|4132037|B3|||Age||years|Median|61.7|61.7|Full Range|7.89|7.89|44.0|70.0|
4305331|NCT00503685|4132038|B2|||Age||years|Median|62.6|62.6|Full Range|12.40|12.4|40.0|84.0|
4305332|NCT00503685|4132039|B1|||Age||years|Median|59.3|59.3|Full Range|8.94|8.94|41.0|79.0|
4305333|NCT00503425|4132083|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4305334|NCT00503425|4132083|B1||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4305335|NCT00503425|4132083|B1|||Age||Years|Mean|56.6|56.6|Standard Deviation|13.1|13.1|||
4305336|NCT00503399|4132091|B3|Without fractures||Number of participants with fractures before study||participants|Number|56|56.0||||||
4305337|NCT00503399|4132092|B2|Without fractures||Number of participants with fractures before study||participants|Number|30|30.0||||||
4305338|NCT00503399|4132093|B1|Without fractures||Number of participants with fractures before study||participants|Number|26|26.0||||||
4305339|NCT00503399|4132091|B3|With fractures||Number of participants with fractures before study||participants|Number|36|36.0||||||
4305340|NCT00503399|4132092|B2|With fractures||Number of participants with fractures before study||participants|Number|17|17.0||||||
4305341|NCT00503399|4132093|B1|With fractures||Number of participants with fractures before study||participants|Number|19|19.0||||||
4305342|NCT00503399|4132091|B3|Spain||Region of Enrollment||participants|Number|27|27.0||||||
4305343|NCT00503399|4132092|B2|Spain||Region of Enrollment||participants|Number|12|12.0||||||
4305344|NCT00503399|4132093|B1|Spain||Region of Enrollment||participants|Number|15|15.0||||||
4305345|NCT00503399|4132091|B3|Italy||Region of Enrollment||participants|Number|13|13.0||||||
4305346|NCT00503399|4132092|B2|Italy||Region of Enrollment||participants|Number|8|8.0||||||
4305347|NCT00503399|4132093|B1|Italy||Region of Enrollment||participants|Number|5|5.0||||||
4305348|NCT00503399|4132091|B3|Greece||Region of Enrollment||participants|Number|12|12.0||||||
4305349|NCT00503399|4132092|B2|Greece||Region of Enrollment||participants|Number|6|6.0||||||
4305350|NCT00503399|4132093|B1|Greece||Region of Enrollment||participants|Number|6|6.0||||||
4305351|NCT00503399|4132091|B3|Germany||Region of Enrollment||participants|Number|40|40.0||||||
4305352|NCT00503399|4132092|B2|Germany||Region of Enrollment||participants|Number|21|21.0||||||
4305353|NCT00503399|4132093|B1|Germany||Region of Enrollment||participants|Number|19|19.0||||||
4305354|NCT00503399|4132091|B3|East Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4305355|NCT00503399|4132092|B2|East Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4305356|NCT00503399|4132093|B1|East Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4305357|NCT00503399|4132091|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4305358|NCT00503399|4132092|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4305359|NCT00503399|4132093|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4305360|NCT00503399|4132091|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|90|90.0||||||
4305361|NCT00503399|4132092|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4305362|NCT00503399|4132093|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4305363|NCT00503399|4132091|B3||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4305364|NCT00503399|4132092|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4305365|NCT00503399|4132093|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4305366|NCT00503399|4132091|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4305367|NCT00503399|4132092|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4305368|NCT00503399|4132093|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4305369|NCT00503399|4132091|B3|||Age||years|Mean|56.3|56.3|Standard Deviation|14.24|14.24|||
4305370|NCT00503399|4132092|B2|||Age||years|Mean|55.1|55.1|Standard Deviation|15.54|15.54|||
4305371|NCT00503399|4132093|B1|||Age||years|Mean|57.5|57.5|Standard Deviation|12.80|12.8|||
4305372|NCT00503308|4132116|B3|United States||Region of Enrollment||participants|Number|281|281.0||||||
4305373|NCT00503308|4132117|B2|United States||Region of Enrollment||participants|Number|135|135.0||||||
4305374|NCT00503308|4132118|B1|United States||Region of Enrollment||participants|Number|146|146.0||||||
4305375|NCT00503308|4132116|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4305376|NCT00503308|4132117|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4305377|NCT00503308|4132118|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4305378|NCT00503308|4132116|B3||Female|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
4305379|NCT00503308|4132117|B2||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4305380|NCT00503308|4132118|B1||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4305381|NCT00503308|4132116|B3|||Age||years|Mean|26.7|26.7|Standard Deviation|5.73|5.73|||
4305382|NCT00503308|4132117|B2|||Age||years|Mean|26.39|26.39|Standard Deviation|5.3|5.3|||
4305383|NCT00503308|4132118|B1|||Age||years|Mean|26.99|26.99|Standard Deviation|6.1|6.1|||
4305384|NCT00503308|4132116|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4305385|NCT00503308|4132117|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4305386|NCT00503308|4132118|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4305387|NCT00503308|4132116|B3||Between 18 and 65 years|Age||Participants|Count of Participants|268|268.0||||||
4305388|NCT00503308|4132117|B2||Between 18 and 65 years|Age||Participants|Count of Participants|130|130.0||||||
4305389|NCT00503308|4132118|B1||Between 18 and 65 years|Age||Participants|Count of Participants|138|138.0||||||
4305390|NCT00503308|4132116|B3||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4305391|NCT00503308|4132117|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4305392|NCT00503308|4132118|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4305393|NCT00503139|4132125|B1||Male|Gender||Participants|Count of Participants|117|117.0||||||
4305394|NCT00503139|4132125|B1||Female|Gender||Participants|Count of Participants|559|559.0||||||
4305395|NCT00503139|4132125|B1|>=65 years||Age, Customized||Participants|Number|222|222.0||||||
4305396|NCT00503139|4132125|B1|<65 years||Age, Customized||Participants|Number|454|454.0||||||
4305397|NCT00503113|4132136|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4305398|NCT00503113|4132137|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4305399|NCT00503113|4132138|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4305400|NCT00503113|4132139|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4305401|NCT00503113|4132136|B4||Female|Sex: Female, Male||Participants|Count of Participants|793|793.0||||||
4305402|NCT00503113|4132137|B3||Female|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
4305403|NCT00503113|4132138|B2||Female|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
4305404|NCT00503113|4132139|B1||Female|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
4305405|NCT00503113|4132136|B4|||Age||years|Mean|71.6|71.6|Standard Deviation|6.32|6.32|||
4305406|NCT00503113|4132137|B3|||Age||years|Mean|71.7|71.7|Standard Deviation|6.3|6.3|||
4305407|NCT00503113|4132138|B2|||Age||years|Mean|71.5|71.5|Standard Deviation|5.89|5.89|||
4305408|NCT00503113|4132139|B1|||Age||years|Mean|71.7|71.7|Standard Deviation|6.77|6.77|||
4305409|NCT00503009|4132170|B4|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4305410|NCT00503009|4132171|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4305411|NCT00503009|4132172|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4305412|NCT00503009|4132173|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4305413|NCT00503009|4132170|B4|American Indian/Alaskan Native/Native Hawaiian/Pac||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4305414|NCT00503009|4132171|B3|American Indian/Alaskan Native/Native Hawaiian/Pac||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4305415|NCT00503009|4132172|B2|American Indian/Alaskan Native/Native Hawaiian/Pac||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4305416|NCT00503009|4132173|B1|American Indian/Alaskan Native/Native Hawaiian/Pac||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4305417|NCT00503009|4132170|B4|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4305418|NCT00503009|4132171|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4305419|NCT00503009|4132172|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4305420|NCT00503009|4132173|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4305421|NCT00503009|4132170|B4|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4305422|NCT00503009|4132171|B3|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4305423|NCT00503009|4132172|B2|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4305424|NCT00503009|4132173|B1|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4305425|NCT00503009|4132170|B4||Male|Gender||Participants|Count of Participants|11|11.0||||||
4305426|NCT00503009|4132171|B3||Male|Gender||Participants|Count of Participants|3|3.0||||||
4305427|NCT00503009|4132172|B2||Male|Gender||Participants|Count of Participants|3|3.0||||||
4305428|NCT00503009|4132173|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
4305429|NCT00503009|4132170|B4||Female|Gender||Participants|Count of Participants|5|5.0||||||
4305430|NCT00503009|4132171|B3||Female|Gender||Participants|Count of Participants|3|3.0||||||
4305431|NCT00503009|4132172|B2||Female|Gender||Participants|Count of Participants|2|2.0||||||
4305432|NCT00503009|4132173|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
4305433|NCT00503009|4132170|B4|||Age||years|Mean|21.25|21.25|Standard Deviation|3.8|3.8|||
4305434|NCT00503009|4132171|B3|||Age||years|Mean|23.0|23.0|Standard Deviation|5.83|5.83|||
4305435|NCT00503009|4132172|B2|||Age||years|Mean|20.0|20.0|Standard Deviation|1.00|1.0|||
4305436|NCT00503009|4132173|B1|||Age||years|Mean|20.4|20.4|Standard Deviation|2.07|2.07|||
4305437|NCT00502996|4132192|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4305438|NCT00502996|4132192|B1||Female|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4305439|NCT00502996|4132192|B1|||Age||years|Mean|48.6|48.6|Standard Deviation|12.2|12.2|||
4305440|NCT00502944|4132216|B3|Missing||Education||participants|Number|41|41.0||||||
4305441|NCT00502944|4132217|B2|Missing||Education||participants|Number|26|26.0||||||
4305442|NCT00502944|4132218|B1|Missing||Education||participants|Number|15|15.0||||||
4305443|NCT00502944|4132216|B3|Some Post-College/Graduate Degree||Education||participants|Number|689|689.0||||||
4305444|NCT00502944|4132217|B2|Some Post-College/Graduate Degree||Education||participants|Number|347|347.0||||||
4305445|NCT00502944|4132218|B1|Some Post-College/Graduate Degree||Education||participants|Number|342|342.0||||||
4305446|NCT00502944|4132216|B3|College Degree||Education||participants|Number|955|955.0||||||
4305447|NCT00502944|4132217|B2|College Degree||Education||participants|Number|438|438.0||||||
4305448|NCT00502944|4132218|B1|College Degree||Education||participants|Number|517|517.0||||||
4305449|NCT00502944|4132216|B3|Some College||Education||participants|Number|1409|1409.0||||||
4305450|NCT00502944|4132217|B2|Some College||Education||participants|Number|713|713.0||||||
4305451|NCT00502944|4132218|B1|Some College||Education||participants|Number|696|696.0||||||
4305452|NCT00502944|4132216|B3|High School Degree||Education||participants|Number|1141|1141.0||||||
4305453|NCT00502944|4132217|B2|High School Degree||Education||participants|Number|575|575.0||||||
4305454|NCT00502944|4132218|B1|High School Degree||Education||participants|Number|566|566.0||||||
4305455|NCT00502944|4132216|B3|Less than High School||Education||participants|Number|620|620.0||||||
4305456|NCT00502944|4132217|B2|Less than High School||Education||participants|Number|310|310.0||||||
4305457|NCT00502944|4132218|B1|Less than High School||Education||participants|Number|310|310.0||||||
4305458|NCT00502944|4132216|B3|Missing||Primary Language||participants|Number|38|38.0||||||
4305459|NCT00502944|4132217|B2|Missing||Primary Language||participants|Number|17|17.0||||||
4305460|NCT00502944|4132218|B1|Missing||Primary Language||participants|Number|21|21.0||||||
4305461|NCT00502944|4132216|B3|Other||Primary Language||participants|Number|291|291.0||||||
4305462|NCT00502944|4132217|B2|Other||Primary Language||participants|Number|137|137.0||||||
4305463|NCT00502944|4132218|B1|Other||Primary Language||participants|Number|154|154.0||||||
4305464|NCT00502944|4132216|B3|Spanish||Primary Language||participants|Number|931|931.0||||||
4305465|NCT00502944|4132217|B2|Spanish||Primary Language||participants|Number|448|448.0||||||
4305466|NCT00502944|4132218|B1|Spanish||Primary Language||participants|Number|483|483.0||||||
4305467|NCT00502944|4132216|B3|English||Primary Language||participants|Number|3595|3595.0||||||
4305468|NCT00502944|4132217|B2|English||Primary Language||participants|Number|1807|1807.0||||||
4305469|NCT00502944|4132218|B1|English||Primary Language||participants|Number|1788|1788.0||||||
4305470|NCT00502944|4132216|B3|Missing||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
4305471|NCT00502944|4132217|B2|Missing||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4305472|NCT00502944|4132218|B1|Missing||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4305473|NCT00502944|4132216|B3|Multi-racial/Other||Race/Ethnicity, Customized||participants|Number|340|340.0||||||
4305474|NCT00502944|4132217|B2|Multi-racial/Other||Race/Ethnicity, Customized||participants|Number|164|164.0||||||
4305475|NCT00502944|4132218|B1|Multi-racial/Other||Race/Ethnicity, Customized||participants|Number|176|176.0||||||
4305476|NCT00502944|4132216|B3|Native American/Alaskan Native||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4305477|NCT00502944|4132217|B2|Native American/Alaskan Native||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4305478|NCT00502944|4132218|B1|Native American/Alaskan Native||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4305479|NCT00502944|4132216|B3|Asian/Asian-American||Race/Ethnicity, Customized||participants|Number|125|125.0||||||
4305480|NCT00502944|4132217|B2|Asian/Asian-American||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
4305481|NCT00502944|4132218|B1|Asian/Asian-American||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
4305482|NCT00502944|4132216|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1377|1377.0||||||
4305483|NCT00502944|4132217|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|670|670.0||||||
4305484|NCT00502944|4132218|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|707|707.0||||||
4305485|NCT00502944|4132216|B3|Non-Hispanic Black||Race/Ethnicity, Customized||participants|Number|1072|1072.0||||||
4305486|NCT00502944|4132217|B2|Non-Hispanic Black||Race/Ethnicity, Customized||participants|Number|546|546.0||||||
4305487|NCT00502944|4132218|B1|Non-Hispanic Black||Race/Ethnicity, Customized||participants|Number|526|526.0||||||
4305488|NCT00502944|4132216|B3|Non-Hispanic White||Race/Ethnicity, Customized||participants|Number|1866|1866.0||||||
4305489|NCT00502944|4132217|B2|Non-Hispanic White||Race/Ethnicity, Customized||participants|Number|928|928.0||||||
4305490|NCT00502944|4132218|B1|Non-Hispanic White||Race/Ethnicity, Customized||participants|Number|938|938.0||||||
4305491|NCT00502944|4132216|B3|Male||Gender|Numbers within the gender category do not add up to total number randomized due to missing data/numbers.|participants|Number|1681|1681.0||||||
4305492|NCT00502944|4132217|B2|Male||Gender|Numbers within the gender category do not add up to total number randomized due to missing data/numbers.|participants|Number|832|832.0||||||
4305493|NCT00502944|4132218|B1|Male||Gender|Numbers within the gender category do not add up to total number randomized due to missing data/numbers.|participants|Number|849|849.0||||||
4305494|NCT00502944|4132216|B3|Female||Gender|Numbers within the gender category do not add up to total number randomized due to missing data/numbers.|participants|Number|3139|3139.0||||||
4305495|NCT00502944|4132217|B2|Female||Gender|Numbers within the gender category do not add up to total number randomized due to missing data/numbers.|participants|Number|1554|1554.0||||||
4305496|NCT00502944|4132218|B1|Female||Gender|Numbers within the gender category do not add up to total number randomized due to missing data/numbers.|participants|Number|1585|1585.0||||||
4305497|NCT00502944|4132216|B3|||Age||years|Mean|37.1|37.1|Standard Deviation|14|14.0|||
4305498|NCT00502944|4132217|B2|||Age||years|Mean|37.1|37.1|Standard Deviation|14|14.0|||
4305499|NCT00502944|4132218|B1|||Age||years|Mean|37.1|37.1|Standard Deviation|14|14.0|||
4305500|NCT00502905|4132231|B1|United States||Region of Enrollment||participants|Number|196|196.0||||||
4305501|NCT00502905|4132231|B1||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4305502|NCT00502905|4132231|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4305503|NCT00502905|4132231|B1|||Age||years|Mean|43|43.0|Standard Deviation|13|13.0|||
4305504|NCT00502853|4132235|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4305505|NCT00502853|4132235|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4305506|NCT00502853|4132235|B1|||Age||years|Mean|52.42|52.42|Standard Deviation|15.681|15.681|||
4305507|NCT00502840|4132260|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4305508|NCT00502840|4132260|B1||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4305509|NCT00502840|4132260|B1|||Age||years|Mean|55.5|55.5|Full Range|||26.0|78.0|
4305510|NCT00502801|4132288|B1|||BMI||kg/m^2|Mean|27.4|27.4|Standard Deviation|8.63|8.63|||
4305511|NCT00502801|4132288|B1|OTHER||ethnicity||participants|Number|5|5.0||||||
4305512|NCT00502801|4132288|B1|NOT HISPANIC OR LATINO||ethnicity||participants|Number|158|158.0||||||
4305513|NCT00502801|4132288|B1|HISPANIC OR LATINO||ethnicity||participants|Number|20|20.0||||||
4305514|NCT00502801|4132288|B1|WHITE||race||participants|Number|151|151.0||||||
4305515|NCT00502801|4132288|B1|OTHER, SPECIFY||race||participants|Number|2|2.0||||||
4305516|NCT00502801|4132288|B1|BLACK OR AFRICAN AMERICAN||race||participants|Number|14|14.0||||||
4305517|NCT00502801|4132288|B1|ASIAN||race||participants|Number|14|14.0||||||
4305518|NCT00502801|4132288|B1|AMERICAN INDIAN OR ALASKA||race||participants|Number|2|2.0||||||
4305519|NCT00502801|4132288|B1|USA||Region of Enrollment||participants|Number|120|120.0||||||
4305520|NCT00502801|4132288|B1|UKRAINE||Region of Enrollment||participants|Number|5|5.0||||||
4305521|NCT00502801|4132288|B1|RUSSIA||Region of Enrollment||participants|Number|2|2.0||||||
4305522|NCT00502801|4132288|B1|INDIA||Region of Enrollment||participants|Number|10|10.0||||||
4305523|NCT00502801|4132288|B1|FRANCE||Region of Enrollment||participants|Number|6|6.0||||||
4305524|NCT00502801|4132288|B1|CROATIA||Region of Enrollment||participants|Number|21|21.0||||||
4305525|NCT00502801|4132288|B1|CHILE||Region of Enrollment||participants|Number|9|9.0||||||
4305526|NCT00502801|4132288|B1|CANADA||Region of Enrollment||participants|Number|6|6.0||||||
4305527|NCT00502801|4132288|B1|ARGENTINA||Region of Enrollment||participants|Number|4|4.0||||||
4305528|NCT00502801|4132288|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4305529|NCT00502801|4132288|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4305530|NCT00502801|4132288|B1|||Age||years|Mean|56|56.0|Standard Deviation|20.23|20.23|||
4305531|NCT00502775|4132293|B4|Other||Race/Ethnicity, Customized||Number of Participants|Number|18|18.0||||||
4305532|NCT00502775|4132294|B3|Other||Race/Ethnicity, Customized||Number of Participants|Number|4|4.0||||||
4305533|NCT00502775|4132295|B2|Other||Race/Ethnicity, Customized||Number of Participants|Number|6|6.0||||||
4305534|NCT00502775|4132296|B1|Other||Race/Ethnicity, Customized||Number of Participants|Number|8|8.0||||||
4305535|NCT00502775|4132293|B4|African American||Race/Ethnicity, Customized||Number of Participants|Number|111|111.0||||||
4305536|NCT00502775|4132294|B3|African American||Race/Ethnicity, Customized||Number of Participants|Number|42|42.0||||||
4305537|NCT00502775|4132295|B2|African American||Race/Ethnicity, Customized||Number of Participants|Number|29|29.0||||||
4305538|NCT00502775|4132296|B1|African American||Race/Ethnicity, Customized||Number of Participants|Number|40|40.0||||||
4305539|NCT00502775|4132293|B4|White||Race/Ethnicity, Customized||Number of Participants|Number|551|551.0||||||
4305540|NCT00502775|4132294|B3|White||Race/Ethnicity, Customized||Number of Participants|Number|181|181.0||||||
4305541|NCT00502775|4132295|B2|White||Race/Ethnicity, Customized||Number of Participants|Number|189|189.0||||||
4305542|NCT00502775|4132296|B1|White||Race/Ethnicity, Customized||Number of Participants|Number|181|181.0||||||
4305543|NCT00502775|4132293|B4||Male|Gender||Participants|Count of Participants|254|254.0||||||
4305544|NCT00502775|4132294|B3||Male|Gender||Participants|Count of Participants|92|92.0||||||
4305545|NCT00502775|4132295|B2||Male|Gender||Participants|Count of Participants|72|72.0||||||
4305546|NCT00502775|4132296|B1||Male|Gender||Participants|Count of Participants|90|90.0||||||
4305547|NCT00502775|4132293|B4||Female|Gender||Participants|Count of Participants|426|426.0||||||
4305548|NCT00502775|4132294|B3||Female|Gender||Participants|Count of Participants|135|135.0||||||
4305549|NCT00502775|4132295|B2||Female|Gender||Participants|Count of Participants|152|152.0||||||
4305550|NCT00502775|4132296|B1||Female|Gender||Participants|Count of Participants|139|139.0||||||
4305551|NCT00502775|4132293|B4|||Age||Years|Mean|34.4|34.4|Standard Deviation|13.29|13.29|||
4305552|NCT00502775|4132294|B3|||Age||Years|Mean|34.3|34.3|Standard Deviation|13.66|13.66|||
4305553|NCT00502775|4132295|B2|||Age||Years|Mean|34.0|34.0|Standard Deviation|13.55|13.55|||
4305554|NCT00502775|4132296|B1|||Age||Years|Mean|34.8|34.8|Standard Deviation|12.71|12.71|||
4305555|NCT00502697|4132339|B3|||Gestational age at enrollment in weeks||weeks|Mean|15.43|15.43|Standard Deviation|4.57|4.57|||
4305556|NCT00502697|4132340|B2|||Gestational age at enrollment in weeks||weeks|Mean|15.29|15.29|Standard Deviation|4.57|4.57|||
4305557|NCT00502697|4132341|B1|||Gestational age at enrollment in weeks||weeks|Mean|15.43|15.43|Standard Deviation|4.57|4.57|||
4305558|NCT00502697|4132339|B3|||Level of education in years||years|Mean|13.3|13.3|Standard Deviation|2.6|2.6|||
4305559|NCT00502697|4132340|B2|||Level of education in years||years|Mean|13.4|13.4|Standard Deviation|2.6|2.6|||
4305560|NCT00502697|4132341|B1|||Level of education in years||years|Mean|13.2|13.2|Standard Deviation|2.5|2.5|||
4305561|NCT00502697|4132339|B3|Unknown or not reported||Type of insurance||participants|Number|2|2.0||||||
4305562|NCT00502697|4132340|B2|Unknown or not reported||Type of insurance||participants|Number|1|1.0||||||
4305563|NCT00502697|4132341|B1|Unknown or not reported||Type of insurance||participants|Number|1|1.0||||||
4305564|NCT00502697|4132339|B3|None/self pay||Type of insurance||participants|Number|3|3.0||||||
4305565|NCT00502697|4132340|B2|None/self pay||Type of insurance||participants|Number|3|3.0||||||
4305566|NCT00502697|4132341|B1|None/self pay||Type of insurance||participants|Number|0|0.0||||||
4305567|NCT00502697|4132339|B3|Private/Champus||Type of insurance||participants|Number|80|80.0||||||
4305568|NCT00502697|4132340|B2|Private/Champus||Type of insurance||participants|Number|36|36.0||||||
4305569|NCT00502697|4132341|B1|Private/Champus||Type of insurance||participants|Number|44|44.0||||||
4305570|NCT00502697|4132339|B3|Medicaid||Type of insurance||participants|Number|126|126.0||||||
4305571|NCT00502697|4132340|B2|Medicaid||Type of insurance||participants|Number|62|62.0||||||
4305572|NCT00502697|4132341|B1|Medicaid||Type of insurance||participants|Number|64|64.0||||||
4305573|NCT00502697|4132339|B3|Never Married||Marital Status||participants|Number|46|46.0||||||
4305574|NCT00502697|4132340|B2|Never Married||Marital Status||participants|Number|19|19.0||||||
4305575|NCT00502697|4132341|B1|Never Married||Marital Status||participants|Number|27|27.0||||||
4305576|NCT00502697|4132339|B3|Divorced or Separated||Marital Status||participants|Number|12|12.0||||||
4305577|NCT00502697|4132340|B2|Divorced or Separated||Marital Status||participants|Number|8|8.0||||||
4305578|NCT00502697|4132341|B1|Divorced or Separated||Marital Status||participants|Number|4|4.0||||||
4305579|NCT00502697|4132339|B3|Married or Partnered||Marital Status||participants|Number|153|153.0||||||
4305580|NCT00502697|4132340|B2|Married or Partnered||Marital Status||participants|Number|75|75.0||||||
4305581|NCT00502697|4132341|B1|Married or Partnered||Marital Status||participants|Number|78|78.0||||||
4305582|NCT00502697|4132339|B3|United States||Region of Enrollment||participants|Number|211|211.0||||||
4305583|NCT00502697|4132340|B2|United States||Region of Enrollment||participants|Number|102|102.0||||||
4305584|NCT00502697|4132341|B1|United States||Region of Enrollment||participants|Number|109|109.0||||||
4305585|NCT00502697|4132339|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4305586|NCT00502697|4132340|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4305587|NCT00502697|4132341|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4305588|NCT00502697|4132339|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305589|NCT00502697|4132340|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305590|NCT00502697|4132341|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305591|NCT00502697|4132339|B3||White|Race (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
4305592|NCT00502697|4132340|B2||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4305593|NCT00502697|4132341|B1||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4305594|NCT00502697|4132339|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4305595|NCT00502697|4132340|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4305596|NCT00502697|4132341|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4305597|NCT00502697|4132339|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305598|NCT00502697|4132340|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305599|NCT00502697|4132341|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305600|NCT00502697|4132339|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305601|NCT00502697|4132340|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305602|NCT00502697|4132341|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305603|NCT00502697|4132339|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305604|NCT00502697|4132340|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305667|NCT00502320|4132893|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4305605|NCT00502697|4132341|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305606|NCT00502697|4132339|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4305607|NCT00502697|4132340|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4305608|NCT00502697|4132341|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4305609|NCT00502697|4132339|B3||Female|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4305610|NCT00502697|4132340|B2||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4305611|NCT00502697|4132341|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4305612|NCT00502697|4132339|B3|||Age||years|Mean|27.6|27.6|Standard Deviation|5.3|5.3|||
4305613|NCT00502697|4132340|B2|||Age||years|Mean|27.8|27.8|Standard Deviation|5.2|5.2|||
4305614|NCT00502697|4132341|B1|||Age||years|Mean|27.4|27.4|Standard Deviation|5.5|5.5|||
4305615|NCT00502697|4132339|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4305616|NCT00502697|4132340|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4305617|NCT00502697|4132341|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4305618|NCT00502697|4132339|B3||Between 18 and 65 years|Age||Participants|Count of Participants|211|211.0||||||
4305619|NCT00502697|4132340|B2||Between 18 and 65 years|Age||Participants|Count of Participants|102|102.0||||||
4305620|NCT00502697|4132341|B1||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
4305621|NCT00502697|4132339|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4305622|NCT00502697|4132340|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4305623|NCT00502697|4132341|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4305624|NCT00502671|4132350|B1||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4305625|NCT00502671|4132350|B1||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4305626|NCT00502671|4132350|B1|||Age||years|Mean|58|58.0|Standard Deviation|9|9.0|||
4305627|NCT00502593|4132355|B13||Male|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4305628|NCT00502593|4132356|B12||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4305629|NCT00502593|4132357|B11||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4305630|NCT00502593|4132358|B10||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4305631|NCT00502593|4132359|B9||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4305632|NCT00502593|4132360|B8||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4305633|NCT00502593|4132361|B7||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4305634|NCT00502593|4132362|B6||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4305635|NCT00502593|4132363|B5||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4305636|NCT00502593|4132364|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4305637|NCT00502593|4132365|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4305638|NCT00502593|4132366|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4305639|NCT00502593|4132367|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4305640|NCT00502593|4132355|B13||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4305641|NCT00502593|4132356|B12||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4305642|NCT00502593|4132357|B11||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4305643|NCT00502593|4132358|B10||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4305644|NCT00502593|4132359|B9||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4305645|NCT00502593|4132360|B8||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4305646|NCT00502593|4132361|B7||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4305647|NCT00502593|4132362|B6||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4305648|NCT00502593|4132363|B5||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4305649|NCT00502593|4132364|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4305650|NCT00502593|4132365|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4305651|NCT00502593|4132366|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4305652|NCT00502593|4132367|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4305653|NCT00502593|4132355|B13|||Age||Years|Mean|6.1|6.1|Standard Deviation|0.92|0.92|||
4305654|NCT00502593|4132356|B12|||Age||Years|Mean|7.4|7.4|Standard Deviation|0.98|0.98|||
4305655|NCT00502593|4132357|B11|||Age||Years|Mean|7.0|7.0|Standard Deviation|1.06|1.06|||
4305656|NCT00502593|4132358|B10|||Age||Years|Mean|3.9|3.9|Standard Deviation|0.93|0.93|||
4305657|NCT00502593|4132359|B9|||Age||Years|Mean|4.2|4.2|Standard Deviation|0.85|0.85|||
4305658|NCT00502593|4132360|B8|||Age||Years|Mean|7.2|7.2|Standard Deviation|1.20|1.2|||
4305659|NCT00502593|4132361|B7|||Age||Years|Mean|7.3|7.3|Standard Deviation|1.28|1.28|||
4305660|NCT00502593|4132362|B6|||Age||Years|Mean|4.4|4.4|Standard Deviation|0.79|0.79|||
4305661|NCT00502593|4132363|B5|||Age||Years|Mean|4.2|4.2|Standard Deviation|0.85|0.85|||
4305662|NCT00502593|4132364|B4|||Age||Years|Mean|7.6|7.6|Standard Deviation|1.38|1.38|||
4305663|NCT00502593|4132365|B3|||Age||Years|Mean|7.6|7.6|Standard Deviation|1.06|1.06|||
4305664|NCT00502593|4132366|B2|||Age||Years|Mean|3.6|3.6|Standard Deviation|0.70|0.7|||
4305665|NCT00502593|4132367|B1|||Age||Years|Mean|3.9|3.9|Standard Deviation|0.84|0.84|||
4305666|NCT00502320|4132892|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4305668|NCT00502320|4132894|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4305669|NCT00502320|4132892|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4305670|NCT00502320|4132893|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4305671|NCT00502320|4132894|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4305672|NCT00502320|4132892|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4305673|NCT00502320|4132893|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4305674|NCT00502320|4132894|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4305675|NCT00502320|4132892|B3|||Age||years|Mean|46.08|46.08|Standard Deviation|11.04|11.04|||
4305676|NCT00502320|4132893|B2|||Age||years|Mean|47.76|47.76|Standard Deviation|10.23|10.23|||
4305677|NCT00502320|4132894|B1|||Age||years|Mean|45.49|45.49|Standard Deviation|11.81|11.81|||
4305678|NCT00502320|4132892|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4305679|NCT00502320|4132893|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4305680|NCT00502320|4132894|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4305681|NCT00502320|4132892|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4305682|NCT00502320|4132893|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4305683|NCT00502320|4132894|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4305684|NCT00502320|4132892|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4305685|NCT00502320|4132893|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4305686|NCT00502320|4132894|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4305687|NCT00502242|4132905|B3||Male|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4305688|NCT00502242|4132906|B2||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4305689|NCT00502242|4132907|B1||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4305690|NCT00502242|4132905|B3||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4305691|NCT00502242|4132906|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4305692|NCT00502242|4132907|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4305693|NCT00502242|4132905|B3|||Age||Years|Mean|47.1|47.1|Standard Deviation|12.8|12.8|||
4305694|NCT00502242|4132906|B2|||Age||Years|Mean|47.5|47.5|Standard Deviation|12.9|12.9|||
4305695|NCT00502242|4132907|B1|||Age||Years|Mean|46.8|46.8|Standard Deviation|12.7|12.7|||
4305696|NCT00502216|4132959|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4305697|NCT00502216|4132960|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4305698|NCT00502216|4132961|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4305699|NCT00502216|4132959|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4305700|NCT00502216|4132960|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4305701|NCT00502216|4132961|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4305702|NCT00502216|4132959|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4305703|NCT00502216|4132960|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4305704|NCT00502216|4132961|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4305705|NCT00502216|4132959|B3|||Age||years|Mean|46.55|46.55|Standard Deviation|11.00|11.0|||
4305706|NCT00502216|4132960|B2|||Age||years|Mean|42.42|42.42|Standard Deviation|9.57|9.57|||
4305707|NCT00502216|4132961|B1|||Age||years|Mean|50.29|50.29|Standard Deviation|11.08|11.08|||
4305708|NCT00502203|4132972|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4305709|NCT00502203|4132972|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4305710|NCT00502203|4132972|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4305711|NCT00502203|4132972|B1|||Age||years|Median|66|66.0|Full Range|||52.0|81.0|
4305712|NCT00501995|4132976|B1|||Number of Participants with diagnosis of scleroderma||participants|Number|6|6.0||||||
4305713|NCT00501995|4132976|B1|United States||Region of Enrollment|Number of participants|participants|Number|6|6.0||||||
4305714|NCT00501995|4132976|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4305715|NCT00501995|4132976|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4305716|NCT00501995|4132976|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4305717|NCT00501995|4132976|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4305718|NCT00501995|4132976|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4305719|NCT00501995|4132976|B1|||Age||years|Mean|39|39.0|Full Range|||19.0|60.0|
4305720|NCT00501969|4132981|B1|Sweden||Region of Enrollment||participants|Number|9|9.0||||||
4305721|NCT00501969|4132981|B1|New Zealand||Region of Enrollment||participants|Number|16|16.0||||||
4305722|NCT00501969|4132981|B1|Norway||Region of Enrollment||participants|Number|8|8.0||||||
4305723|NCT00501969|4132981|B1|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4305724|NCT00501969|4132981|B1|South Africa||Region of Enrollment||participants|Number|52|52.0||||||
4305725|NCT00501969|4132981|B1|Australia||Region of Enrollment||participants|Number|30|30.0||||||
4305726|NCT00501969|4132981|B1|Croatia||Region of Enrollment||participants|Number|27|27.0||||||
4305727|NCT00501969|4132981|B1|Poland||Region of Enrollment||participants|Number|65|65.0||||||
4305728|NCT00501969|4132981|B1|Hungary||Region of Enrollment||participants|Number|11|11.0||||||
4305729|NCT00501969|4132981|B1|Czech Republic||Region of Enrollment||participants|Number|50|50.0||||||
4305730|NCT00501969|4132981|B1|France||Region of Enrollment||participants|Number|9|9.0||||||
4305731|NCT00501969|4132981|B1|Italy||Region of Enrollment||participants|Number|33|33.0||||||
4305732|NCT00501969|4132981|B1|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
4305733|NCT00501969|4132981|B1|Israel||Region of Enrollment||participants|Number|22|22.0||||||
4305734|NCT00501969|4132981|B1|Austria||Region of Enrollment||participants|Number|6|6.0||||||
4305735|NCT00501969|4132981|B1|Spain||Region of Enrollment||participants|Number|35|35.0||||||
4305736|NCT00501969|4132981|B1|Finland||Region of Enrollment||participants|Number|8|8.0||||||
4305737|NCT00501969|4132981|B1||Male|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4305738|NCT00501969|4132981|B1||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4305739|NCT00501969|4132981|B1|||Age||years|Mean|64.4|64.4|Standard Deviation|9.2|9.2|||
4305740|NCT00501969|4132981|B1||>=65 years|Age||Participants|Count of Participants|212|212.0||||||
4305741|NCT00501969|4132981|B1||Between 18 and 65 years|Age||Participants|Count of Participants|183|183.0||||||
4305742|NCT00501969|4132981|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4305743|NCT00501943|4132987|B3|United States||Region of Enrollment||participants|Number|43|43.0||||||
4305744|NCT00501943|4132988|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4305745|NCT00501943|4132989|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4305746|NCT00501943|4132987|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4305747|NCT00501943|4132988|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4305748|NCT00501943|4132989|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4305749|NCT00501943|4132987|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4305750|NCT00501943|4132988|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4305751|NCT00501943|4132989|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4305752|NCT00501943|4132987|B3|||Age||years|Mean|36|36.0|Standard Deviation|9.32|9.32|||
4305753|NCT00501943|4132988|B2|||Age||years|Mean|32.4|32.4|Standard Deviation|7.85|7.85|||
4305754|NCT00501943|4132989|B1|||Age||years|Mean|38.2|38.2|Standard Deviation|9.84|9.84|||
4305755|NCT00501891|4133006|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4305756|NCT00501891|4133006|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4305757|NCT00501891|4133006|B1|||Age||years|Mean|54.4|54.4|Standard Deviation|12.8|12.8|||
4305758|NCT00501852|4133013|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305759|NCT00501852|4133013|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305760|NCT00501852|4133013|B1||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4305761|NCT00501852|4133013|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305762|NCT00501852|4133013|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305763|NCT00501852|4133013|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4305764|NCT00501852|4133013|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305765|NCT00501852|4133013|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4305766|NCT00501852|4133013|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4305767|NCT00501852|4133013|B1|>= 65 years||Age, Customized||participants|Number|44|44.0||||||
4305768|NCT00501852|4133013|B1|40-64 years||Age, Customized||participants|Number|39|39.0||||||
4305769|NCT00501852|4133013|B1|||Age||years|Mean|64.4|64.4|Standard Deviation|9.05|9.05|||
4305770|NCT00501644|4133033|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
4305771|NCT00501644|4133033|B1|Male||Sex/Gender, Customized||participants|Number|0|0.0||||||
4305772|NCT00501644|4133033|B1|Female||Sex/Gender, Customized||participants|Number|59|59.0||||||
4305773|NCT00501644|4133033|B1|||Age||years|Median|61|61.0|Full Range|||35.0|79.0|
4305774|NCT00501631|4133037|B3|Austria||Region of Enrollment||participants|Number|20|20.0||||||
4305775|NCT00501631|4133038|B2|Austria||Region of Enrollment||participants|Number|10|10.0||||||
4305776|NCT00501631|4133039|B1|Austria||Region of Enrollment||participants|Number|10|10.0||||||
4305777|NCT00501631|4133037|B3|Germany||Region of Enrollment||participants|Number|280|280.0||||||
4305778|NCT00501631|4133038|B2|Germany||Region of Enrollment||participants|Number|138|138.0||||||
4305779|NCT00501631|4133039|B1|Germany||Region of Enrollment||participants|Number|142|142.0||||||
4305780|NCT00501631|4133037|B3||Male|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
4305781|NCT00501631|4133038|B2||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4305782|NCT00501631|4133039|B1||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4305783|NCT00501631|4133037|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4305784|NCT00501631|4133038|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4305785|NCT00501631|4133039|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4305786|NCT00501631|4133037|B3|||Age||years|Mean|45.8|45.8|Standard Deviation|8.4|8.4|||
4305787|NCT00501631|4133038|B2|||Age||years|Mean|46.1|46.1|Standard Deviation|8.3|8.3|||
4305788|NCT00501631|4133039|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|8.5|8.5|||
4305789|NCT00501631|4133037|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4305790|NCT00501631|4133038|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4305791|NCT00501631|4133039|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4305792|NCT00501631|4133037|B3||Between 18 and 65 years|Age||Participants|Count of Participants|300|300.0||||||
4305793|NCT00501631|4133038|B2||Between 18 and 65 years|Age||Participants|Count of Participants|148|148.0||||||
4305794|NCT00501631|4133039|B1||Between 18 and 65 years|Age||Participants|Count of Participants|152|152.0||||||
4305795|NCT00501631|4133037|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4305796|NCT00501631|4133038|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4305797|NCT00501631|4133039|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4305798|NCT00501592|4133046|B4|United States||Region of Enrollment||participants|Number|64|64.0||||||
4305799|NCT00501592|4133047|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4305800|NCT00501592|4133048|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4305801|NCT00501592|4133049|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4305802|NCT00501592|4133046|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4305803|NCT00501592|4133047|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4305804|NCT00501592|4133048|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4305805|NCT00501592|4133049|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4305806|NCT00501592|4133046|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4305807|NCT00501592|4133047|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4305808|NCT00501592|4133048|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4305809|NCT00501592|4133049|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4305810|NCT00501592|4133046|B4|||Age||years|Mean|52.1|52.1|Standard Deviation|10.6|10.6|||
4305811|NCT00501592|4133047|B3|||Age||years|Mean|53.1|53.1|Standard Deviation|12.1|12.1|||
4305812|NCT00501592|4133048|B2|||Age||years|Mean|50.5|50.5|Standard Deviation|10.8|10.8|||
4305813|NCT00501592|4133049|B1|||Age||years|Mean|52.7|52.7|Standard Deviation|8.7|8.7|||
4305814|NCT00501592|4133046|B4||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4305815|NCT00501592|4133047|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4305816|NCT00501592|4133048|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4305817|NCT00501592|4133049|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4305818|NCT00501592|4133046|B4||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4305819|NCT00501592|4133047|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4305820|NCT00501592|4133048|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4305821|NCT00501592|4133049|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4305822|NCT00501592|4133046|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4305823|NCT00501592|4133047|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4305824|NCT00501592|4133048|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4305825|NCT00501592|4133049|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4305826|NCT00501540|4133062|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4305827|NCT00501540|4133062|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305828|NCT00501540|4133062|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305829|NCT00501540|4133062|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4305830|NCT00501540|4133062|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305831|NCT00501540|4133062|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305832|NCT00501540|4133062|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305833|NCT00501540|4133062|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305834|NCT00501540|4133062|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305835|NCT00501540|4133062|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4305836|NCT00501540|4133062|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4305837|NCT00501540|4133062|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4305838|NCT00501540|4133062|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4305839|NCT00501540|4133062|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4305840|NCT00501540|4133062|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4305841|NCT00501540|4133062|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4305842|NCT00501540|4133062|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4305843|NCT00501540|4133062|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4305844|NCT00501540|4133062|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4305845|NCT00501345|4133068|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4305846|NCT00501345|4133068|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4305847|NCT00501345|4133068|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4305848|NCT00501345|4133068|B1|||Age||years|Median|78|78.0|Full Range|||39.0|88.0|
4305849|NCT00501293|4133072|B3|United States||Region of Enrollment||participants|Number|163|163.0||||||
4305850|NCT00501293|4133073|B2|United States||Region of Enrollment||participants|Number|53|53.0||||||
4305851|NCT00501293|4133074|B1|United States||Region of Enrollment||participants|Number|110|110.0||||||
4305852|NCT00501293|4133072|B3||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4305853|NCT00501293|4133073|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4305854|NCT00501293|4133074|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4305855|NCT00501293|4133072|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4305856|NCT00501293|4133073|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4305857|NCT00501293|4133074|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4305858|NCT00501293|4133072|B3|||Age||years|Mean|14.5|14.5|Standard Deviation|1.24|1.24|||
4305859|NCT00501293|4133073|B2|||Age||years|Mean|14.5|14.5|Standard Deviation|1.37|1.37|||
4305860|NCT00501293|4133074|B1|||Age||years|Mean|14.5|14.5|Standard Deviation|1.18|1.18|||
4305861|NCT00501293|4133072|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4305862|NCT00501293|4133073|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4305863|NCT00501293|4133074|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4305864|NCT00501293|4133072|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4305865|NCT00501293|4133073|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4305866|NCT00501293|4133074|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4305867|NCT00501293|4133072|B3||<=18 years|Age||Participants|Count of Participants|163|163.0||||||
4305868|NCT00501293|4133073|B2||<=18 years|Age||Participants|Count of Participants|53|53.0||||||
4305869|NCT00501293|4133074|B1||<=18 years|Age||Participants|Count of Participants|110|110.0||||||
4305870|NCT00501228|4133102|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4305871|NCT00501228|4133102|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4305872|NCT00501228|4133102|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4305873|NCT00501228|4133102|B1|||Age||years|Median|48|48.0|Full Range|||40.0|56.0|
4305874|NCT00501085|4133106|B1|||Baseline Excess Weight|Excess weight is equal to subject weight minus ideal weight (ideal weight is based on having a BMI of 25)|pounds (lbs)|Mean|118.7|118.7|Standard Deviation|42.46|42.46|||
4305875|NCT00501085|4133106|B1|||Body Mass Index (BMI) at Baseline||kg/m2|Mean|44.0|44.0|Standard Deviation|6.25|6.25|||
4305876|NCT00501085|4133106|B1|||Baseline Weight||pounds (lbs)|Mean|273.9|273.9|Standard Deviation|51.37|51.37|||
4305877|NCT00501085|4133106|B1|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4305878|NCT00501085|4133106|B1|Other (Native American or unspecified)||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4305879|NCT00501085|4133106|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|443|443.0||||||
4305880|NCT00501085|4133106|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4305881|NCT00501085|4133106|B1|Black||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
4305882|NCT00501085|4133106|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4305883|NCT00501085|4133106|B1||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4305884|NCT00501085|4133106|B1||Female|Sex: Female, Male||Participants|Count of Participants|422|422.0||||||
4305885|NCT00501085|4133106|B1|Median Age||Age, Customized||years|Median|42.7|42.7|Full Range|||18.5|70.6|
4305886|NCT00501085|4133106|B1|||Age||years|Mean|42.7|42.7|Standard Deviation|10.89|10.89|||
4305887|NCT00501059|4133114|B3||Male|Sex: Female, Male||Participants|Count of Participants|8838|8838.0||||||
4305888|NCT00501059|4133115|B2||Male|Sex: Female, Male||Participants|Count of Participants|4419|4419.0||||||
4305889|NCT00501059|4133116|B1||Male|Sex: Female, Male||Participants|Count of Participants|4419|4419.0||||||
4305890|NCT00501059|4133114|B3||Female|Sex: Female, Male||Participants|Count of Participants|3708|3708.0||||||
4305891|NCT00501059|4133115|B2||Female|Sex: Female, Male||Participants|Count of Participants|1857|1857.0||||||
4305892|NCT00501059|4133116|B1||Female|Sex: Female, Male||Participants|Count of Participants|1851|1851.0||||||
4305893|NCT00501059|4133114|B3|||Age||Years|Mean|63.9|63.9|Standard Deviation|7.08|7.08|||
4305894|NCT00501059|4133115|B2|||Age||Years|Mean|63.9|63.9|Standard Deviation|7.05|7.05|||
4305895|NCT00501059|4133116|B1|||Age||Years|Mean|63.9|63.9|Standard Deviation|7.10|7.1|||
4305896|NCT00501046|4133139|B3||Male|Sex: Female, Male||Participants|Count of Participants|560|560.0||||||
4305897|NCT00501046|4133140|B2||Male|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
4305898|NCT00501046|4133141|B1||Male|Sex: Female, Male||Participants|Count of Participants|279|279.0||||||
4305899|NCT00501046|4133139|B3||Female|Sex: Female, Male||Participants|Count of Participants|455|455.0||||||
4305900|NCT00501046|4133140|B2||Female|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
4305901|NCT00501046|4133141|B1||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4305902|NCT00501046|4133139|B3|||Age||years|Mean|55.1|55.1|Standard Deviation|15.11|15.11|||
4305903|NCT00501046|4133140|B2|||Age||years|Mean|55.7|55.7|Standard Deviation|14.66|14.66|||
4305904|NCT00501046|4133141|B1|||Age||years|Mean|54.4|54.4|Standard Deviation|15.52|15.52|||
4305905|NCT00501007|4133148|B1|United States||Region of Enrollment||participants|Number|203|203.0||||||
4305906|NCT00501007|4133148|B1||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4305907|NCT00501007|4133148|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4305908|NCT00501007|4133148|B1|||Age||years|Mean|44.12|44.12|Standard Deviation|10.97|10.97|||
4305909|NCT00501007|4133148|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4305910|NCT00501007|4133148|B1||Between 18 and 65 years|Age||Participants|Count of Participants|203|203.0||||||
4305911|NCT00501007|4133148|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4305912|NCT00500760|4133155|B3|T4||Tumor stage|Staged according to the American Joint Committee on Cancer (AJCC) Staging Manual (6th edition).|Participants|Number|44|44.0||||||
4305913|NCT00500760|4133156|B2|T4||Tumor stage|Staged according to the American Joint Committee on Cancer (AJCC) Staging Manual (6th edition).|Participants|Number|19|19.0||||||
4305914|NCT00500760|4133157|B1|T4||Tumor stage|Staged according to the American Joint Committee on Cancer (AJCC) Staging Manual (6th edition).|Participants|Number|25|25.0||||||
4305915|NCT00500760|4133155|B3|T1-3||Tumor stage|Staged according to the American Joint Committee on Cancer (AJCC) Staging Manual (6th edition).|Participants|Number|109|109.0||||||
4305916|NCT00500760|4133156|B2|T1-3||Tumor stage|Staged according to the American Joint Committee on Cancer (AJCC) Staging Manual (6th edition).|Participants|Number|45|45.0||||||
4305917|NCT00500760|4133157|B1|T1-3||Tumor stage|Staged according to the American Joint Committee on Cancer (AJCC) Staging Manual (6th edition).|Participants|Number|64|64.0||||||
4305918|NCT00500760|4133155|B3|N+||Nodal status|N0: No regional lymph node metastasis. N+: Metastasis in one or more regional lymph nodes|Participants|Number|132|132.0||||||
4305919|NCT00500760|4133156|B2|N+||Nodal status|N0: No regional lymph node metastasis. N+: Metastasis in one or more regional lymph nodes|Participants|Number|55|55.0||||||
4305920|NCT00500760|4133157|B1|N+||Nodal status|N0: No regional lymph node metastasis. N+: Metastasis in one or more regional lymph nodes|Participants|Number|77|77.0||||||
4305921|NCT00500760|4133155|B3|N0||Nodal status|N0: No regional lymph node metastasis. N+: Metastasis in one or more regional lymph nodes|Participants|Number|21|21.0||||||
4305922|NCT00500760|4133156|B2|N0||Nodal status|N0: No regional lymph node metastasis. N+: Metastasis in one or more regional lymph nodes|Participants|Number|9|9.0||||||
4305923|NCT00500760|4133157|B1|N0||Nodal status|N0: No regional lymph node metastasis. N+: Metastasis in one or more regional lymph nodes|Participants|Number|12|12.0||||||
4305924|NCT00500760|4133155|B3|Oral Cavity/Hypopharynx||Primary tumor site||Participants|Number|44|44.0||||||
4305925|NCT00500760|4133156|B2|Oral Cavity/Hypopharynx||Primary tumor site||Participants|Number|23|23.0||||||
4305926|NCT00500760|4133157|B1|Oral Cavity/Hypopharynx||Primary tumor site||Participants|Number|21|21.0||||||
4305927|NCT00500760|4133155|B3|Oropharynx/Larynx||Primary tumor site||Participants|Number|109|109.0||||||
4305928|NCT00500760|4133156|B2|Oropharynx/Larynx||Primary tumor site||Participants|Number|41|41.0||||||
4305929|NCT00500760|4133157|B1|Oropharynx/Larynx||Primary tumor site||Participants|Number|68|68.0||||||
4305930|NCT00500760|4133155|B3|Missing||Radiotherapy delivery modality||Participants|Number|3|3.0||||||
4305931|NCT00500760|4133156|B2|Missing||Radiotherapy delivery modality||Participants|Number|1|1.0||||||
4305932|NCT00500760|4133157|B1|Missing||Radiotherapy delivery modality||Participants|Number|2|2.0||||||
4305933|NCT00500760|4133155|B3|3D-CRT||Radiotherapy delivery modality||Participants|Number|56|56.0||||||
4305934|NCT00500760|4133156|B2|3D-CRT||Radiotherapy delivery modality||Participants|Number|21|21.0||||||
4305935|NCT00500760|4133157|B1|3D-CRT||Radiotherapy delivery modality||Participants|Number|35|35.0||||||
4305936|NCT00500760|4133155|B3|IMRT||Radiotherapy delivery modality||Participants|Number|94|94.0||||||
4305937|NCT00500760|4133156|B2|IMRT||Radiotherapy delivery modality||Participants|Number|42|42.0||||||
4305938|NCT00500760|4133157|B1|IMRT||Radiotherapy delivery modality||Participants|Number|52|52.0||||||
4305939|NCT00500760|4133155|B3|Asian||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4305940|NCT00500760|4133156|B2|Asian||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4305941|NCT00500760|4133157|B1|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4305942|NCT00500760|4133155|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4305943|NCT00500760|4133156|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4305944|NCT00500760|4133157|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4305945|NCT00500760|4133155|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4305946|NCT00500760|4133156|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4305947|NCT00500760|4133157|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4305948|NCT00500760|4133155|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|137|137.0||||||
4305949|NCT00500760|4133156|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|55|55.0||||||
4305950|NCT00500760|4133157|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|82|82.0||||||
4305951|NCT00500760|4133155|B3||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4305952|NCT00500760|4133156|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4305953|NCT00500760|4133157|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4305954|NCT00500760|4133155|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4305955|NCT00500760|4133156|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4305956|NCT00500760|4133157|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4305957|NCT00500760|4133155|B3|||Age||Years|Mean|57.4|57.4|Standard Deviation|8.5|8.5|||
4305958|NCT00500760|4133156|B2|||Age||Years|Mean|56.6|56.6|Standard Deviation|8.8|8.8|||
4305959|NCT00500760|4133157|B1|||Age||Years|Mean|58.0|58.0|Standard Deviation|8.4|8.4|||
4305960|NCT00500682|4133176|B3||Male|Sex: Female, Male||Participants|Count of Participants|646|646.0||||||
4305961|NCT00500682|4133177|B2||Male|Sex: Female, Male||Participants|Count of Participants|331|331.0||||||
4305962|NCT00500682|4133178|B1||Male|Sex: Female, Male||Participants|Count of Participants|315|315.0||||||
4305963|NCT00500682|4133176|B3||Female|Sex: Female, Male||Participants|Count of Participants|374|374.0||||||
4305964|NCT00500682|4133177|B2||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4305965|NCT00500682|4133178|B1||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4305966|NCT00500682|4133176|B3|||Age||years|Mean|56.1|56.1|Standard Deviation|14.95|14.95|||
4305967|NCT00500682|4133177|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|14.99|14.99|||
4305968|NCT00500682|4133178|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|14.93|14.93|||
4305969|NCT00500656|4133185|B5|Switzerland||Region of Enrollment||participants|Number|4|4.0||||||
4305970|NCT00500656|4133186|B4|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
4305971|NCT00500656|4133187|B3|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
4305972|NCT00500656|4133188|B2|Switzerland||Region of Enrollment||participants|Number|2|2.0||||||
4305973|NCT00500656|4133189|B1|Switzerland||Region of Enrollment||participants|Number|2|2.0||||||
4305974|NCT00500656|4133185|B5|Sweden||Region of Enrollment||participants|Number|5|5.0||||||
4305975|NCT00500656|4133186|B4|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
4305976|NCT00500656|4133187|B3|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
4305977|NCT00500656|4133188|B2|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
4305978|NCT00500656|4133189|B1|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
4305979|NCT00500656|4133185|B5|Poland||Region of Enrollment||participants|Number|3|3.0||||||
4305980|NCT00500656|4133186|B4|Poland||Region of Enrollment||participants|Number|0|0.0||||||
4305981|NCT00500656|4133187|B3|Poland||Region of Enrollment||participants|Number|0|0.0||||||
4305982|NCT00500656|4133188|B2|Poland||Region of Enrollment||participants|Number|2|2.0||||||
4305983|NCT00500656|4133189|B1|Poland||Region of Enrollment||participants|Number|1|1.0||||||
4305984|NCT00500656|4133185|B5|Lithuania||Region of Enrollment||participants|Number|3|3.0||||||
4305985|NCT00500656|4133186|B4|Lithuania||Region of Enrollment||participants|Number|0|0.0||||||
4305986|NCT00500656|4133187|B3|Lithuania||Region of Enrollment||participants|Number|0|0.0||||||
4305987|NCT00500656|4133188|B2|Lithuania||Region of Enrollment||participants|Number|2|2.0||||||
4305988|NCT00500656|4133189|B1|Lithuania||Region of Enrollment||participants|Number|1|1.0||||||
4305989|NCT00500656|4133185|B5|Italy||Region of Enrollment||participants|Number|9|9.0||||||
4305990|NCT00500656|4133186|B4|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4305991|NCT00500656|4133187|B3|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4305992|NCT00500656|4133188|B2|Italy||Region of Enrollment||participants|Number|5|5.0||||||
4305993|NCT00500656|4133189|B1|Italy||Region of Enrollment||participants|Number|3|3.0||||||
4305994|NCT00500656|4133185|B5|Israel||Region of Enrollment||participants|Number|15|15.0||||||
4305995|NCT00500656|4133186|B4|Israel||Region of Enrollment||participants|Number|4|4.0||||||
4305996|NCT00500656|4133187|B3|Israel||Region of Enrollment||participants|Number|3|3.0||||||
4305997|NCT00500656|4133188|B2|Israel||Region of Enrollment||participants|Number|4|4.0||||||
4305998|NCT00500656|4133189|B1|Israel||Region of Enrollment||participants|Number|4|4.0||||||
4305999|NCT00500656|4133185|B5|Ireland||Region of Enrollment||participants|Number|1|1.0||||||
4306000|NCT00500656|4133186|B4|Ireland||Region of Enrollment||participants|Number|0|0.0||||||
4306001|NCT00500656|4133187|B3|Ireland||Region of Enrollment||participants|Number|0|0.0||||||
4306002|NCT00500656|4133188|B2|Ireland||Region of Enrollment||participants|Number|1|1.0||||||
4306003|NCT00500656|4133189|B1|Ireland||Region of Enrollment||participants|Number|0|0.0||||||
4306004|NCT00500656|4133185|B5|Hungary||Region of Enrollment||participants|Number|6|6.0||||||
4306005|NCT00500656|4133186|B4|Hungary||Region of Enrollment||participants|Number|0|0.0||||||
4306006|NCT00500656|4133187|B3|Hungary||Region of Enrollment||participants|Number|0|0.0||||||
4306007|NCT00500656|4133188|B2|Hungary||Region of Enrollment||participants|Number|3|3.0||||||
4306008|NCT00500656|4133189|B1|Hungary||Region of Enrollment||participants|Number|3|3.0||||||
4306009|NCT00500656|4133185|B5|Germany||Region of Enrollment||participants|Number|25|25.0||||||
4306010|NCT00500656|4133186|B4|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4306011|NCT00500656|4133187|B3|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4306012|NCT00500656|4133188|B2|Germany||Region of Enrollment||participants|Number|12|12.0||||||
4306013|NCT00500656|4133189|B1|Germany||Region of Enrollment||participants|Number|13|13.0||||||
4306014|NCT00500656|4133185|B5|France||Region of Enrollment||participants|Number|6|6.0||||||
4306015|NCT00500656|4133186|B4|France||Region of Enrollment||participants|Number|2|2.0||||||
4306016|NCT00500656|4133187|B3|France||Region of Enrollment||participants|Number|0|0.0||||||
4306017|NCT00500656|4133188|B2|France||Region of Enrollment||participants|Number|1|1.0||||||
4306018|NCT00500656|4133189|B1|France||Region of Enrollment||participants|Number|3|3.0||||||
4306019|NCT00500656|4133185|B5|Austria||Region of Enrollment||participants|Number|8|8.0||||||
4306020|NCT00500656|4133186|B4|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4306021|NCT00500656|4133187|B3|Austria||Region of Enrollment||participants|Number|0|0.0||||||
4306022|NCT00500656|4133188|B2|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4306023|NCT00500656|4133189|B1|Austria||Region of Enrollment||participants|Number|3|3.0||||||
4306024|NCT00500656|4133185|B5||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4306025|NCT00500656|4133186|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4306026|NCT00500656|4133187|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4306027|NCT00500656|4133188|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4306028|NCT00500656|4133189|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4306029|NCT00500656|4133185|B5||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4306030|NCT00500656|4133186|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4306031|NCT00500656|4133187|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4306032|NCT00500656|4133188|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4306033|NCT00500656|4133189|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4306034|NCT00500656|4133185|B5|||Age||years|Mean|40.9|40.9|Standard Deviation|12.8|12.8|||
4306035|NCT00500656|4133186|B4|||Age||years|Mean|40.6|40.6|Standard Deviation|13.51|13.51|||
4306036|NCT00500656|4133187|B3|||Age||years|Mean|35.0|35.0|Standard Deviation|11.36|11.36|||
4306037|NCT00500656|4133188|B2|||Age||years|Mean|41.9|41.9|Standard Deviation|12.36|12.36|||
4306038|NCT00500656|4133189|B1|||Age||years|Mean|40.4|40.4|Standard Deviation|13.59|13.59|||
4306039|NCT00500578|4133204|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4306040|NCT00500578|4133205|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
4306041|NCT00500578|4133206|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4306042|NCT00500578|4133204|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4306043|NCT00500578|4133205|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4306044|NCT00500578|4133206|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4306045|NCT00500578|4133204|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4306046|NCT00500578|4133205|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4306047|NCT00500578|4133206|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4306048|NCT00500578|4133204|B3|||Age||years|Mean|47.16|47.16|Standard Deviation|13.39|13.39|||
4306049|NCT00500578|4133205|B2|||Age||years|Mean|46.7|46.7|Standard Deviation|14.35|14.35|||
4306050|NCT00500578|4133206|B1|||Age||years|Mean|47.9|47.9|Standard Deviation|11.44|11.44|||
4306051|NCT00500578|4133204|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4306052|NCT00500578|4133205|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4306053|NCT00500578|4133206|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4306054|NCT00500578|4133204|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4306055|NCT00500578|4133205|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4306056|NCT00500578|4133206|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4306057|NCT00500578|4133204|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4306058|NCT00500578|4133205|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4306059|NCT00500578|4133206|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4306060|NCT00500539|4133213|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4306061|NCT00500539|4133213|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4306062|NCT00500539|4133213|B1|||Age||years|Mean|42.7|42.7|Standard Deviation|14.32|14.32|||
4306063|NCT00500539|4133213|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4306064|NCT00500539|4133213|B1||Between 18 and 65 years|Age||Participants|Count of Participants|135|135.0||||||
4306065|NCT00500539|4133213|B1||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4306066|NCT00500448|4133220|B3|||Timed Walking speed||m/s|Mean|1.42|1.42|Standard Deviation|.16|0.16|||
4306067|NCT00500448|4133221|B2|||Timed Walking speed||m/s|Mean|1.43|1.43|Standard Deviation|.19|0.19|||
4306068|NCT00500448|4133222|B1|||Timed Walking speed||m/s|Mean|1.40|1.4|Standard Deviation|.13|0.13|||
4306069|NCT00500448|4133220|B3|||WOMAC disability scale|WOMAC Disability Score ranges from 17 (no loss of function) to 85 (severe loss of function)|units on a scale (range 17-85)|Mean|27.95|27.95|Standard Deviation|13.7|13.7|||
4306070|NCT00500448|4133221|B2|||WOMAC disability scale|WOMAC Disability Score ranges from 17 (no loss of function) to 85 (severe loss of function)|units on a scale (range 17-85)|Mean|27.1|27.1|Standard Deviation|12.1|12.1|||
4306071|NCT00500448|4133222|B1|||WOMAC disability scale|WOMAC Disability Score ranges from 17 (no loss of function) to 85 (severe loss of function)|units on a scale (range 17-85)|Mean|28.8|28.8|Standard Deviation|15.3|15.3|||
4306072|NCT00500448|4133220|B3|||WOMAC Pain Score|WOMAC Pain Score ranges from 5 (no pain) to 25 (worst possible pain)|units on a scale (range 5-25)|Mean|8.25|8.25|Standard Deviation|3.5|3.5|||
4306073|NCT00500448|4133221|B2|||WOMAC Pain Score|WOMAC Pain Score ranges from 5 (no pain) to 25 (worst possible pain)|units on a scale (range 5-25)|Mean|7.6|7.6|Standard Deviation|2.7|2.7|||
4306074|NCT00500448|4133222|B1|||WOMAC Pain Score|WOMAC Pain Score ranges from 5 (no pain) to 25 (worst possible pain)|units on a scale (range 5-25)|Mean|8.9|8.9|Standard Deviation|4.3|4.3|||
4306075|NCT00500448|4133220|B3|||Central Activation Ratio (CAR)|Knee extensionTorque recorded during voluntary contraction/Knee extension torque recorded during contraction with superimposed stimulus|ratio|Mean|.86|0.86|Standard Deviation|.12|0.12|||
4306076|NCT00500448|4133221|B2|||Central Activation Ratio (CAR)|Knee extensionTorque recorded during voluntary contraction/Knee extension torque recorded during contraction with superimposed stimulus|ratio|Mean|.90|0.9|Standard Deviation|.08|0.08|||
4306077|NCT00500448|4133222|B1|||Central Activation Ratio (CAR)|Knee extensionTorque recorded during voluntary contraction/Knee extension torque recorded during contraction with superimposed stimulus|ratio|Mean|.83|0.83|Standard Deviation|.15|0.15|||
4306078|NCT00500448|4133220|B3|||Quadriceps Strength||Nm/kg|Mean|1.26|1.26|Standard Deviation|0.41|0.41|||
4306079|NCT00500448|4133221|B2|||Quadriceps Strength||Nm/kg|Mean|1.29|1.29|Standard Deviation|0.46|0.46|||
4306080|NCT00500448|4133222|B1|||Quadriceps Strength||Nm/kg|Mean|1.24|1.24|Standard Deviation|0.35|0.35|||
4306081|NCT00500448|4133220|B3|||BMI||kg^m2|Mean|32.4|32.4|Standard Deviation|4.6|4.6|||
4306082|NCT00500448|4133221|B2|||BMI||kg^m2|Mean|32.7|32.7|Standard Deviation|4.1|4.1|||
4306083|NCT00500448|4133222|B1|||BMI||kg^m2|Mean|32.1|32.1|Standard Deviation|5.1|5.1|||
4306084|NCT00500448|4133220|B3|||Mass||kg|Mean|87.05|87.05|Standard Deviation|13.05|13.05|||
4306085|NCT00500448|4133221|B2|||Mass||kg|Mean|86.3|86.3|Standard Deviation|13.6|13.6|||
4306086|NCT00500448|4133222|B1|||Mass||kg|Mean|87.8|87.8|Standard Deviation|12.5|12.5|||
4306087|NCT00500448|4133220|B3|||Height||cm|Mean|162.8|162.8|Standard Deviation|5.95|5.95|||
4306088|NCT00500448|4133221|B2|||Height||cm|Mean|162.3|162.3|Standard Deviation|7.4|7.4|||
4306089|NCT00500448|4133222|B1|||Height||cm|Mean|163.3|163.3|Standard Deviation|4.5|4.5|||
4306090|NCT00500448|4133220|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4306091|NCT00500448|4133221|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4306092|NCT00500448|4133222|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4306093|NCT00500448|4133220|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4306094|NCT00500448|4133221|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4306095|NCT00500448|4133222|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4306096|NCT00500448|4133220|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4306097|NCT00500448|4133221|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4306098|NCT00500448|4133222|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4306099|NCT00500448|4133220|B3|||Age||Years|Mean|57.4|57.4|Standard Deviation|2.8|2.8|||
4306100|NCT00500448|4133221|B2|||Age||Years|Mean|58|58.0|Standard Deviation|2.7|2.7|||
4306101|NCT00500448|4133222|B1|||Age||Years|Mean|56.8|56.8|Standard Deviation|2.9|2.9|||
4306102|NCT00500370|4133237|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4306103|NCT00500370|4133238|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4306104|NCT00500370|4133239|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4306105|NCT00500370|4133237|B3||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4306106|NCT00500370|4133238|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4306107|NCT00500370|4133239|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4306108|NCT00500370|4133237|B3|||Age||years|Mean|46.04|46.04|Standard Deviation|11.91|11.91|||
4306109|NCT00500370|4133238|B2|||Age||years|Mean|45.15|45.15|Standard Deviation|12.74|12.74|||
4306110|NCT00500370|4133239|B1|||Age||years|Mean|47.01|47.01|Standard Deviation|10.95|10.95|||
4306111|NCT00500357|4133276|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4306112|NCT00500357|4133276|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4306113|NCT00500357|4133276|B1|||Age||years|Mean|72.8|72.8|Standard Deviation|4.9|4.9|||
4306114|NCT00500331|4133295|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4306115|NCT00500331|4133296|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4306116|NCT00500331|4133297|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4306117|NCT00500331|4133298|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4306118|NCT00500331|4133299|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4306119|NCT00500331|4133300|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4306120|NCT00500331|4133301|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4306121|NCT00500331|4133302|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4306122|NCT00500331|4133295|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4306123|NCT00500331|4133296|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306124|NCT00500331|4133297|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4306125|NCT00500331|4133298|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4306126|NCT00500331|4133299|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4306127|NCT00500331|4133300|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4306128|NCT00500331|4133301|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306129|NCT00500331|4133302|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4306130|NCT00500331|4133295|B8||White|Race (NIH/OMB)||Participants|Count of Participants|276|276.0||||||
4306131|NCT00500331|4133296|B7||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4306132|NCT00500331|4133297|B6||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4306133|NCT00500331|4133298|B5||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4306134|NCT00500331|4133299|B4||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4306135|NCT00500331|4133300|B3||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4306136|NCT00500331|4133301|B2||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4306137|NCT00500331|4133302|B1||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4306138|NCT00500331|4133295|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4306139|NCT00500331|4133296|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306140|NCT00500331|4133297|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306141|NCT00500331|4133298|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306142|NCT00500331|4133299|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306143|NCT00500331|4133300|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306144|NCT00500331|4133301|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4306145|NCT00500331|4133302|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306146|NCT00500331|4133295|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4306147|NCT00500331|4133296|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306148|NCT00500331|4133297|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306149|NCT00500331|4133298|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306150|NCT00500331|4133299|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306151|NCT00500331|4133300|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4306152|NCT00500331|4133301|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4306153|NCT00500331|4133302|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4306154|NCT00500331|4133295|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4306155|NCT00500331|4133296|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4306156|NCT00500331|4133297|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4306157|NCT00500331|4133298|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4306158|NCT00500331|4133299|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4306159|NCT00500331|4133300|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4306160|NCT00500331|4133301|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4306161|NCT00500331|4133302|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4306162|NCT00500331|4133295|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4306163|NCT00500331|4133296|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4306164|NCT00500331|4133297|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4306165|NCT00500331|4133298|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306166|NCT00500331|4133299|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4306167|NCT00500331|4133300|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4306168|NCT00500331|4133301|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4306169|NCT00500331|4133302|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4306170|NCT00500331|4133295|B8||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4306171|NCT00500331|4133296|B7||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4306172|NCT00500331|4133297|B6||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4306173|NCT00500331|4133298|B5||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4306174|NCT00500331|4133299|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4306175|NCT00500331|4133300|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4306176|NCT00500331|4133301|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4306177|NCT00500331|4133302|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4306178|NCT00500331|4133295|B8||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4306179|NCT00500331|4133296|B7||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4306180|NCT00500331|4133297|B6||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4306181|NCT00500331|4133298|B5||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4306182|NCT00500331|4133299|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4306183|NCT00500331|4133300|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4306184|NCT00500331|4133301|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4306185|NCT00500331|4133302|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4306186|NCT00500331|4133295|B8|||Age||Years|Mean|54.8|54.8|Standard Deviation|9.16|9.16|||
4306187|NCT00500331|4133296|B7|||Age||Years|Mean|54.5|54.5|Standard Deviation|9.45|9.45|||
4306188|NCT00500331|4133297|B6|||Age||Years|Mean|52.4|52.4|Standard Deviation|9.03|9.03|||
4306189|NCT00500331|4133298|B5|||Age||Years|Mean|54.6|54.6|Standard Deviation|9.33|9.33|||
4306190|NCT00500331|4133299|B4|||Age||Years|Mean|55.7|55.7|Standard Deviation|9.46|9.46|||
4306191|NCT00500331|4133300|B3|||Age||Years|Mean|56.0|56.0|Standard Deviation|8.11|8.11|||
4306192|NCT00500331|4133301|B2|||Age||Years|Mean|54.3|54.3|Standard Deviation|9.04|9.04|||
4306193|NCT00500331|4133302|B1|||Age||Years|Mean|55.9|55.9|Standard Deviation|9.67|9.67|||
4306194|NCT00500318|4133443|B3|Canada||Region of Enrollment||participants|Number|42|42.0||||||
4306195|NCT00500318|4133444|B2|Canada||Region of Enrollment||participants|Number|20|20.0||||||
4306196|NCT00500318|4133445|B1|Canada||Region of Enrollment||participants|Number|22|22.0||||||
4306197|NCT00500318|4133443|B3|United States||Region of Enrollment||participants|Number|139|139.0||||||
4306198|NCT00500318|4133444|B2|United States||Region of Enrollment||participants|Number|75|75.0||||||
4306199|NCT00500318|4133445|B1|United States||Region of Enrollment||participants|Number|64|64.0||||||
4306200|NCT00500318|4133443|B3||Male|Gender||Participants|Count of Participants|105|105.0||||||
4306201|NCT00500318|4133444|B2||Male|Gender||Participants|Count of Participants|53|53.0||||||
4306202|NCT00500318|4133445|B1||Male|Gender||Participants|Count of Participants|52|52.0||||||
4306203|NCT00500318|4133443|B3||Female|Gender||Participants|Count of Participants|76|76.0||||||
4306204|NCT00500318|4133444|B2||Female|Gender||Participants|Count of Participants|42|42.0||||||
4306205|NCT00500318|4133445|B1||Female|Gender||Participants|Count of Participants|34|34.0||||||
4306206|NCT00500318|4133443|B3|||Age||years|Mean|64.8|64.8|Standard Deviation|8.6|8.6|||
4306207|NCT00500318|4133444|B2|||Age||years|Mean|65.6|65.6|Standard Deviation|7.8|7.8|||
4306208|NCT00500318|4133445|B1|||Age||years|Mean|64.0|64.0|Standard Deviation|9.5|9.5|||
4306209|NCT00500292|4133460|B4||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4306210|NCT00500292|4133461|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4306211|NCT00500292|4133462|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4306212|NCT00500292|4133463|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4306213|NCT00500292|4133460|B4||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4306214|NCT00500292|4133461|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4306215|NCT00500292|4133462|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4306216|NCT00500292|4133463|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4306217|NCT00500292|4133460|B4|||Age||Years|Mean|58|58.0|Full Range|||32.0|81.0|
4306218|NCT00500292|4133461|B3|||Age||Years|Mean|59|59.0|Full Range|||32.0|81.0|
4306219|NCT00500292|4133462|B2|||Age||Years|Mean|58|58.0|Full Range|||37.0|71.0|
4306220|NCT00500292|4133463|B1|||Age||Years|Mean|57|57.0|Full Range|||34.0|75.0|
4306221|NCT00500240|4133473|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
4306222|NCT00500240|4133474|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4306223|NCT00500240|4133475|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4306224|NCT00500240|4133473|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4306225|NCT00500240|4133474|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4306226|NCT00500240|4133475|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4306227|NCT00500240|4133473|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4306228|NCT00500240|4133474|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4306229|NCT00500240|4133475|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4306230|NCT00500240|4133473|B3|||Age||years|Median|52|52.0|Full Range|||17.0|85.0|
4306231|NCT00500240|4133474|B2|||Age||years|Median|57.5|57.5|Full Range|||18.0|85.0|
4306232|NCT00500240|4133475|B1|||Age||years|Median|46|46.0|Full Range|||17.0|70.0|
4306233|NCT00500149|4133486|B1|United States||Region of Enrollment||participants|Number|129|129.0||||||
4306234|NCT00500149|4133486|B1||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4306235|NCT00500149|4133486|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4306236|NCT00500149|4133486|B1|||Age||years|Mean|10.1|10.1|Standard Deviation|1.5|1.5|||
4306237|NCT00500149|4133486|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4306238|NCT00500149|4133486|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4306239|NCT00500149|4133486|B1||<=18 years|Age||Participants|Count of Participants|129|129.0||||||
4306240|NCT00500110|4133495|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4306241|NCT00500110|4133495|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306242|NCT00500110|4133495|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306243|NCT00500110|4133495|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4306244|NCT00500110|4133495|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4306245|NCT00500110|4133495|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306246|NCT00500110|4133495|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306247|NCT00500110|4133495|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306248|NCT00500110|4133495|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4306249|NCT00500110|4133495|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4306250|NCT00500110|4133495|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4306251|NCT00500110|4133495|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4306252|NCT00500110|4133495|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4306253|NCT00500071|4133499|B1|United States||Region of Enrollment||participants|Number|318|318.0||||||
4306254|NCT00500071|4133499|B1||Male|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
4306255|NCT00500071|4133499|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4306256|NCT00500071|4133499|B1|||Age||years|Mean|9.1|9.1|Standard Deviation|1.9|1.9|||
4306257|NCT00500071|4133499|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4306258|NCT00500071|4133499|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4306259|NCT00500071|4133499|B1||<=18 years|Age||Participants|Count of Participants|318|318.0||||||
4306260|NCT00499915|4133508|B3|United States||Region of Enrollment||participants|Number|165|165.0||||||
4306261|NCT00499915|4133509|B2|United States||Region of Enrollment||participants|Number|82|82.0||||||
4306262|NCT00499915|4133510|B1|United States||Region of Enrollment||participants|Number|83|83.0||||||
4306263|NCT00499915|4133508|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4306264|NCT00499915|4133509|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4306265|NCT00499915|4133510|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4306266|NCT00499915|4133508|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4306267|NCT00499915|4133509|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4306268|NCT00499915|4133510|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4306269|NCT00499915|4133508|B3|||Age|Gestational Age (weeks)|Weeks|Mean|28.4|28.4|Standard Deviation|2.5|2.5|||
4306270|NCT00499915|4133509|B2|||Age|Gestational Age (weeks)|Weeks|Mean|28.1|28.1|Standard Deviation|2.5|2.5|||
4306271|NCT00499915|4133510|B1|||Age|Gestational Age (weeks)|Weeks|Mean|28.7|28.7|Standard Deviation|2.4|2.4|||
4306272|NCT00499889|4133517|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4306273|NCT00499889|4133517|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4306274|NCT00499889|4133517|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4306275|NCT00499889|4133517|B1|||Age||years|Median|42.2|42.2|Full Range|42|42.0|14.0|69.0|
4306276|NCT00499889|4133517|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4306277|NCT00499889|4133517|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4306278|NCT00499889|4133517|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4306279|NCT00499863|4133523|B3|United States||Region of Enrollment||participants|Number|217|217.0||||||
4306280|NCT00499863|4133524|B2|United States||Region of Enrollment||participants|Number|72|72.0||||||
4306281|NCT00499863|4133525|B1|United States||Region of Enrollment||participants|Number|145|145.0||||||
4306282|NCT00499863|4133523|B3||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4306283|NCT00499863|4133524|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4306284|NCT00499863|4133525|B1||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4306285|NCT00499863|4133523|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4306286|NCT00499863|4133524|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4306287|NCT00499863|4133525|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4306288|NCT00499863|4133523|B3|||Age||years|Mean|14.6|14.6|Standard Deviation|1.31|1.31|||
4306289|NCT00499863|4133524|B2|||Age||years|Mean|14.6|14.6|Standard Deviation|1.42|1.42|||
4306290|NCT00499863|4133525|B1|||Age||years|Mean|14.5|14.5|Standard Deviation|1.25|1.25|||
4306291|NCT00499863|4133523|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4306292|NCT00499863|4133524|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4306293|NCT00499863|4133525|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4306294|NCT00499863|4133523|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4306295|NCT00499863|4133524|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4306296|NCT00499863|4133525|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4306297|NCT00499863|4133523|B3||<=18 years|Age||Participants|Count of Participants|217|217.0||||||
4306298|NCT00499863|4133524|B2||<=18 years|Age||Participants|Count of Participants|72|72.0||||||
4306299|NCT00499863|4133525|B1||<=18 years|Age||Participants|Count of Participants|145|145.0||||||
4306300|NCT00500266|4133554|B1||Male|Sex: Female, Male||Participants|Count of Participants|465|465.0||||||
4306301|NCT00500266|4133554|B1||Female|Sex: Female, Male||Participants|Count of Participants|584|584.0||||||
4306302|NCT00500266|4133554|B1|||Age||years|Mean|75.3|75.3|Standard Deviation|5.1|5.1|||
4306303|NCT00499746|4133561|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4306304|NCT00499746|4133561|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4306305|NCT00499746|4133561|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4306306|NCT00499746|4133561|B1|||Age||years|Mean|40.3|40.3|Standard Deviation|2.3|2.3|||
4306307|NCT00499746|4133561|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4306308|NCT00499746|4133561|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4306309|NCT00499746|4133561|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4306310|NCT00499694|4133630|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4306311|NCT00499694|4133630|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4306312|NCT00499694|4133630|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4306313|NCT00499694|4133630|B1|||Age||years|Mean|67.5|67.5|Standard Deviation|8.5|8.5|||
4306314|NCT00499681|4133637|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4306315|NCT00499681|4133638|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4306316|NCT00499681|4133639|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4306317|NCT00499681|4133637|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4306318|NCT00499681|4133638|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4306319|NCT00499681|4133639|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4306320|NCT00499681|4133637|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4306321|NCT00499681|4133638|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4306322|NCT00499681|4133639|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4306323|NCT00499681|4133637|B3|||Age||years|Mean|62|62.0|Standard Deviation|1|1.0|||
4306324|NCT00499681|4133638|B2|||Age||years|Mean|74|74.0|Standard Deviation|1|1.0|||
4306325|NCT00499681|4133639|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|1|1.0|||
4306326|NCT00499681|4133637|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4306327|NCT00499681|4133638|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4306328|NCT00499681|4133639|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4306329|NCT00499681|4133637|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4306330|NCT00499681|4133638|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4306331|NCT00499681|4133639|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4306332|NCT00499681|4133637|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4306333|NCT00499681|4133638|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4306334|NCT00499681|4133639|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4306335|NCT00499655|4133646|B3|United States||Region of Enrollment||Participants|Count of Participants|107|107.0||||||
4306336|NCT00499655|4133647|B2|United States||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
4306337|NCT00499655|4133648|B1|United States||Region of Enrollment||Participants|Count of Participants|53|53.0||||||
4306338|NCT00499655|4133646|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4306339|NCT00499655|4133647|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4306340|NCT00499655|4133648|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4306341|NCT00499655|4133646|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4306342|NCT00499655|4133647|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4306343|NCT00499655|4133648|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4306344|NCT00499655|4133646|B3|||Age||years|Median|64|64.0|Full Range|||30.0|80.0|
4306345|NCT00499655|4133647|B2|||Age||years|Median|63.5|63.5|Full Range|||41.0|80.0|
4306346|NCT00499655|4133648|B1|||Age||years|Median|65|65.0|Full Range|||30.0|80.0|
4306347|NCT00499616|4133663|B5|Australia||Region of Enrollment||participants|Number|12|12.0||||||
4306348|NCT00499616|4133664|B4|Australia||Region of Enrollment||participants|Number|2|2.0||||||
4306349|NCT00499616|4133665|B3|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4306350|NCT00499616|4133666|B2|Australia||Region of Enrollment||participants|Number|5|5.0||||||
4306351|NCT00499616|4133667|B1|Australia||Region of Enrollment||participants|Number|5|5.0||||||
4306352|NCT00499616|4133663|B5|United States||Region of Enrollment||participants|Number|412|412.0||||||
4306353|NCT00499616|4133664|B4|United States||Region of Enrollment||participants|Number|50|50.0||||||
4306354|NCT00499616|4133665|B3|United States||Region of Enrollment||participants|Number|78|78.0||||||
4306355|NCT00499616|4133666|B2|United States||Region of Enrollment||participants|Number|131|131.0||||||
4306356|NCT00499616|4133667|B1|United States||Region of Enrollment||participants|Number|153|153.0||||||
4306357|NCT00499616|4133663|B5|Canada||Region of Enrollment||participants|Number|37|37.0||||||
4306358|NCT00499616|4133664|B4|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4306359|NCT00499616|4133665|B3|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4306360|NCT00499616|4133666|B2|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4306361|NCT00499616|4133667|B1|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4306362|NCT00499616|4133663|B5|New Zealand||Region of Enrollment||participants|Number|3|3.0||||||
4306363|NCT00499616|4133664|B4|New Zealand||Region of Enrollment||participants|Number|0|0.0||||||
4306364|NCT00499616|4133665|B3|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
4306365|NCT00499616|4133666|B2|New Zealand||Region of Enrollment||participants|Number|0|0.0||||||
4306366|NCT00499616|4133667|B1|New Zealand||Region of Enrollment||participants|Number|2|2.0||||||
4306367|NCT00499616|4133663|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4306368|NCT00499616|4133664|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4306369|NCT00499616|4133665|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4306370|NCT00499616|4133666|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4306371|NCT00499616|4133667|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4306372|NCT00499616|4133663|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306373|NCT00499616|4133664|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306374|NCT00499616|4133665|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306375|NCT00499616|4133666|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306376|NCT00499616|4133667|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306377|NCT00499616|4133663|B5||White|Race (NIH/OMB)||Participants|Count of Participants|324|324.0||||||
4306378|NCT00499616|4133664|B4||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4306379|NCT00499616|4133665|B3||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4306380|NCT00499616|4133666|B2||White|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
4306381|NCT00499616|4133667|B1||White|Race (NIH/OMB)||Participants|Count of Participants|133|133.0||||||
4306382|NCT00499616|4133663|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4306383|NCT00499616|4133664|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4306384|NCT00499616|4133665|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4306385|NCT00499616|4133666|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4306386|NCT00499616|4133667|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4306387|NCT00499616|4133663|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4306388|NCT00499616|4133664|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4306389|NCT00499616|4133665|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306390|NCT00499616|4133666|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4306391|NCT00499616|4133667|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4306392|NCT00499616|4133663|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4306393|NCT00499616|4133664|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4306394|NCT00499616|4133665|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4306395|NCT00499616|4133666|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4306396|NCT00499616|4133667|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4306397|NCT00499616|4133663|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4306398|NCT00499616|4133664|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306399|NCT00499616|4133665|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4306400|NCT00499616|4133666|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306401|NCT00499616|4133667|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306402|NCT00499616|4133663|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4306403|NCT00499616|4133664|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4306404|NCT00499616|4133665|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4306405|NCT00499616|4133666|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4306406|NCT00499616|4133667|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4306407|NCT00499616|4133663|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|382|382.0||||||
4306408|NCT00499616|4133664|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4306409|NCT00499616|4133665|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4306410|NCT00499616|4133666|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|109|109.0||||||
4306411|NCT00499616|4133667|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|150|150.0||||||
4306412|NCT00499616|4133663|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4306413|NCT00499616|4133664|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4306414|NCT00499616|4133665|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4306415|NCT00499616|4133666|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4306416|NCT00499616|4133667|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4306417|NCT00499616|4133663|B5||Male|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
4306418|NCT00499616|4133664|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4306419|NCT00499616|4133665|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4306420|NCT00499616|4133666|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4306421|NCT00499616|4133667|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4306422|NCT00499616|4133663|B5||Female|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
4306423|NCT00499616|4133664|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4306424|NCT00499616|4133665|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4306425|NCT00499616|4133666|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4306426|NCT00499616|4133667|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4306427|NCT00499616|4133663|B5|||Age||years|Mean|0.99|0.99|Standard Deviation|1.26|1.26|||
4306428|NCT00499616|4133664|B4|||Age||years|Mean|1.51|1.51|Standard Deviation|1.83|1.83|||
4306429|NCT00499616|4133665|B3|||Age||years|Mean|.60|0.6|Standard Deviation|.36|0.36|||
4306430|NCT00499616|4133666|B2|||Age||years|Mean|.74|0.74|Standard Deviation|.89|0.89|||
4306431|NCT00499616|4133667|B1|||Age||years|Mean|1.23|1.23|Standard Deviation|1.47|1.47|||
4306432|NCT00499616|4133663|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4306433|NCT00499616|4133664|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4306434|NCT00499616|4133665|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4306435|NCT00499616|4133666|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4306436|NCT00499616|4133667|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4306437|NCT00499616|4133663|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4306438|NCT00499616|4133664|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4306439|NCT00499616|4133665|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4306440|NCT00499616|4133666|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4306441|NCT00499616|4133667|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4306442|NCT00499616|4133663|B5||<=18 years|Age||Participants|Count of Participants|464|464.0||||||
4306443|NCT00499616|4133664|B4||<=18 years|Age||Participants|Count of Participants|57|57.0||||||
4306444|NCT00499616|4133665|B3||<=18 years|Age||Participants|Count of Participants|89|89.0||||||
4306445|NCT00499616|4133666|B2||<=18 years|Age||Participants|Count of Participants|142|142.0||||||
4306446|NCT00499616|4133667|B1||<=18 years|Age||Participants|Count of Participants|176|176.0||||||
4306447|NCT00499603|4133705|B3|IIIC||Breast Cancer Stage|Participants staged using histologically confirmed disease stages Stage IIA, IIB and IIIA, IIIB, IIIC per the American Joint Committee on Cancer (AJCC) sixth edition for breast cancer.|Participants|Number|12|12.0||||||
4306448|NCT00499603|4133706|B2|IIIC||Breast Cancer Stage|Participants staged using histologically confirmed disease stages Stage IIA, IIB and IIIA, IIIB, IIIC per the American Joint Committee on Cancer (AJCC) sixth edition for breast cancer.|Participants|Number|7|7.0||||||
4306449|NCT00499603|4133707|B1|IIIC||Breast Cancer Stage|Participants staged using histologically confirmed disease stages Stage IIA, IIB and IIIA, IIIB, IIIC per the American Joint Committee on Cancer (AJCC) sixth edition for breast cancer.|Participants|Number|5|5.0||||||
4306450|NCT00499603|4133705|B3|IIIB||Breast Cancer Stage|Participants staged using histologically confirmed disease stages Stage IIA, IIB and IIIA, IIIB, IIIC per the American Joint Committee on Cancer (AJCC) sixth edition for breast cancer.|Participants|Number|2|2.0||||||
4306451|NCT00499603|4133706|B2|IIIB||Breast Cancer Stage|Participants staged using histologically confirmed disease stages Stage IIA, IIB and IIIA, IIIB, IIIC per the American Joint Committee on Cancer (AJCC) sixth edition for breast cancer.|Participants|Number|0|0.0||||||
4306452|NCT00499603|4133707|B1|IIIB||Breast Cancer Stage|Participants staged using histologically confirmed disease stages Stage IIA, IIB and IIIA, IIIB, IIIC per the American Joint Committee on Cancer (AJCC) sixth edition for breast cancer.|Participants|Number|2|2.0||||||
4306453|NCT00499603|4133705|B3|IIIA||Breast Cancer Stage|Participants staged using histologically confirmed disease stages Stage IIA, IIB and IIIA, IIIB, IIIC per the American Joint Committee on Cancer (AJCC) sixth edition for breast cancer.|Participants|Number|6|6.0||||||
4306454|NCT00499603|4133706|B2|IIIA||Breast Cancer Stage|Participants staged using histologically confirmed disease stages Stage IIA, IIB and IIIA, IIIB, IIIC per the American Joint Committee on Cancer (AJCC) sixth edition for breast cancer.|Participants|Number|2|2.0||||||
4306455|NCT00499603|4133707|B1|IIIA||Breast Cancer Stage|Participants staged using histologically confirmed disease stages Stage IIA, IIB and IIIA, IIIB, IIIC per the American Joint Committee on Cancer (AJCC) sixth edition for breast cancer.|Participants|Number|4|4.0||||||
4306456|NCT00499603|4133705|B3|IIB||Breast Cancer Stage|Participants staged using histologically confirmed disease stages Stage IIA, IIB and IIIA, IIIB, IIIC per the American Joint Committee on Cancer (AJCC) sixth edition for breast cancer.|Participants|Number|14|14.0||||||
4306457|NCT00499603|4133706|B2|IIB||Breast Cancer Stage|Participants staged using histologically confirmed disease stages Stage IIA, IIB and IIIA, IIIB, IIIC per the American Joint Committee on Cancer (AJCC) sixth edition for breast cancer.|Participants|Number|6|6.0||||||
4306458|NCT00499603|4133707|B1|IIB||Breast Cancer Stage|Participants staged using histologically confirmed disease stages Stage IIA, IIB and IIIA, IIIB, IIIC per the American Joint Committee on Cancer (AJCC) sixth edition for breast cancer.|Participants|Number|8|8.0||||||
4306459|NCT00499603|4133705|B3|IIA||Breast Cancer Stage|Participants staged using histologically confirmed disease stages Stage IIA, IIB and IIIA, IIIB, IIIC per the American Joint Committee on Cancer (AJCC) sixth edition for breast cancer.|Participants|Number|16|16.0||||||
4306460|NCT00499603|4133706|B2|IIA||Breast Cancer Stage|Participants staged using histologically confirmed disease stages Stage IIA, IIB and IIIA, IIIB, IIIC per the American Joint Committee on Cancer (AJCC) sixth edition for breast cancer.|Participants|Number|8|8.0||||||
4306461|NCT00499603|4133707|B1|IIA||Breast Cancer Stage|Participants staged using histologically confirmed disease stages Stage IIA, IIB and IIIA, IIIB, IIIC per the American Joint Committee on Cancer (AJCC) sixth edition for breast cancer.|Participants|Number|8|8.0||||||
4306462|NCT00499603|4133705|B3|Unknown or Not Reported||Regional Lymph Node Stage|Regional lymph node staging illustrates the amount of cancer spread to nearby lymph nodes, notations are NX: Regional lymph nodes cannot be evaluated; N0: No regional lymph node involvement; N1, N2, N3: Degree of regional lymph node involvement (number and location of lymph nodes)|Participants|Number|1|1.0||||||
4306463|NCT00499603|4133706|B2|Unknown or Not Reported||Regional Lymph Node Stage|Regional lymph node staging illustrates the amount of cancer spread to nearby lymph nodes, notations are NX: Regional lymph nodes cannot be evaluated; N0: No regional lymph node involvement; N1, N2, N3: Degree of regional lymph node involvement (number and location of lymph nodes)|Participants|Number|1|1.0||||||
4306464|NCT00499603|4133707|B1|Unknown or Not Reported||Regional Lymph Node Stage|Regional lymph node staging illustrates the amount of cancer spread to nearby lymph nodes, notations are NX: Regional lymph nodes cannot be evaluated; N0: No regional lymph node involvement; N1, N2, N3: Degree of regional lymph node involvement (number and location of lymph nodes)|Participants|Number|0|0.0||||||
4306465|NCT00499603|4133705|B3|Nx||Regional Lymph Node Stage|Regional lymph node staging illustrates the amount of cancer spread to nearby lymph nodes, notations are NX: Regional lymph nodes cannot be evaluated; N0: No regional lymph node involvement; N1, N2, N3: Degree of regional lymph node involvement (number and location of lymph nodes)|Participants|Number|12|12.0||||||
4306466|NCT00499603|4133706|B2|Nx||Regional Lymph Node Stage|Regional lymph node staging illustrates the amount of cancer spread to nearby lymph nodes, notations are NX: Regional lymph nodes cannot be evaluated; N0: No regional lymph node involvement; N1, N2, N3: Degree of regional lymph node involvement (number and location of lymph nodes)|Participants|Number|7|7.0||||||
4306467|NCT00499603|4133707|B1|Nx||Regional Lymph Node Stage|Regional lymph node staging illustrates the amount of cancer spread to nearby lymph nodes, notations are NX: Regional lymph nodes cannot be evaluated; N0: No regional lymph node involvement; N1, N2, N3: Degree of regional lymph node involvement (number and location of lymph nodes)|Participants|Number|5|5.0||||||
4306468|NCT00499603|4133705|B3|N2||Regional Lymph Node Stage|Regional lymph node staging illustrates the amount of cancer spread to nearby lymph nodes, notations are NX: Regional lymph nodes cannot be evaluated; N0: No regional lymph node involvement; N1, N2, N3: Degree of regional lymph node involvement (number and location of lymph nodes)|Participants|Number|6|6.0||||||
4306469|NCT00499603|4133706|B2|N2||Regional Lymph Node Stage|Regional lymph node staging illustrates the amount of cancer spread to nearby lymph nodes, notations are NX: Regional lymph nodes cannot be evaluated; N0: No regional lymph node involvement; N1, N2, N3: Degree of regional lymph node involvement (number and location of lymph nodes)|Participants|Number|2|2.0||||||
4306470|NCT00499603|4133707|B1|N2||Regional Lymph Node Stage|Regional lymph node staging illustrates the amount of cancer spread to nearby lymph nodes, notations are NX: Regional lymph nodes cannot be evaluated; N0: No regional lymph node involvement; N1, N2, N3: Degree of regional lymph node involvement (number and location of lymph nodes)|Participants|Number|4|4.0||||||
4306497|NCT00499603|4133707|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4306498|NCT00499603|4133705|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306471|NCT00499603|4133705|B3|N1||Regional Lymph Node Stage|Regional lymph node staging illustrates the amount of cancer spread to nearby lymph nodes, notations are NX: Regional lymph nodes cannot be evaluated; N0: No regional lymph node involvement; N1, N2, N3: Degree of regional lymph node involvement (number and location of lymph nodes)|Participants|Number|17|17.0||||||
4306472|NCT00499603|4133706|B2|N1||Regional Lymph Node Stage|Regional lymph node staging illustrates the amount of cancer spread to nearby lymph nodes, notations are NX: Regional lymph nodes cannot be evaluated; N0: No regional lymph node involvement; N1, N2, N3: Degree of regional lymph node involvement (number and location of lymph nodes)|Participants|Number|7|7.0||||||
4306473|NCT00499603|4133707|B1|N1||Regional Lymph Node Stage|Regional lymph node staging illustrates the amount of cancer spread to nearby lymph nodes, notations are NX: Regional lymph nodes cannot be evaluated; N0: No regional lymph node involvement; N1, N2, N3: Degree of regional lymph node involvement (number and location of lymph nodes)|Participants|Number|10|10.0||||||
4306474|NCT00499603|4133705|B3|N0||Regional Lymph Node Stage|Regional lymph node staging illustrates the amount of cancer spread to nearby lymph nodes, notations are NX: Regional lymph nodes cannot be evaluated; N0: No regional lymph node involvement; N1, N2, N3: Degree of regional lymph node involvement (number and location of lymph nodes)|Participants|Number|14|14.0||||||
4306475|NCT00499603|4133706|B2|N0||Regional Lymph Node Stage|Regional lymph node staging illustrates the amount of cancer spread to nearby lymph nodes, notations are NX: Regional lymph nodes cannot be evaluated; N0: No regional lymph node involvement; N1, N2, N3: Degree of regional lymph node involvement (number and location of lymph nodes)|Participants|Number|6|6.0||||||
4306476|NCT00499603|4133707|B1|N0||Regional Lymph Node Stage|Regional lymph node staging illustrates the amount of cancer spread to nearby lymph nodes, notations are NX: Regional lymph nodes cannot be evaluated; N0: No regional lymph node involvement; N1, N2, N3: Degree of regional lymph node involvement (number and location of lymph nodes)|Participants|Number|8|8.0||||||
4306477|NCT00499603|4133705|B3|Unknown or Not Reported||Cancer Clinical Stage|Clinical staging describes the extent or severity of a person’s cancer where T1, T2, T3, T4 define the size and/or extent of the primary tumor with the higher numbers indicating more extensive disease.|participants|Number|1|1.0||||||
4306478|NCT00499603|4133706|B2|Unknown or Not Reported||Cancer Clinical Stage|Clinical staging describes the extent or severity of a person’s cancer where T1, T2, T3, T4 define the size and/or extent of the primary tumor with the higher numbers indicating more extensive disease.|participants|Number|1|1.0||||||
4306479|NCT00499603|4133707|B1|Unknown or Not Reported||Cancer Clinical Stage|Clinical staging describes the extent or severity of a person’s cancer where T1, T2, T3, T4 define the size and/or extent of the primary tumor with the higher numbers indicating more extensive disease.|participants|Number|0|0.0||||||
4306480|NCT00499603|4133705|B3|T4||Cancer Clinical Stage|Clinical staging describes the extent or severity of a person’s cancer where T1, T2, T3, T4 define the size and/or extent of the primary tumor with the higher numbers indicating more extensive disease.|participants|Number|2|2.0||||||
4306481|NCT00499603|4133706|B2|T4||Cancer Clinical Stage|Clinical staging describes the extent or severity of a person’s cancer where T1, T2, T3, T4 define the size and/or extent of the primary tumor with the higher numbers indicating more extensive disease.|participants|Number|1|1.0||||||
4306482|NCT00499603|4133707|B1|T4||Cancer Clinical Stage|Clinical staging describes the extent or severity of a person’s cancer where T1, T2, T3, T4 define the size and/or extent of the primary tumor with the higher numbers indicating more extensive disease.|participants|Number|1|1.0||||||
4306483|NCT00499603|4133705|B3|T3||Cancer Clinical Stage|Clinical staging describes the extent or severity of a person’s cancer where T1, T2, T3, T4 define the size and/or extent of the primary tumor with the higher numbers indicating more extensive disease.|participants|Number|5|5.0||||||
4306484|NCT00499603|4133706|B2|T3||Cancer Clinical Stage|Clinical staging describes the extent or severity of a person’s cancer where T1, T2, T3, T4 define the size and/or extent of the primary tumor with the higher numbers indicating more extensive disease.|participants|Number|1|1.0||||||
4306485|NCT00499603|4133707|B1|T3||Cancer Clinical Stage|Clinical staging describes the extent or severity of a person’s cancer where T1, T2, T3, T4 define the size and/or extent of the primary tumor with the higher numbers indicating more extensive disease.|participants|Number|4|4.0||||||
4306486|NCT00499603|4133705|B3|T2||Cancer Clinical Stage|Clinical staging describes the extent or severity of a person’s cancer where T1, T2, T3, T4 define the size and/or extent of the primary tumor with the higher numbers indicating more extensive disease.|participants|Number|35|35.0||||||
4306487|NCT00499603|4133706|B2|T2||Cancer Clinical Stage|Clinical staging describes the extent or severity of a person’s cancer where T1, T2, T3, T4 define the size and/or extent of the primary tumor with the higher numbers indicating more extensive disease.|participants|Number|17|17.0||||||
4306488|NCT00499603|4133707|B1|T2||Cancer Clinical Stage|Clinical staging describes the extent or severity of a person’s cancer where T1, T2, T3, T4 define the size and/or extent of the primary tumor with the higher numbers indicating more extensive disease.|participants|Number|18|18.0||||||
4306489|NCT00499603|4133705|B3|T1||Cancer Clinical Stage|Clinical staging describes the extent or severity of a person’s cancer where T1, T2, T3, T4 define the size and/or extent of the primary tumor with the higher numbers indicating more extensive disease.|participants|Number|7|7.0||||||
4306490|NCT00499603|4133706|B2|T1||Cancer Clinical Stage|Clinical staging describes the extent or severity of a person’s cancer where T1, T2, T3, T4 define the size and/or extent of the primary tumor with the higher numbers indicating more extensive disease.|participants|Number|3|3.0||||||
4306491|NCT00499603|4133707|B1|T1||Cancer Clinical Stage|Clinical staging describes the extent or severity of a person’s cancer where T1, T2, T3, T4 define the size and/or extent of the primary tumor with the higher numbers indicating more extensive disease.|participants|Number|4|4.0||||||
4306492|NCT00499603|4133705|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4306493|NCT00499603|4133706|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4306494|NCT00499603|4133707|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4306495|NCT00499603|4133705|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4306496|NCT00499603|4133706|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306499|NCT00499603|4133706|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306500|NCT00499603|4133707|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306501|NCT00499603|4133705|B3||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4306502|NCT00499603|4133706|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4306503|NCT00499603|4133707|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4306504|NCT00499603|4133705|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4306505|NCT00499603|4133706|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4306506|NCT00499603|4133707|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4306507|NCT00499603|4133705|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306508|NCT00499603|4133706|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306509|NCT00499603|4133707|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306510|NCT00499603|4133705|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4306511|NCT00499603|4133706|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306512|NCT00499603|4133707|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4306513|NCT00499603|4133705|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306514|NCT00499603|4133706|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306515|NCT00499603|4133707|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306516|NCT00499603|4133705|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306517|NCT00499603|4133706|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306518|NCT00499603|4133707|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306519|NCT00499603|4133705|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4306520|NCT00499603|4133706|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4306521|NCT00499603|4133707|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4306522|NCT00499603|4133705|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4306523|NCT00499603|4133706|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306524|NCT00499603|4133707|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4306525|NCT00499603|4133705|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4306526|NCT00499603|4133706|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4306527|NCT00499603|4133707|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4306528|NCT00499603|4133705|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4306529|NCT00499603|4133706|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4306530|NCT00499603|4133707|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4306531|NCT00499603|4133705|B3|||Age||years|Median|48|48.0|Full Range|||30.0|75.0|
4306532|NCT00499603|4133706|B2|||Age||years|Median|46|46.0|Full Range|||32.0|75.0|
4306533|NCT00499603|4133707|B1|||Age||years|Median|52|52.0|Full Range|||30.0|65.0|
4306534|NCT00499590|4133718|B4|Spain||Region of Enrollment||participants|Number|10|10.0||||||
4306535|NCT00499590|4133719|B3|Spain||Region of Enrollment||participants|Number|7|7.0||||||
4306536|NCT00499590|4133720|B2|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4306537|NCT00499590|4133721|B1|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4306538|NCT00499590|4133718|B4|Portugal||Region of Enrollment||participants|Number|11|11.0||||||
4306539|NCT00499590|4133719|B3|Portugal||Region of Enrollment||participants|Number|5|5.0||||||
4306540|NCT00499590|4133720|B2|Portugal||Region of Enrollment||participants|Number|3|3.0||||||
4306541|NCT00499590|4133721|B1|Portugal||Region of Enrollment||participants|Number|3|3.0||||||
4306542|NCT00499590|4133718|B4|Italy||Region of Enrollment||participants|Number|9|9.0||||||
4306543|NCT00499590|4133719|B3|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4306544|NCT00499590|4133720|B2|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4306545|NCT00499590|4133721|B1|Italy||Region of Enrollment||participants|Number|5|5.0||||||
4306546|NCT00499590|4133718|B4|Israel||Region of Enrollment||participants|Number|22|22.0||||||
4306547|NCT00499590|4133719|B3|Israel||Region of Enrollment||participants|Number|6|6.0||||||
4306548|NCT00499590|4133720|B2|Israel||Region of Enrollment||participants|Number|7|7.0||||||
4306549|NCT00499590|4133721|B1|Israel||Region of Enrollment||participants|Number|9|9.0||||||
4306550|NCT00499590|4133718|B4|France||Region of Enrollment||participants|Number|66|66.0||||||
4306551|NCT00499590|4133719|B3|France||Region of Enrollment||participants|Number|20|20.0||||||
4306552|NCT00499590|4133720|B2|France||Region of Enrollment||participants|Number|24|24.0||||||
4306553|NCT00499590|4133721|B1|France||Region of Enrollment||participants|Number|22|22.0||||||
4306554|NCT00499590|4133718|B4|Canada||Region of Enrollment||participants|Number|23|23.0||||||
4306555|NCT00499590|4133719|B3|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4306556|NCT00499590|4133720|B2|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4306557|NCT00499590|4133721|B1|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4306558|NCT00499590|4133718|B4|Austria||Region of Enrollment||participants|Number|13|13.0||||||
4306559|NCT00499590|4133719|B3|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4306560|NCT00499590|4133720|B2|Austria||Region of Enrollment||participants|Number|5|5.0||||||
4306561|NCT00499590|4133721|B1|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4306562|NCT00499590|4133718|B4|United States||Region of Enrollment||participants|Number|184|184.0||||||
4306563|NCT00499590|4133719|B3|United States||Region of Enrollment||participants|Number|64|64.0||||||
4306564|NCT00499590|4133720|B2|United States||Region of Enrollment||participants|Number|59|59.0||||||
4306565|NCT00499590|4133721|B1|United States||Region of Enrollment||participants|Number|61|61.0||||||
4306566|NCT00499590|4133718|B4||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4306567|NCT00499590|4133719|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4306568|NCT00499590|4133720|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4306569|NCT00499590|4133721|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4306570|NCT00499590|4133718|B4||Female|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4306571|NCT00499590|4133719|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4306572|NCT00499590|4133720|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4306573|NCT00499590|4133721|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4306574|NCT00499590|4133718|B4|||Age||years|Mean|77.7|77.7|Full Range|||52.0|95.0|
4306575|NCT00499590|4133719|B3|||Age||years|Mean|78.3|78.3|Full Range|||57.0|94.0|
4306576|NCT00499590|4133720|B2|||Age||years|Mean|77.2|77.2|Full Range|||52.0|95.0|
4306577|NCT00499590|4133721|B1|||Age||years|Mean|77.6|77.6|Full Range|||56.0|90.0|
4306578|NCT00499486|4133734|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
4306579|NCT00499486|4133734|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4306580|NCT00499486|4133734|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4306581|NCT00499486|4133734|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4306582|NCT00499486|4133734|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4306583|NCT00499486|4133734|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4306584|NCT00499473|4133740|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4306585|NCT00499473|4133741|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4306586|NCT00499473|4133742|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4306587|NCT00499473|4133740|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4306588|NCT00499473|4133741|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4306589|NCT00499473|4133742|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4306590|NCT00499473|4133740|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4306591|NCT00499473|4133741|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4306592|NCT00499473|4133742|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4306593|NCT00499473|4133740|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4306594|NCT00499473|4133741|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4306595|NCT00499473|4133742|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4306596|NCT00499473|4133740|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4306597|NCT00499473|4133741|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4306598|NCT00499473|4133742|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4306599|NCT00499473|4133740|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4306600|NCT00499473|4133741|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4306601|NCT00499473|4133742|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4306602|NCT00499460|4133759|B3|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4306603|NCT00499460|4133760|B2|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4306604|NCT00499460|4133761|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4306605|NCT00499460|4133759|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306606|NCT00499460|4133760|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306607|NCT00499460|4133761|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306608|NCT00499460|4133759|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306609|NCT00499460|4133760|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306610|NCT00499460|4133761|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306611|NCT00499460|4133759|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4306612|NCT00499460|4133760|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4306613|NCT00499460|4133761|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4306614|NCT00499460|4133759|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306615|NCT00499460|4133760|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306616|NCT00499460|4133761|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306617|NCT00499460|4133759|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306618|NCT00499460|4133760|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306677|NCT00499369|4133791|B5|FOLFIRI||Planned concurrent chemotherapy||participants|Number|8|8.0||||||
4306619|NCT00499460|4133761|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306620|NCT00499460|4133759|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4306621|NCT00499460|4133760|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4306622|NCT00499460|4133761|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306623|NCT00499460|4133759|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306624|NCT00499460|4133760|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306625|NCT00499460|4133761|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306626|NCT00499460|4133759|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306627|NCT00499460|4133760|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306628|NCT00499460|4133761|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306629|NCT00499460|4133759|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4306630|NCT00499460|4133760|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4306631|NCT00499460|4133761|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4306632|NCT00499460|4133759|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4306633|NCT00499460|4133760|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306634|NCT00499460|4133761|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4306635|NCT00499460|4133759|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4306636|NCT00499460|4133760|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4306637|NCT00499460|4133761|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4306638|NCT00499460|4133759|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4306639|NCT00499460|4133760|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4306640|NCT00499460|4133761|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4306641|NCT00499460|4133759|B3|||Age||years|Mean|29.9|29.9|Standard Deviation|5.8|5.8|||
4306642|NCT00499460|4133760|B2|||Age||years|Mean|30.5|30.5|Standard Deviation|6.0|6.0|||
4306643|NCT00499460|4133761|B1|||Age||years|Mean|28.3|28.3|Standard Deviation|5.2|5.2|||
4306644|NCT00499447|4133778|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4306645|NCT00499447|4133778|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4306646|NCT00499447|4133778|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4306647|NCT00499447|4133778|B1|||Age||years|Mean|70.5|70.5|Standard Deviation|9.7|9.7|||
4306648|NCT00499447|4133778|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4306649|NCT00499447|4133778|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4306650|NCT00499447|4133778|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4306651|NCT00499408|4133782|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4306652|NCT00499408|4133782|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4306653|NCT00499408|4133782|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4306654|NCT00499408|4133782|B1|||Age||years|Mean|72.4|72.4|Standard Deviation|8.8|8.8|||
4306655|NCT00499408|4133782|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4306656|NCT00499408|4133782|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4306657|NCT00499408|4133782|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4306658|NCT00499369|4133790|B6|43 days or higher||Time from last dose of bevacizumab||participants|Number|14|14.0||||||
4306659|NCT00499369|4133791|B5|43 days or higher||Time from last dose of bevacizumab||participants|Number|4|4.0||||||
4306660|NCT00499369|4133792|B4|43 days or higher||Time from last dose of bevacizumab||participants|Number|2|2.0||||||
4306661|NCT00499369|4133793|B3|43 days or higher||Time from last dose of bevacizumab||participants|Number|3|3.0||||||
4306662|NCT00499369|4133794|B2|43 days or higher||Time from last dose of bevacizumab||participants|Number|3|3.0||||||
4306663|NCT00499369|4133795|B1|43 days or higher||Time from last dose of bevacizumab||participants|Number|2|2.0||||||
4306664|NCT00499369|4133790|B6|14-42 days||Time from last dose of bevacizumab||participants|Number|52|52.0||||||
4306665|NCT00499369|4133791|B5|14-42 days||Time from last dose of bevacizumab||participants|Number|8|8.0||||||
4306666|NCT00499369|4133792|B4|14-42 days||Time from last dose of bevacizumab||participants|Number|6|6.0||||||
4306667|NCT00499369|4133793|B3|14-42 days||Time from last dose of bevacizumab||participants|Number|13|13.0||||||
4306668|NCT00499369|4133794|B2|14-42 days||Time from last dose of bevacizumab||participants|Number|13|13.0||||||
4306669|NCT00499369|4133795|B1|14-42 days||Time from last dose of bevacizumab||participants|Number|12|12.0||||||
4306670|NCT00499369|4133790|B6|Single-agent irinotecan||Planned concurrent chemotherapy||participants|Number|20|20.0||||||
4306671|NCT00499369|4133791|B5|Single-agent irinotecan||Planned concurrent chemotherapy||participants|Number|4|4.0||||||
4306672|NCT00499369|4133792|B4|Single-agent irinotecan||Planned concurrent chemotherapy||participants|Number|3|3.0||||||
4306673|NCT00499369|4133793|B3|Single-agent irinotecan||Planned concurrent chemotherapy||participants|Number|4|4.0||||||
4306674|NCT00499369|4133794|B2|Single-agent irinotecan||Planned concurrent chemotherapy||participants|Number|5|5.0||||||
4306675|NCT00499369|4133795|B1|Single-agent irinotecan||Planned concurrent chemotherapy||participants|Number|4|4.0||||||
4306676|NCT00499369|4133790|B6|FOLFIRI||Planned concurrent chemotherapy||participants|Number|46|46.0||||||
4306678|NCT00499369|4133792|B4|FOLFIRI||Planned concurrent chemotherapy||participants|Number|5|5.0||||||
4306679|NCT00499369|4133793|B3|FOLFIRI||Planned concurrent chemotherapy||participants|Number|12|12.0||||||
4306680|NCT00499369|4133794|B2|FOLFIRI||Planned concurrent chemotherapy||participants|Number|11|11.0||||||
4306681|NCT00499369|4133795|B1|FOLFIRI||Planned concurrent chemotherapy||participants|Number|10|10.0||||||
4306682|NCT00499369|4133790|B6|Did not discontinue||Discontinuation of oxaliplatin while on first-line treatment||participants|Number|31|31.0||||||
4306683|NCT00499369|4133791|B5|Did not discontinue||Discontinuation of oxaliplatin while on first-line treatment||participants|Number|3|3.0||||||
4306684|NCT00499369|4133792|B4|Did not discontinue||Discontinuation of oxaliplatin while on first-line treatment||participants|Number|4|4.0||||||
4306685|NCT00499369|4133793|B3|Did not discontinue||Discontinuation of oxaliplatin while on first-line treatment||participants|Number|8|8.0||||||
4306686|NCT00499369|4133794|B2|Did not discontinue||Discontinuation of oxaliplatin while on first-line treatment||participants|Number|7|7.0||||||
4306687|NCT00499369|4133795|B1|Did not discontinue||Discontinuation of oxaliplatin while on first-line treatment||participants|Number|9|9.0||||||
4306688|NCT00499369|4133790|B6|Discontinued||Discontinuation of oxaliplatin while on first-line treatment||participants|Number|35|35.0||||||
4306689|NCT00499369|4133791|B5|Discontinued||Discontinuation of oxaliplatin while on first-line treatment||participants|Number|9|9.0||||||
4306690|NCT00499369|4133792|B4|Discontinued||Discontinuation of oxaliplatin while on first-line treatment||participants|Number|4|4.0||||||
4306691|NCT00499369|4133793|B3|Discontinued||Discontinuation of oxaliplatin while on first-line treatment||participants|Number|8|8.0||||||
4306692|NCT00499369|4133794|B2|Discontinued||Discontinuation of oxaliplatin while on first-line treatment||participants|Number|9|9.0||||||
4306693|NCT00499369|4133795|B1|Discontinued||Discontinuation of oxaliplatin while on first-line treatment||participants|Number|5|5.0||||||
4306694|NCT00499369|4133790|B6|>= 1||Performance Status|Patients graded according to the Zubrod Performance Status Scale: 0 is fully active, able to carry on all pre-disease performance without restriction; 1 is restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2 is ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours; 3 is capable of limited self-care, confined to bed or chair more than 50% of waking hours; and 4 is completely disabled, cannot carry on any self-care, totally confined to bed or chair.|participants|Number|36|36.0||||||
4306695|NCT00499369|4133791|B5|>= 1||Performance Status|Patients graded according to the Zubrod Performance Status Scale: 0 is fully active, able to carry on all pre-disease performance without restriction; 1 is restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2 is ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours; 3 is capable of limited self-care, confined to bed or chair more than 50% of waking hours; and 4 is completely disabled, cannot carry on any self-care, totally confined to bed or chair.|participants|Number|8|8.0||||||
4306696|NCT00499369|4133792|B4|>= 1||Performance Status|Patients graded according to the Zubrod Performance Status Scale: 0 is fully active, able to carry on all pre-disease performance without restriction; 1 is restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2 is ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours; 3 is capable of limited self-care, confined to bed or chair more than 50% of waking hours; and 4 is completely disabled, cannot carry on any self-care, totally confined to bed or chair.|participants|Number|7|7.0||||||
4306697|NCT00499369|4133793|B3|>= 1||Performance Status|Patients graded according to the Zubrod Performance Status Scale: 0 is fully active, able to carry on all pre-disease performance without restriction; 1 is restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2 is ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours; 3 is capable of limited self-care, confined to bed or chair more than 50% of waking hours; and 4 is completely disabled, cannot carry on any self-care, totally confined to bed or chair.|participants|Number|8|8.0||||||
4306698|NCT00499369|4133794|B2|>= 1||Performance Status|Patients graded according to the Zubrod Performance Status Scale: 0 is fully active, able to carry on all pre-disease performance without restriction; 1 is restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2 is ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours; 3 is capable of limited self-care, confined to bed or chair more than 50% of waking hours; and 4 is completely disabled, cannot carry on any self-care, totally confined to bed or chair.|participants|Number|8|8.0||||||
4306699|NCT00499369|4133795|B1|>= 1||Performance Status|Patients graded according to the Zubrod Performance Status Scale: 0 is fully active, able to carry on all pre-disease performance without restriction; 1 is restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2 is ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours; 3 is capable of limited self-care, confined to bed or chair more than 50% of waking hours; and 4 is completely disabled, cannot carry on any self-care, totally confined to bed or chair.|participants|Number|5|5.0||||||
4306700|NCT00499369|4133790|B6|0||Performance Status|Patients graded according to the Zubrod Performance Status Scale: 0 is fully active, able to carry on all pre-disease performance without restriction; 1 is restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2 is ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours; 3 is capable of limited self-care, confined to bed or chair more than 50% of waking hours; and 4 is completely disabled, cannot carry on any self-care, totally confined to bed or chair.|participants|Number|30|30.0||||||
4306737|NCT00499369|4133791|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306738|NCT00499369|4133792|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306739|NCT00499369|4133793|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4306740|NCT00499369|4133794|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306741|NCT00499369|4133795|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306701|NCT00499369|4133791|B5|0||Performance Status|Patients graded according to the Zubrod Performance Status Scale: 0 is fully active, able to carry on all pre-disease performance without restriction; 1 is restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2 is ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours; 3 is capable of limited self-care, confined to bed or chair more than 50% of waking hours; and 4 is completely disabled, cannot carry on any self-care, totally confined to bed or chair.|participants|Number|4|4.0||||||
4306702|NCT00499369|4133792|B4|0||Performance Status|Patients graded according to the Zubrod Performance Status Scale: 0 is fully active, able to carry on all pre-disease performance without restriction; 1 is restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2 is ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours; 3 is capable of limited self-care, confined to bed or chair more than 50% of waking hours; and 4 is completely disabled, cannot carry on any self-care, totally confined to bed or chair.|participants|Number|1|1.0||||||
4306703|NCT00499369|4133793|B3|0||Performance Status|Patients graded according to the Zubrod Performance Status Scale: 0 is fully active, able to carry on all pre-disease performance without restriction; 1 is restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2 is ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours; 3 is capable of limited self-care, confined to bed or chair more than 50% of waking hours; and 4 is completely disabled, cannot carry on any self-care, totally confined to bed or chair.|participants|Number|8|8.0||||||
4306704|NCT00499369|4133794|B2|0||Performance Status|Patients graded according to the Zubrod Performance Status Scale: 0 is fully active, able to carry on all pre-disease performance without restriction; 1 is restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2 is ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours; 3 is capable of limited self-care, confined to bed or chair more than 50% of waking hours; and 4 is completely disabled, cannot carry on any self-care, totally confined to bed or chair.|participants|Number|8|8.0||||||
4306705|NCT00499369|4133795|B1|0||Performance Status|Patients graded according to the Zubrod Performance Status Scale: 0 is fully active, able to carry on all pre-disease performance without restriction; 1 is restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2 is ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours; 3 is capable of limited self-care, confined to bed or chair more than 50% of waking hours; and 4 is completely disabled, cannot carry on any self-care, totally confined to bed or chair.|participants|Number|9|9.0||||||
4306706|NCT00499369|4133790|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4306707|NCT00499369|4133791|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4306708|NCT00499369|4133792|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4306709|NCT00499369|4133793|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4306710|NCT00499369|4133794|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4306711|NCT00499369|4133795|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4306712|NCT00499369|4133790|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306713|NCT00499369|4133791|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306714|NCT00499369|4133792|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306715|NCT00499369|4133793|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306716|NCT00499369|4133794|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306717|NCT00499369|4133795|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306718|NCT00499369|4133790|B6||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4306719|NCT00499369|4133791|B5||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4306720|NCT00499369|4133792|B4||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4306721|NCT00499369|4133793|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4306722|NCT00499369|4133794|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4306723|NCT00499369|4133795|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4306724|NCT00499369|4133790|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4306725|NCT00499369|4133791|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306726|NCT00499369|4133792|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306727|NCT00499369|4133793|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306728|NCT00499369|4133794|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4306729|NCT00499369|4133795|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4306730|NCT00499369|4133790|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306731|NCT00499369|4133791|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306732|NCT00499369|4133792|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306733|NCT00499369|4133793|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306734|NCT00499369|4133794|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306735|NCT00499369|4133795|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306736|NCT00499369|4133790|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4306742|NCT00499369|4133790|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4306743|NCT00499369|4133791|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306744|NCT00499369|4133792|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306745|NCT00499369|4133793|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4306746|NCT00499369|4133794|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306747|NCT00499369|4133795|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306748|NCT00499369|4133790|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4306749|NCT00499369|4133791|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4306750|NCT00499369|4133792|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306751|NCT00499369|4133793|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4306752|NCT00499369|4133794|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306753|NCT00499369|4133795|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306754|NCT00499369|4133790|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4306755|NCT00499369|4133791|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4306756|NCT00499369|4133792|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4306757|NCT00499369|4133793|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4306758|NCT00499369|4133794|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4306759|NCT00499369|4133795|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4306760|NCT00499369|4133790|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4306761|NCT00499369|4133791|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4306762|NCT00499369|4133792|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4306763|NCT00499369|4133793|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4306764|NCT00499369|4133794|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4306765|NCT00499369|4133795|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4306766|NCT00499369|4133790|B6||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4306767|NCT00499369|4133791|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4306768|NCT00499369|4133792|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4306769|NCT00499369|4133793|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4306770|NCT00499369|4133794|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4306771|NCT00499369|4133795|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4306772|NCT00499369|4133790|B6||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4306773|NCT00499369|4133791|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4306774|NCT00499369|4133792|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4306775|NCT00499369|4133793|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4306776|NCT00499369|4133794|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4306777|NCT00499369|4133795|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4306778|NCT00499369|4133790|B6|||Age||years|Median|60|60.0|Full Range|||37.0|77.0|
4306779|NCT00499369|4133791|B5|||Age||years|Median|59|59.0|Full Range|||38.0|70.0|
4306780|NCT00499369|4133792|B4|||Age||years|Median|65|65.0|Full Range|||47.0|73.0|
4306781|NCT00499369|4133793|B3|||Age||years|Median|58|58.0|Full Range|||46.0|75.0|
4306782|NCT00499369|4133794|B2|||Age||years|Median|63|63.0|Full Range|||37.0|77.0|
4306783|NCT00499369|4133795|B1|||Age||years|Median|60|60.0|Full Range|||44.0|76.0|
4306784|NCT00499343|4133826|B3|United States||Region of Enrollment||participants|Number|84.0|84.0||||||
4306785|NCT00499343|4133827|B2|United States||Region of Enrollment||participants|Number|43|43.0||||||
4306786|NCT00499343|4133828|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4306787|NCT00499343|4133826|B3||Male|Sex: Female, Male||Participants|Count of Participants|53.0|53.0||||||
4306788|NCT00499343|4133827|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4306789|NCT00499343|4133828|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4306790|NCT00499343|4133826|B3||Female|Sex: Female, Male||Participants|Count of Participants|31.0|31.0||||||
4306791|NCT00499343|4133827|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4306792|NCT00499343|4133828|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4306793|NCT00499343|4133826|B3|Between 60 and 79 years||Age, Customized||participants|Number|22.0|22.0||||||
4306794|NCT00499343|4133827|B2|Between 60 and 79 years||Age, Customized||participants|Number|10|10.0||||||
4306795|NCT00499343|4133828|B1|Between 60 and 79 years||Age, Customized||participants|Number|12|12.0||||||
4306796|NCT00499343|4133826|B3|Between 40 and 59 years||Age, Customized||participants|Number|55.0|55.0||||||
4306797|NCT00499343|4133827|B2|Between 40 and 59 years||Age, Customized||participants|Number|29|29.0||||||
4306798|NCT00499343|4133828|B1|Between 40 and 59 years||Age, Customized||participants|Number|26|26.0||||||
4306799|NCT00499343|4133826|B3|Between 20 and 39 years||Age, Customized||participants|Number|7.0|7.0||||||
4306800|NCT00499343|4133827|B2|Between 20 and 39 years||Age, Customized||participants|Number|4|4.0||||||
4306801|NCT00499343|4133828|B1|Between 20 and 39 years||Age, Customized||participants|Number|3|3.0||||||
4306802|NCT00499252|4133835|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4306803|NCT00499252|4133835|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4306804|NCT00499252|4133835|B1|70-79 years||Age, Customized||participants|Number|7|7.0||||||
4306805|NCT00499252|4133835|B1|60-69 years||Age, Customized||participants|Number|15|15.0||||||
4306806|NCT00499252|4133835|B1|50-59 years||Age, Customized||participants|Number|16|16.0||||||
4306807|NCT00499252|4133835|B1|40-49 years||Age, Customized||participants|Number|8|8.0||||||
4306808|NCT00499252|4133835|B1|30-39 years||Age, Customized||participants|Number|1|1.0||||||
4306809|NCT00499252|4133835|B1|20-29 years||Age, Customized||participants|Number|0|0.0||||||
4306810|NCT00499122|4133845|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4306811|NCT00499122|4133845|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306812|NCT00499122|4133845|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306813|NCT00499122|4133845|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4306814|NCT00499122|4133845|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4306815|NCT00499122|4133845|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306816|NCT00499122|4133845|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4306817|NCT00499122|4133845|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306818|NCT00499122|4133845|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4306819|NCT00499122|4133845|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4306820|NCT00499122|4133845|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4306821|NCT00499122|4133845|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4306822|NCT00499122|4133845|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4306823|NCT00499122|4133845|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4306824|NCT00499122|4133845|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4306825|NCT00499122|4133845|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4306826|NCT00499109|4133851|B3|Germany||Region of Enrollment||participants|Number|40|40.0||||||
4306827|NCT00499109|4133852|B2|Germany||Region of Enrollment||participants|Number|16|16.0||||||
4306828|NCT00499109|4133853|B1|Germany||Region of Enrollment||participants|Number|24|24.0||||||
4306829|NCT00499109|4133851|B3|Puerto Rico||Region of Enrollment||participants|Number|4|4.0||||||
4306830|NCT00499109|4133852|B2|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
4306831|NCT00499109|4133853|B1|Puerto Rico||Region of Enrollment||participants|Number|3|3.0||||||
4306832|NCT00499109|4133851|B3|United States||Region of Enrollment||participants|Number|231|231.0||||||
4306833|NCT00499109|4133852|B2|United States||Region of Enrollment||participants|Number|75|75.0||||||
4306834|NCT00499109|4133853|B1|United States||Region of Enrollment||participants|Number|156|156.0||||||
4306835|NCT00499109|4133851|B3||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4306836|NCT00499109|4133852|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4306837|NCT00499109|4133853|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4306838|NCT00499109|4133851|B3||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4306839|NCT00499109|4133852|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4306840|NCT00499109|4133853|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4306841|NCT00499109|4133851|B3|||Age||years|Mean|63.5|63.5|Full Range|||39.6|85.0|
4306842|NCT00499109|4133852|B2|||Age||years|Mean|62.3|62.3|Full Range|||39.6|82.5|
4306843|NCT00499109|4133853|B1|||Age||years|Mean|64.1|64.1|Full Range|||42.1|85.0|
4306844|NCT00499096|4133867|B3|United States||Region of Enrollment||participants|Number|118|118.0||||||
4306845|NCT00499096|4133868|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
4306846|NCT00499096|4133869|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
4306847|NCT00499096|4133867|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4306848|NCT00499096|4133868|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4306849|NCT00499096|4133869|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4306850|NCT00499096|4133867|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4306851|NCT00499096|4133868|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4306852|NCT00499096|4133869|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4306853|NCT00499096|4133867|B3|||Age||years|Mean|52.8|52.8|Standard Deviation|9.9|9.9|||
4306854|NCT00499096|4133868|B2|||Age||years|Mean|52.4|52.4|Standard Deviation|9.2|9.2|||
4306855|NCT00499096|4133869|B1|||Age||years|Mean|53.1|53.1|Standard Deviation|10.6|10.6|||
4306856|NCT00499083|4133888|B1|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4306857|NCT00499083|4133888|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4306858|NCT00499083|4133888|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4306859|NCT00499083|4133888|B1|||Age||years|Median|51.5|51.5|Full Range|||0.0|0.0|Only median value available from existing documentation, no other documentation exists.
4306860|NCT00499031|4133895|B1|Squamous Cell Carcinoma||Cell Type||participants|Number|24|24.0||||||
4306861|NCT00499031|4133895|B1|Adenosquamous||Cell Type||participants|Number|6|6.0||||||
4306862|NCT00499031|4133895|B1|Mixed Epithelial Carcinoma||Cell Type||participants|Number|1|1.0||||||
4306863|NCT00499031|4133895|B1|Adenocarcinoma, Unspecified||Cell Type||participants|Number|4|4.0||||||
4306864|NCT00499031|4133895|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4306865|NCT00499031|4133895|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4306866|NCT00499031|4133895|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4306867|NCT00499031|4133895|B1|60-69 years||Age, Customized||participants|Number|6|6.0||||||
4306868|NCT00499031|4133895|B1|50-59 years||Age, Customized||participants|Number|10|10.0||||||
4306869|NCT00499031|4133895|B1|40-49 years||Age, Customized||participants|Number|16|16.0||||||
4306870|NCT00499031|4133895|B1|30-39 years||Age, Customized||participants|Number|3|3.0||||||
4306871|NCT00499031|4133895|B1|||Age, Customized||years|Mean|49.7|49.7|Standard Deviation|9.3|9.3|||
4306872|NCT00498940|4133900|B3|||QRS duration (ms)||msec|Mean|119.3|119.3|Standard Deviation|25.3|25.3|||
4306873|NCT00498940|4133901|B2|||QRS duration (ms)||msec|Mean|118.6|118.6|Standard Deviation|23.0|23.0|||
4306874|NCT00498940|4133902|B1|||QRS duration (ms)||msec|Mean|120.1|120.1|Standard Deviation|27.9|27.9|||
4306875|NCT00498940|4133900|B3|||Ejection Fraction (%)||percentage of ventricular blood pumped|Mean|33|33.0|Standard Deviation|.1|0.1|||
4306876|NCT00498940|4133901|B2|||Ejection Fraction (%)||percentage of ventricular blood pumped|Mean|32|32.0|Standard Deviation|.2|0.2|||
4306877|NCT00498940|4133902|B1|||Ejection Fraction (%)||percentage of ventricular blood pumped|Mean|34|34.0|Standard Deviation|.1|0.1|||
4306878|NCT00498940|4133900|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4306879|NCT00498940|4133901|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4306880|NCT00498940|4133902|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4306881|NCT00498940|4133900|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4306882|NCT00498940|4133901|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4306883|NCT00498940|4133902|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4306884|NCT00498940|4133900|B3|||Age||years|Mean|67.5|67.5|Standard Deviation|11.4|11.4|||
4306885|NCT00498940|4133901|B2|||Age||years|Mean|67.9|67.9|Standard Deviation|11.7|11.7|||
4306886|NCT00498940|4133902|B1|||Age||years|Mean|67.2|67.2|Standard Deviation|11.2|11.2|||
4306887|NCT00498927|4133911|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4306888|NCT00498927|4133911|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4306889|NCT00498927|4133911|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4306890|NCT00498927|4133911|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4306891|NCT00498927|4133911|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4306892|NCT00498797|4133916|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4306893|NCT00498797|4133917|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4306894|NCT00498797|4133918|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4306895|NCT00498797|4133916|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4306896|NCT00498797|4133917|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4306897|NCT00498797|4133918|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4306898|NCT00498797|4133916|B3|||Age||years|Mean|67|67.0|Full Range|||43.0|81.0|
4306899|NCT00498797|4133917|B2|||Age||years|Mean|67|67.0|Full Range|||43.0|79.0|
4306900|NCT00498797|4133918|B1|||Age||years|Mean|67|67.0|Full Range|||47.0|81.0|
4306901|NCT00498706|4133927|B3|United States||Region of Enrollment||participants|Number|325|325.0||||||
4306902|NCT00498706|4133928|B2|United States||Region of Enrollment||participants|Number|162|162.0||||||
4306903|NCT00498706|4133929|B1|United States||Region of Enrollment||participants|Number|163|163.0||||||
4306904|NCT00498706|4133927|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4306905|NCT00498706|4133928|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4306906|NCT00498706|4133929|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4306907|NCT00498706|4133927|B3||Female|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
4306908|NCT00498706|4133928|B2||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4306909|NCT00498706|4133929|B1||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4306910|NCT00498706|4133927|B3|||Age||years|Mean|47.6|47.6|Standard Deviation|13.1|13.1|||
4306911|NCT00498706|4133928|B2|||Age||years|Mean|47.5|47.5|Standard Deviation|13.5|13.5|||
4306912|NCT00498706|4133929|B1|||Age||years|Mean|47.8|47.8|Standard Deviation|12.6|12.6|||
4306913|NCT00498706|4133927|B3||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4306914|NCT00498706|4133928|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4306915|NCT00498706|4133929|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4306916|NCT00498706|4133927|B3||Between 18 and 65 years|Age||Participants|Count of Participants|298|298.0||||||
4306917|NCT00498706|4133928|B2||Between 18 and 65 years|Age||Participants|Count of Participants|148|148.0||||||
4306918|NCT00498706|4133929|B1||Between 18 and 65 years|Age||Participants|Count of Participants|150|150.0||||||
4306919|NCT00498706|4133927|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4306920|NCT00498706|4133928|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4306921|NCT00498706|4133929|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4306922|NCT00498628|4133942|B3|United States||Region of Enrollment||participants|Number|218|218.0||||||
4306923|NCT00498628|4133943|B2|United States||Region of Enrollment||participants|Number|113|113.0||||||
4306924|NCT00498628|4133944|B1|United States||Region of Enrollment||participants|Number|105|105.0||||||
4306925|NCT00498628|4133942|B3||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4306926|NCT00498628|4133943|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4306927|NCT00498628|4133944|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4306928|NCT00498628|4133942|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4306929|NCT00498628|4133943|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4306930|NCT00498628|4133944|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4306931|NCT00498628|4133942|B3|||Age||years|Mean|45.4|45.4|Standard Deviation|9.4|9.4|||
4306932|NCT00498628|4133943|B2|||Age||years|Mean|45.5|45.5|Standard Deviation|9.8|9.8|||
4306933|NCT00498628|4133944|B1|||Age||years|Mean|45.4|45.4|Standard Deviation|9.3|9.3|||
4306934|NCT00498628|4133942|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4306935|NCT00498628|4133943|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4306936|NCT00498628|4133944|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4306937|NCT00498628|4133942|B3||Between 18 and 65 years|Age||Participants|Count of Participants|218|218.0||||||
4306938|NCT00498628|4133943|B2||Between 18 and 65 years|Age||Participants|Count of Participants|113|113.0||||||
4306939|NCT00498628|4133944|B1||Between 18 and 65 years|Age||Participants|Count of Participants|105|105.0||||||
4306940|NCT00498628|4133942|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4306941|NCT00498628|4133943|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4306942|NCT00498628|4133944|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4306943|NCT00498615|4133951|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4306944|NCT00498615|4133951|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4306945|NCT00498615|4133951|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4306946|NCT00498615|4133951|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4306947|NCT00498615|4133951|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4306948|NCT00498615|4133951|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4306949|NCT00498615|4133951|B1|||Age||years|Mean|51|51.0|Full Range|||30.0|70.0|
4306950|NCT00498602|4133970|B8|Low (16 - 20)||MMSE Stratum|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|number of participants|Number|84|84.0||||||
4306951|NCT00498602|4133971|B7|Low (16 - 20)||MMSE Stratum|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|number of participants|Number|6|6.0||||||
4306952|NCT00498602|4133972|B6|Low (16 - 20)||MMSE Stratum|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|number of participants|Number|15|15.0||||||
4306953|NCT00498602|4133973|B5|Low (16 - 20)||MMSE Stratum|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|number of participants|Number|4|4.0||||||
4306954|NCT00498602|4133974|B4|Low (16 - 20)||MMSE Stratum|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|number of participants|Number|12|12.0||||||
4306955|NCT00498602|4133975|B3|Low (16 - 20)||MMSE Stratum|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|number of participants|Number|16|16.0||||||
4306956|NCT00498602|4133976|B2|Low (16 - 20)||MMSE Stratum|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|number of participants|Number|21|21.0||||||
4306957|NCT00498602|4133977|B1|Low (16 - 20)||MMSE Stratum|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|number of participants|Number|10|10.0||||||
4306958|NCT00498602|4133970|B8|High (21 - 26)||MMSE Stratum|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|number of participants|Number|161|161.0||||||
4306980|NCT00498602|4133976|B2|White||Race/Ethnicity, Customized||number of participants|Number|60|60.0||||||
4306981|NCT00498602|4133977|B1|White||Race/Ethnicity, Customized||number of participants|Number|33|33.0||||||
4307042|NCT00498550|4134020|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4306959|NCT00498602|4133971|B7|High (21 - 26)||MMSE Stratum|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|number of participants|Number|11|11.0||||||
4306960|NCT00498602|4133972|B6|High (21 - 26)||MMSE Stratum|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|number of participants|Number|29|29.0||||||
4306961|NCT00498602|4133973|B5|High (21 - 26)||MMSE Stratum|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|number of participants|Number|8|8.0||||||
4306962|NCT00498602|4133974|B4|High (21 - 26)||MMSE Stratum|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|number of participants|Number|23|23.0||||||
4306963|NCT00498602|4133975|B3|High (21 - 26)||MMSE Stratum|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|number of participants|Number|24|24.0||||||
4306964|NCT00498602|4133976|B2|High (21 - 26)||MMSE Stratum|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|number of participants|Number|40|40.0||||||
4306965|NCT00498602|4133977|B1|High (21 - 26)||MMSE Stratum|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|number of participants|Number|26|26.0||||||
4306966|NCT00498602|4133970|B8|||Mini-Mental State Examination (MMSE) Score|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|score|Mean|21.4|21.4|Standard Deviation|3.13|3.13|||
4306967|NCT00498602|4133971|B7|||Mini-Mental State Examination (MMSE) Score|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|score|Mean|21.2|21.2|Standard Deviation|3.17|3.17|||
4306968|NCT00498602|4133972|B6|||Mini-Mental State Examination (MMSE) Score|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|score|Mean|21.7|21.7|Standard Deviation|3.11|3.11|||
4306969|NCT00498602|4133973|B5|||Mini-Mental State Examination (MMSE) Score|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|score|Mean|21.8|21.8|Standard Deviation|3.60|3.6|||
4306970|NCT00498602|4133974|B4|||Mini-Mental State Examination (MMSE) Score|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|score|Mean|21.6|21.6|Standard Deviation|3.16|3.16|||
4306971|NCT00498602|4133975|B3|||Mini-Mental State Examination (MMSE) Score|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|score|Mean|21.0|21.0|Standard Deviation|2.92|2.92|||
4306972|NCT00498602|4133976|B2|||Mini-Mental State Examination (MMSE) Score|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|score|Mean|21.4|21.4|Standard Deviation|3.38|3.38|||
4306973|NCT00498602|4133977|B1|||Mini-Mental State Examination (MMSE) Score|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|score|Mean|21.4|21.4|Standard Deviation|2.96|2.96|||
4306974|NCT00498602|4133970|B8|White||Race/Ethnicity, Customized||number of participants|Number|236|236.0||||||
4306975|NCT00498602|4133971|B7|White||Race/Ethnicity, Customized||number of participants|Number|17|17.0||||||
4306976|NCT00498602|4133972|B6|White||Race/Ethnicity, Customized||number of participants|Number|43|43.0||||||
4306977|NCT00498602|4133973|B5|White||Race/Ethnicity, Customized||number of participants|Number|11|11.0||||||
4306978|NCT00498602|4133974|B4|White||Race/Ethnicity, Customized||number of participants|Number|34|34.0||||||
4306979|NCT00498602|4133975|B3|White||Race/Ethnicity, Customized||number of participants|Number|38|38.0||||||
4306982|NCT00498602|4133970|B8|Other||Race/Ethnicity, Customized||number of participants|Number|5|5.0||||||
4306983|NCT00498602|4133971|B7|Other||Race/Ethnicity, Customized||number of participants|Number|0|0.0||||||
4306984|NCT00498602|4133972|B6|Other||Race/Ethnicity, Customized||number of participants|Number|0|0.0||||||
4306985|NCT00498602|4133973|B5|Other||Race/Ethnicity, Customized||number of participants|Number|0|0.0||||||
4306986|NCT00498602|4133974|B4|Other||Race/Ethnicity, Customized||number of participants|Number|1|1.0||||||
4306987|NCT00498602|4133975|B3|Other||Race/Ethnicity, Customized||number of participants|Number|1|1.0||||||
4306988|NCT00498602|4133976|B2|Other||Race/Ethnicity, Customized||number of participants|Number|1|1.0||||||
4306989|NCT00498602|4133977|B1|Other||Race/Ethnicity, Customized||number of participants|Number|2|2.0||||||
4306990|NCT00498602|4133970|B8|Black or African American||Race/Ethnicity, Customized||number of participants|Number|3|3.0||||||
4306991|NCT00498602|4133971|B7|Black or African American||Race/Ethnicity, Customized||number of participants|Number|0|0.0||||||
4306992|NCT00498602|4133972|B6|Black or African American||Race/Ethnicity, Customized||number of participants|Number|1|1.0||||||
4306993|NCT00498602|4133973|B5|Black or African American||Race/Ethnicity, Customized||number of participants|Number|0|0.0||||||
4306994|NCT00498602|4133974|B4|Black or African American||Race/Ethnicity, Customized||number of participants|Number|0|0.0||||||
4306995|NCT00498602|4133975|B3|Black or African American||Race/Ethnicity, Customized||number of participants|Number|1|1.0||||||
4306996|NCT00498602|4133976|B2|Black or African American||Race/Ethnicity, Customized||number of participants|Number|0|0.0||||||
4306997|NCT00498602|4133977|B1|Black or African American||Race/Ethnicity, Customized||number of participants|Number|1|1.0||||||
4306998|NCT00498602|4133970|B8|Asian||Race/Ethnicity, Customized||number of participants|Number|1|1.0||||||
4306999|NCT00498602|4133971|B7|Asian||Race/Ethnicity, Customized||number of participants|Number|0|0.0||||||
4307000|NCT00498602|4133972|B6|Asian||Race/Ethnicity, Customized||number of participants|Number|0|0.0||||||
4307001|NCT00498602|4133973|B5|Asian||Race/Ethnicity, Customized||number of participants|Number|1|1.0||||||
4307002|NCT00498602|4133974|B4|Asian||Race/Ethnicity, Customized||number of participants|Number|0|0.0||||||
4307003|NCT00498602|4133975|B3|Asian||Race/Ethnicity, Customized||number of participants|Number|0|0.0||||||
4307004|NCT00498602|4133976|B2|Asian||Race/Ethnicity, Customized||number of participants|Number|0|0.0||||||
4307005|NCT00498602|4133977|B1|Asian||Race/Ethnicity, Customized||number of participants|Number|0|0.0||||||
4307006|NCT00498602|4133970|B8||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4307007|NCT00498602|4133971|B7||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4307008|NCT00498602|4133972|B6||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4307009|NCT00498602|4133973|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4307010|NCT00498602|4133974|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4307011|NCT00498602|4133975|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4307012|NCT00498602|4133976|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4307013|NCT00498602|4133977|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4307014|NCT00498602|4133970|B8||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4307015|NCT00498602|4133971|B7||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4307016|NCT00498602|4133972|B6||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4307017|NCT00498602|4133973|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4307018|NCT00498602|4133974|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4307019|NCT00498602|4133975|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4307020|NCT00498602|4133976|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4307021|NCT00498602|4133977|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4307022|NCT00498602|4133970|B8|||Age||Years|Mean|69.1|69.1|Standard Deviation|8.87|8.87|||
4307023|NCT00498602|4133971|B7|||Age||Years|Mean|69.4|69.4|Standard Deviation|7.82|7.82|||
4307024|NCT00498602|4133972|B6|||Age||Years|Mean|68.8|68.8|Standard Deviation|8.07|8.07|||
4307025|NCT00498602|4133973|B5|||Age||Years|Mean|70.9|70.9|Standard Deviation|9.59|9.59|||
4307026|NCT00498602|4133974|B4|||Age||Years|Mean|71.9|71.9|Standard Deviation|8.96|8.96|||
4307027|NCT00498602|4133975|B3|||Age||Years|Mean|69.0|69.0|Standard Deviation|9.27|9.27|||
4307028|NCT00498602|4133976|B2|||Age||Years|Mean|69.3|69.3|Standard Deviation|9.57|9.57|||
4307029|NCT00498602|4133977|B1|||Age||Years|Mean|65.7|65.7|Standard Deviation|7.75|7.75|||
4307030|NCT00498550|4134020|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4307031|NCT00498550|4134021|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4307032|NCT00498550|4134022|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4307033|NCT00498550|4134020|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4307034|NCT00498550|4134021|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4307035|NCT00498550|4134022|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4307036|NCT00498550|4134020|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4307037|NCT00498550|4134021|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4307038|NCT00498550|4134022|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4307039|NCT00498550|4134020|B3|||Age||years|Mean|36|36.0|Standard Deviation|10.3|10.3|||
4307040|NCT00498550|4134021|B2|||Age||years|Mean|39.0|39.0|Standard Deviation|10.2|10.2|||
4307041|NCT00498550|4134022|B1|||Age||years|Mean|33.3|33.3|Standard Deviation|10.0|10.0|||
4307043|NCT00498550|4134021|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4307044|NCT00498550|4134022|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4307045|NCT00498550|4134020|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4307046|NCT00498550|4134021|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4307047|NCT00498550|4134022|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4307048|NCT00498550|4134020|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4307049|NCT00498550|4134021|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4307050|NCT00498550|4134022|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4307051|NCT00498485|4134029|B3|||Initial illness severity rating||participants|Number|17|17.0||||||
4307052|NCT00498485|4134030|B2|||Initial illness severity rating||participants|Number|10|10.0||||||
4307053|NCT00498485|4134031|B1|||Initial illness severity rating||participants|Number|7|7.0||||||
4307054|NCT00498485|4134029|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4307055|NCT00498485|4134030|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4307056|NCT00498485|4134031|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4307057|NCT00498485|4134029|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4307058|NCT00498485|4134030|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4307059|NCT00498485|4134031|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4307060|NCT00498485|4134029|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4307061|NCT00498485|4134030|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4307062|NCT00498485|4134031|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4307063|NCT00498485|4134029|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4307064|NCT00498485|4134030|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4307065|NCT00498485|4134031|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4307066|NCT00498485|4134029|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4307067|NCT00498485|4134030|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4307068|NCT00498485|4134031|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4307069|NCT00498485|4134029|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4307070|NCT00498485|4134030|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4307071|NCT00498485|4134031|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4307072|NCT00498433|4134040|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4307073|NCT00498433|4134041|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4307074|NCT00498433|4134042|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4307075|NCT00498433|4134043|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4307076|NCT00498433|4134040|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4307077|NCT00498433|4134041|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4307078|NCT00498433|4134042|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4307079|NCT00498433|4134043|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4307080|NCT00498433|4134040|B4|Part 2, Double blind||Age||years|Mean|47.7|47.7|Standard Deviation|10.17|10.17|||
4307081|NCT00498433|4134041|B3|Part 2, Double blind||Age||years|Mean|49.4|49.4|Standard Deviation|10.53|10.53|||
4307082|NCT00498433|4134042|B2|Part 2, Double blind||Age||years|Mean|46.0|46.0|Standard Deviation|10.92|10.92|||
4307083|NCT00498433|4134043|B1|Part 2, Double blind||Age||years|Mean|NA||Standard Deviation|NA||||This arm is used for part 1, open label .
4307084|NCT00498433|4134040|B4|Part 1, Open Label||Age||years|Mean|46|46.0|Standard Deviation|7.5|7.5|||
4307085|NCT00498433|4134041|B3|Part 1, Open Label||Age||years|Mean|NA||Standard Deviation|NA||||This arm is used for part 2, double blind period
4307086|NCT00498433|4134042|B2|Part 1, Open Label||Age||years|Mean|NA||Standard Deviation|NA||||This arm is used for part 2, double blind period
4307087|NCT00498433|4134043|B1|Part 1, Open Label||Age||years|Mean|46|46.0|Standard Deviation|7.5|7.5|||
4307088|NCT00498368|4134088|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
4307089|NCT00498368|4134089|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4307090|NCT00498368|4134090|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4307091|NCT00498368|4134088|B3||Male|Gender||Participants|Count of Participants|25|25.0||||||
4307092|NCT00498368|4134089|B2||Male|Gender||Participants|Count of Participants|15|15.0||||||
4307093|NCT00498368|4134090|B1||Male|Gender||Participants|Count of Participants|10|10.0||||||
4307094|NCT00498368|4134088|B3||Female|Gender||Participants|Count of Participants|9|9.0||||||
4307095|NCT00498368|4134089|B2||Female|Gender||Participants|Count of Participants|2|2.0||||||
4307096|NCT00498368|4134090|B1||Female|Gender||Participants|Count of Participants|7|7.0||||||
4307097|NCT00498368|4134088|B3|||Age||years|Median|40|40.0|Full Range|||21.0|63.0|
4307098|NCT00498368|4134089|B2|||Age||years|Median|33|33.0|Full Range|||21.0|59.0|
4307099|NCT00498368|4134090|B1|||Age||years|Median|43|43.0|Full Range|||29.0|63.0|
4307100|NCT00498355|4134103|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4307101|NCT00498355|4134103|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4307102|NCT00498355|4134103|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4307103|NCT00498355|4134103|B1|||Age||years|Mean|47.4|47.4|Standard Deviation|15.96|15.96|||
4307104|NCT00498355|4134103|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4307105|NCT00498355|4134103|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4307106|NCT00498355|4134103|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4307107|NCT00498186|4134111|B1|||Weight||kilogram (kg)|Mean|74.21|74.21|Standard Deviation|13.19|13.19|||
4307108|NCT00498186|4134111|B1|||Height||cm|Mean|167.5|167.5|Standard Deviation|8.3|8.3|||
4307109|NCT00498186|4134111|B1|||Body Mass Index (BMI)|BMI= weight/height^2|kg/ m^2|Mean|26.37|26.37|Standard Deviation|3.84|3.84|||
4307110|NCT00498186|4134111|B1||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4307111|NCT00498186|4134111|B1||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4307112|NCT00498186|4134111|B1|||Age||years|Mean|58.3|58.3|Standard Deviation|10.1|10.1|||
4307113|NCT00498186|4134111|B1||>=65 years|Age||Participants|Count of Participants|87|87.0||||||
4307114|NCT00498186|4134111|B1||Between 18 and 65 years|Age||Participants|Count of Participants|208|208.0||||||
4307115|NCT00498186|4134111|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4307116|NCT00498173|4134116|B3|||Pediatric Anxiety Rating Scale, 5-Item Total|Scaled score ranges form 0-25 with higher scores indicating more severe anxiety symptoms.|units on a scale|Mean|8.7|8.7|Standard Deviation|6.2|6.2|||
4307117|NCT00498173|4134117|B2|||Pediatric Anxiety Rating Scale, 5-Item Total|Scaled score ranges form 0-25 with higher scores indicating more severe anxiety symptoms.|units on a scale|Mean|8.9|8.9|Standard Deviation|6.0|6.0|||
4307118|NCT00498173|4134118|B1|||Pediatric Anxiety Rating Scale, 5-Item Total|Scaled score ranges form 0-25 with higher scores indicating more severe anxiety symptoms.|units on a scale|Mean|8.5|8.5|Standard Deviation|6.5|6.5|||
4307119|NCT00498173|4134116|B3|||Pediatric Quality of Life Inventory Family Functioning|Scores range from 0–100, with higher scores representing better family functioning.|units on a scale|Mean|52.7|52.7|Standard Deviation|23.6|23.6|||
4307120|NCT00498173|4134117|B2|||Pediatric Quality of Life Inventory Family Functioning|Scores range from 0–100, with higher scores representing better family functioning.|units on a scale|Mean|53.1|53.1|Standard Deviation|23.4|23.4|||
4307121|NCT00498173|4134118|B1|||Pediatric Quality of Life Inventory Family Functioning|Scores range from 0–100, with higher scores representing better family functioning.|units on a scale|Mean|52.4|52.4|Standard Deviation|24.2|24.2|||
4307122|NCT00498173|4134116|B3|||Pediatric Quality of Life Inventory Health Related Functioning|Scores range from 0–100, with higher scores indicating better quality of life.|units on a scale|Mean|58.5|58.5|Standard Deviation|19.2|19.2|||
4307123|NCT00498173|4134117|B2|||Pediatric Quality of Life Inventory Health Related Functioning|Scores range from 0–100, with higher scores indicating better quality of life.|units on a scale|Mean|60.5|60.5|Standard Deviation|19.6|19.6|||
4307124|NCT00498173|4134118|B1|||Pediatric Quality of Life Inventory Health Related Functioning|Scores range from 0–100, with higher scores indicating better quality of life.|units on a scale|Mean|56.3|56.3|Standard Deviation|18.8|18.8|||
4307125|NCT00498173|4134116|B3|||Vineland Adaptive Behavior Composite Score|The Vineland Adaptive Behavior Scales, Second Edition is a measure of adaptive behavior in children, adolescents and adults. The composite score has a mean of 100 and a standard deviation of 15 (range = 20 to 160). Higher scores suggest a higher level of adaptive functioning. A rise in standard scores from Baseline to the Final Visit indicates improvement.|units on a scale|Mean|72.8|72.8|Standard Deviation|10.6|10.6|||
4307126|NCT00498173|4134117|B2|||Vineland Adaptive Behavior Composite Score|The Vineland Adaptive Behavior Scales, Second Edition is a measure of adaptive behavior in children, adolescents and adults. The composite score has a mean of 100 and a standard deviation of 15 (range = 20 to 160). Higher scores suggest a higher level of adaptive functioning. A rise in standard scores from Baseline to the Final Visit indicates improvement.|units on a scale|Mean|72.5|72.5|Standard Deviation|8.7|8.7|||
4307127|NCT00498173|4134118|B1|||Vineland Adaptive Behavior Composite Score|The Vineland Adaptive Behavior Scales, Second Edition is a measure of adaptive behavior in children, adolescents and adults. The composite score has a mean of 100 and a standard deviation of 15 (range = 20 to 160). Higher scores suggest a higher level of adaptive functioning. A rise in standard scores from Baseline to the Final Visit indicates improvement.|units on a scale|Mean|73.1|73.1|Standard Deviation|12.5|12.5|||
4307128|NCT00498173|4134116|B3|||Social Responsiveness Scale||units on a scale|Mean|84.5|84.5|Standard Deviation|10.0|10.0|||
4307129|NCT00498173|4134117|B2|||Social Responsiveness Scale||units on a scale|Mean|84.4|84.4|Standard Deviation|10.3|10.3|||
4307130|NCT00498173|4134118|B1|||Social Responsiveness Scale||units on a scale|Mean|84.5|84.5|Standard Deviation|9.9|9.9|||
4307131|NCT00498173|4134116|B3|||Aberrant Behavior Checklist, Hyperactivity||units on a scale|Mean|30.5|30.5|Standard Deviation|10.9|10.9|||
4307132|NCT00498173|4134117|B2|||Aberrant Behavior Checklist, Hyperactivity||units on a scale|Mean|31.7|31.7|Standard Deviation|10.0|10.0|||
4307133|NCT00498173|4134118|B1|||Aberrant Behavior Checklist, Hyperactivity||units on a scale|Mean|29.1|29.1|Standard Deviation|11.8|11.8|||
4307134|NCT00498173|4134116|B3|||Attention Deficit Hyperactivity Disorder (ADHD) Rating Scale Total|The ADHD Rating Scale (ADHD-RS) is an 18-item scale directly derived from DSM-IV criteria for Attention Deficit Hyperactivity Disorder with established reliability, validity and sensitivity to change. The scale consists of 2 subscales: inattention (9 items) and hyperactivity-impulsivity (9 items). The total score can range from 0 to 54, with a higher score indicating greater severity.|units on a scale|Mean|39.4|39.4|Standard Deviation|7.0|7.0|||
4307135|NCT00498173|4134117|B2|||Attention Deficit Hyperactivity Disorder (ADHD) Rating Scale Total|The ADHD Rating Scale (ADHD-RS) is an 18-item scale directly derived from DSM-IV criteria for Attention Deficit Hyperactivity Disorder with established reliability, validity and sensitivity to change. The scale consists of 2 subscales: inattention (9 items) and hyperactivity-impulsivity (9 items). The total score can range from 0 to 54, with a higher score indicating greater severity.|units on a scale|Mean|41.5|41.5|Standard Deviation|5.8|5.8|||
4307171|NCT00498173|4134117|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
4307172|NCT00498173|4134118|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4307231|NCT00497874|4134149|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4307136|NCT00498173|4134118|B1|||Attention Deficit Hyperactivity Disorder (ADHD) Rating Scale Total|The ADHD Rating Scale (ADHD-RS) is an 18-item scale directly derived from DSM-IV criteria for Attention Deficit Hyperactivity Disorder with established reliability, validity and sensitivity to change. The scale consists of 2 subscales: inattention (9 items) and hyperactivity-impulsivity (9 items). The total score can range from 0 to 54, with a higher score indicating greater severity.|units on a scale|Mean|37.2|37.2|Standard Deviation|7.6|7.6|||
4307137|NCT00498173|4134116|B3|Severe||Clinical Global Impression-Severity||Participants|Count of Participants|2|2.0||||||
4307138|NCT00498173|4134117|B2|Severe||Clinical Global Impression-Severity||Participants|Count of Participants|2|2.0||||||
4307139|NCT00498173|4134118|B1|Severe||Clinical Global Impression-Severity||Participants|Count of Participants|0|0.0||||||
4307140|NCT00498173|4134116|B3|Marked||Clinical Global Impression-Severity||Participants|Count of Participants|25|25.0||||||
4307141|NCT00498173|4134117|B2|Marked||Clinical Global Impression-Severity||Participants|Count of Participants|12|12.0||||||
4307142|NCT00498173|4134118|B1|Marked||Clinical Global Impression-Severity||Participants|Count of Participants|13|13.0||||||
4307143|NCT00498173|4134116|B3|Moderate||Clinical Global Impression-Severity||Participants|Count of Participants|33|33.0||||||
4307144|NCT00498173|4134117|B2|Moderate||Clinical Global Impression-Severity||Participants|Count of Participants|17|17.0||||||
4307145|NCT00498173|4134118|B1|Moderate||Clinical Global Impression-Severity||Participants|Count of Participants|16|16.0||||||
4307146|NCT00498173|4134116|B3|||IQ|IQ was estimated from the Mullen Scale for 1 child assigned to atomoxetine and the Stanford Binet test for all other children.|units on a scale|Mean|79.8|79.8|Standard Deviation|17.4|17.4|||
4307147|NCT00498173|4134117|B2|||IQ|IQ was estimated from the Mullen Scale for 1 child assigned to atomoxetine and the Stanford Binet test for all other children.|units on a scale|Mean|84.4|84.4|Standard Deviation|15.2|15.2|||
4307148|NCT00498173|4134118|B1|||IQ|IQ was estimated from the Mullen Scale for 1 child assigned to atomoxetine and the Stanford Binet test for all other children.|units on a scale|Mean|74.7|74.7|Standard Deviation|18.5|18.5|||
4307149|NCT00498173|4134116|B3|||Concomitant Medication Use||Participants|Count of Participants|42|42.0||||||
4307150|NCT00498173|4134117|B2|||Concomitant Medication Use||Participants|Count of Participants|20|20.0||||||
4307151|NCT00498173|4134118|B1|||Concomitant Medication Use||Participants|Count of Participants|22|22.0||||||
4307152|NCT00498173|4134116|B3|Pervasive Developmental Disorder (PDD-NOS)||DSM-IV Diagnosis||Participants|Count of Participants|23|23.0||||||
4307153|NCT00498173|4134117|B2|Pervasive Developmental Disorder (PDD-NOS)||DSM-IV Diagnosis||Participants|Count of Participants|13|13.0||||||
4307154|NCT00498173|4134118|B1|Pervasive Developmental Disorder (PDD-NOS)||DSM-IV Diagnosis||Participants|Count of Participants|10|10.0||||||
4307155|NCT00498173|4134116|B3|Asperger's Disorder||DSM-IV Diagnosis||Participants|Count of Participants|14|14.0||||||
4307156|NCT00498173|4134117|B2|Asperger's Disorder||DSM-IV Diagnosis||Participants|Count of Participants|9|9.0||||||
4307157|NCT00498173|4134118|B1|Asperger's Disorder||DSM-IV Diagnosis||Participants|Count of Participants|5|5.0||||||
4307158|NCT00498173|4134116|B3|Autistic Disorder||DSM-IV Diagnosis||Participants|Count of Participants|23|23.0||||||
4307159|NCT00498173|4134117|B2|Autistic Disorder||DSM-IV Diagnosis||Participants|Count of Participants|9|9.0||||||
4307160|NCT00498173|4134118|B1|Autistic Disorder||DSM-IV Diagnosis||Participants|Count of Participants|14|14.0||||||
4307161|NCT00498173|4134116|B3|||Tanner Stage 3 or Greater|Tanner stage (1-5) was used to characterize physical development in children, adolescents, and to stratify randomization.The stage was based on external primary and secondary sex characteristics, such as the size of the breasts, genitalia, and development of pubic hair. Tanner stage increases as the child develops. Randomization lists for each of the four strata defined by pubertal status (prepubertal [Tanner Stage I or 2] vs. postpubertal [Tanner Stage 3-5]) and gender (male vs. female) were utilized.|Participants|Count of Participants|4|4.0||||||
4307162|NCT00498173|4134117|B2|||Tanner Stage 3 or Greater|Tanner stage (1-5) was used to characterize physical development in children, adolescents, and to stratify randomization.The stage was based on external primary and secondary sex characteristics, such as the size of the breasts, genitalia, and development of pubic hair. Tanner stage increases as the child develops. Randomization lists for each of the four strata defined by pubertal status (prepubertal [Tanner Stage I or 2] vs. postpubertal [Tanner Stage 3-5]) and gender (male vs. female) were utilized.|Participants|Count of Participants|1|1.0||||||
4307163|NCT00498173|4134118|B1|||Tanner Stage 3 or Greater|Tanner stage (1-5) was used to characterize physical development in children, adolescents, and to stratify randomization.The stage was based on external primary and secondary sex characteristics, such as the size of the breasts, genitalia, and development of pubic hair. Tanner stage increases as the child develops. Randomization lists for each of the four strata defined by pubertal status (prepubertal [Tanner Stage I or 2] vs. postpubertal [Tanner Stage 3-5]) and gender (male vs. female) were utilized.|Participants|Count of Participants|3|3.0||||||
4307164|NCT00498173|4134116|B3|||Indiana University School of Medicine Site||Participants|Count of Participants|52|52.0||||||
4307165|NCT00498173|4134117|B2|||Indiana University School of Medicine Site||Participants|Count of Participants|27|27.0||||||
4307166|NCT00498173|4134118|B1|||Indiana University School of Medicine Site||Participants|Count of Participants|25|25.0||||||
4307167|NCT00498173|4134116|B3|||Attending Public School|All children attended school. Children not attending public school attended private, specialized, or home school, or a specialized classroom with type of school unspecified.|Participants|Count of Participants|51|51.0||||||
4307168|NCT00498173|4134117|B2|||Attending Public School|All children attended school. Children not attending public school attended private, specialized, or home school, or a specialized classroom with type of school unspecified.|Participants|Count of Participants|27|27.0||||||
4307169|NCT00498173|4134118|B1|||Attending Public School|All children attended school. Children not attending public school attended private, specialized, or home school, or a specialized classroom with type of school unspecified.|Participants|Count of Participants|24|24.0||||||
4307170|NCT00498173|4134116|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4307173|NCT00498173|4134116|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4307174|NCT00498173|4134117|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307175|NCT00498173|4134118|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4307176|NCT00498173|4134116|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4307177|NCT00498173|4134117|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4307178|NCT00498173|4134118|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307179|NCT00498173|4134116|B3||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4307180|NCT00498173|4134117|B2||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4307181|NCT00498173|4134118|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4307182|NCT00498173|4134116|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4307183|NCT00498173|4134117|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307184|NCT00498173|4134118|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4307185|NCT00498173|4134116|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307186|NCT00498173|4134117|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307187|NCT00498173|4134118|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307188|NCT00498173|4134116|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307189|NCT00498173|4134117|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307190|NCT00498173|4134118|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307191|NCT00498173|4134116|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307192|NCT00498173|4134117|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307193|NCT00498173|4134118|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307194|NCT00498173|4134116|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4307195|NCT00498173|4134117|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4307196|NCT00498173|4134118|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4307197|NCT00498173|4134116|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4307198|NCT00498173|4134117|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4307199|NCT00498173|4134118|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4307200|NCT00498173|4134116|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4307201|NCT00498173|4134117|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4307202|NCT00498173|4134118|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4307203|NCT00498173|4134116|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4307204|NCT00498173|4134117|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4307205|NCT00498173|4134118|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4307206|NCT00498173|4134116|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4307207|NCT00498173|4134117|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4307208|NCT00498173|4134118|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4307209|NCT00498173|4134116|B3|||Age||years|Mean|8.8|8.8|Standard Deviation|2.4|2.4|||
4307210|NCT00498173|4134117|B2|||Age||years|Mean|8.4|8.4|Standard Deviation|2.1|2.1|||
4307211|NCT00498173|4134118|B1|||Age||years|Mean|9.3|9.3|Standard Deviation|2.6|2.6|||
4307212|NCT00497874|4134148|B3|United States||Region of Enrollment||participants|Number|902|902.0||||||
4307213|NCT00497874|4134149|B2|United States||Region of Enrollment||participants|Number|459|459.0||||||
4307214|NCT00497874|4134150|B1|United States||Region of Enrollment||participants|Number|443|443.0||||||
4307215|NCT00497874|4134148|B3||Male|Sex: Female, Male||Participants|Count of Participants|280|280.0||||||
4307216|NCT00497874|4134149|B2||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4307217|NCT00497874|4134150|B1||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4307218|NCT00497874|4134148|B3||Female|Sex: Female, Male||Participants|Count of Participants|622|622.0||||||
4307219|NCT00497874|4134149|B2||Female|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
4307220|NCT00497874|4134150|B1||Female|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
4307221|NCT00497874|4134148|B3|||Age||years|Mean|47.5|47.5|Standard Deviation|15.0|15.0|||
4307222|NCT00497874|4134149|B2|||Age||years|Mean|47.1|47.1|Standard Deviation|15.3|15.3|||
4307223|NCT00497874|4134150|B1|||Age||years|Mean|48.0|48.0|Standard Deviation|14.7|14.7|||
4307224|NCT00497874|4134148|B3||>=65 years|Age||Participants|Count of Participants|103|103.0||||||
4307225|NCT00497874|4134149|B2||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
4307226|NCT00497874|4134150|B1||>=65 years|Age||Participants|Count of Participants|52|52.0||||||
4307227|NCT00497874|4134148|B3||Between 18 and 65 years|Age||Participants|Count of Participants|799|799.0||||||
4307228|NCT00497874|4134149|B2||Between 18 and 65 years|Age||Participants|Count of Participants|408|408.0||||||
4307229|NCT00497874|4134150|B1||Between 18 and 65 years|Age||Participants|Count of Participants|391|391.0||||||
4307230|NCT00497874|4134148|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4307232|NCT00497874|4134150|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4307233|NCT00497796|4134167|B3|65 to 75 years||Distribution of age||participants|Number|30|30.0||||||
4307234|NCT00497796|4134168|B2|65 to 75 years||Distribution of age||participants|Number|11|11.0||||||
4307235|NCT00497796|4134169|B1|65 to 75 years||Distribution of age||participants|Number|19|19.0||||||
4307236|NCT00497796|4134167|B3|45 to 64 years||Distribution of age||participants|Number|232|232.0||||||
4307237|NCT00497796|4134168|B2|45 to 64 years||Distribution of age||participants|Number|123|123.0||||||
4307238|NCT00497796|4134169|B1|45 to 64 years||Distribution of age||participants|Number|109|109.0||||||
4307239|NCT00497796|4134167|B3|18 to 44 years||Distribution of age||participants|Number|41|41.0||||||
4307240|NCT00497796|4134168|B2|18 to 44 years||Distribution of age||participants|Number|22|22.0||||||
4307241|NCT00497796|4134169|B1|18 to 44 years||Distribution of age||participants|Number|19|19.0||||||
4307242|NCT00497796|4134167|B3||Male|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
4307243|NCT00497796|4134168|B2||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4307244|NCT00497796|4134169|B1||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4307245|NCT00497796|4134167|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4307246|NCT00497796|4134168|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4307247|NCT00497796|4134169|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4307248|NCT00497796|4134167|B3|||Age||years|Mean|54|54.0|Standard Deviation|9.0|9.0|||
4307249|NCT00497796|4134168|B2|||Age||years|Mean|53|53.0|Standard Deviation|8.9|8.9|||
4307250|NCT00497796|4134169|B1|||Age||years|Mean|55|55.0|Standard Deviation|9.0|9.0|||
4307251|NCT00497770|4134198|B5|Unknown||Smoking Status||participants|Number|3|3.0||||||
4307252|NCT00497770|4134199|B4|Unknown||Smoking Status||participants|Number|0|0.0||||||
4307253|NCT00497770|4134200|B3|Unknown||Smoking Status||participants|Number|0|0.0||||||
4307254|NCT00497770|4134201|B2|Unknown||Smoking Status||participants|Number|0|0.0||||||
4307255|NCT00497770|4134202|B1|Unknown||Smoking Status||participants|Number|3|3.0||||||
4307256|NCT00497770|4134198|B5|Not Collected||Smoking Status||participants|Number|1|1.0||||||
4307257|NCT00497770|4134199|B4|Not Collected||Smoking Status||participants|Number|0|0.0||||||
4307258|NCT00497770|4134200|B3|Not Collected||Smoking Status||participants|Number|0|0.0||||||
4307259|NCT00497770|4134201|B2|Not Collected||Smoking Status||participants|Number|0|0.0||||||
4307260|NCT00497770|4134202|B1|Not Collected||Smoking Status||participants|Number|1|1.0||||||
4307261|NCT00497770|4134198|B5|Never||Smoking Status||participants|Number|54|54.0||||||
4307262|NCT00497770|4134199|B4|Never||Smoking Status||participants|Number|7|7.0||||||
4307263|NCT00497770|4134200|B3|Never||Smoking Status||participants|Number|24|24.0||||||
4307264|NCT00497770|4134201|B2|Never||Smoking Status||participants|Number|2|2.0||||||
4307265|NCT00497770|4134202|B1|Never||Smoking Status||participants|Number|21|21.0||||||
4307266|NCT00497770|4134198|B5|Former||Smoking Status||participants|Number|269|269.0||||||
4307267|NCT00497770|4134199|B4|Former||Smoking Status||participants|Number|18|18.0||||||
4307268|NCT00497770|4134200|B3|Former||Smoking Status||participants|Number|13|13.0||||||
4307269|NCT00497770|4134201|B2|Former||Smoking Status||participants|Number|42|42.0||||||
4307270|NCT00497770|4134202|B1|Former||Smoking Status||participants|Number|196|196.0||||||
4307271|NCT00497770|4134198|B5|Current||Smoking Status||participants|Number|107|107.0||||||
4307272|NCT00497770|4134199|B4|Current||Smoking Status||participants|Number|3|3.0||||||
4307273|NCT00497770|4134200|B3|Current||Smoking Status||participants|Number|0|0.0||||||
4307274|NCT00497770|4134201|B2|Current||Smoking Status||participants|Number|21|21.0||||||
4307275|NCT00497770|4134202|B1|Current||Smoking Status||participants|Number|83|83.0||||||
4307276|NCT00497770|4134198|B5|Not available||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|31|31.0||||||
4307277|NCT00497770|4134199|B4|Not available||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|3|3.0||||||
4307278|NCT00497770|4134200|B3|Not available||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|6|6.0||||||
4307279|NCT00497770|4134201|B2|Not available||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|3|3.0||||||
4307280|NCT00497770|4134202|B1|Not available||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|19|19.0||||||
4307281|NCT00497770|4134198|B5|3 - Partially Confined to Bed, Limited Self Care||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|11|11.0||||||
4307282|NCT00497770|4134199|B4|3 - Partially Confined to Bed, Limited Self Care||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|1|1.0||||||
4307283|NCT00497770|4134200|B3|3 - Partially Confined to Bed, Limited Self Care||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|1|1.0||||||
4307284|NCT00497770|4134201|B2|3 - Partially Confined to Bed, Limited Self Care||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|1|1.0||||||
4307285|NCT00497770|4134202|B1|3 - Partially Confined to Bed, Limited Self Care||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|8|8.0||||||
4307286|NCT00497770|4134198|B5|2 - Ambulatory, No Work Activities||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|65|65.0||||||
4307287|NCT00497770|4134199|B4|2 - Ambulatory, No Work Activities||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|2|2.0||||||
4307288|NCT00497770|4134200|B3|2 - Ambulatory, No Work Activities||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|3|3.0||||||
4307289|NCT00497770|4134201|B2|2 - Ambulatory, No Work Activities||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|7|7.0||||||
4307290|NCT00497770|4134202|B1|2 - Ambulatory, No Work Activities||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|53|53.0||||||
4307291|NCT00497770|4134198|B5|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|234|234.0||||||
4307292|NCT00497770|4134199|B4|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|14|14.0||||||
4307293|NCT00497770|4134200|B3|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|15|15.0||||||
4307294|NCT00497770|4134201|B2|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|39|39.0||||||
4307295|NCT00497770|4134202|B1|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|166|166.0||||||
4307296|NCT00497770|4134198|B5|0 - Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|93|93.0||||||
4307297|NCT00497770|4134199|B4|0 - Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|8|8.0||||||
4307298|NCT00497770|4134200|B3|0 - Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|12|12.0||||||
4307299|NCT00497770|4134201|B2|0 - Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|15|15.0||||||
4307300|NCT00497770|4134202|B1|0 - Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|58|58.0||||||
4307301|NCT00497770|4134198|B5|Other [not adenocarcinoma or squamous cell]||Histology of tumor|This was an observational study, as such, the investigators followed the label recommendations and any changes to the label which occurred during the study, including but not limited to the tumor type.|participants|Number|47|47.0||||||
4307302|NCT00497770|4134199|B4|Other [not adenocarcinoma or squamous cell]||Histology of tumor|This was an observational study, as such, the investigators followed the label recommendations and any changes to the label which occurred during the study, including but not limited to the tumor type.|participants|Number|1|1.0||||||
4307303|NCT00497770|4134200|B3|Other [not adenocarcinoma or squamous cell]||Histology of tumor|This was an observational study, as such, the investigators followed the label recommendations and any changes to the label which occurred during the study, including but not limited to the tumor type.|participants|Number|2|2.0||||||
4307304|NCT00497770|4134201|B2|Other [not adenocarcinoma or squamous cell]||Histology of tumor|This was an observational study, as such, the investigators followed the label recommendations and any changes to the label which occurred during the study, including but not limited to the tumor type.|participants|Number|8|8.0||||||
4307305|NCT00497770|4134202|B1|Other [not adenocarcinoma or squamous cell]||Histology of tumor|This was an observational study, as such, the investigators followed the label recommendations and any changes to the label which occurred during the study, including but not limited to the tumor type.|participants|Number|36|36.0||||||
4307306|NCT00497770|4134198|B5|Squamous Cell||Histology of tumor|This was an observational study, as such, the investigators followed the label recommendations and any changes to the label which occurred during the study, including but not limited to the tumor type.|participants|Number|94|94.0||||||
4307307|NCT00497770|4134199|B4|Squamous Cell||Histology of tumor|This was an observational study, as such, the investigators followed the label recommendations and any changes to the label which occurred during the study, including but not limited to the tumor type.|participants|Number|2|2.0||||||
4307308|NCT00497770|4134200|B3|Squamous Cell||Histology of tumor|This was an observational study, as such, the investigators followed the label recommendations and any changes to the label which occurred during the study, including but not limited to the tumor type.|participants|Number|2|2.0||||||
4307309|NCT00497770|4134201|B2|Squamous Cell||Histology of tumor|This was an observational study, as such, the investigators followed the label recommendations and any changes to the label which occurred during the study, including but not limited to the tumor type.|participants|Number|13|13.0||||||
4307337|NCT00497770|4134199|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4307310|NCT00497770|4134202|B1|Squamous Cell||Histology of tumor|This was an observational study, as such, the investigators followed the label recommendations and any changes to the label which occurred during the study, including but not limited to the tumor type.|participants|Number|77|77.0||||||
4307311|NCT00497770|4134198|B5|Adenocarcinoma||Histology of tumor|This was an observational study, as such, the investigators followed the label recommendations and any changes to the label which occurred during the study, including but not limited to the tumor type.|participants|Number|293|293.0||||||
4307312|NCT00497770|4134199|B4|Adenocarcinoma||Histology of tumor|This was an observational study, as such, the investigators followed the label recommendations and any changes to the label which occurred during the study, including but not limited to the tumor type.|participants|Number|25|25.0||||||
4307313|NCT00497770|4134200|B3|Adenocarcinoma||Histology of tumor|This was an observational study, as such, the investigators followed the label recommendations and any changes to the label which occurred during the study, including but not limited to the tumor type.|participants|Number|33|33.0||||||
4307314|NCT00497770|4134201|B2|Adenocarcinoma||Histology of tumor|This was an observational study, as such, the investigators followed the label recommendations and any changes to the label which occurred during the study, including but not limited to the tumor type.|participants|Number|44|44.0||||||
4307315|NCT00497770|4134202|B1|Adenocarcinoma||Histology of tumor|This was an observational study, as such, the investigators followed the label recommendations and any changes to the label which occurred during the study, including but not limited to the tumor type.|participants|Number|191|191.0||||||
4307316|NCT00497770|4134198|B5|IV||Disease Stage|"Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIB - the cancer has spread to nearby tissue or spread to far away lymph nodes (locally advanced).~Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver (metastatic)."|participants|Number|344|344.0||||||
4307317|NCT00497770|4134199|B4|IV||Disease Stage|"Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIB - the cancer has spread to nearby tissue or spread to far away lymph nodes (locally advanced).~Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver (metastatic)."|participants|Number|20|20.0||||||
4307318|NCT00497770|4134200|B3|IV||Disease Stage|"Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIB - the cancer has spread to nearby tissue or spread to far away lymph nodes (locally advanced).~Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver (metastatic)."|participants|Number|29|29.0||||||
4307319|NCT00497770|4134201|B2|IV||Disease Stage|"Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIB - the cancer has spread to nearby tissue or spread to far away lymph nodes (locally advanced).~Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver (metastatic)."|participants|Number|51|51.0||||||
4307320|NCT00497770|4134202|B1|IV||Disease Stage|"Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIB - the cancer has spread to nearby tissue or spread to far away lymph nodes (locally advanced).~Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver (metastatic)."|participants|Number|244|244.0||||||
4307321|NCT00497770|4134198|B5|IIIB||Disease Stage|"Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIB - the cancer has spread to nearby tissue or spread to far away lymph nodes (locally advanced).~Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver (metastatic)."|participants|Number|90|90.0||||||
4307322|NCT00497770|4134199|B4|IIIB||Disease Stage|"Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIB - the cancer has spread to nearby tissue or spread to far away lymph nodes (locally advanced).~Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver (metastatic)."|participants|Number|8|8.0||||||
4307323|NCT00497770|4134200|B3|IIIB||Disease Stage|"Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIB - the cancer has spread to nearby tissue or spread to far away lymph nodes (locally advanced).~Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver (metastatic)."|participants|Number|8|8.0||||||
4307324|NCT00497770|4134201|B2|IIIB||Disease Stage|"Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIB - the cancer has spread to nearby tissue or spread to far away lymph nodes (locally advanced).~Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver (metastatic)."|participants|Number|14|14.0||||||
4307325|NCT00497770|4134202|B1|IIIB||Disease Stage|"Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIB - the cancer has spread to nearby tissue or spread to far away lymph nodes (locally advanced).~Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver (metastatic)."|participants|Number|60|60.0||||||
4307326|NCT00497770|4134198|B5|United States||Region of Enrollment||participants|Number|434|434.0||||||
4307327|NCT00497770|4134199|B4|United States||Region of Enrollment||participants|Number|28|28.0||||||
4307328|NCT00497770|4134200|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
4307329|NCT00497770|4134201|B2|United States||Region of Enrollment||participants|Number|65|65.0||||||
4307330|NCT00497770|4134202|B1|United States||Region of Enrollment||participants|Number|304|304.0||||||
4307331|NCT00497770|4134198|B5||Male|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4307332|NCT00497770|4134199|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4307333|NCT00497770|4134200|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4307334|NCT00497770|4134201|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4307335|NCT00497770|4134202|B1||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4307336|NCT00497770|4134198|B5||Female|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4307338|NCT00497770|4134200|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4307339|NCT00497770|4134201|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4307340|NCT00497770|4134202|B1||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4307341|NCT00497770|4134198|B5|||Age||years|Mean|64.99|64.99|Standard Deviation|10.19|10.19|||
4307342|NCT00497770|4134199|B4|||Age||years|Mean|63.14|63.14|Standard Deviation|13.29|13.29|||
4307343|NCT00497770|4134200|B3|||Age||years|Mean|65.05|65.05|Standard Deviation|11.31|11.31|||
4307344|NCT00497770|4134201|B2|||Age||years|Mean|62.74|62.74|Standard Deviation|8.93|8.93|||
4307345|NCT00497770|4134202|B1|||Age||years|Mean|65.64|65.64|Standard Deviation|9.94|9.94|||
4307346|NCT00497198|4134255|B3||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4307347|NCT00497198|4134256|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4307348|NCT00497198|4134257|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4307349|NCT00497198|4134255|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4307350|NCT00497198|4134256|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4307351|NCT00497198|4134257|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4307352|NCT00497198|4134255|B3||>=65 years|Age||Participants|Count of Participants|68|68.0||||||
4307353|NCT00497198|4134256|B2||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4307354|NCT00497198|4134257|B1||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4307355|NCT00497198|4134255|B3||Between 18 and 65 years|Age||Participants|Count of Participants|115|115.0||||||
4307356|NCT00497198|4134256|B2||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4307357|NCT00497198|4134257|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4307358|NCT00497198|4134255|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4307359|NCT00497198|4134256|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4307360|NCT00497198|4134257|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4307361|NCT00497146|4134272|B3|Male||Gender at Beginning of Long term Follow-up Period||participants|Number|92|92.0||||||
4307362|NCT00497146|4134273|B2|Male||Gender at Beginning of Long term Follow-up Period||participants|Number|47|47.0||||||
4307363|NCT00497146|4134274|B1|Male||Gender at Beginning of Long term Follow-up Period||participants|Number|45|45.0||||||
4307364|NCT00497146|4134272|B3|Female||Gender at Beginning of Long term Follow-up Period||participants|Number|45|45.0||||||
4307365|NCT00497146|4134273|B2|Female||Gender at Beginning of Long term Follow-up Period||participants|Number|25|25.0||||||
4307366|NCT00497146|4134274|B1|Female||Gender at Beginning of Long term Follow-up Period||participants|Number|20|20.0||||||
4307367|NCT00497146|4134272|B3|||Age at Beginning of Long term Follow-up Period|Age demographics for the long-term follow-up population include data for 65 and 72 participants in the paricalcitol and placebo groups, respectively.|years|Mean|65.6|65.6|Standard Deviation|11.58|11.58|||
4307368|NCT00497146|4134273|B2|||Age at Beginning of Long term Follow-up Period|Age demographics for the long-term follow-up population include data for 65 and 72 participants in the paricalcitol and placebo groups, respectively.|years|Mean|66.5|66.5|Standard Deviation|12.09|12.09|||
4307369|NCT00497146|4134274|B1|||Age at Beginning of Long term Follow-up Period|Age demographics for the long-term follow-up population include data for 65 and 72 participants in the paricalcitol and placebo groups, respectively.|years|Mean|64.6|64.6|Standard Deviation|11.01|11.01|||
4307370|NCT00497146|4134272|B3|None||Diabetic Status||participants|Number|107|107.0||||||
4307371|NCT00497146|4134273|B2|None||Diabetic Status||participants|Number|55|55.0||||||
4307372|NCT00497146|4134274|B1|None||Diabetic Status||participants|Number|52|52.0||||||
4307373|NCT00497146|4134272|B3|Type II||Diabetic Status||participants|Number|115|115.0||||||
4307374|NCT00497146|4134273|B2|Type II||Diabetic Status||participants|Number|56|56.0||||||
4307375|NCT00497146|4134274|B1|Type II||Diabetic Status||participants|Number|59|59.0||||||
4307376|NCT00497146|4134272|B3|Type I||Diabetic Status||participants|Number|5|5.0||||||
4307377|NCT00497146|4134273|B2|Type I||Diabetic Status||participants|Number|1|1.0||||||
4307378|NCT00497146|4134274|B1|Type I||Diabetic Status||participants|Number|4|4.0||||||
4307379|NCT00497146|4134272|B3|No||Baseline RAAS Status|Baseline renin angiotensin-aldosterone system (RAAS) status refers to whether or not (yes/no) the participant was receiving RAAS inhibitor therapy at baseline.|participants|Number|50|50.0||||||
4307380|NCT00497146|4134273|B2|No||Baseline RAAS Status|Baseline renin angiotensin-aldosterone system (RAAS) status refers to whether or not (yes/no) the participant was receiving RAAS inhibitor therapy at baseline.|participants|Number|25|25.0||||||
4307381|NCT00497146|4134274|B1|No||Baseline RAAS Status|Baseline renin angiotensin-aldosterone system (RAAS) status refers to whether or not (yes/no) the participant was receiving RAAS inhibitor therapy at baseline.|participants|Number|25|25.0||||||
4307382|NCT00497146|4134272|B3|Yes||Baseline RAAS Status|Baseline renin angiotensin-aldosterone system (RAAS) status refers to whether or not (yes/no) the participant was receiving RAAS inhibitor therapy at baseline.|participants|Number|177|177.0||||||
4307383|NCT00497146|4134273|B2|Yes||Baseline RAAS Status|Baseline renin angiotensin-aldosterone system (RAAS) status refers to whether or not (yes/no) the participant was receiving RAAS inhibitor therapy at baseline.|participants|Number|87|87.0||||||
4307384|NCT00497146|4134274|B1|Yes||Baseline RAAS Status|Baseline renin angiotensin-aldosterone system (RAAS) status refers to whether or not (yes/no) the participant was receiving RAAS inhibitor therapy at baseline.|participants|Number|90|90.0||||||
4307385|NCT00497146|4134272|B3||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4307386|NCT00497146|4134273|B2||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4307387|NCT00497146|4134274|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4307388|NCT00497146|4134272|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4307389|NCT00497146|4134273|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4307390|NCT00497146|4134274|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4307391|NCT00497146|4134272|B3|||Age||years|Mean|65.0|65.0|Standard Deviation|11.75|11.75|||
4307392|NCT00497146|4134273|B2|||Age||years|Mean|65.7|65.7|Standard Deviation|12.20|12.2|||
4307393|NCT00497146|4134274|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|11.30|11.3|||
4307394|NCT00497146|4134272|B3||>=65 years|Age||Participants|Count of Participants|120|120.0||||||
4307395|NCT00497146|4134273|B2||>=65 years|Age||Participants|Count of Participants|61|61.0||||||
4307396|NCT00497146|4134274|B1||>=65 years|Age||Participants|Count of Participants|59|59.0||||||
4307397|NCT00497146|4134272|B3||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
4307398|NCT00497146|4134273|B2||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4307399|NCT00497146|4134274|B1||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4307400|NCT00497146|4134272|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4307401|NCT00497146|4134273|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4307402|NCT00497146|4134274|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4307403|NCT00497081|4134315|B3|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4307404|NCT00497081|4134316|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||7|7.0|||
4307405|NCT00497081|4134317|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||10|10.0|||
4307406|NCT00497081|4134315|B3|Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4307407|NCT00497081|4134316|B2|Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||13|13.0|||
4307408|NCT00497081|4134317|B1|Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||10|10.0|||
4307409|NCT00497081|4134315|B3|African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4307410|NCT00497081|4134316|B2|African American||Race/Ethnicity, Customized||participants|Number|5|5.0||17|17.0|||
4307411|NCT00497081|4134317|B1|African American||Race/Ethnicity, Customized||participants|Number|6|6.0||20|20.0|||
4307412|NCT00497081|4134315|B3|White||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4307413|NCT00497081|4134316|B2|White||Race/Ethnicity, Customized||participants|Number|19|19.0||63|63.0|||
4307414|NCT00497081|4134317|B1|White||Race/Ethnicity, Customized||participants|Number|18|18.0||60|60.0|||
4307415|NCT00497081|4134315|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4307416|NCT00497081|4134316|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4307417|NCT00497081|4134317|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4307418|NCT00497081|4134315|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4307419|NCT00497081|4134316|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4307420|NCT00497081|4134317|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4307421|NCT00497081|4134315|B3|||Age||years|Mean|40.5|40.5|Standard Deviation|9.0|9.0|||
4307422|NCT00497081|4134316|B2|||Age||years|Mean|40.1|40.1|Standard Deviation|10.1|10.1|||
4307423|NCT00497081|4134317|B1|||Age||years|Mean|40.9|40.9|Standard Deviation|8.0|8.0|||
4307424|NCT00497055|4134328|B3|United States||Region of Enrollment||participants|Number|90|90.0||||||
4307425|NCT00497055|4134329|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
4307426|NCT00497055|4134330|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4307427|NCT00497055|4134328|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4307428|NCT00497055|4134329|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4307429|NCT00497055|4134330|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4307430|NCT00497055|4134328|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4307431|NCT00497055|4134329|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4307432|NCT00497055|4134330|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4307433|NCT00497055|4134328|B3|||Age||years|Mean|38.7|38.7|Standard Deviation|10.8|10.8|||
4307434|NCT00497055|4134329|B2|||Age||years|Mean|40|40.0|Standard Deviation|8.9|8.9|||
4307435|NCT00497055|4134330|B1|||Age||years|Mean|37.4|37.4|Standard Deviation|12.3|12.3|||
4307436|NCT00497055|4134328|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4307437|NCT00497055|4134329|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4307438|NCT00497055|4134330|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4307439|NCT00497055|4134328|B3||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
4307440|NCT00497055|4134329|B2||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4307441|NCT00497055|4134330|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4307442|NCT00497055|4134328|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4307443|NCT00497055|4134329|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4307444|NCT00497055|4134330|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4307445|NCT00496964|4134341|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4307446|NCT00496964|4134342|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4307447|NCT00496964|4134343|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4307448|NCT00496964|4134341|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4307449|NCT00496964|4134342|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4307450|NCT00496964|4134343|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4307451|NCT00496964|4134341|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4307452|NCT00496964|4134342|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4307453|NCT00496964|4134343|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4307454|NCT00496964|4134341|B3|||Age||years|Mean|27.0|27.0|Standard Deviation|2.47|2.47|||
4307455|NCT00496964|4134342|B2|||Age||years|Mean|25.5|25.5|Standard Deviation|2.53|2.53|||
4307456|NCT00496964|4134343|B1|||Age||years|Mean|33|33.0|Standard Deviation|||||
4307457|NCT00496964|4134341|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4307458|NCT00496964|4134342|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4307459|NCT00496964|4134343|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4307460|NCT00496964|4134341|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4307461|NCT00496964|4134342|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4307462|NCT00496964|4134343|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4307463|NCT00496964|4134341|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4307464|NCT00496964|4134342|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4307465|NCT00496964|4134343|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4307466|NCT00496873|4134362|B1|United States||Region of Enrollment||participants|Number|85|85.0||||||
4307467|NCT00496873|4134362|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4307468|NCT00496873|4134362|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4307469|NCT00496873|4134362|B1|||Age||years|Median|59|59.0|Full Range|||34.0|84.0|
4307470|NCT00496860|4134368|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307471|NCT00496860|4134369|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307472|NCT00496860|4134370|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307473|NCT00496860|4134371|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307474|NCT00496860|4134368|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307475|NCT00496860|4134369|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307476|NCT00496860|4134370|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307477|NCT00496860|4134371|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307478|NCT00496860|4134368|B4||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4307479|NCT00496860|4134369|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4307480|NCT00496860|4134370|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4307481|NCT00496860|4134371|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4307482|NCT00496860|4134368|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4307483|NCT00496860|4134369|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307484|NCT00496860|4134370|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4307485|NCT00496860|4134371|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307486|NCT00496860|4134368|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307487|NCT00496860|4134369|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307488|NCT00496860|4134370|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307489|NCT00496860|4134371|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307490|NCT00496860|4134368|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307491|NCT00496860|4134369|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307492|NCT00496860|4134370|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307493|NCT00496860|4134371|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307494|NCT00496860|4134368|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307495|NCT00496860|4134369|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307496|NCT00496860|4134370|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307497|NCT00496860|4134371|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307498|NCT00496860|4134368|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4307499|NCT00496860|4134369|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4307500|NCT00496860|4134370|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4307501|NCT00496860|4134371|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4307502|NCT00496860|4134368|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4307503|NCT00496860|4134369|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4307504|NCT00496860|4134370|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4307505|NCT00496860|4134371|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4307506|NCT00496860|4134368|B4|||Age||years|Median|54|54.0|Full Range|||27.0|79.0|
4307507|NCT00496860|4134369|B3|||Age||years|Median|58|58.0|Full Range|||53.0|65.0|
4307508|NCT00496860|4134370|B2|||Age||years|Median|51|51.0|Full Range|||27.0|72.0|
4307509|NCT00496860|4134371|B1|||Age||years|Median|65|65.0|Full Range|||50.0|79.0|
4307510|NCT00496860|4134368|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4307511|NCT00496860|4134369|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4307512|NCT00496860|4134370|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4307513|NCT00496860|4134371|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4307514|NCT00496860|4134368|B4||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4307515|NCT00496860|4134369|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4307516|NCT00496860|4134370|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4307517|NCT00496860|4134371|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4307518|NCT00496860|4134368|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4307519|NCT00496860|4134369|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4307520|NCT00496860|4134370|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4307521|NCT00496860|4134371|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4307522|NCT00496834|4134393|B3|||Weight||Kilograms|Mean|70.4|70.4|Standard Deviation|12.0|12.0|||
4307523|NCT00496834|4134394|B2|||Weight||Kilograms|Mean|69.9|69.9|Standard Deviation|13.2|13.2|||
4307524|NCT00496834|4134395|B1|||Weight||Kilograms|Mean|70.9|70.9|Standard Deviation|10.6|10.6|||
4307525|NCT00496834|4134393|B3|||SBP (systolic blood pressure)||mm Hg|Mean|151.6|151.6|Standard Deviation|11.6|11.6|||
4307526|NCT00496834|4134394|B2|||SBP (systolic blood pressure)||mm Hg|Mean|152.7|152.7|Standard Deviation|12.1|12.1|||
4307527|NCT00496834|4134395|B1|||SBP (systolic blood pressure)||mm Hg|Mean|150.6|150.6|Standard Deviation|11.0|11.0|||
4307528|NCT00496834|4134393|B3|||Pulse||BPM (beats per minute)|Mean|72.0|72.0|Standard Deviation|10.0|10.0|||
4307529|NCT00496834|4134394|B2|||Pulse||BPM (beats per minute)|Mean|72.3|72.3|Standard Deviation|10.0|10.0|||
4307530|NCT00496834|4134395|B1|||Pulse||BPM (beats per minute)|Mean|71.8|71.8|Standard Deviation|10.0|10.0|||
4307531|NCT00496834|4134393|B3|||PWV (pulse wave velocity)||meters/second|Mean|7.6|7.6|Standard Deviation|1.4|1.4|||
4307532|NCT00496834|4134394|B2|||PWV (pulse wave velocity)||meters/second|Mean|7.7|7.7|Standard Deviation|1.4|1.4|||
4307533|NCT00496834|4134395|B1|||PWV (pulse wave velocity)||meters/second|Mean|7.6|7.6|Standard Deviation|1.4|1.4|||
4307534|NCT00496834|4134393|B3|||Height||Centimeters|Mean|164.1|164.1|Standard Deviation|8.5|8.5|||
4307535|NCT00496834|4134394|B2|||Height||Centimeters|Mean|163.3|163.3|Standard Deviation|9.2|9.2|||
4307536|NCT00496834|4134395|B1|||Height||Centimeters|Mean|164.9|164.9|Standard Deviation|7.8|7.8|||
4307537|NCT00496834|4134393|B3|||DBP (diastolic blood pressure)||mm Hg|Mean|96.4|96.4|Standard Deviation|8.5|8.5|||
4307538|NCT00496834|4134394|B2|||DBP (diastolic blood pressure)||mm Hg|Mean|96.4|96.4|Standard Deviation|8.3|8.3|||
4307539|NCT00496834|4134395|B1|||DBP (diastolic blood pressure)||mm Hg|Mean|96.4|96.4|Standard Deviation|8.8|8.8|||
4307540|NCT00496834|4134393|B3||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4307541|NCT00496834|4134394|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4307542|NCT00496834|4134395|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4307543|NCT00496834|4134393|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4307544|NCT00496834|4134394|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4307545|NCT00496834|4134395|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4307546|NCT00496834|4134393|B3|>=65 years||Age, Customized||participants|Number|14|14.0||||||
4307547|NCT00496834|4134394|B2|>=65 years||Age, Customized||participants|Number|9|9.0||||||
4307548|NCT00496834|4134395|B1|>=65 years||Age, Customized||participants|Number|5|5.0||||||
4307549|NCT00496834|4134393|B3|>= 18 to < 65 years||Age, Customized||participants|Number|187|187.0||||||
4307550|NCT00496834|4134394|B2|>= 18 to < 65 years||Age, Customized||participants|Number|91|91.0||||||
4307551|NCT00496834|4134395|B1|>= 18 to < 65 years||Age, Customized||participants|Number|96|96.0||||||
4307552|NCT00496834|4134393|B3|||Age||years|Mean|49.6|49.6|Standard Deviation|9.7|9.7|||
4307553|NCT00496834|4134394|B2|||Age||years|Mean|50.1|50.1|Standard Deviation|10.2|10.2|||
4307554|NCT00496834|4134395|B1|||Age||years|Mean|49.0|49.0|Standard Deviation|9.3|9.3|||
4307555|NCT00496808|4134408|B1|United States||Region of Enrollment||participants|Number|69|69.0||||||
4307556|NCT00496808|4134408|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4307557|NCT00496808|4134408|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4307558|NCT00496808|4134408|B1|||Age||years|Median|53|53.0|Full Range|||31.0|77.0|
4307559|NCT00496782|4134413|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4307560|NCT00496782|4134414|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4307561|NCT00496782|4134415|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4307562|NCT00496782|4134413|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4307563|NCT00496782|4134414|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4307564|NCT00496782|4134415|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4307565|NCT00496782|4134413|B3|||Age||years|Mean|44.0|44.0|Standard Deviation|5.4|5.4|||
4307566|NCT00496782|4134414|B2|||Age||years|Mean|41.0|41.0|Standard Deviation|4.8|4.8|||
4307567|NCT00496782|4134415|B1|||Age||years|Mean|46.3|46.3|Standard Deviation|4.9|4.9|||
4307568|NCT00496769|4134448|B3|Peripheral artery disease||Number of Participants With Risk Factors for Stroke|NYHA=New York Health Authority; LVEF=left ventricular ejection fraction|Participants|Count of Participants|144|144.0||||||
4307569|NCT00496769|4134449|B2|Peripheral artery disease||Number of Participants With Risk Factors for Stroke|NYHA=New York Health Authority; LVEF=left ventricular ejection fraction|Participants|Count of Participants|78|78.0||||||
4307570|NCT00496769|4134450|B1|Peripheral artery disease||Number of Participants With Risk Factors for Stroke|NYHA=New York Health Authority; LVEF=left ventricular ejection fraction|Participants|Count of Participants|66|66.0||||||
4307571|NCT00496769|4134448|B3|Hypertension requiring pharmacologic treatment||Number of Participants With Risk Factors for Stroke|NYHA=New York Health Authority; LVEF=left ventricular ejection fraction|Participants|Count of Participants|4837|4837.0||||||
4307572|NCT00496769|4134449|B2|Hypertension requiring pharmacologic treatment||Number of Participants With Risk Factors for Stroke|NYHA=New York Health Authority; LVEF=left ventricular ejection fraction|Participants|Count of Participants|2429|2429.0||||||
4307573|NCT00496769|4134450|B1|Hypertension requiring pharmacologic treatment||Number of Participants With Risk Factors for Stroke|NYHA=New York Health Authority; LVEF=left ventricular ejection fraction|Participants|Count of Participants|2408|2408.0||||||
4307574|NCT00496769|4134448|B3|Diabetes mellitus||Number of Participants With Risk Factors for Stroke|NYHA=New York Health Authority; LVEF=left ventricular ejection fraction|Participants|Count of Participants|1095|1095.0||||||
4307575|NCT00496769|4134449|B2|Diabetes mellitus||Number of Participants With Risk Factors for Stroke|NYHA=New York Health Authority; LVEF=left ventricular ejection fraction|Participants|Count of Participants|559|559.0||||||
4307576|NCT00496769|4134450|B1|Diabetes mellitus||Number of Participants With Risk Factors for Stroke|NYHA=New York Health Authority; LVEF=left ventricular ejection fraction|Participants|Count of Participants|536|536.0||||||
4307577|NCT00496769|4134448|B3|Heart failure (NYHA class ≥2) or LVEF ≤35%||Number of Participants With Risk Factors for Stroke|NYHA=New York Health Authority; LVEF=left ventricular ejection fraction|Participants|Count of Participants|1887|1887.0||||||
4307578|NCT00496769|4134449|B2|Heart failure (NYHA class ≥2) or LVEF ≤35%||Number of Participants With Risk Factors for Stroke|NYHA=New York Health Authority; LVEF=left ventricular ejection fraction|Participants|Count of Participants|926|926.0||||||
4307579|NCT00496769|4134450|B1|Heart failure (NYHA class ≥2) or LVEF ≤35%||Number of Participants With Risk Factors for Stroke|NYHA=New York Health Authority; LVEF=left ventricular ejection fraction|Participants|Count of Participants|961|961.0||||||
4307580|NCT00496769|4134448|B3|Prior stroke or transient ischemic attack||Number of Participants With Risk Factors for Stroke|NYHA=New York Health Authority; LVEF=left ventricular ejection fraction|Participants|Count of Participants|764|764.0||||||
4307581|NCT00496769|4134449|B2|Prior stroke or transient ischemic attack||Number of Participants With Risk Factors for Stroke|NYHA=New York Health Authority; LVEF=left ventricular ejection fraction|Participants|Count of Participants|374|374.0||||||
4307582|NCT00496769|4134450|B1|Prior stroke or transient ischemic attack||Number of Participants With Risk Factors for Stroke|NYHA=New York Health Authority; LVEF=left ventricular ejection fraction|Participants|Count of Participants|390|390.0||||||
4307583|NCT00496769|4134448|B3|Age of 75 years or older||Number of Participants With Risk Factors for Stroke|NYHA=New York Health Authority; LVEF=left ventricular ejection fraction|Participants|Count of Participants|1891|1891.0||||||
4307584|NCT00496769|4134449|B2|Age of 75 years or older||Number of Participants With Risk Factors for Stroke|NYHA=New York Health Authority; LVEF=left ventricular ejection fraction|Participants|Count of Participants|988|988.0||||||
4307585|NCT00496769|4134450|B1|Age of 75 years or older||Number of Participants With Risk Factors for Stroke|NYHA=New York Health Authority; LVEF=left ventricular ejection fraction|Participants|Count of Participants|903|903.0||||||
4307586|NCT00496769|4134448|B3||2 or more|Number of Participants by Number of Risk Factors for Stroke||Participants|Count of Participants|3436|3436.0||||||
4307587|NCT00496769|4134449|B2||2 or more|Number of Participants by Number of Risk Factors for Stroke||Participants|Count of Participants|1714|1714.0||||||
4307588|NCT00496769|4134450|B1||2 or more|Number of Participants by Number of Risk Factors for Stroke||Participants|Count of Participants|1722|1722.0||||||
4307589|NCT00496769|4134448|B3||1 or fewer|Number of Participants by Number of Risk Factors for Stroke||Participants|Count of Participants|2162|2162.0||||||
4307590|NCT00496769|4134449|B2||1 or fewer|Number of Participants by Number of Risk Factors for Stroke||Participants|Count of Participants|1077|1077.0||||||
4307591|NCT00496769|4134450|B1||1 or fewer|Number of Participants by Number of Risk Factors for Stroke||Participants|Count of Participants|1085|1085.0||||||
4307592|NCT00496769|4134448|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|62|62.0||||||
4307593|NCT00496769|4134449|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
4307594|NCT00496769|4134450|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
4307595|NCT00496769|4134448|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|4399|4399.0||||||
4307596|NCT00496769|4134449|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|2178|2178.0||||||
4307597|NCT00496769|4134450|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|2221|2221.0||||||
4307598|NCT00496769|4134448|B3||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
4307599|NCT00496769|4134449|B2||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
4307600|NCT00496769|4134450|B1||Black or African American|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4307601|NCT00496769|4134448|B3||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4307602|NCT00496769|4134449|B2||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4307603|NCT00496769|4134450|B1||Native Hawaiian or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4307604|NCT00496769|4134448|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1085|1085.0||||||
4307605|NCT00496769|4134449|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|544|544.0||||||
4307606|NCT00496769|4134450|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|541|541.0||||||
4307607|NCT00496769|4134448|B3||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4307608|NCT00496769|4134449|B2||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4307609|NCT00496769|4134450|B1||American Indian or Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4307610|NCT00496769|4134448|B3||Male|Sex: Female, Male||Participants|Count of Participants|3277|3277.0||||||
4307611|NCT00496769|4134449|B2||Male|Sex: Female, Male||Participants|Count of Participants|1617|1617.0||||||
4307612|NCT00496769|4134450|B1||Male|Sex: Female, Male||Participants|Count of Participants|1660|1660.0||||||
4307613|NCT00496769|4134448|B3||Female|Sex: Female, Male||Participants|Count of Participants|2321|2321.0||||||
4307614|NCT00496769|4134449|B2||Female|Sex: Female, Male||Participants|Count of Participants|1174|1174.0||||||
4307615|NCT00496769|4134450|B1||Female|Sex: Female, Male||Participants|Count of Participants|1147|1147.0||||||
4307616|NCT00496769|4134448|B3||>=75 years|Age, Customized||Participants|Count of Participants|1891|1891.0||||||
4307617|NCT00496769|4134449|B2||>=75 years|Age, Customized||Participants|Count of Participants|988|988.0||||||
4307618|NCT00496769|4134450|B1||>=75 years|Age, Customized||Participants|Count of Participants|903|903.0||||||
4307619|NCT00496769|4134448|B3||>=65 but <75 years|Age, Customized||Participants|Count of Participants|1987|1987.0||||||
4307620|NCT00496769|4134449|B2||>=65 but <75 years|Age, Customized||Participants|Count of Participants|938|938.0||||||
4307621|NCT00496769|4134450|B1||>=65 but <75 years|Age, Customized||Participants|Count of Participants|1049|1049.0||||||
4307622|NCT00496769|4134448|B3||< 65 years|Age, Customized||Participants|Count of Participants|1720|1720.0||||||
4307623|NCT00496769|4134449|B2||< 65 years|Age, Customized||Participants|Count of Participants|865|865.0||||||
4307624|NCT00496769|4134450|B1||< 65 years|Age, Customized||Participants|Count of Participants|855|855.0||||||
4307625|NCT00496769|4134448|B3|||Age||years|Mean|69.9|69.9|Standard Deviation|9.58|9.58|||
4307626|NCT00496769|4134449|B2|||Age||years|Mean|70.0|70.0|Standard Deviation|9.71|9.71|||
4307627|NCT00496769|4134450|B1|||Age||years|Mean|69.7|69.7|Standard Deviation|9.44|9.44|||
4307628|NCT00496730|4134475|B3|||Systolic Blood Pressure||mm Hg|Mean|130.34|130.34|Standard Deviation|14.19|14.19|||
4307629|NCT00496730|4134476|B2|||Systolic Blood Pressure||mm Hg|Mean|129.85|129.85|Standard Deviation|14.51|14.51|||
4307630|NCT00496730|4134477|B1|||Systolic Blood Pressure||mm Hg|Mean|130.81|130.81|Standard Deviation|13.91|13.91|||
4307631|NCT00496730|4134475|B3|||LDL-C (low-Density-Lipoprotein-Cholesterol)||mg/dL|Mean|159.95|159.95|Standard Deviation|28.84|28.84|||
4307632|NCT00496730|4134476|B2|||LDL-C (low-Density-Lipoprotein-Cholesterol)||mg/dL|Mean|159.95|159.95|Standard Deviation|27.34|27.34|||
4307633|NCT00496730|4134477|B1|||LDL-C (low-Density-Lipoprotein-Cholesterol)||mg/dL|Mean|159.95|159.95|Standard Deviation|30.33|30.33|||
4307634|NCT00496730|4134475|B3|||Diastolic Blood Pressure||mm Hg|Mean|81.55|81.55|Standard Deviation|8.48|8.48|||
4307635|NCT00496730|4134476|B2|||Diastolic Blood Pressure||mm Hg|Mean|82.11|82.11|Standard Deviation|8.49|8.49|||
4307636|NCT00496730|4134477|B1|||Diastolic Blood Pressure||mm Hg|Mean|81.01|81.01|Standard Deviation|8.47|8.47|||
4307637|NCT00496730|4134475|B3|||Body Mass Index (BMI)||kg/m^2|Mean|26.61|26.61|Standard Deviation|3.46|3.46|||
4307638|NCT00496730|4134476|B2|||Body Mass Index (BMI)||kg/m^2|Mean|26.45|26.45|Standard Deviation|3.34|3.34|||
4307639|NCT00496730|4134477|B1|||Body Mass Index (BMI)||kg/m^2|Mean|26.75|26.75|Standard Deviation|3.59|3.59|||
4307640|NCT00496730|4134475|B3||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4307641|NCT00496730|4134476|B2||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4307642|NCT00496730|4134477|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4307643|NCT00496730|4134475|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4307644|NCT00496730|4134476|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4307645|NCT00496730|4134477|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4307646|NCT00496730|4134475|B3|||Age||years|Mean|59.61|59.61|Standard Deviation|9.44|9.44|||
4307647|NCT00496730|4134476|B2|||Age||years|Mean|60.26|60.26|Standard Deviation|9.44|9.44|||
4307648|NCT00496730|4134477|B1|||Age||years|Mean|58.96|58.96|Standard Deviation|9.42|9.42|||
4307649|NCT00496626|4134488|B3|||Pulse||Beats per minute (BPM)|Mean|74.5|74.5|Standard Deviation|11.2|11.2|||
4307650|NCT00496626|4134489|B2|||Pulse||Beats per minute (BPM)|Mean|74.6|74.6|Standard Deviation|11.2|11.2|||
4307651|NCT00496626|4134490|B1|||Pulse||Beats per minute (BPM)|Mean|74.4|74.4|Standard Deviation|11.9|11.9|||
4307652|NCT00496626|4134488|B3|||Body Temperature||Degrees Celsius|Mean|36.5|36.5|Standard Deviation|0.31|0.31|||
4307653|NCT00496626|4134489|B2|||Body Temperature||Degrees Celsius|Mean|36.5|36.5|Standard Deviation|0.31|0.31|||
4307654|NCT00496626|4134490|B1|||Body Temperature||Degrees Celsius|Mean|36.5|36.5|Standard Deviation|0.31|0.31|||
4307655|NCT00496626|4134488|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4307656|NCT00496626|4134489|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4307657|NCT00496626|4134490|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4307658|NCT00496626|4134488|B3||Female|Sex: Female, Male||Participants|Count of Participants|500|500.0||||||
4307659|NCT00496626|4134489|B2||Female|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
4307660|NCT00496626|4134490|B1||Female|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4307661|NCT00496626|4134488|B3|35-45 Years of Age||Age, Customized||Participants|Number|125|125.0||||||
4307662|NCT00496626|4134489|B2|35-45 Years of Age||Age, Customized||Participants|Number|63|63.0||||||
4307663|NCT00496626|4134490|B1|35-45 Years of Age||Age, Customized||Participants|Number|62|62.0||||||
4307664|NCT00496626|4134488|B3|27-34 Years of Age||Age, Customized||Participants|Number|125|125.0||||||
4307665|NCT00496626|4134489|B2|27-34 Years of Age||Age, Customized||Participants|Number|62|62.0||||||
4307666|NCT00496626|4134490|B1|27-34 Years of Age||Age, Customized||Participants|Number|63|63.0||||||
4307667|NCT00496626|4134488|B3|16-26 Years of Age||Age, Customized||Participants|Number|150|150.0||||||
4307668|NCT00496626|4134489|B2|16-26 Years of Age||Age, Customized||Participants|Number|74|74.0||||||
4307669|NCT00496626|4134490|B1|16-26 Years of Age||Age, Customized||Participants|Number|76|76.0||||||
4307670|NCT00496626|4134488|B3|9-15 Years of Age||Age, Customized||Participants|Number|200|200.0||||||
4307671|NCT00496626|4134489|B2|9-15 Years of Age||Age, Customized||Participants|Number|99|99.0||||||
4307672|NCT00496626|4134490|B1|9-15 Years of Age||Age, Customized||Participants|Number|101|101.0||||||
4307673|NCT00496626|4134488|B3|||Age||years|Mean|24.6|24.6|Standard Deviation|10.9|10.9|||
4307674|NCT00496626|4134489|B2|||Age||years|Mean|24.8|24.8|Standard Deviation|11.0|11.0|||
4307675|NCT00496626|4134490|B1|||Age||years|Mean|24.5|24.5|Standard Deviation|10.9|10.9|||
4307676|NCT00496587|4134503|B1|United States||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
4307677|NCT00496587|4134503|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307678|NCT00496587|4134503|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307679|NCT00496587|4134503|B1||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4307680|NCT00496587|4134503|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4307681|NCT00496587|4134503|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307682|NCT00496587|4134503|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307683|NCT00496587|4134503|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307684|NCT00496587|4134503|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307685|NCT00496587|4134503|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4307686|NCT00496587|4134503|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4307687|NCT00496587|4134503|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4307688|NCT00496587|4134503|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4307689|NCT00496587|4134503|B1|||Age||years|Median|54|54.0|Full Range|||38.0|77.0|
4307690|NCT00496483|4134509|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4307691|NCT00496483|4134509|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4307692|NCT00496483|4134509|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4307693|NCT00496483|4134509|B1|||Age||years|Mean|45.6|45.6|Standard Deviation|12.08|12.08|||
4307694|NCT00496470|4134524|B3||Male|Sex: Female, Male||Participants|Count of Participants|496|496.0||||||
4307695|NCT00496470|4134525|B2||Male|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4307696|NCT00496470|4134526|B1||Male|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4307697|NCT00496470|4134524|B3||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4307698|NCT00496470|4134525|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4307699|NCT00496470|4134526|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4307700|NCT00496470|4134524|B3|||Age||Years|Mean|62.45|62.45|Full Range|||40.0|85.0|
4307701|NCT00496470|4134525|B2|||Age||Years|Mean|62.5|62.5|Full Range|||41.0|82.0|
4307702|NCT00496470|4134526|B1|||Age||Years|Mean|62.4|62.4|Full Range|||40.0|85.0|
4307703|NCT00496379|4134605|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4307704|NCT00496379|4134605|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4307705|NCT00496379|4134605|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4307706|NCT00496379|4134605|B1|||Age||years|Mean|50.3|50.3|Standard Deviation|12.7|12.7|||
4307707|NCT00496379|4134605|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4307708|NCT00496379|4134605|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4307709|NCT00496379|4134605|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4307710|NCT00496366|4134613|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4307711|NCT00496366|4134613|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307712|NCT00496366|4134613|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307713|NCT00496366|4134613|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4307714|NCT00496366|4134613|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4307715|NCT00496366|4134613|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307716|NCT00496366|4134613|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307717|NCT00496366|4134613|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4307718|NCT00496366|4134613|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4307719|NCT00496366|4134613|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4307720|NCT00496366|4134613|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4307721|NCT00496366|4134613|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4307722|NCT00496366|4134613|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4307723|NCT00496366|4134613|B1|||Age||years|Median|60.7|60.7|Full Range|||39.0|78.0|
4307724|NCT00496366|4134613|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4307725|NCT00496366|4134613|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4307726|NCT00496366|4134613|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4307727|NCT00496340|4134618|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4307728|NCT00496340|4134618|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4307729|NCT00496340|4134618|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4307730|NCT00496340|4134618|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4307731|NCT00496340|4134618|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4307732|NCT00496340|4134618|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4307733|NCT00496340|4134618|B1|||Age||years|Median|53|53.0|Full Range|||29.0|73.0|
4307734|NCT00496262|4134631|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4307735|NCT00496262|4134631|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4307736|NCT00496262|4134631|B1|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4307737|NCT00496262|4134631|B1|≥16 to < 65 years||Age, Customized||participants|Number|11|11.0||||||
4307738|NCT00496262|4134631|B1|<16 years||Age, Customized||participants|Number|4|4.0||||||
4307739|NCT00496262|4134631|B1|||Age||years|Mean|29.5|29.5|Standard Deviation|15.9|15.9|||
4307740|NCT00496197|4134644|B1||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4307741|NCT00496197|4134644|B1||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4307742|NCT00496197|4134644|B1|≥ 65 years of age||Age, Customized||participants|Number|94|94.0||||||
4307743|NCT00496197|4134644|B1|45 to 64 years of age||Age, Customized||participants|Number|116|116.0||||||
4307744|NCT00496197|4134644|B1|18 to 44 years of age||Age, Customized||participants|Number|72|72.0||||||
4307745|NCT00496080|4134671|B1|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4307746|NCT00496080|4134671|B1|Mexico||Region of Enrollment||participants|Number|30|30.0||||||
4307747|NCT00496080|4134671|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4307748|NCT00496080|4134671|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4307749|NCT00496080|4134671|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4307750|NCT00496080|4134671|B1|||Age||years|Mean|42.3|42.3|Standard Deviation|4.9|4.9|||
4307751|NCT00496054|4134681|B1|||Weight||Kilograms|Mean|4.73|4.73|Standard Deviation|0.71|0.71|||
4307752|NCT00496054|4134681|B1|||Temperature||Fahrenheit|Mean|98.58|98.58|Standard Deviation|0.70|0.7|||
4307753|NCT00496054|4134681|B1|||Height||Centimeters|Mean|57.61|57.61|Standard Deviation|5.04|5.04|||
4307754|NCT00496054|4134681|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4307755|NCT00496054|4134681|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4307756|NCT00496054|4134681|B1|||Age||Days|Mean|59.01|59.01|Standard Deviation|13.52|13.52|||
4307757|NCT00495820|4134708|B3|||Clinical Global Impression-severity (CGI-S)|Range 0-7, higher scores indicating worsening of condition.|units on a scale|Mean|5.3|5.3|Standard Deviation|0.6|0.6|||
4307758|NCT00495820|4134709|B2|||Clinical Global Impression-severity (CGI-S)|Range 0-7, higher scores indicating worsening of condition.|units on a scale|Mean|5.1|5.1|Standard Deviation|0.6|0.6|||
4307759|NCT00495820|4134710|B1|||Clinical Global Impression-severity (CGI-S)|Range 0-7, higher scores indicating worsening of condition.|units on a scale|Mean|5.5|5.5|Standard Deviation|0.6|0.6|||
4307760|NCT00495820|4134708|B3|||Zarit Burden Scale|Range 0-88. Higher scores indicate higher caregiver burden.|units on a scale|Mean|26.9|26.9|Standard Deviation|13|13.0|||
4307761|NCT00495820|4134709|B2|||Zarit Burden Scale|Range 0-88. Higher scores indicate higher caregiver burden.|units on a scale|Mean|25.3|25.3|Standard Deviation|13.3|13.3|||
4307762|NCT00495820|4134710|B1|||Zarit Burden Scale|Range 0-88. Higher scores indicate higher caregiver burden.|units on a scale|Mean|28.1|28.1|Standard Deviation|13|13.0|||
4307763|NCT00495820|4134708|B3|||The Executive Interview (EXIT-25)|Range: 0-50, higher scores indicate worsening of executive function.|units on a scale|Mean|16.8|16.8|Standard Deviation|6.4|6.4|||
4307764|NCT00495820|4134709|B2|||The Executive Interview (EXIT-25)|Range: 0-50, higher scores indicate worsening of executive function.|units on a scale|Mean|16.8|16.8|Standard Deviation|6.6|6.6|||
4307765|NCT00495820|4134710|B1|||The Executive Interview (EXIT-25)|Range: 0-50, higher scores indicate worsening of executive function.|units on a scale|Mean|16.9|16.9|Standard Deviation|6.3|6.3|||
4307766|NCT00495820|4134708|B3|||Activities of Daily Living|Range 0-24. Higher scores indicate better independence in performing activities of daily living.|units on a scale|Mean|22|22.0|Standard Deviation|2.6|2.6|||
4307767|NCT00495820|4134709|B2|||Activities of Daily Living|Range 0-24. Higher scores indicate better independence in performing activities of daily living.|units on a scale|Mean|22.9|22.9|Standard Deviation|2.2|2.2|||
4307768|NCT00495820|4134710|B1|||Activities of Daily Living|Range 0-24. Higher scores indicate better independence in performing activities of daily living.|units on a scale|Mean|21.3|21.3|Standard Deviation|2.7|2.7|||
4307769|NCT00495820|4134708|B3|||Modified Mini-Mental State Examination (3MS)|Range 0-100. Higher scores indicate better cognition|units on a scale|Mean|81.3|81.3|Standard Deviation|9.5|9.5|||
4307770|NCT00495820|4134709|B2|||Modified Mini-Mental State Examination (3MS)|Range 0-100. Higher scores indicate better cognition|units on a scale|Mean|82.6|82.6|Standard Deviation|10|10.0|||
4307771|NCT00495820|4134710|B1|||Modified Mini-Mental State Examination (3MS)|Range 0-100. Higher scores indicate better cognition|units on a scale|Mean|80.1|80.1|Standard Deviation|9|9.0|||
4307772|NCT00495820|4134708|B3|||Mini-mental State Examination (MMSE)|Range 0-30. Higher scores indicate better cognition|units on a scale|Mean|23.8|23.8|Standard Deviation|2.5|2.5|||
4307773|NCT00495820|4134709|B2|||Mini-mental State Examination (MMSE)|Range 0-30. Higher scores indicate better cognition|units on a scale|Mean|24|24.0|Standard Deviation|2.6|2.6|||
4307774|NCT00495820|4134710|B1|||Mini-mental State Examination (MMSE)|Range 0-30. Higher scores indicate better cognition|units on a scale|Mean|23.7|23.7|Standard Deviation|2.5|2.5|||
4307836|NCT00495625|4134807|B1|||Age||years|Mean|60.65|60.65|Full Range|||24.0|88.0|
4307775|NCT00495820|4134708|B3|||Apathy Evaluation Scale|Range: 18-72 Higher scores indicate worse apathy|units on a scale|Mean|49.7|49.7|Standard Deviation|6.8|6.8|||
4307776|NCT00495820|4134709|B2|||Apathy Evaluation Scale|Range: 18-72 Higher scores indicate worse apathy|units on a scale|Mean|47.6|47.6|Standard Deviation|5.8|5.8|||
4307777|NCT00495820|4134710|B1|||Apathy Evaluation Scale|Range: 18-72 Higher scores indicate worse apathy|units on a scale|Mean|51.9|51.9|Standard Deviation|7.1|7.1|||
4307778|NCT00495820|4134708|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4307779|NCT00495820|4134709|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4307780|NCT00495820|4134710|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4307781|NCT00495820|4134708|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4307782|NCT00495820|4134709|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4307783|NCT00495820|4134710|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4307784|NCT00495820|4134708|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4307785|NCT00495820|4134709|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4307786|NCT00495820|4134710|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4307787|NCT00495820|4134708|B3|||Age||years|Mean|76.6|76.6|Standard Deviation|7.9|7.9|||
4307788|NCT00495820|4134709|B2|||Age||years|Mean|76.1|76.1|Standard Deviation|8.4|8.4|||
4307789|NCT00495820|4134710|B1|||Age||years|Mean|77.5|77.5|Standard Deviation|7.9|7.9|||
4307790|NCT00495794|4134721|B3|United States||Region of Enrollment||participants|Number|4100|4100.0||||||
4307791|NCT00495794|4134722|B2|United States||Region of Enrollment||participants|Number|2303|2303.0||||||
4307792|NCT00495794|4134723|B1|United States||Region of Enrollment||participants|Number|1797|1797.0||||||
4307793|NCT00495794|4134721|B3||Male|Sex: Female, Male||Participants|Count of Participants|2832|2832.0||||||
4307794|NCT00495794|4134722|B2||Male|Sex: Female, Male||Participants|Count of Participants|1582|1582.0||||||
4307795|NCT00495794|4134723|B1||Male|Sex: Female, Male||Participants|Count of Participants|1250|1250.0||||||
4307796|NCT00495794|4134721|B3||Female|Sex: Female, Male||Participants|Count of Participants|1268|1268.0||||||
4307797|NCT00495794|4134722|B2||Female|Sex: Female, Male||Participants|Count of Participants|721|721.0||||||
4307798|NCT00495794|4134723|B1||Female|Sex: Female, Male||Participants|Count of Participants|547|547.0||||||
4307799|NCT00495794|4134721|B3|||Age||years|Mean|65.3|65.3|Standard Deviation|11.9|11.9|||
4307800|NCT00495794|4134722|B2|||Age||years|Mean|65.3|65.3|Standard Deviation|12.1|12.1|||
4307801|NCT00495794|4134723|B1|||Age||years|Mean|65.3|65.3|Standard Deviation|11.7|11.7|||
4307802|NCT00495755|4134734|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4307803|NCT00495755|4134734|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4307804|NCT00495755|4134734|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4307805|NCT00495755|4134734|B1|||Age||years|Mean|54|54.0|Standard Deviation|5|5.0|||
4307806|NCT00495755|4134734|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4307807|NCT00495755|4134734|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4307808|NCT00495755|4134734|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4307809|NCT00495677|4134739|B8||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4307810|NCT00495677|4134740|B7||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4307811|NCT00495677|4134741|B6||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4307812|NCT00495677|4134742|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4307813|NCT00495677|4134743|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4307814|NCT00495677|4134744|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4307815|NCT00495677|4134745|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4307816|NCT00495677|4134746|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4307817|NCT00495677|4134739|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4307818|NCT00495677|4134740|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4307819|NCT00495677|4134741|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4307820|NCT00495677|4134742|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4307821|NCT00495677|4134743|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4307822|NCT00495677|4134744|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4307823|NCT00495677|4134745|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4307824|NCT00495677|4134746|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4307825|NCT00495677|4134739|B8|||Age||years|Mean|35.2|35.2|Standard Deviation|7.8|7.8|||
4307826|NCT00495677|4134740|B7|||Age||years|Mean|29|29.0|Standard Deviation|5.7|5.7|||
4307827|NCT00495677|4134741|B6|||Age||years|Mean|32.9|32.9|Standard Deviation|5|5.0|||
4307828|NCT00495677|4134742|B5|||Age||years|Mean|36.1|36.1|Standard Deviation|9.6|9.6|||
4307829|NCT00495677|4134743|B4|||Age||years|Mean|36.2|36.2|Standard Deviation|9.1|9.1|||
4307830|NCT00495677|4134744|B3|||Age||years|Mean|36.5|36.5|Standard Deviation|5.4|5.4|||
4307831|NCT00495677|4134745|B2|||Age||years|Mean|39.8|39.8|Standard Deviation|8.5|8.5|||
4307832|NCT00495677|4134746|B1|||Age||years|Mean|31.5|31.5|Standard Deviation|8.9|8.9|||
4307833|NCT00495625|4134807|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4307834|NCT00495625|4134807|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4307835|NCT00495625|4134807|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4307837|NCT00495625|4134807|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4307838|NCT00495625|4134807|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4307839|NCT00495625|4134807|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4307840|NCT00495612|4134816|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4307841|NCT00495612|4134817|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4307842|NCT00495612|4134818|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4307843|NCT00495612|4134816|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4307844|NCT00495612|4134817|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4307845|NCT00495612|4134818|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4307846|NCT00495612|4134816|B3|||Age||years|Mean|36.5|36.5|Standard Deviation|11.5|11.5|||
4307847|NCT00495612|4134817|B2|||Age||years|Mean|38.5|38.5|Standard Deviation|12.3|12.3|||
4307848|NCT00495612|4134818|B1|||Age||years|Mean|34.6|34.6|Standard Deviation|10.5|10.5|||
4307849|NCT00495586|4134835|B3|Spain||Region of Enrollment||participants|Number|318|318.0||||||
4307850|NCT00495586|4134836|B2|Spain||Region of Enrollment||participants|Number|162|162.0||||||
4307851|NCT00495586|4134837|B1|Spain||Region of Enrollment||participants|Number|156|156.0||||||
4307852|NCT00495586|4134835|B3||Male|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
4307853|NCT00495586|4134836|B2||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4307854|NCT00495586|4134837|B1||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4307855|NCT00495586|4134835|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4307856|NCT00495586|4134836|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4307857|NCT00495586|4134837|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4307858|NCT00495586|4134835|B3|||Age||years|Mean|68.1|68.1|Standard Deviation|10.4|10.4|||
4307859|NCT00495586|4134836|B2|||Age||years|Mean|68.4|68.4|Standard Deviation|9.9|9.9|||
4307860|NCT00495586|4134837|B1|||Age||years|Mean|67.8|67.8|Standard Deviation|11.0|11.0|||
4307861|NCT00495586|4134835|B3||>=65 years|Age||Participants|Count of Participants|218|218.0||||||
4307862|NCT00495586|4134836|B2||>=65 years|Age||Participants|Count of Participants|116|116.0||||||
4307863|NCT00495586|4134837|B1||>=65 years|Age||Participants|Count of Participants|102|102.0||||||
4307864|NCT00495586|4134835|B3||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4307865|NCT00495586|4134836|B2||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4307866|NCT00495586|4134837|B1||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4307867|NCT00495586|4134835|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4307868|NCT00495586|4134836|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4307869|NCT00495586|4134837|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4307870|NCT00495521|4134846|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4307871|NCT00495521|4134847|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4307872|NCT00495521|4134848|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4307873|NCT00495521|4134846|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4307874|NCT00495521|4134847|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4307875|NCT00495521|4134848|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4307876|NCT00495521|4134846|B3|||Age||years|Mean|13|13.0|Full Range|||12.0|14.0|
4307877|NCT00495521|4134847|B2|||Age||years|Mean|14|14.0|Full Range|||14.0|14.0|
4307878|NCT00495521|4134848|B1|||Age||years|Mean|12|12.0|Full Range|||12.0|12.0|
4307879|NCT00495495|4134879|B1|United States||Region of Enrollment||participants|Number|394|394.0||||||
4307880|NCT00495495|4134879|B1||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4307881|NCT00495495|4134879|B1||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4307882|NCT00495495|4134879|B1|||Age||years|Mean|22.9|22.9|Standard Deviation|7.2|7.2|||
4307883|NCT00495495|4134879|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4307884|NCT00495495|4134879|B1||Between 18 and 65 years|Age||Participants|Count of Participants|292|292.0||||||
4307885|NCT00495495|4134879|B1||<=18 years|Age||Participants|Count of Participants|102|102.0||||||
4307886|NCT00495469|4134892|B8|Mixed Race||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
4307887|NCT00495469|4134893|B7|Mixed Race||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4307888|NCT00495469|4134894|B6|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4307889|NCT00495469|4134895|B5|Mixed Race||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4307890|NCT00495469|4134896|B4|Mixed Race||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4307891|NCT00495469|4134897|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4307892|NCT00495469|4134898|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4307893|NCT00495469|4134899|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4307894|NCT00495469|4134892|B8|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|160|160.0||||||
4307895|NCT00495469|4134893|B7|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
4307896|NCT00495469|4134894|B6|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
4307897|NCT00495469|4134895|B5|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4307898|NCT00495469|4134896|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
4307899|NCT00495469|4134897|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
4307900|NCT00495469|4134898|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4307901|NCT00495469|4134899|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
4307902|NCT00495469|4134892|B8|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4307903|NCT00495469|4134893|B7|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4307904|NCT00495469|4134894|B6|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4307905|NCT00495469|4134895|B5|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4307906|NCT00495469|4134896|B4|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4307907|NCT00495469|4134897|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4307908|NCT00495469|4134898|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4307909|NCT00495469|4134899|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4307910|NCT00495469|4134892|B8|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4307911|NCT00495469|4134893|B7|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4307912|NCT00495469|4134894|B6|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4307913|NCT00495469|4134895|B5|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4307914|NCT00495469|4134896|B4|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4307915|NCT00495469|4134897|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4307916|NCT00495469|4134898|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4307917|NCT00495469|4134899|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4307918|NCT00495469|4134892|B8|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4307919|NCT00495469|4134893|B7|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4307920|NCT00495469|4134894|B6|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4307921|NCT00495469|4134895|B5|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4307922|NCT00495469|4134896|B4|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4307923|NCT00495469|4134897|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4307924|NCT00495469|4134898|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4307925|NCT00495469|4134899|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4307926|NCT00495469|4134892|B8|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
4307927|NCT00495469|4134893|B7|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4307928|NCT00495469|4134894|B6|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4307929|NCT00495469|4134895|B5|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4307930|NCT00495469|4134896|B4|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4307931|NCT00495469|4134897|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4307932|NCT00495469|4134898|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4307933|NCT00495469|4134899|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4307934|NCT00495469|4134892|B8|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4307935|NCT00495469|4134893|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4307936|NCT00495469|4134894|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4307937|NCT00495469|4134895|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4307938|NCT00495469|4134896|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4307939|NCT00495469|4134897|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4307940|NCT00495469|4134898|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4307941|NCT00495469|4134899|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4307942|NCT00495469|4134892|B8|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4307943|NCT00495469|4134893|B7|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4307944|NCT00495469|4134894|B6|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4307945|NCT00495469|4134895|B5|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4307946|NCT00495469|4134896|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4307947|NCT00495469|4134897|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4307948|NCT00495469|4134898|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4307949|NCT00495469|4134899|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4307950|NCT00495469|4134892|B8||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4307951|NCT00495469|4134893|B7||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4307952|NCT00495469|4134894|B6||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4307953|NCT00495469|4134895|B5||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4307954|NCT00495469|4134896|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4307955|NCT00495469|4134897|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4307956|NCT00495469|4134898|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4307957|NCT00495469|4134899|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4307958|NCT00495469|4134892|B8||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4307959|NCT00495469|4134893|B7||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4307960|NCT00495469|4134894|B6||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4307961|NCT00495469|4134895|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4307962|NCT00495469|4134896|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4307963|NCT00495469|4134897|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4307964|NCT00495469|4134898|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4307965|NCT00495469|4134899|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4307966|NCT00495469|4134892|B8|||Age||Years|Mean|52.7|52.7|Standard Deviation|10.19|10.19|||
4307967|NCT00495469|4134893|B7|||Age||Years|Mean|53.2|53.2|Standard Deviation|10.35|10.35|||
4307968|NCT00495469|4134894|B6|||Age||Years|Mean|50.0|50.0|Standard Deviation|10.21|10.21|||
4307969|NCT00495469|4134895|B5|||Age||Years|Mean|54.5|54.5|Standard Deviation|10.19|10.19|||
4307970|NCT00495469|4134896|B4|||Age||Years|Mean|52.6|52.6|Standard Deviation|10.91|10.91|||
4307971|NCT00495469|4134897|B3|||Age||Years|Mean|54.4|54.4|Standard Deviation|9.57|9.57|||
4307972|NCT00495469|4134898|B2|||Age||Years|Mean|53.5|53.5|Standard Deviation|9.35|9.35|||
4307973|NCT00495469|4134899|B1|||Age||Years|Mean|50.6|50.6|Standard Deviation|10.60|10.6|||
4307974|NCT00495391|4135047|B3|United States||Region of Enrollment||participants|Number|64|64.0||||||
4307975|NCT00495391|4135048|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4307976|NCT00495391|4135049|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4307977|NCT00495391|4135047|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4307978|NCT00495391|4135048|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4307979|NCT00495391|4135049|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4307980|NCT00495391|4135047|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4307981|NCT00495391|4135048|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4307982|NCT00495391|4135049|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4307983|NCT00495391|4135047|B3|||Age||years|Mean|53.5|53.5|Standard Deviation|6.9|6.9|||
4307984|NCT00495391|4135048|B2|||Age||years|Mean|53|53.0|Standard Deviation|6|6.0|||
4307985|NCT00495391|4135049|B1|||Age||years|Mean|54|54.0|Standard Deviation|8|8.0|||
4307986|NCT00495391|4135047|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4307987|NCT00495391|4135048|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4307988|NCT00495391|4135049|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4307989|NCT00495391|4135047|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4307990|NCT00495391|4135048|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4307991|NCT00495391|4135049|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4307992|NCT00495391|4135047|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4307993|NCT00495391|4135048|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4307994|NCT00495391|4135049|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4307995|NCT00495222|4135070|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4307996|NCT00495222|4135070|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4307997|NCT00495222|4135070|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4307998|NCT00495222|4135070|B1|||Age||years|Mean|35.5|35.5|Standard Deviation|5.5|5.5|||
4307999|NCT00495222|4135070|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4308000|NCT00495222|4135070|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4308001|NCT00495222|4135070|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308002|NCT00495157|4135073|B4|United States||Region of Enrollment||participants|Number|342|342.0||||||
4308003|NCT00495157|4135074|B3|United States||Region of Enrollment||participants|Number|114|114.0||||||
4308004|NCT00495157|4135075|B2|United States||Region of Enrollment||participants|Number|115|115.0||||||
4308005|NCT00495157|4135076|B1|United States||Region of Enrollment||participants|Number|113|113.0||||||
4308006|NCT00495157|4135073|B4||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4308007|NCT00495157|4135074|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4308008|NCT00495157|4135075|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4308009|NCT00495157|4135076|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4308010|NCT00495157|4135073|B4||Female|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
4308011|NCT00495157|4135074|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4308012|NCT00495157|4135075|B2||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4308013|NCT00495157|4135076|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4308014|NCT00495157|4135073|B4|||Age||years|Mean|35.0|35.0|Standard Deviation|11.8|11.8|||
4308015|NCT00495157|4135074|B3|||Age||years|Mean|34.2|34.2|Standard Deviation|11.9|11.9|||
4308016|NCT00495157|4135075|B2|||Age||years|Mean|34.8|34.8|Standard Deviation|11.3|11.3|||
4308017|NCT00495157|4135076|B1|||Age||years|Mean|36.0|36.0|Standard Deviation|12.2|12.2|||
4308018|NCT00495157|4135073|B4||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4308019|NCT00495157|4135074|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4308020|NCT00495157|4135075|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4308021|NCT00495157|4135076|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4308022|NCT00495157|4135073|B4||Between 18 and 65 years|Age||Participants|Count of Participants|337|337.0||||||
4308023|NCT00495157|4135074|B3||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
4308024|NCT00495157|4135075|B2||Between 18 and 65 years|Age||Participants|Count of Participants|114|114.0||||||
4308025|NCT00495157|4135076|B1||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
4308026|NCT00495157|4135073|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308027|NCT00495157|4135074|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308028|NCT00495157|4135075|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308029|NCT00495157|4135076|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308030|NCT00495131|4135086|B3|Taiwan||Region of Enrollment||participants|Number|308|308.0||||||
4308031|NCT00495131|4135087|B2|Taiwan||Region of Enrollment||participants|Number|154|154.0||||||
4308032|NCT00495131|4135088|B1|Taiwan||Region of Enrollment||participants|Number|154|154.0||||||
4308033|NCT00495131|4135086|B3||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4308034|NCT00495131|4135087|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4308035|NCT00495131|4135088|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4308036|NCT00495131|4135086|B3||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4308037|NCT00495131|4135087|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4308038|NCT00495131|4135088|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4308039|NCT00495131|4135086|B3|||Age||years|Mean|53|53.0|Standard Deviation|10|10.0|||
4308040|NCT00495131|4135087|B2|||Age||years|Mean|53|53.0|Standard Deviation|11|11.0|||
4308041|NCT00495131|4135088|B1|||Age||years|Mean|54|54.0|Standard Deviation|10|10.0|||
4308042|NCT00495131|4135086|B3||>=65 years|Age||Participants|Count of Participants|58|58.0||||||
4308043|NCT00495131|4135087|B2||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4308044|NCT00495131|4135088|B1||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4308045|NCT00495131|4135086|B3||Between 18 and 65 years|Age||Participants|Count of Participants|250|250.0||||||
4308046|NCT00495131|4135087|B2||Between 18 and 65 years|Age||Participants|Count of Participants|128|128.0||||||
4308047|NCT00495131|4135088|B1||Between 18 and 65 years|Age||Participants|Count of Participants|122|122.0||||||
4308048|NCT00495131|4135086|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308049|NCT00495131|4135087|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308050|NCT00495131|4135088|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308051|NCT00495079|4135099|B1|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4308052|NCT00495079|4135099|B1|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4308053|NCT00495079|4135099|B1|Israel||Region of Enrollment||participants|Number|6|6.0||||||
4308054|NCT00495079|4135099|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4308055|NCT00495079|4135099|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
4308056|NCT00495079|4135099|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4308057|NCT00495079|4135099|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4308058|NCT00495079|4135099|B1|||Age||years|Mean|36.3|36.3|Standard Deviation|16.37|16.37|||
4308059|NCT00495079|4135099|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4308060|NCT00495079|4135099|B1||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4308061|NCT00495079|4135099|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308062|NCT00494975|4135106|B3|Taiwan||Region of Enrollment||participants|Number|21|21.0||||||
4308063|NCT00494975|4135107|B2|Taiwan||Region of Enrollment||participants|Number|11|11.0||||||
4308064|NCT00494975|4135108|B1|Taiwan||Region of Enrollment||participants|Number|10|10.0||||||
4308065|NCT00494975|4135106|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4308066|NCT00494975|4135107|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4308067|NCT00494975|4135108|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4308068|NCT00494975|4135106|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4308069|NCT00494975|4135107|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4308070|NCT00494975|4135108|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4308071|NCT00494975|4135106|B3|||Age||years|Mean|62.0|62.0|Standard Deviation|11.2|11.2|||
4308072|NCT00494975|4135107|B2|||Age||years|Mean|60.9|60.9|Standard Deviation|11.5|11.5|||
4308073|NCT00494975|4135108|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|11.3|11.3|||
4308074|NCT00494975|4135106|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4308075|NCT00494975|4135107|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4308076|NCT00494975|4135108|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4308077|NCT00494975|4135106|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4308078|NCT00494975|4135107|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4308079|NCT00494975|4135108|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4308080|NCT00494975|4135106|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308081|NCT00494975|4135107|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308082|NCT00494975|4135108|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308083|NCT00494871|4135115|B3|≥80 mL/min||CL(CR) [creatinine clearance]||Participants|Number|338|338.0||||||
4308084|NCT00494871|4135116|B2|≥80 mL/min||CL(CR) [creatinine clearance]||Participants|Number|168|168.0||||||
4308085|NCT00494871|4135117|B1|≥80 mL/min||CL(CR) [creatinine clearance]||Participants|Number|170|170.0||||||
4308086|NCT00494871|4135115|B3|50 to <80 mL/min||CL(CR) [creatinine clearance]||Participants|Number|658|658.0||||||
4308087|NCT00494871|4135116|B2|50 to <80 mL/min||CL(CR) [creatinine clearance]||Participants|Number|329|329.0||||||
4308088|NCT00494871|4135117|B1|50 to <80 mL/min||CL(CR) [creatinine clearance]||Participants|Number|329|329.0||||||
4308089|NCT00494871|4135115|B3|<50 mL/min||CL(CR) [creatinine clearance]||Participants|Number|284|284.0||||||
4308090|NCT00494871|4135116|B2|<50 mL/min||CL(CR) [creatinine clearance]||Participants|Number|143|143.0||||||
4308091|NCT00494871|4135117|B1|<50 mL/min||CL(CR) [creatinine clearance]||Participants|Number|141|141.0||||||
4308092|NCT00494871|4135115|B3||Male|Sex: Female, Male||Participants|Count of Participants|1030|1030.0||||||
4308093|NCT00494871|4135116|B2||Male|Sex: Female, Male||Participants|Count of Participants|500|500.0||||||
4308094|NCT00494871|4135117|B1||Male|Sex: Female, Male||Participants|Count of Participants|530|530.0||||||
4308095|NCT00494871|4135115|B3||Female|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
4308096|NCT00494871|4135116|B2||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4308097|NCT00494871|4135117|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4308098|NCT00494871|4135115|B3|||Age||Years|Mean|71.1|71.1|Standard Deviation|8.1|8.1|||
4308099|NCT00494871|4135116|B2|||Age||Years|Mean|71.2|71.2|Standard Deviation|7.9|7.9|||
4308100|NCT00494871|4135117|B1|||Age||Years|Mean|71.0|71.0|Standard Deviation|8.3|8.3|||
4308101|NCT00494806|4135148|B3|United States||Region of Enrollment||participants|Number|66|66.0||||||
4308102|NCT00494806|4135149|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
4308103|NCT00494806|4135150|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4308104|NCT00494806|4135148|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4308105|NCT00494806|4135149|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4308106|NCT00494806|4135150|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4308107|NCT00494806|4135148|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4308108|NCT00494806|4135149|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4308109|NCT00494806|4135150|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4308110|NCT00494806|4135148|B3|||Age||years|Mean|55.6|55.6|Standard Deviation|10.7|10.7|||
4308111|NCT00494806|4135149|B2|||Age||years|Mean|54.8|54.8|Standard Deviation|11.4|11.4|||
4308112|NCT00494806|4135150|B1|||Age||years|Mean|56.2|56.2|Standard Deviation|10.1|10.1|||
4308113|NCT00494806|4135148|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4308114|NCT00494806|4135149|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4308115|NCT00494806|4135150|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4308116|NCT00494806|4135148|B3||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4308117|NCT00494806|4135149|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4308118|NCT00494806|4135150|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4308119|NCT00494806|4135148|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308120|NCT00494806|4135149|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308121|NCT00494806|4135150|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308122|NCT00494780|4135157|B3|Hispanic or Latino||Race/Ethnicity, Customized|"Baseline characteristics were collected in the Full Analysis Set (FAS), comprised of all participants who were exposed to trial drug irrespective of their compliance to the planned course of treatment.~One participant was enrolled and randomized to receive 1000 mg Ofatumumab + CHOP, but withdrew prior to initiation of therapy."|participants|Number|2|2.0||||||
4308123|NCT00494780|4135158|B2|Hispanic or Latino||Race/Ethnicity, Customized|"Baseline characteristics were collected in the Full Analysis Set (FAS), comprised of all participants who were exposed to trial drug irrespective of their compliance to the planned course of treatment.~One participant was enrolled and randomized to receive 1000 mg Ofatumumab + CHOP, but withdrew prior to initiation of therapy."|participants|Number|2|2.0||||||
4308124|NCT00494780|4135159|B1|Hispanic or Latino||Race/Ethnicity, Customized|"Baseline characteristics were collected in the Full Analysis Set (FAS), comprised of all participants who were exposed to trial drug irrespective of their compliance to the planned course of treatment.~One participant was enrolled and randomized to receive 1000 mg Ofatumumab + CHOP, but withdrew prior to initiation of therapy."|participants|Number|0|0.0||||||
4308125|NCT00494780|4135157|B3|White||Race/Ethnicity, Customized|"Baseline characteristics were collected in the Full Analysis Set (FAS), comprised of all participants who were exposed to trial drug irrespective of their compliance to the planned course of treatment.~One participant was enrolled and randomized to receive 1000 mg Ofatumumab + CHOP, but withdrew prior to initiation of therapy."|participants|Number|56|56.0||||||
4308126|NCT00494780|4135158|B2|White||Race/Ethnicity, Customized|"Baseline characteristics were collected in the Full Analysis Set (FAS), comprised of all participants who were exposed to trial drug irrespective of their compliance to the planned course of treatment.~One participant was enrolled and randomized to receive 1000 mg Ofatumumab + CHOP, but withdrew prior to initiation of therapy."|participants|Number|27|27.0||||||
4308127|NCT00494780|4135159|B1|White||Race/Ethnicity, Customized|"Baseline characteristics were collected in the Full Analysis Set (FAS), comprised of all participants who were exposed to trial drug irrespective of their compliance to the planned course of treatment.~One participant was enrolled and randomized to receive 1000 mg Ofatumumab + CHOP, but withdrew prior to initiation of therapy."|participants|Number|29|29.0||||||
4308128|NCT00494780|4135157|B3||Male|Sex: Female, Male|"Baseline characteristics were collected in the Full Analysis Set (FAS), comprised of all participants who were exposed to trial drug irrespective of their compliance to the planned course of treatment.~One participant was enrolled and randomized to receive 1000 mg Ofatumumab + CHOP, but withdrew prior to initiation of therapy."|Participants|Count of Participants|23|23.0||||||
4308129|NCT00494780|4135158|B2||Male|Sex: Female, Male|"Baseline characteristics were collected in the Full Analysis Set (FAS), comprised of all participants who were exposed to trial drug irrespective of their compliance to the planned course of treatment.~One participant was enrolled and randomized to receive 1000 mg Ofatumumab + CHOP, but withdrew prior to initiation of therapy."|Participants|Count of Participants|8|8.0||||||
4308130|NCT00494780|4135159|B1||Male|Sex: Female, Male|"Baseline characteristics were collected in the Full Analysis Set (FAS), comprised of all participants who were exposed to trial drug irrespective of their compliance to the planned course of treatment.~One participant was enrolled and randomized to receive 1000 mg Ofatumumab + CHOP, but withdrew prior to initiation of therapy."|Participants|Count of Participants|15|15.0||||||
4308131|NCT00494780|4135157|B3||Female|Sex: Female, Male|"Baseline characteristics were collected in the Full Analysis Set (FAS), comprised of all participants who were exposed to trial drug irrespective of their compliance to the planned course of treatment.~One participant was enrolled and randomized to receive 1000 mg Ofatumumab + CHOP, but withdrew prior to initiation of therapy."|Participants|Count of Participants|35|35.0||||||
4308132|NCT00494780|4135158|B2||Female|Sex: Female, Male|"Baseline characteristics were collected in the Full Analysis Set (FAS), comprised of all participants who were exposed to trial drug irrespective of their compliance to the planned course of treatment.~One participant was enrolled and randomized to receive 1000 mg Ofatumumab + CHOP, but withdrew prior to initiation of therapy."|Participants|Count of Participants|21|21.0||||||
4308133|NCT00494780|4135159|B1||Female|Sex: Female, Male|"Baseline characteristics were collected in the Full Analysis Set (FAS), comprised of all participants who were exposed to trial drug irrespective of their compliance to the planned course of treatment.~One participant was enrolled and randomized to receive 1000 mg Ofatumumab + CHOP, but withdrew prior to initiation of therapy."|Participants|Count of Participants|14|14.0||||||
4308134|NCT00494780|4135157|B3|||Age|"Baseline characteristics were collected in the Full Analysis Set (FAS), comprised of all participants who were exposed to trial drug irrespective of their compliance to the planned course of treatment.~One participant was enrolled and randomized to receive 1000 mg Ofatumumab + CHOP, but withdrew prior to initiation of therapy."|Years|Mean|53.9|53.9|Standard Deviation|10.2|10.2|||
4308135|NCT00494780|4135158|B2|||Age|"Baseline characteristics were collected in the Full Analysis Set (FAS), comprised of all participants who were exposed to trial drug irrespective of their compliance to the planned course of treatment.~One participant was enrolled and randomized to receive 1000 mg Ofatumumab + CHOP, but withdrew prior to initiation of therapy."|Years|Mean|53.7|53.7|Standard Deviation|9.14|9.14|||
4308136|NCT00494780|4135159|B1|||Age|"Baseline characteristics were collected in the Full Analysis Set (FAS), comprised of all participants who were exposed to trial drug irrespective of their compliance to the planned course of treatment.~One participant was enrolled and randomized to receive 1000 mg Ofatumumab + CHOP, but withdrew prior to initiation of therapy."|Years|Mean|54.1|54.1|Standard Deviation|11.4|11.4|||
4308137|NCT00494676|4135198|B1|Left hemianopia||Side of hemianopia||Participants|Number|48|48.0||||||
4308138|NCT00494676|4135198|B1|Right hemianopia||Side of hemianopia||Participants|Number|25|25.0||||||
4308139|NCT00494676|4135198|B1|||Duration of hemianopia||Months|Median|18|18.0|Inter-Quartile Range|||8.0|38.0|
4308140|NCT00494676|4135198|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4308141|NCT00494676|4135198|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4308142|NCT00494676|4135198|B1|||Age||years|Mean|56|56.0|Standard Deviation|16|16.0|||
4308143|NCT00494585|4135206|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4308144|NCT00494585|4135206|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4308145|NCT00494585|4135206|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4308146|NCT00494585|4135206|B1|||Age||years|Median|61|61.0|Full Range|||38.0|83.0|
4308147|NCT00494507|4135210|B5||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4308148|NCT00494507|4135211|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4308149|NCT00494507|4135212|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4308150|NCT00494507|4135213|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4308151|NCT00494507|4135214|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4308152|NCT00494507|4135210|B5||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4308153|NCT00494507|4135211|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4308154|NCT00494507|4135212|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4308155|NCT00494507|4135213|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4308156|NCT00494507|4135214|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4308157|NCT00494507|4135210|B5|||Age||years|Mean|44.2|44.2|Standard Deviation|14.3|14.3|||
4308158|NCT00494507|4135211|B4|||Age||years|Mean|44.0|44.0|Standard Deviation|15.6|15.6|||
4308159|NCT00494507|4135212|B3|||Age||years|Mean|44.8|44.8|Standard Deviation|14.6|14.6|||
4308160|NCT00494507|4135213|B2|||Age||years|Mean|45.2|45.2|Standard Deviation|17.7|17.7|||
4308161|NCT00494507|4135214|B1|||Age||years|Mean|40.6|40.6|Standard Deviation|10.3|10.3|||
4308162|NCT00494494|4135265|B3|United States||Region of Enrollment||participants|Number|79|79.0||||||
4308163|NCT00494494|4135266|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
4308164|NCT00494494|4135267|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4308165|NCT00494494|4135265|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4308166|NCT00494494|4135266|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4308167|NCT00494494|4135267|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4308168|NCT00494494|4135265|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4308169|NCT00494494|4135266|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4308170|NCT00494494|4135267|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4308171|NCT00494494|4135265|B3|||Age||years|Mean|72.14|72.14|Standard Deviation|8.52|8.52|||
4308172|NCT00494494|4135266|B2|||Age||years|Mean|73.95|73.95|Standard Deviation|8.99|8.99|||
4308173|NCT00494494|4135267|B1|||Age||years|Mean|70.33|70.33|Standard Deviation|8.04|8.04|||
4308174|NCT00494494|4135265|B3||>=65 years|Age||Participants|Count of Participants|79|79.0||||||
4308175|NCT00494494|4135266|B2||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4308176|NCT00494494|4135267|B1||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
4308177|NCT00494494|4135265|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4308178|NCT00494494|4135266|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4308179|NCT00494494|4135267|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4308180|NCT00494494|4135265|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308181|NCT00494494|4135266|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308182|NCT00494494|4135267|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308183|NCT00494481|4135282|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4308184|NCT00494481|4135283|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4308185|NCT00494481|4135284|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4308186|NCT00494481|4135282|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4308187|NCT00494481|4135283|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4308188|NCT00494481|4135284|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4308189|NCT00494481|4135282|B3|||Age||Years|Mean|55.5|55.5|Full Range|||33.0|80.0|
4308190|NCT00494481|4135283|B2|||Age||Years|Mean|57|57.0|Full Range|||39.0|74.0|
4308191|NCT00494481|4135284|B1|||Age||Years|Mean|54|54.0|Full Range|||33.0|80.0|
4308192|NCT00494442|4135291|B3||BRCA2|BRCA mutation|BRCA1 or BRCA2 mutations known to cause loss of gene function (clinical deleterious or suspected deleterious mutations).|Participants|Count of Participants|17|17.0||||||
4308193|NCT00494442|4135292|B2||BRCA2|BRCA mutation|BRCA1 or BRCA2 mutations known to cause loss of gene function (clinical deleterious or suspected deleterious mutations).|Participants|Count of Participants|12|12.0||||||
4308194|NCT00494442|4135293|B1||BRCA2|BRCA mutation|BRCA1 or BRCA2 mutations known to cause loss of gene function (clinical deleterious or suspected deleterious mutations).|Participants|Count of Participants|5|5.0||||||
4308195|NCT00494442|4135291|B3||BRCA1|BRCA mutation|BRCA1 or BRCA2 mutations known to cause loss of gene function (clinical deleterious or suspected deleterious mutations).|Participants|Count of Participants|40|40.0||||||
4308196|NCT00494442|4135292|B2||BRCA1|BRCA mutation|BRCA1 or BRCA2 mutations known to cause loss of gene function (clinical deleterious or suspected deleterious mutations).|Participants|Count of Participants|21|21.0||||||
4308197|NCT00494442|4135293|B1||BRCA1|BRCA mutation|BRCA1 or BRCA2 mutations known to cause loss of gene function (clinical deleterious or suspected deleterious mutations).|Participants|Count of Participants|19|19.0||||||
4308198|NCT00494442|4135291|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4308199|NCT00494442|4135292|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4308200|NCT00494442|4135293|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4308201|NCT00494442|4135291|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4308202|NCT00494442|4135292|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4308203|NCT00494442|4135293|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4308204|NCT00494442|4135291|B3|||Age||Years|Mean|56|56.0|Standard Deviation|9|9.0|||
4308205|NCT00494442|4135292|B2|||Age||Years|Mean|56.8|56.8|Standard Deviation|10.49|10.49|||
4308206|NCT00494442|4135293|B1|||Age||Years|Mean|55.6|55.6|Standard Deviation|8.02|8.02|||
4308207|NCT00494299|4135308|B3|2||Number of Prior transcatheter arterial chemoembolization (TACE)|Subjects entering this study must have had previous TACE at a maximum of 2 times.|Participants|Number|163|163.0||||||
4308208|NCT00494299|4135309|B2|2||Number of Prior transcatheter arterial chemoembolization (TACE)|Subjects entering this study must have had previous TACE at a maximum of 2 times.|Participants|Number|81|81.0||||||
4308209|NCT00494299|4135310|B1|2||Number of Prior transcatheter arterial chemoembolization (TACE)|Subjects entering this study must have had previous TACE at a maximum of 2 times.|Participants|Number|82|82.0||||||
4308210|NCT00494299|4135308|B3|1||Number of Prior transcatheter arterial chemoembolization (TACE)|Subjects entering this study must have had previous TACE at a maximum of 2 times.|Participants|Number|295|295.0||||||
4308211|NCT00494299|4135309|B2|1||Number of Prior transcatheter arterial chemoembolization (TACE)|Subjects entering this study must have had previous TACE at a maximum of 2 times.|Participants|Number|148|148.0||||||
4308212|NCT00494299|4135310|B1|1||Number of Prior transcatheter arterial chemoembolization (TACE)|Subjects entering this study must have had previous TACE at a maximum of 2 times.|Participants|Number|147|147.0||||||
4308213|NCT00494299|4135308|B3|Responder Group B||Responder group to transcatheter arterial chemoembolization (TACE)|Responder Group A: percentage of tumor necrosis or tumor shrinkage is 100 percentage. Responder Group B: percentage of tumor necrosis or tumor shrinkage is 25 percentage or more to less than 100 percentage. Subjects entering this study is a responder to TACE.|Participants|Number|174|174.0||||||
4308214|NCT00494299|4135309|B2|Responder Group B||Responder group to transcatheter arterial chemoembolization (TACE)|Responder Group A: percentage of tumor necrosis or tumor shrinkage is 100 percentage. Responder Group B: percentage of tumor necrosis or tumor shrinkage is 25 percentage or more to less than 100 percentage. Subjects entering this study is a responder to TACE.|Participants|Number|87|87.0||||||
4308215|NCT00494299|4135310|B1|Responder Group B||Responder group to transcatheter arterial chemoembolization (TACE)|Responder Group A: percentage of tumor necrosis or tumor shrinkage is 100 percentage. Responder Group B: percentage of tumor necrosis or tumor shrinkage is 25 percentage or more to less than 100 percentage. Subjects entering this study is a responder to TACE.|Participants|Number|87|87.0||||||
4308216|NCT00494299|4135308|B3|Responder Group A||Responder group to transcatheter arterial chemoembolization (TACE)|Responder Group A: percentage of tumor necrosis or tumor shrinkage is 100 percentage. Responder Group B: percentage of tumor necrosis or tumor shrinkage is 25 percentage or more to less than 100 percentage. Subjects entering this study is a responder to TACE.|Participants|Number|284|284.0||||||
4308217|NCT00494299|4135309|B2|Responder Group A||Responder group to transcatheter arterial chemoembolization (TACE)|Responder Group A: percentage of tumor necrosis or tumor shrinkage is 100 percentage. Responder Group B: percentage of tumor necrosis or tumor shrinkage is 25 percentage or more to less than 100 percentage. Subjects entering this study is a responder to TACE.|Participants|Number|142|142.0||||||
4308218|NCT00494299|4135310|B1|Responder Group A||Responder group to transcatheter arterial chemoembolization (TACE)|Responder Group A: percentage of tumor necrosis or tumor shrinkage is 100 percentage. Responder Group B: percentage of tumor necrosis or tumor shrinkage is 25 percentage or more to less than 100 percentage. Subjects entering this study is a responder to TACE.|Participants|Number|142|142.0||||||
4308219|NCT00494299|4135308|B3|Grade 4||Eastern Cooperative Oncology Group (ECOG) performance status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. 0 = fully active, 1 = restricted strenuous activity, 2 = ambulatory, 3 = limited selfcare, 4 = completely disabled, 5 = dead. Subjects entering this study must have had an ECOG score of 0 or 1.|Participants|Number|0|0.0||||||
4308220|NCT00494299|4135309|B2|Grade 4||Eastern Cooperative Oncology Group (ECOG) performance status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. 0 = fully active, 1 = restricted strenuous activity, 2 = ambulatory, 3 = limited selfcare, 4 = completely disabled, 5 = dead. Subjects entering this study must have had an ECOG score of 0 or 1.|Participants|Number|0|0.0||||||
4308221|NCT00494299|4135310|B1|Grade 4||Eastern Cooperative Oncology Group (ECOG) performance status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. 0 = fully active, 1 = restricted strenuous activity, 2 = ambulatory, 3 = limited selfcare, 4 = completely disabled, 5 = dead. Subjects entering this study must have had an ECOG score of 0 or 1.|Participants|Number|0|0.0||||||
4308222|NCT00494299|4135308|B3|Grade 3||Eastern Cooperative Oncology Group (ECOG) performance status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. 0 = fully active, 1 = restricted strenuous activity, 2 = ambulatory, 3 = limited selfcare, 4 = completely disabled, 5 = dead. Subjects entering this study must have had an ECOG score of 0 or 1.|Participants|Number|0|0.0||||||
4308223|NCT00494299|4135309|B2|Grade 3||Eastern Cooperative Oncology Group (ECOG) performance status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. 0 = fully active, 1 = restricted strenuous activity, 2 = ambulatory, 3 = limited selfcare, 4 = completely disabled, 5 = dead. Subjects entering this study must have had an ECOG score of 0 or 1.|Participants|Number|0|0.0||||||
4308224|NCT00494299|4135310|B1|Grade 3||Eastern Cooperative Oncology Group (ECOG) performance status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. 0 = fully active, 1 = restricted strenuous activity, 2 = ambulatory, 3 = limited selfcare, 4 = completely disabled, 5 = dead. Subjects entering this study must have had an ECOG score of 0 or 1.|Participants|Number|0|0.0||||||
4308225|NCT00494299|4135308|B3|Grade 2||Eastern Cooperative Oncology Group (ECOG) performance status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. 0 = fully active, 1 = restricted strenuous activity, 2 = ambulatory, 3 = limited selfcare, 4 = completely disabled, 5 = dead. Subjects entering this study must have had an ECOG score of 0 or 1.|Participants|Number|0|0.0||||||
4308226|NCT00494299|4135309|B2|Grade 2||Eastern Cooperative Oncology Group (ECOG) performance status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. 0 = fully active, 1 = restricted strenuous activity, 2 = ambulatory, 3 = limited selfcare, 4 = completely disabled, 5 = dead. Subjects entering this study must have had an ECOG score of 0 or 1.|Participants|Number|0|0.0||||||
4308227|NCT00494299|4135310|B1|Grade 2||Eastern Cooperative Oncology Group (ECOG) performance status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. 0 = fully active, 1 = restricted strenuous activity, 2 = ambulatory, 3 = limited selfcare, 4 = completely disabled, 5 = dead. Subjects entering this study must have had an ECOG score of 0 or 1.|Participants|Number|0|0.0||||||
4308228|NCT00494299|4135308|B3|Grade 1||Eastern Cooperative Oncology Group (ECOG) performance status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. 0 = fully active, 1 = restricted strenuous activity, 2 = ambulatory, 3 = limited selfcare, 4 = completely disabled, 5 = dead. Subjects entering this study must have had an ECOG score of 0 or 1.|Participants|Number|55|55.0||||||
4308229|NCT00494299|4135309|B2|Grade 1||Eastern Cooperative Oncology Group (ECOG) performance status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. 0 = fully active, 1 = restricted strenuous activity, 2 = ambulatory, 3 = limited selfcare, 4 = completely disabled, 5 = dead. Subjects entering this study must have had an ECOG score of 0 or 1.|Participants|Number|27|27.0||||||
4308230|NCT00494299|4135310|B1|Grade 1||Eastern Cooperative Oncology Group (ECOG) performance status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. 0 = fully active, 1 = restricted strenuous activity, 2 = ambulatory, 3 = limited selfcare, 4 = completely disabled, 5 = dead. Subjects entering this study must have had an ECOG score of 0 or 1.|Participants|Number|28|28.0||||||
4308269|NCT00494234|4135323|B1|>=50 - <65 years||Age, Customized||Participants|Number|6|6.0||||||
4308231|NCT00494299|4135308|B3|Grade 0||Eastern Cooperative Oncology Group (ECOG) performance status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. 0 = fully active, 1 = restricted strenuous activity, 2 = ambulatory, 3 = limited selfcare, 4 = completely disabled, 5 = dead. Subjects entering this study must have had an ECOG score of 0 or 1.|Participants|Number|403|403.0||||||
4308232|NCT00494299|4135309|B2|Grade 0||Eastern Cooperative Oncology Group (ECOG) performance status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. 0 = fully active, 1 = restricted strenuous activity, 2 = ambulatory, 3 = limited selfcare, 4 = completely disabled, 5 = dead. Subjects entering this study must have had an ECOG score of 0 or 1.|Participants|Number|202|202.0||||||
4308233|NCT00494299|4135310|B1|Grade 0||Eastern Cooperative Oncology Group (ECOG) performance status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. 0 = fully active, 1 = restricted strenuous activity, 2 = ambulatory, 3 = limited selfcare, 4 = completely disabled, 5 = dead. Subjects entering this study must have had an ECOG score of 0 or 1.|Participants|Number|201|201.0||||||
4308234|NCT00494299|4135308|B3|Status B||Child Pugh Status|A Child-Pugh (CP) score (determined by encephalopathy grade, ascites, serum bilirubin and albumin, prothrombin time) is used to assess the prognosis of chronic liver disease, mainly cirrhosis. One of the inclusion criterion for this study was a CP class A (good operative risk); class B (moderate risk) score or class C (poor operative risk) was excluded.|Participants|Number|0|0.0||||||
4308235|NCT00494299|4135309|B2|Status B||Child Pugh Status|A Child-Pugh (CP) score (determined by encephalopathy grade, ascites, serum bilirubin and albumin, prothrombin time) is used to assess the prognosis of chronic liver disease, mainly cirrhosis. One of the inclusion criterion for this study was a CP class A (good operative risk); class B (moderate risk) score or class C (poor operative risk) was excluded.|Participants|Number|0|0.0||||||
4308236|NCT00494299|4135310|B1|Status B||Child Pugh Status|A Child-Pugh (CP) score (determined by encephalopathy grade, ascites, serum bilirubin and albumin, prothrombin time) is used to assess the prognosis of chronic liver disease, mainly cirrhosis. One of the inclusion criterion for this study was a CP class A (good operative risk); class B (moderate risk) score or class C (poor operative risk) was excluded.|Participants|Number|0|0.0||||||
4308237|NCT00494299|4135308|B3|Status A||Child Pugh Status|A Child-Pugh (CP) score (determined by encephalopathy grade, ascites, serum bilirubin and albumin, prothrombin time) is used to assess the prognosis of chronic liver disease, mainly cirrhosis. One of the inclusion criterion for this study was a CP class A (good operative risk); class B (moderate risk) score or class C (poor operative risk) was excluded.|Participants|Number|458|458.0||||||
4308238|NCT00494299|4135309|B2|Status A||Child Pugh Status|A Child-Pugh (CP) score (determined by encephalopathy grade, ascites, serum bilirubin and albumin, prothrombin time) is used to assess the prognosis of chronic liver disease, mainly cirrhosis. One of the inclusion criterion for this study was a CP class A (good operative risk); class B (moderate risk) score or class C (poor operative risk) was excluded.|Participants|Number|229|229.0||||||
4308239|NCT00494299|4135310|B1|Status A||Child Pugh Status|A Child-Pugh (CP) score (determined by encephalopathy grade, ascites, serum bilirubin and albumin, prothrombin time) is used to assess the prognosis of chronic liver disease, mainly cirrhosis. One of the inclusion criterion for this study was a CP class A (good operative risk); class B (moderate risk) score or class C (poor operative risk) was excluded.|Participants|Number|229|229.0||||||
4308240|NCT00494299|4135308|B3||Male|Sex: Female, Male||Participants|Count of Participants|342|342.0||||||
4308241|NCT00494299|4135309|B2||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4308242|NCT00494299|4135310|B1||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4308243|NCT00494299|4135308|B3||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4308244|NCT00494299|4135309|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4308245|NCT00494299|4135310|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4308246|NCT00494299|4135308|B3|||Age||Years|Mean|67.8|67.8|Standard Deviation|8.7|8.7|||
4308247|NCT00494299|4135309|B2|||Age||Years|Mean|68.1|68.1|Standard Deviation|8.8|8.8|||
4308248|NCT00494299|4135310|B1|||Age||Years|Mean|67.5|67.5|Standard Deviation|8.7|8.7|||
4308249|NCT00494234|4135321|B3|White||Race/Ethnicity, Customized||Participants|Number|51|51.0||||||
4308250|NCT00494234|4135322|B2|White||Race/Ethnicity, Customized||Participants|Number|26|26.0||||||
4308251|NCT00494234|4135323|B1|White||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
4308252|NCT00494234|4135321|B3|Black or african american||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4308253|NCT00494234|4135322|B2|Black or african american||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4308254|NCT00494234|4135323|B1|Black or african american||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4308255|NCT00494234|4135321|B3|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4308256|NCT00494234|4135322|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4308257|NCT00494234|4135323|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4308258|NCT00494234|4135321|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4308259|NCT00494234|4135322|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4308260|NCT00494234|4135323|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4308261|NCT00494234|4135321|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4308262|NCT00494234|4135322|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4308263|NCT00494234|4135323|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4308264|NCT00494234|4135321|B3|>=65 years||Age, Customized||Participants|Number|4|4.0||||||
4308265|NCT00494234|4135322|B2|>=65 years||Age, Customized||Participants|Number|1|1.0||||||
4308266|NCT00494234|4135323|B1|>=65 years||Age, Customized||Participants|Number|3|3.0||||||
4308267|NCT00494234|4135321|B3|>=50 - <65 years||Age, Customized||Participants|Number|11|11.0||||||
4308268|NCT00494234|4135322|B2|>=50 - <65 years||Age, Customized||Participants|Number|5|5.0||||||
4308270|NCT00494234|4135321|B3|>=35 - <50 years||Age, Customized||Participants|Number|29|29.0||||||
4308271|NCT00494234|4135322|B2|>=35 - <50 years||Age, Customized||Participants|Number|18|18.0||||||
4308272|NCT00494234|4135323|B1|>=35 - <50 years||Age, Customized||Participants|Number|11|11.0||||||
4308273|NCT00494234|4135321|B3|<35 years||Age, Customized||Participants|Number|10|10.0||||||
4308274|NCT00494234|4135322|B2|<35 years||Age, Customized||Participants|Number|3|3.0||||||
4308275|NCT00494234|4135323|B1|<35 years||Age, Customized||Participants|Number|7|7.0||||||
4308276|NCT00494234|4135321|B3|||Age||Years|Mean|44.7|44.7|Standard Deviation|10.74|10.74|28.0|72.0|
4308277|NCT00494234|4135322|B2|||Age||Years|Mean|44.7|44.7|Standard Deviation|9.55|9.55|32.0|72.0|
4308278|NCT00494234|4135323|B1|||Age||Years|Mean|44.7|44.7|Standard Deviation|11.99|11.99|28.0|67.0|
4308279|NCT00494221|4135340|B4||Male|Sex: Female, Male|Gender at informed consent|Participants|Count of Participants|107|107.0||||||
4308280|NCT00494221|4135341|B3||Male|Sex: Female, Male|Gender at informed consent|Participants|Count of Participants|39|39.0||||||
4308281|NCT00494221|4135342|B2||Male|Sex: Female, Male|Gender at informed consent|Participants|Count of Participants|30|30.0||||||
4308282|NCT00494221|4135343|B1||Male|Sex: Female, Male|Gender at informed consent|Participants|Count of Participants|38|38.0||||||
4308283|NCT00494221|4135340|B4||Female|Sex: Female, Male|Gender at informed consent|Participants|Count of Participants|65|65.0||||||
4308284|NCT00494221|4135341|B3||Female|Sex: Female, Male|Gender at informed consent|Participants|Count of Participants|19|19.0||||||
4308285|NCT00494221|4135342|B2||Female|Sex: Female, Male|Gender at informed consent|Participants|Count of Participants|26|26.0||||||
4308286|NCT00494221|4135343|B1||Female|Sex: Female, Male|Gender at informed consent|Participants|Count of Participants|20|20.0||||||
4308287|NCT00494221|4135340|B4|||Age|Age at informed consent|years|Mean|62.2|62.2|Standard Deviation|9.5|9.5|||
4308288|NCT00494221|4135341|B3|||Age|Age at informed consent|years|Mean|62.2|62.2|Standard Deviation|9.6|9.6|||
4308289|NCT00494221|4135342|B2|||Age|Age at informed consent|years|Mean|62.1|62.1|Standard Deviation|9.9|9.9|||
4308290|NCT00494221|4135343|B1|||Age|Age at informed consent|years|Mean|62.4|62.4|Standard Deviation|9.3|9.3|||
4308291|NCT00494143|4135365|B1|||Body Weight||kilograms|Mean|80.9|80.9|Standard Deviation|9.9|9.9|||
4308292|NCT00494143|4135365|B1|||stature|height|meters|Mean|1.85|1.85|Standard Deviation|.05|0.05|||
4308293|NCT00494143|4135365|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4308294|NCT00494143|4135365|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4308295|NCT00494143|4135365|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4308296|NCT00494143|4135365|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|12|12.0|||
4308297|NCT00494143|4135365|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4308298|NCT00494143|4135365|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4308299|NCT00494143|4135365|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308300|NCT00494091|4135384|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4308301|NCT00494091|4135385|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4308302|NCT00494091|4135386|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4308303|NCT00494091|4135384|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4308304|NCT00494091|4135385|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4308305|NCT00494091|4135386|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4308306|NCT00494091|4135384|B3|||Age||years|Mean|55.52|55.52|Standard Deviation|11.43|11.43|||
4308307|NCT00494091|4135385|B2|||Age||years|Mean|55.20|55.2|Standard Deviation|11.52|11.52|||
4308308|NCT00494091|4135386|B1|||Age||years|Mean|59.67|59.67|Standard Deviation|10.29|10.29|||
4308309|NCT00494026|4135409|B1|Caucasian||Race/Ethnicity||participants|Number|4|4.0||||||
4308310|NCT00494026|4135409|B1|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|4|4.0||||||
4308311|NCT00494026|4135409|B1|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4308312|NCT00494026|4135409|B1|Poland||Region of Enrollment||participants|Number|2|2.0||||||
4308313|NCT00494026|4135409|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4308314|NCT00494026|4135409|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4308315|NCT00494026|4135409|B1|||Age||years|Mean|59.85|59.85|Standard Deviation|9.45|9.45|||
4308316|NCT00494013|4135417|B3|||Height||centimeters (cm)|Mean|164.53|164.53|Standard Deviation|10.57|10.57|||
4308317|NCT00494013|4135418|B2|||Height||centimeters (cm)|Mean|165.14|165.14|Standard Deviation|10.94|10.94|||
4308318|NCT00494013|4135419|B1|||Height||centimeters (cm)|Mean|163.94|163.94|Standard Deviation|10.19|10.19|||
4308319|NCT00494013|4135417|B3|||Duration of Diabetes||years|Mean|9.22|9.22|Standard Deviation|5.85|5.85|||
4308320|NCT00494013|4135418|B2|||Duration of Diabetes||years|Mean|8.94|8.94|Standard Deviation|5.59|5.59|||
4308321|NCT00494013|4135419|B1|||Duration of Diabetes||years|Mean|9.48|9.48|Standard Deviation|6.09|6.09|||
4308322|NCT00494013|4135417|B3|||Body Weight||kilograms (kg)|Mean|81.89|81.89|Standard Deviation|18.39|18.39|||
4308323|NCT00494013|4135418|B2|||Body Weight||kilograms (kg)|Mean|82.72|82.72|Standard Deviation|19.32|19.32|||
4308324|NCT00494013|4135419|B1|||Body Weight||kilograms (kg)|Mean|81.10|81.1|Standard Deviation|17.46|17.46|||
4308325|NCT00494013|4135417|B3|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilogram per square meter (kg/m^2)|Mean|30.06|30.06|Standard Deviation|5.06|5.06|||
4308326|NCT00494013|4135418|B2|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilogram per square meter (kg/m^2)|Mean|30.10|30.1|Standard Deviation|5.12|5.12|||
4308327|NCT00494013|4135419|B1|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilogram per square meter (kg/m^2)|Mean|30.03|30.03|Standard Deviation|5.01|5.01|||
4308328|NCT00494013|4135417|B3|Unavailable||Sulfonylurea Group|Patients with previous sulfonylurea use.|participants|Number|1|1.0||||||
4308329|NCT00494013|4135418|B2|Unavailable||Sulfonylurea Group|Patients with previous sulfonylurea use.|participants|Number|1|1.0||||||
4308330|NCT00494013|4135419|B1|Unavailable||Sulfonylurea Group|Patients with previous sulfonylurea use.|participants|Number|0|0.0||||||
4308331|NCT00494013|4135417|B3|No||Sulfonylurea Group|Patients with previous sulfonylurea use.|participants|Number|100|100.0||||||
4308332|NCT00494013|4135418|B2|No||Sulfonylurea Group|Patients with previous sulfonylurea use.|participants|Number|51|51.0||||||
4308333|NCT00494013|4135419|B1|No||Sulfonylurea Group|Patients with previous sulfonylurea use.|participants|Number|49|49.0||||||
4308334|NCT00494013|4135417|B3|Yes||Sulfonylurea Group|Patients with previous sulfonylurea use.|participants|Number|328|328.0||||||
4308335|NCT00494013|4135418|B2|Yes||Sulfonylurea Group|Patients with previous sulfonylurea use.|participants|Number|158|158.0||||||
4308336|NCT00494013|4135419|B1|Yes||Sulfonylurea Group|Patients with previous sulfonylurea use.|participants|Number|170|170.0||||||
4308337|NCT00494013|4135417|B3|West Asian||Race/Ethnicity||participants|Number|83|83.0||||||
4308338|NCT00494013|4135418|B2|West Asian||Race/Ethnicity||participants|Number|40|40.0||||||
4308339|NCT00494013|4135419|B1|West Asian||Race/Ethnicity||participants|Number|43|43.0||||||
4308340|NCT00494013|4135417|B3|Hispanic||Race/Ethnicity||participants|Number|92|92.0||||||
4308341|NCT00494013|4135418|B2|Hispanic||Race/Ethnicity||participants|Number|47|47.0||||||
4308342|NCT00494013|4135419|B1|Hispanic||Race/Ethnicity||participants|Number|45|45.0||||||
4308343|NCT00494013|4135417|B3|East Asian||Race/Ethnicity||participants|Number|68|68.0||||||
4308344|NCT00494013|4135418|B2|East Asian||Race/Ethnicity||participants|Number|33|33.0||||||
4308345|NCT00494013|4135419|B1|East Asian||Race/Ethnicity||participants|Number|35|35.0||||||
4308346|NCT00494013|4135417|B3|Caucasian||Race/Ethnicity||participants|Number|170|170.0||||||
4308347|NCT00494013|4135418|B2|Caucasian||Race/Ethnicity||participants|Number|82|82.0||||||
4308348|NCT00494013|4135419|B1|Caucasian||Race/Ethnicity||participants|Number|88|88.0||||||
4308349|NCT00494013|4135417|B3|African||Race/Ethnicity||participants|Number|16|16.0||||||
4308350|NCT00494013|4135418|B2|African||Race/Ethnicity||participants|Number|8|8.0||||||
4308351|NCT00494013|4135419|B1|African||Race/Ethnicity||participants|Number|8|8.0||||||
4308352|NCT00494013|4135417|B3|United States||Region of Enrollment||participants|Number|116|116.0||||||
4308353|NCT00494013|4135418|B2|United States||Region of Enrollment||participants|Number|56|56.0||||||
4308354|NCT00494013|4135419|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4308355|NCT00494013|4135417|B3|Taiwan||Region of Enrollment||participants|Number|39|39.0||||||
4308356|NCT00494013|4135418|B2|Taiwan||Region of Enrollment||participants|Number|19|19.0||||||
4308357|NCT00494013|4135419|B1|Taiwan||Region of Enrollment||participants|Number|20|20.0||||||
4308358|NCT00494013|4135417|B3|Spain||Region of Enrollment||participants|Number|26|26.0||||||
4308359|NCT00494013|4135418|B2|Spain||Region of Enrollment||participants|Number|13|13.0||||||
4308360|NCT00494013|4135419|B1|Spain||Region of Enrollment||participants|Number|13|13.0||||||
4308361|NCT00494013|4135417|B3|Mexico||Region of Enrollment||participants|Number|55|55.0||||||
4308362|NCT00494013|4135418|B2|Mexico||Region of Enrollment||participants|Number|27|27.0||||||
4308363|NCT00494013|4135419|B1|Mexico||Region of Enrollment||participants|Number|28|28.0||||||
4308364|NCT00494013|4135417|B3|Korea, Republic of||Region of Enrollment||participants|Number|21|21.0||||||
4308365|NCT00494013|4135418|B2|Korea, Republic of||Region of Enrollment||participants|Number|11|11.0||||||
4308366|NCT00494013|4135419|B1|Korea, Republic of||Region of Enrollment||participants|Number|10|10.0||||||
4308367|NCT00494013|4135417|B3|India||Region of Enrollment||participants|Number|81|81.0||||||
4308368|NCT00494013|4135418|B2|India||Region of Enrollment||participants|Number|39|39.0||||||
4308369|NCT00494013|4135419|B1|India||Region of Enrollment||participants|Number|42|42.0||||||
4308370|NCT00494013|4135417|B3|Hungary||Region of Enrollment||participants|Number|70|70.0||||||
4308371|NCT00494013|4135418|B2|Hungary||Region of Enrollment||participants|Number|34|34.0||||||
4308372|NCT00494013|4135419|B1|Hungary||Region of Enrollment||participants|Number|36|36.0||||||
4308373|NCT00494013|4135417|B3|Argentina||Region of Enrollment||participants|Number|21|21.0||||||
4308374|NCT00494013|4135418|B2|Argentina||Region of Enrollment||participants|Number|11|11.0||||||
4308375|NCT00494013|4135419|B1|Argentina||Region of Enrollment||participants|Number|10|10.0||||||
4308376|NCT00494013|4135417|B3||Male|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
4308377|NCT00494013|4135418|B2||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4308378|NCT00494013|4135419|B1||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4308379|NCT00494013|4135417|B3||Female|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4308380|NCT00494013|4135418|B2||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4308381|NCT00494013|4135419|B1||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4308382|NCT00494013|4135417|B3|||Age||years|Mean|56.03|56.03|Standard Deviation|10.04|10.04|||
4308383|NCT00494013|4135418|B2|||Age||years|Mean|55.73|55.73|Standard Deviation|10.20|10.2|||
4308384|NCT00494013|4135419|B1|||Age||years|Mean|56.32|56.32|Standard Deviation|9.91|9.91|||
4308385|NCT00493974|4135448|B3||Unknown or Not Reported|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|0|0.0||||||
4308386|NCT00493974|4135449|B2||Unknown or Not Reported|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|0|0.0||||||
4308387|NCT00493974|4135450|B1||Unknown or Not Reported|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|0|0.0||||||
4308388|NCT00493974|4135448|B3||More than one race|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|10|10.0||||||
4308389|NCT00493974|4135449|B2||More than one race|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|3|3.0||||||
4308390|NCT00493974|4135450|B1||More than one race|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|7|7.0||||||
4308391|NCT00493974|4135448|B3||White|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|67|67.0||||||
4308392|NCT00493974|4135449|B2||White|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|31|31.0||||||
4308393|NCT00493974|4135450|B1||White|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|36|36.0||||||
4308394|NCT00493974|4135448|B3||Black or African American|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|40|40.0||||||
4308395|NCT00493974|4135449|B2||Black or African American|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|24|24.0||||||
4308396|NCT00493974|4135450|B1||Black or African American|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|16|16.0||||||
4308397|NCT00493974|4135448|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|0|0.0||||||
4308398|NCT00493974|4135449|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|0|0.0||||||
4308399|NCT00493974|4135450|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|0|0.0||||||
4308400|NCT00493974|4135448|B3||Asian|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|1|1.0||||||
4308401|NCT00493974|4135449|B2||Asian|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|1|1.0||||||
4308402|NCT00493974|4135450|B1||Asian|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|0|0.0||||||
4308403|NCT00493974|4135448|B3||American Indian or Alaska Native|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|1|1.0||||||
4308404|NCT00493974|4135449|B2||American Indian or Alaska Native|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|0|0.0||||||
4308405|NCT00493974|4135450|B1||American Indian or Alaska Native|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|1|1.0||||||
4308406|NCT00493974|4135448|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4308407|NCT00493974|4135449|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4308408|NCT00493974|4135450|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4308409|NCT00493974|4135448|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
4308410|NCT00493974|4135449|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4308411|NCT00493974|4135450|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4308412|NCT00493974|4135448|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4308413|NCT00493974|4135449|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4308414|NCT00493974|4135450|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4308415|NCT00493974|4135448|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4308416|NCT00493974|4135449|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4308417|NCT00493974|4135450|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4308418|NCT00493974|4135448|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4308419|NCT00493974|4135449|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4308420|NCT00493974|4135450|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4308421|NCT00493974|4135448|B3|||Age||years|Mean|63.2|63.2|Standard Deviation|8.9|8.9|||
4308422|NCT00493974|4135449|B2|||Age||years|Mean|64.3|64.3|Standard Deviation|9.5|9.5|||
4308423|NCT00493974|4135450|B1|||Age||years|Mean|62.2|62.2|Standard Deviation|8.2|8.2|||
4308424|NCT00493805|4135469|B1|Female||Sex/Gender, Customized||Participants|Number|24|24.0||||||
4308425|NCT00493805|4135469|B1|Male||Sex/Gender, Customized||Participants|Number|35|35.0||||||
4308426|NCT00493805|4135469|B1|Between 18 and 65 years||Age, Customized||Participants|Number|59|59.0||||||
4308427|NCT00493779|4135478|B1|||Mean Baseline Soluble CD40 Ligand||ng/L|Mean|223.76|223.76|Standard Deviation|186.513|186.513|||
4308428|NCT00493779|4135478|B1|||Mean Baseline Plasma Soluble P-Selectin||ng/mL|Mean|44.59|44.59|Standard Deviation|14.898|14.898|||
4308429|NCT00493779|4135478|B1|||Mean Baseline High Sensitivity C-Reactive Protein (hs-CRP)||mg/L|Mean|1.70|1.7|Standard Deviation|2.052|2.052|||
4308430|NCT00493779|4135478|B1|Asian Oriental||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4308431|NCT00493779|4135478|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|93|93.0||||||
4308432|NCT00493779|4135478|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4308433|NCT00493779|4135478|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4308434|NCT00493779|4135478|B1|||Age||years|Median|63|63.0|Full Range|||44.0|81.0|
4308435|NCT00493779|4135478|B1|||Age||years|Mean|63.3|63.3|Standard Deviation|8.5|8.5|||
4308436|NCT00493649|4135485|B1|United States||Region of Enrollment||participants|Number|493|493.0||||||
4308437|NCT00493649|4135485|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4308438|NCT00493649|4135485|B1|Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4308439|NCT00493649|4135485|B1|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4308440|NCT00493649|4135485|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4308441|NCT00493649|4135485|B1|Black||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4308442|NCT00493649|4135485|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|414|414.0||||||
4308443|NCT00493649|4135485|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4308444|NCT00493649|4135485|B1||Female|Sex: Female, Male||Participants|Count of Participants|493|493.0||||||
4308445|NCT00493649|4135485|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|10.1|10.1|||
4308446|NCT00493636|4135496|B3|United States||Region of Enrollment||participants|Number|160|160.0||||||
4308447|NCT00493636|4135497|B2|United States||Region of Enrollment||participants|Number|79|79.0||||||
4308448|NCT00493636|4135498|B1|United States||Region of Enrollment||participants|Number|81|81.0||||||
4308449|NCT00493636|4135496|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4308450|NCT00493636|4135497|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4308451|NCT00493636|4135498|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4308452|NCT00493636|4135496|B3||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4308453|NCT00493636|4135497|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4308454|NCT00493636|4135498|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4308455|NCT00493636|4135496|B3|||Age||years|Mean|53.8|53.8|Standard Deviation|10.8|10.8|||
4308456|NCT00493636|4135497|B2|||Age||years|Mean|54.2|54.2|Standard Deviation|11.0|11.0|||
4308457|NCT00493636|4135498|B1|||Age||years|Mean|53.5|53.5|Standard Deviation|10.6|10.6|||
4308458|NCT00493454|4135513|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4308459|NCT00493454|4135513|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4308460|NCT00493454|4135513|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4308461|NCT00493454|4135513|B1|||Age||years|Median|67.5|67.5|Full Range|||55.0|76.0|
4308462|NCT00493311|4135517|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4308463|NCT00493311|4135518|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
4308464|NCT00493311|4135519|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4308465|NCT00493311|4135517|B3||Male|Sex: Female, Male|Only male subjects were allowed to participate in the study.|Participants|Count of Participants|60|60.0||||||
4308466|NCT00493311|4135518|B2||Male|Sex: Female, Male|Only male subjects were allowed to participate in the study.|Participants|Count of Participants|31|31.0||||||
4308467|NCT00493311|4135519|B1||Male|Sex: Female, Male|Only male subjects were allowed to participate in the study.|Participants|Count of Participants|29|29.0||||||
4308468|NCT00493311|4135517|B3||Female|Sex: Female, Male|Only male subjects were allowed to participate in the study.|Participants|Count of Participants|0|0.0||||||
4308469|NCT00493311|4135518|B2||Female|Sex: Female, Male|Only male subjects were allowed to participate in the study.|Participants|Count of Participants|0|0.0||||||
4308470|NCT00493311|4135519|B1||Female|Sex: Female, Male|Only male subjects were allowed to participate in the study.|Participants|Count of Participants|0|0.0||||||
4308471|NCT00493311|4135517|B3|||Age||years|Mean|29.9|29.9|Standard Deviation|8.67|8.67|||
4308472|NCT00493311|4135518|B2|||Age||years|Mean|29.7|29.7|Standard Deviation|7.35|7.35|||
4308473|NCT00493311|4135519|B1|||Age||years|Mean|30.0|30.0|Standard Deviation|10.02|10.02|||
4308474|NCT00493311|4135517|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4308475|NCT00493311|4135518|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4308476|NCT00493311|4135519|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4308477|NCT00493311|4135517|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4308478|NCT00493311|4135518|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4308479|NCT00493311|4135519|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4308480|NCT00493311|4135517|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308481|NCT00493311|4135518|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308482|NCT00493311|4135519|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308483|NCT00493285|4135534|B7||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4308484|NCT00493285|4135535|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4308485|NCT00493285|4135536|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4308486|NCT00493285|4135537|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4308487|NCT00493285|4135538|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4308488|NCT00493285|4135539|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4308489|NCT00493285|4135540|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4308490|NCT00493285|4135534|B7||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4308491|NCT00493285|4135535|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4308492|NCT00493285|4135536|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4308493|NCT00493285|4135537|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4308494|NCT00493285|4135538|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4308495|NCT00493285|4135539|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4308496|NCT00493285|4135540|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4308497|NCT00493285|4135534|B7|||Age||Months|Mean|10.1|10.1|Standard Deviation|4.3|4.3|||
4308498|NCT00493285|4135535|B6|||Age||Months|Mean|9.9|9.9|Standard Deviation|4.3|4.3|||
4308499|NCT00493285|4135536|B5|||Age||Months|Mean|9.3|9.3|Standard Deviation|2.1|2.1|||
4308500|NCT00493285|4135537|B4|||Age||Months|Mean|11.3|11.3|Standard Deviation|3.7|3.7|||
4308501|NCT00493285|4135538|B3|||Age||Months|Mean|8.1|8.1|Standard Deviation|1.8|1.8|||
4308502|NCT00493285|4135539|B2|||Age||Months|Mean|12.2|12.2|Standard Deviation|7.6|7.6|||
4308503|NCT00493285|4135540|B1|||Age||Months|Mean|10.8|10.8|Standard Deviation|5.0|5.0|||
4308504|NCT00493246|4135769|B9||Male|Sex: Female, Male|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|44|44.0||||||
4308505|NCT00493246|4135770|B8||Male|Sex: Female, Male|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|4|4.0||||||
4308506|NCT00493246|4135771|B7||Male|Sex: Female, Male|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|10|10.0||||||
4308507|NCT00493246|4135772|B6||Male|Sex: Female, Male|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|10|10.0||||||
4308508|NCT00493246|4135773|B5||Male|Sex: Female, Male|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|5|5.0||||||
4308509|NCT00493246|4135774|B4||Male|Sex: Female, Male|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|6|6.0||||||
4308510|NCT00493246|4135775|B3||Male|Sex: Female, Male|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|8|8.0||||||
4308511|NCT00493246|4135776|B2||Male|Sex: Female, Male|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|0|0.0||||||
4308512|NCT00493246|4135777|B1||Male|Sex: Female, Male|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|1|1.0||||||
4308513|NCT00493246|4135769|B9||Female|Sex: Female, Male|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|31|31.0||||||
4308514|NCT00493246|4135770|B8||Female|Sex: Female, Male|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|6|6.0||||||
4308515|NCT00493246|4135771|B7||Female|Sex: Female, Male|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|2|2.0||||||
4308516|NCT00493246|4135772|B6||Female|Sex: Female, Male|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|6|6.0||||||
4308517|NCT00493246|4135773|B5||Female|Sex: Female, Male|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|4|4.0||||||
4308518|NCT00493246|4135774|B4||Female|Sex: Female, Male|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|7|7.0||||||
4308519|NCT00493246|4135775|B3||Female|Sex: Female, Male|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|4|4.0||||||
4308520|NCT00493246|4135776|B2||Female|Sex: Female, Male|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|1|1.0||||||
4308521|NCT00493246|4135777|B1||Female|Sex: Female, Male|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|1|1.0||||||
4308522|NCT00493246|4135769|B9||>=65 years|Age|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|0|0.0||||||
4308523|NCT00493246|4135770|B8||>=65 years|Age|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|0|0.0||||||
4308524|NCT00493246|4135771|B7||>=65 years|Age|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|0|0.0||||||
4308525|NCT00493246|4135772|B6||>=65 years|Age|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|0|0.0||||||
4308526|NCT00493246|4135773|B5||>=65 years|Age|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|0|0.0||||||
4308527|NCT00493246|4135774|B4||>=65 years|Age|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|0|0.0||||||
4308528|NCT00493246|4135775|B3||>=65 years|Age|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|0|0.0||||||
4308529|NCT00493246|4135776|B2||>=65 years|Age|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|0|0.0||||||
4308530|NCT00493246|4135777|B1||>=65 years|Age|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|0|0.0||||||
4308531|NCT00493246|4135769|B9||Between 18 and 65 years|Age|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|0|0.0||||||
4308532|NCT00493246|4135770|B8||Between 18 and 65 years|Age|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|0|0.0||||||
4308533|NCT00493246|4135771|B7||Between 18 and 65 years|Age|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|0|0.0||||||
4308534|NCT00493246|4135772|B6||Between 18 and 65 years|Age|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|0|0.0||||||
4308535|NCT00493246|4135773|B5||Between 18 and 65 years|Age|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|0|0.0||||||
4308536|NCT00493246|4135774|B4||Between 18 and 65 years|Age|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|0|0.0||||||
4308537|NCT00493246|4135775|B3||Between 18 and 65 years|Age|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|0|0.0||||||
4308538|NCT00493246|4135776|B2||Between 18 and 65 years|Age|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|0|0.0||||||
4308539|NCT00493246|4135777|B1||Between 18 and 65 years|Age|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|0|0.0||||||
4308540|NCT00493246|4135769|B9||<=18 years|Age|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|75|75.0||||||
4308541|NCT00493246|4135770|B8||<=18 years|Age|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|10|10.0||||||
4308542|NCT00493246|4135771|B7||<=18 years|Age|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|12|12.0||||||
4308543|NCT00493246|4135772|B6||<=18 years|Age|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|16|16.0||||||
4308544|NCT00493246|4135773|B5||<=18 years|Age|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|9|9.0||||||
4308545|NCT00493246|4135774|B4||<=18 years|Age|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|13|13.0||||||
4308546|NCT00493246|4135775|B3||<=18 years|Age|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|12|12.0||||||
4308547|NCT00493246|4135776|B2||<=18 years|Age|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|1|1.0||||||
4308548|NCT00493246|4135777|B1||<=18 years|Age|The Safety Population (subjects who received any part of a dose of IV acetaminophen) are included in this baseline measure.|Participants|Count of Participants|2|2.0||||||
4308549|NCT00493220|4135842|B7|United States||Region of Enrollment||participants|Number|30|30.0||||||
4308550|NCT00493220|4135843|B6|United States||Region of Enrollment||participants|Number|5|5.0||||||
4308551|NCT00493220|4135844|B5|United States||Region of Enrollment||participants|Number|5|5.0||||||
4308552|NCT00493220|4135845|B4|United States||Region of Enrollment||participants|Number|5|5.0||||||
4308553|NCT00493220|4135846|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4308554|NCT00493220|4135847|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4308555|NCT00493220|4135848|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4308556|NCT00493220|4135842|B7||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4308557|NCT00493220|4135843|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4308558|NCT00493220|4135844|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4308559|NCT00493220|4135845|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4308560|NCT00493220|4135846|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4308561|NCT00493220|4135847|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4308562|NCT00493220|4135848|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4308563|NCT00493220|4135842|B7||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4308564|NCT00493220|4135843|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4308565|NCT00493220|4135844|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4308566|NCT00493220|4135845|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4308567|NCT00493220|4135846|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4308568|NCT00493220|4135847|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4308569|NCT00493220|4135848|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4308570|NCT00493220|4135842|B7|||Age||years|Mean|34.5|34.5|Standard Deviation|10.3|10.3|||
4308571|NCT00493220|4135843|B6|||Age||years|Mean|33.2|33.2|Standard Deviation|8.0|8.0|||
4308572|NCT00493220|4135844|B5|||Age||years|Mean|34.8|34.8|Standard Deviation|11.0|11.0|||
4308573|NCT00493220|4135845|B4|||Age||years|Mean|34.8|34.8|Standard Deviation|17.5|17.5|||
4308574|NCT00493220|4135846|B3|||Age||years|Mean|34.2|34.2|Standard Deviation|11.5|11.5|||
4308575|NCT00493220|4135847|B2|||Age||years|Mean|37.6|37.6|Standard Deviation|4.0|4.0|||
4308576|NCT00493220|4135848|B1|||Age||years|Mean|32.2|32.2|Standard Deviation|10.6|10.6|||
4308577|NCT00493220|4135842|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4308578|NCT00493220|4135843|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4308579|NCT00493220|4135844|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4308580|NCT00493220|4135845|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4308581|NCT00493220|4135846|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4308582|NCT00493220|4135847|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4308583|NCT00493220|4135848|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4308584|NCT00493220|4135842|B7||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4308585|NCT00493220|4135843|B6||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4308586|NCT00493220|4135844|B5||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4308587|NCT00493220|4135845|B4||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4308588|NCT00493220|4135846|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4308589|NCT00493220|4135847|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4308590|NCT00493220|4135848|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4308591|NCT00493220|4135842|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308592|NCT00493220|4135843|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308593|NCT00493220|4135844|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308594|NCT00493220|4135845|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308595|NCT00493220|4135846|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308596|NCT00493220|4135847|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308597|NCT00493220|4135848|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308598|NCT00493181|4135870|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4308599|NCT00493181|4135870|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4308600|NCT00493181|4135870|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4308601|NCT00493181|4135870|B1|||Age||years|Median|55|55.0|Full Range|||31.0|59.0|
4308602|NCT00493064|4135874|B1|United States||Region of Enrollment||Participants|Count of Participants|63|63.0||||||
4308603|NCT00493064|4135874|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4308604|NCT00493064|4135874|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4308605|NCT00493064|4135874|B1||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
4308606|NCT00493064|4135874|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4308607|NCT00493064|4135874|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308608|NCT00493038|4135879|B3||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4308609|NCT00493038|4135880|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4308610|NCT00493038|4135881|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4308611|NCT00493038|4135879|B3||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4308612|NCT00493038|4135880|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4308613|NCT00493038|4135881|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4308614|NCT00493038|4135879|B3|>=65 years||Age, Customized||participants|Number|22|22.0||||||
4308615|NCT00493038|4135880|B2|>=65 years||Age, Customized||participants|Number|10|10.0||||||
4308616|NCT00493038|4135881|B1|>=65 years||Age, Customized||participants|Number|12|12.0||||||
4308617|NCT00493038|4135879|B3|>18 and <65 years||Age, Customized||participants|Number|265|265.0||||||
4308618|NCT00493038|4135880|B2|>18 and <65 years||Age, Customized||participants|Number|132|132.0||||||
4308619|NCT00493038|4135881|B1|>18 and <65 years||Age, Customized||participants|Number|133|133.0||||||
4308620|NCT00493038|4135879|B3|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4308621|NCT00493038|4135880|B2|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4308622|NCT00493038|4135881|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4308623|NCT00493038|4135879|B3|||Age||years|Mean|40.7|40.7|Standard Deviation|13.4|13.4|||
4308624|NCT00493038|4135880|B2|||Age||years|Mean|39.7|39.7|Standard Deviation|13.6|13.6|||
4308625|NCT00493038|4135881|B1|||Age||years|Mean|41.7|41.7|Standard Deviation|13.2|13.2|||
4308626|NCT00493025|4135896|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4308627|NCT00493025|4135896|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4308628|NCT00493025|4135896|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4308629|NCT00493025|4135896|B1|||Age|Trial stopped due to early stopping rule, no data analysis completed.|years|Mean|67|67.0|Standard Deviation|7.37|7.37|||
4308630|NCT00493025|4135896|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4308631|NCT00493025|4135896|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4308632|NCT00493025|4135896|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308633|NCT00493012|4135905|B3|Germany||Region of Enrollment||participants|Number|200|200.0||||||
4308634|NCT00493012|4135906|B2|Germany||Region of Enrollment||participants|Number|100|100.0||||||
4308635|NCT00493012|4135907|B1|Germany||Region of Enrollment||participants|Number|100|100.0||||||
4308636|NCT00493012|4135905|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4308637|NCT00493012|4135906|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4308638|NCT00493012|4135907|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4308639|NCT00493012|4135905|B3||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4308640|NCT00493012|4135906|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4308641|NCT00493012|4135907|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4308642|NCT00493012|4135905|B3|||Age||years|Mean|48.1|48.1|Standard Deviation|10.2|10.2|||
4308643|NCT00493012|4135906|B2|||Age||years|Mean|48.8|48.8|Standard Deviation|10.1|10.1|||
4308644|NCT00493012|4135907|B1|||Age||years|Mean|47.4|47.4|Standard Deviation|10.3|10.3|||
4308645|NCT00493012|4135905|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4308646|NCT00493012|4135906|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4308647|NCT00493012|4135907|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4308648|NCT00493012|4135905|B3||Between 18 and 65 years|Age||Participants|Count of Participants|196|196.0||||||
4308649|NCT00493012|4135906|B2||Between 18 and 65 years|Age||Participants|Count of Participants|98|98.0||||||
4308650|NCT00493012|4135907|B1||Between 18 and 65 years|Age||Participants|Count of Participants|98|98.0||||||
4308651|NCT00493012|4135905|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308652|NCT00493012|4135906|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308653|NCT00493012|4135907|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308654|NCT00492973|4135934|B3|United States||Region of Enrollment||participants|Number|76|76.0||||||
4308655|NCT00492973|4135935|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
4308656|NCT00492973|4135936|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4308657|NCT00492973|4135934|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4308658|NCT00492973|4135935|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4308659|NCT00492973|4135936|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4308660|NCT00492973|4135934|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4308661|NCT00492973|4135935|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4308662|NCT00492973|4135936|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4308663|NCT00492973|4135934|B3|||Age||years|Mean|65.5|65.5|Standard Deviation|11.0|11.0|||
4308664|NCT00492973|4135935|B2|||Age||years|Mean|65.8|65.8|Standard Deviation|11.1|11.1|||
4308665|NCT00492973|4135936|B1|||Age||years|Mean|65.2|65.2|Standard Deviation|11.0|11.0|||
4308666|NCT00492973|4135934|B3||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
4308667|NCT00492973|4135935|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4308668|NCT00492973|4135936|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4308669|NCT00492973|4135934|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4308670|NCT00492973|4135935|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4308671|NCT00492973|4135936|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4308672|NCT00492973|4135934|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308673|NCT00492973|4135935|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308674|NCT00492973|4135936|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308675|NCT00492921|4135951|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4308676|NCT00492921|4135951|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4308677|NCT00492921|4135951|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4308678|NCT00492921|4135951|B1|||Age||years|Median|38|38.0|Full Range|||12.0|63.0|
4308679|NCT00492921|4135951|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4308680|NCT00492921|4135951|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4308681|NCT00492921|4135951|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4308682|NCT00492856|4135964|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4308683|NCT00492856|4135964|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
4308684|NCT00492856|4135964|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4308685|NCT00492856|4135964|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4308686|NCT00492856|4135964|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4308687|NCT00492856|4135964|B1||White|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
4308688|NCT00492856|4135964|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4308689|NCT00492856|4135964|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4308690|NCT00492856|4135964|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4308691|NCT00492856|4135964|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4308692|NCT00492856|4135964|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4308693|NCT00492856|4135964|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4308694|NCT00492856|4135964|B1|||Age||years|Median|49|49.0|Full Range|||21.0|82.0|
4308695|NCT00492752|4135979|B3|Present||Tumor burden|Tumor burden refers to the number of cancer cells, the size of a tumor, or the amount of cancer in the body, and is called the tumor load. Randomization was stratified by “tumor burden” assessment ie, the presence of either macroscopic vascular invasion as determined by radiological assessment and/or extra hepatic spread versus none.|Participants|Number|179|179.0||||||
4308696|NCT00492752|4135980|B2|Present||Tumor burden|Tumor burden refers to the number of cancer cells, the size of a tumor, or the amount of cancer in the body, and is called the tumor load. Randomization was stratified by “tumor burden” assessment ie, the presence of either macroscopic vascular invasion as determined by radiological assessment and/or extra hepatic spread versus none.|Participants|Number|61|61.0||||||
4308697|NCT00492752|4135981|B1|Present||Tumor burden|Tumor burden refers to the number of cancer cells, the size of a tumor, or the amount of cancer in the body, and is called the tumor load. Randomization was stratified by “tumor burden” assessment ie, the presence of either macroscopic vascular invasion as determined by radiological assessment and/or extra hepatic spread versus none.|Participants|Number|118|118.0||||||
4308698|NCT00492752|4135979|B3|Absent||Tumor burden|Tumor burden refers to the number of cancer cells, the size of a tumor, or the amount of cancer in the body, and is called the tumor load. Randomization was stratified by “tumor burden” assessment ie, the presence of either macroscopic vascular invasion as determined by radiological assessment and/or extra hepatic spread versus none.|Participants|Number|47|47.0||||||
4308699|NCT00492752|4135980|B2|Absent||Tumor burden|Tumor burden refers to the number of cancer cells, the size of a tumor, or the amount of cancer in the body, and is called the tumor load. Randomization was stratified by “tumor burden” assessment ie, the presence of either macroscopic vascular invasion as determined by radiological assessment and/or extra hepatic spread versus none.|Participants|Number|15|15.0||||||
4308700|NCT00492752|4135981|B1|Absent||Tumor burden|Tumor burden refers to the number of cancer cells, the size of a tumor, or the amount of cancer in the body, and is called the tumor load. Randomization was stratified by “tumor burden” assessment ie, the presence of either macroscopic vascular invasion as determined by radiological assessment and/or extra hepatic spread versus none.|Participants|Number|32|32.0||||||
4308701|NCT00492752|4135979|B3|2||Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) is a scale (range 0 [fully active] to 5 [dead]) that measures how cancer affects a patient. Subjects entering this study were to have an ECOG score of 0, 1 (restricted in physically strenuous activity but ambulatory), or 2 (capable of all self care but cannot carry out work activities.|Participants|Number|13|13.0||||||
4308702|NCT00492752|4135980|B2|2||Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) is a scale (range 0 [fully active] to 5 [dead]) that measures how cancer affects a patient. Subjects entering this study were to have an ECOG score of 0, 1 (restricted in physically strenuous activity but ambulatory), or 2 (capable of all self care but cannot carry out work activities.|Participants|Number|4|4.0||||||
4308703|NCT00492752|4135981|B1|2||Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) is a scale (range 0 [fully active] to 5 [dead]) that measures how cancer affects a patient. Subjects entering this study were to have an ECOG score of 0, 1 (restricted in physically strenuous activity but ambulatory), or 2 (capable of all self care but cannot carry out work activities.|Participants|Number|9|9.0||||||
4308704|NCT00492752|4135979|B3|1||Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) is a scale (range 0 [fully active] to 5 [dead]) that measures how cancer affects a patient. Subjects entering this study were to have an ECOG score of 0, 1 (restricted in physically strenuous activity but ambulatory), or 2 (capable of all self care but cannot carry out work activities.|Participants|Number|158|158.0||||||
4308705|NCT00492752|4135980|B2|1||Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) is a scale (range 0 [fully active] to 5 [dead]) that measures how cancer affects a patient. Subjects entering this study were to have an ECOG score of 0, 1 (restricted in physically strenuous activity but ambulatory), or 2 (capable of all self care but cannot carry out work activities.|Participants|Number|50|50.0||||||
4308706|NCT00492752|4135981|B1|1||Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) is a scale (range 0 [fully active] to 5 [dead]) that measures how cancer affects a patient. Subjects entering this study were to have an ECOG score of 0, 1 (restricted in physically strenuous activity but ambulatory), or 2 (capable of all self care but cannot carry out work activities.|Participants|Number|108|108.0||||||
4308707|NCT00492752|4135979|B3|0||Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) is a scale (range 0 [fully active] to 5 [dead]) that measures how cancer affects a patient. Subjects entering this study were to have an ECOG score of 0, 1 (restricted in physically strenuous activity but ambulatory), or 2 (capable of all self care but cannot carry out work activities.|Participants|Number|55|55.0||||||
4308708|NCT00492752|4135980|B2|0||Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) is a scale (range 0 [fully active] to 5 [dead]) that measures how cancer affects a patient. Subjects entering this study were to have an ECOG score of 0, 1 (restricted in physically strenuous activity but ambulatory), or 2 (capable of all self care but cannot carry out work activities.|Participants|Number|22|22.0||||||
4308709|NCT00492752|4135981|B1|0||Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) is a scale (range 0 [fully active] to 5 [dead]) that measures how cancer affects a patient. Subjects entering this study were to have an ECOG score of 0, 1 (restricted in physically strenuous activity but ambulatory), or 2 (capable of all self care but cannot carry out work activities.|Participants|Number|33|33.0||||||
4308710|NCT00492752|4135979|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4308711|NCT00492752|4135980|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4308712|NCT00492752|4135981|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4308713|NCT00492752|4135979|B3||Female|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4308714|NCT00492752|4135980|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4308715|NCT00492752|4135981|B1||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4308716|NCT00492752|4135979|B3|>=65 years||Age, Customized||Participants|Number|32|32.0||||||
4308717|NCT00492752|4135980|B2|>=65 years||Age, Customized||Participants|Number|13|13.0||||||
4308718|NCT00492752|4135981|B1|>=65 years||Age, Customized||Participants|Number|19|19.0||||||
4308719|NCT00492752|4135979|B3|<65 years||Age, Customized||Participants|Number|194|194.0||||||
4308720|NCT00492752|4135980|B2|<65 years||Age, Customized||Participants|Number|63|63.0||||||
4308721|NCT00492752|4135981|B1|<65 years||Age, Customized||Participants|Number|131|131.0||||||
4308722|NCT00492752|4135979|B3|||Age||Years|Median|51|51.0|Full Range|||23.0|86.0|
4308723|NCT00492752|4135980|B2|||Age||Years|Median|52|52.0|Full Range|||25.0|79.0|
4308724|NCT00492752|4135981|B1|||Age||Years|Median|51|51.0|Full Range|||23.0|86.0|
4308725|NCT00492726|4136017|B3||Male|Sex: Female, Male||Participants|Count of Participants|517|517.0||||||
4308726|NCT00492726|4136018|B2||Male|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
4308727|NCT00492726|4136019|B1||Male|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
4308728|NCT00492726|4136017|B3||Female|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
4308729|NCT00492726|4136018|B2||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4308730|NCT00492726|4136019|B1||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4308731|NCT00492726|4136017|B3|||Age||years|Mean|47.4|47.4|Standard Deviation|18.2|18.2|||
4308732|NCT00492726|4136018|B2|||Age||years|Mean|47.0|47.0|Standard Deviation|18.2|18.2|||
4308733|NCT00492726|4136019|B1|||Age||years|Mean|48.1|48.1|Standard Deviation|18.3|18.3|||
4308734|NCT00492648|4136044|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4308735|NCT00492648|4136044|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4308736|NCT00492648|4136044|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4308737|NCT00492648|4136045|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4308738|NCT00492648|4136046|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4308739|NCT00492648|4136044|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4308740|NCT00492648|4136045|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4308741|NCT00492648|4136046|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4308742|NCT00492648|4136044|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4308743|NCT00492648|4136045|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4308744|NCT00492648|4136046|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4308745|NCT00492648|4136044|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4308746|NCT00492648|4136045|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4308747|NCT00492648|4136046|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4308748|NCT00492648|4136044|B3|||Age||Years|Mean|51.6|51.6|Standard Deviation|12.28|12.28|||
4308749|NCT00492648|4136045|B2|||Age||Years|Mean|56.0|56.0|Standard Deviation|4.59|4.59|||
4308750|NCT00492648|4136046|B1|||Age||Years|Mean|22.7|22.7|Standard Deviation|3.79|3.79|||
4308751|NCT00492648|4136044|B3|||Age||Years|Mean|51.6|51.6|Standard Deviation|11.40|11.4|||
4308752|NCT00492648|4136045|B2|||Age||Years|Mean|54.9|54.9|Standard Deviation|4.19|4.19|||
4308753|NCT00492648|4136046|B1|||Age||Years|Mean|22.3|22.3|Standard Deviation|3.20|3.2|||
4308754|NCT00492622|4136073|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4308755|NCT00492622|4136073|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4308756|NCT00492622|4136073|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4308757|NCT00492622|4136073|B1|||Age||years|Mean|51|51.0|Standard Deviation|10|10.0|||
4308758|NCT00492583|4136083|B3|United States||Region of Enrollment||participants|Number|182|182.0||||||
4308759|NCT00492583|4136084|B2|United States||Region of Enrollment||participants|Number|87|87.0||||||
4308760|NCT00492583|4136085|B1|United States||Region of Enrollment||participants|Number|95|95.0||||||
4308761|NCT00492583|4136083|B3|Missing||Sex/Gender, Customized||participants|Number|19|19.0||||||
4308762|NCT00492583|4136084|B2|Missing||Sex/Gender, Customized||participants|Number|10|10.0||||||
4308763|NCT00492583|4136085|B1|Missing||Sex/Gender, Customized||participants|Number|9|9.0||||||
4308764|NCT00492583|4136083|B3|Male||Sex/Gender, Customized||participants|Number|84|84.0||||||
4308765|NCT00492583|4136084|B2|Male||Sex/Gender, Customized||participants|Number|34|34.0||||||
4308766|NCT00492583|4136085|B1|Male||Sex/Gender, Customized||participants|Number|50|50.0||||||
4308767|NCT00492583|4136083|B3|Female||Sex/Gender, Customized||participants|Number|79|79.0||||||
4308768|NCT00492583|4136084|B2|Female||Sex/Gender, Customized||participants|Number|43|43.0||||||
4308769|NCT00492583|4136085|B1|Female||Sex/Gender, Customized||participants|Number|36|36.0||||||
4308770|NCT00492583|4136083|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4308771|NCT00492583|4136084|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4308772|NCT00492583|4136085|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4308773|NCT00492583|4136083|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4308774|NCT00492583|4136084|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4308775|NCT00492583|4136085|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4308776|NCT00492583|4136083|B3||<=18 years|Age||Participants|Count of Participants|182|182.0||||||
4308777|NCT00492583|4136084|B2||<=18 years|Age||Participants|Count of Participants|87|87.0||||||
4308778|NCT00492583|4136085|B1||<=18 years|Age||Participants|Count of Participants|95|95.0||||||
4308779|NCT00492557|4136092|B3||Male|Sex: Female, Male|"Data for participants in the safety population (ie. those who received at least 1 dose of study vaccine) are presented. The number of participants equals the number receiving Dose 1 in the Participant Flow section (1152), minus 1 participant in the 13vPnC+TIV followed by placebo 1 month later group who received a regimen that was not part of the study."|Participants|Count of Participants|572|572.0||||||
4308814|NCT00492531|4136125|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4308815|NCT00492531|4136123|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4308780|NCT00492557|4136093|B2||Male|Sex: Female, Male|"Data for participants in the safety population (ie. those who received at least 1 dose of study vaccine) are presented. The number of participants equals the number receiving Dose 1 in the Participant Flow section (1152), minus 1 participant in the 13vPnC+TIV followed by placebo 1 month later group who received a regimen that was not part of the study."|Participants|Count of Participants|285|285.0||||||
4308781|NCT00492557|4136094|B1||Male|Sex: Female, Male|"Data for participants in the safety population (ie. those who received at least 1 dose of study vaccine) are presented. The number of participants equals the number receiving Dose 1 in the Participant Flow section (1152), minus 1 participant in the 13vPnC+TIV followed by placebo 1 month later group who received a regimen that was not part of the study."|Participants|Count of Participants|287|287.0||||||
4308782|NCT00492557|4136092|B3||Female|Sex: Female, Male|"Data for participants in the safety population (ie. those who received at least 1 dose of study vaccine) are presented. The number of participants equals the number receiving Dose 1 in the Participant Flow section (1152), minus 1 participant in the 13vPnC+TIV followed by placebo 1 month later group who received a regimen that was not part of the study."|Participants|Count of Participants|579|579.0||||||
4308783|NCT00492557|4136093|B2||Female|Sex: Female, Male|"Data for participants in the safety population (ie. those who received at least 1 dose of study vaccine) are presented. The number of participants equals the number receiving Dose 1 in the Participant Flow section (1152), minus 1 participant in the 13vPnC+TIV followed by placebo 1 month later group who received a regimen that was not part of the study."|Participants|Count of Participants|290|290.0||||||
4308784|NCT00492557|4136094|B1||Female|Sex: Female, Male|"Data for participants in the safety population (ie. those who received at least 1 dose of study vaccine) are presented. The number of participants equals the number receiving Dose 1 in the Participant Flow section (1152), minus 1 participant in the 13vPnC+TIV followed by placebo 1 month later group who received a regimen that was not part of the study."|Participants|Count of Participants|289|289.0||||||
4308785|NCT00492557|4136092|B3|||Age|"Data for participants in the safety population (ie. those who received at least 1 dose of study vaccine) are presented. The number of participants equals the number receiving Dose 1 in the Participant Flow section (1152), minus 1 participant in the 13vPnC+TIV followed by placebo 1 month later group who received a regimen that was not part of the study."|years|Mean|72.1|72.1|Standard Deviation|5.5|5.5|||
4308786|NCT00492557|4136093|B2|||Age|"Data for participants in the safety population (ie. those who received at least 1 dose of study vaccine) are presented. The number of participants equals the number receiving Dose 1 in the Participant Flow section (1152), minus 1 participant in the 13vPnC+TIV followed by placebo 1 month later group who received a regimen that was not part of the study."|years|Mean|72.1|72.1|Standard Deviation|5.5|5.5|||
4308787|NCT00492557|4136094|B1|||Age|"Data for participants in the safety population (ie. those who received at least 1 dose of study vaccine) are presented. The number of participants equals the number receiving Dose 1 in the Participant Flow section (1152), minus 1 participant in the 13vPnC+TIV followed by placebo 1 month later group who received a regimen that was not part of the study."|years|Mean|72.1|72.1|Standard Deviation|5.6|5.6|||
4308788|NCT00492544|4136111|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4308789|NCT00492544|4136111|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4308790|NCT00492544|4136111|B1|||Age||years|Mean|12.1|12.1|Standard Deviation|1.60|1.6|||
4308791|NCT00492531|4136123|B3|||Tricuspid regurgitant jet velocity (TRV)|Tricuspid regurgitant jet velocity was measured by transthoracic Doppler Echocardiography.|m/s|Mean|3.0|3.0|Standard Deviation|0.3|0.3|||
4308792|NCT00492531|4136124|B2|||Tricuspid regurgitant jet velocity (TRV)|Tricuspid regurgitant jet velocity was measured by transthoracic Doppler Echocardiography.|m/s|Mean|3.0|3.0|Standard Deviation|0.3|0.3|||
4308793|NCT00492531|4136125|B1|||Tricuspid regurgitant jet velocity (TRV)|Tricuspid regurgitant jet velocity was measured by transthoracic Doppler Echocardiography.|m/s|Mean|3.0|3.0|Standard Deviation|0.5|0.5|||
4308794|NCT00492531|4136123|B3|||6 minute walk|The distance walked in six minute was used to assess the exercise capacity of the patient at baseline.|Meters|Mean|383|383.0|Standard Deviation|75|75.0|||
4308795|NCT00492531|4136124|B2|||6 minute walk|The distance walked in six minute was used to assess the exercise capacity of the patient at baseline.|Meters|Mean|386|386.0|Standard Deviation|75|75.0|||
4308796|NCT00492531|4136125|B1|||6 minute walk|The distance walked in six minute was used to assess the exercise capacity of the patient at baseline.|Meters|Mean|381|381.0|Standard Deviation|75|75.0|||
4308797|NCT00492531|4136123|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4308798|NCT00492531|4136124|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4308799|NCT00492531|4136125|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4308800|NCT00492531|4136123|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4308801|NCT00492531|4136124|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4308802|NCT00492531|4136125|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4308803|NCT00492531|4136123|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4308804|NCT00492531|4136124|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4308805|NCT00492531|4136125|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4308806|NCT00492531|4136123|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
4308807|NCT00492531|4136124|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4308808|NCT00492531|4136125|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4308809|NCT00492531|4136123|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4308810|NCT00492531|4136124|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4308811|NCT00492531|4136125|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4308812|NCT00492531|4136123|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4308813|NCT00492531|4136124|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4308816|NCT00492531|4136124|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4308817|NCT00492531|4136125|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4308818|NCT00492531|4136123|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4308819|NCT00492531|4136124|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4308820|NCT00492531|4136125|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4308821|NCT00492531|4136123|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
4308822|NCT00492531|4136124|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4308823|NCT00492531|4136125|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4308824|NCT00492531|4136123|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4308825|NCT00492531|4136124|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4308826|NCT00492531|4136125|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4308827|NCT00492531|4136123|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4308828|NCT00492531|4136124|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4308829|NCT00492531|4136125|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4308830|NCT00492531|4136123|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4308831|NCT00492531|4136124|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4308832|NCT00492531|4136125|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4308833|NCT00492531|4136123|B3|||Age||years|Mean|45|45.0|Standard Deviation|13|13.0|||
4308834|NCT00492531|4136124|B2|||Age||years|Mean|44|44.0|Standard Deviation|14|14.0|||
4308835|NCT00492531|4136125|B1|||Age||years|Mean|47|47.0|Standard Deviation|13|13.0|||
4308836|NCT00492401|4136138|B1|Canada||Region of Enrollment||patients|Number|1|1.0||||||
4308837|NCT00492401|4136138|B1|United States||Region of Enrollment||patients|Number|54|54.0||||||
4308838|NCT00492401|4136138|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4308839|NCT00492401|4136138|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4308840|NCT00492401|4136138|B1||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4308841|NCT00492401|4136138|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4308842|NCT00492401|4136138|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4308843|NCT00492401|4136138|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4308844|NCT00492401|4136138|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4308845|NCT00492401|4136138|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4308846|NCT00492401|4136138|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4308847|NCT00492401|4136138|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4308848|NCT00492401|4136138|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4308849|NCT00492401|4136138|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4308850|NCT00492401|4136138|B1||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
4308851|NCT00492401|4136138|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4308852|NCT00492401|4136138|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308853|NCT00492349|4136147|B3|Nonsmoker||Ham-D Total Score|HAMILTON DEPRESSION RATING SCALE In general, the higher the total score the more severe the depression. One can use the following to classify severity: 0 - 13 mild; 14-17 mild to moderate; >17 moderate to severe. However, in this trial, these categorical classifications of severity were not used. Only the raw score was used to compare between the treatment arm and the placebo arm.|units on a scale|Mean|5.8|5.8|Standard Deviation|0.8|0.8|||
4308854|NCT00492349|4136148|B2|Nonsmoker||Ham-D Total Score|HAMILTON DEPRESSION RATING SCALE In general, the higher the total score the more severe the depression. One can use the following to classify severity: 0 - 13 mild; 14-17 mild to moderate; >17 moderate to severe. However, in this trial, these categorical classifications of severity were not used. Only the raw score was used to compare between the treatment arm and the placebo arm.|units on a scale|Mean|6.6|6.6|Standard Deviation|1.0|1.0|||
4308855|NCT00492349|4136149|B1|Nonsmoker||Ham-D Total Score|HAMILTON DEPRESSION RATING SCALE In general, the higher the total score the more severe the depression. One can use the following to classify severity: 0 - 13 mild; 14-17 mild to moderate; >17 moderate to severe. However, in this trial, these categorical classifications of severity were not used. Only the raw score was used to compare between the treatment arm and the placebo arm.|units on a scale|Mean|5.2|5.2|Standard Deviation|0.7|0.7|||
4308856|NCT00492349|4136147|B3|Smoker||Ham-D Total Score|HAMILTON DEPRESSION RATING SCALE In general, the higher the total score the more severe the depression. One can use the following to classify severity: 0 - 13 mild; 14-17 mild to moderate; >17 moderate to severe. However, in this trial, these categorical classifications of severity were not used. Only the raw score was used to compare between the treatment arm and the placebo arm.|units on a scale|Mean|5.38|5.38|Standard Deviation|1.0|1.0|||
4308857|NCT00492349|4136148|B2|Smoker||Ham-D Total Score|HAMILTON DEPRESSION RATING SCALE In general, the higher the total score the more severe the depression. One can use the following to classify severity: 0 - 13 mild; 14-17 mild to moderate; >17 moderate to severe. However, in this trial, these categorical classifications of severity were not used. Only the raw score was used to compare between the treatment arm and the placebo arm.|units on a scale|Mean|5.76|5.76|Standard Deviation|1.15|1.15|||
4309011|NCT00492232|4136262|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|116.0|116.0||||||
4308858|NCT00492349|4136149|B1|Smoker||Ham-D Total Score|HAMILTON DEPRESSION RATING SCALE In general, the higher the total score the more severe the depression. One can use the following to classify severity: 0 - 13 mild; 14-17 mild to moderate; >17 moderate to severe. However, in this trial, these categorical classifications of severity were not used. Only the raw score was used to compare between the treatment arm and the placebo arm.|units on a scale|Mean|5.0|5.0|Standard Deviation|0.9|0.9|||
4308859|NCT00492349|4136147|B3|Non-Smoker||BPRS Total|"BRIEF PSYCHIATRIC RATING SCALE has 20 items:~1 = not present, 2 = very mild, 3 = mild, 4 = moderate, 5 = moderately severe, 6 = severe, 7 = extremely severe. Score range from 20 to 140."|units on a scale|Mean|32.6|32.6|Standard Deviation|2.2|2.2|||
4308860|NCT00492349|4136148|B2|Non-Smoker||BPRS Total|"BRIEF PSYCHIATRIC RATING SCALE has 20 items:~1 = not present, 2 = very mild, 3 = mild, 4 = moderate, 5 = moderately severe, 6 = severe, 7 = extremely severe. Score range from 20 to 140."|units on a scale|Mean|34.0|34.0|Standard Deviation|2.5|2.5|||
4308861|NCT00492349|4136149|B1|Non-Smoker||BPRS Total|"BRIEF PSYCHIATRIC RATING SCALE has 20 items:~1 = not present, 2 = very mild, 3 = mild, 4 = moderate, 5 = moderately severe, 6 = severe, 7 = extremely severe. Score range from 20 to 140."|units on a scale|Mean|31.2|31.2|Standard Deviation|2.0|2.0|||
4308862|NCT00492349|4136147|B3|Smoker||BPRS Total|"BRIEF PSYCHIATRIC RATING SCALE has 20 items:~1 = not present, 2 = very mild, 3 = mild, 4 = moderate, 5 = moderately severe, 6 = severe, 7 = extremely severe. Score range from 20 to 140."|units on a scale|Mean|35.6|35.6|Standard Deviation|1.9|1.9|||
4308863|NCT00492349|4136148|B2|Smoker||BPRS Total|"BRIEF PSYCHIATRIC RATING SCALE has 20 items:~1 = not present, 2 = very mild, 3 = mild, 4 = moderate, 5 = moderately severe, 6 = severe, 7 = extremely severe. Score range from 20 to 140."|units on a scale|Mean|35.0|35.0|Standard Deviation|2.0|2.0|||
4308864|NCT00492349|4136149|B1|Smoker||BPRS Total|"BRIEF PSYCHIATRIC RATING SCALE has 20 items:~1 = not present, 2 = very mild, 3 = mild, 4 = moderate, 5 = moderately severe, 6 = severe, 7 = extremely severe. Score range from 20 to 140."|units on a scale|Mean|36.2|36.2|Standard Deviation|1.9|1.9|||
4308865|NCT00492349|4136147|B3|United States||Region of Enrollment||participants|Number|69|69.0||||||
4308866|NCT00492349|4136148|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
4308867|NCT00492349|4136149|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4308868|NCT00492349|4136147|B3||Male|Sex: Female, Male|Baseline data were available for participants who completed 2 weeks in the study|Participants|Count of Participants|47|47.0||||||
4308869|NCT00492349|4136148|B2||Male|Sex: Female, Male|Baseline data were available for participants who completed 2 weeks in the study|Participants|Count of Participants|24|24.0||||||
4308870|NCT00492349|4136149|B1||Male|Sex: Female, Male|Baseline data were available for participants who completed 2 weeks in the study|Participants|Count of Participants|23|23.0||||||
4308871|NCT00492349|4136147|B3||Female|Sex: Female, Male|Baseline data were available for participants who completed 2 weeks in the study|Participants|Count of Participants|22|22.0||||||
4308872|NCT00492349|4136148|B2||Female|Sex: Female, Male|Baseline data were available for participants who completed 2 weeks in the study|Participants|Count of Participants|10|10.0||||||
4308873|NCT00492349|4136149|B1||Female|Sex: Female, Male|Baseline data were available for participants who completed 2 weeks in the study|Participants|Count of Participants|12|12.0||||||
4308874|NCT00492349|4136147|B3|Non-Smoker||Age||years|Mean|43.9|43.9|Standard Deviation|2.8|2.8|||
4308875|NCT00492349|4136148|B2|Non-Smoker||Age||years|Mean|42.1|42.1|Standard Deviation|3.2|3.2|||
4308876|NCT00492349|4136149|B1|Non-Smoker||Age||years|Mean|45.7|45.7|Standard Deviation|2.6|2.6|||
4308877|NCT00492349|4136147|B3|Smoker||Age||years|Mean|42.2|42.2|Standard Deviation|2.5|2.5|||
4308878|NCT00492349|4136148|B2|Smoker||Age||years|Mean|41.5|41.5|Standard Deviation|2.5|2.5|||
4308879|NCT00492349|4136149|B1|Smoker||Age||years|Mean|43.0|43.0|Standard Deviation|2.5|2.5|||
4308880|NCT00492336|4136170|B3|United States||Region of Enrollment||participants|Number|57|57.0||||||
4308881|NCT00492336|4136171|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4308882|NCT00492336|4136172|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4308883|NCT00492336|4136170|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4308884|NCT00492336|4136171|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4308885|NCT00492336|4136172|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4308886|NCT00492336|4136170|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4308887|NCT00492336|4136171|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4308888|NCT00492336|4136172|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4308889|NCT00492336|4136170|B3|||Age||years|Mean|46.09|46.09|Standard Deviation|11.59|11.59|||
4308890|NCT00492336|4136171|B2|||Age||years|Mean|45.9|45.9|Standard Deviation|11.1|11.1|||
4308891|NCT00492336|4136172|B1|||Age||years|Mean|46.3|46.3|Standard Deviation|12.2|12.2|||
4308892|NCT00492336|4136170|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4308893|NCT00492336|4136171|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4308894|NCT00492336|4136172|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4308895|NCT00492336|4136170|B3||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4308896|NCT00492336|4136171|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4308897|NCT00492336|4136172|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4308898|NCT00492336|4136170|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308899|NCT00492336|4136171|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308900|NCT00492336|4136172|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4308901|NCT00492297|4136199|B1|||Mean time from diagnosis|Mean number of days from initial diagnosis to randomization into the study.|days|Mean|1280|1280.0|Full Range|||9.0|5344.0|
4309012|NCT00492232|4136263|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4308902|NCT00492297|4136199|B1|>= 10 percent above the ULN||Lactate dehydrogenase|Tissue breakdown elevates levels of lactate dehydrogenase (LDH). LDH can be elevated in several disorders, including cancer.|participants|Number|26|26.0||||||
4308903|NCT00492297|4136199|B1|>= ULN but < 10 percent above ULN||Lactate dehydrogenase|Tissue breakdown elevates levels of lactate dehydrogenase (LDH). LDH can be elevated in several disorders, including cancer.|participants|Number|11|11.0||||||
4308904|NCT00492297|4136199|B1|< Upper Limit of Normal (ULN=325 U/L)||Lactate dehydrogenase|Tissue breakdown elevates levels of lactate dehydrogenase (LDH). LDH can be elevated in several disorders, including cancer.|participants|Number|43|43.0||||||
4308905|NCT00492297|4136199|B1|Missing||Lactate dehydrogenase|Tissue breakdown elevates levels of lactate dehydrogenase (LDH). LDH can be elevated in several disorders, including cancer.|participants|Number|3|3.0||||||
4308906|NCT00492297|4136199|B1|Acral lentiginous||Histology|Histologically confirmed melanoma was one of the inclusion criteria for enrollment into the study. This information was collected at the time of enrollment and included in the patient's record.|participants|Number|2|2.0||||||
4308907|NCT00492297|4136199|B1|Nodular||Histology|Histologically confirmed melanoma was one of the inclusion criteria for enrollment into the study. This information was collected at the time of enrollment and included in the patient's record.|participants|Number|29|29.0||||||
4308908|NCT00492297|4136199|B1|Superfical spreading||Histology|Histologically confirmed melanoma was one of the inclusion criteria for enrollment into the study. This information was collected at the time of enrollment and included in the patient's record.|participants|Number|24|24.0||||||
4308909|NCT00492297|4136199|B1|Malignant melanoma||Histology|Histologically confirmed melanoma was one of the inclusion criteria for enrollment into the study. This information was collected at the time of enrollment and included in the patient's record.|participants|Number|4|4.0||||||
4308910|NCT00492297|4136199|B1|Missing||Histology|Histologically confirmed melanoma was one of the inclusion criteria for enrollment into the study. This information was collected at the time of enrollment and included in the patient's record.|participants|Number|24|24.0||||||
4308911|NCT00492297|4136199|B1|1||ECOG status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. The scale ranges from 0 (fully active) to 5 (dead). Subjects entering this study must have had an ECOG score of 0 or 1 (restricted in physically strenuous activity but ambulatory).|participants|Number|28|28.0||||||
4308912|NCT00492297|4136199|B1|0||ECOG status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. The scale ranges from 0 (fully active) to 5 (dead). Subjects entering this study must have had an ECOG score of 0 or 1 (restricted in physically strenuous activity but ambulatory).|participants|Number|52|52.0||||||
4308913|NCT00492297|4136199|B1|Missing||ECOG status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. The scale ranges from 0 (fully active) to 5 (dead). Subjects entering this study must have had an ECOG score of 0 or 1 (restricted in physically strenuous activity but ambulatory).|participants|Number|3|3.0||||||
4308914|NCT00492297|4136199|B1|M1c All other visceral metastases||Disease stage (AJCC)|Disease stage according to the American Joint Committee on Cancer (AJCC) based on the TNM (tumor-node-metastasis) classification. Stage I and stage II (T2bN0M0-T4bN0M0) is localized disease, stage III (Any T1-4a, N1bM0-AnyTN3M0) is locally advanced disease and stage IV (Any T, Any N, Any M except M0) is metastatic disease.|participants|Number|66|66.0||||||
4308915|NCT00492297|4136199|B1|M1b Lung metastases||Disease stage (AJCC)|Disease stage according to the American Joint Committee on Cancer (AJCC) based on the TNM (tumor-node-metastasis) classification. Stage I and stage II (T2bN0M0-T4bN0M0) is localized disease, stage III (Any T1-4a, N1bM0-AnyTN3M0) is locally advanced disease and stage IV (Any T, Any N, Any M except M0) is metastatic disease.|participants|Number|12|12.0||||||
4308916|NCT00492297|4136199|B1|M1a Distant subcutaneous or lymphnode metastases||Disease stage (AJCC)|Disease stage according to the American Joint Committee on Cancer (AJCC) based on the TNM (tumor-node-metastasis) classification. Stage I and stage II (T2bN0M0-T4bN0M0) is localized disease, stage III (Any T1-4a, N1bM0-AnyTN3M0) is locally advanced disease and stage IV (Any T, Any N, Any M except M0) is metastatic disease.|participants|Number|4|4.0||||||
4308917|NCT00492297|4136199|B1|Missing||Disease stage (AJCC)|Disease stage according to the American Joint Committee on Cancer (AJCC) based on the TNM (tumor-node-metastasis) classification. Stage I and stage II (T2bN0M0-T4bN0M0) is localized disease, stage III (Any T1-4a, N1bM0-AnyTN3M0) is locally advanced disease and stage IV (Any T, Any N, Any M except M0) is metastatic disease.|participants|Number|1|1.0||||||
4308918|NCT00492297|4136199|B1|Progressive disease||Clinical disease status|Clinical disease status at the beginning of the study. Stable Disease (SD): No change in tumor size. Progressive Disease (PD): At least a 20% increase in the sum of the longest diameter (LD) of target lesions, taking as reference the smallest sum LD recorded since treatment started, or the appearance of 1 or more new lesions.|participants|Number|74|74.0||||||
4308919|NCT00492297|4136199|B1|Stable disease||Clinical disease status|Clinical disease status at the beginning of the study. Stable Disease (SD): No change in tumor size. Progressive Disease (PD): At least a 20% increase in the sum of the longest diameter (LD) of target lesions, taking as reference the smallest sum LD recorded since treatment started, or the appearance of 1 or more new lesions.|participants|Number|3|3.0||||||
4308920|NCT00492297|4136199|B1|Missing||Clinical disease status|Clinical disease status at the beginning of the study. Stable Disease (SD): No change in tumor size. Progressive Disease (PD): At least a 20% increase in the sum of the longest diameter (LD) of target lesions, taking as reference the smallest sum LD recorded since treatment started, or the appearance of 1 or more new lesions.|participants|Number|6|6.0||||||
4308921|NCT00492297|4136199|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4308922|NCT00492297|4136199|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4308923|NCT00492297|4136199|B1|||Age||years|Mean|53.5|53.5|Full Range|||25.0|78.0|
4308924|NCT00492284|4136213|B5|||Study Eye Best-corrected Visual Acuity Score (ETDRS chart)|Early Treatment Diabetic Retinopathy Study (ETDRS) method at 4 meters. Worst = 0; best = 100|Letters read on ETDRS chart|Mean|55.7|55.7|Standard Deviation|12.0|12.0|||
4308925|NCT00492284|4136214|B4|||Study Eye Best-corrected Visual Acuity Score (ETDRS chart)|Early Treatment Diabetic Retinopathy Study (ETDRS) method at 4 meters. Worst = 0; best = 100|Letters read on ETDRS chart|Mean|56.0|56.0|Standard Deviation|13.1|13.1|||
4308926|NCT00492284|4136215|B3|||Study Eye Best-corrected Visual Acuity Score (ETDRS chart)|Early Treatment Diabetic Retinopathy Study (ETDRS) method at 4 meters. Worst = 0; best = 100|Letters read on ETDRS chart|Mean|53.3|53.3|Standard Deviation|11.9|11.9|||
4308927|NCT00492284|4136216|B2|||Study Eye Best-corrected Visual Acuity Score (ETDRS chart)|Early Treatment Diabetic Retinopathy Study (ETDRS) method at 4 meters. Worst = 0; best = 100|Letters read on ETDRS chart|Mean|55.6|55.6|Standard Deviation|11.2|11.2|||
4308928|NCT00492284|4136217|B1|||Study Eye Best-corrected Visual Acuity Score (ETDRS chart)|Early Treatment Diabetic Retinopathy Study (ETDRS) method at 4 meters. Worst = 0; best = 100|Letters read on ETDRS chart|Mean|58.1|58.1|Standard Deviation|11.8|11.8|||
4308929|NCT00492284|4136213|B5|||Lesion size (greatest linear dimension)||micron|Mean|2860.1|2860.1|Standard Deviation|1049.4|1049.4|||
4308930|NCT00492284|4136214|B4|||Lesion size (greatest linear dimension)||micron|Mean|3118.4|3118.4|Standard Deviation|1155.7|1155.7|||
4308931|NCT00492284|4136215|B3|||Lesion size (greatest linear dimension)||micron|Mean|2796.1|2796.1|Standard Deviation|1122.8|1122.8|||
4308932|NCT00492284|4136216|B2|||Lesion size (greatest linear dimension)||micron|Mean|2740.1|2740.1|Standard Deviation|846.1|846.1|||
4308933|NCT00492284|4136217|B1|||Lesion size (greatest linear dimension)||micron|Mean|2778.8|2778.8|Standard Deviation|1025.6|1025.6|||
4308934|NCT00492284|4136213|B5|||Central retinal thickness||micron|Mean|326.3|326.3|Standard Deviation|105.4|105.4|||
4308935|NCT00492284|4136214|B4|||Central retinal thickness||micron|Mean|311.9|311.9|Standard Deviation|95.5|95.5|||
4308936|NCT00492284|4136215|B3|||Central retinal thickness||micron|Mean|337.3|337.3|Standard Deviation|121.4|121.4|||
4308937|NCT00492284|4136216|B2|||Central retinal thickness||micron|Mean|337.3|337.3|Standard Deviation|106.8|106.8|||
4308938|NCT00492284|4136217|B1|||Central retinal thickness||micron|Mean|318.3|318.3|Standard Deviation|95.9|95.9|||
4308939|NCT00492284|4136213|B5|Predominantly classic||Lesion composition||participants|Number|71|71.0||||||
4308940|NCT00492284|4136214|B4|Predominantly classic||Lesion composition||participants|Number|15|15.0||||||
4308941|NCT00492284|4136215|B3|Predominantly classic||Lesion composition||participants|Number|14|14.0||||||
4308942|NCT00492284|4136216|B2|Predominantly classic||Lesion composition||participants|Number|19|19.0||||||
4308943|NCT00492284|4136217|B1|Predominantly classic||Lesion composition||participants|Number|23|23.0||||||
4308944|NCT00492284|4136213|B5|Occult no classic||Lesion composition||participants|Number|64|64.0||||||
4308945|NCT00492284|4136214|B4|Occult no classic||Lesion composition||participants|Number|18|18.0||||||
4308946|NCT00492284|4136215|B3|Occult no classic||Lesion composition||participants|Number|20|20.0||||||
4308947|NCT00492284|4136216|B2|Occult no classic||Lesion composition||participants|Number|16|16.0||||||
4308948|NCT00492284|4136217|B1|Occult no classic||Lesion composition||participants|Number|10|10.0||||||
4308949|NCT00492284|4136213|B5|Minimally classic||Lesion composition||participants|Number|27|27.0||||||
4308950|NCT00492284|4136214|B4|Minimally classic||Lesion composition||participants|Number|8|8.0||||||
4308951|NCT00492284|4136215|B3|Minimally classic||Lesion composition||participants|Number|9|9.0||||||
4308952|NCT00492284|4136216|B2|Minimally classic||Lesion composition||participants|Number|4|4.0||||||
4308953|NCT00492284|4136217|B1|Minimally classic||Lesion composition||participants|Number|6|6.0||||||
4308954|NCT00492284|4136213|B5||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4308955|NCT00492284|4136214|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4308956|NCT00492284|4136215|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4308957|NCT00492284|4136216|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4308958|NCT00492284|4136217|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4308959|NCT00492284|4136213|B5||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4308960|NCT00492284|4136214|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4308961|NCT00492284|4136215|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4308962|NCT00492284|4136216|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4308963|NCT00492284|4136217|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4308964|NCT00492284|4136213|B5|||Age||years|Mean|79|79.0|Standard Deviation|7|7.0|||
4308965|NCT00492284|4136214|B4|||Age||years|Mean|79|79.0|Standard Deviation|5|5.0|||
4308966|NCT00492284|4136215|B3|||Age||years|Mean|79|79.0|Standard Deviation|6|6.0|||
4308967|NCT00492284|4136216|B2|||Age||years|Mean|78|78.0|Standard Deviation|8|8.0|||
4308968|NCT00492284|4136217|B1|||Age||years|Mean|78|78.0|Standard Deviation|8|8.0|||
4308969|NCT00492232|4136262|B3|||Weekly frequency zolpidem consumption|Average number of nights per week randomized subjects used zolpidem. Ramelteon 8 mg n=64; Placebo n=70.|nights per week|Mean|6.57|6.57|Standard Deviation|0.799|0.799|||
4308970|NCT00492232|4136263|B2|||Weekly frequency zolpidem consumption|Average number of nights per week randomized subjects used zolpidem. Ramelteon 8 mg n=64; Placebo n=70.|nights per week|Mean|6.60|6.6|Standard Deviation|0.769|0.769|||
4308971|NCT00492232|4136264|B1|||Weekly frequency zolpidem consumption|Average number of nights per week randomized subjects used zolpidem. Ramelteon 8 mg n=64; Placebo n=70.|nights per week|Mean|6.53|6.53|Standard Deviation|0.835|0.835|||
4308972|NCT00492232|4136262|B3|||Baseline weekly zolpidem dosage|Baseline for the weekly zolpidem dosage was calculated as the total amount zolpidem intake recorded by a subject during placebo run-in, divided by the number of days in the period, multiplied by 7. Ramelteon 8 mg n=64; Placebo n=70.|Dosage (mg)|Mean|69.5|69.5|Standard Deviation|19.09|19.09|||
4308973|NCT00492232|4136263|B2|||Baseline weekly zolpidem dosage|Baseline for the weekly zolpidem dosage was calculated as the total amount zolpidem intake recorded by a subject during placebo run-in, divided by the number of days in the period, multiplied by 7. Ramelteon 8 mg n=64; Placebo n=70.|Dosage (mg)|Mean|70.3|70.3|Standard Deviation|20.37|20.37|||
4309013|NCT00492232|4136264|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4308974|NCT00492232|4136264|B1|||Baseline weekly zolpidem dosage|Baseline for the weekly zolpidem dosage was calculated as the total amount zolpidem intake recorded by a subject during placebo run-in, divided by the number of days in the period, multiplied by 7. Ramelteon 8 mg n=64; Placebo n=70.|Dosage (mg)|Mean|68.7|68.7|Standard Deviation|17.71|17.71|||
4308975|NCT00492232|4136262|B3|Information not available||Weekly frequency zolpidem consumption|The average number of nights per week subjects took zolpidem was calculated.|subjects|Number|1|1.0||||||
4308976|NCT00492232|4136263|B2|Information not available||Weekly frequency zolpidem consumption|The average number of nights per week subjects took zolpidem was calculated.|subjects|Number|0|0.0||||||
4308977|NCT00492232|4136264|B1|Information not available||Weekly frequency zolpidem consumption|The average number of nights per week subjects took zolpidem was calculated.|subjects|Number|1|1.0||||||
4308978|NCT00492232|4136262|B3|7 nights per week||Weekly frequency zolpidem consumption|The average number of nights per week subjects took zolpidem was calculated.|subjects|Number|99|99.0||||||
4308979|NCT00492232|4136263|B2|7 nights per week||Weekly frequency zolpidem consumption|The average number of nights per week subjects took zolpidem was calculated.|subjects|Number|53|53.0||||||
4308980|NCT00492232|4136264|B1|7 nights per week||Weekly frequency zolpidem consumption|The average number of nights per week subjects took zolpidem was calculated.|subjects|Number|46|46.0||||||
4308981|NCT00492232|4136262|B3|6 nights per week||Weekly frequency zolpidem consumption|The average number of nights per week subjects took zolpidem was calculated.|subjects|Number|15|15.0||||||
4308982|NCT00492232|4136263|B2|6 nights per week||Weekly frequency zolpidem consumption|The average number of nights per week subjects took zolpidem was calculated.|subjects|Number|7|7.0||||||
4308983|NCT00492232|4136264|B1|6 nights per week||Weekly frequency zolpidem consumption|The average number of nights per week subjects took zolpidem was calculated.|subjects|Number|8|8.0||||||
4308984|NCT00492232|4136262|B3|5 nights per week||Weekly frequency zolpidem consumption|The average number of nights per week subjects took zolpidem was calculated.|subjects|Number|17|17.0||||||
4308985|NCT00492232|4136263|B2|5 nights per week||Weekly frequency zolpidem consumption|The average number of nights per week subjects took zolpidem was calculated.|subjects|Number|9|9.0||||||
4308986|NCT00492232|4136264|B1|5 nights per week||Weekly frequency zolpidem consumption|The average number of nights per week subjects took zolpidem was calculated.|subjects|Number|8|8.0||||||
4308987|NCT00492232|4136262|B3|4 nights per week||Weekly frequency zolpidem consumption|The average number of nights per week subjects took zolpidem was calculated.|subjects|Number|3|3.0||||||
4308988|NCT00492232|4136263|B2|4 nights per week||Weekly frequency zolpidem consumption|The average number of nights per week subjects took zolpidem was calculated.|subjects|Number|1|1.0||||||
4308989|NCT00492232|4136264|B1|4 nights per week||Weekly frequency zolpidem consumption|The average number of nights per week subjects took zolpidem was calculated.|subjects|Number|2|2.0||||||
4308990|NCT00492232|4136262|B3|0-3 nights per week||Weekly frequency zolpidem consumption|The average number of nights per week subjects took zolpidem was calculated.|subjects|Number|0|0.0||||||
4308991|NCT00492232|4136263|B2|0-3 nights per week||Weekly frequency zolpidem consumption|The average number of nights per week subjects took zolpidem was calculated.|subjects|Number|0|0.0||||||
4308992|NCT00492232|4136264|B1|0-3 nights per week||Weekly frequency zolpidem consumption|The average number of nights per week subjects took zolpidem was calculated.|subjects|Number|0|0.0||||||
4308993|NCT00492232|4136262|B3|>4 nights per week||Use of pharmacological assistance to sleep|"Randomized subjects responded to the question, How often per week do you use pharmacological assistance to sleep? 4=4 nights/week; >4=5-7 nights/week."|subjects|Number|118|118.0||||||
4308994|NCT00492232|4136263|B2|>4 nights per week||Use of pharmacological assistance to sleep|"Randomized subjects responded to the question, How often per week do you use pharmacological assistance to sleep? 4=4 nights/week; >4=5-7 nights/week."|subjects|Number|61|61.0||||||
4308995|NCT00492232|4136264|B1|>4 nights per week||Use of pharmacological assistance to sleep|"Randomized subjects responded to the question, How often per week do you use pharmacological assistance to sleep? 4=4 nights/week; >4=5-7 nights/week."|subjects|Number|57|57.0||||||
4308996|NCT00492232|4136262|B3|4 nights per week||Use of pharmacological assistance to sleep|"Randomized subjects responded to the question, How often per week do you use pharmacological assistance to sleep? 4=4 nights/week; >4=5-7 nights/week."|subjects|Number|17|17.0||||||
4308997|NCT00492232|4136263|B2|4 nights per week||Use of pharmacological assistance to sleep|"Randomized subjects responded to the question, How often per week do you use pharmacological assistance to sleep? 4=4 nights/week; >4=5-7 nights/week."|subjects|Number|9|9.0||||||
4308998|NCT00492232|4136264|B1|4 nights per week||Use of pharmacological assistance to sleep|"Randomized subjects responded to the question, How often per week do you use pharmacological assistance to sleep? 4=4 nights/week; >4=5-7 nights/week."|subjects|Number|8|8.0||||||
4308999|NCT00492232|4136262|B3|Information not available||Baseline average total daily zolpidem dosage||subjects|Number|1|1.0||||||
4309000|NCT00492232|4136263|B2|Information not available||Baseline average total daily zolpidem dosage||subjects|Number|0|0.0||||||
4309001|NCT00492232|4136264|B1|Information not available||Baseline average total daily zolpidem dosage||subjects|Number|1|1.0||||||
4309002|NCT00492232|4136262|B3|>10 mg||Baseline average total daily zolpidem dosage||subjects|Number|18|18.0||||||
4309003|NCT00492232|4136263|B2|>10 mg||Baseline average total daily zolpidem dosage||subjects|Number|10|10.0||||||
4309004|NCT00492232|4136264|B1|>10 mg||Baseline average total daily zolpidem dosage||subjects|Number|8|8.0||||||
4309005|NCT00492232|4136262|B3|≤10 mg||Baseline average total daily zolpidem dosage||subjects|Number|116|116.0||||||
4309006|NCT00492232|4136263|B2|≤10 mg||Baseline average total daily zolpidem dosage||subjects|Number|60|60.0||||||
4309007|NCT00492232|4136264|B1|≤10 mg||Baseline average total daily zolpidem dosage||subjects|Number|56|56.0||||||
4309008|NCT00492232|4136262|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0.0|0.0||||||
4309009|NCT00492232|4136263|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4309010|NCT00492232|4136264|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4309075|NCT00492063|4136327|B2||Male|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
4309014|NCT00492232|4136262|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19.0|19.0||||||
4309015|NCT00492232|4136263|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4309016|NCT00492232|4136264|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4309017|NCT00492232|4136262|B3|Multiracial||Race/Ethnicity, Customized||Subjects|Number|1.0|1.0||||||
4309018|NCT00492232|4136263|B2|Multiracial||Race/Ethnicity, Customized||Subjects|Number|1|1.0||||||
4309019|NCT00492232|4136264|B1|Multiracial||Race/Ethnicity, Customized||Subjects|Number|0|0.0||||||
4309020|NCT00492232|4136262|B3|White||Race/Ethnicity, Customized||Subjects|Number|118.0|118.0||||||
4309021|NCT00492232|4136263|B2|White||Race/Ethnicity, Customized||Subjects|Number|59|59.0||||||
4309022|NCT00492232|4136264|B1|White||Race/Ethnicity, Customized||Subjects|Number|59|59.0||||||
4309023|NCT00492232|4136262|B3|Black or African American||Race/Ethnicity, Customized||Subjects|Number|14.0|14.0||||||
4309024|NCT00492232|4136263|B2|Black or African American||Race/Ethnicity, Customized||Subjects|Number|9|9.0||||||
4309025|NCT00492232|4136264|B1|Black or African American||Race/Ethnicity, Customized||Subjects|Number|5|5.0||||||
4309026|NCT00492232|4136262|B3|Asian||Race/Ethnicity, Customized||Subjects|Number|2.0|2.0||||||
4309027|NCT00492232|4136263|B2|Asian||Race/Ethnicity, Customized||Subjects|Number|1|1.0||||||
4309028|NCT00492232|4136264|B1|Asian||Race/Ethnicity, Customized||Subjects|Number|1|1.0||||||
4309029|NCT00492232|4136262|B3||Male|Sex: Female, Male||Participants|Count of Participants|44.0|44.0||||||
4309030|NCT00492232|4136263|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4309031|NCT00492232|4136264|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4309032|NCT00492232|4136262|B3||Female|Sex: Female, Male||Participants|Count of Participants|91.0|91.0||||||
4309033|NCT00492232|4136263|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4309034|NCT00492232|4136264|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4309035|NCT00492232|4136262|B3|||Age||years|Mean|49.2|49.2|Standard Deviation|13.35|13.35|||
4309036|NCT00492232|4136263|B2|||Age||years|Mean|47.0|47.0|Standard Deviation|12.98|12.98|||
4309037|NCT00492232|4136264|B1|||Age||years|Mean|51.5|51.5|Standard Deviation|13.45|13.45|||
4309038|NCT00492206|4136297|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4309039|NCT00492206|4136297|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4309040|NCT00492206|4136297|B1||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4309041|NCT00492206|4136297|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4309042|NCT00492206|4136297|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4309043|NCT00492206|4136297|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4309044|NCT00492206|4136297|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4309045|NCT00492206|4136297|B1||Male|Gender||Participants|Count of Participants|26|26.0||||||
4309046|NCT00492206|4136297|B1||Female|Gender||Participants|Count of Participants|14|14.0||||||
4309047|NCT00492206|4136297|B1|||Age|Age greater than or equal to 18 years of age|years|Median|67|67.0|Full Range|||40.0|82.0|
4309048|NCT00492115|4136304|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
4309049|NCT00492115|4136305|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4309050|NCT00492115|4136306|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4309051|NCT00492115|4136304|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4309052|NCT00492115|4136305|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4309053|NCT00492115|4136306|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4309054|NCT00492115|4136304|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4309055|NCT00492115|4136305|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4309056|NCT00492115|4136306|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4309057|NCT00492115|4136304|B3|||Age||years|Mean|67.2|67.2|Standard Deviation|9.3|9.3|||
4309058|NCT00492115|4136305|B2|||Age||years|Mean|67.7|67.7|Standard Deviation|10.0|10.0|||
4309059|NCT00492115|4136306|B1|||Age||years|Mean|66.7|66.7|Standard Deviation|8.5|8.5|||
4309060|NCT00492089|4136315|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4309061|NCT00492089|4136316|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4309062|NCT00492089|4136317|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4309063|NCT00492089|4136315|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4309064|NCT00492089|4136316|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4309065|NCT00492089|4136317|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4309066|NCT00492089|4136315|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4309067|NCT00492089|4136316|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4309068|NCT00492089|4136317|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4309069|NCT00492089|4136315|B3|||Age||years|Mean|47|47.0|Full Range|||39.0|70.0|
4309070|NCT00492089|4136316|B2|||Age||years|Mean|47|47.0|Full Range|||39.0|70.0|
4309071|NCT00492089|4136317|B1|||Age||years|Mean|43|43.0|Full Range|||39.0|59.0|
4309072|NCT00492063|4136324|B5||Male|Sex: Female, Male||Participants|Count of Participants|1143|1143.0||||||
4309073|NCT00492063|4136325|B4||Male|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
4309074|NCT00492063|4136326|B3||Male|Sex: Female, Male||Participants|Count of Participants|289|289.0||||||
4309076|NCT00492063|4136328|B1||Male|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
4309077|NCT00492063|4136324|B5||Female|Sex: Female, Male||Participants|Count of Participants|1511|1511.0||||||
4309078|NCT00492063|4136325|B4||Female|Sex: Female, Male||Participants|Count of Participants|375|375.0||||||
4309079|NCT00492063|4136326|B3||Female|Sex: Female, Male||Participants|Count of Participants|389|389.0||||||
4309080|NCT00492063|4136327|B2||Female|Sex: Female, Male||Participants|Count of Participants|371|371.0||||||
4309081|NCT00492063|4136328|B1||Female|Sex: Female, Male||Participants|Count of Participants|376|376.0||||||
4309082|NCT00492063|4136324|B5|||Age||Years|Mean|54.0|54.0|Standard Deviation|18.2|18.2|||
4309083|NCT00492063|4136325|B4|||Age||Years|Mean|68.8|68.8|Standard Deviation|5.6|5.6|||
4309084|NCT00492063|4136326|B3|||Age||Years|Mean|69.1|69.1|Standard Deviation|5.7|5.7|||
4309085|NCT00492063|4136327|B2|||Age||Years|Mean|38.3|38.3|Standard Deviation|13.3|13.3|||
4309086|NCT00492063|4136328|B1|||Age||Years|Mean|38.7|38.7|Standard Deviation|12.7|12.7|||
4309087|NCT00492024|4136353|B3|||Duration of infection|Subgroup analyses were performed on subjects with differing durations of infection of 7 to 14 days, 15 to 21 days, and 22 to 27 days.|days|Mean|13.0|13.0|Standard Deviation|5.1|5.1|||
4309088|NCT00492024|4136354|B2|||Duration of infection|Subgroup analyses were performed on subjects with differing durations of infection of 7 to 14 days, 15 to 21 days, and 22 to 27 days.|days|Mean|12.7|12.7|Standard Deviation|4.7|4.7|||
4309089|NCT00492024|4136355|B1|||Duration of infection|Subgroup analyses were performed on subjects with differing durations of infection of 7 to 14 days, 15 to 21 days, and 22 to 27 days.|days|Mean|13.2|13.2|Standard Deviation|5.4|5.4|||
4309090|NCT00492024|4136353|B3|Mild||Severity of infection|Severity of infection as asessed by the investigator|participants|Number|10|10.0||||||
4309091|NCT00492024|4136354|B2|Mild||Severity of infection|Severity of infection as asessed by the investigator|participants|Number|2|2.0||||||
4309092|NCT00492024|4136355|B1|Mild||Severity of infection|Severity of infection as asessed by the investigator|participants|Number|8|8.0||||||
4309093|NCT00492024|4136353|B3|Severe||Severity of infection|Severity of infection as asessed by the investigator|participants|Number|139|139.0||||||
4309094|NCT00492024|4136354|B2|Severe||Severity of infection|Severity of infection as asessed by the investigator|participants|Number|49|49.0||||||
4309095|NCT00492024|4136355|B1|Severe||Severity of infection|Severity of infection as asessed by the investigator|participants|Number|90|90.0||||||
4309096|NCT00492024|4136353|B3|Moderate||Severity of infection|Severity of infection as asessed by the investigator|participants|Number|225|225.0||||||
4309097|NCT00492024|4136354|B2|Moderate||Severity of infection|Severity of infection as asessed by the investigator|participants|Number|72|72.0||||||
4309098|NCT00492024|4136355|B1|Moderate||Severity of infection|Severity of infection as asessed by the investigator|participants|Number|153|153.0||||||
4309099|NCT00492024|4136353|B3|Bilateral||Location of infection|Location of sinus infection, left, right, or bilateral|participants|Number|115|115.0||||||
4309100|NCT00492024|4136354|B2|Bilateral||Location of infection|Location of sinus infection, left, right, or bilateral|participants|Number|40|40.0||||||
4309101|NCT00492024|4136355|B1|Bilateral||Location of infection|Location of sinus infection, left, right, or bilateral|participants|Number|75|75.0||||||
4309102|NCT00492024|4136353|B3|Right||Location of infection|Location of sinus infection, left, right, or bilateral|participants|Number|140|140.0||||||
4309103|NCT00492024|4136354|B2|Right||Location of infection|Location of sinus infection, left, right, or bilateral|participants|Number|46|46.0||||||
4309104|NCT00492024|4136355|B1|Right||Location of infection|Location of sinus infection, left, right, or bilateral|participants|Number|94|94.0||||||
4309105|NCT00492024|4136353|B3|Left||Location of infection|Location of sinus infection, left, right, or bilateral|participants|Number|119|119.0||||||
4309106|NCT00492024|4136354|B2|Left||Location of infection|Location of sinus infection, left, right, or bilateral|participants|Number|37|37.0||||||
4309107|NCT00492024|4136355|B1|Left||Location of infection|Location of sinus infection, left, right, or bilateral|participants|Number|82|82.0||||||
4309108|NCT00492024|4136353|B3|No pathogene growth||Causative Organisms Isolated from Pretreatment Specimens at Study Entry|Causative organisms identified by pre-therapy sinus puncture (more than one organism was identified for some patients)|participants|Number|154|154.0||||||
4309109|NCT00492024|4136354|B2|No pathogene growth||Causative Organisms Isolated from Pretreatment Specimens at Study Entry|Causative organisms identified by pre-therapy sinus puncture (more than one organism was identified for some patients)|participants|Number|45|45.0||||||
4309110|NCT00492024|4136355|B1|No pathogene growth||Causative Organisms Isolated from Pretreatment Specimens at Study Entry|Causative organisms identified by pre-therapy sinus puncture (more than one organism was identified for some patients)|participants|Number|109|109.0||||||
4309111|NCT00492024|4136353|B3|Non causative pathogene||Causative Organisms Isolated from Pretreatment Specimens at Study Entry|Causative organisms identified by pre-therapy sinus puncture (more than one organism was identified for some patients)|participants|Number|98|98.0||||||
4309112|NCT00492024|4136354|B2|Non causative pathogene||Causative Organisms Isolated from Pretreatment Specimens at Study Entry|Causative organisms identified by pre-therapy sinus puncture (more than one organism was identified for some patients)|participants|Number|32|32.0||||||
4309113|NCT00492024|4136355|B1|Non causative pathogene||Causative Organisms Isolated from Pretreatment Specimens at Study Entry|Causative organisms identified by pre-therapy sinus puncture (more than one organism was identified for some patients)|participants|Number|66|66.0||||||
4309114|NCT00492024|4136353|B3|Staphylococcus aureus||Causative Organisms Isolated from Pretreatment Specimens at Study Entry|Causative organisms identified by pre-therapy sinus puncture (more than one organism was identified for some patients)|participants|Number|16|16.0||||||
4309115|NCT00492024|4136354|B2|Staphylococcus aureus||Causative Organisms Isolated from Pretreatment Specimens at Study Entry|Causative organisms identified by pre-therapy sinus puncture (more than one organism was identified for some patients)|participants|Number|5|5.0||||||
4309160|NCT00491829|4136382|B2|Germany||Region of Enrollment||participants|Number|54|54.0||||||
4309161|NCT00491829|4136383|B1|Germany||Region of Enrollment||participants|Number|56|56.0||||||
4309116|NCT00492024|4136355|B1|Staphylococcus aureus||Causative Organisms Isolated from Pretreatment Specimens at Study Entry|Causative organisms identified by pre-therapy sinus puncture (more than one organism was identified for some patients)|participants|Number|11|11.0||||||
4309117|NCT00492024|4136353|B3|Streptococcus pyogenes||Causative Organisms Isolated from Pretreatment Specimens at Study Entry|Causative organisms identified by pre-therapy sinus puncture (more than one organism was identified for some patients)|participants|Number|4|4.0||||||
4309118|NCT00492024|4136354|B2|Streptococcus pyogenes||Causative Organisms Isolated from Pretreatment Specimens at Study Entry|Causative organisms identified by pre-therapy sinus puncture (more than one organism was identified for some patients)|participants|Number|2|2.0||||||
4309119|NCT00492024|4136355|B1|Streptococcus pyogenes||Causative Organisms Isolated from Pretreatment Specimens at Study Entry|Causative organisms identified by pre-therapy sinus puncture (more than one organism was identified for some patients)|participants|Number|2|2.0||||||
4309120|NCT00492024|4136353|B3|Haemophilus influenzae||Causative Organisms Isolated from Pretreatment Specimens at Study Entry|Causative organisms identified by pre-therapy sinus puncture (more than one organism was identified for some patients)|participants|Number|43|43.0||||||
4309121|NCT00492024|4136354|B2|Haemophilus influenzae||Causative Organisms Isolated from Pretreatment Specimens at Study Entry|Causative organisms identified by pre-therapy sinus puncture (more than one organism was identified for some patients)|participants|Number|15|15.0||||||
4309122|NCT00492024|4136355|B1|Haemophilus influenzae||Causative Organisms Isolated from Pretreatment Specimens at Study Entry|Causative organisms identified by pre-therapy sinus puncture (more than one organism was identified for some patients)|participants|Number|28|28.0||||||
4309123|NCT00492024|4136353|B3|Moraxella catarrhalis||Causative Organisms Isolated from Pretreatment Specimens at Study Entry|Causative organisms identified by pre-therapy sinus puncture (more than one organism was identified for some patients)|participants|Number|19|19.0||||||
4309124|NCT00492024|4136354|B2|Moraxella catarrhalis||Causative Organisms Isolated from Pretreatment Specimens at Study Entry|Causative organisms identified by pre-therapy sinus puncture (more than one organism was identified for some patients)|participants|Number|12|12.0||||||
4309125|NCT00492024|4136355|B1|Moraxella catarrhalis||Causative Organisms Isolated from Pretreatment Specimens at Study Entry|Causative organisms identified by pre-therapy sinus puncture (more than one organism was identified for some patients)|participants|Number|7|7.0||||||
4309126|NCT00492024|4136353|B3|Streptococcus pneumoniae||Causative Organisms Isolated from Pretreatment Specimens at Study Entry|Causative organisms identified by pre-therapy sinus puncture (more than one organism was identified for some patients)|participants|Number|45|45.0||||||
4309127|NCT00492024|4136354|B2|Streptococcus pneumoniae||Causative Organisms Isolated from Pretreatment Specimens at Study Entry|Causative organisms identified by pre-therapy sinus puncture (more than one organism was identified for some patients)|participants|Number|13|13.0||||||
4309128|NCT00492024|4136355|B1|Streptococcus pneumoniae||Causative Organisms Isolated from Pretreatment Specimens at Study Entry|Causative organisms identified by pre-therapy sinus puncture (more than one organism was identified for some patients)|participants|Number|32|32.0||||||
4309129|NCT00492024|4136353|B3||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4309130|NCT00492024|4136354|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4309131|NCT00492024|4136355|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4309132|NCT00492024|4136353|B3||Female|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4309133|NCT00492024|4136354|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4309134|NCT00492024|4136355|B1||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4309135|NCT00492024|4136353|B3|||Age||years|Mean|40.2|40.2|Standard Deviation|13.5|13.5|||
4309136|NCT00492024|4136354|B2|||Age||years|Mean|40.3|40.3|Standard Deviation|13.0|13.0|||
4309137|NCT00492024|4136355|B1|||Age||years|Mean|40.1|40.1|Standard Deviation|13.8|13.8|||
4309138|NCT00491894|4136372|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4309139|NCT00491894|4136372|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4309140|NCT00491894|4136372|B1||White|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
4309141|NCT00491894|4136372|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4309142|NCT00491894|4136372|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4309143|NCT00491894|4136372|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4309144|NCT00491894|4136372|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4309145|NCT00491894|4136372|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4309146|NCT00491894|4136372|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|121|121.0||||||
4309147|NCT00491894|4136372|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4309148|NCT00491894|4136372|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4309149|NCT00491894|4136372|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4309150|NCT00491894|4136372|B1|||Age||years|Mean|11.0|11.0|Standard Deviation|4.35|4.35|||
4309151|NCT00491894|4136372|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4309152|NCT00491894|4136372|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4309153|NCT00491894|4136372|B1||<=18 years|Age||Participants|Count of Participants|137|137.0||||||
4309154|NCT00491829|4136380|B4|Sweden||Region of Enrollment||participants|Number|116|116.0||||||
4309155|NCT00491829|4136381|B3|Sweden||Region of Enrollment||participants|Number|40|40.0||||||
4309156|NCT00491829|4136382|B2|Sweden||Region of Enrollment||participants|Number|37|37.0||||||
4309157|NCT00491829|4136383|B1|Sweden||Region of Enrollment||participants|Number|39|39.0||||||
4309158|NCT00491829|4136380|B4|Germany||Region of Enrollment||participants|Number|165|165.0||||||
4309159|NCT00491829|4136381|B3|Germany||Region of Enrollment||participants|Number|55|55.0||||||
4309162|NCT00491829|4136380|B4|Norway||Region of Enrollment||participants|Number|34|34.0||||||
4309163|NCT00491829|4136381|B3|Norway||Region of Enrollment||participants|Number|10|10.0||||||
4309164|NCT00491829|4136382|B2|Norway||Region of Enrollment||participants|Number|13|13.0||||||
4309165|NCT00491829|4136383|B1|Norway||Region of Enrollment||participants|Number|11|11.0||||||
4309166|NCT00491829|4136380|B4|Netherlands||Region of Enrollment||participants|Number|96|96.0||||||
4309167|NCT00491829|4136381|B3|Netherlands||Region of Enrollment||participants|Number|34|34.0||||||
4309168|NCT00491829|4136382|B2|Netherlands||Region of Enrollment||participants|Number|32|32.0||||||
4309169|NCT00491829|4136383|B1|Netherlands||Region of Enrollment||participants|Number|30|30.0||||||
4309170|NCT00491829|4136380|B4|Belgium||Region of Enrollment||participants|Number|82|82.0||||||
4309171|NCT00491829|4136381|B3|Belgium||Region of Enrollment||participants|Number|28|28.0||||||
4309172|NCT00491829|4136382|B2|Belgium||Region of Enrollment||participants|Number|27|27.0||||||
4309173|NCT00491829|4136383|B1|Belgium||Region of Enrollment||participants|Number|27|27.0||||||
4309174|NCT00491829|4136380|B4|Czech Republic||Region of Enrollment||participants|Number|63|63.0||||||
4309175|NCT00491829|4136381|B3|Czech Republic||Region of Enrollment||participants|Number|21|21.0||||||
4309176|NCT00491829|4136382|B2|Czech Republic||Region of Enrollment||participants|Number|20|20.0||||||
4309177|NCT00491829|4136383|B1|Czech Republic||Region of Enrollment||participants|Number|22|22.0||||||
4309178|NCT00491829|4136380|B4|Hungary||Region of Enrollment||participants|Number|55|55.0||||||
4309179|NCT00491829|4136381|B3|Hungary||Region of Enrollment||participants|Number|18|18.0||||||
4309180|NCT00491829|4136382|B2|Hungary||Region of Enrollment||participants|Number|18|18.0||||||
4309181|NCT00491829|4136383|B1|Hungary||Region of Enrollment||participants|Number|19|19.0||||||
4309182|NCT00491829|4136380|B4|France||Region of Enrollment||participants|Number|82|82.0||||||
4309183|NCT00491829|4136381|B3|France||Region of Enrollment||participants|Number|28|28.0||||||
4309184|NCT00491829|4136382|B2|France||Region of Enrollment||participants|Number|27|27.0||||||
4309185|NCT00491829|4136383|B1|France||Region of Enrollment||participants|Number|27|27.0||||||
4309186|NCT00491829|4136380|B4|United Kingdom||Region of Enrollment||participants|Number|100|100.0||||||
4309187|NCT00491829|4136381|B3|United Kingdom||Region of Enrollment||participants|Number|35|35.0||||||
4309188|NCT00491829|4136382|B2|United Kingdom||Region of Enrollment||participants|Number|34|34.0||||||
4309189|NCT00491829|4136383|B1|United Kingdom||Region of Enrollment||participants|Number|31|31.0||||||
4309190|NCT00491829|4136380|B4|Italy||Region of Enrollment||participants|Number|29|29.0||||||
4309191|NCT00491829|4136381|B3|Italy||Region of Enrollment||participants|Number|10|10.0||||||
4309192|NCT00491829|4136382|B2|Italy||Region of Enrollment||participants|Number|9|9.0||||||
4309193|NCT00491829|4136383|B1|Italy||Region of Enrollment||participants|Number|10|10.0||||||
4309194|NCT00491829|4136380|B4|Austria||Region of Enrollment||participants|Number|55|55.0||||||
4309195|NCT00491829|4136381|B3|Austria||Region of Enrollment||participants|Number|19|19.0||||||
4309196|NCT00491829|4136382|B2|Austria||Region of Enrollment||participants|Number|20|20.0||||||
4309197|NCT00491829|4136383|B1|Austria||Region of Enrollment||participants|Number|16|16.0||||||
4309198|NCT00491829|4136380|B4|Spain||Region of Enrollment||participants|Number|15|15.0||||||
4309199|NCT00491829|4136381|B3|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4309200|NCT00491829|4136382|B2|Spain||Region of Enrollment||participants|Number|8|8.0||||||
4309201|NCT00491829|4136383|B1|Spain||Region of Enrollment||participants|Number|5|5.0||||||
4309202|NCT00491829|4136380|B4|Finland||Region of Enrollment||participants|Number|53|53.0||||||
4309203|NCT00491829|4136381|B3|Finland||Region of Enrollment||participants|Number|18|18.0||||||
4309204|NCT00491829|4136382|B2|Finland||Region of Enrollment||participants|Number|17|17.0||||||
4309205|NCT00491829|4136383|B1|Finland||Region of Enrollment||participants|Number|18|18.0||||||
4309206|NCT00491829|4136380|B4|Missing||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
4309207|NCT00491829|4136381|B3|Missing||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4309208|NCT00491829|4136382|B2|Missing||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4309209|NCT00491829|4136383|B1|Missing||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4309210|NCT00491829|4136380|B4|Asian Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4309211|NCT00491829|4136381|B3|Asian Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4309212|NCT00491829|4136382|B2|Asian Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4309213|NCT00491829|4136383|B1|Asian Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4309214|NCT00491829|4136380|B4|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4309215|NCT00491829|4136381|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4309216|NCT00491829|4136382|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4309217|NCT00491829|4136383|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4309218|NCT00491829|4136380|B4|Black Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4309219|NCT00491829|4136381|B3|Black Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4309220|NCT00491829|4136382|B2|Black Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4309221|NCT00491829|4136383|B1|Black Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4309222|NCT00491829|4136380|B4|Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4309223|NCT00491829|4136381|B3|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4309224|NCT00491829|4136382|B2|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4309225|NCT00491829|4136383|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4309226|NCT00491829|4136380|B4|White Hispanic||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4309227|NCT00491829|4136381|B3|White Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4309228|NCT00491829|4136382|B2|White Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4309229|NCT00491829|4136383|B1|White Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4309230|NCT00491829|4136380|B4|White||Race/Ethnicity, Customized||participants|Number|843|843.0||||||
4309231|NCT00491829|4136381|B3|White||Race/Ethnicity, Customized||participants|Number|286|286.0||||||
4309232|NCT00491829|4136382|B2|White||Race/Ethnicity, Customized||participants|Number|281|281.0||||||
4309233|NCT00491829|4136383|B1|White||Race/Ethnicity, Customized||participants|Number|276|276.0||||||
4309234|NCT00491829|4136380|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4309235|NCT00491829|4136381|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4309236|NCT00491829|4136382|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4309237|NCT00491829|4136383|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4309238|NCT00491829|4136380|B4||Female|Sex: Female, Male||Participants|Count of Participants|945|945.0||||||
4309239|NCT00491829|4136381|B3||Female|Sex: Female, Male||Participants|Count of Participants|318|318.0||||||
4309240|NCT00491829|4136382|B2||Female|Sex: Female, Male||Participants|Count of Participants|316|316.0||||||
4309241|NCT00491829|4136383|B1||Female|Sex: Female, Male||Participants|Count of Participants|311|311.0||||||
4309242|NCT00491829|4136380|B4|45 years and older||Age, Customized||participants|Number|87|87.0||||||
4309243|NCT00491829|4136381|B3|45 years and older||Age, Customized||participants|Number|23|23.0||||||
4309244|NCT00491829|4136382|B2|45 years and older||Age, Customized||participants|Number|31|31.0||||||
4309245|NCT00491829|4136383|B1|45 years and older||Age, Customized||participants|Number|33|33.0||||||
4309246|NCT00491829|4136380|B4|35-44 years||Age, Customized||participants|Number|437|437.0||||||
4309247|NCT00491829|4136381|B3|35-44 years||Age, Customized||participants|Number|147|147.0||||||
4309248|NCT00491829|4136382|B2|35-44 years||Age, Customized||participants|Number|157|157.0||||||
4309249|NCT00491829|4136383|B1|35-44 years||Age, Customized||participants|Number|133|133.0||||||
4309250|NCT00491829|4136380|B4|18-34 years||Age, Customized||participants|Number|421|421.0||||||
4309251|NCT00491829|4136381|B3|18-34 years||Age, Customized||participants|Number|148|148.0||||||
4309252|NCT00491829|4136382|B2|18-34 years||Age, Customized||participants|Number|128|128.0||||||
4309253|NCT00491829|4136383|B1|18-34 years||Age, Customized||participants|Number|145|145.0||||||
4309254|NCT00491764|4136393|B7||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4309255|NCT00491764|4136394|B6||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4309256|NCT00491764|4136395|B5||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4309257|NCT00491764|4136396|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4309258|NCT00491764|4136397|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4309259|NCT00491764|4136398|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4309260|NCT00491764|4136399|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4309261|NCT00491764|4136393|B7||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4309262|NCT00491764|4136394|B6||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4309263|NCT00491764|4136395|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4309264|NCT00491764|4136396|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4309265|NCT00491764|4136397|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4309266|NCT00491764|4136398|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4309267|NCT00491764|4136399|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4309268|NCT00491764|4136393|B7|||Age||years|Mean|50.8|50.8|Standard Deviation|12.7|12.7|||
4309269|NCT00491764|4136394|B6|||Age||years|Mean|48.4|48.4|Standard Deviation|14.8|14.8|||
4309270|NCT00491764|4136395|B5|||Age||years|Mean|50.1|50.1|Standard Deviation|12.2|12.2|||
4309271|NCT00491764|4136396|B4|||Age||years|Mean|53.5|53.5|Standard Deviation|11.8|11.8|||
4309272|NCT00491764|4136397|B3|||Age||years|Mean|49.9|49.9|Standard Deviation|13.2|13.2|||
4309273|NCT00491764|4136398|B2|||Age||years|Mean|53.6|53.6|Standard Deviation|10.8|10.8|||
4309274|NCT00491764|4136399|B1|||Age||years|Mean|49.0|49.0|Standard Deviation|13.0|13.0|||
4309275|NCT00491751|4136430|B4|United States||Region of Enrollment||participants|Number|108|108.0||||||
4309276|NCT00491751|4136431|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4309277|NCT00491751|4136432|B2|United States||Region of Enrollment||participants|Number|44|44.0||||||
4309278|NCT00491751|4136433|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4309279|NCT00491751|4136430|B4||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4309280|NCT00491751|4136431|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4309281|NCT00491751|4136432|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4309282|NCT00491751|4136433|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4309283|NCT00491751|4136430|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4309284|NCT00491751|4136431|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4309285|NCT00491751|4136432|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4309286|NCT00491751|4136433|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4309287|NCT00491751|4136430|B4|||Age||years|Mean|66|66.0|Standard Deviation|9|9.0|||
4309288|NCT00491751|4136431|B3|||Age||years|Mean|65|65.0|Standard Deviation|9|9.0|||
4309289|NCT00491751|4136432|B2|||Age||years|Mean|66|66.0|Standard Deviation|8|8.0|||
4309290|NCT00491751|4136433|B1|||Age||years|Mean|68|68.0|Standard Deviation|11|11.0|||
4309291|NCT00491751|4136430|B4||>=65 years|Age||Participants|Count of Participants|54|54.0||||||
4309292|NCT00491751|4136431|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4309293|NCT00491751|4136432|B2||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4309294|NCT00491751|4136433|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4309295|NCT00491751|4136430|B4||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4309296|NCT00491751|4136431|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4309297|NCT00491751|4136432|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4309298|NCT00491751|4136433|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4309299|NCT00491751|4136430|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309300|NCT00491751|4136431|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309301|NCT00491751|4136432|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309302|NCT00491751|4136433|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309303|NCT00491738|4136445|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4309304|NCT00491738|4136446|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4309305|NCT00491738|4136447|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4309306|NCT00491738|4136445|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4309307|NCT00491738|4136446|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4309308|NCT00491738|4136447|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4309309|NCT00491738|4136445|B3|||Age||years|Mean|59.4|59.4|Standard Deviation|9.1|9.1|||
4309310|NCT00491738|4136446|B2|||Age||years|Mean|58.7|58.7|Standard Deviation|7.0|7.0|||
4309311|NCT00491738|4136447|B1|||Age||years|Mean|60.4|60.4|Standard Deviation|11.8|11.8|||
4309312|NCT00491738|4136445|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4309313|NCT00491738|4136446|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4309314|NCT00491738|4136447|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4309315|NCT00491738|4136445|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4309316|NCT00491738|4136446|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4309317|NCT00491738|4136447|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4309318|NCT00491738|4136445|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309319|NCT00491738|4136446|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309320|NCT00491738|4136447|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309321|NCT00491608|4136452|B1|White||Race/Ethnicity, Customized||participants|Number|160|160.0||||||
4309322|NCT00491608|4136452|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4309323|NCT00491608|4136452|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4309324|NCT00491608|4136452|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4309325|NCT00491608|4136452|B1||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4309326|NCT00491608|4136452|B1||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4309327|NCT00491608|4136452|B1|Overall (All status)||Age, Customized||Years|Median|64|64.0|Full Range|||30.0|89.0|
4309328|NCT00491556|4136461|B3|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
4309329|NCT00491556|4136462|B2|Puerto Rico||Region of Enrollment||participants|Number|0|0.0||||||
4309330|NCT00491556|4136463|B1|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
4309331|NCT00491556|4136461|B3|United States||Region of Enrollment||participants|Number|99|99.0||||||
4309332|NCT00491556|4136462|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4309333|NCT00491556|4136463|B1|United States||Region of Enrollment||participants|Number|72|72.0||||||
4309334|NCT00491556|4136461|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4309335|NCT00491556|4136462|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4309336|NCT00491556|4136463|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4309337|NCT00491556|4136461|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4309338|NCT00491556|4136462|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4309339|NCT00491556|4136463|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4309340|NCT00491556|4136461|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4309341|NCT00491556|4136462|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4309342|NCT00491556|4136463|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4309343|NCT00491556|4136461|B3|Black non-Hispanic||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
4309344|NCT00491556|4136462|B2|Black non-Hispanic||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4309345|NCT00491556|4136463|B1|Black non-Hispanic||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4309346|NCT00491556|4136461|B3|White non-Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4309347|NCT00491556|4136462|B2|White non-Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4309348|NCT00491556|4136463|B1|White non-Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4309349|NCT00491556|4136461|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4309350|NCT00491556|4136462|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4309351|NCT00491556|4136463|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4309352|NCT00491556|4136461|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4309353|NCT00491556|4136462|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4309354|NCT00491556|4136463|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4309355|NCT00491556|4136461|B3|21-24 years||Age, Customized||participants|Number|59|59.0||||||
4309356|NCT00491556|4136462|B2|21-24 years||Age, Customized||participants|Number|17|17.0||||||
4309357|NCT00491556|4136463|B1|21-24 years||Age, Customized||participants|Number|42|42.0||||||
4309358|NCT00491556|4136461|B3|18-20 years||Age, Customized||participants|Number|41|41.0||||||
4309359|NCT00491556|4136462|B2|18-20 years||Age, Customized||participants|Number|10|10.0||||||
4309360|NCT00491556|4136463|B1|18-20 years||Age, Customized||participants|Number|31|31.0||||||
4309361|NCT00491530|4136520|B4|United States||Region of Enrollment||participants|Number|310|310.0||||||
4309362|NCT00491530|4136521|B3|United States||Region of Enrollment||participants|Number|86|86.0||||||
4309363|NCT00491530|4136522|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
4309364|NCT00491530|4136523|B1|United States||Region of Enrollment||participants|Number|174|174.0||||||
4309365|NCT00491530|4136520|B4||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4309366|NCT00491530|4136521|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4309367|NCT00491530|4136522|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4309368|NCT00491530|4136523|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4309369|NCT00491530|4136520|B4||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4309370|NCT00491530|4136521|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4309371|NCT00491530|4136522|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4309372|NCT00491530|4136523|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4309373|NCT00491530|4136520|B4|||Age||years|Mean|55.8|55.8|Standard Deviation|10.72|10.72|||
4309374|NCT00491530|4136521|B3|||Age||years|Mean|55.4|55.4|Standard Deviation|10.94|10.94|||
4309375|NCT00491530|4136522|B2|||Age||years|Mean|55.3|55.3|Standard Deviation|10.55|10.55|||
4309376|NCT00491530|4136523|B1|||Age||years|Mean|56.1|56.1|Standard Deviation|10.71|10.71|||
4309377|NCT00491530|4136520|B4||>=65 years|Age||Participants|Count of Participants|64|64.0||||||
4309378|NCT00491530|4136521|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4309379|NCT00491530|4136522|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4309380|NCT00491530|4136523|B1||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4309381|NCT00491530|4136520|B4||Between 18 and 65 years|Age||Participants|Count of Participants|246|246.0||||||
4309382|NCT00491530|4136521|B3||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
4309383|NCT00491530|4136522|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4309384|NCT00491530|4136523|B1||Between 18 and 65 years|Age||Participants|Count of Participants|138|138.0||||||
4309385|NCT00491530|4136520|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309386|NCT00491530|4136521|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309387|NCT00491530|4136522|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309388|NCT00491530|4136523|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309389|NCT00491504|4136551|B5||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4309390|NCT00491504|4136552|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4309391|NCT00491504|4136553|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4309392|NCT00491504|4136554|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4309393|NCT00491504|4136555|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4309394|NCT00491504|4136551|B5||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4309395|NCT00491504|4136552|B4||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4309396|NCT00491504|4136553|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4309397|NCT00491504|4136554|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4309398|NCT00491504|4136555|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4309399|NCT00491504|4136551|B5|||Age||years|Mean|37.6|37.6|Standard Deviation|10.6|10.6|||
4309400|NCT00491504|4136552|B4|||Age||years|Mean|38.9|38.9|Standard Deviation|11.2|11.2|||
4309401|NCT00491504|4136553|B3|||Age||years|Mean|36.9|36.9|Standard Deviation|10.2|10.2|||
4309402|NCT00491504|4136554|B2|||Age||years|Mean|36.3|36.3|Standard Deviation|10.1|10.1|||
4309403|NCT00491504|4136555|B1|||Age||years|Mean|38.3|38.3|Standard Deviation|11.1|11.1|||
4309404|NCT00491400|4136566|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
4309405|NCT00491400|4136567|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4309406|NCT00491400|4136568|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4309407|NCT00491400|4136566|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4309408|NCT00491400|4136567|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4309409|NCT00491400|4136568|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4309410|NCT00491400|4136566|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4309411|NCT00491400|4136567|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4309412|NCT00491400|4136568|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4309413|NCT00491400|4136566|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4309414|NCT00491400|4136567|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4309415|NCT00491400|4136568|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4309416|NCT00491400|4136566|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4309417|NCT00491400|4136567|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4309418|NCT00491400|4136568|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4309419|NCT00491400|4136566|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309420|NCT00491400|4136567|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309421|NCT00491400|4136568|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309422|NCT00491387|4136577|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4309423|NCT00491387|4136577|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4309424|NCT00491387|4136577|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4309425|NCT00491387|4136577|B1|||Age||years|Mean|48|48.0|Standard Deviation|11|11.0|||
4309426|NCT00491387|4136577|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4309427|NCT00491387|4136577|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4309428|NCT00491387|4136577|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309429|NCT00491374|4136581|B3|Either Sex||Sex/Gender, Customized||participants|Number|0|0.0||||||
4309430|NCT00491374|4136582|B2|Either Sex||Sex/Gender, Customized||participants|Number|0|0.0||||||
4309431|NCT00491374|4136583|B1|Either Sex||Sex/Gender, Customized||participants|Number|0|0.0||||||
4309432|NCT00491374|4136581|B3|Any Age||Age, Customized||participants|Number|0|0.0||||||
4309433|NCT00491374|4136582|B2|Any Age||Age, Customized||participants|Number|0|0.0||||||
4309434|NCT00491374|4136583|B1|Any Age||Age, Customized||participants|Number|0|0.0||||||
4309435|NCT00491322|4136590|B3|United States||Region of Enrollment||participants|Number|90|90.0||||||
4309436|NCT00491322|4136591|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
4309437|NCT00491322|4136592|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4309438|NCT00491322|4136590|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4309439|NCT00491322|4136591|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4309440|NCT00491322|4136592|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4309441|NCT00491322|4136590|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4309442|NCT00491322|4136591|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4309443|NCT00491322|4136592|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4309444|NCT00491322|4136590|B3|||Age||years|Mean|28|28.0|Standard Deviation|8|8.0|||
4309445|NCT00491322|4136591|B2|||Age||years|Mean|29|29.0|Standard Deviation|9|9.0|||
4309446|NCT00491322|4136592|B1|||Age||years|Mean|28|28.0|Standard Deviation|7|7.0|||
4309447|NCT00491322|4136590|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4309448|NCT00491322|4136591|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4309449|NCT00491322|4136592|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4309450|NCT00491322|4136590|B3||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
4309451|NCT00491322|4136591|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4309452|NCT00491322|4136592|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4309453|NCT00491322|4136590|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309454|NCT00491322|4136591|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309455|NCT00491322|4136592|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309456|NCT00491244|4136599|B3|Taiwan||Region of Enrollment||participants|Number|377|377.0||||||
4309457|NCT00491244|4136600|B2|Taiwan||Region of Enrollment||participants|Number|188|188.0||||||
4309458|NCT00491244|4136601|B1|Taiwan||Region of Enrollment||participants|Number|189|189.0||||||
4309459|NCT00491244|4136599|B3||Male|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
4309460|NCT00491244|4136600|B2||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4309461|NCT00491244|4136601|B1||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4309462|NCT00491244|4136599|B3||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4309463|NCT00491244|4136600|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4309464|NCT00491244|4136601|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4309465|NCT00491244|4136599|B3|||Age||years|Mean|51|51.0|Standard Deviation|10|10.0|||
4309466|NCT00491244|4136600|B2|||Age||years|Mean|51|51.0|Standard Deviation|11|11.0|||
4309467|NCT00491244|4136601|B1|||Age||years|Mean|51|51.0|Standard Deviation|10|10.0|||
4309468|NCT00491244|4136599|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4309469|NCT00491244|4136600|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4309470|NCT00491244|4136601|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4309471|NCT00491244|4136599|B3||Between 18 and 65 years|Age||Participants|Count of Participants|377|377.0||||||
4309472|NCT00491244|4136600|B2||Between 18 and 65 years|Age||Participants|Count of Participants|188|188.0||||||
4309473|NCT00491244|4136601|B1||Between 18 and 65 years|Age||Participants|Count of Participants|189|189.0||||||
4309474|NCT00491244|4136599|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309475|NCT00491244|4136600|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309476|NCT00491244|4136601|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309477|NCT00491179|4136610|B3|Taiwan||Region of Enrollment||participants|Number|35|35.0||||||
4309478|NCT00491179|4136611|B2|Taiwan||Region of Enrollment||participants|Number|10|10.0||||||
4309479|NCT00491179|4136612|B1|Taiwan||Region of Enrollment||participants|Number|25|25.0||||||
4309480|NCT00491179|4136610|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4309481|NCT00491179|4136611|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4309482|NCT00491179|4136612|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4309483|NCT00491179|4136610|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4309484|NCT00491179|4136611|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4309485|NCT00491179|4136612|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4309486|NCT00491179|4136610|B3|||Age||years|Mean|47|47.0|Standard Deviation|10|10.0|||
4309487|NCT00491179|4136611|B2|||Age||years|Mean|44|44.0|Standard Deviation|12|12.0|||
4309488|NCT00491179|4136612|B1|||Age||years|Mean|48|48.0|Standard Deviation|8|8.0|||
4309489|NCT00491179|4136610|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4309490|NCT00491179|4136611|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4309491|NCT00491179|4136612|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4309492|NCT00491179|4136610|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4309493|NCT00491179|4136611|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4309494|NCT00491179|4136612|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4309495|NCT00491179|4136610|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309496|NCT00491179|4136611|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309497|NCT00491179|4136612|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309498|NCT00491075|4136621|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4309499|NCT00491075|4136621|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4309500|NCT00491075|4136621|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4309501|NCT00491075|4136621|B1|||Age||years|Mean|54|54.0|Standard Deviation|12.99|12.99|||
4309502|NCT00491075|4136621|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4309503|NCT00491075|4136621|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4309504|NCT00491075|4136621|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309505|NCT00490971|4136625|B3|<18||AgeCategorical||participants|Number|0|0.0||||||
4309506|NCT00490971|4136626|B2|<18||AgeCategorical||participants|Number|0|0.0||||||
4309507|NCT00490971|4136627|B1|<18||AgeCategorical||participants|Number|0|0.0||||||
4309508|NCT00490971|4136625|B3|>65||AgeCategorical||participants|Number|0|0.0||||||
4309509|NCT00490971|4136626|B2|>65||AgeCategorical||participants|Number|0|0.0||||||
4309510|NCT00490971|4136627|B1|>65||AgeCategorical||participants|Number|0|0.0||||||
4309511|NCT00490971|4136625|B3|51-65||AgeCategorical||participants|Number|165|165.0||||||
4309512|NCT00490971|4136626|B2|51-65||AgeCategorical||participants|Number|27|27.0||||||
4309513|NCT00490971|4136627|B1|51-65||AgeCategorical||participants|Number|138|138.0||||||
4309514|NCT00490971|4136625|B3|26-50||AgeCategorical||participants|Number|474|474.0||||||
4309515|NCT00490971|4136626|B2|26-50||AgeCategorical||participants|Number|96|96.0||||||
4309516|NCT00490971|4136627|B1|26-50||AgeCategorical||participants|Number|378|378.0||||||
4309517|NCT00490971|4136625|B3|18-25||AgeCategorical||participants|Number|123|123.0||||||
4309518|NCT00490971|4136626|B2|18-25||AgeCategorical||participants|Number|25|25.0||||||
4309519|NCT00490971|4136627|B1|18-25||AgeCategorical||participants|Number|98|98.0||||||
4309520|NCT00490971|4136625|B3|United States||Region of Enrollment||participants|Number|218|218.0||||||
4309521|NCT00490971|4136626|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
4309522|NCT00490971|4136627|B1|United States||Region of Enrollment||participants|Number|177|177.0||||||
4309523|NCT00490971|4136625|B3|Turkey||Region of Enrollment||participants|Number|22|22.0||||||
4309524|NCT00490971|4136626|B2|Turkey||Region of Enrollment||participants|Number|4|4.0||||||
4309525|NCT00490971|4136627|B1|Turkey||Region of Enrollment||participants|Number|18|18.0||||||
4309526|NCT00490971|4136625|B3|Tunisia||Region of Enrollment||participants|Number|14|14.0||||||
4309527|NCT00490971|4136626|B2|Tunisia||Region of Enrollment||participants|Number|4|4.0||||||
4309528|NCT00490971|4136627|B1|Tunisia||Region of Enrollment||participants|Number|10|10.0||||||
4309529|NCT00490971|4136625|B3|South Africa||Region of Enrollment||participants|Number|32|32.0||||||
4309530|NCT00490971|4136626|B2|South Africa||Region of Enrollment||participants|Number|6|6.0||||||
4309531|NCT00490971|4136627|B1|South Africa||Region of Enrollment||participants|Number|26|26.0||||||
4309532|NCT00490971|4136625|B3|Panama||Region of Enrollment||participants|Number|4|4.0||||||
4309533|NCT00490971|4136626|B2|Panama||Region of Enrollment||participants|Number|1|1.0||||||
4309534|NCT00490971|4136627|B1|Panama||Region of Enrollment||participants|Number|3|3.0||||||
4309535|NCT00490971|4136625|B3|Morocco||Region of Enrollment||participants|Number|8|8.0||||||
4309536|NCT00490971|4136626|B2|Morocco||Region of Enrollment||participants|Number|2|2.0||||||
4309537|NCT00490971|4136627|B1|Morocco||Region of Enrollment||participants|Number|6|6.0||||||
4309538|NCT00490971|4136625|B3|Costa Rica||Region of Enrollment||participants|Number|16|16.0||||||
4309539|NCT00490971|4136626|B2|Costa Rica||Region of Enrollment||participants|Number|4|4.0||||||
4309540|NCT00490971|4136627|B1|Costa Rica||Region of Enrollment||participants|Number|12|12.0||||||
4309541|NCT00490971|4136625|B3|Romania||Region of Enrollment||participants|Number|27|27.0||||||
4309542|NCT00490971|4136626|B2|Romania||Region of Enrollment||participants|Number|5|5.0||||||
4309543|NCT00490971|4136627|B1|Romania||Region of Enrollment||participants|Number|22|22.0||||||
4309544|NCT00490971|4136625|B3|Poland||Region of Enrollment||participants|Number|21|21.0||||||
4309545|NCT00490971|4136626|B2|Poland||Region of Enrollment||participants|Number|5|5.0||||||
4309546|NCT00490971|4136627|B1|Poland||Region of Enrollment||participants|Number|16|16.0||||||
4309547|NCT00490971|4136625|B3|Germany||Region of Enrollment||participants|Number|9|9.0||||||
4309548|NCT00490971|4136626|B2|Germany||Region of Enrollment||participants|Number|3|3.0||||||
4309549|NCT00490971|4136627|B1|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4309550|NCT00490971|4136625|B3|Bulgaria||Region of Enrollment||participants|Number|33|33.0||||||
4309551|NCT00490971|4136626|B2|Bulgaria||Region of Enrollment||participants|Number|6|6.0||||||
4309552|NCT00490971|4136627|B1|Bulgaria||Region of Enrollment||participants|Number|27|27.0||||||
4309553|NCT00490971|4136625|B3|Ukraine||Region of Enrollment||participants|Number|58|58.0||||||
4309554|NCT00490971|4136626|B2|Ukraine||Region of Enrollment||participants|Number|12|12.0||||||
4309555|NCT00490971|4136627|B1|Ukraine||Region of Enrollment||participants|Number|46|46.0||||||
4309556|NCT00490971|4136625|B3|Serbia||Region of Enrollment||participants|Number|40|40.0||||||
4309557|NCT00490971|4136626|B2|Serbia||Region of Enrollment||participants|Number|8|8.0||||||
4309558|NCT00490971|4136627|B1|Serbia||Region of Enrollment||participants|Number|32|32.0||||||
4309559|NCT00490971|4136625|B3|Russian Federation||Region of Enrollment||participants|Number|62|62.0||||||
4309560|NCT00490971|4136626|B2|Russian Federation||Region of Enrollment||participants|Number|11|11.0||||||
4309561|NCT00490971|4136627|B1|Russian Federation||Region of Enrollment||participants|Number|51|51.0||||||
4309562|NCT00490971|4136625|B3|China||Region of Enrollment||participants|Number|106|106.0||||||
4309563|NCT00490971|4136626|B2|China||Region of Enrollment||participants|Number|20|20.0||||||
4309564|NCT00490971|4136627|B1|China||Region of Enrollment||participants|Number|86|86.0||||||
4309565|NCT00490971|4136625|B3|Malaysia||Region of Enrollment||participants|Number|9|9.0||||||
4309566|NCT00490971|4136626|B2|Malaysia||Region of Enrollment||participants|Number|2|2.0||||||
4309567|NCT00490971|4136627|B1|Malaysia||Region of Enrollment||participants|Number|7|7.0||||||
4309568|NCT00490971|4136625|B3|India||Region of Enrollment||participants|Number|83|83.0||||||
4309569|NCT00490971|4136626|B2|India||Region of Enrollment||participants|Number|14|14.0||||||
4309570|NCT00490971|4136627|B1|India||Region of Enrollment||participants|Number|69|69.0||||||
4309571|NCT00490971|4136625|B3|Other||Region of Enrollment||participants|Number|96|96.0||||||
4309572|NCT00490971|4136626|B2|Other||Region of Enrollment||participants|Number|21|21.0||||||
4309573|NCT00490971|4136627|B1|Other||Region of Enrollment||participants|Number|75|75.0||||||
4309574|NCT00490971|4136625|B3|North America||Region of Enrollment||participants|Number|218|218.0||||||
4309575|NCT00490971|4136626|B2|North America||Region of Enrollment||participants|Number|41|41.0||||||
4309576|NCT00490971|4136627|B1|North America||Region of Enrollment||participants|Number|177|177.0||||||
4309577|NCT00490971|4136625|B3|European Union||Region of Enrollment||participants|Number|90|90.0||||||
4309578|NCT00490971|4136626|B2|European Union||Region of Enrollment||participants|Number|19|19.0||||||
4309579|NCT00490971|4136627|B1|European Union||Region of Enrollment||participants|Number|71|71.0||||||
4309580|NCT00490971|4136625|B3|Eastern Europe||Region of Enrollment||participants|Number|160|160.0||||||
4309581|NCT00490971|4136626|B2|Eastern Europe||Region of Enrollment||participants|Number|31|31.0||||||
4309582|NCT00490971|4136627|B1|Eastern Europe||Region of Enrollment||participants|Number|129|129.0||||||
4309583|NCT00490971|4136625|B3|Asia||Region of Enrollment||participants|Number|198|198.0||||||
4309584|NCT00490971|4136626|B2|Asia||Region of Enrollment||participants|Number|36|36.0||||||
4309585|NCT00490971|4136627|B1|Asia||Region of Enrollment||participants|Number|162|162.0||||||
4309586|NCT00490971|4136625|B3||Male|Sex: Female, Male||Participants|Count of Participants|372|372.0||||||
4309587|NCT00490971|4136626|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4309588|NCT00490971|4136627|B1||Male|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
4309589|NCT00490971|4136625|B3||Female|Sex: Female, Male||Participants|Count of Participants|390|390.0||||||
4309590|NCT00490971|4136626|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4309591|NCT00490971|4136627|B1||Female|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
4309592|NCT00490971|4136625|B3|||Age||years|Mean|39.6|39.6|Standard Deviation|11.84|11.84|||
4309593|NCT00490971|4136626|B2|||Age||years|Mean|39.2|39.2|Standard Deviation|11.49|11.49|||
4309594|NCT00490971|4136627|B1|||Age||years|Mean|39.7|39.7|Standard Deviation|11.93|11.93|||
4309595|NCT00490971|4136625|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4309596|NCT00490971|4136626|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4309597|NCT00490971|4136627|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4309598|NCT00490971|4136625|B3||Between 18 and 65 years|Age||Participants|Count of Participants|751|751.0||||||
4309599|NCT00490971|4136626|B2||Between 18 and 65 years|Age||Participants|Count of Participants|145|145.0||||||
4309600|NCT00490971|4136627|B1||Between 18 and 65 years|Age||Participants|Count of Participants|606|606.0||||||
4309601|NCT00490971|4136625|B3||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4309602|NCT00490971|4136626|B2||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4309603|NCT00490971|4136627|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4309604|NCT00490945|4136673|B6||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4309605|NCT00490945|4136674|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4309606|NCT00490945|4136675|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4309607|NCT00490945|4136676|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4309608|NCT00490945|4136677|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4309609|NCT00490945|4136678|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4309610|NCT00490945|4136673|B6||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4309611|NCT00490945|4136674|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4309612|NCT00490945|4136675|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4309613|NCT00490945|4136676|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4309614|NCT00490945|4136677|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4309615|NCT00490945|4136678|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4309616|NCT00490945|4136673|B6|||Age||years|Mean|30.0|30.0|Standard Deviation|7.9|7.9|||
4309617|NCT00490945|4136674|B5|||Age||years|Mean|30.4|30.4|Standard Deviation|9.5|9.5|||
4309618|NCT00490945|4136675|B4|||Age||years|Mean|27.4|27.4|Standard Deviation|6.2|6.2|||
4309619|NCT00490945|4136676|B3|||Age||years|Mean|32.5|32.5|Standard Deviation|9.6|9.6|||
4309620|NCT00490945|4136677|B2|||Age||years|Mean|31.8|31.8|Standard Deviation|7.4|7.4|||
4309621|NCT00490945|4136678|B1|||Age||years|Mean|27.5|27.5|Standard Deviation|6.7|6.7|||
4309622|NCT00490919|4136716|B3||Male|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
4309623|NCT00490919|4136717|B2||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4309624|NCT00490919|4136718|B1||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4309625|NCT00490919|4136716|B3||Female|Sex: Female, Male||Participants|Count of Participants|296|296.0||||||
4309626|NCT00490919|4136717|B2||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4309627|NCT00490919|4136718|B1||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4309628|NCT00490919|4136716|B3|||Age||years|Mean|49.5|49.5|Standard Deviation|12.93|12.93|||
4309629|NCT00490919|4136717|B2|||Age||years|Mean|50.1|50.1|Standard Deviation|13.31|13.31|||
4309630|NCT00490919|4136718|B1|||Age||years|Mean|48.9|48.9|Standard Deviation|12.50|12.5|||
4309631|NCT00490841|4136731|B1|United States||Region of Enrollment||participants|Number|202|202.0||||||
4309632|NCT00490841|4136731|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4309633|NCT00490841|4136731|B1||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4309634|NCT00490841|4136731|B1|||Age||years|Mean|72.1|72.1|Standard Deviation|9.4|9.4|||
4309635|NCT00490841|4136731|B1||>=65 years|Age||Participants|Count of Participants|163|163.0||||||
4309636|NCT00490841|4136731|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4309637|NCT00490841|4136731|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309638|NCT00490815|4136751|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
4309639|NCT00490815|4136752|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4309640|NCT00490815|4136753|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4309641|NCT00490815|4136751|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4309642|NCT00490815|4136752|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4309643|NCT00490815|4136753|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4309644|NCT00490815|4136751|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4309645|NCT00490815|4136752|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4309646|NCT00490815|4136753|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4309647|NCT00490815|4136751|B3|||Age||years|Mean|66.9|66.9|Standard Deviation|9.7|9.7|||
4309648|NCT00490815|4136752|B2|||Age||years|Mean|67.4|67.4|Standard Deviation|10.3|10.3|||
4309649|NCT00490815|4136753|B1|||Age||years|Mean|66.6|66.6|Standard Deviation|9.4|9.4|||
4309650|NCT00490815|4136751|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4309651|NCT00490815|4136752|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4309652|NCT00490815|4136753|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4309653|NCT00490815|4136751|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4309654|NCT00490815|4136752|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4309655|NCT00490815|4136753|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4309656|NCT00490815|4136751|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309657|NCT00490815|4136752|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309658|NCT00490815|4136753|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309659|NCT00490802|4136762|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4309660|NCT00490802|4136763|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4309661|NCT00490802|4136764|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4309662|NCT00490802|4136762|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4309663|NCT00490802|4136763|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4309664|NCT00490802|4136764|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4309665|NCT00490802|4136762|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4309666|NCT00490802|4136763|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4309667|NCT00490802|4136764|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4309668|NCT00490802|4136762|B3|||Age||years|Mean|33.2|33.2|Standard Deviation|13.3|13.3|||
4309669|NCT00490802|4136763|B2|||Age||years|Mean|32.9|32.9|Standard Deviation|14.4|14.4|||
4309670|NCT00490802|4136764|B1|||Age||years|Mean|33.8|33.8|Standard Deviation|12.7|12.7|||
4309671|NCT00490802|4136762|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4309672|NCT00490802|4136763|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4309673|NCT00490802|4136764|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4309674|NCT00490802|4136762|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4309675|NCT00490802|4136763|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4309676|NCT00490802|4136764|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4309677|NCT00490802|4136762|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309678|NCT00490802|4136763|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309679|NCT00490802|4136764|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309680|NCT00490724|4136779|B4||Male|Sex: Female, Male|The PPS included all participants who met the principal criteria for eligibility, received at least 1 dose of study medication and had 1 efficacy assessment after randomization except those participants who had significant protocol deviations.|Participants|Count of Participants|35|35.0||||||
4309681|NCT00490724|4136780|B3||Male|Sex: Female, Male|The PPS included all participants who met the principal criteria for eligibility, received at least 1 dose of study medication and had 1 efficacy assessment after randomization except those participants who had significant protocol deviations.|Participants|Count of Participants|10|10.0||||||
4309682|NCT00490724|4136781|B2||Male|Sex: Female, Male|The PPS included all participants who met the principal criteria for eligibility, received at least 1 dose of study medication and had 1 efficacy assessment after randomization except those participants who had significant protocol deviations.|Participants|Count of Participants|14|14.0||||||
4309683|NCT00490724|4136782|B1||Male|Sex: Female, Male|The PPS included all participants who met the principal criteria for eligibility, received at least 1 dose of study medication and had 1 efficacy assessment after randomization except those participants who had significant protocol deviations.|Participants|Count of Participants|11|11.0||||||
4309684|NCT00490724|4136779|B4||Female|Sex: Female, Male|The PPS included all participants who met the principal criteria for eligibility, received at least 1 dose of study medication and had 1 efficacy assessment after randomization except those participants who had significant protocol deviations.|Participants|Count of Participants|21|21.0||||||
4309685|NCT00490724|4136780|B3||Female|Sex: Female, Male|The PPS included all participants who met the principal criteria for eligibility, received at least 1 dose of study medication and had 1 efficacy assessment after randomization except those participants who had significant protocol deviations.|Participants|Count of Participants|7|7.0||||||
4309686|NCT00490724|4136781|B2||Female|Sex: Female, Male|The PPS included all participants who met the principal criteria for eligibility, received at least 1 dose of study medication and had 1 efficacy assessment after randomization except those participants who had significant protocol deviations.|Participants|Count of Participants|6|6.0||||||
4309687|NCT00490724|4136782|B1||Female|Sex: Female, Male|The PPS included all participants who met the principal criteria for eligibility, received at least 1 dose of study medication and had 1 efficacy assessment after randomization except those participants who had significant protocol deviations.|Participants|Count of Participants|8|8.0||||||
4309688|NCT00490724|4136779|B4|||Age|Baseline characteristics were analysed for the per protocol set (PPS). The PPS included all participants who met the principal criteria for eligibility, received at least 1 dose of study medication and had 1 efficacy assessment after randomization except those participants who had significant protocol deviations.|Years|Mean|67.9|67.9|Standard Deviation|13.2|13.2|||
4309689|NCT00490724|4136780|B3|||Age|Baseline characteristics were analysed for the per protocol set (PPS). The PPS included all participants who met the principal criteria for eligibility, received at least 1 dose of study medication and had 1 efficacy assessment after randomization except those participants who had significant protocol deviations.|Years|Mean|64.9|64.9|Standard Deviation|11.6|11.6|||
4309690|NCT00490724|4136781|B2|||Age|Baseline characteristics were analysed for the per protocol set (PPS). The PPS included all participants who met the principal criteria for eligibility, received at least 1 dose of study medication and had 1 efficacy assessment after randomization except those participants who had significant protocol deviations.|Years|Mean|67.5|67.5|Standard Deviation|13.5|13.5|||
4309691|NCT00490724|4136782|B1|||Age|Baseline characteristics were analysed for the per protocol set (PPS). The PPS included all participants who met the principal criteria for eligibility, received at least 1 dose of study medication and had 1 efficacy assessment after randomization except those participants who had significant protocol deviations.|Years|Mean|71.1|71.1|Standard Deviation|14.1|14.1|||
4309692|NCT00490698|4136849|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4309693|NCT00490698|4136849|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4309694|NCT00490698|4136849|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4309695|NCT00490698|4136849|B1|||Age||years|Median|56.6|56.6|Full Range|||42.0|71.0|
4309696|NCT00490646|4136853|B3|||Number of participants who received prior chemotherapy in neoadjuvant/adjuvant setting||participants|Number|16|16.0||||||
4309697|NCT00490646|4136854|B2|||Number of participants who received prior chemotherapy in neoadjuvant/adjuvant setting||participants|Number|8|8.0||||||
4309698|NCT00490646|4136855|B1|||Number of participants who received prior chemotherapy in neoadjuvant/adjuvant setting||participants|Number|8|8.0||||||
4309699|NCT00490646|4136853|B3|Not Reported||Menopausal Status||participants|Number|4|4.0||||||
4309700|NCT00490646|4136854|B2|Not Reported||Menopausal Status||participants|Number|2|2.0||||||
4309701|NCT00490646|4136855|B1|Not Reported||Menopausal Status||participants|Number|2|2.0||||||
4309702|NCT00490646|4136853|B3|Post-menopausal||Menopausal Status||participants|Number|29|29.0||||||
4309703|NCT00490646|4136854|B2|Post-menopausal||Menopausal Status||participants|Number|15|15.0||||||
4309704|NCT00490646|4136855|B1|Post-menopausal||Menopausal Status||participants|Number|14|14.0||||||
4309705|NCT00490646|4136853|B3|Peri-menopausal||Menopausal Status||participants|Number|3|3.0||||||
4309706|NCT00490646|4136854|B2|Peri-menopausal||Menopausal Status||participants|Number|2|2.0||||||
4309707|NCT00490646|4136855|B1|Peri-menopausal||Menopausal Status||participants|Number|1|1.0||||||
4309708|NCT00490646|4136853|B3|Pre-menopausal||Menopausal Status||participants|Number|14|14.0||||||
4309709|NCT00490646|4136854|B2|Pre-menopausal||Menopausal Status||participants|Number|6|6.0||||||
4309710|NCT00490646|4136855|B1|Pre-menopausal||Menopausal Status||participants|Number|8|8.0||||||
4309711|NCT00490646|4136853|B3|Not Reported||Karnofsky Performance Status|"Karnofsky Performance Status classifies participants according to their functional impairment. Scores range from 0-100 units on a scale; lower the score, the worse the survival for most serious illnesses.~100: Normal, no complaints. 90: Able to carry on normal activities; minor signs or symptoms of disease. 80: Normal activity with effort. 70: Cares for self. Unable to carry on normal activity or to do active work. Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) Scores were converted to Karnofsky Performance Status Scores."|participants|Number|1|1.0||||||
4309712|NCT00490646|4136854|B2|Not Reported||Karnofsky Performance Status|"Karnofsky Performance Status classifies participants according to their functional impairment. Scores range from 0-100 units on a scale; lower the score, the worse the survival for most serious illnesses.~100: Normal, no complaints. 90: Able to carry on normal activities; minor signs or symptoms of disease. 80: Normal activity with effort. 70: Cares for self. Unable to carry on normal activity or to do active work. Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) Scores were converted to Karnofsky Performance Status Scores."|participants|Number|1|1.0||||||
4309713|NCT00490646|4136855|B1|Not Reported||Karnofsky Performance Status|"Karnofsky Performance Status classifies participants according to their functional impairment. Scores range from 0-100 units on a scale; lower the score, the worse the survival for most serious illnesses.~100: Normal, no complaints. 90: Able to carry on normal activities; minor signs or symptoms of disease. 80: Normal activity with effort. 70: Cares for self. Unable to carry on normal activity or to do active work. Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) Scores were converted to Karnofsky Performance Status Scores."|participants|Number|0|0.0||||||
4309714|NCT00490646|4136853|B3|70||Karnofsky Performance Status|"Karnofsky Performance Status classifies participants according to their functional impairment. Scores range from 0-100 units on a scale; lower the score, the worse the survival for most serious illnesses.~100: Normal, no complaints. 90: Able to carry on normal activities; minor signs or symptoms of disease. 80: Normal activity with effort. 70: Cares for self. Unable to carry on normal activity or to do active work. Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) Scores were converted to Karnofsky Performance Status Scores."|participants|Number|1|1.0||||||
4309715|NCT00490646|4136854|B2|70||Karnofsky Performance Status|"Karnofsky Performance Status classifies participants according to their functional impairment. Scores range from 0-100 units on a scale; lower the score, the worse the survival for most serious illnesses.~100: Normal, no complaints. 90: Able to carry on normal activities; minor signs or symptoms of disease. 80: Normal activity with effort. 70: Cares for self. Unable to carry on normal activity or to do active work. Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) Scores were converted to Karnofsky Performance Status Scores."|participants|Number|0|0.0||||||
4309716|NCT00490646|4136855|B1|70||Karnofsky Performance Status|"Karnofsky Performance Status classifies participants according to their functional impairment. Scores range from 0-100 units on a scale; lower the score, the worse the survival for most serious illnesses.~100: Normal, no complaints. 90: Able to carry on normal activities; minor signs or symptoms of disease. 80: Normal activity with effort. 70: Cares for self. Unable to carry on normal activity or to do active work. Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) Scores were converted to Karnofsky Performance Status Scores."|participants|Number|1|1.0||||||
4309717|NCT00490646|4136853|B3|80||Karnofsky Performance Status|"Karnofsky Performance Status classifies participants according to their functional impairment. Scores range from 0-100 units on a scale; lower the score, the worse the survival for most serious illnesses.~100: Normal, no complaints. 90: Able to carry on normal activities; minor signs or symptoms of disease. 80: Normal activity with effort. 70: Cares for self. Unable to carry on normal activity or to do active work. Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) Scores were converted to Karnofsky Performance Status Scores."|participants|Number|4|4.0||||||
4309718|NCT00490646|4136854|B2|80||Karnofsky Performance Status|"Karnofsky Performance Status classifies participants according to their functional impairment. Scores range from 0-100 units on a scale; lower the score, the worse the survival for most serious illnesses.~100: Normal, no complaints. 90: Able to carry on normal activities; minor signs or symptoms of disease. 80: Normal activity with effort. 70: Cares for self. Unable to carry on normal activity or to do active work. Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) Scores were converted to Karnofsky Performance Status Scores."|participants|Number|0|0.0||||||
4309719|NCT00490646|4136855|B1|80||Karnofsky Performance Status|"Karnofsky Performance Status classifies participants according to their functional impairment. Scores range from 0-100 units on a scale; lower the score, the worse the survival for most serious illnesses.~100: Normal, no complaints. 90: Able to carry on normal activities; minor signs or symptoms of disease. 80: Normal activity with effort. 70: Cares for self. Unable to carry on normal activity or to do active work. Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) Scores were converted to Karnofsky Performance Status Scores."|participants|Number|4|4.0||||||
4309720|NCT00490646|4136853|B3|90||Karnofsky Performance Status|"Karnofsky Performance Status classifies participants according to their functional impairment. Scores range from 0-100 units on a scale; lower the score, the worse the survival for most serious illnesses.~100: Normal, no complaints. 90: Able to carry on normal activities; minor signs or symptoms of disease. 80: Normal activity with effort. 70: Cares for self. Unable to carry on normal activity or to do active work. Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) Scores were converted to Karnofsky Performance Status Scores."|participants|Number|14|14.0||||||
4309721|NCT00490646|4136854|B2|90||Karnofsky Performance Status|"Karnofsky Performance Status classifies participants according to their functional impairment. Scores range from 0-100 units on a scale; lower the score, the worse the survival for most serious illnesses.~100: Normal, no complaints. 90: Able to carry on normal activities; minor signs or symptoms of disease. 80: Normal activity with effort. 70: Cares for self. Unable to carry on normal activity or to do active work. Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) Scores were converted to Karnofsky Performance Status Scores."|participants|Number|9|9.0||||||
4309722|NCT00490646|4136855|B1|90||Karnofsky Performance Status|"Karnofsky Performance Status classifies participants according to their functional impairment. Scores range from 0-100 units on a scale; lower the score, the worse the survival for most serious illnesses.~100: Normal, no complaints. 90: Able to carry on normal activities; minor signs or symptoms of disease. 80: Normal activity with effort. 70: Cares for self. Unable to carry on normal activity or to do active work. Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) Scores were converted to Karnofsky Performance Status Scores."|participants|Number|5|5.0||||||
4309723|NCT00490646|4136853|B3|100||Karnofsky Performance Status|"Karnofsky Performance Status classifies participants according to their functional impairment. Scores range from 0-100 units on a scale; lower the score, the worse the survival for most serious illnesses.~100: Normal, no complaints. 90: Able to carry on normal activities; minor signs or symptoms of disease. 80: Normal activity with effort. 70: Cares for self. Unable to carry on normal activity or to do active work. Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) Scores were converted to Karnofsky Performance Status Scores."|participants|Number|30|30.0||||||
4309724|NCT00490646|4136854|B2|100||Karnofsky Performance Status|"Karnofsky Performance Status classifies participants according to their functional impairment. Scores range from 0-100 units on a scale; lower the score, the worse the survival for most serious illnesses.~100: Normal, no complaints. 90: Able to carry on normal activities; minor signs or symptoms of disease. 80: Normal activity with effort. 70: Cares for self. Unable to carry on normal activity or to do active work. Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) Scores were converted to Karnofsky Performance Status Scores."|participants|Number|15|15.0||||||
4309725|NCT00490646|4136855|B1|100||Karnofsky Performance Status|"Karnofsky Performance Status classifies participants according to their functional impairment. Scores range from 0-100 units on a scale; lower the score, the worse the survival for most serious illnesses.~100: Normal, no complaints. 90: Able to carry on normal activities; minor signs or symptoms of disease. 80: Normal activity with effort. 70: Cares for self. Unable to carry on normal activity or to do active work. Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) Scores were converted to Karnofsky Performance Status Scores."|participants|Number|15|15.0||||||
4309726|NCT00490646|4136853|B3|White||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
4309727|NCT00490646|4136854|B2|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4309728|NCT00490646|4136855|B1|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4309729|NCT00490646|4136853|B3|Female||Sex/Gender, Customized||participants|Number|50|50.0||||||
4309730|NCT00490646|4136854|B2|Female||Sex/Gender, Customized||participants|Number|25|25.0||||||
4309731|NCT00490646|4136855|B1|Female||Sex/Gender, Customized||participants|Number|25|25.0||||||
4309732|NCT00490646|4136853|B3|>=65 years||Age, Customized||participants|Number|10|10.0||||||
4309733|NCT00490646|4136854|B2|>=65 years||Age, Customized||participants|Number|4|4.0||||||
4309734|NCT00490646|4136855|B1|>=65 years||Age, Customized||participants|Number|6|6.0||||||
4309735|NCT00490646|4136853|B3|< 65 years||Age, Customized||participants|Number|40|40.0||||||
4309736|NCT00490646|4136854|B2|< 65 years||Age, Customized||participants|Number|21|21.0||||||
4309737|NCT00490646|4136855|B1|< 65 years||Age, Customized||participants|Number|19|19.0||||||
4309738|NCT00490646|4136853|B3|||Age||years|Median|52.5|52.5|Full Range|||29.0|82.0|
4309739|NCT00490646|4136854|B2|||Age||years|Median|53.0|53.0|Full Range|||37.0|82.0|
4309740|NCT00490646|4136855|B1|||Age||years|Median|52.0|52.0|Full Range|||29.0|71.0|
4309741|NCT00490568|4136876|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4309742|NCT00490568|4136876|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4309743|NCT00490568|4136876|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1396|1396.0||||||
4309744|NCT00490568|4136876|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4309745|NCT00490568|4136876|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4309746|NCT00490568|4136876|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4309747|NCT00490568|4136876|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4309748|NCT00490568|4136876|B1||Male|Sex: Female, Male||Participants|Count of Participants|618|618.0||||||
4309749|NCT00490568|4136876|B1||Female|Sex: Female, Male||Participants|Count of Participants|843|843.0||||||
4309750|NCT00490568|4136876|B1|||Age||Years|Mean|73.9|73.9|Standard Deviation|7.96|7.96|||
4309751|NCT00490555|4136896|B5|||Prostate volume||ml|Median|18|18.0|Inter-Quartile Range|||14.0|22.0|
4309752|NCT00490555|4136897|B4|||Prostate volume||ml|Median|19|19.0|Inter-Quartile Range|||14.0|21.0|
4309753|NCT00490555|4136898|B3|||Prostate volume||ml|Median|15|15.0|Inter-Quartile Range|||13.0|21.0|
4309754|NCT00490555|4136899|B2|||Prostate volume||ml|Median|15|15.0|Inter-Quartile Range|||14.0|19.0|
4309755|NCT00490555|4136900|B1|||Prostate volume||ml|Median|25|25.0|Inter-Quartile Range|||16.0|29.0|
4309756|NCT00490555|4136896|B5|||Prostate-Specific Antigen (PSA)||ng/mL|Median|0.7|0.7|Inter-Quartile Range|||0.5|0.9|
4309757|NCT00490555|4136897|B4|||Prostate-Specific Antigen (PSA)||ng/mL|Median|0.5|0.5|Inter-Quartile Range|||0.4|0.6|
4309758|NCT00490555|4136898|B3|||Prostate-Specific Antigen (PSA)||ng/mL|Median|0.9|0.9|Inter-Quartile Range|||0.7|1.1|
4309759|NCT00490555|4136899|B2|||Prostate-Specific Antigen (PSA)||ng/mL|Median|0.7|0.7|Inter-Quartile Range|||0.4|1.1|
4309760|NCT00490555|4136900|B1|||Prostate-Specific Antigen (PSA)||ng/mL|Median|0.7|0.7|Inter-Quartile Range|||0.6|1.0|
4309761|NCT00490555|4136896|B5|||Dihydrotestosterone (DHT)||ng/mL|Median|0.6|0.6|Inter-Quartile Range|||0.4|0.8|
4309762|NCT00490555|4136897|B4|||Dihydrotestosterone (DHT)||ng/mL|Median|0.6|0.6|Inter-Quartile Range|||0.4|0.8|
4309763|NCT00490555|4136898|B3|||Dihydrotestosterone (DHT)||ng/mL|Median|0.7|0.7|Inter-Quartile Range|||0.6|1.0|
4309764|NCT00490555|4136899|B2|||Dihydrotestosterone (DHT)||ng/mL|Median|0.6|0.6|Inter-Quartile Range|||0.4|0.9|
4309765|NCT00490555|4136900|B1|||Dihydrotestosterone (DHT)||ng/mL|Median|0.5|0.5|Inter-Quartile Range|||0.4|0.5|
4309766|NCT00490555|4136896|B5|||Testosterone (T) concentration||ng/mL|Median|4.1|4.1|Inter-Quartile Range|||3.4|5.7|
4309767|NCT00490555|4136897|B4|||Testosterone (T) concentration||ng/mL|Median|4.0|4.0|Inter-Quartile Range|||3.0|5.8|
4309768|NCT00490555|4136898|B3|||Testosterone (T) concentration||ng/mL|Median|4.8|4.8|Inter-Quartile Range|||3.8|6.3|
4309769|NCT00490555|4136899|B2|||Testosterone (T) concentration||ng/mL|Median|3.9|3.9|Inter-Quartile Range|||2.9|5.9|
4309770|NCT00490555|4136900|B1|||Testosterone (T) concentration||ng/mL|Median|3.9|3.9|Inter-Quartile Range|||3.8|5.0|
4309771|NCT00490555|4136896|B5|||SHBG||nmol/liter|Median|35|35.0|Inter-Quartile Range|||20.0|46.0|
4309772|NCT00490555|4136897|B4|||SHBG||nmol/liter|Median|33|33.0|Inter-Quartile Range|||17.0|38.0|
4309773|NCT00490555|4136898|B3|||SHBG||nmol/liter|Median|38|38.0|Inter-Quartile Range|||26.0|52.0|
4309774|NCT00490555|4136899|B2|||SHBG||nmol/liter|Median|36|36.0|Inter-Quartile Range|||13.0|50.0|
4309775|NCT00490555|4136900|B1|||SHBG||nmol/liter|Median|33|33.0|Inter-Quartile Range|||24.0|45.0|
4309776|NCT00490555|4136896|B5|||Follical-stimulating hormone (FSH)||IU/liter|Median|3.4|3.4|Inter-Quartile Range|||2.5|4.4|
4309777|NCT00490555|4136897|B4|||Follical-stimulating hormone (FSH)||IU/liter|Median|2.8|2.8|Inter-Quartile Range|||2.6|4.2|
4309778|NCT00490555|4136898|B3|||Follical-stimulating hormone (FSH)||IU/liter|Median|4.0|4.0|Inter-Quartile Range|||2.4|5.5|
4309779|NCT00490555|4136899|B2|||Follical-stimulating hormone (FSH)||IU/liter|Median|3.3|3.3|Inter-Quartile Range|||2.6|3.7|
4309780|NCT00490555|4136900|B1|||Follical-stimulating hormone (FSH)||IU/liter|Median|3.6|3.6|Inter-Quartile Range|||2.6|4.4|
4309781|NCT00490555|4136896|B5|||Luteinizing Hormone (LH)||IU/liter|Median|4.1|4.1|Inter-Quartile Range|||3.3|5.4|
4309782|NCT00490555|4136897|B4|||Luteinizing Hormone (LH)||IU/liter|Median|3.2|3.2|Inter-Quartile Range|||2.7|4.0|
4309783|NCT00490555|4136898|B3|||Luteinizing Hormone (LH)||IU/liter|Median|5.3|5.3|Inter-Quartile Range|||4.2|6.6|
4309784|NCT00490555|4136899|B2|||Luteinizing Hormone (LH)||IU/liter|Median|3.9|3.9|Inter-Quartile Range|||2.7|5.5|
4309785|NCT00490555|4136900|B1|||Luteinizing Hormone (LH)||IU/liter|Median|4.0|4.0|Inter-Quartile Range|||3.5|5.6|
4309786|NCT00490555|4136896|B5|United States||Region of Enrollment||participants|Number|32|32.0||||||
4309787|NCT00490555|4136897|B4|United States||Region of Enrollment||participants|Number|7|7.0||||||
4309788|NCT00490555|4136898|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4309789|NCT00490555|4136899|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4309790|NCT00490555|4136900|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4309791|NCT00490555|4136896|B5|Male||Sex/Gender, Customized|Male population, per protocol|participants|Number|32|32.0||||||
4309792|NCT00490555|4136897|B4|Male||Sex/Gender, Customized|Male population, per protocol|participants|Number|7|7.0||||||
4309793|NCT00490555|4136898|B3|Male||Sex/Gender, Customized|Male population, per protocol|participants|Number|9|9.0||||||
4309794|NCT00490555|4136899|B2|Male||Sex/Gender, Customized|Male population, per protocol|participants|Number|8|8.0||||||
4309795|NCT00490555|4136900|B1|Male||Sex/Gender, Customized|Male population, per protocol|participants|Number|8|8.0||||||
4309796|NCT00490555|4136896|B5|Female||Sex/Gender, Customized|Male population, per protocol|participants|Number|0|0.0||||||
4309797|NCT00490555|4136897|B4|Female||Sex/Gender, Customized|Male population, per protocol|participants|Number|0|0.0||||||
4309798|NCT00490555|4136898|B3|Female||Sex/Gender, Customized|Male population, per protocol|participants|Number|0|0.0||||||
4309799|NCT00490555|4136899|B2|Female||Sex/Gender, Customized|Male population, per protocol|participants|Number|0|0.0||||||
4309800|NCT00490555|4136900|B1|Female||Sex/Gender, Customized|Male population, per protocol|participants|Number|0|0.0||||||
4309801|NCT00490555|4136896|B5|||Age||years|Mean|39|39.0|Standard Deviation|3.46|3.46|||
4309802|NCT00490555|4136897|B4|||Age||years|Mean|39|39.0|Standard Deviation|10.11|10.11|||
4309803|NCT00490555|4136898|B3|||Age||years|Mean|37|37.0|Standard Deviation|8.45|8.45|||
4309804|NCT00490555|4136899|B2|||Age||years|Mean|37|37.0|Standard Deviation|6.19|6.19|||
4309805|NCT00490555|4136900|B1|||Age||years|Mean|41|41.0|Standard Deviation|7.72|7.72|||
4309806|NCT00490555|4136896|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4309807|NCT00490555|4136897|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4309808|NCT00490555|4136898|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4309809|NCT00490555|4136899|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4309810|NCT00490555|4136900|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4309811|NCT00490555|4136896|B5||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4309812|NCT00490555|4136897|B4||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4309813|NCT00490555|4136898|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4309814|NCT00490555|4136899|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4309815|NCT00490555|4136900|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4309816|NCT00490555|4136896|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309817|NCT00490555|4136897|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309818|NCT00490555|4136898|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309819|NCT00490555|4136899|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309820|NCT00490555|4136900|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309821|NCT00490542|4136929|B3|United States||Region of Enrollment||participants|Number|73|73.0||||||
4309822|NCT00490542|4136930|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
4309823|NCT00490542|4136931|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4309824|NCT00490542|4136929|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4309825|NCT00490542|4136930|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4309826|NCT00490542|4136931|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4309827|NCT00490542|4136929|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4309828|NCT00490542|4136930|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4309829|NCT00490542|4136931|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4309830|NCT00490542|4136929|B3|||Age||years|Mean|38.7|38.7|Standard Deviation|12.2|12.2|||
4309831|NCT00490542|4136930|B2|||Age||years|Mean|39.1|39.1|Standard Deviation|11.9|11.9|||
4309832|NCT00490542|4136931|B1|||Age||years|Mean|38.6|38.6|Standard Deviation|12.7|12.7|||
4309833|NCT00490542|4136929|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4309834|NCT00490542|4136930|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4309835|NCT00490542|4136931|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4309836|NCT00490542|4136929|B3||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4309837|NCT00490542|4136930|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4309838|NCT00490542|4136931|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4309839|NCT00490542|4136929|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309840|NCT00490542|4136930|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309841|NCT00490542|4136931|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309842|NCT00490490|4136938|B1||Marginal Zone B-Cell Lymphoma|Histology|"Participants were staged according to the Ann Arbor Staging Classification System, as below.~Stage / Characteristics~Involvement of 1 lymphatic region~Involvement of 2+ lymphatic regions on the same side of the diaphragm~Involvement of lymphatic regions on both sides of the diaphragm~Diffuse or disseminated involvement of 1+ extralymphatic organs"|Participants|Count of Participants|2|2.0||||||
4309843|NCT00490490|4136938|B1||Follicular Lymphoma, Grade 3|Histology|"Participants were staged according to the Ann Arbor Staging Classification System, as below.~Stage / Characteristics~Involvement of 1 lymphatic region~Involvement of 2+ lymphatic regions on the same side of the diaphragm~Involvement of lymphatic regions on both sides of the diaphragm~Diffuse or disseminated involvement of 1+ extralymphatic organs"|Participants|Count of Participants|2|2.0||||||
4309844|NCT00490490|4136938|B1||Follicular Lymphoma, Grade 2|Histology|"Participants were staged according to the Ann Arbor Staging Classification System, as below.~Stage / Characteristics~Involvement of 1 lymphatic region~Involvement of 2+ lymphatic regions on the same side of the diaphragm~Involvement of lymphatic regions on both sides of the diaphragm~Diffuse or disseminated involvement of 1+ extralymphatic organs"|Participants|Count of Participants|2|2.0||||||
4309845|NCT00490490|4136938|B1||Follicular Lymphoma, Grade 1|Histology|"Participants were staged according to the Ann Arbor Staging Classification System, as below.~Stage / Characteristics~Involvement of 1 lymphatic region~Involvement of 2+ lymphatic regions on the same side of the diaphragm~Involvement of lymphatic regions on both sides of the diaphragm~Diffuse or disseminated involvement of 1+ extralymphatic organs"|Participants|Count of Participants|2|2.0||||||
4309846|NCT00490490|4136938|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4309847|NCT00490490|4136938|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4309848|NCT00490490|4136938|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4309849|NCT00490490|4136938|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4309850|NCT00490490|4136938|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4309851|NCT00490490|4136938|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4309852|NCT00490490|4136938|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4309853|NCT00490490|4136938|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4309854|NCT00490490|4136938|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4309855|NCT00490490|4136938|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4309856|NCT00490490|4136938|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4309857|NCT00490490|4136938|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4309858|NCT00490490|4136938|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4309859|NCT00490490|4136938|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4309860|NCT00490490|4136938|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309861|NCT00490477|4136944|B3|Italy||Region of Enrollment||participants|Number|16|16.0||||||
4309862|NCT00490477|4136945|B2|Italy||Region of Enrollment||participants|Number|8|8.0||||||
4309863|NCT00490477|4136946|B1|Italy||Region of Enrollment||participants|Number|8|8.0||||||
4309864|NCT00490477|4136944|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4309865|NCT00490477|4136945|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4309866|NCT00490477|4136946|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4309867|NCT00490477|4136944|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4309868|NCT00490477|4136945|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4309869|NCT00490477|4136946|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4309870|NCT00490477|4136944|B3|||Age||years|Mean|60|60.0|Standard Deviation|11|11.0|||
4309871|NCT00490477|4136945|B2|||Age||years|Mean|61|61.0|Standard Deviation|10|10.0|||
4309872|NCT00490477|4136946|B1|||Age||years|Mean|59|59.0|Standard Deviation|13|13.0|||
4309873|NCT00490477|4136944|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4309874|NCT00490477|4136945|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4309875|NCT00490477|4136946|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4309876|NCT00490477|4136944|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4309877|NCT00490477|4136945|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4309878|NCT00490477|4136946|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4309879|NCT00490477|4136944|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309880|NCT00490477|4136945|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309881|NCT00490477|4136946|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309882|NCT00490451|4136953|B3|Unknown||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|Participants|Count of Participants|1|1.0||||||
4309883|NCT00490451|4136954|B2|Unknown||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|Participants|Count of Participants|1|1.0||||||
4309884|NCT00490451|4136955|B1|Unknown||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|Participants|Count of Participants|0|0.0||||||
4309885|NCT00490451|4136953|B3|1 - Ambulatory, restricted strenuous activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|Participants|Count of Participants|52|52.0||||||
4309886|NCT00490451|4136954|B2|1 - Ambulatory, restricted strenuous activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|Participants|Count of Participants|19|19.0||||||
4309887|NCT00490451|4136955|B1|1 - Ambulatory, restricted strenuous activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|Participants|Count of Participants|33|33.0||||||
4309888|NCT00490451|4136953|B3|0 - Fully active||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|Participants|Count of Participants|48|48.0||||||
4309889|NCT00490451|4136954|B2|0 - Fully active||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|Participants|Count of Participants|18|18.0||||||
4309890|NCT00490451|4136955|B1|0 - Fully active||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|Participants|Count of Participants|30|30.0||||||
4309891|NCT00490451|4136953|B3|Spain||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4309892|NCT00490451|4136954|B2|Spain||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4309893|NCT00490451|4136955|B1|Spain||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4309894|NCT00490451|4136953|B3|Argentina||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4309895|NCT00490451|4136954|B2|Argentina||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4309896|NCT00490451|4136955|B1|Argentina||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4309897|NCT00490451|4136953|B3|United States||Region of Enrollment||Participants|Count of Participants|73|73.0||||||
4309898|NCT00490451|4136954|B2|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4309899|NCT00490451|4136955|B1|United States||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
4309900|NCT00490451|4136953|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4309901|NCT00490451|4136954|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4309902|NCT00490451|4136955|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4309903|NCT00490451|4136953|B3|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4309904|NCT00490451|4136954|B2|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4309905|NCT00490451|4136955|B1|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4309906|NCT00490451|4136953|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|83|83.0||||||
4309907|NCT00490451|4136954|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
4309908|NCT00490451|4136955|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|54|54.0||||||
4309909|NCT00490451|4136953|B3|African||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4309910|NCT00490451|4136954|B2|African||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4309911|NCT00490451|4136955|B1|African||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4309912|NCT00490451|4136953|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4309913|NCT00490451|4136954|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4309914|NCT00490451|4136955|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4309915|NCT00490451|4136953|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4309916|NCT00490451|4136954|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4309917|NCT00490451|4136955|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4309918|NCT00490451|4136953|B3|||Age||years|Mean|53.3|53.3|Standard Deviation|14.61|14.61|||
4309919|NCT00490451|4136954|B2|||Age||years|Mean|52.6|52.6|Standard Deviation|13.57|13.57|||
4309920|NCT00490451|4136955|B1|||Age||years|Mean|53.8|53.8|Standard Deviation|15.29|15.29|||
4309921|NCT00490269|4136976|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4309922|NCT00490269|4136977|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4309923|NCT00490269|4136978|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4309924|NCT00490269|4136976|B3||Male|Gender||Participants|Count of Participants|9|9.0||||||
4309925|NCT00490269|4136977|B2||Male|Gender||Participants|Count of Participants|5|5.0||||||
4309926|NCT00490269|4136978|B1||Male|Gender||Participants|Count of Participants|4|4.0||||||
4309927|NCT00490269|4136976|B3||Female|Gender||Participants|Count of Participants|3|3.0||||||
4309928|NCT00490269|4136977|B2||Female|Gender||Participants|Count of Participants|1|1.0||||||
4309929|NCT00490269|4136978|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
4309930|NCT00490269|4136976|B3|||Age||years|Mean|27.2|27.2|Standard Deviation|4.3|4.3|||
4309931|NCT00490269|4136977|B2|||Age||years|Mean|27.2|27.2|Standard Deviation|4.9|4.9|||
4309932|NCT00490269|4136978|B1|||Age||years|Mean|27.2|27.2|Standard Deviation|3.6|3.6|||
4309933|NCT00490269|4136976|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4309934|NCT00490269|4136977|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4309935|NCT00490269|4136978|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4309936|NCT00490269|4136976|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4309937|NCT00490269|4136977|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4309938|NCT00490269|4136978|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4309939|NCT00490269|4136976|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309940|NCT00490269|4136977|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309941|NCT00490269|4136978|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4309942|NCT00490256|4136985|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4309943|NCT00490256|4136986|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4309944|NCT00490256|4136987|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4309945|NCT00490256|4136985|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4309946|NCT00490256|4136986|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4309947|NCT00490256|4136987|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4309948|NCT00490256|4136985|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4309949|NCT00490256|4136986|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4309950|NCT00490256|4136987|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4309951|NCT00490256|4136985|B3|||Age||years|Mean|7.3|7.3|Standard Deviation|6.6|6.6|||
4309952|NCT00490256|4136986|B2|||Age||years|Mean|4.7|4.7|Standard Deviation|2.9|2.9|||
4309953|NCT00490256|4136987|B1|||Age||years|Mean|9.9|9.9|Standard Deviation|8.5|8.5|||
4309954|NCT00490256|4136985|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4309955|NCT00490256|4136986|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4309956|NCT00490256|4136987|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4309957|NCT00490256|4136985|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4309958|NCT00490256|4136986|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4309959|NCT00490256|4136987|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4309960|NCT00490256|4136985|B3||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4309961|NCT00490256|4136986|B2||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4309962|NCT00490256|4136987|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4309963|NCT00490139|4136994|B5|Unknown/Missing||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4309964|NCT00490139|4136995|B4|Unknown/Missing||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4309965|NCT00490139|4136996|B3|Unknown/Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4309966|NCT00490139|4136997|B2|Unknown/Missing||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4309967|NCT00490139|4136998|B1|Unknown/Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4309968|NCT00490139|4136994|B5|Caucasian and Guamanian (Chamorro)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4309969|NCT00490139|4136995|B4|Caucasian and Guamanian (Chamorro)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4309970|NCT00490139|4136996|B3|Caucasian and Guamanian (Chamorro)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4309971|NCT00490139|4136997|B2|Caucasian and Guamanian (Chamorro)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4309972|NCT00490139|4136998|B1|Caucasian and Guamanian (Chamorro)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4309973|NCT00490139|4136994|B5|American Indian or Alaska Native and White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4309974|NCT00490139|4136995|B4|American Indian or Alaska Native and White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4309975|NCT00490139|4136996|B3|American Indian or Alaska Native and White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4309976|NCT00490139|4136997|B2|American Indian or Alaska Native and White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4309977|NCT00490139|4136998|B1|American Indian or Alaska Native and White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4309978|NCT00490139|4136994|B5|Mexican||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4309979|NCT00490139|4136995|B4|Mexican||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4309980|NCT00490139|4136996|B3|Mexican||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4309981|NCT00490139|4136997|B2|Mexican||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4309982|NCT00490139|4136998|B1|Mexican||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4309983|NCT00490139|4136994|B5|Peruvian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4309984|NCT00490139|4136995|B4|Peruvian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4309985|NCT00490139|4136996|B3|Peruvian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4309986|NCT00490139|4136997|B2|Peruvian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4309987|NCT00490139|4136998|B1|Peruvian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4309988|NCT00490139|4136994|B5|Asian (East), NH or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4309989|NCT00490139|4136995|B4|Asian (East), NH or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4309990|NCT00490139|4136996|B3|Asian (East), NH or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4309991|NCT00490139|4136997|B2|Asian (East), NH or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4309992|NCT00490139|4136998|B1|Asian (East), NH or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4309993|NCT00490139|4136994|B5|Northeast of South America and European HER||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4309994|NCT00490139|4136995|B4|Northeast of South America and European HER||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4309995|NCT00490139|4136996|B3|Northeast of South America and European HER||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4309996|NCT00490139|4136997|B2|Northeast of South America and European HER||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4309997|NCT00490139|4136998|B1|Northeast of South America and European HER||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4309998|NCT00490139|4136994|B5|Black from South America||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4309999|NCT00490139|4136995|B4|Black from South America||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310000|NCT00490139|4136996|B3|Black from South America||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310001|NCT00490139|4136997|B2|Black from South America||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310002|NCT00490139|4136998|B1|Black from South America||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4310003|NCT00490139|4136994|B5|South American Latin American and European HER||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4310004|NCT00490139|4136995|B4|South American Latin American and European HER||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310005|NCT00490139|4136996|B3|South American Latin American and European HER||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310006|NCT00490139|4136997|B2|South American Latin American and European HER||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4310007|NCT00490139|4136998|B1|South American Latin American and European HER||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310008|NCT00490139|4136994|B5|Mulatto||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4310009|NCT00490139|4136995|B4|Mulatto||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310010|NCT00490139|4136996|B3|Mulatto||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310011|NCT00490139|4136997|B2|Mulatto||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4310012|NCT00490139|4136998|B1|Mulatto||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310013|NCT00490139|4136994|B5|Southeast and Northeast of South America||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4310014|NCT00490139|4136995|B4|Southeast and Northeast of South America||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310015|NCT00490139|4136996|B3|Southeast and Northeast of South America||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4310016|NCT00490139|4136997|B2|Southeast and Northeast of South America||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310017|NCT00490139|4136998|B1|Southeast and Northeast of South America||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310018|NCT00490139|4136994|B5|White South American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4310019|NCT00490139|4136995|B4|White South American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310020|NCT00490139|4136996|B3|White South American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4310021|NCT00490139|4136997|B2|White South American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310022|NCT00490139|4136998|B1|White South American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4310023|NCT00490139|4136994|B5|White South African||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4310024|NCT00490139|4136995|B4|White South African||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4310025|NCT00490139|4136996|B3|White South African||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310026|NCT00490139|4136997|B2|White South African||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310027|NCT00490139|4136998|B1|White South African||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310028|NCT00490139|4136994|B5|Afrikaans-South Africa||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4310029|NCT00490139|4136995|B4|Afrikaans-South Africa||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310030|NCT00490139|4136996|B3|Afrikaans-South Africa||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310031|NCT00490139|4136997|B2|Afrikaans-South Africa||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310032|NCT00490139|4136998|B1|Afrikaans-South Africa||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4310033|NCT00490139|4136994|B5|South American, African HER and European HER||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4310034|NCT00490139|4136995|B4|South American, African HER and European HER||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310035|NCT00490139|4136996|B3|South American, African HER and European HER||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310036|NCT00490139|4136997|B2|South American, African HER and European HER||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4310037|NCT00490139|4136998|B1|South American, African HER and European HER||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310038|NCT00490139|4136994|B5|European Heritage and South American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4310039|NCT00490139|4136995|B4|European Heritage and South American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310040|NCT00490139|4136996|B3|European Heritage and South American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310041|NCT00490139|4136997|B2|European Heritage and South American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310042|NCT00490139|4136998|B1|European Heritage and South American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4310043|NCT00490139|4136994|B5|NH and White (Arabic/North African Heritage [HER])||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4310044|NCT00490139|4136995|B4|NH and White (Arabic/North African Heritage [HER])||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310045|NCT00490139|4136996|B3|NH and White (Arabic/North African Heritage [HER])||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4310046|NCT00490139|4136997|B2|NH and White (Arabic/North African Heritage [HER])||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310047|NCT00490139|4136998|B1|NH and White (Arabic/North African Heritage [HER])||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310048|NCT00490139|4136994|B5|Coloured||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4310049|NCT00490139|4136995|B4|Coloured||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310050|NCT00490139|4136996|B3|Coloured||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4310051|NCT00490139|4136997|B2|Coloured||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310052|NCT00490139|4136998|B1|Coloured||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4310053|NCT00490139|4136994|B5|Mauritius Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4310054|NCT00490139|4136995|B4|Mauritius Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4310055|NCT00490139|4136996|B3|Mauritius Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310056|NCT00490139|4136997|B2|Mauritius Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310057|NCT00490139|4136998|B1|Mauritius Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310058|NCT00490139|4136994|B5|Mestizo||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4310059|NCT00490139|4136995|B4|Mestizo||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310060|NCT00490139|4136996|B3|Mestizo||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4310061|NCT00490139|4136997|B2|Mestizo||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4310062|NCT00490139|4136998|B1|Mestizo||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4310063|NCT00490139|4136994|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4310064|NCT00490139|4136995|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4310065|NCT00490139|4136996|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4310066|NCT00490139|4136997|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4310067|NCT00490139|4136998|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4310068|NCT00490139|4136994|B5|Mixed Race/Ancestry||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4310069|NCT00490139|4136995|B4|Mixed Race/Ancestry||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4310070|NCT00490139|4136996|B3|Mixed Race/Ancestry||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4310071|NCT00490139|4136997|B2|Mixed Race/Ancestry||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4310072|NCT00490139|4136998|B1|Mixed Race/Ancestry||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4310073|NCT00490139|4136994|B5|White: Caucasian||Race/Ethnicity, Customized||participants|Number|5548|5548.0||||||
4310074|NCT00490139|4136995|B4|White: Caucasian||Race/Ethnicity, Customized||participants|Number|1382|1382.0||||||
4310075|NCT00490139|4136996|B3|White: Caucasian||Race/Ethnicity, Customized||participants|Number|1372|1372.0||||||
4310076|NCT00490139|4136997|B2|White: Caucasian||Race/Ethnicity, Customized||participants|Number|1402|1402.0||||||
4310077|NCT00490139|4136998|B1|White: Caucasian||Race/Ethnicity, Customized||participants|Number|1392|1392.0||||||
4310078|NCT00490139|4136994|B5|White: Arabic||Race/Ethnicity, Customized||participants|Number|236|236.0||||||
4310079|NCT00490139|4136995|B4|White: Arabic||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
4310080|NCT00490139|4136996|B3|White: Arabic||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
4310081|NCT00490139|4136997|B2|White: Arabic||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
4310082|NCT00490139|4136998|B1|White: Arabic||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
4310083|NCT00490139|4136994|B5|Native Hawaiian (NH) or Other Pacific||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4310084|NCT00490139|4136995|B4|Native Hawaiian (NH) or Other Pacific||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4310085|NCT00490139|4136996|B3|Native Hawaiian (NH) or Other Pacific||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4310086|NCT00490139|4136997|B2|Native Hawaiian (NH) or Other Pacific||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4310087|NCT00490139|4136998|B1|Native Hawaiian (NH) or Other Pacific||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4310088|NCT00490139|4136994|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|136|136.0||||||
4310089|NCT00490139|4136995|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4310090|NCT00490139|4136996|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4310091|NCT00490139|4136997|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4310092|NCT00490139|4136998|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4310093|NCT00490139|4136994|B5|Asian: South East||Race/Ethnicity, Customized||participants|Number|383|383.0||||||
4310094|NCT00490139|4136995|B4|Asian: South East||Race/Ethnicity, Customized||participants|Number|89|89.0||||||
4310095|NCT00490139|4136996|B3|Asian: South East||Race/Ethnicity, Customized||participants|Number|107|107.0||||||
4310096|NCT00490139|4136997|B2|Asian: South East||Race/Ethnicity, Customized||participants|Number|92|92.0||||||
4310097|NCT00490139|4136998|B1|Asian: South East||Race/Ethnicity, Customized||participants|Number|95|95.0||||||
4310098|NCT00490139|4136994|B5|Asian: Japanese||Race/Ethnicity, Customized||participants|Number|145|145.0||||||
4310099|NCT00490139|4136995|B4|Asian: Japanese||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4310100|NCT00490139|4136996|B3|Asian: Japanese||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4310101|NCT00490139|4136997|B2|Asian: Japanese||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4310102|NCT00490139|4136998|B1|Asian: Japanese||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4310103|NCT00490139|4136994|B5|Asian: East||Race/Ethnicity, Customized||participants|Number|1236|1236.0||||||
4310104|NCT00490139|4136995|B4|Asian: East||Race/Ethnicity, Customized||participants|Number|314|314.0||||||
4310105|NCT00490139|4136996|B3|Asian: East||Race/Ethnicity, Customized||participants|Number|299|299.0||||||
4310106|NCT00490139|4136997|B2|Asian: East||Race/Ethnicity, Customized||participants|Number|312|312.0||||||
4310107|NCT00490139|4136998|B1|Asian: East||Race/Ethnicity, Customized||participants|Number|311|311.0||||||
4310108|NCT00490139|4136994|B5|Asian: Central/South||Race/Ethnicity, Customized||participants|Number|429|429.0||||||
4310109|NCT00490139|4136995|B4|Asian: Central/South||Race/Ethnicity, Customized||participants|Number|109|109.0||||||
4310110|NCT00490139|4136996|B3|Asian: Central/South||Race/Ethnicity, Customized||participants|Number|110|110.0||||||
4310111|NCT00490139|4136997|B2|Asian: Central/South||Race/Ethnicity, Customized||participants|Number|103|103.0||||||
4310112|NCT00490139|4136998|B1|Asian: Central/South||Race/Ethnicity, Customized||participants|Number|107|107.0||||||
4310113|NCT00490139|4136994|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|187|187.0||||||
4310114|NCT00490139|4136995|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4310115|NCT00490139|4136996|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4310116|NCT00490139|4136997|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4310117|NCT00490139|4136998|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
4310118|NCT00490139|4136994|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4310119|NCT00490139|4136995|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4310120|NCT00490139|4136996|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4310121|NCT00490139|4136997|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4310122|NCT00490139|4136998|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4310123|NCT00490139|4136994|B5||Female|Sex: Female, Male||Participants|Count of Participants|8372|8372.0||||||
4310124|NCT00490139|4136995|B4||Female|Sex: Female, Male||Participants|Count of Participants|2097|2097.0||||||
4310125|NCT00490139|4136996|B3||Female|Sex: Female, Male||Participants|Count of Participants|2098|2098.0||||||
4310126|NCT00490139|4136997|B2||Female|Sex: Female, Male||Participants|Count of Participants|2086|2086.0||||||
4310127|NCT00490139|4136998|B1||Female|Sex: Female, Male||Participants|Count of Participants|2091|2091.0||||||
4310128|NCT00490139|4136994|B5|||Age||years|Mean|51.0|51.0|Standard Deviation|10.24|10.24|||
4310129|NCT00490139|4136995|B4|||Age||years|Mean|51.0|51.0|Standard Deviation|10.25|10.25|||
4310130|NCT00490139|4136996|B3|||Age||years|Mean|51.2|51.2|Standard Deviation|10.18|10.18|||
4310131|NCT00490139|4136997|B2|||Age||years|Mean|50.8|50.8|Standard Deviation|10.32|10.32|||
4310132|NCT00490139|4136998|B1|||Age||years|Mean|50.9|50.9|Standard Deviation|10.23|10.23|||
4310133|NCT00490100|4137031|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4310134|NCT00490100|4137031|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4310135|NCT00490100|4137031|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4310136|NCT00490100|4137031|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4310137|NCT00490100|4137031|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4310138|NCT00490100|4137031|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4310139|NCT00490100|4137031|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4310140|NCT00490100|4137031|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4310141|NCT00490100|4137031|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4310142|NCT00490100|4137031|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4310143|NCT00490100|4137031|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4310144|NCT00490100|4137031|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4310145|NCT00490100|4137031|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4310146|NCT00490100|4137031|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4310147|NCT00490100|4137031|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4310148|NCT00490061|4137036|B1||Male|Gender||Participants|Count of Participants|11|11.0||||||
4310149|NCT00490061|4137036|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
4310150|NCT00490061|4137036|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4310151|NCT00490061|4137036|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4310152|NCT00490061|4137036|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4310153|NCT00490035|4137041|B5|United Kingdom||Region of Enrollment||Participants|Number|6|6.0||||||
4310154|NCT00490035|4137042|B4|United Kingdom||Region of Enrollment||Participants|Number|2|2.0||||||
4310155|NCT00490035|4137043|B3|United Kingdom||Region of Enrollment||Participants|Number|2|2.0||||||
4310156|NCT00490035|4137044|B2|United Kingdom||Region of Enrollment||Participants|Number|2|2.0||||||
4310157|NCT00490035|4137045|B1|United Kingdom||Region of Enrollment||Participants|Number|0|0.0||||||
4310158|NCT00490035|4137041|B5|Switzerland||Region of Enrollment||Participants|Number|15|15.0||||||
4310159|NCT00490035|4137042|B4|Switzerland||Region of Enrollment||Participants|Number|5|5.0||||||
4310160|NCT00490035|4137043|B3|Switzerland||Region of Enrollment||Participants|Number|6|6.0||||||
4310161|NCT00490035|4137044|B2|Switzerland||Region of Enrollment||Participants|Number|3|3.0||||||
4310162|NCT00490035|4137045|B1|Switzerland||Region of Enrollment||Participants|Number|1|1.0||||||
4310163|NCT00490035|4137041|B5|Spain||Region of Enrollment||Participants|Number|22|22.0||||||
4310164|NCT00490035|4137042|B4|Spain||Region of Enrollment||Participants|Number|4|4.0||||||
4310165|NCT00490035|4137043|B3|Spain||Region of Enrollment||Participants|Number|6|6.0||||||
4310166|NCT00490035|4137044|B2|Spain||Region of Enrollment||Participants|Number|4|4.0||||||
4310167|NCT00490035|4137045|B1|Spain||Region of Enrollment||Participants|Number|8|8.0||||||
4310168|NCT00490035|4137041|B5|Netherlands||Region of Enrollment||Participants|Number|7|7.0||||||
4310169|NCT00490035|4137042|B4|Netherlands||Region of Enrollment||Participants|Number|3|3.0||||||
4310170|NCT00490035|4137043|B3|Netherlands||Region of Enrollment||Participants|Number|1|1.0||||||
4310171|NCT00490035|4137044|B2|Netherlands||Region of Enrollment||Participants|Number|0|0.0||||||
4310172|NCT00490035|4137045|B1|Netherlands||Region of Enrollment||Participants|Number|3|3.0||||||
4310173|NCT00490035|4137041|B5|Italy||Region of Enrollment||Participants|Number|20|20.0||||||
4310174|NCT00490035|4137042|B4|Italy||Region of Enrollment||Participants|Number|5|5.0||||||
4310175|NCT00490035|4137043|B3|Italy||Region of Enrollment||Participants|Number|3|3.0||||||
4310176|NCT00490035|4137044|B2|Italy||Region of Enrollment||Participants|Number|8|8.0||||||
4310177|NCT00490035|4137045|B1|Italy||Region of Enrollment||Participants|Number|4|4.0||||||
4310178|NCT00490035|4137041|B5|Germany||Region of Enrollment||Participants|Number|41|41.0||||||
4310179|NCT00490035|4137042|B4|Germany||Region of Enrollment||Participants|Number|9|9.0||||||
4310180|NCT00490035|4137043|B3|Germany||Region of Enrollment||Participants|Number|14|14.0||||||
4310181|NCT00490035|4137044|B2|Germany||Region of Enrollment||Participants|Number|10|10.0||||||
4310182|NCT00490035|4137045|B1|Germany||Region of Enrollment||Participants|Number|8|8.0||||||
4310183|NCT00490035|4137041|B5|France||Region of Enrollment||Participants|Number|60|60.0||||||
4310184|NCT00490035|4137042|B4|France||Region of Enrollment||Participants|Number|15|15.0||||||
4310185|NCT00490035|4137043|B3|France||Region of Enrollment||Participants|Number|11|11.0||||||
4310186|NCT00490035|4137044|B2|France||Region of Enrollment||Participants|Number|17|17.0||||||
4310187|NCT00490035|4137045|B1|France||Region of Enrollment||Participants|Number|17|17.0||||||
4310188|NCT00490035|4137041|B5|Finland||Region of Enrollment||Participants|Number|11|11.0||||||
4310189|NCT00490035|4137042|B4|Finland||Region of Enrollment||Participants|Number|4|4.0||||||
4310190|NCT00490035|4137043|B3|Finland||Region of Enrollment||Participants|Number|1|1.0||||||
4310191|NCT00490035|4137044|B2|Finland||Region of Enrollment||Participants|Number|3|3.0||||||
4310192|NCT00490035|4137045|B1|Finland||Region of Enrollment||Participants|Number|3|3.0||||||
4310193|NCT00490035|4137041|B5|Belgium||Region of Enrollment||Participants|Number|6|6.0||||||
4310194|NCT00490035|4137042|B4|Belgium||Region of Enrollment||Participants|Number|0|0.0||||||
4310195|NCT00490035|4137043|B3|Belgium||Region of Enrollment||Participants|Number|3|3.0||||||
4310196|NCT00490035|4137044|B2|Belgium||Region of Enrollment||Participants|Number|0|0.0||||||
4310197|NCT00490035|4137045|B1|Belgium||Region of Enrollment||Participants|Number|3|3.0||||||
4310198|NCT00490035|4137041|B5|India||Region of Enrollment||Participants|Number|91|91.0||||||
4310199|NCT00490035|4137042|B4|India||Region of Enrollment||Participants|Number|23|23.0||||||
4310200|NCT00490035|4137043|B3|India||Region of Enrollment||Participants|Number|23|23.0||||||
4310201|NCT00490035|4137044|B2|India||Region of Enrollment||Participants|Number|22|22.0||||||
4310202|NCT00490035|4137045|B1|India||Region of Enrollment||Participants|Number|23|23.0||||||
4310203|NCT00490035|4137041|B5|Poland||Region of Enrollment||Participants|Number|108|108.0||||||
4310204|NCT00490035|4137042|B4|Poland||Region of Enrollment||Participants|Number|27|27.0||||||
4310205|NCT00490035|4137043|B3|Poland||Region of Enrollment||Participants|Number|27|27.0||||||
4310206|NCT00490035|4137044|B2|Poland||Region of Enrollment||Participants|Number|28|28.0||||||
4310207|NCT00490035|4137045|B1|Poland||Region of Enrollment||Participants|Number|26|26.0||||||
4310208|NCT00490035|4137041|B5|Hungary||Region of Enrollment||Participants|Number|12|12.0||||||
4310209|NCT00490035|4137042|B4|Hungary||Region of Enrollment||Participants|Number|3|3.0||||||
4310210|NCT00490035|4137043|B3|Hungary||Region of Enrollment||Participants|Number|3|3.0||||||
4310211|NCT00490035|4137044|B2|Hungary||Region of Enrollment||Participants|Number|2|2.0||||||
4310212|NCT00490035|4137045|B1|Hungary||Region of Enrollment||Participants|Number|4|4.0||||||
4310213|NCT00490035|4137041|B5||Male|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
4310214|NCT00490035|4137042|B4||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4310215|NCT00490035|4137043|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4310216|NCT00490035|4137044|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4310217|NCT00490035|4137045|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4310218|NCT00490035|4137041|B5||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4310219|NCT00490035|4137042|B4||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4310220|NCT00490035|4137043|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4310221|NCT00490035|4137044|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4310222|NCT00490035|4137045|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4310223|NCT00490035|4137041|B5|>=65 years||Age, Customized||participants|Number|11|11.0||||||
4310224|NCT00490035|4137042|B4|>=65 years||Age, Customized||participants|Number|3|3.0||||||
4310225|NCT00490035|4137043|B3|>=65 years||Age, Customized||participants|Number|3|3.0||||||
4310226|NCT00490035|4137044|B2|>=65 years||Age, Customized||participants|Number|3|3.0||||||
4310227|NCT00490035|4137045|B1|>=65 years||Age, Customized||participants|Number|2|2.0||||||
4310228|NCT00490035|4137041|B5|Between 18 and 65 years||Age, Customized||participants|Number|383|383.0||||||
4310229|NCT00490035|4137042|B4|Between 18 and 65 years||Age, Customized||participants|Number|96|96.0||||||
4310230|NCT00490035|4137043|B3|Between 18 and 65 years||Age, Customized||participants|Number|97|97.0||||||
4310231|NCT00490035|4137044|B2|Between 18 and 65 years||Age, Customized||participants|Number|94|94.0||||||
4310232|NCT00490035|4137045|B1|Between 18 and 65 years||Age, Customized||participants|Number|96|96.0||||||
4310233|NCT00490035|4137041|B5|<18 years||Age, Customized||participants|Number|5|5.0||||||
4310234|NCT00490035|4137042|B4|<18 years||Age, Customized||participants|Number|1|1.0||||||
4310235|NCT00490035|4137043|B3|<18 years||Age, Customized||participants|Number|0|0.0||||||
4310236|NCT00490035|4137044|B2|<18 years||Age, Customized||participants|Number|2|2.0||||||
4310237|NCT00490035|4137045|B1|<18 years||Age, Customized||participants|Number|2|2.0||||||
4310238|NCT00490035|4137041|B5|||Age||years|Mean|37.24|37.24|Standard Deviation|13.05|13.05|||
4310239|NCT00490035|4137042|B4|||Age||years|Mean|38.0|38.0|Standard Deviation|13.1|13.1|||
4310240|NCT00490035|4137043|B3|||Age||years|Mean|39.0|39.0|Standard Deviation|13.5|13.5|||
4310241|NCT00490035|4137044|B2|||Age||years|Mean|35.7|35.7|Standard Deviation|12.5|12.5|||
4310242|NCT00490035|4137045|B1|||Age||years|Mean|36.4|36.4|Standard Deviation|13.0|13.0|||
4310243|NCT00490022|4137146|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4310244|NCT00490022|4137147|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4310245|NCT00490022|4137148|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4310246|NCT00490022|4137146|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4310247|NCT00490022|4137147|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4310248|NCT00490022|4137148|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4310249|NCT00490022|4137146|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4310250|NCT00490022|4137147|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4310251|NCT00490022|4137148|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4310252|NCT00490022|4137146|B3|||Age||years|Mean|43.6|43.6|Standard Deviation|4.2|4.2|||
4310253|NCT00490022|4137147|B2|||Age||years|Mean|42.7|42.7|Standard Deviation|1.6|1.6|||
4310254|NCT00490022|4137148|B1|||Age||years|Mean|44.4|44.4|Standard Deviation|6.7|6.7|||
4310255|NCT00490022|4137146|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4310256|NCT00490022|4137147|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4310257|NCT00490022|4137148|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4310258|NCT00490022|4137146|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4310259|NCT00490022|4137147|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4310260|NCT00490022|4137148|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4310261|NCT00490022|4137146|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4310262|NCT00490022|4137147|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4310263|NCT00490022|4137148|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4310264|NCT00490009|4137157|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4310265|NCT00490009|4137157|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4310266|NCT00490009|4137157|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4310267|NCT00490009|4137157|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4310268|NCT00490009|4137157|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4310269|NCT00490009|4137157|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4310270|NCT00490009|4137157|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4310271|NCT00490009|4137157|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4310272|NCT00490009|4137157|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4310273|NCT00490009|4137157|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4310274|NCT00490009|4137157|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4310275|NCT00490009|4137157|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4310276|NCT00490009|4137157|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4310277|NCT00490009|4137157|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4310278|NCT00490009|4137157|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4310279|NCT00489970|4137163|B3||Male|Sex: Female, Male||Participants|Count of Participants|555|555.0||||||
4310280|NCT00489970|4137164|B2||Male|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4310281|NCT00489970|4137165|B1||Male|Sex: Female, Male||Participants|Count of Participants|389|389.0||||||
4310282|NCT00489970|4137163|B3||Female|Sex: Female, Male||Participants|Count of Participants|1037|1037.0||||||
4310283|NCT00489970|4137164|B2||Female|Sex: Female, Male||Participants|Count of Participants|357|357.0||||||
4310284|NCT00489970|4137165|B1||Female|Sex: Female, Male||Participants|Count of Participants|680|680.0||||||
4310285|NCT00489970|4137163|B3|||Age||years|Mean|42.0|42.0|Standard Deviation|13.35|13.35|||
4310286|NCT00489970|4137164|B2|||Age||years|Mean|42.5|42.5|Standard Deviation|13.27|13.27|||
4310287|NCT00489970|4137165|B1|||Age||years|Mean|41.7|41.7|Standard Deviation|13.39|13.39|||
4310288|NCT00489918|4137190|B6|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4310289|NCT00489918|4137191|B5|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4310290|NCT00489918|4137192|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310291|NCT00489918|4137193|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310292|NCT00489918|4137194|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310293|NCT00489918|4137195|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310294|NCT00489918|4137190|B6|Hispanic||Race/Ethnicity, Customized||participants|Number|119|119.0||||||
4310295|NCT00489918|4137191|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4310296|NCT00489918|4137192|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4310297|NCT00489918|4137193|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4310298|NCT00489918|4137194|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4310299|NCT00489918|4137195|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4310300|NCT00489918|4137190|B6|Caucasian||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4310301|NCT00489918|4137191|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4310302|NCT00489918|4137192|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4310303|NCT00489918|4137193|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4310304|NCT00489918|4137194|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4310305|NCT00489918|4137195|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4310306|NCT00489918|4137190|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4310307|NCT00489918|4137191|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4310308|NCT00489918|4137192|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4310309|NCT00489918|4137193|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4310310|NCT00489918|4137194|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4310311|NCT00489918|4137195|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4310312|NCT00489918|4137190|B6||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4310313|NCT00489918|4137191|B5||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4310314|NCT00489918|4137192|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4310315|NCT00489918|4137193|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4310316|NCT00489918|4137194|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4310317|NCT00489918|4137195|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4310318|NCT00489918|4137190|B6|||Age||years|Mean|64.06|64.06|Standard Deviation|6.9|6.9|||
4310319|NCT00489918|4137191|B5|||Age||years|Mean|63.2|63.2|Standard Deviation|6.8|6.8|||
4310320|NCT00489918|4137192|B4|||Age||years|Mean|64.6|64.6|Standard Deviation|7.3|7.3|||
4310321|NCT00489918|4137193|B3|||Age||years|Mean|63.6|63.6|Standard Deviation|5.8|5.8|||
4310322|NCT00489918|4137194|B2|||Age||years|Mean|64.1|64.1|Standard Deviation|7.5|7.5|||
4310323|NCT00489918|4137195|B1|||Age||years|Mean|64.8|64.8|Standard Deviation|7.1|7.1|||
4310324|NCT00489866|4137231|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4310325|NCT00489866|4137232|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4310326|NCT00489866|4137233|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4310327|NCT00489866|4137231|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4310328|NCT00489866|4137232|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4310329|NCT00489866|4137233|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4310330|NCT00489866|4137231|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4310331|NCT00489866|4137232|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4310332|NCT00489866|4137233|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4310333|NCT00489866|4137231|B3|||Age||years|Mean|33.81|33.81|Standard Deviation|11.26|11.26|||
4310334|NCT00489866|4137232|B2|||Age||years|Mean|36.14|36.14|Standard Deviation|5.52|5.52|||
4310335|NCT00489866|4137233|B1|||Age||years|Mean|31.49|31.49|Standard Deviation|2.64|2.64|||
4310336|NCT00489866|4137231|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4310337|NCT00489866|4137232|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4310338|NCT00489866|4137233|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4310339|NCT00489866|4137231|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4310340|NCT00489866|4137232|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4310341|NCT00489866|4137233|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4310342|NCT00489866|4137231|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4310343|NCT00489866|4137232|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4310344|NCT00489866|4137233|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4310345|NCT00489853|4137248|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4310346|NCT00489853|4137248|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4310347|NCT00489853|4137248|B1|||Age||Year|Mean|63.7|63.7|Full Range|||42.0|83.0|
4310348|NCT00489736|4137345|B3||Male|Sex: Female, Male||Participants|Count of Participants|358|358.0||||||
4310349|NCT00489736|4137346|B2||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4310350|NCT00489736|4137347|B1||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4310351|NCT00489736|4137345|B3||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4310352|NCT00489736|4137346|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4310353|NCT00489736|4137347|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4310354|NCT00489736|4137345|B3|||Age||years|Mean|64.0|64.0|Standard Deviation|10.7|10.7|||
4310355|NCT00489736|4137346|B2|||Age||years|Mean|63.7|63.7|Standard Deviation|10.6|10.6|||
4310356|NCT00489736|4137347|B1|||Age||years|Mean|64.4|64.4|Standard Deviation|10.8|10.8|||
4310357|NCT00489736|4137345|B3|>= 75 years||Age, Customized||participants|Number|95|95.0||||||
4310358|NCT00489736|4137346|B2|>= 75 years||Age, Customized||participants|Number|47|47.0||||||
4310359|NCT00489736|4137347|B1|>= 75 years||Age, Customized||participants|Number|48|48.0||||||
4310360|NCT00489736|4137345|B3|65 to < 75 years||Age, Customized||participants|Number|146|146.0||||||
4310361|NCT00489736|4137346|B2|65 to < 75 years||Age, Customized||participants|Number|70|70.0||||||
4310362|NCT00489736|4137347|B1|65 to < 75 years||Age, Customized||participants|Number|76|76.0||||||
4310363|NCT00489736|4137345|B3|18 to < 65 years||Age, Customized||participants|Number|263|263.0||||||
4310364|NCT00489736|4137346|B2|18 to < 65 years||Age, Customized||participants|Number|138|138.0||||||
4310365|NCT00489736|4137347|B1|18 to < 65 years||Age, Customized||participants|Number|125|125.0||||||
4310366|NCT00489554|4137358|B1||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4310367|NCT00489554|4137358|B1||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4310368|NCT00489554|4137358|B1|||Age||weeks|Mean|8.2|8.2|Standard Deviation|1.63|1.63|||
4310369|NCT00489541|4137376|B3|TIMI 3||Lesion Characteristic: Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion TIMI 1 - Penetration with minimal perfusion TIMI 2 - Partial perfusion TIMI 3 - Complete perfusion|participants|Number|337|337.0||||||
4310370|NCT00489541|4137377|B2|TIMI 3||Lesion Characteristic: Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion TIMI 1 - Penetration with minimal perfusion TIMI 2 - Partial perfusion TIMI 3 - Complete perfusion|participants|Number|117|117.0||||||
4310371|NCT00489541|4137378|B1|TIMI 3||Lesion Characteristic: Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion TIMI 1 - Penetration with minimal perfusion TIMI 2 - Partial perfusion TIMI 3 - Complete perfusion|participants|Number|220|220.0||||||
4310372|NCT00489541|4137376|B3|TIMI 2||Lesion Characteristic: Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion TIMI 1 - Penetration with minimal perfusion TIMI 2 - Partial perfusion TIMI 3 - Complete perfusion|participants|Number|8|8.0||||||
4310373|NCT00489541|4137377|B2|TIMI 2||Lesion Characteristic: Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion TIMI 1 - Penetration with minimal perfusion TIMI 2 - Partial perfusion TIMI 3 - Complete perfusion|participants|Number|7|7.0||||||
4310374|NCT00489541|4137378|B1|TIMI 2||Lesion Characteristic: Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion TIMI 1 - Penetration with minimal perfusion TIMI 2 - Partial perfusion TIMI 3 - Complete perfusion|participants|Number|1|1.0||||||
4310375|NCT00489541|4137376|B3|TIMI 1||Lesion Characteristic: Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion TIMI 1 - Penetration with minimal perfusion TIMI 2 - Partial perfusion TIMI 3 - Complete perfusion|participants|Number|3|3.0||||||
4310376|NCT00489541|4137377|B2|TIMI 1||Lesion Characteristic: Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion TIMI 1 - Penetration with minimal perfusion TIMI 2 - Partial perfusion TIMI 3 - Complete perfusion|participants|Number|1|1.0||||||
4310377|NCT00489541|4137378|B1|TIMI 1||Lesion Characteristic: Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion TIMI 1 - Penetration with minimal perfusion TIMI 2 - Partial perfusion TIMI 3 - Complete perfusion|participants|Number|2|2.0||||||
4310378|NCT00489541|4137376|B3|TIMI 0||Lesion Characteristic: Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion TIMI 1 - Penetration with minimal perfusion TIMI 2 - Partial perfusion TIMI 3 - Complete perfusion|participants|Number|1|1.0||||||
4310379|NCT00489541|4137377|B2|TIMI 0||Lesion Characteristic: Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion TIMI 1 - Penetration with minimal perfusion TIMI 2 - Partial perfusion TIMI 3 - Complete perfusion|participants|Number|0|0.0||||||
4310380|NCT00489541|4137378|B1|TIMI 0||Lesion Characteristic: Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion TIMI 1 - Penetration with minimal perfusion TIMI 2 - Partial perfusion TIMI 3 - Complete perfusion|participants|Number|1|1.0||||||
4310381|NCT00489541|4137376|B3|Type C||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA)|"Type A lesions: minimally complex, readily accessible, non angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, and an absense of thrombus.~Type B lesions: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, with presence of thrombus.~Type C lesions: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|participants|Number|55|55.0||||||
4310382|NCT00489541|4137377|B2|Type C||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA)|"Type A lesions: minimally complex, readily accessible, non angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, and an absense of thrombus.~Type B lesions: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, with presence of thrombus.~Type C lesions: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|participants|Number|24|24.0||||||
4310383|NCT00489541|4137378|B1|Type C||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA)|"Type A lesions: minimally complex, readily accessible, non angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, and an absense of thrombus.~Type B lesions: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, with presence of thrombus.~Type C lesions: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|participants|Number|31|31.0||||||
4310384|NCT00489541|4137376|B3|Type B2||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA)|"Type A lesions: minimally complex, readily accessible, non angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, and an absense of thrombus.~Type B lesions: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, with presence of thrombus.~Type C lesions: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|participants|Number|172|172.0||||||
4310385|NCT00489541|4137377|B2|Type B2||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA)|"Type A lesions: minimally complex, readily accessible, non angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, and an absense of thrombus.~Type B lesions: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, with presence of thrombus.~Type C lesions: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|participants|Number|73|73.0||||||
4310386|NCT00489541|4137378|B1|Type B2||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA)|"Type A lesions: minimally complex, readily accessible, non angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, and an absense of thrombus.~Type B lesions: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, with presence of thrombus.~Type C lesions: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|participants|Number|99|99.0||||||
4310387|NCT00489541|4137376|B3|Type B1||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA)|"Type A lesions: minimally complex, readily accessible, non angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, and an absense of thrombus.~Type B lesions: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, with presence of thrombus.~Type C lesions: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|participants|Number|94|94.0||||||
4310388|NCT00489541|4137377|B2|Type B1||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA)|"Type A lesions: minimally complex, readily accessible, non angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, and an absense of thrombus.~Type B lesions: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, with presence of thrombus.~Type C lesions: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|participants|Number|21|21.0||||||
4310389|NCT00489541|4137378|B1|Type B1||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA)|"Type A lesions: minimally complex, readily accessible, non angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, and an absense of thrombus.~Type B lesions: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, with presence of thrombus.~Type C lesions: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|participants|Number|73|73.0||||||
4310390|NCT00489541|4137376|B3|Type A||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA)|"Type A lesions: minimally complex, readily accessible, non angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, and an absense of thrombus.~Type B lesions: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, with presence of thrombus.~Type C lesions: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|participants|Number|28|28.0||||||
4310391|NCT00489541|4137377|B2|Type A||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA)|"Type A lesions: minimally complex, readily accessible, non angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, and an absense of thrombus.~Type B lesions: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, with presence of thrombus.~Type C lesions: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|participants|Number|7|7.0||||||
4310417|NCT00489541|4137376|B3|Sidebranch Stenosis||Lesion Characteristics||millimeters|Mean|17.4|17.4|Standard Deviation|23.4|23.4|||
4310418|NCT00489541|4137377|B2|Sidebranch Stenosis||Lesion Characteristics||millimeters|Mean|16.0|16.0|Standard Deviation|21.2|21.2|||
4310392|NCT00489541|4137378|B1|Type A||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA)|"Type A lesions: minimally complex, readily accessible, non angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, and an absense of thrombus.~Type B lesions: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, with presence of thrombus.~Type C lesions: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|participants|Number|21|21.0||||||
4310393|NCT00489541|4137376|B3|> 90 Degree Bend||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|0|0.0||||||
4310394|NCT00489541|4137377|B2|> 90 Degree Bend||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|0|0.0||||||
4310395|NCT00489541|4137378|B1|> 90 Degree Bend||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|0|0.0||||||
4310396|NCT00489541|4137376|B3|> 45 Degree Bend||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|29|29.0||||||
4310397|NCT00489541|4137377|B2|> 45 Degree Bend||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|15|15.0||||||
4310398|NCT00489541|4137378|B1|> 45 Degree Bend||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|14|14.0||||||
4310399|NCT00489541|4137376|B3|Bifurcation||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|80|80.0||||||
4310400|NCT00489541|4137377|B2|Bifurcation||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|27|27.0||||||
4310401|NCT00489541|4137378|B1|Bifurcation||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|53|53.0||||||
4310402|NCT00489541|4137376|B3|Total Occlusion||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|4|4.0||||||
4310403|NCT00489541|4137377|B2|Total Occlusion||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|1|1.0||||||
4310404|NCT00489541|4137378|B1|Total Occlusion||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|3|3.0||||||
4310405|NCT00489541|4137376|B3|Calcification, any||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|56|56.0||||||
4310406|NCT00489541|4137377|B2|Calcification, any||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|26|26.0||||||
4310407|NCT00489541|4137378|B1|Calcification, any||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|30|30.0||||||
4310408|NCT00489541|4137376|B3|Tortuosity, any||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|43|43.0||||||
4310409|NCT00489541|4137377|B2|Tortuosity, any||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|23|23.0||||||
4310410|NCT00489541|4137378|B1|Tortuosity, any||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|20|20.0||||||
4310411|NCT00489541|4137376|B3|Eccentric Lesion||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|227|227.0||||||
4310412|NCT00489541|4137377|B2|Eccentric Lesion||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|78|78.0||||||
4310413|NCT00489541|4137378|B1|Eccentric Lesion||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|149|149.0||||||
4310414|NCT00489541|4137376|B3|||Percent Diameter Stenosis||percent|Mean|72.8|72.8|Standard Deviation|10.3|10.3|||
4310415|NCT00489541|4137377|B2|||Percent Diameter Stenosis||percent|Mean|71.5|71.5|Standard Deviation|10.4|10.4|||
4310416|NCT00489541|4137378|B1|||Percent Diameter Stenosis||percent|Mean|73.5|73.5|Standard Deviation|10.2|10.2|||
4310419|NCT00489541|4137378|B1|Sidebranch Stenosis||Lesion Characteristics||millimeters|Mean|18.1|18.1|Standard Deviation|24.6|24.6|||
4310420|NCT00489541|4137376|B3|Lesion Length||Lesion Characteristics||millimeters|Mean|12.1|12.1|Standard Deviation|5.1|5.1|||
4310421|NCT00489541|4137377|B2|Lesion Length||Lesion Characteristics||millimeters|Mean|12.9|12.9|Standard Deviation|5.1|5.1|||
4310422|NCT00489541|4137378|B1|Lesion Length||Lesion Characteristics||millimeters|Mean|11.7|11.7|Standard Deviation|5.1|5.1|||
4310423|NCT00489541|4137376|B3|Minimum Lumen Diameter||Lesion Characteristics||millimeters|Mean|0.6|0.6|Standard Deviation|0.2|0.2|||
4310424|NCT00489541|4137377|B2|Minimum Lumen Diameter||Lesion Characteristics||millimeters|Mean|0.6|0.6|Standard Deviation|0.2|0.2|||
4310425|NCT00489541|4137378|B1|Minimum Lumen Diameter||Lesion Characteristics||millimeters|Mean|0.6|0.6|Standard Deviation|0.2|0.2|||
4310426|NCT00489541|4137376|B3|Reference Vessel Diameter||Lesion Characteristics||millimeters|Mean|2.1|2.1|Standard Deviation|0.3|0.3|||
4310427|NCT00489541|4137377|B2|Reference Vessel Diameter||Lesion Characteristics||millimeters|Mean|2.2|2.2|Standard Deviation|0.4|0.4|||
4310428|NCT00489541|4137378|B1|Reference Vessel Diameter||Lesion Characteristics||millimeters|Mean|2.1|2.1|Standard Deviation|0.3|0.3|||
4310429|NCT00489541|4137376|B3|Distal||Lesion Characteristic: Lesion Location||participants|Number|41|41.0||||||
4310430|NCT00489541|4137377|B2|Distal||Lesion Characteristic: Lesion Location||participants|Number|22|22.0||||||
4310431|NCT00489541|4137378|B1|Distal||Lesion Characteristic: Lesion Location||participants|Number|19|19.0||||||
4310432|NCT00489541|4137376|B3|Mid||Lesion Characteristic: Lesion Location||participants|Number|156|156.0||||||
4310433|NCT00489541|4137377|B2|Mid||Lesion Characteristic: Lesion Location||participants|Number|56|56.0||||||
4310434|NCT00489541|4137378|B1|Mid||Lesion Characteristic: Lesion Location||participants|Number|100|100.0||||||
4310435|NCT00489541|4137376|B3|Proximal||Lesion Characteristic: Lesion Location||participants|Number|133|133.0||||||
4310436|NCT00489541|4137377|B2|Proximal||Lesion Characteristic: Lesion Location||participants|Number|42|42.0||||||
4310437|NCT00489541|4137378|B1|Proximal||Lesion Characteristic: Lesion Location||participants|Number|91|91.0||||||
4310438|NCT00489541|4137376|B3|Ostial||Lesion Characteristic: Lesion Location||participants|Number|19|19.0||||||
4310439|NCT00489541|4137377|B2|Ostial||Lesion Characteristic: Lesion Location||participants|Number|5|5.0||||||
4310440|NCT00489541|4137378|B1|Ostial||Lesion Characteristic: Lesion Location||participants|Number|14|14.0||||||
4310441|NCT00489541|4137376|B3|Right Coronary Artery||Lesion Characteristic: Target Lesion Vessel||participants|Number|73|73.0||||||
4310442|NCT00489541|4137377|B2|Right Coronary Artery||Lesion Characteristic: Target Lesion Vessel||participants|Number|27|27.0||||||
4310443|NCT00489541|4137378|B1|Right Coronary Artery||Lesion Characteristic: Target Lesion Vessel||participants|Number|46|46.0||||||
4310444|NCT00489541|4137376|B3|Left Circumflex||Lesion Characteristic: Target Lesion Vessel||participants|Number|138|138.0||||||
4310445|NCT00489541|4137377|B2|Left Circumflex||Lesion Characteristic: Target Lesion Vessel||participants|Number|45|45.0||||||
4310446|NCT00489541|4137378|B1|Left Circumflex||Lesion Characteristic: Target Lesion Vessel||participants|Number|93|93.0||||||
4310447|NCT00489541|4137376|B3|Left Anterior Descending||Lesion Characteristic: Target Lesion Vessel||participants|Number|138|138.0||||||
4310448|NCT00489541|4137377|B2|Left Anterior Descending||Lesion Characteristic: Target Lesion Vessel||participants|Number|53|53.0||||||
4310449|NCT00489541|4137378|B1|Left Anterior Descending||Lesion Characteristic: Target Lesion Vessel||participants|Number|85|85.0||||||
4310450|NCT00489541|4137376|B3|History of Gastrointestinal Bleeding||Comorbidities|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|7|7.0||||||
4310451|NCT00489541|4137377|B2|History of Gastrointestinal Bleeding||Comorbidities|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|2|2.0||||||
4310452|NCT00489541|4137378|B1|History of Gastrointestinal Bleeding||Comorbidities|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|5|5.0||||||
4310453|NCT00489541|4137376|B3|History of Renal Disease||Comorbidities|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|9|9.0||||||
4310454|NCT00489541|4137377|B2|History of Renal Disease||Comorbidities|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|0|0.0||||||
4310455|NCT00489541|4137378|B1|History of Renal Disease||Comorbidities|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|9|9.0||||||
4310456|NCT00489541|4137376|B3|Transient Ischemic Attack/Cerebrovascular Accident||Comorbidities|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|26|26.0||||||
4310457|NCT00489541|4137377|B2|Transient Ischemic Attack/Cerebrovascular Accident||Comorbidities|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|5|5.0||||||
4310458|NCT00489541|4137378|B1|Transient Ischemic Attack/Cerebrovascular Accident||Comorbidities|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|21|21.0||||||
4310518|NCT00489541|4137378|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310519|NCT00489541|4137376|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|319|319.0||||||
4310459|NCT00489541|4137376|B3|History of Peripheral Vascular Disease||Comorbidities|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|38|38.0||||||
4310460|NCT00489541|4137377|B2|History of Peripheral Vascular Disease||Comorbidities|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|14|14.0||||||
4310461|NCT00489541|4137378|B1|History of Peripheral Vascular Disease||Comorbidities|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|24|24.0||||||
4310462|NCT00489541|4137376|B3|Family History of Coronary Artery Disease||Cardiac Risk Factors|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|217|217.0||||||
4310463|NCT00489541|4137377|B2|Family History of Coronary Artery Disease||Cardiac Risk Factors|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|73|73.0||||||
4310464|NCT00489541|4137378|B1|Family History of Coronary Artery Disease||Cardiac Risk Factors|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|144|144.0||||||
4310465|NCT00489541|4137376|B3|Hypertension Requiring Medication||Cardiac Risk Factors|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|281|281.0||||||
4310466|NCT00489541|4137377|B2|Hypertension Requiring Medication||Cardiac Risk Factors|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|100|100.0||||||
4310467|NCT00489541|4137378|B1|Hypertension Requiring Medication||Cardiac Risk Factors|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|181|181.0||||||
4310468|NCT00489541|4137376|B3|Hyperlipidemia Requiring Medication||Cardiac Risk Factors|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|288|288.0||||||
4310469|NCT00489541|4137377|B2|Hyperlipidemia Requiring Medication||Cardiac Risk Factors|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|97|97.0||||||
4310470|NCT00489541|4137378|B1|Hyperlipidemia Requiring Medication||Cardiac Risk Factors|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|191|191.0||||||
4310471|NCT00489541|4137376|B3|Medically Treated Diabetes||Cardiac Risk Factors|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|122|122.0||||||
4310472|NCT00489541|4137377|B2|Medically Treated Diabetes||Cardiac Risk Factors|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|40|40.0||||||
4310473|NCT00489541|4137378|B1|Medically Treated Diabetes||Cardiac Risk Factors|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|82|82.0||||||
4310474|NCT00489541|4137376|B3|Smoking, Ever||Cardiac Risk Factors|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|206|206.0||||||
4310475|NCT00489541|4137377|B2|Smoking, Ever||Cardiac Risk Factors|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|69|69.0||||||
4310476|NCT00489541|4137378|B1|Smoking, Ever||Cardiac Risk Factors|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|137|137.0||||||
4310477|NCT00489541|4137376|B3|||Cardiac History: Ejection Fraction||ejection fraction percent|Mean|56.8|56.8|Standard Deviation|9.4|9.4|||
4310478|NCT00489541|4137377|B2|||Cardiac History: Ejection Fraction||ejection fraction percent|Mean|55.0|55.0|Standard Deviation|9.2|9.2|||
4310479|NCT00489541|4137378|B1|||Cardiac History: Ejection Fraction||ejection fraction percent|Mean|57.9|57.9|Standard Deviation|9.4|9.4|||
4310480|NCT00489541|4137376|B3|Silent Ischemia||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|61|61.0||||||
4310481|NCT00489541|4137377|B2|Silent Ischemia||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|18|18.0||||||
4310482|NCT00489541|4137378|B1|Silent Ischemia||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|43|43.0||||||
4310483|NCT00489541|4137376|B3|Unstable Angina||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|82|82.0||||||
4310520|NCT00489541|4137377|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|115|115.0||||||
4310521|NCT00489541|4137378|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|204|204.0||||||
4310484|NCT00489541|4137377|B2|Unstable Angina||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|37|37.0||||||
4310485|NCT00489541|4137378|B1|Unstable Angina||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|45|45.0||||||
4310486|NCT00489541|4137376|B3|Stable Angina||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|206|206.0||||||
4310487|NCT00489541|4137377|B2|Stable Angina||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|70|70.0||||||
4310488|NCT00489541|4137378|B1|Stable Angina||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|136|136.0||||||
4310489|NCT00489541|4137376|B3|Congestive Heart Failure||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|21|21.0||||||
4310490|NCT00489541|4137377|B2|Congestive Heart Failure||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|3|3.0||||||
4310491|NCT00489541|4137378|B1|Congestive Heart Failure||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|18|18.0||||||
4310492|NCT00489541|4137376|B3|Previous Myocardial Infarction (MI)||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|93|93.0||||||
4310493|NCT00489541|4137377|B2|Previous Myocardial Infarction (MI)||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|36|36.0||||||
4310494|NCT00489541|4137378|B1|Previous Myocardial Infarction (MI)||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|57|57.0||||||
4310495|NCT00489541|4137376|B3|Previous Coronary Artery Bypass Graft (CABG)||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|65|65.0||||||
4310496|NCT00489541|4137377|B2|Previous Coronary Artery Bypass Graft (CABG)||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|24|24.0||||||
4310497|NCT00489541|4137378|B1|Previous Coronary Artery Bypass Graft (CABG)||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|41|41.0||||||
4310498|NCT00489541|4137376|B3|Previous Percutaneous Coronary Intervention (PCI)||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|134|134.0||||||
4310499|NCT00489541|4137377|B2|Previous Percutaneous Coronary Intervention (PCI)||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|42|42.0||||||
4310500|NCT00489541|4137378|B1|Previous Percutaneous Coronary Intervention (PCI)||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|92|92.0||||||
4310501|NCT00489541|4137376|B3|United States||Region of Enrollment||participants|Number|349|349.0||||||
4310502|NCT00489541|4137377|B2|United States||Region of Enrollment||participants|Number|125|125.0||||||
4310503|NCT00489541|4137378|B1|United States||Region of Enrollment||participants|Number|224|224.0||||||
4310504|NCT00489541|4137376|B3|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4310505|NCT00489541|4137377|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4310506|NCT00489541|4137378|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4310507|NCT00489541|4137376|B3|American Indian or Alaska native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4310508|NCT00489541|4137377|B2|American Indian or Alaska native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310509|NCT00489541|4137378|B1|American Indian or Alaska native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4310510|NCT00489541|4137376|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310511|NCT00489541|4137377|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310512|NCT00489541|4137378|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310513|NCT00489541|4137376|B3|Black of African heritage||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4310514|NCT00489541|4137377|B2|Black of African heritage||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4310515|NCT00489541|4137378|B1|Black of African heritage||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4310516|NCT00489541|4137376|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310517|NCT00489541|4137377|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310522|NCT00489541|4137376|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4310523|NCT00489541|4137377|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4310524|NCT00489541|4137378|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4310525|NCT00489541|4137376|B3||Male|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
4310526|NCT00489541|4137377|B2||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4310527|NCT00489541|4137378|B1||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4310528|NCT00489541|4137376|B3||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4310529|NCT00489541|4137377|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4310530|NCT00489541|4137378|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4310531|NCT00489541|4137376|B3|||Age||years|Mean|64.5|64.5|Standard Deviation|10.5|10.5|||
4310532|NCT00489541|4137377|B2|||Age||years|Mean|64.2|64.2|Standard Deviation|10.9|10.9|||
4310533|NCT00489541|4137378|B1|||Age||years|Mean|64.7|64.7|Standard Deviation|10.3|10.3|||
4310534|NCT00489541|4137376|B3||>=65 years|Age||Participants|Count of Participants|186|186.0||||||
4310535|NCT00489541|4137377|B2||>=65 years|Age||Participants|Count of Participants|62|62.0||||||
4310536|NCT00489541|4137378|B1||>=65 years|Age||Participants|Count of Participants|124|124.0||||||
4310537|NCT00489541|4137376|B3||Between 18 and 65 years|Age||Participants|Count of Participants|163|163.0||||||
4310538|NCT00489541|4137377|B2||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4310539|NCT00489541|4137378|B1||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4310540|NCT00489541|4137376|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4310541|NCT00489541|4137377|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4310542|NCT00489541|4137378|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4310543|NCT00489489|4137387|B4|Low dose||Dose level of interferon-β|"'High dose': Rebif® 44 μg 3 times per week subcutaneously and, Betaseron® 0.25 mg every other day subcutaneously~'Low dose': Rebif® 22 μg 3 times per week subcutaneously and, Avonex® 30 μg once a week intramuscularly"|participants|Number|39|39.0||||||
4310544|NCT00489489|4137388|B3|Low dose||Dose level of interferon-β|"'High dose': Rebif® 44 μg 3 times per week subcutaneously and, Betaseron® 0.25 mg every other day subcutaneously~'Low dose': Rebif® 22 μg 3 times per week subcutaneously and, Avonex® 30 μg once a week intramuscularly"|participants|Number|14|14.0||||||
4310545|NCT00489489|4137389|B2|Low dose||Dose level of interferon-β|"'High dose': Rebif® 44 μg 3 times per week subcutaneously and, Betaseron® 0.25 mg every other day subcutaneously~'Low dose': Rebif® 22 μg 3 times per week subcutaneously and, Avonex® 30 μg once a week intramuscularly"|participants|Number|12|12.0||||||
4310546|NCT00489489|4137390|B1|Low dose||Dose level of interferon-β|"'High dose': Rebif® 44 μg 3 times per week subcutaneously and, Betaseron® 0.25 mg every other day subcutaneously~'Low dose': Rebif® 22 μg 3 times per week subcutaneously and, Avonex® 30 μg once a week intramuscularly"|participants|Number|13|13.0||||||
4310547|NCT00489489|4137387|B4|High dose||Dose level of interferon-β|"'High dose': Rebif® 44 μg 3 times per week subcutaneously and, Betaseron® 0.25 mg every other day subcutaneously~'Low dose': Rebif® 22 μg 3 times per week subcutaneously and, Avonex® 30 μg once a week intramuscularly"|participants|Number|77|77.0||||||
4310548|NCT00489489|4137388|B3|High dose||Dose level of interferon-β|"'High dose': Rebif® 44 μg 3 times per week subcutaneously and, Betaseron® 0.25 mg every other day subcutaneously~'Low dose': Rebif® 22 μg 3 times per week subcutaneously and, Avonex® 30 μg once a week intramuscularly"|participants|Number|24|24.0||||||
4310549|NCT00489489|4137389|B2|High dose||Dose level of interferon-β|"'High dose': Rebif® 44 μg 3 times per week subcutaneously and, Betaseron® 0.25 mg every other day subcutaneously~'Low dose': Rebif® 22 μg 3 times per week subcutaneously and, Avonex® 30 μg once a week intramuscularly"|participants|Number|25|25.0||||||
4310550|NCT00489489|4137390|B1|High dose||Dose level of interferon-β|"'High dose': Rebif® 44 μg 3 times per week subcutaneously and, Betaseron® 0.25 mg every other day subcutaneously~'Low dose': Rebif® 22 μg 3 times per week subcutaneously and, Avonex® 30 μg once a week intramuscularly"|participants|Number|28|28.0||||||
4310551|NCT00489489|4137387|B4|||Baseline Expanded Disability Status Scale (EDSS) score|"EDSS is an ordinal scale in half-point increments that qualifies disability in patients with MS. It consists of 8 ordinal rating scales assessing seven functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation.~EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS)."|units on a scale|Mean|2.50|2.5|Standard Deviation|1.41|1.41|||
4310552|NCT00489489|4137388|B3|||Baseline Expanded Disability Status Scale (EDSS) score|"EDSS is an ordinal scale in half-point increments that qualifies disability in patients with MS. It consists of 8 ordinal rating scales assessing seven functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation.~EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS)."|units on a scale|Mean|2.46|2.46|Standard Deviation|1.57|1.57|||
4310553|NCT00489489|4137389|B2|||Baseline Expanded Disability Status Scale (EDSS) score|"EDSS is an ordinal scale in half-point increments that qualifies disability in patients with MS. It consists of 8 ordinal rating scales assessing seven functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation.~EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS)."|units on a scale|Mean|2.41|2.41|Standard Deviation|1.44|1.44|||
4310554|NCT00489489|4137390|B1|||Baseline Expanded Disability Status Scale (EDSS) score|"EDSS is an ordinal scale in half-point increments that qualifies disability in patients with MS. It consists of 8 ordinal rating scales assessing seven functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation.~EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS)."|units on a scale|Mean|2.61|2.61|Standard Deviation|1.26|1.26|||
4310555|NCT00489489|4137387|B4|Progressive Relapsing||MS subtype||participants|Number|7|7.0||||||
4310556|NCT00489489|4137388|B3|Progressive Relapsing||MS subtype||participants|Number|1|1.0||||||
4310557|NCT00489489|4137389|B2|Progressive Relapsing||MS subtype||participants|Number|5|5.0||||||
4310558|NCT00489489|4137390|B1|Progressive Relapsing||MS subtype||participants|Number|1|1.0||||||
4310559|NCT00489489|4137387|B4|Secondary Progressive||MS subtype||participants|Number|7|7.0||||||
4310560|NCT00489489|4137388|B3|Secondary Progressive||MS subtype||participants|Number|3|3.0||||||
4310561|NCT00489489|4137389|B2|Secondary Progressive||MS subtype||participants|Number|2|2.0||||||
4310562|NCT00489489|4137390|B1|Secondary Progressive||MS subtype||participants|Number|2|2.0||||||
4310563|NCT00489489|4137387|B4|Relapsing Remitting||MS subtype||participants|Number|102|102.0||||||
4310564|NCT00489489|4137388|B3|Relapsing Remitting||MS subtype||participants|Number|34|34.0||||||
4310565|NCT00489489|4137389|B2|Relapsing Remitting||MS subtype||participants|Number|30|30.0||||||
4310566|NCT00489489|4137390|B1|Relapsing Remitting||MS subtype||participants|Number|38|38.0||||||
4310567|NCT00489489|4137387|B4|||Time since most recent MS relapse onset||months|Mean|27.12|27.12|Standard Deviation|36.03|36.03|||
4310568|NCT00489489|4137388|B3|||Time since most recent MS relapse onset||months|Mean|24.71|24.71|Standard Deviation|35.97|35.97|||
4310569|NCT00489489|4137389|B2|||Time since most recent MS relapse onset||months|Mean|28.97|28.97|Standard Deviation|34.06|34.06|||
4310570|NCT00489489|4137390|B1|||Time since most recent MS relapse onset||months|Mean|27.68|27.68|Standard Deviation|38.49|38.49|||
4310571|NCT00489489|4137387|B4|Within the past 2 years||Number of MS relapses||MS relapses|Median|1|1.0|Full Range|||0.0|5.0|
4310572|NCT00489489|4137388|B3|Within the past 2 years||Number of MS relapses||MS relapses|Median|1|1.0|Full Range|||0.0|4.0|
4310573|NCT00489489|4137389|B2|Within the past 2 years||Number of MS relapses||MS relapses|Median|1|1.0|Full Range|||0.0|5.0|
4310574|NCT00489489|4137390|B1|Within the past 2 years||Number of MS relapses||MS relapses|Median|1|1.0|Full Range|||0.0|5.0|
4310575|NCT00489489|4137387|B4|Within the past year||Number of MS relapses||MS relapses|Median|1|1.0|Full Range|||0.0|4.0|
4310576|NCT00489489|4137388|B3|Within the past year||Number of MS relapses||MS relapses|Median|1|1.0|Full Range|||0.0|3.0|
4310577|NCT00489489|4137389|B2|Within the past year||Number of MS relapses||MS relapses|Median|0|0.0|Full Range|||0.0|3.0|
4310578|NCT00489489|4137390|B1|Within the past year||Number of MS relapses||MS relapses|Median|1|1.0|Full Range|||0.0|4.0|
4310579|NCT00489489|4137387|B4|||Time since first diagnosis of Multiple Sclerosis (MS)||years|Mean|8.38|8.38|Standard Deviation|5.86|5.86|||
4310580|NCT00489489|4137388|B3|||Time since first diagnosis of Multiple Sclerosis (MS)||years|Mean|7.97|7.97|Standard Deviation|6.59|6.59|||
4310581|NCT00489489|4137389|B2|||Time since first diagnosis of Multiple Sclerosis (MS)||years|Mean|8.35|8.35|Standard Deviation|5.44|5.44|||
4310582|NCT00489489|4137390|B1|||Time since first diagnosis of Multiple Sclerosis (MS)||years|Mean|8.78|8.78|Standard Deviation|5.62|5.62|||
4310583|NCT00489489|4137387|B4|North America||Region of Enrollment|"Europe: Germany, Italy and Spain~North America: Canada and United States"|participants|Number|39|39.0||||||
4310584|NCT00489489|4137388|B3|North America||Region of Enrollment|"Europe: Germany, Italy and Spain~North America: Canada and United States"|participants|Number|14|14.0||||||
4310585|NCT00489489|4137389|B2|North America||Region of Enrollment|"Europe: Germany, Italy and Spain~North America: Canada and United States"|participants|Number|12|12.0||||||
4310586|NCT00489489|4137390|B1|North America||Region of Enrollment|"Europe: Germany, Italy and Spain~North America: Canada and United States"|participants|Number|13|13.0||||||
4310587|NCT00489489|4137387|B4|Europe||Region of Enrollment|"Europe: Germany, Italy and Spain~North America: Canada and United States"|participants|Number|77|77.0||||||
4310588|NCT00489489|4137388|B3|Europe||Region of Enrollment|"Europe: Germany, Italy and Spain~North America: Canada and United States"|participants|Number|24|24.0||||||
4310589|NCT00489489|4137389|B2|Europe||Region of Enrollment|"Europe: Germany, Italy and Spain~North America: Canada and United States"|participants|Number|25|25.0||||||
4310590|NCT00489489|4137390|B1|Europe||Region of Enrollment|"Europe: Germany, Italy and Spain~North America: Canada and United States"|participants|Number|28|28.0||||||
4310591|NCT00489489|4137387|B4||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4310592|NCT00489489|4137388|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4310593|NCT00489489|4137389|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4310594|NCT00489489|4137390|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4310595|NCT00489489|4137387|B4||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4310596|NCT00489489|4137388|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4310597|NCT00489489|4137389|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4310598|NCT00489489|4137390|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4310599|NCT00489489|4137387|B4|||Age|Baseline characteristics of the population included in the analyses: the 2 participants not treated were not included, and the participant who received teriflunomide 7 mg instead of teriflunomide 14 mg was included in the teriflunomide 7 mg group.|years|Mean|40.1|40.1|Standard Deviation|8.0|8.0|||
4310600|NCT00489489|4137388|B3|||Age|Baseline characteristics of the population included in the analyses: the 2 participants not treated were not included, and the participant who received teriflunomide 7 mg instead of teriflunomide 14 mg was included in the teriflunomide 7 mg group.|years|Mean|39.6|39.6|Standard Deviation|8.1|8.1|||
4310601|NCT00489489|4137389|B2|||Age|Baseline characteristics of the population included in the analyses: the 2 participants not treated were not included, and the participant who received teriflunomide 7 mg instead of teriflunomide 14 mg was included in the teriflunomide 7 mg group.|years|Mean|41.4|41.4|Standard Deviation|6.8|6.8|||
4310602|NCT00489489|4137390|B1|||Age|Baseline characteristics of the population included in the analyses: the 2 participants not treated were not included, and the participant who received teriflunomide 7 mg instead of teriflunomide 14 mg was included in the teriflunomide 7 mg group.|years|Mean|39.2|39.2|Standard Deviation|9.0|9.0|||
4310603|NCT00489476|4137420|B5|United States||Region of Enrollment||participants|Number|168|168.0||||||
4310604|NCT00489476|4137421|B4|United States||Region of Enrollment||participants|Number|43|43.0||||||
4310605|NCT00489476|4137422|B3|United States||Region of Enrollment||participants|Number|43|43.0||||||
4310606|NCT00489476|4137423|B2|United States||Region of Enrollment||participants|Number|43|43.0||||||
4310607|NCT00489476|4137424|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4310608|NCT00489476|4137420|B5||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4310609|NCT00489476|4137421|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4310610|NCT00489476|4137422|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4310611|NCT00489476|4137423|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4310612|NCT00489476|4137424|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4310613|NCT00489476|4137420|B5||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4310614|NCT00489476|4137421|B4||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4310615|NCT00489476|4137422|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4310616|NCT00489476|4137423|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4310617|NCT00489476|4137424|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4310618|NCT00489476|4137420|B5|||Age||years|Mean|41.1|41.1|Standard Deviation|2.20|2.2|||
4310619|NCT00489476|4137421|B4|||Age||years|Mean|42.3|42.3|Standard Deviation|12.68|12.68|||
4310620|NCT00489476|4137422|B3|||Age||years|Mean|38.5|38.5|Standard Deviation|11.89|11.89|||
4310621|NCT00489476|4137423|B2|||Age||years|Mean|41.7|41.7|Standard Deviation|13.09|13.09|||
4310622|NCT00489476|4137424|B1|||Age||years|Mean|42.2|42.2|Standard Deviation|10.94|10.94|||
4310623|NCT00489476|4137420|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4310624|NCT00489476|4137421|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4310625|NCT00489476|4137422|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4310626|NCT00489476|4137423|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4310627|NCT00489476|4137424|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4310628|NCT00489476|4137420|B5||Between 18 and 65 years|Age||Participants|Count of Participants|168|168.0||||||
4310629|NCT00489476|4137421|B4||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4310630|NCT00489476|4137422|B3||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4310631|NCT00489476|4137423|B2||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4310632|NCT00489476|4137424|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4310633|NCT00489476|4137420|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4310634|NCT00489476|4137421|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4310635|NCT00489476|4137422|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4310636|NCT00489476|4137423|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4310637|NCT00489476|4137424|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4310638|NCT00489424|4137445|B4|Female||Sex/Gender, Customized||participants|Number|793|793.0||||||
4310639|NCT00489424|4137446|B3|Female||Sex/Gender, Customized||participants|Number|262|262.0||||||
4310640|NCT00489424|4137447|B2|Female||Sex/Gender, Customized||participants|Number|264|264.0||||||
4310641|NCT00489424|4137448|B1|Female||Sex/Gender, Customized||participants|Number|267|267.0||||||
4310642|NCT00489424|4137445|B4|>=65 years||Age, Customized||participants|Number|301|301.0||||||
4310643|NCT00489424|4137446|B3|>=65 years||Age, Customized||participants|Number|103|103.0||||||
4310644|NCT00489424|4137447|B2|>=65 years||Age, Customized||participants|Number|97|97.0||||||
4310645|NCT00489424|4137448|B1|>=65 years||Age, Customized||participants|Number|101|101.0||||||
4310646|NCT00489424|4137445|B4|Between 56 and 64 years||Age, Customized||participants|Number|292|292.0||||||
4310647|NCT00489424|4137446|B3|Between 56 and 64 years||Age, Customized||participants|Number|92|92.0||||||
4310648|NCT00489424|4137447|B2|Between 56 and 64 years||Age, Customized||participants|Number|98|98.0||||||
4310649|NCT00489424|4137448|B1|Between 56 and 64 years||Age, Customized||participants|Number|102|102.0||||||
4310650|NCT00489424|4137445|B4|Between 45 and 55 years||Age, Customized||participants|Number|200|200.0||||||
4310651|NCT00489424|4137446|B3|Between 45 and 55 years||Age, Customized||participants|Number|67|67.0||||||
4310652|NCT00489424|4137447|B2|Between 45 and 55 years||Age, Customized||participants|Number|69|69.0||||||
4310653|NCT00489424|4137448|B1|Between 45 and 55 years||Age, Customized||participants|Number|64|64.0||||||
4310654|NCT00489411|4137479|B3|United States||Region of Enrollment||participants|Number|220|220.0||||||
4310655|NCT00489411|4137480|B2|United States||Region of Enrollment||participants|Number|111|111.0||||||
4310656|NCT00489411|4137481|B1|United States||Region of Enrollment||participants|Number|109|109.0||||||
4310657|NCT00489411|4137479|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4310658|NCT00489411|4137480|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4310659|NCT00489411|4137481|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4310660|NCT00489411|4137479|B3||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4310661|NCT00489411|4137480|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4310662|NCT00489411|4137481|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4310663|NCT00489411|4137479|B3|||Age||years|Mean|59.0|59.0|Standard Deviation|10.5|10.5|||
4310664|NCT00489411|4137480|B2|||Age||years|Mean|59.0|59.0|Standard Deviation|10.6|10.6|||
4310665|NCT00489411|4137481|B1|||Age||years|Mean|60.0|60.0|Standard Deviation|10.4|10.4|||
4310698|NCT00489359|4137496|B1|Argentina||Region of Enrollment||participants|Number|0|0.0||||||
4310666|NCT00489359|4137494|B3|>12 months||Platinum-free interval|The time elapsed since completing platinum-based therapy.|participants|Number|54|54.0||||||
4310667|NCT00489359|4137495|B2|>12 months||Platinum-free interval|The time elapsed since completing platinum-based therapy.|participants|Number|40|40.0||||||
4310668|NCT00489359|4137496|B1|>12 months||Platinum-free interval|The time elapsed since completing platinum-based therapy.|participants|Number|14|14.0||||||
4310669|NCT00489359|4137494|B3|6-12 months||Platinum-free interval|The time elapsed since completing platinum-based therapy.|participants|Number|29|29.0||||||
4310670|NCT00489359|4137495|B2|6-12 months||Platinum-free interval|The time elapsed since completing platinum-based therapy.|participants|Number|23|23.0||||||
4310671|NCT00489359|4137496|B1|6-12 months||Platinum-free interval|The time elapsed since completing platinum-based therapy.|participants|Number|6|6.0||||||
4310672|NCT00489359|4137494|B3|<6 months||Platinum-free interval|The time elapsed since completing platinum-based therapy.|participants|Number|3|3.0||||||
4310673|NCT00489359|4137495|B2|<6 months||Platinum-free interval|The time elapsed since completing platinum-based therapy.|participants|Number|3|3.0||||||
4310674|NCT00489359|4137496|B1|<6 months||Platinum-free interval|The time elapsed since completing platinum-based therapy.|participants|Number|0|0.0||||||
4310675|NCT00489359|4137494|B3|Peritoneal Cancer||Tumor Type||participants|Number|10|10.0||||||
4310676|NCT00489359|4137495|B2|Peritoneal Cancer||Tumor Type||participants|Number|5|5.0||||||
4310677|NCT00489359|4137496|B1|Peritoneal Cancer||Tumor Type||participants|Number|5|5.0||||||
4310678|NCT00489359|4137494|B3|Ovarian Cancer||Tumor Type||participants|Number|76|76.0||||||
4310679|NCT00489359|4137495|B2|Ovarian Cancer||Tumor Type||participants|Number|61|61.0||||||
4310680|NCT00489359|4137496|B1|Ovarian Cancer||Tumor Type||participants|Number|15|15.0||||||
4310681|NCT00489359|4137494|B3|ECOG Status 1||Performance Status|"The Eastern Cooperative Oncology Group (ECOG) score is an overall assessment of the functional/physical performance of the patient. Scores are:~0=Fully active, able to carry on all pre-disease performance without restriction. 1=Restricted in strenuous activity but ambulatory and able to carry out work of a sedentary nature. 2=Ambulatory and capable of self care but unable to carry out any work activities: up and about more than 50% of time. 3=Capable of only limited self care, confined to bed or chair more than 50% of waking hours. 4=Completely disabled, cannot carry on any self care."|participants|Number|37|37.0||||||
4310682|NCT00489359|4137495|B2|ECOG Status 1||Performance Status|"The Eastern Cooperative Oncology Group (ECOG) score is an overall assessment of the functional/physical performance of the patient. Scores are:~0=Fully active, able to carry on all pre-disease performance without restriction. 1=Restricted in strenuous activity but ambulatory and able to carry out work of a sedentary nature. 2=Ambulatory and capable of self care but unable to carry out any work activities: up and about more than 50% of time. 3=Capable of only limited self care, confined to bed or chair more than 50% of waking hours. 4=Completely disabled, cannot carry on any self care."|participants|Number|20|20.0||||||
4310683|NCT00489359|4137496|B1|ECOG Status 1||Performance Status|"The Eastern Cooperative Oncology Group (ECOG) score is an overall assessment of the functional/physical performance of the patient. Scores are:~0=Fully active, able to carry on all pre-disease performance without restriction. 1=Restricted in strenuous activity but ambulatory and able to carry out work of a sedentary nature. 2=Ambulatory and capable of self care but unable to carry out any work activities: up and about more than 50% of time. 3=Capable of only limited self care, confined to bed or chair more than 50% of waking hours. 4=Completely disabled, cannot carry on any self care."|participants|Number|17|17.0||||||
4310684|NCT00489359|4137494|B3|ECOG Status 0||Performance Status|"The Eastern Cooperative Oncology Group (ECOG) score is an overall assessment of the functional/physical performance of the patient. Scores are:~0=Fully active, able to carry on all pre-disease performance without restriction. 1=Restricted in strenuous activity but ambulatory and able to carry out work of a sedentary nature. 2=Ambulatory and capable of self care but unable to carry out any work activities: up and about more than 50% of time. 3=Capable of only limited self care, confined to bed or chair more than 50% of waking hours. 4=Completely disabled, cannot carry on any self care."|participants|Number|49|49.0||||||
4310685|NCT00489359|4137495|B2|ECOG Status 0||Performance Status|"The Eastern Cooperative Oncology Group (ECOG) score is an overall assessment of the functional/physical performance of the patient. Scores are:~0=Fully active, able to carry on all pre-disease performance without restriction. 1=Restricted in strenuous activity but ambulatory and able to carry out work of a sedentary nature. 2=Ambulatory and capable of self care but unable to carry out any work activities: up and about more than 50% of time. 3=Capable of only limited self care, confined to bed or chair more than 50% of waking hours. 4=Completely disabled, cannot carry on any self care."|participants|Number|46|46.0||||||
4310686|NCT00489359|4137496|B1|ECOG Status 0||Performance Status|"The Eastern Cooperative Oncology Group (ECOG) score is an overall assessment of the functional/physical performance of the patient. Scores are:~0=Fully active, able to carry on all pre-disease performance without restriction. 1=Restricted in strenuous activity but ambulatory and able to carry out work of a sedentary nature. 2=Ambulatory and capable of self care but unable to carry out any work activities: up and about more than 50% of time. 3=Capable of only limited self care, confined to bed or chair more than 50% of waking hours. 4=Completely disabled, cannot carry on any self care."|participants|Number|3|3.0||||||
4310687|NCT00489359|4137494|B3|Sweden||Region of Enrollment||participants|Number|9|9.0||||||
4310688|NCT00489359|4137495|B2|Sweden||Region of Enrollment||participants|Number|9|9.0||||||
4310689|NCT00489359|4137496|B1|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
4310690|NCT00489359|4137494|B3|Germany||Region of Enrollment||participants|Number|51|51.0||||||
4310691|NCT00489359|4137495|B2|Germany||Region of Enrollment||participants|Number|31|31.0||||||
4310692|NCT00489359|4137496|B1|Germany||Region of Enrollment||participants|Number|20|20.0||||||
4310693|NCT00489359|4137494|B3|Poland||Region of Enrollment||participants|Number|5|5.0||||||
4310694|NCT00489359|4137495|B2|Poland||Region of Enrollment||participants|Number|5|5.0||||||
4310695|NCT00489359|4137496|B1|Poland||Region of Enrollment||participants|Number|0|0.0||||||
4310696|NCT00489359|4137494|B3|Argentina||Region of Enrollment||participants|Number|14|14.0||||||
4310697|NCT00489359|4137495|B2|Argentina||Region of Enrollment||participants|Number|14|14.0||||||
4310699|NCT00489359|4137494|B3|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4310700|NCT00489359|4137495|B2|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4310701|NCT00489359|4137496|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4310702|NCT00489359|4137494|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4310703|NCT00489359|4137495|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4310704|NCT00489359|4137496|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4310705|NCT00489359|4137494|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
4310706|NCT00489359|4137495|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
4310707|NCT00489359|4137496|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4310708|NCT00489359|4137494|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4310709|NCT00489359|4137495|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4310710|NCT00489359|4137496|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4310711|NCT00489359|4137494|B3||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4310712|NCT00489359|4137495|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4310713|NCT00489359|4137496|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4310714|NCT00489359|4137494|B3|||Age||years|Mean|57.54|57.54|Standard Deviation|10.52|10.52|||
4310715|NCT00489359|4137495|B2|||Age||years|Mean|57.71|57.71|Standard Deviation|10.44|10.44|||
4310716|NCT00489359|4137496|B1|||Age||years|Mean|56.99|56.99|Standard Deviation|11.06|11.06|||
4310717|NCT00489268|4137520|B6|Puerto Rico||Region of Enrollment||participants|Number|18|18.0||||||
4310718|NCT00489268|4137521|B5|Puerto Rico||Region of Enrollment||participants|Number|18|18.0||||||
4310719|NCT00489268|4137522|B4|Puerto Rico||Region of Enrollment||participants|Number|0|0.0||||||
4310720|NCT00489268|4137523|B3|Puerto Rico||Region of Enrollment||participants|Number|0|0.0||||||
4310721|NCT00489268|4137524|B2|Puerto Rico||Region of Enrollment||participants|Number|0|0.0||||||
4310722|NCT00489268|4137525|B1|Puerto Rico||Region of Enrollment||participants|Number|0|0.0||||||
4310723|NCT00489268|4137520|B6|United States||Region of Enrollment||participants|Number|84|84.0||||||
4310724|NCT00489268|4137521|B5|United States||Region of Enrollment||participants|Number|52|52.0||||||
4310725|NCT00489268|4137522|B4|United States||Region of Enrollment||participants|Number|11|11.0||||||
4310726|NCT00489268|4137523|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4310727|NCT00489268|4137524|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4310728|NCT00489268|4137525|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4310729|NCT00489268|4137520|B6||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4310730|NCT00489268|4137521|B5||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4310731|NCT00489268|4137522|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4310732|NCT00489268|4137523|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4310733|NCT00489268|4137524|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4310734|NCT00489268|4137525|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4310735|NCT00489268|4137520|B6||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4310736|NCT00489268|4137521|B5||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4310737|NCT00489268|4137522|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4310738|NCT00489268|4137523|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4310739|NCT00489268|4137524|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4310740|NCT00489268|4137525|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4310741|NCT00489268|4137520|B6||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4310742|NCT00489268|4137521|B5||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4310743|NCT00489268|4137522|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4310744|NCT00489268|4137523|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4310745|NCT00489268|4137524|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4310746|NCT00489268|4137525|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4310747|NCT00489268|4137520|B6||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4310748|NCT00489268|4137521|B5||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4310749|NCT00489268|4137522|B4||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4310750|NCT00489268|4137523|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4310751|NCT00489268|4137524|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4310752|NCT00489268|4137525|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4310753|NCT00489268|4137520|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4310754|NCT00489268|4137521|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4310755|NCT00489268|4137522|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4310756|NCT00489268|4137523|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4310757|NCT00489268|4137524|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4310758|NCT00489268|4137525|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4310794|NCT00489216|4137607|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4310795|NCT00489216|4137607|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4310860|NCT00488683|4137666|B1|Caucasians||Race/Ethnicity, Customized||Subjects|Number|95|95.0||||||
4310759|NCT00489255|4137556|B3|||UPDRS motor score for Period 3|Part III (Motor Examination) of the UPDRS contains 14 items designed to assess the severity of the cardinal motor findings (e.g., tremor, rigidity, bradykinesia, postural instability, etc.) in patients with Parkinson's disease. UPDRS motor score range from 0 to 56, with 56 indicative of the worst and 0 no disability.|Score on a scale|Mean|25.2|25.2|Standard Deviation|14.35|14.35|||
4310760|NCT00489255|4137557|B2|||UPDRS motor score for Period 3|Part III (Motor Examination) of the UPDRS contains 14 items designed to assess the severity of the cardinal motor findings (e.g., tremor, rigidity, bradykinesia, postural instability, etc.) in patients with Parkinson's disease. UPDRS motor score range from 0 to 56, with 56 indicative of the worst and 0 no disability.|Score on a scale|Mean|25.1|25.1|Standard Deviation|14.69|14.69|||
4310761|NCT00489255|4137558|B1|||UPDRS motor score for Period 3|Part III (Motor Examination) of the UPDRS contains 14 items designed to assess the severity of the cardinal motor findings (e.g., tremor, rigidity, bradykinesia, postural instability, etc.) in patients with Parkinson's disease. UPDRS motor score range from 0 to 56, with 56 indicative of the worst and 0 no disability.|Score on a scale|Mean|25.5|25.5|Standard Deviation|13.58|13.58|||
4310762|NCT00489255|4137556|B3|||UPDRS total score for Period 3|The UPDRS is a 4-part rating tool to follow the longitudinal course of Parkinson’s disease. The four sections in the scale are 1. Mentation, Behavior and Mood, 2. Activities of Daily Living (ADL), 3. Motor Exam and 4. Complications of Therapy. UPDRS total score range from 0 to 199, with 199 indicative of the worst and 0 no disability.|Score on a scale|Mean|47.6|47.6|Standard Deviation|20.06|20.06|||
4310763|NCT00489255|4137557|B2|||UPDRS total score for Period 3|The UPDRS is a 4-part rating tool to follow the longitudinal course of Parkinson’s disease. The four sections in the scale are 1. Mentation, Behavior and Mood, 2. Activities of Daily Living (ADL), 3. Motor Exam and 4. Complications of Therapy. UPDRS total score range from 0 to 199, with 199 indicative of the worst and 0 no disability.|Score on a scale|Mean|47.5|47.5|Standard Deviation|20.87|20.87|||
4310764|NCT00489255|4137558|B1|||UPDRS total score for Period 3|The UPDRS is a 4-part rating tool to follow the longitudinal course of Parkinson’s disease. The four sections in the scale are 1. Mentation, Behavior and Mood, 2. Activities of Daily Living (ADL), 3. Motor Exam and 4. Complications of Therapy. UPDRS total score range from 0 to 199, with 199 indicative of the worst and 0 no disability.|Score on a scale|Mean|48.1|48.1|Standard Deviation|17.84|17.84|||
4310765|NCT00489255|4137556|B3|||UPDRS motor score for Period 2|Part III (Motor Examination) of the UPDRS contains 14 items designed to assess the severity of the cardinal motor findings (e.g., tremor, rigidity, bradykinesia, postural instability, etc.) in patients with Parkinson's disease. UPDRS motor score range from 0 to 56, with 56 indicative of the worst and 0 no disability.|Score on a scale|Mean|24.9|24.9|Standard Deviation|14.14|14.14|||
4310766|NCT00489255|4137557|B2|||UPDRS motor score for Period 2|Part III (Motor Examination) of the UPDRS contains 14 items designed to assess the severity of the cardinal motor findings (e.g., tremor, rigidity, bradykinesia, postural instability, etc.) in patients with Parkinson's disease. UPDRS motor score range from 0 to 56, with 56 indicative of the worst and 0 no disability.|Score on a scale|Mean|25.5|25.5|Standard Deviation|12.60|12.6|||
4310767|NCT00489255|4137558|B1|||UPDRS motor score for Period 2|Part III (Motor Examination) of the UPDRS contains 14 items designed to assess the severity of the cardinal motor findings (e.g., tremor, rigidity, bradykinesia, postural instability, etc.) in patients with Parkinson's disease. UPDRS motor score range from 0 to 56, with 56 indicative of the worst and 0 no disability.|Score on a scale|Mean|24.3|24.3|Standard Deviation|15.50|15.5|||
4310768|NCT00489255|4137556|B3|||UPDRS total score for Period 2|The UPDRS is a 4-part rating tool to follow the longitudinal course of Parkinson’s disease. The four sections in the scale are 1. Mentation, Behavior and Mood, 2. Activities of Daily Living (ADL), 3. Motor Exam and 4. Complications of Therapy. UPDRS total score range from 0 to 199, with 199 indicative of the worst and 0 no disability.|Score on a scale|Mean|47.1|47.1|Standard Deviation|20.09|20.09|||
4310769|NCT00489255|4137557|B2|||UPDRS total score for Period 2|The UPDRS is a 4-part rating tool to follow the longitudinal course of Parkinson’s disease. The four sections in the scale are 1. Mentation, Behavior and Mood, 2. Activities of Daily Living (ADL), 3. Motor Exam and 4. Complications of Therapy. UPDRS total score range from 0 to 199, with 199 indicative of the worst and 0 no disability.|Score on a scale|Mean|47.6|47.6|Standard Deviation|18.83|18.83|||
4310770|NCT00489255|4137558|B1|||UPDRS total score for Period 2|The UPDRS is a 4-part rating tool to follow the longitudinal course of Parkinson’s disease. The four sections in the scale are 1. Mentation, Behavior and Mood, 2. Activities of Daily Living (ADL), 3. Motor Exam and 4. Complications of Therapy. UPDRS total score range from 0 to 199, with 199 indicative of the worst and 0 no disability.|Score on a scale|Mean|46.7|46.7|Standard Deviation|21.32|21.32|||
4310771|NCT00489255|4137556|B3|||UPDRS motor score for Period 1|Part III (Motor Examination) of the UPDRS contains 14 items designed to assess the severity of the cardinal motor findings (e.g., tremor, rigidity, bradykinesia, postural instability, etc.) in patients with Parkinson's disease. UPDRS motor score range from 0 to 56, with 56 indicative of the worst and 0 no disability.|Score on a scale|Mean|25.6|25.6|Standard Deviation|14.37|14.37|||
4310772|NCT00489255|4137557|B2|||UPDRS motor score for Period 1|Part III (Motor Examination) of the UPDRS contains 14 items designed to assess the severity of the cardinal motor findings (e.g., tremor, rigidity, bradykinesia, postural instability, etc.) in patients with Parkinson's disease. UPDRS motor score range from 0 to 56, with 56 indicative of the worst and 0 no disability.|Score on a scale|Mean|25.2|25.2|Standard Deviation|12.25|12.25|||
4310773|NCT00489255|4137558|B1|||UPDRS motor score for Period 1|Part III (Motor Examination) of the UPDRS contains 14 items designed to assess the severity of the cardinal motor findings (e.g., tremor, rigidity, bradykinesia, postural instability, etc.) in patients with Parkinson's disease. UPDRS motor score range from 0 to 56, with 56 indicative of the worst and 0 no disability.|Score on a scale|Mean|25.7|25.7|Standard Deviation|15.07|15.07|||
4310774|NCT00489255|4137556|B3|||Unified Parkinson's Disease Rating Scale (UPDRS) total score for Period 1|The UPDRS is a 4-part rating tool to follow the longitudinal course of Parkinson’s disease. The four sections in the scale are 1. Mentation, Behavior and Mood, 2. Activities of Daily Living (ADL), 3. Motor Exam and 4. Complications of Therapy. UPDRS total score range from 0 to 199, with 199 indicative of the worst and 0 no disability.|Score on a scale|Mean|48.8|48.8|Standard Deviation|20.40|20.4|||
4310796|NCT00489216|4137607|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4310775|NCT00489255|4137557|B2|||Unified Parkinson's Disease Rating Scale (UPDRS) total score for Period 1|The UPDRS is a 4-part rating tool to follow the longitudinal course of Parkinson’s disease. The four sections in the scale are 1. Mentation, Behavior and Mood, 2. Activities of Daily Living (ADL), 3. Motor Exam and 4. Complications of Therapy. UPDRS total score range from 0 to 199, with 199 indicative of the worst and 0 no disability.|Score on a scale|Mean|47.8|47.8|Standard Deviation|17.83|17.83|||
4310776|NCT00489255|4137558|B1|||Unified Parkinson's Disease Rating Scale (UPDRS) total score for Period 1|The UPDRS is a 4-part rating tool to follow the longitudinal course of Parkinson’s disease. The four sections in the scale are 1. Mentation, Behavior and Mood, 2. Activities of Daily Living (ADL), 3. Motor Exam and 4. Complications of Therapy. UPDRS total score range from 0 to 199, with 199 indicative of the worst and 0 no disability.|Score on a scale|Mean|49.2|49.2|Standard Deviation|21.26|21.26|||
4310777|NCT00489255|4137556|B3||Male|Sex: Female, Male|"Data for Period 1.~Period 2 & 3 are as follows:~Period 2, Re-randomized patients~Female: 19 participants in 'Trimethobenzamide (Tigan®)' arm and 11 participants in 'Placebo' arm.~Male: 45 participants in 'Trimethobenzamide (Tigan®)' arm and 19 participants in 'Placebo' arm.~Period 3, Re-randomized patients~Female: 7 participants in 'Trimethobenzamide (Tigan®)' arm and 8 participants in 'Placebo' arm.~Male: 21 participants in 'Trimethobenzamide (Tigan®)' arm and 22 participants in 'Placebo' arm."|Participants|Count of Participants|125|125.0||||||
4310778|NCT00489255|4137557|B2||Male|Sex: Female, Male|"Data for Period 1.~Period 2 & 3 are as follows:~Period 2, Re-randomized patients~Female: 19 participants in 'Trimethobenzamide (Tigan®)' arm and 11 participants in 'Placebo' arm.~Male: 45 participants in 'Trimethobenzamide (Tigan®)' arm and 19 participants in 'Placebo' arm.~Period 3, Re-randomized patients~Female: 7 participants in 'Trimethobenzamide (Tigan®)' arm and 8 participants in 'Placebo' arm.~Male: 21 participants in 'Trimethobenzamide (Tigan®)' arm and 22 participants in 'Placebo' arm."|Participants|Count of Participants|33|33.0||||||
4310779|NCT00489255|4137558|B1||Male|Sex: Female, Male|"Data for Period 1.~Period 2 & 3 are as follows:~Period 2, Re-randomized patients~Female: 19 participants in 'Trimethobenzamide (Tigan®)' arm and 11 participants in 'Placebo' arm.~Male: 45 participants in 'Trimethobenzamide (Tigan®)' arm and 19 participants in 'Placebo' arm.~Period 3, Re-randomized patients~Female: 7 participants in 'Trimethobenzamide (Tigan®)' arm and 8 participants in 'Placebo' arm.~Male: 21 participants in 'Trimethobenzamide (Tigan®)' arm and 22 participants in 'Placebo' arm."|Participants|Count of Participants|92|92.0||||||
4310780|NCT00489255|4137556|B3||Female|Sex: Female, Male|"Data for Period 1.~Period 2 & 3 are as follows:~Period 2, Re-randomized patients~Female: 19 participants in 'Trimethobenzamide (Tigan®)' arm and 11 participants in 'Placebo' arm.~Male: 45 participants in 'Trimethobenzamide (Tigan®)' arm and 19 participants in 'Placebo' arm.~Period 3, Re-randomized patients~Female: 7 participants in 'Trimethobenzamide (Tigan®)' arm and 8 participants in 'Placebo' arm.~Male: 21 participants in 'Trimethobenzamide (Tigan®)' arm and 22 participants in 'Placebo' arm."|Participants|Count of Participants|55|55.0||||||
4310781|NCT00489255|4137557|B2||Female|Sex: Female, Male|"Data for Period 1.~Period 2 & 3 are as follows:~Period 2, Re-randomized patients~Female: 19 participants in 'Trimethobenzamide (Tigan®)' arm and 11 participants in 'Placebo' arm.~Male: 45 participants in 'Trimethobenzamide (Tigan®)' arm and 19 participants in 'Placebo' arm.~Period 3, Re-randomized patients~Female: 7 participants in 'Trimethobenzamide (Tigan®)' arm and 8 participants in 'Placebo' arm.~Male: 21 participants in 'Trimethobenzamide (Tigan®)' arm and 22 participants in 'Placebo' arm."|Participants|Count of Participants|13|13.0||||||
4310782|NCT00489255|4137558|B1||Female|Sex: Female, Male|"Data for Period 1.~Period 2 & 3 are as follows:~Period 2, Re-randomized patients~Female: 19 participants in 'Trimethobenzamide (Tigan®)' arm and 11 participants in 'Placebo' arm.~Male: 45 participants in 'Trimethobenzamide (Tigan®)' arm and 19 participants in 'Placebo' arm.~Period 3, Re-randomized patients~Female: 7 participants in 'Trimethobenzamide (Tigan®)' arm and 8 participants in 'Placebo' arm.~Male: 21 participants in 'Trimethobenzamide (Tigan®)' arm and 22 participants in 'Placebo' arm."|Participants|Count of Participants|42|42.0||||||
4310783|NCT00489255|4137556|B3|||Age|"Period 3 (Re-randomized patients):~Overall Number of Baseline Participants in 'Trimethobenzamide (Tigan®)' arm is 28.~Overall Number of Baseline Participants in 'Placebo' arm is is 30 (re-randomized) and 82 (all placebo)."|years|Median|64.0|64.0|Full Range|||24.0|86.0|
4310784|NCT00489255|4137557|B2|||Age|"Period 3 (Re-randomized patients):~Overall Number of Baseline Participants in 'Trimethobenzamide (Tigan®)' arm is 28.~Overall Number of Baseline Participants in 'Placebo' arm is is 30 (re-randomized) and 82 (all placebo)."|years|Median|63.0|63.0|Full Range|||33.0|84.0|
4310785|NCT00489255|4137558|B1|||Age|"Period 3 (Re-randomized patients):~Overall Number of Baseline Participants in 'Trimethobenzamide (Tigan®)' arm is 28.~Overall Number of Baseline Participants in 'Placebo' arm is is 30 (re-randomized) and 82 (all placebo)."|years|Median|66.5|66.5|Full Range|||41.0|86.0|
4310786|NCT00489255|4137556|B3|||Age|"Period 2 (Re-randomized patients):~Overall Number of Baseline Participants in 'Trimethobenzamide (Tigan®)' arm is 64.~Overall Number of Baseline Participants in 'Placebo' arm is 30 (re-randomized) and 59 (all placebo)."|years|Median|64.0|64.0|Full Range|||24.0|86.0|
4310787|NCT00489255|4137557|B2|||Age|"Period 2 (Re-randomized patients):~Overall Number of Baseline Participants in 'Trimethobenzamide (Tigan®)' arm is 64.~Overall Number of Baseline Participants in 'Placebo' arm is 30 (re-randomized) and 59 (all placebo)."|years|Median|65.5|65.5|Full Range|||24.0|85.0|
4310788|NCT00489255|4137558|B1|||Age|"Period 2 (Re-randomized patients):~Overall Number of Baseline Participants in 'Trimethobenzamide (Tigan®)' arm is 64.~Overall Number of Baseline Participants in 'Placebo' arm is 30 (re-randomized) and 59 (all placebo)."|years|Median|64.0|64.0|Full Range|||33.0|86.0|
4310789|NCT00489255|4137556|B3|||Age|"Period 1:~Overall Number of Baseline Participants in 'Trimethobenzamide (Tigan®)' arm is 134.~Overall Number of Baseline Participants in 'Placebo' arm is 46."|years|Median|65.0|65.0|Full Range|||24.0|93.0|
4310790|NCT00489255|4137557|B2|||Age|"Period 1:~Overall Number of Baseline Participants in 'Trimethobenzamide (Tigan®)' arm is 134.~Overall Number of Baseline Participants in 'Placebo' arm is 46."|years|Median|63.5|63.5|Full Range|||49.0|79.0|
4310791|NCT00489255|4137558|B1|||Age|"Period 1:~Overall Number of Baseline Participants in 'Trimethobenzamide (Tigan®)' arm is 134.~Overall Number of Baseline Participants in 'Placebo' arm is 46."|years|Median|65.5|65.5|Full Range|||24.0|93.0|
4310792|NCT00489216|4137607|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4310793|NCT00489216|4137607|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4310797|NCT00489216|4137607|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4310798|NCT00489216|4137607|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4310799|NCT00489216|4137607|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4310800|NCT00489216|4137607|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4310801|NCT00489216|4137607|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4310802|NCT00489216|4137607|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4310803|NCT00489216|4137607|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4310804|NCT00489216|4137607|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4310805|NCT00489086|4137616|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4310806|NCT00489086|4137616|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4310807|NCT00489086|4137616|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4310808|NCT00489086|4137616|B1|||Age||years|Mean|53|53.0|Standard Deviation|10|10.0|||
4310809|NCT00489086|4137616|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4310810|NCT00489086|4137616|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4310811|NCT00489086|4137616|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4310812|NCT00488865|4137620|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
4310813|NCT00488865|4137620|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4310814|NCT00488865|4137620|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4310815|NCT00488865|4137620|B1|||Age||years|Mean|59.1|59.1|Standard Deviation|16.7|16.7|||
4310816|NCT00488865|4137620|B1|>=18 years||Age, Customized||participants|Number|100|100.0||||||
4310817|NCT00488865|4137620|B1|<18 years||Age, Customized||participants|Number|0|0.0||||||
4310818|NCT00488826|4137626|B4||Male|Sex: Female, Male||Participants|Count of Participants|444|444.0||||||
4310819|NCT00488826|4137627|B3||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4310820|NCT00488826|4137628|B2||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4310821|NCT00488826|4137629|B1||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4310822|NCT00488826|4137626|B4||Female|Sex: Female, Male||Participants|Count of Participants|356|356.0||||||
4310823|NCT00488826|4137627|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4310824|NCT00488826|4137628|B2||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4310825|NCT00488826|4137629|B1||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4310826|NCT00488826|4137626|B4|||Age||months|Median|3.5|3.5|Standard Deviation|1.23|1.23|||
4310827|NCT00488826|4137627|B3|||Age||months|Median|3.5|3.5|Standard Deviation|1.7|1.7|3.0|4.7|
4310828|NCT00488826|4137628|B2|||Age||months|Median|3.5|3.5|Standard Deviation|1.0|1.0|3.0|4.0|
4310829|NCT00488826|4137629|B1|||Age||months|Median|3.5|3.5|Standard Deviation|1.0|1.0|3.0|4.0|
4310830|NCT00488774|4137642|B5||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4310831|NCT00488774|4137643|B4||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4310832|NCT00488774|4137644|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4310833|NCT00488774|4137645|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4310834|NCT00488774|4137646|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4310835|NCT00488774|4137642|B5||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4310836|NCT00488774|4137643|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4310837|NCT00488774|4137644|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4310838|NCT00488774|4137645|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4310839|NCT00488774|4137646|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4310840|NCT00488774|4137642|B5|||Age||Years|Mean|41|41.0|Standard Deviation|13.74|13.74|||
4310841|NCT00488774|4137643|B4|||Age||Years|Mean|39.9|39.9|Standard Deviation|14.07|14.07|||
4310842|NCT00488774|4137644|B3|||Age||Years|Mean|42.3|42.3|Standard Deviation|13.14|13.14|||
4310843|NCT00488774|4137645|B2|||Age||Years|Mean|40.7|40.7|Standard Deviation|15.51|15.51|||
4310844|NCT00488774|4137646|B1|||Age||Years|Mean|40.9|40.9|Standard Deviation|12.58|12.58|||
4310845|NCT00488683|4137663|B4|Others||Race/Ethnicity, Customized||Subjects|Number|17|17.0||||||
4310846|NCT00488683|4137664|B3|Others||Race/Ethnicity, Customized||Subjects|Number|3|3.0||||||
4310847|NCT00488683|4137665|B2|Others||Race/Ethnicity, Customized||Subjects|Number|4|4.0||||||
4310848|NCT00488683|4137666|B1|Others||Race/Ethnicity, Customized||Subjects|Number|10|10.0||||||
4310849|NCT00488683|4137663|B4|Asian||Race/Ethnicity, Customized||Subjects|Number|2|2.0||||||
4310850|NCT00488683|4137664|B3|Asian||Race/Ethnicity, Customized||Subjects|Number|0|0.0||||||
4310851|NCT00488683|4137665|B2|Asian||Race/Ethnicity, Customized||Subjects|Number|1|1.0||||||
4310852|NCT00488683|4137666|B1|Asian||Race/Ethnicity, Customized||Subjects|Number|1|1.0||||||
4310853|NCT00488683|4137663|B4|Black||Race/Ethnicity, Customized||Subjects|Number|4|4.0||||||
4310854|NCT00488683|4137664|B3|Black||Race/Ethnicity, Customized||Subjects|Number|0|0.0||||||
4310855|NCT00488683|4137665|B2|Black||Race/Ethnicity, Customized||Subjects|Number|2|2.0||||||
4310856|NCT00488683|4137666|B1|Black||Race/Ethnicity, Customized||Subjects|Number|2|2.0||||||
4310857|NCT00488683|4137663|B4|Caucasians||Race/Ethnicity, Customized||Subjects|Number|193|193.0||||||
4310858|NCT00488683|4137664|B3|Caucasians||Race/Ethnicity, Customized||Subjects|Number|51|51.0||||||
4310859|NCT00488683|4137665|B2|Caucasians||Race/Ethnicity, Customized||Subjects|Number|47|47.0||||||
4310861|NCT00488683|4137663|B4||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4310862|NCT00488683|4137664|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4310863|NCT00488683|4137665|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4310864|NCT00488683|4137666|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4310865|NCT00488683|4137663|B4||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4310866|NCT00488683|4137664|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4310867|NCT00488683|4137665|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4310868|NCT00488683|4137666|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4310869|NCT00488683|4137663|B4|||Age||Days|Mean|60.2|60.2|Standard Deviation|3.7|3.7|||
4310870|NCT00488683|4137664|B3|||Age||Days|Mean|59.8|59.8|Standard Deviation|3.6|3.6|||
4310871|NCT00488683|4137665|B2|||Age||Days|Mean|59.8|59.8|Standard Deviation|3.6|3.6|||
4310872|NCT00488683|4137666|B1|||Age||Days|Mean|60.5|60.5|Standard Deviation|3.7|3.7|||
4310873|NCT00488644|4137727|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4310874|NCT00488644|4137727|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4310875|NCT00488644|4137727|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4310876|NCT00488644|4137727|B1|||Age||years|Median|44|44.0|Full Range|||33.0|63.0|
4310877|NCT00488631|4137731|B7||Male|Sex: Female, Male||Participants|Count of Participants|700|700.0||||||
4310878|NCT00488631|4137732|B6||Male|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
4310879|NCT00488631|4137733|B5||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4310880|NCT00488631|4137734|B4||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4310881|NCT00488631|4137735|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4310882|NCT00488631|4137736|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4310883|NCT00488631|4137737|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4310884|NCT00488631|4137731|B7||Female|Sex: Female, Male||Participants|Count of Participants|528|528.0||||||
4310885|NCT00488631|4137732|B6||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4310886|NCT00488631|4137733|B5||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4310887|NCT00488631|4137734|B4||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4310888|NCT00488631|4137735|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4310889|NCT00488631|4137736|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4310890|NCT00488631|4137737|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4310891|NCT00488631|4137731|B7|||Age||years|Mean|40.3|40.3|Standard Deviation|13.44|13.44|||
4310892|NCT00488631|4137732|B6|||Age||years|Mean|41.2|41.2|Standard Deviation|13.6|13.6|||
4310893|NCT00488631|4137733|B5|||Age||years|Mean|40.3|40.3|Standard Deviation|12.67|12.67|||
4310894|NCT00488631|4137734|B4|||Age||years|Mean|38|38.0|Standard Deviation|13.27|13.27|||
4310895|NCT00488631|4137735|B3|||Age||years|Mean|39.1|39.1|Standard Deviation|13.11|13.11|||
4310896|NCT00488631|4137736|B2|||Age||years|Mean|41.4|41.4|Standard Deviation|13.84|13.84|||
4310897|NCT00488631|4137737|B1|||Age||years|Mean|40.2|40.2|Standard Deviation|14.05|14.05|||
4310898|NCT00488618|4137781|B3|||Body Mass Index (BMI)||kg/meter(m)^2|Mean|26.5|26.5|Standard Deviation|5.9|5.9|||
4310899|NCT00488618|4137782|B2|||Body Mass Index (BMI)||kg/meter(m)^2|Mean|25.8|25.8|Standard Deviation|5.9|5.9|||
4310900|NCT00488618|4137783|B1|||Body Mass Index (BMI)||kg/meter(m)^2|Mean|27.2|27.2|Standard Deviation|5.8|5.8|||
4310901|NCT00488618|4137781|B3|||Height||centimeter (cm)|Mean|170.0|170.0|Standard Deviation|10.2|10.2|||
4310902|NCT00488618|4137782|B2|||Height||centimeter (cm)|Mean|169.9|169.9|Standard Deviation|10.0|10.0|||
4310903|NCT00488618|4137783|B1|||Height||centimeter (cm)|Mean|170.0|170.0|Standard Deviation|10.4|10.4|||
4310904|NCT00488618|4137781|B3|||Weight||kilogram (kg)|Mean|77.2|77.2|Standard Deviation|20.2|20.2|||
4310905|NCT00488618|4137782|B2|||Weight||kilogram (kg)|Mean|75.0|75.0|Standard Deviation|20.3|20.3|||
4310906|NCT00488618|4137783|B1|||Weight||kilogram (kg)|Mean|79.3|79.3|Standard Deviation|20.0|20.0|||
4310907|NCT00488618|4137781|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4310908|NCT00488618|4137782|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4310909|NCT00488618|4137783|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4310910|NCT00488618|4137781|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|58|58.0||||||
4310911|NCT00488618|4137782|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
4310912|NCT00488618|4137783|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
4310913|NCT00488618|4137781|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|67|67.0||||||
4310914|NCT00488618|4137782|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
4310915|NCT00488618|4137783|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
4310916|NCT00488618|4137781|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|102|102.0||||||
4310917|NCT00488618|4137782|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
4310918|NCT00488618|4137783|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|55|55.0||||||
4310919|NCT00488618|4137781|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4310920|NCT00488618|4137782|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4310921|NCT00488618|4137783|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4310922|NCT00488618|4137781|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|226|226.0||||||
4310923|NCT00488618|4137782|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|112|112.0||||||
4310924|NCT00488618|4137783|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|114|114.0||||||
4310925|NCT00488618|4137781|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4310926|NCT00488618|4137782|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4310927|NCT00488618|4137783|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4310928|NCT00488618|4137781|B3||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4310929|NCT00488618|4137782|B2||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4310930|NCT00488618|4137783|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4310931|NCT00488618|4137781|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4310932|NCT00488618|4137782|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4310933|NCT00488618|4137783|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4310934|NCT00488618|4137781|B3|||Age||years|Mean|38.3|38.3|Standard Deviation|10.7|10.7|||
4310935|NCT00488618|4137782|B2|||Age||years|Mean|38.0|38.0|Standard Deviation|10.3|10.3|||
4310936|NCT00488618|4137783|B1|||Age||years|Mean|38.7|38.7|Standard Deviation|11.0|11.0|||
4310937|NCT00488592|4137792|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4310938|NCT00488592|4137792|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4310939|NCT00488592|4137792|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4310940|NCT00488592|4137792|B1|||Age||years|Mean|58.9|58.9|Standard Deviation|13.7|13.7|||
4310941|NCT00488592|4137792|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4310942|NCT00488592|4137792|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4310943|NCT00488592|4137792|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4310944|NCT00488514|4137796|B1|American Indian or Alaskan Native and White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4310945|NCT00488514|4137796|B1|African American/African Heritage and White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4310946|NCT00488514|4137796|B1|African American/African Heritage and Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4310947|NCT00488514|4137796|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4310948|NCT00488514|4137796|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4310949|NCT00488514|4137796|B1|Africian American||Race/Ethnicity, Customized||participants|Number|71|71.0||||||
4310950|NCT00488514|4137796|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|527|527.0||||||
4310951|NCT00488514|4137796|B1||Male|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
4310952|NCT00488514|4137796|B1||Female|Sex: Female, Male||Participants|Count of Participants|367|367.0||||||
4310953|NCT00488514|4137796|B1|||Age|"Baseline data were collected in the Safety Population, comprised of all participants in the Enrolled Population (all participants entered into the trial and categorized as started in the Participant Flow module) who took at least one dose of study drug."|Years|Mean|14.7|14.7|Standard Deviation|1.68|1.68|||
4310954|NCT00488488|4137869|B1|Clostridium perfringens (n=1)||Resistance Patterns at Baseline: Percentage of Participants with Resistant Pathogens|Participants with baseline pathogen data documented that had pathogens found to be resistant; n = number of participants with specified pathogen.|percentage of participants|Number|0|0.0||||||
4310955|NCT00488488|4137869|B1|Streptococcus agalactiae (B group) (n=1)||Resistance Patterns at Baseline: Percentage of Participants with Resistant Pathogens|Participants with baseline pathogen data documented that had pathogens found to be resistant; n = number of participants with specified pathogen.|percentage of participants|Number|0|0.0||||||
4310956|NCT00488488|4137869|B1|Bacteroides thetaiotamicron (n=1)||Resistance Patterns at Baseline: Percentage of Participants with Resistant Pathogens|Participants with baseline pathogen data documented that had pathogens found to be resistant; n = number of participants with specified pathogen.|percentage of participants|Number|0|0.0||||||
4310957|NCT00488488|4137869|B1|Morganella morganii (n=1)||Resistance Patterns at Baseline: Percentage of Participants with Resistant Pathogens|Participants with baseline pathogen data documented that had pathogens found to be resistant; n = number of participants with specified pathogen.|percentage of participants|Number|0|0.0||||||
4310958|NCT00488488|4137869|B1|Serratia spp (n=1)||Resistance Patterns at Baseline: Percentage of Participants with Resistant Pathogens|Participants with baseline pathogen data documented that had pathogens found to be resistant; n = number of participants with specified pathogen.|percentage of participants|Number|0|0.0||||||
4310959|NCT00488488|4137869|B1|Peptostreptococcus (n=2)||Resistance Patterns at Baseline: Percentage of Participants with Resistant Pathogens|Participants with baseline pathogen data documented that had pathogens found to be resistant; n = number of participants with specified pathogen.|percentage of participants|Number|0|0.0||||||
4310960|NCT00488488|4137869|B1|Streptococcus pneumoniae (n=2)||Resistance Patterns at Baseline: Percentage of Participants with Resistant Pathogens|Participants with baseline pathogen data documented that had pathogens found to be resistant; n = number of participants with specified pathogen.|percentage of participants|Number|0|0.0||||||
4310961|NCT00488488|4137869|B1|Haemophilus spp (n=2)||Resistance Patterns at Baseline: Percentage of Participants with Resistant Pathogens|Participants with baseline pathogen data documented that had pathogens found to be resistant; n = number of participants with specified pathogen.|percentage of participants|Number|0|0.0||||||
4310962|NCT00488488|4137869|B1|Bacteroides fragilis (n=3)||Resistance Patterns at Baseline: Percentage of Participants with Resistant Pathogens|Participants with baseline pathogen data documented that had pathogens found to be resistant; n = number of participants with specified pathogen.|percentage of participants|Number|0|0.0||||||
4310963|NCT00488488|4137869|B1|Acinetobacter spp. (n=4)||Resistance Patterns at Baseline: Percentage of Participants with Resistant Pathogens|Participants with baseline pathogen data documented that had pathogens found to be resistant; n = number of participants with specified pathogen.|percentage of participants|Number|0|0.0||||||
4310964|NCT00488488|4137869|B1|Other Bacteroides species (n=5)||Resistance Patterns at Baseline: Percentage of Participants with Resistant Pathogens|Participants with baseline pathogen data documented that had pathogens found to be resistant; n = number of participants with specified pathogen.|percentage of participants|Number|0|0.0||||||
4310965|NCT00488488|4137869|B1|Streptococcus anginosus group (n=5)||Resistance Patterns at Baseline: Percentage of Participants with Resistant Pathogens|Participants with baseline pathogen data documented that had pathogens found to be resistant; n = number of participants with specified pathogen.|percentage of participants|Number|0|0.0||||||
4310966|NCT00488488|4137869|B1|Citrobacter freundii (n=5)||Resistance Patterns at Baseline: Percentage of Participants with Resistant Pathogens|Participants with baseline pathogen data documented that had pathogens found to be resistant; n = number of participants with specified pathogen.|percentage of participants|Number|0|0.0||||||
4310967|NCT00488488|4137869|B1|Other clostridiae (n=6)||Resistance Patterns at Baseline: Percentage of Participants with Resistant Pathogens|Participants with baseline pathogen data documented that had pathogens found to be resistant; n = number of participants with specified pathogen.|percentage of participants|Number|0|0.0||||||
4310968|NCT00488488|4137869|B1|Streptococcus pyogenes (A group) (n=7)||Resistance Patterns at Baseline: Percentage of Participants with Resistant Pathogens|Participants with baseline pathogen data documented that had pathogens found to be resistant; n = number of participants with specified pathogen.|percentage of participants|Number|0|0.0||||||
4310969|NCT00488488|4137869|B1|Stenotrophomonas maltophilia (n=8)||Resistance Patterns at Baseline: Percentage of Participants with Resistant Pathogens|Participants with baseline pathogen data documented that had pathogens found to be resistant; n = number of participants with specified pathogen.|percentage of participants|Number|0|0.0||||||
4310970|NCT00488488|4137869|B1|Klebsiella oxytoca (n=16)||Resistance Patterns at Baseline: Percentage of Participants with Resistant Pathogens|Participants with baseline pathogen data documented that had pathogens found to be resistant; n = number of participants with specified pathogen.|percentage of participants|Number|0|0.0||||||
4310971|NCT00488488|4137869|B1|Staphylococcus spp (n=63)||Resistance Patterns at Baseline: Percentage of Participants with Resistant Pathogens|Participants with baseline pathogen data documented that had pathogens found to be resistant; n = number of participants with specified pathogen.|percentage of participants|Number|0|0.0||||||
4310972|NCT00488488|4137869|B1|Staphylococcus aureus (n=120)||Resistance Patterns at Baseline: Percentage of Participants with Resistant Pathogens|Participants with baseline pathogen data documented that had pathogens found to be resistant; n = number of participants with specified pathogen.|percentage of participants|Number|0|0.0||||||
4310973|NCT00488488|4137869|B1|Enterococcus faecium (n=146)||Resistance Patterns at Baseline: Percentage of Participants with Resistant Pathogens|Participants with baseline pathogen data documented that had pathogens found to be resistant; n = number of participants with specified pathogen.|percentage of participants|Number|0|0.0||||||
4310974|NCT00488488|4137869|B1|Escherichia coli (n=99)||Resistance Patterns at Baseline: Percentage of Participants with Resistant Pathogens|Participants with baseline pathogen data documented that had pathogens found to be resistant; n = number of participants with specified pathogen.|percentage of participants|Number|1.0|1.0||||||
4310975|NCT00488488|4137869|B1|Enterococcus faecalis (n=65)||Resistance Patterns at Baseline: Percentage of Participants with Resistant Pathogens|Participants with baseline pathogen data documented that had pathogens found to be resistant; n = number of participants with specified pathogen.|percentage of participants|Number|1.5|1.5||||||
4310976|NCT00488488|4137869|B1|Klebsiella pneumoniae (n=29)||Resistance Patterns at Baseline: Percentage of Participants with Resistant Pathogens|Participants with baseline pathogen data documented that had pathogens found to be resistant; n = number of participants with specified pathogen.|percentage of participants|Number|3.4|3.4||||||
4310977|NCT00488488|4137869|B1|Enterobacter species (spp) (n=26)||Resistance Patterns at Baseline: Percentage of Participants with Resistant Pathogens|Participants with baseline pathogen data documented that had pathogens found to be resistant; n = number of participants with specified pathogen.|percentage of participants|Number|3.8|3.8||||||
4310978|NCT00488488|4137869|B1|Other pathogens (unspecified) (n=30)||Resistance Patterns at Baseline: Percentage of Participants with Resistant Pathogens|Participants with baseline pathogen data documented that had pathogens found to be resistant; n = number of participants with specified pathogen.|percentage of participants|Number|13.3|13.3||||||
4310979|NCT00488488|4137869|B1|Proteus mirabilis (n=6)||Resistance Patterns at Baseline: Percentage of Participants with Resistant Pathogens|Participants with baseline pathogen data documented that had pathogens found to be resistant; n = number of participants with specified pathogen.|percentage of participants|Number|16.7|16.7||||||
4310980|NCT00488488|4137869|B1|Proteus vulgaris (n=3)||Resistance Patterns at Baseline: Percentage of Participants with Resistant Pathogens|Participants with baseline pathogen data documented that had pathogens found to be resistant; n = number of participants with specified pathogen.|percentage of participants|Number|33.3|33.3||||||
4310981|NCT00488488|4137869|B1|Pseudomonas aeruginosa (n=23)||Resistance Patterns at Baseline: Percentage of Participants with Resistant Pathogens|Participants with baseline pathogen data documented that had pathogens found to be resistant; n = number of participants with specified pathogen.|percentage of participants|Number|73.9|73.9||||||
4310982|NCT00488488|4137869|B1|Missing Data (Unspecified)||Sex/Gender, Customized||participants|Number|3|3.0||||||
4310983|NCT00488488|4137869|B1|Male||Sex/Gender, Customized||participants|Number|642|642.0||||||
4310984|NCT00488488|4137869|B1|Female||Sex/Gender, Customized||participants|Number|380|380.0||||||
4310985|NCT00488488|4137869|B1|||Age||years|Mean|64.4|64.4|Standard Deviation|13.7|13.7|||
4310986|NCT00488475|4137884|B1||Male|Sex: Female, Male||Participants|Count of Participants|1219|1219.0||||||
4310987|NCT00488475|4137884|B1||Female|Sex: Female, Male||Participants|Count of Participants|3652|3652.0||||||
4310988|NCT00488475|4137884|B1|||Age|Evaluable participants for this Baseline measure were 4868.|years|Mean|55.9|55.9|Standard Deviation|13.3|13.3|||
4310989|NCT00488345|4137910|B4|Complicated Skin and Skin Structure Infection||Selected Serious Infections||participants|Number|15|15.0||||||
4310990|NCT00488345|4137911|B3|Complicated Skin and Skin Structure Infection||Selected Serious Infections||participants|Number|4|4.0||||||
4310991|NCT00488345|4137912|B2|Complicated Skin and Skin Structure Infection||Selected Serious Infections||participants|Number|7|7.0||||||
4310992|NCT00488345|4137913|B1|Complicated Skin and Skin Structure Infection||Selected Serious Infections||participants|Number|4|4.0||||||
4310993|NCT00488345|4137910|B4|Complicated Intra-abdominal Infection||Selected Serious Infections||participants|Number|24|24.0||||||
4310994|NCT00488345|4137911|B3|Complicated Intra-abdominal Infection||Selected Serious Infections||participants|Number|12|12.0||||||
4310995|NCT00488345|4137912|B2|Complicated Intra-abdominal Infection||Selected Serious Infections||participants|Number|6|6.0||||||
4310996|NCT00488345|4137913|B1|Complicated Intra-abdominal Infection||Selected Serious Infections||participants|Number|6|6.0||||||
4310997|NCT00488345|4137910|B4|Community Acquired Pneumonia||Selected Serious Infections||participants|Number|19|19.0||||||
4310998|NCT00488345|4137911|B3|Community Acquired Pneumonia||Selected Serious Infections||participants|Number|4|4.0||||||
4310999|NCT00488345|4137912|B2|Community Acquired Pneumonia||Selected Serious Infections||participants|Number|8|8.0||||||
4311000|NCT00488345|4137913|B1|Community Acquired Pneumonia||Selected Serious Infections||participants|Number|7|7.0||||||
4311001|NCT00488345|4137910|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4311002|NCT00488345|4137911|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4311003|NCT00488345|4137912|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4311004|NCT00488345|4137913|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4311005|NCT00488345|4137910|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4311006|NCT00488345|4137911|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4311007|NCT00488345|4137912|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4311008|NCT00488345|4137913|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4311009|NCT00488345|4137910|B4|||Age||years|Mean|10.04|10.04|Standard Deviation|1.05|1.05|||
4311010|NCT00488345|4137911|B3|||Age||years|Mean|9.72|9.72|Standard Deviation|0.94|0.94|||
4311011|NCT00488345|4137912|B2|||Age||years|Mean|10.20|10.2|Standard Deviation|1.06|1.06|||
4311012|NCT00488345|4137913|B1|||Age||years|Mean|10.21|10.21|Standard Deviation|1.15|1.15|||
4311013|NCT00488319|4137938|B4|United States of America||Region of Enrollment||participants|Number|60|60.0||||||
4311014|NCT00488319|4137939|B3|United States of America||Region of Enrollment||participants|Number|41|41.0||||||
4311015|NCT00488319|4137940|B2|United States of America||Region of Enrollment||participants|Number|14|14.0||||||
4311016|NCT00488319|4137941|B1|United States of America||Region of Enrollment||participants|Number|5|5.0||||||
4311017|NCT00488319|4137938|B4|Ukraine||Region of Enrollment||participants|Number|48|48.0||||||
4311018|NCT00488319|4137939|B3|Ukraine||Region of Enrollment||participants|Number|18|18.0||||||
4311019|NCT00488319|4137940|B2|Ukraine||Region of Enrollment||participants|Number|22|22.0||||||
4311020|NCT00488319|4137941|B1|Ukraine||Region of Enrollment||participants|Number|8|8.0||||||
4311021|NCT00488319|4137938|B4|Russia||Region of Enrollment||participants|Number|109|109.0||||||
4311022|NCT00488319|4137939|B3|Russia||Region of Enrollment||participants|Number|40|40.0||||||
4311023|NCT00488319|4137940|B2|Russia||Region of Enrollment||participants|Number|51|51.0||||||
4311024|NCT00488319|4137941|B1|Russia||Region of Enrollment||participants|Number|18|18.0||||||
4311025|NCT00488319|4137938|B4|Romania||Region of Enrollment||participants|Number|20|20.0||||||
4311026|NCT00488319|4137939|B3|Romania||Region of Enrollment||participants|Number|10|10.0||||||
4311027|NCT00488319|4137940|B2|Romania||Region of Enrollment||participants|Number|8|8.0||||||
4311028|NCT00488319|4137941|B1|Romania||Region of Enrollment||participants|Number|2|2.0||||||
4311029|NCT00488319|4137938|B4|Poland||Region of Enrollment||participants|Number|47|47.0||||||
4311030|NCT00488319|4137939|B3|Poland||Region of Enrollment||participants|Number|47|47.0||||||
4311031|NCT00488319|4137940|B2|Poland||Region of Enrollment||participants|Number|0|0.0||||||
4311032|NCT00488319|4137941|B1|Poland||Region of Enrollment||participants|Number|0|0.0||||||
4311033|NCT00488319|4137938|B4|Korea||Region of Enrollment||participants|Number|40|40.0||||||
4311034|NCT00488319|4137939|B3|Korea||Region of Enrollment||participants|Number|40|40.0||||||
4311035|NCT00488319|4137940|B2|Korea||Region of Enrollment||participants|Number|0|0.0||||||
4311036|NCT00488319|4137941|B1|Korea||Region of Enrollment||participants|Number|0|0.0||||||
4311037|NCT00488319|4137938|B4|India||Region of Enrollment||participants|Number|64|64.0||||||
4311038|NCT00488319|4137939|B3|India||Region of Enrollment||participants|Number|35|35.0||||||
4311039|NCT00488319|4137940|B2|India||Region of Enrollment||participants|Number|23|23.0||||||
4311040|NCT00488319|4137941|B1|India||Region of Enrollment||participants|Number|6|6.0||||||
4311041|NCT00488319|4137938|B4|Finland||Region of Enrollment||participants|Number|3|3.0||||||
4311042|NCT00488319|4137939|B3|Finland||Region of Enrollment||participants|Number|3|3.0||||||
4311043|NCT00488319|4137940|B2|Finland||Region of Enrollment||participants|Number|0|0.0||||||
4311044|NCT00488319|4137941|B1|Finland||Region of Enrollment||participants|Number|0|0.0||||||
4311045|NCT00488319|4137938|B4|Estonia||Region of Enrollment||participants|Number|3|3.0||||||
4311046|NCT00488319|4137939|B3|Estonia||Region of Enrollment||participants|Number|3|3.0||||||
4311047|NCT00488319|4137940|B2|Estonia||Region of Enrollment||participants|Number|0|0.0||||||
4311048|NCT00488319|4137941|B1|Estonia||Region of Enrollment||participants|Number|0|0.0||||||
4311049|NCT00488319|4137938|B4|Bulgaria||Region of Enrollment||participants|Number|6|6.0||||||
4311050|NCT00488319|4137939|B3|Bulgaria||Region of Enrollment||participants|Number|6|6.0||||||
4311051|NCT00488319|4137940|B2|Bulgaria||Region of Enrollment||participants|Number|0|0.0||||||
4311052|NCT00488319|4137941|B1|Bulgaria||Region of Enrollment||participants|Number|0|0.0||||||
4311053|NCT00488319|4137938|B4||Male|Gender||Participants|Count of Participants|243|243.0||||||
4311054|NCT00488319|4137939|B3||Male|Gender||Participants|Count of Participants|151|151.0||||||
4311055|NCT00488319|4137940|B2||Male|Gender||Participants|Count of Participants|74|74.0||||||
4311056|NCT00488319|4137941|B1||Male|Gender||Participants|Count of Participants|18|18.0||||||
4311057|NCT00488319|4137938|B4||Female|Gender||Participants|Count of Participants|157|157.0||||||
4311058|NCT00488319|4137939|B3||Female|Gender||Participants|Count of Participants|92|92.0||||||
4311059|NCT00488319|4137940|B2||Female|Gender||Participants|Count of Participants|44|44.0||||||
4311060|NCT00488319|4137941|B1||Female|Gender||Participants|Count of Participants|21|21.0||||||
4311061|NCT00488319|4137938|B4|||Age||years|Mean|15.4|15.4|Standard Deviation|1.55|1.55|||
4311062|NCT00488319|4137939|B3|||Age||years|Mean|15.3|15.3|Standard Deviation|1.53|1.53|||
4311063|NCT00488319|4137940|B2|||Age||years|Mean|15.3|15.3|Standard Deviation|1.59|1.59|||
4311064|NCT00488319|4137941|B1|||Age||years|Mean|15.8|15.8|Standard Deviation|1.48|1.48|||
4311065|NCT00488319|4137938|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4311066|NCT00488319|4137939|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4311067|NCT00488319|4137940|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4311068|NCT00488319|4137941|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4311069|NCT00488319|4137938|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4311070|NCT00488319|4137939|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4311071|NCT00488319|4137940|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4311072|NCT00488319|4137941|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4311073|NCT00488319|4137938|B4||<=18 years|Age||Participants|Count of Participants|400|400.0||||||
4311074|NCT00488319|4137939|B3||<=18 years|Age||Participants|Count of Participants|243|243.0||||||
4311075|NCT00488319|4137940|B2||<=18 years|Age||Participants|Count of Participants|118|118.0||||||
4311076|NCT00488319|4137941|B1||<=18 years|Age||Participants|Count of Participants|39|39.0||||||
4311077|NCT00488293|4138028|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4311078|NCT00488293|4138029|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4311079|NCT00488293|4138030|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4311080|NCT00488293|4138028|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|384|384.0||||||
4311081|NCT00488293|4138029|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|191|191.0||||||
4311082|NCT00488293|4138030|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|193|193.0||||||
4311083|NCT00488293|4138028|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4311084|NCT00488293|4138029|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4311085|NCT00488293|4138030|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4311086|NCT00488293|4138028|B3||Male|Sex: Female, Male||Participants|Count of Participants|382|382.0||||||
4311087|NCT00488293|4138029|B2||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4311088|NCT00488293|4138030|B1||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4311089|NCT00488293|4138028|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4311090|NCT00488293|4138029|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4311091|NCT00488293|4138030|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4311092|NCT00488293|4138028|B3|||Age||years|Mean|62.3|62.3|Standard Deviation|14.4|14.4|||
4311093|NCT00488293|4138029|B2|||Age||years|Mean|62.9|62.9|Standard Deviation|13.9|13.9|||
4311094|NCT00488293|4138030|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|14.9|14.9|||
4311095|NCT00488059|4138055|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4311096|NCT00488059|4138055|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4311097|NCT00488059|4138055|B1|||Age||years|Mean|45.4|45.4|Standard Deviation|10.30|10.3|||
4311098|NCT00488033|4138074|B3|||Creatinine||mg/dL|Median|0.91|0.91|Inter-Quartile Range|||0.8|1.1|
4311099|NCT00488033|4138075|B2|||Creatinine||mg/dL|Median|0.91|0.91|Inter-Quartile Range|||0.79|1.1|
4311100|NCT00488033|4138076|B1|||Creatinine||mg/dL|Median|0.92|0.92|Inter-Quartile Range|||0.8|1.1|
4311101|NCT00488033|4138074|B3||>100|LDL Cholesterol Categories||Participants|Count of Participants|222|222.0||||||
4311102|NCT00488033|4138075|B2||>100|LDL Cholesterol Categories||Participants|Count of Participants|116|116.0||||||
4311103|NCT00488033|4138076|B1||>100|LDL Cholesterol Categories||Participants|Count of Participants|106|106.0||||||
4311104|NCT00488033|4138074|B3||70-100|LDL Cholesterol Categories||Participants|Count of Participants|348|348.0||||||
4311105|NCT00488033|4138075|B2||70-100|LDL Cholesterol Categories||Participants|Count of Participants|169|169.0||||||
4311106|NCT00488033|4138076|B1||70-100|LDL Cholesterol Categories||Participants|Count of Participants|179|179.0||||||
4311107|NCT00488033|4138074|B3||≤70|LDL Cholesterol Categories||Participants|Count of Participants|247|247.0||||||
4311108|NCT00488033|4138075|B2||≤70|LDL Cholesterol Categories||Participants|Count of Participants|123|123.0||||||
4311109|NCT00488033|4138076|B1||≤70|LDL Cholesterol Categories||Participants|Count of Participants|124|124.0||||||
4311110|NCT00488033|4138074|B3|||Fasting Triglycerides||mg/dL|Median|139|139.0|Inter-Quartile Range|||96.0|200.0|
4311111|NCT00488033|4138075|B2|||Fasting Triglycerides||mg/dL|Median|144|144.0|Inter-Quartile Range|||99.0|201.0|
4311112|NCT00488033|4138076|B1|||Fasting Triglycerides||mg/dL|Median|132|132.0|Inter-Quartile Range|||92.0|198.0|
4311113|NCT00488033|4138074|B3|HDL cholesterol||Fasting Lipid Panel||mg/dL|Mean|45.3|45.3|Standard Deviation|13.72|13.72|||
4311114|NCT00488033|4138075|B2|HDL cholesterol||Fasting Lipid Panel||mg/dL|Mean|45.4|45.4|Standard Deviation|14.04|14.04|||
4311115|NCT00488033|4138076|B1|HDL cholesterol||Fasting Lipid Panel||mg/dL|Mean|45.3|45.3|Standard Deviation|13.41|13.41|||
4311116|NCT00488033|4138074|B3|LDL cholesterol||Fasting Lipid Panel||mg/dL|Mean|87.0|87.0|Standard Deviation|31.07|31.07|||
4311117|NCT00488033|4138075|B2|LDL cholesterol||Fasting Lipid Panel||mg/dL|Mean|86.3|86.3|Standard Deviation|29.12|29.12|||
4311118|NCT00488033|4138076|B1|LDL cholesterol||Fasting Lipid Panel||mg/dL|Mean|87.7|87.7|Standard Deviation|32.92|32.92|||
4311119|NCT00488033|4138074|B3|||Statin Use||Participants|Count of Participants|668|668.0||||||
4311120|NCT00488033|4138075|B2|||Statin Use||Participants|Count of Participants|346|346.0||||||
4311121|NCT00488033|4138076|B1|||Statin Use||Participants|Count of Participants|322|322.0||||||
4311122|NCT00488033|4138074|B3|Diastolic||Blood Pressure||mmHg|Mean|74.1|74.1|Standard Deviation|8.06|8.06|||
4311123|NCT00488033|4138075|B2|Diastolic||Blood Pressure||mmHg|Mean|74.2|74.2|Standard Deviation|8.41|8.41|||
4311124|NCT00488033|4138076|B1|Diastolic||Blood Pressure||mmHg|Mean|74.1|74.1|Standard Deviation|7.71|7.71|||
4311125|NCT00488033|4138074|B3|Systolic||Blood Pressure||mmHg|Mean|129.8|129.8|Standard Deviation|12.00|12.0|||
4311126|NCT00488033|4138075|B2|Systolic||Blood Pressure||mmHg|Mean|129.1|129.1|Standard Deviation|12.45|12.45|||
4311127|NCT00488033|4138076|B1|Systolic||Blood Pressure||mmHg|Mean|130.5|130.5|Standard Deviation|11.49|11.49|||
4311128|NCT00488033|4138074|B3|||Renal DIsease||Participants|Count of Participants|65|65.0||||||
4311129|NCT00488033|4138075|B2|||Renal DIsease||Participants|Count of Participants|33|33.0||||||
4311130|NCT00488033|4138076|B1|||Renal DIsease||Participants|Count of Participants|32|32.0||||||
4311131|NCT00488033|4138074|B3|||Arthritis||Participants|Count of Participants|19|19.0||||||
4311132|NCT00488033|4138075|B2|||Arthritis||Participants|Count of Participants|8|8.0||||||
4311133|NCT00488033|4138076|B1|||Arthritis||Participants|Count of Participants|11|11.0||||||
4311134|NCT00488033|4138074|B3|||Asthma||Participants|Count of Participants|93|93.0||||||
4311135|NCT00488033|4138075|B2|||Asthma||Participants|Count of Participants|45|45.0||||||
4311136|NCT00488033|4138076|B1|||Asthma||Participants|Count of Participants|48|48.0||||||
4311137|NCT00488033|4138074|B3|||Sleep Apnea||Participants|Count of Participants|236|236.0||||||
4311138|NCT00488033|4138075|B2|||Sleep Apnea||Participants|Count of Participants|121|121.0||||||
4311139|NCT00488033|4138076|B1|||Sleep Apnea||Participants|Count of Participants|115|115.0||||||
4311140|NCT00488033|4138074|B3|||Gastroesophageal Reflux DIsease||Participants|Count of Participants|190|190.0||||||
4311141|NCT00488033|4138075|B2|||Gastroesophageal Reflux DIsease||Participants|Count of Participants|92|92.0||||||
4311142|NCT00488033|4138076|B1|||Gastroesophageal Reflux DIsease||Participants|Count of Participants|98|98.0||||||
4311143|NCT00488033|4138074|B3|||Depression||Participants|Count of Participants|117|117.0||||||
4311144|NCT00488033|4138075|B2|||Depression||Participants|Count of Participants|59|59.0||||||
4311145|NCT00488033|4138076|B1|||Depression||Participants|Count of Participants|58|58.0||||||
4311146|NCT00488033|4138074|B3|||Hypothyroidism/Hyperthyroidism||Participants|Count of Participants|208|208.0||||||
4311147|NCT00488033|4138075|B2|||Hypothyroidism/Hyperthyroidism||Participants|Count of Participants|104|104.0||||||
4311148|NCT00488033|4138076|B1|||Hypothyroidism/Hyperthyroidism||Participants|Count of Participants|104|104.0||||||
4311149|NCT00488033|4138074|B3|||Hyperlipidemia||Participants|Count of Participants|567|567.0||||||
4311150|NCT00488033|4138075|B2|||Hyperlipidemia||Participants|Count of Participants|285|285.0||||||
4311151|NCT00488033|4138076|B1|||Hyperlipidemia||Participants|Count of Participants|282|282.0||||||
4311152|NCT00488033|4138074|B3|||Hypertension||Participants|Count of Participants|595|595.0||||||
4311153|NCT00488033|4138075|B2|||Hypertension||Participants|Count of Participants|287|287.0||||||
4311154|NCT00488033|4138076|B1|||Hypertension||Participants|Count of Participants|308|308.0||||||
4311155|NCT00488033|4138074|B3|||Family History of Cardiovascular Disease||Participants|Count of Participants|157|157.0||||||
4311156|NCT00488033|4138075|B2|||Family History of Cardiovascular Disease||Participants|Count of Participants|69|69.0||||||
4311157|NCT00488033|4138076|B1|||Family History of Cardiovascular Disease||Participants|Count of Participants|88|88.0||||||
4311158|NCT00488033|4138074|B3|||Family History of Diabetes Mellitus||Participants|Count of Participants|103|103.0||||||
4311159|NCT00488033|4138075|B2|||Family History of Diabetes Mellitus||Participants|Count of Participants|44|44.0||||||
4311160|NCT00488033|4138076|B1|||Family History of Diabetes Mellitus||Participants|Count of Participants|59|59.0||||||
4311161|NCT00488033|4138074|B3||>8.0|Hemoglobin A1C Category||Participants|Count of Participants|203|203.0||||||
4311162|NCT00488033|4138075|B2||>8.0|Hemoglobin A1C Category||Participants|Count of Participants|98|98.0||||||
4311163|NCT00488033|4138076|B1||>8.0|Hemoglobin A1C Category||Participants|Count of Participants|105|105.0||||||
4311164|NCT00488033|4138074|B3||6.5-8.0|Hemoglobin A1C Category||Participants|Count of Participants|435|435.0||||||
4311165|NCT00488033|4138075|B2||6.5-8.0|Hemoglobin A1C Category||Participants|Count of Participants|210|210.0||||||
4311166|NCT00488033|4138076|B1||6.5-8.0|Hemoglobin A1C Category||Participants|Count of Participants|225|225.0||||||
4311167|NCT00488033|4138074|B3||≤ 6.5|Hemoglobin A1C Category||Participants|Count of Participants|221|221.0||||||
4311168|NCT00488033|4138075|B2||≤ 6.5|Hemoglobin A1C Category||Participants|Count of Participants|120|120.0||||||
4311169|NCT00488033|4138076|B1||≤ 6.5|Hemoglobin A1C Category||Participants|Count of Participants|101|101.0||||||
4311170|NCT00488033|4138074|B3|||Hemoglobin A1C||percentage|Mean|7.5|7.5|Standard Deviation|1.41|1.41|||
4311171|NCT00488033|4138075|B2|||Hemoglobin A1C||percentage|Mean|7.4|7.4|Standard Deviation|1.40|1.4|||
4311172|NCT00488033|4138076|B1|||Hemoglobin A1C||percentage|Mean|7.5|7.5|Standard Deviation|1.41|1.41|||
4311173|NCT00488033|4138074|B3||Both Non-Insulin Agent and Insulin|Diabetes Mellitus Medications||Participants|Count of Participants|207|207.0||||||
4311174|NCT00488033|4138075|B2||Both Non-Insulin Agent and Insulin|Diabetes Mellitus Medications||Participants|Count of Participants|110|110.0||||||
4311175|NCT00488033|4138076|B1||Both Non-Insulin Agent and Insulin|Diabetes Mellitus Medications||Participants|Count of Participants|97|97.0||||||
4311176|NCT00488033|4138074|B3||Insulin Only|Diabetes Mellitus Medications||Participants|Count of Participants|179|179.0||||||
4311177|NCT00488033|4138075|B2||Insulin Only|Diabetes Mellitus Medications||Participants|Count of Participants|84|84.0||||||
4311178|NCT00488033|4138076|B1||Insulin Only|Diabetes Mellitus Medications||Participants|Count of Participants|95|95.0||||||
4311179|NCT00488033|4138074|B3||Non-Insulin Agent Only|Diabetes Mellitus Medications||Participants|Count of Participants|513|513.0||||||
4311180|NCT00488033|4138075|B2||Non-Insulin Agent Only|Diabetes Mellitus Medications||Participants|Count of Participants|258|258.0||||||
4311181|NCT00488033|4138076|B1||Non-Insulin Agent Only|Diabetes Mellitus Medications||Participants|Count of Participants|255|255.0||||||
4311182|NCT00488033|4138074|B3||Type II|Diabetes Mellitus Type||Participants|Count of Participants|791|791.0||||||
4311183|NCT00488033|4138075|B2||Type II|Diabetes Mellitus Type||Participants|Count of Participants|396|396.0||||||
4311184|NCT00488033|4138076|B1||Type II|Diabetes Mellitus Type||Participants|Count of Participants|395|395.0||||||
4311185|NCT00488033|4138074|B3||Type I|Diabetes Mellitus Type||Participants|Count of Participants|108|108.0||||||
4311186|NCT00488033|4138075|B2||Type I|Diabetes Mellitus Type||Participants|Count of Participants|56|56.0||||||
4311187|NCT00488033|4138076|B1||Type I|Diabetes Mellitus Type||Participants|Count of Participants|52|52.0||||||
4311188|NCT00488033|4138074|B3|||Diabetes Mellitus||years|Mean|12.9|12.9|Standard Deviation|10.01|10.01|||
4311189|NCT00488033|4138075|B2|||Diabetes Mellitus||years|Mean|12.3|12.3|Standard Deviation|9.23|9.23|||
4311190|NCT00488033|4138076|B1|||Diabetes Mellitus||years|Mean|13.5|13.5|Standard Deviation|10.72|10.72|||
4311191|NCT00488033|4138074|B3|||Smoking History or Current||Participants|Count of Participants|143|143.0||||||
4311192|NCT00488033|4138075|B2|||Smoking History or Current||Participants|Count of Participants|75|75.0||||||
4311193|NCT00488033|4138076|B1|||Smoking History or Current||Participants|Count of Participants|68|68.0||||||
4311194|NCT00488033|4138074|B3|||Body Mass Index (BMI)||kg/m^2|Mean|33.1|33.1|Standard Deviation|6.90|6.9|||
4311195|NCT00488033|4138075|B2|||Body Mass Index (BMI)||kg/m^2|Mean|32.9|32.9|Standard Deviation|6.76|6.76|||
4311196|NCT00488033|4138076|B1|||Body Mass Index (BMI)||kg/m^2|Mean|33.4|33.4|Standard Deviation|7.05|7.05|||
4311197|NCT00488033|4138074|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4311198|NCT00488033|4138075|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4311199|NCT00488033|4138076|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4311200|NCT00488033|4138074|B3|American Indian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4311201|NCT00488033|4138075|B2|American Indian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4311202|NCT00488033|4138076|B1|American Indian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4311203|NCT00488033|4138074|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4311204|NCT00488033|4138075|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4311205|NCT00488033|4138076|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4311206|NCT00488033|4138074|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4311207|NCT00488033|4138075|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4311208|NCT00488033|4138076|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4311209|NCT00488033|4138074|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
4311210|NCT00488033|4138075|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4311211|NCT00488033|4138076|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4311212|NCT00488033|4138074|B3|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|861|861.0||||||
4311213|NCT00488033|4138075|B2|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|434|434.0||||||
4311214|NCT00488033|4138076|B1|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|427|427.0||||||
4311215|NCT00488033|4138074|B3||Male|Sex: Female, Male||Participants|Count of Participants|469|469.0||||||
4311216|NCT00488033|4138075|B2||Male|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
4311217|NCT00488033|4138076|B1||Male|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4311218|NCT00488033|4138074|B3||Female|Sex: Female, Male||Participants|Count of Participants|430|430.0||||||
4311219|NCT00488033|4138075|B2||Female|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4311220|NCT00488033|4138076|B1||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4311221|NCT00488033|4138074|B3|||Age||years|Mean|61.5|61.5|Standard Deviation|8.14|8.14|||
4311222|NCT00488033|4138075|B2|||Age||years|Mean|61.5|61.5|Standard Deviation|7.94|7.94|||
4311223|NCT00488033|4138076|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|8.35|8.35|||
4311224|NCT00487981|4138093|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4311225|NCT00487981|4138093|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4311226|NCT00487981|4138093|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4311227|NCT00487981|4138093|B1|||Age||years|Mean|59|59.0|Standard Deviation|0|0.0|||
4311228|NCT00487981|4138093|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4311229|NCT00487981|4138093|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4311230|NCT00487981|4138093|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4311231|NCT00487942|4138097|B5|United States||Region of Enrollment||participants|Number|60|60.0||||||
4311232|NCT00487942|4138098|B4|United States||Region of Enrollment||participants|Number|15|15.0||||||
4311233|NCT00487942|4138099|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4311234|NCT00487942|4138100|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4311235|NCT00487942|4138101|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4311236|NCT00487942|4138097|B5||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4311237|NCT00487942|4138098|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4311238|NCT00487942|4138099|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4311239|NCT00487942|4138100|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4311240|NCT00487942|4138101|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4311241|NCT00487942|4138097|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4311242|NCT00487942|4138098|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4311243|NCT00487942|4138099|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4311244|NCT00487942|4138100|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4311245|NCT00487942|4138101|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4311246|NCT00487942|4138097|B5|||Age||years|Mean|43.2|43.2|Standard Deviation|9.62|9.62|||
4311247|NCT00487942|4138098|B4|||Age||years|Mean|46.0|46.0|Standard Deviation|7.80|7.8|||
4311248|NCT00487942|4138099|B3|||Age||years|Mean|41.4|41.4|Standard Deviation|9.78|9.78|||
4311249|NCT00487942|4138100|B2|||Age||years|Mean|40.4|40.4|Standard Deviation|9.58|9.58|||
4311250|NCT00487942|4138101|B1|||Age||years|Mean|44.9|44.9|Standard Deviation|10.88|10.88|||
4311251|NCT00487942|4138097|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4311252|NCT00487942|4138098|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4311253|NCT00487942|4138099|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4311254|NCT00487942|4138100|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4311255|NCT00487942|4138101|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4311256|NCT00487942|4138097|B5||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4311257|NCT00487942|4138098|B4||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4311258|NCT00487942|4138099|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4311259|NCT00487942|4138100|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4311260|NCT00487942|4138101|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4311261|NCT00487942|4138097|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4311262|NCT00487942|4138098|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4311263|NCT00487942|4138099|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4311264|NCT00487942|4138100|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4311265|NCT00487942|4138101|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4311266|NCT00487825|4138486|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4311267|NCT00487825|4138487|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4311268|NCT00487825|4138488|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4311269|NCT00487825|4138486|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4311270|NCT00487825|4138487|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4311271|NCT00487825|4138488|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4311272|NCT00487825|4138486|B3|||Age||Years|Mean|50.9|50.9|Standard Deviation|13.9|13.9|||
4311273|NCT00487825|4138487|B2|||Age||Years|Mean|49.7|49.7|Standard Deviation|14.15|14.15|||
4311274|NCT00487825|4138488|B1|||Age||Years|Mean|51.6|51.6|Standard Deviation|12.78|12.78|||
4311275|NCT00487747|4138501|B1|||HBeAg-negative participants||Participants|Count of Participants|14|14.0||||||
4311276|NCT00487747|4138501|B1|||Hepatitis B Early Antigen (HBeAg) positive participants||participants|Number|4|4.0||||||
4311277|NCT00487747|4138501|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4311278|NCT00487747|4138501|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4311279|NCT00487747|4138501|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4311280|NCT00487747|4138501|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4311281|NCT00487747|4138501|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4311282|NCT00487721|4138510|B3|United States||Region of Enrollment||Participants|Number|12|12.0||||||
4311283|NCT00487721|4138511|B2|United States||Region of Enrollment||Participants|Number|6|6.0||||||
4311284|NCT00487721|4138512|B1|United States||Region of Enrollment||Participants|Number|6|6.0||||||
4311285|NCT00487721|4138510|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4311286|NCT00487721|4138511|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4311287|NCT00487721|4138512|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4311288|NCT00487721|4138510|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4311289|NCT00487721|4138511|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4311290|NCT00487721|4138512|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4311291|NCT00487721|4138510|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4311292|NCT00487721|4138511|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4311293|NCT00487721|4138512|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4311294|NCT00487721|4138510|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4311295|NCT00487721|4138511|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4311296|NCT00487721|4138512|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4311297|NCT00487721|4138510|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4311298|NCT00487721|4138511|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4311299|NCT00487721|4138512|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4311300|NCT00487721|4138510|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4311301|NCT00487721|4138511|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4311302|NCT00487721|4138512|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4311303|NCT00487721|4138510|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4311304|NCT00487721|4138511|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4311305|NCT00487721|4138512|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4311306|NCT00487721|4138510|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4311307|NCT00487721|4138511|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4311308|NCT00487721|4138512|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4311309|NCT00487721|4138510|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4311310|NCT00487721|4138511|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4311311|NCT00487721|4138512|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4311312|NCT00487721|4138510|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4311313|NCT00487721|4138511|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4311314|NCT00487721|4138512|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4311315|NCT00487721|4138510|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4311316|NCT00487721|4138511|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4311317|NCT00487721|4138512|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4311318|NCT00487721|4138510|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4311319|NCT00487721|4138511|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4311320|NCT00487721|4138512|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4311321|NCT00487721|4138510|B3|||Age||Years|Mean|57|57.0|Full Range|||46.0|66.0|
4311322|NCT00487721|4138511|B2|||Age||Years|Mean|57.5|57.5|Full Range|||49.0|65.0|
4311323|NCT00487721|4138512|B1|||Age||Years|Mean|56.5|56.5|Full Range|||46.0|66.0|
4311324|NCT00487721|4138510|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4311325|NCT00487721|4138511|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4311326|NCT00487721|4138512|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4311327|NCT00487721|4138510|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4311328|NCT00487721|4138511|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4311329|NCT00487721|4138512|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4311330|NCT00487721|4138510|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4311331|NCT00487721|4138511|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4311332|NCT00487721|4138512|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4311333|NCT00487695|4138518|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4311334|NCT00487695|4138518|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4311335|NCT00487695|4138518|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4311336|NCT00487695|4138518|B1|||Age||years|Mean|63.8|63.8|Standard Deviation|9.3|9.3|||
4311337|NCT00487695|4138518|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4311338|NCT00487695|4138518|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4311339|NCT00487695|4138518|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4311340|NCT00487669|4138535|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4311341|NCT00487669|4138535|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4311342|NCT00487669|4138535|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4311343|NCT00487669|4138535|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4311344|NCT00487669|4138535|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4311345|NCT00487669|4138535|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4311346|NCT00487578|4138545|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4311347|NCT00487578|4138546|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4311348|NCT00487578|4138547|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4311349|NCT00487578|4138545|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4311350|NCT00487578|4138546|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4311351|NCT00487578|4138547|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4311352|NCT00487578|4138545|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4311353|NCT00487578|4138546|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4311354|NCT00487578|4138547|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4311355|NCT00487578|4138545|B3|||Age||years|Mean|37.83|37.83|Standard Deviation|9.53|9.53|||
4311356|NCT00487578|4138546|B2|||Age||years|Mean|37.22|37.22|Standard Deviation|9.65|9.65|||
4311357|NCT00487578|4138547|B1|||Age||years|Mean|39.66|39.66|Standard Deviation|10.96|10.96|||
4311358|NCT00487578|4138545|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4311359|NCT00487578|4138546|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4311360|NCT00487578|4138547|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4311361|NCT00487578|4138545|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4311362|NCT00487578|4138546|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4311363|NCT00487578|4138547|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4311364|NCT00487578|4138545|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4311365|NCT00487578|4138546|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4311366|NCT00487578|4138547|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4311367|NCT00487565|4138564|B1|Switzerland||Region of Enrollment||participants|Number|30|30.0||||||
4311368|NCT00487565|4138564|B1|United States||Region of Enrollment||participants|Number|180|180.0||||||
4311369|NCT00487565|4138564|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4311370|NCT00487565|4138564|B1||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4311371|NCT00487565|4138564|B1|Age||Age||participants|Mean|63.8|63.8|Standard Deviation|9.8|9.8|||
4311372|NCT00487552|4138568|B1|Patients with no current treatments||Current Treatments||participants|Number|3|3.0||||||
4311373|NCT00487552|4138568|B1|Other||Current Treatments||participants|Number|1|1.0||||||
4311374|NCT00487552|4138568|B1|No treatment - Palliative care only||Current Treatments||participants|Number|10|10.0||||||
4311375|NCT00487552|4138568|B1|Brachytherapy||Current Treatments||participants|Number|0|0.0||||||
4311376|NCT00487552|4138568|B1|Radiotherapy||Current Treatments||participants|Number|0|0.0||||||
4311377|NCT00487552|4138568|B1|Chemotherapy||Current Treatments||participants|Number|4|4.0||||||
4311378|NCT00487552|4138568|B1|Other||Presenting Condition||participants|Number|2|2.0||||||
4311379|NCT00487552|4138568|B1|Pancreatic cancer||Presenting Condition||participants|Number|12|12.0||||||
4311380|NCT00487552|4138568|B1|Gastric cancer||Presenting Condition||participants|Number|1|1.0||||||
4311381|NCT00487552|4138568|B1|Cholangio cancer||Presenting Condition||participants|Number|3|3.0||||||
4311382|NCT00487552|4138568|B1|||Karnofsky Score|The Karnofsky score allows patients to be classified as to their functional impairment. It runs from 100 to 0, where 100 is “perfect” health and 0 is death.|Units on a scale|Mean|72.2|72.2|Standard Deviation|9.4|9.4|||
4311383|NCT00487552|4138568|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4311384|NCT00487552|4138568|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4311385|NCT00487552|4138568|B1|||Age||years|Mean|68.3|68.3|Standard Deviation|11|11.0|||
4311386|NCT00487539|4138573|B5||Male|Sex: Female, Male||Participants|Count of Participants|596|596.0||||||
4311387|NCT00487539|4138574|B4||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4311388|NCT00487539|4138575|B3||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4311389|NCT00487539|4138576|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4311390|NCT00487539|4138577|B1||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4311391|NCT00487539|4138573|B5||Female|Sex: Female, Male||Participants|Count of Participants|469|469.0||||||
4311392|NCT00487539|4138574|B4||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4311393|NCT00487539|4138575|B3||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4311394|NCT00487539|4138576|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4311395|NCT00487539|4138577|B1||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4311396|NCT00487539|4138573|B5|||Age||Years|Mean|40|40.0|Standard Deviation|13.37|13.37|||
4311397|NCT00487539|4138574|B4|||Age||Years|Mean|40.7|40.7|Standard Deviation|13.75|13.75|||
4311398|NCT00487539|4138575|B3|||Age||Years|Mean|40|40.0|Standard Deviation|13.54|13.54|||
4311399|NCT00487539|4138576|B2|||Age||Years|Mean|40.9|40.9|Standard Deviation|12.19|12.19|||
4311400|NCT00487539|4138577|B1|||Age||Years|Mean|39|39.0|Standard Deviation|13.04|13.04|||
4311401|NCT00487461|4138598|B4|United States||Region of Enrollment||participants|Number|25|25.0||||||
4311402|NCT00487461|4138599|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4311403|NCT00487461|4138600|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4311404|NCT00487461|4138601|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4311405|NCT00487461|4138598|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4311406|NCT00487461|4138599|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4311407|NCT00487461|4138600|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4311408|NCT00487461|4138601|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4311409|NCT00487461|4138598|B4|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4311410|NCT00487461|4138599|B3|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4311411|NCT00487461|4138600|B2|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4311412|NCT00487461|4138601|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4311413|NCT00487461|4138598|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4311414|NCT00487461|4138599|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4311415|NCT00487461|4138600|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4311416|NCT00487461|4138601|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4311417|NCT00487461|4138598|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4311418|NCT00487461|4138599|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4311419|NCT00487461|4138600|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4311420|NCT00487461|4138601|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4311421|NCT00487461|4138598|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4311422|NCT00487461|4138599|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4311423|NCT00487461|4138600|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4311424|NCT00487461|4138601|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4311425|NCT00487461|4138598|B4|< 40 years||Age, Customized||participants|Number|3|3.0||||||
4311426|NCT00487461|4138599|B3|< 40 years||Age, Customized||participants|Number|1|1.0||||||
4311427|NCT00487461|4138600|B2|< 40 years||Age, Customized||participants|Number|2|2.0||||||
4311428|NCT00487461|4138601|B1|< 40 years||Age, Customized||participants|Number|0|0.0||||||
4311429|NCT00487461|4138598|B4|40-50 years||Age, Customized||participants|Number|10|10.0||||||
4311430|NCT00487461|4138599|B3|40-50 years||Age, Customized||participants|Number|4|4.0||||||
4311431|NCT00487461|4138600|B2|40-50 years||Age, Customized||participants|Number|6|6.0||||||
4311432|NCT00487461|4138601|B1|40-50 years||Age, Customized||participants|Number|0|0.0||||||
4311433|NCT00487461|4138598|B4|50-60 years||Age, Customized||participants|Number|7|7.0||||||
4311434|NCT00487461|4138599|B3|50-60 years||Age, Customized||participants|Number|3|3.0||||||
4311435|NCT00487461|4138600|B2|50-60 years||Age, Customized||participants|Number|3|3.0||||||
4311436|NCT00487461|4138601|B1|50-60 years||Age, Customized||participants|Number|1|1.0||||||
4311437|NCT00487461|4138598|B4|60-70 years||Age, Customized||participants|Number|2|2.0||||||
4311438|NCT00487461|4138599|B3|60-70 years||Age, Customized||participants|Number|1|1.0||||||
4311439|NCT00487461|4138600|B2|60-70 years||Age, Customized||participants|Number|0|0.0||||||
4311440|NCT00487461|4138601|B1|60-70 years||Age, Customized||participants|Number|1|1.0||||||
4311441|NCT00487461|4138598|B4|> 70 years||Age, Customized||participants|Number|3|3.0||||||
4311442|NCT00487461|4138599|B3|> 70 years||Age, Customized||participants|Number|2|2.0||||||
4311443|NCT00487461|4138600|B2|> 70 years||Age, Customized||participants|Number|1|1.0||||||
4311444|NCT00487461|4138601|B1|> 70 years||Age, Customized||participants|Number|0|0.0||||||
4311445|NCT00487461|4138598|B4|||Age||years|Median|49|49.0|Standard Deviation|10.9|10.9|||
4311446|NCT00487461|4138599|B3|||Age||years|Median|50|50.0|Standard Deviation|11.6|11.6|||
4311447|NCT00487461|4138600|B2|||Age||years|Median|47|47.0|Standard Deviation|10.7|10.7|||
4311448|NCT00487461|4138601|B1|||Age||years|Median|57|57.0|Standard Deviation|5.6|5.6|||
4311449|NCT00487435|4138614|B1|United States of America||Region Enroll||participants|Number|951|951.0||||||
4311450|NCT00487435|4138614|B1|New Zealand||Region Enroll||participants|Number|10|10.0||||||
4311451|NCT00487435|4138614|B1|Canada||Region Enroll||participants|Number|178|178.0||||||
4311452|NCT00487435|4138614|B1|Australia||Region Enroll||participants|Number|15|15.0||||||
4311453|NCT00487435|4138614|B1||Male|Sex: Female, Male||Participants|Count of Participants|486|486.0||||||
4311454|NCT00487435|4138614|B1||Female|Sex: Female, Male||Participants|Count of Participants|668|668.0||||||
4311455|NCT00487435|4138614|B1|||Age||years|Mean|54.3|54.3|Standard Deviation|11.43|11.43|||
4311456|NCT00487435|4138614|B1||>=65 years|Age||Participants|Count of Participants|200|200.0||||||
4311457|NCT00487435|4138614|B1||Between 18 and 65 years|Age||Participants|Count of Participants|954|954.0||||||
4311458|NCT00487435|4138614|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4311459|NCT00487396|4138619|B1|Sweden||Region of Enrollment||participants|Number|14|14.0||||||
4311460|NCT00487396|4138619|B1|Israel||Region of Enrollment||participants|Number|20|20.0||||||
4311461|NCT00487396|4138619|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4311462|NCT00487396|4138619|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4311463|NCT00487396|4138619|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4311464|NCT00487396|4138619|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4311465|NCT00487396|4138619|B1|||Age||years|Mean|28.35|28.35|Standard Deviation|13.25|13.25|||
4311466|NCT00487396|4138619|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4311467|NCT00487396|4138619|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4311468|NCT00487396|4138619|B1||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
4311469|NCT00487279|4138625|B3|United States||Region of Enrollment||participants|Number|81|81.0||||||
4311470|NCT00487279|4138626|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4311471|NCT00487279|4138627|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4311472|NCT00487279|4138625|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4311473|NCT00487279|4138626|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4311474|NCT00487279|4138627|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4311475|NCT00487279|4138625|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4311476|NCT00487279|4138626|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4311477|NCT00487279|4138627|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4311478|NCT00487279|4138625|B3|||Age||years|Mean|63|63.0|Standard Deviation|12|12.0|||
4311479|NCT00487279|4138626|B2|||Age||years|Mean|65|65.0|Standard Deviation|12|12.0|||
4311480|NCT00487279|4138627|B1|||Age||years|Mean|62|62.0|Standard Deviation|11|11.0|||
4311481|NCT00487279|4138625|B3||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
4311482|NCT00487279|4138626|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4311483|NCT00487279|4138627|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4311484|NCT00487279|4138625|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4311485|NCT00487279|4138626|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4311486|NCT00487279|4138627|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4311487|NCT00487279|4138625|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4311488|NCT00487279|4138626|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4311489|NCT00487279|4138627|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4311490|NCT00487240|4138636|B3|||Hemoglobin A1c (HbA1c)||percent of HbA1c|Mean|8.75|8.75|Standard Deviation|1.28|1.28|||
4311491|NCT00487240|4138637|B2|||Hemoglobin A1c (HbA1c)||percent of HbA1c|Mean|8.64|8.64|Standard Deviation|1.27|1.27|||
4311492|NCT00487240|4138638|B1|||Hemoglobin A1c (HbA1c)||percent of HbA1c|Mean|8.87|8.87|Standard Deviation|1.29|1.29|||
4311493|NCT00487240|4138636|B3|||Duration of Diabetes||years|Mean|14.20|14.2|Standard Deviation|10.26|10.26|||
4311494|NCT00487240|4138637|B2|||Duration of Diabetes||years|Mean|13.83|13.83|Standard Deviation|9.80|9.8|||
4311495|NCT00487240|4138638|B1|||Duration of Diabetes||years|Mean|14.58|14.58|Standard Deviation|10.69|10.69|||
4311496|NCT00487240|4138636|B3|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by square height.|kilograms per square meter (kg/m^2)|Mean|25.30|25.3|Standard Deviation|4.17|4.17|||
4311497|NCT00487240|4138637|B2|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by square height.|kilograms per square meter (kg/m^2)|Mean|25.46|25.46|Standard Deviation|4.17|4.17|||
4311498|NCT00487240|4138638|B1|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by square height.|kilograms per square meter (kg/m^2)|Mean|25.15|25.15|Standard Deviation|4.17|4.17|||
4311499|NCT00487240|4138636|B3|Aboriginal and/or Torres Strait Islander||Race/Ethnicity||participants|Number|0|0.0||||||
4311500|NCT00487240|4138637|B2|Aboriginal and/or Torres Strait Islander||Race/Ethnicity||participants|Number|0|0.0||||||
4311501|NCT00487240|4138638|B1|Aboriginal and/or Torres Strait Islander||Race/Ethnicity||participants|Number|0|0.0||||||
4311502|NCT00487240|4138636|B3|West Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4311503|NCT00487240|4138637|B2|West Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4311504|NCT00487240|4138638|B1|West Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4311505|NCT00487240|4138636|B3|Native American||Race/Ethnicity||participants|Number|0|0.0||||||
4311506|NCT00487240|4138637|B2|Native American||Race/Ethnicity||participants|Number|0|0.0||||||
4311507|NCT00487240|4138638|B1|Native American||Race/Ethnicity||participants|Number|0|0.0||||||
4311508|NCT00487240|4138636|B3|Hispanic||Race/Ethnicity||participants|Number|53|53.0||||||
4311509|NCT00487240|4138637|B2|Hispanic||Race/Ethnicity||participants|Number|28|28.0||||||
4311510|NCT00487240|4138638|B1|Hispanic||Race/Ethnicity||participants|Number|25|25.0||||||
4311511|NCT00487240|4138636|B3|East Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4311512|NCT00487240|4138637|B2|East Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4311513|NCT00487240|4138638|B1|East Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4311514|NCT00487240|4138636|B3|Caucasian||Race/Ethnicity||participants|Number|325|325.0||||||
4311515|NCT00487240|4138637|B2|Caucasian||Race/Ethnicity||participants|Number|160|160.0||||||
4311516|NCT00487240|4138638|B1|Caucasian||Race/Ethnicity||participants|Number|165|165.0||||||
4311517|NCT00487240|4138636|B3|African||Race/Ethnicity||participants|Number|3|3.0||||||
4311518|NCT00487240|4138637|B2|African||Race/Ethnicity||participants|Number|1|1.0||||||
4311519|NCT00487240|4138638|B1|African||Race/Ethnicity||participants|Number|2|2.0||||||
4311520|NCT00487240|4138636|B3|Russian Federation||Region of Enrollment||participants|Number|73|73.0||||||
4311521|NCT00487240|4138637|B2|Russian Federation||Region of Enrollment||participants|Number|36|36.0||||||
4311522|NCT00487240|4138638|B1|Russian Federation||Region of Enrollment||participants|Number|37|37.0||||||
4311523|NCT00487240|4138636|B3|Australia||Region of Enrollment||participants|Number|34|34.0||||||
4311524|NCT00487240|4138637|B2|Australia||Region of Enrollment||participants|Number|17|17.0||||||
4311525|NCT00487240|4138638|B1|Australia||Region of Enrollment||participants|Number|17|17.0||||||
4311526|NCT00487240|4138636|B3|Romania||Region of Enrollment||participants|Number|43|43.0||||||
4311527|NCT00487240|4138637|B2|Romania||Region of Enrollment||participants|Number|21|21.0||||||
4311528|NCT00487240|4138638|B1|Romania||Region of Enrollment||participants|Number|22|22.0||||||
4311529|NCT00487240|4138636|B3|Brazil||Region of Enrollment||participants|Number|39|39.0||||||
4311530|NCT00487240|4138637|B2|Brazil||Region of Enrollment||participants|Number|19|19.0||||||
4311531|NCT00487240|4138638|B1|Brazil||Region of Enrollment||participants|Number|20|20.0||||||
4311532|NCT00487240|4138636|B3|Argentina||Region of Enrollment||participants|Number|32|32.0||||||
4311533|NCT00487240|4138637|B2|Argentina||Region of Enrollment||participants|Number|16|16.0||||||
4311534|NCT00487240|4138638|B1|Argentina||Region of Enrollment||participants|Number|16|16.0||||||
4311535|NCT00487240|4138636|B3|Greece||Region of Enrollment||participants|Number|32|32.0||||||
4311536|NCT00487240|4138637|B2|Greece||Region of Enrollment||participants|Number|16|16.0||||||
4311537|NCT00487240|4138638|B1|Greece||Region of Enrollment||participants|Number|16|16.0||||||
4311538|NCT00487240|4138636|B3|Mexico||Region of Enrollment||participants|Number|26|26.0||||||
4311539|NCT00487240|4138637|B2|Mexico||Region of Enrollment||participants|Number|12|12.0||||||
4311540|NCT00487240|4138638|B1|Mexico||Region of Enrollment||participants|Number|14|14.0||||||
4311541|NCT00487240|4138636|B3|Hungary||Region of Enrollment||participants|Number|33|33.0||||||
4311542|NCT00487240|4138637|B2|Hungary||Region of Enrollment||participants|Number|17|17.0||||||
4311543|NCT00487240|4138638|B1|Hungary||Region of Enrollment||participants|Number|16|16.0||||||
4311544|NCT00487240|4138636|B3|United States||Region of Enrollment||participants|Number|69|69.0||||||
4311545|NCT00487240|4138637|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
4311546|NCT00487240|4138638|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4311547|NCT00487240|4138636|B3||Male|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4311548|NCT00487240|4138637|B2||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4311549|NCT00487240|4138638|B1||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4311550|NCT00487240|4138636|B3||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4311551|NCT00487240|4138637|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4311552|NCT00487240|4138638|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4311553|NCT00487240|4138636|B3|||Age||years|Mean|36.14|36.14|Standard Deviation|13.20|13.2|||
4311554|NCT00487240|4138637|B2|||Age||years|Mean|36.19|36.19|Standard Deviation|13.09|13.09|||
4311555|NCT00487240|4138638|B1|||Age||years|Mean|36.10|36.1|Standard Deviation|13.33|13.33|||
4311556|NCT00487188|4138665|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4311557|NCT00487188|4138666|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4311558|NCT00487188|4138667|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4311559|NCT00487188|4138665|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4311560|NCT00487188|4138666|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4311561|NCT00487188|4138667|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4311562|NCT00487188|4138665|B3|||Age||years|Mean|43.3|43.3|Standard Deviation|8.52|8.52|||
4311563|NCT00487188|4138666|B2|||Age||years|Mean|41.9|41.9|Standard Deviation|10.57|10.57|||
4311564|NCT00487188|4138667|B1|||Age||years|Mean|44.1|44.1|Standard Deviation|7.04|7.04|||
4311565|NCT00487162|4138706|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4311566|NCT00487162|4138707|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4311567|NCT00487162|4138708|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4311568|NCT00487162|4138706|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4311569|NCT00487162|4138707|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4311570|NCT00487162|4138708|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4311571|NCT00487162|4138706|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4311572|NCT00487162|4138707|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4311573|NCT00487162|4138708|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4311574|NCT00487162|4138706|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4311575|NCT00487162|4138707|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4311576|NCT00487162|4138708|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4311577|NCT00487162|4138706|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4311578|NCT00487162|4138707|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4311579|NCT00487162|4138708|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4311580|NCT00487084|4138717|B4|United States||Region of Enrollment||participants|Number|99|99.0||||||
4311581|NCT00487084|4138718|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
4311582|NCT00487084|4138719|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4311583|NCT00487084|4138720|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4311584|NCT00487084|4138717|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4311585|NCT00487084|4138718|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4311586|NCT00487084|4138719|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4311587|NCT00487084|4138720|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4311588|NCT00487084|4138717|B4||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4311589|NCT00487084|4138718|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4311590|NCT00487084|4138719|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4311591|NCT00487084|4138720|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4311592|NCT00487084|4138717|B4|||Age||years|Mean|30|30.0|Standard Deviation|4|4.0|||
4311593|NCT00487084|4138718|B3|||Age||years|Mean|29|29.0|Standard Deviation|4|4.0|||
4311594|NCT00487084|4138719|B2|||Age||years|Mean|31|31.0|Standard Deviation|5|5.0|||
4311595|NCT00487084|4138720|B1|||Age||years|Mean|33|33.0|Standard Deviation|4|4.0|||
4311596|NCT00487084|4138717|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4311597|NCT00487084|4138718|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4311598|NCT00487084|4138719|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4311599|NCT00487084|4138720|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4311600|NCT00487084|4138717|B4||Between 18 and 65 years|Age||Participants|Count of Participants|99|99.0||||||
4311601|NCT00487084|4138718|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4311602|NCT00487084|4138719|B2||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4311603|NCT00487084|4138720|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4311604|NCT00487084|4138717|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4311605|NCT00487084|4138718|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4311606|NCT00487084|4138719|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4311607|NCT00487084|4138720|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4311608|NCT00486954|4138739|B5|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4311609|NCT00486954|4138740|B4|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4311610|NCT00486954|4138741|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4311611|NCT00486954|4138742|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4311612|NCT00486954|4138743|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4311613|NCT00486954|4138739|B5|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|148|148.0||||||
4311614|NCT00486954|4138740|B4|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|75|75.0||||||
4311615|NCT00486954|4138741|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|73|73.0||||||
4311616|NCT00486954|4138742|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4311617|NCT00486954|4138743|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4311618|NCT00486954|4138739|B5|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|112|112.0||||||
4311619|NCT00486954|4138740|B4|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|48|48.0||||||
4311620|NCT00486954|4138741|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|52|52.0||||||
4311621|NCT00486954|4138742|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4311622|NCT00486954|4138743|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4311623|NCT00486954|4138739|B5||Male|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4311624|NCT00486954|4138740|B4||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4311625|NCT00486954|4138741|B3||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4311626|NCT00486954|4138742|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4311627|NCT00486954|4138743|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4311628|NCT00486954|4138739|B5||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4311629|NCT00486954|4138740|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4311630|NCT00486954|4138741|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4311631|NCT00486954|4138742|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4311632|NCT00486954|4138743|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4311633|NCT00486954|4138739|B5|||Age||Years|Mean|60.5|60.5|Standard Deviation|10.23|10.23|||
4311634|NCT00486954|4138740|B4|||Age||Years|Mean|60.4|60.4|Standard Deviation|10.96|10.96|||
4311635|NCT00486954|4138741|B3|||Age||Years|Mean|60.8|60.8|Standard Deviation|9.45|9.45|||
4311636|NCT00486954|4138742|B2|||Age||Years|Mean|57.2|57.2|Standard Deviation|10.98|10.98|||
4311637|NCT00486954|4138743|B1|||Age||Years|Mean|57.5|57.5|Standard Deviation|11.31|11.31|||
4311638|NCT00486902|4138843|B3|United States||Region of Enrollment||participants|Number|188|188.0||||||
4311639|NCT00486902|4138844|B2|United States||Region of Enrollment||participants|Number|94|94.0||||||
4311640|NCT00486902|4138845|B1|United States||Region of Enrollment||participants|Number|94|94.0||||||
4311641|NCT00486902|4138843|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4311642|NCT00486902|4138844|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4311643|NCT00486902|4138845|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4311644|NCT00486902|4138843|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4311645|NCT00486902|4138844|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4311646|NCT00486902|4138845|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4311647|NCT00486902|4138843|B3||White|Race (NIH/OMB)||Participants|Count of Participants|147|147.0||||||
4311648|NCT00486902|4138844|B2||White|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
4311649|NCT00486902|4138845|B1||White|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
4311650|NCT00486902|4138843|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4311651|NCT00486902|4138844|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4311652|NCT00486902|4138845|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4311653|NCT00486902|4138843|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4311654|NCT00486902|4138844|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4311655|NCT00486902|4138845|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4311656|NCT00486902|4138843|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4311657|NCT00486902|4138844|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4311658|NCT00486902|4138845|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4311659|NCT00486902|4138843|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4311660|NCT00486902|4138844|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4311661|NCT00486902|4138845|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4311662|NCT00486902|4138843|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4311663|NCT00486902|4138844|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4311664|NCT00486902|4138845|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4311665|NCT00486902|4138843|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|176|176.0||||||
4311666|NCT00486902|4138844|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4311667|NCT00486902|4138845|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4311668|NCT00486902|4138843|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4311669|NCT00486902|4138844|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4311670|NCT00486902|4138845|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4311671|NCT00486902|4138843|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4311672|NCT00486902|4138844|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4311673|NCT00486902|4138845|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4311674|NCT00486902|4138843|B3||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4311675|NCT00486902|4138844|B2||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4311676|NCT00486902|4138845|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4311677|NCT00486902|4138843|B3|||Age||years|Mean|34|34.0|Standard Deviation|3|3.0|||
4311678|NCT00486902|4138844|B2|||Age||years|Mean|34|34.0|Standard Deviation|3|3.0|||
4311679|NCT00486902|4138845|B1|||Age||years|Mean|34|34.0|Standard Deviation|3|3.0|||
4311680|NCT00486902|4138843|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4311681|NCT00486902|4138844|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4311682|NCT00486902|4138845|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4311683|NCT00486902|4138843|B3||Between 18 and 65 years|Age||Participants|Count of Participants|188|188.0||||||
4311684|NCT00486902|4138844|B2||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
4311685|NCT00486902|4138845|B1||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
4311686|NCT00486902|4138843|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4311687|NCT00486902|4138844|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4311688|NCT00486902|4138845|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4311689|NCT00486863|4138866|B3|Philippines||Region of Enrollment||participants|Number|370|370.0||||||
4311690|NCT00486863|4138867|B2|Philippines||Region of Enrollment||participants|Number|186|186.0||||||
4311691|NCT00486863|4138868|B1|Philippines||Region of Enrollment||participants|Number|184|184.0||||||
4311692|NCT00486863|4138866|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4311693|NCT00486863|4138867|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4311694|NCT00486863|4138868|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4311695|NCT00486863|4138866|B3||Female|Sex: Female, Male||Participants|Count of Participants|370|370.0||||||
4311696|NCT00486863|4138867|B2||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4311697|NCT00486863|4138868|B1||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4311698|NCT00486863|4138866|B3|||Age||years|Mean|26.1|26.1|Standard Deviation|6.4|6.4|||
4311699|NCT00486863|4138867|B2|||Age||years|Mean|26.2|26.2|Standard Deviation|6.6|6.6|||
4311700|NCT00486863|4138868|B1|||Age||years|Mean|25.9|25.9|Standard Deviation|6.3|6.3|||
4311701|NCT00486863|4138866|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4311702|NCT00486863|4138867|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4311703|NCT00486863|4138868|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4311704|NCT00486863|4138866|B3||Between 18 and 65 years|Age||Participants|Count of Participants|370|370.0||||||
4311705|NCT00486863|4138867|B2||Between 18 and 65 years|Age||Participants|Count of Participants|186|186.0||||||
4311706|NCT00486863|4138868|B1||Between 18 and 65 years|Age||Participants|Count of Participants|184|184.0||||||
4311707|NCT00486863|4138866|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4311708|NCT00486863|4138867|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4311709|NCT00486863|4138868|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4311710|NCT00486837|4138911|B3|Absolute Change||Free Elastase during the Run-In Phase||µg/mL|Mean|-7.25|-7.25|Standard Deviation|29.6|29.6|||
4311711|NCT00486837|4138912|B2|Absolute Change||Free Elastase during the Run-In Phase||µg/mL|Mean|-10.9|-10.9|Standard Deviation|36.9|36.9|||
4311712|NCT00486837|4138913|B1|Absolute Change||Free Elastase during the Run-In Phase||µg/mL|Mean|-4.0|-4.0|Standard Deviation|21.3|21.3|||
4311713|NCT00486837|4138911|B3|Week 2||Free Elastase during the Run-In Phase||µg/mL|Mean|29.1|29.1|Standard Deviation|27.0|27.0|||
4311714|NCT00486837|4138912|B2|Week 2||Free Elastase during the Run-In Phase||µg/mL|Mean|25.0|25.0|Standard Deviation|20.1|20.1|||
4311715|NCT00486837|4138913|B1|Week 2||Free Elastase during the Run-In Phase||µg/mL|Mean|32.7|32.7|Standard Deviation|31.7|31.7|||
4311716|NCT00486837|4138911|B3|Week 0||Free Elastase during the Run-In Phase||µg/mL|Mean|36.2|36.2|Standard Deviation|36.9|36.9|||
4311717|NCT00486837|4138912|B2|Week 0||Free Elastase during the Run-In Phase||µg/mL|Mean|35.9|35.9|Standard Deviation|38.8|38.8|||
4311718|NCT00486837|4138913|B1|Week 0||Free Elastase during the Run-In Phase||µg/mL|Mean|36.6|36.6|Standard Deviation|35.9|35.9|||
4311719|NCT00486837|4138911|B3|Germany||Region of Enrollment||participants|Number|72|72.0||||||
4311720|NCT00486837|4138912|B2|Germany||Region of Enrollment||participants|Number|35|35.0||||||
4311721|NCT00486837|4138913|B1|Germany||Region of Enrollment||participants|Number|37|37.0||||||
4311722|NCT00486837|4138911|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4311723|NCT00486837|4138912|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4311724|NCT00486837|4138913|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4311725|NCT00486837|4138911|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4311726|NCT00486837|4138912|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4311727|NCT00486837|4138913|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4311728|NCT00486837|4138911|B3|||Age||years|Mean|25.46|25.46|Standard Deviation|8.84|8.84|||
4311729|NCT00486837|4138912|B2|||Age||years|Mean|27.42|27.42|Standard Deviation|9.78|9.78|||
4311730|NCT00486837|4138913|B1|||Age||years|Mean|23.78|23.78|Standard Deviation|7.54|7.54|||
4311731|NCT00486837|4138911|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4311732|NCT00486837|4138912|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4311733|NCT00486837|4138913|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4311734|NCT00486837|4138911|B3||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4311735|NCT00486837|4138912|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4311736|NCT00486837|4138913|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4311737|NCT00486837|4138911|B3||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
4311738|NCT00486837|4138912|B2||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4311739|NCT00486837|4138913|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4311740|NCT00486824|4138930|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4311741|NCT00486824|4138931|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4311742|NCT00486824|4138932|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4311743|NCT00486824|4138930|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4311744|NCT00486824|4138931|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4311745|NCT00486824|4138932|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4311746|NCT00486824|4138930|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4311747|NCT00486824|4138931|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4311748|NCT00486824|4138932|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4311749|NCT00486824|4138930|B3|||Age||years|Median|26.5|26.5|Full Range|||19.0|37.0|
4311750|NCT00486824|4138931|B2|||Age||years|Median|30|30.0|Full Range|||19.0|37.0|
4311751|NCT00486824|4138932|B1|||Age||years|Median|26.0|26.0|Full Range|||20.0|37.0|
4311752|NCT00486824|4138930|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4311753|NCT00486824|4138931|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4311754|NCT00486824|4138932|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4311755|NCT00486824|4138930|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4311756|NCT00486824|4138931|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4311757|NCT00486824|4138932|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4311758|NCT00486824|4138930|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4311759|NCT00486824|4138931|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4311760|NCT00486824|4138932|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4311761|NCT00486811|4138951|B4|Netherlands||Region of Enrollment||participants|Number|26|26.0||||||
4311762|NCT00486811|4138952|B3|Netherlands||Region of Enrollment||participants|Number|9|9.0||||||
4311763|NCT00486811|4138953|B2|Netherlands||Region of Enrollment||participants|Number|9|9.0||||||
4311764|NCT00486811|4138954|B1|Netherlands||Region of Enrollment||participants|Number|8|8.0||||||
4311765|NCT00486811|4138951|B4|Latvia||Region of Enrollment||participants|Number|69|69.0||||||
4311766|NCT00486811|4138952|B3|Latvia||Region of Enrollment||participants|Number|24|24.0||||||
4311767|NCT00486811|4138953|B2|Latvia||Region of Enrollment||participants|Number|21|21.0||||||
4311768|NCT00486811|4138954|B1|Latvia||Region of Enrollment||participants|Number|24|24.0||||||
4311769|NCT00486811|4138951|B4|Germany||Region of Enrollment||participants|Number|177|177.0||||||
4311770|NCT00486811|4138952|B3|Germany||Region of Enrollment||participants|Number|59|59.0||||||
4311771|NCT00486811|4138953|B2|Germany||Region of Enrollment||participants|Number|60|60.0||||||
4311772|NCT00486811|4138954|B1|Germany||Region of Enrollment||participants|Number|58|58.0||||||
4311773|NCT00486811|4138951|B4|Croatia||Region of Enrollment||participants|Number|29|29.0||||||
4311774|NCT00486811|4138952|B3|Croatia||Region of Enrollment||participants|Number|8|8.0||||||
4311775|NCT00486811|4138953|B2|Croatia||Region of Enrollment||participants|Number|9|9.0||||||
4311776|NCT00486811|4138954|B1|Croatia||Region of Enrollment||participants|Number|12|12.0||||||
4311777|NCT00486811|4138951|B4|Romania||Region of Enrollment||participants|Number|314|314.0||||||
4311778|NCT00486811|4138952|B3|Romania||Region of Enrollment||participants|Number|104|104.0||||||
4311779|NCT00486811|4138953|B2|Romania||Region of Enrollment||participants|Number|103|103.0||||||
4311780|NCT00486811|4138954|B1|Romania||Region of Enrollment||participants|Number|107|107.0||||||
4311781|NCT00486811|4138951|B4|Poland||Region of Enrollment||participants|Number|35|35.0||||||
4311782|NCT00486811|4138952|B3|Poland||Region of Enrollment||participants|Number|13|13.0||||||
4311783|NCT00486811|4138953|B2|Poland||Region of Enrollment||participants|Number|11|11.0||||||
4311784|NCT00486811|4138954|B1|Poland||Region of Enrollment||participants|Number|11|11.0||||||
4311785|NCT00486811|4138951|B4|Hungary||Region of Enrollment||participants|Number|105|105.0||||||
4311786|NCT00486811|4138952|B3|Hungary||Region of Enrollment||participants|Number|34|34.0||||||
4311787|NCT00486811|4138953|B2|Hungary||Region of Enrollment||participants|Number|35|35.0||||||
4311788|NCT00486811|4138954|B1|Hungary||Region of Enrollment||participants|Number|36|36.0||||||
4311789|NCT00486811|4138951|B4|United Kingdom||Region of Enrollment||participants|Number|75|75.0||||||
4311790|NCT00486811|4138952|B3|United Kingdom||Region of Enrollment||participants|Number|28|28.0||||||
4311791|NCT00486811|4138953|B2|United Kingdom||Region of Enrollment||participants|Number|24|24.0||||||
4311792|NCT00486811|4138954|B1|United Kingdom||Region of Enrollment||participants|Number|23|23.0||||||
4311793|NCT00486811|4138951|B4|Austria||Region of Enrollment||participants|Number|41|41.0||||||
4311794|NCT00486811|4138952|B3|Austria||Region of Enrollment||participants|Number|15|15.0||||||
4311795|NCT00486811|4138953|B2|Austria||Region of Enrollment||participants|Number|12|12.0||||||
4311796|NCT00486811|4138954|B1|Austria||Region of Enrollment||participants|Number|14|14.0||||||
4311797|NCT00486811|4138951|B4|Spain||Region of Enrollment||participants|Number|77|77.0||||||
4311798|NCT00486811|4138952|B3|Spain||Region of Enrollment||participants|Number|25|25.0||||||
4311799|NCT00486811|4138953|B2|Spain||Region of Enrollment||participants|Number|23|23.0||||||
4311800|NCT00486811|4138954|B1|Spain||Region of Enrollment||participants|Number|29|29.0||||||
4311801|NCT00486811|4138951|B4|Slovakia||Region of Enrollment||participants|Number|24|24.0||||||
4311802|NCT00486811|4138952|B3|Slovakia||Region of Enrollment||participants|Number|9|9.0||||||
4311803|NCT00486811|4138953|B2|Slovakia||Region of Enrollment||participants|Number|8|8.0||||||
4311804|NCT00486811|4138954|B1|Slovakia||Region of Enrollment||participants|Number|7|7.0||||||
4311805|NCT00486811|4138951|B4|Portugal||Region of Enrollment||participants|Number|15|15.0||||||
4311806|NCT00486811|4138952|B3|Portugal||Region of Enrollment||participants|Number|3|3.0||||||
4311807|NCT00486811|4138953|B2|Portugal||Region of Enrollment||participants|Number|4|4.0||||||
4311808|NCT00486811|4138954|B1|Portugal||Region of Enrollment||participants|Number|8|8.0||||||
4311809|NCT00486811|4138951|B4||Male|Sex: Female, Male||Participants|Count of Participants|280|280.0||||||
4311810|NCT00486811|4138952|B3||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4311811|NCT00486811|4138953|B2||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4311812|NCT00486811|4138954|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4311813|NCT00486811|4138951|B4||Female|Sex: Female, Male||Participants|Count of Participants|707|707.0||||||
4311814|NCT00486811|4138952|B3||Female|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
4311815|NCT00486811|4138953|B2||Female|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
4311816|NCT00486811|4138954|B1||Female|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
4311817|NCT00486811|4138951|B4|>=65 years||Age, Customized||participants|Number|388|388.0||||||
4311818|NCT00486811|4138952|B3|>=65 years||Age, Customized||participants|Number|120|120.0||||||
4311819|NCT00486811|4138953|B2|>=65 years||Age, Customized||participants|Number|125|125.0||||||
4311820|NCT00486811|4138954|B1|>=65 years||Age, Customized||participants|Number|143|143.0||||||
4311821|NCT00486811|4138951|B4|Between 18 and 65 years||Age, Customized||participants|Number|599|599.0||||||
4311822|NCT00486811|4138952|B3|Between 18 and 65 years||Age, Customized||participants|Number|211|211.0||||||
4311823|NCT00486811|4138953|B2|Between 18 and 65 years||Age, Customized||participants|Number|194|194.0||||||
4311824|NCT00486811|4138954|B1|Between 18 and 65 years||Age, Customized||participants|Number|194|194.0||||||
4311825|NCT00486811|4138951|B4|||Age||years|Mean|62.1|62.1|Standard Deviation|9.26|9.26|||
4311826|NCT00486811|4138952|B3|||Age||years|Mean|61.8|61.8|Standard Deviation|9.09|9.09|||
4311827|NCT00486811|4138953|B2|||Age||years|Mean|62.4|62.4|Standard Deviation|9.35|9.35|||
4311828|NCT00486811|4138954|B1|||Age||years|Mean|62.2|62.2|Standard Deviation|9.35|9.35|||
4311829|NCT00486759|4138997|B3||Male|Sex: Female, Male||Participants|Count of Participants|387|387.0||||||
4311830|NCT00486759|4138998|B2||Male|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4311831|NCT00486759|4138999|B1||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4311832|NCT00486759|4138997|B3||Female|Sex: Female, Male||Participants|Count of Participants|400|400.0||||||
4311833|NCT00486759|4138998|B2||Female|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4311834|NCT00486759|4138999|B1||Female|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4311835|NCT00486759|4138997|B3|||Age||years|Mean|57.44|57.44|Standard Deviation|14.841|14.841|||
4311836|NCT00486759|4138998|B2|||Age||years|Mean|56.98|56.98|Standard Deviation|15.399|15.399|||
4311837|NCT00486759|4138999|B1|||Age||years|Mean|57.89|57.89|Standard Deviation|14.256|14.256|||
4311838|NCT00486720|4139010|B3|No||Prior Myelodysplastic Syndromes Therapy||Participants|Number|12|12.0||||||
4311839|NCT00486720|4139011|B2|No||Prior Myelodysplastic Syndromes Therapy||Participants|Number|9|9.0||||||
4311840|NCT00486720|4139012|B1|No||Prior Myelodysplastic Syndromes Therapy||Participants|Number|3|3.0||||||
4311841|NCT00486720|4139010|B3|Yes||Prior Myelodysplastic Syndromes Therapy||Participants|Number|9|9.0||||||
4311842|NCT00486720|4139011|B2|Yes||Prior Myelodysplastic Syndromes Therapy||Participants|Number|3|3.0||||||
4311843|NCT00486720|4139012|B1|Yes||Prior Myelodysplastic Syndromes Therapy||Participants|Number|6|6.0||||||
4311844|NCT00486720|4139010|B3|Intermediate-1||International Prognostic Scoring System Risk (IPSS)|"IPSS Risk: Low [Score = 0; Time to Acute myeloid leukemia (AML) (yrs) = 9.4; Median Survival (yrs) = 5.7]~IPSS Risk: INT-1 [Score = 0.5 - 1; Time to AML (yrs) = 3.3; Median Survival (yrs) = 3.5]~IPSS Risk: INT-2 [Score = 1.5 - 2; Time to AML (yrs) = 1.1; Median Survival (yrs) = 1.2]~IPSS Risk: High [Score = >2; Time to AML (yrs) = 0.2; Median Survival (yrs) = 0.4]"|Participants|Number|14|14.0||||||
4311845|NCT00486720|4139011|B2|Intermediate-1||International Prognostic Scoring System Risk (IPSS)|"IPSS Risk: Low [Score = 0; Time to Acute myeloid leukemia (AML) (yrs) = 9.4; Median Survival (yrs) = 5.7]~IPSS Risk: INT-1 [Score = 0.5 - 1; Time to AML (yrs) = 3.3; Median Survival (yrs) = 3.5]~IPSS Risk: INT-2 [Score = 1.5 - 2; Time to AML (yrs) = 1.1; Median Survival (yrs) = 1.2]~IPSS Risk: High [Score = >2; Time to AML (yrs) = 0.2; Median Survival (yrs) = 0.4]"|Participants|Number|8|8.0||||||
4311846|NCT00486720|4139012|B1|Intermediate-1||International Prognostic Scoring System Risk (IPSS)|"IPSS Risk: Low [Score = 0; Time to Acute myeloid leukemia (AML) (yrs) = 9.4; Median Survival (yrs) = 5.7]~IPSS Risk: INT-1 [Score = 0.5 - 1; Time to AML (yrs) = 3.3; Median Survival (yrs) = 3.5]~IPSS Risk: INT-2 [Score = 1.5 - 2; Time to AML (yrs) = 1.1; Median Survival (yrs) = 1.2]~IPSS Risk: High [Score = >2; Time to AML (yrs) = 0.2; Median Survival (yrs) = 0.4]"|Participants|Number|6|6.0||||||
4311847|NCT00486720|4139010|B3|Low||International Prognostic Scoring System Risk (IPSS)|"IPSS Risk: Low [Score = 0; Time to Acute myeloid leukemia (AML) (yrs) = 9.4; Median Survival (yrs) = 5.7]~IPSS Risk: INT-1 [Score = 0.5 - 1; Time to AML (yrs) = 3.3; Median Survival (yrs) = 3.5]~IPSS Risk: INT-2 [Score = 1.5 - 2; Time to AML (yrs) = 1.1; Median Survival (yrs) = 1.2]~IPSS Risk: High [Score = >2; Time to AML (yrs) = 0.2; Median Survival (yrs) = 0.4]"|Participants|Number|7|7.0||||||
4311848|NCT00486720|4139011|B2|Low||International Prognostic Scoring System Risk (IPSS)|"IPSS Risk: Low [Score = 0; Time to Acute myeloid leukemia (AML) (yrs) = 9.4; Median Survival (yrs) = 5.7]~IPSS Risk: INT-1 [Score = 0.5 - 1; Time to AML (yrs) = 3.3; Median Survival (yrs) = 3.5]~IPSS Risk: INT-2 [Score = 1.5 - 2; Time to AML (yrs) = 1.1; Median Survival (yrs) = 1.2]~IPSS Risk: High [Score = >2; Time to AML (yrs) = 0.2; Median Survival (yrs) = 0.4]"|Participants|Number|4|4.0||||||
4311849|NCT00486720|4139012|B1|Low||International Prognostic Scoring System Risk (IPSS)|"IPSS Risk: Low [Score = 0; Time to Acute myeloid leukemia (AML) (yrs) = 9.4; Median Survival (yrs) = 5.7]~IPSS Risk: INT-1 [Score = 0.5 - 1; Time to AML (yrs) = 3.3; Median Survival (yrs) = 3.5]~IPSS Risk: INT-2 [Score = 1.5 - 2; Time to AML (yrs) = 1.1; Median Survival (yrs) = 1.2]~IPSS Risk: High [Score = >2; Time to AML (yrs) = 0.2; Median Survival (yrs) = 0.4]"|Participants|Number|3|3.0||||||
4311850|NCT00486720|4139010|B3|2 = In bed < 50% of the time||Eastern Cooperative Oncology Group (ECOG) Performance Scale Status|ECOG Scale: 0 = Normal Activity, 1 = Symptoms, but ambulatory, 2 = In bed <50% of the time, 3 = In bed >50% of the time, 4 = 100% Bedridden, 5 = Dead|participants|Number|2|2.0||||||
4311851|NCT00486720|4139011|B2|2 = In bed < 50% of the time||Eastern Cooperative Oncology Group (ECOG) Performance Scale Status|ECOG Scale: 0 = Normal Activity, 1 = Symptoms, but ambulatory, 2 = In bed <50% of the time, 3 = In bed >50% of the time, 4 = 100% Bedridden, 5 = Dead|participants|Number|1|1.0||||||
4311852|NCT00486720|4139012|B1|2 = In bed < 50% of the time||Eastern Cooperative Oncology Group (ECOG) Performance Scale Status|ECOG Scale: 0 = Normal Activity, 1 = Symptoms, but ambulatory, 2 = In bed <50% of the time, 3 = In bed >50% of the time, 4 = 100% Bedridden, 5 = Dead|participants|Number|1|1.0||||||
4311853|NCT00486720|4139010|B3|1 = Symptoms, but ambulatory||Eastern Cooperative Oncology Group (ECOG) Performance Scale Status|ECOG Scale: 0 = Normal Activity, 1 = Symptoms, but ambulatory, 2 = In bed <50% of the time, 3 = In bed >50% of the time, 4 = 100% Bedridden, 5 = Dead|participants|Number|5|5.0||||||
4311854|NCT00486720|4139011|B2|1 = Symptoms, but ambulatory||Eastern Cooperative Oncology Group (ECOG) Performance Scale Status|ECOG Scale: 0 = Normal Activity, 1 = Symptoms, but ambulatory, 2 = In bed <50% of the time, 3 = In bed >50% of the time, 4 = 100% Bedridden, 5 = Dead|participants|Number|1|1.0||||||
4311855|NCT00486720|4139012|B1|1 = Symptoms, but ambulatory||Eastern Cooperative Oncology Group (ECOG) Performance Scale Status|ECOG Scale: 0 = Normal Activity, 1 = Symptoms, but ambulatory, 2 = In bed <50% of the time, 3 = In bed >50% of the time, 4 = 100% Bedridden, 5 = Dead|participants|Number|4|4.0||||||
4311856|NCT00486720|4139010|B3|0 = Normal Activity||Eastern Cooperative Oncology Group (ECOG) Performance Scale Status|ECOG Scale: 0 = Normal Activity, 1 = Symptoms, but ambulatory, 2 = In bed <50% of the time, 3 = In bed >50% of the time, 4 = 100% Bedridden, 5 = Dead|participants|Number|14|14.0||||||
4311857|NCT00486720|4139011|B2|0 = Normal Activity||Eastern Cooperative Oncology Group (ECOG) Performance Scale Status|ECOG Scale: 0 = Normal Activity, 1 = Symptoms, but ambulatory, 2 = In bed <50% of the time, 3 = In bed >50% of the time, 4 = 100% Bedridden, 5 = Dead|participants|Number|10|10.0||||||
4311858|NCT00486720|4139012|B1|0 = Normal Activity||Eastern Cooperative Oncology Group (ECOG) Performance Scale Status|ECOG Scale: 0 = Normal Activity, 1 = Symptoms, but ambulatory, 2 = In bed <50% of the time, 3 = In bed >50% of the time, 4 = 100% Bedridden, 5 = Dead|participants|Number|4|4.0||||||
4311859|NCT00486720|4139010|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4311860|NCT00486720|4139011|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4311861|NCT00486720|4139012|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4311862|NCT00486720|4139010|B3|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4311863|NCT00486720|4139011|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4311864|NCT00486720|4139012|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4311865|NCT00486720|4139010|B3|White||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4311866|NCT00486720|4139011|B2|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4311867|NCT00486720|4139012|B1|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4311868|NCT00486720|4139010|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4311869|NCT00486720|4139011|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4311870|NCT00486720|4139012|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4311871|NCT00486720|4139010|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4311872|NCT00486720|4139011|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4311873|NCT00486720|4139012|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4311874|NCT00486720|4139010|B3|||Age||years|Mean|66.0|66.0|Standard Deviation|14.1|14.1|||
4311875|NCT00486720|4139011|B2|||Age||years|Mean|64.0|64.0|Standard Deviation|10.5|10.5|||
4311876|NCT00486720|4139012|B1|||Age||years|Mean|69.0|69.0|Standard Deviation|18.5|18.5|||
4311877|NCT00486642|4139021|B3|Canada||Region of Enrollment||participants|Number|23|23.0||||||
4311878|NCT00486642|4139022|B2|Canada||Region of Enrollment||participants|Number|13|13.0||||||
4311879|NCT00486642|4139023|B1|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4311880|NCT00486642|4139021|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4311881|NCT00486642|4139022|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4311882|NCT00486642|4139023|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4311883|NCT00486642|4139021|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4311884|NCT00486642|4139022|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4311885|NCT00486642|4139023|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4311886|NCT00486642|4139021|B3|||Age||years|Median|71|71.0|Full Range|||51.0|85.0|
4311887|NCT00486642|4139022|B2|||Age||years|Median|70|70.0|Full Range|||51.0|85.0|
4311888|NCT00486642|4139023|B1|||Age||years|Median|71|71.0|Full Range|||54.0|77.0|
4311889|NCT00486642|4139021|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4311890|NCT00486642|4139022|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4311891|NCT00486642|4139023|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4311892|NCT00486642|4139021|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4311893|NCT00486642|4139022|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4311894|NCT00486642|4139023|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4311895|NCT00486642|4139021|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4311896|NCT00486642|4139022|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4311897|NCT00486642|4139023|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4311898|NCT00486525|4139046|B3|||Time since treatment||months|Mean|10.9|10.9|Standard Deviation|7.9|7.9|||
4311899|NCT00486525|4139047|B2|||Time since treatment||months|Mean|11.8|11.8|Standard Deviation|8.5|8.5|||
4311900|NCT00486525|4139048|B1|||Time since treatment||months|Mean|9.9|9.9|Standard Deviation|7.1|7.1|||
4311901|NCT00486525|4139046|B3|||Time since diagnosis||months|Mean|17.3|17.3|Standard Deviation|8.1|8.1|||
4311902|NCT00486525|4139047|B2|||Time since diagnosis||months|Mean|18.4|18.4|Standard Deviation|8.5|8.5|||
4311903|NCT00486525|4139048|B1|||Time since diagnosis||months|Mean|16.3|16.3|Standard Deviation|7.5|7.5|||
4311904|NCT00486525|4139046|B3|||Post-menopausal||participants|Number|153|153.0||||||
4311905|NCT00486525|4139047|B2|||Post-menopausal||participants|Number|77|77.0||||||
4311906|NCT00486525|4139048|B1|||Post-menopausal||participants|Number|76|76.0||||||
4311907|NCT00486525|4139046|B3|||Usage of Tamoxifen/Aromatase Inhibitors||participants|Number|143|143.0||||||
4311908|NCT00486525|4139047|B2|||Usage of Tamoxifen/Aromatase Inhibitors||participants|Number|71|71.0||||||
4311909|NCT00486525|4139048|B1|||Usage of Tamoxifen/Aromatase Inhibitors||participants|Number|72|72.0||||||
4311910|NCT00486525|4139046|B3|Unknown||Estrogen Receptor Status||participants|Number|9|9.0||||||
4311911|NCT00486525|4139047|B2|Unknown||Estrogen Receptor Status||participants|Number|5|5.0||||||
4311912|NCT00486525|4139048|B1|Unknown||Estrogen Receptor Status||participants|Number|4|4.0||||||
4311913|NCT00486525|4139046|B3|Negative||Estrogen Receptor Status||participants|Number|32|32.0||||||
4311914|NCT00486525|4139047|B2|Negative||Estrogen Receptor Status||participants|Number|17|17.0||||||
4311915|NCT00486525|4139048|B1|Negative||Estrogen Receptor Status||participants|Number|15|15.0||||||
4311916|NCT00486525|4139046|B3|Positive||Estrogen Receptor Status||participants|Number|159|159.0||||||
4311917|NCT00486525|4139047|B2|Positive||Estrogen Receptor Status||participants|Number|78|78.0||||||
4311918|NCT00486525|4139048|B1|Positive||Estrogen Receptor Status||participants|Number|81|81.0||||||
4311919|NCT00486525|4139046|B3|Unknown||Progesterone Receptor Status||participants|Number|9|9.0||||||
4311920|NCT00486525|4139047|B2|Unknown||Progesterone Receptor Status||participants|Number|5|5.0||||||
4311921|NCT00486525|4139048|B1|Unknown||Progesterone Receptor Status||participants|Number|4|4.0||||||
4311922|NCT00486525|4139046|B3|Negative||Progesterone Receptor Status||participants|Number|49|49.0||||||
4311923|NCT00486525|4139047|B2|Negative||Progesterone Receptor Status||participants|Number|26|26.0||||||
4311924|NCT00486525|4139048|B1|Negative||Progesterone Receptor Status||participants|Number|23|23.0||||||
4311925|NCT00486525|4139046|B3|Positive||Progesterone Receptor Status||participants|Number|142|142.0||||||
4311926|NCT00486525|4139047|B2|Positive||Progesterone Receptor Status||participants|Number|69|69.0||||||
4311927|NCT00486525|4139048|B1|Positive||Progesterone Receptor Status||participants|Number|73|73.0||||||
4311928|NCT00486525|4139046|B3|Unknown||HER2 Receptor Status||participants|Number|19|19.0||||||
4311929|NCT00486525|4139047|B2|Unknown||HER2 Receptor Status||participants|Number|11|11.0||||||
4311930|NCT00486525|4139048|B1|Unknown||HER2 Receptor Status||participants|Number|8|8.0||||||
4311931|NCT00486525|4139046|B3|Negative||HER2 Receptor Status||participants|Number|146|146.0||||||
4311932|NCT00486525|4139047|B2|Negative||HER2 Receptor Status||participants|Number|72|72.0||||||
4311933|NCT00486525|4139048|B1|Negative||HER2 Receptor Status||participants|Number|74|74.0||||||
4311934|NCT00486525|4139046|B3|Positive||HER2 Receptor Status||participants|Number|35|35.0||||||
4311935|NCT00486525|4139047|B2|Positive||HER2 Receptor Status||participants|Number|17|17.0||||||
4311936|NCT00486525|4139048|B1|Positive||HER2 Receptor Status||participants|Number|18|18.0||||||
4311937|NCT00486525|4139046|B3|Stage IIIA||Cancer Stage||participants|Number|18|18.0||||||
4311938|NCT00486525|4139047|B2|Stage IIIA||Cancer Stage||participants|Number|10|10.0||||||
4311939|NCT00486525|4139048|B1|Stage IIIA||Cancer Stage||participants|Number|8|8.0||||||
4311940|NCT00486525|4139046|B3|Stage IIB||Cancer Stage||participants|Number|23|23.0||||||
4311941|NCT00486525|4139047|B2|Stage IIB||Cancer Stage||participants|Number|13|13.0||||||
4311942|NCT00486525|4139048|B1|Stage IIB||Cancer Stage||participants|Number|10|10.0||||||
4311943|NCT00486525|4139046|B3|Stage IIA||Cancer Stage||participants|Number|52|52.0||||||
4311944|NCT00486525|4139047|B2|Stage IIA||Cancer Stage||participants|Number|25|25.0||||||
4311945|NCT00486525|4139048|B1|Stage IIA||Cancer Stage||participants|Number|27|27.0||||||
4311946|NCT00486525|4139046|B3|Stage I||Cancer Stage||participants|Number|89|89.0||||||
4311947|NCT00486525|4139047|B2|Stage I||Cancer Stage||participants|Number|43|43.0||||||
4311948|NCT00486525|4139048|B1|Stage I||Cancer Stage||participants|Number|46|46.0||||||
4311949|NCT00486525|4139046|B3|Stage 0||Cancer Stage||participants|Number|18|18.0||||||
4311950|NCT00486525|4139047|B2|Stage 0||Cancer Stage||participants|Number|9|9.0||||||
4311951|NCT00486525|4139048|B1|Stage 0||Cancer Stage||participants|Number|9|9.0||||||
4311952|NCT00486525|4139046|B3|Surgery + Radiation + Chemotherapy||Type of Treatment||participants|Number|76|76.0||||||
4311953|NCT00486525|4139047|B2|Surgery + Radiation + Chemotherapy||Type of Treatment||participants|Number|40|40.0||||||
4311954|NCT00486525|4139048|B1|Surgery + Radiation + Chemotherapy||Type of Treatment||participants|Number|36|36.0||||||
4311955|NCT00486525|4139046|B3|Surgery + Chemotherapy||Type of Treatment||participants|Number|46|46.0||||||
4311956|NCT00486525|4139047|B2|Surgery + Chemotherapy||Type of Treatment||participants|Number|23|23.0||||||
4311957|NCT00486525|4139048|B1|Surgery + Chemotherapy||Type of Treatment||participants|Number|23|23.0||||||
4311958|NCT00486525|4139046|B3|Surgery + Radiation||Type of Treatment||participants|Number|52|52.0||||||
4311959|NCT00486525|4139047|B2|Surgery + Radiation||Type of Treatment||participants|Number|24|24.0||||||
4311960|NCT00486525|4139048|B1|Surgery + Radiation||Type of Treatment||participants|Number|28|28.0||||||
4311961|NCT00486525|4139046|B3|Surgery Only||Type of Treatment||participants|Number|26|26.0||||||
4311962|NCT00486525|4139047|B2|Surgery Only||Type of Treatment||participants|Number|13|13.0||||||
4311963|NCT00486525|4139048|B1|Surgery Only||Type of Treatment||participants|Number|13|13.0||||||
4311964|NCT00486525|4139046|B3|No report||Income level||participants|Number|17|17.0||||||
4311965|NCT00486525|4139047|B2|No report||Income level||participants|Number|8|8.0||||||
4311966|NCT00486525|4139048|B1|No report||Income level||participants|Number|9|9.0||||||
4311967|NCT00486525|4139046|B3|>$100,000||Income level||participants|Number|59|59.0||||||
4311968|NCT00486525|4139047|B2|>$100,000||Income level||participants|Number|29|29.0||||||
4311969|NCT00486525|4139048|B1|>$100,000||Income level||participants|Number|30|30.0||||||
4311970|NCT00486525|4139046|B3|$75,000-$100,000||Income level||participants|Number|46|46.0||||||
4311971|NCT00486525|4139047|B2|$75,000-$100,000||Income level||participants|Number|23|23.0||||||
4311972|NCT00486525|4139048|B1|$75,000-$100,000||Income level||participants|Number|23|23.0||||||
4311973|NCT00486525|4139046|B3|$50,000-$75,000||Income level||participants|Number|35|35.0||||||
4311974|NCT00486525|4139047|B2|$50,000-$75,000||Income level||participants|Number|18|18.0||||||
4311975|NCT00486525|4139048|B1|$50,000-$75,000||Income level||participants|Number|17|17.0||||||
4311976|NCT00486525|4139046|B3|$25,000-$50,000||Income level||participants|Number|33|33.0||||||
4311977|NCT00486525|4139047|B2|$25,000-$50,000||Income level||participants|Number|15|15.0||||||
4311978|NCT00486525|4139048|B1|$25,000-$50,000||Income level||participants|Number|18|18.0||||||
4311979|NCT00486525|4139046|B3|$0-$25,000||Income level||participants|Number|10|10.0||||||
4311980|NCT00486525|4139047|B2|$0-$25,000||Income level||participants|Number|7|7.0||||||
4311981|NCT00486525|4139048|B1|$0-$25,000||Income level||participants|Number|3|3.0||||||
4311982|NCT00486525|4139046|B3|Retired||Employment Status||participants|Number|28|28.0||||||
4311983|NCT00486525|4139047|B2|Retired||Employment Status||participants|Number|14|14.0||||||
4311984|NCT00486525|4139048|B1|Retired||Employment Status||participants|Number|14|14.0||||||
4311985|NCT00486525|4139046|B3|Unemployed||Employment Status||participants|Number|35|35.0||||||
4311986|NCT00486525|4139047|B2|Unemployed||Employment Status||participants|Number|20|20.0||||||
4311987|NCT00486525|4139048|B1|Unemployed||Employment Status||participants|Number|15|15.0||||||
4311988|NCT00486525|4139046|B3|Employed full or part time||Employment Status||participants|Number|137|137.0||||||
4311989|NCT00486525|4139047|B2|Employed full or part time||Employment Status||participants|Number|66|66.0||||||
4311990|NCT00486525|4139048|B1|Employed full or part time||Employment Status||participants|Number|71|71.0||||||
4311991|NCT00486525|4139046|B3|Postgraduate||Education level||participants|Number|77|77.0||||||
4311992|NCT00486525|4139047|B2|Postgraduate||Education level||participants|Number|38|38.0||||||
4311993|NCT00486525|4139048|B1|Postgraduate||Education level||participants|Number|39|39.0||||||
4311994|NCT00486525|4139046|B3|College Grad||Education level||participants|Number|62|62.0||||||
4311995|NCT00486525|4139047|B2|College Grad||Education level||participants|Number|33|33.0||||||
4311996|NCT00486525|4139048|B1|College Grad||Education level||participants|Number|29|29.0||||||
4311997|NCT00486525|4139046|B3|Some College||Education level||participants|Number|49|49.0||||||
4311998|NCT00486525|4139047|B2|Some College||Education level||participants|Number|22|22.0||||||
4311999|NCT00486525|4139048|B1|Some College||Education level||participants|Number|27|27.0||||||
4312000|NCT00486525|4139046|B3|High School or Less||Education level||participants|Number|12|12.0||||||
4312001|NCT00486525|4139047|B2|High School or Less||Education level||participants|Number|7|7.0||||||
4312002|NCT00486525|4139048|B1|High School or Less||Education level||participants|Number|5|5.0||||||
4312003|NCT00486525|4139046|B3|Widowed||Marital Status||participants|Number|5|5.0||||||
4312004|NCT00486525|4139047|B2|Widowed||Marital Status||participants|Number|5|5.0||||||
4312005|NCT00486525|4139048|B1|Widowed||Marital Status||participants|Number|0|0.0||||||
4312006|NCT00486525|4139046|B3|Separated/Divorced||Marital Status||participants|Number|29|29.0||||||
4312007|NCT00486525|4139047|B2|Separated/Divorced||Marital Status||participants|Number|15|15.0||||||
4312008|NCT00486525|4139048|B1|Separated/Divorced||Marital Status||participants|Number|14|14.0||||||
4312009|NCT00486525|4139046|B3|Married||Marital Status||participants|Number|140|140.0||||||
4312010|NCT00486525|4139047|B2|Married||Marital Status||participants|Number|72|72.0||||||
4312011|NCT00486525|4139048|B1|Married||Marital Status||participants|Number|68|68.0||||||
4312012|NCT00486525|4139046|B3|Single||Marital Status||participants|Number|26|26.0||||||
4312013|NCT00486525|4139047|B2|Single||Marital Status||participants|Number|8|8.0||||||
4312014|NCT00486525|4139048|B1|Single||Marital Status||participants|Number|18|18.0||||||
4312015|NCT00486525|4139046|B3|||SF-36 Vitality|The SF-36's (RAND Health Survey) energy/fatigue (vitality) scale focuses on the frequency of feelings of fatigue over the last month. Standardized scores on the RAND SF-36 vigor/vitality scale range from 0-100, with higher scores indicating less fatigue.|units on a scale|Mean|46.5|46.5|Standard Deviation|20.6|20.6|||
4312016|NCT00486525|4139047|B2|||SF-36 Vitality|The SF-36's (RAND Health Survey) energy/fatigue (vitality) scale focuses on the frequency of feelings of fatigue over the last month. Standardized scores on the RAND SF-36 vigor/vitality scale range from 0-100, with higher scores indicating less fatigue.|units on a scale|Mean|44.4|44.4|Standard Deviation|20.9|20.9|||
4312017|NCT00486525|4139048|B1|||SF-36 Vitality|The SF-36's (RAND Health Survey) energy/fatigue (vitality) scale focuses on the frequency of feelings of fatigue over the last month. Standardized scores on the RAND SF-36 vigor/vitality scale range from 0-100, with higher scores indicating less fatigue.|units on a scale|Mean|48.6|48.6|Standard Deviation|20.2|20.2|||
4312018|NCT00486525|4139046|B3|||MFSI-SF Fatigue|The 30-item Multidimensional Fatigue Symptom Inventory-Short form (MFSI-SF) assesses behavioral, cognitive, physical, and affective expressions of fatigue. Items are rated on a 5-point scale indicating how true each statement was for the respondent during the last week (0=not at all; 4=extremely). The total score represents the sum of the subscales measuring general, physical, emotional, and mental fatigue, minus the vigor scale, providing a possible range of scores from -24 to 96, with higher scores indicating greater fatigue.|units on a scale|Mean|15.8|15.8|Standard Deviation|20.1|20.1|||
4312019|NCT00486525|4139047|B2|||MFSI-SF Fatigue|The 30-item Multidimensional Fatigue Symptom Inventory-Short form (MFSI-SF) assesses behavioral, cognitive, physical, and affective expressions of fatigue. Items are rated on a 5-point scale indicating how true each statement was for the respondent during the last week (0=not at all; 4=extremely). The total score represents the sum of the subscales measuring general, physical, emotional, and mental fatigue, minus the vigor scale, providing a possible range of scores from -24 to 96, with higher scores indicating greater fatigue.|units on a scale|Mean|17.3|17.3|Standard Deviation|20.5|20.5|||
4312020|NCT00486525|4139048|B1|||MFSI-SF Fatigue|The 30-item Multidimensional Fatigue Symptom Inventory-Short form (MFSI-SF) assesses behavioral, cognitive, physical, and affective expressions of fatigue. Items are rated on a 5-point scale indicating how true each statement was for the respondent during the last week (0=not at all; 4=extremely). The total score represents the sum of the subscales measuring general, physical, emotional, and mental fatigue, minus the vigor scale, providing a possible range of scores from -24 to 96, with higher scores indicating greater fatigue.|units on a scale|Mean|14.3|14.3|Standard Deviation|19.6|19.6|||
4312021|NCT00486525|4139046|B3|||CHAMPS activity|The Community Health Activities Model Program for Seniors questionnaire (CHAMPS) assessed the weekly frequency and duration of various physical activities.|total hours/week|Mean|6.3|6.3|Standard Deviation|5.7|5.7|||
4312022|NCT00486525|4139047|B2|||CHAMPS activity|The Community Health Activities Model Program for Seniors questionnaire (CHAMPS) assessed the weekly frequency and duration of various physical activities.|total hours/week|Mean|5.8|5.8|Standard Deviation|5.1|5.1|||
4312023|NCT00486525|4139048|B1|||CHAMPS activity|The Community Health Activities Model Program for Seniors questionnaire (CHAMPS) assessed the weekly frequency and duration of various physical activities.|total hours/week|Mean|6.8|6.8|Standard Deviation|6.3|6.3|||
4312024|NCT00486525|4139046|B3|||Usage of Cardiac Medication||participants|Number|33|33.0||||||
4312025|NCT00486525|4139047|B2|||Usage of Cardiac Medication||participants|Number|16|16.0||||||
4312026|NCT00486525|4139048|B1|||Usage of Cardiac Medication||participants|Number|17|17.0||||||
4312027|NCT00486525|4139046|B3|||CES-D depressive symptoms|The Center for Epidemiological Studies Depression Scale (CES-D) has been used extensively to measure depressive symptomatology. Each of the 20 items are rated on a four-point scale, yielding a total score that can range from 0 to 60. Higher values represent more depressive symptoms.|units on a scale|Mean|10.7|10.7|Standard Deviation|8.2|8.2|||
4312028|NCT00486525|4139047|B2|||CES-D depressive symptoms|The Center for Epidemiological Studies Depression Scale (CES-D) has been used extensively to measure depressive symptomatology. Each of the 20 items are rated on a four-point scale, yielding a total score that can range from 0 to 60. Higher values represent more depressive symptoms.|units on a scale|Mean|11.2|11.2|Standard Deviation|8.2|8.2|||
4312029|NCT00486525|4139048|B1|||CES-D depressive symptoms|The Center for Epidemiological Studies Depression Scale (CES-D) has been used extensively to measure depressive symptomatology. Each of the 20 items are rated on a four-point scale, yielding a total score that can range from 0 to 60. Higher values represent more depressive symptoms.|units on a scale|Mean|10.2|10.2|Standard Deviation|8.2|8.2|||
4312030|NCT00486525|4139046|B3|Not Reported||Ethnicity||participants|Number|1|1.0||||||
4312031|NCT00486525|4139047|B2|Not Reported||Ethnicity||participants|Number|0|0.0||||||
4312032|NCT00486525|4139048|B1|Not Reported||Ethnicity||participants|Number|1|1.0||||||
4312033|NCT00486525|4139046|B3|White||Ethnicity||participants|Number|176|176.0||||||
4312034|NCT00486525|4139047|B2|White||Ethnicity||participants|Number|88|88.0||||||
4312035|NCT00486525|4139048|B1|White||Ethnicity||participants|Number|88|88.0||||||
4312036|NCT00486525|4139046|B3|Black or African American||Ethnicity||participants|Number|18|18.0||||||
4312037|NCT00486525|4139047|B2|Black or African American||Ethnicity||participants|Number|10|10.0||||||
4312038|NCT00486525|4139048|B1|Black or African American||Ethnicity||participants|Number|8|8.0||||||
4312039|NCT00486525|4139046|B3|Asian||Ethnicity||participants|Number|5|5.0||||||
4312040|NCT00486525|4139047|B2|Asian||Ethnicity||participants|Number|2|2.0||||||
4312041|NCT00486525|4139048|B1|Asian||Ethnicity||participants|Number|3|3.0||||||
4312042|NCT00486525|4139046|B3|||SAD|Sagittal Abdominal Diameter|cm|Mean|20.8|20.8|Standard Deviation|3.4|3.4|||
4312043|NCT00486525|4139047|B2|||SAD|Sagittal Abdominal Diameter|cm|Mean|21.0|21.0|Standard Deviation|3.6|3.6|||
4312044|NCT00486525|4139048|B1|||SAD|Sagittal Abdominal Diameter|cm|Mean|20.7|20.7|Standard Deviation|3.3|3.3|||
4312045|NCT00486525|4139046|B3|||BMI|Body Mass Index|kg/m^2|Mean|27.8|27.8|Standard Deviation|5.7|5.7|||
4312046|NCT00486525|4139047|B2|||BMI|Body Mass Index|kg/m^2|Mean|27.6|27.6|Standard Deviation|6.0|6.0|||
4312047|NCT00486525|4139048|B1|||BMI|Body Mass Index|kg/m^2|Mean|27.9|27.9|Standard Deviation|5.3|5.3|||
4312048|NCT00486525|4139046|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4312049|NCT00486525|4139047|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4312050|NCT00486525|4139048|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4312051|NCT00486525|4139046|B3||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4312052|NCT00486525|4139047|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4312053|NCT00486525|4139048|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4312054|NCT00486525|4139046|B3|||Age||years|Mean|51.6|51.6|Standard Deviation|9.2|9.2|||
4312055|NCT00486525|4139047|B2|||Age||years|Mean|51.3|51.3|Standard Deviation|8.7|8.7|||
4312056|NCT00486525|4139048|B1|||Age||years|Mean|51.8|51.8|Standard Deviation|9.8|9.8|||
4312057|NCT00486447|4139065|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4312058|NCT00486447|4139065|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4312059|NCT00486447|4139065|B1|||Age||years|Mean|30|30.0|Full Range|||18.0|80.0|
4312060|NCT00486434|4139070|B3|Denmark||Region of Enrollment||participants|Number|739|739.0||||||
4312061|NCT00486434|4139071|B2|Denmark||Region of Enrollment||participants|Number|369|369.0||||||
4312062|NCT00486434|4139072|B1|Denmark||Region of Enrollment||participants|Number|370|370.0||||||
4312063|NCT00486434|4139070|B3|Romania||Region of Enrollment||participants|Number|79|79.0||||||
4312064|NCT00486434|4139071|B2|Romania||Region of Enrollment||participants|Number|39|39.0||||||
4312065|NCT00486434|4139072|B1|Romania||Region of Enrollment||participants|Number|40|40.0||||||
4312066|NCT00486434|4139070|B3|Poland||Region of Enrollment||participants|Number|67|67.0||||||
4312067|NCT00486434|4139071|B2|Poland||Region of Enrollment||participants|Number|34|34.0||||||
4312068|NCT00486434|4139072|B1|Poland||Region of Enrollment||participants|Number|33|33.0||||||
4312069|NCT00486434|4139070|B3|Estonia||Region of Enrollment||participants|Number|94|94.0||||||
4312070|NCT00486434|4139071|B2|Estonia||Region of Enrollment||participants|Number|47|47.0||||||
4312071|NCT00486434|4139072|B1|Estonia||Region of Enrollment||participants|Number|47|47.0||||||
4312072|NCT00486434|4139070|B3|Czech Republic||Region of Enrollment||participants|Number|95|95.0||||||
4312073|NCT00486434|4139071|B2|Czech Republic||Region of Enrollment||participants|Number|48|48.0||||||
4312074|NCT00486434|4139072|B1|Czech Republic||Region of Enrollment||participants|Number|47|47.0||||||
4312075|NCT00486434|4139070|B3|Hong Kong||Region of Enrollment||participants|Number|102|102.0||||||
4312076|NCT00486434|4139071|B2|Hong Kong||Region of Enrollment||participants|Number|51|51.0||||||
4312077|NCT00486434|4139072|B1|Hong Kong||Region of Enrollment||participants|Number|51|51.0||||||
4312078|NCT00486434|4139070|B3||Male|Sex: Female, Male||Participants|Count of Participants|372|372.0||||||
4312079|NCT00486434|4139071|B2||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4312080|NCT00486434|4139072|B1||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4312081|NCT00486434|4139070|B3||Female|Sex: Female, Male||Participants|Count of Participants|804|804.0||||||
4312082|NCT00486434|4139071|B2||Female|Sex: Female, Male||Participants|Count of Participants|386|386.0||||||
4312083|NCT00486434|4139072|B1||Female|Sex: Female, Male||Participants|Count of Participants|418|418.0||||||
4312084|NCT00486434|4139070|B3|||Age||years|Mean|64.0|64.0|Standard Deviation|6.63|6.63|||
4312085|NCT00486434|4139071|B2|||Age||years|Mean|63.9|63.9|Standard Deviation|6.41|6.41|||
4312086|NCT00486434|4139072|B1|||Age||years|Mean|64.1|64.1|Standard Deviation|6.84|6.84|||
4312087|NCT00486434|4139070|B3||>=65 years|Age||Participants|Count of Participants|562|562.0||||||
4312088|NCT00486434|4139071|B2||>=65 years|Age||Participants|Count of Participants|267|267.0||||||
4312089|NCT00486434|4139072|B1||>=65 years|Age||Participants|Count of Participants|295|295.0||||||
4312090|NCT00486434|4139070|B3||Between 18 and 65 years|Age||Participants|Count of Participants|614|614.0||||||
4312091|NCT00486434|4139071|B2||Between 18 and 65 years|Age||Participants|Count of Participants|321|321.0||||||
4312092|NCT00486434|4139072|B1||Between 18 and 65 years|Age||Participants|Count of Participants|293|293.0||||||
4312093|NCT00486434|4139070|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4312094|NCT00486434|4139071|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4312095|NCT00486434|4139072|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4312096|NCT00486330|4139083|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4312097|NCT00486330|4139083|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4312098|NCT00486330|4139083|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4312099|NCT00486330|4139083|B1|||Age||years|Mean|44|44.0|Full Range|10|10.0|21.0|53.0|
4312100|NCT00486291|4139087|B3|United States||Region of Enrollment||participants|Number|206|206.0||||||
4312101|NCT00486291|4139088|B2|United States||Region of Enrollment||participants|Number|104|104.0||||||
4312102|NCT00486291|4139089|B1|United States||Region of Enrollment||participants|Number|102|102.0||||||
4312103|NCT00486291|4139087|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4312104|NCT00486291|4139088|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4312105|NCT00486291|4139089|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4312106|NCT00486291|4139087|B3||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4312107|NCT00486291|4139088|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4312108|NCT00486291|4139089|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4312109|NCT00486291|4139087|B3|||Age||years|Mean|49.4|49.4|Standard Deviation|9.1|9.1|||
4312110|NCT00486291|4139088|B2|||Age||years|Mean|48.5|48.5|Standard Deviation|9.72|9.72|||
4312111|NCT00486291|4139089|B1|||Age||years|Mean|50.2|50.2|Standard Deviation|8.39|8.39|||
4312112|NCT00486278|4139098|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4312113|NCT00486278|4139098|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4312114|NCT00486278|4139098|B1|||Age||years|Mean|28|28.0|Standard Deviation|12.4|12.4|||
4312115|NCT00486265|4139232|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4312116|NCT00486265|4139232|B1|White||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4312117|NCT00486265|4139232|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4312118|NCT00486265|4139232|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4312119|NCT00486265|4139232|B1|>=75 Yrs||Age, Customized||Participants|Number|2|2.0||||||
4312120|NCT00486265|4139232|B1|>=65 - < 75 Yrs||Age, Customized||Participants|Number|1|1.0||||||
4312121|NCT00486265|4139232|B1|>=18 - < 65 Years||Age, Customized||Participants|Number|6|6.0||||||
4312122|NCT00486265|4139232|B1|< 18 Years||Age, Customized||Participants|Number|0|0.0||||||
4312123|NCT00486252|4139236|B1|Unspecified||Sex/Gender, Customized||participants|Number|5|5.0||||||
4312124|NCT00486252|4139236|B1|Female||Sex/Gender, Customized||participants|Number|596|596.0||||||
4312125|NCT00486252|4139236|B1|Male||Sex/Gender, Customized||participants|Number|395|395.0||||||
4312126|NCT00486252|4139236|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|13.4|13.4|||
4312127|NCT00486226|4139251|B1|||Previous Neurological Surgical Procedures||Participants|Count of Participants|36|36.0||||||
4312128|NCT00486226|4139251|B1|TIA/CVA||Neurological History||Participants|Number|21|21.0||||||
4312129|NCT00486226|4139251|B1|Cranial Nerve Palsy/ Paresis||Neurological History||Participants|Number|2|2.0||||||
4312130|NCT00486226|4139251|B1|Epilepsy||Neurological History||Participants|Number|3|3.0||||||
4312131|NCT00486226|4139251|B1|Recurrent Headache||Neurological History||Participants|Number|18|18.0||||||
4312132|NCT00486226|4139251|B1|Hypertension||Medical History||Participants|Number|38|38.0||||||
4312133|NCT00486226|4139251|B1|Other||Medical History||Participants|Number|4|4.0||||||
4312134|NCT00486226|4139251|B1|Smoking||Medical History||Participants|Number|1|1.0||||||
4312135|NCT00486226|4139251|B1|Obesity||Medical History||Participants|Number|1|1.0||||||
4312136|NCT00486226|4139251|B1|Vasculitis||Medical History||Participants|Number|1|1.0||||||
4312137|NCT00486226|4139251|B1|Dyslipidemia/Hypercolesterolemia||Medical History||Participants|Number|4|4.0||||||
4312138|NCT00486226|4139251|B1|Cancer||Medical History||Participants|Number|6|6.0||||||
4312139|NCT00486226|4139251|B1|Renal Disease||Medical History||Participants|Number|2|2.0||||||
4312140|NCT00486226|4139251|B1|Diabetes||Medical History||Participants|Number|2|2.0||||||
4312141|NCT00486226|4139251|B1|Endocrice/Metabolic Disease||Medical History||Participants|Number|1|1.0||||||
4312142|NCT00486226|4139251|B1|Immunologic||Medical History||Participants|Number|1|1.0||||||
4312143|NCT00486226|4139251|B1|Chronic Pulmonary Disease||Medical History||Participants|Number|1|1.0||||||
4312144|NCT00486226|4139251|B1|Cardiovascular Disease||Medical History||Participants|Number|4|4.0||||||
4312145|NCT00486226|4139251|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4312146|NCT00486226|4139251|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4312147|NCT00486226|4139251|B1|||Age||years|Mean|55.3|55.3|Standard Deviation|12.6|12.6|||
4312148|NCT00486044|4139259|B3|||Cerebrospinal fluid beta-amyloid-42|Primary outcome measured by xMAP; secondary analyses included measurement by Triplex method as well.|ng/L|Mean|338.7|338.7|Standard Deviation|80.2|80.2|||
4312149|NCT00486044|4139260|B2|||Cerebrospinal fluid beta-amyloid-42|Primary outcome measured by xMAP; secondary analyses included measurement by Triplex method as well.|ng/L|Mean|331.0|331.0|Standard Deviation|83.7|83.7|||
4312150|NCT00486044|4139261|B1|||Cerebrospinal fluid beta-amyloid-42|Primary outcome measured by xMAP; secondary analyses included measurement by Triplex method as well.|ng/L|Mean|345.6|345.6|Standard Deviation|77.1|77.1|||
4312151|NCT00486044|4139259|B3|||High-sensitivity c-reactive protein||mg/L|Mean|2.32|2.32|Standard Deviation|3.06|3.06|||
4312152|NCT00486044|4139260|B2|||High-sensitivity c-reactive protein||mg/L|Mean|2.03|2.03|Standard Deviation|2.21|2.21|||
4312153|NCT00486044|4139261|B1|||High-sensitivity c-reactive protein||mg/L|Mean|2.59|2.59|Standard Deviation|3.71|3.71|||
4312208|NCT00486018|4139279|B3|45 to < 65 years||Age, Customized||participants|Number|51|51.0||||||
4312154|NCT00486044|4139259|B3|||Total cholesterol|Measured by nuclear magnetic resonance (NMR) spectroscopy|mg/dL|Mean|190.3|190.3|Standard Deviation|32.4|32.4|||
4312155|NCT00486044|4139260|B2|||Total cholesterol|Measured by nuclear magnetic resonance (NMR) spectroscopy|mg/dL|Mean|187.6|187.6|Standard Deviation|27.7|27.7|||
4312156|NCT00486044|4139261|B1|||Total cholesterol|Measured by nuclear magnetic resonance (NMR) spectroscopy|mg/dL|Mean|192.8|192.8|Standard Deviation|36.4|36.4|||
4312157|NCT00486044|4139259|B3|||Apolipoprotein E4 carrier|Apolipoprotein E4 is a genetic risk factor for Alzheimer's disease, which increases your risk of developing Alzheimer's disease by 2-10 fold depending on if you're a carrier of the allele.|participants|Number|38|38.0||||||
4312158|NCT00486044|4139260|B2|||Apolipoprotein E4 carrier|Apolipoprotein E4 is a genetic risk factor for Alzheimer's disease, which increases your risk of developing Alzheimer's disease by 2-10 fold depending on if you're a carrier of the allele.|participants|Number|17|17.0||||||
4312159|NCT00486044|4139261|B1|||Apolipoprotein E4 carrier|Apolipoprotein E4 is a genetic risk factor for Alzheimer's disease, which increases your risk of developing Alzheimer's disease by 2-10 fold depending on if you're a carrier of the allele.|participants|Number|21|21.0||||||
4312160|NCT00486044|4139259|B3|||Mini Mental State Exam|0-30 points score range where higher scores represent better outcomes; <24 points indicate cognitive dysfunction.|points|Mean|29.5|29.5|Standard Deviation|0.7|0.7|||
4312161|NCT00486044|4139260|B2|||Mini Mental State Exam|0-30 points score range where higher scores represent better outcomes; <24 points indicate cognitive dysfunction.|points|Mean|29.6|29.6|Standard Deviation|0.6|0.6|||
4312162|NCT00486044|4139261|B1|||Mini Mental State Exam|0-30 points score range where higher scores represent better outcomes; <24 points indicate cognitive dysfunction.|points|Mean|29.5|29.5|Standard Deviation|0.8|0.8|||
4312163|NCT00486044|4139259|B3|||Education||years|Mean|16.2|16.2|Standard Deviation|2.9|2.9|||
4312164|NCT00486044|4139260|B2|||Education||years|Mean|16.3|16.3|Standard Deviation|3.2|3.2|||
4312165|NCT00486044|4139261|B1|||Education||years|Mean|16.1|16.1|Standard Deviation|2.|0.0|||
4312166|NCT00486044|4139259|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
4312167|NCT00486044|4139260|B2|United States||Region of Enrollment||participants|Number|49|49.0||||||
4312168|NCT00486044|4139261|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4312169|NCT00486044|4139259|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4312170|NCT00486044|4139260|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4312171|NCT00486044|4139261|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4312172|NCT00486044|4139259|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4312173|NCT00486044|4139260|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4312174|NCT00486044|4139261|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4312175|NCT00486044|4139259|B3|||Age||years|Mean|52.8|52.8|Standard Deviation|8.0|8.0|||
4312176|NCT00486044|4139260|B2|||Age||years|Mean|52.4|52.4|Standard Deviation|8.5|8.5|||
4312177|NCT00486044|4139261|B1|||Age||years|Mean|53.3|53.3|Standard Deviation|7.4|7.4|||
4312178|NCT00486044|4139259|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4312179|NCT00486044|4139260|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4312180|NCT00486044|4139261|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4312181|NCT00486044|4139259|B3||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
4312182|NCT00486044|4139260|B2||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4312183|NCT00486044|4139261|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4312184|NCT00486044|4139259|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4312185|NCT00486044|4139260|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4312186|NCT00486044|4139261|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4312187|NCT00486031|4139274|B1||Male|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
4312188|NCT00486031|4139274|B1||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4312189|NCT00486031|4139274|B1|>=65||Age, Customized||Participants|Count of Participants|28|28.0||||||
4312190|NCT00486031|4139274|B1|<65||Age, Customized||Participants|Count of Participants|412|412.0||||||
4312191|NCT00486018|4139278|B4||Male|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4312192|NCT00486018|4139279|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4312193|NCT00486018|4139280|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4312194|NCT00486018|4139281|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4312195|NCT00486018|4139278|B4||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4312196|NCT00486018|4139279|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4312197|NCT00486018|4139280|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4312198|NCT00486018|4139281|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4312199|NCT00486018|4139278|B4|≥ 85 years||Age, Customized||participants|Number|16|16.0||||||
4312200|NCT00486018|4139279|B3|≥ 85 years||Age, Customized||participants|Number|7|7.0||||||
4312201|NCT00486018|4139280|B2|≥ 85 years||Age, Customized||participants|Number|4|4.0||||||
4312202|NCT00486018|4139281|B1|≥ 85 years||Age, Customized||participants|Number|5|5.0||||||
4312203|NCT00486018|4139278|B4|65 to < 85 years||Age, Customized||participants|Number|203|203.0||||||
4312204|NCT00486018|4139279|B3|65 to < 85 years||Age, Customized||participants|Number|69|69.0||||||
4312205|NCT00486018|4139280|B2|65 to < 85 years||Age, Customized||participants|Number|74|74.0||||||
4312206|NCT00486018|4139281|B1|65 to < 85 years||Age, Customized||participants|Number|60|60.0||||||
4312207|NCT00486018|4139278|B4|45 to < 65 years||Age, Customized||participants|Number|161|161.0||||||
4312209|NCT00486018|4139280|B2|45 to < 65 years||Age, Customized||participants|Number|51|51.0||||||
4312210|NCT00486018|4139281|B1|45 to < 65 years||Age, Customized||participants|Number|59|59.0||||||
4312211|NCT00486018|4139278|B4|< 45 years||Age, Customized||participants|Number|17|17.0||||||
4312212|NCT00486018|4139279|B3|< 45 years||Age, Customized||participants|Number|4|4.0||||||
4312213|NCT00486018|4139280|B2|< 45 years||Age, Customized||participants|Number|5|5.0||||||
4312214|NCT00486018|4139281|B1|< 45 years||Age, Customized||participants|Number|8|8.0||||||
4312215|NCT00486018|4139278|B4|||Age||years|Mean|66.4|66.4|Standard Deviation|11.9|11.9|||
4312216|NCT00486018|4139279|B3|||Age||years|Mean|67.5|67.5|Standard Deviation|11.8|11.8|||
4312217|NCT00486018|4139280|B2|||Age||years|Mean|66.6|66.6|Standard Deviation|11.2|11.2|||
4312218|NCT00486018|4139281|B1|||Age||years|Mean|65.2|65.2|Standard Deviation|12.7|12.7|||
4312219|NCT00485953|4139309|B3|United States||Region of Enrollment||participants|Number|109|109.0||||||
4312220|NCT00485953|4139310|B2|United States||Region of Enrollment||participants|Number|54|54.0||||||
4312221|NCT00485953|4139311|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4312222|NCT00485953|4139309|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312223|NCT00485953|4139310|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312224|NCT00485953|4139311|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312225|NCT00485953|4139309|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
4312226|NCT00485953|4139310|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4312227|NCT00485953|4139311|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4312228|NCT00485953|4139309|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4312229|NCT00485953|4139310|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4312230|NCT00485953|4139311|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312231|NCT00485953|4139309|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312232|NCT00485953|4139310|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312233|NCT00485953|4139311|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312234|NCT00485953|4139309|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4312235|NCT00485953|4139310|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312236|NCT00485953|4139311|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4312237|NCT00485953|4139309|B3||White|Race (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
4312238|NCT00485953|4139310|B2||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4312239|NCT00485953|4139311|B1||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4312240|NCT00485953|4139309|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4312241|NCT00485953|4139310|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312242|NCT00485953|4139311|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4312243|NCT00485953|4139309|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312244|NCT00485953|4139310|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312245|NCT00485953|4139311|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312246|NCT00485953|4139309|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4312247|NCT00485953|4139310|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4312248|NCT00485953|4139311|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4312249|NCT00485953|4139309|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312250|NCT00485953|4139310|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312251|NCT00485953|4139311|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312252|NCT00485953|4139309|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4312253|NCT00485953|4139310|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4312254|NCT00485953|4139311|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4312255|NCT00485953|4139309|B3||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4312256|NCT00485953|4139310|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4312257|NCT00485953|4139311|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4312258|NCT00485953|4139309|B3||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
4312259|NCT00485953|4139310|B2||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4312260|NCT00485953|4139311|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4312261|NCT00485953|4139309|B3||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4312262|NCT00485953|4139310|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4312263|NCT00485953|4139311|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4312264|NCT00485953|4139309|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4312265|NCT00485953|4139310|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4312266|NCT00485953|4139311|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4312267|NCT00485836|4139322|B4||Male|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4312268|NCT00485836|4139323|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4312269|NCT00485836|4139324|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4312270|NCT00485836|4139325|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4312271|NCT00485836|4139322|B4||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4312272|NCT00485836|4139323|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4312273|NCT00485836|4139324|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4312274|NCT00485836|4139325|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4312275|NCT00485836|4139322|B4|≥ 85 years||Age, Customized||participants|Number|22|22.0||||||
4312276|NCT00485836|4139323|B3|≥ 85 years||Age, Customized||participants|Number|8|8.0||||||
4312277|NCT00485836|4139324|B2|≥ 85 years||Age, Customized||participants|Number|11|11.0||||||
4312278|NCT00485836|4139325|B1|≥ 85 years||Age, Customized||participants|Number|3|3.0||||||
4312279|NCT00485836|4139322|B4|65 to < 85 years||Age, Customized||participants|Number|218|218.0||||||
4312280|NCT00485836|4139323|B3|65 to < 85 years||Age, Customized||participants|Number|71|71.0||||||
4312281|NCT00485836|4139324|B2|65 to < 85 years||Age, Customized||participants|Number|80|80.0||||||
4312282|NCT00485836|4139325|B1|65 to < 85 years||Age, Customized||participants|Number|67|67.0||||||
4312283|NCT00485836|4139322|B4|45 to < 65 years||Age, Customized||participants|Number|132|132.0||||||
4312284|NCT00485836|4139323|B3|45 to < 65 years||Age, Customized||participants|Number|46|46.0||||||
4312285|NCT00485836|4139324|B2|45 to < 65 years||Age, Customized||participants|Number|36|36.0||||||
4312286|NCT00485836|4139325|B1|45 to < 65 years||Age, Customized||participants|Number|50|50.0||||||
4312287|NCT00485836|4139322|B4|< 45 years||Age, Customized||participants|Number|20|20.0||||||
4312288|NCT00485836|4139323|B3|< 45 years||Age, Customized||participants|Number|5|5.0||||||
4312289|NCT00485836|4139324|B2|< 45 years||Age, Customized||participants|Number|5|5.0||||||
4312290|NCT00485836|4139325|B1|< 45 years||Age, Customized||participants|Number|10|10.0||||||
4312291|NCT00485836|4139322|B4|||Age||years|Mean|67.6|67.6|Standard Deviation|12.5|12.5|||
4312292|NCT00485836|4139323|B3|||Age||years|Mean|67.6|67.6|Standard Deviation|12.4|12.4|||
4312293|NCT00485836|4139324|B2|||Age||years|Mean|69.7|69.7|Standard Deviation|11.6|11.6|||
4312294|NCT00485836|4139325|B1|||Age||years|Mean|65.4|65.4|Standard Deviation|13.1|13.1|||
4312295|NCT00485758|4139353|B3|||Triglycerides||milligrams/deciliter (mg/dl)|Median|127.00|127.0|Full Range|||32.0|628.0|
4312296|NCT00485758|4139354|B2|||Triglycerides||milligrams/deciliter (mg/dl)|Median|129.00|129.0|Full Range|||39.0|509.0|
4312297|NCT00485758|4139355|B1|||Triglycerides||milligrams/deciliter (mg/dl)|Median|126.00|126.0|Full Range|||32.0|628.0|
4312298|NCT00485758|4139353|B3|||Low-density lipoprotein cholesterol||milligrams/deciliter (mg/dl)|Mean|86.34|86.34|Standard Deviation|19.50|19.5|||
4312299|NCT00485758|4139354|B2|||Low-density lipoprotein cholesterol||milligrams/deciliter (mg/dl)|Mean|85.22|85.22|Standard Deviation|18.00|18.0|||
4312300|NCT00485758|4139355|B1|||Low-density lipoprotein cholesterol||milligrams/deciliter (mg/dl)|Mean|87.19|87.19|Standard Deviation|20.54|20.54|||
4312301|NCT00485758|4139353|B3|||High-density lipoprotein cholesterol||milligrams/deciliter (mg/dl)|Mean|50.07|50.07|Standard Deviation|13.37|13.37|||
4312302|NCT00485758|4139354|B2|||High-density lipoprotein cholesterol||milligrams/deciliter (mg/dl)|Mean|50.26|50.26|Standard Deviation|13.23|13.23|||
4312303|NCT00485758|4139355|B1|||High-density lipoprotein cholesterol||milligrams/deciliter (mg/dl)|Mean|49.93|49.93|Standard Deviation|13.49|13.49|||
4312304|NCT00485758|4139353|B3|||Fasting Plasma Glucose||milligrams/deciliter|Mean|132.7|132.7|Standard Deviation|33.3|33.3|||
4312305|NCT00485758|4139354|B2|||Fasting Plasma Glucose||milligrams/deciliter|Mean|133.6|133.6|Standard Deviation|32.4|32.4|||
4312306|NCT00485758|4139355|B1|||Fasting Plasma Glucose||milligrams/deciliter|Mean|132.0|132.0|Standard Deviation|33.9|33.9|||
4312307|NCT00485758|4139353|B3||Male|Sex: Female, Male||Participants|Count of Participants|482|482.0||||||
4312308|NCT00485758|4139354|B2||Male|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4312309|NCT00485758|4139355|B1||Male|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
4312310|NCT00485758|4139353|B3||Female|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
4312311|NCT00485758|4139354|B2||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4312312|NCT00485758|4139355|B1||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4312313|NCT00485758|4139353|B3|||Age||years|Mean|62.0|62.0|Standard Deviation|9.3|9.3|||
4312314|NCT00485758|4139354|B2|||Age||years|Mean|62.0|62.0|Standard Deviation|9.4|9.4|||
4312315|NCT00485758|4139355|B1|||Age||years|Mean|62.0|62.0|Standard Deviation|9.3|9.3|||
4312316|NCT00485732|4139366|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4312317|NCT00485732|4139367|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4312318|NCT00485732|4139368|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4312319|NCT00485732|4139366|B3||Female|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
4312320|NCT00485732|4139367|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4312321|NCT00485732|4139368|B1||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4312322|NCT00485732|4139366|B3|||Age||years|Mean|22.0|22.0|Standard Deviation|2.37|2.37|||
4312323|NCT00485732|4139367|B2|||Age||years|Mean|21.9|21.9|Standard Deviation|2.63|2.63|||
4312324|NCT00485732|4139368|B1|||Age||years|Mean|22.0|22.0|Standard Deviation|2.24|2.24|||
4312325|NCT00485693|4139389|B3|Czech Republic||Region of Enrollment||participants|Number|41|41.0||||||
4312326|NCT00485693|4139390|B2|Czech Republic||Region of Enrollment||participants|Number|35|35.0||||||
4312327|NCT00485693|4139391|B1|Czech Republic||Region of Enrollment||participants|Number|6|6.0||||||
4312328|NCT00485693|4139389|B3|United States||Region of Enrollment||participants|Number|97|97.0||||||
4312329|NCT00485693|4139390|B2|United States||Region of Enrollment||participants|Number|69|69.0||||||
4312330|NCT00485693|4139391|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4312331|NCT00485693|4139389|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4312332|NCT00485693|4139390|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4312333|NCT00485693|4139391|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4312334|NCT00485693|4139389|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4312335|NCT00485693|4139390|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4312336|NCT00485693|4139391|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4312337|NCT00485693|4139389|B3|||Age||years|Mean|62.2|62.2|Standard Deviation|7.3|7.3|||
4312338|NCT00485693|4139390|B2|||Age||years|Mean|62.3|62.3|Standard Deviation|7.4|7.4|||
4312339|NCT00485693|4139391|B1|||Age||years|Mean|62.2|62.2|Standard Deviation|7.2|7.2|||
4312340|NCT00485693|4139389|B3||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
4312341|NCT00485693|4139390|B2||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
4312342|NCT00485693|4139391|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4312343|NCT00485693|4139389|B3||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
4312344|NCT00485693|4139390|B2||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
4312345|NCT00485693|4139391|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4312346|NCT00485693|4139389|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4312347|NCT00485693|4139390|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4312348|NCT00485693|4139391|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4312349|NCT00485485|4139401|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4312350|NCT00485485|4139401|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4312351|NCT00485485|4139401|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4312352|NCT00485485|4139401|B1|||Age||years|Mean|62|62.0|Standard Deviation|1|1.0|||
4312353|NCT00485485|4139401|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4312354|NCT00485485|4139401|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4312355|NCT00485485|4139401|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4312356|NCT00485472|4139405|B3|Romania||Region of Enrollment||participants|Number|17|17.0||||||
4312357|NCT00485472|4139406|B2|Romania||Region of Enrollment||participants|Number|8|8.0||||||
4312358|NCT00485472|4139407|B1|Romania||Region of Enrollment||participants|Number|9|9.0||||||
4312359|NCT00485472|4139405|B3|Poland||Region of Enrollment||participants|Number|18|18.0||||||
4312360|NCT00485472|4139406|B2|Poland||Region of Enrollment||participants|Number|9|9.0||||||
4312361|NCT00485472|4139407|B1|Poland||Region of Enrollment||participants|Number|9|9.0||||||
4312362|NCT00485472|4139405|B3|Germany||Region of Enrollment||participants|Number|54|54.0||||||
4312363|NCT00485472|4139406|B2|Germany||Region of Enrollment||participants|Number|27|27.0||||||
4312364|NCT00485472|4139407|B1|Germany||Region of Enrollment||participants|Number|27|27.0||||||
4312365|NCT00485472|4139405|B3|Czech Republic||Region of Enrollment||participants|Number|18|18.0||||||
4312366|NCT00485472|4139406|B2|Czech Republic||Region of Enrollment||participants|Number|10|10.0||||||
4312367|NCT00485472|4139407|B1|Czech Republic||Region of Enrollment||participants|Number|8|8.0||||||
4312368|NCT00485472|4139405|B3|Hungary||Region of Enrollment||participants|Number|42|42.0||||||
4312369|NCT00485472|4139406|B2|Hungary||Region of Enrollment||participants|Number|22|22.0||||||
4312370|NCT00485472|4139407|B1|Hungary||Region of Enrollment||participants|Number|20|20.0||||||
4312371|NCT00485472|4139405|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4312372|NCT00485472|4139406|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4312373|NCT00485472|4139407|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4312374|NCT00485472|4139405|B3||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4312375|NCT00485472|4139406|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4312376|NCT00485472|4139407|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4312377|NCT00485472|4139405|B3|||Age||years|Mean|61.7|61.7|Standard Deviation|7.40|7.4|||
4312378|NCT00485472|4139406|B2|||Age||years|Mean|62.3|62.3|Standard Deviation|6.74|6.74|||
4312379|NCT00485472|4139407|B1|||Age||years|Mean|61.0|61.0|Standard Deviation|8.03|8.03|||
4312380|NCT00485472|4139405|B3||>=65 years|Age||Participants|Count of Participants|63|63.0||||||
4312381|NCT00485472|4139406|B2||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4312382|NCT00485472|4139407|B1||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
4312383|NCT00485472|4139405|B3||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
4312384|NCT00485472|4139406|B2||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4312385|NCT00485472|4139407|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4312386|NCT00485472|4139405|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4312387|NCT00485472|4139406|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4312388|NCT00485472|4139407|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4312389|NCT00485433|4139430|B5|United States||Region of Enrollment||participants|Number|98|98.0||||||
4312390|NCT00485433|4139431|B4|United States||Region of Enrollment||participants|Number|25|25.0||||||
4312391|NCT00485433|4139432|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4312392|NCT00485433|4139433|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4312393|NCT00485433|4139434|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4312394|NCT00485433|4139430|B5||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4312395|NCT00485433|4139431|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4312396|NCT00485433|4139432|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4312397|NCT00485433|4139433|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4312398|NCT00485433|4139434|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4312399|NCT00485433|4139430|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4312400|NCT00485433|4139431|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4312401|NCT00485433|4139432|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4312402|NCT00485433|4139433|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4312403|NCT00485433|4139434|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4312404|NCT00485433|4139430|B5|||Age||years|Mean|51.1|51.1|Standard Deviation|16.2|16.2|||
4312405|NCT00485433|4139431|B4|||Age||years|Mean|52.1|52.1|Standard Deviation|15.6|15.6|||
4312406|NCT00485433|4139432|B3|||Age||years|Mean|54|54.0|Standard Deviation|15.1|15.1|||
4312407|NCT00485433|4139433|B2|||Age||years|Mean|51.2|51.2|Standard Deviation|17.3|17.3|||
4312408|NCT00485433|4139434|B1|||Age||years|Mean|47.3|47.3|Standard Deviation|16.9|16.9|||
4312409|NCT00485433|4139430|B5||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4312410|NCT00485433|4139431|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4312411|NCT00485433|4139432|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4312412|NCT00485433|4139433|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4312413|NCT00485433|4139434|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4312414|NCT00485433|4139430|B5||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
4312415|NCT00485433|4139431|B4||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4312416|NCT00485433|4139432|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4312417|NCT00485433|4139433|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4312418|NCT00485433|4139434|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4312419|NCT00485433|4139430|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4312420|NCT00485433|4139431|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4312421|NCT00485433|4139432|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4312422|NCT00485433|4139433|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4312423|NCT00485433|4139434|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4312424|NCT00485303|4139445|B1|United States||Region of Enrollment||Participants|Number|54|54.0||||||
4312425|NCT00485303|4139445|B1|United Kingdom||Region of Enrollment||Participants|Number|4|4.0||||||
4312426|NCT00485303|4139445|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4312427|NCT00485303|4139445|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4312428|NCT00485303|4139445|B1|||Age||Years|Mean|68.6|68.6|Standard Deviation|9.78|9.78|||
4312429|NCT00485264|4139457|B7|Missing||Genotypic sensitivity score|The Genotypic Sensitivity score (GSS) was defined as the total number of ARVs in OBT to which the subject's viral isolate showed genotypic sensitivity, based on pre-study resistance tests. The GSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the GSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|6|6.0||||||
4312430|NCT00485264|4139458|B6|Missing||Genotypic sensitivity score|The Genotypic Sensitivity score (GSS) was defined as the total number of ARVs in OBT to which the subject's viral isolate showed genotypic sensitivity, based on pre-study resistance tests. The GSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the GSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|3|3.0||||||
4312431|NCT00485264|4139459|B5|Missing||Genotypic sensitivity score|The Genotypic Sensitivity score (GSS) was defined as the total number of ARVs in OBT to which the subject's viral isolate showed genotypic sensitivity, based on pre-study resistance tests. The GSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the GSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|1|1.0||||||
4312432|NCT00485264|4139460|B4|Missing||Genotypic sensitivity score|The Genotypic Sensitivity score (GSS) was defined as the total number of ARVs in OBT to which the subject's viral isolate showed genotypic sensitivity, based on pre-study resistance tests. The GSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the GSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|1|1.0||||||
4312501|NCT00485264|4139459|B5|No||Use of prior PIs||participants|Number|9|9.0||||||
4312502|NCT00485264|4139460|B4|No||Use of prior PIs||participants|Number|8|8.0||||||
4312503|NCT00485264|4139461|B3|No||Use of prior PIs||participants|Number|5|5.0||||||
4312504|NCT00485264|4139462|B2|No||Use of prior PIs||participants|Number|3|3.0||||||
4312433|NCT00485264|4139461|B3|Missing||Genotypic sensitivity score|The Genotypic Sensitivity score (GSS) was defined as the total number of ARVs in OBT to which the subject's viral isolate showed genotypic sensitivity, based on pre-study resistance tests. The GSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the GSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|0|0.0||||||
4312434|NCT00485264|4139462|B2|Missing||Genotypic sensitivity score|The Genotypic Sensitivity score (GSS) was defined as the total number of ARVs in OBT to which the subject's viral isolate showed genotypic sensitivity, based on pre-study resistance tests. The GSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the GSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|0|0.0||||||
4312435|NCT00485264|4139463|B1|Missing||Genotypic sensitivity score|The Genotypic Sensitivity score (GSS) was defined as the total number of ARVs in OBT to which the subject's viral isolate showed genotypic sensitivity, based on pre-study resistance tests. The GSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the GSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|1|1.0||||||
4312436|NCT00485264|4139457|B7|≥3||Genotypic sensitivity score|The Genotypic Sensitivity score (GSS) was defined as the total number of ARVs in OBT to which the subject's viral isolate showed genotypic sensitivity, based on pre-study resistance tests. The GSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the GSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|45|45.0||||||
4312437|NCT00485264|4139458|B6|≥3||Genotypic sensitivity score|The Genotypic Sensitivity score (GSS) was defined as the total number of ARVs in OBT to which the subject's viral isolate showed genotypic sensitivity, based on pre-study resistance tests. The GSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the GSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|3|3.0||||||
4312438|NCT00485264|4139459|B5|≥3||Genotypic sensitivity score|The Genotypic Sensitivity score (GSS) was defined as the total number of ARVs in OBT to which the subject's viral isolate showed genotypic sensitivity, based on pre-study resistance tests. The GSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the GSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|10|10.0||||||
4312439|NCT00485264|4139460|B4|≥3||Genotypic sensitivity score|The Genotypic Sensitivity score (GSS) was defined as the total number of ARVs in OBT to which the subject's viral isolate showed genotypic sensitivity, based on pre-study resistance tests. The GSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the GSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|7|7.0||||||
4312440|NCT00485264|4139461|B3|≥3||Genotypic sensitivity score|The Genotypic Sensitivity score (GSS) was defined as the total number of ARVs in OBT to which the subject's viral isolate showed genotypic sensitivity, based on pre-study resistance tests. The GSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the GSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|2|2.0||||||
4312441|NCT00485264|4139462|B2|≥3||Genotypic sensitivity score|The Genotypic Sensitivity score (GSS) was defined as the total number of ARVs in OBT to which the subject's viral isolate showed genotypic sensitivity, based on pre-study resistance tests. The GSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the GSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|5|5.0||||||
4312442|NCT00485264|4139463|B1|≥3||Genotypic sensitivity score|The Genotypic Sensitivity score (GSS) was defined as the total number of ARVs in OBT to which the subject's viral isolate showed genotypic sensitivity, based on pre-study resistance tests. The GSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the GSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|18|18.0||||||
4312443|NCT00485264|4139457|B7|2||Genotypic sensitivity score|The Genotypic Sensitivity score (GSS) was defined as the total number of ARVs in OBT to which the subject's viral isolate showed genotypic sensitivity, based on pre-study resistance tests. The GSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the GSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|52|52.0||||||
4312505|NCT00485264|4139463|B1|No||Use of prior PIs||participants|Number|2|2.0||||||
4312506|NCT00485264|4139457|B7|Yes||Use of prior PIs||participants|Number|113|113.0||||||
4312507|NCT00485264|4139458|B6|Yes||Use of prior PIs||participants|Number|0|0.0||||||
4312508|NCT00485264|4139459|B5|Yes||Use of prior PIs||participants|Number|5|5.0||||||
4312444|NCT00485264|4139458|B6|2||Genotypic sensitivity score|The Genotypic Sensitivity score (GSS) was defined as the total number of ARVs in OBT to which the subject's viral isolate showed genotypic sensitivity, based on pre-study resistance tests. The GSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the GSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|5|5.0||||||
4312445|NCT00485264|4139459|B5|2||Genotypic sensitivity score|The Genotypic Sensitivity score (GSS) was defined as the total number of ARVs in OBT to which the subject's viral isolate showed genotypic sensitivity, based on pre-study resistance tests. The GSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the GSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|3|3.0||||||
4312446|NCT00485264|4139460|B4|2||Genotypic sensitivity score|The Genotypic Sensitivity score (GSS) was defined as the total number of ARVs in OBT to which the subject's viral isolate showed genotypic sensitivity, based on pre-study resistance tests. The GSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the GSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|11|11.0||||||
4312447|NCT00485264|4139461|B3|2||Genotypic sensitivity score|The Genotypic Sensitivity score (GSS) was defined as the total number of ARVs in OBT to which the subject's viral isolate showed genotypic sensitivity, based on pre-study resistance tests. The GSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the GSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|7|7.0||||||
4312448|NCT00485264|4139462|B2|2||Genotypic sensitivity score|The Genotypic Sensitivity score (GSS) was defined as the total number of ARVs in OBT to which the subject's viral isolate showed genotypic sensitivity, based on pre-study resistance tests. The GSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the GSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|6|6.0||||||
4312449|NCT00485264|4139463|B1|2||Genotypic sensitivity score|The Genotypic Sensitivity score (GSS) was defined as the total number of ARVs in OBT to which the subject's viral isolate showed genotypic sensitivity, based on pre-study resistance tests. The GSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the GSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|20|20.0||||||
4312450|NCT00485264|4139457|B7|1||Genotypic sensitivity score|The Genotypic Sensitivity score (GSS) was defined as the total number of ARVs in OBT to which the subject's viral isolate showed genotypic sensitivity, based on pre-study resistance tests. The GSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the GSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|39|39.0||||||
4312451|NCT00485264|4139458|B6|1||Genotypic sensitivity score|The Genotypic Sensitivity score (GSS) was defined as the total number of ARVs in OBT to which the subject's viral isolate showed genotypic sensitivity, based on pre-study resistance tests. The GSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the GSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|1|1.0||||||
4312452|NCT00485264|4139459|B5|1||Genotypic sensitivity score|The Genotypic Sensitivity score (GSS) was defined as the total number of ARVs in OBT to which the subject's viral isolate showed genotypic sensitivity, based on pre-study resistance tests. The GSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the GSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|0|0.0||||||
4312453|NCT00485264|4139460|B4|1||Genotypic sensitivity score|The Genotypic Sensitivity score (GSS) was defined as the total number of ARVs in OBT to which the subject's viral isolate showed genotypic sensitivity, based on pre-study resistance tests. The GSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the GSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|2|2.0||||||
4312454|NCT00485264|4139461|B3|1||Genotypic sensitivity score|The Genotypic Sensitivity score (GSS) was defined as the total number of ARVs in OBT to which the subject's viral isolate showed genotypic sensitivity, based on pre-study resistance tests. The GSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the GSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|9|9.0||||||
4312509|NCT00485264|4139460|B4|Yes||Use of prior PIs||participants|Number|13|13.0||||||
4312510|NCT00485264|4139461|B3|Yes||Use of prior PIs||participants|Number|13|13.0||||||
4312511|NCT00485264|4139462|B2|Yes||Use of prior PIs||participants|Number|13|13.0||||||
4312512|NCT00485264|4139463|B1|Yes||Use of prior PIs||participants|Number|69|69.0||||||
4312753|NCT00485173|4139556|B1|Yes||Unresolved Spinal Litigation||participants|Number|28|28.0||||||
4312455|NCT00485264|4139462|B2|1||Genotypic sensitivity score|The Genotypic Sensitivity score (GSS) was defined as the total number of ARVs in OBT to which the subject's viral isolate showed genotypic sensitivity, based on pre-study resistance tests. The GSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the GSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|4|4.0||||||
4312456|NCT00485264|4139463|B1|1||Genotypic sensitivity score|The Genotypic Sensitivity score (GSS) was defined as the total number of ARVs in OBT to which the subject's viral isolate showed genotypic sensitivity, based on pre-study resistance tests. The GSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the GSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|23|23.0||||||
4312457|NCT00485264|4139457|B7|0||Genotypic sensitivity score|The Genotypic Sensitivity score (GSS) was defined as the total number of ARVs in OBT to which the subject's viral isolate showed genotypic sensitivity, based on pre-study resistance tests. The GSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the GSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|10|10.0||||||
4312458|NCT00485264|4139458|B6|0||Genotypic sensitivity score|The Genotypic Sensitivity score (GSS) was defined as the total number of ARVs in OBT to which the subject's viral isolate showed genotypic sensitivity, based on pre-study resistance tests. The GSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the GSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|0|0.0||||||
4312459|NCT00485264|4139459|B5|0||Genotypic sensitivity score|The Genotypic Sensitivity score (GSS) was defined as the total number of ARVs in OBT to which the subject's viral isolate showed genotypic sensitivity, based on pre-study resistance tests. The GSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the GSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|0|0.0||||||
4312460|NCT00485264|4139460|B4|0||Genotypic sensitivity score|The Genotypic Sensitivity score (GSS) was defined as the total number of ARVs in OBT to which the subject's viral isolate showed genotypic sensitivity, based on pre-study resistance tests. The GSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the GSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|0|0.0||||||
4312461|NCT00485264|4139461|B3|0||Genotypic sensitivity score|The Genotypic Sensitivity score (GSS) was defined as the total number of ARVs in OBT to which the subject's viral isolate showed genotypic sensitivity, based on pre-study resistance tests. The GSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the GSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|0|0.0||||||
4312462|NCT00485264|4139462|B2|0||Genotypic sensitivity score|The Genotypic Sensitivity score (GSS) was defined as the total number of ARVs in OBT to which the subject's viral isolate showed genotypic sensitivity, based on pre-study resistance tests. The GSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the GSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|1|1.0||||||
4312463|NCT00485264|4139463|B1|0||Genotypic sensitivity score|The Genotypic Sensitivity score (GSS) was defined as the total number of ARVs in OBT to which the subject's viral isolate showed genotypic sensitivity, based on pre-study resistance tests. The GSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the GSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|9|9.0||||||
4312464|NCT00485264|4139457|B7|Missing||Phenotypic Sensitivity score|The Phenotypic Sensitivity score (PSS) was defined as the total number of ARVs in optimized background therapy (OBT) to which the subject's viral isolate showed phenotypic sensitivity, based on pre-study resistance tests. The PSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the PSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|18|18.0||||||
4312465|NCT00485264|4139458|B6|Missing||Phenotypic Sensitivity score|The Phenotypic Sensitivity score (PSS) was defined as the total number of ARVs in optimized background therapy (OBT) to which the subject's viral isolate showed phenotypic sensitivity, based on pre-study resistance tests. The PSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the PSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|2|2.0||||||
4312513|NCT00485264|4139457|B7|No||Prior use of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI)||participants|Number|34|34.0||||||
4312514|NCT00485264|4139458|B6|No||Prior use of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI)||participants|Number|1|1.0||||||
4312515|NCT00485264|4139459|B5|No||Prior use of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI)||participants|Number|6|6.0||||||
4312466|NCT00485264|4139459|B5|Missing||Phenotypic Sensitivity score|The Phenotypic Sensitivity score (PSS) was defined as the total number of ARVs in optimized background therapy (OBT) to which the subject's viral isolate showed phenotypic sensitivity, based on pre-study resistance tests. The PSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the PSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|3|3.0||||||
4312467|NCT00485264|4139460|B4|Missing||Phenotypic Sensitivity score|The Phenotypic Sensitivity score (PSS) was defined as the total number of ARVs in optimized background therapy (OBT) to which the subject's viral isolate showed phenotypic sensitivity, based on pre-study resistance tests. The PSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the PSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|5|5.0||||||
4312468|NCT00485264|4139461|B3|Missing||Phenotypic Sensitivity score|The Phenotypic Sensitivity score (PSS) was defined as the total number of ARVs in optimized background therapy (OBT) to which the subject's viral isolate showed phenotypic sensitivity, based on pre-study resistance tests. The PSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the PSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|1|1.0||||||
4312469|NCT00485264|4139462|B2|Missing||Phenotypic Sensitivity score|The Phenotypic Sensitivity score (PSS) was defined as the total number of ARVs in optimized background therapy (OBT) to which the subject's viral isolate showed phenotypic sensitivity, based on pre-study resistance tests. The PSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the PSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|2|2.0||||||
4312470|NCT00485264|4139463|B1|Missing||Phenotypic Sensitivity score|The Phenotypic Sensitivity score (PSS) was defined as the total number of ARVs in optimized background therapy (OBT) to which the subject's viral isolate showed phenotypic sensitivity, based on pre-study resistance tests. The PSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the PSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|5|5.0||||||
4312471|NCT00485264|4139457|B7|≥3||Phenotypic Sensitivity score|The Phenotypic Sensitivity score (PSS) was defined as the total number of ARVs in optimized background therapy (OBT) to which the subject's viral isolate showed phenotypic sensitivity, based on pre-study resistance tests. The PSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the PSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|49|49.0||||||
4312472|NCT00485264|4139458|B6|≥3||Phenotypic Sensitivity score|The Phenotypic Sensitivity score (PSS) was defined as the total number of ARVs in optimized background therapy (OBT) to which the subject's viral isolate showed phenotypic sensitivity, based on pre-study resistance tests. The PSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the PSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|4|4.0||||||
4312473|NCT00485264|4139459|B5|≥3||Phenotypic Sensitivity score|The Phenotypic Sensitivity score (PSS) was defined as the total number of ARVs in optimized background therapy (OBT) to which the subject's viral isolate showed phenotypic sensitivity, based on pre-study resistance tests. The PSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the PSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|9|9.0||||||
4312474|NCT00485264|4139460|B4|≥3||Phenotypic Sensitivity score|The Phenotypic Sensitivity score (PSS) was defined as the total number of ARVs in optimized background therapy (OBT) to which the subject's viral isolate showed phenotypic sensitivity, based on pre-study resistance tests. The PSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the PSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|6|6.0||||||
4312475|NCT00485264|4139461|B3|≥3||Phenotypic Sensitivity score|The Phenotypic Sensitivity score (PSS) was defined as the total number of ARVs in optimized background therapy (OBT) to which the subject's viral isolate showed phenotypic sensitivity, based on pre-study resistance tests. The PSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the PSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|2|2.0||||||
4312476|NCT00485264|4139462|B2|≥3||Phenotypic Sensitivity score|The Phenotypic Sensitivity score (PSS) was defined as the total number of ARVs in optimized background therapy (OBT) to which the subject's viral isolate showed phenotypic sensitivity, based on pre-study resistance tests. The PSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the PSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|7|7.0||||||
4312516|NCT00485264|4139460|B4|No||Prior use of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI)||participants|Number|11|11.0||||||
4312477|NCT00485264|4139463|B1|≥3||Phenotypic Sensitivity score|The Phenotypic Sensitivity score (PSS) was defined as the total number of ARVs in optimized background therapy (OBT) to which the subject's viral isolate showed phenotypic sensitivity, based on pre-study resistance tests. The PSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the PSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|21|21.0||||||
4312478|NCT00485264|4139457|B7|2||Phenotypic Sensitivity score|The Phenotypic Sensitivity score (PSS) was defined as the total number of ARVs in optimized background therapy (OBT) to which the subject's viral isolate showed phenotypic sensitivity, based on pre-study resistance tests. The PSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the PSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|50|50.0||||||
4312479|NCT00485264|4139458|B6|2||Phenotypic Sensitivity score|The Phenotypic Sensitivity score (PSS) was defined as the total number of ARVs in optimized background therapy (OBT) to which the subject's viral isolate showed phenotypic sensitivity, based on pre-study resistance tests. The PSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the PSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|5|5.0||||||
4312480|NCT00485264|4139459|B5|2||Phenotypic Sensitivity score|The Phenotypic Sensitivity score (PSS) was defined as the total number of ARVs in optimized background therapy (OBT) to which the subject's viral isolate showed phenotypic sensitivity, based on pre-study resistance tests. The PSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the PSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|2|2.0||||||
4312481|NCT00485264|4139460|B4|2||Phenotypic Sensitivity score|The Phenotypic Sensitivity score (PSS) was defined as the total number of ARVs in optimized background therapy (OBT) to which the subject's viral isolate showed phenotypic sensitivity, based on pre-study resistance tests. The PSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the PSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|8|8.0||||||
4312482|NCT00485264|4139461|B3|2||Phenotypic Sensitivity score|The Phenotypic Sensitivity score (PSS) was defined as the total number of ARVs in optimized background therapy (OBT) to which the subject's viral isolate showed phenotypic sensitivity, based on pre-study resistance tests. The PSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the PSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|8|8.0||||||
4312483|NCT00485264|4139462|B2|2||Phenotypic Sensitivity score|The Phenotypic Sensitivity score (PSS) was defined as the total number of ARVs in optimized background therapy (OBT) to which the subject's viral isolate showed phenotypic sensitivity, based on pre-study resistance tests. The PSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the PSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|2|2.0||||||
4312484|NCT00485264|4139463|B1|2||Phenotypic Sensitivity score|The Phenotypic Sensitivity score (PSS) was defined as the total number of ARVs in optimized background therapy (OBT) to which the subject's viral isolate showed phenotypic sensitivity, based on pre-study resistance tests. The PSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the PSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|25|25.0||||||
4312485|NCT00485264|4139457|B7|1||Phenotypic Sensitivity score|The Phenotypic Sensitivity score (PSS) was defined as the total number of ARVs in optimized background therapy (OBT) to which the subject's viral isolate showed phenotypic sensitivity, based on pre-study resistance tests. The PSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the PSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|29|29.0||||||
4312486|NCT00485264|4139458|B6|1||Phenotypic Sensitivity score|The Phenotypic Sensitivity score (PSS) was defined as the total number of ARVs in optimized background therapy (OBT) to which the subject's viral isolate showed phenotypic sensitivity, based on pre-study resistance tests. The PSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the PSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|1|1.0||||||
4312487|NCT00485264|4139459|B5|1||Phenotypic Sensitivity score|The Phenotypic Sensitivity score (PSS) was defined as the total number of ARVs in optimized background therapy (OBT) to which the subject's viral isolate showed phenotypic sensitivity, based on pre-study resistance tests. The PSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the PSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|0|0.0||||||
4312517|NCT00485264|4139461|B3|No||Prior use of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI)||participants|Number|3|3.0||||||
4312488|NCT00485264|4139460|B4|1||Phenotypic Sensitivity score|The Phenotypic Sensitivity score (PSS) was defined as the total number of ARVs in optimized background therapy (OBT) to which the subject's viral isolate showed phenotypic sensitivity, based on pre-study resistance tests. The PSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the PSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|2|2.0||||||
4312489|NCT00485264|4139461|B3|1||Phenotypic Sensitivity score|The Phenotypic Sensitivity score (PSS) was defined as the total number of ARVs in optimized background therapy (OBT) to which the subject's viral isolate showed phenotypic sensitivity, based on pre-study resistance tests. The PSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the PSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|7|7.0||||||
4312490|NCT00485264|4139462|B2|1||Phenotypic Sensitivity score|The Phenotypic Sensitivity score (PSS) was defined as the total number of ARVs in optimized background therapy (OBT) to which the subject's viral isolate showed phenotypic sensitivity, based on pre-study resistance tests. The PSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the PSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|4|4.0||||||
4312491|NCT00485264|4139463|B1|1||Phenotypic Sensitivity score|The Phenotypic Sensitivity score (PSS) was defined as the total number of ARVs in optimized background therapy (OBT) to which the subject's viral isolate showed phenotypic sensitivity, based on pre-study resistance tests. The PSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the PSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|15|15.0||||||
4312492|NCT00485264|4139457|B7|0||Phenotypic Sensitivity score|The Phenotypic Sensitivity score (PSS) was defined as the total number of ARVs in optimized background therapy (OBT) to which the subject's viral isolate showed phenotypic sensitivity, based on pre-study resistance tests. The PSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the PSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|6|6.0||||||
4312493|NCT00485264|4139458|B6|0||Phenotypic Sensitivity score|The Phenotypic Sensitivity score (PSS) was defined as the total number of ARVs in optimized background therapy (OBT) to which the subject's viral isolate showed phenotypic sensitivity, based on pre-study resistance tests. The PSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the PSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|0|0.0||||||
4312494|NCT00485264|4139459|B5|0||Phenotypic Sensitivity score|The Phenotypic Sensitivity score (PSS) was defined as the total number of ARVs in optimized background therapy (OBT) to which the subject's viral isolate showed phenotypic sensitivity, based on pre-study resistance tests. The PSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the PSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|0|0.0||||||
4312495|NCT00485264|4139460|B4|0||Phenotypic Sensitivity score|The Phenotypic Sensitivity score (PSS) was defined as the total number of ARVs in optimized background therapy (OBT) to which the subject's viral isolate showed phenotypic sensitivity, based on pre-study resistance tests. The PSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the PSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|0|0.0||||||
4312496|NCT00485264|4139461|B3|0||Phenotypic Sensitivity score|The Phenotypic Sensitivity score (PSS) was defined as the total number of ARVs in optimized background therapy (OBT) to which the subject's viral isolate showed phenotypic sensitivity, based on pre-study resistance tests. The PSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the PSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|0|0.0||||||
4312497|NCT00485264|4139462|B2|0||Phenotypic Sensitivity score|The Phenotypic Sensitivity score (PSS) was defined as the total number of ARVs in optimized background therapy (OBT) to which the subject's viral isolate showed phenotypic sensitivity, based on pre-study resistance tests. The PSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the PSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|1|1.0||||||
4312498|NCT00485264|4139463|B1|0||Phenotypic Sensitivity score|The Phenotypic Sensitivity score (PSS) was defined as the total number of ARVs in optimized background therapy (OBT) to which the subject's viral isolate showed phenotypic sensitivity, based on pre-study resistance tests. The PSS score range is from 0 (meaning there was no ARV the subject was sensitive to) to >=3 (the subject was sensitive to >=3 of the ARVs in his/her OBT). If no resistance results were available for a drug, it was scored as one active drug in the PSS if there was history of prior use, and was considered not active if no prior use. Scoring did not include Raltegravir.|participants|Number|5|5.0||||||
4312499|NCT00485264|4139457|B7|No||Use of prior PIs||participants|Number|39|39.0||||||
4312500|NCT00485264|4139458|B6|No||Use of prior PIs||participants|Number|12|12.0||||||
4312518|NCT00485264|4139462|B2|No||Prior use of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI)||participants|Number|2|2.0||||||
4312519|NCT00485264|4139463|B1|No||Prior use of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI)||participants|Number|11|11.0||||||
4312520|NCT00485264|4139457|B7|Yes||Prior use of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI)||participants|Number|118|118.0||||||
4312521|NCT00485264|4139458|B6|Yes||Prior use of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI)||participants|Number|11|11.0||||||
4312522|NCT00485264|4139459|B5|Yes||Prior use of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI)||participants|Number|8|8.0||||||
4312523|NCT00485264|4139460|B4|Yes||Prior use of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI)||participants|Number|10|10.0||||||
4312524|NCT00485264|4139461|B3|Yes||Prior use of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI)||participants|Number|15|15.0||||||
4312525|NCT00485264|4139462|B2|Yes||Prior use of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI)||participants|Number|14|14.0||||||
4312526|NCT00485264|4139463|B1|Yes||Prior use of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI)||participants|Number|60|60.0||||||
4312527|NCT00485264|4139457|B7|||Duration of ARVs previously used||years|Mean|7.7|7.7|Standard Deviation|5.6|5.6|||
4312528|NCT00485264|4139458|B6|||Duration of ARVs previously used||years|Mean|0.1|0.1|Standard Deviation|0.1|0.1|||
4312529|NCT00485264|4139459|B5|||Duration of ARVs previously used||years|Mean|0.4|0.4|Standard Deviation|0.5|0.5|||
4312530|NCT00485264|4139460|B4|||Duration of ARVs previously used||years|Mean|2.4|2.4|Standard Deviation|1.4|1.4|||
4312531|NCT00485264|4139461|B3|||Duration of ARVs previously used||years|Mean|7.1|7.1|Standard Deviation|3|3.0|||
4312532|NCT00485264|4139462|B2|||Duration of ARVs previously used||years|Mean|8.5|8.5|Standard Deviation|2.3|2.3|||
4312533|NCT00485264|4139463|B1|||Duration of ARVs previously used||years|Mean|12|12.0|Standard Deviation|3.8|3.8|||
4312534|NCT00485264|4139457|B7|≥3||Number of antiretroviral (ARV) classes previously used||participants|Number|86|86.0||||||
4312535|NCT00485264|4139458|B6|≥3||Number of antiretroviral (ARV) classes previously used||participants|Number|0|0.0||||||
4312536|NCT00485264|4139459|B5|≥3||Number of antiretroviral (ARV) classes previously used||participants|Number|2|2.0||||||
4312537|NCT00485264|4139460|B4|≥3||Number of antiretroviral (ARV) classes previously used||participants|Number|5|5.0||||||
4312538|NCT00485264|4139461|B3|≥3||Number of antiretroviral (ARV) classes previously used||participants|Number|10|10.0||||||
4312539|NCT00485264|4139462|B2|≥3||Number of antiretroviral (ARV) classes previously used||participants|Number|11|11.0||||||
4312540|NCT00485264|4139463|B1|≥3||Number of antiretroviral (ARV) classes previously used||participants|Number|60|60.0||||||
4312541|NCT00485264|4139457|B7|2||Number of antiretroviral (ARV) classes previously used||participants|Number|35|35.0||||||
4312542|NCT00485264|4139458|B6|2||Number of antiretroviral (ARV) classes previously used||participants|Number|2|2.0||||||
4312543|NCT00485264|4139459|B5|2||Number of antiretroviral (ARV) classes previously used||participants|Number|4|4.0||||||
4312544|NCT00485264|4139460|B4|2||Number of antiretroviral (ARV) classes previously used||participants|Number|13|13.0||||||
4312545|NCT00485264|4139461|B3|2||Number of antiretroviral (ARV) classes previously used||participants|Number|8|8.0||||||
4312546|NCT00485264|4139462|B2|2||Number of antiretroviral (ARV) classes previously used||participants|Number|5|5.0||||||
4312547|NCT00485264|4139463|B1|2||Number of antiretroviral (ARV) classes previously used||participants|Number|9|9.0||||||
4312548|NCT00485264|4139457|B7|1||Number of antiretroviral (ARV) classes previously used||participants|Number|4|4.0||||||
4312549|NCT00485264|4139458|B6|1||Number of antiretroviral (ARV) classes previously used||participants|Number|10|10.0||||||
4312550|NCT00485264|4139459|B5|1||Number of antiretroviral (ARV) classes previously used||participants|Number|8|8.0||||||
4312551|NCT00485264|4139460|B4|1||Number of antiretroviral (ARV) classes previously used||participants|Number|2|2.0||||||
4312552|NCT00485264|4139461|B3|1||Number of antiretroviral (ARV) classes previously used||participants|Number|0|0.0||||||
4312553|NCT00485264|4139462|B2|1||Number of antiretroviral (ARV) classes previously used||participants|Number|0|0.0||||||
4312554|NCT00485264|4139463|B1|1||Number of antiretroviral (ARV) classes previously used||participants|Number|2|2.0||||||
4312555|NCT00485264|4139457|B7|0||Number of antiretroviral (ARV) classes previously used||participants|Number|1|1.0||||||
4312556|NCT00485264|4139458|B6|0||Number of antiretroviral (ARV) classes previously used||participants|Number|0|0.0||||||
4312557|NCT00485264|4139459|B5|0||Number of antiretroviral (ARV) classes previously used||participants|Number|0|0.0||||||
4312558|NCT00485264|4139460|B4|0||Number of antiretroviral (ARV) classes previously used||participants|Number|1|1.0||||||
4312559|NCT00485264|4139461|B3|0||Number of antiretroviral (ARV) classes previously used||participants|Number|0|0.0||||||
4312560|NCT00485264|4139462|B2|0||Number of antiretroviral (ARV) classes previously used||participants|Number|0|0.0||||||
4312561|NCT00485264|4139463|B1|0||Number of antiretroviral (ARV) classes previously used||participants|Number|0|0.0||||||
4312562|NCT00485264|4139457|B7|N||CDC HIV Clinical Classification|The CDC Classification System for HIV Infection is the medical classification system used by the United States Centers for Disease Control and Prevention (CDC) to classify HIV disease and infection. http://www.cdc.gov/mmwr/preview/mmwrhtml/00032890.htm|participants|Number|14|14.0||||||
4312563|NCT00485264|4139458|B6|N||CDC HIV Clinical Classification|The CDC Classification System for HIV Infection is the medical classification system used by the United States Centers for Disease Control and Prevention (CDC) to classify HIV disease and infection. http://www.cdc.gov/mmwr/preview/mmwrhtml/00032890.htm|participants|Number|7|7.0||||||
4312564|NCT00485264|4139459|B5|N||CDC HIV Clinical Classification|The CDC Classification System for HIV Infection is the medical classification system used by the United States Centers for Disease Control and Prevention (CDC) to classify HIV disease and infection. http://www.cdc.gov/mmwr/preview/mmwrhtml/00032890.htm|participants|Number|3|3.0||||||
4312634|NCT00485264|4139459|B5|||Plasma HIV RNA, continuous||log10 copies/mL|Mean|5.4|5.4|Standard Deviation|1|1.0|||
4312754|NCT00485173|4139554|B3|No||Worker's Compensation||participants|Number|659|659.0||||||
4312565|NCT00485264|4139460|B4|N||CDC HIV Clinical Classification|The CDC Classification System for HIV Infection is the medical classification system used by the United States Centers for Disease Control and Prevention (CDC) to classify HIV disease and infection. http://www.cdc.gov/mmwr/preview/mmwrhtml/00032890.htm|participants|Number|7|7.0||||||
4312566|NCT00485264|4139461|B3|N||CDC HIV Clinical Classification|The CDC Classification System for HIV Infection is the medical classification system used by the United States Centers for Disease Control and Prevention (CDC) to classify HIV disease and infection. http://www.cdc.gov/mmwr/preview/mmwrhtml/00032890.htm|participants|Number|5|5.0||||||
4312567|NCT00485264|4139462|B2|N||CDC HIV Clinical Classification|The CDC Classification System for HIV Infection is the medical classification system used by the United States Centers for Disease Control and Prevention (CDC) to classify HIV disease and infection. http://www.cdc.gov/mmwr/preview/mmwrhtml/00032890.htm|participants|Number|1|1.0||||||
4312568|NCT00485264|4139463|B1|N||CDC HIV Clinical Classification|The CDC Classification System for HIV Infection is the medical classification system used by the United States Centers for Disease Control and Prevention (CDC) to classify HIV disease and infection. http://www.cdc.gov/mmwr/preview/mmwrhtml/00032890.htm|participants|Number|1|1.0||||||
4312569|NCT00485264|4139457|B7|C||CDC HIV Clinical Classification|The CDC Classification System for HIV Infection is the medical classification system used by the United States Centers for Disease Control and Prevention (CDC) to classify HIV disease and infection. http://www.cdc.gov/mmwr/preview/mmwrhtml/00032890.htm|participants|Number|41|41.0||||||
4312570|NCT00485264|4139458|B6|C||CDC HIV Clinical Classification|The CDC Classification System for HIV Infection is the medical classification system used by the United States Centers for Disease Control and Prevention (CDC) to classify HIV disease and infection. http://www.cdc.gov/mmwr/preview/mmwrhtml/00032890.htm|participants|Number|0|0.0||||||
4312571|NCT00485264|4139459|B5|C||CDC HIV Clinical Classification|The CDC Classification System for HIV Infection is the medical classification system used by the United States Centers for Disease Control and Prevention (CDC) to classify HIV disease and infection. http://www.cdc.gov/mmwr/preview/mmwrhtml/00032890.htm|participants|Number|3|3.0||||||
4312572|NCT00485264|4139460|B4|C||CDC HIV Clinical Classification|The CDC Classification System for HIV Infection is the medical classification system used by the United States Centers for Disease Control and Prevention (CDC) to classify HIV disease and infection. http://www.cdc.gov/mmwr/preview/mmwrhtml/00032890.htm|participants|Number|8|8.0||||||
4312573|NCT00485264|4139461|B3|C||CDC HIV Clinical Classification|The CDC Classification System for HIV Infection is the medical classification system used by the United States Centers for Disease Control and Prevention (CDC) to classify HIV disease and infection. http://www.cdc.gov/mmwr/preview/mmwrhtml/00032890.htm|participants|Number|2|2.0||||||
4312574|NCT00485264|4139462|B2|C||CDC HIV Clinical Classification|The CDC Classification System for HIV Infection is the medical classification system used by the United States Centers for Disease Control and Prevention (CDC) to classify HIV disease and infection. http://www.cdc.gov/mmwr/preview/mmwrhtml/00032890.htm|participants|Number|7|7.0||||||
4312575|NCT00485264|4139463|B1|C||CDC HIV Clinical Classification|The CDC Classification System for HIV Infection is the medical classification system used by the United States Centers for Disease Control and Prevention (CDC) to classify HIV disease and infection. http://www.cdc.gov/mmwr/preview/mmwrhtml/00032890.htm|participants|Number|24|24.0||||||
4312576|NCT00485264|4139457|B7|B||CDC HIV Clinical Classification|The CDC Classification System for HIV Infection is the medical classification system used by the United States Centers for Disease Control and Prevention (CDC) to classify HIV disease and infection. http://www.cdc.gov/mmwr/preview/mmwrhtml/00032890.htm|participants|Number|38|38.0||||||
4312577|NCT00485264|4139458|B6|B||CDC HIV Clinical Classification|The CDC Classification System for HIV Infection is the medical classification system used by the United States Centers for Disease Control and Prevention (CDC) to classify HIV disease and infection. http://www.cdc.gov/mmwr/preview/mmwrhtml/00032890.htm|participants|Number|1|1.0||||||
4312578|NCT00485264|4139459|B5|B||CDC HIV Clinical Classification|The CDC Classification System for HIV Infection is the medical classification system used by the United States Centers for Disease Control and Prevention (CDC) to classify HIV disease and infection. http://www.cdc.gov/mmwr/preview/mmwrhtml/00032890.htm|participants|Number|2|2.0||||||
4312579|NCT00485264|4139460|B4|B||CDC HIV Clinical Classification|The CDC Classification System for HIV Infection is the medical classification system used by the United States Centers for Disease Control and Prevention (CDC) to classify HIV disease and infection. http://www.cdc.gov/mmwr/preview/mmwrhtml/00032890.htm|participants|Number|1|1.0||||||
4312580|NCT00485264|4139461|B3|B||CDC HIV Clinical Classification|The CDC Classification System for HIV Infection is the medical classification system used by the United States Centers for Disease Control and Prevention (CDC) to classify HIV disease and infection. http://www.cdc.gov/mmwr/preview/mmwrhtml/00032890.htm|participants|Number|5|5.0||||||
4312581|NCT00485264|4139462|B2|B||CDC HIV Clinical Classification|The CDC Classification System for HIV Infection is the medical classification system used by the United States Centers for Disease Control and Prevention (CDC) to classify HIV disease and infection. http://www.cdc.gov/mmwr/preview/mmwrhtml/00032890.htm|participants|Number|3|3.0||||||
4312582|NCT00485264|4139463|B1|B||CDC HIV Clinical Classification|The CDC Classification System for HIV Infection is the medical classification system used by the United States Centers for Disease Control and Prevention (CDC) to classify HIV disease and infection. http://www.cdc.gov/mmwr/preview/mmwrhtml/00032890.htm|participants|Number|29|29.0||||||
4312583|NCT00485264|4139457|B7|A||CDC HIV Clinical Classification|The CDC Classification System for HIV Infection is the medical classification system used by the United States Centers for Disease Control and Prevention (CDC) to classify HIV disease and infection. http://www.cdc.gov/mmwr/preview/mmwrhtml/00032890.htm|participants|Number|33|33.0||||||
4312584|NCT00485264|4139458|B6|A||CDC HIV Clinical Classification|The CDC Classification System for HIV Infection is the medical classification system used by the United States Centers for Disease Control and Prevention (CDC) to classify HIV disease and infection. http://www.cdc.gov/mmwr/preview/mmwrhtml/00032890.htm|participants|Number|4|4.0||||||
4312585|NCT00485264|4139459|B5|A||CDC HIV Clinical Classification|The CDC Classification System for HIV Infection is the medical classification system used by the United States Centers for Disease Control and Prevention (CDC) to classify HIV disease and infection. http://www.cdc.gov/mmwr/preview/mmwrhtml/00032890.htm|participants|Number|6|6.0||||||
4312586|NCT00485264|4139460|B4|A||CDC HIV Clinical Classification|The CDC Classification System for HIV Infection is the medical classification system used by the United States Centers for Disease Control and Prevention (CDC) to classify HIV disease and infection. http://www.cdc.gov/mmwr/preview/mmwrhtml/00032890.htm|participants|Number|5|5.0||||||
4312587|NCT00485264|4139461|B3|A||CDC HIV Clinical Classification|The CDC Classification System for HIV Infection is the medical classification system used by the United States Centers for Disease Control and Prevention (CDC) to classify HIV disease and infection. http://www.cdc.gov/mmwr/preview/mmwrhtml/00032890.htm|participants|Number|6|6.0||||||
4312588|NCT00485264|4139462|B2|A||CDC HIV Clinical Classification|The CDC Classification System for HIV Infection is the medical classification system used by the United States Centers for Disease Control and Prevention (CDC) to classify HIV disease and infection. http://www.cdc.gov/mmwr/preview/mmwrhtml/00032890.htm|participants|Number|5|5.0||||||
4312589|NCT00485264|4139463|B1|A||CDC HIV Clinical Classification|The CDC Classification System for HIV Infection is the medical classification system used by the United States Centers for Disease Control and Prevention (CDC) to classify HIV disease and infection. http://www.cdc.gov/mmwr/preview/mmwrhtml/00032890.htm|participants|Number|17|17.0||||||
4312590|NCT00485264|4139457|B7|||CD4 percentage||Percentage of total lymphocytes|Mean|23|23.0|Standard Deviation|9.9|9.9|||
4312591|NCT00485264|4139458|B6|||CD4 percentage||Percentage of total lymphocytes|Mean|18.4|18.4|Standard Deviation|11.5|11.5|||
4312592|NCT00485264|4139459|B5|||CD4 percentage||Percentage of total lymphocytes|Mean|22.6|22.6|Standard Deviation|8.1|8.1|||
4312593|NCT00485264|4139460|B4|||CD4 percentage||Percentage of total lymphocytes|Mean|27.9|27.9|Standard Deviation|8.2|8.2|||
4312594|NCT00485264|4139461|B3|||CD4 percentage||Percentage of total lymphocytes|Mean|26.7|26.7|Standard Deviation|10.6|10.6|||
4312595|NCT00485264|4139462|B2|||CD4 percentage||Percentage of total lymphocytes|Mean|25.4|25.4|Standard Deviation|8.2|8.2|||
4312596|NCT00485264|4139463|B1|||CD4 percentage||Percentage of total lymphocytes|Mean|19.9|19.9|Standard Deviation|9.6|9.6|||
4312597|NCT00485264|4139457|B7|||CD4 cell count||cells/µL|Mean|744.3|744.3|Standard Deviation|654.9|654.9|||
4312598|NCT00485264|4139458|B6|||CD4 cell count||cells/µL|Mean|1359.6|1359.6|Standard Deviation|1003.8|1003.8|||
4312599|NCT00485264|4139459|B5|||CD4 cell count||cells/µL|Mean|1647.5|1647.5|Standard Deviation|965.7|965.7|||
4312600|NCT00485264|4139460|B4|||CD4 cell count||cells/µL|Mean|1122.9|1122.9|Standard Deviation|537.1|537.1|||
4312601|NCT00485264|4139461|B3|||CD4 cell count||cells/µL|Mean|545.4|545.4|Standard Deviation|280.2|280.2|||
4312602|NCT00485264|4139462|B2|||CD4 cell count||cells/µL|Mean|652.3|652.3|Standard Deviation|360.4|360.4|||
4312603|NCT00485264|4139463|B1|||CD4 cell count||cells/µL|Mean|410.7|410.7|Standard Deviation|238.2|238.2|||
4312604|NCT00485264|4139457|B7|>100,000 copies/mL||Plasma HIV RNA, categorical||participants|Number|13|13.0||||||
4312605|NCT00485264|4139458|B6|>100,000 copies/mL||Plasma HIV RNA, categorical||participants|Number|9|9.0||||||
4312606|NCT00485264|4139459|B5|>100,000 copies/mL||Plasma HIV RNA, categorical||participants|Number|9|9.0||||||
4312607|NCT00485264|4139460|B4|>100,000 copies/mL||Plasma HIV RNA, categorical||participants|Number|4|4.0||||||
4312608|NCT00485264|4139461|B3|>100,000 copies/mL||Plasma HIV RNA, categorical||participants|Number|1|1.0||||||
4312609|NCT00485264|4139462|B2|>100,000 copies/mL||Plasma HIV RNA, categorical||participants|Number|1|1.0||||||
4312610|NCT00485264|4139463|B1|>100,000 copies/mL||Plasma HIV RNA, categorical||participants|Number|7|7.0||||||
4312611|NCT00485264|4139457|B7|>50,000 to ≤100,000 copies/mL||Plasma HIV RNA, categorical||participants|Number|23|23.0||||||
4312612|NCT00485264|4139458|B6|>50,000 to ≤100,000 copies/mL||Plasma HIV RNA, categorical||participants|Number|1|1.0||||||
4312613|NCT00485264|4139459|B5|>50,000 to ≤100,000 copies/mL||Plasma HIV RNA, categorical||participants|Number|3|3.0||||||
4312614|NCT00485264|4139460|B4|>50,000 to ≤100,000 copies/mL||Plasma HIV RNA, categorical||participants|Number|4|4.0||||||
4312615|NCT00485264|4139461|B3|>50,000 to ≤100,000 copies/mL||Plasma HIV RNA, categorical||participants|Number|4|4.0||||||
4312616|NCT00485264|4139462|B2|>50,000 to ≤100,000 copies/mL||Plasma HIV RNA, categorical||participants|Number|1|1.0||||||
4312617|NCT00485264|4139463|B1|>50,000 to ≤100,000 copies/mL||Plasma HIV RNA, categorical||participants|Number|14|14.0||||||
4312618|NCT00485264|4139457|B7|>4,000 to ≤50,000 copies/mL||Plasma HIV RNA, categorical||participants|Number|74|74.0||||||
4312619|NCT00485264|4139458|B6|>4,000 to ≤50,000 copies/mL||Plasma HIV RNA, categorical||participants|Number|2|2.0||||||
4312620|NCT00485264|4139459|B5|>4,000 to ≤50,000 copies/mL||Plasma HIV RNA, categorical||participants|Number|1|1.0||||||
4312621|NCT00485264|4139460|B4|>4,000 to ≤50,000 copies/mL||Plasma HIV RNA, categorical||participants|Number|11|11.0||||||
4312622|NCT00485264|4139461|B3|>4,000 to ≤50,000 copies/mL||Plasma HIV RNA, categorical||participants|Number|11|11.0||||||
4312623|NCT00485264|4139462|B2|>4,000 to ≤50,000 copies/mL||Plasma HIV RNA, categorical||participants|Number|12|12.0||||||
4312624|NCT00485264|4139463|B1|>4,000 to ≤50,000 copies/mL||Plasma HIV RNA, categorical||participants|Number|40|40.0||||||
4312625|NCT00485264|4139457|B7|0 to ≤4,000 copies/mL||Plasma HIV RNA, categorical||participants|Number|16|16.0||||||
4312626|NCT00485264|4139458|B6|0 to ≤4,000 copies/mL||Plasma HIV RNA, categorical||participants|Number|0|0.0||||||
4312627|NCT00485264|4139459|B5|0 to ≤4,000 copies/mL||Plasma HIV RNA, categorical||participants|Number|1|1.0||||||
4312628|NCT00485264|4139460|B4|0 to ≤4,000 copies/mL||Plasma HIV RNA, categorical||participants|Number|2|2.0||||||
4312629|NCT00485264|4139461|B3|0 to ≤4,000 copies/mL||Plasma HIV RNA, categorical||participants|Number|2|2.0||||||
4312630|NCT00485264|4139462|B2|0 to ≤4,000 copies/mL||Plasma HIV RNA, categorical||participants|Number|2|2.0||||||
4312631|NCT00485264|4139463|B1|0 to ≤4,000 copies/mL||Plasma HIV RNA, categorical||participants|Number|10|10.0||||||
4312632|NCT00485264|4139457|B7|||Plasma HIV RNA, continuous||log10 copies/mL|Mean|4.6|4.6|Standard Deviation|0.9|0.9|||
4312633|NCT00485264|4139458|B6|||Plasma HIV RNA, continuous||log10 copies/mL|Mean|6|6.0|Standard Deviation|1.2|1.2|||
4312635|NCT00485264|4139460|B4|||Plasma HIV RNA, continuous||log10 copies/mL|Mean|4.4|4.4|Standard Deviation|0.8|0.8|||
4312636|NCT00485264|4139461|B3|||Plasma HIV RNA, continuous||log10 copies/mL|Mean|4.3|4.3|Standard Deviation|0.5|0.5|||
4312637|NCT00485264|4139462|B2|||Plasma HIV RNA, continuous||log10 copies/mL|Mean|4.3|4.3|Standard Deviation|0.6|0.6|||
4312638|NCT00485264|4139463|B1|||Plasma HIV RNA, continuous||log10 copies/mL|Mean|4.3|4.3|Standard Deviation|0.6|0.6|||
4312639|NCT00485264|4139457|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4312640|NCT00485264|4139458|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312641|NCT00485264|4139459|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4312642|NCT00485264|4139460|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4312643|NCT00485264|4139461|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4312644|NCT00485264|4139462|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4312645|NCT00485264|4139463|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4312646|NCT00485264|4139457|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4312647|NCT00485264|4139458|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312648|NCT00485264|4139459|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4312649|NCT00485264|4139460|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4312650|NCT00485264|4139461|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312651|NCT00485264|4139462|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312652|NCT00485264|4139463|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312653|NCT00485264|4139457|B7||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4312654|NCT00485264|4139458|B6||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312655|NCT00485264|4139459|B5||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4312656|NCT00485264|4139460|B4||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4312657|NCT00485264|4139461|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4312658|NCT00485264|4139462|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4312659|NCT00485264|4139463|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4312660|NCT00485264|4139457|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
4312661|NCT00485264|4139458|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4312662|NCT00485264|4139459|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4312663|NCT00485264|4139460|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4312664|NCT00485264|4139461|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4312665|NCT00485264|4139462|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4312666|NCT00485264|4139463|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4312667|NCT00485264|4139457|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312668|NCT00485264|4139458|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312669|NCT00485264|4139459|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312670|NCT00485264|4139460|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312671|NCT00485264|4139461|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312672|NCT00485264|4139462|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312673|NCT00485264|4139463|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312674|NCT00485264|4139457|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312675|NCT00485264|4139458|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312676|NCT00485264|4139459|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312677|NCT00485264|4139460|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312678|NCT00485264|4139461|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312679|NCT00485264|4139462|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312680|NCT00485264|4139463|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312681|NCT00485264|4139457|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4312682|NCT00485264|4139458|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312683|NCT00485264|4139459|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312684|NCT00485264|4139460|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312685|NCT00485264|4139461|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312686|NCT00485264|4139462|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312687|NCT00485264|4139463|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4312688|NCT00485264|4139457|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4312689|NCT00485264|4139458|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4312690|NCT00485264|4139459|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4312691|NCT00485264|4139460|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4312692|NCT00485264|4139461|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312693|NCT00485264|4139462|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4312694|NCT00485264|4139463|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4312695|NCT00485264|4139457|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
4312696|NCT00485264|4139458|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4312697|NCT00485264|4139459|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4312698|NCT00485264|4139460|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4312699|NCT00485264|4139461|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4312700|NCT00485264|4139462|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4312701|NCT00485264|4139463|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4312702|NCT00485264|4139457|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4312703|NCT00485264|4139458|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312704|NCT00485264|4139459|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4312705|NCT00485264|4139460|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4312706|NCT00485264|4139461|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4312707|NCT00485264|4139462|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4312708|NCT00485264|4139463|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4312709|NCT00485264|4139457|B7||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4312710|NCT00485264|4139458|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4312711|NCT00485264|4139459|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4312712|NCT00485264|4139460|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4312713|NCT00485264|4139461|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4312714|NCT00485264|4139462|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4312715|NCT00485264|4139463|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4312716|NCT00485264|4139457|B7||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4312717|NCT00485264|4139458|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4312718|NCT00485264|4139459|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4312719|NCT00485264|4139460|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4312720|NCT00485264|4139461|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4312721|NCT00485264|4139462|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4312722|NCT00485264|4139463|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4312723|NCT00485264|4139457|B7|||Age||years|Mean|9.5|9.5|Standard Deviation|6.1|6.1|||
4312724|NCT00485264|4139458|B6|||Age||years|Mean|0.3|0.3|Standard Deviation|0.1|0.1|||
4312725|NCT00485264|4139459|B5|||Age||years|Mean|1.0|1.0|Standard Deviation|0.5|0.5|||
4312726|NCT00485264|4139460|B4|||Age||years|Mean|3.1|3.1|Standard Deviation|1.2|1.2|||
4312727|NCT00485264|4139461|B3|||Age||years|Mean|8.9|8.9|Standard Deviation|1.6|1.6|||
4312728|NCT00485264|4139462|B2|||Age||years|Mean|9.1|9.1|Standard Deviation|1.6|1.6|||
4312729|NCT00485264|4139463|B1|||Age||years|Mean|15|15.0|Standard Deviation|2|2.0|||
4312730|NCT00485173|4139554|B3|No||Preop Work Status||participants|Number|247|247.0||||||
4312731|NCT00485173|4139555|B2|No||Preop Work Status||participants|Number|176|176.0||||||
4312732|NCT00485173|4139556|B1|No||Preop Work Status||participants|Number|71|71.0||||||
4312733|NCT00485173|4139554|B3|Yes||Preop Work Status||participants|Number|462|462.0||||||
4312734|NCT00485173|4139555|B2|Yes||Preop Work Status||participants|Number|309|309.0||||||
4312735|NCT00485173|4139556|B1|Yes||Preop Work Status||participants|Number|153|153.0||||||
4312736|NCT00485173|4139554|B3|No||Alcohol Used||participants|Number|449|449.0||||||
4312737|NCT00485173|4139555|B2|No||Alcohol Used||participants|Number|336|336.0||||||
4312738|NCT00485173|4139556|B1|No||Alcohol Used||participants|Number|113|113.0||||||
4312739|NCT00485173|4139554|B3|Yes||Alcohol Used||participants|Number|261|261.0||||||
4312740|NCT00485173|4139555|B2|Yes||Alcohol Used||participants|Number|150|150.0||||||
4312741|NCT00485173|4139556|B1|Yes||Alcohol Used||participants|Number|111|111.0||||||
4312742|NCT00485173|4139554|B3|No||Tobacco Used||participants|Number|498|498.0||||||
4312743|NCT00485173|4139555|B2|No||Tobacco Used||participants|Number|341|341.0||||||
4312744|NCT00485173|4139556|B1|No||Tobacco Used||participants|Number|157|157.0||||||
4312745|NCT00485173|4139554|B3|Yes||Tobacco Used||participants|Number|211|211.0||||||
4312746|NCT00485173|4139555|B2|Yes||Tobacco Used||participants|Number|145|145.0||||||
4312747|NCT00485173|4139556|B1|Yes||Tobacco Used||participants|Number|66|66.0||||||
4312748|NCT00485173|4139554|B3|No||Unresolved Spinal Litigation||participants|Number|644|644.0||||||
4312749|NCT00485173|4139555|B2|No||Unresolved Spinal Litigation||participants|Number|448|448.0||||||
4312750|NCT00485173|4139556|B1|No||Unresolved Spinal Litigation||participants|Number|196|196.0||||||
4312751|NCT00485173|4139554|B3|Yes||Unresolved Spinal Litigation||participants|Number|66|66.0||||||
4312752|NCT00485173|4139555|B2|Yes||Unresolved Spinal Litigation||participants|Number|38|38.0||||||
4312755|NCT00485173|4139555|B2|No||Worker's Compensation||participants|Number|440|440.0||||||
4312756|NCT00485173|4139556|B1|No||Worker's Compensation||participants|Number|219|219.0||||||
4312757|NCT00485173|4139554|B3|Yes||Worker's Compensation||participants|Number|51|51.0||||||
4312758|NCT00485173|4139555|B2|Yes||Worker's Compensation||participants|Number|46|46.0||||||
4312759|NCT00485173|4139556|B1|Yes||Worker's Compensation||participants|Number|5|5.0||||||
4312760|NCT00485173|4139554|B3|> high School||Education Level||participants|Number|448|448.0||||||
4312761|NCT00485173|4139555|B2|> high School||Education Level||participants|Number|314|314.0||||||
4312762|NCT00485173|4139556|B1|> high School||Education Level||participants|Number|134|134.0||||||
4312763|NCT00485173|4139554|B3|High School||Education Level||participants|Number|222|222.0||||||
4312764|NCT00485173|4139555|B2|High School||Education Level||participants|Number|142|142.0||||||
4312765|NCT00485173|4139556|B1|High School||Education Level||participants|Number|80|80.0||||||
4312766|NCT00485173|4139554|B3|< high School||Education Level||participants|Number|39|39.0||||||
4312767|NCT00485173|4139555|B2|< high School||Education Level||participants|Number|29|29.0||||||
4312768|NCT00485173|4139556|B1|< high School||Education Level||participants|Number|10|10.0||||||
4312769|NCT00485173|4139554|B3|Widowed||Marital Status||participants|Number|7|7.0||||||
4312770|NCT00485173|4139555|B2|Widowed||Marital Status||participants|Number|4|4.0||||||
4312771|NCT00485173|4139556|B1|Widowed||Marital Status||participants|Number|3|3.0||||||
4312772|NCT00485173|4139554|B3|Separated||Marital Status||participants|Number|11|11.0||||||
4312773|NCT00485173|4139555|B2|Separated||Marital Status||participants|Number|4|4.0||||||
4312774|NCT00485173|4139556|B1|Separated||Marital Status||participants|Number|7|7.0||||||
4312775|NCT00485173|4139554|B3|Divorced||Marital Status||participants|Number|65|65.0||||||
4312776|NCT00485173|4139555|B2|Divorced||Marital Status||participants|Number|44|44.0||||||
4312777|NCT00485173|4139556|B1|Divorced||Marital Status||participants|Number|21|21.0||||||
4312778|NCT00485173|4139554|B3|Married||Marital Status||participants|Number|536|536.0||||||
4312779|NCT00485173|4139555|B2|Married||Marital Status||participants|Number|373|373.0||||||
4312780|NCT00485173|4139556|B1|Married||Marital Status||participants|Number|163|163.0||||||
4312781|NCT00485173|4139554|B3|Single||Marital Status||participants|Number|91|91.0||||||
4312782|NCT00485173|4139555|B2|Single||Marital Status||participants|Number|61|61.0||||||
4312783|NCT00485173|4139556|B1|Single||Marital Status||participants|Number|30|30.0||||||
4312784|NCT00485173|4139554|B3|||Weight||lbs.|Mean|184.5|184.5|Standard Deviation|41.5|41.5|||
4312785|NCT00485173|4139555|B2|||Weight||lbs.|Mean|182.5|182.5|Standard Deviation|40.4|40.4|||
4312786|NCT00485173|4139556|B1|||Weight||lbs.|Mean|188.8|188.8|Standard Deviation|43.6|43.6|||
4312787|NCT00485173|4139554|B3|||Height||in.|Mean|67.5|67.5|Standard Deviation|4.1|4.1|||
4312788|NCT00485173|4139555|B2|||Height||in.|Mean|67.5|67.5|Standard Deviation|4.0|4.0|||
4312789|NCT00485173|4139556|B1|||Height||in.|Mean|67.5|67.5|Standard Deviation|4.2|4.2|||
4312790|NCT00485173|4139554|B3|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4312791|NCT00485173|4139555|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4312792|NCT00485173|4139556|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4312793|NCT00485173|4139554|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4312794|NCT00485173|4139555|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4312795|NCT00485173|4139556|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4312796|NCT00485173|4139554|B3|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4312797|NCT00485173|4139555|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4312798|NCT00485173|4139556|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4312799|NCT00485173|4139554|B3|Black||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4312800|NCT00485173|4139555|B2|Black||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4312801|NCT00485173|4139556|B1|Black||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4312802|NCT00485173|4139554|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|645|645.0||||||
4312803|NCT00485173|4139555|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|447|447.0||||||
4312804|NCT00485173|4139556|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|198|198.0||||||
4312805|NCT00485173|4139554|B3||Male|Sex: Female, Male||Participants|Count of Participants|341|341.0||||||
4312806|NCT00485173|4139555|B2||Male|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4312807|NCT00485173|4139556|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4312808|NCT00485173|4139554|B3||Female|Sex: Female, Male||Participants|Count of Participants|369|369.0||||||
4312809|NCT00485173|4139555|B2||Female|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4312810|NCT00485173|4139556|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4312811|NCT00485173|4139554|B3|||Age||years|Mean|45.0|45.0|Standard Deviation|9.3|9.3|||
4312812|NCT00485173|4139555|B2|||Age||years|Mean|44.2|44.2|Standard Deviation|8.7|8.7|||
4312813|NCT00485173|4139556|B1|||Age||years|Mean|46.8|46.8|Standard Deviation|10.2|10.2|||
4312814|NCT00485134|4139597|B9|Data Missing||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4312815|NCT00485134|4139598|B8|Data Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4312816|NCT00485134|4139599|B7|Data Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4312817|NCT00485134|4139600|B6|Data Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4312818|NCT00485134|4139601|B5|Data Missing||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4312981|NCT00484354|4139782|B3||White|Race (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
4312819|NCT00485134|4139602|B4|Data Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4312820|NCT00485134|4139603|B3|Data Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4312821|NCT00485134|4139604|B2|Data Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4312822|NCT00485134|4139605|B1|Data Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4312823|NCT00485134|4139597|B9|Other||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4312824|NCT00485134|4139598|B8|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4312825|NCT00485134|4139599|B7|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4312826|NCT00485134|4139600|B6|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4312827|NCT00485134|4139601|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4312828|NCT00485134|4139602|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4312829|NCT00485134|4139603|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4312830|NCT00485134|4139604|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4312831|NCT00485134|4139605|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4312832|NCT00485134|4139597|B9|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
4312833|NCT00485134|4139598|B8|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4312834|NCT00485134|4139599|B7|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4312835|NCT00485134|4139600|B6|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4312836|NCT00485134|4139601|B5|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4312837|NCT00485134|4139602|B4|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4312838|NCT00485134|4139603|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4312839|NCT00485134|4139604|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4312840|NCT00485134|4139605|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4312841|NCT00485134|4139597|B9|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|82|82.0||||||
4312842|NCT00485134|4139598|B8|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4312843|NCT00485134|4139599|B7|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
4312844|NCT00485134|4139600|B6|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4312845|NCT00485134|4139601|B5|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4312846|NCT00485134|4139602|B4|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4312847|NCT00485134|4139603|B3|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4312848|NCT00485134|4139604|B2|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4312849|NCT00485134|4139605|B1|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4312850|NCT00485134|4139597|B9||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4312851|NCT00485134|4139598|B8||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4312852|NCT00485134|4139599|B7||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4312853|NCT00485134|4139600|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4312854|NCT00485134|4139601|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4312855|NCT00485134|4139602|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4312856|NCT00485134|4139603|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4312857|NCT00485134|4139604|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4312858|NCT00485134|4139605|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4312859|NCT00485134|4139597|B9||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4312860|NCT00485134|4139598|B8||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4312861|NCT00485134|4139599|B7||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4312862|NCT00485134|4139600|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4312863|NCT00485134|4139601|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4312864|NCT00485134|4139602|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4312865|NCT00485134|4139603|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4312866|NCT00485134|4139604|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4312867|NCT00485134|4139605|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4312868|NCT00485134|4139597|B9|||Age|Age for stage 2 groups do not include data from individuals who were at Walter Reed Army Institute of Research (WRAIR) Clinical Trials Center (CTC) (10 immunized and 7 controls). Data is entered as presented in the Final Clinical Study Report.|years|Mean|33.5|33.5|Standard Deviation|7.7|7.7|||
4312869|NCT00485134|4139598|B8|||Age|Age for stage 2 groups do not include data from individuals who were at Walter Reed Army Institute of Research (WRAIR) Clinical Trials Center (CTC) (10 immunized and 7 controls). Data is entered as presented in the Final Clinical Study Report.|years|Mean|31.3|31.3|Standard Deviation|8.2|8.2|||
4312870|NCT00485134|4139599|B7|||Age|Age for stage 2 groups do not include data from individuals who were at Walter Reed Army Institute of Research (WRAIR) Clinical Trials Center (CTC) (10 immunized and 7 controls). Data is entered as presented in the Final Clinical Study Report.|years|Mean|32.2|32.2|Standard Deviation|8.3|8.3|||
4312871|NCT00485134|4139600|B6|||Age|Age for stage 2 groups do not include data from individuals who were at Walter Reed Army Institute of Research (WRAIR) Clinical Trials Center (CTC) (10 immunized and 7 controls). Data is entered as presented in the Final Clinical Study Report.|years|Mean|34.4|34.4|Standard Deviation|10.4|10.4|||
4312872|NCT00485134|4139601|B5|||Age|Age for stage 2 groups do not include data from individuals who were at Walter Reed Army Institute of Research (WRAIR) Clinical Trials Center (CTC) (10 immunized and 7 controls). Data is entered as presented in the Final Clinical Study Report.|years|Mean|35.1|35.1|Standard Deviation|10.2|10.2|||
4312873|NCT00485134|4139602|B4|||Age|Age for stage 2 groups do not include data from individuals who were at Walter Reed Army Institute of Research (WRAIR) Clinical Trials Center (CTC) (10 immunized and 7 controls). Data is entered as presented in the Final Clinical Study Report.|years|Mean|29.3|29.3|Standard Deviation|7.1|7.1|||
4312874|NCT00485134|4139603|B3|||Age|Age for stage 2 groups do not include data from individuals who were at Walter Reed Army Institute of Research (WRAIR) Clinical Trials Center (CTC) (10 immunized and 7 controls). Data is entered as presented in the Final Clinical Study Report.|years|Mean|30.7|30.7|Standard Deviation|7.3|7.3|||
4312875|NCT00485134|4139604|B2|||Age|Age for stage 2 groups do not include data from individuals who were at Walter Reed Army Institute of Research (WRAIR) Clinical Trials Center (CTC) (10 immunized and 7 controls). Data is entered as presented in the Final Clinical Study Report.|years|Mean|39.6|39.6|Standard Deviation|4.4|4.4|||
4312876|NCT00485134|4139605|B1|||Age|Age for stage 2 groups do not include data from individuals who were at Walter Reed Army Institute of Research (WRAIR) Clinical Trials Center (CTC) (10 immunized and 7 controls). Data is entered as presented in the Final Clinical Study Report.|years|Mean|38.1|38.1|Standard Deviation|7.1|7.1|||
4312877|NCT00485069|4139632|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4312878|NCT00485069|4139633|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4312879|NCT00485069|4139634|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4312880|NCT00485069|4139632|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|123|123.0||||||
4312881|NCT00485069|4139633|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
4312882|NCT00485069|4139634|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
4312883|NCT00485069|4139632|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4312884|NCT00485069|4139633|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4312885|NCT00485069|4139634|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4312886|NCT00485069|4139632|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4312887|NCT00485069|4139633|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4312888|NCT00485069|4139634|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4312889|NCT00485069|4139632|B3|||Age||Years|Mean|65.8|65.8|Standard Deviation|7.56|7.56|||
4312890|NCT00485069|4139633|B2|||Age||Years|Mean|65.5|65.5|Standard Deviation|7.18|7.18|||
4312891|NCT00485069|4139634|B1|||Age||Years|Mean|66.0|66.0|Standard Deviation|7.94|7.94|||
4312892|NCT00484939|4139678|B3||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4312893|NCT00484939|4139679|B2||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4312894|NCT00484939|4139680|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4312895|NCT00484939|4139678|B3||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4312896|NCT00484939|4139679|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4312897|NCT00484939|4139680|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4312898|NCT00484939|4139678|B3|||Age||years|Mean|76.3|76.3|Standard Deviation|4.04|4.04|||
4312899|NCT00484939|4139679|B2|||Age||years|Mean|76.5|76.5|Standard Deviation|3.91|3.91|||
4312900|NCT00484939|4139680|B1|||Age||years|Mean|76.1|76.1|Standard Deviation|4.18|4.18|||
4312901|NCT00484874|4139701|B1|||Post-transplant|Previously received blood or marrow transplant.|Participants|Count of Participants|6|6.0||||||
4312902|NCT00484874|4139701|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4312903|NCT00484874|4139701|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4312904|NCT00484874|4139701|B1|||Age||years|Mean|36|36.0|Full Range|||20.0|54.0|
4312905|NCT00484874|4139701|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4312906|NCT00484874|4139701|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4312907|NCT00484874|4139701|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4312908|NCT00484679|4139708|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4312909|NCT00484679|4139708|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4312910|NCT00484679|4139708|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4312911|NCT00484679|4139708|B1|||Age||years|Mean|46.6|46.6|Standard Deviation|14.53|14.53|||
4312912|NCT00484679|4139708|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4312913|NCT00484679|4139708|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4312914|NCT00484679|4139708|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4312915|NCT00484419|4139712|B4|||HbA1c|baseline glycosylated hemoglobin|percent|Mean|8.11|8.11|Full Range|||6.5|9.9|
4312916|NCT00484419|4139713|B3|||HbA1c|baseline glycosylated hemoglobin|percent|Mean|8.17|8.17|Full Range|||6.5|9.9|
4312917|NCT00484419|4139714|B2|||HbA1c|baseline glycosylated hemoglobin|percent|Mean|8.06|8.06|Full Range|||6.7|9.7|
4312918|NCT00484419|4139715|B1|||HbA1c|baseline glycosylated hemoglobin|percent|Mean|8.10|8.1|Full Range|||6.8|9.7|
4312919|NCT00484419|4139712|B4|||Fasting Plasma Glucose|baseline Fasting Plasma Glucose (FPG)|mg/dL|Mean|177.6|177.6|Full Range|||85.0|469.0|
4312982|NCT00484354|4139783|B2||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4312920|NCT00484419|4139713|B3|||Fasting Plasma Glucose|baseline Fasting Plasma Glucose (FPG)|mg/dL|Mean|180.6|180.6|Full Range|||85.0|456.0|
4312921|NCT00484419|4139714|B2|||Fasting Plasma Glucose|baseline Fasting Plasma Glucose (FPG)|mg/dL|Mean|177.7|177.7|Full Range|||101.0|469.0|
4312922|NCT00484419|4139715|B1|||Fasting Plasma Glucose|baseline Fasting Plasma Glucose (FPG)|mg/dL|Mean|174.5|174.5|Full Range|||109.0|270.0|
4312923|NCT00484419|4139712|B4|||Fasting Insulin|baseline fasting insulin|uIU/mL|Mean|9.396|9.396|Full Range|||1.22|47.77|
4312924|NCT00484419|4139713|B3|||Fasting Insulin|baseline fasting insulin|uIU/mL|Mean|8.886|8.886|Full Range|||1.32|24.02|
4312925|NCT00484419|4139714|B2|||Fasting Insulin|baseline fasting insulin|uIU/mL|Mean|9.945|9.945|Full Range|||1.22|42.37|
4312926|NCT00484419|4139715|B1|||Fasting Insulin|baseline fasting insulin|uIU/mL|Mean|9.406|9.406|Full Range|||1.63|47.77|
4312927|NCT00484419|4139712|B4|United States||Region of Enrollment||participants|Number|74|74.0||||||
4312928|NCT00484419|4139713|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4312929|NCT00484419|4139714|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4312930|NCT00484419|4139715|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4312931|NCT00484419|4139712|B4|Mexico||Region of Enrollment||participants|Number|43|43.0||||||
4312932|NCT00484419|4139713|B3|Mexico||Region of Enrollment||participants|Number|12|12.0||||||
4312933|NCT00484419|4139714|B2|Mexico||Region of Enrollment||participants|Number|19|19.0||||||
4312934|NCT00484419|4139715|B1|Mexico||Region of Enrollment||participants|Number|12|12.0||||||
4312935|NCT00484419|4139712|B4|Colombia||Region of Enrollment||participants|Number|52|52.0||||||
4312936|NCT00484419|4139713|B3|Colombia||Region of Enrollment||participants|Number|19|19.0||||||
4312937|NCT00484419|4139714|B2|Colombia||Region of Enrollment||participants|Number|12|12.0||||||
4312938|NCT00484419|4139715|B1|Colombia||Region of Enrollment||participants|Number|21|21.0||||||
4312939|NCT00484419|4139712|B4||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4312940|NCT00484419|4139713|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4312941|NCT00484419|4139714|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4312942|NCT00484419|4139715|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4312943|NCT00484419|4139712|B4||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4312944|NCT00484419|4139713|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4312945|NCT00484419|4139714|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4312946|NCT00484419|4139715|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4312947|NCT00484419|4139712|B4|||Age||years|Mean|55.4|55.4|Standard Deviation|9.96|9.96|||
4312948|NCT00484419|4139713|B3|||Age||years|Mean|54.8|54.8|Standard Deviation|9.76|9.76|||
4312949|NCT00484419|4139714|B2|||Age||years|Mean|54.7|54.7|Standard Deviation|10.92|10.92|||
4312950|NCT00484419|4139715|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|9.19|9.19|||
4312951|NCT00484419|4139712|B4||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
4312952|NCT00484419|4139713|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4312953|NCT00484419|4139714|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4312954|NCT00484419|4139715|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4312955|NCT00484419|4139712|B4||Between 18 and 65 years|Age||Participants|Count of Participants|135|135.0||||||
4312956|NCT00484419|4139713|B3||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4312957|NCT00484419|4139714|B2||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4312958|NCT00484419|4139715|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4312959|NCT00484419|4139712|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4312960|NCT00484419|4139713|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4312961|NCT00484419|4139714|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4312962|NCT00484419|4139715|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4312963|NCT00484393|4139773|B3|Male||Sex/Gender, Customized||participants|Number|2|2.0||||||
4312964|NCT00484393|4139774|B2|Male||Sex/Gender, Customized||participants|Number|1|1.0||||||
4312965|NCT00484393|4139775|B1|Male||Sex/Gender, Customized||participants|Number|1|1.0||||||
4312966|NCT00484393|4139773|B3|Female||Sex/Gender, Customized||participants|Number|5|5.0||||||
4312967|NCT00484393|4139774|B2|Female||Sex/Gender, Customized||participants|Number|2|2.0||||||
4312968|NCT00484393|4139775|B1|Female||Sex/Gender, Customized||participants|Number|3|3.0||||||
4312969|NCT00484393|4139773|B3|2-6 months||Age, Customized||participants|Number|7|7.0||||||
4312970|NCT00484393|4139774|B2|2-6 months||Age, Customized||participants|Number|3|3.0||||||
4312971|NCT00484393|4139775|B1|2-6 months||Age, Customized||participants|Number|4|4.0||||||
4312972|NCT00484354|4139782|B3|United States||Region of Enrollment||participants|Number|123|123.0||||||
4312973|NCT00484354|4139783|B2|United States||Region of Enrollment||participants|Number|59|59.0||||||
4312974|NCT00484354|4139784|B1|United States||Region of Enrollment||participants|Number|64|64.0||||||
4312975|NCT00484354|4139782|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4312976|NCT00484354|4139783|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4312977|NCT00484354|4139784|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4312978|NCT00484354|4139782|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312979|NCT00484354|4139783|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312980|NCT00484354|4139784|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312983|NCT00484354|4139784|B1||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4312984|NCT00484354|4139782|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4312985|NCT00484354|4139783|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4312986|NCT00484354|4139784|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4312987|NCT00484354|4139782|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312988|NCT00484354|4139783|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312989|NCT00484354|4139784|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312990|NCT00484354|4139782|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312991|NCT00484354|4139783|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312992|NCT00484354|4139784|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312993|NCT00484354|4139782|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312994|NCT00484354|4139783|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312995|NCT00484354|4139784|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4312996|NCT00484354|4139782|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4312997|NCT00484354|4139783|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4312998|NCT00484354|4139784|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4312999|NCT00484354|4139782|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4313000|NCT00484354|4139783|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4313001|NCT00484354|4139784|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4313002|NCT00484354|4139782|B3|||Age||years|Mean|70|70.0|Standard Deviation|13|13.0|||
4313003|NCT00484354|4139783|B2|||Age||years|Mean|69.7|69.7|Standard Deviation|13.5|13.5|||
4313004|NCT00484354|4139784|B1|||Age||years|Mean|70.2|70.2|Standard Deviation|12.6|12.6|||
4313005|NCT00484315|4139799|B3|TIMI 3||Lesion Characteristic - Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion TIMI 1 - Penetration with minimal perfusion TIMI 2 - Partial perfusion TIMI 3 - Complete perfusion|participants|Number|1216|1216.0||||||
4313006|NCT00484315|4139800|B2|TIMI 3||Lesion Characteristic - Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion TIMI 1 - Penetration with minimal perfusion TIMI 2 - Partial perfusion TIMI 3 - Complete perfusion|participants|Number|314|314.0||||||
4313007|NCT00484315|4139801|B1|TIMI 3||Lesion Characteristic - Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion TIMI 1 - Penetration with minimal perfusion TIMI 2 - Partial perfusion TIMI 3 - Complete perfusion|participants|Number|902|902.0||||||
4313008|NCT00484315|4139799|B3|TIMI 2||Lesion Characteristic - Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion TIMI 1 - Penetration with minimal perfusion TIMI 2 - Partial perfusion TIMI 3 - Complete perfusion|participants|Number|38|38.0||||||
4313009|NCT00484315|4139800|B2|TIMI 2||Lesion Characteristic - Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion TIMI 1 - Penetration with minimal perfusion TIMI 2 - Partial perfusion TIMI 3 - Complete perfusion|participants|Number|4|4.0||||||
4313010|NCT00484315|4139801|B1|TIMI 2||Lesion Characteristic - Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion TIMI 1 - Penetration with minimal perfusion TIMI 2 - Partial perfusion TIMI 3 - Complete perfusion|participants|Number|34|34.0||||||
4313011|NCT00484315|4139799|B3|TIMI 1||Lesion Characteristic - Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion TIMI 1 - Penetration with minimal perfusion TIMI 2 - Partial perfusion TIMI 3 - Complete perfusion|participants|Number|4|4.0||||||
4313012|NCT00484315|4139800|B2|TIMI 1||Lesion Characteristic - Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion TIMI 1 - Penetration with minimal perfusion TIMI 2 - Partial perfusion TIMI 3 - Complete perfusion|participants|Number|0|0.0||||||
4313013|NCT00484315|4139801|B1|TIMI 1||Lesion Characteristic - Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion TIMI 1 - Penetration with minimal perfusion TIMI 2 - Partial perfusion TIMI 3 - Complete perfusion|participants|Number|4|4.0||||||
4313014|NCT00484315|4139799|B3|TIMI 0||Lesion Characteristic - Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion TIMI 1 - Penetration with minimal perfusion TIMI 2 - Partial perfusion TIMI 3 - Complete perfusion|participants|Number|4|4.0||||||
4313015|NCT00484315|4139800|B2|TIMI 0||Lesion Characteristic - Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion TIMI 1 - Penetration with minimal perfusion TIMI 2 - Partial perfusion TIMI 3 - Complete perfusion|participants|Number|2|2.0||||||
4313016|NCT00484315|4139801|B1|TIMI 0||Lesion Characteristic - Pre-Procedure Thrombolysis In Myocardial Infarction (TIMI) Flow|TIMI 0 - No perfusion TIMI 1 - Penetration with minimal perfusion TIMI 2 - Partial perfusion TIMI 3 - Complete perfusion|participants|Number|2|2.0||||||
4313017|NCT00484315|4139799|B3|Type C||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A lesions: minimally complex, readily accessible, non angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, and an absense of thrombus.~Type B lesions: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, with presence of thrombus.~Type C lesions: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|participants|Number|323|323.0||||||
4313053|NCT00484315|4139799|B3|Sidebranch Stenosis||Lesion Characteristics||millimeter|Mean|24.7|24.7|Standard Deviation|28.3|28.3|||
4313054|NCT00484315|4139800|B2|Sidebranch Stenosis||Lesion Characteristics||millimeter|Mean|25.7|25.7|Standard Deviation|28.8|28.8|||
4313055|NCT00484315|4139801|B1|Sidebranch Stenosis||Lesion Characteristics||millimeter|Mean|24.4|24.4|Standard Deviation|28.1|28.1|||
4313018|NCT00484315|4139800|B2|Type C||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A lesions: minimally complex, readily accessible, non angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, and an absense of thrombus.~Type B lesions: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, with presence of thrombus.~Type C lesions: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|participants|Number|77|77.0||||||
4313019|NCT00484315|4139801|B1|Type C||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A lesions: minimally complex, readily accessible, non angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, and an absense of thrombus.~Type B lesions: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, with presence of thrombus.~Type C lesions: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|participants|Number|246|246.0||||||
4313020|NCT00484315|4139799|B3|Type B2||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A lesions: minimally complex, readily accessible, non angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, and an absense of thrombus.~Type B lesions: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, with presence of thrombus.~Type C lesions: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|participants|Number|514|514.0||||||
4313021|NCT00484315|4139800|B2|Type B2||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A lesions: minimally complex, readily accessible, non angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, and an absense of thrombus.~Type B lesions: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, with presence of thrombus.~Type C lesions: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|participants|Number|130|130.0||||||
4313022|NCT00484315|4139801|B1|Type B2||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A lesions: minimally complex, readily accessible, non angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, and an absense of thrombus.~Type B lesions: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, with presence of thrombus.~Type C lesions: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|participants|Number|384|384.0||||||
4313023|NCT00484315|4139799|B3|Type B1||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A lesions: minimally complex, readily accessible, non angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, and an absense of thrombus.~Type B lesions: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, with presence of thrombus.~Type C lesions: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|participants|Number|318|318.0||||||
4313024|NCT00484315|4139800|B2|Type B1||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A lesions: minimally complex, readily accessible, non angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, and an absense of thrombus.~Type B lesions: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, with presence of thrombus.~Type C lesions: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|participants|Number|85|85.0||||||
4313025|NCT00484315|4139801|B1|Type B1||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A lesions: minimally complex, readily accessible, non angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, and an absense of thrombus.~Type B lesions: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, with presence of thrombus.~Type C lesions: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|participants|Number|233|233.0||||||
4313026|NCT00484315|4139799|B3|Type A||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A lesions: minimally complex, readily accessible, non angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, and an absense of thrombus.~Type B lesions: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, with presence of thrombus.~Type C lesions: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|participants|Number|107|107.0||||||
4313027|NCT00484315|4139800|B2|Type A||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A lesions: minimally complex, readily accessible, non angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, and an absense of thrombus.~Type B lesions: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, with presence of thrombus.~Type C lesions: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|participants|Number|28|28.0||||||
4313056|NCT00484315|4139799|B3|Lesion Length||Lesion Characteristics||millimeter|Mean|14.2|14.2|Standard Deviation|6.0|6.0|||
4313318|NCT00484159|4139906|B4||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4313028|NCT00484315|4139801|B1|Type A||Lesion Characteristics: American College of Cardiology (ACC)/American Heart Association (AHA) Class|"Type A lesions: minimally complex, readily accessible, non angulated, smooth contour, little to no calcification, less than totally occlusive, not ostial in location, no major side branch involvement, and an absense of thrombus.~Type B lesions: moderately complex, eccentric, moderate tortuosity and angulation, moderate or heavy calcification, total occlusion < 3 months old, ostial in location, with presence of thrombus.~Type C lesions: severely complex, diffuse, excessive tortuosity and angulation, total occlusions > 3 months old, degenerated vein grafts and friable lesions."|participants|Number|79|79.0||||||
4313029|NCT00484315|4139799|B3|Bifurcation||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|472|472.0||||||
4313030|NCT00484315|4139800|B2|Bifurcation||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|129|129.0||||||
4313031|NCT00484315|4139801|B1|Bifurcation||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|343|343.0||||||
4313032|NCT00484315|4139799|B3|Total Occlusion||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|8|8.0||||||
4313033|NCT00484315|4139800|B2|Total Occlusion||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|2|2.0||||||
4313034|NCT00484315|4139801|B1|Total Occlusion||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|6|6.0||||||
4313035|NCT00484315|4139799|B3|Calcification, any||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|314|314.0||||||
4313036|NCT00484315|4139800|B2|Calcification, any||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|86|86.0||||||
4313037|NCT00484315|4139801|B1|Calcification, any||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|228|228.0||||||
4313038|NCT00484315|4139799|B3|Tortuosity, any||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|73|73.0||||||
4313039|NCT00484315|4139800|B2|Tortuosity, any||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|14|14.0||||||
4313040|NCT00484315|4139801|B1|Tortuosity, any||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|59|59.0||||||
4313041|NCT00484315|4139799|B3|> 90 Degree Bend||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|3|3.0||||||
4313042|NCT00484315|4139800|B2|> 90 Degree Bend||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|1|1.0||||||
4313043|NCT00484315|4139801|B1|> 90 Degree Bend||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|2|2.0||||||
4313044|NCT00484315|4139799|B3|> 45 Degree Bend||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|83|83.0||||||
4313045|NCT00484315|4139800|B2|> 45 Degree Bend||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|22|22.0||||||
4313046|NCT00484315|4139801|B1|> 45 Degree Bend||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|61|61.0||||||
4313047|NCT00484315|4139799|B3|Eccentric Lesion||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|648|648.0||||||
4313048|NCT00484315|4139800|B2|Eccentric Lesion||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|161|161.0||||||
4313049|NCT00484315|4139801|B1|Eccentric Lesion||Lesion Characteristics|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|487|487.0||||||
4313050|NCT00484315|4139799|B3|||Lesion Characteristic: Percent Diameter Stenosis||percent|Mean|72.0|72.0|Standard Deviation|10.9|10.9|||
4313051|NCT00484315|4139800|B2|||Lesion Characteristic: Percent Diameter Stenosis||percent|Mean|71.7|71.7|Standard Deviation|10.9|10.9|||
4313052|NCT00484315|4139801|B1|||Lesion Characteristic: Percent Diameter Stenosis||percent|Mean|72.1|72.1|Standard Deviation|10.9|10.9|||
4313057|NCT00484315|4139800|B2|Lesion Length||Lesion Characteristics||millimeter|Mean|14.1|14.1|Standard Deviation|5.8|5.8|||
4313058|NCT00484315|4139801|B1|Lesion Length||Lesion Characteristics||millimeter|Mean|14.2|14.2|Standard Deviation|6.1|6.1|||
4313059|NCT00484315|4139799|B3|Minimum Lumen Diameter||Lesion Characteristics||millimeter|Mean|0.8|0.8|Standard Deviation|0.3|0.3|||
4313060|NCT00484315|4139800|B2|Minimum Lumen Diameter||Lesion Characteristics||millimeter|Mean|0.8|0.8|Standard Deviation|0.4|0.4|||
4313061|NCT00484315|4139801|B1|Minimum Lumen Diameter||Lesion Characteristics||millimeter|Mean|0.8|0.8|Standard Deviation|0.3|0.3|||
4313062|NCT00484315|4139799|B3|Reference Vessel Diameter||Lesion Characteristics||millimeter|Mean|2.8|2.8|Standard Deviation|0.5|0.5|||
4313063|NCT00484315|4139800|B2|Reference Vessel Diameter||Lesion Characteristics||millimeter|Mean|2.8|2.8|Standard Deviation|0.5|0.5|||
4313064|NCT00484315|4139801|B1|Reference Vessel Diameter||Lesion Characteristics||millimeter|Mean|2.8|2.8|Standard Deviation|0.5|0.5|||
4313065|NCT00484315|4139799|B3|Distal||Lesion Characteristic: Lesion Location||participants|Number|94|94.0||||||
4313066|NCT00484315|4139800|B2|Distal||Lesion Characteristic: Lesion Location||participants|Number|30|30.0||||||
4313067|NCT00484315|4139801|B1|Distal||Lesion Characteristic: Lesion Location||participants|Number|64|64.0||||||
4313068|NCT00484315|4139799|B3|Mid||Lesion Characteristic: Lesion Location||participants|Number|639|639.0||||||
4313069|NCT00484315|4139800|B2|Mid||Lesion Characteristic: Lesion Location||participants|Number|154|154.0||||||
4313070|NCT00484315|4139801|B1|Mid||Lesion Characteristic: Lesion Location||participants|Number|485|485.0||||||
4313071|NCT00484315|4139799|B3|Proximal||Lesion Characteristic: Lesion Location||participants|Number|496|496.0||||||
4313072|NCT00484315|4139800|B2|Proximal||Lesion Characteristic: Lesion Location||participants|Number|128|128.0||||||
4313073|NCT00484315|4139801|B1|Proximal||Lesion Characteristic: Lesion Location||participants|Number|368|368.0||||||
4313074|NCT00484315|4139799|B3|Ostial||Lesion Characteristic: Lesion Location||participants|Number|33|33.0||||||
4313075|NCT00484315|4139800|B2|Ostial||Lesion Characteristic: Lesion Location||participants|Number|8|8.0||||||
4313076|NCT00484315|4139801|B1|Ostial||Lesion Characteristic: Lesion Location||participants|Number|25|25.0||||||
4313077|NCT00484315|4139799|B3|Right Coronary Artery||Lesion Characteristic: Target Lesion Vessel||participants|Number|430|430.0||||||
4313078|NCT00484315|4139800|B2|Right Coronary Artery||Lesion Characteristic: Target Lesion Vessel||participants|Number|111|111.0||||||
4313079|NCT00484315|4139801|B1|Right Coronary Artery||Lesion Characteristic: Target Lesion Vessel||participants|Number|319|319.0||||||
4313080|NCT00484315|4139799|B3|Left Circumflex Artery||Lesion Characteristic: Target Lesion Vessel||participants|Number|286|286.0||||||
4313081|NCT00484315|4139800|B2|Left Circumflex Artery||Lesion Characteristic: Target Lesion Vessel||participants|Number|69|69.0||||||
4313082|NCT00484315|4139801|B1|Left Circumflex Artery||Lesion Characteristic: Target Lesion Vessel||participants|Number|217|217.0||||||
4313083|NCT00484315|4139799|B3|Left Anterior Descending Artery||Lesion Characteristic: Target Lesion Vessel||participants|Number|546|546.0||||||
4313084|NCT00484315|4139800|B2|Left Anterior Descending Artery||Lesion Characteristic: Target Lesion Vessel||participants|Number|140|140.0||||||
4313085|NCT00484315|4139801|B1|Left Anterior Descending Artery||Lesion Characteristic: Target Lesion Vessel||participants|Number|406|406.0||||||
4313086|NCT00484315|4139799|B3|History of Gastrointestinal Bleeding||Comorbidities|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|16|16.0||||||
4313087|NCT00484315|4139800|B2|History of Gastrointestinal Bleeding||Comorbidities|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|7|7.0||||||
4313088|NCT00484315|4139801|B1|History of Gastrointestinal Bleeding||Comorbidities|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|9|9.0||||||
4313089|NCT00484315|4139799|B3|History of Renal Disease||Comorbidities|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|56|56.0||||||
4313090|NCT00484315|4139800|B2|History of Renal Disease||Comorbidities|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|11|11.0||||||
4313091|NCT00484315|4139801|B1|History of Renal Disease||Comorbidities|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|45|45.0||||||
4313092|NCT00484315|4139799|B3|History of Cerebrovascular Accident||Comorbidities|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|42|42.0||||||
4313093|NCT00484315|4139800|B2|History of Cerebrovascular Accident||Comorbidities|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|12|12.0||||||
4313094|NCT00484315|4139801|B1|History of Cerebrovascular Accident||Comorbidities|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|30|30.0||||||
4313095|NCT00484315|4139799|B3|History of Transient Ischemic Attack||Comorbidities|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|44|44.0||||||
4313181|NCT00484315|4139801|B1|||Age||years|Mean|62.2|62.2|Standard Deviation|9.6|9.6|||
4313182|NCT00484315|4139799|B3||>=65 years|Age||Participants|Count of Participants|559|559.0||||||
4313096|NCT00484315|4139800|B2|History of Transient Ischemic Attack||Comorbidities|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|14|14.0||||||
4313097|NCT00484315|4139801|B1|History of Transient Ischemic Attack||Comorbidities|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|30|30.0||||||
4313098|NCT00484315|4139799|B3|History of Peripheral Vascular Disease||Comorbidities|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|135|135.0||||||
4313099|NCT00484315|4139800|B2|History of Peripheral Vascular Disease||Comorbidities|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|36|36.0||||||
4313100|NCT00484315|4139801|B1|History of Peripheral Vascular Disease||Comorbidities|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|99|99.0||||||
4313101|NCT00484315|4139799|B3|Family History of Coronary Artery Disease||Cardiac Risk Factors|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|785|785.0||||||
4313102|NCT00484315|4139800|B2|Family History of Coronary Artery Disease||Cardiac Risk Factors|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|196|196.0||||||
4313103|NCT00484315|4139801|B1|Family History of Coronary Artery Disease||Cardiac Risk Factors|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|589|589.0||||||
4313104|NCT00484315|4139799|B3|Hypertension Requiring Medication||Cardiac Risk Factors|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|965|965.0||||||
4313105|NCT00484315|4139800|B2|Hypertension Requiring Medication||Cardiac Risk Factors|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|256|256.0||||||
4313106|NCT00484315|4139801|B1|Hypertension Requiring Medication||Cardiac Risk Factors|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|709|709.0||||||
4313107|NCT00484315|4139799|B3|Hyperlipidemia Requiring Medication||Cardiac Risk Factors|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|960|960.0||||||
4313108|NCT00484315|4139800|B2|Hyperlipidemia Requiring Medication||Cardiac Risk Factors|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|243|243.0||||||
4313109|NCT00484315|4139801|B1|Hyperlipidemia Requiring Medication||Cardiac Risk Factors|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|717|717.0||||||
4313110|NCT00484315|4139799|B3|Medically Treated Diabetes||Cardiac Risk Factors|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|312|312.0||||||
4313111|NCT00484315|4139800|B2|Medically Treated Diabetes||Cardiac Risk Factors|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|80|80.0||||||
4313112|NCT00484315|4139801|B1|Medically Treated Diabetes||Cardiac Risk Factors|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|232|232.0||||||
4313113|NCT00484315|4139799|B3|Smoking, Ever||Cardiac Risk Factors|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|827|827.0||||||
4313114|NCT00484315|4139800|B2|Smoking, Ever||Cardiac Risk Factors|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|216|216.0||||||
4313115|NCT00484315|4139801|B1|Smoking, Ever||Cardiac Risk Factors|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|611|611.0||||||
4313116|NCT00484315|4139799|B3|||Cardiac History: Ejection Fraction||ejection fraction percent|Mean|57.9|57.9|Standard Deviation|9.4|9.4|||
4313117|NCT00484315|4139800|B2|||Cardiac History: Ejection Fraction||ejection fraction percent|Mean|57.8|57.8|Standard Deviation|9.8|9.8|||
4313118|NCT00484315|4139801|B1|||Cardiac History: Ejection Fraction||ejection fraction percent|Mean|58.0|58.0|Standard Deviation|9.3|9.3|||
4313119|NCT00484315|4139799|B3|Silent Ischemia||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|156|156.0||||||
4313120|NCT00484315|4139800|B2|Silent Ischemia||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|39|39.0||||||
4313183|NCT00484315|4139800|B2||>=65 years|Age||Participants|Count of Participants|157|157.0||||||
4313121|NCT00484315|4139801|B1|Silent Ischemia||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|117|117.0||||||
4313122|NCT00484315|4139799|B3|Unstable Angina||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|263|263.0||||||
4313123|NCT00484315|4139800|B2|Unstable Angina||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|68|68.0||||||
4313124|NCT00484315|4139801|B1|Unstable Angina||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|195|195.0||||||
4313125|NCT00484315|4139799|B3|Stable Angina||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|842|842.0||||||
4313126|NCT00484315|4139800|B2|Stable Angina||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|213|213.0||||||
4313127|NCT00484315|4139801|B1|Stable Angina||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|629|629.0||||||
4313128|NCT00484315|4139799|B3|Congestive Heart Failure||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|80|80.0||||||
4313129|NCT00484315|4139800|B2|Congestive Heart Failure||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|24|24.0||||||
4313130|NCT00484315|4139801|B1|Congestive Heart Failure||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|56|56.0||||||
4313131|NCT00484315|4139799|B3|Previous Myocardial Infarction (MI)||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|255|255.0||||||
4313132|NCT00484315|4139800|B2|Previous Myocardial Infarction (MI)||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|60|60.0||||||
4313133|NCT00484315|4139801|B1|Previous Myocardial Infarction (MI)||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|195|195.0||||||
4313134|NCT00484315|4139799|B3|Previous Coronary Artery Bypass Graft (CABG)||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|62|62.0||||||
4313135|NCT00484315|4139800|B2|Previous Coronary Artery Bypass Graft (CABG)||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|20|20.0||||||
4313136|NCT00484315|4139801|B1|Previous Coronary Artery Bypass Graft (CABG)||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|42|42.0||||||
4313137|NCT00484315|4139799|B3|Previous Percutaneous Coronary Intervention (PCI)||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|296|296.0||||||
4313138|NCT00484315|4139800|B2|Previous Percutaneous Coronary Intervention (PCI)||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|80|80.0||||||
4313139|NCT00484315|4139801|B1|Previous Percutaneous Coronary Intervention (PCI)||Cardiac History|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|216|216.0||||||
4313140|NCT00484315|4139799|B3|New Zealand||Region of Enrollment||participants|Number|23|23.0||||||
4313141|NCT00484315|4139800|B2|New Zealand||Region of Enrollment||participants|Number|6|6.0||||||
4313142|NCT00484315|4139801|B1|New Zealand||Region of Enrollment||participants|Number|17|17.0||||||
4313143|NCT00484315|4139799|B3|Australia||Region of Enrollment||participants|Number|82|82.0||||||
4313144|NCT00484315|4139800|B2|Australia||Region of Enrollment||participants|Number|22|22.0||||||
4313145|NCT00484315|4139801|B1|Australia||Region of Enrollment||participants|Number|60|60.0||||||
4313146|NCT00484315|4139799|B3|Singapore||Region of Enrollment||participants|Number|8|8.0||||||
4313147|NCT00484315|4139800|B2|Singapore||Region of Enrollment||participants|Number|2|2.0||||||
4313148|NCT00484315|4139801|B1|Singapore||Region of Enrollment||participants|Number|6|6.0||||||
4313149|NCT00484315|4139799|B3|United States||Region of Enrollment||participants|Number|1149|1149.0||||||
4313150|NCT00484315|4139800|B2|United States||Region of Enrollment||participants|Number|290|290.0||||||
4313151|NCT00484315|4139801|B1|United States||Region of Enrollment||participants|Number|859|859.0||||||
4313184|NCT00484315|4139801|B1||>=65 years|Age||Participants|Count of Participants|402|402.0||||||
4313185|NCT00484315|4139799|B3||Between 18 and 65 years|Age||Participants|Count of Participants|703|703.0||||||
4313152|NCT00484315|4139799|B3|Other||Race/Ethnicity, Customized|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|4|4.0||||||
4313153|NCT00484315|4139800|B2|Other||Race/Ethnicity, Customized|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|0|0.0||||||
4313154|NCT00484315|4139801|B1|Other||Race/Ethnicity, Customized|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|4|4.0||||||
4313155|NCT00484315|4139799|B3|American Indian or Alaska native||Race/Ethnicity, Customized|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|3|3.0||||||
4313156|NCT00484315|4139800|B2|American Indian or Alaska native||Race/Ethnicity, Customized|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|0|0.0||||||
4313157|NCT00484315|4139801|B1|American Indian or Alaska native||Race/Ethnicity, Customized|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|3|3.0||||||
4313158|NCT00484315|4139799|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|5|5.0||||||
4313159|NCT00484315|4139800|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|1|1.0||||||
4313160|NCT00484315|4139801|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|4|4.0||||||
4313161|NCT00484315|4139799|B3|Black of African heritage||Race/Ethnicity, Customized|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|50|50.0||||||
4313162|NCT00484315|4139800|B2|Black of African heritage||Race/Ethnicity, Customized|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|13|13.0||||||
4313163|NCT00484315|4139801|B1|Black of African heritage||Race/Ethnicity, Customized|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|37|37.0||||||
4313164|NCT00484315|4139799|B3|Asian||Race/Ethnicity, Customized|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|21|21.0||||||
4313165|NCT00484315|4139800|B2|Asian||Race/Ethnicity, Customized|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|6|6.0||||||
4313166|NCT00484315|4139801|B1|Asian||Race/Ethnicity, Customized|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|15|15.0||||||
4313167|NCT00484315|4139799|B3|Caucasian||Race/Ethnicity, Customized|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|1168|1168.0||||||
4313168|NCT00484315|4139800|B2|Caucasian||Race/Ethnicity, Customized|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|296|296.0||||||
4313169|NCT00484315|4139801|B1|Caucasian||Race/Ethnicity, Customized|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|872|872.0||||||
4313170|NCT00484315|4139799|B3|Hispanic or Latino||Race/Ethnicity, Customized|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|16|16.0||||||
4313171|NCT00484315|4139800|B2|Hispanic or Latino||Race/Ethnicity, Customized|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|6|6.0||||||
4313172|NCT00484315|4139801|B1|Hispanic or Latino||Race/Ethnicity, Customized|The same participant may be included in more than one category, therefore the number of participants for this baseline measure does not equal the total number of participants in the group.|participants|Number|10|10.0||||||
4313173|NCT00484315|4139799|B3||Male|Sex: Female, Male||Participants|Count of Participants|887|887.0||||||
4313174|NCT00484315|4139800|B2||Male|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
4313175|NCT00484315|4139801|B1||Male|Sex: Female, Male||Participants|Count of Participants|667|667.0||||||
4313176|NCT00484315|4139799|B3||Female|Sex: Female, Male||Participants|Count of Participants|375|375.0||||||
4313177|NCT00484315|4139800|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4313178|NCT00484315|4139801|B1||Female|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4313179|NCT00484315|4139799|B3|||Age||years|Mean|62.5|62.5|Standard Deviation|9.6|9.6|||
4313180|NCT00484315|4139800|B2|||Age||years|Mean|63.5|63.5|Standard Deviation|9.5|9.5|||
4313186|NCT00484315|4139800|B2||Between 18 and 65 years|Age||Participants|Count of Participants|163|163.0||||||
4313187|NCT00484315|4139801|B1||Between 18 and 65 years|Age||Participants|Count of Participants|540|540.0||||||
4313188|NCT00484315|4139799|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4313189|NCT00484315|4139800|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4313190|NCT00484315|4139801|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4313191|NCT00484289|4139810|B4|||Oral Corticosteroids Usage at Registration|Dosage of oral corticosteroids was calculated using prednisolone volume. n=13, 146, and 23 for participants from phase I study, phase II study, and new participants with MTX, respectively.|mg/day|Mean|5.85|5.85|Standard Deviation|2.41|2.41|||
4313192|NCT00484289|4139811|B3|||Oral Corticosteroids Usage at Registration|Dosage of oral corticosteroids was calculated using prednisolone volume. n=13, 146, and 23 for participants from phase I study, phase II study, and new participants with MTX, respectively.|mg/day|Mean|6.78|6.78|Standard Deviation|2.48|2.48|||
4313193|NCT00484289|4139812|B2|||Oral Corticosteroids Usage at Registration|Dosage of oral corticosteroids was calculated using prednisolone volume. n=13, 146, and 23 for participants from phase I study, phase II study, and new participants with MTX, respectively.|mg/day|Mean|5.67|5.67|Standard Deviation|2.38|2.38|||
4313194|NCT00484289|4139813|B1|||Oral Corticosteroids Usage at Registration|Dosage of oral corticosteroids was calculated using prednisolone volume. n=13, 146, and 23 for participants from phase I study, phase II study, and new participants with MTX, respectively.|mg/day|Mean|6.15|6.15|Standard Deviation|2.37|2.37|||
4313195|NCT00484289|4139810|B4|||Methotrexate Usage at Registration|n=9, 175, and 0 for participants from phase I study,phase II study, and new participants with MTX, respectively.|mg/week|Mean|7.11|7.11|Standard Deviation|1.09|1.09|||
4313196|NCT00484289|4139811|B3|||Methotrexate Usage at Registration|n=9, 175, and 0 for participants from phase I study,phase II study, and new participants with MTX, respectively.|mg/week|Mean|NA||Standard Deviation|NA||||This arm had only participants to whom MTX could not be administered for safety reasons
4313197|NCT00484289|4139812|B2|||Methotrexate Usage at Registration|n=9, 175, and 0 for participants from phase I study,phase II study, and new participants with MTX, respectively.|mg/week|Mean|7.11|7.11|Standard Deviation|1.07|1.07|||
4313198|NCT00484289|4139813|B1|||Methotrexate Usage at Registration|n=9, 175, and 0 for participants from phase I study,phase II study, and new participants with MTX, respectively.|mg/week|Mean|7.11|7.11|Standard Deviation|1.45|1.45|||
4313199|NCT00484289|4139810|B4|Positive (>20 IU/mL)||Rheumatoid Factor Status|Rheumatoid factor (RF or RhF) is an autoantibody (antibody directed against an organism's own tissues) most relevant in rheumatoid arthritis. It is an antibody against the Fc portion of Immunoglobulin (Ig)G, which in itself is an antibody. RF and IgG join to form immune complexes which contribute to the disease process. RF levels are considered positive if value is >20 IU/mL and considered negative if value is <20.|participants|Number|188|188.0||||||
4313200|NCT00484289|4139811|B3|Positive (>20 IU/mL)||Rheumatoid Factor Status|Rheumatoid factor (RF or RhF) is an autoantibody (antibody directed against an organism's own tissues) most relevant in rheumatoid arthritis. It is an antibody against the Fc portion of Immunoglobulin (Ig)G, which in itself is an antibody. RF and IgG join to form immune complexes which contribute to the disease process. RF levels are considered positive if value is >20 IU/mL and considered negative if value is <20.|participants|Number|22|22.0||||||
4313201|NCT00484289|4139812|B2|Positive (>20 IU/mL)||Rheumatoid Factor Status|Rheumatoid factor (RF or RhF) is an autoantibody (antibody directed against an organism's own tissues) most relevant in rheumatoid arthritis. It is an antibody against the Fc portion of Immunoglobulin (Ig)G, which in itself is an antibody. RF and IgG join to form immune complexes which contribute to the disease process. RF levels are considered positive if value is >20 IU/mL and considered negative if value is <20.|participants|Number|154|154.0||||||
4313202|NCT00484289|4139813|B1|Positive (>20 IU/mL)||Rheumatoid Factor Status|Rheumatoid factor (RF or RhF) is an autoantibody (antibody directed against an organism's own tissues) most relevant in rheumatoid arthritis. It is an antibody against the Fc portion of Immunoglobulin (Ig)G, which in itself is an antibody. RF and IgG join to form immune complexes which contribute to the disease process. RF levels are considered positive if value is >20 IU/mL and considered negative if value is <20.|participants|Number|12|12.0||||||
4313203|NCT00484289|4139810|B4|Negative (<=20 IU/mL)||Rheumatoid Factor Status|Rheumatoid factor (RF or RhF) is an autoantibody (antibody directed against an organism's own tissues) most relevant in rheumatoid arthritis. It is an antibody against the Fc portion of Immunoglobulin (Ig)G, which in itself is an antibody. RF and IgG join to form immune complexes which contribute to the disease process. RF levels are considered positive if value is >20 IU/mL and considered negative if value is <20.|participants|Number|29|29.0||||||
4313204|NCT00484289|4139811|B3|Negative (<=20 IU/mL)||Rheumatoid Factor Status|Rheumatoid factor (RF or RhF) is an autoantibody (antibody directed against an organism's own tissues) most relevant in rheumatoid arthritis. It is an antibody against the Fc portion of Immunoglobulin (Ig)G, which in itself is an antibody. RF and IgG join to form immune complexes which contribute to the disease process. RF levels are considered positive if value is >20 IU/mL and considered negative if value is <20.|participants|Number|4|4.0||||||
4313205|NCT00484289|4139812|B2|Negative (<=20 IU/mL)||Rheumatoid Factor Status|Rheumatoid factor (RF or RhF) is an autoantibody (antibody directed against an organism's own tissues) most relevant in rheumatoid arthritis. It is an antibody against the Fc portion of Immunoglobulin (Ig)G, which in itself is an antibody. RF and IgG join to form immune complexes which contribute to the disease process. RF levels are considered positive if value is >20 IU/mL and considered negative if value is <20.|participants|Number|24|24.0||||||
4313206|NCT00484289|4139813|B1|Negative (<=20 IU/mL)||Rheumatoid Factor Status|Rheumatoid factor (RF or RhF) is an autoantibody (antibody directed against an organism's own tissues) most relevant in rheumatoid arthritis. It is an antibody against the Fc portion of Immunoglobulin (Ig)G, which in itself is an antibody. RF and IgG join to form immune complexes which contribute to the disease process. RF levels are considered positive if value is >20 IU/mL and considered negative if value is <20.|participants|Number|1|1.0||||||
4313207|NCT00484289|4139810|B4|||Morning stiffness||minutes|Mean|86.7|86.7|Standard Deviation|143.0|143.0|||
4313208|NCT00484289|4139811|B3|||Morning stiffness||minutes|Mean|166.6|166.6|Standard Deviation|195.7|195.7|||
4313209|NCT00484289|4139812|B2|||Morning stiffness||minutes|Mean|72.7|72.7|Standard Deviation|124.9|124.9|||
4313210|NCT00484289|4139813|B1|||Morning stiffness||minutes|Mean|117.7|117.7|Standard Deviation|201.3|201.3|||
4313211|NCT00484289|4139810|B4|||C-Reactive Protein (CRP) Level|CRP is a acute phase reactant protein that is a clinical marker for Rheumatoid Arthritis (RA). Levels of CRP can be used to determine DAS 28.|mg/dL|Mean|2.57|2.57|Standard Deviation|2.55|2.55|||
4313212|NCT00484289|4139811|B3|||C-Reactive Protein (CRP) Level|CRP is a acute phase reactant protein that is a clinical marker for Rheumatoid Arthritis (RA). Levels of CRP can be used to determine DAS 28.|mg/dL|Mean|4.67|4.67|Standard Deviation|3.65|3.65|||
4313213|NCT00484289|4139812|B2|||C-Reactive Protein (CRP) Level|CRP is a acute phase reactant protein that is a clinical marker for Rheumatoid Arthritis (RA). Levels of CRP can be used to determine DAS 28.|mg/dL|Mean|2.32|2.32|Standard Deviation|2.18|2.18|||
4313214|NCT00484289|4139813|B1|||C-Reactive Protein (CRP) Level|CRP is a acute phase reactant protein that is a clinical marker for Rheumatoid Arthritis (RA). Levels of CRP can be used to determine DAS 28.|mg/dL|Mean|1.84|1.84|Standard Deviation|2.84|2.84|||
4313215|NCT00484289|4139810|B4|||Participant Global Assessment|"Participants used a horizontal visual analog scale (VAS) of 100 mm for overall assessment of rheumatoid arthritis. Scale ranged from 0 (very well) to 100 (very poor). Participants were instructed to draw a vertical through a horizontal line to indicate state of rheumatoid arthritis. Distance from the very well end of the horizontal line to the vertical line drawn by the participant was the global disease assessment score on a scale of 1-10, where 1=controlled or equivocal rheumatoid arthritis activity, 1.1-4=mild activity, 4.1-8=moderate activity, and 8.1-10=high activity."|units on a scale|Mean|53.7|53.7|Standard Deviation|24.8|24.8|||
4313216|NCT00484289|4139811|B3|||Participant Global Assessment|"Participants used a horizontal visual analog scale (VAS) of 100 mm for overall assessment of rheumatoid arthritis. Scale ranged from 0 (very well) to 100 (very poor). Participants were instructed to draw a vertical through a horizontal line to indicate state of rheumatoid arthritis. Distance from the very well end of the horizontal line to the vertical line drawn by the participant was the global disease assessment score on a scale of 1-10, where 1=controlled or equivocal rheumatoid arthritis activity, 1.1-4=mild activity, 4.1-8=moderate activity, and 8.1-10=high activity."|units on a scale|Mean|77.3|77.3|Standard Deviation|20.4|20.4|||
4313217|NCT00484289|4139812|B2|||Participant Global Assessment|"Participants used a horizontal visual analog scale (VAS) of 100 mm for overall assessment of rheumatoid arthritis. Scale ranged from 0 (very well) to 100 (very poor). Participants were instructed to draw a vertical through a horizontal line to indicate state of rheumatoid arthritis. Distance from the very well end of the horizontal line to the vertical line drawn by the participant was the global disease assessment score on a scale of 1-10, where 1=controlled or equivocal rheumatoid arthritis activity, 1.1-4=mild activity, 4.1-8=moderate activity, and 8.1-10=high activity."|units on a scale|Mean|50.8|50.8|Standard Deviation|23.8|23.8|||
4313218|NCT00484289|4139813|B1|||Participant Global Assessment|"Participants used a horizontal visual analog scale (VAS) of 100 mm for overall assessment of rheumatoid arthritis. Scale ranged from 0 (very well) to 100 (very poor). Participants were instructed to draw a vertical through a horizontal line to indicate state of rheumatoid arthritis. Distance from the very well end of the horizontal line to the vertical line drawn by the participant was the global disease assessment score on a scale of 1-10, where 1=controlled or equivocal rheumatoid arthritis activity, 1.1-4=mild activity, 4.1-8=moderate activity, and 8.1-10=high activity."|units on a scale|Mean|47.1|47.1|Standard Deviation|20.7|20.7|||
4313219|NCT00484289|4139810|B4|||Physician Global Assessment|Physician Global Assessment of the participant’s disease activity using a visual analog scale (VAS) of 0 - 100 mm with 100 mm being the worst case), a component of the ACR criteria.|Units on a scale|Mean|51.4|51.4|Standard Deviation|24.9|24.9|||
4313220|NCT00484289|4139811|B3|||Physician Global Assessment|Physician Global Assessment of the participant’s disease activity using a visual analog scale (VAS) of 0 - 100 mm with 100 mm being the worst case), a component of the ACR criteria.|Units on a scale|Mean|75.5|75.5|Standard Deviation|16.5|16.5|||
4313221|NCT00484289|4139812|B2|||Physician Global Assessment|Physician Global Assessment of the participant’s disease activity using a visual analog scale (VAS) of 0 - 100 mm with 100 mm being the worst case), a component of the ACR criteria.|Units on a scale|Mean|47.5|47.5|Standard Deviation|24.0|24.0|||
4313222|NCT00484289|4139813|B1|||Physician Global Assessment|Physician Global Assessment of the participant’s disease activity using a visual analog scale (VAS) of 0 - 100 mm with 100 mm being the worst case), a component of the ACR criteria.|Units on a scale|Mean|56.5|56.5|Standard Deviation|24.7|24.7|||
4313223|NCT00484289|4139810|B4|||Physical Function (Health Assessment Questionnaire [HAQ])|The disability section of the full HAQ includes 20 questions to assess physical functions in 8 domains: dressing, arising, eating, walking, hygiene, reach, grip and common activities. The questions are evaluated on a 4-point scale: 0=without any difficulty, 1= with some difficulty, 2= with much difficulty, and 3= unable to do. Higher scores= greater dysfunction. A disability index was calculated by summing the worst scores in each domain and dividing by the number of domains answered. Clinically meaningful HAQ response=an improvement of at least 0.3 units from baseline in HAQ disability Index.|units on a scale|Mean|1.22|1.22|Standard Deviation|0.79|0.79|||
4313224|NCT00484289|4139811|B3|||Physical Function (Health Assessment Questionnaire [HAQ])|The disability section of the full HAQ includes 20 questions to assess physical functions in 8 domains: dressing, arising, eating, walking, hygiene, reach, grip and common activities. The questions are evaluated on a 4-point scale: 0=without any difficulty, 1= with some difficulty, 2= with much difficulty, and 3= unable to do. Higher scores= greater dysfunction. A disability index was calculated by summing the worst scores in each domain and dividing by the number of domains answered. Clinically meaningful HAQ response=an improvement of at least 0.3 units from baseline in HAQ disability Index.|units on a scale|Mean|1.80|1.8|Standard Deviation|0.90|0.9|||
4313225|NCT00484289|4139812|B2|||Physical Function (Health Assessment Questionnaire [HAQ])|The disability section of the full HAQ includes 20 questions to assess physical functions in 8 domains: dressing, arising, eating, walking, hygiene, reach, grip and common activities. The questions are evaluated on a 4-point scale: 0=without any difficulty, 1= with some difficulty, 2= with much difficulty, and 3= unable to do. Higher scores= greater dysfunction. A disability index was calculated by summing the worst scores in each domain and dividing by the number of domains answered. Clinically meaningful HAQ response=an improvement of at least 0.3 units from baseline in HAQ disability Index.|units on a scale|Mean|1.16|1.16|Standard Deviation|0.75|0.75|||
4313226|NCT00484289|4139813|B1|||Physical Function (Health Assessment Questionnaire [HAQ])|The disability section of the full HAQ includes 20 questions to assess physical functions in 8 domains: dressing, arising, eating, walking, hygiene, reach, grip and common activities. The questions are evaluated on a 4-point scale: 0=without any difficulty, 1= with some difficulty, 2= with much difficulty, and 3= unable to do. Higher scores= greater dysfunction. A disability index was calculated by summing the worst scores in each domain and dividing by the number of domains answered. Clinically meaningful HAQ response=an improvement of at least 0.3 units from baseline in HAQ disability Index.|units on a scale|Mean|0.98|0.98|Standard Deviation|0.57|0.57|||
4313227|NCT00484289|4139810|B4|||Participant Pain Assessment|The participant self-reported pain assessment is a core component of the ACR scoring system where increasing score indicates increasing level of severity as indicated on a 100 mm Visual Analog Scale (VAS) with 0 mm representing “no pain” and 100 mm representing the “most pain possible”.|units on a scale|Mean|55.1|55.1|Standard Deviation|26.0|26.0|||
4313228|NCT00484289|4139811|B3|||Participant Pain Assessment|The participant self-reported pain assessment is a core component of the ACR scoring system where increasing score indicates increasing level of severity as indicated on a 100 mm Visual Analog Scale (VAS) with 0 mm representing “no pain” and 100 mm representing the “most pain possible”.|units on a scale|Mean|80.6|80.6|Standard Deviation|20.1|20.1|||
4313229|NCT00484289|4139812|B2|||Participant Pain Assessment|The participant self-reported pain assessment is a core component of the ACR scoring system where increasing score indicates increasing level of severity as indicated on a 100 mm Visual Analog Scale (VAS) with 0 mm representing “no pain” and 100 mm representing the “most pain possible”.|units on a scale|Mean|52.3|52.3|Standard Deviation|24.9|24.9|||
4313230|NCT00484289|4139813|B1|||Participant Pain Assessment|The participant self-reported pain assessment is a core component of the ACR scoring system where increasing score indicates increasing level of severity as indicated on a 100 mm Visual Analog Scale (VAS) with 0 mm representing “no pain” and 100 mm representing the “most pain possible”.|units on a scale|Mean|43.1|43.1|Standard Deviation|23.5|23.5|||
4313231|NCT00484289|4139810|B4|||Number of Swollen Joints|Swollen joints are an indicator of Rheumatoid Arthritis. The number of swollen joints in a standard 66 joint count was evaluated. The number of swollen joints ranges from 0 swollen joints to 66, where an increased number of swollen joints indicate increasing level of disease severity.|joints|Mean|12.1|12.1|Standard Deviation|8.9|8.9|||
4313232|NCT00484289|4139811|B3|||Number of Swollen Joints|Swollen joints are an indicator of Rheumatoid Arthritis. The number of swollen joints in a standard 66 joint count was evaluated. The number of swollen joints ranges from 0 swollen joints to 66, where an increased number of swollen joints indicate increasing level of disease severity.|joints|Mean|17.2|17.2|Standard Deviation|10.0|10.0|||
4313233|NCT00484289|4139812|B2|||Number of Swollen Joints|Swollen joints are an indicator of Rheumatoid Arthritis. The number of swollen joints in a standard 66 joint count was evaluated. The number of swollen joints ranges from 0 swollen joints to 66, where an increased number of swollen joints indicate increasing level of disease severity.|joints|Mean|11.6|11.6|Standard Deviation|8.7|8.7|||
4313234|NCT00484289|4139813|B1|||Number of Swollen Joints|Swollen joints are an indicator of Rheumatoid Arthritis. The number of swollen joints in a standard 66 joint count was evaluated. The number of swollen joints ranges from 0 swollen joints to 66, where an increased number of swollen joints indicate increasing level of disease severity.|joints|Mean|9.1|9.1|Standard Deviation|4.7|4.7|||
4313235|NCT00484289|4139810|B4|||Number of Tender Joints|Tender joints are an indicator of Rheumatoid Arthritis. The number of tender joints in a standard 68 joint count was evaluated. The number of tender joints ranges from 0 tender joints to 68, where an increased number of tender joints indicates increasing level of disease severity.|joints|Mean|14.9|14.9|Standard Deviation|11.6|11.6|||
4313236|NCT00484289|4139811|B3|||Number of Tender Joints|Tender joints are an indicator of Rheumatoid Arthritis. The number of tender joints in a standard 68 joint count was evaluated. The number of tender joints ranges from 0 tender joints to 68, where an increased number of tender joints indicates increasing level of disease severity.|joints|Mean|22.7|22.7|Standard Deviation|13.3|13.3|||
4313237|NCT00484289|4139812|B2|||Number of Tender Joints|Tender joints are an indicator of Rheumatoid Arthritis. The number of tender joints in a standard 68 joint count was evaluated. The number of tender joints ranges from 0 tender joints to 68, where an increased number of tender joints indicates increasing level of disease severity.|joints|Mean|14.3|14.3|Standard Deviation|11.2|11.2|||
4313238|NCT00484289|4139813|B1|||Number of Tender Joints|Tender joints are an indicator of Rheumatoid Arthritis. The number of tender joints in a standard 68 joint count was evaluated. The number of tender joints ranges from 0 tender joints to 68, where an increased number of tender joints indicates increasing level of disease severity.|joints|Mean|8.4|8.4|Standard Deviation|5.2|5.2|||
4313239|NCT00484289|4139810|B4|Class IV||American College of Rheumatology (ACR) Functional Status Classification|ACR Classification Criteria for Determining Progression of Rheumatoid Arthritis – Class I: Completely able to perform usual activities of daily living; II: Able to perform usual self-care and vocational activities, but limited in avocational activities ; III: Able to perform usual self-care activities, but limited in vocational and avocational activities ; IV: Limited ability to perform usual self-care, vocational, and avocational activities|participants|Number|0|0.0||||||
4313240|NCT00484289|4139811|B3|Class IV||American College of Rheumatology (ACR) Functional Status Classification|ACR Classification Criteria for Determining Progression of Rheumatoid Arthritis – Class I: Completely able to perform usual activities of daily living; II: Able to perform usual self-care and vocational activities, but limited in avocational activities ; III: Able to perform usual self-care activities, but limited in vocational and avocational activities ; IV: Limited ability to perform usual self-care, vocational, and avocational activities|participants|Number|0|0.0||||||
4313241|NCT00484289|4139812|B2|Class IV||American College of Rheumatology (ACR) Functional Status Classification|ACR Classification Criteria for Determining Progression of Rheumatoid Arthritis – Class I: Completely able to perform usual activities of daily living; II: Able to perform usual self-care and vocational activities, but limited in avocational activities ; III: Able to perform usual self-care activities, but limited in vocational and avocational activities ; IV: Limited ability to perform usual self-care, vocational, and avocational activities|participants|Number|0|0.0||||||
4313255|NCT00484289|4139810|B4|> 10 years||Duration of Rheumatoid Arthritis||participants|Number|69|69.0||||||
4313242|NCT00484289|4139813|B1|Class IV||American College of Rheumatology (ACR) Functional Status Classification|ACR Classification Criteria for Determining Progression of Rheumatoid Arthritis – Class I: Completely able to perform usual activities of daily living; II: Able to perform usual self-care and vocational activities, but limited in avocational activities ; III: Able to perform usual self-care activities, but limited in vocational and avocational activities ; IV: Limited ability to perform usual self-care, vocational, and avocational activities|participants|Number|0|0.0||||||
4313243|NCT00484289|4139810|B4|Class III||American College of Rheumatology (ACR) Functional Status Classification|ACR Classification Criteria for Determining Progression of Rheumatoid Arthritis – Class I: Completely able to perform usual activities of daily living; II: Able to perform usual self-care and vocational activities, but limited in avocational activities ; III: Able to perform usual self-care activities, but limited in vocational and avocational activities ; IV: Limited ability to perform usual self-care, vocational, and avocational activities|participants|Number|47|47.0||||||
4313244|NCT00484289|4139811|B3|Class III||American College of Rheumatology (ACR) Functional Status Classification|ACR Classification Criteria for Determining Progression of Rheumatoid Arthritis – Class I: Completely able to perform usual activities of daily living; II: Able to perform usual self-care and vocational activities, but limited in avocational activities ; III: Able to perform usual self-care activities, but limited in vocational and avocational activities ; IV: Limited ability to perform usual self-care, vocational, and avocational activities|participants|Number|9|9.0||||||
4313245|NCT00484289|4139812|B2|Class III||American College of Rheumatology (ACR) Functional Status Classification|ACR Classification Criteria for Determining Progression of Rheumatoid Arthritis – Class I: Completely able to perform usual activities of daily living; II: Able to perform usual self-care and vocational activities, but limited in avocational activities ; III: Able to perform usual self-care activities, but limited in vocational and avocational activities ; IV: Limited ability to perform usual self-care, vocational, and avocational activities|participants|Number|37|37.0||||||
4313246|NCT00484289|4139813|B1|Class III||American College of Rheumatology (ACR) Functional Status Classification|ACR Classification Criteria for Determining Progression of Rheumatoid Arthritis – Class I: Completely able to perform usual activities of daily living; II: Able to perform usual self-care and vocational activities, but limited in avocational activities ; III: Able to perform usual self-care activities, but limited in vocational and avocational activities ; IV: Limited ability to perform usual self-care, vocational, and avocational activities|participants|Number|1|1.0||||||
4313247|NCT00484289|4139810|B4|Class II||American College of Rheumatology (ACR) Functional Status Classification|ACR Classification Criteria for Determining Progression of Rheumatoid Arthritis – Class I: Completely able to perform usual activities of daily living; II: Able to perform usual self-care and vocational activities, but limited in avocational activities ; III: Able to perform usual self-care activities, but limited in vocational and avocational activities ; IV: Limited ability to perform usual self-care, vocational, and avocational activities|participants|Number|141|141.0||||||
4313248|NCT00484289|4139811|B3|Class II||American College of Rheumatology (ACR) Functional Status Classification|ACR Classification Criteria for Determining Progression of Rheumatoid Arthritis – Class I: Completely able to perform usual activities of daily living; II: Able to perform usual self-care and vocational activities, but limited in avocational activities ; III: Able to perform usual self-care activities, but limited in vocational and avocational activities ; IV: Limited ability to perform usual self-care, vocational, and avocational activities|participants|Number|17|17.0||||||
4313249|NCT00484289|4139812|B2|Class II||American College of Rheumatology (ACR) Functional Status Classification|ACR Classification Criteria for Determining Progression of Rheumatoid Arthritis – Class I: Completely able to perform usual activities of daily living; II: Able to perform usual self-care and vocational activities, but limited in avocational activities ; III: Able to perform usual self-care activities, but limited in vocational and avocational activities ; IV: Limited ability to perform usual self-care, vocational, and avocational activities|participants|Number|112|112.0||||||
4313250|NCT00484289|4139813|B1|Class II||American College of Rheumatology (ACR) Functional Status Classification|ACR Classification Criteria for Determining Progression of Rheumatoid Arthritis – Class I: Completely able to perform usual activities of daily living; II: Able to perform usual self-care and vocational activities, but limited in avocational activities ; III: Able to perform usual self-care activities, but limited in vocational and avocational activities ; IV: Limited ability to perform usual self-care, vocational, and avocational activities|participants|Number|12|12.0||||||
4313251|NCT00484289|4139810|B4|Class I||American College of Rheumatology (ACR) Functional Status Classification|ACR Classification Criteria for Determining Progression of Rheumatoid Arthritis – Class I: Completely able to perform usual activities of daily living; II: Able to perform usual self-care and vocational activities, but limited in avocational activities ; III: Able to perform usual self-care activities, but limited in vocational and avocational activities ; IV: Limited ability to perform usual self-care, vocational, and avocational activities|participants|Number|29|29.0||||||
4313252|NCT00484289|4139811|B3|Class I||American College of Rheumatology (ACR) Functional Status Classification|ACR Classification Criteria for Determining Progression of Rheumatoid Arthritis – Class I: Completely able to perform usual activities of daily living; II: Able to perform usual self-care and vocational activities, but limited in avocational activities ; III: Able to perform usual self-care activities, but limited in vocational and avocational activities ; IV: Limited ability to perform usual self-care, vocational, and avocational activities|participants|Number|0|0.0||||||
4313253|NCT00484289|4139812|B2|Class I||American College of Rheumatology (ACR) Functional Status Classification|ACR Classification Criteria for Determining Progression of Rheumatoid Arthritis – Class I: Completely able to perform usual activities of daily living; II: Able to perform usual self-care and vocational activities, but limited in avocational activities ; III: Able to perform usual self-care activities, but limited in vocational and avocational activities ; IV: Limited ability to perform usual self-care, vocational, and avocational activities|participants|Number|29|29.0||||||
4313254|NCT00484289|4139813|B1|Class I||American College of Rheumatology (ACR) Functional Status Classification|ACR Classification Criteria for Determining Progression of Rheumatoid Arthritis – Class I: Completely able to perform usual activities of daily living; II: Able to perform usual self-care and vocational activities, but limited in avocational activities ; III: Able to perform usual self-care activities, but limited in vocational and avocational activities ; IV: Limited ability to perform usual self-care, vocational, and avocational activities|participants|Number|0|0.0||||||
4313256|NCT00484289|4139811|B3|> 10 years||Duration of Rheumatoid Arthritis||participants|Number|8|8.0||||||
4313257|NCT00484289|4139812|B2|> 10 years||Duration of Rheumatoid Arthritis||participants|Number|52|52.0||||||
4313258|NCT00484289|4139813|B1|> 10 years||Duration of Rheumatoid Arthritis||participants|Number|9|9.0||||||
4313259|NCT00484289|4139810|B4|> 5 to <= 10 years||Duration of Rheumatoid Arthritis||participants|Number|71|71.0||||||
4313260|NCT00484289|4139811|B3|> 5 to <= 10 years||Duration of Rheumatoid Arthritis||participants|Number|12|12.0||||||
4313261|NCT00484289|4139812|B2|> 5 to <= 10 years||Duration of Rheumatoid Arthritis||participants|Number|57|57.0||||||
4313262|NCT00484289|4139813|B1|> 5 to <= 10 years||Duration of Rheumatoid Arthritis||participants|Number|2|2.0||||||
4313263|NCT00484289|4139810|B4|>2 to <= 5 years||Duration of Rheumatoid Arthritis||participants|Number|51|51.0||||||
4313264|NCT00484289|4139811|B3|>2 to <= 5 years||Duration of Rheumatoid Arthritis||participants|Number|4|4.0||||||
4313265|NCT00484289|4139812|B2|>2 to <= 5 years||Duration of Rheumatoid Arthritis||participants|Number|45|45.0||||||
4313266|NCT00484289|4139813|B1|>2 to <= 5 years||Duration of Rheumatoid Arthritis||participants|Number|2|2.0||||||
4313267|NCT00484289|4139810|B4|<= 2 years||Duration of Rheumatoid Arthritis||participants|Number|26|26.0||7.9|7.9|||
4313268|NCT00484289|4139811|B3|<= 2 years||Duration of Rheumatoid Arthritis||participants|Number|2|2.0||10.1|10.1|||
4313269|NCT00484289|4139812|B2|<= 2 years||Duration of Rheumatoid Arthritis||participants|Number|24|24.0||7.3|7.3|||
4313270|NCT00484289|4139813|B1|<= 2 years||Duration of Rheumatoid Arthritis||participants|Number|0|0.0||9.0|9.0|||
4313271|NCT00484289|4139810|B4|||Weight||kg|Mean|56.5|56.5|Standard Deviation|9.6|9.6|||
4313272|NCT00484289|4139811|B3|||Weight||kg|Mean|53.9|53.9|Standard Deviation|10.8|10.8|||
4313273|NCT00484289|4139812|B2|||Weight||kg|Mean|56.9|56.9|Standard Deviation|9.4|9.4|||
4313274|NCT00484289|4139813|B1|||Weight||kg|Mean|55.2|55.2|Standard Deviation|9.7|9.7|||
4313275|NCT00484289|4139810|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4313276|NCT00484289|4139811|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4313277|NCT00484289|4139812|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4313278|NCT00484289|4139813|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4313279|NCT00484289|4139810|B4||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4313280|NCT00484289|4139811|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4313281|NCT00484289|4139812|B2||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4313282|NCT00484289|4139813|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4313283|NCT00484289|4139810|B4|≥ 60 years||Age, Customized||participants|Number|66|66.0||||||
4313284|NCT00484289|4139811|B3|≥ 60 years||Age, Customized||participants|Number|13|13.0||||||
4313285|NCT00484289|4139812|B2|≥ 60 years||Age, Customized||participants|Number|49|49.0||||||
4313286|NCT00484289|4139813|B1|≥ 60 years||Age, Customized||participants|Number|4|4.0||||||
4313287|NCT00484289|4139810|B4|50 - 59 years||Age, Customized||participants|Number|83|83.0||||||
4313288|NCT00484289|4139811|B3|50 - 59 years||Age, Customized||participants|Number|7|7.0||||||
4313289|NCT00484289|4139812|B2|50 - 59 years||Age, Customized||participants|Number|70|70.0||||||
4313290|NCT00484289|4139813|B1|50 - 59 years||Age, Customized||participants|Number|6|6.0||||||
4313291|NCT00484289|4139810|B4|40 - 49 years||Age, Customized||participants|Number|44|44.0||||||
4313292|NCT00484289|4139811|B3|40 - 49 years||Age, Customized||participants|Number|5|5.0||||||
4313293|NCT00484289|4139812|B2|40 - 49 years||Age, Customized||participants|Number|39|39.0||||||
4313294|NCT00484289|4139813|B1|40 - 49 years||Age, Customized||participants|Number|0|0.0||||||
4313295|NCT00484289|4139810|B4|30 - 39 years||Age, Customized||participants|Number|16|16.0||||||
4313296|NCT00484289|4139811|B3|30 - 39 years||Age, Customized||participants|Number|1|1.0||||||
4313297|NCT00484289|4139812|B2|30 - 39 years||Age, Customized||participants|Number|13|13.0||||||
4313298|NCT00484289|4139813|B1|30 - 39 years||Age, Customized||participants|Number|2|2.0||||||
4313299|NCT00484289|4139810|B4|20 - 29 years||Age, Customized||participants|Number|8|8.0||||||
4313300|NCT00484289|4139811|B3|20 - 29 years||Age, Customized||participants|Number|0|0.0||||||
4313301|NCT00484289|4139812|B2|20 - 29 years||Age, Customized||participants|Number|7|7.0||||||
4313302|NCT00484289|4139813|B1|20 - 29 years||Age, Customized||participants|Number|1|1.0||||||
4313303|NCT00484289|4139810|B4|||Age||years|Mean|53.8|53.8|Standard Deviation|11.4|11.4|||
4313304|NCT00484289|4139811|B3|||Age||years|Mean|57.8|57.8|Standard Deviation|10.6|10.6|||
4313305|NCT00484289|4139812|B2|||Age||years|Mean|53.2|53.2|Standard Deviation|11.5|11.5|||
4313306|NCT00484289|4139813|B1|||Age||years|Mean|52.8|52.8|Standard Deviation|11.6|11.6|||
4313307|NCT00484185|4139887|B1||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4313308|NCT00484185|4139887|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4313309|NCT00484185|4139887|B1|||Age||years|Mean|25.1|25.1|Standard Deviation|16.1|16.1|||
4313310|NCT00484159|4139906|B4||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4313311|NCT00484159|4139907|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4313312|NCT00484159|4139908|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4313313|NCT00484159|4139909|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4313314|NCT00484159|4139906|B4||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4313315|NCT00484159|4139907|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4313316|NCT00484159|4139908|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4313317|NCT00484159|4139909|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4313319|NCT00484159|4139907|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4313320|NCT00484159|4139908|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4313321|NCT00484159|4139909|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4313322|NCT00484159|4139906|B4||Between 18 and 65 years|Age||Participants|Count of Participants|133|133.0||||||
4313323|NCT00484159|4139907|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4313324|NCT00484159|4139908|B2||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4313325|NCT00484159|4139909|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4313326|NCT00484159|4139906|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4313327|NCT00484159|4139907|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4313328|NCT00484159|4139908|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4313329|NCT00484159|4139909|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4313330|NCT00484094|4139922|B1|Unknown||Type of Donation||Participants|Number|1|1.0||||||
4313331|NCT00484094|4139922|B1|Living||Type of Donation||Participants|Number|132|132.0||||||
4313332|NCT00484094|4139922|B1|Cadaveric||Type of Donation||Participants|Number|76|76.0||||||
4313333|NCT00484094|4139922|B1|Secondary Transplantation||Type of Transplantation|"Primary transplantation: Participants received renal transplantation for the first time.~Secondary transplantation: Participants received renal re-transplantation."|Participants|Number|10|10.0||||||
4313334|NCT00484094|4139922|B1|Primary Transplantation||Type of Transplantation|"Primary transplantation: Participants received renal transplantation for the first time.~Secondary transplantation: Participants received renal re-transplantation."|Participants|Number|199|199.0||||||
4313335|NCT00484094|4139922|B1||Male|Gender||Participants|Count of Participants|128|128.0||||||
4313336|NCT00484094|4139922|B1||Female|Gender||Participants|Count of Participants|81|81.0||||||
4313337|NCT00484094|4139922|B1|||Age||Years|Mean|47.93|47.93|Standard Deviation|13.10|13.1|||
4313338|NCT00483938|4139931|B8||Male|Gender||Participants|Count of Participants|151|151.0||||||
4313339|NCT00483938|4139932|B7||Male|Gender||Participants|Count of Participants|27|27.0||||||
4313340|NCT00483938|4139933|B6||Male|Gender||Participants|Count of Participants|17|17.0||||||
4313341|NCT00483938|4139934|B5||Male|Gender||Participants|Count of Participants|19|19.0||||||
4313342|NCT00483938|4139935|B4||Male|Gender||Participants|Count of Participants|19|19.0||||||
4313343|NCT00483938|4139936|B3||Male|Gender||Participants|Count of Participants|20|20.0||||||
4313344|NCT00483938|4139937|B2||Male|Gender||Participants|Count of Participants|24|24.0||||||
4313345|NCT00483938|4139938|B1||Male|Gender||Participants|Count of Participants|25|25.0||||||
4313346|NCT00483938|4139931|B8||Female|Gender||Participants|Count of Participants|85|85.0||||||
4313347|NCT00483938|4139932|B7||Female|Gender||Participants|Count of Participants|13|13.0||||||
4313348|NCT00483938|4139933|B6||Female|Gender||Participants|Count of Participants|9|9.0||||||
4313349|NCT00483938|4139934|B5||Female|Gender||Participants|Count of Participants|6|6.0||||||
4313350|NCT00483938|4139935|B4||Female|Gender||Participants|Count of Participants|12|12.0||||||
4313351|NCT00483938|4139936|B3||Female|Gender||Participants|Count of Participants|10|10.0||||||
4313352|NCT00483938|4139937|B2||Female|Gender||Participants|Count of Participants|19|19.0||||||
4313353|NCT00483938|4139938|B1||Female|Gender||Participants|Count of Participants|16|16.0||||||
4313354|NCT00483938|4139931|B8|||Age||years|Mean|49.5|49.5|Standard Deviation|9.13|9.13|||
4313355|NCT00483938|4139932|B7|||Age||years|Mean|51.7|51.7|Standard Deviation|7.52|7.52|||
4313356|NCT00483938|4139933|B6|||Age||years|Mean|47.0|47.0|Standard Deviation|9.76|9.76|||
4313357|NCT00483938|4139934|B5|||Age||years|Mean|47.0|47.0|Standard Deviation|10.38|10.38|||
4313358|NCT00483938|4139935|B4|||Age||years|Mean|47.8|47.8|Standard Deviation|9.16|9.16|||
4313359|NCT00483938|4139936|B3|||Age||years|Mean|48.7|48.7|Standard Deviation|11.54|11.54|||
4313360|NCT00483938|4139937|B2|||Age||years|Mean|51.0|51.0|Standard Deviation|7.39|7.39|||
4313361|NCT00483938|4139938|B1|||Age||years|Mean|50.9|50.9|Standard Deviation|8.55|8.55|||
4313362|NCT00483756|4139965|B4||Male|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
4313363|NCT00483756|4139966|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4313364|NCT00483756|4139967|B2||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4313365|NCT00483756|4139968|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4313366|NCT00483756|4139965|B4||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4313367|NCT00483756|4139966|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4313368|NCT00483756|4139967|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4313369|NCT00483756|4139968|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4313370|NCT00483756|4139965|B4|Greater Than or Equal to (>=) 65 Years||Age, Customized||participants|Number|21|21.0||||||
4313371|NCT00483756|4139966|B3|Greater Than or Equal to (>=) 65 Years||Age, Customized||participants|Number|5|5.0||||||
4313372|NCT00483756|4139967|B2|Greater Than or Equal to (>=) 65 Years||Age, Customized||participants|Number|9|9.0||||||
4313373|NCT00483756|4139968|B1|Greater Than or Equal to (>=) 65 Years||Age, Customized||participants|Number|7|7.0||||||
4313374|NCT00483756|4139965|B4|45 to 64 Years||Age, Customized||participants|Number|167|167.0||||||
4313375|NCT00483756|4139966|B3|45 to 64 Years||Age, Customized||participants|Number|56|56.0||||||
4313376|NCT00483756|4139967|B2|45 to 64 Years||Age, Customized||participants|Number|54|54.0||||||
4313377|NCT00483756|4139968|B1|45 to 64 Years||Age, Customized||participants|Number|57|57.0||||||
4313378|NCT00483756|4139965|B4|18 to 44 Years||Age, Customized||participants|Number|134|134.0||||||
4313379|NCT00483756|4139966|B3|18 to 44 Years||Age, Customized||participants|Number|46|46.0||||||
4313380|NCT00483756|4139967|B2|18 to 44 Years||Age, Customized||participants|Number|43|43.0||||||
4313381|NCT00483756|4139968|B1|18 to 44 Years||Age, Customized||participants|Number|45|45.0||||||
4313382|NCT00483717|4140032|B3|Finland||Region of Enrollment||participants|Number|75|75.0||||||
4313383|NCT00483717|4140033|B2|Finland||Region of Enrollment||participants|Number|38|38.0||||||
4313384|NCT00483717|4140034|B1|Finland||Region of Enrollment||participants|Number|37|37.0||||||
4313385|NCT00483717|4140032|B3|Germany||Region of Enrollment||participants|Number|98|98.0||||||
4313386|NCT00483717|4140033|B2|Germany||Region of Enrollment||participants|Number|48|48.0||||||
4313387|NCT00483717|4140034|B1|Germany||Region of Enrollment||participants|Number|50|50.0||||||
4313388|NCT00483717|4140032|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4313389|NCT00483717|4140033|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4313390|NCT00483717|4140034|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4313391|NCT00483717|4140032|B3||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4313392|NCT00483717|4140033|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4313393|NCT00483717|4140034|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4313394|NCT00483717|4140032|B3|||Age||years|Mean|38.3|38.3|Standard Deviation|11.5|11.5|||
4313395|NCT00483717|4140033|B2|||Age||years|Mean|38.5|38.5|Standard Deviation|11.6|11.6|||
4313396|NCT00483717|4140034|B1|||Age||years|Mean|38.2|38.2|Standard Deviation|11.4|11.4|||
4313397|NCT00483717|4140032|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4313398|NCT00483717|4140033|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4313399|NCT00483717|4140034|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4313400|NCT00483717|4140032|B3||Between 18 and 65 years|Age||Participants|Count of Participants|171|171.0||||||
4313401|NCT00483717|4140033|B2||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
4313402|NCT00483717|4140034|B1||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
4313403|NCT00483717|4140032|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4313404|NCT00483717|4140033|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4313405|NCT00483717|4140034|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4313406|NCT00483704|4140055|B4||Male|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
4313407|NCT00483704|4140056|B3||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4313408|NCT00483704|4140057|B2||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4313409|NCT00483704|4140058|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4313410|NCT00483704|4140055|B4||Female|Sex: Female, Male||Participants|Count of Participants|1631|1631.0||||||
4313411|NCT00483704|4140056|B3||Female|Sex: Female, Male||Participants|Count of Participants|540|540.0||||||
4313412|NCT00483704|4140057|B2||Female|Sex: Female, Male||Participants|Count of Participants|549|549.0||||||
4313413|NCT00483704|4140058|B1||Female|Sex: Female, Male||Participants|Count of Participants|542|542.0||||||
4313414|NCT00483704|4140055|B4|||Age||Years|Mean|42.6|42.6|Standard Deviation|11.8|11.8|||
4313415|NCT00483704|4140056|B3|||Age||Years|Mean|41.9|41.9|Standard Deviation|11.7|11.7|||
4313416|NCT00483704|4140057|B2|||Age||Years|Mean|42.6|42.6|Standard Deviation|11.8|11.8|||
4313417|NCT00483704|4140058|B1|||Age||Years|Mean|43.2|43.2|Standard Deviation|11.7|11.7|||
4313418|NCT00483652|4140104|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4313419|NCT00483652|4140105|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4313420|NCT00483652|4140106|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4313421|NCT00483652|4140104|B3||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4313422|NCT00483652|4140105|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4313423|NCT00483652|4140106|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4313424|NCT00483652|4140104|B3|||Age||years|Mean|51.7|51.7|Standard Deviation|9.67|9.67|||
4313425|NCT00483652|4140105|B2|||Age||years|Mean|51.7|51.7|Standard Deviation|9.83|9.83|||
4313426|NCT00483652|4140106|B1|||Age||years|Mean|51.8|51.8|Standard Deviation|9.55|9.55|||
4313427|NCT00483574|4140115|B3|United States||Region of Enrollment||participants|Number|1374|1374.0||||||
4313428|NCT00483574|4140116|B2|United States||Region of Enrollment||participants|Number|321|321.0||||||
4313429|NCT00483574|4140117|B1|United States||Region of Enrollment||participants|Number|1053|1053.0||||||
4313430|NCT00483574|4140115|B3||Male|Sex: Female, Male||Participants|Count of Participants|705|705.0||||||
4313431|NCT00483574|4140116|B2||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4313432|NCT00483574|4140117|B1||Male|Sex: Female, Male||Participants|Count of Participants|542|542.0||||||
4313433|NCT00483574|4140115|B3||Female|Sex: Female, Male||Participants|Count of Participants|669|669.0||||||
4313434|NCT00483574|4140116|B2||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4313435|NCT00483574|4140117|B1||Female|Sex: Female, Male||Participants|Count of Participants|511|511.0||||||
4313436|NCT00483574|4140115|B3|||Age||Days|Mean|304.3|304.3|Standard Deviation|40.22|40.22|||
4313437|NCT00483574|4140116|B2|||Age||Days|Mean|374.6|374.6|Standard Deviation|8.93|8.93|||
4313438|NCT00483574|4140117|B1|||Age||Days|Mean|282.8|282.8|Standard Deviation|10.79|10.79|||
4313439|NCT00483574|4140115|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4313440|NCT00483574|4140116|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4313441|NCT00483574|4140117|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4313442|NCT00483574|4140115|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4313443|NCT00483574|4140116|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4313444|NCT00483574|4140117|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4313445|NCT00483574|4140115|B3||<=18 years|Age||Participants|Count of Participants|1374|1374.0||||||
4313446|NCT00483574|4140116|B2||<=18 years|Age||Participants|Count of Participants|321|321.0||||||
4313447|NCT00483574|4140117|B1||<=18 years|Age||Participants|Count of Participants|1053|1053.0||||||
4313448|NCT00483561|4140126|B1|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
4313449|NCT00483561|4140126|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313450|NCT00483561|4140126|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4313451|NCT00483561|4140126|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313452|NCT00483561|4140126|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4313453|NCT00483561|4140126|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4313454|NCT00483561|4140126|B1|Number of subjects 19 years of age and older||Age, Customized||Participants|Count of Participants|26|26.0||||||
4313455|NCT00483548|4140131|B3||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4313456|NCT00483548|4140132|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4313457|NCT00483548|4140133|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4313458|NCT00483548|4140131|B3||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4313459|NCT00483548|4140132|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4313460|NCT00483548|4140133|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4313461|NCT00483548|4140131|B3|>65 years||Age, Customized||participants|Number|1|1.0||||||
4313462|NCT00483548|4140132|B2|>65 years||Age, Customized||participants|Number|1|1.0||||||
4313463|NCT00483548|4140133|B1|>65 years||Age, Customized||participants|Number|0|0.0||||||
4313464|NCT00483548|4140131|B3|Between 18 and 65 years||Age, Customized||participants|Number|293|293.0||||||
4313465|NCT00483548|4140132|B2|Between 18 and 65 years||Age, Customized||participants|Number|146|146.0||||||
4313466|NCT00483548|4140133|B1|Between 18 and 65 years||Age, Customized||participants|Number|147|147.0||||||
4313467|NCT00483496|4140172|B1|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4313468|NCT00483496|4140172|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4313469|NCT00483496|4140172|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4313470|NCT00483496|4140172|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4313471|NCT00483496|4140172|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4313472|NCT00483496|4140172|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4313473|NCT00483496|4140172|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4313474|NCT00483496|4140172|B1|||Age||years|Mean|50.2|50.2|Full Range|||26.0|82.0|
4313475|NCT00483405|4140184|B1|None||Prior Therapy||Participants|Count of Participants|15|15.0||||||
4313476|NCT00483405|4140184|B1|Yes||Prior Therapy||Participants|Count of Participants|13|13.0||||||
4313477|NCT00483405|4140184|B1|Class C (10-15 points)||Childs-Pugh Classification|Child-Pugh scores five clinical features and is used to assess the prognosis of chronic liver disease and cirrhosis. The lower the points total, the better prognosis.|Participants|Count of Participants|0|0.0||||||
4313478|NCT00483405|4140184|B1|Class B (7-9 points)||Childs-Pugh Classification|Child-Pugh scores five clinical features and is used to assess the prognosis of chronic liver disease and cirrhosis. The lower the points total, the better prognosis.|Participants|Count of Participants|6|6.0||||||
4313479|NCT00483405|4140184|B1|Class A (5-6 points)||Childs-Pugh Classification|Child-Pugh scores five clinical features and is used to assess the prognosis of chronic liver disease and cirrhosis. The lower the points total, the better prognosis.|Participants|Count of Participants|18|18.0||||||
4313480|NCT00483405|4140184|B1|2||The Eastern Cooperative Oncology Group (ECOG) Performance Status|"A scale from 0-5 to describe a patient's level of functioning in terms of self care ability and activity level.~0. Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all self care but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited self care; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any self care; totally confined to bed or chair~Dead"|Participants|Count of Participants|1|1.0||||||
4313481|NCT00483405|4140184|B1|1||The Eastern Cooperative Oncology Group (ECOG) Performance Status|"A scale from 0-5 to describe a patient's level of functioning in terms of self care ability and activity level.~0. Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all self care but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited self care; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any self care; totally confined to bed or chair~Dead"|Participants|Count of Participants|12|12.0||||||
4313482|NCT00483405|4140184|B1|0||The Eastern Cooperative Oncology Group (ECOG) Performance Status|"A scale from 0-5 to describe a patient's level of functioning in terms of self care ability and activity level.~0. Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all self care but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited self care; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any self care; totally confined to bed or chair~Dead"|Participants|Count of Participants|14|14.0||||||
4313483|NCT00483405|4140184|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4313484|NCT00483405|4140184|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313485|NCT00483405|4140184|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4313486|NCT00483405|4140184|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4313487|NCT00483405|4140184|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313488|NCT00483405|4140184|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313489|NCT00483405|4140184|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313490|NCT00483405|4140184|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313491|NCT00483405|4140184|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4313492|NCT00483405|4140184|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4313493|NCT00483405|4140184|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4313494|NCT00483405|4140184|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4313495|NCT00483405|4140184|B1|||Age||years|Median|59|59.0|Full Range|||46.0|79.0|
4313496|NCT00483379|4140191|B3|Unknown||Cross-Reactive Immunologic Material (CRIM) Assay Result||participants|Number|9|9.0||||||
4313497|NCT00483379|4140192|B2|Unknown||Cross-Reactive Immunologic Material (CRIM) Assay Result||participants|Number|4|4.0||||||
4313498|NCT00483379|4140193|B1|Unknown||Cross-Reactive Immunologic Material (CRIM) Assay Result||participants|Number|5|5.0||||||
4313499|NCT00483379|4140191|B3|Negative||Cross-Reactive Immunologic Material (CRIM) Assay Result||participants|Number|1|1.0||||||
4313500|NCT00483379|4140192|B2|Negative||Cross-Reactive Immunologic Material (CRIM) Assay Result||participants|Number|0|0.0||||||
4313501|NCT00483379|4140193|B1|Negative||Cross-Reactive Immunologic Material (CRIM) Assay Result||participants|Number|1|1.0||||||
4313502|NCT00483379|4140191|B3|Positive||Cross-Reactive Immunologic Material (CRIM) Assay Result||participants|Number|3|3.0||||||
4313503|NCT00483379|4140192|B2|Positive||Cross-Reactive Immunologic Material (CRIM) Assay Result||participants|Number|3|3.0||||||
4313504|NCT00483379|4140193|B1|Positive||Cross-Reactive Immunologic Material (CRIM) Assay Result||participants|Number|0|0.0||||||
4313505|NCT00483379|4140191|B3|Motor Skills||Parameter in Clinical Decline|Participant counts of the parameter in clinical decline (cardiac, respiratory or motor skills as compared to their condition prior to the beginning alglucosidase alfa treatment) for which participants were included in the study.|participants|Number|11|11.0||||||
4313506|NCT00483379|4140192|B2|Motor Skills||Parameter in Clinical Decline|Participant counts of the parameter in clinical decline (cardiac, respiratory or motor skills as compared to their condition prior to the beginning alglucosidase alfa treatment) for which participants were included in the study.|participants|Number|6|6.0||||||
4313507|NCT00483379|4140193|B1|Motor Skills||Parameter in Clinical Decline|Participant counts of the parameter in clinical decline (cardiac, respiratory or motor skills as compared to their condition prior to the beginning alglucosidase alfa treatment) for which participants were included in the study.|participants|Number|5|5.0||||||
4313508|NCT00483379|4140191|B3|Respiratory||Parameter in Clinical Decline|Participant counts of the parameter in clinical decline (cardiac, respiratory or motor skills as compared to their condition prior to the beginning alglucosidase alfa treatment) for which participants were included in the study.|participants|Number|2|2.0||||||
4313509|NCT00483379|4140192|B2|Respiratory||Parameter in Clinical Decline|Participant counts of the parameter in clinical decline (cardiac, respiratory or motor skills as compared to their condition prior to the beginning alglucosidase alfa treatment) for which participants were included in the study.|participants|Number|1|1.0||||||
4313510|NCT00483379|4140193|B1|Respiratory||Parameter in Clinical Decline|Participant counts of the parameter in clinical decline (cardiac, respiratory or motor skills as compared to their condition prior to the beginning alglucosidase alfa treatment) for which participants were included in the study.|participants|Number|1|1.0||||||
4313511|NCT00483379|4140191|B3|Cardiac||Parameter in Clinical Decline|Participant counts of the parameter in clinical decline (cardiac, respiratory or motor skills as compared to their condition prior to the beginning alglucosidase alfa treatment) for which participants were included in the study.|participants|Number|0|0.0||||||
4313512|NCT00483379|4140192|B2|Cardiac||Parameter in Clinical Decline|Participant counts of the parameter in clinical decline (cardiac, respiratory or motor skills as compared to their condition prior to the beginning alglucosidase alfa treatment) for which participants were included in the study.|participants|Number|0|0.0||||||
4313513|NCT00483379|4140193|B1|Cardiac||Parameter in Clinical Decline|Participant counts of the parameter in clinical decline (cardiac, respiratory or motor skills as compared to their condition prior to the beginning alglucosidase alfa treatment) for which participants were included in the study.|participants|Number|0|0.0||||||
4313514|NCT00483379|4140191|B3|Late-onset Pompe Disease||Life-stage of Disease Onset||participants|Number|4|4.0||||||
4313515|NCT00483379|4140192|B2|Late-onset Pompe Disease||Life-stage of Disease Onset||participants|Number|2|2.0||||||
4313516|NCT00483379|4140193|B1|Late-onset Pompe Disease||Life-stage of Disease Onset||participants|Number|2|2.0||||||
4313517|NCT00483379|4140191|B3|Infantile-onset Pompe Disease||Life-stage of Disease Onset||participants|Number|9|9.0||||||
4313518|NCT00483379|4140192|B2|Infantile-onset Pompe Disease||Life-stage of Disease Onset||participants|Number|5|5.0||||||
4313519|NCT00483379|4140193|B1|Infantile-onset Pompe Disease||Life-stage of Disease Onset||participants|Number|4|4.0||||||
4313520|NCT00483379|4140191|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313521|NCT00483379|4140192|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313522|NCT00483379|4140193|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313523|NCT00483379|4140191|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313524|NCT00483379|4140192|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313525|NCT00483379|4140193|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313526|NCT00483379|4140191|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4313527|NCT00483379|4140192|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4313528|NCT00483379|4140193|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4313529|NCT00483379|4140191|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313530|NCT00483379|4140192|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313531|NCT00483379|4140193|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313532|NCT00483379|4140191|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313533|NCT00483379|4140192|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313534|NCT00483379|4140193|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313535|NCT00483379|4140191|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4313536|NCT00483379|4140192|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4313537|NCT00483379|4140193|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313538|NCT00483379|4140191|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313539|NCT00483379|4140192|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313540|NCT00483379|4140193|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313541|NCT00483379|4140191|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4313542|NCT00483379|4140192|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4313543|NCT00483379|4140193|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4313544|NCT00483379|4140191|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4313545|NCT00483379|4140192|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4313546|NCT00483379|4140193|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4313547|NCT00483379|4140191|B3|>65 years||Age, Customized||participants|Number|0|0.0||||||
4313548|NCT00483379|4140192|B2|>65 years||Age, Customized||participants|Number|0|0.0||||||
4313549|NCT00483379|4140193|B1|>65 years||Age, Customized||participants|Number|0|0.0||||||
4313550|NCT00483379|4140191|B3|>= 18 and <=65 years||Age, Customized||participants|Number|4|4.0||||||
4313551|NCT00483379|4140192|B2|>= 18 and <=65 years||Age, Customized||participants|Number|2|2.0||||||
4313552|NCT00483379|4140193|B1|>= 18 and <=65 years||Age, Customized||participants|Number|2|2.0||||||
4313553|NCT00483379|4140191|B3|<18 years||Age, Customized||participants|Number|9|9.0||||||
4313554|NCT00483379|4140192|B2|<18 years||Age, Customized||participants|Number|5|5.0||||||
4313555|NCT00483379|4140193|B1|<18 years||Age, Customized||participants|Number|4|4.0||||||
4313556|NCT00483379|4140191|B3|||Age||years|Mean|19.8|19.8|Standard Deviation|21.29|21.29|||
4313557|NCT00483379|4140192|B2|||Age||years|Mean|16.8|16.8|Standard Deviation|15.56|15.56|||
4313558|NCT00483379|4140193|B1|||Age||years|Mean|23.3|23.3|Standard Deviation|27.75|27.75|||
4313559|NCT00483327|4140230|B1|FIGO Grade 2 endometrioid carcinoma||Histological Diagnosis||participants|Number|2|2.0||||||
4313560|NCT00483327|4140230|B1|FIGO Grade 1 endometrioid carcinoma||Histological Diagnosis||participants|Number|9|9.0||||||
4313561|NCT00483327|4140230|B1|Atypical endometrial hyperplasia||Histological Diagnosis||participants|Number|20|20.0||||||
4313562|NCT00483327|4140230|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4313563|NCT00483327|4140230|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4313564|NCT00483327|4140230|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313565|NCT00483327|4140230|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4313566|NCT00483327|4140230|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4313567|NCT00483327|4140230|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313568|NCT00483327|4140230|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4313569|NCT00483327|4140230|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313570|NCT00483327|4140230|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4313571|NCT00483327|4140230|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4313572|NCT00483327|4140230|B1|55-64 yeras||Age, Customized||participants|Number|2|2.0||||||
4313573|NCT00483327|4140230|B1|45-54 years||Age, Customized||participants|Number|4|4.0||||||
4313574|NCT00483327|4140230|B1|35-44 years||Age, Customized||participants|Number|12|12.0||||||
4313575|NCT00483327|4140230|B1|25-34 years||Age, Customized||participants|Number|12|12.0||||||
4313576|NCT00483327|4140230|B1|18-24 years||Age, Customized||participants|Number|1|1.0||||||
4313577|NCT00483262|4140239|B3|United States||Region of Enrollment||participants|Number|63|63.0||||||
4313578|NCT00483262|4140240|B2|United States||Region of Enrollment||participants|Number|43|43.0||||||
4313579|NCT00483262|4140241|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4313580|NCT00483262|4140239|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4313581|NCT00483262|4140240|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4313582|NCT00483262|4140241|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4313583|NCT00483262|4140239|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4313584|NCT00483262|4140240|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4313585|NCT00483262|4140241|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4313586|NCT00483262|4140239|B3||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4313587|NCT00483262|4140240|B2||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4313588|NCT00483262|4140241|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4313589|NCT00483262|4140239|B3||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4313590|NCT00483262|4140240|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4313591|NCT00483262|4140241|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4313592|NCT00483262|4140239|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4313593|NCT00483262|4140240|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4313594|NCT00483262|4140241|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4313595|NCT00483223|4140252|B1|Carboplatin (cohort 2)||Treatment cohort|The number of participants assigned to each treatment cohort within the single arm of this study.|Participants|Count of Participants|43|43.0||||||
4313596|NCT00483223|4140252|B1|Cisplatin (cohort 1)||Treatment cohort|The number of participants assigned to each treatment cohort within the single arm of this study.|Participants|Count of Participants|43|43.0||||||
4313597|NCT00483223|4140252|B1|Taxane||Prior chemotherapy|The prior chemotherapy received by the participants.The rows represent the number of participants that received any adjuvant/neoadjuvant as well as the number of participant that received Anthracycline or Taxane as their adjuvant/neoadjuvant drug.|participants|Number|67|67.0||||||
4313598|NCT00483223|4140252|B1|Anthracycline||Prior chemotherapy|The prior chemotherapy received by the participants.The rows represent the number of participants that received any adjuvant/neoadjuvant as well as the number of participant that received Anthracycline or Taxane as their adjuvant/neoadjuvant drug.|participants|Number|65|65.0||||||
4313599|NCT00483223|4140252|B1|Adjuvant/neoadjuvant||Prior chemotherapy|The prior chemotherapy received by the participants.The rows represent the number of participants that received any adjuvant/neoadjuvant as well as the number of participant that received Anthracycline or Taxane as their adjuvant/neoadjuvant drug.|participants|Number|74|74.0||||||
4313600|NCT00483223|4140252|B1|4||Stage at initial diagnosis of breast cancer|This describes the stage of breast cancer at diagnosis according to the American Joint Commission on Cancer (AJCC) Version 7. Generally, stage 1 is a cancer that is less than 2 cm and lymph node negative, stage 2 is a tumor between 2-5 cm and/or 1-3 lymph nodes positive, and stage 3 is a tumor with more than 3 lymph nodes positive or a tumor invading the skin. Stage 4 indicates that the cancer has spread into distant parts of the body. In general, lower stage cancers have a better prognosis, and higher stage cancers are more advanced.|Participants|Count of Participants|7|7.0||||||
4313601|NCT00483223|4140252|B1|3||Stage at initial diagnosis of breast cancer|This describes the stage of breast cancer at diagnosis according to the American Joint Commission on Cancer (AJCC) Version 7. Generally, stage 1 is a cancer that is less than 2 cm and lymph node negative, stage 2 is a tumor between 2-5 cm and/or 1-3 lymph nodes positive, and stage 3 is a tumor with more than 3 lymph nodes positive or a tumor invading the skin. Stage 4 indicates that the cancer has spread into distant parts of the body. In general, lower stage cancers have a better prognosis, and higher stage cancers are more advanced.|Participants|Count of Participants|37|37.0||||||
4313602|NCT00483223|4140252|B1|2||Stage at initial diagnosis of breast cancer|This describes the stage of breast cancer at diagnosis according to the American Joint Commission on Cancer (AJCC) Version 7. Generally, stage 1 is a cancer that is less than 2 cm and lymph node negative, stage 2 is a tumor between 2-5 cm and/or 1-3 lymph nodes positive, and stage 3 is a tumor with more than 3 lymph nodes positive or a tumor invading the skin. Stage 4 indicates that the cancer has spread into distant parts of the body. In general, lower stage cancers have a better prognosis, and higher stage cancers are more advanced.|Participants|Count of Participants|32|32.0||||||
4313603|NCT00483223|4140252|B1|1||Stage at initial diagnosis of breast cancer|This describes the stage of breast cancer at diagnosis according to the American Joint Commission on Cancer (AJCC) Version 7. Generally, stage 1 is a cancer that is less than 2 cm and lymph node negative, stage 2 is a tumor between 2-5 cm and/or 1-3 lymph nodes positive, and stage 3 is a tumor with more than 3 lymph nodes positive or a tumor invading the skin. Stage 4 indicates that the cancer has spread into distant parts of the body. In general, lower stage cancers have a better prognosis, and higher stage cancers are more advanced.|Participants|Count of Participants|10|10.0||||||
4313604|NCT00483223|4140252|B1|Brain||Site of metastases|The number of participants with metastases at the specified cites.|participants|Number|4|4.0||||||
4313605|NCT00483223|4140252|B1|Skin||Site of metastases|The number of participants with metastases at the specified cites.|participants|Number|16|16.0||||||
4313606|NCT00483223|4140252|B1|Liver||Site of metastases|The number of participants with metastases at the specified cites.|participants|Number|25|25.0||||||
4313607|NCT00483223|4140252|B1|Bone||Site of metastases|The number of participants with metastases at the specified cites.|participants|Number|25|25.0||||||
4313608|NCT00483223|4140252|B1|Lung||Site of metastases|The number of participants with metastases at the specified cites.|participants|Number|44|44.0||||||
4313609|NCT00483223|4140252|B1|Lymph nodes||Site of metastases|The number of participants with metastases at the specified cites.|participants|Number|54|54.0||||||
4313610|NCT00483223|4140252|B1|Not reported||ECOG PS|"Eastern Cooperative Oncology Group performance score. The performance scale describes a participants level of functioning in terms of their ability to care for themselves. daily activity, and physical ability.~0. Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|Participants|Count of Participants|6|6.0||||||
4313611|NCT00483223|4140252|B1|2||ECOG PS|"Eastern Cooperative Oncology Group performance score. The performance scale describes a participants level of functioning in terms of their ability to care for themselves. daily activity, and physical ability.~0. Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|Participants|Count of Participants|5|5.0||||||
4313666|NCT00483119|4140273|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4313667|NCT00483119|4140274|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4313612|NCT00483223|4140252|B1|1||ECOG PS|"Eastern Cooperative Oncology Group performance score. The performance scale describes a participants level of functioning in terms of their ability to care for themselves. daily activity, and physical ability.~0. Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|Participants|Count of Participants|20|20.0||||||
4313613|NCT00483223|4140252|B1|0||ECOG PS|"Eastern Cooperative Oncology Group performance score. The performance scale describes a participants level of functioning in terms of their ability to care for themselves. daily activity, and physical ability.~0. Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|Participants|Count of Participants|55|55.0||||||
4313614|NCT00483223|4140252|B1|United States||Region of Enrollment||Participants|Count of Participants|86|86.0||||||
4313615|NCT00483223|4140252|B1|> one or other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4313616|NCT00483223|4140252|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4313617|NCT00483223|4140252|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4313618|NCT00483223|4140252|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|69|69.0||||||
4313619|NCT00483223|4140252|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4313620|NCT00483223|4140252|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4313621|NCT00483223|4140252|B1|> 65||Age, Customized||Participants|Count of Participants|10|10.0||||||
4313622|NCT00483223|4140252|B1|40-65||Age, Customized||Participants|Count of Participants|63|63.0||||||
4313623|NCT00483223|4140252|B1|< 40||Age, Customized||Participants|Count of Participants|13|13.0||||||
4313624|NCT00483223|4140252|B1|||Age||years|Median|52|52.0|Full Range|||30.0|78.0|
4313625|NCT00483184|4140259|B4|Turkey||Region of Enrollment||participants|Number|84|84.0||||||
4313626|NCT00483184|4140260|B3|Turkey||Region of Enrollment||participants|Number|26|26.0||||||
4313627|NCT00483184|4140261|B2|Turkey||Region of Enrollment||participants|Number|31|31.0||||||
4313628|NCT00483184|4140262|B1|Turkey||Region of Enrollment||participants|Number|27|27.0||||||
4313629|NCT00483184|4140259|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4313630|NCT00483184|4140260|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4313631|NCT00483184|4140261|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4313632|NCT00483184|4140262|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4313633|NCT00483184|4140259|B4||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4313634|NCT00483184|4140260|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4313635|NCT00483184|4140261|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4313636|NCT00483184|4140262|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4313637|NCT00483184|4140259|B4|||Age||years|Mean|37|37.0|Standard Deviation|9.4|9.4|||
4313638|NCT00483184|4140260|B3|||Age||years|Mean|36|36.0|Standard Deviation|9.4|9.4|||
4313639|NCT00483184|4140261|B2|||Age||years|Mean|37|37.0|Standard Deviation|10.2|10.2|||
4313640|NCT00483184|4140262|B1|||Age||years|Mean|36|36.0|Standard Deviation|8.6|8.6|||
4313641|NCT00483184|4140259|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4313642|NCT00483184|4140260|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4313643|NCT00483184|4140261|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4313644|NCT00483184|4140262|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4313645|NCT00483184|4140259|B4||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
4313646|NCT00483184|4140260|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4313647|NCT00483184|4140261|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4313648|NCT00483184|4140262|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4313649|NCT00483184|4140259|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4313650|NCT00483184|4140260|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4313651|NCT00483184|4140261|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4313652|NCT00483184|4140262|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4313653|NCT00483119|4140272|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4313654|NCT00483119|4140273|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4313655|NCT00483119|4140274|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4313656|NCT00483119|4140272|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4313657|NCT00483119|4140273|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4313658|NCT00483119|4140274|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4313659|NCT00483119|4140272|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4313660|NCT00483119|4140273|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4313661|NCT00483119|4140274|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4313662|NCT00483119|4140272|B3|||Age||years|Mean|59|59.0|Full Range|||45.0|68.0|
4313663|NCT00483119|4140273|B2|||Age||years|Mean|56.25|56.25|Full Range|||47.0|66.0|
4313664|NCT00483119|4140274|B1|||Age||years|Mean|61.2|61.2|Full Range|||45.0|68.0|
4313665|NCT00483119|4140272|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4313668|NCT00483119|4140272|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4313669|NCT00483119|4140273|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4313670|NCT00483119|4140274|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4313671|NCT00483119|4140272|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4313672|NCT00483119|4140273|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4313673|NCT00483119|4140274|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4313674|NCT00483041|4140287|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4313675|NCT00483041|4140288|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4313676|NCT00483041|4140289|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4313677|NCT00483041|4140287|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4313678|NCT00483041|4140288|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4313679|NCT00483041|4140289|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4313680|NCT00483041|4140287|B3|||Age||Years|Mean|25.5|25.5|Standard Deviation|6.4|6.4|||
4313681|NCT00483041|4140288|B2|||Age||Years|Mean|22.3|22.3|Standard Deviation|2.7|2.7|||
4313682|NCT00483041|4140289|B1|||Age||Years|Mean|29.2|29.2|Standard Deviation|7.8|7.8|||
4313683|NCT00483002|4140320|B1||Male|Sex: Female, Male||Participants|Count of Participants|3379|3379.0||||||
4313684|NCT00483002|4140320|B1||Female|Sex: Female, Male||Participants|Count of Participants|340|340.0||||||
4313685|NCT00483002|4140320|B1|||Age||Years|Mean|49.4|49.4|Standard Deviation|11.7|11.7|||
4313686|NCT00482911|4140326|B3|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4313687|NCT00482911|4140327|B2|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4313688|NCT00482911|4140328|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4313689|NCT00482911|4140326|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313690|NCT00482911|4140327|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313691|NCT00482911|4140328|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313692|NCT00482911|4140326|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313693|NCT00482911|4140327|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313694|NCT00482911|4140328|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313695|NCT00482911|4140326|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4313696|NCT00482911|4140327|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4313697|NCT00482911|4140328|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4313698|NCT00482911|4140326|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4313699|NCT00482911|4140327|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4313700|NCT00482911|4140328|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313701|NCT00482911|4140326|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313702|NCT00482911|4140327|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313703|NCT00482911|4140328|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313704|NCT00482911|4140326|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313705|NCT00482911|4140327|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313706|NCT00482911|4140328|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313707|NCT00482911|4140326|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313708|NCT00482911|4140327|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313709|NCT00482911|4140328|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313710|NCT00482911|4140326|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313711|NCT00482911|4140327|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313712|NCT00482911|4140328|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313713|NCT00482911|4140326|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4313714|NCT00482911|4140327|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4313715|NCT00482911|4140328|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4313716|NCT00482911|4140326|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313717|NCT00482911|4140327|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313718|NCT00482911|4140328|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313719|NCT00482911|4140326|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4313720|NCT00482911|4140327|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4313721|NCT00482911|4140328|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4313722|NCT00482911|4140326|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4313723|NCT00482911|4140327|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4313724|NCT00482911|4140328|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4313725|NCT00482911|4140326|B3|||Age||years|Mean|57.27|57.27|Standard Deviation|9.61|9.61|||
4313726|NCT00482911|4140327|B2|||Age||years|Mean|54.89|54.89|Standard Deviation|6.44|6.44|||
4313727|NCT00482911|4140328|B1|||Age||years|Mean|64.4|64.4|Standard Deviation|15.52|15.52|||
4313728|NCT00482911|4140326|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4313729|NCT00482911|4140327|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4313730|NCT00482911|4140328|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4313731|NCT00482911|4140326|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4313732|NCT00482911|4140327|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4313733|NCT00482911|4140328|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4313734|NCT00482911|4140326|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4313735|NCT00482911|4140327|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4313736|NCT00482911|4140328|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4313737|NCT00482729|4140343|B3|||Hemoglobin A1c (A1C)||Percent|Mean|9.87|9.87|Standard Deviation|1.80|1.8|||
4313738|NCT00482729|4140344|B2|||Hemoglobin A1c (A1C)||Percent|Mean|9.83|9.83|Standard Deviation|1.77|1.77|||
4313739|NCT00482729|4140345|B1|||Hemoglobin A1c (A1C)||Percent|Mean|9.91|9.91|Standard Deviation|1.83|1.83|||
4313740|NCT00482729|4140343|B3|Other||Race/Ethnicity, Customized||Participants|Number|38|38.0||||||
4313741|NCT00482729|4140344|B2|Other||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
4313742|NCT00482729|4140345|B1|Other||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4313743|NCT00482729|4140343|B3|White||Race/Ethnicity, Customized||Participants|Number|997|997.0||||||
4313744|NCT00482729|4140344|B2|White||Race/Ethnicity, Customized||Participants|Number|489|489.0||||||
4313745|NCT00482729|4140345|B1|White||Race/Ethnicity, Customized||Participants|Number|508|508.0||||||
4313746|NCT00482729|4140343|B3|Black||Race/Ethnicity, Customized||Participants|Number|170|170.0||||||
4313747|NCT00482729|4140344|B2|Black||Race/Ethnicity, Customized||Participants|Number|88|88.0||||||
4313748|NCT00482729|4140345|B1|Black||Race/Ethnicity, Customized||Participants|Number|82|82.0||||||
4313749|NCT00482729|4140343|B3|Asian||Race/Ethnicity, Customized||Participants|Number|41|41.0||||||
4313750|NCT00482729|4140344|B2|Asian||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
4313751|NCT00482729|4140345|B1|Asian||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4313752|NCT00482729|4140343|B3||Male|Sex: Female, Male||Participants|Count of Participants|708|708.0||||||
4313753|NCT00482729|4140344|B2||Male|Sex: Female, Male||Participants|Count of Participants|355|355.0||||||
4313754|NCT00482729|4140345|B1||Male|Sex: Female, Male||Participants|Count of Participants|353|353.0||||||
4313755|NCT00482729|4140343|B3||Female|Sex: Female, Male||Participants|Count of Participants|538|538.0||||||
4313756|NCT00482729|4140344|B2||Female|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
4313757|NCT00482729|4140345|B1||Female|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
4313758|NCT00482729|4140343|B3|||Age||years|Mean|49.7|49.7|Standard Deviation|10.5|10.5|||
4313759|NCT00482729|4140344|B2|||Age||years|Mean|50.0|50.0|Standard Deviation|10.5|10.5|||
4313760|NCT00482729|4140345|B1|||Age||years|Mean|49.4|49.4|Standard Deviation|10.5|10.5|||
4313761|NCT00482703|4140360|B3|Imatinib-intolerant||Imatinib Status|Resistance to Imatinib=Previously treated with imatinib at a dose of ≥ 400 mg/day AND developed progressive disease while receiving imatinib at that dose. Intolerance to Imatinib=development of a Grade ≥3 toxicity considered at least possibly related to imatinib at a dose of ≤400 mg/day which led to discontinuation of therapy.|participants|Number|9|9.0||||||
4313762|NCT00482703|4140361|B2|Imatinib-intolerant||Imatinib Status|Resistance to Imatinib=Previously treated with imatinib at a dose of ≥ 400 mg/day AND developed progressive disease while receiving imatinib at that dose. Intolerance to Imatinib=development of a Grade ≥3 toxicity considered at least possibly related to imatinib at a dose of ≤400 mg/day which led to discontinuation of therapy.|participants|Number|5|5.0||||||
4313763|NCT00482703|4140362|B1|Imatinib-intolerant||Imatinib Status|Resistance to Imatinib=Previously treated with imatinib at a dose of ≥ 400 mg/day AND developed progressive disease while receiving imatinib at that dose. Intolerance to Imatinib=development of a Grade ≥3 toxicity considered at least possibly related to imatinib at a dose of ≤400 mg/day which led to discontinuation of therapy.|participants|Number|4|4.0||||||
4313764|NCT00482703|4140360|B3|Imatinib-resistant||Imatinib Status|Resistance to Imatinib=Previously treated with imatinib at a dose of ≥ 400 mg/day AND developed progressive disease while receiving imatinib at that dose. Intolerance to Imatinib=development of a Grade ≥3 toxicity considered at least possibly related to imatinib at a dose of ≤400 mg/day which led to discontinuation of therapy.|participants|Number|14|14.0||||||
4313765|NCT00482703|4140361|B2|Imatinib-resistant||Imatinib Status|Resistance to Imatinib=Previously treated with imatinib at a dose of ≥ 400 mg/day AND developed progressive disease while receiving imatinib at that dose. Intolerance to Imatinib=development of a Grade ≥3 toxicity considered at least possibly related to imatinib at a dose of ≤400 mg/day which led to discontinuation of therapy.|participants|Number|7|7.0||||||
4313766|NCT00482703|4140362|B1|Imatinib-resistant||Imatinib Status|Resistance to Imatinib=Previously treated with imatinib at a dose of ≥ 400 mg/day AND developed progressive disease while receiving imatinib at that dose. Intolerance to Imatinib=development of a Grade ≥3 toxicity considered at least possibly related to imatinib at a dose of ≤400 mg/day which led to discontinuation of therapy.|participants|Number|7|7.0||||||
4313767|NCT00482703|4140360|B3|Status=5||Eastern Cooperative Oncology Group Performace Status (ECOG-PS)|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|0|0.0||||||
4313821|NCT00482677|4140408|B3|Japan||Region of Enrollment||participants|Number|17|17.0||||||
4313768|NCT00482703|4140361|B2|Status=5||Eastern Cooperative Oncology Group Performace Status (ECOG-PS)|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|0|0.0||||||
4313769|NCT00482703|4140362|B1|Status=5||Eastern Cooperative Oncology Group Performace Status (ECOG-PS)|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|0|0.0||||||
4313770|NCT00482703|4140360|B3|Status=4||Eastern Cooperative Oncology Group Performace Status (ECOG-PS)|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|0|0.0||||||
4313771|NCT00482703|4140361|B2|Status=4||Eastern Cooperative Oncology Group Performace Status (ECOG-PS)|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|0|0.0||||||
4313772|NCT00482703|4140362|B1|Status=4||Eastern Cooperative Oncology Group Performace Status (ECOG-PS)|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|0|0.0||||||
4313773|NCT00482703|4140360|B3|Status=3||Eastern Cooperative Oncology Group Performace Status (ECOG-PS)|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|0|0.0||||||
4313774|NCT00482703|4140361|B2|Status=3||Eastern Cooperative Oncology Group Performace Status (ECOG-PS)|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|0|0.0||||||
4313775|NCT00482703|4140362|B1|Status=3||Eastern Cooperative Oncology Group Performace Status (ECOG-PS)|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|0|0.0||||||
4313776|NCT00482703|4140360|B3|Status=2||Eastern Cooperative Oncology Group Performace Status (ECOG-PS)|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|0|0.0||||||
4313777|NCT00482703|4140361|B2|Status=2||Eastern Cooperative Oncology Group Performace Status (ECOG-PS)|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|0|0.0||||||
4313778|NCT00482703|4140362|B1|Status=2||Eastern Cooperative Oncology Group Performace Status (ECOG-PS)|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|0|0.0||||||
4313779|NCT00482703|4140360|B3|Status=1||Eastern Cooperative Oncology Group Performace Status (ECOG-PS)|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|0|0.0||||||
4313780|NCT00482703|4140361|B2|Status=1||Eastern Cooperative Oncology Group Performace Status (ECOG-PS)|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|0|0.0||||||
4313822|NCT00482677|4140409|B2|Japan||Region of Enrollment||participants|Number|9|9.0||||||
4313823|NCT00482677|4140410|B1|Japan||Region of Enrollment||participants|Number|8|8.0||||||
4313781|NCT00482703|4140362|B1|Status=1||Eastern Cooperative Oncology Group Performace Status (ECOG-PS)|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|0|0.0||||||
4313782|NCT00482703|4140360|B3|Status=0||Eastern Cooperative Oncology Group Performace Status (ECOG-PS)|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|23|23.0||||||
4313783|NCT00482703|4140361|B2|Status=0||Eastern Cooperative Oncology Group Performace Status (ECOG-PS)|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|12|12.0||||||
4313784|NCT00482703|4140362|B1|Status=0||Eastern Cooperative Oncology Group Performace Status (ECOG-PS)|ECOG PS scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale=0-5, with 0=fully active, 1=restricted in physically strenuous activity but ambulatory, 2=ambulatory and capable of all selfcare but unable to work, 3= limited selfcare ability and confined to bed/chair >50% of waking hours, 4=completely disabled and no selfcare ability and confined to bed/chair, and 5=death|participants|Number|11|11.0||||||
4313785|NCT00482703|4140360|B3|Japan||Region of Enrollment||participants|Number|23|23.0||||||
4313786|NCT00482703|4140361|B2|Japan||Region of Enrollment||participants|Number|12|12.0||||||
4313787|NCT00482703|4140362|B1|Japan||Region of Enrollment||participants|Number|11|11.0||||||
4313788|NCT00482703|4140360|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4313789|NCT00482703|4140361|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4313790|NCT00482703|4140362|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4313791|NCT00482703|4140360|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4313792|NCT00482703|4140361|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4313793|NCT00482703|4140362|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4313794|NCT00482703|4140360|B3|>=65 years||Age, Customized||participants|Number|4|4.0||||||
4313795|NCT00482703|4140361|B2|>=65 years||Age, Customized||participants|Number|2|2.0||||||
4313796|NCT00482703|4140362|B1|>=65 years||Age, Customized||participants|Number|2|2.0||||||
4313797|NCT00482703|4140360|B3|<65 years||Age, Customized||participants|Number|19|19.0||||||
4313798|NCT00482703|4140361|B2|<65 years||Age, Customized||participants|Number|10|10.0||||||
4313799|NCT00482703|4140362|B1|<65 years||Age, Customized||participants|Number|9|9.0||||||
4313800|NCT00482703|4140360|B3|||Age||years|Mean|49.3|49.3|Standard Deviation|14.8|14.8|||
4313801|NCT00482703|4140361|B2|||Age||years|Mean|49.9|49.9|Standard Deviation|16.0|16.0|||
4313802|NCT00482703|4140362|B1|||Age||years|Mean|48.5|48.5|Standard Deviation|14.2|14.2|||
4313803|NCT00482677|4140408|B3|||Mini Mental Status Examination||participants|Median|27|27.0|Full Range|||5.0|30.0|
4313804|NCT00482677|4140409|B2|||Mini Mental Status Examination||participants|Median|27|27.0|Full Range|||7.0|30.0|
4313805|NCT00482677|4140410|B1|||Mini Mental Status Examination||participants|Median|27|27.0|Full Range|||5.0|30.0|
4313806|NCT00482677|4140408|B3|Complete/incomplete resection||Resection||Participants|Count of Participants|396|396.0||||||
4313807|NCT00482677|4140409|B2|Complete/incomplete resection||Resection||Participants|Count of Participants|199|199.0||||||
4313808|NCT00482677|4140410|B1|Complete/incomplete resection||Resection||Participants|Count of Participants|197|197.0||||||
4313809|NCT00482677|4140408|B3|Biopsy only||Resection||Participants|Count of Participants|166|166.0||||||
4313810|NCT00482677|4140409|B2|Biopsy only||Resection||Participants|Count of Participants|82|82.0||||||
4313811|NCT00482677|4140410|B1|Biopsy only||Resection||Participants|Count of Participants|84|84.0||||||
4313812|NCT00482677|4140408|B3||2|ECOG Performance Status|"The ECOG Scale of Performance Status ranges between 0 (Fully active, able to carry on all pre-disease performance without restriction) and 5 (Dead)."|Participants|Count of Participants|130|130.0||||||
4313813|NCT00482677|4140409|B2||2|ECOG Performance Status|"The ECOG Scale of Performance Status ranges between 0 (Fully active, able to carry on all pre-disease performance without restriction) and 5 (Dead)."|Participants|Count of Participants|64|64.0||||||
4313814|NCT00482677|4140410|B1||2|ECOG Performance Status|"The ECOG Scale of Performance Status ranges between 0 (Fully active, able to carry on all pre-disease performance without restriction) and 5 (Dead)."|Participants|Count of Participants|66|66.0||||||
4313815|NCT00482677|4140408|B3||0, 1|ECOG Performance Status|"The ECOG Scale of Performance Status ranges between 0 (Fully active, able to carry on all pre-disease performance without restriction) and 5 (Dead)."|Participants|Count of Participants|432|432.0||||||
4313816|NCT00482677|4140409|B2||0, 1|ECOG Performance Status|"The ECOG Scale of Performance Status ranges between 0 (Fully active, able to carry on all pre-disease performance without restriction) and 5 (Dead)."|Participants|Count of Participants|217|217.0||||||
4313817|NCT00482677|4140410|B1||0, 1|ECOG Performance Status|"The ECOG Scale of Performance Status ranges between 0 (Fully active, able to carry on all pre-disease performance without restriction) and 5 (Dead)."|Participants|Count of Participants|215|215.0||||||
4313818|NCT00482677|4140408|B3|Germany||Region of Enrollment||participants|Number|249|249.0||||||
4313819|NCT00482677|4140409|B2|Germany||Region of Enrollment||participants|Number|125|125.0||||||
4313820|NCT00482677|4140410|B1|Germany||Region of Enrollment||participants|Number|124|124.0||||||
4313824|NCT00482677|4140408|B3|Netherlands||Region of Enrollment||participants|Number|97|97.0||||||
4313825|NCT00482677|4140409|B2|Netherlands||Region of Enrollment||participants|Number|49|49.0||||||
4313826|NCT00482677|4140410|B1|Netherlands||Region of Enrollment||participants|Number|48|48.0||||||
4313827|NCT00482677|4140408|B3|Canada||Region of Enrollment||participants|Number|199|199.0||||||
4313828|NCT00482677|4140409|B2|Canada||Region of Enrollment||participants|Number|98|98.0||||||
4313829|NCT00482677|4140410|B1|Canada||Region of Enrollment||participants|Number|101|101.0||||||
4313830|NCT00482677|4140408|B3||Male|Sex: Female, Male||Participants|Count of Participants|343|343.0||||||
4313831|NCT00482677|4140409|B2||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4313832|NCT00482677|4140410|B1||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4313833|NCT00482677|4140408|B3||Female|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
4313834|NCT00482677|4140409|B2||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4313835|NCT00482677|4140410|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4313836|NCT00482677|4140408|B3|||Age||years|Median|73|73.0|Full Range|||65.0|90.0|
4313837|NCT00482677|4140409|B2|||Age||years|Median|73|73.0|Full Range|||65.0|88.0|
4313838|NCT00482677|4140410|B1|||Age||years|Median|73|73.0|Full Range|||65.0|90.0|
4313839|NCT00482625|4140421|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4313840|NCT00482625|4140421|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4313841|NCT00482625|4140421|B1|||Age||years|Mean|61.17|61.17|Standard Deviation|14.48|14.48|||
4313842|NCT00482612|4140430|B5||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4313843|NCT00482612|4140431|B4||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4313844|NCT00482612|4140432|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4313845|NCT00482612|4140433|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4313846|NCT00482612|4140434|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4313847|NCT00482612|4140430|B5||Female|Sex: Female, Male||Participants|Count of Participants|339|339.0||||||
4313848|NCT00482612|4140431|B4||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4313849|NCT00482612|4140432|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4313850|NCT00482612|4140433|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4313851|NCT00482612|4140434|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4313852|NCT00482612|4140430|B5|||Age||Years|Mean|45.3|45.3|Standard Deviation|12.0|12.0|||
4313853|NCT00482612|4140431|B4|||Age||Years|Mean|46.2|46.2|Standard Deviation|11.3|11.3|||
4313854|NCT00482612|4140432|B3|||Age||Years|Mean|44.5|44.5|Standard Deviation|12.2|12.2|||
4313855|NCT00482612|4140433|B2|||Age||Years|Mean|45.6|45.6|Standard Deviation|12.0|12.0|||
4313856|NCT00482612|4140434|B1|||Age||Years|Mean|44.8|44.8|Standard Deviation|12.4|12.4|||
4313857|NCT00482547|4140463|B3|United States||Region of Enrollment||participants|Number|1188.0|1188.0||||||
4313858|NCT00482547|4140464|B2|United States||Region of Enrollment||participants|Number|589|589.0||||||
4313859|NCT00482547|4140465|B1|United States||Region of Enrollment||participants|Number|599|599.0||||||
4313860|NCT00482547|4140463|B3||Male|Gender||Participants|Count of Participants|515|515.0||||||
4313861|NCT00482547|4140464|B2||Male|Gender||Participants|Count of Participants|257|257.0||||||
4313862|NCT00482547|4140465|B1||Male|Gender||Participants|Count of Participants|258|258.0||||||
4313863|NCT00482547|4140463|B3||Female|Gender||Participants|Count of Participants|673|673.0||||||
4313864|NCT00482547|4140464|B2||Female|Gender||Participants|Count of Participants|332|332.0||||||
4313865|NCT00482547|4140465|B1||Female|Gender||Participants|Count of Participants|341|341.0||||||
4313866|NCT00482547|4140463|B3|||Age||years|Mean|64.0|64.0|Standard Deviation|15.2|15.2|||
4313867|NCT00482547|4140464|B2|||Age||years|Mean|64.3|64.3|Standard Deviation|14.5|14.5|||
4313868|NCT00482547|4140465|B1|||Age||years|Mean|63.7|63.7|Standard Deviation|15.9|15.9|||
4313869|NCT00482547|4140463|B3||>=65 years|Age||Participants|Count of Participants|599|599.0||||||
4313870|NCT00482547|4140464|B2||>=65 years|Age||Participants|Count of Participants|302|302.0||||||
4313871|NCT00482547|4140465|B1||>=65 years|Age||Participants|Count of Participants|297|297.0||||||
4313872|NCT00482547|4140463|B3||Between 18 and 65 years|Age||Participants|Count of Participants|589|589.0||||||
4313873|NCT00482547|4140464|B2||Between 18 and 65 years|Age||Participants|Count of Participants|287|287.0||||||
4313874|NCT00482547|4140465|B1||Between 18 and 65 years|Age||Participants|Count of Participants|302|302.0||||||
4313875|NCT00482547|4140463|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4313876|NCT00482547|4140464|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4313877|NCT00482547|4140465|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4313878|NCT00482391|4140486|B1|United States||Region of Enrollment||participants|Number|95|95.0||||||
4313879|NCT00482391|4140486|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4313880|NCT00482391|4140486|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4313881|NCT00482391|4140486|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4313882|NCT00482391|4140486|B1||Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
4313883|NCT00482391|4140486|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4313884|NCT00482274|4140491|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4313885|NCT00482274|4140491|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4313886|NCT00482274|4140491|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4313887|NCT00482274|4140491|B1|||Age||years|Mean|66|66.0|Standard Deviation|2.49|2.49|||
4313888|NCT00482274|4140491|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4313889|NCT00482274|4140491|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4313890|NCT00482274|4140491|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4313891|NCT00482170|4140499|B3||Male|Sex: Female, Male|Out of a total of 421 participants, data for baseline measure (gender) was available for 417 participants who were treated and had at least 1 efficacy evaluation.|Participants|Count of Participants|281|281.0||||||
4313892|NCT00482170|4140500|B2||Male|Sex: Female, Male|Out of a total of 421 participants, data for baseline measure (gender) was available for 417 participants who were treated and had at least 1 efficacy evaluation.|Participants|Count of Participants|146|146.0||||||
4313893|NCT00482170|4140501|B1||Male|Sex: Female, Male|Out of a total of 421 participants, data for baseline measure (gender) was available for 417 participants who were treated and had at least 1 efficacy evaluation.|Participants|Count of Participants|135|135.0||||||
4313894|NCT00482170|4140499|B3||Female|Sex: Female, Male|Out of a total of 421 participants, data for baseline measure (gender) was available for 417 participants who were treated and had at least 1 efficacy evaluation.|Participants|Count of Participants|136|136.0||||||
4313895|NCT00482170|4140500|B2||Female|Sex: Female, Male|Out of a total of 421 participants, data for baseline measure (gender) was available for 417 participants who were treated and had at least 1 efficacy evaluation.|Participants|Count of Participants|65|65.0||||||
4313896|NCT00482170|4140501|B1||Female|Sex: Female, Male|Out of a total of 421 participants, data for baseline measure (gender) was available for 417 participants who were treated and had at least 1 efficacy evaluation.|Participants|Count of Participants|71|71.0||||||
4313897|NCT00482170|4140499|B3|||Age|Out of a total of 421 participants, data for baseline measure (age) was available for 417 participants who were treated and had at least 1 efficacy evaluation.|years|Mean|46.1|46.1|Standard Deviation|13.3|13.3|||
4313898|NCT00482170|4140500|B2|||Age|Out of a total of 421 participants, data for baseline measure (age) was available for 417 participants who were treated and had at least 1 efficacy evaluation.|years|Mean|46.1|46.1|Standard Deviation|13.4|13.4|||
4313899|NCT00482170|4140501|B1|||Age|Out of a total of 421 participants, data for baseline measure (age) was available for 417 participants who were treated and had at least 1 efficacy evaluation.|years|Mean|46.1|46.1|Standard Deviation|13.2|13.2|||
4313900|NCT00482053|4140620|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4313901|NCT00482053|4140620|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313902|NCT00482053|4140620|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4313903|NCT00482053|4140620|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313904|NCT00482053|4140620|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313905|NCT00482053|4140620|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313906|NCT00482053|4140620|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313907|NCT00482053|4140620|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313908|NCT00482053|4140620|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4313909|NCT00482053|4140620|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4313910|NCT00482053|4140620|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4313911|NCT00482053|4140620|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4313912|NCT00482053|4140620|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4313913|NCT00482053|4140620|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4313914|NCT00482053|4140620|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4313915|NCT00482014|4140630|B5|India||Region of Enrollment||participants|Number|12|12.0||||||
4313916|NCT00482014|4140631|B4|India||Region of Enrollment||participants|Number|9|9.0||||||
4313917|NCT00482014|4140632|B3|India||Region of Enrollment||participants|Number|3|3.0||||||
4313918|NCT00482014|4140633|B2|India||Region of Enrollment||participants|Number|0|0.0||||||
4313919|NCT00482014|4140634|B1|India||Region of Enrollment||participants|Number|0|0.0||||||
4313920|NCT00482014|4140630|B5|United States||Region of Enrollment||participants|Number|108|108.0||||||
4313921|NCT00482014|4140631|B4|United States||Region of Enrollment||participants|Number|43|43.0||||||
4313922|NCT00482014|4140632|B3|United States||Region of Enrollment||participants|Number|43|43.0||||||
4313923|NCT00482014|4140633|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4313924|NCT00482014|4140634|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4313925|NCT00482014|4140630|B5|West Asian (Indian sub continent||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4313926|NCT00482014|4140631|B4|West Asian (Indian sub continent||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4313927|NCT00482014|4140632|B3|West Asian (Indian sub continent||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4313928|NCT00482014|4140633|B2|West Asian (Indian sub continent||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4313929|NCT00482014|4140634|B1|West Asian (Indian sub continent||Race/Ethnicity, Customized||participants|Number|0|0.0||11.7|11.7|||
4313930|NCT00482014|4140630|B5|East Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4313931|NCT00482014|4140631|B4|East Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4313932|NCT00482014|4140632|B3|East Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4313933|NCT00482014|4140633|B2|East Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4313934|NCT00482014|4140634|B1|East Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||1.7|1.7|||
4313935|NCT00482014|4140630|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4313936|NCT00482014|4140631|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4313937|NCT00482014|4140632|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4313938|NCT00482014|4140633|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4313939|NCT00482014|4140634|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||1.7|1.7|||
4313940|NCT00482014|4140630|B5|African||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4313941|NCT00482014|4140631|B4|African||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4313942|NCT00482014|4140632|B3|African||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4313943|NCT00482014|4140633|B2|African||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4313944|NCT00482014|4140634|B1|African||Race/Ethnicity, Customized||participants|Number|1|1.0||11.7|11.7|||
4313945|NCT00482014|4140630|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|88|88.0||||||
4313946|NCT00482014|4140631|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4313947|NCT00482014|4140632|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4313948|NCT00482014|4140633|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4313949|NCT00482014|4140634|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|8|8.0||73.3|73.3|||
4313950|NCT00482014|4140630|B5||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4313951|NCT00482014|4140631|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4313952|NCT00482014|4140632|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4313953|NCT00482014|4140633|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4313954|NCT00482014|4140634|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4313955|NCT00482014|4140630|B5||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4313956|NCT00482014|4140631|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4313957|NCT00482014|4140632|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4313958|NCT00482014|4140633|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4313959|NCT00482014|4140634|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4313960|NCT00482014|4140630|B5|||Age||Years|Mean|63.4|63.4|Standard Deviation|9.77|9.77|||
4313961|NCT00482014|4140631|B4|||Age||Years|Mean|64.1|64.1|Standard Deviation|9.44|9.44|||
4313962|NCT00482014|4140632|B3|||Age||Years|Mean|63.6|63.6|Standard Deviation|9.92|9.92|||
4313963|NCT00482014|4140633|B2|||Age||Years|Mean|61.0|61.0|Standard Deviation|11.66|11.66|||
4313964|NCT00482014|4140634|B1|||Age||Years|Mean|61.9|61.9|Standard Deviation|8.70|8.7|||
4313965|NCT00481988|4140659|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4313966|NCT00481988|4140660|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4313967|NCT00481988|4140661|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4313968|NCT00481988|4140659|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4313969|NCT00481988|4140660|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4313970|NCT00481988|4140661|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4313971|NCT00481988|4140659|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4313972|NCT00481988|4140660|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4313973|NCT00481988|4140661|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4313974|NCT00481988|4140659|B3|||Age||years|Mean|45|45.0|Standard Deviation|2|2.0|||
4313975|NCT00481988|4140660|B2|||Age||years|Mean|45|45.0|Standard Deviation|2|2.0|||
4313976|NCT00481988|4140661|B1|||Age||years|Mean|45|45.0|Standard Deviation|2|2.0|||
4313977|NCT00481988|4140659|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4313978|NCT00481988|4140660|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4313979|NCT00481988|4140661|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4313980|NCT00481988|4140659|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4313981|NCT00481988|4140660|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4313982|NCT00481988|4140661|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4313983|NCT00481988|4140659|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4313984|NCT00481988|4140660|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4313985|NCT00481988|4140661|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4313986|NCT00481871|4140670|B6|United States||Region of Enrollment||participants|Number|107|107.0||||||
4313987|NCT00481871|4140671|B5|United States||Region of Enrollment||participants|Number|34|34.0||||||
4313988|NCT00481871|4140672|B4|United States||Region of Enrollment||participants|Number|38|38.0||||||
4313989|NCT00481871|4140673|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4313990|NCT00481871|4140674|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4313991|NCT00481871|4140675|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4313992|NCT00481871|4140670|B6||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4313993|NCT00481871|4140671|B5||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4313994|NCT00481871|4140672|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4313995|NCT00481871|4140673|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4313996|NCT00481871|4140674|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4313997|NCT00481871|4140675|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4313998|NCT00481871|4140670|B6||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4313999|NCT00481871|4140671|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4314000|NCT00481871|4140672|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4314001|NCT00481871|4140673|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4314002|NCT00481871|4140674|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4314003|NCT00481871|4140675|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4314004|NCT00481871|4140670|B6|||Age||years|Mean|56.4|56.4|Standard Deviation|16.1|16.1|||
4314005|NCT00481871|4140671|B5|||Age||years|Mean|53.2|53.2|Standard Deviation|15|15.0|||
4314006|NCT00481871|4140672|B4|||Age||years|Mean|57.9|57.9|Standard Deviation|16|16.0|||
4314007|NCT00481871|4140673|B3|||Age||years|Mean|57.4|57.4|Standard Deviation|17|17.0|||
4314008|NCT00481871|4140674|B2|||Age||years|Mean|52.4|52.4|Standard Deviation|18|18.0|||
4314009|NCT00481871|4140675|B1|||Age||years|Mean|67.6|67.6|Standard Deviation|15|15.0|||
4314010|NCT00481871|4140670|B6||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4314011|NCT00481871|4140671|B5||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4314012|NCT00481871|4140672|B4||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4314013|NCT00481871|4140673|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4314014|NCT00481871|4140674|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4314015|NCT00481871|4140675|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4314016|NCT00481871|4140670|B6||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4314017|NCT00481871|4140671|B5||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4314018|NCT00481871|4140672|B4||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4314019|NCT00481871|4140673|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4314020|NCT00481871|4140674|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4314021|NCT00481871|4140675|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4314022|NCT00481871|4140670|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4314023|NCT00481871|4140671|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4314024|NCT00481871|4140672|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4314025|NCT00481871|4140673|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4314026|NCT00481871|4140674|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4314027|NCT00481871|4140675|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4314028|NCT00481845|4140693|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4314029|NCT00481845|4140694|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4314030|NCT00481845|4140695|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4314031|NCT00481845|4140693|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4314032|NCT00481845|4140694|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4314033|NCT00481845|4140695|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4314034|NCT00481845|4140693|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4314035|NCT00481845|4140694|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4314036|NCT00481845|4140695|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4314037|NCT00481845|4140693|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4314038|NCT00481845|4140694|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4314039|NCT00481845|4140695|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4314040|NCT00481845|4140693|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4314041|NCT00481845|4140694|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4314042|NCT00481845|4140695|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4314043|NCT00481845|4140693|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4314044|NCT00481845|4140694|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4314045|NCT00481845|4140695|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4314046|NCT00481845|4140693|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4314047|NCT00481845|4140694|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4314048|NCT00481845|4140695|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4314049|NCT00481845|4140693|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4314050|NCT00481845|4140694|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4314051|NCT00481845|4140695|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4314052|NCT00481845|4140693|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4314053|NCT00481845|4140694|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4314054|NCT00481845|4140695|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4314055|NCT00481845|4140693|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4314056|NCT00481845|4140694|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4314057|NCT00481845|4140695|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4314058|NCT00481845|4140693|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
4314059|NCT00481845|4140694|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
4314060|NCT00481845|4140695|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4314061|NCT00481845|4140693|B3||Female|Gender||Participants|Count of Participants|1|1.0||||||
4314062|NCT00481845|4140694|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
4314063|NCT00481845|4140695|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
4314064|NCT00481845|4140693|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4314065|NCT00481845|4140694|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4314066|NCT00481845|4140695|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4314067|NCT00481845|4140693|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4314068|NCT00481845|4140694|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4314069|NCT00481845|4140695|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4314070|NCT00481845|4140693|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4314071|NCT00481845|4140694|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4314072|NCT00481845|4140695|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4314073|NCT00481832|4140704|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4314074|NCT00481832|4140704|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4314075|NCT00481832|4140704|B1||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4314076|NCT00481832|4140704|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4314077|NCT00481832|4140704|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4314078|NCT00481832|4140704|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4314079|NCT00481832|4140704|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4314080|NCT00481832|4140704|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4314081|NCT00481832|4140704|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4314082|NCT00481832|4140704|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4314083|NCT00481832|4140704|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4314084|NCT00481832|4140704|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4314085|NCT00481832|4140704|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4314086|NCT00481832|4140704|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4314087|NCT00481832|4140704|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4314088|NCT00481767|4140717|B3|Not specified||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
4314089|NCT00481767|4140718|B2|Not specified||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4314090|NCT00481767|4140719|B1|Not specified||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
4314091|NCT00481767|4140717|B3|African/African american||Race/Ethnicity, Customized||Participants|Count of Participants|650|650.0||||||
4314092|NCT00481767|4140718|B2|African/African american||Race/Ethnicity, Customized||Participants|Count of Participants|219|219.0||||||
4314093|NCT00481767|4140719|B1|African/African american||Race/Ethnicity, Customized||Participants|Count of Participants|431|431.0||||||
4314094|NCT00481767|4140717|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4314095|NCT00481767|4140718|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4314096|NCT00481767|4140719|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4314097|NCT00481767|4140717|B3||Female|Sex: Female, Male||Participants|Count of Participants|676|676.0||||||
4314098|NCT00481767|4140718|B2||Female|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
4314099|NCT00481767|4140719|B1||Female|Sex: Female, Male||Participants|Count of Participants|450|450.0||||||
4314100|NCT00481767|4140717|B3|||Age||Years|Mean|16.9|16.9|Standard Deviation|4.29|4.29|||
4314101|NCT00481767|4140718|B2|||Age||Years|Mean|16.8|16.8|Standard Deviation|4.16|4.16|||
4314102|NCT00481767|4140719|B1|||Age||Years|Mean|16.9|16.9|Standard Deviation|4.36|4.36|||
4314103|NCT00481676|4140752|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4314104|NCT00481676|4140753|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4314105|NCT00481676|4140754|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4314106|NCT00481676|4140752|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4314107|NCT00481676|4140753|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4314108|NCT00481676|4140754|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4314109|NCT00481676|4140752|B3|||Age||years|Mean|40.5|40.5|Standard Deviation|12.0|12.0|||
4314110|NCT00481676|4140753|B2|||Age||years|Mean|42.3|42.3|Standard Deviation|15.0|15.0|||
4314111|NCT00481676|4140754|B1|||Age||years|Mean|39.1|39.1|Standard Deviation|9.0|9.0|||
4314112|NCT00481507|4140777|B3|United States||Region of Enrollment||participants|Number|125|125.0||||||
4314113|NCT00481507|4140778|B2|United States||Region of Enrollment||participants|Number|61|61.0||||||
4314114|NCT00481507|4140779|B1|United States||Region of Enrollment||participants|Number|64|64.0||||||
4314115|NCT00481507|4140777|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4314116|NCT00481507|4140778|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4314117|NCT00481507|4140779|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4314118|NCT00481507|4140777|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4314119|NCT00481507|4140778|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4314120|NCT00481507|4140779|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4314121|NCT00481507|4140777|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4314122|NCT00481507|4140778|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4314123|NCT00481507|4140779|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4314124|NCT00481507|4140777|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4314125|NCT00481507|4140778|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4314126|NCT00481507|4140779|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4314127|NCT00481507|4140777|B3||<=18 years|Age||Participants|Count of Participants|125|125.0||||||
4314128|NCT00481507|4140778|B2||<=18 years|Age||Participants|Count of Participants|61|61.0||||||
4314129|NCT00481507|4140779|B1||<=18 years|Age||Participants|Count of Participants|64|64.0||||||
4314130|NCT00481351|4140786|B3|||triglycerides fractional clearance rate||min-1|Mean|0.016602|0.016602|Standard Deviation|0.01004|0.01004|||
4314131|NCT00481351|4140787|B2|||triglycerides fractional clearance rate||min-1|Mean|0.0161|0.0161|Standard Deviation|0.0096|0.0096|||
4314132|NCT00481351|4140788|B1|||triglycerides fractional clearance rate||min-1|Mean|0.0171|0.0171|Standard Deviation|0.0108|0.0108|||
4314133|NCT00481351|4140786|B3|||cholesteryl ester fractional clearance rate||min-1|Mean|0.0048576|0.0048576|Standard Deviation|0.00381|0.00381|||
4314134|NCT00481351|4140787|B2|||cholesteryl ester fractional clearance rate||min-1|Mean|0.0046|0.0046|Standard Deviation|0.0029|0.0029|||
4314135|NCT00481351|4140788|B1|||cholesteryl ester fractional clearance rate||min-1|Mean|0.0051|0.0051|Standard Deviation|0.0046|0.0046|||
4314136|NCT00481351|4140786|B3|||Triglycerides||mg/dl|Mean|188.52|188.52|Standard Deviation|19.60|19.6|||
4314137|NCT00481351|4140787|B2|||Triglycerides||mg/dl|Mean|213.75|213.75|Standard Deviation|112.85|112.85|||
4314138|NCT00481351|4140788|B1|||Triglycerides||mg/dl|Mean|165.23|165.23|Standard Deviation|80.76|80.76|||
4314139|NCT00481351|4140786|B3|||High Density Lipoprotein||mg/dl|Mean|46.64|46.64|Standard Deviation|12.28|12.28|||
4314140|NCT00481351|4140787|B2|||High Density Lipoprotein||mg/dl|Mean|45.08|45.08|Standard Deviation|13.04|13.04|||
4314141|NCT00481351|4140788|B1|||High Density Lipoprotein||mg/dl|Mean|48.08|48.08|Standard Deviation|11.88|11.88|||
4314142|NCT00481351|4140786|B3|||Low Density Lipoprotein||mg/dl|Median|140.68|140.68|Standard Deviation|21.61|21.61|||
4314143|NCT00481351|4140787|B2|||Low Density Lipoprotein||mg/dl|Median|139.42|139.42|Standard Deviation|22.19|22.19|||
4314144|NCT00481351|4140788|B1|||Low Density Lipoprotein||mg/dl|Median|141.85|141.85|Standard Deviation|21.91|21.91|||
4314145|NCT00481351|4140786|B3|||Total cholesterol||mg/dl|Mean|219.08|219.08|Standard Deviation|28.61|28.61|||
4314146|NCT00481351|4140787|B2|||Total cholesterol||mg/dl|Mean|215.33|215.33|Standard Deviation|33.32|33.32|||
4314147|NCT00481351|4140788|B1|||Total cholesterol||mg/dl|Mean|222.54|222.54|Standard Deviation|24.35|24.35|||
4314148|NCT00481351|4140786|B3|||Apolipoprotein B||mg/dl|Median|119.86|119.86|Standard Deviation|27.06|27.06|||
4314149|NCT00481351|4140787|B2|||Apolipoprotein B||mg/dl|Median|115.74|115.74|Standard Deviation|19.37|19.37|||
4314150|NCT00481351|4140788|B1|||Apolipoprotein B||mg/dl|Median|123.67|123.67|Standard Deviation|32.99|32.99|||
4314151|NCT00481351|4140786|B3|||Apolipoprotein A||mg/dl|Mean|137.89|137.89|Standard Deviation|29.39|29.39|||
4314152|NCT00481351|4140787|B2|||Apolipoprotein A||mg/dl|Mean|136.5|136.5|Standard Deviation|30.66|30.66|||
4314153|NCT00481351|4140788|B1|||Apolipoprotein A||mg/dl|Mean|139.18|139.18|Standard Deviation|29.36|29.36|||
4314154|NCT00481351|4140786|B3|||Glucose||mg/dl|Mean|97.64|97.64|Standard Deviation|11.10|11.1|||
4314155|NCT00481351|4140787|B2|||Glucose||mg/dl|Mean|102.17|102.17|Standard Deviation|11.39|11.39|||
4314156|NCT00481351|4140788|B1|||Glucose||mg/dl|Mean|93.46|93.46|Standard Deviation|9.40|9.4|||
4314157|NCT00481351|4140786|B3|||alanine aminotransferase||mg/dl|Mean|22.2|22.2|Standard Deviation|9.06|9.06|||
4314158|NCT00481351|4140787|B2|||alanine aminotransferase||mg/dl|Mean|20|20.0|Standard Deviation|4.88|4.88|||
4314159|NCT00481351|4140788|B1|||alanine aminotransferase||mg/dl|Mean|24.23|24.23|Standard Deviation|11.54|11.54|||
4314160|NCT00481351|4140786|B3|||Body Mass Index||kg/m2|Mean|27.96|27.96|Standard Deviation|3.63|3.63|||
4314161|NCT00481351|4140787|B2|||Body Mass Index||kg/m2|Mean|27.96|27.96|Standard Deviation|3.63|3.63|||
4314162|NCT00481351|4140788|B1|||Body Mass Index||kg/m2|Mean|27.11|27.11|Standard Deviation|3.41|3.41|||
4314163|NCT00481351|4140786|B3|||Waist||cm|Median|95.92|95.92|Standard Deviation|8.81|8.81|||
4314164|NCT00481351|4140787|B2|||Waist||cm|Median|97.08|97.08|Standard Deviation|8.63|8.63|||
4314165|NCT00481351|4140788|B1|||Waist||cm|Median|94.85|94.85|Standard Deviation|9.18|9.18|||
4314166|NCT00481351|4140786|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4314167|NCT00481351|4140787|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4314168|NCT00481351|4140788|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4314169|NCT00481351|4140786|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4314170|NCT00481351|4140787|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4314171|NCT00481351|4140788|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4314172|NCT00481351|4140786|B3|||Age||years|Mean|60.68|60.68|Standard Deviation|4.96|4.96|||
4314173|NCT00481351|4140787|B2|||Age||years|Mean|60.08|60.08|Standard Deviation|3.42|3.42|||
4314174|NCT00481351|4140788|B1|||Age||years|Mean|61.23|61.23|Standard Deviation|6.4|6.4|||
4314175|NCT00481351|4140786|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4314176|NCT00481351|4140787|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4314177|NCT00481351|4140788|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4314178|NCT00481351|4140786|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4314179|NCT00481351|4140787|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4314180|NCT00481351|4140788|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4314181|NCT00481351|4140786|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4314182|NCT00481351|4140787|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4314183|NCT00481351|4140788|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4314184|NCT00481247|4140803|B3|||Number of Participants With Spleen Involvement||Participants|Number|154|154.0||||||
4314185|NCT00481247|4140804|B2|||Number of Participants With Spleen Involvement||Participants|Number|71|71.0||||||
4314186|NCT00481247|4140805|B1|||Number of Participants With Spleen Involvement||Participants|Number|83|83.0||||||
4314187|NCT00481247|4140803|B3|||Number of Patients With Liver Involvement||Participants|Number|55|55.0||||||
4314188|NCT00481247|4140804|B2|||Number of Patients With Liver Involvement||Participants|Number|18|18.0||||||
4314189|NCT00481247|4140805|B1|||Number of Patients With Liver Involvement||Participants|Number|37|37.0||||||
4314190|NCT00481247|4140803|B3|ECOG score=2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|2|2.0||||||
4314191|NCT00481247|4140804|B2|ECOG score=2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|2|2.0||||||
4314192|NCT00481247|4140805|B1|ECOG score=2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|0|0.0||||||
4314193|NCT00481247|4140803|B3|ECOG score=1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|99|99.0||||||
4314194|NCT00481247|4140804|B2|ECOG score=1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|53|53.0||||||
4314195|NCT00481247|4140805|B1|ECOG score=1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|46|46.0||||||
4314196|NCT00481247|4140803|B3|ECOG score=0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|418|418.0||||||
4314197|NCT00481247|4140804|B2|ECOG score=0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|205|205.0||||||
4314198|NCT00481247|4140805|B1|ECOG score=0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all predisease performance without restriction and (worst score) 5=death.|Participants|Number|213|213.0||||||
4314199|NCT00481247|4140803|B3|Other||Race/Ethnicity, Customized||Participants|Number|38|38.0||||||
4314200|NCT00481247|4140804|B2|Other||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
4314201|NCT00481247|4140805|B1|Other||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4314202|NCT00481247|4140803|B3|Asian||Race/Ethnicity, Customized||Participants|Number|203|203.0||||||
4314203|NCT00481247|4140804|B2|Asian||Race/Ethnicity, Customized||Participants|Number|95|95.0||||||
4314204|NCT00481247|4140805|B1|Asian||Race/Ethnicity, Customized||Participants|Number|108|108.0||||||
4314205|NCT00481247|4140803|B3|Black/African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4314206|NCT00481247|4140804|B2|Black/African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4314207|NCT00481247|4140805|B1|Black/African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4314208|NCT00481247|4140803|B3|White||Race/Ethnicity, Customized||Participants|Number|275|275.0||||||
4314209|NCT00481247|4140804|B2|White||Race/Ethnicity, Customized||Participants|Number|143|143.0||||||
4314210|NCT00481247|4140805|B1|White||Race/Ethnicity, Customized||Participants|Number|132|132.0||||||
4314211|NCT00481247|4140803|B3||Male|Gender||Participants|Count of Participants|307|307.0||||||
4314212|NCT00481247|4140804|B2||Male|Gender||Participants|Count of Participants|163|163.0||||||
4314213|NCT00481247|4140805|B1||Male|Gender||Participants|Count of Participants|144|144.0||||||
4314214|NCT00481247|4140803|B3||Female|Gender||Participants|Count of Participants|212|212.0||||||
4314215|NCT00481247|4140804|B2||Female|Gender||Participants|Count of Participants|97|97.0||||||
4314216|NCT00481247|4140805|B1||Female|Gender||Participants|Count of Participants|115|115.0||||||
4314217|NCT00481247|4140803|B3|>75 years||Age, Customized||Participants|Number|11|11.0||||||
4314218|NCT00481247|4140804|B2|>75 years||Age, Customized||Participants|Number|4|4.0||||||
4314219|NCT00481247|4140805|B1|>75 years||Age, Customized||Participants|Number|7|7.0||||||
4314220|NCT00481247|4140803|B3|Between 66 and 75 years||Age, Customized||Participants|Number|33|33.0||||||
4314221|NCT00481247|4140804|B2|Between 66 and 75 years||Age, Customized||Participants|Number|20|20.0||||||
4314222|NCT00481247|4140805|B1|Between 66 and 75 years||Age, Customized||Participants|Number|13|13.0||||||
4314223|NCT00481247|4140803|B3|Between 46 and 65 years||Age, Customized||Participants|Number|236|236.0||||||
4314224|NCT00481247|4140804|B2|Between 46 and 65 years||Age, Customized||Participants|Number|125|125.0||||||
4314225|NCT00481247|4140805|B1|Between 46 and 65 years||Age, Customized||Participants|Number|111|111.0||||||
4314226|NCT00481247|4140803|B3|Between 21 and 45 years||Age, Customized||Participants|Number|225|225.0||||||
4314227|NCT00481247|4140804|B2|Between 21 and 45 years||Age, Customized||Participants|Number|102|102.0||||||
4314228|NCT00481247|4140805|B1|Between 21 and 45 years||Age, Customized||Participants|Number|123|123.0||||||
4314229|NCT00481247|4140803|B3|<20 years||Age, Customized||Participants|Number|14|14.0||||||
4314230|NCT00481247|4140804|B2|<20 years||Age, Customized||Participants|Number|9|9.0||||||
4314231|NCT00481247|4140805|B1|<20 years||Age, Customized||Participants|Number|5|5.0||||||
4314232|NCT00481247|4140803|B3|||Age||Years|Mean|46.7|46.7|Standard Deviation|14.2|14.2|||
4314233|NCT00481247|4140804|B2|||Age||Years|Mean|47.1|47.1|Standard Deviation|13.9|13.9|||
4314234|NCT00481247|4140805|B1|||Age||Years|Mean|46.4|46.4|Standard Deviation|14.6|14.6|||
4314235|NCT00481195|4140828|B3|Bulgaria||Region of Enrollment||participants|Number|23|23.0||||||
4314236|NCT00481195|4140829|B2|Bulgaria||Region of Enrollment||participants|Number|15|15.0||||||
4314237|NCT00481195|4140830|B1|Bulgaria||Region of Enrollment||participants|Number|8|8.0||||||
4314238|NCT00481195|4140828|B3|Romania||Region of Enrollment||participants|Number|12|12.0||||||
4314239|NCT00481195|4140829|B2|Romania||Region of Enrollment||participants|Number|7|7.0||||||
4314240|NCT00481195|4140830|B1|Romania||Region of Enrollment||participants|Number|5|5.0||||||
4314241|NCT00481195|4140828|B3|Hungary||Region of Enrollment||participants|Number|2|2.0||||||
4314242|NCT00481195|4140829|B2|Hungary||Region of Enrollment||participants|Number|2|2.0||||||
4314243|NCT00481195|4140830|B1|Hungary||Region of Enrollment||participants|Number|0|0.0||||||
4314244|NCT00481195|4140828|B3|United States||Region of Enrollment||participants|Number|220|220.0||||||
4314245|NCT00481195|4140829|B2|United States||Region of Enrollment||participants|Number|105|105.0||||||
4314246|NCT00481195|4140830|B1|United States||Region of Enrollment||participants|Number|115|115.0||||||
4314247|NCT00481195|4140828|B3||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4314248|NCT00481195|4140829|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4314249|NCT00481195|4140830|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4314250|NCT00481195|4140828|B3||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4314251|NCT00481195|4140829|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4314252|NCT00481195|4140830|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4314253|NCT00481195|4140828|B3|||Age||years|Mean|43.7|43.7|Standard Deviation|11.47|11.47|||
4314254|NCT00481195|4140829|B2|||Age||years|Mean|44.9|44.9|Standard Deviation|11.53|11.53|||
4314255|NCT00481195|4140830|B1|||Age||years|Mean|42.6|42.6|Standard Deviation|11.34|11.34|||
4314256|NCT00481195|4140828|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4314257|NCT00481195|4140829|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4314258|NCT00481195|4140830|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4314259|NCT00481195|4140828|B3||Between 18 and 65 years|Age||Participants|Count of Participants|257|257.0||||||
4314260|NCT00481195|4140829|B2||Between 18 and 65 years|Age||Participants|Count of Participants|129|129.0||||||
4314261|NCT00481195|4140830|B1||Between 18 and 65 years|Age||Participants|Count of Participants|128|128.0||||||
4314262|NCT00481195|4140828|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4314263|NCT00481195|4140829|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4314264|NCT00481195|4140830|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4314265|NCT00481078|4140915|B3|United States||Region of Enrollment||participants|Number|94|94.0||||||
4314266|NCT00481078|4140916|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
4314267|NCT00481078|4140917|B1|United States||Region of Enrollment||participants|Number|62|62.0||||||
4314268|NCT00481078|4140915|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4314269|NCT00481078|4140916|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4314270|NCT00481078|4140917|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4314271|NCT00481078|4140915|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4314272|NCT00481078|4140916|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4314273|NCT00481078|4140917|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4314274|NCT00481078|4140915|B3|||Age||years|Median|65|65.0|Full Range|||32.0|85.0|
4314275|NCT00481078|4140916|B2|||Age||years|Median|66.5|66.5|Full Range|||48.0|85.0|
4314276|NCT00481078|4140917|B1|||Age||years|Median|64|64.0|Full Range|||32.0|83.0|
4314277|NCT00481065|4140928|B9||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4314278|NCT00481065|4140929|B8||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4314279|NCT00481065|4140930|B7||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4314280|NCT00481065|4140931|B6||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4314281|NCT00481065|4140932|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4314282|NCT00481065|4140933|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4314283|NCT00481065|4140934|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4314284|NCT00481065|4140935|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4314285|NCT00481065|4140936|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4314286|NCT00481065|4140928|B9||Female|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
4314287|NCT00481065|4140929|B8||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4314288|NCT00481065|4140930|B7||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4314289|NCT00481065|4140931|B6||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4314290|NCT00481065|4140932|B5||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4314291|NCT00481065|4140933|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4314292|NCT00481065|4140934|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4314293|NCT00481065|4140935|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4314294|NCT00481065|4140936|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4314295|NCT00481065|4140928|B9|||Age||years|Mean|29.3|29.3|Standard Deviation|6.2|6.2|||
4314296|NCT00481065|4140929|B8|||Age||years|Mean|30.1|30.1|Standard Deviation|6.2|6.2|||
4314297|NCT00481065|4140930|B7|||Age||years|Mean|27.9|27.9|Standard Deviation|6.2|6.2|||
4314298|NCT00481065|4140931|B6|||Age||years|Mean|28.8|28.8|Standard Deviation|6.2|6.2|||
4314299|NCT00481065|4140932|B5|||Age||years|Mean|29.6|29.6|Standard Deviation|6.1|6.1|||
4314300|NCT00481065|4140933|B4|||Age||years|Mean|29.8|29.8|Standard Deviation|6.8|6.8|||
4314301|NCT00481065|4140934|B3|||Age||years|Mean|29.5|29.5|Standard Deviation|6.5|6.5|||
4314302|NCT00481065|4140935|B2|||Age||years|Mean|29.4|29.4|Standard Deviation|5.8|5.8|||
4314303|NCT00481065|4140936|B1|||Age||years|Mean|29|29.0|Standard Deviation|6.2|6.2|||
4314304|NCT00480987|4141029|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4314305|NCT00480987|4141029|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4314306|NCT00480987|4141029|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4314307|NCT00480987|4141029|B1|||Age||years|Median|58|58.0|Full Range|||6.0|72.0|
4314308|NCT00480857|4141033|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4314309|NCT00480857|4141033|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4314310|NCT00480857|4141033|B1|||Age||years|Mean|66|66.0|Full Range|||43.0|78.0|
4314311|NCT00480779|4141041|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
4314312|NCT00480779|4141042|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4314313|NCT00480779|4141043|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4314314|NCT00480779|4141041|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4314315|NCT00480779|4141042|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4314316|NCT00480779|4141043|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4314317|NCT00480779|4141041|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4314318|NCT00480779|4141042|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4314319|NCT00480779|4141043|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4314320|NCT00480779|4141041|B3|||Age||years|Mean|59.1|59.1|Standard Deviation|12.8|12.8|||
4314321|NCT00480779|4141042|B2|||Age||years|Mean|57.3|57.3|Standard Deviation|13.6|13.6|||
4314322|NCT00480779|4141043|B1|||Age||years|Mean|61.0|61.0|Standard Deviation|11.9|11.9|||
4314323|NCT00480740|4141068|B4|Ebstein's anomaly||Primary diagnosis||participants|Number|1|1.0||||||
4314324|NCT00480740|4141069|B3|Ebstein's anomaly||Primary diagnosis||participants|Number|1|1.0||||||
4314325|NCT00480740|4141070|B2|Ebstein's anomaly||Primary diagnosis||participants|Number|0|0.0||||||
4314326|NCT00480740|4141071|B1|Ebstein's anomaly||Primary diagnosis||participants|Number|0|0.0||||||
4314327|NCT00480740|4141068|B4|DORV||Primary diagnosis||participants|Number|1|1.0||||||
4314328|NCT00480740|4141069|B3|DORV||Primary diagnosis||participants|Number|1|1.0||||||
4314329|NCT00480740|4141070|B2|DORV||Primary diagnosis||participants|Number|0|0.0||||||
4314330|NCT00480740|4141071|B1|DORV||Primary diagnosis||participants|Number|0|0.0||||||
4314331|NCT00480740|4141068|B4|Tricuspid Atresia||Primary diagnosis||participants|Number|2|2.0||||||
4314332|NCT00480740|4141069|B3|Tricuspid Atresia||Primary diagnosis||participants|Number|2|2.0||||||
4314333|NCT00480740|4141070|B2|Tricuspid Atresia||Primary diagnosis||participants|Number|0|0.0||||||
4314334|NCT00480740|4141071|B1|Tricuspid Atresia||Primary diagnosis||participants|Number|0|0.0||||||
4314335|NCT00480740|4141068|B4|Cardiomyopathy||Primary diagnosis||participants|Number|4|4.0||||||
4314336|NCT00480740|4141069|B3|Cardiomyopathy||Primary diagnosis||participants|Number|0|0.0||||||
4314337|NCT00480740|4141070|B2|Cardiomyopathy||Primary diagnosis||participants|Number|4|4.0||||||
4314338|NCT00480740|4141071|B1|Cardiomyopathy||Primary diagnosis||participants|Number|0|0.0||||||
4314339|NCT00480740|4141068|B4|Unbalanced AVC||Primary diagnosis||participants|Number|1|1.0||||||
4314340|NCT00480740|4141069|B3|Unbalanced AVC||Primary diagnosis||participants|Number|0|0.0||||||
4314341|NCT00480740|4141070|B2|Unbalanced AVC||Primary diagnosis||participants|Number|1|1.0||||||
4314342|NCT00480740|4141071|B1|Unbalanced AVC||Primary diagnosis||participants|Number|0|0.0||||||
4314343|NCT00480740|4141068|B4|HLHS||Primary diagnosis||participants|Number|4|4.0||||||
4314344|NCT00480740|4141069|B3|HLHS||Primary diagnosis||participants|Number|2|2.0||||||
4314345|NCT00480740|4141070|B2|HLHS||Primary diagnosis||participants|Number|2|2.0||||||
4314346|NCT00480740|4141071|B1|HLHS||Primary diagnosis||participants|Number|0|0.0||||||
4314347|NCT00480740|4141068|B4|PA with IVS||Primary diagnosis||participants|Number|2|2.0||||||
4314348|NCT00480740|4141069|B3|PA with IVS||Primary diagnosis||participants|Number|0|0.0||||||
4314349|NCT00480740|4141070|B2|PA with IVS||Primary diagnosis||participants|Number|2|2.0||||||
4314350|NCT00480740|4141071|B1|PA with IVS||Primary diagnosis||participants|Number|0|0.0||||||
4314351|NCT00480740|4141068|B4|PDA||Primary diagnosis||participants|Number|16|16.0||||||
4314352|NCT00480740|4141069|B3|PDA||Primary diagnosis||participants|Number|0|0.0||||||
4314353|NCT00480740|4141070|B2|PDA||Primary diagnosis||participants|Number|0|0.0||||||
4314354|NCT00480740|4141071|B1|PDA||Primary diagnosis||participants|Number|16|16.0||||||
4314355|NCT00480740|4141068|B4|ASD||Primary diagnosis||participants|Number|10|10.0||||||
4314356|NCT00480740|4141069|B3|ASD||Primary diagnosis||participants|Number|0|0.0||||||
4314357|NCT00480740|4141070|B2|ASD||Primary diagnosis||participants|Number|0|0.0||||||
4314358|NCT00480740|4141071|B1|ASD||Primary diagnosis||participants|Number|10|10.0||||||
4314359|NCT00480740|4141068|B4|ASA 3||American Society of Anesthesiology (ASA) physical status classification|Category 1 means healthy patient Category 2 means mild systemic disease Category 3 means severe systemic disease|participants|Number|6|6.0||||||
4314360|NCT00480740|4141069|B3|ASA 3||American Society of Anesthesiology (ASA) physical status classification|Category 1 means healthy patient Category 2 means mild systemic disease Category 3 means severe systemic disease|participants|Number|6|6.0||||||
4314361|NCT00480740|4141070|B2|ASA 3||American Society of Anesthesiology (ASA) physical status classification|Category 1 means healthy patient Category 2 means mild systemic disease Category 3 means severe systemic disease|participants|Number|0|0.0||||||
4314362|NCT00480740|4141071|B1|ASA 3||American Society of Anesthesiology (ASA) physical status classification|Category 1 means healthy patient Category 2 means mild systemic disease Category 3 means severe systemic disease|participants|Number|0|0.0||||||
4314363|NCT00480740|4141068|B4|ASA 2||American Society of Anesthesiology (ASA) physical status classification|Category 1 means healthy patient Category 2 means mild systemic disease Category 3 means severe systemic disease|participants|Number|17|17.0||||||
4314364|NCT00480740|4141069|B3|ASA 2||American Society of Anesthesiology (ASA) physical status classification|Category 1 means healthy patient Category 2 means mild systemic disease Category 3 means severe systemic disease|participants|Number|0|0.0||||||
4314365|NCT00480740|4141070|B2|ASA 2||American Society of Anesthesiology (ASA) physical status classification|Category 1 means healthy patient Category 2 means mild systemic disease Category 3 means severe systemic disease|participants|Number|9|9.0||||||
4314366|NCT00480740|4141071|B1|ASA 2||American Society of Anesthesiology (ASA) physical status classification|Category 1 means healthy patient Category 2 means mild systemic disease Category 3 means severe systemic disease|participants|Number|8|8.0||||||
4314367|NCT00480740|4141068|B4|ASA 1||American Society of Anesthesiology (ASA) physical status classification|Category 1 means healthy patient Category 2 means mild systemic disease Category 3 means severe systemic disease|participants|Number|18|18.0||||||
4314368|NCT00480740|4141069|B3|ASA 1||American Society of Anesthesiology (ASA) physical status classification|Category 1 means healthy patient Category 2 means mild systemic disease Category 3 means severe systemic disease|participants|Number|0|0.0||||||
4314369|NCT00480740|4141070|B2|ASA 1||American Society of Anesthesiology (ASA) physical status classification|Category 1 means healthy patient Category 2 means mild systemic disease Category 3 means severe systemic disease|participants|Number|0|0.0||||||
4314370|NCT00480740|4141071|B1|ASA 1||American Society of Anesthesiology (ASA) physical status classification|Category 1 means healthy patient Category 2 means mild systemic disease Category 3 means severe systemic disease|participants|Number|18|18.0||||||
4314371|NCT00480740|4141068|B4|||Weight (kg)||kg|Mean|27.3|27.3|Standard Deviation|13.6|13.6|||
4314372|NCT00480740|4141069|B3|||Weight (kg)||kg|Mean|21.4|21.4|Standard Deviation|8.7|8.7|||
4314373|NCT00480740|4141070|B2|||Weight (kg)||kg|Mean|35.2|35.2|Standard Deviation|17.8|17.8|||
4314374|NCT00480740|4141071|B1|||Weight (kg)||kg|Mean|19.1|19.1|Standard Deviation|14.3|14.3|||
4314375|NCT00480740|4141068|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4314376|NCT00480740|4141069|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4314377|NCT00480740|4141070|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4314378|NCT00480740|4141071|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4314379|NCT00480740|4141068|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4314380|NCT00480740|4141069|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4314381|NCT00480740|4141070|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4314382|NCT00480740|4141071|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4314383|NCT00480740|4141068|B4|||Age||years|Mean|6.9|6.9|Standard Deviation|6.2|6.2|||
4314384|NCT00480740|4141069|B3|||Age||years|Mean|5.5|5.5|Standard Deviation|3.3|3.3|||
4314385|NCT00480740|4141070|B2|||Age||years|Mean|11|11.0|Standard Deviation|4.5|4.5|||
4314386|NCT00480740|4141071|B1|||Age||years|Mean|4.3|4.3|Standard Deviation|4|4.0|||
4314387|NCT00480636|4141081|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4314388|NCT00480636|4141081|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4314389|NCT00480636|4141081|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|10.1|10.1|||
4314390|NCT00480636|4141081|B1|Unspecified||Age, Customized||Participants|Number|1|1.0||||||
4314391|NCT00480636|4141081|B1|>= 65 years||Age, Customized||Participants|Number|39|39.0||||||
4314392|NCT00480636|4141081|B1|Between 45 and 64 years||Age, Customized||Participants|Number|58|58.0||||||
4314393|NCT00480636|4141081|B1|Between 18 and 44 years||Age, Customized||Participants|Number|4|4.0||||||
4314394|NCT00480532|4141089|B5|United States||Region of Enrollment||participants|Number|131|131.0||||||
4314395|NCT00480532|4141090|B4|United States||Region of Enrollment||participants|Number|32|32.0||||||
4314396|NCT00480532|4141091|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
4314397|NCT00480532|4141092|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4314398|NCT00480532|4141093|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4314399|NCT00480532|4141089|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4314400|NCT00480532|4141090|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4314401|NCT00480532|4141091|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4314402|NCT00480532|4141092|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4314403|NCT00480532|4141093|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4314404|NCT00480532|4141089|B5||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4314405|NCT00480532|4141090|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4314406|NCT00480532|4141091|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4314407|NCT00480532|4141092|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4314408|NCT00480532|4141093|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4314409|NCT00480532|4141089|B5|||Age||years|Mean|28.0|28.0|Standard Deviation|7.0|7.0|||
4314410|NCT00480532|4141090|B4|||Age||years|Mean|28.6|28.6|Standard Deviation|6.1|6.1|||
4314411|NCT00480532|4141091|B3|||Age||years|Mean|27.8|27.8|Standard Deviation|5.4|5.4|||
4314412|NCT00480532|4141092|B2|||Age||years|Mean|27.5|27.5|Standard Deviation|6.8|6.8|||
4314413|NCT00480532|4141093|B1|||Age||years|Mean|28.0|28.0|Standard Deviation|6.6|6.6|||
4314414|NCT00480532|4141089|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4314415|NCT00480532|4141090|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4314416|NCT00480532|4141091|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4314417|NCT00480532|4141092|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4314418|NCT00480532|4141093|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4314419|NCT00480532|4141089|B5||Between 18 and 65 years|Age||Participants|Count of Participants|130|130.0||||||
4314420|NCT00480532|4141090|B4||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4314421|NCT00480532|4141091|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4314422|NCT00480532|4141092|B2||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4314423|NCT00480532|4141093|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4314424|NCT00480532|4141089|B5||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4314425|NCT00480532|4141090|B4||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4314426|NCT00480532|4141091|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4314427|NCT00480532|4141092|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4314428|NCT00480532|4141093|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4314429|NCT00480493|4141114|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4314430|NCT00480493|4141115|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4314431|NCT00480493|4141116|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4314432|NCT00480493|4141114|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4314433|NCT00480493|4141115|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4314434|NCT00480493|4141116|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4314435|NCT00480493|4141114|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4314436|NCT00480493|4141115|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4314437|NCT00480493|4141116|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4314438|NCT00480493|4141114|B3|||Age||years|Mean|36|36.0|Standard Deviation|6|6.0|||
4314439|NCT00480493|4141115|B2|||Age||years|Mean|36|36.0|Standard Deviation|6|6.0|||
4314440|NCT00480493|4141116|B1|||Age||years|Mean|36|36.0|Standard Deviation|6.5|6.5|||
4314441|NCT00480493|4141114|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4314442|NCT00480493|4141115|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4314443|NCT00480493|4141116|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4314444|NCT00480493|4141114|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4314445|NCT00480493|4141115|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4314446|NCT00480493|4141116|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4314447|NCT00480493|4141114|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4314448|NCT00480493|4141115|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4314449|NCT00480493|4141116|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4314450|NCT00480324|4141127|B3||Male|Sex: Female, Male||Participants|Count of Participants|402|402.0||||||
4314451|NCT00480324|4141128|B2||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4314452|NCT00480324|4141129|B1||Male|Sex: Female, Male||Participants|Count of Participants|279|279.0||||||
4314453|NCT00480324|4141127|B3||Female|Sex: Female, Male||Participants|Count of Participants|363|363.0||||||
4314454|NCT00480324|4141128|B2||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4314455|NCT00480324|4141129|B1||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4314456|NCT00480324|4141127|B3|||Age||weeks|Mean|7.7|7.7|Standard Deviation|2.01|2.01|||
4314457|NCT00480324|4141128|B2|||Age||weeks|Mean|7.7|7.7|Standard Deviation|2.05|2.05|||
4314458|NCT00480324|4141129|B1|||Age||weeks|Mean|7.7|7.7|Standard Deviation|1.99|1.99|||
4314459|NCT00479882|4141156|B5||Male|Sex: Female, Male||Participants|Count of Participants|1126|1126.0||||||
4314460|NCT00479882|4141157|B4||Male|Sex: Female, Male||Participants|Count of Participants|289|289.0||||||
4314461|NCT00479882|4141158|B3||Male|Sex: Female, Male||Participants|Count of Participants|284|284.0||||||
4314462|NCT00479882|4141159|B2||Male|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
4314463|NCT00479882|4141160|B1||Male|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
4314464|NCT00479882|4141156|B5||Female|Sex: Female, Male||Participants|Count of Participants|1288|1288.0||||||
4314465|NCT00479882|4141157|B4||Female|Sex: Female, Male||Participants|Count of Participants|316|316.0||||||
4314466|NCT00479882|4141158|B3||Female|Sex: Female, Male||Participants|Count of Participants|313|313.0||||||
4314467|NCT00479882|4141159|B2||Female|Sex: Female, Male||Participants|Count of Participants|334|334.0||||||
4314468|NCT00479882|4141160|B1||Female|Sex: Female, Male||Participants|Count of Participants|325|325.0||||||
4314469|NCT00479882|4141156|B5||>=65 years|Age||Participants|Count of Participants|508|508.0||||||
4314470|NCT00479882|4141157|B4||>=65 years|Age||Participants|Count of Participants|128|128.0||||||
4314471|NCT00479882|4141158|B3||>=65 years|Age||Participants|Count of Participants|129|129.0||||||
4314472|NCT00479882|4141159|B2||>=65 years|Age||Participants|Count of Participants|132|132.0||||||
4314473|NCT00479882|4141160|B1||>=65 years|Age||Participants|Count of Participants|119|119.0||||||
4314474|NCT00479882|4141156|B5||Between 18 and 65 years|Age||Participants|Count of Participants|1906|1906.0||||||
4314475|NCT00479882|4141157|B4||Between 18 and 65 years|Age||Participants|Count of Participants|477|477.0||||||
4314476|NCT00479882|4141158|B3||Between 18 and 65 years|Age||Participants|Count of Participants|468|468.0||||||
4314477|NCT00479882|4141159|B2||Between 18 and 65 years|Age||Participants|Count of Participants|470|470.0||||||
4314478|NCT00479882|4141160|B1||Between 18 and 65 years|Age||Participants|Count of Participants|491|491.0||||||
4314479|NCT00479882|4141156|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4314480|NCT00479882|4141157|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4314481|NCT00479882|4141158|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4314482|NCT00479882|4141159|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4314483|NCT00479882|4141160|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4314484|NCT00479856|4141293|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4314485|NCT00479856|4141293|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4314486|NCT00479856|4141293|B1|White||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4314487|NCT00479856|4141293|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4314488|NCT00479856|4141293|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4314489|NCT00479856|4141293|B1|||Age||years|Mean|61.9|61.9|Standard Deviation|12.3|12.3|||
4314490|NCT00479765|4141302|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4314491|NCT00479765|4141302|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4314492|NCT00479765|4141302|B1|||Age||years|Mean|60|60.0|Full Range|||46.0|73.0|
4314493|NCT00479713|4141306|B3|||Triglycerides||mg/dL|Median|1.42|1.42|Standard Deviation|0.88|0.88|||
4314494|NCT00479713|4141307|B2|||Triglycerides||mg/dL|Median|1.41|1.41|Standard Deviation|0.87|0.87|||
4314495|NCT00479713|4141308|B1|||Triglycerides||mg/dL|Median|1.46|1.46|Standard Deviation|0.86|0.86|||
4314496|NCT00479713|4141306|B3|||Total cholesterol:High Density Lipoprotein-Cholesterol (HDL-C) ratio||Total cholesterol:HDL-C ratio|Mean|3.95|3.95|Standard Deviation|0.90|0.9|||
4314497|NCT00479713|4141307|B2|||Total cholesterol:High Density Lipoprotein-Cholesterol (HDL-C) ratio||Total cholesterol:HDL-C ratio|Mean|3.96|3.96|Standard Deviation|0.90|0.9|||
4314498|NCT00479713|4141308|B1|||Total cholesterol:High Density Lipoprotein-Cholesterol (HDL-C) ratio||Total cholesterol:HDL-C ratio|Mean|3.94|3.94|Standard Deviation|0.89|0.89|||
4314499|NCT00479713|4141306|B3|||Total Cholesterol||mg/dL|Mean|5.38|5.38|Standard Deviation|0.59|0.59|||
4314500|NCT00479713|4141307|B2|||Total Cholesterol||mg/dL|Mean|5.38|5.38|Standard Deviation|0.61|0.61|||
4314501|NCT00479713|4141308|B1|||Total Cholesterol||mg/dL|Mean|5.38|5.38|Standard Deviation|0.57|0.57|||
4314502|NCT00479713|4141306|B3|||Non-High Density Lipoprotein-Cholesterol (Non-HDL-C)||mg/dL|Mean|3.95|3.95|Standard Deviation|0.55|0.55|||
4314503|NCT00479713|4141307|B2|||Non-High Density Lipoprotein-Cholesterol (Non-HDL-C)||mg/dL|Mean|3.95|3.95|Standard Deviation|0.56|0.56|||
4314504|NCT00479713|4141308|B1|||Non-High Density Lipoprotein-Cholesterol (Non-HDL-C)||mg/dL|Mean|3.95|3.95|Standard Deviation|0.55|0.55|||
4314505|NCT00479713|4141306|B3|||Low Density Lipoprotein-Cholesterol (LDL-C):High Density Lipoprotein-Cholesterol (HDL-C) ratio||LDL-C:HDL-C ratio|Mean|2.39|2.39|Standard Deviation|0.65|0.65|||
4314506|NCT00479713|4141307|B2|||Low Density Lipoprotein-Cholesterol (LDL-C):High Density Lipoprotein-Cholesterol (HDL-C) ratio||LDL-C:HDL-C ratio|Mean|2.40|2.4|Standard Deviation|0.65|0.65|||
4314507|NCT00479713|4141308|B1|||Low Density Lipoprotein-Cholesterol (LDL-C):High Density Lipoprotein-Cholesterol (HDL-C) ratio||LDL-C:HDL-C ratio|Mean|2.38|2.38|Standard Deviation|0.65|0.65|||
4314508|NCT00479713|4141306|B3|||Low Density Lipoprotein-Cholesterol (LDL-C)||mg/dL|Mean|3.23|3.23|Standard Deviation|0.43|0.43|||
4314509|NCT00479713|4141307|B2|||Low Density Lipoprotein-Cholesterol (LDL-C)||mg/dL|Mean|3.24|3.24|Standard Deviation|0.44|0.44|||
4314510|NCT00479713|4141308|B1|||Low Density Lipoprotein-Cholesterol (LDL-C)||mg/dL|Mean|3.21|3.21|Standard Deviation|0.42|0.42|||
4314511|NCT00479713|4141306|B3|||High Density Lipoprotein-Cholesterol||mg/dL|Mean|1.43|1.43|Standard Deviation|0.36|0.36|||
4314512|NCT00479713|4141307|B2|||High Density Lipoprotein-Cholesterol||mg/dL|Mean|1.43|1.43|Standard Deviation|0.36|0.36|||
4314513|NCT00479713|4141308|B1|||High Density Lipoprotein-Cholesterol||mg/dL|Mean|1.43|1.43|Standard Deviation|0.37|0.37|||
4314514|NCT00479713|4141306|B3|||C Reactive Protein||mg/dL|Median|0.16|0.16|Standard Deviation|0.26|0.26|||
4314515|NCT00479713|4141307|B2|||C Reactive Protein||mg/dL|Median|0.15|0.15|Standard Deviation|0.26|0.26|||
4314516|NCT00479713|4141308|B1|||C Reactive Protein||mg/dL|Median|0.16|0.16|Standard Deviation|0.26|0.26|||
4314517|NCT00479713|4141306|B3|||Apolipoprotein B||mg/dL|Median|1.19|1.19|Standard Deviation|0.21|0.21|||
4314518|NCT00479713|4141307|B2|||Apolipoprotein B||mg/dL|Median|1.18|1.18|Standard Deviation|0.21|0.21|||
4314519|NCT00479713|4141308|B1|||Apolipoprotein B||mg/dL|Median|1.20|1.2|Standard Deviation|0.20|0.2|||
4314520|NCT00479713|4141306|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|538|538.0||||||
4314521|NCT00479713|4141307|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|261|261.0||||||
4314522|NCT00479713|4141308|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|277|277.0||||||
4314523|NCT00479713|4141306|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|80|80.0||||||
4314524|NCT00479713|4141307|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|43|43.0||||||
4314525|NCT00479713|4141308|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
4314526|NCT00479713|4141306|B3|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4314527|NCT00479713|4141307|B2|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4314528|NCT00479713|4141308|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4314529|NCT00479713|4141306|B3|White||Race/Ethnicity, Customized||participants|Number|616|616.0||||||
4314530|NCT00479713|4141307|B2|White||Race/Ethnicity, Customized||participants|Number|302|302.0||||||
4314531|NCT00479713|4141308|B1|White||Race/Ethnicity, Customized||participants|Number|314|314.0||||||
4314532|NCT00479713|4141306|B3||Male|Sex: Female, Male||Participants|Count of Participants|370|370.0||||||
4314533|NCT00479713|4141307|B2||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4314534|NCT00479713|4141308|B1||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4314535|NCT00479713|4141306|B3||Female|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
4314536|NCT00479713|4141307|B2||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4314537|NCT00479713|4141308|B1||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4314538|NCT00479713|4141306|B3|||Age||years|Mean|63.15|63.15|Full Range|||27.0|82.0|
4314539|NCT00479713|4141307|B2|||Age||years|Mean|63.1|63.1|Full Range|||27.0|80.0|
4314540|NCT00479713|4141308|B1|||Age||years|Mean|63.2|63.2|Full Range|||38.0|82.0|
4314541|NCT00479674|4141333|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4314542|NCT00479674|4141333|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4314543|NCT00479674|4141333|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4314544|NCT00479674|4141333|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4314545|NCT00479674|4141333|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4314546|NCT00479674|4141333|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4314547|NCT00479674|4141333|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4314548|NCT00479674|4141333|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4314549|NCT00479674|4141333|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4314550|NCT00479674|4141333|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4314551|NCT00479674|4141333|B1|||Age||years|Mean|50|50.0|Standard Deviation|11|11.0|||
4314552|NCT00479557|4141341|B8|Low (16 - 20)||MMSE Stratum|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|number of participants|Number|84|84.0||||||
4314553|NCT00479557|4141342|B7|Low (16 - 20)||MMSE Stratum|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|number of participants|Number|6|6.0||||||
4314554|NCT00479557|4141343|B6|Low (16 - 20)||MMSE Stratum|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|number of participants|Number|15|15.0||||||
4314555|NCT00479557|4141344|B5|Low (16 - 20)||MMSE Stratum|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|number of participants|Number|4|4.0||||||
4314556|NCT00479557|4141345|B4|Low (16 - 20)||MMSE Stratum|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|number of participants|Number|12|12.0||||||
4314624|NCT00479557|4141341|B8|||Age||year|Mean|69.1|69.1|Standard Deviation|8.87|8.87|||
4314557|NCT00479557|4141346|B3|Low (16 - 20)||MMSE Stratum|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|number of participants|Number|16|16.0||||||
4314558|NCT00479557|4141347|B2|Low (16 - 20)||MMSE Stratum|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|number of participants|Number|21|21.0||||||
4314559|NCT00479557|4141348|B1|Low (16 - 20)||MMSE Stratum|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|number of participants|Number|10|10.0||||||
4314560|NCT00479557|4141341|B8|High (21 - 26)||MMSE Stratum|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|number of participants|Number|161|161.0||||||
4314561|NCT00479557|4141342|B7|High (21 - 26)||MMSE Stratum|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|number of participants|Number|11|11.0||||||
4314562|NCT00479557|4141343|B6|High (21 - 26)||MMSE Stratum|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|number of participants|Number|29|29.0||||||
4314563|NCT00479557|4141344|B5|High (21 - 26)||MMSE Stratum|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|number of participants|Number|8|8.0||||||
4314564|NCT00479557|4141345|B4|High (21 - 26)||MMSE Stratum|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|number of participants|Number|23|23.0||||||
4314565|NCT00479557|4141346|B3|High (21 - 26)||MMSE Stratum|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|number of participants|Number|24|24.0||||||
4314566|NCT00479557|4141347|B2|High (21 - 26)||MMSE Stratum|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|number of participants|Number|40|40.0||||||
4314567|NCT00479557|4141348|B1|High (21 - 26)||MMSE Stratum|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|number of participants|Number|26|26.0||||||
4314568|NCT00479557|4141341|B8|||Mini-Mental State Examination (MMSE) Score|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|score|Mean|21.4|21.4|Standard Deviation|3.13|3.13|||
4314569|NCT00479557|4141342|B7|||Mini-Mental State Examination (MMSE) Score|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|score|Mean|21.2|21.2|Standard Deviation|3.17|3.17|||
4314570|NCT00479557|4141343|B6|||Mini-Mental State Examination (MMSE) Score|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|score|Mean|21.7|21.7|Standard Deviation|3.11|3.11|||
4314571|NCT00479557|4141344|B5|||Mini-Mental State Examination (MMSE) Score|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|score|Mean|21.8|21.8|Standard Deviation|3.60|3.6|||
4314572|NCT00479557|4141345|B4|||Mini-Mental State Examination (MMSE) Score|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|score|Mean|21.6|21.6|Standard Deviation|3.16|3.16|||
4314625|NCT00479557|4141342|B7|||Age||year|Mean|69.4|69.4|Standard Deviation|7.82|7.82|||
4314626|NCT00479557|4141343|B6|||Age||year|Mean|68.8|68.8|Standard Deviation|8.07|8.07|||
4314627|NCT00479557|4141344|B5|||Age||year|Mean|70.9|70.9|Standard Deviation|9.59|9.59|||
4314573|NCT00479557|4141346|B3|||Mini-Mental State Examination (MMSE) Score|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|score|Mean|21.0|21.0|Standard Deviation|2.92|2.92|||
4314574|NCT00479557|4141347|B2|||Mini-Mental State Examination (MMSE) Score|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|score|Mean|21.4|21.4|Standard Deviation|3.38|3.38|||
4314575|NCT00479557|4141348|B1|||Mini-Mental State Examination (MMSE) Score|The MMSE was used to systematically and thoroughly assess mental status of participants. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The total score ranges from 0 to 30. A score of 23 or lower is indicative of cognitive impairment.|score|Mean|21.4|21.4|Standard Deviation|2.96|2.96|||
4314576|NCT00479557|4141341|B8|White||Race/Ethnicity, Customized||number of participants|Number|236|236.0||||||
4314577|NCT00479557|4141342|B7|White||Race/Ethnicity, Customized||number of participants|Number|17|17.0||||||
4314578|NCT00479557|4141343|B6|White||Race/Ethnicity, Customized||number of participants|Number|43|43.0||||||
4314579|NCT00479557|4141344|B5|White||Race/Ethnicity, Customized||number of participants|Number|11|11.0||||||
4314580|NCT00479557|4141345|B4|White||Race/Ethnicity, Customized||number of participants|Number|34|34.0||||||
4314581|NCT00479557|4141346|B3|White||Race/Ethnicity, Customized||number of participants|Number|38|38.0||||||
4314582|NCT00479557|4141347|B2|White||Race/Ethnicity, Customized||number of participants|Number|60|60.0||||||
4314583|NCT00479557|4141348|B1|White||Race/Ethnicity, Customized||number of participants|Number|33|33.0||||||
4314584|NCT00479557|4141341|B8|Other||Race/Ethnicity, Customized||number of participants|Number|5|5.0||||||
4314585|NCT00479557|4141342|B7|Other||Race/Ethnicity, Customized||number of participants|Number|0|0.0||||||
4314586|NCT00479557|4141343|B6|Other||Race/Ethnicity, Customized||number of participants|Number|0|0.0||||||
4314587|NCT00479557|4141344|B5|Other||Race/Ethnicity, Customized||number of participants|Number|0|0.0||||||
4314588|NCT00479557|4141345|B4|Other||Race/Ethnicity, Customized||number of participants|Number|1|1.0||||||
4314589|NCT00479557|4141346|B3|Other||Race/Ethnicity, Customized||number of participants|Number|1|1.0||||||
4314590|NCT00479557|4141347|B2|Other||Race/Ethnicity, Customized||number of participants|Number|1|1.0||||||
4314591|NCT00479557|4141348|B1|Other||Race/Ethnicity, Customized||number of participants|Number|2|2.0||||||
4314592|NCT00479557|4141341|B8|Black or African American||Race/Ethnicity, Customized||number of participants|Number|3|3.0||||||
4314593|NCT00479557|4141342|B7|Black or African American||Race/Ethnicity, Customized||number of participants|Number|0|0.0||||||
4314594|NCT00479557|4141343|B6|Black or African American||Race/Ethnicity, Customized||number of participants|Number|1|1.0||||||
4314595|NCT00479557|4141344|B5|Black or African American||Race/Ethnicity, Customized||number of participants|Number|0|0.0||||||
4314596|NCT00479557|4141345|B4|Black or African American||Race/Ethnicity, Customized||number of participants|Number|0|0.0||||||
4314597|NCT00479557|4141346|B3|Black or African American||Race/Ethnicity, Customized||number of participants|Number|1|1.0||||||
4314598|NCT00479557|4141347|B2|Black or African American||Race/Ethnicity, Customized||number of participants|Number|0|0.0||||||
4314599|NCT00479557|4141348|B1|Black or African American||Race/Ethnicity, Customized||number of participants|Number|1|1.0||||||
4314600|NCT00479557|4141341|B8|Asian||Race/Ethnicity, Customized||number of participants|Number|1|1.0||||||
4314601|NCT00479557|4141342|B7|Asian||Race/Ethnicity, Customized||number of participants|Number|0|0.0||||||
4314602|NCT00479557|4141343|B6|Asian||Race/Ethnicity, Customized||number of participants|Number|0|0.0||||||
4314603|NCT00479557|4141344|B5|Asian||Race/Ethnicity, Customized||number of participants|Number|1|1.0||||||
4314604|NCT00479557|4141345|B4|Asian||Race/Ethnicity, Customized||number of participants|Number|0|0.0||||||
4314605|NCT00479557|4141346|B3|Asian||Race/Ethnicity, Customized||number of participants|Number|0|0.0||||||
4314606|NCT00479557|4141347|B2|Asian||Race/Ethnicity, Customized||number of participants|Number|0|0.0||||||
4314607|NCT00479557|4141348|B1|Asian||Race/Ethnicity, Customized||number of participants|Number|0|0.0||||||
4314608|NCT00479557|4141341|B8||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4314609|NCT00479557|4141342|B7||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4314610|NCT00479557|4141343|B6||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4314611|NCT00479557|4141344|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4314612|NCT00479557|4141345|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4314613|NCT00479557|4141346|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4314614|NCT00479557|4141347|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4314615|NCT00479557|4141348|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4314616|NCT00479557|4141341|B8||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4314617|NCT00479557|4141342|B7||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4314618|NCT00479557|4141343|B6||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4314619|NCT00479557|4141344|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4314620|NCT00479557|4141345|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4314621|NCT00479557|4141346|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4314622|NCT00479557|4141347|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4314623|NCT00479557|4141348|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4314628|NCT00479557|4141345|B4|||Age||year|Mean|71.9|71.9|Standard Deviation|8.96|8.96|||
4314629|NCT00479557|4141346|B3|||Age||year|Mean|69.0|69.0|Standard Deviation|9.27|9.27|||
4314630|NCT00479557|4141347|B2|||Age||year|Mean|69.3|69.3|Standard Deviation|9.57|9.57|||
4314631|NCT00479557|4141348|B1|||Age||year|Mean|65.7|65.7|Standard Deviation|7.75|7.75|||
4314632|NCT00479466|4141391|B7||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4314633|NCT00479466|4141392|B6||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4314634|NCT00479466|4141393|B5||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4314635|NCT00479466|4141394|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4314636|NCT00479466|4141395|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4314637|NCT00479466|4141396|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4314638|NCT00479466|4141397|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4314639|NCT00479466|4141391|B7||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4314640|NCT00479466|4141392|B6||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4314641|NCT00479466|4141393|B5||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4314642|NCT00479466|4141394|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4314643|NCT00479466|4141395|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4314644|NCT00479466|4141396|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4314645|NCT00479466|4141397|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4314646|NCT00479466|4141391|B7|||Age||years|Mean|54.7|54.7|Standard Deviation|8.9|8.9|||
4314647|NCT00479466|4141392|B6|||Age||years|Mean|55.1|55.1|Standard Deviation|8.2|8.2|||
4314648|NCT00479466|4141393|B5|||Age||years|Mean|53.5|53.5|Standard Deviation|10.4|10.4|||
4314649|NCT00479466|4141394|B4|||Age||years|Mean|56.1|56.1|Standard Deviation|7.9|7.9|||
4314650|NCT00479466|4141395|B3|||Age||years|Mean|53.7|53.7|Standard Deviation|8.2|8.2|||
4314651|NCT00479466|4141396|B2|||Age||years|Mean|55.6|55.6|Standard Deviation|8.2|8.2|||
4314652|NCT00479466|4141397|B1|||Age||years|Mean|54.1|54.1|Standard Deviation|10.2|10.2|||
4314653|NCT00479401|4141428|B4||Male|Sex: Female, Male||Participants|Count of Participants|299|299.0||||||
4314654|NCT00479401|4141429|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4314655|NCT00479401|4141430|B2||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4314656|NCT00479401|4141431|B1||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4314657|NCT00479401|4141428|B4||Female|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
4314658|NCT00479401|4141429|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4314659|NCT00479401|4141430|B2||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4314660|NCT00479401|4141431|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4314661|NCT00479401|4141428|B4|||Age||years|Mean|61.6|61.6|Standard Deviation|9.7|9.7|||
4314662|NCT00479401|4141429|B3|||Age||years|Mean|62.0|62.0|Standard Deviation|9.6|9.6|||
4314663|NCT00479401|4141430|B2|||Age||years|Mean|61.7|61.7|Standard Deviation|9.6|9.6|||
4314664|NCT00479401|4141431|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|9.8|9.8|||
4314665|NCT00479388|4141486|B3|||Triglycerides (TG)||mg/dL|Median|130.00|130.0|Full Range|||42.0|852.0|
4314666|NCT00479388|4141487|B2|||Triglycerides (TG)||mg/dL|Median|124.00|124.0|Full Range|||42.0|852.0|
4314667|NCT00479388|4141488|B1|||Triglycerides (TG)||mg/dL|Median|136.00|136.0|Full Range|||46.0|594.0|
4314668|NCT00479388|4141486|B3|||Low-density lipoprotein cholesterol||mg/dL|Mean|116.68|116.68|Standard Deviation|28.52|28.52|||
4314669|NCT00479388|4141487|B2|||Low-density lipoprotein cholesterol||mg/dL|Mean|115.82|115.82|Standard Deviation|28.37|28.37|||
4314670|NCT00479388|4141488|B1|||Low-density lipoprotein cholesterol||mg/dL|Mean|117.55|117.55|Standard Deviation|28.66|28.66|||
4314671|NCT00479388|4141486|B3|||High-density lipoprotein cholesterol||mg/dL|Mean|54.93|54.93|Standard Deviation|14.17|14.17|||
4314672|NCT00479388|4141487|B2|||High-density lipoprotein cholesterol||mg/dL|Mean|54.97|54.97|Standard Deviation|13.91|13.91|||
4314673|NCT00479388|4141488|B1|||High-density lipoprotein cholesterol||mg/dL|Mean|54.89|54.89|Standard Deviation|14.45|14.45|||
4314674|NCT00479388|4141486|B3|||Fasting Serum Glucose (FSG)||mg/dL|Mean|108.5|108.5|Standard Deviation|27.4|27.4|||
4314675|NCT00479388|4141487|B2|||Fasting Serum Glucose (FSG)||mg/dL|Mean|108.7|108.7|Standard Deviation|27.7|27.7|||
4314676|NCT00479388|4141488|B1|||Fasting Serum Glucose (FSG)||mg/dL|Mean|108.3|108.3|Standard Deviation|27.2|27.2|||
4314677|NCT00479388|4141486|B3|Atorvastatin 10 mg||Lipid Modification Type/Dose at Run-in||participants|Number|238|238.0||||||
4314678|NCT00479388|4141487|B2|Atorvastatin 10 mg||Lipid Modification Type/Dose at Run-in||participants|Number|109|109.0||||||
4314679|NCT00479388|4141488|B1|Atorvastatin 10 mg||Lipid Modification Type/Dose at Run-in||participants|Number|129|129.0||||||
4314680|NCT00479388|4141486|B3|Simvastatin 20 mg||Lipid Modification Type/Dose at Run-in||participants|Number|527|527.0||||||
4314681|NCT00479388|4141487|B2|Simvastatin 20 mg||Lipid Modification Type/Dose at Run-in||participants|Number|268|268.0||||||
4314682|NCT00479388|4141488|B1|Simvastatin 20 mg||Lipid Modification Type/Dose at Run-in||participants|Number|259|259.0||||||
4314683|NCT00479388|4141486|B3|Simvastatin 10 mg||Lipid Modification Type/Dose at Run-in||participants|Number|451|451.0||||||
4314684|NCT00479388|4141487|B2|Simvastatin 10 mg||Lipid Modification Type/Dose at Run-in||participants|Number|233|233.0||||||
4314685|NCT00479388|4141488|B1|Simvastatin 10 mg||Lipid Modification Type/Dose at Run-in||participants|Number|218|218.0||||||
4314686|NCT00479388|4141486|B3|High Risk Not at Goal||Coronary Heart Disease Risk Category by Goal||Participants|Number|499|499.0||||||
4314687|NCT00479388|4141487|B2|High Risk Not at Goal||Coronary Heart Disease Risk Category by Goal||Participants|Number|262|262.0||||||
4314688|NCT00479388|4141488|B1|High Risk Not at Goal||Coronary Heart Disease Risk Category by Goal||Participants|Number|237|237.0||||||
4314689|NCT00479388|4141486|B3|High Risk at Goal||Coronary Heart Disease Risk Category by Goal||Participants|Number|298|298.0||||||
4314690|NCT00479388|4141487|B2|High Risk at Goal||Coronary Heart Disease Risk Category by Goal||Participants|Number|155|155.0||||||
4314691|NCT00479388|4141488|B1|High Risk at Goal||Coronary Heart Disease Risk Category by Goal||Participants|Number|143|143.0||||||
4314692|NCT00479388|4141486|B3|Multiple Risk Not at Goal||Coronary Heart Disease Risk Category by Goal||Participants|Number|163|163.0||||||
4314693|NCT00479388|4141487|B2|Multiple Risk Not at Goal||Coronary Heart Disease Risk Category by Goal||Participants|Number|71|71.0||||||
4314694|NCT00479388|4141488|B1|Multiple Risk Not at Goal||Coronary Heart Disease Risk Category by Goal||Participants|Number|92|92.0||||||
4314695|NCT00479388|4141486|B3|Multiple Risk at Goal||Coronary Heart Disease Risk Category by Goal||Participants|Number|173|173.0||||||
4314696|NCT00479388|4141487|B2|Multiple Risk at Goal||Coronary Heart Disease Risk Category by Goal||Participants|Number|82|82.0||||||
4314697|NCT00479388|4141488|B1|Multiple Risk at Goal||Coronary Heart Disease Risk Category by Goal||Participants|Number|91|91.0||||||
4314698|NCT00479388|4141486|B3|Low Risk Not at Goal||Coronary Heart Disease Risk Category by Goal||Participants|Number|30|30.0||||||
4314699|NCT00479388|4141487|B2|Low Risk Not at Goal||Coronary Heart Disease Risk Category by Goal||Participants|Number|14|14.0||||||
4314700|NCT00479388|4141488|B1|Low Risk Not at Goal||Coronary Heart Disease Risk Category by Goal||Participants|Number|16|16.0||||||
4314701|NCT00479388|4141486|B3|Low Risk at Goal||Coronary Heart Disease Risk Category by Goal||Participants|Number|53|53.0||||||
4314702|NCT00479388|4141487|B2|Low Risk at Goal||Coronary Heart Disease Risk Category by Goal||Participants|Number|26|26.0||||||
4314703|NCT00479388|4141488|B1|Low Risk at Goal||Coronary Heart Disease Risk Category by Goal||Participants|Number|27|27.0||||||
4314704|NCT00479388|4141486|B3||Male|Sex: Female, Male||Participants|Count of Participants|623|623.0||||||
4314705|NCT00479388|4141487|B2||Male|Sex: Female, Male||Participants|Count of Participants|321|321.0||||||
4314706|NCT00479388|4141488|B1||Male|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
4314707|NCT00479388|4141486|B3||Female|Sex: Female, Male||Participants|Count of Participants|593|593.0||||||
4314708|NCT00479388|4141487|B2||Female|Sex: Female, Male||Participants|Count of Participants|289|289.0||||||
4314709|NCT00479388|4141488|B1||Female|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
4314710|NCT00479388|4141486|B3|||Age||years|Mean|60.5|60.5|Standard Deviation|9.7|9.7|||
4314711|NCT00479388|4141487|B2|||Age||years|Mean|60.6|60.6|Standard Deviation|9.8|9.8|||
4314712|NCT00479388|4141488|B1|||Age||years|Mean|60.4|60.4|Standard Deviation|9.7|9.7|||
4314713|NCT00479336|4141499|B5|Japan||Region of Enrollment||participants|Number|101|101.0||||||
4314714|NCT00479336|4141500|B4|Japan||Region of Enrollment||participants|Number|25|25.0||||||
4314715|NCT00479336|4141501|B3|Japan||Region of Enrollment||participants|Number|25|25.0||||||
4314716|NCT00479336|4141502|B2|Japan||Region of Enrollment||participants|Number|25|25.0||||||
4314717|NCT00479336|4141503|B1|Japan||Region of Enrollment||participants|Number|26|26.0||||||
4314718|NCT00479336|4141499|B5||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4314719|NCT00479336|4141500|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4314720|NCT00479336|4141501|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4314721|NCT00479336|4141502|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4314722|NCT00479336|4141503|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4314723|NCT00479336|4141499|B5||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4314724|NCT00479336|4141500|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4314725|NCT00479336|4141501|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4314726|NCT00479336|4141502|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4314727|NCT00479336|4141503|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4314728|NCT00479336|4141499|B5||>=65 years|Age||Participants|Count of Participants|53|53.0||||||
4314729|NCT00479336|4141500|B4||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4314730|NCT00479336|4141501|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4314731|NCT00479336|4141502|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4314732|NCT00479336|4141503|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4314733|NCT00479336|4141499|B5||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4314734|NCT00479336|4141500|B4||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4314735|NCT00479336|4141501|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4314736|NCT00479336|4141502|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4314737|NCT00479336|4141503|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4314738|NCT00479336|4141499|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4314739|NCT00479336|4141500|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4314740|NCT00479336|4141501|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4314741|NCT00479336|4141502|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4314742|NCT00479336|4141503|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4314743|NCT00479336|4141499|B5|||Age||years|Mean|63.9|63.9|Standard Deviation|9.8|9.8|||
4314744|NCT00479336|4141500|B4|||Age||years|Mean|62.8|62.8|Standard Deviation|10.4|10.4|||
4314745|NCT00479336|4141501|B3|||Age||years|Mean|64.8|64.8|Standard Deviation|9.7|9.7|||
4314746|NCT00479336|4141502|B2|||Age||years|Mean|64.5|64.5|Standard Deviation|9.4|9.4|||
4314747|NCT00479336|4141503|B1|||Age||years|Mean|63.5|63.5|Standard Deviation|10.1|10.1|||
4314748|NCT00479232|4141527|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4314749|NCT00479232|4141528|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4314750|NCT00479232|4141529|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4314751|NCT00479232|4141527|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4314752|NCT00479232|4141528|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4314753|NCT00479232|4141529|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4314754|NCT00479232|4141527|B3|||Age||years|Mean|65.3|65.3|Standard Deviation|13.4|13.4|||
4314755|NCT00479232|4141528|B2|||Age||years|Mean|66.6|66.6|Standard Deviation|13.8|13.8|||
4314756|NCT00479232|4141529|B1|||Age||years|Mean|63.9|63.9|Standard Deviation|13.0|13.0|||
4314757|NCT00479154|4141552|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4314758|NCT00479154|4141553|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4314759|NCT00479154|4141554|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4314760|NCT00479154|4141552|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4314761|NCT00479154|4141553|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4314762|NCT00479154|4141554|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4314763|NCT00479154|4141552|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4314764|NCT00479154|4141553|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4314765|NCT00479154|4141554|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4314766|NCT00479154|4141552|B3|||Age||years|Mean|57.7|57.7|Standard Deviation|8.8|8.8|||
4314767|NCT00479154|4141553|B2|||Age||years|Mean|61.7|61.7|Standard Deviation|2.5|2.5|||
4314768|NCT00479154|4141554|B1|||Age||years|Mean|53.7|53.7|Standard Deviation|11.8|11.8|||
4314769|NCT00479154|4141552|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4314770|NCT00479154|4141553|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4314771|NCT00479154|4141554|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4314772|NCT00479154|4141552|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4314773|NCT00479154|4141553|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4314774|NCT00479154|4141554|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4314775|NCT00479154|4141552|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4314776|NCT00479154|4141553|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4314777|NCT00479154|4141554|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4314778|NCT00479089|4141561|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4314779|NCT00479089|4141562|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4314780|NCT00479089|4141563|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4314781|NCT00479089|4141561|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4314782|NCT00479089|4141562|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4314783|NCT00479089|4141563|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4314784|NCT00479089|4141561|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4314785|NCT00479089|4141562|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4314786|NCT00479089|4141563|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4314787|NCT00479089|4141561|B3|||Age||years|Median|64|64.0|Full Range|||40.0|80.0|
4314788|NCT00479089|4141562|B2|||Age||years|Median|62|62.0|Full Range|||40.0|80.0|
4314789|NCT00479089|4141563|B1|||Age||years|Median|64|64.0|Full Range|||51.0|76.0|
4314790|NCT00479037|4141574|B3|Female||Sex/Gender, Customized||participants|Number|81|81.0||||||
4314791|NCT00479037|4141575|B2|Female||Sex/Gender, Customized||participants|Number|40|40.0||||||
4314792|NCT00479037|4141576|B1|Female||Sex/Gender, Customized||participants|Number|41|41.0||||||
4314793|NCT00479037|4141574|B3|||Age||years|Mean|64.4|64.4|Standard Deviation|8.52|8.52|||
4314794|NCT00479037|4141575|B2|||Age||years|Mean|64.9|64.9|Standard Deviation|8.49|8.49|||
4314795|NCT00479037|4141576|B1|||Age||years|Mean|64.0|64.0|Standard Deviation|8.64|8.64|||
4314796|NCT00478933|4141587|B1|United Kingdom||Region of Enrollment|Measures are completed for total enrolled population, including those with inadequate data for analysis.|participants|Number|13|13.0||||||
4314797|NCT00478933|4141587|B1|Poland||Region of Enrollment|Measures are completed for total enrolled population, including those with inadequate data for analysis.|participants|Number|134|134.0||||||
4314798|NCT00478933|4141587|B1|Norway||Region of Enrollment|Measures are completed for total enrolled population, including those with inadequate data for analysis.|participants|Number|26|26.0||||||
4314799|NCT00478933|4141587|B1|Italy||Region of Enrollment|Measures are completed for total enrolled population, including those with inadequate data for analysis.|participants|Number|54|54.0||||||
4314800|NCT00478933|4141587|B1|Hungary||Region of Enrollment|Measures are completed for total enrolled population, including those with inadequate data for analysis.|participants|Number|59|59.0||||||
4314801|NCT00478933|4141587|B1|Greece||Region of Enrollment|Measures are completed for total enrolled population, including those with inadequate data for analysis.|participants|Number|26|26.0||||||
4314802|NCT00478933|4141587|B1|Germany||Region of Enrollment|Measures are completed for total enrolled population, including those with inadequate data for analysis.|participants|Number|491|491.0||||||
4314909|NCT00478673|4141645|B1||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4314803|NCT00478933|4141587|B1|France||Region of Enrollment|Measures are completed for total enrolled population, including those with inadequate data for analysis.|participants|Number|84|84.0||||||
4314804|NCT00478933|4141587|B1|Finland||Region of Enrollment|Measures are completed for total enrolled population, including those with inadequate data for analysis.|participants|Number|25|25.0||||||
4314805|NCT00478933|4141587|B1|Spain||Region of Enrollment|Measures are completed for total enrolled population, including those with inadequate data for analysis.|participants|Number|189|189.0||||||
4314806|NCT00478933|4141587|B1|Denmark||Region of Enrollment|Measures are completed for total enrolled population, including those with inadequate data for analysis.|participants|Number|57|57.0||||||
4314807|NCT00478933|4141587|B1|Austria||Region of Enrollment|Measures are completed for total enrolled population, including those with inadequate data for analysis.|participants|Number|40|40.0||||||
4314808|NCT00478933|4141587|B1||Male|Sex: Female, Male||Participants|Count of Participants|1004|1004.0||||||
4314809|NCT00478933|4141587|B1||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4314810|NCT00478933|4141587|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|10.9|10.9|||
4314811|NCT00478881|4141611|B3||Male|Sex: Female, Male|Gender and age are given for those subjects who received treatment (Safety population).|Participants|Count of Participants|167|167.0||||||
4314812|NCT00478881|4141612|B2||Male|Sex: Female, Male|Gender and age are given for those subjects who received treatment (Safety population).|Participants|Count of Participants|85|85.0||||||
4314813|NCT00478881|4141613|B1||Male|Sex: Female, Male|Gender and age are given for those subjects who received treatment (Safety population).|Participants|Count of Participants|82|82.0||||||
4314814|NCT00478881|4141611|B3||Female|Sex: Female, Male|Gender and age are given for those subjects who received treatment (Safety population).|Participants|Count of Participants|229|229.0||||||
4314815|NCT00478881|4141612|B2||Female|Sex: Female, Male|Gender and age are given for those subjects who received treatment (Safety population).|Participants|Count of Participants|113|113.0||||||
4314816|NCT00478881|4141613|B1||Female|Sex: Female, Male|Gender and age are given for those subjects who received treatment (Safety population).|Participants|Count of Participants|116|116.0||||||
4314817|NCT00478881|4141611|B3|||Age||years|Mean|56.9|56.9|Standard Deviation|13.5|13.5|||
4314818|NCT00478881|4141612|B2|||Age||years|Mean|58.3|58.3|Standard Deviation|12.8|12.8|||
4314819|NCT00478881|4141613|B1|||Age||years|Mean|55.5|55.5|Standard Deviation|14.2|14.2|||
4314820|NCT00478777|4141638|B1|Germany||Region of Enrollment||participants|Number|144|144.0||||||
4314821|NCT00478777|4141638|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4314822|NCT00478777|4141638|B1|White||Race/Ethnicity, Customized||participants|Number|142|142.0||||||
4314823|NCT00478777|4141638|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4314824|NCT00478777|4141638|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4314825|NCT00478777|4141638|B1|||Age||years|Mean|64.7|64.7|Standard Deviation|9.9|9.9|||
4314826|NCT00478673|4141645|B1|Unknown||History of Mantle or Head and Neck Radiation||Participants|Number|2|2.0||||||
4314827|NCT00478673|4141645|B1|No History of Mantle or Head and Neck Radiation||History of Mantle or Head and Neck Radiation||Participants|Number|281|281.0||||||
4314828|NCT00478673|4141645|B1|History of Mantle or Head and Neck Radiation||History of Mantle or Head and Neck Radiation||Participants|Number|15|15.0||||||
4314829|NCT00478673|4141645|B1|Unknown||History of Significant Bleeding||Participants|Number|1|1.0||||||
4314830|NCT00478673|4141645|B1|No History of Significant Bleeding||History of Significant Bleeding||Participants|Number|286|286.0||||||
4314831|NCT00478673|4141645|B1|History of Significant Bleeding||History of Significant Bleeding||Participants|Number|11|11.0||||||
4314832|NCT00478673|4141645|B1|Unknown||History of Peripheral Vascular Disease (PVD)||Participants|Number|9|9.0||||||
4314833|NCT00478673|4141645|B1|No History of PVD||History of Peripheral Vascular Disease (PVD)||Participants|Number|172|172.0||||||
4314834|NCT00478673|4141645|B1|History of PVD||History of Peripheral Vascular Disease (PVD)||Participants|Number|117|117.0||||||
4314835|NCT00478673|4141645|B1|Unknown||History of Hypertension||Participants|Number|1|1.0||||||
4314836|NCT00478673|4141645|B1|No History of Hypertension||History of Hypertension||Participants|Number|29|29.0||||||
4314837|NCT00478673|4141645|B1|History of Hypertension||History of Hypertension||Participants|Number|268|268.0||||||
4314838|NCT00478673|4141645|B1|Unknown||History of Hyperlipidemia||Participants|Number|1|1.0||||||
4314839|NCT00478673|4141645|B1|No History of Hyperlipidemia||History of Hyperlipidemia||Participants|Number|40|40.0||||||
4314840|NCT00478673|4141645|B1|History of Hyperlipidemia||History of Hyperlipidemia||Participants|Number|257|257.0||||||
4314841|NCT00478673|4141645|B1|Unknown||History of Diabetes||Participants|Number|2|2.0||||||
4314842|NCT00478673|4141645|B1|No History of Diabetes||History of Diabetes||Participants|Number|182|182.0||||||
4314843|NCT00478673|4141645|B1|History of Diabetes||History of Diabetes||Participants|Number|114|114.0||||||
4314844|NCT00478673|4141645|B1|Unknown||History of Smoking||Participants|Number|9|9.0||||||
4314845|NCT00478673|4141645|B1|Never||History of Smoking||Participants|Number|77|77.0||||||
4314846|NCT00478673|4141645|B1|Previous||History of Smoking||Participants|Number|145|145.0||||||
4314847|NCT00478673|4141645|B1|Current||History of Smoking||Participants|Number|67|67.0||||||
4314848|NCT00478673|4141645|B1|Unknown||History of Atrial Fibrillation/Flutter||Participants|Number|7|7.0||||||
4314849|NCT00478673|4141645|B1|No History of Atrial Fibrillation/Flutter||History of Atrial Fibrillation/Flutter||Participants|Number|241|241.0||||||
4314850|NCT00478673|4141645|B1|History of Atrial Fibrillation/Flutter||History of Atrial Fibrillation/Flutter||Participants|Number|50|50.0||||||
4314851|NCT00478673|4141645|B1|Unknown||History of Coronary Artery Bypass Grafting (CABG)||Participants|Number|1|1.0||||||
4314852|NCT00478673|4141645|B1|No History of CABG||History of Coronary Artery Bypass Grafting (CABG)||Participants|Number|212|212.0||||||
4314853|NCT00478673|4141645|B1|History of CABG||History of Coronary Artery Bypass Grafting (CABG)||Participants|Number|85|85.0||||||
4314854|NCT00478673|4141645|B1|Unknown||History of Percutaneous Coronary Intervention (PCI)||Participants|Number|5|5.0||||||
4314855|NCT00478673|4141645|B1|No History of PCI||History of Percutaneous Coronary Intervention (PCI)||Participants|Number|196|196.0||||||
4314856|NCT00478673|4141645|B1|History of PCI||History of Percutaneous Coronary Intervention (PCI)||Participants|Number|97|97.0||||||
4314857|NCT00478673|4141645|B1|None||Current Angina||Participants|Number|243|243.0||||||
4314858|NCT00478673|4141645|B1|Silent Ischemia||Current Angina||Participants|Number|3|3.0||||||
4314859|NCT00478673|4141645|B1|Unstable Angina||Current Angina||Participants|Number|10|10.0||||||
4314860|NCT00478673|4141645|B1|Stable Angina||Current Angina||Participants|Number|42|42.0||||||
4314861|NCT00478673|4141645|B1|Unknown||History of Congestive Heart Failure (CHF)||Participants|Number|3|3.0||||||
4314862|NCT00478673|4141645|B1|No History of CHF||History of Congestive Heart Failure (CHF)||Participants|Number|241|241.0||||||
4314863|NCT00478673|4141645|B1|History of CHF||History of Congestive Heart Failure (CHF)||Participants|Number|54|54.0||||||
4314864|NCT00478673|4141645|B1|Unknown||History of Myocardial Infarction (MI)||Participants|Number|11|11.0||||||
4314865|NCT00478673|4141645|B1|No History of MI||History of Myocardial Infarction (MI)||Participants|Number|206|206.0||||||
4314866|NCT00478673|4141645|B1|History of MI||History of Myocardial Infarction (MI)||Participants|Number|81|81.0||||||
4314867|NCT00478673|4141645|B1|Unknown||History of Coronary Artery Disease (CAD)||Participants|Number|8|8.0||||||
4314868|NCT00478673|4141645|B1|No History of CAD||History of Coronary Artery Disease (CAD)||Participants|Number|94|94.0||||||
4314869|NCT00478673|4141645|B1|History of CAD||History of Coronary Artery Disease (CAD)||Participants|Number|196|196.0||||||
4314870|NCT00478673|4141645|B1|Unknown||History of Upper Extremity Fibromuscular Dysplasia (FMD)||Participants|Number|5|5.0||||||
4314871|NCT00478673|4141645|B1|No History of Upper Extremity FMD||History of Upper Extremity Fibromuscular Dysplasia (FMD)||Participants|Number|292|292.0||||||
4314872|NCT00478673|4141645|B1|History of Upper Extremity FMD||History of Upper Extremity Fibromuscular Dysplasia (FMD)||Participants|Number|1|1.0||||||
4314873|NCT00478673|4141645|B1|Unknown||History of Carotid Restenosis||Participants|Number|3|3.0||||||
4314874|NCT00478673|4141645|B1|No History of Carotid Restenosis||History of Carotid Restenosis||Participants|Number|246|246.0||||||
4314875|NCT00478673|4141645|B1|History of Carotid Restenosis||History of Carotid Restenosis||Participants|Number|49|49.0||||||
4314876|NCT00478673|4141645|B1|Unknown||History of Percutaneous Transluminal Angioplasty (PTA)||Participants|Number|1|1.0||||||
4314877|NCT00478673|4141645|B1|No History of PTA||History of Percutaneous Transluminal Angioplasty (PTA)||Participants|Number|282|282.0||||||
4314878|NCT00478673|4141645|B1|History of PTA||History of Percutaneous Transluminal Angioplasty (PTA)||Participants|Number|15|15.0||||||
4314879|NCT00478673|4141645|B1|Unknown||History of Carotid Endarterectomy (CEA)||Participants|Number|1|1.0||||||
4314880|NCT00478673|4141645|B1|No History of CEA||History of Carotid Endarterectomy (CEA)||Participants|Number|223|223.0||||||
4314881|NCT00478673|4141645|B1|History of CEA||History of Carotid Endarterectomy (CEA)||Participants|Number|74|74.0||||||
4314882|NCT00478673|4141645|B1|Unknown||History of Seizure||Participants|Number|3|3.0||||||
4314883|NCT00478673|4141645|B1|No History of Seizure||History of Seizure||Participants|Number|290|290.0||||||
4314884|NCT00478673|4141645|B1|History of Seizure||History of Seizure||Participants|Number|5|5.0||||||
4314885|NCT00478673|4141645|B1|Unknown||History of Vertebrobasilar Occlusive Disease||Participants|Number|20|20.0||||||
4314886|NCT00478673|4141645|B1|No History of Vertebrobasilar Occlusive Disease||History of Vertebrobasilar Occlusive Disease||Participants|Number|267|267.0||||||
4314887|NCT00478673|4141645|B1|History of Vertebrobasilar Occlusive Disease||History of Vertebrobasilar Occlusive Disease||Participants|Number|11|11.0||||||
4314888|NCT00478673|4141645|B1|Unknown||History of Cerebrovascular Accident (CVA)||Participants|Number|3|3.0||||||
4314889|NCT00478673|4141645|B1|No History of CVA||History of Cerebrovascular Accident (CVA)||Participants|Number|233|233.0||||||
4314890|NCT00478673|4141645|B1|History of CVA||History of Cerebrovascular Accident (CVA)||Participants|Number|62|62.0||||||
4314891|NCT00478673|4141645|B1|Unknown||History of Transient Ischemic Attack (TIA)||Participants|Number|14|14.0||||||
4314892|NCT00478673|4141645|B1|No History of TIA||History of Transient Ischemic Attack (TIA)||Participants|Number|207|207.0||||||
4314893|NCT00478673|4141645|B1|History of TIA||History of Transient Ischemic Attack (TIA)||Participants|Number|77|77.0||||||
4314894|NCT00478673|4141645|B1|Unknown||History of Carotid Atherosclerosis||Participants|Number|10|10.0||||||
4314895|NCT00478673|4141645|B1|No History of Carotid Atherosclerosis||History of Carotid Atherosclerosis||Participants|Number|101|101.0||||||
4314896|NCT00478673|4141645|B1|History of Carotid Atherosclerosis||History of Carotid Atherosclerosis||Participants|Number|187|187.0||||||
4314897|NCT00478673|4141645|B1|Unknown||Current Carotid Bruit||Participants|Number|41|41.0||||||
4314898|NCT00478673|4141645|B1|No Current Carotid Bruit||Current Carotid Bruit||Participants|Number|82|82.0||||||
4314899|NCT00478673|4141645|B1|Current Carotid Bruit||Current Carotid Bruit||Participants|Number|175|175.0||||||
4314900|NCT00478673|4141645|B1|United States||Region of Enrollment||Participants|Number|298|298.0||||||
4314901|NCT00478673|4141645|B1|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4314902|NCT00478673|4141645|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4314903|NCT00478673|4141645|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4314904|NCT00478673|4141645|B1|Black, of African Heritage||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
4314905|NCT00478673|4141645|B1|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4314906|NCT00478673|4141645|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|258|258.0||||||
4314907|NCT00478673|4141645|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4314908|NCT00478673|4141645|B1||Male|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4314910|NCT00478673|4141645|B1|||Age||Years|Mean|72.2|72.2|Standard Deviation|9.6|9.6|||
4314911|NCT00478647|4141650|B1|||Baseline spleen volume||Percent (%) body weight|Median|0.50|0.5|Full Range|||0.2|3.2|
4314912|NCT00478647|4141650|B1|||Baseline platelet count||10^9 per liter (10^9/L)|Median|162.00|162.0|Full Range|||29.0|399.0|
4314913|NCT00478647|4141650|B1|||Baseline liver volume||Percent (%) body weight|Median|1.90|1.9|Full Range|||1.4|3.9|
4314914|NCT00478647|4141650|B1|||Baseline hemoglobin concentration||gram per deciliter (g/dL)|Median|13.775|13.775|Full Range|||10.4|16.45|
4314915|NCT00478647|4141650|B1|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4314916|NCT00478647|4141650|B1|Israel||Region of Enrollment||participants|Number|9|9.0||||||
4314917|NCT00478647|4141650|B1|Poland||Region of Enrollment||participants|Number|5|5.0||||||
4314918|NCT00478647|4141650|B1|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4314919|NCT00478647|4141650|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4314920|NCT00478647|4141650|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4314921|NCT00478647|4141650|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4314922|NCT00478647|4141650|B1|||Age||years|Mean|35.6|35.6|Standard Deviation|18.37|18.37|||
4314923|NCT00478647|4141650|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4314924|NCT00478647|4141650|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4314925|NCT00478647|4141650|B1||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4314926|NCT00478608|4141658|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4314927|NCT00478608|4141658|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4314928|NCT00478608|4141658|B1|||Age||years|Mean|40.16|40.16|Standard Deviation|12.69|12.69|||
4314929|NCT00478569|4141666|B1|Missing||Was Patient/relative/helper instructed in PTH(1-84) (self) injection technique?||participants|Number|2|2.0||||||
4314930|NCT00478569|4141666|B1|No||Was Patient/relative/helper instructed in PTH(1-84) (self) injection technique?||participants|Number|1|1.0||||||
4314931|NCT00478569|4141666|B1|Yes||Was Patient/relative/helper instructed in PTH(1-84) (self) injection technique?||participants|Number|1167|1167.0||||||
4314932|NCT00478569|4141666|B1|||Number of Participants With at Least One Fracture||participants|Number|904|904.0||||||
4314933|NCT00478569|4141666|B1|||Spine T-score|The total number of participants for whom Baseline spine T-score data was available was 954.|units on a scale|Mean|-3.10|-3.1|Standard Deviation|1.130|1.13|||
4314934|NCT00478569|4141666|B1|||Spine Bone Mineral Density (BMD)|The total number of participants for whom baseline spine bone mineral density data was available was 738.|g/cm^2|Mean|0.763|0.763|Standard Deviation|0.1480|0.148|||
4314935|NCT00478569|4141666|B1|||Total Hip T-score|"T-score is the bone mineral density (BMD) at the site when compared to the young normal reference mean; a healthy thirty-year-old.~Normal is a T-score of -1.0 or higher; Osteopenia is defined as between -1.0 and -2.5 Osteoporosis is defined as -2.5 or lower.~The total number of participants for whom Baseline hip T-score data was available was 812."|units on a scale|Mean|-2.46|-2.46|Standard Deviation|0.965|0.965|||
4314936|NCT00478569|4141666|B1|||Total Hip Bone Mineral Density (BMD)|Measured by dual energy X-ray absorptiometry (DXA). The total number of participants for whom baseline hip BMD data was available was 654.|g/cm^2|Mean|0.680|0.68|Standard Deviation|0.1239|0.1239|||
4314937|NCT00478569|4141666|B1|Missing||Glucocorticosteroid Use||participants|Number|3|3.0||||||
4314938|NCT00478569|4141666|B1|No||Glucocorticosteroid Use||participants|Number|1038|1038.0||||||
4314939|NCT00478569|4141666|B1|Yes||Glucocorticosteroid Use||participants|Number|129|129.0||||||
4314940|NCT00478569|4141666|B1|Missing||Past Smoker||participants|Number|2|2.0||||||
4314941|NCT00478569|4141666|B1|No||Past Smoker||participants|Number|1009|1009.0||||||
4314942|NCT00478569|4141666|B1|Yes||Past Smoker||participants|Number|159|159.0||||||
4314943|NCT00478569|4141666|B1|Missing||Current Smoker||participants|Number|2|2.0||||||
4314944|NCT00478569|4141666|B1|No||Current Smoker||participants|Number|1057|1057.0||||||
4314945|NCT00478569|4141666|B1|Yes||Current Smoker||participants|Number|111|111.0||||||
4314946|NCT00478569|4141666|B1|Missing||Alcohol Consumption||participants|Number|26|26.0||||||
4314947|NCT00478569|4141666|B1|Daily||Alcohol Consumption||participants|Number|50|50.0||||||
4314948|NCT00478569|4141666|B1|Occasionally||Alcohol Consumption||participants|Number|385|385.0||||||
4314949|NCT00478569|4141666|B1|Never||Alcohol Consumption||participants|Number|709|709.0||||||
4314950|NCT00478569|4141666|B1|Missing||Family History of Osteoporosis||participants|Number|50|50.0||||||
4314951|NCT00478569|4141666|B1|Unknown||Family History of Osteoporosis||participants|Number|1|1.0||||||
4314952|NCT00478569|4141666|B1|No||Family History of Osteoporosis||participants|Number|896|896.0||||||
4314953|NCT00478569|4141666|B1|Yes||Family History of Osteoporosis||participants|Number|223|223.0||||||
4314954|NCT00478569|4141666|B1|Missing||PTH (1-84) Dosing Frequency||participants|Number|2|2.0||||||
4314955|NCT00478569|4141666|B1|Every Other Day||PTH (1-84) Dosing Frequency||participants|Number|6|6.0||||||
4314956|NCT00478569|4141666|B1|Once Daily||PTH (1-84) Dosing Frequency||participants|Number|1162|1162.0||||||
4314957|NCT00478569|4141666|B1|||Time Since Starting PTH(1-84)||days|Mean|8.1|8.1|Standard Deviation|15.52|15.52|||
4314958|NCT00478569|4141666|B1|Missing||Calcium and/or Vitamin D Supplement||participants|Number|2|2.0||||||
4314959|NCT00478569|4141666|B1|No||Calcium and/or Vitamin D Supplement||participants|Number|122|122.0||||||
4314960|NCT00478569|4141666|B1|Yes||Calcium and/or Vitamin D Supplement||participants|Number|1046|1046.0||||||
4314961|NCT00478569|4141666|B1|Missing||Type of Menopause|Total number of menopausal participants at baseline was 1148.|participants|Number|20|20.0||||||
4314962|NCT00478569|4141666|B1|Other||Type of Menopause|Total number of menopausal participants at baseline was 1148.|participants|Number|25|25.0||||||
4314963|NCT00478569|4141666|B1|Natural||Type of Menopause|Total number of menopausal participants at baseline was 1148.|participants|Number|966|966.0||||||
4314964|NCT00478569|4141666|B1|Surgical||Type of Menopause|Total number of menopausal participants at baseline was 1148.|participants|Number|137|137.0||||||
4314965|NCT00478569|4141666|B1|Missing||Age at Onset of Menopause by Category|Total number of menopausal participants at baseline was 1148, respectively.|participants|Number|116|116.0||||||
4314966|NCT00478569|4141666|B1|> 45 years||Age at Onset of Menopause by Category|Total number of menopausal participants at baseline was 1148, respectively.|participants|Number|749|749.0||||||
4314967|NCT00478569|4141666|B1|≤ 45 years||Age at Onset of Menopause by Category|Total number of menopausal participants at baseline was 1148, respectively.|participants|Number|283|283.0||||||
4314968|NCT00478569|4141666|B1|||Age at Onset of Menopause|Total number of menopausal participants at baseline was 1148.|years|Mean|47.9|47.9|Standard Deviation|5.49|5.49|||
4314969|NCT00478569|4141666|B1|||Body Mass Index (BMI)||kg/m^2|Mean|25.9|25.9|Standard Deviation|4.59|4.59|||
4314970|NCT00478569|4141666|B1|||Weight||kg|Mean|63.4|63.4|Standard Deviation|12.25|12.25|||
4314971|NCT00478569|4141666|B1|||Height||cm|Mean|156.3|156.3|Standard Deviation|7.98|7.98|||
4314972|NCT00478569|4141666|B1|United Kingdom||Region of Enrollment||participants|Number|21|21.0||||||
4314973|NCT00478569|4141666|B1|Spain||Region of Enrollment||participants|Number|272|272.0||||||
4314974|NCT00478569|4141666|B1|Netherlands||Region of Enrollment||participants|Number|65|65.0||||||
4314975|NCT00478569|4141666|B1|Ireland||Region of Enrollment||participants|Number|29|29.0||||||
4314976|NCT00478569|4141666|B1|Greece||Region of Enrollment||participants|Number|300|300.0||||||
4314977|NCT00478569|4141666|B1|Germany||Region of Enrollment||participants|Number|246|246.0||||||
4314978|NCT00478569|4141666|B1|Denmark||Region of Enrollment||participants|Number|79|79.0||||||
4314979|NCT00478569|4141666|B1|Austria||Region of Enrollment||participants|Number|158|158.0||||||
4314980|NCT00478569|4141666|B1|Missing||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4314981|NCT00478569|4141666|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4314982|NCT00478569|4141666|B1|African||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4314983|NCT00478569|4141666|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4314984|NCT00478569|4141666|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|1165|1165.0||||||
4314985|NCT00478569|4141666|B1|Missing||Sex/Gender, Customized|Although the indication in the Summary of Product characteristics is only females, some males were initially enrolled in countries where the PTH treatment is reimbursed.|participants|Number|2|2.0||||||
4314986|NCT00478569|4141666|B1|Female||Sex/Gender, Customized|Although the indication in the Summary of Product characteristics is only females, some males were initially enrolled in countries where the PTH treatment is reimbursed.|participants|Number|1149|1149.0||||||
4314987|NCT00478569|4141666|B1|Male||Sex/Gender, Customized|Although the indication in the Summary of Product characteristics is only females, some males were initially enrolled in countries where the PTH treatment is reimbursed.|participants|Number|19|19.0||||||
4314988|NCT00478569|4141666|B1|||Age||years|Mean|72.3|72.3|Standard Deviation|9.05|9.05|||
4314989|NCT00478556|4141680|B3|United States||Region of Enrollment||participants|Number|300|300.0||||||
4314990|NCT00478556|4141681|B2|United States||Region of Enrollment||participants|Number|149|149.0||||||
4314991|NCT00478556|4141682|B1|United States||Region of Enrollment||participants|Number|151|151.0||||||
4314992|NCT00478556|4141680|B3||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4314993|NCT00478556|4141681|B2||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4314994|NCT00478556|4141682|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4314995|NCT00478556|4141680|B3||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4314996|NCT00478556|4141681|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4314997|NCT00478556|4141682|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4314998|NCT00478556|4141680|B3|||Age||years|Mean|57|57.0|Standard Deviation|15|15.0|||
4314999|NCT00478556|4141681|B2|||Age||years|Mean|57|57.0|Standard Deviation|15|15.0|||
4315000|NCT00478556|4141682|B1|||Age||years|Mean|56|56.0|Standard Deviation|15|15.0|||
4315001|NCT00478556|4141680|B3||>=65 years|Age||Participants|Count of Participants|93|93.0||||||
4315002|NCT00478556|4141681|B2||>=65 years|Age||Participants|Count of Participants|53|53.0||||||
4315003|NCT00478556|4141682|B1||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
4315004|NCT00478556|4141680|B3||Between 18 and 65 years|Age||Participants|Count of Participants|207|207.0||||||
4315005|NCT00478556|4141681|B2||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
4315006|NCT00478556|4141682|B1||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
4315007|NCT00478556|4141680|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315008|NCT00478556|4141681|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315009|NCT00478556|4141682|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315010|NCT00478335|4141691|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4315011|NCT00478335|4141692|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4315012|NCT00478335|4141693|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4315013|NCT00478335|4141691|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4315014|NCT00478335|4141692|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4315015|NCT00478335|4141693|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4315016|NCT00478335|4141691|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4315017|NCT00478335|4141692|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4315018|NCT00478335|4141693|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4315019|NCT00478335|4141691|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4315020|NCT00478335|4141692|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4315021|NCT00478335|4141693|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4315022|NCT00478335|4141691|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4315023|NCT00478335|4141692|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4315024|NCT00478335|4141693|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4315025|NCT00478257|4141700|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
4315026|NCT00478257|4141701|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4315027|NCT00478257|4141702|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4315028|NCT00478257|4141700|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4315029|NCT00478257|4141701|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4315030|NCT00478257|4141702|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4315031|NCT00478257|4141700|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4315032|NCT00478257|4141701|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4315033|NCT00478257|4141702|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4315034|NCT00478257|4141700|B3|||Age||years|Mean|53.9|53.9|Standard Deviation|9|9.0|||
4315035|NCT00478257|4141701|B2|||Age||years|Mean|53.5|53.5|Standard Deviation|9|9.0|||
4315036|NCT00478257|4141702|B1|||Age||years|Mean|54.3|54.3|Standard Deviation|9|9.0|||
4315037|NCT00478257|4141700|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4315038|NCT00478257|4141701|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4315039|NCT00478257|4141702|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4315040|NCT00478257|4141700|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4315041|NCT00478257|4141701|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4315042|NCT00478257|4141702|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4315043|NCT00478257|4141700|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315044|NCT00478257|4141701|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315045|NCT00478257|4141702|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315046|NCT00478244|4141709|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4315047|NCT00478244|4141709|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4315048|NCT00478244|4141709|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4315049|NCT00478244|4141709|B1|||Age||years|Mean|6.0|6.0|Standard Deviation|4.5|4.5|||
4315050|NCT00478244|4141709|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4315051|NCT00478244|4141709|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4315052|NCT00478244|4141709|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4315053|NCT00478231|4141722|B1||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4315054|NCT00478231|4141722|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4315055|NCT00478231|4141722|B1|||Age||Years|Mean|43.2|43.2|Standard Deviation|7.6|7.6|||
4315056|NCT00478218|4141741|B3|No||Parameter of Hematologic Response - Bone Marrow Plasma Cells > 30%||participants|Number|22|22.0||||||
4315057|NCT00478218|4141742|B2|No||Parameter of Hematologic Response - Bone Marrow Plasma Cells > 30%||participants|Number|5|5.0||||||
4315058|NCT00478218|4141743|B1|No||Parameter of Hematologic Response - Bone Marrow Plasma Cells > 30%||participants|Number|17|17.0||||||
4315059|NCT00478218|4141741|B3|Yes||Parameter of Hematologic Response - Bone Marrow Plasma Cells > 30%||participants|Number|31|31.0||||||
4315060|NCT00478218|4141742|B2|Yes||Parameter of Hematologic Response - Bone Marrow Plasma Cells > 30%||participants|Number|14|14.0||||||
4315061|NCT00478218|4141743|B1|Yes||Parameter of Hematologic Response - Bone Marrow Plasma Cells > 30%||participants|Number|17|17.0||||||
4315062|NCT00478218|4141741|B3|No||Parameter of Hematologic Response - Urine M-Spike >= 200 mg/24 hours||participants|Number|37|37.0||||||
4315063|NCT00478218|4141742|B2|No||Parameter of Hematologic Response - Urine M-Spike >= 200 mg/24 hours||participants|Number|14|14.0||||||
4315064|NCT00478218|4141743|B1|No||Parameter of Hematologic Response - Urine M-Spike >= 200 mg/24 hours||participants|Number|23|23.0||||||
4315065|NCT00478218|4141741|B3|Yes||Parameter of Hematologic Response - Urine M-Spike >= 200 mg/24 hours||participants|Number|16|16.0||||||
4315066|NCT00478218|4141742|B2|Yes||Parameter of Hematologic Response - Urine M-Spike >= 200 mg/24 hours||participants|Number|5|5.0||||||
4315067|NCT00478218|4141743|B1|Yes||Parameter of Hematologic Response - Urine M-Spike >= 200 mg/24 hours||participants|Number|11|11.0||||||
4315068|NCT00478218|4141741|B3|No||Parameter of Hematologic Response - Serum Immunoglobulin Free Light Chain >= 10 mg/dL||participants|Number|18|18.0||||||
4315069|NCT00478218|4141742|B2|No||Parameter of Hematologic Response - Serum Immunoglobulin Free Light Chain >= 10 mg/dL||participants|Number|5|5.0||||||
4315070|NCT00478218|4141743|B1|No||Parameter of Hematologic Response - Serum Immunoglobulin Free Light Chain >= 10 mg/dL||participants|Number|13|13.0||||||
4315071|NCT00478218|4141741|B3|Yes||Parameter of Hematologic Response - Serum Immunoglobulin Free Light Chain >= 10 mg/dL||participants|Number|35|35.0||||||
4315072|NCT00478218|4141742|B2|Yes||Parameter of Hematologic Response - Serum Immunoglobulin Free Light Chain >= 10 mg/dL||participants|Number|14|14.0||||||
4315073|NCT00478218|4141743|B1|Yes||Parameter of Hematologic Response - Serum Immunoglobulin Free Light Chain >= 10 mg/dL||participants|Number|21|21.0||||||
4315074|NCT00478218|4141741|B3|No||Parameter of Hematologic Response - Serum M-spike >= 1 g/dL||participants|Number|14|14.0||||||
4315075|NCT00478218|4141742|B2|No||Parameter of Hematologic Response - Serum M-spike >= 1 g/dL||participants|Number|5|5.0||||||
4315169|NCT00478036|4141814|B4|||Age||years|Median|69|69.0|Inter-Quartile Range|||63.0|72.5|
4315076|NCT00478218|4141743|B1|No||Parameter of Hematologic Response - Serum M-spike >= 1 g/dL||participants|Number|9|9.0||||||
4315077|NCT00478218|4141741|B3|Yes||Parameter of Hematologic Response - Serum M-spike >= 1 g/dL||participants|Number|39|39.0||||||
4315078|NCT00478218|4141742|B2|Yes||Parameter of Hematologic Response - Serum M-spike >= 1 g/dL||participants|Number|14|14.0||||||
4315079|NCT00478218|4141743|B1|Yes||Parameter of Hematologic Response - Serum M-spike >= 1 g/dL||participants|Number|25|25.0||||||
4315080|NCT00478218|4141741|B3|Stage IIIA/B - High Cell Mass||Durie Salmon Stage||paricipants|Number|31|31.0||||||
4315081|NCT00478218|4141742|B2|Stage IIIA/B - High Cell Mass||Durie Salmon Stage||paricipants|Number|7|7.0||||||
4315082|NCT00478218|4141743|B1|Stage IIIA/B - High Cell Mass||Durie Salmon Stage||paricipants|Number|24|24.0||||||
4315083|NCT00478218|4141741|B3|Stage IIA - Intermediate Cell Mass||Durie Salmon Stage||paricipants|Number|18|18.0||||||
4315084|NCT00478218|4141742|B2|Stage IIA - Intermediate Cell Mass||Durie Salmon Stage||paricipants|Number|11|11.0||||||
4315085|NCT00478218|4141743|B1|Stage IIA - Intermediate Cell Mass||Durie Salmon Stage||paricipants|Number|7|7.0||||||
4315086|NCT00478218|4141741|B3|Stage IA - Low Cell Mass||Durie Salmon Stage||paricipants|Number|4|4.0||||||
4315087|NCT00478218|4141742|B2|Stage IA - Low Cell Mass||Durie Salmon Stage||paricipants|Number|1|1.0||||||
4315088|NCT00478218|4141743|B1|Stage IA - Low Cell Mass||Durie Salmon Stage||paricipants|Number|3|3.0||||||
4315089|NCT00478218|4141741|B3|United States||Region of Enrollment||participants|Number|53|53.0||||||
4315090|NCT00478218|4141742|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4315091|NCT00478218|4141743|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4315092|NCT00478218|4141741|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4315093|NCT00478218|4141742|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4315094|NCT00478218|4141743|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4315095|NCT00478218|4141741|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4315096|NCT00478218|4141742|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4315097|NCT00478218|4141743|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4315098|NCT00478218|4141741|B3|||Age||years|Median|64|64.0|Full Range|||37.0|82.0|
4315099|NCT00478218|4141742|B2|||Age||years|Median|65|65.0|Full Range|||37.0|82.0|
4315100|NCT00478218|4141743|B1|||Age||years|Median|63.5|63.5|Full Range|||44.0|79.0|
4315101|NCT00478205|4141756|B3|Other||Race/Ethnicity, Customized|Race (Safety Population)|Participants|Number|8|8.0||||||
4315102|NCT00478205|4141757|B2|Other||Race/Ethnicity, Customized|Race (Safety Population)|Participants|Number|3|3.0||||||
4315103|NCT00478205|4141758|B1|Other||Race/Ethnicity, Customized|Race (Safety Population)|Participants|Number|5|5.0||||||
4315104|NCT00478205|4141756|B3|Asian/Pacific||Race/Ethnicity, Customized|Race (Safety Population)|Participants|Number|248|248.0||||||
4315105|NCT00478205|4141757|B2|Asian/Pacific||Race/Ethnicity, Customized|Race (Safety Population)|Participants|Number|87|87.0||||||
4315106|NCT00478205|4141758|B1|Asian/Pacific||Race/Ethnicity, Customized|Race (Safety Population)|Participants|Number|161|161.0||||||
4315107|NCT00478205|4141756|B3|Native American||Race/Ethnicity, Customized|Race (Safety Population)|Participants|Number|0|0.0||||||
4315108|NCT00478205|4141757|B2|Native American||Race/Ethnicity, Customized|Race (Safety Population)|Participants|Number|0|0.0||||||
4315109|NCT00478205|4141758|B1|Native American||Race/Ethnicity, Customized|Race (Safety Population)|Participants|Number|0|0.0||||||
4315110|NCT00478205|4141756|B3|Hispanic||Race/Ethnicity, Customized|Race (Safety Population)|Participants|Number|93|93.0||||||
4315111|NCT00478205|4141757|B2|Hispanic||Race/Ethnicity, Customized|Race (Safety Population)|Participants|Number|26|26.0||||||
4315112|NCT00478205|4141758|B1|Hispanic||Race/Ethnicity, Customized|Race (Safety Population)|Participants|Number|67|67.0||||||
4315113|NCT00478205|4141756|B3|White||Race/Ethnicity, Customized|Race (Safety Population)|Participants|Number|1054|1054.0||||||
4315114|NCT00478205|4141757|B2|White||Race/Ethnicity, Customized|Race (Safety Population)|Participants|Number|346|346.0||||||
4315115|NCT00478205|4141758|B1|White||Race/Ethnicity, Customized|Race (Safety Population)|Participants|Number|708|708.0||||||
4315116|NCT00478205|4141756|B3|Black||Race/Ethnicity, Customized|Race (Safety Population)|Participants|Number|31|31.0||||||
4315117|NCT00478205|4141757|B2|Black||Race/Ethnicity, Customized|Race (Safety Population)|Participants|Number|9|9.0||||||
4315118|NCT00478205|4141758|B1|Black||Race/Ethnicity, Customized|Race (Safety Population)|Participants|Number|22|22.0||||||
4315119|NCT00478205|4141756|B3||Male|Sex: Female, Male|Safety Population: All patients randomized who took at least one dose of study medication and who had at least one postbaseline safety assessment.|Participants|Count of Participants|533|533.0||37.2|37.2|||
4315120|NCT00478205|4141757|B2||Male|Sex: Female, Male|Safety Population: All patients randomized who took at least one dose of study medication and who had at least one postbaseline safety assessment.|Participants|Count of Participants|177|177.0||37.6|37.6|||
4315121|NCT00478205|4141758|B1||Male|Sex: Female, Male|Safety Population: All patients randomized who took at least one dose of study medication and who had at least one postbaseline safety assessment.|Participants|Count of Participants|356|356.0||37.0|37.0|||
4315122|NCT00478205|4141756|B3||Female|Sex: Female, Male|Safety Population: All patients randomized who took at least one dose of study medication and who had at least one postbaseline safety assessment.|Participants|Count of Participants|901|901.0||62.8|62.8|||
4315123|NCT00478205|4141757|B2||Female|Sex: Female, Male|Safety Population: All patients randomized who took at least one dose of study medication and who had at least one postbaseline safety assessment.|Participants|Count of Participants|294|294.0||62.4|62.4|||
4315124|NCT00478205|4141758|B1||Female|Sex: Female, Male|Safety Population: All patients randomized who took at least one dose of study medication and who had at least one postbaseline safety assessment.|Participants|Count of Participants|607|607.0||63.0|63.0|||
4315125|NCT00478205|4141756|B3|||Age|Safety Population|Years|Mean|73.8|73.8|Standard Deviation|8.53|8.53|||
4315126|NCT00478205|4141757|B2|||Age|Safety Population|Years|Mean|73.8|73.8|Standard Deviation|8.56|8.56|||
4315127|NCT00478205|4141758|B1|||Age|Safety Population|Years|Mean|73.9|73.9|Standard Deviation|8.53|8.53|||
4315128|NCT00478192|4141771|B4|White||Race/Ethnicity, Customized|Population is Safety Analysis Set: All randomized patients who received at least one dose of study drug.|participants|Number|31|31.0||||||
4315129|NCT00478192|4141772|B3|White||Race/Ethnicity, Customized|Population is Safety Analysis Set: All randomized patients who received at least one dose of study drug.|participants|Number|4|4.0||||||
4315130|NCT00478192|4141773|B2|White||Race/Ethnicity, Customized|Population is Safety Analysis Set: All randomized patients who received at least one dose of study drug.|participants|Number|15|15.0||||||
4315131|NCT00478192|4141774|B1|White||Race/Ethnicity, Customized|Population is Safety Analysis Set: All randomized patients who received at least one dose of study drug.|participants|Number|12|12.0||||||
4315132|NCT00478192|4141771|B4|Black or African American||Race/Ethnicity, Customized|Population is Safety Analysis Set: All randomized patients who received at least one dose of study drug.|participants|Number|4|4.0||||||
4315133|NCT00478192|4141772|B3|Black or African American||Race/Ethnicity, Customized|Population is Safety Analysis Set: All randomized patients who received at least one dose of study drug.|participants|Number|2|2.0||||||
4315134|NCT00478192|4141773|B2|Black or African American||Race/Ethnicity, Customized|Population is Safety Analysis Set: All randomized patients who received at least one dose of study drug.|participants|Number|1|1.0||||||
4315135|NCT00478192|4141774|B1|Black or African American||Race/Ethnicity, Customized|Population is Safety Analysis Set: All randomized patients who received at least one dose of study drug.|participants|Number|1|1.0||||||
4315136|NCT00478192|4141771|B4|Asian||Race/Ethnicity, Customized|Population is Safety Analysis Set: All randomized patients who received at least one dose of study drug.|participants|Number|14|14.0||||||
4315137|NCT00478192|4141772|B3|Asian||Race/Ethnicity, Customized|Population is Safety Analysis Set: All randomized patients who received at least one dose of study drug.|participants|Number|3|3.0||||||
4315138|NCT00478192|4141773|B2|Asian||Race/Ethnicity, Customized|Population is Safety Analysis Set: All randomized patients who received at least one dose of study drug.|participants|Number|4|4.0||||||
4315139|NCT00478192|4141774|B1|Asian||Race/Ethnicity, Customized|Population is Safety Analysis Set: All randomized patients who received at least one dose of study drug.|participants|Number|7|7.0||||||
4315140|NCT00478192|4141771|B4||Male|Sex: Female, Male|Population is Safety Analysis Set: All randomized patients who received at least one dose of study drug.|Participants|Count of Participants|23|23.0||||||
4315141|NCT00478192|4141772|B3||Male|Sex: Female, Male|Population is Safety Analysis Set: All randomized patients who received at least one dose of study drug.|Participants|Count of Participants|1|1.0||||||
4315142|NCT00478192|4141773|B2||Male|Sex: Female, Male|Population is Safety Analysis Set: All randomized patients who received at least one dose of study drug.|Participants|Count of Participants|9|9.0||||||
4315143|NCT00478192|4141774|B1||Male|Sex: Female, Male|Population is Safety Analysis Set: All randomized patients who received at least one dose of study drug.|Participants|Count of Participants|13|13.0||||||
4315144|NCT00478192|4141771|B4||Female|Sex: Female, Male|Population is Safety Analysis Set: All randomized patients who received at least one dose of study drug.|Participants|Count of Participants|26|26.0||||||
4315145|NCT00478192|4141772|B3||Female|Sex: Female, Male|Population is Safety Analysis Set: All randomized patients who received at least one dose of study drug.|Participants|Count of Participants|8|8.0||||||
4315146|NCT00478192|4141773|B2||Female|Sex: Female, Male|Population is Safety Analysis Set: All randomized patients who received at least one dose of study drug.|Participants|Count of Participants|11|11.0||||||
4315147|NCT00478192|4141774|B1||Female|Sex: Female, Male|Population is Safety Analysis Set: All randomized patients who received at least one dose of study drug.|Participants|Count of Participants|7|7.0||||||
4315148|NCT00478192|4141771|B4|||Age|Population is Safety Analysis Set: All randomized patients who received at least one dose of study drug.|years|Mean|62.8|62.8|Standard Deviation|17.01|17.01|||
4315149|NCT00478192|4141772|B3|||Age|Population is Safety Analysis Set: All randomized patients who received at least one dose of study drug.|years|Mean|61.8|61.8|Standard Deviation|20.19|20.19|||
4315150|NCT00478192|4141773|B2|||Age|Population is Safety Analysis Set: All randomized patients who received at least one dose of study drug.|years|Mean|67.5|67.5|Standard Deviation|14.70|14.7|||
4315151|NCT00478192|4141774|B1|||Age|Population is Safety Analysis Set: All randomized patients who received at least one dose of study drug.|years|Mean|58.6|58.6|Standard Deviation|17.36|17.36|||
4315152|NCT00478140|4141803|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4315153|NCT00478140|4141803|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4315154|NCT00478140|4141803|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4315155|NCT00478140|4141803|B1|||Age||years|Median|52|52.0|Full Range|||38.0|62.0|
4315156|NCT00478062|4141807|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4315157|NCT00478062|4141807|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4315158|NCT00478062|4141807|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4315159|NCT00478062|4141807|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4315160|NCT00478062|4141807|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315161|NCT00478036|4141814|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4315162|NCT00478036|4141815|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4315163|NCT00478036|4141816|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4315164|NCT00478036|4141817|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4315165|NCT00478036|4141814|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4315166|NCT00478036|4141815|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4315167|NCT00478036|4141816|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4315168|NCT00478036|4141817|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4315170|NCT00478036|4141815|B3|||Age||years|Median|73|73.0|Inter-Quartile Range|||66.5|77.5|
4315171|NCT00478036|4141816|B2|||Age||years|Median|69.5|69.5|Inter-Quartile Range|||60.5|73.0|
4315172|NCT00478036|4141817|B1|||Age||years|Median|68|68.0|Inter-Quartile Range|||62.0|71.0|
4315173|NCT00478036|4141814|B4||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4315174|NCT00478036|4141815|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4315175|NCT00478036|4141816|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4315176|NCT00478036|4141817|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4315177|NCT00478036|4141814|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4315178|NCT00478036|4141815|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4315179|NCT00478036|4141816|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4315180|NCT00478036|4141817|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4315181|NCT00478036|4141814|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315182|NCT00478036|4141815|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315183|NCT00478036|4141816|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315184|NCT00478036|4141817|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315185|NCT00478023|4141827|B6|Latvia||Region of Enrollment||participants|Number|104|104.0||||||
4315186|NCT00478023|4141828|B5|Latvia||Region of Enrollment||participants|Number|20|20.0||||||
4315187|NCT00478023|4141829|B4|Latvia||Region of Enrollment||participants|Number|21|21.0||||||
4315188|NCT00478023|4141830|B3|Latvia||Region of Enrollment||participants|Number|22|22.0||||||
4315189|NCT00478023|4141831|B2|Latvia||Region of Enrollment||participants|Number|21|21.0||||||
4315190|NCT00478023|4141832|B1|Latvia||Region of Enrollment||participants|Number|20|20.0||||||
4315191|NCT00478023|4141827|B6|Russian Federation||Region of Enrollment||participants|Number|107|107.0||||||
4315192|NCT00478023|4141828|B5|Russian Federation||Region of Enrollment||participants|Number|22|22.0||||||
4315193|NCT00478023|4141829|B4|Russian Federation||Region of Enrollment||participants|Number|22|22.0||||||
4315194|NCT00478023|4141830|B3|Russian Federation||Region of Enrollment||participants|Number|21|21.0||||||
4315195|NCT00478023|4141831|B2|Russian Federation||Region of Enrollment||participants|Number|21|21.0||||||
4315196|NCT00478023|4141832|B1|Russian Federation||Region of Enrollment||participants|Number|21|21.0||||||
4315197|NCT00478023|4141827|B6|Romania||Region of Enrollment||participants|Number|172|172.0||||||
4315198|NCT00478023|4141828|B5|Romania||Region of Enrollment||participants|Number|35|35.0||||||
4315199|NCT00478023|4141829|B4|Romania||Region of Enrollment||participants|Number|36|36.0||||||
4315200|NCT00478023|4141830|B3|Romania||Region of Enrollment||participants|Number|34|34.0||||||
4315201|NCT00478023|4141831|B2|Romania||Region of Enrollment||participants|Number|33|33.0||||||
4315202|NCT00478023|4141832|B1|Romania||Region of Enrollment||participants|Number|34|34.0||||||
4315203|NCT00478023|4141827|B6|Ukraine||Region of Enrollment||participants|Number|66|66.0||||||
4315204|NCT00478023|4141828|B5|Ukraine||Region of Enrollment||participants|Number|13|13.0||||||
4315205|NCT00478023|4141829|B4|Ukraine||Region of Enrollment||participants|Number|14|14.0||||||
4315206|NCT00478023|4141830|B3|Ukraine||Region of Enrollment||participants|Number|14|14.0||||||
4315207|NCT00478023|4141831|B2|Ukraine||Region of Enrollment||participants|Number|11|11.0||||||
4315208|NCT00478023|4141832|B1|Ukraine||Region of Enrollment||participants|Number|14|14.0||||||
4315209|NCT00478023|4141827|B6|Poland||Region of Enrollment||participants|Number|179|179.0||||||
4315210|NCT00478023|4141828|B5|Poland||Region of Enrollment||participants|Number|36|36.0||||||
4315211|NCT00478023|4141829|B4|Poland||Region of Enrollment||participants|Number|37|37.0||||||
4315212|NCT00478023|4141830|B3|Poland||Region of Enrollment||participants|Number|34|34.0||||||
4315213|NCT00478023|4141831|B2|Poland||Region of Enrollment||participants|Number|36|36.0||||||
4315214|NCT00478023|4141832|B1|Poland||Region of Enrollment||participants|Number|36|36.0||||||
4315215|NCT00478023|4141827|B6|Slovakia||Region of Enrollment||participants|Number|124|124.0||||||
4315216|NCT00478023|4141828|B5|Slovakia||Region of Enrollment||participants|Number|24|24.0||||||
4315217|NCT00478023|4141829|B4|Slovakia||Region of Enrollment||participants|Number|25|25.0||||||
4315218|NCT00478023|4141830|B3|Slovakia||Region of Enrollment||participants|Number|25|25.0||||||
4315219|NCT00478023|4141831|B2|Slovakia||Region of Enrollment||participants|Number|25|25.0||||||
4315220|NCT00478023|4141832|B1|Slovakia||Region of Enrollment||participants|Number|25|25.0||||||
4315221|NCT00478023|4141827|B6|Hungary||Region of Enrollment||participants|Number|25|25.0||||||
4315222|NCT00478023|4141828|B5|Hungary||Region of Enrollment||participants|Number|4|4.0||||||
4315223|NCT00478023|4141829|B4|Hungary||Region of Enrollment||participants|Number|5|5.0||||||
4315224|NCT00478023|4141830|B3|Hungary||Region of Enrollment||participants|Number|5|5.0||||||
4315225|NCT00478023|4141831|B2|Hungary||Region of Enrollment||participants|Number|6|6.0||||||
4315226|NCT00478023|4141832|B1|Hungary||Region of Enrollment||participants|Number|5|5.0||||||
4315227|NCT00478023|4141827|B6|Serbia||Region of Enrollment||participants|Number|77|77.0||||||
4315228|NCT00478023|4141828|B5|Serbia||Region of Enrollment||participants|Number|15|15.0||||||
4315229|NCT00478023|4141829|B4|Serbia||Region of Enrollment||participants|Number|16|16.0||||||
4315230|NCT00478023|4141830|B3|Serbia||Region of Enrollment||participants|Number|16|16.0||||||
4315231|NCT00478023|4141831|B2|Serbia||Region of Enrollment||participants|Number|15|15.0||||||
4315232|NCT00478023|4141832|B1|Serbia||Region of Enrollment||participants|Number|15|15.0||||||
4315233|NCT00478023|4141827|B6|Female||Sex/Gender, Customized||participants|Number|854|854.0||||||
4315234|NCT00478023|4141828|B5|Female||Sex/Gender, Customized||participants|Number|169|169.0||||||
4315235|NCT00478023|4141829|B4|Female||Sex/Gender, Customized||participants|Number|176|176.0||||||
4315236|NCT00478023|4141830|B3|Female||Sex/Gender, Customized||participants|Number|171|171.0||||||
4315237|NCT00478023|4141831|B2|Female||Sex/Gender, Customized||participants|Number|168|168.0||||||
4315238|NCT00478023|4141832|B1|Female||Sex/Gender, Customized||participants|Number|170|170.0||||||
4315239|NCT00478023|4141827|B6|||Age||years|Mean|47.5|47.5|Standard Deviation|6.03|6.03|||
4315240|NCT00478023|4141828|B5|||Age||years|Mean|47.2|47.2|Standard Deviation|5.83|5.83|||
4315241|NCT00478023|4141829|B4|||Age||years|Mean|47.5|47.5|Standard Deviation|6.43|6.43|||
4315242|NCT00478023|4141830|B3|||Age||years|Mean|47.1|47.1|Standard Deviation|5.37|5.37|||
4315243|NCT00478023|4141831|B2|||Age||years|Mean|47.0|47.0|Standard Deviation|5.56|5.56|||
4315244|NCT00478023|4141832|B1|||Age||years|Mean|48.5|48.5|Standard Deviation|6.75|6.75|||
4315245|NCT00478023|4141827|B6||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4315246|NCT00478023|4141828|B5||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4315247|NCT00478023|4141829|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4315248|NCT00478023|4141830|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4315249|NCT00478023|4141831|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4315250|NCT00478023|4141832|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4315251|NCT00478023|4141827|B6||Between 18 and 65 years|Age||Participants|Count of Participants|840|840.0||||||
4315252|NCT00478023|4141828|B5||Between 18 and 65 years|Age||Participants|Count of Participants|166|166.0||||||
4315253|NCT00478023|4141829|B4||Between 18 and 65 years|Age||Participants|Count of Participants|173|173.0||||||
4315254|NCT00478023|4141830|B3||Between 18 and 65 years|Age||Participants|Count of Participants|170|170.0||||||
4315255|NCT00478023|4141831|B2||Between 18 and 65 years|Age||Participants|Count of Participants|166|166.0||||||
4315256|NCT00478023|4141832|B1||Between 18 and 65 years|Age||Participants|Count of Participants|165|165.0||||||
4315257|NCT00478023|4141827|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315258|NCT00478023|4141828|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315259|NCT00478023|4141829|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315260|NCT00478023|4141830|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315261|NCT00478023|4141831|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315262|NCT00478023|4141832|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315263|NCT00477971|4141853|B3|High||Risk Group|"Low Risk (requires all of the following): 1 or 2 organs involved, Cardiac EF >= 50%, Age <= 65 years, NYHA class 1 or 2, Alkaline phosphatase <= 4 x institutional ULN, cardiac involvement fully compensated or asymptomatic, serum creatinine <= 2.0 mg/dL~High Risk (any one of the following): >2 organs involved, Cardiac EF <50%, Age > 65 years, NYHA class 3, Alkaline phosphatase 4-6 x institutional ULN, symptomatic cardiac involvement, serum creatinine 2.1-3.0 mg/dL"|participants|Number|31|31.0||||||
4315264|NCT00477971|4141854|B2|High||Risk Group|"Low Risk (requires all of the following): 1 or 2 organs involved, Cardiac EF >= 50%, Age <= 65 years, NYHA class 1 or 2, Alkaline phosphatase <= 4 x institutional ULN, cardiac involvement fully compensated or asymptomatic, serum creatinine <= 2.0 mg/dL~High Risk (any one of the following): >2 organs involved, Cardiac EF <50%, Age > 65 years, NYHA class 3, Alkaline phosphatase 4-6 x institutional ULN, symptomatic cardiac involvement, serum creatinine 2.1-3.0 mg/dL"|participants|Number|17|17.0||||||
4315265|NCT00477971|4141855|B1|High||Risk Group|"Low Risk (requires all of the following): 1 or 2 organs involved, Cardiac EF >= 50%, Age <= 65 years, NYHA class 1 or 2, Alkaline phosphatase <= 4 x institutional ULN, cardiac involvement fully compensated or asymptomatic, serum creatinine <= 2.0 mg/dL~High Risk (any one of the following): >2 organs involved, Cardiac EF <50%, Age > 65 years, NYHA class 3, Alkaline phosphatase 4-6 x institutional ULN, symptomatic cardiac involvement, serum creatinine 2.1-3.0 mg/dL"|participants|Number|14|14.0||||||
4315266|NCT00477971|4141853|B3|Low||Risk Group|"Low Risk (requires all of the following): 1 or 2 organs involved, Cardiac EF >= 50%, Age <= 65 years, NYHA class 1 or 2, Alkaline phosphatase <= 4 x institutional ULN, cardiac involvement fully compensated or asymptomatic, serum creatinine <= 2.0 mg/dL~High Risk (any one of the following): >2 organs involved, Cardiac EF <50%, Age > 65 years, NYHA class 3, Alkaline phosphatase 4-6 x institutional ULN, symptomatic cardiac involvement, serum creatinine 2.1-3.0 mg/dL"|participants|Number|58|58.0||||||
4315267|NCT00477971|4141854|B2|Low||Risk Group|"Low Risk (requires all of the following): 1 or 2 organs involved, Cardiac EF >= 50%, Age <= 65 years, NYHA class 1 or 2, Alkaline phosphatase <= 4 x institutional ULN, cardiac involvement fully compensated or asymptomatic, serum creatinine <= 2.0 mg/dL~High Risk (any one of the following): >2 organs involved, Cardiac EF <50%, Age > 65 years, NYHA class 3, Alkaline phosphatase 4-6 x institutional ULN, symptomatic cardiac involvement, serum creatinine 2.1-3.0 mg/dL"|participants|Number|38|38.0||||||
4315268|NCT00477971|4141855|B1|Low||Risk Group|"Low Risk (requires all of the following): 1 or 2 organs involved, Cardiac EF >= 50%, Age <= 65 years, NYHA class 1 or 2, Alkaline phosphatase <= 4 x institutional ULN, cardiac involvement fully compensated or asymptomatic, serum creatinine <= 2.0 mg/dL~High Risk (any one of the following): >2 organs involved, Cardiac EF <50%, Age > 65 years, NYHA class 3, Alkaline phosphatase 4-6 x institutional ULN, symptomatic cardiac involvement, serum creatinine 2.1-3.0 mg/dL"|participants|Number|20|20.0||||||
4315269|NCT00477971|4141853|B3|2||ECOG Performance Score|Classifies patients according to their functional impairment. 0: Fully active, able to carry on all pre-disease performance without restriction; 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2: Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours|participants|Number|14|14.0||||||
4315312|NCT00477750|4141868|B1|No||Parameter of Hematologic Response - Serum Immunoglobulin Free Light Chain >= 10mg/dL||participants|Number|14|14.0||||||
4315313|NCT00477750|4141868|B1|Yes||Parameter of Hematologic Response - Serum Immunoglobulin Free Light Chain >= 10mg/dL||participants|Number|12|12.0||||||
4315270|NCT00477971|4141854|B2|2||ECOG Performance Score|Classifies patients according to their functional impairment. 0: Fully active, able to carry on all pre-disease performance without restriction; 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2: Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours|participants|Number|5|5.0||||||
4315271|NCT00477971|4141855|B1|2||ECOG Performance Score|Classifies patients according to their functional impairment. 0: Fully active, able to carry on all pre-disease performance without restriction; 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2: Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours|participants|Number|9|9.0||||||
4315272|NCT00477971|4141853|B3|0-1||ECOG Performance Score|Classifies patients according to their functional impairment. 0: Fully active, able to carry on all pre-disease performance without restriction; 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2: Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours|participants|Number|75|75.0||||||
4315273|NCT00477971|4141854|B2|0-1||ECOG Performance Score|Classifies patients according to their functional impairment. 0: Fully active, able to carry on all pre-disease performance without restriction; 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2: Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours|participants|Number|50|50.0||||||
4315274|NCT00477971|4141855|B1|0-1||ECOG Performance Score|Classifies patients according to their functional impairment. 0: Fully active, able to carry on all pre-disease performance without restriction; 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2: Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours|participants|Number|25|25.0||||||
4315275|NCT00477971|4141853|B3|United States||Region of Enrollment||participants|Number|89|89.0||||||
4315276|NCT00477971|4141854|B2|United States||Region of Enrollment||participants|Number|55|55.0||||||
4315277|NCT00477971|4141855|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4315278|NCT00477971|4141853|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4315279|NCT00477971|4141854|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4315280|NCT00477971|4141855|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4315281|NCT00477971|4141853|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315282|NCT00477971|4141854|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315283|NCT00477971|4141855|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315284|NCT00477971|4141853|B3||White|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
4315285|NCT00477971|4141854|B2||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4315286|NCT00477971|4141855|B1||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4315287|NCT00477971|4141853|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4315288|NCT00477971|4141854|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4315289|NCT00477971|4141855|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4315290|NCT00477971|4141853|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4315291|NCT00477971|4141854|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4315292|NCT00477971|4141855|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315293|NCT00477971|4141853|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4315294|NCT00477971|4141854|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4315295|NCT00477971|4141855|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315296|NCT00477971|4141853|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315297|NCT00477971|4141854|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315298|NCT00477971|4141855|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315299|NCT00477971|4141853|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4315300|NCT00477971|4141854|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4315301|NCT00477971|4141855|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4315302|NCT00477971|4141853|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4315303|NCT00477971|4141854|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4315304|NCT00477971|4141855|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4315305|NCT00477971|4141853|B3|||Age||years|Median|59|59.0|Full Range|||44.0|74.0|
4315306|NCT00477971|4141854|B2|||Age||years|Median|57|57.0|Full Range|||44.0|73.0|
4315307|NCT00477971|4141855|B1|||Age||years|Median|62|62.0|Full Range|||48.0|74.0|
4315308|NCT00477750|4141868|B1|No||Parameter of Hematologic Response - None (non-secretory myeloma, bone marrow only)||participants|Number|26|26.0||||||
4315309|NCT00477750|4141868|B1|Yes||Parameter of Hematologic Response - None (non-secretory myeloma, bone marrow only)||participants|Number|0|0.0||||||
4315310|NCT00477750|4141868|B1|No||Parameter of Hematologic Response - Urine M-spike >= 200 mg/24 hours||participants|Number|20|20.0||||||
4315311|NCT00477750|4141868|B1|Yes||Parameter of Hematologic Response - Urine M-spike >= 200 mg/24 hours||participants|Number|6|6.0||||||
4315314|NCT00477750|4141868|B1|No||Parameter of Hematologic Response - Serum M-spike >= 1g/dL||participants|Number|6|6.0||||||
4315315|NCT00477750|4141868|B1|Yes||Parameter of Hematologic Response - Serum M-spike >= 1g/dL||participants|Number|20|20.0||||||
4315316|NCT00477750|4141868|B1|unknown||Durie-Salmon Stage at Diagnosis||participants|Number|3|3.0||||||
4315317|NCT00477750|4141868|B1|III - High Cell Mass||Durie-Salmon Stage at Diagnosis||participants|Number|11|11.0||||||
4315318|NCT00477750|4141868|B1|II - Intermediate Cell Mass||Durie-Salmon Stage at Diagnosis||participants|Number|11|11.0||||||
4315319|NCT00477750|4141868|B1|I - Low Cell Mass||Durie-Salmon Stage at Diagnosis||participants|Number|1|1.0||||||
4315320|NCT00477750|4141868|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4315321|NCT00477750|4141868|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4315322|NCT00477750|4141868|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4315323|NCT00477750|4141868|B1|||Age||years|Median|73.5|73.5|Full Range|||64.0|87.0|
4315324|NCT00477685|4141872|B1|India||Region of Enrollment||participants|Number|10|10.0||||||
4315325|NCT00477685|4141872|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4315326|NCT00477685|4141872|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4315327|NCT00477685|4141872|B1|||Age||years|Mean|65|65.0|Standard Deviation|4|4.0|||
4315328|NCT00477685|4141872|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4315329|NCT00477685|4141872|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4315330|NCT00477685|4141872|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315331|NCT00477672|4141877|B4|Europe||Region of Enrollment||participants|Number|131|131.0||||||
4315332|NCT00477672|4141878|B3|Europe||Region of Enrollment||participants|Number|43|43.0||||||
4315333|NCT00477672|4141879|B2|Europe||Region of Enrollment||participants|Number|44|44.0||||||
4315334|NCT00477672|4141880|B1|Europe||Region of Enrollment||participants|Number|44|44.0||||||
4315335|NCT00477672|4141877|B4|India||Region of Enrollment||participants|Number|30|30.0||||||
4315336|NCT00477672|4141878|B3|India||Region of Enrollment||participants|Number|10|10.0||||||
4315337|NCT00477672|4141879|B2|India||Region of Enrollment||participants|Number|10|10.0||||||
4315338|NCT00477672|4141880|B1|India||Region of Enrollment||participants|Number|10|10.0||||||
4315339|NCT00477672|4141877|B4|United States||Region of Enrollment||participants|Number|134|134.0||||||
4315340|NCT00477672|4141878|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
4315341|NCT00477672|4141879|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
4315342|NCT00477672|4141880|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4315343|NCT00477672|4141877|B4||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4315344|NCT00477672|4141878|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4315345|NCT00477672|4141879|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4315346|NCT00477672|4141880|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4315347|NCT00477672|4141877|B4||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4315348|NCT00477672|4141878|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4315349|NCT00477672|4141879|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4315350|NCT00477672|4141880|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4315351|NCT00477672|4141877|B4|||Age||years|Mean|69.3|69.3|Standard Deviation|8.71|8.71|||
4315352|NCT00477672|4141878|B3|||Age||years|Mean|69.4|69.4|Standard Deviation|7.84|7.84|||
4315353|NCT00477672|4141879|B2|||Age||years|Mean|69.0|69.0|Standard Deviation|8.61|8.61|||
4315354|NCT00477672|4141880|B1|||Age||years|Mean|69.6|69.6|Standard Deviation|9.67|9.67|||
4315355|NCT00477672|4141877|B4||>=65 years|Age||Participants|Count of Participants|215|215.0||||||
4315356|NCT00477672|4141878|B3||>=65 years|Age||Participants|Count of Participants|75|75.0||||||
4315357|NCT00477672|4141879|B2||>=65 years|Age||Participants|Count of Participants|69|69.0||||||
4315358|NCT00477672|4141880|B1||>=65 years|Age||Participants|Count of Participants|71|71.0||||||
4315359|NCT00477672|4141877|B4||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4315360|NCT00477672|4141878|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4315361|NCT00477672|4141879|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4315362|NCT00477672|4141880|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4315363|NCT00477672|4141877|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315364|NCT00477672|4141878|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315365|NCT00477672|4141879|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315366|NCT00477672|4141880|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315367|NCT00477633|4141893|B1|United States||Region of Enrollment||participants|Number|1700|1700.0||||||
4315368|NCT00477633|4141893|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4315369|NCT00477633|4141893|B1||Female|Sex: Female, Male||Participants|Count of Participants|1700|1700.0||||||
4315370|NCT00477633|4141893|B1|>35 years||Age, Customized|MITT Population|participants|Number|319|319.0||||||
4315371|NCT00477633|4141893|B1|Between 18 and 35 years||Age, Customized|MITT Population|participants|Number|1251|1251.0||||||
4315372|NCT00477633|4141893|B1|||Age|MITT Population|years|Mean|28.8|28.8|Standard Deviation|7.1|7.1|||
4315373|NCT00477607|4141899|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
4315374|NCT00477607|4141900|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4315375|NCT00477607|4141901|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4315376|NCT00477607|4141899|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4315377|NCT00477607|4141900|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4315378|NCT00477607|4141901|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4315379|NCT00477607|4141899|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4315380|NCT00477607|4141900|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4315381|NCT00477607|4141901|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4315382|NCT00477607|4141899|B3|||Age||years|Mean|61.2|61.2|Standard Deviation|11.2|11.2|||
4315383|NCT00477607|4141900|B2|||Age||years|Mean|60.6|60.6|Standard Deviation|12.3|12.3|||
4315384|NCT00477607|4141901|B1|||Age||years|Mean|62.0|62.0|Standard Deviation|10.2|10.2|||
4315385|NCT00477607|4141899|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4315386|NCT00477607|4141900|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4315387|NCT00477607|4141901|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4315388|NCT00477607|4141899|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4315389|NCT00477607|4141900|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4315390|NCT00477607|4141901|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4315391|NCT00477607|4141899|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315392|NCT00477607|4141900|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315393|NCT00477607|4141901|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315394|NCT00477594|4141912|B3|Never||Alcohol use||participants|Number|4|4.0||||||
4315395|NCT00477594|4141913|B2|Never||Alcohol use||participants|Number|2|2.0||||||
4315396|NCT00477594|4141914|B1|Never||Alcohol use||participants|Number|2|2.0||||||
4315397|NCT00477594|4141912|B3|Non-current||Alcohol use||participants|Number|1|1.0||||||
4315398|NCT00477594|4141913|B2|Non-current||Alcohol use||participants|Number|0|0.0||||||
4315399|NCT00477594|4141914|B1|Non-current||Alcohol use||participants|Number|1|1.0||||||
4315400|NCT00477594|4141912|B3|Current||Alcohol use||participants|Number|16|16.0||||||
4315401|NCT00477594|4141913|B2|Current||Alcohol use||participants|Number|3|3.0||||||
4315402|NCT00477594|4141914|B1|Current||Alcohol use||participants|Number|13|13.0||||||
4315403|NCT00477594|4141912|B3|Never||Tobacco Use||participants|Number|13|13.0||||||
4315404|NCT00477594|4141913|B2|Never||Tobacco Use||participants|Number|3|3.0||||||
4315405|NCT00477594|4141914|B1|Never||Tobacco Use||participants|Number|10|10.0||||||
4315406|NCT00477594|4141912|B3|Non-current||Tobacco Use||participants|Number|7|7.0||||||
4315407|NCT00477594|4141913|B2|Non-current||Tobacco Use||participants|Number|2|2.0||||||
4315408|NCT00477594|4141914|B1|Non-current||Tobacco Use||participants|Number|5|5.0||||||
4315409|NCT00477594|4141912|B3|Current||Tobacco Use||participants|Number|1|1.0||||||
4315410|NCT00477594|4141913|B2|Current||Tobacco Use||participants|Number|0|0.0||||||
4315411|NCT00477594|4141914|B1|Current||Tobacco Use||participants|Number|1|1.0||||||
4315412|NCT00477594|4141912|B3|Yes||Metabolic syndrome|"A patient was classified as having metabolic syndrome if any 3 of the following risk factors existed: 1) Waist circumference ≥102 cm (men) or ≥88 cm (women); 2) Triglycerides ≥150 mg/dL*; 3) High density lipoprotein cholesterol <40 mg/dL (men) or <50 mg/dL (women)*; 4) Systolic blood pressure ≥130 or diastolic ≥85 mmHg*; 5) Fasting glucose ≥100 mg/dL*.~* = or on medication for the specified risk factor."|participants|Number|10|10.0||||||
4315413|NCT00477594|4141913|B2|Yes||Metabolic syndrome|"A patient was classified as having metabolic syndrome if any 3 of the following risk factors existed: 1) Waist circumference ≥102 cm (men) or ≥88 cm (women); 2) Triglycerides ≥150 mg/dL*; 3) High density lipoprotein cholesterol <40 mg/dL (men) or <50 mg/dL (women)*; 4) Systolic blood pressure ≥130 or diastolic ≥85 mmHg*; 5) Fasting glucose ≥100 mg/dL*.~* = or on medication for the specified risk factor."|participants|Number|2|2.0||||||
4315414|NCT00477594|4141914|B1|Yes||Metabolic syndrome|"A patient was classified as having metabolic syndrome if any 3 of the following risk factors existed: 1) Waist circumference ≥102 cm (men) or ≥88 cm (women); 2) Triglycerides ≥150 mg/dL*; 3) High density lipoprotein cholesterol <40 mg/dL (men) or <50 mg/dL (women)*; 4) Systolic blood pressure ≥130 or diastolic ≥85 mmHg*; 5) Fasting glucose ≥100 mg/dL*.~* = or on medication for the specified risk factor."|participants|Number|8|8.0||||||
4315415|NCT00477594|4141912|B3|No||Metabolic syndrome|"A patient was classified as having metabolic syndrome if any 3 of the following risk factors existed: 1) Waist circumference ≥102 cm (men) or ≥88 cm (women); 2) Triglycerides ≥150 mg/dL*; 3) High density lipoprotein cholesterol <40 mg/dL (men) or <50 mg/dL (women)*; 4) Systolic blood pressure ≥130 or diastolic ≥85 mmHg*; 5) Fasting glucose ≥100 mg/dL*.~* = or on medication for the specified risk factor."|participants|Number|11|11.0||||||
4315416|NCT00477594|4141913|B2|No||Metabolic syndrome|"A patient was classified as having metabolic syndrome if any 3 of the following risk factors existed: 1) Waist circumference ≥102 cm (men) or ≥88 cm (women); 2) Triglycerides ≥150 mg/dL*; 3) High density lipoprotein cholesterol <40 mg/dL (men) or <50 mg/dL (women)*; 4) Systolic blood pressure ≥130 or diastolic ≥85 mmHg*; 5) Fasting glucose ≥100 mg/dL*.~* = or on medication for the specified risk factor."|participants|Number|3|3.0||||||
4315417|NCT00477594|4141914|B1|No||Metabolic syndrome|"A patient was classified as having metabolic syndrome if any 3 of the following risk factors existed: 1) Waist circumference ≥102 cm (men) or ≥88 cm (women); 2) Triglycerides ≥150 mg/dL*; 3) High density lipoprotein cholesterol <40 mg/dL (men) or <50 mg/dL (women)*; 4) Systolic blood pressure ≥130 or diastolic ≥85 mmHg*; 5) Fasting glucose ≥100 mg/dL*.~* = or on medication for the specified risk factor."|participants|Number|8|8.0||||||
4315418|NCT00477594|4141912|B3|||Body Mass Index (BMI)||kg/m^2|Mean|28.6|28.6|Standard Deviation|5.34|5.34|||
4315419|NCT00477594|4141913|B2|||Body Mass Index (BMI)||kg/m^2|Mean|27.4|27.4|Standard Deviation|4.81|4.81|||
4315420|NCT00477594|4141914|B1|||Body Mass Index (BMI)||kg/m^2|Mean|28.9|28.9|Standard Deviation|5.60|5.6|||
4315421|NCT00477594|4141912|B3|Multiple||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4315422|NCT00477594|4141913|B2|Multiple||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4315423|NCT00477594|4141914|B1|Multiple||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4315424|NCT00477594|4141912|B3|Other race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4315425|NCT00477594|4141913|B2|Other race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4315426|NCT00477594|4141914|B1|Other race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4315427|NCT00477594|4141912|B3|White||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4315428|NCT00477594|4141913|B2|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4315429|NCT00477594|4141914|B1|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4315430|NCT00477594|4141912|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4315431|NCT00477594|4141913|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4315432|NCT00477594|4141914|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4315433|NCT00477594|4141912|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4315434|NCT00477594|4141913|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4315435|NCT00477594|4141914|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4315436|NCT00477594|4141912|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4315437|NCT00477594|4141913|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4315438|NCT00477594|4141914|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4315439|NCT00477594|4141912|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4315440|NCT00477594|4141913|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4315441|NCT00477594|4141914|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4315442|NCT00477594|4141912|B3|||Age||years|Mean|48.9|48.9|Standard Deviation|12.7|12.7|||
4315443|NCT00477594|4141913|B2|||Age||years|Mean|54.6|54.6|Standard Deviation|15.7|15.7|||
4315444|NCT00477594|4141914|B1|||Age||years|Mean|47.1|47.1|Standard Deviation|11.6|11.6|||
4315445|NCT00477490|4141971|B6|Not Hispanic||Ethnic Origin||participants|Number|705|705.0||||||
4315446|NCT00477490|4141972|B5|Not Hispanic||Ethnic Origin||participants|Number|140|140.0||||||
4315447|NCT00477490|4141973|B4|Not Hispanic||Ethnic Origin||participants|Number|135|135.0||||||
4315448|NCT00477490|4141974|B3|Not Hispanic||Ethnic Origin||participants|Number|142|142.0||||||
4315449|NCT00477490|4141975|B2|Not Hispanic||Ethnic Origin||participants|Number|145|145.0||||||
4315450|NCT00477490|4141976|B1|Not Hispanic||Ethnic Origin||participants|Number|143|143.0||||||
4315451|NCT00477490|4141971|B6|Hispanic||Ethnic Origin||participants|Number|52|52.0||||||
4315452|NCT00477490|4141972|B5|Hispanic||Ethnic Origin||participants|Number|6|6.0||||||
4315453|NCT00477490|4141973|B4|Hispanic||Ethnic Origin||participants|Number|13|13.0||||||
4315454|NCT00477490|4141974|B3|Hispanic||Ethnic Origin||participants|Number|10|10.0||||||
4315455|NCT00477490|4141975|B2|Hispanic||Ethnic Origin||participants|Number|10|10.0||||||
4315456|NCT00477490|4141976|B1|Hispanic||Ethnic Origin||participants|Number|13|13.0||||||
4315457|NCT00477490|4141971|B6|Other||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4315458|NCT00477490|4141972|B5|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4315459|NCT00477490|4141973|B4|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4315460|NCT00477490|4141974|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4315461|NCT00477490|4141975|B2|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4315462|NCT00477490|4141976|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4315463|NCT00477490|4141971|B6|Native Hawaiian/other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4315464|NCT00477490|4141972|B5|Native Hawaiian/other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4315465|NCT00477490|4141973|B4|Native Hawaiian/other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4315466|NCT00477490|4141974|B3|Native Hawaiian/other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4315467|NCT00477490|4141975|B2|Native Hawaiian/other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4315468|NCT00477490|4141976|B1|Native Hawaiian/other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4315469|NCT00477490|4141971|B6|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4315470|NCT00477490|4141972|B5|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4315471|NCT00477490|4141973|B4|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4315472|NCT00477490|4141974|B3|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4315473|NCT00477490|4141975|B2|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4315474|NCT00477490|4141976|B1|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4315475|NCT00477490|4141971|B6|Asian||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4315476|NCT00477490|4141972|B5|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4315477|NCT00477490|4141973|B4|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4315478|NCT00477490|4141974|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4315479|NCT00477490|4141975|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4315480|NCT00477490|4141976|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4315481|NCT00477490|4141971|B6|Black/African American||Race/Ethnicity, Customized||participants|Number|116|116.0||||||
4315482|NCT00477490|4141972|B5|Black/African American||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4315483|NCT00477490|4141973|B4|Black/African American||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4315484|NCT00477490|4141974|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4315485|NCT00477490|4141975|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4315486|NCT00477490|4141976|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4315487|NCT00477490|4141971|B6|Caucasian||Race/Ethnicity, Customized||participants|Number|609|609.0||||||
4315488|NCT00477490|4141972|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|111|111.0||||||
4315489|NCT00477490|4141973|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|119|119.0||||||
4315490|NCT00477490|4141974|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|120|120.0||||||
4315491|NCT00477490|4141975|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|123|123.0||||||
4315492|NCT00477490|4141976|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|136|136.0||||||
4315493|NCT00477490|4141971|B6||Male|Sex: Female, Male||Participants|Count of Participants|416|416.0||||||
4315494|NCT00477490|4141972|B5||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4315495|NCT00477490|4141973|B4||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4315496|NCT00477490|4141974|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4315497|NCT00477490|4141975|B2||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4315498|NCT00477490|4141976|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4315499|NCT00477490|4141971|B6||Female|Sex: Female, Male||Participants|Count of Participants|341|341.0||||||
4315500|NCT00477490|4141972|B5||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4315501|NCT00477490|4141973|B4||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4315502|NCT00477490|4141974|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4315503|NCT00477490|4141975|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4315504|NCT00477490|4141976|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4315505|NCT00477490|4141971|B6|||Age||years|Mean|62.0|62.0|Standard Deviation|13.05|13.05|||
4315506|NCT00477490|4141972|B5|||Age||years|Mean|62.1|62.1|Standard Deviation|12.34|12.34|||
4315507|NCT00477490|4141973|B4|||Age||years|Mean|61.6|61.6|Standard Deviation|11.80|11.8|||
4315508|NCT00477490|4141974|B3|||Age||years|Mean|62.4|62.4|Standard Deviation|13.22|13.22|||
4315509|NCT00477490|4141975|B2|||Age||years|Mean|61.7|61.7|Standard Deviation|14.41|14.41|||
4315510|NCT00477490|4141976|B1|||Age||years|Mean|62.1|62.1|Standard Deviation|13.39|13.39|||
4315511|NCT00477464|4142068|B1|||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4315512|NCT00477464|4142068|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4315513|NCT00477464|4142068|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4315514|NCT00477464|4142068|B1|||Age||Years|Mean|55.5|55.5|Standard Deviation|8.85|8.85|||
4315515|NCT00477451|4142091|B5|United States||Region of Enrollment||Participants|Count of Participants|49|49.0||||||
4315516|NCT00477451|4142092|B4|United States||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4315517|NCT00477451|4142093|B3|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4315518|NCT00477451|4142094|B2|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4315519|NCT00477451|4142095|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4315520|NCT00477451|4142091|B5||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4315521|NCT00477451|4142092|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4315522|NCT00477451|4142093|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4315523|NCT00477451|4142094|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4315524|NCT00477451|4142095|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4315525|NCT00477451|4142091|B5||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4315526|NCT00477451|4142092|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4315527|NCT00477451|4142093|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4315528|NCT00477451|4142094|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4315529|NCT00477451|4142095|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4315530|NCT00477451|4142091|B5|||Age||years|Mean|34.3|34.3|Standard Deviation|10.66|10.66|||
4315531|NCT00477451|4142092|B4|||Age||years|Mean|37.5|37.5|Standard Deviation|0.707|0.707|||
4315532|NCT00477451|4142093|B3|||Age||years|Mean|43.1|43.1|Standard Deviation|13.6|13.6|||
4315533|NCT00477451|4142094|B2|||Age||years|Mean|32.1|32.1|Standard Deviation|9.45|9.45|||
4315534|NCT00477451|4142095|B1|||Age||years|Mean|33.2|33.2|Standard Deviation|10.2|10.2|||
4315535|NCT00477451|4142091|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4315536|NCT00477451|4142092|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4315537|NCT00477451|4142093|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4315538|NCT00477451|4142094|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4315539|NCT00477451|4142095|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4315540|NCT00477451|4142091|B5||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4315541|NCT00477451|4142092|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4315542|NCT00477451|4142093|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4315543|NCT00477451|4142094|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4315544|NCT00477451|4142095|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4315545|NCT00477451|4142091|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315546|NCT00477451|4142092|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315547|NCT00477451|4142093|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315548|NCT00477451|4142094|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315549|NCT00477451|4142095|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315550|NCT00477386|4142110|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315551|NCT00477386|4142111|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315552|NCT00477386|4142112|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315553|NCT00477386|4142110|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315554|NCT00477386|4142111|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315555|NCT00477386|4142112|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315556|NCT00477386|4142110|B3||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4315557|NCT00477386|4142111|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4315558|NCT00477386|4142112|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4315559|NCT00477386|4142110|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315560|NCT00477386|4142111|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315561|NCT00477386|4142112|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315562|NCT00477386|4142110|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315563|NCT00477386|4142111|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315564|NCT00477386|4142112|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315565|NCT00477386|4142110|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315566|NCT00477386|4142111|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315567|NCT00477386|4142112|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315568|NCT00477386|4142110|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315569|NCT00477386|4142111|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315570|NCT00477386|4142112|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315571|NCT00477386|4142110|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315572|NCT00477386|4142111|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315573|NCT00477386|4142112|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315574|NCT00477386|4142110|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4315575|NCT00477386|4142111|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4315576|NCT00477386|4142112|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4315577|NCT00477386|4142110|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315578|NCT00477386|4142111|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315579|NCT00477386|4142112|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315580|NCT00477386|4142110|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4315581|NCT00477386|4142111|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4315582|NCT00477386|4142112|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4315583|NCT00477386|4142110|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4315584|NCT00477386|4142111|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4315585|NCT00477386|4142112|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4315586|NCT00477386|4142110|B3|||Age||Years|Mean|61.2|61.2|Standard Deviation|9.6|9.6|||
4315587|NCT00477386|4142111|B2|||Age||Years|Mean|61.4|61.4|Standard Deviation|10.9|10.9|||
4315588|NCT00477386|4142112|B1|||Age||Years|Mean|60.8|60.8|Standard Deviation|7.8|7.8|||
4315589|NCT00477386|4142110|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4315590|NCT00477386|4142111|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4315591|NCT00477386|4142112|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4315592|NCT00477386|4142110|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4315593|NCT00477386|4142111|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4315594|NCT00477386|4142112|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4315595|NCT00477386|4142110|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315596|NCT00477386|4142111|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315597|NCT00477386|4142112|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315598|NCT00477334|4142121|B3|||Genital herpes recurrence in last 12 months|"Number of genital herpes recurrences during the last 12 months or in the 12 months immediately preceding suppressive treatment.~Intent to Treat population consists of all randomized participants who initiated treatment with the study drug with the intention of treating genital herpes recurrences"|Genital herpes recurrences|Mean|5.9|5.9|Standard Deviation|3.09|3.09|||
4315633|NCT00477230|4142235|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4315599|NCT00477334|4142122|B2|||Genital herpes recurrence in last 12 months|"Number of genital herpes recurrences during the last 12 months or in the 12 months immediately preceding suppressive treatment.~Intent to Treat population consists of all randomized participants who initiated treatment with the study drug with the intention of treating genital herpes recurrences"|Genital herpes recurrences|Mean|5.8|5.8|Standard Deviation|2.72|2.72|||
4315600|NCT00477334|4142123|B1|||Genital herpes recurrence in last 12 months|"Number of genital herpes recurrences during the last 12 months or in the 12 months immediately preceding suppressive treatment.~Intent to Treat population consists of all randomized participants who initiated treatment with the study drug with the intention of treating genital herpes recurrences"|Genital herpes recurrences|Mean|6.0|6.0|Standard Deviation|3.26|3.26|||
4315601|NCT00477334|4142121|B3|||Number of Years: recurrent genital herpes|Number of years the participant has experienced recurrent genital herpes. Intent to Treat population consists of all randomized participants who initiated treatment with the study drug with the intention of treating genital herpes recurrences|Years|Mean|7.0|7.0|Standard Deviation|6.66|6.66|||
4315602|NCT00477334|4142122|B2|||Number of Years: recurrent genital herpes|Number of years the participant has experienced recurrent genital herpes. Intent to Treat population consists of all randomized participants who initiated treatment with the study drug with the intention of treating genital herpes recurrences|Years|Mean|7.0|7.0|Standard Deviation|6.50|6.5|||
4315603|NCT00477334|4142123|B1|||Number of Years: recurrent genital herpes|Number of years the participant has experienced recurrent genital herpes. Intent to Treat population consists of all randomized participants who initiated treatment with the study drug with the intention of treating genital herpes recurrences|Years|Mean|6.9|6.9|Standard Deviation|6.75|6.75|||
4315604|NCT00477334|4142121|B3||Male|Sex: Female, Male|Intent to Treat population consists of all randomized patients who initiated treatment with the study drug with the intention of treating genital herpes recurrences|Participants|Count of Participants|103|103.0||||||
4315605|NCT00477334|4142122|B2||Male|Sex: Female, Male|Intent to Treat population consists of all randomized patients who initiated treatment with the study drug with the intention of treating genital herpes recurrences|Participants|Count of Participants|29|29.0||||||
4315606|NCT00477334|4142123|B1||Male|Sex: Female, Male|Intent to Treat population consists of all randomized patients who initiated treatment with the study drug with the intention of treating genital herpes recurrences|Participants|Count of Participants|74|74.0||||||
4315607|NCT00477334|4142121|B3||Female|Sex: Female, Male|Intent to Treat population consists of all randomized patients who initiated treatment with the study drug with the intention of treating genital herpes recurrences|Participants|Count of Participants|196|196.0||||||
4315608|NCT00477334|4142122|B2||Female|Sex: Female, Male|Intent to Treat population consists of all randomized patients who initiated treatment with the study drug with the intention of treating genital herpes recurrences|Participants|Count of Participants|69|69.0||||||
4315609|NCT00477334|4142123|B1||Female|Sex: Female, Male|Intent to Treat population consists of all randomized patients who initiated treatment with the study drug with the intention of treating genital herpes recurrences|Participants|Count of Participants|127|127.0||||||
4315610|NCT00477334|4142121|B3|||Age|Intent to Treat population consists of all randomized participants who initiated treatment with the study drug with the intention of treating genital herpes recurrences|years|Mean|37.8|37.8|Standard Deviation|10.34|10.34|||
4315611|NCT00477334|4142122|B2|||Age|Intent to Treat population consists of all randomized participants who initiated treatment with the study drug with the intention of treating genital herpes recurrences|years|Mean|38.5|38.5|Standard Deviation|10.34|10.34|||
4315612|NCT00477334|4142123|B1|||Age|Intent to Treat population consists of all randomized participants who initiated treatment with the study drug with the intention of treating genital herpes recurrences|years|Mean|37.5|37.5|Standard Deviation|10.35|10.35|||
4315613|NCT00477295|4142148|B3||Male|Sex: Female, Male|Safety Population: All randomized subjects who received at least one dose of study medication.|Participants|Count of Participants|346|346.0||||||
4315614|NCT00477295|4142149|B2||Male|Sex: Female, Male|Safety Population: All randomized subjects who received at least one dose of study medication.|Participants|Count of Participants|172|172.0||||||
4315615|NCT00477295|4142150|B1||Male|Sex: Female, Male|Safety Population: All randomized subjects who received at least one dose of study medication.|Participants|Count of Participants|174|174.0||||||
4315616|NCT00477295|4142148|B3||Female|Sex: Female, Male|Safety Population: All randomized subjects who received at least one dose of study medication.|Participants|Count of Participants|235|235.0||||||
4315617|NCT00477295|4142149|B2||Female|Sex: Female, Male|Safety Population: All randomized subjects who received at least one dose of study medication.|Participants|Count of Participants|128|128.0||||||
4315618|NCT00477295|4142150|B1||Female|Sex: Female, Male|Safety Population: All randomized subjects who received at least one dose of study medication.|Participants|Count of Participants|107|107.0||||||
4315619|NCT00477295|4142148|B3|||Age|Safety Population.|years|Mean|36.4|36.4|Standard Deviation|15.91|15.91|||
4315620|NCT00477295|4142149|B2|||Age|Safety Population.|years|Mean|35.6|35.6|Standard Deviation|15.50|15.5|||
4315621|NCT00477295|4142150|B1|||Age|Safety Population.|years|Mean|37.1|37.1|Standard Deviation|16.33|16.33|||
4315622|NCT00477269|4142177|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4315623|NCT00477269|4142178|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4315624|NCT00477269|4142179|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4315625|NCT00477269|4142177|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4315626|NCT00477269|4142178|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4315627|NCT00477269|4142179|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4315628|NCT00477269|4142177|B3|||Age||years|Mean|44.3|44.3|Standard Deviation|15.4|15.4|||
4315629|NCT00477269|4142178|B2|||Age||years|Mean|44.2|44.2|Standard Deviation|15.7|15.7|||
4315630|NCT00477269|4142179|B1|||Age||years|Mean|44.4|44.4|Standard Deviation|15.3|15.3|||
4315631|NCT00477230|4142233|B3|United States||Region of Enrollment||participants|Number|64|64.0||||||
4315632|NCT00477230|4142234|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
4315634|NCT00477230|4142233|B3|Unknown||Sex/Gender, Customized||Participants|Number|64|64.0||||||
4315635|NCT00477230|4142234|B2|Unknown||Sex/Gender, Customized||Participants|Number|32|32.0||||||
4315636|NCT00477230|4142235|B1|Unknown||Sex/Gender, Customized||Participants|Number|32|32.0||||||
4315637|NCT00477230|4142233|B3|Female||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4315638|NCT00477230|4142234|B2|Female||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4315639|NCT00477230|4142235|B1|Female||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4315640|NCT00477230|4142233|B3|Male||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4315641|NCT00477230|4142234|B2|Male||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4315642|NCT00477230|4142235|B1|Male||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4315643|NCT00477230|4142233|B3|Greater than or equal to 18 Years||Age, Customized||Participants|Number|64|64.0||||||
4315644|NCT00477230|4142234|B2|Greater than or equal to 18 Years||Age, Customized||Participants|Number|32|32.0||||||
4315645|NCT00477230|4142235|B1|Greater than or equal to 18 Years||Age, Customized||Participants|Number|32|32.0||||||
4315646|NCT00477230|4142233|B3|Less than 18 Years||Age, Customized||Participants|Number|0|0.0||||||
4315647|NCT00477230|4142234|B2|Less than 18 Years||Age, Customized||Participants|Number|0|0.0||||||
4315648|NCT00477230|4142235|B1|Less than 18 Years||Age, Customized||Participants|Number|0|0.0||||||
4315649|NCT00477204|4142242|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4315650|NCT00477204|4142243|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4315651|NCT00477204|4142244|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4315652|NCT00477204|4142242|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4315653|NCT00477204|4142243|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4315654|NCT00477204|4142244|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4315655|NCT00477204|4142242|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4315656|NCT00477204|4142243|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4315657|NCT00477204|4142244|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4315658|NCT00477204|4142242|B3|||Age||years|Mean|15.8|15.8|Standard Deviation|2.8|2.8|||
4315659|NCT00477204|4142243|B2|||Age||years|Mean|17.5|17.5|Standard Deviation|2.3|2.3|||
4315660|NCT00477204|4142244|B1|||Age||years|Mean|13.7|13.7|Standard Deviation|1.8|1.8|||
4315661|NCT00477204|4142242|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4315662|NCT00477204|4142243|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4315663|NCT00477204|4142244|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4315664|NCT00477204|4142242|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4315665|NCT00477204|4142243|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4315666|NCT00477204|4142244|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4315667|NCT00477204|4142242|B3||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4315668|NCT00477204|4142243|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4315669|NCT00477204|4142244|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4315670|NCT00477191|4142251|B1|||Psoriasis Area Severity Index (PASI)|The PASI is a measure of psoriatic disease severity taking into account qualitative lesion characteristics (erythema, thickness, and scaling) and degree of skin surface area involvement on defined anatomical regions. PASI scores range from 0 to 72, with higher scores reflecting greater disease severity. Erythema, thickness, and scaling are scored on a scale of 0 (none) to 4 (very severe) on 4 anatomic regions of the body: head, trunk, upper limbs, and lower limbs. Degree of involvement on each of the 4 anatomic regions is scored on a scale of 0 (no involvement) to 6 (90% to 100% involvement).|units on a scale|Mean|16.9|16.9|Standard Deviation|1.5|1.5|||
4315671|NCT00477191|4142251|B1|||BMI||kg/m^2|Mean|38.9|38.9|Standard Deviation|5.6|5.6|||
4315672|NCT00477191|4142251|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4315673|NCT00477191|4142251|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4315674|NCT00477191|4142251|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4315675|NCT00477191|4142251|B1|||Age||years|Mean|43.5|43.5|Standard Deviation|11.6|11.6|||
4315676|NCT00477191|4142251|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4315677|NCT00477191|4142251|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4315678|NCT00477191|4142251|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315679|NCT00477165|4142258|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
4315680|NCT00477165|4142259|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4315681|NCT00477165|4142260|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4315682|NCT00477165|4142258|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4315683|NCT00477165|4142259|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4315684|NCT00477165|4142260|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4315685|NCT00477165|4142258|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4315686|NCT00477165|4142259|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4315687|NCT00477165|4142260|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4315688|NCT00477165|4142258|B3|||Age||years|Mean|52|52.0|Full Range|||27.0|75.0|
4315689|NCT00477165|4142259|B2|||Age||years|Mean|51|51.0|Full Range|||30.0|75.0|
4315690|NCT00477165|4142260|B1|||Age||years|Mean|53|53.0|Full Range|||27.0|75.0|
4315749|NCT00476957|4142286|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315691|NCT00477152|4142273|B1|||Gorelick Dehydration Score|Score indicates the number of moderate-to-severe signs/symptoms of dehydration, based on assessment of each of the following ten patient parameters: general condition, quality of radial pulse, quality of respiration, skin elasticity, eyes, tears, mucous membranes, urine output, heart rate and fingertip capillary refill time. Minimum score = 0; maximum score = 10. (Note: study inclusion criterion required a baseline score of 1 to 6.)|Number of moderate/severe symptoms|Mean|3.5|3.5|Standard Deviation|1.19|1.19|||
4315692|NCT00477152|4142273|B1|>= 3 years to <= 10 years||Age||participants|Number|8|8.0||||||
4315693|NCT00477152|4142273|B1|>= 2 months to < 3 years||Age||participants|Number|43|43.0||||||
4315694|NCT00477152|4142273|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4315695|NCT00477152|4142273|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4315696|NCT00477152|4142273|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4315697|NCT00477152|4142273|B1|||Age||years|Mean|1.91|1.91|Standard Deviation|1.949|1.949|||
4315698|NCT00477087|4142280|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4315699|NCT00477087|4142280|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315700|NCT00477087|4142280|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4315701|NCT00477087|4142280|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315702|NCT00477087|4142280|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315703|NCT00477087|4142280|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4315704|NCT00477087|4142280|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315705|NCT00477087|4142280|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315706|NCT00477087|4142280|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4315707|NCT00477087|4142280|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315708|NCT00477087|4142280|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4315709|NCT00477087|4142280|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4315710|NCT00477087|4142280|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4315711|NCT00477087|4142280|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4315712|NCT00477087|4142280|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315713|NCT00476957|4142286|B3|Middle East||Region of Enrollment||participants|Number|326|326.0||||||
4315714|NCT00476957|4142287|B2|Middle East||Region of Enrollment||participants|Number|162|162.0||||||
4315715|NCT00476957|4142288|B1|Middle East||Region of Enrollment||participants|Number|164|164.0||||||
4315716|NCT00476957|4142286|B3|New Zealand||Region of Enrollment||participants|Number|85|85.0||||||
4315717|NCT00476957|4142287|B2|New Zealand||Region of Enrollment||participants|Number|42|42.0||||||
4315718|NCT00476957|4142288|B1|New Zealand||Region of Enrollment||participants|Number|43|43.0||||||
4315719|NCT00476957|4142286|B3|Australia||Region of Enrollment||participants|Number|414|414.0||||||
4315720|NCT00476957|4142287|B2|Australia||Region of Enrollment||participants|Number|207|207.0||||||
4315721|NCT00476957|4142288|B1|Australia||Region of Enrollment||participants|Number|207|207.0||||||
4315722|NCT00476957|4142286|B3|South America||Region of Enrollment||participants|Number|50|50.0||||||
4315723|NCT00476957|4142287|B2|South America||Region of Enrollment||participants|Number|25|25.0||||||
4315724|NCT00476957|4142288|B1|South America||Region of Enrollment||participants|Number|25|25.0||||||
4315725|NCT00476957|4142286|B3|North America||Region of Enrollment||participants|Number|230|230.0||||||
4315726|NCT00476957|4142287|B2|North America||Region of Enrollment||participants|Number|115|115.0||||||
4315727|NCT00476957|4142288|B1|North America||Region of Enrollment||participants|Number|115|115.0||||||
4315728|NCT00476957|4142286|B3|South Asia||Region of Enrollment||participants|Number|1245|1245.0||||||
4315729|NCT00476957|4142287|B2|South Asia||Region of Enrollment||participants|Number|622|622.0||||||
4315730|NCT00476957|4142288|B1|South Asia||Region of Enrollment||participants|Number|623|623.0||||||
4315731|NCT00476957|4142286|B3|Europe||Region of Enrollment||participants|Number|6359|6359.0||||||
4315732|NCT00476957|4142287|B2|Europe||Region of Enrollment||participants|Number|3179|3179.0||||||
4315733|NCT00476957|4142288|B1|Europe||Region of Enrollment||participants|Number|3180|3180.0||||||
4315734|NCT00476957|4142286|B3||Male|Sex: Female, Male||Participants|Count of Participants|6648|6648.0||||||
4315735|NCT00476957|4142287|B2||Male|Sex: Female, Male||Participants|Count of Participants|3308|3308.0||||||
4315736|NCT00476957|4142288|B1||Male|Sex: Female, Male||Participants|Count of Participants|3340|3340.0||||||
4315737|NCT00476957|4142286|B3||Female|Sex: Female, Male||Participants|Count of Participants|2061|2061.0||||||
4315738|NCT00476957|4142287|B2||Female|Sex: Female, Male||Participants|Count of Participants|1044|1044.0||||||
4315739|NCT00476957|4142288|B1||Female|Sex: Female, Male||Participants|Count of Participants|1017|1017.0||||||
4315740|NCT00476957|4142286|B3|||Age||years|Mean|62.2|62.2|Standard Deviation|10.6|10.6|||
4315741|NCT00476957|4142287|B2|||Age||years|Mean|62.1|62.1|Standard Deviation|10.7|10.7|||
4315742|NCT00476957|4142288|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|10.6|10.6|||
4315743|NCT00476957|4142286|B3||>=65 years|Age||Participants|Count of Participants|3813|3813.0||||||
4315744|NCT00476957|4142287|B2||>=65 years|Age||Participants|Count of Participants|1884|1884.0||||||
4315745|NCT00476957|4142288|B1||>=65 years|Age||Participants|Count of Participants|1929|1929.0||||||
4315746|NCT00476957|4142286|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4896|4896.0||||||
4315747|NCT00476957|4142287|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2468|2468.0||||||
4315748|NCT00476957|4142288|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2428|2428.0||||||
4315750|NCT00476957|4142287|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315751|NCT00476957|4142288|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315752|NCT00476827|4142297|B7|United States||Region of Enrollment||participants|Number|8|8.0||||||
4315753|NCT00476827|4142298|B6|United States||Region of Enrollment||participants|Number|2|2.0||||||
4315754|NCT00476827|4142299|B5|United States||Region of Enrollment||participants|Number|2|2.0||||||
4315755|NCT00476827|4142301|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4315756|NCT00476827|4142303|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4315757|NCT00476827|4142297|B7|Male||Gender||participants|Number|0|0.0||||||
4315758|NCT00476827|4142298|B6|Male||Gender||participants|Number|0|0.0||||||
4315759|NCT00476827|4142299|B5|Male||Gender||participants|Number|0|0.0||||||
4315760|NCT00476827|4142301|B3|Male||Gender||participants|Number|0|0.0||||||
4315761|NCT00476827|4142303|B1|Male||Gender||participants|Number|0|0.0||||||
4315762|NCT00476827|4142297|B7|Female||Gender||participants|Number|8|8.0||||||
4315763|NCT00476827|4142298|B6|Female||Gender||participants|Number|2|2.0||||||
4315764|NCT00476827|4142299|B5|Female||Gender||participants|Number|2|2.0||||||
4315765|NCT00476827|4142301|B3|Female||Gender||participants|Number|1|1.0||||||
4315766|NCT00476827|4142303|B1|Female||Gender||participants|Number|3|3.0||||||
4315767|NCT00476827|4142297|B7|||Age||years|Mean|50.6|50.6|Standard Deviation|5.8|5.8|||
4315768|NCT00476827|4142298|B6|||Age||years|Mean|56.5|56.5|Standard Deviation|NA||||The study did not meet expected accrual
4315769|NCT00476827|4142299|B5|||Age||years|Mean|52.5|52.5|Standard Deviation|NA||||The study did not meet expected accrual
4315770|NCT00476827|4142301|B3|||Age||years|Mean|42|42.0|Standard Deviation|NA||||The study did not meet expected accrual
4315771|NCT00476827|4142303|B1|||Age||years|Mean|48.3|48.3|Standard Deviation|NA||||The study did not meet expected accrual
4315772|NCT00476827|4142297|B7|>=65 years||Age||participants|Number|0|0.0||||||
4315773|NCT00476827|4142298|B6|>=65 years||Age||participants|Number|0|0.0||||||
4315774|NCT00476827|4142299|B5|>=65 years||Age||participants|Number|0|0.0||||||
4315775|NCT00476827|4142301|B3|>=65 years||Age||participants|Number|0|0.0||||||
4315776|NCT00476827|4142303|B1|>=65 years||Age||participants|Number|0|0.0||||||
4315777|NCT00476827|4142297|B7|Between 18 and 65 years||Age||participants|Number|8|8.0||||||
4315778|NCT00476827|4142298|B6|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
4315779|NCT00476827|4142299|B5|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
4315780|NCT00476827|4142301|B3|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
4315781|NCT00476827|4142303|B1|Between 18 and 65 years||Age||participants|Number|3|3.0||||||
4315782|NCT00476827|4142297|B7|<=18 years||Age||participants|Number|0|0.0||||||
4315783|NCT00476827|4142298|B6|<=18 years||Age||participants|Number|0|0.0||||||
4315784|NCT00476827|4142299|B5|<=18 years||Age||participants|Number|0|0.0||||||
4315785|NCT00476827|4142301|B3|<=18 years||Age||participants|Number|0|0.0||||||
4315786|NCT00476827|4142303|B1|<=18 years||Age||participants|Number|0|0.0||||||
4315787|NCT00476788|4142338|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4315788|NCT00476788|4142338|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4315789|NCT00476788|4142338|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4315790|NCT00476788|4142338|B1|||Age||years|Mean|6.275|6.275|Standard Deviation|2.875|2.875|||
4315791|NCT00476788|4142338|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4315792|NCT00476788|4142338|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4315793|NCT00476788|4142338|B1||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4315794|NCT00476645|4142343|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315795|NCT00476645|4142343|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315796|NCT00476645|4142343|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4315797|NCT00476645|4142343|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315798|NCT00476645|4142343|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315799|NCT00476645|4142343|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4315800|NCT00476645|4142343|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315801|NCT00476645|4142343|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315802|NCT00476645|4142343|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4315803|NCT00476645|4142343|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4315804|NCT00476645|4142343|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4315805|NCT00476645|4142343|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4315806|NCT00476645|4142343|B1|||Age||years|Median|75|75.0|Full Range|||58.0|99.0|
4315807|NCT00476593|4142349|B5|Norway||Region of Enrollment||participants|Number|176|176.0||||||
4315808|NCT00476593|4142350|B4|Norway||Region of Enrollment||participants|Number|107|107.0||||||
4315809|NCT00476593|4142351|B3|Norway||Region of Enrollment||participants|Number|30|30.0||||||
4315810|NCT00476593|4142352|B2|Norway||Region of Enrollment||participants|Number|17|17.0||||||
4315811|NCT00476593|4142353|B1|Norway||Region of Enrollment||participants|Number|22|22.0||||||
4315812|NCT00476593|4142349|B5||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4315813|NCT00476593|4142350|B4||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4315814|NCT00476593|4142351|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4315815|NCT00476593|4142352|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4315816|NCT00476593|4142353|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4315817|NCT00476593|4142349|B5||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4315818|NCT00476593|4142350|B4||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4315819|NCT00476593|4142351|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4315820|NCT00476593|4142352|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4315821|NCT00476593|4142353|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4315822|NCT00476593|4142349|B5|||Age||years|Mean|45.1|45.1|Standard Deviation|11|11.0|||
4315823|NCT00476593|4142350|B4|||Age||years|Mean|42.4|42.4|Standard Deviation|11.8|11.8|||
4315824|NCT00476593|4142351|B3|||Age||years|Mean|40.5|40.5|Standard Deviation|2.3|2.3|||
4315825|NCT00476593|4142352|B2|||Age||years|Mean|46.2|46.2|Standard Deviation|11.4|11.4|||
4315826|NCT00476593|4142353|B1|||Age||years|Mean|44.2|44.2|Standard Deviation|10.9|10.9|||
4315827|NCT00476593|4142349|B5||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4315828|NCT00476593|4142350|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4315829|NCT00476593|4142351|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4315830|NCT00476593|4142352|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4315831|NCT00476593|4142353|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4315832|NCT00476593|4142349|B5||Between 18 and 65 years|Age||Participants|Count of Participants|175|175.0||||||
4315833|NCT00476593|4142350|B4||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
4315834|NCT00476593|4142351|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4315835|NCT00476593|4142352|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4315836|NCT00476593|4142353|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4315837|NCT00476593|4142349|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315838|NCT00476593|4142350|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315839|NCT00476593|4142351|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315840|NCT00476593|4142352|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315841|NCT00476593|4142353|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315842|NCT00476476|4142366|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
4315843|NCT00476476|4142367|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4315844|NCT00476476|4142368|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4315845|NCT00476476|4142366|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4315846|NCT00476476|4142367|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4315847|NCT00476476|4142368|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4315848|NCT00476476|4142366|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4315849|NCT00476476|4142367|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4315850|NCT00476476|4142368|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4315851|NCT00476476|4142366|B3|||Age||years|Mean|73|73.0|Full Range|||49.0|94.0|
4315852|NCT00476476|4142367|B2|||Age||years|Mean|71.5|71.5|Full Range|||49.0|86.0|
4315853|NCT00476476|4142368|B1|||Age||years|Mean|75|75.0|Full Range|||58.0|94.0|
4315854|NCT00476242|4142374|B3|United States||Region of Enrollment||participants|Number|55|55.0||||||
4315855|NCT00476242|4142375|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4315856|NCT00476242|4142376|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4315857|NCT00476242|4142374|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4315858|NCT00476242|4142375|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4315859|NCT00476242|4142376|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4315860|NCT00476242|4142374|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4315861|NCT00476242|4142375|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4315862|NCT00476242|4142376|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4315863|NCT00476242|4142374|B3|||Age||years|Mean|39.4|39.4|Standard Deviation|11.5|11.5|||
4315864|NCT00476242|4142375|B2|||Age||years|Mean|39.0|39.0|Standard Deviation|11.5|11.5|||
4315865|NCT00476242|4142376|B1|||Age||years|Mean|39.7|39.7|Standard Deviation|12.0|12.0|||
4315866|NCT00476229|4142387|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4315867|NCT00476229|4142387|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4315868|NCT00476229|4142387|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4315869|NCT00476229|4142387|B1|||Age||years|Median|30|30.0|Full Range|||20.0|40.0|
4315870|NCT00476151|4142391|B3|India||Region of Enrollment||participants|Number|226|226.0||||||
4315871|NCT00476151|4142392|B2|India||Region of Enrollment||participants|Number|114|114.0||||||
4315872|NCT00476151|4142393|B1|India||Region of Enrollment||participants|Number|112|112.0||||||
4315873|NCT00476151|4142391|B3||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4315874|NCT00476151|4142392|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4315875|NCT00476151|4142393|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4315876|NCT00476151|4142391|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4315877|NCT00476151|4142392|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4315878|NCT00476151|4142393|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4315879|NCT00476151|4142391|B3|||Age||years|Mean|55.56|55.56|Standard Deviation|10.214|10.214|||
4315880|NCT00476151|4142392|B2|||Age||years|Mean|56.06|56.06|Standard Deviation|9.350|9.35|||
4315881|NCT00476151|4142393|B1|||Age||years|Mean|55.05|55.05|Standard Deviation|11.044|11.044|||
4315882|NCT00476151|4142391|B3||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
4315883|NCT00476151|4142392|B2||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4315884|NCT00476151|4142393|B1||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4315885|NCT00476151|4142391|B3||Between 18 and 65 years|Age||Participants|Count of Participants|180|180.0||||||
4315886|NCT00476151|4142392|B2||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
4315887|NCT00476151|4142393|B1||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
4315888|NCT00476151|4142391|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315889|NCT00476151|4142392|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315890|NCT00476151|4142393|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315891|NCT00476086|4142400|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4315892|NCT00476086|4142400|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4315893|NCT00476086|4142400|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4315894|NCT00476086|4142400|B1|||Age||years|Mean|63|63.0|Full Range|||49.0|73.0|
4315895|NCT00476047|4142406|B1||Negative|Minimal Residual Disease (MRD) status before 131 I-tositumomab|MRD was assessed on bone marrow samples using 8 color flow cytometry to detect CLL/SLL cells. Any level of residual disease by flow cytometry or cytogenetics was considered MRD positive. Negativity of both tests was required to classify a patient as MRD negative.|Participants|Count of Participants|4|4.0||||||
4315896|NCT00476047|4142406|B1||Positive|Minimal Residual Disease (MRD) status before 131 I-tositumomab|MRD was assessed on bone marrow samples using 8 color flow cytometry to detect CLL/SLL cells. Any level of residual disease by flow cytometry or cytogenetics was considered MRD positive. Negativity of both tests was required to classify a patient as MRD negative.|Participants|Count of Participants|12|12.0||||||
4315897|NCT00476047|4142406|B1||PR (partial response)|Disease status before 131 I-tositumomab|"CRITERIA FOR RESPONSE Criteria for response are specified by the NCI working group guidelines; in addition, patients will be required to meet computed tomography (CT) scan criteria as defined in the protocol.~Complete response (CR) Partial response (PR) Progressive Disease (PD) Stable Disease (SD)"|Participants|Count of Participants|12|12.0||||||
4315898|NCT00476047|4142406|B1||CR (complete response)|Disease status before 131 I-tositumomab|"CRITERIA FOR RESPONSE Criteria for response are specified by the NCI working group guidelines; in addition, patients will be required to meet computed tomography (CT) scan criteria as defined in the protocol.~Complete response (CR) Partial response (PR) Progressive Disease (PD) Stable Disease (SD)"|Participants|Count of Participants|4|4.0||||||
4315899|NCT00476047|4142406|B1||R-CHOP|Prior chemotherapy||Participants|Count of Participants|1|1.0||||||
4315900|NCT00476047|4142406|B1||BR (bendamustine and rituximab)|Prior chemotherapy||Participants|Count of Participants|2|2.0||||||
4315901|NCT00476047|4142406|B1||FCR(fludaribine, cyclophosphamide and rituximab)|Prior chemotherapy||Participants|Count of Participants|4|4.0||||||
4315902|NCT00476047|4142406|B1||FR (fludaribine and rituximab)|Prior chemotherapy||Participants|Count of Participants|9|9.0||||||
4315903|NCT00476047|4142406|B1||SLL (Small lymphocytic leukemia)|CLL or SLL||Participants|Count of Participants|5|5.0||||||
4315904|NCT00476047|4142406|B1||CLL (Chronic lymphocytic leukemia)|CLL or SLL||Participants|Count of Participants|11|11.0||||||
4315905|NCT00476047|4142406|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4315906|NCT00476047|4142406|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4315907|NCT00476047|4142406|B1|||Age||years|Mean|61|61.0|Full Range|||38.0|78.0|
4315908|NCT00476021|4142413|B3|Did not receive IUD per protocol||Received IUD per protocol||participants|Number|6|6.0||||||
4315909|NCT00476021|4142414|B2|Did not receive IUD per protocol||Received IUD per protocol||participants|Number|5|5.0||||||
4315910|NCT00476021|4142415|B1|Did not receive IUD per protocol||Received IUD per protocol||participants|Number|1|1.0||||||
4315911|NCT00476021|4142413|B3|Received IUD per protocol||Received IUD per protocol||participants|Number|96|96.0||||||
4315912|NCT00476021|4142414|B2|Received IUD per protocol||Received IUD per protocol||participants|Number|46|46.0||||||
4315913|NCT00476021|4142415|B1|Received IUD per protocol||Received IUD per protocol||participants|Number|50|50.0||||||
4315914|NCT00476021|4142413|B3|United States||Region of Enrollment||participants|Number|102|102.0||||||
4315915|NCT00476021|4142414|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
4315916|NCT00476021|4142415|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4315917|NCT00476021|4142413|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4315918|NCT00476021|4142414|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4315919|NCT00476021|4142415|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4315920|NCT00476021|4142413|B3||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4315921|NCT00476021|4142414|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4315922|NCT00476021|4142415|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4315923|NCT00476021|4142413|B3|||Age||years|Mean|25.1|25.1|Standard Deviation|5.2|5.2|||
4315924|NCT00476021|4142414|B2|||Age||years|Mean|24.7|24.7|Standard Deviation|5.2|5.2|||
4315925|NCT00476021|4142415|B1|||Age||years|Mean|25.4|25.4|Standard Deviation|5.3|5.3|||
4315926|NCT00476021|4142413|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4315927|NCT00476021|4142414|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4315928|NCT00476021|4142415|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4315929|NCT00476021|4142413|B3||Between 18 and 65 years|Age||Participants|Count of Participants|102|102.0||||||
4315930|NCT00476021|4142414|B2||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4315931|NCT00476021|4142415|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4315932|NCT00476021|4142413|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315933|NCT00476021|4142414|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315934|NCT00476021|4142415|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315935|NCT00476008|4142430|B3|United States||Region of Enrollment||participants|Number|43|43.0||||||
4315936|NCT00476008|4142431|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4315937|NCT00476008|4142432|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4315938|NCT00476008|4142430|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4315939|NCT00476008|4142431|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4315940|NCT00476008|4142432|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4315941|NCT00476008|4142430|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4315942|NCT00476008|4142431|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4315943|NCT00476008|4142432|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4315944|NCT00476008|4142430|B3|||Age||years|Mean|79.28|79.28|Standard Deviation|6.21|6.21|||
4315945|NCT00476008|4142431|B2|||Age||years|Mean|80.47|80.47|Standard Deviation|5.92|5.92|||
4315946|NCT00476008|4142432|B1|||Age||years|Mean|78.13|78.13|Standard Deviation|6.38|6.38|||
4315947|NCT00476008|4142430|B3||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
4315948|NCT00476008|4142431|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4315949|NCT00476008|4142432|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4315950|NCT00476008|4142430|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4315951|NCT00476008|4142431|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4315952|NCT00476008|4142432|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4315953|NCT00476008|4142430|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315954|NCT00476008|4142431|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315955|NCT00476008|4142432|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315956|NCT00475904|4142457|B4|India||Region of Enrollment||participants|Number|360|360.0||||||
4315957|NCT00475904|4142458|B3|India||Region of Enrollment||participants|Number|76|76.0||||||
4315958|NCT00475904|4142459|B2|India||Region of Enrollment||participants|Number|144|144.0||||||
4315959|NCT00475904|4142460|B1|India||Region of Enrollment||participants|Number|140|140.0||||||
4315960|NCT00475904|4142457|B4||Male|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
4315961|NCT00475904|4142458|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4315962|NCT00475904|4142459|B2||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4315963|NCT00475904|4142460|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4315964|NCT00475904|4142457|B4||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4315965|NCT00475904|4142458|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4315966|NCT00475904|4142459|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4315967|NCT00475904|4142460|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4315968|NCT00475904|4142457|B4|||Age||years|Mean|52.5|52.5|Standard Deviation|15.91|15.91|||
4315969|NCT00475904|4142458|B3|||Age||years|Mean|53.2|53.2|Standard Deviation|16.47|16.47|||
4315970|NCT00475904|4142459|B2|||Age||years|Mean|53.2|53.2|Standard Deviation|15.53|15.53|||
4315971|NCT00475904|4142460|B1|||Age||years|Mean|51.3|51.3|Standard Deviation|16.04|16.04|||
4315972|NCT00475904|4142457|B4||>=65 years|Age||Participants|Count of Participants|90|90.0||||||
4315973|NCT00475904|4142458|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4315974|NCT00475904|4142459|B2||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
4315975|NCT00475904|4142460|B1||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
4315976|NCT00475904|4142457|B4||Between 18 and 65 years|Age||Participants|Count of Participants|270|270.0||||||
4315977|NCT00475904|4142458|B3||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4315978|NCT00475904|4142459|B2||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
4315979|NCT00475904|4142460|B1||Between 18 and 65 years|Age||Participants|Count of Participants|106|106.0||||||
4315980|NCT00475904|4142457|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315981|NCT00475904|4142458|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315982|NCT00475904|4142459|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315983|NCT00475904|4142460|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4315984|NCT00475878|4142473|B3|United States||Region of Enrollment||participants|Number|147|147.0||||||
4315985|NCT00475878|4142474|B2|United States||Region of Enrollment||participants|Number|72|72.0||||||
4315986|NCT00475878|4142475|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
4315987|NCT00475878|4142473|B3||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4315988|NCT00475878|4142474|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4315989|NCT00475878|4142475|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4315990|NCT00475878|4142473|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4315991|NCT00475878|4142474|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4315992|NCT00475878|4142475|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4315993|NCT00475878|4142473|B3|||Age||years|Mean|37.5|37.5|Standard Deviation|9.9|9.9|||
4315994|NCT00475878|4142474|B2|||Age||years|Mean|38.3|38.3|Standard Deviation|9.6|9.6|||
4315995|NCT00475878|4142475|B1|||Age||years|Mean|36.8|36.8|Standard Deviation|9.8|9.8|||
4315996|NCT00475878|4142473|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4315997|NCT00475878|4142474|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4315998|NCT00475878|4142475|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4315999|NCT00475878|4142473|B3||Between 18 and 65 years|Age||Participants|Count of Participants|147|147.0||||||
4316000|NCT00475878|4142474|B2||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
4316001|NCT00475878|4142475|B1||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4316002|NCT00475878|4142473|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4316003|NCT00475878|4142474|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4316004|NCT00475878|4142475|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4316005|NCT00475865|4142484|B4|||Baseline Expanded Disability Status Scale [EDSS] score|"EDSS is an ordinal scale in half-point increments that qualifies disability in patients with MS. It consists of 8 ordinal rating scales assessing seven functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation.~EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS)."|units on a scale|Mean|2.52|2.52|Standard Deviation|1.20|1.2|||
4316006|NCT00475865|4142485|B3|||Baseline Expanded Disability Status Scale [EDSS] score|"EDSS is an ordinal scale in half-point increments that qualifies disability in patients with MS. It consists of 8 ordinal rating scales assessing seven functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation.~EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS)."|units on a scale|Mean|2.60|2.6|Standard Deviation|1.28|1.28|||
4316007|NCT00475865|4142486|B2|||Baseline Expanded Disability Status Scale [EDSS] score|"EDSS is an ordinal scale in half-point increments that qualifies disability in patients with MS. It consists of 8 ordinal rating scales assessing seven functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation.~EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS)."|units on a scale|Mean|2.43|2.43|Standard Deviation|1.23|1.23|||
4316008|NCT00475865|4142487|B1|||Baseline Expanded Disability Status Scale [EDSS] score|"EDSS is an ordinal scale in half-point increments that qualifies disability in patients with MS. It consists of 8 ordinal rating scales assessing seven functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation.~EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS)."|units on a scale|Mean|2.54|2.54|Standard Deviation|1.11|1.11|||
4316009|NCT00475865|4142484|B4|Progressive Relapsing||MS subtype||participants|Number|0|0.0||||||
4316010|NCT00475865|4142485|B3|Progressive Relapsing||MS subtype||participants|Number|0|0.0||||||
4316011|NCT00475865|4142486|B2|Progressive Relapsing||MS subtype||participants|Number|0|0.0||||||
4316012|NCT00475865|4142487|B1|Progressive Relapsing||MS subtype||participants|Number|0|0.0||||||
4316013|NCT00475865|4142484|B4|Secondary Progressive||MS subtype||participants|Number|7|7.0||||||
4316014|NCT00475865|4142485|B3|Secondary Progressive||MS subtype||participants|Number|3|3.0||||||
4316015|NCT00475865|4142486|B2|Secondary Progressive||MS subtype||participants|Number|2|2.0||||||
4316016|NCT00475865|4142487|B1|Secondary Progressive||MS subtype||participants|Number|2|2.0||||||
4316017|NCT00475865|4142484|B4|Relapsing Remitting||MS subtype||participants|Number|116|116.0||||||
4316018|NCT00475865|4142485|B3|Relapsing Remitting||MS subtype||participants|Number|37|37.0||||||
4316019|NCT00475865|4142486|B2|Relapsing Remitting||MS subtype||participants|Number|40|40.0||||||
4316020|NCT00475865|4142487|B1|Relapsing Remitting||MS subtype||participants|Number|39|39.0||||||
4316021|NCT00475865|4142484|B4|||Time since most recent MS relapse onset||months|Mean|23.41|23.41|Standard Deviation|32.09|32.09|||
4316022|NCT00475865|4142485|B3|||Time since most recent MS relapse onset||months|Mean|23.88|23.88|Standard Deviation|31.53|31.53|||
4316023|NCT00475865|4142486|B2|||Time since most recent MS relapse onset||months|Mean|21.52|21.52|Standard Deviation|30.48|30.48|||
4316024|NCT00475865|4142487|B1|||Time since most recent MS relapse onset||months|Mean|24.90|24.9|Standard Deviation|34.84|34.84|||
4316025|NCT00475865|4142484|B4|Within the past 2 years||Number of MS relapses||MS relapses|Median|1|1.0|Full Range|||0.0|7.0|
4316026|NCT00475865|4142485|B3|Within the past 2 years||Number of MS relapses||MS relapses|Median|1|1.0|Full Range|||0.0|6.0|
4316027|NCT00475865|4142486|B2|Within the past 2 years||Number of MS relapses||MS relapses|Median|1|1.0|Full Range|||0.0|7.0|
4316028|NCT00475865|4142487|B1|Within the past 2 years||Number of MS relapses||MS relapses|Median|1|1.0|Full Range|||0.0|5.0|
4316029|NCT00475865|4142484|B4|Within the past year||Number of MS relapses||MS relapses|Median|1|1.0|Full Range|||0.0|4.0|
4316030|NCT00475865|4142485|B3|Within the past year||Number of MS relapses||MS relapses|Median|1|1.0|Full Range|||0.0|4.0|
4316031|NCT00475865|4142486|B2|Within the past year||Number of MS relapses||MS relapses|Median|1|1.0|Full Range|||0.0|3.0|
4316032|NCT00475865|4142487|B1|Within the past year||Number of MS relapses||MS relapses|Median|1|1.0|Full Range|||0.0|3.0|
4316033|NCT00475865|4142484|B4|||Time since first diagnosis of Multiple Sclerosis [MS]||years|Mean|8.02|8.02|Standard Deviation|5.95|5.95|||
4316034|NCT00475865|4142485|B3|||Time since first diagnosis of Multiple Sclerosis [MS]||years|Mean|7.60|7.6|Standard Deviation|6.03|6.03|||
4316035|NCT00475865|4142486|B2|||Time since first diagnosis of Multiple Sclerosis [MS]||years|Mean|8.82|8.82|Standard Deviation|5.85|5.85|||
4316036|NCT00475865|4142487|B1|||Time since first diagnosis of Multiple Sclerosis [MS]||years|Mean|7.61|7.61|Standard Deviation|6.04|6.04|||
4316097|NCT00475852|4142518|B2|MYS||Region of Enrollment||participants|Number|37|37.0||||||
4316037|NCT00475865|4142484|B4|North America||Region of Enrollment|"Europe: Austria, Germany, Italy and United Kingdom~North America: Canada and United States"|participants|Number|57|57.0||||||
4316038|NCT00475865|4142485|B3|North America||Region of Enrollment|"Europe: Austria, Germany, Italy and United Kingdom~North America: Canada and United States"|participants|Number|19|19.0||||||
4316039|NCT00475865|4142486|B2|North America||Region of Enrollment|"Europe: Austria, Germany, Italy and United Kingdom~North America: Canada and United States"|participants|Number|20|20.0||||||
4316040|NCT00475865|4142487|B1|North America||Region of Enrollment|"Europe: Austria, Germany, Italy and United Kingdom~North America: Canada and United States"|participants|Number|18|18.0||||||
4316041|NCT00475865|4142484|B4|Europe||Region of Enrollment|"Europe: Austria, Germany, Italy and United Kingdom~North America: Canada and United States"|participants|Number|66|66.0||||||
4316042|NCT00475865|4142485|B3|Europe||Region of Enrollment|"Europe: Austria, Germany, Italy and United Kingdom~North America: Canada and United States"|participants|Number|21|21.0||||||
4316043|NCT00475865|4142486|B2|Europe||Region of Enrollment|"Europe: Austria, Germany, Italy and United Kingdom~North America: Canada and United States"|participants|Number|22|22.0||||||
4316044|NCT00475865|4142487|B1|Europe||Region of Enrollment|"Europe: Austria, Germany, Italy and United Kingdom~North America: Canada and United States"|participants|Number|23|23.0||||||
4316045|NCT00475865|4142484|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4316046|NCT00475865|4142485|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4316047|NCT00475865|4142486|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4316048|NCT00475865|4142487|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4316049|NCT00475865|4142484|B4||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4316050|NCT00475865|4142485|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4316051|NCT00475865|4142486|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4316052|NCT00475865|4142487|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4316053|NCT00475865|4142484|B4|||Age||years|Mean|41.4|41.4|Standard Deviation|7.9|7.9|||
4316054|NCT00475865|4142485|B3|||Age||years|Mean|40.3|40.3|Standard Deviation|7.5|7.5|||
4316055|NCT00475865|4142486|B2|||Age||years|Mean|42.1|42.1|Standard Deviation|7.8|7.8|||
4316056|NCT00475865|4142487|B1|||Age||years|Mean|41.8|41.8|Standard Deviation|8.5|8.5|||
4316057|NCT00475852|4142517|B3|||Baseline BMI||kg/cm2|Mean|29.0|29.0|Standard Deviation|7.81|7.81|||
4316058|NCT00475852|4142518|B2|||Baseline BMI||kg/cm2|Mean|29.1|29.1|Standard Deviation|7.77|7.77|||
4316059|NCT00475852|4142519|B1|||Baseline BMI||kg/cm2|Mean|28.9|28.9|Standard Deviation|7.86|7.86|||
4316060|NCT00475852|4142517|B3|USA||Region of Enrollment||participants|Number|2767|2767.0||||||
4316061|NCT00475852|4142518|B2|USA||Region of Enrollment||participants|Number|1388|1388.0||||||
4316062|NCT00475852|4142519|B1|USA||Region of Enrollment||participants|Number|1379|1379.0||||||
4316063|NCT00475852|4142517|B3|UKR||Region of Enrollment||participants|Number|189|189.0||||||
4316064|NCT00475852|4142518|B2|UKR||Region of Enrollment||participants|Number|92|92.0||||||
4316065|NCT00475852|4142519|B1|UKR||Region of Enrollment||participants|Number|97|97.0||||||
4316066|NCT00475852|4142517|B3|TWN||Region of Enrollment||participants|Number|77|77.0||||||
4316067|NCT00475852|4142518|B2|TWN||Region of Enrollment||participants|Number|39|39.0||||||
4316068|NCT00475852|4142519|B1|TWN||Region of Enrollment||participants|Number|38|38.0||||||
4316069|NCT00475852|4142517|B3|THA||Region of Enrollment||participants|Number|46|46.0||||||
4316070|NCT00475852|4142518|B2|THA||Region of Enrollment||participants|Number|23|23.0||||||
4316071|NCT00475852|4142519|B1|THA||Region of Enrollment||participants|Number|23|23.0||||||
4316072|NCT00475852|4142517|B3|SWE||Region of Enrollment||participants|Number|5|5.0||||||
4316073|NCT00475852|4142518|B2|SWE||Region of Enrollment||participants|Number|3|3.0||||||
4316074|NCT00475852|4142519|B1|SWE||Region of Enrollment||participants|Number|2|2.0||||||
4316075|NCT00475852|4142517|B3|SGP||Region of Enrollment||participants|Number|53|53.0||||||
4316076|NCT00475852|4142518|B2|SGP||Region of Enrollment||participants|Number|26|26.0||||||
4316077|NCT00475852|4142519|B1|SGP||Region of Enrollment||participants|Number|27|27.0||||||
4316078|NCT00475852|4142517|B3|RUS||Region of Enrollment||participants|Number|295|295.0||||||
4316079|NCT00475852|4142518|B2|RUS||Region of Enrollment||participants|Number|147|147.0||||||
4316080|NCT00475852|4142519|B1|RUS||Region of Enrollment||participants|Number|148|148.0||||||
4316081|NCT00475852|4142517|B3|ROU||Region of Enrollment||participants|Number|52|52.0||||||
4316082|NCT00475852|4142518|B2|ROU||Region of Enrollment||participants|Number|28|28.0||||||
4316083|NCT00475852|4142519|B1|ROU||Region of Enrollment||participants|Number|24|24.0||||||
4316084|NCT00475852|4142517|B3|POL||Region of Enrollment||participants|Number|267|267.0||||||
4316085|NCT00475852|4142518|B2|POL||Region of Enrollment||participants|Number|133|133.0||||||
4316086|NCT00475852|4142519|B1|POL||Region of Enrollment||participants|Number|134|134.0||||||
4316087|NCT00475852|4142517|B3|NZL||Region of Enrollment||participants|Number|14|14.0||||||
4316088|NCT00475852|4142518|B2|NZL||Region of Enrollment||participants|Number|7|7.0||||||
4316089|NCT00475852|4142519|B1|NZL||Region of Enrollment||participants|Number|7|7.0||||||
4316090|NCT00475852|4142517|B3|NOR||Region of Enrollment||participants|Number|56|56.0||||||
4316091|NCT00475852|4142518|B2|NOR||Region of Enrollment||participants|Number|29|29.0||||||
4316092|NCT00475852|4142519|B1|NOR||Region of Enrollment||participants|Number|27|27.0||||||
4316093|NCT00475852|4142517|B3|NLD||Region of Enrollment||participants|Number|141|141.0||||||
4316094|NCT00475852|4142518|B2|NLD||Region of Enrollment||participants|Number|70|70.0||||||
4316095|NCT00475852|4142519|B1|NLD||Region of Enrollment||participants|Number|71|71.0||||||
4316096|NCT00475852|4142517|B3|MYS||Region of Enrollment||participants|Number|75|75.0||||||
4316098|NCT00475852|4142519|B1|MYS||Region of Enrollment||participants|Number|38|38.0||||||
4316099|NCT00475852|4142517|B3|MEX||Region of Enrollment||participants|Number|219|219.0||||||
4316100|NCT00475852|4142518|B2|MEX||Region of Enrollment||participants|Number|111|111.0||||||
4316101|NCT00475852|4142519|B1|MEX||Region of Enrollment||participants|Number|108|108.0||||||
4316102|NCT00475852|4142517|B3|LTU||Region of Enrollment||participants|Number|97|97.0||||||
4316103|NCT00475852|4142518|B2|LTU||Region of Enrollment||participants|Number|49|49.0||||||
4316104|NCT00475852|4142519|B1|LTU||Region of Enrollment||participants|Number|48|48.0||||||
4316105|NCT00475852|4142517|B3|KOR||Region of Enrollment||participants|Number|148|148.0||||||
4316106|NCT00475852|4142518|B2|KOR||Region of Enrollment||participants|Number|74|74.0||||||
4316107|NCT00475852|4142519|B1|KOR||Region of Enrollment||participants|Number|74|74.0||||||
4316108|NCT00475852|4142517|B3|ITA||Region of Enrollment||participants|Number|72|72.0||||||
4316109|NCT00475852|4142518|B2|ITA||Region of Enrollment||participants|Number|36|36.0||||||
4316110|NCT00475852|4142519|B1|ITA||Region of Enrollment||participants|Number|36|36.0||||||
4316111|NCT00475852|4142517|B3|ISR||Region of Enrollment||participants|Number|78|78.0||||||
4316112|NCT00475852|4142518|B2|ISR||Region of Enrollment||participants|Number|40|40.0||||||
4316113|NCT00475852|4142519|B1|ISR||Region of Enrollment||participants|Number|38|38.0||||||
4316114|NCT00475852|4142517|B3|IND||Region of Enrollment||participants|Number|1001|1001.0||||||
4316115|NCT00475852|4142518|B2|IND||Region of Enrollment||participants|Number|502|502.0||||||
4316116|NCT00475852|4142519|B1|IND||Region of Enrollment||participants|Number|499|499.0||||||
4316117|NCT00475852|4142517|B3|GRC||Region of Enrollment||participants|Number|48|48.0||||||
4316118|NCT00475852|4142518|B2|GRC||Region of Enrollment||participants|Number|24|24.0||||||
4316119|NCT00475852|4142519|B1|GRC||Region of Enrollment||participants|Number|24|24.0||||||
4316120|NCT00475852|4142517|B3|FRA||Region of Enrollment||participants|Number|98|98.0||||||
4316121|NCT00475852|4142518|B2|FRA||Region of Enrollment||participants|Number|47|47.0||||||
4316122|NCT00475852|4142519|B1|FRA||Region of Enrollment||participants|Number|51|51.0||||||
4316123|NCT00475852|4142517|B3|DEU||Region of Enrollment||participants|Number|6|6.0||||||
4316124|NCT00475852|4142518|B2|DEU||Region of Enrollment||participants|Number|3|3.0||||||
4316125|NCT00475852|4142519|B1|DEU||Region of Enrollment||participants|Number|3|3.0||||||
4316126|NCT00475852|4142517|B3|COL||Region of Enrollment||participants|Number|30|30.0||||||
4316127|NCT00475852|4142518|B2|COL||Region of Enrollment||participants|Number|15|15.0||||||
4316128|NCT00475852|4142519|B1|COL||Region of Enrollment||participants|Number|15|15.0||||||
4316129|NCT00475852|4142517|B3|CHN||Region of Enrollment||participants|Number|314|314.0||||||
4316130|NCT00475852|4142518|B2|CHN||Region of Enrollment||participants|Number|160|160.0||||||
4316131|NCT00475852|4142519|B1|CHN||Region of Enrollment||participants|Number|154|154.0||||||
4316132|NCT00475852|4142517|B3|CHL||Region of Enrollment||participants|Number|50|50.0||||||
4316133|NCT00475852|4142518|B2|CHL||Region of Enrollment||participants|Number|25|25.0||||||
4316134|NCT00475852|4142519|B1|CHL||Region of Enrollment||participants|Number|25|25.0||||||
4316135|NCT00475852|4142517|B3|CAN||Region of Enrollment||participants|Number|476|476.0||||||
4316136|NCT00475852|4142518|B2|CAN||Region of Enrollment||participants|Number|236|236.0||||||
4316137|NCT00475852|4142519|B1|CAN||Region of Enrollment||participants|Number|240|240.0||||||
4316138|NCT00475852|4142517|B3|BRA||Region of Enrollment||participants|Number|150|150.0||||||
4316139|NCT00475852|4142518|B2|BRA||Region of Enrollment||participants|Number|77|77.0||||||
4316140|NCT00475852|4142519|B1|BRA||Region of Enrollment||participants|Number|73|73.0||||||
4316141|NCT00475852|4142517|B3|BGR||Region of Enrollment||participants|Number|67|67.0||||||
4316142|NCT00475852|4142518|B2|BGR||Region of Enrollment||participants|Number|32|32.0||||||
4316143|NCT00475852|4142519|B1|BGR||Region of Enrollment||participants|Number|35|35.0||||||
4316144|NCT00475852|4142517|B3|AUS||Region of Enrollment||participants|Number|34|34.0||||||
4316145|NCT00475852|4142518|B2|AUS||Region of Enrollment||participants|Number|16|16.0||||||
4316146|NCT00475852|4142519|B1|AUS||Region of Enrollment||participants|Number|18|18.0||||||
4316147|NCT00475852|4142517|B3|ARG||Region of Enrollment||participants|Number|216|216.0||||||
4316148|NCT00475852|4142518|B2|ARG||Region of Enrollment||participants|Number|108|108.0||||||
4316149|NCT00475852|4142519|B1|ARG||Region of Enrollment||participants|Number|108|108.0||||||
4316150|NCT00475852|4142517|B3||Male|Sex: Female, Male||Participants|Count of Participants|4697|4697.0||||||
4316151|NCT00475852|4142518|B2||Male|Sex: Female, Male||Participants|Count of Participants|2330|2330.0||||||
4316152|NCT00475852|4142519|B1||Male|Sex: Female, Male||Participants|Count of Participants|2367|2367.0||||||
4316153|NCT00475852|4142517|B3||Female|Sex: Female, Male||Participants|Count of Participants|2444|2444.0||||||
4316154|NCT00475852|4142518|B2||Female|Sex: Female, Male||Participants|Count of Participants|1247|1247.0||||||
4316155|NCT00475852|4142519|B1||Female|Sex: Female, Male||Participants|Count of Participants|1197|1197.0||||||
4316156|NCT00475852|4142517|B3|>=75||Age, Customized||participants|Number|2127|2127.0||||||
4316157|NCT00475852|4142518|B2|>=75||Age, Customized||participants|Number|1077|1077.0||||||
4316158|NCT00475852|4142519|B1|>=75||Age, Customized||participants|Number|1050|1050.0||||||
4316159|NCT00475852|4142517|B3|65-74||Age, Customized||participants|Number|1839|1839.0||||||
4316160|NCT00475852|4142518|B2|65-74||Age, Customized||participants|Number|901|901.0||||||
4316161|NCT00475852|4142519|B1|65-74||Age, Customized||participants|Number|938|938.0||||||
4316162|NCT00475852|4142517|B3|<=64||Age, Customized||participants|Number|3175|3175.0||||||
4316163|NCT00475852|4142518|B2|<=64||Age, Customized||participants|Number|1599|1599.0||||||
4316164|NCT00475852|4142519|B1|<=64||Age, Customized||participants|Number|1576|1576.0||||||
4316165|NCT00475852|4142517|B3|||Age||years|Mean|65.5|65.5|Standard Deviation|14.14|14.14|||
4316166|NCT00475852|4142518|B2|||Age||years|Mean|65.4|65.4|Standard Deviation|14.20|14.2|||
4316167|NCT00475852|4142519|B1|||Age||years|Mean|65.5|65.5|Standard Deviation|14.09|14.09|||
4316168|NCT00475852|4142517|B3||>=65 years|Age||Participants|Count of Participants|3966|3966.0||||||
4316169|NCT00475852|4142518|B2||>=65 years|Age||Participants|Count of Participants|1978|1978.0||||||
4316170|NCT00475852|4142519|B1||>=65 years|Age||Participants|Count of Participants|1988|1988.0||||||
4316171|NCT00475852|4142517|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3169|3169.0||||||
4316172|NCT00475852|4142518|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1597|1597.0||||||
4316173|NCT00475852|4142519|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1572|1572.0||||||
4316174|NCT00475852|4142517|B3||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4316175|NCT00475852|4142518|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4316176|NCT00475852|4142519|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4316177|NCT00475787|4142548|B3||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4316178|NCT00475787|4142549|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4316179|NCT00475787|4142550|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4316180|NCT00475787|4142548|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4316181|NCT00475787|4142549|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4316182|NCT00475787|4142550|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4316183|NCT00475787|4142548|B3|||Age||years|Mean|77|77.0|Standard Deviation|6.8|6.8|||
4316184|NCT00475787|4142549|B2|||Age||years|Mean|77|77.0|Standard Deviation|6.81|6.81|||
4316185|NCT00475787|4142550|B1|||Age||years|Mean|77|77.0|Standard Deviation|6.8|6.8|||
4316186|NCT00475735|4142565|B7||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4316187|NCT00475735|4142566|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4316188|NCT00475735|4142567|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4316189|NCT00475735|4142568|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4316190|NCT00475735|4142569|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4316191|NCT00475735|4142570|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4316192|NCT00475735|4142571|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4316193|NCT00475735|4142565|B7||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4316194|NCT00475735|4142566|B6||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4316195|NCT00475735|4142567|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4316196|NCT00475735|4142568|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4316197|NCT00475735|4142569|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4316198|NCT00475735|4142570|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4316199|NCT00475735|4142571|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4316200|NCT00475735|4142565|B7|||Age||years|Mean|38.4|38.4|Standard Deviation|10.8|10.8|||
4316201|NCT00475735|4142566|B6|||Age||years|Mean|36.5|36.5|Standard Deviation|13.3|13.3|||
4316202|NCT00475735|4142567|B5|||Age||years|Mean|39.8|39.8|Standard Deviation|11.1|11.1|||
4316203|NCT00475735|4142568|B4|||Age||years|Mean|39.0|39.0|Standard Deviation|12.3|12.3|||
4316204|NCT00475735|4142569|B3|||Age||years|Mean|39.3|39.3|Standard Deviation|7.5|7.5|||
4316205|NCT00475735|4142570|B2|||Age||years|Mean|36.9|36.9|Standard Deviation|11.0|11.0|||
4316206|NCT00475735|4142571|B1|||Age||years|Mean|39.6|39.6|Standard Deviation|9.2|9.2|||
4316207|NCT00475722|4142587|B3|United States||Region of Enrollment||participants|Number|120|120.0||||||
4316208|NCT00475722|4142588|B2|United States||Region of Enrollment||participants|Number|59|59.0||||||
4316209|NCT00475722|4142589|B1|United States||Region of Enrollment||participants|Number|61|61.0||||||
4316210|NCT00475722|4142587|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316211|NCT00475722|4142588|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316212|NCT00475722|4142589|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316213|NCT00475722|4142587|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4316214|NCT00475722|4142588|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316215|NCT00475722|4142589|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4316216|NCT00475722|4142587|B3||White|Race (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
4316217|NCT00475722|4142588|B2||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4316218|NCT00475722|4142589|B1||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4316219|NCT00475722|4142587|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4316220|NCT00475722|4142588|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4316221|NCT00475722|4142589|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4316222|NCT00475722|4142587|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316223|NCT00475722|4142588|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316224|NCT00475722|4142589|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316225|NCT00475722|4142587|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4316226|NCT00475722|4142588|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4316227|NCT00475722|4142589|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4316228|NCT00475722|4142587|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4316229|NCT00475722|4142588|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316230|NCT00475722|4142589|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4316231|NCT00475722|4142587|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316232|NCT00475722|4142588|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316233|NCT00475722|4142589|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316234|NCT00475722|4142587|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
4316235|NCT00475722|4142588|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4316236|NCT00475722|4142589|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4316237|NCT00475722|4142587|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4316238|NCT00475722|4142588|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4316239|NCT00475722|4142589|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316240|NCT00475722|4142587|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4316241|NCT00475722|4142588|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4316242|NCT00475722|4142589|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4316243|NCT00475722|4142587|B3||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4316244|NCT00475722|4142588|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4316245|NCT00475722|4142589|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4316246|NCT00475722|4142587|B3|||Age||years|Mean|53|53.0|Standard Deviation|12|12.0|||
4316247|NCT00475722|4142588|B2|||Age||years|Mean|55|55.0|Standard Deviation|10|10.0|||
4316248|NCT00475722|4142589|B1|||Age||years|Mean|51|51.0|Standard Deviation|13|13.0|||
4316249|NCT00475709|4142596|B1||Male|Sex: Female, Male||Participants|Count of Participants|650|650.0||||||
4316250|NCT00475709|4142596|B1||Female|Sex: Female, Male||Participants|Count of Participants|364|364.0||||||
4316251|NCT00475709|4142596|B1|||Age||years|Mean|72.5|72.5|Standard Deviation|9.0|9.0|||
4316252|NCT00475670|4142602|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4316253|NCT00475670|4142603|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4316254|NCT00475670|4142604|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4316255|NCT00475670|4142602|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4316256|NCT00475670|4142603|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4316257|NCT00475670|4142604|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4316258|NCT00475670|4142602|B3|||Age||years|Median|54|54.0|Full Range|||31.0|78.0|
4316259|NCT00475670|4142603|B2|||Age||years|Median|54|54.0|Full Range|||31.0|78.0|
4316260|NCT00475670|4142604|B1|||Age||years|Median|40|40.0|Full Range|||35.0|58.0|
4316261|NCT00475657|4142629|B1|||Weight||kilograms|Mean|76.0|76.0|Standard Deviation|5.9|5.9|||
4316262|NCT00475657|4142629|B1|||Height||centimeters|Mean|163.9|163.9|Standard Deviation|4.2|4.2|||
4316263|NCT00475657|4142629|B1|Caucasian||Race/Ethnicity||participants|Number|5|5.0||||||
4316264|NCT00475657|4142629|B1|Spain||Region of Enrollment||participants|Number|5|5.0||||||
4316265|NCT00475657|4142629|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4316266|NCT00475657|4142629|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4316267|NCT00475657|4142629|B1|||Age||years|Mean|66.6|66.6|Standard Deviation|5.9|5.9|||
4316268|NCT00475644|4142637|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4316269|NCT00475644|4142637|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316270|NCT00475644|4142637|B1||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4316271|NCT00475644|4142637|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4316272|NCT00475644|4142637|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316273|NCT00475644|4142637|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316274|NCT00475644|4142637|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316275|NCT00475644|4142637|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316276|NCT00475644|4142637|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4316277|NCT00475644|4142637|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4316278|NCT00475644|4142637|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4316279|NCT00475644|4142637|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4316280|NCT00475644|4142637|B1|||Age||years|Mean|60.55|60.55|Standard Deviation|11.851|11.851|||
4316281|NCT00475501|4142645|B5||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4316282|NCT00475501|4142646|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4316283|NCT00475501|4142647|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4316284|NCT00475501|4142648|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4316285|NCT00475501|4142649|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4316286|NCT00475501|4142645|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4316287|NCT00475501|4142646|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4316288|NCT00475501|4142647|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4316289|NCT00475501|4142648|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4316290|NCT00475501|4142649|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4316291|NCT00475501|4142645|B5|||Age||years|Mean|68.25|68.25|Standard Deviation|8.29|8.29|||
4316292|NCT00475501|4142646|B4|||Age||years|Mean|70.8|70.8|Standard Deviation|9.7|9.7|||
4316293|NCT00475501|4142647|B3|||Age||years|Mean|64.2|64.2|Standard Deviation|4.8|4.8|||
4316294|NCT00475501|4142648|B2|||Age||years|Mean|69.5|69.5|Standard Deviation|9.2|9.2|||
4316295|NCT00475501|4142649|B1|||Age||years|Mean|69.2|69.2|Standard Deviation|8.0|8.0|||
4316296|NCT00475423|4142702|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4316297|NCT00475423|4142702|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4316298|NCT00475423|4142702|B1|||Age||years|Mean|49.5|49.5|Standard Deviation|18.59|18.59|||
4316299|NCT00475332|4142723|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4316300|NCT00475332|4142723|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4316301|NCT00475332|4142723|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4316302|NCT00475332|4142723|B1|||Age||years|Mean|58|58.0|Standard Deviation|9|9.0|||
4316303|NCT00475332|4142723|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4316304|NCT00475332|4142723|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4316305|NCT00475332|4142723|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4316306|NCT00475319|4142728|B4|Japan||Region of Enrollment||participants|Number|308|308.0||||||
4316307|NCT00475319|4142729|B3|Japan||Region of Enrollment||participants|Number|103|103.0||||||
4316308|NCT00475319|4142730|B2|Japan||Region of Enrollment||participants|Number|102|102.0||||||
4316309|NCT00475319|4142731|B1|Japan||Region of Enrollment||participants|Number|103|103.0||||||
4316310|NCT00475319|4142728|B4||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4316311|NCT00475319|4142729|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4316312|NCT00475319|4142730|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4316313|NCT00475319|4142731|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4316314|NCT00475319|4142728|B4||Female|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
4316315|NCT00475319|4142729|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4316316|NCT00475319|4142730|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4316317|NCT00475319|4142731|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4316318|NCT00475319|4142728|B4|||Age||years|Mean|55.2|55.2|Standard Deviation|16.9|16.9|||
4316319|NCT00475319|4142729|B3|||Age||years|Mean|55.6|55.6|Standard Deviation|17.2|17.2|||
4316320|NCT00475319|4142730|B2|||Age||years|Mean|56.3|56.3|Standard Deviation|16.9|16.9|||
4316321|NCT00475319|4142731|B1|||Age||years|Mean|53.7|53.7|Standard Deviation|16.6|16.6|||
4316322|NCT00475319|4142728|B4||>=65 years|Age||Participants|Count of Participants|115|115.0||||||
4316323|NCT00475319|4142729|B3||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
4316324|NCT00475319|4142730|B2||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
4316325|NCT00475319|4142731|B1||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
4316326|NCT00475319|4142728|B4||Between 18 and 65 years|Age||Participants|Count of Participants|193|193.0||||||
4316327|NCT00475319|4142729|B3||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4316328|NCT00475319|4142730|B2||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4316329|NCT00475319|4142731|B1||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4316330|NCT00475319|4142728|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4316331|NCT00475319|4142729|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4316332|NCT00475319|4142730|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4316333|NCT00475319|4142731|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4316334|NCT00475306|4142744|B5||Male|Sex: Female, Male|Please note: Only patients who completed the study are reported here|Participants|Count of Participants|76|76.0||||||
4316335|NCT00475306|4142745|B4||Male|Sex: Female, Male|Please note: Only patients who completed the study are reported here|Participants|Count of Participants|20|20.0||||||
4316336|NCT00475306|4142746|B3||Male|Sex: Female, Male|Please note: Only patients who completed the study are reported here|Participants|Count of Participants|17|17.0||||||
4316337|NCT00475306|4142747|B2||Male|Sex: Female, Male|Please note: Only patients who completed the study are reported here|Participants|Count of Participants|19|19.0||||||
4316338|NCT00475306|4142748|B1||Male|Sex: Female, Male|Please note: Only patients who completed the study are reported here|Participants|Count of Participants|20|20.0||||||
4316339|NCT00475306|4142744|B5||Female|Sex: Female, Male|Please note: Only patients who completed the study are reported here|Participants|Count of Participants|210|210.0||||||
4316340|NCT00475306|4142745|B4||Female|Sex: Female, Male|Please note: Only patients who completed the study are reported here|Participants|Count of Participants|51|51.0||||||
4316341|NCT00475306|4142746|B3||Female|Sex: Female, Male|Please note: Only patients who completed the study are reported here|Participants|Count of Participants|55|55.0||||||
4316342|NCT00475306|4142747|B2||Female|Sex: Female, Male|Please note: Only patients who completed the study are reported here|Participants|Count of Participants|52|52.0||||||
4316343|NCT00475306|4142748|B1||Female|Sex: Female, Male|Please note: Only patients who completed the study are reported here|Participants|Count of Participants|52|52.0||||||
4316344|NCT00475306|4142744|B5|||Age||Years|Mean|40|40.0|Standard Deviation|13|13.0|||
4316345|NCT00475306|4142745|B4|||Age||Years|Mean|39|39.0|Standard Deviation|13|13.0|||
4316346|NCT00475306|4142746|B3|||Age||Years|Mean|40|40.0|Standard Deviation|13|13.0|||
4316347|NCT00475306|4142747|B2|||Age||Years|Mean|42|42.0|Standard Deviation|14|14.0|||
4316348|NCT00475306|4142748|B1|||Age||Years|Mean|39|39.0|Standard Deviation|12|12.0|||
4316349|NCT00475241|4142765|B3|||CAPS|Clinician Adminstered PTSD Scale (CAPS) assesses PTSD symptom severity. Scores range from 0 to 136. Higher scores represent more severe symptoms.|units on a scale|Mean|78.2|78.2|Standard Deviation|11.9|11.9|||
4316350|NCT00475241|4142766|B2|||CAPS|Clinician Adminstered PTSD Scale (CAPS) assesses PTSD symptom severity. Scores range from 0 to 136. Higher scores represent more severe symptoms.|units on a scale|Mean|77.4|77.4|Standard Deviation|12.1|12.1|||
4316351|NCT00475241|4142767|B1|||CAPS|Clinician Adminstered PTSD Scale (CAPS) assesses PTSD symptom severity. Scores range from 0 to 136. Higher scores represent more severe symptoms.|units on a scale|Mean|79.2|79.2|Standard Deviation|12.1|12.1|||
4316352|NCT00475241|4142765|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4316353|NCT00475241|4142766|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4316354|NCT00475241|4142767|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4316355|NCT00475241|4142765|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4316356|NCT00475241|4142766|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4316357|NCT00475241|4142767|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4316358|NCT00475241|4142765|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4316359|NCT00475241|4142766|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4316360|NCT00475241|4142767|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4316361|NCT00475241|4142765|B3|||Age||years|Mean|31.6|31.6|Standard Deviation|7.0|7.0|||
4316362|NCT00475241|4142766|B2|||Age||years|Mean|32.9|32.9|Standard Deviation|7.2|7.2|||
4316363|NCT00475241|4142767|B1|||Age||years|Mean|29.8|29.8|Standard Deviation|6.5|6.5|||
4316364|NCT00475228|4142774|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4316365|NCT00475228|4142775|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4316366|NCT00475228|4142776|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4316367|NCT00475228|4142774|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4316368|NCT00475228|4142775|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4316369|NCT00475228|4142776|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4316370|NCT00475228|4142774|B3|at least 18 years of age||Age, Customized||participants|Number|88|88.0||||||
4316371|NCT00475228|4142775|B2|at least 18 years of age||Age, Customized||participants|Number|44|44.0||||||
4316372|NCT00475228|4142776|B1|at least 18 years of age||Age, Customized||participants|Number|44|44.0||||||
4316373|NCT00475176|4142787|B1|||Baseline HCV RNA Level||log10 (IU/mL)|Mean|6.3|6.3|Standard Deviation|0.6|0.6|||
4316374|NCT00475176|4142787|B1|Peginterferon/ribavirin||Previous Therapy||participants|Number|21|21.0||||||
4316375|NCT00475176|4142787|B1|Interferon/ribavirin||Previous Therapy||participants|Number|3|3.0||||||
4316376|NCT00475176|4142787|B1|Non-Cirrhosis||Cirrhosis||participants|Number|19|19.0||||||
4316377|NCT00475176|4142787|B1|Cirrhosis||Cirrhosis||participants|Number|5|5.0||||||
4316378|NCT00475176|4142787|B1|||Ishak Fibrosis|Possible range is 0 to 6. Higher values represent worse outcomes.|Units on a scale|Median|2|2.0|Full Range|||0.0|6.0|
4316379|NCT00475176|4142787|B1|||Body Mass Index||kg/m^2|Mean|27.2|27.2|Standard Deviation|3.74|3.74|||
4316380|NCT00475176|4142787|B1|White||Race/Ethnicity, Customized|Race|participants|Number|21|21.0||||||
4316381|NCT00475176|4142787|B1|Black||Race/Ethnicity, Customized|Race|participants|Number|2|2.0||||||
4316382|NCT00475176|4142787|B1|Hispanic||Race/Ethnicity, Customized|Race|participants|Number|1|1.0||||||
4316383|NCT00475176|4142787|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4316384|NCT00475176|4142787|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4316385|NCT00475176|4142787|B1|||Age||year|Median|52.5|52.5|Full Range|||41.0|65.0|
4316386|NCT00475150|4142792|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
4316387|NCT00475150|4142793|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4316388|NCT00475150|4142794|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4316389|NCT00475150|4142792|B3||Male|Gender||Participants|Count of Participants|21|21.0||||||
4316390|NCT00475150|4142793|B2||Male|Gender||Participants|Count of Participants|10|10.0||||||
4316391|NCT00475150|4142794|B1||Male|Gender||Participants|Count of Participants|11|11.0||||||
4316392|NCT00475150|4142792|B3||Female|Gender||Participants|Count of Participants|18|18.0||||||
4316393|NCT00475150|4142793|B2||Female|Gender||Participants|Count of Participants|6|6.0||||||
4316394|NCT00475150|4142794|B1||Female|Gender||Participants|Count of Participants|12|12.0||||||
4316395|NCT00475150|4142792|B3|||Age||years|Median|72|72.0|Full Range|||61.0|87.0|
4316396|NCT00475150|4142793|B2|||Age||years|Median|73|73.0|Full Range|||61.0|87.0|
4316397|NCT00475150|4142794|B1|||Age||years|Median|70|70.0|Full Range|||61.0|86.0|
4316398|NCT00475085|4142808|B5|||Previous Radiotherapy||participants|Number|39|39.0||||||
4316399|NCT00475085|4142809|B4|||Previous Radiotherapy||participants|Number|9|9.0||||||
4316400|NCT00475085|4142810|B3|||Previous Radiotherapy||participants|Number|12|12.0||||||
4316401|NCT00475085|4142811|B2|||Previous Radiotherapy||participants|Number|12|12.0||||||
4316402|NCT00475085|4142812|B1|||Previous Radiotherapy||participants|Number|6|6.0||||||
4316403|NCT00475085|4142808|B5|||Previous Surgery||participants|Number|781|781.0||||||
4316404|NCT00475085|4142809|B4|||Previous Surgery||participants|Number|198|198.0||||||
4316405|NCT00475085|4142810|B3|||Previous Surgery||participants|Number|196|196.0||||||
4316406|NCT00475085|4142811|B2|||Previous Surgery||participants|Number|194|194.0||||||
4316407|NCT00475085|4142812|B1|||Previous Surgery||participants|Number|193|193.0||||||
4316408|NCT00475085|4142808|B5|United States||Region of Enrollment||participants|Number|1021|1021.0||||||
4316409|NCT00475085|4142809|B4|United States||Region of Enrollment||participants|Number|253|253.0||||||
4316410|NCT00475085|4142810|B3|United States||Region of Enrollment||participants|Number|254|254.0||||||
4316411|NCT00475085|4142811|B2|United States||Region of Enrollment||participants|Number|260|260.0||||||
4316412|NCT00475085|4142812|B1|United States||Region of Enrollment||participants|Number|254|254.0||||||
4316413|NCT00475085|4142808|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316414|NCT00475085|4142809|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316415|NCT00475085|4142810|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316416|NCT00475085|4142811|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316417|NCT00475085|4142812|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316418|NCT00475085|4142808|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316419|NCT00475085|4142809|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316420|NCT00475085|4142810|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316421|NCT00475085|4142811|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316422|NCT00475085|4142812|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316423|NCT00475085|4142808|B5||White|Race (NIH/OMB)||Participants|Count of Participants|918|918.0||||||
4316424|NCT00475085|4142809|B4||White|Race (NIH/OMB)||Participants|Count of Participants|229|229.0||||||
4316425|NCT00475085|4142810|B3||White|Race (NIH/OMB)||Participants|Count of Participants|231|231.0||||||
4316426|NCT00475085|4142811|B2||White|Race (NIH/OMB)||Participants|Count of Participants|226|226.0||||||
4316427|NCT00475085|4142812|B1||White|Race (NIH/OMB)||Participants|Count of Participants|232|232.0||||||
4316428|NCT00475085|4142808|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
4316429|NCT00475085|4142809|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4316430|NCT00475085|4142810|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4316431|NCT00475085|4142811|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4316432|NCT00475085|4142812|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4316433|NCT00475085|4142808|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4316434|NCT00475085|4142809|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4316435|NCT00475085|4142810|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316436|NCT00475085|4142811|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316437|NCT00475085|4142812|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316438|NCT00475085|4142808|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4316439|NCT00475085|4142809|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4316440|NCT00475085|4142810|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316441|NCT00475085|4142811|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4316442|NCT00475085|4142812|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4316443|NCT00475085|4142808|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4316444|NCT00475085|4142809|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4316445|NCT00475085|4142810|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4316446|NCT00475085|4142811|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4316447|NCT00475085|4142812|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4316448|NCT00475085|4142808|B5||Male|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4316449|NCT00475085|4142809|B4||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4316450|NCT00475085|4142810|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4316451|NCT00475085|4142811|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4316452|NCT00475085|4142812|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4316453|NCT00475085|4142808|B5||Female|Sex: Female, Male||Participants|Count of Participants|810|810.0||||||
4316454|NCT00475085|4142809|B4||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4316455|NCT00475085|4142810|B3||Female|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4316456|NCT00475085|4142811|B2||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4316457|NCT00475085|4142812|B1||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4316458|NCT00475085|4142808|B5|||Age||years|Mean|57.8|57.8|Standard Deviation|12.0|12.0|||
4316459|NCT00475085|4142809|B4|||Age||years|Mean|58.2|58.2|Standard Deviation|11.4|11.4|||
4316460|NCT00475085|4142810|B3|||Age||years|Mean|57.1|57.1|Standard Deviation|12.4|12.4|||
4316461|NCT00475085|4142811|B2|||Age||years|Mean|58.6|58.6|Standard Deviation|11.4|11.4|||
4316462|NCT00475085|4142812|B1|||Age||years|Mean|57.2|57.2|Standard Deviation|12.7|12.7|||
4316463|NCT00475033|4142825|B3||Male|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
4316464|NCT00475033|4142826|B2||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4316465|NCT00475033|4142827|B1||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4316466|NCT00475033|4142825|B3||Female|Sex: Female, Male||Participants|Count of Participants|295|295.0||||||
4316467|NCT00475033|4142826|B2||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4316468|NCT00475033|4142827|B1||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4316469|NCT00475033|4142825|B3|||Age|Age at enrollment|months|Mean|2.1|2.1|Standard Deviation|0.3|0.3|||
4316470|NCT00475033|4142826|B2|||Age|Age at enrollment|months|Mean|2.1|2.1|Standard Deviation|0.3|0.3|||
4316471|NCT00475033|4142827|B1|||Age|Age at enrollment|months|Mean|2.1|2.1|Standard Deviation|0.3|0.3|||
4316472|NCT00475020|4142876|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
4316473|NCT00475020|4142876|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316474|NCT00475020|4142876|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316475|NCT00475020|4142876|B1||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4316476|NCT00475020|4142876|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4316477|NCT00475020|4142876|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316478|NCT00475020|4142876|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4316479|NCT00475020|4142876|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316480|NCT00475020|4142876|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4316481|NCT00475020|4142876|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4316482|NCT00475020|4142876|B1|||Age||years|Median|59|59.0|Full Range|||27.0|72.0|
4316483|NCT00475020|4142876|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4316484|NCT00475020|4142876|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4316485|NCT00475020|4142876|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4316486|NCT00474994|4142881|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4316487|NCT00474994|4142881|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4316488|NCT00474994|4142881|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4316489|NCT00474994|4142881|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4316490|NCT00474994|4142881|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4316491|NCT00474968|4142885|B3|United States||Region of Enrollment||participants|Number|737|737.0||||||
4316492|NCT00474968|4142886|B2|United States||Region of Enrollment||participants|Number|371|371.0||||||
4316493|NCT00474968|4142887|B1|United States||Region of Enrollment||participants|Number|366|366.0||||||
4316494|NCT00474968|4142885|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4316495|NCT00474968|4142886|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4316496|NCT00474968|4142887|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4316497|NCT00474968|4142885|B3||Female|Sex: Female, Male||Participants|Count of Participants|737|737.0||||||
4316498|NCT00474968|4142886|B2||Female|Sex: Female, Male||Participants|Count of Participants|371|371.0||||||
4316499|NCT00474968|4142887|B1||Female|Sex: Female, Male||Participants|Count of Participants|366|366.0||||||
4316500|NCT00474968|4142885|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4316501|NCT00474968|4142886|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4316502|NCT00474968|4142887|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4316503|NCT00474968|4142885|B3||Between 18 and 65 years|Age||Participants|Count of Participants|731|731.0||||||
4316504|NCT00474968|4142886|B2||Between 18 and 65 years|Age||Participants|Count of Participants|365|365.0||||||
4316505|NCT00474968|4142887|B1||Between 18 and 65 years|Age||Participants|Count of Participants|366|366.0||||||
4316506|NCT00474968|4142885|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4316507|NCT00474968|4142886|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4316508|NCT00474968|4142887|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4316509|NCT00474955|4142898|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4316510|NCT00474955|4142898|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4316511|NCT00474955|4142898|B1|||Age||years|Mean|44|44.0|Standard Deviation|11|11.0|||
4316512|NCT00474929|4142909|B6|United States||Region of Enrollment||participants|Number|98|98.0||||||
4316513|NCT00474929|4142910|B5|United States||Region of Enrollment||participants|Number|77|77.0||||||
4316514|NCT00474929|4142911|B4|United States||Region of Enrollment||participants|Number|5|5.0||||||
4316515|NCT00474929|4142912|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4316516|NCT00474929|4142913|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4316517|NCT00474929|4142914|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4316518|NCT00474929|4142909|B6||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4316519|NCT00474929|4142910|B5||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4316520|NCT00474929|4142911|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4316521|NCT00474929|4142912|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4316522|NCT00474929|4142913|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4316523|NCT00474929|4142914|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4316524|NCT00474929|4142909|B6||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4316525|NCT00474929|4142910|B5||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4316526|NCT00474929|4142911|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4316527|NCT00474929|4142912|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4316528|NCT00474929|4142913|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4316529|NCT00474929|4142914|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4316530|NCT00474929|4142909|B6|||Age||years|Median|61|61.0|Full Range|||22.0|83.0|
4316531|NCT00474929|4142910|B5|||Age||years|Median|61|61.0|Full Range|||22.0|83.0|
4316532|NCT00474929|4142911|B4|||Age||years|Median|61|61.0|Full Range|||24.0|69.0|
4316533|NCT00474929|4142912|B3|||Age||years|Median|56|56.0|Full Range|||43.0|63.0|
4316534|NCT00474929|4142913|B2|||Age||years|Median|63|63.0|Full Range|||50.0|67.0|
4316535|NCT00474929|4142914|B1|||Age||years|Median|43|43.0|Full Range|||22.0|64.0|
4316536|NCT00474903|4142932|B4|United States||Region of Enrollment||participants|Number|120|120.0||||||
4316537|NCT00474903|4142933|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
4316538|NCT00474903|4142934|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
4316539|NCT00474903|4142935|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4316540|NCT00474903|4142932|B4||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4316541|NCT00474903|4142933|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4316542|NCT00474903|4142934|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4316543|NCT00474903|4142935|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4316544|NCT00474903|4142932|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4316545|NCT00474903|4142933|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4316546|NCT00474903|4142934|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4316547|NCT00474903|4142935|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4316548|NCT00474903|4142932|B4|||Age||years|Median|60|60.0|Full Range|||32.0|86.0|
4316549|NCT00474903|4142933|B3|||Age||years|Median|59|59.0|Full Range|||35.0|82.0|
4316550|NCT00474903|4142934|B2|||Age||years|Median|59|59.0|Full Range|||34.0|81.0|
4316551|NCT00474903|4142935|B1|||Age||years|Median|61|61.0|Full Range|||32.0|86.0|
4316552|NCT00474851|4142948|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
4316553|NCT00474851|4142949|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4316554|NCT00474851|4142950|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4316555|NCT00474851|4142948|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316556|NCT00474851|4142949|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316557|NCT00474851|4142950|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316558|NCT00474851|4142948|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316559|NCT00474851|4142949|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316560|NCT00474851|4142950|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316561|NCT00474851|4142948|B3||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4316562|NCT00474851|4142949|B2||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4316563|NCT00474851|4142950|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4316564|NCT00474851|4142948|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4316565|NCT00474851|4142949|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316566|NCT00474851|4142950|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4316567|NCT00474851|4142948|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316568|NCT00474851|4142949|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316569|NCT00474851|4142950|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316570|NCT00474851|4142948|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4316571|NCT00474851|4142949|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316572|NCT00474851|4142950|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4316573|NCT00474851|4142948|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316574|NCT00474851|4142949|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316575|NCT00474851|4142950|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316576|NCT00474851|4142948|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316577|NCT00474851|4142949|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316578|NCT00474851|4142950|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316579|NCT00474851|4142948|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4316580|NCT00474851|4142949|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4316581|NCT00474851|4142950|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4316582|NCT00474851|4142948|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316583|NCT00474851|4142949|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316584|NCT00474851|4142950|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316585|NCT00474851|4142948|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4316586|NCT00474851|4142949|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4316587|NCT00474851|4142950|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4316588|NCT00474851|4142948|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4316589|NCT00474851|4142949|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4316590|NCT00474851|4142950|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4316591|NCT00474851|4142948|B3|||Age||years|Mean|17.9|17.9|Standard Deviation|1.7|1.7|||
4316592|NCT00474851|4142949|B2|||Age||years|Mean|18.1|18.1|Standard Deviation|1.9|1.9|||
4316593|NCT00474851|4142950|B1|||Age||years|Mean|17.7|17.7|Standard Deviation|1.4|1.4|||
4316594|NCT00474812|4142959|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4316595|NCT00474812|4142959|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4316596|NCT00474812|4142959|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316597|NCT00474812|4142959|B1||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4316598|NCT00474812|4142959|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4316599|NCT00474812|4142959|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316600|NCT00474812|4142959|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316601|NCT00474812|4142959|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316602|NCT00474812|4142959|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4316603|NCT00474812|4142959|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4316604|NCT00474812|4142959|B1|||Age||years|Median|61|61.0|Full Range|||43.0|80.0|
4316605|NCT00474786|4142967|B3||Male|Sex: Female, Male||Participants|Count of Participants|385|385.0||||||
4316606|NCT00474786|4142968|B2||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4316607|NCT00474786|4142969|B1||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4316608|NCT00474786|4142967|B3||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4316609|NCT00474786|4142968|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4316610|NCT00474786|4142969|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4316611|NCT00474786|4142967|B3|||Age||years|Mean|59.85|59.85|Standard Deviation|10.25|10.25|||
4316612|NCT00474786|4142968|B2|||Age||years|Mean|59.74|59.74|Standard Deviation|10.33|10.33|||
4316613|NCT00474786|4142969|B1|||Age||years|Mean|59.96|59.96|Standard Deviation|10.20|10.2|||
4316614|NCT00474760|4142988|B8||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4316615|NCT00474760|4142989|B7||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4316616|NCT00474760|4142990|B6||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4316617|NCT00474760|4142991|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4316618|NCT00474760|4142992|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4316619|NCT00474760|4142993|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4316620|NCT00474760|4142994|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4316621|NCT00474760|4142995|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4316622|NCT00474760|4142988|B8||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4316623|NCT00474760|4142989|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4316624|NCT00474760|4142990|B6||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4316625|NCT00474760|4142991|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4316626|NCT00474760|4142992|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4316627|NCT00474760|4142993|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4316628|NCT00474760|4142994|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4316629|NCT00474760|4142995|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4316630|NCT00474760|4142988|B8|Equal to or greater than (>=) 70 years||Age, Customized||participants|Number|1|1.0||||||
4316631|NCT00474760|4142989|B7|Equal to or greater than (>=) 70 years||Age, Customized||participants|Number|0|0.0||||||
4316632|NCT00474760|4142990|B6|Equal to or greater than (>=) 70 years||Age, Customized||participants|Number|1|1.0||||||
4316633|NCT00474760|4142991|B5|Equal to or greater than (>=) 70 years||Age, Customized||participants|Number|0|0.0||||||
4316634|NCT00474760|4142992|B4|Equal to or greater than (>=) 70 years||Age, Customized||participants|Number|0|0.0||||||
4316635|NCT00474760|4142993|B3|Equal to or greater than (>=) 70 years||Age, Customized||participants|Number|0|0.0||||||
4316636|NCT00474760|4142994|B2|Equal to or greater than (>=) 70 years||Age, Customized||participants|Number|0|0.0||||||
4316637|NCT00474760|4142995|B1|Equal to or greater than (>=) 70 years||Age, Customized||participants|Number|0|0.0||||||
4316638|NCT00474760|4142988|B8|Less than (<) 70 years||Age, Customized||participants|Number|64|64.0||||||
4316639|NCT00474760|4142989|B7|Less than (<) 70 years||Age, Customized||participants|Number|11|11.0||||||
4316640|NCT00474760|4142990|B6|Less than (<) 70 years||Age, Customized||participants|Number|28|28.0||||||
4316641|NCT00474760|4142991|B5|Less than (<) 70 years||Age, Customized||participants|Number|13|13.0||||||
4316642|NCT00474760|4142992|B4|Less than (<) 70 years||Age, Customized||participants|Number|3|3.0||||||
4316643|NCT00474760|4142993|B3|Less than (<) 70 years||Age, Customized||participants|Number|3|3.0||||||
4316644|NCT00474760|4142994|B2|Less than (<) 70 years||Age, Customized||participants|Number|3|3.0||||||
4316645|NCT00474760|4142995|B1|Less than (<) 70 years||Age, Customized||participants|Number|3|3.0||||||
4316646|NCT00474708|4143106|B3||Male|Sex: Female, Male||Participants|Count of Participants|466.0|466.0||||||
4316647|NCT00474708|4143107|B2||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4316648|NCT00474708|4143108|B1||Male|Sex: Female, Male||Participants|Count of Participants|327|327.0||||||
4316649|NCT00474708|4143106|B3||Female|Sex: Female, Male||Participants|Count of Participants|685.0|685.0||||||
4316650|NCT00474708|4143107|B2||Female|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
4316651|NCT00474708|4143108|B1||Female|Sex: Female, Male||Participants|Count of Participants|460|460.0||||||
4316652|NCT00474708|4143106|B3|||Age||years|Mean|40.13|40.13|Standard Deviation|12.92|12.92|||
4316653|NCT00474708|4143107|B2|||Age||years|Mean|40.49|40.49|Standard Deviation|13.08|13.08|||
4316654|NCT00474708|4143108|B1|||Age||years|Mean|39.97|39.97|Standard Deviation|12.84|12.84|||
4316655|NCT00474630|4143117|B3|||BMI||kg/m^2|Mean|36.40|36.4|Standard Deviation|4.66|4.66|||
4316656|NCT00474630|4143118|B2|||BMI||kg/m^2|Mean|36.40|36.4|Standard Deviation|4.50|4.5|||
4316657|NCT00474630|4143119|B1|||BMI||kg/m^2|Mean|36.40|36.4|Standard Deviation|4.75|4.75|||
4316658|NCT00474630|4143117|B3|||Weight||kg|Mean|104.51|104.51|Standard Deviation|18.28|18.28|||
4316659|NCT00474630|4143118|B2|||Weight||kg|Mean|105.08|105.08|Standard Deviation|16.99|16.99|||
4316660|NCT00474630|4143119|B1|||Weight||kg|Mean|104.22|104.22|Standard Deviation|18.93|18.93|||
4316661|NCT00474630|4143117|B3|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4316662|NCT00474630|4143118|B2|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4316663|NCT00474630|4143119|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4316664|NCT00474630|4143117|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4316665|NCT00474630|4143118|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4316666|NCT00474630|4143119|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4316667|NCT00474630|4143117|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4316668|NCT00474630|4143118|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4316669|NCT00474630|4143119|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4316670|NCT00474630|4143117|B3|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4316671|NCT00474630|4143118|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4316672|NCT00474630|4143119|B1|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4316673|NCT00474630|4143117|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
4316674|NCT00474630|4143118|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4316675|NCT00474630|4143119|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
4316676|NCT00474630|4143117|B3|White||Race/Ethnicity, Customized||participants|Number|401|401.0||||||
4316677|NCT00474630|4143118|B2|White||Race/Ethnicity, Customized||participants|Number|140|140.0||||||
4316678|NCT00474630|4143119|B1|White||Race/Ethnicity, Customized||participants|Number|261|261.0||||||
4316679|NCT00474630|4143117|B3||Male|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
4316680|NCT00474630|4143118|B2||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4316681|NCT00474630|4143119|B1||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4316682|NCT00474630|4143117|B3||Female|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
4316683|NCT00474630|4143118|B2||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4316684|NCT00474630|4143119|B1||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4316685|NCT00474630|4143117|B3|||Age||years|Mean|53.83|53.83|Standard Deviation|9.32|9.32|||
4316686|NCT00474630|4143118|B2|||Age||years|Mean|53.46|53.46|Standard Deviation|9.83|9.83|||
4316687|NCT00474630|4143119|B1|||Age||years|Mean|54.02|54.02|Standard Deviation|9.05|9.05|||
4316688|NCT00474539|4143174|B3||Male|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
4316689|NCT00474539|4143175|B2||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4316690|NCT00474539|4143176|B1||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4316691|NCT00474539|4143174|B3||Female|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
4316692|NCT00474539|4143175|B2||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4316693|NCT00474539|4143176|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4316694|NCT00474539|4143174|B3|||Age||months|Mean|2.1|2.1|Standard Deviation|0.4|0.4|||
4316695|NCT00474539|4143175|B2|||Age||months|Mean|2.0|2.0|Standard Deviation|0.4|0.4|||
4316696|NCT00474539|4143176|B1|||Age||months|Mean|2.1|2.1|Standard Deviation|0.4|0.4|||
4316697|NCT00474526|4143225|B18||Male|Sex: Female, Male||Participants|Count of Participants|2322|2322.0||||||
4316698|NCT00474526|4143226|B17||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4316699|NCT00474526|4143227|B16||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4316700|NCT00474526|4143228|B15||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4316701|NCT00474526|4143229|B14||Male|Sex: Female, Male||Participants|Count of Participants|744|744.0||||||
4316702|NCT00474526|4143230|B13||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4316703|NCT00474526|4143231|B12||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4316704|NCT00474526|4143232|B11||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4316705|NCT00474526|4143233|B10||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4316706|NCT00474526|4143234|B9||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4316707|NCT00474526|4143235|B8||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4316708|NCT00474526|4143236|B7||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4316709|NCT00474526|4143237|B6||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4316710|NCT00474526|4143238|B5||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4316711|NCT00474526|4143239|B4||Male|Sex: Female, Male||Participants|Count of Participants|340|340.0||||||
4316712|NCT00474526|4143240|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4316713|NCT00474526|4143241|B2||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4316714|NCT00474526|4143242|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4316715|NCT00474526|4143225|B18||Female|Sex: Female, Male||Participants|Count of Participants|2223|2223.0||||||
4316716|NCT00474526|4143226|B17||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4316717|NCT00474526|4143227|B16||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4316718|NCT00474526|4143228|B15||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4316719|NCT00474526|4143229|B14||Female|Sex: Female, Male||Participants|Count of Participants|682|682.0||||||
4316720|NCT00474526|4143230|B13||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4316721|NCT00474526|4143231|B12||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4316722|NCT00474526|4143232|B11||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4316723|NCT00474526|4143233|B10||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4316724|NCT00474526|4143234|B9||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4316725|NCT00474526|4143235|B8||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4316726|NCT00474526|4143236|B7||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4316727|NCT00474526|4143237|B6||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4316728|NCT00474526|4143238|B5||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4316729|NCT00474526|4143239|B4||Female|Sex: Female, Male||Participants|Count of Participants|340|340.0||||||
4316730|NCT00474526|4143240|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4316731|NCT00474526|4143241|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4316732|NCT00474526|4143242|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4316733|NCT00474526|4143225|B18|||Age||days|Mean|65.7|65.7|Standard Deviation|8.3|8.3|||
4316734|NCT00474526|4143226|B17|||Age||days|Mean|65.0|65.0|Standard Deviation|7.9|7.9|||
4316735|NCT00474526|4143227|B16|||Age||days|Mean|59.5|59.5|Standard Deviation|6.2|6.2|||
4316736|NCT00474526|4143228|B15|||Age||days|Mean|67.7|67.7|Standard Deviation|9.7|9.7|||
4316737|NCT00474526|4143229|B14|||Age||days|Mean|65.0|65.0|Standard Deviation|9.4|9.4|||
4316738|NCT00474526|4143230|B13|||Age||days|Mean|67.5|67.5|Standard Deviation|8.0|8.0|||
4316739|NCT00474526|4143231|B12|||Age||days|Mean|68.4|68.4|Standard Deviation|8.7|8.7|||
4316740|NCT00474526|4143232|B11|||Age||days|Mean|67.0|67.0|Standard Deviation|7.9|7.9|||
4316741|NCT00474526|4143233|B10|||Age||days|Mean|67.8|67.8|Standard Deviation|8.3|8.3|||
4316742|NCT00474526|4143234|B9|||Age||days|Mean|68.6|68.6|Standard Deviation|8.9|8.9|||
4316743|NCT00474526|4143235|B8|||Age||days|Mean|68.0|68.0|Standard Deviation|7.7|7.7|||
4316744|NCT00474526|4143236|B7|||Age||days|Mean|65.9|65.9|Standard Deviation|6.5|6.5|||
4316745|NCT00474526|4143237|B6|||Age||days|Mean|65.0|65.0|Standard Deviation|6.5|6.5|||
4316746|NCT00474526|4143238|B5|||Age||days|Mean|66.1|66.1|Standard Deviation|6.2|6.2|||
4316747|NCT00474526|4143239|B4|||Age||days|Mean|65.0|65.0|Standard Deviation|6.0|6.0|||
4316748|NCT00474526|4143240|B3|||Age||days|Mean|65.7|65.7|Standard Deviation|6.5|6.5|||
4316749|NCT00474526|4143241|B2|||Age||days|Mean|65.8|65.8|Standard Deviation|6.6|6.6|||
4316750|NCT00474526|4143242|B1|||Age||days|Mean|66.1|66.1|Standard Deviation|7.2|7.2|||
4316751|NCT00474487|4143419|B5|Not Available||Race/Ethnicity, Customized||Subjects|Number|1|1.0||||||
4316752|NCT00474487|4143420|B4|Not Available||Race/Ethnicity, Customized||Subjects|Number|0|0.0||||||
4316753|NCT00474487|4143421|B3|Not Available||Race/Ethnicity, Customized||Subjects|Number|1|1.0||||||
4316754|NCT00474487|4143422|B2|Not Available||Race/Ethnicity, Customized||Subjects|Number|0|0.0||||||
4316755|NCT00474487|4143423|B1|Not Available||Race/Ethnicity, Customized||Subjects|Number|0|0.0||||||
4316756|NCT00474487|4143419|B5|Other||Race/Ethnicity, Customized||Subjects|Number|10|10.0||||||
4316757|NCT00474487|4143420|B4|Other||Race/Ethnicity, Customized||Subjects|Number|1|1.0||||||
4316758|NCT00474487|4143421|B3|Other||Race/Ethnicity, Customized||Subjects|Number|3|3.0||||||
4316759|NCT00474487|4143422|B2|Other||Race/Ethnicity, Customized||Subjects|Number|2|2.0||||||
4316760|NCT00474487|4143423|B1|Other||Race/Ethnicity, Customized||Subjects|Number|4|4.0||||||
4316761|NCT00474487|4143419|B5|Hispanic||Race/Ethnicity, Customized||Subjects|Number|2110|2110.0||||||
4316762|NCT00474487|4143420|B4|Hispanic||Race/Ethnicity, Customized||Subjects|Number|77|77.0||||||
4316763|NCT00474487|4143421|B3|Hispanic||Race/Ethnicity, Customized||Subjects|Number|658|658.0||||||
4316764|NCT00474487|4143422|B2|Hispanic||Race/Ethnicity, Customized||Subjects|Number|158|158.0||||||
4316765|NCT00474487|4143423|B1|Hispanic||Race/Ethnicity, Customized||Subjects|Number|1217|1217.0||||||
4316766|NCT00474487|4143419|B5|Caucasian||Race/Ethnicity, Customized||Subjects|Number|437|437.0||||||
4316767|NCT00474487|4143420|B4|Caucasian||Race/Ethnicity, Customized||Subjects|Number|23|23.0||||||
4316768|NCT00474487|4143421|B3|Caucasian||Race/Ethnicity, Customized||Subjects|Number|127|127.0||||||
4316769|NCT00474487|4143422|B2|Caucasian||Race/Ethnicity, Customized||Subjects|Number|38|38.0||||||
4316770|NCT00474487|4143423|B1|Caucasian||Race/Ethnicity, Customized||Subjects|Number|249|249.0||||||
4316771|NCT00474487|4143419|B5|Black||Race/Ethnicity, Customized||Subjects|Number|270|270.0||||||
4316772|NCT00474487|4143420|B4|Black||Race/Ethnicity, Customized||Subjects|Number|8|8.0||||||
4316773|NCT00474487|4143421|B3|Black||Race/Ethnicity, Customized||Subjects|Number|109|109.0||||||
4316774|NCT00474487|4143422|B2|Black||Race/Ethnicity, Customized||Subjects|Number|18|18.0||||||
4316775|NCT00474487|4143423|B1|Black||Race/Ethnicity, Customized||Subjects|Number|135|135.0||||||
4316776|NCT00474487|4143419|B5|Asian||Race/Ethnicity, Customized||Subjects|Number|3|3.0||||||
4316777|NCT00474487|4143420|B4|Asian||Race/Ethnicity, Customized||Subjects|Number|0|0.0||||||
4316778|NCT00474487|4143421|B3|Asian||Race/Ethnicity, Customized||Subjects|Number|1|1.0||||||
4316779|NCT00474487|4143422|B2|Asian||Race/Ethnicity, Customized||Subjects|Number|1|1.0||||||
4316780|NCT00474487|4143423|B1|Asian||Race/Ethnicity, Customized||Subjects|Number|1|1.0||||||
4316781|NCT00474487|4143419|B5||Male|Sex: Female, Male||Participants|Count of Participants|870|870.0||||||
4316782|NCT00474487|4143420|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4316783|NCT00474487|4143421|B3||Male|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
4316784|NCT00474487|4143422|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4316785|NCT00474487|4143423|B1||Male|Sex: Female, Male||Participants|Count of Participants|514|514.0||||||
4316786|NCT00474487|4143419|B5||Female|Sex: Female, Male||Participants|Count of Participants|1961|1961.0||||||
4316787|NCT00474487|4143420|B4||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4316788|NCT00474487|4143421|B3||Female|Sex: Female, Male||Participants|Count of Participants|627|627.0||||||
4316789|NCT00474487|4143422|B2||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4316790|NCT00474487|4143423|B1||Female|Sex: Female, Male||Participants|Count of Participants|1092|1092.0||||||
4316791|NCT00474487|4143419|B5|||Age||Years|Mean|37.6|37.6|Standard Deviation|12.6|12.6|||
4316792|NCT00474487|4143420|B4|||Age||Years|Mean|60.1|60.1|Standard Deviation|2.6|2.6|||
4316793|NCT00474487|4143421|B3|||Age||Years|Mean|34.8|34.8|Standard Deviation|10.4|10.4|||
4316794|NCT00474487|4143422|B2|||Age||Years|Mean|60.1|60.1|Standard Deviation|2.7|2.7|||
4316795|NCT00474487|4143423|B1|||Age||Years|Mean|34.6|34.6|Standard Deviation|10.1|10.1|||
4316796|NCT00474383|4143446|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4316797|NCT00474383|4143446|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4316798|NCT00474383|4143446|B1|||Age||years|Mean|67|67.0|Standard Deviation|8.42|8.42|||
4316799|NCT00474266|4143458|B5|White - Arabic / North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4316800|NCT00474266|4143459|B4|White - Arabic / North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4316801|NCT00474266|4143460|B3|White - Arabic / North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4316802|NCT00474266|4143461|B2|White - Arabic / North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4316803|NCT00474266|4143462|B1|White - Arabic / North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4316804|NCT00474266|4143458|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4316805|NCT00474266|4143459|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4316806|NCT00474266|4143460|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4316807|NCT00474266|4143461|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4316808|NCT00474266|4143462|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4316809|NCT00474266|4143458|B5|White-Caucasian/ European heritage, n (%)||Race/Ethnicity, Customized||Participants|Count of Participants|987|987.0||||||
4316810|NCT00474266|4143459|B4|White-Caucasian/ European heritage, n (%)||Race/Ethnicity, Customized||Participants|Count of Participants|123|123.0||||||
4316811|NCT00474266|4143460|B3|White-Caucasian/ European heritage, n (%)||Race/Ethnicity, Customized||Participants|Count of Participants|123|123.0||||||
4316812|NCT00474266|4143461|B2|White-Caucasian/ European heritage, n (%)||Race/Ethnicity, Customized||Participants|Count of Participants|372|372.0||||||
4316813|NCT00474266|4143462|B1|White-Caucasian/ European heritage, n (%)||Race/Ethnicity, Customized||Participants|Count of Participants|369|369.0||||||
4316814|NCT00474266|4143458|B5|Male||Sex/Gender, Customized||Participants|Count of Participants|518|518.0||||||
4316815|NCT00474266|4143459|B4|Male||Sex/Gender, Customized||Participants|Count of Participants|65|65.0||||||
4316816|NCT00474266|4143460|B3|Male||Sex/Gender, Customized||Participants|Count of Participants|58|58.0||||||
4316817|NCT00474266|4143461|B2|Male||Sex/Gender, Customized||Participants|Count of Participants|200|200.0||||||
4316818|NCT00474266|4143462|B1|Male||Sex/Gender, Customized||Participants|Count of Participants|195|195.0||||||
4316819|NCT00474266|4143458|B5|Female||Sex/Gender, Customized||Participants|Count of Participants|482|482.0||||||
4316820|NCT00474266|4143459|B4|Female||Sex/Gender, Customized||Participants|Count of Participants|60|60.0||||||
4316821|NCT00474266|4143460|B3|Female||Sex/Gender, Customized||Participants|Count of Participants|68|68.0||||||
4316822|NCT00474266|4143461|B2|Female||Sex/Gender, Customized||Participants|Count of Participants|174|174.0||||||
4316823|NCT00474266|4143462|B1|Female||Sex/Gender, Customized||Participants|Count of Participants|180|180.0||||||
4316824|NCT00474266|4143458|B5|||Age||Months|Mean|14.61|14.61|Standard Deviation|1.48|1.48|||
4316825|NCT00474266|4143459|B4|||Age||Months|Mean|14.4|14.4|Standard Deviation|1.47|1.47|||
4316826|NCT00474266|4143460|B3|||Age||Months|Mean|14.6|14.6|Standard Deviation|1.41|1.41|||
4316827|NCT00474266|4143461|B2|||Age||Months|Mean|14.6|14.6|Standard Deviation|1.49|1.49|||
4316828|NCT00474266|4143462|B1|||Age||Months|Mean|14.7|14.7|Standard Deviation|1.5|1.5|||
4316829|NCT00474240|4143567|B7|United States||Region of Enrollment||participants|Number|157|157.0||||||
4316830|NCT00474240|4143568|B6|United States||Region of Enrollment||participants|Number|26|26.0||||||
4316831|NCT00474240|4143569|B5|United States||Region of Enrollment||participants|Number|26|26.0||||||
4316832|NCT00474240|4143570|B4|United States||Region of Enrollment||participants|Number|26|26.0||||||
4316833|NCT00474240|4143571|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4316834|NCT00474240|4143572|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4316835|NCT00474240|4143573|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4316836|NCT00474240|4143567|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4316837|NCT00474240|4143568|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316838|NCT00474240|4143569|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4316839|NCT00474240|4143570|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4316840|NCT00474240|4143571|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4316841|NCT00474240|4143572|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316842|NCT00474240|4143573|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316843|NCT00474240|4143567|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316844|NCT00474240|4143568|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316845|NCT00474240|4143569|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316846|NCT00474240|4143570|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316847|NCT00474240|4143571|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316848|NCT00474240|4143572|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316849|NCT00474240|4143573|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316850|NCT00474240|4143567|B7||White|Race (NIH/OMB)||Participants|Count of Participants|127|127.0||||||
4316851|NCT00474240|4143568|B6||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4316852|NCT00474240|4143569|B5||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4316853|NCT00474240|4143570|B4||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4316854|NCT00474240|4143571|B3||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4316855|NCT00474240|4143572|B2||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4316856|NCT00474240|4143573|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4316857|NCT00474240|4143567|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4316858|NCT00474240|4143568|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4316859|NCT00474240|4143569|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4316860|NCT00474240|4143570|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4316861|NCT00474240|4143571|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4316862|NCT00474240|4143572|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4316863|NCT00474240|4143573|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4316864|NCT00474240|4143567|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316865|NCT00474240|4143568|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316866|NCT00474240|4143569|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316867|NCT00474240|4143570|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316868|NCT00474240|4143571|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316869|NCT00474240|4143572|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316870|NCT00474240|4143573|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316871|NCT00474240|4143567|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4316872|NCT00474240|4143568|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316873|NCT00474240|4143569|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316874|NCT00474240|4143570|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316875|NCT00474240|4143571|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316876|NCT00474240|4143572|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316877|NCT00474240|4143573|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4316878|NCT00474240|4143567|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4316879|NCT00474240|4143568|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4316880|NCT00474240|4143569|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316881|NCT00474240|4143570|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316882|NCT00474240|4143571|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316883|NCT00474240|4143572|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316884|NCT00474240|4143573|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316885|NCT00474240|4143567|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316886|NCT00474240|4143568|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316887|NCT00474240|4143569|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316888|NCT00474240|4143570|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316889|NCT00474240|4143571|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316890|NCT00474240|4143572|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316891|NCT00474240|4143573|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316892|NCT00474240|4143567|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|150|150.0||||||
4316893|NCT00474240|4143568|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4316894|NCT00474240|4143569|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4316895|NCT00474240|4143570|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4316896|NCT00474240|4143571|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4316897|NCT00474240|4143572|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4316898|NCT00474240|4143573|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4316899|NCT00474240|4143567|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4316900|NCT00474240|4143568|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316901|NCT00474240|4143569|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4316902|NCT00474240|4143570|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4316903|NCT00474240|4143571|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4316904|NCT00474240|4143572|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316905|NCT00474240|4143573|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316906|NCT00474240|4143567|B7||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4316907|NCT00474240|4143568|B6||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4316908|NCT00474240|4143569|B5||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4316909|NCT00474240|4143570|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4316910|NCT00474240|4143571|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4316911|NCT00474240|4143572|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4316912|NCT00474240|4143573|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4316913|NCT00474240|4143567|B7||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4316914|NCT00474240|4143568|B6||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4316915|NCT00474240|4143569|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4316916|NCT00474240|4143570|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4316917|NCT00474240|4143571|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4316918|NCT00474240|4143572|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4316919|NCT00474240|4143573|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4316920|NCT00474240|4143567|B7|||Age||Years|Mean|54|54.0|Standard Deviation|10|10.0|||
4316921|NCT00474240|4143568|B6|||Age||Years|Mean|53|53.0|Standard Deviation|9.7|9.7|||
4316922|NCT00474240|4143569|B5|||Age||Years|Mean|51|51.0|Standard Deviation|10.1|10.1|||
4316923|NCT00474240|4143570|B4|||Age||Years|Mean|54|54.0|Standard Deviation|11.6|11.6|||
4316924|NCT00474240|4143571|B3|||Age||Years|Mean|56|56.0|Standard Deviation|8.3|8.3|||
4316925|NCT00474240|4143572|B2|||Age||Years|Mean|56|56.0|Standard Deviation|8.4|8.4|||
4316926|NCT00474240|4143573|B1|||Age||Years|Mean|53|53.0|Standard Deviation|11.1|11.1|||
4316927|NCT00474201|4143598|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4316928|NCT00474201|4143598|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4316929|NCT00474201|4143598|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4316930|NCT00474201|4143598|B1|||Age||years|Mean|37|37.0|Standard Deviation|10|10.0|||
4316931|NCT00474201|4143598|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4316932|NCT00474201|4143598|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4316933|NCT00474201|4143598|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4316934|NCT00474188|4143603|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4316935|NCT00474188|4143603|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4316936|NCT00474188|4143603|B1|Australia||Region of Enrollment||participants|Number|4|4.0||||||
4316937|NCT00474188|4143603|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4316938|NCT00474188|4143603|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4316939|NCT00474188|4143603|B1|||Age||years|Mean|66.7|66.7|Standard Deviation|11.42|11.42|||
4316940|NCT00474188|4143603|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4316941|NCT00474188|4143603|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4316942|NCT00474188|4143603|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4316943|NCT00474175|4143610|B4||Male|Sex: Female, Male|Demographic data is only available for 576 participants who received study medication, except 1 participant who was randomized but not treated.|Participants|Count of Participants|276|276.0||||||
4316944|NCT00474175|4143611|B3||Male|Sex: Female, Male|Demographic data is only available for 576 participants who received study medication, except 1 participant who was randomized but not treated.|Participants|Count of Participants|110|110.0||||||
4316945|NCT00474175|4143612|B2||Male|Sex: Female, Male|Demographic data is only available for 576 participants who received study medication, except 1 participant who was randomized but not treated.|Participants|Count of Participants|113|113.0||||||
4316946|NCT00474175|4143613|B1||Male|Sex: Female, Male|Demographic data is only available for 576 participants who received study medication, except 1 participant who was randomized but not treated.|Participants|Count of Participants|53|53.0||||||
4316947|NCT00474175|4143610|B4||Female|Sex: Female, Male|Demographic data is only available for 576 participants who received study medication, except 1 participant who was randomized but not treated.|Participants|Count of Participants|300|300.0||||||
4316948|NCT00474175|4143611|B3||Female|Sex: Female, Male|Demographic data is only available for 576 participants who received study medication, except 1 participant who was randomized but not treated.|Participants|Count of Participants|118|118.0||||||
4316949|NCT00474175|4143612|B2||Female|Sex: Female, Male|Demographic data is only available for 576 participants who received study medication, except 1 participant who was randomized but not treated.|Participants|Count of Participants|120|120.0||||||
4316950|NCT00474175|4143613|B1||Female|Sex: Female, Male|Demographic data is only available for 576 participants who received study medication, except 1 participant who was randomized but not treated.|Participants|Count of Participants|62|62.0||||||
4316951|NCT00474175|4143610|B4|||Age|Demographic data is only available for 576 participants who received study medication, except 1 participant who was randomized but not treated.|Years|Mean|31.1|31.1|Standard Deviation|12.7|12.7|||
4316952|NCT00474175|4143611|B3|||Age|Demographic data is only available for 576 participants who received study medication, except 1 participant who was randomized but not treated.|Years|Mean|31.3|31.3|Standard Deviation|12.8|12.8|||
4316953|NCT00474175|4143612|B2|||Age|Demographic data is only available for 576 participants who received study medication, except 1 participant who was randomized but not treated.|Years|Mean|30.8|30.8|Standard Deviation|12.7|12.7|||
4316954|NCT00474175|4143613|B1|||Age|Demographic data is only available for 576 participants who received study medication, except 1 participant who was randomized but not treated.|Years|Mean|31.2|31.2|Standard Deviation|12.6|12.6|||
4316955|NCT00474123|4143650|B3|Brazil||Region of Enrollment||participants|Number|78|78.0||||||
4316956|NCT00474123|4143651|B2|Brazil||Region of Enrollment||participants|Number|40|40.0||||||
4316957|NCT00474123|4143652|B1|Brazil||Region of Enrollment||participants|Number|38|38.0||||||
4316958|NCT00474123|4143650|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4316959|NCT00474123|4143651|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4316960|NCT00474123|4143652|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4316961|NCT00474123|4143650|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4316962|NCT00474123|4143651|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4316963|NCT00474123|4143652|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4316964|NCT00474123|4143650|B3|||Age||years|Mean|63.2|63.2|Standard Deviation|10|10.0|||
4316965|NCT00474123|4143651|B2|||Age||years|Mean|64.5|64.5|Standard Deviation|9|9.0|||
4316966|NCT00474123|4143652|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|10|10.0|||
4316967|NCT00474123|4143650|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4316968|NCT00474123|4143651|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4316969|NCT00474123|4143652|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4316970|NCT00474123|4143650|B3||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
4316971|NCT00474123|4143651|B2||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4316972|NCT00474123|4143652|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4316973|NCT00474123|4143650|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4316974|NCT00474123|4143651|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4316975|NCT00474123|4143652|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4316976|NCT00474058|4143677|B3|||Weight||kg|Mean|77.1|77.1|Standard Deviation|15.5|15.5|||
4316977|NCT00474058|4143678|B2|||Weight||kg|Mean|78.0|78.0|Standard Deviation|16.2|16.2|||
4316978|NCT00474058|4143679|B1|||Weight||kg|Mean|76.6|76.6|Standard Deviation|15.1|15.1|||
4316979|NCT00474058|4143677|B3|||Height||cm|Mean|169.60|169.6|Standard Deviation|9.18|9.18|||
4316980|NCT00474058|4143678|B2|||Height||cm|Mean|170.73|170.73|Standard Deviation|9.27|9.27|||
4316981|NCT00474058|4143679|B1|||Height||cm|Mean|169.04|169.04|Standard Deviation|9.11|9.11|||
4316982|NCT00474058|4143677|B3|||Body Mass Index (BMI)||kg/ m^2|Mean|26.665|26.665|Standard Deviation|4.295|4.295|||
4316983|NCT00474058|4143678|B2|||Body Mass Index (BMI)||kg/ m^2|Mean|26.645|26.645|Standard Deviation|4.569|4.569|||
4316984|NCT00474058|4143679|B1|||Body Mass Index (BMI)||kg/ m^2|Mean|26.676|26.676|Standard Deviation|4.164|4.164|||
4316985|NCT00474058|4143677|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4316986|NCT00474058|4143678|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4316987|NCT00474058|4143679|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4316988|NCT00474058|4143677|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316989|NCT00474058|4143678|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316990|NCT00474058|4143679|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316991|NCT00474058|4143677|B3||White|Race (NIH/OMB)||Participants|Count of Participants|243|243.0||||||
4316992|NCT00474058|4143678|B2||White|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
4316993|NCT00474058|4143679|B1||White|Race (NIH/OMB)||Participants|Count of Participants|164|164.0||||||
4316994|NCT00474058|4143677|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4316995|NCT00474058|4143678|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4316996|NCT00474058|4143679|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4316997|NCT00474058|4143677|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316998|NCT00474058|4143678|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4316999|NCT00474058|4143679|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317000|NCT00474058|4143677|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4317001|NCT00474058|4143678|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4317002|NCT00474058|4143679|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4317003|NCT00474058|4143677|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317004|NCT00474058|4143678|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317005|NCT00474058|4143679|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317006|NCT00474058|4143677|B3||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4317007|NCT00474058|4143678|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4317008|NCT00474058|4143679|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4317009|NCT00474058|4143677|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4317010|NCT00474058|4143678|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4317011|NCT00474058|4143679|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4317012|NCT00474058|4143677|B3|||Age||years|Mean|64.6|64.6|Standard Deviation|9.7|9.7|||
4317013|NCT00474058|4143678|B2|||Age||years|Mean|64.5|64.5|Standard Deviation|10.4|10.4|||
4317014|NCT00474058|4143679|B1|||Age||years|Mean|64.7|64.7|Standard Deviation|9.4|9.4|||
4317015|NCT00474058|4143677|B3||>=65 years|Age||Participants|Count of Participants|140|140.0||||||
4317016|NCT00474058|4143678|B2||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
4317017|NCT00474058|4143679|B1||>=65 years|Age||Participants|Count of Participants|91|91.0||||||
4317018|NCT00474058|4143677|B3||Between 18 and 65 years|Age||Participants|Count of Participants|127|127.0||||||
4317019|NCT00474058|4143678|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4317020|NCT00474058|4143679|B1||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
4317021|NCT00474058|4143677|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4317022|NCT00474058|4143678|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4317023|NCT00474058|4143679|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4317024|NCT00474045|4143692|B3|||Diabetes History||years|Mean|12.26|12.26|Standard Deviation|8.02|8.02|||
4317025|NCT00474045|4143693|B2|||Diabetes History||years|Mean|12.78|12.78|Standard Deviation|7.94|7.94|||
4317026|NCT00474045|4143694|B1|||Diabetes History||years|Mean|11.72|11.72|Standard Deviation|8.08|8.08|||
4317027|NCT00474045|4143692|B3|||Fasting Plasma Glucose (FPG)|The number of subjects (N) analysed in the insulin detemir (IDet) group was 139 and NPH group was 151 instead of 152 and 158, respectively.Therefore the total number of subjects analysed were 290 instead of 310.|mmol/L|Mean|5.94|5.94|Standard Deviation|3.25|3.25|||
4317028|NCT00474045|4143693|B2|||Fasting Plasma Glucose (FPG)|The number of subjects (N) analysed in the insulin detemir (IDet) group was 139 and NPH group was 151 instead of 152 and 158, respectively.Therefore the total number of subjects analysed were 290 instead of 310.|mmol/L|Mean|5.99|5.99|Standard Deviation|3.23|3.23|||
4317029|NCT00474045|4143694|B1|||Fasting Plasma Glucose (FPG)|The number of subjects (N) analysed in the insulin detemir (IDet) group was 139 and NPH group was 151 instead of 152 and 158, respectively.Therefore the total number of subjects analysed were 290 instead of 310.|mmol/L|Mean|5.89|5.89|Standard Deviation|3.29|3.29|||
4317030|NCT00474045|4143692|B3|||Glycosylated Haemoglobin (HbA1c)||Percent (%) glycosylated haemoglobin|Mean|7.01|7.01|Standard Deviation|0.79|0.79|||
4317031|NCT00474045|4143693|B2|||Glycosylated Haemoglobin (HbA1c)||Percent (%) glycosylated haemoglobin|Mean|7.08|7.08|Standard Deviation|0.76|0.76|||
4317032|NCT00474045|4143694|B1|||Glycosylated Haemoglobin (HbA1c)||Percent (%) glycosylated haemoglobin|Mean|6.95|6.95|Standard Deviation|0.82|0.82|||
4317033|NCT00474045|4143692|B3|Pregnant at Randomisation||Stratification||participants|Number|162|162.0||||||
4317034|NCT00474045|4143693|B2|Pregnant at Randomisation||Stratification||participants|Number|83|83.0||||||
4317035|NCT00474045|4143694|B1|Pregnant at Randomisation||Stratification||participants|Number|79|79.0||||||
4317036|NCT00474045|4143692|B3|Pregnant after Randomisation||Stratification||participants|Number|148|148.0||||||
4317037|NCT00474045|4143693|B2|Pregnant after Randomisation||Stratification||participants|Number|75|75.0||||||
4317038|NCT00474045|4143694|B1|Pregnant after Randomisation||Stratification||participants|Number|73|73.0||||||
4317039|NCT00474045|4143692|B3|Yes||Daily Use of Alcohol||participants|Number|2|2.0||||||
4317040|NCT00474045|4143693|B2|Yes||Daily Use of Alcohol||participants|Number|0|0.0||||||
4317041|NCT00474045|4143694|B1|Yes||Daily Use of Alcohol||participants|Number|2|2.0||||||
4317042|NCT00474045|4143692|B3|No||Daily Use of Alcohol||participants|Number|308|308.0||||||
4317043|NCT00474045|4143693|B2|No||Daily Use of Alcohol||participants|Number|158|158.0||||||
4317044|NCT00474045|4143694|B1|No||Daily Use of Alcohol||participants|Number|150|150.0||||||
4317045|NCT00474045|4143692|B3|Yes||Smoker||participants|Number|20|20.0||||||
4317046|NCT00474045|4143693|B2|Yes||Smoker||participants|Number|11|11.0||||||
4317047|NCT00474045|4143694|B1|Yes||Smoker||participants|Number|9|9.0||||||
4317048|NCT00474045|4143692|B3|No||Smoker||participants|Number|290|290.0||||||
4317049|NCT00474045|4143693|B2|No||Smoker||participants|Number|147|147.0||||||
4317050|NCT00474045|4143694|B1|No||Smoker||participants|Number|143|143.0||||||
4317051|NCT00474045|4143692|B3|||Body Mass Index (BMI)|The number of subjects (N) analysed in the NPH group was 157 instead of 158.|kg/m^2|Mean|24.76|24.76|Standard Deviation|4.1|4.1|||
4317052|NCT00474045|4143693|B2|||Body Mass Index (BMI)|The number of subjects (N) analysed in the NPH group was 157 instead of 158.|kg/m^2|Mean|25.17|25.17|Standard Deviation|4.22|4.22|||
4317053|NCT00474045|4143694|B1|||Body Mass Index (BMI)|The number of subjects (N) analysed in the NPH group was 157 instead of 158.|kg/m^2|Mean|24.34|24.34|Standard Deviation|3.95|3.95|||
4317054|NCT00474045|4143692|B3|||Body Weight|The number of subjects (N) analysed in the NPH group was 157 instead of 158.|kg|Mean|68.2|68.2|Standard Deviation|12.3|12.3|||
4317055|NCT00474045|4143693|B2|||Body Weight|The number of subjects (N) analysed in the NPH group was 157 instead of 158.|kg|Mean|68.7|68.7|Standard Deviation|12.4|12.4|||
4317056|NCT00474045|4143694|B1|||Body Weight|The number of subjects (N) analysed in the NPH group was 157 instead of 158.|kg|Mean|67.6|67.6|Standard Deviation|12.3|12.3|||
4317057|NCT00474045|4143692|B3|||Height|The number of subjects (N) analysed in the Neutral Protamine Hagedorn (NPH) group was 157 instead of 158.|meters|Mean|1.66|1.66|Standard Deviation|0.07|0.07|||
4317058|NCT00474045|4143693|B2|||Height|The number of subjects (N) analysed in the Neutral Protamine Hagedorn (NPH) group was 157 instead of 158.|meters|Mean|1.65|1.65|Standard Deviation|0.06|0.06|||
4317059|NCT00474045|4143694|B1|||Height|The number of subjects (N) analysed in the Neutral Protamine Hagedorn (NPH) group was 157 instead of 158.|meters|Mean|1.67|1.67|Standard Deviation|0.07|0.07|||
4317060|NCT00474045|4143692|B3|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4317061|NCT00474045|4143693|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4317062|NCT00474045|4143694|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4317063|NCT00474045|4143692|B3|Unknown||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4317064|NCT00474045|4143693|B2|Unknown||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4317065|NCT00474045|4143694|B1|Unknown||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4317066|NCT00474045|4143692|B3|White||Race/Ethnicity, Customized||participants|Number|277|277.0||||||
4317067|NCT00474045|4143693|B2|White||Race/Ethnicity, Customized||participants|Number|142|142.0||||||
4317068|NCT00474045|4143694|B1|White||Race/Ethnicity, Customized||participants|Number|135|135.0||||||
4317069|NCT00474045|4143692|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4317070|NCT00474045|4143693|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4317071|NCT00474045|4143694|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4317072|NCT00474045|4143692|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4317073|NCT00474045|4143693|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4317074|NCT00474045|4143694|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4317075|NCT00474045|4143692|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4317076|NCT00474045|4143693|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4317077|NCT00474045|4143694|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4317078|NCT00474045|4143692|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4317079|NCT00474045|4143693|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4317080|NCT00474045|4143694|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4317081|NCT00474045|4143692|B3||Female|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
4317082|NCT00474045|4143693|B2||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4317083|NCT00474045|4143694|B1||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4317084|NCT00474045|4143692|B3|||Age||years|Mean|30.1|30.1|Standard Deviation|4.43|4.43|||
4317085|NCT00474045|4143693|B2|||Age||years|Mean|30.4|30.4|Standard Deviation|4.21|4.21|||
4317086|NCT00474045|4143694|B1|||Age||years|Mean|29.7|29.7|Standard Deviation|4.62|4.62|||
4317087|NCT00473889|4143793|B3|Rest of the World||Geographic region where the participant lived||Participants|Number|74|74.0||||||
4317088|NCT00473889|4143794|B2|Rest of the World||Geographic region where the participant lived||Participants|Number|36|36.0||||||
4317089|NCT00473889|4143795|B1|Rest of the World||Geographic region where the participant lived||Participants|Number|38|38.0||||||
4317090|NCT00473889|4143793|B3|Asia||Geographic region where the participant lived||Participants|Number|46|46.0||||||
4317091|NCT00473889|4143794|B2|Asia||Geographic region where the participant lived||Participants|Number|24|24.0||||||
4317092|NCT00473889|4143795|B1|Asia||Geographic region where the participant lived||Participants|Number|22|22.0||||||
4317093|NCT00473889|4143793|B3|Europe (United Kingdom, Italy, Germany, and Spain)||Geographic region where the participant lived||Participants|Number|81|81.0||||||
4317094|NCT00473889|4143794|B2|Europe (United Kingdom, Italy, Germany, and Spain)||Geographic region where the participant lived||Participants|Number|40|40.0||||||
4317095|NCT00473889|4143795|B1|Europe (United Kingdom, Italy, Germany, and Spain)||Geographic region where the participant lived||Participants|Number|41|41.0||||||
4317096|NCT00473889|4143793|B3|North America||Geographic region where the participant lived||Participants|Number|52|52.0||||||
4317097|NCT00473889|4143794|B2|North America||Geographic region where the participant lived||Participants|Number|27|27.0||||||
4317098|NCT00473889|4143795|B1|North America||Geographic region where the participant lived||Participants|Number|25|25.0||||||
4317099|NCT00473889|4143793|B3|Unknown||Eligibility to receive treatment with Bevacizumab||Participants|Number|5|5.0||||||
4317100|NCT00473889|4143794|B2|Unknown||Eligibility to receive treatment with Bevacizumab||Participants|Number|4|4.0||||||
4317101|NCT00473889|4143795|B1|Unknown||Eligibility to receive treatment with Bevacizumab||Participants|Number|1|1.0||||||
4317102|NCT00473889|4143793|B3|Ineligible||Eligibility to receive treatment with Bevacizumab||Participants|Number|115|115.0||||||
4317103|NCT00473889|4143794|B2|Ineligible||Eligibility to receive treatment with Bevacizumab||Participants|Number|60|60.0||||||
4317104|NCT00473889|4143795|B1|Ineligible||Eligibility to receive treatment with Bevacizumab||Participants|Number|55|55.0||||||
4317105|NCT00473889|4143793|B3|Eligible||Eligibility to receive treatment with Bevacizumab||Participants|Number|133|133.0||||||
4317106|NCT00473889|4143794|B2|Eligible||Eligibility to receive treatment with Bevacizumab||Participants|Number|63|63.0||||||
4317107|NCT00473889|4143795|B1|Eligible||Eligibility to receive treatment with Bevacizumab||Participants|Number|70|70.0||||||
4317108|NCT00473889|4143793|B3|IV||Cancer Stage||Participants|Number|224|224.0||||||
4317109|NCT00473889|4143794|B2|IV||Cancer Stage||Participants|Number|112|112.0||||||
4317110|NCT00473889|4143795|B1|IV||Cancer Stage||Participants|Number|112|112.0||||||
4317111|NCT00473889|4143793|B3|IIIB||Cancer Stage||Participants|Number|29|29.0||||||
4317112|NCT00473889|4143794|B2|IIIB||Cancer Stage||Participants|Number|15|15.0||||||
4317113|NCT00473889|4143795|B1|IIIB||Cancer Stage||Participants|Number|14|14.0||||||
4317114|NCT00473889|4143793|B3|American Indian or Alaskan Native mix||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4317115|NCT00473889|4143794|B2|American Indian or Alaskan Native mix||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4317116|NCT00473889|4143795|B1|American Indian or Alaskan Native mix||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4317117|NCT00473889|4143793|B3|Asian||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
4317118|NCT00473889|4143794|B2|Asian||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4317119|NCT00473889|4143795|B1|Asian||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4317120|NCT00473889|4143793|B3|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4317121|NCT00473889|4143794|B2|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4317122|NCT00473889|4143795|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4317123|NCT00473889|4143793|B3|White||Race/Ethnicity, Customized||participants|Number|158|158.0||||||
4317124|NCT00473889|4143794|B2|White||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
4317125|NCT00473889|4143795|B1|White||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
4317126|NCT00473889|4143793|B3||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4317127|NCT00473889|4143794|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4317128|NCT00473889|4143795|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4317129|NCT00473889|4143793|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4317130|NCT00473889|4143794|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4317131|NCT00473889|4143795|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4317132|NCT00473889|4143793|B3|65 years or Older||Age, Customized||participants|Number|94|94.0||||||
4317133|NCT00473889|4143794|B2|65 years or Older||Age, Customized||participants|Number|38|38.0||||||
4317134|NCT00473889|4143795|B1|65 years or Older||Age, Customized||participants|Number|56|56.0||||||
4317135|NCT00473889|4143793|B3|Less Than 65 years||Age, Customized||participants|Number|159|159.0||||||
4317136|NCT00473889|4143794|B2|Less Than 65 years||Age, Customized||participants|Number|89|89.0||||||
4317137|NCT00473889|4143795|B1|Less Than 65 years||Age, Customized||participants|Number|70|70.0||||||
4317138|NCT00473876|4143806|B3|United Kingdom||Region of Enrollment||participants|Number|62|62.0||||||
4317139|NCT00473876|4143807|B2|United Kingdom||Region of Enrollment||participants|Number|23|23.0||||||
4317140|NCT00473876|4143808|B1|United Kingdom||Region of Enrollment||participants|Number|39|39.0||||||
4317141|NCT00473876|4143806|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4317142|NCT00473876|4143807|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4317143|NCT00473876|4143808|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4317144|NCT00473876|4143806|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4317145|NCT00473876|4143807|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4317146|NCT00473876|4143808|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4317147|NCT00473876|4143806|B3|||Age||years|Mean|65|65.0|Standard Deviation|8|8.0|||
4317148|NCT00473876|4143807|B2|||Age||years|Mean|68|68.0|Standard Deviation|7|7.0|||
4317149|NCT00473876|4143808|B1|||Age||years|Mean|64|64.0|Standard Deviation|8|8.0|||
4317150|NCT00473876|4143806|B3||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4317151|NCT00473876|4143807|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4317152|NCT00473876|4143808|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4317153|NCT00473876|4143806|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4317154|NCT00473876|4143807|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4317155|NCT00473876|4143808|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4317156|NCT00473876|4143806|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4317157|NCT00473876|4143807|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4317158|NCT00473876|4143808|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4317159|NCT00473837|4143817|B3|Gambia||Region of Enrollment||participants|Number|96|96.0||||||
4317160|NCT00473837|4143818|B2|Gambia||Region of Enrollment||participants|Number|46|46.0||||||
4317161|NCT00473837|4143819|B1|Gambia||Region of Enrollment||participants|Number|50|50.0||||||
4317162|NCT00473837|4143817|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4317163|NCT00473837|4143818|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4317164|NCT00473837|4143819|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4317165|NCT00473837|4143817|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4317166|NCT00473837|4143818|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4317167|NCT00473837|4143819|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4317168|NCT00473837|4143817|B3|||Age||months|Mean|40.3|40.3|Standard Deviation|17.9|17.9|||
4317169|NCT00473837|4143818|B2|||Age||months|Mean|38.7|38.7|Standard Deviation|17.8|17.8|||
4317170|NCT00473837|4143819|B1|||Age||months|Mean|41.9|41.9|Standard Deviation|18.1|18.1|||
4317171|NCT00473837|4143817|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4317172|NCT00473837|4143818|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4317173|NCT00473837|4143819|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4317174|NCT00473837|4143817|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4317175|NCT00473837|4143818|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4317176|NCT00473837|4143819|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4317177|NCT00473837|4143817|B3||<=18 years|Age||Participants|Count of Participants|96|96.0||||||
4317178|NCT00473837|4143818|B2||<=18 years|Age||Participants|Count of Participants|46|46.0||||||
4317179|NCT00473837|4143819|B1||<=18 years|Age||Participants|Count of Participants|50|50.0||||||
4317180|NCT00473824|4143826|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4317181|NCT00473824|4143827|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4317182|NCT00473824|4143828|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4317183|NCT00473824|4143826|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4317184|NCT00473824|4143827|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4317185|NCT00473824|4143828|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4317186|NCT00473824|4143826|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4317187|NCT00473824|4143827|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4317188|NCT00473824|4143828|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4317189|NCT00473824|4143826|B3|||Age||years|Mean|50|50.0|Standard Deviation|6.5|6.5|||
4317190|NCT00473824|4143827|B2|||Age||years|Mean|47|47.0|Standard Deviation|11.3|11.3|||
4317191|NCT00473824|4143828|B1|||Age||years|Mean|51.2|51.2|Standard Deviation|5.0|5.0|||
4317192|NCT00473824|4143826|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4317193|NCT00473824|4143827|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4317194|NCT00473824|4143828|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4317195|NCT00473824|4143826|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4317196|NCT00473824|4143827|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4317197|NCT00473824|4143828|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4317198|NCT00473824|4143826|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4317199|NCT00473824|4143827|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4317200|NCT00473824|4143828|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4317201|NCT00473746|4143835|B6|United States||Region of Enrollment||participants|Number|66|66.0||||||
4317202|NCT00473746|4143836|B5|United States||Region of Enrollment||participants|Number|33|33.0||||||
4317203|NCT00473746|4143837|B4|United States||Region of Enrollment||participants|Number|12|12.0||||||
4317204|NCT00473746|4143838|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4317205|NCT00473746|4143839|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4317206|NCT00473746|4143840|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4317207|NCT00473746|4143835|B6||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4317208|NCT00473746|4143836|B5||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4317209|NCT00473746|4143837|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4317210|NCT00473746|4143838|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4317211|NCT00473746|4143839|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4317212|NCT00473746|4143840|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4317213|NCT00473746|4143835|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4317214|NCT00473746|4143836|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4317215|NCT00473746|4143837|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4317216|NCT00473746|4143838|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4317217|NCT00473746|4143839|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4317218|NCT00473746|4143840|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4317219|NCT00473746|4143835|B6|||Age||years|Mean|70.3|70.3|Standard Deviation|8.05|8.05|||
4317220|NCT00473746|4143836|B5|||Age||years|Mean|70.3|70.3|Standard Deviation|8.51|8.51|||
4317221|NCT00473746|4143837|B4|||Age||years|Mean|72.9|72.9|Standard Deviation|8.3|8.3|||
4317222|NCT00473746|4143838|B3|||Age||years|Mean|73.2|73.2|Standard Deviation|8.18|8.18|||
4317223|NCT00473746|4143839|B2|||Age||years|Mean|67.6|67.6|Standard Deviation|6.5|6.5|||
4317224|NCT00473746|4143840|B1|||Age||years|Mean|66.7|66.7|Standard Deviation|6.19|6.19|||
4317225|NCT00473668|4143889|B4||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4317226|NCT00473668|4143890|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4317227|NCT00473668|4143891|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4317228|NCT00473668|4143892|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4317229|NCT00473668|4143889|B4||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4317230|NCT00473668|4143890|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4317231|NCT00473668|4143891|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4317232|NCT00473668|4143892|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4317233|NCT00473668|4143889|B4|||Age||weeks|Mean|6.3|6.3|Standard Deviation|0.58|0.58|||
4317234|NCT00473668|4143890|B3|||Age||weeks|Mean|6.3|6.3|Standard Deviation|0.51|0.51|||
4317235|NCT00473668|4143891|B2|||Age||weeks|Mean|6.4|6.4|Standard Deviation|0.64|0.64|||
4317236|NCT00473668|4143892|B1|||Age||weeks|Mean|6.3|6.3|Standard Deviation|0.59|0.59|||
4317237|NCT00473655|4143944|B4|Tg levels||TG levels, continuous||mg/dL|Mean|308.25|308.25|Standard Deviation|110.22|110.22|||
4317238|NCT00473655|4143945|B3|Tg levels||TG levels, continuous||mg/dL|Mean|309.46|309.46|Standard Deviation|99.55|99.55|||
4317239|NCT00473655|4143946|B2|Tg levels||TG levels, continuous||mg/dL|Mean|296.78|296.78|Standard Deviation|95.19|95.19|||
4317240|NCT00473655|4143947|B1|Tg levels||TG levels, continuous||mg/dL|Mean|319.51|319.51|Standard Deviation|131.95|131.95|||
4317241|NCT00473655|4143944|B4|LDL-C||LDL-C, continuous||mg/dL|Mean|129.84|129.84|Standard Deviation|29.45|29.45|||
4317242|NCT00473655|4143945|B3|LDL-C||LDL-C, continuous||mg/dL|Mean|129.77|129.77|Standard Deviation|31.10|31.1|||
4317243|NCT00473655|4143946|B2|LDL-C||LDL-C, continuous||mg/dL|Mean|130.51|130.51|Standard Deviation|29.19|29.19|||
4317244|NCT00473655|4143947|B1|LDL-C||LDL-C, continuous||mg/dL|Mean|129.24|129.24|Standard Deviation|28.23|28.23|||
4317245|NCT00473655|4143944|B4|HDL-C||HDL-C levels, continuous||mg/dL|Mean|33.28|33.28|Standard Deviation|6.99|6.99|||
4317246|NCT00473655|4143945|B3|HDL-C||HDL-C levels, continuous||mg/dL|Mean|32.30|32.3|Standard Deviation|6.49|6.49|||
4317247|NCT00473655|4143946|B2|HDL-C||HDL-C levels, continuous||mg/dL|Mean|34.05|34.05|Standard Deviation|6.88|6.88|||
4317248|NCT00473655|4143947|B1|HDL-C||HDL-C levels, continuous||mg/dL|Mean|33.50|33.5|Standard Deviation|7.52|7.52|||
4317249|NCT00473655|4143944|B4|Body mass index||Body mass index continuous||Kg/m2|Mean|30.28|30.28|Standard Deviation|4.71|4.71|||
4317250|NCT00473655|4143945|B3|Body mass index||Body mass index continuous||Kg/m2|Mean|30.36|30.36|Standard Deviation|4.90|4.9|||
4317251|NCT00473655|4143946|B2|Body mass index||Body mass index continuous||Kg/m2|Mean|29.77|29.77|Standard Deviation|4.04|4.04|||
4317252|NCT00473655|4143947|B1|Body mass index||Body mass index continuous||Kg/m2|Mean|30.72|30.72|Standard Deviation|5.11|5.11|||
4317253|NCT00473655|4143944|B4|Diabetes mellitus||Diabetes mellitus||Participants|Number|41|41.0||||||
4317254|NCT00473655|4143945|B3|Diabetes mellitus||Diabetes mellitus||Participants|Number|13|13.0||||||
4317255|NCT00473655|4143946|B2|Diabetes mellitus||Diabetes mellitus||Participants|Number|16|16.0||||||
4317256|NCT00473655|4143947|B1|Diabetes mellitus||Diabetes mellitus||Participants|Number|12|12.0||||||
4317257|NCT00473655|4143944|B4|Arterial Hypertension||Arterial Hypertension||Participants|Number|105|105.0||||||
4317258|NCT00473655|4143945|B3|Arterial Hypertension||Arterial Hypertension||Participants|Number|34|34.0||||||
4317259|NCT00473655|4143946|B2|Arterial Hypertension||Arterial Hypertension||Participants|Number|35|35.0||||||
4317260|NCT00473655|4143947|B1|Arterial Hypertension||Arterial Hypertension||Participants|Number|36|36.0||||||
4317261|NCT00473655|4143944|B4||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4317262|NCT00473655|4143945|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4317263|NCT00473655|4143946|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4317264|NCT00473655|4143947|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4317265|NCT00473655|4143944|B4||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4317266|NCT00473655|4143945|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4317267|NCT00473655|4143946|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4317268|NCT00473655|4143947|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4317269|NCT00473655|4143944|B4|Age||Age||Years|Mean|52.4|52.4|Standard Deviation|12.74|12.74|||
4317270|NCT00473655|4143945|B3|Age||Age||Years|Mean|51.48|51.48|Standard Deviation|13.47|13.47|||
4317271|NCT00473655|4143946|B2|Age||Age||Years|Mean|53.14|53.14|Standard Deviation|12|12.0|||
4317272|NCT00473655|4143947|B1|Age||Age||Years|Mean|52.57|52.57|Standard Deviation|12.77|12.77|||
4317273|NCT00473642|4143981|B4|United States||Region of Enrollment||participants|Number|31|31.0||||||
4317274|NCT00473642|4143982|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4317275|NCT00473642|4143983|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4317276|NCT00473642|4143984|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4317277|NCT00473642|4143981|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4317278|NCT00473642|4143982|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4317279|NCT00473642|4143983|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4317280|NCT00473642|4143984|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4317281|NCT00473642|4143981|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4317282|NCT00473642|4143982|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4317283|NCT00473642|4143983|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4317284|NCT00473642|4143984|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4317285|NCT00473642|4143981|B4|||Age||years|Mean|74|74.0|Standard Deviation|2.7|2.7|||
4317286|NCT00473642|4143982|B3|||Age||years|Mean|76.3|76.3|Standard Deviation|2.8|2.8|||
4317287|NCT00473642|4143983|B2|||Age||years|Mean|73.4|73.4|Standard Deviation|2.1|2.1|||
4317288|NCT00473642|4143984|B1|||Age||years|Mean|76.9|76.9|Standard Deviation|3.1|3.1|||
4317289|NCT00473642|4143981|B4||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4317290|NCT00473642|4143982|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4317291|NCT00473642|4143983|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4317292|NCT00473642|4143984|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4317293|NCT00473642|4143981|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4317294|NCT00473642|4143982|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4317295|NCT00473642|4143983|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4317296|NCT00473642|4143984|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4317297|NCT00473642|4143981|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4317298|NCT00473642|4143982|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4317299|NCT00473642|4143983|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4317300|NCT00473642|4143984|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4317301|NCT00473590|4143994|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4317302|NCT00473590|4143995|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4317303|NCT00473590|4143996|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4317304|NCT00473590|4143994|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4317305|NCT00473590|4143995|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4317306|NCT00473590|4143996|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4317307|NCT00473590|4143994|B3|||Age||years|Mean|65.2|65.2|Standard Deviation|9.2|9.2|||
4317308|NCT00473590|4143995|B2|||Age||years|Mean|65.6|65.6|Standard Deviation|9.3|9.3|||
4317309|NCT00473590|4143996|B1|||Age||years|Mean|64.9|64.9|Standard Deviation|9.2|9.2|||
4317310|NCT00473564|4144013|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317311|NCT00473564|4144013|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317312|NCT00473564|4144013|B1||White|Race (NIH/OMB)||Participants|Count of Participants|154|154.0||||||
4317313|NCT00473564|4144013|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4317314|NCT00473564|4144013|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4317315|NCT00473564|4144013|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317316|NCT00473564|4144013|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317317|NCT00473564|4144013|B1||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4317318|NCT00473564|4144013|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4317319|NCT00473564|4144013|B1||>=65 years|Age||Participants|Count of Participants|57|57.0||||||
4317320|NCT00473564|4144013|B1||Between 18 and 65 years|Age||Participants|Count of Participants|113|113.0||||||
4317321|NCT00473564|4144013|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4317322|NCT00473512|4144018|B6||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4317323|NCT00473512|4144019|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4317324|NCT00473512|4144020|B4||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4317325|NCT00473512|4144021|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4317326|NCT00473512|4144022|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4317327|NCT00473512|4144023|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4317328|NCT00473512|4144018|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4317329|NCT00473512|4144019|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4317330|NCT00473512|4144020|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4317331|NCT00473512|4144021|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4317332|NCT00473512|4144022|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4317333|NCT00473512|4144023|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4317334|NCT00473512|4144018|B6|||Age||years|Mean|69.9|69.9|Standard Deviation|8.04|8.04|||
4317335|NCT00473512|4144019|B5|||Age||years|Mean|68|68.0|Standard Deviation|12.17|12.17|||
4317336|NCT00473512|4144020|B4|||Age||years|Mean|70.4|70.4|Standard Deviation|7.42|7.42|||
4317337|NCT00473512|4144021|B3|||Age||years|Mean|76|76.0|Standard Deviation|8.19|8.19|||
4317338|NCT00473512|4144022|B2|||Age||years|Mean|68.7|68.7|Standard Deviation|10.41|10.41|||
4317339|NCT00473512|4144023|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|9.07|9.07|||
4317340|NCT00473434|4144085|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4317341|NCT00473434|4144085|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4317342|NCT00473434|4144085|B1|||Age||years|Mean|37.0|37.0|Standard Deviation|10.4|10.4|||
4317343|NCT00473382|4144147|B4||Male|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
4317344|NCT00473382|4144148|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4317345|NCT00473382|4144149|B2||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4317346|NCT00473382|4144150|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4317347|NCT00473382|4144147|B4||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4317348|NCT00473382|4144148|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4317349|NCT00473382|4144149|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4317350|NCT00473382|4144150|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4317351|NCT00473382|4144147|B4|||Age||years|Mean|62.7|62.7|Standard Deviation|10.7|10.7|||
4317352|NCT00473382|4144148|B3|||Age||years|Mean|63.5|63.5|Standard Deviation|10.8|10.8|||
4317353|NCT00473382|4144149|B2|||Age||years|Mean|61.8|61.8|Standard Deviation|10.1|10.1|||
4317354|NCT00473382|4144150|B1|||Age||years|Mean|62.7|62.7|Standard Deviation|11.1|11.1|||
4317355|NCT00473330|4144207|B4||Male|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4317356|NCT00473330|4144208|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4317357|NCT00473330|4144209|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4317358|NCT00473330|4144210|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4317359|NCT00473330|4144207|B4||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4317360|NCT00473330|4144208|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4317361|NCT00473330|4144209|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4317362|NCT00473330|4144210|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4317363|NCT00473330|4144207|B4|||Age||years|Mean|62.1|62.1|Standard Deviation|9.6|9.6|||
4317364|NCT00473330|4144208|B3|||Age||years|Mean|61.8|61.8|Standard Deviation|9.8|9.8|||
4317365|NCT00473330|4144209|B2|||Age||years|Mean|62.8|62.8|Standard Deviation|10.0|10.0|||
4317366|NCT00473330|4144210|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|8.9|8.9|||
4317367|NCT00473265|4144267|B1|United States||Region of Enrollment||participants|Number|68|68.0||||||
4317368|NCT00473265|4144267|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4317369|NCT00473265|4144267|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4317370|NCT00473265|4144267|B1|||Age||years|Mean|45|45.0|Standard Deviation|27|27.0|||
4317371|NCT00473265|4144267|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4317372|NCT00473265|4144267|B1||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4317373|NCT00473265|4144267|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4317374|NCT00473083|4144276|B4|Canada||Region of Enrollment||participants|Number|150|150.0||||||
4317375|NCT00473083|4144277|B3|Canada||Region of Enrollment||participants|Number|50|50.0||||||
4317376|NCT00473083|4144278|B2|Canada||Region of Enrollment||participants|Number|50|50.0||||||
4317377|NCT00473083|4144279|B1|Canada||Region of Enrollment||participants|Number|50|50.0||||||
4317378|NCT00473083|4144276|B4||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4317379|NCT00473083|4144277|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4317380|NCT00473083|4144278|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4317381|NCT00473083|4144279|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4317382|NCT00473083|4144276|B4||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4317383|NCT00473083|4144277|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4317384|NCT00473083|4144278|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4317385|NCT00473083|4144279|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4317386|NCT00473083|4144276|B4|||Age||years|Median|64.9|64.9|Full Range|||30.0|83.0|
4317387|NCT00473083|4144277|B3|||Age||years|Median|64.4|64.4|Full Range|||46.0|82.0|
4317388|NCT00473083|4144278|B2|||Age||years|Median|65.9|65.9|Full Range|||48.0|83.0|
4317389|NCT00473083|4144279|B1|||Age||years|Median|64.3|64.3|Full Range|||30.0|79.0|
4317390|NCT00472849|4144307|B3|United States||Region of Enrollment||participants|Number|90|90.0||||||
4317391|NCT00472849|4144308|B2|United States||Region of Enrollment||participants|Number|78|78.0||||||
4317392|NCT00472849|4144309|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4317393|NCT00472849|4144307|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4317394|NCT00472849|4144308|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4317395|NCT00472849|4144309|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4317396|NCT00472849|4144307|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4317397|NCT00472849|4144308|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4317398|NCT00472849|4144309|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4317399|NCT00472849|4144307|B3|||Age||Years|Median|63|63.0|Full Range|||40.0|81.0|
4317400|NCT00472849|4144308|B2|||Age||Years|Median|63|63.0|Full Range|||40.0|81.0|
4317401|NCT00472849|4144309|B1|||Age||Years|Median|65|65.0|Full Range|||46.0|76.0|
4317402|NCT00472797|4144316|B3|United States||Region of Enrollment||participants|Number|232.0|232.0||||||
4317403|NCT00472797|4144317|B2|United States||Region of Enrollment||participants|Number|113|113.0||||||
4317404|NCT00472797|4144318|B1|United States||Region of Enrollment||participants|Number|119|119.0||||||
4317405|NCT00472797|4144316|B3||Male|Sex: Female, Male||Participants|Count of Participants|52.0|52.0||||||
4317406|NCT00472797|4144317|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4317407|NCT00472797|4144318|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4317408|NCT00472797|4144316|B3||Female|Sex: Female, Male||Participants|Count of Participants|180.0|180.0||||||
4317409|NCT00472797|4144317|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4317410|NCT00472797|4144318|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4317411|NCT00472797|4144316|B3|||Age||years|Mean|43.7|43.7|Standard Deviation|9.2|9.2|||
4317412|NCT00472797|4144317|B2|||Age||years|Mean|42.8|42.8|Standard Deviation|9.4|9.4|||
4317413|NCT00472797|4144318|B1|||Age||years|Mean|44.6|44.6|Standard Deviation|9.0|9.0|||
4317414|NCT00472797|4144316|B3||>=65 years|Age||Participants|Count of Participants|0.0|0.0||||||
4317415|NCT00472797|4144317|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4317416|NCT00472797|4144318|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4317417|NCT00472797|4144316|B3||Between 18 and 65 years|Age||Participants|Count of Participants|232.0|232.0||||||
4317418|NCT00472797|4144317|B2||Between 18 and 65 years|Age||Participants|Count of Participants|113|113.0||||||
4317419|NCT00472797|4144318|B1||Between 18 and 65 years|Age||Participants|Count of Participants|119|119.0||||||
4317420|NCT00472797|4144316|B3||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4317421|NCT00472797|4144317|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4317422|NCT00472797|4144318|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4317423|NCT00472732|4144343|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
4317424|NCT00472732|4144344|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4317425|NCT00472732|4144345|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4317426|NCT00472732|4144343|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317427|NCT00472732|4144344|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317428|NCT00472732|4144345|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317429|NCT00472732|4144343|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317430|NCT00472732|4144344|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317431|NCT00472732|4144345|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317432|NCT00472732|4144343|B3||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4317433|NCT00472732|4144344|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4317434|NCT00472732|4144345|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4317435|NCT00472732|4144343|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4317436|NCT00472732|4144344|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4317437|NCT00472732|4144345|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317438|NCT00472732|4144343|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317439|NCT00472732|4144344|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317440|NCT00472732|4144345|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317441|NCT00472732|4144343|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4317442|NCT00472732|4144344|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4317443|NCT00472732|4144345|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4317444|NCT00472732|4144343|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317445|NCT00472732|4144344|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317446|NCT00472732|4144345|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317447|NCT00472732|4144343|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317448|NCT00472732|4144344|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317449|NCT00472732|4144345|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317450|NCT00472732|4144343|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4317451|NCT00472732|4144344|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4317452|NCT00472732|4144345|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4317453|NCT00472732|4144343|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4317454|NCT00472732|4144344|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4317455|NCT00472732|4144345|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4317456|NCT00472732|4144343|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4317457|NCT00472732|4144344|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4317458|NCT00472732|4144345|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4317459|NCT00472732|4144343|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4317460|NCT00472732|4144344|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4317461|NCT00472732|4144345|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4317462|NCT00472732|4144343|B3|Age||Age, Customized||years|Mean|32.46|32.46|Full Range|||18.0|59.0|
4317463|NCT00472732|4144344|B2|Age||Age, Customized||years|Mean|32.38|32.38|Full Range|||18.0|59.0|
4317464|NCT00472732|4144345|B1|Age||Age, Customized||years|Mean|32.55|32.55|Full Range|||18.0|58.0|
4317465|NCT00472641|4144356|B1|||Waist Circumference||inches|Mean|41.7|41.7|Standard Deviation|4.4|4.4|||
4317466|NCT00472641|4144356|B1|||BMI||kg/m^2|Mean|32.9|32.9|Standard Deviation|3.5|3.5|||
4317467|NCT00472641|4144356|B1|||Weight||pounds|Mean|205.2|205.2|Standard Deviation|31.7|31.7|||
4317468|NCT00472641|4144356|B1||Bipolar NOS|Bipolar Subtype|"Bipolar I is characterized by one or more manic episodes or mixed episodes. Typically a person will experience periods of depression as well. Bipolar I disorder is marked by manic episodes. Bipolar II disorder is diagnosed after one or more major depressive episodes and at least one episode of hypomania, with possible periods of level mood between episodes.~Bipolar disorder that does not follow a particular pattern is called bipolar disorder Not Otherwise Specified (NOS).~Diagnosis follows criteria put forth by the DSM-4"|Participants|Count of Participants|1|1.0||||||
4317469|NCT00472641|4144356|B1||Bipolar 2|Bipolar Subtype|"Bipolar I is characterized by one or more manic episodes or mixed episodes. Typically a person will experience periods of depression as well. Bipolar I disorder is marked by manic episodes. Bipolar II disorder is diagnosed after one or more major depressive episodes and at least one episode of hypomania, with possible periods of level mood between episodes.~Bipolar disorder that does not follow a particular pattern is called bipolar disorder Not Otherwise Specified (NOS).~Diagnosis follows criteria put forth by the DSM-4"|Participants|Count of Participants|14|14.0||||||
4317470|NCT00472641|4144356|B1||Bipolar 1|Bipolar Subtype|"Bipolar I is characterized by one or more manic episodes or mixed episodes. Typically a person will experience periods of depression as well. Bipolar I disorder is marked by manic episodes. Bipolar II disorder is diagnosed after one or more major depressive episodes and at least one episode of hypomania, with possible periods of level mood between episodes.~Bipolar disorder that does not follow a particular pattern is called bipolar disorder Not Otherwise Specified (NOS).~Diagnosis follows criteria put forth by the DSM-4"|Participants|Count of Participants|10|10.0||||||
4317471|NCT00472641|4144356|B1|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4317472|NCT00472641|4144356|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4317473|NCT00472641|4144356|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4317474|NCT00472641|4144356|B1|||Age||years|Mean|46.8|46.8|Standard Deviation|11.2|11.2|||
4317475|NCT00472576|4144361|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4317476|NCT00472576|4144362|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4317477|NCT00472576|4144363|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4317478|NCT00472576|4144361|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4317479|NCT00472576|4144362|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4317480|NCT00472576|4144363|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4317481|NCT00472576|4144361|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4317482|NCT00472576|4144362|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4317483|NCT00472576|4144363|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4317484|NCT00472576|4144361|B3|||Age||years|Mean|43|43.0|Standard Deviation|13|13.0|||
4317485|NCT00472576|4144362|B2|||Age||years|Mean|36|36.0|Standard Deviation|12|12.0|||
4317486|NCT00472576|4144363|B1|||Age||years|Mean|55|55.0|Standard Deviation|0|0.0|||
4317487|NCT00472576|4144361|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4317488|NCT00472576|4144362|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4317489|NCT00472576|4144363|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4317490|NCT00472576|4144361|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4317491|NCT00472576|4144362|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4317492|NCT00472576|4144363|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4317493|NCT00472576|4144361|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4317494|NCT00472576|4144362|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4317495|NCT00472576|4144363|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4317496|NCT00472446|4144372|B5|||specimen weight||gram|Mean|47.0|47.0|Standard Deviation|43.4|43.4|||
4317497|NCT00472446|4144373|B4|||specimen weight||gram|Mean|39.8|39.8|Standard Deviation|41.2|41.2|||
4317498|NCT00472446|4144374|B3|||specimen weight||gram|Mean|51.0|51.0|Standard Deviation|43.6|43.6|||
4317499|NCT00472446|4144375|B2|||specimen weight||gram|Mean|42.2|42.2|Standard Deviation|32.0|32.0|||
4317500|NCT00472446|4144376|B1|||specimen weight||gram|Mean|60.4|60.4|Standard Deviation|55.1|55.1|||
4317501|NCT00472446|4144372|B5|||duration of surgery||minutes|Mean|135.7|135.7|Standard Deviation|45.7|45.7|||
4317502|NCT00472446|4144373|B4|||duration of surgery||minutes|Mean|141.9|141.9|Standard Deviation|50.4|50.4|||
4317503|NCT00472446|4144374|B3|||duration of surgery||minutes|Mean|129.6|129.6|Standard Deviation|48.1|48.1|||
4317504|NCT00472446|4144375|B2|||duration of surgery||minutes|Mean|130.5|130.5|Standard Deviation|37.0|37.0|||
4317505|NCT00472446|4144376|B1|||duration of surgery||minutes|Mean|140.8|140.8|Standard Deviation|48.1|48.1|||
4317506|NCT00472446|4144372|B5|bilateral||resection location||participants|Number|69|69.0||||||
4317507|NCT00472446|4144373|B4|bilateral||resection location||participants|Number|13|13.0||||||
4317508|NCT00472446|4144374|B3|bilateral||resection location||participants|Number|14|14.0||||||
4317509|NCT00472446|4144375|B2|bilateral||resection location||participants|Number|19|19.0||||||
4317510|NCT00472446|4144376|B1|bilateral||resection location||participants|Number|23|23.0||||||
4317511|NCT00472446|4144372|B5|unilateral||resection location||participants|Number|90|90.0||||||
4317512|NCT00472446|4144373|B4|unilateral||resection location||participants|Number|26|26.0||||||
4317513|NCT00472446|4144374|B3|unilateral||resection location||participants|Number|24|24.0||||||
4317514|NCT00472446|4144375|B2|unilateral||resection location||participants|Number|22|22.0||||||
4317515|NCT00472446|4144376|B1|unilateral||resection location||participants|Number|18|18.0||||||
4317516|NCT00472446|4144372|B5|Switzerland||Region of Enrollment||participants|Number|159|159.0||||||
4317517|NCT00472446|4144373|B4|Switzerland||Region of Enrollment||participants|Number|39|39.0||||||
4317518|NCT00472446|4144374|B3|Switzerland||Region of Enrollment||participants|Number|38|38.0||||||
4317519|NCT00472446|4144375|B2|Switzerland||Region of Enrollment||participants|Number|41|41.0||||||
4317520|NCT00472446|4144376|B1|Switzerland||Region of Enrollment||participants|Number|41|41.0||||||
4317521|NCT00472446|4144372|B5||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4317522|NCT00472446|4144373|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4317523|NCT00472446|4144374|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4317524|NCT00472446|4144375|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4317525|NCT00472446|4144376|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4317526|NCT00472446|4144372|B5||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4317527|NCT00472446|4144373|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4317528|NCT00472446|4144374|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4317529|NCT00472446|4144375|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4317530|NCT00472446|4144376|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4317531|NCT00472446|4144372|B5|||Age||years|Mean|48.2|48.2|Standard Deviation|13.7|13.7|||
4317532|NCT00472446|4144373|B4|||Age||years|Mean|47.3|47.3|Standard Deviation|14.4|14.4|||
4317533|NCT00472446|4144374|B3|||Age||years|Mean|49.9|49.9|Standard Deviation|13.5|13.5|||
4317534|NCT00472446|4144375|B2|||Age||years|Mean|46.5|46.5|Standard Deviation|13.3|13.3|||
4317535|NCT00472446|4144376|B1|||Age||years|Mean|49.1|49.1|Standard Deviation|14.0|14.0|||
4317536|NCT00472420|4144409|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4317537|NCT00472420|4144409|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4317538|NCT00472420|4144409|B1|||Age|47 participants were included in the calculation of age.|years|Median|70.20|70.2|Full Range|||44.46|82.31|
4317539|NCT00472303|4144415|B3|Sweden||Region of Enrollment||participants|Number|5|5.0||||||
4317540|NCT00472303|4144416|B2|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
4317541|NCT00472303|4144417|B1|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
4317542|NCT00472303|4144415|B3|Spain||Region of Enrollment||participants|Number|24|24.0||||||
4317543|NCT00472303|4144416|B2|Spain||Region of Enrollment||participants|Number|6|6.0||||||
4317544|NCT00472303|4144417|B1|Spain||Region of Enrollment||participants|Number|18|18.0||||||
4317545|NCT00472303|4144415|B3|Slovakia||Region of Enrollment||participants|Number|5|5.0||||||
4317546|NCT00472303|4144416|B2|Slovakia||Region of Enrollment||participants|Number|1|1.0||||||
4317547|NCT00472303|4144417|B1|Slovakia||Region of Enrollment||participants|Number|4|4.0||||||
4317548|NCT00472303|4144415|B3|Serbia||Region of Enrollment||participants|Number|56|56.0||||||
4317549|NCT00472303|4144416|B2|Serbia||Region of Enrollment||participants|Number|19|19.0||||||
4317550|NCT00472303|4144417|B1|Serbia||Region of Enrollment||participants|Number|37|37.0||||||
4317551|NCT00472303|4144415|B3|Russian Federation||Region of Enrollment||participants|Number|77|77.0||||||
4317552|NCT00472303|4144416|B2|Russian Federation||Region of Enrollment||participants|Number|26|26.0||||||
4317553|NCT00472303|4144417|B1|Russian Federation||Region of Enrollment||participants|Number|51|51.0||||||
4317554|NCT00472303|4144415|B3|Romania||Region of Enrollment||participants|Number|68|68.0||||||
4317555|NCT00472303|4144416|B2|Romania||Region of Enrollment||participants|Number|21|21.0||||||
4317556|NCT00472303|4144417|B1|Romania||Region of Enrollment||participants|Number|47|47.0||||||
4317557|NCT00472303|4144415|B3|Poland||Region of Enrollment||participants|Number|37|37.0||||||
4317558|NCT00472303|4144416|B2|Poland||Region of Enrollment||participants|Number|13|13.0||||||
4317559|NCT00472303|4144417|B1|Poland||Region of Enrollment||participants|Number|24|24.0||||||
4317560|NCT00472303|4144415|B3|Moldova, Republic of||Region of Enrollment||participants|Number|19|19.0||||||
4317561|NCT00472303|4144416|B2|Moldova, Republic of||Region of Enrollment||participants|Number|5|5.0||||||
4317562|NCT00472303|4144417|B1|Moldova, Republic of||Region of Enrollment||participants|Number|14|14.0||||||
4317563|NCT00472303|4144415|B3|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4317564|NCT00472303|4144416|B2|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4317565|NCT00472303|4144417|B1|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4317566|NCT00472303|4144415|B3|Hungary||Region of Enrollment||participants|Number|61|61.0||||||
4317567|NCT00472303|4144416|B2|Hungary||Region of Enrollment||participants|Number|21|21.0||||||
4317568|NCT00472303|4144417|B1|Hungary||Region of Enrollment||participants|Number|40|40.0||||||
4317569|NCT00472303|4144415|B3|Germany||Region of Enrollment||participants|Number|47|47.0||||||
4317570|NCT00472303|4144416|B2|Germany||Region of Enrollment||participants|Number|14|14.0||||||
4317571|NCT00472303|4144417|B1|Germany||Region of Enrollment||participants|Number|33|33.0||||||
4317572|NCT00472303|4144415|B3|France||Region of Enrollment||participants|Number|1|1.0||||||
4317573|NCT00472303|4144416|B2|France||Region of Enrollment||participants|Number|0|0.0||||||
4317574|NCT00472303|4144417|B1|France||Region of Enrollment||participants|Number|1|1.0||||||
4317575|NCT00472303|4144415|B3|Czech Republic||Region of Enrollment||participants|Number|15|15.0||||||
4317576|NCT00472303|4144416|B2|Czech Republic||Region of Enrollment||participants|Number|3|3.0||||||
4317577|NCT00472303|4144417|B1|Czech Republic||Region of Enrollment||participants|Number|12|12.0||||||
4317578|NCT00472303|4144415|B3|Croatia||Region of Enrollment||participants|Number|38|38.0||||||
4317579|NCT00472303|4144416|B2|Croatia||Region of Enrollment||participants|Number|11|11.0||||||
4317580|NCT00472303|4144417|B1|Croatia||Region of Enrollment||participants|Number|27|27.0||||||
4317581|NCT00472303|4144415|B3|Bulgaria||Region of Enrollment||participants|Number|34|34.0||||||
4317582|NCT00472303|4144416|B2|Bulgaria||Region of Enrollment||participants|Number|13|13.0||||||
4317583|NCT00472303|4144417|B1|Bulgaria||Region of Enrollment||participants|Number|21|21.0||||||
4317584|NCT00472303|4144415|B3|Austria||Region of Enrollment||participants|Number|8|8.0||||||
4317585|NCT00472303|4144416|B2|Austria||Region of Enrollment||participants|Number|3|3.0||||||
4317586|NCT00472303|4144417|B1|Austria||Region of Enrollment||participants|Number|5|5.0||||||
4317587|NCT00472303|4144415|B3||Male|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
4317588|NCT00472303|4144416|B2||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4317589|NCT00472303|4144417|B1||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4317590|NCT00472303|4144415|B3||Female|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
4317591|NCT00472303|4144416|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4317592|NCT00472303|4144417|B1||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4317593|NCT00472303|4144415|B3|||Age||years|Mean|60.4|60.4|Standard Deviation|10.35|10.35|||
4317594|NCT00472303|4144416|B2|||Age||years|Mean|61.5|61.5|Standard Deviation|10.21|10.21|||
4317595|NCT00472303|4144417|B1|||Age||years|Mean|59.8|59.8|Standard Deviation|10.39|10.39|||
4317596|NCT00472303|4144415|B3||>=65 years|Age||Participants|Count of Participants|170|170.0||||||
4317597|NCT00472303|4144416|B2||>=65 years|Age||Participants|Count of Participants|56|56.0||||||
4317598|NCT00472303|4144417|B1||>=65 years|Age||Participants|Count of Participants|114|114.0||||||
4317599|NCT00472303|4144415|B3||Between 18 and 65 years|Age||Participants|Count of Participants|326|326.0||||||
4317600|NCT00472303|4144416|B2||Between 18 and 65 years|Age||Participants|Count of Participants|102|102.0||||||
4317601|NCT00472303|4144417|B1||Between 18 and 65 years|Age||Participants|Count of Participants|224|224.0||||||
4317602|NCT00472303|4144415|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4317603|NCT00472303|4144416|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4317604|NCT00472303|4144417|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4317605|NCT00472290|4144482|B1|||Baseline Platelet Count||10^9/L|Mean|27.6|27.6|Standard Deviation|15.5|15.5|||
4317606|NCT00472290|4144482|B1|>=3: Capable of only limited selfcare or worse||Eastern Cooperative Oncology (ECOG) performance status||Participants|Number|0|0.0||||||
4317607|NCT00472290|4144482|B1|2: Capable of selfcare but unable to work||Eastern Cooperative Oncology (ECOG) performance status||Participants|Number|5|5.0||||||
4317608|NCT00472290|4144482|B1|1: Can carry out light or sedentary work||Eastern Cooperative Oncology (ECOG) performance status||Participants|Number|25|25.0||||||
4317609|NCT00472290|4144482|B1|0: Fully active||Eastern Cooperative Oncology (ECOG) performance status||Participants|Number|42|42.0||||||
4317610|NCT00472290|4144482|B1|MDS associated with isolated del(5q)||Myelodysplastic Syndromes World Health Organization Classification at Study Screening||Participants|Number|0|0.0||||||
4317611|NCT00472290|4144482|B1|MDS-U: Myelodysplastic syndrome – unclassified||Myelodysplastic Syndromes World Health Organization Classification at Study Screening||Participants|Number|15|15.0||||||
4317612|NCT00472290|4144482|B1|RCMD-RS: RCMD and ringed sideroblasts||Myelodysplastic Syndromes World Health Organization Classification at Study Screening||Participants|Number|3|3.0||||||
4317613|NCT00472290|4144482|B1|RCMD:Refractory cytopenia w multilineage dysplasia||Myelodysplastic Syndromes World Health Organization Classification at Study Screening||Participants|Number|24|24.0||||||
4317614|NCT00472290|4144482|B1|RAEB-2: Refractory Anemia with Excess Blasts-2||Myelodysplastic Syndromes World Health Organization Classification at Study Screening||Participants|Number|2|2.0||||||
4317615|NCT00472290|4144482|B1|RAEB-1: Refractory Anemia with Excess Blasts-1||Myelodysplastic Syndromes World Health Organization Classification at Study Screening||Participants|Number|7|7.0||||||
4317616|NCT00472290|4144482|B1|RARS: Refractory Anemia with Ringed Sideroblasts||Myelodysplastic Syndromes World Health Organization Classification at Study Screening||Participants|Number|1|1.0||||||
4317617|NCT00472290|4144482|B1|RA: Refractory Anemia||Myelodysplastic Syndromes World Health Organization Classification at Study Screening||Participants|Number|20|20.0||||||
4317618|NCT00472290|4144482|B1|Other||Race/Ethnicity, Customized||Participant|Number|4|4.0||||||
4317619|NCT00472290|4144482|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participant|Number|3|3.0||||||
4317620|NCT00472290|4144482|B1|Black or African American||Race/Ethnicity, Customized||Participant|Number|4|4.0||||||
4317621|NCT00472290|4144482|B1|White or Caucasian||Race/Ethnicity, Customized||Participant|Number|61|61.0||||||
4317622|NCT00472290|4144482|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4317623|NCT00472290|4144482|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4317624|NCT00472290|4144482|B1|||Age||Years|Mean|68.9|68.9|Standard Deviation|11.1|11.1|||
4317625|NCT00472199|4144492|B3||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4317626|NCT00472199|4144493|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4317627|NCT00472199|4144494|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4317628|NCT00472199|4144492|B3||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4317629|NCT00472199|4144493|B2||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4317630|NCT00472199|4144494|B1||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4317631|NCT00472199|4144492|B3|||Age||years|Mean|56.8|56.8|Standard Deviation|12.1|12.1|||
4317632|NCT00472199|4144493|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|11.4|11.4|||
4317633|NCT00472199|4144494|B1|||Age||years|Mean|57.9|57.9|Standard Deviation|12.7|12.7|||
4317634|NCT00472082|4144561|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4317635|NCT00472082|4144561|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4317636|NCT00472082|4144561|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4317637|NCT00472082|4144561|B1|||Age||years|Mean|48|48.0|Standard Deviation|21|21.0|||
4317638|NCT00472082|4144561|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4317639|NCT00472082|4144561|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4317640|NCT00472082|4144561|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4317641|NCT00472056|4144566|B5|United States||Region of Enrollment||participants|Number|93|93.0||||||
4317642|NCT00472056|4144567|B4|United States||Region of Enrollment||participants|Number|17|17.0||||||
4317643|NCT00472056|4144568|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4317644|NCT00472056|4144569|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4317645|NCT00472056|4144570|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4317646|NCT00472056|4144566|B5||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4317647|NCT00472056|4144567|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4317648|NCT00472056|4144568|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4317649|NCT00472056|4144569|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4317650|NCT00472056|4144570|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4317651|NCT00472056|4144566|B5||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4317652|NCT00472056|4144567|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4317653|NCT00472056|4144568|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4317654|NCT00472056|4144569|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4317655|NCT00472056|4144570|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4317656|NCT00472056|4144566|B5|||Age||years|Mean|61|61.0|Standard Deviation|11.17466|11.17466|||
4317657|NCT00472056|4144567|B4|||Age||years|Mean|69.8|69.8|Standard Deviation|3.43211|3.43211|||
4317658|NCT00472056|4144568|B3|||Age||years|Mean|53.3|53.3|Standard Deviation|11.93155|11.93155|||
4317659|NCT00472056|4144569|B2|||Age||years|Mean|70.2|70.2|Standard Deviation|3.50522|3.50522|||
4317660|NCT00472056|4144570|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|7.58288|7.58288|||
4317661|NCT00472056|4144566|B5||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4317662|NCT00472056|4144567|B4||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4317663|NCT00472056|4144568|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4317664|NCT00472056|4144569|B2||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4317665|NCT00472056|4144570|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4317666|NCT00472056|4144566|B5||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4317667|NCT00472056|4144567|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4317668|NCT00472056|4144568|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4317669|NCT00472056|4144569|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4317670|NCT00472056|4144570|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4317671|NCT00472056|4144566|B5||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4317672|NCT00472056|4144567|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4317673|NCT00472056|4144568|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4317674|NCT00472056|4144569|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4317675|NCT00472056|4144570|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4317676|NCT00472030|4144581|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4317677|NCT00472030|4144583|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4317678|NCT00472030|4144581|B3|Male||Gender||participants|Number|0|0.0||||||
4317679|NCT00472030|4144583|B1|Male||Gender||participants|Number|0|0.0||||||
4317680|NCT00472030|4144581|B3|Female||Gender||participants|Number|2|2.0||||||
4317681|NCT00472030|4144583|B1|Female||Gender||participants|Number|2|2.0||||||
4317682|NCT00472030|4144581|B3|||Age||years|Mean|78|78.0|Standard Deviation|0|0.0|||
4317683|NCT00472030|4144583|B1|||Age||years|Mean|78|78.0|Standard Deviation|0|0.0|||
4317684|NCT00472030|4144581|B3|>=65 years||Age||participants|Number|2|2.0||||||
4317685|NCT00472030|4144583|B1|>=65 years||Age||participants|Number|2|2.0||||||
4317686|NCT00472030|4144581|B3|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
4317687|NCT00472030|4144583|B1|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
4317688|NCT00472030|4144581|B3|<=18 years||Age||participants|Number|0|0.0||||||
4317689|NCT00472030|4144583|B1|<=18 years||Age||participants|Number|0|0.0||||||
4317690|NCT00471822|4144600|B1||Male|Sex: Female, Male||Participants|Count of Participants|5276|5276.0||||||
4317691|NCT00471822|4144600|B1||Female|Sex: Female, Male||Participants|Count of Participants|4429|4429.0||||||
4317692|NCT00471822|4144600|B1|||Age||Years|Mean|2.05|2.05|Standard Deviation|1.41|1.41|||
4317693|NCT00471718|4144608|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4317694|NCT00471718|4144608|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4317695|NCT00471718|4144608|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4317696|NCT00471718|4144608|B1|||Age||years|Mean|65|65.0|Standard Deviation|1|1.0|||
4317697|NCT00471718|4144608|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4317698|NCT00471718|4144608|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4317699|NCT00471718|4144608|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4317700|NCT00471705|4144617|B4|Colombia||Region of Enrollment||participants|Number|437|437.0||||||
4317701|NCT00471705|4144618|B3|Colombia||Region of Enrollment||participants|Number|149|149.0||||||
4317702|NCT00471705|4144619|B2|Colombia||Region of Enrollment||participants|Number|143|143.0||||||
4317703|NCT00471705|4144620|B1|Colombia||Region of Enrollment||participants|Number|145|145.0||||||
4317704|NCT00471705|4144617|B4||Male|Sex: Female, Male||Participants|Count of Participants|437|437.0||||||
4317705|NCT00471705|4144618|B3||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4317706|NCT00471705|4144619|B2||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4317707|NCT00471705|4144620|B1||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4317708|NCT00471705|4144617|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4317709|NCT00471705|4144618|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4317710|NCT00471705|4144619|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4317711|NCT00471705|4144620|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4317712|NCT00471705|4144617|B4|||Age||years|Median|23|23.0|Inter-Quartile Range|||19.0|38.0|
4317713|NCT00471705|4144618|B3|||Age||years|Median|23|23.0|Inter-Quartile Range|||19.0|39.0|
4317714|NCT00471705|4144619|B2|||Age||years|Median|23|23.0|Inter-Quartile Range|||19.0|38.0|
4317715|NCT00471705|4144620|B1|||Age||years|Median|23|23.0|Inter-Quartile Range|||19.0|37.0|
4317716|NCT00471536|4144636|B1|Australia||Region of Enrollment||participants|Number|2|2.0||||||
4317717|NCT00471536|4144636|B1|Hong Kong||Region of Enrollment||participants|Number|2|2.0||||||
4317718|NCT00471536|4144636|B1|Korea, Republic of||Region of Enrollment||participants|Number|1|1.0||||||
4317719|NCT00471536|4144636|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4317720|NCT00471536|4144636|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4317721|NCT00471536|4144636|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4317722|NCT00471536|4144636|B1|||Age||years|Median|66|66.0|Full Range|||42.0|80.0|
4317723|NCT00471497|4144645|B4||Male|Sex: Female, Male||Participants|Count of Participants|491|491.0||||||
4317724|NCT00471497|4144646|B3||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4317725|NCT00471497|4144647|B2||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4317726|NCT00471497|4144648|B1||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4317727|NCT00471497|4144645|B4||Female|Sex: Female, Male||Participants|Count of Participants|355|355.0||||||
4317728|NCT00471497|4144646|B3||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4317729|NCT00471497|4144647|B2||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4317730|NCT00471497|4144648|B1||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4317731|NCT00471497|4144645|B4|>=65 years||Age, Customized||Participants|Number|99|99.0||||||
4317732|NCT00471497|4144646|B3|>=65 years||Age, Customized||Participants|Number|28|28.0||||||
4317733|NCT00471497|4144647|B2|>=65 years||Age, Customized||Participants|Number|36|36.0||||||
4317734|NCT00471497|4144648|B1|>=65 years||Age, Customized||Participants|Number|35|35.0||||||
4317735|NCT00471497|4144645|B4|>=55 - < 65 years||Age, Customized||Participants|Number|176|176.0||||||
4317736|NCT00471497|4144646|B3|>=55 - < 65 years||Age, Customized||Participants|Number|64|64.0||||||
4317737|NCT00471497|4144647|B2|>=55 - < 65 years||Age, Customized||Participants|Number|57|57.0||||||
4317738|NCT00471497|4144648|B1|>=55 - < 65 years||Age, Customized||Participants|Number|55|55.0||||||
4317739|NCT00471497|4144645|B4|>=45 - <55 years||Age, Customized||Participants|Number|200|200.0||||||
4317740|NCT00471497|4144646|B3|>=45 - <55 years||Age, Customized||Participants|Number|65|65.0||||||
4317741|NCT00471497|4144647|B2|>=45 - <55 years||Age, Customized||Participants|Number|72|72.0||||||
4317742|NCT00471497|4144648|B1|>=45 - <55 years||Age, Customized||Participants|Number|63|63.0||||||
4317743|NCT00471497|4144645|B4|>= 35 - <45 years||Age, Customized||Participants|Number|176|176.0||||||
4317744|NCT00471497|4144646|B3|>= 35 - <45 years||Age, Customized||Participants|Number|59|59.0||||||
4317745|NCT00471497|4144647|B2|>= 35 - <45 years||Age, Customized||Participants|Number|50|50.0||||||
4317746|NCT00471497|4144648|B1|>= 35 - <45 years||Age, Customized||Participants|Number|67|67.0||||||
4317747|NCT00471497|4144645|B4|<35 years||Age, Customized||Participants|Number|195|195.0||||||
4317748|NCT00471497|4144646|B3|<35 years||Age, Customized||Participants|Number|65|65.0||13.90|13.9|||
4317749|NCT00471497|4144647|B2|<35 years||Age, Customized||Participants|Number|67|67.0||14.53|14.53|||
4317750|NCT00471497|4144648|B1|<35 years||Age, Customized||Participants|Number|63|63.0||14.34|14.34|||
4317751|NCT00471445|4144658|B3|Non-Taxane||Regimen||participants|Number|212|212.0||||||
4317752|NCT00471445|4144659|B2|Non-Taxane||Regimen||participants|Number|111|111.0||||||
4317753|NCT00471445|4144660|B1|Non-Taxane||Regimen||participants|Number|101|101.0||||||
4317754|NCT00471445|4144658|B3|Taxanes||Regimen||participants|Number|246|246.0||||||
4317755|NCT00471445|4144659|B2|Taxanes||Regimen||participants|Number|120|120.0||||||
4317756|NCT00471445|4144660|B1|Taxanes||Regimen||participants|Number|126|126.0||||||
4317757|NCT00471445|4144658|B3|Other||Site|Sum of participants in each site category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|9|9.0||||||
4317992|NCT00471237|4144739|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4317758|NCT00471445|4144659|B2|Other||Site|Sum of participants in each site category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|4|4.0||||||
4317759|NCT00471445|4144660|B1|Other||Site|Sum of participants in each site category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|5|5.0||||||
4317760|NCT00471445|4144658|B3|Cardiac||Site|Sum of participants in each site category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|1|1.0||||||
4317761|NCT00471445|4144659|B2|Cardiac||Site|Sum of participants in each site category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|1|1.0||||||
4317762|NCT00471445|4144660|B1|Cardiac||Site|Sum of participants in each site category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|0|0.0||||||
4317763|NCT00471445|4144658|B3|Bone and cartilaginous||Site|Sum of participants in each site category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|2|2.0||||||
4317764|NCT00471445|4144659|B2|Bone and cartilaginous||Site|Sum of participants in each site category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|0|0.0||||||
4317765|NCT00471445|4144660|B1|Bone and cartilaginous||Site|Sum of participants in each site category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|2|2.0||||||
4317766|NCT00471445|4144658|B3|Soft tissue sarcoma||Site|Sum of participants in each site category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|3|3.0||||||
4317767|NCT00471445|4144659|B2|Soft tissue sarcoma||Site|Sum of participants in each site category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|1|1.0||||||
4317768|NCT00471445|4144660|B1|Soft tissue sarcoma||Site|Sum of participants in each site category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|2|2.0||||||
4317769|NCT00471445|4144658|B3|Melanoma||Site|Sum of participants in each site category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|1|1.0||||||
4317770|NCT00471445|4144659|B2|Melanoma||Site|Sum of participants in each site category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|1|1.0||||||
4317771|NCT00471445|4144660|B1|Melanoma||Site|Sum of participants in each site category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|0|0.0||||||
4317772|NCT00471445|4144658|B3|Skin||Site|Sum of participants in each site category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|2|2.0||||||
4317773|NCT00471445|4144659|B2|Skin||Site|Sum of participants in each site category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|1|1.0||||||
4317774|NCT00471445|4144660|B1|Skin||Site|Sum of participants in each site category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|1|1.0||||||
4317775|NCT00471445|4144658|B3|Breast||Site|Sum of participants in each site category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|184|184.0||||||
4317776|NCT00471445|4144659|B2|Breast||Site|Sum of participants in each site category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|88|88.0||||||
4317777|NCT00471445|4144660|B1|Breast||Site|Sum of participants in each site category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|96|96.0||||||
4317778|NCT00471445|4144658|B3|Gynecologic||Site|Sum of participants in each site category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|31|31.0||||||
4317779|NCT00471445|4144659|B2|Gynecologic||Site|Sum of participants in each site category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|16|16.0||||||
4317780|NCT00471445|4144660|B1|Gynecologic||Site|Sum of participants in each site category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|15|15.0||||||
4317781|NCT00471445|4144658|B3|Genitourinary tract||Site|Sum of participants in each site category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|24|24.0||||||
4317782|NCT00471445|4144659|B2|Genitourinary tract||Site|Sum of participants in each site category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|9|9.0||||||
4317783|NCT00471445|4144660|B1|Genitourinary tract||Site|Sum of participants in each site category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|15|15.0||||||
4317784|NCT00471445|4144658|B3|GI||Site|Sum of participants in each site category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|124|124.0||||||
4317785|NCT00471445|4144659|B2|GI||Site|Sum of participants in each site category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|69|69.0||||||
4317786|NCT00471445|4144660|B1|GI||Site|Sum of participants in each site category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|55|55.0||||||
4317787|NCT00471445|4144658|B3|Lung||Site|Sum of participants in each site category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|35|35.0||||||
4317788|NCT00471445|4144659|B2|Lung||Site|Sum of participants in each site category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|23|23.0||||||
4317789|NCT00471445|4144660|B1|Lung||Site|Sum of participants in each site category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|12|12.0||||||
4317790|NCT00471445|4144658|B3|Head and neck||Site|Sum of participants in each site category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|12|12.0||||||
4317791|NCT00471445|4144659|B2|Head and neck||Site|Sum of participants in each site category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|5|5.0||||||
4317792|NCT00471445|4144660|B1|Head and neck||Site|Sum of participants in each site category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|7|7.0||||||
4317793|NCT00471445|4144658|B3|Hematologic||Site|Sum of participants in each site category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|42|42.0||||||
4317794|NCT00471445|4144659|B2|Hematologic||Site|Sum of participants in each site category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|18|18.0||||||
4317795|NCT00471445|4144660|B1|Hematologic||Site|Sum of participants in each site category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|24|24.0||||||
4317796|NCT00471445|4144658|B3|Previous radiation therapy||Previous treatment|Sum of participants in each treatment category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|223|223.0||||||
4317797|NCT00471445|4144659|B2|Previous radiation therapy||Previous treatment|Sum of participants in each treatment category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|109|109.0||||||
4317798|NCT00471445|4144660|B1|Previous radiation therapy||Previous treatment|Sum of participants in each treatment category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|114|114.0||||||
4317799|NCT00471445|4144658|B3|Previous chemotherapy||Previous treatment|Sum of participants in each treatment category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|458|458.0||||||
4317800|NCT00471445|4144659|B2|Previous chemotherapy||Previous treatment|Sum of participants in each treatment category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|231|231.0||||||
4317801|NCT00471445|4144660|B1|Previous chemotherapy||Previous treatment|Sum of participants in each treatment category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|227|227.0||||||
4317802|NCT00471445|4144658|B3|Previous surgery||Previous treatment|Sum of participants in each treatment category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|393|393.0||||||
4317803|NCT00471445|4144659|B2|Previous surgery||Previous treatment|Sum of participants in each treatment category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|195|195.0||||||
4317804|NCT00471445|4144660|B1|Previous surgery||Previous treatment|Sum of participants in each treatment category will not sum to the overall number of baseline participants since participants may belong in multiple categories.|participants|Number|198|198.0||||||
4317805|NCT00471445|4144658|B3|Widowed||Marital status||participants|Number|39|39.0||||||
4317806|NCT00471445|4144659|B2|Widowed||Marital status||participants|Number|22|22.0||||||
4317807|NCT00471445|4144660|B1|Widowed||Marital status||participants|Number|17|17.0||||||
4317808|NCT00471445|4144658|B3|Single||Marital status||participants|Number|44|44.0||||||
4317809|NCT00471445|4144659|B2|Single||Marital status||participants|Number|21|21.0||||||
4317810|NCT00471445|4144660|B1|Single||Marital status||participants|Number|23|23.0||||||
4317811|NCT00471445|4144658|B3|Separated||Marital status||participants|Number|5|5.0||||||
4317812|NCT00471445|4144659|B2|Separated||Marital status||participants|Number|3|3.0||||||
4317813|NCT00471445|4144660|B1|Separated||Marital status||participants|Number|2|2.0||||||
4317814|NCT00471445|4144658|B3|Divorced||Marital status||participants|Number|45|45.0||||||
4317815|NCT00471445|4144659|B2|Divorced||Marital status||participants|Number|25|25.0||||||
4317816|NCT00471445|4144660|B1|Divorced||Marital status||participants|Number|20|20.0||||||
4317817|NCT00471445|4144658|B3|Married||Marital status||participants|Number|325|325.0||||||
4317818|NCT00471445|4144659|B2|Married||Marital status||participants|Number|160|160.0||||||
4317819|NCT00471445|4144660|B1|Married||Marital status||participants|Number|165|165.0||||||
4317820|NCT00471445|4144658|B3|Not high school educated||Education||participants|Number|19|19.0||||||
4317821|NCT00471445|4144659|B2|Not high school educated||Education||participants|Number|12|12.0||||||
4317822|NCT00471445|4144660|B1|Not high school educated||Education||participants|Number|7|7.0||||||
4317823|NCT00471445|4144658|B3|High school graduate||Education||participants|Number|128|128.0||||||
4317824|NCT00471445|4144659|B2|High school graduate||Education||participants|Number|65|65.0||||||
4317825|NCT00471445|4144660|B1|High school graduate||Education||participants|Number|63|63.0||||||
4317826|NCT00471445|4144658|B3|Partial college training (<4 years)||Education||participants|Number|156|156.0||||||
4317827|NCT00471445|4144659|B2|Partial college training (<4 years)||Education||participants|Number|80|80.0||||||
4317828|NCT00471445|4144660|B1|Partial college training (<4 years)||Education||participants|Number|76|76.0||||||
4317829|NCT00471445|4144658|B3|Standard college or university (4 years)||Education||participants|Number|108|108.0||||||
4317830|NCT00471445|4144659|B2|Standard college or university (4 years)||Education||participants|Number|55|55.0||||||
4317831|NCT00471445|4144660|B1|Standard college or university (4 years)||Education||participants|Number|53|53.0||||||
4317832|NCT00471445|4144658|B3|Completed graduate training||Education||participants|Number|47|47.0||||||
4317833|NCT00471445|4144659|B2|Completed graduate training||Education||participants|Number|19|19.0||||||
4317834|NCT00471445|4144660|B1|Completed graduate training||Education||participants|Number|28|28.0||||||
4317835|NCT00471445|4144658|B3|United States||Region of Enrollment||participants|Number|458|458.0||||||
4317836|NCT00471445|4144659|B2|United States||Region of Enrollment||participants|Number|231|231.0||||||
4317837|NCT00471445|4144660|B1|United States||Region of Enrollment||participants|Number|227|227.0||||||
4317838|NCT00471445|4144658|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317839|NCT00471445|4144659|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317840|NCT00471445|4144660|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317841|NCT00471445|4144658|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4317842|NCT00471445|4144659|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4317843|NCT00471445|4144660|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4317844|NCT00471445|4144658|B3||White|Race (NIH/OMB)||Participants|Count of Participants|405|405.0||||||
4317845|NCT00471445|4144659|B2||White|Race (NIH/OMB)||Participants|Count of Participants|206|206.0||||||
4317846|NCT00471445|4144660|B1||White|Race (NIH/OMB)||Participants|Count of Participants|199|199.0||||||
4317847|NCT00471445|4144658|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4317848|NCT00471445|4144659|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4317849|NCT00471445|4144660|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4317850|NCT00471445|4144658|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317851|NCT00471445|4144659|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317852|NCT00471445|4144660|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317853|NCT00471445|4144658|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317854|NCT00471445|4144659|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317855|NCT00471445|4144660|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317856|NCT00471445|4144658|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317857|NCT00471445|4144659|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317858|NCT00471445|4144660|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317859|NCT00471445|4144658|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4317860|NCT00471445|4144659|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4317861|NCT00471445|4144660|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4317862|NCT00471445|4144658|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|444|444.0||||||
4317863|NCT00471445|4144659|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|224|224.0||||||
4317864|NCT00471445|4144660|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|220|220.0||||||
4317865|NCT00471445|4144658|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4317866|NCT00471445|4144659|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4317867|NCT00471445|4144660|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4317868|NCT00471445|4144658|B3||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4317869|NCT00471445|4144659|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4317870|NCT00471445|4144660|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4317871|NCT00471445|4144658|B3||Female|Sex: Female, Male||Participants|Count of Participants|327|327.0||||||
4317872|NCT00471445|4144659|B2||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4317873|NCT00471445|4144660|B1||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4317874|NCT00471445|4144658|B3|||Age||years|Mean|60.7|60.7|Standard Deviation|10.2|10.2|||
4317875|NCT00471445|4144659|B2|||Age||years|Mean|60.6|60.6|Standard Deviation|10.0|10.0|||
4317876|NCT00471445|4144660|B1|||Age||years|Mean|60.7|60.7|Standard Deviation|10.5|10.5|||
4317877|NCT00471380|4144667|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4317878|NCT00471380|4144667|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4317879|NCT00471380|4144667|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4317880|NCT00471380|4144667|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4317881|NCT00471380|4144667|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4317882|NCT00471354|4144674|B1|||Weight||kilograms (kg)|Mean|33.3|33.3|Standard Deviation|8.0|8.0|||
4317883|NCT00471354|4144674|B1|||School Grade Score (SGA) Science Score|Science school grade on a scale of 0-100, with higher scores indicating better grades/apptitude in science.|units on a scale|Mean|75.0|75.0|Standard Deviation|17.04|17.04|||
4317884|NCT00471354|4144674|B1|||School Grade Average (SGA) Total Score|School grades in the classes of Language, Math, and Science were obtained. A score between 0 and 100 was provided for each of the three classes, and the average taken to get a SGA Total Score between 0 and 100, with higher scores indicating better grades/apptitude.|units on a scale|Mean|73.9|73.9|Standard Deviation|15.82|15.82|||
4317993|NCT00471237|4144740|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4317885|NCT00471354|4144674|B1|||School Grade Average (SGA) Math Score|Math school grade on a scale of 0-100, with higher scores indicating better grades/apptitude in math.|units on a scale|Mean|72.7|72.7|Standard Deviation|19.89|19.89|||
4317886|NCT00471354|4144674|B1|||School Grade Average (SGA) Language Score|Language school grade on a scale of 0-100, with higher scores indicating better grades/apptitude in language.|units on a scale|Mean|73.8|73.8|Standard Deviation|18.35|18.35|||
4317887|NCT00471354|4144674|B1|||Height||centimeters (cm)|Mean|136.4|136.4|Standard Deviation|8.25|8.25|||
4317888|NCT00471354|4144674|B1|||Conners' Parent Rating Scale-Revised:Short Form - ADHD Index Subscale|A 27-item rating scale (0 [not at all/never] to 3 [very much true/very often]) completed by the parent to assess problem behaviors related to ADHD. ADHD Index score ranges from 0 to 36. Higher scores reflect more severe problem behaviors related to ADHD.|units on a scale|Mean|24.5|24.5|Standard Deviation|5.90|5.9|||
4317889|NCT00471354|4144674|B1|||Clinical Global Impression-Attention Deficit Hyperactivity Disorder-Severity Scale (CGI-ADHD-S)|Measures severity of the patient's overall severity of ADHD symptoms on a scale of 1-7 (1=normal, not at all ill; 7=among the most extremely ill patients).|units on a scale|Mean|5.0|5.0|Standard Deviation|0.80|0.8|||
4317890|NCT00471354|4144674|B1|||Attention-Deficit/Hyperactivity Disorder Rating Scale (ADHD-RS) Total Score|Attention-Deficit/Hyperactivity Disorder Rating Scale-IV-Parent Version:Investigator-Administered and Scored - Total Score measures the 18 symptoms contained in the DSM-IV diagnosis of Attention-Deficit/Hyperactivity Disorder. Individual item scores range from 0 (none/never or rarely) to 3 (severe/very often). Total scores range from 0 to 54.|units on a scale|Mean|35.3|35.3|Standard Deviation|7.09|7.09|||
4317891|NCT00471354|4144674|B1|East Asian||Race/Ethnicity||participants|Number|228|228.0||||||
4317892|NCT00471354|4144674|B1|Inattentive||Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Subtypes||participants|Number|82|82.0||||||
4317893|NCT00471354|4144674|B1|Combined||Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Subtypes||participants|Number|141|141.0||||||
4317894|NCT00471354|4144674|B1|Hyperactive||Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Subtypes||participants|Number|5|5.0||||||
4317895|NCT00471354|4144674|B1|Korea, Republic of||Region of Enrollment||participants|Number|70|70.0||||||
4317896|NCT00471354|4144674|B1|China||Region of Enrollment||participants|Number|82|82.0||||||
4317897|NCT00471354|4144674|B1|Taiwan||Region of Enrollment||participants|Number|76|76.0||||||
4317898|NCT00471354|4144674|B1||Male|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4317899|NCT00471354|4144674|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4317900|NCT00471354|4144674|B1|||Age||years|Mean|9.6|9.6|Standard Deviation|0.96|0.96|||
4317901|NCT00471328|4144684|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4317902|NCT00471328|4144685|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4317903|NCT00471328|4144686|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4317904|NCT00471328|4144684|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317905|NCT00471328|4144685|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317906|NCT00471328|4144686|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317907|NCT00471328|4144684|B3||White|Race (NIH/OMB)||Participants|Count of Participants|201|201.0||||||
4317908|NCT00471328|4144685|B2||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4317909|NCT00471328|4144686|B1||White|Race (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
4317910|NCT00471328|4144684|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4317911|NCT00471328|4144685|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4317912|NCT00471328|4144686|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4317913|NCT00471328|4144684|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4317914|NCT00471328|4144685|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317915|NCT00471328|4144686|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4317916|NCT00471328|4144684|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4317917|NCT00471328|4144685|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4317918|NCT00471328|4144686|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4317919|NCT00471328|4144684|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317920|NCT00471328|4144685|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317921|NCT00471328|4144686|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4317922|NCT00471328|4144684|B3||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4317923|NCT00471328|4144685|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4317924|NCT00471328|4144686|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4317925|NCT00471328|4144684|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4317926|NCT00471328|4144685|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4317927|NCT00471328|4144686|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4317928|NCT00471328|4144684|B3|||Age||years|Mean|57.8|57.8|Standard Deviation|12.01|12.01|||
4317929|NCT00471328|4144685|B2|||Age||years|Mean|58.6|58.6|Standard Deviation|10.57|10.57|||
4317930|NCT00471328|4144686|B1|||Age||years|Mean|57.4|57.4|Standard Deviation|12.69|12.69|||
4317931|NCT00471328|4144684|B3||>=65 years|Age||Participants|Count of Participants|73|73.0||||||
4317932|NCT00471328|4144685|B2||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4317933|NCT00471328|4144686|B1||>=65 years|Age||Participants|Count of Participants|47|47.0||||||
4317934|NCT00471328|4144684|B3||Between 18 and 65 years|Age||Participants|Count of Participants|175|175.0||||||
4317935|NCT00471328|4144685|B2||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4317936|NCT00471328|4144686|B1||Between 18 and 65 years|Age||Participants|Count of Participants|118|118.0||||||
4317937|NCT00471328|4144684|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4317938|NCT00471328|4144685|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4317939|NCT00471328|4144686|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4317940|NCT00471315|4144706|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4317941|NCT00471315|4144706|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4317942|NCT00471315|4144706|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4317943|NCT00471315|4144706|B1|||Age||years|Mean|43.7|43.7|Standard Deviation|10.3|10.3|||
4317944|NCT00471276|4144711|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4317945|NCT00471276|4144711|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4317946|NCT00471276|4144711|B1|||Age||Years|Mean|57.5|57.5|Standard Deviation|10.9|10.9|||
4317947|NCT00471237|4144734|B8|African American/African Heritage & White||Race/Ethnicity, Customized||Participant|Number|7|7.0||||||
4317948|NCT00471237|4144735|B7|African American/African Heritage & White||Race/Ethnicity, Customized||Participant|Number|0|0.0||||||
4317949|NCT00471237|4144736|B6|African American/African Heritage & White||Race/Ethnicity, Customized||Participant|Number|0|0.0||||||
4317950|NCT00471237|4144737|B5|African American/African Heritage & White||Race/Ethnicity, Customized||Participant|Number|1|1.0||||||
4317951|NCT00471237|4144738|B4|African American/African Heritage & White||Race/Ethnicity, Customized||Participant|Number|1|1.0||||||
4317952|NCT00471237|4144739|B3|African American/African Heritage & White||Race/Ethnicity, Customized||Participant|Number|2|2.0||||||
4317953|NCT00471237|4144740|B2|African American/African Heritage & White||Race/Ethnicity, Customized||Participant|Number|2|2.0||||||
4317954|NCT00471237|4144741|B1|African American/African Heritage & White||Race/Ethnicity, Customized||Participant|Number|1|1.0||||||
4317955|NCT00471237|4144734|B8|White||Race/Ethnicity, Customized||Participant|Number|465|465.0||||||
4317956|NCT00471237|4144735|B7|White||Race/Ethnicity, Customized||Participant|Number|35|35.0||||||
4317957|NCT00471237|4144736|B6|White||Race/Ethnicity, Customized||Participant|Number|76|76.0||||||
4317958|NCT00471237|4144737|B5|White||Race/Ethnicity, Customized||Participant|Number|71|71.0||||||
4317959|NCT00471237|4144738|B4|White||Race/Ethnicity, Customized||Participant|Number|73|73.0||||||
4317960|NCT00471237|4144739|B3|White||Race/Ethnicity, Customized||Participant|Number|66|66.0||||||
4317961|NCT00471237|4144740|B2|White||Race/Ethnicity, Customized||Participant|Number|71|71.0||||||
4317962|NCT00471237|4144741|B1|White||Race/Ethnicity, Customized||Participant|Number|73|73.0||||||
4317963|NCT00471237|4144734|B8|Asian||Race/Ethnicity, Customized||Participant|Number|59|59.0||||||
4317964|NCT00471237|4144735|B7|Asian||Race/Ethnicity, Customized||Participant|Number|3|3.0||||||
4317965|NCT00471237|4144736|B6|Asian||Race/Ethnicity, Customized||Participant|Number|8|8.0||||||
4317966|NCT00471237|4144737|B5|Asian||Race/Ethnicity, Customized||Participant|Number|10|10.0||||||
4317967|NCT00471237|4144738|B4|Asian||Race/Ethnicity, Customized||Participant|Number|11|11.0||||||
4317968|NCT00471237|4144739|B3|Asian||Race/Ethnicity, Customized||Participant|Number|10|10.0||||||
4317969|NCT00471237|4144740|B2|Asian||Race/Ethnicity, Customized||Participant|Number|7|7.0||||||
4317970|NCT00471237|4144741|B1|Asian||Race/Ethnicity, Customized||Participant|Number|10|10.0||||||
4317971|NCT00471237|4144734|B8|American Indian or Alaska Native||Race/Ethnicity, Customized||Participant|Number|24|24.0||||||
4317972|NCT00471237|4144735|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||Participant|Number|3|3.0||||||
4317973|NCT00471237|4144736|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||Participant|Number|4|4.0||||||
4317974|NCT00471237|4144737|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participant|Number|1|1.0||||||
4317975|NCT00471237|4144738|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participant|Number|3|3.0||||||
4317976|NCT00471237|4144739|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participant|Number|3|3.0||||||
4317977|NCT00471237|4144740|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participant|Number|5|5.0||||||
4317978|NCT00471237|4144741|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participant|Number|5|5.0||||||
4317979|NCT00471237|4144734|B8|African American/African Heritage||Race/Ethnicity, Customized||Participant|Number|9|9.0||||||
4317980|NCT00471237|4144735|B7|African American/African Heritage||Race/Ethnicity, Customized||Participant|Number|0|0.0||||||
4317981|NCT00471237|4144736|B6|African American/African Heritage||Race/Ethnicity, Customized||Participant|Number|1|1.0||||||
4317982|NCT00471237|4144737|B5|African American/African Heritage||Race/Ethnicity, Customized||Participant|Number|4|4.0||||||
4317983|NCT00471237|4144738|B4|African American/African Heritage||Race/Ethnicity, Customized||Participant|Number|0|0.0||||||
4317984|NCT00471237|4144739|B3|African American/African Heritage||Race/Ethnicity, Customized||Participant|Number|1|1.0||||||
4317985|NCT00471237|4144740|B2|African American/African Heritage||Race/Ethnicity, Customized||Participant|Number|2|2.0||||||
4317986|NCT00471237|4144741|B1|African American/African Heritage||Race/Ethnicity, Customized||Participant|Number|1|1.0||||||
4317987|NCT00471237|4144734|B8||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4317988|NCT00471237|4144735|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4317989|NCT00471237|4144736|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4317990|NCT00471237|4144737|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4317991|NCT00471237|4144738|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4317994|NCT00471237|4144741|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4317995|NCT00471237|4144734|B8||Female|Sex: Female, Male||Participants|Count of Participants|564|564.0||||||
4317996|NCT00471237|4144735|B7||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4317997|NCT00471237|4144736|B6||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4317998|NCT00471237|4144737|B5||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4317999|NCT00471237|4144738|B4||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4318000|NCT00471237|4144739|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4318001|NCT00471237|4144740|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4318002|NCT00471237|4144741|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4318003|NCT00471237|4144734|B8|||Age||Years|Mean|64.24|64.24|Standard Deviation|7.04|7.04|||
4318004|NCT00471237|4144735|B7|||Age||Years|Mean|63.17|63.17|Standard Deviation|5.92|5.92|||
4318005|NCT00471237|4144736|B6|||Age||Years|Mean|65.11|65.11|Standard Deviation|7.04|7.04|||
4318006|NCT00471237|4144737|B5|||Age||Years|Mean|64.97|64.97|Standard Deviation|7.60|7.6|||
4318007|NCT00471237|4144738|B4|||Age||Years|Mean|64.34|64.34|Standard Deviation|6.57|6.57|||
4318008|NCT00471237|4144739|B3|||Age||Years|Mean|64.16|64.16|Standard Deviation|7.03|7.03|||
4318009|NCT00471237|4144740|B2|||Age||Years|Mean|64.17|64.17|Standard Deviation|7.69|7.69|||
4318010|NCT00471237|4144741|B1|||Age||Years|Mean|63.20|63.2|Standard Deviation|6.75|6.75|||
4318011|NCT00471146|4144895|B3||Male|Sex: Female, Male||Participants|Count of Participants|379|379.0||||||
4318012|NCT00471146|4144896|B2||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4318013|NCT00471146|4144897|B1||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4318014|NCT00471146|4144895|B3||Female|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4318015|NCT00471146|4144896|B2||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4318016|NCT00471146|4144897|B1||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4318017|NCT00471146|4144895|B3|Greater than or equal to 65 years||Age, Customized||Participants|Number|248|248.0||||||
4318018|NCT00471146|4144896|B2|Greater than or equal to 65 years||Age, Customized||Participants|Number|137|137.0||||||
4318019|NCT00471146|4144897|B1|Greater than or equal to 65 years||Age, Customized||Participants|Number|111|111.0||||||
4318020|NCT00471146|4144895|B3|Less than 65 years||Age, Customized||Participants|Number|382|382.0||||||
4318021|NCT00471146|4144896|B2|Less than 65 years||Age, Customized||Participants|Number|179|179.0||||||
4318022|NCT00471146|4144897|B1|Less than 65 years||Age, Customized||Participants|Number|203|203.0||||||
4318023|NCT00471107|4144920|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4318024|NCT00471107|4144921|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4318025|NCT00471107|4144922|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4318026|NCT00471107|4144923|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4318027|NCT00471107|4144920|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4318028|NCT00471107|4144921|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4318029|NCT00471107|4144922|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4318030|NCT00471107|4144923|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4318031|NCT00471107|4144920|B4|||Age||years|Mean|30.57|30.57|Standard Deviation|11.60|11.6|||
4318032|NCT00471107|4144921|B3|||Age||years|Mean|32.5|32.5|Standard Deviation|11.29|11.29|||
4318033|NCT00471107|4144922|B2|||Age||years|Mean|32.4|32.4|Standard Deviation|14.05|14.05|||
4318034|NCT00471107|4144923|B1|||Age||years|Mean|26.5|26.5|Standard Deviation|8.06|8.06|||
4318035|NCT00471081|4144933|B3||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4318036|NCT00471081|4144934|B2||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4318037|NCT00471081|4144935|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4318038|NCT00471081|4144933|B3||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4318039|NCT00471081|4144934|B2||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4318040|NCT00471081|4144935|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4318041|NCT00471081|4144933|B3|||Age||Months|Mean|9|9.0|Standard Deviation|0.05|0.05|||
4318042|NCT00471081|4144934|B2|||Age||Months|Mean|9|9.0|Standard Deviation|0.0|0.0|||
4318043|NCT00471081|4144935|B1|||Age||Months|Mean|9|9.0|Standard Deviation|0.08|0.08|||
4318044|NCT00471068|4144973|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4318045|NCT00471068|4144974|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4318046|NCT00471068|4144975|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4318047|NCT00471068|4144973|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4318048|NCT00471068|4144974|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4318049|NCT00471068|4144975|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4318050|NCT00471068|4144973|B3||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4318051|NCT00471068|4144974|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4318052|NCT00471068|4144975|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4318053|NCT00471068|4144973|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4318054|NCT00471068|4144974|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4318055|NCT00471068|4144975|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4318056|NCT00471068|4144973|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4318057|NCT00471068|4144974|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4318058|NCT00471068|4144975|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4318059|NCT00470847|4144982|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4318060|NCT00470847|4144982|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4318061|NCT00470847|4144982|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4318062|NCT00470847|4144982|B1|Between 30 and 78||Age, Customized||participants|Number|35|35.0||||||
4318063|NCT00470834|4144993|B3|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|101|101.0||||||
4318064|NCT00470834|4144994|B2|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
4318065|NCT00470834|4144995|B1|White-White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4318066|NCT00470834|4144993|B3|Asian-South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4318067|NCT00470834|4144994|B2|Asian-South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4318068|NCT00470834|4144995|B1|Asian-South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4318069|NCT00470834|4144993|B3|Asian-Japanese Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4318070|NCT00470834|4144994|B2|Asian-Japanese Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4318071|NCT00470834|4144995|B1|Asian-Japanese Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4318072|NCT00470834|4144993|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4318073|NCT00470834|4144994|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4318074|NCT00470834|4144995|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4318075|NCT00470834|4144993|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4318076|NCT00470834|4144994|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4318077|NCT00470834|4144995|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4318078|NCT00470834|4144993|B3||Male|Gender||Participants|Count of Participants|127|127.0||||||
4318079|NCT00470834|4144994|B2||Male|Gender||Participants|Count of Participants|62|62.0||||||
4318080|NCT00470834|4144995|B1||Male|Gender||Participants|Count of Participants|65|65.0||||||
4318081|NCT00470834|4144993|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
4318082|NCT00470834|4144994|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
4318083|NCT00470834|4144995|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
4318084|NCT00470834|4144993|B3|||Age||Years|Mean|78.3|78.3|Standard Deviation|7.02|7.02|||
4318085|NCT00470834|4144994|B2|||Age||Years|Mean|78.9|78.9|Standard Deviation|5.94|5.94|||
4318086|NCT00470834|4144995|B1|||Age||Years|Mean|77.6|77.6|Standard Deviation|7.90|7.9|||
4318087|NCT00470626|4145010|B1|No Trauma||Trauma||participants|Number|91|91.0||||||
4318088|NCT00470626|4145010|B1|Trauma||Trauma||participants|Number|38|38.0||||||
4318089|NCT00470626|4145010|B1|No Stroke||Stroke||participants|Number|122|122.0||||||
4318090|NCT00470626|4145010|B1|Stroke||Stroke||participants|Number|7|7.0||||||
4318091|NCT00470626|4145010|B1|No Renal Disease||Renal Disease||participants|Number|124|124.0||||||
4318092|NCT00470626|4145010|B1|Renal Disease||Renal Disease||participants|Number|5|5.0||||||
4318093|NCT00470626|4145010|B1|No Pulmonary Disease||Pulmonary Disease||participants|Number|96|96.0||||||
4318094|NCT00470626|4145010|B1|Pulmonary Disease||Pulmonary Disease||participants|Number|33|33.0||||||
4318095|NCT00470626|4145010|B1|No PVD||Peripheral Vascular Disease (PVD)||participants|Number|122|122.0||||||
4318096|NCT00470626|4145010|B1|PVD||Peripheral Vascular Disease (PVD)||participants|Number|7|7.0||||||
4318097|NCT00470626|4145010|B1|No Hypertension||Hypertension||participants|Number|129|129.0||||||
4318098|NCT00470626|4145010|B1|Hypertension||Hypertension||participants|Number|0|0.0||||||
4318099|NCT00470626|4145010|B1|No Hepatic Disease||Hepatic Disease||participants|Number|126|126.0||||||
4318100|NCT00470626|4145010|B1|Hepatic Disease||Hepatic Disease||participants|Number|3|3.0||||||
4318101|NCT00470626|4145010|B1|No GI Disease||Gastrointestinal (GI) Disease||participants|Number|121|121.0||||||
4318102|NCT00470626|4145010|B1|GI Disease||Gastrointestinal (GI) Disease||participants|Number|8|8.0||||||
4318103|NCT00470626|4145010|B1|No Diabetes||Diabetes||participants|Number|117|117.0||||||
4318104|NCT00470626|4145010|B1|Diabetes Type II||Diabetes||participants|Number|10|10.0||||||
4318105|NCT00470626|4145010|B1|Diabetes Type I||Diabetes||participants|Number|2|2.0||||||
4318106|NCT00470626|4145010|B1|No Current PE||Current Pulmonary Embolism (PE)||participants|Number|79|79.0||||||
4318107|NCT00470626|4145010|B1|Current PE||Current Pulmonary Embolism (PE)||participants|Number|50|50.0||||||
4318108|NCT00470626|4145010|B1|No Current DVT||Current Deep Venous Thrombosis (DVT)||participants|Number|57|57.0||||||
4318109|NCT00470626|4145010|B1|Current DVT||Current Deep Venous Thrombosis (DVT)||participants|Number|72|72.0||||||
4318110|NCT00470626|4145010|B1|No CHD||Coronary Heart Disease (CHD)||participants|Number|128|128.0||||||
4318111|NCT00470626|4145010|B1|CHD||Coronary Heart Disease (CHD)||participants|Number|1|1.0||||||
4318112|NCT00470626|4145010|B1|No CHF||Congestive Heart Failure (CHF)||participants|Number|128|128.0||||||
4318113|NCT00470626|4145010|B1|CHF||Congestive Heart Failure (CHF)||participants|Number|1|1.0||||||
4318114|NCT00470626|4145010|B1|No Coagulation Disorder||Coagulation Disorder||participants|Number|125|125.0||||||
4318115|NCT00470626|4145010|B1|Coagulation Disorder||Coagulation Disorder||participants|Number|4|4.0||||||
4318116|NCT00470626|4145010|B1|No Cancer||Cancer||participants|Number|106|106.0||||||
4318117|NCT00470626|4145010|B1|Cancer||Cancer||participants|Number|23|23.0||||||
4318118|NCT00470626|4145010|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4318119|NCT00470626|4145010|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4318120|NCT00470626|4145010|B1|||Age||years|Mean|51|51.0|Standard Deviation|19|19.0|||
4318121|NCT00470600|4145016|B3|South Africa||Region of Enrollment||participants|Number|54|54.0||||||
4318122|NCT00470600|4145017|B2|South Africa||Region of Enrollment||participants|Number|29|29.0||||||
4318123|NCT00470600|4145018|B1|South Africa||Region of Enrollment||participants|Number|25|25.0||||||
4318124|NCT00470600|4145016|B3|United States||Region of Enrollment||participants|Number|131|131.0||||||
4318125|NCT00470600|4145017|B2|United States||Region of Enrollment||participants|Number|70|70.0||||||
4318126|NCT00470600|4145018|B1|United States||Region of Enrollment||participants|Number|61|61.0||||||
4318127|NCT00470600|4145016|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4318128|NCT00470600|4145017|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4318129|NCT00470600|4145018|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4318130|NCT00470600|4145016|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4318131|NCT00470600|4145017|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4318132|NCT00470600|4145018|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4318133|NCT00470600|4145016|B3|>= 45 years||Age, Customized||participants|Number|176|176.0||||||
4318134|NCT00470600|4145017|B2|>= 45 years||Age, Customized||participants|Number|96|96.0||||||
4318135|NCT00470600|4145018|B1|>= 45 years||Age, Customized||participants|Number|80|80.0||||||
4318136|NCT00470600|4145016|B3|<45years||Age, Customized||participants|Number|9|9.0||||||
4318137|NCT00470600|4145017|B2|<45years||Age, Customized||participants|Number|3|3.0||||||
4318138|NCT00470600|4145018|B1|<45years||Age, Customized||participants|Number|6|6.0||||||
4318139|NCT00470600|4145016|B3|||Age||years|Mean|61|61.0|Standard Deviation|10.2|10.2|||
4318140|NCT00470600|4145017|B2|||Age||years|Mean|62|62.0|Standard Deviation|10.3|10.3|||
4318141|NCT00470600|4145018|B1|||Age||years|Mean|60|60.0|Standard Deviation|9.9|9.9|||
4318142|NCT00470548|4145029|B3|United States||Region of Enrollment||Participants|Count of Participants|49|49.0||||||
4318143|NCT00470548|4145030|B2|United States||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
4318144|NCT00470548|4145031|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4318145|NCT00470548|4145029|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4318146|NCT00470548|4145030|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4318147|NCT00470548|4145031|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4318148|NCT00470548|4145029|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4318149|NCT00470548|4145030|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4318150|NCT00470548|4145031|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4318151|NCT00470548|4145029|B3|||Age||years|Median|63|63.0|Full Range|||45.0|77.0|
4318152|NCT00470548|4145030|B2|||Age||years|Median|63|63.0|Full Range|||45.0|77.0|
4318153|NCT00470548|4145031|B1|||Age||years|Median|70|70.0|Full Range|||51.0|76.0|
4318154|NCT00470535|4145052|B1||Male|Gender||Participants|Count of Participants|9|9.0||||||
4318155|NCT00470535|4145052|B1||Female|Gender||Participants|Count of Participants|9|9.0||||||
4318156|NCT00470535|4145052|B1|||Age||years|Mean|65.6|65.6|Standard Deviation|10.2|10.2|||
4318157|NCT00470470|4145061|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4318158|NCT00470470|4145061|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4318159|NCT00470470|4145061|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4318160|NCT00470470|4145061|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4318161|NCT00470470|4145061|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4318162|NCT00470470|4145061|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4318163|NCT00470470|4145061|B1|||Age||years|Median|68.5|68.5|Standard Deviation|27.57716447|27.57716447|||
4318164|NCT00470418|4145066|B3|||Education||Years of Education|Mean|15.15|15.15|Standard Deviation|4.0|4.0|||
4318165|NCT00470418|4145067|B2|||Education||Years of Education|Mean|18.0|18.0|Standard Deviation|2.0|2.0|||
4318166|NCT00470418|4145068|B1|||Education||Years of Education|Mean|12.3|12.3|Standard Deviation|4.6|4.6|||
4318167|NCT00470418|4145066|B3||Male|Gender||Participants|Count of Participants|6|6.0||||||
4318168|NCT00470418|4145067|B2||Male|Gender||Participants|Count of Participants|2|2.0||||||
4318169|NCT00470418|4145068|B1||Male|Gender||Participants|Count of Participants|4|4.0||||||
4318170|NCT00470418|4145066|B3||Female|Gender||Participants|Count of Participants|4|4.0||||||
4318171|NCT00470418|4145067|B2||Female|Gender||Participants|Count of Participants|1|1.0||||||
4318172|NCT00470418|4145068|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
4318173|NCT00470418|4145066|B3|||Age||years|Mean|70.05|70.05|Standard Deviation|.49|0.49|||
4318174|NCT00470418|4145067|B2|||Age||years|Mean|69.7|69.7|Standard Deviation|13.9|13.9|||
4318175|NCT00470418|4145068|B1|||Age||years|Mean|70.4|70.4|Standard Deviation|12.5|12.5|||
4318176|NCT00470392|4145077|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4318177|NCT00470392|4145078|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4318178|NCT00470392|4145079|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4318179|NCT00470392|4145077|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4318180|NCT00470392|4145078|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4318181|NCT00470392|4145079|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4318182|NCT00470392|4145077|B3|>=80 years||Age, Customized||participants|Number|0|0.0||||||
4318183|NCT00470392|4145078|B2|>=80 years||Age, Customized||participants|Number|0|0.0||||||
4318184|NCT00470392|4145079|B1|>=80 years||Age, Customized||participants|Number|0|0.0||||||
4318185|NCT00470392|4145077|B3|Between 18 and 80 years||Age, Customized||participants|Number|9|9.0||||||
4318186|NCT00470392|4145078|B2|Between 18 and 80 years||Age, Customized||participants|Number|2|2.0||||||
4318187|NCT00470392|4145079|B1|Between 18 and 80 years||Age, Customized||participants|Number|7|7.0||||||
4318188|NCT00470392|4145077|B3|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4318189|NCT00470392|4145078|B2|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4318190|NCT00470392|4145079|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4318191|NCT00470366|4145090|B1|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
4318192|NCT00470366|4145090|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4318193|NCT00470366|4145090|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318194|NCT00470366|4145090|B1||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4318195|NCT00470366|4145090|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4318196|NCT00470366|4145090|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318197|NCT00470366|4145090|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4318198|NCT00470366|4145090|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318199|NCT00470366|4145090|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4318200|NCT00470366|4145090|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4318201|NCT00470366|4145090|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4318202|NCT00470366|4145090|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4318203|NCT00470366|4145090|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4318204|NCT00470366|4145090|B1|||Age||years|Median|28|28.0|Full Range|||18.0|56.0|
4318205|NCT00470301|4145097|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4318206|NCT00470301|4145097|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4318207|NCT00470301|4145097|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4318208|NCT00470301|4145097|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4318209|NCT00470301|4145097|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4318210|NCT00470301|4145097|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4318211|NCT00470275|4145101|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4318212|NCT00470275|4145101|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4318213|NCT00470275|4145101|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4318214|NCT00470275|4145101|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318215|NCT00470275|4145101|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4318216|NCT00470275|4145101|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318217|NCT00470275|4145101|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318218|NCT00470275|4145101|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318219|NCT00470275|4145101|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318220|NCT00470275|4145101|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4318221|NCT00470275|4145101|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4318222|NCT00470275|4145101|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4318223|NCT00470275|4145101|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4318224|NCT00470275|4145101|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4318225|NCT00470275|4145101|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4318226|NCT00470275|4145101|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4318227|NCT00470275|4145101|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4318228|NCT00470262|4145105|B3|||BMI||kg/m^2|Mean|33.99|33.99|Standard Deviation|3.43|3.43|||
4318229|NCT00470262|4145106|B2|||BMI||kg/m^2|Mean|33.93|33.93|Standard Deviation|3.49|3.49|||
4318230|NCT00470262|4145107|B1|||BMI||kg/m^2|Mean|34.06|34.06|Standard Deviation|3.51|3.51|||
4318231|NCT00470262|4145105|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
4318232|NCT00470262|4145106|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4318233|NCT00470262|4145107|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4318234|NCT00470262|4145105|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4318235|NCT00470262|4145106|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4318236|NCT00470262|4145107|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4318237|NCT00470262|4145105|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4318238|NCT00470262|4145106|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4318239|NCT00470262|4145107|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4318240|NCT00470262|4145105|B3|||Age||years|Mean|46.76|46.76|Standard Deviation|10.03|10.03|||
4318241|NCT00470262|4145106|B2|||Age||years|Mean|44.67|44.67|Standard Deviation|11.49|11.49|||
4318242|NCT00470262|4145107|B1|||Age||years|Mean|48.69|48.69|Standard Deviation|8.46|8.46|||
4318243|NCT00470184|4145116|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4318244|NCT00470184|4145116|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4318245|NCT00470184|4145116|B1|||Age||years|Mean|59.53|59.53|Standard Deviation|10.06|10.06|||
4318246|NCT00470158|4145123|B6|Bangladesh||Region of Enrollment||participants|Number|1000|1000.0||||||
4318247|NCT00470158|4145124|B5|Bangladesh||Region of Enrollment||participants|Number|201|201.0||||||
4318248|NCT00470158|4145125|B4|Bangladesh||Region of Enrollment||participants|Number|198|198.0||||||
4318249|NCT00470158|4145126|B3|Bangladesh||Region of Enrollment||participants|Number|201|201.0||||||
4318250|NCT00470158|4145127|B2|Bangladesh||Region of Enrollment||participants|Number|199|199.0||||||
4318251|NCT00470158|4145128|B1|Bangladesh||Region of Enrollment||participants|Number|201|201.0||||||
4318252|NCT00470158|4145123|B6||Male|Sex: Female, Male||Participants|Count of Participants|516|516.0||||||
4318253|NCT00470158|4145124|B5||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4318254|NCT00470158|4145125|B4||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4318255|NCT00470158|4145126|B3||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4318256|NCT00470158|4145127|B2||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4318257|NCT00470158|4145128|B1||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4318258|NCT00470158|4145123|B6||Female|Sex: Female, Male||Participants|Count of Participants|484|484.0||||||
4318259|NCT00470158|4145124|B5||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4318260|NCT00470158|4145125|B4||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4318261|NCT00470158|4145126|B3||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4318262|NCT00470158|4145127|B2||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4318263|NCT00470158|4145128|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4318264|NCT00470158|4145123|B6|||Age||years|Mean|0.92|0.92|Standard Deviation|0.32|0.32|||
4318265|NCT00470158|4145124|B5|||Age||years|Mean|0.9|0.9|Standard Deviation|0.32|0.32|||
4318266|NCT00470158|4145125|B4|||Age||years|Mean|0.925|0.925|Standard Deviation|0.33|0.33|||
4318267|NCT00470158|4145126|B3|||Age||years|Mean|0.9|0.9|Standard Deviation|0.33|0.33|||
4318268|NCT00470158|4145127|B2|||Age||years|Mean|0.925|0.925|Standard Deviation|0.32|0.32|||
4318269|NCT00470158|4145128|B1|||Age||years|Mean|0.93|0.93|Standard Deviation|0.31|0.31|||
4318270|NCT00470158|4145123|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4318271|NCT00470158|4145124|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4318272|NCT00470158|4145125|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4318273|NCT00470158|4145126|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4318274|NCT00470158|4145127|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4318275|NCT00470158|4145128|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4318276|NCT00470158|4145123|B6||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4318277|NCT00470158|4145124|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4318278|NCT00470158|4145125|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4318279|NCT00470158|4145126|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4318280|NCT00470158|4145127|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4318281|NCT00470158|4145128|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4318282|NCT00470158|4145123|B6||<=18 years|Age||Participants|Count of Participants|1000|1000.0||||||
4318283|NCT00470158|4145124|B5||<=18 years|Age||Participants|Count of Participants|201|201.0||||||
4318284|NCT00470158|4145125|B4||<=18 years|Age||Participants|Count of Participants|198|198.0||||||
4318285|NCT00470158|4145126|B3||<=18 years|Age||Participants|Count of Participants|201|201.0||||||
4318286|NCT00470158|4145127|B2||<=18 years|Age||Participants|Count of Participants|199|199.0||||||
4318287|NCT00470158|4145128|B1||<=18 years|Age||Participants|Count of Participants|201|201.0||||||
4318288|NCT00470106|4145144|B5|||Affect perception|This is a performance-based measure (range 0-56, with higher being better) in which subjects identify the emotion depicted in still photographs of faces. Number of correct identifications is the dependent measure.|number of correct answers|Mean|39.8|39.8|Standard Deviation|7.0|7.0|||
4318289|NCT00470106|4145145|B4|||Affect perception|This is a performance-based measure (range 0-56, with higher being better) in which subjects identify the emotion depicted in still photographs of faces. Number of correct identifications is the dependent measure.|number of correct answers|Mean|43.4|43.4|Standard Deviation|3.7|3.7|||
4318290|NCT00470106|4145146|B3|||Affect perception|This is a performance-based measure (range 0-56, with higher being better) in which subjects identify the emotion depicted in still photographs of faces. Number of correct identifications is the dependent measure.|number of correct answers|Mean|38.6|38.6|Standard Deviation|8.3|8.3|||
4318291|NCT00470106|4145147|B2|||Affect perception|This is a performance-based measure (range 0-56, with higher being better) in which subjects identify the emotion depicted in still photographs of faces. Number of correct identifications is the dependent measure.|number of correct answers|Mean|40.6|40.6|Standard Deviation|8.4|8.4|||
4318292|NCT00470106|4145148|B1|||Affect perception|This is a performance-based measure (range 0-56, with higher being better) in which subjects identify the emotion depicted in still photographs of faces. Number of correct identifications is the dependent measure.|number of correct answers|Mean|37.1|37.1|Standard Deviation|6.1|6.1|||
4318293|NCT00470106|4145144|B5|United States||Region of Enrollment||participants|Number|68|68.0||||||
4318294|NCT00470106|4145145|B4|United States||Region of Enrollment||participants|Number|19|19.0||||||
4318295|NCT00470106|4145146|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4318296|NCT00470106|4145147|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4318297|NCT00470106|4145148|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4318298|NCT00470106|4145144|B5||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4318299|NCT00470106|4145145|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4318300|NCT00470106|4145146|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4318301|NCT00470106|4145147|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4318302|NCT00470106|4145148|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4318303|NCT00470106|4145144|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4318304|NCT00470106|4145145|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4318305|NCT00470106|4145146|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4318306|NCT00470106|4145147|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4318307|NCT00470106|4145148|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4318308|NCT00470106|4145144|B5|||Age||years|Mean|48.4|48.4|Standard Deviation|8.6|8.6|||
4318309|NCT00470106|4145145|B4|||Age||years|Mean|45.1|45.1|Standard Deviation|11.2|11.2|||
4318310|NCT00470106|4145146|B3|||Age||years|Mean|50.4|50.4|Standard Deviation|10.1|10.1|||
4318311|NCT00470106|4145147|B2|||Age||years|Mean|46.6|46.6|Standard Deviation|7.4|7.4|||
4318312|NCT00470106|4145148|B1|||Age||years|Mean|51.0|51.0|Standard Deviation|7.1|7.1|||
4318313|NCT00470093|4145165|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318314|NCT00470093|4145165|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318315|NCT00470093|4145165|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4318316|NCT00470093|4145165|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318317|NCT00470093|4145165|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318318|NCT00470093|4145165|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318319|NCT00470093|4145165|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318320|NCT00470093|4145165|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318321|NCT00470093|4145165|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4318322|NCT00470093|4145165|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318323|NCT00470093|4145165|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4318324|NCT00470093|4145165|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4318325|NCT00470093|4145165|B1|||Age||years|Median|54.5|54.5|Full Range|||50.0|59.0|
4318326|NCT00470093|4145165|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4318327|NCT00470093|4145165|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4318328|NCT00470093|4145165|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4318329|NCT00470067|4145172|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4318330|NCT00470067|4145172|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4318331|NCT00470067|4145172|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4318332|NCT00470067|4145172|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4318333|NCT00470067|4145172|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4318334|NCT00470067|4145172|B1|||Age||years|Mean|63.9|63.9|Standard Deviation|8.04|8.04|||
4318335|NCT00470054|4145176|B1|1 - Ambulatory, restricted strenuous activity||ECOG Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|31|31.0||||||
4318336|NCT00470054|4145176|B1|0 - Fully Active||ECOG Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|12|12.0||||||
4318337|NCT00470054|4145176|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4318338|NCT00470054|4145176|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4318339|NCT00470054|4145176|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4318340|NCT00470054|4145176|B1|||Age||years|Median|64|64.0|Full Range|||35.0|84.0|
4318341|NCT00469911|4145184|B3|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4318342|NCT00469911|4145185|B2|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4318343|NCT00469911|4145186|B1|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4318344|NCT00469911|4145184|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4318345|NCT00469911|4145185|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4318346|NCT00469911|4145186|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4318347|NCT00469911|4145184|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318348|NCT00469911|4145185|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318349|NCT00469911|4145186|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318350|NCT00469911|4145184|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318351|NCT00469911|4145185|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318352|NCT00469911|4145186|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318353|NCT00469911|4145184|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318354|NCT00469911|4145185|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318355|NCT00469911|4145186|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318356|NCT00469911|4145184|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318357|NCT00469911|4145185|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318358|NCT00469911|4145186|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318359|NCT00469911|4145184|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318360|NCT00469911|4145185|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318361|NCT00469911|4145186|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318362|NCT00469911|4145184|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318363|NCT00469911|4145185|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318364|NCT00469911|4145186|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318365|NCT00469911|4145184|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4318366|NCT00469911|4145185|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4318367|NCT00469911|4145186|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4318368|NCT00469911|4145184|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318369|NCT00469911|4145185|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318370|NCT00469911|4145186|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318371|NCT00469911|4145184|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318372|NCT00469911|4145185|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318373|NCT00469911|4145186|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318374|NCT00469911|4145184|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4318375|NCT00469911|4145185|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4318376|NCT00469911|4145186|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4318377|NCT00469911|4145184|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4318378|NCT00469911|4145185|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4318379|NCT00469911|4145186|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4318380|NCT00469911|4145184|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4318381|NCT00469911|4145185|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4318382|NCT00469911|4145186|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4318383|NCT00469911|4145184|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4318384|NCT00469911|4145185|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4318385|NCT00469911|4145186|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4318386|NCT00469911|4145184|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4318387|NCT00469911|4145185|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4318388|NCT00469911|4145186|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4318389|NCT00469898|4145192|B1|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4318390|NCT00469898|4145192|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4318391|NCT00469898|4145192|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4318392|NCT00469898|4145192|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4318393|NCT00469898|4145192|B1|||Age||years|Mean|59.5|59.5|Standard Deviation|1|1.0|||
4318394|NCT00469898|4145192|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4318395|NCT00469898|4145192|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4318396|NCT00469898|4145192|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4318397|NCT00469859|4145199|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4318398|NCT00469859|4145200|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4318399|NCT00469859|4145201|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4318400|NCT00469859|4145199|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318401|NCT00469859|4145200|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318402|NCT00469859|4145201|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318403|NCT00469859|4145199|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318404|NCT00469859|4145200|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318405|NCT00469859|4145201|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318406|NCT00469859|4145199|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4318407|NCT00469859|4145200|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4318408|NCT00469859|4145201|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4318409|NCT00469859|4145199|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4318410|NCT00469859|4145200|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4318411|NCT00469859|4145201|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4318412|NCT00469859|4145199|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318413|NCT00469859|4145200|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318414|NCT00469859|4145201|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318415|NCT00469859|4145199|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4318416|NCT00469859|4145200|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4318417|NCT00469859|4145201|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4318418|NCT00469859|4145199|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318419|NCT00469859|4145200|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318420|NCT00469859|4145201|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318421|NCT00469859|4145199|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4318422|NCT00469859|4145200|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318423|NCT00469859|4145201|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4318424|NCT00469859|4145199|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4318425|NCT00469859|4145200|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4318426|NCT00469859|4145201|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4318427|NCT00469859|4145199|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4318428|NCT00469859|4145200|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318429|NCT00469859|4145201|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4318430|NCT00469859|4145199|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4318431|NCT00469859|4145200|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4318432|NCT00469859|4145201|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4318433|NCT00469859|4145199|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4318434|NCT00469859|4145200|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4318435|NCT00469859|4145201|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4318436|NCT00469859|4145199|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4318437|NCT00469859|4145200|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4318438|NCT00469859|4145201|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4318439|NCT00469859|4145199|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4318440|NCT00469859|4145200|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4318441|NCT00469859|4145201|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4318442|NCT00469859|4145199|B3||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4318443|NCT00469859|4145200|B2||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4318444|NCT00469859|4145201|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4318445|NCT00469833|4145210|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4318446|NCT00469833|4145210|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4318447|NCT00469833|4145210|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4318448|NCT00469833|4145210|B1|||Age||years|Mean|58.1|58.1|Standard Deviation|6.6|6.6|||
4318449|NCT00469833|4145210|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4318450|NCT00469833|4145210|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4318451|NCT00469833|4145210|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4318452|NCT00469612|4145220|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4318453|NCT00469612|4145222|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4318454|NCT00469612|4145220|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4318455|NCT00469612|4145220|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4318456|NCT00469612|4145222|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4318457|NCT00469612|4145220|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4318458|NCT00469612|4145222|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4318459|NCT00469612|4145220|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4318460|NCT00469612|4145221|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4318461|NCT00469612|4145222|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4318462|NCT00469612|4145220|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4318463|NCT00469612|4145221|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4318464|NCT00469612|4145222|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4318465|NCT00469612|4145220|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4318466|NCT00469612|4145221|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4318467|NCT00469612|4145222|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4318468|NCT00469508|4145233|B3|United States||Region of Enrollment||participants|Number|71|71.0||||||
4318469|NCT00469508|4145234|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4318470|NCT00469508|4145235|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4318471|NCT00469508|4145233|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4318472|NCT00469508|4145234|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4318473|NCT00469508|4145235|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4318474|NCT00469508|4145233|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4318475|NCT00469508|4145234|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4318476|NCT00469508|4145235|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4318477|NCT00469508|4145233|B3|||Age||years|Mean|38.4|38.4|Standard Deviation|10.5|10.5|||
4318478|NCT00469508|4145234|B2|||Age||years|Mean|37.8|37.8|Standard Deviation|10.1|10.1|||
4318479|NCT00469508|4145235|B1|||Age||years|Mean|39.1|39.1|Standard Deviation|11.1|11.1|||
4318480|NCT00469508|4145233|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4318481|NCT00469508|4145234|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4318482|NCT00469508|4145235|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4318483|NCT00469508|4145233|B3||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4318484|NCT00469508|4145234|B2||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4318485|NCT00469508|4145235|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4318486|NCT00469508|4145233|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4318487|NCT00469508|4145234|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4318488|NCT00469508|4145235|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4318489|NCT00469456|4145248|B3|New Zealand||Region of Enrollment||participants|Number|34|34.0||||||
4318490|NCT00469456|4145249|B2|New Zealand||Region of Enrollment||participants|Number|18|18.0||||||
4318491|NCT00469456|4145250|B1|New Zealand||Region of Enrollment||participants|Number|16|16.0||||||
4318492|NCT00469456|4145248|B3|South Africa||Region of Enrollment||participants|Number|120|120.0||||||
4318493|NCT00469456|4145249|B2|South Africa||Region of Enrollment||participants|Number|62|62.0||||||
4318494|NCT00469456|4145250|B1|South Africa||Region of Enrollment||participants|Number|58|58.0||||||
4318495|NCT00469456|4145248|B3|Australia||Region of Enrollment||participants|Number|110|110.0||||||
4318496|NCT00469456|4145249|B2|Australia||Region of Enrollment||participants|Number|55|55.0||||||
4318497|NCT00469456|4145250|B1|Australia||Region of Enrollment||participants|Number|55|55.0||||||
4318498|NCT00469456|4145248|B3||Male|Sex: Female, Male|One patient was randomized but did not receive study drug.|Participants|Count of Participants|110|110.0||||||
4318499|NCT00469456|4145249|B2||Male|Sex: Female, Male|One patient was randomized but did not receive study drug.|Participants|Count of Participants|55|55.0||||||
4318500|NCT00469456|4145250|B1||Male|Sex: Female, Male|One patient was randomized but did not receive study drug.|Participants|Count of Participants|55|55.0||||||
4318501|NCT00469456|4145248|B3||Female|Sex: Female, Male|One patient was randomized but did not receive study drug.|Participants|Count of Participants|154|154.0||||||
4318502|NCT00469456|4145249|B2||Female|Sex: Female, Male|One patient was randomized but did not receive study drug.|Participants|Count of Participants|80|80.0||||||
4318503|NCT00469456|4145250|B1||Female|Sex: Female, Male|One patient was randomized but did not receive study drug.|Participants|Count of Participants|74|74.0||||||
4318504|NCT00469456|4145248|B3|||Age||years|Mean|74.9|74.9|Standard Deviation|8.35|8.35|||
4318505|NCT00469456|4145249|B2|||Age||years|Mean|74.8|74.8|Standard Deviation|8.05|8.05|||
4318506|NCT00469456|4145250|B1|||Age||years|Mean|75.1|75.1|Standard Deviation|8.68|8.68|||
4318507|NCT00469456|4145248|B3|>=85 years||Age, Customized||participants|Number|33|33.0||||||
4318508|NCT00469456|4145249|B2|>=85 years||Age, Customized||participants|Number|15|15.0||||||
4318509|NCT00469456|4145250|B1|>=85 years||Age, Customized||participants|Number|18|18.0||||||
4318510|NCT00469456|4145248|B3|75-84 years||Age, Customized||participants|Number|115|115.0||||||
4318511|NCT00469456|4145249|B2|75-84 years||Age, Customized||participants|Number|56|56.0||||||
4318512|NCT00469456|4145250|B1|75-84 years||Age, Customized||participants|Number|59|59.0||||||
4318513|NCT00469456|4145248|B3|65-74 years||Age, Customized||participants|Number|84|84.0||||||
4318514|NCT00469456|4145249|B2|65-74 years||Age, Customized||participants|Number|51|51.0||||||
4318515|NCT00469456|4145250|B1|65-74 years||Age, Customized||participants|Number|33|33.0||||||
4318516|NCT00469456|4145248|B3|<=64 years||Age, Customized||participants|Number|32|32.0||||||
4318517|NCT00469456|4145249|B2|<=64 years||Age, Customized||participants|Number|13|13.0||||||
4318518|NCT00469456|4145250|B1|<=64 years||Age, Customized||participants|Number|19|19.0||||||
4318519|NCT00469391|4145259|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
4318520|NCT00469391|4145260|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4318521|NCT00469391|4145261|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4318522|NCT00469391|4145259|B3||Male|Gender||Participants|Count of Participants|9|9.0||||||
4318523|NCT00469391|4145260|B2||Male|Gender||Participants|Count of Participants|3|3.0||||||
4318524|NCT00469391|4145261|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
4318525|NCT00469391|4145259|B3||Female|Gender||Participants|Count of Participants|38|38.0||||||
4318526|NCT00469391|4145260|B2||Female|Gender||Participants|Count of Participants|23|23.0||||||
4318527|NCT00469391|4145261|B1||Female|Gender||Participants|Count of Participants|15|15.0||||||
4318528|NCT00469391|4145259|B3|||Age||years|Mean|43.7|43.7|Standard Deviation|8.8|8.8|||
4318529|NCT00469391|4145260|B2|||Age||years|Mean|42.7|42.7|Standard Deviation|9.5|9.5|||
4318530|NCT00469391|4145261|B1|||Age||years|Mean|44.8|44.8|Standard Deviation|7.4|7.4|||
4318531|NCT00469274|4145268|B3|United States||Region of Enrollment||participants|Number|86|86.0||||||
4318532|NCT00469274|4145269|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
4318533|NCT00469274|4145270|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4318534|NCT00469274|4145268|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4318535|NCT00469274|4145269|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4318536|NCT00469274|4145270|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4318537|NCT00469274|4145268|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4318538|NCT00469274|4145269|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4318539|NCT00469274|4145270|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4318540|NCT00469274|4145268|B3|||Age||years|Mean|29|29.0|Standard Deviation|2|2.0|||
4318541|NCT00469274|4145269|B2|||Age||years|Mean|27|27.0|Standard Deviation|2|2.0|||
4318542|NCT00469274|4145270|B1|||Age||years|Mean|32|32.0|Standard Deviation|2|2.0|||
4318543|NCT00469274|4145268|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4318544|NCT00469274|4145269|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4318545|NCT00469274|4145270|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4318546|NCT00469274|4145268|B3||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
4318547|NCT00469274|4145269|B2||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4318548|NCT00469274|4145270|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4318549|NCT00469274|4145268|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4318550|NCT00469274|4145269|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4318551|NCT00469274|4145270|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4318552|NCT00469209|4145277|B4|United States||Region of Enrollment||participants|Number|60|60.0||||||
4318553|NCT00469209|4145278|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4318554|NCT00469209|4145279|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4318555|NCT00469209|4145280|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4318556|NCT00469209|4145277|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4318557|NCT00469209|4145278|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4318558|NCT00469209|4145279|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4318559|NCT00469209|4145280|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4318560|NCT00469209|4145277|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4318561|NCT00469209|4145278|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4318562|NCT00469209|4145279|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4318563|NCT00469209|4145280|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4318564|NCT00469209|4145277|B4|||Age||years|Median|60|60.0|Full Range|||45.0|75.0|
4318565|NCT00469209|4145278|B3|||Age||years|Median|64|64.0|Full Range|||49.0|75.0|
4318566|NCT00469209|4145279|B2|||Age||years|Median|59|59.0|Full Range|||45.0|67.0|
4318567|NCT00469209|4145280|B1|||Age||years|Median|61|61.0|Full Range|||47.0|70.0|
4318568|NCT00469092|4145290|B3|||Weight||kg|Mean|77.4|77.4|Standard Deviation|15.0|15.0|||
4318569|NCT00469092|4145291|B2|||Weight||kg|Mean|77.3|77.3|Standard Deviation|15.4|15.4|||
4318570|NCT00469092|4145292|B1|||Weight||kg|Mean|77.5|77.5|Standard Deviation|14.6|14.6|||
4318571|NCT00469092|4145290|B3|||HbA1c|Glycosylated Haemoglobin|percentage of total haemoglobin|Mean|9.0|9.0|Standard Deviation|1.1|1.1|||
4318572|NCT00469092|4145291|B2|||HbA1c|Glycosylated Haemoglobin|percentage of total haemoglobin|Mean|9.0|9.0|Standard Deviation|1.1|1.1|||
4318573|NCT00469092|4145292|B1|||HbA1c|Glycosylated Haemoglobin|percentage of total haemoglobin|Mean|8.9|8.9|Standard Deviation|1.0|1.0|||
4318574|NCT00469092|4145290|B3|||Diabetes duration|Number of years since diagnosis of diabetes|years|Mean|9.3|9.3|Standard Deviation|6.0|6.0|||
4318575|NCT00469092|4145291|B2|||Diabetes duration|Number of years since diagnosis of diabetes|years|Mean|9.5|9.5|Standard Deviation|6.1|6.1|||
4318576|NCT00469092|4145292|B1|||Diabetes duration|Number of years since diagnosis of diabetes|years|Mean|9.1|9.1|Standard Deviation|5.8|5.8|||
4318577|NCT00469092|4145290|B3|||BMI|Body Mass Index|kg/m^2|Mean|29.1|29.1|Standard Deviation|4.6|4.6|||
4318578|NCT00469092|4145291|B2|||BMI|Body Mass Index|kg/m^2|Mean|29.1|29.1|Standard Deviation|4.6|4.6|||
4318579|NCT00469092|4145292|B1|||BMI|Body Mass Index|kg/m^2|Mean|29.0|29.0|Standard Deviation|4.6|4.6|||
4318580|NCT00469092|4145290|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4318581|NCT00469092|4145291|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4318582|NCT00469092|4145292|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4318583|NCT00469092|4145290|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4318584|NCT00469092|4145291|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4318585|NCT00469092|4145292|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4318586|NCT00469092|4145290|B3||White|Race (NIH/OMB)||Participants|Count of Participants|258|258.0||||||
4318587|NCT00469092|4145291|B2||White|Race (NIH/OMB)||Participants|Count of Participants|133|133.0||||||
4318588|NCT00469092|4145292|B1||White|Race (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
4318589|NCT00469092|4145290|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4318590|NCT00469092|4145291|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4318591|NCT00469092|4145292|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4318592|NCT00469092|4145290|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318593|NCT00469092|4145291|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318594|NCT00469092|4145292|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318595|NCT00469092|4145290|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|155|155.0||||||
4318596|NCT00469092|4145291|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
4318597|NCT00469092|4145292|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
4318598|NCT00469092|4145290|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4318599|NCT00469092|4145291|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4318600|NCT00469092|4145292|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4318601|NCT00469092|4145290|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4318602|NCT00469092|4145291|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4318603|NCT00469092|4145292|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4318604|NCT00469092|4145290|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|388|388.0||||||
4318605|NCT00469092|4145291|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|196|196.0||||||
4318606|NCT00469092|4145292|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|192|192.0||||||
4318607|NCT00469092|4145290|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4318608|NCT00469092|4145291|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4318609|NCT00469092|4145292|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4318610|NCT00469092|4145290|B3||Male|Gender||Participants|Count of Participants|206|206.0||||||
4318611|NCT00469092|4145291|B2||Male|Gender||Participants|Count of Participants|98|98.0||||||
4318612|NCT00469092|4145292|B1||Male|Gender||Participants|Count of Participants|108|108.0||||||
4318613|NCT00469092|4145290|B3||Female|Gender||Participants|Count of Participants|263|263.0||||||
4318614|NCT00469092|4145291|B2||Female|Gender||Participants|Count of Participants|140|140.0||||||
4318615|NCT00469092|4145292|B1||Female|Gender||Participants|Count of Participants|123|123.0||||||
4318616|NCT00469092|4145290|B3|||Age||years|Mean|56.0|56.0|Standard Deviation|9.9|9.9|||
4318617|NCT00469092|4145291|B2|||Age||years|Mean|56.1|56.1|Standard Deviation|10.0|10.0|||
4318618|NCT00469092|4145292|B1|||Age||years|Mean|55.9|55.9|Standard Deviation|9.7|9.7|||
4318619|NCT00469079|4145309|B4|||Fagerstrom Test for Nicotine Dependence Score|Fagerstrom Test for Nicotine Dependence. Minimum value is 0 and maximum value is 10. Higher scores indicate greater dependence.|Scores on a scale|Mean|4.5|4.5|Standard Deviation|1.3|1.3|||
4318620|NCT00469079|4145310|B3|||Fagerstrom Test for Nicotine Dependence Score|Fagerstrom Test for Nicotine Dependence. Minimum value is 0 and maximum value is 10. Higher scores indicate greater dependence.|Scores on a scale|Mean|4.4|4.4|Standard Deviation|1.6|1.6|||
4318621|NCT00469079|4145311|B2|||Fagerstrom Test for Nicotine Dependence Score|Fagerstrom Test for Nicotine Dependence. Minimum value is 0 and maximum value is 10. Higher scores indicate greater dependence.|Scores on a scale|Mean|3.8|3.8|Standard Deviation|1.1|1.1|||
4318622|NCT00469079|4145312|B1|||Fagerstrom Test for Nicotine Dependence Score|Fagerstrom Test for Nicotine Dependence. Minimum value is 0 and maximum value is 10. Higher scores indicate greater dependence.|Scores on a scale|Mean|5.2|5.2|Standard Deviation|1.2|1.2|||
4318623|NCT00469079|4145309|B4|United States||Region of Enrollment||participants|Number|130|130.0||||||
4318624|NCT00469079|4145310|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
4318625|NCT00469079|4145311|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
4318626|NCT00469079|4145312|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4318627|NCT00469079|4145309|B4||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4318628|NCT00469079|4145310|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4318629|NCT00469079|4145311|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4318630|NCT00469079|4145312|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4318631|NCT00469079|4145309|B4||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4318632|NCT00469079|4145310|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4318633|NCT00469079|4145311|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4318634|NCT00469079|4145312|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4318635|NCT00469079|4145309|B4|||Age||years|Mean|42.8|42.8|Standard Deviation|11.8|11.8|||
4318636|NCT00469079|4145310|B3|||Age||years|Mean|43.6|43.6|Standard Deviation|11.5|11.5|||
4318637|NCT00469079|4145311|B2|||Age||years|Mean|42.4|42.4|Standard Deviation|11.2|11.2|||
4318638|NCT00469079|4145312|B1|||Age||years|Mean|42.4|42.4|Standard Deviation|12.8|12.8|||
4318639|NCT00469079|4145309|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4318640|NCT00469079|4145310|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4318641|NCT00469079|4145311|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4318642|NCT00469079|4145312|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4318643|NCT00469079|4145309|B4||Between 18 and 65 years|Age||Participants|Count of Participants|130|130.0||||||
4318644|NCT00469079|4145310|B3||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4318645|NCT00469079|4145311|B2||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4318646|NCT00469079|4145312|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4318647|NCT00469079|4145309|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4318648|NCT00469079|4145310|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4318649|NCT00469079|4145311|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4318650|NCT00469079|4145312|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4318651|NCT00468910|4145331|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318652|NCT00468910|4145332|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318653|NCT00468910|4145333|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318654|NCT00468910|4145331|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4318655|NCT00468910|4145332|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318656|NCT00468910|4145333|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4318657|NCT00468910|4145331|B3||White|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
4318658|NCT00468910|4145332|B2||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4318659|NCT00468910|4145333|B1||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4318660|NCT00468910|4145331|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4318661|NCT00468910|4145332|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4318662|NCT00468910|4145333|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4318663|NCT00468910|4145331|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318664|NCT00468910|4145332|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318665|NCT00468910|4145333|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318666|NCT00468910|4145331|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4318667|NCT00468910|4145332|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4318668|NCT00468910|4145333|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318669|NCT00468910|4145331|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318670|NCT00468910|4145332|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318671|NCT00468910|4145333|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318672|NCT00468910|4145331|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318673|NCT00468910|4145332|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318674|NCT00468910|4145333|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318675|NCT00468910|4145331|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
4318676|NCT00468910|4145332|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4318677|NCT00468910|4145333|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4318678|NCT00468910|4145331|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4318679|NCT00468910|4145332|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318680|NCT00468910|4145333|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4318681|NCT00468910|4145331|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4318682|NCT00468910|4145332|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4318683|NCT00468910|4145333|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4318684|NCT00468910|4145331|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4318685|NCT00468910|4145332|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4318686|NCT00468910|4145333|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4318687|NCT00468910|4145331|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4318688|NCT00468910|4145332|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4318689|NCT00468910|4145333|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4318690|NCT00468910|4145331|B3||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
4318691|NCT00468910|4145332|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4318692|NCT00468910|4145333|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4318693|NCT00468910|4145331|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4318694|NCT00468910|4145332|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4318695|NCT00468910|4145333|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4318696|NCT00468858|4145350|B4|Puerto Rico||Region of Enrollment||Participants|Count of Participants|636|636.0||||||
4318697|NCT00468858|4145351|B3|Puerto Rico||Region of Enrollment||Participants|Count of Participants|213|213.0||||||
4318698|NCT00468858|4145352|B2|Puerto Rico||Region of Enrollment||Participants|Count of Participants|212|212.0||||||
4318699|NCT00468858|4145353|B1|Puerto Rico||Region of Enrollment||Participants|Count of Participants|211|211.0||||||
4318700|NCT00468858|4145350|B4|Race|White - Caucasian / European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|98|98.0||||||
4318754|NCT00468858|4145352|B2||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4318701|NCT00468858|4145351|B3|Race|White - Caucasian / European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
4318702|NCT00468858|4145352|B2|Race|White - Caucasian / European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
4318703|NCT00468858|4145353|B1|Race|White - Caucasian / European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
4318704|NCT00468858|4145350|B4|Race|White-Arabic / North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4318705|NCT00468858|4145351|B3|Race|White-Arabic / North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4318706|NCT00468858|4145352|B2|Race|White-Arabic / North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4318707|NCT00468858|4145353|B1|Race|White-Arabic / North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4318708|NCT00468858|4145350|B4|Race|Puerto Rican|Race/Ethnicity, Customized||Participants|Count of Participants|494|494.0||||||
4318709|NCT00468858|4145351|B3|Race|Puerto Rican|Race/Ethnicity, Customized||Participants|Count of Participants|164|164.0||||||
4318710|NCT00468858|4145352|B2|Race|Puerto Rican|Race/Ethnicity, Customized||Participants|Count of Participants|166|166.0||||||
4318711|NCT00468858|4145353|B1|Race|Puerto Rican|Race/Ethnicity, Customized||Participants|Count of Participants|164|164.0||||||
4318712|NCT00468858|4145350|B4|Race|Peruvian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4318713|NCT00468858|4145351|B3|Race|Peruvian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4318714|NCT00468858|4145352|B2|Race|Peruvian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4318715|NCT00468858|4145353|B1|Race|Peruvian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4318716|NCT00468858|4145350|B4|Race|Mixed|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
4318717|NCT00468858|4145351|B3|Race|Mixed|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4318718|NCT00468858|4145352|B2|Race|Mixed|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4318719|NCT00468858|4145353|B1|Race|Mixed|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4318720|NCT00468858|4145350|B4|Race|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4318721|NCT00468858|4145351|B3|Race|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4318722|NCT00468858|4145352|B2|Race|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4318723|NCT00468858|4145353|B1|Race|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4318724|NCT00468858|4145350|B4|Race|Dominican|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4318725|NCT00468858|4145351|B3|Race|Dominican|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4318726|NCT00468858|4145352|B2|Race|Dominican|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4318727|NCT00468858|4145353|B1|Race|Dominican|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4318728|NCT00468858|4145350|B4|Race|American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4318729|NCT00468858|4145351|B3|Race|American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4318730|NCT00468858|4145352|B2|Race|American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4318731|NCT00468858|4145353|B1|Race|American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4318732|NCT00468858|4145350|B4|Race|African heritage / African American|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4318733|NCT00468858|4145351|B3|Race|African heritage / African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4318734|NCT00468858|4145352|B2|Race|African heritage / African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4318735|NCT00468858|4145353|B1|Race|African heritage / African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4318736|NCT00468858|4145350|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318737|NCT00468858|4145351|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318738|NCT00468858|4145352|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318739|NCT00468858|4145353|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318740|NCT00468858|4145350|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4318741|NCT00468858|4145351|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318742|NCT00468858|4145352|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4318743|NCT00468858|4145353|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4318744|NCT00468858|4145350|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|635|635.0||||||
4318745|NCT00468858|4145351|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|213|213.0||||||
4318746|NCT00468858|4145352|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|212|212.0||||||
4318747|NCT00468858|4145353|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|210|210.0||||||
4318748|NCT00468858|4145350|B4||Male|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
4318749|NCT00468858|4145351|B3||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4318750|NCT00468858|4145352|B2||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4318751|NCT00468858|4145353|B1||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4318752|NCT00468858|4145350|B4||Female|Sex: Female, Male||Participants|Count of Participants|335|335.0||||||
4318753|NCT00468858|4145351|B3||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4318755|NCT00468858|4145353|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4318756|NCT00468858|4145350|B4|||Age||years|Mean|13.4|13.4|Standard Deviation|13.50|13.5|||
4318757|NCT00468858|4145351|B3|||Age||years|Mean|13.6|13.6|Standard Deviation|13.89|13.89|||
4318758|NCT00468858|4145352|B2|||Age||years|Mean|12.8|12.8|Standard Deviation|12.51|12.51|||
4318759|NCT00468858|4145353|B1|||Age||years|Mean|13.8|13.8|Standard Deviation|14.10|14.1|||
4318760|NCT00468845|4145473|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4318761|NCT00468845|4145474|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4318762|NCT00468845|4145475|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4318763|NCT00468845|4145476|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4318764|NCT00468845|4145473|B4||Female|Sex: Female, Male||Participants|Count of Participants|501|501.0||||||
4318765|NCT00468845|4145474|B3||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4318766|NCT00468845|4145475|B2||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4318767|NCT00468845|4145476|B1||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4318768|NCT00468845|4145473|B4|Unspecified||Age, Customized||participants|Number|7|7.0||||||
4318769|NCT00468845|4145474|B3|Unspecified||Age, Customized||participants|Number|2|2.0||||||
4318770|NCT00468845|4145475|B2|Unspecified||Age, Customized||participants|Number|4|4.0||||||
4318771|NCT00468845|4145476|B1|Unspecified||Age, Customized||participants|Number|1|1.0||||||
4318772|NCT00468845|4145473|B4|45-70 years||Age, Customized||participants|Number|253|253.0||||||
4318773|NCT00468845|4145474|B3|45-70 years||Age, Customized||participants|Number|79|79.0||||||
4318774|NCT00468845|4145475|B2|45-70 years||Age, Customized||participants|Number|90|90.0||||||
4318775|NCT00468845|4145476|B1|45-70 years||Age, Customized||participants|Number|84|84.0||||||
4318776|NCT00468845|4145473|B4|25-44 years||Age, Customized||participants|Number|241|241.0||||||
4318777|NCT00468845|4145474|B3|25-44 years||Age, Customized||participants|Number|88|88.0||||||
4318778|NCT00468845|4145475|B2|25-44 years||Age, Customized||participants|Number|76|76.0||||||
4318779|NCT00468845|4145476|B1|25-44 years||Age, Customized||participants|Number|77|77.0||||||
4318780|NCT00468819|4145612|B4|||Body Weight||kg|Mean|36.48|36.48|Standard Deviation|19.447|19.447|||
4318781|NCT00468819|4145613|B3|||Body Weight||kg|Mean|57.19|57.19|Standard Deviation|14.245|14.245|||
4318782|NCT00468819|4145614|B2|||Body Weight||kg|Mean|33.75|33.75|Standard Deviation|8.956|8.956|||
4318783|NCT00468819|4145615|B1|||Body Weight||kg|Mean|17.49|17.49|Standard Deviation|5.434|5.434|||
4318784|NCT00468819|4145612|B4||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4318785|NCT00468819|4145613|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4318786|NCT00468819|4145614|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4318787|NCT00468819|4145615|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4318788|NCT00468819|4145612|B4||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4318789|NCT00468819|4145613|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4318790|NCT00468819|4145614|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4318791|NCT00468819|4145615|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4318792|NCT00468819|4145612|B4|||Age||years|Mean|9.2|9.2|Standard Deviation|4.83|4.83|||
4318793|NCT00468819|4145613|B3|||Age||years|Mean|14.7|14.7|Standard Deviation|1.80|1.8|||
4318794|NCT00468819|4145614|B2|||Age||years|Mean|9.0|9.0|Standard Deviation|1.38|1.38|||
4318795|NCT00468819|4145615|B1|||Age||years|Mean|3.7|3.7|Standard Deviation|1.46|1.46|||
4318796|NCT00468728|4145695|B3|Sweden||Region of Enrollment||participants|Number|11|11.0||||||
4318797|NCT00468728|4145696|B2|Sweden||Region of Enrollment||participants|Number|4|4.0||||||
4318798|NCT00468728|4145697|B1|Sweden||Region of Enrollment||participants|Number|7|7.0||||||
4318799|NCT00468728|4145695|B3|Italy||Region of Enrollment||participants|Number|27|27.0||||||
4318800|NCT00468728|4145696|B2|Italy||Region of Enrollment||participants|Number|14|14.0||||||
4318801|NCT00468728|4145697|B1|Italy||Region of Enrollment||participants|Number|13|13.0||||||
4318802|NCT00468728|4145695|B3|United Kingdom||Region of Enrollment||participants|Number|53|53.0||||||
4318803|NCT00468728|4145696|B2|United Kingdom||Region of Enrollment||participants|Number|26|26.0||||||
4318804|NCT00468728|4145697|B1|United Kingdom||Region of Enrollment||participants|Number|27|27.0||||||
4318805|NCT00468728|4145695|B3|Germany||Region of Enrollment||participants|Number|37|37.0||||||
4318806|NCT00468728|4145696|B2|Germany||Region of Enrollment||participants|Number|18|18.0||||||
4318807|NCT00468728|4145697|B1|Germany||Region of Enrollment||participants|Number|19|19.0||||||
4318808|NCT00468728|4145695|B3|Belgium||Region of Enrollment||participants|Number|42|42.0||||||
4318809|NCT00468728|4145696|B2|Belgium||Region of Enrollment||participants|Number|22|22.0||||||
4318810|NCT00468728|4145697|B1|Belgium||Region of Enrollment||participants|Number|20|20.0||||||
4318811|NCT00468728|4145695|B3|Spain||Region of Enrollment||participants|Number|9|9.0||||||
4318812|NCT00468728|4145696|B2|Spain||Region of Enrollment||participants|Number|5|5.0||||||
4318813|NCT00468728|4145697|B1|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4318814|NCT00468728|4145695|B3|Canada||Region of Enrollment||participants|Number|161|161.0||||||
4318815|NCT00468728|4145696|B2|Canada||Region of Enrollment||participants|Number|79|79.0||||||
4318816|NCT00468728|4145697|B1|Canada||Region of Enrollment||participants|Number|82|82.0||||||
4318817|NCT00468728|4145695|B3|United States||Region of Enrollment||participants|Number|150|150.0||||||
4318818|NCT00468728|4145696|B2|United States||Region of Enrollment||participants|Number|74|74.0||||||
4318819|NCT00468728|4145697|B1|United States||Region of Enrollment||participants|Number|76|76.0||||||
4318820|NCT00468728|4145695|B3|France||Region of Enrollment||participants|Number|19|19.0||||||
4318821|NCT00468728|4145696|B2|France||Region of Enrollment||participants|Number|11|11.0||||||
4318822|NCT00468728|4145697|B1|France||Region of Enrollment||participants|Number|8|8.0||||||
4318823|NCT00468728|4145695|B3||Male|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4318824|NCT00468728|4145696|B2||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4318825|NCT00468728|4145697|B1||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4318826|NCT00468728|4145695|B3||Female|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
4318827|NCT00468728|4145696|B2||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4318828|NCT00468728|4145697|B1||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4318829|NCT00468728|4145695|B3|||Age||years|Mean|63.4|63.4|Standard Deviation|18.1|18.1|||
4318830|NCT00468728|4145696|B2|||Age||years|Mean|64.1|64.1|Standard Deviation|18.0|18.0|||
4318831|NCT00468728|4145697|B1|||Age||years|Mean|62.7|62.7|Standard Deviation|18.3|18.3|||
4318832|NCT00468676|4145708|B3|United States||Region of Enrollment||participants|Number|214|214.0||||||
4318833|NCT00468676|4145709|B2|United States||Region of Enrollment||participants|Number|106|106.0||||||
4318834|NCT00468676|4145710|B1|United States||Region of Enrollment||participants|Number|108|108.0||||||
4318835|NCT00468676|4145708|B3||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4318836|NCT00468676|4145709|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4318837|NCT00468676|4145710|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4318838|NCT00468676|4145708|B3||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4318839|NCT00468676|4145709|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4318840|NCT00468676|4145710|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4318841|NCT00468676|4145708|B3|||Age||years|Mean|56.8|56.8|Standard Deviation|11.3|11.3|||
4318842|NCT00468676|4145709|B2|||Age||years|Mean|57.4|57.4|Standard Deviation|10.5|10.5|||
4318843|NCT00468676|4145710|B1|||Age||years|Mean|56.3|56.3|Standard Deviation|12.1|12.1|||
4318844|NCT00468676|4145708|B3||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
4318845|NCT00468676|4145709|B2||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4318846|NCT00468676|4145710|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4318847|NCT00468676|4145708|B3||Between 18 and 65 years|Age||Participants|Count of Participants|163|163.0||||||
4318848|NCT00468676|4145709|B2||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
4318849|NCT00468676|4145710|B1||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
4318850|NCT00468676|4145708|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4318851|NCT00468676|4145709|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4318852|NCT00468676|4145710|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4318853|NCT00468650|4145728|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4318854|NCT00468650|4145728|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4318855|NCT00468650|4145728|B1|||Age||years|Mean|53.3|53.3|Standard Deviation|11|11.0|||
4318856|NCT00468585|4145772|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4318857|NCT00468585|4145773|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4318858|NCT00468585|4145774|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4318859|NCT00468585|4145775|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4318860|NCT00468585|4145776|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4318861|NCT00468585|4145772|B5||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4318862|NCT00468585|4145773|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4318863|NCT00468585|4145774|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4318864|NCT00468585|4145775|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4318865|NCT00468585|4145776|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4318866|NCT00468585|4145772|B5||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4318867|NCT00468585|4145773|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4318868|NCT00468585|4145774|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4318869|NCT00468585|4145775|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4318870|NCT00468585|4145776|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4318871|NCT00468585|4145772|B5||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4318872|NCT00468585|4145773|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4318873|NCT00468585|4145774|B3||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4318874|NCT00468585|4145775|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4318875|NCT00468585|4145776|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4318876|NCT00468585|4145772|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4318877|NCT00468585|4145773|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4318878|NCT00468585|4145774|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4318879|NCT00468585|4145775|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4318880|NCT00468585|4145776|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4318881|NCT00468559|4145789|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4318882|NCT00468559|4145790|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4318883|NCT00468559|4145791|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4318884|NCT00468559|4145789|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4318885|NCT00468559|4145790|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4318886|NCT00468559|4145791|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4318887|NCT00468559|4145789|B3|||Age||Months|Mean|4.9|4.9|Standard Deviation|2.9|2.9|||
4318888|NCT00468559|4145790|B2|||Age||Months|Mean|4.9|4.9|Standard Deviation|3.2|3.2|||
4318889|NCT00468559|4145791|B1|||Age||Months|Mean|4.9|4.9|Standard Deviation|2.6|2.6|||
4318890|NCT00468546|4145819|B3||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4318891|NCT00468546|4145820|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4318892|NCT00468546|4145821|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4318893|NCT00468546|4145819|B3||Female|Sex: Female, Male||Participants|Count of Participants|419|419.0||||||
4318894|NCT00468546|4145820|B2||Female|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4318895|NCT00468546|4145821|B1||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4318896|NCT00468546|4145819|B3|||Age||years|Median|53.0|53.0|Full Range|||20.0|81.0|
4318897|NCT00468546|4145820|B2|||Age||years|Median|53.0|53.0|Full Range|||20.0|81.0|
4318898|NCT00468546|4145821|B1|||Age||years|Median|55.0|55.0|Full Range|||20.0|79.0|
4318899|NCT00468481|4145850|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4318900|NCT00468481|4145851|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4318901|NCT00468481|4145852|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4318902|NCT00468481|4145850|B3||Female|Sex: Female, Male||Participants|Count of Participants|379|379.0||||||
4318903|NCT00468481|4145851|B2||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4318904|NCT00468481|4145852|B1||Female|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
4318905|NCT00468481|4145850|B3|||Age||years|Mean|24.7|24.7|Full Range|||18.0|40.0|
4318906|NCT00468481|4145851|B2|||Age||years|Mean|24.6|24.6|Full Range|||18.0|39.0|
4318907|NCT00468481|4145852|B1|||Age||years|Mean|24.8|24.8|Full Range|||18.0|40.0|
4318908|NCT00468312|4145951|B3||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4318909|NCT00468312|4145952|B2||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4318910|NCT00468312|4145953|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4318911|NCT00468312|4145951|B3||Female|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
4318912|NCT00468312|4145952|B2||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4318913|NCT00468312|4145953|B1||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4318914|NCT00468312|4145951|B3|>=65 years||Age, Customized|One subject was 12 years of age at the time of enrollment/screening but turned 13 years of age at the time of randomization.|participants|Number|8|8.0||||||
4318915|NCT00468312|4145952|B2|>=65 years||Age, Customized|One subject was 12 years of age at the time of enrollment/screening but turned 13 years of age at the time of randomization.|participants|Number|3|3.0||||||
4318916|NCT00468312|4145953|B1|>=65 years||Age, Customized|One subject was 12 years of age at the time of enrollment/screening but turned 13 years of age at the time of randomization.|participants|Number|5|5.0||||||
4318917|NCT00468312|4145951|B3|18 - <65 years||Age, Customized|One subject was 12 years of age at the time of enrollment/screening but turned 13 years of age at the time of randomization.|participants|Number|365|365.0||||||
4318918|NCT00468312|4145952|B2|18 - <65 years||Age, Customized|One subject was 12 years of age at the time of enrollment/screening but turned 13 years of age at the time of randomization.|participants|Number|181|181.0||||||
4318919|NCT00468312|4145953|B1|18 - <65 years||Age, Customized|One subject was 12 years of age at the time of enrollment/screening but turned 13 years of age at the time of randomization.|participants|Number|184|184.0||||||
4318920|NCT00468312|4145951|B3|12 - <18 years||Age, Customized|One subject was 12 years of age at the time of enrollment/screening but turned 13 years of age at the time of randomization.|participants|Number|55|55.0||||||
4318921|NCT00468312|4145952|B2|12 - <18 years||Age, Customized|One subject was 12 years of age at the time of enrollment/screening but turned 13 years of age at the time of randomization.|participants|Number|24|24.0||||||
4318922|NCT00468312|4145953|B1|12 - <18 years||Age, Customized|One subject was 12 years of age at the time of enrollment/screening but turned 13 years of age at the time of randomization.|participants|Number|31|31.0||||||
4318923|NCT00468312|4145951|B3|6 - <12 years||Age, Customized|One subject was 12 years of age at the time of enrollment/screening but turned 13 years of age at the time of randomization.|participants|Number|1|1.0||||||
4318924|NCT00468312|4145952|B2|6 - <12 years||Age, Customized|One subject was 12 years of age at the time of enrollment/screening but turned 13 years of age at the time of randomization.|participants|Number|1|1.0||||||
4318925|NCT00468312|4145953|B1|6 - <12 years||Age, Customized|One subject was 12 years of age at the time of enrollment/screening but turned 13 years of age at the time of randomization.|participants|Number|0|0.0||||||
4318926|NCT00468299|4145968|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4318927|NCT00468299|4145969|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4318928|NCT00468299|4145970|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4318929|NCT00468299|4145968|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4318930|NCT00468299|4145969|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4318931|NCT00468299|4145970|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4318932|NCT00468299|4145968|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4318933|NCT00468299|4145969|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4318934|NCT00468299|4145970|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4318935|NCT00468299|4145968|B3|||Age||years|Mean|28|28.0|Standard Deviation|3|3.0|||
4318936|NCT00468299|4145969|B2|||Age||years|Mean|29|29.0|Standard Deviation|4|4.0|||
4318937|NCT00468299|4145970|B1|||Age||years|Mean|28|28.0|Standard Deviation|4|4.0|||
4318938|NCT00468299|4145968|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4318939|NCT00468299|4145969|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4318940|NCT00468299|4145970|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4318941|NCT00468299|4145968|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4318942|NCT00468299|4145969|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4318943|NCT00468299|4145970|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4318944|NCT00468299|4145968|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4318945|NCT00468299|4145969|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4318946|NCT00468299|4145970|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4318947|NCT00468286|4145979|B3|||Serum LH||IU/L|Median|5.3|5.3|Full Range|||1.4|34.0|
4318948|NCT00468286|4145980|B2|||Serum LH||IU/L|Median|4.6|4.6|Full Range|||1.9|34.0|
4318949|NCT00468286|4145981|B1|||Serum LH||IU/L|Median|5.9|5.9|Full Range|||1.4|14.0|
4318950|NCT00468286|4145979|B3|||Serum FSH||IU/L|Median|7.0|7.0|Full Range|||1.6|56.2|
4318951|NCT00468286|4145980|B2|||Serum FSH||IU/L|Median|6.9|6.9|Full Range|||1.6|52.2|
4318952|NCT00468286|4145981|B1|||Serum FSH||IU/L|Median|8.4|8.4|Full Range|||2.2|39.8|
4318953|NCT00468286|4145979|B3|||Serum PSA|ITT population.|ng/mL|Median|20.3|20.3|Full Range|||0.5|5309.6|
4318954|NCT00468286|4145980|B2|||Serum PSA|ITT population.|ng/mL|Median|18.2|18.2|Full Range|||0.5|2668.4|
4318955|NCT00468286|4145981|B1|||Serum PSA|ITT population.|ng/mL|Median|22.9|22.9|Full Range|||2.1|5309.6|
4318956|NCT00468286|4145979|B3|||Serum Testosterone|ITT population.|ng/mL|Median|4.1|4.1|Full Range|||1.6|10.4|
4318957|NCT00468286|4145980|B2|||Serum Testosterone|ITT population.|ng/mL|Median|4.1|4.1|Full Range|||1.6|9.1|
4318958|NCT00468286|4145981|B1|||Serum Testosterone|ITT population.|ng/mL|Median|4.1|4.1|Full Range|||2.0|10.4|
4318959|NCT00468286|4145979|B3|||Time Since Prostate Cancer Diagnosis||days|Mean|319|319.0|Standard Deviation|802|802.0|||
4318960|NCT00468286|4145980|B2|||Time Since Prostate Cancer Diagnosis||days|Mean|265|265.0|Standard Deviation|499|499.0|||
4318961|NCT00468286|4145981|B1|||Time Since Prostate Cancer Diagnosis||days|Mean|370|370.0|Standard Deviation|1011|1011.0|||
4318962|NCT00468286|4145979|B3|Not classifiable||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis.|participants|Number|19|19.0||||||
4318963|NCT00468286|4145980|B2|Not classifiable||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis.|participants|Number|9|9.0||||||
4318964|NCT00468286|4145981|B1|Not classifiable||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis.|participants|Number|10|10.0||||||
4318965|NCT00468286|4145979|B3|Metastatic||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis.|participants|Number|30|30.0||||||
4318966|NCT00468286|4145980|B2|Metastatic||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis.|participants|Number|16|16.0||||||
4318967|NCT00468286|4145981|B1|Metastatic||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis.|participants|Number|14|14.0||||||
4318968|NCT00468286|4145979|B3|Locally advanced||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis.|participants|Number|39|39.0||||||
4318969|NCT00468286|4145980|B2|Locally advanced||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis.|participants|Number|22|22.0||||||
4318993|NCT00468286|4145980|B2|||Body mass index|ITT population.|kilogram per square meter|Mean|27.4|27.4|Standard Deviation|3.4|3.4|||
4318994|NCT00468286|4145981|B1|||Body mass index|ITT population.|kilogram per square meter|Mean|27|27.0|Standard Deviation|4.0|4.0|||
4318970|NCT00468286|4145981|B1|Locally advanced||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis.|participants|Number|17|17.0||||||
4318971|NCT00468286|4145979|B3|Localized||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis.|participants|Number|45|45.0||||||
4318972|NCT00468286|4145980|B2|Localized||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis.|participants|Number|19|19.0||||||
4318973|NCT00468286|4145981|B1|Localized||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis.|participants|Number|26|26.0||||||
4318974|NCT00468286|4145979|B3|Data missing||Gleason Score|"ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.~Gleason score for 1 patient is missing"|participants|Number|1|1.0||||||
4318975|NCT00468286|4145980|B2|Data missing||Gleason Score|"ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.~Gleason score for 1 patient is missing"|participants|Number|0|0.0||||||
4318976|NCT00468286|4145981|B1|Data missing||Gleason Score|"ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.~Gleason score for 1 patient is missing"|participants|Number|1|1.0||||||
4318977|NCT00468286|4145979|B3|7-10||Gleason Score|"ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.~Gleason score for 1 patient is missing"|participants|Number|78|78.0||||||
4318978|NCT00468286|4145980|B2|7-10||Gleason Score|"ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.~Gleason score for 1 patient is missing"|participants|Number|39|39.0||||||
4318979|NCT00468286|4145981|B1|7-10||Gleason Score|"ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.~Gleason score for 1 patient is missing"|participants|Number|39|39.0||||||
4318980|NCT00468286|4145979|B3|5-6||Gleason Score|"ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.~Gleason score for 1 patient is missing"|participants|Number|43|43.0||||||
4318981|NCT00468286|4145980|B2|5-6||Gleason Score|"ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.~Gleason score for 1 patient is missing"|participants|Number|24|24.0||||||
4318982|NCT00468286|4145981|B1|5-6||Gleason Score|"ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.~Gleason score for 1 patient is missing"|participants|Number|19|19.0||||||
4318983|NCT00468286|4145979|B3|2-4||Gleason Score|"ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.~Gleason score for 1 patient is missing"|participants|Number|11|11.0||||||
4318984|NCT00468286|4145980|B2|2-4||Gleason Score|"ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.~Gleason score for 1 patient is missing"|participants|Number|3|3.0||||||
4318985|NCT00468286|4145981|B1|2-4||Gleason Score|"ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.~Gleason score for 1 patient is missing"|participants|Number|8|8.0||||||
4318986|NCT00468286|4145979|B3|No||Curative intent|ITT population. Curative intent refers to radical prostatectomy or radiotherapy.|participants|Number|120|120.0||||||
4318987|NCT00468286|4145980|B2|No||Curative intent|ITT population. Curative intent refers to radical prostatectomy or radiotherapy.|participants|Number|60|60.0||||||
4318988|NCT00468286|4145981|B1|No||Curative intent|ITT population. Curative intent refers to radical prostatectomy or radiotherapy.|participants|Number|60|60.0||||||
4318989|NCT00468286|4145979|B3|Yes||Curative intent|ITT population. Curative intent refers to radical prostatectomy or radiotherapy.|participants|Number|13|13.0||||||
4318990|NCT00468286|4145980|B2|Yes||Curative intent|ITT population. Curative intent refers to radical prostatectomy or radiotherapy.|participants|Number|6|6.0||||||
4318991|NCT00468286|4145981|B1|Yes||Curative intent|ITT population. Curative intent refers to radical prostatectomy or radiotherapy.|participants|Number|7|7.0||||||
4318992|NCT00468286|4145979|B3|||Body mass index|ITT population.|kilogram per square meter|Mean|27.2|27.2|Standard Deviation|3.7|3.7|||
4318995|NCT00468286|4145979|B3|||Weight|ITT population.|kilogram|Mean|80.6|80.6|Standard Deviation|13.2|13.2|||
4318996|NCT00468286|4145980|B2|||Weight|ITT population.|kilogram|Mean|82.4|82.4|Standard Deviation|13.4|13.4|||
4318997|NCT00468286|4145981|B1|||Weight|ITT population.|kilogram|Mean|78.9|78.9|Standard Deviation|12.9|12.9|||
4318998|NCT00468286|4145979|B3||Unknown or Not Reported|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|0|0.0||||||
4318999|NCT00468286|4145980|B2||Unknown or Not Reported|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|0|0.0||||||
4319000|NCT00468286|4145981|B1||Unknown or Not Reported|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|0|0.0||||||
4319001|NCT00468286|4145979|B3||More than one race|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|0|0.0||||||
4319002|NCT00468286|4145980|B2||More than one race|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|0|0.0||||||
4319003|NCT00468286|4145981|B1||More than one race|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|0|0.0||||||
4319004|NCT00468286|4145979|B3||White|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|127|127.0||||||
4319005|NCT00468286|4145980|B2||White|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|63|63.0||||||
4319006|NCT00468286|4145981|B1||White|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|64|64.0||||||
4319007|NCT00468286|4145979|B3||Black or African American|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|5|5.0||||||
4319008|NCT00468286|4145980|B2||Black or African American|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|3|3.0||||||
4319009|NCT00468286|4145981|B1||Black or African American|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|2|2.0||||||
4319010|NCT00468286|4145979|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|0|0.0||||||
4319011|NCT00468286|4145980|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|0|0.0||||||
4319012|NCT00468286|4145981|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|0|0.0||||||
4319013|NCT00468286|4145979|B3||Asian|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|1|1.0||||||
4319014|NCT00468286|4145980|B2||Asian|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|0|0.0||||||
4319015|NCT00468286|4145981|B1||Asian|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|1|1.0||||||
4319016|NCT00468286|4145979|B3||American Indian or Alaska Native|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|0|0.0||||||
4319017|NCT00468286|4145980|B2||American Indian or Alaska Native|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|0|0.0||||||
4319018|NCT00468286|4145981|B1||American Indian or Alaska Native|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|0|0.0||||||
4319019|NCT00468286|4145979|B3||Male|Sex: Female, Male|ITT population.|Participants|Count of Participants|133|133.0||||||
4319020|NCT00468286|4145980|B2||Male|Sex: Female, Male|ITT population.|Participants|Count of Participants|66|66.0||||||
4319021|NCT00468286|4145981|B1||Male|Sex: Female, Male|ITT population.|Participants|Count of Participants|67|67.0||||||
4319022|NCT00468286|4145979|B3||Female|Sex: Female, Male|ITT population.|Participants|Count of Participants|0|0.0||||||
4319023|NCT00468286|4145980|B2||Female|Sex: Female, Male|ITT population.|Participants|Count of Participants|0|0.0||||||
4319024|NCT00468286|4145981|B1||Female|Sex: Female, Male|ITT population.|Participants|Count of Participants|0|0.0||||||
4319025|NCT00468286|4145979|B3|||Age|ITT population.|years|Mean|73.4|73.4|Standard Deviation|7.9|7.9|||
4319026|NCT00468286|4145980|B2|||Age|ITT population.|years|Mean|72.7|72.7|Standard Deviation|8.5|8.5|||
4319027|NCT00468286|4145981|B1|||Age|ITT population.|years|Mean|74.1|74.1|Standard Deviation|7.3|7.3|||
4319028|NCT00468208|4146004|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4319029|NCT00468208|4146004|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319030|NCT00468208|4146004|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319031|NCT00468208|4146004|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4319032|NCT00468208|4146004|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319033|NCT00468208|4146004|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319034|NCT00468208|4146004|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319035|NCT00468208|4146004|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319036|NCT00468208|4146004|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4319037|NCT00468208|4146004|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4319038|NCT00468208|4146004|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4319039|NCT00468208|4146004|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4319040|NCT00468208|4146004|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4319041|NCT00468208|4146004|B1|||Age||years|Mean|45.1|45.1|Standard Deviation|16.8|16.8|||
4319042|NCT00468208|4146004|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4319043|NCT00468208|4146004|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4319044|NCT00468208|4146004|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4319045|NCT00468143|4146012|B1|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4319046|NCT00468143|4146012|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4319047|NCT00468143|4146012|B1|African American||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4319048|NCT00468143|4146012|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|46|46.0||||||
4319049|NCT00468143|4146012|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4319050|NCT00468143|4146012|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4319051|NCT00468143|4146012|B1|||Age||years|Mean|35.7|35.7|Standard Deviation|10.3|10.3|||
4319052|NCT00468104|4146027|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
4319053|NCT00468104|4146027|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4319054|NCT00468104|4146027|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4319055|NCT00468104|4146027|B1|||Age||years|Mean|67|67.0|Standard Deviation|15|15.0|||
4319056|NCT00468104|4146027|B1||>=65 years|Age||Participants|Count of Participants|61|61.0||||||
4319057|NCT00468104|4146027|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4319058|NCT00468104|4146027|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4319059|NCT00468052|4146043|B3|United States||Region of Enrollment||participants|Number|122|122.0||||||
4319060|NCT00468052|4146044|B2|United States||Region of Enrollment||participants|Number|61|61.0||||||
4319061|NCT00468052|4146045|B1|United States||Region of Enrollment||participants|Number|61|61.0||||||
4319062|NCT00468052|4146043|B3||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4319063|NCT00468052|4146044|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4319064|NCT00468052|4146045|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4319065|NCT00468052|4146043|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4319066|NCT00468052|4146044|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4319067|NCT00468052|4146045|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4319068|NCT00468052|4146043|B3|||Age||years|Mean|4.0|4.0|Standard Deviation|1.8|1.8|||
4319069|NCT00468052|4146044|B2|||Age||years|Mean|4.2|4.2|Standard Deviation|2.1|2.1|||
4319070|NCT00468052|4146045|B1|||Age||years|Mean|3.8|3.8|Standard Deviation|1.5|1.5|||
4319071|NCT00468052|4146043|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4319072|NCT00468052|4146044|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4319073|NCT00468052|4146045|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4319074|NCT00468052|4146043|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4319075|NCT00468052|4146044|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4319076|NCT00468052|4146045|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4319077|NCT00468052|4146043|B3||<=18 years|Age||Participants|Count of Participants|122|122.0||||||
4319078|NCT00468052|4146044|B2||<=18 years|Age||Participants|Count of Participants|61|61.0||||||
4319079|NCT00468052|4146045|B1||<=18 years|Age||Participants|Count of Participants|61|61.0||||||
4319080|NCT00467961|4146064|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4319081|NCT00467961|4146064|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4319082|NCT00467961|4146064|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4319083|NCT00467961|4146064|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4319084|NCT00467961|4146064|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4319085|NCT00467961|4146064|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4319086|NCT00467896|4146068|B1|United States||Region of Enrollment||participants|Number|62|62.0||||||
4319087|NCT00467896|4146068|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4319088|NCT00467896|4146068|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4319089|NCT00467896|4146068|B1|||Age||years|Mean|52.5|52.5|Standard Deviation|14.87|14.87|||
4319090|NCT00467896|4146068|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4319091|NCT00467896|4146068|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4319092|NCT00467896|4146068|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4319093|NCT00467870|4146088|B7|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4319094|NCT00467870|4146089|B6|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4319095|NCT00467870|4146090|B5|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4319096|NCT00467870|4146091|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4319097|NCT00467870|4146092|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4319098|NCT00467870|4146093|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4319099|NCT00467870|4146094|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4319100|NCT00467870|4146088|B7|Hispanic||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4319101|NCT00467870|4146089|B6|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4319102|NCT00467870|4146090|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4319103|NCT00467870|4146091|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4319104|NCT00467870|4146092|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4319105|NCT00467870|4146093|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4319106|NCT00467870|4146094|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4319107|NCT00467870|4146088|B7|Black||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
4319108|NCT00467870|4146089|B6|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4319109|NCT00467870|4146090|B5|Black||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4319110|NCT00467870|4146091|B4|Black||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4319111|NCT00467870|4146092|B3|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4319112|NCT00467870|4146093|B2|Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4319113|NCT00467870|4146094|B1|Black||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4319114|NCT00467870|4146088|B7|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4319115|NCT00467870|4146089|B6|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4319116|NCT00467870|4146090|B5|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4319117|NCT00467870|4146091|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4319118|NCT00467870|4146092|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4319119|NCT00467870|4146093|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4319120|NCT00467870|4146094|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4319121|NCT00467870|4146088|B7|White||Race/Ethnicity, Customized||participants|Number|432|432.0||||||
4319122|NCT00467870|4146089|B6|White||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4319123|NCT00467870|4146090|B5|White||Race/Ethnicity, Customized||participants|Number|97|97.0||||||
4319124|NCT00467870|4146091|B4|White||Race/Ethnicity, Customized||participants|Number|92|92.0||||||
4319125|NCT00467870|4146092|B3|White||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4319126|NCT00467870|4146093|B2|White||Race/Ethnicity, Customized||participants|Number|106|106.0||||||
4319127|NCT00467870|4146094|B1|White||Race/Ethnicity, Customized||participants|Number|101|101.0||||||
4319128|NCT00467870|4146088|B7||Male|Sex/Gender, Customized||Participants|Count of Participants|524|524.0||||||
4319129|NCT00467870|4146089|B6||Male|Sex/Gender, Customized||Participants|Count of Participants|23|23.0||||||
4319130|NCT00467870|4146090|B5||Male|Sex/Gender, Customized||Participants|Count of Participants|130|130.0||||||
4319131|NCT00467870|4146091|B4||Male|Sex/Gender, Customized||Participants|Count of Participants|112|112.0||||||
4319132|NCT00467870|4146092|B3||Male|Sex/Gender, Customized||Participants|Count of Participants|22|22.0||||||
4319133|NCT00467870|4146093|B2||Male|Sex/Gender, Customized||Participants|Count of Participants|117|117.0||||||
4319134|NCT00467870|4146094|B1||Male|Sex/Gender, Customized||Participants|Count of Participants|120|120.0||||||
4319135|NCT00467870|4146088|B7||Female|Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
4319136|NCT00467870|4146089|B6||Female|Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
4319137|NCT00467870|4146090|B5||Female|Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
4319138|NCT00467870|4146091|B4||Female|Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
4319139|NCT00467870|4146092|B3||Female|Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
4319140|NCT00467870|4146093|B2||Female|Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
4319141|NCT00467870|4146094|B1||Female|Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
4319142|NCT00467870|4146088|B7|||Age, Customized||years|Mean|54.4|54.4|Standard Deviation|10.56|10.56|||
4319143|NCT00467870|4146089|B6|||Age, Customized||years|Mean|54.5|54.5|Standard Deviation|10.63|10.63|||
4319144|NCT00467870|4146090|B5|||Age, Customized||years|Mean|54.2|54.2|Standard Deviation|10.25|10.25|||
4319145|NCT00467870|4146091|B4|||Age, Customized||years|Mean|52.9|52.9|Standard Deviation|10.96|10.96|||
4319146|NCT00467870|4146092|B3|||Age, Customized||years|Mean|55.3|55.3|Standard Deviation|10.40|10.4|||
4319147|NCT00467870|4146093|B2|||Age, Customized||years|Mean|55.9|55.9|Standard Deviation|10.77|10.77|||
4319148|NCT00467870|4146094|B1|||Age, Customized||years|Mean|55.0|55.0|Standard Deviation|10.64|10.64|||
4319149|NCT00467857|4146140|B3|Class IV||New York Heart Association (NYHA) Functional Classification|"The NYHA Functional Classification provides a simple way of classifying the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity:~Class I: No symptoms and no limitation in ordinary physical activity.~Class II: Mild symptoms and slight limitation during ordinary activity. Comfortable at rest.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity. Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest."|participants|Number|10|10.0||||||
4319150|NCT00467857|4146141|B2|Class IV||New York Heart Association (NYHA) Functional Classification|"The NYHA Functional Classification provides a simple way of classifying the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity:~Class I: No symptoms and no limitation in ordinary physical activity.~Class II: Mild symptoms and slight limitation during ordinary activity. Comfortable at rest.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity. Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest."|participants|Number|5|5.0||||||
4319151|NCT00467857|4146142|B1|Class IV||New York Heart Association (NYHA) Functional Classification|"The NYHA Functional Classification provides a simple way of classifying the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity:~Class I: No symptoms and no limitation in ordinary physical activity.~Class II: Mild symptoms and slight limitation during ordinary activity. Comfortable at rest.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity. Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest."|participants|Number|5|5.0||||||
4319152|NCT00467857|4146140|B3|Class III||New York Heart Association (NYHA) Functional Classification|"The NYHA Functional Classification provides a simple way of classifying the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity:~Class I: No symptoms and no limitation in ordinary physical activity.~Class II: Mild symptoms and slight limitation during ordinary activity. Comfortable at rest.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity. Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest."|participants|Number|82|82.0||||||
4319180|NCT00467857|4146141|B2|Not obese||Obesity||participants|Number|127|127.0||||||
4319181|NCT00467857|4146142|B1|Not obese||Obesity||participants|Number|106|106.0||||||
4319153|NCT00467857|4146141|B2|Class III||New York Heart Association (NYHA) Functional Classification|"The NYHA Functional Classification provides a simple way of classifying the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity:~Class I: No symptoms and no limitation in ordinary physical activity.~Class II: Mild symptoms and slight limitation during ordinary activity. Comfortable at rest.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity. Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest."|participants|Number|43|43.0||||||
4319154|NCT00467857|4146142|B1|Class III||New York Heart Association (NYHA) Functional Classification|"The NYHA Functional Classification provides a simple way of classifying the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity:~Class I: No symptoms and no limitation in ordinary physical activity.~Class II: Mild symptoms and slight limitation during ordinary activity. Comfortable at rest.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity. Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest."|participants|Number|39|39.0||||||
4319155|NCT00467857|4146140|B3|Class II||New York Heart Association (NYHA) Functional Classification|"The NYHA Functional Classification provides a simple way of classifying the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity:~Class I: No symptoms and no limitation in ordinary physical activity.~Class II: Mild symptoms and slight limitation during ordinary activity. Comfortable at rest.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity. Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest."|participants|Number|134|134.0||||||
4319156|NCT00467857|4146141|B2|Class II||New York Heart Association (NYHA) Functional Classification|"The NYHA Functional Classification provides a simple way of classifying the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity:~Class I: No symptoms and no limitation in ordinary physical activity.~Class II: Mild symptoms and slight limitation during ordinary activity. Comfortable at rest.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity. Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest."|participants|Number|61|61.0||||||
4319157|NCT00467857|4146142|B1|Class II||New York Heart Association (NYHA) Functional Classification|"The NYHA Functional Classification provides a simple way of classifying the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity:~Class I: No symptoms and no limitation in ordinary physical activity.~Class II: Mild symptoms and slight limitation during ordinary activity. Comfortable at rest.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity. Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest."|participants|Number|73|73.0||||||
4319158|NCT00467857|4146140|B3|Class I||New York Heart Association (NYHA) Functional Classification|"The NYHA Functional Classification provides a simple way of classifying the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity:~Class I: No symptoms and no limitation in ordinary physical activity.~Class II: Mild symptoms and slight limitation during ordinary activity. Comfortable at rest.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity. Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest."|participants|Number|67|67.0||||||
4319159|NCT00467857|4146141|B2|Class I||New York Heart Association (NYHA) Functional Classification|"The NYHA Functional Classification provides a simple way of classifying the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity:~Class I: No symptoms and no limitation in ordinary physical activity.~Class II: Mild symptoms and slight limitation during ordinary activity. Comfortable at rest.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity. Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest."|participants|Number|38|38.0||||||
4319160|NCT00467857|4146142|B1|Class I||New York Heart Association (NYHA) Functional Classification|"The NYHA Functional Classification provides a simple way of classifying the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity:~Class I: No symptoms and no limitation in ordinary physical activity.~Class II: Mild symptoms and slight limitation during ordinary activity. Comfortable at rest.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity. Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest."|participants|Number|29|29.0||||||
4319161|NCT00467857|4146140|B3|No||Alcohol Use||participants|Number|199|199.0||||||
4319162|NCT00467857|4146141|B2|No||Alcohol Use||participants|Number|95|95.0||||||
4319163|NCT00467857|4146142|B1|No||Alcohol Use||participants|Number|104|104.0||||||
4319164|NCT00467857|4146140|B3|Yes||Alcohol Use||participants|Number|94|94.0||||||
4319165|NCT00467857|4146141|B2|Yes||Alcohol Use||participants|Number|52|52.0||||||
4319166|NCT00467857|4146142|B1|Yes||Alcohol Use||participants|Number|42|42.0||||||
4319167|NCT00467857|4146140|B3|no||Tobacco Use||participants|Number|118|118.0||||||
4319168|NCT00467857|4146141|B2|no||Tobacco Use||participants|Number|56|56.0||||||
4319169|NCT00467857|4146142|B1|no||Tobacco Use||participants|Number|62|62.0||||||
4319170|NCT00467857|4146140|B3|yes||Tobacco Use||participants|Number|175|175.0||||||
4319171|NCT00467857|4146141|B2|yes||Tobacco Use||participants|Number|91|91.0||||||
4319172|NCT00467857|4146142|B1|yes||Tobacco Use||participants|Number|84|84.0||||||
4319173|NCT00467857|4146140|B3|absent||Diabetes mellitus, type 1 or 2||participants|Number|195|195.0||||||
4319174|NCT00467857|4146141|B2|absent||Diabetes mellitus, type 1 or 2||participants|Number|98|98.0||||||
4319175|NCT00467857|4146142|B1|absent||Diabetes mellitus, type 1 or 2||participants|Number|97|97.0||||||
4319176|NCT00467857|4146140|B3|present||Diabetes mellitus, type 1 or 2||participants|Number|98|98.0||||||
4319177|NCT00467857|4146141|B2|present||Diabetes mellitus, type 1 or 2||participants|Number|49|49.0||||||
4319178|NCT00467857|4146142|B1|present||Diabetes mellitus, type 1 or 2||participants|Number|49|49.0||||||
4319179|NCT00467857|4146140|B3|Not obese||Obesity||participants|Number|233|233.0||||||
4319182|NCT00467857|4146140|B3|Obese (BMI>30.0 kg/m^2)||Obesity||participants|Number|60|60.0||||||
4319183|NCT00467857|4146141|B2|Obese (BMI>30.0 kg/m^2)||Obesity||participants|Number|20|20.0||||||
4319184|NCT00467857|4146142|B1|Obese (BMI>30.0 kg/m^2)||Obesity||participants|Number|40|40.0||||||
4319185|NCT00467857|4146140|B3|||Body Mass Index (BMI)|Results for n=145 microbial skin sealant, n=147 control.|kg/m^2|Mean|26.9|26.9|Standard Deviation|3.71|3.71|||
4319186|NCT00467857|4146141|B2|||Body Mass Index (BMI)|Results for n=145 microbial skin sealant, n=147 control.|kg/m^2|Mean|26.6|26.6|Standard Deviation|3.4|3.4|||
4319187|NCT00467857|4146142|B1|||Body Mass Index (BMI)|Results for n=145 microbial skin sealant, n=147 control.|kg/m^2|Mean|27.3|27.3|Standard Deviation|4.0|4.0|||
4319188|NCT00467857|4146140|B3|||Weight||kilograms|Mean|75.0|75.0|Standard Deviation|13.3|13.3|||
4319189|NCT00467857|4146141|B2|||Weight||kilograms|Mean|73.8|73.8|Standard Deviation|12.0|12.0|||
4319190|NCT00467857|4146142|B1|||Weight||kilograms|Mean|76.2|76.2|Standard Deviation|14.4|14.4|||
4319191|NCT00467857|4146140|B3|||Height|Data for n=145 microbial skin sealant, n=147 control|meters|Mean|1.67|1.67|Standard Deviation|0.10|0.1|||
4319192|NCT00467857|4146141|B2|||Height|Data for n=145 microbial skin sealant, n=147 control|meters|Mean|1.66|1.66|Standard Deviation|0.09|0.09|||
4319193|NCT00467857|4146142|B1|||Height|Data for n=145 microbial skin sealant, n=147 control|meters|Mean|1.67|1.67|Standard Deviation|0.10|0.1|||
4319194|NCT00467857|4146140|B3||Male|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
4319195|NCT00467857|4146141|B2||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4319196|NCT00467857|4146142|B1||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4319197|NCT00467857|4146140|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4319198|NCT00467857|4146141|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4319199|NCT00467857|4146142|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4319200|NCT00467857|4146140|B3|||Age||years|Mean|63.06|63.06|Standard Deviation|9.28|9.28|||
4319201|NCT00467857|4146141|B2|||Age||years|Mean|62.94|62.94|Standard Deviation|9.97|9.97|||
4319202|NCT00467857|4146142|B1|||Age||years|Mean|63.18|63.18|Standard Deviation|8.53|8.53|||
4319203|NCT00467844|4146175|B4|Argentina||Region of Enrollment||participants|Number|47|47.0||||||
4319204|NCT00467844|4146176|B3|Argentina||Region of Enrollment||participants|Number|16|16.0||||||
4319205|NCT00467844|4146177|B2|Argentina||Region of Enrollment||participants|Number|17|17.0||||||
4319206|NCT00467844|4146178|B1|Argentina||Region of Enrollment||participants|Number|14|14.0||||||
4319207|NCT00467844|4146175|B4|United States||Region of Enrollment||participants|Number|112|112.0||||||
4319208|NCT00467844|4146176|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4319209|NCT00467844|4146177|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4319210|NCT00467844|4146178|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4319211|NCT00467844|4146175|B4||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4319212|NCT00467844|4146176|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4319213|NCT00467844|4146177|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4319214|NCT00467844|4146178|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4319215|NCT00467844|4146175|B4||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4319216|NCT00467844|4146176|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4319217|NCT00467844|4146177|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4319218|NCT00467844|4146178|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4319219|NCT00467844|4146175|B4|||Age||years|Mean|65.9|65.9|Standard Deviation|9.74|9.74|||
4319220|NCT00467844|4146176|B3|||Age||years|Mean|65.6|65.6|Standard Deviation|8.73|8.73|||
4319221|NCT00467844|4146177|B2|||Age||years|Mean|66.3|66.3|Standard Deviation|10.51|10.51|||
4319222|NCT00467844|4146178|B1|||Age||years|Mean|65.7|65.7|Standard Deviation|10.03|10.03|||
4319223|NCT00467844|4146175|B4||>=65 years|Age||Participants|Count of Participants|88|88.0||||||
4319224|NCT00467844|4146176|B3||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4319225|NCT00467844|4146177|B2||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4319226|NCT00467844|4146178|B1||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4319227|NCT00467844|4146175|B4||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4319228|NCT00467844|4146176|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4319229|NCT00467844|4146177|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4319230|NCT00467844|4146178|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4319231|NCT00467844|4146175|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4319232|NCT00467844|4146176|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4319233|NCT00467844|4146177|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4319234|NCT00467844|4146178|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4319235|NCT00467831|4146191|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4319236|NCT00467831|4146191|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4319237|NCT00467831|4146191|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4319238|NCT00467831|4146191|B1|||Age||years|Mean|51|51.0|Standard Deviation|9|9.0|||
4319239|NCT00467831|4146191|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4319240|NCT00467831|4146191|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4319241|NCT00467831|4146191|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4319242|NCT00467779|4146195|B16||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4319243|NCT00467779|4146196|B15||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4319244|NCT00467779|4146197|B14||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4319245|NCT00467779|4146198|B13||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4319246|NCT00467779|4146199|B12||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4319247|NCT00467779|4146200|B11||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4319248|NCT00467779|4146201|B10||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4319249|NCT00467779|4146202|B9||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4319250|NCT00467779|4146203|B8||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4319251|NCT00467779|4146204|B7||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4319252|NCT00467779|4146205|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4319253|NCT00467779|4146206|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4319254|NCT00467779|4146207|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4319255|NCT00467779|4146208|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4319256|NCT00467779|4146209|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4319257|NCT00467779|4146210|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4319258|NCT00467779|4146195|B16||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4319259|NCT00467779|4146196|B15||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4319260|NCT00467779|4146197|B14||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4319261|NCT00467779|4146198|B13||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4319262|NCT00467779|4146199|B12||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4319263|NCT00467779|4146200|B11||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4319264|NCT00467779|4146201|B10||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4319265|NCT00467779|4146202|B9||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4319266|NCT00467779|4146203|B8||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4319267|NCT00467779|4146204|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4319268|NCT00467779|4146205|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4319269|NCT00467779|4146206|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4319270|NCT00467779|4146207|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4319271|NCT00467779|4146208|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4319272|NCT00467779|4146209|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4319273|NCT00467779|4146210|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4319274|NCT00467779|4146195|B16|||Age||years|Mean|59.1|59.1|Standard Deviation|12.8|12.8|||
4319275|NCT00467779|4146196|B15|||Age||years|Mean|57.1|57.1|Standard Deviation|15.60|15.6|||
4319276|NCT00467779|4146197|B14|||Age||years|Mean|61.1|61.1|Standard Deviation|11.45|11.45|||
4319277|NCT00467779|4146198|B13|||Age||years|Mean|61.5|61.5|Standard Deviation|13.61|13.61|||
4319278|NCT00467779|4146199|B12|||Age||years|Mean|55.1|55.1|Standard Deviation|13.46|13.46|||
4319279|NCT00467779|4146200|B11|||Age||years|Mean|49.7|49.7|Standard Deviation|21.08|21.08|||
4319280|NCT00467779|4146201|B10|||Age||years|Mean|52.7|52.7|Standard Deviation|13.20|13.2|||
4319281|NCT00467779|4146202|B9|||Age||years|Mean|59.7|59.7|Standard Deviation|13.08|13.08|||
4319282|NCT00467779|4146203|B8|||Age||years|Mean|54.4|54.4|Standard Deviation|8.40|8.4|||
4319283|NCT00467779|4146204|B7|||Age||years|Mean|63.9|63.9|Standard Deviation|5.87|5.87|||
4319284|NCT00467779|4146205|B6|||Age||years|Mean|62.0|62.0|Standard Deviation|12.38|12.38|||
4319285|NCT00467779|4146206|B5|||Age||years|Mean|60.7|60.7|Standard Deviation|9.61|9.61|||
4319286|NCT00467779|4146207|B4|||Age||years|Mean|66.0|66.0|Standard Deviation|10.82|10.82|||
4319287|NCT00467779|4146208|B3|||Age||years|Mean|51.3|51.3|Standard Deviation|6.35|6.35|||
4319288|NCT00467779|4146209|B2|||Age||years|Mean|60.7|60.7|Standard Deviation|19.73|19.73|||
4319289|NCT00467779|4146210|B1|||Age||years|Mean|66.0|66.0|Standard Deviation|11.52|11.52|||
4319290|NCT00467753|4146396|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4319291|NCT00467753|4146397|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4319292|NCT00467753|4146398|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4319293|NCT00467753|4146396|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4319294|NCT00467753|4146397|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4319295|NCT00467753|4146398|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4319296|NCT00467753|4146396|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4319297|NCT00467753|4146397|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4319298|NCT00467753|4146398|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4319299|NCT00467753|4146396|B3|||Age||years|Mean|9.8|9.8|Standard Deviation|2|2.0|||
4319300|NCT00467753|4146397|B2|||Age||years|Mean|12.5|12.5|Standard Deviation|3|3.0|||
4319301|NCT00467753|4146398|B1|||Age||years|Mean|7.6|7.6|Standard Deviation|2|2.0|||
4319302|NCT00467753|4146396|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4319303|NCT00467753|4146397|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4319304|NCT00467753|4146398|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4319305|NCT00467753|4146396|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4319306|NCT00467753|4146397|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4319307|NCT00467753|4146398|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4319308|NCT00467753|4146396|B3||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4319309|NCT00467753|4146397|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4319310|NCT00467753|4146398|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4319311|NCT00467740|4146405|B6||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4319312|NCT00467740|4146406|B5||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4319313|NCT00467740|4146407|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4319314|NCT00467740|4146408|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4319315|NCT00467740|4146409|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4319316|NCT00467740|4146410|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4319317|NCT00467740|4146405|B6||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4319318|NCT00467740|4146406|B5||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4319319|NCT00467740|4146407|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4319320|NCT00467740|4146408|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4319321|NCT00467740|4146409|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4319322|NCT00467740|4146410|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4319323|NCT00467740|4146405|B6|||Age||years|Mean|45.23|45.23|Standard Deviation|13.88|13.88|||
4319324|NCT00467740|4146406|B5|||Age||years|Mean|44.62|44.62|Standard Deviation|12.95|12.95|||
4319325|NCT00467740|4146407|B4|||Age||years|Mean|46.25|46.25|Standard Deviation|14.45|14.45|||
4319326|NCT00467740|4146408|B3|||Age||years|Mean|46.17|46.17|Standard Deviation|12.96|12.96|||
4319327|NCT00467740|4146409|B2|||Age||years|Mean|45.36|45.36|Standard Deviation|15.12|15.12|||
4319328|NCT00467740|4146410|B1|||Age||years|Mean|43.59|43.59|Standard Deviation|14.11|14.11|||
4319329|NCT00467649|4146601|B3|||Weight||kg|Mean|105.67|105.67|Standard Deviation|20.032|20.032|||
4319330|NCT00467649|4146602|B2|||Weight||kg|Mean|103.46|103.46|Standard Deviation|17.908|17.908|||
4319331|NCT00467649|4146603|B1|||Weight||kg|Mean|107.87|107.87|Standard Deviation|21.893|21.893|||
4319332|NCT00467649|4146601|B3|||Waist Circumference||cm|Mean|116.73|116.73|Standard Deviation|14.297|14.297|||
4319333|NCT00467649|4146602|B2|||Waist Circumference||cm|Mean|117.15|117.15|Standard Deviation|13.198|13.198|||
4319334|NCT00467649|4146603|B1|||Waist Circumference||cm|Mean|116.31|116.31|Standard Deviation|15.427|15.427|||
4319335|NCT00467649|4146601|B3|||HbA1c||Percent|Mean|8.22|8.22|Standard Deviation|0.825|0.825|||
4319336|NCT00467649|4146602|B2|||HbA1c||Percent|Mean|8.25|8.25|Standard Deviation|0.816|0.816|||
4319337|NCT00467649|4146603|B1|||HbA1c||Percent|Mean|8.19|8.19|Standard Deviation|0.840|0.84|||
4319338|NCT00467649|4146601|B3|Triglycerides||Fasting Serum Lipids||mg/dL|Mean|183.95|183.95|Standard Deviation|136.273|136.273|||
4319339|NCT00467649|4146602|B2|Triglycerides||Fasting Serum Lipids||mg/dL|Mean|193.59|193.59|Standard Deviation|159.508|159.508|||
4319340|NCT00467649|4146603|B1|Triglycerides||Fasting Serum Lipids||mg/dL|Mean|174.13|174.13|Standard Deviation|108.257|108.257|||
4319341|NCT00467649|4146601|B3|LDL||Fasting Serum Lipids||mg/dL|Mean|89.78|89.78|Standard Deviation|36.133|36.133|||
4319342|NCT00467649|4146602|B2|LDL||Fasting Serum Lipids||mg/dL|Mean|90.41|90.41|Standard Deviation|34.114|34.114|||
4319343|NCT00467649|4146603|B1|LDL||Fasting Serum Lipids||mg/dL|Mean|89.15|89.15|Standard Deviation|38.386|38.386|||
4319344|NCT00467649|4146601|B3|HDL||Fasting Serum Lipids||mg/dL|Mean|43.23|43.23|Standard Deviation|10.790|10.79|||
4319345|NCT00467649|4146602|B2|HDL||Fasting Serum Lipids||mg/dL|Mean|41.77|41.77|Standard Deviation|9.468|9.468|||
4319346|NCT00467649|4146603|B1|HDL||Fasting Serum Lipids||mg/dL|Mean|44.71|44.71|Standard Deviation|11.893|11.893|||
4319347|NCT00467649|4146601|B3|Total Cholesterol||Fasting Serum Lipids||mg/dL|Mean|168.70|168.7|Standard Deviation|47.903|47.903|||
4319348|NCT00467649|4146602|B2|Total Cholesterol||Fasting Serum Lipids||mg/dL|Mean|169.86|169.86|Standard Deviation|49.121|49.121|||
4319349|NCT00467649|4146603|B1|Total Cholesterol||Fasting Serum Lipids||mg/dL|Mean|167.53|167.53|Standard Deviation|47.054|47.054|||
4319350|NCT00467649|4146601|B3|||Fasting Plasma Glucose||mg/dL|Mean|159.7|159.7|Standard Deviation|44.92|44.92|||
4319351|NCT00467649|4146602|B2|||Fasting Plasma Glucose||mg/dL|Mean|164.3|164.3|Standard Deviation|49.61|49.61|||
4319352|NCT00467649|4146603|B1|||Fasting Plasma Glucose||mg/dL|Mean|155.1|155.1|Standard Deviation|39.60|39.6|||
4319353|NCT00467649|4146601|B3|United States||Region of Enrollment||participants|Number|112|112.0||||||
4319354|NCT00467649|4146602|B2|United States||Region of Enrollment||participants|Number|56|56.0||||||
4319355|NCT00467649|4146603|B1|United States||Region of Enrollment||participants|Number|56|56.0||||||
4319356|NCT00467649|4146601|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4319357|NCT00467649|4146602|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4319358|NCT00467649|4146603|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4319359|NCT00467649|4146601|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4319360|NCT00467649|4146602|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4319361|NCT00467649|4146603|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4319362|NCT00467649|4146601|B3|||Age||years|Mean|54.3|54.3|Standard Deviation|10.53|10.53|||
4319363|NCT00467649|4146602|B2|||Age||years|Mean|53.6|53.6|Standard Deviation|9.70|9.7|||
4319364|NCT00467649|4146603|B1|||Age||years|Mean|55.0|55.0|Standard Deviation|11.35|11.35|||
4319365|NCT00467649|4146601|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4319366|NCT00467649|4146602|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4319367|NCT00467649|4146603|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4319368|NCT00467649|4146601|B3||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
4319369|NCT00467649|4146602|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4319370|NCT00467649|4146603|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4319371|NCT00467649|4146601|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4319372|NCT00467649|4146602|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4319373|NCT00467649|4146603|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4319374|NCT00467610|4146648|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4319375|NCT00467610|4146648|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4319376|NCT00467610|4146648|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4319377|NCT00467610|4146648|B1|||Age||years|Mean|73|73.0|Full Range|0|0.0|64.0|80.0|
4319378|NCT00467610|4146648|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4319379|NCT00467610|4146648|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4319380|NCT00467610|4146648|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4319381|NCT00467597|4146655|B5|||mAIMS at Screening|Modified Abnormal Involuntary Movement Rating Scale (mAIMS). This is a commonly utilized scale that is completed by an observer who judges the severity of levodopa induced dyskinesia (LID) in 7 body parts (face, neck, trunk, both legs, and both arms) during the finger tapping task, and during the Get-Up and go task (both described below). All body parts are rated separately on this 0 (none) to 4 (severe – markedly impairs activities) scale. Thus, the total score can range from 0 – 28 with 28 indicating the most severe LID.|units on a scale|Mean|3.1|3.1|Standard Deviation|5.0|5.0|||
4319382|NCT00467597|4146656|B4|||mAIMS at Screening|Modified Abnormal Involuntary Movement Rating Scale (mAIMS). This is a commonly utilized scale that is completed by an observer who judges the severity of levodopa induced dyskinesia (LID) in 7 body parts (face, neck, trunk, both legs, and both arms) during the finger tapping task, and during the Get-Up and go task (both described below). All body parts are rated separately on this 0 (none) to 4 (severe – markedly impairs activities) scale. Thus, the total score can range from 0 – 28 with 28 indicating the most severe LID.|units on a scale|Mean|0|0.0|Standard Deviation|0|0.0|||
4319383|NCT00467597|4146657|B3|||mAIMS at Screening|Modified Abnormal Involuntary Movement Rating Scale (mAIMS). This is a commonly utilized scale that is completed by an observer who judges the severity of levodopa induced dyskinesia (LID) in 7 body parts (face, neck, trunk, both legs, and both arms) during the finger tapping task, and during the Get-Up and go task (both described below). All body parts are rated separately on this 0 (none) to 4 (severe – markedly impairs activities) scale. Thus, the total score can range from 0 – 28 with 28 indicating the most severe LID.|units on a scale|Mean|11.8|11.8|Standard Deviation|3.5|3.5|||
4319384|NCT00467597|4146658|B2|||mAIMS at Screening|Modified Abnormal Involuntary Movement Rating Scale (mAIMS). This is a commonly utilized scale that is completed by an observer who judges the severity of levodopa induced dyskinesia (LID) in 7 body parts (face, neck, trunk, both legs, and both arms) during the finger tapping task, and during the Get-Up and go task (both described below). All body parts are rated separately on this 0 (none) to 4 (severe – markedly impairs activities) scale. Thus, the total score can range from 0 – 28 with 28 indicating the most severe LID.|units on a scale|Mean|1.6|1.6|Standard Deviation|2.4|2.4|||
4319385|NCT00467597|4146659|B1|||mAIMS at Screening|Modified Abnormal Involuntary Movement Rating Scale (mAIMS). This is a commonly utilized scale that is completed by an observer who judges the severity of levodopa induced dyskinesia (LID) in 7 body parts (face, neck, trunk, both legs, and both arms) during the finger tapping task, and during the Get-Up and go task (both described below). All body parts are rated separately on this 0 (none) to 4 (severe – markedly impairs activities) scale. Thus, the total score can range from 0 – 28 with 28 indicating the most severe LID.|units on a scale|Mean|0|0.0|Standard Deviation|0|0.0|||
4319386|NCT00467597|4146655|B5|||UPDRS (part III)|Unified Parkinson's Disease Rating Scale - Part III (Motor Section). This scale rates from 0 (normal) to 4 (Can barely perform the task) several motor areas including speech, facial expression, tremor, rigidity, hand movements, agility, posture, and gait. Higher values on this scale represent a more severe stage of the disease. the total score ranges from 0 to 108, with higher scores representing a more sever stage of the disease.|units on a scale|Mean|15.3|15.3|Standard Deviation|13.1|13.1|||
4319387|NCT00467597|4146656|B4|||UPDRS (part III)|Unified Parkinson's Disease Rating Scale - Part III (Motor Section). This scale rates from 0 (normal) to 4 (Can barely perform the task) several motor areas including speech, facial expression, tremor, rigidity, hand movements, agility, posture, and gait. Higher values on this scale represent a more severe stage of the disease. the total score ranges from 0 to 108, with higher scores representing a more sever stage of the disease.|units on a scale|Mean|0|0.0|Standard Deviation|0|0.0|||
4319388|NCT00467597|4146657|B3|||UPDRS (part III)|Unified Parkinson's Disease Rating Scale - Part III (Motor Section). This scale rates from 0 (normal) to 4 (Can barely perform the task) several motor areas including speech, facial expression, tremor, rigidity, hand movements, agility, posture, and gait. Higher values on this scale represent a more severe stage of the disease. the total score ranges from 0 to 108, with higher scores representing a more sever stage of the disease.|units on a scale|Mean|12.0|12.0|Standard Deviation|8.0|8.0|||
4319389|NCT00467597|4146658|B2|||UPDRS (part III)|Unified Parkinson's Disease Rating Scale - Part III (Motor Section). This scale rates from 0 (normal) to 4 (Can barely perform the task) several motor areas including speech, facial expression, tremor, rigidity, hand movements, agility, posture, and gait. Higher values on this scale represent a more severe stage of the disease. the total score ranges from 0 to 108, with higher scores representing a more sever stage of the disease.|units on a scale|Mean|23.5|23.5|Standard Deviation|12.7|12.7|||
4319448|NCT00467558|4146684|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4319449|NCT00467558|4146685|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4319390|NCT00467597|4146659|B1|||UPDRS (part III)|Unified Parkinson's Disease Rating Scale - Part III (Motor Section). This scale rates from 0 (normal) to 4 (Can barely perform the task) several motor areas including speech, facial expression, tremor, rigidity, hand movements, agility, posture, and gait. Higher values on this scale represent a more severe stage of the disease. the total score ranges from 0 to 108, with higher scores representing a more sever stage of the disease.|units on a scale|Mean|21.3|21.3|Standard Deviation|7.9|7.9|||
4319391|NCT00467597|4146655|B5|||Duration of Disease (years)||years|Mean|9.5|9.5|Standard Deviation|5.9|5.9|||
4319392|NCT00467597|4146656|B4|||Duration of Disease (years)||years|Mean|0|0.0|Standard Deviation|0|0.0|||
4319393|NCT00467597|4146657|B3|||Duration of Disease (years)||years|Mean|10.5|10.5|Standard Deviation|4.8|4.8|||
4319394|NCT00467597|4146658|B2|||Duration of Disease (years)||years|Mean|10.2|10.2|Standard Deviation|5.0|5.0|||
4319395|NCT00467597|4146659|B1|||Duration of Disease (years)||years|Mean|4.7|4.7|Standard Deviation|3.1|3.1|||
4319396|NCT00467597|4146655|B5|United States||Region of Enrollment||participants|Number|27|27.0||||||
4319397|NCT00467597|4146656|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
4319398|NCT00467597|4146657|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4319399|NCT00467597|4146658|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4319400|NCT00467597|4146659|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4319401|NCT00467597|4146655|B5||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4319402|NCT00467597|4146656|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4319403|NCT00467597|4146657|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4319404|NCT00467597|4146658|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4319405|NCT00467597|4146659|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4319406|NCT00467597|4146655|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4319407|NCT00467597|4146656|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4319408|NCT00467597|4146657|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4319409|NCT00467597|4146658|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4319410|NCT00467597|4146659|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4319411|NCT00467597|4146655|B5|||Age||years|Mean|64.0|64.0|Standard Deviation|8.7|8.7|||
4319412|NCT00467597|4146656|B4|||Age||years|Mean|68.3|68.3|Standard Deviation|8.2|8.2|||
4319413|NCT00467597|4146657|B3|||Age||years|Mean|61.4|61.4|Standard Deviation|6.8|6.8|||
4319414|NCT00467597|4146658|B2|||Age||years|Mean|62.8|62.8|Standard Deviation|10.6|10.6|||
4319415|NCT00467597|4146659|B1|||Age||years|Mean|63.5|63.5|Standard Deviation|6.1|6.1|||
4319416|NCT00467584|4146670|B4|United States||Region of Enrollment||participants|Number|62|62.0||||||
4319417|NCT00467584|4146671|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4319418|NCT00467584|4146672|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4319419|NCT00467584|4146673|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4319420|NCT00467584|4146670|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4319421|NCT00467584|4146671|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4319422|NCT00467584|4146672|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4319423|NCT00467584|4146673|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4319424|NCT00467584|4146670|B4||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4319425|NCT00467584|4146671|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4319426|NCT00467584|4146672|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4319427|NCT00467584|4146673|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4319428|NCT00467584|4146670|B4|||Age||years|Mean|47.0|47.0|Standard Deviation|9.0|9.0|||
4319429|NCT00467584|4146671|B3|||Age||years|Mean|47.4|47.4|Standard Deviation|8.0|8.0|||
4319430|NCT00467584|4146672|B2|||Age||years|Mean|47.0|47.0|Standard Deviation|10.3|10.3|||
4319431|NCT00467584|4146673|B1|||Age||years|Mean|46.6|46.6|Standard Deviation|8.6|8.6|||
4319432|NCT00467558|4146683|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4319433|NCT00467558|4146684|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4319434|NCT00467558|4146685|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4319435|NCT00467558|4146683|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4319436|NCT00467558|4146684|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4319437|NCT00467558|4146685|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4319438|NCT00467558|4146683|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4319439|NCT00467558|4146684|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4319440|NCT00467558|4146685|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4319441|NCT00467558|4146683|B3|||Age||years|Mean|31.87|31.87|Standard Deviation|9.31|9.31|||
4319442|NCT00467558|4146684|B2|||Age||years|Mean|35.67|35.67|Standard Deviation|10.69|10.69|||
4319443|NCT00467558|4146685|B1|||Age||years|Mean|27.67|27.67|Standard Deviation|7.37|7.37|||
4319444|NCT00467558|4146683|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4319445|NCT00467558|4146684|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4319446|NCT00467558|4146685|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4319447|NCT00467558|4146683|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4319450|NCT00467558|4146683|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4319451|NCT00467558|4146684|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4319452|NCT00467558|4146685|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4319453|NCT00467519|4146694|B3|Canada||Region of Enrollment||participants|Number|18|18.0||||||
4319454|NCT00467519|4146695|B2|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4319455|NCT00467519|4146696|B1|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4319456|NCT00467519|4146694|B3|United States||Region of Enrollment||participants|Number|1024|1024.0||||||
4319457|NCT00467519|4146695|B2|United States||Region of Enrollment||participants|Number|502|502.0||||||
4319458|NCT00467519|4146696|B1|United States||Region of Enrollment||participants|Number|522|522.0||||||
4319459|NCT00467519|4146694|B3||Male|Sex: Female, Male||Participants|Count of Participants|523|523.0||||||
4319460|NCT00467519|4146695|B2||Male|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
4319461|NCT00467519|4146696|B1||Male|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
4319462|NCT00467519|4146694|B3||Female|Sex: Female, Male||Participants|Count of Participants|519|519.0||||||
4319463|NCT00467519|4146695|B2||Female|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
4319464|NCT00467519|4146696|B1||Female|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4319465|NCT00467519|4146694|B3|||Age||Years|Mean|4.44|4.44|Standard Deviation|0.48|0.48|||
4319466|NCT00467519|4146695|B2|||Age||Years|Mean|4.42|4.42|Standard Deviation|0.47|0.47|||
4319467|NCT00467519|4146696|B1|||Age||Years|Mean|4.45|4.45|Standard Deviation|0.48|0.48|||
4319468|NCT00467519|4146694|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4319469|NCT00467519|4146695|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4319470|NCT00467519|4146696|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4319471|NCT00467519|4146694|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4319472|NCT00467519|4146695|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4319473|NCT00467519|4146696|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4319474|NCT00467519|4146694|B3||<=18 years|Age||Participants|Count of Participants|1042|1042.0||||||
4319475|NCT00467519|4146695|B2||<=18 years|Age||Participants|Count of Participants|511|511.0||||||
4319476|NCT00467519|4146696|B1||<=18 years|Age||Participants|Count of Participants|531|531.0||||||
4319477|NCT00467389|4146713|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4319478|NCT00467389|4146713|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4319479|NCT00467389|4146713|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4319480|NCT00467389|4146713|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4319481|NCT00467389|4146713|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4319482|NCT00467389|4146713|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4319483|NCT00467389|4146713|B1|||Age||Years|Mean|46.4|46.4|Standard Deviation|0.8|0.8|||
4319484|NCT00467363|4146724|B3|Non-White||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
4319485|NCT00467363|4146725|B2|Non-White||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4319486|NCT00467363|4146726|B1|Non-White||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4319487|NCT00467363|4146724|B3|White||Race/Ethnicity, Customized||participants|Number|1162|1162.0||||||
4319488|NCT00467363|4146725|B2|White||Race/Ethnicity, Customized||participants|Number|586|586.0||||||
4319489|NCT00467363|4146726|B1|White||Race/Ethnicity, Customized||participants|Number|576|576.0||||||
4319490|NCT00467363|4146724|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
4319491|NCT00467363|4146725|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
4319492|NCT00467363|4146726|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4319493|NCT00467363|4146724|B3||Female|Gender||Participants|Count of Participants|1228|1228.0||||||
4319494|NCT00467363|4146725|B2||Female|Gender||Participants|Count of Participants|613|613.0||||||
4319495|NCT00467363|4146726|B1||Female|Gender||Participants|Count of Participants|615|615.0||||||
4319496|NCT00467363|4146724|B3|||Age||years|Mean|28.7|28.7|Standard Deviation|4.8|4.8|||
4319497|NCT00467363|4146725|B2|||Age||years|Mean|28.7|28.7|Standard Deviation|4.7|4.7|||
4319498|NCT00467363|4146726|B1|||Age||years|Mean|28.8|28.8|Standard Deviation|4.9|4.9|||
4319499|NCT00467298|4146761|B3||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4319500|NCT00467298|4146762|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4319501|NCT00467298|4146763|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4319502|NCT00467298|4146761|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4319503|NCT00467298|4146762|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4319504|NCT00467298|4146763|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4319505|NCT00467298|4146761|B3|||Age||years|Mean|66|66.0|Standard Deviation|9|9.0|||
4319506|NCT00467298|4146762|B2|||Age||years|Mean|66.4|66.4|Standard Deviation|8|8.0|||
4319507|NCT00467298|4146763|B1|||Age||years|Mean|65.6|65.6|Standard Deviation|10|10.0|||
4319508|NCT00467285|4146772|B3|||Ctx||pg/mL|Mean|22|22.0|Standard Deviation|3|3.0|||
4319509|NCT00467285|4146773|B2|||Ctx||pg/mL|Mean|19|19.0|Standard Deviation|3|3.0|||
4319510|NCT00467285|4146774|B1|||Ctx||pg/mL|Mean|29|29.0|Standard Deviation|2|2.0|||
4319511|NCT00467285|4146772|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4319512|NCT00467285|4146773|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4319513|NCT00467285|4146774|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4319514|NCT00467285|4146772|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4319515|NCT00467285|4146773|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4319516|NCT00467285|4146774|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4319517|NCT00467285|4146772|B3|||Age||years|Mean|49|49.0|Standard Deviation|2|2.0|||
4319518|NCT00467285|4146773|B2|||Age||years|Mean|49|49.0|Standard Deviation|2|2.0|||
4319519|NCT00467285|4146774|B1|||Age||years|Mean|49|49.0|Standard Deviation|2|2.0|||
4319520|NCT00467285|4146772|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4319521|NCT00467285|4146773|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4319522|NCT00467285|4146774|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4319523|NCT00467285|4146772|B3||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
4319524|NCT00467285|4146773|B2||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4319525|NCT00467285|4146774|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4319526|NCT00467285|4146772|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4319527|NCT00467285|4146773|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4319528|NCT00467285|4146774|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4319529|NCT00467259|4146793|B3|United States||Region of Enrollment||participants|Number|1271|1271.0||||||
4319530|NCT00467259|4146794|B2|United States||Region of Enrollment||participants|Number|1020|1020.0||||||
4319531|NCT00467259|4146795|B1|United States||Region of Enrollment||participants|Number|251|251.0||||||
4319532|NCT00467259|4146793|B3|Spanish||Race/Ethnicity, Customized|ITT Population|Participants|Number|1|1.0||||||
4319533|NCT00467259|4146794|B2|Spanish||Race/Ethnicity, Customized|ITT Population|Participants|Number|0|0.0||||||
4319534|NCT00467259|4146795|B1|Spanish||Race/Ethnicity, Customized|ITT Population|Participants|Number|1|1.0||||||
4319535|NCT00467259|4146793|B3|Hawaiian / Pacific Islander||Race/Ethnicity, Customized|ITT Population|Participants|Number|1|1.0||||||
4319536|NCT00467259|4146794|B2|Hawaiian / Pacific Islander||Race/Ethnicity, Customized|ITT Population|Participants|Number|1|1.0||||||
4319537|NCT00467259|4146795|B1|Hawaiian / Pacific Islander||Race/Ethnicity, Customized|ITT Population|Participants|Number|0|0.0||||||
4319538|NCT00467259|4146793|B3|Multi-Racial||Race/Ethnicity, Customized|ITT Population|Participants|Number|5|5.0||||||
4319539|NCT00467259|4146794|B2|Multi-Racial||Race/Ethnicity, Customized|ITT Population|Participants|Number|1|1.0||||||
4319540|NCT00467259|4146795|B1|Multi-Racial||Race/Ethnicity, Customized|ITT Population|Participants|Number|4|4.0||||||
4319541|NCT00467259|4146793|B3|Mexican||Race/Ethnicity, Customized|ITT Population|Participants|Number|1|1.0||||||
4319542|NCT00467259|4146794|B2|Mexican||Race/Ethnicity, Customized|ITT Population|Participants|Number|0|0.0||||||
4319543|NCT00467259|4146795|B1|Mexican||Race/Ethnicity, Customized|ITT Population|Participants|Number|1|1.0||||||
4319544|NCT00467259|4146793|B3|Latino||Race/Ethnicity, Customized|ITT Population|Participants|Number|2|2.0||||||
4319545|NCT00467259|4146794|B2|Latino||Race/Ethnicity, Customized|ITT Population|Participants|Number|2|2.0||||||
4319546|NCT00467259|4146795|B1|Latino||Race/Ethnicity, Customized|ITT Population|Participants|Number|0|0.0||||||
4319547|NCT00467259|4146793|B3|Indian (Asian)||Race/Ethnicity, Customized|ITT Population|Participants|Number|1|1.0||||||
4319548|NCT00467259|4146794|B2|Indian (Asian)||Race/Ethnicity, Customized|ITT Population|Participants|Number|1|1.0||||||
4319549|NCT00467259|4146795|B1|Indian (Asian)||Race/Ethnicity, Customized|ITT Population|Participants|Number|0|0.0||||||
4319550|NCT00467259|4146793|B3|Hispanic||Race/Ethnicity, Customized|ITT Population|Participants|Number|4|4.0||||||
4319551|NCT00467259|4146794|B2|Hispanic||Race/Ethnicity, Customized|ITT Population|Participants|Number|3|3.0||||||
4319552|NCT00467259|4146795|B1|Hispanic||Race/Ethnicity, Customized|ITT Population|Participants|Number|1|1.0||||||
4319553|NCT00467259|4146793|B3|Caucasian||Race/Ethnicity, Customized|ITT Population|Participants|Number|1151|1151.0||||||
4319554|NCT00467259|4146794|B2|Caucasian||Race/Ethnicity, Customized|ITT Population|Participants|Number|920|920.0||||||
4319555|NCT00467259|4146795|B1|Caucasian||Race/Ethnicity, Customized|ITT Population|Participants|Number|231|231.0||||||
4319556|NCT00467259|4146793|B3|Black or African American||Race/Ethnicity, Customized|ITT Population|Participants|Number|91|91.0||||||
4319557|NCT00467259|4146794|B2|Black or African American||Race/Ethnicity, Customized|ITT Population|Participants|Number|82|82.0||||||
4319558|NCT00467259|4146795|B1|Black or African American||Race/Ethnicity, Customized|ITT Population|Participants|Number|9|9.0||||||
4319559|NCT00467259|4146793|B3|Asian (Oriental)||Race/Ethnicity, Customized|ITT Population|Participants|Number|9|9.0||||||
4319560|NCT00467259|4146794|B2|Asian (Oriental)||Race/Ethnicity, Customized|ITT Population|Participants|Number|6|6.0||||||
4319561|NCT00467259|4146795|B1|Asian (Oriental)||Race/Ethnicity, Customized|ITT Population|Participants|Number|3|3.0||||||
4319562|NCT00467259|4146793|B3|Indian (American)||Race/Ethnicity, Customized|ITT Population|Participants|Number|4|4.0||||||
4319563|NCT00467259|4146794|B2|Indian (American)||Race/Ethnicity, Customized|ITT Population|Participants|Number|3|3.0||||||
4319564|NCT00467259|4146795|B1|Indian (American)||Race/Ethnicity, Customized|ITT Population|Participants|Number|1|1.0||||||
4319565|NCT00467259|4146793|B3|Unknown or Not Reported||Ethnicity (NIH/OMB)|ITT Population|Participants|Number|0|0.0||||||
4319566|NCT00467259|4146794|B2|Unknown or Not Reported||Ethnicity (NIH/OMB)|ITT Population|Participants|Number|0|0.0||||||
4319567|NCT00467259|4146795|B1|Unknown or Not Reported||Ethnicity (NIH/OMB)|ITT Population|Participants|Number|0|0.0||||||
4319568|NCT00467259|4146793|B3|Not Hispanic or Latino||Ethnicity (NIH/OMB)|ITT Population|Participants|Number|1206|1206.0||||||
4319569|NCT00467259|4146794|B2|Not Hispanic or Latino||Ethnicity (NIH/OMB)|ITT Population|Participants|Number|969|969.0||||||
4319570|NCT00467259|4146795|B1|Not Hispanic or Latino||Ethnicity (NIH/OMB)|ITT Population|Participants|Number|237|237.0||||||
4319571|NCT00467259|4146793|B3|Hispanic or Latino||Ethnicity (NIH/OMB)|ITT Population|Participants|Number|64|64.0||||||
4319572|NCT00467259|4146794|B2|Hispanic or Latino||Ethnicity (NIH/OMB)|ITT Population|Participants|Number|50|50.0||||||
4319573|NCT00467259|4146795|B1|Hispanic or Latino||Ethnicity (NIH/OMB)|ITT Population|Participants|Number|14|14.0||||||
4319574|NCT00467259|4146793|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4319575|NCT00467259|4146794|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4319576|NCT00467259|4146795|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4319577|NCT00467259|4146793|B3||Female|Sex: Female, Male||Participants|Count of Participants|1271|1271.0||||||
4319578|NCT00467259|4146794|B2||Female|Sex: Female, Male||Participants|Count of Participants|1020|1020.0||||||
4319579|NCT00467259|4146795|B1||Female|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4319580|NCT00467259|4146793|B3|66 + years old||Age, Customized|ITT Population|Participants|Number|44|44.0||||||
4319581|NCT00467259|4146794|B2|66 + years old||Age, Customized|ITT Population|Participants|Number|35|35.0||||||
4319582|NCT00467259|4146795|B1|66 + years old||Age, Customized|ITT Population|Participants|Number|9|9.0||||||
4319583|NCT00467259|4146793|B3|60-65 years old||Age, Customized|ITT Population|Participants|Number|228|228.0||||||
4319584|NCT00467259|4146794|B2|60-65 years old||Age, Customized|ITT Population|Participants|Number|189|189.0||||||
4319585|NCT00467259|4146795|B1|60-65 years old||Age, Customized|ITT Population|Participants|Number|39|39.0||||||
4319586|NCT00467259|4146793|B3|50-59 years old||Age, Customized|ITT Population|Participants|Number|882|882.0||||||
4319587|NCT00467259|4146794|B2|50-59 years old||Age, Customized|ITT Population|Participants|Number|700|700.0||||||
4319588|NCT00467259|4146795|B1|50-59 years old||Age, Customized|ITT Population|Participants|Number|182|182.0||||||
4319589|NCT00467259|4146793|B3|40-49 years old||Age, Customized|ITT Population|Participants|Number|116|116.0||||||
4319590|NCT00467259|4146794|B2|40-49 years old||Age, Customized|ITT Population|Participants|Number|95|95.0||||||
4319591|NCT00467259|4146795|B1|40-49 years old||Age, Customized|ITT Population|Participants|Number|21|21.0||||||
4319592|NCT00467259|4146793|B3|||Age|ITT Population|years|Mean|55.7|55.7|Standard Deviation|4.9|4.9|||
4319593|NCT00467259|4146794|B2|||Age|ITT Population|years|Mean|55.8|55.8|Standard Deviation|4.9|4.9|||
4319594|NCT00467259|4146795|B1|||Age|ITT Population|years|Mean|55.5|55.5|Standard Deviation|4.8|4.8|||
4319595|NCT00467077|4146806|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4319596|NCT00467077|4146806|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4319597|NCT00467077|4146806|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4319598|NCT00467077|4146806|B1|||Age||years|Median|60|60.0|Full Range|||41.0|80.0|
4319599|NCT00467051|4146813|B1|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
4319600|NCT00467051|4146813|B1|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4319601|NCT00467051|4146813|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4319602|NCT00467051|4146813|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4319603|NCT00467051|4146813|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4319604|NCT00467051|4146813|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319605|NCT00467051|4146813|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4319606|NCT00467051|4146813|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4319607|NCT00467051|4146813|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319608|NCT00467051|4146813|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4319609|NCT00467051|4146813|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319610|NCT00467051|4146813|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4319611|NCT00467051|4146813|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4319612|NCT00467051|4146813|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4319613|NCT00467051|4146813|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4319614|NCT00467051|4146813|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4319615|NCT00467051|4146813|B1|||Age||years|Median|13.5|13.5|Full Range|||1.0|18.0|
4319616|NCT00467051|4146813|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4319617|NCT00467051|4146813|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4319618|NCT00467051|4146813|B1||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
4319619|NCT00467038|4146818|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4319620|NCT00467038|4146819|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4319621|NCT00467038|4146820|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4319622|NCT00467038|4146818|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4319623|NCT00467038|4146819|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4319624|NCT00467038|4146820|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4319625|NCT00467038|4146818|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4319626|NCT00467038|4146819|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4319627|NCT00467038|4146820|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4319628|NCT00467038|4146818|B3|||Age||years|Mean|31.6|31.6|Standard Deviation|11|11.0|||
4319629|NCT00467038|4146819|B2|||Age||years|Mean|30.4|30.4|Standard Deviation|10.4|10.4|||
4319630|NCT00467038|4146820|B1|||Age||years|Mean|32.8|32.8|Standard Deviation|11.5|11.5|||
4319631|NCT00467038|4146818|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4319632|NCT00467038|4146819|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4319633|NCT00467038|4146820|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4319634|NCT00467038|4146818|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4319635|NCT00467038|4146819|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4319636|NCT00467038|4146820|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4319637|NCT00467038|4146818|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4319638|NCT00467038|4146819|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4319639|NCT00467038|4146820|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4319640|NCT00466960|4146829|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319641|NCT00466960|4146829|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4319642|NCT00466960|4146829|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4319643|NCT00466960|4146829|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319644|NCT00466960|4146829|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319645|NCT00466960|4146829|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319646|NCT00466960|4146829|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319647|NCT00466960|4146829|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319648|NCT00466960|4146829|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4319649|NCT00466960|4146829|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4319650|NCT00466960|4146829|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4319651|NCT00466960|4146829|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4319652|NCT00466960|4146829|B1|||Age||years|Median|61|61.0|Full Range|||30.0|92.0|
4319653|NCT00466947|4146838|B3|Panama||Region of Enrollment|Baseline measures presented below correspond to those of the subjects whose data were exploited towards analysis of results at the end of the study|Subjects|Number|7214|7214.0||||||
4319654|NCT00466947|4146839|B2|Panama||Region of Enrollment|Baseline measures presented below correspond to those of the subjects whose data were exploited towards analysis of results at the end of the study|Subjects|Number|3612|3612.0||||||
4319655|NCT00466947|4146840|B1|Panama||Region of Enrollment|Baseline measures presented below correspond to those of the subjects whose data were exploited towards analysis of results at the end of the study|Subjects|Number|3602|3602.0||||||
4319656|NCT00466947|4146838|B3|Columbia||Region of Enrollment|Baseline measures presented below correspond to those of the subjects whose data were exploited towards analysis of results at the end of the study|Subjects|Number|2402|2402.0||||||
4319657|NCT00466947|4146839|B2|Columbia||Region of Enrollment|Baseline measures presented below correspond to those of the subjects whose data were exploited towards analysis of results at the end of the study|Subjects|Number|1196|1196.0||||||
4319658|NCT00466947|4146840|B1|Columbia||Region of Enrollment|Baseline measures presented below correspond to those of the subjects whose data were exploited towards analysis of results at the end of the study|Subjects|Number|1206|1206.0||||||
4319659|NCT00466947|4146838|B3|Argentina||Region of Enrollment|Baseline measures presented below correspond to those of the subjects whose data were exploited towards analysis of results at the end of the study|Subjects|Number|13981|13981.0||||||
4319660|NCT00466947|4146839|B2|Argentina||Region of Enrollment|Baseline measures presented below correspond to those of the subjects whose data were exploited towards analysis of results at the end of the study|Subjects|Number|6991|6991.0||||||
4319661|NCT00466947|4146840|B1|Argentina||Region of Enrollment|Baseline measures presented below correspond to those of the subjects whose data were exploited towards analysis of results at the end of the study|Subjects|Number|6990|6990.0||||||
4319662|NCT00466947|4146838|B3||Male|Gender|Baseline measures presented below correspond to those of the subjects whose data were exploited towards analysis of results at the end of the study|Participants|Count of Participants|12034|12034.0||||||
4319663|NCT00466947|4146839|B2||Male|Gender|Baseline measures presented below correspond to those of the subjects whose data were exploited towards analysis of results at the end of the study|Participants|Count of Participants|6032|6032.0||||||
4319664|NCT00466947|4146840|B1||Male|Gender|Baseline measures presented below correspond to those of the subjects whose data were exploited towards analysis of results at the end of the study|Participants|Count of Participants|6002|6002.0||||||
4319665|NCT00466947|4146838|B3||Female|Gender|Baseline measures presented below correspond to those of the subjects whose data were exploited towards analysis of results at the end of the study|Participants|Count of Participants|11563|11563.0||||||
4319666|NCT00466947|4146839|B2||Female|Gender|Baseline measures presented below correspond to those of the subjects whose data were exploited towards analysis of results at the end of the study|Participants|Count of Participants|5767|5767.0||||||
4319667|NCT00466947|4146840|B1||Female|Gender|Baseline measures presented below correspond to those of the subjects whose data were exploited towards analysis of results at the end of the study|Participants|Count of Participants|5796|5796.0||||||
4319668|NCT00466947|4146838|B3|||Age|Baseline measures presented below correspond to those of the subjects whose data were exploited towards analysis of results at the end of the study|Weeks|Mean|9.2|9.2|Standard Deviation|1.92|1.92|||
4319669|NCT00466947|4146839|B2|||Age|Baseline measures presented below correspond to those of the subjects whose data were exploited towards analysis of results at the end of the study|Weeks|Mean|9.2|9.2|Standard Deviation|1.92|1.92|||
4319670|NCT00466947|4146840|B1|||Age|Baseline measures presented below correspond to those of the subjects whose data were exploited towards analysis of results at the end of the study|Weeks|Mean|9.2|9.2|Standard Deviation|1.93|1.93|||
4319671|NCT00466817|4146963|B3|United States||Region of Enrollment||participants|Number|96|96.0||||||
4319672|NCT00466817|4146964|B2|United States||Region of Enrollment||participants|Number|47|47.0||||||
4319673|NCT00466817|4146965|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
4319674|NCT00466817|4146963|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4319675|NCT00466817|4146964|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4319676|NCT00466817|4146965|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4319677|NCT00466817|4146963|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4319678|NCT00466817|4146964|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4319679|NCT00466817|4146965|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4319680|NCT00466817|4146963|B3|||Age||weeks|Median|15|15.0|Full Range|||2.0|30.0|
4319681|NCT00466817|4146964|B2|||Age||weeks|Median|14|14.0|Full Range|||5.0|30.0|
4319682|NCT00466817|4146965|B1|||Age||weeks|Median|19|19.0|Full Range|||2.0|30.0|
4319683|NCT00466752|4147019|B3|||Gleason Score at Diagnosis|Gleason score is the sum of 2 numbers,each between 1-5, representing the pattern of tumor cells seen by a pathologist reviewing a prostate biopsy. 1 is given to cells that resemble normal cells. 5 is given to cells that least resemble normal cells. 1st number represents the most predominant cell pattern in a prostate biopsy, 2nd number represents the 2nd most predominant cell pattern in the same biopsy. Gleason score is the sum of these numbers. Lower Gleason scores (2-4) have been associated with less aggressive cancers, higher Gleason scores have been associated with more aggressive cancers.|units on a scale|Median|7|7.0|Full Range|||7.0|9.0|
4319684|NCT00466752|4147021|B1|||Gleason Score at Diagnosis|Gleason score is the sum of 2 numbers,each between 1-5, representing the pattern of tumor cells seen by a pathologist reviewing a prostate biopsy. 1 is given to cells that resemble normal cells. 5 is given to cells that least resemble normal cells. 1st number represents the most predominant cell pattern in a prostate biopsy, 2nd number represents the 2nd most predominant cell pattern in the same biopsy. Gleason score is the sum of these numbers. Lower Gleason scores (2-4) have been associated with less aggressive cancers, higher Gleason scores have been associated with more aggressive cancers.|units on a scale|Median|7|7.0|Full Range|||7.0|9.0|
4319685|NCT00466752|4147019|B3|||Baseline PSA||ng/mL|Median|14.76|14.76|Full Range|||6.14|120.76|
4319686|NCT00466752|4147021|B1|||Baseline PSA||ng/mL|Median|14.76|14.76|Full Range|||6.14|120.76|
4319687|NCT00466752|4147019|B3|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4319688|NCT00466752|4147021|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4319689|NCT00466752|4147019|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319690|NCT00466752|4147020|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319691|NCT00466752|4147021|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319692|NCT00466752|4147019|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319693|NCT00466752|4147020|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319694|NCT00466752|4147021|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319695|NCT00466752|4147019|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4319696|NCT00466752|4147020|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319697|NCT00466752|4147021|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4319698|NCT00466752|4147019|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319699|NCT00466752|4147020|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319700|NCT00466752|4147021|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319701|NCT00466752|4147019|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319702|NCT00466752|4147020|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319703|NCT00466752|4147021|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319704|NCT00466752|4147019|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319705|NCT00466752|4147020|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319706|NCT00466752|4147021|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319707|NCT00466752|4147019|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319708|NCT00466752|4147020|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319709|NCT00466752|4147021|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319710|NCT00466752|4147019|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4319711|NCT00466752|4147020|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319712|NCT00466752|4147021|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4319713|NCT00466752|4147019|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4319714|NCT00466752|4147020|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319715|NCT00466752|4147021|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4319716|NCT00466752|4147019|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319717|NCT00466752|4147020|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319718|NCT00466752|4147021|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319719|NCT00466752|4147019|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4319720|NCT00466752|4147020|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4319721|NCT00466752|4147021|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4319722|NCT00466752|4147019|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4319723|NCT00466752|4147020|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4319724|NCT00466752|4147021|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4319725|NCT00466752|4147019|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4319726|NCT00466752|4147020|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4319727|NCT00466752|4147021|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4319728|NCT00466752|4147019|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4319729|NCT00466752|4147020|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4319730|NCT00466752|4147021|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4319731|NCT00466752|4147019|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4319732|NCT00466752|4147020|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4319733|NCT00466752|4147021|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4319734|NCT00466726|4147032|B1|Italy||Region of Enrollment||participants|Number|43|43.0||||||
4319735|NCT00466726|4147032|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4319736|NCT00466726|4147032|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4319737|NCT00466726|4147032|B1|||Age||years|Median|56.5|56.5|Full Range|||29.0|78.0|
4319738|NCT00466687|4147038|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4319739|NCT00466687|4147038|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4319740|NCT00466687|4147038|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4319741|NCT00466687|4147038|B1|||Age||years|Mean|64|64.0|Standard Deviation|1|1.0|||
4319742|NCT00466687|4147038|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4319743|NCT00466687|4147038|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4319744|NCT00466687|4147038|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4319745|NCT00466661|4147045|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
4319746|NCT00466661|4147046|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4319747|NCT00466661|4147047|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4319748|NCT00466661|4147045|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4319749|NCT00466661|4147046|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4319750|NCT00466661|4147047|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4319751|NCT00466661|4147045|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4319752|NCT00466661|4147046|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4319753|NCT00466661|4147047|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4319754|NCT00466661|4147045|B3|||Age||years|Mean|42.1|42.1|Standard Deviation|9.3|9.3|||
4319755|NCT00466661|4147046|B2|||Age||years|Mean|43.7|43.7|Standard Deviation|11.3|11.3|||
4319756|NCT00466661|4147047|B1|||Age||years|Mean|40.8|40.8|Standard Deviation|6.7|6.7|||
4319757|NCT00466505|4147070|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4319758|NCT00466505|4147070|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4319759|NCT00466505|4147070|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4319760|NCT00466505|4147070|B1|||Age||years|Mean|60|60.0|Standard Deviation|1|1.0|||
4319761|NCT00466505|4147070|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4319762|NCT00466505|4147070|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4319763|NCT00466505|4147070|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4319764|NCT00466323|4147082|B3|United States||Region of Enrollment||participants|Number|232|232.0||||||
4319765|NCT00466323|4147083|B2|United States||Region of Enrollment||participants|Number|115|115.0||||||
4319766|NCT00466323|4147084|B1|United States||Region of Enrollment||participants|Number|117|117.0||||||
4319767|NCT00466323|4147082|B3||Male|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4319768|NCT00466323|4147083|B2||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4319769|NCT00466323|4147084|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4319770|NCT00466323|4147082|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4319771|NCT00466323|4147083|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4319772|NCT00466323|4147084|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4319773|NCT00466323|4147082|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4319774|NCT00466323|4147083|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4319775|NCT00466323|4147084|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4319776|NCT00466323|4147082|B3||Between 18 and 65 years|Age||Participants|Count of Participants|223|223.0||||||
4319777|NCT00466323|4147083|B2||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
4319778|NCT00466323|4147084|B1||Between 18 and 65 years|Age||Participants|Count of Participants|114|114.0||||||
4319779|NCT00466323|4147082|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4319780|NCT00466323|4147083|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4319781|NCT00466323|4147084|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4319782|NCT00466323|4147082|B3|||Age||years|Mean|51.5|51.5|Standard Deviation|9.0|9.0|||
4319783|NCT00466323|4147083|B2|||Age||years|Mean|51.2|51.2|Standard Deviation|8.7|8.7|||
4319784|NCT00466323|4147084|B1|||Age||years|Mean|51.8|51.8|Standard Deviation|9.4|9.4|||
4319785|NCT00466310|4147097|B4|United States||Region of Enrollment||participants|Number|71|71.0||||||
4319786|NCT00466310|4147098|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4319787|NCT00466310|4147099|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4319788|NCT00466310|4147100|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4319789|NCT00466310|4147097|B4||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4319790|NCT00466310|4147098|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4319791|NCT00466310|4147099|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4319792|NCT00466310|4147100|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4319793|NCT00466310|4147097|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4319794|NCT00466310|4147098|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4319795|NCT00466310|4147099|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4319796|NCT00466310|4147100|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4319797|NCT00466310|4147097|B4|||Age||years|Mean|33.63|33.63|Standard Deviation|11.6|11.6|||
4319798|NCT00466310|4147098|B3|||Age||years|Mean|37.9|37.9|Standard Deviation|9.1|9.1|||
4319799|NCT00466310|4147099|B2|||Age||years|Mean|36.6|36.6|Standard Deviation|12.7|12.7|||
4319800|NCT00466310|4147100|B1|||Age||years|Mean|27|27.0|Standard Deviation|9.8|9.8|||
4319801|NCT00466310|4147097|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4319802|NCT00466310|4147098|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4319803|NCT00466310|4147099|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4319804|NCT00466310|4147100|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4319805|NCT00466310|4147097|B4||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4319806|NCT00466310|4147098|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4319807|NCT00466310|4147099|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4319808|NCT00466310|4147100|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4319809|NCT00466310|4147097|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4319810|NCT00466310|4147098|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4319811|NCT00466310|4147099|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4319812|NCT00466310|4147100|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4319813|NCT00466206|4147110|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4319814|NCT00466206|4147110|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4319815|NCT00466206|4147110|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4319816|NCT00466206|4147110|B1|||Age||years|Mean|12.7|12.7|Standard Deviation|2|2.0|||
4319817|NCT00466206|4147110|B1||>=65 years|Age|Between 8 and 14 years of age|Participants|Count of Participants|0|0.0||||||
4319818|NCT00466206|4147110|B1||Between 18 and 65 years|Age|Between 8 and 14 years of age|Participants|Count of Participants|0|0.0||||||
4319819|NCT00466206|4147110|B1||<=18 years|Age|Between 8 and 14 years of age|Participants|Count of Participants|10|10.0||||||
4319820|NCT00466193|4147118|B3|||Weight||kilograms|Mean|74.99|74.99|Standard Deviation|14.273|14.273|||
4319821|NCT00466193|4147119|B2|||Weight||kilograms|Mean|75.73|75.73|Standard Deviation|13.434|13.434|||
4319822|NCT00466193|4147120|B1|||Weight||kilograms|Mean|74.27|74.27|Standard Deviation|15.050|15.05|||
4319823|NCT00466193|4147118|B3|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilogram per square meter|Mean|26.35|26.35|Standard Deviation|3.807|3.807|||
4319824|NCT00466193|4147119|B2|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilogram per square meter|Mean|26.55|26.55|Standard Deviation|3.754|3.754|||
4319825|NCT00466193|4147120|B1|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilogram per square meter|Mean|26.17|26.17|Standard Deviation|3.860|3.86|||
4319826|NCT00466193|4147118|B3|United States||Region of Enrollment||participants|Number|295|295.0||||||
4319827|NCT00466193|4147119|B2|United States||Region of Enrollment||participants|Number|145|145.0||||||
4319828|NCT00466193|4147120|B1|United States||Region of Enrollment||participants|Number|150|150.0||||||
4319829|NCT00466193|4147118|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4319830|NCT00466193|4147119|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4319831|NCT00466193|4147120|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4319832|NCT00466193|4147118|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319833|NCT00466193|4147119|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319834|NCT00466193|4147120|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319835|NCT00466193|4147118|B3||White|Race (NIH/OMB)||Participants|Count of Participants|190|190.0||||||
4319836|NCT00466193|4147119|B2||White|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
4319837|NCT00466193|4147120|B1||White|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4319838|NCT00466193|4147118|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
4319839|NCT00466193|4147119|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4319840|NCT00466193|4147120|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4319841|NCT00466193|4147118|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4319842|NCT00466193|4147119|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319843|NCT00466193|4147120|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4319844|NCT00466193|4147118|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4319845|NCT00466193|4147119|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4319846|NCT00466193|4147120|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4319847|NCT00466193|4147118|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4319848|NCT00466193|4147119|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4319849|NCT00466193|4147120|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4319850|NCT00466193|4147118|B3||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4319851|NCT00466193|4147119|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4319852|NCT00466193|4147120|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4319853|NCT00466193|4147118|B3||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4319854|NCT00466193|4147119|B2||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4319855|NCT00466193|4147120|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4319856|NCT00466193|4147118|B3|||Age||years|Mean|42.8|42.8|Standard Deviation|11.33|11.33|||
4319857|NCT00466193|4147119|B2|||Age||years|Mean|43.4|43.4|Standard Deviation|11.30|11.3|||
4319858|NCT00466193|4147120|B1|||Age||years|Mean|42.3|42.3|Standard Deviation|11.38|11.38|||
4319859|NCT00466193|4147118|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4319860|NCT00466193|4147119|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4319861|NCT00466193|4147120|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4319862|NCT00466193|4147118|B3||Between 18 and 65 years|Age||Participants|Count of Participants|295|295.0||||||
4319863|NCT00466193|4147119|B2||Between 18 and 65 years|Age||Participants|Count of Participants|145|145.0||||||
4319864|NCT00466193|4147120|B1||Between 18 and 65 years|Age||Participants|Count of Participants|150|150.0||||||
4319865|NCT00466193|4147118|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4319866|NCT00466193|4147119|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4319867|NCT00466193|4147120|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4319868|NCT00466167|4147145|B4||Male|Sex: Female, Male||Participants|Count of Participants|284|284.0||||||
4319869|NCT00466167|4147146|B3||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4319870|NCT00466167|4147147|B2||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4319871|NCT00466167|4147148|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4319872|NCT00466167|4147145|B4||Female|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
4319873|NCT00466167|4147146|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4319874|NCT00466167|4147147|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4319875|NCT00466167|4147148|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4319876|NCT00466167|4147145|B4|||Age||years|Mean|61.5|61.5|Standard Deviation|9.9|9.9|||
4319877|NCT00466167|4147146|B3|||Age||years|Mean|60.9|60.9|Standard Deviation|9.7|9.7|||
4319878|NCT00466167|4147147|B2|||Age||years|Mean|62.0|62.0|Standard Deviation|10.3|10.3|||
4319879|NCT00466167|4147148|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|9.7|9.7|||
4319880|NCT00465998|4147206|B1|Norway||Region of Enrollment||participants|Number|275|275.0||||||
4319881|NCT00465998|4147206|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4319882|NCT00465998|4147206|B1||Female|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4319883|NCT00465998|4147206|B1|||Age||years|Median|30|30.0|Full Range|||18.0|45.0|
4319884|NCT00465998|4147206|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4319885|NCT00465998|4147206|B1||Between 18 and 65 years|Age||Participants|Count of Participants|272|272.0||||||
4319886|NCT00465998|4147206|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4319887|NCT00465985|4147211|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4319888|NCT00465985|4147211|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4319889|NCT00465985|4147211|B1|||Age||years|Mean|34|34.0|Standard Deviation|14.89|14.89|||
4319890|NCT00465972|4147233|B3|||Piper Fatigue Scale|A 22 item survey measuring level of fatigue. Subjects answer each item on a scale of 1 - 10, with 1 being low fatigue, and 10 being severe fatigue. Total range of overall score is 22-220, with 220 being severe fatigue.|Scores on a scale|Mean|116|116.0|Standard Deviation|45|45.0|||
4319891|NCT00465972|4147234|B2|||Piper Fatigue Scale|A 22 item survey measuring level of fatigue. Subjects answer each item on a scale of 1 - 10, with 1 being low fatigue, and 10 being severe fatigue. Total range of overall score is 22-220, with 220 being severe fatigue.|Scores on a scale|Mean|114|114.0|Standard Deviation|48|48.0|||
4319892|NCT00465972|4147235|B1|||Piper Fatigue Scale|A 22 item survey measuring level of fatigue. Subjects answer each item on a scale of 1 - 10, with 1 being low fatigue, and 10 being severe fatigue. Total range of overall score is 22-220, with 220 being severe fatigue.|Scores on a scale|Mean|138|138.0|Standard Deviation|42|42.0|||
4319893|NCT00465972|4147233|B3|||Insomnia Severity Index|Measures the severity of insomnia on 7 items, with a rating of 0 (low severity) to 4 (high severity). Total range for the index is 0-28; with 28 being the most severe.|Scores on a scale|Mean|17.1|17.1|Standard Deviation|5.0|5.0|||
4319894|NCT00465972|4147234|B2|||Insomnia Severity Index|Measures the severity of insomnia on 7 items, with a rating of 0 (low severity) to 4 (high severity). Total range for the index is 0-28; with 28 being the most severe.|Scores on a scale|Mean|16.6|16.6|Standard Deviation|5.1|5.1|||
4319895|NCT00465972|4147235|B1|||Insomnia Severity Index|Measures the severity of insomnia on 7 items, with a rating of 0 (low severity) to 4 (high severity). Total range for the index is 0-28; with 28 being the most severe.|Scores on a scale|Mean|17.7|17.7|Standard Deviation|4.9|4.9|||
4319896|NCT00465972|4147233|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319897|NCT00465972|4147234|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319898|NCT00465972|4147235|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319899|NCT00465972|4147233|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319900|NCT00465972|4147234|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319901|NCT00465972|4147235|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319902|NCT00465972|4147233|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4319903|NCT00465972|4147234|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4319904|NCT00465972|4147235|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4319905|NCT00465972|4147233|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4319906|NCT00465972|4147234|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4319907|NCT00465972|4147235|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4319908|NCT00465972|4147233|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319909|NCT00465972|4147234|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319910|NCT00465972|4147235|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319911|NCT00465972|4147233|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319912|NCT00465972|4147234|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319913|NCT00465972|4147235|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319914|NCT00465972|4147233|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319915|NCT00465972|4147234|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319916|NCT00465972|4147235|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4319917|NCT00465972|4147233|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4319918|NCT00465972|4147234|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4319919|NCT00465972|4147235|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4319920|NCT00465972|4147233|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4319921|NCT00465972|4147234|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4319922|NCT00465972|4147235|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4319923|NCT00465972|4147233|B3|||Age||Years|Mean|48.1|48.1|Standard Deviation|6.6|6.6|||
4319924|NCT00465972|4147234|B2|||Age||Years|Mean|47.8|47.8|Standard Deviation|7.9|7.9|||
4319925|NCT00465972|4147235|B1|||Age||Years|Mean|48.46|48.46|Standard Deviation|5.1|5.1|||
4319926|NCT00465894|4147244|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4319927|NCT00465894|4147245|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4319928|NCT00465894|4147246|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4319929|NCT00465894|4147244|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4319930|NCT00465894|4147245|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4319931|NCT00465894|4147246|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4319932|NCT00465894|4147244|B3|||Age||years|Mean|61.5|61.5|Standard Deviation|4|4.0|||
4319933|NCT00465894|4147245|B2|||Age||years|Mean|60|60.0|Standard Deviation|2|2.0|||
4319934|NCT00465894|4147246|B1|||Age||years|Mean|63|63.0|Standard Deviation|6|6.0|||
4319935|NCT00465816|4147277|B4|Not specified||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4319936|NCT00465816|4147278|B3|Not specified||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4319937|NCT00465816|4147279|B2|Not specified||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4319938|NCT00465816|4147280|B1|Not specified||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4319939|NCT00465816|4147277|B4|White - Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|599|599.0||||||
4319940|NCT00465816|4147278|B3|White - Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|121|121.0||||||
4319941|NCT00465816|4147279|B2|White - Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|117|117.0||||||
4319942|NCT00465816|4147280|B1|White - Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|361|361.0||||||
4319943|NCT00465816|4147277|B4|White - Arabic/north African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4319944|NCT00465816|4147278|B3|White - Arabic/north African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4319945|NCT00465816|4147279|B2|White - Arabic/north African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4319946|NCT00465816|4147280|B1|White - Arabic/north African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4319947|NCT00465816|4147277|B4|Asian - south east Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4319948|NCT00465816|4147278|B3|Asian - south east Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4319949|NCT00465816|4147279|B2|Asian - south east Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4319950|NCT00465816|4147280|B1|Asian - south east Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4319951|NCT00465816|4147277|B4|Asian - east Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4319952|NCT00465816|4147278|B3|Asian - east Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4319953|NCT00465816|4147279|B2|Asian - east Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4319954|NCT00465816|4147280|B1|Asian - east Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4319955|NCT00465816|4147277|B4|Asian - central/south Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4319956|NCT00465816|4147278|B3|Asian - central/south Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4319957|NCT00465816|4147279|B2|Asian - central/south Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4319958|NCT00465816|4147280|B1|Asian - central/south Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4319959|NCT00465816|4147277|B4|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4319960|NCT00465816|4147278|B3|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4319961|NCT00465816|4147279|B2|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4319962|NCT00465816|4147280|B1|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4319963|NCT00465816|4147277|B4||Male|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
4319964|NCT00465816|4147278|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4319965|NCT00465816|4147279|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4319966|NCT00465816|4147280|B1||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4319967|NCT00465816|4147277|B4||Female|Sex: Female, Male||Participants|Count of Participants|324|324.0||||||
4319968|NCT00465816|4147278|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4319969|NCT00465816|4147279|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4319970|NCT00465816|4147280|B1||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4319971|NCT00465816|4147277|B4|||Age||Years|Mean|14.3|14.3|Standard Deviation|1.89|1.89|||
4319972|NCT00465816|4147278|B3|||Age||Years|Mean|14.3|14.3|Standard Deviation|1.94|1.94|||
4319973|NCT00465816|4147279|B2|||Age||Years|Mean|14.3|14.3|Standard Deviation|1.84|1.84|||
4319974|NCT00465816|4147280|B1|||Age||Years|Mean|14.3|14.3|Standard Deviation|1.89|1.89|||
4319975|NCT00465738|4147343|B3|Missing||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4319976|NCT00465738|4147344|B2|Missing||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4319977|NCT00465738|4147345|B1|Missing||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4319978|NCT00465738|4147343|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4319979|NCT00465738|4147344|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4319980|NCT00465738|4147345|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4319981|NCT00465738|4147343|B3|Negroid||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4319982|NCT00465738|4147344|B2|Negroid||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4319983|NCT00465738|4147345|B1|Negroid||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4319984|NCT00465738|4147343|B3|Oriental||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4319985|NCT00465738|4147344|B2|Oriental||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4319986|NCT00465738|4147345|B1|Oriental||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4319987|NCT00465738|4147343|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4319988|NCT00465738|4147344|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4319989|NCT00465738|4147345|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4319990|NCT00465738|4147343|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|154|154.0||||||
4319991|NCT00465738|4147344|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|78|78.0||||||
4319992|NCT00465738|4147345|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
4319993|NCT00465738|4147343|B3||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4319994|NCT00465738|4147344|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4319995|NCT00465738|4147345|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4319996|NCT00465738|4147343|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4319997|NCT00465738|4147344|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4319998|NCT00465738|4147345|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4319999|NCT00465738|4147343|B3|||Age||years|Mean|55.4|55.4|Standard Deviation|14.29|14.29|||
4320000|NCT00465738|4147344|B2|||Age||years|Mean|55.5|55.5|Standard Deviation|13.74|13.74|||
4320001|NCT00465738|4147345|B1|||Age||years|Mean|55.3|55.3|Standard Deviation|14.88|14.88|||
4320002|NCT00465647|4147436|B5|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4320003|NCT00465647|4147437|B4|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4320004|NCT00465647|4147438|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4320005|NCT00465647|4147439|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4320006|NCT00465647|4147440|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4320007|NCT00465647|4147436|B5|White||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
4320008|NCT00465647|4147437|B4|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4320009|NCT00465647|4147438|B3|White||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4320010|NCT00465647|4147439|B2|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4320011|NCT00465647|4147440|B1|White||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4320012|NCT00465647|4147436|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4320013|NCT00465647|4147437|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4320014|NCT00465647|4147438|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4320015|NCT00465647|4147439|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4320016|NCT00465647|4147440|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4320017|NCT00465647|4147436|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4320018|NCT00465647|4147437|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4320019|NCT00465647|4147438|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4320020|NCT00465647|4147439|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4320021|NCT00465647|4147440|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4320022|NCT00465647|4147436|B5|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4320023|NCT00465647|4147437|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4320024|NCT00465647|4147438|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4320025|NCT00465647|4147439|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4320026|NCT00465647|4147440|B1|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4320027|NCT00465647|4147436|B5||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4320028|NCT00465647|4147437|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4320029|NCT00465647|4147438|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4320030|NCT00465647|4147439|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4320031|NCT00465647|4147440|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4320032|NCT00465647|4147436|B5||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4320033|NCT00465647|4147437|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4320034|NCT00465647|4147438|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4320035|NCT00465647|4147439|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4320036|NCT00465647|4147440|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4320037|NCT00465647|4147436|B5|||Age||months|Mean|73.5|73.5|Standard Deviation|69.32|69.32|||
4320038|NCT00465647|4147437|B4|||Age||months|Mean|178.3|178.3|Standard Deviation|17.05|17.05|||
4320039|NCT00465647|4147438|B3|||Age||months|Mean|105.9|105.9|Standard Deviation|27.06|27.06|||
4320040|NCT00465647|4147439|B2|||Age||months|Mean|33.6|33.6|Standard Deviation|14.90|14.9|||
4320041|NCT00465647|4147440|B1|||Age||months|Mean|5.9|5.9|Standard Deviation|2.76|2.76|||
4320042|NCT00465595|4147466|B3||Post-graduate|Education||Participants|Count of Participants|27|27.0||||||
4320043|NCT00465595|4147467|B2||Post-graduate|Education||Participants|Count of Participants|11|11.0||||||
4320044|NCT00465595|4147468|B1||Post-graduate|Education||Participants|Count of Participants|16|16.0||||||
4320045|NCT00465595|4147466|B3||College|Education||Participants|Count of Participants|23|23.0||||||
4320046|NCT00465595|4147467|B2||College|Education||Participants|Count of Participants|15|15.0||||||
4320047|NCT00465595|4147468|B1||College|Education||Participants|Count of Participants|8|8.0||||||
4320048|NCT00465595|4147466|B3||High School|Education||Participants|Count of Participants|1|1.0||||||
4320049|NCT00465595|4147467|B2||High School|Education||Participants|Count of Participants|0|0.0||||||
4320050|NCT00465595|4147468|B1||High School|Education||Participants|Count of Participants|1|1.0||||||
4320051|NCT00465595|4147466|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4320052|NCT00465595|4147467|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4320053|NCT00465595|4147468|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4320054|NCT00465595|4147466|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4320055|NCT00465595|4147467|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4320056|NCT00465595|4147468|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4320057|NCT00465595|4147466|B3||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4320058|NCT00465595|4147467|B2||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4320059|NCT00465595|4147468|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4320060|NCT00465595|4147466|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4320061|NCT00465595|4147467|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4320062|NCT00465595|4147468|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4320063|NCT00465595|4147466|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4320064|NCT00465595|4147467|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4320065|NCT00465595|4147468|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4320066|NCT00465595|4147466|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4320067|NCT00465595|4147467|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4320068|NCT00465595|4147468|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4320069|NCT00465595|4147466|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4320070|NCT00465595|4147467|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4320071|NCT00465595|4147468|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4320072|NCT00465595|4147466|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4320073|NCT00465595|4147467|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4320074|NCT00465595|4147468|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4320075|NCT00465595|4147466|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4320076|NCT00465595|4147467|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4320077|NCT00465595|4147468|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4320078|NCT00465595|4147466|B3|||Age||years|Mean|56.3|56.3|Standard Deviation|9.99|9.99|||
4320079|NCT00465595|4147467|B2|||Age||years|Mean|56.5|56.5|Standard Deviation|9.18|9.18|||
4320080|NCT00465595|4147468|B1|||Age||years|Mean|56.1|56.1|Standard Deviation|11.5|11.5|||
4320081|NCT00465569|4147489|B3|||History of other food allergy||Participants|Count of Participants|15|15.0||||||
4320082|NCT00465569|4147490|B2|||History of other food allergy||Participants|Count of Participants|5|5.0||||||
4320083|NCT00465569|4147491|B1|||History of other food allergy||Participants|Count of Participants|10|10.0||||||
4320084|NCT00465569|4147489|B3|||Current asthma||Participants|Count of Participants|12|12.0||||||
4320085|NCT00465569|4147490|B2|||Current asthma||Participants|Count of Participants|3|3.0||||||
4320086|NCT00465569|4147491|B1|||Current asthma||Participants|Count of Participants|9|9.0||||||
4320087|NCT00465569|4147489|B3|||History of asthma||Participants|Count of Participants|17|17.0||||||
4320088|NCT00465569|4147490|B2|||History of asthma||Participants|Count of Participants|5|5.0||||||
4320089|NCT00465569|4147491|B1|||History of asthma||Participants|Count of Participants|12|12.0||||||
4320090|NCT00465569|4147489|B3|||Current eczema||Participants|Count of Participants|6|6.0||||||
4320091|NCT00465569|4147490|B2|||Current eczema||Participants|Count of Participants|2|2.0||||||
4320092|NCT00465569|4147491|B1|||Current eczema||Participants|Count of Participants|4|4.0||||||
4320093|NCT00465569|4147489|B3|||History of eczema||Participants|Count of Participants|11|11.0||||||
4320094|NCT00465569|4147490|B2|||History of eczema||Participants|Count of Participants|4|4.0||||||
4320095|NCT00465569|4147491|B1|||History of eczema||Participants|Count of Participants|7|7.0||||||
4320096|NCT00465569|4147489|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4320097|NCT00465569|4147490|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4320098|NCT00465569|4147491|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4320099|NCT00465569|4147489|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4320100|NCT00465569|4147490|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4320101|NCT00465569|4147491|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4320102|NCT00465569|4147489|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4320103|NCT00465569|4147490|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4320104|NCT00465569|4147491|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4320105|NCT00465569|4147489|B3|||Age||years|Mean|9.5|9.5|Standard Deviation|2.6|2.6|||
4320106|NCT00465569|4147490|B2|||Age||years|Mean|10.2|10.2|Standard Deviation|3.3|3.3|||
4320107|NCT00465569|4147491|B1|||Age||years|Mean|9.3|9.3|Standard Deviation|3.3|3.3|||
4320108|NCT00465569|4147489|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4320109|NCT00465569|4147490|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4320110|NCT00465569|4147491|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4320111|NCT00465569|4147489|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4320112|NCT00465569|4147490|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4320113|NCT00465569|4147491|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4320114|NCT00465569|4147489|B3||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
4320115|NCT00465569|4147490|B2||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4320116|NCT00465569|4147491|B1||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4320117|NCT00465530|4147502|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4320118|NCT00465530|4147503|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4320119|NCT00465530|4147504|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4320120|NCT00465530|4147502|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4320121|NCT00465530|4147503|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4320122|NCT00465530|4147504|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4320123|NCT00465530|4147502|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4320124|NCT00465530|4147503|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4320125|NCT00465530|4147504|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4320126|NCT00465530|4147502|B3||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4320127|NCT00465530|4147503|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4320128|NCT00465530|4147504|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4320129|NCT00465530|4147502|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4320130|NCT00465530|4147503|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4320131|NCT00465530|4147504|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4320132|NCT00465530|4147502|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4320133|NCT00465530|4147503|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4320134|NCT00465530|4147504|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4320135|NCT00465530|4147502|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4320136|NCT00465530|4147503|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4320137|NCT00465530|4147504|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4320138|NCT00465530|4147502|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4320139|NCT00465530|4147503|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4320140|NCT00465530|4147504|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4320141|NCT00465530|4147502|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4320142|NCT00465530|4147503|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4320143|NCT00465530|4147504|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4320144|NCT00465530|4147502|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4320145|NCT00465530|4147503|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4320146|NCT00465530|4147504|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4320147|NCT00465530|4147502|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4320148|NCT00465530|4147503|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4320149|NCT00465530|4147504|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4320150|NCT00465530|4147502|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4320151|NCT00465530|4147503|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4320152|NCT00465530|4147504|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4320153|NCT00465530|4147502|B3||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
4320154|NCT00465530|4147503|B2||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
4320155|NCT00465530|4147504|B1||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
4320156|NCT00465361|4147515|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4320157|NCT00465361|4147515|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4320158|NCT00465361|4147515|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4320159|NCT00465361|4147515|B1|||Age||years|Mean|28|28.0|Standard Deviation|2|2.0|||
4320160|NCT00465361|4147515|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4320161|NCT00465361|4147515|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4320162|NCT00465361|4147515|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4320163|NCT00465270|4147519|B3||Male|Sex: Female, Male||Participants|Count of Participants|536|536.0||||||
4320164|NCT00465270|4147520|B2||Male|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
4320165|NCT00465270|4147521|B1||Male|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
4320166|NCT00465270|4147519|B3||Female|Sex: Female, Male||Participants|Count of Participants|444|444.0||||||
4320167|NCT00465270|4147520|B2||Female|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
4320168|NCT00465270|4147521|B1||Female|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
4320169|NCT00465270|4147519|B3|||Age||years|Mean|45.9|45.9|Standard Deviation|9.9|9.9|||
4320170|NCT00465270|4147520|B2|||Age||years|Mean|46.2|46.2|Standard Deviation|10.0|10.0|||
4320171|NCT00465270|4147521|B1|||Age||years|Mean|45.7|45.7|Standard Deviation|9.7|9.7|||
4320172|NCT00465179|4147531|B1|United States||Region of Enrollment||participants|Number|57|57.0||||||
4320173|NCT00465179|4147531|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4320174|NCT00465179|4147531|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4320175|NCT00465179|4147531|B1|||Age||years|Median|57|57.0|Full Range|||22.0|85.0|
4320176|NCT00465101|4147537|B1|||International Prostate Symptom Score (IPSS) at Baseline|The IPSS measures the severity of BPH symptoms and is calculated as the sum of 7-items from a participant-administered instrument. The IPSS ranges from 0 (asymptomatic) to 35 (severely symptomatic) with higher values indicating a worse condition.|Scores on a scale|Mean|22.9|22.9|Standard Deviation|5.8|5.8|||
4320177|NCT00465101|4147537|B1|||Prostate Volume (cc)||cc|Mean|58.5|58.5|Standard Deviation|28.4|28.4|||
4320178|NCT00465101|4147537|B1|||Serum Prostate Specific Antigen (PSA) level (ng/ml)||ng/ml|Mean|2.5|2.5|Standard Deviation|2.1|2.1|||
4320179|NCT00465101|4147537|B1|||Post-void Residual Volume (ml)||ml|Mean|112.5|112.5|Standard Deviation|115.5|115.5|||
4320180|NCT00465101|4147537|B1|||Peak Flow Rate (ml/sec)||ml/sec|Mean|10.7|10.7|Standard Deviation|5.4|5.4|||
4320181|NCT00465101|4147537|B1|||Average Duration of Obstructive Symptoms (months)||months|Mean|74.9|74.9|Standard Deviation|60.2|60.2|||
4320182|NCT00465101|4147537|B1|||Previous BPH Treatment||participants|Number|134|134.0||||||
4320183|NCT00465101|4147537|B1|||Smoker||participants|Number|10|10.0||||||
4320184|NCT00465101|4147537|B1|||Weight (kg)||kg|Mean|87.3|87.3|Standard Deviation|14.8|14.8|||
4320185|NCT00465101|4147537|B1|||Height (cm)||cm|Mean|178.5|178.5|Standard Deviation|7.0|7.0|||
4320186|NCT00465101|4147537|B1|United States||Region of Enrollment||participants|Number|150|150.0||||||
4320187|NCT00465101|4147537|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4320188|NCT00465101|4147537|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|148|148.0||||||
4320189|NCT00465101|4147537|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4320190|NCT00465101|4147537|B1||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4320191|NCT00465101|4147537|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4320192|NCT00465101|4147537|B1|||Age||years|Mean|66.3|66.3|Standard Deviation|7.8|7.8|||
4320193|NCT00465088|4147570|B3|United States||Region of Enrollment||participants|Number|193|193.0||||||
4320194|NCT00465088|4147571|B2|United States||Region of Enrollment||participants|Number|79|79.0||||||
4320195|NCT00465088|4147572|B1|United States||Region of Enrollment||participants|Number|114|114.0||||||
4320196|NCT00465088|4147570|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4320197|NCT00465088|4147571|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4320198|NCT00465088|4147572|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4320199|NCT00465088|4147570|B3||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4320200|NCT00465088|4147571|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4320201|NCT00465088|4147572|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4320202|NCT00465088|4147570|B3|||Age||years|Mean|53.6|53.6|Standard Deviation|11.80|11.8|||
4320203|NCT00465088|4147571|B2|||Age||years|Mean|51.5|51.5|Standard Deviation|11.12|11.12|||
4320204|NCT00465088|4147572|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|12.06|12.06|||
4320205|NCT00465088|4147570|B3||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4320206|NCT00465088|4147571|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4320207|NCT00465088|4147572|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4320208|NCT00465088|4147570|B3||Between 18 and 65 years|Age||Participants|Count of Participants|166|166.0||||||
4320209|NCT00465088|4147571|B2||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4320210|NCT00465088|4147572|B1||Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
4320211|NCT00465088|4147570|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4320212|NCT00465088|4147571|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4320213|NCT00465088|4147572|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4320214|NCT00464945|4147605|B3||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4320215|NCT00464945|4147606|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4320216|NCT00464945|4147607|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4320217|NCT00464945|4147605|B3||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4320218|NCT00464945|4147606|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4320219|NCT00464945|4147607|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4320220|NCT00464945|4147605|B3|||Age||months|Mean|2.1|2.1|Standard Deviation|0.5|0.5|||
4320221|NCT00464945|4147606|B2|||Age||months|Mean|2.1|2.1|Standard Deviation|0.5|0.5|||
4320222|NCT00464945|4147607|B1|||Age||months|Mean|2.1|2.1|Standard Deviation|0.6|0.6|||
4320223|NCT00464815|4147636|B3|Geographic ancestry|Asian-South East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|395|395.0||||||
4320224|NCT00464815|4147637|B2|Geographic ancestry|Asian-South East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|98|98.0||||||
4320225|NCT00464815|4147638|B1|Geographic ancestry|Asian-South East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|297|297.0||||||
4320226|NCT00464815|4147636|B3|Geographic ancestry|Asian-East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|234|234.0||||||
4320227|NCT00464815|4147637|B2|Geographic ancestry|Asian-East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|59|59.0||||||
4320228|NCT00464815|4147638|B1|Geographic ancestry|Asian-East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|175|175.0||||||
4320229|NCT00464815|4147636|B3|Geographic ancestry|Asian-Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|396|396.0||||||
4320230|NCT00464815|4147637|B2|Geographic ancestry|Asian-Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|100|100.0||||||
4320231|NCT00464815|4147638|B1|Geographic ancestry|Asian-Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|296|296.0||||||
4320232|NCT00464815|4147636|B3||Male|Sex: Female, Male||Participants|Count of Participants|476|476.0||||||
4320233|NCT00464815|4147637|B2||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4320234|NCT00464815|4147638|B1||Male|Sex: Female, Male||Participants|Count of Participants|354|354.0||||||
4320235|NCT00464815|4147636|B3||Female|Sex: Female, Male||Participants|Count of Participants|549|549.0||||||
4320236|NCT00464815|4147637|B2||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4320237|NCT00464815|4147638|B1||Female|Sex: Female, Male||Participants|Count of Participants|414|414.0||||||
4320238|NCT00464815|4147636|B3|||Age||Years|Mean|14.3|14.3|Standard Deviation|1.97|1.97|||
4320239|NCT00464815|4147637|B2|||Age||Years|Mean|14.3|14.3|Standard Deviation|1.97|1.97|||
4320240|NCT00464815|4147638|B1|||Age||Years|Mean|14.3|14.3|Standard Deviation|1.97|1.97|||
4320241|NCT00464737|4147669|B4|United States||Region of Enrollment||participants|Number|229|229.0||||||
4320242|NCT00464737|4147670|B3|United States||Region of Enrollment||participants|Number|74|74.0||||||
4320243|NCT00464737|4147671|B2|United States||Region of Enrollment||participants|Number|73|73.0||||||
4320244|NCT00464737|4147672|B1|United States||Region of Enrollment||participants|Number|82|82.0||||||
4320245|NCT00464737|4147669|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4320246|NCT00464737|4147670|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4320247|NCT00464737|4147671|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4320248|NCT00464737|4147672|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4320249|NCT00464737|4147669|B4||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4320250|NCT00464737|4147670|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4320251|NCT00464737|4147671|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4320252|NCT00464737|4147672|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4320253|NCT00464737|4147669|B4|||Age||years|Mean|47.0|47.0|Standard Deviation|10.8|10.8|||
4320254|NCT00464737|4147670|B3|||Age||years|Mean|47.0|47.0|Standard Deviation|11.6|11.6|||
4320255|NCT00464737|4147671|B2|||Age||years|Mean|47.5|47.5|Standard Deviation|10.3|10.3|||
4320256|NCT00464737|4147672|B1|||Age||years|Mean|46.4|46.4|Standard Deviation|10.7|10.7|||
4320257|NCT00464737|4147669|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4320258|NCT00464737|4147670|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4320259|NCT00464737|4147671|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4320260|NCT00464737|4147672|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4320261|NCT00464737|4147669|B4||Between 18 and 65 years|Age||Participants|Count of Participants|227|227.0||||||
4320262|NCT00464737|4147670|B3||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4320263|NCT00464737|4147671|B2||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4320264|NCT00464737|4147672|B1||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
4320265|NCT00464737|4147669|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4320266|NCT00464737|4147670|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4320267|NCT00464737|4147671|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4320268|NCT00464737|4147672|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4320269|NCT00464711|4147721|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4320270|NCT00464711|4147721|B1||Male|Gender||Participants|Count of Participants|19|19.0||||||
4320271|NCT00464711|4147721|B1||Female|Gender||Participants|Count of Participants|21|21.0||||||
4320272|NCT00464711|4147721|B1|||Age||years|Mean|38.675|38.675|Standard Deviation|14.08|14.08|||
4320273|NCT00464711|4147721|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4320274|NCT00464711|4147721|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4320275|NCT00464711|4147721|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4320276|NCT00464698|4147725|B1|||Duration of illness|Mean duration of OCD|years|Mean|14.80|14.8|Standard Deviation|12.88|12.88|||
4320277|NCT00464698|4147725|B1|||Yale-Brown Obsessive Compulsive Scale (YBOCS)|"Minimum score possible: 0 Maximum score possible: 40~Greater scores indicate higher symptom severity"|units on a scale|Mean|27.45|27.45|Standard Deviation|4.08|4.08|||
4320278|NCT00464698|4147725|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4320279|NCT00464698|4147725|B1||Male|Gender||Participants|Count of Participants|9|9.0||||||
4320280|NCT00464698|4147725|B1||Female|Gender||Participants|Count of Participants|11|11.0||||||
4320281|NCT00464698|4147725|B1|Age of OCD onset||Age, Customized|Age of OCD onset|years|Mean|15.35|15.35|Standard Deviation|10.479|10.479|||
4320282|NCT00464698|4147725|B1|||Age||years|Mean|29.90|29.9|Standard Deviation|10.66|10.66|||
4320283|NCT00464698|4147725|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4320284|NCT00464698|4147725|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4320285|NCT00464698|4147725|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4320286|NCT00464685|4147735|B3||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4320287|NCT00464685|4147736|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4320288|NCT00464685|4147737|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4320289|NCT00464685|4147735|B3||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4320290|NCT00464685|4147736|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4320291|NCT00464685|4147737|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4320292|NCT00464685|4147735|B3|>65 years||Age, Customized||Participants|Number|87|87.0||||||
4320293|NCT00464685|4147736|B2|>65 years||Age, Customized||Participants|Number|40|40.0||||||
4320294|NCT00464685|4147737|B1|>65 years||Age, Customized||Participants|Number|47|47.0||||||
4320295|NCT00464685|4147735|B3|45 to 65 years||Age, Customized||Participants|Number|156|156.0||||||
4320296|NCT00464685|4147736|B2|45 to 65 years||Age, Customized||Participants|Number|84|84.0||||||
4320297|NCT00464685|4147737|B1|45 to 65 years||Age, Customized||Participants|Number|72|72.0||||||
4320298|NCT00464685|4147735|B3|<45 years||Age, Customized||Participants|Number|10|10.0||||||
4320299|NCT00464685|4147736|B2|<45 years||Age, Customized||Participants|Number|3|3.0||||||
4320300|NCT00464685|4147737|B1|<45 years||Age, Customized||Participants|Number|7|7.0||||||
4320301|NCT00464672|4147752|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4320302|NCT00464672|4147753|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4320303|NCT00464672|4147754|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4320304|NCT00464672|4147752|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|144|144.0||||||
4320305|NCT00464672|4147753|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
4320306|NCT00464672|4147754|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|92|92.0||||||
4320307|NCT00464672|4147752|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|1747|1747.0||||||
4320308|NCT00464672|4147753|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|579|579.0||||||
4320309|NCT00464672|4147754|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|1168|1168.0||||||
4320310|NCT00464672|4147752|B3|Female||Sex/Gender, Customized||participants|Number|1024|1024.0||||||
4320311|NCT00464672|4147753|B2|Female||Sex/Gender, Customized||participants|Number|337|337.0||||||
4320312|NCT00464672|4147754|B1|Female||Sex/Gender, Customized||participants|Number|687|687.0||||||
4320313|NCT00464672|4147752|B3|Male||Sex/Gender, Customized||participants|Number|869|869.0||||||
4320314|NCT00464672|4147753|B2|Male||Sex/Gender, Customized||participants|Number|294|294.0||||||
4320315|NCT00464672|4147754|B1|Male||Sex/Gender, Customized||participants|Number|575|575.0||||||
4320316|NCT00464672|4147752|B3|Adults 18 to 64 years of age||Age||years|Mean|38.5|38.5|Standard Deviation|12.5|12.5|||
4320317|NCT00464672|4147753|B2|Adults 18 to 64 years of age||Age||years|Mean|37.8|37.8|Standard Deviation|12.6|12.6|||
4320318|NCT00464672|4147754|B1|Adults 18 to 64 years of age||Age||years|Mean|38.8|38.8|Standard Deviation|14.4|14.4|||
4320319|NCT00464672|4147752|B3|Children/Adolescents 9 to 17 years of age||Age||years|Mean|12.7|12.7|Standard Deviation|2.6|2.6|||
4320320|NCT00464672|4147753|B2|Children/Adolescents 9 to 17 years of age||Age||years|Mean|12.8|12.8|Standard Deviation|2.6|2.6|||
4320321|NCT00464672|4147754|B1|Children/Adolescents 9 to 17 years of age||Age||years|Mean|12.7|12.7|Standard Deviation|2.6|2.6|||
4320322|NCT00464672|4147752|B3|Chilren 3 to 8 years of age||Age||years|Mean|5.5|5.5|Standard Deviation|1.7|1.7|||
4320323|NCT00464672|4147753|B2|Chilren 3 to 8 years of age||Age||years|Mean|5.4|5.4|Standard Deviation|1.7|1.7|||
4320324|NCT00464672|4147754|B1|Chilren 3 to 8 years of age||Age||years|Mean|5.5|5.5|Standard Deviation|1.7|1.7|||
4320325|NCT00464646|4147829|B3|Unknown||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4320326|NCT00464646|4147830|B2|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4320327|NCT00464646|4147831|B1|Unknown||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4320328|NCT00464646|4147829|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|99|99.0||||||
4320329|NCT00464646|4147830|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4320330|NCT00464646|4147831|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
4320331|NCT00464646|4147829|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4320332|NCT00464646|4147830|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4320333|NCT00464646|4147831|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4320334|NCT00464646|4147829|B3|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4320335|NCT00464646|4147830|B2|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4320336|NCT00464646|4147831|B1|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4320337|NCT00464646|4147829|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4320338|NCT00464646|4147830|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4320339|NCT00464646|4147831|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4320340|NCT00464646|4147829|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4320341|NCT00464646|4147830|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4320342|NCT00464646|4147831|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4320343|NCT00464646|4147829|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4320344|NCT00464646|4147830|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4320345|NCT00464646|4147831|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4320346|NCT00464646|4147829|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4320347|NCT00464646|4147830|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4320348|NCT00464646|4147831|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4320349|NCT00464646|4147829|B3|White||Race/Ethnicity, Customized||participants|Number|91|91.0||||||
4320350|NCT00464646|4147830|B2|White||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4320351|NCT00464646|4147831|B1|White||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
4320352|NCT00464646|4147829|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4320353|NCT00464646|4147830|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4320354|NCT00464646|4147831|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4320355|NCT00464646|4147829|B3||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4320356|NCT00464646|4147830|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4320357|NCT00464646|4147831|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4320358|NCT00464646|4147829|B3|> 59 years||Age, Customized||participants|Number|21|21.0||||||
4320359|NCT00464646|4147830|B2|> 59 years||Age, Customized||participants|Number|11|11.0||||||
4320360|NCT00464646|4147831|B1|> 59 years||Age, Customized||participants|Number|10|10.0||||||
4320361|NCT00464646|4147829|B3|>=50 years and <=59 years||Age, Customized||participants|Number|35|35.0||||||
4320362|NCT00464646|4147830|B2|>=50 years and <=59 years||Age, Customized||participants|Number|8|8.0||||||
4320363|NCT00464646|4147831|B1|>=50 years and <=59 years||Age, Customized||participants|Number|27|27.0||||||
4320364|NCT00464646|4147829|B3|18 to less than 50 years||Age, Customized||participants|Number|49|49.0||||||
4320365|NCT00464646|4147830|B2|18 to less than 50 years||Age, Customized||participants|Number|10|10.0||||||
4320366|NCT00464646|4147831|B1|18 to less than 50 years||Age, Customized||participants|Number|39|39.0||||||
4320367|NCT00464646|4147829|B3|||Age||years|Mean|49.7|49.7|Standard Deviation|10.4|10.4|||
4320368|NCT00464646|4147830|B2|||Age||years|Mean|53.8|53.8|Standard Deviation|11.4|11.4|||
4320369|NCT00464646|4147831|B1|||Age||years|Mean|48.1|48.1|Standard Deviation|9.6|9.6|||
4320370|NCT00464620|4147838|B1|Indolent|Native American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4320371|NCT00464620|4147838|B1|Indolent|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4320372|NCT00464620|4147838|B1|Indolent|Other|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4320373|NCT00464620|4147838|B1|Indolent|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4320374|NCT00464620|4147838|B1|Indolent|Black|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4320375|NCT00464620|4147838|B1|Indolent|White|Race/Ethnicity, Customized||Participants|Count of Participants|94|94.0||||||
4320376|NCT00464620|4147838|B1|GIST|Native American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4320377|NCT00464620|4147838|B1|GIST|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4320378|NCT00464620|4147838|B1|GIST|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4320379|NCT00464620|4147838|B1|GIST|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4320380|NCT00464620|4147838|B1|GIST|Black|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4320381|NCT00464620|4147838|B1|GIST|White|Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
4320382|NCT00464620|4147838|B1|Aggressive subtype|Native American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4320383|NCT00464620|4147838|B1|Aggressive subtype|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4320384|NCT00464620|4147838|B1|Aggressive subtype|Other|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4320385|NCT00464620|4147838|B1|Aggressive subtype|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4320386|NCT00464620|4147838|B1|Aggressive subtype|Black|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
4320387|NCT00464620|4147838|B1|Aggressive subtype|White|Race/Ethnicity, Customized||Participants|Count of Participants|171|171.0||||||
4320388|NCT00464620|4147838|B1|Indolent|Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4320389|NCT00464620|4147838|B1|Indolent|Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4320390|NCT00464620|4147838|B1|GIST|Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4320391|NCT00464620|4147838|B1|GIST|Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4320392|NCT00464620|4147838|B1|Aggressive subtype|Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4320393|NCT00464620|4147838|B1|Aggressive subtype|Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4320394|NCT00464620|4147838|B1|Indolent||Age||years|Median|54|54.0|Full Range|||22.0|87.0|
4320395|NCT00464620|4147838|B1|GIST||Age||years|Median|60|60.0|Full Range|||19.0|78.0|
4320396|NCT00464620|4147838|B1|Aggressive subtype||Age||years|Median|52|52.0|Full Range|||14.8|87.3|
4320397|NCT00464568|4147867|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
4320398|NCT00464568|4147867|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4320399|NCT00464568|4147867|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4320400|NCT00464568|4147867|B1|||Age||Years|Mean|35.7|35.7|Standard Deviation|8.54|8.54|||
4320401|NCT00464542|4147940|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4320402|NCT00464542|4147940|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4320403|NCT00464542|4147940|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4320404|NCT00464542|4147940|B1|||Age||years|Mean|24|24.0|Standard Deviation|2.5|2.5|||
4320405|NCT00464542|4147940|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4320406|NCT00464542|4147940|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4320407|NCT00464542|4147940|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4320408|NCT00464490|4147945|B3|||Ramsay Sedation Scale (RSS)|The RSS defines the conscious state from a level 1: the patient is anxious, agitated or restless, through the continuum of sedation to a level 6: the patient is completely unresponsive.|units on a scale|Mean|3|3.0|Standard Deviation|3|3.0|||
4320409|NCT00464490|4147946|B2|||Ramsay Sedation Scale (RSS)|The RSS defines the conscious state from a level 1: the patient is anxious, agitated or restless, through the continuum of sedation to a level 6: the patient is completely unresponsive.|units on a scale|Mean|2.1|2.1|Standard Deviation|1.1|1.1|||
4320410|NCT00464490|4147947|B1|||Ramsay Sedation Scale (RSS)|The RSS defines the conscious state from a level 1: the patient is anxious, agitated or restless, through the continuum of sedation to a level 6: the patient is completely unresponsive.|units on a scale|Mean|3.5|3.5|Standard Deviation|1.2|1.2|||
4320411|NCT00464490|4147945|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4320412|NCT00464490|4147946|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4320413|NCT00464490|4147947|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4320414|NCT00464490|4147945|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4320415|NCT00464490|4147946|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4320416|NCT00464490|4147947|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4320417|NCT00464490|4147945|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4320418|NCT00464490|4147946|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4320419|NCT00464490|4147947|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4320420|NCT00464490|4147945|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4320421|NCT00464490|4147946|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4320422|NCT00464490|4147947|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4320423|NCT00464490|4147945|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4320424|NCT00464490|4147946|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4320425|NCT00464490|4147947|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4320426|NCT00464490|4147945|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4320427|NCT00464490|4147946|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4320428|NCT00464490|4147947|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4320429|NCT00464464|4147954|B3|||Dementia Rating Scale score|"The Dementia Rating Scale - 2 (DRS-2) was used to assess severity of symptoms associated with dementia in study participants. The measure includes sub-scales addressing Attention (ATT), Initiation/Perseveration (I/P), Construction (CONST), Conceptualization (CONCEPT), and Memory (MEM).~The total score (a sum of the five sub-scale scores) was used as the outcome measure value. Possible DRS total scores range from 0 to 144, with higher values representing more severe dementia symptomatology, and lower scores representing less severe dementia symptomatology."|units on a scale|Mean|138.24|138.24|Standard Deviation|4.9|4.9|||
4320430|NCT00464464|4147955|B2|||Dementia Rating Scale score|"The Dementia Rating Scale - 2 (DRS-2) was used to assess severity of symptoms associated with dementia in study participants. The measure includes sub-scales addressing Attention (ATT), Initiation/Perseveration (I/P), Construction (CONST), Conceptualization (CONCEPT), and Memory (MEM).~The total score (a sum of the five sub-scale scores) was used as the outcome measure value. Possible DRS total scores range from 0 to 144, with higher values representing more severe dementia symptomatology, and lower scores representing less severe dementia symptomatology."|units on a scale|Mean|136.97|136.97|Standard Deviation|5.5|5.5|||
4320431|NCT00464464|4147956|B1|||Dementia Rating Scale score|"The Dementia Rating Scale - 2 (DRS-2) was used to assess severity of symptoms associated with dementia in study participants. The measure includes sub-scales addressing Attention (ATT), Initiation/Perseveration (I/P), Construction (CONST), Conceptualization (CONCEPT), and Memory (MEM).~The total score (a sum of the five sub-scale scores) was used as the outcome measure value. Possible DRS total scores range from 0 to 144, with higher values representing more severe dementia symptomatology, and lower scores representing less severe dementia symptomatology."|units on a scale|Mean|139.44|139.44|Standard Deviation|3.8|3.8|||
4320432|NCT00464464|4147954|B3|||Parkinson's disease duration||years|Mean|6.34|6.34|Standard Deviation|5.51|5.51|||
4320433|NCT00464464|4147955|B2|||Parkinson's disease duration||years|Mean|6.13|6.13|Standard Deviation|5.56|5.56|||
4320434|NCT00464464|4147956|B1|||Parkinson's disease duration||years|Mean|6.53|6.53|Standard Deviation|5.53|5.53|||
4320435|NCT00464464|4147954|B3|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
4320436|NCT00464464|4147955|B2|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4320437|NCT00464464|4147956|B1|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4320438|NCT00464464|4147954|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4320439|NCT00464464|4147955|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4320440|NCT00464464|4147956|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4320441|NCT00464464|4147954|B3|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4320442|NCT00464464|4147955|B2|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4320443|NCT00464464|4147956|B1|Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4320444|NCT00464464|4147954|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4320445|NCT00464464|4147955|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4320446|NCT00464464|4147956|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4320447|NCT00464464|4147954|B3|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4320448|NCT00464464|4147955|B2|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4320449|NCT00464464|4147956|B1|African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4320450|NCT00464464|4147954|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
4320451|NCT00464464|4147955|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4320452|NCT00464464|4147956|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4320453|NCT00464464|4147954|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4320454|NCT00464464|4147955|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4320455|NCT00464464|4147956|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4320456|NCT00464464|4147954|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4320457|NCT00464464|4147955|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4320458|NCT00464464|4147956|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4320459|NCT00464464|4147954|B3|||Age||years|Mean|64.56|64.56|Standard Deviation|10.53|10.53|||
4320460|NCT00464464|4147955|B2|||Age||years|Mean|65.44|65.44|Standard Deviation|11.23|11.23|||
4320461|NCT00464464|4147956|B1|||Age||years|Mean|63.73|63.73|Standard Deviation|9.89|9.89|||
4320462|NCT00464438|4147969|B3||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4320463|NCT00464438|4147970|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4320464|NCT00464438|4147971|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4320465|NCT00464438|4147969|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4320466|NCT00464438|4147970|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4320467|NCT00464438|4147971|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4320468|NCT00464438|4147969|B3|||Age||days|Mean|15.2|15.2|Standard Deviation|6.31|6.31|||
4320469|NCT00464438|4147970|B2|||Age||days|Mean|15.2|15.2|Standard Deviation|6.05|6.05|||
4320470|NCT00464438|4147971|B1|||Age||days|Mean|15.2|15.2|Standard Deviation|6.59|6.59|||
4320471|NCT00464334|4147984|B12||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4320472|NCT00464334|4147985|B11||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4320473|NCT00464334|4147986|B10||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4320474|NCT00464334|4147987|B9||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4320475|NCT00464334|4147988|B8||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4320476|NCT00464334|4147989|B7||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4320477|NCT00464334|4147990|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4320478|NCT00464334|4147991|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4320479|NCT00464334|4147992|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4320480|NCT00464334|4147993|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4320481|NCT00464334|4147994|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4320482|NCT00464334|4147995|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4320483|NCT00464334|4147984|B12||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4320484|NCT00464334|4147985|B11||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4320485|NCT00464334|4147986|B10||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4320486|NCT00464334|4147987|B9||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4320487|NCT00464334|4147988|B8||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4320488|NCT00464334|4147989|B7||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4320489|NCT00464334|4147990|B6||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4320490|NCT00464334|4147991|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4320491|NCT00464334|4147992|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4320492|NCT00464334|4147993|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4320493|NCT00464334|4147994|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4320494|NCT00464334|4147995|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4320495|NCT00464334|4147984|B12|||Age||years|Mean|74.2|74.2|Standard Deviation|8.85|8.85|||
4320496|NCT00464334|4147985|B11|||Age||years|Mean|75.5|75.5|Standard Deviation|10.04|10.04|||
4320497|NCT00464334|4147986|B10|||Age||years|Mean|70.6|70.6|Standard Deviation|8.38|8.38|||
4320498|NCT00464334|4147987|B9|||Age||years|Mean|81.5|81.5|Standard Deviation|5.48|5.48|||
4320499|NCT00464334|4147988|B8|||Age||years|Mean|72.5|72.5|Standard Deviation|10.10|10.1|||
4320500|NCT00464334|4147989|B7|||Age||years|Mean|72.6|72.6|Standard Deviation|9.26|9.26|||
4320501|NCT00464334|4147990|B6|||Age||years|Mean|73.4|73.4|Standard Deviation|10.89|10.89|||
4320502|NCT00464334|4147991|B5|||Age||years|Mean|76.1|76.1|Standard Deviation|8.01|8.01|||
4320503|NCT00464334|4147992|B4|||Age||years|Mean|73.6|73.6|Standard Deviation|8.07|8.07|||
4320504|NCT00464334|4147993|B3|||Age||years|Mean|76.9|76.9|Standard Deviation|4.39|4.39|||
4320505|NCT00464334|4147994|B2|||Age||years|Mean|70.7|70.7|Standard Deviation|9.6|9.6|||
4320506|NCT00464334|4147995|B1|||Age||years|Mean|73.6|73.6|Standard Deviation|10.69|10.69|||
4320507|NCT00464308|4148062|B4|Australia||Region of Enrollment||participants|Number|1392|1392.0||||||
4320508|NCT00464308|4148063|B3|Australia||Region of Enrollment||participants|Number|459|459.0||||||
4320509|NCT00464308|4148064|B2|Australia||Region of Enrollment||participants|Number|469|469.0||||||
4320510|NCT00464308|4148065|B1|Australia||Region of Enrollment||participants|Number|464|464.0||||||
4320511|NCT00464308|4148062|B4||Male|Sex: Female, Male||Participants|Count of Participants|772|772.0||||||
4320512|NCT00464308|4148063|B3||Male|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4320513|NCT00464308|4148064|B2||Male|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
4320514|NCT00464308|4148065|B1||Male|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
4320515|NCT00464308|4148062|B4||Female|Sex: Female, Male||Participants|Count of Participants|620|620.0||||||
4320516|NCT00464308|4148063|B3||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4320517|NCT00464308|4148064|B2||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4320518|NCT00464308|4148065|B1||Female|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4320519|NCT00464308|4148062|B4|||Age||years|Mean|46.7|46.7|Standard Deviation|14.8|14.8|||
4320520|NCT00464308|4148063|B3|||Age||years|Mean|46.2|46.2|Standard Deviation|14.8|14.8|||
4320521|NCT00464308|4148064|B2|||Age||years|Mean|48|48.0|Standard Deviation|14.7|14.7|||
4320522|NCT00464308|4148065|B1|||Age||years|Mean|45.8|45.8|Standard Deviation|14.8|14.8|||
4320523|NCT00464269|4148093|B5||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4320524|NCT00464269|4148094|B4||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4320525|NCT00464269|4148095|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4320526|NCT00464269|4148096|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4320527|NCT00464269|4148097|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4320528|NCT00464269|4148093|B5||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4320529|NCT00464269|4148094|B4||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4320530|NCT00464269|4148095|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4320531|NCT00464269|4148096|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4320532|NCT00464269|4148097|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4320533|NCT00464269|4148093|B5|65 - < 85 years||Age, Customized||participants|Number|6|6.0||||||
4320534|NCT00464269|4148094|B4|65 - < 85 years||Age, Customized||participants|Number|1|1.0||||||
4320535|NCT00464269|4148095|B3|65 - < 85 years||Age, Customized||participants|Number|2|2.0||||||
4320536|NCT00464269|4148096|B2|65 - < 85 years||Age, Customized||participants|Number|2|2.0||||||
4320537|NCT00464269|4148097|B1|65 - < 85 years||Age, Customized||participants|Number|1|1.0||||||
4320538|NCT00464269|4148093|B5|18 - < 65 years||Age, Customized||participants|Number|380|380.0||||||
4320539|NCT00464269|4148094|B4|18 - < 65 years||Age, Customized||participants|Number|99|99.0||||||
4320540|NCT00464269|4148095|B3|18 - < 65 years||Age, Customized||participants|Number|93|93.0||||||
4320541|NCT00464269|4148096|B2|18 - < 65 years||Age, Customized||participants|Number|97|97.0||||||
4320542|NCT00464269|4148097|B1|18 - < 65 years||Age, Customized||participants|Number|91|91.0||||||
4320543|NCT00464269|4148093|B5|< 18 years||Age, Customized||participants|Number|14|14.0||||||
4320544|NCT00464269|4148094|B4|< 18 years||Age, Customized||participants|Number|2|2.0||||||
4320545|NCT00464269|4148095|B3|< 18 years||Age, Customized||participants|Number|5|5.0||||||
4320546|NCT00464269|4148096|B2|< 18 years||Age, Customized||participants|Number|0|0.0||||||
4320547|NCT00464269|4148097|B1|< 18 years||Age, Customized||participants|Number|7|7.0||||||
4320548|NCT00464269|4148093|B5|||Age||years|Mean|38.2|38.2|Standard Deviation|12.5|12.5|||
4320549|NCT00464269|4148094|B4|||Age||years|Mean|39.0|39.0|Standard Deviation|12.3|12.3|||
4320550|NCT00464269|4148095|B3|||Age||years|Mean|37.3|37.3|Standard Deviation|13.3|13.3|||
4320551|NCT00464269|4148096|B2|||Age||years|Mean|38.8|38.8|Standard Deviation|11.6|11.6|||
4320552|NCT00464269|4148097|B1|||Age||years|Mean|37.6|37.6|Standard Deviation|12.6|12.6|||
4320553|NCT00464204|4148198|B3|Ears-nose-throat system||Origin of sepsis|Multiple origins of sepsis could be reported for a single patient.|participants|Number|2|2.0||||||
4320554|NCT00464204|4148199|B2|Ears-nose-throat system||Origin of sepsis|Multiple origins of sepsis could be reported for a single patient.|participants|Number|0|0.0||||||
4320555|NCT00464204|4148200|B1|Ears-nose-throat system||Origin of sepsis|Multiple origins of sepsis could be reported for a single patient.|participants|Number|2|2.0||||||
4320556|NCT00464204|4148198|B3|Neurological system||Origin of sepsis|Multiple origins of sepsis could be reported for a single patient.|participants|Number|5|5.0||||||
4320557|NCT00464204|4148199|B2|Neurological system||Origin of sepsis|Multiple origins of sepsis could be reported for a single patient.|participants|Number|2|2.0||||||
4320558|NCT00464204|4148200|B1|Neurological system||Origin of sepsis|Multiple origins of sepsis could be reported for a single patient.|participants|Number|3|3.0||||||
4320559|NCT00464204|4148198|B3|Unknown||Origin of sepsis|Multiple origins of sepsis could be reported for a single patient.|participants|Number|6|6.0||||||
4320560|NCT00464204|4148199|B2|Unknown||Origin of sepsis|Multiple origins of sepsis could be reported for a single patient.|participants|Number|2|2.0||||||
4320561|NCT00464204|4148200|B1|Unknown||Origin of sepsis|Multiple origins of sepsis could be reported for a single patient.|participants|Number|4|4.0||||||
4320562|NCT00464204|4148198|B3|Other||Origin of sepsis|Multiple origins of sepsis could be reported for a single patient.|participants|Number|7|7.0||||||
4320563|NCT00464204|4148199|B2|Other||Origin of sepsis|Multiple origins of sepsis could be reported for a single patient.|participants|Number|2|2.0||||||
4320564|NCT00464204|4148200|B1|Other||Origin of sepsis|Multiple origins of sepsis could be reported for a single patient.|participants|Number|5|5.0||||||
4320565|NCT00464204|4148198|B3|Skin, bone and soft tissue||Origin of sepsis|Multiple origins of sepsis could be reported for a single patient.|participants|Number|10|10.0||||||
4320566|NCT00464204|4148199|B2|Skin, bone and soft tissue||Origin of sepsis|Multiple origins of sepsis could be reported for a single patient.|participants|Number|4|4.0||||||
4320567|NCT00464204|4148200|B1|Skin, bone and soft tissue||Origin of sepsis|Multiple origins of sepsis could be reported for a single patient.|participants|Number|6|6.0||||||
4320568|NCT00464204|4148198|B3|Urogenital||Origin of sepsis|Multiple origins of sepsis could be reported for a single patient.|participants|Number|22|22.0||||||
4320569|NCT00464204|4148199|B2|Urogenital||Origin of sepsis|Multiple origins of sepsis could be reported for a single patient.|participants|Number|14|14.0||||||
4320570|NCT00464204|4148200|B1|Urogenital||Origin of sepsis|Multiple origins of sepsis could be reported for a single patient.|participants|Number|8|8.0||||||
4320571|NCT00464204|4148198|B3|Abdomen||Origin of sepsis|Multiple origins of sepsis could be reported for a single patient.|participants|Number|42|42.0||||||
4320572|NCT00464204|4148199|B2|Abdomen||Origin of sepsis|Multiple origins of sepsis could be reported for a single patient.|participants|Number|18|18.0||||||
4320573|NCT00464204|4148200|B1|Abdomen||Origin of sepsis|Multiple origins of sepsis could be reported for a single patient.|participants|Number|24|24.0||||||
4320574|NCT00464204|4148198|B3|Lungs||Origin of sepsis|Multiple origins of sepsis could be reported for a single patient.|participants|Number|111|111.0||||||
4320575|NCT00464204|4148199|B2|Lungs||Origin of sepsis|Multiple origins of sepsis could be reported for a single patient.|participants|Number|58|58.0||||||
4320576|NCT00464204|4148200|B1|Lungs||Origin of sepsis|Multiple origins of sepsis could be reported for a single patient.|participants|Number|53|53.0||||||
4320577|NCT00464204|4148198|B3|Germany||Region of Enrollment||participants|Number|25|25.0||||||
4320578|NCT00464204|4148199|B2|Germany||Region of Enrollment||participants|Number|12|12.0||||||
4320579|NCT00464204|4148200|B1|Germany||Region of Enrollment||participants|Number|13|13.0||||||
4320580|NCT00464204|4148198|B3|France||Region of Enrollment||participants|Number|171|171.0||||||
4320581|NCT00464204|4148199|B2|France||Region of Enrollment||participants|Number|84|84.0||||||
4320582|NCT00464204|4148200|B1|France||Region of Enrollment||participants|Number|87|87.0||||||
4320583|NCT00464204|4148198|B3||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4320584|NCT00464204|4148199|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4320585|NCT00464204|4148200|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4320586|NCT00464204|4148198|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4320587|NCT00464204|4148199|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4320588|NCT00464204|4148200|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4320589|NCT00464204|4148198|B3|||Age||years|Mean|65.8|65.8|Standard Deviation|15.0|15.0|||
4320590|NCT00464204|4148199|B2|||Age||years|Mean|65.9|65.9|Standard Deviation|14.7|14.7|||
4320591|NCT00464204|4148200|B1|||Age||years|Mean|65.8|65.8|Standard Deviation|15.4|15.4|||
4320592|NCT00464087|4148235|B4|Canada||Region of Enrollment||participants|Number|66|66.0||||||
4320593|NCT00464087|4148236|B3|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4320594|NCT00464087|4148237|B2|Canada||Region of Enrollment||participants|Number|33|33.0||||||
4320595|NCT00464087|4148238|B1|Canada||Region of Enrollment||participants|Number|33|33.0||||||
4320596|NCT00464087|4148235|B4|United States||Region of Enrollment||participants|Number|63|63.0||||||
4320597|NCT00464087|4148236|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
4320598|NCT00464087|4148237|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4320599|NCT00464087|4148238|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4320600|NCT00464087|4148235|B4||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4320601|NCT00464087|4148236|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4320602|NCT00464087|4148237|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4320603|NCT00464087|4148238|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4320604|NCT00464087|4148235|B4||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4320605|NCT00464087|4148236|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4320606|NCT00464087|4148237|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4320607|NCT00464087|4148238|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4320608|NCT00464087|4148235|B4|||Age||years|Mean|60.45|60.45|Standard Deviation|14.42|14.42|||
4320609|NCT00464087|4148236|B3|||Age||years|Mean|54.45|54.45|Standard Deviation|13.62|13.62|||
4320610|NCT00464087|4148237|B2|||Age||years|Mean|63.33|63.33|Standard Deviation|12.17|12.17|||
4320611|NCT00464087|4148238|B1|||Age||years|Mean|62.18|62.18|Standard Deviation|13.36|13.36|||
4320612|NCT00464087|4148235|B4||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
4320613|NCT00464087|4148236|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4320614|NCT00464087|4148237|B2||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4320615|NCT00464087|4148238|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4320616|NCT00464087|4148235|B4||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4320617|NCT00464087|4148236|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4320618|NCT00464087|4148237|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4320619|NCT00464087|4148238|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4320620|NCT00464087|4148235|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4320621|NCT00464087|4148236|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4320622|NCT00464087|4148237|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4320623|NCT00464087|4148238|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4320624|NCT00463866|4148256|B3|Percent Included||Pulmonary function test at baseline.|Peak Expiratory Flow (PEF) was recorded at baseline, the assessment was performed at least 15 minutes after 2 inhalations of Symbicort 160/4.5µg. pn=predicted normal. Symbicort SMART 1*2 arm: n=4001 and Symbicort SMART 2*2 arm: n=4003.|Percent of predicted normal value of PEF|Mean|90.4|90.4|Full Range|||0.0|100.0|
4320625|NCT00463866|4148257|B2|Percent Included||Pulmonary function test at baseline.|Peak Expiratory Flow (PEF) was recorded at baseline, the assessment was performed at least 15 minutes after 2 inhalations of Symbicort 160/4.5µg. pn=predicted normal. Symbicort SMART 1*2 arm: n=4001 and Symbicort SMART 2*2 arm: n=4003.|Percent of predicted normal value of PEF|Mean|90.1|90.1|Full Range|||0.0|100.0|
4320626|NCT00463866|4148258|B1|Percent Included||Pulmonary function test at baseline.|Peak Expiratory Flow (PEF) was recorded at baseline, the assessment was performed at least 15 minutes after 2 inhalations of Symbicort 160/4.5µg. pn=predicted normal. Symbicort SMART 1*2 arm: n=4001 and Symbicort SMART 2*2 arm: n=4003.|Percent of predicted normal value of PEF|Mean|90.8|90.8|Full Range|||0.0|100.0|
4320627|NCT00463866|4148256|B3|||Participants with a well controlled asthma week at study entry.||Percentage of participants|Mean|11.87|11.87|Full Range|||0.0|100.0|
4320628|NCT00463866|4148257|B2|||Participants with a well controlled asthma week at study entry.||Percentage of participants|Mean|11.77|11.77|Full Range|||0.0|100.0|
4320629|NCT00463866|4148258|B1|||Participants with a well controlled asthma week at study entry.||Percentage of participants|Mean|11.97|11.97|Full Range|||0.0|100.0|
4320630|NCT00463866|4148256|B3|IGCS dose at study entry||Inhaled glucocorticosteroids (IGCS) dose at study entry.||μg/day|Mean|1042|1042.0|Standard Deviation|585|585.0|||
4320631|NCT00463866|4148257|B2|IGCS dose at study entry||Inhaled glucocorticosteroids (IGCS) dose at study entry.||μg/day|Mean|1037|1037.0|Standard Deviation|575|575.0|||
4320632|NCT00463866|4148258|B1|IGCS dose at study entry||Inhaled glucocorticosteroids (IGCS) dose at study entry.||μg/day|Mean|1046|1046.0|Standard Deviation|595|595.0|||
4320724|NCT00463606|4148306|B4|||Age||years|Mean|55.3|55.3|Standard Deviation|11.10|11.1|||
4320633|NCT00463866|4148256|B3|||Exacerbations past 12 months before study start.||Number of exacerbations per participant|Mean|1.45|1.45|Standard Deviation|2.42|2.42|||
4320634|NCT00463866|4148257|B2|||Exacerbations past 12 months before study start.||Number of exacerbations per participant|Mean|1.42|1.42|Standard Deviation|2.42|2.42|||
4320635|NCT00463866|4148258|B1|||Exacerbations past 12 months before study start.||Number of exacerbations per participant|Mean|1.47|1.47|Standard Deviation|2.42|2.42|||
4320636|NCT00463866|4148256|B3|ACQ5 score at study entry||Asthma control questionnaire (ACQ5) score at study entry|ACQ5 was used. The lower value the better with a full range from 0=no impairment, 6= maximum impairment. Awakenings, morning symptoms, limitations, shortness of breath and wheeze.|Units on a scale|Mean|1.85|1.85|Standard Deviation|0.99|0.99|||
4320637|NCT00463866|4148257|B2|ACQ5 score at study entry||Asthma control questionnaire (ACQ5) score at study entry|ACQ5 was used. The lower value the better with a full range from 0=no impairment, 6= maximum impairment. Awakenings, morning symptoms, limitations, shortness of breath and wheeze.|Units on a scale|Mean|1.86|1.86|Standard Deviation|1.01|1.01|||
4320638|NCT00463866|4148258|B1|ACQ5 score at study entry||Asthma control questionnaire (ACQ5) score at study entry|ACQ5 was used. The lower value the better with a full range from 0=no impairment, 6= maximum impairment. Awakenings, morning symptoms, limitations, shortness of breath and wheeze.|Units on a scale|Mean|1.85|1.85|Standard Deviation|0.98|0.98|||
4320639|NCT00463866|4148256|B3|Number of participants without LABA at baseline.||Treatment with Long-Acting β2 agonist (LABA) at baseline.||Participants|Number|1827|1827.0||||||
4320640|NCT00463866|4148257|B2|Number of participants without LABA at baseline.||Treatment with Long-Acting β2 agonist (LABA) at baseline.||Participants|Number|927|927.0||||||
4320641|NCT00463866|4148258|B1|Number of participants without LABA at baseline.||Treatment with Long-Acting β2 agonist (LABA) at baseline.||Participants|Number|900|900.0||||||
4320642|NCT00463866|4148256|B3|Number of participants using LABA at baseline.||Treatment with Long-Acting β2 agonist (LABA) at baseline.||Participants|Number|6226|6226.0||||||
4320643|NCT00463866|4148257|B2|Number of participants using LABA at baseline.||Treatment with Long-Acting β2 agonist (LABA) at baseline.||Participants|Number|3118|3118.0||||||
4320644|NCT00463866|4148258|B1|Number of participants using LABA at baseline.||Treatment with Long-Acting β2 agonist (LABA) at baseline.||Participants|Number|3108|3108.0||||||
4320645|NCT00463866|4148256|B3||Male|Sex: Female, Male||Participants|Count of Participants|3058|3058.0||||||
4320646|NCT00463866|4148257|B2||Male|Sex: Female, Male||Participants|Count of Participants|1533|1533.0||||||
4320647|NCT00463866|4148258|B1||Male|Sex: Female, Male||Participants|Count of Participants|1525|1525.0||||||
4320648|NCT00463866|4148256|B3||Female|Sex: Female, Male||Participants|Count of Participants|4995|4995.0||||||
4320649|NCT00463866|4148257|B2||Female|Sex: Female, Male||Participants|Count of Participants|2512|2512.0||||||
4320650|NCT00463866|4148258|B1||Female|Sex: Female, Male||Participants|Count of Participants|2483|2483.0||||||
4320651|NCT00463866|4148256|B3|||Age||Years|Mean|47.8|47.8|Full Range|||18.0|96.0|
4320652|NCT00463866|4148257|B2|||Age||Years|Mean|47.9|47.9|Full Range|||18.0|90.0|
4320653|NCT00463866|4148258|B1|||Age||Years|Mean|47.8|47.8|Full Range|||18.0|96.0|
4320654|NCT00463840|4148279|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4320655|NCT00463840|4148279|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4320656|NCT00463840|4148279|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4320657|NCT00463840|4148279|B1|||Age||years|Median|63.7|63.7|Full Range|||46.0|76.0|
4320658|NCT00463840|4148279|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4320659|NCT00463840|4148279|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4320660|NCT00463840|4148279|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4320661|NCT00463801|4148284|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4320662|NCT00463801|4148284|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4320663|NCT00463801|4148284|B1|Age 27-88 years||Age, Customized||participants|Number|52|52.0||||||
4320664|NCT00463788|4148288|B3|||Duration from initial breast cancer diagnosis to date of metastasis|"Number of participants analyzed N are 108 and 55 for each arm group respectively for this specific parameter."|months|Median|15.5|15.5|Full Range|||-4.0|349.0|
4320665|NCT00463788|4148289|B2|||Duration from initial breast cancer diagnosis to date of metastasis|"Number of participants analyzed N are 108 and 55 for each arm group respectively for this specific parameter."|months|Median|15.4|15.4|Full Range|||-4.0|199.0|
4320666|NCT00463788|4148290|B1|||Duration from initial breast cancer diagnosis to date of metastasis|"Number of participants analyzed N are 108 and 55 for each arm group respectively for this specific parameter."|months|Median|15.7|15.7|Full Range|||0.0|349.0|
4320667|NCT00463788|4148288|B3|||Duration of metastatic breast cancer from metastasis to informed consent|"Number of participants analyzed N are 113 and 56 for each arm group respectively for this specific parameter."|months|Median|0.9|0.9|Full Range|||0.0|56.0|
4320668|NCT00463788|4148289|B2|||Duration of metastatic breast cancer from metastasis to informed consent|"Number of participants analyzed N are 113 and 56 for each arm group respectively for this specific parameter."|months|Median|0.8|0.8|Full Range|||0.0|41.0|
4320669|NCT00463788|4148290|B1|||Duration of metastatic breast cancer from metastasis to informed consent|"Number of participants analyzed N are 113 and 56 for each arm group respectively for this specific parameter."|months|Median|0.9|0.9|Full Range|||0.0|56.0|
4320670|NCT00463788|4148288|B3|Other||Participants categorized by site of metastasis|A participant can have more than one site of metastasis.|participants|Number|23|23.0||||||
4320671|NCT00463788|4148289|B2|Other||Participants categorized by site of metastasis|A participant can have more than one site of metastasis.|participants|Number|8|8.0||||||
4320672|NCT00463788|4148290|B1|Other||Participants categorized by site of metastasis|A participant can have more than one site of metastasis.|participants|Number|15|15.0||||||
4320673|NCT00463788|4148288|B3|Skin||Participants categorized by site of metastasis|A participant can have more than one site of metastasis.|participants|Number|28|28.0||||||
4320674|NCT00463788|4148289|B2|Skin||Participants categorized by site of metastasis|A participant can have more than one site of metastasis.|participants|Number|8|8.0||||||
4320675|NCT00463788|4148290|B1|Skin||Participants categorized by site of metastasis|A participant can have more than one site of metastasis.|participants|Number|20|20.0||||||
4320676|NCT00463788|4148288|B3|Liver||Participants categorized by site of metastasis|A participant can have more than one site of metastasis.|participants|Number|53|53.0||||||
4320677|NCT00463788|4148289|B2|Liver||Participants categorized by site of metastasis|A participant can have more than one site of metastasis.|participants|Number|17|17.0||||||
4320678|NCT00463788|4148290|B1|Liver||Participants categorized by site of metastasis|A participant can have more than one site of metastasis.|participants|Number|36|36.0||||||
4320679|NCT00463788|4148288|B3|Bone||Participants categorized by site of metastasis|A participant can have more than one site of metastasis.|participants|Number|57|57.0||||||
4320680|NCT00463788|4148289|B2|Bone||Participants categorized by site of metastasis|A participant can have more than one site of metastasis.|participants|Number|20|20.0||||||
4320681|NCT00463788|4148290|B1|Bone||Participants categorized by site of metastasis|A participant can have more than one site of metastasis.|participants|Number|37|37.0||||||
4320682|NCT00463788|4148288|B3|Lymph nodes (by medical review)||Participants categorized by site of metastasis|A participant can have more than one site of metastasis.|participants|Number|71|71.0||||||
4320683|NCT00463788|4148289|B2|Lymph nodes (by medical review)||Participants categorized by site of metastasis|A participant can have more than one site of metastasis.|participants|Number|22|22.0||||||
4320684|NCT00463788|4148290|B1|Lymph nodes (by medical review)||Participants categorized by site of metastasis|A participant can have more than one site of metastasis.|participants|Number|49|49.0||||||
4320685|NCT00463788|4148288|B3|Lung||Participants categorized by site of metastasis|A participant can have more than one site of metastasis.|participants|Number|90|90.0||||||
4320686|NCT00463788|4148289|B2|Lung||Participants categorized by site of metastasis|A participant can have more than one site of metastasis.|participants|Number|26|26.0||||||
4320687|NCT00463788|4148290|B1|Lung||Participants categorized by site of metastasis|A participant can have more than one site of metastasis.|participants|Number|64|64.0||||||
4320688|NCT00463788|4148288|B3|||Duration of breast cancer from primary tumor diagnosis to informed consent|"Number of participants analyzed N are 110 and 56 for each arm group respectively for this specific parameter."|months|Median|18.7|18.7|Full Range|||0.0|350.0|
4320689|NCT00463788|4148289|B2|||Duration of breast cancer from primary tumor diagnosis to informed consent|"Number of participants analyzed N are 110 and 56 for each arm group respectively for this specific parameter."|months|Median|17.3|17.3|Full Range|||0.0|199.0|
4320690|NCT00463788|4148290|B1|||Duration of breast cancer from primary tumor diagnosis to informed consent|"Number of participants analyzed N are 110 and 56 for each arm group respectively for this specific parameter."|months|Median|19.2|19.2|Full Range|||0.0|350.0|
4320691|NCT00463788|4148288|B3|No||Naturally post menopausal participants||participants|Number|73|73.0||||||
4320692|NCT00463788|4148289|B2|No||Naturally post menopausal participants||participants|Number|22|22.0||||||
4320693|NCT00463788|4148290|B1|No||Naturally post menopausal participants||participants|Number|51|51.0||||||
4320694|NCT00463788|4148288|B3|Yes||Naturally post menopausal participants||participants|Number|100|100.0||||||
4320695|NCT00463788|4148289|B2|Yes||Naturally post menopausal participants||participants|Number|36|36.0||||||
4320696|NCT00463788|4148290|B1|Yes||Naturally post menopausal participants||participants|Number|64|64.0||||||
4320697|NCT00463788|4148288|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4320698|NCT00463788|4148289|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4320699|NCT00463788|4148290|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4320700|NCT00463788|4148288|B3||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4320701|NCT00463788|4148289|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4320702|NCT00463788|4148290|B1||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4320703|NCT00463788|4148288|B3|>= 65 years||Age, Customized||participants|Number|29|29.0||||||
4320704|NCT00463788|4148289|B2|>= 65 years||Age, Customized||participants|Number|7|7.0||||||
4320705|NCT00463788|4148290|B1|>= 65 years||Age, Customized||participants|Number|22|22.0||||||
4320706|NCT00463788|4148288|B3|< 65 years||Age, Customized||participants|Number|144|144.0||||||
4320707|NCT00463788|4148289|B2|< 65 years||Age, Customized||participants|Number|51|51.0||||||
4320708|NCT00463788|4148290|B1|< 65 years||Age, Customized||participants|Number|93|93.0||||||
4320709|NCT00463788|4148288|B3|||Age||years|Mean|52.5|52.5|Standard Deviation|11.92|11.92|||
4320710|NCT00463788|4148289|B2|||Age||years|Mean|51.7|51.7|Standard Deviation|10.67|10.67|||
4320711|NCT00463788|4148290|B1|||Age||years|Mean|52.9|52.9|Standard Deviation|12.53|12.53|||
4320712|NCT00463606|4148306|B4|United States||Region of Enrollment||participants|Number|758|758.0||||||
4320713|NCT00463606|4148307|B3|United States||Region of Enrollment||participants|Number|251|251.0||||||
4320714|NCT00463606|4148308|B2|United States||Region of Enrollment||participants|Number|254|254.0||||||
4320715|NCT00463606|4148309|B1|United States||Region of Enrollment||participants|Number|253|253.0||||||
4320716|NCT00463606|4148306|B4||Male|Sex: Female, Male||Participants|Count of Participants|303|303.0||||||
4320717|NCT00463606|4148307|B3||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4320718|NCT00463606|4148308|B2||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4320719|NCT00463606|4148309|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4320720|NCT00463606|4148306|B4||Female|Sex: Female, Male||Participants|Count of Participants|455|455.0||||||
4320721|NCT00463606|4148307|B3||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4320722|NCT00463606|4148308|B2||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4320723|NCT00463606|4148309|B1||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4320725|NCT00463606|4148307|B3|||Age||years|Mean|55.3|55.3|Standard Deviation|10.71|10.71|||
4320726|NCT00463606|4148308|B2|||Age||years|Mean|54.4|54.4|Standard Deviation|11.24|11.24|||
4320727|NCT00463606|4148309|B1|||Age||years|Mean|56.2|56.2|Standard Deviation|11.30|11.3|||
4320728|NCT00463606|4148306|B4||>=65 years|Age||Participants|Count of Participants|156|156.0||||||
4320729|NCT00463606|4148307|B3||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
4320730|NCT00463606|4148308|B2||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
4320731|NCT00463606|4148309|B1||>=65 years|Age||Participants|Count of Participants|59|59.0||||||
4320732|NCT00463606|4148306|B4||Between 18 and 65 years|Age||Participants|Count of Participants|602|602.0||||||
4320733|NCT00463606|4148307|B3||Between 18 and 65 years|Age||Participants|Count of Participants|205|205.0||||||
4320734|NCT00463606|4148308|B2||Between 18 and 65 years|Age||Participants|Count of Participants|203|203.0||||||
4320735|NCT00463606|4148309|B1||Between 18 and 65 years|Age||Participants|Count of Participants|194|194.0||||||
4320736|NCT00463606|4148306|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4320737|NCT00463606|4148307|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4320738|NCT00463606|4148308|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4320739|NCT00463606|4148309|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4320740|NCT00463580|4148334|B3|||Hamilton Depression Rating Scale-17 item (HDRS-17)|Hamilton Depression Rating Scale-17 item; Minimum score= 0 Maximum score= 54; Higher scores represent greater symptom severity|scores on a scale|Mean|23.8|23.8|Standard Deviation|3.9|3.9|||
4320741|NCT00463580|4148335|B2|||Hamilton Depression Rating Scale-17 item (HDRS-17)|Hamilton Depression Rating Scale-17 item; Minimum score= 0 Maximum score= 54; Higher scores represent greater symptom severity|scores on a scale|Mean|23.6|23.6|Standard Deviation|3.8|3.8|||
4320742|NCT00463580|4148336|B1|||Hamilton Depression Rating Scale-17 item (HDRS-17)|Hamilton Depression Rating Scale-17 item; Minimum score= 0 Maximum score= 54; Higher scores represent greater symptom severity|scores on a scale|Mean|24.1|24.1|Standard Deviation|4.0|4.0|||
4320743|NCT00463580|4148334|B3|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
4320744|NCT00463580|4148335|B2|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4320745|NCT00463580|4148336|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4320746|NCT00463580|4148334|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4320747|NCT00463580|4148335|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4320748|NCT00463580|4148336|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4320749|NCT00463580|4148334|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4320750|NCT00463580|4148335|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4320751|NCT00463580|4148336|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4320752|NCT00463580|4148334|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
4320753|NCT00463580|4148335|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
4320754|NCT00463580|4148336|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
4320755|NCT00463580|4148334|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4320756|NCT00463580|4148335|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4320757|NCT00463580|4148336|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4320758|NCT00463580|4148334|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4320759|NCT00463580|4148335|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4320760|NCT00463580|4148336|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4320761|NCT00463580|4148334|B3|||Age||years|Mean|43.4|43.4|Standard Deviation|8.8|8.8|||
4320762|NCT00463580|4148335|B2|||Age||years|Mean|44.3|44.3|Standard Deviation|9.4|9.4|||
4320763|NCT00463580|4148336|B1|||Age||years|Mean|42.5|42.5|Standard Deviation|8.2|8.2|||
4320764|NCT00463567|4148363|B8||Male|Sex: Female, Male||Participants|Count of Participants|1266|1266.0||||||
4320765|NCT00463567|4148364|B7||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4320766|NCT00463567|4148365|B6||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4320767|NCT00463567|4148366|B5||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4320768|NCT00463567|4148367|B4||Male|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
4320769|NCT00463567|4148368|B3||Male|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
4320770|NCT00463567|4148369|B2||Male|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
4320771|NCT00463567|4148370|B1||Male|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
4320772|NCT00463567|4148363|B8||Female|Sex: Female, Male||Participants|Count of Participants|770|770.0||||||
4320773|NCT00463567|4148364|B7||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4320774|NCT00463567|4148365|B6||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4320775|NCT00463567|4148366|B5||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4320776|NCT00463567|4148367|B4||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4320777|NCT00463567|4148368|B3||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4320778|NCT00463567|4148369|B2||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4320779|NCT00463567|4148370|B1||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4320780|NCT00463567|4148363|B8|≥65 years||Age, Customized|Baseline Measures were based on the Safety Population that included all participants who received at least one dose of study drug.|participants|Number|988|988.0||||||
4320781|NCT00463567|4148364|B7|≥65 years||Age, Customized|Baseline Measures were based on the Safety Population that included all participants who received at least one dose of study drug.|participants|Number|66|66.0||||||
4320782|NCT00463567|4148365|B6|≥65 years||Age, Customized|Baseline Measures were based on the Safety Population that included all participants who received at least one dose of study drug.|participants|Number|62|62.0||||||
4320783|NCT00463567|4148366|B5|≥65 years||Age, Customized|Baseline Measures were based on the Safety Population that included all participants who received at least one dose of study drug.|participants|Number|69|69.0||||||
4320784|NCT00463567|4148367|B4|≥65 years||Age, Customized|Baseline Measures were based on the Safety Population that included all participants who received at least one dose of study drug.|participants|Number|203|203.0||||||
4320785|NCT00463567|4148368|B3|≥65 years||Age, Customized|Baseline Measures were based on the Safety Population that included all participants who received at least one dose of study drug.|participants|Number|200|200.0||||||
4320786|NCT00463567|4148369|B2|≥65 years||Age, Customized|Baseline Measures were based on the Safety Population that included all participants who received at least one dose of study drug.|participants|Number|186|186.0||||||
4320787|NCT00463567|4148370|B1|≥65 years||Age, Customized|Baseline Measures were based on the Safety Population that included all participants who received at least one dose of study drug.|participants|Number|202|202.0||||||
4320788|NCT00463567|4148363|B8|Between 40 and 64 years||Age, Customized|Baseline Measures were based on the Safety Population that included all participants who received at least one dose of study drug.|participants|Number|1048|1048.0||||||
4320789|NCT00463567|4148364|B7|Between 40 and 64 years||Age, Customized|Baseline Measures were based on the Safety Population that included all participants who received at least one dose of study drug.|participants|Number|56|56.0||||||
4320790|NCT00463567|4148365|B6|Between 40 and 64 years||Age, Customized|Baseline Measures were based on the Safety Population that included all participants who received at least one dose of study drug.|participants|Number|60|60.0||||||
4320791|NCT00463567|4148366|B5|Between 40 and 64 years||Age, Customized|Baseline Measures were based on the Safety Population that included all participants who received at least one dose of study drug.|participants|Number|58|58.0||||||
4320792|NCT00463567|4148367|B4|Between 40 and 64 years||Age, Customized|Baseline Measures were based on the Safety Population that included all participants who received at least one dose of study drug.|participants|Number|215|215.0||||||
4320793|NCT00463567|4148368|B3|Between 40 and 64 years||Age, Customized|Baseline Measures were based on the Safety Population that included all participants who received at least one dose of study drug.|participants|Number|215|215.0||||||
4320794|NCT00463567|4148369|B2|Between 40 and 64 years||Age, Customized|Baseline Measures were based on the Safety Population that included all participants who received at least one dose of study drug.|participants|Number|230|230.0||||||
4320795|NCT00463567|4148370|B1|Between 40 and 64 years||Age, Customized|Baseline Measures were based on the Safety Population that included all participants who received at least one dose of study drug.|participants|Number|214|214.0||||||
4320796|NCT00463437|4148407|B5||Male|Sex: Female, Male||Participants|Count of Participants|713|713.0||||||
4320797|NCT00463437|4148408|B4||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4320798|NCT00463437|4148409|B3||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4320799|NCT00463437|4148410|B2||Male|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4320800|NCT00463437|4148411|B1||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4320801|NCT00463437|4148407|B5||Female|Sex: Female, Male||Participants|Count of Participants|724|724.0||||||
4320802|NCT00463437|4148408|B4||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4320803|NCT00463437|4148409|B3||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4320804|NCT00463437|4148410|B2||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4320805|NCT00463437|4148411|B1||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4320806|NCT00463437|4148407|B5|||Age||Months|Mean|14.3|14.3|Standard Deviation|1.78|1.78|||
4320807|NCT00463437|4148408|B4|||Age||Months|Mean|14.3|14.3|Standard Deviation|1.78|1.78|||
4320808|NCT00463437|4148409|B3|||Age||Months|Mean|14.3|14.3|Standard Deviation|1.78|1.78|||
4320809|NCT00463437|4148410|B2|||Age||Months|Mean|14.3|14.3|Standard Deviation|1.74|1.74|||
4320810|NCT00463437|4148411|B1|||Age||Months|Mean|14.3|14.3|Standard Deviation|1.81|1.81|||
4320811|NCT00463385|4148476|B5|||RBC Transfusion Burden||units/28 days|Median|1.0|1.0|Full Range|||0.0|7.0|
4320812|NCT00463385|4148477|B4|||RBC Transfusion Burden||units/28 days|Median|2.0|2.0|Full Range|||0.0|4.0|
4320813|NCT00463385|4148478|B3|||RBC Transfusion Burden||units/28 days|Median|0.0|0.0|Full Range|||0.0|6.0|
4320814|NCT00463385|4148479|B2|||RBC Transfusion Burden||units/28 days|Median|1.0|1.0|Full Range|||0.0|6.0|
4320815|NCT00463385|4148480|B1|||RBC Transfusion Burden||units/28 days|Median|2.0|2.0|Full Range|||0.0|7.0|
4320816|NCT00463385|4148476|B5|No||Red Blood Cell (RBC) Transfusion Dependence|A patient who receives at least a total of two units of RBC transfusion within 28 days on or prior to the first study drug dosing date is an RBC-transfusion-dependent patient. Otherwise a patient is an RBC-transfusion-independent patient.|participants|Number|45|45.0||||||
4320817|NCT00463385|4148477|B4|No||Red Blood Cell (RBC) Transfusion Dependence|A patient who receives at least a total of two units of RBC transfusion within 28 days on or prior to the first study drug dosing date is an RBC-transfusion-dependent patient. Otherwise a patient is an RBC-transfusion-independent patient.|participants|Number|10|10.0||||||
4320818|NCT00463385|4148478|B3|No||Red Blood Cell (RBC) Transfusion Dependence|A patient who receives at least a total of two units of RBC transfusion within 28 days on or prior to the first study drug dosing date is an RBC-transfusion-dependent patient. Otherwise a patient is an RBC-transfusion-independent patient.|participants|Number|13|13.0||||||
4320819|NCT00463385|4148479|B2|No||Red Blood Cell (RBC) Transfusion Dependence|A patient who receives at least a total of two units of RBC transfusion within 28 days on or prior to the first study drug dosing date is an RBC-transfusion-dependent patient. Otherwise a patient is an RBC-transfusion-independent patient.|participants|Number|12|12.0||||||
4320820|NCT00463385|4148480|B1|No||Red Blood Cell (RBC) Transfusion Dependence|A patient who receives at least a total of two units of RBC transfusion within 28 days on or prior to the first study drug dosing date is an RBC-transfusion-dependent patient. Otherwise a patient is an RBC-transfusion-independent patient.|participants|Number|10|10.0||||||
4320821|NCT00463385|4148476|B5|Yes||Red Blood Cell (RBC) Transfusion Dependence|A patient who receives at least a total of two units of RBC transfusion within 28 days on or prior to the first study drug dosing date is an RBC-transfusion-dependent patient. Otherwise a patient is an RBC-transfusion-independent patient.|participants|Number|43|43.0||||||
4320822|NCT00463385|4148477|B4|Yes||Red Blood Cell (RBC) Transfusion Dependence|A patient who receives at least a total of two units of RBC transfusion within 28 days on or prior to the first study drug dosing date is an RBC-transfusion-dependent patient. Otherwise a patient is an RBC-transfusion-independent patient.|participants|Number|12|12.0||||||
4320823|NCT00463385|4148478|B3|Yes||Red Blood Cell (RBC) Transfusion Dependence|A patient who receives at least a total of two units of RBC transfusion within 28 days on or prior to the first study drug dosing date is an RBC-transfusion-dependent patient. Otherwise a patient is an RBC-transfusion-independent patient.|participants|Number|9|9.0||||||
4320824|NCT00463385|4148479|B2|Yes||Red Blood Cell (RBC) Transfusion Dependence|A patient who receives at least a total of two units of RBC transfusion within 28 days on or prior to the first study drug dosing date is an RBC-transfusion-dependent patient. Otherwise a patient is an RBC-transfusion-independent patient.|participants|Number|10|10.0||||||
4320825|NCT00463385|4148480|B1|Yes||Red Blood Cell (RBC) Transfusion Dependence|A patient who receives at least a total of two units of RBC transfusion within 28 days on or prior to the first study drug dosing date is an RBC-transfusion-dependent patient. Otherwise a patient is an RBC-transfusion-independent patient.|participants|Number|12|12.0||||||
4320826|NCT00463385|4148476|B5|||Time Since Myelofibrosis Diagnosis||years|Median|1.1|1.1|Full Range|||0.0|14.3|
4320827|NCT00463385|4148477|B4|||Time Since Myelofibrosis Diagnosis||years|Median|1.7|1.7|Full Range|||0.0|10.9|
4320828|NCT00463385|4148478|B3|||Time Since Myelofibrosis Diagnosis||years|Median|1.1|1.1|Full Range|||0.0|13.0|
4320829|NCT00463385|4148479|B2|||Time Since Myelofibrosis Diagnosis||years|Median|0.6|0.6|Full Range|||0.0|6.3|
4320830|NCT00463385|4148480|B1|||Time Since Myelofibrosis Diagnosis||years|Median|1.5|1.5|Full Range|||0.0|14.3|
4320831|NCT00463385|4148476|B5|Postthromocythemic Myeloid Metaplasia (PTMM)||Myelofibrosis with myeloid metaplasia Subtype||participants|Number|14|14.0||||||
4320832|NCT00463385|4148477|B4|Postthromocythemic Myeloid Metaplasia (PTMM)||Myelofibrosis with myeloid metaplasia Subtype||participants|Number|7|7.0||||||
4320833|NCT00463385|4148478|B3|Postthromocythemic Myeloid Metaplasia (PTMM)||Myelofibrosis with myeloid metaplasia Subtype||participants|Number|2|2.0||||||
4320834|NCT00463385|4148479|B2|Postthromocythemic Myeloid Metaplasia (PTMM)||Myelofibrosis with myeloid metaplasia Subtype||participants|Number|2|2.0||||||
4320835|NCT00463385|4148480|B1|Postthromocythemic Myeloid Metaplasia (PTMM)||Myelofibrosis with myeloid metaplasia Subtype||participants|Number|3|3.0||||||
4320836|NCT00463385|4148476|B5|Postpolycythemic Myeloid Metaplasia (PPMM)||Myelofibrosis with myeloid metaplasia Subtype||participants|Number|13|13.0||||||
4320837|NCT00463385|4148477|B4|Postpolycythemic Myeloid Metaplasia (PPMM)||Myelofibrosis with myeloid metaplasia Subtype||participants|Number|2|2.0||||||
4320838|NCT00463385|4148478|B3|Postpolycythemic Myeloid Metaplasia (PPMM)||Myelofibrosis with myeloid metaplasia Subtype||participants|Number|4|4.0||||||
4320839|NCT00463385|4148479|B2|Postpolycythemic Myeloid Metaplasia (PPMM)||Myelofibrosis with myeloid metaplasia Subtype||participants|Number|4|4.0||||||
4320840|NCT00463385|4148480|B1|Postpolycythemic Myeloid Metaplasia (PPMM)||Myelofibrosis with myeloid metaplasia Subtype||participants|Number|3|3.0||||||
4320841|NCT00463385|4148476|B5|Agnogenic Myeloid Metaplasia (AMM)||Myelofibrosis with myeloid metaplasia Subtype||participants|Number|61|61.0||||||
4320842|NCT00463385|4148477|B4|Agnogenic Myeloid Metaplasia (AMM)||Myelofibrosis with myeloid metaplasia Subtype||participants|Number|13|13.0||||||
4320843|NCT00463385|4148478|B3|Agnogenic Myeloid Metaplasia (AMM)||Myelofibrosis with myeloid metaplasia Subtype||participants|Number|16|16.0||||||
4320844|NCT00463385|4148479|B2|Agnogenic Myeloid Metaplasia (AMM)||Myelofibrosis with myeloid metaplasia Subtype||participants|Number|16|16.0||||||
4320845|NCT00463385|4148480|B1|Agnogenic Myeloid Metaplasia (AMM)||Myelofibrosis with myeloid metaplasia Subtype||participants|Number|16|16.0||||||
4320846|NCT00463385|4148476|B5|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status scale and criteria used to assess disease progression, how the disease affects the daily living abilities of the patient, and determine appropriate treatment:~0=Fully active, able to carry on all pre-disease activities;~Restricted in physically strenuous activity; ambulatory and able to carry out light work;~Ambulatory and capable of all selfcare; unable to perform work activities. Up and about > 50% of waking hours;~Capable of only limited selfcare, confined to bed/chair > 50% of waking hours;~Completely disabled. Confined to bed or chair;~Dead"|participants|Number|1|1.0||||||
4320847|NCT00463385|4148477|B4|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status scale and criteria used to assess disease progression, how the disease affects the daily living abilities of the patient, and determine appropriate treatment:~0=Fully active, able to carry on all pre-disease activities;~Restricted in physically strenuous activity; ambulatory and able to carry out light work;~Ambulatory and capable of all selfcare; unable to perform work activities. Up and about > 50% of waking hours;~Capable of only limited selfcare, confined to bed/chair > 50% of waking hours;~Completely disabled. Confined to bed or chair;~Dead"|participants|Number|0|0.0||||||
4320848|NCT00463385|4148478|B3|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status scale and criteria used to assess disease progression, how the disease affects the daily living abilities of the patient, and determine appropriate treatment:~0=Fully active, able to carry on all pre-disease activities;~Restricted in physically strenuous activity; ambulatory and able to carry out light work;~Ambulatory and capable of all selfcare; unable to perform work activities. Up and about > 50% of waking hours;~Capable of only limited selfcare, confined to bed/chair > 50% of waking hours;~Completely disabled. Confined to bed or chair;~Dead"|participants|Number|1|1.0||||||
4320943|NCT00463229|4148546|B1||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
4320849|NCT00463385|4148479|B2|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status scale and criteria used to assess disease progression, how the disease affects the daily living abilities of the patient, and determine appropriate treatment:~0=Fully active, able to carry on all pre-disease activities;~Restricted in physically strenuous activity; ambulatory and able to carry out light work;~Ambulatory and capable of all selfcare; unable to perform work activities. Up and about > 50% of waking hours;~Capable of only limited selfcare, confined to bed/chair > 50% of waking hours;~Completely disabled. Confined to bed or chair;~Dead"|participants|Number|0|0.0||||||
4320850|NCT00463385|4148480|B1|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status scale and criteria used to assess disease progression, how the disease affects the daily living abilities of the patient, and determine appropriate treatment:~0=Fully active, able to carry on all pre-disease activities;~Restricted in physically strenuous activity; ambulatory and able to carry out light work;~Ambulatory and capable of all selfcare; unable to perform work activities. Up and about > 50% of waking hours;~Capable of only limited selfcare, confined to bed/chair > 50% of waking hours;~Completely disabled. Confined to bed or chair;~Dead"|participants|Number|0|0.0||||||
4320851|NCT00463385|4148476|B5|Grade 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status scale and criteria used to assess disease progression, how the disease affects the daily living abilities of the patient, and determine appropriate treatment:~0=Fully active, able to carry on all pre-disease activities;~Restricted in physically strenuous activity; ambulatory and able to carry out light work;~Ambulatory and capable of all selfcare; unable to perform work activities. Up and about > 50% of waking hours;~Capable of only limited selfcare, confined to bed/chair > 50% of waking hours;~Completely disabled. Confined to bed or chair;~Dead"|participants|Number|11|11.0||||||
4320852|NCT00463385|4148477|B4|Grade 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status scale and criteria used to assess disease progression, how the disease affects the daily living abilities of the patient, and determine appropriate treatment:~0=Fully active, able to carry on all pre-disease activities;~Restricted in physically strenuous activity; ambulatory and able to carry out light work;~Ambulatory and capable of all selfcare; unable to perform work activities. Up and about > 50% of waking hours;~Capable of only limited selfcare, confined to bed/chair > 50% of waking hours;~Completely disabled. Confined to bed or chair;~Dead"|participants|Number|2|2.0||||||
4320853|NCT00463385|4148478|B3|Grade 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status scale and criteria used to assess disease progression, how the disease affects the daily living abilities of the patient, and determine appropriate treatment:~0=Fully active, able to carry on all pre-disease activities;~Restricted in physically strenuous activity; ambulatory and able to carry out light work;~Ambulatory and capable of all selfcare; unable to perform work activities. Up and about > 50% of waking hours;~Capable of only limited selfcare, confined to bed/chair > 50% of waking hours;~Completely disabled. Confined to bed or chair;~Dead"|participants|Number|5|5.0||||||
4320854|NCT00463385|4148479|B2|Grade 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status scale and criteria used to assess disease progression, how the disease affects the daily living abilities of the patient, and determine appropriate treatment:~0=Fully active, able to carry on all pre-disease activities;~Restricted in physically strenuous activity; ambulatory and able to carry out light work;~Ambulatory and capable of all selfcare; unable to perform work activities. Up and about > 50% of waking hours;~Capable of only limited selfcare, confined to bed/chair > 50% of waking hours;~Completely disabled. Confined to bed or chair;~Dead"|participants|Number|2|2.0||||||
4320855|NCT00463385|4148480|B1|Grade 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status scale and criteria used to assess disease progression, how the disease affects the daily living abilities of the patient, and determine appropriate treatment:~0=Fully active, able to carry on all pre-disease activities;~Restricted in physically strenuous activity; ambulatory and able to carry out light work;~Ambulatory and capable of all selfcare; unable to perform work activities. Up and about > 50% of waking hours;~Capable of only limited selfcare, confined to bed/chair > 50% of waking hours;~Completely disabled. Confined to bed or chair;~Dead"|participants|Number|2|2.0||||||
4320856|NCT00463385|4148476|B5|Grade 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status scale and criteria used to assess disease progression, how the disease affects the daily living abilities of the patient, and determine appropriate treatment:~0=Fully active, able to carry on all pre-disease activities;~Restricted in physically strenuous activity; ambulatory and able to carry out light work;~Ambulatory and capable of all selfcare; unable to perform work activities. Up and about > 50% of waking hours;~Capable of only limited selfcare, confined to bed/chair > 50% of waking hours;~Completely disabled. Confined to bed or chair;~Dead"|participants|Number|33|33.0||||||
4320857|NCT00463385|4148477|B4|Grade 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status scale and criteria used to assess disease progression, how the disease affects the daily living abilities of the patient, and determine appropriate treatment:~0=Fully active, able to carry on all pre-disease activities;~Restricted in physically strenuous activity; ambulatory and able to carry out light work;~Ambulatory and capable of all selfcare; unable to perform work activities. Up and about > 50% of waking hours;~Capable of only limited selfcare, confined to bed/chair > 50% of waking hours;~Completely disabled. Confined to bed or chair;~Dead"|participants|Number|6|6.0||||||
4320858|NCT00463385|4148478|B3|Grade 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status scale and criteria used to assess disease progression, how the disease affects the daily living abilities of the patient, and determine appropriate treatment:~0=Fully active, able to carry on all pre-disease activities;~Restricted in physically strenuous activity; ambulatory and able to carry out light work;~Ambulatory and capable of all selfcare; unable to perform work activities. Up and about > 50% of waking hours;~Capable of only limited selfcare, confined to bed/chair > 50% of waking hours;~Completely disabled. Confined to bed or chair;~Dead"|participants|Number|10|10.0||||||
4320859|NCT00463385|4148479|B2|Grade 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status scale and criteria used to assess disease progression, how the disease affects the daily living abilities of the patient, and determine appropriate treatment:~0=Fully active, able to carry on all pre-disease activities;~Restricted in physically strenuous activity; ambulatory and able to carry out light work;~Ambulatory and capable of all selfcare; unable to perform work activities. Up and about > 50% of waking hours;~Capable of only limited selfcare, confined to bed/chair > 50% of waking hours;~Completely disabled. Confined to bed or chair;~Dead"|participants|Number|9|9.0||||||
4320860|NCT00463385|4148480|B1|Grade 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status scale and criteria used to assess disease progression, how the disease affects the daily living abilities of the patient, and determine appropriate treatment:~0=Fully active, able to carry on all pre-disease activities;~Restricted in physically strenuous activity; ambulatory and able to carry out light work;~Ambulatory and capable of all selfcare; unable to perform work activities. Up and about > 50% of waking hours;~Capable of only limited selfcare, confined to bed/chair > 50% of waking hours;~Completely disabled. Confined to bed or chair;~Dead"|participants|Number|8|8.0||||||
4320861|NCT00463385|4148476|B5|Grade 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status scale and criteria used to assess disease progression, how the disease affects the daily living abilities of the patient, and determine appropriate treatment:~0=Fully active, able to carry on all pre-disease activities;~Restricted in physically strenuous activity; ambulatory and able to carry out light work;~Ambulatory and capable of all selfcare; unable to perform work activities. Up and about > 50% of waking hours;~Capable of only limited selfcare, confined to bed/chair > 50% of waking hours;~Completely disabled. Confined to bed or chair;~Dead"|participants|Number|43|43.0||||||
4320862|NCT00463385|4148477|B4|Grade 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status scale and criteria used to assess disease progression, how the disease affects the daily living abilities of the patient, and determine appropriate treatment:~0=Fully active, able to carry on all pre-disease activities;~Restricted in physically strenuous activity; ambulatory and able to carry out light work;~Ambulatory and capable of all selfcare; unable to perform work activities. Up and about > 50% of waking hours;~Capable of only limited selfcare, confined to bed/chair > 50% of waking hours;~Completely disabled. Confined to bed or chair;~Dead"|participants|Number|14|14.0||||||
4320863|NCT00463385|4148478|B3|Grade 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status scale and criteria used to assess disease progression, how the disease affects the daily living abilities of the patient, and determine appropriate treatment:~0=Fully active, able to carry on all pre-disease activities;~Restricted in physically strenuous activity; ambulatory and able to carry out light work;~Ambulatory and capable of all selfcare; unable to perform work activities. Up and about > 50% of waking hours;~Capable of only limited selfcare, confined to bed/chair > 50% of waking hours;~Completely disabled. Confined to bed or chair;~Dead"|participants|Number|6|6.0||||||
4320864|NCT00463385|4148479|B2|Grade 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status scale and criteria used to assess disease progression, how the disease affects the daily living abilities of the patient, and determine appropriate treatment:~0=Fully active, able to carry on all pre-disease activities;~Restricted in physically strenuous activity; ambulatory and able to carry out light work;~Ambulatory and capable of all selfcare; unable to perform work activities. Up and about > 50% of waking hours;~Capable of only limited selfcare, confined to bed/chair > 50% of waking hours;~Completely disabled. Confined to bed or chair;~Dead"|participants|Number|11|11.0||||||
4320865|NCT00463385|4148480|B1|Grade 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG performance status scale and criteria used to assess disease progression, how the disease affects the daily living abilities of the patient, and determine appropriate treatment:~0=Fully active, able to carry on all pre-disease activities;~Restricted in physically strenuous activity; ambulatory and able to carry out light work;~Ambulatory and capable of all selfcare; unable to perform work activities. Up and about > 50% of waking hours;~Capable of only limited selfcare, confined to bed/chair > 50% of waking hours;~Completely disabled. Confined to bed or chair;~Dead"|participants|Number|12|12.0||||||
4320866|NCT00463385|4148476|B5|Missing||Janus kinase 2 (JAK2) Mutation|JAK2^V617F mutation result based on quantitative polymerase chain reaction (PCR) analysis in neutrophil preparation.|participants|Number|16|16.0||||||
4320867|NCT00463385|4148477|B4|Missing||Janus kinase 2 (JAK2) Mutation|JAK2^V617F mutation result based on quantitative polymerase chain reaction (PCR) analysis in neutrophil preparation.|participants|Number|5|5.0||||||
4320868|NCT00463385|4148478|B3|Missing||Janus kinase 2 (JAK2) Mutation|JAK2^V617F mutation result based on quantitative polymerase chain reaction (PCR) analysis in neutrophil preparation.|participants|Number|4|4.0||||||
4320869|NCT00463385|4148479|B2|Missing||Janus kinase 2 (JAK2) Mutation|JAK2^V617F mutation result based on quantitative polymerase chain reaction (PCR) analysis in neutrophil preparation.|participants|Number|4|4.0||||||
4320870|NCT00463385|4148480|B1|Missing||Janus kinase 2 (JAK2) Mutation|JAK2^V617F mutation result based on quantitative polymerase chain reaction (PCR) analysis in neutrophil preparation.|participants|Number|3|3.0||||||
4320871|NCT00463385|4148476|B5|Positive||Janus kinase 2 (JAK2) Mutation|JAK2^V617F mutation result based on quantitative polymerase chain reaction (PCR) analysis in neutrophil preparation.|participants|Number|43|43.0||||||
4320872|NCT00463385|4148477|B4|Positive||Janus kinase 2 (JAK2) Mutation|JAK2^V617F mutation result based on quantitative polymerase chain reaction (PCR) analysis in neutrophil preparation.|participants|Number|9|9.0||||||
4320873|NCT00463385|4148478|B3|Positive||Janus kinase 2 (JAK2) Mutation|JAK2^V617F mutation result based on quantitative polymerase chain reaction (PCR) analysis in neutrophil preparation.|participants|Number|10|10.0||||||
4320874|NCT00463385|4148479|B2|Positive||Janus kinase 2 (JAK2) Mutation|JAK2^V617F mutation result based on quantitative polymerase chain reaction (PCR) analysis in neutrophil preparation.|participants|Number|11|11.0||||||
4320875|NCT00463385|4148480|B1|Positive||Janus kinase 2 (JAK2) Mutation|JAK2^V617F mutation result based on quantitative polymerase chain reaction (PCR) analysis in neutrophil preparation.|participants|Number|13|13.0||||||
4320876|NCT00463385|4148476|B5|Negative||Janus kinase 2 (JAK2) Mutation|JAK2^V617F mutation result based on quantitative polymerase chain reaction (PCR) analysis in neutrophil preparation.|participants|Number|29|29.0||||||
4320877|NCT00463385|4148477|B4|Negative||Janus kinase 2 (JAK2) Mutation|JAK2^V617F mutation result based on quantitative polymerase chain reaction (PCR) analysis in neutrophil preparation.|participants|Number|8|8.0||||||
4320878|NCT00463385|4148478|B3|Negative||Janus kinase 2 (JAK2) Mutation|JAK2^V617F mutation result based on quantitative polymerase chain reaction (PCR) analysis in neutrophil preparation.|participants|Number|8|8.0||||||
4320879|NCT00463385|4148479|B2|Negative||Janus kinase 2 (JAK2) Mutation|JAK2^V617F mutation result based on quantitative polymerase chain reaction (PCR) analysis in neutrophil preparation.|participants|Number|7|7.0||||||
4320944|NCT00463229|4148544|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4320880|NCT00463385|4148480|B1|Negative||Janus kinase 2 (JAK2) Mutation|JAK2^V617F mutation result based on quantitative polymerase chain reaction (PCR) analysis in neutrophil preparation.|participants|Number|6|6.0||||||
4320881|NCT00463385|4148476|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4320882|NCT00463385|4148477|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4320883|NCT00463385|4148478|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4320884|NCT00463385|4148479|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4320885|NCT00463385|4148480|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4320886|NCT00463385|4148476|B5|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4320887|NCT00463385|4148477|B4|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4320888|NCT00463385|4148478|B3|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4320889|NCT00463385|4148479|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4320890|NCT00463385|4148480|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4320891|NCT00463385|4148476|B5|White||Race/Ethnicity, Customized||participants|Number|86|86.0||||||
4320892|NCT00463385|4148477|B4|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4320893|NCT00463385|4148478|B3|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4320894|NCT00463385|4148479|B2|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4320895|NCT00463385|4148480|B1|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4320896|NCT00463385|4148476|B5||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4320897|NCT00463385|4148477|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4320898|NCT00463385|4148478|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4320899|NCT00463385|4148479|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4320900|NCT00463385|4148480|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4320901|NCT00463385|4148476|B5||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4320902|NCT00463385|4148477|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4320903|NCT00463385|4148478|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4320904|NCT00463385|4148479|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4320905|NCT00463385|4148480|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4320906|NCT00463385|4148476|B5|||Age||years|Median|67.5|67.5|Full Range|||36.0|86.0|
4320907|NCT00463385|4148477|B4|||Age||years|Median|69.5|69.5|Full Range|||43.0|86.0|
4320908|NCT00463385|4148478|B3|||Age||years|Median|67.5|67.5|Full Range|||36.0|82.0|
4320909|NCT00463385|4148479|B2|||Age||years|Median|68.0|68.0|Full Range|||50.0|83.0|
4320910|NCT00463385|4148480|B1|||Age||years|Median|66.0|66.0|Full Range|||44.0|80.0|
4320911|NCT00463346|4148533|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4320912|NCT00463346|4148534|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4320913|NCT00463346|4148535|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4320914|NCT00463346|4148533|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4320915|NCT00463346|4148534|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4320916|NCT00463346|4148535|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4320917|NCT00463346|4148533|B3|||Age||years|Mean|50.73|50.73|Standard Deviation|7.31|7.31|||
4320918|NCT00463346|4148534|B2|||Age||years|Mean|49.18|49.18|Standard Deviation|4.64|4.64|||
4320919|NCT00463346|4148535|B1|||Age||years|Mean|52.27|52.27|Standard Deviation|9.24|9.24|||
4320920|NCT00463346|4148533|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4320921|NCT00463346|4148534|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4320922|NCT00463346|4148535|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4320923|NCT00463346|4148533|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4320924|NCT00463346|4148534|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4320925|NCT00463346|4148535|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4320926|NCT00463346|4148533|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4320927|NCT00463346|4148534|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4320928|NCT00463346|4148535|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4320929|NCT00463229|4148544|B3|Canada||Region of Enrollment||participants|Number|101|101.0||||||
4320930|NCT00463229|4148545|B2|Canada||Region of Enrollment||participants|Number|49|49.0||||||
4320931|NCT00463229|4148546|B1|Canada||Region of Enrollment||participants|Number|52|52.0||||||
4320932|NCT00463229|4148544|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4320933|NCT00463229|4148545|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4320934|NCT00463229|4148546|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4320935|NCT00463229|4148544|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4320936|NCT00463229|4148545|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4320937|NCT00463229|4148546|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4320938|NCT00463229|4148544|B3|||Age||years|Mean|74.31|74.31|Standard Deviation|13.33|13.33|||
4320939|NCT00463229|4148545|B2|||Age||years|Mean|72.32|72.32|Standard Deviation|14.14|14.14|||
4320940|NCT00463229|4148546|B1|||Age||years|Mean|76.18|76.18|Standard Deviation|12.35|12.35|||
4320941|NCT00463229|4148544|B3||>=65 years|Age||Participants|Count of Participants|78|78.0||||||
4320942|NCT00463229|4148545|B2||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4320945|NCT00463229|4148545|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4320946|NCT00463229|4148546|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4320947|NCT00463229|4148544|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4320948|NCT00463229|4148545|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4320949|NCT00463229|4148546|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4320950|NCT00463060|4148565|B3|>=2||Number of involved organs||participants|Number|15|15.0||||||
4320951|NCT00463060|4148566|B2|>=2||Number of involved organs||participants|Number|11|11.0||||||
4320952|NCT00463060|4148567|B1|>=2||Number of involved organs||participants|Number|4|4.0||||||
4320953|NCT00463060|4148565|B3|1||Number of involved organs||participants|Number|31|31.0||||||
4320954|NCT00463060|4148566|B2|1||Number of involved organs||participants|Number|14|14.0||||||
4320955|NCT00463060|4148567|B1|1||Number of involved organs||participants|Number|17|17.0||||||
4320956|NCT00463060|4148565|B3|>=3cm||Largest Tumor size||participants|Number|20|20.0||||||
4320957|NCT00463060|4148566|B2|>=3cm||Largest Tumor size||participants|Number|10|10.0||||||
4320958|NCT00463060|4148567|B1|>=3cm||Largest Tumor size||participants|Number|10|10.0||||||
4320959|NCT00463060|4148565|B3|<=3cm||Largest Tumor size||participants|Number|26|26.0||||||
4320960|NCT00463060|4148566|B2|<=3cm||Largest Tumor size||participants|Number|15|15.0||||||
4320961|NCT00463060|4148567|B1|<=3cm||Largest Tumor size||participants|Number|11|11.0||||||
4320962|NCT00463060|4148565|B3|>=3||Number of metastases||participants|Number|12|12.0||||||
4320963|NCT00463060|4148566|B2|>=3||Number of metastases||participants|Number|7|7.0||||||
4320964|NCT00463060|4148567|B1|>=3||Number of metastases||participants|Number|5|5.0||||||
4320965|NCT00463060|4148565|B3|2||Number of metastases||participants|Number|8|8.0||||||
4320966|NCT00463060|4148566|B2|2||Number of metastases||participants|Number|5|5.0||||||
4320967|NCT00463060|4148567|B1|2||Number of metastases||participants|Number|3|3.0||||||
4320968|NCT00463060|4148565|B3|1||Number of metastases||participants|Number|26|26.0||||||
4320969|NCT00463060|4148566|B2|1||Number of metastases||participants|Number|13|13.0||||||
4320970|NCT00463060|4148567|B1|1||Number of metastases||participants|Number|13|13.0||||||
4320971|NCT00463060|4148565|B3|No||Prior radiation therapy||participants|Number|25|25.0||||||
4320972|NCT00463060|4148566|B2|No||Prior radiation therapy||participants|Number|15|15.0||||||
4320973|NCT00463060|4148567|B1|No||Prior radiation therapy||participants|Number|10|10.0||||||
4320974|NCT00463060|4148565|B3|Yes||Prior radiation therapy||participants|Number|21|21.0||||||
4320975|NCT00463060|4148566|B2|Yes||Prior radiation therapy||participants|Number|10|10.0||||||
4320976|NCT00463060|4148567|B1|Yes||Prior radiation therapy||participants|Number|11|11.0||||||
4320977|NCT00463060|4148565|B3|No||Prior systemic chemotherapy||participants|Number|22|22.0||||||
4320978|NCT00463060|4148566|B2|No||Prior systemic chemotherapy||participants|Number|14|14.0||||||
4320979|NCT00463060|4148567|B1|No||Prior systemic chemotherapy||participants|Number|8|8.0||||||
4320980|NCT00463060|4148565|B3|Yes||Prior systemic chemotherapy||participants|Number|24|24.0||||||
4320981|NCT00463060|4148566|B2|Yes||Prior systemic chemotherapy||participants|Number|11|11.0||||||
4320982|NCT00463060|4148567|B1|Yes||Prior systemic chemotherapy||participants|Number|13|13.0||||||
4320983|NCT00463060|4148565|B3|2||ECOG Performance status|"ECOG performance status is an attempt to quantify cancer patients' general well-being and activities of daily life.~0 Fully active, able to carry on all predisease activities with restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all self-care but unable to carry out any work activities. Out of bed > 50%~Capable of only limited self-care , confined to bed or chair > 50% waking hours~Completely disabled, cannot carry on any self-care, totally confined to bed or chair"|participants|Number|13|13.0||||||
4320984|NCT00463060|4148566|B2|2||ECOG Performance status|"ECOG performance status is an attempt to quantify cancer patients' general well-being and activities of daily life.~0 Fully active, able to carry on all predisease activities with restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all self-care but unable to carry out any work activities. Out of bed > 50%~Capable of only limited self-care , confined to bed or chair > 50% waking hours~Completely disabled, cannot carry on any self-care, totally confined to bed or chair"|participants|Number|8|8.0||||||
4320985|NCT00463060|4148567|B1|2||ECOG Performance status|"ECOG performance status is an attempt to quantify cancer patients' general well-being and activities of daily life.~0 Fully active, able to carry on all predisease activities with restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all self-care but unable to carry out any work activities. Out of bed > 50%~Capable of only limited self-care , confined to bed or chair > 50% waking hours~Completely disabled, cannot carry on any self-care, totally confined to bed or chair"|participants|Number|5|5.0||||||
4320986|NCT00463060|4148565|B3|1||ECOG Performance status|"ECOG performance status is an attempt to quantify cancer patients' general well-being and activities of daily life.~0 Fully active, able to carry on all predisease activities with restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all self-care but unable to carry out any work activities. Out of bed > 50%~Capable of only limited self-care , confined to bed or chair > 50% waking hours~Completely disabled, cannot carry on any self-care, totally confined to bed or chair"|participants|Number|22|22.0||||||
4320987|NCT00463060|4148566|B2|1||ECOG Performance status|"ECOG performance status is an attempt to quantify cancer patients' general well-being and activities of daily life.~0 Fully active, able to carry on all predisease activities with restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all self-care but unable to carry out any work activities. Out of bed > 50%~Capable of only limited self-care , confined to bed or chair > 50% waking hours~Completely disabled, cannot carry on any self-care, totally confined to bed or chair"|participants|Number|13|13.0||||||
4320988|NCT00463060|4148567|B1|1||ECOG Performance status|"ECOG performance status is an attempt to quantify cancer patients' general well-being and activities of daily life.~0 Fully active, able to carry on all predisease activities with restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all self-care but unable to carry out any work activities. Out of bed > 50%~Capable of only limited self-care , confined to bed or chair > 50% waking hours~Completely disabled, cannot carry on any self-care, totally confined to bed or chair"|participants|Number|9|9.0||||||
4320989|NCT00463060|4148565|B3|0||ECOG Performance status|"ECOG performance status is an attempt to quantify cancer patients' general well-being and activities of daily life.~0 Fully active, able to carry on all predisease activities with restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all self-care but unable to carry out any work activities. Out of bed > 50%~Capable of only limited self-care , confined to bed or chair > 50% waking hours~Completely disabled, cannot carry on any self-care, totally confined to bed or chair"|participants|Number|11|11.0||||||
4320990|NCT00463060|4148566|B2|0||ECOG Performance status|"ECOG performance status is an attempt to quantify cancer patients' general well-being and activities of daily life.~0 Fully active, able to carry on all predisease activities with restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all self-care but unable to carry out any work activities. Out of bed > 50%~Capable of only limited self-care , confined to bed or chair > 50% waking hours~Completely disabled, cannot carry on any self-care, totally confined to bed or chair"|participants|Number|4|4.0||||||
4320991|NCT00463060|4148567|B1|0||ECOG Performance status|"ECOG performance status is an attempt to quantify cancer patients' general well-being and activities of daily life.~0 Fully active, able to carry on all predisease activities with restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all self-care but unable to carry out any work activities. Out of bed > 50%~Capable of only limited self-care , confined to bed or chair > 50% waking hours~Completely disabled, cannot carry on any self-care, totally confined to bed or chair"|participants|Number|7|7.0||||||
4320992|NCT00463060|4148565|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4320993|NCT00463060|4148566|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4320994|NCT00463060|4148567|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4320995|NCT00463060|4148565|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4320996|NCT00463060|4148566|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4320997|NCT00463060|4148567|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4320998|NCT00463060|4148565|B3|||Age||years|Median|64|64.0|Full Range|||47.0|83.0|
4320999|NCT00463060|4148566|B2|||Age||years|Median|63|63.0|Full Range|||54.0|83.0|
4321000|NCT00463060|4148567|B1|||Age||years|Median|65|65.0|Full Range|||47.0|82.0|
4321001|NCT00463047|4148581|B1|United States||Region of Enrollment||participants|Number|323|323.0||||||
4321002|NCT00463047|4148581|B1||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4321003|NCT00463047|4148581|B1||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4321004|NCT00463047|4148581|B1|||Age||years|Mean|50.2|50.2|Standard Deviation|9.81|9.81|||
4321005|NCT00463047|4148581|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4321006|NCT00463047|4148581|B1||Between 18 and 65 years|Age||Participants|Count of Participants|323|323.0||||||
4321007|NCT00463047|4148581|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4321008|NCT00462982|4148667|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4321009|NCT00462982|4148667|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4321010|NCT00462982|4148667|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4321011|NCT00462982|4148667|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4321012|NCT00462982|4148667|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4321013|NCT00462943|4148671|B4|||Time from Initial Chronic Myeloid Leukemia (CML) Diagnosis||months|Median|74.0|74.0|Full Range|||6.6|221.0|
4321014|NCT00462943|4148672|B3|||Time from Initial Chronic Myeloid Leukemia (CML) Diagnosis||months|Median|68.7|68.7|Full Range|||6.6|195.5|
4321015|NCT00462943|4148673|B2|||Time from Initial Chronic Myeloid Leukemia (CML) Diagnosis||months|Median|83.5|83.5|Full Range|||20.3|197.1|
4321016|NCT00462943|4148674|B1|||Time from Initial Chronic Myeloid Leukemia (CML) Diagnosis||months|Median|74.4|74.4|Full Range|||7.9|221.0|
4321017|NCT00462943|4148671|B4|Grade 3||Eastern Cooperative Oncology Group Performance Status|"Grade 0: Fully active, able to carry on all pre-disease activities without restriction;~Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature;~Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours;~Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours;~Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|1|1.0||||||
4321018|NCT00462943|4148672|B3|Grade 3||Eastern Cooperative Oncology Group Performance Status|"Grade 0: Fully active, able to carry on all pre-disease activities without restriction;~Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature;~Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours;~Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours;~Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|1|1.0||||||
4321019|NCT00462943|4148673|B2|Grade 3||Eastern Cooperative Oncology Group Performance Status|"Grade 0: Fully active, able to carry on all pre-disease activities without restriction;~Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature;~Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours;~Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours;~Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|0|0.0||||||
4321020|NCT00462943|4148674|B1|Grade 3||Eastern Cooperative Oncology Group Performance Status|"Grade 0: Fully active, able to carry on all pre-disease activities without restriction;~Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature;~Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours;~Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours;~Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|0|0.0||||||
4321021|NCT00462943|4148671|B4|Grade 2||Eastern Cooperative Oncology Group Performance Status|"Grade 0: Fully active, able to carry on all pre-disease activities without restriction;~Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature;~Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours;~Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours;~Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|12|12.0||||||
4321022|NCT00462943|4148672|B3|Grade 2||Eastern Cooperative Oncology Group Performance Status|"Grade 0: Fully active, able to carry on all pre-disease activities without restriction;~Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature;~Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours;~Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours;~Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|5|5.0||||||
4321023|NCT00462943|4148673|B2|Grade 2||Eastern Cooperative Oncology Group Performance Status|"Grade 0: Fully active, able to carry on all pre-disease activities without restriction;~Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature;~Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours;~Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours;~Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|5|5.0||||||
4321024|NCT00462943|4148674|B1|Grade 2||Eastern Cooperative Oncology Group Performance Status|"Grade 0: Fully active, able to carry on all pre-disease activities without restriction;~Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature;~Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours;~Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours;~Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|2|2.0||||||
4321025|NCT00462943|4148671|B4|Grade 1||Eastern Cooperative Oncology Group Performance Status|"Grade 0: Fully active, able to carry on all pre-disease activities without restriction;~Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature;~Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours;~Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours;~Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|47|47.0||||||
4321026|NCT00462943|4148672|B3|Grade 1||Eastern Cooperative Oncology Group Performance Status|"Grade 0: Fully active, able to carry on all pre-disease activities without restriction;~Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature;~Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours;~Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours;~Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|11|11.0||||||
4321027|NCT00462943|4148673|B2|Grade 1||Eastern Cooperative Oncology Group Performance Status|"Grade 0: Fully active, able to carry on all pre-disease activities without restriction;~Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature;~Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours;~Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours;~Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|19|19.0||||||
4321028|NCT00462943|4148674|B1|Grade 1||Eastern Cooperative Oncology Group Performance Status|"Grade 0: Fully active, able to carry on all pre-disease activities without restriction;~Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature;~Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours;~Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours;~Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|17|17.0||||||
4321029|NCT00462943|4148671|B4|Grade 0||Eastern Cooperative Oncology Group Performance Status|"Grade 0: Fully active, able to carry on all pre-disease activities without restriction;~Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature;~Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours;~Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours;~Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|40|40.0||||||
4321030|NCT00462943|4148672|B3|Grade 0||Eastern Cooperative Oncology Group Performance Status|"Grade 0: Fully active, able to carry on all pre-disease activities without restriction;~Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature;~Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours;~Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours;~Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|6|6.0||||||
4321031|NCT00462943|4148673|B2|Grade 0||Eastern Cooperative Oncology Group Performance Status|"Grade 0: Fully active, able to carry on all pre-disease activities without restriction;~Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature;~Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours;~Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours;~Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|7|7.0||||||
4321063|NCT00462943|4148673|B2|||Height||centimeter|Median|167.5|167.5|Full Range|||148.0|195.0|
4321064|NCT00462943|4148674|B1|||Height||centimeter|Median|167.7|167.7|Full Range|||155.0|188.0|
4321032|NCT00462943|4148674|B1|Grade 0||Eastern Cooperative Oncology Group Performance Status|"Grade 0: Fully active, able to carry on all pre-disease activities without restriction;~Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature;~Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours;~Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours;~Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|27|27.0||||||
4321033|NCT00462943|4148671|B4|Not available||New York Heart Association (NYHA) Classification|"Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20–100 m). Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|2|2.0||||||
4321034|NCT00462943|4148672|B3|Not available||New York Heart Association (NYHA) Classification|"Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20–100 m). Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|0|0.0||||||
4321035|NCT00462943|4148673|B2|Not available||New York Heart Association (NYHA) Classification|"Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20–100 m). Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|2|2.0||||||
4321036|NCT00462943|4148674|B1|Not available||New York Heart Association (NYHA) Classification|"Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20–100 m). Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|0|0.0||||||
4321037|NCT00462943|4148671|B4|Class IV||New York Heart Association (NYHA) Classification|"Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20–100 m). Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|0|0.0||||||
4321038|NCT00462943|4148672|B3|Class IV||New York Heart Association (NYHA) Classification|"Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20–100 m). Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|0|0.0||||||
4321039|NCT00462943|4148673|B2|Class IV||New York Heart Association (NYHA) Classification|"Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20–100 m). Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|0|0.0||||||
4321040|NCT00462943|4148674|B1|Class IV||New York Heart Association (NYHA) Classification|"Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20–100 m). Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|0|0.0||||||
4321041|NCT00462943|4148671|B4|Class III||New York Heart Association (NYHA) Classification|"Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20–100 m). Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|0|0.0||||||
4321042|NCT00462943|4148672|B3|Class III||New York Heart Association (NYHA) Classification|"Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20–100 m). Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|0|0.0||||||
4321065|NCT00462943|4148671|B4|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4321066|NCT00462943|4148672|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4321067|NCT00462943|4148673|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4321068|NCT00462943|4148674|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4321069|NCT00462943|4148671|B4|Asian||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4321043|NCT00462943|4148673|B2|Class III||New York Heart Association (NYHA) Classification|"Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20–100 m). Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|0|0.0||||||
4321044|NCT00462943|4148674|B1|Class III||New York Heart Association (NYHA) Classification|"Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20–100 m). Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|0|0.0||||||
4321045|NCT00462943|4148671|B4|Class II||New York Heart Association (NYHA) Classification|"Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20–100 m). Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|2|2.0||||||
4321046|NCT00462943|4148672|B3|Class II||New York Heart Association (NYHA) Classification|"Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20–100 m). Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|0|0.0||||||
4321047|NCT00462943|4148673|B2|Class II||New York Heart Association (NYHA) Classification|"Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20–100 m). Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|0|0.0||||||
4321048|NCT00462943|4148674|B1|Class II||New York Heart Association (NYHA) Classification|"Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20–100 m). Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|2|2.0||||||
4321049|NCT00462943|4148671|B4|Class I||New York Heart Association (NYHA) Classification|"Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20–100 m). Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|96|96.0||||||
4321050|NCT00462943|4148672|B3|Class I||New York Heart Association (NYHA) Classification|"Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20–100 m). Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|23|23.0||||||
4321051|NCT00462943|4148673|B2|Class I||New York Heart Association (NYHA) Classification|"Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20–100 m). Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|29|29.0||||||
4321052|NCT00462943|4148674|B1|Class I||New York Heart Association (NYHA) Classification|"Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20–100 m). Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|44|44.0||||||
4321053|NCT00462943|4148671|B4|||Body Surface Area (BSA)||meters^2|Median|1.9|1.9|Full Range|||1.3|2.5|
4321054|NCT00462943|4148672|B3|||Body Surface Area (BSA)||meters^2|Median|1.9|1.9|Full Range|||1.4|2.5|
4321055|NCT00462943|4148673|B2|||Body Surface Area (BSA)||meters^2|Median|1.7|1.7|Full Range|||1.4|2.2|
4321056|NCT00462943|4148674|B1|||Body Surface Area (BSA)||meters^2|Median|1.9|1.9|Full Range|||1.3|2.5|
4321057|NCT00462943|4148671|B4|||Weight||kilograms|Median|74.2|74.2|Full Range|||36.5|138.0|
4321058|NCT00462943|4148672|B3|||Weight||kilograms|Median|74.0|74.0|Full Range|||41.0|136.4|
4321059|NCT00462943|4148673|B2|||Weight||kilograms|Median|67.4|67.4|Full Range|||36.5|111.8|
4321060|NCT00462943|4148674|B1|||Weight||kilograms|Median|79.5|79.5|Full Range|||40.0|138.0|
4321061|NCT00462943|4148671|B4|||Height||centimeter|Median|167.6|167.6|Full Range|||148.0|195.0|
4321062|NCT00462943|4148672|B3|||Height||centimeter|Median|171.0|171.0|Full Range|||149.9|191.0|
4321070|NCT00462943|4148672|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4321071|NCT00462943|4148673|B2|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4321072|NCT00462943|4148674|B1|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4321073|NCT00462943|4148671|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4321074|NCT00462943|4148672|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4321075|NCT00462943|4148673|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4321076|NCT00462943|4148674|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4321077|NCT00462943|4148671|B4|Black||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4321078|NCT00462943|4148672|B3|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4321079|NCT00462943|4148673|B2|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4321080|NCT00462943|4148674|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4321081|NCT00462943|4148671|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
4321082|NCT00462943|4148672|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4321083|NCT00462943|4148673|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4321084|NCT00462943|4148674|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4321085|NCT00462943|4148671|B4||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4321086|NCT00462943|4148672|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4321087|NCT00462943|4148673|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4321088|NCT00462943|4148674|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4321089|NCT00462943|4148671|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4321090|NCT00462943|4148672|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4321091|NCT00462943|4148673|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4321092|NCT00462943|4148674|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4321093|NCT00462943|4148671|B4|||Age||years|Median|57|57.0|Full Range|||20.0|78.0|
4321094|NCT00462943|4148672|B3|||Age||years|Median|57|57.0|Full Range|||30.0|68.0|
4321095|NCT00462943|4148673|B2|||Age||years|Median|56|56.0|Full Range|||23.0|71.0|
4321096|NCT00462943|4148674|B1|||Age||years|Median|58|58.0|Full Range|||20.0|78.0|
4321097|NCT00462917|4148743|B5|||Depression (Center for Epidemiological Studies Depression Scale: CES-D)|Scores on the Center for Epidemiological Studies Depression Scale (CES-D), a 20-item scale measuring general depression. Scores range from 0-60, with higher scores indicating greater general depression.|units on a scale|Mean|5.7|5.7|Standard Deviation|5.1|5.1|||
4321098|NCT00462917|4148744|B4|||Depression (Center for Epidemiological Studies Depression Scale: CES-D)|Scores on the Center for Epidemiological Studies Depression Scale (CES-D), a 20-item scale measuring general depression. Scores range from 0-60, with higher scores indicating greater general depression.|units on a scale|Mean|6.6|6.6|Standard Deviation|5.3|5.3|||
4321099|NCT00462917|4148745|B3|||Depression (Center for Epidemiological Studies Depression Scale: CES-D)|Scores on the Center for Epidemiological Studies Depression Scale (CES-D), a 20-item scale measuring general depression. Scores range from 0-60, with higher scores indicating greater general depression.|units on a scale|Mean|5.5|5.5|Standard Deviation|5.0|5.0|||
4321100|NCT00462917|4148746|B2|||Depression (Center for Epidemiological Studies Depression Scale: CES-D)|Scores on the Center for Epidemiological Studies Depression Scale (CES-D), a 20-item scale measuring general depression. Scores range from 0-60, with higher scores indicating greater general depression.|units on a scale|Mean|5.5|5.5|Standard Deviation|5.4|5.4|||
4321101|NCT00462917|4148747|B1|||Depression (Center for Epidemiological Studies Depression Scale: CES-D)|Scores on the Center for Epidemiological Studies Depression Scale (CES-D), a 20-item scale measuring general depression. Scores range from 0-60, with higher scores indicating greater general depression.|units on a scale|Mean|5.1|5.1|Standard Deviation|4.6|4.6|||
4321102|NCT00462917|4148743|B5|||Anxiety (Beck Anxiety Index: BAI)|Scores on the Beck Anxiety Index (BAI), a 21-item scale measuring general anxiety. Scores range from 0-63, with higher scores indicating greater anxiety.|units on a scale|Mean|3.5|3.5|Standard Deviation|3.5|3.5|||
4321103|NCT00462917|4148744|B4|||Anxiety (Beck Anxiety Index: BAI)|Scores on the Beck Anxiety Index (BAI), a 21-item scale measuring general anxiety. Scores range from 0-63, with higher scores indicating greater anxiety.|units on a scale|Mean|4.0|4.0|Standard Deviation|3.8|3.8|||
4321104|NCT00462917|4148745|B3|||Anxiety (Beck Anxiety Index: BAI)|Scores on the Beck Anxiety Index (BAI), a 21-item scale measuring general anxiety. Scores range from 0-63, with higher scores indicating greater anxiety.|units on a scale|Mean|3.8|3.8|Standard Deviation|3.7|3.7|||
4321105|NCT00462917|4148746|B2|||Anxiety (Beck Anxiety Index: BAI)|Scores on the Beck Anxiety Index (BAI), a 21-item scale measuring general anxiety. Scores range from 0-63, with higher scores indicating greater anxiety.|units on a scale|Mean|3.6|3.6|Standard Deviation|3.4|3.4|||
4321106|NCT00462917|4148747|B1|||Anxiety (Beck Anxiety Index: BAI)|Scores on the Beck Anxiety Index (BAI), a 21-item scale measuring general anxiety. Scores range from 0-63, with higher scores indicating greater anxiety.|units on a scale|Mean|2.7|2.7|Standard Deviation|2.9|2.9|||
4321107|NCT00462917|4148743|B5|United States||Region of Enrollment||participants|Number|257|257.0||||||
4321108|NCT00462917|4148744|B4|United States||Region of Enrollment||participants|Number|68|68.0||||||
4321109|NCT00462917|4148745|B3|United States||Region of Enrollment||participants|Number|55|55.0||||||
4321110|NCT00462917|4148746|B2|United States||Region of Enrollment||participants|Number|70|70.0||||||
4321111|NCT00462917|4148747|B1|United States||Region of Enrollment||participants|Number|64|64.0||||||
4321112|NCT00462917|4148743|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4321113|NCT00462917|4148744|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4321114|NCT00462917|4148745|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4321115|NCT00462917|4148746|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4321116|NCT00462917|4148747|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321117|NCT00462917|4148743|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321118|NCT00462917|4148744|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321119|NCT00462917|4148745|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321120|NCT00462917|4148746|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321121|NCT00462917|4148747|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321122|NCT00462917|4148743|B5||White|Race (NIH/OMB)||Participants|Count of Participants|215|215.0||||||
4321123|NCT00462917|4148744|B4||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4321124|NCT00462917|4148745|B3||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4321125|NCT00462917|4148746|B2||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4321126|NCT00462917|4148747|B1||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4321127|NCT00462917|4148743|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4321128|NCT00462917|4148744|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4321129|NCT00462917|4148745|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4321130|NCT00462917|4148746|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4321131|NCT00462917|4148747|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4321132|NCT00462917|4148743|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321133|NCT00462917|4148744|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321134|NCT00462917|4148745|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321135|NCT00462917|4148746|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321136|NCT00462917|4148747|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321137|NCT00462917|4148743|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321138|NCT00462917|4148744|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321139|NCT00462917|4148745|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321140|NCT00462917|4148746|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321141|NCT00462917|4148747|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321142|NCT00462917|4148743|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4321143|NCT00462917|4148744|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321144|NCT00462917|4148745|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321145|NCT00462917|4148746|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4321146|NCT00462917|4148747|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321147|NCT00462917|4148743|B5||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4321148|NCT00462917|4148744|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4321149|NCT00462917|4148745|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4321150|NCT00462917|4148746|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4321151|NCT00462917|4148747|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4321152|NCT00462917|4148743|B5||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4321153|NCT00462917|4148744|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4321154|NCT00462917|4148745|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4321155|NCT00462917|4148746|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4321156|NCT00462917|4148747|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4321157|NCT00462917|4148743|B5|||Age||years|Mean|58|58.0|Standard Deviation|13|13.0|||
4321158|NCT00462917|4148744|B4|||Age||years|Mean|59|59.0|Standard Deviation|12|12.0|||
4321159|NCT00462917|4148745|B3|||Age||years|Mean|59|59.0|Standard Deviation|13|13.0|||
4321160|NCT00462917|4148746|B2|||Age||years|Mean|57|57.0|Standard Deviation|13|13.0|||
4321161|NCT00462917|4148747|B1|||Age||years|Mean|57|57.0|Standard Deviation|12|12.0|||
4321162|NCT00462865|4148768|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4321163|NCT00462865|4148768|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4321164|NCT00462865|4148768|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4321165|NCT00462865|4148768|B1|||Age||years|Mean|50|50.0|Standard Deviation|4.8|4.8|||
4321166|NCT00462865|4148768|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4321167|NCT00462865|4148768|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4321168|NCT00462865|4148768|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4321169|NCT00462839|4148772|B3|United States||Region of Enrollment||participants|Number|106|106.0||||||
4321170|NCT00462839|4148773|B2|United States||Region of Enrollment||participants|Number|53|53.0||||||
4321171|NCT00462839|4148774|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
4321172|NCT00462839|4148772|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4321173|NCT00462839|4148773|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4321174|NCT00462839|4148774|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4321175|NCT00462839|4148772|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4321176|NCT00462839|4148773|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4321177|NCT00462839|4148774|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4321178|NCT00462839|4148772|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4321179|NCT00462839|4148773|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4321180|NCT00462839|4148774|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4321181|NCT00462839|4148772|B3||Between 18 and 65 years|Age||Participants|Count of Participants|106|106.0||||||
4321182|NCT00462839|4148773|B2||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4321183|NCT00462839|4148774|B1||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4321184|NCT00462839|4148772|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4321185|NCT00462839|4148773|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4321186|NCT00462839|4148774|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4321187|NCT00462826|4148787|B1|Indeterminate||Tumor Response||participants|Number|11|11.0||||||
4321188|NCT00462826|4148787|B1|Increase Disease||Tumor Response||participants|Number|16|16.0||||||
4321189|NCT00462826|4148787|B1|Stable Disease||Tumor Response||participants|Number|14|14.0||||||
4321190|NCT00462826|4148787|B1|Partial Response||Tumor Response||participants|Number|3|3.0||||||
4321191|NCT00462826|4148787|B1|Other||Reason Off Study Therapy||participants|Number|1|1.0||||||
4321192|NCT00462826|4148787|B1|Death||Reason Off Study Therapy||participants|Number|3|3.0||||||
4321193|NCT00462826|4148787|B1|Toxicity as permitted||Reason Off Study Therapy||participants|Number|14|14.0||||||
4321194|NCT00462826|4148787|B1|Refused Further Treatment||Reason Off Study Therapy||participants|Number|1|1.0||||||
4321195|NCT00462826|4148787|B1|Disease Progression||Reason Off Study Therapy||participants|Number|25|25.0||||||
4321196|NCT00462826|4148787|B1|Serous Adenocarcinoma||Cell Type||participants|Number|11|11.0||||||
4321197|NCT00462826|4148787|B1|Carcinsarcoma, MMT||Cell Type||participants|Number|1|1.0||||||
4321198|NCT00462826|4148787|B1|Mixed Epithelial Carcinoma||Cell Type||participants|Number|6|6.0||||||
4321199|NCT00462826|4148787|B1|Mucinous Adenocarcinoma||Cell Type||participants|Number|1|1.0||||||
4321200|NCT00462826|4148787|B1|Endometrioid Adenocarcinoma||Cell Type||participants|Number|23|23.0||||||
4321201|NCT00462826|4148787|B1|Clear Cell Carcinoma||Cell Type||participants|Number|1|1.0||||||
4321202|NCT00462826|4148787|B1|Adenocarcinoma, Unspecified||Cell Type||participants|Number|1|1.0||||||
4321203|NCT00462826|4148787|B1|||International Federation of Gynecology and Obstetrics (FIGO) Recurrent/Persistent Disease||participants|Number|44|44.0||||||
4321204|NCT00462826|4148787|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4321205|NCT00462826|4148787|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4321206|NCT00462826|4148787|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4321207|NCT00462826|4148787|B1|80-89 years||Age, Customized||participants|Number|1|1.0||||||
4321208|NCT00462826|4148787|B1|70-79 years||Age, Customized||participants|Number|12|12.0||||||
4321209|NCT00462826|4148787|B1|60-69 years||Age, Customized||participants|Number|15|15.0||||||
4321210|NCT00462826|4148787|B1|50-59 years||Age, Customized||participants|Number|13|13.0||||||
4321211|NCT00462826|4148787|B1|40-49 years||Age, Customized||participants|Number|3|3.0||||||
4321212|NCT00462826|4148787|B1|||Age||years|Mean|64.2|64.2|Standard Deviation|8.4|8.4|||
4321213|NCT00462748|4148800|B4|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4321214|NCT00462748|4148801|B3|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4321215|NCT00462748|4148802|B2|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4321216|NCT00462748|4148803|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4321217|NCT00462748|4148800|B4|Black||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4321218|NCT00462748|4148801|B3|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4321219|NCT00462748|4148802|B2|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4321220|NCT00462748|4148803|B1|Black||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4321221|NCT00462748|4148800|B4|White||Race/Ethnicity, Customized||Participants|Number|772|772.0||||||
4321222|NCT00462748|4148801|B3|White||Race/Ethnicity, Customized||Participants|Number|257|257.0||||||
4321223|NCT00462748|4148802|B2|White||Race/Ethnicity, Customized||Participants|Number|261|261.0||||||
4321224|NCT00462748|4148803|B1|White||Race/Ethnicity, Customized||Participants|Number|254|254.0||||||
4321225|NCT00462748|4148800|B4|Asian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4321226|NCT00462748|4148801|B3|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4321227|NCT00462748|4148802|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4321228|NCT00462748|4148803|B1|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4321229|NCT00462748|4148800|B4||Male|Sex: Female, Male||Participants|Count of Participants|523|523.0||||||
4321230|NCT00462748|4148801|B3||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4321231|NCT00462748|4148802|B2||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4321232|NCT00462748|4148803|B1||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4321233|NCT00462748|4148800|B4||Female|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
4321234|NCT00462748|4148801|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4321235|NCT00462748|4148802|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4321236|NCT00462748|4148803|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4321237|NCT00462748|4148800|B4|>=70 years||Age, Customized||participants|Number|219|219.0||||||
4321238|NCT00462748|4148801|B3|>=70 years||Age, Customized||participants|Number|67|67.0||||||
4321239|NCT00462748|4148802|B2|>=70 years||Age, Customized||participants|Number|76|76.0||||||
4321240|NCT00462748|4148803|B1|>=70 years||Age, Customized||participants|Number|76|76.0||||||
4321241|NCT00462748|4148800|B4|< 70 years||Age, Customized||participants|Number|567|567.0||||||
4321242|NCT00462748|4148801|B3|< 70 years||Age, Customized||participants|Number|195|195.0||||||
4321243|NCT00462748|4148802|B2|< 70 years||Age, Customized||participants|Number|187|187.0||||||
4321244|NCT00462748|4148803|B1|< 70 years||Age, Customized||participants|Number|185|185.0||||||
4321245|NCT00462748|4148800|B4|||Age||years|Mean|64.3|64.3|Standard Deviation|8.56|8.56|||
4321246|NCT00462748|4148801|B3|||Age||years|Mean|63.9|63.9|Standard Deviation|8.61|8.61|||
4321247|NCT00462748|4148802|B2|||Age||years|Mean|64.2|64.2|Standard Deviation|8.44|8.44|||
4321248|NCT00462748|4148803|B1|||Age||years|Mean|64.7|64.7|Standard Deviation|8.65|8.65|||
4321249|NCT00462735|4148813|B1|Unknown primary||Primary site||participants|Number|2|2.0||||||
4321250|NCT00462735|4148813|B1|Hyopharynx||Primary site||participants|Number|4|4.0||||||
4321251|NCT00462735|4148813|B1|Larynx||Primary site||participants|Number|2|2.0||||||
4321252|NCT00462735|4148813|B1|Salivary gland||Primary site||participants|Number|1|1.0||||||
4321253|NCT00462735|4148813|B1|Oral cavity||Primary site||participants|Number|6|6.0||||||
4321254|NCT00462735|4148813|B1|Oropharynx||Primary site||participants|Number|14|14.0||||||
4321255|NCT00462735|4148813|B1|Nasopharynx||Primary site||participants|Number|2|2.0||||||
4321256|NCT00462735|4148813|B1|Sinonasal||Primary site||participants|Number|2|2.0||||||
4321257|NCT00462735|4148813|B1|>40 pack-y||Smoking||participants|Number|8|8.0||||||
4321258|NCT00462735|4148813|B1|20.1-40 packk-y||Smoking||participants|Number|7|7.0||||||
4321259|NCT00462735|4148813|B1|≤20 pack-y||Smoking||participants|Number|9|9.0||||||
4321260|NCT00462735|4148813|B1|Cigar, pipe, or betel nut only||Smoking||participants|Number|3|3.0||||||
4321261|NCT00462735|4148813|B1|None||Smoking||participants|Number|6|6.0||||||
4321262|NCT00462735|4148813|B1|Heavy||Alcohol consumption||participants|Number|7|7.0||||||
4321263|NCT00462735|4148813|B1|Moderate||Alcohol consumption||participants|Number|2|2.0||||||
4321264|NCT00462735|4148813|B1|Occasional||Alcohol consumption||participants|Number|14|14.0||||||
4321265|NCT00462735|4148813|B1|None||Alcohol consumption||participants|Number|10|10.0||||||
4321266|NCT00462735|4148813|B1|≥2||Charlson comorbidity score|The Charlson Comorbidity Index contains 19 categories of comorbidity and predicts the ten-year mortality for a patient who may have a range of co-morbid conditions. Each condition is assigned a score of 1, 2, 3, or 6, depending on the risk of dying associated with each one. Scores are summed to provide a total score to predict mortality. Higher scores indicating greater comorbidity (patients with a score > 5 have essentially a 100% risk of dying at one year).|participants|Number|6|6.0||||||
4321267|NCT00462735|4148813|B1|0-1||Charlson comorbidity score|The Charlson Comorbidity Index contains 19 categories of comorbidity and predicts the ten-year mortality for a patient who may have a range of co-morbid conditions. Each condition is assigned a score of 1, 2, 3, or 6, depending on the risk of dying associated with each one. Scores are summed to provide a total score to predict mortality. Higher scores indicating greater comorbidity (patients with a score > 5 have essentially a 100% risk of dying at one year).|participants|Number|27|27.0||||||
4321268|NCT00462735|4148813|B1|2||Performance score|"The Eastern Cooperative Oncology Group (ECOG)~0 - Fully active, able to carry on all pre-disease performance without restriction~1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature 2- Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|participants|Number|2|2.0||||||
4321269|NCT00462735|4148813|B1|1||Performance score|"The Eastern Cooperative Oncology Group (ECOG)~0 - Fully active, able to carry on all pre-disease performance without restriction~1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature 2- Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|participants|Number|19|19.0||||||
4321270|NCT00462735|4148813|B1|0||Performance score|"The Eastern Cooperative Oncology Group (ECOG)~0 - Fully active, able to carry on all pre-disease performance without restriction~1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature 2- Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|participants|Number|12|12.0||||||
4321271|NCT00462735|4148813|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4321272|NCT00462735|4148813|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4321273|NCT00462735|4148813|B1|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4321274|NCT00462735|4148813|B1|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4321275|NCT00462735|4148813|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4321276|NCT00462735|4148813|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4321277|NCT00462735|4148813|B1|||Age||years|Median|59|59.0|Full Range|||18.0|77.0|
4321278|NCT00462722|4148821|B4|United States||Region of Enrollment||participants|Number|130|130.0||||||
4321279|NCT00462722|4148822|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4321280|NCT00462722|4148823|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
4321281|NCT00462722|4148824|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4321282|NCT00462722|4148821|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321283|NCT00462722|4148822|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321284|NCT00462722|4148823|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321285|NCT00462722|4148824|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321286|NCT00462722|4148821|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4321287|NCT00462722|4148822|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321288|NCT00462722|4148823|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321289|NCT00462722|4148824|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4321290|NCT00462722|4148821|B4||White|Race (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
4321291|NCT00462722|4148822|B3||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4321292|NCT00462722|4148823|B2||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4321293|NCT00462722|4148824|B1||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4321294|NCT00462722|4148821|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4321295|NCT00462722|4148822|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4321296|NCT00462722|4148823|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4321297|NCT00462722|4148824|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321298|NCT00462722|4148821|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321299|NCT00462722|4148822|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321300|NCT00462722|4148823|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321301|NCT00462722|4148824|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321302|NCT00462722|4148821|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4321303|NCT00462722|4148822|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4321304|NCT00462722|4148823|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4321305|NCT00462722|4148824|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4321306|NCT00462722|4148821|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4321307|NCT00462722|4148822|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4321308|NCT00462722|4148823|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4321309|NCT00462722|4148824|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321310|NCT00462722|4148821|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321311|NCT00462722|4148822|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321312|NCT00462722|4148823|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321313|NCT00462722|4148824|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321314|NCT00462722|4148821|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
4321315|NCT00462722|4148822|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4321316|NCT00462722|4148823|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4321317|NCT00462722|4148824|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4321318|NCT00462722|4148821|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4321319|NCT00462722|4148822|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4321320|NCT00462722|4148823|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4321321|NCT00462722|4148824|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4321322|NCT00462722|4148821|B4||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4321323|NCT00462722|4148822|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4321324|NCT00462722|4148823|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4321325|NCT00462722|4148824|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4321326|NCT00462722|4148821|B4||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4321327|NCT00462722|4148822|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4321328|NCT00462722|4148823|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4321329|NCT00462722|4148824|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4321330|NCT00462722|4148821|B4|||Age||years|Mean|64|64.0|Standard Deviation|4|4.0|||
4321331|NCT00462722|4148822|B3|||Age||years|Mean|66|66.0|Standard Deviation|4|4.0|||
4321332|NCT00462722|4148823|B2|||Age||years|Mean|64|64.0|Standard Deviation|4|4.0|||
4321333|NCT00462722|4148824|B1|||Age||years|Mean|64|64.0|Standard Deviation|4|4.0|||
4321334|NCT00462709|4148858|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4321335|NCT00462709|4148858|B1||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4321336|NCT00462709|4148858|B1|||Age||years|Mean|36.5|36.5|Standard Deviation|16.48|16.48|||
4321337|NCT00462670|4148865|B3|Japan||Region of Enrollment||participants|Number|110|110.0||||||
4321338|NCT00462670|4148866|B2|Japan||Region of Enrollment||participants|Number|53|53.0||||||
4321339|NCT00462670|4148867|B1|Japan||Region of Enrollment||participants|Number|57|57.0||||||
4321340|NCT00462670|4148865|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4321341|NCT00462670|4148866|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4321342|NCT00462670|4148867|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4321343|NCT00462670|4148865|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4321344|NCT00462670|4148866|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4321345|NCT00462670|4148867|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4321346|NCT00462670|4148865|B3|||Age||years|Mean|71.2|71.2|Standard Deviation|10.7|10.7|||
4321347|NCT00462670|4148866|B2|||Age||years|Mean|71.3|71.3|Standard Deviation|10.6|10.6|||
4321348|NCT00462670|4148867|B1|||Age||years|Mean|71.0|71.0|Standard Deviation|10.9|10.9|||
4321349|NCT00462670|4148865|B3||>=65 years|Age||Participants|Count of Participants|79|79.0||||||
4321350|NCT00462670|4148866|B2||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
4321351|NCT00462670|4148867|B1||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4321352|NCT00462670|4148865|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4321353|NCT00462670|4148866|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4321354|NCT00462670|4148867|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4321355|NCT00462670|4148865|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4321356|NCT00462670|4148866|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4321357|NCT00462670|4148867|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4321358|NCT00462644|4148876|B3|United States||Region of Enrollment||participants|Number|30.0|30.0||||||
4321359|NCT00462644|4148877|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4321360|NCT00462644|4148878|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4321361|NCT00462644|4148876|B3||Male|Sex: Female, Male||Participants|Count of Participants|19.0|19.0||||||
4321362|NCT00462644|4148877|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4321363|NCT00462644|4148878|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4321364|NCT00462644|4148876|B3||Female|Sex: Female, Male||Participants|Count of Participants|11.0|11.0||||||
4321365|NCT00462644|4148877|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4321366|NCT00462644|4148878|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4321367|NCT00462644|4148876|B3|||Age||years|Mean|42.6|42.6|Standard Deviation|22.3|22.3|||
4321368|NCT00462644|4148877|B2|||Age||years|Mean|43.9|43.9|Standard Deviation|19.5|19.5|||
4321369|NCT00462644|4148878|B1|||Age||years|Mean|41.8|41.8|Standard Deviation|24.5|24.5|||
4321370|NCT00462644|4148876|B3||>=65 years|Age||Participants|Count of Participants|6.0|6.0||||||
4321371|NCT00462644|4148877|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4321372|NCT00462644|4148878|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4321373|NCT00462644|4148876|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24.0|24.0||||||
4321374|NCT00462644|4148877|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4321375|NCT00462644|4148878|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4321376|NCT00462644|4148876|B3||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4321377|NCT00462644|4148877|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4321378|NCT00462644|4148878|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4321379|NCT00462605|4148897|B1|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
4321380|NCT00462605|4148897|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4321381|NCT00462605|4148897|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4321382|NCT00462605|4148897|B1|||Age||years|Median|71|71.0|Full Range|||52.0|84.0|
4321383|NCT00462501|4148905|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4321384|NCT00462501|4148905|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4321385|NCT00462501|4148905|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4321386|NCT00462501|4148905|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4321387|NCT00462501|4148905|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4321388|NCT00462501|4148905|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4321389|NCT00462462|4148909|B3|||Lesional volume||cm3|Mean|298.926|298.926|Standard Deviation|801.306|801.306|||
4321390|NCT00462462|4148910|B2|||Lesional volume||cm3|Mean|561.472|561.472|Standard Deviation|1147.306|1147.306|||
4321391|NCT00462462|4148911|B1|||Lesional volume||cm3|Mean|82.712|82.712|Standard Deviation|156.316|156.316|||
4321392|NCT00462462|4148909|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4321393|NCT00462462|4148910|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4321394|NCT00462462|4148911|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4321395|NCT00462462|4148909|B3|France||Region of Enrollment||participants|Number|15|15.0||||||
4321396|NCT00462462|4148910|B2|France||Region of Enrollment||participants|Number|7|7.0||||||
4321397|NCT00462462|4148911|B1|France||Region of Enrollment||participants|Number|8|8.0||||||
4321398|NCT00462462|4148909|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4321399|NCT00462462|4148910|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4321400|NCT00462462|4148911|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4321401|NCT00462462|4148909|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4321402|NCT00462462|4148910|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4321403|NCT00462462|4148911|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4321404|NCT00462462|4148909|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4321405|NCT00462462|4148910|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4321406|NCT00462462|4148911|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4321407|NCT00462462|4148909|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4321408|NCT00462462|4148910|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4321409|NCT00462462|4148911|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4321410|NCT00462462|4148909|B3||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4321411|NCT00462462|4148910|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4321412|NCT00462462|4148911|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4321413|NCT00462449|4148920|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4321414|NCT00462449|4148921|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4321415|NCT00462449|4148922|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4321416|NCT00462449|4148920|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4321417|NCT00462449|4148921|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4321418|NCT00462449|4148922|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4321419|NCT00462449|4148920|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4321420|NCT00462449|4148921|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4321421|NCT00462449|4148922|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4321422|NCT00462449|4148920|B3|||Age||years|Mean|47.4|47.4|Standard Deviation|14.0|14.0|||
4321423|NCT00462449|4148921|B2|||Age||years|Mean|54|54.0|Standard Deviation|10.3|10.3|||
4321424|NCT00462449|4148922|B1|||Age||years|Mean|41.2|41.2|Standard Deviation|14.2|14.2|||
4321425|NCT00462449|4148920|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4321426|NCT00462449|4148921|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4321427|NCT00462449|4148922|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4321428|NCT00462449|4148920|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4321429|NCT00462449|4148921|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4321430|NCT00462449|4148922|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4321431|NCT00462449|4148920|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4321432|NCT00462449|4148921|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4321433|NCT00462449|4148922|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4321434|NCT00462423|4148933|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4321435|NCT00462423|4148933|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4321436|NCT00462423|4148933|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4321437|NCT00462423|4148933|B1|||Age||years|Mean|62|62.0|Full Range|NA||25.0|89.0|
4321438|NCT00462423|4148933|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4321439|NCT00462423|4148933|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4321440|NCT00462423|4148933|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4321441|NCT00462384|4148940|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4321442|NCT00462384|4148940|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4321443|NCT00462384|4148940|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|18.25|18.25|||
4321444|NCT00462345|4148948|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4321445|NCT00462345|4148948|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4321446|NCT00462345|4148948|B1|||Age||years|Mean|49.9|49.9|Standard Deviation|11.4|11.4|||
4321447|NCT00462332|4148970|B3|Italy||Region of Enrollment||participants|Number|86|86.0||||||
4321448|NCT00462332|4148971|B2|Italy||Region of Enrollment||participants|Number|41|41.0||||||
4321449|NCT00462332|4148972|B1|Italy||Region of Enrollment||participants|Number|45|45.0||||||
4321450|NCT00462332|4148970|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4321451|NCT00462332|4148971|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4321452|NCT00462332|4148972|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4321453|NCT00462332|4148970|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4321454|NCT00462332|4148971|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4321455|NCT00462332|4148972|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4321456|NCT00462332|4148970|B3|||Age||years|Mean|53.02|53.02|Standard Deviation|6.13|6.13|||
4321457|NCT00462332|4148971|B2|||Age||years|Mean|52.73|52.73|Standard Deviation|6.24|6.24|||
4321458|NCT00462332|4148972|B1|||Age||years|Mean|53.02|53.02|Standard Deviation|6.09|6.09|||
4321459|NCT00462332|4148970|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4321460|NCT00462332|4148971|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4321461|NCT00462332|4148972|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4321462|NCT00462332|4148970|B3||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
4321463|NCT00462332|4148971|B2||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4321464|NCT00462332|4148972|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4321465|NCT00462332|4148970|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4321466|NCT00462332|4148971|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4321467|NCT00462332|4148972|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4321468|NCT00462306|4148981|B3|United States||Region of Enrollment||participants|Number|4577|4577.0||||||
4321469|NCT00462306|4148982|B2|United States||Region of Enrollment||participants|Number|503|503.0||||||
4321470|NCT00462306|4148983|B1|United States||Region of Enrollment||participants|Number|4074|4074.0||||||
4321471|NCT00462306|4148981|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4321472|NCT00462306|4148982|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4321473|NCT00462306|4148983|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4321474|NCT00462306|4148981|B3||Female|Sex: Female, Male||Participants|Count of Participants|4577|4577.0||||||
4321475|NCT00462306|4148982|B2||Female|Sex: Female, Male||Participants|Count of Participants|503|503.0||||||
4321476|NCT00462306|4148983|B1||Female|Sex: Female, Male||Participants|Count of Participants|4074|4074.0||||||
4321477|NCT00462306|4148981|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4321478|NCT00462306|4148982|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4321479|NCT00462306|4148983|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4321480|NCT00462306|4148981|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4577|4577.0||||||
4321481|NCT00462306|4148982|B2||Between 18 and 65 years|Age||Participants|Count of Participants|503|503.0||||||
4321482|NCT00462306|4148983|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4074|4074.0||||||
4321483|NCT00462306|4148981|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4321484|NCT00462306|4148982|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4321485|NCT00462306|4148983|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4321486|NCT00462280|4148992|B5|United States||Region of Enrollment||participants|Number|80|80.0||||||
4321487|NCT00462280|4148993|B4|United States||Region of Enrollment||participants|Number|7|7.0||||||
4321488|NCT00462280|4148994|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4321489|NCT00462280|4148995|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
4321490|NCT00462280|4148996|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4321491|NCT00462280|4148992|B5||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4321492|NCT00462280|4148993|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4321493|NCT00462280|4148994|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4321494|NCT00462280|4148995|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4321495|NCT00462280|4148996|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4321496|NCT00462280|4148992|B5||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4321497|NCT00462280|4148993|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4321498|NCT00462280|4148994|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4321499|NCT00462280|4148995|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4321500|NCT00462280|4148996|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4321501|NCT00462280|4148992|B5|||Age||years|Mean|42.24|42.24|Standard Deviation|11.16|11.16|||
4321502|NCT00462280|4148993|B4|||Age||years|Mean|36.29|36.29|Standard Deviation|11.98|11.98|||
4321503|NCT00462280|4148994|B3|||Age||years|Mean|45.71|45.71|Standard Deviation|10.98|10.98|||
4321504|NCT00462280|4148995|B2|||Age||years|Mean|42.16|42.16|Standard Deviation|11.28|11.28|||
4321505|NCT00462280|4148996|B1|||Age||years|Mean|42.82|42.82|Standard Deviation|10.96|10.96|||
4321506|NCT00462228|4149059|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4321507|NCT00462228|4149059|B1||Male|Gender||Participants|Count of Participants|9|9.0||||||
4321508|NCT00462228|4149059|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
4321509|NCT00462228|4149059|B1|||Age||years|Mean|34.6|34.6|Standard Deviation|8.1|8.1|||
4321510|NCT00462228|4149059|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4321511|NCT00462228|4149059|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4321512|NCT00462228|4149059|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4321513|NCT00462072|4149080|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4321514|NCT00462072|4149081|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4321515|NCT00462072|4149082|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4321516|NCT00462072|4149083|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4321517|NCT00462072|4149080|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4321518|NCT00462072|4149081|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4321519|NCT00462072|4149082|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4321520|NCT00462072|4149083|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4321521|NCT00462072|4149080|B4|||Age||years|Mean|48|48.0|Standard Deviation|14|14.0|||
4321522|NCT00462072|4149081|B3|||Age||years|Mean|41|41.0|Standard Deviation|15|15.0|||
4321523|NCT00462072|4149082|B2|||Age||years|Mean|53|53.0|Standard Deviation|13|13.0|||
4321524|NCT00462072|4149083|B1|||Age||years|Mean|52|52.0|Standard Deviation|11|11.0|||
4321525|NCT00462072|4149080|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4321526|NCT00462072|4149081|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4321527|NCT00462072|4149082|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4321528|NCT00462072|4149083|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4321529|NCT00462072|4149080|B4||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4321530|NCT00462072|4149081|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4321531|NCT00462072|4149082|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4321532|NCT00462072|4149083|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4321533|NCT00462072|4149080|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4321534|NCT00462072|4149081|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4321535|NCT00462072|4149082|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4321536|NCT00462072|4149083|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4321537|NCT00462020|4149099|B3|United States||Region of Enrollment||participants|Number|102|102.0||||||
4321538|NCT00462020|4149100|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
4321539|NCT00462020|4149101|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
4321540|NCT00462020|4149099|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4321541|NCT00462020|4149100|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4321542|NCT00462020|4149101|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4321543|NCT00462020|4149099|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4321544|NCT00462020|4149100|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4321545|NCT00462020|4149101|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4321546|NCT00462020|4149099|B3|||Age||years|Mean|9.9|9.9|Standard Deviation|4.4|4.4|||
4321547|NCT00462020|4149100|B2|||Age||years|Mean|10.1|10.1|Standard Deviation|4.6|4.6|||
4321548|NCT00462020|4149101|B1|||Age||years|Mean|9.7|9.7|Standard Deviation|4.2|4.2|||
4321549|NCT00462020|4149099|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4321550|NCT00462020|4149100|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4321551|NCT00462020|4149101|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4321552|NCT00462020|4149099|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4321553|NCT00462020|4149100|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4321554|NCT00462020|4149101|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4321555|NCT00462020|4149099|B3||<=18 years|Age||Participants|Count of Participants|102|102.0||||||
4321556|NCT00462020|4149100|B2||<=18 years|Age||Participants|Count of Participants|50|50.0||||||
4321557|NCT00462020|4149101|B1||<=18 years|Age||Participants|Count of Participants|52|52.0||||||
4321558|NCT00461981|4149108|B3|United States||Region of Enrollment||participants|Number|101|101.0||||||
4321559|NCT00461981|4149109|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
4321560|NCT00461981|4149110|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4321561|NCT00461981|4149108|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321562|NCT00461981|4149109|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321563|NCT00461981|4149110|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321564|NCT00461981|4149108|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4321565|NCT00461981|4149109|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4321566|NCT00461981|4149110|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4321567|NCT00461981|4149108|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4321568|NCT00461981|4149109|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4321569|NCT00461981|4149110|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4321570|NCT00461981|4149108|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321571|NCT00461981|4149109|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321572|NCT00461981|4149110|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321573|NCT00461981|4149108|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4321574|NCT00461981|4149109|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4321575|NCT00461981|4149110|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4321576|NCT00461981|4149108|B3||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4321577|NCT00461981|4149109|B2||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4321578|NCT00461981|4149110|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4321579|NCT00461981|4149108|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4321580|NCT00461981|4149109|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4321581|NCT00461981|4149110|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4321582|NCT00461981|4149108|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321583|NCT00461981|4149109|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321584|NCT00461981|4149110|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321585|NCT00461981|4149108|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321586|NCT00461981|4149109|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321587|NCT00461981|4149110|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321588|NCT00461981|4149108|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321589|NCT00461981|4149109|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321590|NCT00461981|4149110|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321591|NCT00461981|4149108|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4321592|NCT00461981|4149109|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4321593|NCT00461981|4149110|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4321594|NCT00461981|4149108|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4321595|NCT00461981|4149109|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4321596|NCT00461981|4149110|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4321597|NCT00461981|4149108|B3|24 to < 36 months||Age, Customized||participants|Number|51|51.0||||||
4321598|NCT00461981|4149109|B2|24 to < 36 months||Age, Customized||participants|Number|27|27.0||||||
4321599|NCT00461981|4149110|B1|24 to < 36 months||Age, Customized||participants|Number|24|24.0||||||
4321600|NCT00461981|4149108|B3|12 to < 24 months||Age, Customized||participants|Number|50|50.0||||||
4321601|NCT00461981|4149109|B2|12 to < 24 months||Age, Customized||participants|Number|24|24.0||||||
4321602|NCT00461981|4149110|B1|12 to < 24 months||Age, Customized||participants|Number|26|26.0||||||
4321603|NCT00461981|4149108|B3|||Age||months|Mean|23.8|23.8|Standard Deviation|7.0|7.0|||
4321604|NCT00461981|4149109|B2|||Age||months|Mean|24.4|24.4|Standard Deviation|7.0|7.0|||
4321605|NCT00461981|4149110|B1|||Age||months|Mean|23.1|23.1|Standard Deviation|7.0|7.0|||
4321606|NCT00461851|4149221|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4321607|NCT00461851|4149221|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321608|NCT00461851|4149221|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321609|NCT00461851|4149221|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4321610|NCT00461851|4149221|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4321611|NCT00461851|4149221|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321612|NCT00461851|4149221|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321613|NCT00461851|4149221|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321614|NCT00461851|4149221|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4321615|NCT00461851|4149221|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4321616|NCT00461851|4149221|B1|||Age||years|Mean|65|65.0|Full Range|||47.0|86.0|
4321617|NCT00461851|4149221|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4321618|NCT00461851|4149221|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4321619|NCT00461851|4149221|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4321620|NCT00461812|4149227|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4321621|NCT00461812|4149227|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4321622|NCT00461812|4149227|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4321623|NCT00461812|4149227|B1|>=18, <=16 years||Age, Customized||Participants|Count of Participants|10|10.0||||||
4321624|NCT00461786|4149232|B1|Unspecified||Tumor Grade|Tumor grade is a system used to classify tumors based on certain characteristics of their cells. The grade is directly related to prognosis. The more they look like normal cells, the better the prognosis. Grades range from 1 (well-differentiated) to 4 (undifferentiated). The higher the grade, the worse the prognosis.|participants|Number|1|1.0||||||
4321625|NCT00461786|4149232|B1|3 - Poorly Differentiated||Tumor Grade|Tumor grade is a system used to classify tumors based on certain characteristics of their cells. The grade is directly related to prognosis. The more they look like normal cells, the better the prognosis. Grades range from 1 (well-differentiated) to 4 (undifferentiated). The higher the grade, the worse the prognosis.|participants|Number|31|31.0||||||
4321626|NCT00461786|4149232|B1|2 - Moderately Differentiated||Tumor Grade|Tumor grade is a system used to classify tumors based on certain characteristics of their cells. The grade is directly related to prognosis. The more they look like normal cells, the better the prognosis. Grades range from 1 (well-differentiated) to 4 (undifferentiated). The higher the grade, the worse the prognosis.|participants|Number|15|15.0||||||
4321627|NCT00461786|4149232|B1|1 - Well-Differentiated||Tumor Grade|Tumor grade is a system used to classify tumors based on certain characteristics of their cells. The grade is directly related to prognosis. The more they look like normal cells, the better the prognosis. Grades range from 1 (well-differentiated) to 4 (undifferentiated). The higher the grade, the worse the prognosis.|participants|Number|1|1.0||||||
4321628|NCT00461786|4149232|B1|Black||Race/Ethnicity||participants|Number|1|1.0||||||
4321629|NCT00461786|4149232|B1|White||Race/Ethnicity||participants|Number|47|47.0||||||
4321630|NCT00461786|4149232|B1|No||Prior Radiotherapy||participants|Number|47|47.0||||||
4321631|NCT00461786|4149232|B1|Yes||Prior Radiotherapy||participants|Number|1|1.0||||||
4321632|NCT00461786|4149232|B1|No||Prior Chemotherapy||participants|Number|0|0.0||||||
4321633|NCT00461786|4149232|B1|Yes||Prior Chemotherapy||participants|Number|48|48.0||||||
4321634|NCT00461786|4149232|B1|2 - Ambulatory, No Work Activities||Gynecologic Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|3|3.0||||||
4321635|NCT00461786|4149232|B1|1 - Ambulatory, Restricted Strenuous Activity||Gynecologic Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|15|15.0||||||
4321636|NCT00461786|4149232|B1|0 - Fully active||Gynecologic Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|30|30.0||||||
4321637|NCT00461786|4149232|B1|Undifferentiated Carcinoma||Cell Type||participants|Number|1|1.0||||||
4321638|NCT00461786|4149232|B1|Adenocarcinoma, Unspecified||Cell Type||participants|Number|1|1.0||||||
4321639|NCT00461786|4149232|B1|Endometrioid||Cell Type||participants|Number|1|1.0||||||
4321640|NCT00461786|4149232|B1|Mixed Epithelial||Cell Type||participants|Number|6|6.0||||||
4321641|NCT00461786|4149232|B1|Clear Cell||Cell Type||participants|Number|5|5.0||||||
4321642|NCT00461786|4149232|B1|Serous||Cell Type||participants|Number|34|34.0||||||
4321643|NCT00461786|4149232|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4321644|NCT00461786|4149232|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4321645|NCT00461786|4149232|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4321646|NCT00461786|4149232|B1|>79 years||Age, Customized||participants|Number|2|2.0||||||
4321647|NCT00461786|4149232|B1|70-79 years||Age, Customized||participants|Number|11|11.0||||||
4321648|NCT00461786|4149232|B1|60-69 years||Age, Customized||participants|Number|14|14.0||||||
4321649|NCT00461786|4149232|B1|50-59 years||Age, Customized||participants|Number|14|14.0||||||
4321650|NCT00461786|4149232|B1|40-49 years||Age, Customized||participants|Number|6|6.0||||||
4321651|NCT00461786|4149232|B1|<40 years||Age, Customized||participants|Number|1|1.0||||||
4321652|NCT00461734|4149240|B3|Australia||Region of Enrollment||participants|Number|128|128.0||||||
4321653|NCT00461734|4149241|B2|Australia||Region of Enrollment||participants|Number|64|64.0||||||
4321654|NCT00461734|4149242|B1|Australia||Region of Enrollment||participants|Number|64|64.0||||||
4321655|NCT00461734|4149240|B3|United Kingdom||Region of Enrollment||participants|Number|86|86.0||||||
4321656|NCT00461734|4149241|B2|United Kingdom||Region of Enrollment||participants|Number|42|42.0||||||
4321657|NCT00461734|4149242|B1|United Kingdom||Region of Enrollment||participants|Number|44|44.0||||||
4321658|NCT00461734|4149240|B3|New Zealand||Region of Enrollment||participants|Number|26|26.0||||||
4321659|NCT00461734|4149241|B2|New Zealand||Region of Enrollment||participants|Number|14|14.0||||||
4321660|NCT00461734|4149242|B1|New Zealand||Region of Enrollment||participants|Number|12|12.0||||||
4321661|NCT00461734|4149240|B3||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4321662|NCT00461734|4149241|B2||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4321663|NCT00461734|4149242|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4321664|NCT00461734|4149240|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4321665|NCT00461734|4149241|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4321666|NCT00461734|4149242|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4321667|NCT00461734|4149240|B3|||Age||years|Mean|74.2|74.2|Standard Deviation|10.5|10.5|||
4321668|NCT00461734|4149241|B2|||Age||years|Mean|74.7|74.7|Standard Deviation|10|10.0|||
4321669|NCT00461734|4149242|B1|||Age||years|Mean|73.7|73.7|Standard Deviation|11.1|11.1|||
4321670|NCT00461734|4149240|B3||>=65 years|Age||Participants|Count of Participants|196|196.0||||||
4321671|NCT00461734|4149241|B2||>=65 years|Age||Participants|Count of Participants|101|101.0||||||
4321672|NCT00461734|4149242|B1||>=65 years|Age||Participants|Count of Participants|95|95.0||||||
4321673|NCT00461734|4149240|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4321674|NCT00461734|4149241|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4321675|NCT00461734|4149242|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4321676|NCT00461734|4149240|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4321677|NCT00461734|4149241|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4321678|NCT00461734|4149242|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4321679|NCT00461708|4149275|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4321680|NCT00461708|4149276|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4321681|NCT00461708|4149277|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4321682|NCT00461708|4149275|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4321683|NCT00461708|4149276|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4321684|NCT00461708|4149277|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4321685|NCT00461708|4149275|B3|||Age||years|Mean|63.2|63.2|Standard Deviation|10.1|10.1|||
4321686|NCT00461708|4149276|B2|||Age||years|Mean|62.0|62.0|Standard Deviation|10.6|10.6|||
4321687|NCT00461708|4149277|B1|||Age||years|Mean|63.6|63.6|Standard Deviation|9.9|9.9|||
4321688|NCT00461682|4149304|B1|White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4321689|NCT00461682|4149304|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4321690|NCT00461682|4149304|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4321691|NCT00461682|4149304|B1|Years||Age||Years|Mean|21|21.0|Standard Deviation|NA||||Data not reported
4321692|NCT00461630|4149330|B3|Europe||Region of Enrollment||participants|Number|14741|14741.0||||||
4321693|NCT00461630|4149331|B2|Europe||Region of Enrollment||participants|Number|7367|7367.0||||||
4321694|NCT00461630|4149332|B1|Europe||Region of Enrollment||participants|Number|7374|7374.0||||||
4321695|NCT00461630|4149330|B3|China||Region of Enrollment||participants|Number|10932|10932.0||||||
4321696|NCT00461630|4149331|B2|China||Region of Enrollment||participants|Number|5468|5468.0||||||
4321697|NCT00461630|4149332|B1|China||Region of Enrollment||participants|Number|5464|5464.0||||||
4321698|NCT00461630|4149330|B3||Male|Sex: Female, Male||Participants|Count of Participants|21229|21229.0||||||
4321699|NCT00461630|4149331|B2||Male|Sex: Female, Male||Participants|Count of Participants|10615|10615.0||||||
4321700|NCT00461630|4149332|B1||Male|Sex: Female, Male||Participants|Count of Participants|10614|10614.0||||||
4321701|NCT00461630|4149330|B3||Female|Sex: Female, Male||Participants|Count of Participants|4444|4444.0||||||
4321702|NCT00461630|4149331|B2||Female|Sex: Female, Male||Participants|Count of Participants|2220|2220.0||||||
4321703|NCT00461630|4149332|B1||Female|Sex: Female, Male||Participants|Count of Participants|2224|2224.0||||||
4321704|NCT00461630|4149330|B3|Age||Age||years|Mean|64.9|64.9|Standard Deviation|7.5|7.5|||
4321705|NCT00461630|4149331|B2|Age||Age||years|Mean|64.9|64.9|Standard Deviation|7.5|7.5|||
4321706|NCT00461630|4149332|B1|Age||Age||years|Mean|64.9|64.9|Standard Deviation|7.5|7.5|||
4321707|NCT00461630|4149330|B3||>=65 years|Age||Participants|Count of Participants|12741|12741.0||||||
4321708|NCT00461630|4149331|B2||>=65 years|Age||Participants|Count of Participants|6373|6373.0||||||
4321709|NCT00461630|4149332|B1||>=65 years|Age||Participants|Count of Participants|6368|6368.0||||||
4321710|NCT00461630|4149330|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12932|12932.0||||||
4321711|NCT00461630|4149331|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6462|6462.0||||||
4321712|NCT00461630|4149332|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6470|6470.0||||||
4321713|NCT00461630|4149330|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4321714|NCT00461630|4149331|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4321715|NCT00461630|4149332|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4321716|NCT00461591|4149347|B3|Poland||Region of Enrollment||participants|Number|46|46.0||||||
4321717|NCT00461591|4149348|B2|Poland||Region of Enrollment||participants|Number|21|21.0||||||
4321718|NCT00461591|4149349|B1|Poland||Region of Enrollment||participants|Number|25|25.0||||||
4321719|NCT00461591|4149347|B3|United States||Region of Enrollment||participants|Number|756|756.0||||||
4321720|NCT00461591|4149348|B2|United States||Region of Enrollment||participants|Number|375|375.0||||||
4321721|NCT00461591|4149349|B1|United States||Region of Enrollment||participants|Number|381|381.0||||||
4321722|NCT00461591|4149347|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321723|NCT00461591|4149348|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321724|NCT00461591|4149349|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321725|NCT00461591|4149347|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4321726|NCT00461591|4149348|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4321727|NCT00461591|4149349|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4321728|NCT00461591|4149347|B3||White|Race (NIH/OMB)||Participants|Count of Participants|775|775.0||||||
4321729|NCT00461591|4149348|B2||White|Race (NIH/OMB)||Participants|Count of Participants|383|383.0||||||
4321730|NCT00461591|4149349|B1||White|Race (NIH/OMB)||Participants|Count of Participants|392|392.0||||||
4321731|NCT00461591|4149347|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4321732|NCT00461591|4149348|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4321733|NCT00461591|4149349|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4321734|NCT00461591|4149347|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321735|NCT00461591|4149348|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321736|NCT00461591|4149349|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321737|NCT00461591|4149347|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4321738|NCT00461591|4149348|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4321739|NCT00461591|4149349|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4321740|NCT00461591|4149347|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321741|NCT00461591|4149348|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321742|NCT00461591|4149349|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321743|NCT00461591|4149347|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321744|NCT00461591|4149348|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321745|NCT00461591|4149349|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321746|NCT00461591|4149347|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|772|772.0||||||
4321747|NCT00461591|4149348|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|379|379.0||||||
4321748|NCT00461591|4149349|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|393|393.0||||||
4321749|NCT00461591|4149347|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4321750|NCT00461591|4149348|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4321751|NCT00461591|4149349|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4321752|NCT00461591|4149347|B3||Male|Sex: Female, Male||Participants|Count of Participants|592|592.0||||||
4321753|NCT00461591|4149348|B2||Male|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
4321754|NCT00461591|4149349|B1||Male|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
4321755|NCT00461591|4149347|B3||Female|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4321756|NCT00461591|4149348|B2||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4321757|NCT00461591|4149349|B1||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4321758|NCT00461591|4149347|B3|Age|>75|Age, Customized||Participants|Count of Participants|218|218.0||||||
4321759|NCT00461591|4149348|B2|Age|>75|Age, Customized||Participants|Count of Participants|111|111.0||||||
4321760|NCT00461591|4149349|B1|Age|>75|Age, Customized||Participants|Count of Participants|107|107.0||||||
4321761|NCT00461591|4149347|B3|Age|65-75|Age, Customized||Participants|Count of Participants|279|279.0||||||
4321762|NCT00461591|4149348|B2|Age|65-75|Age, Customized||Participants|Count of Participants|139|139.0||||||
4321763|NCT00461591|4149349|B1|Age|65-75|Age, Customized||Participants|Count of Participants|140|140.0||||||
4321764|NCT00461591|4149347|B3|Age|<65|Age, Customized||Participants|Count of Participants|305|305.0||||||
4321765|NCT00461591|4149348|B2|Age|<65|Age, Customized||Participants|Count of Participants|146|146.0||||||
4321766|NCT00461591|4149349|B1|Age|<65|Age, Customized||Participants|Count of Participants|159|159.0||||||
4321767|NCT00461591|4149347|B3|||Age||years|Mean|67.8|67.8|Standard Deviation|10.82|10.82|||
4321768|NCT00461591|4149348|B2|||Age||years|Mean|68.2|68.2|Standard Deviation|10.72|10.72|||
4321769|NCT00461591|4149349|B1|||Age||years|Mean|67.5|67.5|Standard Deviation|10.92|10.92|||
4321770|NCT00461513|4149370|B3|||Kansas City Cardiomyopathy Overall Score|The Kansas City Cardiomyopathy Questionnaire Overall Summary Score ranges from 0-100, where higher scores represent better overall patient health status among patients with congestive heart failure. Here we report the mean and standard deviation of the baseline Kansas City Cardiomyopathy Questionnaire Overall Summary Score for the Intervention and Usual Care groups.|units on a scale|Mean|37.4|37.4|Standard Deviation|13.8|13.8|||
4321771|NCT00461513|4149371|B2|||Kansas City Cardiomyopathy Overall Score|The Kansas City Cardiomyopathy Questionnaire Overall Summary Score ranges from 0-100, where higher scores represent better overall patient health status among patients with congestive heart failure. Here we report the mean and standard deviation of the baseline Kansas City Cardiomyopathy Questionnaire Overall Summary Score for the Intervention and Usual Care groups.|units on a scale|Mean|36.9|36.9|Standard Deviation|14.6|14.6|||
4321772|NCT00461513|4149372|B1|||Kansas City Cardiomyopathy Overall Score|The Kansas City Cardiomyopathy Questionnaire Overall Summary Score ranges from 0-100, where higher scores represent better overall patient health status among patients with congestive heart failure. Here we report the mean and standard deviation of the baseline Kansas City Cardiomyopathy Questionnaire Overall Summary Score for the Intervention and Usual Care groups.|units on a scale|Mean|37.9|37.9|Standard Deviation|13.3|13.3|||
4321773|NCT00461513|4149370|B3|Non-white race||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
4321774|NCT00461513|4149371|B2|Non-white race||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4321775|NCT00461513|4149372|B1|Non-white race||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4321776|NCT00461513|4149370|B3|White race||Race/Ethnicity, Customized||participants|Number|314|314.0||||||
4321777|NCT00461513|4149371|B2|White race||Race/Ethnicity, Customized||participants|Number|165|165.0||||||
4321778|NCT00461513|4149372|B1|White race||Race/Ethnicity, Customized||participants|Number|149|149.0||||||
4321779|NCT00461513|4149370|B3||Male|Sex: Female, Male||Participants|Count of Participants|371|371.0||||||
4321780|NCT00461513|4149371|B2||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4321781|NCT00461513|4149372|B1||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4321782|NCT00461513|4149370|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4321783|NCT00461513|4149371|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4321784|NCT00461513|4149372|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4321785|NCT00461513|4149370|B3|||Age||years|Mean|67.6|67.6|Standard Deviation|10.0|10.0|||
4321786|NCT00461513|4149371|B2|||Age||years|Mean|67.9|67.9|Standard Deviation|10.6|10.6|||
4321787|NCT00461513|4149372|B1|||Age||years|Mean|67.3|67.3|Standard Deviation|9.6|9.6|||
4321788|NCT00461500|4149383|B3|Never Smoked||Smoking Status||participants|Number|58|58.0||||||
4321789|NCT00461500|4149384|B2|Never Smoked||Smoking Status||participants|Number|34|34.0||||||
4321790|NCT00461500|4149385|B1|Never Smoked||Smoking Status||participants|Number|24|24.0||||||
4321791|NCT00461500|4149383|B3|Ex-Smoker||Smoking Status||participants|Number|10|10.0||||||
4321792|NCT00461500|4149384|B2|Ex-Smoker||Smoking Status||participants|Number|5|5.0||||||
4321793|NCT00461500|4149385|B1|Ex-Smoker||Smoking Status||participants|Number|5|5.0||||||
4321794|NCT00461500|4149383|B3|Current Smoker||Smoking Status||participants|Number|9|9.0||||||
4321795|NCT00461500|4149384|B2|Current Smoker||Smoking Status||participants|Number|4|4.0||||||
4321796|NCT00461500|4149385|B1|Current Smoker||Smoking Status||participants|Number|5|5.0||||||
4321797|NCT00461500|4149383|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4321798|NCT00461500|4149384|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4321799|NCT00461500|4149385|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4321800|NCT00461500|4149383|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4321801|NCT00461500|4149384|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4321802|NCT00461500|4149385|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4321803|NCT00461500|4149383|B3|||Age||years|Mean|48.4|48.4|Standard Deviation|18.6|18.6|||
4321804|NCT00461500|4149384|B2|||Age||years|Mean|49.3|49.3|Standard Deviation|19.3|19.3|||
4321805|NCT00461500|4149385|B1|||Age||years|Mean|47.3|47.3|Standard Deviation|17.9|17.9|||
4321806|NCT00461331|4149416|B1||Male|Gender||Participants|Count of Participants|4|4.0||||||
4321807|NCT00461331|4149416|B1||Female|Gender||Participants|Count of Participants|16|16.0||||||
4321808|NCT00461331|4149416|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|14.3|14.3|||
4321809|NCT00461305|4149427|B3|||Body Mass Index||kg/m^2|Mean|20.70|20.7|Full Range|||15.3|29.9|
4321810|NCT00461305|4149428|B2|||Body Mass Index||kg/m^2|Mean|20.56|20.56|Full Range|||15.3|28.7|
4321811|NCT00461305|4149429|B1|||Body Mass Index||kg/m^2|Mean|20.73|20.73|Full Range|||16.2|29.9|
4321812|NCT00461305|4149427|B3|||Average length of menstrual cycle||days|Mean|29.5|29.5|Full Range|||25.0|38.0|
4321813|NCT00461305|4149428|B2|||Average length of menstrual cycle||days|Mean|29.5|29.5|Full Range|||25.0|38.0|
4321814|NCT00461305|4149429|B1|||Average length of menstrual cycle||days|Mean|29.5|29.5|Full Range|||25.0|38.0|
4321815|NCT00461305|4149427|B3|Uterine enlargement||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|1|1.0||||||
4321816|NCT00461305|4149428|B2|Uterine enlargement||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|0|0.0||||||
4321817|NCT00461305|4149429|B1|Uterine enlargement||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|1|1.0||||||
4321818|NCT00461305|4149427|B3|Multiple endometrial polyp||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|1|1.0||||||
4321819|NCT00461305|4149428|B2|Multiple endometrial polyp||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|0|0.0||||||
4321820|NCT00461305|4149429|B1|Multiple endometrial polyp||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|1|1.0||||||
4321821|NCT00461305|4149427|B3|Bicornuate uterus||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|3|3.0||||||
4321822|NCT00461305|4149428|B2|Bicornuate uterus||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|0|0.0||||||
4321823|NCT00461305|4149429|B1|Bicornuate uterus||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|3|3.0||||||
4321824|NCT00461305|4149427|B3|Endometrial polyp||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|1|1.0||||||
4321825|NCT00461305|4149428|B2|Endometrial polyp||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|0|0.0||||||
4321826|NCT00461305|4149429|B1|Endometrial polyp||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|1|1.0||||||
4321827|NCT00461305|4149427|B3|Uterine adenomyosis||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|43|43.0||||||
4321828|NCT00461305|4149428|B2|Uterine adenomyosis||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|8|8.0||||||
4321829|NCT00461305|4149429|B1|Uterine adenomyosis||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|35|35.0||||||
4321830|NCT00461305|4149427|B3|Uterine fibroids||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|34|34.0||||||
4321831|NCT00461305|4149428|B2|Uterine fibroids||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|7|7.0||||||
4321832|NCT00461305|4149429|B1|Uterine fibroids||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|27|27.0||||||
4321833|NCT00461305|4149427|B3|Endometriosis||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|28|28.0||||||
4321834|NCT00461305|4149428|B2|Endometriosis||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|4|4.0||||||
4321835|NCT00461305|4149429|B1|Endometriosis||Details of organic dysmenorrhea|Not all participants had organic dysmenorrhea. Some of participants were diagnosed as having a multiple type of organic dysmenorrhea.|participants|Number|24|24.0||||||
4321836|NCT00461305|4149427|B3|Organic dysmenorrhea||Diagnosis type||participants|Number|88|88.0||||||
4321837|NCT00461305|4149428|B2|Organic dysmenorrhea||Diagnosis type||participants|Number|12|12.0||||||
4321838|NCT00461305|4149429|B1|Organic dysmenorrhea||Diagnosis type||participants|Number|76|76.0||||||
4321839|NCT00461305|4149427|B3|Functional dysmenorrhea||Diagnosis type||participants|Number|326|326.0||||||
4321840|NCT00461305|4149428|B2|Functional dysmenorrhea||Diagnosis type||participants|Number|53|53.0||||||
4321841|NCT00461305|4149429|B1|Functional dysmenorrhea||Diagnosis type||participants|Number|273|273.0||||||
4321842|NCT00461305|4149427|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4321843|NCT00461305|4149428|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4321844|NCT00461305|4149429|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4321845|NCT00461305|4149427|B3||Female|Sex: Female, Male||Participants|Count of Participants|414|414.0||||||
4321846|NCT00461305|4149428|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4321847|NCT00461305|4149429|B1||Female|Sex: Female, Male||Participants|Count of Participants|349|349.0||||||
4321848|NCT00461305|4149427|B3|||Age||years|Mean|29.3|29.3|Full Range|||20.0|44.0|
4321849|NCT00461305|4149428|B2|||Age||years|Mean|30.9|30.9|Full Range|||20.0|43.0|
4321850|NCT00461305|4149429|B1|||Age||years|Mean|29.0|29.0|Full Range|||20.0|44.0|
4321851|NCT00461292|4149490|B4||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4321852|NCT00461292|4149491|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4321853|NCT00461292|4149492|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4321854|NCT00461292|4149493|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4321855|NCT00461292|4149490|B4||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4321856|NCT00461292|4149491|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4321857|NCT00461292|4149492|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4321858|NCT00461292|4149493|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4321859|NCT00461292|4149490|B4|>= 75 years||Age, Customized||participants|Number|3|3.0||||||
4321860|NCT00461292|4149491|B3|>= 75 years||Age, Customized||participants|Number|1|1.0||||||
4321861|NCT00461292|4149492|B2|>= 75 years||Age, Customized||participants|Number|1|1.0||||||
4321862|NCT00461292|4149493|B1|>= 75 years||Age, Customized||participants|Number|1|1.0||||||
4321863|NCT00461292|4149490|B4|Between 65 and 74 years||Age, Customized||participants|Number|14|14.0||||||
4321864|NCT00461292|4149491|B3|Between 65 and 74 years||Age, Customized||participants|Number|5|5.0||||||
4321865|NCT00461292|4149492|B2|Between 65 and 74 years||Age, Customized||participants|Number|5|5.0||||||
4321866|NCT00461292|4149493|B1|Between 65 and 74 years||Age, Customized||participants|Number|4|4.0||||||
4321867|NCT00461292|4149490|B4|Between 40 and 64 years||Age, Customized||participants|Number|172|172.0||||||
4321868|NCT00461292|4149491|B3|Between 40 and 64 years||Age, Customized||participants|Number|61|61.0||||||
4321869|NCT00461292|4149492|B2|Between 40 and 64 years||Age, Customized||participants|Number|55|55.0||||||
4321870|NCT00461292|4149493|B1|Between 40 and 64 years||Age, Customized||participants|Number|56|56.0||||||
4321871|NCT00461292|4149490|B4|< 40 years||Age, Customized||participants|Number|86|86.0||||||
4321872|NCT00461292|4149491|B3|< 40 years||Age, Customized||participants|Number|25|25.0||||||
4321873|NCT00461292|4149492|B2|< 40 years||Age, Customized||participants|Number|31|31.0||||||
4321874|NCT00461292|4149493|B1|< 40 years||Age, Customized||participants|Number|30|30.0||||||
4321875|NCT00461253|4149512|B3|Finland||Region of Enrollment||participants|Number|16490|16490.0||||||
4321876|NCT00461253|4149513|B2|Finland||Region of Enrollment||participants|Number|13192|13192.0||||||
4321877|NCT00461253|4149514|B1|Finland||Region of Enrollment||participants|Number|3298|3298.0||||||
4321878|NCT00461253|4149512|B3|Germany||Region of Enrollment||participants|Number|9075|9075.0||||||
4321879|NCT00461253|4149513|B2|Germany||Region of Enrollment||participants|Number|7260|7260.0||||||
4321880|NCT00461253|4149514|B1|Germany||Region of Enrollment||participants|Number|1815|1815.0||||||
4321881|NCT00461253|4149512|B3|Male||Gender||participants|Number|0|0.0||||||
4321882|NCT00461253|4149513|B2|Male||Gender||participants|Number|0|0.0||||||
4321883|NCT00461253|4149514|B1|Male||Gender||participants|Number|0|0.0||||||
4321884|NCT00461253|4149512|B3|Female||Gender||participants|Number|25565|25565.0||||||
4321885|NCT00461253|4149513|B2|Female||Gender||participants|Number|20,452|20.0||||||
4321886|NCT00461253|4149514|B1|Female||Gender||participants|Number|5,113|5.0||||||
4321887|NCT00461253|4149512|B3|||Age||years|Mean|44.3|44.3|Standard Deviation|5.1|5.1|||
4321888|NCT00461253|4149513|B2|||Age||years|Mean|44.2|44.2|Standard Deviation|5.1|5.1|||
4321889|NCT00461253|4149514|B1|||Age||years|Mean|44.5|44.5|Standard Deviation|5.1|5.1|||
4321890|NCT00461175|4149521|B3|Poland||Region of Enrollment||participants|Number|1644|1644.0||||||
4321891|NCT00461175|4149522|B2|Poland||Region of Enrollment||participants|Number|1013|1013.0||||||
4321892|NCT00461175|4149523|B1|Poland||Region of Enrollment||participants|Number|631|631.0||||||
4321893|NCT00461175|4149521|B3|Sweden||Region of Enrollment||participants|Number|4711|4711.0||||||
4321894|NCT00461175|4149522|B2|Sweden||Region of Enrollment||participants|Number|2018|2018.0||||||
4321895|NCT00461175|4149523|B1|Sweden||Region of Enrollment||participants|Number|2693|2693.0||||||
4321896|NCT00461175|4149521|B3|United Kingdom||Region of Enrollment||participants|Number|20974|20974.0||||||
4321897|NCT00461175|4149522|B2|United Kingdom||Region of Enrollment||participants|Number|6784|6784.0||||||
4321898|NCT00461175|4149523|B1|United Kingdom||Region of Enrollment||participants|Number|14190|14190.0||||||
4321899|NCT00461175|4149521|B3|Finland||Region of Enrollment||participants|Number|2865|2865.0||||||
4321900|NCT00461175|4149522|B2|Finland||Region of Enrollment||participants|Number|585|585.0||||||
4321901|NCT00461175|4149523|B1|Finland||Region of Enrollment||participants|Number|2280|2280.0||||||
4321902|NCT00461175|4149521|B3|Austria||Region of Enrollment||participants|Number|8250|8250.0||||||
4321903|NCT00461175|4149522|B2|Austria||Region of Enrollment||participants|Number|1947|1947.0||||||
4321904|NCT00461175|4149523|B1|Austria||Region of Enrollment||participants|Number|6303|6303.0||||||
4321905|NCT00461175|4149521|B3|Germany||Region of Enrollment||participants|Number|23004|23004.0||||||
4321906|NCT00461175|4149522|B2|Germany||Region of Enrollment||participants|Number|6023|6023.0||||||
4321907|NCT00461175|4149523|B1|Germany||Region of Enrollment||participants|Number|16981|16981.0||||||
4321908|NCT00461175|4149521|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4321909|NCT00461175|4149522|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4321910|NCT00461175|4149523|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4321911|NCT00461175|4149521|B3||Female|Sex: Female, Male||Participants|Count of Participants|61448|61448.0||||||
4321912|NCT00461175|4149522|B2||Female|Sex: Female, Male||Participants|Count of Participants|18370|18370.0||||||
4321913|NCT00461175|4149523|B1||Female|Sex: Female, Male||Participants|Count of Participants|43078|43078.0||||||
4321914|NCT00461175|4149521|B3|||Age||years|Mean|36.2|36.2|Standard Deviation|7.8|7.8|||
4321915|NCT00461175|4149522|B2|||Age||years|Mean|33.33|33.33|Standard Deviation|7.64|7.64|||
4321916|NCT00461175|4149523|B1|||Age||years|Mean|37.37|37.37|Standard Deviation|7.54|7.54|||
4321917|NCT00461175|4149521|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4321918|NCT00461175|4149522|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4321919|NCT00461175|4149523|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4321920|NCT00461175|4149521|B3||Between 18 and 65 years|Age||Participants|Count of Participants|61439|61439.0||||||
4321921|NCT00461175|4149522|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18370|18370.0||||||
4321922|NCT00461175|4149523|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43069|43069.0||||||
4321923|NCT00461175|4149521|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4321924|NCT00461175|4149522|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4321925|NCT00461175|4149523|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4321926|NCT00461123|4149532|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4321927|NCT00461123|4149533|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4321928|NCT00461123|4149534|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4321929|NCT00461123|4149532|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4321930|NCT00461123|4149533|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4321931|NCT00461123|4149534|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4321932|NCT00461123|4149532|B3|||Age||years|Mean|65.9|65.9|Standard Deviation|7.6|7.6|||
4321933|NCT00461123|4149533|B2|||Age||years|Mean|65.9|65.9|Standard Deviation|7.9|7.9|||
4321934|NCT00461123|4149534|B1|||Age||years|Mean|65.8|65.8|Standard Deviation|7.5|7.5|||
4321935|NCT00461097|4149549|B3|||Age at Initial Egg Allergic Reaction||years|Mean|2.0|2.0|Standard Deviation|2.0|2.0|||
4321936|NCT00461097|4149550|B2|||Age at Initial Egg Allergic Reaction||years|Mean|1.3|1.3|Standard Deviation|1.4|1.4|||
4321937|NCT00461097|4149551|B1|||Age at Initial Egg Allergic Reaction||years|Mean|2.3|2.3|Standard Deviation|2.1|2.1|||
4321938|NCT00461097|4149549|B3|||Egg Skin Prick Test Score|This score is calculated by subtracting the size of the saline wheal (in mm) from the size of the egg wheal (in mm) observed for a skin prick test. Individuals with an egg skin prick test score of < 3 mm are considered to have a negative result.|mm|Mean|12.1|12.1|Standard Deviation|5.4|5.4|||
4321939|NCT00461097|4149550|B2|||Egg Skin Prick Test Score|This score is calculated by subtracting the size of the saline wheal (in mm) from the size of the egg wheal (in mm) observed for a skin prick test. Individuals with an egg skin prick test score of < 3 mm are considered to have a negative result.|mm|Mean|12.8|12.8|Standard Deviation|4.3|4.3|||
4321940|NCT00461097|4149551|B1|||Egg Skin Prick Test Score|This score is calculated by subtracting the size of the saline wheal (in mm) from the size of the egg wheal (in mm) observed for a skin prick test. Individuals with an egg skin prick test score of < 3 mm are considered to have a negative result.|mm|Mean|11.8|11.8|Standard Deviation|5.7|5.7|||
4321941|NCT00461097|4149549|B3|||Egg IgE|Amount of serum egg-specific immunoglobulin E. Individuals with an egg IgE of <0.35 kUA/L are considered not to be sensitized to egg.|kUA/L|Mean|32.7|32.7|Standard Deviation|48.5|48.5|||
4321942|NCT00461097|4149550|B2|||Egg IgE|Amount of serum egg-specific immunoglobulin E. Individuals with an egg IgE of <0.35 kUA/L are considered not to be sensitized to egg.|kUA/L|Mean|32.1|32.1|Standard Deviation|27.3|27.3|||
4321943|NCT00461097|4149551|B1|||Egg IgE|Amount of serum egg-specific immunoglobulin E. Individuals with an egg IgE of <0.35 kUA/L are considered not to be sensitized to egg.|kUA/L|Mean|32.9|32.9|Standard Deviation|54.7|54.7|||
4321944|NCT00461097|4149549|B3|||Total IgE|Total amount of serum immunoglobulin E. Individuals who are not allergic may have a total IgE as high as 304 kU/L.|kU/L|Mean|1402.1|1402.1|Standard Deviation|1588.1|1588.1|||
4321945|NCT00461097|4149550|B2|||Total IgE|Total amount of serum immunoglobulin E. Individuals who are not allergic may have a total IgE as high as 304 kU/L.|kU/L|Mean|1464.7|1464.7|Standard Deviation|1182.7|1182.7|||
4321946|NCT00461097|4149551|B1|||Total IgE|Total amount of serum immunoglobulin E. Individuals who are not allergic may have a total IgE as high as 304 kU/L.|kU/L|Mean|1378.7|1378.7|Standard Deviation|1728.6|1728.6|||
4321947|NCT00461097|4149549|B3|||Atopic Dermatitis Total Score|The Atopic Dermatitis Total Score is scored on a 10 point scale from 0 to 9 where a higher score indicates increased severity of atopic dermatitis. This score is a combination of 3 scores that range from 0 to 3 in the following areas: body surface area score, disease course, and disease intensity.|Scores on a scale|Mean|3.1|3.1|Standard Deviation|2.5|2.5|||
4321948|NCT00461097|4149550|B2|||Atopic Dermatitis Total Score|The Atopic Dermatitis Total Score is scored on a 10 point scale from 0 to 9 where a higher score indicates increased severity of atopic dermatitis. This score is a combination of 3 scores that range from 0 to 3 in the following areas: body surface area score, disease course, and disease intensity.|Scores on a scale|Mean|3.0|3.0|Standard Deviation|2.8|2.8|||
4321949|NCT00461097|4149551|B1|||Atopic Dermatitis Total Score|The Atopic Dermatitis Total Score is scored on a 10 point scale from 0 to 9 where a higher score indicates increased severity of atopic dermatitis. This score is a combination of 3 scores that range from 0 to 3 in the following areas: body surface area score, disease course, and disease intensity.|Scores on a scale|Mean|3.1|3.1|Standard Deviation|2.5|2.5|||
4321950|NCT00461097|4149549|B3|United States||Region of Enrollment||participants|Number|55|55.0||||||
4321951|NCT00461097|4149550|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4321952|NCT00461097|4149551|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4321953|NCT00461097|4149549|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321954|NCT00461097|4149550|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321955|NCT00461097|4149551|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321956|NCT00461097|4149549|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321957|NCT00461097|4149550|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321958|NCT00461097|4149551|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321959|NCT00461097|4149549|B3||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4321960|NCT00461097|4149550|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4321961|NCT00461097|4149551|B1||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4321962|NCT00461097|4149549|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4321963|NCT00461097|4149550|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4321964|NCT00461097|4149551|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4321965|NCT00461097|4149549|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321966|NCT00461097|4149550|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321967|NCT00461097|4149551|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321968|NCT00461097|4149549|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4321969|NCT00461097|4149550|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321970|NCT00461097|4149551|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4321971|NCT00461097|4149549|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321972|NCT00461097|4149550|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321973|NCT00461097|4149551|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321974|NCT00461097|4149549|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321975|NCT00461097|4149550|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321976|NCT00461097|4149551|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4321977|NCT00461097|4149549|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4321978|NCT00461097|4149550|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4321979|NCT00461097|4149551|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4321980|NCT00461097|4149549|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4321981|NCT00461097|4149550|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4321982|NCT00461097|4149551|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4321983|NCT00461097|4149549|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4321984|NCT00461097|4149550|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4321985|NCT00461097|4149551|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4321986|NCT00461097|4149549|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4321987|NCT00461097|4149550|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4321988|NCT00461097|4149551|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4321989|NCT00461097|4149549|B3|||Age||years|Mean|7.1|7.1|Standard Deviation|1.6|1.6|||
4321990|NCT00461097|4149550|B2|||Age||years|Mean|7.1|7.1|Standard Deviation|1.6|1.6|||
4321991|NCT00461097|4149551|B1|||Age||years|Mean|7.1|7.1|Standard Deviation|1.6|1.6|||
4321992|NCT00461097|4149549|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4321993|NCT00461097|4149550|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4321994|NCT00461097|4149551|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4321995|NCT00461097|4149549|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4321996|NCT00461097|4149550|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4321997|NCT00461097|4149551|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4321998|NCT00461097|4149549|B3||<=18 years|Age||Participants|Count of Participants|55|55.0||||||
4321999|NCT00461097|4149550|B2||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4322000|NCT00461097|4149551|B1||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
4322001|NCT00461045|4149568|B1|>3 Relapses||Number of Relapses||participants|Number|11|11.0||||||
4322002|NCT00461045|4149568|B1|3 Relapses||Number of Relapses||participants|Number|2|2.0||||||
4322003|NCT00461045|4149568|B1|2 Relapses||Number of Relapses||participants|Number|2|2.0||||||
4322004|NCT00461045|4149568|B1|1 Relapse||Number of Relapses||participants|Number|0|0.0||||||
4322005|NCT00461045|4149568|B1|||Time Since Initial Diagnosis||years|Mean|5.2|5.2|Standard Deviation|3.79|3.79|||
4322006|NCT00461045|4149568|B1|||Karnofsky Performance Status (KPS) Score|KPS Score: 100=Normal, no complaints; 90=Able to carry on normal activity, minor signs or symptoms of disease; 80=Normal activity with effort; 70= Unable to carry on normal activity or perform active work, cares for self.|KPS Score|Mean|87.3|87.3|Full Range|||70.0|100.0|
4322007|NCT00461045|4149568|B1||Male|Fertility Status||Participants|Count of Participants|10|10.0||||||
4322008|NCT00461045|4149568|B1||Post menopausal|Fertility Status||Participants|Count of Participants|4|4.0||||||
4322009|NCT00461045|4149568|B1||Surgically sterile|Fertility Status||Participants|Count of Participants|1|1.0||||||
4322010|NCT00461045|4149568|B1||Potential able to bear children|Fertility Status||Participants|Count of Participants|0|0.0||||||
4322011|NCT00461045|4149568|B1|||Body Surface Area (BSA)||m^2|Mean|1.893|1.893|Standard Deviation|0.2629|0.2629|||
4322012|NCT00461045|4149568|B1|||Baseline Weight||kg|Mean|77.27|77.27|Standard Deviation|17.825|17.825|||
4322013|NCT00461045|4149568|B1|||Baseline Height||cm|Mean|170.97|170.97|Standard Deviation|12.152|12.152|||
4322014|NCT00461045|4149568|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4322015|NCT00461045|4149568|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4322016|NCT00461045|4149568|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4322017|NCT00461045|4149568|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4322018|NCT00461045|4149568|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4322019|NCT00461045|4149568|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4322020|NCT00461045|4149568|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4322021|NCT00461045|4149568|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4322022|NCT00461045|4149568|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4322023|NCT00461045|4149568|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4322024|NCT00461045|4149568|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4322025|NCT00461045|4149568|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4322026|NCT00461045|4149568|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4322027|NCT00461045|4149568|B1|||Age||years|Mean|61.9|61.9|Standard Deviation|8.02|8.02|||
4322028|NCT00461032|4149578|B3|||β-Agonist Use|The number of puffs used per day was entered by the Participant or parent/guardian into a Participant diary during the 2-week period prior to the start of the study drug.|puffs/day|Mean|0.58|0.58|Standard Deviation|1.03|1.03|||
4322029|NCT00461032|4149579|B2|||β-Agonist Use|The number of puffs used per day was entered by the Participant or parent/guardian into a Participant diary during the 2-week period prior to the start of the study drug.|puffs/day|Mean|0.54|0.54|Standard Deviation|0.94|0.94|||
4322030|NCT00461032|4149580|B1|||β-Agonist Use|The number of puffs used per day was entered by the Participant or parent/guardian into a Participant diary during the 2-week period prior to the start of the study drug.|puffs/day|Mean|0.62|0.62|Standard Deviation|1.11|1.11|||
4322031|NCT00461032|4149578|B3|||Daytime Asthma Symptom Score|The Participant or parent/guardian scored his/her/child's symptoms [from 0 (best) to 5 (worst)] on a daily basis. Scores were entered into a Participant diary during the 2-week period prior to the start of the study drug.|Units on a Scale|Mean|1.34|1.34|Standard Deviation|1.88|1.88|||
4322032|NCT00461032|4149579|B2|||Daytime Asthma Symptom Score|The Participant or parent/guardian scored his/her/child's symptoms [from 0 (best) to 5 (worst)] on a daily basis. Scores were entered into a Participant diary during the 2-week period prior to the start of the study drug.|Units on a Scale|Mean|1.35|1.35|Standard Deviation|1.94|1.94|||
4322033|NCT00461032|4149580|B1|||Daytime Asthma Symptom Score|The Participant or parent/guardian scored his/her/child's symptoms [from 0 (best) to 5 (worst)] on a daily basis. Scores were entered into a Participant diary during the 2-week period prior to the start of the study drug.|Units on a Scale|Mean|1.32|1.32|Standard Deviation|1.81|1.81|||
4322034|NCT00461032|4149578|B3||Male|Sex: Female, Male||Participants|Count of Participants|701|701.0||||||
4322035|NCT00461032|4149579|B2||Male|Sex: Female, Male||Participants|Count of Participants|355|355.0||||||
4322036|NCT00461032|4149580|B1||Male|Sex: Female, Male||Participants|Count of Participants|346|346.0||||||
4322037|NCT00461032|4149578|B3||Female|Sex: Female, Male||Participants|Count of Participants|461|461.0||||||
4322038|NCT00461032|4149579|B2||Female|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
4322039|NCT00461032|4149580|B1||Female|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
4322040|NCT00461032|4149578|B3|||Age||years|Mean|9.9|9.9|Standard Deviation|2.5|2.5|||
4322041|NCT00461032|4149579|B2|||Age||years|Mean|9.9|9.9|Standard Deviation|2.4|2.4|||
4322042|NCT00461032|4149580|B1|||Age||years|Mean|9.9|9.9|Standard Deviation|2.5|2.5|||
4322043|NCT00460993|4149593|B3|||Sleep Efficiency||percent of sleep|Median|59.1|59.1|Full Range|||12.3|74.9|
4322044|NCT00460993|4149594|B2|||Sleep Efficiency||percent of sleep|Median|60.7|60.7|Full Range|||12.3|70.8|
4322045|NCT00460993|4149595|B1|||Sleep Efficiency||percent of sleep|Median|56.1|56.1|Full Range|||28.2|74.9|
4322046|NCT00460993|4149593|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4322047|NCT00460993|4149594|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4322048|NCT00460993|4149595|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4322049|NCT00460993|4149593|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4322050|NCT00460993|4149594|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4322051|NCT00460993|4149595|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4322052|NCT00460993|4149593|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4322053|NCT00460993|4149594|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4322054|NCT00460993|4149595|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4322055|NCT00460993|4149593|B3|||Age||years|Mean|86.3|86.3|Standard Deviation|7.7|7.7|||
4322056|NCT00460993|4149594|B2|||Age||years|Mean|88.9|88.9|Standard Deviation|5.6|5.6|||
4322057|NCT00460993|4149595|B1|||Age||years|Mean|83.1|83.1|Standard Deviation|8.5|8.5|||
4322058|NCT00460993|4149593|B3||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4322059|NCT00460993|4149594|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4322060|NCT00460993|4149595|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4322061|NCT00460993|4149593|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4322062|NCT00460993|4149594|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4322063|NCT00460993|4149595|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4322064|NCT00460993|4149593|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4322065|NCT00460993|4149594|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4322066|NCT00460993|4149595|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4322067|NCT00460811|4149602|B6|Canada||Region of Enrollment||participants|Number|19|19.0||||||
4322068|NCT00460811|4149603|B5|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4322069|NCT00460811|4149604|B4|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4322070|NCT00460811|4149605|B3|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4322071|NCT00460811|4149606|B2|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4322072|NCT00460811|4149607|B1|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4322073|NCT00460811|4149602|B6|United States||Region of Enrollment||participants|Number|401|401.0||||||
4322074|NCT00460811|4149603|B5|United States||Region of Enrollment||participants|Number|81|81.0||||||
4322075|NCT00460811|4149604|B4|United States||Region of Enrollment||participants|Number|86|86.0||||||
4322076|NCT00460811|4149605|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
4322077|NCT00460811|4149606|B2|United States||Region of Enrollment||participants|Number|79|79.0||||||
4322078|NCT00460811|4149607|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
4322079|NCT00460811|4149602|B6||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4322080|NCT00460811|4149603|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4322081|NCT00460811|4149604|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4322082|NCT00460811|4149605|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4322083|NCT00460811|4149606|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4322084|NCT00460811|4149607|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4322085|NCT00460811|4149602|B6||Female|Sex: Female, Male||Participants|Count of Participants|387|387.0||||||
4322086|NCT00460811|4149603|B5||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4322087|NCT00460811|4149604|B4||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4322088|NCT00460811|4149605|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4322089|NCT00460811|4149606|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4322090|NCT00460811|4149607|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4322091|NCT00460811|4149602|B6|Older than 65 years||Age, Customized||Participants|Number|12|12.0||||||
4322092|NCT00460811|4149603|B5|Older than 65 years||Age, Customized||Participants|Number|0|0.0||||||
4322093|NCT00460811|4149604|B4|Older than 65 years||Age, Customized||Participants|Number|3|3.0||||||
4322094|NCT00460811|4149605|B3|Older than 65 years||Age, Customized||Participants|Number|4|4.0||||||
4322095|NCT00460811|4149606|B2|Older than 65 years||Age, Customized||Participants|Number|3|3.0||||||
4322096|NCT00460811|4149607|B1|Older than 65 years||Age, Customized||Participants|Number|2|2.0||||||
4322097|NCT00460811|4149602|B6|18 years to 65 years||Age, Customized||Participants|Number|408|408.0||||||
4322098|NCT00460811|4149603|B5|18 years to 65 years||Age, Customized||Participants|Number|85|85.0||||||
4322099|NCT00460811|4149604|B4|18 years to 65 years||Age, Customized||Participants|Number|86|86.0||||||
4322100|NCT00460811|4149605|B3|18 years to 65 years||Age, Customized||Participants|Number|81|81.0||||||
4322101|NCT00460811|4149606|B2|18 years to 65 years||Age, Customized||Participants|Number|79|79.0||||||
4322102|NCT00460811|4149607|B1|18 years to 65 years||Age, Customized||Participants|Number|77|77.0||||||
4322103|NCT00460811|4149602|B6|||Age||years|Mean|44.4|44.4|Standard Deviation|11.5|11.5|||
4322104|NCT00460811|4149603|B5|||Age||years|Mean|44.3|44.3|Standard Deviation|11.3|11.3|||
4322105|NCT00460811|4149604|B4|||Age||years|Mean|43.7|43.7|Standard Deviation|11.4|11.4|||
4322106|NCT00460811|4149605|B3|||Age||years|Mean|45.8|45.8|Standard Deviation|11.4|11.4|||
4322107|NCT00460811|4149606|B2|||Age||years|Mean|45.6|45.6|Standard Deviation|10.8|10.8|||
4322108|NCT00460811|4149607|B1|||Age||years|Mean|42.3|42.3|Standard Deviation|12.5|12.5|||
4322109|NCT00460798|4149653|B1|Unspecified||Sex/Gender, Customized||Participants|Number|1|1.0||||||
4322110|NCT00460798|4149653|B1|Female||Sex/Gender, Customized||Participants|Number|103|103.0||||||
4322111|NCT00460798|4149653|B1|Male||Sex/Gender, Customized||Participants|Number|314|314.0||||||
4322112|NCT00460798|4149653|B1|Unspecified||Age, Customized||Participants|Number|2|2.0||||||
4322113|NCT00460798|4149653|B1|>=65 Years||Age, Customized||Participants|Number|256|256.0||||||
4322114|NCT00460798|4149653|B1|45 to 64 Years||Age, Customized||Participants|Number|148|148.0||||||
4322115|NCT00460798|4149653|B1|18 to 44 Years||Age, Customized||Participants|Number|12|12.0||||||
4322116|NCT00460746|4149661|B1|||CD4 count||cells/mm^3|Median|301|301.0|Full Range|||187.0|663.0|
4322117|NCT00460746|4149661|B1|||Viral Load <50 copies/mL||participants|Number|10|10.0||||||
4322118|NCT00460746|4149661|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4322119|NCT00460746|4149661|B1|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4322120|NCT00460746|4149661|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4322121|NCT00460746|4149661|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4322122|NCT00460746|4149661|B1|||Age||years|Median|48|48.0|Full Range|||35.0|61.0|
4322123|NCT00460655|4149674|B3|Asian-Japanese||Race/Ethnicity, Customized||participants|Number|120|120.0||||||
4322124|NCT00460655|4149675|B2|Asian-Japanese||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
4322125|NCT00460655|4149676|B1|Asian-Japanese||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
4322126|NCT00460655|4149674|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4322127|NCT00460655|4149675|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4322128|NCT00460655|4149676|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4322129|NCT00460655|4149674|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4322130|NCT00460655|4149675|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4322131|NCT00460655|4149676|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4322132|NCT00460655|4149674|B3|||Age||years|Mean|62.5|62.5|Standard Deviation|8.97|8.97|||
4322133|NCT00460655|4149675|B2|||Age||years|Mean|62.5|62.5|Standard Deviation|9.32|9.32|||
4322134|NCT00460655|4149676|B1|||Age||years|Mean|62.4|62.4|Standard Deviation|8.66|8.66|||
4322135|NCT00460603|4149711|B13||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4322136|NCT00460603|4149712|B12||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4322137|NCT00460603|4149713|B11||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4322138|NCT00460603|4149714|B10||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4322139|NCT00460603|4149715|B9||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4322140|NCT00460603|4149716|B8||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4322141|NCT00460603|4149717|B7||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4322142|NCT00460603|4149718|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4322143|NCT00460603|4149719|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4322144|NCT00460603|4149720|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4322145|NCT00460603|4149721|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4322146|NCT00460603|4149722|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4322147|NCT00460603|4149723|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4322148|NCT00460603|4149711|B13||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4322149|NCT00460603|4149712|B12||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4322150|NCT00460603|4149713|B11||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4322151|NCT00460603|4149714|B10||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4322152|NCT00460603|4149715|B9||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4322153|NCT00460603|4149716|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4322154|NCT00460603|4149717|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4322155|NCT00460603|4149718|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4322156|NCT00460603|4149719|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4322157|NCT00460603|4149720|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4322158|NCT00460603|4149721|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4322159|NCT00460603|4149722|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4322160|NCT00460603|4149723|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4322161|NCT00460603|4149711|B13|Greater than or equal to (>=) 65 years||Age, Customized||Participants|Number|70|70.0||||||
4322162|NCT00460603|4149712|B12|Greater than or equal to (>=) 65 years||Age, Customized||Participants|Number|10|10.0||||||
4322163|NCT00460603|4149713|B11|Greater than or equal to (>=) 65 years||Age, Customized||Participants|Number|21|21.0||||||
4322164|NCT00460603|4149714|B10|Greater than or equal to (>=) 65 years||Age, Customized||Participants|Number|18|18.0||||||
4322165|NCT00460603|4149715|B9|Greater than or equal to (>=) 65 years||Age, Customized||Participants|Number|4|4.0||||||
4322166|NCT00460603|4149716|B8|Greater than or equal to (>=) 65 years||Age, Customized||Participants|Number|0|0.0||||||
4322167|NCT00460603|4149717|B7|Greater than or equal to (>=) 65 years||Age, Customized||Participants|Number|1|1.0||||||
4322168|NCT00460603|4149718|B6|Greater than or equal to (>=) 65 years||Age, Customized||Participants|Number|2|2.0||||||
4322169|NCT00460603|4149719|B5|Greater than or equal to (>=) 65 years||Age, Customized||Participants|Number|3|3.0||||||
4322170|NCT00460603|4149720|B4|Greater than or equal to (>=) 65 years||Age, Customized||Participants|Number|4|4.0||||||
4322171|NCT00460603|4149721|B3|Greater than or equal to (>=) 65 years||Age, Customized||Participants|Number|1|1.0||||||
4322172|NCT00460603|4149722|B2|Greater than or equal to (>=) 65 years||Age, Customized||Participants|Number|3|3.0||||||
4322173|NCT00460603|4149723|B1|Greater than or equal to (>=) 65 years||Age, Customized||Participants|Number|3|3.0||||||
4322174|NCT00460603|4149711|B13|45 to 64 years||Age, Customized||Participants|Number|96|96.0||||||
4322175|NCT00460603|4149712|B12|45 to 64 years||Age, Customized||Participants|Number|23|23.0||||||
4322176|NCT00460603|4149713|B11|45 to 64 years||Age, Customized||Participants|Number|18|18.0||||||
4322177|NCT00460603|4149714|B10|45 to 64 years||Age, Customized||Participants|Number|22|22.0||||||
4322178|NCT00460603|4149715|B9|45 to 64 years||Age, Customized||Participants|Number|13|13.0||||||
4322179|NCT00460603|4149716|B8|45 to 64 years||Age, Customized||Participants|Number|3|3.0||||||
4322180|NCT00460603|4149717|B7|45 to 64 years||Age, Customized||Participants|Number|5|5.0||||||
4322181|NCT00460603|4149718|B6|45 to 64 years||Age, Customized||Participants|Number|1|1.0||||||
4322182|NCT00460603|4149719|B5|45 to 64 years||Age, Customized||Participants|Number|2|2.0||||||
4322183|NCT00460603|4149720|B4|45 to 64 years||Age, Customized||Participants|Number|3|3.0||||||
4322184|NCT00460603|4149721|B3|45 to 64 years||Age, Customized||Participants|Number|3|3.0||||||
4322185|NCT00460603|4149722|B2|45 to 64 years||Age, Customized||Participants|Number|1|1.0||||||
4322186|NCT00460603|4149723|B1|45 to 64 years||Age, Customized||Participants|Number|2|2.0||||||
4322187|NCT00460603|4149711|B13|18 to 44 years||Age, Customized||Participants|Number|21|21.0||||||
4322188|NCT00460603|4149712|B12|18 to 44 years||Age, Customized||Participants|Number|8|8.0||||||
4322189|NCT00460603|4149713|B11|18 to 44 years||Age, Customized||Participants|Number|4|4.0||||||
4322190|NCT00460603|4149714|B10|18 to 44 years||Age, Customized||Participants|Number|2|2.0||||||
4322191|NCT00460603|4149715|B9|18 to 44 years||Age, Customized||Participants|Number|1|1.0||||||
4322192|NCT00460603|4149716|B8|18 to 44 years||Age, Customized||Participants|Number|0|0.0||||||
4322193|NCT00460603|4149717|B7|18 to 44 years||Age, Customized||Participants|Number|0|0.0||||||
4322194|NCT00460603|4149718|B6|18 to 44 years||Age, Customized||Participants|Number|1|1.0||||||
4322195|NCT00460603|4149719|B5|18 to 44 years||Age, Customized||Participants|Number|1|1.0||||||
4322196|NCT00460603|4149720|B4|18 to 44 years||Age, Customized||Participants|Number|1|1.0||||||
4322197|NCT00460603|4149721|B3|18 to 44 years||Age, Customized||Participants|Number|0|0.0||||||
4322198|NCT00460603|4149722|B2|18 to 44 years||Age, Customized||Participants|Number|2|2.0||||||
4322199|NCT00460603|4149723|B1|18 to 44 years||Age, Customized||Participants|Number|1|1.0||||||
4322200|NCT00460603|4149711|B13|Less than (<) 18 years||Age, Customized||Participants|Number|0|0.0||||||
4322201|NCT00460603|4149712|B12|Less than (<) 18 years||Age, Customized||Participants|Number|0|0.0||||||
4322202|NCT00460603|4149713|B11|Less than (<) 18 years||Age, Customized||Participants|Number|0|0.0||||||
4322203|NCT00460603|4149714|B10|Less than (<) 18 years||Age, Customized||Participants|Number|0|0.0||||||
4322204|NCT00460603|4149715|B9|Less than (<) 18 years||Age, Customized||Participants|Number|0|0.0||||||
4322205|NCT00460603|4149716|B8|Less than (<) 18 years||Age, Customized||Participants|Number|0|0.0||||||
4322206|NCT00460603|4149717|B7|Less than (<) 18 years||Age, Customized||Participants|Number|0|0.0||||||
4322207|NCT00460603|4149718|B6|Less than (<) 18 years||Age, Customized||Participants|Number|0|0.0||||||
4322208|NCT00460603|4149719|B5|Less than (<) 18 years||Age, Customized||Participants|Number|0|0.0||||||
4322209|NCT00460603|4149720|B4|Less than (<) 18 years||Age, Customized||Participants|Number|0|0.0||||||
4322210|NCT00460603|4149721|B3|Less than (<) 18 years||Age, Customized||Participants|Number|0|0.0||||||
4322211|NCT00460603|4149722|B2|Less than (<) 18 years||Age, Customized||Participants|Number|0|0.0||||||
4322212|NCT00460603|4149723|B1|Less than (<) 18 years||Age, Customized||Participants|Number|0|0.0||||||
4322213|NCT00460577|4149826|B3|||Conway Clinical Scale|Mean of Clinical Scale score measured by assessment of the following: Wheezing, Accessory Muscle Use and Pulse Frequency in a 0 to 3 point scale according to severity for a minimum of 0 points and a total of 9 points in a very severe clinical case.|score on a scale|Mean|4.05|4.05|Standard Deviation|0|0.0|||
4322214|NCT00460577|4149827|B2|||Conway Clinical Scale|Mean of Clinical Scale score measured by assessment of the following: Wheezing, Accessory Muscle Use and Pulse Frequency in a 0 to 3 point scale according to severity for a minimum of 0 points and a total of 9 points in a very severe clinical case.|score on a scale|Mean|4.0|4.0|Standard Deviation|1.5|1.5|||
4322215|NCT00460577|4149828|B1|||Conway Clinical Scale|Mean of Clinical Scale score measured by assessment of the following: Wheezing, Accessory Muscle Use and Pulse Frequency in a 0 to 3 point scale according to severity for a minimum of 0 points and a total of 9 points in a very severe clinical case.|score on a scale|Mean|4.1|4.1|Standard Deviation|1.4|1.4|||
4322216|NCT00460577|4149826|B3|||Forced Expiratory Flow 1 sec as a Percentage of Predicted|Mean Expiratory Flow 1 second as a Percentage of Predicted|Percentage of Predicted|Mean|69.11|69.11|Standard Deviation|0|0.0|||
4322217|NCT00460577|4149827|B2|||Forced Expiratory Flow 1 sec as a Percentage of Predicted|Mean Expiratory Flow 1 second as a Percentage of Predicted|Percentage of Predicted|Mean|71.17|71.17|Standard Deviation|15.76|15.76|||
4322218|NCT00460577|4149828|B1|||Forced Expiratory Flow 1 sec as a Percentage of Predicted|Mean Expiratory Flow 1 second as a Percentage of Predicted|Percentage of Predicted|Mean|67.05|67.05|Standard Deviation|15.22|15.22|||
4322219|NCT00460577|4149826|B3|||Forced Expiratory Flow 1 sec|Mean of Forced Expiratory Flow one second (FEV1) defined as the volume of air that can be forced out in 1 second after taking a deep breath.|Liters|Mean|1.09|1.09|Standard Deviation|0|0.0|||
4322220|NCT00460577|4149827|B2|||Forced Expiratory Flow 1 sec|Mean of Forced Expiratory Flow one second (FEV1) defined as the volume of air that can be forced out in 1 second after taking a deep breath.|Liters|Mean|1.12|1.12|Standard Deviation|0.289|0.289|||
4322221|NCT00460577|4149828|B1|||Forced Expiratory Flow 1 sec|Mean of Forced Expiratory Flow one second (FEV1) defined as the volume of air that can be forced out in 1 second after taking a deep breath.|Liters|Mean|1.06|1.06|Standard Deviation|0.280|0.28|||
4322222|NCT00460577|4149826|B3|||Maximum Expiratory Flow|Mean of Maximum Expiratory Flow|Liters/minute|Mean|145.3|145.3|Standard Deviation|0|0.0|||
4322223|NCT00460577|4149827|B2|||Maximum Expiratory Flow|Mean of Maximum Expiratory Flow|Liters/minute|Mean|150.3|150.3|Standard Deviation|36.6|36.6|||
4322224|NCT00460577|4149828|B1|||Maximum Expiratory Flow|Mean of Maximum Expiratory Flow|Liters/minute|Mean|140.3|140.3|Standard Deviation|33.1|33.1|||
4322225|NCT00460577|4149826|B3|||Maximum Inspiratory Flow|Mean of the Maximum Inspiratory Flow|Liters/minute|Mean|78.8|78.8|Standard Deviation|0|0.0|||
4322226|NCT00460577|4149827|B2|||Maximum Inspiratory Flow|Mean of the Maximum Inspiratory Flow|Liters/minute|Mean|79.9|79.9|Standard Deviation|17.5|17.5|||
4322227|NCT00460577|4149828|B1|||Maximum Inspiratory Flow|Mean of the Maximum Inspiratory Flow|Liters/minute|Mean|77.7|77.7|Standard Deviation|16.7|16.7|||
4322228|NCT00460577|4149826|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4322229|NCT00460577|4149827|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4322230|NCT00460577|4149828|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4322231|NCT00460577|4149826|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4322232|NCT00460577|4149827|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4322233|NCT00460577|4149828|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4322234|NCT00460577|4149826|B3|||Age||years|Mean|7.8|7.8|Standard Deviation|0|0.0|||
4322235|NCT00460577|4149827|B2|||Age||years|Mean|7.8|7.8|Standard Deviation|2.1|2.1|||
4322236|NCT00460577|4149828|B1|||Age||years|Mean|7.8|7.8|Standard Deviation|1.5|1.5|||
4322237|NCT00460577|4149826|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4322238|NCT00460577|4149827|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4322239|NCT00460577|4149828|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4322240|NCT00460577|4149826|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4322241|NCT00460577|4149827|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4322242|NCT00460577|4149828|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4322243|NCT00460577|4149826|B3||<=18 years|Age||Participants|Count of Participants|60|60.0||||||
4322244|NCT00460577|4149827|B2||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4322245|NCT00460577|4149828|B1||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4322246|NCT00460564|4149843|B5|Asian-Japanese||Race/Ethnicity, Customized||participants|Number|109|109.0||||||
4322247|NCT00460564|4149844|B4|Asian-Japanese||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4322248|NCT00460564|4149845|B3|Asian-Japanese||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4322249|NCT00460564|4149846|B2|Asian-Japanese||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4322250|NCT00460564|4149847|B1|Asian-Japanese||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4322251|NCT00460564|4149843|B5||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4322252|NCT00460564|4149844|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4322253|NCT00460564|4149845|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4322254|NCT00460564|4149846|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4322255|NCT00460564|4149847|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4322256|NCT00460564|4149843|B5||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4322257|NCT00460564|4149844|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4322258|NCT00460564|4149845|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4322259|NCT00460564|4149846|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4322260|NCT00460564|4149847|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4322261|NCT00460564|4149843|B5|||Age||years|Mean|63.2|63.2|Standard Deviation|9.73|9.73|||
4322262|NCT00460564|4149844|B4|||Age||years|Mean|62.3|62.3|Standard Deviation|9.61|9.61|||
4322263|NCT00460564|4149845|B3|||Age||years|Mean|62.7|62.7|Standard Deviation|9.74|9.74|||
4322264|NCT00460564|4149846|B2|||Age||years|Mean|63.6|63.6|Standard Deviation|11.03|11.03|||
4322265|NCT00460564|4149847|B1|||Age||years|Mean|63.5|63.5|Standard Deviation|9.32|9.32|||
4322266|NCT00460551|4149948|B1|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4322267|NCT00460551|4149948|B1|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4322268|NCT00460551|4149948|B1|Belgium||Region of Enrollment||participants|Number|6|6.0||||||
4322269|NCT00460551|4149948|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4322270|NCT00460551|4149948|B1|France||Region of Enrollment||participants|Number|2|2.0||||||
4322271|NCT00460551|4149948|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4322272|NCT00460551|4149948|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4322273|NCT00460551|4149948|B1|||Age||years|Median|66|66.0|Full Range|||42.0|78.0|
4322274|NCT00460551|4149948|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4322275|NCT00460551|4149948|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4322276|NCT00460551|4149948|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4322277|NCT00460525|4149953|B3|Mali||Region of Enrollment||participants|Number|400|400.0||||||
4322278|NCT00460525|4149954|B2|Mali||Region of Enrollment||participants|Number|199|199.0||||||
4322279|NCT00460525|4149955|B1|Mali||Region of Enrollment||participants|Number|201|201.0||||||
4322280|NCT00460525|4149953|B3||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4322281|NCT00460525|4149954|B2||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4322282|NCT00460525|4149955|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4322283|NCT00460525|4149953|B3||Female|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
4322284|NCT00460525|4149954|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4322285|NCT00460525|4149955|B1||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4322286|NCT00460525|4149953|B3|||Age||years|Mean|3.4|3.4|Standard Deviation|1.5|1.5|||
4322287|NCT00460525|4149954|B2|||Age||years|Mean|3.4|3.4|Standard Deviation|1.6|1.6|||
4322288|NCT00460525|4149955|B1|||Age||years|Mean|3.4|3.4|Standard Deviation|1.5|1.5|||
4322289|NCT00460525|4149953|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4322290|NCT00460525|4149954|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4322291|NCT00460525|4149955|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4322292|NCT00460525|4149953|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4322293|NCT00460525|4149954|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4322294|NCT00460525|4149955|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4322295|NCT00460525|4149953|B3||<=18 years|Age||Participants|Count of Participants|400|400.0||||||
4322296|NCT00460525|4149954|B2||<=18 years|Age||Participants|Count of Participants|199|199.0||||||
4322297|NCT00460525|4149955|B1||<=18 years|Age||Participants|Count of Participants|201|201.0||||||
4322298|NCT00460434|4149996|B3|||Concomitant Hysterectomy||Participants|Count of Participants|165|165.0||||||
4322299|NCT00460434|4149997|B2|||Concomitant Hysterectomy||Participants|Count of Participants|83|83.0||||||
4322300|NCT00460434|4149998|B1|||Concomitant Hysterectomy||Participants|Count of Participants|82|82.0||||||
4322301|NCT00460434|4149996|B3|||Previous Hysterectomy||Participants|Count of Participants|128|128.0||||||
4322302|NCT00460434|4149997|B2|||Previous Hysterectomy||Participants|Count of Participants|66|66.0||||||
4322303|NCT00460434|4149998|B1|||Previous Hysterectomy||Participants|Count of Participants|62|62.0||||||
4322304|NCT00460434|4149996|B3|||Posterior Vaginal - Prolapse Repair||Participants|Count of Participants|154|154.0||||||
4322305|NCT00460434|4149997|B2|||Posterior Vaginal - Prolapse Repair||Participants|Count of Participants|80|80.0||||||
4322306|NCT00460434|4149998|B1|||Posterior Vaginal - Prolapse Repair||Participants|Count of Participants|74|74.0||||||
4322307|NCT00460434|4149996|B3|Colpocleisis||Anterior Vaginal - Prolapse Repair||Participants|Count of Participants|24|24.0||||||
4322308|NCT00460434|4149997|B2|Colpocleisis||Anterior Vaginal - Prolapse Repair||Participants|Count of Participants|13|13.0||||||
4322309|NCT00460434|4149998|B1|Colpocleisis||Anterior Vaginal - Prolapse Repair||Participants|Count of Participants|11|11.0||||||
4322310|NCT00460434|4149996|B3|Both Anterior Repair and Apical Suspension||Anterior Vaginal - Prolapse Repair||Participants|Count of Participants|201|201.0||||||
4322311|NCT00460434|4149997|B2|Both Anterior Repair and Apical Suspension||Anterior Vaginal - Prolapse Repair||Participants|Count of Participants|100|100.0||||||
4322312|NCT00460434|4149998|B1|Both Anterior Repair and Apical Suspension||Anterior Vaginal - Prolapse Repair||Participants|Count of Participants|101|101.0||||||
4322313|NCT00460434|4149996|B3|Apical Suspension Only||Anterior Vaginal - Prolapse Repair||Participants|Count of Participants|74|74.0||||||
4322314|NCT00460434|4149997|B2|Apical Suspension Only||Anterior Vaginal - Prolapse Repair||Participants|Count of Participants|42|42.0||||||
4322315|NCT00460434|4149998|B1|Apical Suspension Only||Anterior Vaginal - Prolapse Repair||Participants|Count of Participants|32|32.0||||||
4322316|NCT00460434|4149996|B3|Anterior Repair Only||Anterior Vaginal - Prolapse Repair||Participants|Count of Participants|37|37.0||||||
4322317|NCT00460434|4149997|B2|Anterior Repair Only||Anterior Vaginal - Prolapse Repair||Participants|Count of Participants|17|17.0||||||
4322318|NCT00460434|4149998|B1|Anterior Repair Only||Anterior Vaginal - Prolapse Repair||Participants|Count of Participants|20|20.0||||||
4322319|NCT00460434|4149996|B3|||Positive Cough Stress Test|A leakage of urine with coughing or straining in either the supine or standing position with the bladder filled through a urethral catheter to 300ml.|Participants|Count of Participants|111|111.0||||||
4322320|NCT00460434|4149997|B2|||Positive Cough Stress Test|A leakage of urine with coughing or straining in either the supine or standing position with the bladder filled through a urethral catheter to 300ml.|Participants|Count of Participants|57|57.0||||||
4322321|NCT00460434|4149998|B1|||Positive Cough Stress Test|A leakage of urine with coughing or straining in either the supine or standing position with the bladder filled through a urethral catheter to 300ml.|Participants|Count of Participants|54|54.0||||||
4322322|NCT00460434|4149996|B3|4||Pelvic Organ Prolapse Quantification|(1=lowest point of prolapse is >1cm above the hymen; 2=within 1 cm above or below the hymen; 3= >1cm below the hymen but protrudes no more than 2cm less than the total vaginal length; 4=complete vaginal eversion)|Participants|Count of Participants|31|31.0||||||
4322323|NCT00460434|4149997|B2|4||Pelvic Organ Prolapse Quantification|(1=lowest point of prolapse is >1cm above the hymen; 2=within 1 cm above or below the hymen; 3= >1cm below the hymen but protrudes no more than 2cm less than the total vaginal length; 4=complete vaginal eversion)|Participants|Count of Participants|18|18.0||||||
4322324|NCT00460434|4149998|B1|4||Pelvic Organ Prolapse Quantification|(1=lowest point of prolapse is >1cm above the hymen; 2=within 1 cm above or below the hymen; 3= >1cm below the hymen but protrudes no more than 2cm less than the total vaginal length; 4=complete vaginal eversion)|Participants|Count of Participants|13|13.0||||||
4322325|NCT00460434|4149996|B3|3||Pelvic Organ Prolapse Quantification|(1=lowest point of prolapse is >1cm above the hymen; 2=within 1 cm above or below the hymen; 3= >1cm below the hymen but protrudes no more than 2cm less than the total vaginal length; 4=complete vaginal eversion)|Participants|Count of Participants|213|213.0||||||
4322326|NCT00460434|4149997|B2|3||Pelvic Organ Prolapse Quantification|(1=lowest point of prolapse is >1cm above the hymen; 2=within 1 cm above or below the hymen; 3= >1cm below the hymen but protrudes no more than 2cm less than the total vaginal length; 4=complete vaginal eversion)|Participants|Count of Participants|106|106.0||||||
4322327|NCT00460434|4149998|B1|3||Pelvic Organ Prolapse Quantification|(1=lowest point of prolapse is >1cm above the hymen; 2=within 1 cm above or below the hymen; 3= >1cm below the hymen but protrudes no more than 2cm less than the total vaginal length; 4=complete vaginal eversion)|Participants|Count of Participants|107|107.0||||||
4322328|NCT00460434|4149996|B3|2||Pelvic Organ Prolapse Quantification|(1=lowest point of prolapse is >1cm above the hymen; 2=within 1 cm above or below the hymen; 3= >1cm below the hymen but protrudes no more than 2cm less than the total vaginal length; 4=complete vaginal eversion)|Participants|Count of Participants|93|93.0||||||
4322329|NCT00460434|4149997|B2|2||Pelvic Organ Prolapse Quantification|(1=lowest point of prolapse is >1cm above the hymen; 2=within 1 cm above or below the hymen; 3= >1cm below the hymen but protrudes no more than 2cm less than the total vaginal length; 4=complete vaginal eversion)|Participants|Count of Participants|48|48.0||||||
4322330|NCT00460434|4149998|B1|2||Pelvic Organ Prolapse Quantification|(1=lowest point of prolapse is >1cm above the hymen; 2=within 1 cm above or below the hymen; 3= >1cm below the hymen but protrudes no more than 2cm less than the total vaginal length; 4=complete vaginal eversion)|Participants|Count of Participants|45|45.0||||||
4322331|NCT00460434|4149996|B3|||Body Mass Index||Kg/m^2|Mean|28.0|28.0|Standard Deviation|5.2|5.2|||
4322332|NCT00460434|4149997|B2|||Body Mass Index||Kg/m^2|Mean|28.1|28.1|Standard Deviation|5.5|5.5|||
4322333|NCT00460434|4149998|B1|||Body Mass Index||Kg/m^2|Mean|27.8|27.8|Standard Deviation|4.9|4.9|||
4322334|NCT00460434|4149996|B3|||Married||Participants|Count of Participants|222|222.0||||||
4322335|NCT00460434|4149997|B2|||Married||Participants|Count of Participants|101|101.0||||||
4322336|NCT00460434|4149998|B1|||Married||Participants|Count of Participants|121|121.0||||||
4322337|NCT00460434|4149996|B3|||Annual Income <$30,000||Participants|Count of Participants|58|58.0||||||
4322338|NCT00460434|4149997|B2|||Annual Income <$30,000||Participants|Count of Participants|27|27.0||||||
4322339|NCT00460434|4149998|B1|||Annual Income <$30,000||Participants|Count of Participants|31|31.0||||||
4322340|NCT00460434|4149996|B3|Not Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|289|289.0||||||
4322341|NCT00460434|4149997|B2|Not Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|145|145.0||||||
4322342|NCT00460434|4149998|B1|Not Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|144|144.0||||||
4322343|NCT00460434|4149996|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
4322344|NCT00460434|4149997|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
4322345|NCT00460434|4149998|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
4322346|NCT00460434|4149996|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
4322347|NCT00460434|4149997|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4322348|NCT00460434|4149998|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4322349|NCT00460434|4149996|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4322350|NCT00460434|4149997|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4322351|NCT00460434|4149998|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4322352|NCT00460434|4149996|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
4322353|NCT00460434|4149997|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4322354|NCT00460434|4149998|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4322355|NCT00460434|4149996|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|286|286.0||||||
4322356|NCT00460434|4149997|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|143|143.0||||||
4322357|NCT00460434|4149998|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|143|143.0||||||
4322358|NCT00460434|4149996|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4322359|NCT00460434|4149997|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4322360|NCT00460434|4149998|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4322361|NCT00460434|4149996|B3||Female|Sex: Female, Male||Participants|Count of Participants|337|337.0||||||
4322362|NCT00460434|4149997|B2||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4322363|NCT00460434|4149998|B1||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4322364|NCT00460434|4149996|B3|||Age||years|Mean|62.8|62.8|Standard Deviation|10.5|10.5|||
4322365|NCT00460434|4149997|B2|||Age||years|Mean|62.2|62.2|Standard Deviation|10.2|10.2|||
4322366|NCT00460434|4149998|B1|||Age||years|Mean|63.4|63.4|Standard Deviation|10.8|10.8|||
4322367|NCT00460421|4150025|B4|United States||Region of Enrollment||participants|Number|27|27.0||||||
4322368|NCT00460421|4150026|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4322369|NCT00460421|4150027|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4322370|NCT00460421|4150028|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4322371|NCT00460421|4150025|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4322372|NCT00460421|4150026|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4322373|NCT00460421|4150027|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4322374|NCT00460421|4150028|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4322375|NCT00460421|4150025|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4322376|NCT00460421|4150026|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4322377|NCT00460421|4150027|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4322378|NCT00460421|4150028|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4322379|NCT00460421|4150025|B4|||Age||years|Mean|7.6|7.6|Standard Deviation|5.9|5.9|||
4322380|NCT00460421|4150026|B3|||Age||years|Mean|8.0|8.0|Standard Deviation|6.6|6.6|||
4322381|NCT00460421|4150027|B2|||Age||years|Mean|7.4|7.4|Standard Deviation|5.6|5.6|||
4322382|NCT00460421|4150028|B1|||Age||years|Mean|7.4|7.4|Standard Deviation|6.3|6.3|||
4322383|NCT00460421|4150025|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4322384|NCT00460421|4150026|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4322385|NCT00460421|4150027|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4322386|NCT00460421|4150028|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4322387|NCT00460421|4150025|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4322388|NCT00460421|4150026|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4322389|NCT00460421|4150027|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4322390|NCT00460421|4150028|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4322391|NCT00460421|4150025|B4||<=18 years|Age||Participants|Count of Participants|27|27.0||||||
4322392|NCT00460421|4150026|B3||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4322393|NCT00460421|4150027|B2||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4322394|NCT00460421|4150028|B1||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4322395|NCT00460408|4150074|B5|Exsmoker||Smoking status|Data missing for 1 participant in Macugen monotherapy reporting group.|participants|Number|130|130.0||||||
4322396|NCT00460408|4150075|B4|Exsmoker||Smoking status|Data missing for 1 participant in Macugen monotherapy reporting group.|participants|Number|2|2.0||||||
4322397|NCT00460408|4150076|B3|Exsmoker||Smoking status|Data missing for 1 participant in Macugen monotherapy reporting group.|participants|Number|22|22.0||||||
4322398|NCT00460408|4150077|B2|Exsmoker||Smoking status|Data missing for 1 participant in Macugen monotherapy reporting group.|participants|Number|3|3.0||||||
4322399|NCT00460408|4150078|B1|Exsmoker||Smoking status|Data missing for 1 participant in Macugen monotherapy reporting group.|participants|Number|103|103.0||||||
4322400|NCT00460408|4150074|B5|Current smoker||Smoking status|Data missing for 1 participant in Macugen monotherapy reporting group.|participants|Number|43|43.0||||||
4322401|NCT00460408|4150075|B4|Current smoker||Smoking status|Data missing for 1 participant in Macugen monotherapy reporting group.|participants|Number|0|0.0||||||
4322402|NCT00460408|4150076|B3|Current smoker||Smoking status|Data missing for 1 participant in Macugen monotherapy reporting group.|participants|Number|8|8.0||||||
4322403|NCT00460408|4150077|B2|Current smoker||Smoking status|Data missing for 1 participant in Macugen monotherapy reporting group.|participants|Number|1|1.0||||||
4322404|NCT00460408|4150078|B1|Current smoker||Smoking status|Data missing for 1 participant in Macugen monotherapy reporting group.|participants|Number|34|34.0||||||
4322405|NCT00460408|4150074|B5|Never smoked||Smoking status|Data missing for 1 participant in Macugen monotherapy reporting group.|participants|Number|327|327.0||||||
4322406|NCT00460408|4150075|B4|Never smoked||Smoking status|Data missing for 1 participant in Macugen monotherapy reporting group.|participants|Number|5|5.0||||||
4322407|NCT00460408|4150076|B3|Never smoked||Smoking status|Data missing for 1 participant in Macugen monotherapy reporting group.|participants|Number|45|45.0||||||
4322408|NCT00460408|4150077|B2|Never smoked||Smoking status|Data missing for 1 participant in Macugen monotherapy reporting group.|participants|Number|12|12.0||||||
4322409|NCT00460408|4150078|B1|Never smoked||Smoking status|Data missing for 1 participant in Macugen monotherapy reporting group.|participants|Number|265|265.0||||||
4322410|NCT00460408|4150074|B5||Male|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4322411|NCT00460408|4150075|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4322412|NCT00460408|4150076|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4322413|NCT00460408|4150077|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4322414|NCT00460408|4150078|B1||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4322415|NCT00460408|4150074|B5||Female|Sex: Female, Male||Participants|Count of Participants|307|307.0||||||
4322416|NCT00460408|4150075|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4322417|NCT00460408|4150076|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4322418|NCT00460408|4150077|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4322419|NCT00460408|4150078|B1||Female|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4322420|NCT00460408|4150074|B5|greater than or equal to (≥) 75 years||Age, Customized||participants|Number|268|268.0||||||
4322421|NCT00460408|4150075|B4|greater than or equal to (≥) 75 years||Age, Customized||participants|Number|4|4.0||||||
4322422|NCT00460408|4150076|B3|greater than or equal to (≥) 75 years||Age, Customized||participants|Number|47|47.0||||||
4322423|NCT00460408|4150077|B2|greater than or equal to (≥) 75 years||Age, Customized||participants|Number|8|8.0||||||
4322424|NCT00460408|4150078|B1|greater than or equal to (≥) 75 years||Age, Customized||participants|Number|209|209.0||||||
4322425|NCT00460408|4150074|B5|65 to 74 years||Age, Customized||participants|Number|149|149.0||||||
4322426|NCT00460408|4150075|B4|65 to 74 years||Age, Customized||participants|Number|2|2.0||||||
4322427|NCT00460408|4150076|B3|65 to 74 years||Age, Customized||participants|Number|19|19.0||||||
4322428|NCT00460408|4150077|B2|65 to 74 years||Age, Customized||participants|Number|7|7.0||||||
4322429|NCT00460408|4150078|B1|65 to 74 years||Age, Customized||participants|Number|121|121.0||||||
4322430|NCT00460408|4150074|B5|51 to 64 years||Age, Customized||participants|Number|79|79.0||||||
4322431|NCT00460408|4150075|B4|51 to 64 years||Age, Customized||participants|Number|1|1.0||||||
4322432|NCT00460408|4150076|B3|51 to 64 years||Age, Customized||participants|Number|9|9.0||||||
4322433|NCT00460408|4150077|B2|51 to 64 years||Age, Customized||participants|Number|1|1.0||||||
4322434|NCT00460408|4150078|B1|51 to 64 years||Age, Customized||participants|Number|68|68.0||||||
4322435|NCT00460408|4150074|B5|less than or equal to (≤) 50 years||Age, Customized||participants|Number|5|5.0||||||
4322436|NCT00460408|4150075|B4|less than or equal to (≤) 50 years||Age, Customized||participants|Number|0|0.0||||||
4322437|NCT00460408|4150076|B3|less than or equal to (≤) 50 years||Age, Customized||participants|Number|0|0.0||||||
4322438|NCT00460408|4150077|B2|less than or equal to (≤) 50 years||Age, Customized||participants|Number|0|0.0||||||
4322439|NCT00460408|4150078|B1|less than or equal to (≤) 50 years||Age, Customized||participants|Number|5|5.0||||||
4322440|NCT00460265|4150116|B3|Oral cavity and hypopharynx||Primary tumor site, oropharynx&larynx/oral cavity&hypopharynx||subjects|Number|280|280.0||||||
4322441|NCT00460265|4150117|B2|Oral cavity and hypopharynx||Primary tumor site, oropharynx&larynx/oral cavity&hypopharynx||subjects|Number|139|139.0||||||
4322442|NCT00460265|4150118|B1|Oral cavity and hypopharynx||Primary tumor site, oropharynx&larynx/oral cavity&hypopharynx||subjects|Number|141|141.0||||||
4322443|NCT00460265|4150116|B3|Oropharynx and larynx||Primary tumor site, oropharynx&larynx/oral cavity&hypopharynx||subjects|Number|377|377.0||||||
4322444|NCT00460265|4150117|B2|Oropharynx and larynx||Primary tumor site, oropharynx&larynx/oral cavity&hypopharynx||subjects|Number|191|191.0||||||
4322445|NCT00460265|4150118|B1|Oropharynx and larynx||Primary tumor site, oropharynx&larynx/oral cavity&hypopharynx||subjects|Number|186|186.0||||||
4322446|NCT00460265|4150116|B3|2||ECOG perfomance score, 0/1/2||subjects|Number|6|6.0||||||
4322447|NCT00460265|4150117|B2|2||ECOG perfomance score, 0/1/2||subjects|Number|4|4.0||||||
4322448|NCT00460265|4150118|B1|2||ECOG perfomance score, 0/1/2||subjects|Number|2|2.0||||||
4322449|NCT00460265|4150116|B3|1||ECOG perfomance score, 0/1/2||subjects|Number|455|455.0||||||
4322450|NCT00460265|4150117|B2|1||ECOG perfomance score, 0/1/2||subjects|Number|228|228.0||||||
4322451|NCT00460265|4150118|B1|1||ECOG perfomance score, 0/1/2||subjects|Number|227|227.0||||||
4322452|NCT00460265|4150116|B3|0||ECOG perfomance score, 0/1/2||subjects|Number|196|196.0||||||
4322453|NCT00460265|4150117|B2|0||ECOG perfomance score, 0/1/2||subjects|Number|98|98.0||||||
4322454|NCT00460265|4150118|B1|0||ECOG perfomance score, 0/1/2||subjects|Number|98|98.0||||||
4322455|NCT00460265|4150116|B3|No||Previously treated with chemotherapy and/or radiotherapy, Yes/No||subjects|Number|127|127.0||||||
4322456|NCT00460265|4150117|B2|No||Previously treated with chemotherapy and/or radiotherapy, Yes/No||subjects|Number|67|67.0||||||
4322457|NCT00460265|4150118|B1|No||Previously treated with chemotherapy and/or radiotherapy, Yes/No||subjects|Number|60|60.0||||||
4322458|NCT00460265|4150116|B3|Yes||Previously treated with chemotherapy and/or radiotherapy, Yes/No||subjects|Number|530|530.0||||||
4322459|NCT00460265|4150117|B2|Yes||Previously treated with chemotherapy and/or radiotherapy, Yes/No||subjects|Number|263|263.0||||||
4322460|NCT00460265|4150118|B1|Yes||Previously treated with chemotherapy and/or radiotherapy, Yes/No||subjects|Number|267|267.0||||||
4322461|NCT00460265|4150116|B3|Unknown/Missing||Race/Ethnicity, Customized||subjects|Number|2|2.0||||||
4322462|NCT00460265|4150117|B2|Unknown/Missing||Race/Ethnicity, Customized||subjects|Number|2|2.0||||||
4322463|NCT00460265|4150118|B1|Unknown/Missing||Race/Ethnicity, Customized||subjects|Number|0|0.0||||||
4322464|NCT00460265|4150116|B3|Other||Race/Ethnicity, Customized||subjects|Number|9|9.0||||||
4322465|NCT00460265|4150117|B2|Other||Race/Ethnicity, Customized||subjects|Number|6|6.0||||||
4322466|NCT00460265|4150118|B1|Other||Race/Ethnicity, Customized||subjects|Number|3|3.0||||||
4322467|NCT00460265|4150116|B3|Aborigine||Race/Ethnicity, Customized||subjects|Number|1|1.0||||||
4322468|NCT00460265|4150117|B2|Aborigine||Race/Ethnicity, Customized||subjects|Number|0|0.0||||||
4322469|NCT00460265|4150118|B1|Aborigine||Race/Ethnicity, Customized||subjects|Number|1|1.0||||||
4322470|NCT00460265|4150116|B3|Japanese||Race/Ethnicity, Customized||subjects|Number|20|20.0||||||
4322471|NCT00460265|4150117|B2|Japanese||Race/Ethnicity, Customized||subjects|Number|7|7.0||||||
4322472|NCT00460265|4150118|B1|Japanese||Race/Ethnicity, Customized||subjects|Number|13|13.0||||||
4322473|NCT00460265|4150116|B3|Asian||Race/Ethnicity, Customized||subjects|Number|55|55.0||||||
4322474|NCT00460265|4150117|B2|Asian||Race/Ethnicity, Customized||subjects|Number|30|30.0||||||
4322475|NCT00460265|4150118|B1|Asian||Race/Ethnicity, Customized||subjects|Number|25|25.0||||||
4322476|NCT00460265|4150116|B3|Hispanic or Latino||Race/Ethnicity, Customized||subjects|Number|25|25.0||||||
4322477|NCT00460265|4150117|B2|Hispanic or Latino||Race/Ethnicity, Customized||subjects|Number|12|12.0||||||
4322478|NCT00460265|4150118|B1|Hispanic or Latino||Race/Ethnicity, Customized||subjects|Number|13|13.0||||||
4322479|NCT00460265|4150116|B3|Black or African American||Race/Ethnicity, Customized||subjects|Number|6|6.0||||||
4322480|NCT00460265|4150117|B2|Black or African American||Race/Ethnicity, Customized||subjects|Number|2|2.0||||||
4322481|NCT00460265|4150118|B1|Black or African American||Race/Ethnicity, Customized||subjects|Number|4|4.0||||||
4322482|NCT00460265|4150116|B3|White or Caucasian||Race/Ethnicity, Customized||subjects|Number|539|539.0||||||
4322483|NCT00460265|4150117|B2|White or Caucasian||Race/Ethnicity, Customized||subjects|Number|271|271.0||||||
4322484|NCT00460265|4150118|B1|White or Caucasian||Race/Ethnicity, Customized||subjects|Number|268|268.0||||||
4322485|NCT00460265|4150116|B3||Male|Sex: Female, Male||Participants|Count of Participants|570|570.0||||||
4322486|NCT00460265|4150117|B2||Male|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
4322487|NCT00460265|4150118|B1||Male|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
4322488|NCT00460265|4150116|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4322489|NCT00460265|4150117|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4322490|NCT00460265|4150118|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4322491|NCT00460265|4150116|B3|||Age||years|Mean|58.1|58.1|Standard Deviation|8.2|8.2|||
4322492|NCT00460265|4150117|B2|||Age||years|Mean|58.6|58.6|Standard Deviation|7.8|7.8|||
4322493|NCT00460265|4150118|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|8.5|8.5|||
4322494|NCT00460239|4150135|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4322495|NCT00460239|4150135|B1||Male|Gender||Participants|Count of Participants|12|12.0||||||
4322496|NCT00460239|4150135|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
4322497|NCT00460239|4150135|B1|||Age||years|Mean|39.2|39.2|Standard Deviation|6.48|6.48|||
4322498|NCT00460239|4150135|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4322499|NCT00460239|4150135|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4322500|NCT00460239|4150135|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4322501|NCT00460109|4150212|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4322502|NCT00460109|4150212|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4322503|NCT00460109|4150212|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4322504|NCT00460109|4150212|B1|||Age||years|Median|60.0|60.0|Full Range|||27.0|79.0|
4322505|NCT00460031|4150220|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4322506|NCT00460031|4150220|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4322507|NCT00460031|4150220|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4322508|NCT00460031|4150220|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4322509|NCT00460031|4150220|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4322510|NCT00460031|4150220|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4322511|NCT00460031|4150220|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4322571|NCT00459862|4150251|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4322512|NCT00460031|4150220|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4322513|NCT00460031|4150220|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4322514|NCT00460031|4150220|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4322515|NCT00460031|4150220|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4322516|NCT00460031|4150220|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4322517|NCT00460031|4150220|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4322518|NCT00460031|4150220|B1|80-89 years||Age, Customized||participants|Number|6|6.0||||||
4322519|NCT00460031|4150220|B1|70-79 years||Age, Customized||participants|Number|11|11.0||||||
4322520|NCT00460031|4150220|B1|60-69 years||Age, Customized||participants|Number|10|10.0||||||
4322521|NCT00460031|4150220|B1|50-59 years||Age, Customized||participants|Number|5|5.0||||||
4322522|NCT00460031|4150220|B1|40-49 years||Age, Customized||participants|Number|2|2.0||||||
4322523|NCT00459979|4150228|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4322524|NCT00459979|4150228|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4322525|NCT00459979|4150228|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4322526|NCT00459979|4150228|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4322527|NCT00459979|4150228|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4322528|NCT00459979|4150228|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4322529|NCT00459979|4150228|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4322530|NCT00459979|4150228|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4322531|NCT00459979|4150228|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4322532|NCT00459979|4150228|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4322533|NCT00459979|4150228|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4322534|NCT00459979|4150228|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4322535|NCT00459979|4150228|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4322536|NCT00459979|4150228|B1|Median age||Age||Years|Median|61|61.0|Full Range|10.0|10.0|37.0|80.0|
4322537|NCT00459953|4150238|B3|United States||Region of Enrollment||participants|Number|141|141.0||||||
4322538|NCT00459953|4150239|B2|United States||Region of Enrollment||participants|Number|70|70.0||||||
4322539|NCT00459953|4150240|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
4322540|NCT00459953|4150238|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4322541|NCT00459953|4150239|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4322542|NCT00459953|4150240|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4322543|NCT00459953|4150238|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4322544|NCT00459953|4150239|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4322545|NCT00459953|4150240|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4322546|NCT00459953|4150238|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
4322547|NCT00459953|4150239|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4322548|NCT00459953|4150240|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4322549|NCT00459953|4150238|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4322550|NCT00459953|4150239|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4322551|NCT00459953|4150240|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4322552|NCT00459953|4150238|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4322553|NCT00459953|4150239|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4322554|NCT00459953|4150240|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4322555|NCT00459953|4150238|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4322556|NCT00459953|4150239|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4322557|NCT00459953|4150240|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4322558|NCT00459953|4150238|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4322559|NCT00459953|4150239|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4322560|NCT00459953|4150240|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4322561|NCT00459953|4150238|B3||<=18 years|Age||Participants|Count of Participants|141|141.0||||||
4322562|NCT00459953|4150239|B2||<=18 years|Age||Participants|Count of Participants|70|70.0||||||
4322563|NCT00459953|4150240|B1||<=18 years|Age||Participants|Count of Participants|71|71.0||||||
4322564|NCT00459875|4150247|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4322565|NCT00459875|4150247|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4322566|NCT00459875|4150247|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4322567|NCT00459875|4150247|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4322568|NCT00459875|4150247|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4322569|NCT00459862|4150251|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4322570|NCT00459862|4150251|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4322572|NCT00459862|4150251|B1|||Age||years|Median|73|73.0|Full Range|||49.0|84.0|
4322573|NCT00459810|4150260|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4322574|NCT00459810|4150260|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4322575|NCT00459810|4150260|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4322576|NCT00459810|4150260|B1|||Age||years|Mean|70|70.0|Standard Deviation|7.6|7.6|||
4322577|NCT00459810|4150260|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4322578|NCT00459810|4150260|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4322579|NCT00459810|4150260|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4322580|NCT00459732|4150268|B3|||Spine Z-score|Spine standard deviation score (Z-score) determined by baseline DXA bone density scan|Z-score|Mean|-2.1|-2.1|Standard Deviation|1.0|1.0|||
4322581|NCT00459732|4150269|B2|||Spine Z-score|Spine standard deviation score (Z-score) determined by baseline DXA bone density scan|Z-score|Mean|-2.4|-2.4|Standard Deviation|1.1|1.1|||
4322582|NCT00459732|4150270|B1|||Spine Z-score|Spine standard deviation score (Z-score) determined by baseline DXA bone density scan|Z-score|Mean|-1.9|-1.9|Standard Deviation|1.0|1.0|||
4322583|NCT00459732|4150268|B3|||Plasma Zinc|Concentration of zinc within the plasma at baseline, mcg/dL|mcg/dL|Mean|78|78.0|Standard Deviation|12|12.0|||
4322584|NCT00459732|4150269|B2|||Plasma Zinc|Concentration of zinc within the plasma at baseline, mcg/dL|mcg/dL|Mean|79|79.0|Standard Deviation|14|14.0|||
4322585|NCT00459732|4150270|B1|||Plasma Zinc|Concentration of zinc within the plasma at baseline, mcg/dL|mcg/dL|Mean|77|77.0|Standard Deviation|11|11.0|||
4322586|NCT00459732|4150268|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4322587|NCT00459732|4150269|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4322588|NCT00459732|4150270|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4322589|NCT00459732|4150268|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4322590|NCT00459732|4150269|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4322591|NCT00459732|4150270|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4322592|NCT00459732|4150268|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4322593|NCT00459732|4150269|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4322594|NCT00459732|4150270|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4322595|NCT00459732|4150268|B3|||Age||years|Mean|17.6|17.6|Standard Deviation|5.3|5.3|||
4322596|NCT00459732|4150269|B2|||Age||years|Mean|17.4|17.4|Standard Deviation|4.9|4.9|||
4322597|NCT00459732|4150270|B1|||Age||years|Mean|17.7|17.7|Standard Deviation|5.6|5.6|||
4322598|NCT00459732|4150268|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4322599|NCT00459732|4150269|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4322600|NCT00459732|4150270|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4322601|NCT00459732|4150268|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4322602|NCT00459732|4150269|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4322603|NCT00459732|4150270|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4322604|NCT00459732|4150268|B3||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
4322605|NCT00459732|4150269|B2||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4322606|NCT00459732|4150270|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4322607|NCT00459706|4150281|B3|Female||Sex/Gender, Customized||participants|Number|477|477.0||||||
4322608|NCT00459706|4150282|B2|Female||Sex/Gender, Customized||participants|Number|237|237.0||||||
4322609|NCT00459706|4150283|B1|Female||Sex/Gender, Customized||participants|Number|240|240.0||||||
4322610|NCT00459706|4150281|B3|Male||Sex/Gender, Customized||participants|Number|163|163.0||||||
4322611|NCT00459706|4150282|B2|Male||Sex/Gender, Customized||participants|Number|78|78.0||||||
4322612|NCT00459706|4150283|B1|Male||Sex/Gender, Customized||participants|Number|85|85.0||||||
4322613|NCT00459706|4150281|B3|||Age||years|Mean|54.7|54.7|Standard Deviation|12.9|12.9|||
4322614|NCT00459706|4150282|B2|||Age||years|Mean|54.8|54.8|Standard Deviation|12.9|12.9|||
4322615|NCT00459706|4150283|B1|||Age||years|Mean|54.7|54.7|Standard Deviation|12.9|12.9|||
4322616|NCT00459667|4150424|B4||Male|Sex: Female, Male||Participants|Count of Participants|439|439.0||||||
4322617|NCT00459667|4150425|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4322618|NCT00459667|4150426|B2||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4322619|NCT00459667|4150427|B1||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4322620|NCT00459667|4150424|B4||Female|Sex: Female, Male||Participants|Count of Participants|972|972.0||||||
4322621|NCT00459667|4150425|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4322622|NCT00459667|4150426|B2||Female|Sex: Female, Male||Participants|Count of Participants|445|445.0||||||
4322623|NCT00459667|4150427|B1||Female|Sex: Female, Male||Participants|Count of Participants|414|414.0||||||
4322624|NCT00459667|4150424|B4|>=55 years||Age, Customized||participants|Number|0|0.0||||||
4322625|NCT00459667|4150425|B3|>=55 years||Age, Customized||participants|Number|0|0.0||||||
4322626|NCT00459667|4150426|B2|>=55 years||Age, Customized||participants|Number|0|0.0||||||
4322627|NCT00459667|4150427|B1|>=55 years||Age, Customized||participants|Number|0|0.0||||||
4322628|NCT00459667|4150424|B4|>18 and <55 years||Age, Customized||participants|Number|1398|1398.0||||||
4322629|NCT00459667|4150425|B3|>18 and <55 years||Age, Customized||participants|Number|178|178.0||||||
4322630|NCT00459667|4150426|B2|>18 and <55 years||Age, Customized||participants|Number|640|640.0||||||
4322631|NCT00459667|4150427|B1|>18 and <55 years||Age, Customized||participants|Number|580|580.0||||||
4322632|NCT00459667|4150424|B4|<=18 years||Age, Customized||participants|Number|13|13.0||||||
4322633|NCT00459667|4150425|B3|<=18 years||Age, Customized||participants|Number|2|2.0||||||
4322634|NCT00459667|4150426|B2|<=18 years||Age, Customized||participants|Number|5|5.0||||||
4322635|NCT00459667|4150427|B1|<=18 years||Age, Customized||participants|Number|6|6.0||||||
4322636|NCT00459667|4150424|B4|Mean±Standard Deviation||Age||years|Mean|35.9|35.9|Standard Deviation|9.29|9.29|||
4322637|NCT00459667|4150425|B3|Mean±Standard Deviation||Age||years|Mean|34.9|34.9|Standard Deviation|9.5|9.5|||
4322638|NCT00459667|4150426|B2|Mean±Standard Deviation||Age||years|Mean|35.8|35.8|Standard Deviation|9.17|9.17|||
4322639|NCT00459667|4150427|B1|Mean±Standard Deviation||Age||years|Mean|36.2|36.2|Standard Deviation|9.36|9.36|||
4322640|NCT00459537|4150449|B3||Male|Sex: Female, Male||Participants|Count of Participants|721|721.0||||||
4322641|NCT00459537|4150450|B2||Male|Sex: Female, Male||Participants|Count of Participants|372|372.0||||||
4322642|NCT00459537|4150451|B1||Male|Sex: Female, Male||Participants|Count of Participants|349|349.0||||||
4322643|NCT00459537|4150449|B3||Female|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
4322644|NCT00459537|4150450|B2||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4322645|NCT00459537|4150451|B1||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4322646|NCT00459537|4150449|B3||>=65 years|Age||Participants|Count of Participants|193|193.0||||||
4322647|NCT00459537|4150450|B2||>=65 years|Age||Participants|Count of Participants|111|111.0||||||
4322648|NCT00459537|4150451|B1||>=65 years|Age||Participants|Count of Participants|82|82.0||||||
4322649|NCT00459537|4150449|B3||Between 18 and 65 years|Age||Participants|Count of Participants|835|835.0||||||
4322650|NCT00459537|4150450|B2||Between 18 and 65 years|Age||Participants|Count of Participants|410|410.0||||||
4322651|NCT00459537|4150451|B1||Between 18 and 65 years|Age||Participants|Count of Participants|425|425.0||||||
4322652|NCT00459537|4150449|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4322653|NCT00459537|4150450|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4322654|NCT00459537|4150451|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4322655|NCT00459381|4150466|B1|No||Surgery for recurrence for current progression prior to enrollment||participants|Number|27|27.0||||||
4322656|NCT00459381|4150466|B1|Yes||Surgery for recurrence for current progression prior to enrollment||participants|Number|8|8.0||||||
4322657|NCT00459381|4150466|B1|3||Number of Prior chemotherapy reginmens||participants|Number|2|2.0||||||
4322658|NCT00459381|4150466|B1|2||Number of Prior chemotherapy reginmens||participants|Number|9|9.0||||||
4322659|NCT00459381|4150466|B1|1||Number of Prior chemotherapy reginmens||participants|Number|24|24.0||||||
4322660|NCT00459381|4150466|B1|||Time from Radiotherapy to study enrollment||months|Median|10|10.0|Full Range|||1.0|169.0|
4322661|NCT00459381|4150466|B1|||Prior Radiotherapy||participants|Number|35|35.0||||||
4322662|NCT00459381|4150466|B1|60-80||Karnofsky Performance Status Scale|Higher score better 100 normal no complaints/disease 90 capable normal activity few symptoms/disease 80 normal activity, some difficulty some symptoms/signs 70 caring for self not capable normal activity/work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care/help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures/treatment 10 moribund rapidly progressive fatal disease processes 0 death|participants|Number|9|9.0||||||
4322663|NCT00459381|4150466|B1|90-100||Karnofsky Performance Status Scale|Higher score better 100 normal no complaints/disease 90 capable normal activity few symptoms/disease 80 normal activity, some difficulty some symptoms/signs 70 caring for self not capable normal activity/work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care/help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures/treatment 10 moribund rapidly progressive fatal disease processes 0 death|participants|Number|26|26.0||||||
4322664|NCT00459381|4150466|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4322665|NCT00459381|4150466|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4322666|NCT00459381|4150466|B1|||Age||years|Median|53|53.0|Full Range|||29.0|73.0|
4322667|NCT00459368|4150476|B3|United States||Region of Enrollment||participants|Number|2698|2698.0||||||
4322668|NCT00459368|4150477|B2|United States||Region of Enrollment||participants|Number|1363|1363.0||||||
4322669|NCT00459368|4150478|B1|United States||Region of Enrollment||participants|Number|1335|1335.0||||||
4322670|NCT00459368|4150476|B3||Male|Sex: Female, Male||Participants|Count of Participants|1208|1208.0||||||
4322671|NCT00459368|4150477|B2||Male|Sex: Female, Male||Participants|Count of Participants|610|610.0||||||
4322672|NCT00459368|4150478|B1||Male|Sex: Female, Male||Participants|Count of Participants|598|598.0||||||
4322673|NCT00459368|4150476|B3||Female|Sex: Female, Male||Participants|Count of Participants|1490|1490.0||||||
4322674|NCT00459368|4150477|B2||Female|Sex: Female, Male||Participants|Count of Participants|753|753.0||||||
4322675|NCT00459368|4150478|B1||Female|Sex: Female, Male||Participants|Count of Participants|737|737.0||||||
4322676|NCT00459368|4150476|B3|||Age||years|Mean|26.6|26.6|Standard Deviation|37.9|37.9|||
4322677|NCT00459368|4150477|B2|||Age||years|Mean|27.7|27.7|Standard Deviation|38.5|38.5|||
4322678|NCT00459368|4150478|B1|||Age||years|Mean|25.6|25.6|Standard Deviation|37.3|37.3|||
4322679|NCT00459368|4150476|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4322680|NCT00459368|4150477|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4322681|NCT00459368|4150478|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4322682|NCT00459368|4150476|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1503|1503.0||||||
4322683|NCT00459368|4150477|B2||Between 18 and 65 years|Age||Participants|Count of Participants|759|759.0||||||
4322684|NCT00459368|4150478|B1||Between 18 and 65 years|Age||Participants|Count of Participants|744|744.0||||||
4322685|NCT00459368|4150476|B3||<=18 years|Age||Participants|Count of Participants|1195|1195.0||||||
4322686|NCT00459368|4150477|B2||<=18 years|Age||Participants|Count of Participants|604|604.0||||||
4322687|NCT00459368|4150478|B1||<=18 years|Age||Participants|Count of Participants|591|591.0||||||
4322688|NCT00459355|4150485|B3|||Functional Activities Questionnaire|Scores range from 0 - 30 with higher scores representing greater disability|Units on a scale|Mean|NA||Standard Deviation|NA||||Data are locked
4322689|NCT00459355|4150486|B2|||Functional Activities Questionnaire|Scores range from 0 - 30 with higher scores representing greater disability|Units on a scale|Mean|26.4|26.4|Standard Deviation|3.1|3.1|||
4322690|NCT00459355|4150487|B1|||Functional Activities Questionnaire|Scores range from 0 - 30 with higher scores representing greater disability|Units on a scale|Mean|25.8|25.8|Standard Deviation|4.1|4.1|||
4322691|NCT00459355|4150485|B3|||Mini Mental State Exam|Scores range from 0 - 30 with lower scores representing greater cognitive impairment|Units on a scale|Mean|NA||Standard Deviation|NA||||Data are locked
4322692|NCT00459355|4150486|B2|||Mini Mental State Exam|Scores range from 0 - 30 with lower scores representing greater cognitive impairment|Units on a scale|Mean|13.0|13.0|Standard Deviation|6.9|6.9|||
4322693|NCT00459355|4150487|B1|||Mini Mental State Exam|Scores range from 0 - 30 with lower scores representing greater cognitive impairment|Units on a scale|Mean|12.4|12.4|Standard Deviation|6.6|6.6|||
4322694|NCT00459355|4150485|B3|||Physical Self Maintenance Scale|Scores range from 6 - 30 with higher scores indicating greater disability|Units on a scale|Mean|NA||Standard Deviation|NA||||Data are locked
4322695|NCT00459355|4150486|B2|||Physical Self Maintenance Scale|Scores range from 6 - 30 with higher scores indicating greater disability|Units on a scale|Mean|15.1|15.1|Standard Deviation|4.0|4.0|||
4322696|NCT00459355|4150487|B1|||Physical Self Maintenance Scale|Scores range from 6 - 30 with higher scores indicating greater disability|Units on a scale|Mean|14.6|14.6|Standard Deviation|4.3|4.3|||
4322697|NCT00459355|4150485|B3|United States||Region of Enrollment||participants|Number|216|216.0||||||
4322698|NCT00459355|4150486|B2|United States||Region of Enrollment||participants|Number|96|96.0||||||
4322699|NCT00459355|4150487|B1|United States||Region of Enrollment||participants|Number|120|120.0||||||
4322700|NCT00459355|4150485|B3|Male||Gender|These are caregivers|participants|Number|21|21.0||||||
4322701|NCT00459355|4150486|B2|Male||Gender|These are caregivers|participants|Number|10|10.0||||||
4322702|NCT00459355|4150487|B1|Male||Gender|These are caregivers|participants|Number|11|11.0||||||
4322703|NCT00459355|4150485|B3|Female||Gender|These are caregivers|participants|Number|87|87.0||||||
4322704|NCT00459355|4150486|B2|Female||Gender|These are caregivers|participants|Number|38|38.0||||||
4322705|NCT00459355|4150487|B1|Female||Gender|These are caregivers|participants|Number|49|49.0||||||
4322706|NCT00459355|4150485|B3|Male||Gender|These are care recipients|participants|Number|94|94.0||||||
4322707|NCT00459355|4150486|B2|Male||Gender|These are care recipients|participants|Number|42|42.0||||||
4322708|NCT00459355|4150487|B1|Male||Gender|These are care recipients|participants|Number|52|52.0||||||
4322709|NCT00459355|4150485|B3|Female||Gender|These are care recipients|participants|Number|14|14.0||||||
4322710|NCT00459355|4150486|B2|Female||Gender|These are care recipients|participants|Number|6|6.0||||||
4322711|NCT00459355|4150487|B1|Female||Gender|These are care recipients|participants|Number|8|8.0||||||
4322712|NCT00459355|4150485|B3|care-recipient||Age||years|Mean|NA||Standard Deviation|NA||||Data are locked
4322713|NCT00459355|4150486|B2|care-recipient||Age||years|Mean|80.9|80.9|Standard Deviation|7.2|7.2|||
4322714|NCT00459355|4150487|B1|care-recipient||Age||years|Mean|80.4|80.4|Standard Deviation|6.7|6.7|||
4322715|NCT00459355|4150485|B3|caregiver||Age||years|Mean|NA||Standard Deviation|NA||||Data are locked
4322716|NCT00459355|4150486|B2|caregiver||Age||years|Mean|69.4|69.4|Standard Deviation|12.9|12.9|||
4322717|NCT00459355|4150487|B1|caregiver||Age||years|Mean|70.6|70.6|Standard Deviation|11.4|11.4|||
4322718|NCT00459342|4150500|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4322719|NCT00459342|4150500|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4322720|NCT00459342|4150500|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4322721|NCT00459342|4150500|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4322722|NCT00459342|4150500|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4322723|NCT00459342|4150500|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4322724|NCT00459342|4150500|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4322725|NCT00459342|4150500|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4322726|NCT00459342|4150500|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4322727|NCT00459342|4150500|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4322728|NCT00459342|4150500|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4322729|NCT00459342|4150500|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4322730|NCT00459342|4150500|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4322731|NCT00459342|4150500|B1|||Age||years|Median|69|69.0|Full Range|||51.0|79.0|
4322732|NCT00459316|4150505|B5|No ARV||Antiretroviral (ARV) Treatment at Entry||participants|Number|86|86.0||||||
4322733|NCT00459316|4150506|B4|No ARV||Antiretroviral (ARV) Treatment at Entry||participants|Number|6|6.0||||||
4322734|NCT00459316|4150507|B3|No ARV||Antiretroviral (ARV) Treatment at Entry||participants|Number|13|13.0||||||
4322735|NCT00459316|4150508|B2|No ARV||Antiretroviral (ARV) Treatment at Entry||participants|Number|30|30.0||||||
4322736|NCT00459316|4150509|B1|No ARV||Antiretroviral (ARV) Treatment at Entry||participants|Number|37|37.0||||||
4322737|NCT00459316|4150505|B5|Other ARV||Antiretroviral (ARV) Treatment at Entry||participants|Number|16|16.0||||||
4322738|NCT00459316|4150506|B4|Other ARV||Antiretroviral (ARV) Treatment at Entry||participants|Number|1|1.0||||||
4322739|NCT00459316|4150507|B3|Other ARV||Antiretroviral (ARV) Treatment at Entry||participants|Number|1|1.0||||||
4322740|NCT00459316|4150508|B2|Other ARV||Antiretroviral (ARV) Treatment at Entry||participants|Number|8|8.0||||||
4322741|NCT00459316|4150509|B1|Other ARV||Antiretroviral (ARV) Treatment at Entry||participants|Number|6|6.0||||||
4322742|NCT00459316|4150505|B5|HAART with NNRTI (no PI)||Antiretroviral (ARV) Treatment at Entry||participants|Number|65|65.0||||||
4322743|NCT00459316|4150506|B4|HAART with NNRTI (no PI)||Antiretroviral (ARV) Treatment at Entry||participants|Number|14|14.0||||||
4322744|NCT00459316|4150507|B3|HAART with NNRTI (no PI)||Antiretroviral (ARV) Treatment at Entry||participants|Number|3|3.0||||||
4322745|NCT00459316|4150508|B2|HAART with NNRTI (no PI)||Antiretroviral (ARV) Treatment at Entry||participants|Number|34|34.0||||||
4322746|NCT00459316|4150509|B1|HAART with NNRTI (no PI)||Antiretroviral (ARV) Treatment at Entry||participants|Number|14|14.0||||||
4322747|NCT00459316|4150505|B5|HAART with PI||Antiretroviral (ARV) Treatment at Entry||participants|Number|211|211.0||||||
4322748|NCT00459316|4150506|B4|HAART with PI||Antiretroviral (ARV) Treatment at Entry||participants|Number|38|38.0||||||
4322749|NCT00459316|4150507|B3|HAART with PI||Antiretroviral (ARV) Treatment at Entry||participants|Number|22|22.0||||||
4322750|NCT00459316|4150508|B2|HAART with PI||Antiretroviral (ARV) Treatment at Entry||participants|Number|81|81.0||||||
4322751|NCT00459316|4150509|B1|HAART with PI||Antiretroviral (ARV) Treatment at Entry||participants|Number|70|70.0||||||
4322752|NCT00459316|4150505|B5|Not C||CDC Classification at Study Entry||participants|Number|294|294.0||||||
4322753|NCT00459316|4150506|B4|Not C||CDC Classification at Study Entry||participants|Number|51|51.0||||||
4322754|NCT00459316|4150507|B3|Not C||CDC Classification at Study Entry||participants|Number|28|28.0||||||
4322755|NCT00459316|4150508|B2|Not C||CDC Classification at Study Entry||participants|Number|116|116.0||||||
4322756|NCT00459316|4150509|B1|Not C||CDC Classification at Study Entry||participants|Number|99|99.0||||||
4322757|NCT00459316|4150505|B5|C||CDC Classification at Study Entry||participants|Number|84|84.0||||||
4322758|NCT00459316|4150506|B4|C||CDC Classification at Study Entry||participants|Number|8|8.0||||||
4322759|NCT00459316|4150507|B3|C||CDC Classification at Study Entry||participants|Number|11|11.0||||||
4322760|NCT00459316|4150508|B2|C||CDC Classification at Study Entry||participants|Number|37|37.0||||||
4322761|NCT00459316|4150509|B1|C||CDC Classification at Study Entry||participants|Number|28|28.0||||||
4322762|NCT00459316|4150505|B5|≥ 400 copies/mL||Entry plasma HIV RNA viral load, copies/mL||participants|Number|214|214.0||||||
4322763|NCT00459316|4150506|B4|≥ 400 copies/mL||Entry plasma HIV RNA viral load, copies/mL||participants|Number|16|16.0||||||
4322764|NCT00459316|4150507|B3|≥ 400 copies/mL||Entry plasma HIV RNA viral load, copies/mL||participants|Number|36|36.0||||||
4322765|NCT00459316|4150508|B2|≥ 400 copies/mL||Entry plasma HIV RNA viral load, copies/mL||participants|Number|70|70.0||||||
4322766|NCT00459316|4150509|B1|≥ 400 copies/mL||Entry plasma HIV RNA viral load, copies/mL||participants|Number|92|92.0||||||
4322767|NCT00459316|4150505|B5|<400 copies/mL||Entry plasma HIV RNA viral load, copies/mL||participants|Number|164|164.0||||||
4322768|NCT00459316|4150506|B4|<400 copies/mL||Entry plasma HIV RNA viral load, copies/mL||participants|Number|43|43.0||||||
4322769|NCT00459316|4150507|B3|<400 copies/mL||Entry plasma HIV RNA viral load, copies/mL||participants|Number|3|3.0||||||
4322770|NCT00459316|4150508|B2|<400 copies/mL||Entry plasma HIV RNA viral load, copies/mL||participants|Number|83|83.0||||||
4322771|NCT00459316|4150509|B1|<400 copies/mL||Entry plasma HIV RNA viral load, copies/mL||participants|Number|35|35.0||||||
4322772|NCT00459316|4150505|B5|||Screening CD4%||percent|Median|27.9|27.9|Full Range|||1.0|56.0|
4322773|NCT00459316|4150506|B4|||Screening CD4%||percent|Median|36.0|36.0|Full Range|||25.0|56.0|
4322774|NCT00459316|4150507|B3|||Screening CD4%||percent|Median|8.5|8.5|Full Range|||1.0|14.0|
4322775|NCT00459316|4150508|B2|||Screening CD4%||percent|Median|33.0|33.0|Full Range|||25.0|53.1|
4322776|NCT00459316|4150509|B1|||Screening CD4%||percent|Median|20.0|20.0|Full Range|||14.0|24.9|
4322777|NCT00459316|4150505|B5|Unknown||Ethnicity||participants|Number|4|4.0||||||
4322778|NCT00459316|4150506|B4|Unknown||Ethnicity||participants|Number|1|1.0||||||
4322779|NCT00459316|4150507|B3|Unknown||Ethnicity||participants|Number|0|0.0||||||
4322780|NCT00459316|4150508|B2|Unknown||Ethnicity||participants|Number|3|3.0||||||
4322781|NCT00459316|4150509|B1|Unknown||Ethnicity||participants|Number|0|0.0||||||
4322782|NCT00459316|4150505|B5|Not Hispanic or Latino||Ethnicity||participants|Number|235|235.0||||||
4322783|NCT00459316|4150506|B4|Not Hispanic or Latino||Ethnicity||participants|Number|40|40.0||||||
4322784|NCT00459316|4150507|B3|Not Hispanic or Latino||Ethnicity||participants|Number|23|23.0||||||
4322785|NCT00459316|4150508|B2|Not Hispanic or Latino||Ethnicity||participants|Number|89|89.0||||||
4322786|NCT00459316|4150509|B1|Not Hispanic or Latino||Ethnicity||participants|Number|83|83.0||||||
4322787|NCT00459316|4150505|B5|Hispanic or Latino||Ethnicity||participants|Number|139|139.0||||||
4322788|NCT00459316|4150506|B4|Hispanic or Latino||Ethnicity||participants|Number|18|18.0||||||
4322789|NCT00459316|4150507|B3|Hispanic or Latino||Ethnicity||participants|Number|16|16.0||||||
4322790|NCT00459316|4150508|B2|Hispanic or Latino||Ethnicity||participants|Number|61|61.0||||||
4322791|NCT00459316|4150509|B1|Hispanic or Latino||Ethnicity||participants|Number|44|44.0||||||
4322792|NCT00459316|4150505|B5|Unknown||Race||participants|Number|8|8.0||||||
4322793|NCT00459316|4150506|B4|Unknown||Race||participants|Number|1|1.0||||||
4322794|NCT00459316|4150507|B3|Unknown||Race||participants|Number|1|1.0||||||
4322795|NCT00459316|4150508|B2|Unknown||Race||participants|Number|2|2.0||||||
4322796|NCT00459316|4150509|B1|Unknown||Race||participants|Number|4|4.0||||||
4322797|NCT00459316|4150505|B5|More than One race||Race||participants|Number|5|5.0||||||
4322798|NCT00459316|4150506|B4|More than One race||Race||participants|Number|0|0.0||||||
4322799|NCT00459316|4150507|B3|More than One race||Race||participants|Number|2|2.0||||||
4322800|NCT00459316|4150508|B2|More than One race||Race||participants|Number|3|3.0||||||
4322801|NCT00459316|4150509|B1|More than One race||Race||participants|Number|0|0.0||||||
4322802|NCT00459316|4150505|B5|American Indian||Race||participants|Number|5|5.0||||||
4322803|NCT00459316|4150506|B4|American Indian||Race||participants|Number|0|0.0||||||
4322804|NCT00459316|4150507|B3|American Indian||Race||participants|Number|0|0.0||||||
4322805|NCT00459316|4150508|B2|American Indian||Race||participants|Number|3|3.0||||||
4322806|NCT00459316|4150509|B1|American Indian||Race||participants|Number|2|2.0||||||
4322807|NCT00459316|4150505|B5|White||Race||participants|Number|157|157.0||||||
4322808|NCT00459316|4150506|B4|White||Race||participants|Number|21|21.0||||||
4322809|NCT00459316|4150507|B3|White||Race||participants|Number|14|14.0||||||
4322810|NCT00459316|4150508|B2|White||Race||participants|Number|75|75.0||||||
4322811|NCT00459316|4150509|B1|White||Race||participants|Number|47|47.0||||||
4322812|NCT00459316|4150505|B5|Black or African American||Race||participants|Number|197|197.0||||||
4322813|NCT00459316|4150506|B4|Black or African American||Race||participants|Number|34|34.0||||||
4322814|NCT00459316|4150507|B3|Black or African American||Race||participants|Number|22|22.0||||||
4322815|NCT00459316|4150508|B2|Black or African American||Race||participants|Number|69|69.0||||||
4322816|NCT00459316|4150509|B1|Black or African American||Race||participants|Number|72|72.0||||||
4322817|NCT00459316|4150505|B5|Native Hawaiian or other Pacific islander||Race||participants|Number|2|2.0||||||
4322818|NCT00459316|4150506|B4|Native Hawaiian or other Pacific islander||Race||participants|Number|1|1.0||||||
4322819|NCT00459316|4150507|B3|Native Hawaiian or other Pacific islander||Race||participants|Number|0|0.0||||||
4322820|NCT00459316|4150508|B2|Native Hawaiian or other Pacific islander||Race||participants|Number|0|0.0||||||
4322821|NCT00459316|4150509|B1|Native Hawaiian or other Pacific islander||Race||participants|Number|1|1.0||||||
4322822|NCT00459316|4150505|B5|Asian||Race||participants|Number|4|4.0||||||
4322823|NCT00459316|4150506|B4|Asian||Race||participants|Number|2|2.0||||||
4322824|NCT00459316|4150507|B3|Asian||Race||participants|Number|0|0.0||||||
4322825|NCT00459316|4150508|B2|Asian||Race||participants|Number|1|1.0||||||
4322826|NCT00459316|4150509|B1|Asian||Race||participants|Number|1|1.0||||||
4322827|NCT00459316|4150505|B5||Male|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
4322828|NCT00459316|4150506|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4322829|NCT00459316|4150507|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4322830|NCT00459316|4150508|B2||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4322831|NCT00459316|4150509|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4322832|NCT00459316|4150505|B5||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4322833|NCT00459316|4150506|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4322834|NCT00459316|4150507|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4322835|NCT00459316|4150508|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4322836|NCT00459316|4150509|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4322837|NCT00459316|4150505|B5|||Age||years|Median|16|16.0|Full Range|||2.0|24.0|
4322838|NCT00459316|4150506|B4|||Age||years|Median|6|6.0|Full Range|||2.0|10.0|
4322839|NCT00459316|4150507|B3|||Age||years|Median|20|20.0|Full Range|||14.0|24.0|
4322840|NCT00459316|4150508|B2|||Age||years|Median|16|16.0|Full Range|||11.0|24.0|
4322841|NCT00459316|4150509|B1|||Age||years|Median|18|18.0|Full Range|||11.0|24.0|
4322842|NCT00459303|4150565|B1|Taiwan||Region of Enrollment||participants|Number|20|20.0||||||
4322843|NCT00459303|4150565|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4322844|NCT00459303|4150565|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4322845|NCT00459303|4150565|B1|||Age||years|Mean|70.4|70.4|Standard Deviation|9.34|9.34|||
4322846|NCT00459303|4150565|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4322847|NCT00459303|4150565|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4322848|NCT00459303|4150565|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4322849|NCT00459290|4150576|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4322850|NCT00459290|4150576|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4322851|NCT00459290|4150576|B1|80-89 years||Age, Customized||participants|Number|1|1.0||||||
4322852|NCT00459290|4150576|B1|70-79 years||Age, Customized||participants|Number|6|6.0||||||
4322853|NCT00459290|4150576|B1|60-69 years||Age, Customized||participants|Number|8|8.0||||||
4322854|NCT00459290|4150576|B1|50-59 years||Age, Customized||participants|Number|6|6.0||||||
4322855|NCT00459290|4150576|B1|40-49 years||Age, Customized||participants|Number|1|1.0||||||
4322856|NCT00459186|4150591|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4322857|NCT00459186|4150591|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4322858|NCT00459186|4150591|B1|||Age||years|Median|62|62.0|Full Range|||50.0|79.0|
4322859|NCT00459134|4150596|B3|United States||Region of Enrollment||participants|Number|186|186.0||||||
4322860|NCT00459134|4150597|B2|United States||Region of Enrollment||participants|Number|92|92.0||||||
4322861|NCT00459134|4150598|B1|United States||Region of Enrollment||participants|Number|94|94.0||||||
4322862|NCT00459134|4150596|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4322863|NCT00459134|4150597|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4322864|NCT00459134|4150598|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4322865|NCT00459134|4150596|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4322866|NCT00459134|4150597|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4322867|NCT00459134|4150598|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4322868|NCT00459134|4150596|B3||White|Race (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
4322869|NCT00459134|4150597|B2||White|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
4322870|NCT00459134|4150598|B1||White|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
4322871|NCT00459134|4150596|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4322872|NCT00459134|4150597|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4322873|NCT00459134|4150598|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4322874|NCT00459134|4150596|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4322875|NCT00459134|4150597|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4322876|NCT00459134|4150598|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4322877|NCT00459134|4150596|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4322878|NCT00459134|4150597|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4322879|NCT00459134|4150598|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4322880|NCT00459134|4150596|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4322881|NCT00459134|4150597|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4322882|NCT00459134|4150598|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4322883|NCT00459134|4150596|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4322884|NCT00459134|4150597|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4322885|NCT00459134|4150598|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4322886|NCT00459134|4150596|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|176|176.0||||||
4322887|NCT00459134|4150597|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
4322888|NCT00459134|4150598|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
4322889|NCT00459134|4150596|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4322890|NCT00459134|4150597|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4322891|NCT00459134|4150598|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4322892|NCT00459134|4150596|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4322893|NCT00459134|4150597|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4322894|NCT00459134|4150598|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4322895|NCT00459134|4150596|B3||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4322896|NCT00459134|4150597|B2||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4322897|NCT00459134|4150598|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4322898|NCT00459134|4150596|B3|||Age||years|Median|50|50.0|Full Range|||23.0|72.0|
4322899|NCT00459134|4150597|B2|||Age||years|Median|49|49.0|Full Range|||23.0|71.0|
4322900|NCT00459134|4150598|B1|||Age||years|Median|51|51.0|Full Range|||28.0|72.0|
4322901|NCT00459134|4150596|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4322902|NCT00459134|4150597|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4322903|NCT00459134|4150598|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4322904|NCT00459134|4150596|B3||Between 18 and 65 years|Age||Participants|Count of Participants|169|169.0||||||
4322905|NCT00459134|4150597|B2||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
4322906|NCT00459134|4150598|B1||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
4322907|NCT00459134|4150596|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4322908|NCT00459134|4150597|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4322909|NCT00459134|4150598|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4322910|NCT00459121|4150607|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4322911|NCT00459121|4150607|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4322912|NCT00459121|4150607|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4322913|NCT00459121|4150607|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|0|0.0|||
4322914|NCT00459121|4150607|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4322915|NCT00459121|4150607|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4322916|NCT00459121|4150607|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4322917|NCT00459108|4150611|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4322918|NCT00459108|4150611|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4322919|NCT00459108|4150611|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4322920|NCT00459108|4150611|B1|||Age||years|Median|61|61.0|Full Range|||27.0|85.0|
4322921|NCT00459056|4150619|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4322922|NCT00459056|4150620|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4322923|NCT00459056|4150621|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4322924|NCT00459056|4150619|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4322925|NCT00459056|4150620|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4322926|NCT00459056|4150621|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4322927|NCT00459056|4150619|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4322928|NCT00459056|4150620|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4322929|NCT00459056|4150621|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4322930|NCT00459056|4150619|B3|||Age||years|Mean|54.0|54.0|Standard Deviation|7.5|7.5|||
4322931|NCT00459056|4150620|B2|||Age||years|Mean|54.9|54.9|Standard Deviation|6.39|6.39|||
4322932|NCT00459056|4150621|B1|||Age||years|Mean|52.7|52.7|Standard Deviation|9.21|9.21|||
4322933|NCT00459056|4150619|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4322934|NCT00459056|4150620|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4322935|NCT00459056|4150621|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4322936|NCT00459056|4150619|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4322937|NCT00459056|4150620|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4322938|NCT00459056|4150621|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4322939|NCT00459056|4150619|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4322940|NCT00459056|4150620|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4322941|NCT00459056|4150621|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4322942|NCT00459043|4150628|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
4322943|NCT00459043|4150629|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4322944|NCT00459043|4150630|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4322945|NCT00459043|4150628|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4322946|NCT00459043|4150629|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4322947|NCT00459043|4150630|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4322948|NCT00459043|4150628|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4322949|NCT00459043|4150629|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4322950|NCT00459043|4150630|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4322951|NCT00459043|4150628|B3|||Age||years|Mean|58|58.0|Standard Deviation|46|46.0|||
4322952|NCT00459043|4150629|B2|||Age||years|Mean|60|60.0|Standard Deviation|35|35.0|||
4322953|NCT00459043|4150630|B1|||Age||years|Mean|56|56.0|Standard Deviation|42|42.0|||
4322954|NCT00459043|4150628|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4322955|NCT00459043|4150629|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4322956|NCT00459043|4150630|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4322957|NCT00459043|4150628|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4322958|NCT00459043|4150629|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4322959|NCT00459043|4150630|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4322960|NCT00459043|4150628|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4322961|NCT00459043|4150629|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4322962|NCT00459043|4150630|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4322963|NCT00458952|4150641|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4322964|NCT00458952|4150642|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4322965|NCT00458952|4150643|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4322966|NCT00458952|4150641|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4322967|NCT00458952|4150642|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4322968|NCT00458952|4150643|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4322969|NCT00458952|4150641|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4322970|NCT00458952|4150642|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4322971|NCT00458952|4150643|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4322972|NCT00458952|4150641|B3|||Age||years|Mean|50.4|50.4|Standard Deviation|13.02|13.02|||
4322973|NCT00458952|4150642|B2|||Age||years|Mean|52.4|52.4|Standard Deviation|11.41|11.41|||
4322974|NCT00458952|4150643|B1|||Age||years|Mean|46.4|46.4|Standard Deviation|15.99|15.99|||
4322975|NCT00458952|4150641|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4322976|NCT00458952|4150642|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4322977|NCT00458952|4150643|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4322978|NCT00458952|4150641|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4322979|NCT00458952|4150642|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4322980|NCT00458952|4150643|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4322981|NCT00458952|4150641|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4322982|NCT00458952|4150642|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4322983|NCT00458952|4150643|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4322984|NCT00458822|4150648|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4322985|NCT00458822|4150648|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4322986|NCT00458822|4150648|B1|||Age||years|Median|57|57.0|Full Range|||38.0|67.0|
4322987|NCT00458705|4150652|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4322988|NCT00458705|4150652|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4322989|NCT00458705|4150652|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4322990|NCT00458705|4150652|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4322991|NCT00458705|4150652|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4322992|NCT00458705|4150652|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4322993|NCT00458536|4150656|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4322994|NCT00458536|4150656|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4322995|NCT00458536|4150656|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4322996|NCT00458536|4150656|B1|||Age, Customized||years|Median|56|56.0|Full Range|||43.0|79.0|
4322997|NCT00458406|4150660|B3|United States||Region of Enrollment||participants|Number|56|56.0||||||
4322998|NCT00458406|4150661|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4322999|NCT00458406|4150662|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4323000|NCT00458406|4150660|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4323001|NCT00458406|4150661|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4323002|NCT00458406|4150662|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4323003|NCT00458406|4150660|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4323004|NCT00458406|4150661|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4323005|NCT00458406|4150662|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4323006|NCT00458406|4150660|B3|||Age||years|Mean|12|12.0|Standard Deviation|4|4.0|||
4323007|NCT00458406|4150661|B2|||Age||years|Mean|12|12.0|Standard Deviation|4|4.0|||
4323008|NCT00458406|4150662|B1|||Age||years|Mean|12|12.0|Standard Deviation|4|4.0|||
4323009|NCT00458406|4150660|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4323010|NCT00458406|4150661|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4323011|NCT00458406|4150662|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4323012|NCT00458406|4150660|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4323013|NCT00458406|4150661|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4323014|NCT00458406|4150662|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4323015|NCT00458406|4150660|B3||<=18 years|Age||Participants|Count of Participants|56|56.0||||||
4323016|NCT00458406|4150661|B2||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4323017|NCT00458406|4150662|B1||<=18 years|Age||Participants|Count of Participants|43|43.0||||||
4323018|NCT00458393|4150681|B3|Peru||Region of Enrollment||participants|Number|1400|1400.0||||||
4323019|NCT00458393|4150682|B2|Peru||Region of Enrollment||participants|Number|700|700.0||||||
4323020|NCT00458393|4150683|B1|Peru||Region of Enrollment||participants|Number|700|700.0||||||
4323021|NCT00458393|4150681|B3|Thailand||Region of Enrollment||participants|Number|114|114.0||||||
4323022|NCT00458393|4150682|B2|Thailand||Region of Enrollment||participants|Number|57|57.0||||||
4323023|NCT00458393|4150683|B1|Thailand||Region of Enrollment||participants|Number|57|57.0||||||
4323024|NCT00458393|4150681|B3|South Africa||Region of Enrollment||participants|Number|88|88.0||||||
4323025|NCT00458393|4150682|B2|South Africa||Region of Enrollment||participants|Number|43|43.0||||||
4323026|NCT00458393|4150683|B1|South Africa||Region of Enrollment||participants|Number|45|45.0||||||
4323027|NCT00458393|4150681|B3|Brazil||Region of Enrollment||participants|Number|370|370.0||||||
4323028|NCT00458393|4150682|B2|Brazil||Region of Enrollment||participants|Number|184|184.0||||||
4323029|NCT00458393|4150683|B1|Brazil||Region of Enrollment||participants|Number|186|186.0||||||
4323030|NCT00458393|4150681|B3|United States||Region of Enrollment||participants|Number|227|227.0||||||
4323031|NCT00458393|4150682|B2|United States||Region of Enrollment||participants|Number|114|114.0||||||
4323032|NCT00458393|4150683|B1|United States||Region of Enrollment||participants|Number|113|113.0||||||
4323033|NCT00458393|4150681|B3|Ecuador||Region of Enrollment||participants|Number|300|300.0||||||
4323034|NCT00458393|4150682|B2|Ecuador||Region of Enrollment||participants|Number|150|150.0||||||
4323035|NCT00458393|4150683|B1|Ecuador||Region of Enrollment||participants|Number|150|150.0||||||
4323036|NCT00458393|4150681|B3|Male Sex at Birth. Identify Male||Sex/Gender, Customized||Participants|Count of Participants|2160|2160.0||||||
4323037|NCT00458393|4150682|B2|Male Sex at Birth. Identify Male||Sex/Gender, Customized||Participants|Count of Participants|1079|1079.0||||||
4323038|NCT00458393|4150683|B1|Male Sex at Birth. Identify Male||Sex/Gender, Customized||Participants|Count of Participants|1081|1081.0||||||
4323039|NCT00458393|4150681|B3|Male Sex at Birth. Identify Female||Sex/Gender, Customized||Participants|Count of Participants|29|29.0||||||
4323040|NCT00458393|4150682|B2|Male Sex at Birth. Identify Female||Sex/Gender, Customized||Participants|Count of Participants|14|14.0||||||
4323041|NCT00458393|4150683|B1|Male Sex at Birth. Identify Female||Sex/Gender, Customized||Participants|Count of Participants|15|15.0||||||
4323042|NCT00458393|4150681|B3|Male Sex at Birth. Identify Trans||Sex/Gender, Customized||Participants|Count of Participants|310|310.0||||||
4323043|NCT00458393|4150682|B2|Male Sex at Birth. Identify Trans||Sex/Gender, Customized||Participants|Count of Participants|155|155.0||||||
4323044|NCT00458393|4150683|B1|Male Sex at Birth. Identify Trans||Sex/Gender, Customized||Participants|Count of Participants|155|155.0||||||
4323045|NCT00458393|4150681|B3|||Age||years|Median|24|24.0|Full Range|||18.0|67.0|
4323046|NCT00458393|4150682|B2|||Age||years|Median|24|24.0|Full Range|||18.0|63.0|
4323047|NCT00458393|4150683|B1|||Age||years|Median|25|25.0|Full Range|||18.0|67.0|
4323048|NCT00458393|4150681|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4323049|NCT00458393|4150682|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4323050|NCT00458393|4150683|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4323051|NCT00458393|4150681|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2305|2305.0||||||
4323052|NCT00458393|4150682|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1147|1147.0||||||
4323053|NCT00458393|4150683|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1158|1158.0||||||
4323054|NCT00458393|4150681|B3||<=18 years|Age||Participants|Count of Participants|193|193.0||||||
4323055|NCT00458393|4150682|B2||<=18 years|Age||Participants|Count of Participants|101|101.0||||||
4323056|NCT00458393|4150683|B1||<=18 years|Age||Participants|Count of Participants|92|92.0||||||
4323057|NCT00458302|4150730|B3|||CD4+ cell count (absolute count)||cells/µl|Median|573.5|573.5|Full Range|||162.0|1888.0|
4323058|NCT00458302|4150731|B2|||CD4+ cell count (absolute count)||cells/µl|Median|571.0|571.0|Full Range|||162.0|1451.0|
4323059|NCT00458302|4150732|B1|||CD4+ cell count (absolute count)||cells/µl|Median|579.0|579.0|Full Range|||163.0|1888.0|
4323060|NCT00458302|4150730|B3|> 1000||plasma viral load|plasma viral load (HIV-1 RNA copies/ml)|participants|Number|2|2.0||||||
4323061|NCT00458302|4150731|B2|> 1000||plasma viral load|plasma viral load (HIV-1 RNA copies/ml)|participants|Number|2|2.0||||||
4323062|NCT00458302|4150732|B1|> 1000||plasma viral load|plasma viral load (HIV-1 RNA copies/ml)|participants|Number|0|0.0||||||
4323063|NCT00458302|4150730|B3|400-1000||plasma viral load|plasma viral load (HIV-1 RNA copies/ml)|participants|Number|0|0.0||||||
4323064|NCT00458302|4150731|B2|400-1000||plasma viral load|plasma viral load (HIV-1 RNA copies/ml)|participants|Number|0|0.0||||||
4323065|NCT00458302|4150732|B1|400-1000||plasma viral load|plasma viral load (HIV-1 RNA copies/ml)|participants|Number|0|0.0||||||
4323066|NCT00458302|4150730|B3|50-400||plasma viral load|plasma viral load (HIV-1 RNA copies/ml)|participants|Number|11|11.0||||||
4323067|NCT00458302|4150731|B2|50-400||plasma viral load|plasma viral load (HIV-1 RNA copies/ml)|participants|Number|7|7.0||||||
4323068|NCT00458302|4150732|B1|50-400||plasma viral load|plasma viral load (HIV-1 RNA copies/ml)|participants|Number|4|4.0||||||
4323069|NCT00458302|4150730|B3|< 50||plasma viral load|plasma viral load (HIV-1 RNA copies/ml)|participants|Number|243|243.0||||||
4323070|NCT00458302|4150731|B2|< 50||plasma viral load|plasma viral load (HIV-1 RNA copies/ml)|participants|Number|118|118.0||||||
4323071|NCT00458302|4150732|B1|< 50||plasma viral load|plasma viral load (HIV-1 RNA copies/ml)|participants|Number|125|125.0||||||
4323072|NCT00458302|4150730|B3|UNITED KINGDOM||Region of Enrollment||participants|Number|21|21.0||||||
4323073|NCT00458302|4150731|B2|UNITED KINGDOM||Region of Enrollment||participants|Number|9|9.0||||||
4323074|NCT00458302|4150732|B1|UNITED KINGDOM||Region of Enrollment||participants|Number|12|12.0||||||
4323075|NCT00458302|4150730|B3|SWITZERLAND||Region of Enrollment||participants|Number|2|2.0||||||
4323076|NCT00458302|4150731|B2|SWITZERLAND||Region of Enrollment||participants|Number|1|1.0||||||
4323077|NCT00458302|4150732|B1|SWITZERLAND||Region of Enrollment||participants|Number|1|1.0||||||
4323078|NCT00458302|4150730|B3|SPAIN||Region of Enrollment||participants|Number|48|48.0||||||
4323079|NCT00458302|4150731|B2|SPAIN||Region of Enrollment||participants|Number|24|24.0||||||
4323080|NCT00458302|4150732|B1|SPAIN||Region of Enrollment||participants|Number|24|24.0||||||
4323081|NCT00458302|4150730|B3|RUSSIAN FEDERATION||Region of Enrollment||participants|Number|11|11.0||||||
4323082|NCT00458302|4150731|B2|RUSSIAN FEDERATION||Region of Enrollment||participants|Number|2|2.0||||||
4323083|NCT00458302|4150732|B1|RUSSIAN FEDERATION||Region of Enrollment||participants|Number|9|9.0||||||
4323084|NCT00458302|4150730|B3|PORTUGAL||Region of Enrollment||participants|Number|14|14.0||||||
4323085|NCT00458302|4150731|B2|PORTUGAL||Region of Enrollment||participants|Number|7|7.0||||||
4323086|NCT00458302|4150732|B1|PORTUGAL||Region of Enrollment||participants|Number|7|7.0||||||
4323087|NCT00458302|4150730|B3|POLAND||Region of Enrollment||participants|Number|29|29.0||||||
4323088|NCT00458302|4150731|B2|POLAND||Region of Enrollment||participants|Number|20|20.0||||||
4323089|NCT00458302|4150732|B1|POLAND||Region of Enrollment||participants|Number|9|9.0||||||
4323090|NCT00458302|4150730|B3|ITALY||Region of Enrollment||participants|Number|16|16.0||||||
4323091|NCT00458302|4150731|B2|ITALY||Region of Enrollment||participants|Number|5|5.0||||||
4323092|NCT00458302|4150732|B1|ITALY||Region of Enrollment||participants|Number|11|11.0||||||
4323093|NCT00458302|4150730|B3|ISRAEL||Region of Enrollment||participants|Number|8|8.0||||||
4323094|NCT00458302|4150731|B2|ISRAEL||Region of Enrollment||participants|Number|7|7.0||||||
4323095|NCT00458302|4150732|B1|ISRAEL||Region of Enrollment||participants|Number|1|1.0||||||
4323096|NCT00458302|4150730|B3|HUNGARY||Region of Enrollment||participants|Number|11|11.0||||||
4323097|NCT00458302|4150731|B2|HUNGARY||Region of Enrollment||participants|Number|5|5.0||||||
4323098|NCT00458302|4150732|B1|HUNGARY||Region of Enrollment||participants|Number|6|6.0||||||
4323099|NCT00458302|4150730|B3|GERMANY||Region of Enrollment||participants|Number|28|28.0||||||
4323100|NCT00458302|4150731|B2|GERMANY||Region of Enrollment||participants|Number|14|14.0||||||
4323101|NCT00458302|4150732|B1|GERMANY||Region of Enrollment||participants|Number|14|14.0||||||
4323102|NCT00458302|4150730|B3|DENMARK||Region of Enrollment||participants|Number|28|28.0||||||
4323103|NCT00458302|4150731|B2|DENMARK||Region of Enrollment||participants|Number|14|14.0||||||
4323104|NCT00458302|4150732|B1|DENMARK||Region of Enrollment||participants|Number|14|14.0||||||
4323105|NCT00458302|4150730|B3|BELGIUM||Region of Enrollment||participants|Number|24|24.0||||||
4323106|NCT00458302|4150731|B2|BELGIUM||Region of Enrollment||participants|Number|12|12.0||||||
4323107|NCT00458302|4150732|B1|BELGIUM||Region of Enrollment||participants|Number|12|12.0||||||
4323108|NCT00458302|4150730|B3|AUSTRIA||Region of Enrollment||participants|Number|16|16.0||||||
4323109|NCT00458302|4150731|B2|AUSTRIA||Region of Enrollment||participants|Number|7|7.0||||||
4323110|NCT00458302|4150732|B1|AUSTRIA||Region of Enrollment||participants|Number|9|9.0||||||
4323111|NCT00458302|4150730|B3||Male|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
4323112|NCT00458302|4150731|B2||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4323113|NCT00458302|4150732|B1||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4323114|NCT00458302|4150730|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4323115|NCT00458302|4150731|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4323116|NCT00458302|4150732|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4323117|NCT00458302|4150730|B3|||Age||years|Mean|43.7|43.7|Standard Deviation|9.43|9.43|||
4323118|NCT00458302|4150731|B2|||Age||years|Mean|43.4|43.4|Standard Deviation|9.14|9.14|||
4323119|NCT00458302|4150732|B1|||Age||years|Mean|44.1|44.1|Standard Deviation|9.74|9.74|||
4323120|NCT00458302|4150730|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4323121|NCT00458302|4150731|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4323122|NCT00458302|4150732|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4323123|NCT00458302|4150730|B3||Between 18 and 65 years|Age||Participants|Count of Participants|253|253.0||||||
4323124|NCT00458302|4150731|B2||Between 18 and 65 years|Age||Participants|Count of Participants|125|125.0||||||
4323125|NCT00458302|4150732|B1||Between 18 and 65 years|Age||Participants|Count of Participants|128|128.0||||||
4323126|NCT00458302|4150730|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4323127|NCT00458302|4150731|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4323128|NCT00458302|4150732|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4323129|NCT00458237|4150764|B4|United States||Region of Enrollment||participants|Number|11|11.0||||||
4323130|NCT00458237|4150765|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4323131|NCT00458237|4150766|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4323132|NCT00458237|4150767|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4323133|NCT00458237|4150764|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4323134|NCT00458237|4150765|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4323135|NCT00458237|4150766|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4323136|NCT00458237|4150767|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4323137|NCT00458237|4150764|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4323138|NCT00458237|4150765|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4323139|NCT00458237|4150766|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4323140|NCT00458237|4150767|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4323141|NCT00458237|4150764|B4|||Age||years|Mean|45|45.0|Full Range|||28.0|61.0|
4323142|NCT00458237|4150765|B3|||Age||years|Mean|42|42.0|Full Range|||28.0|54.0|
4323143|NCT00458237|4150766|B2|||Age||years|Mean|42|42.0|Full Range|||40.0|43.0|
4323144|NCT00458237|4150767|B1|||Age||years|Mean|53|53.0|Full Range|||43.0|61.0|
4323145|NCT00458211|4150778|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4323146|NCT00458211|4150778|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4323147|NCT00458211|4150778|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4323148|NCT00458211|4150778|B1|||Age||years|Mean|42|42.0|Standard Deviation|15|15.0|||
4323149|NCT00458211|4150778|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4323150|NCT00458211|4150778|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4323151|NCT00458211|4150778|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4323152|NCT00457977|4150789|B3|Previously Vaccinated||Vaccine Naive||participants|Number|94|94.0||||||
4323153|NCT00457977|4150790|B2|Previously Vaccinated||Vaccine Naive||participants|Number|46|46.0||||||
4323154|NCT00457977|4150791|B1|Previously Vaccinated||Vaccine Naive||participants|Number|48|48.0||||||
4323155|NCT00457977|4150789|B3|Vaccine Naive||Vaccine Naive||participants|Number|87|87.0||||||
4323156|NCT00457977|4150790|B2|Vaccine Naive||Vaccine Naive||participants|Number|45|45.0||||||
4323157|NCT00457977|4150791|B1|Vaccine Naive||Vaccine Naive||participants|Number|42|42.0||||||
4323158|NCT00457977|4150789|B3|Non-Current Smoker||Current Smoker||participants|Number|116|116.0||||||
4323159|NCT00457977|4150790|B2|Non-Current Smoker||Current Smoker||participants|Number|58|58.0||||||
4323160|NCT00457977|4150791|B1|Non-Current Smoker||Current Smoker||participants|Number|58|58.0||||||
4323161|NCT00457977|4150789|B3|Current Smoker||Current Smoker||participants|Number|65|65.0||||||
4323162|NCT00457977|4150790|B2|Current Smoker||Current Smoker||participants|Number|33|33.0||||||
4323163|NCT00457977|4150791|B1|Current Smoker||Current Smoker||participants|Number|32|32.0||||||
4323164|NCT00457977|4150789|B3|||Pack years smoking||pack years|Mean|53.4|53.4|Standard Deviation|27.3|27.3|||
4323165|NCT00457977|4150790|B2|||Pack years smoking||pack years|Mean|52.0|52.0|Standard Deviation|27.6|27.6|||
4323166|NCT00457977|4150791|B1|||Pack years smoking||pack years|Mean|54.9|54.9|Standard Deviation|27.1|27.1|||
4323167|NCT00457977|4150789|B3|Non-oxygen user||Oxygen use at baseline||participants|Number|131|131.0||||||
4323168|NCT00457977|4150790|B2|Non-oxygen user||Oxygen use at baseline||participants|Number|70|70.0||||||
4323169|NCT00457977|4150791|B1|Non-oxygen user||Oxygen use at baseline||participants|Number|61|61.0||||||
4323170|NCT00457977|4150789|B3|Oxygen User||Oxygen use at baseline||participants|Number|50|50.0||||||
4323171|NCT00457977|4150790|B2|Oxygen User||Oxygen use at baseline||participants|Number|21|21.0||||||
4323172|NCT00457977|4150791|B1|Oxygen User||Oxygen use at baseline||participants|Number|29|29.0||||||
4323173|NCT00457977|4150789|B3|More than one||Race||participants|Number|3|3.0||||||
4323174|NCT00457977|4150790|B2|More than one||Race||participants|Number|0|0.0||||||
4323175|NCT00457977|4150791|B1|More than one||Race||participants|Number|3|3.0||||||
4323176|NCT00457977|4150789|B3|Pacific Islander||Race||participants|Number|1|1.0||||||
4323177|NCT00457977|4150790|B2|Pacific Islander||Race||participants|Number|0|0.0||||||
4323178|NCT00457977|4150791|B1|Pacific Islander||Race||participants|Number|1|1.0||||||
4323179|NCT00457977|4150789|B3|Native American||Race||participants|Number|1|1.0||||||
4323180|NCT00457977|4150790|B2|Native American||Race||participants|Number|1|1.0||||||
4323181|NCT00457977|4150791|B1|Native American||Race||participants|Number|0|0.0||||||
4323182|NCT00457977|4150789|B3|Asian||Race||participants|Number|2|2.0||||||
4323183|NCT00457977|4150790|B2|Asian||Race||participants|Number|2|2.0||||||
4323184|NCT00457977|4150791|B1|Asian||Race||participants|Number|0|0.0||||||
4323185|NCT00457977|4150789|B3|African American||Race||participants|Number|36|36.0||||||
4323186|NCT00457977|4150790|B2|African American||Race||participants|Number|18|18.0||||||
4323187|NCT00457977|4150791|B1|African American||Race||participants|Number|18|18.0||||||
4323188|NCT00457977|4150789|B3|Caucasian||Race||participants|Number|138|138.0||||||
4323189|NCT00457977|4150790|B2|Caucasian||Race||participants|Number|70|70.0||||||
4323190|NCT00457977|4150791|B1|Caucasian||Race||participants|Number|68|68.0||||||
4323191|NCT00457977|4150789|B3|||forced expiratory volume at one second/forced vital capacity (FEV1/FVC)||percentage of FEV1/FVC|Mean|45.4|45.4|Standard Deviation|12.5|12.5|||
4323192|NCT00457977|4150790|B2|||forced expiratory volume at one second/forced vital capacity (FEV1/FVC)||percentage of FEV1/FVC|Mean|45.8|45.8|Standard Deviation|12.6|12.6|||
4323193|NCT00457977|4150791|B1|||forced expiratory volume at one second/forced vital capacity (FEV1/FVC)||percentage of FEV1/FVC|Mean|45.0|45.0|Standard Deviation|12.5|12.5|||
4323194|NCT00457977|4150789|B3|||FEV1 (% Predicted)||percent predicted|Mean|44.8|44.8|Standard Deviation|14.9|14.9|||
4323195|NCT00457977|4150790|B2|||FEV1 (% Predicted)||percent predicted|Mean|44.9|44.9|Standard Deviation|14.7|14.7|||
4323196|NCT00457977|4150791|B1|||FEV1 (% Predicted)||percent predicted|Mean|44.8|44.8|Standard Deviation|15.1|15.1|||
4323197|NCT00457977|4150789|B3|||Forced expiratory volume at one second (FEV1)||LIters (L)|Mean|1.30|1.3|Standard Deviation|0.51|0.51|||
4323198|NCT00457977|4150790|B2|||Forced expiratory volume at one second (FEV1)||LIters (L)|Mean|1.33|1.33|Standard Deviation|0.53|0.53|||
4323199|NCT00457977|4150791|B1|||Forced expiratory volume at one second (FEV1)||LIters (L)|Mean|1.27|1.27|Standard Deviation|0.50|0.5|||
4323200|NCT00457977|4150789|B3|United States||Region of Enrollment||participants|Number|181|181.0||||||
4323201|NCT00457977|4150790|B2|United States||Region of Enrollment||participants|Number|91|91.0||||||
4323202|NCT00457977|4150791|B1|United States||Region of Enrollment||participants|Number|90|90.0||||||
4323203|NCT00457977|4150789|B3||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4323204|NCT00457977|4150790|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4323205|NCT00457977|4150791|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4323206|NCT00457977|4150789|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4323207|NCT00457977|4150790|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4323208|NCT00457977|4150791|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4323209|NCT00457977|4150789|B3|||Age||years|Mean|64|64.0|Standard Deviation|9|9.0|||
4323210|NCT00457977|4150790|B2|||Age||years|Mean|63|63.0|Standard Deviation|9|9.0|||
4323211|NCT00457977|4150791|B1|||Age||years|Mean|64|64.0|Standard Deviation|10|10.0|||
4323212|NCT00457951|4150800|B4|United States||Region of Enrollment||participants|Number|151|151.0||||||
4323213|NCT00457951|4150801|B3|United States||Region of Enrollment||participants|Number|72|72.0||||||
4323214|NCT00457951|4150802|B2|United States||Region of Enrollment||participants|Number|66|66.0||||||
4323215|NCT00457951|4150803|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4323216|NCT00457951|4150800|B4||Male|Sex/Gender, Customized||Participants|Count of Participants|94|94.0||||||
4323217|NCT00457951|4150801|B3||Male|Sex/Gender, Customized||Participants|Count of Participants|49|49.0||||||
4323218|NCT00457951|4150802|B2||Male|Sex/Gender, Customized||Participants|Count of Participants|41|41.0||||||
4323219|NCT00457951|4150803|B1||Male|Sex/Gender, Customized||Participants|Count of Participants|4|4.0||||||
4323220|NCT00457951|4150800|B4||Female|Sex/Gender, Customized||Participants|Count of Participants|57|57.0||||||
4323221|NCT00457951|4150801|B3||Female|Sex/Gender, Customized||Participants|Count of Participants|23|23.0||||||
4323222|NCT00457951|4150802|B2||Female|Sex/Gender, Customized||Participants|Count of Participants|25|25.0||||||
4323223|NCT00457951|4150803|B1||Female|Sex/Gender, Customized||Participants|Count of Participants|9|9.0||||||
4323224|NCT00457951|4150800|B4|||Age, Customized||years|Mean|66.5|66.5|Standard Deviation|10.43|10.43|||
4323225|NCT00457951|4150801|B3|||Age, Customized||years|Mean|67.2|67.2|Standard Deviation|9.53|9.53|||
4323226|NCT00457951|4150802|B2|||Age, Customized||years|Mean|68.5|68.5|Standard Deviation|10.24|10.24|||
4323227|NCT00457951|4150803|B1|||Age, Customized||years|Mean|63.8|63.8|Standard Deviation|15|15.0|||
4323228|NCT00457821|4150812|B9|G551D/G542X||Genotype||participants|Number|1|1.0||||||
4323229|NCT00457821|4150813|B8|G551D/G542X||Genotype||participants|Number|0|0.0||||||
4323230|NCT00457821|4150814|B7|G551D/G542X||Genotype||participants|Number|1|1.0||||||
4323231|NCT00457821|4150815|B6|G551D/G542X||Genotype||participants|Number|0|0.0||||||
4323232|NCT00457821|4150816|B5|G551D/G542X||Genotype||participants|Number|0|0.0||||||
4323233|NCT00457821|4150817|B4|G551D/G542X||Genotype||participants|Number|0|0.0||||||
4323234|NCT00457821|4150818|B3|G551D/G542X||Genotype||participants|Number|0|0.0||||||
4323235|NCT00457821|4150819|B2|G551D/G542X||Genotype||participants|Number|0|0.0||||||
4323236|NCT00457821|4150820|B1|G551D/G542X||Genotype||participants|Number|0|0.0||||||
4323237|NCT00457821|4150812|B9|G551D/6214 + 1G > 7T||Genotype||participants|Number|1|1.0||||||
4323238|NCT00457821|4150813|B8|G551D/6214 + 1G > 7T||Genotype||participants|Number|0|0.0||||||
4323239|NCT00457821|4150814|B7|G551D/6214 + 1G > 7T||Genotype||participants|Number|0|0.0||||||
4323240|NCT00457821|4150815|B6|G551D/6214 + 1G > 7T||Genotype||participants|Number|1|1.0||||||
4323241|NCT00457821|4150816|B5|G551D/6214 + 1G > 7T||Genotype||participants|Number|0|0.0||||||
4323242|NCT00457821|4150817|B4|G551D/6214 + 1G > 7T||Genotype||participants|Number|0|0.0||||||
4323243|NCT00457821|4150818|B3|G551D/6214 + 1G > 7T||Genotype||participants|Number|0|0.0||||||
4323244|NCT00457821|4150819|B2|G551D/6214 + 1G > 7T||Genotype||participants|Number|0|0.0||||||
4323245|NCT00457821|4150820|B1|G551D/6214 + 1G > 7T||Genotype||participants|Number|0|0.0||||||
4323246|NCT00457821|4150812|B9|G551D/3849 AND 10KBC||Genotype||participants|Number|1|1.0||||||
4323247|NCT00457821|4150813|B8|G551D/3849 AND 10KBC||Genotype||participants|Number|0|0.0||||||
4323248|NCT00457821|4150814|B7|G551D/3849 AND 10KBC||Genotype||participants|Number|1|1.0||||||
4323249|NCT00457821|4150815|B6|G551D/3849 AND 10KBC||Genotype||participants|Number|0|0.0||||||
4323250|NCT00457821|4150816|B5|G551D/3849 AND 10KBC||Genotype||participants|Number|0|0.0||||||
4323251|NCT00457821|4150817|B4|G551D/3849 AND 10KBC||Genotype||participants|Number|0|0.0||||||
4323252|NCT00457821|4150818|B3|G551D/3849 AND 10KBC||Genotype||participants|Number|0|0.0||||||
4323253|NCT00457821|4150819|B2|G551D/3849 AND 10KBC||Genotype||participants|Number|0|0.0||||||
4323254|NCT00457821|4150820|B1|G551D/3849 AND 10KBC||Genotype||participants|Number|0|0.0||||||
4323255|NCT00457821|4150812|B9|G551D/R553X||Genotype||participants|Number|1|1.0||||||
4323256|NCT00457821|4150813|B8|G551D/R553X||Genotype||participants|Number|0|0.0||||||
4323257|NCT00457821|4150814|B7|G551D/R553X||Genotype||participants|Number|0|0.0||||||
4323258|NCT00457821|4150815|B6|G551D/R553X||Genotype||participants|Number|0|0.0||||||
4323259|NCT00457821|4150816|B5|G551D/R553X||Genotype||participants|Number|0|0.0||||||
4323260|NCT00457821|4150817|B4|G551D/R553X||Genotype||participants|Number|1|1.0||||||
4323261|NCT00457821|4150818|B3|G551D/R553X||Genotype||participants|Number|0|0.0||||||
4323262|NCT00457821|4150819|B2|G551D/R553X||Genotype||participants|Number|0|0.0||||||
4323263|NCT00457821|4150820|B1|G551D/R553X||Genotype||participants|Number|0|0.0||||||
4323264|NCT00457821|4150812|B9|G551D/N1303K||Genotype||participants|Number|1|1.0||||||
4323265|NCT00457821|4150813|B8|G551D/N1303K||Genotype||participants|Number|0|0.0||||||
4323266|NCT00457821|4150814|B7|G551D/N1303K||Genotype||participants|Number|0|0.0||||||
4323267|NCT00457821|4150815|B6|G551D/N1303K||Genotype||participants|Number|0|0.0||||||
4323268|NCT00457821|4150816|B5|G551D/N1303K||Genotype||participants|Number|0|0.0||||||
4323269|NCT00457821|4150817|B4|G551D/N1303K||Genotype||participants|Number|1|1.0||||||
4323270|NCT00457821|4150818|B3|G551D/N1303K||Genotype||participants|Number|0|0.0||||||
4323271|NCT00457821|4150819|B2|G551D/N1303K||Genotype||participants|Number|0|0.0||||||
4323272|NCT00457821|4150820|B1|G551D/N1303K||Genotype||participants|Number|0|0.0||||||
4323273|NCT00457821|4150812|B9|G551D/G551D||Genotype||participants|Number|1|1.0||||||
4323274|NCT00457821|4150813|B8|G551D/G551D||Genotype||participants|Number|0|0.0||||||
4323275|NCT00457821|4150814|B7|G551D/G551D||Genotype||participants|Number|0|0.0||||||
4323276|NCT00457821|4150815|B6|G551D/G551D||Genotype||participants|Number|0|0.0||||||
4323277|NCT00457821|4150816|B5|G551D/G551D||Genotype||participants|Number|1|1.0||||||
4323278|NCT00457821|4150817|B4|G551D/G551D||Genotype||participants|Number|0|0.0||||||
4323279|NCT00457821|4150818|B3|G551D/G551D||Genotype||participants|Number|0|0.0||||||
4323280|NCT00457821|4150819|B2|G551D/G551D||Genotype||participants|Number|0|0.0||||||
4323281|NCT00457821|4150820|B1|G551D/G551D||Genotype||participants|Number|0|0.0||||||
4323282|NCT00457821|4150812|B9|G551D/DELTA F508||Genotype||participants|Number|32|32.0||||||
4323283|NCT00457821|4150813|B8|G551D/DELTA F508||Genotype||participants|Number|4|4.0||||||
4323284|NCT00457821|4150814|B7|G551D/DELTA F508||Genotype||participants|Number|5|5.0||||||
4323285|NCT00457821|4150815|B6|G551D/DELTA F508||Genotype||participants|Number|7|7.0||||||
4323286|NCT00457821|4150816|B5|G551D/DELTA F508||Genotype||participants|Number|3|3.0||||||
4323287|NCT00457821|4150817|B4|G551D/DELTA F508||Genotype||participants|Number|2|2.0||||||
4323288|NCT00457821|4150818|B3|G551D/DELTA F508||Genotype||participants|Number|4|4.0||||||
4323289|NCT00457821|4150819|B2|G551D/DELTA F508||Genotype||participants|Number|4|4.0||||||
4323290|NCT00457821|4150820|B1|G551D/DELTA F508||Genotype||participants|Number|3|3.0||||||
4323291|NCT00457821|4150812|B9|G551D/1078 DEL T||Genotype||participants|Number|1|1.0||||||
4323292|NCT00457821|4150813|B8|G551D/1078 DEL T||Genotype||participants|Number|0|0.0||||||
4323293|NCT00457821|4150814|B7|G551D/1078 DEL T||Genotype||participants|Number|0|0.0||||||
4323294|NCT00457821|4150815|B6|G551D/1078 DEL T||Genotype||participants|Number|0|0.0||||||
4323295|NCT00457821|4150816|B5|G551D/1078 DEL T||Genotype||participants|Number|0|0.0||||||
4323296|NCT00457821|4150817|B4|G551D/1078 DEL T||Genotype||participants|Number|0|0.0||||||
4323297|NCT00457821|4150818|B3|G551D/1078 DEL T||Genotype||participants|Number|0|0.0||||||
4323298|NCT00457821|4150819|B2|G551D/1078 DEL T||Genotype||participants|Number|0|0.0||||||
4323299|NCT00457821|4150820|B1|G551D/1078 DEL T||Genotype||participants|Number|1|1.0||||||
4323300|NCT00457821|4150812|B9|||Percent Predicted Forced Expiratory Volume in 1 Second (FEV1)|Percent predicted for age, gender, and height.|percentage of volume in liters|Mean|67.3|67.3|Standard Deviation|22.17|22.17|||
4323301|NCT00457821|4150813|B8|||Percent Predicted Forced Expiratory Volume in 1 Second (FEV1)|Percent predicted for age, gender, and height.|percentage of volume in liters|Mean|79.351|79.351|Standard Deviation|28.7018|28.7018|||
4323302|NCT00457821|4150814|B7|||Percent Predicted Forced Expiratory Volume in 1 Second (FEV1)|Percent predicted for age, gender, and height.|percentage of volume in liters|Mean|72.674|72.674|Standard Deviation|21.5223|21.5223|||
4323303|NCT00457821|4150815|B6|||Percent Predicted Forced Expiratory Volume in 1 Second (FEV1)|Percent predicted for age, gender, and height.|percentage of volume in liters|Mean|70.443|70.443|Standard Deviation|25.4442|25.4442|||
4323304|NCT00457821|4150816|B5|||Percent Predicted Forced Expiratory Volume in 1 Second (FEV1)|Percent predicted for age, gender, and height.|percentage of volume in liters|Mean|49.270|49.27|Standard Deviation|7.5615|7.5615|||
4323305|NCT00457821|4150817|B4|||Percent Predicted Forced Expiratory Volume in 1 Second (FEV1)|Percent predicted for age, gender, and height.|percentage of volume in liters|Mean|68.284|68.284|Standard Deviation|24.7014|24.7014|||
4323306|NCT00457821|4150818|B3|||Percent Predicted Forced Expiratory Volume in 1 Second (FEV1)|Percent predicted for age, gender, and height.|percentage of volume in liters|Mean|54.885|54.885|Standard Deviation|9.6772|9.6772|||
4323307|NCT00457821|4150819|B2|||Percent Predicted Forced Expiratory Volume in 1 Second (FEV1)|Percent predicted for age, gender, and height.|percentage of volume in liters|Mean|71.073|71.073|Standard Deviation|27.2307|27.2307|||
4323308|NCT00457821|4150820|B1|||Percent Predicted Forced Expiratory Volume in 1 Second (FEV1)|Percent predicted for age, gender, and height.|percentage of volume in liters|Mean|64.902|64.902|Standard Deviation|22.6821|22.6821|||
4323309|NCT00457821|4150812|B9|||Body Mass Index||kilograms per square meter|Mean|22.3|22.3|Standard Deviation|2.37|2.37|||
4323310|NCT00457821|4150813|B8|||Body Mass Index||kilograms per square meter|Mean|22.035|22.035|Standard Deviation|0.6999|0.6999|||
4323311|NCT00457821|4150814|B7|||Body Mass Index||kilograms per square meter|Mean|22.703|22.703|Standard Deviation|1.3980|1.398|||
4323312|NCT00457821|4150815|B6|||Body Mass Index||kilograms per square meter|Mean|21.896|21.896|Standard Deviation|0.9770|0.977|||
4323313|NCT00457821|4150816|B5|||Body Mass Index||kilograms per square meter|Mean|20.788|20.788|Standard Deviation|4.1527|4.1527|||
4323314|NCT00457821|4150817|B4|||Body Mass Index||kilograms per square meter|Mean|20.960|20.96|Standard Deviation|2.2522|2.2522|||
4323315|NCT00457821|4150818|B3|||Body Mass Index||kilograms per square meter|Mean|23.653|23.653|Standard Deviation|3.6216|3.6216|||
4323316|NCT00457821|4150819|B2|||Body Mass Index||kilograms per square meter|Mean|22.455|22.455|Standard Deviation|2.3133|2.3133|||
4323317|NCT00457821|4150820|B1|||Body Mass Index||kilograms per square meter|Mean|24.195|24.195|Standard Deviation|3.2002|3.2002|||
4323318|NCT00457821|4150812|B9|||Weight||kilograms|Mean|64.1|64.1|Standard Deviation|12.42|12.42|||
4323319|NCT00457821|4150813|B8|||Weight||kilograms|Mean|63.50|63.5|Standard Deviation|7.391|7.391|||
4323320|NCT00457821|4150814|B7|||Weight||kilograms|Mean|64.46|64.46|Standard Deviation|13.027|13.027|||
4323321|NCT00457821|4150815|B6|||Weight||kilograms|Mean|61.19|61.19|Standard Deviation|9.857|9.857|||
4323322|NCT00457821|4150816|B5|||Weight||kilograms|Mean|59.35|59.35|Standard Deviation|18.401|18.401|||
4323323|NCT00457821|4150817|B4|||Weight||kilograms|Mean|57.48|57.48|Standard Deviation|8.663|8.663|||
4323324|NCT00457821|4150818|B3|||Weight||kilograms|Mean|73.43|73.43|Standard Deviation|14.366|14.366|||
4323325|NCT00457821|4150819|B2|||Weight||kilograms|Mean|66.05|66.05|Standard Deviation|12.628|12.628|||
4323326|NCT00457821|4150820|B1|||Weight||kilograms|Mean|70.05|70.05|Standard Deviation|16.507|16.507|||
4323327|NCT00457821|4150812|B9|Caucasian||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4323328|NCT00457821|4150813|B8|Caucasian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4323329|NCT00457821|4150814|B7|Caucasian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4323330|NCT00457821|4150815|B6|Caucasian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4323331|NCT00457821|4150816|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4323332|NCT00457821|4150817|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4323333|NCT00457821|4150818|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4323334|NCT00457821|4150819|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4323335|NCT00457821|4150820|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4323336|NCT00457821|4150812|B9||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4323337|NCT00457821|4150813|B8||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4323338|NCT00457821|4150814|B7||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4323339|NCT00457821|4150815|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4323340|NCT00457821|4150816|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4323341|NCT00457821|4150817|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4323342|NCT00457821|4150818|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4323343|NCT00457821|4150819|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4323344|NCT00457821|4150820|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4323345|NCT00457821|4150812|B9||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4323346|NCT00457821|4150813|B8||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4323347|NCT00457821|4150814|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4323348|NCT00457821|4150815|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4323349|NCT00457821|4150816|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4323350|NCT00457821|4150817|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4323351|NCT00457821|4150818|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4323352|NCT00457821|4150819|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4323353|NCT00457821|4150820|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4323354|NCT00457821|4150812|B9|||Age||years|Mean|28.7|28.7|Standard Deviation|10.03|10.03|||
4323355|NCT00457821|4150813|B8|||Age||years|Mean|26.8|26.8|Standard Deviation|10.69|10.69|||
4323356|NCT00457821|4150814|B7|||Age||years|Mean|26.0|26.0|Standard Deviation|7.07|7.07|||
4323357|NCT00457821|4150815|B6|||Age||years|Mean|25.6|25.6|Standard Deviation|7.98|7.98|||
4323358|NCT00457821|4150816|B5|||Age||years|Mean|23.5|23.5|Standard Deviation|6.45|6.45|||
4323359|NCT00457821|4150817|B4|||Age||years|Mean|26.3|26.3|Standard Deviation|7.85|7.85|||
4323360|NCT00457821|4150818|B3|||Age||years|Mean|38.5|38.5|Standard Deviation|11.82|11.82|||
4323361|NCT00457821|4150819|B2|||Age||years|Mean|33.5|33.5|Standard Deviation|12.50|12.5|||
4323362|NCT00457821|4150820|B1|||Age||years|Mean|34.5|34.5|Standard Deviation|14.66|14.66|||
4323363|NCT00457795|4150856|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4323364|NCT00457795|4150856|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4323365|NCT00457795|4150856|B1|||Age||years|Mean|58.3|58.3|Standard Deviation|7.8|7.8|||
4323366|NCT00457743|4150863|B4|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Grade 0: Fully active, able to carry on all pre-disease performance without restriction.~Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work."|participants|Number|13|13.0||||||
4323367|NCT00457743|4150864|B3|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Grade 0: Fully active, able to carry on all pre-disease performance without restriction.~Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work."|participants|Number|1|1.0||||||
4323368|NCT00457743|4150865|B2|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Grade 0: Fully active, able to carry on all pre-disease performance without restriction.~Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work."|participants|Number|12|12.0||||||
4323369|NCT00457743|4150866|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Grade 0: Fully active, able to carry on all pre-disease performance without restriction.~Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work."|participants|Number|0|0.0||||||
4323370|NCT00457743|4150863|B4|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Grade 0: Fully active, able to carry on all pre-disease performance without restriction.~Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work."|participants|Number|23|23.0||||||
4323371|NCT00457743|4150864|B3|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Grade 0: Fully active, able to carry on all pre-disease performance without restriction.~Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work."|participants|Number|2|2.0||||||
4323372|NCT00457743|4150865|B2|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Grade 0: Fully active, able to carry on all pre-disease performance without restriction.~Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work."|participants|Number|18|18.0||||||
4323373|NCT00457743|4150866|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Grade 0: Fully active, able to carry on all pre-disease performance without restriction.~Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work."|participants|Number|3|3.0||||||
4323374|NCT00457743|4150863|B4|Japan||Region of Enrollment||participants|Number|36|36.0||||||
4323375|NCT00457743|4150864|B3|Japan||Region of Enrollment||participants|Number|3|3.0||||||
4323376|NCT00457743|4150865|B2|Japan||Region of Enrollment||participants|Number|30|30.0||||||
4323377|NCT00457743|4150866|B1|Japan||Region of Enrollment||participants|Number|3|3.0||||||
4323378|NCT00457743|4150863|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4323379|NCT00457743|4150864|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4323380|NCT00457743|4150865|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4323381|NCT00457743|4150866|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4323382|NCT00457743|4150863|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4323383|NCT00457743|4150864|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4323384|NCT00457743|4150865|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4323385|NCT00457743|4150866|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4323386|NCT00457743|4150863|B4|>=65 years||Age, Customized||participants|Number|6|6.0||||||
4323387|NCT00457743|4150864|B3|>=65 years||Age, Customized||participants|Number|2|2.0||||||
4323388|NCT00457743|4150865|B2|>=65 years||Age, Customized||participants|Number|4|4.0||||||
4323389|NCT00457743|4150866|B1|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4323390|NCT00457743|4150863|B4|45-64 years||Age, Customized||participants|Number|26|26.0||||||
4323391|NCT00457743|4150864|B3|45-64 years||Age, Customized||participants|Number|1|1.0||||||
4323392|NCT00457743|4150865|B2|45-64 years||Age, Customized||participants|Number|24|24.0||||||
4323393|NCT00457743|4150866|B1|45-64 years||Age, Customized||participants|Number|1|1.0||||||
4323394|NCT00457743|4150863|B4|18-44 years||Age, Customized||participants|Number|4|4.0||||||
4323395|NCT00457743|4150864|B3|18-44 years||Age, Customized||participants|Number|0|0.0||||||
4323396|NCT00457743|4150865|B2|18-44 years||Age, Customized||participants|Number|2|2.0||||||
4323397|NCT00457743|4150866|B1|18-44 years||Age, Customized||participants|Number|2|2.0||||||
4323398|NCT00457730|4150910|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4323399|NCT00457730|4150911|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4323400|NCT00457730|4150912|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4323401|NCT00457730|4150910|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4323402|NCT00457730|4150911|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4323403|NCT00457730|4150912|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4323404|NCT00457730|4150910|B3|||Age||years|Mean|56.3|56.3|Standard Deviation|9.97|9.97|||
4323405|NCT00457730|4150911|B2|||Age||years|Mean|56.33|56.33|Standard Deviation|11.23|11.23|||
4323406|NCT00457730|4150912|B1|||Age||years|Mean|54.71|54.71|Standard Deviation|9.97|9.97|||
4323407|NCT00457691|4150923|B3||Male|Sex: Female, Male||Participants|Count of Participants|425|425.0||||||
4323408|NCT00457691|4150924|B2||Male|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4323409|NCT00457691|4150925|B1||Male|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4323410|NCT00457691|4150923|B3||Female|Sex: Female, Male||Participants|Count of Participants|343|343.0||||||
4323411|NCT00457691|4150924|B2||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4323412|NCT00457691|4150925|B1||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4323413|NCT00457691|4150923|B3|||Age||years|Mean|58.1|58.1|Standard Deviation|10.57|10.57|||
4323414|NCT00457691|4150924|B2|||Age||years|Mean|57.6|57.6|Standard Deviation|10.77|10.77|||
4323415|NCT00457691|4150925|B1|||Age||years|Mean|58.6|58.6|Standard Deviation|10.36|10.36|||
4323416|NCT00457418|4150946|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4323417|NCT00457418|4150946|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4323418|NCT00457418|4150946|B1|||Age||years|Mean|49.1|49.1|Standard Deviation|12.8|12.8|||
4323419|NCT00457392|4150956|B3||Male|Sex: Female, Male||Participants|Count of Participants|581|581.0||||||
4323420|NCT00457392|4150957|B2||Male|Sex: Female, Male||Participants|Count of Participants|284|284.0||||||
4323421|NCT00457392|4150958|B1||Male|Sex: Female, Male||Participants|Count of Participants|297|297.0||||||
4323422|NCT00457392|4150956|B3||Female|Sex: Female, Male||Participants|Count of Participants|379|379.0||||||
4323423|NCT00457392|4150957|B2||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4323424|NCT00457392|4150958|B1||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4323425|NCT00457392|4150956|B3|||Age||Years|Mean|60.90|60.9|Standard Deviation|9.56|9.56|||
4323426|NCT00457392|4150957|B2|||Age||Years|Mean|60.80|60.8|Standard Deviation|9.13|9.13|||
4323427|NCT00457392|4150958|B1|||Age||Years|Mean|61.10|61.1|Standard Deviation|9.97|9.97|||
4323428|NCT00457301|4150975|B3||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4323429|NCT00457301|4150976|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4323430|NCT00457301|4150977|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4323431|NCT00457301|4150975|B3||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4323432|NCT00457301|4150976|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4323433|NCT00457301|4150977|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4323434|NCT00457301|4150975|B3|||Age||years|Mean|53.3|53.3|Standard Deviation|12.7|12.7|||
4323435|NCT00457301|4150976|B2|||Age||years|Mean|53.2|53.2|Standard Deviation|12.6|12.6|||
4323436|NCT00457301|4150977|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|12.9|12.9|||
4323437|NCT00457249|4150990|B3|United States||Region of Enrollment||participants|Number|1561|1561.0||||||
4323438|NCT00457249|4150991|B2|United States||Region of Enrollment||participants|Number|391|391.0||||||
4323439|NCT00457249|4150992|B1|United States||Region of Enrollment||participants|Number|1170|1170.0||||||
4323440|NCT00457249|4150990|B3||Male|Sex: Female, Male||Participants|Count of Participants|784|784.0||||||
4323441|NCT00457249|4150991|B2||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4323442|NCT00457249|4150992|B1||Male|Sex: Female, Male||Participants|Count of Participants|591|591.0||||||
4323443|NCT00457249|4150990|B3||Female|Sex: Female, Male||Participants|Count of Participants|777|777.0||||||
4323444|NCT00457249|4150991|B2||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4323445|NCT00457249|4150992|B1||Female|Sex: Female, Male||Participants|Count of Participants|579|579.0||||||
4323446|NCT00457249|4150990|B3|||Age||Years|Mean|72.2|72.2|Standard Deviation|5.71|5.71|||
4323447|NCT00457249|4150991|B2|||Age||Years|Mean|72.3|72.3|Standard Deviation|5.63|5.63|||
4323448|NCT00457249|4150992|B1|||Age||Years|Mean|72.2|72.2|Standard Deviation|5.74|5.74|||
4323449|NCT00457249|4150990|B3||>=65 years|Age||Participants|Count of Participants|1561|1561.0||||||
4323450|NCT00457249|4150991|B2||>=65 years|Age||Participants|Count of Participants|391|391.0||||||
4323451|NCT00457249|4150992|B1||>=65 years|Age||Participants|Count of Participants|1170|1170.0||||||
4323452|NCT00457249|4150990|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4323453|NCT00457249|4150991|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4323454|NCT00457249|4150992|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4323455|NCT00457249|4150990|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4323456|NCT00457249|4150991|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4323457|NCT00457249|4150992|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4323458|NCT00457197|4151005|B3|||Mood and craving scales: Penn Alcohol Craving Scale|Minimum: 0 Maximum: 30 Lower score associated with better outcome|units on a scale|Mean|19.9|19.9|Standard Deviation|6.5|6.5|||
4323459|NCT00457197|4151006|B2|||Mood and craving scales: Penn Alcohol Craving Scale|Minimum: 0 Maximum: 30 Lower score associated with better outcome|units on a scale|Mean|20.6|20.6|Standard Deviation|6.3|6.3|||
4323460|NCT00457197|4151007|B1|||Mood and craving scales: Penn Alcohol Craving Scale|Minimum: 0 Maximum: 30 Lower score associated with better outcome|units on a scale|Mean|19.2|19.2|Standard Deviation|6.6|6.6|||
4323461|NCT00457197|4151005|B3|||Mood and craving scales: Young Mania Rating Scale|Minimum: 0 Maximum: 60 Lower score associated with better outcome|units on a scale|Mean|13.8|13.8|Standard Deviation|7.5|7.5|||
4323462|NCT00457197|4151006|B2|||Mood and craving scales: Young Mania Rating Scale|Minimum: 0 Maximum: 60 Lower score associated with better outcome|units on a scale|Mean|13.9|13.9|Standard Deviation|6.7|6.7|||
4323463|NCT00457197|4151007|B1|||Mood and craving scales: Young Mania Rating Scale|Minimum: 0 Maximum: 60 Lower score associated with better outcome|units on a scale|Mean|13.6|13.6|Standard Deviation|8.2|8.2|||
4323464|NCT00457197|4151005|B3|||Mood and craving scales: Inventory of Depressive Symptomatology-Self-Report|Minimum= 0 Maximum= 84 Lower score associated with better outcome Normal= 7 or less|units on a scale|Mean|31.3|31.3|Standard Deviation|12.65|12.65|||
4323465|NCT00457197|4151006|B2|||Mood and craving scales: Inventory of Depressive Symptomatology-Self-Report|Minimum= 0 Maximum= 84 Lower score associated with better outcome Normal= 7 or less|units on a scale|Mean|33.9|33.9|Standard Deviation|14.6|14.6|||
4323466|NCT00457197|4151007|B1|||Mood and craving scales: Inventory of Depressive Symptomatology-Self-Report|Minimum= 0 Maximum= 84 Lower score associated with better outcome Normal= 7 or less|units on a scale|Mean|28.6|28.6|Standard Deviation|10.7|10.7|||
4323467|NCT00457197|4151005|B3|||Mood and craving scales: Hamilton Rating Scale for Depression|Minimum: 0 Maximum: 50 Lower score associated with better outcome Normal= 7 or less|units on a scale|Mean|18.5|18.5|Standard Deviation|6.9|6.9|||
4323468|NCT00457197|4151006|B2|||Mood and craving scales: Hamilton Rating Scale for Depression|Minimum: 0 Maximum: 50 Lower score associated with better outcome Normal= 7 or less|units on a scale|Mean|18.6|18.6|Standard Deviation|7.0|7.0|||
4323469|NCT00457197|4151007|B1|||Mood and craving scales: Hamilton Rating Scale for Depression|Minimum: 0 Maximum: 50 Lower score associated with better outcome Normal= 7 or less|units on a scale|Mean|18.3|18.3|Standard Deviation|6.7|6.7|||
4323470|NCT00457197|4151005|B3|No sedatives/hypnotics||Concomitant medications||participants|Number|78|78.0||||||
4323471|NCT00457197|4151006|B2|No sedatives/hypnotics||Concomitant medications||participants|Number|36|36.0||||||
4323472|NCT00457197|4151007|B1|No sedatives/hypnotics||Concomitant medications||participants|Number|42|42.0||||||
4323473|NCT00457197|4151005|B3|Sedatives/hypnotics||Concomitant medications||participants|Number|10|10.0||||||
4323474|NCT00457197|4151006|B2|Sedatives/hypnotics||Concomitant medications||participants|Number|8|8.0||||||
4323475|NCT00457197|4151007|B1|Sedatives/hypnotics||Concomitant medications||participants|Number|2|2.0||||||
4323476|NCT00457197|4151005|B3|No antidepressants||Concomitant medications||participants|Number|71|71.0||||||
4323477|NCT00457197|4151006|B2|No antidepressants||Concomitant medications||participants|Number|33|33.0||||||
4323478|NCT00457197|4151007|B1|No antidepressants||Concomitant medications||participants|Number|38|38.0||||||
4323479|NCT00457197|4151005|B3|Antidepressants||Concomitant medications||participants|Number|17|17.0||||||
4323480|NCT00457197|4151006|B2|Antidepressants||Concomitant medications||participants|Number|11|11.0||||||
4323481|NCT00457197|4151007|B1|Antidepressants||Concomitant medications||participants|Number|6|6.0||||||
4323482|NCT00457197|4151005|B3|No anticonvulsants||Concomitant medications||participants|Number|62|62.0||||||
4323483|NCT00457197|4151006|B2|No anticonvulsants||Concomitant medications||participants|Number|31|31.0||||||
4323484|NCT00457197|4151007|B1|No anticonvulsants||Concomitant medications||participants|Number|31|31.0||||||
4323485|NCT00457197|4151005|B3|Anticonvulsants||Concomitant medications||participants|Number|26|26.0||||||
4323486|NCT00457197|4151006|B2|Anticonvulsants||Concomitant medications||participants|Number|13|13.0||||||
4323487|NCT00457197|4151007|B1|Anticonvulsants||Concomitant medications||participants|Number|13|13.0||||||
4323488|NCT00457197|4151005|B3|No Lithium||Concomitant medications||participants|Number|33|33.0||||||
4323489|NCT00457197|4151006|B2|No Lithium||Concomitant medications||participants|Number|17|17.0||||||
4323490|NCT00457197|4151007|B1|No Lithium||Concomitant medications||participants|Number|16|16.0||||||
4323491|NCT00457197|4151005|B3|Lithium||Concomitant medications||participants|Number|55|55.0||||||
4323492|NCT00457197|4151006|B2|Lithium||Concomitant medications||participants|Number|27|27.0||||||
4323493|NCT00457197|4151007|B1|Lithium||Concomitant medications||participants|Number|28|28.0||||||
4323494|NCT00457197|4151005|B3|ALT (alanine aminotransferase)||Liver enzymes||IU/I|Mean|29.0|29.0|Standard Deviation|20.9|20.9|||
4323495|NCT00457197|4151006|B2|ALT (alanine aminotransferase)||Liver enzymes||IU/I|Mean|28.9|28.9|Standard Deviation|17.3|17.3|||
4323496|NCT00457197|4151007|B1|ALT (alanine aminotransferase)||Liver enzymes||IU/I|Mean|29.0|29.0|Standard Deviation|24.5|24.5|||
4323497|NCT00457197|4151005|B3|AST (aspartate aminotransferase)||Liver enzymes||IU/I|Mean|28.6|28.6|Standard Deviation|14.2|14.2|||
4323498|NCT00457197|4151006|B2|AST (aspartate aminotransferase)||Liver enzymes||IU/I|Mean|29.7|29.7|Standard Deviation|13.5|13.5|||
4323499|NCT00457197|4151007|B1|AST (aspartate aminotransferase)||Liver enzymes||IU/I|Mean|27.4|27.4|Standard Deviation|14.8|14.8|||
4323500|NCT00457197|4151005|B3|GGT (gamma-glutamyltransferase||Liver enzymes||IU/I|Mean|61.05|61.05|Standard Deviation|53.45|53.45|||
4323501|NCT00457197|4151006|B2|GGT (gamma-glutamyltransferase||Liver enzymes||IU/I|Mean|74.3|74.3|Standard Deviation|69.3|69.3|||
4323502|NCT00457197|4151007|B1|GGT (gamma-glutamyltransferase||Liver enzymes||IU/I|Mean|47.8|47.8|Standard Deviation|37.6|37.6|||
4323503|NCT00457197|4151005|B3|||Drinks per day||drinks|Mean|6.3|6.3|Standard Deviation|3.4|3.4|||
4323504|NCT00457197|4151006|B2|||Drinks per day||drinks|Mean|6.0|6.0|Standard Deviation|3.4|3.4|||
4323505|NCT00457197|4151007|B1|||Drinks per day||drinks|Mean|6.5|6.5|Standard Deviation|3.4|3.4|||
4323791|NCT00456846|4151152|B3|Premenopausal||Menopausal Status||participants|Number|24|24.0||||||
4323506|NCT00457197|4151005|B3|||% Days Heavy Alcohol Use In Past Week||Days|Mean|56.5|56.5|Standard Deviation|30.5|30.5|||
4323507|NCT00457197|4151006|B2|||% Days Heavy Alcohol Use In Past Week||Days|Mean|53.0|53.0|Standard Deviation|30.9|30.9|||
4323508|NCT00457197|4151007|B1|||% Days Heavy Alcohol Use In Past Week||Days|Mean|60.0|60.0|Standard Deviation|30.1|30.1|||
4323509|NCT00457197|4151005|B3|||% Days Alcohol Use In Past Week||days|Mean|74.4|74.4|Standard Deviation|26.7|26.7|||
4323510|NCT00457197|4151006|B2|||% Days Alcohol Use In Past Week||days|Mean|74.2|74.2|Standard Deviation|27.3|27.3|||
4323511|NCT00457197|4151007|B1|||% Days Alcohol Use In Past Week||days|Mean|74.6|74.6|Standard Deviation|26.1|26.1|||
4323512|NCT00457197|4151005|B3|No History||History of treatment for drug/alcohol||participants|Number|33|33.0||||||
4323513|NCT00457197|4151006|B2|No History||History of treatment for drug/alcohol||participants|Number|14|14.0||||||
4323514|NCT00457197|4151007|B1|No History||History of treatment for drug/alcohol||participants|Number|19|19.0||||||
4323515|NCT00457197|4151005|B3|History||History of treatment for drug/alcohol||participants|Number|55|55.0||||||
4323516|NCT00457197|4151006|B2|History||History of treatment for drug/alcohol||participants|Number|30|30.0||||||
4323517|NCT00457197|4151007|B1|History||History of treatment for drug/alcohol||participants|Number|25|25.0||||||
4323518|NCT00457197|4151005|B3|Mixed (both depression and mania at same time)||Mood states||participants|Number|10|10.0||||||
4323519|NCT00457197|4151006|B2|Mixed (both depression and mania at same time)||Mood states||participants|Number|6|6.0||||||
4323520|NCT00457197|4151007|B1|Mixed (both depression and mania at same time)||Mood states||participants|Number|4|4.0||||||
4323521|NCT00457197|4151005|B3|Depressed||Mood states||participants|Number|78|78.0||||||
4323522|NCT00457197|4151006|B2|Depressed||Mood states||participants|Number|38|38.0||||||
4323523|NCT00457197|4151007|B1|Depressed||Mood states||participants|Number|40|40.0||||||
4323524|NCT00457197|4151005|B3|||Education||years|Mean|13.5|13.5|Standard Deviation|2.5|2.5|||
4323525|NCT00457197|4151006|B2|||Education||years|Mean|13.6|13.6|Standard Deviation|2.5|2.5|||
4323526|NCT00457197|4151007|B1|||Education||years|Mean|13.3|13.3|Standard Deviation|2.4|2.4|||
4323527|NCT00457197|4151005|B3|Not Married||Married||participants|Number|70|70.0||||||
4323528|NCT00457197|4151006|B2|Not Married||Married||participants|Number|34|34.0||||||
4323529|NCT00457197|4151007|B1|Not Married||Married||participants|Number|36|36.0||||||
4323530|NCT00457197|4151005|B3|Married||Married||participants|Number|18|18.0||||||
4323531|NCT00457197|4151006|B2|Married||Married||participants|Number|10|10.0||||||
4323532|NCT00457197|4151007|B1|Married||Married||participants|Number|8|8.0||||||
4323533|NCT00457197|4151005|B3|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4323534|NCT00457197|4151006|B2|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4323535|NCT00457197|4151007|B1|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4323536|NCT00457197|4151005|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4323537|NCT00457197|4151006|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4323538|NCT00457197|4151007|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4323539|NCT00457197|4151005|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4323540|NCT00457197|4151006|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4323541|NCT00457197|4151007|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4323542|NCT00457197|4151005|B3|African American||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4323543|NCT00457197|4151006|B2|African American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4323544|NCT00457197|4151007|B1|African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4323545|NCT00457197|4151005|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4323546|NCT00457197|4151006|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4323547|NCT00457197|4151007|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4323548|NCT00457197|4151005|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4323549|NCT00457197|4151006|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4323550|NCT00457197|4151007|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4323551|NCT00457197|4151005|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4323552|NCT00457197|4151006|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4323553|NCT00457197|4151007|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4323554|NCT00457197|4151005|B3|||Age||years|Mean|41.5|41.5|Standard Deviation|9.2|9.2|||
4323555|NCT00457197|4151006|B2|||Age||years|Mean|43.3|43.3|Standard Deviation|8.2|8.2|||
4323556|NCT00457197|4151007|B1|||Age||years|Mean|39.7|39.7|Standard Deviation|10.1|10.1|||
4323557|NCT00457015|4151030|B3|Cutaneous||Symptom Complexes at Baseline|More than one baseline symptom complex could be reported per patient; hence the number of complexes is greater than the number of patients in each group. Patient were to have at least one symptom complex that was moderate or severe. The total number of symptom complexes was 155.|symptom complexes|Number|55|55.0||||||
4323558|NCT00457015|4151031|B2|Cutaneous||Symptom Complexes at Baseline|More than one baseline symptom complex could be reported per patient; hence the number of complexes is greater than the number of patients in each group. Patient were to have at least one symptom complex that was moderate or severe. The total number of symptom complexes was 155.|symptom complexes|Number|21|21.0||||||
4323559|NCT00457015|4151032|B1|Cutaneous||Symptom Complexes at Baseline|More than one baseline symptom complex could be reported per patient; hence the number of complexes is greater than the number of patients in each group. Patient were to have at least one symptom complex that was moderate or severe. The total number of symptom complexes was 155.|symptom complexes|Number|34|34.0||||||
4323792|NCT00456846|4151153|B2|Premenopausal||Menopausal Status||participants|Number|12|12.0||||||
4323560|NCT00457015|4151030|B3|External Head/Neck||Symptom Complexes at Baseline|More than one baseline symptom complex could be reported per patient; hence the number of complexes is greater than the number of patients in each group. Patient were to have at least one symptom complex that was moderate or severe. The total number of symptom complexes was 155.|symptom complexes|Number|23|23.0||||||
4323561|NCT00457015|4151031|B2|External Head/Neck||Symptom Complexes at Baseline|More than one baseline symptom complex could be reported per patient; hence the number of complexes is greater than the number of patients in each group. Patient were to have at least one symptom complex that was moderate or severe. The total number of symptom complexes was 155.|symptom complexes|Number|9|9.0||||||
4323562|NCT00457015|4151032|B1|External Head/Neck||Symptom Complexes at Baseline|More than one baseline symptom complex could be reported per patient; hence the number of complexes is greater than the number of patients in each group. Patient were to have at least one symptom complex that was moderate or severe. The total number of symptom complexes was 155.|symptom complexes|Number|14|14.0||||||
4323563|NCT00457015|4151030|B3|Genital/Buttocks||Symptom Complexes at Baseline|More than one baseline symptom complex could be reported per patient; hence the number of complexes is greater than the number of patients in each group. Patient were to have at least one symptom complex that was moderate or severe. The total number of symptom complexes was 155.|symptom complexes|Number|11|11.0||||||
4323564|NCT00457015|4151031|B2|Genital/Buttocks||Symptom Complexes at Baseline|More than one baseline symptom complex could be reported per patient; hence the number of complexes is greater than the number of patients in each group. Patient were to have at least one symptom complex that was moderate or severe. The total number of symptom complexes was 155.|symptom complexes|Number|5|5.0||||||
4323565|NCT00457015|4151032|B1|Genital/Buttocks||Symptom Complexes at Baseline|More than one baseline symptom complex could be reported per patient; hence the number of complexes is greater than the number of patients in each group. Patient were to have at least one symptom complex that was moderate or severe. The total number of symptom complexes was 155.|symptom complexes|Number|6|6.0||||||
4323566|NCT00457015|4151030|B3|Stomach/GI||Symptom Complexes at Baseline|More than one baseline symptom complex could be reported per patient; hence the number of complexes is greater than the number of patients in each group. Patient were to have at least one symptom complex that was moderate or severe. The total number of symptom complexes was 155.|symptom complexes|Number|45|45.0||||||
4323567|NCT00457015|4151031|B2|Stomach/GI||Symptom Complexes at Baseline|More than one baseline symptom complex could be reported per patient; hence the number of complexes is greater than the number of patients in each group. Patient were to have at least one symptom complex that was moderate or severe. The total number of symptom complexes was 155.|symptom complexes|Number|27|27.0||||||
4323568|NCT00457015|4151032|B1|Stomach/GI||Symptom Complexes at Baseline|More than one baseline symptom complex could be reported per patient; hence the number of complexes is greater than the number of patients in each group. Patient were to have at least one symptom complex that was moderate or severe. The total number of symptom complexes was 155.|symptom complexes|Number|18|18.0||||||
4323569|NCT00457015|4151030|B3|Internal Head/Neck||Symptom Complexes at Baseline|More than one baseline symptom complex could be reported per patient; hence the number of complexes is greater than the number of patients in each group. Patient were to have at least one symptom complex that was moderate or severe. The total number of symptom complexes was 155.|symptom complexes|Number|21|21.0||||||
4323570|NCT00457015|4151031|B2|Internal Head/Neck||Symptom Complexes at Baseline|More than one baseline symptom complex could be reported per patient; hence the number of complexes is greater than the number of patients in each group. Patient were to have at least one symptom complex that was moderate or severe. The total number of symptom complexes was 155.|symptom complexes|Number|13|13.0||||||
4323571|NCT00457015|4151032|B1|Internal Head/Neck||Symptom Complexes at Baseline|More than one baseline symptom complex could be reported per patient; hence the number of complexes is greater than the number of patients in each group. Patient were to have at least one symptom complex that was moderate or severe. The total number of symptom complexes was 155.|symptom complexes|Number|8|8.0||||||
4323572|NCT00457015|4151030|B3|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4323573|NCT00457015|4151031|B2|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4323574|NCT00457015|4151032|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4323575|NCT00457015|4151030|B3|United States||Region of Enrollment||participants|Number|95|95.0||||||
4323576|NCT00457015|4151031|B2|United States||Region of Enrollment||participants|Number|48|48.0||||||
4323577|NCT00457015|4151032|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
4323578|NCT00457015|4151030|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4323579|NCT00457015|4151031|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4323580|NCT00457015|4151032|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4323581|NCT00457015|4151030|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4323582|NCT00457015|4151031|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4323583|NCT00457015|4151032|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4323584|NCT00457015|4151030|B3|||Age||years|Mean|37.5|37.5|Standard Deviation|12.61|12.61|||
4323585|NCT00457015|4151031|B2|||Age||years|Mean|38.0|38.0|Standard Deviation|12.19|12.19|||
4323586|NCT00457015|4151032|B1|||Age||years|Mean|37.0|37.0|Standard Deviation|13.12|13.12|||
4323587|NCT00457002|4151047|B3|Chronic Heart Failure||Participants with Risk Factors|This baseline measures randomized participants.|participants|Number|3068|3068.0||||||
4323588|NCT00457002|4151048|B2|Chronic Heart Failure||Participants with Risk Factors|This baseline measures randomized participants.|participants|Number|1537|1537.0||||||
4323589|NCT00457002|4151049|B1|Chronic Heart Failure||Participants with Risk Factors|This baseline measures randomized participants.|participants|Number|1531|1531.0||||||
4323590|NCT00457002|4151047|B3|History of Malignancy||Participants with Risk Factors|This baseline measures randomized participants.|participants|Number|632|632.0||||||
4323591|NCT00457002|4151048|B2|History of Malignancy||Participants with Risk Factors|This baseline measures randomized participants.|participants|Number|320|320.0||||||
4323592|NCT00457002|4151049|B1|History of Malignancy||Participants with Risk Factors|This baseline measures randomized participants.|participants|Number|312|312.0||||||
4323593|NCT00457002|4151047|B3|Estrogenic Hormone Therapy||Participants with Risk Factors|This baseline measures randomized participants.|participants|Number|76|76.0||||||
4323594|NCT00457002|4151048|B2|Estrogenic Hormone Therapy||Participants with Risk Factors|This baseline measures randomized participants.|participants|Number|27|27.0||||||
4323595|NCT00457002|4151049|B1|Estrogenic Hormone Therapy||Participants with Risk Factors|This baseline measures randomized participants.|participants|Number|49|49.0||||||
4323596|NCT00457002|4151047|B3|Previous Venous Thromboembolism (VTE)||Participants with Risk Factors|This baseline measures randomized participants.|participants|Number|265|265.0||||||
4323597|NCT00457002|4151048|B2|Previous Venous Thromboembolism (VTE)||Participants with Risk Factors|This baseline measures randomized participants.|participants|Number|124|124.0||||||
4323598|NCT00457002|4151049|B1|Previous Venous Thromboembolism (VTE)||Participants with Risk Factors|This baseline measures randomized participants.|participants|Number|141|141.0||||||
4323599|NCT00457002|4151047|B3|Sweden||Region of Enrollment|Randomized Participants.|participants|Number|4|4.0||||||
4323600|NCT00457002|4151048|B2|Sweden||Region of Enrollment|Randomized Participants.|participants|Number|2|2.0||||||
4323601|NCT00457002|4151049|B1|Sweden||Region of Enrollment|Randomized Participants.|participants|Number|2|2.0||||||
4323602|NCT00457002|4151047|B3|Germany||Region of Enrollment|Randomized Participants.|participants|Number|67|67.0||||||
4323603|NCT00457002|4151048|B2|Germany||Region of Enrollment|Randomized Participants.|participants|Number|32|32.0||||||
4323604|NCT00457002|4151049|B1|Germany||Region of Enrollment|Randomized Participants.|participants|Number|35|35.0||||||
4323605|NCT00457002|4151047|B3|Norway||Region of Enrollment|Randomized Participants.|participants|Number|5|5.0||||||
4323606|NCT00457002|4151048|B2|Norway||Region of Enrollment|Randomized Participants.|participants|Number|2|2.0||||||
4323607|NCT00457002|4151049|B1|Norway||Region of Enrollment|Randomized Participants.|participants|Number|3|3.0||||||
4323608|NCT00457002|4151047|B3|Singapore||Region of Enrollment|Randomized Participants.|participants|Number|20|20.0||||||
4323609|NCT00457002|4151048|B2|Singapore||Region of Enrollment|Randomized Participants.|participants|Number|12|12.0||||||
4323610|NCT00457002|4151049|B1|Singapore||Region of Enrollment|Randomized Participants.|participants|Number|8|8.0||||||
4323611|NCT00457002|4151047|B3|Poland||Region of Enrollment|Randomized Participants.|participants|Number|117|117.0||||||
4323612|NCT00457002|4151048|B2|Poland||Region of Enrollment|Randomized Participants.|participants|Number|60|60.0||||||
4323613|NCT00457002|4151049|B1|Poland||Region of Enrollment|Randomized Participants.|participants|Number|57|57.0||||||
4323614|NCT00457002|4151047|B3|Belgium||Region of Enrollment|Randomized Participants.|participants|Number|43|43.0||||||
4323615|NCT00457002|4151048|B2|Belgium||Region of Enrollment|Randomized Participants.|participants|Number|22|22.0||||||
4323616|NCT00457002|4151049|B1|Belgium||Region of Enrollment|Randomized Participants.|participants|Number|21|21.0||||||
4323617|NCT00457002|4151047|B3|Brazil||Region of Enrollment|Randomized Participants.|participants|Number|86|86.0||||||
4323618|NCT00457002|4151048|B2|Brazil||Region of Enrollment|Randomized Participants.|participants|Number|45|45.0||||||
4323619|NCT00457002|4151049|B1|Brazil||Region of Enrollment|Randomized Participants.|participants|Number|41|41.0||||||
4323620|NCT00457002|4151047|B3|Argentina||Region of Enrollment|Randomized Participants.|participants|Number|155|155.0||||||
4323621|NCT00457002|4151048|B2|Argentina||Region of Enrollment|Randomized Participants.|participants|Number|77|77.0||||||
4323622|NCT00457002|4151049|B1|Argentina||Region of Enrollment|Randomized Participants.|participants|Number|78|78.0||||||
4323623|NCT00457002|4151047|B3|Canada||Region of Enrollment|Randomized Participants.|participants|Number|92|92.0||||||
4323624|NCT00457002|4151048|B2|Canada||Region of Enrollment|Randomized Participants.|participants|Number|47|47.0||||||
4323625|NCT00457002|4151049|B1|Canada||Region of Enrollment|Randomized Participants.|participants|Number|45|45.0||||||
4323626|NCT00457002|4151047|B3|Mexico||Region of Enrollment|Randomized Participants.|participants|Number|117|117.0||||||
4323627|NCT00457002|4151048|B2|Mexico||Region of Enrollment|Randomized Participants.|participants|Number|59|59.0||||||
4323628|NCT00457002|4151049|B1|Mexico||Region of Enrollment|Randomized Participants.|participants|Number|58|58.0||||||
4323629|NCT00457002|4151047|B3|Czech Republic||Region of Enrollment|Randomized Participants.|participants|Number|109|109.0||||||
4323630|NCT00457002|4151048|B2|Czech Republic||Region of Enrollment|Randomized Participants.|participants|Number|56|56.0||||||
4323631|NCT00457002|4151049|B1|Czech Republic||Region of Enrollment|Randomized Participants.|participants|Number|53|53.0||||||
4323632|NCT00457002|4151047|B3|Hungary||Region of Enrollment|Randomized Participants.|participants|Number|34|34.0||||||
4323633|NCT00457002|4151048|B2|Hungary||Region of Enrollment|Randomized Participants.|participants|Number|16|16.0||||||
4323634|NCT00457002|4151049|B1|Hungary||Region of Enrollment|Randomized Participants.|participants|Number|18|18.0||||||
4323635|NCT00457002|4151047|B3|United Kingdom||Region of Enrollment|Randomized Participants.|participants|Number|389|389.0||||||
4323636|NCT00457002|4151048|B2|United Kingdom||Region of Enrollment|Randomized Participants.|participants|Number|194|194.0||||||
4323637|NCT00457002|4151049|B1|United Kingdom||Region of Enrollment|Randomized Participants.|participants|Number|195|195.0||||||
4323638|NCT00457002|4151047|B3|Austria||Region of Enrollment|Randomized Participants.|participants|Number|12|12.0||||||
4323639|NCT00457002|4151048|B2|Austria||Region of Enrollment|Randomized Participants.|participants|Number|7|7.0||||||
4323640|NCT00457002|4151049|B1|Austria||Region of Enrollment|Randomized Participants.|participants|Number|5|5.0||||||
4323641|NCT00457002|4151047|B3|Turkey||Region of Enrollment|Randomized Participants.|participants|Number|19|19.0||||||
4323642|NCT00457002|4151048|B2|Turkey||Region of Enrollment|Randomized Participants.|participants|Number|10|10.0||||||
4323643|NCT00457002|4151049|B1|Turkey||Region of Enrollment|Randomized Participants.|participants|Number|9|9.0||||||
4323644|NCT00457002|4151047|B3|Korea, Republic of||Region of Enrollment|Randomized Participants.|participants|Number|66|66.0||||||
4323645|NCT00457002|4151048|B2|Korea, Republic of||Region of Enrollment|Randomized Participants.|participants|Number|33|33.0||||||
4323646|NCT00457002|4151049|B1|Korea, Republic of||Region of Enrollment|Randomized Participants.|participants|Number|33|33.0||||||
4323647|NCT00457002|4151047|B3|Netherlands||Region of Enrollment|Randomized Participants.|participants|Number|1|1.0||||||
4323648|NCT00457002|4151048|B2|Netherlands||Region of Enrollment|Randomized Participants.|participants|Number|0|0.0||||||
4323649|NCT00457002|4151049|B1|Netherlands||Region of Enrollment|Randomized Participants.|participants|Number|1|1.0||||||
4323650|NCT00457002|4151047|B3|South Africa||Region of Enrollment|Randomized Participants.|participants|Number|100|100.0||||||
4323651|NCT00457002|4151048|B2|South Africa||Region of Enrollment|Randomized Participants.|participants|Number|48|48.0||||||
4323652|NCT00457002|4151049|B1|South Africa||Region of Enrollment|Randomized Participants.|participants|Number|52|52.0||||||
4323653|NCT00457002|4151047|B3|Peru||Region of Enrollment|Randomized Participants.|participants|Number|240|240.0||||||
4323654|NCT00457002|4151048|B2|Peru||Region of Enrollment|Randomized Participants.|participants|Number|121|121.0||||||
4323655|NCT00457002|4151049|B1|Peru||Region of Enrollment|Randomized Participants.|participants|Number|119|119.0||||||
4323656|NCT00457002|4151047|B3|Australia||Region of Enrollment|Randomized Participants.|participants|Number|100|100.0||||||
4323657|NCT00457002|4151048|B2|Australia||Region of Enrollment|Randomized Participants.|participants|Number|49|49.0||||||
4323658|NCT00457002|4151049|B1|Australia||Region of Enrollment|Randomized Participants.|participants|Number|51|51.0||||||
4323659|NCT00457002|4151047|B3|Denmark||Region of Enrollment|Randomized Participants.|participants|Number|103|103.0||||||
4323660|NCT00457002|4151048|B2|Denmark||Region of Enrollment|Randomized Participants.|participants|Number|54|54.0||||||
4323661|NCT00457002|4151049|B1|Denmark||Region of Enrollment|Randomized Participants.|participants|Number|49|49.0||||||
4323662|NCT00457002|4151047|B3|Malaysia||Region of Enrollment|Randomized Participants.|participants|Number|20|20.0||||||
4323663|NCT00457002|4151048|B2|Malaysia||Region of Enrollment|Randomized Participants.|participants|Number|11|11.0||||||
4323664|NCT00457002|4151049|B1|Malaysia||Region of Enrollment|Randomized Participants.|participants|Number|9|9.0||||||
4323665|NCT00457002|4151047|B3|France||Region of Enrollment|Randomized Participants.|participants|Number|403|403.0||||||
4323666|NCT00457002|4151048|B2|France||Region of Enrollment|Randomized Participants.|participants|Number|200|200.0||||||
4323667|NCT00457002|4151049|B1|France||Region of Enrollment|Randomized Participants.|participants|Number|203|203.0||||||
4323668|NCT00457002|4151047|B3|India||Region of Enrollment|Randomized Participants.|participants|Number|400|400.0||||||
4323669|NCT00457002|4151048|B2|India||Region of Enrollment|Randomized Participants.|participants|Number|202|202.0||||||
4323670|NCT00457002|4151049|B1|India||Region of Enrollment|Randomized Participants.|participants|Number|198|198.0||||||
4323671|NCT00457002|4151047|B3|Italy||Region of Enrollment|Randomized Participants.|participants|Number|69|69.0||||||
4323672|NCT00457002|4151048|B2|Italy||Region of Enrollment|Randomized Participants.|participants|Number|34|34.0||||||
4323673|NCT00457002|4151049|B1|Italy||Region of Enrollment|Randomized Participants.|participants|Number|35|35.0||||||
4323674|NCT00457002|4151047|B3|Colombia||Region of Enrollment|Randomized Participants.|participants|Number|24|24.0||||||
4323675|NCT00457002|4151048|B2|Colombia||Region of Enrollment|Randomized Participants.|participants|Number|14|14.0||||||
4323676|NCT00457002|4151049|B1|Colombia||Region of Enrollment|Randomized Participants.|participants|Number|10|10.0||||||
4323677|NCT00457002|4151047|B3|Russian Federation||Region of Enrollment|Randomized Participants.|participants|Number|1264|1264.0||||||
4323678|NCT00457002|4151048|B2|Russian Federation||Region of Enrollment|Randomized Participants.|participants|Number|632|632.0||||||
4323679|NCT00457002|4151049|B1|Russian Federation||Region of Enrollment|Randomized Participants.|participants|Number|632|632.0||||||
4323680|NCT00457002|4151047|B3|Israel||Region of Enrollment|Randomized Participants.|participants|Number|336|336.0||||||
4323681|NCT00457002|4151048|B2|Israel||Region of Enrollment|Randomized Participants.|participants|Number|168|168.0||||||
4323682|NCT00457002|4151049|B1|Israel||Region of Enrollment|Randomized Participants.|participants|Number|168|168.0||||||
4323683|NCT00457002|4151047|B3|Chile||Region of Enrollment|Randomized Participants.|participants|Number|130|130.0||||||
4323684|NCT00457002|4151048|B2|Chile||Region of Enrollment|Randomized Participants.|participants|Number|65|65.0||||||
4323685|NCT00457002|4151049|B1|Chile||Region of Enrollment|Randomized Participants.|participants|Number|65|65.0||||||
4323686|NCT00457002|4151047|B3|Ukraine||Region of Enrollment|Randomized Participants.|participants|Number|546|546.0||||||
4323687|NCT00457002|4151048|B2|Ukraine||Region of Enrollment|Randomized Participants.|participants|Number|276|276.0||||||
4323688|NCT00457002|4151049|B1|Ukraine||Region of Enrollment|Randomized Participants.|participants|Number|270|270.0||||||
4323689|NCT00457002|4151047|B3|Spain||Region of Enrollment|Randomized Participants.|participants|Number|101|101.0||||||
4323690|NCT00457002|4151048|B2|Spain||Region of Enrollment|Randomized Participants.|participants|Number|50|50.0||||||
4323691|NCT00457002|4151049|B1|Spain||Region of Enrollment|Randomized Participants.|participants|Number|51|51.0||||||
4323692|NCT00457002|4151047|B3|Taiwan||Region of Enrollment|Randomized Participants.|participants|Number|15|15.0||||||
4323693|NCT00457002|4151048|B2|Taiwan||Region of Enrollment|Randomized Participants.|participants|Number|7|7.0||||||
4323694|NCT00457002|4151049|B1|Taiwan||Region of Enrollment|Randomized Participants.|participants|Number|8|8.0||||||
4323695|NCT00457002|4151047|B3|Hong Kong||Region of Enrollment|Randomized Participants.|participants|Number|52|52.0||||||
4323696|NCT00457002|4151048|B2|Hong Kong||Region of Enrollment|Randomized Participants.|participants|Number|26|26.0||||||
4323697|NCT00457002|4151049|B1|Hong Kong||Region of Enrollment|Randomized Participants.|participants|Number|26|26.0||||||
4323698|NCT00457002|4151047|B3|Philippines||Region of Enrollment|Randomized Participants.|participants|Number|44|44.0||||||
4323699|NCT00457002|4151048|B2|Philippines||Region of Enrollment|Randomized Participants.|participants|Number|22|22.0||||||
4323700|NCT00457002|4151049|B1|Philippines||Region of Enrollment|Randomized Participants.|participants|Number|22|22.0||||||
4323701|NCT00457002|4151047|B3|United States||Region of Enrollment|Randomized Participants.|participants|Number|1245|1245.0||||||
4323702|NCT00457002|4151048|B2|United States||Region of Enrollment|Randomized Participants.|participants|Number|620|620.0||||||
4323703|NCT00457002|4151049|B1|United States||Region of Enrollment|Randomized Participants.|participants|Number|625|625.0||||||
4323704|NCT00457002|4151047|B3||Male|Sex: Female, Male||Participants|Count of Participants|3203|3203.0||||||
4323705|NCT00457002|4151048|B2||Male|Sex: Female, Male||Participants|Count of Participants|1577|1577.0||||||
4323706|NCT00457002|4151049|B1||Male|Sex: Female, Male||Participants|Count of Participants|1626|1626.0||||||
4323707|NCT00457002|4151047|B3||Female|Sex: Female, Male||Participants|Count of Participants|3325|3325.0||||||
4323708|NCT00457002|4151048|B2||Female|Sex: Female, Male||Participants|Count of Participants|1696|1696.0||||||
4323709|NCT00457002|4151049|B1||Female|Sex: Female, Male||Participants|Count of Participants|1629|1629.0||||||
4323710|NCT00457002|4151047|B3|>= 75 years||Age, Customized||participants|Number|1942|1942.0||||||
4323711|NCT00457002|4151048|B2|>= 75 years||Age, Customized||participants|Number|978|978.0||||||
4323712|NCT00457002|4151049|B1|>= 75 years||Age, Customized||participants|Number|964|964.0||||||
4323713|NCT00457002|4151047|B3|Greater than, equal to (>=) 65 and < 75 years||Age, Customized||participants|Number|1774|1774.0||||||
4323714|NCT00457002|4151048|B2|Greater than, equal to (>=) 65 and < 75 years||Age, Customized||participants|Number|884|884.0||||||
4323715|NCT00457002|4151049|B1|Greater than, equal to (>=) 65 and < 75 years||Age, Customized||participants|Number|890|890.0||||||
4323716|NCT00457002|4151047|B3|Less than (<) 65 years||Age, Customized||participants|Number|2812|2812.0||||||
4323717|NCT00457002|4151048|B2|Less than (<) 65 years||Age, Customized||participants|Number|1411|1411.0||||||
4323718|NCT00457002|4151049|B1|Less than (<) 65 years||Age, Customized||participants|Number|1401|1401.0||||||
4323719|NCT00457002|4151047|B3|||Age||years|Median|67.0|67.0|Full Range|||40.0|101.0|
4323720|NCT00457002|4151048|B2|||Age||years|Median|67.0|67.0|Full Range|||40.0|98.0|
4323721|NCT00457002|4151049|B1|||Age||years|Median|68.0|68.0|Full Range|||40.0|101.0|
4323722|NCT00456989|4151118|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4323723|NCT00456989|4151118|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4323724|NCT00456989|4151118|B1|>=18||Age, Customized||Participants|Number|39|39.0||||||
4323725|NCT00456885|4151122|B1|||Resting Energy Expenditure|Using indirect calorimetry|Kilocalories|Mean|1439|1439.0|Standard Deviation|196|196.0|||
4323726|NCT00456885|4151122|B1|||Leptin||ng/ml|Mean|36|36.0|Standard Deviation|18|18.0|||
4323727|NCT00456885|4151122|B1|||Adiponectin||micrograms/ml|Mean|6|6.0|Standard Deviation|3|3.0|||
4323728|NCT00456885|4151122|B1|||Two Hour Glucose||mg/dl|Mean|110|110.0|Standard Deviation|32|32.0|||
4323729|NCT00456885|4151122|B1|||Fasting Glucose||mg/dl|Mean|85|85.0|Standard Deviation|12|12.0|||
4323730|NCT00456885|4151122|B1|||Fasting Insulin||mU per liter|Mean|8|8.0|Standard Deviation|6|6.0|||
4323731|NCT00456885|4151122|B1|||Triglycerides||mg/dl|Mean|111|111.0|Standard Deviation|64|64.0|||
4323732|NCT00456885|4151122|B1|||Total Cholesterol||mg/dl|Mean|198|198.0|Standard Deviation|32|32.0|||
4323733|NCT00456885|4151122|B1|||LDL||mg/dl|Mean|114|114.0|Standard Deviation|28|28.0|||
4323734|NCT00456885|4151122|B1|||HDL||mg/dl|Mean|62|62.0|Standard Deviation|19|19.0|||
4323735|NCT00456885|4151122|B1|||Diastolic BP||mm of Mercury|Mean|75|75.0|Standard Deviation|8|8.0|||
4323736|NCT00456885|4151122|B1|||Systolic BP||mm of mercury|Mean|128|128.0|Standard Deviation|14|14.0|||
4323737|NCT00456885|4151122|B1|||Body Fat|Measured using bio-electrical impedance|percent|Mean|40|40.0|Standard Deviation|5|5.0|||
4323738|NCT00456885|4151122|B1|||Waist|centimeters|centrimeters|Mean|105|105.0|Standard Deviation|12|12.0|||
4323739|NCT00456885|4151122|B1|||HOMA IR|This is the ratio of fasting glucose to fasting insulin. It has no definable upper limit. We are showing scores in our study participants.|Ratio|Mean|2|2.0|Standard Deviation|1|1.0|||
4323740|NCT00456885|4151122|B1|||BMI||Kg/meter^2|Mean|33|33.0|Standard Deviation|4|4.0|||
4323741|NCT00456885|4151122|B1|||Weight||Kilograms|Mean|89|89.0|Standard Deviation|14|14.0|||
4323742|NCT00456885|4151122|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4323743|NCT00456885|4151122|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4323744|NCT00456885|4151122|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4323745|NCT00456885|4151122|B1|||Age||years|Mean|48|48.0|Standard Deviation|11|11.0|||
4323746|NCT00456846|4151152|B3|Grade 1||Physician Assessment of Peripheral Neuropathy] [2]|"The physician assessed sensory neuropathy using the National Cancer Institute's Common Terminology Criteria for Adverse Events (NCI CTCAE) of Neurology -- Neuropathy - Sensory. The scale is 0 = normal, 1 = asymptomatic; loss of deep tendon reflexes or paresthesia (including tingling) but not interfering with function, 2 = sensory alteration or paresthesia (including tingling), interfering with activities of daily living (ADL); 3 = Sensory alteration or parasthesia interfering with ADLs; 4 = disabling"|participants|Number|17|17.0||||||
4323747|NCT00456846|4151153|B2|Grade 1||Physician Assessment of Peripheral Neuropathy] [2]|"The physician assessed sensory neuropathy using the National Cancer Institute's Common Terminology Criteria for Adverse Events (NCI CTCAE) of Neurology -- Neuropathy - Sensory. The scale is 0 = normal, 1 = asymptomatic; loss of deep tendon reflexes or paresthesia (including tingling) but not interfering with function, 2 = sensory alteration or paresthesia (including tingling), interfering with activities of daily living (ADL); 3 = Sensory alteration or parasthesia interfering with ADLs; 4 = disabling"|participants|Number|7|7.0||||||
4323793|NCT00456846|4151154|B1|Premenopausal||Menopausal Status||participants|Number|12|12.0||||||
4323860|NCT00456547|4151223|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4323748|NCT00456846|4151154|B1|Grade 1||Physician Assessment of Peripheral Neuropathy] [2]|"The physician assessed sensory neuropathy using the National Cancer Institute's Common Terminology Criteria for Adverse Events (NCI CTCAE) of Neurology -- Neuropathy - Sensory. The scale is 0 = normal, 1 = asymptomatic; loss of deep tendon reflexes or paresthesia (including tingling) but not interfering with function, 2 = sensory alteration or paresthesia (including tingling), interfering with activities of daily living (ADL); 3 = Sensory alteration or parasthesia interfering with ADLs; 4 = disabling"|participants|Number|10|10.0||||||
4323749|NCT00456846|4151152|B3|Grade 0||Physician Assessment of Peripheral Neuropathy] [2]|"The physician assessed sensory neuropathy using the National Cancer Institute's Common Terminology Criteria for Adverse Events (NCI CTCAE) of Neurology -- Neuropathy - Sensory. The scale is 0 = normal, 1 = asymptomatic; loss of deep tendon reflexes or paresthesia (including tingling) but not interfering with function, 2 = sensory alteration or paresthesia (including tingling), interfering with activities of daily living (ADL); 3 = Sensory alteration or parasthesia interfering with ADLs; 4 = disabling"|participants|Number|106|106.0||||||
4323750|NCT00456846|4151153|B2|Grade 0||Physician Assessment of Peripheral Neuropathy] [2]|"The physician assessed sensory neuropathy using the National Cancer Institute's Common Terminology Criteria for Adverse Events (NCI CTCAE) of Neurology -- Neuropathy - Sensory. The scale is 0 = normal, 1 = asymptomatic; loss of deep tendon reflexes or paresthesia (including tingling) but not interfering with function, 2 = sensory alteration or paresthesia (including tingling), interfering with activities of daily living (ADL); 3 = Sensory alteration or parasthesia interfering with ADLs; 4 = disabling"|participants|Number|69|69.0||||||
4323751|NCT00456846|4151154|B1|Grade 0||Physician Assessment of Peripheral Neuropathy] [2]|"The physician assessed sensory neuropathy using the National Cancer Institute's Common Terminology Criteria for Adverse Events (NCI CTCAE) of Neurology -- Neuropathy - Sensory. The scale is 0 = normal, 1 = asymptomatic; loss of deep tendon reflexes or paresthesia (including tingling) but not interfering with function, 2 = sensory alteration or paresthesia (including tingling), interfering with activities of daily living (ADL); 3 = Sensory alteration or parasthesia interfering with ADLs; 4 = disabling"|participants|Number|37|37.0||||||
4323752|NCT00456846|4151152|B3|3 (limited self-care) + 4 (completely disabled)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|0|0.0||||||
4323753|NCT00456846|4151153|B2|3 (limited self-care) + 4 (completely disabled)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|0|0.0||||||
4323754|NCT00456846|4151154|B1|3 (limited self-care) + 4 (completely disabled)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|0|0.0||||||
4323755|NCT00456846|4151152|B3|2 (ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|12|12.0||||||
4323756|NCT00456846|4151153|B2|2 (ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|8|8.0||||||
4323757|NCT00456846|4151154|B1|2 (ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|4|4.0||||||
4323758|NCT00456846|4151152|B3|1 (restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|52|52.0||||||
4323759|NCT00456846|4151153|B2|1 (restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|30|30.0||||||
4323760|NCT00456846|4151154|B1|1 (restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|22|22.0||||||
4323761|NCT00456846|4151152|B3|0 (fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|59|59.0||||||
4323762|NCT00456846|4151153|B2|0 (fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|38|38.0||||||
4323763|NCT00456846|4151154|B1|0 (fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|21|21.0||||||
4323794|NCT00456846|4151152|B3|Other-Unspecified||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4323795|NCT00456846|4151153|B2|Other-Unspecified||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4323764|NCT00456846|4151152|B3|Unknown||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes. Stage IIb-a larger tumor than earlier phases. Stage IIIa-axillary lymph nodes clumping together. Stage IIIb-spread further to the skin, breast bone or chest wall. Stage IIIc-expanded involvement of lymph nodes. Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|3|3.0||||||
4323765|NCT00456846|4151153|B2|Unknown||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes. Stage IIb-a larger tumor than earlier phases. Stage IIIa-axillary lymph nodes clumping together. Stage IIIb-spread further to the skin, breast bone or chest wall. Stage IIIc-expanded involvement of lymph nodes. Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|3|3.0||||||
4323766|NCT00456846|4151154|B1|Unknown||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes. Stage IIb-a larger tumor than earlier phases. Stage IIIa-axillary lymph nodes clumping together. Stage IIIb-spread further to the skin, breast bone or chest wall. Stage IIIc-expanded involvement of lymph nodes. Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|0|0.0||||||
4323767|NCT00456846|4151152|B3|Stage IV||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes. Stage IIb-a larger tumor than earlier phases. Stage IIIa-axillary lymph nodes clumping together. Stage IIIb-spread further to the skin, breast bone or chest wall. Stage IIIc-expanded involvement of lymph nodes. Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|19|19.0||||||
4323768|NCT00456846|4151153|B2|Stage IV||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes. Stage IIb-a larger tumor than earlier phases. Stage IIIa-axillary lymph nodes clumping together. Stage IIIb-spread further to the skin, breast bone or chest wall. Stage IIIc-expanded involvement of lymph nodes. Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|19|19.0||||||
4323769|NCT00456846|4151154|B1|Stage IV||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes. Stage IIb-a larger tumor than earlier phases. Stage IIIa-axillary lymph nodes clumping together. Stage IIIb-spread further to the skin, breast bone or chest wall. Stage IIIc-expanded involvement of lymph nodes. Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|0|0.0||||||
4323770|NCT00456846|4151152|B3|Stage IIIc||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes. Stage IIb-a larger tumor than earlier phases. Stage IIIa-axillary lymph nodes clumping together. Stage IIIb-spread further to the skin, breast bone or chest wall. Stage IIIc-expanded involvement of lymph nodes. Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|10|10.0||||||
4323771|NCT00456846|4151153|B2|Stage IIIc||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes. Stage IIb-a larger tumor than earlier phases. Stage IIIa-axillary lymph nodes clumping together. Stage IIIb-spread further to the skin, breast bone or chest wall. Stage IIIc-expanded involvement of lymph nodes. Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|5|5.0||||||
4323772|NCT00456846|4151154|B1|Stage IIIc||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes. Stage IIb-a larger tumor than earlier phases. Stage IIIa-axillary lymph nodes clumping together. Stage IIIb-spread further to the skin, breast bone or chest wall. Stage IIIc-expanded involvement of lymph nodes. Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|5|5.0||||||
4323773|NCT00456846|4151152|B3|Stage IIIb||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes. Stage IIb-a larger tumor than earlier phases. Stage IIIa-axillary lymph nodes clumping together. Stage IIIb-spread further to the skin, breast bone or chest wall. Stage IIIc-expanded involvement of lymph nodes. Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|10|10.0||||||
4323774|NCT00456846|4151153|B2|Stage IIIb||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes. Stage IIb-a larger tumor than earlier phases. Stage IIIa-axillary lymph nodes clumping together. Stage IIIb-spread further to the skin, breast bone or chest wall. Stage IIIc-expanded involvement of lymph nodes. Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|4|4.0||||||
4323775|NCT00456846|4151154|B1|Stage IIIb||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes. Stage IIb-a larger tumor than earlier phases. Stage IIIa-axillary lymph nodes clumping together. Stage IIIb-spread further to the skin, breast bone or chest wall. Stage IIIc-expanded involvement of lymph nodes. Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|6|6.0||||||
4323796|NCT00456846|4151154|B1|Other-Unspecified||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4323797|NCT00456846|4151152|B3|White, Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4323798|NCT00456846|4151153|B2|White, Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4323776|NCT00456846|4151152|B3|Stage IIIa||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes. Stage IIb-a larger tumor than earlier phases. Stage IIIa-axillary lymph nodes clumping together. Stage IIIb-spread further to the skin, breast bone or chest wall. Stage IIIc-expanded involvement of lymph nodes. Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|19|19.0||||||
4323777|NCT00456846|4151153|B2|Stage IIIa||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes. Stage IIb-a larger tumor than earlier phases. Stage IIIa-axillary lymph nodes clumping together. Stage IIIb-spread further to the skin, breast bone or chest wall. Stage IIIc-expanded involvement of lymph nodes. Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|8|8.0||||||
4323778|NCT00456846|4151154|B1|Stage IIIa||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes. Stage IIb-a larger tumor than earlier phases. Stage IIIa-axillary lymph nodes clumping together. Stage IIIb-spread further to the skin, breast bone or chest wall. Stage IIIc-expanded involvement of lymph nodes. Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|11|11.0||||||
4323779|NCT00456846|4151152|B3|Stage IIb||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes. Stage IIb-a larger tumor than earlier phases. Stage IIIa-axillary lymph nodes clumping together. Stage IIIb-spread further to the skin, breast bone or chest wall. Stage IIIc-expanded involvement of lymph nodes. Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|27|27.0||||||
4323780|NCT00456846|4151153|B2|Stage IIb||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes. Stage IIb-a larger tumor than earlier phases. Stage IIIa-axillary lymph nodes clumping together. Stage IIIb-spread further to the skin, breast bone or chest wall. Stage IIIc-expanded involvement of lymph nodes. Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|13|13.0||||||
4323781|NCT00456846|4151154|B1|Stage IIb||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes. Stage IIb-a larger tumor than earlier phases. Stage IIIa-axillary lymph nodes clumping together. Stage IIIb-spread further to the skin, breast bone or chest wall. Stage IIIc-expanded involvement of lymph nodes. Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|14|14.0||||||
4323782|NCT00456846|4151152|B3|Stage IIa||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes. Stage IIb-a larger tumor than earlier phases. Stage IIIa-axillary lymph nodes clumping together. Stage IIIb-spread further to the skin, breast bone or chest wall. Stage IIIc-expanded involvement of lymph nodes. Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|19|19.0||||||
4323783|NCT00456846|4151153|B2|Stage IIa||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes. Stage IIb-a larger tumor than earlier phases. Stage IIIa-axillary lymph nodes clumping together. Stage IIIb-spread further to the skin, breast bone or chest wall. Stage IIIc-expanded involvement of lymph nodes. Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|12|12.0||||||
4323784|NCT00456846|4151154|B1|Stage IIa||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes. Stage IIb-a larger tumor than earlier phases. Stage IIIa-axillary lymph nodes clumping together. Stage IIIb-spread further to the skin, breast bone or chest wall. Stage IIIc-expanded involvement of lymph nodes. Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|7|7.0||||||
4323785|NCT00456846|4151152|B3|Stage I||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes. Stage IIb-a larger tumor than earlier phases. Stage IIIa-axillary lymph nodes clumping together. Stage IIIb-spread further to the skin, breast bone or chest wall. Stage IIIc-expanded involvement of lymph nodes. Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|16|16.0||||||
4323786|NCT00456846|4151153|B2|Stage I||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes. Stage IIb-a larger tumor than earlier phases. Stage IIIa-axillary lymph nodes clumping together. Stage IIIb-spread further to the skin, breast bone or chest wall. Stage IIIc-expanded involvement of lymph nodes. Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|12|12.0||||||
4323787|NCT00456846|4151154|B1|Stage I||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes. Stage IIb-a larger tumor than earlier phases. Stage IIIa-axillary lymph nodes clumping together. Stage IIIb-spread further to the skin, breast bone or chest wall. Stage IIIc-expanded involvement of lymph nodes. Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|4|4.0||||||
4323788|NCT00456846|4151152|B3|Postmenopausal||Menopausal Status||participants|Number|99|99.0||||||
4323789|NCT00456846|4151153|B2|Postmenopausal||Menopausal Status||participants|Number|64|64.0||||||
4323790|NCT00456846|4151154|B1|Postmenopausal||Menopausal Status||participants|Number|35|35.0||||||
4323799|NCT00456846|4151154|B1|White, Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4323800|NCT00456846|4151152|B3|White, Non-Hispanic/Non Latino||Race/Ethnicity, Customized||participants|Number|101|101.0||||||
4323801|NCT00456846|4151153|B2|White, Non-Hispanic/Non Latino||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
4323802|NCT00456846|4151154|B1|White, Non-Hispanic/Non Latino||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4323803|NCT00456846|4151152|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4323804|NCT00456846|4151153|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4323805|NCT00456846|4151154|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4323806|NCT00456846|4151152|B3|Black, of African Heritage||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4323807|NCT00456846|4151153|B2|Black, of African Heritage||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4323808|NCT00456846|4151154|B1|Black, of African Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4323809|NCT00456846|4151152|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4323810|NCT00456846|4151153|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4323811|NCT00456846|4151154|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4323812|NCT00456846|4151152|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4323813|NCT00456846|4151153|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4323814|NCT00456846|4151154|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4323815|NCT00456846|4151152|B3||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4323816|NCT00456846|4151153|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4323817|NCT00456846|4151154|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4323818|NCT00456846|4151152|B3|||Age||years|Mean|57.2|57.2|Standard Deviation|10.54|10.54|||
4323819|NCT00456846|4151153|B2|||Age||years|Mean|58.3|58.3|Standard Deviation|10.88|10.88|||
4323820|NCT00456846|4151154|B1|||Age||years|Mean|55.3|55.3|Standard Deviation|9.78|9.78|||
4323821|NCT00456807|4151175|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
4323822|NCT00456807|4151176|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
4323823|NCT00456807|4151177|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4323824|NCT00456807|4151175|B3||Female|Gender||Participants|Count of Participants|100|100.0||||||
4323825|NCT00456807|4151176|B2||Female|Gender||Participants|Count of Participants|47|47.0||||||
4323826|NCT00456807|4151177|B1||Female|Gender||Participants|Count of Participants|53|53.0||||||
4323827|NCT00456807|4151175|B3|||Age||years|Mean|40.6|40.6|Standard Deviation|8.63|8.63|||
4323828|NCT00456807|4151176|B2|||Age||years|Mean|40.3|40.3|Standard Deviation|8.83|8.83|||
4323829|NCT00456807|4151177|B1|||Age||years|Mean|40.9|40.9|Standard Deviation|8.44|8.44|||
4323830|NCT00456755|4151194|B3|Hong Kong||Region of Enrollment||participants|Number|126|126.0||||||
4323831|NCT00456755|4151195|B2|Hong Kong||Region of Enrollment||participants|Number|63|63.0||||||
4323832|NCT00456755|4151196|B1|Hong Kong||Region of Enrollment||participants|Number|63|63.0||||||
4323833|NCT00456755|4151194|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4323834|NCT00456755|4151195|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4323835|NCT00456755|4151196|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4323836|NCT00456755|4151194|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4323837|NCT00456755|4151195|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4323838|NCT00456755|4151196|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4323839|NCT00456755|4151194|B3|Age||Age||Year|Mean|38.60|38.6|Standard Deviation|12.01|12.01|||
4323840|NCT00456755|4151195|B2|Age||Age||Year|Mean|36.02|36.02|Standard Deviation|11.14|11.14|||
4323841|NCT00456755|4151196|B1|Age||Age||Year|Mean|41.19|41.19|Standard Deviation|12.38|12.38|||
4323842|NCT00456625|4151205|B1||Male|Gender||Participants|Count of Participants|40|40.0||||||
4323843|NCT00456625|4151205|B1||Female|Gender||Participants|Count of Participants|36|36.0||||||
4323844|NCT00456625|4151205|B1|||Age||years|Mean|19.9|19.9|Standard Deviation|0.59|0.59|||
4323845|NCT00456612|4151211|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4323846|NCT00456612|4151211|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4323847|NCT00456612|4151211|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4323848|NCT00456612|4151211|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4323849|NCT00456612|4151211|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4323850|NCT00456612|4151211|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4323851|NCT00456599|4151216|B1|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4323852|NCT00456599|4151216|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
4323853|NCT00456599|4151216|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4323854|NCT00456599|4151216|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4323855|NCT00456599|4151216|B1|||Age||years|Mean|64|64.0|Full Range|||42.0|83.0|
4323856|NCT00456547|4151222|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4323857|NCT00456547|4151223|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4323858|NCT00456547|4151224|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4323859|NCT00456547|4151222|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4323861|NCT00456547|4151224|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4323862|NCT00456547|4151222|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4323863|NCT00456547|4151223|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4323864|NCT00456547|4151224|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4323865|NCT00456547|4151222|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4323866|NCT00456547|4151223|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4323867|NCT00456547|4151224|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4323868|NCT00456547|4151222|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4323869|NCT00456547|4151223|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4323870|NCT00456547|4151224|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4323871|NCT00456547|4151222|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4323872|NCT00456547|4151223|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4323873|NCT00456547|4151224|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4323874|NCT00456521|4151237|B3|||BMI||kg/m^2|Mean|36.50|36.5|Standard Deviation|4.17|4.17|||
4323875|NCT00456521|4151238|B2|||BMI||kg/m^2|Mean|36.96|36.96|Standard Deviation|4.18|4.18|||
4323876|NCT00456521|4151239|B1|||BMI||kg/m^2|Mean|36.34|36.34|Standard Deviation|4.16|4.16|||
4323877|NCT00456521|4151237|B3|||Weight||kg|Mean|100.60|100.6|Standard Deviation|15.31|15.31|||
4323878|NCT00456521|4151238|B2|||Weight||kg|Mean|101.88|101.88|Standard Deviation|14.96|14.96|||
4323879|NCT00456521|4151239|B1|||Weight||kg|Mean|100.16|100.16|Standard Deviation|15.42|15.42|||
4323880|NCT00456521|4151237|B3|Other||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4323881|NCT00456521|4151238|B2|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4323882|NCT00456521|4151239|B1|Other||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4323883|NCT00456521|4151237|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4323884|NCT00456521|4151238|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4323885|NCT00456521|4151239|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4323886|NCT00456521|4151237|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4323887|NCT00456521|4151238|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4323888|NCT00456521|4151239|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4323889|NCT00456521|4151237|B3|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4323890|NCT00456521|4151238|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4323891|NCT00456521|4151239|B1|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4323892|NCT00456521|4151237|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|189|189.0||||||
4323893|NCT00456521|4151238|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4323894|NCT00456521|4151239|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|145|145.0||||||
4323895|NCT00456521|4151237|B3|White||Race/Ethnicity, Customized||participants|Number|554|554.0||||||
4323896|NCT00456521|4151238|B2|White||Race/Ethnicity, Customized||participants|Number|149|149.0||||||
4323897|NCT00456521|4151239|B1|White||Race/Ethnicity, Customized||participants|Number|405|405.0||||||
4323898|NCT00456521|4151237|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4323899|NCT00456521|4151238|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4323900|NCT00456521|4151239|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4323901|NCT00456521|4151237|B3||Female|Sex: Female, Male||Participants|Count of Participants|713|713.0||||||
4323902|NCT00456521|4151238|B2||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4323903|NCT00456521|4151239|B1||Female|Sex: Female, Male||Participants|Count of Participants|528|528.0||||||
4323904|NCT00456521|4151237|B3|||Age||years|Mean|45.82|45.82|Standard Deviation|10.66|10.66|||
4323905|NCT00456521|4151238|B2|||Age||years|Mean|45.59|45.59|Standard Deviation|11.35|11.35|||
4323906|NCT00456521|4151239|B1|||Age||years|Mean|45.89|45.89|Standard Deviation|10.42|10.42|||
4323907|NCT00456508|4151280|B1|Jordan||Region of Enrollment||participants|Number|5|5.0||||||
4323908|NCT00456508|4151280|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4323909|NCT00456508|4151280|B1|United States||Region of Enrollment||participants|Number|141|141.0||||||
4323910|NCT00456508|4151280|B1||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4323911|NCT00456508|4151280|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4323912|NCT00456508|4151280|B1|||Age||years|Mean|35.8|35.8|Standard Deviation|14.39|14.39|||
4323913|NCT00456495|4151286|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4323914|NCT00456495|4151286|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4323915|NCT00456495|4151286|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4323916|NCT00456495|4151286|B1|||Age||years|Mean|53|53.0|Standard Deviation|11|11.0|||
4323917|NCT00456495|4151286|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4323918|NCT00456495|4151286|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4323919|NCT00456495|4151286|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4323920|NCT00456365|4151291|B3|||LDL cholesterol||mg/dL|Mean|86|86.0|Standard Deviation|22|22.0|||
4323921|NCT00456365|4151292|B2|||LDL cholesterol||mg/dL|Mean|90|90.0|Standard Deviation|21|21.0|||
4323922|NCT00456365|4151293|B1|||LDL cholesterol||mg/dL|Mean|84|84.0|Standard Deviation|23|23.0|||
4323923|NCT00456365|4151291|B3|||Total cholesterol||mg/dL|Mean|148|148.0|Standard Deviation|29|29.0|||
4323924|NCT00456365|4151292|B2|||Total cholesterol||mg/dL|Mean|151|151.0|Standard Deviation|27|27.0|||
4323925|NCT00456365|4151293|B1|||Total cholesterol||mg/dL|Mean|145|145.0|Standard Deviation|30|30.0|||
4323926|NCT00456365|4151291|B3|||Left ventricular mass index|Left ventricular mass index in g/m^2 by MRI|g/m^2|Mean|54|54.0|Standard Deviation|11|11.0|||
4323927|NCT00456365|4151292|B2|||Left ventricular mass index|Left ventricular mass index in g/m^2 by MRI|g/m^2|Mean|53|53.0|Standard Deviation|10|10.0|||
4323928|NCT00456365|4151293|B1|||Left ventricular mass index|Left ventricular mass index in g/m^2 by MRI|g/m^2|Mean|55|55.0|Standard Deviation|12|12.0|||
4323929|NCT00456365|4151291|B3|||Urinary albumin excretion|Urinary albumin excretion in mcg/min|mcg/min|Mean|39|39.0|Standard Deviation|79|79.0|||
4323930|NCT00456365|4151292|B2|||Urinary albumin excretion|Urinary albumin excretion in mcg/min|mcg/min|Mean|51|51.0|Standard Deviation|123|123.0|||
4323931|NCT00456365|4151293|B1|||Urinary albumin excretion|Urinary albumin excretion in mcg/min|mcg/min|Mean|27|27.0|Standard Deviation|37|37.0|||
4323932|NCT00456365|4151291|B3|||Total kidney volume corrected for height|Total kidney volume corrected for height (HtTKV, ml/m)|ml/m|Mean|326|326.0|Standard Deviation|181|181.0|||
4323933|NCT00456365|4151292|B2|||Total kidney volume corrected for height|Total kidney volume corrected for height (HtTKV, ml/m)|ml/m|Mean|315|315.0|Standard Deviation|175|175.0|||
4323934|NCT00456365|4151293|B1|||Total kidney volume corrected for height|Total kidney volume corrected for height (HtTKV, ml/m)|ml/m|Mean|336|336.0|Standard Deviation|187|187.0|||
4323935|NCT00456365|4151291|B3|United States||Region of Enrollment||participants|Number|110|110.0||||||
4323936|NCT00456365|4151292|B2|United States||Region of Enrollment||participants|Number|54|54.0||||||
4323937|NCT00456365|4151293|B1|United States||Region of Enrollment||participants|Number|56|56.0||||||
4323938|NCT00456365|4151291|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4323939|NCT00456365|4151292|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4323940|NCT00456365|4151293|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4323941|NCT00456365|4151291|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4323942|NCT00456365|4151292|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4323943|NCT00456365|4151293|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4323944|NCT00456365|4151291|B3|||Age||years|Mean|16|16.0|Standard Deviation|4|4.0|||
4323945|NCT00456365|4151292|B2|||Age||years|Mean|16|16.0|Standard Deviation|4|4.0|||
4323946|NCT00456365|4151293|B1|||Age||years|Mean|16|16.0|Standard Deviation|4|4.0|||
4323947|NCT00456261|4151306|B3|United States||Region of Enrollment||participants|Number|110|110.0||||||
4323948|NCT00456261|4151307|B2|United States||Region of Enrollment||participants|Number|55|55.0||||||
4323949|NCT00456261|4151308|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4323950|NCT00456261|4151306|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4323951|NCT00456261|4151307|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4323952|NCT00456261|4151308|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4323953|NCT00456261|4151306|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4323954|NCT00456261|4151307|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4323955|NCT00456261|4151308|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4323956|NCT00456261|4151306|B3|||Age||years|Median|77|77.0|Full Range|||70.0|89.0|
4323957|NCT00456261|4151307|B2|||Age||years|Median|77|77.0|Full Range|||70.0|88.0|
4323958|NCT00456261|4151308|B1|||Age||years|Median|76|76.0|Full Range|||70.0|89.0|
4323959|NCT00456014|4151319|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4323960|NCT00456014|4151319|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4323961|NCT00456014|4151319|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4323962|NCT00456014|4151319|B1|||Age||years|Mean|37.35|37.35|Standard Deviation|13.61|13.61|||
4323963|NCT00456014|4151319|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4323964|NCT00456014|4151319|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4323965|NCT00456014|4151319|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4323966|NCT00455975|4151325|B3|United States||Region of Enrollment||participants|Number|119|119.0||||||
4323967|NCT00455975|4151326|B2|United States||Region of Enrollment||participants|Number|61|61.0||||||
4323968|NCT00455975|4151327|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
4323969|NCT00455975|4151325|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4323970|NCT00455975|4151326|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4323971|NCT00455975|4151327|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4323972|NCT00455975|4151325|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4323973|NCT00455975|4151326|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4323974|NCT00455975|4151327|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4323975|NCT00455975|4151325|B3|||Age||years|Median|63|63.0|Full Range|||40.0|88.0|
4323976|NCT00455975|4151326|B2|||Age||years|Median|60|60.0|Full Range|||40.0|88.0|
4323977|NCT00455975|4151327|B1|||Age||years|Median|65|65.0|Full Range|||44.0|88.0|
4323978|NCT00455962|4151340|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4323979|NCT00455962|4151341|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4323980|NCT00455962|4151342|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4323981|NCT00455962|4151340|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4323982|NCT00455962|4151341|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4323983|NCT00455962|4151342|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4323984|NCT00455962|4151340|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4323985|NCT00455962|4151341|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4323986|NCT00455962|4151342|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4323987|NCT00455962|4151340|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4323988|NCT00455962|4151341|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4323989|NCT00455962|4151342|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4323990|NCT00455962|4151340|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4323991|NCT00455962|4151341|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4323992|NCT00455962|4151342|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4323993|NCT00455962|4151340|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4323994|NCT00455962|4151341|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4323995|NCT00455962|4151342|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4323996|NCT00455962|4151340|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4323997|NCT00455962|4151341|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4323998|NCT00455962|4151342|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4323999|NCT00455962|4151340|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324000|NCT00455962|4151341|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324001|NCT00455962|4151342|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324002|NCT00455962|4151340|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324003|NCT00455962|4151341|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324004|NCT00455962|4151342|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324005|NCT00455962|4151340|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4324006|NCT00455962|4151341|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4324007|NCT00455962|4151342|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4324008|NCT00455962|4151340|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324009|NCT00455962|4151341|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324010|NCT00455962|4151342|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324011|NCT00455962|4151340|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4324012|NCT00455962|4151341|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4324013|NCT00455962|4151342|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4324014|NCT00455962|4151340|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4324015|NCT00455962|4151341|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4324016|NCT00455962|4151342|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4324017|NCT00455962|4151340|B3|||Age||years|Mean|28|28.0|Full Range|||22.0|36.0|
4324018|NCT00455962|4151341|B2|||Age||years|Mean|28|28.0|Full Range|||23.0|36.0|
4324019|NCT00455962|4151342|B1|||Age||years|Mean|28|28.0|Full Range|||22.0|36.0|
4324020|NCT00455923|4151349|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324021|NCT00455923|4151350|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324022|NCT00455923|4151351|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324023|NCT00455923|4151349|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324024|NCT00455923|4151350|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324025|NCT00455923|4151351|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324026|NCT00455923|4151349|B3||White|Race (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
4324027|NCT00455923|4151350|B2||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4324028|NCT00455923|4151351|B1||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4324029|NCT00455923|4151349|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324030|NCT00455923|4151350|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324031|NCT00455923|4151351|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324032|NCT00455923|4151349|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324033|NCT00455923|4151350|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324034|NCT00455923|4151351|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324035|NCT00455923|4151349|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324036|NCT00455923|4151350|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324037|NCT00455923|4151351|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324038|NCT00455923|4151349|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324039|NCT00455923|4151350|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324040|NCT00455923|4151351|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324041|NCT00455923|4151349|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4324042|NCT00455923|4151350|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4324043|NCT00455923|4151351|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4324044|NCT00455923|4151349|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4324045|NCT00455923|4151350|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4324046|NCT00455923|4151351|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4324047|NCT00455923|4151349|B3|>=18 to 70 years||Age, Customized||Participants|Count of Participants|100|100.0||||||
4324048|NCT00455923|4151350|B2|>=18 to 70 years||Age, Customized||Participants|Count of Participants|50|50.0||||||
4324049|NCT00455923|4151351|B1|>=18 to 70 years||Age, Customized||Participants|Count of Participants|50|50.0||||||
4324050|NCT00455858|4151368|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4324051|NCT00455858|4151368|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4324052|NCT00455858|4151368|B1|||Age||years|Mean|55.7|55.7|Standard Deviation|9.5|9.5|||
4324053|NCT00455741|4151376|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4324054|NCT00455741|4151377|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4324055|NCT00455741|4151378|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4324056|NCT00455741|4151376|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324057|NCT00455741|4151377|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324058|NCT00455741|4151378|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324059|NCT00455741|4151376|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324060|NCT00455741|4151377|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324061|NCT00455741|4151378|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324062|NCT00455741|4151376|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4324063|NCT00455741|4151377|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4324064|NCT00455741|4151378|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4324065|NCT00455741|4151376|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4324066|NCT00455741|4151377|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324067|NCT00455741|4151378|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4324068|NCT00455741|4151376|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324069|NCT00455741|4151377|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324070|NCT00455741|4151378|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324071|NCT00455741|4151376|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324072|NCT00455741|4151377|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324073|NCT00455741|4151378|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324074|NCT00455741|4151376|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324075|NCT00455741|4151377|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324076|NCT00455741|4151378|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324077|NCT00455741|4151376|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4324078|NCT00455741|4151377|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4324079|NCT00455741|4151378|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4324080|NCT00455741|4151376|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4324081|NCT00455741|4151377|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4324082|NCT00455741|4151378|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4324083|NCT00455741|4151376|B3|||Age, Customized||years|Mean|61.3|61.3|Standard Deviation|13.4|13.4|||
4324084|NCT00455741|4151377|B2|||Age, Customized||years|Mean|75.2|75.2|Standard Deviation|3.6|3.6|||
4324085|NCT00455741|4151378|B1|||Age, Customized||years|Mean|49.9|49.9|Standard Deviation|3.8|3.8|||
4324086|NCT00455702|4151395|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
4324087|NCT00455702|4151396|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4324088|NCT00455702|4151397|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4324089|NCT00455702|4151395|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4324090|NCT00455702|4151396|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4324091|NCT00455702|4151397|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4324092|NCT00455702|4151395|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4324093|NCT00455702|4151396|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4324094|NCT00455702|4151397|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4324095|NCT00455702|4151395|B3|||Age||years|Mean|49.05|49.05|Standard Deviation|7.905|7.905|||
4324096|NCT00455702|4151396|B2|||Age||years|Mean|48|48.0|Standard Deviation|6.66|6.66|||
4324097|NCT00455702|4151397|B1|||Age||years|Mean|50.1|50.1|Standard Deviation|9.15|9.15|||
4324098|NCT00455702|4151395|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4324099|NCT00455702|4151396|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4324100|NCT00455702|4151397|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4324101|NCT00455702|4151395|B3||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4324102|NCT00455702|4151396|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4324103|NCT00455702|4151397|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4324104|NCT00455702|4151395|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4324105|NCT00455702|4151396|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4324106|NCT00455702|4151397|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4324107|NCT00455689|4151406|B3|Hispanic or African-American||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4324108|NCT00455689|4151407|B2|Hispanic or African-American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4324109|NCT00455689|4151408|B1|Hispanic or African-American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4324110|NCT00455689|4151406|B3|Non-Hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4324111|NCT00455689|4151407|B2|Non-Hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4324112|NCT00455689|4151408|B1|Non-Hispanic White||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4324113|NCT00455689|4151406|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4324114|NCT00455689|4151407|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4324115|NCT00455689|4151408|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4324116|NCT00455689|4151406|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4324117|NCT00455689|4151407|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4324118|NCT00455689|4151408|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4324119|NCT00455689|4151406|B3|||Age||years|Mean|30.6|30.6|Standard Deviation|8.9|8.9|||
4324120|NCT00455689|4151407|B2|||Age||years|Mean|25.5|25.5|Standard Deviation|6.7|6.7|||
4324121|NCT00455689|4151408|B1|||Age||years|Mean|32.8|32.8|Standard Deviation|9.0|9.0|||
4324122|NCT00455663|4151416|B4||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4324123|NCT00455663|4151417|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4324124|NCT00455663|4151418|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4324125|NCT00455663|4151419|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4324126|NCT00455663|4151416|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4324127|NCT00455663|4151417|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4324128|NCT00455663|4151418|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4324129|NCT00455663|4151419|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4324130|NCT00455663|4151416|B4|||Age||years|Mean|39.0|39.0|Standard Deviation|10.7|10.7|||
4324131|NCT00455663|4151417|B3|||Age||years|Mean|39|39.0|Standard Deviation|22.1|22.1|||
4324132|NCT00455663|4151418|B2|||Age||years|Mean|40|40.0|Standard Deviation|11.1|11.1|||
4324133|NCT00455663|4151419|B1|||Age||years|Mean|37|37.0|Standard Deviation|9.4|9.4|||
4324134|NCT00455650|4151438|B3|United States||Region of Enrollment||participants|Number|71|71.0||||||
4324135|NCT00455650|4151439|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
4324136|NCT00455650|4151440|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4324137|NCT00455650|4151438|B3|Unknown||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4324138|NCT00455650|4151439|B2|Unknown||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4324139|NCT00455650|4151440|B1|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4324140|NCT00455650|4151438|B3|Asian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4324141|NCT00455650|4151439|B2|Asian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4324142|NCT00455650|4151440|B1|Asian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4324143|NCT00455650|4151438|B3|African American||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4324144|NCT00455650|4151439|B2|African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4324145|NCT00455650|4151440|B1|African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4324146|NCT00455650|4151438|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4324147|NCT00455650|4151439|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4324148|NCT00455650|4151440|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4324149|NCT00455650|4151438|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4324150|NCT00455650|4151439|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4324151|NCT00455650|4151440|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4324152|NCT00455650|4151438|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4324153|NCT00455650|4151439|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4324154|NCT00455650|4151440|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4324155|NCT00455650|4151438|B3|||Age||years|Mean|42|42.0|Standard Deviation|13|13.0|||
4324156|NCT00455650|4151439|B2|||Age||years|Mean|37|37.0|Standard Deviation|16|16.0|||
4324157|NCT00455650|4151440|B1|||Age||years|Mean|47|47.0|Standard Deviation|10|10.0|||
4324158|NCT00455533|4151473|B3|Not Reported||Menopausal Status||Participants|Number|6|6.0||||||
4324159|NCT00455533|4151474|B2|Not Reported||Menopausal Status||Participants|Number|2|2.0||||||
4324160|NCT00455533|4151475|B1|Not Reported||Menopausal Status||Participants|Number|4|4.0||||||
4324161|NCT00455533|4151473|B3|Post-Menopausal||Menopausal Status||Participants|Number|131|131.0||||||
4324162|NCT00455533|4151474|B2|Post-Menopausal||Menopausal Status||Participants|Number|64|64.0||||||
4324163|NCT00455533|4151475|B1|Post-Menopausal||Menopausal Status||Participants|Number|67|67.0||||||
4324164|NCT00455533|4151473|B3|Peri-Menopausal||Menopausal Status||Participants|Number|12|12.0||||||
4324165|NCT00455533|4151474|B2|Peri-Menopausal||Menopausal Status||Participants|Number|6|6.0||||||
4324166|NCT00455533|4151475|B1|Peri-Menopausal||Menopausal Status||Participants|Number|6|6.0||||||
4324167|NCT00455533|4151473|B3|Pre-Menopausal||Menopausal Status||Participants|Number|146|146.0||||||
4324168|NCT00455533|4151474|B2|Pre-Menopausal||Menopausal Status||Participants|Number|75|75.0||||||
4324169|NCT00455533|4151475|B1|Pre-Menopausal||Menopausal Status||Participants|Number|71|71.0||||||
4324170|NCT00455533|4151473|B3|<=60 Needs increasing assistance up to Death (0)||Karnofsky Performance Status-Baseline|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|0|0.0||||||
4324171|NCT00455533|4151474|B2|<=60 Needs increasing assistance up to Death (0)||Karnofsky Performance Status-Baseline|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|0|0.0||||||
4324172|NCT00455533|4151475|B1|<=60 Needs increasing assistance up to Death (0)||Karnofsky Performance Status-Baseline|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|0|0.0||||||
4324173|NCT00455533|4151473|B3|70 - Unable to carry on normal activity||Karnofsky Performance Status-Baseline|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|0|0.0||||||
4324174|NCT00455533|4151474|B2|70 - Unable to carry on normal activity||Karnofsky Performance Status-Baseline|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|0|0.0||||||
4324175|NCT00455533|4151475|B1|70 - Unable to carry on normal activity||Karnofsky Performance Status-Baseline|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|0|0.0||||||
4324176|NCT00455533|4151473|B3|80 - Activity with effort; some signs of disease||Karnofsky Performance Status-Baseline|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|18|18.0||||||
4324177|NCT00455533|4151474|B2|80 - Activity with effort; some signs of disease||Karnofsky Performance Status-Baseline|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|5|5.0||||||
4324178|NCT00455533|4151475|B1|80 - Activity with effort; some signs of disease||Karnofsky Performance Status-Baseline|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|13|13.0||||||
4324179|NCT00455533|4151473|B3|90 - Normal activity; minor signs of disease||Karnofsky Performance Status-Baseline|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|67|67.0||||||
4324180|NCT00455533|4151474|B2|90 - Normal activity; minor signs of disease||Karnofsky Performance Status-Baseline|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|39|39.0||||||
4324181|NCT00455533|4151475|B1|90 - Normal activity; minor signs of disease||Karnofsky Performance Status-Baseline|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|28|28.0||||||
4324182|NCT00455533|4151473|B3|100 - Normal no complaints; no evidence of disease||Karnofsky Performance Status-Baseline|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|210|210.0||||||
4324183|NCT00455533|4151474|B2|100 - Normal no complaints; no evidence of disease||Karnofsky Performance Status-Baseline|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|103|103.0||||||
4324184|NCT00455533|4151475|B1|100 - Normal no complaints; no evidence of disease||Karnofsky Performance Status-Baseline|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|107|107.0||||||
4324185|NCT00455533|4151473|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4324186|NCT00455533|4151474|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4324187|NCT00455533|4151475|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4324188|NCT00455533|4151473|B3|Asian Other||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4324189|NCT00455533|4151474|B2|Asian Other||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4324190|NCT00455533|4151475|B1|Asian Other||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4324191|NCT00455533|4151473|B3|Chinese||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4324192|NCT00455533|4151474|B2|Chinese||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4324193|NCT00455533|4151475|B1|Chinese||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4324194|NCT00455533|4151473|B3|Asian Indian||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
4324195|NCT00455533|4151474|B2|Asian Indian||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4324196|NCT00455533|4151475|B1|Asian Indian||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4324197|NCT00455533|4151473|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4324198|NCT00455533|4151474|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4324199|NCT00455533|4151475|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4324200|NCT00455533|4151473|B3|White||Race/Ethnicity, Customized||participants|Number|150|150.0||||||
4324201|NCT00455533|4151474|B2|White||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
4324202|NCT00455533|4151475|B1|White||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
4324203|NCT00455533|4151473|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4324204|NCT00455533|4151474|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4324205|NCT00455533|4151475|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4324206|NCT00455533|4151473|B3||Female|Sex: Female, Male||Participants|Count of Participants|295|295.0||||||
4324207|NCT00455533|4151474|B2||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4324208|NCT00455533|4151475|B1||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4324209|NCT00455533|4151473|B3|>=50 years||Age, Customized||participants|Number|128|128.0||||||
4324210|NCT00455533|4151474|B2|>=50 years||Age, Customized||participants|Number|65|65.0||||||
4324211|NCT00455533|4151475|B1|>=50 years||Age, Customized||participants|Number|63|63.0||||||
4324212|NCT00455533|4151473|B3|<50 years||Age, Customized||participants|Number|167|167.0||||||
4324213|NCT00455533|4151474|B2|<50 years||Age, Customized||participants|Number|82|82.0||||||
4324214|NCT00455533|4151475|B1|<50 years||Age, Customized||participants|Number|85|85.0||||||
4324215|NCT00455533|4151473|B3|>=65 years||Age, Customized||participants|Number|24|24.0||||||
4324216|NCT00455533|4151474|B2|>=65 years||Age, Customized||participants|Number|10|10.0||||||
4324217|NCT00455533|4151475|B1|>=65 years||Age, Customized||participants|Number|14|14.0||||||
4324218|NCT00455533|4151473|B3|<65 years||Age, Customized||participants|Number|271|271.0||||||
4324219|NCT00455533|4151474|B2|<65 years||Age, Customized||participants|Number|137|137.0||||||
4324220|NCT00455533|4151475|B1|<65 years||Age, Customized||participants|Number|134|134.0||||||
4324221|NCT00455533|4151473|B3|||Age||years|Median|48.0|48.0|Full Range|||25.0|79.0|
4324222|NCT00455533|4151474|B2|||Age||years|Median|46.0|46.0|Full Range|||26.0|74.0|
4324223|NCT00455533|4151475|B1|||Age||years|Median|48.0|48.0|Full Range|||25.0|79.0|
4324224|NCT00455520|4151524|B3|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4324225|NCT00455520|4151525|B2|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4324226|NCT00455520|4151526|B1|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4324227|NCT00455520|4151524|B3|United States||Region of Enrollment||participants|Number|380|380.0||||||
4324228|NCT00455520|4151525|B2|United States||Region of Enrollment||participants|Number|189|189.0||||||
4324229|NCT00455520|4151526|B1|United States||Region of Enrollment||participants|Number|191|191.0||||||
4324230|NCT00455520|4151524|B3||Male|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4324231|NCT00455520|4151525|B2||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4324232|NCT00455520|4151526|B1||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4324233|NCT00455520|4151524|B3||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4324234|NCT00455520|4151525|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4324235|NCT00455520|4151526|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4324236|NCT00455520|4151524|B3|||Age||years|Mean|60.2|60.2|Standard Deviation|10.62|10.62|||
4324237|NCT00455520|4151525|B2|||Age||years|Mean|60.6|60.6|Standard Deviation|10.56|10.56|||
4324238|NCT00455520|4151526|B1|||Age||years|Mean|59.9|59.9|Standard Deviation|10.68|10.68|||
4324239|NCT00455520|4151524|B3||>=65 years|Age||Participants|Count of Participants|133|133.0||||||
4324240|NCT00455520|4151525|B2||>=65 years|Age||Participants|Count of Participants|73|73.0||||||
4324241|NCT00455520|4151526|B1||>=65 years|Age||Participants|Count of Participants|60|60.0||||||
4324242|NCT00455520|4151524|B3||Between 18 and 65 years|Age||Participants|Count of Participants|256|256.0||||||
4324243|NCT00455520|4151525|B2||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
4324244|NCT00455520|4151526|B1||Between 18 and 65 years|Age||Participants|Count of Participants|136|136.0||||||
4324245|NCT00455520|4151524|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4324246|NCT00455520|4151525|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4324247|NCT00455520|4151526|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4324248|NCT00455455|4151543|B1|Canada||Region of Enrollment||participants|Number|50|50.0||||||
4324249|NCT00455455|4151543|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4324250|NCT00455455|4151543|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4324251|NCT00455455|4151543|B1|||Age||years|Mean|25|25.0|Standard Deviation|7|7.0|||
4324252|NCT00455455|4151543|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4324253|NCT00455455|4151543|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4324254|NCT00455455|4151543|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4324255|NCT00455429|4151560|B5||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4324256|NCT00455429|4151561|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4324257|NCT00455429|4151562|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4324258|NCT00455429|4151563|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4324259|NCT00455429|4151564|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4324260|NCT00455429|4151560|B5||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4324261|NCT00455429|4151561|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4324262|NCT00455429|4151562|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4324263|NCT00455429|4151563|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4324264|NCT00455429|4151564|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4324265|NCT00455429|4151560|B5|||Age||years|Mean|36.0|36.0|Standard Deviation|13.84|13.84|||
4324266|NCT00455429|4151561|B4|||Age||years|Mean|38.7|38.7|Standard Deviation|14.50|14.5|||
4324267|NCT00455429|4151562|B3|||Age||years|Mean|34.6|34.6|Standard Deviation|13.98|13.98|||
4324268|NCT00455429|4151563|B2|||Age||years|Mean|34.8|34.8|Standard Deviation|14.67|14.67|||
4324269|NCT00455429|4151564|B1|||Age||years|Mean|33.2|33.2|Standard Deviation|11.84|11.84|||
4324270|NCT00455312|4151624|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4324271|NCT00455312|4151625|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4324272|NCT00455312|4151626|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4324273|NCT00455312|4151624|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4324274|NCT00455312|4151625|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4324275|NCT00455312|4151626|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4324276|NCT00455312|4151624|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4324277|NCT00455312|4151625|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4324278|NCT00455312|4151626|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4324279|NCT00455312|4151624|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4324280|NCT00455312|4151625|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4324281|NCT00455312|4151626|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4324282|NCT00455312|4151624|B3||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
4324283|NCT00455312|4151625|B2||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4324284|NCT00455312|4151626|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4324285|NCT00455195|4151651|B3|Unknown or Not Reported||Race/Ethnicity, Customized|The Alglucosidase Alfa/Alglucosidase Alfa treatment arm includes participants' study experience in the double-blind study (AGLU02704 (NCT00158600)) and the extension study (AGLU03206 (NCT00455195) hence 60 participants are represented. The Placebo/Alglucosidase Alfa treatment arm includes participants' study experience on Alglucosidase Alfa in the extension study (AGLU03206) hence 26 participants are represented.|participants|Number|2|2.0||||||
4324286|NCT00455195|4151652|B2|Unknown or Not Reported||Race/Ethnicity, Customized|The Alglucosidase Alfa/Alglucosidase Alfa treatment arm includes participants' study experience in the double-blind study (AGLU02704 (NCT00158600)) and the extension study (AGLU03206 (NCT00455195) hence 60 participants are represented. The Placebo/Alglucosidase Alfa treatment arm includes participants' study experience on Alglucosidase Alfa in the extension study (AGLU03206) hence 26 participants are represented.|participants|Number|1|1.0||||||
4324287|NCT00455195|4151653|B1|Unknown or Not Reported||Race/Ethnicity, Customized|The Alglucosidase Alfa/Alglucosidase Alfa treatment arm includes participants' study experience in the double-blind study (AGLU02704 (NCT00158600)) and the extension study (AGLU03206 (NCT00455195) hence 60 participants are represented. The Placebo/Alglucosidase Alfa treatment arm includes participants' study experience on Alglucosidase Alfa in the extension study (AGLU03206) hence 26 participants are represented.|participants|Number|1|1.0||||||
4324288|NCT00455195|4151651|B3|White||Race/Ethnicity, Customized|The Alglucosidase Alfa/Alglucosidase Alfa treatment arm includes participants' study experience in the double-blind study (AGLU02704 (NCT00158600)) and the extension study (AGLU03206 (NCT00455195) hence 60 participants are represented. The Placebo/Alglucosidase Alfa treatment arm includes participants' study experience on Alglucosidase Alfa in the extension study (AGLU03206) hence 26 participants are represented.|participants|Number|81|81.0||||||
4324289|NCT00455195|4151652|B2|White||Race/Ethnicity, Customized|The Alglucosidase Alfa/Alglucosidase Alfa treatment arm includes participants' study experience in the double-blind study (AGLU02704 (NCT00158600)) and the extension study (AGLU03206 (NCT00455195) hence 60 participants are represented. The Placebo/Alglucosidase Alfa treatment arm includes participants' study experience on Alglucosidase Alfa in the extension study (AGLU03206) hence 26 participants are represented.|participants|Number|24|24.0||||||
4324290|NCT00455195|4151653|B1|White||Race/Ethnicity, Customized|The Alglucosidase Alfa/Alglucosidase Alfa treatment arm includes participants' study experience in the double-blind study (AGLU02704 (NCT00158600)) and the extension study (AGLU03206 (NCT00455195) hence 60 participants are represented. The Placebo/Alglucosidase Alfa treatment arm includes participants' study experience on Alglucosidase Alfa in the extension study (AGLU03206) hence 26 participants are represented.|participants|Number|57|57.0||||||
4324291|NCT00455195|4151651|B3|Black or African American||Race/Ethnicity, Customized|The Alglucosidase Alfa/Alglucosidase Alfa treatment arm includes participants' study experience in the double-blind study (AGLU02704 (NCT00158600)) and the extension study (AGLU03206 (NCT00455195) hence 60 participants are represented. The Placebo/Alglucosidase Alfa treatment arm includes participants' study experience on Alglucosidase Alfa in the extension study (AGLU03206) hence 26 participants are represented.|participants|Number|0|0.0||||||
4324292|NCT00455195|4151652|B2|Black or African American||Race/Ethnicity, Customized|The Alglucosidase Alfa/Alglucosidase Alfa treatment arm includes participants' study experience in the double-blind study (AGLU02704 (NCT00158600)) and the extension study (AGLU03206 (NCT00455195) hence 60 participants are represented. The Placebo/Alglucosidase Alfa treatment arm includes participants' study experience on Alglucosidase Alfa in the extension study (AGLU03206) hence 26 participants are represented.|participants|Number|0|0.0||||||
4324361|NCT00454909|4151814|B4|White-Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4324416|NCT00454818|4151882|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324293|NCT00455195|4151653|B1|Black or African American||Race/Ethnicity, Customized|The Alglucosidase Alfa/Alglucosidase Alfa treatment arm includes participants' study experience in the double-blind study (AGLU02704 (NCT00158600)) and the extension study (AGLU03206 (NCT00455195) hence 60 participants are represented. The Placebo/Alglucosidase Alfa treatment arm includes participants' study experience on Alglucosidase Alfa in the extension study (AGLU03206) hence 26 participants are represented.|participants|Number|0|0.0||||||
4324294|NCT00455195|4151651|B3|Asian||Race/Ethnicity, Customized|The Alglucosidase Alfa/Alglucosidase Alfa treatment arm includes participants' study experience in the double-blind study (AGLU02704 (NCT00158600)) and the extension study (AGLU03206 (NCT00455195) hence 60 participants are represented. The Placebo/Alglucosidase Alfa treatment arm includes participants' study experience on Alglucosidase Alfa in the extension study (AGLU03206) hence 26 participants are represented.|participants|Number|1|1.0||||||
4324295|NCT00455195|4151652|B2|Asian||Race/Ethnicity, Customized|The Alglucosidase Alfa/Alglucosidase Alfa treatment arm includes participants' study experience in the double-blind study (AGLU02704 (NCT00158600)) and the extension study (AGLU03206 (NCT00455195) hence 60 participants are represented. The Placebo/Alglucosidase Alfa treatment arm includes participants' study experience on Alglucosidase Alfa in the extension study (AGLU03206) hence 26 participants are represented.|participants|Number|0|0.0||||||
4324296|NCT00455195|4151653|B1|Asian||Race/Ethnicity, Customized|The Alglucosidase Alfa/Alglucosidase Alfa treatment arm includes participants' study experience in the double-blind study (AGLU02704 (NCT00158600)) and the extension study (AGLU03206 (NCT00455195) hence 60 participants are represented. The Placebo/Alglucosidase Alfa treatment arm includes participants' study experience on Alglucosidase Alfa in the extension study (AGLU03206) hence 26 participants are represented.|participants|Number|1|1.0||||||
4324297|NCT00455195|4151651|B3|Hispanic||Race/Ethnicity, Customized|The Alglucosidase Alfa/Alglucosidase Alfa treatment arm includes participants' study experience in the double-blind study (AGLU02704 (NCT00158600)) and the extension study (AGLU03206 (NCT00455195) hence 60 participants are represented. The Placebo/Alglucosidase Alfa treatment arm includes participants' study experience on Alglucosidase Alfa in the extension study (AGLU03206) hence 26 participants are represented.|participants|Number|2|2.0||||||
4324298|NCT00455195|4151652|B2|Hispanic||Race/Ethnicity, Customized|The Alglucosidase Alfa/Alglucosidase Alfa treatment arm includes participants' study experience in the double-blind study (AGLU02704 (NCT00158600)) and the extension study (AGLU03206 (NCT00455195) hence 60 participants are represented. The Placebo/Alglucosidase Alfa treatment arm includes participants' study experience on Alglucosidase Alfa in the extension study (AGLU03206) hence 26 participants are represented.|participants|Number|1|1.0||||||
4324299|NCT00455195|4151653|B1|Hispanic||Race/Ethnicity, Customized|The Alglucosidase Alfa/Alglucosidase Alfa treatment arm includes participants' study experience in the double-blind study (AGLU02704 (NCT00158600)) and the extension study (AGLU03206 (NCT00455195) hence 60 participants are represented. The Placebo/Alglucosidase Alfa treatment arm includes participants' study experience on Alglucosidase Alfa in the extension study (AGLU03206) hence 26 participants are represented.|participants|Number|1|1.0||||||
4324300|NCT00455195|4151651|B3||Male|Sex: Female, Male|The Alglucosidase Alfa/Alglucosidase Alfa treatment arm includes participants' study experience in the double-blind study (AGLU02704 (NCT00158600)) and the extension study (AGLU03206 (NCT00455195) hence 60 participants are represented. The Placebo/Alglucosidase Alfa treatment arm includes participants' study experience on Alglucosidase Alfa in the extension study (AGLU03206) hence 26 participants are represented.|Participants|Count of Participants|45|45.0||||||
4324301|NCT00455195|4151652|B2||Male|Sex: Female, Male|The Alglucosidase Alfa/Alglucosidase Alfa treatment arm includes participants' study experience in the double-blind study (AGLU02704 (NCT00158600)) and the extension study (AGLU03206 (NCT00455195) hence 60 participants are represented. The Placebo/Alglucosidase Alfa treatment arm includes participants' study experience on Alglucosidase Alfa in the extension study (AGLU03206) hence 26 participants are represented.|Participants|Count of Participants|11|11.0||||||
4324302|NCT00455195|4151653|B1||Male|Sex: Female, Male|The Alglucosidase Alfa/Alglucosidase Alfa treatment arm includes participants' study experience in the double-blind study (AGLU02704 (NCT00158600)) and the extension study (AGLU03206 (NCT00455195) hence 60 participants are represented. The Placebo/Alglucosidase Alfa treatment arm includes participants' study experience on Alglucosidase Alfa in the extension study (AGLU03206) hence 26 participants are represented.|Participants|Count of Participants|34|34.0||||||
4324303|NCT00455195|4151651|B3||Female|Sex: Female, Male|The Alglucosidase Alfa/Alglucosidase Alfa treatment arm includes participants' study experience in the double-blind study (AGLU02704 (NCT00158600)) and the extension study (AGLU03206 (NCT00455195) hence 60 participants are represented. The Placebo/Alglucosidase Alfa treatment arm includes participants' study experience on Alglucosidase Alfa in the extension study (AGLU03206) hence 26 participants are represented.|Participants|Count of Participants|41|41.0||||||
4324304|NCT00455195|4151652|B2||Female|Sex: Female, Male|The Alglucosidase Alfa/Alglucosidase Alfa treatment arm includes participants' study experience in the double-blind study (AGLU02704 (NCT00158600)) and the extension study (AGLU03206 (NCT00455195) hence 60 participants are represented. The Placebo/Alglucosidase Alfa treatment arm includes participants' study experience on Alglucosidase Alfa in the extension study (AGLU03206) hence 26 participants are represented.|Participants|Count of Participants|15|15.0||||||
4324305|NCT00455195|4151653|B1||Female|Sex: Female, Male|The Alglucosidase Alfa/Alglucosidase Alfa treatment arm includes participants' study experience in the double-blind study (AGLU02704 (NCT00158600)) and the extension study (AGLU03206 (NCT00455195) hence 60 participants are represented. The Placebo/Alglucosidase Alfa treatment arm includes participants' study experience on Alglucosidase Alfa in the extension study (AGLU03206) hence 26 participants are represented.|Participants|Count of Participants|26|26.0||||||
4324306|NCT00455195|4151651|B3|||Age|Age at first infusion of alglucosidase alfa. The Alglucosidase Alfa/Alglucosidase Alfa treatment arm includes participants' study experience in the double-blind study (AGLU02704 (NCT00158600)) and the extension study (AGLU03206 (NCT00455195) hence 60 participants are represented. The Placebo/Alglucosidase Alfa treatment arm includes participants' study experience on Alglucosidase Alfa in the extension study (AGLU03206) hence 26 participants are represented.|years|Mean|45.73|45.73|Standard Deviation|11.34|11.34|||
4324362|NCT00454909|4151815|B3|White-Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4324363|NCT00454909|4151816|B2|White-Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4324307|NCT00455195|4151652|B2|||Age|Age at first infusion of alglucosidase alfa. The Alglucosidase Alfa/Alglucosidase Alfa treatment arm includes participants' study experience in the double-blind study (AGLU02704 (NCT00158600)) and the extension study (AGLU03206 (NCT00455195) hence 60 participants are represented. The Placebo/Alglucosidase Alfa treatment arm includes participants' study experience on Alglucosidase Alfa in the extension study (AGLU03206) hence 26 participants are represented.|years|Mean|46.8|46.8|Standard Deviation|8.62|8.62|||
4324308|NCT00455195|4151653|B1|||Age|Age at first infusion of alglucosidase alfa. The Alglucosidase Alfa/Alglucosidase Alfa treatment arm includes participants' study experience in the double-blind study (AGLU02704 (NCT00158600)) and the extension study (AGLU03206 (NCT00455195) hence 60 participants are represented. The Placebo/Alglucosidase Alfa treatment arm includes participants' study experience on Alglucosidase Alfa in the extension study (AGLU03206) hence 26 participants are represented.|years|Mean|45.3|45.3|Standard Deviation|12.37|12.37|||
4324309|NCT00455013|4151668|B4|Europe||Region of Enrollment||participants|Number|31|31.0||||||
4324310|NCT00455013|4151669|B3|Europe||Region of Enrollment||participants|Number|10|10.0||||||
4324311|NCT00455013|4151670|B2|Europe||Region of Enrollment||participants|Number|10|10.0||||||
4324312|NCT00455013|4151671|B1|Europe||Region of Enrollment||participants|Number|11|11.0||||||
4324313|NCT00455013|4151668|B4|North America||Region of Enrollment||participants|Number|58|58.0||||||
4324314|NCT00455013|4151669|B3|North America||Region of Enrollment||participants|Number|20|20.0||||||
4324315|NCT00455013|4151670|B2|North America||Region of Enrollment||participants|Number|16|16.0||||||
4324316|NCT00455013|4151671|B1|North America||Region of Enrollment||participants|Number|22|22.0||||||
4324317|NCT00455013|4151668|B4||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4324318|NCT00455013|4151669|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4324319|NCT00455013|4151670|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4324320|NCT00455013|4151671|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4324321|NCT00455013|4151668|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4324322|NCT00455013|4151669|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4324323|NCT00455013|4151670|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4324324|NCT00455013|4151671|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4324325|NCT00455013|4151668|B4|||Age||years|Mean|51.7|51.7|Standard Deviation|11.8|11.8|||
4324326|NCT00455013|4151669|B3|||Age||years|Mean|53.6|53.6|Standard Deviation|13.2|13.2|||
4324327|NCT00455013|4151670|B2|||Age||years|Mean|52.7|52.7|Standard Deviation|10.8|10.8|||
4324328|NCT00455013|4151671|B1|||Age||years|Mean|49.2|49.2|Standard Deviation|11.1|11.1|||
4324329|NCT00455013|4151668|B4||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4324330|NCT00455013|4151669|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4324331|NCT00455013|4151670|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4324332|NCT00455013|4151671|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4324333|NCT00455013|4151668|B4||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
4324334|NCT00455013|4151669|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4324335|NCT00455013|4151670|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4324336|NCT00455013|4151671|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4324337|NCT00455013|4151668|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4324338|NCT00455013|4151669|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4324339|NCT00455013|4151670|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4324340|NCT00455013|4151671|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4324341|NCT00454987|4151738|B4||Male|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4324342|NCT00454987|4151739|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4324343|NCT00454987|4151740|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4324344|NCT00454987|4151741|B1||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4324345|NCT00454987|4151738|B4||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4324346|NCT00454987|4151739|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4324347|NCT00454987|4151740|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4324348|NCT00454987|4151741|B1||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4324349|NCT00454987|4151738|B4|||Age||Months|Mean|40.58|40.58|Standard Deviation|0.75|0.75|||
4324350|NCT00454987|4151739|B3|||Age||Months|Mean|40.5|40.5|Standard Deviation|0.71|0.71|||
4324351|NCT00454987|4151740|B2|||Age||Months|Mean|40.6|40.6|Standard Deviation|0.74|0.74|||
4324352|NCT00454987|4151741|B1|||Age||Months|Mean|40.6|40.6|Standard Deviation|0.76|0.76|||
4324353|NCT00454909|4151814|B4|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|201|201.0||||||
4324354|NCT00454909|4151815|B3|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
4324355|NCT00454909|4151816|B2|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
4324356|NCT00454909|4151817|B1|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|138|138.0||||||
4324357|NCT00454909|4151814|B4|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|419|419.0||||||
4324358|NCT00454909|4151815|B3|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
4324359|NCT00454909|4151816|B2|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|95|95.0||||||
4324360|NCT00454909|4151817|B1|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|290|290.0||||||
4324364|NCT00454909|4151817|B1|White-Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4324365|NCT00454909|4151814|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4324366|NCT00454909|4151815|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4324367|NCT00454909|4151816|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4324368|NCT00454909|4151817|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4324369|NCT00454909|4151814|B4|Asian-South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|62|62.0||||||
4324370|NCT00454909|4151815|B3|Asian-South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4324371|NCT00454909|4151816|B2|Asian-South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4324372|NCT00454909|4151817|B1|Asian-South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
4324373|NCT00454909|4151814|B4|Asian-Japanese heritage||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4324374|NCT00454909|4151815|B3|Asian-Japanese heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4324375|NCT00454909|4151816|B2|Asian-Japanese heritage||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4324376|NCT00454909|4151817|B1|Asian-Japanese heritage||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4324377|NCT00454909|4151814|B4|Asian-East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
4324378|NCT00454909|4151815|B3|Asian-East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4324379|NCT00454909|4151816|B2|Asian-East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4324380|NCT00454909|4151817|B1|Asian-East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4324381|NCT00454909|4151814|B4|Asian-Central/South Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4324382|NCT00454909|4151815|B3|Asian-Central/South Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4324383|NCT00454909|4151816|B2|Asian-Central/South Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4324384|NCT00454909|4151817|B1|Asian-Central/South Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4324385|NCT00454909|4151814|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|79|79.0||||||
4324386|NCT00454909|4151815|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4324387|NCT00454909|4151816|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
4324388|NCT00454909|4151817|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|49|49.0||||||
4324389|NCT00454909|4151814|B4|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|56|56.0||||||
4324390|NCT00454909|4151815|B3|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4324391|NCT00454909|4151816|B2|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4324392|NCT00454909|4151817|B1|African heritage/African American||Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
4324393|NCT00454909|4151814|B4||Male|Sex: Female, Male||Participants|Count of Participants|446|446.0||||||
4324394|NCT00454909|4151815|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4324395|NCT00454909|4151816|B2||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4324396|NCT00454909|4151817|B1||Male|Sex: Female, Male||Participants|Count of Participants|313|313.0||||||
4324397|NCT00454909|4151814|B4||Female|Sex: Female, Male||Participants|Count of Participants|426|426.0||||||
4324398|NCT00454909|4151815|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4324399|NCT00454909|4151816|B2||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4324400|NCT00454909|4151817|B1||Female|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
4324401|NCT00454909|4151814|B4|||Age||Years|Mean|14.29|14.29|Standard Deviation|2.95|2.95|||
4324402|NCT00454909|4151815|B3|||Age||Years|Mean|10|10.0|Standard Deviation|0|0.0|||
4324403|NCT00454909|4151816|B2|||Age||Years|Mean|14.7|14.7|Standard Deviation|2.78|2.78|||
4324404|NCT00454909|4151817|B1|||Age||Years|Mean|14.8|14.8|Standard Deviation|2.69|2.69|||
4324405|NCT00454857|4151857|B1||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4324406|NCT00454857|4151857|B1||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4324407|NCT00454857|4151857|B1|||Age||Years|Mean|53.4|53.4|Standard Deviation|18.1|18.1|||
4324408|NCT00454818|4151874|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324409|NCT00454818|4151875|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324410|NCT00454818|4151876|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324411|NCT00454818|4151877|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324412|NCT00454818|4151878|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324413|NCT00454818|4151879|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324414|NCT00454818|4151880|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324415|NCT00454818|4151881|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324417|NCT00454818|4151874|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324418|NCT00454818|4151875|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324419|NCT00454818|4151876|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324420|NCT00454818|4151877|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324421|NCT00454818|4151878|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324422|NCT00454818|4151879|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324423|NCT00454818|4151880|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324424|NCT00454818|4151881|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324425|NCT00454818|4151882|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324426|NCT00454818|4151874|B9||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4324427|NCT00454818|4151875|B8||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4324428|NCT00454818|4151876|B7||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4324429|NCT00454818|4151877|B6||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4324430|NCT00454818|4151878|B5||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4324431|NCT00454818|4151879|B4||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4324432|NCT00454818|4151880|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4324433|NCT00454818|4151881|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4324434|NCT00454818|4151882|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4324435|NCT00454818|4151874|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4324436|NCT00454818|4151875|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4324437|NCT00454818|4151876|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4324438|NCT00454818|4151877|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324439|NCT00454818|4151878|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324440|NCT00454818|4151879|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324441|NCT00454818|4151880|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4324442|NCT00454818|4151881|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324443|NCT00454818|4151882|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324444|NCT00454818|4151874|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324445|NCT00454818|4151875|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324446|NCT00454818|4151876|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324447|NCT00454818|4151877|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324448|NCT00454818|4151878|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324449|NCT00454818|4151879|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324450|NCT00454818|4151880|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324451|NCT00454818|4151881|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324452|NCT00454818|4151882|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324453|NCT00454818|4151874|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324454|NCT00454818|4151875|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324455|NCT00454818|4151876|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324456|NCT00454818|4151877|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324457|NCT00454818|4151878|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324458|NCT00454818|4151879|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324459|NCT00454818|4151880|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324460|NCT00454818|4151881|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324461|NCT00454818|4151882|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324462|NCT00454818|4151874|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324463|NCT00454818|4151875|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324464|NCT00454818|4151876|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324465|NCT00454818|4151877|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324466|NCT00454818|4151878|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324467|NCT00454818|4151879|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324468|NCT00454818|4151880|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324469|NCT00454818|4151881|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324470|NCT00454818|4151882|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324471|NCT00454818|4151874|B9||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4324472|NCT00454818|4151875|B8||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4324473|NCT00454818|4151876|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4324474|NCT00454818|4151877|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4324475|NCT00454818|4151878|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4324476|NCT00454818|4151879|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4324477|NCT00454818|4151880|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4324478|NCT00454818|4151881|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4324479|NCT00454818|4151882|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4324480|NCT00454818|4151874|B9||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4324481|NCT00454818|4151875|B8||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4324482|NCT00454818|4151876|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4324483|NCT00454818|4151877|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4324484|NCT00454818|4151878|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4324485|NCT00454818|4151879|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4324486|NCT00454818|4151880|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4324487|NCT00454818|4151881|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4324488|NCT00454818|4151882|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4324489|NCT00454818|4151874|B9|||Age||years|Mean|60.5|60.5|Standard Deviation|11.39|11.39|||
4324490|NCT00454818|4151875|B8|||Age||years|Mean|61.0|61.0|Standard Deviation|11.94|11.94|||
4324491|NCT00454818|4151876|B7|||Age||years|Mean|56.6|56.6|Standard Deviation|13.96|13.96|||
4324492|NCT00454818|4151877|B6|||Age||years|Mean|63.9|63.9|Standard Deviation|8.85|8.85|||
4324493|NCT00454818|4151878|B5|||Age||years|Mean|60.3|60.3|Standard Deviation|10.27|10.27|||
4324494|NCT00454818|4151879|B4|||Age||years|Mean|58.77|58.77|Standard Deviation|19.01|19.01|||
4324495|NCT00454818|4151880|B3|||Age||years|Mean|48.0|48.0|Standard Deviation|8.54|8.54|||
4324496|NCT00454818|4151881|B2|||Age||years|Mean|55.7|55.7|Standard Deviation|4.51|4.51|||
4324497|NCT00454818|4151882|B1|||Age||years|Mean|53.7|53.7|Standard Deviation|7.02|7.02|||
4324498|NCT00454805|4151963|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4324499|NCT00454805|4151964|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4324500|NCT00454805|4151965|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4324501|NCT00454805|4151963|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4324502|NCT00454805|4151964|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4324503|NCT00454805|4151965|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4324504|NCT00454805|4151963|B3|||Age||Years|Mean|59.1|59.1|Standard Deviation|10.6|10.6|||
4324505|NCT00454805|4151964|B2|||Age||Years|Mean|57.9|57.9|Standard Deviation|9.7|9.7|||
4324506|NCT00454805|4151965|B1|||Age||Years|Mean|60.4|60.4|Standard Deviation|11.4|11.4|||
4324507|NCT00454779|4151980|B3||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4324508|NCT00454779|4151981|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4324509|NCT00454779|4151982|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4324510|NCT00454779|4151980|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4324511|NCT00454779|4151981|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4324512|NCT00454779|4151982|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4324513|NCT00454779|4151980|B3|||Age||Years|Mean|58.6|58.6|Standard Deviation|8.0|8.0|||
4324514|NCT00454779|4151981|B2|||Age||Years|Mean|58.9|58.9|Standard Deviation|7.4|7.4|||
4324515|NCT00454779|4151982|B1|||Age||Years|Mean|58.2|58.2|Standard Deviation|8.6|8.6|||
4324516|NCT00454649|4152011|B11||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4324517|NCT00454649|4152012|B10||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4324518|NCT00454649|4152013|B9||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4324519|NCT00454649|4152014|B8||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4324520|NCT00454649|4152015|B7||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4324521|NCT00454649|4152016|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4324522|NCT00454649|4152017|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4324523|NCT00454649|4152018|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4324524|NCT00454649|4152019|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4324525|NCT00454649|4152020|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4324526|NCT00454649|4152021|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4324527|NCT00454649|4152011|B11||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4324528|NCT00454649|4152012|B10||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4324529|NCT00454649|4152013|B9||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4324530|NCT00454649|4152014|B8||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4324531|NCT00454649|4152015|B7||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4324532|NCT00454649|4152016|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4324533|NCT00454649|4152017|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4324534|NCT00454649|4152018|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4324535|NCT00454649|4152019|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4324536|NCT00454649|4152020|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4324537|NCT00454649|4152021|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4324538|NCT00454649|4152011|B11|||Age||years|Mean|57.8|57.8|Standard Deviation|11.1|11.1|||
4324539|NCT00454649|4152012|B10|||Age||years|Mean|58.8|58.8|Standard Deviation|9.0|9.0|||
4324540|NCT00454649|4152013|B9|||Age||years|Mean|54|54.0|Standard Deviation|10.3|10.3|||
4324541|NCT00454649|4152014|B8|||Age||years|Mean|53.4|53.4|Standard Deviation|10.6|10.6|||
4324542|NCT00454649|4152015|B7|||Age||years|Mean|60.4|60.4|Standard Deviation|12.4|12.4|||
4324543|NCT00454649|4152016|B6|||Age||years|Mean|63.4|63.4|Standard Deviation|11.9|11.9|||
4324544|NCT00454649|4152017|B5|||Age||years|Mean|64|64.0|Standard Deviation|NA||||Standard deviation was not calculated as only one participant was evaluable.
4324545|NCT00454649|4152018|B4|||Age||years|Mean|60.7|60.7|Standard Deviation|10.2|10.2|||
4324546|NCT00454649|4152019|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|10.6|10.6|||
4324547|NCT00454649|4152020|B2|||Age||years|Mean|62|62.0|Standard Deviation|16.6|16.6|||
4324548|NCT00454649|4152021|B1|||Age||years|Mean|61|61.0|Standard Deviation|11.4|11.4|||
4324549|NCT00454636|4152155|B5||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4324550|NCT00454636|4152156|B4||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4324551|NCT00454636|4152157|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4324552|NCT00454636|4152158|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4324553|NCT00454636|4152159|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4324554|NCT00454636|4152155|B5||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4324555|NCT00454636|4152156|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4324556|NCT00454636|4152157|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4324557|NCT00454636|4152158|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4324558|NCT00454636|4152159|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4324559|NCT00454636|4152155|B5|||Age||years|Median|61|61.0|Full Range|||20.0|79.0|
4324560|NCT00454636|4152156|B4|||Age||years|Median|58|58.0|Full Range|||20.0|78.0|
4324561|NCT00454636|4152157|B3|||Age||years|Median|62|62.0|Full Range|||40.0|79.0|
4324562|NCT00454636|4152158|B2|||Age||years|Median|60|60.0|Full Range|||38.0|78.0|
4324563|NCT00454636|4152159|B1|||Age||years|Median|66|66.0|Full Range|||39.0|77.0|
4324564|NCT00454584|4152192|B4||Male|Sex: Female, Male||Participants|Count of Participants|613|613.0||||||
4324565|NCT00454584|4152193|B3||Male|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
4324566|NCT00454584|4152194|B2||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4324567|NCT00454584|4152195|B1||Male|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
4324568|NCT00454584|4152192|B4||Female|Sex: Female, Male||Participants|Count of Participants|290|290.0||||||
4324569|NCT00454584|4152193|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4324570|NCT00454584|4152194|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4324571|NCT00454584|4152195|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4324572|NCT00454584|4152192|B4|||Age||years|Mean|45.2|45.2|Standard Deviation|12.78|12.78|||
4324573|NCT00454584|4152193|B3|||Age||years|Mean|44.8|44.8|Standard Deviation|12.29|12.29|||
4324574|NCT00454584|4152194|B2|||Age||years|Mean|45.1|45.1|Standard Deviation|12.56|12.56|||
4324575|NCT00454584|4152195|B1|||Age||years|Mean|45.7|45.7|Standard Deviation|13.40|13.4|||
4324576|NCT00454571|4152220|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4324577|NCT00454571|4152221|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4324578|NCT00454571|4152222|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4324579|NCT00454571|4152220|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4324580|NCT00454571|4152221|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4324581|NCT00454571|4152222|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4324582|NCT00454571|4152220|B3|||Age||years|Median|72|72.0|Full Range|||60.0|90.0|
4324583|NCT00454571|4152221|B2|||Age||years|Median|71|71.0|Full Range|||63.0|83.0|
4324584|NCT00454571|4152222|B1|||Age||years|Median|74|74.0|Full Range|||60.0|90.0|
4324585|NCT00454532|4152231|B5|United States||Region of Enrollment||participants|Number|27|27.0||||||
4324586|NCT00454532|4152232|B4|United States||Region of Enrollment||participants|Number|7|7.0||||||
4324587|NCT00454532|4152233|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4324588|NCT00454532|4152234|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4324589|NCT00454532|4152235|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4324590|NCT00454532|4152231|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324591|NCT00454532|4152232|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324592|NCT00454532|4152233|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324593|NCT00454532|4152234|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324594|NCT00454532|4152235|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324595|NCT00454532|4152231|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324596|NCT00454532|4152232|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324597|NCT00454532|4152233|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324598|NCT00454532|4152234|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324599|NCT00454532|4152235|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324600|NCT00454532|4152231|B5||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4324601|NCT00454532|4152232|B4||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4324602|NCT00454532|4152233|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4324603|NCT00454532|4152234|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4324604|NCT00454532|4152235|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4324605|NCT00454532|4152231|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4324606|NCT00454532|4152232|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4324607|NCT00454532|4152233|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4324608|NCT00454532|4152234|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4324609|NCT00454532|4152235|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4324610|NCT00454532|4152231|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324611|NCT00454532|4152232|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324612|NCT00454532|4152233|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324613|NCT00454532|4152234|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324614|NCT00454532|4152235|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324615|NCT00454532|4152231|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324616|NCT00454532|4152232|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324617|NCT00454532|4152233|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324618|NCT00454532|4152234|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324619|NCT00454532|4152235|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324620|NCT00454532|4152231|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324621|NCT00454532|4152232|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324622|NCT00454532|4152233|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324623|NCT00454532|4152234|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324624|NCT00454532|4152235|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324625|NCT00454532|4152231|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324626|NCT00454532|4152232|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324627|NCT00454532|4152233|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324628|NCT00454532|4152234|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324629|NCT00454532|4152235|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324630|NCT00454532|4152231|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4324631|NCT00454532|4152232|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4324632|NCT00454532|4152233|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4324633|NCT00454532|4152234|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4324634|NCT00454532|4152235|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4324635|NCT00454532|4152231|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4324636|NCT00454532|4152232|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4324637|NCT00454532|4152233|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324638|NCT00454532|4152234|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4324639|NCT00454532|4152235|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4324640|NCT00454532|4152231|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4324641|NCT00454532|4152232|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4324642|NCT00454532|4152233|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4324643|NCT00454532|4152234|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4324644|NCT00454532|4152235|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4324645|NCT00454532|4152231|B5||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4324646|NCT00454532|4152232|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4324647|NCT00454532|4152233|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4324648|NCT00454532|4152234|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4324649|NCT00454532|4152235|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4324650|NCT00454532|4152231|B5|||Age||years|Median|59|59.0|Full Range|||32.0|78.0|
4324651|NCT00454532|4152232|B4|||Age||years|Median|61|61.0|Full Range|||35.0|66.0|
4324652|NCT00454532|4152233|B3|||Age||years|Median|55|55.0|Full Range|||54.0|67.0|
4324653|NCT00454532|4152234|B2|||Age||years|Median|67|67.0|Full Range|||42.0|78.0|
4324654|NCT00454532|4152235|B1|||Age||years|Median|57|57.0|Full Range|||32.0|78.0|
4324655|NCT00454363|4152256|B3|MD Anderson Cancer Center||Participant from Enrolling Institutions||participants|Number|34|34.0||||||
4324656|NCT00454363|4152257|B2|MD Anderson Cancer Center||Participant from Enrolling Institutions||participants|Number|20|20.0||||||
4324657|NCT00454363|4152258|B1|MD Anderson Cancer Center||Participant from Enrolling Institutions||participants|Number|14|14.0||||||
4324658|NCT00454363|4152256|B3|Dana Farber Cancer Institute||Participant from Enrolling Institutions||participants|Number|17|17.0||||||
4324659|NCT00454363|4152257|B2|Dana Farber Cancer Institute||Participant from Enrolling Institutions||participants|Number|11|11.0||||||
4324660|NCT00454363|4152258|B1|Dana Farber Cancer Institute||Participant from Enrolling Institutions||participants|Number|6|6.0||||||
4324661|NCT00454363|4152256|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
4324662|NCT00454363|4152257|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
4324663|NCT00454363|4152258|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4324664|NCT00454363|4152256|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324665|NCT00454363|4152257|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324666|NCT00454363|4152258|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324667|NCT00454363|4152256|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324668|NCT00454363|4152257|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324669|NCT00454363|4152258|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324670|NCT00454363|4152256|B3||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4324671|NCT00454363|4152257|B2||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4324672|NCT00454363|4152258|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4324673|NCT00454363|4152256|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4324674|NCT00454363|4152257|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4324675|NCT00454363|4152258|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324676|NCT00454363|4152256|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324677|NCT00454363|4152257|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324678|NCT00454363|4152258|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324679|NCT00454363|4152256|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324680|NCT00454363|4152257|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324681|NCT00454363|4152258|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324682|NCT00454363|4152256|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4324683|NCT00454363|4152257|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4324684|NCT00454363|4152258|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324685|NCT00454363|4152256|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324686|NCT00454363|4152257|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324687|NCT00454363|4152258|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324688|NCT00454363|4152256|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4324689|NCT00454363|4152257|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4324690|NCT00454363|4152258|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4324691|NCT00454363|4152256|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4324692|NCT00454363|4152257|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4324693|NCT00454363|4152258|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4324694|NCT00454363|4152256|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4324695|NCT00454363|4152257|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4324696|NCT00454363|4152258|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4324697|NCT00454363|4152256|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4324698|NCT00454363|4152257|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4324699|NCT00454363|4152258|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4324700|NCT00454363|4152256|B3|||Age||years|Median|60|60.0|Full Range|||34.0|79.0|
4324701|NCT00454363|4152257|B2|||Age||years|Median|55|55.0|Full Range|||34.0|77.0|
4324702|NCT00454363|4152258|B1|||Age||years|Median|63|63.0|Full Range|||43.0|79.0|
4324703|NCT00454324|4152266|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
4324704|NCT00454324|4152267|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4324705|NCT00454324|4152268|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4324706|NCT00454324|4152266|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324707|NCT00454324|4152267|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324708|NCT00454324|4152268|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324709|NCT00454324|4152266|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324710|NCT00454324|4152267|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324811|NCT00454181|4152365|B3|United States||Region of Enrollment||participants|Number|59|59.0||||||
4324711|NCT00454324|4152268|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324712|NCT00454324|4152266|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4324713|NCT00454324|4152267|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4324714|NCT00454324|4152268|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4324715|NCT00454324|4152266|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4324716|NCT00454324|4152267|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4324717|NCT00454324|4152268|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4324718|NCT00454324|4152266|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324719|NCT00454324|4152267|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324720|NCT00454324|4152268|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324721|NCT00454324|4152266|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324722|NCT00454324|4152267|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324723|NCT00454324|4152268|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324724|NCT00454324|4152266|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324725|NCT00454324|4152267|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324726|NCT00454324|4152268|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4324727|NCT00454324|4152266|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4324728|NCT00454324|4152267|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4324729|NCT00454324|4152268|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4324730|NCT00454324|4152266|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4324731|NCT00454324|4152267|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4324732|NCT00454324|4152268|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4324733|NCT00454324|4152266|B3|||Age||years|Mean|70|70.0|Full Range|||53.0|87.0|
4324734|NCT00454324|4152267|B2|||Age||years|Mean|70.4|70.4|Full Range|||60.0|80.0|
4324735|NCT00454324|4152268|B1|||Age||years|Mean|70|70.0|Full Range|||53.0|87.0|
4324736|NCT00454246|4152281|B4||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4324737|NCT00454246|4152282|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4324738|NCT00454246|4152283|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4324739|NCT00454246|4152284|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4324740|NCT00454246|4152281|B4||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4324741|NCT00454246|4152282|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4324742|NCT00454246|4152283|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4324743|NCT00454246|4152284|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4324744|NCT00454246|4152281|B4|||Age|There were four (4) patients who did not receive at least one dose of study medication in the methoxy polyethylene glycol-epoetin beta group and three (3) in the Epoetin Alfa group.|years|Mean|70.3|70.3|Standard Deviation|11.68|11.68|||
4324745|NCT00454246|4152282|B3|||Age|There were four (4) patients who did not receive at least one dose of study medication in the methoxy polyethylene glycol-epoetin beta group and three (3) in the Epoetin Alfa group.|years|Mean|69.1|69.1|Standard Deviation|12.61|12.61|||
4324746|NCT00454246|4152283|B2|||Age|There were four (4) patients who did not receive at least one dose of study medication in the methoxy polyethylene glycol-epoetin beta group and three (3) in the Epoetin Alfa group.|years|Mean|72.2|72.2|Standard Deviation|11.48|11.48|||
4324747|NCT00454246|4152284|B1|||Age|There were four (4) patients who did not receive at least one dose of study medication in the methoxy polyethylene glycol-epoetin beta group and three (3) in the Epoetin Alfa group.|years|Mean|69.8|69.8|Standard Deviation|11.74|11.74|||
4324748|NCT00454207|4152300|B3|Japan||Region of Enrollment||participants|Number|44|44.0||||||
4324749|NCT00454207|4152301|B2|Japan||Region of Enrollment||participants|Number|23|23.0||||||
4324750|NCT00454207|4152302|B1|Japan||Region of Enrollment||participants|Number|21|21.0||||||
4324751|NCT00454207|4152300|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4324752|NCT00454207|4152301|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4324753|NCT00454207|4152302|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4324754|NCT00454207|4152300|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4324755|NCT00454207|4152301|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4324756|NCT00454207|4152302|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4324757|NCT00454207|4152300|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4324758|NCT00454207|4152301|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4324759|NCT00454207|4152302|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4324760|NCT00454207|4152300|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4324761|NCT00454207|4152301|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4324762|NCT00454207|4152302|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4324763|NCT00454207|4152300|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4324764|NCT00454207|4152301|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4324765|NCT00454207|4152302|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4324766|NCT00454194|4152346|B3||Large Cell Neuroendocrine|Histology||Participants|Count of Participants|1|1.0||||||
4324767|NCT00454194|4152347|B2||Large Cell Neuroendocrine|Histology||Participants|Count of Participants|1|1.0||||||
4324768|NCT00454194|4152348|B1||Large Cell Neuroendocrine|Histology||Participants|Count of Participants|0|0.0||||||
4324769|NCT00454194|4152346|B3||Large Cell|Histology||Participants|Count of Participants|4|4.0||||||
4324770|NCT00454194|4152347|B2||Large Cell|Histology||Participants|Count of Participants|2|2.0||||||
4324771|NCT00454194|4152348|B1||Large Cell|Histology||Participants|Count of Participants|2|2.0||||||
4324772|NCT00454194|4152346|B3||Non-small cell lung cancer,not otherwise specified|Histology||Participants|Count of Participants|21|21.0||||||
4324773|NCT00454194|4152347|B2||Non-small cell lung cancer,not otherwise specified|Histology||Participants|Count of Participants|11|11.0||||||
4324774|NCT00454194|4152348|B1||Non-small cell lung cancer,not otherwise specified|Histology||Participants|Count of Participants|10|10.0||||||
4324775|NCT00454194|4152346|B3||Adenocarcinoma|Histology||Participants|Count of Participants|70|70.0||||||
4324776|NCT00454194|4152347|B2||Adenocarcinoma|Histology||Participants|Count of Participants|36|36.0||||||
4324777|NCT00454194|4152348|B1||Adenocarcinoma|Histology||Participants|Count of Participants|34|34.0||||||
4324778|NCT00454194|4152346|B3||Bronchioloalveolar Carcinoma|Histology||Participants|Count of Participants|2|2.0||||||
4324779|NCT00454194|4152347|B2||Bronchioloalveolar Carcinoma|Histology||Participants|Count of Participants|1|1.0||||||
4324780|NCT00454194|4152348|B1||Bronchioloalveolar Carcinoma|Histology||Participants|Count of Participants|1|1.0||||||
4324781|NCT00454194|4152346|B3||No|Prior Bevacizumab||Participants|Count of Participants|48|48.0||||||
4324782|NCT00454194|4152347|B2||No|Prior Bevacizumab||Participants|Count of Participants|21|21.0||||||
4324783|NCT00454194|4152348|B1||No|Prior Bevacizumab||Participants|Count of Participants|27|27.0||||||
4324784|NCT00454194|4152346|B3||Yes|Prior Bevacizumab||Participants|Count of Participants|50|50.0||||||
4324785|NCT00454194|4152347|B2||Yes|Prior Bevacizumab||Participants|Count of Participants|30|30.0||||||
4324786|NCT00454194|4152348|B1||Yes|Prior Bevacizumab||Participants|Count of Participants|20|20.0||||||
4324787|NCT00454194|4152346|B3||IV|Stage|Stage IIIB: The cancer is continuing to spread from the lungs to the lymph nodes or to nearby structures and organs, such as the heart, trachea and esophagus. > Stage IV: The cancer has metastasized throughout the body and may now affect the liver, bones or brain.|Participants|Count of Participants|84|84.0||||||
4324788|NCT00454194|4152347|B2||IV|Stage|Stage IIIB: The cancer is continuing to spread from the lungs to the lymph nodes or to nearby structures and organs, such as the heart, trachea and esophagus. > Stage IV: The cancer has metastasized throughout the body and may now affect the liver, bones or brain.|Participants|Count of Participants|45|45.0||||||
4324789|NCT00454194|4152348|B1||IV|Stage|Stage IIIB: The cancer is continuing to spread from the lungs to the lymph nodes or to nearby structures and organs, such as the heart, trachea and esophagus. > Stage IV: The cancer has metastasized throughout the body and may now affect the liver, bones or brain.|Participants|Count of Participants|39|39.0||||||
4324790|NCT00454194|4152346|B3||IIIB|Stage|Stage IIIB: The cancer is continuing to spread from the lungs to the lymph nodes or to nearby structures and organs, such as the heart, trachea and esophagus. > Stage IV: The cancer has metastasized throughout the body and may now affect the liver, bones or brain.|Participants|Count of Participants|14|14.0||||||
4324791|NCT00454194|4152347|B2||IIIB|Stage|Stage IIIB: The cancer is continuing to spread from the lungs to the lymph nodes or to nearby structures and organs, such as the heart, trachea and esophagus. > Stage IV: The cancer has metastasized throughout the body and may now affect the liver, bones or brain.|Participants|Count of Participants|6|6.0||||||
4324792|NCT00454194|4152348|B1||IIIB|Stage|Stage IIIB: The cancer is continuing to spread from the lungs to the lymph nodes or to nearby structures and organs, such as the heart, trachea and esophagus. > Stage IV: The cancer has metastasized throughout the body and may now affect the liver, bones or brain.|Participants|Count of Participants|8|8.0||||||
4324793|NCT00454194|4152346|B3||1=Symptomatic and fully ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|52|52.0||||||
4324794|NCT00454194|4152347|B2||1=Symptomatic and fully ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|27|27.0||||||
4324795|NCT00454194|4152348|B1||1=Symptomatic and fully ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|25|25.0||||||
4324796|NCT00454194|4152346|B3||0=Asymptomatic and fully active|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|46|46.0||||||
4324797|NCT00454194|4152347|B2||0=Asymptomatic and fully active|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|24|24.0||||||
4324798|NCT00454194|4152348|B1||0=Asymptomatic and fully active|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|22|22.0||||||
4324799|NCT00454194|4152346|B3|United States||Region of Enrollment||Participants|Count of Participants|98|98.0||||||
4324800|NCT00454194|4152347|B2|United States||Region of Enrollment||Participants|Count of Participants|51|51.0||||||
4324801|NCT00454194|4152348|B1|United States||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
4324802|NCT00454194|4152346|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4324803|NCT00454194|4152347|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4324804|NCT00454194|4152348|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4324805|NCT00454194|4152346|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4324806|NCT00454194|4152347|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4324807|NCT00454194|4152348|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4324808|NCT00454194|4152346|B3|||Age||years|Median|62|62.0|Full Range|||43.0|83.0|
4324809|NCT00454194|4152347|B2|||Age||years|Median|62|62.0|Full Range|||49.0|83.0|
4324810|NCT00454194|4152348|B1|||Age||years|Median|62|62.0|Full Range|||43.0|79.0|
4324812|NCT00454181|4152366|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4324813|NCT00454181|4152367|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4324814|NCT00454181|4152365|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4324815|NCT00454181|4152366|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4324816|NCT00454181|4152367|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4324817|NCT00454181|4152365|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4324818|NCT00454181|4152366|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4324819|NCT00454181|4152367|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4324820|NCT00454181|4152365|B3|||Age||years|Mean|45.4|45.4|Standard Deviation|5.14|5.14|||
4324821|NCT00454181|4152366|B2|||Age||years|Mean|46.6|46.6|Standard Deviation|5.43|5.43|||
4324822|NCT00454181|4152367|B1|||Age||years|Mean|45.0|45.0|Standard Deviation|5.05|5.05|||
4324823|NCT00454181|4152365|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4324824|NCT00454181|4152366|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4324825|NCT00454181|4152367|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4324826|NCT00454181|4152365|B3||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4324827|NCT00454181|4152366|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4324828|NCT00454181|4152367|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4324829|NCT00454181|4152365|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4324830|NCT00454181|4152366|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4324831|NCT00454181|4152367|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4324832|NCT00454142|4152384|B1|Singapore||Region of Enrollment||participants|Number|33|33.0||||||
4324833|NCT00454142|4152384|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4324834|NCT00454142|4152384|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4324835|NCT00454142|4152384|B1|||Age||years|Mean|50|50.0|Standard Deviation|8.4|8.4|||
4324836|NCT00454142|4152384|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4324837|NCT00454142|4152384|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4324838|NCT00454142|4152384|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4324839|NCT00454116|4152399|B4||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4324840|NCT00454116|4152400|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4324841|NCT00454116|4152401|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4324842|NCT00454116|4152402|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4324843|NCT00454116|4152399|B4||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4324844|NCT00454116|4152400|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4324845|NCT00454116|4152401|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4324846|NCT00454116|4152402|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4324847|NCT00454116|4152399|B4|||Age||years|Mean|58|58.0|Full Range|||30.0|80.0|
4324848|NCT00454116|4152400|B3|||Age||years|Mean|59|59.0|Full Range|||37.0|73.0|
4324849|NCT00454116|4152401|B2|||Age||years|Mean|57|57.0|Full Range|||30.0|73.0|
4324850|NCT00454116|4152402|B1|||Age||years|Mean|57|57.0|Full Range|||39.0|80.0|
4324851|NCT00454051|4152412|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4324852|NCT00454051|4152413|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4324853|NCT00454051|4152414|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4324854|NCT00454051|4152412|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4324855|NCT00454051|4152413|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4324856|NCT00454051|4152414|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4324857|NCT00454051|4152412|B3|||Age||years|Mean|47.4|47.4|Standard Deviation|14.37|14.37|||
4324858|NCT00454051|4152413|B2|||Age||years|Mean|50.6|50.6|Standard Deviation|16.31|16.31|||
4324859|NCT00454051|4152414|B1|||Age||years|Mean|45.7|45.7|Standard Deviation|13.30|13.3|||
4324860|NCT00453999|4152445|B4|>= 94%||Transcutaneous Oxygen Saturation at Randomization||participants|Number|95|95.0||||||
4324861|NCT00453999|4152446|B3|>= 94%||Transcutaneous Oxygen Saturation at Randomization||participants|Number|32|32.0||||||
4324862|NCT00453999|4152447|B2|>= 94%||Transcutaneous Oxygen Saturation at Randomization||participants|Number|32|32.0||||||
4324863|NCT00453999|4152448|B1|>= 94%||Transcutaneous Oxygen Saturation at Randomization||participants|Number|31|31.0||||||
4324864|NCT00453999|4152445|B4|< 94%||Transcutaneous Oxygen Saturation at Randomization||participants|Number|42|42.0||||||
4324865|NCT00453999|4152446|B3|< 94%||Transcutaneous Oxygen Saturation at Randomization||participants|Number|14|14.0||||||
4324866|NCT00453999|4152447|B2|< 94%||Transcutaneous Oxygen Saturation at Randomization||participants|Number|14|14.0||||||
4324867|NCT00453999|4152448|B1|< 94%||Transcutaneous Oxygen Saturation at Randomization||participants|Number|14|14.0||||||
4324868|NCT00453999|4152445|B4|Not confirmed||Influenza Infection|"Confirmed included all subjects with confirmed influenza defined as a positive polymerase chain reaction (PCR) assay, positive viral culture, or paired serology showing a ≥ 4-fold increase in antibody to influenza A or B."|participants|Number|15|15.0||||||
4324869|NCT00453999|4152446|B3|Not confirmed||Influenza Infection|"Confirmed included all subjects with confirmed influenza defined as a positive polymerase chain reaction (PCR) assay, positive viral culture, or paired serology showing a ≥ 4-fold increase in antibody to influenza A or B."|participants|Number|5|5.0||||||
4324986|NCT00453986|4152475|B4|||Age||Years|Mean|34.9|34.9|Standard Deviation|10.73|10.73|||
4324870|NCT00453999|4152447|B2|Not confirmed||Influenza Infection|"Confirmed included all subjects with confirmed influenza defined as a positive polymerase chain reaction (PCR) assay, positive viral culture, or paired serology showing a ≥ 4-fold increase in antibody to influenza A or B."|participants|Number|6|6.0||||||
4324871|NCT00453999|4152448|B1|Not confirmed||Influenza Infection|"Confirmed included all subjects with confirmed influenza defined as a positive polymerase chain reaction (PCR) assay, positive viral culture, or paired serology showing a ≥ 4-fold increase in antibody to influenza A or B."|participants|Number|4|4.0||||||
4324872|NCT00453999|4152445|B4|Confirmed Influenza B||Influenza Infection|"Confirmed included all subjects with confirmed influenza defined as a positive polymerase chain reaction (PCR) assay, positive viral culture, or paired serology showing a ≥ 4-fold increase in antibody to influenza A or B."|participants|Number|32|32.0||||||
4324873|NCT00453999|4152446|B3|Confirmed Influenza B||Influenza Infection|"Confirmed included all subjects with confirmed influenza defined as a positive polymerase chain reaction (PCR) assay, positive viral culture, or paired serology showing a ≥ 4-fold increase in antibody to influenza A or B."|participants|Number|11|11.0||||||
4324874|NCT00453999|4152447|B2|Confirmed Influenza B||Influenza Infection|"Confirmed included all subjects with confirmed influenza defined as a positive polymerase chain reaction (PCR) assay, positive viral culture, or paired serology showing a ≥ 4-fold increase in antibody to influenza A or B."|participants|Number|6|6.0||||||
4324875|NCT00453999|4152448|B1|Confirmed Influenza B||Influenza Infection|"Confirmed included all subjects with confirmed influenza defined as a positive polymerase chain reaction (PCR) assay, positive viral culture, or paired serology showing a ≥ 4-fold increase in antibody to influenza A or B."|participants|Number|15|15.0||||||
4324876|NCT00453999|4152445|B4|Confirmed Influenza A||Influenza Infection|"Confirmed included all subjects with confirmed influenza defined as a positive polymerase chain reaction (PCR) assay, positive viral culture, or paired serology showing a ≥ 4-fold increase in antibody to influenza A or B."|participants|Number|90|90.0||||||
4324877|NCT00453999|4152446|B3|Confirmed Influenza A||Influenza Infection|"Confirmed included all subjects with confirmed influenza defined as a positive polymerase chain reaction (PCR) assay, positive viral culture, or paired serology showing a ≥ 4-fold increase in antibody to influenza A or B."|participants|Number|30|30.0||||||
4324878|NCT00453999|4152447|B2|Confirmed Influenza A||Influenza Infection|"Confirmed included all subjects with confirmed influenza defined as a positive polymerase chain reaction (PCR) assay, positive viral culture, or paired serology showing a ≥ 4-fold increase in antibody to influenza A or B."|participants|Number|34|34.0||||||
4324879|NCT00453999|4152448|B1|Confirmed Influenza A||Influenza Infection|"Confirmed included all subjects with confirmed influenza defined as a positive polymerase chain reaction (PCR) assay, positive viral culture, or paired serology showing a ≥ 4-fold increase in antibody to influenza A or B."|participants|Number|26|26.0||||||
4324880|NCT00453999|4152445|B4|Missing||Current Smoking Status|A smoker was defined as a subject who had smoked cigarettes in the last 30 days or currently used other tobacco products. Data were available for 135 participants (44 in the Peramivir 200 mg group; 45 in the Peramivir 400 mg group; and 46 in the Oseltamivir group).|participants|Number|2|2.0||||||
4324881|NCT00453999|4152446|B3|Missing||Current Smoking Status|A smoker was defined as a subject who had smoked cigarettes in the last 30 days or currently used other tobacco products. Data were available for 135 participants (44 in the Peramivir 200 mg group; 45 in the Peramivir 400 mg group; and 46 in the Oseltamivir group).|participants|Number|0|0.0||||||
4324882|NCT00453999|4152447|B2|Missing||Current Smoking Status|A smoker was defined as a subject who had smoked cigarettes in the last 30 days or currently used other tobacco products. Data were available for 135 participants (44 in the Peramivir 200 mg group; 45 in the Peramivir 400 mg group; and 46 in the Oseltamivir group).|participants|Number|1|1.0||||||
4324883|NCT00453999|4152448|B1|Missing||Current Smoking Status|A smoker was defined as a subject who had smoked cigarettes in the last 30 days or currently used other tobacco products. Data were available for 135 participants (44 in the Peramivir 200 mg group; 45 in the Peramivir 400 mg group; and 46 in the Oseltamivir group).|participants|Number|1|1.0||||||
4324884|NCT00453999|4152445|B4|Nonsmoker||Current Smoking Status|A smoker was defined as a subject who had smoked cigarettes in the last 30 days or currently used other tobacco products. Data were available for 135 participants (44 in the Peramivir 200 mg group; 45 in the Peramivir 400 mg group; and 46 in the Oseltamivir group).|participants|Number|118|118.0||||||
4324885|NCT00453999|4152446|B3|Nonsmoker||Current Smoking Status|A smoker was defined as a subject who had smoked cigarettes in the last 30 days or currently used other tobacco products. Data were available for 135 participants (44 in the Peramivir 200 mg group; 45 in the Peramivir 400 mg group; and 46 in the Oseltamivir group).|participants|Number|42|42.0||||||
4324886|NCT00453999|4152447|B2|Nonsmoker||Current Smoking Status|A smoker was defined as a subject who had smoked cigarettes in the last 30 days or currently used other tobacco products. Data were available for 135 participants (44 in the Peramivir 200 mg group; 45 in the Peramivir 400 mg group; and 46 in the Oseltamivir group).|participants|Number|40|40.0||||||
4324887|NCT00453999|4152448|B1|Nonsmoker||Current Smoking Status|A smoker was defined as a subject who had smoked cigarettes in the last 30 days or currently used other tobacco products. Data were available for 135 participants (44 in the Peramivir 200 mg group; 45 in the Peramivir 400 mg group; and 46 in the Oseltamivir group).|participants|Number|36|36.0||||||
4324888|NCT00453999|4152445|B4|Smoker||Current Smoking Status|A smoker was defined as a subject who had smoked cigarettes in the last 30 days or currently used other tobacco products. Data were available for 135 participants (44 in the Peramivir 200 mg group; 45 in the Peramivir 400 mg group; and 46 in the Oseltamivir group).|participants|Number|17|17.0||||||
4324889|NCT00453999|4152446|B3|Smoker||Current Smoking Status|A smoker was defined as a subject who had smoked cigarettes in the last 30 days or currently used other tobacco products. Data were available for 135 participants (44 in the Peramivir 200 mg group; 45 in the Peramivir 400 mg group; and 46 in the Oseltamivir group).|participants|Number|4|4.0||||||
4324890|NCT00453999|4152447|B2|Smoker||Current Smoking Status|A smoker was defined as a subject who had smoked cigarettes in the last 30 days or currently used other tobacco products. Data were available for 135 participants (44 in the Peramivir 200 mg group; 45 in the Peramivir 400 mg group; and 46 in the Oseltamivir group).|participants|Number|5|5.0||||||
4324931|NCT00453999|4152448|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4324891|NCT00453999|4152448|B1|Smoker||Current Smoking Status|A smoker was defined as a subject who had smoked cigarettes in the last 30 days or currently used other tobacco products. Data were available for 135 participants (44 in the Peramivir 200 mg group; 45 in the Peramivir 400 mg group; and 46 in the Oseltamivir group).|participants|Number|8|8.0||||||
4324892|NCT00453999|4152445|B4|||Initial Composite Symptom Score|Initial Composite Symptom Score is defined as the sum of the 7 symptoms of influenza recorded at the predose visit. (cough; sore throat; nasal congestion; myalgia [aches and pains]; headache; feverishness; and fatigue), each graded on a 4-point severity scale (0, absent; 1, mild; 2, moderate; 3, severe); for the composite score, individual scores were summed, with a range from 0 to 21. Data were available for 122 participants (39 in the Peramivir 200 mg group; 41 in the Peramivir 400 mg group; and 42 in the Oseltamivir group).|units on a scale|Mean|12.4|12.4|Standard Deviation|5.51|5.51|||
4324893|NCT00453999|4152446|B3|||Initial Composite Symptom Score|Initial Composite Symptom Score is defined as the sum of the 7 symptoms of influenza recorded at the predose visit. (cough; sore throat; nasal congestion; myalgia [aches and pains]; headache; feverishness; and fatigue), each graded on a 4-point severity scale (0, absent; 1, mild; 2, moderate; 3, severe); for the composite score, individual scores were summed, with a range from 0 to 21. Data were available for 122 participants (39 in the Peramivir 200 mg group; 41 in the Peramivir 400 mg group; and 42 in the Oseltamivir group).|units on a scale|Mean|12.3|12.3|Standard Deviation|5.46|5.46|||
4324894|NCT00453999|4152447|B2|||Initial Composite Symptom Score|Initial Composite Symptom Score is defined as the sum of the 7 symptoms of influenza recorded at the predose visit. (cough; sore throat; nasal congestion; myalgia [aches and pains]; headache; feverishness; and fatigue), each graded on a 4-point severity scale (0, absent; 1, mild; 2, moderate; 3, severe); for the composite score, individual scores were summed, with a range from 0 to 21. Data were available for 122 participants (39 in the Peramivir 200 mg group; 41 in the Peramivir 400 mg group; and 42 in the Oseltamivir group).|units on a scale|Mean|12.2|12.2|Standard Deviation|5.95|5.95|||
4324895|NCT00453999|4152448|B1|||Initial Composite Symptom Score|Initial Composite Symptom Score is defined as the sum of the 7 symptoms of influenza recorded at the predose visit. (cough; sore throat; nasal congestion; myalgia [aches and pains]; headache; feverishness; and fatigue), each graded on a 4-point severity scale (0, absent; 1, mild; 2, moderate; 3, severe); for the composite score, individual scores were summed, with a range from 0 to 21. Data were available for 122 participants (39 in the Peramivir 200 mg group; 41 in the Peramivir 400 mg group; and 42 in the Oseltamivir group).|units on a scale|Mean|12.7|12.7|Standard Deviation|5.19|5.19|||
4324896|NCT00453999|4152445|B4|>= 48 hours to <=72 hours||Duration of Illness at Randomization||participants|Number|43|43.0||||||
4324897|NCT00453999|4152446|B3|>= 48 hours to <=72 hours||Duration of Illness at Randomization||participants|Number|15|15.0||||||
4324898|NCT00453999|4152447|B2|>= 48 hours to <=72 hours||Duration of Illness at Randomization||participants|Number|14|14.0||||||
4324899|NCT00453999|4152448|B1|>= 48 hours to <=72 hours||Duration of Illness at Randomization||participants|Number|14|14.0||||||
4324900|NCT00453999|4152445|B4|< 48 hours||Duration of Illness at Randomization||participants|Number|94|94.0||||||
4324901|NCT00453999|4152446|B3|< 48 hours||Duration of Illness at Randomization||participants|Number|31|31.0||||||
4324902|NCT00453999|4152447|B2|< 48 hours||Duration of Illness at Randomization||participants|Number|32|32.0||||||
4324903|NCT00453999|4152448|B1|< 48 hours||Duration of Illness at Randomization||participants|Number|31|31.0||||||
4324904|NCT00453999|4152445|B4|||Weight||kg|Mean|72.4|72.4|Standard Deviation|22.5|22.5|||
4324905|NCT00453999|4152446|B3|||Weight||kg|Mean|79.5|79.5|Standard Deviation|22.7|22.7|||
4324906|NCT00453999|4152447|B2|||Weight||kg|Mean|72.4|72.4|Standard Deviation|22.9|22.9|||
4324907|NCT00453999|4152448|B1|||Weight||kg|Mean|64.9|64.9|Standard Deviation|19.8|19.8|||
4324908|NCT00453999|4152445|B4|||Height||cm|Mean|164.4|164.4|Standard Deviation|11.5|11.5|||
4324909|NCT00453999|4152446|B3|||Height||cm|Mean|168.4|168.4|Standard Deviation|11.8|11.8|||
4324910|NCT00453999|4152447|B2|||Height||cm|Mean|161.6|161.6|Standard Deviation|11.8|11.8|||
4324911|NCT00453999|4152448|B1|||Height||cm|Mean|163.0|163.0|Standard Deviation|9.9|9.9|||
4324912|NCT00453999|4152445|B4|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4324913|NCT00453999|4152446|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4324914|NCT00453999|4152447|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4324915|NCT00453999|4152448|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4324916|NCT00453999|4152445|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4324917|NCT00453999|4152446|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4324918|NCT00453999|4152447|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4324919|NCT00453999|4152448|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4324920|NCT00453999|4152445|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4324921|NCT00453999|4152446|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4324922|NCT00453999|4152447|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4324923|NCT00453999|4152448|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4324924|NCT00453999|4152445|B4|Asian||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4324925|NCT00453999|4152446|B3|Asian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4324926|NCT00453999|4152447|B2|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4324927|NCT00453999|4152448|B1|Asian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4324928|NCT00453999|4152445|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4324929|NCT00453999|4152446|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4324930|NCT00453999|4152447|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4324932|NCT00453999|4152445|B4|White or Caucasian||Race/Ethnicity, Customized||participants|Number|64|64.0||||||
4324933|NCT00453999|4152446|B3|White or Caucasian||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4324934|NCT00453999|4152447|B2|White or Caucasian||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4324935|NCT00453999|4152448|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4324936|NCT00453999|4152445|B4||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4324937|NCT00453999|4152446|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4324938|NCT00453999|4152447|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4324939|NCT00453999|4152448|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4324940|NCT00453999|4152445|B4||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4324941|NCT00453999|4152446|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4324942|NCT00453999|4152447|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4324943|NCT00453999|4152448|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4324944|NCT00453999|4152445|B4|||Age||years|Mean|59.2|59.2|Standard Deviation|22.0|22.0|||
4324945|NCT00453999|4152446|B3|||Age||years|Mean|62.0|62.0|Standard Deviation|21.3|21.3|||
4324946|NCT00453999|4152447|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|20.9|20.9|||
4324947|NCT00453999|4152448|B1|||Age||years|Mean|56.9|56.9|Standard Deviation|24.0|24.0|||
4324948|NCT00453986|4152473|B6|White - Caucasian / European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4324949|NCT00453986|4152474|B5|White - Caucasian / European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4324950|NCT00453986|4152475|B4|White - Caucasian / European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4324951|NCT00453986|4152476|B3|White - Caucasian / European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4324952|NCT00453986|4152477|B2|White - Caucasian / European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4324953|NCT00453986|4152478|B1|White - Caucasian / European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4324954|NCT00453986|4152473|B6|White - Arabic / North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|351|351.0||||||
4324955|NCT00453986|4152474|B5|White - Arabic / North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4324956|NCT00453986|4152475|B4|White - Arabic / North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|88|88.0||||||
4324957|NCT00453986|4152476|B3|White - Arabic / North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|87|87.0||||||
4324958|NCT00453986|4152477|B2|White - Arabic / North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|88|88.0||||||
4324959|NCT00453986|4152478|B1|White - Arabic / North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|88|88.0||||||
4324960|NCT00453986|4152473|B6|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4324961|NCT00453986|4152474|B5|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4324962|NCT00453986|4152475|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4324963|NCT00453986|4152476|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4324964|NCT00453986|4152477|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4324965|NCT00453986|4152478|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4324966|NCT00453986|4152473|B6|Asian - South east Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|999|999.0||||||
4324967|NCT00453986|4152474|B5|Asian - South east Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|105|105.0||||||
4324968|NCT00453986|4152475|B4|Asian - South east Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|224|224.0||||||
4324969|NCT00453986|4152476|B3|Asian - South east Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|224|224.0||||||
4324970|NCT00453986|4152477|B2|Asian - South east Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|223|223.0||||||
4324971|NCT00453986|4152478|B1|Asian - South east Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|223|223.0||||||
4324972|NCT00453986|4152473|B6||Male|Sex: Female, Male||Participants|Count of Participants|754|754.0||||||
4324973|NCT00453986|4152474|B5||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4324974|NCT00453986|4152475|B4||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4324975|NCT00453986|4152476|B3||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4324976|NCT00453986|4152477|B2||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4324977|NCT00453986|4152478|B1||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4324978|NCT00453986|4152473|B6||Female|Sex: Female, Male||Participants|Count of Participants|598|598.0||||||
4324979|NCT00453986|4152474|B5||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4324980|NCT00453986|4152475|B4||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4324981|NCT00453986|4152476|B3||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4324982|NCT00453986|4152477|B2||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4324983|NCT00453986|4152478|B1||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4324984|NCT00453986|4152473|B6|||Age||Years|Mean|35.4|35.4|Standard Deviation|10.57|10.57|||
4324985|NCT00453986|4152474|B5|||Age||Years|Mean|35.9|35.9|Standard Deviation|10.40|10.4|||
4324987|NCT00453986|4152476|B3|||Age||Years|Mean|35.7|35.7|Standard Deviation|10.75|10.75|||
4324988|NCT00453986|4152477|B2|||Age||Years|Mean|35.1|35.1|Standard Deviation|10.50|10.5|||
4324989|NCT00453986|4152478|B1|||Age||Years|Mean|35.2|35.2|Standard Deviation|10.48|10.48|||
4324990|NCT00453973|4152573|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4324991|NCT00453973|4152574|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4324992|NCT00453973|4152575|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4324993|NCT00453973|4152573|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4324994|NCT00453973|4152574|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4324995|NCT00453973|4152575|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4324996|NCT00453973|4152573|B3|||Age||years|Mean|60.5|60.5|Standard Deviation|14.36|14.36|||
4324997|NCT00453973|4152574|B2|||Age||years|Mean|66.4|66.4|Standard Deviation|13.48|13.48|||
4324998|NCT00453973|4152575|B1|||Age||years|Mean|53.2|53.2|Standard Deviation|11.92|11.92|||
4324999|NCT00453973|4152573|B3||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
4325000|NCT00453973|4152574|B2||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
4325001|NCT00453973|4152575|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4325002|NCT00453973|4152573|B3||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4325003|NCT00453973|4152574|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4325004|NCT00453973|4152575|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4325005|NCT00453973|4152573|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4325006|NCT00453973|4152574|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4325007|NCT00453973|4152575|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4325008|NCT00453921|4152582|B5|United States||Region of Enrollment||Participants|Count of Participants|75|75.0||||||
4325009|NCT00453921|4152583|B4|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4325010|NCT00453921|4152584|B3|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4325011|NCT00453921|4152585|B2|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4325012|NCT00453921|4152586|B1|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4325013|NCT00453921|4152582|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325014|NCT00453921|4152583|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325015|NCT00453921|4152584|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325016|NCT00453921|4152585|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325017|NCT00453921|4152586|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325018|NCT00453921|4152582|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325019|NCT00453921|4152583|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325020|NCT00453921|4152584|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325021|NCT00453921|4152585|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325022|NCT00453921|4152586|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325023|NCT00453921|4152582|B5||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4325024|NCT00453921|4152583|B4||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4325025|NCT00453921|4152584|B3||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4325026|NCT00453921|4152585|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4325027|NCT00453921|4152586|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4325028|NCT00453921|4152582|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4325029|NCT00453921|4152583|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325030|NCT00453921|4152584|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4325031|NCT00453921|4152585|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4325032|NCT00453921|4152586|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325033|NCT00453921|4152582|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325034|NCT00453921|4152583|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325035|NCT00453921|4152584|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325036|NCT00453921|4152585|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325037|NCT00453921|4152586|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325038|NCT00453921|4152582|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325039|NCT00453921|4152583|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325040|NCT00453921|4152584|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325041|NCT00453921|4152585|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325042|NCT00453921|4152586|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325043|NCT00453921|4152582|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4325044|NCT00453921|4152583|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4325359|NCT00452790|4152867|B2|||Age||weeks|Mean|7.2|7.2|Standard Deviation|1.1|1.1|||
4325045|NCT00453921|4152584|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325046|NCT00453921|4152585|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325047|NCT00453921|4152586|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325048|NCT00453921|4152582|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325049|NCT00453921|4152583|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325050|NCT00453921|4152584|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325051|NCT00453921|4152585|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325052|NCT00453921|4152586|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325053|NCT00453921|4152582|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
4325054|NCT00453921|4152583|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4325055|NCT00453921|4152584|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4325056|NCT00453921|4152585|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4325057|NCT00453921|4152586|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4325058|NCT00453921|4152582|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4325059|NCT00453921|4152583|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4325060|NCT00453921|4152584|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325061|NCT00453921|4152585|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4325062|NCT00453921|4152586|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325063|NCT00453921|4152582|B5||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4325064|NCT00453921|4152583|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4325065|NCT00453921|4152584|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4325066|NCT00453921|4152585|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4325067|NCT00453921|4152586|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4325068|NCT00453921|4152582|B5||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4325069|NCT00453921|4152583|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4325070|NCT00453921|4152584|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4325071|NCT00453921|4152585|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4325072|NCT00453921|4152586|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4325073|NCT00453921|4152582|B5|||Age||years|Mean|40.1|40.1|Standard Deviation|13.3|13.3|||
4325074|NCT00453921|4152583|B4|||Age||years|Mean|37.2|37.2|Standard Deviation|12.0|12.0|||
4325075|NCT00453921|4152584|B3|||Age||years|Mean|43.0|43.0|Standard Deviation|15.0|15.0|||
4325076|NCT00453921|4152585|B2|||Age||years|Mean|43.1|43.1|Standard Deviation|12.3|12.3|||
4325077|NCT00453921|4152586|B1|||Age||years|Mean|37.3|37.3|Standard Deviation|14.2|14.2|||
4325078|NCT00453479|4152623|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325079|NCT00453479|4152624|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325080|NCT00453479|4152625|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325081|NCT00453479|4152626|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325082|NCT00453479|4152623|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325083|NCT00453479|4152624|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325084|NCT00453479|4152625|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325085|NCT00453479|4152626|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325086|NCT00453479|4152623|B4||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4325087|NCT00453479|4152624|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4325088|NCT00453479|4152625|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4325089|NCT00453479|4152626|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4325090|NCT00453479|4152623|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325091|NCT00453479|4152624|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325092|NCT00453479|4152625|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325093|NCT00453479|4152626|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325094|NCT00453479|4152623|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325095|NCT00453479|4152624|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325096|NCT00453479|4152625|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325097|NCT00453479|4152626|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325098|NCT00453479|4152623|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325099|NCT00453479|4152624|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325100|NCT00453479|4152625|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325101|NCT00453479|4152626|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325102|NCT00453479|4152623|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325103|NCT00453479|4152624|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325104|NCT00453479|4152625|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325105|NCT00453479|4152626|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325106|NCT00453479|4152623|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4325107|NCT00453479|4152624|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4325108|NCT00453479|4152625|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4325109|NCT00453479|4152626|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4325110|NCT00453479|4152623|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4325111|NCT00453479|4152624|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4325112|NCT00453479|4152625|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4325113|NCT00453479|4152626|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4325114|NCT00453479|4152623|B4|||Age||Years|Mean|62.2|62.2|Standard Deviation|8.48|8.48|||
4325115|NCT00453479|4152624|B3|||Age||Years|Mean|59.0|59.0|Standard Deviation|7.27|7.27|||
4325116|NCT00453479|4152625|B2|||Age||Years|Mean|66.4|66.4|Standard Deviation|6.31|6.31|||
4325117|NCT00453479|4152626|B1|||Age||Years|Mean|60.0|60.0|Standard Deviation|11.15|11.15|||
4325118|NCT00453388|4152699|B5|Brazil||Region of Enrollment||participants|Number|2|2.0||||||
4325119|NCT00453388|4152701|B3|Brazil||Region of Enrollment||participants|Number|0|0.0||||||
4325120|NCT00453388|4152702|B2|Brazil||Region of Enrollment||participants|Number|2|2.0||||||
4325121|NCT00453388|4152699|B5|United States||Region of Enrollment||participants|Number|4|4.0||||||
4325122|NCT00453388|4152701|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4325123|NCT00453388|4152702|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4325124|NCT00453388|4152699|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4325125|NCT00453388|4152701|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4325126|NCT00453388|4152702|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4325127|NCT00453388|4152699|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4325128|NCT00453388|4152701|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4325129|NCT00453388|4152702|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4325130|NCT00453388|4152699|B5|||Age||years|Median|11.1|11.1|Full Range|||6.9|13.9|
4325131|NCT00453388|4152701|B3|||Age||years|Median|11.9|11.9|Full Range|||11.9|11.9|
4325132|NCT00453388|4152702|B2|||Age||years|Median|11.1|11.1|Full Range|||6.9|13.9|
4325133|NCT00453388|4152699|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4325134|NCT00453388|4152701|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4325135|NCT00453388|4152702|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4325136|NCT00453388|4152699|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4325137|NCT00453388|4152701|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4325138|NCT00453388|4152702|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4325139|NCT00453388|4152699|B5||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4325140|NCT00453388|4152701|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4325141|NCT00453388|4152702|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4325142|NCT00453362|4152728|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4325143|NCT00453362|4152728|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4325144|NCT00453362|4152728|B1|||Age|Patients who were treated with any dose of erlotinib were included in the summary of baseline measures.|years|Mean|62.9|62.9|Standard Deviation|9.2|9.2|||
4325145|NCT00453349|4152752|B3|||Total pelvic pain score (using modified McCormack score)|Modified McCormack score was used to assess the tenderness at the abdominal and pelvic examination, 0=tenderness absent, 1=tenderness described by the subject but not manifested by facial expression or muscle tone changes, 2=tenderness resulting in altered facial expression or muscle tone, 3=tenderness causing observable marked distress.|points on a scale|Mean|11.5|11.5|Standard Deviation|3.8|3.8|||
4325146|NCT00453349|4152753|B2|||Total pelvic pain score (using modified McCormack score)|Modified McCormack score was used to assess the tenderness at the abdominal and pelvic examination, 0=tenderness absent, 1=tenderness described by the subject but not manifested by facial expression or muscle tone changes, 2=tenderness resulting in altered facial expression or muscle tone, 3=tenderness causing observable marked distress.|points on a scale|Mean|11.6|11.6|Standard Deviation|3.8|3.8|||
4325147|NCT00453349|4152754|B1|||Total pelvic pain score (using modified McCormack score)|Modified McCormack score was used to assess the tenderness at the abdominal and pelvic examination, 0=tenderness absent, 1=tenderness described by the subject but not manifested by facial expression or muscle tone changes, 2=tenderness resulting in altered facial expression or muscle tone, 3=tenderness causing observable marked distress.|points on a scale|Mean|11.3|11.3|Standard Deviation|3.8|3.8|||
4325148|NCT00453349|4152752|B3|||Microbiology recovery|Endocervical samples were taken for culture and Polymerase Chain Reaction (PCR) tests within 48 hours prior to start of therapy. The PCR tests were repeated at TOC and Follow-up visits if the pre-therapy results were positive for Neisseria gonorrhoeae and Chlamydia trachomatis.|number of participants with pathogenes|Number|72|72.0||||||
4325242|NCT00453154|4152817|B4|6 cycles||Number of combination chemotherapy cycles|Number of cycles of combination chemotherapy received prior to maintenance randomization.|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4325149|NCT00453349|4152753|B2|||Microbiology recovery|Endocervical samples were taken for culture and Polymerase Chain Reaction (PCR) tests within 48 hours prior to start of therapy. The PCR tests were repeated at TOC and Follow-up visits if the pre-therapy results were positive for Neisseria gonorrhoeae and Chlamydia trachomatis.|number of participants with pathogenes|Number|36|36.0||||||
4325150|NCT00453349|4152754|B1|||Microbiology recovery|Endocervical samples were taken for culture and Polymerase Chain Reaction (PCR) tests within 48 hours prior to start of therapy. The PCR tests were repeated at TOC and Follow-up visits if the pre-therapy results were positive for Neisseria gonorrhoeae and Chlamydia trachomatis.|number of participants with pathogenes|Number|36|36.0||||||
4325151|NCT00453349|4152752|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4325152|NCT00453349|4152753|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4325153|NCT00453349|4152754|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4325154|NCT00453349|4152752|B3||Female|Sex: Female, Male||Participants|Count of Participants|460|460.0||||||
4325155|NCT00453349|4152753|B2||Female|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
4325156|NCT00453349|4152754|B1||Female|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
4325157|NCT00453349|4152752|B3|||Age||years|Mean|35.2|35.2|Standard Deviation|8.6|8.6|||
4325158|NCT00453349|4152753|B2|||Age||years|Mean|35.4|35.4|Standard Deviation|8.7|8.7|||
4325159|NCT00453349|4152754|B1|||Age||years|Mean|35.2|35.2|Standard Deviation|8.4|8.4|||
4325160|NCT00453336|4152781|B1|Verrucous Carcinoma||Pathology||participants|Number|1|1.0||||||
4325161|NCT00453336|4152781|B1|Carcinoma in situ||Pathology||participants|Number|9|9.0||||||
4325162|NCT00453336|4152781|B1|Severe Dysplasia||Pathology||participants|Number|13|13.0||||||
4325163|NCT00453336|4152781|B1|Squamous Cell Carcinoma||Pathology||participants|Number|22|22.0||||||
4325164|NCT00453336|4152781|B1|Other Lesions||Types of Lesions|The types of lesions participants had at time of enrollment|participants|Number|3|3.0||||||
4325165|NCT00453336|4152781|B1|Layngeal Lesions||Types of Lesions|The types of lesions participants had at time of enrollment|participants|Number|18|18.0||||||
4325166|NCT00453336|4152781|B1|Oral Cavity Lesions||Types of Lesions|The types of lesions participants had at time of enrollment|participants|Number|24|24.0||||||
4325167|NCT00453336|4152781|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4325168|NCT00453336|4152781|B1||Male|Gender||Participants|Count of Participants|22|22.0||||||
4325169|NCT00453336|4152781|B1||Female|Gender||Participants|Count of Participants|23|23.0||||||
4325170|NCT00453336|4152781|B1|||Age||years|Median|66|66.0|Full Range|||30.0|92.0|
4325171|NCT00453336|4152781|B1||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
4325172|NCT00453336|4152781|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4325173|NCT00453336|4152781|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4325174|NCT00453310|4152786|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4325175|NCT00453310|4152786|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4325176|NCT00453310|4152786|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4325177|NCT00453310|4152786|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4325178|NCT00453310|4152786|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4325179|NCT00453206|4152790|B1|United States||Region of Enrollment||participants|Number|66|66.0||||||
4325180|NCT00453206|4152790|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325181|NCT00453206|4152790|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4325182|NCT00453206|4152790|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4325183|NCT00453206|4152790|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325184|NCT00453206|4152790|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325185|NCT00453206|4152790|B1||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4325186|NCT00453206|4152790|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4325187|NCT00453206|4152790|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325188|NCT00453206|4152790|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325189|NCT00453206|4152790|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325190|NCT00453206|4152790|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4325191|NCT00453206|4152790|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4325192|NCT00453206|4152790|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4325193|NCT00453206|4152790|B1||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4325194|NCT00453206|4152790|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4325195|NCT00453206|4152790|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|7.5|7.5|||
4325196|NCT00453193|4152794|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4325197|NCT00453193|4152794|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4325198|NCT00453193|4152794|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4325199|NCT00453193|4152794|B1|||Age||years|Median|57|57.0|Full Range|||21.0|79.0|
4325200|NCT00453180|4152798|B3||7. Extremly ill|Clinical Global Impression-Severity|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale that requires the clinician to rate the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis. Considering total clinical experience, a patient is assessed on severity of mental illness at the time of rating 1, normal, not at all ill; 2, borderline ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|Participants|Count of Participants|0|0.0||||||
4325201|NCT00453180|4152799|B2||7. Extremly ill|Clinical Global Impression-Severity|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale that requires the clinician to rate the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis. Considering total clinical experience, a patient is assessed on severity of mental illness at the time of rating 1, normal, not at all ill; 2, borderline ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|Participants|Count of Participants|0|0.0||||||
4325202|NCT00453180|4152800|B1||7. Extremly ill|Clinical Global Impression-Severity|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale that requires the clinician to rate the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis. Considering total clinical experience, a patient is assessed on severity of mental illness at the time of rating 1, normal, not at all ill; 2, borderline ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|Participants|Count of Participants|0|0.0||||||
4325203|NCT00453180|4152798|B3||6. Severly ill|Clinical Global Impression-Severity|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale that requires the clinician to rate the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis. Considering total clinical experience, a patient is assessed on severity of mental illness at the time of rating 1, normal, not at all ill; 2, borderline ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|Participants|Count of Participants|1|1.0||||||
4325204|NCT00453180|4152799|B2||6. Severly ill|Clinical Global Impression-Severity|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale that requires the clinician to rate the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis. Considering total clinical experience, a patient is assessed on severity of mental illness at the time of rating 1, normal, not at all ill; 2, borderline ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|Participants|Count of Participants|0|0.0||||||
4325205|NCT00453180|4152800|B1||6. Severly ill|Clinical Global Impression-Severity|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale that requires the clinician to rate the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis. Considering total clinical experience, a patient is assessed on severity of mental illness at the time of rating 1, normal, not at all ill; 2, borderline ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|Participants|Count of Participants|1|1.0||||||
4325206|NCT00453180|4152798|B3||5. Markedly ill|Clinical Global Impression-Severity|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale that requires the clinician to rate the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis. Considering total clinical experience, a patient is assessed on severity of mental illness at the time of rating 1, normal, not at all ill; 2, borderline ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|Participants|Count of Participants|15|15.0||||||
4325207|NCT00453180|4152799|B2||5. Markedly ill|Clinical Global Impression-Severity|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale that requires the clinician to rate the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis. Considering total clinical experience, a patient is assessed on severity of mental illness at the time of rating 1, normal, not at all ill; 2, borderline ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|Participants|Count of Participants|6|6.0||||||
4325208|NCT00453180|4152800|B1||5. Markedly ill|Clinical Global Impression-Severity|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale that requires the clinician to rate the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis. Considering total clinical experience, a patient is assessed on severity of mental illness at the time of rating 1, normal, not at all ill; 2, borderline ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|Participants|Count of Participants|9|9.0||||||
4325209|NCT00453180|4152798|B3||4. Moderatly ill|Clinical Global Impression-Severity|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale that requires the clinician to rate the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis. Considering total clinical experience, a patient is assessed on severity of mental illness at the time of rating 1, normal, not at all ill; 2, borderline ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|Participants|Count of Participants|15|15.0||||||
4325210|NCT00453180|4152799|B2||4. Moderatly ill|Clinical Global Impression-Severity|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale that requires the clinician to rate the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis. Considering total clinical experience, a patient is assessed on severity of mental illness at the time of rating 1, normal, not at all ill; 2, borderline ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|Participants|Count of Participants|9|9.0||||||
4325211|NCT00453180|4152800|B1||4. Moderatly ill|Clinical Global Impression-Severity|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale that requires the clinician to rate the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis. Considering total clinical experience, a patient is assessed on severity of mental illness at the time of rating 1, normal, not at all ill; 2, borderline ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|Participants|Count of Participants|6|6.0||||||
4325212|NCT00453180|4152798|B3||3..Mildly ill|Clinical Global Impression-Severity|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale that requires the clinician to rate the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis. Considering total clinical experience, a patient is assessed on severity of mental illness at the time of rating 1, normal, not at all ill; 2, borderline ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|Participants|Count of Participants|0|0.0||||||
4325213|NCT00453180|4152799|B2||3..Mildly ill|Clinical Global Impression-Severity|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale that requires the clinician to rate the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis. Considering total clinical experience, a patient is assessed on severity of mental illness at the time of rating 1, normal, not at all ill; 2, borderline ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|Participants|Count of Participants|0|0.0||||||
4325214|NCT00453180|4152800|B1||3..Mildly ill|Clinical Global Impression-Severity|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale that requires the clinician to rate the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis. Considering total clinical experience, a patient is assessed on severity of mental illness at the time of rating 1, normal, not at all ill; 2, borderline ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|Participants|Count of Participants|0|0.0||||||
4325215|NCT00453180|4152798|B3||2. Borderline ill|Clinical Global Impression-Severity|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale that requires the clinician to rate the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis. Considering total clinical experience, a patient is assessed on severity of mental illness at the time of rating 1, normal, not at all ill; 2, borderline ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|Participants|Count of Participants|0|0.0||||||
4325216|NCT00453180|4152799|B2||2. Borderline ill|Clinical Global Impression-Severity|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale that requires the clinician to rate the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis. Considering total clinical experience, a patient is assessed on severity of mental illness at the time of rating 1, normal, not at all ill; 2, borderline ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|Participants|Count of Participants|0|0.0||||||
4325217|NCT00453180|4152800|B1||2. Borderline ill|Clinical Global Impression-Severity|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale that requires the clinician to rate the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis. Considering total clinical experience, a patient is assessed on severity of mental illness at the time of rating 1, normal, not at all ill; 2, borderline ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|Participants|Count of Participants|0|0.0||||||
4325218|NCT00453180|4152798|B3||1. Normal, not al all ill|Clinical Global Impression-Severity|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale that requires the clinician to rate the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis. Considering total clinical experience, a patient is assessed on severity of mental illness at the time of rating 1, normal, not at all ill; 2, borderline ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|Participants|Count of Participants|0|0.0||||||
4325219|NCT00453180|4152799|B2||1. Normal, not al all ill|Clinical Global Impression-Severity|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale that requires the clinician to rate the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis. Considering total clinical experience, a patient is assessed on severity of mental illness at the time of rating 1, normal, not at all ill; 2, borderline ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|Participants|Count of Participants|0|0.0||||||
4325220|NCT00453180|4152800|B1||1. Normal, not al all ill|Clinical Global Impression-Severity|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale that requires the clinician to rate the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis. Considering total clinical experience, a patient is assessed on severity of mental illness at the time of rating 1, normal, not at all ill; 2, borderline ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|Participants|Count of Participants|0|0.0||||||
4325221|NCT00453180|4152798|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4325222|NCT00453180|4152799|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4325223|NCT00453180|4152800|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4325224|NCT00453180|4152798|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4325225|NCT00453180|4152799|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4325226|NCT00453180|4152800|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4325227|NCT00453180|4152798|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4325228|NCT00453180|4152799|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4325229|NCT00453180|4152800|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4325230|NCT00453180|4152798|B3|||Age||Years|Mean|7.8|7.8|Standard Deviation|2.7|2.7|||
4325231|NCT00453180|4152799|B2|||Age||Years|Mean|8.2|8.2|Standard Deviation|2.9|2.9|||
4325232|NCT00453180|4152800|B1|||Age||Years|Mean|7.6|7.6|Standard Deviation|2.5|2.5|||
4325233|NCT00453180|4152798|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4325234|NCT00453180|4152799|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4325235|NCT00453180|4152800|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4325236|NCT00453180|4152798|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4325237|NCT00453180|4152799|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4325238|NCT00453180|4152800|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4325239|NCT00453180|4152798|B3||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
4325240|NCT00453180|4152799|B2||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4325241|NCT00453180|4152800|B1||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4325243|NCT00453154|4152818|B3|6 cycles||Number of combination chemotherapy cycles|Number of cycles of combination chemotherapy received prior to maintenance randomization.|participants|Number|32|32.0||||||
4325244|NCT00453154|4152819|B2|6 cycles||Number of combination chemotherapy cycles|Number of cycles of combination chemotherapy received prior to maintenance randomization.|participants|Number|32|32.0||||||
4325245|NCT00453154|4152820|B1|6 cycles||Number of combination chemotherapy cycles|Number of cycles of combination chemotherapy received prior to maintenance randomization.|participants|Number|NA|||||||Stratification factor for Phase II, not collected for Phase I patients.
4325246|NCT00453154|4152817|B4|< 6 cycles||Number of combination chemotherapy cycles|Number of cycles of combination chemotherapy received prior to maintenance randomization.|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4325247|NCT00453154|4152818|B3|< 6 cycles||Number of combination chemotherapy cycles|Number of cycles of combination chemotherapy received prior to maintenance randomization.|participants|Number|9|9.0||||||
4325248|NCT00453154|4152819|B2|< 6 cycles||Number of combination chemotherapy cycles|Number of cycles of combination chemotherapy received prior to maintenance randomization.|participants|Number|12|12.0||||||
4325249|NCT00453154|4152820|B1|< 6 cycles||Number of combination chemotherapy cycles|Number of cycles of combination chemotherapy received prior to maintenance randomization.|participants|Number|NA|||||||Stratification factor for Phase II, not collected for Phase I patients.
4325250|NCT00453154|4152817|B4|Carboplatin||Chemotherapy Agent|Type of treatment received prior to maintenance randomization.|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4325251|NCT00453154|4152818|B3|Carboplatin||Chemotherapy Agent|Type of treatment received prior to maintenance randomization.|participants|Number|30|30.0||||||
4325252|NCT00453154|4152819|B2|Carboplatin||Chemotherapy Agent|Type of treatment received prior to maintenance randomization.|participants|Number|32|32.0||||||
4325253|NCT00453154|4152820|B1|Carboplatin||Chemotherapy Agent|Type of treatment received prior to maintenance randomization.|participants|Number|NA|||||||Stratification factor for Phase II, not collected for Phase I patients.
4325254|NCT00453154|4152817|B4|Cisplatin||Chemotherapy Agent|Type of treatment received prior to maintenance randomization.|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4325255|NCT00453154|4152818|B3|Cisplatin||Chemotherapy Agent|Type of treatment received prior to maintenance randomization.|participants|Number|11|11.0||||||
4325256|NCT00453154|4152819|B2|Cisplatin||Chemotherapy Agent|Type of treatment received prior to maintenance randomization.|participants|Number|12|12.0||||||
4325257|NCT00453154|4152820|B1|Cisplatin||Chemotherapy Agent|Type of treatment received prior to maintenance randomization.|participants|Number|NA|||||||Stratification factor for Phase II, not collected for Phase I patients.
4325258|NCT00453154|4152817|B4|United States||Region of Enrollment||participants|Number|97|97.0||||||
4325259|NCT00453154|4152818|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
4325260|NCT00453154|4152819|B2|United States||Region of Enrollment||participants|Number|44|44.0||||||
4325261|NCT00453154|4152820|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4325262|NCT00453154|4152817|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325263|NCT00453154|4152818|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325264|NCT00453154|4152819|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325265|NCT00453154|4152820|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325266|NCT00453154|4152817|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325267|NCT00453154|4152818|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325268|NCT00453154|4152819|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325269|NCT00453154|4152820|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325270|NCT00453154|4152817|B4||White|Race (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
4325271|NCT00453154|4152818|B3||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4325272|NCT00453154|4152819|B2||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4325273|NCT00453154|4152820|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4325274|NCT00453154|4152817|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4325275|NCT00453154|4152818|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4325276|NCT00453154|4152819|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4325277|NCT00453154|4152820|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325278|NCT00453154|4152817|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325279|NCT00453154|4152818|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325280|NCT00453154|4152819|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325281|NCT00453154|4152820|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325282|NCT00453154|4152817|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325283|NCT00453154|4152818|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325284|NCT00453154|4152819|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325285|NCT00453154|4152820|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325286|NCT00453154|4152817|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325287|NCT00453154|4152818|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325288|NCT00453154|4152819|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325289|NCT00453154|4152820|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325290|NCT00453154|4152817|B4||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4325291|NCT00453154|4152818|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4325292|NCT00453154|4152819|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4325293|NCT00453154|4152820|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4325294|NCT00453154|4152817|B4||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4325295|NCT00453154|4152818|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4325296|NCT00453154|4152819|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4325297|NCT00453154|4152820|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4325298|NCT00453154|4152817|B4|||Age||years|Median|60|60.0|Full Range|||39.0|77.0|
4325299|NCT00453154|4152818|B3|||Age||years|Median|61|61.0|Full Range|||56.0|77.0|
4325300|NCT00453154|4152819|B2|||Age||years|Median|60|60.0|Full Range|||39.0|69.0|
4325301|NCT00453154|4152820|B1|||Age||years|Median|57|57.0|Full Range|||43.0|72.0|
4325302|NCT00453102|4152836|B1|High risk||Follicular Lymphoma International Prognostic Index (FLIPI) Risk Group|"Number of participants grouped by their prognosis with follicular lymphoma. One point is assigned for each of the following factors:~Age > 60 years~Stage III or IV disease~> 4 lymph node groups involved~Serum hemoglobin < 12 g/dL~Elevated serum LDH~The sum of the points allotted correlates with the following risk groups:~Low risk (0-1 points) - 5 and 10-year survivals of 91% and 71%, respectively~Intermediate risk (2 points) - 5 and 10-year survivals of 78% and 51%, respectively~High risk (3-5 points) - 5 and 10-year survivals of 53% and 36%, respectively"|participants|Number|2|2.0||||||
4325303|NCT00453102|4152836|B1|Intermediate risk||Follicular Lymphoma International Prognostic Index (FLIPI) Risk Group|"Number of participants grouped by their prognosis with follicular lymphoma. One point is assigned for each of the following factors:~Age > 60 years~Stage III or IV disease~> 4 lymph node groups involved~Serum hemoglobin < 12 g/dL~Elevated serum LDH~The sum of the points allotted correlates with the following risk groups:~Low risk (0-1 points) - 5 and 10-year survivals of 91% and 71%, respectively~Intermediate risk (2 points) - 5 and 10-year survivals of 78% and 51%, respectively~High risk (3-5 points) - 5 and 10-year survivals of 53% and 36%, respectively"|participants|Number|7|7.0||||||
4325304|NCT00453102|4152836|B1|Low risk||Follicular Lymphoma International Prognostic Index (FLIPI) Risk Group|"Number of participants grouped by their prognosis with follicular lymphoma. One point is assigned for each of the following factors:~Age > 60 years~Stage III or IV disease~> 4 lymph node groups involved~Serum hemoglobin < 12 g/dL~Elevated serum LDH~The sum of the points allotted correlates with the following risk groups:~Low risk (0-1 points) - 5 and 10-year survivals of 91% and 71%, respectively~Intermediate risk (2 points) - 5 and 10-year survivals of 78% and 51%, respectively~High risk (3-5 points) - 5 and 10-year survivals of 53% and 36%, respectively"|participants|Number|7|7.0||||||
4325305|NCT00453102|4152836|B1|High risk||International Prognostic Index (IPI) Risk Group|"Number of participants grouped by their prognosis with aggressive non-Hodgkin's lymphoma. One point is assigned for each of the following risk factors:~Age > 60 years~Stage III/IV disease~Elevated serum LDH~ECOG/Zubrod performance status of 2, 3, or 4~> 1 extranodal site~The sum of the points allotted correlates with the following risk groups:~Low risk (0-1 points) - 5-year survival of 73%~Low-intermediate risk (2 points) - 5-year survival of 51%~High-intermediate risk (3 points) - 5-year survival of 43%~High risk (4-5 points) - 5-year survival of 26%"|participants|Number|0|0.0||||||
4325306|NCT00453102|4152836|B1|Intermediate/high risk||International Prognostic Index (IPI) Risk Group|"Number of participants grouped by their prognosis with aggressive non-Hodgkin's lymphoma. One point is assigned for each of the following risk factors:~Age > 60 years~Stage III/IV disease~Elevated serum LDH~ECOG/Zubrod performance status of 2, 3, or 4~> 1 extranodal site~The sum of the points allotted correlates with the following risk groups:~Low risk (0-1 points) - 5-year survival of 73%~Low-intermediate risk (2 points) - 5-year survival of 51%~High-intermediate risk (3 points) - 5-year survival of 43%~High risk (4-5 points) - 5-year survival of 26%"|participants|Number|4|4.0||||||
4325307|NCT00453102|4152836|B1|Low/intermediate risk||International Prognostic Index (IPI) Risk Group|"Number of participants grouped by their prognosis with aggressive non-Hodgkin's lymphoma. One point is assigned for each of the following risk factors:~Age > 60 years~Stage III/IV disease~Elevated serum LDH~ECOG/Zubrod performance status of 2, 3, or 4~> 1 extranodal site~The sum of the points allotted correlates with the following risk groups:~Low risk (0-1 points) - 5-year survival of 73%~Low-intermediate risk (2 points) - 5-year survival of 51%~High-intermediate risk (3 points) - 5-year survival of 43%~High risk (4-5 points) - 5-year survival of 26%"|participants|Number|9|9.0||||||
4325308|NCT00453102|4152836|B1|Low risk||International Prognostic Index (IPI) Risk Group|"Number of participants grouped by their prognosis with aggressive non-Hodgkin's lymphoma. One point is assigned for each of the following risk factors:~Age > 60 years~Stage III/IV disease~Elevated serum LDH~ECOG/Zubrod performance status of 2, 3, or 4~> 1 extranodal site~The sum of the points allotted correlates with the following risk groups:~Low risk (0-1 points) - 5-year survival of 73%~Low-intermediate risk (2 points) - 5-year survival of 51%~High-intermediate risk (3 points) - 5-year survival of 43%~High risk (4-5 points) - 5-year survival of 26%"|participants|Number|3|3.0||||||
4325309|NCT00453102|4152836|B1|More than 5 cm||Bulky disease (cm)|Number of patients grouped by the size of large tumors or lymph nodes in centimeters (cm) present at baseline.|participants|Number|7|7.0||||||
4325310|NCT00453102|4152836|B1|5 and less cm||Bulky disease (cm)|Number of patients grouped by the size of large tumors or lymph nodes in centimeters (cm) present at baseline.|participants|Number|9|9.0||||||
4325311|NCT00453102|4152836|B1|Elevated||Lactate dehydrogenase (LDH) Levels|Number of participants grouped by serum levels of LDH at baseline.|participants|Number|2|2.0||||||
4325312|NCT00453102|4152836|B1|Normal||Lactate dehydrogenase (LDH) Levels|Number of participants grouped by serum levels of LDH at baseline.|participants|Number|14|14.0||||||
4325313|NCT00453102|4152836|B1|No||Bone Marrow involvement|Number of participants grouped by the presence of lymphoma cells in the bone marrow at baseline.|participants|Number|16|16.0||||||
4325314|NCT00453102|4152836|B1|Yes||Bone Marrow involvement|Number of participants grouped by the presence of lymphoma cells in the bone marrow at baseline.|participants|Number|0|0.0||||||
4325315|NCT00453102|4152836|B1|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Number of participants grouped according to their Eastern Cooperative Oncology Group (ECOG) performance status or score at baseline. The ECOG score attempts to quantify patients' general well being and level of activities of daily life. The higher the score, the less healthy the patient's general well being and lower the the patient's level of the daily activity.|participants|Number|0|0.0||||||
4325316|NCT00453102|4152836|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Number of participants grouped according to their Eastern Cooperative Oncology Group (ECOG) performance status or score at baseline. The ECOG score attempts to quantify patients' general well being and level of activities of daily life. The higher the score, the less healthy the patient's general well being and lower the the patient's level of the daily activity.|participants|Number|2|2.0||||||
4325317|NCT00453102|4152836|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Number of participants grouped according to their Eastern Cooperative Oncology Group (ECOG) performance status or score at baseline. The ECOG score attempts to quantify patients' general well being and level of activities of daily life. The higher the score, the less healthy the patient's general well being and lower the the patient's level of the daily activity.|participants|Number|14|14.0||||||
4325318|NCT00453102|4152836|B1|2 or more sites||Extranodal disease sites|Number of participants grouped by the number of sites outside of the lymph nodes where lymphoma is present at baseline.|participants|Number|5|5.0||||||
4325319|NCT00453102|4152836|B1|0, 1 sites||Extranodal disease sites|Number of participants grouped by the number of sites outside of the lymph nodes where lymphoma is present at baseline.|participants|Number|11|11.0||||||
4325320|NCT00453102|4152836|B1|Stage III/IV||Disease Stage|"Number of participants grouped by extent (reach) and location of the lymphoma at Baseline: Stage I, Stage II, Stage III and Stage IV. The stage depends on both the place where the malignant tissue is located and on systemic symptoms due to the lymphoma (B symptoms: night sweats, weight loss of >10% or fevers).The higher the stage number, the larger the extent of the lymphoma, and/or the more it has grown into nearby tissues."|participants|Number|13|13.0||||||
4325321|NCT00453102|4152836|B1|Stage I/II||Disease Stage|"Number of participants grouped by extent (reach) and location of the lymphoma at Baseline: Stage I, Stage II, Stage III and Stage IV. The stage depends on both the place where the malignant tissue is located and on systemic symptoms due to the lymphoma (B symptoms: night sweats, weight loss of >10% or fevers).The higher the stage number, the larger the extent of the lymphoma, and/or the more it has grown into nearby tissues."|participants|Number|3|3.0||||||
4325322|NCT00453102|4152836|B1||Male|Sex: Female, Male|Data reported for only 16 of 18 participants due to 2 participants withdrawing consent.|Participants|Count of Participants|9|9.0||||||
4325323|NCT00453102|4152836|B1||Female|Sex: Female, Male|Data reported for only 16 of 18 participants due to 2 participants withdrawing consent.|Participants|Count of Participants|7|7.0||||||
4325324|NCT00453102|4152836|B1|||Age||years|Mean|62|62.0|Full Range|||37.0|84.0|
4325325|NCT00453102|4152836|B1|||Age||years|Mean|62|62.0|Standard Deviation|13|13.0|||
4325326|NCT00453102|4152836|B1|||Age||years|Median|62|62.0|Inter-Quartile Range|||55.0|70.0|
4325327|NCT00453063|4152845|B3||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4325328|NCT00453063|4152846|B2||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4325329|NCT00453063|4152847|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4325330|NCT00453063|4152845|B3||Female|Sex: Female, Male||Participants|Count of Participants|270|270.0||||||
4325331|NCT00453063|4152846|B2||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4325332|NCT00453063|4152847|B1||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4325333|NCT00453063|4152845|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4325334|NCT00453063|4152846|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4325335|NCT00453063|4152847|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4325336|NCT00453063|4152845|B3||Between 18 and 65 years|Age||Participants|Count of Participants|369|369.0||||||
4325337|NCT00453063|4152846|B2||Between 18 and 65 years|Age||Participants|Count of Participants|181|181.0||||||
4325338|NCT00453063|4152847|B1||Between 18 and 65 years|Age||Participants|Count of Participants|188|188.0||||||
4325339|NCT00453063|4152845|B3||<=18 years|Age||Participants|Count of Participants|48|48.0||||||
4325340|NCT00453063|4152846|B2||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4325341|NCT00453063|4152847|B1||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
4325342|NCT00452868|4152862|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4325343|NCT00452868|4152862|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4325344|NCT00452868|4152862|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4325345|NCT00452868|4152862|B1|||Age||years|Mean|12.81|12.81|Standard Deviation|3|3.0|||
4325346|NCT00452868|4152862|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4325347|NCT00452868|4152862|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4325348|NCT00452868|4152862|B1||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4325349|NCT00452790|4152866|B3|Unknown||Sex/Gender, Customized||participants|Number|1|1.0||||||
4325350|NCT00452790|4152867|B2|Unknown||Sex/Gender, Customized||participants|Number|0|0.0||||||
4325351|NCT00452790|4152868|B1|Unknown||Sex/Gender, Customized||participants|Number|1|1.0||||||
4325352|NCT00452790|4152866|B3|Female||Sex/Gender, Customized||participants|Number|338|338.0||||||
4325353|NCT00452790|4152867|B2|Female||Sex/Gender, Customized||participants|Number|169|169.0||||||
4325354|NCT00452790|4152868|B1|Female||Sex/Gender, Customized||participants|Number|169|169.0||||||
4325355|NCT00452790|4152866|B3|Male||Sex/Gender, Customized||participants|Number|370|370.0||||||
4325356|NCT00452790|4152867|B2|Male||Sex/Gender, Customized||participants|Number|186|186.0||||||
4325357|NCT00452790|4152868|B1|Male||Sex/Gender, Customized||participants|Number|184|184.0||||||
4325358|NCT00452790|4152866|B3|||Age||weeks|Mean|7.1|7.1|Standard Deviation|1.1|1.1|||
4325360|NCT00452790|4152868|B1|||Age||weeks|Mean|7.1|7.1|Standard Deviation|1.1|1.1|||
4325361|NCT00452790|4152866|B3|||Age||months|Mean|1.6|1.6|Standard Deviation|0.3|0.3|||
4325362|NCT00452790|4152867|B2|||Age||months|Mean|1.6|1.6|Standard Deviation|0.2|0.2|||
4325363|NCT00452790|4152868|B1|||Age||months|Mean|1.6|1.6|Standard Deviation|0.3|0.3|||
4325364|NCT00452699|4152903|B3|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4325365|NCT00452699|4152904|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4325366|NCT00452699|4152905|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4325367|NCT00452699|4152903|B3|American Indian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4325368|NCT00452699|4152904|B2|American Indian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4325369|NCT00452699|4152905|B1|American Indian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4325370|NCT00452699|4152903|B3|Asian||Race/Ethnicity, Customized||participants|Number|80|80.0||||||
4325371|NCT00452699|4152904|B2|Asian||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4325372|NCT00452699|4152905|B1|Asian||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4325373|NCT00452699|4152903|B3|African American||Race/Ethnicity, Customized||participants|Number|124|124.0||||||
4325374|NCT00452699|4152904|B2|African American||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
4325375|NCT00452699|4152905|B1|African American||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
4325376|NCT00452699|4152903|B3|White||Race/Ethnicity, Customized||participants|Number|405|405.0||||||
4325377|NCT00452699|4152904|B2|White||Race/Ethnicity, Customized||participants|Number|208|208.0||||||
4325378|NCT00452699|4152905|B1|White||Race/Ethnicity, Customized||participants|Number|197|197.0||||||
4325379|NCT00452699|4152903|B3||Male|Gender||Participants|Count of Participants|229|229.0||||||
4325380|NCT00452699|4152904|B2||Male|Gender||Participants|Count of Participants|114|114.0||||||
4325381|NCT00452699|4152905|B1||Male|Gender||Participants|Count of Participants|115|115.0||||||
4325382|NCT00452699|4152903|B3||Female|Gender||Participants|Count of Participants|392|392.0||||||
4325383|NCT00452699|4152904|B2||Female|Gender||Participants|Count of Participants|201|201.0||||||
4325384|NCT00452699|4152905|B1||Female|Gender||Participants|Count of Participants|191|191.0||||||
4325385|NCT00452699|4152903|B3|||Age||years|Mean|38.1|38.1|Standard Deviation|15.55|15.55|||
4325386|NCT00452699|4152904|B2|||Age||years|Mean|39.3|39.3|Standard Deviation|15.52|15.52|||
4325387|NCT00452699|4152905|B1|||Age||years|Mean|36.8|36.8|Standard Deviation|15.52|15.52|||
4325388|NCT00452673|4152918|B5|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4325389|NCT00452673|4152919|B4|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4325390|NCT00452673|4152920|B3|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4325391|NCT00452673|4152921|B2|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4325392|NCT00452673|4152922|B1|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4325393|NCT00452673|4152918|B5|Spain||Region of Enrollment||participants|Number|21|21.0||||||
4325394|NCT00452673|4152919|B4|Spain||Region of Enrollment||participants|Number|11|11.0||||||
4325395|NCT00452673|4152920|B3|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4325396|NCT00452673|4152921|B2|Spain||Region of Enrollment||participants|Number|6|6.0||||||
4325397|NCT00452673|4152922|B1|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4325398|NCT00452673|4152918|B5|United States||Region of Enrollment||participants|Number|29|29.0||||||
4325399|NCT00452673|4152919|B4|United States||Region of Enrollment||participants|Number|17|17.0||||||
4325400|NCT00452673|4152920|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4325401|NCT00452673|4152921|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4325402|NCT00452673|4152922|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4325403|NCT00452673|4152918|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4325404|NCT00452673|4152919|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4325405|NCT00452673|4152920|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4325406|NCT00452673|4152921|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4325407|NCT00452673|4152922|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4325408|NCT00452673|4152918|B5||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4325409|NCT00452673|4152919|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4325410|NCT00452673|4152920|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4325411|NCT00452673|4152921|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4325412|NCT00452673|4152922|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4325413|NCT00452673|4152918|B5|>= 50 years||Age, Customized||participants|Number|32|32.0||||||
4325414|NCT00452673|4152919|B4|>= 50 years||Age, Customized||participants|Number|18|18.0||||||
4325415|NCT00452673|4152920|B3|>= 50 years||Age, Customized||participants|Number|3|3.0||||||
4325416|NCT00452673|4152921|B2|>= 50 years||Age, Customized||participants|Number|6|6.0||||||
4325417|NCT00452673|4152922|B1|>= 50 years||Age, Customized||participants|Number|5|5.0||||||
4325418|NCT00452673|4152918|B5|< 50 years||Age, Customized||participants|Number|20|20.0||||||
4325419|NCT00452673|4152919|B4|< 50 years||Age, Customized||participants|Number|12|12.0||||||
4325420|NCT00452673|4152920|B3|< 50 years||Age, Customized||participants|Number|3|3.0||||||
4325421|NCT00452673|4152921|B2|< 50 years||Age, Customized||participants|Number|3|3.0||||||
4325422|NCT00452673|4152922|B1|< 50 years||Age, Customized||participants|Number|2|2.0||||||
4325423|NCT00452673|4152918|B5|||Age||years|Mean|53.5|53.5|Standard Deviation|11.56|11.56|||
4325424|NCT00452673|4152919|B4|||Age||years|Mean|54.2|54.2|Standard Deviation|10.91|10.91|||
4325425|NCT00452673|4152920|B3|||Age||years|Mean|49.5|49.5|Standard Deviation|10.78|10.78|||
4325426|NCT00452673|4152921|B2|||Age||years|Mean|56.2|56.2|Standard Deviation|15.52|15.52|||
4325427|NCT00452673|4152922|B1|||Age||years|Mean|50.1|50.1|Standard Deviation|10.02|10.02|||
4325428|NCT00452543|4152956|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4325429|NCT00452543|4152957|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4325430|NCT00452543|4152958|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4325431|NCT00452543|4152956|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4325432|NCT00452543|4152957|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4325433|NCT00452543|4152958|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4325434|NCT00452543|4152956|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4325435|NCT00452543|4152957|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4325436|NCT00452543|4152958|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4325437|NCT00452543|4152956|B3|||Age||years|Mean|47|47.0|Standard Deviation|12|12.0|||
4325438|NCT00452543|4152957|B2|||Age||years|Mean|43|43.0|Standard Deviation|14|14.0|||
4325439|NCT00452543|4152958|B1|||Age||years|Mean|49|49.0|Standard Deviation|13|13.0|||
4325440|NCT00452543|4152956|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4325441|NCT00452543|4152957|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4325442|NCT00452543|4152958|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4325443|NCT00452543|4152956|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4325444|NCT00452543|4152957|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4325445|NCT00452543|4152958|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4325446|NCT00452543|4152956|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4325447|NCT00452543|4152957|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4325448|NCT00452543|4152958|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4325449|NCT00452530|4152971|B3|Pulmonary embolism||Type of Risk Factor||Participants|Number|20|20.0||||||
4325450|NCT00452530|4152972|B2|Pulmonary embolism||Type of Risk Factor||Participants|Number|10|10.0||||||
4325451|NCT00452530|4152973|B1|Pulmonary embolism||Type of Risk Factor||Participants|Number|10|10.0||||||
4325452|NCT00452530|4152971|B3|Deep vein thrombosis||Type of Risk Factor||Participants|Number|68|68.0||||||
4325453|NCT00452530|4152972|B2|Deep vein thrombosis||Type of Risk Factor||Participants|Number|32|32.0||||||
4325454|NCT00452530|4152973|B1|Deep vein thrombosis||Type of Risk Factor||Participants|Number|36|36.0||||||
4325455|NCT00452530|4152971|B3|Hip or knee fracture surgery||Type of Risk Factor||Participants|Number|104|104.0||||||
4325456|NCT00452530|4152972|B2|Hip or knee fracture surgery||Type of Risk Factor||Participants|Number|49|49.0||||||
4325457|NCT00452530|4152973|B1|Hip or knee fracture surgery||Type of Risk Factor||Participants|Number|55|55.0||||||
4325458|NCT00452530|4152971|B3|Hip replacement||Type of Risk Factor||Participants|Number|170|170.0||||||
4325459|NCT00452530|4152972|B2|Hip replacement||Type of Risk Factor||Participants|Number|80|80.0||||||
4325460|NCT00452530|4152973|B1|Hip replacement||Type of Risk Factor||Participants|Number|90|90.0||||||
4325461|NCT00452530|4152971|B3|Knee replacement||Type of Risk Factor||Participants|Number|543|543.0||||||
4325462|NCT00452530|4152972|B2|Knee replacement||Type of Risk Factor||Participants|Number|286|286.0||||||
4325463|NCT00452530|4152973|B1|Knee replacement||Type of Risk Factor||Participants|Number|257|257.0||||||
4325464|NCT00452530|4152971|B3|Sweden||Region of Enrollment||Participants|Number|1|1.0||||||
4325465|NCT00452530|4152972|B2|Sweden||Region of Enrollment||Participants|Number|0|0.0||||||
4325466|NCT00452530|4152973|B1|Sweden||Region of Enrollment||Participants|Number|1|1.0||||||
4325467|NCT00452530|4152971|B3|Germany||Region of Enrollment||Participants|Number|244|244.0||||||
4325468|NCT00452530|4152972|B2|Germany||Region of Enrollment||Participants|Number|122|122.0||||||
4325469|NCT00452530|4152973|B1|Germany||Region of Enrollment||Participants|Number|122|122.0||||||
4325470|NCT00452530|4152971|B3|Norway||Region of Enrollment||Participants|Number|71|71.0||||||
4325471|NCT00452530|4152972|B2|Norway||Region of Enrollment||Participants|Number|36|36.0||||||
4325472|NCT00452530|4152973|B1|Norway||Region of Enrollment||Participants|Number|35|35.0||||||
4325473|NCT00452530|4152971|B3|Singapore||Region of Enrollment||Participants|Number|17|17.0||||||
4325474|NCT00452530|4152972|B2|Singapore||Region of Enrollment||Participants|Number|9|9.0||||||
4325475|NCT00452530|4152973|B1|Singapore||Region of Enrollment||Participants|Number|8|8.0||||||
4325476|NCT00452530|4152971|B3|Poland||Region of Enrollment||Participants|Number|86|86.0||||||
4325477|NCT00452530|4152972|B2|Poland||Region of Enrollment||Participants|Number|45|45.0||||||
4325478|NCT00452530|4152973|B1|Poland||Region of Enrollment||Participants|Number|41|41.0||||||
4325479|NCT00452530|4152971|B3|Brazil||Region of Enrollment||Participants|Number|34|34.0||||||
4325480|NCT00452530|4152972|B2|Brazil||Region of Enrollment||Participants|Number|17|17.0||||||
4325481|NCT00452530|4152973|B1|Brazil||Region of Enrollment||Participants|Number|17|17.0||||||
4325482|NCT00452530|4152971|B3|Belgium||Region of Enrollment||Participants|Number|52|52.0||||||
4325483|NCT00452530|4152972|B2|Belgium||Region of Enrollment||Participants|Number|25|25.0||||||
4325484|NCT00452530|4152973|B1|Belgium||Region of Enrollment||Participants|Number|27|27.0||||||
4325485|NCT00452530|4152971|B3|Mexico||Region of Enrollment||Participants|Number|119|119.0||||||
4325486|NCT00452530|4152972|B2|Mexico||Region of Enrollment||Participants|Number|59|59.0||||||
4325487|NCT00452530|4152973|B1|Mexico||Region of Enrollment||Participants|Number|60|60.0||||||
4325488|NCT00452530|4152971|B3|Hungary||Region of Enrollment||Participants|Number|36|36.0||||||
4325489|NCT00452530|4152972|B2|Hungary||Region of Enrollment||Participants|Number|19|19.0||||||
4325490|NCT00452530|4152973|B1|Hungary||Region of Enrollment||Participants|Number|17|17.0||||||
4325491|NCT00452530|4152971|B3|Czech Republic||Region of Enrollment||Participants|Number|98|98.0||||||
4325492|NCT00452530|4152972|B2|Czech Republic||Region of Enrollment||Participants|Number|50|50.0||||||
4325493|NCT00452530|4152973|B1|Czech Republic||Region of Enrollment||Participants|Number|48|48.0||||||
4325494|NCT00452530|4152971|B3|United Kingdom||Region of Enrollment||Participants|Number|124|124.0||||||
4325495|NCT00452530|4152972|B2|United Kingdom||Region of Enrollment||Participants|Number|61|61.0||||||
4325496|NCT00452530|4152973|B1|United Kingdom||Region of Enrollment||Participants|Number|63|63.0||||||
4325497|NCT00452530|4152971|B3|Austria||Region of Enrollment||Participants|Number|307|307.0||||||
4325498|NCT00452530|4152972|B2|Austria||Region of Enrollment||Participants|Number|151|151.0||||||
4325499|NCT00452530|4152973|B1|Austria||Region of Enrollment||Participants|Number|156|156.0||||||
4325500|NCT00452530|4152971|B3|Korea, Republic of||Region of Enrollment||Participants|Number|78|78.0||||||
4325501|NCT00452530|4152972|B2|Korea, Republic of||Region of Enrollment||Participants|Number|38|38.0||||||
4325502|NCT00452530|4152973|B1|Korea, Republic of||Region of Enrollment||Participants|Number|40|40.0||||||
4325503|NCT00452530|4152971|B3|China||Region of Enrollment||Participants|Number|180|180.0||||||
4325504|NCT00452530|4152972|B2|China||Region of Enrollment||Participants|Number|90|90.0||||||
4325505|NCT00452530|4152973|B1|China||Region of Enrollment||Participants|Number|90|90.0||||||
4325506|NCT00452530|4152971|B3|South Africa||Region of Enrollment||Participants|Number|112|112.0||||||
4325507|NCT00452530|4152972|B2|South Africa||Region of Enrollment||Participants|Number|56|56.0||||||
4325508|NCT00452530|4152973|B1|South Africa||Region of Enrollment||Participants|Number|56|56.0||||||
4325509|NCT00452530|4152971|B3|Denmark||Region of Enrollment||Participants|Number|49|49.0||||||
4325510|NCT00452530|4152972|B2|Denmark||Region of Enrollment||Participants|Number|23|23.0||||||
4325511|NCT00452530|4152973|B1|Denmark||Region of Enrollment||Participants|Number|26|26.0||||||
4325512|NCT00452530|4152971|B3|Malaysia||Region of Enrollment||Participants|Number|8|8.0||||||
4325513|NCT00452530|4152972|B2|Malaysia||Region of Enrollment||Participants|Number|4|4.0||||||
4325514|NCT00452530|4152973|B1|Malaysia||Region of Enrollment||Participants|Number|4|4.0||||||
4325515|NCT00452530|4152971|B3|France||Region of Enrollment||Participants|Number|140|140.0||||||
4325516|NCT00452530|4152972|B2|France||Region of Enrollment||Participants|Number|68|68.0||||||
4325517|NCT00452530|4152973|B1|France||Region of Enrollment||Participants|Number|72|72.0||||||
4325518|NCT00452530|4152971|B3|India||Region of Enrollment||Participants|Number|184|184.0||||||
4325519|NCT00452530|4152972|B2|India||Region of Enrollment||Participants|Number|92|92.0||||||
4325520|NCT00452530|4152973|B1|India||Region of Enrollment||Participants|Number|92|92.0||||||
4325521|NCT00452530|4152971|B3|Italy||Region of Enrollment||Participants|Number|138|138.0||||||
4325522|NCT00452530|4152972|B2|Italy||Region of Enrollment||Participants|Number|69|69.0||||||
4325523|NCT00452530|4152973|B1|Italy||Region of Enrollment||Participants|Number|69|69.0||||||
4325524|NCT00452530|4152971|B3|Colombia||Region of Enrollment||Participants|Number|71|71.0||||||
4325525|NCT00452530|4152972|B2|Colombia||Region of Enrollment||Participants|Number|35|35.0||||||
4325526|NCT00452530|4152973|B1|Colombia||Region of Enrollment||Participants|Number|36|36.0||||||
4325527|NCT00452530|4152971|B3|Chile||Region of Enrollment||Participants|Number|6|6.0||||||
4325528|NCT00452530|4152972|B2|Chile||Region of Enrollment||Participants|Number|5|5.0||||||
4325529|NCT00452530|4152973|B1|Chile||Region of Enrollment||Participants|Number|1|1.0||||||
4325530|NCT00452530|4152971|B3|Israel||Region of Enrollment||Participants|Number|86|86.0||||||
4325531|NCT00452530|4152972|B2|Israel||Region of Enrollment||Participants|Number|43|43.0||||||
4325532|NCT00452530|4152973|B1|Israel||Region of Enrollment||Participants|Number|43|43.0||||||
4325533|NCT00452530|4152971|B3|Russian Federation||Region of Enrollment||Participants|Number|306|306.0||||||
4325534|NCT00452530|4152972|B2|Russian Federation||Region of Enrollment||Participants|Number|156|156.0||||||
4325535|NCT00452530|4152973|B1|Russian Federation||Region of Enrollment||Participants|Number|150|150.0||||||
4325536|NCT00452530|4152971|B3|Ukraine||Region of Enrollment||Participants|Number|363|363.0||||||
4325537|NCT00452530|4152972|B2|Ukraine||Region of Enrollment||Participants|Number|182|182.0||||||
4325538|NCT00452530|4152973|B1|Ukraine||Region of Enrollment||Participants|Number|181|181.0||||||
4325539|NCT00452530|4152971|B3|Spain||Region of Enrollment||Participants|Number|121|121.0||||||
4325540|NCT00452530|4152972|B2|Spain||Region of Enrollment||Participants|Number|60|60.0||||||
4325541|NCT00452530|4152973|B1|Spain||Region of Enrollment||Participants|Number|61|61.0||||||
4325542|NCT00452530|4152971|B3|Philippines||Region of Enrollment||Participants|Number|26|26.0||||||
4325543|NCT00452530|4152972|B2|Philippines||Region of Enrollment||Participants|Number|14|14.0||||||
4325544|NCT00452530|4152973|B1|Philippines||Region of Enrollment||Participants|Number|12|12.0||||||
4325545|NCT00452530|4152971|B3|Ethnicity not reported||Race/Ethnicity, Customized||Participants|Number|2946|2946.0||||||
4325546|NCT00452530|4152972|B2|Ethnicity not reported||Race/Ethnicity, Customized||Participants|Number|1471|1471.0||||||
4325547|NCT00452530|4152973|B1|Ethnicity not reported||Race/Ethnicity, Customized||Participants|Number|1475|1475.0||||||
4325548|NCT00452530|4152971|B3|Not Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|110|110.0||||||
4325549|NCT00452530|4152972|B2|Not Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|57|57.0||||||
4325610|NCT00452426|4153022|B1|||Age||years|Mean|53|53.0|Standard Deviation|13|13.0|||
4325550|NCT00452530|4152973|B1|Not Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|53|53.0||||||
4325551|NCT00452530|4152971|B3|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4325552|NCT00452530|4152972|B2|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4325553|NCT00452530|4152973|B1|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4325554|NCT00452530|4152971|B3|Other [Not specified]||Race/Ethnicity, Customized||Participants|Number|91|91.0||||||
4325555|NCT00452530|4152972|B2|Other [Not specified]||Race/Ethnicity, Customized||Participants|Number|46|46.0||||||
4325556|NCT00452530|4152973|B1|Other [Not specified]||Race/Ethnicity, Customized||Participants|Number|45|45.0||||||
4325557|NCT00452530|4152971|B3|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4325558|NCT00452530|4152972|B2|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4325559|NCT00452530|4152973|B1|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4325560|NCT00452530|4152971|B3|Asian||Race/Ethnicity, Customized||Participants|Number|506|506.0||||||
4325561|NCT00452530|4152972|B2|Asian||Race/Ethnicity, Customized||Participants|Number|254|254.0||||||
4325562|NCT00452530|4152973|B1|Asian||Race/Ethnicity, Customized||Participants|Number|252|252.0||||||
4325563|NCT00452530|4152971|B3|Black/African American||Race/Ethnicity, Customized||Participants|Number|31|31.0||||||
4325564|NCT00452530|4152972|B2|Black/African American||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4325565|NCT00452530|4152973|B1|Black/African American||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4325566|NCT00452530|4152971|B3|White||Race/Ethnicity, Customized||Participants|Number|2427|2427.0||||||
4325567|NCT00452530|4152972|B2|White||Race/Ethnicity, Customized||Participants|Number|1211|1211.0||||||
4325568|NCT00452530|4152973|B1|White||Race/Ethnicity, Customized||Participants|Number|1216|1216.0||||||
4325569|NCT00452530|4152971|B3||Male|Sex: Female, Male||Participants|Count of Participants|841|841.0||||||
4325570|NCT00452530|4152972|B2||Male|Sex: Female, Male||Participants|Count of Participants|402|402.0||||||
4325571|NCT00452530|4152973|B1||Male|Sex: Female, Male||Participants|Count of Participants|439|439.0||||||
4325572|NCT00452530|4152971|B3||Female|Sex: Female, Male||Participants|Count of Participants|2216|2216.0||||||
4325573|NCT00452530|4152972|B2||Female|Sex: Female, Male||Participants|Count of Participants|1127|1127.0||||||
4325574|NCT00452530|4152973|B1||Female|Sex: Female, Male||Participants|Count of Participants|1089|1089.0||||||
4325575|NCT00452530|4152971|B3|75 years and older||Age, Customized||Participants|Number|605|605.0||||||
4325576|NCT00452530|4152972|B2|75 years and older||Age, Customized||Participants|Number|317|317.0||||||
4325577|NCT00452530|4152973|B1|75 years and older||Age, Customized||Participants|Number|288|288.0||||||
4325578|NCT00452530|4152971|B3|65 years to younger than 75 years||Age, Customized||Participants|Number|1184|1184.0||||||
4325579|NCT00452530|4152972|B2|65 years to younger than 75 years||Age, Customized||Participants|Number|576|576.0||||||
4325580|NCT00452530|4152973|B1|65 years to younger than 75 years||Age, Customized||Participants|Number|608|608.0||||||
4325581|NCT00452530|4152971|B3|Younger than 65 years||Age, Customized||Participants|Number|1268|1268.0||||||
4325582|NCT00452530|4152972|B2|Younger than 65 years||Age, Customized||Participants|Number|636|636.0||||||
4325583|NCT00452530|4152973|B1|Younger than 65 years||Age, Customized||Participants|Number|632|632.0||||||
4325584|NCT00452530|4152971|B3|||Age||Years|Median|67|67.0|Standard Deviation|9.84|9.84|||
4325585|NCT00452530|4152972|B2|||Age||Years|Median|67|67.0|Standard Deviation|9.82|9.82|||
4325586|NCT00452530|4152973|B1|||Age||Years|Median|67|67.0|Standard Deviation|9.85|9.85|||
4325587|NCT00452452|4152992|B4||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4325588|NCT00452452|4152993|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4325589|NCT00452452|4152994|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4325590|NCT00452452|4152995|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4325591|NCT00452452|4152992|B4||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4325592|NCT00452452|4152993|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4325593|NCT00452452|4152994|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4325594|NCT00452452|4152995|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4325595|NCT00452452|4152992|B4|||Age||months|Mean|25.9|25.9|Standard Deviation|17.0|17.0|||
4325596|NCT00452452|4152993|B3|||Age||months|Mean|42.0|42.0|Standard Deviation|13.1|13.1|||
4325597|NCT00452452|4152994|B2|||Age||months|Mean|17.6|17.6|Standard Deviation|3.5|3.5|||
4325598|NCT00452452|4152995|B1|||Age||months|Mean|8.7|8.7|Standard Deviation|1.6|1.6|||
4325599|NCT00452426|4153020|B3|United States||Region of Enrollment||participants|Number|1000|1000.0||||||
4325600|NCT00452426|4153021|B2|United States||Region of Enrollment||participants|Number|504|504.0||||||
4325601|NCT00452426|4153022|B1|United States||Region of Enrollment||participants|Number|496|496.0||||||
4325602|NCT00452426|4153020|B3||Male|Sex: Female, Male||Participants|Count of Participants|486|486.0||||||
4325603|NCT00452426|4153021|B2||Male|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
4325604|NCT00452426|4153022|B1||Male|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4325605|NCT00452426|4153020|B3||Female|Sex: Female, Male||Participants|Count of Participants|514|514.0||||||
4325606|NCT00452426|4153021|B2||Female|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
4325607|NCT00452426|4153022|B1||Female|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
4325608|NCT00452426|4153020|B3|||Age||years|Mean|53|53.0|Standard Deviation|13|13.0|||
4325609|NCT00452426|4153021|B2|||Age||years|Mean|53|53.0|Standard Deviation|14|14.0|||
4325611|NCT00452400|4153037|B6||Male|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
4325612|NCT00452400|4153038|B5||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4325613|NCT00452400|4153039|B4||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4325614|NCT00452400|4153040|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4325615|NCT00452400|4153041|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4325616|NCT00452400|4153042|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4325617|NCT00452400|4153037|B6||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4325618|NCT00452400|4153038|B5||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4325619|NCT00452400|4153039|B4||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4325620|NCT00452400|4153040|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4325621|NCT00452400|4153041|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4325622|NCT00452400|4153042|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4325623|NCT00452400|4153037|B6|||Age||years|Mean|63.30|63.3|Standard Deviation|8.92|8.92|||
4325624|NCT00452400|4153038|B5|||Age||years|Mean|63.19|63.19|Standard Deviation|9.00|9.0|||
4325625|NCT00452400|4153039|B4|||Age||years|Mean|63.55|63.55|Standard Deviation|7.92|7.92|||
4325626|NCT00452400|4153040|B3|||Age||years|Mean|63.25|63.25|Standard Deviation|9.47|9.47|||
4325627|NCT00452400|4153041|B2|||Age||years|Mean|63.81|63.81|Standard Deviation|8.63|8.63|||
4325628|NCT00452400|4153042|B1|||Age||years|Mean|62.66|62.66|Standard Deviation|9.74|9.74|||
4325629|NCT00452387|4153218|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4325630|NCT00452387|4153218|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325631|NCT00452387|4153218|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325632|NCT00452387|4153218|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4325633|NCT00452387|4153218|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4325634|NCT00452387|4153218|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325635|NCT00452387|4153218|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325636|NCT00452387|4153218|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325637|NCT00452387|4153218|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4325638|NCT00452387|4153218|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4325639|NCT00452387|4153218|B1|||Age||years|Mean|67|67.0|Standard Deviation|9|9.0|||
4325640|NCT00452387|4153218|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4325641|NCT00452387|4153218|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4325642|NCT00452387|4153218|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4325643|NCT00452374|4153226|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4325644|NCT00452374|4153226|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4325645|NCT00452374|4153226|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4325646|NCT00452374|4153226|B1|||Age||years|Median|61|61.0|Full Range|||37.0|78.0|
4325647|NCT00452361|4153231|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4325648|NCT00452361|4153232|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4325649|NCT00452361|4153233|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4325650|NCT00452361|4153231|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4325651|NCT00452361|4153232|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4325652|NCT00452361|4153233|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4325653|NCT00452361|4153231|B3|||Age||years|Mean|43.3|43.3|Standard Deviation|10.2|10.2|||
4325654|NCT00452361|4153232|B2|||Age||years|Mean|42.2|42.2|Standard Deviation|13.9|13.9|||
4325655|NCT00452361|4153233|B1|||Age||years|Mean|46.8|46.8|Standard Deviation|7.9|7.9|||
4325656|NCT00452348|4153276|B3|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4325657|NCT00452348|4153277|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4325658|NCT00452348|4153278|B1|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4325659|NCT00452348|4153276|B3|American Indian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4325660|NCT00452348|4153277|B2|American Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4325661|NCT00452348|4153278|B1|American Indian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4325662|NCT00452348|4153276|B3|Asian||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4325663|NCT00452348|4153277|B2|Asian||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4325664|NCT00452348|4153278|B1|Asian||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4325665|NCT00452348|4153276|B3|African American||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
4325666|NCT00452348|4153277|B2|African American||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4325667|NCT00452348|4153278|B1|African American||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4325668|NCT00452348|4153276|B3|White||Race/Ethnicity, Customized||participants|Number|516|516.0||||||
4325669|NCT00452348|4153277|B2|White||Race/Ethnicity, Customized||participants|Number|262|262.0||||||
4325670|NCT00452348|4153278|B1|White||Race/Ethnicity, Customized||participants|Number|254|254.0||||||
4325671|NCT00452348|4153276|B3||Male|Gender||Participants|Count of Participants|261|261.0||||||
4325672|NCT00452348|4153277|B2||Male|Gender||Participants|Count of Participants|137|137.0||||||
4325673|NCT00452348|4153278|B1||Male|Gender||Participants|Count of Participants|124|124.0||||||
4325674|NCT00452348|4153276|B3||Female|Gender||Participants|Count of Participants|367|367.0||||||
4325675|NCT00452348|4153277|B2||Female|Gender||Participants|Count of Participants|181|181.0||||||
4325676|NCT00452348|4153278|B1||Female|Gender||Participants|Count of Participants|186|186.0||||||
4325677|NCT00452348|4153276|B3|||Age||years|Mean|40.2|40.2|Standard Deviation|16.15|16.15|||
4325678|NCT00452348|4153277|B2|||Age||years|Mean|39.6|39.6|Standard Deviation|16.56|16.56|||
4325679|NCT00452348|4153278|B1|||Age||years|Mean|40.9|40.9|Standard Deviation|15.71|15.71|||
4325680|NCT00452335|4153291|B4|United States||Region of Enrollment||participants|Number|124|124.0||||||
4325681|NCT00452335|4153292|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4325682|NCT00452335|4153293|B2|United States||Region of Enrollment||participants|Number|65|65.0||||||
4325683|NCT00452335|4153294|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4325684|NCT00452335|4153291|B4||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4325685|NCT00452335|4153292|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4325686|NCT00452335|4153293|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4325687|NCT00452335|4153294|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4325688|NCT00452335|4153291|B4||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4325689|NCT00452335|4153292|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4325690|NCT00452335|4153293|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4325691|NCT00452335|4153294|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4325692|NCT00452335|4153291|B4|||Age||years|Mean|10.2|10.2|Standard Deviation|3.91|3.91|||
4325693|NCT00452335|4153292|B3|||Age||years|Mean|13.9|13.9|Standard Deviation|3.00|3.0|||
4325694|NCT00452335|4153293|B2|||Age||years|Mean|10.3|10.3|Standard Deviation|2.78|2.78|||
4325695|NCT00452335|4153294|B1|||Age||years|Mean|5.5|5.5|Standard Deviation|1.67|1.67|||
4325696|NCT00452335|4153291|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4325697|NCT00452335|4153292|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4325698|NCT00452335|4153293|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4325699|NCT00452335|4153294|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4325700|NCT00452335|4153291|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4325701|NCT00452335|4153292|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4325702|NCT00452335|4153293|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4325703|NCT00452335|4153294|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4325704|NCT00452335|4153291|B4||<=18 years|Age||Participants|Count of Participants|124|124.0||||||
4325705|NCT00452335|4153292|B3||<=18 years|Age||Participants|Count of Participants|32|32.0||||||
4325706|NCT00452335|4153293|B2||<=18 years|Age||Participants|Count of Participants|65|65.0||||||
4325707|NCT00452335|4153294|B1||<=18 years|Age||Participants|Count of Participants|27|27.0||||||
4325708|NCT00452114|4153331|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
4325709|NCT00452114|4153332|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4325710|NCT00452114|4153333|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4325711|NCT00452114|4153331|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4325712|NCT00452114|4153332|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4325713|NCT00452114|4153333|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4325714|NCT00452114|4153331|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4325715|NCT00452114|4153332|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4325716|NCT00452114|4153333|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4325717|NCT00452114|4153331|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4325718|NCT00452114|4153332|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4325719|NCT00452114|4153333|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4325720|NCT00452114|4153331|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4325721|NCT00452114|4153332|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4325722|NCT00452114|4153333|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4325723|NCT00452114|4153331|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4325724|NCT00452114|4153332|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4325725|NCT00452114|4153333|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4325726|NCT00451958|4153346|B5|||Serum Prostate-Specific Antigen (PSA) Levels|CS21A ITT population.|nanograms per milliliter|Median|21.0|21.0|Full Range|||1.5|10952.0|
4325727|NCT00451958|4153347|B4|||Serum Prostate-Specific Antigen (PSA) Levels|CS21A ITT population.|nanograms per milliliter|Median|14.0|14.0|Full Range|||1.6|10952.0|
4325728|NCT00451958|4153348|B3|||Serum Prostate-Specific Antigen (PSA) Levels|CS21A ITT population.|nanograms per milliliter|Median|25.5|25.5|Full Range|||1.6|2112.0|
4325729|NCT00451958|4153349|B2|||Serum Prostate-Specific Antigen (PSA) Levels|CS21A ITT population.|nanograms per milliliter|Median|22.5|22.5|Full Range|||1.5|4902.0|
4325730|NCT00451958|4153350|B1|||Serum Prostate-Specific Antigen (PSA) Levels|CS21A ITT population.|nanograms per milliliter|Median|22.2|22.2|Full Range|||1.7|3187.0|
4325731|NCT00451958|4153346|B5|||Serum Testosterone Levels|CS21A ITT population.|nanograms per milliliter|Median|4.23|4.23|Full Range|||0.37|12.5|
4325732|NCT00451958|4153347|B4|||Serum Testosterone Levels|CS21A ITT population.|nanograms per milliliter|Median|3.51|3.51|Full Range|||0.37|8.0|
4325733|NCT00451958|4153348|B3|||Serum Testosterone Levels|CS21A ITT population.|nanograms per milliliter|Median|4.32|4.32|Full Range|||1.34|12.5|
4325734|NCT00451958|4153349|B2|||Serum Testosterone Levels|CS21A ITT population.|nanograms per milliliter|Median|4.02|4.02|Full Range|||0.55|10.6|
4325735|NCT00451958|4153350|B1|||Serum Testosterone Levels|CS21A ITT population.|nanograms per milliliter|Median|4.63|4.63|Full Range|||1.28|10.6|
4325736|NCT00451958|4153346|B5|Not classifiable||Stage of Prostate Cancer|CS21A ITT population. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|64|64.0||||||
4325737|NCT00451958|4153347|B4|Not classifiable||Stage of Prostate Cancer|CS21A ITT population. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|13|13.0||||||
4325738|NCT00451958|4153348|B3|Not classifiable||Stage of Prostate Cancer|CS21A ITT population. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|10|10.0||||||
4325739|NCT00451958|4153349|B2|Not classifiable||Stage of Prostate Cancer|CS21A ITT population. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|24|24.0||||||
4325740|NCT00451958|4153350|B1|Not classifiable||Stage of Prostate Cancer|CS21A ITT population. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|17|17.0||||||
4325741|NCT00451958|4153346|B5|Metastatic||Stage of Prostate Cancer|CS21A ITT population. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|75|75.0||||||
4325742|NCT00451958|4153347|B4|Metastatic||Stage of Prostate Cancer|CS21A ITT population. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|9|9.0||||||
4325743|NCT00451958|4153348|B3|Metastatic||Stage of Prostate Cancer|CS21A ITT population. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|21|21.0||||||
4325744|NCT00451958|4153349|B2|Metastatic||Stage of Prostate Cancer|CS21A ITT population. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|22|22.0||||||
4325745|NCT00451958|4153350|B1|Metastatic||Stage of Prostate Cancer|CS21A ITT population. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|23|23.0||||||
4325746|NCT00451958|4153346|B5|Locally advanced||Stage of Prostate Cancer|CS21A ITT population. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|132|132.0||||||
4325747|NCT00451958|4153347|B4|Locally advanced||Stage of Prostate Cancer|CS21A ITT population. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|24|24.0||||||
4325748|NCT00451958|4153348|B3|Locally advanced||Stage of Prostate Cancer|CS21A ITT population. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|18|18.0||||||
4325749|NCT00451958|4153349|B2|Locally advanced||Stage of Prostate Cancer|CS21A ITT population. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|44|44.0||||||
4325750|NCT00451958|4153350|B1|Locally advanced||Stage of Prostate Cancer|CS21A ITT population. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|46|46.0||||||
4325751|NCT00451958|4153346|B5|Localised||Stage of Prostate Cancer|CS21A ITT population. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|114|114.0||||||
4325752|NCT00451958|4153347|B4|Localised||Stage of Prostate Cancer|CS21A ITT population. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|19|19.0||||||
4325753|NCT00451958|4153348|B3|Localised||Stage of Prostate Cancer|CS21A ITT population. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|20|20.0||||||
4325754|NCT00451958|4153349|B2|Localised||Stage of Prostate Cancer|CS21A ITT population. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|36|36.0||||||
4325755|NCT00451958|4153350|B1|Localised||Stage of Prostate Cancer|CS21A ITT population. Prostate cancer stage was classified according to the Tumor, Nodes, and Metastatic (TNM) scale to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|39|39.0||||||
4325756|NCT00451958|4153346|B5|Gleason Score 7-10||Gleason Score|CS21A ITT population. The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Two of the participants did not have a Gleason Score at Baseline.|participants|Number|208|208.0||||||
4325757|NCT00451958|4153347|B4|Gleason Score 7-10||Gleason Score|CS21A ITT population. The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Two of the participants did not have a Gleason Score at Baseline.|participants|Number|36|36.0||||||
4325758|NCT00451958|4153348|B3|Gleason Score 7-10||Gleason Score|CS21A ITT population. The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Two of the participants did not have a Gleason Score at Baseline.|participants|Number|36|36.0||||||
4325759|NCT00451958|4153349|B2|Gleason Score 7-10||Gleason Score|CS21A ITT population. The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Two of the participants did not have a Gleason Score at Baseline.|participants|Number|63|63.0||||||
4325760|NCT00451958|4153350|B1|Gleason Score 7-10||Gleason Score|CS21A ITT population. The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Two of the participants did not have a Gleason Score at Baseline.|participants|Number|73|73.0||||||
4325761|NCT00451958|4153346|B5|Gleason Score 5-6||Gleason Score|CS21A ITT population. The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Two of the participants did not have a Gleason Score at Baseline.|participants|Number|124|124.0||||||
4325762|NCT00451958|4153347|B4|Gleason Score 5-6||Gleason Score|CS21A ITT population. The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Two of the participants did not have a Gleason Score at Baseline.|participants|Number|18|18.0||||||
4325763|NCT00451958|4153348|B3|Gleason Score 5-6||Gleason Score|CS21A ITT population. The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Two of the participants did not have a Gleason Score at Baseline.|participants|Number|25|25.0||||||
4325764|NCT00451958|4153349|B2|Gleason Score 5-6||Gleason Score|CS21A ITT population. The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Two of the participants did not have a Gleason Score at Baseline.|participants|Number|44|44.0||||||
4325765|NCT00451958|4153350|B1|Gleason Score 5-6||Gleason Score|CS21A ITT population. The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Two of the participants did not have a Gleason Score at Baseline.|participants|Number|37|37.0||||||
4325766|NCT00451958|4153346|B5|Gleason Score 2-4||Gleason Score|CS21A ITT population. The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Two of the participants did not have a Gleason Score at Baseline.|participants|Number|51|51.0||||||
4325767|NCT00451958|4153347|B4|Gleason Score 2-4||Gleason Score|CS21A ITT population. The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Two of the participants did not have a Gleason Score at Baseline.|participants|Number|11|11.0||||||
4325768|NCT00451958|4153348|B3|Gleason Score 2-4||Gleason Score|CS21A ITT population. The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Two of the participants did not have a Gleason Score at Baseline.|participants|Number|8|8.0||||||
4325769|NCT00451958|4153349|B2|Gleason Score 2-4||Gleason Score|CS21A ITT population. The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Two of the participants did not have a Gleason Score at Baseline.|participants|Number|17|17.0||||||
4325770|NCT00451958|4153350|B1|Gleason Score 2-4||Gleason Score|CS21A ITT population. The Gleason Score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Two of the participants did not have a Gleason Score at Baseline.|participants|Number|15|15.0||||||
4325771|NCT00451958|4153346|B5|||Body Mass Index|CS21A ITT population.|kilogram per square meter|Mean|26.8|26.8|Standard Deviation|3.84|3.84|||
4325772|NCT00451958|4153347|B4|||Body Mass Index|CS21A ITT population.|kilogram per square meter|Mean|27.1|27.1|Standard Deviation|3.67|3.67|||
4325773|NCT00451958|4153348|B3|||Body Mass Index|CS21A ITT population.|kilogram per square meter|Mean|26.9|26.9|Standard Deviation|3.94|3.94|||
4325774|NCT00451958|4153349|B2|||Body Mass Index|CS21A ITT population.|kilogram per square meter|Mean|26.9|26.9|Standard Deviation|3.79|3.79|||
4325775|NCT00451958|4153350|B1|||Body Mass Index|CS21A ITT population.|kilogram per square meter|Mean|26.4|26.4|Standard Deviation|3.92|3.92|||
4325776|NCT00451958|4153346|B5|||Body Weight|CS21A ITT population.|kilogram|Mean|79.0|79.0|Standard Deviation|12.5|12.5|||
4325777|NCT00451958|4153347|B4|||Body Weight|CS21A ITT population.|kilogram|Mean|80.0|80.0|Standard Deviation|12.1|12.1|||
4325778|NCT00451958|4153348|B3|||Body Weight|CS21A ITT population.|kilogram|Mean|78.7|78.7|Standard Deviation|11.3|11.3|||
4325779|NCT00451958|4153349|B2|||Body Weight|CS21A ITT population.|kilogram|Mean|79.2|79.2|Standard Deviation|13.4|13.4|||
4325780|NCT00451958|4153350|B1|||Body Weight|CS21A ITT population.|kilogram|Mean|78.4|78.4|Standard Deviation|12.6|12.6|||
4325781|NCT00451958|4153346|B5|United Kingdom||Region of Enrollment|CS21A ITT population.|participants|Number|2|2.0||||||
4325782|NCT00451958|4153347|B4|United Kingdom||Region of Enrollment|CS21A ITT population.|participants|Number|0|0.0||||||
4325783|NCT00451958|4153348|B3|United Kingdom||Region of Enrollment|CS21A ITT population.|participants|Number|0|0.0||||||
4325784|NCT00451958|4153349|B2|United Kingdom||Region of Enrollment|CS21A ITT population.|participants|Number|1|1.0||||||
4325785|NCT00451958|4153350|B1|United Kingdom||Region of Enrollment|CS21A ITT population.|participants|Number|1|1.0||||||
4325786|NCT00451958|4153346|B5|Germany||Region of Enrollment|CS21A ITT population.|participants|Number|1|1.0||||||
4325787|NCT00451958|4153347|B4|Germany||Region of Enrollment|CS21A ITT population.|participants|Number|0|0.0||||||
4325788|NCT00451958|4153348|B3|Germany||Region of Enrollment|CS21A ITT population.|participants|Number|1|1.0||||||
4325789|NCT00451958|4153349|B2|Germany||Region of Enrollment|CS21A ITT population.|participants|Number|0|0.0||||||
4325790|NCT00451958|4153350|B1|Germany||Region of Enrollment|CS21A ITT population.|participants|Number|0|0.0||||||
4325791|NCT00451958|4153346|B5|Netherlands||Region of Enrollment|CS21A ITT population.|participants|Number|3|3.0||||||
4325792|NCT00451958|4153347|B4|Netherlands||Region of Enrollment|CS21A ITT population.|participants|Number|1|1.0||||||
4325793|NCT00451958|4153348|B3|Netherlands||Region of Enrollment|CS21A ITT population.|participants|Number|0|0.0||||||
4325794|NCT00451958|4153349|B2|Netherlands||Region of Enrollment|CS21A ITT population.|participants|Number|0|0.0||||||
4325795|NCT00451958|4153350|B1|Netherlands||Region of Enrollment|CS21A ITT population.|participants|Number|2|2.0||||||
4325796|NCT00451958|4153346|B5|Russian Federation||Region of Enrollment|CS21A ITT population.|participants|Number|64|64.0||||||
4325797|NCT00451958|4153347|B4|Russian Federation||Region of Enrollment|CS21A ITT population.|participants|Number|13|13.0||||||
4325798|NCT00451958|4153348|B3|Russian Federation||Region of Enrollment|CS21A ITT population.|participants|Number|6|6.0||||||
4325799|NCT00451958|4153349|B2|Russian Federation||Region of Enrollment|CS21A ITT population.|participants|Number|19|19.0||||||
4325800|NCT00451958|4153350|B1|Russian Federation||Region of Enrollment|CS21A ITT population.|participants|Number|26|26.0||||||
4325801|NCT00451958|4153346|B5|Romania||Region of Enrollment|CS21A ITT population.|participants|Number|106|106.0||||||
4325802|NCT00451958|4153347|B4|Romania||Region of Enrollment|CS21A ITT population.|participants|Number|15|15.0||||||
4325803|NCT00451958|4153348|B3|Romania||Region of Enrollment|CS21A ITT population.|participants|Number|16|16.0||||||
4325804|NCT00451958|4153349|B2|Romania||Region of Enrollment|CS21A ITT population.|participants|Number|39|39.0||||||
4325805|NCT00451958|4153350|B1|Romania||Region of Enrollment|CS21A ITT population.|participants|Number|36|36.0||||||
4325806|NCT00451958|4153346|B5|Ukraine||Region of Enrollment|CS21A ITT population.|participants|Number|31|31.0||||||
4325807|NCT00451958|4153347|B4|Ukraine||Region of Enrollment|CS21A ITT population.|participants|Number|3|3.0||||||
4325808|NCT00451958|4153348|B3|Ukraine||Region of Enrollment|CS21A ITT population.|participants|Number|7|7.0||||||
4325809|NCT00451958|4153349|B2|Ukraine||Region of Enrollment|CS21A ITT population.|participants|Number|10|10.0||||||
4325810|NCT00451958|4153350|B1|Ukraine||Region of Enrollment|CS21A ITT population.|participants|Number|11|11.0||||||
4325811|NCT00451958|4153346|B5|Canada||Region of Enrollment|CS21A ITT population.|participants|Number|18|18.0||||||
4325812|NCT00451958|4153347|B4|Canada||Region of Enrollment|CS21A ITT population.|participants|Number|4|4.0||||||
4325813|NCT00451958|4153348|B3|Canada||Region of Enrollment|CS21A ITT population.|participants|Number|5|5.0||||||
4325814|NCT00451958|4153349|B2|Canada||Region of Enrollment|CS21A ITT population.|participants|Number|5|5.0||||||
4325815|NCT00451958|4153350|B1|Canada||Region of Enrollment|CS21A ITT population.|participants|Number|4|4.0||||||
4325816|NCT00451958|4153346|B5|Mexico||Region of Enrollment|CS21A ITT population.|participants|Number|49|49.0||||||
4325817|NCT00451958|4153347|B4|Mexico||Region of Enrollment|CS21A ITT population.|participants|Number|7|7.0||||||
4325818|NCT00451958|4153348|B3|Mexico||Region of Enrollment|CS21A ITT population.|participants|Number|10|10.0||||||
4325819|NCT00451958|4153349|B2|Mexico||Region of Enrollment|CS21A ITT population.|participants|Number|17|17.0||||||
4325820|NCT00451958|4153350|B1|Mexico||Region of Enrollment|CS21A ITT population.|participants|Number|15|15.0||||||
4325821|NCT00451958|4153346|B5|Czech Republic||Region of Enrollment|CS21A ITT population.|participants|Number|37|37.0||||||
4325822|NCT00451958|4153347|B4|Czech Republic||Region of Enrollment|CS21A ITT population.|participants|Number|8|8.0||||||
4325823|NCT00451958|4153348|B3|Czech Republic||Region of Enrollment|CS21A ITT population.|participants|Number|6|6.0||||||
4325824|NCT00451958|4153349|B2|Czech Republic||Region of Enrollment|CS21A ITT population.|participants|Number|12|12.0||||||
4325825|NCT00451958|4153350|B1|Czech Republic||Region of Enrollment|CS21A ITT population.|participants|Number|11|11.0||||||
4325826|NCT00451958|4153346|B5|Hungary||Region of Enrollment|CS21A ITT population.|participants|Number|26|26.0||||||
4325827|NCT00451958|4153347|B4|Hungary||Region of Enrollment|CS21A ITT population.|participants|Number|5|5.0||||||
4325828|NCT00451958|4153348|B3|Hungary||Region of Enrollment|CS21A ITT population.|participants|Number|5|5.0||||||
4325829|NCT00451958|4153349|B2|Hungary||Region of Enrollment|CS21A ITT population.|participants|Number|9|9.0||||||
4325830|NCT00451958|4153350|B1|Hungary||Region of Enrollment|CS21A ITT population.|participants|Number|7|7.0||||||
4325831|NCT00451958|4153346|B5|United States||Region of Enrollment|CS21A ITT population.|participants|Number|48|48.0||||||
4325832|NCT00451958|4153347|B4|United States||Region of Enrollment|CS21A ITT population.|participants|Number|9|9.0||||||
4325833|NCT00451958|4153348|B3|United States||Region of Enrollment|CS21A ITT population.|participants|Number|13|13.0||||||
4325834|NCT00451958|4153349|B2|United States||Region of Enrollment|CS21A ITT population.|participants|Number|14|14.0||||||
4325835|NCT00451958|4153350|B1|United States||Region of Enrollment|CS21A ITT population.|participants|Number|12|12.0||||||
4325836|NCT00451958|4153346|B5||Male|Sex: Female, Male|CS21A ITT population.|Participants|Count of Participants|385|385.0||||||
4325837|NCT00451958|4153347|B4||Male|Sex: Female, Male|CS21A ITT population.|Participants|Count of Participants|65|65.0||||||
4325838|NCT00451958|4153348|B3||Male|Sex: Female, Male|CS21A ITT population.|Participants|Count of Participants|69|69.0||||||
4325839|NCT00451958|4153349|B2||Male|Sex: Female, Male|CS21A ITT population.|Participants|Count of Participants|126|126.0||||||
4325840|NCT00451958|4153350|B1||Male|Sex: Female, Male|CS21A ITT population.|Participants|Count of Participants|125|125.0||||||
4325841|NCT00451958|4153346|B5||Female|Sex: Female, Male|CS21A ITT population.|Participants|Count of Participants|0|0.0||||||
4325842|NCT00451958|4153347|B4||Female|Sex: Female, Male|CS21A ITT population.|Participants|Count of Participants|0|0.0||||||
4325843|NCT00451958|4153348|B3||Female|Sex: Female, Male|CS21A ITT population.|Participants|Count of Participants|0|0.0||||||
4325844|NCT00451958|4153349|B2||Female|Sex: Female, Male|CS21A ITT population.|Participants|Count of Participants|0|0.0||||||
4325845|NCT00451958|4153350|B1||Female|Sex: Female, Male|CS21A ITT population.|Participants|Count of Participants|0|0.0||||||
4325846|NCT00451958|4153346|B5|||Age|CS21A intention-to-treat (ITT) population.|years|Mean|71.1|71.1|Standard Deviation|8.29|8.29|||
4325847|NCT00451958|4153347|B4|||Age|CS21A intention-to-treat (ITT) population.|years|Mean|71.4|71.4|Standard Deviation|8.24|8.24|||
4325848|NCT00451958|4153348|B3|||Age|CS21A intention-to-treat (ITT) population.|years|Mean|72.4|72.4|Standard Deviation|9.46|9.46|||
4325849|NCT00451958|4153349|B2|||Age|CS21A intention-to-treat (ITT) population.|years|Mean|71.1|71.1|Standard Deviation|8.25|8.25|||
4325850|NCT00451958|4153350|B1|||Age|CS21A intention-to-treat (ITT) population.|years|Mean|70.1|70.1|Standard Deviation|7.62|7.62|||
4325851|NCT00451906|4153384|B1||Male|Sex: Female, Male||Participants|Count of Participants|1306|1306.0||||||
4325852|NCT00451906|4153384|B1||Female|Sex: Female, Male||Participants|Count of Participants|866|866.0||||||
4325853|NCT00451906|4153384|B1|||Age||years|Mean|58.8|58.8|Standard Deviation|10.3|10.3|||
4325854|NCT00451698|4153392|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4325855|NCT00451698|4153393|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4325856|NCT00451698|4153394|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4325857|NCT00451698|4153392|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4325858|NCT00451698|4153393|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4325859|NCT00451698|4153394|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4325860|NCT00451698|4153392|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4325861|NCT00451698|4153393|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4325862|NCT00451698|4153394|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4325863|NCT00451698|4153392|B3|||Age||years|Mean|9.6|9.6|Standard Deviation|6.1|6.1|||
4325864|NCT00451698|4153393|B2|||Age||years|Mean|12.9|12.9|Standard Deviation|4.5|4.5|||
4325865|NCT00451698|4153394|B1|||Age||years|Mean|3.1|3.1|Standard Deviation|1.2|1.2|||
4325866|NCT00451698|4153392|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4325867|NCT00451698|4153393|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4325868|NCT00451698|4153394|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4325869|NCT00451698|4153392|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4325870|NCT00451698|4153393|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4325871|NCT00451698|4153394|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4325872|NCT00451698|4153392|B3||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4325873|NCT00451698|4153393|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4325874|NCT00451698|4153394|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4325875|NCT00451451|4153409|B5|||Mean number of Gadolinium(Gd)-enhancing T1-weighted lesions|This baseline measure could only be assessed in the magnetic resonance imaging (MRI) cohort. The MRI cohort included 681 intent-to-treat (ITT) subjects who were enrolled at sites that participated in the MRI portion of the study and who had MRI data (167 placebo, 169 BG00012 BID, 170 BG00012 TID, and 175 GA). Sites could participate only if their MRI capability was validated by the independent MRI reading center. Approximately 95% of all subjects enrolled at MRI sites participated in the MRI portion of the study.|Number of Gd enhancing lesions|Mean|2.4|2.4|Standard Deviation|6.51|6.51|||
4325876|NCT00451451|4153410|B4|||Mean number of Gadolinium(Gd)-enhancing T1-weighted lesions|This baseline measure could only be assessed in the magnetic resonance imaging (MRI) cohort. The MRI cohort included 681 intent-to-treat (ITT) subjects who were enrolled at sites that participated in the MRI portion of the study and who had MRI data (167 placebo, 169 BG00012 BID, 170 BG00012 TID, and 175 GA). Sites could participate only if their MRI capability was validated by the independent MRI reading center. Approximately 95% of all subjects enrolled at MRI sites participated in the MRI portion of the study.|Number of Gd enhancing lesions|Mean|2.4|2.4|Standard Deviation|6.81|6.81|||
4325877|NCT00451451|4153411|B3|||Mean number of Gadolinium(Gd)-enhancing T1-weighted lesions|This baseline measure could only be assessed in the magnetic resonance imaging (MRI) cohort. The MRI cohort included 681 intent-to-treat (ITT) subjects who were enrolled at sites that participated in the MRI portion of the study and who had MRI data (167 placebo, 169 BG00012 BID, 170 BG00012 TID, and 175 GA). Sites could participate only if their MRI capability was validated by the independent MRI reading center. Approximately 95% of all subjects enrolled at MRI sites participated in the MRI portion of the study.|Number of Gd enhancing lesions|Mean|1.9|1.9|Standard Deviation|5.02|5.02|||
4325878|NCT00451451|4153412|B2|||Mean number of Gadolinium(Gd)-enhancing T1-weighted lesions|This baseline measure could only be assessed in the magnetic resonance imaging (MRI) cohort. The MRI cohort included 681 intent-to-treat (ITT) subjects who were enrolled at sites that participated in the MRI portion of the study and who had MRI data (167 placebo, 169 BG00012 BID, 170 BG00012 TID, and 175 GA). Sites could participate only if their MRI capability was validated by the independent MRI reading center. Approximately 95% of all subjects enrolled at MRI sites participated in the MRI portion of the study.|Number of Gd enhancing lesions|Mean|2.7|2.7|Standard Deviation|6.22|6.22|||
4325879|NCT00451451|4153413|B1|||Mean number of Gadolinium(Gd)-enhancing T1-weighted lesions|This baseline measure could only be assessed in the magnetic resonance imaging (MRI) cohort. The MRI cohort included 681 intent-to-treat (ITT) subjects who were enrolled at sites that participated in the MRI portion of the study and who had MRI data (167 placebo, 169 BG00012 BID, 170 BG00012 TID, and 175 GA). Sites could participate only if their MRI capability was validated by the independent MRI reading center. Approximately 95% of all subjects enrolled at MRI sites participated in the MRI portion of the study.|Number of Gd enhancing lesions|Mean|2.7|2.7|Standard Deviation|7.71|7.71|||
4325880|NCT00451451|4153409|B5|||Time since first multiple sclerosis (MS) diagnosis||years|Mean|4.7|4.7|Standard Deviation|5.01|5.01|||
4325881|NCT00451451|4153410|B4|||Time since first multiple sclerosis (MS) diagnosis||years|Mean|4.4|4.4|Standard Deviation|4.70|4.7|||
4325882|NCT00451451|4153411|B3|||Time since first multiple sclerosis (MS) diagnosis||years|Mean|4.6|4.6|Standard Deviation|5.23|5.23|||
4325883|NCT00451451|4153412|B2|||Time since first multiple sclerosis (MS) diagnosis||years|Mean|4.9|4.9|Standard Deviation|5.11|5.11|||
4325884|NCT00451451|4153413|B1|||Time since first multiple sclerosis (MS) diagnosis||years|Mean|4.8|4.8|Standard Deviation|5.01|5.01|||
4325885|NCT00451451|4153409|B5|||Mean number of relapses within the past 12 months||Number of relapses|Mean|1.4|1.4|Standard Deviation|0.70|0.7|||
4325886|NCT00451451|4153410|B4|||Mean number of relapses within the past 12 months||Number of relapses|Mean|1.4|1.4|Standard Deviation|0.64|0.64|||
4325887|NCT00451451|4153411|B3|||Mean number of relapses within the past 12 months||Number of relapses|Mean|1.4|1.4|Standard Deviation|0.72|0.72|||
4325888|NCT00451451|4153412|B2|||Mean number of relapses within the past 12 months||Number of relapses|Mean|1.3|1.3|Standard Deviation|0.63|0.63|||
4325889|NCT00451451|4153413|B1|||Mean number of relapses within the past 12 months||Number of relapses|Mean|1.4|1.4|Standard Deviation|0.80|0.8|||
4325890|NCT00451451|4153409|B5|||Mean number of relapses within the previous 3 years||Number of relapses|Mean|2.5|2.5|Standard Deviation|1.39|1.39|||
4325891|NCT00451451|4153410|B4|||Mean number of relapses within the previous 3 years||Number of relapses|Mean|2.4|2.4|Standard Deviation|1.32|1.32|||
4325892|NCT00451451|4153411|B3|||Mean number of relapses within the previous 3 years||Number of relapses|Mean|2.6|2.6|Standard Deviation|1.50|1.5|||
4325893|NCT00451451|4153412|B2|||Mean number of relapses within the previous 3 years||Number of relapses|Mean|2.4|2.4|Standard Deviation|1.27|1.27|||
4325894|NCT00451451|4153413|B1|||Mean number of relapses within the previous 3 years||Number of relapses|Mean|2.5|2.5|Standard Deviation|1.46|1.46|||
4325895|NCT00451451|4153409|B5|||Mean Expanded Disability Status Scale (EDSS) score|The EDSS scores range from 0.0 (normal exam) to 10.0 (death due to MS).|units on a scale|Mean|2.56|2.56|Standard Deviation|1.194|1.194|||
4325896|NCT00451451|4153410|B4|||Mean Expanded Disability Status Scale (EDSS) score|The EDSS scores range from 0.0 (normal exam) to 10.0 (death due to MS).|units on a scale|Mean|2.57|2.57|Standard Deviation|1.223|1.223|||
4325897|NCT00451451|4153411|B3|||Mean Expanded Disability Status Scale (EDSS) score|The EDSS scores range from 0.0 (normal exam) to 10.0 (death due to MS).|units on a scale|Mean|2.52|2.52|Standard Deviation|1.185|1.185|||
4325898|NCT00451451|4153412|B2|||Mean Expanded Disability Status Scale (EDSS) score|The EDSS scores range from 0.0 (normal exam) to 10.0 (death due to MS).|units on a scale|Mean|2.56|2.56|Standard Deviation|1.202|1.202|||
4325956|NCT00451321|4153448|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325899|NCT00451451|4153413|B1|||Mean Expanded Disability Status Scale (EDSS) score|The EDSS scores range from 0.0 (normal exam) to 10.0 (death due to MS).|units on a scale|Mean|2.59|2.59|Standard Deviation|1.170|1.17|||
4325900|NCT00451451|4153409|B5||Male|Sex: Female, Male||Participants|Count of Participants|424|424.0||||||
4325901|NCT00451451|4153410|B4||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4325902|NCT00451451|4153411|B3||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4325903|NCT00451451|4153412|B2||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4325904|NCT00451451|4153413|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4325905|NCT00451451|4153409|B5||Female|Sex: Female, Male||Participants|Count of Participants|993|993.0||||||
4325906|NCT00451451|4153410|B4||Female|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
4325907|NCT00451451|4153411|B3||Female|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
4325908|NCT00451451|4153412|B2||Female|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4325909|NCT00451451|4153413|B1||Female|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4325910|NCT00451451|4153409|B5|||Age||Years|Mean|37.3|37.3|Standard Deviation|9.26|9.26|||
4325911|NCT00451451|4153410|B4|||Age||Years|Mean|36.7|36.7|Standard Deviation|9.06|9.06|||
4325912|NCT00451451|4153411|B3|||Age||Years|Mean|37.8|37.8|Standard Deviation|9.39|9.39|||
4325913|NCT00451451|4153412|B2|||Age||Years|Mean|37.8|37.8|Standard Deviation|9.35|9.35|||
4325914|NCT00451451|4153413|B1|||Age||Years|Mean|36.9|36.9|Standard Deviation|9.24|9.24|||
4325915|NCT00451321|4153443|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325916|NCT00451321|4153444|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325917|NCT00451321|4153445|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325918|NCT00451321|4153446|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325919|NCT00451321|4153447|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325920|NCT00451321|4153448|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325921|NCT00451321|4153449|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325922|NCT00451321|4153450|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325923|NCT00451321|4153451|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325924|NCT00451321|4153443|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4325925|NCT00451321|4153444|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325926|NCT00451321|4153445|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325927|NCT00451321|4153446|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325928|NCT00451321|4153447|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325929|NCT00451321|4153448|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325930|NCT00451321|4153449|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4325931|NCT00451321|4153450|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325932|NCT00451321|4153451|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325933|NCT00451321|4153443|B9||White|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4325934|NCT00451321|4153444|B8||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4325935|NCT00451321|4153445|B7||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4325936|NCT00451321|4153446|B6||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4325937|NCT00451321|4153447|B5||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4325938|NCT00451321|4153448|B4||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4325939|NCT00451321|4153449|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4325940|NCT00451321|4153450|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4325941|NCT00451321|4153451|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4325942|NCT00451321|4153443|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4325943|NCT00451321|4153444|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325944|NCT00451321|4153445|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325945|NCT00451321|4153446|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325946|NCT00451321|4153447|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325947|NCT00451321|4153448|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325948|NCT00451321|4153449|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4325949|NCT00451321|4153450|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325950|NCT00451321|4153451|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325951|NCT00451321|4153443|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325952|NCT00451321|4153444|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325953|NCT00451321|4153445|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325954|NCT00451321|4153446|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325955|NCT00451321|4153447|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325957|NCT00451321|4153449|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325958|NCT00451321|4153450|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325959|NCT00451321|4153451|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325960|NCT00451321|4153443|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325961|NCT00451321|4153444|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325962|NCT00451321|4153445|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325963|NCT00451321|4153446|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325964|NCT00451321|4153447|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325965|NCT00451321|4153448|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325966|NCT00451321|4153449|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325967|NCT00451321|4153450|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325968|NCT00451321|4153451|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325969|NCT00451321|4153443|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325970|NCT00451321|4153444|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325971|NCT00451321|4153445|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325972|NCT00451321|4153446|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325973|NCT00451321|4153447|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325974|NCT00451321|4153448|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325975|NCT00451321|4153449|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325976|NCT00451321|4153450|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325977|NCT00451321|4153451|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4325978|NCT00451321|4153443|B9||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4325979|NCT00451321|4153444|B8||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4325980|NCT00451321|4153445|B7||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4325981|NCT00451321|4153446|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4325982|NCT00451321|4153447|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4325983|NCT00451321|4153448|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4325984|NCT00451321|4153449|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4325985|NCT00451321|4153450|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4325986|NCT00451321|4153451|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4325987|NCT00451321|4153443|B9||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4325988|NCT00451321|4153444|B8||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4325989|NCT00451321|4153445|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4325990|NCT00451321|4153446|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4325991|NCT00451321|4153447|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4325992|NCT00451321|4153448|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4325993|NCT00451321|4153449|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4325994|NCT00451321|4153450|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4325995|NCT00451321|4153451|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4325996|NCT00451321|4153443|B9|||Age||Years|Mean|31.6|31.6|Standard Deviation|12.49|12.49|||
4325997|NCT00451321|4153444|B8|||Age||Years|Mean|28.8|28.8|Standard Deviation|6.79|6.79|||
4325998|NCT00451321|4153445|B7|||Age||Years|Mean|37.2|37.2|Standard Deviation|14.37|14.37|||
4325999|NCT00451321|4153446|B6|||Age||Years|Mean|28.9|28.9|Standard Deviation|10.74|10.74|||
4326000|NCT00451321|4153447|B5|||Age||Years|Mean|36.1|36.1|Standard Deviation|9.70|9.7|||
4326001|NCT00451321|4153448|B4|||Age||Years|Mean|34.6|34.6|Standard Deviation|9.89|9.89|||
4326002|NCT00451321|4153449|B3|||Age||Years|Mean|18.9|18.9|Standard Deviation|5.17|5.17|||
4326003|NCT00451321|4153450|B2|||Age||Years|Mean|42.3|42.3|Standard Deviation|13.25|13.25|||
4326004|NCT00451321|4153451|B1|||Age||Years|Mean|29.8|29.8|Standard Deviation|11.36|11.36|||
4326005|NCT00451282|4153628|B3|United States||Region of Enrollment||participants|Number|85|85.0||||||
4326006|NCT00451282|4153629|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
4326007|NCT00451282|4153630|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4326008|NCT00451282|4153628|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4326009|NCT00451282|4153629|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4326010|NCT00451282|4153630|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4326011|NCT00451282|4153628|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4326012|NCT00451282|4153629|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4326013|NCT00451282|4153630|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4326014|NCT00451282|4153628|B3|||Age||years|Mean|11.5|11.5|Standard Deviation|2.5|2.5|||
4326015|NCT00451282|4153629|B2|||Age||years|Mean|11.9|11.9|Standard Deviation|2.7|2.7|||
4326016|NCT00451282|4153630|B1|||Age||years|Mean|11.2|11.2|Standard Deviation|2.2|2.2|||
4326017|NCT00451282|4153628|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4326018|NCT00451282|4153629|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4326019|NCT00451282|4153630|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4326020|NCT00451282|4153628|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4326021|NCT00451282|4153629|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4326022|NCT00451282|4153630|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4326023|NCT00451282|4153628|B3||<=18 years|Age||Participants|Count of Participants|85|85.0||||||
4326024|NCT00451282|4153629|B2||<=18 years|Age||Participants|Count of Participants|39|39.0||||||
4326025|NCT00451282|4153630|B1||<=18 years|Age||Participants|Count of Participants|46|46.0||||||
4326026|NCT00451204|4153643|B3|United States||Region of Enrollment||participants|Number|158|158.0||||||
4326027|NCT00451204|4153644|B2|United States||Region of Enrollment||participants|Number|76|76.0||||||
4326028|NCT00451204|4153645|B1|United States||Region of Enrollment||participants|Number|82|82.0||||||
4326029|NCT00451204|4153643|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4326030|NCT00451204|4153644|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4326031|NCT00451204|4153645|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4326032|NCT00451204|4153643|B3||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4326033|NCT00451204|4153644|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4326034|NCT00451204|4153645|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4326035|NCT00451204|4153643|B3|||Age||years|Mean|37.4|37.4|Standard Deviation|7.45|7.45|||
4326036|NCT00451204|4153644|B2|||Age||years|Mean|37.1|37.1|Standard Deviation|7.3|7.3|||
4326037|NCT00451204|4153645|B1|||Age||years|Mean|37.7|37.7|Standard Deviation|7.6|7.6|||
4326038|NCT00451204|4153643|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4326039|NCT00451204|4153644|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4326040|NCT00451204|4153645|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4326041|NCT00451204|4153643|B3||Between 18 and 65 years|Age||Participants|Count of Participants|158|158.0||||||
4326042|NCT00451204|4153644|B2||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
4326043|NCT00451204|4153645|B1||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
4326044|NCT00451204|4153643|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4326045|NCT00451204|4153644|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4326046|NCT00451204|4153645|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4326047|NCT00451191|4153662|B3|United States||Region of Enrollment||participants|Number|134|134.0||||||
4326048|NCT00451191|4153663|B2|United States||Region of Enrollment||participants|Number|66|66.0||||||
4326049|NCT00451191|4153664|B1|United States||Region of Enrollment||participants|Number|68|68.0||||||
4326050|NCT00451191|4153662|B3||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4326051|NCT00451191|4153663|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4326052|NCT00451191|4153664|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4326053|NCT00451191|4153662|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4326054|NCT00451191|4153663|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4326055|NCT00451191|4153664|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4326056|NCT00451191|4153662|B3|>=50 years||Age, Customized||participants|Number|134|134.0||||||
4326057|NCT00451191|4153663|B2|>=50 years||Age, Customized||participants|Number|66|66.0||||||
4326058|NCT00451191|4153664|B1|>=50 years||Age, Customized||participants|Number|68|68.0||||||
4326059|NCT00451191|4153662|B3|<50 years||Age, Customized||participants|Number|0|0.0||||||
4326060|NCT00451191|4153663|B2|<50 years||Age, Customized||participants|Number|0|0.0||||||
4326061|NCT00451191|4153664|B1|<50 years||Age, Customized||participants|Number|0|0.0||||||
4326062|NCT00451048|4153671|B1|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4326063|NCT00451048|4153671|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4326064|NCT00451048|4153671|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4326065|NCT00451048|4153671|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4326066|NCT00451048|4153671|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4326067|NCT00451048|4153671|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4326068|NCT00451048|4153671|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4326069|NCT00451048|4153671|B1|||Age||years|Median|69|69.0|Full Range|||62.0|87.0|
4326070|NCT00450983|4153680|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326071|NCT00450983|4153680|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326072|NCT00450983|4153680|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4326073|NCT00450983|4153680|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326074|NCT00450983|4153680|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326075|NCT00450983|4153680|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326076|NCT00450983|4153680|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326077|NCT00450983|4153680|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326078|NCT00450983|4153680|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4326079|NCT00450983|4153680|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326080|NCT00450983|4153680|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4326081|NCT00450983|4153680|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4326082|NCT00450983|4153680|B1|||Age||years|Median|1.7|1.7|Full Range|||1.7|1.7|
4326083|NCT00450866|4153692|B1|Group B||Central Nervous System (CNS) metastases|Group A: Patients with progressive, radiographically measurable parenchymal brain metastases after whole brain radiation therapy (WBRT) Group B: an exploratory cohort of patients, with either leptomeningeal metastases (LMD) or unirradiated, asymptomatic brain metastasis from breast cancer (BCBM).|participants|Number|10|10.0||||||
4326084|NCT00450866|4153692|B1|Group A||Central Nervous System (CNS) metastases|Group A: Patients with progressive, radiographically measurable parenchymal brain metastases after whole brain radiation therapy (WBRT) Group B: an exploratory cohort of patients, with either leptomeningeal metastases (LMD) or unirradiated, asymptomatic brain metastasis from breast cancer (BCBM).|participants|Number|45|45.0||||||
4326085|NCT00450866|4153692|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4326086|NCT00450866|4153692|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4326087|NCT00450866|4153692|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326088|NCT00450866|4153692|B1||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4326089|NCT00450866|4153692|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4326090|NCT00450866|4153692|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326091|NCT00450866|4153692|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4326092|NCT00450866|4153692|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326093|NCT00450866|4153692|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4326094|NCT00450866|4153692|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4326095|NCT00450866|4153692|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4326096|NCT00450866|4153692|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4326097|NCT00450866|4153692|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4326098|NCT00450866|4153692|B1|||Age||years|Median|50|50.0|Full Range|8.6|8.6|31.0|68.0|
4326099|NCT00450801|4153703|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4326100|NCT00450801|4153703|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4326101|NCT00450801|4153703|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4326102|NCT00450801|4153703|B1|70 - 79 years||Age, Customized||participants|Number|3|3.0||||||
4326103|NCT00450801|4153703|B1|60 - 69 years||Age, Customized||participants|Number|5|5.0||||||
4326104|NCT00450801|4153703|B1|50 - 59 years||Age, Customized||participants|Number|8|8.0||||||
4326105|NCT00450801|4153703|B1|< 50 years||Age, Customized||participants|Number|6|6.0||||||
4326106|NCT00450801|4153703|B1|||Age||years|Median|56.5|56.5|Full Range|||39.0|73.0|
4326107|NCT00450749|4153714|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
4326108|NCT00450749|4153715|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4326109|NCT00450749|4153716|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4326110|NCT00450749|4153717|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4326111|NCT00450749|4153714|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4326112|NCT00450749|4153715|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4326113|NCT00450749|4153716|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4326114|NCT00450749|4153717|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4326115|NCT00450749|4153714|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4326116|NCT00450749|4153715|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4326117|NCT00450749|4153716|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4326118|NCT00450749|4153717|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4326119|NCT00450749|4153714|B4|||Age||years|Median|66.5|66.5|Full Range|||45.0|72.0|
4326120|NCT00450749|4153715|B3|||Age||years|Median|66|66.0|Full Range|||52.0|68.0|
4326121|NCT00450749|4153716|B2|||Age||years|Median|56|56.0|Full Range|||45.0|71.0|
4326122|NCT00450749|4153717|B1|||Age||years|Median|71|71.0|Full Range|||56.0|72.0|
4326123|NCT00450723|4153727|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4326124|NCT00450723|4153727|B1||Male|Gender||Participants|Count of Participants|1|1.0||||||
4326125|NCT00450723|4153727|B1||Female|Gender||Participants|Count of Participants|33|33.0||||||
4326126|NCT00450723|4153727|B1|||Age||years|Median|50|50.0|Full Range|||32.0|67.0|
4326127|NCT00450723|4153727|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4326128|NCT00450723|4153727|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4326129|NCT00450723|4153727|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4326130|NCT00450658|4153733|B3|United States||Region of Enrollment||participants|Number|627|627.0||||||
4326131|NCT00450658|4153734|B2|United States||Region of Enrollment||participants|Number|212|212.0||||||
4326132|NCT00450658|4153735|B1|United States||Region of Enrollment||participants|Number|415|415.0||||||
4326133|NCT00450658|4153733|B3||Male|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4326134|NCT00450658|4153734|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4326135|NCT00450658|4153735|B1||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4326136|NCT00450658|4153733|B3||Female|Sex: Female, Male||Participants|Count of Participants|424|424.0||||||
4326137|NCT00450658|4153734|B2||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4326138|NCT00450658|4153735|B1||Female|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
4326139|NCT00450658|4153733|B3|||Age||years|Mean|55.4|55.4|Standard Deviation|9.1|9.1|||
4326140|NCT00450658|4153734|B2|||Age||years|Mean|55.7|55.7|Standard Deviation|9.5|9.5|||
4326141|NCT00450658|4153735|B1|||Age||years|Mean|55.3|55.3|Standard Deviation|9.0|9.0|||
4326142|NCT00450658|4153733|B3||>=65 years|Age||Participants|Count of Participants|112|112.0||||||
4326143|NCT00450658|4153734|B2||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4326144|NCT00450658|4153735|B1||>=65 years|Age||Participants|Count of Participants|73|73.0||||||
4326145|NCT00450658|4153733|B3||Between 18 and 65 years|Age||Participants|Count of Participants|515|515.0||||||
4326146|NCT00450658|4153734|B2||Between 18 and 65 years|Age||Participants|Count of Participants|173|173.0||||||
4326147|NCT00450658|4153735|B1||Between 18 and 65 years|Age||Participants|Count of Participants|342|342.0||||||
4326148|NCT00450658|4153733|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4326149|NCT00450658|4153734|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4326150|NCT00450658|4153735|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4326151|NCT00450619|4153748|B3|||Alkaline Phosphatase||U/L|Median|149.25|149.25|Full Range|||71.0|693.0|
4326152|NCT00450619|4153749|B2|||Alkaline Phosphatase||U/L|Median|121.5|121.5|Full Range|||52.0|661.0|
4326153|NCT00450619|4153750|B1|||Alkaline Phosphatase||U/L|Median|177|177.0|Full Range|||90.0|725.0|
4326154|NCT00450619|4153748|B3|||Hemoglobin||g/dl|Median|11.15|11.15|Full Range|||7.9|14.0|
4326155|NCT00450619|4153749|B2|||Hemoglobin||g/dl|Median|11.1|11.1|Full Range|||7.0|14.8|
4326156|NCT00450619|4153750|B1|||Hemoglobin||g/dl|Median|11.2|11.2|Full Range|||8.8|13.2|
4326157|NCT00450619|4153748|B3|||Lactate Dehydrogenase (serum)||U/L|Median|227.25|227.25|Full Range|||145.0|657.5|
4326158|NCT00450619|4153749|B2|||Lactate Dehydrogenase (serum)||U/L|Median|200|200.0|Full Range|||115.0|962.0|
4326159|NCT00450619|4153750|B1|||Lactate Dehydrogenase (serum)||U/L|Median|254.5|254.5|Full Range|||175.0|353.0|
4326160|NCT00450619|4153748|B3|||Median Days since Prior Chemotherapy||Days|Median|72|72.0|Full Range|||16.0|559.5|
4326161|NCT00450619|4153749|B2|||Median Days since Prior Chemotherapy||Days|Median|86.5|86.5|Full Range|||21.0|818.0|
4326162|NCT00450619|4153750|B1|||Median Days since Prior Chemotherapy||Days|Median|57.5|57.5|Full Range|||11.0|301.0|
4326163|NCT00450619|4153748|B3|||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status Scale:Grade 0 - Normal activity, Fully active, able to carry on all pre-disease performance without restriction.; Grade 1 -Symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., office work).; Grade 2 - In bed<50% of the time. Ambulatory and capable of all self-care.; Grade 3 - In bed >50% of the time. Capable of only limited self-care, confined to bed or chair>50% of waking hours.; Grade 4 - 100% bedridden, Completely disabled. Cannot carry on any self-care.; Grade 5 - Dead.|Scores on a scale|Median|1|1.0|Full Range|||0.0|2.0|
4326164|NCT00450619|4153749|B2|||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status Scale:Grade 0 - Normal activity, Fully active, able to carry on all pre-disease performance without restriction.; Grade 1 -Symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., office work).; Grade 2 - In bed<50% of the time. Ambulatory and capable of all self-care.; Grade 3 - In bed >50% of the time. Capable of only limited self-care, confined to bed or chair>50% of waking hours.; Grade 4 - 100% bedridden, Completely disabled. Cannot carry on any self-care.; Grade 5 - Dead.|Scores on a scale|Median|1|1.0|Full Range|||0.0|2.0|
4326165|NCT00450619|4153750|B1|||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status Scale:Grade 0 - Normal activity, Fully active, able to carry on all pre-disease performance without restriction.; Grade 1 -Symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., office work).; Grade 2 - In bed<50% of the time. Ambulatory and capable of all self-care.; Grade 3 - In bed >50% of the time. Capable of only limited self-care, confined to bed or chair>50% of waking hours.; Grade 4 - 100% bedridden, Completely disabled. Cannot carry on any self-care.; Grade 5 - Dead.|Scores on a scale|Median|1|1.0|Full Range|||0.0|1.0|
4326166|NCT00450619|4153748|B3|||Prostate-Specific Antigen on Study||ng/mL of blood|Median|286.3|286.3|Full Range|||13.55|3282.0|
4326167|NCT00450619|4153749|B2|||Prostate-Specific Antigen on Study||ng/mL of blood|Median|313.5|313.5|Full Range|||4.9|4708.0|
4326168|NCT00450619|4153750|B1|||Prostate-Specific Antigen on Study||ng/mL of blood|Median|259.1|259.1|Full Range|||22.2|1856.0|
4326169|NCT00450619|4153748|B3|||Gleason Score|Gleason score is a commonly used pathology score. The range of the score is 2 to 10 with two being associated with better outcomes and 10 being associated with worse outcomes.|Scores on a scale|Median|7.75|7.75|Full Range|||5.5|9.5|
4326170|NCT00450619|4153749|B2|||Gleason Score|Gleason score is a commonly used pathology score. The range of the score is 2 to 10 with two being associated with better outcomes and 10 being associated with worse outcomes.|Scores on a scale|Median|7.5|7.5|Full Range|||5.0|10.0|
4326171|NCT00450619|4153750|B1|||Gleason Score|Gleason score is a commonly used pathology score. The range of the score is 2 to 10 with two being associated with better outcomes and 10 being associated with worse outcomes.|Scores on a scale|Median|8|8.0|Full Range|||6.0|9.0|
4326172|NCT00450619|4153748|B3|||Subjects requiring narcotic pain control||participants|Number|19|19.0||||||
4326173|NCT00450619|4153749|B2|||Subjects requiring narcotic pain control||participants|Number|8|8.0||||||
4326174|NCT00450619|4153750|B1|||Subjects requiring narcotic pain control||participants|Number|11|11.0||||||
4326175|NCT00450619|4153748|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
4326176|NCT00450619|4153749|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4326177|NCT00450619|4153750|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4326178|NCT00450619|4153748|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4326179|NCT00450619|4153749|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4326180|NCT00450619|4153750|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326181|NCT00450619|4153748|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326182|NCT00450619|4153749|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326183|NCT00450619|4153750|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326184|NCT00450619|4153748|B3||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4326185|NCT00450619|4153749|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4326186|NCT00450619|4153750|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4326187|NCT00450619|4153748|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4326188|NCT00450619|4153749|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4326189|NCT00450619|4153750|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4326190|NCT00450619|4153748|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326191|NCT00450619|4153749|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326192|NCT00450619|4153750|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326193|NCT00450619|4153748|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4326194|NCT00450619|4153749|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326195|NCT00450619|4153750|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4326196|NCT00450619|4153748|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326197|NCT00450619|4153749|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326198|NCT00450619|4153750|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326199|NCT00450619|4153748|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326200|NCT00450619|4153749|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326201|NCT00450619|4153750|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326202|NCT00450619|4153748|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4326203|NCT00450619|4153749|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4326204|NCT00450619|4153750|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4326205|NCT00450619|4153748|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4326206|NCT00450619|4153749|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4326207|NCT00450619|4153750|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326208|NCT00450619|4153748|B3||Male|Gender||Participants|Count of Participants|44|44.0||||||
4326209|NCT00450619|4153749|B2||Male|Gender||Participants|Count of Participants|22|22.0||||||
4326210|NCT00450619|4153750|B1||Male|Gender||Participants|Count of Participants|22|22.0||||||
4326211|NCT00450619|4153748|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
4326212|NCT00450619|4153749|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
4326213|NCT00450619|4153750|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
4326214|NCT00450619|4153748|B3|||Age||years|Mean|67.18|67.18|Standard Deviation|8.49|8.49|||
4326215|NCT00450619|4153749|B2|||Age||years|Mean|69.65|69.65|Standard Deviation|8.5|8.5|||
4326216|NCT00450619|4153750|B1|||Age||years|Mean|64.73|64.73|Standard Deviation|7.91|7.91|||
4326217|NCT00450619|4153748|B3||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4326218|NCT00450619|4153749|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4326219|NCT00450619|4153750|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4326220|NCT00450619|4153748|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4326221|NCT00450619|4153749|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4326222|NCT00450619|4153750|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4326223|NCT00450619|4153748|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4326224|NCT00450619|4153749|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4326225|NCT00450619|4153750|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4326226|NCT00450580|4153775|B3|Mixed race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4326227|NCT00450580|4153776|B2|Mixed race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4326228|NCT00450580|4153777|B1|Mixed race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4326229|NCT00450580|4153775|B3|White – White/Caucasian/European||Race/Ethnicity, Customized||participants|Number|153|153.0||||||
4326230|NCT00450580|4153776|B2|White – White/Caucasian/European||Race/Ethnicity, Customized||participants|Number|78|78.0||||||
4326231|NCT00450580|4153777|B1|White – White/Caucasian/European||Race/Ethnicity, Customized||participants|Number|75|75.0||||||
4326232|NCT00450580|4153775|B3|White – Arabic/North African||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4326233|NCT00450580|4153776|B2|White – Arabic/North African||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4326234|NCT00450580|4153777|B1|White – Arabic/North African||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4326235|NCT00450580|4153775|B3|Asian – South East Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4326236|NCT00450580|4153776|B2|Asian – South East Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4326237|NCT00450580|4153777|B1|Asian – South East Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4326238|NCT00450580|4153775|B3|American Indian/Alaskan native||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4326239|NCT00450580|4153776|B2|American Indian/Alaskan native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4326240|NCT00450580|4153777|B1|American Indian/Alaskan native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4326241|NCT00450580|4153775|B3|African American/African heritage||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4326242|NCT00450580|4153776|B2|African American/African heritage||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4326243|NCT00450580|4153777|B1|African American/African heritage||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4326244|NCT00450580|4153775|B3||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4326245|NCT00450580|4153776|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4326246|NCT00450580|4153777|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4326247|NCT00450580|4153775|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4326248|NCT00450580|4153776|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4326249|NCT00450580|4153777|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4326250|NCT00450580|4153775|B3|||Age, Customized||years|Mean|38|38.0|Full Range|||18.0|70.0|
4326251|NCT00450580|4153776|B2|||Age, Customized||years|Mean|38|38.0|Full Range|||19.0|69.0|
4326252|NCT00450580|4153777|B1|||Age, Customized||years|Mean|37|37.0|Full Range|||18.0|70.0|
4326253|NCT00450463|4153796|B3|United States||Region of Enrollment||Participants|Count of Participants|64|64.0||||||
4326254|NCT00450463|4153797|B2|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
4326255|NCT00450463|4153798|B1|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
4326256|NCT00450463|4153796|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326257|NCT00450463|4153797|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326258|NCT00450463|4153798|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326259|NCT00450463|4153796|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326260|NCT00450463|4153797|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326261|NCT00450463|4153798|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326262|NCT00450463|4153796|B3||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4326263|NCT00450463|4153797|B2||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4326264|NCT00450463|4153798|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4326265|NCT00450463|4153796|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4326266|NCT00450463|4153797|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4326267|NCT00450463|4153798|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4326268|NCT00450463|4153796|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326269|NCT00450463|4153797|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326270|NCT00450463|4153798|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326271|NCT00450463|4153796|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326272|NCT00450463|4153797|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326273|NCT00450463|4153798|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326274|NCT00450463|4153796|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326275|NCT00450463|4153797|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326276|NCT00450463|4153798|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326277|NCT00450463|4153796|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326278|NCT00450463|4153797|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326279|NCT00450463|4153798|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326280|NCT00450463|4153796|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4326281|NCT00450463|4153797|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4326282|NCT00450463|4153798|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4326283|NCT00450463|4153796|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4326284|NCT00450463|4153797|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4326285|NCT00450463|4153798|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4326286|NCT00450463|4153796|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4326287|NCT00450463|4153797|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4326288|NCT00450463|4153798|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4326289|NCT00450463|4153796|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4326290|NCT00450463|4153797|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4326291|NCT00450463|4153798|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4326292|NCT00450463|4153796|B3|||Age||years|Mean|70.83|70.83|Standard Deviation|8.74|8.74|||
4326293|NCT00450463|4153797|B2|||Age||years|Mean|69.84|69.84|Standard Deviation|8.87|8.87|||
4326294|NCT00450463|4153798|B1|||Age||years|Mean|71.82|71.82|Standard Deviation|8.61|8.61|||
4326295|NCT00450463|4153796|B3||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
4326296|NCT00450463|4153797|B2||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4326297|NCT00450463|4153798|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4326298|NCT00450463|4153796|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4326299|NCT00450463|4153797|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4326300|NCT00450463|4153798|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4326301|NCT00450463|4153796|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4326302|NCT00450463|4153797|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4326303|NCT00450463|4153798|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4326304|NCT00450450|4153813|B3|Australia||Region of Enrollment||Participants|Number|1|1.0||||||
4326305|NCT00450450|4153814|B2|Australia||Region of Enrollment||Participants|Number|0|0.0||||||
4326306|NCT00450450|4153815|B1|Australia||Region of Enrollment||Participants|Number|1|1.0||||||
4326307|NCT00450450|4153813|B3|United States||Region of Enrollment||Participants|Number|26|26.0||||||
4326308|NCT00450450|4153814|B2|United States||Region of Enrollment||Participants|Number|14|14.0||||||
4326309|NCT00450450|4153815|B1|United States||Region of Enrollment||Participants|Number|12|12.0||||||
4326310|NCT00450450|4153813|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4326311|NCT00450450|4153814|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4326312|NCT00450450|4153815|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4326313|NCT00450450|4153813|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326314|NCT00450450|4153814|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326315|NCT00450450|4153815|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326316|NCT00450450|4153813|B3||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4326317|NCT00450450|4153814|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4326318|NCT00450450|4153815|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4326319|NCT00450450|4153813|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4326320|NCT00450450|4153814|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4326321|NCT00450450|4153815|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4326322|NCT00450450|4153813|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326323|NCT00450450|4153814|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326324|NCT00450450|4153815|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326325|NCT00450450|4153813|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4326326|NCT00450450|4153814|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4326327|NCT00450450|4153815|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326328|NCT00450450|4153813|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326329|NCT00450450|4153814|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326330|NCT00450450|4153815|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326331|NCT00450450|4153813|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326332|NCT00450450|4153814|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326333|NCT00450450|4153815|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326334|NCT00450450|4153813|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4326335|NCT00450450|4153814|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4326336|NCT00450450|4153815|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4326337|NCT00450450|4153813|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4326338|NCT00450450|4153814|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4326339|NCT00450450|4153815|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4326340|NCT00450450|4153813|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4326341|NCT00450450|4153814|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4326342|NCT00450450|4153815|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4326343|NCT00450450|4153813|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4326344|NCT00450450|4153814|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4326345|NCT00450450|4153815|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4326346|NCT00450450|4153813|B3|||Age||Whole year|Median|12|12.0|Full Range|||0.0|20.0|
4326347|NCT00450450|4153814|B2|||Age||Whole year|Median|11|11.0|Full Range|||3.0|20.0|
4326348|NCT00450450|4153815|B1|||Age||Whole year|Median|12|12.0|Full Range|||0.0|20.0|
4326349|NCT00450437|4153838|B3|Other (19 to 55 years)||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4326350|NCT00450437|4153839|B2|Other (19 to 55 years)||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4326351|NCT00450437|4153840|B1|Other (19 to 55 years)||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4326352|NCT00450437|4153838|B3|Hispanic (19 to 55 years)||Race/Ethnicity, Customized||participants|Number|89|89.0||||||
4326353|NCT00450437|4153839|B2|Hispanic (19 to 55 years)||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4326354|NCT00450437|4153840|B1|Hispanic (19 to 55 years)||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
4326355|NCT00450437|4153838|B3|Caucasian (19 to 55 years)||Race/Ethnicity, Customized||participants|Number|1089|1089.0||||||
4326356|NCT00450437|4153839|B2|Caucasian (19 to 55 years)||Race/Ethnicity, Customized||participants|Number|261|261.0||||||
4326357|NCT00450437|4153840|B1|Caucasian (19 to 55 years)||Race/Ethnicity, Customized||participants|Number|828|828.0||||||
4326358|NCT00450437|4153838|B3|Black (19 to 55 years)||Race/Ethnicity, Customized||participants|Number|119|119.0||||||
4326359|NCT00450437|4153839|B2|Black (19 to 55 years)||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4326360|NCT00450437|4153840|B1|Black (19 to 55 years)||Race/Ethnicity, Customized||participants|Number|85|85.0||||||
4326361|NCT00450437|4153838|B3|Asian (19 to 55 years)||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4326362|NCT00450437|4153839|B2|Asian (19 to 55 years)||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4326363|NCT00450437|4153840|B1|Asian (19 to 55 years)||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4326364|NCT00450437|4153838|B3|Other (11 to 18 years)||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
4326365|NCT00450437|4153839|B2|Other (11 to 18 years)||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4326366|NCT00450437|4153840|B1|Other (11 to 18 years)||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4326367|NCT00450437|4153838|B3|Hispanic (11 to 18 years)||Race/Ethnicity, Customized||participants|Number|160|160.0||||||
4326368|NCT00450437|4153839|B2|Hispanic (11 to 18 years)||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4326369|NCT00450437|4153840|B1|Hispanic (11 to 18 years)||Race/Ethnicity, Customized||participants|Number|126|126.0||||||
4326370|NCT00450437|4153838|B3|Caucasian (11 to 18 years)||Race/Ethnicity, Customized||participants|Number|1703|1703.0||||||
4326371|NCT00450437|4153839|B2|Caucasian (11 to 18 years)||Race/Ethnicity, Customized||participants|Number|423|423.0||||||
4326372|NCT00450437|4153840|B1|Caucasian (11 to 18 years)||Race/Ethnicity, Customized||participants|Number|1280|1280.0||||||
4326373|NCT00450437|4153838|B3|Black (11 to 18 years)||Race/Ethnicity, Customized||participants|Number|183|183.0||||||
4326374|NCT00450437|4153839|B2|Black (11 to 18 years)||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4326375|NCT00450437|4153840|B1|Black (11 to 18 years)||Race/Ethnicity, Customized||participants|Number|138|138.0||||||
4326376|NCT00450437|4153838|B3|Asian (11 to 18 years)||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
4326377|NCT00450437|4153839|B2|Asian (11 to 18 years)||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4326378|NCT00450437|4153840|B1|Asian (11 to 18 years)||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4326379|NCT00450437|4153838|B3|Male (19 to 55 years)||Sex/Gender, Customized||participants|Number|333|333.0||||||
4326380|NCT00450437|4153839|B2|Male (19 to 55 years)||Sex/Gender, Customized||participants|Number|84|84.0||||||
4326381|NCT00450437|4153840|B1|Male (19 to 55 years)||Sex/Gender, Customized||participants|Number|249|249.0||||||
4326382|NCT00450437|4153838|B3|Female (19 to 55 years)||Sex/Gender, Customized||participants|Number|1026|1026.0||||||
4326383|NCT00450437|4153839|B2|Female (19 to 55 years)||Sex/Gender, Customized||participants|Number|252|252.0||||||
4326384|NCT00450437|4153840|B1|Female (19 to 55 years)||Sex/Gender, Customized||participants|Number|774|774.0||||||
4326385|NCT00450437|4153838|B3|Male (11 to 18 years)||Sex/Gender, Customized||participants|Number|1160|1160.0||||||
4326386|NCT00450437|4153839|B2|Male (11 to 18 years)||Sex/Gender, Customized||participants|Number|289|289.0||||||
4326387|NCT00450437|4153840|B1|Male (11 to 18 years)||Sex/Gender, Customized||participants|Number|871|871.0||||||
4326388|NCT00450437|4153838|B3|Female (11 to 18 years)||Sex/Gender, Customized||participants|Number|1020|1020.0||||||
4326389|NCT00450437|4153839|B2|Female (11 to 18 years)||Sex/Gender, Customized||participants|Number|251|251.0||||||
4326390|NCT00450437|4153840|B1|Female (11 to 18 years)||Sex/Gender, Customized||participants|Number|769|769.0||||||
4326391|NCT00450437|4153838|B3|19 to 55 years||Age||years|Mean|39|39.0|Standard Deviation|38.7|38.7|||
4326392|NCT00450437|4153839|B2|19 to 55 years||Age||years|Mean|38.7|38.7|Standard Deviation|9.9|9.9|||
4326393|NCT00450437|4153840|B1|19 to 55 years||Age||years|Mean|39.0|39.0|Standard Deviation|9.6|9.6|||
4326394|NCT00450437|4153838|B3|11 to 18 years||Age||years|Mean|14.2|14.2|Standard Deviation|14.1|14.1|||
4326395|NCT00450437|4153839|B2|11 to 18 years||Age||years|Mean|14.1|14.1|Standard Deviation|2.2|2.2|||
4326396|NCT00450437|4153840|B1|11 to 18 years||Age||years|Mean|14.2|14.2|Standard Deviation|2.2|2.2|||
4326397|NCT00450424|4153865|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326398|NCT00450424|4153866|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326399|NCT00450424|4153867|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326400|NCT00450424|4153865|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|234|234.0||||||
4326401|NCT00450424|4153866|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
4326402|NCT00450424|4153867|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|114|114.0||||||
4326403|NCT00450424|4153865|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4326404|NCT00450424|4153866|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4326405|NCT00450424|4153867|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4326406|NCT00450424|4153865|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4326407|NCT00450424|4153866|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4326408|NCT00450424|4153867|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4326409|NCT00450424|4153865|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326410|NCT00450424|4153866|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326411|NCT00450424|4153867|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326412|NCT00450424|4153865|B3||White|Race (NIH/OMB)||Participants|Count of Participants|214|214.0||||||
4326413|NCT00450424|4153866|B2||White|Race (NIH/OMB)||Participants|Count of Participants|112|112.0||||||
4326414|NCT00450424|4153867|B1||White|Race (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
4326415|NCT00450424|4153865|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4326416|NCT00450424|4153866|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4326417|NCT00450424|4153867|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4326418|NCT00450424|4153865|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326419|NCT00450424|4153866|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326420|NCT00450424|4153867|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326421|NCT00450424|4153865|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4326422|NCT00450424|4153866|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4326423|NCT00450424|4153867|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4326424|NCT00450424|4153865|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4326425|NCT00450424|4153866|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4326426|NCT00450424|4153867|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4326427|NCT00450424|4153865|B3||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4326428|NCT00450424|4153866|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4326429|NCT00450424|4153867|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4326430|NCT00450424|4153865|B3||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4326431|NCT00450424|4153866|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4326432|NCT00450424|4153867|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4326433|NCT00450424|4153865|B3|||Age||years|Mean|46.53|46.53|Standard Deviation|8.04|8.04|||
4326434|NCT00450424|4153866|B2|||Age||years|Mean|47.33|47.33|Standard Deviation|8.58|8.58|||
4326435|NCT00450424|4153867|B1|||Age||years|Mean|45.69|45.69|Standard Deviation|7.38|7.38|||
4326436|NCT00450411|4153874|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4326437|NCT00450411|4153874|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4326438|NCT00450411|4153874|B1|||Age||years|Median|70|70.0|Full Range|||55.0|82.0|
4326439|NCT00450385|4153879|B1|United States||Region of Enrollment||Participants|Count of Participants|57|57.0||||||
4326440|NCT00450385|4153879|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4326441|NCT00450385|4153879|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4326442|NCT00450385|4153879|B1||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4326443|NCT00450385|4153879|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4326444|NCT00450385|4153879|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4326445|NCT00450372|4153888|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4326446|NCT00450372|4153888|B1||Male|Gender||Participants|Count of Participants|25|25.0||||||
4326447|NCT00450372|4153888|B1||Female|Gender||Participants|Count of Participants|13|13.0||||||
4326448|NCT00450372|4153888|B1|||Age||years|Mean|69|69.0|Full Range|||25.0|85.0|
4326449|NCT00450372|4153888|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4326450|NCT00450372|4153888|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4326451|NCT00450372|4153888|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4326452|NCT00450333|4153897|B5|New Zealand||Region of Enrollment||participants|Number|10|10.0||||||
4326453|NCT00450333|4153898|B4|New Zealand||Region of Enrollment||participants|Number|2|2.0||||||
4326454|NCT00450333|4153899|B3|New Zealand||Region of Enrollment||participants|Number|2|2.0||||||
4326455|NCT00450333|4153900|B2|New Zealand||Region of Enrollment||participants|Number|3|3.0||||||
4326456|NCT00450333|4153901|B1|New Zealand||Region of Enrollment||participants|Number|3|3.0||||||
4326457|NCT00450333|4153897|B5|Lithuania||Region of Enrollment||participants|Number|19|19.0||||||
4326458|NCT00450333|4153898|B4|Lithuania||Region of Enrollment||participants|Number|0|0.0||||||
4326459|NCT00450333|4153899|B3|Lithuania||Region of Enrollment||participants|Number|0|0.0||||||
4326460|NCT00450333|4153900|B2|Lithuania||Region of Enrollment||participants|Number|9|9.0||||||
4326461|NCT00450333|4153901|B1|Lithuania||Region of Enrollment||participants|Number|10|10.0||||||
4326462|NCT00450333|4153897|B5|Latvia||Region of Enrollment||participants|Number|38|38.0||||||
4326463|NCT00450333|4153898|B4|Latvia||Region of Enrollment||participants|Number|4|4.0||||||
4326464|NCT00450333|4153899|B3|Latvia||Region of Enrollment||participants|Number|4|4.0||||||
4326465|NCT00450333|4153900|B2|Latvia||Region of Enrollment||participants|Number|16|16.0||||||
4326466|NCT00450333|4153901|B1|Latvia||Region of Enrollment||participants|Number|14|14.0||||||
4326467|NCT00450333|4153897|B5|Hungary||Region of Enrollment||participants|Number|17|17.0||||||
4326468|NCT00450333|4153898|B4|Hungary||Region of Enrollment||participants|Number|1|1.0||||||
4326469|NCT00450333|4153899|B3|Hungary||Region of Enrollment||participants|Number|0|0.0||||||
4326470|NCT00450333|4153900|B2|Hungary||Region of Enrollment||participants|Number|8|8.0||||||
4326471|NCT00450333|4153901|B1|Hungary||Region of Enrollment||participants|Number|8|8.0||||||
4326472|NCT00450333|4153897|B5|Australia||Region of Enrollment||participants|Number|54|54.0||||||
4326473|NCT00450333|4153898|B4|Australia||Region of Enrollment||participants|Number|6|6.0||||||
4326474|NCT00450333|4153899|B3|Australia||Region of Enrollment||participants|Number|7|7.0||||||
4326475|NCT00450333|4153900|B2|Australia||Region of Enrollment||participants|Number|22|22.0||||||
4326476|NCT00450333|4153901|B1|Australia||Region of Enrollment||participants|Number|19|19.0||||||
4326477|NCT00450333|4153897|B5|Italy||Region of Enrollment||participants|Number|73|73.0||||||
4326478|NCT00450333|4153898|B4|Italy||Region of Enrollment||participants|Number|35|35.0||||||
4326479|NCT00450333|4153899|B3|Italy||Region of Enrollment||participants|Number|28|28.0||||||
4326480|NCT00450333|4153900|B2|Italy||Region of Enrollment||participants|Number|5|5.0||||||
4326481|NCT00450333|4153901|B1|Italy||Region of Enrollment||participants|Number|5|5.0||||||
4326482|NCT00450333|4153897|B5|United Kingdom||Region of Enrollment||participants|Number|48|48.0||||||
4326483|NCT00450333|4153898|B4|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
4326484|NCT00450333|4153899|B3|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
4326485|NCT00450333|4153900|B2|United Kingdom||Region of Enrollment||participants|Number|15|15.0||||||
4326486|NCT00450333|4153901|B1|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
4326487|NCT00450333|4153897|B5|Germany||Region of Enrollment||participants|Number|60|60.0||||||
4326488|NCT00450333|4153898|B4|Germany||Region of Enrollment||participants|Number|14|14.0||||||
4326489|NCT00450333|4153899|B3|Germany||Region of Enrollment||participants|Number|15|15.0||||||
4326490|NCT00450333|4153900|B2|Germany||Region of Enrollment||participants|Number|16|16.0||||||
4326491|NCT00450333|4153901|B1|Germany||Region of Enrollment||participants|Number|15|15.0||||||
4326492|NCT00450333|4153897|B5|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4326493|NCT00450333|4153898|B4|Austria||Region of Enrollment||participants|Number|0|0.0||||||
4326494|NCT00450333|4153899|B3|Austria||Region of Enrollment||participants|Number|0|0.0||||||
4326495|NCT00450333|4153900|B2|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4326496|NCT00450333|4153901|B1|Austria||Region of Enrollment||participants|Number|3|3.0||||||
4326497|NCT00450333|4153897|B5|Belgium||Region of Enrollment||participants|Number|27|27.0||||||
4326498|NCT00450333|4153898|B4|Belgium||Region of Enrollment||participants|Number|11|11.0||||||
4326499|NCT00450333|4153899|B3|Belgium||Region of Enrollment||participants|Number|12|12.0||||||
4326500|NCT00450333|4153900|B2|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
4326501|NCT00450333|4153901|B1|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
4326502|NCT00450333|4153897|B5|Spain||Region of Enrollment||participants|Number|32|32.0||||||
4326503|NCT00450333|4153898|B4|Spain||Region of Enrollment||participants|Number|14|14.0||||||
4326504|NCT00450333|4153899|B3|Spain||Region of Enrollment||participants|Number|13|13.0||||||
4326505|NCT00450333|4153900|B2|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4326506|NCT00450333|4153901|B1|Spain||Region of Enrollment||participants|Number|3|3.0||||||
4326507|NCT00450333|4153897|B5|France||Region of Enrollment||participants|Number|25|25.0||||||
4326508|NCT00450333|4153898|B4|France||Region of Enrollment||participants|Number|3|3.0||||||
4326509|NCT00450333|4153899|B3|France||Region of Enrollment||participants|Number|8|8.0||||||
4326510|NCT00450333|4153900|B2|France||Region of Enrollment||participants|Number|8|8.0||||||
4326511|NCT00450333|4153901|B1|France||Region of Enrollment||participants|Number|6|6.0||||||
4326512|NCT00450333|4153897|B5||Male|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
4326513|NCT00450333|4153898|B4||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4326514|NCT00450333|4153899|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4326515|NCT00450333|4153900|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4326516|NCT00450333|4153901|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4326517|NCT00450333|4153897|B5||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4326518|NCT00450333|4153898|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4326519|NCT00450333|4153899|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4326520|NCT00450333|4153900|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4326521|NCT00450333|4153901|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4326522|NCT00450333|4153897|B5|||Age||years|Mean|65.7|65.7|Standard Deviation|14.33|14.33|||
4326523|NCT00450333|4153898|B4|||Age||years|Mean|65.5|65.5|Standard Deviation|16.04|16.04|||
4326524|NCT00450333|4153899|B3|||Age||years|Mean|64.2|64.2|Standard Deviation|13.86|13.86|||
4326525|NCT00450333|4153900|B2|||Age||years|Mean|67.0|67.0|Standard Deviation|12.45|12.45|||
4326526|NCT00450333|4153901|B1|||Age||years|Mean|66.2|66.2|Standard Deviation|14.97|14.97|||
4326527|NCT00450333|4153897|B5||>=65 years|Age||Participants|Count of Participants|252|252.0||||||
4326528|NCT00450333|4153898|B4||>=65 years|Age||Participants|Count of Participants|67|67.0||||||
4326529|NCT00450333|4153899|B3||>=65 years|Age||Participants|Count of Participants|52|52.0||||||
4326530|NCT00450333|4153900|B2||>=65 years|Age||Participants|Count of Participants|72|72.0||||||
4326531|NCT00450333|4153901|B1||>=65 years|Age||Participants|Count of Participants|61|61.0||||||
4326532|NCT00450333|4153897|B5||Between 18 and 65 years|Age||Participants|Count of Participants|155|155.0||||||
4326533|NCT00450333|4153898|B4||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4326534|NCT00450333|4153899|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4326535|NCT00450333|4153900|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4326536|NCT00450333|4153901|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4326537|NCT00450333|4153897|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4326538|NCT00450333|4153898|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4326539|NCT00450333|4153899|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4326540|NCT00450333|4153900|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4326541|NCT00450333|4153901|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4326542|NCT00450294|4153922|B1|ASA V (moribund person)||ASA Physical Status|"ASA physical status classification is a score given to the patient by the anesthesiologist following a preoperative assessment. It pertains to the patient's preoperative fitness. The full categorization scheme is as follows:~Healthy person.~Mild systemic disease.~Severe systemic disease.~Severe systemic disease that is a constant threat to life.~A moribund person who is not expected to survive without the operation."|participants|Number|0|0.0||||||
4326543|NCT00450294|4153922|B1|ASA IV (Severe systemic disease, constant threat)||ASA Physical Status|"ASA physical status classification is a score given to the patient by the anesthesiologist following a preoperative assessment. It pertains to the patient's preoperative fitness. The full categorization scheme is as follows:~Healthy person.~Mild systemic disease.~Severe systemic disease.~Severe systemic disease that is a constant threat to life.~A moribund person who is not expected to survive without the operation."|participants|Number|0|0.0||||||
4326544|NCT00450294|4153922|B1|AASA III (Severe systemic disease)||ASA Physical Status|"ASA physical status classification is a score given to the patient by the anesthesiologist following a preoperative assessment. It pertains to the patient's preoperative fitness. The full categorization scheme is as follows:~Healthy person.~Mild systemic disease.~Severe systemic disease.~Severe systemic disease that is a constant threat to life.~A moribund person who is not expected to survive without the operation."|participants|Number|10|10.0||||||
4326545|NCT00450294|4153922|B1|ASA II (mild systemic disease)||ASA Physical Status|"ASA physical status classification is a score given to the patient by the anesthesiologist following a preoperative assessment. It pertains to the patient's preoperative fitness. The full categorization scheme is as follows:~Healthy person.~Mild systemic disease.~Severe systemic disease.~Severe systemic disease that is a constant threat to life.~A moribund person who is not expected to survive without the operation."|participants|Number|0|0.0||||||
4326546|NCT00450294|4153922|B1|ASA I (healthy person)||ASA Physical Status|"ASA physical status classification is a score given to the patient by the anesthesiologist following a preoperative assessment. It pertains to the patient's preoperative fitness. The full categorization scheme is as follows:~Healthy person.~Mild systemic disease.~Severe systemic disease.~Severe systemic disease that is a constant threat to life.~A moribund person who is not expected to survive without the operation."|participants|Number|0|0.0||||||
4326547|NCT00450294|4153922|B1|N) Mannitol||Mannitol||participants|Number|0|0.0||||||
4326548|NCT00450294|4153922|B1|Received Mannitol||Mannitol||participants|Number|10|10.0||||||
4326549|NCT00450294|4153922|B1|NO vasopressor infusion||Vasopressor infusion||participants|Number|0|0.0||||||
4326550|NCT00450294|4153922|B1|Vasopressor Infusion||Vasopressor infusion||participants|Number|10|10.0||||||
4326551|NCT00450294|4153922|B1|||Cumulative Crystalloid||L|Mean|2.84|2.84|Standard Deviation|0.13|0.13|||
4326552|NCT00450294|4153922|B1|NO Epidural||Epidural||participants|Number|0|0.0||||||
4326553|NCT00450294|4153922|B1|Epidural||Epidural||participants|Number|10|10.0||||||
4326554|NCT00450294|4153922|B1|NO Hyperlipidemia||Hyperlipidemia||participants|Number|0|0.0||||||
4326555|NCT00450294|4153922|B1|HAS Hyperlipidemia||Hyperlipidemia||participants|Number|10|10.0||||||
4326556|NCT00450294|4153922|B1|NO HTN||Hypertension||participants|Number|0|0.0||||||
4326557|NCT00450294|4153922|B1|HAS HTN||Hypertension||participants|Number|10|10.0||||||
4326558|NCT00450294|4153922|B1|NO DM||Diabetes mellitus||participants|Number|0|0.0||||||
4326559|NCT00450294|4153922|B1|HAS DM||Diabetes mellitus||participants|Number|10|10.0||||||
4326560|NCT00450294|4153922|B1|No CVA||Cerebrovascular Accident (CVA)||participants|Number|6|6.0||||||
4326561|NCT00450294|4153922|B1|HAS CVA||Cerebrovascular Accident (CVA)||participants|Number|4|4.0||||||
4326562|NCT00450294|4153922|B1|||Abdominal Aortic Aneurysm Size||cm|Mean|5.7|5.7|Standard Deviation|0.5|0.5|||
4326563|NCT00450294|4153922|B1|||Body mass index||kg/m2|Mean|27.3|27.3|Standard Deviation|3.4|3.4|||
4326564|NCT00450294|4153922|B1|||Preop Left Intraocular Pressure||mm HG|Mean|16.7|16.7|Standard Deviation|2.7|2.7|||
4326565|NCT00450294|4153922|B1|||Preop Right Intraocular Pressure||mm Hg|Mean|16.9|16.9|Standard Deviation|2.6|2.6|||
4326566|NCT00450294|4153922|B1|||Cross Clamp Duration||min|Mean|58|58.0|Standard Deviation|15.3|15.3|||
4326567|NCT00450294|4153922|B1|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4326568|NCT00450294|4153922|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4326569|NCT00450294|4153922|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4326570|NCT00450294|4153922|B1|||Age||years|Mean|68.5|68.5|Standard Deviation|11.2|11.2|||
4326571|NCT00450294|4153922|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4326572|NCT00450294|4153922|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4326573|NCT00450294|4153922|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4326574|NCT00450255|4153927|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4326575|NCT00450255|4153927|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4326576|NCT00450255|4153927|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4326577|NCT00450255|4153927|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4326578|NCT00450255|4153927|B1|||Age||years|Median|57|57.0|Full Range|||23.0|84.0|
4326579|NCT00450242|4153935|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4326580|NCT00450242|4153936|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4326581|NCT00450242|4153937|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4326582|NCT00450242|4153935|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4326583|NCT00450242|4153936|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4326584|NCT00450242|4153937|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4326585|NCT00450242|4153935|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4326586|NCT00450242|4153936|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4326587|NCT00450242|4153937|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4326588|NCT00450242|4153935|B3|||Age||years|Mean|29.9|29.9|Standard Deviation|7.0|7.0|||
4326589|NCT00450242|4153936|B2|||Age||years|Mean|29.4|29.4|Standard Deviation|5.7|5.7|||
4326590|NCT00450242|4153937|B1|||Age||years|Mean|30.9|30.9|Standard Deviation|8.5|8.5|||
4326591|NCT00450242|4153935|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4326592|NCT00450242|4153936|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4326593|NCT00450242|4153937|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4326594|NCT00450242|4153935|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4326595|NCT00450242|4153936|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4326596|NCT00450242|4153937|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4326597|NCT00450242|4153935|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4326598|NCT00450242|4153936|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4326599|NCT00450242|4153937|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4326600|NCT00450216|4153950|B3|United States||Region of Enrollment||participants|Number|906|906.0||||||
4326601|NCT00450216|4153951|B2|United States||Region of Enrollment||participants|Number|299|299.0||||||
4326602|NCT00450216|4153952|B1|United States||Region of Enrollment||participants|Number|607|607.0||||||
4326603|NCT00450216|4153950|B3||Male|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
4326604|NCT00450216|4153951|B2||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4326605|NCT00450216|4153952|B1||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4326606|NCT00450216|4153950|B3||Female|Sex: Female, Male||Participants|Count of Participants|624|624.0||||||
4326607|NCT00450216|4153951|B2||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4326608|NCT00450216|4153952|B1||Female|Sex: Female, Male||Participants|Count of Participants|416|416.0||||||
4326609|NCT00450216|4153950|B3|||Age||years|Mean|55.6|55.6|Standard Deviation|9.2|9.2|||
4326610|NCT00450216|4153951|B2|||Age||years|Mean|55.9|55.9|Standard Deviation|9.3|9.3|||
4326611|NCT00450216|4153952|B1|||Age||years|Mean|55.5|55.5|Standard Deviation|9.2|9.2|||
4326612|NCT00450216|4153950|B3||>=65 years|Age||Participants|Count of Participants|166|166.0||||||
4326613|NCT00450216|4153951|B2||>=65 years|Age||Participants|Count of Participants|59|59.0||||||
4326614|NCT00450216|4153952|B1||>=65 years|Age||Participants|Count of Participants|107|107.0||||||
4326615|NCT00450216|4153950|B3||Between 18 and 65 years|Age||Participants|Count of Participants|740|740.0||||||
4326616|NCT00450216|4153951|B2||Between 18 and 65 years|Age||Participants|Count of Participants|240|240.0||||||
4326617|NCT00450216|4153952|B1||Between 18 and 65 years|Age||Participants|Count of Participants|500|500.0||||||
4326618|NCT00450216|4153950|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4326619|NCT00450216|4153951|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4326620|NCT00450216|4153952|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4326621|NCT00450190|4153965|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4326622|NCT00450190|4153965|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4326623|NCT00450190|4153965|B1|||Age||years|Mean|11.30|11.3|Standard Deviation|2.66|2.66|||
4326624|NCT00450112|4153973|B3|||Physician Global Evaluations|Observed physician evaluations on Visual Analog Scale (VAS) of 100 mm.; 0 mm meaning excellent feeling in knee joint; 100 mm meaning poor feeling in knee joint.|scores on a scale|Mean|61.3|61.3|Standard Deviation|18.29|18.29|||
4326625|NCT00450112|4153974|B2|||Physician Global Evaluations|Observed physician evaluations on Visual Analog Scale (VAS) of 100 mm.; 0 mm meaning excellent feeling in knee joint; 100 mm meaning poor feeling in knee joint.|scores on a scale|Mean|62.6|62.6|Standard Deviation|20.51|20.51|||
4326626|NCT00450112|4153975|B1|||Physician Global Evaluations|Observed physician evaluations on Visual Analog Scale (VAS) of 100 mm.; 0 mm meaning excellent feeling in knee joint; 100 mm meaning poor feeling in knee joint.|scores on a scale|Mean|60.5|60.5|Standard Deviation|16.85|16.85|||
4326627|NCT00450112|4153973|B3|||Subject Global Evaluations|Observed subject evaluations on Visual Analog Scale (VAS) of 100 mm.; 0 mm meaning excellent feeling in knee joint; 100 mm meaning poor feeling in knee joint.|scores on a scale|Mean|66.9|66.9|Standard Deviation|20.70|20.7|||
4326628|NCT00450112|4153974|B2|||Subject Global Evaluations|Observed subject evaluations on Visual Analog Scale (VAS) of 100 mm.; 0 mm meaning excellent feeling in knee joint; 100 mm meaning poor feeling in knee joint.|scores on a scale|Mean|68.2|68.2|Standard Deviation|18.85|18.85|||
4326629|NCT00450112|4153975|B1|||Subject Global Evaluations|Observed subject evaluations on Visual Analog Scale (VAS) of 100 mm.; 0 mm meaning excellent feeling in knee joint; 100 mm meaning poor feeling in knee joint.|scores on a scale|Mean|66.1|66.1|Standard Deviation|21.81|21.81|||
4326668|NCT00450073|4154001|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4326669|NCT00450073|4153998|B4|||Age||years|Mean|32.1|32.1|Standard Deviation|10|10.0|||
4326670|NCT00450073|4153999|B3|||Age||years|Mean|33.3|33.3|Standard Deviation|15.7|15.7|||
4326630|NCT00450112|4153973|B3|||WOMAC VAS Total Score|Mean of Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Visual Analog Scale (VAS) pain, stiffness and physical function subscores on VAS of 100 mm.; 0 mm meaning no pain, stiffness and difficulty; 100 mm meaning extreme pain, stiffness and difficulty.|scores on a scale|Mean|69.0|69.0|Standard Deviation|16.58|16.58|||
4326631|NCT00450112|4153974|B2|||WOMAC VAS Total Score|Mean of Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Visual Analog Scale (VAS) pain, stiffness and physical function subscores on VAS of 100 mm.; 0 mm meaning no pain, stiffness and difficulty; 100 mm meaning extreme pain, stiffness and difficulty.|scores on a scale|Mean|69.9|69.9|Standard Deviation|15.79|15.79|||
4326632|NCT00450112|4153975|B1|||WOMAC VAS Total Score|Mean of Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Visual Analog Scale (VAS) pain, stiffness and physical function subscores on VAS of 100 mm.; 0 mm meaning no pain, stiffness and difficulty; 100 mm meaning extreme pain, stiffness and difficulty.|scores on a scale|Mean|68.4|68.4|Standard Deviation|17.07|17.07|||
4326633|NCT00450112|4153973|B3|||WOMAC VAS Physical Function Subcore|Assessed Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Visual Analog Scale (VAS) physical function subscores on VAS of 100 mm.; 0 mm meaning no difficulty; 100 mm meaning extreme difficulty.|scores on a scale|Mean|68.7|68.7|Standard Deviation|17.35|17.35|||
4326634|NCT00450112|4153974|B2|||WOMAC VAS Physical Function Subcore|Assessed Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Visual Analog Scale (VAS) physical function subscores on VAS of 100 mm.; 0 mm meaning no difficulty; 100 mm meaning extreme difficulty.|scores on a scale|Mean|69.9|69.9|Standard Deviation|16.35|16.35|||
4326635|NCT00450112|4153975|B1|||WOMAC VAS Physical Function Subcore|Assessed Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Visual Analog Scale (VAS) physical function subscores on VAS of 100 mm.; 0 mm meaning no difficulty; 100 mm meaning extreme difficulty.|scores on a scale|Mean|68.0|68.0|Standard Deviation|17.96|17.96|||
4326636|NCT00450112|4153973|B3|||WOMAC VAS Stiffness Subscore|Assessed Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Visual Analog Scale (VAS) stiffness subscores on VAS of 100 mm.; 0 mm meaning no stiffness; 100 mm meaning extreme stiffness.|scores on a scale|Mean|70.1|70.1|Standard Deviation|18.30|18.3|||
4326637|NCT00450112|4153974|B2|||WOMAC VAS Stiffness Subscore|Assessed Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Visual Analog Scale (VAS) stiffness subscores on VAS of 100 mm.; 0 mm meaning no stiffness; 100 mm meaning extreme stiffness.|scores on a scale|Mean|70.7|70.7|Standard Deviation|18.40|18.4|||
4326638|NCT00450112|4153975|B1|||WOMAC VAS Stiffness Subscore|Assessed Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Visual Analog Scale (VAS) stiffness subscores on VAS of 100 mm.; 0 mm meaning no stiffness; 100 mm meaning extreme stiffness.|scores on a scale|Mean|69.7|69.7|Standard Deviation|18.31|18.31|||
4326639|NCT00450112|4153973|B3|||WOMAC VAS Pain Subscore|Assessed Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Visual Analog Scale (VAS) pain subscores on VAS of 100 mm.; 0 mm meaning no pain; 100 mm meaning extreme pain.|Scores on a scale|Mean|69.5|69.5|Standard Deviation|15.53|15.53|||
4326640|NCT00450112|4153974|B2|||WOMAC VAS Pain Subscore|Assessed Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Visual Analog Scale (VAS) pain subscores on VAS of 100 mm.; 0 mm meaning no pain; 100 mm meaning extreme pain.|Scores on a scale|Mean|69.9|69.9|Standard Deviation|15.13|15.13|||
4326641|NCT00450112|4153975|B1|||WOMAC VAS Pain Subscore|Assessed Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Visual Analog Scale (VAS) pain subscores on VAS of 100 mm.; 0 mm meaning no pain; 100 mm meaning extreme pain.|Scores on a scale|Mean|69.4|69.4|Standard Deviation|15.82|15.82|||
4326642|NCT00450112|4153973|B3|||Body Mass Index (BMI)||kilograms/meters square|Mean|28.8|28.8|Standard Deviation|4.09|4.09|||
4326643|NCT00450112|4153974|B2|||Body Mass Index (BMI)||kilograms/meters square|Mean|29.1|29.1|Standard Deviation|4.01|4.01|||
4326644|NCT00450112|4153975|B1|||Body Mass Index (BMI)||kilograms/meters square|Mean|28.6|28.6|Standard Deviation|4.14|4.14|||
4326645|NCT00450112|4153973|B3|United States||Region of Enrollment||participants|Number|196|196.0||||||
4326646|NCT00450112|4153974|B2|United States||Region of Enrollment||participants|Number|74|74.0||||||
4326647|NCT00450112|4153975|B1|United States||Region of Enrollment||participants|Number|122|122.0||||||
4326648|NCT00450112|4153973|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4326649|NCT00450112|4153974|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4326650|NCT00450112|4153975|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4326651|NCT00450112|4153973|B3||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4326652|NCT00450112|4153974|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4326653|NCT00450112|4153975|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4326654|NCT00450112|4153973|B3|||Age||years|Mean|61.4|61.4|Standard Deviation|10.35|10.35|||
4326655|NCT00450112|4153974|B2|||Age||years|Mean|61.6|61.6|Standard Deviation|10.50|10.5|||
4326656|NCT00450112|4153975|B1|||Age||years|Mean|61.4|61.4|Standard Deviation|10.29|10.29|||
4326657|NCT00450073|4153998|B4|United States||Region of Enrollment||participants|Number|30|30.0||||||
4326658|NCT00450073|4153999|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4326659|NCT00450073|4154000|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4326660|NCT00450073|4154001|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4326661|NCT00450073|4153998|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4326662|NCT00450073|4153999|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4326663|NCT00450073|4154000|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4326664|NCT00450073|4154001|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4326665|NCT00450073|4153998|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4326666|NCT00450073|4153999|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4326667|NCT00450073|4154000|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4326671|NCT00450073|4154000|B2|||Age||years|Mean|27.9|27.9|Standard Deviation|11.9|11.9|||
4326672|NCT00450073|4154001|B1|||Age||years|Mean|35.7|35.7|Standard Deviation|12.5|12.5|||
4326673|NCT00450073|4153998|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4326674|NCT00450073|4153999|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4326675|NCT00450073|4154000|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4326676|NCT00450073|4154001|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4326677|NCT00450073|4153998|B4||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4326678|NCT00450073|4153999|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4326679|NCT00450073|4154000|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4326680|NCT00450073|4154001|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4326681|NCT00450073|4153998|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4326682|NCT00450073|4153999|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4326683|NCT00450073|4154000|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4326684|NCT00450073|4154001|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4326685|NCT00449956|4154011|B4|||Intraocular pressure (IOP) at Hour 2||mmHg|Mean|20.42|20.42|Standard Deviation|2.13|2.13|||
4326686|NCT00449956|4154012|B3|||Intraocular pressure (IOP) at Hour 2||mmHg|Mean|20.38|20.38|Standard Deviation|2.31|2.31|||
4326687|NCT00449956|4154013|B2|||Intraocular pressure (IOP) at Hour 2||mmHg|Mean|20.23|20.23|Standard Deviation|1.85|1.85|||
4326688|NCT00449956|4154014|B1|||Intraocular pressure (IOP) at Hour 2||mmHg|Mean|20.54|20.54|Standard Deviation|2.07|2.07|||
4326689|NCT00449956|4154011|B4|Ocular hypertension||Diagnosis||participants|Number|208|208.0||||||
4326690|NCT00449956|4154012|B3|Ocular hypertension||Diagnosis||participants|Number|99|99.0||||||
4326691|NCT00449956|4154013|B2|Ocular hypertension||Diagnosis||participants|Number|35|35.0||||||
4326692|NCT00449956|4154014|B1|Ocular hypertension||Diagnosis||participants|Number|74|74.0||||||
4326693|NCT00449956|4154011|B4|Normal-tension glaucoma||Diagnosis||participants|Number|18|18.0||||||
4326694|NCT00449956|4154012|B3|Normal-tension glaucoma||Diagnosis||participants|Number|4|4.0||||||
4326695|NCT00449956|4154013|B2|Normal-tension glaucoma||Diagnosis||participants|Number|6|6.0||||||
4326696|NCT00449956|4154014|B1|Normal-tension glaucoma||Diagnosis||participants|Number|8|8.0||||||
4326697|NCT00449956|4154011|B4|Open-angle glaucoma||Diagnosis||participants|Number|248|248.0||||||
4326698|NCT00449956|4154012|B3|Open-angle glaucoma||Diagnosis||participants|Number|90|90.0||||||
4326699|NCT00449956|4154013|B2|Open-angle glaucoma||Diagnosis||participants|Number|51|51.0||||||
4326700|NCT00449956|4154014|B1|Open-angle glaucoma||Diagnosis||participants|Number|107|107.0||||||
4326701|NCT00449956|4154011|B4||Male|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4326702|NCT00449956|4154012|B3||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4326703|NCT00449956|4154013|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4326704|NCT00449956|4154014|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4326705|NCT00449956|4154011|B4||Female|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4326706|NCT00449956|4154012|B3||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4326707|NCT00449956|4154013|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4326708|NCT00449956|4154014|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4326709|NCT00449956|4154011|B4|>=65 years||Age, Customized||participants|Number|230|230.0||||||
4326710|NCT00449956|4154012|B3|>=65 years||Age, Customized||participants|Number|91|91.0||||||
4326711|NCT00449956|4154013|B2|>=65 years||Age, Customized||participants|Number|42|42.0||||||
4326712|NCT00449956|4154014|B1|>=65 years||Age, Customized||participants|Number|97|97.0||||||
4326713|NCT00449956|4154011|B4|<65 years||Age, Customized||participants|Number|244|244.0||||||
4326714|NCT00449956|4154012|B3|<65 years||Age, Customized||participants|Number|102|102.0||||||
4326715|NCT00449956|4154013|B2|<65 years||Age, Customized||participants|Number|50|50.0||||||
4326716|NCT00449956|4154014|B1|<65 years||Age, Customized||participants|Number|92|92.0||||||
4326717|NCT00449956|4154011|B4|||Age||Years|Mean|62.4|62.4|Standard Deviation|11.7|11.7|||
4326718|NCT00449956|4154012|B3|||Age||Years|Mean|62.3|62.3|Standard Deviation|12.7|12.7|||
4326719|NCT00449956|4154013|B2|||Age||Years|Mean|61.3|61.3|Standard Deviation|11.6|11.6|||
4326720|NCT00449956|4154014|B1|||Age||Years|Mean|63.2|63.2|Standard Deviation|10.8|10.8|||
4326721|NCT00449930|4154030|B3|||Hemoglobin A1c (HbA1c)||Percent|Mean|7.3|7.3|Standard Deviation|0.7|0.7|||
4326722|NCT00449930|4154031|B2|||Hemoglobin A1c (HbA1c)||Percent|Mean|7.3|7.3|Standard Deviation|0.7|0.7|||
4326723|NCT00449930|4154032|B1|||Hemoglobin A1c (HbA1c)||Percent|Mean|7.2|7.2|Standard Deviation|0.7|0.7|||
4326724|NCT00449930|4154030|B3|||Body Weight||Kilograms|Mean|84.7|84.7|Standard Deviation|17.5|17.5|||
4326725|NCT00449930|4154031|B2|||Body Weight||Kilograms|Mean|84.6|84.6|Standard Deviation|17.2|17.2|||
4326726|NCT00449930|4154032|B1|||Body Weight||Kilograms|Mean|84.9|84.9|Standard Deviation|17.7|17.7|||
4326727|NCT00449930|4154030|B3|Other||Race/Ethnicity, Customized||participants|Number|89|89.0||||||
4326728|NCT00449930|4154031|B2|Other||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4326729|NCT00449930|4154032|B1|Other||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4326730|NCT00449930|4154030|B3|Asian||Race/Ethnicity, Customized||participants|Number|126|126.0||||||
4326731|NCT00449930|4154031|B2|Asian||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
4326732|NCT00449930|4154032|B1|Asian||Race/Ethnicity, Customized||participants|Number|64|64.0||||||
4326733|NCT00449930|4154030|B3|Black||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4326734|NCT00449930|4154031|B2|Black||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4326735|NCT00449930|4154032|B1|Black||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4326736|NCT00449930|4154030|B3|White||Race/Ethnicity, Customized||participants|Number|792|792.0||||||
4326737|NCT00449930|4154031|B2|White||Race/Ethnicity, Customized||participants|Number|395|395.0||||||
4326738|NCT00449930|4154032|B1|White||Race/Ethnicity, Customized||participants|Number|397|397.0||||||
4326739|NCT00449930|4154030|B3||Male|Sex: Female, Male||Participants|Count of Participants|484|484.0||||||
4326740|NCT00449930|4154031|B2||Male|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
4326741|NCT00449930|4154032|B1||Male|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
4326742|NCT00449930|4154030|B3||Female|Sex: Female, Male||Participants|Count of Participants|566|566.0||||||
4326743|NCT00449930|4154031|B2||Female|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
4326744|NCT00449930|4154032|B1||Female|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
4326745|NCT00449930|4154030|B3|||Age||years|Mean|56.0|56.0|Standard Deviation|10.6|10.6|||
4326746|NCT00449930|4154031|B2|||Age||years|Mean|56.1|56.1|Standard Deviation|10.4|10.4|||
4326747|NCT00449930|4154032|B1|||Age||years|Mean|55.9|55.9|Standard Deviation|10.7|10.7|||
4326748|NCT00449865|4154047|B3|||Total Unified Parkinson's Disease Rating Scale (UPDRS)|The total UPDRS is the sum of parts I, II, and III. The possible range of the total UPDRS is from 0-176. Higher values indicate worse outcomes.|units on a scale|Mean|26.2|26.2|Standard Deviation|11.4|11.4|||
4326749|NCT00449865|4154048|B2|||Total Unified Parkinson's Disease Rating Scale (UPDRS)|The total UPDRS is the sum of parts I, II, and III. The possible range of the total UPDRS is from 0-176. Higher values indicate worse outcomes.|units on a scale|Mean|26.5|26.5|Standard Deviation|11.7|11.7|||
4326750|NCT00449865|4154049|B1|||Total Unified Parkinson's Disease Rating Scale (UPDRS)|The total UPDRS is the sum of parts I, II, and III. The possible range of the total UPDRS is from 0-176. Higher values indicate worse outcomes.|units on a scale|Mean|25.9|25.9|Standard Deviation|11|11.0|||
4326751|NCT00449865|4154047|B3|||Time since diagnosis, y||years|Mean|1.5|1.5|Standard Deviation|1.1|1.1|||
4326752|NCT00449865|4154048|B2|||Time since diagnosis, y||years|Mean|1.5|1.5|Standard Deviation|1.1|1.1|||
4326753|NCT00449865|4154049|B1|||Time since diagnosis, y||years|Mean|1.6|1.6|Standard Deviation|1.1|1.1|||
4326754|NCT00449865|4154047|B3||Male|Sex: Female, Male||Participants|Count of Participants|1123|1123.0||||||
4326755|NCT00449865|4154048|B2||Male|Sex: Female, Male||Participants|Count of Participants|569|569.0||||||
4326756|NCT00449865|4154049|B1||Male|Sex: Female, Male||Participants|Count of Participants|554|554.0||||||
4326757|NCT00449865|4154047|B3||Female|Sex: Female, Male||Participants|Count of Participants|618|618.0||||||
4326758|NCT00449865|4154048|B2||Female|Sex: Female, Male||Participants|Count of Participants|305|305.0||||||
4326759|NCT00449865|4154049|B1||Female|Sex: Female, Male||Participants|Count of Participants|313|313.0||||||
4326760|NCT00449865|4154047|B3|||Age||years|Mean|61.8|61.8|Standard Deviation|9.6|9.6|||
4326761|NCT00449865|4154048|B2|||Age||years|Mean|62.1|62.1|Standard Deviation|9.7|9.7|||
4326762|NCT00449865|4154049|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|9.6|9.6|||
4326763|NCT00449787|4154056|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4326764|NCT00449787|4154057|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4326765|NCT00449787|4154058|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4326766|NCT00449787|4154056|B3||Female|Sex: Female, Male||Participants|Count of Participants|341|341.0||||||
4326767|NCT00449787|4154057|B2||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4326768|NCT00449787|4154058|B1||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4326769|NCT00449787|4154056|B3|||Age||years|Mean|36|36.0|Standard Deviation|10|10.0|||
4326770|NCT00449787|4154057|B2|||Age||years|Mean|35|35.0|Standard Deviation|10|10.0|||
4326771|NCT00449787|4154058|B1|||Age||years|Mean|36|36.0|Standard Deviation|10|10.0|||
4326772|NCT00449748|4154069|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4326773|NCT00449748|4154069|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4326774|NCT00449748|4154069|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4326775|NCT00449748|4154069|B1|||Age||years|Median|56|56.0|Full Range|||43.0|75.0|
4326776|NCT00449696|4154073|B3|||Physician Global Evaluations|Observed physician evaluations on Visual Analog Scale (VAS) of 100 mm.; 0 mm meaning excellent feeling in knee joint; 100 mm meaning poor feeling in knee joint.|scores on a scale|Mean|62.4|62.4|Standard Deviation|14.65|14.65|||
4326777|NCT00449696|4154074|B2|||Physician Global Evaluations|Observed physician evaluations on Visual Analog Scale (VAS) of 100 mm.; 0 mm meaning excellent feeling in knee joint; 100 mm meaning poor feeling in knee joint.|scores on a scale|Mean|64.2|64.2|Standard Deviation|14.25|14.25|||
4326778|NCT00449696|4154075|B1|||Physician Global Evaluations|Observed physician evaluations on Visual Analog Scale (VAS) of 100 mm.; 0 mm meaning excellent feeling in knee joint; 100 mm meaning poor feeling in knee joint.|scores on a scale|Mean|61.5|61.5|Standard Deviation|14.79|14.79|||
4326779|NCT00449696|4154073|B3|||Subject Global Evaluations|Observed subject evaluations on Visual Analog Scale (VAS) of 100 mm.; 0 mm meaning excellent feeling in knee joint; 100 mm meaning poor feeling in knee joint.|scores on a scale|Mean|65.3|65.3|Standard Deviation|21.61|21.61|||
4326780|NCT00449696|4154074|B2|||Subject Global Evaluations|Observed subject evaluations on Visual Analog Scale (VAS) of 100 mm.; 0 mm meaning excellent feeling in knee joint; 100 mm meaning poor feeling in knee joint.|scores on a scale|Mean|66.5|66.5|Standard Deviation|21.21|21.21|||
4326781|NCT00449696|4154075|B1|||Subject Global Evaluations|Observed subject evaluations on Visual Analog Scale (VAS) of 100 mm.; 0 mm meaning excellent feeling in knee joint; 100 mm meaning poor feeling in knee joint.|scores on a scale|Mean|64.7|64.7|Standard Deviation|21.83|21.83|||
4326782|NCT00449696|4154073|B3|||WOMAC VAS Total Score|Mean of Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Visual Analog Scale (VAS) pain, stiffness and physical function subscores on VAS of 100 mm.; 0 mm meaning no pain, stiffness and difficulty; 100 mm meaning extreme pain, stiffness and difficulty.|scores on a scale|Mean|68.9|68.9|Standard Deviation|15.56|15.56|||
4326783|NCT00449696|4154074|B2|||WOMAC VAS Total Score|Mean of Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Visual Analog Scale (VAS) pain, stiffness and physical function subscores on VAS of 100 mm.; 0 mm meaning no pain, stiffness and difficulty; 100 mm meaning extreme pain, stiffness and difficulty.|scores on a scale|Mean|67.8|67.8|Standard Deviation|14.68|14.68|||
4326784|NCT00449696|4154075|B1|||WOMAC VAS Total Score|Mean of Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Visual Analog Scale (VAS) pain, stiffness and physical function subscores on VAS of 100 mm.; 0 mm meaning no pain, stiffness and difficulty; 100 mm meaning extreme pain, stiffness and difficulty.|scores on a scale|Mean|69.5|69.5|Standard Deviation|15.99|15.99|||
4326785|NCT00449696|4154073|B3|||WOMAC VAS Physical Function Subcore|Assessed Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Visual Analog Scale (VAS) physical function subscores on VAS of 100 mm.; 0 mm meaning no difficulty; 100 mm meaning extreme difficulty.|scores on a scale|Mean|68.5|68.5|Standard Deviation|16.87|16.87|||
4326786|NCT00449696|4154074|B2|||WOMAC VAS Physical Function Subcore|Assessed Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Visual Analog Scale (VAS) physical function subscores on VAS of 100 mm.; 0 mm meaning no difficulty; 100 mm meaning extreme difficulty.|scores on a scale|Mean|67.6|67.6|Standard Deviation|15.80|15.8|||
4326787|NCT00449696|4154075|B1|||WOMAC VAS Physical Function Subcore|Assessed Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Visual Analog Scale (VAS) physical function subscores on VAS of 100 mm.; 0 mm meaning no difficulty; 100 mm meaning extreme difficulty.|scores on a scale|Mean|68.9|68.9|Standard Deviation|17.41|17.41|||
4326788|NCT00449696|4154073|B3|||WOMAC VAS Stiffness Subscore|Assessed Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Visual Analog Scale (VAS) stiffness subscores on VAS of 100 mm.; 0 mm meaning no stiffness; 100 mm meaning extreme stiffness.|scores on a scale|Mean|70.8|70.8|Standard Deviation|17.43|17.43|||
4326789|NCT00449696|4154074|B2|||WOMAC VAS Stiffness Subscore|Assessed Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Visual Analog Scale (VAS) stiffness subscores on VAS of 100 mm.; 0 mm meaning no stiffness; 100 mm meaning extreme stiffness.|scores on a scale|Mean|69.3|69.3|Standard Deviation|17.31|17.31|||
4326790|NCT00449696|4154075|B1|||WOMAC VAS Stiffness Subscore|Assessed Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Visual Analog Scale (VAS) stiffness subscores on VAS of 100 mm.; 0 mm meaning no stiffness; 100 mm meaning extreme stiffness.|scores on a scale|Mean|71.6|71.6|Standard Deviation|17.48|17.48|||
4326791|NCT00449696|4154073|B3|||WOMAC VAS Pain Subscore|Assessed Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Visual Analog Scale (VAS) pain subscores on VAS of 100 mm.; 0 mm meaning no pain; 100 mm meaning extreme pain.|scores on a scale|Mean|69.8|69.8|Standard Deviation|14.01|14.01|||
4326792|NCT00449696|4154074|B2|||WOMAC VAS Pain Subscore|Assessed Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Visual Analog Scale (VAS) pain subscores on VAS of 100 mm.; 0 mm meaning no pain; 100 mm meaning extreme pain.|scores on a scale|Mean|68.0|68.0|Standard Deviation|13.05|13.05|||
4326793|NCT00449696|4154075|B1|||WOMAC VAS Pain Subscore|Assessed Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Visual Analog Scale (VAS) pain subscores on VAS of 100 mm.; 0 mm meaning no pain; 100 mm meaning extreme pain.|scores on a scale|Mean|70.7|70.7|Standard Deviation|14.42|14.42|||
4326794|NCT00449696|4154073|B3|||Body Mass Index (BMI)||kilograms/meters square|Mean|28.5|28.5|Standard Deviation|4.04|4.04|||
4326795|NCT00449696|4154074|B2|||Body Mass Index (BMI)||kilograms/meters square|Mean|28.7|28.7|Standard Deviation|3.83|3.83|||
4326796|NCT00449696|4154075|B1|||Body Mass Index (BMI)||kilograms/meters square|Mean|28.3|28.3|Standard Deviation|4.14|4.14|||
4326797|NCT00449696|4154073|B3|United States||Region of Enrollment||participants|Number|375|375.0||||||
4326798|NCT00449696|4154074|B2|United States||Region of Enrollment||participants|Number|128|128.0||||||
4326799|NCT00449696|4154075|B1|United States||Region of Enrollment||participants|Number|247|247.0||||||
4326800|NCT00449696|4154073|B3||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4326801|NCT00449696|4154074|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4326802|NCT00449696|4154075|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4326803|NCT00449696|4154073|B3||Female|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
4326804|NCT00449696|4154074|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4326805|NCT00449696|4154075|B1||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4326806|NCT00449696|4154073|B3|||Age||years|Mean|60.7|60.7|Standard Deviation|10.14|10.14|||
4326807|NCT00449696|4154074|B2|||Age||years|Mean|60.3|60.3|Standard Deviation|9.97|9.97|||
4326808|NCT00449696|4154075|B1|||Age||years|Mean|60.9|60.9|Standard Deviation|10.24|10.24|||
4326809|NCT00449644|4154098|B5||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4326810|NCT00449644|4154099|B4||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4326811|NCT00449644|4154100|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4326812|NCT00449644|4154101|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4326813|NCT00449644|4154102|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4326814|NCT00449644|4154098|B5||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4326815|NCT00449644|4154099|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4326816|NCT00449644|4154100|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4326817|NCT00449644|4154101|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4326818|NCT00449644|4154102|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4326819|NCT00449644|4154098|B5|||Age||years|Mean|35.7|35.7|Standard Deviation|11.88|11.88|||
4326820|NCT00449644|4154099|B4|||Age||years|Mean|35.8|35.8|Standard Deviation|11.01|11.01|||
4326821|NCT00449644|4154100|B3|||Age||years|Mean|36.2|36.2|Standard Deviation|13.13|13.13|||
4326822|NCT00449644|4154101|B2|||Age||years|Mean|33.6|33.6|Standard Deviation|11.04|11.04|||
4326823|NCT00449644|4154102|B1|||Age||years|Mean|35.6|35.6|Standard Deviation|11.66|11.66|||
4326824|NCT00449540|4154123|B3|United States||Region of Enrollment||participants|Number|201|201.0||||||
4326825|NCT00449540|4154124|B2|United States||Region of Enrollment||participants|Number|99|99.0||||||
4326826|NCT00449540|4154125|B1|United States||Region of Enrollment||participants|Number|102|102.0||||||
4326827|NCT00449540|4154123|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4326828|NCT00449540|4154124|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4326829|NCT00449540|4154125|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4326830|NCT00449540|4154123|B3||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4326831|NCT00449540|4154124|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4326832|NCT00449540|4154125|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4326833|NCT00449540|4154123|B3|||Age||years|Mean|39.4|39.4|Standard Deviation|11.0|11.0|||
4326834|NCT00449540|4154124|B2|||Age||years|Mean|40.1|40.1|Standard Deviation|10.83|10.83|||
4326835|NCT00449540|4154125|B1|||Age||years|Mean|38.8|38.8|Standard Deviation|11.2|11.2|||
4326836|NCT00449540|4154123|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4326837|NCT00449540|4154124|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4326838|NCT00449540|4154125|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4326839|NCT00449540|4154123|B3||Between 18 and 65 years|Age||Participants|Count of Participants|201|201.0||||||
4326840|NCT00449540|4154124|B2||Between 18 and 65 years|Age||Participants|Count of Participants|99|99.0||||||
4326841|NCT00449540|4154125|B1||Between 18 and 65 years|Age||Participants|Count of Participants|102|102.0||||||
4326842|NCT00449540|4154123|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4326843|NCT00449540|4154124|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4326844|NCT00449540|4154125|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4326845|NCT00449176|4154141|B4||Male|Sex: Female, Male||Participants|Count of Participants|406|406.0||||||
4326846|NCT00449176|4154142|B3||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4326847|NCT00449176|4154143|B2||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4326848|NCT00449176|4154144|B1||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4326849|NCT00449176|4154141|B4||Female|Sex: Female, Male||Participants|Count of Participants|559|559.0||||||
4326850|NCT00449176|4154142|B3||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4326851|NCT00449176|4154143|B2||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4326852|NCT00449176|4154144|B1||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4326853|NCT00449176|4154141|B4|||Age||years|Mean|49.9|49.9|Standard Deviation|13.83|13.83|||
4326854|NCT00449176|4154142|B3|||Age||years|Mean|50.4|50.4|Standard Deviation|14.05|14.05|||
4326855|NCT00449176|4154143|B2|||Age||years|Mean|50.0|50.0|Standard Deviation|14.21|14.21|||
4326856|NCT00449176|4154144|B1|||Age||years|Mean|49.4|49.4|Standard Deviation|13.21|13.21|||
4326857|NCT00449163|4154172|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4326858|NCT00449163|4154172|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4326859|NCT00449163|4154172|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4326860|NCT00449163|4154172|B1|||Age||years|Median|57|57.0|Full Range|||38.0|82.0|
4326861|NCT00449163|4154172|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4326862|NCT00449163|4154172|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4326863|NCT00449163|4154172|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4326864|NCT00449150|4154179|B4|Germany||Region of Enrollment||participants|Number|83|83.0||||||
4326865|NCT00449150|4154180|B3|Germany||Region of Enrollment||participants|Number|27|27.0||||||
4326866|NCT00449150|4154181|B2|Germany||Region of Enrollment||participants|Number|28|28.0||||||
4326867|NCT00449150|4154182|B1|Germany||Region of Enrollment||participants|Number|28|28.0||||||
4326868|NCT00449150|4154179|B4|Bulgaria||Region of Enrollment||participants|Number|35|35.0||||||
4326869|NCT00449150|4154180|B3|Bulgaria||Region of Enrollment||participants|Number|12|12.0||||||
4326870|NCT00449150|4154181|B2|Bulgaria||Region of Enrollment||participants|Number|12|12.0||||||
4326871|NCT00449150|4154182|B1|Bulgaria||Region of Enrollment||participants|Number|11|11.0||||||
4326872|NCT00449150|4154179|B4|Canada||Region of Enrollment||participants|Number|119|119.0||||||
4326873|NCT00449150|4154180|B3|Canada||Region of Enrollment||participants|Number|39|39.0||||||
4326874|NCT00449150|4154181|B2|Canada||Region of Enrollment||participants|Number|42|42.0||||||
4326875|NCT00449150|4154182|B1|Canada||Region of Enrollment||participants|Number|38|38.0||||||
4326876|NCT00449150|4154179|B4|United States||Region of Enrollment||participants|Number|430|430.0||||||
4326877|NCT00449150|4154180|B3|United States||Region of Enrollment||participants|Number|140|140.0||||||
4326878|NCT00449150|4154181|B2|United States||Region of Enrollment||participants|Number|148|148.0||||||
4326879|NCT00449150|4154182|B1|United States||Region of Enrollment||participants|Number|142|142.0||||||
4326880|NCT00449150|4154179|B4||Male|Sex: Female, Male||Participants|Count of Participants|667|667.0||||||
4326881|NCT00449150|4154180|B3||Male|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4326882|NCT00449150|4154181|B2||Male|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4326883|NCT00449150|4154182|B1||Male|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
4326884|NCT00449150|4154179|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4326885|NCT00449150|4154180|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4326886|NCT00449150|4154181|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4326887|NCT00449150|4154182|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4326888|NCT00449150|4154179|B4|||Age||years|Mean|64.03|64.03|Standard Deviation|7.84|7.84|||
4326889|NCT00449150|4154180|B3|||Age||years|Mean|64.20|64.2|Standard Deviation|7.76|7.76|||
4326890|NCT00449150|4154181|B2|||Age||years|Mean|64.04|64.04|Standard Deviation|7.54|7.54|||
4326891|NCT00449150|4154182|B1|||Age||years|Mean|63.86|63.86|Standard Deviation|8.27|8.27|||
4326892|NCT00449150|4154179|B4||>=65 years|Age||Participants|Count of Participants|321|321.0||||||
4326893|NCT00449150|4154180|B3||>=65 years|Age||Participants|Count of Participants|107|107.0||||||
4326894|NCT00449150|4154181|B2||>=65 years|Age||Participants|Count of Participants|104|104.0||||||
4326895|NCT00449150|4154182|B1||>=65 years|Age||Participants|Count of Participants|110|110.0||||||
4326896|NCT00449150|4154179|B4||Between 18 and 65 years|Age||Participants|Count of Participants|346|346.0||||||
4326897|NCT00449150|4154180|B3||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
4326898|NCT00449150|4154181|B2||Between 18 and 65 years|Age||Participants|Count of Participants|126|126.0||||||
4326899|NCT00449150|4154182|B1||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
4326900|NCT00449150|4154179|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4326901|NCT00449150|4154180|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4326902|NCT00449150|4154181|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4326903|NCT00449150|4154182|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4326904|NCT00449072|4154195|B3|Stage 5||Tanner classification at randomization|Tanner classification distinguishes stages of puberty. Each stage differentiates the extent of breast, genitalia and pubic hair growth. Tanner Stage I represents the preadolescent stage where breast, genitalia and pubic hair growth are of the same size and shape as in early childhood; and in Tanner Stage 5 breasts and genitalia are of adult shape and size, and pubic hair is adult in quantity (mature stage). Stages 2, 3 and 4 are intermediate stages.|participants|Number|0|0.0||||||
4326905|NCT00449072|4154196|B2|Stage 5||Tanner classification at randomization|Tanner classification distinguishes stages of puberty. Each stage differentiates the extent of breast, genitalia and pubic hair growth. Tanner Stage I represents the preadolescent stage where breast, genitalia and pubic hair growth are of the same size and shape as in early childhood; and in Tanner Stage 5 breasts and genitalia are of adult shape and size, and pubic hair is adult in quantity (mature stage). Stages 2, 3 and 4 are intermediate stages.|participants|Number|0|0.0||||||
4326906|NCT00449072|4154197|B1|Stage 5||Tanner classification at randomization|Tanner classification distinguishes stages of puberty. Each stage differentiates the extent of breast, genitalia and pubic hair growth. Tanner Stage I represents the preadolescent stage where breast, genitalia and pubic hair growth are of the same size and shape as in early childhood; and in Tanner Stage 5 breasts and genitalia are of adult shape and size, and pubic hair is adult in quantity (mature stage). Stages 2, 3 and 4 are intermediate stages.|participants|Number|0|0.0||||||
4326907|NCT00449072|4154195|B3|Stage 4||Tanner classification at randomization|Tanner classification distinguishes stages of puberty. Each stage differentiates the extent of breast, genitalia and pubic hair growth. Tanner Stage I represents the preadolescent stage where breast, genitalia and pubic hair growth are of the same size and shape as in early childhood; and in Tanner Stage 5 breasts and genitalia are of adult shape and size, and pubic hair is adult in quantity (mature stage). Stages 2, 3 and 4 are intermediate stages.|participants|Number|0|0.0||||||
4326908|NCT00449072|4154196|B2|Stage 4||Tanner classification at randomization|Tanner classification distinguishes stages of puberty. Each stage differentiates the extent of breast, genitalia and pubic hair growth. Tanner Stage I represents the preadolescent stage where breast, genitalia and pubic hair growth are of the same size and shape as in early childhood; and in Tanner Stage 5 breasts and genitalia are of adult shape and size, and pubic hair is adult in quantity (mature stage). Stages 2, 3 and 4 are intermediate stages.|participants|Number|0|0.0||||||
4326909|NCT00449072|4154197|B1|Stage 4||Tanner classification at randomization|Tanner classification distinguishes stages of puberty. Each stage differentiates the extent of breast, genitalia and pubic hair growth. Tanner Stage I represents the preadolescent stage where breast, genitalia and pubic hair growth are of the same size and shape as in early childhood; and in Tanner Stage 5 breasts and genitalia are of adult shape and size, and pubic hair is adult in quantity (mature stage). Stages 2, 3 and 4 are intermediate stages.|participants|Number|0|0.0||||||
4326910|NCT00449072|4154195|B3|Stage 3||Tanner classification at randomization|Tanner classification distinguishes stages of puberty. Each stage differentiates the extent of breast, genitalia and pubic hair growth. Tanner Stage I represents the preadolescent stage where breast, genitalia and pubic hair growth are of the same size and shape as in early childhood; and in Tanner Stage 5 breasts and genitalia are of adult shape and size, and pubic hair is adult in quantity (mature stage). Stages 2, 3 and 4 are intermediate stages.|participants|Number|0|0.0||||||
4326911|NCT00449072|4154196|B2|Stage 3||Tanner classification at randomization|Tanner classification distinguishes stages of puberty. Each stage differentiates the extent of breast, genitalia and pubic hair growth. Tanner Stage I represents the preadolescent stage where breast, genitalia and pubic hair growth are of the same size and shape as in early childhood; and in Tanner Stage 5 breasts and genitalia are of adult shape and size, and pubic hair is adult in quantity (mature stage). Stages 2, 3 and 4 are intermediate stages.|participants|Number|0|0.0||||||
4326912|NCT00449072|4154197|B1|Stage 3||Tanner classification at randomization|Tanner classification distinguishes stages of puberty. Each stage differentiates the extent of breast, genitalia and pubic hair growth. Tanner Stage I represents the preadolescent stage where breast, genitalia and pubic hair growth are of the same size and shape as in early childhood; and in Tanner Stage 5 breasts and genitalia are of adult shape and size, and pubic hair is adult in quantity (mature stage). Stages 2, 3 and 4 are intermediate stages.|participants|Number|0|0.0||||||
4326913|NCT00449072|4154195|B3|Stage 2||Tanner classification at randomization|Tanner classification distinguishes stages of puberty. Each stage differentiates the extent of breast, genitalia and pubic hair growth. Tanner Stage I represents the preadolescent stage where breast, genitalia and pubic hair growth are of the same size and shape as in early childhood; and in Tanner Stage 5 breasts and genitalia are of adult shape and size, and pubic hair is adult in quantity (mature stage). Stages 2, 3 and 4 are intermediate stages.|participants|Number|0|0.0||||||
4326914|NCT00449072|4154196|B2|Stage 2||Tanner classification at randomization|Tanner classification distinguishes stages of puberty. Each stage differentiates the extent of breast, genitalia and pubic hair growth. Tanner Stage I represents the preadolescent stage where breast, genitalia and pubic hair growth are of the same size and shape as in early childhood; and in Tanner Stage 5 breasts and genitalia are of adult shape and size, and pubic hair is adult in quantity (mature stage). Stages 2, 3 and 4 are intermediate stages.|participants|Number|0|0.0||||||
4326915|NCT00449072|4154197|B1|Stage 2||Tanner classification at randomization|Tanner classification distinguishes stages of puberty. Each stage differentiates the extent of breast, genitalia and pubic hair growth. Tanner Stage I represents the preadolescent stage where breast, genitalia and pubic hair growth are of the same size and shape as in early childhood; and in Tanner Stage 5 breasts and genitalia are of adult shape and size, and pubic hair is adult in quantity (mature stage). Stages 2, 3 and 4 are intermediate stages.|participants|Number|0|0.0||||||
4326916|NCT00449072|4154195|B3|Stage 1||Tanner classification at randomization|Tanner classification distinguishes stages of puberty. Each stage differentiates the extent of breast, genitalia and pubic hair growth. Tanner Stage I represents the preadolescent stage where breast, genitalia and pubic hair growth are of the same size and shape as in early childhood; and in Tanner Stage 5 breasts and genitalia are of adult shape and size, and pubic hair is adult in quantity (mature stage). Stages 2, 3 and 4 are intermediate stages.|participants|Number|299|299.0||||||
4326917|NCT00449072|4154196|B2|Stage 1||Tanner classification at randomization|Tanner classification distinguishes stages of puberty. Each stage differentiates the extent of breast, genitalia and pubic hair growth. Tanner Stage I represents the preadolescent stage where breast, genitalia and pubic hair growth are of the same size and shape as in early childhood; and in Tanner Stage 5 breasts and genitalia are of adult shape and size, and pubic hair is adult in quantity (mature stage). Stages 2, 3 and 4 are intermediate stages.|participants|Number|151|151.0||||||
4326918|NCT00449072|4154197|B1|Stage 1||Tanner classification at randomization|Tanner classification distinguishes stages of puberty. Each stage differentiates the extent of breast, genitalia and pubic hair growth. Tanner Stage I represents the preadolescent stage where breast, genitalia and pubic hair growth are of the same size and shape as in early childhood; and in Tanner Stage 5 breasts and genitalia are of adult shape and size, and pubic hair is adult in quantity (mature stage). Stages 2, 3 and 4 are intermediate stages.|participants|Number|148|148.0||||||
4326919|NCT00449072|4154195|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|243|243.0||||||
4326920|NCT00449072|4154196|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|118|118.0||||||
4326921|NCT00449072|4154197|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|125|125.0||||||
4326922|NCT00449072|4154195|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
4326923|NCT00449072|4154196|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4326924|NCT00449072|4154197|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4326925|NCT00449072|4154195|B3|Other||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4326926|NCT00449072|4154196|B2|Other||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4326927|NCT00449072|4154197|B1|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4326928|NCT00449072|4154195|B3|Native Hawaiian or other Pacific Island||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4326929|NCT00449072|4154196|B2|Native Hawaiian or other Pacific Island||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4326930|NCT00449072|4154197|B1|Native Hawaiian or other Pacific Island||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4326931|NCT00449072|4154195|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4326932|NCT00449072|4154196|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4326933|NCT00449072|4154197|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4326934|NCT00449072|4154195|B3|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4326935|NCT00449072|4154196|B2|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4326936|NCT00449072|4154197|B1|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4326937|NCT00449072|4154195|B3|Black||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
4326938|NCT00449072|4154196|B2|Black||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4326939|NCT00449072|4154197|B1|Black||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4326940|NCT00449072|4154195|B3|Caucasian/White||Race/Ethnicity, Customized||participants|Number|225|225.0||||||
4326941|NCT00449072|4154196|B2|Caucasian/White||Race/Ethnicity, Customized||participants|Number|111|111.0||||||
4326942|NCT00449072|4154197|B1|Caucasian/White||Race/Ethnicity, Customized||participants|Number|114|114.0||||||
4326943|NCT00449072|4154195|B3|Female||Sex/Gender, Customized||participants|Number|126|126.0||||||
4326944|NCT00449072|4154196|B2|Female||Sex/Gender, Customized||participants|Number|64|64.0||||||
4326945|NCT00449072|4154197|B1|Female||Sex/Gender, Customized||participants|Number|62|62.0||||||
4326946|NCT00449072|4154195|B3|Male||Sex/Gender, Customized||participants|Number|173|173.0||||||
4326947|NCT00449072|4154196|B2|Male||Sex/Gender, Customized||participants|Number|87|87.0||||||
4326948|NCT00449072|4154197|B1|Male||Sex/Gender, Customized||participants|Number|86|86.0||||||
4326949|NCT00449072|4154195|B3|<=6 to <10 years||Age, Customized|Age group at screening.|participants|Number|170|170.0||||||
4326950|NCT00449072|4154196|B2|<=6 to <10 years||Age, Customized|Age group at screening.|participants|Number|86|86.0||||||
4326951|NCT00449072|4154197|B1|<=6 to <10 years||Age, Customized|Age group at screening.|participants|Number|84|84.0||||||
4326952|NCT00449072|4154195|B3|<=3 to <6 years||Age, Customized|Age group at screening.|participants|Number|129|129.0||||||
4326953|NCT00449072|4154196|B2|<=3 to <6 years||Age, Customized|Age group at screening.|participants|Number|65|65.0||||||
4326954|NCT00449072|4154197|B1|<=3 to <6 years||Age, Customized|Age group at screening.|participants|Number|64|64.0||||||
4326955|NCT00449072|4154195|B3|||Age|Age at screening|years|Mean|6.18|6.18|Standard Deviation|1.58|1.58|||
4326956|NCT00449072|4154196|B2|||Age|Age at screening|years|Mean|6.12|6.12|Standard Deviation|1.62|1.62|||
4326957|NCT00449072|4154197|B1|||Age|Age at screening|years|Mean|6.24|6.24|Standard Deviation|1.55|1.55|||
4326958|NCT00449046|4154222|B1|White||Race/Ethnicity, Customized|One participant counted twice due to having multiple races.|participants|Number|1|1.0||||||
4326959|NCT00449046|4154222|B1|Asian||Race/Ethnicity, Customized|One participant counted twice due to having multiple races.|participants|Number|39|39.0||||||
4326960|NCT00449046|4154222|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4326961|NCT00449046|4154222|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4326962|NCT00449046|4154222|B1|||Age||years|Mean|8.7|8.7|Standard Deviation|2.50|2.5|||
4326963|NCT00449033|4154233|B3|1||ECOG (Eastern Cooperative Oncology Group) Performance Status at randomization|ECOG 0 versus 1 was a stratification factor for randomization. ECOG Performance Status is a rating of daily living abilities, from 0 to 5: 0= fully active without restriction. 1= restricted in physically strenuous activity; 2= ambulatory, capable of all selfcare; 3= capable of limited selfcare; 4= completely disabled; 5= dead.|Participants|Number|553|553.0||||||
4326964|NCT00449033|4154234|B2|1||ECOG (Eastern Cooperative Oncology Group) Performance Status at randomization|ECOG 0 versus 1 was a stratification factor for randomization. ECOG Performance Status is a rating of daily living abilities, from 0 to 5: 0= fully active without restriction. 1= restricted in physically strenuous activity; 2= ambulatory, capable of all selfcare; 3= capable of limited selfcare; 4= completely disabled; 5= dead.|Participants|Number|277|277.0||||||
4326965|NCT00449033|4154235|B1|1||ECOG (Eastern Cooperative Oncology Group) Performance Status at randomization|ECOG 0 versus 1 was a stratification factor for randomization. ECOG Performance Status is a rating of daily living abilities, from 0 to 5: 0= fully active without restriction. 1= restricted in physically strenuous activity; 2= ambulatory, capable of all selfcare; 3= capable of limited selfcare; 4= completely disabled; 5= dead.|Participants|Number|276|276.0||||||
4326966|NCT00449033|4154233|B3|0||ECOG (Eastern Cooperative Oncology Group) Performance Status at randomization|ECOG 0 versus 1 was a stratification factor for randomization. ECOG Performance Status is a rating of daily living abilities, from 0 to 5: 0= fully active without restriction. 1= restricted in physically strenuous activity; 2= ambulatory, capable of all selfcare; 3= capable of limited selfcare; 4= completely disabled; 5= dead.|Participants|Number|351|351.0||||||
4326967|NCT00449033|4154234|B2|0||ECOG (Eastern Cooperative Oncology Group) Performance Status at randomization|ECOG 0 versus 1 was a stratification factor for randomization. ECOG Performance Status is a rating of daily living abilities, from 0 to 5: 0= fully active without restriction. 1= restricted in physically strenuous activity; 2= ambulatory, capable of all selfcare; 3= capable of limited selfcare; 4= completely disabled; 5= dead.|Participants|Number|175|175.0||||||
4326968|NCT00449033|4154235|B1|0||ECOG (Eastern Cooperative Oncology Group) Performance Status at randomization|ECOG 0 versus 1 was a stratification factor for randomization. ECOG Performance Status is a rating of daily living abilities, from 0 to 5: 0= fully active without restriction. 1= restricted in physically strenuous activity; 2= ambulatory, capable of all selfcare; 3= capable of limited selfcare; 4= completely disabled; 5= dead.|Participants|Number|176|176.0||||||
4326969|NCT00449033|4154233|B3|Stage IV||Tumor stage at randomization|Categorized information on tumor size, lymph node involvement and metastases. Stages I-IV. The higher the stage the more advanced cancer. Stage IIIB versus IV was a stratification factor for randomization. Stage IIIB (according to American Joint Committee on Cancer): primary tumor any stage, regional lymph node stage N3, no distant metastasis OR primary tumor stage T4, regional lymph node any stage, no distant metastasis. Stage IV: primary tumor any stage, regional lymph node any stage, distant metastasis present.|Participants|Number|792|792.0||||||
4326970|NCT00449033|4154234|B2|Stage IV||Tumor stage at randomization|Categorized information on tumor size, lymph node involvement and metastases. Stages I-IV. The higher the stage the more advanced cancer. Stage IIIB versus IV was a stratification factor for randomization. Stage IIIB (according to American Joint Committee on Cancer): primary tumor any stage, regional lymph node stage N3, no distant metastasis OR primary tumor stage T4, regional lymph node any stage, no distant metastasis. Stage IV: primary tumor any stage, regional lymph node any stage, distant metastasis present.|Participants|Number|397|397.0||||||
4326971|NCT00449033|4154235|B1|Stage IV||Tumor stage at randomization|Categorized information on tumor size, lymph node involvement and metastases. Stages I-IV. The higher the stage the more advanced cancer. Stage IIIB versus IV was a stratification factor for randomization. Stage IIIB (according to American Joint Committee on Cancer): primary tumor any stage, regional lymph node stage N3, no distant metastasis OR primary tumor stage T4, regional lymph node any stage, no distant metastasis. Stage IV: primary tumor any stage, regional lymph node any stage, distant metastasis present.|Participants|Number|395|395.0||||||
4326972|NCT00449033|4154233|B3|Stage III B||Tumor stage at randomization|Categorized information on tumor size, lymph node involvement and metastases. Stages I-IV. The higher the stage the more advanced cancer. Stage IIIB versus IV was a stratification factor for randomization. Stage IIIB (according to American Joint Committee on Cancer): primary tumor any stage, regional lymph node stage N3, no distant metastasis OR primary tumor stage T4, regional lymph node any stage, no distant metastasis. Stage IV: primary tumor any stage, regional lymph node any stage, distant metastasis present.|Participants|Number|112|112.0||||||
4326973|NCT00449033|4154234|B2|Stage III B||Tumor stage at randomization|Categorized information on tumor size, lymph node involvement and metastases. Stages I-IV. The higher the stage the more advanced cancer. Stage IIIB versus IV was a stratification factor for randomization. Stage IIIB (according to American Joint Committee on Cancer): primary tumor any stage, regional lymph node stage N3, no distant metastasis OR primary tumor stage T4, regional lymph node any stage, no distant metastasis. Stage IV: primary tumor any stage, regional lymph node any stage, distant metastasis present.|Participants|Number|55|55.0||||||
4327033|NCT00448864|4154349|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4326974|NCT00449033|4154235|B1|Stage III B||Tumor stage at randomization|Categorized information on tumor size, lymph node involvement and metastases. Stages I-IV. The higher the stage the more advanced cancer. Stage IIIB versus IV was a stratification factor for randomization. Stage IIIB (according to American Joint Committee on Cancer): primary tumor any stage, regional lymph node stage N3, no distant metastasis OR primary tumor stage T4, regional lymph node any stage, no distant metastasis. Stage IV: primary tumor any stage, regional lymph node any stage, distant metastasis present.|Participants|Number|57|57.0||||||
4326975|NCT00449033|4154233|B3|Not available||Smoking history||Participants|Number|1|1.0||||||
4326976|NCT00449033|4154234|B2|Not available||Smoking history||Participants|Number|0|0.0||||||
4326977|NCT00449033|4154235|B1|Not available||Smoking history||Participants|Number|1|1.0||||||
4326978|NCT00449033|4154233|B3|Past or present smoker||Smoking history||Participants|Number|680|680.0||||||
4326979|NCT00449033|4154234|B2|Past or present smoker||Smoking history||Participants|Number|342|342.0||||||
4326980|NCT00449033|4154235|B1|Past or present smoker||Smoking history||Participants|Number|338|338.0||||||
4326981|NCT00449033|4154233|B3|Passive smoker||Smoking history||Participants|Number|5|5.0||||||
4326982|NCT00449033|4154234|B2|Passive smoker||Smoking history||Participants|Number|3|3.0||||||
4326983|NCT00449033|4154235|B1|Passive smoker||Smoking history||Participants|Number|2|2.0||||||
4326984|NCT00449033|4154233|B3|Non-smoker||Smoking history||Participants|Number|218|218.0||||||
4326985|NCT00449033|4154234|B2|Non-smoker||Smoking history||Participants|Number|107|107.0||||||
4326986|NCT00449033|4154235|B1|Non-smoker||Smoking history||Participants|Number|111|111.0||||||
4326987|NCT00449033|4154233|B3|||Time since initial diagnosis||Weeks|Median|2.7|2.7|Full Range|||0.0|924.0|
4326988|NCT00449033|4154234|B2|||Time since initial diagnosis||Weeks|Median|2.9|2.9|Full Range|||0.0|924.0|
4326989|NCT00449033|4154235|B1|||Time since initial diagnosis||Weeks|Median|2.6|2.6|Full Range|||0.0|552.0|
4326990|NCT00449033|4154233|B3|Squamous||histology of the tumor||Participants|Number|132|132.0||||||
4326991|NCT00449033|4154234|B2|Squamous||histology of the tumor||Participants|Number|65|65.0||||||
4326992|NCT00449033|4154235|B1|Squamous||histology of the tumor||Participants|Number|67|67.0||||||
4326993|NCT00449033|4154233|B3|Non-squamous||histology of the tumor||Participants|Number|772|772.0||||||
4326994|NCT00449033|4154234|B2|Non-squamous||histology of the tumor||Participants|Number|387|387.0||||||
4326995|NCT00449033|4154235|B1|Non-squamous||histology of the tumor||Participants|Number|385|385.0||||||
4326996|NCT00449033|4154233|B3||Male|Sex: Female, Male||Participants|Count of Participants|581|581.0||||||
4326997|NCT00449033|4154234|B2||Male|Sex: Female, Male||Participants|Count of Participants|297|297.0||||||
4326998|NCT00449033|4154235|B1||Male|Sex: Female, Male||Participants|Count of Participants|284|284.0||||||
4326999|NCT00449033|4154233|B3||Female|Sex: Female, Male||Participants|Count of Participants|323|323.0||||||
4327000|NCT00449033|4154234|B2||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4327001|NCT00449033|4154235|B1||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4327002|NCT00449033|4154233|B3|||Age||Years|Median|59|59.0|Full Range|||22.0|82.0|
4327003|NCT00449033|4154234|B2|||Age||Years|Median|59|59.0|Full Range|||22.0|82.0|
4327004|NCT00449033|4154235|B1|||Age||Years|Median|60|60.0|Full Range|||28.0|81.0|
4327005|NCT00448916|4154270|B5||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4327006|NCT00448916|4154271|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4327007|NCT00448916|4154272|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4327008|NCT00448916|4154273|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4327009|NCT00448916|4154274|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4327010|NCT00448916|4154270|B5||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4327011|NCT00448916|4154271|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4327012|NCT00448916|4154272|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4327013|NCT00448916|4154273|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4327014|NCT00448916|4154274|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4327015|NCT00448916|4154270|B5|||Age||Years|Mean|6.74|6.74|Standard Deviation|5.35|5.35|||
4327016|NCT00448916|4154271|B4|||Age||Years|Mean|14.86|14.86|Standard Deviation|1.53|1.53|||
4327017|NCT00448916|4154272|B3|||Age||Years|Mean|9.98|9.98|Standard Deviation|1.30|1.3|||
4327018|NCT00448916|4154273|B2|||Age||Years|Mean|4.14|4.14|Standard Deviation|1.23|1.23|||
4327019|NCT00448916|4154274|B1|||Age||Years|Mean|1.18|1.18|Standard Deviation|0.57|0.57|||
4327020|NCT00448864|4154348|B4||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4327021|NCT00448864|4154349|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4327022|NCT00448864|4154350|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4327023|NCT00448864|4154351|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4327024|NCT00448864|4154348|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4327025|NCT00448864|4154349|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4327026|NCT00448864|4154350|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4327027|NCT00448864|4154351|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4327028|NCT00448864|4154348|B4||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4327029|NCT00448864|4154349|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4327030|NCT00448864|4154350|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4327031|NCT00448864|4154351|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4327032|NCT00448864|4154348|B4||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4327034|NCT00448864|4154350|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4327035|NCT00448864|4154351|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4327036|NCT00448864|4154348|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4327037|NCT00448864|4154349|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4327038|NCT00448864|4154350|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4327039|NCT00448864|4154351|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4327040|NCT00448760|4154369|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4327041|NCT00448760|4154369|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4327042|NCT00448760|4154369|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4327043|NCT00448760|4154369|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4327044|NCT00448760|4154369|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4327045|NCT00448760|4154369|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4327046|NCT00448760|4154369|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4327047|NCT00448760|4154369|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4327048|NCT00448760|4154369|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4327049|NCT00448760|4154369|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4327050|NCT00448760|4154369|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4327051|NCT00448760|4154369|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
4327052|NCT00448760|4154369|B1||Female|Gender||Participants|Count of Participants|23|23.0||||||
4327053|NCT00448760|4154369|B1|||Age||years|Mean|62|62.0|Full Range|||50.0|80.0|
4327054|NCT00448760|4154369|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4327055|NCT00448760|4154369|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4327056|NCT00448760|4154369|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4327057|NCT00448708|4154376|B3|United States||Region of Enrollment||participants|Number|222|222.0||||||
4327058|NCT00448708|4154377|B2|United States||Region of Enrollment||participants|Number|110|110.0||||||
4327059|NCT00448708|4154378|B1|United States||Region of Enrollment||participants|Number|112|112.0||||||
4327060|NCT00448708|4154376|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4327061|NCT00448708|4154377|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4327062|NCT00448708|4154378|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4327063|NCT00448708|4154376|B3||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4327064|NCT00448708|4154377|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4327065|NCT00448708|4154378|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4327066|NCT00448708|4154376|B3|||Age||years|Mean|63|63.0|Standard Deviation|14.70|14.7|||
4327067|NCT00448708|4154377|B2|||Age||years|Mean|61|61.0|Standard Deviation|15.58|15.58|||
4327068|NCT00448708|4154378|B1|||Age||years|Mean|64|64.0|Standard Deviation|13.72|13.72|||
4327069|NCT00448708|4154376|B3||>=65 years|Age||Participants|Count of Participants|106|106.0||||||
4327070|NCT00448708|4154377|B2||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4327071|NCT00448708|4154378|B1||>=65 years|Age||Participants|Count of Participants|58|58.0||||||
4327072|NCT00448708|4154376|B3||Between 18 and 65 years|Age||Participants|Count of Participants|116|116.0||||||
4327073|NCT00448708|4154377|B2||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4327074|NCT00448708|4154378|B1||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4327075|NCT00448708|4154376|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4327076|NCT00448708|4154377|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4327077|NCT00448708|4154378|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4327078|NCT00448682|4154387|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4327079|NCT00448682|4154387|B1||Male|Gender||Participants|Count of Participants|18|18.0||||||
4327080|NCT00448682|4154387|B1||Female|Gender||Participants|Count of Participants|7|7.0||||||
4327081|NCT00448682|4154387|B1|||Age||years|Mean|62|62.0|Full Range|||39.0|85.0|
4327082|NCT00448630|4154393|B1|Turkey||Region of Enrollment||participants|Number|328|328.0||||||
4327083|NCT00448630|4154393|B1||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4327084|NCT00448630|4154393|B1||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
4327085|NCT00448630|4154393|B1|||Age||years|Mean|37.7|37.7|Standard Deviation|10.8|10.8|||
4327086|NCT00448591|4154438|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4327087|NCT00448591|4154438|B1||Female|Sex: Female, Male||Participants|Count of Participants|2252|2252.0||||||
4327088|NCT00448591|4154438|B1|||Age||years|Mean|53.2|53.2|Standard Deviation|11.0|11.0|||
4327089|NCT00448539|4154447|B3|Other||Race/Ethnicity, Customized|Race (safety population)|participants|Number|3|3.0||||||
4327090|NCT00448539|4154448|B2|Other||Race/Ethnicity, Customized|Race (safety population)|participants|Number|3|3.0||||||
4327091|NCT00448539|4154449|B1|Other||Race/Ethnicity, Customized|Race (safety population)|participants|Number|0|0.0||||||
4327092|NCT00448539|4154447|B3|Asian/Pacific Islander||Race/Ethnicity, Customized|Race (safety population)|participants|Number|4|4.0||||||
4327093|NCT00448539|4154448|B2|Asian/Pacific Islander||Race/Ethnicity, Customized|Race (safety population)|participants|Number|2|2.0||||||
4327324|NCT00448136|4154592|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4327094|NCT00448539|4154449|B1|Asian/Pacific Islander||Race/Ethnicity, Customized|Race (safety population)|participants|Number|2|2.0||||||
4327095|NCT00448539|4154447|B3|Native American||Race/Ethnicity, Customized|Race (safety population)|participants|Number|2|2.0||||||
4327096|NCT00448539|4154448|B2|Native American||Race/Ethnicity, Customized|Race (safety population)|participants|Number|2|2.0||||||
4327097|NCT00448539|4154449|B1|Native American||Race/Ethnicity, Customized|Race (safety population)|participants|Number|0|0.0||||||
4327098|NCT00448539|4154447|B3|Hispanic||Race/Ethnicity, Customized|Race (safety population)|participants|Number|21|21.0||||||
4327099|NCT00448539|4154448|B2|Hispanic||Race/Ethnicity, Customized|Race (safety population)|participants|Number|11|11.0||||||
4327100|NCT00448539|4154449|B1|Hispanic||Race/Ethnicity, Customized|Race (safety population)|participants|Number|10|10.0||||||
4327101|NCT00448539|4154447|B3|White||Race/Ethnicity, Customized|Race (safety population)|participants|Number|236|236.0||||||
4327102|NCT00448539|4154448|B2|White||Race/Ethnicity, Customized|Race (safety population)|participants|Number|121|121.0||||||
4327103|NCT00448539|4154449|B1|White||Race/Ethnicity, Customized|Race (safety population)|participants|Number|115|115.0||||||
4327104|NCT00448539|4154447|B3|Black||Race/Ethnicity, Customized|Race (safety population)|participants|Number|20|20.0||||||
4327105|NCT00448539|4154448|B2|Black||Race/Ethnicity, Customized|Race (safety population)|participants|Number|13|13.0||||||
4327106|NCT00448539|4154449|B1|Black||Race/Ethnicity, Customized|Race (safety population)|participants|Number|7|7.0||||||
4327107|NCT00448539|4154447|B3||Male|Sex: Female, Male|Safety population: All subjects who received at least 1 dose of study medication|Participants|Count of Participants|143|143.0||||||
4327108|NCT00448539|4154448|B2||Male|Sex: Female, Male|Safety population: All subjects who received at least 1 dose of study medication|Participants|Count of Participants|72|72.0||||||
4327109|NCT00448539|4154449|B1||Male|Sex: Female, Male|Safety population: All subjects who received at least 1 dose of study medication|Participants|Count of Participants|71|71.0||||||
4327110|NCT00448539|4154447|B3||Female|Sex: Female, Male|Safety population: All subjects who received at least 1 dose of study medication|Participants|Count of Participants|143|143.0||||||
4327111|NCT00448539|4154448|B2||Female|Sex: Female, Male|Safety population: All subjects who received at least 1 dose of study medication|Participants|Count of Participants|80|80.0||||||
4327112|NCT00448539|4154449|B1||Female|Sex: Female, Male|Safety population: All subjects who received at least 1 dose of study medication|Participants|Count of Participants|63|63.0||||||
4327113|NCT00448539|4154447|B3|>=65 years||Age, Customized|Safety population|participants|Number|10|10.0||||||
4327114|NCT00448539|4154448|B2|>=65 years||Age, Customized|Safety population|participants|Number|5|5.0||||||
4327115|NCT00448539|4154449|B1|>=65 years||Age, Customized|Safety population|participants|Number|5|5.0||||||
4327116|NCT00448539|4154447|B3|18 to <65 years||Age, Customized|Safety population|participants|Number|252|252.0||||||
4327117|NCT00448539|4154448|B2|18 to <65 years||Age, Customized|Safety population|participants|Number|129|129.0||||||
4327118|NCT00448539|4154449|B1|18 to <65 years||Age, Customized|Safety population|participants|Number|123|123.0||||||
4327119|NCT00448539|4154447|B3|12 to <18 years||Age, Customized|Safety population|participants|Number|24|24.0||||||
4327120|NCT00448539|4154448|B2|12 to <18 years||Age, Customized|Safety population|participants|Number|18|18.0||||||
4327121|NCT00448539|4154449|B1|12 to <18 years||Age, Customized|Safety population|participants|Number|6|6.0||||||
4327122|NCT00448448|4154456|B3|Triple||Curve type using SRS classification|The Scoliosis Research Society has classified scoliosis according to the apex of the curvature(s).|participants|Number|18|18.0||||||
4327123|NCT00448448|4154457|B2|Triple||Curve type using SRS classification|The Scoliosis Research Society has classified scoliosis according to the apex of the curvature(s).|participants|Number|6|6.0||||||
4327124|NCT00448448|4154458|B1|Triple||Curve type using SRS classification|The Scoliosis Research Society has classified scoliosis according to the apex of the curvature(s).|participants|Number|12|12.0||||||
4327125|NCT00448448|4154456|B3|Thoracic/Thoracolumbar||Curve type using SRS classification|The Scoliosis Research Society has classified scoliosis according to the apex of the curvature(s).|participants|Number|33|33.0||||||
4327126|NCT00448448|4154457|B2|Thoracic/Thoracolumbar||Curve type using SRS classification|The Scoliosis Research Society has classified scoliosis according to the apex of the curvature(s).|participants|Number|13|13.0||||||
4327127|NCT00448448|4154458|B1|Thoracic/Thoracolumbar||Curve type using SRS classification|The Scoliosis Research Society has classified scoliosis according to the apex of the curvature(s).|participants|Number|20|20.0||||||
4327128|NCT00448448|4154456|B3|Double Thoracic||Curve type using SRS classification|The Scoliosis Research Society has classified scoliosis according to the apex of the curvature(s).|participants|Number|22|22.0||||||
4327129|NCT00448448|4154457|B2|Double Thoracic||Curve type using SRS classification|The Scoliosis Research Society has classified scoliosis according to the apex of the curvature(s).|participants|Number|7|7.0||||||
4327130|NCT00448448|4154458|B1|Double Thoracic||Curve type using SRS classification|The Scoliosis Research Society has classified scoliosis according to the apex of the curvature(s).|participants|Number|15|15.0||||||
4327131|NCT00448448|4154456|B3|Double Major||Curve type using SRS classification|The Scoliosis Research Society has classified scoliosis according to the apex of the curvature(s).|participants|Number|69|69.0||||||
4327132|NCT00448448|4154457|B2|Double Major||Curve type using SRS classification|The Scoliosis Research Society has classified scoliosis according to the apex of the curvature(s).|participants|Number|32|32.0||||||
4327133|NCT00448448|4154458|B1|Double Major||Curve type using SRS classification|The Scoliosis Research Society has classified scoliosis according to the apex of the curvature(s).|participants|Number|37|37.0||||||
4327134|NCT00448448|4154456|B3|Lumbar||Curve type using SRS classification|The Scoliosis Research Society has classified scoliosis according to the apex of the curvature(s).|participants|Number|9|9.0||||||
4327135|NCT00448448|4154457|B2|Lumbar||Curve type using SRS classification|The Scoliosis Research Society has classified scoliosis according to the apex of the curvature(s).|participants|Number|4|4.0||||||
4327215|NCT00448357|4154492|B1||Myelodysplasia|Disease histology||Participants|Count of Participants|8|8.0||||||
4327136|NCT00448448|4154458|B1|Lumbar||Curve type using SRS classification|The Scoliosis Research Society has classified scoliosis according to the apex of the curvature(s).|participants|Number|5|5.0||||||
4327137|NCT00448448|4154456|B3|Thoracolumbar||Curve type using SRS classification|The Scoliosis Research Society has classified scoliosis according to the apex of the curvature(s).|participants|Number|32|32.0||||||
4327138|NCT00448448|4154457|B2|Thoracolumbar||Curve type using SRS classification|The Scoliosis Research Society has classified scoliosis according to the apex of the curvature(s).|participants|Number|13|13.0||||||
4327139|NCT00448448|4154458|B1|Thoracolumbar||Curve type using SRS classification|The Scoliosis Research Society has classified scoliosis according to the apex of the curvature(s).|participants|Number|19|19.0||||||
4327140|NCT00448448|4154456|B3|Thoracic||Curve type using SRS classification|The Scoliosis Research Society has classified scoliosis according to the apex of the curvature(s).|participants|Number|59|59.0||||||
4327141|NCT00448448|4154457|B2|Thoracic||Curve type using SRS classification|The Scoliosis Research Society has classified scoliosis according to the apex of the curvature(s).|participants|Number|21|21.0||||||
4327142|NCT00448448|4154458|B1|Thoracic||Curve type using SRS classification|The Scoliosis Research Society has classified scoliosis according to the apex of the curvature(s).|participants|Number|38|38.0||||||
4327143|NCT00448448|4154456|B3|||Cobb angle|The Cobb angle is the most frequently used measurement of the magnitude of the curvature of the spine, and is a function of the tilt of the vertebrae at the top and bottom of the spinal curvature. A Cobb angle of 10 degrees or greater in association with rotation of the vertebrae indicates the presence of scoliosis.|angle in degrees|Mean|30.4|30.4|Standard Deviation|6.0|6.0|||
4327144|NCT00448448|4154457|B2|||Cobb angle|The Cobb angle is the most frequently used measurement of the magnitude of the curvature of the spine, and is a function of the tilt of the vertebrae at the top and bottom of the spinal curvature. A Cobb angle of 10 degrees or greater in association with rotation of the vertebrae indicates the presence of scoliosis.|angle in degrees|Mean|30.3|30.3|Standard Deviation|6.5|6.5|||
4327145|NCT00448448|4154458|B1|||Cobb angle|The Cobb angle is the most frequently used measurement of the magnitude of the curvature of the spine, and is a function of the tilt of the vertebrae at the top and bottom of the spinal curvature. A Cobb angle of 10 degrees or greater in association with rotation of the vertebrae indicates the presence of scoliosis.|angle in degrees|Mean|30.5|30.5|Standard Deviation|5.8|5.8|||
4327146|NCT00448448|4154456|B3|MISSING||Risser grade|The Risser grade is a measure of the amount of ossification and eventual fusion of the iliac apophysis reflecting skeletal maturity. Grades range from 0 to 5, with higher grades indicating greater maturity. Patients who are classified as being Risser 0, 1 or 2 are regarded as having significant skeletal growth remaining and therefore as being at higher risk for scoliosis progression relative to those classified as Risser 3 or greater. Girls are generally considered skeletally mature at Risser 4 or greater; boys at Risser 5.|participants|Number|2|2.0||||||
4327147|NCT00448448|4154457|B2|MISSING||Risser grade|The Risser grade is a measure of the amount of ossification and eventual fusion of the iliac apophysis reflecting skeletal maturity. Grades range from 0 to 5, with higher grades indicating greater maturity. Patients who are classified as being Risser 0, 1 or 2 are regarded as having significant skeletal growth remaining and therefore as being at higher risk for scoliosis progression relative to those classified as Risser 3 or greater. Girls are generally considered skeletally mature at Risser 4 or greater; boys at Risser 5.|participants|Number|2|2.0||||||
4327148|NCT00448448|4154458|B1|MISSING||Risser grade|The Risser grade is a measure of the amount of ossification and eventual fusion of the iliac apophysis reflecting skeletal maturity. Grades range from 0 to 5, with higher grades indicating greater maturity. Patients who are classified as being Risser 0, 1 or 2 are regarded as having significant skeletal growth remaining and therefore as being at higher risk for scoliosis progression relative to those classified as Risser 3 or greater. Girls are generally considered skeletally mature at Risser 4 or greater; boys at Risser 5.|participants|Number|0|0.0||||||
4327149|NCT00448448|4154456|B3|5||Risser grade|The Risser grade is a measure of the amount of ossification and eventual fusion of the iliac apophysis reflecting skeletal maturity. Grades range from 0 to 5, with higher grades indicating greater maturity. Patients who are classified as being Risser 0, 1 or 2 are regarded as having significant skeletal growth remaining and therefore as being at higher risk for scoliosis progression relative to those classified as Risser 3 or greater. Girls are generally considered skeletally mature at Risser 4 or greater; boys at Risser 5.|participants|Number|1|1.0||||||
4327150|NCT00448448|4154457|B2|5||Risser grade|The Risser grade is a measure of the amount of ossification and eventual fusion of the iliac apophysis reflecting skeletal maturity. Grades range from 0 to 5, with higher grades indicating greater maturity. Patients who are classified as being Risser 0, 1 or 2 are regarded as having significant skeletal growth remaining and therefore as being at higher risk for scoliosis progression relative to those classified as Risser 3 or greater. Girls are generally considered skeletally mature at Risser 4 or greater; boys at Risser 5.|participants|Number|0|0.0||||||
4327151|NCT00448448|4154458|B1|5||Risser grade|The Risser grade is a measure of the amount of ossification and eventual fusion of the iliac apophysis reflecting skeletal maturity. Grades range from 0 to 5, with higher grades indicating greater maturity. Patients who are classified as being Risser 0, 1 or 2 are regarded as having significant skeletal growth remaining and therefore as being at higher risk for scoliosis progression relative to those classified as Risser 3 or greater. Girls are generally considered skeletally mature at Risser 4 or greater; boys at Risser 5.|participants|Number|1|1.0||||||
4327152|NCT00448448|4154456|B3|4||Risser grade|The Risser grade is a measure of the amount of ossification and eventual fusion of the iliac apophysis reflecting skeletal maturity. Grades range from 0 to 5, with higher grades indicating greater maturity. Patients who are classified as being Risser 0, 1 or 2 are regarded as having significant skeletal growth remaining and therefore as being at higher risk for scoliosis progression relative to those classified as Risser 3 or greater. Girls are generally considered skeletally mature at Risser 4 or greater; boys at Risser 5.|participants|Number|1|1.0||||||
4327216|NCT00448357|4154492|B1||Myelogenous leukemia|Disease histology||Participants|Count of Participants|26|26.0||||||
4327217|NCT00448357|4154492|B1||Positive|Host cytomegalovirus (CMV) status||Participants|Count of Participants|36|36.0||||||
4327218|NCT00448357|4154492|B1||Negative|Host cytomegalovirus (CMV) status||Participants|Count of Participants|18|18.0||||||
4327325|NCT00448136|4154590|B3|||Age||years|Mean|59.29|59.29|Standard Deviation|10.15|10.15|||
4327153|NCT00448448|4154457|B2|4||Risser grade|The Risser grade is a measure of the amount of ossification and eventual fusion of the iliac apophysis reflecting skeletal maturity. Grades range from 0 to 5, with higher grades indicating greater maturity. Patients who are classified as being Risser 0, 1 or 2 are regarded as having significant skeletal growth remaining and therefore as being at higher risk for scoliosis progression relative to those classified as Risser 3 or greater. Girls are generally considered skeletally mature at Risser 4 or greater; boys at Risser 5.|participants|Number|0|0.0||||||
4327154|NCT00448448|4154458|B1|4||Risser grade|The Risser grade is a measure of the amount of ossification and eventual fusion of the iliac apophysis reflecting skeletal maturity. Grades range from 0 to 5, with higher grades indicating greater maturity. Patients who are classified as being Risser 0, 1 or 2 are regarded as having significant skeletal growth remaining and therefore as being at higher risk for scoliosis progression relative to those classified as Risser 3 or greater. Girls are generally considered skeletally mature at Risser 4 or greater; boys at Risser 5.|participants|Number|1|1.0||||||
4327155|NCT00448448|4154456|B3|3||Risser grade|The Risser grade is a measure of the amount of ossification and eventual fusion of the iliac apophysis reflecting skeletal maturity. Grades range from 0 to 5, with higher grades indicating greater maturity. Patients who are classified as being Risser 0, 1 or 2 are regarded as having significant skeletal growth remaining and therefore as being at higher risk for scoliosis progression relative to those classified as Risser 3 or greater. Girls are generally considered skeletally mature at Risser 4 or greater; boys at Risser 5.|participants|Number|5|5.0||||||
4327156|NCT00448448|4154457|B2|3||Risser grade|The Risser grade is a measure of the amount of ossification and eventual fusion of the iliac apophysis reflecting skeletal maturity. Grades range from 0 to 5, with higher grades indicating greater maturity. Patients who are classified as being Risser 0, 1 or 2 are regarded as having significant skeletal growth remaining and therefore as being at higher risk for scoliosis progression relative to those classified as Risser 3 or greater. Girls are generally considered skeletally mature at Risser 4 or greater; boys at Risser 5.|participants|Number|3|3.0||||||
4327157|NCT00448448|4154458|B1|3||Risser grade|The Risser grade is a measure of the amount of ossification and eventual fusion of the iliac apophysis reflecting skeletal maturity. Grades range from 0 to 5, with higher grades indicating greater maturity. Patients who are classified as being Risser 0, 1 or 2 are regarded as having significant skeletal growth remaining and therefore as being at higher risk for scoliosis progression relative to those classified as Risser 3 or greater. Girls are generally considered skeletally mature at Risser 4 or greater; boys at Risser 5.|participants|Number|2|2.0||||||
4327158|NCT00448448|4154456|B3|2||Risser grade|The Risser grade is a measure of the amount of ossification and eventual fusion of the iliac apophysis reflecting skeletal maturity. Grades range from 0 to 5, with higher grades indicating greater maturity. Patients who are classified as being Risser 0, 1 or 2 are regarded as having significant skeletal growth remaining and therefore as being at higher risk for scoliosis progression relative to those classified as Risser 3 or greater. Girls are generally considered skeletally mature at Risser 4 or greater; boys at Risser 5.|participants|Number|27|27.0||||||
4327159|NCT00448448|4154457|B2|2||Risser grade|The Risser grade is a measure of the amount of ossification and eventual fusion of the iliac apophysis reflecting skeletal maturity. Grades range from 0 to 5, with higher grades indicating greater maturity. Patients who are classified as being Risser 0, 1 or 2 are regarded as having significant skeletal growth remaining and therefore as being at higher risk for scoliosis progression relative to those classified as Risser 3 or greater. Girls are generally considered skeletally mature at Risser 4 or greater; boys at Risser 5.|participants|Number|12|12.0||||||
4327160|NCT00448448|4154458|B1|2||Risser grade|The Risser grade is a measure of the amount of ossification and eventual fusion of the iliac apophysis reflecting skeletal maturity. Grades range from 0 to 5, with higher grades indicating greater maturity. Patients who are classified as being Risser 0, 1 or 2 are regarded as having significant skeletal growth remaining and therefore as being at higher risk for scoliosis progression relative to those classified as Risser 3 or greater. Girls are generally considered skeletally mature at Risser 4 or greater; boys at Risser 5.|participants|Number|15|15.0||||||
4327161|NCT00448448|4154456|B3|1||Risser grade|The Risser grade is a measure of the amount of ossification and eventual fusion of the iliac apophysis reflecting skeletal maturity. Grades range from 0 to 5, with higher grades indicating greater maturity. Patients who are classified as being Risser 0, 1 or 2 are regarded as having significant skeletal growth remaining and therefore as being at higher risk for scoliosis progression relative to those classified as Risser 3 or greater. Girls are generally considered skeletally mature at Risser 4 or greater; boys at Risser 5.|participants|Number|64|64.0||||||
4327162|NCT00448448|4154457|B2|1||Risser grade|The Risser grade is a measure of the amount of ossification and eventual fusion of the iliac apophysis reflecting skeletal maturity. Grades range from 0 to 5, with higher grades indicating greater maturity. Patients who are classified as being Risser 0, 1 or 2 are regarded as having significant skeletal growth remaining and therefore as being at higher risk for scoliosis progression relative to those classified as Risser 3 or greater. Girls are generally considered skeletally mature at Risser 4 or greater; boys at Risser 5.|participants|Number|19|19.0||||||
4327163|NCT00448448|4154458|B1|1||Risser grade|The Risser grade is a measure of the amount of ossification and eventual fusion of the iliac apophysis reflecting skeletal maturity. Grades range from 0 to 5, with higher grades indicating greater maturity. Patients who are classified as being Risser 0, 1 or 2 are regarded as having significant skeletal growth remaining and therefore as being at higher risk for scoliosis progression relative to those classified as Risser 3 or greater. Girls are generally considered skeletally mature at Risser 4 or greater; boys at Risser 5.|participants|Number|45|45.0||||||
4327164|NCT00448448|4154456|B3|0||Risser grade|The Risser grade is a measure of the amount of ossification and eventual fusion of the iliac apophysis reflecting skeletal maturity. Grades range from 0 to 5, with higher grades indicating greater maturity. Patients who are classified as being Risser 0, 1 or 2 are regarded as having significant skeletal growth remaining and therefore as being at higher risk for scoliosis progression relative to those classified as Risser 3 or greater. Girls are generally considered skeletally mature at Risser 4 or greater; boys at Risser 5.|participants|Number|142|142.0||||||
4327219|NCT00448357|4154492|B1||Female-Female|Donor-recipient sex||Participants|Count of Participants|14|14.0||||||
4327220|NCT00448357|4154492|B1||Male-Male|Donor-recipient sex||Participants|Count of Participants|22|22.0||||||
4327221|NCT00448357|4154492|B1||Female-Male|Donor-recipient sex||Participants|Count of Participants|12|12.0||||||
4327165|NCT00448448|4154457|B2|0||Risser grade|The Risser grade is a measure of the amount of ossification and eventual fusion of the iliac apophysis reflecting skeletal maturity. Grades range from 0 to 5, with higher grades indicating greater maturity. Patients who are classified as being Risser 0, 1 or 2 are regarded as having significant skeletal growth remaining and therefore as being at higher risk for scoliosis progression relative to those classified as Risser 3 or greater. Girls are generally considered skeletally mature at Risser 4 or greater; boys at Risser 5.|participants|Number|60|60.0||||||
4327166|NCT00448448|4154458|B1|0||Risser grade|The Risser grade is a measure of the amount of ossification and eventual fusion of the iliac apophysis reflecting skeletal maturity. Grades range from 0 to 5, with higher grades indicating greater maturity. Patients who are classified as being Risser 0, 1 or 2 are regarded as having significant skeletal growth remaining and therefore as being at higher risk for scoliosis progression relative to those classified as Risser 3 or greater. Girls are generally considered skeletally mature at Risser 4 or greater; boys at Risser 5.|participants|Number|82|82.0||||||
4327167|NCT00448448|4154456|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4327168|NCT00448448|4154457|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4327169|NCT00448448|4154458|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4327170|NCT00448448|4154456|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4327171|NCT00448448|4154457|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4327172|NCT00448448|4154458|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4327173|NCT00448448|4154456|B3||White|Race (NIH/OMB)||Participants|Count of Participants|189|189.0||||||
4327174|NCT00448448|4154457|B2||White|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
4327175|NCT00448448|4154458|B1||White|Race (NIH/OMB)||Participants|Count of Participants|116|116.0||||||
4327176|NCT00448448|4154456|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4327177|NCT00448448|4154457|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4327178|NCT00448448|4154458|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4327179|NCT00448448|4154456|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4327180|NCT00448448|4154457|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4327181|NCT00448448|4154458|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4327182|NCT00448448|4154456|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4327183|NCT00448448|4154457|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4327184|NCT00448448|4154458|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4327185|NCT00448448|4154456|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4327186|NCT00448448|4154457|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4327187|NCT00448448|4154458|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4327188|NCT00448448|4154456|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4327189|NCT00448448|4154457|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4327190|NCT00448448|4154458|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4327191|NCT00448448|4154456|B3||Female|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
4327192|NCT00448448|4154457|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4327193|NCT00448448|4154458|B1||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4327194|NCT00448448|4154456|B3|||Age||years|Mean|12.7|12.7|Standard Deviation|1.1|1.1|||
4327195|NCT00448448|4154457|B2|||Age||years|Mean|12.7|12.7|Standard Deviation|1.2|1.2|||
4327196|NCT00448448|4154458|B1|||Age||years|Mean|12.7|12.7|Standard Deviation|1.0|1.0|||
4327197|NCT00448435|4154465|B1|Japan||Region of Enrollment||participants|Number|51|51.0||||||
4327198|NCT00448435|4154465|B1|Asian-Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|51|51.0||||||
4327199|NCT00448435|4154465|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4327200|NCT00448435|4154465|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4327201|NCT00448435|4154465|B1|||Age||Years|Mean|8.3|8.3|Standard Deviation|2.41|2.41|||
4327202|NCT00448357|4154492|B1||High|Disease risk||Participants|Count of Participants|18|18.0||||||
4327203|NCT00448357|4154492|B1||Intermediate|Disease risk||Participants|Count of Participants|20|20.0||||||
4327204|NCT00448357|4154492|B1||Low|Disease risk||Participants|Count of Participants|16|16.0||||||
4327205|NCT00448357|4154492|B1||Matched unrelated donor (MRD)|Type of transplant||Participants|Count of Participants|20|20.0||||||
4327206|NCT00448357|4154492|B1||Matched unrelated donor (MUD)|Type of transplant||Participants|Count of Participants|34|34.0||||||
4327207|NCT00448357|4154492|B1||Plastic cell leukemia|Disease histology||Participants|Count of Participants|2|2.0||||||
4327208|NCT00448357|4154492|B1||Chronic myelomonocytic leukemia|Disease histology||Participants|Count of Participants|1|1.0||||||
4327209|NCT00448357|4154492|B1||Chronic lymphoblastic leukemia|Disease histology||Participants|Count of Participants|1|1.0||||||
4327210|NCT00448357|4154492|B1||Myelofibrosis|Disease histology||Participants|Count of Participants|1|1.0||||||
4327211|NCT00448357|4154492|B1||Hodgkin lymphoma|Disease histology||Participants|Count of Participants|2|2.0||||||
4327212|NCT00448357|4154492|B1||Non-Hodgkin Lymphoma|Disease histology||Participants|Count of Participants|5|5.0||||||
4327213|NCT00448357|4154492|B1||Acute lymphoblastic leukemia|Disease histology||Participants|Count of Participants|7|7.0||||||
4327214|NCT00448357|4154492|B1||Chronic myelogenous leukemia|Disease histology||Participants|Count of Participants|1|1.0||||||
4327222|NCT00448357|4154492|B1||Male-Female|Donor-recipient sex||Participants|Count of Participants|6|6.0||||||
4327223|NCT00448357|4154492|B1|United States||Region of Enrollment||participants|Number|54|54.0||||||
4327224|NCT00448357|4154492|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4327225|NCT00448357|4154492|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4327226|NCT00448357|4154492|B1||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4327227|NCT00448357|4154492|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4327228|NCT00448357|4154492|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4327229|NCT00448357|4154492|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4327230|NCT00448357|4154492|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4327231|NCT00448357|4154492|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4327232|NCT00448357|4154492|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4327233|NCT00448357|4154492|B1|||Age||years|Median|50|50.0|Full Range|||27.0|66.0|
4327234|NCT00448344|4154515|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4327235|NCT00448344|4154516|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4327236|NCT00448344|4154517|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4327237|NCT00448344|4154515|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4327238|NCT00448344|4154516|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4327239|NCT00448344|4154517|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4327240|NCT00448344|4154515|B3||White|Race (NIH/OMB)||Participants|Count of Participants|251|251.0||||||
4327241|NCT00448344|4154516|B2||White|Race (NIH/OMB)||Participants|Count of Participants|121|121.0||||||
4327242|NCT00448344|4154517|B1||White|Race (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
4327243|NCT00448344|4154515|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|188|188.0||||||
4327244|NCT00448344|4154516|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4327245|NCT00448344|4154517|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
4327246|NCT00448344|4154515|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4327247|NCT00448344|4154516|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4327248|NCT00448344|4154517|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4327249|NCT00448344|4154515|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4327250|NCT00448344|4154516|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4327251|NCT00448344|4154517|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4327252|NCT00448344|4154515|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4327253|NCT00448344|4154516|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4327254|NCT00448344|4154517|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4327255|NCT00448344|4154515|B3||Male|Sex: Female, Male||Participants|Count of Participants|431|431.0||||||
4327256|NCT00448344|4154516|B2||Male|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
4327257|NCT00448344|4154517|B1||Male|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4327258|NCT00448344|4154515|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4327259|NCT00448344|4154516|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4327260|NCT00448344|4154517|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4327261|NCT00448344|4154515|B3|||Age||years|Mean|59.2|59.2|Standard Deviation|7.9|7.9|||
4327262|NCT00448344|4154516|B2|||Age||years|Mean|59.2|59.2|Standard Deviation|7.7|7.7|||
4327263|NCT00448344|4154517|B1|||Age||years|Mean|59.1|59.1|Standard Deviation|8|8.0|||
4327264|NCT00448279|4154526|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4327265|NCT00448279|4154527|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4327266|NCT00448279|4154528|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4327267|NCT00448279|4154526|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4327268|NCT00448279|4154527|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4327269|NCT00448279|4154528|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4327270|NCT00448279|4154526|B3|||Age||years|Median|58|58.0|Full Range|||38.0|82.0|
4327271|NCT00448279|4154527|B2|||Age||years|Median|57|57.0|Full Range|||39.0|82.0|
4327272|NCT00448279|4154528|B1|||Age||years|Median|59|59.0|Full Range|||38.0|81.0|
4327273|NCT00448227|4154545|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4327274|NCT00448227|4154545|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4327275|NCT00448227|4154545|B1|6 to 12 months||Age, Customized||participants|Number|5|5.0||||||
4327276|NCT00448227|4154545|B1|3 to <6 months||Age, Customized||participants|Number|5|5.0||||||
4327277|NCT00448227|4154545|B1|1 to <3 months||Age, Customized||participants|Number|8|8.0||||||
4327278|NCT00448227|4154545|B1|||Age||months|Mean|4|4.0|Standard Deviation|3.60|3.6|||
4327321|NCT00448136|4154592|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4327322|NCT00448136|4154590|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4327323|NCT00448136|4154591|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4327279|NCT00448201|4154572|B1|Undetermined||Disease Risk Index (DRI)|The DRI uses a combination of a ternary breakdown for disease type and a binary breakdown for remission status to assign patients to 1 of 4 risk categories that differ very significantly (statistically and clinically) with respect to overall survival (OS) and Progression free survival (PFS).|Participants|Count of Participants|2|2.0||||||
4327280|NCT00448201|4154572|B1|Very High||Disease Risk Index (DRI)|The DRI uses a combination of a ternary breakdown for disease type and a binary breakdown for remission status to assign patients to 1 of 4 risk categories that differ very significantly (statistically and clinically) with respect to overall survival (OS) and Progression free survival (PFS).|Participants|Count of Participants|1|1.0||||||
4327281|NCT00448201|4154572|B1|High||Disease Risk Index (DRI)|The DRI uses a combination of a ternary breakdown for disease type and a binary breakdown for remission status to assign patients to 1 of 4 risk categories that differ very significantly (statistically and clinically) with respect to overall survival (OS) and Progression free survival (PFS).|Participants|Count of Participants|19|19.0||||||
4327282|NCT00448201|4154572|B1|Intermediate||Disease Risk Index (DRI)|The DRI uses a combination of a ternary breakdown for disease type and a binary breakdown for remission status to assign patients to 1 of 4 risk categories that differ very significantly (statistically and clinically) with respect to overall survival (OS) and Progression free survival (PFS).|Participants|Count of Participants|40|40.0||||||
4327283|NCT00448201|4154572|B1|Low||Disease Risk Index (DRI)|The DRI uses a combination of a ternary breakdown for disease type and a binary breakdown for remission status to assign patients to 1 of 4 risk categories that differ very significantly (statistically and clinically) with respect to overall survival (OS) and Progression free survival (PFS).|Participants|Count of Participants|9|9.0||||||
4327284|NCT00448201|4154572|B1|||Comorbidity Index (CI)|The Hematopoietic Cell Transplantation-Specific Comorbidity Index (HCT-CI) was developed to identify relevant comorbidities in the allogeneic stem cell transplantation population and to enable risk assessment before allogeneic transplant. Comorbidities are given a a weighted score of 1 to 3 if present. The total score can range from 0 to 29, with higher numbers indicating more/worse comorbidities. The HCT-CI scores were further collapsed into 3 risk groups: 0 (low risk), 1 to 2 (intermediate risk), and 3 or more (high risk).|units on a scale|Median|3|3.0|Full Range|||0.0|8.0|
4327285|NCT00448201|4154572|B1|MUD or HLA-mismatched grafts||Donor Types|Human leukocyte antigen (HLA) typing is used to match a recipient with a donor for bone marrow or cord blood transplant. Donor types are either HLA-matched related donor (MRD) or matched unrelated donor (MUD) or HLA-mismatched grafts.|Participants|Count of Participants|34|34.0||||||
4327286|NCT00448201|4154572|B1|HLA-matched related donor (MRD)||Donor Types|Human leukocyte antigen (HLA) typing is used to match a recipient with a donor for bone marrow or cord blood transplant. Donor types are either HLA-matched related donor (MRD) or matched unrelated donor (MUD) or HLA-mismatched grafts.|Participants|Count of Participants|37|37.0||||||
4327287|NCT00448201|4154572|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
4327288|NCT00448201|4154572|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4327289|NCT00448201|4154572|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4327290|NCT00448201|4154572|B1||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4327291|NCT00448201|4154572|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4327292|NCT00448201|4154572|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4327293|NCT00448201|4154572|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4327294|NCT00448201|4154572|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4327295|NCT00448201|4154572|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4327296|NCT00448201|4154572|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4327297|NCT00448201|4154572|B1|||Age||years|Median|58|58.0|Full Range|||28.0|69.0|
4327298|NCT00448175|4154581|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
4327299|NCT00448175|4154582|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
4327300|NCT00448175|4154583|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4327301|NCT00448175|4154581|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4327302|NCT00448175|4154582|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4327303|NCT00448175|4154583|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4327304|NCT00448175|4154581|B3||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4327305|NCT00448175|4154582|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4327306|NCT00448175|4154583|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4327307|NCT00448175|4154581|B3|||Age||years|Mean|57.85|57.85|Standard Deviation|13.25|13.25|||
4327308|NCT00448175|4154582|B2|||Age||years|Mean|58.2|58.2|Standard Deviation|11.3|11.3|||
4327309|NCT00448175|4154583|B1|||Age||years|Mean|57.5|57.5|Standard Deviation|15.2|15.2|||
4327310|NCT00448175|4154581|B3||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4327311|NCT00448175|4154582|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4327312|NCT00448175|4154583|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4327313|NCT00448175|4154581|B3||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
4327314|NCT00448175|4154582|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4327315|NCT00448175|4154583|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4327316|NCT00448175|4154581|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4327317|NCT00448175|4154582|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4327318|NCT00448175|4154583|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4327319|NCT00448136|4154590|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4327320|NCT00448136|4154591|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4327326|NCT00448136|4154591|B2|||Age||years|Mean|61.64|61.64|Standard Deviation|9.20|9.2|||
4327327|NCT00448136|4154592|B1|||Age||years|Mean|55.93|55.93|Standard Deviation|10.63|10.63|||
4327328|NCT00448123|4154629|B3|United States||Region of Enrollment||participants|Number|127|127.0||||||
4327329|NCT00448123|4154630|B2|United States||Region of Enrollment||participants|Number|65|65.0||||||
4327330|NCT00448123|4154631|B1|United States||Region of Enrollment||participants|Number|62|62.0||||||
4327331|NCT00448123|4154629|B3||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4327332|NCT00448123|4154630|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4327333|NCT00448123|4154631|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4327334|NCT00448123|4154629|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4327335|NCT00448123|4154630|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4327336|NCT00448123|4154631|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4327337|NCT00448123|4154629|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4327338|NCT00448123|4154630|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4327339|NCT00448123|4154631|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4327340|NCT00448123|4154629|B3||Between 18 and 65 years|Age||Participants|Count of Participants|127|127.0||||||
4327341|NCT00448123|4154630|B2||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4327342|NCT00448123|4154631|B1||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4327343|NCT00448123|4154629|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4327344|NCT00448123|4154630|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4327345|NCT00448123|4154631|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4327346|NCT00448019|4154642|B1|United States||Region of Enrollment||participants|Number|64|64.0||||||
4327347|NCT00448019|4154642|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4327348|NCT00448019|4154642|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4327349|NCT00448019|4154642|B1|||Age||years|Median|62|62.0|Full Range|||39.0|84.0|
4327350|NCT00447902|4154648|B3||Male|Sex: Female, Male|Included patients who discontinued due to early termination|Participants|Count of Participants|8|8.0||||||
4327351|NCT00447902|4154649|B2||Male|Sex: Female, Male|Included patients who discontinued due to early termination|Participants|Count of Participants|5|5.0||||||
4327352|NCT00447902|4154650|B1||Male|Sex: Female, Male|Included patients who discontinued due to early termination|Participants|Count of Participants|3|3.0||||||
4327353|NCT00447902|4154648|B3||Female|Sex: Female, Male|Included patients who discontinued due to early termination|Participants|Count of Participants|2|2.0||||||
4327354|NCT00447902|4154649|B2||Female|Sex: Female, Male|Included patients who discontinued due to early termination|Participants|Count of Participants|1|1.0||||||
4327355|NCT00447902|4154650|B1||Female|Sex: Female, Male|Included patients who discontinued due to early termination|Participants|Count of Participants|1|1.0||||||
4327356|NCT00447902|4154648|B3|||Age||years|Mean|45.50|45.5|Standard Deviation|4.40|4.4|||
4327357|NCT00447902|4154649|B2|||Age||years|Mean|45.20|45.2|Standard Deviation|5.40|5.4|||
4327358|NCT00447902|4154650|B1|||Age||years|Mean|46.00|46.0|Standard Deviation|2.90|2.9|||
4327359|NCT00447876|4154691|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4327360|NCT00447876|4154692|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4327361|NCT00447876|4154693|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4327362|NCT00447876|4154691|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4327363|NCT00447876|4154692|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4327364|NCT00447876|4154693|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4327365|NCT00447876|4154691|B3|||Age||years|Mean|52.1|52.1|Standard Deviation|10.9|10.9|||
4327366|NCT00447876|4154692|B2|||Age||years|Mean|51.8|51.8|Standard Deviation|11.3|11.3|||
4327367|NCT00447876|4154693|B1|||Age||years|Mean|52.4|52.4|Standard Deviation|10.7|10.7|||
4327368|NCT00447772|4154724|B1||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4327369|NCT00447772|4154724|B1||Female|Sex: Female, Male||Participants|Count of Participants|353|353.0||||||
4327370|NCT00447772|4154724|B1|||Age||years|Mean|51.9|51.9|Standard Deviation|12.7|12.7|||
4327371|NCT00447603|4154744|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4327372|NCT00447603|4154744|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4327373|NCT00447603|4154744|B1|||Age||years|Mean|13.7|13.7|Standard Deviation|2.58|2.58|||
4327374|NCT00447590|4154766|B1|||Excess Weight|Excess weight is equal to operative weight minus ideal weight at visit.|pounds (lb)|Mean|152.3|152.3|Full Range|||51.8|346.9|
4327375|NCT00447590|4154766|B1|||Body Mass Index (BMI)||kg/m2|Mean|48.5|48.5|Full Range|||34.0|73.3|
4327376|NCT00447590|4154766|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4327377|NCT00447590|4154766|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4327378|NCT00447590|4154766|B1|Black/African-American||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4327379|NCT00447590|4154766|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|102|102.0||||||
4327380|NCT00447590|4154766|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4327381|NCT00447590|4154766|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4327382|NCT00447590|4154766|B1|Age 18||Age, Customized||participants|Number|2|2.0||||||
4327383|NCT00447590|4154766|B1|Age 17||Age, Customized||participants|Number|46|46.0||||||
4327384|NCT00447590|4154766|B1|Age 16||Age, Customized||participants|Number|47|47.0||||||
4327385|NCT00447590|4154766|B1|Age 15||Age, Customized||participants|Number|33|33.0||||||
4327386|NCT00447590|4154766|B1|Age 14||Age, Customized||participants|Number|25|25.0||||||
4327387|NCT00447590|4154766|B1|||Age||years|Mean|15.8|15.8|Full Range|||14.0|18.0|
4327388|NCT00447499|4154775|B1|||Weight||Kg|Mean|93.0|93.0|Standard Deviation|23.8|23.8|||
4327389|NCT00447499|4154775|B1|||Time Since Last Somatostatin Analogue Treatment||Days|Mean|78.8|78.8|Standard Deviation|173.3|173.3|||
4327390|NCT00447499|4154775|B1|||Time Since Last Pituitary Surgery||Years|Mean|6.7|6.7|Standard Deviation|6.2|6.2|||
4327391|NCT00447499|4154775|B1|||Duration of Acromegaly||Years|Mean|7.8|7.8|Standard Deviation|6.7|6.7|||
4327392|NCT00447499|4154775|B1|Missing||Prior Somatostatin Analogue Treatment||participants|Number|15|15.0||||||
4327393|NCT00447499|4154775|B1|No||Prior Somatostatin Analogue Treatment||participants|Number|6|6.0||||||
4327394|NCT00447499|4154775|B1|Yes||Prior Somatostatin Analogue Treatment||participants|Number|38|38.0||||||
4327395|NCT00447499|4154775|B1|No||Previous Pituitary Surgery||participants|Number|7|7.0||||||
4327396|NCT00447499|4154775|B1|Yes||Previous Pituitary Surgery||participants|Number|52|52.0||||||
4327397|NCT00447499|4154775|B1|Missing||Dopamine Agonist Treatment||Participants|Number|15|15.0||||||
4327398|NCT00447499|4154775|B1|No||Dopamine Agonist Treatment||Participants|Number|33|33.0||||||
4327399|NCT00447499|4154775|B1|Yes||Dopamine Agonist Treatment||Participants|Number|11|11.0||||||
4327400|NCT00447499|4154775|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
4327401|NCT00447499|4154775|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4327402|NCT00447499|4154775|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4327403|NCT00447499|4154775|B1||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4327404|NCT00447499|4154775|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4327405|NCT00447499|4154775|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4327406|NCT00447499|4154775|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4327407|NCT00447499|4154775|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4327408|NCT00447499|4154775|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4327409|NCT00447499|4154775|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4327410|NCT00447499|4154775|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4327411|NCT00447499|4154775|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4327412|NCT00447499|4154775|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4327413|NCT00447499|4154775|B1|||Age||Years|Mean|53.1|53.1|Standard Deviation|11.9|11.9|||
4327414|NCT00447421|4154785|B1|Netherlands||Region of Enrollment||participants|Number|7|7.0||||||
4327415|NCT00447421|4154785|B1|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
4327416|NCT00447421|4154785|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4327417|NCT00447421|4154785|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4327418|NCT00447421|4154785|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4327419|NCT00447421|4154785|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4327420|NCT00447421|4154785|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4327421|NCT00447382|4154795|B3|||Diabetes History|Average number of years since diagnosis|years|Mean|14.07|14.07|Standard Deviation|10.8|10.8|||
4327422|NCT00447382|4154796|B2|||Diabetes History|Average number of years since diagnosis|years|Mean|13.66|13.66|Standard Deviation|10.3|10.3|||
4327423|NCT00447382|4154797|B1|||Diabetes History|Average number of years since diagnosis|years|Mean|14.48|14.48|Standard Deviation|11.2|11.2|||
4327424|NCT00447382|4154795|B3|||HbA1c (Glycosylated haemoglobin)||Percent (%) glycosylated haemoglobin|Mean|7.96|7.96|Standard Deviation|1.35|1.35|||
4327425|NCT00447382|4154796|B2|||HbA1c (Glycosylated haemoglobin)||Percent (%) glycosylated haemoglobin|Mean|7.99|7.99|Standard Deviation|1.38|1.38|||
4327426|NCT00447382|4154797|B1|||HbA1c (Glycosylated haemoglobin)||Percent (%) glycosylated haemoglobin|Mean|7.93|7.93|Standard Deviation|1.31|1.31|||
4327427|NCT00447382|4154795|B3|||BMI (Body Mass Index)||kg/m^2|Mean|25.45|25.45|Standard Deviation|3.83|3.83|||
4327428|NCT00447382|4154796|B2|||BMI (Body Mass Index)||kg/m^2|Mean|25.23|25.23|Standard Deviation|3.59|3.59|||
4327429|NCT00447382|4154797|B1|||BMI (Body Mass Index)||kg/m^2|Mean|25.68|25.68|Standard Deviation|4.05|4.05|||
4327430|NCT00447382|4154795|B3|||Body weight||kg|Mean|76.4|76.4|Standard Deviation|14.7|14.7|||
4327431|NCT00447382|4154796|B2|||Body weight||kg|Mean|75.1|75.1|Standard Deviation|14.9|14.9|||
4327432|NCT00447382|4154797|B1|||Body weight||kg|Mean|77.6|77.6|Standard Deviation|14.6|14.6|||
4327433|NCT00447382|4154795|B3|||Height||meter|Mean|1.73|1.73|Standard Deviation|0.1|0.1|||
4327434|NCT00447382|4154796|B2|||Height||meter|Mean|1.72|1.72|Standard Deviation|0.1|0.1|||
4327435|NCT00447382|4154797|B1|||Height||meter|Mean|1.74|1.74|Standard Deviation|0.09|0.09|||
4327436|NCT00447382|4154795|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4327437|NCT00447382|4154796|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4327438|NCT00447382|4154797|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4327439|NCT00447382|4154795|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4327440|NCT00447382|4154796|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4327441|NCT00447382|4154797|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4327442|NCT00447382|4154795|B3||White|Race (NIH/OMB)||Participants|Count of Participants|304|304.0||||||
4327443|NCT00447382|4154796|B2||White|Race (NIH/OMB)||Participants|Count of Participants|152|152.0||||||
4327444|NCT00447382|4154797|B1||White|Race (NIH/OMB)||Participants|Count of Participants|152|152.0||||||
4327445|NCT00447382|4154795|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4327446|NCT00447382|4154796|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4327447|NCT00447382|4154797|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4327448|NCT00447382|4154795|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4327449|NCT00447382|4154796|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4327450|NCT00447382|4154797|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4327451|NCT00447382|4154795|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4327452|NCT00447382|4154796|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4327453|NCT00447382|4154797|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4327454|NCT00447382|4154795|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4327455|NCT00447382|4154796|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4327456|NCT00447382|4154797|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4327457|NCT00447382|4154795|B3||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4327458|NCT00447382|4154796|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4327459|NCT00447382|4154797|B1||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4327460|NCT00447382|4154795|B3||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4327461|NCT00447382|4154796|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4327462|NCT00447382|4154797|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4327463|NCT00447382|4154795|B3|||Age||years|Mean|39.3|39.3|Standard Deviation|14.2|14.2|||
4327464|NCT00447382|4154796|B2|||Age||years|Mean|38.6|38.6|Standard Deviation|13.6|13.6|||
4327465|NCT00447382|4154797|B1|||Age||years|Mean|39.9|39.9|Standard Deviation|14.9|14.9|||
4327466|NCT00447330|4154850|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4327467|NCT00447330|4154850|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4327468|NCT00447330|4154850|B1|||Age||years|Mean|58|58.0|Standard Deviation|12|12.0|||
4327469|NCT00447278|4154857|B3|||Weight||kilograms (kg)|Mean|37.5|37.5|Standard Deviation|13.82|13.82|||
4327470|NCT00447278|4154858|B2|||Weight||kilograms (kg)|Mean|37.6|37.6|Standard Deviation|13.35|13.35|||
4327471|NCT00447278|4154859|B1|||Weight||kilograms (kg)|Mean|37.5|37.5|Standard Deviation|14.30|14.3|||
4327472|NCT00447278|4154857|B3|||Time Since Onset of ADHD||years|Mean|5.1|5.1|Standard Deviation|2.81|2.81|||
4327473|NCT00447278|4154858|B2|||Time Since Onset of ADHD||years|Mean|5.2|5.2|Standard Deviation|2.97|2.97|||
4327474|NCT00447278|4154859|B1|||Time Since Onset of ADHD||years|Mean|5.0|5.0|Standard Deviation|2.65|2.65|||
4327475|NCT00447278|4154857|B3|||Height||centimeters|Mean|139.4|139.4|Standard Deviation|15.16|15.16|||
4327476|NCT00447278|4154858|B2|||Height||centimeters|Mean|140.1|140.1|Standard Deviation|15.71|15.71|||
4327477|NCT00447278|4154859|B1|||Height||centimeters|Mean|138.8|138.8|Standard Deviation|14.59|14.59|||
4327478|NCT00447278|4154857|B3|||Age at Onset of Attention-Deficit/Hyperactivity Disorder (ADHD)||years|Mean|4.2|4.2|Standard Deviation|1.89|1.89|||
4327479|NCT00447278|4154858|B2|||Age at Onset of Attention-Deficit/Hyperactivity Disorder (ADHD)||years|Mean|4.2|4.2|Standard Deviation|1.91|1.91|||
4327480|NCT00447278|4154859|B1|||Age at Onset of Attention-Deficit/Hyperactivity Disorder (ADHD)||years|Mean|4.3|4.3|Standard Deviation|1.88|1.88|||
4327481|NCT00447278|4154857|B3|Missing Information||Kiddie Schedule for Affective Disorders - Tic Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|7|7.0||||||
4327482|NCT00447278|4154858|B2|Missing Information||Kiddie Schedule for Affective Disorders - Tic Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|2|2.0||||||
4327483|NCT00447278|4154859|B1|Missing Information||Kiddie Schedule for Affective Disorders - Tic Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|5|5.0||||||
4327552|NCT00447278|4154859|B1|Italy||Region of Enrollment||participants|Number|20|20.0||||||
4327553|NCT00447278|4154857|B3|United Kingdom||Region of Enrollment||participants|Number|34|34.0||||||
4327554|NCT00447278|4154858|B2|United Kingdom||Region of Enrollment||participants|Number|18|18.0||||||
4327555|NCT00447278|4154859|B1|United Kingdom||Region of Enrollment||participants|Number|16|16.0||||||
4327484|NCT00447278|4154857|B3|3 Tic Disorders||Kiddie Schedule for Affective Disorders - Tic Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|6|6.0||||||
4327485|NCT00447278|4154858|B2|3 Tic Disorders||Kiddie Schedule for Affective Disorders - Tic Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|3|3.0||||||
4327486|NCT00447278|4154859|B1|3 Tic Disorders||Kiddie Schedule for Affective Disorders - Tic Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|3|3.0||||||
4327487|NCT00447278|4154857|B3|2 Tic Disorders||Kiddie Schedule for Affective Disorders - Tic Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|4|4.0||||||
4327488|NCT00447278|4154858|B2|2 Tic Disorders||Kiddie Schedule for Affective Disorders - Tic Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|2|2.0||||||
4327489|NCT00447278|4154859|B1|2 Tic Disorders||Kiddie Schedule for Affective Disorders - Tic Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|2|2.0||||||
4327490|NCT00447278|4154857|B3|1 Tic Disorder||Kiddie Schedule for Affective Disorders - Tic Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|27|27.0||||||
4327491|NCT00447278|4154858|B2|1 Tic Disorder||Kiddie Schedule for Affective Disorders - Tic Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|14|14.0||||||
4327492|NCT00447278|4154859|B1|1 Tic Disorder||Kiddie Schedule for Affective Disorders - Tic Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|13|13.0||||||
4327493|NCT00447278|4154857|B3|0 Tic Disorders||Kiddie Schedule for Affective Disorders - Tic Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|354|354.0||||||
4327494|NCT00447278|4154858|B2|0 Tic Disorders||Kiddie Schedule for Affective Disorders - Tic Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|178|178.0||||||
4327556|NCT00447278|4154857|B3|Norway||Region of Enrollment||participants|Number|20|20.0||||||
4327557|NCT00447278|4154858|B2|Norway||Region of Enrollment||participants|Number|10|10.0||||||
4327558|NCT00447278|4154859|B1|Norway||Region of Enrollment||participants|Number|10|10.0||||||
4327495|NCT00447278|4154859|B1|0 Tic Disorders||Kiddie Schedule for Affective Disorders - Tic Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|176|176.0||||||
4327496|NCT00447278|4154857|B3|No (never had the disorder)||Kiddie Schedule for Affective Disorders - Oppositional Defiant Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|240|240.0||||||
4327497|NCT00447278|4154858|B2|No (never had the disorder)||Kiddie Schedule for Affective Disorders - Oppositional Defiant Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|122|122.0||||||
4327498|NCT00447278|4154859|B1|No (never had the disorder)||Kiddie Schedule for Affective Disorders - Oppositional Defiant Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|118|118.0||||||
4327499|NCT00447278|4154857|B3|Yes, but not present (had disorder in the past)||Kiddie Schedule for Affective Disorders - Oppositional Defiant Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|6|6.0||||||
4327500|NCT00447278|4154858|B2|Yes, but not present (had disorder in the past)||Kiddie Schedule for Affective Disorders - Oppositional Defiant Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|4|4.0||||||
4327501|NCT00447278|4154859|B1|Yes, but not present (had disorder in the past)||Kiddie Schedule for Affective Disorders - Oppositional Defiant Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|2|2.0||||||
4327502|NCT00447278|4154857|B3|Yes (currently have the disorder)||Kiddie Schedule for Affective Disorders - Oppositional Defiant Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|152|152.0||||||
4327503|NCT00447278|4154858|B2|Yes (currently have the disorder)||Kiddie Schedule for Affective Disorders - Oppositional Defiant Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|73|73.0||||||
4327504|NCT00447278|4154859|B1|Yes (currently have the disorder)||Kiddie Schedule for Affective Disorders - Oppositional Defiant Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|79|79.0||||||
4327505|NCT00447278|4154857|B3|No (never had the disorder)||Kiddie Schedule for Affective Disorders - Conduct Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|371|371.0||||||
4327506|NCT00447278|4154858|B2|No (never had the disorder)||Kiddie Schedule for Affective Disorders - Conduct Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|187|187.0||||||
4327507|NCT00447278|4154859|B1|No (never had the disorder)||Kiddie Schedule for Affective Disorders - Conduct Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|184|184.0||||||
4327508|NCT00447278|4154857|B3|Yes, but not present (had disorder in the past)||Kiddie Schedule for Affective Disorders - Conduct Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|4|4.0||||||
4327509|NCT00447278|4154858|B2|Yes, but not present (had disorder in the past)||Kiddie Schedule for Affective Disorders - Conduct Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|2|2.0||||||
4327510|NCT00447278|4154859|B1|Yes, but not present (had disorder in the past)||Kiddie Schedule for Affective Disorders - Conduct Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|2|2.0||||||
4327511|NCT00447278|4154857|B3|Yes (currently have the disorder)||Kiddie Schedule for Affective Disorders - Conduct Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|23|23.0||||||
4327512|NCT00447278|4154858|B2|Yes (currently have the disorder)||Kiddie Schedule for Affective Disorders - Conduct Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|10|10.0||||||
4327513|NCT00447278|4154859|B1|Yes (currently have the disorder)||Kiddie Schedule for Affective Disorders - Conduct Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|13|13.0||||||
4327514|NCT00447278|4154857|B3|Inattentive ADHD Subtype||Kiddie Schedule for Affective Disorders - Attention-Deficit/Hyperactivity Disorder (ADHD) Subtypes|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|75|75.0||||||
4327515|NCT00447278|4154858|B2|Inattentive ADHD Subtype||Kiddie Schedule for Affective Disorders - Attention-Deficit/Hyperactivity Disorder (ADHD) Subtypes|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|36|36.0||||||
4327516|NCT00447278|4154859|B1|Inattentive ADHD Subtype||Kiddie Schedule for Affective Disorders - Attention-Deficit/Hyperactivity Disorder (ADHD) Subtypes|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|39|39.0||||||
4327517|NCT00447278|4154857|B3|Hyperactive/Impulsive ADHD Subtype||Kiddie Schedule for Affective Disorders - Attention-Deficit/Hyperactivity Disorder (ADHD) Subtypes|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|11|11.0||||||
4327518|NCT00447278|4154858|B2|Hyperactive/Impulsive ADHD Subtype||Kiddie Schedule for Affective Disorders - Attention-Deficit/Hyperactivity Disorder (ADHD) Subtypes|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|7|7.0||||||
4327519|NCT00447278|4154859|B1|Hyperactive/Impulsive ADHD Subtype||Kiddie Schedule for Affective Disorders - Attention-Deficit/Hyperactivity Disorder (ADHD) Subtypes|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|4|4.0||||||
4327520|NCT00447278|4154857|B3|Combined ADHD Subtype||Kiddie Schedule for Affective Disorders - Attention-Deficit/Hyperactivity Disorder (ADHD) Subtypes|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|312|312.0||||||
4327521|NCT00447278|4154858|B2|Combined ADHD Subtype||Kiddie Schedule for Affective Disorders - Attention-Deficit/Hyperactivity Disorder (ADHD) Subtypes|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|156|156.0||||||
4327522|NCT00447278|4154859|B1|Combined ADHD Subtype||Kiddie Schedule for Affective Disorders - Attention-Deficit/Hyperactivity Disorder (ADHD) Subtypes|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|156|156.0||||||
4327523|NCT00447278|4154857|B3|Missing Information||Kiddie Schedule for Affective Disorders - Anxiety Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|7|7.0||||||
4327524|NCT00447278|4154858|B2|Missing Information||Kiddie Schedule for Affective Disorders - Anxiety Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|2|2.0||||||
4327525|NCT00447278|4154859|B1|Missing Information||Kiddie Schedule for Affective Disorders - Anxiety Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|5|5.0||||||
4327526|NCT00447278|4154857|B3|4 Anxiety Disorders||Kiddie Schedule for Affective Disorders - Anxiety Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|1|1.0||||||
4327527|NCT00447278|4154858|B2|4 Anxiety Disorders||Kiddie Schedule for Affective Disorders - Anxiety Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|0|0.0||||||
4327528|NCT00447278|4154859|B1|4 Anxiety Disorders||Kiddie Schedule for Affective Disorders - Anxiety Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|1|1.0||||||
4327529|NCT00447278|4154857|B3|3 Anxiety Disorders||Kiddie Schedule for Affective Disorders - Anxiety Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|2|2.0||||||
4327530|NCT00447278|4154858|B2|3 Anxiety Disorders||Kiddie Schedule for Affective Disorders - Anxiety Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|0|0.0||||||
4327531|NCT00447278|4154859|B1|3 Anxiety Disorders||Kiddie Schedule for Affective Disorders - Anxiety Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|2|2.0||||||
4327532|NCT00447278|4154857|B3|2 Anxiety Disorders||Kiddie Schedule for Affective Disorders - Anxiety Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|10|10.0||||||
4327533|NCT00447278|4154858|B2|2 Anxiety Disorders||Kiddie Schedule for Affective Disorders - Anxiety Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|6|6.0||||||
4327534|NCT00447278|4154859|B1|2 Anxiety Disorders||Kiddie Schedule for Affective Disorders - Anxiety Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|4|4.0||||||
4327535|NCT00447278|4154857|B3|1 Anxiety Disorder||Kiddie Schedule for Affective Disorders - Anxiety Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|29|29.0||||||
4327536|NCT00447278|4154858|B2|1 Anxiety Disorder||Kiddie Schedule for Affective Disorders - Anxiety Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|18|18.0||||||
4327537|NCT00447278|4154859|B1|1 Anxiety Disorder||Kiddie Schedule for Affective Disorders - Anxiety Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|11|11.0||||||
4327538|NCT00447278|4154857|B3|0 Anxiety Disorders||Kiddie Schedule for Affective Disorders - Anxiety Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|349|349.0||||||
4327559|NCT00447278|4154857|B3|Turkey||Region of Enrollment||participants|Number|47|47.0||||||
4327560|NCT00447278|4154858|B2|Turkey||Region of Enrollment||participants|Number|24|24.0||||||
4327561|NCT00447278|4154859|B1|Turkey||Region of Enrollment||participants|Number|23|23.0||||||
4327539|NCT00447278|4154858|B2|0 Anxiety Disorders||Kiddie Schedule for Affective Disorders - Anxiety Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|173|173.0||||||
4327540|NCT00447278|4154859|B1|0 Anxiety Disorders||Kiddie Schedule for Affective Disorders - Anxiety Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|176|176.0||||||
4327541|NCT00447278|4154857|B3|Missing Information||Kiddie Schedule for Affective Disorders - Affective Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|17|17.0||||||
4327542|NCT00447278|4154858|B2|Missing Information||Kiddie Schedule for Affective Disorders - Affective Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|9|9.0||||||
4327543|NCT00447278|4154859|B1|Missing Information||Kiddie Schedule for Affective Disorders - Affective Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|8|8.0||||||
4327544|NCT00447278|4154857|B3|1 Affective Disorder||Kiddie Schedule for Affective Disorders - Affective Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|3|3.0||||||
4327545|NCT00447278|4154858|B2|1 Affective Disorder||Kiddie Schedule for Affective Disorders - Affective Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|1|1.0||||||
4327546|NCT00447278|4154859|B1|1 Affective Disorder||Kiddie Schedule for Affective Disorders - Affective Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|2|2.0||||||
4327547|NCT00447278|4154857|B3|0 Affective Disorders||Kiddie Schedule for Affective Disorders - Affective Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|378|378.0||||||
4327548|NCT00447278|4154858|B2|0 Affective Disorders||Kiddie Schedule for Affective Disorders - Affective Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|189|189.0||||||
4327549|NCT00447278|4154859|B1|0 Affective Disorders||Kiddie Schedule for Affective Disorders - Affective Disorder|The Kiddie-SADS-Present and Lifetime Version is an instrument completed through a semi-structured diagnostic interview designed to assess current and lifetime history of psychopathology in children and adolescents according to Diagnostic and Statistical Manual of Mental Disorders Third Edition, Revision (DSM-III-R) and DSM Fourth Edition (DSM-IV) criteria. The ‘Summary Lifetime Diagnoses Checklist’ aggregates diagnoses-related data to make a final decision as to the presence or absence of the evaluated condition/disease.|participants|Number|189|189.0||||||
4327550|NCT00447278|4154857|B3|Italy||Region of Enrollment||participants|Number|40|40.0||||||
4327551|NCT00447278|4154858|B2|Italy||Region of Enrollment||participants|Number|20|20.0||||||
4327562|NCT00447278|4154857|B3|Ireland||Region of Enrollment||participants|Number|5|5.0||||||
4327563|NCT00447278|4154858|B2|Ireland||Region of Enrollment||participants|Number|2|2.0||||||
4327564|NCT00447278|4154859|B1|Ireland||Region of Enrollment||participants|Number|3|3.0||||||
4327565|NCT00447278|4154857|B3|Spain||Region of Enrollment||participants|Number|119|119.0||||||
4327566|NCT00447278|4154858|B2|Spain||Region of Enrollment||participants|Number|58|58.0||||||
4327567|NCT00447278|4154859|B1|Spain||Region of Enrollment||participants|Number|61|61.0||||||
4327568|NCT00447278|4154857|B3|Belgium||Region of Enrollment||participants|Number|46|46.0||||||
4327569|NCT00447278|4154858|B2|Belgium||Region of Enrollment||participants|Number|23|23.0||||||
4327570|NCT00447278|4154859|B1|Belgium||Region of Enrollment||participants|Number|23|23.0||||||
4327571|NCT00447278|4154857|B3|Mexico||Region of Enrollment||participants|Number|23|23.0||||||
4327572|NCT00447278|4154858|B2|Mexico||Region of Enrollment||participants|Number|12|12.0||||||
4327573|NCT00447278|4154859|B1|Mexico||Region of Enrollment||participants|Number|11|11.0||||||
4327574|NCT00447278|4154857|B3|France||Region of Enrollment||participants|Number|64|64.0||||||
4327575|NCT00447278|4154858|B2|France||Region of Enrollment||participants|Number|32|32.0||||||
4327576|NCT00447278|4154859|B1|France||Region of Enrollment||participants|Number|32|32.0||||||
4327577|NCT00447278|4154857|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4327578|NCT00447278|4154858|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4327579|NCT00447278|4154859|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4327580|NCT00447278|4154857|B3|East Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4327581|NCT00447278|4154858|B2|East Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4327582|NCT00447278|4154859|B1|East Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4327583|NCT00447278|4154857|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|361|361.0||||||
4327584|NCT00447278|4154858|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|181|181.0||||||
4327585|NCT00447278|4154859|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|180|180.0||||||
4327586|NCT00447278|4154857|B3|African||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4327587|NCT00447278|4154858|B2|African||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4327588|NCT00447278|4154859|B1|African||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4327589|NCT00447278|4154857|B3||Male|Sex: Female, Male||Participants|Count of Participants|316|316.0||||||
4327590|NCT00447278|4154858|B2||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4327591|NCT00447278|4154859|B1||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4327592|NCT00447278|4154857|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4327593|NCT00447278|4154858|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4327594|NCT00447278|4154859|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4327595|NCT00447278|4154857|B3|||Age||years|Mean|9.3|9.3|Standard Deviation|2.60|2.6|||
4327596|NCT00447278|4154858|B2|||Age||years|Mean|9.4|9.4|Standard Deviation|2.64|2.64|||
4327597|NCT00447278|4154859|B1|||Age||years|Mean|9.2|9.2|Standard Deviation|2.57|2.57|||
4327598|NCT00447265|4154881|B1|||SLEDAI total score|The Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) is a concise measure of lupus disease activity with excellent test-retest reliability and high responsiveness to clinically important changes in the disease. The total score is derived from ratings on 24 conditions plus the Physician's Global Assessment; 0 indicates inactive disease and the maximum theoretical score is 105 with higher scores representing increased disease activity.|Score|Mean|22|22.0|Full Range|||22.0|22.0|
4327599|NCT00447265|4154881|B1|||Day 0 random urine protein||mg/dL|Mean|141|141.0|Full Range|||141.0|141.0|
4327600|NCT00447265|4154881|B1|||Day 0 GFR (mL/min per 1.73m^2)|"Glomerular filtration rate (GFR) is calculated based on the Modification of Diet in Renal Disease equation (Levy, AS, Coresh J, Galk E et al, National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med, 139(2): 137-47, 2003)"|mL/min/1.73m^2|Mean|96.9|96.9|Full Range|||96.9|96.9|
4327601|NCT00447265|4154881|B1|United States||Region of Enrollment||Participants|Number|1|1.0||||||
4327602|NCT00447265|4154881|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4327603|NCT00447265|4154881|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4327604|NCT00447265|4154881|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4327605|NCT00447265|4154881|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4327606|NCT00447265|4154881|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4327607|NCT00447226|4154895|B1|African American/ African heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4327608|NCT00447226|4154895|B1|White||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4327609|NCT00447226|4154895|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4327610|NCT00447226|4154895|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4327611|NCT00447226|4154895|B1|||Age||years|Mean|65|65.0|Standard Deviation|10.25|10.25|||
4327612|NCT00447122|4154914|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4327613|NCT00447122|4154914|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4327614|NCT00447122|4154914|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4327615|NCT00447122|4154914|B1|||Age||years|Mean|62|62.0|Standard Deviation|7|7.0|||
4327616|NCT00447122|4154914|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4327617|NCT00447122|4154914|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4327618|NCT00447122|4154914|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4327619|NCT00447083|4154918|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4327620|NCT00447083|4154919|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4327621|NCT00447083|4154920|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4327622|NCT00447083|4154918|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4327623|NCT00447083|4154918|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4327624|NCT00447083|4154919|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4327625|NCT00447083|4154920|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4327626|NCT00447083|4154918|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4327627|NCT00447083|4154919|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4327628|NCT00447083|4154920|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4327629|NCT00447083|4154918|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4327630|NCT00447083|4154919|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4327631|NCT00447083|4154920|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4327632|NCT00447083|4154918|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4327633|NCT00447083|4154919|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4327634|NCT00447083|4154920|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4327635|NCT00447083|4154918|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4327636|NCT00447083|4154919|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4327637|NCT00447083|4154920|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4327638|NCT00447057|4154935|B5|Unknown||Pack-years, smokers only|Pack-year equals the number of cigarette packs smoked per day multiplied by the number of years the participant has smoked. For example, 1 pack-year is equal to smoking an average of 20 cigarettes per day (1 pack) for 1 year.|participants|Number|36|36.0||||||
4327639|NCT00447057|4154936|B4|Unknown||Pack-years, smokers only|Pack-year equals the number of cigarette packs smoked per day multiplied by the number of years the participant has smoked. For example, 1 pack-year is equal to smoking an average of 20 cigarettes per day (1 pack) for 1 year.|participants|Number|0|0.0||||||
4327640|NCT00447057|4154937|B3|Unknown||Pack-years, smokers only|Pack-year equals the number of cigarette packs smoked per day multiplied by the number of years the participant has smoked. For example, 1 pack-year is equal to smoking an average of 20 cigarettes per day (1 pack) for 1 year.|participants|Number|3|3.0||||||
4327641|NCT00447057|4154938|B2|Unknown||Pack-years, smokers only|Pack-year equals the number of cigarette packs smoked per day multiplied by the number of years the participant has smoked. For example, 1 pack-year is equal to smoking an average of 20 cigarettes per day (1 pack) for 1 year.|participants|Number|15|15.0||||||
4327642|NCT00447057|4154939|B1|Unknown||Pack-years, smokers only|Pack-year equals the number of cigarette packs smoked per day multiplied by the number of years the participant has smoked. For example, 1 pack-year is equal to smoking an average of 20 cigarettes per day (1 pack) for 1 year.|participants|Number|18|18.0||||||
4327643|NCT00447057|4154935|B5|More than 15 pack-years||Pack-years, smokers only|Pack-year equals the number of cigarette packs smoked per day multiplied by the number of years the participant has smoked. For example, 1 pack-year is equal to smoking an average of 20 cigarettes per day (1 pack) for 1 year.|participants|Number|148|148.0||||||
4327644|NCT00447057|4154936|B4|More than 15 pack-years||Pack-years, smokers only|Pack-year equals the number of cigarette packs smoked per day multiplied by the number of years the participant has smoked. For example, 1 pack-year is equal to smoking an average of 20 cigarettes per day (1 pack) for 1 year.|participants|Number|25|25.0||||||
4327645|NCT00447057|4154937|B3|More than 15 pack-years||Pack-years, smokers only|Pack-year equals the number of cigarette packs smoked per day multiplied by the number of years the participant has smoked. For example, 1 pack-year is equal to smoking an average of 20 cigarettes per day (1 pack) for 1 year.|participants|Number|15|15.0||||||
4327646|NCT00447057|4154938|B2|More than 15 pack-years||Pack-years, smokers only|Pack-year equals the number of cigarette packs smoked per day multiplied by the number of years the participant has smoked. For example, 1 pack-year is equal to smoking an average of 20 cigarettes per day (1 pack) for 1 year.|participants|Number|48|48.0||||||
4327647|NCT00447057|4154939|B1|More than 15 pack-years||Pack-years, smokers only|Pack-year equals the number of cigarette packs smoked per day multiplied by the number of years the participant has smoked. For example, 1 pack-year is equal to smoking an average of 20 cigarettes per day (1 pack) for 1 year.|participants|Number|60|60.0||||||
4327648|NCT00447057|4154935|B5|Up to 15 pack-years||Pack-years, smokers only|Pack-year equals the number of cigarette packs smoked per day multiplied by the number of years the participant has smoked. For example, 1 pack-year is equal to smoking an average of 20 cigarettes per day (1 pack) for 1 year.|participants|Number|20|20.0||||||
4327649|NCT00447057|4154936|B4|Up to 15 pack-years||Pack-years, smokers only|Pack-year equals the number of cigarette packs smoked per day multiplied by the number of years the participant has smoked. For example, 1 pack-year is equal to smoking an average of 20 cigarettes per day (1 pack) for 1 year.|participants|Number|1|1.0||||||
4327650|NCT00447057|4154937|B3|Up to 15 pack-years||Pack-years, smokers only|Pack-year equals the number of cigarette packs smoked per day multiplied by the number of years the participant has smoked. For example, 1 pack-year is equal to smoking an average of 20 cigarettes per day (1 pack) for 1 year.|participants|Number|1|1.0||||||
4327651|NCT00447057|4154938|B2|Up to 15 pack-years||Pack-years, smokers only|Pack-year equals the number of cigarette packs smoked per day multiplied by the number of years the participant has smoked. For example, 1 pack-year is equal to smoking an average of 20 cigarettes per day (1 pack) for 1 year.|participants|Number|13|13.0||||||
4327652|NCT00447057|4154939|B1|Up to 15 pack-years||Pack-years, smokers only|Pack-year equals the number of cigarette packs smoked per day multiplied by the number of years the participant has smoked. For example, 1 pack-year is equal to smoking an average of 20 cigarettes per day (1 pack) for 1 year.|participants|Number|5|5.0||||||
4327653|NCT00447057|4154935|B5|Current smoker||Smoking status||participants|Number|54|54.0||||||
4327654|NCT00447057|4154936|B4|Current smoker||Smoking status||participants|Number|7|7.0||||||
4327655|NCT00447057|4154937|B3|Current smoker||Smoking status||participants|Number|7|7.0||||||
4327656|NCT00447057|4154938|B2|Current smoker||Smoking status||participants|Number|15|15.0||||||
4327657|NCT00447057|4154939|B1|Current smoker||Smoking status||participants|Number|25|25.0||||||
4327658|NCT00447057|4154935|B5|Ex-smoker||Smoking status||participants|Number|126|126.0||||||
4327659|NCT00447057|4154936|B4|Ex-smoker||Smoking status||participants|Number|19|19.0||||||
4327660|NCT00447057|4154937|B3|Ex-smoker||Smoking status||participants|Number|12|12.0||||||
4327661|NCT00447057|4154938|B2|Ex-smoker||Smoking status||participants|Number|51|51.0||||||
4327662|NCT00447057|4154939|B1|Ex-smoker||Smoking status||participants|Number|44|44.0||||||
4327663|NCT00447057|4154935|B5|Never smoked||Smoking status||participants|Number|24|24.0||||||
4327664|NCT00447057|4154936|B4|Never smoked||Smoking status||participants|Number|0|0.0||||||
4327665|NCT00447057|4154937|B3|Never smoked||Smoking status||participants|Number|0|0.0||||||
4327666|NCT00447057|4154938|B2|Never smoked||Smoking status||participants|Number|10|10.0||||||
4327667|NCT00447057|4154939|B1|Never smoked||Smoking status||participants|Number|14|14.0||||||
4327668|NCT00447057|4154935|B5|Stage IV||Stage of Disease at Study Entry|"Disease Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body).~Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver"|participants|Number|168|168.0||||||
4327669|NCT00447057|4154936|B4|Stage IV||Stage of Disease at Study Entry|"Disease Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body).~Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver"|participants|Number|21|21.0||||||
4327670|NCT00447057|4154937|B3|Stage IV||Stage of Disease at Study Entry|"Disease Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body).~Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver"|participants|Number|13|13.0||||||
4327671|NCT00447057|4154938|B2|Stage IV||Stage of Disease at Study Entry|"Disease Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body).~Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver"|participants|Number|64|64.0||||||
4327672|NCT00447057|4154939|B1|Stage IV||Stage of Disease at Study Entry|"Disease Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body).~Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver"|participants|Number|70|70.0||||||
4327673|NCT00447057|4154935|B5|Stage IIIB||Stage of Disease at Study Entry|"Disease Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body).~Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver"|participants|Number|30|30.0||||||
4327674|NCT00447057|4154936|B4|Stage IIIB||Stage of Disease at Study Entry|"Disease Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body).~Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver"|participants|Number|5|5.0||||||
4327675|NCT00447057|4154937|B3|Stage IIIB||Stage of Disease at Study Entry|"Disease Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body).~Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver"|participants|Number|4|4.0||||||
4327676|NCT00447057|4154938|B2|Stage IIIB||Stage of Disease at Study Entry|"Disease Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body).~Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver"|participants|Number|11|11.0||||||
4327730|NCT00447057|4154937|B3|Histopathological||Basis for Diagnosis||participants|Number|18|18.0||||||
4327731|NCT00447057|4154938|B2|Histopathological||Basis for Diagnosis||participants|Number|61|61.0||||||
4327677|NCT00447057|4154939|B1|Stage IIIB||Stage of Disease at Study Entry|"Disease Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body).~Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver"|participants|Number|10|10.0||||||
4327678|NCT00447057|4154935|B5|Stage IIIA||Stage of Disease at Study Entry|"Disease Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body).~Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver"|participants|Number|6|6.0||||||
4327679|NCT00447057|4154936|B4|Stage IIIA||Stage of Disease at Study Entry|"Disease Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body).~Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver"|participants|Number|0|0.0||||||
4327680|NCT00447057|4154937|B3|Stage IIIA||Stage of Disease at Study Entry|"Disease Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body).~Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver"|participants|Number|2|2.0||||||
4327681|NCT00447057|4154938|B2|Stage IIIA||Stage of Disease at Study Entry|"Disease Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body).~Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver"|participants|Number|1|1.0||||||
4327682|NCT00447057|4154939|B1|Stage IIIA||Stage of Disease at Study Entry|"Disease Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body).~Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver"|participants|Number|3|3.0||||||
4327683|NCT00447057|4154935|B5|Stage II||Stage of Disease at Study Entry|"Disease Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body).~Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver"|participants|Number|0|0.0||||||
4327684|NCT00447057|4154936|B4|Stage II||Stage of Disease at Study Entry|"Disease Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body).~Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver"|participants|Number|0|0.0||||||
4327685|NCT00447057|4154937|B3|Stage II||Stage of Disease at Study Entry|"Disease Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body).~Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver"|participants|Number|0|0.0||||||
4327686|NCT00447057|4154938|B2|Stage II||Stage of Disease at Study Entry|"Disease Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body).~Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver"|participants|Number|0|0.0||||||
4327687|NCT00447057|4154939|B1|Stage II||Stage of Disease at Study Entry|"Disease Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body).~Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver"|participants|Number|0|0.0||||||
4327688|NCT00447057|4154935|B5|Stage I||Stage of Disease at Study Entry|"Disease Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body).~Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver"|participants|Number|0|0.0||||||
4327689|NCT00447057|4154936|B4|Stage I||Stage of Disease at Study Entry|"Disease Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body).~Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver"|participants|Number|0|0.0||||||
4327690|NCT00447057|4154937|B3|Stage I||Stage of Disease at Study Entry|"Disease Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body).~Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver"|participants|Number|0|0.0||||||
4327691|NCT00447057|4154938|B2|Stage I||Stage of Disease at Study Entry|"Disease Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body).~Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver"|participants|Number|0|0.0||||||
4327692|NCT00447057|4154939|B1|Stage I||Stage of Disease at Study Entry|"Disease Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body).~Stage 0 - the cancer has not spread beyond the inner lining of the lung Stage I - the cancer is small and hasn't spread to the lymph nodes Stage II - the cancer has spread to some lymph nodes near the original tumor Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver"|participants|Number|0|0.0||||||
4327693|NCT00447057|4154935|B5|Unknown||Initial Pathological Diagnosis||participants|Number|6|6.0||||||
4327694|NCT00447057|4154936|B4|Unknown||Initial Pathological Diagnosis||participants|Number|0|0.0||||||
4327695|NCT00447057|4154937|B3|Unknown||Initial Pathological Diagnosis||participants|Number|0|0.0||||||
4327696|NCT00447057|4154938|B2|Unknown||Initial Pathological Diagnosis||participants|Number|4|4.0||||||
4327697|NCT00447057|4154939|B1|Unknown||Initial Pathological Diagnosis||participants|Number|2|2.0||||||
4327698|NCT00447057|4154935|B5|Squamous cell carcinoma of the lung||Initial Pathological Diagnosis||participants|Number|45|45.0||||||
4327699|NCT00447057|4154936|B4|Squamous cell carcinoma of the lung||Initial Pathological Diagnosis||participants|Number|26|26.0||||||
4327700|NCT00447057|4154937|B3|Squamous cell carcinoma of the lung||Initial Pathological Diagnosis||participants|Number|19|19.0||||||
4327701|NCT00447057|4154938|B2|Squamous cell carcinoma of the lung||Initial Pathological Diagnosis||participants|Number|0|0.0||||||
4327702|NCT00447057|4154939|B1|Squamous cell carcinoma of the lung||Initial Pathological Diagnosis||participants|Number|0|0.0||||||
4327703|NCT00447057|4154935|B5|Bronchioalveolar carcinoma||Initial Pathological Diagnosis||participants|Number|5|5.0||||||
4327704|NCT00447057|4154936|B4|Bronchioalveolar carcinoma||Initial Pathological Diagnosis||participants|Number|0|0.0||||||
4327705|NCT00447057|4154937|B3|Bronchioalveolar carcinoma||Initial Pathological Diagnosis||participants|Number|0|0.0||||||
4327706|NCT00447057|4154938|B2|Bronchioalveolar carcinoma||Initial Pathological Diagnosis||participants|Number|1|1.0||||||
4327707|NCT00447057|4154939|B1|Bronchioalveolar carcinoma||Initial Pathological Diagnosis||participants|Number|4|4.0||||||
4327708|NCT00447057|4154935|B5|Large cell lung carcinoma||Initial Pathological Diagnosis||participants|Number|15|15.0||||||
4327709|NCT00447057|4154936|B4|Large cell lung carcinoma||Initial Pathological Diagnosis||participants|Number|0|0.0||||||
4327710|NCT00447057|4154937|B3|Large cell lung carcinoma||Initial Pathological Diagnosis||participants|Number|0|0.0||||||
4327711|NCT00447057|4154938|B2|Large cell lung carcinoma||Initial Pathological Diagnosis||participants|Number|9|9.0||||||
4327712|NCT00447057|4154939|B1|Large cell lung carcinoma||Initial Pathological Diagnosis||participants|Number|6|6.0||||||
4327713|NCT00447057|4154935|B5|Mixed cell (squamous/adenocarcinoma)||Initial Pathological Diagnosis||participants|Number|2|2.0||||||
4327714|NCT00447057|4154936|B4|Mixed cell (squamous/adenocarcinoma)||Initial Pathological Diagnosis||participants|Number|0|0.0||||||
4327715|NCT00447057|4154937|B3|Mixed cell (squamous/adenocarcinoma)||Initial Pathological Diagnosis||participants|Number|0|0.0||||||
4327716|NCT00447057|4154938|B2|Mixed cell (squamous/adenocarcinoma)||Initial Pathological Diagnosis||participants|Number|1|1.0||||||
4327717|NCT00447057|4154939|B1|Mixed cell (squamous/adenocarcinoma)||Initial Pathological Diagnosis||participants|Number|1|1.0||||||
4327718|NCT00447057|4154935|B5|Adenocarcinoma of the lung||Initial Pathological Diagnosis||participants|Number|131|131.0||||||
4327719|NCT00447057|4154936|B4|Adenocarcinoma of the lung||Initial Pathological Diagnosis||participants|Number|0|0.0||||||
4327720|NCT00447057|4154937|B3|Adenocarcinoma of the lung||Initial Pathological Diagnosis||participants|Number|0|0.0||||||
4327721|NCT00447057|4154938|B2|Adenocarcinoma of the lung||Initial Pathological Diagnosis||participants|Number|61|61.0||||||
4327722|NCT00447057|4154939|B1|Adenocarcinoma of the lung||Initial Pathological Diagnosis||participants|Number|70|70.0||||||
4327723|NCT00447057|4154935|B5|Cytological||Basis for Diagnosis||participants|Number|39|39.0||||||
4327724|NCT00447057|4154936|B4|Cytological||Basis for Diagnosis||participants|Number|4|4.0||||||
4327725|NCT00447057|4154937|B3|Cytological||Basis for Diagnosis||participants|Number|1|1.0||||||
4327726|NCT00447057|4154938|B2|Cytological||Basis for Diagnosis||participants|Number|15|15.0||||||
4327727|NCT00447057|4154939|B1|Cytological||Basis for Diagnosis||participants|Number|19|19.0||||||
4327728|NCT00447057|4154935|B5|Histopathological||Basis for Diagnosis||participants|Number|165|165.0||||||
4327729|NCT00447057|4154936|B4|Histopathological||Basis for Diagnosis||participants|Number|22|22.0||||||
4327732|NCT00447057|4154939|B1|Histopathological||Basis for Diagnosis||participants|Number|64|64.0||||||
4327733|NCT00447057|4154935|B5|Unknown||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).~0 - Fully Active~- Ambulatory, Restricted Strenuous Activity~- Ambulatory, No Work Activities~- Partially Confined to Bed, Limited Self Care~- Completely Disabled"|Participants|Number|1|1.0||||||
4327734|NCT00447057|4154936|B4|Unknown||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).~0 - Fully Active~- Ambulatory, Restricted Strenuous Activity~- Ambulatory, No Work Activities~- Partially Confined to Bed, Limited Self Care~- Completely Disabled"|Participants|Number|0|0.0||||||
4327735|NCT00447057|4154937|B3|Unknown||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).~0 - Fully Active~- Ambulatory, Restricted Strenuous Activity~- Ambulatory, No Work Activities~- Partially Confined to Bed, Limited Self Care~- Completely Disabled"|Participants|Number|0|0.0||||||
4327736|NCT00447057|4154938|B2|Unknown||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).~0 - Fully Active~- Ambulatory, Restricted Strenuous Activity~- Ambulatory, No Work Activities~- Partially Confined to Bed, Limited Self Care~- Completely Disabled"|Participants|Number|1|1.0||||||
4327737|NCT00447057|4154939|B1|Unknown||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).~0 - Fully Active~- Ambulatory, Restricted Strenuous Activity~- Ambulatory, No Work Activities~- Partially Confined to Bed, Limited Self Care~- Completely Disabled"|Participants|Number|0|0.0||||||
4327738|NCT00447057|4154935|B5|Status 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).~0 - Fully Active~- Ambulatory, Restricted Strenuous Activity~- Ambulatory, No Work Activities~- Partially Confined to Bed, Limited Self Care~- Completely Disabled"|Participants|Number|29|29.0||||||
4327739|NCT00447057|4154936|B4|Status 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).~0 - Fully Active~- Ambulatory, Restricted Strenuous Activity~- Ambulatory, No Work Activities~- Partially Confined to Bed, Limited Self Care~- Completely Disabled"|Participants|Number|4|4.0||||||
4327740|NCT00447057|4154937|B3|Status 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).~0 - Fully Active~- Ambulatory, Restricted Strenuous Activity~- Ambulatory, No Work Activities~- Partially Confined to Bed, Limited Self Care~- Completely Disabled"|Participants|Number|5|5.0||||||
4327741|NCT00447057|4154938|B2|Status 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).~0 - Fully Active~- Ambulatory, Restricted Strenuous Activity~- Ambulatory, No Work Activities~- Partially Confined to Bed, Limited Self Care~- Completely Disabled"|Participants|Number|9|9.0||||||
4327742|NCT00447057|4154939|B1|Status 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).~0 - Fully Active~- Ambulatory, Restricted Strenuous Activity~- Ambulatory, No Work Activities~- Partially Confined to Bed, Limited Self Care~- Completely Disabled"|Participants|Number|11|11.0||||||
4327743|NCT00447057|4154935|B5|Status 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).~0 - Fully Active~- Ambulatory, Restricted Strenuous Activity~- Ambulatory, No Work Activities~- Partially Confined to Bed, Limited Self Care~- Completely Disabled"|Participants|Number|92|92.0||||||
4327744|NCT00447057|4154936|B4|Status 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).~0 - Fully Active~- Ambulatory, Restricted Strenuous Activity~- Ambulatory, No Work Activities~- Partially Confined to Bed, Limited Self Care~- Completely Disabled"|Participants|Number|13|13.0||||||
4327745|NCT00447057|4154937|B3|Status 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).~0 - Fully Active~- Ambulatory, Restricted Strenuous Activity~- Ambulatory, No Work Activities~- Partially Confined to Bed, Limited Self Care~- Completely Disabled"|Participants|Number|7|7.0||||||
4327746|NCT00447057|4154938|B2|Status 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).~0 - Fully Active~- Ambulatory, Restricted Strenuous Activity~- Ambulatory, No Work Activities~- Partially Confined to Bed, Limited Self Care~- Completely Disabled"|Participants|Number|33|33.0||||||
4327747|NCT00447057|4154939|B1|Status 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).~0 - Fully Active~- Ambulatory, Restricted Strenuous Activity~- Ambulatory, No Work Activities~- Partially Confined to Bed, Limited Self Care~- Completely Disabled"|Participants|Number|39|39.0||||||
4327748|NCT00447057|4154935|B5|Status 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).~0 - Fully Active~- Ambulatory, Restricted Strenuous Activity~- Ambulatory, No Work Activities~- Partially Confined to Bed, Limited Self Care~- Completely Disabled"|Participants|Number|82|82.0||||||
4327749|NCT00447057|4154936|B4|Status 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).~0 - Fully Active~- Ambulatory, Restricted Strenuous Activity~- Ambulatory, No Work Activities~- Partially Confined to Bed, Limited Self Care~- Completely Disabled"|Participants|Number|9|9.0||||||
4327750|NCT00447057|4154937|B3|Status 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).~0 - Fully Active~- Ambulatory, Restricted Strenuous Activity~- Ambulatory, No Work Activities~- Partially Confined to Bed, Limited Self Care~- Completely Disabled"|Participants|Number|7|7.0||||||
4327751|NCT00447057|4154938|B2|Status 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).~0 - Fully Active~- Ambulatory, Restricted Strenuous Activity~- Ambulatory, No Work Activities~- Partially Confined to Bed, Limited Self Care~- Completely Disabled"|Participants|Number|33|33.0||||||
4327752|NCT00447057|4154939|B1|Status 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Eastern Cooperative Oncology Group (ECOG) Performance Status classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).~0 - Fully Active~- Ambulatory, Restricted Strenuous Activity~- Ambulatory, No Work Activities~- Partially Confined to Bed, Limited Self Care~- Completely Disabled"|Participants|Number|33|33.0||||||
4327753|NCT00447057|4154935|B5|Sweden||Region of Enrollment||participants|Number|16|16.0||||||
4327754|NCT00447057|4154936|B4|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
4327755|NCT00447057|4154937|B3|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
4327756|NCT00447057|4154938|B2|Sweden||Region of Enrollment||participants|Number|11|11.0||||||
4327757|NCT00447057|4154939|B1|Sweden||Region of Enrollment||participants|Number|5|5.0||||||
4327758|NCT00447057|4154935|B5|Hungary||Region of Enrollment||participants|Number|34|34.0||||||
4327759|NCT00447057|4154936|B4|Hungary||Region of Enrollment||participants|Number|4|4.0||||||
4327760|NCT00447057|4154937|B3|Hungary||Region of Enrollment||participants|Number|4|4.0||||||
4327761|NCT00447057|4154938|B2|Hungary||Region of Enrollment||participants|Number|14|14.0||||||
4327762|NCT00447057|4154939|B1|Hungary||Region of Enrollment||participants|Number|12|12.0||||||
4327763|NCT00447057|4154935|B5|Spain||Region of Enrollment||participants|Number|41|41.0||||||
4327764|NCT00447057|4154936|B4|Spain||Region of Enrollment||participants|Number|7|7.0||||||
4327765|NCT00447057|4154937|B3|Spain||Region of Enrollment||participants|Number|7|7.0||||||
4327766|NCT00447057|4154938|B2|Spain||Region of Enrollment||participants|Number|9|9.0||||||
4327767|NCT00447057|4154939|B1|Spain||Region of Enrollment||participants|Number|18|18.0||||||
4327768|NCT00447057|4154935|B5|Germany||Region of Enrollment||participants|Number|102|102.0||||||
4327769|NCT00447057|4154936|B4|Germany||Region of Enrollment||participants|Number|15|15.0||||||
4327770|NCT00447057|4154937|B3|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4327771|NCT00447057|4154938|B2|Germany||Region of Enrollment||participants|Number|37|37.0||||||
4327772|NCT00447057|4154939|B1|Germany||Region of Enrollment||participants|Number|44|44.0||||||
4327773|NCT00447057|4154935|B5|Austria||Region of Enrollment||participants|Number|11|11.0||||||
4327774|NCT00447057|4154936|B4|Austria||Region of Enrollment||participants|Number|0|0.0||||||
4327775|NCT00447057|4154937|B3|Austria||Region of Enrollment||participants|Number|2|2.0||||||
4327776|NCT00447057|4154938|B2|Austria||Region of Enrollment||participants|Number|5|5.0||||||
4327777|NCT00447057|4154939|B1|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4327778|NCT00447057|4154935|B5|West Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4327779|NCT00447057|4154936|B4|West Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4327780|NCT00447057|4154937|B3|West Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4327781|NCT00447057|4154938|B2|West Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4327782|NCT00447057|4154939|B1|West Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4327783|NCT00447057|4154935|B5|East Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4327784|NCT00447057|4154936|B4|East Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4327785|NCT00447057|4154937|B3|East Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4327786|NCT00447057|4154938|B2|East Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4327787|NCT00447057|4154939|B1|East Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4327788|NCT00447057|4154935|B5|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4327789|NCT00447057|4154936|B4|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4327790|NCT00447057|4154937|B3|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4327791|NCT00447057|4154938|B2|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4327792|NCT00447057|4154939|B1|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4327793|NCT00447057|4154935|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4327794|NCT00447057|4154936|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4327795|NCT00447057|4154937|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4327796|NCT00447057|4154938|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4327797|NCT00447057|4154939|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4327798|NCT00447057|4154935|B5|African||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4327799|NCT00447057|4154936|B4|African||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4327800|NCT00447057|4154937|B3|African||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4327801|NCT00447057|4154938|B2|African||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4327802|NCT00447057|4154939|B1|African||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4327803|NCT00447057|4154935|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|202|202.0||||||
4327804|NCT00447057|4154936|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4327805|NCT00447057|4154937|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4327806|NCT00447057|4154938|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|75|75.0||||||
4327807|NCT00447057|4154939|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
4327808|NCT00447057|4154935|B5||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4327809|NCT00447057|4154936|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4327810|NCT00447057|4154937|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4327811|NCT00447057|4154938|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4327812|NCT00447057|4154939|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4327813|NCT00447057|4154935|B5||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4327814|NCT00447057|4154936|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4327815|NCT00447057|4154937|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4327816|NCT00447057|4154938|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4327817|NCT00447057|4154939|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4327818|NCT00447057|4154935|B5|||Age||years|Mean|62.3|62.3|Standard Deviation|9.96|9.96|||
4327819|NCT00447057|4154936|B4|||Age||years|Mean|66.1|66.1|Standard Deviation|8.58|8.58|||
4327820|NCT00447057|4154937|B3|||Age||years|Mean|63.9|63.9|Standard Deviation|9.33|9.33|||
4327821|NCT00447057|4154938|B2|||Age||years|Mean|63.5|63.5|Standard Deviation|9.70|9.7|||
4327822|NCT00447057|4154939|B1|||Age||years|Mean|59.8|59.8|Standard Deviation|10.25|10.25|||
4327823|NCT00447005|4154960|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4327824|NCT00447005|4154960|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4327825|NCT00447005|4154960|B1|||Age||years|Mean|60.2|60.2|Standard Deviation|13.1|13.1|||
4327826|NCT00446992|4154974|B1|No||Parental History of Type II Diabetes Mellitus||participants|Number|23|23.0||||||
4327827|NCT00446992|4154974|B1|Yes||Parental History of Type II Diabetes Mellitus||participants|Number|7|7.0||||||
4327828|NCT00446992|4154974|B1|||HDL||mg/dL|Mean|50|50.0|Standard Deviation|14|14.0|||
4327829|NCT00446992|4154974|B1|||LDL||mg/dL|Mean|97|97.0|Standard Deviation|27|27.0|||
4327830|NCT00446992|4154974|B1|||Triglycerides||mg/dL|Mean|80|80.0|Standard Deviation|26|26.0|||
4327831|NCT00446992|4154974|B1|||Total Cholesterol||mg/dL|Mean|163|163.0|Standard Deviation|30|30.0|||
4327832|NCT00446992|4154974|B1|||Cortisol||mg/dL|Mean|18.3|18.3|Standard Deviation|5.6|5.6|||
4327833|NCT00446992|4154974|B1|||Leptin||mg/dL|Mean|7.3|7.3|Standard Deviation|10.4|10.4|||
4327834|NCT00446992|4154974|B1|||Adiponectin||mg/dL|Mean|12.3|12.3|Standard Deviation|5.9|5.9|||
4327835|NCT00446992|4154974|B1|||C-Reactive Protein||mg/dL|Mean|.21|0.21|Standard Deviation|.34|0.34|||
4327836|NCT00446992|4154974|B1|PANSS Total||Positive and Negative Syndromes Scale (PANSS)|Scale ranges from a minimum of 30 (not impaired) to a maximum of 210 (greatest impairment) for the total score. Positive, Negative and General scales range from 7 (not impaired) to 49 (greatest impairment), 7 (not impaired) to 49 (greatest impairment), and 16 (not impaired) to 112 (greatest impairment), respectively.|units on a scale|Mean|87|87.0|Standard Deviation|20|20.0|||
4327837|NCT00446992|4154974|B1|PANSS General||Positive and Negative Syndromes Scale (PANSS)|Scale ranges from a minimum of 30 (not impaired) to a maximum of 210 (greatest impairment) for the total score. Positive, Negative and General scales range from 7 (not impaired) to 49 (greatest impairment), 7 (not impaired) to 49 (greatest impairment), and 16 (not impaired) to 112 (greatest impairment), respectively.|units on a scale|Mean|39|39.0|Standard Deviation|10|10.0|||
4327838|NCT00446992|4154974|B1|PANSS Negative||Positive and Negative Syndromes Scale (PANSS)|Scale ranges from a minimum of 30 (not impaired) to a maximum of 210 (greatest impairment) for the total score. Positive, Negative and General scales range from 7 (not impaired) to 49 (greatest impairment), 7 (not impaired) to 49 (greatest impairment), and 16 (not impaired) to 112 (greatest impairment), respectively.|units on a scale|Mean|23|23.0|Standard Deviation|9|9.0|||
4327839|NCT00446992|4154974|B1|PANSS Positive||Positive and Negative Syndromes Scale (PANSS)|Scale ranges from a minimum of 30 (not impaired) to a maximum of 210 (greatest impairment) for the total score. Positive, Negative and General scales range from 7 (not impaired) to 49 (greatest impairment), 7 (not impaired) to 49 (greatest impairment), and 16 (not impaired) to 112 (greatest impairment), respectively.|units on a scale|Mean|25|25.0|Standard Deviation|7|7.0|||
4327840|NCT00446992|4154974|B1|||Interleukin 6 (IL-6)||pg/mL|Mean|3.5|3.5|Standard Deviation|7.2|7.2|||
4327841|NCT00446992|4154974|B1|||Hemoglobin A1c||Percentage|Mean|4.4|4.4|Standard Deviation|0.3|0.3|||
4327842|NCT00446992|4154974|B1|||Fasting Insulin||mg/dL|Mean|9.7|9.7|Standard Deviation|4.4|4.4|||
4327843|NCT00446992|4154974|B1|||Oral Glucose Tolerance Test (OGGT)|2-hour, 75-g OGGT, which began between 8 and 9 am after an overnight fast|mg/dL|Mean|110|110.0|Standard Deviation|35|35.0|||
4327844|NCT00446992|4154974|B1|||Fasting Glucose||mg/dL|Mean|82|82.0|Standard Deviation|8|8.0|||
4327845|NCT00446992|4154974|B1|||Duration of Untreated Psychosis||Months|Mean|1.5|1.5|Standard Deviation|1.4|1.4|||
4327846|NCT00446992|4154974|B1|||Number of Cigarettes Per Day||cigarettes per day|Mean|8.1|8.1|Standard Deviation|9.7|9.7|||
4327847|NCT00446992|4154974|B1|||Body Mass Index||kg/m^2|Mean|22.1|22.1|Standard Deviation|3.0|3.0|||
4327848|NCT00446992|4154974|B1|||Socioeconomic Status (SES)|Hollingshead Redlich Scale. Scale: five social classes 1 though 5 (5 being the poorest).|units on a scale|Mean|4.9|4.9|Standard Deviation|1.6|1.6|||
4327849|NCT00446992|4154974|B1|Spain||Region of Enrollment||participants|Number|30|30.0||||||
4327850|NCT00446992|4154974|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4327851|NCT00446992|4154974|B1|White||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4327852|NCT00446992|4154974|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4327853|NCT00446992|4154974|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4327854|NCT00446992|4154974|B1|||Age||years|Mean|27.5|27.5|Standard Deviation|7.0|7.0|||
4327855|NCT00446966|4154986|B3|United States||Region of Enrollment||participants|Number|260|260.0||||||
4327856|NCT00446966|4154987|B2|United States||Region of Enrollment||participants|Number|130|130.0||||||
4327857|NCT00446966|4154988|B1|United States||Region of Enrollment||participants|Number|130|130.0||||||
4327858|NCT00446966|4154986|B3||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4327859|NCT00446966|4154987|B2||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4327860|NCT00446966|4154988|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4327861|NCT00446966|4154986|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4327862|NCT00446966|4154987|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4327863|NCT00446966|4154988|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4327864|NCT00446966|4154986|B3|||Age||years|Mean|62|62.0|Standard Deviation|10.3|10.3|||
4327865|NCT00446966|4154987|B2|||Age||years|Mean|62|62.0|Standard Deviation|11.4|11.4|||
4327866|NCT00446966|4154988|B1|||Age||years|Mean|63|63.0|Standard Deviation|9.5|9.5|||
4327867|NCT00446849|4154995|B1|United States||Region of Enrollment||participants|Number|208|208.0||||||
4327868|NCT00446849|4154995|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4327869|NCT00446849|4154995|B1||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4327870|NCT00446849|4154995|B1|||Age||years|Mean|46.9|46.9|Standard Deviation|13.70|13.7|||
4327871|NCT00446849|4154995|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4327872|NCT00446849|4154995|B1||Between 18 and 65 years|Age||Participants|Count of Participants|185|185.0||||||
4327873|NCT00446849|4154995|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4327874|NCT00446797|4155005|B3||Male|Sex: Female, Male||Participants|Count of Participants|167.0|167.0||||||
4327875|NCT00446797|4155006|B2||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4327876|NCT00446797|4155007|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4327877|NCT00446797|4155005|B3||Female|Sex: Female, Male||Participants|Count of Participants|111.0|111.0||||||
4327878|NCT00446797|4155006|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4327879|NCT00446797|4155007|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4327880|NCT00446797|4155005|B3|||Age||years|Mean|30.5|30.5|Full Range|||18.0|74.0|
4327881|NCT00446797|4155006|B2|||Age||years|Mean|30.4|30.4|Full Range|||18.0|74.0|
4327882|NCT00446797|4155007|B1|||Age||years|Mean|30.6|30.6|Full Range|||18.0|66.0|
4327883|NCT00446654|4155052|B3|Russian Federation||Region of Enrollment||participants|Number|34|34.0||||||
4327884|NCT00446654|4155053|B2|Russian Federation||Region of Enrollment||participants|Number|20|20.0||||||
4327885|NCT00446654|4155054|B1|Russian Federation||Region of Enrollment||participants|Number|14|14.0||||||
4327886|NCT00446654|4155052|B3|Mexico||Region of Enrollment||participants|Number|6|6.0||||||
4327887|NCT00446654|4155053|B2|Mexico||Region of Enrollment||participants|Number|1|1.0||||||
4327888|NCT00446654|4155054|B1|Mexico||Region of Enrollment||participants|Number|5|5.0||||||
4327889|NCT00446654|4155052|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4327890|NCT00446654|4155053|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4327891|NCT00446654|4155054|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4327892|NCT00446654|4155052|B3|Male||Gender|Demographic data is missing for 5 patients.|participants|Number|14|14.0||||||
4327893|NCT00446654|4155053|B2|Male||Gender|Demographic data is missing for 5 patients.|participants|Number|6|6.0||||||
4327894|NCT00446654|4155054|B1|Male||Gender|Demographic data is missing for 5 patients.|participants|Number|8|8.0||||||
4327895|NCT00446654|4155052|B3|Female||Gender|Demographic data is missing for 5 patients.|participants|Number|24|24.0||||||
4327896|NCT00446654|4155053|B2|Female||Gender|Demographic data is missing for 5 patients.|participants|Number|12|12.0||||||
4327897|NCT00446654|4155054|B1|Female||Gender|Demographic data is missing for 5 patients.|participants|Number|12|12.0||||||
4327898|NCT00446654|4155052|B3|||Age|Demographic data is missing for 5 patients.|years|Mean|68.7|68.7|Standard Deviation|7.7|7.7|||
4327899|NCT00446654|4155053|B2|||Age|Demographic data is missing for 5 patients.|years|Mean|68.1|68.1|Standard Deviation|7.0|7.0|||
4327900|NCT00446654|4155054|B1|||Age|Demographic data is missing for 5 patients.|years|Mean|69.3|69.3|Standard Deviation|8.5|8.5|||
4327901|NCT00446654|4155052|B3|>=65 years||Age|Demographic data is missing for 5 patients.|participants|Number|28|28.0||||||
4327902|NCT00446654|4155053|B2|>=65 years||Age|Demographic data is missing for 5 patients.|participants|Number|15|15.0||||||
4327903|NCT00446654|4155054|B1|>=65 years||Age|Demographic data is missing for 5 patients.|participants|Number|13|13.0||||||
4327904|NCT00446654|4155052|B3|Between 18 and 65 years||Age|Demographic data is missing for 5 patients.|participants|Number|10|10.0||||||
4327905|NCT00446654|4155053|B2|Between 18 and 65 years||Age|Demographic data is missing for 5 patients.|participants|Number|3|3.0||||||
4327906|NCT00446654|4155054|B1|Between 18 and 65 years||Age|Demographic data is missing for 5 patients.|participants|Number|7|7.0||||||
4327907|NCT00446654|4155052|B3|<=18 years||Age|Demographic data is missing for 5 patients.|participants|Number|0|0.0||||||
4327908|NCT00446654|4155053|B2|<=18 years||Age|Demographic data is missing for 5 patients.|participants|Number|0|0.0||||||
4327909|NCT00446654|4155054|B1|<=18 years||Age|Demographic data is missing for 5 patients.|participants|Number|0|0.0||||||
4327910|NCT00446641|4155061|B3|Korea, Republic of||Region of Enrollment||participants|Number|244|244.0||||||
4327911|NCT00446641|4155062|B2|Korea, Republic of||Region of Enrollment||participants|Number|119|119.0||||||
4327912|NCT00446641|4155063|B1|Korea, Republic of||Region of Enrollment||participants|Number|125|125.0||||||
4327913|NCT00446641|4155061|B3||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4327914|NCT00446641|4155062|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4327915|NCT00446641|4155063|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4327916|NCT00446641|4155061|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4327917|NCT00446641|4155062|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4327918|NCT00446641|4155063|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4327919|NCT00446641|4155061|B3|||Age||years|Mean|62.02|62.02|Standard Deviation|10.095|10.095|||
4327920|NCT00446641|4155062|B2|||Age||years|Mean|62.83|62.83|Standard Deviation|9.963|9.963|||
4327921|NCT00446641|4155063|B1|||Age||years|Mean|61.24|61.24|Standard Deviation|10.198|10.198|||
4327922|NCT00446641|4155061|B3||>=65 years|Age||Participants|Count of Participants|98|98.0||||||
4327923|NCT00446641|4155062|B2||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4327924|NCT00446641|4155063|B1||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
4327925|NCT00446641|4155061|B3||Between 18 and 65 years|Age||Participants|Count of Participants|146|146.0||||||
4327926|NCT00446641|4155062|B2||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4327927|NCT00446641|4155063|B1||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4327928|NCT00446641|4155061|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4327929|NCT00446641|4155062|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4327930|NCT00446641|4155063|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4327931|NCT00446563|4155082|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4327932|NCT00446563|4155083|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4327933|NCT00446563|4155084|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4327934|NCT00446563|4155082|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4327935|NCT00446563|4155083|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4327936|NCT00446563|4155084|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4327937|NCT00446563|4155082|B3|||Age||years|Mean|57.7|57.7|Standard Deviation|11.5|11.5|||
4327938|NCT00446563|4155083|B2|||Age||years|Mean|57.2|57.2|Standard Deviation|10.9|10.9|||
4327939|NCT00446563|4155084|B1|||Age||years|Mean|58.2|58.2|Standard Deviation|12.2|12.2|||
4327940|NCT00446550|4155119|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4327941|NCT00446550|4155120|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4327942|NCT00446550|4155121|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4327943|NCT00446550|4155119|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4327944|NCT00446550|4155120|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4327945|NCT00446550|4155121|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4327946|NCT00446550|4155119|B3|||Age||years|Mean|41.4|41.4|Standard Deviation|16.48|16.48|||
4327947|NCT00446550|4155120|B2|||Age||years|Mean|39.1|39.1|Standard Deviation|17.62|17.62|||
4327948|NCT00446550|4155121|B1|||Age||years|Mean|43|43.0|Standard Deviation|16.27|16.27|||
4327949|NCT00446511|4155130|B5||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4327950|NCT00446511|4155131|B4||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4327951|NCT00446511|4155132|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4327952|NCT00446511|4155133|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4327953|NCT00446511|4155134|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4327954|NCT00446511|4155130|B5||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4327955|NCT00446511|4155131|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4327956|NCT00446511|4155132|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4327957|NCT00446511|4155133|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4327958|NCT00446511|4155134|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4327959|NCT00446511|4155130|B5|||Age||years|Mean|13.0|13.0|Standard Deviation|2.89|2.89|||
4327960|NCT00446511|4155131|B4|||Age||years|Mean|13.3|13.3|Standard Deviation|2.81|2.81|||
4327961|NCT00446511|4155132|B3|||Age||years|Mean|13.1|13.1|Standard Deviation|2.75|2.75|||
4327962|NCT00446511|4155133|B2|||Age||years|Mean|12.1|12.1|Standard Deviation|3.07|3.07|||
4327963|NCT00446511|4155134|B1|||Age||years|Mean|11.4|11.4|Standard Deviation|3.40|3.4|||
4327964|NCT00446459|4155161|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4327965|NCT00446459|4155161|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4327966|NCT00446459|4155161|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4327967|NCT00446459|4155161|B1|||Age||years|Mean|46.5|46.5|Standard Deviation|11.2|11.2|||
4327968|NCT00446459|4155161|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4327969|NCT00446459|4155161|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4327970|NCT00446459|4155161|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4327971|NCT00446446|4155169|B1|2 = (Ambulatory unable to Work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|"A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction;~= Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature;~= Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours;~= Capable of only limited self-care, confined to bed or chair > 50% of waking hours;~= Completely disabled, confined to bed or chair;~= Dead."|participants|Number|1|1.0||||||
4327972|NCT00446446|4155169|B1|1 = (Restrictive but Ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|"A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction;~= Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature;~= Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours;~= Capable of only limited self-care, confined to bed or chair > 50% of waking hours;~= Completely disabled, confined to bed or chair;~= Dead."|participants|Number|31|31.0||||||
4327973|NCT00446446|4155169|B1|0 = (Fully Active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|"A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction;~= Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature;~= Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours;~= Capable of only limited self-care, confined to bed or chair > 50% of waking hours;~= Completely disabled, confined to bed or chair;~= Dead."|participants|Number|20|20.0||||||
4327974|NCT00446446|4155169|B1|Prior surgery||Prior Treatment for Head and neck Cancer|Participants may have received more than one prior treatment.|participants|Number|46|46.0||||||
4327975|NCT00446446|4155169|B1|Prior radiotherapy||Prior Treatment for Head and neck Cancer|Participants may have received more than one prior treatment.|participants|Number|48|48.0||||||
4327976|NCT00446446|4155169|B1|Prior chemotherapy||Prior Treatment for Head and neck Cancer|Participants may have received more than one prior treatment.|participants|Number|52|52.0||||||
4327977|NCT00446446|4155169|B1|Metastatic||Cancer Stage of Diagnosis||participants|Number|41|41.0||||||
4327978|NCT00446446|4155169|B1|Locally recurrent disease without metastases||Cancer Stage of Diagnosis||participants|Number|11|11.0||||||
4327979|NCT00446446|4155169|B1|Oral Cavity||Primary Tumor Site||participants|Number|20|20.0||||||
4327980|NCT00446446|4155169|B1|Larynx||Primary Tumor Site||participants|Number|13|13.0||||||
4327981|NCT00446446|4155169|B1|Hypopharynx||Primary Tumor Site||participants|Number|1|1.0||||||
4327982|NCT00446446|4155169|B1|Oropharynx||Primary Tumor Site||participants|Number|18|18.0||||||
4327983|NCT00446446|4155169|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4327984|NCT00446446|4155169|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4327985|NCT00446446|4155169|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
4327986|NCT00446446|4155169|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4327987|NCT00446446|4155169|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4327988|NCT00446446|4155169|B1|||Age||years|Mean|59.8|59.8|Standard Deviation|8.9|8.9|||
4327989|NCT00446290|4155180|B1|Korea, Republic of||Region of Enrollment||participants|Number|21|21.0||||||
4327990|NCT00446290|4155180|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4327991|NCT00446290|4155180|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4327992|NCT00446290|4155180|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4327993|NCT00446290|4155180|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4327994|NCT00446290|4155180|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4327995|NCT00446290|4155180|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4327996|NCT00446290|4155180|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4327997|NCT00446290|4155180|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4327998|NCT00446290|4155180|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4327999|NCT00446290|4155180|B1|||Age, Customized||years|Median|50|50.0|Full Range|||21.0|65.0|
4328000|NCT00446264|4155184|B1|France||Region of Enrollment||participants|Number|14|14.0||||||
4328001|NCT00446264|4155184|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4328002|NCT00446264|4155184|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4328003|NCT00446264|4155184|B1|||Age||years|Mean|44|44.0|Standard Deviation|13|13.0|||
4328004|NCT00446264|4155184|B1||>=65 years|Age|18-65|Participants|Count of Participants|0|0.0||||||
4328005|NCT00446264|4155184|B1||Between 18 and 65 years|Age|18-65|Participants|Count of Participants|14|14.0||||||
4328006|NCT00446264|4155184|B1||<=18 years|Age|18-65|Participants|Count of Participants|0|0.0||||||
4328007|NCT00446251|4155193|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4328008|NCT00446251|4155193|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4328009|NCT00446251|4155193|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4328010|NCT00446251|4155193|B1|||Age||years|Mean|41.3|41.3|Standard Deviation|8.81|8.81|||
4328011|NCT00446251|4155193|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4328012|NCT00446251|4155193|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4328013|NCT00446251|4155193|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4328014|NCT00446199|4155199|B5|||Years since last menstruation at baseline|The population included all randomized participants with Baseline VMS data and at least 1 day VMS data postdose. Full Analysis Set (FAS).|years|Mean|9.355|9.355|Standard Deviation|8.4560|8.456|||
4328092|NCT00446134|4155296|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328015|NCT00446199|4155200|B4|||Years since last menstruation at baseline|The population included all randomized participants with Baseline VMS data and at least 1 day VMS data postdose. Full Analysis Set (FAS).|years|Mean|9.509|9.509|Standard Deviation|8.9693|8.9693|||
4328016|NCT00446199|4155201|B3|||Years since last menstruation at baseline|The population included all randomized participants with Baseline VMS data and at least 1 day VMS data postdose. Full Analysis Set (FAS).|years|Mean|9.214|9.214|Standard Deviation|8.1892|8.1892|||
4328017|NCT00446199|4155202|B2|||Years since last menstruation at baseline|The population included all randomized participants with Baseline VMS data and at least 1 day VMS data postdose. Full Analysis Set (FAS).|years|Mean|8.784|8.784|Standard Deviation|7.9947|7.9947|||
4328018|NCT00446199|4155203|B1|||Years since last menstruation at baseline|The population included all randomized participants with Baseline VMS data and at least 1 day VMS data postdose. Full Analysis Set (FAS).|years|Mean|9.913|9.913|Standard Deviation|8.6719|8.6719|||
4328019|NCT00446199|4155199|B5|||Body Mass Index (BMI)|The population included all randomized participants with Baseline VMS data and at least 1 day VMS data postdose. Full Analysis Set (FAS).|kg/sqm|Mean|28.543|28.543|Standard Deviation|5.8370|5.837|||
4328020|NCT00446199|4155200|B4|||Body Mass Index (BMI)|The population included all randomized participants with Baseline VMS data and at least 1 day VMS data postdose. Full Analysis Set (FAS).|kg/sqm|Mean|27.882|27.882|Standard Deviation|5.7859|5.7859|||
4328021|NCT00446199|4155201|B3|||Body Mass Index (BMI)|The population included all randomized participants with Baseline VMS data and at least 1 day VMS data postdose. Full Analysis Set (FAS).|kg/sqm|Mean|29.080|29.08|Standard Deviation|5.7410|5.741|||
4328022|NCT00446199|4155202|B2|||Body Mass Index (BMI)|The population included all randomized participants with Baseline VMS data and at least 1 day VMS data postdose. Full Analysis Set (FAS).|kg/sqm|Mean|28.190|28.19|Standard Deviation|5.6965|5.6965|||
4328023|NCT00446199|4155203|B1|||Body Mass Index (BMI)|The population included all randomized participants with Baseline VMS data and at least 1 day VMS data postdose. Full Analysis Set (FAS).|kg/sqm|Mean|29.070|29.07|Standard Deviation|6.0636|6.0636|||
4328024|NCT00446199|4155199|B5|oophorectomized||Number of participants with hysterectomy/oophorectomy|The population included all randomized participants with Baseline VMS data and at least 1 day VMS data postdose. Full Analysis Set (FAS).|Participants|Number|244|244.0||||||
4328025|NCT00446199|4155200|B4|oophorectomized||Number of participants with hysterectomy/oophorectomy|The population included all randomized participants with Baseline VMS data and at least 1 day VMS data postdose. Full Analysis Set (FAS).|Participants|Number|59|59.0||||||
4328026|NCT00446199|4155201|B3|oophorectomized||Number of participants with hysterectomy/oophorectomy|The population included all randomized participants with Baseline VMS data and at least 1 day VMS data postdose. Full Analysis Set (FAS).|Participants|Number|63|63.0||||||
4328027|NCT00446199|4155202|B2|oophorectomized||Number of participants with hysterectomy/oophorectomy|The population included all randomized participants with Baseline VMS data and at least 1 day VMS data postdose. Full Analysis Set (FAS).|Participants|Number|61|61.0||||||
4328028|NCT00446199|4155203|B1|oophorectomized||Number of participants with hysterectomy/oophorectomy|The population included all randomized participants with Baseline VMS data and at least 1 day VMS data postdose. Full Analysis Set (FAS).|Participants|Number|61|61.0||||||
4328029|NCT00446199|4155199|B5|hysterectomized||Number of participants with hysterectomy/oophorectomy|The population included all randomized participants with Baseline VMS data and at least 1 day VMS data postdose. Full Analysis Set (FAS).|Participants|Number|386|386.0||||||
4328030|NCT00446199|4155200|B4|hysterectomized||Number of participants with hysterectomy/oophorectomy|The population included all randomized participants with Baseline VMS data and at least 1 day VMS data postdose. Full Analysis Set (FAS).|Participants|Number|99|99.0||||||
4328031|NCT00446199|4155201|B3|hysterectomized||Number of participants with hysterectomy/oophorectomy|The population included all randomized participants with Baseline VMS data and at least 1 day VMS data postdose. Full Analysis Set (FAS).|Participants|Number|98|98.0||||||
4328032|NCT00446199|4155202|B2|hysterectomized||Number of participants with hysterectomy/oophorectomy|The population included all randomized participants with Baseline VMS data and at least 1 day VMS data postdose. Full Analysis Set (FAS).|Participants|Number|91|91.0||||||
4328033|NCT00446199|4155203|B1|hysterectomized||Number of participants with hysterectomy/oophorectomy|The population included all randomized participants with Baseline VMS data and at least 1 day VMS data postdose. Full Analysis Set (FAS).|Participants|Number|98|98.0||||||
4328034|NCT00446199|4155199|B5||Male|Sex: Female, Male|The population included all randomized participants with Baseline VMS data and at least 1 day VMS data postdose. Full Analysis Set (FAS).|Participants|Count of Participants|0|0.0||||||
4328035|NCT00446199|4155200|B4||Male|Sex: Female, Male|The population included all randomized participants with Baseline VMS data and at least 1 day VMS data postdose. Full Analysis Set (FAS).|Participants|Count of Participants|0|0.0||||||
4328036|NCT00446199|4155201|B3||Male|Sex: Female, Male|The population included all randomized participants with Baseline VMS data and at least 1 day VMS data postdose. Full Analysis Set (FAS).|Participants|Count of Participants|0|0.0||||||
4328037|NCT00446199|4155202|B2||Male|Sex: Female, Male|The population included all randomized participants with Baseline VMS data and at least 1 day VMS data postdose. Full Analysis Set (FAS).|Participants|Count of Participants|0|0.0||||||
4328038|NCT00446199|4155203|B1||Male|Sex: Female, Male|The population included all randomized participants with Baseline VMS data and at least 1 day VMS data postdose. Full Analysis Set (FAS).|Participants|Count of Participants|0|0.0||||||
4328039|NCT00446199|4155199|B5||Female|Sex: Female, Male|The population included all randomized participants with Baseline VMS data and at least 1 day VMS data postdose. Full Analysis Set (FAS).|Participants|Count of Participants|710|710.0||||||
4328040|NCT00446199|4155200|B4||Female|Sex: Female, Male|The population included all randomized participants with Baseline VMS data and at least 1 day VMS data postdose. Full Analysis Set (FAS).|Participants|Count of Participants|176|176.0||||||
4328041|NCT00446199|4155201|B3||Female|Sex: Female, Male|The population included all randomized participants with Baseline VMS data and at least 1 day VMS data postdose. Full Analysis Set (FAS).|Participants|Count of Participants|179|179.0||||||
4328093|NCT00446134|4155297|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328042|NCT00446199|4155202|B2||Female|Sex: Female, Male|The population included all randomized participants with Baseline VMS data and at least 1 day VMS data postdose. Full Analysis Set (FAS).|Participants|Count of Participants|177|177.0||||||
4328043|NCT00446199|4155203|B1||Female|Sex: Female, Male|The population included all randomized participants with Baseline VMS data and at least 1 day VMS data postdose. Full Analysis Set (FAS).|Participants|Count of Participants|178|178.0||||||
4328044|NCT00446199|4155199|B5|||Age|The population included all randomized participants with Baseline VMS data and at least 1 day VMS data postdose. Full Analysis Set (FAS).|years|Mean|53.5|53.5|Standard Deviation|5.97|5.97|||
4328045|NCT00446199|4155200|B4|||Age|The population included all randomized participants with Baseline VMS data and at least 1 day VMS data postdose. Full Analysis Set (FAS).|years|Mean|53.4|53.4|Standard Deviation|6.46|6.46|||
4328046|NCT00446199|4155201|B3|||Age|The population included all randomized participants with Baseline VMS data and at least 1 day VMS data postdose. Full Analysis Set (FAS).|years|Mean|53.3|53.3|Standard Deviation|6.05|6.05|||
4328047|NCT00446199|4155202|B2|||Age|The population included all randomized participants with Baseline VMS data and at least 1 day VMS data postdose. Full Analysis Set (FAS).|years|Mean|53.5|53.5|Standard Deviation|5.77|5.77|||
4328048|NCT00446199|4155203|B1|||Age|The population included all randomized participants with Baseline VMS data and at least 1 day VMS data postdose. Full Analysis Set (FAS).|years|Mean|53.8|53.8|Standard Deviation|5.61|5.61|||
4328049|NCT00446147|4155284|B3|Korea, Republic of||Region of Enrollment||participants|Number|360|360.0||||||
4328050|NCT00446147|4155285|B2|Korea, Republic of||Region of Enrollment||participants|Number|180|180.0||||||
4328051|NCT00446147|4155286|B1|Korea, Republic of||Region of Enrollment||participants|Number|180|180.0||||||
4328052|NCT00446147|4155284|B3||Male|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
4328053|NCT00446147|4155285|B2||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4328054|NCT00446147|4155286|B1||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4328055|NCT00446147|4155284|B3||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4328056|NCT00446147|4155285|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4328057|NCT00446147|4155286|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4328058|NCT00446147|4155284|B3|Age_median||Age, Customized||years|Median|56|56.0|Full Range|||20.0|75.0|
4328059|NCT00446147|4155285|B2|Age_median||Age, Customized||years|Median|56|56.0|Full Range|||20.0|75.0|
4328060|NCT00446147|4155286|B1|Age_median||Age, Customized||years|Median|56|56.0|Full Range|||28.0|74.0|
4328061|NCT00446134|4155295|B5|||Plasma Hepatitis C Virus (HCV) Ribonucleic Acid (RNA) (log 10)||Copies/mL|Mean|6.6|6.6|Standard Deviation|0.77|0.77|||
4328062|NCT00446134|4155296|B4|||Plasma Hepatitis C Virus (HCV) Ribonucleic Acid (RNA) (log 10)||Copies/mL|Mean|6.5|6.5|Standard Deviation|0.84|0.84|||
4328063|NCT00446134|4155297|B3|||Plasma Hepatitis C Virus (HCV) Ribonucleic Acid (RNA) (log 10)||Copies/mL|Mean|6.6|6.6|Standard Deviation|0.78|0.78|||
4328064|NCT00446134|4155298|B2|||Plasma Hepatitis C Virus (HCV) Ribonucleic Acid (RNA) (log 10)||Copies/mL|Mean|6.6|6.6|Standard Deviation|0.78|0.78|||
4328065|NCT00446134|4155299|B1|||Plasma Hepatitis C Virus (HCV) Ribonucleic Acid (RNA) (log 10)||Copies/mL|Mean|6.6|6.6|Standard Deviation|0.71|0.71|||
4328066|NCT00446134|4155295|B5|||Weight||kilograms|Mean|82.1|82.1|Standard Deviation|17.09|17.09|||
4328067|NCT00446134|4155296|B4|||Weight||kilograms|Mean|82.3|82.3|Standard Deviation|17.1|17.1|||
4328068|NCT00446134|4155297|B3|||Weight||kilograms|Mean|82.2|82.2|Standard Deviation|18.0|18.0|||
4328069|NCT00446134|4155298|B2|||Weight||kilograms|Mean|82.6|82.6|Standard Deviation|16.8|16.8|||
4328070|NCT00446134|4155299|B1|||Weight||kilograms|Mean|81.5|81.5|Standard Deviation|16.9|16.9|||
4328071|NCT00446134|4155295|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4328072|NCT00446134|4155296|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4328073|NCT00446134|4155297|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4328074|NCT00446134|4155298|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4328075|NCT00446134|4155299|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4328076|NCT00446134|4155295|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328077|NCT00446134|4155296|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328078|NCT00446134|4155297|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328079|NCT00446134|4155298|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328080|NCT00446134|4155299|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328081|NCT00446134|4155295|B5||White|Race (NIH/OMB)||Participants|Count of Participants|178|178.0||||||
4328082|NCT00446134|4155296|B4||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4328083|NCT00446134|4155297|B3||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4328084|NCT00446134|4155298|B2||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4328085|NCT00446134|4155299|B1||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4328086|NCT00446134|4155295|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4328087|NCT00446134|4155296|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4328088|NCT00446134|4155297|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4328089|NCT00446134|4155298|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4328090|NCT00446134|4155299|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4328091|NCT00446134|4155295|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328094|NCT00446134|4155298|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328095|NCT00446134|4155299|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328096|NCT00446134|4155295|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4328097|NCT00446134|4155296|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4328098|NCT00446134|4155297|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4328099|NCT00446134|4155298|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4328100|NCT00446134|4155299|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4328101|NCT00446134|4155295|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328102|NCT00446134|4155296|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328103|NCT00446134|4155297|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328104|NCT00446134|4155298|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328105|NCT00446134|4155299|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328106|NCT00446134|4155295|B5||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4328107|NCT00446134|4155296|B4||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4328108|NCT00446134|4155297|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4328109|NCT00446134|4155298|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4328110|NCT00446134|4155299|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4328111|NCT00446134|4155295|B5||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4328112|NCT00446134|4155296|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4328113|NCT00446134|4155297|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4328114|NCT00446134|4155298|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4328115|NCT00446134|4155299|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4328116|NCT00446134|4155295|B5|||Age||years|Mean|48.8|48.8|Standard Deviation|8.63|8.63|||
4328117|NCT00446134|4155296|B4|||Age||years|Mean|49.7|49.7|Standard Deviation|8.30|8.3|||
4328118|NCT00446134|4155297|B3|||Age||years|Mean|49.6|49.6|Standard Deviation|7.24|7.24|||
4328119|NCT00446134|4155298|B2|||Age||years|Mean|47.5|47.5|Standard Deviation|9.42|9.42|||
4328120|NCT00446134|4155299|B1|||Age||years|Mean|48.5|48.5|Standard Deviation|9.39|9.39|||
4328121|NCT00446095|4155324|B6|Other: Russian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4328122|NCT00446095|4155325|B5|Other: Russian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4328123|NCT00446095|4155326|B4|Other: Russian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4328124|NCT00446095|4155327|B3|Other: Russian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4328125|NCT00446095|4155328|B2|Other: Russian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4328126|NCT00446095|4155329|B1|Other: Russian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4328127|NCT00446095|4155324|B6|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4328128|NCT00446095|4155325|B5|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4328129|NCT00446095|4155326|B4|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4328130|NCT00446095|4155327|B3|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4328131|NCT00446095|4155328|B2|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4328132|NCT00446095|4155329|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4328133|NCT00446095|4155324|B6|Black/African American||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4328134|NCT00446095|4155325|B5|Black/African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4328135|NCT00446095|4155326|B4|Black/African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4328136|NCT00446095|4155327|B3|Black/African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4328137|NCT00446095|4155328|B2|Black/African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4328138|NCT00446095|4155329|B1|Black/African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4328139|NCT00446095|4155324|B6|Caucasian||Race/Ethnicity, Customized||Participants|Number|71|71.0||||||
4328140|NCT00446095|4155325|B5|Caucasian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4328141|NCT00446095|4155326|B4|Caucasian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4328142|NCT00446095|4155327|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
4328143|NCT00446095|4155328|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4328144|NCT00446095|4155329|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
4328145|NCT00446095|4155324|B6||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4328146|NCT00446095|4155325|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4328147|NCT00446095|4155326|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4328148|NCT00446095|4155327|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4328149|NCT00446095|4155328|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4328150|NCT00446095|4155329|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4328151|NCT00446095|4155324|B6||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4328152|NCT00446095|4155325|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4328153|NCT00446095|4155326|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4328154|NCT00446095|4155327|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4328155|NCT00446095|4155328|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4328156|NCT00446095|4155329|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4328157|NCT00446095|4155324|B6|||Age||Years|Mean|61.5|61.5|Full Range|61.5|61.5|41.0|87.0|
4328158|NCT00446095|4155325|B5|||Age||Years|Mean|61|61.0|Full Range|||52.0|80.0|
4328159|NCT00446095|4155326|B4|||Age||Years|Mean|78.5|78.5|Full Range|||70.0|91.0|
4328160|NCT00446095|4155327|B3|||Age||Years|Mean|62.0|62.0|Full Range|62|62.0|51.0|77.0|
4328161|NCT00446095|4155328|B2|||Age||Years|Mean|59.0|59.0|Full Range|59|59.0|41.0|74.0|
4328162|NCT00446095|4155329|B1|||Age||Years|Mean|63.0|63.0|Full Range|63|63.0|41.0|87.0|
4328163|NCT00446030|4155354|B3|ECOG Performance Score is 1||Eastern Cooperative Oncology Group (ECOG) performance status score|"The ECOG performance status score is used to assess how a patient's disease is progressing and to assess how the disease affects the patient's daily living abilities. The ECOG score ranges from 0-5, with 0 indicating the best outcome and a score of 5 indicating the worst outcome. An ECOG score 0 reflects a fully active patient, able to carry on all pre-disease performance without restriction. An ECOG score 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature."|Participants|Number|10|10.0||||||
4328164|NCT00446030|4155355|B2|ECOG Performance Score is 1||Eastern Cooperative Oncology Group (ECOG) performance status score|"The ECOG performance status score is used to assess how a patient's disease is progressing and to assess how the disease affects the patient's daily living abilities. The ECOG score ranges from 0-5, with 0 indicating the best outcome and a score of 5 indicating the worst outcome. An ECOG score 0 reflects a fully active patient, able to carry on all pre-disease performance without restriction. An ECOG score 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature."|Participants|Number|4|4.0||||||
4328165|NCT00446030|4155356|B1|ECOG Performance Score is 1||Eastern Cooperative Oncology Group (ECOG) performance status score|"The ECOG performance status score is used to assess how a patient's disease is progressing and to assess how the disease affects the patient's daily living abilities. The ECOG score ranges from 0-5, with 0 indicating the best outcome and a score of 5 indicating the worst outcome. An ECOG score 0 reflects a fully active patient, able to carry on all pre-disease performance without restriction. An ECOG score 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature."|Participants|Number|6|6.0||||||
4328166|NCT00446030|4155354|B3|ECOG Performance Score is 0||Eastern Cooperative Oncology Group (ECOG) performance status score|"The ECOG performance status score is used to assess how a patient's disease is progressing and to assess how the disease affects the patient's daily living abilities. The ECOG score ranges from 0-5, with 0 indicating the best outcome and a score of 5 indicating the worst outcome. An ECOG score 0 reflects a fully active patient, able to carry on all pre-disease performance without restriction. An ECOG score 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature."|Participants|Number|116|116.0||||||
4328167|NCT00446030|4155355|B2|ECOG Performance Score is 0||Eastern Cooperative Oncology Group (ECOG) performance status score|"The ECOG performance status score is used to assess how a patient's disease is progressing and to assess how the disease affects the patient's daily living abilities. The ECOG score ranges from 0-5, with 0 indicating the best outcome and a score of 5 indicating the worst outcome. An ECOG score 0 reflects a fully active patient, able to carry on all pre-disease performance without restriction. An ECOG score 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature."|Participants|Number|30|30.0||||||
4328168|NCT00446030|4155356|B1|ECOG Performance Score is 0||Eastern Cooperative Oncology Group (ECOG) performance status score|"The ECOG performance status score is used to assess how a patient's disease is progressing and to assess how the disease affects the patient's daily living abilities. The ECOG score ranges from 0-5, with 0 indicating the best outcome and a score of 5 indicating the worst outcome. An ECOG score 0 reflects a fully active patient, able to carry on all pre-disease performance without restriction. An ECOG score 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature."|Participants|Number|86|86.0||||||
4328169|NCT00446030|4155354|B3|||weight||kg|Mean|75.21|75.21|Standard Deviation|16.925|16.925|||
4328170|NCT00446030|4155355|B2|||weight||kg|Mean|72.09|72.09|Standard Deviation|14.766|14.766|||
4328171|NCT00446030|4155356|B1|||weight||kg|Mean|76.37|76.37|Standard Deviation|17.590|17.59|||
4328172|NCT00446030|4155354|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4328173|NCT00446030|4155355|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4328174|NCT00446030|4155356|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4328175|NCT00446030|4155354|B3|Asian, Oriental||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4328176|NCT00446030|4155355|B2|Asian, Oriental||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4328177|NCT00446030|4155356|B1|Asian, Oriental||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4328178|NCT00446030|4155354|B3|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4328179|NCT00446030|4155355|B2|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4328180|NCT00446030|4155356|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4328181|NCT00446030|4155354|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|105|105.0||||||
4328182|NCT00446030|4155355|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4328183|NCT00446030|4155356|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
4328184|NCT00446030|4155354|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4328185|NCT00446030|4155355|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4328186|NCT00446030|4155356|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4328187|NCT00446030|4155354|B3||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4328188|NCT00446030|4155355|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4328189|NCT00446030|4155356|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4328190|NCT00446030|4155354|B3|>=65 years||Age, Customized||participants|Number|9|9.0||||||
4328191|NCT00446030|4155355|B2|>=65 years||Age, Customized||participants|Number|1|1.0||||||
4328192|NCT00446030|4155356|B1|>=65 years||Age, Customized||participants|Number|8|8.0||||||
4328193|NCT00446030|4155354|B3|< 65 years||Age, Customized||participants|Number|117|117.0||||||
4328194|NCT00446030|4155355|B2|< 65 years||Age, Customized||participants|Number|33|33.0||||||
4328195|NCT00446030|4155356|B1|< 65 years||Age, Customized||participants|Number|84|84.0||||||
4328196|NCT00446030|4155354|B3|||Age||years|Mean|50.5|50.5|Standard Deviation|9.88|9.88|||
4328197|NCT00446030|4155355|B2|||Age||years|Mean|49.9|49.9|Standard Deviation|9.38|9.38|||
4328198|NCT00446030|4155356|B1|||Age||years|Mean|50.7|50.7|Standard Deviation|10.9|10.9|||
4328199|NCT00445939|4155365|B4|Japan||Region of Enrollment||participants|Number|90|90.0||||||
4328200|NCT00445939|4155366|B3|Japan||Region of Enrollment||participants|Number|23|23.0||||||
4328201|NCT00445939|4155367|B2|Japan||Region of Enrollment||participants|Number|34|34.0||||||
4328202|NCT00445939|4155368|B1|Japan||Region of Enrollment||participants|Number|33|33.0||||||
4328203|NCT00445939|4155365|B4||Male|Sex: Female, Male|Gender, Male/Female who received first dose of study drug|Participants|Count of Participants|52|52.0||||||
4328204|NCT00445939|4155366|B3||Male|Sex: Female, Male|Gender, Male/Female who received first dose of study drug|Participants|Count of Participants|16|16.0||||||
4328205|NCT00445939|4155367|B2||Male|Sex: Female, Male|Gender, Male/Female who received first dose of study drug|Participants|Count of Participants|16|16.0||||||
4328206|NCT00445939|4155368|B1||Male|Sex: Female, Male|Gender, Male/Female who received first dose of study drug|Participants|Count of Participants|20|20.0||||||
4328207|NCT00445939|4155365|B4||Female|Sex: Female, Male|Gender, Male/Female who received first dose of study drug|Participants|Count of Participants|38|38.0||||||
4328208|NCT00445939|4155366|B3||Female|Sex: Female, Male|Gender, Male/Female who received first dose of study drug|Participants|Count of Participants|7|7.0||||||
4328209|NCT00445939|4155367|B2||Female|Sex: Female, Male|Gender, Male/Female who received first dose of study drug|Participants|Count of Participants|18|18.0||||||
4328210|NCT00445939|4155368|B1||Female|Sex: Female, Male|Gender, Male/Female who received first dose of study drug|Participants|Count of Participants|13|13.0||||||
4328211|NCT00445939|4155365|B4|||Age||years|Mean|31.1|31.1|Standard Deviation|8.80|8.8|||
4328212|NCT00445939|4155366|B3|||Age||years|Mean|30.4|30.4|Standard Deviation|6.93|6.93|||
4328213|NCT00445939|4155367|B2|||Age||years|Mean|30.6|30.6|Standard Deviation|9.26|9.26|||
4328214|NCT00445939|4155368|B1|||Age||years|Mean|32.0|32.0|Standard Deviation|9.60|9.6|||
4328215|NCT00445887|4155394|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4328216|NCT00445887|4155395|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4328217|NCT00445887|4155396|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4328218|NCT00445887|4155394|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4328219|NCT00445887|4155395|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4328220|NCT00445887|4155396|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4328221|NCT00445887|4155394|B3|60-69 years||Age, Customized||Participants|Count of Participants|4|4.0||||||
4328222|NCT00445887|4155395|B2|60-69 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
4328223|NCT00445887|4155396|B1|60-69 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
4328224|NCT00445887|4155394|B3|50-59 years||Age, Customized||Participants|Count of Participants|23|23.0||||||
4328225|NCT00445887|4155395|B2|50-59 years||Age, Customized||Participants|Count of Participants|9|9.0||||||
4328226|NCT00445887|4155396|B1|50-59 years||Age, Customized||Participants|Count of Participants|14|14.0||||||
4328227|NCT00445887|4155394|B3|40-49 years||Age, Customized||Participants|Count of Participants|27|27.0||||||
4328228|NCT00445887|4155395|B2|40-49 years||Age, Customized||Participants|Count of Participants|13|13.0||||||
4328229|NCT00445887|4155396|B1|40-49 years||Age, Customized||Participants|Count of Participants|14|14.0||||||
4328230|NCT00445887|4155394|B3|30-39 years||Age, Customized||Participants|Count of Participants|10|10.0||||||
4328231|NCT00445887|4155395|B2|30-39 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
4328232|NCT00445887|4155396|B1|30-39 years||Age, Customized||Participants|Count of Participants|4|4.0||||||
4328233|NCT00445887|4155394|B3|20-29 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4328234|NCT00445887|4155395|B2|20-29 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4328235|NCT00445887|4155396|B1|20-29 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4328236|NCT00445848|4155419|B1|IV||Stage|"Patients were required to have histologically proven stage IIIB (by pleural effusion) or IV lung adenocarcinoma as outlined below (AJCC Cancer Staging Manual, 6th Edition, 2002) Stage IIIB: T4, Any N, M0; Stage IV: Any T, Any N, M1. Any disease that is recurrent after surgery or radiation is classified as Stage IV.~Following are more details about staging criteria:~Any T: presence of tumor; T4: extensive tumor growth; Any N: lymph involvement; M0: no metastasis; M1: metastasis."|participants|Number|70|70.0||||||
4328237|NCT00445848|4155419|B1|IIIB(pleural effusion)||Stage|"Patients were required to have histologically proven stage IIIB (by pleural effusion) or IV lung adenocarcinoma as outlined below (AJCC Cancer Staging Manual, 6th Edition, 2002) Stage IIIB: T4, Any N, M0; Stage IV: Any T, Any N, M1. Any disease that is recurrent after surgery or radiation is classified as Stage IV.~Following are more details about staging criteria:~Any T: presence of tumor; T4: extensive tumor growth; Any N: lymph involvement; M0: no metastasis; M1: metastasis."|participants|Number|15|15.0||||||
4328263|NCT00445770|4155429|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4328238|NCT00445848|4155419|B1|2||Performance Status|Patients with a SouthWest Oncology Group (SWOG) performance status (PS) of 0, 1, or 2 were eligible. Per protocol, PS = 0 Fully active, able to carry on all pre-disease performance without restriction; PS =1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work; PS = 2 Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours.|participants|Number|3|3.0||||||
4328239|NCT00445848|4155419|B1|0/1||Performance Status|Patients with a SouthWest Oncology Group (SWOG) performance status (PS) of 0, 1, or 2 were eligible. Per protocol, PS = 0 Fully active, able to carry on all pre-disease performance without restriction; PS =1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work; PS = 2 Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours.|participants|Number|82|82.0||||||
4328240|NCT00445848|4155419|B1|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4328241|NCT00445848|4155419|B1|Native American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4328242|NCT00445848|4155419|B1|Asian||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4328243|NCT00445848|4155419|B1|African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4328244|NCT00445848|4155419|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
4328245|NCT00445848|4155419|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4328246|NCT00445848|4155419|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4328247|NCT00445848|4155419|B1|||Age||years|Median|61|61.0|Full Range|||31.0|84.0|
4328248|NCT00445770|4155426|B4|||Joint Space Narrowing (JSN) Score|JSN score: severity of JSN in 42 joints (15 per hand and 6 per foot), including subluxation, scored from 0 (no/normal JSN) to 4 (complete loss of joint space, bony ankylosis, or luxation). Total JSN scores possible ranged from 0 (no/normal JSN) to 168 (worst possible total score).|scores on a scale|Mean|17.73|17.73|Standard Deviation|20.03|20.03|||
4328249|NCT00445770|4155427|B3|||Joint Space Narrowing (JSN) Score|JSN score: severity of JSN in 42 joints (15 per hand and 6 per foot), including subluxation, scored from 0 (no/normal JSN) to 4 (complete loss of joint space, bony ankylosis, or luxation). Total JSN scores possible ranged from 0 (no/normal JSN) to 168 (worst possible total score).|scores on a scale|Mean|16.75|16.75|Standard Deviation|19.11|19.11|||
4328250|NCT00445770|4155428|B2|||Joint Space Narrowing (JSN) Score|JSN score: severity of JSN in 42 joints (15 per hand and 6 per foot), including subluxation, scored from 0 (no/normal JSN) to 4 (complete loss of joint space, bony ankylosis, or luxation). Total JSN scores possible ranged from 0 (no/normal JSN) to 168 (worst possible total score).|scores on a scale|Mean|18.50|18.5|Standard Deviation|19.14|19.14|||
4328251|NCT00445770|4155429|B1|||Joint Space Narrowing (JSN) Score|JSN score: severity of JSN in 42 joints (15 per hand and 6 per foot), including subluxation, scored from 0 (no/normal JSN) to 4 (complete loss of joint space, bony ankylosis, or luxation). Total JSN scores possible ranged from 0 (no/normal JSN) to 168 (worst possible total score).|scores on a scale|Mean|17.92|17.92|Standard Deviation|21.93|21.93|||
4328252|NCT00445770|4155426|B4|||Erosion Score|Joint erosion score: erosion severity in 44 joints (16 per hand and 6 per foot). Each joint scored according to surface area involved, from 0 (no erosion) to 5 (extensive bone loss from more than one half of articulating bone). Because each side of foot joint was graded, maximum erosion score for foot joint was 10. Thus, total erosion score possible ranged from 0 (no erosion) to 280 (worst possible total score).|scores on a scale|Mean|25.69|25.69|Standard Deviation|24.05|24.05|||
4328253|NCT00445770|4155427|B3|||Erosion Score|Joint erosion score: erosion severity in 44 joints (16 per hand and 6 per foot). Each joint scored according to surface area involved, from 0 (no erosion) to 5 (extensive bone loss from more than one half of articulating bone). Because each side of foot joint was graded, maximum erosion score for foot joint was 10. Thus, total erosion score possible ranged from 0 (no erosion) to 280 (worst possible total score).|scores on a scale|Mean|25.23|25.23|Standard Deviation|23.88|23.88|||
4328254|NCT00445770|4155428|B2|||Erosion Score|Joint erosion score: erosion severity in 44 joints (16 per hand and 6 per foot). Each joint scored according to surface area involved, from 0 (no erosion) to 5 (extensive bone loss from more than one half of articulating bone). Because each side of foot joint was graded, maximum erosion score for foot joint was 10. Thus, total erosion score possible ranged from 0 (no erosion) to 280 (worst possible total score).|scores on a scale|Mean|26.66|26.66|Standard Deviation|22.1|22.1|||
4328255|NCT00445770|4155429|B1|||Erosion Score|Joint erosion score: erosion severity in 44 joints (16 per hand and 6 per foot). Each joint scored according to surface area involved, from 0 (no erosion) to 5 (extensive bone loss from more than one half of articulating bone). Because each side of foot joint was graded, maximum erosion score for foot joint was 10. Thus, total erosion score possible ranged from 0 (no erosion) to 280 (worst possible total score).|scores on a scale|Mean|25.09|25.09|Standard Deviation|26.30|26.3|||
4328256|NCT00445770|4155426|B4|||modified Total Sharp Score (mTSS)|mTSS=sum of erosion and JSN scores for 44 joints (16 per hand and 6 per foot). Total mTSS scores possible ranged from 0 (normal) to 448 (worst possible total score).|scores on a scale|Mean|43.42|43.42|Standard Deviation|42.28|42.28|||
4328257|NCT00445770|4155427|B3|||modified Total Sharp Score (mTSS)|mTSS=sum of erosion and JSN scores for 44 joints (16 per hand and 6 per foot). Total mTSS scores possible ranged from 0 (normal) to 448 (worst possible total score).|scores on a scale|Mean|41.98|41.98|Standard Deviation|41.51|41.51|||
4328258|NCT00445770|4155428|B2|||modified Total Sharp Score (mTSS)|mTSS=sum of erosion and JSN scores for 44 joints (16 per hand and 6 per foot). Total mTSS scores possible ranged from 0 (normal) to 448 (worst possible total score).|scores on a scale|Mean|45.17|45.17|Standard Deviation|38.75|38.75|||
4328259|NCT00445770|4155429|B1|||modified Total Sharp Score (mTSS)|mTSS=sum of erosion and JSN scores for 44 joints (16 per hand and 6 per foot). Total mTSS scores possible ranged from 0 (normal) to 448 (worst possible total score).|scores on a scale|Mean|43.01|43.01|Standard Deviation|46.78|46.78|||
4328260|NCT00445770|4155426|B4||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4328261|NCT00445770|4155427|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4328262|NCT00445770|4155428|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4328264|NCT00445770|4155426|B4||Female|Sex: Female, Male||Participants|Count of Participants|439|439.0||||||
4328265|NCT00445770|4155427|B3||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4328266|NCT00445770|4155428|B2||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4328267|NCT00445770|4155429|B1||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4328268|NCT00445770|4155426|B4|||Age||years|Mean|51.24|51.24|Standard Deviation|11.74|11.74|||
4328269|NCT00445770|4155427|B3|||Age||years|Mean|51.81|51.81|Standard Deviation|11.07|11.07|||
4328270|NCT00445770|4155428|B2|||Age||years|Mean|51.46|51.46|Standard Deviation|12.21|12.21|||
4328271|NCT00445770|4155429|B1|||Age||years|Mean|50.40|50.4|Standard Deviation|11.91|11.91|||
4328272|NCT00445744|4155498|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4328273|NCT00445744|4155498|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4328274|NCT00445744|4155498|B1|||Age||years|Median|55|55.0|Full Range|||30.0|65.0|
4328275|NCT00445705|4155503|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4328276|NCT00445705|4155504|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4328277|NCT00445705|4155505|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4328278|NCT00445705|4155506|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4328279|NCT00445705|4155507|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4328280|NCT00445705|4155503|B5||Female|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4328281|NCT00445705|4155504|B4||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4328282|NCT00445705|4155505|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4328283|NCT00445705|4155506|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4328284|NCT00445705|4155507|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4328285|NCT00445705|4155503|B5|||Age||years|Median|50.0|50.0|Full Range|||18.0|71.0|
4328286|NCT00445705|4155504|B4|||Age||years|Median|51.0|51.0|Full Range|||24.0|71.0|
4328287|NCT00445705|4155505|B3|||Age||years|Median|49.5|49.5|Full Range|||18.0|67.0|
4328288|NCT00445705|4155506|B2|||Age||years|Median|50.0|50.0|Full Range|||25.0|69.0|
4328289|NCT00445705|4155507|B1|||Age||years|Median|50.5|50.5|Full Range|||23.0|68.0|
4328290|NCT00445692|4155532|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4328291|NCT00445692|4155532|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328292|NCT00445692|4155532|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4328293|NCT00445692|4155532|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4328294|NCT00445692|4155532|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328295|NCT00445692|4155532|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328296|NCT00445692|4155532|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328297|NCT00445692|4155532|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4328298|NCT00445692|4155532|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4328299|NCT00445692|4155532|B1|||Age|Age at transplant|years|Mean|58|58.0|Full Range|||28.0|72.0|
4328300|NCT00445679|4155538|B5||Male|Sex: Female, Male||Participants|Count of Participants|318|318.0||||||
4328301|NCT00445679|4155539|B4||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4328302|NCT00445679|4155540|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4328303|NCT00445679|4155541|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4328304|NCT00445679|4155542|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4328305|NCT00445679|4155538|B5||Female|Sex: Female, Male||Participants|Count of Participants|489|489.0||||||
4328306|NCT00445679|4155539|B4||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4328307|NCT00445679|4155540|B3||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4328308|NCT00445679|4155541|B2||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4328309|NCT00445679|4155542|B1||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4328310|NCT00445679|4155538|B5|||Age||years|Mean|38.86|38.86|Standard Deviation|13.53|13.53|||
4328311|NCT00445679|4155539|B4|||Age||years|Mean|38.27|38.27|Standard Deviation|13.22|13.22|||
4328312|NCT00445679|4155540|B3|||Age||years|Mean|39.26|39.26|Standard Deviation|14.69|14.69|||
4328313|NCT00445679|4155541|B2|||Age||years|Mean|39.26|39.26|Standard Deviation|13.22|13.22|||
4328314|NCT00445679|4155542|B1|||Age||years|Mean|38.63|38.63|Standard Deviation|12.96|12.96|||
4328315|NCT00445601|4155579|B3||Unknown|Smoking history||Participants|Count of Participants|4|4.0||||||
4328316|NCT00445601|4155580|B2||Unknown|Smoking history||Participants|Count of Participants|4|4.0||||||
4328317|NCT00445601|4155581|B1||Unknown|Smoking history||Participants|Count of Participants|0|0.0||||||
4328318|NCT00445601|4155579|B3||Never|Smoking history||Participants|Count of Participants|100|100.0||||||
4328319|NCT00445601|4155580|B2||Never|Smoking history||Participants|Count of Participants|46|46.0||||||
4328320|NCT00445601|4155581|B1||Never|Smoking history||Participants|Count of Participants|54|54.0||||||
4328321|NCT00445601|4155579|B3||Prior|Smoking history||Participants|Count of Participants|199|199.0||||||
4328322|NCT00445601|4155580|B2||Prior|Smoking history||Participants|Count of Participants|101|101.0||||||
4328323|NCT00445601|4155581|B1||Prior|Smoking history||Participants|Count of Participants|98|98.0||||||
4328324|NCT00445601|4155579|B3||Current|Smoking history||Participants|Count of Participants|103|103.0||||||
4328325|NCT00445601|4155580|B2||Current|Smoking history||Participants|Count of Participants|54|54.0||||||
4328326|NCT00445601|4155581|B1||Current|Smoking history||Participants|Count of Participants|49|49.0||||||
4328327|NCT00445601|4155579|B3||1|Zubrod Performance Status|"Zubrod Performance Status Scale:~0. Fully active, able to carry on all pre-disease performance without restriction.~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours.~Capable of limited self-care, confined to bed or chair more than 50% of waking hours.~Completely disabled; cannot carry on any self-care; totally confined to bed or chair."|Participants|Count of Participants|84|84.0||||||
4328328|NCT00445601|4155580|B2||1|Zubrod Performance Status|"Zubrod Performance Status Scale:~0. Fully active, able to carry on all pre-disease performance without restriction.~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours.~Capable of limited self-care, confined to bed or chair more than 50% of waking hours.~Completely disabled; cannot carry on any self-care; totally confined to bed or chair."|Participants|Count of Participants|40|40.0||||||
4328329|NCT00445601|4155581|B1||1|Zubrod Performance Status|"Zubrod Performance Status Scale:~0. Fully active, able to carry on all pre-disease performance without restriction.~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours.~Capable of limited self-care, confined to bed or chair more than 50% of waking hours.~Completely disabled; cannot carry on any self-care; totally confined to bed or chair."|Participants|Count of Participants|44|44.0||||||
4328330|NCT00445601|4155579|B3||0|Zubrod Performance Status|"Zubrod Performance Status Scale:~0. Fully active, able to carry on all pre-disease performance without restriction.~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours.~Capable of limited self-care, confined to bed or chair more than 50% of waking hours.~Completely disabled; cannot carry on any self-care; totally confined to bed or chair."|Participants|Count of Participants|322|322.0||||||
4328331|NCT00445601|4155580|B2||0|Zubrod Performance Status|"Zubrod Performance Status Scale:~0. Fully active, able to carry on all pre-disease performance without restriction.~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours.~Capable of limited self-care, confined to bed or chair more than 50% of waking hours.~Completely disabled; cannot carry on any self-care; totally confined to bed or chair."|Participants|Count of Participants|165|165.0||||||
4328332|NCT00445601|4155581|B1||0|Zubrod Performance Status|"Zubrod Performance Status Scale:~0. Fully active, able to carry on all pre-disease performance without restriction.~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours.~Capable of limited self-care, confined to bed or chair more than 50% of waking hours.~Completely disabled; cannot carry on any self-care; totally confined to bed or chair."|Participants|Count of Participants|157|157.0||||||
4328333|NCT00445601|4155579|B3||No|Prior intravesical therapy||Participants|Count of Participants|328|328.0||||||
4328334|NCT00445601|4155580|B2||No|Prior intravesical therapy||Participants|Count of Participants|166|166.0||||||
4328335|NCT00445601|4155581|B1||No|Prior intravesical therapy||Participants|Count of Participants|162|162.0||||||
4328336|NCT00445601|4155579|B3||Yes|Prior intravesical therapy||Participants|Count of Participants|78|78.0||||||
4328337|NCT00445601|4155580|B2||Yes|Prior intravesical therapy||Participants|Count of Participants|39|39.0||||||
4328338|NCT00445601|4155581|B1||Yes|Prior intravesical therapy||Participants|Count of Participants|39|39.0||||||
4328339|NCT00445601|4155579|B3||>= 2|Number of tumors||Participants|Count of Participants|131|131.0||||||
4328340|NCT00445601|4155580|B2||>= 2|Number of tumors||Participants|Count of Participants|65|65.0||||||
4328341|NCT00445601|4155581|B1||>= 2|Number of tumors||Participants|Count of Participants|66|66.0||||||
4328342|NCT00445601|4155579|B3||1|Number of tumors||Participants|Count of Participants|275|275.0||||||
4328343|NCT00445601|4155580|B2||1|Number of tumors||Participants|Count of Participants|140|140.0||||||
4328344|NCT00445601|4155581|B1||1|Number of tumors||Participants|Count of Participants|135|135.0||||||
4328345|NCT00445601|4155579|B3||Unknown|Occurence status||Participants|Count of Participants|7|7.0||||||
4328346|NCT00445601|4155580|B2||Unknown|Occurence status||Participants|Count of Participants|0|0.0||||||
4328347|NCT00445601|4155581|B1||Unknown|Occurence status||Participants|Count of Participants|7|7.0||||||
4328348|NCT00445601|4155579|B3||Recurrent|Occurence status||Participants|Count of Participants|143|143.0||||||
4328349|NCT00445601|4155580|B2||Recurrent|Occurence status||Participants|Count of Participants|77|77.0||||||
4328350|NCT00445601|4155581|B1||Recurrent|Occurence status||Participants|Count of Participants|66|66.0||||||
4328351|NCT00445601|4155579|B3||First Occurence|Occurence status||Participants|Count of Participants|256|256.0||||||
4328352|NCT00445601|4155580|B2||First Occurence|Occurence status||Participants|Count of Participants|128|128.0||||||
4328353|NCT00445601|4155581|B1||First Occurence|Occurence status||Participants|Count of Participants|128|128.0||||||
4328354|NCT00445601|4155579|B3|Race|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4328355|NCT00445601|4155580|B2|Race|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4328356|NCT00445601|4155581|B1|Race|Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4328357|NCT00445601|4155579|B3|Race|Native American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4328358|NCT00445601|4155580|B2|Race|Native American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4328359|NCT00445601|4155581|B1|Race|Native American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4328360|NCT00445601|4155579|B3|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4328361|NCT00445601|4155580|B2|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4328362|NCT00445601|4155581|B1|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4328363|NCT00445601|4155579|B3|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
4328364|NCT00445601|4155580|B2|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4328365|NCT00445601|4155581|B1|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4328366|NCT00445601|4155579|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|371|371.0||||||
4328367|NCT00445601|4155580|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|185|185.0||||||
4328368|NCT00445601|4155581|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|186|186.0||||||
4328369|NCT00445601|4155579|B3||Male|Sex: Female, Male||Participants|Count of Participants|344|344.0||||||
4328370|NCT00445601|4155580|B2||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4328371|NCT00445601|4155581|B1||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4328372|NCT00445601|4155579|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4328373|NCT00445601|4155580|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4328374|NCT00445601|4155581|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4328375|NCT00445601|4155579|B3|||Age||years|Median|66|66.0|Full Range|||35.0|97.0|
4328376|NCT00445601|4155580|B2|||Age||years|Median|66|66.0|Full Range|||35.0|93.0|
4328377|NCT00445601|4155581|B1|||Age||years|Median|66|66.0|Full Range|||38.0|97.0|
4328378|NCT00445588|4155594|B1|60-80||Karnosky Performance Status|100 - Normal; no complaints; no evidence of disease 90 - Able to carry on normal activity; minor signs or symptoms of disease 80 - Normal activity with effort; some signs or symptoms of disease 70 - Cares for self; unable to carry on normal activity or to do active work 60 - Requires occasional assistance, but is able to care for most of his personal needs|participants|Number|30|30.0||||||
4328379|NCT00445588|4155594|B1|90-100||Karnosky Performance Status|100 - Normal; no complaints; no evidence of disease 90 - Able to carry on normal activity; minor signs or symptoms of disease 80 - Normal activity with effort; some signs or symptoms of disease 70 - Cares for self; unable to carry on normal activity or to do active work 60 - Requires occasional assistance, but is able to care for most of his personal needs|participants|Number|26|26.0||||||
4328380|NCT00445588|4155594|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4328381|NCT00445588|4155594|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4328382|NCT00445588|4155594|B1|||Age||years|Median|56|56.0|Full Range|||31.0|78.0|
4328383|NCT00445549|4155599|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4328384|NCT00445549|4155599|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4328385|NCT00445549|4155599|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4328386|NCT00445549|4155599|B1|||Age||years|Mean|59.13|59.13|Standard Deviation|9.88|9.88|||
4328387|NCT00445549|4155599|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4328388|NCT00445549|4155599|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4328389|NCT00445549|4155599|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4328390|NCT00445484|4155604|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4328391|NCT00445484|4155605|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4328392|NCT00445484|4155606|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4328393|NCT00445484|4155604|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4328394|NCT00445484|4155605|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4328395|NCT00445484|4155606|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4328396|NCT00445484|4155604|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4328397|NCT00445484|4155605|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4328398|NCT00445484|4155606|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4328399|NCT00445484|4155604|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4328400|NCT00445484|4155605|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4328401|NCT00445484|4155606|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4328402|NCT00445484|4155604|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4328403|NCT00445484|4155605|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4328404|NCT00445484|4155606|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4328405|NCT00445484|4155604|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4328406|NCT00445484|4155605|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4328407|NCT00445484|4155606|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4328408|NCT00445484|4155604|B3|||Age||years|Mean|66.0|66.0|Standard Deviation|9.5|9.5|||
4328409|NCT00445484|4155605|B2|||Age||years|Mean|65.8|65.8|Standard Deviation|10.3|10.3|||
4328410|NCT00445484|4155606|B1|||Age||years|Mean|66.3|66.3|Standard Deviation|9.0|9.0|||
4328411|NCT00445458|4155619|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4328412|NCT00445458|4155620|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4328413|NCT00445458|4155621|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328414|NCT00445458|4155622|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328415|NCT00445458|4155623|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4328416|NCT00445458|4155619|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328417|NCT00445458|4155620|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328418|NCT00445458|4155621|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328419|NCT00445458|4155622|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328420|NCT00445458|4155623|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328421|NCT00445458|4155619|B5||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4328422|NCT00445458|4155620|B4||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4328423|NCT00445458|4155621|B3||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4328424|NCT00445458|4155622|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4328425|NCT00445458|4155623|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328426|NCT00445458|4155619|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4328427|NCT00445458|4155620|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328428|NCT00445458|4155621|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4328429|NCT00445458|4155622|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328430|NCT00445458|4155623|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328431|NCT00445458|4155619|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328432|NCT00445458|4155620|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328433|NCT00445458|4155621|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328434|NCT00445458|4155622|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328435|NCT00445458|4155623|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328436|NCT00445458|4155619|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
4328437|NCT00445458|4155620|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4328438|NCT00445458|4155621|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4328439|NCT00445458|4155622|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4328440|NCT00445458|4155623|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4328441|NCT00445458|4155619|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328442|NCT00445458|4155620|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328443|NCT00445458|4155621|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328444|NCT00445458|4155622|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328445|NCT00445458|4155623|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328446|NCT00445458|4155619|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4328447|NCT00445458|4155620|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4328448|NCT00445458|4155621|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4328449|NCT00445458|4155622|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4328450|NCT00445458|4155623|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4328451|NCT00445458|4155619|B5||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4328452|NCT00445458|4155620|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4328453|NCT00445458|4155621|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4328454|NCT00445458|4155622|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4328455|NCT00445458|4155623|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4328456|NCT00445458|4155619|B5|||Age||years|Mean|50.0|50.0|Standard Deviation|9.82|9.82|||
4328457|NCT00445458|4155620|B4|||Age||years|Mean|51.4|51.4|Standard Deviation|8.50|8.5|||
4328458|NCT00445458|4155621|B3|||Age||years|Mean|49.2|49.2|Standard Deviation|10.10|10.1|||
4328459|NCT00445458|4155622|B2|||Age||years|Mean|49.6|49.6|Standard Deviation|11.72|11.72|||
4328460|NCT00445458|4155623|B1|||Age||years|Mean|56.3|56.3|Standard Deviation|14.57|14.57|||
4328461|NCT00445432|4155641|B4|Japan||Region of Enrollment||participants|Number|82|82.0||||||
4328462|NCT00445432|4155642|B3|Japan||Region of Enrollment||participants|Number|32|32.0||||||
4328463|NCT00445432|4155643|B2|Japan||Region of Enrollment||participants|Number|25|25.0||||||
4328464|NCT00445432|4155644|B1|Japan||Region of Enrollment||participants|Number|25|25.0||||||
4328465|NCT00445432|4155641|B4||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4328466|NCT00445432|4155642|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4328467|NCT00445432|4155643|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4328468|NCT00445432|4155644|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4328469|NCT00445432|4155641|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4328470|NCT00445432|4155642|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4328471|NCT00445432|4155643|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4328472|NCT00445432|4155644|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4328473|NCT00445432|4155641|B4|||Age||years|Mean|31.02|31.02|Standard Deviation|8.808|8.808|||
4328474|NCT00445432|4155642|B3|||Age||years|Mean|30.75|30.75|Standard Deviation|8.359|8.359|||
4328475|NCT00445432|4155643|B2|||Age||years|Mean|30.80|30.8|Standard Deviation|10.939|10.939|||
4328476|NCT00445432|4155644|B1|||Age||years|Mean|31.60|31.6|Standard Deviation|7.171|7.171|||
4328477|NCT00445432|4155641|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4328478|NCT00445432|4155642|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4328479|NCT00445432|4155643|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4328480|NCT00445432|4155644|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4328481|NCT00445432|4155641|B4||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
4328482|NCT00445432|4155642|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4328483|NCT00445432|4155643|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4328484|NCT00445432|4155644|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4328485|NCT00445432|4155641|B4||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4328486|NCT00445432|4155642|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4328487|NCT00445432|4155643|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4328488|NCT00445432|4155644|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4328489|NCT00445341|4155680|B1|United States||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
4328490|NCT00445341|4155680|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328491|NCT00445341|4155680|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328492|NCT00445341|4155680|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4328493|NCT00445341|4155680|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4328494|NCT00445341|4155680|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328495|NCT00445341|4155680|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4328496|NCT00445341|4155680|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328497|NCT00445341|4155680|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328498|NCT00445341|4155680|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4328499|NCT00445341|4155680|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4328500|NCT00445341|4155680|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4328501|NCT00445341|4155680|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4328502|NCT00445341|4155680|B1|||Age||years|Mean|58.71|58.71|Standard Deviation|13.52|13.52|||
4328503|NCT00445341|4155680|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4328504|NCT00445341|4155680|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4328505|NCT00445341|4155680|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4328506|NCT00445328|4155685|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4328507|NCT00445328|4155686|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4328508|NCT00445328|4155687|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4328509|NCT00445328|4155685|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4328510|NCT00445328|4155686|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4328511|NCT00445328|4155687|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4328512|NCT00445328|4155685|B3|||Age||years|Mean|61.3|61.3|Standard Deviation|10.7|10.7|||
4328513|NCT00445328|4155686|B2|||Age||years|Mean|60.8|60.8|Standard Deviation|10.9|10.9|||
4328514|NCT00445328|4155687|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|10.6|10.6|||
4328515|NCT00445315|4155706|B6||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4328516|NCT00445315|4155707|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4328517|NCT00445315|4155708|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4328518|NCT00445315|4155709|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4328519|NCT00445315|4155710|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4328520|NCT00445315|4155711|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4328521|NCT00445315|4155706|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4328522|NCT00445315|4155707|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4328523|NCT00445315|4155708|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4328524|NCT00445315|4155709|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4328525|NCT00445315|4155710|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4328526|NCT00445315|4155711|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4328527|NCT00445315|4155706|B6|greater than or equal to 65 years||Age, Customized||participants|Number|1|1.0||||||
4328528|NCT00445315|4155707|B5|greater than or equal to 65 years||Age, Customized||participants|Number|0|0.0||||||
4328529|NCT00445315|4155708|B4|greater than or equal to 65 years||Age, Customized||participants|Number|0|0.0||||||
4328530|NCT00445315|4155709|B3|greater than or equal to 65 years||Age, Customized||participants|Number|1|1.0||||||
4328531|NCT00445315|4155710|B2|greater than or equal to 65 years||Age, Customized||participants|Number|0|0.0||||||
4328532|NCT00445315|4155711|B1|greater than or equal to 65 years||Age, Customized||participants|Number|0|0.0||||||
4328533|NCT00445315|4155706|B6|45 to 64 years||Age, Customized||participants|Number|14|14.0||||||
4328534|NCT00445315|4155707|B5|45 to 64 years||Age, Customized||participants|Number|2|2.0||||||
4328535|NCT00445315|4155708|B4|45 to 64 years||Age, Customized||participants|Number|2|2.0||||||
4328536|NCT00445315|4155709|B3|45 to 64 years||Age, Customized||participants|Number|3|3.0||||||
4328537|NCT00445315|4155710|B2|45 to 64 years||Age, Customized||participants|Number|4|4.0||||||
4328538|NCT00445315|4155711|B1|45 to 64 years||Age, Customized||participants|Number|3|3.0||||||
4328539|NCT00445315|4155706|B6|18 to 44 years||Age, Customized||participants|Number|17|17.0||||||
4328540|NCT00445315|4155707|B5|18 to 44 years||Age, Customized||participants|Number|6|6.0||||||
4328541|NCT00445315|4155708|B4|18 to 44 years||Age, Customized||participants|Number|4|4.0||||||
4328542|NCT00445315|4155709|B3|18 to 44 years||Age, Customized||participants|Number|2|2.0||||||
4328543|NCT00445315|4155710|B2|18 to 44 years||Age, Customized||participants|Number|2|2.0||||||
4328544|NCT00445315|4155711|B1|18 to 44 years||Age, Customized||participants|Number|3|3.0||||||
4328545|NCT00445302|4155805|B5|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4328546|NCT00445302|4155806|B4|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4328547|NCT00445302|4155807|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4328548|NCT00445302|4155808|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4328549|NCT00445302|4155809|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4328550|NCT00445302|4155805|B5|African-American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4328551|NCT00445302|4155806|B4|African-American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4328552|NCT00445302|4155807|B3|African-American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4328553|NCT00445302|4155808|B2|African-American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4328554|NCT00445302|4155809|B1|African-American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4328555|NCT00445302|4155805|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4328556|NCT00445302|4155806|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4328557|NCT00445302|4155807|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4328558|NCT00445302|4155808|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4328559|NCT00445302|4155809|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4328560|NCT00445302|4155805|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4328561|NCT00445302|4155806|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4328562|NCT00445302|4155807|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4328563|NCT00445302|4155808|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4328564|NCT00445302|4155809|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4328565|NCT00445302|4155805|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4328566|NCT00445302|4155806|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4328567|NCT00445302|4155807|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4328568|NCT00445302|4155808|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4328569|NCT00445302|4155809|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4328570|NCT00445302|4155805|B5|||Age||years|Mean|54.7|54.7|Standard Deviation|12.51|12.51|||
4328571|NCT00445302|4155806|B4|||Age||years|Mean|55.7|55.7|Standard Deviation|11.98|11.98|||
4328572|NCT00445302|4155807|B3|||Age||years|Mean|65.0|65.0|Standard Deviation|5.83|5.83|||
4328573|NCT00445302|4155808|B2|||Age||years|Mean|56.2|56.2|Standard Deviation|14.45|14.45|||
4328574|NCT00445302|4155809|B1|||Age||years|Mean|42.3|42.3|Standard Deviation|5.50|5.5|||
4328575|NCT00445263|4155838|B3|No||On aspirin||participants|Number|98|98.0||||||
4328576|NCT00445263|4155839|B2|No||On aspirin||participants|Number|54|54.0||||||
4328577|NCT00445263|4155840|B1|No||On aspirin||participants|Number|44|44.0||||||
4328578|NCT00445263|4155838|B3|Yes||On aspirin||participants|Number|71|71.0||||||
4328579|NCT00445263|4155839|B2|Yes||On aspirin||participants|Number|32|32.0||||||
4328580|NCT00445263|4155840|B1|Yes||On aspirin||participants|Number|39|39.0||||||
4328581|NCT00445263|4155838|B3|No||Previous CABG||participants|Number|157|157.0||||||
4328582|NCT00445263|4155839|B2|No||Previous CABG||participants|Number|82|82.0||||||
4328583|NCT00445263|4155840|B1|No||Previous CABG||participants|Number|75|75.0||||||
4328584|NCT00445263|4155838|B3|Yes||Previous CABG||participants|Number|12|12.0||||||
4328585|NCT00445263|4155839|B2|Yes||Previous CABG||participants|Number|4|4.0||||||
4328586|NCT00445263|4155840|B1|Yes||Previous CABG||participants|Number|8|8.0||||||
4328587|NCT00445263|4155838|B3|No||Previous PCI||participants|Number|131|131.0||||||
4328588|NCT00445263|4155839|B2|No||Previous PCI||participants|Number|68|68.0||||||
4328589|NCT00445263|4155840|B1|No||Previous PCI||participants|Number|63|63.0||||||
4328590|NCT00445263|4155838|B3|Yes||Previous PCI||participants|Number|38|38.0||||||
4328591|NCT00445263|4155839|B2|Yes||Previous PCI||participants|Number|18|18.0||||||
4328592|NCT00445263|4155840|B1|Yes||Previous PCI||participants|Number|20|20.0||||||
4328593|NCT00445263|4155838|B3|No||Previous MI||participants|Number|130|130.0||||||
4328594|NCT00445263|4155839|B2|No||Previous MI||participants|Number|66|66.0||||||
4328595|NCT00445263|4155840|B1|No||Previous MI||participants|Number|64|64.0||||||
4328596|NCT00445263|4155838|B3|Yes||Previous MI||participants|Number|39|39.0||||||
4328597|NCT00445263|4155839|B2|Yes||Previous MI||participants|Number|20|20.0||||||
4328598|NCT00445263|4155840|B1|Yes||Previous MI||participants|Number|19|19.0||||||
4328599|NCT00445263|4155838|B3|No||Dyslipidemia||participants|Number|79|79.0||||||
4328600|NCT00445263|4155839|B2|No||Dyslipidemia||participants|Number|41|41.0||||||
4328601|NCT00445263|4155840|B1|No||Dyslipidemia||participants|Number|38|38.0||||||
4328602|NCT00445263|4155838|B3|Yes||Dyslipidemia||participants|Number|90|90.0||||||
4328603|NCT00445263|4155839|B2|Yes||Dyslipidemia||participants|Number|45|45.0||||||
4328604|NCT00445263|4155840|B1|Yes||Dyslipidemia||participants|Number|45|45.0||||||
4328605|NCT00445263|4155838|B3|No||Hypertension||participants|Number|68|68.0||||||
4328606|NCT00445263|4155839|B2|No||Hypertension||participants|Number|35|35.0||||||
4328607|NCT00445263|4155840|B1|No||Hypertension||participants|Number|33|33.0||||||
4328608|NCT00445263|4155838|B3|Yes||Hypertension||participants|Number|101|101.0||||||
4328609|NCT00445263|4155839|B2|Yes||Hypertension||participants|Number|51|51.0||||||
4328610|NCT00445263|4155840|B1|Yes||Hypertension||participants|Number|50|50.0||||||
4328611|NCT00445263|4155838|B3|No||Diabetes mellitus||participants|Number|106|106.0||||||
4328612|NCT00445263|4155839|B2|No||Diabetes mellitus||participants|Number|58|58.0||||||
4328613|NCT00445263|4155840|B1|No||Diabetes mellitus||participants|Number|48|48.0||||||
4328614|NCT00445263|4155838|B3|Yes||Diabetes mellitus||participants|Number|63|63.0||||||
4328615|NCT00445263|4155839|B2|Yes||Diabetes mellitus||participants|Number|28|28.0||||||
4328616|NCT00445263|4155840|B1|Yes||Diabetes mellitus||participants|Number|35|35.0||||||
4328617|NCT00445263|4155838|B3|No||Current smoker||participants|Number|84|84.0||||||
4328618|NCT00445263|4155839|B2|No||Current smoker||participants|Number|45|45.0||||||
4328619|NCT00445263|4155840|B1|No||Current smoker||participants|Number|39|39.0||||||
4328620|NCT00445263|4155838|B3|Yes||Current smoker||participants|Number|85|85.0||||||
4328621|NCT00445263|4155839|B2|Yes||Current smoker||participants|Number|41|41.0||||||
4328622|NCT00445263|4155840|B1|Yes||Current smoker||participants|Number|44|44.0||||||
4328623|NCT00445263|4155838|B3|No||Family history of CVS disease||participants|Number|127|127.0||||||
4328624|NCT00445263|4155839|B2|No||Family history of CVS disease||participants|Number|64|64.0||||||
4328625|NCT00445263|4155840|B1|No||Family history of CVS disease||participants|Number|63|63.0||||||
4328626|NCT00445263|4155838|B3|Yes||Family history of CVS disease||participants|Number|42|42.0||||||
4328627|NCT00445263|4155839|B2|Yes||Family history of CVS disease||participants|Number|22|22.0||||||
4328628|NCT00445263|4155840|B1|Yes||Family history of CVS disease||participants|Number|20|20.0||||||
4328629|NCT00445263|4155838|B3|||BMI||kg/m2|Median|26.6|26.6|Inter-Quartile Range|||24.1|30.1|
4328630|NCT00445263|4155839|B2|||BMI||kg/m2|Median|26.6|26.6|Inter-Quartile Range|||24.2|30.4|
4328631|NCT00445263|4155840|B1|||BMI||kg/m2|Median|27.0|27.0|Inter-Quartile Range|||23.6|29.4|
4328632|NCT00445263|4155838|B3||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4328633|NCT00445263|4155839|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4328634|NCT00445263|4155840|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4328635|NCT00445263|4155838|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4328636|NCT00445263|4155839|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4328637|NCT00445263|4155840|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4328638|NCT00445263|4155838|B3|||Age||years|Median|65.3|65.3|Inter-Quartile Range|||57.1|75.2|
4328639|NCT00445263|4155839|B2|||Age||years|Median|66.5|66.5|Inter-Quartile Range|||57.5|75.8|
4328640|NCT00445263|4155840|B1|||Age||years|Median|63.9|63.9|Inter-Quartile Range|||55.6|72.5|
4328641|NCT00445224|4155847|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
4328642|NCT00445224|4155848|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4328643|NCT00445224|4155849|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4328644|NCT00445224|4155847|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4328645|NCT00445224|4155848|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4328646|NCT00445224|4155849|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4328647|NCT00445224|4155847|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4328648|NCT00445224|4155848|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4328649|NCT00445224|4155849|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4328650|NCT00445224|4155847|B3|||Age||years|Mean|25|25.0|Standard Deviation|5.5|5.5|||
4328651|NCT00445224|4155848|B2|||Age||years|Mean|25.7|25.7|Standard Deviation|5.9|5.9|||
4328652|NCT00445224|4155849|B1|||Age||years|Mean|24.6|24.6|Standard Deviation|5.3|5.3|||
4328653|NCT00445224|4155847|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4328654|NCT00445224|4155848|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4328655|NCT00445224|4155849|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4328656|NCT00445224|4155847|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4328657|NCT00445224|4155848|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4328658|NCT00445224|4155849|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4328659|NCT00445224|4155847|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4328660|NCT00445224|4155848|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4328661|NCT00445224|4155849|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4328662|NCT00445211|4155860|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4328663|NCT00445211|4155861|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4328664|NCT00445211|4155862|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4328665|NCT00445211|4155860|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4328666|NCT00445211|4155861|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4328667|NCT00445211|4155862|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4328668|NCT00445211|4155860|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4328669|NCT00445211|4155861|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4328670|NCT00445211|4155862|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4328671|NCT00445211|4155860|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4328672|NCT00445211|4155861|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4328673|NCT00445211|4155862|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4328674|NCT00445211|4155860|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4328675|NCT00445211|4155861|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4328676|NCT00445211|4155862|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4328677|NCT00445146|4155877|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4328678|NCT00445146|4155877|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4328679|NCT00445146|4155877|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
4328680|NCT00445146|4155877|B1|White||Race/Ethnicity, Customized||participants|Number|139|139.0||||||
4328681|NCT00445146|4155877|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4328682|NCT00445146|4155877|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|153|153.0||||||
4328683|NCT00445146|4155877|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4328684|NCT00445146|4155877|B1||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4328685|NCT00445146|4155877|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4328686|NCT00445146|4155877|B1|||Age||years|Mean|45|45.0|Standard Deviation|9.2|9.2|||
4328687|NCT00445003|4155896|B4|cannot grade||Early Treatment Diabetic Retinopath Study Retinopathy severity level from photograph grading|Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|Eyes|Number|12|12.0||||||
4328688|NCT00445003|4155897|B3|cannot grade||Early Treatment Diabetic Retinopath Study Retinopathy severity level from photograph grading|Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|Eyes|Number|4|4.0||||||
4328689|NCT00445003|4155898|B2|cannot grade||Early Treatment Diabetic Retinopath Study Retinopathy severity level from photograph grading|Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|Eyes|Number|4|4.0||||||
4328690|NCT00445003|4155899|B1|cannot grade||Early Treatment Diabetic Retinopath Study Retinopathy severity level from photograph grading|Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|Eyes|Number|4|4.0||||||
4328691|NCT00445003|4155896|B4|Level 71, 75 (High-risk PDR)||Early Treatment Diabetic Retinopath Study Retinopathy severity level from photograph grading|Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|Eyes|Number|118|118.0||||||
4328692|NCT00445003|4155897|B3|Level 71, 75 (High-risk PDR)||Early Treatment Diabetic Retinopath Study Retinopathy severity level from photograph grading|Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|Eyes|Number|43|43.0||||||
4328693|NCT00445003|4155898|B2|Level 71, 75 (High-risk PDR)||Early Treatment Diabetic Retinopath Study Retinopathy severity level from photograph grading|Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|Eyes|Number|43|43.0||||||
4328694|NCT00445003|4155899|B1|Level 71, 75 (High-risk PDR)||Early Treatment Diabetic Retinopath Study Retinopathy severity level from photograph grading|Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|Eyes|Number|32|32.0||||||
4328695|NCT00445003|4155896|B4|Level 61 (Mild/Moderate PDR)||Early Treatment Diabetic Retinopath Study Retinopathy severity level from photograph grading|Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|Eyes|Number|122|122.0||||||
4328696|NCT00445003|4155897|B3|Level 61 (Mild/Moderate PDR)||Early Treatment Diabetic Retinopath Study Retinopathy severity level from photograph grading|Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|Eyes|Number|38|38.0||||||
4328697|NCT00445003|4155898|B2|Level 61 (Mild/Moderate PDR)||Early Treatment Diabetic Retinopath Study Retinopathy severity level from photograph grading|Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|Eyes|Number|36|36.0||||||
4328698|NCT00445003|4155899|B1|Level 61 (Mild/Moderate PDR)||Early Treatment Diabetic Retinopath Study Retinopathy severity level from photograph grading|Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|Eyes|Number|48|48.0||||||
4328699|NCT00445003|4155896|B4|Level 60 (Prior PRP without active neovascularizat||Early Treatment Diabetic Retinopath Study Retinopathy severity level from photograph grading|Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|Eyes|Number|9|9.0||||||
4328700|NCT00445003|4155897|B3|Level 60 (Prior PRP without active neovascularizat||Early Treatment Diabetic Retinopath Study Retinopathy severity level from photograph grading|Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|Eyes|Number|3|3.0||||||
4328730|NCT00445003|4155899|B1|||Central subfield thickness on optical coherence tomography||Microns|Median|355|355.0|Inter-Quartile Range|||285.0|510.0|
4328701|NCT00445003|4155898|B2|Level 60 (Prior PRP without active neovascularizat||Early Treatment Diabetic Retinopath Study Retinopathy severity level from photograph grading|Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|Eyes|Number|4|4.0||||||
4328702|NCT00445003|4155899|B1|Level 60 (Prior PRP without active neovascularizat||Early Treatment Diabetic Retinopath Study Retinopathy severity level from photograph grading|Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|Eyes|Number|2|2.0||||||
4328703|NCT00445003|4155896|B4|Level 53 (Severe NPDR)||Early Treatment Diabetic Retinopath Study Retinopathy severity level from photograph grading|Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|Eyes|Number|16|16.0||||||
4328704|NCT00445003|4155897|B3|Level 53 (Severe NPDR)||Early Treatment Diabetic Retinopath Study Retinopathy severity level from photograph grading|Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|Eyes|Number|5|5.0||||||
4328705|NCT00445003|4155898|B2|Level 53 (Severe NPDR)||Early Treatment Diabetic Retinopath Study Retinopathy severity level from photograph grading|Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|Eyes|Number|6|6.0||||||
4328706|NCT00445003|4155899|B1|Level 53 (Severe NPDR)||Early Treatment Diabetic Retinopath Study Retinopathy severity level from photograph grading|Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|Eyes|Number|5|5.0||||||
4328707|NCT00445003|4155896|B4|Level 47 (Moderately severe NPDR)||Early Treatment Diabetic Retinopath Study Retinopathy severity level from photograph grading|Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|Eyes|Number|51|51.0||||||
4328708|NCT00445003|4155897|B3|Level 47 (Moderately severe NPDR)||Early Treatment Diabetic Retinopath Study Retinopathy severity level from photograph grading|Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|Eyes|Number|10|10.0||||||
4328709|NCT00445003|4155898|B2|Level 47 (Moderately severe NPDR)||Early Treatment Diabetic Retinopath Study Retinopathy severity level from photograph grading|Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|Eyes|Number|15|15.0||||||
4328710|NCT00445003|4155899|B1|Level 47 (Moderately severe NPDR)||Early Treatment Diabetic Retinopath Study Retinopathy severity level from photograph grading|Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|Eyes|Number|26|26.0||||||
4328711|NCT00445003|4155896|B4|Level 35, 43 (Mild/Moderate NPDR)||Early Treatment Diabetic Retinopath Study Retinopathy severity level from photograph grading|Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|Eyes|Number|17|17.0||||||
4328712|NCT00445003|4155897|B3|Level 35, 43 (Mild/Moderate NPDR)||Early Treatment Diabetic Retinopath Study Retinopathy severity level from photograph grading|Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|Eyes|Number|6|6.0||||||
4328713|NCT00445003|4155898|B2|Level 35, 43 (Mild/Moderate NPDR)||Early Treatment Diabetic Retinopath Study Retinopathy severity level from photograph grading|Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|Eyes|Number|5|5.0||||||
4328714|NCT00445003|4155899|B1|Level 35, 43 (Mild/Moderate NPDR)||Early Treatment Diabetic Retinopath Study Retinopathy severity level from photograph grading|Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833|Eyes|Number|6|6.0||||||
4328715|NCT00445003|4155896|B4|No||Optical coherence tomography cystoid abnormality (questionable or definite)|From reading center grading.|Eyes|Number|45|45.0||||||
4328716|NCT00445003|4155897|B3|No||Optical coherence tomography cystoid abnormality (questionable or definite)|From reading center grading.|Eyes|Number|13|13.0||||||
4328717|NCT00445003|4155898|B2|No||Optical coherence tomography cystoid abnormality (questionable or definite)|From reading center grading.|Eyes|Number|17|17.0||||||
4328718|NCT00445003|4155899|B1|No||Optical coherence tomography cystoid abnormality (questionable or definite)|From reading center grading.|Eyes|Number|15|15.0||||||
4328719|NCT00445003|4155896|B4|Yes||Optical coherence tomography cystoid abnormality (questionable or definite)|From reading center grading.|Eyes|Number|300|300.0||||||
4328720|NCT00445003|4155897|B3|Yes||Optical coherence tomography cystoid abnormality (questionable or definite)|From reading center grading.|Eyes|Number|96|96.0||||||
4328721|NCT00445003|4155898|B2|Yes||Optical coherence tomography cystoid abnormality (questionable or definite)|From reading center grading.|Eyes|Number|96|96.0||||||
4328722|NCT00445003|4155899|B1|Yes||Optical coherence tomography cystoid abnormality (questionable or definite)|From reading center grading.|Eyes|Number|108|108.0||||||
4328723|NCT00445003|4155896|B4|||Retinal volume on optical coherence tomography||cubic millimetre|Median|9.2|9.2|Inter-Quartile Range|||8.1|11.0|
4328724|NCT00445003|4155897|B3|||Retinal volume on optical coherence tomography||cubic millimetre|Median|9.1|9.1|Inter-Quartile Range|||8.1|10.0|
4328725|NCT00445003|4155898|B2|||Retinal volume on optical coherence tomography||cubic millimetre|Median|9.2|9.2|Inter-Quartile Range|||8.3|11.0|
4328726|NCT00445003|4155899|B1|||Retinal volume on optical coherence tomography||cubic millimetre|Median|9.4|9.4|Inter-Quartile Range|||8.4|10.6|
4328727|NCT00445003|4155896|B4|||Central subfield thickness on optical coherence tomography||Microns|Median|355|355.0|Inter-Quartile Range|||283.0|510.0|
4328728|NCT00445003|4155897|B3|||Central subfield thickness on optical coherence tomography||Microns|Median|359|359.0|Inter-Quartile Range|||271.0|472.0|
4328729|NCT00445003|4155898|B2|||Central subfield thickness on optical coherence tomography||Microns|Median|352|352.0|Inter-Quartile Range|||283.0|476.0|
4328731|NCT00445003|4155896|B4|||Baseline visual acuity by randomization strata|Visual Acuity was measured with the Electronic Early Treatment Study (E-ETDRS) visual acuity test. Unit of measure is based on the E-ETDRS letter score scale, 0-97, where 0 = worst and 97 = best.|Letter Score|Median|67|67.0|Inter-Quartile Range|||52.0|75.0|
4328732|NCT00445003|4155897|B3|||Baseline visual acuity by randomization strata|Visual Acuity was measured with the Electronic Early Treatment Study (E-ETDRS) visual acuity test. Unit of measure is based on the E-ETDRS letter score scale, 0-97, where 0 = worst and 97 = best.|Letter Score|Median|67|67.0|Inter-Quartile Range|||59.0|75.0|
4328733|NCT00445003|4155898|B2|||Baseline visual acuity by randomization strata|Visual Acuity was measured with the Electronic Early Treatment Study (E-ETDRS) visual acuity test. Unit of measure is based on the E-ETDRS letter score scale, 0-97, where 0 = worst and 97 = best.|Letter Score|Median|68|68.0|Inter-Quartile Range|||56.0|75.0|
4328734|NCT00445003|4155899|B1|||Baseline visual acuity by randomization strata|Visual Acuity was measured with the Electronic Early Treatment Study (E-ETDRS) visual acuity test. Unit of measure is based on the E-ETDRS letter score scale, 0-97, where 0 = worst and 97 = best.|Letter Score|Median|67|67.0|Inter-Quartile Range|||52.0|75.0|
4328735|NCT00445003|4155896|B4|Pseudophakic||Lens status (clinical examination)||Eyes|Number|44|44.0||||||
4328736|NCT00445003|4155897|B3|Pseudophakic||Lens status (clinical examination)||Eyes|Number|10|10.0||||||
4328737|NCT00445003|4155898|B2|Pseudophakic||Lens status (clinical examination)||Eyes|Number|22|22.0||||||
4328738|NCT00445003|4155899|B1|Pseudophakic||Lens status (clinical examination)||Eyes|Number|12|12.0||||||
4328739|NCT00445003|4155896|B4|Phakic||Lens status (clinical examination)||Eyes|Number|301|301.0||||||
4328740|NCT00445003|4155897|B3|Phakic||Lens status (clinical examination)||Eyes|Number|99|99.0||||||
4328741|NCT00445003|4155898|B2|Phakic||Lens status (clinical examination)||Eyes|Number|91|91.0||||||
4328742|NCT00445003|4155899|B1|Phakic||Lens status (clinical examination)||Eyes|Number|111|111.0||||||
4328743|NCT00445003|4155896|B4|No||Currently on intraocular pressure lowering medication for glaucoma or ocular hypertension||Eyes|Number|342|342.0||||||
4328744|NCT00445003|4155897|B3|No||Currently on intraocular pressure lowering medication for glaucoma or ocular hypertension||Eyes|Number|109|109.0||||||
4328745|NCT00445003|4155898|B2|No||Currently on intraocular pressure lowering medication for glaucoma or ocular hypertension||Eyes|Number|110|110.0||||||
4328746|NCT00445003|4155899|B1|No||Currently on intraocular pressure lowering medication for glaucoma or ocular hypertension||Eyes|Number|123|123.0||||||
4328747|NCT00445003|4155896|B4|Yes||Currently on intraocular pressure lowering medication for glaucoma or ocular hypertension||Eyes|Number|3|3.0||||||
4328748|NCT00445003|4155897|B3|Yes||Currently on intraocular pressure lowering medication for glaucoma or ocular hypertension||Eyes|Number|0|0.0||||||
4328749|NCT00445003|4155898|B2|Yes||Currently on intraocular pressure lowering medication for glaucoma or ocular hypertension||Eyes|Number|3|3.0||||||
4328750|NCT00445003|4155899|B1|Yes||Currently on intraocular pressure lowering medication for glaucoma or ocular hypertension||Eyes|Number|0|0.0||||||
4328751|NCT00445003|4155896|B4|No||prior anti- vascular endothelial growth factor for diabetic macular edema||Eyes|Number|335|335.0||||||
4328752|NCT00445003|4155897|B3|No||prior anti- vascular endothelial growth factor for diabetic macular edema||Eyes|Number|106|106.0||||||
4328753|NCT00445003|4155898|B2|No||prior anti- vascular endothelial growth factor for diabetic macular edema||Eyes|Number|112|112.0||||||
4328754|NCT00445003|4155899|B1|No||prior anti- vascular endothelial growth factor for diabetic macular edema||Eyes|Number|117|117.0||||||
4328755|NCT00445003|4155896|B4|Yes||prior anti- vascular endothelial growth factor for diabetic macular edema||Eyes|Number|10|10.0||||||
4328756|NCT00445003|4155897|B3|Yes||prior anti- vascular endothelial growth factor for diabetic macular edema||Eyes|Number|3|3.0||||||
4328757|NCT00445003|4155898|B2|Yes||prior anti- vascular endothelial growth factor for diabetic macular edema||Eyes|Number|1|1.0||||||
4328758|NCT00445003|4155899|B1|Yes||prior anti- vascular endothelial growth factor for diabetic macular edema||Eyes|Number|6|6.0||||||
4328759|NCT00445003|4155896|B4|No||Prior peribulbar triamcinolone for diabetic macular edema||Eyes|Number|343|343.0||||||
4328760|NCT00445003|4155897|B3|No||Prior peribulbar triamcinolone for diabetic macular edema||Eyes|Number|108|108.0||||||
4328761|NCT00445003|4155898|B2|No||Prior peribulbar triamcinolone for diabetic macular edema||Eyes|Number|113|113.0||||||
4328762|NCT00445003|4155899|B1|No||Prior peribulbar triamcinolone for diabetic macular edema||Eyes|Number|122|122.0||||||
4328763|NCT00445003|4155896|B4|Yes||Prior peribulbar triamcinolone for diabetic macular edema||Eyes|Number|2|2.0||||||
4328764|NCT00445003|4155897|B3|Yes||Prior peribulbar triamcinolone for diabetic macular edema||Eyes|Number|1|1.0||||||
4328765|NCT00445003|4155898|B2|Yes||Prior peribulbar triamcinolone for diabetic macular edema||Eyes|Number|0|0.0||||||
4328766|NCT00445003|4155899|B1|Yes||Prior peribulbar triamcinolone for diabetic macular edema||Eyes|Number|1|1.0||||||
4328767|NCT00445003|4155896|B4|No||Prior vitrectomy for diabetic macular edema||Eyes|Number|343|343.0||||||
4328768|NCT00445003|4155897|B3|No||Prior vitrectomy for diabetic macular edema||Eyes|Number|109|109.0||||||
4328769|NCT00445003|4155898|B2|No||Prior vitrectomy for diabetic macular edema||Eyes|Number|113|113.0||||||
4328770|NCT00445003|4155899|B1|No||Prior vitrectomy for diabetic macular edema||Eyes|Number|121|121.0||||||
4328771|NCT00445003|4155896|B4|Yes||Prior vitrectomy for diabetic macular edema||Eyes|Number|2|2.0||||||
4328772|NCT00445003|4155897|B3|Yes||Prior vitrectomy for diabetic macular edema||Eyes|Number|0|0.0||||||
4328773|NCT00445003|4155898|B2|Yes||Prior vitrectomy for diabetic macular edema||Eyes|Number|0|0.0||||||
4328774|NCT00445003|4155899|B1|Yes||Prior vitrectomy for diabetic macular edema||Eyes|Number|2|2.0||||||
4328775|NCT00445003|4155896|B4|No||Prior intravitreal triamcinolone for diabetic macular edema||Eyes|Number|332|332.0||||||
4328776|NCT00445003|4155897|B3|No||Prior intravitreal triamcinolone for diabetic macular edema||Eyes|Number|106|106.0||||||
4328777|NCT00445003|4155898|B2|No||Prior intravitreal triamcinolone for diabetic macular edema||Eyes|Number|104|104.0||||||
4328778|NCT00445003|4155899|B1|No||Prior intravitreal triamcinolone for diabetic macular edema||Eyes|Number|122|122.0||||||
4328779|NCT00445003|4155896|B4|Yes||Prior intravitreal triamcinolone for diabetic macular edema||Eyes|Number|13|13.0||||||
4328780|NCT00445003|4155897|B3|Yes||Prior intravitreal triamcinolone for diabetic macular edema||Eyes|Number|3|3.0||||||
4328781|NCT00445003|4155898|B2|Yes||Prior intravitreal triamcinolone for diabetic macular edema||Eyes|Number|9|9.0||||||
4328782|NCT00445003|4155899|B1|Yes||Prior intravitreal triamcinolone for diabetic macular edema||Eyes|Number|1|1.0||||||
4328783|NCT00445003|4155896|B4|No||Prior laser for diabetic macular edema||Eyes|Number|236|236.0||||||
4328784|NCT00445003|4155897|B3|No||Prior laser for diabetic macular edema||Eyes|Number|73|73.0||||||
4328785|NCT00445003|4155898|B2|No||Prior laser for diabetic macular edema||Eyes|Number|80|80.0||||||
4328786|NCT00445003|4155899|B1|No||Prior laser for diabetic macular edema||Eyes|Number|83|83.0||||||
4328787|NCT00445003|4155896|B4|Yes||Prior laser for diabetic macular edema||Eyes|Number|109|109.0||||||
4328788|NCT00445003|4155897|B3|Yes||Prior laser for diabetic macular edema||Eyes|Number|36|36.0||||||
4328789|NCT00445003|4155898|B2|Yes||Prior laser for diabetic macular edema||Eyes|Number|33|33.0||||||
4328790|NCT00445003|4155899|B1|Yes||Prior laser for diabetic macular edema||Eyes|Number|40|40.0||||||
4328791|NCT00445003|4155896|B4|No||prior treatment for diabetic macular edema||Eyes|Number|118|118.0||||||
4328792|NCT00445003|4155897|B3|No||prior treatment for diabetic macular edema||Eyes|Number|37|37.0||||||
4328793|NCT00445003|4155898|B2|No||prior treatment for diabetic macular edema||Eyes|Number|38|38.0||||||
4328794|NCT00445003|4155899|B1|No||prior treatment for diabetic macular edema||Eyes|Number|43|43.0||||||
4328795|NCT00445003|4155896|B4|Yes||prior treatment for diabetic macular edema||Eyes|Number|227|227.0||||||
4328796|NCT00445003|4155897|B3|Yes||prior treatment for diabetic macular edema||Eyes|Number|72|72.0||||||
4328797|NCT00445003|4155898|B2|Yes||prior treatment for diabetic macular edema||Eyes|Number|75|75.0||||||
4328798|NCT00445003|4155899|B1|Yes||prior treatment for diabetic macular edema||Eyes|Number|80|80.0||||||
4328799|NCT00445003|4155896|B4|No||Prior Panretinal scatter photocoagulation||Eyes|Number|290|290.0||||||
4328800|NCT00445003|4155897|B3|No||Prior Panretinal scatter photocoagulation||Eyes|Number|90|90.0||||||
4328801|NCT00445003|4155898|B2|No||Prior Panretinal scatter photocoagulation||Eyes|Number|93|93.0||||||
4328802|NCT00445003|4155899|B1|No||Prior Panretinal scatter photocoagulation||Eyes|Number|107|107.0||||||
4328803|NCT00445003|4155896|B4|Yes||Prior Panretinal scatter photocoagulation||Eyes|Number|55|55.0||||||
4328804|NCT00445003|4155897|B3|Yes||Prior Panretinal scatter photocoagulation||Eyes|Number|19|19.0||||||
4328805|NCT00445003|4155898|B2|Yes||Prior Panretinal scatter photocoagulation||Eyes|Number|20|20.0||||||
4328806|NCT00445003|4155899|B1|Yes||Prior Panretinal scatter photocoagulation||Eyes|Number|16|16.0||||||
4328807|NCT00445003|4155896|B4|2 study eyes||Number of study eyes||Participants|Number|52|52.0||||||
4328808|NCT00445003|4155897|B3|2 study eyes||Number of study eyes||Participants|Number|13|13.0||||||
4328809|NCT00445003|4155898|B2|2 study eyes||Number of study eyes||Participants|Number|13|13.0||||||
4328810|NCT00445003|4155899|B1|2 study eyes||Number of study eyes||Participants|Number|26|26.0||||||
4328811|NCT00445003|4155896|B4|1 study eye||Number of study eyes||Participants|Number|293|293.0||||||
4328812|NCT00445003|4155897|B3|1 study eye||Number of study eyes||Participants|Number|96|96.0||||||
4328813|NCT00445003|4155898|B2|1 study eye||Number of study eyes||Participants|Number|100|100.0||||||
4328814|NCT00445003|4155899|B1|1 study eye||Number of study eyes||Participants|Number|97|97.0||||||
4328815|NCT00445003|4155896|B4|No||Hypertension||Participants|Number|78|78.0||||||
4328816|NCT00445003|4155897|B3|No||Hypertension||Participants|Number|27|27.0||||||
4328817|NCT00445003|4155898|B2|No||Hypertension||Participants|Number|25|25.0||||||
4328818|NCT00445003|4155899|B1|No||Hypertension||Participants|Number|26|26.0||||||
4328819|NCT00445003|4155896|B4|Yes||Hypertension||Participants|Number|267|267.0||||||
4328820|NCT00445003|4155897|B3|Yes||Hypertension||Participants|Number|82|82.0||||||
4328821|NCT00445003|4155898|B2|Yes||Hypertension||Participants|Number|88|88.0||||||
4328822|NCT00445003|4155899|B1|Yes||Hypertension||Participants|Number|97|97.0||||||
4328823|NCT00445003|4155896|B4|No||Prior Cardiovascular event||Participants|Number|261|261.0||||||
4328824|NCT00445003|4155897|B3|No||Prior Cardiovascular event||Participants|Number|81|81.0||||||
4328825|NCT00445003|4155898|B2|No||Prior Cardiovascular event||Participants|Number|78|78.0||||||
4328826|NCT00445003|4155899|B1|No||Prior Cardiovascular event||Participants|Number|102|102.0||||||
4328827|NCT00445003|4155896|B4|Yes||Prior Cardiovascular event||Participants|Number|84|84.0||||||
4328828|NCT00445003|4155897|B3|Yes||Prior Cardiovascular event||Participants|Number|28|28.0||||||
4328829|NCT00445003|4155898|B2|Yes||Prior Cardiovascular event||Participants|Number|35|35.0||||||
4328830|NCT00445003|4155899|B1|Yes||Prior Cardiovascular event||Participants|Number|21|21.0||||||
4328831|NCT00445003|4155896|B4|||Hemoglobin A1c|Missing hemoglobin A1c data for study participants in the sham, ranibizumab, and triamcinolone, respectively: 4, 10, 7|Percentage|Median|8.0|8.0|Inter-Quartile Range|||7.0|9.9|
4328832|NCT00445003|4155897|B3|||Hemoglobin A1c|Missing hemoglobin A1c data for study participants in the sham, ranibizumab, and triamcinolone, respectively: 4, 10, 7|Percentage|Median|8.1|8.1|Inter-Quartile Range|||7.0|9.7|
4328833|NCT00445003|4155898|B2|||Hemoglobin A1c|Missing hemoglobin A1c data for study participants in the sham, ranibizumab, and triamcinolone, respectively: 4, 10, 7|Percentage|Median|8.1|8.1|Inter-Quartile Range|||7.1|9.9|
4328834|NCT00445003|4155899|B1|||Hemoglobin A1c|Missing hemoglobin A1c data for study participants in the sham, ranibizumab, and triamcinolone, respectively: 4, 10, 7|Percentage|Median|7.9|7.9|Inter-Quartile Range|||7.0|9.6|
4328835|NCT00445003|4155896|B4|||Duration of diabetes||Years|Median|15|15.0|Inter-Quartile Range|||8.0|21.0|
4328836|NCT00445003|4155897|B3|||Duration of diabetes||Years|Median|15|15.0|Inter-Quartile Range|||10.0|19.0|
4328837|NCT00445003|4155898|B2|||Duration of diabetes||Years|Median|15|15.0|Inter-Quartile Range|||10.0|21.0|
4328838|NCT00445003|4155899|B1|||Duration of diabetes||Years|Median|15|15.0|Inter-Quartile Range|||8.0|21.0|
4328839|NCT00445003|4155896|B4|Uncertain||Diabetes Type||Participants|Number|11|11.0||||||
4328840|NCT00445003|4155897|B3|Uncertain||Diabetes Type||Participants|Number|2|2.0||||||
4328841|NCT00445003|4155898|B2|Uncertain||Diabetes Type||Participants|Number|7|7.0||||||
4328842|NCT00445003|4155899|B1|Uncertain||Diabetes Type||Participants|Number|2|2.0||||||
4328843|NCT00445003|4155896|B4|Type 2||Diabetes Type||Participants|Number|289|289.0||||||
4328844|NCT00445003|4155897|B3|Type 2||Diabetes Type||Participants|Number|95|95.0||||||
4328845|NCT00445003|4155898|B2|Type 2||Diabetes Type||Participants|Number|93|93.0||||||
4328846|NCT00445003|4155899|B1|Type 2||Diabetes Type||Participants|Number|101|101.0||||||
4328847|NCT00445003|4155896|B4|Type 1||Diabetes Type||Participants|Number|45|45.0||||||
4328848|NCT00445003|4155897|B3|Type 1||Diabetes Type||Participants|Number|12|12.0||||||
4328849|NCT00445003|4155898|B2|Type 1||Diabetes Type||Participants|Number|13|13.0||||||
4328850|NCT00445003|4155899|B1|Type 1||Diabetes Type||Participants|Number|20|20.0||||||
4328851|NCT00445003|4155896|B4|||Intraocular Pressure||mmHg|Median|15|15.0|Inter-Quartile Range|||13.0|18.0|
4328852|NCT00445003|4155897|B3|||Intraocular Pressure||mmHg|Median|15|15.0|Inter-Quartile Range|||13.0|18.0|
4328853|NCT00445003|4155898|B2|||Intraocular Pressure||mmHg|Median|16|16.0|Inter-Quartile Range|||14.0|18.0|
4328854|NCT00445003|4155899|B1|||Intraocular Pressure||mmHg|Median|15|15.0|Inter-Quartile Range|||13.0|18.0|
4328855|NCT00445003|4155896|B4|Predominantly diffuse||Classification of diabetic macular edema on clinical exam||Eyes|Number|205|205.0||||||
4328856|NCT00445003|4155897|B3|Predominantly diffuse||Classification of diabetic macular edema on clinical exam||Eyes|Number|68|68.0||||||
4328857|NCT00445003|4155898|B2|Predominantly diffuse||Classification of diabetic macular edema on clinical exam||Eyes|Number|69|69.0||||||
4328858|NCT00445003|4155899|B1|Predominantly diffuse||Classification of diabetic macular edema on clinical exam||Eyes|Number|68|68.0||||||
4328859|NCT00445003|4155896|B4|Neither perdominantly focal or diffuse||Classification of diabetic macular edema on clinical exam||Eyes|Number|57|57.0||||||
4328860|NCT00445003|4155897|B3|Neither perdominantly focal or diffuse||Classification of diabetic macular edema on clinical exam||Eyes|Number|14|14.0||||||
4328861|NCT00445003|4155898|B2|Neither perdominantly focal or diffuse||Classification of diabetic macular edema on clinical exam||Eyes|Number|25|25.0||||||
4328862|NCT00445003|4155899|B1|Neither perdominantly focal or diffuse||Classification of diabetic macular edema on clinical exam||Eyes|Number|18|18.0||||||
4328863|NCT00445003|4155896|B4|Predominantly Focal`||Classification of diabetic macular edema on clinical exam||Eyes|Number|83|83.0||||||
4328864|NCT00445003|4155897|B3|Predominantly Focal`||Classification of diabetic macular edema on clinical exam||Eyes|Number|27|27.0||||||
4328865|NCT00445003|4155898|B2|Predominantly Focal`||Classification of diabetic macular edema on clinical exam||Eyes|Number|19|19.0||||||
4328866|NCT00445003|4155899|B1|Predominantly Focal`||Classification of diabetic macular edema on clinical exam||Eyes|Number|37|37.0||||||
4328867|NCT00445003|4155896|B4|No||Optical coherence tomography subretinal fluid present (questionable or definite)|Based on standard reading center grading|Eyes|Number|252|252.0||||||
4328868|NCT00445003|4155897|B3|No||Optical coherence tomography subretinal fluid present (questionable or definite)|Based on standard reading center grading|Eyes|Number|77|77.0||||||
4328869|NCT00445003|4155898|B2|No||Optical coherence tomography subretinal fluid present (questionable or definite)|Based on standard reading center grading|Eyes|Number|82|82.0||||||
4328870|NCT00445003|4155899|B1|No||Optical coherence tomography subretinal fluid present (questionable or definite)|Based on standard reading center grading|Eyes|Number|93|93.0||||||
4328871|NCT00445003|4155896|B4|Yes||Optical coherence tomography subretinal fluid present (questionable or definite)|Based on standard reading center grading|Eyes|Number|93|93.0||||||
4328872|NCT00445003|4155897|B3|Yes||Optical coherence tomography subretinal fluid present (questionable or definite)|Based on standard reading center grading|Eyes|Number|32|32.0||||||
4328873|NCT00445003|4155898|B2|Yes||Optical coherence tomography subretinal fluid present (questionable or definite)|Based on standard reading center grading|Eyes|Number|31|31.0||||||
4328874|NCT00445003|4155899|B1|Yes||Optical coherence tomography subretinal fluid present (questionable or definite)|Based on standard reading center grading|Eyes|Number|30|30.0||||||
4328875|NCT00445003|4155896|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
4328876|NCT00445003|4155897|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4328877|NCT00445003|4155898|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4328878|NCT00445003|4155899|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4328879|NCT00445003|4155896|B4|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4328880|NCT00445003|4155897|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4328881|NCT00445003|4155898|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4328882|NCT00445003|4155899|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4328883|NCT00445003|4155896|B4|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4328884|NCT00445003|4155897|B3|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4328885|NCT00445003|4155898|B2|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4328886|NCT00445003|4155899|B1|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4328887|NCT00445003|4155896|B4|White||Race/Ethnicity, Customized||participants|Number|209|209.0||||||
4328888|NCT00445003|4155897|B3|White||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
4328889|NCT00445003|4155898|B2|White||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
4328890|NCT00445003|4155899|B1|White||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
4329012|NCT00444821|4156047|B3||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4328891|NCT00445003|4155896|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4328892|NCT00445003|4155897|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4328893|NCT00445003|4155898|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4328894|NCT00445003|4155899|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4328895|NCT00445003|4155896|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4328896|NCT00445003|4155897|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4328897|NCT00445003|4155898|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4328898|NCT00445003|4155899|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4328899|NCT00445003|4155896|B4|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4328900|NCT00445003|4155897|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4328901|NCT00445003|4155898|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4328902|NCT00445003|4155899|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4328903|NCT00445003|4155896|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4328904|NCT00445003|4155897|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4328905|NCT00445003|4155898|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4328906|NCT00445003|4155899|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4328907|NCT00445003|4155896|B4||Male|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4328908|NCT00445003|4155897|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4328909|NCT00445003|4155898|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4328910|NCT00445003|4155899|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4328911|NCT00445003|4155896|B4||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4328912|NCT00445003|4155897|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4328913|NCT00445003|4155898|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4328914|NCT00445003|4155899|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4328915|NCT00445003|4155896|B4|||Age, Customized||years|Median|56|56.0|Inter-Quartile Range|||45.0|64.0|
4328916|NCT00445003|4155897|B3|||Age, Customized||years|Median|58|58.0|Inter-Quartile Range|||49.0|64.0|
4328917|NCT00445003|4155898|B2|||Age, Customized||years|Median|57|57.0|Inter-Quartile Range|||48.0|64.0|
4328918|NCT00445003|4155899|B1|||Age, Customized||years|Median|54|54.0|Inter-Quartile Range|||45.0|61.0|
4328919|NCT00444951|4155930|B4|Saudi Arabia||Region of Enrollment||participants|Number|450|450.0||||||
4328920|NCT00444951|4155931|B3|Saudi Arabia||Region of Enrollment||participants|Number|163|163.0||||||
4328921|NCT00444951|4155932|B2|Saudi Arabia||Region of Enrollment||participants|Number|142|142.0||||||
4328922|NCT00444951|4155933|B1|Saudi Arabia||Region of Enrollment||participants|Number|145|145.0||||||
4328923|NCT00444951|4155930|B4||Male|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
4328924|NCT00444951|4155931|B3||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4328925|NCT00444951|4155932|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4328926|NCT00444951|4155933|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4328927|NCT00444951|4155930|B4||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4328928|NCT00444951|4155931|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4328929|NCT00444951|4155932|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4328930|NCT00444951|4155933|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4328931|NCT00444951|4155930|B4|||Age||Years|Mean|17.84|17.84|Standard Deviation|1.16|1.16|||
4328932|NCT00444951|4155931|B3|||Age||Years|Mean|17.85|17.85|Standard Deviation|1.15|1.15|||
4328933|NCT00444951|4155932|B2|||Age||Years|Mean|17.77|17.77|Standard Deviation|1.15|1.15|||
4328934|NCT00444951|4155933|B1|||Age||Years|Mean|17.90|17.9|Standard Deviation|1.20|1.2|||
4328935|NCT00444951|4155930|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4328936|NCT00444951|4155931|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4328937|NCT00444951|4155932|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4328938|NCT00444951|4155933|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4328939|NCT00444951|4155930|B4||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
4328940|NCT00444951|4155931|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4328941|NCT00444951|4155932|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4328942|NCT00444951|4155933|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4328943|NCT00444951|4155930|B4||<=18 years|Age||Participants|Count of Participants|359|359.0||||||
4328944|NCT00444951|4155931|B3||<=18 years|Age||Participants|Count of Participants|134|134.0||||||
4328945|NCT00444951|4155932|B2||<=18 years|Age||Participants|Count of Participants|115|115.0||||||
4328946|NCT00444951|4155933|B1||<=18 years|Age||Participants|Count of Participants|110|110.0||||||
4328947|NCT00444925|4155949|B4||Male|Sex: Female, Male||Participants|Count of Participants|306|306.0||||||
4328948|NCT00444925|4155950|B3||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4328949|NCT00444925|4155951|B2||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4328950|NCT00444925|4155952|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4328951|NCT00444925|4155949|B4||Female|Sex: Female, Male||Participants|Count of Participants|1391|1391.0||||||
4328952|NCT00444925|4155950|B3||Female|Sex: Female, Male||Participants|Count of Participants|558|558.0||||||
4328953|NCT00444925|4155951|B2||Female|Sex: Female, Male||Participants|Count of Participants|564|564.0||||||
4328954|NCT00444925|4155952|B1||Female|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
4328955|NCT00444925|4155949|B4|>= 65 years||Age, Customized||participants|Number|560|560.0||||||
4328956|NCT00444925|4155950|B3|>= 65 years||Age, Customized||participants|Number|216|216.0||||||
4328957|NCT00444925|4155951|B2|>= 65 years||Age, Customized||participants|Number|232|232.0||||||
4328958|NCT00444925|4155952|B1|>= 65 years||Age, Customized||participants|Number|112|112.0||||||
4328959|NCT00444925|4155949|B4|45 - 64 years||Age, Customized||participants|Number|883|883.0||||||
4328960|NCT00444925|4155950|B3|45 - 64 years||Age, Customized||participants|Number|367|367.0||||||
4328961|NCT00444925|4155951|B2|45 - 64 years||Age, Customized||participants|Number|349|349.0||||||
4328962|NCT00444925|4155952|B1|45 - 64 years||Age, Customized||participants|Number|167|167.0||||||
4328963|NCT00444925|4155949|B4|18 - 44 years||Age, Customized||participants|Number|254|254.0||||||
4328964|NCT00444925|4155950|B3|18 - 44 years||Age, Customized||participants|Number|96|96.0||||||
4328965|NCT00444925|4155951|B2|18 - 44 years||Age, Customized||participants|Number|103|103.0||||||
4328966|NCT00444925|4155952|B1|18 - 44 years||Age, Customized||participants|Number|55|55.0||||||
4328967|NCT00444912|4156016|B3|Non-Hodgkin lymphoma (NHL)||Disease Diagnosis||Participants|Number|12|12.0||||||
4328968|NCT00444912|4156017|B2|Non-Hodgkin lymphoma (NHL)||Disease Diagnosis||Participants|Number|11|11.0||||||
4328969|NCT00444912|4156018|B1|Non-Hodgkin lymphoma (NHL)||Disease Diagnosis||Participants|Number|1|1.0||||||
4328970|NCT00444912|4156016|B3|Hodgkin disease (HD)||Disease Diagnosis||Participants|Number|18|18.0||||||
4328971|NCT00444912|4156017|B2|Hodgkin disease (HD)||Disease Diagnosis||Participants|Number|4|4.0||||||
4328972|NCT00444912|4156018|B1|Hodgkin disease (HD)||Disease Diagnosis||Participants|Number|14|14.0||||||
4328973|NCT00444912|4156016|B3|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4328974|NCT00444912|4156017|B2|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4328975|NCT00444912|4156018|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4328976|NCT00444912|4156016|B3|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4328977|NCT00444912|4156017|B2|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4328978|NCT00444912|4156018|B1|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4328979|NCT00444912|4156016|B3|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4328980|NCT00444912|4156017|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4328981|NCT00444912|4156018|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4328982|NCT00444912|4156016|B3|African-American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4328983|NCT00444912|4156017|B2|African-American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4328984|NCT00444912|4156018|B1|African-American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4328985|NCT00444912|4156016|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4328986|NCT00444912|4156017|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4328987|NCT00444912|4156018|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4328988|NCT00444912|4156016|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4328989|NCT00444912|4156017|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4328990|NCT00444912|4156018|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4328991|NCT00444912|4156016|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4328992|NCT00444912|4156017|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4328993|NCT00444912|4156018|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4328994|NCT00444912|4156016|B3|||Age||years|Mean|42.9|42.9|Standard Deviation|13.5|13.5|||
4328995|NCT00444912|4156017|B2|||Age||years|Mean|46.5|46.5|Standard Deviation|14.9|14.9|||
4328996|NCT00444912|4156018|B1|||Age||years|Mean|39.3|39.3|Standard Deviation|11.3|11.3|||
4328997|NCT00444821|4156047|B3|||Baseline AAA size||cm|Mean|4.45|4.45|Standard Deviation|0.27|0.27|||
4328998|NCT00444821|4156048|B2|||Baseline AAA size||cm|Mean|4.45|4.45|Standard Deviation|0.27|0.27|||
4328999|NCT00444821|4156049|B1|||Baseline AAA size||cm|Mean|4.45|4.45|Standard Deviation|0.27|0.27|||
4329000|NCT00444821|4156047|B3|United States||Region of Enrollment||Participants|Count of Participants|728|728.0||||||
4329001|NCT00444821|4156048|B2|United States||Region of Enrollment||Participants|Count of Participants|366|366.0||||||
4329002|NCT00444821|4156049|B1|United States||Region of Enrollment||Participants|Count of Participants|362|362.0||||||
4329003|NCT00444821|4156047|B3|Hispanic ethnicity||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4329004|NCT00444821|4156048|B2|Hispanic ethnicity||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4329005|NCT00444821|4156049|B1|Hispanic ethnicity||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4329006|NCT00444821|4156047|B3|White race||Race/Ethnicity, Customized||Participants|Count of Participants|683|683.0||||||
4329007|NCT00444821|4156048|B2|White race||Race/Ethnicity, Customized||Participants|Count of Participants|340|340.0||||||
4329008|NCT00444821|4156049|B1|White race||Race/Ethnicity, Customized||Participants|Count of Participants|343|343.0||||||
4329009|NCT00444821|4156047|B3||Male|Sex: Female, Male||Participants|Count of Participants|631|631.0||||||
4329010|NCT00444821|4156048|B2||Male|Sex: Female, Male||Participants|Count of Participants|325|325.0||||||
4329011|NCT00444821|4156049|B1||Male|Sex: Female, Male||Participants|Count of Participants|306|306.0||||||
4329013|NCT00444821|4156048|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4329014|NCT00444821|4156049|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4329015|NCT00444821|4156047|B3|||Age||years|Mean|70.46|70.46|Standard Deviation|7.74|7.74|||
4329016|NCT00444821|4156048|B2|||Age||years|Mean|70.46|70.46|Standard Deviation|7.80|7.8|||
4329017|NCT00444821|4156049|B1|||Age||years|Mean|70.47|70.47|Standard Deviation|7.67|7.67|||
4329018|NCT00444795|4156060|B1|Data Missing||Diagnosis||Participants|Number|1|1.0||||||
4329019|NCT00444795|4156060|B1|Progressive Pancreatic Neuroendocrine Carcinoma||Diagnosis||Participants|Number|2|2.0||||||
4329020|NCT00444795|4156060|B1|Gastrointestinal Stromal Tumor||Diagnosis||Participants|Number|64|64.0||||||
4329021|NCT00444795|4156060|B1|Advanced Renal Cell Carcinoma||Diagnosis||Participants|Number|550|550.0||||||
4329022|NCT00444795|4156060|B1||Male|Gender||Participants|Count of Participants|468|468.0||||||
4329023|NCT00444795|4156060|B1||Female|Gender||Participants|Count of Participants|149|149.0||||||
4329024|NCT00444795|4156060|B1|||Age||Years|Mean|57.94|57.94|Standard Deviation|11.29|11.29|||
4329025|NCT00444626|4156065|B1|Not Available||Race/Ethnicity, Customized|Multiple responses were possible for race as the screening visit CRF stated “check all that apply”.|participants|Number|3|3.0||||||
4329026|NCT00444626|4156065|B1|Other||Race/Ethnicity, Customized|Multiple responses were possible for race as the screening visit CRF stated “check all that apply”.|participants|Number|5|5.0||||||
4329027|NCT00444626|4156065|B1|White||Race/Ethnicity, Customized|Multiple responses were possible for race as the screening visit CRF stated “check all that apply”.|participants|Number|100|100.0||||||
4329028|NCT00444626|4156065|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Multiple responses were possible for race as the screening visit CRF stated “check all that apply”.|participants|Number|2|2.0||||||
4329029|NCT00444626|4156065|B1|Black or African American||Race/Ethnicity, Customized|Multiple responses were possible for race as the screening visit CRF stated “check all that apply”.|participants|Number|24|24.0||||||
4329030|NCT00444626|4156065|B1|Asian||Race/Ethnicity, Customized|Multiple responses were possible for race as the screening visit CRF stated “check all that apply”.|participants|Number|1|1.0||||||
4329031|NCT00444626|4156065|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized|Multiple responses were possible for race as the screening visit CRF stated “check all that apply”.|participants|Number|9|9.0||||||
4329032|NCT00444626|4156065|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4329033|NCT00444626|4156065|B1||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4329034|NCT00444626|4156065|B1|||Age||years|Mean|52.7|52.7|Standard Deviation|9.3|9.3|||
4329035|NCT00444600|4156091|B5|Missing||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|19|19.0||||||
4329036|NCT00444600|4156092|B4|Missing||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|2|2.0||||||
4329037|NCT00444600|4156093|B3|Missing||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|9|9.0||||||
4329038|NCT00444600|4156094|B2|Missing||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|3|3.0||||||
4329039|NCT00444600|4156095|B1|Missing||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|5|5.0||||||
4329040|NCT00444600|4156091|B5|Cannot grade||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|17|17.0||||||
4329041|NCT00444600|4156092|B4|Cannot grade||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|4|4.0||||||
4329042|NCT00444600|4156093|B3|Cannot grade||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|2|2.0||||||
4329043|NCT00444600|4156094|B2|Cannot grade||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|1|1.0||||||
4329044|NCT00444600|4156095|B1|Cannot grade||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|10|10.0||||||
4329171|NCT00444600|4156092|B4|Yes||Prior peribulbar triamcinolone for diabetic macular edema||Eyes|Number|5|5.0||||||
4329045|NCT00444600|4156091|B5|High risk proliferative DR||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|15|15.0||||||
4329046|NCT00444600|4156092|B4|High risk proliferative DR||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|3|3.0||||||
4329047|NCT00444600|4156093|B3|High risk proliferative DR||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|1|1.0||||||
4329048|NCT00444600|4156094|B2|High risk proliferative DR||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|4|4.0||||||
4329049|NCT00444600|4156095|B1|High risk proliferative DR||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|7|7.0||||||
4329050|NCT00444600|4156091|B5|Mild to moderate proliferative DR||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|113|113.0||||||
4329051|NCT00444600|4156092|B4|Mild to moderate proliferative DR||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|34|34.0||||||
4329052|NCT00444600|4156093|B3|Mild to moderate proliferative DR||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|22|22.0||||||
4329053|NCT00444600|4156094|B2|Mild to moderate proliferative DR||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|24|24.0||||||
4329054|NCT00444600|4156095|B1|Mild to moderate proliferative DR||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|33|33.0||||||
4329055|NCT00444600|4156091|B5|Scars of full or partial PRP present;PDR absent||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|127|127.0||||||
4329056|NCT00444600|4156092|B4|Scars of full or partial PRP present;PDR absent||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|29|29.0||||||
4329057|NCT00444600|4156093|B3|Scars of full or partial PRP present;PDR absent||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|30|30.0||||||
4329058|NCT00444600|4156094|B2|Scars of full or partial PRP present;PDR absent||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|30|30.0||||||
4329059|NCT00444600|4156095|B1|Scars of full or partial PRP present;PDR absent||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|38|38.0||||||
4329060|NCT00444600|4156091|B5|Severe non-proliferative DR||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|64|64.0||||||
4329061|NCT00444600|4156092|B4|Severe non-proliferative DR||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|15|15.0||||||
4329172|NCT00444600|4156093|B3|Yes||Prior peribulbar triamcinolone for diabetic macular edema||Eyes|Number|5|5.0||||||
4329173|NCT00444600|4156094|B2|Yes||Prior peribulbar triamcinolone for diabetic macular edema||Eyes|Number|9|9.0||||||
4329062|NCT00444600|4156093|B3|Severe non-proliferative DR||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|11|11.0||||||
4329063|NCT00444600|4156094|B2|Severe non-proliferative DR||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|16|16.0||||||
4329064|NCT00444600|4156095|B1|Severe non-proliferative DR||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|22|22.0||||||
4329065|NCT00444600|4156091|B5|Mild to moderately severe non-proliferative DR||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|476|476.0||||||
4329066|NCT00444600|4156092|B4|Mild to moderately severe non-proliferative DR||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|95|95.0||||||
4329067|NCT00444600|4156093|B3|Mild to moderately severe non-proliferative DR||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|107|107.0||||||
4329068|NCT00444600|4156094|B2|Mild to moderately severe non-proliferative DR||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|103|103.0||||||
4329069|NCT00444600|4156095|B1|Mild to moderately severe non-proliferative DR||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|171|171.0||||||
4329070|NCT00444600|4156091|B5|Minimal non-proliferative DR||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|10|10.0||||||
4329071|NCT00444600|4156092|B4|Minimal non-proliferative DR||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|3|3.0||||||
4329072|NCT00444600|4156093|B3|Minimal non-proliferative DR||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|3|3.0||||||
4329073|NCT00444600|4156094|B2|Minimal non-proliferative DR||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|2|2.0||||||
4329074|NCT00444600|4156095|B1|Minimal non-proliferative DR||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|2|2.0||||||
4329075|NCT00444600|4156091|B5|Diabetic retinopathy absent||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|13|13.0||||||
4329076|NCT00444600|4156092|B4|Diabetic retinopathy absent||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|1|1.0||||||
4329077|NCT00444600|4156093|B3|Diabetic retinopathy absent||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|3|3.0||||||
4329078|NCT00444600|4156094|B2|Diabetic retinopathy absent||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|4|4.0||||||
4329174|NCT00444600|4156095|B1|Yes||Prior peribulbar triamcinolone for diabetic macular edema||Eyes|Number|12|12.0||||||
4329175|NCT00444600|4156091|B5|No||Prior vitrectomy for diabetic macular edema||Eyes|Number|815|815.0||||||
4329079|NCT00444600|4156095|B1|Diabetic retinopathy absent||ETDRS retinopathy severity level (ETDRS description)|"ETDRS = Early Treatment Diabetic Retinopathy Study; DR = diabetic retinopathy; PDR = proliferative diabetic retinopathy.~Criteria are based on the ETDRS fundus photographic risk factors for the progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98:823-833"|Eyes|Number|5|5.0||||||
4329080|NCT00444600|4156091|B5|Cannot grade||Optical coherence tomography subretinal fluid present||Eyes|Number|8|8.0||||||
4329081|NCT00444600|4156092|B4|Cannot grade||Optical coherence tomography subretinal fluid present||Eyes|Number|2|2.0||||||
4329082|NCT00444600|4156093|B3|Cannot grade||Optical coherence tomography subretinal fluid present||Eyes|Number|3|3.0||||||
4329083|NCT00444600|4156094|B2|Cannot grade||Optical coherence tomography subretinal fluid present||Eyes|Number|2|2.0||||||
4329084|NCT00444600|4156095|B1|Cannot grade||Optical coherence tomography subretinal fluid present||Eyes|Number|1|1.0||||||
4329085|NCT00444600|4156091|B5|Questionable or definite||Optical coherence tomography subretinal fluid present||Eyes|Number|189|189.0||||||
4329086|NCT00444600|4156092|B4|Questionable or definite||Optical coherence tomography subretinal fluid present||Eyes|Number|38|38.0||||||
4329087|NCT00444600|4156093|B3|Questionable or definite||Optical coherence tomography subretinal fluid present||Eyes|Number|45|45.0||||||
4329088|NCT00444600|4156094|B2|Questionable or definite||Optical coherence tomography subretinal fluid present||Eyes|Number|36|36.0||||||
4329089|NCT00444600|4156095|B1|Questionable or definite||Optical coherence tomography subretinal fluid present||Eyes|Number|70|70.0||||||
4329090|NCT00444600|4156091|B5|No evidence||Optical coherence tomography subretinal fluid present||Eyes|Number|657|657.0||||||
4329091|NCT00444600|4156092|B4|No evidence||Optical coherence tomography subretinal fluid present||Eyes|Number|146|146.0||||||
4329092|NCT00444600|4156093|B3|No evidence||Optical coherence tomography subretinal fluid present||Eyes|Number|140|140.0||||||
4329093|NCT00444600|4156094|B2|No evidence||Optical coherence tomography subretinal fluid present||Eyes|Number|149|149.0||||||
4329094|NCT00444600|4156095|B1|No evidence||Optical coherence tomography subretinal fluid present||Eyes|Number|222|222.0||||||
4329095|NCT00444600|4156091|B5|Cannot grade or missing||Optical coherence tomography cystoid abnormality||Eyes|Number|6|6.0||||||
4329096|NCT00444600|4156092|B4|Cannot grade or missing||Optical coherence tomography cystoid abnormality||Eyes|Number|1|1.0||||||
4329097|NCT00444600|4156093|B3|Cannot grade or missing||Optical coherence tomography cystoid abnormality||Eyes|Number|2|2.0||||||
4329098|NCT00444600|4156094|B2|Cannot grade or missing||Optical coherence tomography cystoid abnormality||Eyes|Number|3|3.0||||||
4329099|NCT00444600|4156095|B1|Cannot grade or missing||Optical coherence tomography cystoid abnormality||Eyes|Number|0|0.0||||||
4329100|NCT00444600|4156091|B5|Questionable or definite||Optical coherence tomography cystoid abnormality||Eyes|Number|796|796.0||||||
4329101|NCT00444600|4156092|B4|Questionable or definite||Optical coherence tomography cystoid abnormality||Eyes|Number|177|177.0||||||
4329102|NCT00444600|4156093|B3|Questionable or definite||Optical coherence tomography cystoid abnormality||Eyes|Number|174|174.0||||||
4329103|NCT00444600|4156094|B2|Questionable or definite||Optical coherence tomography cystoid abnormality||Eyes|Number|171|171.0||||||
4329104|NCT00444600|4156095|B1|Questionable or definite||Optical coherence tomography cystoid abnormality||Eyes|Number|274|274.0||||||
4329105|NCT00444600|4156091|B5|No evidence||Optical coherence tomography cystoid abnormality||Eyes|Number|52|52.0||||||
4329106|NCT00444600|4156092|B4|No evidence||Optical coherence tomography cystoid abnormality||Eyes|Number|8|8.0||||||
4329107|NCT00444600|4156093|B3|No evidence||Optical coherence tomography cystoid abnormality||Eyes|Number|12|12.0||||||
4329108|NCT00444600|4156094|B2|No evidence||Optical coherence tomography cystoid abnormality||Eyes|Number|13|13.0||||||
4329109|NCT00444600|4156095|B1|No evidence||Optical coherence tomography cystoid abnormality||Eyes|Number|19|19.0||||||
4329110|NCT00444600|4156091|B5|||Retinal volume on optical coherence tomography||microns|Median|8.5|8.5|Inter-Quartile Range|||7.7|9.7|
4329111|NCT00444600|4156092|B4|||Retinal volume on optical coherence tomography||microns|Median|8.5|8.5|Inter-Quartile Range|||7.8|9.7|
4329112|NCT00444600|4156093|B3|||Retinal volume on optical coherence tomography||microns|Median|8.4|8.4|Inter-Quartile Range|||7.4|9.8|
4329113|NCT00444600|4156094|B2|||Retinal volume on optical coherence tomography||microns|Median|8.4|8.4|Inter-Quartile Range|||7.5|9.6|
4329114|NCT00444600|4156095|B1|||Retinal volume on optical coherence tomography||microns|Median|8.7|8.7|Inter-Quartile Range|||7.8|10.0|
4329115|NCT00444600|4156091|B5|||Central subfield thickness on optical coherence tomography||microns|Median|381|381.0|Inter-Quartile Range|||306.0|485.0|
4329116|NCT00444600|4156092|B4|||Central subfield thickness on optical coherence tomography||microns|Median|374|374.0|Inter-Quartile Range|||298.0|463.0|
4329117|NCT00444600|4156093|B3|||Central subfield thickness on optical coherence tomography||microns|Median|382|382.0|Inter-Quartile Range|||298.0|488.0|
4329118|NCT00444600|4156094|B2|||Central subfield thickness on optical coherence tomography||microns|Median|371|371.0|Inter-Quartile Range|||302.0|464.0|
4329119|NCT00444600|4156095|B1|||Central subfield thickness on optical coherence tomography||microns|Median|407|407.0|Inter-Quartile Range|||309.0|505.0|
4329120|NCT00444600|4156091|B5|||E-ETDRS Visual Acuity Letter Score|Best corrected visual acuity letter score as measured by a certified tester using an electronic visual acuity testing machine based on the Early Treatment Diabetic Retinopathy Study (ETDRS) method. Best value on the scale 97, worst 0.|Letter Score|Median|66|66.0|Inter-Quartile Range|||56.0|72.0|
4329121|NCT00444600|4156092|B4|||E-ETDRS Visual Acuity Letter Score|Best corrected visual acuity letter score as measured by a certified tester using an electronic visual acuity testing machine based on the Early Treatment Diabetic Retinopathy Study (ETDRS) method. Best value on the scale 97, worst 0.|Letter Score|Median|66|66.0|Inter-Quartile Range|||57.0|72.0|
4329122|NCT00444600|4156093|B3|||E-ETDRS Visual Acuity Letter Score|Best corrected visual acuity letter score as measured by a certified tester using an electronic visual acuity testing machine based on the Early Treatment Diabetic Retinopathy Study (ETDRS) method. Best value on the scale 97, worst 0.|Letter Score|Median|66|66.0|Inter-Quartile Range|||58.0|72.0|
4329123|NCT00444600|4156094|B2|||E-ETDRS Visual Acuity Letter Score|Best corrected visual acuity letter score as measured by a certified tester using an electronic visual acuity testing machine based on the Early Treatment Diabetic Retinopathy Study (ETDRS) method. Best value on the scale 97, worst 0.|Letter Score|Median|66|66.0|Inter-Quartile Range|||55.0|72.0|
4329124|NCT00444600|4156095|B1|||E-ETDRS Visual Acuity Letter Score|Best corrected visual acuity letter score as measured by a certified tester using an electronic visual acuity testing machine based on the Early Treatment Diabetic Retinopathy Study (ETDRS) method. Best value on the scale 97, worst 0.|Letter Score|Median|65|65.0|Inter-Quartile Range|||56.0|73.0|
4329125|NCT00444600|4156091|B5|Posterior Chamber Intraocular Lense||Lens status|Based on clinical exam.|Eyes|Number|268|268.0||||||
4329126|NCT00444600|4156092|B4|Posterior Chamber Intraocular Lense||Lens status|Based on clinical exam.|Eyes|Number|62|62.0||||||
4329127|NCT00444600|4156093|B3|Posterior Chamber Intraocular Lense||Lens status|Based on clinical exam.|Eyes|Number|53|53.0||||||
4329128|NCT00444600|4156094|B2|Posterior Chamber Intraocular Lense||Lens status|Based on clinical exam.|Eyes|Number|55|55.0||||||
4329129|NCT00444600|4156095|B1|Posterior Chamber Intraocular Lense||Lens status|Based on clinical exam.|Eyes|Number|98|98.0||||||
4329130|NCT00444600|4156091|B5|Anterior Chamber Intraocular Lense||Lens status|Based on clinical exam.|Eyes|Number|5|5.0||||||
4329131|NCT00444600|4156092|B4|Anterior Chamber Intraocular Lense||Lens status|Based on clinical exam.|Eyes|Number|0|0.0||||||
4329132|NCT00444600|4156093|B3|Anterior Chamber Intraocular Lense||Lens status|Based on clinical exam.|Eyes|Number|1|1.0||||||
4329133|NCT00444600|4156094|B2|Anterior Chamber Intraocular Lense||Lens status|Based on clinical exam.|Eyes|Number|1|1.0||||||
4329134|NCT00444600|4156095|B1|Anterior Chamber Intraocular Lense||Lens status|Based on clinical exam.|Eyes|Number|3|3.0||||||
4329135|NCT00444600|4156091|B5|Phakic||Lens status|Based on clinical exam.|Eyes|Number|581|581.0||||||
4329136|NCT00444600|4156092|B4|Phakic||Lens status|Based on clinical exam.|Eyes|Number|124|124.0||||||
4329137|NCT00444600|4156093|B3|Phakic||Lens status|Based on clinical exam.|Eyes|Number|134|134.0||||||
4329138|NCT00444600|4156094|B2|Phakic||Lens status|Based on clinical exam.|Eyes|Number|131|131.0||||||
4329139|NCT00444600|4156095|B1|Phakic||Lens status|Based on clinical exam.|Eyes|Number|192|192.0||||||
4329140|NCT00444600|4156091|B5|No||Currently on intraocular pressure lowering medicine for glaucoma or ocular hypertension||Eyes|Number|837|837.0||||||
4329141|NCT00444600|4156092|B4|No||Currently on intraocular pressure lowering medicine for glaucoma or ocular hypertension||Eyes|Number|184|184.0||||||
4329142|NCT00444600|4156093|B3|No||Currently on intraocular pressure lowering medicine for glaucoma or ocular hypertension||Eyes|Number|184|184.0||||||
4329143|NCT00444600|4156094|B2|No||Currently on intraocular pressure lowering medicine for glaucoma or ocular hypertension||Eyes|Number|181|181.0||||||
4329144|NCT00444600|4156095|B1|No||Currently on intraocular pressure lowering medicine for glaucoma or ocular hypertension||Eyes|Number|288|288.0||||||
4329145|NCT00444600|4156091|B5|Yes||Currently on intraocular pressure lowering medicine for glaucoma or ocular hypertension||Eyes|Number|17|17.0||||||
4329146|NCT00444600|4156092|B4|Yes||Currently on intraocular pressure lowering medicine for glaucoma or ocular hypertension||Eyes|Number|2|2.0||||||
4329147|NCT00444600|4156093|B3|Yes||Currently on intraocular pressure lowering medicine for glaucoma or ocular hypertension||Eyes|Number|4|4.0||||||
4329148|NCT00444600|4156094|B2|Yes||Currently on intraocular pressure lowering medicine for glaucoma or ocular hypertension||Eyes|Number|6|6.0||||||
4329149|NCT00444600|4156095|B1|Yes||Currently on intraocular pressure lowering medicine for glaucoma or ocular hypertension||Eyes|Number|5|5.0||||||
4329150|NCT00444600|4156091|B5|||Intraocular pressure||mmHg|Median|16|16.0|Inter-Quartile Range|||14.0|18.0|
4329151|NCT00444600|4156092|B4|||Intraocular pressure||mmHg|Median|16|16.0|Inter-Quartile Range|||14.0|18.0|
4329152|NCT00444600|4156093|B3|||Intraocular pressure||mmHg|Median|16|16.0|Inter-Quartile Range|||14.0|18.0|
4329153|NCT00444600|4156094|B2|||Intraocular pressure||mmHg|Median|16|16.0|Inter-Quartile Range|||14.0|18.0|
4329154|NCT00444600|4156095|B1|||Intraocular pressure||mmHg|Median|16|16.0|Inter-Quartile Range|||14.0|18.0|
4329155|NCT00444600|4156091|B5|No||Prior anti-VEGF for diabetic macular edema|VEGF = vascular endothelial growth factor|Eyes|Number|765|765.0||||||
4329156|NCT00444600|4156092|B4|No||Prior anti-VEGF for diabetic macular edema|VEGF = vascular endothelial growth factor|Eyes|Number|166|166.0||||||
4329157|NCT00444600|4156093|B3|No||Prior anti-VEGF for diabetic macular edema|VEGF = vascular endothelial growth factor|Eyes|Number|167|167.0||||||
4329158|NCT00444600|4156094|B2|No||Prior anti-VEGF for diabetic macular edema|VEGF = vascular endothelial growth factor|Eyes|Number|163|163.0||||||
4329159|NCT00444600|4156095|B1|No||Prior anti-VEGF for diabetic macular edema|VEGF = vascular endothelial growth factor|Eyes|Number|269|269.0||||||
4329160|NCT00444600|4156091|B5|Yes||Prior anti-VEGF for diabetic macular edema|VEGF = vascular endothelial growth factor|Eyes|Number|89|89.0||||||
4329161|NCT00444600|4156092|B4|Yes||Prior anti-VEGF for diabetic macular edema|VEGF = vascular endothelial growth factor|Eyes|Number|20|20.0||||||
4329162|NCT00444600|4156093|B3|Yes||Prior anti-VEGF for diabetic macular edema|VEGF = vascular endothelial growth factor|Eyes|Number|21|21.0||||||
4329163|NCT00444600|4156094|B2|Yes||Prior anti-VEGF for diabetic macular edema|VEGF = vascular endothelial growth factor|Eyes|Number|24|24.0||||||
4329164|NCT00444600|4156095|B1|Yes||Prior anti-VEGF for diabetic macular edema|VEGF = vascular endothelial growth factor|Eyes|Number|24|24.0||||||
4329165|NCT00444600|4156091|B5|No||Prior peribulbar triamcinolone for diabetic macular edema||Eyes|Number|823|823.0||||||
4329166|NCT00444600|4156092|B4|No||Prior peribulbar triamcinolone for diabetic macular edema||Eyes|Number|181|181.0||||||
4329167|NCT00444600|4156093|B3|No||Prior peribulbar triamcinolone for diabetic macular edema||Eyes|Number|183|183.0||||||
4329168|NCT00444600|4156094|B2|No||Prior peribulbar triamcinolone for diabetic macular edema||Eyes|Number|178|178.0||||||
4329169|NCT00444600|4156095|B1|No||Prior peribulbar triamcinolone for diabetic macular edema||Eyes|Number|281|281.0||||||
4329170|NCT00444600|4156091|B5|Yes||Prior peribulbar triamcinolone for diabetic macular edema||Eyes|Number|31|31.0||||||
4329176|NCT00444600|4156092|B4|No||Prior vitrectomy for diabetic macular edema||Eyes|Number|174|174.0||||||
4329177|NCT00444600|4156093|B3|No||Prior vitrectomy for diabetic macular edema||Eyes|Number|183|183.0||||||
4329178|NCT00444600|4156094|B2|No||Prior vitrectomy for diabetic macular edema||Eyes|Number|180|180.0||||||
4329179|NCT00444600|4156095|B1|No||Prior vitrectomy for diabetic macular edema||Eyes|Number|278|278.0||||||
4329180|NCT00444600|4156091|B5|Yes||Prior vitrectomy for diabetic macular edema||Eyes|Number|39|39.0||||||
4329181|NCT00444600|4156092|B4|Yes||Prior vitrectomy for diabetic macular edema||Eyes|Number|12|12.0||||||
4329182|NCT00444600|4156093|B3|Yes||Prior vitrectomy for diabetic macular edema||Eyes|Number|5|5.0||||||
4329183|NCT00444600|4156094|B2|Yes||Prior vitrectomy for diabetic macular edema||Eyes|Number|7|7.0||||||
4329184|NCT00444600|4156095|B1|Yes||Prior vitrectomy for diabetic macular edema||Eyes|Number|15|15.0||||||
4329185|NCT00444600|4156091|B5|No||Prior IVT for diabetic macular edema|IVT = intravitreal triamcinolone|Eyes|Number|726|726.0||||||
4329186|NCT00444600|4156092|B4|No||Prior IVT for diabetic macular edema|IVT = intravitreal triamcinolone|Eyes|Number|155|155.0||||||
4329187|NCT00444600|4156093|B3|No||Prior IVT for diabetic macular edema|IVT = intravitreal triamcinolone|Eyes|Number|152|152.0||||||
4329188|NCT00444600|4156094|B2|No||Prior IVT for diabetic macular edema|IVT = intravitreal triamcinolone|Eyes|Number|165|165.0||||||
4329189|NCT00444600|4156095|B1|No||Prior IVT for diabetic macular edema|IVT = intravitreal triamcinolone|Eyes|Number|254|254.0||||||
4329190|NCT00444600|4156091|B5|Yes||Prior IVT for diabetic macular edema|IVT = intravitreal triamcinolone|Eyes|Number|128|128.0||||||
4329191|NCT00444600|4156092|B4|Yes||Prior IVT for diabetic macular edema|IVT = intravitreal triamcinolone|Eyes|Number|31|31.0||||||
4329192|NCT00444600|4156093|B3|Yes||Prior IVT for diabetic macular edema|IVT = intravitreal triamcinolone|Eyes|Number|36|36.0||||||
4329193|NCT00444600|4156094|B2|Yes||Prior IVT for diabetic macular edema|IVT = intravitreal triamcinolone|Eyes|Number|22|22.0||||||
4329194|NCT00444600|4156095|B1|Yes||Prior IVT for diabetic macular edema|IVT = intravitreal triamcinolone|Eyes|Number|39|39.0||||||
4329195|NCT00444600|4156091|B5|No||Prior laser for diabetic macular edema||Eyes|Number|365|365.0||||||
4329196|NCT00444600|4156092|B4|No||Prior laser for diabetic macular edema||Eyes|Number|72|72.0||||||
4329197|NCT00444600|4156093|B3|No||Prior laser for diabetic macular edema||Eyes|Number|87|87.0||||||
4329198|NCT00444600|4156094|B2|No||Prior laser for diabetic macular edema||Eyes|Number|86|86.0||||||
4329199|NCT00444600|4156095|B1|No||Prior laser for diabetic macular edema||Eyes|Number|120|120.0||||||
4329200|NCT00444600|4156091|B5|Yes||Prior laser for diabetic macular edema||Eyes|Number|489|489.0||||||
4329201|NCT00444600|4156092|B4|Yes||Prior laser for diabetic macular edema||Eyes|Number|114|114.0||||||
4329202|NCT00444600|4156093|B3|Yes||Prior laser for diabetic macular edema||Eyes|Number|101|101.0||||||
4329203|NCT00444600|4156094|B2|Yes||Prior laser for diabetic macular edema||Eyes|Number|101|101.0||||||
4329204|NCT00444600|4156095|B1|Yes||Prior laser for diabetic macular edema||Eyes|Number|173|173.0||||||
4329205|NCT00444600|4156091|B5|Yes||Prior treatment for diabetic macular edema||Eyes|Number|540|540.0||||||
4329206|NCT00444600|4156092|B4|Yes||Prior treatment for diabetic macular edema||Eyes|Number|125|125.0||||||
4329207|NCT00444600|4156093|B3|Yes||Prior treatment for diabetic macular edema||Eyes|Number|114|114.0||||||
4329208|NCT00444600|4156094|B2|Yes||Prior treatment for diabetic macular edema||Eyes|Number|113|113.0||||||
4329209|NCT00444600|4156095|B1|Yes||Prior treatment for diabetic macular edema||Eyes|Number|188|188.0||||||
4329210|NCT00444600|4156091|B5|No||Prior treatment for diabetic macular edema||Eyes|Number|314|314.0||||||
4329211|NCT00444600|4156092|B4|No||Prior treatment for diabetic macular edema||Eyes|Number|61|61.0||||||
4329212|NCT00444600|4156093|B3|No||Prior treatment for diabetic macular edema||Eyes|Number|74|74.0||||||
4329213|NCT00444600|4156094|B2|No||Prior treatment for diabetic macular edema||Eyes|Number|74|74.0||||||
4329214|NCT00444600|4156095|B1|No||Prior treatment for diabetic macular edema||Eyes|Number|105|105.0||||||
4329215|NCT00444600|4156091|B5|No||Prior Panretinal Photocoagulation||Eyes|Number|702|702.0||||||
4329216|NCT00444600|4156092|B4|No||Prior Panretinal Photocoagulation||Eyes|Number|149|149.0||||||
4329217|NCT00444600|4156093|B3|No||Prior Panretinal Photocoagulation||Eyes|Number|157|157.0||||||
4329218|NCT00444600|4156094|B2|No||Prior Panretinal Photocoagulation||Eyes|Number|151|151.0||||||
4329219|NCT00444600|4156095|B1|No||Prior Panretinal Photocoagulation||Eyes|Number|245|245.0||||||
4329220|NCT00444600|4156091|B5|Yes||Prior Panretinal Photocoagulation||Eyes|Number|152|152.0||||||
4329221|NCT00444600|4156092|B4|Yes||Prior Panretinal Photocoagulation||Eyes|Number|37|37.0||||||
4329222|NCT00444600|4156093|B3|Yes||Prior Panretinal Photocoagulation||Eyes|Number|31|31.0||||||
4329223|NCT00444600|4156094|B2|Yes||Prior Panretinal Photocoagulation||Eyes|Number|36|36.0||||||
4329224|NCT00444600|4156095|B1|Yes||Prior Panretinal Photocoagulation||Eyes|Number|48|48.0||||||
4329225|NCT00444600|4156091|B5|No||Hypertension||Participants|Number|156|156.0||||||
4329226|NCT00444600|4156092|B4|No||Hypertension||Participants|Number|38|38.0||||||
4329227|NCT00444600|4156093|B3|No||Hypertension||Participants|Number|32|32.0||||||
4329228|NCT00444600|4156094|B2|No||Hypertension||Participants|Number|33|33.0||||||
4329229|NCT00444600|4156095|B1|No||Hypertension||Participants|Number|53|53.0||||||
4329230|NCT00444600|4156091|B5|Yes||Hypertension||Participants|Number|698|698.0||||||
4329231|NCT00444600|4156092|B4|Yes||Hypertension||Participants|Number|148|148.0||||||
4329232|NCT00444600|4156093|B3|Yes||Hypertension||Participants|Number|156|156.0||||||
4329233|NCT00444600|4156094|B2|Yes||Hypertension||Participants|Number|154|154.0||||||
4329234|NCT00444600|4156095|B1|Yes||Hypertension||Participants|Number|240|240.0||||||
4329235|NCT00444600|4156091|B5|No||Prior cardiovascular event|Based on medical history of condition.|Participants|Number|573|573.0||||||
4329236|NCT00444600|4156092|B4|No||Prior cardiovascular event|Based on medical history of condition.|Participants|Number|125|125.0||||||
4329237|NCT00444600|4156093|B3|No||Prior cardiovascular event|Based on medical history of condition.|Participants|Number|127|127.0||||||
4329238|NCT00444600|4156094|B2|No||Prior cardiovascular event|Based on medical history of condition.|Participants|Number|121|121.0||||||
4329239|NCT00444600|4156095|B1|No||Prior cardiovascular event|Based on medical history of condition.|Participants|Number|200|200.0||||||
4329240|NCT00444600|4156091|B5|Yes||Prior cardiovascular event|Based on medical history of condition.|Participants|Number|281|281.0||||||
4329241|NCT00444600|4156092|B4|Yes||Prior cardiovascular event|Based on medical history of condition.|Participants|Number|61|61.0||||||
4329242|NCT00444600|4156093|B3|Yes||Prior cardiovascular event|Based on medical history of condition.|Participants|Number|61|61.0||||||
4329243|NCT00444600|4156094|B2|Yes||Prior cardiovascular event|Based on medical history of condition.|Participants|Number|66|66.0||||||
4329244|NCT00444600|4156095|B1|Yes||Prior cardiovascular event|Based on medical history of condition.|Participants|Number|93|93.0||||||
4329245|NCT00444600|4156091|B5|||HbA1c|Missing HbA1c data for 17, 3, 7 and 8 study participants in the sham+prompt laser, ranibizumab+prompt laser, ranibizumab+deferred laser and triamcinolone+prompt laser groups, respectively.|Percentage|Median|7.3|7.3|Inter-Quartile Range|||6.6|8.4|
4329246|NCT00444600|4156092|B4|||HbA1c|Missing HbA1c data for 17, 3, 7 and 8 study participants in the sham+prompt laser, ranibizumab+prompt laser, ranibizumab+deferred laser and triamcinolone+prompt laser groups, respectively.|Percentage|Median|7.4|7.4|Inter-Quartile Range|||6.5|8.6|
4329247|NCT00444600|4156093|B3|||HbA1c|Missing HbA1c data for 17, 3, 7 and 8 study participants in the sham+prompt laser, ranibizumab+prompt laser, ranibizumab+deferred laser and triamcinolone+prompt laser groups, respectively.|Percentage|Median|7.5|7.5|Inter-Quartile Range|||6.7|8.4|
4329248|NCT00444600|4156094|B2|||HbA1c|Missing HbA1c data for 17, 3, 7 and 8 study participants in the sham+prompt laser, ranibizumab+prompt laser, ranibizumab+deferred laser and triamcinolone+prompt laser groups, respectively.|Percentage|Median|7.3|7.3|Inter-Quartile Range|||6.6|8.4|
4329249|NCT00444600|4156095|B1|||HbA1c|Missing HbA1c data for 17, 3, 7 and 8 study participants in the sham+prompt laser, ranibizumab+prompt laser, ranibizumab+deferred laser and triamcinolone+prompt laser groups, respectively.|Percentage|Median|7.3|7.3|Inter-Quartile Range|||6.6|8.3|
4329250|NCT00444600|4156091|B5|||Duration of diabetes||Years|Median|16|16.0|Inter-Quartile Range|||10.0|23.0|
4329251|NCT00444600|4156092|B4|||Duration of diabetes||Years|Median|17|17.0|Inter-Quartile Range|||11.0|24.0|
4329252|NCT00444600|4156093|B3|||Duration of diabetes||Years|Median|17|17.0|Inter-Quartile Range|||11.0|22.0|
4329253|NCT00444600|4156094|B2|||Duration of diabetes||Years|Median|18|18.0|Inter-Quartile Range|||12.0|24.0|
4329254|NCT00444600|4156095|B1|||Duration of diabetes||Years|Median|16|16.0|Inter-Quartile Range|||9.0|22.0|
4329255|NCT00444600|4156091|B5|Uncertain||Diabetes Type||Participants|Number|21|21.0||||||
4329256|NCT00444600|4156092|B4|Uncertain||Diabetes Type||Participants|Number|6|6.0||||||
4329257|NCT00444600|4156093|B3|Uncertain||Diabetes Type||Participants|Number|3|3.0||||||
4329258|NCT00444600|4156094|B2|Uncertain||Diabetes Type||Participants|Number|4|4.0||||||
4329259|NCT00444600|4156095|B1|Uncertain||Diabetes Type||Participants|Number|8|8.0||||||
4329260|NCT00444600|4156091|B5|Type 2||Diabetes Type||Participants|Number|768|768.0||||||
4329261|NCT00444600|4156092|B4|Type 2||Diabetes Type||Participants|Number|166|166.0||||||
4329262|NCT00444600|4156093|B3|Type 2||Diabetes Type||Participants|Number|170|170.0||||||
4329263|NCT00444600|4156094|B2|Type 2||Diabetes Type||Participants|Number|172|172.0||||||
4329264|NCT00444600|4156095|B1|Type 2||Diabetes Type||Participants|Number|260|260.0||||||
4329265|NCT00444600|4156091|B5|Type 1||Diabetes Type||Participants|Number|65|65.0||||||
4329266|NCT00444600|4156092|B4|Type 1||Diabetes Type||Participants|Number|14|14.0||||||
4329267|NCT00444600|4156093|B3|Type 1||Diabetes Type||Participants|Number|15|15.0||||||
4329268|NCT00444600|4156094|B2|Type 1||Diabetes Type||Participants|Number|11|11.0||||||
4329269|NCT00444600|4156095|B1|Type 1||Diabetes Type||Participants|Number|25|25.0||||||
4329270|NCT00444600|4156091|B5|2 study eyes||Number of study eyes||Participants|Number|326|326.0||||||
4329271|NCT00444600|4156092|B4|2 study eyes||Number of study eyes||Participants|Number|51|51.0||||||
4329272|NCT00444600|4156093|B3|2 study eyes||Number of study eyes||Participants|Number|56|56.0||||||
4329273|NCT00444600|4156094|B2|2 study eyes||Number of study eyes||Participants|Number|56|56.0||||||
4329274|NCT00444600|4156095|B1|2 study eyes||Number of study eyes||Participants|Number|163|163.0||||||
4329275|NCT00444600|4156091|B5|1 study eye||Number of study eyes||Participants|Number|528|528.0||||||
4329276|NCT00444600|4156092|B4|1 study eye||Number of study eyes||Participants|Number|135|135.0||||||
4329277|NCT00444600|4156093|B3|1 study eye||Number of study eyes||Participants|Number|132|132.0||||||
4329278|NCT00444600|4156094|B2|1 study eye||Number of study eyes||Participants|Number|131|131.0||||||
4329279|NCT00444600|4156095|B1|1 study eye||Number of study eyes||Participants|Number|130|130.0||||||
4329280|NCT00444600|4156091|B5|Predominantly diffuse||Classification of diabetic macular edema|Based on clinical exam.|Eyes|Number|389|389.0||||||
4329281|NCT00444600|4156092|B4|Predominantly diffuse||Classification of diabetic macular edema|Based on clinical exam.|Eyes|Number|85|85.0||||||
4329282|NCT00444600|4156093|B3|Predominantly diffuse||Classification of diabetic macular edema|Based on clinical exam.|Eyes|Number|79|79.0||||||
4329283|NCT00444600|4156094|B2|Predominantly diffuse||Classification of diabetic macular edema|Based on clinical exam.|Eyes|Number|81|81.0||||||
4329284|NCT00444600|4156095|B1|Predominantly diffuse||Classification of diabetic macular edema|Based on clinical exam.|Eyes|Number|144|144.0||||||
4329285|NCT00444600|4156091|B5|Neither predominantly focal or diffuse||Classification of diabetic macular edema|Based on clinical exam.|Eyes|Number|206|206.0||||||
4329286|NCT00444600|4156092|B4|Neither predominantly focal or diffuse||Classification of diabetic macular edema|Based on clinical exam.|Eyes|Number|48|48.0||||||
4329287|NCT00444600|4156093|B3|Neither predominantly focal or diffuse||Classification of diabetic macular edema|Based on clinical exam.|Eyes|Number|41|41.0||||||
4329288|NCT00444600|4156094|B2|Neither predominantly focal or diffuse||Classification of diabetic macular edema|Based on clinical exam.|Eyes|Number|46|46.0||||||
4329289|NCT00444600|4156095|B1|Neither predominantly focal or diffuse||Classification of diabetic macular edema|Based on clinical exam.|Eyes|Number|71|71.0||||||
4329290|NCT00444600|4156091|B5|Predominantly focal||Classification of diabetic macular edema|Based on clinical exam.|Eyes|Number|259|259.0||||||
4329291|NCT00444600|4156092|B4|Predominantly focal||Classification of diabetic macular edema|Based on clinical exam.|Eyes|Number|53|53.0||||||
4329292|NCT00444600|4156093|B3|Predominantly focal||Classification of diabetic macular edema|Based on clinical exam.|Eyes|Number|68|68.0||||||
4329293|NCT00444600|4156094|B2|Predominantly focal||Classification of diabetic macular edema|Based on clinical exam.|Eyes|Number|60|60.0||||||
4329294|NCT00444600|4156095|B1|Predominantly focal||Classification of diabetic macular edema|Based on clinical exam.|Eyes|Number|78|78.0||||||
4329295|NCT00444600|4156091|B5|≤65 (20/50 or worse)||Visual Acuity Letter Score (approximate Snellen equivalent) by randomization strata||Eyes|Number|425|425.0||||||
4329296|NCT00444600|4156092|B4|≤65 (20/50 or worse)||Visual Acuity Letter Score (approximate Snellen equivalent) by randomization strata||Eyes|Number|93|93.0||||||
4329297|NCT00444600|4156093|B3|≤65 (20/50 or worse)||Visual Acuity Letter Score (approximate Snellen equivalent) by randomization strata||Eyes|Number|93|93.0||||||
4329298|NCT00444600|4156094|B2|≤65 (20/50 or worse)||Visual Acuity Letter Score (approximate Snellen equivalent) by randomization strata||Eyes|Number|92|92.0||||||
4329299|NCT00444600|4156095|B1|≤65 (20/50 or worse)||Visual Acuity Letter Score (approximate Snellen equivalent) by randomization strata||Eyes|Number|147|147.0||||||
4329300|NCT00444600|4156091|B5|≥66 (better than 20/50)||Visual Acuity Letter Score (approximate Snellen equivalent) by randomization strata||Eyes|Number|429|429.0||||||
4329301|NCT00444600|4156092|B4|≥66 (better than 20/50)||Visual Acuity Letter Score (approximate Snellen equivalent) by randomization strata||Eyes|Number|93|93.0||||||
4329302|NCT00444600|4156093|B3|≥66 (better than 20/50)||Visual Acuity Letter Score (approximate Snellen equivalent) by randomization strata||Eyes|Number|95|95.0||||||
4329303|NCT00444600|4156094|B2|≥66 (better than 20/50)||Visual Acuity Letter Score (approximate Snellen equivalent) by randomization strata||Eyes|Number|95|95.0||||||
4329304|NCT00444600|4156095|B1|≥66 (better than 20/50)||Visual Acuity Letter Score (approximate Snellen equivalent) by randomization strata||Eyes|Number|146|146.0||||||
4329305|NCT00444600|4156091|B5|Unknown/not reported||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4329306|NCT00444600|4156092|B4|Unknown/not reported||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4329307|NCT00444600|4156093|B3|Unknown/not reported||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4329308|NCT00444600|4156094|B2|Unknown/not reported||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4329309|NCT00444600|4156095|B1|Unknown/not reported||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4329310|NCT00444600|4156091|B5|More than one race||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4329311|NCT00444600|4156092|B4|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4329312|NCT00444600|4156093|B3|More than one race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4329313|NCT00444600|4156094|B2|More than one race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4329314|NCT00444600|4156095|B1|More than one race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4329315|NCT00444600|4156091|B5|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4329316|NCT00444600|4156092|B4|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4329317|NCT00444600|4156093|B3|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4329318|NCT00444600|4156094|B2|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4329319|NCT00444600|4156095|B1|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4329320|NCT00444600|4156091|B5|Asian||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4329321|NCT00444600|4156092|B4|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4329322|NCT00444600|4156093|B3|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4329323|NCT00444600|4156094|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4329324|NCT00444600|4156095|B1|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4329325|NCT00444600|4156091|B5|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|95|95.0||||||
4329326|NCT00444600|4156092|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4329327|NCT00444600|4156093|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
4329328|NCT00444600|4156094|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
4329329|NCT00444600|4156095|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|34|34.0||||||
4329330|NCT00444600|4156091|B5|African American||Race/Ethnicity, Customized||Participants|Number|138|138.0||||||
4329331|NCT00444600|4156092|B4|African American||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
4329332|NCT00444600|4156093|B3|African American||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
4329333|NCT00444600|4156094|B2|African American||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
4329334|NCT00444600|4156095|B1|African American||Race/Ethnicity, Customized||Participants|Number|51|51.0||||||
4329335|NCT00444600|4156091|B5|White||Race/Ethnicity, Customized||Participants|Number|601|601.0||||||
4329336|NCT00444600|4156092|B4|White||Race/Ethnicity, Customized||Participants|Number|134|134.0||||||
4329337|NCT00444600|4156093|B3|White||Race/Ethnicity, Customized||Participants|Number|134|134.0||||||
4329338|NCT00444600|4156094|B2|White||Race/Ethnicity, Customized||Participants|Number|131|131.0||||||
4329339|NCT00444600|4156095|B1|White||Race/Ethnicity, Customized||Participants|Number|202|202.0||||||
4329340|NCT00444600|4156091|B5||Male|Sex: Female, Male||Participants|Count of Participants|482|482.0||||||
4329341|NCT00444600|4156092|B4||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4329342|NCT00444600|4156093|B3||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4329343|NCT00444600|4156094|B2||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4329344|NCT00444600|4156095|B1||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4329345|NCT00444600|4156091|B5||Female|Sex: Female, Male||Participants|Count of Participants|372|372.0||||||
4329346|NCT00444600|4156092|B4||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4329347|NCT00444600|4156093|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4329348|NCT00444600|4156094|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4329349|NCT00444600|4156095|B1||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4329350|NCT00444600|4156091|B5|||Age||years|Median|63|63.0|Inter-Quartile Range|||56.0|70.0|
4329351|NCT00444600|4156092|B4|||Age||years|Median|62|62.0|Inter-Quartile Range|||55.0|70.0|
4329352|NCT00444600|4156093|B3|||Age||years|Median|64|64.0|Inter-Quartile Range|||58.0|70.0|
4329353|NCT00444600|4156094|B2|||Age||years|Median|62|62.0|Inter-Quartile Range|||56.0|70.0|
4329354|NCT00444600|4156095|B1|||Age||years|Median|63|63.0|Inter-Quartile Range|||57.0|69.0|
4329355|NCT00444587|4156188|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4329356|NCT00444587|4156189|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4329357|NCT00444587|4156190|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4329358|NCT00444587|4156188|B3||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4329359|NCT00444587|4156189|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4329360|NCT00444587|4156190|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4329361|NCT00444587|4156188|B3|||Age||years|Mean|55.5|55.5|Standard Deviation|12.4|12.4|||
4329362|NCT00444587|4156189|B2|||Age||years|Mean|56.3|56.3|Standard Deviation|10.2|10.2|||
4329363|NCT00444587|4156190|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|12.8|12.8|||
4329364|NCT00444535|4156212|B1|Asian and White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4329365|NCT00444535|4156212|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4329366|NCT00444535|4156212|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4329367|NCT00444535|4156212|B1|White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4329368|NCT00444535|4156212|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4329369|NCT00444535|4156212|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4329370|NCT00444535|4156212|B1|||Age||years|Mean|52.5|52.5|Standard Deviation|10.2|10.2|||
4329371|NCT00444457|4156219|B5|Unknown||Sex/Gender, Customized||participants|Number|3|3.0||||||
4329372|NCT00444457|4156220|B4|Unknown||Sex/Gender, Customized||participants|Number|0|0.0||||||
4329373|NCT00444457|4156221|B3|Unknown||Sex/Gender, Customized||participants|Number|1|1.0||||||
4329374|NCT00444457|4156222|B2|Unknown||Sex/Gender, Customized||participants|Number|2|2.0||||||
4329375|NCT00444457|4156223|B1|Unknown||Sex/Gender, Customized||participants|Number|0|0.0||||||
4329376|NCT00444457|4156219|B5|Male||Sex/Gender, Customized||participants|Number|925|925.0||||||
4329377|NCT00444457|4156220|B4|Male||Sex/Gender, Customized||participants|Number|131|131.0||||||
4329378|NCT00444457|4156221|B3|Male||Sex/Gender, Customized||participants|Number|275|275.0||||||
4329379|NCT00444457|4156222|B2|Male||Sex/Gender, Customized||participants|Number|260|260.0||||||
4329380|NCT00444457|4156223|B1|Male||Sex/Gender, Customized||participants|Number|259|259.0||||||
4329381|NCT00444457|4156219|B5|Female||Sex/Gender, Customized||participants|Number|784|784.0||||||
4329382|NCT00444457|4156220|B4|Female||Sex/Gender, Customized||participants|Number|115|115.0||||||
4329383|NCT00444457|4156221|B3|Female||Sex/Gender, Customized||participants|Number|213|213.0||||||
4329384|NCT00444457|4156222|B2|Female||Sex/Gender, Customized||participants|Number|226|226.0||||||
4329385|NCT00444457|4156223|B1|Female||Sex/Gender, Customized||participants|Number|230|230.0||||||
4329386|NCT00444457|4156219|B5|||Age||months|Mean|2.2|2.2|Standard Deviation|0.3|0.3|||
4329387|NCT00444457|4156220|B4|||Age||months|Mean|2.2|2.2|Standard Deviation|0.3|0.3|||
4329388|NCT00444457|4156221|B3|||Age||months|Mean|2.2|2.2|Standard Deviation|0.3|0.3|||
4329389|NCT00444457|4156222|B2|||Age||months|Mean|2.2|2.2|Standard Deviation|0.3|0.3|||
4329390|NCT00444457|4156223|B1|||Age||months|Mean|2.2|2.2|Standard Deviation|0.3|0.3|||
4329391|NCT00444275|4156288|B4||Male|Sex: Female, Male||Participants|Count of Participants|1283|1283.0||||||
4329392|NCT00444275|4156289|B3||Male|Sex: Female, Male||Participants|Count of Participants|419|419.0||||||
4329393|NCT00444275|4156290|B2||Male|Sex: Female, Male||Participants|Count of Participants|442|442.0||||||
4329394|NCT00444275|4156291|B1||Male|Sex: Female, Male||Participants|Count of Participants|422|422.0||||||
4329395|NCT00444275|4156288|B4||Female|Sex: Female, Male||Participants|Count of Participants|1275|1275.0||||||
4329396|NCT00444275|4156289|B3||Female|Sex: Female, Male||Participants|Count of Participants|411|411.0||||||
4329397|NCT00444275|4156290|B2||Female|Sex: Female, Male||Participants|Count of Participants|415|415.0||||||
4329398|NCT00444275|4156291|B1||Female|Sex: Female, Male||Participants|Count of Participants|449|449.0||||||
4329399|NCT00444275|4156288|B4|||Age||years|Mean|41.64|41.64|Standard Deviation|9.91|9.91|||
4329400|NCT00444275|4156289|B3|||Age||years|Mean|41.6|41.6|Standard Deviation|10|10.0|||
4329401|NCT00444275|4156290|B2|||Age||years|Mean|41.79|41.79|Standard Deviation|9.97|9.97|||
4329402|NCT00444275|4156291|B1|||Age||years|Mean|41.5|41.5|Standard Deviation|9.83|9.83|||
4329403|NCT00444145|4156345|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4329404|NCT00444145|4156345|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4329405|NCT00444145|4156345|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4329406|NCT00444145|4156345|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4329407|NCT00444145|4156345|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4329408|NCT00444145|4156345|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4329409|NCT00444106|4156349|B4|||Body Weight||kg|Mean|62.8|62.8|Standard Deviation|14.64|14.64|||
4329410|NCT00444106|4156350|B3|||Body Weight||kg|Mean|65.2|65.2|Standard Deviation|15.37|15.37|||
4329411|NCT00444106|4156351|B2|||Body Weight||kg|Mean|60.3|60.3|Standard Deviation|14.54|14.54|||
4329412|NCT00444106|4156352|B1|||Body Weight||kg|Mean|62.8|62.8|Standard Deviation|14.39|14.39|||
4329413|NCT00444106|4156349|B4||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4329414|NCT00444106|4156350|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4329415|NCT00444106|4156351|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4329416|NCT00444106|4156352|B1||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4329417|NCT00444106|4156349|B4||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4329418|NCT00444106|4156350|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4329419|NCT00444106|4156351|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4329420|NCT00444106|4156352|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4329421|NCT00444106|4156349|B4|||Age||years|Mean|25.4|25.4|Standard Deviation|11.4|11.4|||
4329422|NCT00444106|4156350|B3|||Age||years|Mean|25.2|25.2|Standard Deviation|11.26|11.26|||
4329423|NCT00444106|4156351|B2|||Age||years|Mean|25.1|25.1|Standard Deviation|11.16|11.16|||
4329424|NCT00444106|4156352|B1|||Age||years|Mean|25.6|25.6|Standard Deviation|11.6|11.6|||
4329425|NCT00444106|4156349|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4329426|NCT00444106|4156350|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4329427|NCT00444106|4156351|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4329428|NCT00444106|4156352|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4329429|NCT00444106|4156349|B4||Between 18 and 65 years|Age||Participants|Count of Participants|175|175.0||||||
4329430|NCT00444106|4156350|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4329431|NCT00444106|4156351|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4329432|NCT00444106|4156352|B1||Between 18 and 65 years|Age||Participants|Count of Participants|108|108.0||||||
4329433|NCT00444106|4156349|B4||<=18 years|Age||Participants|Count of Participants|90|90.0||||||
4329434|NCT00444106|4156350|B3||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
4329435|NCT00444106|4156351|B2||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
4329436|NCT00444106|4156352|B1||<=18 years|Age||Participants|Count of Participants|51|51.0||||||
4329437|NCT00444067|4156369|B3|||Age (Statistics)||years|Mean|44.36|44.36|Standard Deviation|12.62|12.62|||
4329438|NCT00444067|4156370|B2|||Age (Statistics)||years|Mean|44.70|44.7|Standard Deviation|11.44|11.44|||
4329439|NCT00444067|4156371|B1|||Age (Statistics)||years|Mean|44.25|44.25|Standard Deviation|13.06|13.06|||
4329440|NCT00444067|4156369|B3|United States||Region of Enrollment||participants|Number|98|98.0||||||
4329441|NCT00444067|4156370|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4329442|NCT00444067|4156371|B1|United States||Region of Enrollment||participants|Number|74|74.0||||||
4329443|NCT00444067|4156369|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4329444|NCT00444067|4156370|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4329445|NCT00444067|4156371|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4329446|NCT00444067|4156369|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4329447|NCT00444067|4156370|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4329448|NCT00444067|4156371|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4329449|NCT00444067|4156369|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4329450|NCT00444067|4156370|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4329451|NCT00444067|4156371|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4329452|NCT00444067|4156369|B3||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
4329453|NCT00444067|4156370|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4329454|NCT00444067|4156371|B1||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
4329455|NCT00444067|4156369|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4329456|NCT00444067|4156370|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4329457|NCT00444067|4156371|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4329458|NCT00444028|4156382|B7|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
4329459|NCT00444028|4156383|B6|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4329460|NCT00444028|4156384|B5|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4329461|NCT00444028|4156385|B4|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4329462|NCT00444028|4156386|B3|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4329463|NCT00444028|4156387|B2|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4329632|NCT00443755|4156516|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4329464|NCT00444028|4156388|B1|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4329465|NCT00444028|4156382|B7||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4329466|NCT00444028|4156383|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4329467|NCT00444028|4156384|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4329468|NCT00444028|4156385|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4329469|NCT00444028|4156386|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4329470|NCT00444028|4156387|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4329471|NCT00444028|4156388|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4329472|NCT00444028|4156382|B7||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4329473|NCT00444028|4156383|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4329474|NCT00444028|4156384|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4329475|NCT00444028|4156385|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4329476|NCT00444028|4156386|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4329477|NCT00444028|4156387|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4329478|NCT00444028|4156388|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4329479|NCT00444028|4156382|B7|||Age||years|Mean|31.7|31.7|Standard Deviation|10.14|10.14|||
4329480|NCT00444028|4156383|B6|||Age||years|Mean|27.4|27.4|Standard Deviation|7.65|7.65|||
4329481|NCT00444028|4156384|B5|||Age||years|Mean|30.1|30.1|Standard Deviation|13.53|13.53|||
4329482|NCT00444028|4156385|B4|||Age||years|Mean|28.2|28.2|Standard Deviation|6.05|6.05|||
4329483|NCT00444028|4156386|B3|||Age||years|Mean|28|28.0|Standard Deviation|7.11|7.11|||
4329484|NCT00444028|4156387|B2|||Age||years|Mean|33.4|33.4|Standard Deviation|10.44|10.44|||
4329485|NCT00444028|4156388|B1|||Age||years|Mean|37.8|37.8|Standard Deviation|10.55|10.55|||
4329486|NCT00444028|4156382|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4329487|NCT00444028|4156383|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4329488|NCT00444028|4156384|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4329489|NCT00444028|4156385|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4329490|NCT00444028|4156386|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4329491|NCT00444028|4156387|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4329492|NCT00444028|4156388|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4329493|NCT00444028|4156382|B7||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4329494|NCT00444028|4156383|B6||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4329495|NCT00444028|4156384|B5||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4329496|NCT00444028|4156385|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4329497|NCT00444028|4156386|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4329498|NCT00444028|4156387|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4329499|NCT00444028|4156388|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4329500|NCT00444028|4156382|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4329501|NCT00444028|4156383|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4329502|NCT00444028|4156384|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4329503|NCT00444028|4156385|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4329504|NCT00444028|4156386|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4329505|NCT00444028|4156387|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4329506|NCT00444028|4156388|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4329507|NCT00443898|4156431|B5||Male|Sex: Female, Male||Participants|Count of Participants|411|411.0||||||
4329508|NCT00443898|4156432|B4||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4329509|NCT00443898|4156433|B3||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4329510|NCT00443898|4156434|B2||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4329511|NCT00443898|4156435|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4329512|NCT00443898|4156431|B5||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4329513|NCT00443898|4156432|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4329514|NCT00443898|4156433|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4329515|NCT00443898|4156434|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4329516|NCT00443898|4156435|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4329517|NCT00443898|4156431|B5||>=65 years|Age||Participants|Count of Participants|94|94.0||||||
4329518|NCT00443898|4156432|B4||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4329519|NCT00443898|4156433|B3||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4329520|NCT00443898|4156434|B2||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4329521|NCT00443898|4156435|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4329522|NCT00443898|4156431|B5||Between 18 and 65 years|Age||Participants|Count of Participants|424|424.0||||||
4329523|NCT00443898|4156432|B4||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4329524|NCT00443898|4156433|B3||Between 18 and 65 years|Age||Participants|Count of Participants|116|116.0||||||
4329525|NCT00443898|4156434|B2||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
4329526|NCT00443898|4156435|B1||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
4329527|NCT00443898|4156431|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4329528|NCT00443898|4156432|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4329529|NCT00443898|4156433|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4329530|NCT00443898|4156434|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4329531|NCT00443898|4156435|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4329532|NCT00443872|4156460|B1|United States||Region of Enrollment||participants|Number|77|77.0||||||
4329533|NCT00443872|4156460|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4329534|NCT00443872|4156460|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4329535|NCT00443872|4156460|B1|||Age||years|Mean|66.9|66.9|Standard Deviation|8.6|8.6|||
4329536|NCT00443872|4156460|B1||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
4329537|NCT00443872|4156460|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4329538|NCT00443872|4156460|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4329539|NCT00443846|4156473|B3||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4329540|NCT00443846|4156474|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4329541|NCT00443846|4156475|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4329542|NCT00443846|4156473|B3||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4329543|NCT00443846|4156474|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4329544|NCT00443846|4156475|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4329545|NCT00443846|4156473|B3|||Age||Weeks|Mean|7.1|7.1|Standard Deviation|0.5|0.5|||
4329546|NCT00443846|4156474|B2|||Age||Weeks|Mean|7.2|7.2|Standard Deviation|0.6|0.6|||
4329547|NCT00443846|4156475|B1|||Age||Weeks|Mean|7.1|7.1|Standard Deviation|0.5|0.5|||
4329548|NCT00443820|4156482|B5||Male|Sex: Female, Male||Participants|Count of Participants|377|377.0||||||
4329549|NCT00443820|4156483|B4||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4329550|NCT00443820|4156484|B3||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4329551|NCT00443820|4156485|B2||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4329552|NCT00443820|4156486|B1||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4329553|NCT00443820|4156482|B5||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4329554|NCT00443820|4156483|B4||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4329555|NCT00443820|4156484|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4329556|NCT00443820|4156485|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4329557|NCT00443820|4156486|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4329558|NCT00443820|4156482|B5||>=65 years|Age||Participants|Count of Participants|137|137.0||||||
4329559|NCT00443820|4156483|B4||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4329560|NCT00443820|4156484|B3||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
4329561|NCT00443820|4156485|B2||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4329562|NCT00443820|4156486|B1||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
4329563|NCT00443820|4156482|B5||Between 18 and 65 years|Age||Participants|Count of Participants|388|388.0||||||
4329564|NCT00443820|4156483|B4||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
4329565|NCT00443820|4156484|B3||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
4329566|NCT00443820|4156485|B2||Between 18 and 65 years|Age||Participants|Count of Participants|103|103.0||||||
4329567|NCT00443820|4156486|B1||Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
4329568|NCT00443820|4156482|B5||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4329569|NCT00443820|4156483|B4||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4329570|NCT00443820|4156484|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4329571|NCT00443820|4156485|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4329572|NCT00443820|4156486|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4329573|NCT00443781|4156511|B1|United States||Region of Enrollment||participants|Number|62|62.0||||||
4329574|NCT00443781|4156511|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4329575|NCT00443781|4156511|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4329576|NCT00443781|4156511|B1|||Age||years|Mean|40.7|40.7|Standard Deviation|9.8|9.8|||
4329577|NCT00443781|4156511|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4329578|NCT00443781|4156511|B1||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4329579|NCT00443781|4156511|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4329580|NCT00443755|4156515|B3|||Adiponectin||milligrams per milliliter|Mean|5.63|5.63|Standard Deviation|2.15|2.15|||
4329581|NCT00443755|4156516|B2|||Adiponectin||milligrams per milliliter|Mean|5.22|5.22|Standard Deviation|2.13|2.13|||
4329582|NCT00443755|4156517|B1|||Adiponectin||milligrams per milliliter|Mean|6.08|6.08|Standard Deviation|2.17|2.17|||
4329583|NCT00443755|4156515|B3|||Tumor Necrosis Factor-alpha (TNF-α)||picograms per milliliter|Mean|2.22|2.22|Standard Deviation|3.91|3.91|||
4329584|NCT00443755|4156516|B2|||Tumor Necrosis Factor-alpha (TNF-α)||picograms per milliliter|Mean|2.98|2.98|Standard Deviation|5.39|5.39|||
4329585|NCT00443755|4156517|B1|||Tumor Necrosis Factor-alpha (TNF-α)||picograms per milliliter|Mean|1.39|1.39|Standard Deviation|0.57|0.57|||
4329586|NCT00443755|4156515|B3|||Interleukin-6 (IL-6)||picograms per milliliter|Mean|2.88|2.88|Standard Deviation|3.59|3.59|||
4329587|NCT00443755|4156516|B2|||Interleukin-6 (IL-6)||picograms per milliliter|Mean|3.28|3.28|Standard Deviation|4.79|4.79|||
4329588|NCT00443755|4156517|B1|||Interleukin-6 (IL-6)||picograms per milliliter|Mean|2.46|2.46|Standard Deviation|1.68|1.68|||
4329589|NCT00443755|4156515|B3|||C-Reactive Protein (CRP)||milligrams per deciliter|Mean|0.42|0.42|Standard Deviation|0.45|0.45|||
4329590|NCT00443755|4156516|B2|||C-Reactive Protein (CRP)||milligrams per deciliter|Mean|0.43|0.43|Standard Deviation|0.49|0.49|||
4329591|NCT00443755|4156517|B1|||C-Reactive Protein (CRP)||milligrams per deciliter|Mean|0.42|0.42|Standard Deviation|0.43|0.43|||
4329592|NCT00443755|4156515|B3|||Plasminogen Activator Inhibitor 1 (PAI-1)||nanograms per milliliter|Mean|68.3|68.3|Standard Deviation|31.1|31.1|||
4329593|NCT00443755|4156516|B2|||Plasminogen Activator Inhibitor 1 (PAI-1)||nanograms per milliliter|Mean|55.85|55.85|Standard Deviation|33.70|33.7|||
4329594|NCT00443755|4156517|B1|||Plasminogen Activator Inhibitor 1 (PAI-1)||nanograms per milliliter|Mean|81.83|81.83|Standard Deviation|22.01|22.01|||
4329595|NCT00443755|4156515|B3|||Fibrinogen||milligrams per deciliter|Mean|406.80|406.8|Standard Deviation|89.57|89.57|||
4329596|NCT00443755|4156516|B2|||Fibrinogen||milligrams per deciliter|Mean|418.92|418.92|Standard Deviation|100.23|100.23|||
4329597|NCT00443755|4156517|B1|||Fibrinogen||milligrams per deciliter|Mean|393.67|393.67|Standard Deviation|78.63|78.63|||
4329598|NCT00443755|4156515|B3|Non-HDL-Cholesterol||Lipid Profile||milligrams per deciliter|Mean|133.96|133.96|Standard Deviation|23.47|23.47|||
4329599|NCT00443755|4156516|B2|Non-HDL-Cholesterol||Lipid Profile||milligrams per deciliter|Mean|132.46|132.46|Standard Deviation|21.65|21.65|||
4329600|NCT00443755|4156517|B1|Non-HDL-Cholesterol||Lipid Profile||milligrams per deciliter|Mean|135.58|135.58|Standard Deviation|26.17|26.17|||
4329601|NCT00443755|4156515|B3|High Density Lipoprotein-Cholesterol (HDL-C)||Lipid Profile||milligrams per deciliter|Mean|41.20|41.2|Standard Deviation|10.84|10.84|||
4329602|NCT00443755|4156516|B2|High Density Lipoprotein-Cholesterol (HDL-C)||Lipid Profile||milligrams per deciliter|Mean|39.23|39.23|Standard Deviation|8.74|8.74|||
4329603|NCT00443755|4156517|B1|High Density Lipoprotein-Cholesterol (HDL-C)||Lipid Profile||milligrams per deciliter|Mean|43.33|43.33|Standard Deviation|12.78|12.78|||
4329604|NCT00443755|4156515|B3|Triglycerides||Lipid Profile||milligrams per deciliter|Mean|133.28|133.28|Standard Deviation|51.93|51.93|||
4329605|NCT00443755|4156516|B2|Triglycerides||Lipid Profile||milligrams per deciliter|Mean|135.00|135.0|Standard Deviation|51.36|51.36|||
4329606|NCT00443755|4156517|B1|Triglycerides||Lipid Profile||milligrams per deciliter|Mean|131.42|131.42|Standard Deviation|54.76|54.76|||
4329607|NCT00443755|4156515|B3|||Insulin level||micro International Units per milliliter|Mean|12.82|12.82|Standard Deviation|8.23|8.23|||
4329608|NCT00443755|4156516|B2|||Insulin level||micro International Units per milliliter|Mean|10.18|10.18|Standard Deviation|5.70|5.7|||
4329609|NCT00443755|4156517|B1|||Insulin level||micro International Units per milliliter|Mean|15.68|15.68|Standard Deviation|9.75|9.75|||
4329610|NCT00443755|4156515|B3|||Glucose Infusion Rate (GIR)|FFM is Fat Free Mass|micromols/kilogram of FFM/minute|Mean|22.86|22.86|Standard Deviation|14.68|14.68|||
4329611|NCT00443755|4156516|B2|||Glucose Infusion Rate (GIR)|FFM is Fat Free Mass|micromols/kilogram of FFM/minute|Mean|23.40|23.4|Standard Deviation|15.27|15.27|||
4329612|NCT00443755|4156517|B1|||Glucose Infusion Rate (GIR)|FFM is Fat Free Mass|micromols/kilogram of FFM/minute|Mean|22.28|22.28|Standard Deviation|14.67|14.67|||
4329613|NCT00443755|4156515|B3|||Glycosylated Hemoglobin (HbA1c)|The HbA1c level reflects the average glucose (blood sugar) concentration over the previous 3 month period.|Percentage|Mean|6.11|6.11|Standard Deviation|0.68|0.68|||
4329614|NCT00443755|4156516|B2|||Glycosylated Hemoglobin (HbA1c)|The HbA1c level reflects the average glucose (blood sugar) concentration over the previous 3 month period.|Percentage|Mean|6.25|6.25|Standard Deviation|0.65|0.65|||
4329615|NCT00443755|4156517|B1|||Glycosylated Hemoglobin (HbA1c)|The HbA1c level reflects the average glucose (blood sugar) concentration over the previous 3 month period.|Percentage|Mean|5.97|5.97|Standard Deviation|0.71|0.71|||
4329616|NCT00443755|4156515|B3|||Fasting Blood Glucose||milligrams per deciliter|Mean|127.68|127.68|Standard Deviation|23.82|23.82|||
4329617|NCT00443755|4156516|B2|||Fasting Blood Glucose||milligrams per deciliter|Mean|129.00|129.0|Standard Deviation|26.32|26.32|||
4329618|NCT00443755|4156517|B1|||Fasting Blood Glucose||milligrams per deciliter|Mean|126.25|126.25|Standard Deviation|21.87|21.87|||
4329619|NCT00443755|4156515|B3|||Body Fat||Percentage of body weight|Mean|44.81|44.81|Standard Deviation|7.80|7.8|||
4329620|NCT00443755|4156516|B2|||Body Fat||Percentage of body weight|Mean|43.26|43.26|Standard Deviation|9.17|9.17|||
4329621|NCT00443755|4156517|B1|||Body Fat||Percentage of body weight|Mean|46.49|46.49|Standard Deviation|5.92|5.92|||
4329622|NCT00443755|4156515|B3|||Fat-Free Mass||Kilograms|Mean|47.70|47.7|Standard Deviation|13.66|13.66|||
4329623|NCT00443755|4156516|B2|||Fat-Free Mass||Kilograms|Mean|46.67|46.67|Standard Deviation|13.54|13.54|||
4329624|NCT00443755|4156517|B1|||Fat-Free Mass||Kilograms|Mean|48.81|48.81|Standard Deviation|14.29|14.29|||
4329625|NCT00443755|4156515|B3|||Body Mass Index|Body Mass Index (BMI) is a health index for comparing weight to height. BMI is a person's weight in kilograms (kg) divided by his or her height in meters squared.|kilograms/m^2|Mean|31.00|31.0|Standard Deviation|4.71|4.71|||
4329626|NCT00443755|4156516|B2|||Body Mass Index|Body Mass Index (BMI) is a health index for comparing weight to height. BMI is a person's weight in kilograms (kg) divided by his or her height in meters squared.|kilograms/m^2|Mean|29.67|29.67|Standard Deviation|3.34|3.34|||
4329627|NCT00443755|4156517|B1|||Body Mass Index|Body Mass Index (BMI) is a health index for comparing weight to height. BMI is a person's weight in kilograms (kg) divided by his or her height in meters squared.|kilograms/m^2|Mean|32.43|32.43|Standard Deviation|5.65|5.65|||
4329628|NCT00443755|4156515|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4329629|NCT00443755|4156516|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4329630|NCT00443755|4156517|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4329631|NCT00443755|4156515|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4329633|NCT00443755|4156517|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4329634|NCT00443755|4156515|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4329635|NCT00443755|4156516|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4329636|NCT00443755|4156517|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4329637|NCT00443755|4156515|B3|||Age||years|Mean|52.4|52.4|Standard Deviation|16.6|16.6|||
4329638|NCT00443755|4156516|B2|||Age||years|Mean|52.2|52.2|Standard Deviation|18.2|18.2|||
4329639|NCT00443755|4156517|B1|||Age||years|Mean|52.5|52.5|Standard Deviation|15.6|15.6|||
4329640|NCT00443729|4156550|B3|||Non-HDL-C||mg/dL|Mean|165.8|165.8|Standard Deviation|60.3|60.3|||
4329641|NCT00443729|4156551|B2|||Non-HDL-C||mg/dL|Mean|163.4|163.4|Standard Deviation|45.7|45.7|||
4329642|NCT00443729|4156552|B1|||Non-HDL-C||mg/dL|Mean|168.2|168.2|Standard Deviation|71.8|71.8|||
4329643|NCT00443729|4156550|B3|||Fasting (non-random) serum triglyceride|Standard Deviation (Robust): calculated as interquartile range (IQR)/1.075, where IQR=3rd quartile-1st quartile.|mg/dL|Mean|212.5|212.5|Standard Deviation|156.3|156.3|||
4329644|NCT00443729|4156551|B2|||Fasting (non-random) serum triglyceride|Standard Deviation (Robust): calculated as interquartile range (IQR)/1.075, where IQR=3rd quartile-1st quartile.|mg/dL|Mean|217.5|217.5|Standard Deviation|156.3|156.3|||
4329645|NCT00443729|4156552|B1|||Fasting (non-random) serum triglyceride|Standard Deviation (Robust): calculated as interquartile range (IQR)/1.075, where IQR=3rd quartile-1st quartile.|mg/dL|Mean|204.5|204.5|Standard Deviation|156.3|156.3|||
4329646|NCT00443729|4156550|B3|||Fasting (non-random) serum cholesterol||mg/dL|Mean|212.7|212.7|Standard Deviation|59.2|59.2|||
4329647|NCT00443729|4156551|B2|||Fasting (non-random) serum cholesterol||mg/dL|Mean|210.8|210.8|Standard Deviation|46.4|46.4|||
4329648|NCT00443729|4156552|B1|||Fasting (non-random) serum cholesterol||mg/dL|Mean|214.7|214.7|Standard Deviation|69.7|69.7|||
4329649|NCT00443729|4156550|B3|||Fasting (non-random) serum Low-Density Lipoprotein-Cholesterol (LDL-C)||mg/dL|Mean|103.9|103.9|Standard Deviation|36.2|36.2|||
4329650|NCT00443729|4156551|B2|||Fasting (non-random) serum Low-Density Lipoprotein-Cholesterol (LDL-C)||mg/dL|Mean|104.3|104.3|Standard Deviation|30.6|30.6|||
4329651|NCT00443729|4156552|B1|||Fasting (non-random) serum Low-Density Lipoprotein-Cholesterol (LDL-C)||mg/dL|Mean|103.5|103.5|Standard Deviation|41.0|41.0|||
4329652|NCT00443729|4156550|B3|||Fasting (non-random) serum High-Density Lipoprotein-Cholesterol (HDL-C)||mg/dL|Mean|47.2|47.2|Standard Deviation|12.7|12.7|||
4329653|NCT00443729|4156551|B2|||Fasting (non-random) serum High-Density Lipoprotein-Cholesterol (HDL-C)||mg/dL|Mean|47.9|47.9|Standard Deviation|12.7|12.7|||
4329654|NCT00443729|4156552|B1|||Fasting (non-random) serum High-Density Lipoprotein-Cholesterol (HDL-C)||mg/dL|Mean|46.5|46.5|Standard Deviation|12.8|12.8|||
4329655|NCT00443729|4156550|B3|||Cluster of Differentiation 4 (CD4) Cell Count||cells/mm3|Mean|476.6|476.6|Full Range|||16.0|1916.0|
4329656|NCT00443729|4156551|B2|||Cluster of Differentiation 4 (CD4) Cell Count||cells/mm3|Mean|482.4|482.4|Full Range|||100.0|1744.0|
4329657|NCT00443729|4156552|B1|||Cluster of Differentiation 4 (CD4) Cell Count||cells/mm3|Mean|470.8|470.8|Full Range|||16.0|1916.0|
4329658|NCT00443729|4156550|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4329659|NCT00443729|4156551|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4329660|NCT00443729|4156552|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4329661|NCT00443729|4156550|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4329662|NCT00443729|4156551|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4329663|NCT00443729|4156552|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4329664|NCT00443729|4156550|B3||White|Race (NIH/OMB)||Participants|Count of Participants|166|166.0||||||
4329665|NCT00443729|4156551|B2||White|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
4329666|NCT00443729|4156552|B1||White|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
4329667|NCT00443729|4156550|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4329668|NCT00443729|4156551|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4329669|NCT00443729|4156552|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4329670|NCT00443729|4156550|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4329671|NCT00443729|4156551|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4329672|NCT00443729|4156552|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4329673|NCT00443729|4156550|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4329674|NCT00443729|4156551|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4329675|NCT00443729|4156552|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4329676|NCT00443729|4156550|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4329677|NCT00443729|4156551|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4329678|NCT00443729|4156552|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4329679|NCT00443729|4156550|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4329680|NCT00443729|4156551|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4329681|NCT00443729|4156552|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4329682|NCT00443729|4156550|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|213|213.0||||||
4329683|NCT00443729|4156551|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
4329684|NCT00443729|4156552|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
4329685|NCT00443729|4156550|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|141|141.0||||||
4329686|NCT00443729|4156551|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
4329687|NCT00443729|4156552|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4329688|NCT00443729|4156550|B3||Male|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4329689|NCT00443729|4156551|B2||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4329690|NCT00443729|4156552|B1||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4329691|NCT00443729|4156550|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4329692|NCT00443729|4156551|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4329693|NCT00443729|4156552|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4329694|NCT00443729|4156550|B3|||Age||Years|Mean|42.0|42.0|Full Range|||21.0|74.0|
4329695|NCT00443729|4156551|B2|||Age||Years|Mean|41.9|41.9|Full Range|||23.0|74.0|
4329696|NCT00443729|4156552|B1|||Age||Years|Mean|42.0|42.0|Full Range|||21.0|71.0|
4329697|NCT00443703|4156599|B3|||Non-HDL-C||mg/dL|Mean|161.1|161.1|Standard Deviation|50.9|50.9|||
4329698|NCT00443703|4156600|B2|||Non-HDL-C||mg/dL|Mean|156.8|156.8|Standard Deviation|53.0|53.0|||
4329699|NCT00443703|4156601|B1|||Non-HDL-C||mg/dL|Mean|165.5|165.5|Standard Deviation|48.5|48.5|||
4329700|NCT00443703|4156599|B3|||Fasting (non-random) serum triglyceride|Standard Deviation (Robust): calculated as interquartile range (IQR)/1.075, where IQR=3rd quartile-1st quartile.|mg/dL|Mean|175.0|175.0|Standard Deviation|126.5|126.5|||
4329701|NCT00443703|4156600|B2|||Fasting (non-random) serum triglyceride|Standard Deviation (Robust): calculated as interquartile range (IQR)/1.075, where IQR=3rd quartile-1st quartile.|mg/dL|Mean|162.0|162.0|Standard Deviation|112.6|112.6|||
4329702|NCT00443703|4156601|B1|||Fasting (non-random) serum triglyceride|Standard Deviation (Robust): calculated as interquartile range (IQR)/1.075, where IQR=3rd quartile-1st quartile.|mg/dL|Mean|189.5|189.5|Standard Deviation|134.0|134.0|||
4329703|NCT00443703|4156599|B3|||Fasting (non-random) serum cholesterol||mg/dL|Mean|209.6|209.6|Standard Deviation|50.6|50.6|||
4329704|NCT00443703|4156600|B2|||Fasting (non-random) serum cholesterol||mg/dL|Mean|203.9|203.9|Standard Deviation|52.3|52.3|||
4329705|NCT00443703|4156601|B1|||Fasting (non-random) serum cholesterol||mg/dL|Mean|215.3|215.3|Standard Deviation|48.2|48.2|||
4329706|NCT00443703|4156599|B3|||Fasting (non-random) serum Low Density Lipoprotein-Cholesterol (LDL-C)||mg/dL|Mean|110.0|110.0|Standard Deviation|38.5|38.5|||
4329707|NCT00443703|4156600|B2|||Fasting (non-random) serum Low Density Lipoprotein-Cholesterol (LDL-C)||mg/dL|Mean|104.8|104.8|Standard Deviation|35.9|35.9|||
4329708|NCT00443703|4156601|B1|||Fasting (non-random) serum Low Density Lipoprotein-Cholesterol (LDL-C)||mg/dL|Mean|115.3|115.3|Standard Deviation|40.3|40.3|||
4329709|NCT00443703|4156599|B3|||Fasting (non-random) serum High Density Lipoprotein-Cholesterol (HDL-C)||mg/dL|Mean|47.9|47.9|Standard Deviation|15.2|15.2|||
4329710|NCT00443703|4156600|B2|||Fasting (non-random) serum High Density Lipoprotein-Cholesterol (HDL-C)||mg/dL|Mean|47.1|47.1|Standard Deviation|14.0|14.0|||
4329711|NCT00443703|4156601|B1|||Fasting (non-random) serum High Density Lipoprotein-Cholesterol (HDL-C)||mg/dL|Mean|48.8|48.8|Standard Deviation|16.4|16.4|||
4329712|NCT00443703|4156599|B3|||Cluster of Differentiation 4 (CD4) Cell Count||cells/mm3|Mean|492.9|492.9|Full Range|||65.0|1510.0|
4329713|NCT00443703|4156600|B2|||Cluster of Differentiation 4 (CD4) Cell Count||cells/mm3|Mean|508.2|508.2|Full Range|||87.0|1510.0|
4329714|NCT00443703|4156601|B1|||Cluster of Differentiation 4 (CD4) Cell Count||cells/mm3|Mean|477.6|477.6|Full Range|||65.0|1446.0|
4329715|NCT00443703|4156599|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4329716|NCT00443703|4156600|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4329717|NCT00443703|4156601|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4329718|NCT00443703|4156599|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4329719|NCT00443703|4156600|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4329720|NCT00443703|4156601|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4329721|NCT00443703|4156599|B3||White|Race (NIH/OMB)||Participants|Count of Participants|287|287.0||||||
4329722|NCT00443703|4156600|B2||White|Race (NIH/OMB)||Participants|Count of Participants|141|141.0||||||
4329723|NCT00443703|4156601|B1||White|Race (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
4329724|NCT00443703|4156599|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4329725|NCT00443703|4156600|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4329726|NCT00443703|4156601|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4329727|NCT00443703|4156599|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4329728|NCT00443703|4156600|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4329729|NCT00443703|4156601|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4329730|NCT00443703|4156599|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4329731|NCT00443703|4156600|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4329732|NCT00443703|4156601|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4329733|NCT00443703|4156599|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4329734|NCT00443703|4156600|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4329735|NCT00443703|4156601|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4329736|NCT00443703|4156599|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4329737|NCT00443703|4156600|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4329738|NCT00443703|4156601|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4329739|NCT00443703|4156599|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|300|300.0||||||
4329740|NCT00443703|4156600|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|151|151.0||||||
4329741|NCT00443703|4156601|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|149|149.0||||||
4329742|NCT00443703|4156599|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4329743|NCT00443703|4156600|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4329744|NCT00443703|4156601|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4329745|NCT00443703|4156599|B3||Male|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4329746|NCT00443703|4156600|B2||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4329747|NCT00443703|4156601|B1||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4329748|NCT00443703|4156599|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4329749|NCT00443703|4156600|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4329750|NCT00443703|4156601|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4329751|NCT00443703|4156599|B3|||Age||years|Mean|44.0|44.0|Full Range|||23.0|71.0|
4329752|NCT00443703|4156600|B2|||Age||years|Mean|43.6|43.6|Full Range|||24.0|71.0|
4329753|NCT00443703|4156601|B1|||Age||years|Mean|44.4|44.4|Full Range|||23.0|70.0|
4329754|NCT00443651|4156652|B3||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4329755|NCT00443651|4156653|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4329756|NCT00443651|4156654|B1||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4329757|NCT00443651|4156652|B3||Female|Sex: Female, Male||Participants|Count of Participants|456|456.0||||||
4329758|NCT00443651|4156653|B2||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4329759|NCT00443651|4156654|B1||Female|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
4329760|NCT00443651|4156652|B3|> 85||Age, Customized||Participants|Number|0|0.0||||||
4329761|NCT00443651|4156653|B2|> 85||Age, Customized||Participants|Number|0|0.0||||||
4329762|NCT00443651|4156654|B1|> 85||Age, Customized||Participants|Number|0|0.0||||||
4329763|NCT00443651|4156652|B3|76 - 85 years||Age, Customized||Participants|Number|12|12.0||||||
4329764|NCT00443651|4156653|B2|76 - 85 years||Age, Customized||Participants|Number|3|3.0||||||
4329765|NCT00443651|4156654|B1|76 - 85 years||Age, Customized||Participants|Number|9|9.0||||||
4329766|NCT00443651|4156652|B3|66 - 75 years||Age, Customized||Participants|Number|57|57.0||||||
4329767|NCT00443651|4156653|B2|66 - 75 years||Age, Customized||Participants|Number|19|19.0||||||
4329768|NCT00443651|4156654|B1|66 - 75 years||Age, Customized||Participants|Number|38|38.0||||||
4329769|NCT00443651|4156652|B3|56 - 65 years||Age, Customized||Participants|Number|200|200.0||||||
4329770|NCT00443651|4156653|B2|56 - 65 years||Age, Customized||Participants|Number|67|67.0||||||
4329771|NCT00443651|4156654|B1|56 - 65 years||Age, Customized||Participants|Number|133|133.0||||||
4329772|NCT00443651|4156652|B3|46 - 55 years||Age, Customized||Participants|Number|180|180.0||||||
4329773|NCT00443651|4156653|B2|46 - 55 years||Age, Customized||Participants|Number|48|48.0||||||
4329774|NCT00443651|4156654|B1|46 - 55 years||Age, Customized||Participants|Number|132|132.0||||||
4329775|NCT00443651|4156652|B3|36 - 45 years||Age, Customized||Participants|Number|85|85.0||||||
4329776|NCT00443651|4156653|B2|36 - 45 years||Age, Customized||Participants|Number|26|26.0||||||
4329777|NCT00443651|4156654|B1|36 - 45 years||Age, Customized||Participants|Number|59|59.0||||||
4329778|NCT00443651|4156652|B3|26 - 35 years||Age, Customized||Participants|Number|30|30.0||||||
4329779|NCT00443651|4156653|B2|26 - 35 years||Age, Customized||Participants|Number|8|8.0||||||
4329780|NCT00443651|4156654|B1|26 - 35 years||Age, Customized||Participants|Number|22|22.0||||||
4329781|NCT00443651|4156652|B3|18 - 25 years||Age, Customized||Participants|Number|13|13.0||||||
4329782|NCT00443651|4156653|B2|18 - 25 years||Age, Customized||Participants|Number|5|5.0||||||
4329783|NCT00443651|4156654|B1|18 - 25 years||Age, Customized||Participants|Number|8|8.0||||||
4329784|NCT00443599|4156673|B3|United States||Region of Enrollment||participants|Number|980|980.0||||||
4329785|NCT00443599|4156674|B2|United States||Region of Enrollment||participants|Number|490|490.0||||||
4329786|NCT00443599|4156675|B1|United States||Region of Enrollment||participants|Number|490|490.0||||||
4329787|NCT00443599|4156673|B3||Male|Sex: Female, Male||Participants|Count of Participants|522|522.0||||||
4329788|NCT00443599|4156674|B2||Male|Sex: Female, Male||Participants|Count of Participants|273|273.0||||||
4329789|NCT00443599|4156675|B1||Male|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
4329790|NCT00443599|4156673|B3||Female|Sex: Female, Male||Participants|Count of Participants|458|458.0||||||
4329791|NCT00443599|4156674|B2||Female|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
4329792|NCT00443599|4156675|B1||Female|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
4329793|NCT00443599|4156673|B3|||Age||months|Median|4.6|4.6|Inter-Quartile Range|||2.0|10.2|
4329794|NCT00443599|4156674|B2|||Age||months|Median|4.9|4.9|Inter-Quartile Range|||2.3|10.8|
4329795|NCT00443599|4156675|B1|||Age||months|Median|4.3|4.3|Inter-Quartile Range|||1.8|9.7|
4329796|NCT00443599|4156673|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4329797|NCT00443599|4156674|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4329798|NCT00443599|4156675|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4329799|NCT00443599|4156673|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4329800|NCT00443599|4156674|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4329801|NCT00443599|4156675|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4329802|NCT00443599|4156673|B3||<=18 years|Age||Participants|Count of Participants|980|980.0||||||
4329803|NCT00443599|4156674|B2||<=18 years|Age||Participants|Count of Participants|490|490.0||||||
4329804|NCT00443599|4156675|B1||<=18 years|Age||Participants|Count of Participants|490|490.0||||||
4329805|NCT00443560|4156708|B3|United States||Region of Enrollment||participants|Number|2162|2162.0||||||
4329806|NCT00443560|4156709|B2|United States||Region of Enrollment||participants|Number|1081|1081.0||||||
4329807|NCT00443560|4156710|B1|United States||Region of Enrollment||participants|Number|1081|1081.0||||||
4329808|NCT00443560|4156708|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4329809|NCT00443560|4156709|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4329810|NCT00443560|4156710|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4329811|NCT00443560|4156708|B3||Female|Sex: Female, Male||Participants|Count of Participants|2162|2162.0||||||
4329812|NCT00443560|4156709|B2||Female|Sex: Female, Male||Participants|Count of Participants|1081|1081.0||||||
4329813|NCT00443560|4156710|B1||Female|Sex: Female, Male||Participants|Count of Participants|1081|1081.0||||||
4329814|NCT00443560|4156708|B3|||Age||years|Mean|31|31.0|Standard Deviation|3|3.0|||
4329815|NCT00443560|4156709|B2|||Age||years|Mean|31|31.0|Standard Deviation|3|3.0|||
4329816|NCT00443560|4156710|B1|||Age||years|Mean|32|32.0|Standard Deviation|3|3.0|||
4329817|NCT00443560|4156708|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4329818|NCT00443560|4156709|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4329819|NCT00443560|4156710|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4329820|NCT00443560|4156708|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2162|2162.0||||||
4329821|NCT00443560|4156709|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1081|1081.0||||||
4329822|NCT00443560|4156710|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1081|1081.0||||||
4329823|NCT00443560|4156708|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4329824|NCT00443560|4156709|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4329825|NCT00443560|4156710|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4329826|NCT00443534|4156721|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4329827|NCT00443534|4156721|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4329828|NCT00443534|4156721|B1|||Age||years|Mean|59.9|59.9|Standard Deviation|11.7|11.7|||
4329829|NCT00443456|4156728|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4329830|NCT00443456|4156728|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4329831|NCT00443456|4156728|B1|>=65 years||Age, Customized||participants|Number|56|56.0||||||
4329832|NCT00443456|4156728|B1|45 to 64 years||Age, Customized||participants|Number|65|65.0||||||
4329833|NCT00443456|4156728|B1|20 to 44 years||Age, Customized||participants|Number|13|13.0||||||
4329834|NCT00443430|4156761|B3|United States||Region of Enrollment||participants|Number|85|85.0||||||
4329835|NCT00443430|4156762|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
4329836|NCT00443430|4156763|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4329837|NCT00443430|4156761|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4329838|NCT00443430|4156762|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4329839|NCT00443430|4156763|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4329840|NCT00443430|4156761|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4329841|NCT00443430|4156762|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4329842|NCT00443430|4156763|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4329843|NCT00443430|4156761|B3|||Age||years|Mean|10.5|10.5|Standard Deviation|4.3|4.3|||
4329844|NCT00443430|4156762|B2|||Age||years|Mean|9.9|9.9|Standard Deviation|4.6|4.6|||
4329845|NCT00443430|4156763|B1|||Age||years|Mean|11.1|11.1|Standard Deviation|4.1|4.1|||
4329846|NCT00443430|4156761|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4329847|NCT00443430|4156762|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4329848|NCT00443430|4156763|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4329849|NCT00443430|4156761|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4329850|NCT00443430|4156762|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4329851|NCT00443430|4156763|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4329852|NCT00443430|4156761|B3||<=18 years|Age||Participants|Count of Participants|85|85.0||||||
4329853|NCT00443430|4156762|B2||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
4329854|NCT00443430|4156763|B1||<=18 years|Age||Participants|Count of Participants|43|43.0||||||
4329855|NCT00443352|4156774|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4329856|NCT00443352|4156774|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4329857|NCT00443352|4156774|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4329858|NCT00443352|4156774|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4329859|NCT00443352|4156774|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4329860|NCT00443352|4156774|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4329861|NCT00443352|4156774|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4329862|NCT00443352|4156774|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4329863|NCT00443352|4156774|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4329864|NCT00443352|4156774|B1|||Age||years|Mean|38.4|38.4|Standard Deviation|11.4|11.4|||
4329865|NCT00443261|4156778|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4329866|NCT00443261|4156778|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4329867|NCT00443261|4156778|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
4329868|NCT00443261|4156778|B1|||Age||Years|Median|52|52.0|Standard Deviation|0|0.0|||
4329869|NCT00443261|4156778|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4329870|NCT00443261|4156778|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4329871|NCT00443261|4156778|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4329872|NCT00443209|4156782|B3||Male|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
4329873|NCT00443209|4156783|B2||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4329874|NCT00443209|4156784|B1||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4329875|NCT00443209|4156782|B3||Female|Sex: Female, Male||Participants|Count of Participants|739|739.0||||||
4329876|NCT00443209|4156783|B2||Female|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
4329877|NCT00443209|4156784|B1||Female|Sex: Female, Male||Participants|Count of Participants|502|502.0||||||
4329878|NCT00443209|4156782|B3|||Age||Years|Mean|42.3|42.3|Standard Deviation|11.0|11.0|||
4329879|NCT00443209|4156783|B2|||Age||Years|Mean|41.9|41.9|Standard Deviation|11.1|11.1|||
4329880|NCT00443209|4156784|B1|||Age||Years|Mean|42.5|42.5|Standard Deviation|10.9|10.9|||
4329881|NCT00443118|4156799|B4|NO||ANTENATAL STEROIDS||participants|Number|729|729.0||||||
4329882|NCT00443118|4156800|B3|NO||ANTENATAL STEROIDS||participants|Number|154|154.0||||||
4329883|NCT00443118|4156801|B2|NO||ANTENATAL STEROIDS||participants|Number|206|206.0||||||
4329884|NCT00443118|4156802|B1|NO||ANTENATAL STEROIDS||participants|Number|369|369.0||||||
4329885|NCT00443118|4156799|B4|YES||ANTENATAL STEROIDS||participants|Number|298|298.0||||||
4329886|NCT00443118|4156800|B3|YES||ANTENATAL STEROIDS||participants|Number|72|72.0||||||
4329887|NCT00443118|4156801|B2|YES||ANTENATAL STEROIDS||participants|Number|84|84.0||||||
4329888|NCT00443118|4156802|B1|YES||ANTENATAL STEROIDS||participants|Number|142|142.0||||||
4329889|NCT00443118|4156799|B4|multiparous||previous deliveries||number of participants|Number|564|564.0||||||
4329890|NCT00443118|4156800|B3|multiparous||previous deliveries||number of participants|Number|120|120.0||||||
4329891|NCT00443118|4156801|B2|multiparous||previous deliveries||number of participants|Number|153|153.0||||||
4329892|NCT00443118|4156802|B1|multiparous||previous deliveries||number of participants|Number|291|291.0||||||
4329893|NCT00443118|4156799|B4|primiparous||previous deliveries||number of participants|Number|463|463.0||||||
4329894|NCT00443118|4156800|B3|primiparous||previous deliveries||number of participants|Number|106|106.0||||||
4329895|NCT00443118|4156801|B2|primiparous||previous deliveries||number of participants|Number|137|137.0||||||
4329896|NCT00443118|4156802|B1|primiparous||previous deliveries||number of participants|Number|220|220.0||||||
4329897|NCT00443118|4156799|B4||Male|Sex: Female, Male||Participants|Count of Participants|601|601.0||||||
4329898|NCT00443118|4156800|B3||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4329899|NCT00443118|4156801|B2||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4329900|NCT00443118|4156802|B1||Male|Sex: Female, Male||Participants|Count of Participants|303|303.0||||||
4329901|NCT00443118|4156799|B4||Female|Sex: Female, Male||Participants|Count of Participants|426|426.0||||||
4329902|NCT00443118|4156800|B3||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4329903|NCT00443118|4156801|B2||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4329904|NCT00443118|4156802|B1||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4329905|NCT00443118|4156799|B4|||Age|Gestational age of enrolled infants|weeks|Mean|36|36.0|Standard Deviation|4.2|4.2|||
4329906|NCT00443118|4156800|B3|||Age|Gestational age of enrolled infants|weeks|Mean|37|37.0|Standard Deviation|4|4.0|||
4329907|NCT00443118|4156801|B2|||Age|Gestational age of enrolled infants|weeks|Mean|35|35.0|Standard Deviation|5|5.0|||
4329908|NCT00443118|4156802|B1|||Age|Gestational age of enrolled infants|weeks|Mean|36|36.0|Standard Deviation|4.1|4.1|||
4329909|NCT00443118|4156799|B4|||Age|Maternal age. As the subjects are all newborns, the baseline important data includes Maternal data|years|Mean|28|28.0|Standard Deviation|7|7.0|||
4329910|NCT00443118|4156800|B3|||Age|Maternal age. As the subjects are all newborns, the baseline important data includes Maternal data|years|Mean|27|27.0|Standard Deviation|7|7.0|||
4329911|NCT00443118|4156801|B2|||Age|Maternal age. As the subjects are all newborns, the baseline important data includes Maternal data|years|Mean|28|28.0|Standard Deviation|7|7.0|||
4329912|NCT00443118|4156802|B1|||Age|Maternal age. As the subjects are all newborns, the baseline important data includes Maternal data|years|Mean|28|28.0|Standard Deviation|7|7.0|||
4329913|NCT00443053|4156851|B3|Missing||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4329914|NCT00443053|4156852|B2|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4329915|NCT00443053|4156853|B1|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4329916|NCT00443053|4156851|B3|Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4329917|NCT00443053|4156852|B2|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4329918|NCT00443053|4156853|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4329919|NCT00443053|4156851|B3|Asian/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4329920|NCT00443053|4156852|B2|Asian/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4329921|NCT00443053|4156853|B1|Asian/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4329922|NCT00443053|4156851|B3|African American Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4329923|NCT00443053|4156852|B2|African American Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4329924|NCT00443053|4156853|B1|African American Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4329925|NCT00443053|4156851|B3|Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4329926|NCT00443053|4156852|B2|Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4329927|NCT00443053|4156853|B1|Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4329928|NCT00443053|4156851|B3|White, European Heritage||Race/Ethnicity, Customized||participants|Number|2977|2977.0||||||
4329929|NCT00443053|4156852|B2|White, European Heritage||Race/Ethnicity, Customized||participants|Number|1492|1492.0||||||
4329930|NCT00443053|4156853|B1|White, European Heritage||Race/Ethnicity, Customized||participants|Number|1485|1485.0||||||
4329931|NCT00443053|4156851|B3||Male|Sex: Female, Male||Participants|Count of Participants|1084|1084.0||||||
4329932|NCT00443053|4156852|B2||Male|Sex: Female, Male||Participants|Count of Participants|556|556.0||||||
4329933|NCT00443053|4156853|B1||Male|Sex: Female, Male||Participants|Count of Participants|528|528.0||||||
4329934|NCT00443053|4156851|B3||Female|Sex: Female, Male||Participants|Count of Participants|1918|1918.0||||||
4329935|NCT00443053|4156852|B2||Female|Sex: Female, Male||Participants|Count of Participants|944|944.0||||||
4329936|NCT00443053|4156853|B1||Female|Sex: Female, Male||Participants|Count of Participants|974|974.0||||||
4329937|NCT00443053|4156851|B3|||Age||years|Mean|57.0|57.0|Standard Deviation|13.43|13.43|||
4329938|NCT00443053|4156852|B2|||Age||years|Mean|56.9|56.9|Standard Deviation|13.56|13.56|||
4329939|NCT00443053|4156853|B1|||Age||years|Mean|57.1|57.1|Standard Deviation|13.29|13.29|||
4329940|NCT00443040|4156872|B4|United States||Region of Enrollment||participants|Number|35|35.0||||||
4329941|NCT00443040|4156873|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4329942|NCT00443040|4156874|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4329943|NCT00443040|4156875|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4329944|NCT00443040|4156872|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4329945|NCT00443040|4156873|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4329946|NCT00443040|4156874|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4329947|NCT00443040|4156875|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4329948|NCT00443040|4156872|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4329949|NCT00443040|4156873|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4329950|NCT00443040|4156874|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4329951|NCT00443040|4156875|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4329952|NCT00443040|4156872|B4|||Age||years|Mean|58|58.0|Standard Deviation|12.2|12.2|||
4329953|NCT00443040|4156873|B3|||Age||years|Mean|57|57.0|Standard Deviation|15.3|15.3|||
4329954|NCT00443040|4156874|B2|||Age||years|Mean|60|60.0|Standard Deviation|12.9|12.9|||
4329955|NCT00443040|4156875|B1|||Age||years|Mean|58|58.0|Standard Deviation|9.7|9.7|||
4329956|NCT00443040|4156872|B4||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4329957|NCT00443040|4156873|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4329958|NCT00443040|4156874|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4329959|NCT00443040|4156875|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4329960|NCT00443040|4156872|B4||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4329961|NCT00443040|4156873|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4329962|NCT00443040|4156874|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4329963|NCT00443040|4156875|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4329964|NCT00443040|4156872|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4329965|NCT00443040|4156873|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4329966|NCT00443040|4156874|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4329967|NCT00443040|4156875|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4329968|NCT00442962|4156885|B1|More than 250,000 copies/mL||Plasma HIV-1 RNA, Categorical||participants|Number|2|2.0||||||
4329969|NCT00442962|4156885|B1|Between 75,001 and 250,000 copies/mL||Plasma HIV-1 RNA, Categorical||participants|Number|12|12.0||||||
4329970|NCT00442962|4156885|B1|Between 50,001 and 75,000 copies/mL||Plasma HIV-1 RNA, Categorical||participants|Number|11|11.0||||||
4329971|NCT00442962|4156885|B1|Between 10,001 and 50,000 copies/mL||Plasma HIV-1 RNA, Categorical||participants|Number|20|20.0||||||
4329972|NCT00442962|4156885|B1|Between 1001 and 10,000 copies/mL||Plasma HIV-1 RNA, Categorical||participants|Number|8|8.0||||||
4329973|NCT00442962|4156885|B1|Between 401 and 1000 copies/mL||Plasma HIV-1 RNA, Categorical||participants|Number|1|1.0||||||
4329974|NCT00442962|4156885|B1|<= 400 copies/mL||Plasma HIV-1 RNA, Categorical||participants|Number|0|0.0||||||
4329975|NCT00442962|4156885|B1|||Plasma HIV-1 RNA, Continuous||log10 copies/mL|Mean|4.5|4.5|Standard Deviation|0.6|0.6|||
4329976|NCT00442962|4156885|B1|400 or more cells/mm^3||CD4 count, Categorical||participants|Number|5|5.0||||||
4329977|NCT00442962|4156885|B1|Between 300 and 399 cells/mm^3||CD4 count, Categorical||participants|Number|15|15.0||||||
4329978|NCT00442962|4156885|B1|Between 200 and 299 cells/mm^3||CD4 count, Categorical||participants|Number|18|18.0||||||
4329979|NCT00442962|4156885|B1|Between 100 and 199 cells/mm^3||CD4 count, Categorical||participants|Number|15|15.0||||||
4329980|NCT00442962|4156885|B1|Between 50 and 99 cells/mm^3||CD4 count, Categorical||participants|Number|0|0.0||||||
4329981|NCT00442962|4156885|B1|< 50 cells/mm^3||CD4 count, Categorical||participants|Number|1|1.0||||||
4329982|NCT00442962|4156885|B1|||CD4 count, Continuous||cells/mm^3|Mean|264|264.0|Standard Deviation|104|104.0|||
4329983|NCT00442962|4156885|B1|Peru||Region of Enrollment||participants|Number|20|20.0||||||
4329984|NCT00442962|4156885|B1|Brazil||Region of Enrollment||participants|Number|22|22.0||||||
4329985|NCT00442962|4156885|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4329986|NCT00442962|4156885|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4329987|NCT00442962|4156885|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4329988|NCT00442962|4156885|B1|Between 40 and 45 years||Age, Customized||participants|Number|4|4.0||||||
4329989|NCT00442962|4156885|B1|Between 36 and 40 years||Age, Customized||participants|Number|6|6.0||||||
4329990|NCT00442962|4156885|B1|Between 31 and 35 years||Age, Customized||participants|Number|9|9.0||||||
4329991|NCT00442962|4156885|B1|Between 26 and 30 years||Age, Customized||participants|Number|16|16.0||||||
4329992|NCT00442962|4156885|B1|Between 19 and 25 years||Age, Customized||participants|Number|19|19.0||||||
4329993|NCT00442962|4156885|B1|||Age||years|Mean|29|29.0|Standard Deviation|7|7.0|||
4329994|NCT00442936|4156899|B5||Male|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4329995|NCT00442936|4156900|B4||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4329996|NCT00442936|4156901|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4329997|NCT00442936|4156902|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4329998|NCT00442936|4156903|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4329999|NCT00442936|4156899|B5||Female|Sex: Female, Male||Participants|Count of Participants|1169|1169.0||||||
4330000|NCT00442936|4156900|B4||Female|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
4330001|NCT00442936|4156901|B3||Female|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
4330002|NCT00442936|4156902|B2||Female|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
4330003|NCT00442936|4156903|B1||Female|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
4330004|NCT00442936|4156899|B5|||Age||Years|Mean|42.3|42.3|Standard Deviation|11.4|11.4|||
4330005|NCT00442936|4156900|B4|||Age||Years|Mean|42.3|42.3|Standard Deviation|11.6|11.6|||
4330006|NCT00442936|4156901|B3|||Age||Years|Mean|41.7|41.7|Standard Deviation|11.7|11.7|||
4330007|NCT00442936|4156902|B2|||Age||Years|Mean|42.6|42.6|Standard Deviation|11.4|11.4|||
4330008|NCT00442936|4156903|B1|||Age||Years|Mean|42.7|42.7|Standard Deviation|11.2|11.2|||
4330009|NCT00442897|4156952|B3|||Systolic Blood Pressure||mm Hg|Mean|127.94|127.94|Standard Deviation|15.98|15.98|||
4330010|NCT00442897|4156953|B2|||Systolic Blood Pressure||mm Hg|Mean|129.53|129.53|Standard Deviation|16.65|16.65|||
4330011|NCT00442897|4156954|B1|||Systolic Blood Pressure||mm Hg|Mean|126.44|126.44|Standard Deviation|15.23|15.23|||
4330012|NCT00442897|4156952|B3|||Diastolic Blood Pressure||mm Hg|Mean|76.77|76.77|Standard Deviation|15.98|15.98|||
4330013|NCT00442897|4156953|B2|||Diastolic Blood Pressure||mm Hg|Mean|77.74|77.74|Standard Deviation|10.53|10.53|||
4330014|NCT00442897|4156954|B1|||Diastolic Blood Pressure||mm Hg|Mean|75.86|75.86|Standard Deviation|10.16|10.16|||
4330015|NCT00442897|4156952|B3|||Body Weight||Kilograms (Kg)|Mean|64.51|64.51|Standard Deviation|10.12|10.12|||
4330016|NCT00442897|4156953|B2|||Body Weight||Kilograms (Kg)|Mean|64.40|64.4|Standard Deviation|10.51|10.51|||
4330017|NCT00442897|4156954|B1|||Body Weight||Kilograms (Kg)|Mean|64.61|64.61|Standard Deviation|9.78|9.78|||
4330018|NCT00442897|4156952|B3|||Body Mass Index (BMI)||Kg/m2|Mean|24.92|24.92|Standard Deviation|2.78|2.78|||
4330019|NCT00442897|4156953|B2|||Body Mass Index (BMI)||Kg/m2|Mean|24.86|24.86|Standard Deviation|2.64|2.64|||
4330020|NCT00442897|4156954|B1|||Body Mass Index (BMI)||Kg/m2|Mean|24.97|24.97|Standard Deviation|2.92|2.92|||
4330021|NCT00442897|4156952|B3|||Baseline values for Triglycerides (TG)||mg/dL|Mean|143|143.0|Standard Deviation|73.69|73.69|||
4330022|NCT00442897|4156953|B2|||Baseline values for Triglycerides (TG)||mg/dL|Mean|144|144.0|Standard Deviation|57.34|57.34|||
4330023|NCT00442897|4156954|B1|||Baseline values for Triglycerides (TG)||mg/dL|Mean|142|142.0|Standard Deviation|86.27|86.27|||
4330024|NCT00442897|4156952|B3|||Baseline values for Total Cholesterol (TC)||mg/dL|Mean|240.51|240.51|Standard Deviation|35.51|35.51|||
4330025|NCT00442897|4156953|B2|||Baseline values for Total Cholesterol (TC)||mg/dL|Mean|239.58|239.58|Standard Deviation|30.86|30.86|||
4330026|NCT00442897|4156954|B1|||Baseline values for Total Cholesterol (TC)||mg/dL|Mean|241.4|241.4|Standard Deviation|39.53|39.53|||
4330027|NCT00442897|4156952|B3|||Baseline values for Non HDL-C||mg/dL|Mean|191.14|191.14|Standard Deviation|34.88|34.88|||
4330028|NCT00442897|4156953|B2|||Baseline values for Non HDL-C||mg/dL|Mean|190.72|190.72|Standard Deviation|31.11|31.11|||
4330029|NCT00442897|4156954|B1|||Baseline values for Non HDL-C||mg/dL|Mean|191.54|191.54|Standard Deviation|38.25|38.25|||
4330030|NCT00442897|4156952|B3|||Baseline values for Low-Density Lipoprotein Cholesterol(LDL-C)||mg/dL|Mean|163.36|163.36|Standard Deviation|30.37|30.37|||
4330031|NCT00442897|4156953|B2|||Baseline values for Low-Density Lipoprotein Cholesterol(LDL-C)||mg/dL|Mean|162.56|162.56|Standard Deviation|26.75|26.75|||
4330032|NCT00442897|4156954|B1|||Baseline values for Low-Density Lipoprotein Cholesterol(LDL-C)||mg/dL|Mean|164.11|164.11|Standard Deviation|33.52|33.52|||
4330033|NCT00442897|4156952|B3|||Baseline values for LDL-C:HDL-C||Ratio|Mean|3.54|3.54|Standard Deviation|1.08|1.08|||
4330034|NCT00442897|4156953|B2|||Baseline values for LDL-C:HDL-C||Ratio|Mean|3.54|3.54|Standard Deviation|1.04|1.04|||
4330035|NCT00442897|4156954|B1|||Baseline values for LDL-C:HDL-C||Ratio|Mean|3.54|3.54|Standard Deviation|1.13|1.13|||
4330036|NCT00442897|4156952|B3|||Baseline values for High-Density Lipoprotein Cholesterol (HDL-C)||mg/dL|Mean|48.55|48.55|Standard Deviation|11.65|11.65|||
4330037|NCT00442897|4156953|B2|||Baseline values for High-Density Lipoprotein Cholesterol (HDL-C)||mg/dL|Mean|48.9|48.9|Standard Deviation|13.01|13.01|||
4330038|NCT00442897|4156954|B1|||Baseline values for High-Density Lipoprotein Cholesterol (HDL-C)||mg/dL|Mean|48.23|48.23|Standard Deviation|10.25|10.25|||
4330039|NCT00442897|4156952|B3|||Baseline values for Apolipoprotein B (Apo B)||mg/dL|Mean|111.97|111.97|Standard Deviation|31.25|31.25|||
4330040|NCT00442897|4156953|B2|||Baseline values for Apolipoprotein B (Apo B)||mg/dL|Mean|110.63|110.63|Standard Deviation|31.63|31.63|||
4330041|NCT00442897|4156954|B1|||Baseline values for Apolipoprotein B (Apo B)||mg/dL|Mean|113.23|113.23|Standard Deviation|30.97|30.97|||
4330042|NCT00442897|4156952|B3|LDL-C <130mg/dl||Baseline Low Density Lipoprotein-Cholesterol (LDL-C) allocation strata||Participants|Number|1|1.0||||||
4330043|NCT00442897|4156953|B2|LDL-C <130mg/dl||Baseline Low Density Lipoprotein-Cholesterol (LDL-C) allocation strata||Participants|Number|1|1.0||||||
4330044|NCT00442897|4156954|B1|LDL-C <130mg/dl||Baseline Low Density Lipoprotein-Cholesterol (LDL-C) allocation strata||Participants|Number|0|0.0||||||
4330045|NCT00442897|4156952|B3|LDL-C >=190mg/dl||Baseline Low Density Lipoprotein-Cholesterol (LDL-C) allocation strata||Participants|Number|34|34.0||||||
4330046|NCT00442897|4156953|B2|LDL-C >=190mg/dl||Baseline Low Density Lipoprotein-Cholesterol (LDL-C) allocation strata||Participants|Number|18|18.0||||||
4330047|NCT00442897|4156954|B1|LDL-C >=190mg/dl||Baseline Low Density Lipoprotein-Cholesterol (LDL-C) allocation strata||Participants|Number|16|16.0||||||
4330048|NCT00442897|4156952|B3|LDL-C 160-189mg/dl||Baseline Low Density Lipoprotein-Cholesterol (LDL-C) allocation strata||Participants|Number|69|69.0||||||
4330049|NCT00442897|4156953|B2|LDL-C 160-189mg/dl||Baseline Low Density Lipoprotein-Cholesterol (LDL-C) allocation strata||Participants|Number|31|31.0||||||
4330050|NCT00442897|4156954|B1|LDL-C 160-189mg/dl||Baseline Low Density Lipoprotein-Cholesterol (LDL-C) allocation strata||Participants|Number|38|38.0||||||
4330051|NCT00442897|4156952|B3|LDL-C 130-159mg/dl||Baseline Low Density Lipoprotein-Cholesterol (LDL-C) allocation strata||Participants|Number|125|125.0||||||
4330052|NCT00442897|4156953|B2|LDL-C 130-159mg/dl||Baseline Low Density Lipoprotein-Cholesterol (LDL-C) allocation strata||Participants|Number|61|61.0||||||
4330053|NCT00442897|4156954|B1|LDL-C 130-159mg/dl||Baseline Low Density Lipoprotein-Cholesterol (LDL-C) allocation strata||Participants|Number|64|64.0||||||
4330054|NCT00442897|4156952|B3||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4330055|NCT00442897|4156953|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4330056|NCT00442897|4156954|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4330057|NCT00442897|4156952|B3||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4330058|NCT00442897|4156953|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4330059|NCT00442897|4156954|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4330060|NCT00442897|4156952|B3|||Age||years|Mean|61.30|61.3|Standard Deviation|9.59|9.59|||
4330061|NCT00442897|4156953|B2|||Age||years|Mean|61.74|61.74|Standard Deviation|9.94|9.94|||
4330062|NCT00442897|4156954|B1|||Age||years|Mean|60.89|60.89|Standard Deviation|9.28|9.28|||
4330063|NCT00442767|4156963|B1|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4330064|NCT00442767|4156963|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4330065|NCT00442767|4156963|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4330066|NCT00442767|4156963|B1|||Age||years|Mean|16.2|16.2|Standard Deviation|1|1.0|||
4330067|NCT00442767|4156963|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4330068|NCT00442767|4156963|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4330069|NCT00442767|4156963|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4330070|NCT00442702|4156971|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4330071|NCT00442702|4156972|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4330072|NCT00442702|4156973|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4330073|NCT00442702|4156971|B3||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4330074|NCT00442702|4156972|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4330075|NCT00442702|4156973|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4330076|NCT00442702|4156971|B3|||Age||years|Mean|70.4|70.4|Standard Deviation|12.62|12.62|||
4330077|NCT00442702|4156972|B2|||Age||years|Mean|69.6|69.6|Standard Deviation|14.02|14.02|||
4330078|NCT00442702|4156973|B1|||Age||years|Mean|71.3|71.3|Standard Deviation|11.03|11.03|||
4330079|NCT00442689|4156986|B4|||Body mass index (kg/m^2)||kg/m^2|Mean|39.3|39.3|Standard Deviation|6.0|6.0|||
4330080|NCT00442689|4156987|B3|||Body mass index (kg/m^2)||kg/m^2|Mean|40.0|40.0|Standard Deviation|6.7|6.7|||
4330081|NCT00442689|4156988|B2|||Body mass index (kg/m^2)||kg/m^2|Mean|40.1|40.1|Standard Deviation|5.6|5.6|||
4330082|NCT00442689|4156989|B1|||Body mass index (kg/m^2)||kg/m^2|Mean|37.1|37.1|Standard Deviation|5.5|5.5|||
4330083|NCT00442689|4156986|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4330084|NCT00442689|4156987|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4330085|NCT00442689|4156988|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4330086|NCT00442689|4156989|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4330087|NCT00442689|4156986|B4||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4330088|NCT00442689|4156987|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4330089|NCT00442689|4156988|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4330090|NCT00442689|4156989|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4330091|NCT00442689|4156986|B4|||Age||years|Mean|28|28.0|Standard Deviation|4|4.0|||
4330092|NCT00442689|4156987|B3|||Age||years|Mean|28|28.0|Standard Deviation|5|5.0|||
4330093|NCT00442689|4156988|B2|||Age||years|Mean|28|28.0|Standard Deviation|4|4.0|||
4330094|NCT00442689|4156989|B1|||Age||years|Mean|28|28.0|Standard Deviation|4|4.0|||
4330095|NCT00442611|4157017|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4330096|NCT00442611|4157018|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4330097|NCT00442611|4157019|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4330098|NCT00442611|4157017|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4330099|NCT00442611|4157018|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4330100|NCT00442611|4157019|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4330101|NCT00442611|4157017|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4330102|NCT00442611|4157018|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4330103|NCT00442611|4157019|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4330104|NCT00442611|4157017|B3|||Age||years|Mean|44.2|44.2|Standard Deviation|12.5|12.5|||
4330105|NCT00442611|4157018|B2|||Age||years|Mean|48.6|48.6|Standard Deviation|13.9|13.9|||
4330106|NCT00442611|4157019|B1|||Age||years|Mean|39.8|39.8|Standard Deviation|11.4|11.4|||
4330107|NCT00442598|4157036|B4|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4330108|NCT00442598|4157038|B2|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4330109|NCT00442598|4157039|B1|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4330110|NCT00442598|4157036|B4|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4330111|NCT00442598|4157038|B2|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4330112|NCT00442598|4157039|B1|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4330113|NCT00442598|4157036|B4|White||Race (NIH/OMB)||participants|Number|17|17.0||||||
4330114|NCT00442598|4157038|B2|White||Race (NIH/OMB)||participants|Number|10|10.0||||||
4330115|NCT00442598|4157039|B1|White||Race (NIH/OMB)||participants|Number|7|7.0||||||
4330116|NCT00442598|4157036|B4|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
4330117|NCT00442598|4157038|B2|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
4330118|NCT00442598|4157039|B1|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
4330119|NCT00442598|4157036|B4|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4330120|NCT00442598|4157038|B2|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4330121|NCT00442598|4157039|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4330122|NCT00442598|4157036|B4|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
4330123|NCT00442598|4157038|B2|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
4330124|NCT00442598|4157039|B1|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
4330125|NCT00442598|4157036|B4|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
4330126|NCT00442598|4157038|B2|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
4330127|NCT00442598|4157039|B1|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
4330128|NCT00442598|4157036|B4|Male||Gender||participants|Number|0|0.0||||||
4330129|NCT00442598|4157038|B2|Male||Gender||participants|Number|0|0.0||||||
4330130|NCT00442598|4157039|B1|Male||Gender||participants|Number|0|0.0||||||
4330131|NCT00442598|4157036|B4|Female||Gender||participants|Number|17|17.0||||||
4330132|NCT00442598|4157038|B2|Female||Gender||participants|Number|10|10.0||||||
4330133|NCT00442598|4157039|B1|Female||Gender||participants|Number|7|7.0||||||
4330134|NCT00442598|4157036|B4|||Age||years|Median|58|58.0|Full Range|||40.0|74.0|
4330135|NCT00442598|4157038|B2|||Age||years|Median|52|52.0|Full Range|||40.0|67.0|
4330136|NCT00442598|4157039|B1|||Age||years|Median|60|60.0|Full Range|||44.0|74.0|
4330137|NCT00442598|4157036|B4|>=65 years||Age||participants|Number|5|5.0||||||
4330138|NCT00442598|4157038|B2|>=65 years||Age||participants|Number|4|4.0||||||
4330139|NCT00442598|4157039|B1|>=65 years||Age||participants|Number|1|1.0||||||
4330140|NCT00442598|4157036|B4|Between 18 and 65 years||Age||participants|Number|12|12.0||||||
4330141|NCT00442598|4157038|B2|Between 18 and 65 years||Age||participants|Number|6|6.0||||||
4330142|NCT00442598|4157039|B1|Between 18 and 65 years||Age||participants|Number|6|6.0||||||
4330143|NCT00442598|4157036|B4|<=18 years||Age||participants|Number|0|0.0||||||
4330144|NCT00442598|4157038|B2|<=18 years||Age||participants|Number|0|0.0||||||
4330145|NCT00442598|4157039|B1|<=18 years||Age||participants|Number|0|0.0||||||
4330146|NCT00442572|4157057|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4330147|NCT00442572|4157058|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4330148|NCT00442572|4157059|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4330149|NCT00442572|4157057|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4330150|NCT00442572|4157058|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4330151|NCT00442572|4157059|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4330152|NCT00442572|4157057|B3|||Age||years|Median|42|42.0|Full Range|||22.0|61.0|
4330153|NCT00442572|4157058|B2|||Age||years|Median|38.5|38.5|Full Range|||22.0|50.0|
4330154|NCT00442572|4157059|B1|||Age||years|Median|44|44.0|Full Range|||23.0|61.0|
4330155|NCT00442559|4157098|B3|||Duration of asthma|The primary efficacy parameter was a mean change from baseline to treatment for daytime asthma symptom score. Therefore 138 participants who didn't have a daytime asthma symptom score from the participant diary were not included.|Years|Mean|0.9|0.9|Standard Deviation|1.1|1.1|||
4330156|NCT00442559|4157099|B2|||Duration of asthma|The primary efficacy parameter was a mean change from baseline to treatment for daytime asthma symptom score. Therefore 138 participants who didn't have a daytime asthma symptom score from the participant diary were not included.|Years|Mean|1.1|1.1|Standard Deviation|1.2|1.2|||
4330157|NCT00442559|4157100|B1|||Duration of asthma|The primary efficacy parameter was a mean change from baseline to treatment for daytime asthma symptom score. Therefore 138 participants who didn't have a daytime asthma symptom score from the participant diary were not included.|Years|Mean|0.6|0.6|Standard Deviation|0.7|0.7|||
4330158|NCT00442559|4157098|B3|||Duration of allergic rhinitis|24 participants were included in the Montelukast group and 28 participants were included in the ICS group.|Years|Mean|0.6|0.6|Standard Deviation|0.9|0.9|||
4330159|NCT00442559|4157099|B2|||Duration of allergic rhinitis|24 participants were included in the Montelukast group and 28 participants were included in the ICS group.|Years|Mean|0.8|0.8|Standard Deviation|1|1.0|||
4330160|NCT00442559|4157100|B1|||Duration of allergic rhinitis|24 participants were included in the Montelukast group and 28 participants were included in the ICS group.|Years|Mean|0.4|0.4|Standard Deviation|0.6|0.6|||
4330161|NCT00442559|4157098|B3|||Daytime asthma symptom score|The score is an ordinal scale from 0 (no symptoms) to 5 (most symptoms). The primary efficacy parameter was a mean change from baseline to treatment for daytime asthma symptom score. Therefore 138 participants who didn't have a daytime asthma symptom score from the participant diary were not included.|Units on scale|Mean|0.30|0.3|Standard Deviation|0.40|0.4|||
4330162|NCT00442559|4157099|B2|||Daytime asthma symptom score|The score is an ordinal scale from 0 (no symptoms) to 5 (most symptoms). The primary efficacy parameter was a mean change from baseline to treatment for daytime asthma symptom score. Therefore 138 participants who didn't have a daytime asthma symptom score from the participant diary were not included.|Units on scale|Mean|0.29|0.29|Standard Deviation|0.40|0.4|||
4330163|NCT00442559|4157100|B1|||Daytime asthma symptom score|The score is an ordinal scale from 0 (no symptoms) to 5 (most symptoms). The primary efficacy parameter was a mean change from baseline to treatment for daytime asthma symptom score. Therefore 138 participants who didn't have a daytime asthma symptom score from the participant diary were not included.|Units on scale|Mean|0.32|0.32|Standard Deviation|0.42|0.42|||
4330164|NCT00442559|4157098|B3|||Daily allergic rhinitis symptom score|The score is an ordinal scale from 0 (no symptoms) to 3 (most symptoms). 24 participants with baseline scores were included in the Montelukast group and 28 participants with baseline scores were included in the ICS group.|Units on scale|Mean|0.37|0.37|Standard Deviation|0.35|0.35|||
4330165|NCT00442559|4157099|B2|||Daily allergic rhinitis symptom score|The score is an ordinal scale from 0 (no symptoms) to 3 (most symptoms). 24 participants with baseline scores were included in the Montelukast group and 28 participants with baseline scores were included in the ICS group.|Units on scale|Mean|0.31|0.31|Standard Deviation|0.34|0.34|||
4330166|NCT00442559|4157100|B1|||Daily allergic rhinitis symptom score|The score is an ordinal scale from 0 (no symptoms) to 3 (most symptoms). 24 participants with baseline scores were included in the Montelukast group and 28 participants with baseline scores were included in the ICS group.|Units on scale|Mean|0.45|0.45|Standard Deviation|0.35|0.35|||
4330167|NCT00442559|4157098|B3|Perennial||Type of allergic rhinitis|The primary efficacy parameter was a mean change from baseline to treatment for daytime asthma symptom score. Therefore 138 participants who didn't have a daytime asthma symptom score from the participant diary were not included.|Participants|Number|25|25.0||||||
4330168|NCT00442559|4157099|B2|Perennial||Type of allergic rhinitis|The primary efficacy parameter was a mean change from baseline to treatment for daytime asthma symptom score. Therefore 138 participants who didn't have a daytime asthma symptom score from the participant diary were not included.|Participants|Number|14|14.0||||||
4330169|NCT00442559|4157100|B1|Perennial||Type of allergic rhinitis|The primary efficacy parameter was a mean change from baseline to treatment for daytime asthma symptom score. Therefore 138 participants who didn't have a daytime asthma symptom score from the participant diary were not included.|Participants|Number|11|11.0||||||
4330170|NCT00442559|4157098|B3|Seasonal||Type of allergic rhinitis|The primary efficacy parameter was a mean change from baseline to treatment for daytime asthma symptom score. Therefore 138 participants who didn't have a daytime asthma symptom score from the participant diary were not included.|Participants|Number|28|28.0||||||
4330171|NCT00442559|4157099|B2|Seasonal||Type of allergic rhinitis|The primary efficacy parameter was a mean change from baseline to treatment for daytime asthma symptom score. Therefore 138 participants who didn't have a daytime asthma symptom score from the participant diary were not included.|Participants|Number|15|15.0||||||
4330172|NCT00442559|4157100|B1|Seasonal||Type of allergic rhinitis|The primary efficacy parameter was a mean change from baseline to treatment for daytime asthma symptom score. Therefore 138 participants who didn't have a daytime asthma symptom score from the participant diary were not included.|Participants|Number|13|13.0||||||
4330173|NCT00442559|4157098|B3|Mild-persistent||Allergic rhinitis|Based on GINA guidelines. The primary efficacy parameter was a mean change from baseline to treatment for daytime asthma symptom score. Therefore 138 participants who didn't have a daytime asthma symptom score from the participant diary were not included.|participants|Number|22|22.0||||||
4330174|NCT00442559|4157099|B2|Mild-persistent||Allergic rhinitis|Based on GINA guidelines. The primary efficacy parameter was a mean change from baseline to treatment for daytime asthma symptom score. Therefore 138 participants who didn't have a daytime asthma symptom score from the participant diary were not included.|participants|Number|12|12.0||||||
4330175|NCT00442559|4157100|B1|Mild-persistent||Allergic rhinitis|Based on GINA guidelines. The primary efficacy parameter was a mean change from baseline to treatment for daytime asthma symptom score. Therefore 138 participants who didn't have a daytime asthma symptom score from the participant diary were not included.|participants|Number|10|10.0||||||
4330176|NCT00442559|4157098|B3|Mild-intermittent||Allergic rhinitis|Based on GINA guidelines. The primary efficacy parameter was a mean change from baseline to treatment for daytime asthma symptom score. Therefore 138 participants who didn't have a daytime asthma symptom score from the participant diary were not included.|participants|Number|31|31.0||||||
4330177|NCT00442559|4157099|B2|Mild-intermittent||Allergic rhinitis|Based on GINA guidelines. The primary efficacy parameter was a mean change from baseline to treatment for daytime asthma symptom score. Therefore 138 participants who didn't have a daytime asthma symptom score from the participant diary were not included.|participants|Number|17|17.0||||||
4330178|NCT00442559|4157100|B1|Mild-intermittent||Allergic rhinitis|Based on GINA guidelines. The primary efficacy parameter was a mean change from baseline to treatment for daytime asthma symptom score. Therefore 138 participants who didn't have a daytime asthma symptom score from the participant diary were not included.|participants|Number|14|14.0||||||
4330179|NCT00442559|4157098|B3||Male|Sex: Female, Male|The primary efficacy parameter was a mean change from baseline to treatment for daytime asthma symptom score. Therefore 138 participants who didn't have a daytime asthma symptom score from the participant diary were not included.|Participants|Count of Participants|39|39.0||||||
4330180|NCT00442559|4157099|B2||Male|Sex: Female, Male|The primary efficacy parameter was a mean change from baseline to treatment for daytime asthma symptom score. Therefore 138 participants who didn't have a daytime asthma symptom score from the participant diary were not included.|Participants|Count of Participants|20|20.0||||||
4330181|NCT00442559|4157100|B1||Male|Sex: Female, Male|The primary efficacy parameter was a mean change from baseline to treatment for daytime asthma symptom score. Therefore 138 participants who didn't have a daytime asthma symptom score from the participant diary were not included.|Participants|Count of Participants|19|19.0||||||
4330182|NCT00442559|4157098|B3||Female|Sex: Female, Male|The primary efficacy parameter was a mean change from baseline to treatment for daytime asthma symptom score. Therefore 138 participants who didn't have a daytime asthma symptom score from the participant diary were not included.|Participants|Count of Participants|14|14.0||||||
4330183|NCT00442559|4157099|B2||Female|Sex: Female, Male|The primary efficacy parameter was a mean change from baseline to treatment for daytime asthma symptom score. Therefore 138 participants who didn't have a daytime asthma symptom score from the participant diary were not included.|Participants|Count of Participants|9|9.0||||||
4330184|NCT00442559|4157100|B1||Female|Sex: Female, Male|The primary efficacy parameter was a mean change from baseline to treatment for daytime asthma symptom score. Therefore 138 participants who didn't have a daytime asthma symptom score from the participant diary were not included.|Participants|Count of Participants|5|5.0||||||
4330185|NCT00442559|4157098|B3|||Age|The primary efficacy parameter was a mean change from baseline to treatment for daytime asthma symptom score. Therefore 138 participants who didn't have a daytime asthma symptom score from the participant diary were not included.|years|Mean|5.8|5.8|Standard Deviation|2.8|2.8|||
4330186|NCT00442559|4157099|B2|||Age|The primary efficacy parameter was a mean change from baseline to treatment for daytime asthma symptom score. Therefore 138 participants who didn't have a daytime asthma symptom score from the participant diary were not included.|years|Mean|6.1|6.1|Standard Deviation|2.6|2.6|||
4330187|NCT00442559|4157100|B1|||Age|The primary efficacy parameter was a mean change from baseline to treatment for daytime asthma symptom score. Therefore 138 participants who didn't have a daytime asthma symptom score from the participant diary were not included.|years|Mean|5.4|5.4|Standard Deviation|3.0|3.0|||
4330188|NCT00442546|4157113|B4||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4330189|NCT00442546|4157114|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4330190|NCT00442546|4157115|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4330191|NCT00442546|4157116|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4330192|NCT00442546|4157113|B4||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4330193|NCT00442546|4157114|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4330194|NCT00442546|4157115|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4330195|NCT00442546|4157116|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4330196|NCT00442546|4157113|B4|> = 65 years||Age, Customized||participants|Number|140|140.0||||||
4330197|NCT00442546|4157114|B3|> = 65 years||Age, Customized||participants|Number|45|45.0||||||
4330198|NCT00442546|4157115|B2|> = 65 years||Age, Customized||participants|Number|50|50.0||||||
4330199|NCT00442546|4157116|B1|> = 65 years||Age, Customized||participants|Number|45|45.0||||||
4330200|NCT00442546|4157113|B4|45 to 64 years||Age, Customized||participants|Number|145|145.0||||||
4330201|NCT00442546|4157114|B3|45 to 64 years||Age, Customized||participants|Number|49|49.0||||||
4330202|NCT00442546|4157115|B2|45 to 64 years||Age, Customized||participants|Number|44|44.0||||||
4330203|NCT00442546|4157116|B1|45 to 64 years||Age, Customized||participants|Number|52|52.0||||||
4330204|NCT00442546|4157113|B4|18 to 44 years||Age, Customized||participants|Number|7|7.0||||||
4330205|NCT00442546|4157114|B3|18 to 44 years||Age, Customized||participants|Number|4|4.0||||||
4330206|NCT00442546|4157115|B2|18 to 44 years||Age, Customized||participants|Number|2|2.0||||||
4330207|NCT00442546|4157116|B1|18 to 44 years||Age, Customized||participants|Number|1|1.0||||||
4330208|NCT00442507|4157240|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4330209|NCT00442507|4157240|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4330210|NCT00442507|4157240|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4330211|NCT00442507|4157240|B1|||Age||years|Median|63.5|63.5|Full Range|||42.0|67.0|
4330212|NCT00442468|4157247|B1|||BMI|Body Mass Index (BMI, this is the ratio of the body mass in kilograms [kg] by the square of the height in meters [m2])|kg/m2|Mean|28.7|28.7|Standard Deviation|6.52|6.52|||
4330213|NCT00442468|4157247|B1|Former smokers||Smoking Status|Number of current and former smokers enrolled in the study|participants|Number|167|167.0||||||
4330214|NCT00442468|4157247|B1|Current smokers||Smoking Status|Number of current and former smokers enrolled in the study|participants|Number|1116|1116.0||||||
4330215|NCT00442468|4157247|B1|Native Hawain/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4330216|NCT00442468|4157247|B1|Asian - Central/South Central Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4330298|NCT00442338|4157324|B4|From 65-84 years||Age, Customized||Participants|Number|33|33.0||||||
4330217|NCT00442468|4157247|B1|Asian - Japanese||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4330218|NCT00442468|4157247|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4330219|NCT00442468|4157247|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4330220|NCT00442468|4157247|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4330221|NCT00442468|4157247|B1|African American/African||Race/Ethnicity, Customized||participants|Number|219|219.0||||||
4330222|NCT00442468|4157247|B1|White - White/Caucasian/European||Race/Ethnicity, Customized||participants|Number|1030|1030.0||||||
4330223|NCT00442468|4157247|B1||Male|Sex: Female, Male||Participants|Count of Participants|579|579.0||||||
4330224|NCT00442468|4157247|B1||Female|Sex: Female, Male||Participants|Count of Participants|704|704.0||||||
4330225|NCT00442468|4157247|B1|||Age||years|Mean|52.9|52.9|Standard Deviation|9.08|9.08|||
4330226|NCT00442416|4157275|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4330227|NCT00442416|4157276|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4330228|NCT00442416|4157277|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4330229|NCT00442416|4157275|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4330230|NCT00442416|4157276|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4330231|NCT00442416|4157277|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4330232|NCT00442416|4157275|B3|||Age||Years|Mean|56.0|56.0|Standard Deviation|14.48|14.48|||
4330233|NCT00442416|4157276|B2|||Age||Years|Mean|53.6|53.6|Standard Deviation|15.86|15.86|||
4330234|NCT00442416|4157277|B1|||Age||Years|Mean|58.5|58.5|Standard Deviation|12.59|12.59|||
4330235|NCT00442364|4157311|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330236|NCT00442364|4157311|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330237|NCT00442364|4157311|B1||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4330238|NCT00442364|4157311|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330239|NCT00442364|4157311|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330240|NCT00442364|4157311|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4330241|NCT00442364|4157311|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330242|NCT00442364|4157311|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4330243|NCT00442364|4157311|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4330244|NCT00442364|4157311|B1|||Age||years|Mean|43.6|43.6|Standard Deviation|9.17|9.17|||
4330245|NCT00442351|4157315|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4330246|NCT00442351|4157316|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4330247|NCT00442351|4157317|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4330248|NCT00442351|4157315|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4330249|NCT00442351|4157316|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4330250|NCT00442351|4157317|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4330251|NCT00442351|4157315|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4330252|NCT00442351|4157316|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4330253|NCT00442351|4157317|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4330254|NCT00442351|4157315|B3|||Age||years|Mean|42.1|42.1|Standard Deviation|13.5|13.5|||
4330255|NCT00442351|4157316|B2|||Age||years|Mean|42.6|42.6|Standard Deviation|17.0|17.0|||
4330256|NCT00442351|4157317|B1|||Age||years|Mean|41.9|41.9|Standard Deviation|11.9|11.9|||
4330257|NCT00442351|4157315|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4330258|NCT00442351|4157316|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4330259|NCT00442351|4157317|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4330260|NCT00442351|4157315|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4330261|NCT00442351|4157316|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4330262|NCT00442351|4157317|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4330263|NCT00442351|4157315|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4330264|NCT00442351|4157316|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4330265|NCT00442351|4157317|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4330266|NCT00442338|4157324|B4|||Duration of Asthma||Years|Mean|15.2|15.2|Standard Deviation|12.0|12.0|||
4330267|NCT00442338|4157325|B3|||Duration of Asthma||Years|Mean|16.7|16.7|Standard Deviation|14.1|14.1|||
4330268|NCT00442338|4157326|B2|||Duration of Asthma||Years|Mean|13.9|13.9|Standard Deviation|11.5|11.5|||
4330269|NCT00442338|4157327|B1|||Duration of Asthma||Years|Mean|14.9|14.9|Standard Deviation|10.4|10.4|||
4330270|NCT00442338|4157324|B4|||Baseline Forced Expiratory Volume in One Second (FEV1)||Liter|Mean|1.32|1.32|Standard Deviation|0.41|0.41|||
4330271|NCT00442338|4157325|B3|||Baseline Forced Expiratory Volume in One Second (FEV1)||Liter|Mean|1.43|1.43|Standard Deviation|0.53|0.53|||
4330272|NCT00442338|4157326|B2|||Baseline Forced Expiratory Volume in One Second (FEV1)||Liter|Mean|1.18|1.18|Standard Deviation|0.33|0.33|||
4330273|NCT00442338|4157327|B1|||Baseline Forced Expiratory Volume in One Second (FEV1)||Liter|Mean|1.35|1.35|Standard Deviation|0.29|0.29|||
4330299|NCT00442338|4157325|B3|From 65-84 years||Age, Customized||Participants|Number|11|11.0||||||
4330300|NCT00442338|4157326|B2|From 65-84 years||Age, Customized||Participants|Number|13|13.0||||||
4330274|NCT00442338|4157324|B4|Serious||Asthma Attack Severity based on Asthma Prevention and Management Guideline 2003, Japan|Mild (Peak Expiratory Flow: 70%-80%), Moderate (Peak Expiratory Flow: 50%-70%), Severe (Peak Expiratory Flow: <=50%) or Serious (Peak Expiratory Flow: incapable measurement, cyanosis, head trip, disturbed consciousness, incontinence or asphyxia)|Participants|Number|0|0.0||||||
4330275|NCT00442338|4157325|B3|Serious||Asthma Attack Severity based on Asthma Prevention and Management Guideline 2003, Japan|Mild (Peak Expiratory Flow: 70%-80%), Moderate (Peak Expiratory Flow: 50%-70%), Severe (Peak Expiratory Flow: <=50%) or Serious (Peak Expiratory Flow: incapable measurement, cyanosis, head trip, disturbed consciousness, incontinence or asphyxia)|Participants|Number|0|0.0||||||
4330276|NCT00442338|4157326|B2|Serious||Asthma Attack Severity based on Asthma Prevention and Management Guideline 2003, Japan|Mild (Peak Expiratory Flow: 70%-80%), Moderate (Peak Expiratory Flow: 50%-70%), Severe (Peak Expiratory Flow: <=50%) or Serious (Peak Expiratory Flow: incapable measurement, cyanosis, head trip, disturbed consciousness, incontinence or asphyxia)|Participants|Number|0|0.0||||||
4330277|NCT00442338|4157327|B1|Serious||Asthma Attack Severity based on Asthma Prevention and Management Guideline 2003, Japan|Mild (Peak Expiratory Flow: 70%-80%), Moderate (Peak Expiratory Flow: 50%-70%), Severe (Peak Expiratory Flow: <=50%) or Serious (Peak Expiratory Flow: incapable measurement, cyanosis, head trip, disturbed consciousness, incontinence or asphyxia)|Participants|Number|0|0.0||||||
4330278|NCT00442338|4157324|B4|Severe||Asthma Attack Severity based on Asthma Prevention and Management Guideline 2003, Japan|Mild (Peak Expiratory Flow: 70%-80%), Moderate (Peak Expiratory Flow: 50%-70%), Severe (Peak Expiratory Flow: <=50%) or Serious (Peak Expiratory Flow: incapable measurement, cyanosis, head trip, disturbed consciousness, incontinence or asphyxia)|Participants|Number|0|0.0||||||
4330279|NCT00442338|4157325|B3|Severe||Asthma Attack Severity based on Asthma Prevention and Management Guideline 2003, Japan|Mild (Peak Expiratory Flow: 70%-80%), Moderate (Peak Expiratory Flow: 50%-70%), Severe (Peak Expiratory Flow: <=50%) or Serious (Peak Expiratory Flow: incapable measurement, cyanosis, head trip, disturbed consciousness, incontinence or asphyxia)|Participants|Number|0|0.0||||||
4330280|NCT00442338|4157326|B2|Severe||Asthma Attack Severity based on Asthma Prevention and Management Guideline 2003, Japan|Mild (Peak Expiratory Flow: 70%-80%), Moderate (Peak Expiratory Flow: 50%-70%), Severe (Peak Expiratory Flow: <=50%) or Serious (Peak Expiratory Flow: incapable measurement, cyanosis, head trip, disturbed consciousness, incontinence or asphyxia)|Participants|Number|0|0.0||||||
4330281|NCT00442338|4157327|B1|Severe||Asthma Attack Severity based on Asthma Prevention and Management Guideline 2003, Japan|Mild (Peak Expiratory Flow: 70%-80%), Moderate (Peak Expiratory Flow: 50%-70%), Severe (Peak Expiratory Flow: <=50%) or Serious (Peak Expiratory Flow: incapable measurement, cyanosis, head trip, disturbed consciousness, incontinence or asphyxia)|Participants|Number|0|0.0||||||
4330282|NCT00442338|4157324|B4|Moderate||Asthma Attack Severity based on Asthma Prevention and Management Guideline 2003, Japan|Mild (Peak Expiratory Flow: 70%-80%), Moderate (Peak Expiratory Flow: 50%-70%), Severe (Peak Expiratory Flow: <=50%) or Serious (Peak Expiratory Flow: incapable measurement, cyanosis, head trip, disturbed consciousness, incontinence or asphyxia)|Participants|Number|26|26.0||||||
4330283|NCT00442338|4157325|B3|Moderate||Asthma Attack Severity based on Asthma Prevention and Management Guideline 2003, Japan|Mild (Peak Expiratory Flow: 70%-80%), Moderate (Peak Expiratory Flow: 50%-70%), Severe (Peak Expiratory Flow: <=50%) or Serious (Peak Expiratory Flow: incapable measurement, cyanosis, head trip, disturbed consciousness, incontinence or asphyxia)|Participants|Number|5|5.0||||||
4330284|NCT00442338|4157326|B2|Moderate||Asthma Attack Severity based on Asthma Prevention and Management Guideline 2003, Japan|Mild (Peak Expiratory Flow: 70%-80%), Moderate (Peak Expiratory Flow: 50%-70%), Severe (Peak Expiratory Flow: <=50%) or Serious (Peak Expiratory Flow: incapable measurement, cyanosis, head trip, disturbed consciousness, incontinence or asphyxia)|Participants|Number|12|12.0||||||
4330285|NCT00442338|4157327|B1|Moderate||Asthma Attack Severity based on Asthma Prevention and Management Guideline 2003, Japan|Mild (Peak Expiratory Flow: 70%-80%), Moderate (Peak Expiratory Flow: 50%-70%), Severe (Peak Expiratory Flow: <=50%) or Serious (Peak Expiratory Flow: incapable measurement, cyanosis, head trip, disturbed consciousness, incontinence or asphyxia)|Participants|Number|9|9.0||||||
4330286|NCT00442338|4157324|B4|Mild||Asthma Attack Severity based on Asthma Prevention and Management Guideline 2003, Japan|Mild (Peak Expiratory Flow: 70%-80%), Moderate (Peak Expiratory Flow: 50%-70%), Severe (Peak Expiratory Flow: <=50%) or Serious (Peak Expiratory Flow: incapable measurement, cyanosis, head trip, disturbed consciousness, incontinence or asphyxia)|Participants|Number|65|65.0||||||
4330287|NCT00442338|4157325|B3|Mild||Asthma Attack Severity based on Asthma Prevention and Management Guideline 2003, Japan|Mild (Peak Expiratory Flow: 70%-80%), Moderate (Peak Expiratory Flow: 50%-70%), Severe (Peak Expiratory Flow: <=50%) or Serious (Peak Expiratory Flow: incapable measurement, cyanosis, head trip, disturbed consciousness, incontinence or asphyxia)|Participants|Number|26|26.0||0.53|0.53|||
4330288|NCT00442338|4157326|B2|Mild||Asthma Attack Severity based on Asthma Prevention and Management Guideline 2003, Japan|Mild (Peak Expiratory Flow: 70%-80%), Moderate (Peak Expiratory Flow: 50%-70%), Severe (Peak Expiratory Flow: <=50%) or Serious (Peak Expiratory Flow: incapable measurement, cyanosis, head trip, disturbed consciousness, incontinence or asphyxia)|Participants|Number|18|18.0||0.33|0.33|||
4330289|NCT00442338|4157327|B1|Mild||Asthma Attack Severity based on Asthma Prevention and Management Guideline 2003, Japan|Mild (Peak Expiratory Flow: 70%-80%), Moderate (Peak Expiratory Flow: 50%-70%), Severe (Peak Expiratory Flow: <=50%) or Serious (Peak Expiratory Flow: incapable measurement, cyanosis, head trip, disturbed consciousness, incontinence or asphyxia)|Participants|Number|21|21.0||0.29|0.29|||
4330290|NCT00442338|4157324|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4330291|NCT00442338|4157325|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4330292|NCT00442338|4157326|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4330293|NCT00442338|4157327|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4330294|NCT00442338|4157324|B4||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4330295|NCT00442338|4157325|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4330296|NCT00442338|4157326|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4330297|NCT00442338|4157327|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4330301|NCT00442338|4157327|B1|From 65-84 years||Age, Customized||Participants|Number|9|9.0||||||
4330302|NCT00442338|4157324|B4|Adults (18-64 years)||Age, Customized||Participants|Number|57|57.0||||||
4330303|NCT00442338|4157325|B3|Adults (18-64 years)||Age, Customized||Participants|Number|20|20.0||||||
4330304|NCT00442338|4157326|B2|Adults (18-64 years)||Age, Customized||Participants|Number|16|16.0||||||
4330305|NCT00442338|4157327|B1|Adults (18-64 years)||Age, Customized||Participants|Number|21|21.0||||||
4330306|NCT00442338|4157324|B4|Adolescents (12-17 years)||Age, Customized||Participants|Number|1|1.0||||||
4330307|NCT00442338|4157325|B3|Adolescents (12-17 years)||Age, Customized||Participants|Number|0|0.0||14.5|14.5|||
4330308|NCT00442338|4157326|B2|Adolescents (12-17 years)||Age, Customized||Participants|Number|1|1.0||15.2|15.2|||
4330309|NCT00442338|4157327|B1|Adolescents (12-17 years)||Age, Customized||Participants|Number|0|0.0||12.3|12.3|||
4330310|NCT00442338|4157324|B4|||Age||Years|Mean|56.0|56.0|Standard Deviation|13.9|13.9|||
4330311|NCT00442338|4157325|B3|||Age||Years|Mean|55.4|55.4|Standard Deviation|14.5|14.5|||
4330312|NCT00442338|4157326|B2|||Age||Years|Mean|56.7|56.7|Standard Deviation|15.2|15.2|||
4330313|NCT00442338|4157327|B1|||Age||Years|Mean|56.0|56.0|Standard Deviation|12.3|12.3|||
4330314|NCT00442286|4157337|B4|Germany||Region of Enrollment||participants|Number|13|13.0||||||
4330315|NCT00442286|4157338|B3|Germany||Region of Enrollment||participants|Number|5|5.0||||||
4330316|NCT00442286|4157339|B2|Germany||Region of Enrollment||participants|Number|8|8.0||||||
4330317|NCT00442286|4157340|B1|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4330318|NCT00442286|4157337|B4|United States||Region of Enrollment||participants|Number|294|294.0||||||
4330319|NCT00442286|4157338|B3|United States||Region of Enrollment||participants|Number|74|74.0||||||
4330320|NCT00442286|4157339|B2|United States||Region of Enrollment||participants|Number|165|165.0||||||
4330321|NCT00442286|4157340|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4330322|NCT00442286|4157337|B4|Netherlands||Region of Enrollment||participants|Number|13|13.0||||||
4330323|NCT00442286|4157338|B3|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
4330324|NCT00442286|4157339|B2|Netherlands||Region of Enrollment||participants|Number|8|8.0||||||
4330325|NCT00442286|4157340|B1|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4330326|NCT00442286|4157337|B4|Other||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4330327|NCT00442286|4157338|B3|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4330328|NCT00442286|4157339|B2|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4330329|NCT00442286|4157340|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4330330|NCT00442286|4157337|B4|White/Caucasian||Race/Ethnicity, Customized||Participants|Number|245|245.0||||||
4330331|NCT00442286|4157338|B3|White/Caucasian||Race/Ethnicity, Customized||Participants|Number|59|59.0||||||
4330332|NCT00442286|4157339|B2|White/Caucasian||Race/Ethnicity, Customized||Participants|Number|146|146.0||||||
4330333|NCT00442286|4157340|B1|White/Caucasian||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
4330334|NCT00442286|4157337|B4|Hispanic||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4330335|NCT00442286|4157338|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4330336|NCT00442286|4157339|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4330337|NCT00442286|4157340|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4330338|NCT00442286|4157337|B4|African American||Race/Ethnicity, Customized||Participants|Number|59|59.0||||||
4330339|NCT00442286|4157338|B3|African American||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4330340|NCT00442286|4157339|B2|African American||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
4330341|NCT00442286|4157340|B1|African American||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4330342|NCT00442286|4157337|B4||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4330343|NCT00442286|4157338|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4330344|NCT00442286|4157339|B2||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4330345|NCT00442286|4157340|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4330346|NCT00442286|4157337|B4||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4330347|NCT00442286|4157338|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4330348|NCT00442286|4157339|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4330349|NCT00442286|4157340|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4330350|NCT00442286|4157337|B4||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4330351|NCT00442286|4157338|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4330352|NCT00442286|4157339|B2||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4330353|NCT00442286|4157340|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4330354|NCT00442286|4157337|B4||Between 18 and 65 years|Age||Participants|Count of Participants|272|272.0||||||
4330355|NCT00442286|4157338|B3||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4330356|NCT00442286|4157339|B2||Between 18 and 65 years|Age||Participants|Count of Participants|151|151.0||||||
4330357|NCT00442286|4157340|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4330358|NCT00442286|4157337|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4330359|NCT00442286|4157338|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4330360|NCT00442286|4157339|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4330361|NCT00442286|4157340|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4330362|NCT00442169|4157352|B7|United States||Region of Enrollment||Participants|Number|194|194.0||||||
4330363|NCT00442169|4157353|B6|United States||Region of Enrollment||Participants|Number|57|57.0||||||
4330364|NCT00442169|4157354|B5|United States||Region of Enrollment||Participants|Number|25|25.0||||||
4330365|NCT00442169|4157355|B4|United States||Region of Enrollment||Participants|Number|31|31.0||||||
4330366|NCT00442169|4157356|B3|United States||Region of Enrollment||Participants|Number|40|40.0||||||
4330367|NCT00442169|4157357|B2|United States||Region of Enrollment||Participants|Number|24|24.0||||||
4330368|NCT00442169|4157358|B1|United States||Region of Enrollment||Participants|Number|17|17.0||||||
4330369|NCT00442169|4157352|B7||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4330370|NCT00442169|4157353|B6||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4330371|NCT00442169|4157354|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4330372|NCT00442169|4157355|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4330373|NCT00442169|4157356|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4330374|NCT00442169|4157357|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4330375|NCT00442169|4157358|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4330376|NCT00442169|4157352|B7||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4330377|NCT00442169|4157353|B6||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4330378|NCT00442169|4157354|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4330379|NCT00442169|4157355|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4330380|NCT00442169|4157356|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4330381|NCT00442169|4157357|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4330382|NCT00442169|4157358|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4330383|NCT00442169|4157352|B7|||Age||Years|Mean|25.7|25.7|Standard Deviation|6.13|6.13|||
4330384|NCT00442169|4157353|B6|||Age||Years|Mean|61.0|61.0|Standard Deviation|11.3|11.3|||
4330385|NCT00442169|4157354|B5|||Age||Years|Mean|61.4|61.4|Standard Deviation|11.8|11.8|||
4330386|NCT00442169|4157355|B4|||Age||Years|Mean|25.1|25.1|Standard Deviation|6.47|6.47|||
4330387|NCT00442169|4157356|B3|||Age||Years|Mean|25|25.0|Standard Deviation|5.43|5.43|||
4330388|NCT00442169|4157357|B2|||Age||Years|Mean|25.4|25.4|Standard Deviation|5.62|5.62|||
4330389|NCT00442169|4157358|B1|||Age||Years|Mean|26.6|26.6|Standard Deviation|6.41|6.41|||
4330390|NCT00442169|4157352|B7||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
4330391|NCT00442169|4157353|B6||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4330392|NCT00442169|4157354|B5||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4330393|NCT00442169|4157355|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4330394|NCT00442169|4157356|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4330395|NCT00442169|4157357|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4330396|NCT00442169|4157358|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4330397|NCT00442169|4157352|B7||Between 18 and 65 years|Age||Participants|Count of Participants|152|152.0||||||
4330398|NCT00442169|4157353|B6||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4330399|NCT00442169|4157354|B5||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4330400|NCT00442169|4157355|B4||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4330401|NCT00442169|4157356|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4330402|NCT00442169|4157357|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4330403|NCT00442169|4157358|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4330404|NCT00442169|4157352|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4330405|NCT00442169|4157353|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4330406|NCT00442169|4157354|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4330407|NCT00442169|4157355|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4330408|NCT00442169|4157356|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4330409|NCT00442169|4157357|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4330410|NCT00442169|4157358|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4330411|NCT00442117|4157401|B3||Male|Sex: Female, Male|Number of participants analyzed includes data of the total enrolled population|Participants|Count of Participants|92|92.0||||||
4330412|NCT00442117|4157402|B2||Male|Sex: Female, Male|Number of participants analyzed includes data of the total enrolled population|Participants|Count of Participants|49|49.0||||||
4330413|NCT00442117|4157403|B1||Male|Sex: Female, Male|Number of participants analyzed includes data of the total enrolled population|Participants|Count of Participants|43|43.0||||||
4330414|NCT00442117|4157401|B3||Female|Sex: Female, Male|Number of participants analyzed includes data of the total enrolled population|Participants|Count of Participants|88|88.0||||||
4330415|NCT00442117|4157402|B2||Female|Sex: Female, Male|Number of participants analyzed includes data of the total enrolled population|Participants|Count of Participants|40|40.0||||||
4330416|NCT00442117|4157403|B1||Female|Sex: Female, Male|Number of participants analyzed includes data of the total enrolled population|Participants|Count of Participants|48|48.0||||||
4330417|NCT00442117|4157401|B3|||Age, Customized|Number of participants analyzed includes data of the total enrolled population|participants|Number|180|180.0||||||
4330418|NCT00442117|4157402|B2|||Age, Customized|Number of participants analyzed includes data of the total enrolled population|participants|Number|89|89.0||||||
4330419|NCT00442117|4157403|B1|||Age, Customized|Number of participants analyzed includes data of the total enrolled population|participants|Number|91|91.0||||||
4330420|NCT00442013|4157416|B3|United States||Region of Enrollment||participants|Number|306|306.0||||||
4330421|NCT00442013|4157417|B2|United States||Region of Enrollment||participants|Number|149|149.0||||||
4330422|NCT00442013|4157418|B1|United States||Region of Enrollment||participants|Number|157|157.0||||||
4330423|NCT00442013|4157416|B3||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4330424|NCT00442013|4157417|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4330425|NCT00442013|4157418|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4330426|NCT00442013|4157416|B3||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4330427|NCT00442013|4157417|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4330428|NCT00442013|4157418|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4330429|NCT00442013|4157416|B3|||Age||years|Mean|11|11.0|Standard Deviation|3|3.0|||
4330430|NCT00442013|4157417|B2|||Age||years|Mean|11|11.0|Standard Deviation|3|3.0|||
4330431|NCT00442013|4157418|B1|||Age||years|Mean|11|11.0|Standard Deviation|3|3.0|||
4330432|NCT00442013|4157416|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4330433|NCT00442013|4157417|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4330434|NCT00442013|4157418|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4330435|NCT00442013|4157416|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4330436|NCT00442013|4157417|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4330437|NCT00442013|4157418|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4330438|NCT00442013|4157416|B3||<=18 years|Age||Participants|Count of Participants|306|306.0||||||
4330439|NCT00442013|4157417|B2||<=18 years|Age||Participants|Count of Participants|149|149.0||||||
4330440|NCT00442013|4157418|B1||<=18 years|Age||Participants|Count of Participants|157|157.0||||||
4330441|NCT00441974|4157435|B1|Asian||Race/Ethnicity, Customized|The Intent-to-Treat (ITT) Population was used as the analysis population.|participants|Number|1467|1467.0||||||
4330442|NCT00441974|4157435|B1||Male|Sex: Female, Male|The Intent-to-Treat (ITT) Population was used as the analysis population.|Participants|Count of Participants|1176|1176.0||||||
4330443|NCT00441974|4157435|B1||Female|Sex: Female, Male|The Intent-to-Treat (ITT) Population was used as the analysis population.|Participants|Count of Participants|291|291.0||||||
4330444|NCT00441974|4157435|B1|||Age|The Intent-to-Treat (ITT) Population was used as the analysis population.|years|Mean|31.5|31.5|Standard Deviation|9.8|9.8|||
4330445|NCT00441792|4157449|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4330446|NCT00441792|4157450|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4330447|NCT00441792|4157451|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4330448|NCT00441792|4157449|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4330449|NCT00441792|4157450|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4330450|NCT00441792|4157451|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4330451|NCT00441792|4157449|B3|||Age, Customized||years|Median|72|72.0|Inter-Quartile Range|||60.0|82.0|
4330452|NCT00441792|4157450|B2|||Age, Customized||years|Median|70|70.0|Inter-Quartile Range|||60.0|83.0|
4330453|NCT00441792|4157451|B1|||Age, Customized||years|Median|73|73.0|Inter-Quartile Range|||60.0|80.0|
4330454|NCT00441766|4157460|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4330455|NCT00441766|4157461|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4330456|NCT00441766|4157462|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4330457|NCT00441766|4157463|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4330458|NCT00441766|4157464|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4330459|NCT00441766|4157460|B5||Female|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
4330460|NCT00441766|4157461|B4||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4330461|NCT00441766|4157462|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4330462|NCT00441766|4157463|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4330463|NCT00441766|4157464|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4330464|NCT00441766|4157460|B5|>=65 years||Age, Customized||participants|Number|13|13.0||||||
4330465|NCT00441766|4157461|B4|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4330466|NCT00441766|4157462|B3|>=65 years||Age, Customized||participants|Number|3|3.0||||||
4330467|NCT00441766|4157463|B2|>=65 years||Age, Customized||participants|Number|5|5.0||||||
4330468|NCT00441766|4157464|B1|>=65 years||Age, Customized||participants|Number|5|5.0||||||
4330469|NCT00441766|4157460|B5|18 to 64 years||Age, Customized||participants|Number|200|200.0||||||
4330470|NCT00441766|4157461|B4|18 to 64 years||Age, Customized||participants|Number|54|54.0||||||
4330471|NCT00441766|4157462|B3|18 to 64 years||Age, Customized||participants|Number|50|50.0||||||
4330472|NCT00441766|4157463|B2|18 to 64 years||Age, Customized||participants|Number|48|48.0||||||
4330473|NCT00441766|4157464|B1|18 to 64 years||Age, Customized||participants|Number|48|48.0||||||
4330474|NCT00441727|4157489|B4||Male|Sex: Female, Male||Participants|Count of Participants|1269|1269.0||||||
4330475|NCT00441727|4157490|B3||Male|Sex: Female, Male||Participants|Count of Participants|403|403.0||||||
4330476|NCT00441727|4157491|B2||Male|Sex: Female, Male||Participants|Count of Participants|429|429.0||||||
4330477|NCT00441727|4157492|B1||Male|Sex: Female, Male||Participants|Count of Participants|437|437.0||||||
4330478|NCT00441727|4157489|B4||Female|Sex: Female, Male||Participants|Count of Participants|1157|1157.0||||||
4330479|NCT00441727|4157490|B3||Female|Sex: Female, Male||Participants|Count of Participants|402|402.0||||||
4330480|NCT00441727|4157491|B2||Female|Sex: Female, Male||Participants|Count of Participants|375|375.0||||||
4330481|NCT00441727|4157492|B1||Female|Sex: Female, Male||Participants|Count of Participants|380|380.0||||||
4330482|NCT00441727|4157489|B4||>=65 years|Age||Participants|Count of Participants|1680|1680.0||||||
4330483|NCT00441727|4157490|B3||>=65 years|Age||Participants|Count of Participants|545|545.0||||||
4330484|NCT00441727|4157491|B2||>=65 years|Age||Participants|Count of Participants|558|558.0||||||
4330485|NCT00441727|4157492|B1||>=65 years|Age||Participants|Count of Participants|577|577.0||||||
4330486|NCT00441727|4157489|B4||Between 18 and 65 years|Age||Participants|Count of Participants|746|746.0||||||
4330487|NCT00441727|4157490|B3||Between 18 and 65 years|Age||Participants|Count of Participants|260|260.0||||||
4330488|NCT00441727|4157491|B2||Between 18 and 65 years|Age||Participants|Count of Participants|246|246.0||||||
4330489|NCT00441727|4157492|B1||Between 18 and 65 years|Age||Participants|Count of Participants|240|240.0||||||
4330490|NCT00441727|4157489|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4330491|NCT00441727|4157490|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4330492|NCT00441727|4157491|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4330493|NCT00441727|4157492|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4330494|NCT00441701|4157517|B11||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4330495|NCT00441701|4157522|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4330496|NCT00441701|4157523|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4330497|NCT00441701|4157524|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4330498|NCT00441701|4157525|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4330499|NCT00441701|4157526|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4330500|NCT00441701|4157527|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4330501|NCT00441701|4157517|B11||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4330502|NCT00441701|4157522|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4330503|NCT00441701|4157523|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4330504|NCT00441701|4157524|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4330505|NCT00441701|4157525|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4330506|NCT00441701|4157526|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4330507|NCT00441701|4157527|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4330508|NCT00441701|4157517|B11|||Age||Years|Mean|57.9|57.9|Standard Deviation|7.8|7.8|||
4330509|NCT00441701|4157522|B6|||Age||Years|Mean|58.3|58.3|Standard Deviation|9.4|9.4|||
4330510|NCT00441701|4157523|B5|||Age||Years|Mean|56.1|56.1|Standard Deviation|7.8|7.8|||
4330511|NCT00441701|4157524|B4|||Age||Years|Mean|60.2|60.2|Standard Deviation|7.8|7.8|||
4330512|NCT00441701|4157525|B3|||Age||Years|Mean|61.8|61.8|Standard Deviation|7.3|7.3|||
4330513|NCT00441701|4157526|B2|||Age||Years|Mean|57.2|57.2|Standard Deviation|8.6|8.6|||
4330514|NCT00441701|4157527|B1|||Age||Years|Mean|54.7|54.7|Standard Deviation|5.5|5.5|||
4330515|NCT00441584|4157618|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4330516|NCT00441584|4157618|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4330517|NCT00441584|4157618|B1|||Age||years|Mean|48.54|48.54|Standard Deviation|11.02|11.02|||
4330518|NCT00441558|4157622|B1|Asian||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4330519|NCT00441558|4157622|B1|Black Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4330520|NCT00441558|4157622|B1|Black||Race/Ethnicity, Customized||participants|Number|119|119.0||||||
4330521|NCT00441558|4157622|B1|White Hispanic||Race/Ethnicity, Customized||participants|Number|85|85.0||||||
4330522|NCT00441558|4157622|B1|White||Race/Ethnicity, Customized||participants|Number|1492|1492.0||||||
4330523|NCT00441558|4157622|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4330524|NCT00441558|4157622|B1||Female|Sex: Female, Male||Participants|Count of Participants|1723|1723.0||||||
4330525|NCT00441558|4157622|B1|50 years and older||Age, Customized||participants|Number|36|36.0||||||
4330526|NCT00441558|4157622|B1|40-49 years||Age, Customized||participants|Number|672|672.0||||||
4330527|NCT00441558|4157622|B1|30-39 years||Age, Customized||participants|Number|749|749.0||||||
4330528|NCT00441558|4157622|B1|18-29 years||Age, Customized||participants|Number|266|266.0||||||
4330529|NCT00441545|4157626|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4330530|NCT00441545|4157626|B1|Germany||Region of Enrollment||participants|Number|41|41.0||||||
4330531|NCT00441545|4157626|B1|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
4330532|NCT00441545|4157626|B1|United States||Region of Enrollment||participants|Number|139|139.0||||||
4330533|NCT00441545|4157626|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4330534|NCT00441545|4157626|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4330535|NCT00441545|4157626|B1|||Age||years|Mean|55.5|55.5|Standard Deviation|13.10|13.1|||
4330536|NCT00441545|4157626|B1||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
4330537|NCT00441545|4157626|B1||Between 18 and 65 years|Age||Participants|Count of Participants|140|140.0||||||
4330538|NCT00441545|4157626|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4330539|NCT00441480|4157639|B3|Israel||Region of Enrollment||participants|Number|91|91.0||||||
4330540|NCT00441480|4157640|B2|Israel||Region of Enrollment||participants|Number|45|45.0||||||
4330541|NCT00441480|4157641|B1|Israel||Region of Enrollment||participants|Number|46|46.0||||||
4330542|NCT00441480|4157639|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4330543|NCT00441480|4157640|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4330544|NCT00441480|4157641|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4330545|NCT00441480|4157639|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4330546|NCT00441480|4157640|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4330547|NCT00441480|4157641|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4330548|NCT00441480|4157639|B3|||Age||years|Mean|50.2|50.2|Standard Deviation|10.1|10.1|||
4330549|NCT00441480|4157640|B2|||Age||years|Mean|49.4|49.4|Standard Deviation|9.3|9.3|||
4330550|NCT00441480|4157641|B1|||Age||years|Mean|51|51.0|Standard Deviation|10.8|10.8|||
4330551|NCT00441480|4157639|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4330552|NCT00441480|4157640|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4330553|NCT00441480|4157641|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4330554|NCT00441480|4157639|B3||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
4330555|NCT00441480|4157640|B2||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4330556|NCT00441480|4157641|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4330557|NCT00441480|4157639|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4330558|NCT00441480|4157640|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4330559|NCT00441480|4157641|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4330560|NCT00441467|4157674|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330561|NCT00441467|4157674|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330562|NCT00441467|4157674|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4330563|NCT00441467|4157674|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4330564|NCT00441467|4157674|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330565|NCT00441467|4157674|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4330566|NCT00441467|4157674|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330567|NCT00441467|4157674|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4330568|NCT00441467|4157674|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4330569|NCT00441467|4157674|B1|||Age||years|Median|53.5|53.5|Full Range|||19.0|76.0|
4330570|NCT00441467|4157674|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4330571|NCT00441467|4157674|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4330572|NCT00441467|4157674|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4330573|NCT00441441|4157680|B3|Mixed Race||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4330574|NCT00441441|4157681|B2|Mixed Race||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4330575|NCT00441441|4157682|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4330576|NCT00441441|4157680|B3|South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4330577|NCT00441441|4157681|B2|South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4330578|NCT00441441|4157682|B1|South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4330579|NCT00441441|4157680|B3|Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4330580|NCT00441441|4157681|B2|Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4330581|NCT00441441|4157682|B1|Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4330582|NCT00441441|4157680|B3|Japanese Heritage||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4330583|NCT00441441|4157681|B2|Japanese Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4330584|NCT00441441|4157682|B1|Japanese Heritage||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4330585|NCT00441441|4157680|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4330586|NCT00441441|4157681|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4330587|NCT00441441|4157682|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4330588|NCT00441441|4157680|B3|Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4330589|NCT00441441|4157681|B2|Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4330590|NCT00441441|4157682|B1|Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4330591|NCT00441441|4157680|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4330592|NCT00441441|4157681|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4330593|NCT00441441|4157682|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4330594|NCT00441441|4157680|B3|White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|227|227.0||||||
4330595|NCT00441441|4157681|B2|White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|113|113.0||||||
4330596|NCT00441441|4157682|B1|White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|114|114.0||||||
4330597|NCT00441441|4157680|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330598|NCT00441441|4157681|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330599|NCT00441441|4157682|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330600|NCT00441441|4157680|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|207|207.0||||||
4330601|NCT00441441|4157681|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
4330602|NCT00441441|4157682|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
4330603|NCT00441441|4157680|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|143|143.0||||||
4330604|NCT00441441|4157681|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
4330605|NCT00441441|4157682|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4330606|NCT00441441|4157680|B3||Male|Gender||Participants|Count of Participants|213|213.0||||||
4330607|NCT00441441|4157681|B2||Male|Gender||Participants|Count of Participants|106|106.0||||||
4330608|NCT00441441|4157682|B1||Male|Gender||Participants|Count of Participants|107|107.0||||||
4330609|NCT00441441|4157680|B3||Female|Gender||Participants|Count of Participants|137|137.0||||||
4330610|NCT00441441|4157681|B2||Female|Gender||Participants|Count of Participants|71|71.0||||||
4330611|NCT00441441|4157682|B1||Female|Gender||Participants|Count of Participants|66|66.0||||||
4330612|NCT00441441|4157680|B3|6-11 years||Age, Customized||participants|Number|273|273.0||||||
4330613|NCT00441441|4157681|B2|6-11 years||Age, Customized||participants|Number|136|136.0||||||
4330614|NCT00441441|4157682|B1|6-11 years||Age, Customized||participants|Number|137|137.0||||||
4330615|NCT00441441|4157680|B3|4-5 years||Age, Customized||participants|Number|77|77.0||||||
4330616|NCT00441441|4157681|B2|4-5 years||Age, Customized||participants|Number|41|41.0||||||
4330617|NCT00441441|4157682|B1|4-5 years||Age, Customized||participants|Number|36|36.0||||||
4330618|NCT00441363|4157741|B3|United States||Region of Enrollment||participants|Number|66|66.0||||||
4330619|NCT00441363|4157742|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
4330620|NCT00441363|4157743|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4330621|NCT00441363|4157741|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4330622|NCT00441363|4157742|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4330623|NCT00441363|4157743|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4330624|NCT00441363|4157741|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4330625|NCT00441363|4157742|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4330626|NCT00441363|4157743|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4330627|NCT00441363|4157741|B3|||Age||years|Mean|53|53.0|Standard Deviation|9.8|9.8|||
4330628|NCT00441363|4157742|B2|||Age||years|Mean|53|53.0|Standard Deviation|9.3|9.3|||
4330629|NCT00441363|4157743|B1|||Age||years|Mean|54|54.0|Standard Deviation|10.5|10.5|||
4330630|NCT00441337|4157752|B5|Stage IV||Stage of Malignancy at Screening Diagnosis|The investigator reported the screening malignancy stage for each type of cancer using the American Joint Committee on Cancer Classification (Stages I, II, III, and IV).|participants|Number|38|38.0||||||
4330631|NCT00441337|4157753|B4|Stage IV||Stage of Malignancy at Screening Diagnosis|The investigator reported the screening malignancy stage for each type of cancer using the American Joint Committee on Cancer Classification (Stages I, II, III, and IV).|participants|Number|21|21.0||||||
4330632|NCT00441337|4157754|B3|Stage IV||Stage of Malignancy at Screening Diagnosis|The investigator reported the screening malignancy stage for each type of cancer using the American Joint Committee on Cancer Classification (Stages I, II, III, and IV).|participants|Number|6|6.0||||||
4330633|NCT00441337|4157755|B2|Stage IV||Stage of Malignancy at Screening Diagnosis|The investigator reported the screening malignancy stage for each type of cancer using the American Joint Committee on Cancer Classification (Stages I, II, III, and IV).|participants|Number|6|6.0||||||
4330634|NCT00441337|4157756|B1|Stage IV||Stage of Malignancy at Screening Diagnosis|The investigator reported the screening malignancy stage for each type of cancer using the American Joint Committee on Cancer Classification (Stages I, II, III, and IV).|participants|Number|5|5.0||||||
4330635|NCT00441337|4157752|B5|Stage III||Stage of Malignancy at Screening Diagnosis|The investigator reported the screening malignancy stage for each type of cancer using the American Joint Committee on Cancer Classification (Stages I, II, III, and IV).|participants|Number|1|1.0||||||
4330636|NCT00441337|4157753|B4|Stage III||Stage of Malignancy at Screening Diagnosis|The investigator reported the screening malignancy stage for each type of cancer using the American Joint Committee on Cancer Classification (Stages I, II, III, and IV).|participants|Number|0|0.0||||||
4330637|NCT00441337|4157754|B3|Stage III||Stage of Malignancy at Screening Diagnosis|The investigator reported the screening malignancy stage for each type of cancer using the American Joint Committee on Cancer Classification (Stages I, II, III, and IV).|participants|Number|0|0.0||||||
4330638|NCT00441337|4157755|B2|Stage III||Stage of Malignancy at Screening Diagnosis|The investigator reported the screening malignancy stage for each type of cancer using the American Joint Committee on Cancer Classification (Stages I, II, III, and IV).|participants|Number|0|0.0||||||
4330639|NCT00441337|4157756|B1|Stage III||Stage of Malignancy at Screening Diagnosis|The investigator reported the screening malignancy stage for each type of cancer using the American Joint Committee on Cancer Classification (Stages I, II, III, and IV).|participants|Number|1|1.0||||||
4330640|NCT00441337|4157752|B5|Stage II||Stage of Malignancy at Screening Diagnosis|The investigator reported the screening malignancy stage for each type of cancer using the American Joint Committee on Cancer Classification (Stages I, II, III, and IV).|participants|Number|0|0.0||||||
4330641|NCT00441337|4157753|B4|Stage II||Stage of Malignancy at Screening Diagnosis|The investigator reported the screening malignancy stage for each type of cancer using the American Joint Committee on Cancer Classification (Stages I, II, III, and IV).|participants|Number|0|0.0||||||
4330642|NCT00441337|4157754|B3|Stage II||Stage of Malignancy at Screening Diagnosis|The investigator reported the screening malignancy stage for each type of cancer using the American Joint Committee on Cancer Classification (Stages I, II, III, and IV).|participants|Number|0|0.0||||||
4330643|NCT00441337|4157755|B2|Stage II||Stage of Malignancy at Screening Diagnosis|The investigator reported the screening malignancy stage for each type of cancer using the American Joint Committee on Cancer Classification (Stages I, II, III, and IV).|participants|Number|0|0.0||||||
4330644|NCT00441337|4157756|B1|Stage II||Stage of Malignancy at Screening Diagnosis|The investigator reported the screening malignancy stage for each type of cancer using the American Joint Committee on Cancer Classification (Stages I, II, III, and IV).|participants|Number|0|0.0||||||
4330645|NCT00441337|4157752|B5|Stage I||Stage of Malignancy at Screening Diagnosis|The investigator reported the screening malignancy stage for each type of cancer using the American Joint Committee on Cancer Classification (Stages I, II, III, and IV).|participants|Number|0|0.0||||||
4330646|NCT00441337|4157753|B4|Stage I||Stage of Malignancy at Screening Diagnosis|The investigator reported the screening malignancy stage for each type of cancer using the American Joint Committee on Cancer Classification (Stages I, II, III, and IV).|participants|Number|0|0.0||||||
4330647|NCT00441337|4157754|B3|Stage I||Stage of Malignancy at Screening Diagnosis|The investigator reported the screening malignancy stage for each type of cancer using the American Joint Committee on Cancer Classification (Stages I, II, III, and IV).|participants|Number|0|0.0||||||
4330648|NCT00441337|4157755|B2|Stage I||Stage of Malignancy at Screening Diagnosis|The investigator reported the screening malignancy stage for each type of cancer using the American Joint Committee on Cancer Classification (Stages I, II, III, and IV).|participants|Number|0|0.0||||||
4330649|NCT00441337|4157756|B1|Stage I||Stage of Malignancy at Screening Diagnosis|The investigator reported the screening malignancy stage for each type of cancer using the American Joint Committee on Cancer Classification (Stages I, II, III, and IV).|participants|Number|0|0.0||||||
4330650|NCT00441337|4157752|B5|Colorectal cancer||Type of Malignancy||participants|Number|14|14.0||||||
4330651|NCT00441337|4157753|B4|Colorectal cancer||Type of Malignancy||participants|Number|5|5.0||||||
4330652|NCT00441337|4157754|B3|Colorectal cancer||Type of Malignancy||participants|Number|2|2.0||||||
4330653|NCT00441337|4157755|B2|Colorectal cancer||Type of Malignancy||participants|Number|2|2.0||||||
4330654|NCT00441337|4157756|B1|Colorectal cancer||Type of Malignancy||participants|Number|5|5.0||||||
4330655|NCT00441337|4157752|B5|Renal cell cancer||Type of Malignancy||participants|Number|1|1.0||||||
4330656|NCT00441337|4157753|B4|Renal cell cancer||Type of Malignancy||participants|Number|1|1.0||||||
4330657|NCT00441337|4157754|B3|Renal cell cancer||Type of Malignancy||participants|Number|0|0.0||||||
4330658|NCT00441337|4157755|B2|Renal cell cancer||Type of Malignancy||participants|Number|0|0.0||||||
4330659|NCT00441337|4157756|B1|Renal cell cancer||Type of Malignancy||participants|Number|0|0.0||||||
4330660|NCT00441337|4157752|B5|Non-small cell lung cancer||Type of Malignancy||participants|Number|6|6.0||||||
4330661|NCT00441337|4157753|B4|Non-small cell lung cancer||Type of Malignancy||participants|Number|2|2.0||||||
4330662|NCT00441337|4157754|B3|Non-small cell lung cancer||Type of Malignancy||participants|Number|2|2.0||||||
4330663|NCT00441337|4157755|B2|Non-small cell lung cancer||Type of Malignancy||participants|Number|1|1.0||||||
4330664|NCT00441337|4157756|B1|Non-small cell lung cancer||Type of Malignancy||participants|Number|1|1.0||||||
4330665|NCT00441337|4157752|B5|Melanoma||Type of Malignancy||participants|Number|10|10.0||||||
4330666|NCT00441337|4157753|B4|Melanoma||Type of Malignancy||participants|Number|8|8.0||||||
4330667|NCT00441337|4157754|B3|Melanoma||Type of Malignancy||participants|Number|0|0.0||||||
4330668|NCT00441337|4157755|B2|Melanoma||Type of Malignancy||participants|Number|2|2.0||||||
4330669|NCT00441337|4157756|B1|Melanoma||Type of Malignancy||participants|Number|0|0.0||||||
4330670|NCT00441337|4157752|B5|Prostate Cancer||Type of Malignancy||participants|Number|8|8.0||||||
4330671|NCT00441337|4157753|B4|Prostate Cancer||Type of Malignancy||participants|Number|5|5.0||||||
4330672|NCT00441337|4157754|B3|Prostate Cancer||Type of Malignancy||participants|Number|2|2.0||||||
4330673|NCT00441337|4157755|B2|Prostate Cancer||Type of Malignancy||participants|Number|1|1.0||||||
4330674|NCT00441337|4157756|B1|Prostate Cancer||Type of Malignancy||participants|Number|0|0.0||||||
4330675|NCT00441337|4157752|B5|||Time since initial diagnosis (years)||Years|Median|3.8|3.8|Full Range|||0.7|19.8|
4330676|NCT00441337|4157753|B4|||Time since initial diagnosis (years)||Years|Median|4.1|4.1|Full Range|||1.0|19.8|
4330677|NCT00441337|4157754|B3|||Time since initial diagnosis (years)||Years|Median|5.6|5.6|Full Range|||0.7|11.4|
4330678|NCT00441337|4157755|B2|||Time since initial diagnosis (years)||Years|Median|2.7|2.7|Full Range|||1.5|14.0|
4330679|NCT00441337|4157756|B1|||Time since initial diagnosis (years)||Years|Median|3.7|3.7|Full Range|||1.4|6.8|
4330680|NCT00441337|4157752|B5|||Body Weight in kilograms (kg)||kg|Median|81.3|81.3|Full Range|||55.0|136.0|
4330681|NCT00441337|4157753|B4|||Body Weight in kilograms (kg)||kg|Median|81.3|81.3|Full Range|||56.0|118.0|
4330682|NCT00441337|4157754|B3|||Body Weight in kilograms (kg)||kg|Median|81.9|81.9|Full Range|||55.0|98.0|
4330683|NCT00441337|4157755|B2|||Body Weight in kilograms (kg)||kg|Median|73.9|73.9|Full Range|||62.0|80.0|
4330684|NCT00441337|4157756|B1|||Body Weight in kilograms (kg)||kg|Median|96.8|96.8|Full Range|||88.0|136.0|
4330685|NCT00441337|4157752|B5|United States||Region of Enrollment||participants|Number|39|39.0||||||
4330686|NCT00441337|4157753|B4|United States||Region of Enrollment||participants|Number|21|21.0||||||
4330687|NCT00441337|4157754|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4330688|NCT00441337|4157755|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4330689|NCT00441337|4157756|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4330690|NCT00441337|4157752|B5|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4330691|NCT00441337|4157753|B4|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4330692|NCT00441337|4157754|B3|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4330693|NCT00441337|4157755|B2|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4330694|NCT00441337|4157756|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4330695|NCT00441337|4157752|B5|White||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4330696|NCT00441337|4157753|B4|White||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4330697|NCT00441337|4157754|B3|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4330698|NCT00441337|4157755|B2|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4330699|NCT00441337|4157756|B1|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4330700|NCT00441337|4157752|B5||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4330701|NCT00441337|4157753|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4330702|NCT00441337|4157754|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4330703|NCT00441337|4157755|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4330704|NCT00441337|4157756|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4330705|NCT00441337|4157752|B5||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4330706|NCT00441337|4157753|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4330707|NCT00441337|4157754|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4330708|NCT00441337|4157755|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4330709|NCT00441337|4157756|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4330710|NCT00441337|4157752|B5|||Age||years|Mean|62.6|62.6|Standard Deviation|9.7|9.7|||
4330711|NCT00441337|4157753|B4|||Age||years|Mean|63.2|63.2|Standard Deviation|10.0|10.0|||
4330712|NCT00441337|4157754|B3|||Age||years|Mean|61.0|61.0|Standard Deviation|10.4|10.4|||
4330713|NCT00441337|4157755|B2|||Age||years|Mean|68.3|68.3|Standard Deviation|9.4|9.4|||
4330714|NCT00441337|4157756|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|5.7|5.7|||
4330715|NCT00441285|4157837|B6|Peru||Region of Enrollment||participants|Number|156|156.0||||||
4330716|NCT00441285|4157838|B5|Peru||Region of Enrollment||participants|Number|43|43.0||||||
4330717|NCT00441285|4157839|B4|Peru||Region of Enrollment||participants|Number|40|40.0||||||
4330718|NCT00441285|4157840|B3|Peru||Region of Enrollment||participants|Number|41|41.0||||||
4330719|NCT00441285|4157841|B2|Peru||Region of Enrollment||participants|Number|16|16.0||||||
4330720|NCT00441285|4157842|B1|Peru||Region of Enrollment||participants|Number|16|16.0||||||
4330721|NCT00441285|4157837|B6||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4330722|NCT00441285|4157838|B5||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4330723|NCT00441285|4157839|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4330724|NCT00441285|4157840|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4330725|NCT00441285|4157841|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4330726|NCT00441285|4157842|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4330727|NCT00441285|4157837|B6||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4330728|NCT00441285|4157838|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4330729|NCT00441285|4157839|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4330730|NCT00441285|4157840|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4330731|NCT00441285|4157841|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4330732|NCT00441285|4157842|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4330733|NCT00441285|4157837|B6|||Age||years|Mean|28|28.0|Standard Deviation|10.2|10.2|||
4330734|NCT00441285|4157838|B5|||Age||years|Mean|35|35.0|Standard Deviation|13|13.0|||
4330735|NCT00441285|4157839|B4|||Age||years|Mean|34|34.0|Standard Deviation|12|12.0|||
4330736|NCT00441285|4157840|B3|||Age||years|Mean|34|34.0|Standard Deviation|14|14.0|||
4330737|NCT00441285|4157841|B2|||Age||years|Mean|27.5|27.5|Standard Deviation|11|11.0|||
4330738|NCT00441285|4157842|B1|||Age||years|Mean|29.3|29.3|Standard Deviation|9.7|9.7|||
4330739|NCT00441285|4157837|B6||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4330740|NCT00441285|4157838|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4330741|NCT00441285|4157839|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4330742|NCT00441285|4157840|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4330743|NCT00441285|4157841|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4330744|NCT00441285|4157842|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4330745|NCT00441285|4157837|B6||Between 18 and 65 years|Age||Participants|Count of Participants|146|146.0||||||
4330746|NCT00441285|4157838|B5||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4330747|NCT00441285|4157839|B4||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4330748|NCT00441285|4157840|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4330749|NCT00441285|4157841|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4330750|NCT00441285|4157842|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4330751|NCT00441285|4157837|B6||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4330752|NCT00441285|4157838|B5||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4330753|NCT00441285|4157839|B4||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4330754|NCT00441285|4157840|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4330755|NCT00441285|4157841|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4330756|NCT00441285|4157842|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4330757|NCT00441272|4157870|B3|United States||Region of Enrollment||participants|Number|50.0|50.0||||||
4330758|NCT00441272|4157871|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4330759|NCT00441272|4157872|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4330760|NCT00441272|4157870|B3||Male|Sex: Female, Male||Participants|Count of Participants|25.0|25.0||||||
4330761|NCT00441272|4157871|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4330762|NCT00441272|4157872|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4330763|NCT00441272|4157870|B3||Female|Sex: Female, Male||Participants|Count of Participants|25.0|25.0||||||
4330764|NCT00441272|4157871|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4330765|NCT00441272|4157872|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4330766|NCT00441272|4157870|B3|||Age||years|Mean|40|40.0|Standard Deviation|5|5.0|||
4330767|NCT00441272|4157871|B2|||Age||years|Mean|40|40.0|Standard Deviation|5|5.0|||
4330768|NCT00441272|4157872|B1|||Age||years|Mean|40|40.0|Standard Deviation|5|5.0|||
4330769|NCT00441272|4157870|B3||>=65 years|Age||Participants|Count of Participants|0.0|0.0||||||
4330770|NCT00441272|4157871|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4330771|NCT00441272|4157872|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4330772|NCT00441272|4157870|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50.0|50.0||||||
4330773|NCT00441272|4157871|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4330774|NCT00441272|4157872|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4330775|NCT00441272|4157870|B3||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4330776|NCT00441272|4157871|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4330777|NCT00441272|4157872|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4330778|NCT00441259|4157879|B3|India||Region of Enrollment||Participants|Number|96|96.0||||||
4330779|NCT00441259|4157880|B2|India||Region of Enrollment||Participants|Number|48|48.0||||||
4330780|NCT00441259|4157881|B1|India||Region of Enrollment||Participants|Number|48|48.0||||||
4330781|NCT00441259|4157879|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4330782|NCT00441259|4157880|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4330783|NCT00441259|4157881|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4330784|NCT00441259|4157879|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4330785|NCT00441259|4157880|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4330786|NCT00441259|4157881|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4330787|NCT00441259|4157879|B3|||Age||Years|Mean|3.7|3.7|Standard Deviation|2.52|2.52|||
4330788|NCT00441259|4157880|B2|||Age||Years|Mean|3.7|3.7|Standard Deviation|2.89|2.89|||
4330789|NCT00441259|4157881|B1|||Age||Years|Mean|3.8|3.8|Standard Deviation|2.98|2.98|||
4330790|NCT00441259|4157879|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4330791|NCT00441259|4157880|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4330792|NCT00441259|4157881|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4330793|NCT00441259|4157879|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4330794|NCT00441259|4157880|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4330795|NCT00441259|4157881|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4330796|NCT00441259|4157879|B3||<=18 years|Age||Participants|Count of Participants|96|96.0||||||
4330797|NCT00441259|4157880|B2||<=18 years|Age||Participants|Count of Participants|48|48.0||||||
4330798|NCT00441259|4157881|B1||<=18 years|Age||Participants|Count of Participants|48|48.0||||||
4330799|NCT00441168|4157898|B3|||Weight||kg|Mean|77.0|77.0|Standard Deviation|15.0|15.0|||
4330800|NCT00441168|4157899|B2|||Weight||kg|Mean|78.3|78.3|Standard Deviation|14.5|14.5|||
4330801|NCT00441168|4157900|B1|||Weight||kg|Mean|75.9|75.9|Standard Deviation|15.7|15.7|||
4330802|NCT00441168|4157898|B3|||Height||cm|Mean|169.3|169.3|Standard Deviation|10.3|10.3|||
4330803|NCT00441168|4157899|B2|||Height||cm|Mean|169.8|169.8|Standard Deviation|9.5|9.5|||
4330804|NCT00441168|4157900|B1|||Height||cm|Mean|168.8|168.8|Standard Deviation|11.2|11.2|||
4330805|NCT00441168|4157898|B3|||Body Surface Area||m2|Mean|1.886|1.886|Standard Deviation|0.226|0.226|||
4330806|NCT00441168|4157899|B2|||Body Surface Area||m2|Mean|1.924|1.924|Standard Deviation|0.219|0.219|||
4330807|NCT00441168|4157900|B1|||Body Surface Area||m2|Mean|1.855|1.855|Standard Deviation|0.233|0.233|||
4330808|NCT00441168|4157898|B3|100||Karnofsky Performance Status|A standard way of measuring the ability of cancer patients to perform ordinary tasks. The Karnofsky Performance Scores (KPS) range from 0 to 100. A higher score means the patient is better able to carry out daily activities. KPS may be used to determine a patient's prognosis, to measure changes in a patient’s ability to function, or to decide if a patient could be included in a clinical trial.|participants|Number|3|3.0||||||
4330809|NCT00441168|4157899|B2|100||Karnofsky Performance Status|A standard way of measuring the ability of cancer patients to perform ordinary tasks. The Karnofsky Performance Scores (KPS) range from 0 to 100. A higher score means the patient is better able to carry out daily activities. KPS may be used to determine a patient's prognosis, to measure changes in a patient’s ability to function, or to decide if a patient could be included in a clinical trial.|participants|Number|3|3.0||||||
4330810|NCT00441168|4157900|B1|100||Karnofsky Performance Status|A standard way of measuring the ability of cancer patients to perform ordinary tasks. The Karnofsky Performance Scores (KPS) range from 0 to 100. A higher score means the patient is better able to carry out daily activities. KPS may be used to determine a patient's prognosis, to measure changes in a patient’s ability to function, or to decide if a patient could be included in a clinical trial.|participants|Number|0|0.0||||||
4330827|NCT00441168|4157899|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330828|NCT00441168|4157900|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330829|NCT00441168|4157898|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330811|NCT00441168|4157898|B3|90||Karnofsky Performance Status|A standard way of measuring the ability of cancer patients to perform ordinary tasks. The Karnofsky Performance Scores (KPS) range from 0 to 100. A higher score means the patient is better able to carry out daily activities. KPS may be used to determine a patient's prognosis, to measure changes in a patient’s ability to function, or to decide if a patient could be included in a clinical trial.|participants|Number|8|8.0||||||
4330812|NCT00441168|4157899|B2|90||Karnofsky Performance Status|A standard way of measuring the ability of cancer patients to perform ordinary tasks. The Karnofsky Performance Scores (KPS) range from 0 to 100. A higher score means the patient is better able to carry out daily activities. KPS may be used to determine a patient's prognosis, to measure changes in a patient’s ability to function, or to decide if a patient could be included in a clinical trial.|participants|Number|3|3.0||||||
4330813|NCT00441168|4157900|B1|90||Karnofsky Performance Status|A standard way of measuring the ability of cancer patients to perform ordinary tasks. The Karnofsky Performance Scores (KPS) range from 0 to 100. A higher score means the patient is better able to carry out daily activities. KPS may be used to determine a patient's prognosis, to measure changes in a patient’s ability to function, or to decide if a patient could be included in a clinical trial.|participants|Number|5|5.0||||||
4330814|NCT00441168|4157898|B3|80||Karnofsky Performance Status|A standard way of measuring the ability of cancer patients to perform ordinary tasks. The Karnofsky Performance Scores (KPS) range from 0 to 100. A higher score means the patient is better able to carry out daily activities. KPS may be used to determine a patient's prognosis, to measure changes in a patient’s ability to function, or to decide if a patient could be included in a clinical trial.|participants|Number|12|12.0||||||
4330815|NCT00441168|4157899|B2|80||Karnofsky Performance Status|A standard way of measuring the ability of cancer patients to perform ordinary tasks. The Karnofsky Performance Scores (KPS) range from 0 to 100. A higher score means the patient is better able to carry out daily activities. KPS may be used to determine a patient's prognosis, to measure changes in a patient’s ability to function, or to decide if a patient could be included in a clinical trial.|participants|Number|3|3.0||||||
4330816|NCT00441168|4157900|B1|80||Karnofsky Performance Status|A standard way of measuring the ability of cancer patients to perform ordinary tasks. The Karnofsky Performance Scores (KPS) range from 0 to 100. A higher score means the patient is better able to carry out daily activities. KPS may be used to determine a patient's prognosis, to measure changes in a patient’s ability to function, or to decide if a patient could be included in a clinical trial.|participants|Number|9|9.0||||||
4330817|NCT00441168|4157898|B3|70||Karnofsky Performance Status|A standard way of measuring the ability of cancer patients to perform ordinary tasks. The Karnofsky Performance Scores (KPS) range from 0 to 100. A higher score means the patient is better able to carry out daily activities. KPS may be used to determine a patient's prognosis, to measure changes in a patient’s ability to function, or to decide if a patient could be included in a clinical trial.|participants|Number|4|4.0||||||
4330818|NCT00441168|4157899|B2|70||Karnofsky Performance Status|A standard way of measuring the ability of cancer patients to perform ordinary tasks. The Karnofsky Performance Scores (KPS) range from 0 to 100. A higher score means the patient is better able to carry out daily activities. KPS may be used to determine a patient's prognosis, to measure changes in a patient’s ability to function, or to decide if a patient could be included in a clinical trial.|participants|Number|3|3.0||||||
4330819|NCT00441168|4157900|B1|70||Karnofsky Performance Status|A standard way of measuring the ability of cancer patients to perform ordinary tasks. The Karnofsky Performance Scores (KPS) range from 0 to 100. A higher score means the patient is better able to carry out daily activities. KPS may be used to determine a patient's prognosis, to measure changes in a patient’s ability to function, or to decide if a patient could be included in a clinical trial.|participants|Number|1|1.0||||||
4330820|NCT00441168|4157898|B3|60||Karnofsky Performance Status|A standard way of measuring the ability of cancer patients to perform ordinary tasks. The Karnofsky Performance Scores (KPS) range from 0 to 100. A higher score means the patient is better able to carry out daily activities. KPS may be used to determine a patient's prognosis, to measure changes in a patient’s ability to function, or to decide if a patient could be included in a clinical trial.|participants|Number|2|2.0||||||
4330821|NCT00441168|4157899|B2|60||Karnofsky Performance Status|A standard way of measuring the ability of cancer patients to perform ordinary tasks. The Karnofsky Performance Scores (KPS) range from 0 to 100. A higher score means the patient is better able to carry out daily activities. KPS may be used to determine a patient's prognosis, to measure changes in a patient’s ability to function, or to decide if a patient could be included in a clinical trial.|participants|Number|1|1.0||||||
4330822|NCT00441168|4157900|B1|60||Karnofsky Performance Status|A standard way of measuring the ability of cancer patients to perform ordinary tasks. The Karnofsky Performance Scores (KPS) range from 0 to 100. A higher score means the patient is better able to carry out daily activities. KPS may be used to determine a patient's prognosis, to measure changes in a patient’s ability to function, or to decide if a patient could be included in a clinical trial.|participants|Number|1|1.0||||||
4330823|NCT00441168|4157898|B3|≤50||Karnofsky Performance Status|A standard way of measuring the ability of cancer patients to perform ordinary tasks. The Karnofsky Performance Scores (KPS) range from 0 to 100. A higher score means the patient is better able to carry out daily activities. KPS may be used to determine a patient's prognosis, to measure changes in a patient’s ability to function, or to decide if a patient could be included in a clinical trial.|participants|Number|0|0.0||||||
4330824|NCT00441168|4157899|B2|≤50||Karnofsky Performance Status|A standard way of measuring the ability of cancer patients to perform ordinary tasks. The Karnofsky Performance Scores (KPS) range from 0 to 100. A higher score means the patient is better able to carry out daily activities. KPS may be used to determine a patient's prognosis, to measure changes in a patient’s ability to function, or to decide if a patient could be included in a clinical trial.|participants|Number|0|0.0||||||
4330825|NCT00441168|4157900|B1|≤50||Karnofsky Performance Status|A standard way of measuring the ability of cancer patients to perform ordinary tasks. The Karnofsky Performance Scores (KPS) range from 0 to 100. A higher score means the patient is better able to carry out daily activities. KPS may be used to determine a patient's prognosis, to measure changes in a patient’s ability to function, or to decide if a patient could be included in a clinical trial.|participants|Number|0|0.0||||||
4330826|NCT00441168|4157898|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330956|NCT00441116|4157947|B3||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4330830|NCT00441168|4157899|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330831|NCT00441168|4157900|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330832|NCT00441168|4157898|B3||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4330833|NCT00441168|4157899|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4330834|NCT00441168|4157900|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4330835|NCT00441168|4157898|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330836|NCT00441168|4157899|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330837|NCT00441168|4157900|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330838|NCT00441168|4157898|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330839|NCT00441168|4157899|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330840|NCT00441168|4157900|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330841|NCT00441168|4157898|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330842|NCT00441168|4157899|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330843|NCT00441168|4157900|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330844|NCT00441168|4157898|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330845|NCT00441168|4157899|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330846|NCT00441168|4157900|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330847|NCT00441168|4157898|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4330848|NCT00441168|4157899|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4330849|NCT00441168|4157900|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4330850|NCT00441168|4157898|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4330851|NCT00441168|4157899|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4330852|NCT00441168|4157900|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4330853|NCT00441168|4157898|B3|||Age||years|Mean|62.9|62.9|Standard Deviation|10.2|10.2|||
4330854|NCT00441168|4157899|B2|||Age||years|Mean|61.5|61.5|Standard Deviation|11.3|11.3|||
4330855|NCT00441168|4157900|B1|||Age||years|Mean|64.0|64.0|Standard Deviation|9.4|9.4|||
4330856|NCT00441142|4157911|B5|60||Baseline (Day 1) Karnofsky Performance Score (KPS)|100 Normal; no complaints/evidence of dz 90 Able to carry on normal activity; minor signs/symptoms of dz 80 Normal activity w/ effort; some sign/symptoms of dz 70 Cares for self; unable to carry on normal activity or do active work 60 Requires occasional assistance, but able to care for most personal needs 50 Requires considerable assistance & frequent medical care 40 Disabled; requires special care & assistance 30 Severely disabled; hosp indicated, although death not imminent 20 Very sick; hosp & active support tx necessary 10 Moribund; fatal processes progressing rapidly 0 Dead|Participants|Number|4|4.0||||||
4330857|NCT00441142|4157912|B4|60||Baseline (Day 1) Karnofsky Performance Score (KPS)|100 Normal; no complaints/evidence of dz 90 Able to carry on normal activity; minor signs/symptoms of dz 80 Normal activity w/ effort; some sign/symptoms of dz 70 Cares for self; unable to carry on normal activity or do active work 60 Requires occasional assistance, but able to care for most personal needs 50 Requires considerable assistance & frequent medical care 40 Disabled; requires special care & assistance 30 Severely disabled; hosp indicated, although death not imminent 20 Very sick; hosp & active support tx necessary 10 Moribund; fatal processes progressing rapidly 0 Dead|Participants|Number|2|2.0||||||
4330858|NCT00441142|4157913|B3|60||Baseline (Day 1) Karnofsky Performance Score (KPS)|100 Normal; no complaints/evidence of dz 90 Able to carry on normal activity; minor signs/symptoms of dz 80 Normal activity w/ effort; some sign/symptoms of dz 70 Cares for self; unable to carry on normal activity or do active work 60 Requires occasional assistance, but able to care for most personal needs 50 Requires considerable assistance & frequent medical care 40 Disabled; requires special care & assistance 30 Severely disabled; hosp indicated, although death not imminent 20 Very sick; hosp & active support tx necessary 10 Moribund; fatal processes progressing rapidly 0 Dead|Participants|Number|2|2.0||||||
4330859|NCT00441142|4157914|B2|60||Baseline (Day 1) Karnofsky Performance Score (KPS)|100 Normal; no complaints/evidence of dz 90 Able to carry on normal activity; minor signs/symptoms of dz 80 Normal activity w/ effort; some sign/symptoms of dz 70 Cares for self; unable to carry on normal activity or do active work 60 Requires occasional assistance, but able to care for most personal needs 50 Requires considerable assistance & frequent medical care 40 Disabled; requires special care & assistance 30 Severely disabled; hosp indicated, although death not imminent 20 Very sick; hosp & active support tx necessary 10 Moribund; fatal processes progressing rapidly 0 Dead|Participants|Number|0|0.0||||||
4330860|NCT00441142|4157915|B1|60||Baseline (Day 1) Karnofsky Performance Score (KPS)|100 Normal; no complaints/evidence of dz 90 Able to carry on normal activity; minor signs/symptoms of dz 80 Normal activity w/ effort; some sign/symptoms of dz 70 Cares for self; unable to carry on normal activity or do active work 60 Requires occasional assistance, but able to care for most personal needs 50 Requires considerable assistance & frequent medical care 40 Disabled; requires special care & assistance 30 Severely disabled; hosp indicated, although death not imminent 20 Very sick; hosp & active support tx necessary 10 Moribund; fatal processes progressing rapidly 0 Dead|Participants|Number|0|0.0||||||
4330861|NCT00441142|4157911|B5|70||Baseline (Day 1) Karnofsky Performance Score (KPS)|100 Normal; no complaints/evidence of dz 90 Able to carry on normal activity; minor signs/symptoms of dz 80 Normal activity w/ effort; some sign/symptoms of dz 70 Cares for self; unable to carry on normal activity or do active work 60 Requires occasional assistance, but able to care for most personal needs 50 Requires considerable assistance & frequent medical care 40 Disabled; requires special care & assistance 30 Severely disabled; hosp indicated, although death not imminent 20 Very sick; hosp & active support tx necessary 10 Moribund; fatal processes progressing rapidly 0 Dead|Participants|Number|11|11.0||||||
4330862|NCT00441142|4157912|B4|70||Baseline (Day 1) Karnofsky Performance Score (KPS)|100 Normal; no complaints/evidence of dz 90 Able to carry on normal activity; minor signs/symptoms of dz 80 Normal activity w/ effort; some sign/symptoms of dz 70 Cares for self; unable to carry on normal activity or do active work 60 Requires occasional assistance, but able to care for most personal needs 50 Requires considerable assistance & frequent medical care 40 Disabled; requires special care & assistance 30 Severely disabled; hosp indicated, although death not imminent 20 Very sick; hosp & active support tx necessary 10 Moribund; fatal processes progressing rapidly 0 Dead|Participants|Number|5|5.0||||||
4330863|NCT00441142|4157913|B3|70||Baseline (Day 1) Karnofsky Performance Score (KPS)|100 Normal; no complaints/evidence of dz 90 Able to carry on normal activity; minor signs/symptoms of dz 80 Normal activity w/ effort; some sign/symptoms of dz 70 Cares for self; unable to carry on normal activity or do active work 60 Requires occasional assistance, but able to care for most personal needs 50 Requires considerable assistance & frequent medical care 40 Disabled; requires special care & assistance 30 Severely disabled; hosp indicated, although death not imminent 20 Very sick; hosp & active support tx necessary 10 Moribund; fatal processes progressing rapidly 0 Dead|Participants|Number|3|3.0||||||
4330864|NCT00441142|4157914|B2|70||Baseline (Day 1) Karnofsky Performance Score (KPS)|100 Normal; no complaints/evidence of dz 90 Able to carry on normal activity; minor signs/symptoms of dz 80 Normal activity w/ effort; some sign/symptoms of dz 70 Cares for self; unable to carry on normal activity or do active work 60 Requires occasional assistance, but able to care for most personal needs 50 Requires considerable assistance & frequent medical care 40 Disabled; requires special care & assistance 30 Severely disabled; hosp indicated, although death not imminent 20 Very sick; hosp & active support tx necessary 10 Moribund; fatal processes progressing rapidly 0 Dead|Participants|Number|0|0.0||||||
4330865|NCT00441142|4157915|B1|70||Baseline (Day 1) Karnofsky Performance Score (KPS)|100 Normal; no complaints/evidence of dz 90 Able to carry on normal activity; minor signs/symptoms of dz 80 Normal activity w/ effort; some sign/symptoms of dz 70 Cares for self; unable to carry on normal activity or do active work 60 Requires occasional assistance, but able to care for most personal needs 50 Requires considerable assistance & frequent medical care 40 Disabled; requires special care & assistance 30 Severely disabled; hosp indicated, although death not imminent 20 Very sick; hosp & active support tx necessary 10 Moribund; fatal processes progressing rapidly 0 Dead|Participants|Number|3|3.0||||||
4330866|NCT00441142|4157911|B5|80||Baseline (Day 1) Karnofsky Performance Score (KPS)|100 Normal; no complaints/evidence of dz 90 Able to carry on normal activity; minor signs/symptoms of dz 80 Normal activity w/ effort; some sign/symptoms of dz 70 Cares for self; unable to carry on normal activity or do active work 60 Requires occasional assistance, but able to care for most personal needs 50 Requires considerable assistance & frequent medical care 40 Disabled; requires special care & assistance 30 Severely disabled; hosp indicated, although death not imminent 20 Very sick; hosp & active support tx necessary 10 Moribund; fatal processes progressing rapidly 0 Dead|Participants|Number|20|20.0||||||
4330867|NCT00441142|4157912|B4|80||Baseline (Day 1) Karnofsky Performance Score (KPS)|100 Normal; no complaints/evidence of dz 90 Able to carry on normal activity; minor signs/symptoms of dz 80 Normal activity w/ effort; some sign/symptoms of dz 70 Cares for self; unable to carry on normal activity or do active work 60 Requires occasional assistance, but able to care for most personal needs 50 Requires considerable assistance & frequent medical care 40 Disabled; requires special care & assistance 30 Severely disabled; hosp indicated, although death not imminent 20 Very sick; hosp & active support tx necessary 10 Moribund; fatal processes progressing rapidly 0 Dead|Participants|Number|17|17.0||||||
4330868|NCT00441142|4157913|B3|80||Baseline (Day 1) Karnofsky Performance Score (KPS)|100 Normal; no complaints/evidence of dz 90 Able to carry on normal activity; minor signs/symptoms of dz 80 Normal activity w/ effort; some sign/symptoms of dz 70 Cares for self; unable to carry on normal activity or do active work 60 Requires occasional assistance, but able to care for most personal needs 50 Requires considerable assistance & frequent medical care 40 Disabled; requires special care & assistance 30 Severely disabled; hosp indicated, although death not imminent 20 Very sick; hosp & active support tx necessary 10 Moribund; fatal processes progressing rapidly 0 Dead|Participants|Number|2|2.0||||||
4330869|NCT00441142|4157914|B2|80||Baseline (Day 1) Karnofsky Performance Score (KPS)|100 Normal; no complaints/evidence of dz 90 Able to carry on normal activity; minor signs/symptoms of dz 80 Normal activity w/ effort; some sign/symptoms of dz 70 Cares for self; unable to carry on normal activity or do active work 60 Requires occasional assistance, but able to care for most personal needs 50 Requires considerable assistance & frequent medical care 40 Disabled; requires special care & assistance 30 Severely disabled; hosp indicated, although death not imminent 20 Very sick; hosp & active support tx necessary 10 Moribund; fatal processes progressing rapidly 0 Dead|Participants|Number|0|0.0||||||
4330870|NCT00441142|4157915|B1|80||Baseline (Day 1) Karnofsky Performance Score (KPS)|100 Normal; no complaints/evidence of dz 90 Able to carry on normal activity; minor signs/symptoms of dz 80 Normal activity w/ effort; some sign/symptoms of dz 70 Cares for self; unable to carry on normal activity or do active work 60 Requires occasional assistance, but able to care for most personal needs 50 Requires considerable assistance & frequent medical care 40 Disabled; requires special care & assistance 30 Severely disabled; hosp indicated, although death not imminent 20 Very sick; hosp & active support tx necessary 10 Moribund; fatal processes progressing rapidly 0 Dead|Participants|Number|1|1.0||||||
4330871|NCT00441142|4157911|B5|90||Baseline (Day 1) Karnofsky Performance Score (KPS)|100 Normal; no complaints/evidence of dz 90 Able to carry on normal activity; minor signs/symptoms of dz 80 Normal activity w/ effort; some sign/symptoms of dz 70 Cares for self; unable to carry on normal activity or do active work 60 Requires occasional assistance, but able to care for most personal needs 50 Requires considerable assistance & frequent medical care 40 Disabled; requires special care & assistance 30 Severely disabled; hosp indicated, although death not imminent 20 Very sick; hosp & active support tx necessary 10 Moribund; fatal processes progressing rapidly 0 Dead|Participants|Number|49|49.0||||||
4330872|NCT00441142|4157912|B4|90||Baseline (Day 1) Karnofsky Performance Score (KPS)|100 Normal; no complaints/evidence of dz 90 Able to carry on normal activity; minor signs/symptoms of dz 80 Normal activity w/ effort; some sign/symptoms of dz 70 Cares for self; unable to carry on normal activity or do active work 60 Requires occasional assistance, but able to care for most personal needs 50 Requires considerable assistance & frequent medical care 40 Disabled; requires special care & assistance 30 Severely disabled; hosp indicated, although death not imminent 20 Very sick; hosp & active support tx necessary 10 Moribund; fatal processes progressing rapidly 0 Dead|Participants|Number|30|30.0||||||
4330873|NCT00441142|4157913|B3|90||Baseline (Day 1) Karnofsky Performance Score (KPS)|100 Normal; no complaints/evidence of dz 90 Able to carry on normal activity; minor signs/symptoms of dz 80 Normal activity w/ effort; some sign/symptoms of dz 70 Cares for self; unable to carry on normal activity or do active work 60 Requires occasional assistance, but able to care for most personal needs 50 Requires considerable assistance & frequent medical care 40 Disabled; requires special care & assistance 30 Severely disabled; hosp indicated, although death not imminent 20 Very sick; hosp & active support tx necessary 10 Moribund; fatal processes progressing rapidly 0 Dead|Participants|Number|15|15.0||||||
4330874|NCT00441142|4157914|B2|90||Baseline (Day 1) Karnofsky Performance Score (KPS)|100 Normal; no complaints/evidence of dz 90 Able to carry on normal activity; minor signs/symptoms of dz 80 Normal activity w/ effort; some sign/symptoms of dz 70 Cares for self; unable to carry on normal activity or do active work 60 Requires occasional assistance, but able to care for most personal needs 50 Requires considerable assistance & frequent medical care 40 Disabled; requires special care & assistance 30 Severely disabled; hosp indicated, although death not imminent 20 Very sick; hosp & active support tx necessary 10 Moribund; fatal processes progressing rapidly 0 Dead|Participants|Number|2|2.0||||||
4330875|NCT00441142|4157915|B1|90||Baseline (Day 1) Karnofsky Performance Score (KPS)|100 Normal; no complaints/evidence of dz 90 Able to carry on normal activity; minor signs/symptoms of dz 80 Normal activity w/ effort; some sign/symptoms of dz 70 Cares for self; unable to carry on normal activity or do active work 60 Requires occasional assistance, but able to care for most personal needs 50 Requires considerable assistance & frequent medical care 40 Disabled; requires special care & assistance 30 Severely disabled; hosp indicated, although death not imminent 20 Very sick; hosp & active support tx necessary 10 Moribund; fatal processes progressing rapidly 0 Dead|Participants|Number|2|2.0||||||
4330876|NCT00441142|4157911|B5|100||Baseline (Day 1) Karnofsky Performance Score (KPS)|100 Normal; no complaints/evidence of dz 90 Able to carry on normal activity; minor signs/symptoms of dz 80 Normal activity w/ effort; some sign/symptoms of dz 70 Cares for self; unable to carry on normal activity or do active work 60 Requires occasional assistance, but able to care for most personal needs 50 Requires considerable assistance & frequent medical care 40 Disabled; requires special care & assistance 30 Severely disabled; hosp indicated, although death not imminent 20 Very sick; hosp & active support tx necessary 10 Moribund; fatal processes progressing rapidly 0 Dead|Participants|Number|27|27.0||||||
4330877|NCT00441142|4157912|B4|100||Baseline (Day 1) Karnofsky Performance Score (KPS)|100 Normal; no complaints/evidence of dz 90 Able to carry on normal activity; minor signs/symptoms of dz 80 Normal activity w/ effort; some sign/symptoms of dz 70 Cares for self; unable to carry on normal activity or do active work 60 Requires occasional assistance, but able to care for most personal needs 50 Requires considerable assistance & frequent medical care 40 Disabled; requires special care & assistance 30 Severely disabled; hosp indicated, although death not imminent 20 Very sick; hosp & active support tx necessary 10 Moribund; fatal processes progressing rapidly 0 Dead|Participants|Number|15|15.0||||||
4330878|NCT00441142|4157913|B3|100||Baseline (Day 1) Karnofsky Performance Score (KPS)|100 Normal; no complaints/evidence of dz 90 Able to carry on normal activity; minor signs/symptoms of dz 80 Normal activity w/ effort; some sign/symptoms of dz 70 Cares for self; unable to carry on normal activity or do active work 60 Requires occasional assistance, but able to care for most personal needs 50 Requires considerable assistance & frequent medical care 40 Disabled; requires special care & assistance 30 Severely disabled; hosp indicated, although death not imminent 20 Very sick; hosp & active support tx necessary 10 Moribund; fatal processes progressing rapidly 0 Dead|Participants|Number|7|7.0||||||
4330879|NCT00441142|4157914|B2|100||Baseline (Day 1) Karnofsky Performance Score (KPS)|100 Normal; no complaints/evidence of dz 90 Able to carry on normal activity; minor signs/symptoms of dz 80 Normal activity w/ effort; some sign/symptoms of dz 70 Cares for self; unable to carry on normal activity or do active work 60 Requires occasional assistance, but able to care for most personal needs 50 Requires considerable assistance & frequent medical care 40 Disabled; requires special care & assistance 30 Severely disabled; hosp indicated, although death not imminent 20 Very sick; hosp & active support tx necessary 10 Moribund; fatal processes progressing rapidly 0 Dead|Participants|Number|5|5.0||||||
4330880|NCT00441142|4157915|B1|100||Baseline (Day 1) Karnofsky Performance Score (KPS)|100 Normal; no complaints/evidence of dz 90 Able to carry on normal activity; minor signs/symptoms of dz 80 Normal activity w/ effort; some sign/symptoms of dz 70 Cares for self; unable to carry on normal activity or do active work 60 Requires occasional assistance, but able to care for most personal needs 50 Requires considerable assistance & frequent medical care 40 Disabled; requires special care & assistance 30 Severely disabled; hosp indicated, although death not imminent 20 Very sick; hosp & active support tx necessary 10 Moribund; fatal processes progressing rapidly 0 Dead|Participants|Number|0|0.0||||||
4330881|NCT00441142|4157911|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4330882|NCT00441142|4157912|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4330883|NCT00441142|4157913|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4330884|NCT00441142|4157914|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330885|NCT00441142|4157915|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330886|NCT00441142|4157911|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330887|NCT00441142|4157912|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330888|NCT00441142|4157913|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330889|NCT00441142|4157914|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330890|NCT00441142|4157915|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330891|NCT00441142|4157911|B5||White|Race (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
4330892|NCT00441142|4157912|B4||White|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4330893|NCT00441142|4157913|B3||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4330894|NCT00441142|4157914|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4330895|NCT00441142|4157915|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4330896|NCT00441142|4157911|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4330897|NCT00441142|4157912|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4330898|NCT00441142|4157913|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4330899|NCT00441142|4157914|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330900|NCT00441142|4157915|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330901|NCT00441142|4157911|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330902|NCT00441142|4157912|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330903|NCT00441142|4157913|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330904|NCT00441142|4157914|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330905|NCT00441142|4157915|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330906|NCT00441142|4157911|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4330907|NCT00441142|4157912|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4330908|NCT00441142|4157913|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4330909|NCT00441142|4157914|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330910|NCT00441142|4157915|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330911|NCT00441142|4157911|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330912|NCT00441142|4157912|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330913|NCT00441142|4157913|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330914|NCT00441142|4157914|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330915|NCT00441142|4157915|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4330916|NCT00441142|4157911|B5||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4330917|NCT00441142|4157912|B4||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4330918|NCT00441142|4157913|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4330919|NCT00441142|4157914|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4330920|NCT00441142|4157915|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4330921|NCT00441142|4157911|B5||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4330922|NCT00441142|4157912|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4330923|NCT00441142|4157913|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4330924|NCT00441142|4157914|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4330925|NCT00441142|4157915|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4330926|NCT00441142|4157911|B5||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4330927|NCT00441142|4157912|B4||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4330928|NCT00441142|4157913|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4330929|NCT00441142|4157914|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4330930|NCT00441142|4157915|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4330931|NCT00441142|4157911|B5||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
4330932|NCT00441142|4157912|B4||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4330933|NCT00441142|4157913|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4330934|NCT00441142|4157914|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4330935|NCT00441142|4157915|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4330936|NCT00441142|4157911|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4330937|NCT00441142|4157912|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4330938|NCT00441142|4157913|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4330939|NCT00441142|4157914|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4330940|NCT00441142|4157915|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4330941|NCT00441129|4157934|B3|France||Region of Enrollment||participants|Number|115|115.0||||||
4330942|NCT00441129|4157935|B2|France||Region of Enrollment||participants|Number|55|55.0||||||
4330943|NCT00441129|4157936|B1|France||Region of Enrollment||participants|Number|60|60.0||||||
4330944|NCT00441129|4157934|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4330945|NCT00441129|4157935|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4330946|NCT00441129|4157936|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4330947|NCT00441129|4157934|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4330948|NCT00441129|4157935|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4330949|NCT00441129|4157936|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4330950|NCT00441129|4157934|B3|||Age||years|Mean|28.5|28.5|Standard Deviation|15.9|15.9|||
4330951|NCT00441129|4157935|B2|||Age||years|Mean|28.1|28.1|Standard Deviation|15.1|15.1|||
4330952|NCT00441129|4157936|B1|||Age||years|Mean|28.8|28.8|Standard Deviation|16.7|16.7|||
4330953|NCT00441116|4157947|B3|Korea, Democratic People's Republic of||Region of Enrollment||participants|Number|153|153.0||0|0.0|0.0|0.0|
4330954|NCT00441116|4157948|B2|Korea, Democratic People's Republic of||Region of Enrollment||participants|Number|77|77.0||||||
4330955|NCT00441116|4157949|B1|Korea, Democratic People's Republic of||Region of Enrollment||participants|Number|76|76.0||||||
4330957|NCT00441116|4157948|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4330958|NCT00441116|4157949|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4330959|NCT00441116|4157947|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4330960|NCT00441116|4157948|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4330961|NCT00441116|4157949|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4330962|NCT00441116|4157947|B3|||Age||years|Mean|38.097|38.097|Standard Deviation|6.84|6.84|||
4330963|NCT00441116|4157948|B2|||Age||years|Mean|38.41|38.41|Standard Deviation|6.61|6.61|||
4330964|NCT00441116|4157949|B1|||Age||years|Mean|37.78|37.78|Standard Deviation|7.07|7.07|||
4330965|NCT00441103|4158016|B3|Spain||Region of Enrollment||participants|Number|9|9.0||||||
4330966|NCT00441103|4158017|B2|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4330967|NCT00441103|4158018|B1|Spain||Region of Enrollment||participants|Number|5|5.0||||||
4330968|NCT00441103|4158016|B3|Serbia||Region of Enrollment||participants|Number|29|29.0||||||
4330969|NCT00441103|4158017|B2|Serbia||Region of Enrollment||participants|Number|9|9.0||||||
4330970|NCT00441103|4158018|B1|Serbia||Region of Enrollment||participants|Number|20|20.0||||||
4330971|NCT00441103|4158016|B3|Russian Federation||Region of Enrollment||participants|Number|32|32.0||||||
4330972|NCT00441103|4158017|B2|Russian Federation||Region of Enrollment||participants|Number|12|12.0||||||
4330973|NCT00441103|4158018|B1|Russian Federation||Region of Enrollment||participants|Number|20|20.0||||||
4330974|NCT00441103|4158016|B3|Romania||Region of Enrollment||participants|Number|19|19.0||||||
4330975|NCT00441103|4158017|B2|Romania||Region of Enrollment||participants|Number|8|8.0||||||
4330976|NCT00441103|4158018|B1|Romania||Region of Enrollment||participants|Number|11|11.0||||||
4330977|NCT00441103|4158016|B3|Lithuania||Region of Enrollment||participants|Number|8|8.0||||||
4330978|NCT00441103|4158017|B2|Lithuania||Region of Enrollment||participants|Number|3|3.0||||||
4330979|NCT00441103|4158018|B1|Lithuania||Region of Enrollment||participants|Number|5|5.0||||||
4330980|NCT00441103|4158016|B3|Italy||Region of Enrollment||participants|Number|11|11.0||||||
4330981|NCT00441103|4158017|B2|Italy||Region of Enrollment||participants|Number|4|4.0||||||
4330982|NCT00441103|4158018|B1|Italy||Region of Enrollment||participants|Number|7|7.0||||||
4330983|NCT00441103|4158016|B3|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4330984|NCT00441103|4158017|B2|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4330985|NCT00441103|4158018|B1|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4330986|NCT00441103|4158016|B3|Estonia||Region of Enrollment||participants|Number|13|13.0||||||
4330987|NCT00441103|4158017|B2|Estonia||Region of Enrollment||participants|Number|5|5.0||||||
4330988|NCT00441103|4158018|B1|Estonia||Region of Enrollment||participants|Number|8|8.0||||||
4330989|NCT00441103|4158016|B3|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4330990|NCT00441103|4158017|B2|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4330991|NCT00441103|4158018|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4330992|NCT00441103|4158016|B3|Bulgaria||Region of Enrollment||participants|Number|52|52.0||||||
4330993|NCT00441103|4158017|B2|Bulgaria||Region of Enrollment||participants|Number|12|12.0||||||
4330994|NCT00441103|4158018|B1|Bulgaria||Region of Enrollment||participants|Number|40|40.0||||||
4330995|NCT00441103|4158016|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4330996|NCT00441103|4158017|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4330997|NCT00441103|4158018|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4330998|NCT00441103|4158016|B3||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4330999|NCT00441103|4158017|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4331000|NCT00441103|4158018|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4331001|NCT00441103|4158016|B3|||Age||years|Mean|34.4|34.4|Standard Deviation|8.8|8.8|||
4331002|NCT00441103|4158017|B2|||Age||years|Mean|35.2|35.2|Standard Deviation|10.5|10.5|||
4331003|NCT00441103|4158018|B1|||Age||years|Mean|34.0|34.0|Standard Deviation|7.8|7.8|||
4331004|NCT00441103|4158016|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4331005|NCT00441103|4158017|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4331006|NCT00441103|4158018|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4331007|NCT00441103|4158016|B3||Between 18 and 65 years|Age||Participants|Count of Participants|180|180.0||||||
4331008|NCT00441103|4158017|B2||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4331009|NCT00441103|4158018|B1||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
4331010|NCT00441103|4158016|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331011|NCT00441103|4158017|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331012|NCT00441103|4158018|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331013|NCT00441090|4158030|B6||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4331014|NCT00441090|4158031|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4331015|NCT00441090|4158032|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4331016|NCT00441090|4158033|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4331017|NCT00441090|4158034|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4331018|NCT00441090|4158035|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4331019|NCT00441090|4158030|B6||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4331020|NCT00441090|4158031|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4331021|NCT00441090|4158032|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4331022|NCT00441090|4158033|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4331023|NCT00441090|4158034|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4331024|NCT00441090|4158035|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4331025|NCT00441090|4158030|B6|||Age||Years|Mean|52.3|52.3|Standard Deviation|17.81|17.81|||
4331026|NCT00441090|4158031|B5|||Age||Years|Mean|39.6|39.6|Standard Deviation|20.63|20.63|||
4331027|NCT00441090|4158032|B4|||Age||Years|Mean|47.9|47.9|Standard Deviation|16.54|16.54|||
4331028|NCT00441090|4158033|B3|||Age||Years|Mean|57.5|57.5|Standard Deviation|17.88|17.88|||
4331029|NCT00441090|4158034|B2|||Age||Years|Mean|55.6|55.6|Standard Deviation|18.03|18.03|||
4331030|NCT00441090|4158035|B1|||Age||Years|Mean|52.9|52.9|Standard Deviation|17.84|17.84|||
4331031|NCT00441064|4158081|B3|||MADBP|Mean Ambulatory Diastolic Blood Pressure (MADBP)|mm Hg|Mean|87.1|87.1|Standard Deviation|6.99|6.99|||
4331032|NCT00441064|4158082|B2|||MADBP|Mean Ambulatory Diastolic Blood Pressure (MADBP)|mm Hg|Mean|87.7|87.7|Standard Deviation|7.28|7.28|||
4331033|NCT00441064|4158083|B1|||MADBP|Mean Ambulatory Diastolic Blood Pressure (MADBP)|mm Hg|Mean|86.6|86.6|Standard Deviation|6.73|6.73|||
4331034|NCT00441064|4158081|B3|||MASBP|Mean Ambulatory Systolic Blood Pressure (MASBP)|mm Hg|Mean|138.9|138.9|Standard Deviation|8.38|8.38|||
4331035|NCT00441064|4158082|B2|||MASBP|Mean Ambulatory Systolic Blood Pressure (MASBP)|mm Hg|Mean|139.1|139.1|Standard Deviation|8.52|8.52|||
4331036|NCT00441064|4158083|B1|||MASBP|Mean Ambulatory Systolic Blood Pressure (MASBP)|mm Hg|Mean|138.7|138.7|Standard Deviation|8.30|8.3|||
4331037|NCT00441064|4158081|B3|||MSDBP|Mean Sitting Diastolic Blood Pressure (MSDBP)|mm Hg|Mean|93.1|93.1|Standard Deviation|9.11|9.11|||
4331038|NCT00441064|4158082|B2|||MSDBP|Mean Sitting Diastolic Blood Pressure (MSDBP)|mm Hg|Mean|93.6|93.6|Standard Deviation|8.33|8.33|||
4331039|NCT00441064|4158083|B1|||MSDBP|Mean Sitting Diastolic Blood Pressure (MSDBP)|mm Hg|Mean|92.7|92.7|Standard Deviation|9.81|9.81|||
4331040|NCT00441064|4158081|B3|||MSSBP|Mean Sitting Systolic Blood Pressure (MSSBP)|mm Hg|Mean|146.9|146.9|Standard Deviation|9.07|9.07|||
4331041|NCT00441064|4158082|B2|||MSSBP|Mean Sitting Systolic Blood Pressure (MSSBP)|mm Hg|Mean|146.2|146.2|Standard Deviation|8.94|8.94|||
4331042|NCT00441064|4158083|B1|||MSSBP|Mean Sitting Systolic Blood Pressure (MSSBP)|mm Hg|Mean|147.6|147.6|Standard Deviation|9.21|9.21|||
4331043|NCT00441064|4158081|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4331044|NCT00441064|4158082|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4331045|NCT00441064|4158083|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4331046|NCT00441064|4158081|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4331047|NCT00441064|4158082|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4331048|NCT00441064|4158083|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4331049|NCT00441064|4158081|B3|||Age||years|Mean|51.5|51.5|Standard Deviation|7.44|7.44|||
4331050|NCT00441064|4158082|B2|||Age||years|Mean|52.1|52.1|Standard Deviation|7.75|7.75|||
4331051|NCT00441064|4158083|B1|||Age||years|Mean|51.0|51.0|Standard Deviation|7.16|7.16|||
4331052|NCT00441012|4158094|B3||Male|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
4331053|NCT00441012|4158095|B2||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4331054|NCT00441012|4158096|B1||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4331055|NCT00441012|4158094|B3||Female|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
4331056|NCT00441012|4158095|B2||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4331057|NCT00441012|4158096|B1||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4331058|NCT00441012|4158094|B3|||Age||Days|Mean|68.0|68.0|Full Range|||40.0|83.0|
4331059|NCT00441012|4158095|B2|||Age||Days|Mean|68.3|68.3|Full Range|||40.0|83.0|
4331060|NCT00441012|4158096|B1|||Age||Days|Mean|67.7|67.7|Full Range|||41.0|82.0|
4331061|NCT00441012|4158094|B3|||Age||Days|Mean|68.0|68.0|Standard Deviation|8.7|8.7|||
4331062|NCT00441012|4158095|B2|||Age||Days|Mean|68.3|68.3|Standard Deviation|8.5|8.5|||
4331063|NCT00441012|4158096|B1|||Age||Days|Mean|67.7|67.7|Standard Deviation|8.9|8.9|||
4331064|NCT00440947|4158111|B1|||Median Baseline HIV-1 RNA Level||log10 copies/ml|Median|5.076|5.076|Full Range|||2.989|6.62|
4331065|NCT00440947|4158111|B1|||Median Baseline CD4+ Cell Count||cells per cubic millimeter|Median|199|199.0|Full Range|||19.0|754.0|
4331066|NCT00440947|4158111|B1|AIDS||Number of participants with the indicated Center for Disease Control (CDC) Classification|AIDS, Acquired Immunodeficiency Syndrome CDC classifications are Asymptomatic, Symptomatic, or AIDs.|participants|Number|65|65.0||||||
4331067|NCT00440947|4158111|B1|Symptomatic (non-AIDS) condition||Number of participants with the indicated Center for Disease Control (CDC) Classification|AIDS, Acquired Immunodeficiency Syndrome CDC classifications are Asymptomatic, Symptomatic, or AIDs.|participants|Number|97|97.0||||||
4331068|NCT00440947|4158111|B1|Asymptomatic HIV Infection||Number of participants with the indicated Center for Disease Control (CDC) Classification|AIDS, Acquired Immunodeficiency Syndrome CDC classifications are Asymptomatic, Symptomatic, or AIDs.|participants|Number|353|353.0||||||
4331069|NCT00440947|4158111|B1|CD4+ cells >=200||Number of participants with the indicated Baseline CD4+ Cell Count|A CD4+ cell is a T lymphocyte that carries the CD4 antigen. Immunologic response was assessed by CD4+ counts.|participants|Number|256|256.0||||||
4331070|NCT00440947|4158111|B1|CD4+ cells 50-<200||Number of participants with the indicated Baseline CD4+ Cell Count|A CD4+ cell is a T lymphocyte that carries the CD4 antigen. Immunologic response was assessed by CD4+ counts.|participants|Number|190|190.0||||||
4331071|NCT00440947|4158111|B1|CD4+ cells <50||Number of participants with the indicated Baseline CD4+ Cell Count|A CD4+ cell is a T lymphocyte that carries the CD4 antigen. Immunologic response was assessed by CD4+ counts.|participants|Number|69|69.0||||||
4331072|NCT00440947|4158111|B1|HIV-1 RNA >=500,000||Number of participants with the indicated baseline HIV-RNA level|HIV-1 RNA, Human Immunodeficiency Virus type 1 Ribonucleic acid. HIV-1 viral load was measured as virus copies per milliliter (ml) at baseline.|participants|Number|72|72.0||||||
4331073|NCT00440947|4158111|B1|HIV-1 RNA 250,000-<500,000||Number of participants with the indicated baseline HIV-RNA level|HIV-1 RNA, Human Immunodeficiency Virus type 1 Ribonucleic acid. HIV-1 viral load was measured as virus copies per milliliter (ml) at baseline.|participants|Number|73|73.0||||||
4331074|NCT00440947|4158111|B1|HIV-1 RNA 100,000-<250,000||Number of participants with the indicated baseline HIV-RNA level|HIV-1 RNA, Human Immunodeficiency Virus type 1 Ribonucleic acid. HIV-1 viral load was measured as virus copies per milliliter (ml) at baseline.|participants|Number|143|143.0||||||
4331075|NCT00440947|4158111|B1|HIV-1 RNA <100,000||Number of participants with the indicated baseline HIV-RNA level|HIV-1 RNA, Human Immunodeficiency Virus type 1 Ribonucleic acid. HIV-1 viral load was measured as virus copies per milliliter (ml) at baseline.|participants|Number|227|227.0||||||
4331076|NCT00440947|4158111|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4331077|NCT00440947|4158111|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|316|316.0||||||
4331078|NCT00440947|4158111|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4331079|NCT00440947|4158111|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4331080|NCT00440947|4158111|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4331081|NCT00440947|4158111|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4331082|NCT00440947|4158111|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4331083|NCT00440947|4158111|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4331084|NCT00440947|4158111|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4331085|NCT00440947|4158111|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|167|167.0||||||
4331086|NCT00440947|4158111|B1||Male|Sex: Female, Male||Participants|Count of Participants|429|429.0||||||
4331087|NCT00440947|4158111|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4331088|NCT00440947|4158111|B1|||Age||Years|Mean|38.3|38.3|Standard Deviation|10.03|10.03|||
4331089|NCT00440830|4158166|B5|United States||Region of Enrollment||participants|Number|68|68.0||||||
4331090|NCT00440830|4158167|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
4331091|NCT00440830|4158168|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4331092|NCT00440830|4158169|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4331093|NCT00440830|4158170|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4331094|NCT00440830|4158166|B5||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4331095|NCT00440830|4158167|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4331096|NCT00440830|4158168|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4331097|NCT00440830|4158169|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4331098|NCT00440830|4158170|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4331099|NCT00440830|4158166|B5||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4331100|NCT00440830|4158167|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4331101|NCT00440830|4158168|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4331102|NCT00440830|4158169|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4331103|NCT00440830|4158170|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4331104|NCT00440830|4158166|B5|||Age||years|Mean|47|47.0|Standard Deviation|3|3.0|||
4331105|NCT00440830|4158167|B4|||Age||years|Mean|52|52.0|Standard Deviation|4|4.0|||
4331106|NCT00440830|4158168|B3|||Age||years|Mean|48|48.0|Standard Deviation|3|3.0|||
4331107|NCT00440830|4158169|B2|||Age||years|Mean|43|43.0|Standard Deviation|4|4.0|||
4331108|NCT00440830|4158170|B1|||Age||years|Mean|46|46.0|Standard Deviation|2|2.0|||
4331109|NCT00440830|4158166|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4331110|NCT00440830|4158167|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4331111|NCT00440830|4158168|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4331112|NCT00440830|4158169|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4331113|NCT00440830|4158170|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4331114|NCT00440830|4158166|B5||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
4331115|NCT00440830|4158167|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4331116|NCT00440830|4158168|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4331117|NCT00440830|4158169|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4331118|NCT00440830|4158170|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4331119|NCT00440830|4158166|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331120|NCT00440830|4158167|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331121|NCT00440830|4158168|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331122|NCT00440830|4158169|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331123|NCT00440830|4158170|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331124|NCT00440700|4158187|B4|United States||Region of Enrollment||participants|Number|364|364.0||||||
4331125|NCT00440700|4158188|B3|United States||Region of Enrollment||participants|Number|124|124.0||||||
4331126|NCT00440700|4158189|B2|United States||Region of Enrollment||participants|Number|118|118.0||||||
4331127|NCT00440700|4158190|B1|United States||Region of Enrollment||participants|Number|122|122.0||||||
4331128|NCT00440700|4158187|B4||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4331129|NCT00440700|4158188|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4331130|NCT00440700|4158189|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4331131|NCT00440700|4158190|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4331132|NCT00440700|4158187|B4||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4331133|NCT00440700|4158188|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4331134|NCT00440700|4158189|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4331135|NCT00440700|4158190|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4331136|NCT00440700|4158187|B4|||Age||years|Mean|59.2|59.2|Standard Deviation|14.4|14.4|||
4331137|NCT00440700|4158188|B3|||Age||years|Mean|57.8|57.8|Standard Deviation|13.5|13.5|||
4331138|NCT00440700|4158189|B2|||Age||years|Mean|59.4|59.4|Standard Deviation|14.3|14.3|||
4331139|NCT00440700|4158190|B1|||Age||years|Mean|60.4|60.4|Standard Deviation|15.4|15.4|||
4331140|NCT00440700|4158187|B4||>=65 years|Age||Participants|Count of Participants|91|91.0||||||
4331141|NCT00440700|4158188|B3||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4331142|NCT00440700|4158189|B2||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4331143|NCT00440700|4158190|B1||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
4331144|NCT00440700|4158187|B4||Between 18 and 65 years|Age||Participants|Count of Participants|273|273.0||||||
4331145|NCT00440700|4158188|B3||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
4331146|NCT00440700|4158189|B2||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
4331147|NCT00440700|4158190|B1||Between 18 and 65 years|Age||Participants|Count of Participants|88|88.0||||||
4331148|NCT00440700|4158187|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331149|NCT00440700|4158188|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331150|NCT00440700|4158189|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331151|NCT00440700|4158190|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331152|NCT00440557|4158212|B4||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4331153|NCT00440557|4158213|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4331154|NCT00440557|4158214|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4331155|NCT00440557|4158215|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4331156|NCT00440557|4158212|B4||Female|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
4331157|NCT00440557|4158213|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4331158|NCT00440557|4158214|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4331159|NCT00440557|4158215|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4331160|NCT00440557|4158212|B4|||Age||years|Mean|69.6|69.6|Standard Deviation|12.65|12.65|||
4331161|NCT00440557|4158213|B3|||Age||years|Mean|68.9|68.9|Standard Deviation|13.02|13.02|||
4331162|NCT00440557|4158214|B2|||Age||years|Mean|68.9|68.9|Standard Deviation|11.86|11.86|||
4331163|NCT00440557|4158215|B1|||Age||years|Mean|71.1|71.1|Standard Deviation|13.02|13.02|||
4331164|NCT00440557|4158212|B4||>=65 years|Age||Participants|Count of Participants|253|253.0||||||
4331165|NCT00440557|4158213|B3||>=65 years|Age||Participants|Count of Participants|81|81.0||||||
4331166|NCT00440557|4158214|B2||>=65 years|Age||Participants|Count of Participants|82|82.0||||||
4331167|NCT00440557|4158215|B1||>=65 years|Age||Participants|Count of Participants|90|90.0||||||
4331168|NCT00440557|4158212|B4||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
4331169|NCT00440557|4158213|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4331170|NCT00440557|4158214|B2||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4331171|NCT00440557|4158215|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4331172|NCT00440557|4158212|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331173|NCT00440557|4158213|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331174|NCT00440557|4158214|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331175|NCT00440557|4158215|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331176|NCT00440531|4158246|B4||Male|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
4331177|NCT00440531|4158247|B3||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4331178|NCT00440531|4158248|B2||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4331179|NCT00440531|4158249|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4331180|NCT00440531|4158246|B4||Female|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
4331181|NCT00440531|4158247|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4331182|NCT00440531|4158248|B2||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4331183|NCT00440531|4158249|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4331184|NCT00440531|4158246|B4|||Age||years|Mean|60.2|60.2|Standard Deviation|7.4|7.4|||
4331185|NCT00440531|4158247|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|6.5|6.5|||
4331186|NCT00440531|4158248|B2|||Age||years|Mean|60.4|60.4|Standard Deviation|7.6|7.6|||
4331187|NCT00440531|4158249|B1|||Age||years|Mean|60.3|60.3|Standard Deviation|7.9|7.9|||
4331188|NCT00440518|4158265|B4|United States||Region of Enrollment||participants|Number|218|218.0||||||
4331189|NCT00440518|4158266|B3|United States||Region of Enrollment||participants|Number|74|74.0||||||
4331190|NCT00440518|4158267|B2|United States||Region of Enrollment||participants|Number|72|72.0||||||
4331191|NCT00440518|4158268|B1|United States||Region of Enrollment||participants|Number|72|72.0||||||
4331192|NCT00440518|4158265|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4331193|NCT00440518|4158266|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4331194|NCT00440518|4158267|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4331195|NCT00440518|4158268|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4331196|NCT00440518|4158265|B4||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4331197|NCT00440518|4158266|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4331198|NCT00440518|4158267|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4331199|NCT00440518|4158268|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4331200|NCT00440518|4158265|B4|||Age||years|Mean|39.9|39.9|Standard Deviation|11.78|11.78|||
4331201|NCT00440518|4158266|B3|||Age||years|Mean|40.2|40.2|Standard Deviation|11.40|11.4|||
4331202|NCT00440518|4158267|B2|||Age||years|Mean|40.1|40.1|Standard Deviation|11.86|11.86|||
4331203|NCT00440518|4158268|B1|||Age||years|Mean|39.3|39.3|Standard Deviation|12.23|12.23|||
4331204|NCT00440518|4158265|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4331205|NCT00440518|4158266|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4331206|NCT00440518|4158267|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4331207|NCT00440518|4158268|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4331208|NCT00440518|4158265|B4||Between 18 and 65 years|Age||Participants|Count of Participants|218|218.0||||||
4331209|NCT00440518|4158266|B3||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
4331210|NCT00440518|4158267|B2||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
4331211|NCT00440518|4158268|B1||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
4331212|NCT00440518|4158265|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331213|NCT00440518|4158266|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331214|NCT00440518|4158267|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331215|NCT00440518|4158268|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331216|NCT00440505|4158290|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4331217|NCT00440505|4158290|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4331218|NCT00440505|4158290|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4331219|NCT00440505|4158290|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4331220|NCT00440505|4158290|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4331221|NCT00440505|4158290|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331222|NCT00440466|4158312|B4||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4331223|NCT00440466|4158313|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4331224|NCT00440466|4158314|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4331225|NCT00440466|4158315|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4331226|NCT00440466|4158312|B4||Female|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
4331227|NCT00440466|4158313|B3||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4331228|NCT00440466|4158314|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4331229|NCT00440466|4158315|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4331230|NCT00440466|4158312|B4|||Age||years|Mean|71|71.0|Standard Deviation|12.18|12.18|||
4331231|NCT00440466|4158313|B3|||Age||years|Mean|71.1|71.1|Standard Deviation|12.48|12.48|||
4331232|NCT00440466|4158314|B2|||Age||years|Mean|71.7|71.7|Standard Deviation|10.63|10.63|||
4331233|NCT00440466|4158315|B1|||Age||years|Mean|70.3|70.3|Standard Deviation|13.04|13.04|||
4331234|NCT00440466|4158312|B4||>=65 years|Age||Participants|Count of Participants|314|314.0||||||
4331235|NCT00440466|4158313|B3||>=65 years|Age||Participants|Count of Participants|158|158.0||||||
4331236|NCT00440466|4158314|B2||>=65 years|Age||Participants|Count of Participants|81|81.0||||||
4331237|NCT00440466|4158315|B1||>=65 years|Age||Participants|Count of Participants|75|75.0||||||
4331238|NCT00440466|4158312|B4||Between 18 and 65 years|Age||Participants|Count of Participants|116|116.0||||||
4331239|NCT00440466|4158313|B3||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4331240|NCT00440466|4158314|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4331241|NCT00440466|4158315|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4331242|NCT00440466|4158312|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331243|NCT00440466|4158313|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331244|NCT00440466|4158314|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331245|NCT00440466|4158315|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331246|NCT00440401|4158349|B3|Vessel||Type of tissue|Type of tissue treated with randomized treatment|participants|Number|81|81.0||||||
4331247|NCT00440401|4158350|B2|Vessel||Type of tissue|Type of tissue treated with randomized treatment|participants|Number|38|38.0||||||
4331248|NCT00440401|4158351|B1|Vessel||Type of tissue|Type of tissue treated with randomized treatment|participants|Number|43|43.0||||||
4331249|NCT00440401|4158349|B3|Tissue||Type of tissue|Type of tissue treated with randomized treatment|participants|Number|38|38.0||||||
4331250|NCT00440401|4158350|B2|Tissue||Type of tissue|Type of tissue treated with randomized treatment|participants|Number|22|22.0||||||
4331251|NCT00440401|4158351|B1|Tissue||Type of tissue|Type of tissue treated with randomized treatment|participants|Number|16|16.0||||||
4331252|NCT00440401|4158349|B3|None||Primary haemostatic treatment|"Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|22|22.0||||||
4331253|NCT00440401|4158350|B2|None||Primary haemostatic treatment|"Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|12|12.0||||||
4331254|NCT00440401|4158351|B1|None||Primary haemostatic treatment|"Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|10|10.0||||||
4331255|NCT00440401|4158349|B3|Gauze||Primary haemostatic treatment|"Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|1|1.0||||||
4331256|NCT00440401|4158350|B2|Gauze||Primary haemostatic treatment|"Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|1|1.0||||||
4331257|NCT00440401|4158351|B1|Gauze||Primary haemostatic treatment|"Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|0|0.0||||||
4331258|NCT00440401|4158349|B3|Clips||Primary haemostatic treatment|"Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|5|5.0||||||
4331259|NCT00440401|4158350|B2|Clips||Primary haemostatic treatment|"Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|2|2.0||||||
4331260|NCT00440401|4158351|B1|Clips||Primary haemostatic treatment|"Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|3|3.0||||||
4331261|NCT00440401|4158349|B3|Electro-coagulation||Primary haemostatic treatment|"Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|11|11.0||||||
4331262|NCT00440401|4158350|B2|Electro-coagulation||Primary haemostatic treatment|"Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|5|5.0||||||
4331263|NCT00440401|4158351|B1|Electro-coagulation||Primary haemostatic treatment|"Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|6|6.0||||||
4331264|NCT00440401|4158349|B3|Suturing||Primary haemostatic treatment|"Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|86|86.0||||||
4331265|NCT00440401|4158350|B2|Suturing||Primary haemostatic treatment|"Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|43|43.0||||||
4331266|NCT00440401|4158351|B1|Suturing||Primary haemostatic treatment|"Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|43|43.0||||||
4331267|NCT00440401|4158349|B3|Other||Identification of target area for efficacy evaluation|"In order to avoid selection bias, intra-operative randomization was only performed if supportive haemostatic treatment was required after completion of primary haemostasis.~Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|5|5.0||||||
4331268|NCT00440401|4158350|B2|Other||Identification of target area for efficacy evaluation|"In order to avoid selection bias, intra-operative randomization was only performed if supportive haemostatic treatment was required after completion of primary haemostasis.~Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|2|2.0||||||
4331269|NCT00440401|4158351|B1|Other||Identification of target area for efficacy evaluation|"In order to avoid selection bias, intra-operative randomization was only performed if supportive haemostatic treatment was required after completion of primary haemostasis.~Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|3|3.0||||||
4331270|NCT00440401|4158349|B3|Right ventricle||Identification of target area for efficacy evaluation|"In order to avoid selection bias, intra-operative randomization was only performed if supportive haemostatic treatment was required after completion of primary haemostasis.~Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|19|19.0||||||
4331271|NCT00440401|4158350|B2|Right ventricle||Identification of target area for efficacy evaluation|"In order to avoid selection bias, intra-operative randomization was only performed if supportive haemostatic treatment was required after completion of primary haemostasis.~Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|8|8.0||||||
4331272|NCT00440401|4158351|B1|Right ventricle||Identification of target area for efficacy evaluation|"In order to avoid selection bias, intra-operative randomization was only performed if supportive haemostatic treatment was required after completion of primary haemostasis.~Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|11|11.0||||||
4331273|NCT00440401|4158349|B3|Right atrium||Identification of target area for efficacy evaluation|"In order to avoid selection bias, intra-operative randomization was only performed if supportive haemostatic treatment was required after completion of primary haemostasis.~Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|15|15.0||||||
4331274|NCT00440401|4158350|B2|Right atrium||Identification of target area for efficacy evaluation|"In order to avoid selection bias, intra-operative randomization was only performed if supportive haemostatic treatment was required after completion of primary haemostasis.~Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|10|10.0||||||
4331366|NCT00440232|4158421|B3|||Age||years|Mean|39.49|39.49|Standard Deviation|12.3|12.3|||
4331275|NCT00440401|4158351|B1|Right atrium||Identification of target area for efficacy evaluation|"In order to avoid selection bias, intra-operative randomization was only performed if supportive haemostatic treatment was required after completion of primary haemostasis.~Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|5|5.0||||||
4331276|NCT00440401|4158349|B3|Left ventricle||Identification of target area for efficacy evaluation|"In order to avoid selection bias, intra-operative randomization was only performed if supportive haemostatic treatment was required after completion of primary haemostasis.~Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|5|5.0||||||
4331277|NCT00440401|4158350|B2|Left ventricle||Identification of target area for efficacy evaluation|"In order to avoid selection bias, intra-operative randomization was only performed if supportive haemostatic treatment was required after completion of primary haemostasis.~Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|2|2.0||||||
4331278|NCT00440401|4158351|B1|Left ventricle||Identification of target area for efficacy evaluation|"In order to avoid selection bias, intra-operative randomization was only performed if supportive haemostatic treatment was required after completion of primary haemostasis.~Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|3|3.0||||||
4331279|NCT00440401|4158349|B3|Left atrium||Identification of target area for efficacy evaluation|"In order to avoid selection bias, intra-operative randomization was only performed if supportive haemostatic treatment was required after completion of primary haemostasis.~Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|5|5.0||||||
4331280|NCT00440401|4158350|B2|Left atrium||Identification of target area for efficacy evaluation|"In order to avoid selection bias, intra-operative randomization was only performed if supportive haemostatic treatment was required after completion of primary haemostasis.~Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|2|2.0||||||
4331281|NCT00440401|4158351|B1|Left atrium||Identification of target area for efficacy evaluation|"In order to avoid selection bias, intra-operative randomization was only performed if supportive haemostatic treatment was required after completion of primary haemostasis.~Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|3|3.0||||||
4331282|NCT00440401|4158349|B3|Internal mammary artery vascular bed||Identification of target area for efficacy evaluation|"In order to avoid selection bias, intra-operative randomization was only performed if supportive haemostatic treatment was required after completion of primary haemostasis.~Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|2|2.0||||||
4331283|NCT00440401|4158350|B2|Internal mammary artery vascular bed||Identification of target area for efficacy evaluation|"In order to avoid selection bias, intra-operative randomization was only performed if supportive haemostatic treatment was required after completion of primary haemostasis.~Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|1|1.0||||||
4331284|NCT00440401|4158351|B1|Internal mammary artery vascular bed||Identification of target area for efficacy evaluation|"In order to avoid selection bias, intra-operative randomization was only performed if supportive haemostatic treatment was required after completion of primary haemostasis.~Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|1|1.0||||||
4331285|NCT00440401|4158349|B3|Coronary anastomosis||Identification of target area for efficacy evaluation|"In order to avoid selection bias, intra-operative randomization was only performed if supportive haemostatic treatment was required after completion of primary haemostasis.~Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|5|5.0||||||
4331286|NCT00440401|4158350|B2|Coronary anastomosis||Identification of target area for efficacy evaluation|"In order to avoid selection bias, intra-operative randomization was only performed if supportive haemostatic treatment was required after completion of primary haemostasis.~Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|3|3.0||||||
4331287|NCT00440401|4158351|B1|Coronary anastomosis||Identification of target area for efficacy evaluation|"In order to avoid selection bias, intra-operative randomization was only performed if supportive haemostatic treatment was required after completion of primary haemostasis.~Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|2|2.0||||||
4331288|NCT00440401|4158349|B3|Aorta||Identification of target area for efficacy evaluation|"In order to avoid selection bias, intra-operative randomization was only performed if supportive haemostatic treatment was required after completion of primary haemostasis.~Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|67|67.0||||||
4331289|NCT00440401|4158350|B2|Aorta||Identification of target area for efficacy evaluation|"In order to avoid selection bias, intra-operative randomization was only performed if supportive haemostatic treatment was required after completion of primary haemostasis.~Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|32|32.0||||||
4331290|NCT00440401|4158351|B1|Aorta||Identification of target area for efficacy evaluation|"In order to avoid selection bias, intra-operative randomization was only performed if supportive haemostatic treatment was required after completion of primary haemostasis.~Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|35|35.0||||||
4331291|NCT00440401|4158349|B3|Severe haemorrhage||Evaluation of bleeding at target area before randomization|"In order to avoid selection bias, evaluation of bleeding at target area was performed after completion of primary hemostasis and prior to randomization.~Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|7|7.0||||||
4331292|NCT00440401|4158350|B2|Severe haemorrhage||Evaluation of bleeding at target area before randomization|"In order to avoid selection bias, evaluation of bleeding at target area was performed after completion of primary hemostasis and prior to randomization.~Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|2|2.0||||||
4331293|NCT00440401|4158351|B1|Severe haemorrhage||Evaluation of bleeding at target area before randomization|"In order to avoid selection bias, evaluation of bleeding at target area was performed after completion of primary hemostasis and prior to randomization.~Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|5|5.0||||||
4331294|NCT00440401|4158349|B3|Moderate haemorrhage||Evaluation of bleeding at target area before randomization|"In order to avoid selection bias, evaluation of bleeding at target area was performed after completion of primary hemostasis and prior to randomization.~Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|69|69.0||||||
4331295|NCT00440401|4158350|B2|Moderate haemorrhage||Evaluation of bleeding at target area before randomization|"In order to avoid selection bias, evaluation of bleeding at target area was performed after completion of primary hemostasis and prior to randomization.~Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|34|34.0||||||
4331296|NCT00440401|4158351|B1|Moderate haemorrhage||Evaluation of bleeding at target area before randomization|"In order to avoid selection bias, evaluation of bleeding at target area was performed after completion of primary hemostasis and prior to randomization.~Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|35|35.0||||||
4331297|NCT00440401|4158349|B3|Mild haemorrhage||Evaluation of bleeding at target area before randomization|"In order to avoid selection bias, evaluation of bleeding at target area was performed after completion of primary hemostasis and prior to randomization.~Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|43|43.0||||||
4331298|NCT00440401|4158350|B2|Mild haemorrhage||Evaluation of bleeding at target area before randomization|"In order to avoid selection bias, evaluation of bleeding at target area was performed after completion of primary hemostasis and prior to randomization.~Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|24|24.0||||||
4331299|NCT00440401|4158351|B1|Mild haemorrhage||Evaluation of bleeding at target area before randomization|"In order to avoid selection bias, evaluation of bleeding at target area was performed after completion of primary hemostasis and prior to randomization.~Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|19|19.0||||||
4331300|NCT00440401|4158349|B3|Venous||Evaluation of bleeding at target area before randomization|"In order to avoid selection bias, evaluation of bleeding at target area was performed after completion of primary hemostasis and prior to randomization.~Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|31|31.0||||||
4331301|NCT00440401|4158350|B2|Venous||Evaluation of bleeding at target area before randomization|"In order to avoid selection bias, evaluation of bleeding at target area was performed after completion of primary hemostasis and prior to randomization.~Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|20|20.0||||||
4331302|NCT00440401|4158351|B1|Venous||Evaluation of bleeding at target area before randomization|"In order to avoid selection bias, evaluation of bleeding at target area was performed after completion of primary hemostasis and prior to randomization.~Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|11|11.0||||||
4331303|NCT00440401|4158349|B3|Arterial||Evaluation of bleeding at target area before randomization|"In order to avoid selection bias, evaluation of bleeding at target area was performed after completion of primary hemostasis and prior to randomization.~Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|88|88.0||||||
4331304|NCT00440401|4158350|B2|Arterial||Evaluation of bleeding at target area before randomization|"In order to avoid selection bias, evaluation of bleeding at target area was performed after completion of primary hemostasis and prior to randomization.~Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|40|40.0||||||
4331305|NCT00440401|4158351|B1|Arterial||Evaluation of bleeding at target area before randomization|"In order to avoid selection bias, evaluation of bleeding at target area was performed after completion of primary hemostasis and prior to randomization.~Data obtained prior to final assessment of patient eligibility and randomization.~More than one record/condition per patient possible."|participants|Number|48|48.0||||||
4331306|NCT00440401|4158349|B3|||Classification of surgery|"Planned elective surgery on the heart, the ascending aorta or arch, requiring cardiopulmonary bypass procedure.~The information about planned surgery reflects the protocol defined eligibility criterion no. 5. In addition, the actually performed surgery is categorized into simple and combined/complex cardiovascular procedures. The proportions of patients undergoing combined/complex cardiovascular procedures in the TachoSil® group and the Standard Treatment group, respectively, were 44 and 59 percent. The calculated total (103) is irrelevant and inappropriate arithmetic."|Percentage of subjects|Number|103|103.0||||||
4331307|NCT00440401|4158350|B2|||Classification of surgery|"Planned elective surgery on the heart, the ascending aorta or arch, requiring cardiopulmonary bypass procedure.~The information about planned surgery reflects the protocol defined eligibility criterion no. 5. In addition, the actually performed surgery is categorized into simple and combined/complex cardiovascular procedures. The proportions of patients undergoing combined/complex cardiovascular procedures in the TachoSil® group and the Standard Treatment group, respectively, were 44 and 59 percent. The calculated total (103) is irrelevant and inappropriate arithmetic."|Percentage of subjects|Number|59|59.0||||||
4331367|NCT00440232|4158422|B2|||Age||years|Mean|38.7|38.7|Standard Deviation|12.7|12.7|||
4331368|NCT00440232|4158423|B1|||Age||years|Mean|40.15|40.15|Standard Deviation|11.8|11.8|||
4331308|NCT00440401|4158351|B1|||Classification of surgery|"Planned elective surgery on the heart, the ascending aorta or arch, requiring cardiopulmonary bypass procedure.~The information about planned surgery reflects the protocol defined eligibility criterion no. 5. In addition, the actually performed surgery is categorized into simple and combined/complex cardiovascular procedures. The proportions of patients undergoing combined/complex cardiovascular procedures in the TachoSil® group and the Standard Treatment group, respectively, were 44 and 59 percent. The calculated total (103) is irrelevant and inappropriate arithmetic."|Percentage of subjects|Number|44|44.0||||||
4331309|NCT00440401|4158349|B3|Caucasian||Race/Ethnicity, Customized|All patients were Caucasian|participants|Number|119|119.0||||||
4331310|NCT00440401|4158350|B2|Caucasian||Race/Ethnicity, Customized|All patients were Caucasian|participants|Number|60|60.0||||||
4331311|NCT00440401|4158351|B1|Caucasian||Race/Ethnicity, Customized|All patients were Caucasian|participants|Number|59|59.0||||||
4331312|NCT00440401|4158349|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4331313|NCT00440401|4158350|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4331314|NCT00440401|4158351|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4331315|NCT00440401|4158349|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4331316|NCT00440401|4158350|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4331317|NCT00440401|4158351|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4331318|NCT00440401|4158349|B3|65 years or above||Age, Customized||participants|Number|74|74.0||||||
4331319|NCT00440401|4158350|B2|65 years or above||Age, Customized||participants|Number|39|39.0||||||
4331320|NCT00440401|4158351|B1|65 years or above||Age, Customized||participants|Number|35|35.0||||||
4331321|NCT00440401|4158349|B3|18-65 years||Age, Customized||participants|Number|45|45.0||||||
4331322|NCT00440401|4158350|B2|18-65 years||Age, Customized||participants|Number|21|21.0||||||
4331323|NCT00440401|4158351|B1|18-65 years||Age, Customized||participants|Number|24|24.0||||||
4331324|NCT00440310|4158360|B3||Male|Sex: Female, Male||Participants|Count of Participants|279|279.0||||||
4331325|NCT00440310|4158361|B2||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4331326|NCT00440310|4158362|B1||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4331327|NCT00440310|4158360|B3||Female|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4331328|NCT00440310|4158361|B2||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4331329|NCT00440310|4158362|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4331330|NCT00440310|4158360|B3|||Age, Customized||years|Median|60.0|60.0|Full Range|||20.0|83.0|
4331331|NCT00440310|4158361|B2|||Age, Customized||years|Median|61.0|61.0|Full Range|||31.0|81.0|
4331332|NCT00440310|4158362|B1|||Age, Customized||years|Median|60.0|60.0|Full Range|||20.0|83.0|
4331333|NCT00440310|4158360|B3|||Age||years|Mean|59.7|59.7|Standard Deviation|10.0|10.0|||
4331334|NCT00440310|4158361|B2|||Age||years|Mean|60.1|60.1|Standard Deviation|10.2|10.2|||
4331335|NCT00440310|4158362|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|9.8|9.8|||
4331336|NCT00440297|4158369|B3||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4331337|NCT00440297|4158370|B2||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4331338|NCT00440297|4158371|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4331339|NCT00440297|4158369|B3||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4331340|NCT00440297|4158370|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4331341|NCT00440297|4158371|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4331342|NCT00440297|4158369|B3|||Age||Years|Mean|69.5|69.5|Standard Deviation|13.0|13.0|||
4331343|NCT00440297|4158370|B2|||Age||Years|Mean|69.2|69.2|Standard Deviation|12.7|12.7|||
4331344|NCT00440297|4158371|B1|||Age||Years|Mean|69.7|69.7|Standard Deviation|13.4|13.4|||
4331345|NCT00440297|4158369|B3|||Age||years|Mean|69.5|69.5|Full Range|||20.0|91.0|
4331346|NCT00440297|4158370|B2|||Age||years|Mean|69.2|69.2|Full Range|||30.0|90.0|
4331347|NCT00440297|4158371|B1|||Age||years|Mean|69.7|69.7|Full Range|||20.0|91.0|
4331348|NCT00440271|4158386|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4331349|NCT00440271|4158387|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4331350|NCT00440271|4158388|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4331351|NCT00440271|4158386|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4331352|NCT00440271|4158387|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4331353|NCT00440271|4158388|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4331354|NCT00440271|4158386|B3|||Age||years|Mean|44.5|44.5|Standard Deviation|9.6|9.6|||
4331355|NCT00440271|4158387|B2|||Age||years|Mean|43.2|43.2|Standard Deviation|10.6|10.6|||
4331356|NCT00440271|4158388|B1|||Age||years|Mean|46.1|46.1|Standard Deviation|8.2|8.2|||
4331357|NCT00440232|4158421|B3|United States||Region of Enrollment||participants|Number|74|74.0||||||
4331358|NCT00440232|4158422|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
4331359|NCT00440232|4158423|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4331360|NCT00440232|4158421|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4331361|NCT00440232|4158422|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4331362|NCT00440232|4158423|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4331363|NCT00440232|4158421|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4331364|NCT00440232|4158422|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4331365|NCT00440232|4158423|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4331369|NCT00440232|4158421|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4331370|NCT00440232|4158422|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4331371|NCT00440232|4158423|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4331372|NCT00440232|4158421|B3||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
4331373|NCT00440232|4158422|B2||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4331374|NCT00440232|4158423|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4331375|NCT00440232|4158421|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331376|NCT00440232|4158422|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331377|NCT00440232|4158423|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331378|NCT00440193|4158432|B3||Male|Sex: Female, Male||Participants|Count of Participants|1960|1960.0||||||
4331379|NCT00440193|4158433|B2||Male|Sex: Female, Male||Participants|Count of Participants|967|967.0||||||
4331380|NCT00440193|4158434|B1||Male|Sex: Female, Male||Participants|Count of Participants|993|993.0||||||
4331381|NCT00440193|4158432|B3||Female|Sex: Female, Male||Participants|Count of Participants|1489|1489.0||||||
4331382|NCT00440193|4158433|B2||Female|Sex: Female, Male||Participants|Count of Participants|751|751.0||||||
4331383|NCT00440193|4158434|B1||Female|Sex: Female, Male||Participants|Count of Participants|738|738.0||||||
4331384|NCT00440193|4158432|B3|≥ 75 years||Age, Customized||participants|Number|503|503.0||||||
4331385|NCT00440193|4158433|B2|≥ 75 years||Age, Customized||participants|Number|258|258.0||||||
4331386|NCT00440193|4158434|B1|≥ 75 years||Age, Customized||participants|Number|245|245.0||||||
4331387|NCT00440193|4158432|B3|60 - < 75 years||Age, Customized||participants|Number|1049|1049.0||||||
4331388|NCT00440193|4158433|B2|60 - < 75 years||Age, Customized||participants|Number|519|519.0||||||
4331389|NCT00440193|4158434|B1|60 - < 75 years||Age, Customized||participants|Number|530|530.0||||||
4331390|NCT00440193|4158432|B3|40 - < 60 years||Age, Customized||participants|Number|1304|1304.0||||||
4331391|NCT00440193|4158433|B2|40 - < 60 years||Age, Customized||participants|Number|662|662.0||||||
4331392|NCT00440193|4158434|B1|40 - < 60 years||Age, Customized||participants|Number|642|642.0||||||
4331393|NCT00440193|4158432|B3|18 - < 40 years||Age, Customized||participants|Number|593|593.0||||||
4331394|NCT00440193|4158433|B2|18 - < 40 years||Age, Customized||participants|Number|279|279.0||||||
4331395|NCT00440193|4158434|B1|18 - < 40 years||Age, Customized||participants|Number|314|314.0||||||
4331396|NCT00440193|4158432|B3|||Age||years|Mean|56.1|56.1|Standard Deviation|16.4|16.4|||
4331397|NCT00440193|4158433|B2|||Age||years|Mean|56.4|56.4|Standard Deviation|16.3|16.3|||
4331398|NCT00440193|4158434|B1|||Age||years|Mean|55.8|55.8|Standard Deviation|16.4|16.4|||
4331399|NCT00440180|4158469|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4331400|NCT00440180|4158470|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4331401|NCT00440180|4158471|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4331402|NCT00440180|4158469|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4331403|NCT00440180|4158470|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4331404|NCT00440180|4158471|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4331405|NCT00440180|4158469|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4331406|NCT00440180|4158470|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4331407|NCT00440180|4158471|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4331408|NCT00440180|4158469|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4331409|NCT00440180|4158470|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4331410|NCT00440180|4158471|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4331411|NCT00440180|4158469|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331412|NCT00440180|4158470|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331413|NCT00440180|4158471|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331414|NCT00440115|4158478|B4|Preparation||Stage of change||Participants|Count of Participants|228|228.0||||||
4331415|NCT00440115|4158479|B3|Preparation||Stage of change||Participants|Count of Participants|70|70.0||||||
4331416|NCT00440115|4158480|B2|Preparation||Stage of change||Participants|Count of Participants|76|76.0||||||
4331417|NCT00440115|4158481|B1|Preparation||Stage of change||Participants|Count of Participants|82|82.0||||||
4331418|NCT00440115|4158478|B4|Contemplation||Stage of change||Participants|Count of Participants|457|457.0||||||
4331419|NCT00440115|4158479|B3|Contemplation||Stage of change||Participants|Count of Participants|158|158.0||||||
4331420|NCT00440115|4158480|B2|Contemplation||Stage of change||Participants|Count of Participants|153|153.0||||||
4331421|NCT00440115|4158481|B1|Contemplation||Stage of change||Participants|Count of Participants|146|146.0||||||
4331422|NCT00440115|4158478|B4|Precontemplation||Stage of change||Participants|Count of Participants|65|65.0||||||
4331423|NCT00440115|4158479|B3|Precontemplation||Stage of change||Participants|Count of Participants|22|22.0||||||
4331424|NCT00440115|4158480|B2|Precontemplation||Stage of change||Participants|Count of Participants|20|20.0||||||
4331425|NCT00440115|4158481|B1|Precontemplation||Stage of change||Participants|Count of Participants|23|23.0||||||
4331426|NCT00440115|4158478|B4|United States||Region of Enrollment||Participants|Count of Participants|750|750.0||||||
4331427|NCT00440115|4158479|B3|United States||Region of Enrollment||Participants|Count of Participants|250|250.0||||||
4331428|NCT00440115|4158480|B2|United States||Region of Enrollment||Participants|Count of Participants|249|249.0||||||
4331429|NCT00440115|4158481|B1|United States||Region of Enrollment||Participants|Count of Participants|251|251.0||||||
4331430|NCT00440115|4158478|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4331431|NCT00440115|4158479|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4331432|NCT00440115|4158480|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4331433|NCT00440115|4158481|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4331434|NCT00440115|4158478|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4331435|NCT00440115|4158479|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4331436|NCT00440115|4158480|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4331437|NCT00440115|4158481|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4331438|NCT00440115|4158478|B4||White|Race (NIH/OMB)||Participants|Count of Participants|671|671.0||||||
4331439|NCT00440115|4158479|B3||White|Race (NIH/OMB)||Participants|Count of Participants|225|225.0||||||
4331440|NCT00440115|4158480|B2||White|Race (NIH/OMB)||Participants|Count of Participants|225|225.0||||||
4331441|NCT00440115|4158481|B1||White|Race (NIH/OMB)||Participants|Count of Participants|221|221.0||||||
4331442|NCT00440115|4158478|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4331443|NCT00440115|4158479|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4331444|NCT00440115|4158480|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4331445|NCT00440115|4158481|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4331446|NCT00440115|4158478|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4331447|NCT00440115|4158479|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4331448|NCT00440115|4158480|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4331449|NCT00440115|4158481|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4331450|NCT00440115|4158478|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4331451|NCT00440115|4158479|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4331452|NCT00440115|4158480|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4331453|NCT00440115|4158481|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4331454|NCT00440115|4158478|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4331455|NCT00440115|4158479|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4331456|NCT00440115|4158480|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4331457|NCT00440115|4158481|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4331458|NCT00440115|4158478|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4331459|NCT00440115|4158479|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4331460|NCT00440115|4158480|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4331461|NCT00440115|4158481|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4331462|NCT00440115|4158478|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|738|738.0||||||
4331463|NCT00440115|4158479|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|246|246.0||||||
4331464|NCT00440115|4158480|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|243|243.0||||||
4331465|NCT00440115|4158481|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|249|249.0||||||
4331466|NCT00440115|4158478|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4331467|NCT00440115|4158479|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4331468|NCT00440115|4158480|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4331469|NCT00440115|4158481|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4331470|NCT00440115|4158478|B4||Male|Sex: Female, Male||Participants|Count of Participants|311|311.0||||||
4331471|NCT00440115|4158479|B3||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4331472|NCT00440115|4158480|B2||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4331473|NCT00440115|4158481|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4331474|NCT00440115|4158478|B4||Female|Sex: Female, Male||Participants|Count of Participants|439|439.0||||||
4331475|NCT00440115|4158479|B3||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4331476|NCT00440115|4158480|B2||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4331477|NCT00440115|4158481|B1||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4331478|NCT00440115|4158478|B4|||Age||years|Mean|47.2|47.2|Standard Deviation|13.1|13.1|||
4331479|NCT00440115|4158479|B3|||Age||years|Mean|47.1|47.1|Standard Deviation|13.4|13.4|||
4331480|NCT00440115|4158480|B2|||Age||years|Mean|48.2|48.2|Standard Deviation|12.4|12.4|||
4331481|NCT00440115|4158481|B1|||Age||years|Mean|46.4|46.4|Standard Deviation|13.5|13.5|||
4331482|NCT00440050|4158497|B3|United States||Region of Enrollment||participants|Number|402|402.0||||||
4331483|NCT00440050|4158498|B2|United States||Region of Enrollment||participants|Number|238|238.0||||||
4331484|NCT00440050|4158499|B1|United States||Region of Enrollment||participants|Number|164|164.0||||||
4331485|NCT00440050|4158497|B3||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4331486|NCT00440050|4158498|B2||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4331487|NCT00440050|4158499|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4331488|NCT00440050|4158497|B3||Female|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4331489|NCT00440050|4158498|B2||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4331490|NCT00440050|4158499|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4331491|NCT00440050|4158497|B3|||Age||years|Mean|76|76.0|Standard Deviation|8.7|8.7|||
4331492|NCT00440050|4158498|B2|||Age||years|Mean|76|76.0|Standard Deviation|7.8|7.8|||
4331493|NCT00440050|4158499|B1|||Age||years|Mean|76|76.0|Standard Deviation|9.3|9.3|||
4331494|NCT00440011|4158512|B3|United States||Region of Enrollment||participants|Number|266|266.0||||||
4331495|NCT00440011|4158513|B2|United States||Region of Enrollment||participants|Number|135|135.0||||||
4331496|NCT00440011|4158514|B1|United States||Region of Enrollment||participants|Number|131|131.0||||||
4331497|NCT00440011|4158512|B3||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4331498|NCT00440011|4158513|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4331499|NCT00440011|4158514|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4331500|NCT00440011|4158512|B3||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4331501|NCT00440011|4158513|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4331502|NCT00440011|4158514|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4331503|NCT00440011|4158512|B3|||Age||years|Mean|63.0|63.0|Standard Deviation|12.3|12.3|||
4331504|NCT00440011|4158513|B2|||Age||years|Mean|62.7|62.7|Standard Deviation|12.4|12.4|||
4331505|NCT00440011|4158514|B1|||Age||years|Mean|63.4|63.4|Standard Deviation|12.3|12.3|||
4331506|NCT00439946|4158523|B1|||Baseline 6 Minute Walk Distance (6MWD)|This measure includes 6 patients. Two subjects did not have Baseline 6-Minute Walk Tests (6MWTs) conducted.|meters|Mean|390.5|390.5|Full Range|||294.0|506.0|
4331507|NCT00439946|4158523|B1|||epoprostenol dose||ng/kg/min|Mean|34.05|34.05|Full Range|||7.7|71.0|
4331508|NCT00439946|4158523|B1|Class III||World Health Organization (WHO) functional class at time of transition|WHO functional class is a system to help clinicians determine how limited a patient is in their ability to do the activities of daily living. The scale ranges from class I to class IV. In general, patients with more severe Pulmonary Hypertension (PH) tend to have a higher functional class.|participants|Number|2|2.0||||||
4331509|NCT00439946|4158523|B1|Class II||World Health Organization (WHO) functional class at time of transition|WHO functional class is a system to help clinicians determine how limited a patient is in their ability to do the activities of daily living. The scale ranges from class I to class IV. In general, patients with more severe Pulmonary Hypertension (PH) tend to have a higher functional class.|participants|Number|6|6.0||||||
4331510|NCT00439946|4158523|B1|||Years since PAH diagnosis||years|Mean|7|7.0|Full Range|||1.5|12.9|
4331511|NCT00439946|4158523|B1|cardiovascular disease (CVD)||Pulmonary Arterial Hypertension (PAH) etiology||participants|Number|2|2.0||||||
4331512|NCT00439946|4158523|B1|IPAH||Pulmonary Arterial Hypertension (PAH) etiology||participants|Number|6|6.0||||||
4331513|NCT00439946|4158523|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4331514|NCT00439946|4158523|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4331515|NCT00439946|4158523|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4331516|NCT00439946|4158523|B1|||Age||years|Mean|49.5|49.5|Full Range|||45.0|59.0|
4331517|NCT00439946|4158523|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4331518|NCT00439946|4158523|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4331519|NCT00439946|4158523|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331520|NCT00439777|4158540|B3||Male|Sex: Female, Male|Intention-to-treat (ITT) population|Participants|Count of Participants|2276|2276.0||||||
4331521|NCT00439777|4158541|B2||Male|Sex: Female, Male|Intention-to-treat (ITT) population|Participants|Count of Participants|1166|1166.0||||||
4331522|NCT00439777|4158542|B1||Male|Sex: Female, Male|Intention-to-treat (ITT) population|Participants|Count of Participants|1110|1110.0||||||
4331523|NCT00439777|4158540|B3||Female|Sex: Female, Male|Intention-to-treat (ITT) population|Participants|Count of Participants|2556|2556.0||||||
4331524|NCT00439777|4158541|B2||Female|Sex: Female, Male|Intention-to-treat (ITT) population|Participants|Count of Participants|1247|1247.0||||||
4331525|NCT00439777|4158542|B1||Female|Sex: Female, Male|Intention-to-treat (ITT) population|Participants|Count of Participants|1309|1309.0||||||
4331526|NCT00439777|4158540|B3|≥ 75 years||Age, Customized|Intention-to-treat (ITT) population|Participants|Number|923|923.0||||||
4331527|NCT00439777|4158541|B2|≥ 75 years||Age, Customized|Intention-to-treat (ITT) population|Participants|Number|448|448.0||||||
4331528|NCT00439777|4158542|B1|≥ 75 years||Age, Customized|Intention-to-treat (ITT) population|Participants|Number|475|475.0||||||
4331529|NCT00439777|4158540|B3|60 - < 75 years||Age, Customized|Intention-to-treat (ITT) population|Participants|Number|1494|1494.0||||||
4331530|NCT00439777|4158541|B2|60 - < 75 years||Age, Customized|Intention-to-treat (ITT) population|Participants|Number|754|754.0||||||
4331531|NCT00439777|4158542|B1|60 - < 75 years||Age, Customized|Intention-to-treat (ITT) population|Participants|Number|740|740.0||||||
4331532|NCT00439777|4158540|B3|40 - < 60 years||Age, Customized|Intention-to-treat (ITT) population|Participants|Number|1573|1573.0||||||
4331533|NCT00439777|4158541|B2|40 - < 60 years||Age, Customized|Intention-to-treat (ITT) population|Participants|Number|779|779.0||||||
4331534|NCT00439777|4158542|B1|40 - < 60 years||Age, Customized|Intention-to-treat (ITT) population|Participants|Number|794|794.0||||||
4331535|NCT00439777|4158540|B3|18 - < 40 years||Age, Customized|Intention-to-treat (ITT) population|Participants|Number|842|842.0||||||
4331536|NCT00439777|4158541|B2|18 - < 40 years||Age, Customized|Intention-to-treat (ITT) population|Participants|Number|432|432.0||||||
4331537|NCT00439777|4158542|B1|18 - < 40 years||Age, Customized|Intention-to-treat (ITT) population|Participants|Number|410|410.0||||||
4331538|NCT00439777|4158540|B3|||Age|Intention-to-treat (ITT) population|Years|Mean|57.7|57.7|Standard Deviation|17.3|17.3|||
4331539|NCT00439777|4158541|B2|||Age|Intention-to-treat (ITT) population|Years|Mean|57.5|57.5|Standard Deviation|17.2|17.2|||
4331540|NCT00439777|4158542|B1|||Age|Intention-to-treat (ITT) population|Years|Mean|57.9|57.9|Standard Deviation|17.3|17.3|||
4331541|NCT00439738|4158579|B3||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4331542|NCT00439738|4158580|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4331543|NCT00439738|4158581|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4331544|NCT00439738|4158579|B3||Female|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
4331545|NCT00439738|4158580|B2||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4331546|NCT00439738|4158581|B1||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4331547|NCT00439738|4158579|B3|>=65 years||Age, Customized||participants|Number|60|60.0||14.6|14.6|||
4331548|NCT00439738|4158580|B2|>=65 years||Age, Customized||participants|Number|26|26.0||12.6|12.6|||
4331549|NCT00439738|4158581|B1|>=65 years||Age, Customized||participants|Number|34|34.0||16.5|16.5|||
4331550|NCT00439738|4158579|B3|< 65 years||Age, Customized||participants|Number|352|352.0||85.4|85.4|||
4331551|NCT00439738|4158580|B2|< 65 years||Age, Customized||participants|Number|180|180.0||87.4|87.4|||
4331552|NCT00439738|4158581|B1|< 65 years||Age, Customized||participants|Number|172|172.0||83.5|83.5|||
4331553|NCT00439725|4158598|B3||Male|Sex: Female, Male|Number of participants analyzed for Baseline is intention-to-treat (ITT) population.|Participants|Count of Participants|693|693.0||||||
4331554|NCT00439725|4158599|B2||Male|Sex: Female, Male|Number of participants analyzed for Baseline is intention-to-treat (ITT) population.|Participants|Count of Participants|339|339.0||||||
4331555|NCT00439725|4158600|B1||Male|Sex: Female, Male|Number of participants analyzed for Baseline is intention-to-treat (ITT) population.|Participants|Count of Participants|354|354.0||||||
4331556|NCT00439725|4158598|B3||Female|Sex: Female, Male|Number of participants analyzed for Baseline is intention-to-treat (ITT) population.|Participants|Count of Participants|503|503.0||||||
4331557|NCT00439725|4158599|B2||Female|Sex: Female, Male|Number of participants analyzed for Baseline is intention-to-treat (ITT) population.|Participants|Count of Participants|255|255.0||||||
4331558|NCT00439725|4158600|B1||Female|Sex: Female, Male|Number of participants analyzed for Baseline is intention-to-treat (ITT) population.|Participants|Count of Participants|248|248.0||||||
4331559|NCT00439725|4158598|B3|>75 years||Age, Customized|Number of participants analyzed for Baseline is intention-to-treat (ITT) population.|participants|Number|188|188.0||||||
4331560|NCT00439725|4158599|B2|>75 years||Age, Customized|Number of participants analyzed for Baseline is intention-to-treat (ITT) population.|participants|Number|99|99.0||||||
4331561|NCT00439725|4158600|B1|>75 years||Age, Customized|Number of participants analyzed for Baseline is intention-to-treat (ITT) population.|participants|Number|89|89.0||||||
4331562|NCT00439725|4158598|B3|65 - 75 years||Age, Customized|Number of participants analyzed for Baseline is intention-to-treat (ITT) population.|participants|Number|274|274.0||||||
4331563|NCT00439725|4158599|B2|65 - 75 years||Age, Customized|Number of participants analyzed for Baseline is intention-to-treat (ITT) population.|participants|Number|121|121.0||||||
4331564|NCT00439725|4158600|B1|65 - 75 years||Age, Customized|Number of participants analyzed for Baseline is intention-to-treat (ITT) population.|participants|Number|153|153.0||||||
4331565|NCT00439725|4158598|B3|>40 - <65 years||Age, Customized|Number of participants analyzed for Baseline is intention-to-treat (ITT) population.|participants|Number|553|553.0||||||
4331566|NCT00439725|4158599|B2|>40 - <65 years||Age, Customized|Number of participants analyzed for Baseline is intention-to-treat (ITT) population.|participants|Number|280|280.0||||||
4331567|NCT00439725|4158600|B1|>40 - <65 years||Age, Customized|Number of participants analyzed for Baseline is intention-to-treat (ITT) population.|participants|Number|273|273.0||||||
4331568|NCT00439725|4158598|B3|18 - 40 years||Age, Customized|Number of participants analyzed for Baseline is intention-to-treat (ITT) population.|participants|Number|181|181.0||||||
4331569|NCT00439725|4158599|B2|18 - 40 years||Age, Customized|Number of participants analyzed for Baseline is intention-to-treat (ITT) population.|participants|Number|94|94.0||||||
4331570|NCT00439725|4158600|B1|18 - 40 years||Age, Customized|Number of participants analyzed for Baseline is intention-to-treat (ITT) population.|participants|Number|87|87.0||||||
4331571|NCT00439725|4158598|B3|||Age|Number of participants analyzed for Baseline is intention-to-treat (ITT) population.|years|Mean|58.3|58.3|Standard Deviation|15.8|15.8|||
4331572|NCT00439725|4158599|B2|||Age|Number of participants analyzed for Baseline is intention-to-treat (ITT) population.|years|Mean|58.4|58.4|Standard Deviation|16.0|16.0|||
4331573|NCT00439725|4158600|B1|||Age|Number of participants analyzed for Baseline is intention-to-treat (ITT) population.|years|Mean|58.2|58.2|Standard Deviation|15.6|15.6|||
4331574|NCT00439673|4158645|B1|Italy||Region of Enrollment||participants|Number|62|62.0||||||
4331575|NCT00439673|4158645|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4331576|NCT00439673|4158645|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4331577|NCT00439673|4158645|B1|Age||Age, Customized||years|Median|69.6|69.6|Full Range|||52.9|83.2|
4331578|NCT00439647|4158650|B3||Male|Sex: Female, Male||Participants|Count of Participants|1199|1199.0||||||
4331579|NCT00439647|4158651|B2||Male|Sex: Female, Male||Participants|Count of Participants|611|611.0||||||
4331580|NCT00439647|4158652|B1||Male|Sex: Female, Male||Participants|Count of Participants|588|588.0||||||
4331581|NCT00439647|4158650|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4331582|NCT00439647|4158651|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4331583|NCT00439647|4158652|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4331584|NCT00439647|4158650|B3|||Age||years|Mean|65.8|65.8|Standard Deviation|8.5|8.5|||
4331585|NCT00439647|4158651|B2|||Age||years|Mean|65.7|65.7|Standard Deviation|8.6|8.6|||
4331586|NCT00439647|4158652|B1|||Age||years|Mean|65.8|65.8|Standard Deviation|8.3|8.3|||
4331587|NCT00439608|4158685|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4331588|NCT00439608|4158685|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4331589|NCT00439608|4158685|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4331590|NCT00439608|4158685|B1|||Age||years|Mean|65|65.0|Standard Deviation|5|5.0|||
4331591|NCT00439608|4158685|B1||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
4331592|NCT00439608|4158685|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4331593|NCT00439608|4158685|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331594|NCT00439569|4158690|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4331595|NCT00439569|4158690|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4331596|NCT00439569|4158690|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4331597|NCT00439569|4158690|B1|>96 and < 144 months||Age, Customized||Participants|Number|1|1.0||||||
4331598|NCT00439569|4158690|B1|49 -96 months||Age, Customized||Participants|Number|3|3.0||||||
4331599|NCT00439569|4158690|B1|24 - 48 months||Age, Customized||Participants|Number|5|5.0||||||
4331600|NCT00439517|4158701|B3|Germany||Region of Enrollment||participants|Number|55|55.0||||||
4331601|NCT00439517|4158702|B2|Germany||Region of Enrollment||participants|Number|28|28.0||||||
4331602|NCT00439517|4158703|B1|Germany||Region of Enrollment||participants|Number|27|27.0||||||
4331603|NCT00439517|4158701|B3|Australia||Region of Enrollment||participants|Number|11|11.0||||||
4331604|NCT00439517|4158702|B2|Australia||Region of Enrollment||participants|Number|5|5.0||||||
4331605|NCT00439517|4158703|B1|Australia||Region of Enrollment||participants|Number|6|6.0||||||
4331606|NCT00439517|4158701|B3|Belgium||Region of Enrollment||participants|Number|12|12.0||||||
4331607|NCT00439517|4158702|B2|Belgium||Region of Enrollment||participants|Number|7|7.0||||||
4331608|NCT00439517|4158703|B1|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
4331609|NCT00439517|4158701|B3|Poland||Region of Enrollment||participants|Number|57|57.0||||||
4331610|NCT00439517|4158702|B2|Poland||Region of Enrollment||participants|Number|27|27.0||||||
4331611|NCT00439517|4158703|B1|Poland||Region of Enrollment||participants|Number|30|30.0||||||
4331612|NCT00439517|4158701|B3|Brazil||Region of Enrollment||participants|Number|14|14.0||||||
4331613|NCT00439517|4158702|B2|Brazil||Region of Enrollment||participants|Number|9|9.0||||||
4331614|NCT00439517|4158703|B1|Brazil||Region of Enrollment||participants|Number|5|5.0||||||
4331615|NCT00439517|4158701|B3|Argentina||Region of Enrollment||participants|Number|11|11.0||||||
4331616|NCT00439517|4158702|B2|Argentina||Region of Enrollment||participants|Number|6|6.0||||||
4331617|NCT00439517|4158703|B1|Argentina||Region of Enrollment||participants|Number|5|5.0||||||
4331618|NCT00439517|4158701|B3|Mexico||Region of Enrollment||participants|Number|4|4.0||||||
4331619|NCT00439517|4158702|B2|Mexico||Region of Enrollment||participants|Number|0|0.0||||||
4331620|NCT00439517|4158703|B1|Mexico||Region of Enrollment||participants|Number|4|4.0||||||
4331621|NCT00439517|4158701|B3|France||Region of Enrollment||participants|Number|14|14.0||||||
4331622|NCT00439517|4158702|B2|France||Region of Enrollment||participants|Number|8|8.0||||||
4331623|NCT00439517|4158703|B1|France||Region of Enrollment||participants|Number|6|6.0||||||
4331624|NCT00439517|4158701|B3|Italy||Region of Enrollment||participants|Number|61|61.0||||||
4331625|NCT00439517|4158702|B2|Italy||Region of Enrollment||participants|Number|33|33.0||||||
4331626|NCT00439517|4158703|B1|Italy||Region of Enrollment||participants|Number|28|28.0||||||
4331627|NCT00439517|4158701|B3|Austria||Region of Enrollment||participants|Number|22|22.0||||||
4331628|NCT00439517|4158702|B2|Austria||Region of Enrollment||participants|Number|9|9.0||||||
4331629|NCT00439517|4158703|B1|Austria||Region of Enrollment||participants|Number|13|13.0||||||
4331630|NCT00439517|4158701|B3|Thailand||Region of Enrollment||participants|Number|16|16.0||||||
4331631|NCT00439517|4158702|B2|Thailand||Region of Enrollment||participants|Number|9|9.0||||||
4331632|NCT00439517|4158703|B1|Thailand||Region of Enrollment||participants|Number|7|7.0||||||
4331633|NCT00439517|4158701|B3|Greece||Region of Enrollment||participants|Number|14|14.0||||||
4331634|NCT00439517|4158702|B2|Greece||Region of Enrollment||participants|Number|5|5.0||||||
4331635|NCT00439517|4158703|B1|Greece||Region of Enrollment||participants|Number|9|9.0||||||
4331636|NCT00439517|4158701|B3|Hong Kong||Region of Enrollment||participants|Number|11|11.0||||||
4331637|NCT00439517|4158702|B2|Hong Kong||Region of Enrollment||participants|Number|4|4.0||||||
4331638|NCT00439517|4158703|B1|Hong Kong||Region of Enrollment||participants|Number|7|7.0||||||
4331639|NCT00439517|4158701|B3||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4331640|NCT00439517|4158702|B2||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4331641|NCT00439517|4158703|B1||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4331642|NCT00439517|4158701|B3||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4331643|NCT00439517|4158702|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4331644|NCT00439517|4158703|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4331645|NCT00439517|4158701|B3|Missing||Age, Customized||participants|Number|2|2.0||||||
4331646|NCT00439517|4158702|B2|Missing||Age, Customized||participants|Number|0|0.0||||||
4331647|NCT00439517|4158703|B1|Missing||Age, Customized||participants|Number|2|2.0||||||
4331648|NCT00439517|4158701|B3|>=65 years||Age, Customized||participants|Number|123|123.0||||||
4331649|NCT00439517|4158702|B2|>=65 years||Age, Customized||participants|Number|66|66.0||||||
4331650|NCT00439517|4158703|B1|>=65 years||Age, Customized||participants|Number|57|57.0||||||
4331651|NCT00439517|4158701|B3|<65 years||Age, Customized||participants|Number|177|177.0||||||
4331652|NCT00439517|4158702|B2|<65 years||Age, Customized||participants|Number|84|84.0||||||
4331653|NCT00439517|4158703|B1|<65 years||Age, Customized||participants|Number|93|93.0||||||
4331654|NCT00439517|4158701|B3|||Age||years|Mean|60.5|60.5|Standard Deviation|10.53|10.53|||
4331655|NCT00439517|4158702|B2|||Age||years|Mean|61|61.0|Standard Deviation|11.04|11.04|||
4331656|NCT00439517|4158703|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|10.01|10.01|||
4331657|NCT00439413|4158726|B3|United States||Region of Enrollment||participants|Number|246|246.0||||||
4331658|NCT00439413|4158727|B2|United States||Region of Enrollment||participants|Number|125|125.0||||||
4331659|NCT00439413|4158728|B1|United States||Region of Enrollment||participants|Number|121|121.0||||||
4331660|NCT00439413|4158726|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4331661|NCT00439413|4158727|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4331662|NCT00439413|4158728|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4331663|NCT00439413|4158726|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4331664|NCT00439413|4158727|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4331665|NCT00439413|4158728|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4331666|NCT00439413|4158726|B3||White|Race (NIH/OMB)||Participants|Count of Participants|173|173.0||||||
4331667|NCT00439413|4158727|B2||White|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
4331668|NCT00439413|4158728|B1||White|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4331669|NCT00439413|4158726|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4331670|NCT00439413|4158727|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4331671|NCT00439413|4158728|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4331672|NCT00439413|4158726|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4331673|NCT00439413|4158727|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4331674|NCT00439413|4158728|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4331675|NCT00439413|4158726|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4331676|NCT00439413|4158727|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4331677|NCT00439413|4158728|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4331678|NCT00439413|4158726|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4331679|NCT00439413|4158727|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4331680|NCT00439413|4158728|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4331681|NCT00439413|4158726|B3||Male|Gender||Participants|Count of Participants|125|125.0||||||
4331682|NCT00439413|4158727|B2||Male|Gender||Participants|Count of Participants|66|66.0||||||
4331683|NCT00439413|4158728|B1||Male|Gender||Participants|Count of Participants|59|59.0||||||
4331684|NCT00439413|4158726|B3||Female|Gender||Participants|Count of Participants|121|121.0||||||
4331685|NCT00439413|4158727|B2||Female|Gender||Participants|Count of Participants|59|59.0||||||
4331686|NCT00439413|4158728|B1||Female|Gender||Participants|Count of Participants|62|62.0||||||
4331687|NCT00439413|4158726|B3|||Age||years|Mean|46.5|46.5|Standard Deviation|14|14.0|||
4331688|NCT00439413|4158727|B2|||Age||years|Mean|47.3|47.3|Standard Deviation|13.6|13.6|||
4331689|NCT00439413|4158728|B1|||Age||years|Mean|45.6|45.6|Standard Deviation|14.2|14.2|||
4331690|NCT00439335|4158737|B3|United States||Region of Enrollment||participants|Number|227|227.0||||||
4331691|NCT00439335|4158738|B2|United States||Region of Enrollment||participants|Number|114|114.0||||||
4331692|NCT00439335|4158739|B1|United States||Region of Enrollment||participants|Number|113|113.0||||||
4331693|NCT00439335|4158737|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4331694|NCT00439335|4158738|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4331695|NCT00439335|4158739|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4331696|NCT00439335|4158737|B3||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4331697|NCT00439335|4158738|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4331698|NCT00439335|4158739|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4331699|NCT00439335|4158737|B3|||Age||years|Mean|30.1|30.1|Standard Deviation|7.7|7.7|||
4331700|NCT00439335|4158738|B2|||Age||years|Mean|30.5|30.5|Standard Deviation|8.0|8.0|||
4331701|NCT00439335|4158739|B1|||Age||years|Mean|29.7|29.7|Standard Deviation|7.4|7.4|||
4331702|NCT00439335|4158737|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4331703|NCT00439335|4158738|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4331704|NCT00439335|4158739|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4331705|NCT00439335|4158737|B3||Between 18 and 65 years|Age||Participants|Count of Participants|227|227.0||||||
4331706|NCT00439335|4158738|B2||Between 18 and 65 years|Age||Participants|Count of Participants|114|114.0||||||
4331707|NCT00439335|4158739|B1||Between 18 and 65 years|Age||Participants|Count of Participants|113|113.0||||||
4331708|NCT00439335|4158737|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331709|NCT00439335|4158738|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331710|NCT00439335|4158739|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331711|NCT00439309|4158770|B3|United States||Region of Enrollment||participants|Number|69|69.0||||||
4331712|NCT00439309|4158771|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4331713|NCT00439309|4158772|B1|United States||Region of Enrollment||participants|Number|54|54.0||||||
4331714|NCT00439309|4158770|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4331715|NCT00439309|4158771|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4331716|NCT00439309|4158772|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4331717|NCT00439309|4158770|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4331718|NCT00439309|4158771|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4331719|NCT00439309|4158772|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4331720|NCT00439309|4158770|B3|||Age||years|Mean|62.51|62.51|Standard Deviation|11.904|11.904|||
4331721|NCT00439309|4158771|B2|||Age||years|Mean|60.91|60.91|Standard Deviation|12.958|12.958|||
4331722|NCT00439309|4158772|B1|||Age||years|Mean|63.45|63.45|Standard Deviation|11.773|11.773|||
4331723|NCT00439309|4158770|B3||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4331724|NCT00439309|4158771|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4331725|NCT00439309|4158772|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4331726|NCT00439309|4158770|B3||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4331727|NCT00439309|4158771|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4331728|NCT00439309|4158772|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4331729|NCT00439309|4158770|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331730|NCT00439309|4158771|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331731|NCT00439309|4158772|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331732|NCT00439270|4158787|B6|Not Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|45|45.0||||||
4331733|NCT00439270|4158788|B5|Not Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4331734|NCT00439270|4158789|B4|Not Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|33|33.0||||||
4331735|NCT00439270|4158790|B3|Not Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4331736|NCT00439270|4158791|B2|Not Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4331737|NCT00439270|4158792|B1|Not Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4331738|NCT00439270|4158787|B6|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4331739|NCT00439270|4158788|B5|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4331740|NCT00439270|4158789|B4|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4331741|NCT00439270|4158790|B3|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4331742|NCT00439270|4158791|B2|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4331743|NCT00439270|4158792|B1|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4331744|NCT00439270|4158787|B6|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4331745|NCT00439270|4158788|B5|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4331746|NCT00439270|4158789|B4|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4331747|NCT00439270|4158790|B3|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4331748|NCT00439270|4158791|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4331749|NCT00439270|4158792|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4331750|NCT00439270|4158787|B6|White||Race/Ethnicity, Customized||Participants|Number|41|41.0||||||
4331751|NCT00439270|4158788|B5|White||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4331752|NCT00439270|4158789|B4|White||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
4331753|NCT00439270|4158790|B3|White||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4331754|NCT00439270|4158791|B2|White||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4331755|NCT00439270|4158792|B1|White||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4331756|NCT00439270|4158787|B6|Black or African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4331757|NCT00439270|4158788|B5|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4331758|NCT00439270|4158789|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4331759|NCT00439270|4158790|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4331760|NCT00439270|4158791|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4331761|NCT00439270|4158792|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4331762|NCT00439270|4158787|B6||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4331763|NCT00439270|4158788|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4331764|NCT00439270|4158789|B4||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4331765|NCT00439270|4158790|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4331766|NCT00439270|4158791|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4331767|NCT00439270|4158792|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4331768|NCT00439270|4158787|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4331769|NCT00439270|4158788|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4331770|NCT00439270|4158789|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4331771|NCT00439270|4158790|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4331772|NCT00439270|4158791|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4331773|NCT00439270|4158792|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4331774|NCT00439270|4158787|B6|>=65 years||Age, Customized||Participants|Number|23|23.0||||||
4331775|NCT00439270|4158788|B5|>=65 years||Age, Customized||Participants|Number|1|1.0||||||
4331776|NCT00439270|4158789|B4|>=65 years||Age, Customized||Participants|Number|15|15.0||||||
4331777|NCT00439270|4158790|B3|>=65 years||Age, Customized||Participants|Number|2|2.0||||||
4331778|NCT00439270|4158791|B2|>=65 years||Age, Customized||Participants|Number|2|2.0||||||
4331779|NCT00439270|4158792|B1|>=65 years||Age, Customized||Participants|Number|3|3.0||||||
4331780|NCT00439270|4158787|B6|<65 years||Age, Customized||Participants|Number|23|23.0||||||
4331781|NCT00439270|4158788|B5|<65 years||Age, Customized||Participants|Number|2|2.0||13.23|13.23|||
4331782|NCT00439270|4158789|B4|<65 years||Age, Customized||Participants|Number|19|19.0||8.43|8.43|||
4331783|NCT00439270|4158790|B3|<65 years||Age, Customized||Participants|Number|1|1.0||11.02|11.02|||
4331784|NCT00439270|4158791|B2|<65 years||Age, Customized||Participants|Number|1|1.0||5.03|5.03|||
4331785|NCT00439270|4158792|B1|<65 years||Age, Customized||Participants|Number|0|0.0||3.51|3.51|||
4331786|NCT00439244|4158835|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4331787|NCT00439244|4158836|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4331788|NCT00439244|4158837|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4331789|NCT00439244|4158838|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4331790|NCT00439244|4158835|B4||Female|Sex: Female, Male||Participants|Count of Participants|412|412.0||||||
4331791|NCT00439244|4158836|B3||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4331792|NCT00439244|4158837|B2||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4331793|NCT00439244|4158838|B1||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4331794|NCT00439244|4158835|B4|||Age||years|Mean|65.0|65.0|Standard Deviation|8.99|8.99|||
4331795|NCT00439244|4158836|B3|||Age||years|Mean|63.8|63.8|Standard Deviation|9.08|9.08|||
4331796|NCT00439244|4158837|B2|||Age||years|Mean|66.1|66.1|Standard Deviation|9.02|9.02|||
4331797|NCT00439244|4158838|B1|||Age||years|Mean|65.0|65.0|Standard Deviation|8.78|8.78|||
4331798|NCT00439231|4158860|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4331799|NCT00439231|4158860|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4331800|NCT00439231|4158860|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4331801|NCT00439231|4158860|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4331802|NCT00439231|4158860|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4331803|NCT00439231|4158860|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4331804|NCT00439231|4158860|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4331805|NCT00439231|4158860|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4331806|NCT00439231|4158860|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4331807|NCT00439231|4158860|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4331808|NCT00439231|4158860|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4331809|NCT00439231|4158860|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4331810|NCT00439231|4158860|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4331811|NCT00439231|4158860|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4331812|NCT00439231|4158860|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331813|NCT00439218|4158864|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4331814|NCT00439218|4158864|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4331815|NCT00439218|4158864|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4331816|NCT00439218|4158864|B1|13-18 months||Age, Customized||months|Number|3|3.0||||||
4331817|NCT00439218|4158864|B1|7-12 months||Age, Customized||months|Number|2|2.0||||||
4331818|NCT00439179|4158875|B5|United States||Region of Enrollment||participants|Number|25|25.0||||||
4331819|NCT00439179|4158876|B4|United States||Region of Enrollment||participants|Number|5|5.0||||||
4331820|NCT00439179|4158877|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4331821|NCT00439179|4158878|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4331822|NCT00439179|4158879|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4331823|NCT00439179|4158875|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4331824|NCT00439179|4158876|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4331825|NCT00439179|4158877|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4331826|NCT00439179|4158878|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4331827|NCT00439179|4158879|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4331828|NCT00439179|4158875|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4331829|NCT00439179|4158876|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4331830|NCT00439179|4158877|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4331831|NCT00439179|4158878|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4331832|NCT00439179|4158879|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4331833|NCT00439179|4158875|B5|||Age||years|Mean|63.7|63.7|Standard Deviation|10.7|10.7|||
4331834|NCT00439179|4158876|B4|||Age||years|Mean|64.2|64.2|Standard Deviation|12|12.0|||
4331835|NCT00439179|4158877|B3|||Age||years|Mean|61.5|61.5|Standard Deviation|6|6.0|||
4331836|NCT00439179|4158878|B2|||Age||years|Mean|66|66.0|Standard Deviation|11|11.0|||
4331837|NCT00439179|4158879|B1|||Age||years|Mean|58.6|58.6|Standard Deviation|17|17.0|||
4331838|NCT00439179|4158875|B5||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4331839|NCT00439179|4158876|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4331840|NCT00439179|4158877|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4331841|NCT00439179|4158878|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4331842|NCT00439179|4158879|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4331843|NCT00439179|4158875|B5||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4331844|NCT00439179|4158876|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4331845|NCT00439179|4158877|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4331846|NCT00439179|4158878|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4331847|NCT00439179|4158879|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4331848|NCT00439179|4158875|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331849|NCT00439179|4158876|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331850|NCT00439179|4158877|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331851|NCT00439179|4158878|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331852|NCT00439179|4158879|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331853|NCT00439140|4158896|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4331854|NCT00439140|4158897|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4331855|NCT00439140|4158898|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4331856|NCT00439140|4158899|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4331857|NCT00439140|4158896|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4331858|NCT00439140|4158897|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4331859|NCT00439140|4158898|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4331860|NCT00439140|4158899|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4331861|NCT00439140|4158896|B4|≥ 65 Years||Age, Customized||participants|Number|2|2.0||||||
4331862|NCT00439140|4158897|B3|≥ 65 Years||Age, Customized||participants|Number|0|0.0||||||
4331863|NCT00439140|4158898|B2|≥ 65 Years||Age, Customized||participants|Number|0|0.0||||||
4331864|NCT00439140|4158899|B1|≥ 65 Years||Age, Customized||participants|Number|2|2.0||||||
4331865|NCT00439140|4158896|B4|40-64 Years||Age, Customized||participants|Number|16|16.0||||||
4331866|NCT00439140|4158897|B3|40-64 Years||Age, Customized||participants|Number|6|6.0||||||
4331867|NCT00439140|4158898|B2|40-64 Years||Age, Customized||participants|Number|6|6.0||||||
4331868|NCT00439140|4158899|B1|40-64 Years||Age, Customized||participants|Number|4|4.0||||||
4331869|NCT00439140|4158896|B4|< 40 Years||Age, Customized||participants|Number|23|23.0||||||
4331870|NCT00439140|4158897|B3|< 40 Years||Age, Customized||participants|Number|6|6.0||||||
4331871|NCT00439140|4158898|B2|< 40 Years||Age, Customized||participants|Number|8|8.0||||||
4331872|NCT00439140|4158899|B1|< 40 Years||Age, Customized||participants|Number|9|9.0||||||
4331873|NCT00438971|4158930|B1|||Panic Attack Scale (PAS)||units on a scale|Mean|3.90|3.9|Standard Deviation|2.38|2.38|||
4331874|NCT00438971|4158930|B1|||Clinical Global Impression of Severity scale (CGI-S)||units on a scale|Mean|4.80|4.8|Standard Deviation|0.67|0.67|||
4331875|NCT00438971|4158930|B1|||Panic Disorder Severity Scale (PDSS) - Primary Outcome||units on a scale|Mean|14.2|14.2|Standard Deviation|4.28|4.28|||
4331876|NCT00438971|4158930|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4331877|NCT00438971|4158930|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4331878|NCT00438971|4158930|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4331879|NCT00438971|4158930|B1|||Age||years|Mean|41.1|41.1|Standard Deviation|15|15.0|||
4331880|NCT00438971|4158930|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4331881|NCT00438971|4158930|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4331882|NCT00438971|4158930|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331883|NCT00438932|4158941|B5|||24-hr urine phosphate|measured from 24 hour urine collections; 2 separate collections were obtained; values are means of the two collections; pre-intervention|mg|Mean|775.2|775.2|Standard Deviation|320.0|320.0|564.0|889.0|
4331884|NCT00438932|4158942|B4|||24-hr urine phosphate|measured from 24 hour urine collections; 2 separate collections were obtained; values are means of the two collections; pre-intervention|mg|Mean|934.6|934.6|Standard Deviation|545.5|545.5|607.0|1262.0|
4331885|NCT00438932|4158943|B3|||24-hr urine phosphate|measured from 24 hour urine collections; 2 separate collections were obtained; values are means of the two collections; pre-intervention|mg|Mean|745.4|745.4|Standard Deviation|287.0|287.0|503.0|988.0|
4331886|NCT00438932|4158944|B2|||24-hr urine phosphate|measured from 24 hour urine collections; 2 separate collections were obtained; values are means of the two collections; pre-intervention|mg|Mean|761.8|761.8|Standard Deviation|77.4|77.4|704.0|820.0|
4331887|NCT00438932|4158945|B1|||24-hr urine phosphate|measured from 24 hour urine collections; 2 separate collections were obtained; values are means of the two collections; pre-intervention|mg|Mean|659.0|659.0|Standard Deviation|269.8|269.8|491.0|827.0|
4331947|NCT00438815|4158984|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4331888|NCT00438932|4158941|B5|||Fibroblast Growth Factor 23 (FGF-23)|Plasma FGF-23 at the baseline visit was measured using C-terminal FGF23 assay.|Ru/ml|Mean|182.0|182.0|Standard Deviation|116.3|116.3|95.0|223.0|
4331889|NCT00438932|4158942|B4|||Fibroblast Growth Factor 23 (FGF-23)|Plasma FGF-23 at the baseline visit was measured using C-terminal FGF23 assay.|Ru/ml|Mean|121.8|121.8|Standard Deviation|60.0|60.0|85.0|158.0|
4331890|NCT00438932|4158943|B3|||Fibroblast Growth Factor 23 (FGF-23)|Plasma FGF-23 at the baseline visit was measured using C-terminal FGF23 assay.|Ru/ml|Mean|178.8|178.8|Standard Deviation|97.6|97.6|103.0|254.0|
4331891|NCT00438932|4158944|B2|||Fibroblast Growth Factor 23 (FGF-23)|Plasma FGF-23 at the baseline visit was measured using C-terminal FGF23 assay.|Ru/ml|Mean|263.1|263.1|Standard Deviation|167.9|167.9|158.0|368.0|
4331892|NCT00438932|4158945|B1|||Fibroblast Growth Factor 23 (FGF-23)|Plasma FGF-23 at the baseline visit was measured using C-terminal FGF23 assay.|Ru/ml|Mean|164.3|164.3|Standard Deviation|110.9|110.9|77.0|252.0|
4331893|NCT00438932|4158941|B5|United States||Region of Enrollment||participants|Number|16|16.0||||||
4331894|NCT00438932|4158942|B4|United States||Region of Enrollment||participants|Number|4|4.0||||||
4331895|NCT00438932|4158943|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4331896|NCT00438932|4158944|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4331897|NCT00438932|4158945|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4331898|NCT00438932|4158941|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4331899|NCT00438932|4158942|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4331900|NCT00438932|4158943|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4331901|NCT00438932|4158944|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4331902|NCT00438932|4158945|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4331903|NCT00438932|4158941|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4331904|NCT00438932|4158942|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4331905|NCT00438932|4158943|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4331906|NCT00438932|4158944|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4331907|NCT00438932|4158945|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4331908|NCT00438932|4158941|B5|||Age||years|Mean|62|62.0|Standard Deviation|15|15.0|||
4331909|NCT00438932|4158942|B4|||Age||years|Mean|68|68.0|Standard Deviation|17|17.0|||
4331910|NCT00438932|4158943|B3|||Age||years|Mean|56|56.0|Standard Deviation|21|21.0|||
4331911|NCT00438932|4158944|B2|||Age||years|Mean|62|62.0|Standard Deviation|13|13.0|||
4331912|NCT00438932|4158945|B1|||Age||years|Mean|63|63.0|Standard Deviation|11|11.0|||
4331913|NCT00438932|4158941|B5||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4331914|NCT00438932|4158942|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4331915|NCT00438932|4158943|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4331916|NCT00438932|4158944|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4331917|NCT00438932|4158945|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4331918|NCT00438932|4158941|B5||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4331919|NCT00438932|4158942|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4331920|NCT00438932|4158943|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4331921|NCT00438932|4158944|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4331922|NCT00438932|4158945|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4331923|NCT00438932|4158941|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331924|NCT00438932|4158942|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331925|NCT00438932|4158943|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331926|NCT00438932|4158944|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331927|NCT00438932|4158945|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331928|NCT00438880|4158962|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
4331929|NCT00438880|4158963|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4331930|NCT00438880|4158964|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4331931|NCT00438880|4158962|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4331932|NCT00438880|4158963|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4331933|NCT00438880|4158964|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4331934|NCT00438880|4158962|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4331935|NCT00438880|4158963|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4331936|NCT00438880|4158964|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4331937|NCT00438880|4158962|B3|||Age||years|Median|62.5|62.5|Full Range|||36.0|83.0|
4331938|NCT00438880|4158963|B2|||Age||years|Median|68.5|68.5|Full Range|||42.0|83.0|
4331939|NCT00438880|4158964|B1|||Age||years|Median|60.5|60.5|Full Range|||36.0|80.0|
4331940|NCT00438854|4158977|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4331941|NCT00438854|4158977|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4331942|NCT00438854|4158977|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4331943|NCT00438854|4158977|B1|||Age||years|Mean|60.67|60.67|Standard Deviation|12|12.0|||
4331944|NCT00438854|4158977|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4331945|NCT00438854|4158977|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4331946|NCT00438854|4158977|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331948|NCT00438815|4158984|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4331949|NCT00438815|4158984|B1|||Age||years|Mean|34.5|34.5|Standard Deviation|17.6|17.6|||
4331950|NCT00438802|4158994|B4|United States||Region of Enrollment||participants|Number|23|23.0||||||
4331951|NCT00438802|4158995|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4331952|NCT00438802|4158996|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4331953|NCT00438802|4158997|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4331954|NCT00438802|4158994|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4331955|NCT00438802|4158995|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4331956|NCT00438802|4158996|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4331957|NCT00438802|4158997|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4331958|NCT00438802|4158994|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4331959|NCT00438802|4158995|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4331960|NCT00438802|4158996|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4331961|NCT00438802|4158997|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4331962|NCT00438802|4158994|B4|||Age||years|Median|64|64.0|Full Range|||46.0|80.0|
4331963|NCT00438802|4158995|B3|||Age||years|Median|66|66.0|Full Range|||56.0|76.0|
4331964|NCT00438802|4158996|B2|||Age||years|Median|69|69.0|Full Range|||48.0|80.0|
4331965|NCT00438802|4158997|B1|||Age||years|Median|50.5|50.5|Full Range|||46.0|80.0|
4331966|NCT00438750|4159011|B3|United States||Region of Enrollment||participants|Number|94|94.0||||||
4331967|NCT00438750|4159012|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
4331968|NCT00438750|4159013|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4331969|NCT00438750|4159011|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4331970|NCT00438750|4159012|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4331971|NCT00438750|4159013|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4331972|NCT00438750|4159011|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4331973|NCT00438750|4159012|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4331974|NCT00438750|4159013|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4331975|NCT00438750|4159011|B3|||Age||years|Mean|50|50.0|Standard Deviation|15|15.0|||
4331976|NCT00438750|4159012|B2|||Age||years|Mean|51|51.0|Standard Deviation|15|15.0|||
4331977|NCT00438750|4159013|B1|||Age||years|Mean|49|49.0|Standard Deviation|15|15.0|||
4331978|NCT00438750|4159011|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4331979|NCT00438750|4159012|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4331980|NCT00438750|4159013|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4331981|NCT00438750|4159011|B3||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
4331982|NCT00438750|4159012|B2||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4331983|NCT00438750|4159013|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4331984|NCT00438750|4159011|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331985|NCT00438750|4159012|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331986|NCT00438750|4159013|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4331987|NCT00438672|4159032|B3|United States||Region of Enrollment||participants|Number|64|64.0||||||
4331988|NCT00438672|4159033|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4331989|NCT00438672|4159034|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4331990|NCT00438672|4159032|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4331991|NCT00438672|4159033|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4331992|NCT00438672|4159034|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4331993|NCT00438672|4159032|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4331994|NCT00438672|4159033|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4331995|NCT00438672|4159034|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4331996|NCT00438672|4159032|B3|||Age||years|Mean|49|49.0|Standard Deviation|9|9.0|||
4331997|NCT00438672|4159033|B2|||Age||years|Mean|49|49.0|Standard Deviation|10|10.0|||
4331998|NCT00438672|4159034|B1|||Age||years|Mean|48|48.0|Standard Deviation|8|8.0|||
4331999|NCT00438672|4159032|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4332000|NCT00438672|4159033|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4332001|NCT00438672|4159034|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4332002|NCT00438672|4159032|B3||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4332003|NCT00438672|4159033|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4332004|NCT00438672|4159034|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4332005|NCT00438672|4159032|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4332006|NCT00438672|4159033|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4332007|NCT00438672|4159034|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4332008|NCT00438659|4159043|B3|United States||Region of Enrollment||participants|Number|169|169.0||||||
4332009|NCT00438659|4159044|B2|United States||Region of Enrollment||participants|Number|84|84.0||||||
4332010|NCT00438659|4159045|B1|United States||Region of Enrollment||participants|Number|85|85.0||||||
4332011|NCT00438659|4159043|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4332012|NCT00438659|4159044|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4332013|NCT00438659|4159045|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4332014|NCT00438659|4159043|B3||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4332015|NCT00438659|4159044|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4332016|NCT00438659|4159045|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4332017|NCT00438659|4159043|B3|||Age||years|Median|59|59.0|Full Range|13.29|13.29|27.0|89.0|
4332018|NCT00438659|4159044|B2|||Age||years|Median|57|57.0|Full Range|11.8|11.8|27.0|85.0|
4332019|NCT00438659|4159045|B1|||Age||years|Median|60|60.0|Full Range|14.63|14.63|35.0|89.0|
4332020|NCT00438490|4159068|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4332021|NCT00438490|4159069|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4332022|NCT00438490|4159070|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4332023|NCT00438490|4159068|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4332024|NCT00438490|4159069|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4332025|NCT00438490|4159070|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4332026|NCT00438490|4159068|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4332027|NCT00438490|4159069|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4332028|NCT00438490|4159070|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4332029|NCT00438490|4159068|B3|||Age||years|Mean|28.4|28.4|Standard Deviation|5.4|5.4|||
4332030|NCT00438490|4159069|B2|||Age||years|Mean|27.9|27.9|Standard Deviation|6.4|6.4|||
4332031|NCT00438490|4159070|B1|||Age||years|Mean|29.1|29.1|Standard Deviation|4.0|4.0|||
4332032|NCT00438490|4159068|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4332033|NCT00438490|4159069|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4332034|NCT00438490|4159070|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4332035|NCT00438490|4159068|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4332036|NCT00438490|4159069|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4332037|NCT00438490|4159070|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4332038|NCT00438490|4159068|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4332039|NCT00438490|4159069|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4332040|NCT00438490|4159070|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4332041|NCT00438464|4159083|B3|United States||Region of Enrollment||participants|Number|183|183.0||||||
4332042|NCT00438464|4159084|B2|United States||Region of Enrollment||participants|Number|94|94.0||||||
4332043|NCT00438464|4159085|B1|United States||Region of Enrollment||participants|Number|89|89.0||||||
4332044|NCT00438464|4159083|B3|White||Race/Ethnicity, Customized||participants|Number|163|163.0||||||
4332045|NCT00438464|4159084|B2|White||Race/Ethnicity, Customized||participants|Number|85|85.0||||||
4332046|NCT00438464|4159085|B1|White||Race/Ethnicity, Customized||participants|Number|78|78.0||||||
4332047|NCT00438464|4159083|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4332048|NCT00438464|4159084|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4332049|NCT00438464|4159085|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4332050|NCT00438464|4159083|B3|Black||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4332051|NCT00438464|4159084|B2|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4332052|NCT00438464|4159085|B1|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4332053|NCT00438464|4159083|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4332054|NCT00438464|4159084|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4332055|NCT00438464|4159085|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4332056|NCT00438464|4159083|B3||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4332057|NCT00438464|4159084|B2||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4332058|NCT00438464|4159085|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4332059|NCT00438464|4159083|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4332060|NCT00438464|4159084|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4332061|NCT00438464|4159085|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4332062|NCT00438464|4159083|B3|||Age||years|Median|60|60.0|Full Range|||45.0|73.0|
4332063|NCT00438464|4159084|B2|||Age||years|Median|62|62.0|Full Range|||48.0|73.0|
4332064|NCT00438464|4159085|B1|||Age||years|Median|59|59.0|Full Range|||45.0|73.0|
4332065|NCT00438451|4159138|B4|Missing||CCT (Cranial Computed Tomography) pathological|is shown for ITT population|participants|Number|76|76.0||||||
4332066|NCT00438451|4159139|B3|Missing||CCT (Cranial Computed Tomography) pathological|is shown for ITT population|participants|Number|34|34.0||||||
4332067|NCT00438451|4159140|B2|Missing||CCT (Cranial Computed Tomography) pathological|is shown for ITT population|participants|Number|19|19.0||||||
4332068|NCT00438451|4159141|B1|Missing||CCT (Cranial Computed Tomography) pathological|is shown for ITT population|participants|Number|23|23.0||||||
4332069|NCT00438451|4159138|B4|No||CCT (Cranial Computed Tomography) pathological|is shown for ITT population|participants|Number|61|61.0||||||
4332070|NCT00438451|4159139|B3|No||CCT (Cranial Computed Tomography) pathological|is shown for ITT population|participants|Number|19|19.0||||||
4332071|NCT00438451|4159140|B2|No||CCT (Cranial Computed Tomography) pathological|is shown for ITT population|participants|Number|19|19.0||||||
4332072|NCT00438451|4159141|B1|No||CCT (Cranial Computed Tomography) pathological|is shown for ITT population|participants|Number|23|23.0||||||
4332073|NCT00438451|4159138|B4|Yes||CCT (Cranial Computed Tomography) pathological|is shown for ITT population|participants|Number|222|222.0||||||
4332074|NCT00438451|4159139|B3|Yes||CCT (Cranial Computed Tomography) pathological|is shown for ITT population|participants|Number|64|64.0||||||
4332075|NCT00438451|4159140|B2|Yes||CCT (Cranial Computed Tomography) pathological|is shown for ITT population|participants|Number|82|82.0||||||
4332076|NCT00438451|4159141|B1|Yes||CCT (Cranial Computed Tomography) pathological|is shown for ITT population|participants|Number|76|76.0||||||
4332077|NCT00438451|4159138|B4|Missing||MRT (Magnetic Resonance Tomograhy) pathological|is shown for ITT population|participants|Number|141|141.0||||||
4332078|NCT00438451|4159139|B3|Missing||MRT (Magnetic Resonance Tomograhy) pathological|is shown for ITT population|participants|Number|42|42.0||||||
4332079|NCT00438451|4159140|B2|Missing||MRT (Magnetic Resonance Tomograhy) pathological|is shown for ITT population|participants|Number|47|47.0||||||
4332080|NCT00438451|4159141|B1|Missing||MRT (Magnetic Resonance Tomograhy) pathological|is shown for ITT population|participants|Number|52|52.0||||||
4332081|NCT00438451|4159138|B4|No||MRT (Magnetic Resonance Tomograhy) pathological|is shown for ITT population|participants|Number|34|34.0||||||
4332082|NCT00438451|4159139|B3|No||MRT (Magnetic Resonance Tomograhy) pathological|is shown for ITT population|participants|Number|13|13.0||||||
4332083|NCT00438451|4159140|B2|No||MRT (Magnetic Resonance Tomograhy) pathological|is shown for ITT population|participants|Number|10|10.0||||||
4332084|NCT00438451|4159141|B1|No||MRT (Magnetic Resonance Tomograhy) pathological|is shown for ITT population|participants|Number|11|11.0||||||
4332085|NCT00438451|4159138|B4|Yes||MRT (Magnetic Resonance Tomograhy) pathological|is shown for ITT population|participants|Number|184|184.0||||||
4332086|NCT00438451|4159139|B3|Yes||MRT (Magnetic Resonance Tomograhy) pathological|is shown for ITT population|participants|Number|62|62.0||||||
4332087|NCT00438451|4159140|B2|Yes||MRT (Magnetic Resonance Tomograhy) pathological|is shown for ITT population|participants|Number|63|63.0||||||
4332088|NCT00438451|4159141|B1|Yes||MRT (Magnetic Resonance Tomograhy) pathological|is shown for ITT population|participants|Number|59|59.0||||||
4332089|NCT00438451|4159138|B4|Missing||EEG (electroencephalogram) pathological|is shown for ITT population|participants|Number|2|2.0||||||
4332090|NCT00438451|4159139|B3|Missing||EEG (electroencephalogram) pathological|is shown for ITT population|participants|Number|1|1.0||||||
4332091|NCT00438451|4159140|B2|Missing||EEG (electroencephalogram) pathological|is shown for ITT population|participants|Number|0|0.0||||||
4332092|NCT00438451|4159141|B1|Missing||EEG (electroencephalogram) pathological|is shown for ITT population|participants|Number|1|1.0||||||
4332093|NCT00438451|4159138|B4|No||EEG (electroencephalogram) pathological|is shown for ITT population|participants|Number|116|116.0||||||
4332094|NCT00438451|4159139|B3|No||EEG (electroencephalogram) pathological|is shown for ITT population|participants|Number|45|45.0||||||
4332095|NCT00438451|4159140|B2|No||EEG (electroencephalogram) pathological|is shown for ITT population|participants|Number|36|36.0||||||
4332096|NCT00438451|4159141|B1|No||EEG (electroencephalogram) pathological|is shown for ITT population|participants|Number|35|35.0||||||
4332097|NCT00438451|4159138|B4|Yes||EEG (electroencephalogram) pathological|is shown for ITT population|participants|Number|241|241.0||||||
4332098|NCT00438451|4159139|B3|Yes||EEG (electroencephalogram) pathological|is shown for ITT population|participants|Number|71|71.0||||||
4332099|NCT00438451|4159140|B2|Yes||EEG (electroencephalogram) pathological|is shown for ITT population|participants|Number|84|84.0||||||
4332100|NCT00438451|4159141|B1|Yes||EEG (electroencephalogram) pathological|is shown for ITT population|participants|Number|86|86.0||||||
4332101|NCT00438451|4159138|B4|No||Epileptic history - Special seizure|is shown for ITT population|participants|Number|326|326.0||||||
4332102|NCT00438451|4159139|B3|No||Epileptic history - Special seizure|is shown for ITT population|participants|Number|105|105.0||||||
4332103|NCT00438451|4159140|B2|No||Epileptic history - Special seizure|is shown for ITT population|participants|Number|107|107.0||||||
4332104|NCT00438451|4159141|B1|No||Epileptic history - Special seizure|is shown for ITT population|participants|Number|114|114.0||||||
4332105|NCT00438451|4159138|B4|Yes||Epileptic history - Special seizure|is shown for ITT population|participants|Number|33|33.0||||||
4332106|NCT00438451|4159139|B3|Yes||Epileptic history - Special seizure|is shown for ITT population|participants|Number|12|12.0||||||
4332107|NCT00438451|4159140|B2|Yes||Epileptic history - Special seizure|is shown for ITT population|participants|Number|13|13.0||||||
4332108|NCT00438451|4159141|B1|Yes||Epileptic history - Special seizure|is shown for ITT population|participants|Number|8|8.0||||||
4332109|NCT00438451|4159138|B4|No||Epilepsy history - Motor seizure|is shown for ITT population|participants|Number|68|68.0||||||
4332110|NCT00438451|4159139|B3|No||Epilepsy history - Motor seizure|is shown for ITT population|participants|Number|22|22.0||||||
4332111|NCT00438451|4159140|B2|No||Epilepsy history - Motor seizure|is shown for ITT population|participants|Number|19|19.0||||||
4332112|NCT00438451|4159141|B1|No||Epilepsy history - Motor seizure|is shown for ITT population|participants|Number|27|27.0||||||
4332113|NCT00438451|4159138|B4|Yes||Epilepsy history - Motor seizure|is shown for ITT population|participants|Number|291|291.0||||||
4332114|NCT00438451|4159139|B3|Yes||Epilepsy history - Motor seizure|is shown for ITT population|participants|Number|95|95.0||||||
4332115|NCT00438451|4159140|B2|Yes||Epilepsy history - Motor seizure|is shown for ITT population|participants|Number|101|101.0||||||
4332116|NCT00438451|4159141|B1|Yes||Epilepsy history - Motor seizure|is shown for ITT population|participants|Number|95|95.0||||||
4332117|NCT00438451|4159138|B4|No||Epilepsy history - Dialeptic seizure|is shown for ITT population|participants|Number|313|313.0||||||
4332118|NCT00438451|4159139|B3|No||Epilepsy history - Dialeptic seizure|is shown for ITT population|participants|Number|99|99.0||||||
4332119|NCT00438451|4159140|B2|No||Epilepsy history - Dialeptic seizure|is shown for ITT population|participants|Number|105|105.0||||||
4332120|NCT00438451|4159141|B1|No||Epilepsy history - Dialeptic seizure|is shown for ITT population|participants|Number|109|109.0||||||
4332121|NCT00438451|4159138|B4|Yes||Epilepsy history - Dialeptic seizure|is shown for ITT population|participants|Number|46|46.0||||||
4332122|NCT00438451|4159139|B3|Yes||Epilepsy history - Dialeptic seizure|is shown for ITT population|participants|Number|18|18.0||||||
4332123|NCT00438451|4159140|B2|Yes||Epilepsy history - Dialeptic seizure|is shown for ITT population|participants|Number|15|15.0||||||
4332124|NCT00438451|4159141|B1|Yes||Epilepsy history - Dialeptic seizure|is shown for ITT population|participants|Number|13|13.0||||||
4332125|NCT00438451|4159138|B4|No||Epilepsy history - Autonomic seizure|is shown for ITT population|participants|Number|356|356.0||||||
4332126|NCT00438451|4159139|B3|No||Epilepsy history - Autonomic seizure|is shown for ITT population|participants|Number|117|117.0||||||
4332127|NCT00438451|4159140|B2|No||Epilepsy history - Autonomic seizure|is shown for ITT population|participants|Number|118|118.0||||||
4332128|NCT00438451|4159141|B1|No||Epilepsy history - Autonomic seizure|is shown for ITT population|participants|Number|121|121.0||||||
4332129|NCT00438451|4159138|B4|Yes||Epilepsy history - Autonomic seizure|is shown for ITT population|participants|Number|3|3.0||||||
4332130|NCT00438451|4159139|B3|Yes||Epilepsy history - Autonomic seizure|is shown for ITT population|participants|Number|0|0.0||||||
4332131|NCT00438451|4159140|B2|Yes||Epilepsy history - Autonomic seizure|is shown for ITT population|participants|Number|2|2.0||||||
4332132|NCT00438451|4159141|B1|Yes||Epilepsy history - Autonomic seizure|is shown for ITT population|participants|Number|1|1.0||||||
4332133|NCT00438451|4159138|B4|NA||Epilepsy history - Aura|"is shown for ITT population NA refer to the fact that the epilepsy history - Aura is unknown"|participants|Number|1|1.0||||||
4332134|NCT00438451|4159139|B3|NA||Epilepsy history - Aura|"is shown for ITT population NA refer to the fact that the epilepsy history - Aura is unknown"|participants|Number|1|1.0||||||
4332135|NCT00438451|4159140|B2|NA||Epilepsy history - Aura|"is shown for ITT population NA refer to the fact that the epilepsy history - Aura is unknown"|participants|Number|0|0.0||||||
4332136|NCT00438451|4159141|B1|NA||Epilepsy history - Aura|"is shown for ITT population NA refer to the fact that the epilepsy history - Aura is unknown"|participants|Number|0|0.0||||||
4332137|NCT00438451|4159138|B4|No||Epilepsy history - Aura|"is shown for ITT population NA refer to the fact that the epilepsy history - Aura is unknown"|participants|Number|286|286.0||||||
4332138|NCT00438451|4159139|B3|No||Epilepsy history - Aura|"is shown for ITT population NA refer to the fact that the epilepsy history - Aura is unknown"|participants|Number|95|95.0||||||
4332139|NCT00438451|4159140|B2|No||Epilepsy history - Aura|"is shown for ITT population NA refer to the fact that the epilepsy history - Aura is unknown"|participants|Number|92|92.0||||||
4332140|NCT00438451|4159141|B1|No||Epilepsy history - Aura|"is shown for ITT population NA refer to the fact that the epilepsy history - Aura is unknown"|participants|Number|99|99.0||||||
4332141|NCT00438451|4159138|B4|Yes||Epilepsy history - Aura|"is shown for ITT population NA refer to the fact that the epilepsy history - Aura is unknown"|participants|Number|72|72.0||||||
4332142|NCT00438451|4159139|B3|Yes||Epilepsy history - Aura|"is shown for ITT population NA refer to the fact that the epilepsy history - Aura is unknown"|participants|Number|21|21.0||||||
4332143|NCT00438451|4159140|B2|Yes||Epilepsy history - Aura|"is shown for ITT population NA refer to the fact that the epilepsy history - Aura is unknown"|participants|Number|28|28.0||||||
4332144|NCT00438451|4159141|B1|Yes||Epilepsy history - Aura|"is shown for ITT population NA refer to the fact that the epilepsy history - Aura is unknown"|participants|Number|23|23.0||||||
4332145|NCT00438451|4159138|B4|||Epilepsy history - number of seizures|is shown for ITT population|number of seizures|Mean|3.75|3.75|Standard Deviation|8.69|8.69|||
4332146|NCT00438451|4159139|B3|||Epilepsy history - number of seizures|is shown for ITT population|number of seizures|Mean|2.7|2.7|Standard Deviation|3.14|3.14|||
4332147|NCT00438451|4159140|B2|||Epilepsy history - number of seizures|is shown for ITT population|number of seizures|Mean|4.8|4.8|Standard Deviation|10.78|10.78|||
4332148|NCT00438451|4159141|B1|||Epilepsy history - number of seizures|is shown for ITT population|number of seizures|Mean|3.8|3.8|Standard Deviation|9.85|9.85|||
4332149|NCT00438451|4159138|B4|Switzerland||Region of Enrollment|Region of enrollment is shown for ITT population|participants|Number|29|29.0||||||
4332150|NCT00438451|4159139|B3|Switzerland||Region of Enrollment|Region of enrollment is shown for ITT population|participants|Number|10|10.0||||||
4332151|NCT00438451|4159140|B2|Switzerland||Region of Enrollment|Region of enrollment is shown for ITT population|participants|Number|10|10.0||||||
4332152|NCT00438451|4159141|B1|Switzerland||Region of Enrollment|Region of enrollment is shown for ITT population|participants|Number|9|9.0||||||
4332153|NCT00438451|4159138|B4|Austria||Region of Enrollment|Region of enrollment is shown for ITT population|participants|Number|52|52.0||||||
4332154|NCT00438451|4159139|B3|Austria||Region of Enrollment|Region of enrollment is shown for ITT population|participants|Number|16|16.0||||||
4332155|NCT00438451|4159140|B2|Austria||Region of Enrollment|Region of enrollment is shown for ITT population|participants|Number|18|18.0||||||
4332156|NCT00438451|4159141|B1|Austria||Region of Enrollment|Region of enrollment is shown for ITT population|participants|Number|18|18.0||||||
4332157|NCT00438451|4159138|B4|Germany||Region of Enrollment|Region of enrollment is shown for ITT population|participants|Number|278|278.0||||||
4332158|NCT00438451|4159139|B3|Germany||Region of Enrollment|Region of enrollment is shown for ITT population|participants|Number|91|91.0||||||
4332159|NCT00438451|4159140|B2|Germany||Region of Enrollment|Region of enrollment is shown for ITT population|participants|Number|92|92.0||||||
4332160|NCT00438451|4159141|B1|Germany||Region of Enrollment|Region of enrollment is shown for ITT population|participants|Number|95|95.0||||||
4332161|NCT00438451|4159138|B4||Unknown or Not Reported|Race (NIH/OMB)|Race is shown for ITT population|Participants|Count of Participants|0|0.0||||||
4332162|NCT00438451|4159139|B3||Unknown or Not Reported|Race (NIH/OMB)|Race is shown for ITT population|Participants|Count of Participants|0|0.0||||||
4332163|NCT00438451|4159140|B2||Unknown or Not Reported|Race (NIH/OMB)|Race is shown for ITT population|Participants|Count of Participants|0|0.0||||||
4332164|NCT00438451|4159141|B1||Unknown or Not Reported|Race (NIH/OMB)|Race is shown for ITT population|Participants|Count of Participants|0|0.0||||||
4332165|NCT00438451|4159138|B4||More than one race|Race (NIH/OMB)|Race is shown for ITT population|Participants|Count of Participants|0|0.0||||||
4332166|NCT00438451|4159139|B3||More than one race|Race (NIH/OMB)|Race is shown for ITT population|Participants|Count of Participants|0|0.0||||||
4332167|NCT00438451|4159140|B2||More than one race|Race (NIH/OMB)|Race is shown for ITT population|Participants|Count of Participants|0|0.0||||||
4332168|NCT00438451|4159141|B1||More than one race|Race (NIH/OMB)|Race is shown for ITT population|Participants|Count of Participants|0|0.0||||||
4332169|NCT00438451|4159138|B4||White|Race (NIH/OMB)|Race is shown for ITT population|Participants|Count of Participants|359|359.0||||||
4332170|NCT00438451|4159139|B3||White|Race (NIH/OMB)|Race is shown for ITT population|Participants|Count of Participants|117|117.0||||||
4332171|NCT00438451|4159140|B2||White|Race (NIH/OMB)|Race is shown for ITT population|Participants|Count of Participants|120|120.0||||||
4332172|NCT00438451|4159141|B1||White|Race (NIH/OMB)|Race is shown for ITT population|Participants|Count of Participants|122|122.0||||||
4332173|NCT00438451|4159138|B4||Black or African American|Race (NIH/OMB)|Race is shown for ITT population|Participants|Count of Participants|0|0.0||||||
4332174|NCT00438451|4159139|B3||Black or African American|Race (NIH/OMB)|Race is shown for ITT population|Participants|Count of Participants|0|0.0||||||
4332175|NCT00438451|4159140|B2||Black or African American|Race (NIH/OMB)|Race is shown for ITT population|Participants|Count of Participants|0|0.0||||||
4332176|NCT00438451|4159141|B1||Black or African American|Race (NIH/OMB)|Race is shown for ITT population|Participants|Count of Participants|0|0.0||||||
4332177|NCT00438451|4159138|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race is shown for ITT population|Participants|Count of Participants|0|0.0||||||
4332178|NCT00438451|4159139|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race is shown for ITT population|Participants|Count of Participants|0|0.0||||||
4332179|NCT00438451|4159140|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race is shown for ITT population|Participants|Count of Participants|0|0.0||||||
4332180|NCT00438451|4159141|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race is shown for ITT population|Participants|Count of Participants|0|0.0||||||
4332181|NCT00438451|4159138|B4||Asian|Race (NIH/OMB)|Race is shown for ITT population|Participants|Count of Participants|0|0.0||||||
4332182|NCT00438451|4159139|B3||Asian|Race (NIH/OMB)|Race is shown for ITT population|Participants|Count of Participants|0|0.0||||||
4332183|NCT00438451|4159140|B2||Asian|Race (NIH/OMB)|Race is shown for ITT population|Participants|Count of Participants|0|0.0||||||
4332184|NCT00438451|4159141|B1||Asian|Race (NIH/OMB)|Race is shown for ITT population|Participants|Count of Participants|0|0.0||||||
4332185|NCT00438451|4159138|B4||American Indian or Alaska Native|Race (NIH/OMB)|Race is shown for ITT population|Participants|Count of Participants|0|0.0||||||
4332186|NCT00438451|4159139|B3||American Indian or Alaska Native|Race (NIH/OMB)|Race is shown for ITT population|Participants|Count of Participants|0|0.0||||||
4332187|NCT00438451|4159140|B2||American Indian or Alaska Native|Race (NIH/OMB)|Race is shown for ITT population|Participants|Count of Participants|0|0.0||||||
4332188|NCT00438451|4159141|B1||American Indian or Alaska Native|Race (NIH/OMB)|Race is shown for ITT population|Participants|Count of Participants|0|0.0||||||
4332189|NCT00438451|4159138|B4||Male|Sex: Female, Male|Gender is shown for ITT population|Participants|Count of Participants|215|215.0||||||
4332190|NCT00438451|4159139|B3||Male|Sex: Female, Male|Gender is shown for ITT population|Participants|Count of Participants|69|69.0||||||
4332191|NCT00438451|4159140|B2||Male|Sex: Female, Male|Gender is shown for ITT population|Participants|Count of Participants|65|65.0||||||
4332192|NCT00438451|4159141|B1||Male|Sex: Female, Male|Gender is shown for ITT population|Participants|Count of Participants|81|81.0||||||
4332193|NCT00438451|4159138|B4||Female|Sex: Female, Male|Gender is shown for ITT population|Participants|Count of Participants|144|144.0||||||
4332194|NCT00438451|4159139|B3||Female|Sex: Female, Male|Gender is shown for ITT population|Participants|Count of Participants|48|48.0||||||
4332195|NCT00438451|4159140|B2||Female|Sex: Female, Male|Gender is shown for ITT population|Participants|Count of Participants|55|55.0||||||
4332196|NCT00438451|4159141|B1||Female|Sex: Female, Male|Gender is shown for ITT population|Participants|Count of Participants|41|41.0||||||
4332197|NCT00438451|4159138|B4|||Age|Age is shown for ITT population|years|Mean|71.4|71.4|Standard Deviation|7.2|7.2|||
4332198|NCT00438451|4159139|B3|||Age|Age is shown for ITT population|years|Mean|70.7|70.7|Standard Deviation|7.43|7.43|||
4332199|NCT00438451|4159140|B2|||Age|Age is shown for ITT population|years|Mean|71.7|71.7|Standard Deviation|6.66|6.66|||
4332200|NCT00438451|4159141|B1|||Age|Age is shown for ITT population|years|Mean|71.8|71.8|Standard Deviation|7.49|7.49|||
4332201|NCT00438399|4159184|B4|Germany||Region of Enrollment||participants|Number|105|105.0||||||
4332202|NCT00438399|4159185|B3|Germany||Region of Enrollment||participants|Number|34|34.0||||||
4332203|NCT00438399|4159186|B2|Germany||Region of Enrollment||participants|Number|35|35.0||||||
4332204|NCT00438399|4159187|B1|Germany||Region of Enrollment||participants|Number|36|36.0||||||
4332205|NCT00438399|4159184|B4|Spain||Region of Enrollment||participants|Number|23|23.0||||||
4332206|NCT00438399|4159185|B3|Spain||Region of Enrollment||participants|Number|9|9.0||||||
4332207|NCT00438399|4159186|B2|Spain||Region of Enrollment||participants|Number|5|5.0||||||
4332208|NCT00438399|4159187|B1|Spain||Region of Enrollment||participants|Number|9|9.0||||||
4332209|NCT00438399|4159184|B4|United Kingdom||Region of Enrollment||participants|Number|43|43.0||||||
4332210|NCT00438399|4159185|B3|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
4332211|NCT00438399|4159186|B2|United Kingdom||Region of Enrollment||participants|Number|15|15.0||||||
4332212|NCT00438399|4159187|B1|United Kingdom||Region of Enrollment||participants|Number|17|17.0||||||
4332213|NCT00438399|4159184|B4|Italy||Region of Enrollment||participants|Number|48|48.0||||||
4332214|NCT00438399|4159185|B3|Italy||Region of Enrollment||participants|Number|16|16.0||||||
4332215|NCT00438399|4159186|B2|Italy||Region of Enrollment||participants|Number|16|16.0||||||
4332216|NCT00438399|4159187|B1|Italy||Region of Enrollment||participants|Number|16|16.0||||||
4332217|NCT00438399|4159184|B4||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4332218|NCT00438399|4159185|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4332219|NCT00438399|4159186|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4332220|NCT00438399|4159187|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4332221|NCT00438399|4159184|B4||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4332222|NCT00438399|4159185|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4332223|NCT00438399|4159186|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4332224|NCT00438399|4159187|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4332225|NCT00438399|4159184|B4|||Age||years|Mean|49.3|49.3|Standard Deviation|15.6|15.6|||
4332226|NCT00438399|4159185|B3|||Age||years|Mean|47.8|47.8|Standard Deviation|16.2|16.2|||
4332227|NCT00438399|4159186|B2|||Age||years|Mean|49.2|49.2|Standard Deviation|14.9|14.9|||
4332228|NCT00438399|4159187|B1|||Age||years|Mean|50.8|50.8|Standard Deviation|15.9|15.9|||
4332229|NCT00438399|4159184|B4||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4332230|NCT00438399|4159185|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4332231|NCT00438399|4159186|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4332232|NCT00438399|4159187|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4332233|NCT00438399|4159184|B4||Between 18 and 65 years|Age||Participants|Count of Participants|170|170.0||||||
4332234|NCT00438399|4159185|B3||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4332235|NCT00438399|4159186|B2||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4332236|NCT00438399|4159187|B1||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4332237|NCT00438399|4159184|B4||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4332238|NCT00438399|4159185|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4332239|NCT00438399|4159186|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4332240|NCT00438399|4159187|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4332241|NCT00438360|4159201|B3||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4332242|NCT00438360|4159202|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4332243|NCT00438360|4159203|B1||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4332244|NCT00438360|4159201|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4332245|NCT00438360|4159202|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4332246|NCT00438360|4159203|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4332247|NCT00438360|4159201|B3|>=65 years||Age, Customized|Baseline measures are based on intention to treat (ITT) population.|Participants|Number|3|3.0||||||
4332248|NCT00438360|4159202|B2|>=65 years||Age, Customized|Baseline measures are based on intention to treat (ITT) population.|Participants|Number|2|2.0||||||
4332249|NCT00438360|4159203|B1|>=65 years||Age, Customized|Baseline measures are based on intention to treat (ITT) population.|Participants|Number|1|1.0||||||
4332250|NCT00438360|4159201|B3|Between 46 and 65 years||Age, Customized|Baseline measures are based on intention to treat (ITT) population.|Participants|Number|88|88.0||||||
4332251|NCT00438360|4159202|B2|Between 46 and 65 years||Age, Customized|Baseline measures are based on intention to treat (ITT) population.|Participants|Number|29|29.0||||||
4332252|NCT00438360|4159203|B1|Between 46 and 65 years||Age, Customized|Baseline measures are based on intention to treat (ITT) population.|Participants|Number|59|59.0||||||
4332253|NCT00438360|4159201|B3|between 18-45 years||Age, Customized|Baseline measures are based on intention to treat (ITT) population.|Participants|Number|148|148.0||||||
4332254|NCT00438360|4159202|B2|between 18-45 years||Age, Customized|Baseline measures are based on intention to treat (ITT) population.|Participants|Number|48|48.0||||||
4332255|NCT00438360|4159203|B1|between 18-45 years||Age, Customized|Baseline measures are based on intention to treat (ITT) population.|Participants|Number|100|100.0||||||
4332256|NCT00438204|4159218|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4332257|NCT00438204|4159218|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4332258|NCT00438204|4159218|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4332259|NCT00438204|4159218|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4332260|NCT00438204|4159218|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4332261|NCT00438204|4159218|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4332262|NCT00438191|4159226|B3|||Grip Strength|Grip strength measured as a percentage of the non-affected hand.|percentage of non-affected hand|Mean|56.3|56.3|Standard Deviation|21.0|21.0|||
4332263|NCT00438191|4159227|B2|||Grip Strength|Grip strength measured as a percentage of the non-affected hand.|percentage of non-affected hand|Mean|58.6|58.6|Standard Deviation|18.7|18.7|||
4332264|NCT00438191|4159228|B1|||Grip Strength|Grip strength measured as a percentage of the non-affected hand.|percentage of non-affected hand|Mean|54.1|54.1|Standard Deviation|22.9|22.9|||
4332265|NCT00438191|4159226|B3|||Pain Catastrophizing scale (PCS)|The Pain Catastrophizing Scale measures a set of mal-adaptive cognitive conditions while in pain. The score ranges from 0-52, ranging from least to most catastrophic thinking.|units on a scale|Mean|19.3|19.3|Standard Deviation|9.2|9.2|||
4332266|NCT00438191|4159227|B2|||Pain Catastrophizing scale (PCS)|The Pain Catastrophizing Scale measures a set of mal-adaptive cognitive conditions while in pain. The score ranges from 0-52, ranging from least to most catastrophic thinking.|units on a scale|Mean|17.5|17.5|Standard Deviation|9.5|9.5|||
4332312|NCT00437658|4159265|B2||Caucasian, Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4332267|NCT00438191|4159228|B1|||Pain Catastrophizing scale (PCS)|The Pain Catastrophizing Scale measures a set of mal-adaptive cognitive conditions while in pain. The score ranges from 0-52, ranging from least to most catastrophic thinking.|units on a scale|Mean|20.9|20.9|Standard Deviation|8.7|8.7|||
4332268|NCT00438191|4159226|B3|||Center for Epidemiologic Studies Depression Scale - Revised (CES-D)|The CESD-R measures symptom of depression in nine different groups. The range of possible scores is between 0 (for those who say ‘not at all or less than one day to all 20 questions) and 60 (nearly everyday for 2 weeks for all 20 questions).|units on a scale|Mean|16.3|16.3|Standard Deviation|7.6|7.6|||
4332269|NCT00438191|4159227|B2|||Center for Epidemiologic Studies Depression Scale - Revised (CES-D)|The CESD-R measures symptom of depression in nine different groups. The range of possible scores is between 0 (for those who say ‘not at all or less than one day to all 20 questions) and 60 (nearly everyday for 2 weeks for all 20 questions).|units on a scale|Mean|16.3|16.3|Standard Deviation|8.7|8.7|||
4332270|NCT00438191|4159228|B1|||Center for Epidemiologic Studies Depression Scale - Revised (CES-D)|The CESD-R measures symptom of depression in nine different groups. The range of possible scores is between 0 (for those who say ‘not at all or less than one day to all 20 questions) and 60 (nearly everyday for 2 weeks for all 20 questions).|units on a scale|Mean|16.3|16.3|Standard Deviation|6.5|6.5|||
4332271|NCT00438191|4159226|B3|||Pain Intensity|Pain intensity was measured using the Numeric Rating Scale, on a scale from 0-10, where 0 is no pain and 10 is the most pain.|units on a scale|Mean|5.6|5.6|Standard Deviation|2.4|2.4|||
4332272|NCT00438191|4159227|B2|||Pain Intensity|Pain intensity was measured using the Numeric Rating Scale, on a scale from 0-10, where 0 is no pain and 10 is the most pain.|units on a scale|Mean|5.8|5.8|Standard Deviation|2.4|2.4|||
4332273|NCT00438191|4159228|B1|||Pain Intensity|Pain intensity was measured using the Numeric Rating Scale, on a scale from 0-10, where 0 is no pain and 10 is the most pain.|units on a scale|Mean|5.5|5.5|Standard Deviation|2.3|2.3|||
4332274|NCT00438191|4159226|B3|||Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire|The DASH questionnaire measures the upper extremity disability on a scale from 0-100, 0 is no disability and 100 is the most disability.|units on a scale|Mean|34.96|34.96|Standard Deviation|18.40|18.4|||
4332275|NCT00438191|4159227|B2|||Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire|The DASH questionnaire measures the upper extremity disability on a scale from 0-100, 0 is no disability and 100 is the most disability.|units on a scale|Mean|33.3|33.3|Standard Deviation|17.8|17.8|||
4332276|NCT00438191|4159228|B1|||Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire|The DASH questionnaire measures the upper extremity disability on a scale from 0-100, 0 is no disability and 100 is the most disability.|units on a scale|Mean|36.5|36.5|Standard Deviation|19.0|19.0|||
4332277|NCT00438191|4159226|B3|United States||Region of Enrollment||participants|Number|83|83.0||||||
4332278|NCT00438191|4159227|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4332279|NCT00438191|4159228|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4332280|NCT00438191|4159226|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4332281|NCT00438191|4159227|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4332282|NCT00438191|4159228|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4332283|NCT00438191|4159226|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4332284|NCT00438191|4159227|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4332285|NCT00438191|4159228|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4332286|NCT00438191|4159226|B3|||Age||years|Mean|49.26|49.26|Standard Deviation|14.55|14.55|||
4332287|NCT00438191|4159227|B2|||Age||years|Mean|48.74|48.74|Standard Deviation|13.90|13.9|||
4332288|NCT00438191|4159228|B1|||Age||years|Mean|49.93|49.93|Standard Deviation|14.58|14.58|||
4332289|NCT00438100|4159241|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4332290|NCT00438100|4159242|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4332291|NCT00438100|4159243|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4332292|NCT00438100|4159241|B3||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4332293|NCT00438100|4159242|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4332294|NCT00438100|4159243|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4332295|NCT00438100|4159241|B3|||Age||years|Median|62|62.0|Full Range|||33.0|86.0|
4332296|NCT00438100|4159242|B2|||Age||years|Median|62|62.0|Full Range|||33.0|83.0|
4332297|NCT00438100|4159243|B1|||Age||years|Median|61|61.0|Full Range|||35.0|86.0|
4332298|NCT00437983|4159250|B3|Israel||Region of Enrollment||participants|Number|157|157.0||||||
4332299|NCT00437983|4159251|B2|Israel||Region of Enrollment||participants|Number|78|78.0||||||
4332300|NCT00437983|4159252|B1|Israel||Region of Enrollment||participants|Number|79|79.0||||||
4332301|NCT00437983|4159250|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4332302|NCT00437983|4159251|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4332303|NCT00437983|4159252|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4332304|NCT00437983|4159250|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4332305|NCT00437983|4159251|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4332306|NCT00437983|4159252|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4332307|NCT00437983|4159250|B3|||Age||years|Mean|72.52|72.52|Standard Deviation|8.20|8.2|||
4332308|NCT00437983|4159251|B2|||Age||years|Mean|72.46|72.46|Standard Deviation|8.33|8.33|||
4332309|NCT00437983|4159252|B1|||Age||years|Mean|72.58|72.58|Standard Deviation|8.12|8.12|||
4332310|NCT00437658|4159263|B4||Caucasian, Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4332311|NCT00437658|4159264|B3||Caucasian, Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4332371|NCT00437489|4159377|B3|18 - 44 years||Age, Customized||participants|Number|8|8.0||||||
4332313|NCT00437658|4159266|B1||Caucasian, Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4332314|NCT00437658|4159263|B4||Black, Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4332315|NCT00437658|4159264|B3||Black, Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4332316|NCT00437658|4159265|B2||Black, Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4332317|NCT00437658|4159266|B1||Black, Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4332318|NCT00437658|4159263|B4||American Indian or Alaska Native, Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4332319|NCT00437658|4159264|B3||American Indian or Alaska Native, Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4332320|NCT00437658|4159265|B2||American Indian or Alaska Native, Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4332321|NCT00437658|4159266|B1||American Indian or Alaska Native, Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4332322|NCT00437658|4159263|B4||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
4332323|NCT00437658|4159264|B3||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4332324|NCT00437658|4159265|B2||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4332325|NCT00437658|4159266|B1||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4332326|NCT00437658|4159263|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|203|203.0||||||
4332327|NCT00437658|4159264|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|65|65.0||||||
4332328|NCT00437658|4159265|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|70|70.0||||||
4332329|NCT00437658|4159266|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|68|68.0||||||
4332330|NCT00437658|4159263|B4||Black|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
4332331|NCT00437658|4159264|B3||Black|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4332332|NCT00437658|4159265|B2||Black|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4332333|NCT00437658|4159266|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4332334|NCT00437658|4159263|B4||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4332335|NCT00437658|4159264|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4332336|NCT00437658|4159265|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4332337|NCT00437658|4159266|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4332338|NCT00437658|4159263|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4332339|NCT00437658|4159264|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4332340|NCT00437658|4159265|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4332341|NCT00437658|4159266|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4332342|NCT00437658|4159263|B4||Female|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
4332343|NCT00437658|4159264|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4332344|NCT00437658|4159265|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4332345|NCT00437658|4159266|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4332346|NCT00437658|4159263|B4|||Age||years|Mean|31.6|31.6|Standard Deviation|6.7|6.7|||
4332347|NCT00437658|4159264|B3|||Age||years|Mean|30.9|30.9|Standard Deviation|6.3|6.3|||
4332348|NCT00437658|4159265|B2|||Age||years|Mean|31.4|31.4|Standard Deviation|6.1|6.1|||
4332349|NCT00437658|4159266|B1|||Age||years|Mean|32.4|32.4|Standard Deviation|7.5|7.5|||
4332350|NCT00437645|4159360|B3||Male|Sex: Female, Male||Participants|Count of Participants|614|614.0||||||
4332351|NCT00437645|4159361|B2||Male|Sex: Female, Male||Participants|Count of Participants|307|307.0||||||
4332352|NCT00437645|4159362|B1||Male|Sex: Female, Male||Participants|Count of Participants|307|307.0||||||
4332353|NCT00437645|4159360|B3||Female|Sex: Female, Male||Participants|Count of Participants|569|569.0||||||
4332354|NCT00437645|4159361|B2||Female|Sex: Female, Male||Participants|Count of Participants|284|284.0||||||
4332355|NCT00437645|4159362|B1||Female|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
4332356|NCT00437645|4159360|B3|Overall study||Age||Age (years)|Mean|65.5|65.5|Standard Deviation|7.36|7.36|||
4332357|NCT00437645|4159361|B2|Overall study||Age||Age (years)|Mean|65.4|65.4|Standard Deviation|7.16|7.16|||
4332358|NCT00437645|4159362|B1|Overall study||Age||Age (years)|Mean|65.6|65.6|Standard Deviation|7.56|7.56|||
4332359|NCT00437489|4159377|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4332360|NCT00437489|4159378|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4332361|NCT00437489|4159379|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4332362|NCT00437489|4159377|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4332363|NCT00437489|4159378|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4332364|NCT00437489|4159379|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4332365|NCT00437489|4159377|B3|>= 65 years||Age, Customized||participants|Number|4|4.0||||||
4332366|NCT00437489|4159378|B2|>= 65 years||Age, Customized||participants|Number|2|2.0||||||
4332367|NCT00437489|4159379|B1|>= 65 years||Age, Customized||participants|Number|2|2.0||||||
4332368|NCT00437489|4159377|B3|45 - 64 years||Age, Customized||participants|Number|37|37.0||||||
4332369|NCT00437489|4159378|B2|45 - 64 years||Age, Customized||participants|Number|17|17.0||||||
4332370|NCT00437489|4159379|B1|45 - 64 years||Age, Customized||participants|Number|20|20.0||||||
4332372|NCT00437489|4159378|B2|18 - 44 years||Age, Customized||participants|Number|5|5.0||||||
4332373|NCT00437489|4159379|B1|18 - 44 years||Age, Customized||participants|Number|3|3.0||||||
4332374|NCT00437489|4159377|B3|<18 years||Age, Customized||participants|Number|0|0.0||||||
4332375|NCT00437489|4159378|B2|<18 years||Age, Customized||participants|Number|0|0.0||||||
4332376|NCT00437489|4159379|B1|<18 years||Age, Customized||participants|Number|0|0.0||||||
4332377|NCT00437398|4159392|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4332378|NCT00437398|4159392|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4332379|NCT00437398|4159392|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4332380|NCT00437398|4159392|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4332381|NCT00437398|4159392|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4332382|NCT00437398|4159392|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4332383|NCT00437281|4159397|B21||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4332384|NCT00437281|4159398|B20||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4332385|NCT00437281|4159399|B19||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4332386|NCT00437281|4159400|B18||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4332387|NCT00437281|4159401|B17||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4332388|NCT00437281|4159402|B16||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4332389|NCT00437281|4159403|B15||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4332390|NCT00437281|4159404|B14||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4332391|NCT00437281|4159405|B13||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4332392|NCT00437281|4159406|B12||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4332393|NCT00437281|4159407|B11||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4332394|NCT00437281|4159408|B10||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4332395|NCT00437281|4159409|B9||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4332396|NCT00437281|4159410|B8||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4332397|NCT00437281|4159411|B7||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4332398|NCT00437281|4159412|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4332399|NCT00437281|4159413|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4332400|NCT00437281|4159414|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4332401|NCT00437281|4159415|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4332402|NCT00437281|4159416|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4332403|NCT00437281|4159417|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4332404|NCT00437281|4159397|B21||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4332405|NCT00437281|4159398|B20||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4332406|NCT00437281|4159399|B19||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4332407|NCT00437281|4159400|B18||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4332408|NCT00437281|4159401|B17||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4332409|NCT00437281|4159402|B16||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4332410|NCT00437281|4159403|B15||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4332411|NCT00437281|4159404|B14||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4332412|NCT00437281|4159405|B13||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4332413|NCT00437281|4159406|B12||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4332414|NCT00437281|4159407|B11||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4332415|NCT00437281|4159408|B10||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4332416|NCT00437281|4159409|B9||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4332417|NCT00437281|4159410|B8||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4332418|NCT00437281|4159411|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4332419|NCT00437281|4159412|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4332420|NCT00437281|4159413|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4332421|NCT00437281|4159414|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4332422|NCT00437281|4159415|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4332423|NCT00437281|4159416|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4332424|NCT00437281|4159417|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4332425|NCT00437281|4159397|B21|||Age||years|Mean|6.9|6.9|Standard Deviation|5.2|5.2|||
4332426|NCT00437281|4159398|B20|||Age||years|Mean|13.0|13.0|Standard Deviation|1.7|1.7|||
4332427|NCT00437281|4159399|B19|||Age||years|Mean|15.5|15.5|Standard Deviation|0.7|0.7|||
4332428|NCT00437281|4159400|B18|||Age||years|Mean|14.0|14.0|Standard Deviation|1.8|1.8|||
4332429|NCT00437281|4159401|B17|||Age||years|Mean|13.7|13.7|Standard Deviation|2.1|2.1|||
4332430|NCT00437281|4159402|B16|||Age||years|Mean|15.7|15.7|Standard Deviation|0.6|0.6|||
4332431|NCT00437281|4159403|B15|||Age||years|Mean|9.2|9.2|Standard Deviation|1.5|1.5|||
4332432|NCT00437281|4159404|B14|||Age||years|Mean|9.0|9.0|Standard Deviation|1.0|1.0|||
4332433|NCT00437281|4159405|B13|||Age||years|Mean|10.0|10.0|Standard Deviation|0.0|0.0|||
4332434|NCT00437281|4159406|B12|||Age||years|Mean|9.7|9.7|Standard Deviation|2.3|2.3|||
4332435|NCT00437281|4159407|B11|||Age||years|Mean|9.3|9.3|Standard Deviation|1.2|1.2|||
4332436|NCT00437281|4159408|B10|||Age||years|Mean|3.7|3.7|Standard Deviation|1.0|1.0|||
4332437|NCT00437281|4159409|B9|||Age||years|Mean|3.9|3.9|Standard Deviation|1.8|1.8|||
4332438|NCT00437281|4159410|B8|||Age||years|Mean|4.0|4.0|Standard Deviation|1.7|1.7|||
4332439|NCT00437281|4159411|B7|||Age||years|Mean|2.9|2.9|Standard Deviation|0.1|0.1|||
4332440|NCT00437281|4159412|B6|||Age||years|Mean|4.0|4.0|Standard Deviation|0.8|0.8|||
4332441|NCT00437281|4159413|B5|||Age||years|Mean|1.6|1.6|Standard Deviation|0.3|0.3|||
4332442|NCT00437281|4159414|B4|||Age||years|Mean|0.6|0.6|Standard Deviation|0.1|0.1|||
4332443|NCT00437281|4159415|B3|||Age||years|Mean|0.7|0.7|Standard Deviation|0.5|0.5|||
4332444|NCT00437281|4159416|B2|||Age||years|Mean|1.4|1.4|Standard Deviation|0.5|0.5|||
4332445|NCT00437281|4159417|B1|||Age||years|Mean|1.2|1.2|Standard Deviation|0.7|0.7|||
4332446|NCT00437203|4159730|B11||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4332447|NCT00437203|4159731|B10||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4332448|NCT00437203|4159732|B9||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4332449|NCT00437203|4159733|B8||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4332450|NCT00437203|4159734|B7||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4332451|NCT00437203|4159735|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4332452|NCT00437203|4159736|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4332453|NCT00437203|4159737|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4332454|NCT00437203|4159738|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4332455|NCT00437203|4159739|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4332456|NCT00437203|4159740|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4332457|NCT00437203|4159730|B11||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4332458|NCT00437203|4159731|B10||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4332459|NCT00437203|4159732|B9||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4332460|NCT00437203|4159733|B8||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4332461|NCT00437203|4159734|B7||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4332462|NCT00437203|4159735|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4332463|NCT00437203|4159736|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4332464|NCT00437203|4159737|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4332465|NCT00437203|4159738|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4332466|NCT00437203|4159739|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4332467|NCT00437203|4159740|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4332468|NCT00437203|4159730|B11|||Age||years|Mean|53.7|53.7|Standard Deviation|10.7|10.7|||
4332469|NCT00437203|4159731|B10|||Age||years|Mean|49.5|49.5|Standard Deviation|7.1|7.1|||
4332470|NCT00437203|4159732|B9|||Age||years|Mean|46.0|46.0|Standard Deviation|6.9|6.9|||
4332471|NCT00437203|4159733|B8|||Age||years|Mean|55.7|55.7|Standard Deviation|4.6|4.6|||
4332472|NCT00437203|4159734|B7|||Age||years|Mean|54.0|54.0|Standard Deviation|8.9|8.9|||
4332473|NCT00437203|4159735|B6|||Age||years|Mean|44.3|44.3|Standard Deviation|12.1|12.1|||
4332474|NCT00437203|4159736|B5|||Age||years|Mean|55.0|55.0|Standard Deviation|11.5|11.5|||
4332475|NCT00437203|4159737|B4|||Age||years|Mean|45.0|45.0|Standard Deviation|3.6|3.6|||
4332476|NCT00437203|4159738|B3|||Age||years|Mean|55.0|55.0|Standard Deviation|5.2|5.2|||
4332477|NCT00437203|4159739|B2|||Age||years|Mean|62.3|62.3|Standard Deviation|6.8|6.8|||
4332478|NCT00437203|4159740|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|18.3|18.3|||
4332479|NCT00437125|4159853|B1|||Mini Mental State Examination (MMSE) Total Score|The MMSE is used to screen cognitive functioning and provides measures of orientation, registration (immediate memory), memory, and language functioning. The score range is 0-30; normal: 25-30; mild impairment: 21-24; moderate impairment: 10-20; severe impairment: <10.|units on a scale|Mean|28.3|28.3|Standard Deviation|1.8|1.8|||
4332480|NCT00437125|4159853|B1|yes||Presence of major depressive episode diagnosed with Mini International Neuropsychiatric Interview|The Mini International Neuropsychiatric Interview (MINI) is a standardized diagnostic interview based on Diagnostic and Statistical Manual of Mental Disorders version 4 (DSM-IV) criteria. It was developed as a more concise and easily administered alternative to the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID).|participants|Number|149|149.0||||||
4332481|NCT00437125|4159853|B1|no||Presence of major depressive episode diagnosed with Mini International Neuropsychiatric Interview|The Mini International Neuropsychiatric Interview (MINI) is a standardized diagnostic interview based on Diagnostic and Statistical Manual of Mental Disorders version 4 (DSM-IV) criteria. It was developed as a more concise and easily administered alternative to the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID).|participants|Number|2|2.0||||||
4332482|NCT00437125|4159853|B1|yes||Other Axis 1 disorder in sibling or child of participant|Any axis 1 disorder except depressive disorder.|participants|Number|1|1.0||||||
4332483|NCT00437125|4159853|B1|no||Other Axis 1 disorder in sibling or child of participant|Any axis 1 disorder except depressive disorder.|participants|Number|150|150.0||||||
4332484|NCT00437125|4159853|B1|yes||Other Axis 1 disorder in second degree relative of participant|Any axis 1 disorder except depressive disorder.|participants|Number|24|24.0||||||
4332485|NCT00437125|4159853|B1|no||Other Axis 1 disorder in second degree relative of participant|Any axis 1 disorder except depressive disorder.|participants|Number|127|127.0||||||
4332486|NCT00437125|4159853|B1|unknown||Other Axis 1 disorder in parents of participant|Any axis 1 disorder except depressive disorder.|participants|Number|1|1.0||||||
4332487|NCT00437125|4159853|B1|yes||Other Axis 1 disorder in parents of participant|Any axis 1 disorder except depressive disorder.|participants|Number|1|1.0||||||
4332488|NCT00437125|4159853|B1|no||Other Axis 1 disorder in parents of participant|Any axis 1 disorder except depressive disorder.|participants|Number|149|149.0||||||
4332489|NCT00437125|4159853|B1|yes||Other Axis 1 disorder in distant relative of participant|Any axis 1 disorder except depressive disorder.|participants|Number|32|32.0||||||
4332490|NCT00437125|4159853|B1|no||Other Axis 1 disorder in distant relative of participant|Any axis 1 disorder except depressive disorder.|participants|Number|119|119.0||||||
4332491|NCT00437125|4159853|B1|mild to moderate bilateral disease||Disease stage of the modified Hoen and Yahr staging scale|Stage 1: unilateral disease; stage 1.5: unilateral plus axial involvement; Stage 2: bilateral disease, without impairment of balance; Stage 2.5: mild bilateral disease with recovery on pull test; Stage 3: mild to moderate bilateral disease, some postural instability, physically independent; Stage 4: severe disability, still able to walk or stand unassisted; Stage 5: wheelchair or bedridden unless aided.|participants|Number|9|9.0||||||
4332492|NCT00437125|4159853|B1|mild bilateral disease||Disease stage of the modified Hoen and Yahr staging scale|Stage 1: unilateral disease; stage 1.5: unilateral plus axial involvement; Stage 2: bilateral disease, without impairment of balance; Stage 2.5: mild bilateral disease with recovery on pull test; Stage 3: mild to moderate bilateral disease, some postural instability, physically independent; Stage 4: severe disability, still able to walk or stand unassisted; Stage 5: wheelchair or bedridden unless aided.|participants|Number|40|40.0||||||
4332493|NCT00437125|4159853|B1|bilateral disease, without impairment of balance||Disease stage of the modified Hoen and Yahr staging scale|Stage 1: unilateral disease; stage 1.5: unilateral plus axial involvement; Stage 2: bilateral disease, without impairment of balance; Stage 2.5: mild bilateral disease with recovery on pull test; Stage 3: mild to moderate bilateral disease, some postural instability, physically independent; Stage 4: severe disability, still able to walk or stand unassisted; Stage 5: wheelchair or bedridden unless aided.|participants|Number|63|63.0||||||
4332494|NCT00437125|4159853|B1|unilateral plus axial involvement||Disease stage of the modified Hoen and Yahr staging scale|Stage 1: unilateral disease; stage 1.5: unilateral plus axial involvement; Stage 2: bilateral disease, without impairment of balance; Stage 2.5: mild bilateral disease with recovery on pull test; Stage 3: mild to moderate bilateral disease, some postural instability, physically independent; Stage 4: severe disability, still able to walk or stand unassisted; Stage 5: wheelchair or bedridden unless aided.|participants|Number|16|16.0||||||
4332495|NCT00437125|4159853|B1|unilateral disease||Disease stage of the modified Hoen and Yahr staging scale|Stage 1: unilateral disease; stage 1.5: unilateral plus axial involvement; Stage 2: bilateral disease, without impairment of balance; Stage 2.5: mild bilateral disease with recovery on pull test; Stage 3: mild to moderate bilateral disease, some postural instability, physically independent; Stage 4: severe disability, still able to walk or stand unassisted; Stage 5: wheelchair or bedridden unless aided.|participants|Number|23|23.0||||||
4332496|NCT00437125|4159853|B1|yes||Depression in sibling or child of participant||participants|Number|1|1.0||||||
4332497|NCT00437125|4159853|B1|no||Depression in sibling or child of participant||participants|Number|150|150.0||||||
4332498|NCT00437125|4159853|B1|unknown||Depression in mother or father of participant||participants|Number|1|1.0||||||
4332499|NCT00437125|4159853|B1|yes||Depression in mother or father of participant||participants|Number|1|1.0||||||
4332500|NCT00437125|4159853|B1|no||Depression in mother or father of participant||participants|Number|149|149.0||||||
4332501|NCT00437125|4159853|B1|yes||Depression in a second degree relative of the participant||participants|Number|25|25.0||||||
4332502|NCT00437125|4159853|B1|no||Depression in a second degree relative of the participant||participants|Number|126|126.0||||||
4332503|NCT00437125|4159853|B1|unknown||Depression in a distant relative of the participant||participants|Number|30|30.0||||||
4332504|NCT00437125|4159853|B1|yes||Depression in a distant relative of the participant||participants|Number|1|1.0||||||
4332505|NCT00437125|4159853|B1|no||Depression in a distant relative of the participant||participants|Number|120|120.0||||||
4332506|NCT00437125|4159853|B1|yes||Current use of tobacco products by participants||participants|Number|11|11.0||||||
4332507|NCT00437125|4159853|B1|no||Current use of tobacco products by participants||participants|Number|140|140.0||||||
4332508|NCT00437125|4159853|B1|yes||Current alcohol consumption by participants||participants|Number|21|21.0||||||
4332509|NCT00437125|4159853|B1|no||Current alcohol consumption by participants||participants|Number|130|130.0||||||
4332510|NCT00437125|4159853|B1|Italy||Region of Enrollment||participants|Number|151|151.0||||||
4332511|NCT00437125|4159853|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|151|151.0||||||
4332512|NCT00437125|4159853|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4332513|NCT00437125|4159853|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4332514|NCT00437125|4159853|B1|||Age||years|Mean|63.6|63.6|Standard Deviation|8.9|8.9|||
4332515|NCT00437073|4159872|B3|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4332516|NCT00437073|4159873|B2|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4332517|NCT00437073|4159874|B1|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4332518|NCT00437073|4159872|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4332519|NCT00437073|4159873|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4332520|NCT00437073|4159874|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4332521|NCT00437073|4159872|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4332522|NCT00437073|4159873|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4332523|NCT00437073|4159874|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4332524|NCT00437073|4159872|B3|||Age||Years|Mean|51.5|51.5|Standard Deviation|9.92|9.92|||
4332525|NCT00437073|4159873|B2|||Age||Years|Mean|54.6|54.6|Standard Deviation|10.54|10.54|||
4332526|NCT00437073|4159874|B1|||Age||Years|Mean|49.4|49.4|Standard Deviation|9.29|9.29|||
4332527|NCT00437034|4159903|B1|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4332528|NCT00437034|4159903|B1|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4332529|NCT00437034|4159903|B1|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4332530|NCT00437034|4159903|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4332531|NCT00437034|4159903|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4332532|NCT00437034|4159903|B1|||Age||years|Median|59|59.0|Full Range|||37.0|68.0|
4332533|NCT00436982|4159907|B3|Sweden||Region of Enrollment||participants|Number|60|60.0||||||
4332534|NCT00436982|4159908|B2|Sweden||Region of Enrollment||participants|Number|30|30.0||||||
4332535|NCT00436982|4159909|B1|Sweden||Region of Enrollment||participants|Number|30|30.0||||||
4332536|NCT00436982|4159907|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4332537|NCT00436982|4159908|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4332538|NCT00436982|4159909|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4332539|NCT00436982|4159907|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4332540|NCT00436982|4159908|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4332541|NCT00436982|4159909|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4332542|NCT00436982|4159907|B3|||Age||years|Mean|68|68.0|Full Range|||47.0|86.0|
4332543|NCT00436982|4159908|B2|||Age||years|Mean|66|66.0|Full Range|||47.0|84.0|
4332544|NCT00436982|4159909|B1|||Age||years|Mean|69|69.0|Full Range|||47.0|86.0|
4332545|NCT00436969|4159930|B3|United States||Region of Enrollment||participants|Number|270|270.0||||||
4332546|NCT00436969|4159931|B2|United States||Region of Enrollment||participants|Number|183|183.0||||||
4332547|NCT00436969|4159932|B1|United States||Region of Enrollment||participants|Number|87|87.0||||||
4332548|NCT00436969|4159930|B3||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4332549|NCT00436969|4159931|B2||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4332550|NCT00436969|4159932|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4332551|NCT00436969|4159930|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4332552|NCT00436969|4159931|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4332553|NCT00436969|4159932|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4332554|NCT00436969|4159930|B3|70 to 79 years||Age, Customized||participants|Number|37|37.0||||||
4332555|NCT00436969|4159931|B2|70 to 79 years||Age, Customized||participants|Number|31|31.0||||||
4332556|NCT00436969|4159932|B1|70 to 79 years||Age, Customized||participants|Number|6|6.0||||||
4332557|NCT00436969|4159930|B3|60 to 69 years||Age, Customized||participants|Number|111|111.0||||||
4332558|NCT00436969|4159931|B2|60 to 69 years||Age, Customized||participants|Number|68|68.0||||||
4332559|NCT00436969|4159932|B1|60 to 69 years||Age, Customized||participants|Number|43|43.0||||||
4332560|NCT00436969|4159930|B3|50 to 59 years||Age, Customized||participants|Number|72|72.0||||||
4332561|NCT00436969|4159931|B2|50 to 59 years||Age, Customized||participants|Number|50|50.0||||||
4332562|NCT00436969|4159932|B1|50 to 59 years||Age, Customized||participants|Number|22|22.0||||||
4332563|NCT00436969|4159930|B3|40 to 49 years||Age, Customized||participants|Number|33|33.0||||||
4332564|NCT00436969|4159931|B2|40 to 49 years||Age, Customized||participants|Number|22|22.0||||||
4332565|NCT00436969|4159932|B1|40 to 49 years||Age, Customized||participants|Number|11|11.0||||||
4332566|NCT00436969|4159930|B3|30 and 39 years||Age, Customized||participants|Number|15|15.0||||||
4332567|NCT00436969|4159931|B2|30 and 39 years||Age, Customized||participants|Number|11|11.0||||||
4332568|NCT00436969|4159932|B1|30 and 39 years||Age, Customized||participants|Number|4|4.0||||||
4332569|NCT00436969|4159930|B3|18 to 29||Age, Customized||participants|Number|2|2.0||||||
4332570|NCT00436969|4159931|B2|18 to 29||Age, Customized||participants|Number|1|1.0||||||
4332571|NCT00436969|4159932|B1|18 to 29||Age, Customized||participants|Number|1|1.0||||||
4332572|NCT00436969|4159930|B3|||Age||years|Mean|58.4|58.4|Standard Deviation|10.40|10.4|||
4332573|NCT00436969|4159931|B2|||Age||years|Mean|58.6|58.6|Standard Deviation|10.68|10.68|||
4332574|NCT00436969|4159932|B1|||Age||years|Mean|58.0|58.0|Standard Deviation|9.84|9.84|||
4332575|NCT00436956|4159981|B1|United States||Region of Enrollment||Participants|Count of Participants|59|59.0||||||
4332576|NCT00436956|4159981|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4332577|NCT00436956|4159981|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|52|52.0||||||
4332578|NCT00436956|4159981|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4332579|NCT00436956|4159981|B1|Afican-American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4332580|NCT00436956|4159981|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4332581|NCT00436956|4159981|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4332582|NCT00436956|4159981|B1|||Age||years|Median|68.9|68.9|Full Range|||51.4|79.8|
4332583|NCT00436956|4159981|B1||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4332584|NCT00436956|4159981|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4332585|NCT00436956|4159981|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4332586|NCT00436917|4159996|B1|||Bone Mineral Density Measurement in Lumbar Spine|Baseline bone mineral density measurement in lumbar spine for the 30 participants analyzed in primary analysis.|g/cm2|Mean|0.86|0.86|Standard Deviation|0.12|0.12|||
4332587|NCT00436917|4159996|B1|No||Previous fracture by history or X-ray||participants|Number|47|47.0||||||
4332588|NCT00436917|4159996|B1|Yes||Previous fracture by history or X-ray||participants|Number|7|7.0||||||
4332589|NCT00436917|4159996|B1|No||Prior chemotherapy||participants|Number|33|33.0||||||
4332590|NCT00436917|4159996|B1|Yes||Prior chemotherapy||participants|Number|21|21.0||||||
4332591|NCT00436917|4159996|B1|>=1 year||Time since tamoxifen ended||participants|Number|4|4.0||||||
4332592|NCT00436917|4159996|B1|<1 year||Time since tamoxifen ended||participants|Number|20|20.0||||||
4332593|NCT00436917|4159996|B1|Missing||Time since tamoxifen ended||participants|Number|30|30.0||||||
4332594|NCT00436917|4159996|B1|>2 years||Duration of tamoxifen use||participants|Number|20|20.0||||||
4332595|NCT00436917|4159996|B1|<=2 years||Duration of tamoxifen use||participants|Number|4|4.0||||||
4332596|NCT00436917|4159996|B1|Missing||Duration of tamoxifen use||participants|Number|30|30.0||||||
4332597|NCT00436917|4159996|B1|No||Prior tamoxifen||participants|Number|30|30.0||||||
4332598|NCT00436917|4159996|B1|Yes||Prior tamoxifen||participants|Number|24|24.0||||||
4332599|NCT00436917|4159996|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332600|NCT00436917|4159996|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332601|NCT00436917|4159996|B1||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4332602|NCT00436917|4159996|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4332603|NCT00436917|4159996|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332604|NCT00436917|4159996|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4332605|NCT00436917|4159996|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332606|NCT00436917|4159996|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4332607|NCT00436917|4159996|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4332608|NCT00436917|4159996|B1|||Age||years|Mean|66.7|66.7|Standard Deviation|10.13|10.13|||
4332609|NCT00436904|4160000|B1|1 - Ambulatory, restricted strenuous activity||Performance Score|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|3|3.0||||||
4332610|NCT00436904|4160000|B1|0 - Fully Active||Performance Score|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|27|27.0||||||
4332611|NCT00436904|4160000|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4332612|NCT00436904|4160000|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4332613|NCT00436904|4160000|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4332614|NCT00436904|4160000|B1|||Age||years|Median|61|61.0|Full Range|||29.0|77.0|
4332615|NCT00436852|4160009|B3|Jamaica||Region of Enrollment||participants|Number|1|1.0||||||
4332616|NCT00436852|4160010|B2|Jamaica||Region of Enrollment||participants|Number|1|1.0||||||
4332617|NCT00436852|4160011|B1|Jamaica||Region of Enrollment||participants|Number|0|0.0||||||
4332618|NCT00436852|4160009|B3|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4332619|NCT00436852|4160010|B2|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4332620|NCT00436852|4160011|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4332621|NCT00436852|4160009|B3|United States||Region of Enrollment||participants|Number|81|81.0||||||
4332622|NCT00436852|4160010|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
4332623|NCT00436852|4160011|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4332624|NCT00436852|4160009|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4332625|NCT00436852|4160010|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4332626|NCT00436852|4160011|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4332627|NCT00436852|4160009|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332628|NCT00436852|4160010|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332629|NCT00436852|4160011|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332630|NCT00436852|4160009|B3||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4332631|NCT00436852|4160010|B2||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4332632|NCT00436852|4160011|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4332633|NCT00436852|4160009|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4332634|NCT00436852|4160010|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4332635|NCT00436852|4160011|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4332636|NCT00436852|4160009|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332637|NCT00436852|4160010|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332638|NCT00436852|4160011|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332639|NCT00436852|4160009|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4332640|NCT00436852|4160010|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4332641|NCT00436852|4160011|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332642|NCT00436852|4160009|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332643|NCT00436852|4160010|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332644|NCT00436852|4160011|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332645|NCT00436852|4160009|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4332646|NCT00436852|4160010|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4332647|NCT00436852|4160011|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4332648|NCT00436852|4160009|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
4332649|NCT00436852|4160010|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4332650|NCT00436852|4160011|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4332651|NCT00436852|4160009|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4332652|NCT00436852|4160010|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4332653|NCT00436852|4160011|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4332654|NCT00436852|4160009|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4332655|NCT00436852|4160010|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4332656|NCT00436852|4160011|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4332657|NCT00436852|4160009|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4332658|NCT00436852|4160010|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4332659|NCT00436852|4160011|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4332660|NCT00436852|4160009|B3|||Age||years|Median|8.00|8.0|Inter-Quartile Range|||6.07|12.67|
4332661|NCT00436852|4160010|B2|||Age||years|Median|7.55|7.55|Inter-Quartile Range|||5.91|12.43|
4332662|NCT00436852|4160011|B1|||Age||years|Median|8.46|8.46|Inter-Quartile Range|||6.23|12.91|
4332663|NCT00436852|4160009|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4332664|NCT00436852|4160010|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4332665|NCT00436852|4160011|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4332666|NCT00436852|4160009|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4332667|NCT00436852|4160010|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4332668|NCT00436852|4160011|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4332669|NCT00436852|4160009|B3||<=18 years|Age||Participants|Count of Participants|87|87.0||||||
4332670|NCT00436852|4160010|B2||<=18 years|Age||Participants|Count of Participants|45|45.0||||||
4332671|NCT00436852|4160011|B1||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
4332672|NCT00436826|4160020|B3|||Number of Time constant 1 (T1) hypointense lesions||lesions|Mean|9.1|9.1|Standard Deviation|9.3|9.3|||
4332673|NCT00436826|4160021|B2|||Number of Time constant 1 (T1) hypointense lesions||lesions|Mean|9.3|9.3|Standard Deviation|9.9|9.9|||
4332674|NCT00436826|4160022|B1|||Number of Time constant 1 (T1) hypointense lesions||lesions|Mean|9.0|9.0|Standard Deviation|9.2|9.2|||
4332675|NCT00436826|4160020|B3|||Number of Gadolinium-enhanced lesions||lesions|Mean|0.9|0.9|Standard Deviation|3.4|3.4|||
4332676|NCT00436826|4160021|B2|||Number of Gadolinium-enhanced lesions||lesions|Mean|0.6|0.6|Standard Deviation|1.2|1.2|||
4332677|NCT00436826|4160022|B1|||Number of Gadolinium-enhanced lesions||lesions|Mean|1.1|1.1|Standard Deviation|4.0|4.0|||
4332678|NCT00436826|4160020|B3|||Expanded disability status scale (EDSS) score|Expanded disability status scale (EDSS) assesses disability in 8 functional systems. An overall score ranging from 0 (normal) to 10 (death due to MS) was calculated.|unit on scale|Mean|2.9|2.9|Standard Deviation|1.2|1.2|||
4332679|NCT00436826|4160021|B2|||Expanded disability status scale (EDSS) score|Expanded disability status scale (EDSS) assesses disability in 8 functional systems. An overall score ranging from 0 (normal) to 10 (death due to MS) was calculated.|unit on scale|Mean|3.0|3.0|Standard Deviation|1.2|1.2|||
4332680|NCT00436826|4160022|B1|||Expanded disability status scale (EDSS) score|Expanded disability status scale (EDSS) assesses disability in 8 functional systems. An overall score ranging from 0 (normal) to 10 (death due to MS) was calculated.|unit on scale|Mean|2.9|2.9|Standard Deviation|1.2|1.2|||
4332681|NCT00436826|4160020|B3|||Time (years) from first attack to study Day 1||years|Mean|10.22|10.22|Standard Deviation|7.44|7.44|||
4332682|NCT00436826|4160021|B2|||Time (years) from first attack to study Day 1||years|Mean|10.83|10.83|Standard Deviation|7.98|7.98|||
4332683|NCT00436826|4160022|B1|||Time (years) from first attack to study Day 1||years|Mean|9.98|9.98|Standard Deviation|7.24|7.24|||
4332684|NCT00436826|4160020|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4332685|NCT00436826|4160021|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4332686|NCT00436826|4160022|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4332687|NCT00436826|4160020|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4332688|NCT00436826|4160021|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4332689|NCT00436826|4160022|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4332690|NCT00436826|4160020|B3|||Age||years|Mean|38.9|38.9|Standard Deviation|10.2|10.2|||
4332691|NCT00436826|4160021|B2|||Age||years|Mean|40.1|40.1|Standard Deviation|10.3|10.3|||
4332692|NCT00436826|4160022|B1|||Age||years|Mean|38.5|38.5|Standard Deviation|10.2|10.2|||
4332693|NCT00436748|4160047|B3|||Hemoglobin Concentration||g/dL|Mean|8.66|8.66|Standard Deviation|0.84|0.84|||
4332694|NCT00436748|4160048|B2|||Hemoglobin Concentration||g/dL|Mean|8.73|8.73|Standard Deviation|0.84|0.84|||
4332695|NCT00436748|4160049|B1|||Hemoglobin Concentration||g/dL|Mean|8.59|8.59|Standard Deviation|0.84|0.84|||
4332696|NCT00436748|4160047|B3|Receiving peritoneal dialysis||Dialysis Status||participants|Number|19|19.0||||||
4332697|NCT00436748|4160048|B2|Receiving peritoneal dialysis||Dialysis Status||participants|Number|9|9.0||||||
4332698|NCT00436748|4160049|B1|Receiving peritoneal dialysis||Dialysis Status||participants|Number|10|10.0||||||
4332699|NCT00436748|4160047|B3|Receiving hemodialysis||Dialysis Status||participants|Number|29|29.0||||||
4332700|NCT00436748|4160048|B2|Receiving hemodialysis||Dialysis Status||participants|Number|14|14.0||||||
4332701|NCT00436748|4160049|B1|Receiving hemodialysis||Dialysis Status||participants|Number|15|15.0||||||
4332702|NCT00436748|4160047|B3|Not receiving dialysis||Dialysis Status||participants|Number|66|66.0||||||
4332703|NCT00436748|4160048|B2|Not receiving dialysis||Dialysis Status||participants|Number|33|33.0||||||
4332704|NCT00436748|4160049|B1|Not receiving dialysis||Dialysis Status||participants|Number|33|33.0||||||
4332705|NCT00436748|4160047|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4332706|NCT00436748|4160048|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4332707|NCT00436748|4160049|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4332708|NCT00436748|4160047|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4332709|NCT00436748|4160048|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4332710|NCT00436748|4160049|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4332711|NCT00436748|4160047|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4332712|NCT00436748|4160048|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4332713|NCT00436748|4160049|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4332714|NCT00436748|4160047|B3|White or Caucasian||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
4332715|NCT00436748|4160048|B2|White or Caucasian||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4332716|NCT00436748|4160049|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4332717|NCT00436748|4160047|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4332718|NCT00436748|4160048|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4332719|NCT00436748|4160049|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4332720|NCT00436748|4160047|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4332721|NCT00436748|4160048|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4332722|NCT00436748|4160049|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4332723|NCT00436748|4160047|B3|12 - 18 years||Age, Customized||participants|Number|74|74.0||||||
4332724|NCT00436748|4160048|B2|12 - 18 years||Age, Customized||participants|Number|37|37.0||||||
4332725|NCT00436748|4160049|B1|12 - 18 years||Age, Customized||participants|Number|37|37.0||||||
4332726|NCT00436748|4160047|B3|6 - < 12 years||Age, Customized||participants|Number|37|37.0||||||
4332727|NCT00436748|4160048|B2|6 - < 12 years||Age, Customized||participants|Number|18|18.0||||||
4332728|NCT00436748|4160049|B1|6 - < 12 years||Age, Customized||participants|Number|19|19.0||||||
4332729|NCT00436748|4160047|B3|1 - < 6 years||Age, Customized||participants|Number|3|3.0||||||
4332730|NCT00436748|4160048|B2|1 - < 6 years||Age, Customized||participants|Number|1|1.0||||||
4332731|NCT00436748|4160049|B1|1 - < 6 years||Age, Customized||participants|Number|2|2.0||||||
4332732|NCT00436748|4160047|B3|||Age||years|Mean|12.7|12.7|Standard Deviation|3.6|3.6|||
4332733|NCT00436748|4160048|B2|||Age||years|Mean|12.8|12.8|Standard Deviation|3.7|3.7|||
4332734|NCT00436748|4160049|B1|||Age||years|Mean|12.6|12.6|Standard Deviation|3.6|3.6|||
4332735|NCT00436644|4160084|B1|Platinum Refractory||Primary Tumor Status||participants|Number|13|13.0||||||
4332736|NCT00436644|4160084|B1|Platinum Resistant||Primary Tumor Status||participants|Number|5|5.0||||||
4332737|NCT00436644|4160084|B1|Peritoneal||Primary Tumor Site||participants|Number|2|2.0||||||
4332738|NCT00436644|4160084|B1|Ovarian||Primary Tumor Site||participants|Number|16|16.0||||||
4332739|NCT00436644|4160084|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4332740|NCT00436644|4160084|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4332741|NCT00436644|4160084|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4332742|NCT00436644|4160084|B1|||Age, Customized||Years|Median|66|66.0|Full Range|||27.0|94.0|
4332743|NCT00436618|4160091|B4|Non-Hodgkin Lymphoma||Hodgkin versus Non-Hodgkin Lymphoma||participants|Number|247|247.0||||||
4332744|NCT00436618|4160092|B3|Non-Hodgkin Lymphoma||Hodgkin versus Non-Hodgkin Lymphoma||participants|Number|78|78.0||||||
4332745|NCT00436618|4160093|B2|Non-Hodgkin Lymphoma||Hodgkin versus Non-Hodgkin Lymphoma||participants|Number|55|55.0||||||
4332746|NCT00436618|4160094|B1|Non-Hodgkin Lymphoma||Hodgkin versus Non-Hodgkin Lymphoma||participants|Number|114|114.0||||||
4332747|NCT00436618|4160091|B4|Hodgkin Lymphoma||Hodgkin versus Non-Hodgkin Lymphoma||participants|Number|29|29.0||||||
4332748|NCT00436618|4160092|B3|Hodgkin Lymphoma||Hodgkin versus Non-Hodgkin Lymphoma||participants|Number|29|29.0||||||
4332749|NCT00436618|4160093|B2|Hodgkin Lymphoma||Hodgkin versus Non-Hodgkin Lymphoma||participants|Number|0|0.0||||||
4332750|NCT00436618|4160094|B1|Hodgkin Lymphoma||Hodgkin versus Non-Hodgkin Lymphoma||participants|Number|0|0.0||||||
4332751|NCT00436618|4160091|B4|United States||Region of Enrollment||participants|Number|276|276.0||||||
4332752|NCT00436618|4160092|B3|United States||Region of Enrollment||participants|Number|107|107.0||||||
4332753|NCT00436618|4160093|B2|United States||Region of Enrollment||participants|Number|55|55.0||||||
4332754|NCT00436618|4160094|B1|United States||Region of Enrollment||participants|Number|114|114.0||||||
4332755|NCT00436618|4160091|B4||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4332756|NCT00436618|4160092|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4332757|NCT00436618|4160093|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4332758|NCT00436618|4160094|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4332759|NCT00436618|4160091|B4||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4332760|NCT00436618|4160092|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4332761|NCT00436618|4160093|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4332762|NCT00436618|4160094|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4332763|NCT00436618|4160091|B4|||Age||years|Median|66|66.0|Full Range|||20.0|92.0|
4332764|NCT00436618|4160092|B3|||Age||years|Median|60|60.0|Full Range|||20.0|85.0|
4332765|NCT00436618|4160093|B2|||Age||years|Median|67|67.0|Full Range|||33.0|85.0|
4332766|NCT00436618|4160094|B1|||Age||years|Median|70|70.0|Full Range|||36.0|92.0|
4332767|NCT00436605|4160113|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4332768|NCT00436605|4160113|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4332769|NCT00436605|4160113|B1|||Age||years|Mean|64|64.0|Full Range|||37.0|84.0|
4332770|NCT00436566|4160118|B1|Beyond high school||Education level||participants|Number|71|71.0||||||
4332771|NCT00436566|4160118|B1|High school||Education level||participants|Number|35|35.0||||||
4332772|NCT00436566|4160118|B1|Less than high school||Education level||participants|Number|3|3.0||||||
4332773|NCT00436566|4160118|B1|Postmenopausal||Menopausal status||participants|Number|58|58.0||||||
4332774|NCT00436566|4160118|B1|Perimenopausal||Menopausal status||participants|Number|8|8.0||||||
4332775|NCT00436566|4160118|B1|Premenopausal||Menopausal status||participants|Number|43|43.0||||||
4332776|NCT00436566|4160118|B1|No||History of diabetes||participants|Number|99|99.0||||||
4332777|NCT00436566|4160118|B1|Yes||History of diabetes||participants|Number|10|10.0||||||
4332778|NCT00436566|4160118|B1|No||Current use of hypertensive medication||participants|Number|81|81.0||||||
4332779|NCT00436566|4160118|B1|Yes||Current use of hypertensive medication||participants|Number|28|28.0||||||
4332780|NCT00436566|4160118|B1|Current||Smoking status||participants|Number|25|25.0||||||
4332781|NCT00436566|4160118|B1|Former||Smoking status||participants|Number|24|24.0||||||
4332782|NCT00436566|4160118|B1|Never||Smoking status||participants|Number|60|60.0||||||
4332783|NCT00436566|4160118|B1|||Left Ventricular Ejection Fraction (LVEF) Measurement||percentage|Median|63.3|63.3|Full Range|||52.0|78.0|
4332784|NCT00436566|4160118|B1|FISH Not Done/IHC Pos||HER2 Status - Positive|FISH Amp/IHC refers to fluorescence in situ hybridization amplification/immunohistochemistry|participants|Number|2|2.0||||||
4332785|NCT00436566|4160118|B1|FISH Not Amp/IHC Pos||HER2 Status - Positive|FISH Amp/IHC refers to fluorescence in situ hybridization amplification/immunohistochemistry|participants|Number|6|6.0||||||
4332786|NCT00436566|4160118|B1|FISH Amp/IHC Neg||HER2 Status - Positive|FISH Amp/IHC refers to fluorescence in situ hybridization amplification/immunohistochemistry|participants|Number|8|8.0||||||
4332787|NCT00436566|4160118|B1|FISH Amp/IHC Pos||HER2 Status - Positive|FISH Amp/IHC refers to fluorescence in situ hybridization amplification/immunohistochemistry|participants|Number|93|93.0||||||
4332788|NCT00436566|4160118|B1|Estrogen and Progesterone Negative||Hormonal Status||participants|Number|55|55.0||||||
4332789|NCT00436566|4160118|B1|Estrogen and/or Progesterone Positive||Hormonal Status||participants|Number|54|54.0||||||
4332790|NCT00436566|4160118|B1|SLN+ without full axillary dissection||Nodal Status|N0=Node negative (either by negative sentinel node or by axillary dissection); N1=Node positive (axillary nodal dissection with 1-3 + nodes); N2=Node positive (axillary nodal dissection with 4-9 + nodes); N3=Node positive (axillary nodal dissection with 10+ nodes); SLN+ refers to Positive Sentinel Node|participants|Number|2|2.0||||||
4332791|NCT00436566|4160118|B1|N3||Nodal Status|N0=Node negative (either by negative sentinel node or by axillary dissection); N1=Node positive (axillary nodal dissection with 1-3 + nodes); N2=Node positive (axillary nodal dissection with 4-9 + nodes); N3=Node positive (axillary nodal dissection with 10+ nodes); SLN+ refers to Positive Sentinel Node|participants|Number|14|14.0||||||
4332792|NCT00436566|4160118|B1|N2||Nodal Status|N0=Node negative (either by negative sentinel node or by axillary dissection); N1=Node positive (axillary nodal dissection with 1-3 + nodes); N2=Node positive (axillary nodal dissection with 4-9 + nodes); N3=Node positive (axillary nodal dissection with 10+ nodes); SLN+ refers to Positive Sentinel Node|participants|Number|12|12.0||||||
4332793|NCT00436566|4160118|B1|N1||Nodal Status|N0=Node negative (either by negative sentinel node or by axillary dissection); N1=Node positive (axillary nodal dissection with 1-3 + nodes); N2=Node positive (axillary nodal dissection with 4-9 + nodes); N3=Node positive (axillary nodal dissection with 10+ nodes); SLN+ refers to Positive Sentinel Node|participants|Number|32|32.0||||||
4332794|NCT00436566|4160118|B1|N0||Nodal Status|N0=Node negative (either by negative sentinel node or by axillary dissection); N1=Node positive (axillary nodal dissection with 1-3 + nodes); N2=Node positive (axillary nodal dissection with 4-9 + nodes); N3=Node positive (axillary nodal dissection with 10+ nodes); SLN+ refers to Positive Sentinel Node|participants|Number|49|49.0||||||
4332795|NCT00436566|4160118|B1|Missing||T Stage||participants|Number|2|2.0||||||
4332796|NCT00436566|4160118|B1|T3=Tumor > 5 cm across||T Stage||participants|Number|6|6.0||||||
4332797|NCT00436566|4160118|B1|T2=2cm < Tumor <5 cm across||T Stage||participants|Number|58|58.0||||||
4332798|NCT00436566|4160118|B1|T1=Tumor <=2 cm (3/4 of an inch) across||T Stage||participants|Number|43|43.0||||||
4332799|NCT00436566|4160118|B1|1||Eastern Cooperative Oncology Group (ECOG) performance status|"Performance Status Grade:~0=Fully active, able to carry on all predisease activities without restriction (Karnofsky 90-100); 1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work (Karnofsky 70-80)."|participants|Number|18|18.0||||||
4332800|NCT00436566|4160118|B1|0||Eastern Cooperative Oncology Group (ECOG) performance status|"Performance Status Grade:~0=Fully active, able to carry on all predisease activities without restriction (Karnofsky 90-100); 1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work (Karnofsky 70-80)."|participants|Number|91|91.0||||||
4332801|NCT00436566|4160118|B1|United States||Region of Enrollment||participants|Number|109|109.0||||||
4332802|NCT00436566|4160118|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332803|NCT00436566|4160118|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332804|NCT00436566|4160118|B1||White|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
4332805|NCT00436566|4160118|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4332806|NCT00436566|4160118|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332807|NCT00436566|4160118|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4332808|NCT00436566|4160118|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4332809|NCT00436566|4160118|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4332810|NCT00436566|4160118|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4332811|NCT00436566|4160118|B1|||Age||years|Median|51|51.0|Full Range|||28.0|72.0|
4332812|NCT00436553|4160122|B4||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4332813|NCT00436553|4160123|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4332814|NCT00436553|4160124|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4332815|NCT00436553|4160125|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4332816|NCT00436553|4160122|B4||Female|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4332817|NCT00436553|4160123|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4332818|NCT00436553|4160124|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4332819|NCT00436553|4160125|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4332820|NCT00436553|4160122|B4|||Age||years|Mean|77.3|77.3|Standard Deviation|8.26|8.26|||
4332821|NCT00436553|4160123|B3|||Age||years|Mean|77.2|77.2|Standard Deviation|7.97|7.97|||
4332822|NCT00436553|4160124|B2|||Age||years|Mean|77.4|77.4|Standard Deviation|8.48|8.48|||
4332823|NCT00436553|4160125|B1|||Age||years|Mean|77.5|77.5|Standard Deviation|8.42|8.42|||
4332824|NCT00436501|4160146|B3|Unclassified||Participant Cancer Histology|Histological classification of participant cancer based on pathology report from most recent pre-registration diagnostic biopsy or surgery, confirmed within 14 days after registration for baseline measurements/data.|participants|Number|2|2.0||||||
4332825|NCT00436501|4160147|B2|Unclassified||Participant Cancer Histology|Histological classification of participant cancer based on pathology report from most recent pre-registration diagnostic biopsy or surgery, confirmed within 14 days after registration for baseline measurements/data.|participants|Number|2|2.0||||||
4332826|NCT00436501|4160148|B1|Unclassified||Participant Cancer Histology|Histological classification of participant cancer based on pathology report from most recent pre-registration diagnostic biopsy or surgery, confirmed within 14 days after registration for baseline measurements/data.|participants|Number|0|0.0||||||
4332827|NCT00436501|4160146|B3|Transitional cell||Participant Cancer Histology|Histological classification of participant cancer based on pathology report from most recent pre-registration diagnostic biopsy or surgery, confirmed within 14 days after registration for baseline measurements/data.|participants|Number|2|2.0||||||
4332828|NCT00436501|4160147|B2|Transitional cell||Participant Cancer Histology|Histological classification of participant cancer based on pathology report from most recent pre-registration diagnostic biopsy or surgery, confirmed within 14 days after registration for baseline measurements/data.|participants|Number|0|0.0||||||
4332829|NCT00436501|4160148|B1|Transitional cell||Participant Cancer Histology|Histological classification of participant cancer based on pathology report from most recent pre-registration diagnostic biopsy or surgery, confirmed within 14 days after registration for baseline measurements/data.|participants|Number|2|2.0||||||
4332830|NCT00436501|4160146|B3|Serous||Participant Cancer Histology|Histological classification of participant cancer based on pathology report from most recent pre-registration diagnostic biopsy or surgery, confirmed within 14 days after registration for baseline measurements/data.|participants|Number|37|37.0||||||
4332831|NCT00436501|4160147|B2|Serous||Participant Cancer Histology|Histological classification of participant cancer based on pathology report from most recent pre-registration diagnostic biopsy or surgery, confirmed within 14 days after registration for baseline measurements/data.|participants|Number|31|31.0||||||
4332832|NCT00436501|4160148|B1|Serous||Participant Cancer Histology|Histological classification of participant cancer based on pathology report from most recent pre-registration diagnostic biopsy or surgery, confirmed within 14 days after registration for baseline measurements/data.|participants|Number|6|6.0||||||
4332833|NCT00436501|4160146|B3|Mixed||Participant Cancer Histology|Histological classification of participant cancer based on pathology report from most recent pre-registration diagnostic biopsy or surgery, confirmed within 14 days after registration for baseline measurements/data.|participants|Number|5|5.0||||||
4332834|NCT00436501|4160147|B2|Mixed||Participant Cancer Histology|Histological classification of participant cancer based on pathology report from most recent pre-registration diagnostic biopsy or surgery, confirmed within 14 days after registration for baseline measurements/data.|participants|Number|5|5.0||||||
4332835|NCT00436501|4160148|B1|Mixed||Participant Cancer Histology|Histological classification of participant cancer based on pathology report from most recent pre-registration diagnostic biopsy or surgery, confirmed within 14 days after registration for baseline measurements/data.|participants|Number|0|0.0||||||
4332836|NCT00436501|4160146|B3|Endometrioid||Participant Cancer Histology|Histological classification of participant cancer based on pathology report from most recent pre-registration diagnostic biopsy or surgery, confirmed within 14 days after registration for baseline measurements/data.|participants|Number|1|1.0||||||
4332837|NCT00436501|4160147|B2|Endometrioid||Participant Cancer Histology|Histological classification of participant cancer based on pathology report from most recent pre-registration diagnostic biopsy or surgery, confirmed within 14 days after registration for baseline measurements/data.|participants|Number|1|1.0||||||
4332838|NCT00436501|4160148|B1|Endometrioid||Participant Cancer Histology|Histological classification of participant cancer based on pathology report from most recent pre-registration diagnostic biopsy or surgery, confirmed within 14 days after registration for baseline measurements/data.|participants|Number|0|0.0||||||
4332887|NCT00436436|4160160|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4332839|NCT00436501|4160146|B3|Clear cell||Participant Cancer Histology|Histological classification of participant cancer based on pathology report from most recent pre-registration diagnostic biopsy or surgery, confirmed within 14 days after registration for baseline measurements/data.|participants|Number|5|5.0||||||
4332840|NCT00436501|4160147|B2|Clear cell||Participant Cancer Histology|Histological classification of participant cancer based on pathology report from most recent pre-registration diagnostic biopsy or surgery, confirmed within 14 days after registration for baseline measurements/data.|participants|Number|4|4.0||||||
4332841|NCT00436501|4160148|B1|Clear cell||Participant Cancer Histology|Histological classification of participant cancer based on pathology report from most recent pre-registration diagnostic biopsy or surgery, confirmed within 14 days after registration for baseline measurements/data.|participants|Number|1|1.0||||||
4332842|NCT00436501|4160146|B3|Adenocarcinoma||Participant Cancer Histology|Histological classification of participant cancer based on pathology report from most recent pre-registration diagnostic biopsy or surgery, confirmed within 14 days after registration for baseline measurements/data.|participants|Number|3|3.0||||||
4332843|NCT00436501|4160147|B2|Adenocarcinoma||Participant Cancer Histology|Histological classification of participant cancer based on pathology report from most recent pre-registration diagnostic biopsy or surgery, confirmed within 14 days after registration for baseline measurements/data.|participants|Number|3|3.0||||||
4332844|NCT00436501|4160148|B1|Adenocarcinoma||Participant Cancer Histology|Histological classification of participant cancer based on pathology report from most recent pre-registration diagnostic biopsy or surgery, confirmed within 14 days after registration for baseline measurements/data.|participants|Number|0|0.0||||||
4332845|NCT00436501|4160146|B3|United States||Region of Enrollment||participants|Number|55|55.0||||||
4332846|NCT00436501|4160147|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
4332847|NCT00436501|4160148|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4332848|NCT00436501|4160146|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332849|NCT00436501|4160147|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332850|NCT00436501|4160148|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332851|NCT00436501|4160146|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332852|NCT00436501|4160147|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332853|NCT00436501|4160148|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332854|NCT00436501|4160146|B3||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4332855|NCT00436501|4160147|B2||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4332856|NCT00436501|4160148|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4332857|NCT00436501|4160146|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4332858|NCT00436501|4160147|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4332859|NCT00436501|4160148|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4332860|NCT00436501|4160146|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332861|NCT00436501|4160147|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332862|NCT00436501|4160148|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332863|NCT00436501|4160146|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4332864|NCT00436501|4160147|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332865|NCT00436501|4160148|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4332866|NCT00436501|4160146|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332867|NCT00436501|4160147|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332868|NCT00436501|4160148|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332869|NCT00436501|4160146|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332870|NCT00436501|4160147|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332871|NCT00436501|4160148|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332872|NCT00436501|4160146|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4332873|NCT00436501|4160147|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4332874|NCT00436501|4160148|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4332875|NCT00436501|4160146|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4332876|NCT00436501|4160147|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4332877|NCT00436501|4160148|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332878|NCT00436501|4160146|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4332879|NCT00436501|4160147|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4332880|NCT00436501|4160148|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4332881|NCT00436501|4160146|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4332882|NCT00436501|4160147|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4332883|NCT00436501|4160148|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4332884|NCT00436501|4160146|B3|||Age||years|Median|58|58.0|Full Range|||38.0|80.0|
4332885|NCT00436501|4160147|B2|||Age||years|Median|58|58.0|Full Range|||38.0|80.0|
4332886|NCT00436501|4160148|B1|||Age||years|Median|59|59.0|Full Range|||49.0|71.0|
4332888|NCT00436436|4160160|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332889|NCT00436436|4160160|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332890|NCT00436436|4160160|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4332891|NCT00436436|4160160|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4332892|NCT00436436|4160160|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332893|NCT00436436|4160160|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4332894|NCT00436436|4160160|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332895|NCT00436436|4160160|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4332896|NCT00436436|4160160|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4332897|NCT00436436|4160160|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332898|NCT00436436|4160160|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4332899|NCT00436436|4160160|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4332900|NCT00436436|4160160|B1|||Age||years|Mean|52.03|52.03|Standard Deviation|9.64|9.64|||
4332901|NCT00436436|4160160|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4332902|NCT00436436|4160160|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4332903|NCT00436436|4160160|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4332904|NCT00436345|4160169|B3|||Simplified acute physiology score (SAPS II) score|"The SAPS II score consists of adding the points from 17 variables: age, 12 physiological variables, type of admission, and 3 chronic disease variables. These variables are added to give a SAPS II score with a range of 0 (predicted mortality 0%) to 163 (predicted mortality 100%). SAPS II data were collected from local laboratories for 24 hours following ICU admission."|Points on a scale|Mean|23.23|23.23|Standard Deviation|16.30|16.3|||
4332905|NCT00436345|4160170|B2|||Simplified acute physiology score (SAPS II) score|"The SAPS II score consists of adding the points from 17 variables: age, 12 physiological variables, type of admission, and 3 chronic disease variables. These variables are added to give a SAPS II score with a range of 0 (predicted mortality 0%) to 163 (predicted mortality 100%). SAPS II data were collected from local laboratories for 24 hours following ICU admission."|Points on a scale|Mean|20.9|20.9|Standard Deviation|16.1|16.1|||
4332906|NCT00436345|4160171|B1|||Simplified acute physiology score (SAPS II) score|"The SAPS II score consists of adding the points from 17 variables: age, 12 physiological variables, type of admission, and 3 chronic disease variables. These variables are added to give a SAPS II score with a range of 0 (predicted mortality 0%) to 163 (predicted mortality 100%). SAPS II data were collected from local laboratories for 24 hours following ICU admission."|Points on a scale|Mean|25.7|25.7|Standard Deviation|16.7|16.7|||
4332907|NCT00436345|4160169|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4332908|NCT00436345|4160170|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4332909|NCT00436345|4160171|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4332910|NCT00436345|4160169|B3|White||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4332911|NCT00436345|4160170|B2|White||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4332912|NCT00436345|4160171|B1|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4332913|NCT00436345|4160169|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4332914|NCT00436345|4160170|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4332915|NCT00436345|4160171|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4332916|NCT00436345|4160169|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4332917|NCT00436345|4160170|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4332918|NCT00436345|4160171|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4332919|NCT00436345|4160169|B3|||Age||years|Mean|61.23|61.23|Standard Deviation|12.32|12.32|||
4332920|NCT00436345|4160170|B2|||Age||years|Mean|60.2|60.2|Standard Deviation|14.3|14.3|||
4332921|NCT00436345|4160171|B1|||Age||years|Mean|62.1|62.1|Standard Deviation|10.7|10.7|||
4332922|NCT00436332|4160225|B1||Unknown|Weight Loss Last 6 Months||Participants|Count of Participants|4|4.0||||||
4332923|NCT00436332|4160225|B1||10-20%|Weight Loss Last 6 Months||Participants|Count of Participants|10|10.0||||||
4332924|NCT00436332|4160225|B1||5-<10%|Weight Loss Last 6 Months||Participants|Count of Participants|8|8.0||||||
4332925|NCT00436332|4160225|B1||<5%|Weight Loss Last 6 Months||Participants|Count of Participants|57|57.0||||||
4332926|NCT00436332|4160225|B1||IV|Stage|"Patients must have selected Stage IIIB disease or Stage IV disease as outlined below (AJCC Cancer Staging Manual, 6th Edition, 2002):~IIIB~T4 (cytology confirmed malignant pleural effusion, OR pleural tumor foci that are separate from direct pleural invasion by the primary tumor)~Any N~M0~Stage IV~Any T~Any N~M1 (distant metastases present)~NOTE: Any disease that is recurrent after surgery or radiation is classified as Stage IV."|Participants|Count of Participants|76|76.0||||||
4332927|NCT00436332|4160225|B1||IIIB|Stage|"Patients must have selected Stage IIIB disease or Stage IV disease as outlined below (AJCC Cancer Staging Manual, 6th Edition, 2002):~IIIB~T4 (cytology confirmed malignant pleural effusion, OR pleural tumor foci that are separate from direct pleural invasion by the primary tumor)~Any N~M0~Stage IV~Any T~Any N~M1 (distant metastases present)~NOTE: Any disease that is recurrent after surgery or radiation is classified as Stage IV."|Participants|Count of Participants|3|3.0||||||
4332928|NCT00436332|4160225|B1||Never|Smoking History||Participants|Count of Participants|7|7.0||||||
4332929|NCT00436332|4160225|B1||Former|Smoking History||Participants|Count of Participants|61|61.0||||||
4332930|NCT00436332|4160225|B1||Current|Smoking History||Participants|Count of Participants|11|11.0||||||
4332978|NCT00436046|4160250|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4332931|NCT00436332|4160225|B1||2|Performance Status|"0: Fully active, able to carry on all pre-disease performance without restriction.~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours.~Capable of limited self-care, confined to bed or chair more than 50% of waking hours.~Completely disabled; cannot carry on any self-care; totally confined to bed or chair."|Participants|Count of Participants|3|3.0||||||
4332932|NCT00436332|4160225|B1||1|Performance Status|"0: Fully active, able to carry on all pre-disease performance without restriction.~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours.~Capable of limited self-care, confined to bed or chair more than 50% of waking hours.~Completely disabled; cannot carry on any self-care; totally confined to bed or chair."|Participants|Count of Participants|39|39.0||||||
4332933|NCT00436332|4160225|B1||0|Performance Status|"0: Fully active, able to carry on all pre-disease performance without restriction.~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours.~Capable of limited self-care, confined to bed or chair more than 50% of waking hours.~Completely disabled; cannot carry on any self-care; totally confined to bed or chair."|Participants|Count of Participants|37|37.0||||||
4332934|NCT00436332|4160225|B1||Bronchioloalveolar Carcinoma|Histology||Participants|Count of Participants|23|23.0||||||
4332935|NCT00436332|4160225|B1||Adenocarcinoma with Bronchioloalveolar Carcinoma|Histology||Participants|Count of Participants|56|56.0||||||
4332936|NCT00436332|4160225|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4332937|NCT00436332|4160225|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332938|NCT00436332|4160225|B1||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4332939|NCT00436332|4160225|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4332940|NCT00436332|4160225|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332941|NCT00436332|4160225|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332942|NCT00436332|4160225|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332943|NCT00436332|4160225|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4332944|NCT00436332|4160225|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
4332945|NCT00436332|4160225|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4332946|NCT00436332|4160225|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4332947|NCT00436332|4160225|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4332948|NCT00436332|4160225|B1|||Age||years|Median|69.2|69.2|Full Range|||39.1|92.8|
4332949|NCT00436215|4160232|B1|United States||Region of Enrollment||Participants|Count of Participants|55|55.0||||||
4332950|NCT00436215|4160232|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332951|NCT00436215|4160232|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332952|NCT00436215|4160232|B1||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4332953|NCT00436215|4160232|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4332954|NCT00436215|4160232|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332955|NCT00436215|4160232|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4332956|NCT00436215|4160232|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332957|NCT00436215|4160232|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332958|NCT00436215|4160232|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4332959|NCT00436215|4160232|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4332960|NCT00436215|4160232|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4332961|NCT00436215|4160232|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4332962|NCT00436215|4160232|B1|||Age||years|Mean|56.37|56.37|Standard Deviation|12.41|12.41|||
4332963|NCT00436215|4160232|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4332964|NCT00436215|4160232|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4332965|NCT00436215|4160232|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4332966|NCT00436163|4160238|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4332967|NCT00436163|4160238|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4332968|NCT00436163|4160238|B1|||Age||years|Mean|36.28|36.28|Standard Deviation|13.141|13.141|||
4332969|NCT00436046|4160249|B4|United States||Region of Enrollment||participants|Number|95|95.0||||||
4332970|NCT00436046|4160250|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4332971|NCT00436046|4160251|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
4332972|NCT00436046|4160252|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4332973|NCT00436046|4160249|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4332974|NCT00436046|4160250|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4332975|NCT00436046|4160251|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4332976|NCT00436046|4160252|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4332977|NCT00436046|4160249|B4||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4332979|NCT00436046|4160251|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4332980|NCT00436046|4160252|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4332981|NCT00436046|4160249|B4|||Age||years|Mean|25.1|25.1|Standard Deviation|4.9|4.9|||
4332982|NCT00436046|4160250|B3|||Age||years|Mean|24.7|24.7|Standard Deviation|4.9|4.9|||
4332983|NCT00436046|4160251|B2|||Age||years|Mean|25.2|25.2|Standard Deviation|4.8|4.8|||
4332984|NCT00436046|4160252|B1|||Age||years|Mean|25.3|25.3|Standard Deviation|5.2|5.2|||
4332985|NCT00436046|4160249|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4332986|NCT00436046|4160250|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4332987|NCT00436046|4160251|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4332988|NCT00436046|4160252|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4332989|NCT00436046|4160249|B4||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
4332990|NCT00436046|4160250|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4332991|NCT00436046|4160251|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4332992|NCT00436046|4160252|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4332993|NCT00436046|4160249|B4||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4332994|NCT00436046|4160250|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4332995|NCT00436046|4160251|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4332996|NCT00436046|4160252|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4332997|NCT00436007|4160283|B4|Tanzania||Region of Enrollment||Subjects|Number|210|210.0||||||
4332998|NCT00436007|4160284|B3|Tanzania||Region of Enrollment||Subjects|Number|70|70.0||||||
4332999|NCT00436007|4160285|B2|Tanzania||Region of Enrollment||Subjects|Number|70|70.0||||||
4333000|NCT00436007|4160286|B1|Tanzania||Region of Enrollment||Subjects|Number|70|70.0||||||
4333001|NCT00436007|4160283|B4|Ghana||Region of Enrollment||Subjects|Number|81|81.0||||||
4333002|NCT00436007|4160284|B3|Ghana||Region of Enrollment||Subjects|Number|27|27.0||||||
4333003|NCT00436007|4160285|B2|Ghana||Region of Enrollment||Subjects|Number|27|27.0||||||
4333004|NCT00436007|4160286|B1|Ghana||Region of Enrollment||Subjects|Number|27|27.0||||||
4333005|NCT00436007|4160283|B4|Gabon||Region of Enrollment||Subjects|Number|220|220.0||||||
4333006|NCT00436007|4160284|B3|Gabon||Region of Enrollment||Subjects|Number|74|74.0||||||
4333007|NCT00436007|4160285|B2|Gabon||Region of Enrollment||Subjects|Number|73|73.0||||||
4333008|NCT00436007|4160286|B1|Gabon||Region of Enrollment||Subjects|Number|73|73.0||||||
4333009|NCT00436007|4160283|B4||Male|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
4333010|NCT00436007|4160284|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4333011|NCT00436007|4160285|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4333012|NCT00436007|4160286|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4333013|NCT00436007|4160283|B4||Female|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
4333014|NCT00436007|4160284|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4333015|NCT00436007|4160285|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4333016|NCT00436007|4160286|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4333017|NCT00436007|4160283|B4|||Age||Weeks|Mean|7.0|7.0|Standard Deviation|1.00|1.0|||
4333018|NCT00436007|4160284|B3|||Age||Weeks|Mean|7.0|7.0|Standard Deviation|0.97|0.97|||
4333019|NCT00436007|4160285|B2|||Age||Weeks|Mean|7.1|7.1|Standard Deviation|1.05|1.05|||
4333020|NCT00436007|4160286|B1|||Age||Weeks|Mean|7.0|7.0|Standard Deviation|0.97|0.97|||
4333021|NCT00435994|4160333|B4|United States||Region of Enrollment||participants|Number|59|59.0||||||
4333022|NCT00435994|4160334|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4333023|NCT00435994|4160335|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4333024|NCT00435994|4160336|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4333025|NCT00435994|4160333|B4||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4333026|NCT00435994|4160334|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4333027|NCT00435994|4160335|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4333028|NCT00435994|4160336|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4333029|NCT00435994|4160333|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4333030|NCT00435994|4160334|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4333031|NCT00435994|4160335|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4333032|NCT00435994|4160336|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4333033|NCT00435994|4160333|B4|||Age||months|Mean|11|11.0|Standard Deviation|6|6.0|||
4333034|NCT00435994|4160334|B3|||Age||months|Mean|7|7.0|Standard Deviation|4|4.0|||
4333035|NCT00435994|4160335|B2|||Age||months|Mean|7|7.0|Standard Deviation|6|6.0|||
4333036|NCT00435994|4160336|B1|||Age||months|Mean|13|13.0|Standard Deviation|5|5.0|||
4333037|NCT00435942|4160347|B3|United States||Region of Enrollment||participants|Number|180|180.0||||||
4333038|NCT00435942|4160348|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
4333039|NCT00435942|4160349|B1|United States||Region of Enrollment||participants|Number|120|120.0||||||
4333040|NCT00435942|4160347|B3||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4333041|NCT00435942|4160348|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4333042|NCT00435942|4160349|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4333043|NCT00435942|4160347|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4333044|NCT00435942|4160348|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4333045|NCT00435942|4160349|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4333046|NCT00435942|4160347|B3|||Age||years|Mean|71.84|71.84|Standard Deviation|10.39|10.39|||
4333047|NCT00435942|4160348|B2|||Age||years|Mean|70.0|70.0|Standard Deviation|9.17|9.17|||
4333048|NCT00435942|4160349|B1|||Age||years|Mean|72.8|72.8|Standard Deviation|11.02|11.02|||
4333049|NCT00435942|4160347|B3||>=65 years|Age||Participants|Count of Participants|147|147.0||||||
4333050|NCT00435942|4160348|B2||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4333051|NCT00435942|4160349|B1||>=65 years|Age||Participants|Count of Participants|99|99.0||||||
4333052|NCT00435942|4160347|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4333053|NCT00435942|4160348|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4333054|NCT00435942|4160349|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4333055|NCT00435942|4160347|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333056|NCT00435942|4160348|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333057|NCT00435942|4160349|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333058|NCT00435929|4160357|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4333059|NCT00435929|4160358|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4333060|NCT00435929|4160359|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4333061|NCT00435929|4160357|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4333062|NCT00435929|4160358|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4333063|NCT00435929|4160359|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4333064|NCT00435929|4160357|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4333065|NCT00435929|4160358|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4333066|NCT00435929|4160359|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4333067|NCT00435929|4160357|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4333068|NCT00435929|4160358|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4333069|NCT00435929|4160359|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4333070|NCT00435929|4160357|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333071|NCT00435929|4160358|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333072|NCT00435929|4160359|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333073|NCT00435825|4160386|B5||Male|Sex: Female, Male||Participants|Count of Participants|377|377.0||||||
4333074|NCT00435825|4160387|B4||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4333075|NCT00435825|4160388|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4333076|NCT00435825|4160389|B2||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4333077|NCT00435825|4160390|B1||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4333078|NCT00435825|4160386|B5||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4333079|NCT00435825|4160387|B4||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4333080|NCT00435825|4160388|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4333081|NCT00435825|4160389|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4333082|NCT00435825|4160390|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4333083|NCT00435825|4160386|B5|||Age, Customized||Years|Mean|32.98|32.98|Full Range|||16.0|69.0|
4333084|NCT00435825|4160387|B4|||Age, Customized||Years|Mean|33.3|33.3|Full Range|10.89|10.89|18.0|69.0|
4333085|NCT00435825|4160388|B3|||Age, Customized||Years|Mean|33.8|33.8|Full Range|10.48|10.48|16.0|62.0|
4333086|NCT00435825|4160389|B2|||Age, Customized||Years|Mean|33.0|33.0|Full Range|10.52|10.52|18.0|66.0|
4333087|NCT00435825|4160390|B1|||Age, Customized||Years|Mean|31.8|31.8|Full Range|9.77|9.77|18.0|56.0|
4333088|NCT00435812|4160447|B3|Germany||Region of Enrollment||Participants|Count of Participants|939|939.0||||||
4333089|NCT00435812|4160448|B2|Germany||Region of Enrollment||Participants|Count of Participants|241|241.0||||||
4333090|NCT00435812|4160449|B1|Germany||Region of Enrollment||Participants|Count of Participants|698|698.0||||||
4333091|NCT00435812|4160447|B3|Canada||Region of Enrollment||Participants|Count of Participants|1489|1489.0||||||
4333092|NCT00435812|4160448|B2|Canada||Region of Enrollment||Participants|Count of Participants|366|366.0||||||
4333093|NCT00435812|4160449|B1|Canada||Region of Enrollment||Participants|Count of Participants|1123|1123.0||||||
4333094|NCT00435812|4160447|B3||Male|Sex: Female, Male||Participants|Count of Participants|1123|1123.0||||||
4333095|NCT00435812|4160448|B2||Male|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
4333096|NCT00435812|4160449|B1||Male|Sex: Female, Male||Participants|Count of Participants|862|862.0||||||
4333097|NCT00435812|4160447|B3||Female|Sex: Female, Male||Participants|Count of Participants|1305|1305.0||||||
4333098|NCT00435812|4160448|B2||Female|Sex: Female, Male||Participants|Count of Participants|346|346.0||||||
4333099|NCT00435812|4160449|B1||Female|Sex: Female, Male||Participants|Count of Participants|959|959.0||||||
4333100|NCT00435812|4160447|B3|≥18 and ≤ 55 years||Age, Customized||Participants|Count of Participants|2415|2415.0||||||
4333101|NCT00435812|4160448|B2|≥18 and ≤ 55 years||Age, Customized||Participants|Count of Participants|605|605.0||||||
4333102|NCT00435812|4160449|B1|≥18 and ≤ 55 years||Age, Customized||Participants|Count of Participants|1810|1810.0||||||
4333103|NCT00435812|4160447|B3|11 to 17 years||Age, Customized||Participants|Count of Participants|13|13.0||||||
4333104|NCT00435812|4160448|B2|11 to 17 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
4333105|NCT00435812|4160449|B1|11 to 17 years||Age, Customized||Participants|Count of Participants|11|11.0||||||
4333106|NCT00435591|4160458|B5|Hypervolemic/ Unknown||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|2|2.0||||||
4333107|NCT00435591|4160459|B4|Hypervolemic/ Unknown||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|0|0.0||||||
4333108|NCT00435591|4160460|B3|Hypervolemic/ Unknown||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|2|2.0||||||
4333109|NCT00435591|4160461|B2|Hypervolemic/ Unknown||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|0|0.0||||||
4333110|NCT00435591|4160462|B1|Hypervolemic/ Unknown||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|0|0.0||||||
4333111|NCT00435591|4160458|B5|Hypervolemic/ CHF||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|7|7.0||||||
4333112|NCT00435591|4160459|B4|Hypervolemic/ CHF||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|2|2.0||||||
4333113|NCT00435591|4160460|B3|Hypervolemic/ CHF||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|0|0.0||||||
4333114|NCT00435591|4160461|B2|Hypervolemic/ CHF||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|2|2.0||||||
4333115|NCT00435591|4160462|B1|Hypervolemic/ CHF||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|3|3.0||||||
4333116|NCT00435591|4160458|B5|Hypervolemic/ SIADH||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|1|1.0||||||
4333117|NCT00435591|4160459|B4|Hypervolemic/ SIADH||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|0|0.0||||||
4333118|NCT00435591|4160460|B3|Hypervolemic/ SIADH||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|1|1.0||||||
4333119|NCT00435591|4160461|B2|Hypervolemic/ SIADH||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|0|0.0||||||
4333120|NCT00435591|4160462|B1|Hypervolemic/ SIADH||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|0|0.0||||||
4333121|NCT00435591|4160458|B5|Euvolemic/ Other||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|19|19.0||||||
4333122|NCT00435591|4160459|B4|Euvolemic/ Other||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|6|6.0||||||
4333123|NCT00435591|4160460|B3|Euvolemic/ Other||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|4|4.0||||||
4333124|NCT00435591|4160461|B2|Euvolemic/ Other||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|7|7.0||||||
4333125|NCT00435591|4160462|B1|Euvolemic/ Other||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|2|2.0||||||
4333126|NCT00435591|4160458|B5|Euvolemic/ Unknown||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|32|32.0||||||
4333127|NCT00435591|4160459|B4|Euvolemic/ Unknown||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|10|10.0||||||
4333128|NCT00435591|4160460|B3|Euvolemic/ Unknown||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|8|8.0||||||
4333129|NCT00435591|4160461|B2|Euvolemic/ Unknown||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|8|8.0||||||
4333130|NCT00435591|4160462|B1|Euvolemic/ Unknown||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|6|6.0||||||
4333131|NCT00435591|4160458|B5|Euvolemic/ COPD||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|1|1.0||||||
4333132|NCT00435591|4160459|B4|Euvolemic/ COPD||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|0|0.0||||||
4333133|NCT00435591|4160460|B3|Euvolemic/ COPD||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|0|0.0||||||
4333134|NCT00435591|4160461|B2|Euvolemic/ COPD||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|0|0.0||||||
4333135|NCT00435591|4160462|B1|Euvolemic/ COPD||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|1|1.0||||||
4333136|NCT00435591|4160458|B5|Euvolemic/ Idiopathic||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|4|4.0||||||
4333137|NCT00435591|4160459|B4|Euvolemic/ Idiopathic||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|2|2.0||||||
4333138|NCT00435591|4160460|B3|Euvolemic/ Idiopathic||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|1|1.0||||||
4333139|NCT00435591|4160461|B2|Euvolemic/ Idiopathic||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|1|1.0||||||
4333140|NCT00435591|4160462|B1|Euvolemic/ Idiopathic||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|0|0.0||||||
4333141|NCT00435591|4160458|B5|Euvolemic/ Malignancy||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|4|4.0||||||
4333142|NCT00435591|4160459|B4|Euvolemic/ Malignancy||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|0|0.0||||||
4333143|NCT00435591|4160460|B3|Euvolemic/ Malignancy||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|3|3.0||||||
4333144|NCT00435591|4160461|B2|Euvolemic/ Malignancy||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|1|1.0||||||
4333145|NCT00435591|4160462|B1|Euvolemic/ Malignancy||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|0|0.0||||||
4333146|NCT00435591|4160458|B5|Euvolemic/ CHF||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|1|1.0||||||
4333147|NCT00435591|4160459|B4|Euvolemic/ CHF||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|0|0.0||||||
4333148|NCT00435591|4160460|B3|Euvolemic/ CHF||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|0|0.0||||||
4333149|NCT00435591|4160461|B2|Euvolemic/ CHF||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|0|0.0||||||
4333150|NCT00435591|4160462|B1|Euvolemic/ CHF||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|1|1.0||||||
4333151|NCT00435591|4160458|B5|Euvolemic/ SIADH||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|46|46.0||||||
4333152|NCT00435591|4160459|B4|Euvolemic/ SIADH||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|9|9.0||||||
4333153|NCT00435591|4160460|B3|Euvolemic/ SIADH||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|11|11.0||||||
4333154|NCT00435591|4160461|B2|Euvolemic/ SIADH||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|11|11.0||||||
4333155|NCT00435591|4160462|B1|Euvolemic/ SIADH||Volume Status/ Underlying Cause of Hyponatremia|"Population represented is Safety Analysis Set (SAF)~SIADH: Syndrome of inappropriate antidiuretic hormone secretion CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease"|Participants|Number|15|15.0||||||
4333156|NCT00435591|4160458|B5|American Indian / Alaskan||Race/Ethnicity, Customized|Population represented is Safety Analysis Set (SAF)|Participants|Number|1|1.0||||||
4333157|NCT00435591|4160459|B4|American Indian / Alaskan||Race/Ethnicity, Customized|Population represented is Safety Analysis Set (SAF)|Participants|Number|0|0.0||||||
4333158|NCT00435591|4160460|B3|American Indian / Alaskan||Race/Ethnicity, Customized|Population represented is Safety Analysis Set (SAF)|Participants|Number|1|1.0||||||
4333159|NCT00435591|4160461|B2|American Indian / Alaskan||Race/Ethnicity, Customized|Population represented is Safety Analysis Set (SAF)|Participants|Number|0|0.0||||||
4333160|NCT00435591|4160462|B1|American Indian / Alaskan||Race/Ethnicity, Customized|Population represented is Safety Analysis Set (SAF)|Participants|Number|0|0.0||||||
4333161|NCT00435591|4160458|B5|Asian||Race/Ethnicity, Customized|Population represented is Safety Analysis Set (SAF)|Participants|Number|55|55.0||||||
4333162|NCT00435591|4160459|B4|Asian||Race/Ethnicity, Customized|Population represented is Safety Analysis Set (SAF)|Participants|Number|13|13.0||||||
4333163|NCT00435591|4160460|B3|Asian||Race/Ethnicity, Customized|Population represented is Safety Analysis Set (SAF)|Participants|Number|15|15.0||||||
4333164|NCT00435591|4160461|B2|Asian||Race/Ethnicity, Customized|Population represented is Safety Analysis Set (SAF)|Participants|Number|13|13.0||||||
4333165|NCT00435591|4160462|B1|Asian||Race/Ethnicity, Customized|Population represented is Safety Analysis Set (SAF)|Participants|Number|14|14.0||||||
4333166|NCT00435591|4160458|B5|Black/ African -American||Race/Ethnicity, Customized|Population represented is Safety Analysis Set (SAF)|Participants|Number|1|1.0||||||
4333167|NCT00435591|4160459|B4|Black/ African -American||Race/Ethnicity, Customized|Population represented is Safety Analysis Set (SAF)|Participants|Number|0|0.0||||||
4333168|NCT00435591|4160460|B3|Black/ African -American||Race/Ethnicity, Customized|Population represented is Safety Analysis Set (SAF)|Participants|Number|0|0.0||||||
4333169|NCT00435591|4160461|B2|Black/ African -American||Race/Ethnicity, Customized|Population represented is Safety Analysis Set (SAF)|Participants|Number|1|1.0||||||
4333170|NCT00435591|4160462|B1|Black/ African -American||Race/Ethnicity, Customized|Population represented is Safety Analysis Set (SAF)|Participants|Number|0|0.0||||||
4333171|NCT00435591|4160458|B5|White||Race/Ethnicity, Customized|Population represented is Safety Analysis Set (SAF)|Participants|Number|60|60.0||||||
4333172|NCT00435591|4160459|B4|White||Race/Ethnicity, Customized|Population represented is Safety Analysis Set (SAF)|Participants|Number|16|16.0||||||
4333173|NCT00435591|4160460|B3|White||Race/Ethnicity, Customized|Population represented is Safety Analysis Set (SAF)|Participants|Number|14|14.0||||||
4333174|NCT00435591|4160461|B2|White||Race/Ethnicity, Customized|Population represented is Safety Analysis Set (SAF)|Participants|Number|16|16.0||||||
4333175|NCT00435591|4160462|B1|White||Race/Ethnicity, Customized|Population represented is Safety Analysis Set (SAF)|Participants|Number|14|14.0||||||
4333176|NCT00435591|4160458|B5||Male|Sex: Female, Male|Population represented is Safety Analysis Set (SAF)|Participants|Count of Participants|56|56.0||||||
4333177|NCT00435591|4160459|B4||Male|Sex: Female, Male|Population represented is Safety Analysis Set (SAF)|Participants|Count of Participants|11|11.0||||||
4333178|NCT00435591|4160460|B3||Male|Sex: Female, Male|Population represented is Safety Analysis Set (SAF)|Participants|Count of Participants|14|14.0||||||
4333179|NCT00435591|4160461|B2||Male|Sex: Female, Male|Population represented is Safety Analysis Set (SAF)|Participants|Count of Participants|17|17.0||||||
4333180|NCT00435591|4160462|B1||Male|Sex: Female, Male|Population represented is Safety Analysis Set (SAF)|Participants|Count of Participants|14|14.0||||||
4333181|NCT00435591|4160458|B5||Female|Sex: Female, Male|Population represented is Safety Analysis Set (SAF)|Participants|Count of Participants|61|61.0||||||
4333182|NCT00435591|4160459|B4||Female|Sex: Female, Male|Population represented is Safety Analysis Set (SAF)|Participants|Count of Participants|18|18.0||||||
4333183|NCT00435591|4160460|B3||Female|Sex: Female, Male|Population represented is Safety Analysis Set (SAF)|Participants|Count of Participants|16|16.0||||||
4333184|NCT00435591|4160461|B2||Female|Sex: Female, Male|Population represented is Safety Analysis Set (SAF)|Participants|Count of Participants|13|13.0||||||
4333185|NCT00435591|4160462|B1||Female|Sex: Female, Male|Population represented is Safety Analysis Set (SAF)|Participants|Count of Participants|14|14.0||||||
4333186|NCT00435591|4160458|B5|||Age|Population represented is Safety Analysis Set (SAF)|years|Mean|62.1|62.1|Standard Deviation|19.28|19.28|||
4333187|NCT00435591|4160459|B4|||Age|Population represented is Safety Analysis Set (SAF)|years|Mean|63.3|63.3|Standard Deviation|22.31|22.31|||
4333188|NCT00435591|4160460|B3|||Age|Population represented is Safety Analysis Set (SAF)|years|Mean|64.8|64.8|Standard Deviation|14.13|14.13|||
4333189|NCT00435591|4160461|B2|||Age|Population represented is Safety Analysis Set (SAF)|years|Mean|61.1|61.1|Standard Deviation|20.14|20.14|||
4333190|NCT00435591|4160462|B1|||Age|Population represented is Safety Analysis Set (SAF)|years|Mean|59.1|59.1|Standard Deviation|20.28|20.28|||
4333191|NCT00435539|4160490|B6||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4333192|NCT00435539|4160491|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4333193|NCT00435539|4160492|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4333194|NCT00435539|4160493|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4333195|NCT00435539|4160494|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4333196|NCT00435539|4160495|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4333197|NCT00435539|4160490|B6||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4333198|NCT00435539|4160491|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4333199|NCT00435539|4160492|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4333200|NCT00435539|4160493|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4333201|NCT00435539|4160494|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4333202|NCT00435539|4160495|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4333203|NCT00435539|4160490|B6|||Age||years|Mean|69.79|69.79|Standard Deviation|7.66|7.66|||
4333204|NCT00435539|4160491|B5|||Age||years|Mean|70.28|70.28|Standard Deviation|8.58|8.58|||
4333205|NCT00435539|4160492|B4|||Age||years|Mean|70.61|70.61|Standard Deviation|6.67|6.67|||
4333206|NCT00435539|4160493|B3|||Age||years|Mean|66.11|66.11|Standard Deviation|9.08|9.08|||
4333207|NCT00435539|4160494|B2|||Age||years|Mean|74.67|74.67|Standard Deviation|5.78|5.78|||
4333208|NCT00435539|4160495|B1|||Age||years|Mean|66.58|66.58|Standard Deviation|5.57|5.57|||
4333209|NCT00435487|4160514|B3||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4333210|NCT00435487|4160515|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4333211|NCT00435487|4160516|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4333212|NCT00435487|4160514|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4333213|NCT00435487|4160515|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4333214|NCT00435487|4160516|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4333215|NCT00435487|4160514|B3|>=65 years||Age, Customized||participants|Number|84|84.0||||||
4333216|NCT00435487|4160515|B2|>=65 years||Age, Customized||participants|Number|38|38.0||||||
4333217|NCT00435487|4160516|B1|>=65 years||Age, Customized||participants|Number|46|46.0||||||
4333218|NCT00435487|4160514|B3|45 - 64 years||Age, Customized||participants|Number|76|76.0||||||
4333219|NCT00435487|4160515|B2|45 - 64 years||Age, Customized||participants|Number|40|40.0||||||
4333220|NCT00435487|4160516|B1|45 - 64 years||Age, Customized||participants|Number|36|36.0||||||
4333221|NCT00435487|4160514|B3|18 - 44 years||Age, Customized||participants|Number|11|11.0||||||
4333222|NCT00435487|4160515|B2|18 - 44 years||Age, Customized||participants|Number|5|5.0||||||
4333223|NCT00435487|4160516|B1|18 - 44 years||Age, Customized||participants|Number|6|6.0||||||
4333224|NCT00435461|4160533|B4|Mixed Race||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4333225|NCT00435461|4160534|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4333226|NCT00435461|4160535|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4333227|NCT00435461|4160536|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4333228|NCT00435461|4160533|B4|White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|824|824.0||||||
4333229|NCT00435461|4160534|B3|White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|286|286.0||||||
4333230|NCT00435461|4160535|B2|White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|268|268.0||||||
4333231|NCT00435461|4160536|B1|White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|270|270.0||||||
4333232|NCT00435461|4160533|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4333233|NCT00435461|4160534|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4333234|NCT00435461|4160535|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4333235|NCT00435461|4160536|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4333236|NCT00435461|4160533|B4|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4333237|NCT00435461|4160534|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4333238|NCT00435461|4160535|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4333239|NCT00435461|4160536|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4333240|NCT00435461|4160533|B4|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4333241|NCT00435461|4160534|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4333242|NCT00435461|4160535|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4333243|NCT00435461|4160536|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4333244|NCT00435461|4160533|B4|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4333245|NCT00435461|4160534|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4333246|NCT00435461|4160535|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4333247|NCT00435461|4160536|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4333452|NCT00434967|4160776|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4333248|NCT00435461|4160533|B4|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4333249|NCT00435461|4160534|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4333250|NCT00435461|4160535|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4333251|NCT00435461|4160536|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4333252|NCT00435461|4160533|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4333253|NCT00435461|4160534|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4333254|NCT00435461|4160535|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4333255|NCT00435461|4160536|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4333256|NCT00435461|4160533|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|57|57.0||||||
4333257|NCT00435461|4160534|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4333258|NCT00435461|4160535|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|26|26.0||||||
4333259|NCT00435461|4160536|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4333260|NCT00435461|4160533|B4||Male|Sex: Female, Male||Participants|Count of Participants|334|334.0||||||
4333261|NCT00435461|4160534|B3||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4333262|NCT00435461|4160535|B2||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4333263|NCT00435461|4160536|B1||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4333264|NCT00435461|4160533|B4||Female|Sex: Female, Male||Participants|Count of Participants|602|602.0||||||
4333265|NCT00435461|4160534|B3||Female|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4333266|NCT00435461|4160535|B2||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4333267|NCT00435461|4160536|B1||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4333268|NCT00435461|4160533|B4|||Age||Years|Mean|38.4|38.4|Standard Deviation|14.34|14.34|||
4333269|NCT00435461|4160534|B3|||Age||Years|Mean|39.6|39.6|Standard Deviation|14.63|14.63|||
4333270|NCT00435461|4160535|B2|||Age||Years|Mean|37.8|37.8|Standard Deviation|13.95|13.95|||
4333271|NCT00435461|4160536|B1|||Age||Years|Mean|37.8|37.8|Standard Deviation|14.39|14.39|||
4333272|NCT00435409|4160573|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4333273|NCT00435409|4160574|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4333274|NCT00435409|4160575|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4333275|NCT00435409|4160573|B3||Female|Sex: Female, Male||Participants|Count of Participants|438|438.0||||||
4333276|NCT00435409|4160574|B2||Female|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
4333277|NCT00435409|4160575|B1||Female|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4333278|NCT00435409|4160573|B3|Greater than or equal to 65 years||Age, Customized||participants|Number|75|75.0||||||
4333279|NCT00435409|4160574|B2|Greater than or equal to 65 years||Age, Customized||participants|Number|36|36.0||||||
4333280|NCT00435409|4160575|B1|Greater than or equal to 65 years||Age, Customized||participants|Number|39|39.0||||||
4333281|NCT00435409|4160573|B3|Less than 65 years||Age, Customized||participants|Number|367|367.0||||||
4333282|NCT00435409|4160574|B2|Less than 65 years||Age, Customized||participants|Number|185|185.0||||||
4333283|NCT00435409|4160575|B1|Less than 65 years||Age, Customized||participants|Number|182|182.0||||||
4333284|NCT00435370|4160597|B3|China||Region of Enrollment||participants|Number|179|179.0||||||
4333285|NCT00435370|4160598|B2|China||Region of Enrollment||participants|Number|89|89.0||||||
4333286|NCT00435370|4160599|B1|China||Region of Enrollment||participants|Number|90|90.0||||||
4333287|NCT00435370|4160597|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4333288|NCT00435370|4160598|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4333289|NCT00435370|4160599|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4333290|NCT00435370|4160597|B3||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4333291|NCT00435370|4160598|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4333292|NCT00435370|4160599|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4333293|NCT00435370|4160597|B3|||Age||years|Mean|28.6|28.6|Standard Deviation|9.6|9.6|||
4333294|NCT00435370|4160598|B2|||Age||years|Mean|28.3|28.3|Standard Deviation|9.9|9.9|||
4333295|NCT00435370|4160599|B1|||Age||years|Mean|28.8|28.8|Standard Deviation|9.2|9.2|||
4333296|NCT00435370|4160597|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4333297|NCT00435370|4160598|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4333298|NCT00435370|4160599|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4333299|NCT00435370|4160597|B3||Between 18 and 65 years|Age||Participants|Count of Participants|179|179.0||||||
4333300|NCT00435370|4160598|B2||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
4333301|NCT00435370|4160599|B1||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
4333302|NCT00435370|4160597|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333303|NCT00435370|4160598|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333304|NCT00435370|4160599|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333305|NCT00435188|4160606|B3|Participants reporting no use of assistive devices||Assistive device|Number of participants reporting the use of an assistive device|participants|Number|319|319.0||||||
4333346|NCT00435188|4160608|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4333306|NCT00435188|4160607|B2|Participants reporting no use of assistive devices||Assistive device|Number of participants reporting the use of an assistive device|participants|Number|160|160.0||||||
4333307|NCT00435188|4160608|B1|Participants reporting no use of assistive devices||Assistive device|Number of participants reporting the use of an assistive device|participants|Number|159|159.0||||||
4333308|NCT00435188|4160606|B3|Participants reporting assistive device use||Assistive device|Number of participants reporting the use of an assistive device|participants|Number|79|79.0||||||
4333309|NCT00435188|4160607|B2|Participants reporting assistive device use||Assistive device|Number of participants reporting the use of an assistive device|participants|Number|39|39.0||||||
4333310|NCT00435188|4160608|B1|Participants reporting assistive device use||Assistive device|Number of participants reporting the use of an assistive device|participants|Number|40|40.0||||||
4333311|NCT00435188|4160606|B3|Health QOL rated as Good, Fair, or Poor||Health quality of life of excellent or very good|Reported as the number of participants who reported health quality of life as excellent or very good from a 5 point likert scale ranging from poor to excellent|participants|Number|251|251.0||||||
4333312|NCT00435188|4160607|B2|Health QOL rated as Good, Fair, or Poor||Health quality of life of excellent or very good|Reported as the number of participants who reported health quality of life as excellent or very good from a 5 point likert scale ranging from poor to excellent|participants|Number|123|123.0||||||
4333313|NCT00435188|4160608|B1|Health QOL rated as Good, Fair, or Poor||Health quality of life of excellent or very good|Reported as the number of participants who reported health quality of life as excellent or very good from a 5 point likert scale ranging from poor to excellent|participants|Number|128|128.0||||||
4333314|NCT00435188|4160606|B3|Health QOL rated as Excellent or Very Good||Health quality of life of excellent or very good|Reported as the number of participants who reported health quality of life as excellent or very good from a 5 point likert scale ranging from poor to excellent|participants|Number|147|147.0||||||
4333315|NCT00435188|4160607|B2|Health QOL rated as Excellent or Very Good||Health quality of life of excellent or very good|Reported as the number of participants who reported health quality of life as excellent or very good from a 5 point likert scale ranging from poor to excellent|participants|Number|76|76.0||||||
4333316|NCT00435188|4160608|B1|Health QOL rated as Excellent or Very Good||Health quality of life of excellent or very good|Reported as the number of participants who reported health quality of life as excellent or very good from a 5 point likert scale ranging from poor to excellent|participants|Number|71|71.0||||||
4333317|NCT00435188|4160606|B3|||Number of diseases|By self report from a list of 35 conditions adapted from the Older Americans Resources and Services survey|Diseases|Mean|5.3|5.3|Standard Deviation|2.6|2.6|||
4333318|NCT00435188|4160607|B2|||Number of diseases|By self report from a list of 35 conditions adapted from the Older Americans Resources and Services survey|Diseases|Mean|5.5|5.5|Standard Deviation|2.7|2.7|||
4333319|NCT00435188|4160608|B1|||Number of diseases|By self report from a list of 35 conditions adapted from the Older Americans Resources and Services survey|Diseases|Mean|5.2|5.2|Standard Deviation|2.5|2.5|||
4333320|NCT00435188|4160606|B3|||Body mass index||kg/m2|Mean|29|29.0|Standard Deviation|4.6|4.6|||
4333321|NCT00435188|4160607|B2|||Body mass index||kg/m2|Mean|29.1|29.1|Standard Deviation|4.6|4.6|||
4333322|NCT00435188|4160608|B1|||Body mass index||kg/m2|Mean|28.9|28.9|Standard Deviation|4.7|4.7|||
4333323|NCT00435188|4160606|B3|College graduate||Education|Number of participants completing a categorical level of education as described|participants|Number|107|107.0||||||
4333324|NCT00435188|4160607|B2|College graduate||Education|Number of participants completing a categorical level of education as described|participants|Number|55|55.0||||||
4333325|NCT00435188|4160608|B1|College graduate||Education|Number of participants completing a categorical level of education as described|participants|Number|52|52.0||||||
4333326|NCT00435188|4160606|B3|Some college or trade school||Education|Number of participants completing a categorical level of education as described|participants|Number|108|108.0||||||
4333327|NCT00435188|4160607|B2|Some college or trade school||Education|Number of participants completing a categorical level of education as described|participants|Number|52|52.0||||||
4333328|NCT00435188|4160608|B1|Some college or trade school||Education|Number of participants completing a categorical level of education as described|participants|Number|56|56.0||||||
4333329|NCT00435188|4160606|B3|Less or equal to high school||Education|Number of participants completing a categorical level of education as described|participants|Number|183|183.0||||||
4333330|NCT00435188|4160607|B2|Less or equal to high school||Education|Number of participants completing a categorical level of education as described|participants|Number|92|92.0||||||
4333331|NCT00435188|4160608|B1|Less or equal to high school||Education|Number of participants completing a categorical level of education as described|participants|Number|91|91.0||||||
4333332|NCT00435188|4160606|B3|United States||Region of Enrollment||participants|Number|398|398.0||||||
4333333|NCT00435188|4160607|B2|United States||Region of Enrollment||participants|Number|199|199.0||||||
4333334|NCT00435188|4160608|B1|United States||Region of Enrollment||participants|Number|199|199.0||||||
4333335|NCT00435188|4160606|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4333336|NCT00435188|4160607|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4333337|NCT00435188|4160608|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4333338|NCT00435188|4160606|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4333339|NCT00435188|4160607|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4333340|NCT00435188|4160608|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4333341|NCT00435188|4160606|B3||White|Race (NIH/OMB)||Participants|Count of Participants|308|308.0||||||
4333342|NCT00435188|4160607|B2||White|Race (NIH/OMB)||Participants|Count of Participants|157|157.0||||||
4333343|NCT00435188|4160608|B1||White|Race (NIH/OMB)||Participants|Count of Participants|151|151.0||||||
4333344|NCT00435188|4160606|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4333345|NCT00435188|4160607|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4333347|NCT00435188|4160606|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4333348|NCT00435188|4160607|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4333349|NCT00435188|4160608|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4333350|NCT00435188|4160606|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4333351|NCT00435188|4160607|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4333352|NCT00435188|4160608|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4333353|NCT00435188|4160606|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4333354|NCT00435188|4160607|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4333355|NCT00435188|4160608|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4333356|NCT00435188|4160606|B3||Male|Sex: Female, Male|This study was conducted at a VA Medical Center. Only 3 females were randomized into the study which was not unexpected given the targeted sample and relative paucity of females in VA receiving care in this particular age group at the time. On submitting primary paper, the authors were required to eliminate the females from the study. No females were included in data presented|Participants|Count of Participants|398|398.0||||||
4333357|NCT00435188|4160607|B2||Male|Sex: Female, Male|This study was conducted at a VA Medical Center. Only 3 females were randomized into the study which was not unexpected given the targeted sample and relative paucity of females in VA receiving care in this particular age group at the time. On submitting primary paper, the authors were required to eliminate the females from the study. No females were included in data presented|Participants|Count of Participants|199|199.0||||||
4333358|NCT00435188|4160608|B1||Male|Sex: Female, Male|This study was conducted at a VA Medical Center. Only 3 females were randomized into the study which was not unexpected given the targeted sample and relative paucity of females in VA receiving care in this particular age group at the time. On submitting primary paper, the authors were required to eliminate the females from the study. No females were included in data presented|Participants|Count of Participants|199|199.0||||||
4333359|NCT00435188|4160606|B3||Female|Sex: Female, Male|This study was conducted at a VA Medical Center. Only 3 females were randomized into the study which was not unexpected given the targeted sample and relative paucity of females in VA receiving care in this particular age group at the time. On submitting primary paper, the authors were required to eliminate the females from the study. No females were included in data presented|Participants|Count of Participants|0|0.0||||||
4333360|NCT00435188|4160607|B2||Female|Sex: Female, Male|This study was conducted at a VA Medical Center. Only 3 females were randomized into the study which was not unexpected given the targeted sample and relative paucity of females in VA receiving care in this particular age group at the time. On submitting primary paper, the authors were required to eliminate the females from the study. No females were included in data presented|Participants|Count of Participants|0|0.0||||||
4333361|NCT00435188|4160608|B1||Female|Sex: Female, Male|This study was conducted at a VA Medical Center. Only 3 females were randomized into the study which was not unexpected given the targeted sample and relative paucity of females in VA receiving care in this particular age group at the time. On submitting primary paper, the authors were required to eliminate the females from the study. No females were included in data presented|Participants|Count of Participants|0|0.0||||||
4333362|NCT00435188|4160606|B3|||Age||years|Mean|77.5|77.5|Standard Deviation|5|5.0|||
4333363|NCT00435188|4160607|B2|||Age||years|Mean|77.4|77.4|Standard Deviation|4.9|4.9|||
4333364|NCT00435188|4160608|B1|||Age||years|Mean|77.7|77.7|Standard Deviation|5.0|5.0|||
4333365|NCT00435162|4160649|B4||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4333366|NCT00435162|4160650|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4333367|NCT00435162|4160651|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4333368|NCT00435162|4160652|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4333369|NCT00435162|4160649|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4333370|NCT00435162|4160650|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4333371|NCT00435162|4160651|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4333372|NCT00435162|4160652|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4333373|NCT00435162|4160649|B4|||Age||years|Mean|3.3|3.3|Standard Deviation|1.41|1.41|||
4333374|NCT00435162|4160650|B3|||Age||years|Mean|3.3|3.3|Standard Deviation|1.53|1.53|||
4333375|NCT00435162|4160651|B2|||Age||years|Mean|3.2|3.2|Standard Deviation|1.48|1.48|||
4333376|NCT00435162|4160652|B1|||Age||years|Mean|3.4|3.4|Standard Deviation|1.28|1.28|||
4333377|NCT00435045|4160675|B3|Non-white||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4333378|NCT00435045|4160676|B2|Non-white||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4333379|NCT00435045|4160677|B1|Non-white||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4333380|NCT00435045|4160675|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4333381|NCT00435045|4160676|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4333382|NCT00435045|4160677|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4333383|NCT00435045|4160675|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4333384|NCT00435045|4160676|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4333385|NCT00435045|4160677|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4333386|NCT00435045|4160675|B3|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4333387|NCT00435045|4160676|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4333388|NCT00435045|4160677|B1|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4333389|NCT00435045|4160675|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4333390|NCT00435045|4160676|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4333391|NCT00435045|4160677|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4333392|NCT00435045|4160675|B3|White||Race/Ethnicity, Customized||participants|Number|218|218.0||||||
4333393|NCT00435045|4160676|B2|White||Race/Ethnicity, Customized||participants|Number|110|110.0||||||
4333394|NCT00435045|4160677|B1|White||Race/Ethnicity, Customized||participants|Number|108|108.0||||||
4333395|NCT00435045|4160675|B3||Male|Gender||Participants|Count of Participants|142|142.0||||||
4333396|NCT00435045|4160676|B2||Male|Gender||Participants|Count of Participants|71|71.0||||||
4333397|NCT00435045|4160677|B1||Male|Gender||Participants|Count of Participants|71|71.0||||||
4333398|NCT00435045|4160675|B3||Female|Gender||Participants|Count of Participants|103|103.0||||||
4333399|NCT00435045|4160676|B2||Female|Gender||Participants|Count of Participants|51|51.0||||||
4333400|NCT00435045|4160677|B1||Female|Gender||Participants|Count of Participants|52|52.0||||||
4333401|NCT00435045|4160675|B3|||Age||years|Mean|56.1|56.1|Standard Deviation|10.23|10.23|||
4333402|NCT00435045|4160676|B2|||Age||years|Mean|56.0|56.0|Standard Deviation|10.84|10.84|||
4333403|NCT00435045|4160677|B1|||Age||years|Mean|56.3|56.3|Standard Deviation|9.64|9.64|||
4333404|NCT00435019|4160732|B3||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4333405|NCT00435019|4160733|B2||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4333406|NCT00435019|4160734|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4333407|NCT00435019|4160732|B3||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4333408|NCT00435019|4160733|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4333409|NCT00435019|4160734|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4333410|NCT00435019|4160732|B3|||Age||years|Mean|9.9|9.9|Standard Deviation|3.99|3.99|||
4333411|NCT00435019|4160733|B2|||Age||years|Mean|9.8|9.8|Standard Deviation|3.90|3.9|||
4333412|NCT00435019|4160734|B1|||Age||years|Mean|10.0|10.0|Standard Deviation|4.09|4.09|||
4333413|NCT00435019|4160732|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4333414|NCT00435019|4160733|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4333415|NCT00435019|4160734|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4333416|NCT00435019|4160732|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4333417|NCT00435019|4160733|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4333418|NCT00435019|4160734|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4333419|NCT00435019|4160732|B3||<=18 years|Age||Participants|Count of Participants|347|347.0||||||
4333420|NCT00435019|4160733|B2||<=18 years|Age||Participants|Count of Participants|170|170.0||||||
4333421|NCT00435019|4160734|B1||<=18 years|Age||Participants|Count of Participants|177|177.0||||||
4333422|NCT00434993|4160745|B3|United States||Region of Enrollment||participants|Number|282|282.0||||||
4333423|NCT00434993|4160746|B2|United States||Region of Enrollment||participants|Number|130|130.0||||||
4333424|NCT00434993|4160747|B1|United States||Region of Enrollment||participants|Number|152|152.0||||||
4333425|NCT00434993|4160745|B3||Male|Gender||Participants|Count of Participants|156|156.0||||||
4333426|NCT00434993|4160746|B2||Male|Gender||Participants|Count of Participants|71|71.0||||||
4333427|NCT00434993|4160747|B1||Male|Gender||Participants|Count of Participants|85|85.0||||||
4333428|NCT00434993|4160745|B3||Female|Gender||Participants|Count of Participants|126|126.0||||||
4333429|NCT00434993|4160746|B2||Female|Gender||Participants|Count of Participants|59|59.0||||||
4333430|NCT00434993|4160747|B1||Female|Gender||Participants|Count of Participants|67|67.0||||||
4333431|NCT00434993|4160745|B3|||Age||years|Mean|51.6|51.6|Standard Deviation|16.2|16.2|||
4333432|NCT00434993|4160746|B2|||Age||years|Mean|50.9|50.9|Standard Deviation|16.2|16.2|||
4333433|NCT00434993|4160747|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|16.4|16.4|||
4333434|NCT00434993|4160745|B3||>=65 years|Age||Participants|Count of Participants|66|66.0||||||
4333435|NCT00434993|4160746|B2||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4333436|NCT00434993|4160747|B1||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4333437|NCT00434993|4160745|B3||Between 18 and 65 years|Age||Participants|Count of Participants|211|211.0||||||
4333438|NCT00434993|4160746|B2||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4333439|NCT00434993|4160747|B1||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
4333440|NCT00434993|4160745|B3||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4333441|NCT00434993|4160746|B2||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4333442|NCT00434993|4160747|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4333443|NCT00434967|4160772|B5||Male|Sex: Female, Male||Participants|Count of Participants|635|635.0||||||
4333444|NCT00434967|4160773|B4||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4333445|NCT00434967|4160774|B3||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4333446|NCT00434967|4160775|B2||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4333447|NCT00434967|4160776|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4333448|NCT00434967|4160772|B5||Female|Sex: Female, Male||Participants|Count of Participants|864|864.0||||||
4333449|NCT00434967|4160773|B4||Female|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
4333450|NCT00434967|4160774|B3||Female|Sex: Female, Male||Participants|Count of Participants|273|273.0||||||
4333451|NCT00434967|4160775|B2||Female|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
4333453|NCT00434967|4160772|B5|||Age||years|Mean|52|52.0|Full Range|||21.0|79.0|
4333454|NCT00434967|4160773|B4|||Age||years|Mean|52.7|52.7|Full Range|||22.0|77.0|
4333455|NCT00434967|4160774|B3|||Age||years|Mean|50.9|50.9|Full Range|||21.0|78.0|
4333456|NCT00434967|4160775|B2|||Age||years|Mean|51.7|51.7|Full Range|||21.0|79.0|
4333457|NCT00434967|4160776|B1|||Age||years|Mean|52.7|52.7|Full Range|||28.0|76.0|
4333458|NCT00434954|4160797|B3|||Glycosylated hemoglobin (HbA1c)||percentage|Mean|7.88|7.88|Standard Deviation|0.869|0.869|||
4333459|NCT00434954|4160798|B2|||Glycosylated hemoglobin (HbA1c)||percentage|Mean|7.88|7.88|Standard Deviation|0.918|0.918|||
4333460|NCT00434954|4160799|B1|||Glycosylated hemoglobin (HbA1c)||percentage|Mean|7.89|7.89|Standard Deviation|0.822|0.822|||
4333461|NCT00434954|4160797|B3|||Duration of Diabetes||years|Mean|5.0|5.0|Standard Deviation|4.53|4.53|||
4333462|NCT00434954|4160798|B2|||Duration of Diabetes||years|Mean|5.2|5.2|Standard Deviation|4.67|4.67|||
4333463|NCT00434954|4160799|B1|||Duration of Diabetes||years|Mean|4.8|4.8|Standard Deviation|4.39|4.39|||
4333464|NCT00434954|4160797|B3|||Body Weight||kg|Mean|98.0|98.0|Standard Deviation|16.85|16.85|||
4333465|NCT00434954|4160798|B2|||Body Weight||kg|Mean|96.6|96.6|Standard Deviation|17.40|17.4|||
4333466|NCT00434954|4160799|B1|||Body Weight||kg|Mean|99.4|99.4|Standard Deviation|16.22|16.22|||
4333467|NCT00434954|4160797|B3|||Body Mass Index (BMI)||kg / m^2|Mean|33.2|33.2|Standard Deviation|4.30|4.3|||
4333468|NCT00434954|4160798|B2|||Body Mass Index (BMI)||kg / m^2|Mean|32.9|32.9|Standard Deviation|4.37|4.37|||
4333469|NCT00434954|4160799|B1|||Body Mass Index (BMI)||kg / m^2|Mean|33.4|33.4|Standard Deviation|4.23|4.23|||
4333470|NCT00434954|4160797|B3||Male|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4333471|NCT00434954|4160798|B2||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4333472|NCT00434954|4160799|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4333473|NCT00434954|4160797|B3||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4333474|NCT00434954|4160798|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4333475|NCT00434954|4160799|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4333476|NCT00434954|4160797|B3|||Age||years|Mean|57.1|57.1|Standard Deviation|9.97|9.97|||
4333477|NCT00434954|4160798|B2|||Age||years|Mean|56.9|56.9|Standard Deviation|9.94|9.94|||
4333478|NCT00434954|4160799|B1|||Age||years|Mean|57.2|57.2|Standard Deviation|10.03|10.03|||
4333479|NCT00434954|4160797|B3||>=65 years|Age||Participants|Count of Participants|83|83.0||||||
4333480|NCT00434954|4160798|B2||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
4333481|NCT00434954|4160799|B1||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
4333482|NCT00434954|4160797|B3||Between 18 and 65 years|Age||Participants|Count of Participants|271|271.0||||||
4333483|NCT00434954|4160798|B2||Between 18 and 65 years|Age||Participants|Count of Participants|133|133.0||||||
4333484|NCT00434954|4160799|B1||Between 18 and 65 years|Age||Participants|Count of Participants|138|138.0||||||
4333485|NCT00434954|4160797|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333486|NCT00434954|4160798|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333487|NCT00434954|4160799|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333488|NCT00434876|4160828|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4333489|NCT00434876|4160829|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4333490|NCT00434876|4160830|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4333491|NCT00434876|4160828|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4333492|NCT00434876|4160829|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4333493|NCT00434876|4160830|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4333494|NCT00434876|4160828|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4333495|NCT00434876|4160829|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4333496|NCT00434876|4160830|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4333497|NCT00434876|4160828|B3|||Age||years|Mean|52|52.0|Standard Deviation|7|7.0|||
4333498|NCT00434876|4160829|B2|||Age||years|Mean|51|51.0|Standard Deviation|8|8.0|||
4333499|NCT00434876|4160830|B1|||Age||years|Mean|53|53.0|Standard Deviation|6|6.0|||
4333500|NCT00434876|4160828|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4333501|NCT00434876|4160829|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4333502|NCT00434876|4160830|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4333503|NCT00434876|4160828|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4333504|NCT00434876|4160829|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4333505|NCT00434876|4160830|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4333506|NCT00434876|4160828|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333507|NCT00434876|4160829|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333508|NCT00434876|4160830|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333509|NCT00434759|4160843|B3|Germany||Region of Enrollment||participants|Number|89|89.0||||||
4333510|NCT00434759|4160844|B2|Germany||Region of Enrollment||participants|Number|43|43.0||||||
4333511|NCT00434759|4160845|B1|Germany||Region of Enrollment||participants|Number|46|46.0||||||
4333512|NCT00434759|4160843|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4333513|NCT00434759|4160844|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4333514|NCT00434759|4160845|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4333515|NCT00434759|4160843|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4333516|NCT00434759|4160844|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4333517|NCT00434759|4160845|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4333518|NCT00434759|4160843|B3|||Age||years|Mean|37.84|37.84|Standard Deviation|10.33|10.33|||
4333519|NCT00434759|4160844|B2|||Age||years|Mean|38.47|38.47|Standard Deviation|10.26|10.26|||
4333520|NCT00434759|4160845|B1|||Age||years|Mean|37.26|37.26|Standard Deviation|10.47|10.47|||
4333521|NCT00434759|4160843|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4333522|NCT00434759|4160844|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4333523|NCT00434759|4160845|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4333524|NCT00434759|4160843|B3||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
4333525|NCT00434759|4160844|B2||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4333526|NCT00434759|4160845|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4333527|NCT00434759|4160843|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333528|NCT00434759|4160844|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333529|NCT00434759|4160845|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333530|NCT00434642|4160860|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4333531|NCT00434642|4160861|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4333532|NCT00434642|4160862|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4333533|NCT00434642|4160860|B3||Female|Sex: Female, Male||Participants|Count of Participants|484|484.0||||||
4333534|NCT00434642|4160861|B2||Female|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
4333535|NCT00434642|4160862|B1||Female|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
4333536|NCT00434642|4160860|B3|||Age||years|Mean|61.0|61.0|Standard Deviation|10.0|10.0|||
4333537|NCT00434642|4160861|B2|||Age||years|Mean|60.5|60.5|Standard Deviation|9.8|9.8|||
4333538|NCT00434642|4160862|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|10.2|10.2|||
4333539|NCT00434590|4160879|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4333540|NCT00434590|4160880|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4333541|NCT00434590|4160881|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4333542|NCT00434590|4160879|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4333543|NCT00434590|4160880|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4333544|NCT00434590|4160881|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4333545|NCT00434590|4160879|B3|||Age||Years|Mean|55.2|55.2|Standard Deviation|12.8|12.8|||
4333546|NCT00434590|4160880|B2|||Age||Years|Mean|58.0|58.0|Standard Deviation|12.5|12.5|||
4333547|NCT00434590|4160881|B1|||Age||Years|Mean|52.4|52.4|Standard Deviation|13.8|13.8|||
4333548|NCT00434434|4160888|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4333549|NCT00434434|4160889|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4333550|NCT00434434|4160890|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4333551|NCT00434434|4160891|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4333552|NCT00434434|4160888|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4333553|NCT00434434|4160889|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4333554|NCT00434434|4160890|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4333555|NCT00434434|4160891|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4333556|NCT00434434|4160888|B4|||Age||years|Mean|30.1|30.1|Standard Deviation|11.1|11.1|||
4333557|NCT00434434|4160889|B3|||Age||years|Mean|32.0|32.0|Standard Deviation|9.6|9.6|||
4333558|NCT00434434|4160890|B2|||Age||years|Mean|30.6|30.6|Standard Deviation|12.8|12.8|||
4333559|NCT00434434|4160891|B1|||Age||years|Mean|28.5|28.5|Standard Deviation|10.3|10.3|||
4333560|NCT00434434|4160888|B4|> 65 years||Age, Customized||participants|Number|2|2.0||||||
4333561|NCT00434434|4160889|B3|> 65 years||Age, Customized||participants|Number|0|0.0||||||
4333562|NCT00434434|4160890|B2|> 65 years||Age, Customized||participants|Number|2|2.0||||||
4333563|NCT00434434|4160891|B1|> 65 years||Age, Customized||participants|Number|0|0.0||||||
4333564|NCT00434434|4160888|B4|41 to 65 years||Age, Customized||participants|Number|9|9.0||||||
4333565|NCT00434434|4160889|B3|41 to 65 years||Age, Customized||participants|Number|3|3.0||||||
4333566|NCT00434434|4160890|B2|41 to 65 years||Age, Customized||participants|Number|1|1.0||||||
4333567|NCT00434434|4160891|B1|41 to 65 years||Age, Customized||participants|Number|5|5.0||||||
4333568|NCT00434434|4160888|B4|18 to 40 years||Age, Customized||participants|Number|50|50.0||||||
4333569|NCT00434434|4160889|B3|18 to 40 years||Age, Customized||participants|Number|11|11.0||||||
4333570|NCT00434434|4160890|B2|18 to 40 years||Age, Customized||participants|Number|21|21.0||||||
4333571|NCT00434434|4160891|B1|18 to 40 years||Age, Customized||participants|Number|18|18.0||||||
4333572|NCT00434421|4160904|B1|No||Asthma status (Mild-to-moderate persistent asthma)|Asthma status as defined by self-reported doctor diagnosis over a year before study pre-screening and reported symptoms and controller medication use. Mild-to-moderate persistent asthma is defined as (i) symptoms at least 3 times a week on no controller medication or (ii) symptoms < 3 times a week on controller medication. Qualifying controller medication regimens included: leukotriene; fluticasone (up to 500 mcg/day) or equivalent; leukotriene modifier plus fluticasone (up to 500 mcg/day) or equivalent; salmeterol plus fluticasone (up to 500 mcg/day) or equivalent.|participants|Number|18|18.0||||||
4333623|NCT00434330|4160926|B7||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4333573|NCT00434421|4160904|B1|Yes||Asthma status (Mild-to-moderate persistent asthma)|Asthma status as defined by self-reported doctor diagnosis over a year before study pre-screening and reported symptoms and controller medication use. Mild-to-moderate persistent asthma is defined as (i) symptoms at least 3 times a week on no controller medication or (ii) symptoms < 3 times a week on controller medication. Qualifying controller medication regimens included: leukotriene; fluticasone (up to 500 mcg/day) or equivalent; leukotriene modifier plus fluticasone (up to 500 mcg/day) or equivalent; salmeterol plus fluticasone (up to 500 mcg/day) or equivalent.|participants|Number|10|10.0||||||
4333574|NCT00434421|4160904|B1|Low||German Cockroach Skin Test Sensitivity|Sensitivity to German cockroach allergen as measured by wheal size at baseline skin prick test. High sensitivity is defined as equal to or greater than a 6 mm wheal; low sensitivity, as equal to or greater than 3 mm wheal and less than 6 mm.|participants|Number|10|10.0||||||
4333575|NCT00434421|4160904|B1|High||German Cockroach Skin Test Sensitivity|Sensitivity to German cockroach allergen as measured by wheal size at baseline skin prick test. High sensitivity is defined as equal to or greater than a 6 mm wheal; low sensitivity, as equal to or greater than 3 mm wheal and less than 6 mm.|participants|Number|18|18.0||||||
4333576|NCT00434421|4160904|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4333577|NCT00434421|4160904|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4333578|NCT00434421|4160904|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4333579|NCT00434421|4160904|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4333580|NCT00434421|4160904|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4333581|NCT00434421|4160904|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4333582|NCT00434421|4160904|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4333583|NCT00434421|4160904|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4333584|NCT00434421|4160904|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4333585|NCT00434421|4160904|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4333586|NCT00434421|4160904|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4333587|NCT00434421|4160904|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4333588|NCT00434421|4160904|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4333589|NCT00434421|4160904|B1|5-7 years||Age, Customized||participants|Number|9|9.0||||||
4333590|NCT00434421|4160904|B1|8-17 years||Age, Customized||participants|Number|10|10.0||||||
4333591|NCT00434421|4160904|B1|18-55 years||Age, Customized||participants|Number|9|9.0||||||
4333592|NCT00434421|4160904|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4333593|NCT00434421|4160904|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4333594|NCT00434421|4160904|B1||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
4333595|NCT00434356|4160908|B3||Male|Sex: Female, Male|Randomized patients|Participants|Count of Participants|0|0.0||||||
4333596|NCT00434356|4160909|B2||Male|Sex: Female, Male|Randomized patients|Participants|Count of Participants|0|0.0||||||
4333597|NCT00434356|4160910|B1||Male|Sex: Female, Male|Randomized patients|Participants|Count of Participants|0|0.0||||||
4333598|NCT00434356|4160908|B3||Female|Sex: Female, Male|Randomized patients|Participants|Count of Participants|46|46.0||||||
4333599|NCT00434356|4160909|B2||Female|Sex: Female, Male|Randomized patients|Participants|Count of Participants|23|23.0||||||
4333600|NCT00434356|4160910|B1||Female|Sex: Female, Male|Randomized patients|Participants|Count of Participants|23|23.0||||||
4333601|NCT00434356|4160908|B3|||Age|Randomized patients|years|Mean|54|54.0|Standard Deviation|12.8|12.8|||
4333602|NCT00434356|4160909|B2|||Age|Randomized patients|years|Mean|50.8|50.8|Standard Deviation|11.7|11.7|||
4333603|NCT00434356|4160910|B1|||Age|Randomized patients|years|Mean|57.3|57.3|Standard Deviation|13.3|13.3|||
4333604|NCT00434356|4160908|B3|>= 65 Years||Age, Customized|Randomized patients|participants|Number|7|7.0||||||
4333605|NCT00434356|4160909|B2|>= 65 Years||Age, Customized|Randomized patients|participants|Number|1|1.0||||||
4333606|NCT00434356|4160910|B1|>= 65 Years||Age, Customized|Randomized patients|participants|Number|6|6.0||||||
4333607|NCT00434356|4160908|B3|Between 41 and 64 Years||Age, Customized|Randomized patients|participants|Number|32|32.0||||||
4333608|NCT00434356|4160909|B2|Between 41 and 64 Years||Age, Customized|Randomized patients|participants|Number|17|17.0||||||
4333609|NCT00434356|4160910|B1|Between 41 and 64 Years||Age, Customized|Randomized patients|participants|Number|15|15.0||||||
4333610|NCT00434356|4160908|B3|Between 18 and 40 Years||Age, Customized|Randomized patients|participants|Number|7|7.0||||||
4333611|NCT00434356|4160909|B2|Between 18 and 40 Years||Age, Customized|Randomized patients|participants|Number|5|5.0||||||
4333612|NCT00434356|4160910|B1|Between 18 and 40 Years||Age, Customized|Randomized patients|participants|Number|2|2.0||||||
4333613|NCT00434356|4160908|B3|< 18 Years||Age, Customized|Randomized patients|participants|Number|0|0.0||||||
4333614|NCT00434356|4160909|B2|< 18 Years||Age, Customized|Randomized patients|participants|Number|0|0.0||||||
4333615|NCT00434356|4160910|B1|< 18 Years||Age, Customized|Randomized patients|participants|Number|0|0.0||||||
4333616|NCT00434330|4160926|B7||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4333617|NCT00434330|4160927|B6||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4333618|NCT00434330|4160928|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4333619|NCT00434330|4160929|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4333620|NCT00434330|4160930|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4333621|NCT00434330|4160931|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4333622|NCT00434330|4160932|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4333624|NCT00434330|4160927|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4333625|NCT00434330|4160928|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4333626|NCT00434330|4160929|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4333627|NCT00434330|4160930|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4333628|NCT00434330|4160931|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4333629|NCT00434330|4160932|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4333630|NCT00434330|4160926|B7|||Age||years|Mean|51.9|51.9|Standard Deviation|13.74|13.74|||
4333631|NCT00434330|4160927|B6|||Age||years|Mean|53|53.0|Standard Deviation|13.22|13.22|||
4333632|NCT00434330|4160928|B5|||Age||years|Mean|51.1|51.1|Standard Deviation|11.43|11.43|||
4333633|NCT00434330|4160929|B4|||Age||years|Mean|50.4|50.4|Standard Deviation|12.47|12.47|||
4333634|NCT00434330|4160930|B3|||Age||years|Mean|46.1|46.1|Standard Deviation|17.22|17.22|||
4333635|NCT00434330|4160931|B2|||Age||years|Mean|58.1|58.1|Standard Deviation|13.91|13.91|||
4333636|NCT00434330|4160932|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|12.42|12.42|||
4333637|NCT00434330|4160926|B7||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4333638|NCT00434330|4160927|B6||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4333639|NCT00434330|4160928|B5||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4333640|NCT00434330|4160929|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4333641|NCT00434330|4160930|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4333642|NCT00434330|4160931|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4333643|NCT00434330|4160932|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4333644|NCT00434330|4160926|B7||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4333645|NCT00434330|4160927|B6||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4333646|NCT00434330|4160928|B5||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4333647|NCT00434330|4160929|B4||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4333648|NCT00434330|4160930|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4333649|NCT00434330|4160931|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4333650|NCT00434330|4160932|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4333651|NCT00434330|4160926|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333652|NCT00434330|4160927|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333653|NCT00434330|4160928|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333654|NCT00434330|4160929|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333655|NCT00434330|4160930|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333656|NCT00434330|4160931|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333657|NCT00434330|4160932|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333658|NCT00434304|4160969|B1|Asian – Japanese Heritage||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
4333659|NCT00434304|4160969|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4333660|NCT00434304|4160969|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4333661|NCT00434304|4160969|B1|||Age||years|Mean|67.2|67.2|Standard Deviation|8.05|8.05|||
4333662|NCT00434278|4161005|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4333663|NCT00434278|4161006|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4333664|NCT00434278|4161007|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4333665|NCT00434278|4161005|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4333666|NCT00434278|4161006|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4333667|NCT00434278|4161007|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4333668|NCT00434278|4161005|B3|||Age||years|Mean|27.1|27.1|Standard Deviation|8.8|8.8|||
4333669|NCT00434278|4161006|B2|||Age||years|Mean|29.8|29.8|Standard Deviation|10.0|10.0|||
4333670|NCT00434278|4161007|B1|||Age||years|Mean|24.6|24.6|Standard Deviation|7.0|7.0|||
4333671|NCT00434252|4161016|B3||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4333672|NCT00434252|4161017|B2||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4333673|NCT00434252|4161018|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4333674|NCT00434252|4161016|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4333675|NCT00434252|4161017|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4333676|NCT00434252|4161018|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4333677|NCT00434252|4161016|B3|> 65 years||Age, Customized||participants|Number|64|64.0||||||
4333678|NCT00434252|4161017|B2|> 65 years||Age, Customized||participants|Number|39|39.0||||||
4333679|NCT00434252|4161018|B1|> 65 years||Age, Customized||participants|Number|25|25.0||||||
4333680|NCT00434252|4161016|B3|<= 65 years||Age, Customized||participants|Number|150|150.0||||||
4333681|NCT00434252|4161017|B2|<= 65 years||Age, Customized||participants|Number|104|104.0||||||
4333682|NCT00434252|4161018|B1|<= 65 years||Age, Customized||participants|Number|46|46.0||||||
4333683|NCT00434252|4161016|B3|||Age||years|Mean|58.9|58.9|Standard Deviation|11.7|11.7|||
4333684|NCT00434252|4161017|B2|||Age||years|Mean|59.1|59.1|Standard Deviation|11.3|11.3|||
4333685|NCT00434252|4161018|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|12.6|12.6|||
4333686|NCT00434226|4161039|B3||Male|Sex: Female, Male|Intent-to-treat population|Participants|Count of Participants|30|30.0||||||
4333687|NCT00434226|4161040|B2||Male|Sex: Female, Male|Intent-to-treat population|Participants|Count of Participants|14|14.0||||||
4333688|NCT00434226|4161041|B1||Male|Sex: Female, Male|Intent-to-treat population|Participants|Count of Participants|16|16.0||||||
4333689|NCT00434226|4161039|B3||Female|Sex: Female, Male|Intent-to-treat population|Participants|Count of Participants|26|26.0||||||
4333690|NCT00434226|4161040|B2||Female|Sex: Female, Male|Intent-to-treat population|Participants|Count of Participants|12|12.0||||||
4333691|NCT00434226|4161041|B1||Female|Sex: Female, Male|Intent-to-treat population|Participants|Count of Participants|14|14.0||||||
4333692|NCT00434226|4161039|B3|>=65 Years||Age, Customized|Intent-to-treat population|participants|Number|28|28.0||||||
4333693|NCT00434226|4161040|B2|>=65 Years||Age, Customized|Intent-to-treat population|participants|Number|13|13.0||||||
4333694|NCT00434226|4161041|B1|>=65 Years||Age, Customized|Intent-to-treat population|participants|Number|15|15.0||||||
4333695|NCT00434226|4161039|B3|Between 18 and 64 Years||Age, Customized|Intent-to-treat population|participants|Number|28|28.0||||||
4333696|NCT00434226|4161040|B2|Between 18 and 64 Years||Age, Customized|Intent-to-treat population|participants|Number|13|13.0||||||
4333697|NCT00434226|4161041|B1|Between 18 and 64 Years||Age, Customized|Intent-to-treat population|participants|Number|15|15.0||||||
4333698|NCT00434226|4161039|B3|<18 Years||Age, Customized|Intent-to-treat population|participants|Number|0|0.0||||||
4333699|NCT00434226|4161040|B2|<18 Years||Age, Customized|Intent-to-treat population|participants|Number|0|0.0||||||
4333700|NCT00434226|4161041|B1|<18 Years||Age, Customized|Intent-to-treat population|participants|Number|0|0.0||||||
4333701|NCT00434226|4161039|B3|||Age|Intent-to-treat population|years|Mean|64.2|64.2|Standard Deviation|10.0|10.0|||
4333702|NCT00434226|4161040|B2|||Age|Intent-to-treat population|years|Mean|64.8|64.8|Standard Deviation|10.7|10.7|||
4333703|NCT00434226|4161041|B1|||Age|Intent-to-treat population|years|Mean|63.7|63.7|Standard Deviation|9.5|9.5|||
4333704|NCT00434213|4161053|B1|United States||Region of Enrollment||participants|Number|309|309.0||||||
4333705|NCT00434213|4161053|B1||Male|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4333706|NCT00434213|4161053|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4333707|NCT00434213|4161053|B1|||Age||years|Mean|9.1|9.1|Standard Deviation|1.95|1.95|||
4333708|NCT00434213|4161053|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4333709|NCT00434213|4161053|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4333710|NCT00434213|4161053|B1||<=18 years|Age||Participants|Count of Participants|309|309.0||||||
4333711|NCT00434161|4161058|B4|Denmark||Region of Enrollment||participants|Number|3|3.0||||||
4333712|NCT00434161|4161059|B3|Denmark||Region of Enrollment||participants|Number|0|0.0||||||
4333713|NCT00434161|4161060|B2|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
4333714|NCT00434161|4161061|B1|Denmark||Region of Enrollment||participants|Number|2|2.0||||||
4333715|NCT00434161|4161058|B4|Sweden||Region of Enrollment||participants|Number|4|4.0||||||
4333716|NCT00434161|4161059|B3|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
4333717|NCT00434161|4161060|B2|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
4333718|NCT00434161|4161061|B1|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
4333719|NCT00434161|4161058|B4|Ireland||Region of Enrollment||participants|Number|7|7.0||||||
4333720|NCT00434161|4161059|B3|Ireland||Region of Enrollment||participants|Number|3|3.0||||||
4333721|NCT00434161|4161060|B2|Ireland||Region of Enrollment||participants|Number|2|2.0||||||
4333722|NCT00434161|4161061|B1|Ireland||Region of Enrollment||participants|Number|2|2.0||||||
4333723|NCT00434161|4161058|B4|Netherlands||Region of Enrollment||participants|Number|10|10.0||||||
4333724|NCT00434161|4161059|B3|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
4333725|NCT00434161|4161060|B2|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4333726|NCT00434161|4161061|B1|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
4333727|NCT00434161|4161058|B4|Finland||Region of Enrollment||participants|Number|10|10.0||||||
4333728|NCT00434161|4161059|B3|Finland||Region of Enrollment||participants|Number|4|4.0||||||
4333729|NCT00434161|4161060|B2|Finland||Region of Enrollment||participants|Number|3|3.0||||||
4333730|NCT00434161|4161061|B1|Finland||Region of Enrollment||participants|Number|3|3.0||||||
4333731|NCT00434161|4161058|B4|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
4333732|NCT00434161|4161059|B3|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4333733|NCT00434161|4161060|B2|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4333734|NCT00434161|4161061|B1|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4333735|NCT00434161|4161058|B4|Switzerland||Region of Enrollment||participants|Number|15|15.0||||||
4333736|NCT00434161|4161059|B3|Switzerland||Region of Enrollment||participants|Number|6|6.0||||||
4333737|NCT00434161|4161060|B2|Switzerland||Region of Enrollment||participants|Number|5|5.0||||||
4333738|NCT00434161|4161061|B1|Switzerland||Region of Enrollment||participants|Number|4|4.0||||||
4333739|NCT00434161|4161058|B4|Italy||Region of Enrollment||participants|Number|17|17.0||||||
4333740|NCT00434161|4161059|B3|Italy||Region of Enrollment||participants|Number|9|9.0||||||
4333741|NCT00434161|4161060|B2|Italy||Region of Enrollment||participants|Number|4|4.0||||||
4333742|NCT00434161|4161061|B1|Italy||Region of Enrollment||participants|Number|4|4.0||||||
4333743|NCT00434161|4161058|B4|Czech Republic||Region of Enrollment||participants|Number|18|18.0||||||
4333744|NCT00434161|4161059|B3|Czech Republic||Region of Enrollment||participants|Number|7|7.0||||||
4333745|NCT00434161|4161060|B2|Czech Republic||Region of Enrollment||participants|Number|4|4.0||||||
4333746|NCT00434161|4161061|B1|Czech Republic||Region of Enrollment||participants|Number|7|7.0||||||
4333747|NCT00434161|4161058|B4|Belgium||Region of Enrollment||participants|Number|20|20.0||||||
4333748|NCT00434161|4161059|B3|Belgium||Region of Enrollment||participants|Number|11|11.0||||||
4333749|NCT00434161|4161060|B2|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4333750|NCT00434161|4161061|B1|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
4333751|NCT00434161|4161058|B4|Austria||Region of Enrollment||participants|Number|30|30.0||||||
4333752|NCT00434161|4161059|B3|Austria||Region of Enrollment||participants|Number|9|9.0||||||
4333753|NCT00434161|4161060|B2|Austria||Region of Enrollment||participants|Number|5|5.0||||||
4333754|NCT00434161|4161061|B1|Austria||Region of Enrollment||participants|Number|16|16.0||||||
4333755|NCT00434161|4161058|B4|France||Region of Enrollment||participants|Number|41|41.0||||||
4333756|NCT00434161|4161059|B3|France||Region of Enrollment||participants|Number|16|16.0||||||
4333757|NCT00434161|4161060|B2|France||Region of Enrollment||participants|Number|10|10.0||||||
4333758|NCT00434161|4161061|B1|France||Region of Enrollment||participants|Number|15|15.0||||||
4333759|NCT00434161|4161058|B4|Hungary||Region of Enrollment||participants|Number|47|47.0||||||
4333760|NCT00434161|4161059|B3|Hungary||Region of Enrollment||participants|Number|16|16.0||||||
4333761|NCT00434161|4161060|B2|Hungary||Region of Enrollment||participants|Number|9|9.0||||||
4333762|NCT00434161|4161061|B1|Hungary||Region of Enrollment||participants|Number|22|22.0||||||
4333763|NCT00434161|4161058|B4|Germany||Region of Enrollment||participants|Number|48|48.0||||||
4333764|NCT00434161|4161059|B3|Germany||Region of Enrollment||participants|Number|23|23.0||||||
4333765|NCT00434161|4161060|B2|Germany||Region of Enrollment||participants|Number|9|9.0||||||
4333766|NCT00434161|4161061|B1|Germany||Region of Enrollment||participants|Number|16|16.0||||||
4333767|NCT00434161|4161058|B4||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4333768|NCT00434161|4161059|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4333769|NCT00434161|4161060|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4333770|NCT00434161|4161061|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4333771|NCT00434161|4161058|B4||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4333772|NCT00434161|4161059|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4333773|NCT00434161|4161060|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4333774|NCT00434161|4161061|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4333775|NCT00434161|4161058|B4|||Age||years|Mean|56|56.0|Standard Deviation|7.7|7.7|||
4333776|NCT00434161|4161059|B3|||Age||years|Mean|56.1|56.1|Standard Deviation|7.5|7.5|||
4333777|NCT00434161|4161060|B2|||Age||years|Mean|57.1|57.1|Standard Deviation|7.0|7.0|||
4333778|NCT00434161|4161061|B1|||Age||years|Mean|55.3|55.3|Standard Deviation|8.4|8.4|||
4333779|NCT00434161|4161058|B4||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
4333780|NCT00434161|4161059|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4333781|NCT00434161|4161060|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4333782|NCT00434161|4161061|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4333783|NCT00434161|4161058|B4||Between 18 and 65 years|Age||Participants|Count of Participants|239|239.0||||||
4333784|NCT00434161|4161059|B3||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4333785|NCT00434161|4161060|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4333786|NCT00434161|4161061|B1||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
4333787|NCT00434161|4161058|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333788|NCT00434161|4161059|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333789|NCT00434161|4161060|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333790|NCT00434161|4161061|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333791|NCT00434148|4161105|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4333792|NCT00434148|4161106|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4333793|NCT00434148|4161107|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4333794|NCT00434148|4161105|B3||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4333795|NCT00434148|4161106|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4333796|NCT00434148|4161107|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4333797|NCT00434148|4161105|B3|||Age||years|Mean|40.2|40.2|Standard Deviation|11.90|11.9|||
4333798|NCT00434148|4161106|B2|||Age||years|Mean|39.9|39.9|Standard Deviation|10.77|10.77|||
4333799|NCT00434148|4161107|B1|||Age||years|Mean|40.5|40.5|Standard Deviation|12.97|12.97|||
4333800|NCT00434122|4161142|B3|Belgium||Region of Enrollment|ITT population|participants|Number|11|11.0||||||
4333801|NCT00434122|4161143|B2|Belgium||Region of Enrollment|ITT population|participants|Number|6|6.0||||||
4333802|NCT00434122|4161144|B1|Belgium||Region of Enrollment|ITT population|participants|Number|5|5.0||||||
4333803|NCT00434122|4161142|B3|Spain||Region of Enrollment|ITT population|participants|Number|53|53.0||||||
4333804|NCT00434122|4161143|B2|Spain||Region of Enrollment|ITT population|participants|Number|26|26.0||||||
4333805|NCT00434122|4161144|B1|Spain||Region of Enrollment|ITT population|participants|Number|27|27.0||||||
4333806|NCT00434122|4161142|B3|Czech Republic||Region of Enrollment|ITT population|participants|Number|14|14.0||||||
4333807|NCT00434122|4161143|B2|Czech Republic||Region of Enrollment|ITT population|participants|Number|7|7.0||||||
4333808|NCT00434122|4161144|B1|Czech Republic||Region of Enrollment|ITT population|participants|Number|7|7.0||||||
4333809|NCT00434122|4161142|B3||Male|Sex: Female, Male|ITT population|Participants|Count of Participants|0|0.0||||||
4333810|NCT00434122|4161143|B2||Male|Sex: Female, Male|ITT population|Participants|Count of Participants|0|0.0||||||
4333811|NCT00434122|4161144|B1||Male|Sex: Female, Male|ITT population|Participants|Count of Participants|0|0.0||||||
4333812|NCT00434122|4161142|B3||Female|Sex: Female, Male|ITT population|Participants|Count of Participants|78|78.0||||||
4333813|NCT00434122|4161143|B2||Female|Sex: Female, Male|ITT population|Participants|Count of Participants|39|39.0||||||
4333814|NCT00434122|4161144|B1||Female|Sex: Female, Male|ITT population|Participants|Count of Participants|39|39.0||||||
4333815|NCT00434122|4161142|B3|||Age|ITT population|years|Mean|28.4|28.4|Standard Deviation|4.0|4.0|||
4333816|NCT00434122|4161143|B2|||Age|ITT population|years|Mean|28.0|28.0|Standard Deviation|3.9|3.9|||
4333817|NCT00434122|4161144|B1|||Age|ITT population|years|Mean|28.9|28.9|Standard Deviation|4.1|4.1|||
4333818|NCT00434122|4161142|B3||>=65 years|Age|Intention-to-treat (ITT) population|Participants|Count of Participants|0|0.0||||||
4333819|NCT00434122|4161143|B2||>=65 years|Age|Intention-to-treat (ITT) population|Participants|Count of Participants|0|0.0||||||
4333820|NCT00434122|4161144|B1||>=65 years|Age|Intention-to-treat (ITT) population|Participants|Count of Participants|0|0.0||||||
4333821|NCT00434122|4161142|B3||Between 18 and 65 years|Age|Intention-to-treat (ITT) population|Participants|Count of Participants|78|78.0||||||
4333822|NCT00434122|4161143|B2||Between 18 and 65 years|Age|Intention-to-treat (ITT) population|Participants|Count of Participants|39|39.0||||||
4333823|NCT00434122|4161144|B1||Between 18 and 65 years|Age|Intention-to-treat (ITT) population|Participants|Count of Participants|39|39.0||||||
4333824|NCT00434122|4161142|B3||<=18 years|Age|Intention-to-treat (ITT) population|Participants|Count of Participants|0|0.0||||||
4333825|NCT00434122|4161143|B2||<=18 years|Age|Intention-to-treat (ITT) population|Participants|Count of Participants|0|0.0||||||
4333826|NCT00434122|4161144|B1||<=18 years|Age|Intention-to-treat (ITT) population|Participants|Count of Participants|0|0.0||||||
4333827|NCT00434109|4161154|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4333828|NCT00434109|4161154|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4333829|NCT00434109|4161154|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4333830|NCT00434109|4161154|B1|||Age, Customized||years|Median|61|61.0|Full Range|||40.0|75.0|
4333831|NCT00434109|4161154|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4333832|NCT00434109|4161154|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4333833|NCT00434109|4161154|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333834|NCT00434057|4161163|B1|United States||Region of Enrollment||participants|Number|1383|1383.0||||||
4333835|NCT00434057|4161163|B1||Male|Sex: Female, Male||Participants|Count of Participants|638|638.0||||||
4333836|NCT00434057|4161163|B1||Female|Sex: Female, Male||Participants|Count of Participants|745|745.0||||||
4333837|NCT00434057|4161163|B1|||Age||years|Mean|48|48.0|Standard Deviation|18.3|18.3|||
4333838|NCT00434057|4161163|B1||>=65 years|Age||Participants|Count of Participants|271|271.0||||||
4333839|NCT00434057|4161163|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1056|1056.0||||||
4333840|NCT00434057|4161163|B1||<=18 years|Age||Participants|Count of Participants|56|56.0||||||
4333841|NCT00434018|4161167|B3|United States||Region of Enrollment||participants|Number|138|138.0||||||
4333842|NCT00434018|4161168|B2|United States||Region of Enrollment||participants|Number|69|69.0||||||
4333843|NCT00434018|4161169|B1|United States||Region of Enrollment||participants|Number|69|69.0||||||
4333844|NCT00434018|4161167|B3||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4333845|NCT00434018|4161168|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4333846|NCT00434018|4161169|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4333847|NCT00434018|4161167|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4333848|NCT00434018|4161168|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4333849|NCT00434018|4161169|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4333850|NCT00434018|4161167|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4333851|NCT00434018|4161168|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4333852|NCT00434018|4161169|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4333853|NCT00434018|4161167|B3||Between 18 and 65 years|Age||Participants|Count of Participants|124|124.0||||||
4333854|NCT00434018|4161168|B2||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4333855|NCT00434018|4161169|B1||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4333856|NCT00434018|4161167|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333857|NCT00434018|4161168|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333858|NCT00434018|4161169|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333859|NCT00434018|4161167|B3|||Age||years|Mean|45.7|45.7|Standard Deviation|13.2|13.2|||
4333860|NCT00434018|4161168|B2|||Age||years|Mean|45.3|45.3|Standard Deviation|13|13.0|||
4333861|NCT00434018|4161169|B1|||Age||years|Mean|46.0|46.0|Standard Deviation|13.5|13.5|||
4333862|NCT00433992|4161186|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4333863|NCT00433992|4161187|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4333864|NCT00433992|4161188|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4333865|NCT00433992|4161186|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4333866|NCT00433992|4161187|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4333867|NCT00433992|4161188|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4333868|NCT00433992|4161186|B3||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4333869|NCT00433992|4161187|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4333870|NCT00433992|4161188|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4333871|NCT00433992|4161186|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4333872|NCT00433992|4161187|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4333873|NCT00433992|4161188|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4333874|NCT00433992|4161186|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4333875|NCT00433992|4161187|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4333876|NCT00433992|4161188|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4333877|NCT00433992|4161186|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4333878|NCT00433992|4161187|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4333879|NCT00433992|4161188|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4333880|NCT00433992|4161186|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4333881|NCT00433992|4161187|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4333882|NCT00433992|4161188|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4333883|NCT00433992|4161186|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4333884|NCT00433992|4161187|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4333885|NCT00433992|4161188|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4333886|NCT00433992|4161186|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4333887|NCT00433992|4161187|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4333888|NCT00433992|4161188|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4333889|NCT00433992|4161186|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4333890|NCT00433992|4161187|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4333891|NCT00433992|4161188|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4333892|NCT00433992|4161186|B3||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4333893|NCT00433992|4161187|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4333894|NCT00433992|4161188|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4333895|NCT00433992|4161186|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333896|NCT00433992|4161187|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333897|NCT00433992|4161188|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333898|NCT00433966|4161199|B3||Male|Sex: Female, Male||Participants|Count of Participants|2760|2760.0||||||
4333899|NCT00433966|4161200|B2||Male|Sex: Female, Male||Participants|Count of Participants|1372|1372.0||||||
4333900|NCT00433966|4161201|B1||Male|Sex: Female, Male||Participants|Count of Participants|1388|1388.0||||||
4333901|NCT00433966|4161199|B3||Female|Sex: Female, Male||Participants|Count of Participants|842|842.0||||||
4333902|NCT00433966|4161200|B2||Female|Sex: Female, Male||Participants|Count of Participants|430|430.0||||||
4333903|NCT00433966|4161201|B1||Female|Sex: Female, Male||Participants|Count of Participants|412|412.0||||||
4333904|NCT00433966|4161199|B3|||Age||years|Median|60.2|60.2|Inter-Quartile Range|||52.4|69.9|
4333905|NCT00433966|4161200|B2|||Age||years|Median|60.7|60.7|Inter-Quartile Range|||52.9|70.1|
4333906|NCT00433966|4161201|B1|||Age||years|Median|59.8|59.8|Inter-Quartile Range|||51.9|69.5|
4333907|NCT00433914|4161224|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4333908|NCT00433914|4161225|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4333909|NCT00433914|4161226|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4333910|NCT00433914|4161224|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4333911|NCT00433914|4161225|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4333912|NCT00433914|4161226|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4333913|NCT00433914|4161224|B3|||Age||Months|Mean|7.1|7.1|Standard Deviation|0.7|0.7|||
4333914|NCT00433914|4161225|B2|||Age||Months|Mean|7.1|7.1|Standard Deviation|0.7|0.7|||
4333915|NCT00433914|4161226|B1|||Age||Months|Mean|7.0|7.0|Standard Deviation|0.8|0.8|||
4333916|NCT00433836|4161245|B3||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4333917|NCT00433836|4161246|B2||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4333918|NCT00433836|4161247|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4333919|NCT00433836|4161245|B3||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4333920|NCT00433836|4161246|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4333921|NCT00433836|4161247|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4333922|NCT00433836|4161245|B3|||Age||years|Mean|12.9|12.9|Standard Deviation|2.93|2.93|||
4333923|NCT00433836|4161246|B2|||Age||years|Mean|13.0|13.0|Standard Deviation|2.94|2.94|||
4333924|NCT00433836|4161247|B1|||Age||years|Mean|12.7|12.7|Standard Deviation|2.93|2.93|||
4333925|NCT00433771|4161260|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
4333926|NCT00433771|4161260|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4333927|NCT00433771|4161260|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4333928|NCT00433771|4161260|B1|||Age||years|Mean|67.91|67.91|Standard Deviation|14.35|14.35|||
4333929|NCT00433771|4161260|B1||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4333930|NCT00433771|4161260|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4333931|NCT00433771|4161260|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333932|NCT00433745|4161276|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4333933|NCT00433745|4161276|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4333934|NCT00433745|4161276|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4333935|NCT00433745|4161276|B1|||Age||years|Mean|54|54.0|Standard Deviation|18|18.0|||
4333936|NCT00433745|4161276|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4333937|NCT00433745|4161276|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4333938|NCT00433745|4161276|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333939|NCT00433654|4161281|B3|Middle East||Region of Enrollment||participants|Number|1|1.0||||||
4333940|NCT00433654|4161282|B2|Middle East||Region of Enrollment||participants|Number|0|0.0||||||
4333941|NCT00433654|4161283|B1|Middle East||Region of Enrollment||participants|Number|1|1.0||||||
4333942|NCT00433654|4161281|B3|Canada||Region of Enrollment||participants|Number|66|66.0||||||
4333943|NCT00433654|4161282|B2|Canada||Region of Enrollment||participants|Number|32|32.0||||||
4333944|NCT00433654|4161283|B1|Canada||Region of Enrollment||participants|Number|34|34.0||||||
4333945|NCT00433654|4161281|B3|Europe||Region of Enrollment||participants|Number|298|298.0||||||
4333946|NCT00433654|4161282|B2|Europe||Region of Enrollment||participants|Number|141|141.0||||||
4333947|NCT00433654|4161283|B1|Europe||Region of Enrollment||participants|Number|157|157.0||||||
4333948|NCT00433654|4161281|B3|United States||Region of Enrollment||participants|Number|99|99.0||||||
4333949|NCT00433654|4161282|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4333950|NCT00433654|4161283|B1|United States||Region of Enrollment||participants|Number|66|66.0||||||
4333951|NCT00433654|4161281|B3||Male|Sex: Female, Male||Participants|Count of Participants|289|289.0||||||
4333952|NCT00433654|4161282|B2||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4333953|NCT00433654|4161283|B1||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4333954|NCT00433654|4161281|B3||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4333955|NCT00433654|4161282|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4333956|NCT00433654|4161283|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4333957|NCT00433654|4161281|B3|||Age||years|Mean|68.7|68.7|Standard Deviation|12.8|12.8|||
4333958|NCT00433654|4161282|B2|||Age||years|Mean|68.0|68.0|Standard Deviation|12.6|12.6|||
4333959|NCT00433654|4161283|B1|||Age||years|Mean|69.3|69.3|Standard Deviation|12.9|12.9|||
4333960|NCT00433654|4161281|B3||>=65 years|Age||Participants|Count of Participants|322|322.0||||||
4333961|NCT00433654|4161282|B2||>=65 years|Age||Participants|Count of Participants|139|139.0||||||
4333962|NCT00433654|4161283|B1||>=65 years|Age||Participants|Count of Participants|183|183.0||||||
4333963|NCT00433654|4161281|B3||Between 18 and 65 years|Age||Participants|Count of Participants|142|142.0||||||
4333964|NCT00433654|4161282|B2||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
4333965|NCT00433654|4161283|B1||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4333966|NCT00433654|4161281|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333967|NCT00433654|4161282|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333968|NCT00433654|4161283|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4333969|NCT00433550|4161315|B4|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
4333970|NCT00433550|4161316|B3|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4333971|NCT00433550|4161317|B2|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4333972|NCT00433550|4161318|B1|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
4333973|NCT00433550|4161315|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4333974|NCT00433550|4161316|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4333975|NCT00433550|4161317|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4333976|NCT00433550|4161318|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4333977|NCT00433550|4161315|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4333978|NCT00433550|4161316|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4333979|NCT00433550|4161317|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4333980|NCT00433550|4161318|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4333981|NCT00433550|4161315|B4|||Age||years|Median|64|64.0|Full Range|||41.0|77.0|
4333982|NCT00433550|4161316|B3|||Age||years|Median|62.5|62.5|Full Range|||43.0|74.0|
4333983|NCT00433550|4161317|B2|||Age||years|Median|66.5|66.5|Full Range|||42.0|77.0|
4333984|NCT00433550|4161318|B1|||Age||years|Median|64|64.0|Full Range|||41.0|75.0|
4333985|NCT00433537|4161330|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4333986|NCT00433537|4161330|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4333987|NCT00433537|4161330|B1|||Age||years|Median|62|62.0|Full Range|||40.0|76.0|
4333988|NCT00433446|4161341|B1|No||Prior Taxane Therapy||participants|Number|0|0.0||||||
4333989|NCT00433446|4161341|B1|Yes||Prior Taxane Therapy||participants|Number|53|53.0||||||
4334031|NCT00433290|4161376|B2|||Duration of Osteoarthritis Pain Since Onset||years|Mean|6.74|6.74|Standard Deviation|6.58|6.58|||
4334032|NCT00433290|4161377|B1|||Duration of Osteoarthritis Pain Since Onset||years|Mean|8.14|8.14|Standard Deviation|7.64|7.64|||
4334083|NCT00433290|4161377|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4334084|NCT00433290|4161375|B3|||Age||years|Mean|62.53|62.53|Standard Deviation|8.98|8.98|||
4333990|NCT00433446|4161341|B1|2||Performance Status|Patients will be graded according to the Zubrod performance status scale. 0: Fully active, able to carry all pre-disease performance without restriction. 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. 2: Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours. 3: Capable of limited self-care, confined to bed or chair more than 50% of waking hours. 4: Completely disabled; cannot carry on any self-care; totally confined to bed or chair.|participants|Number|6|6.0||||||
4333991|NCT00433446|4161341|B1|1||Performance Status|Patients will be graded according to the Zubrod performance status scale. 0: Fully active, able to carry all pre-disease performance without restriction. 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. 2: Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours. 3: Capable of limited self-care, confined to bed or chair more than 50% of waking hours. 4: Completely disabled; cannot carry on any self-care; totally confined to bed or chair.|participants|Number|28|28.0||||||
4333992|NCT00433446|4161341|B1|0||Performance Status|Patients will be graded according to the Zubrod performance status scale. 0: Fully active, able to carry all pre-disease performance without restriction. 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. 2: Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours. 3: Capable of limited self-care, confined to bed or chair more than 50% of waking hours. 4: Completely disabled; cannot carry on any self-care; totally confined to bed or chair.|participants|Number|19|19.0||||||
4333993|NCT00433446|4161341|B1|||Baseline PSA (ng/dL)||ng/dL|Median|75.1|75.1|Full Range|||6.3|10181.0|
4333994|NCT00433446|4161341|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4333995|NCT00433446|4161341|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4333996|NCT00433446|4161341|B1||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4333997|NCT00433446|4161341|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4333998|NCT00433446|4161341|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4333999|NCT00433446|4161341|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4334000|NCT00433446|4161341|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4334001|NCT00433446|4161341|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4334002|NCT00433446|4161341|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4334003|NCT00433446|4161341|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4334004|NCT00433446|4161341|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4334005|NCT00433446|4161341|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4334006|NCT00433446|4161341|B1|||Age||years|Median|71|71.0|Full Range|||46.0|92.0|
4334007|NCT00433381|4161349|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4334008|NCT00433381|4161350|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4334009|NCT00433381|4161351|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4334010|NCT00433381|4161349|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4334011|NCT00433381|4161350|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4334012|NCT00433381|4161351|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4334013|NCT00433381|4161349|B3|||Age||years|Median|56|56.0|Full Range|||23.0|82.0|
4334014|NCT00433381|4161350|B2|||Age||years|Median|55|55.0|Full Range|||23.0|78.0|
4334015|NCT00433381|4161351|B1|||Age||years|Median|57.5|57.5|Full Range|||24.0|82.0|
4334016|NCT00433329|4161371|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
4334017|NCT00433329|4161371|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4334018|NCT00433329|4161371|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4334019|NCT00433329|4161371|B1|Between 21 and 84 years||Age, Customized||participants|Number|100|100.0||||||
4334020|NCT00433329|4161371|B1|||Age||years|Mean|55.5|55.5|Standard Deviation|15.99|15.99|||
4334021|NCT00433290|4161375|B3|||Weekly Mean of 24 Hour Average Pain Severity|This is an ordinal scale with scores from 0 (no pain) to 10 (worst possible pain). Data presented represents the weekly mean of the scores of the average pain severity over the last 24 hours.|units on a scale|Mean|6.04|6.04|Standard Deviation|1.22|1.22|||
4334022|NCT00433290|4161376|B2|||Weekly Mean of 24 Hour Average Pain Severity|This is an ordinal scale with scores from 0 (no pain) to 10 (worst possible pain). Data presented represents the weekly mean of the scores of the average pain severity over the last 24 hours.|units on a scale|Mean|6.07|6.07|Standard Deviation|1.26|1.26|||
4334023|NCT00433290|4161377|B1|||Weekly Mean of 24 Hour Average Pain Severity|This is an ordinal scale with scores from 0 (no pain) to 10 (worst possible pain). Data presented represents the weekly mean of the scores of the average pain severity over the last 24 hours.|units on a scale|Mean|6.02|6.02|Standard Deviation|1.18|1.18|||
4334024|NCT00433290|4161375|B3|||Height||centimeters|Mean|165.51|165.51|Standard Deviation|8.34|8.34|||
4334025|NCT00433290|4161376|B2|||Height||centimeters|Mean|165.02|165.02|Standard Deviation|7.99|7.99|||
4334026|NCT00433290|4161377|B1|||Height||centimeters|Mean|165.99|165.99|Standard Deviation|8.69|8.69|||
4334027|NCT00433290|4161375|B3|||Duration of Osteoarthritis Since Diagnosis||years|Mean|5.89|5.89|Standard Deviation|6.04|6.04|||
4334028|NCT00433290|4161376|B2|||Duration of Osteoarthritis Since Diagnosis||years|Mean|5.62|5.62|Standard Deviation|6.20|6.2|||
4334029|NCT00433290|4161377|B1|||Duration of Osteoarthritis Since Diagnosis||years|Mean|6.16|6.16|Standard Deviation|5.88|5.88|||
4334030|NCT00433290|4161375|B3|||Duration of Osteoarthritis Pain Since Onset||years|Mean|7.44|7.44|Standard Deviation|7.15|7.15|||
4334033|NCT00433290|4161375|B3|||Clinical Global Impressions of Severity Scale (CGI-S)|Measures severity of illness at the time of assessment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill patients.|units on a scale|Mean|3.34|3.34|Standard Deviation|1.27|1.27|||
4334034|NCT00433290|4161376|B2|||Clinical Global Impressions of Severity Scale (CGI-S)|Measures severity of illness at the time of assessment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill patients.|units on a scale|Mean|3.34|3.34|Standard Deviation|1.33|1.33|||
4334035|NCT00433290|4161377|B1|||Clinical Global Impressions of Severity Scale (CGI-S)|Measures severity of illness at the time of assessment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill patients.|units on a scale|Mean|3.34|3.34|Standard Deviation|1.21|1.21|||
4334036|NCT00433290|4161375|B3|||Brief Pain Inventory Average Pain|A self-reported scale that measures the severity of pain based on the average pain over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|6.11|6.11|Standard Deviation|1.33|1.33|||
4334037|NCT00433290|4161376|B2|||Brief Pain Inventory Average Pain|A self-reported scale that measures the severity of pain based on the average pain over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|6.14|6.14|Standard Deviation|1.27|1.27|||
4334038|NCT00433290|4161377|B1|||Brief Pain Inventory Average Pain|A self-reported scale that measures the severity of pain based on the average pain over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|6.07|6.07|Standard Deviation|1.39|1.39|||
4334039|NCT00433290|4161375|B3|||Body Weight||kilograms|Mean|80.80|80.8|Standard Deviation|12.98|12.98|||
4334040|NCT00433290|4161376|B2|||Body Weight||kilograms|Mean|80.55|80.55|Standard Deviation|12.24|12.24|||
4334041|NCT00433290|4161377|B1|||Body Weight||kilograms|Mean|81.05|81.05|Standard Deviation|13.73|13.73|||
4334042|NCT00433290|4161375|B3|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/meters squared|Mean|29.55|29.55|Standard Deviation|4.58|4.58|||
4334043|NCT00433290|4161376|B2|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/meters squared|Mean|29.65|29.65|Standard Deviation|4.52|4.52|||
4334044|NCT00433290|4161377|B1|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/meters squared|Mean|29.44|29.44|Standard Deviation|4.66|4.66|||
4334045|NCT00433290|4161375|B3|Hispanic||Race/Ethnicity||participants|Number|2|2.0||||||
4334046|NCT00433290|4161376|B2|Hispanic||Race/Ethnicity||participants|Number|0|0.0||||||
4334047|NCT00433290|4161377|B1|Hispanic||Race/Ethnicity||participants|Number|2|2.0||||||
4334048|NCT00433290|4161375|B3|East Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4334049|NCT00433290|4161376|B2|East Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4334050|NCT00433290|4161377|B1|East Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4334051|NCT00433290|4161375|B3|Caucasian||Race/Ethnicity||participants|Number|250|250.0||||||
4334052|NCT00433290|4161376|B2|Caucasian||Race/Ethnicity||participants|Number|124|124.0||||||
4334053|NCT00433290|4161377|B1|Caucasian||Race/Ethnicity||participants|Number|126|126.0||||||
4334054|NCT00433290|4161375|B3|African||Race/Ethnicity||participants|Number|3|3.0||||||
4334055|NCT00433290|4161376|B2|African||Race/Ethnicity||participants|Number|3|3.0||||||
4334056|NCT00433290|4161377|B1|African||Race/Ethnicity||participants|Number|0|0.0||||||
4334057|NCT00433290|4161375|B3|Yes||Nonsteroidal Anti-Inflammatory Drug (NSAID) Use||participants|Number|100|100.0||||||
4334058|NCT00433290|4161376|B2|Yes||Nonsteroidal Anti-Inflammatory Drug (NSAID) Use||participants|Number|53|53.0||||||
4334059|NCT00433290|4161377|B1|Yes||Nonsteroidal Anti-Inflammatory Drug (NSAID) Use||participants|Number|47|47.0||||||
4334060|NCT00433290|4161375|B3|No||Nonsteroidal Anti-Inflammatory Drug (NSAID) Use||participants|Number|156|156.0||||||
4334061|NCT00433290|4161376|B2|No||Nonsteroidal Anti-Inflammatory Drug (NSAID) Use||participants|Number|75|75.0||||||
4334062|NCT00433290|4161377|B1|No||Nonsteroidal Anti-Inflammatory Drug (NSAID) Use||participants|Number|81|81.0||||||
4334063|NCT00433290|4161375|B3|Canada||Region of Enrollment||participants|Number|48|48.0||||||
4334064|NCT00433290|4161376|B2|Canada||Region of Enrollment||participants|Number|23|23.0||||||
4334065|NCT00433290|4161377|B1|Canada||Region of Enrollment||participants|Number|25|25.0||||||
4334066|NCT00433290|4161375|B3|Sweden||Region of Enrollment||participants|Number|28|28.0||||||
4334067|NCT00433290|4161376|B2|Sweden||Region of Enrollment||participants|Number|14|14.0||||||
4334068|NCT00433290|4161377|B1|Sweden||Region of Enrollment||participants|Number|14|14.0||||||
4334069|NCT00433290|4161375|B3|Russian Federation||Region of Enrollment||participants|Number|127|127.0||||||
4334070|NCT00433290|4161376|B2|Russian Federation||Region of Enrollment||participants|Number|65|65.0||||||
4334071|NCT00433290|4161377|B1|Russian Federation||Region of Enrollment||participants|Number|62|62.0||||||
4334072|NCT00433290|4161375|B3|Greece||Region of Enrollment||participants|Number|32|32.0||||||
4334073|NCT00433290|4161376|B2|Greece||Region of Enrollment||participants|Number|16|16.0||||||
4334074|NCT00433290|4161377|B1|Greece||Region of Enrollment||participants|Number|16|16.0||||||
4334075|NCT00433290|4161375|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4334076|NCT00433290|4161376|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4334077|NCT00433290|4161377|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4334078|NCT00433290|4161375|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4334079|NCT00433290|4161376|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4334080|NCT00433290|4161377|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4334081|NCT00433290|4161375|B3||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4334082|NCT00433290|4161376|B2||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4334085|NCT00433290|4161376|B2|||Age||years|Mean|61.90|61.9|Standard Deviation|9.20|9.2|||
4334086|NCT00433290|4161377|B1|||Age||years|Mean|63.16|63.16|Standard Deviation|8.75|8.75|||
4334087|NCT00433199|4161445|B3|United States||Region of Enrollment|The Baseline analysis is presented on the Full analysis set.|participants|Number|251|251.0||||||
4334088|NCT00433199|4161446|B2|United States||Region of Enrollment|The Baseline analysis is presented on the Full analysis set.|participants|Number|214|214.0||||||
4334089|NCT00433199|4161447|B1|United States||Region of Enrollment|The Baseline analysis is presented on the Full analysis set.|participants|Number|37|37.0||||||
4334090|NCT00433199|4161445|B3||Male|Sex: Female, Male|The Baseline analysis is presented on the Full analysis set.|Participants|Count of Participants|251|251.0||||||
4334091|NCT00433199|4161446|B2||Male|Sex: Female, Male|The Baseline analysis is presented on the Full analysis set.|Participants|Count of Participants|214|214.0||||||
4334092|NCT00433199|4161447|B1||Male|Sex: Female, Male|The Baseline analysis is presented on the Full analysis set.|Participants|Count of Participants|37|37.0||||||
4334093|NCT00433199|4161445|B3||Female|Sex: Female, Male|The Baseline analysis is presented on the Full analysis set.|Participants|Count of Participants|0|0.0||||||
4334094|NCT00433199|4161446|B2||Female|Sex: Female, Male|The Baseline analysis is presented on the Full analysis set.|Participants|Count of Participants|0|0.0||||||
4334095|NCT00433199|4161447|B1||Female|Sex: Female, Male|The Baseline analysis is presented on the Full analysis set.|Participants|Count of Participants|0|0.0||||||
4334096|NCT00433199|4161445|B3|>= 65 years||Age, Customized|The Baseline analysis is presented on the Full analysis set.|participants|Number|37|37.0||||||
4334097|NCT00433199|4161446|B2|>= 65 years||Age, Customized|The Baseline analysis is presented on the Full analysis set.|participants|Number|30|30.0||||||
4334098|NCT00433199|4161447|B1|>= 65 years||Age, Customized|The Baseline analysis is presented on the Full analysis set.|participants|Number|7|7.0||||||
4334099|NCT00433199|4161445|B3|55-64 years||Age, Customized|The Baseline analysis is presented on the Full analysis set.|participants|Number|83|83.0||||||
4334100|NCT00433199|4161446|B2|55-64 years||Age, Customized|The Baseline analysis is presented on the Full analysis set.|participants|Number|67|67.0||||||
4334101|NCT00433199|4161447|B1|55-64 years||Age, Customized|The Baseline analysis is presented on the Full analysis set.|participants|Number|16|16.0||||||
4334102|NCT00433199|4161445|B3|45-54 years||Age, Customized|The Baseline analysis is presented on the Full analysis set.|participants|Number|90|90.0||||||
4334103|NCT00433199|4161446|B2|45-54 years||Age, Customized|The Baseline analysis is presented on the Full analysis set.|participants|Number|83|83.0||||||
4334104|NCT00433199|4161447|B1|45-54 years||Age, Customized|The Baseline analysis is presented on the Full analysis set.|participants|Number|7|7.0||||||
4334105|NCT00433199|4161445|B3|<45 years||Age, Customized|The Baseline analysis is presented on the Full analysis set.|participants|Number|41|41.0||||||
4334106|NCT00433199|4161446|B2|<45 years||Age, Customized|The Baseline analysis is presented on the Full analysis set.|participants|Number|34|34.0||||||
4334107|NCT00433199|4161447|B1|<45 years||Age, Customized|The Baseline analysis is presented on the Full analysis set.|participants|Number|7|7.0||||||
4334108|NCT00433160|4161466|B3|||Weight||kilograms (kg)|Mean|49.24|49.24|Standard Deviation|7.29|7.29|||
4334109|NCT00433160|4161467|B2|||Weight||kilograms (kg)|Mean|50.25|50.25|Standard Deviation|8.10|8.1|||
4334110|NCT00433160|4161468|B1|||Weight||kilograms (kg)|Mean|48.74|48.74|Standard Deviation|6.83|6.83|||
4334111|NCT00433160|4161466|B3|||Height||centimeters (cm)|Mean|150.36|150.36|Standard Deviation|5.89|5.89|||
4334112|NCT00433160|4161467|B2|||Height||centimeters (cm)|Mean|150.30|150.3|Standard Deviation|5.74|5.74|||
4334113|NCT00433160|4161468|B1|||Height||centimeters (cm)|Mean|150.40|150.4|Standard Deviation|5.97|5.97|||
4334114|NCT00433160|4161466|B3|||Bone Mineral Density (BMD) Total Spine||grams per square centimeter (g/cm^2)|Mean|0.6143|0.6143|Standard Deviation|0.0726|0.0726|||
4334115|NCT00433160|4161467|B2|||Bone Mineral Density (BMD) Total Spine||grams per square centimeter (g/cm^2)|Mean|0.6123|0.6123|Standard Deviation|0.0780|0.078|||
4334116|NCT00433160|4161468|B1|||Bone Mineral Density (BMD) Total Spine||grams per square centimeter (g/cm^2)|Mean|0.6153|0.6153|Standard Deviation|0.0701|0.0701|||
4334117|NCT00433160|4161466|B3|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared (kg/m^2).|kilograms per square meter (kg/m^2)|Mean|21.80|21.8|Standard Deviation|3.15|3.15|||
4334118|NCT00433160|4161467|B2|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared (kg/m^2).|kilograms per square meter (kg/m^2)|Mean|22.24|22.24|Standard Deviation|3.34|3.34|||
4334119|NCT00433160|4161468|B1|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared (kg/m^2).|kilograms per square meter (kg/m^2)|Mean|21.58|21.58|Standard Deviation|3.03|3.03|||
4334120|NCT00433160|4161466|B3|Current Smoker||Smoking History||participants|Number|21|21.0||||||
4334121|NCT00433160|4161467|B2|Current Smoker||Smoking History||participants|Number|5|5.0||||||
4334122|NCT00433160|4161468|B1|Current Smoker||Smoking History||participants|Number|16|16.0||||||
4334123|NCT00433160|4161466|B3|Past Smoker||Smoking History||participants|Number|15|15.0||||||
4334124|NCT00433160|4161467|B2|Past Smoker||Smoking History||participants|Number|9|9.0||||||
4334125|NCT00433160|4161468|B1|Past Smoker||Smoking History||participants|Number|6|6.0||||||
4334126|NCT00433160|4161466|B3|Non-Smoker||Smoking History||participants|Number|167|167.0||||||
4334127|NCT00433160|4161467|B2|Non-Smoker||Smoking History||participants|Number|53|53.0||||||
4334128|NCT00433160|4161468|B1|Non-Smoker||Smoking History||participants|Number|114|114.0||||||
4334129|NCT00433160|4161466|B3|Yes||Previous Osteoporosis Drug Use||participants|Number|73|73.0||||||
4334130|NCT00433160|4161467|B2|Yes||Previous Osteoporosis Drug Use||participants|Number|23|23.0||||||
4334131|NCT00433160|4161468|B1|Yes||Previous Osteoporosis Drug Use||participants|Number|50|50.0||||||
4334132|NCT00433160|4161466|B3|No||Previous Osteoporosis Drug Use||participants|Number|130|130.0||||||
4334133|NCT00433160|4161467|B2|No||Previous Osteoporosis Drug Use||participants|Number|44|44.0||||||
4334134|NCT00433160|4161468|B1|No||Previous Osteoporosis Drug Use||participants|Number|86|86.0||||||
4334135|NCT00433160|4161466|B3|5 or More Fractures||Number of Previous Vertebral Fractures||participants|Number|3|3.0||||||
4334136|NCT00433160|4161467|B2|5 or More Fractures||Number of Previous Vertebral Fractures||participants|Number|1|1.0||||||
4334137|NCT00433160|4161468|B1|5 or More Fractures||Number of Previous Vertebral Fractures||participants|Number|2|2.0||||||
4334138|NCT00433160|4161466|B3|4 Fractures||Number of Previous Vertebral Fractures||participants|Number|5|5.0||||||
4334139|NCT00433160|4161467|B2|4 Fractures||Number of Previous Vertebral Fractures||participants|Number|1|1.0||||||
4334140|NCT00433160|4161468|B1|4 Fractures||Number of Previous Vertebral Fractures||participants|Number|4|4.0||||||
4334141|NCT00433160|4161466|B3|3 Fractures||Number of Previous Vertebral Fractures||participants|Number|6|6.0||||||
4334142|NCT00433160|4161467|B2|3 Fractures||Number of Previous Vertebral Fractures||participants|Number|3|3.0||||||
4334143|NCT00433160|4161468|B1|3 Fractures||Number of Previous Vertebral Fractures||participants|Number|3|3.0||||||
4334144|NCT00433160|4161466|B3|2 Fractures||Number of Previous Vertebral Fractures||participants|Number|18|18.0||||||
4334145|NCT00433160|4161467|B2|2 Fractures||Number of Previous Vertebral Fractures||participants|Number|8|8.0||||||
4334146|NCT00433160|4161468|B1|2 Fractures||Number of Previous Vertebral Fractures||participants|Number|10|10.0||||||
4334147|NCT00433160|4161466|B3|1 Fracture||Number of Previous Vertebral Fractures||participants|Number|51|51.0||||||
4334148|NCT00433160|4161467|B2|1 Fracture||Number of Previous Vertebral Fractures||participants|Number|16|16.0||||||
4334149|NCT00433160|4161468|B1|1 Fracture||Number of Previous Vertebral Fractures||participants|Number|35|35.0||||||
4334150|NCT00433160|4161466|B3|0 Fractures||Number of Previous Vertebral Fractures||participants|Number|120|120.0||||||
4334151|NCT00433160|4161467|B2|0 Fractures||Number of Previous Vertebral Fractures||participants|Number|38|38.0||||||
4334152|NCT00433160|4161468|B1|0 Fractures||Number of Previous Vertebral Fractures||participants|Number|82|82.0||||||
4334153|NCT00433160|4161466|B3|Yes||Alcohol Consumption||participants|Number|53|53.0||||||
4334154|NCT00433160|4161467|B2|Yes||Alcohol Consumption||participants|Number|16|16.0||||||
4334155|NCT00433160|4161468|B1|Yes||Alcohol Consumption||participants|Number|37|37.0||||||
4334156|NCT00433160|4161466|B3|No||Alcohol Consumption||participants|Number|150|150.0||||||
4334157|NCT00433160|4161467|B2|No||Alcohol Consumption||participants|Number|51|51.0||||||
4334158|NCT00433160|4161468|B1|No||Alcohol Consumption||participants|Number|99|99.0||||||
4334159|NCT00433160|4161466|B3|Japan||Region of Enrollment||participants|Number|203|203.0||||||
4334160|NCT00433160|4161467|B2|Japan||Region of Enrollment||participants|Number|67|67.0||||||
4334161|NCT00433160|4161468|B1|Japan||Region of Enrollment||participants|Number|136|136.0||||||
4334162|NCT00433160|4161466|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4334163|NCT00433160|4161467|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4334164|NCT00433160|4161468|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4334165|NCT00433160|4161466|B3||Female|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4334166|NCT00433160|4161467|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4334167|NCT00433160|4161468|B1||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4334168|NCT00433160|4161466|B3|||Age||years|Mean|69.6|69.6|Standard Deviation|6.0|6.0|||
4334169|NCT00433160|4161467|B2|||Age||years|Mean|70.4|70.4|Standard Deviation|5.4|5.4|||
4334170|NCT00433160|4161468|B1|||Age||years|Mean|69.2|69.2|Standard Deviation|6.3|6.3|||
4334171|NCT00433147|4161517|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4334172|NCT00433147|4161518|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4334173|NCT00433147|4161519|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4334174|NCT00433147|4161520|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4334175|NCT00433147|4161521|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4334176|NCT00433147|4161517|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4334177|NCT00433147|4161518|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4334178|NCT00433147|4161519|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4334179|NCT00433147|4161520|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4334180|NCT00433147|4161521|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4334181|NCT00433147|4161517|B5|||Age||years|Mean|41.3|41.3|Standard Deviation|14.01|14.01|||
4334182|NCT00433147|4161518|B4|||Age||years|Mean|45.0|45.0|Standard Deviation|12.3|12.3|||
4334183|NCT00433147|4161519|B3|||Age||years|Mean|36.7|36.7|Standard Deviation|12.0|12.0|||
4334184|NCT00433147|4161520|B2|||Age||years|Mean|43.4|43.4|Standard Deviation|18.0|18.0|||
4334185|NCT00433147|4161521|B1|||Age||years|Mean|41.4|41.4|Standard Deviation|15.1|15.1|||
4334186|NCT00433017|4161538|B3||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4334187|NCT00433017|4161539|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4334188|NCT00433017|4161540|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4334189|NCT00433017|4161538|B3||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4334190|NCT00433017|4161539|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4334191|NCT00433017|4161540|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4334192|NCT00433017|4161538|B3|||Age||years|Mean|76.1|76.1|Standard Deviation|7.55|7.55|||
4334193|NCT00433017|4161539|B2|||Age||years|Mean|75.5|75.5|Standard Deviation|7.44|7.44|||
4334194|NCT00433017|4161540|B1|||Age||years|Mean|76.8|76.8|Standard Deviation|7.65|7.65|||
4334195|NCT00433004|4161555|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4334196|NCT00433004|4161556|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4334197|NCT00433004|4161557|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4334198|NCT00433004|4161555|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4334199|NCT00433004|4161556|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4334200|NCT00433004|4161557|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4334201|NCT00433004|4161555|B3|||Age||years|Mean|17.6|17.6|Full Range|||14.0|19.0|
4334202|NCT00433004|4161556|B2|||Age||years|Mean|17.6|17.6|Full Range|||14.0|19.0|
4334203|NCT00433004|4161557|B1|||Age||years|Mean|17.6|17.6|Full Range|||14.0|19.0|
4334204|NCT00432991|4161568|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4334205|NCT00432991|4161568|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4334206|NCT00432991|4161569|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4334207|NCT00432991|4161570|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4334208|NCT00432991|4161568|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4334209|NCT00432991|4161569|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4334210|NCT00432991|4161570|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4334211|NCT00432991|4161568|B3|||Age||years|Mean|33.7|33.7|Standard Deviation|4.45|4.45|||
4334212|NCT00432991|4161569|B2|||Age||years|Mean|33.4|33.4|Standard Deviation|4.4|4.4|||
4334213|NCT00432991|4161570|B1|||Age||years|Mean|34.1|34.1|Standard Deviation|4.64|4.64|||
4334214|NCT00432965|4161581|B3|United States||Region of Enrollment||Participants|Count of Participants|327|327.0||||||
4334215|NCT00432965|4161582|B2|United States||Region of Enrollment||Participants|Count of Participants|162|162.0||||||
4334216|NCT00432965|4161583|B1|United States||Region of Enrollment||Participants|Count of Participants|165|165.0||||||
4334217|NCT00432965|4161581|B3|Canada||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4334218|NCT00432965|4161582|B2|Canada||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4334219|NCT00432965|4161583|B1|Canada||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4334220|NCT00432965|4161581|B3|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4334221|NCT00432965|4161582|B2|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4334222|NCT00432965|4161583|B1|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4334223|NCT00432965|4161581|B3|Race/Ethnicity|Native American|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4334224|NCT00432965|4161582|B2|Race/Ethnicity|Native American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4334225|NCT00432965|4161583|B1|Race/Ethnicity|Native American|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4334226|NCT00432965|4161581|B3|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|81|81.0||||||
4334227|NCT00432965|4161582|B2|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
4334228|NCT00432965|4161583|B1|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
4334229|NCT00432965|4161581|B3|Race/Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|195|195.0||||||
4334230|NCT00432965|4161582|B2|Race/Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|100|100.0||||||
4334231|NCT00432965|4161583|B1|Race/Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|95|95.0||||||
4334232|NCT00432965|4161581|B3|Race/Ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
4334233|NCT00432965|4161582|B2|Race/Ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
4334234|NCT00432965|4161583|B1|Race/Ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
4334235|NCT00432965|4161581|B3||Male|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
4334236|NCT00432965|4161582|B2||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4334237|NCT00432965|4161583|B1||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4334238|NCT00432965|4161581|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4334239|NCT00432965|4161582|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4334240|NCT00432965|4161583|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4334241|NCT00432965|4161581|B3|||Age||years|Mean|58.1|58.1|Standard Deviation|11.96|11.96|||
4334242|NCT00432965|4161582|B2|||Age||years|Mean|58.9|58.9|Standard Deviation|11.51|11.51|||
4334243|NCT00432965|4161583|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|12.3|12.3|||
4334244|NCT00432835|4161590|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
4334245|NCT00432835|4161591|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4334246|NCT00432835|4161592|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4334247|NCT00432835|4161590|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4334248|NCT00432835|4161591|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4334249|NCT00432835|4161592|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4334250|NCT00432835|4161590|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4334251|NCT00432835|4161591|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4334252|NCT00432835|4161592|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4334253|NCT00432835|4161590|B3|||Age||years|Mean|47|47.0|Standard Deviation|13|13.0|||
4334254|NCT00432835|4161591|B2|||Age||years|Mean|47|47.0|Standard Deviation|14|14.0|||
4334255|NCT00432835|4161592|B1|||Age||years|Mean|47|47.0|Standard Deviation|13|13.0|||
4334256|NCT00432835|4161590|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4334257|NCT00432835|4161591|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4334258|NCT00432835|4161592|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4334259|NCT00432835|4161590|B3||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4334260|NCT00432835|4161591|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4334261|NCT00432835|4161592|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4334262|NCT00432835|4161590|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4334263|NCT00432835|4161591|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4334264|NCT00432835|4161592|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4334265|NCT00432809|4161603|B4|Not taking Anticoagulants||Cardiovascular medication - Anticoagulant||participant|Number|87|87.0||||||
4334266|NCT00432809|4161604|B3|Not taking Anticoagulants||Cardiovascular medication - Anticoagulant||participant|Number|34|34.0||||||
4334267|NCT00432809|4161605|B2|Not taking Anticoagulants||Cardiovascular medication - Anticoagulant||participant|Number|29|29.0||||||
4334268|NCT00432809|4161606|B1|Not taking Anticoagulants||Cardiovascular medication - Anticoagulant||participant|Number|24|24.0||||||
4334269|NCT00432809|4161603|B4|Taking Anticoagulants||Cardiovascular medication - Anticoagulant||participant|Number|63|63.0||||||
4334270|NCT00432809|4161604|B3|Taking Anticoagulants||Cardiovascular medication - Anticoagulant||participant|Number|16|16.0||||||
4334271|NCT00432809|4161605|B2|Taking Anticoagulants||Cardiovascular medication - Anticoagulant||participant|Number|21|21.0||||||
4334272|NCT00432809|4161606|B1|Taking Anticoagulants||Cardiovascular medication - Anticoagulant||participant|Number|26|26.0||||||
4334273|NCT00432809|4161603|B4|Not taking ACE Inhibitor or ARB||Cardiovascular medications - ACE Inhibitors or ARB||participant|Number|63|63.0||||||
4334274|NCT00432809|4161604|B3|Not taking ACE Inhibitor or ARB||Cardiovascular medications - ACE Inhibitors or ARB||participant|Number|25|25.0||||||
4334275|NCT00432809|4161605|B2|Not taking ACE Inhibitor or ARB||Cardiovascular medications - ACE Inhibitors or ARB||participant|Number|18|18.0||||||
4334276|NCT00432809|4161606|B1|Not taking ACE Inhibitor or ARB||Cardiovascular medications - ACE Inhibitors or ARB||participant|Number|20|20.0||||||
4334277|NCT00432809|4161603|B4|Taking ACE Inhibitor or ARB||Cardiovascular medications - ACE Inhibitors or ARB||participant|Number|87|87.0||||||
4334278|NCT00432809|4161604|B3|Taking ACE Inhibitor or ARB||Cardiovascular medications - ACE Inhibitors or ARB||participant|Number|25|25.0||||||
4334279|NCT00432809|4161605|B2|Taking ACE Inhibitor or ARB||Cardiovascular medications - ACE Inhibitors or ARB||participant|Number|32|32.0||||||
4334280|NCT00432809|4161606|B1|Taking ACE Inhibitor or ARB||Cardiovascular medications - ACE Inhibitors or ARB||participant|Number|30|30.0||||||
4334281|NCT00432809|4161603|B4|Not taking Beta Blocker||Cardiovascular medication - Beta blocker||participant|Number|126|126.0||||||
4334282|NCT00432809|4161604|B3|Not taking Beta Blocker||Cardiovascular medication - Beta blocker||participant|Number|44|44.0||||||
4334283|NCT00432809|4161605|B2|Not taking Beta Blocker||Cardiovascular medication - Beta blocker||participant|Number|41|41.0||||||
4334284|NCT00432809|4161606|B1|Not taking Beta Blocker||Cardiovascular medication - Beta blocker||participant|Number|41|41.0||||||
4334285|NCT00432809|4161603|B4|Taking Beta Blocker||Cardiovascular medication - Beta blocker||participant|Number|24|24.0||||||
4334286|NCT00432809|4161604|B3|Taking Beta Blocker||Cardiovascular medication - Beta blocker||participant|Number|6|6.0||||||
4334287|NCT00432809|4161605|B2|Taking Beta Blocker||Cardiovascular medication - Beta blocker||participant|Number|9|9.0||||||
4334288|NCT00432809|4161606|B1|Taking Beta Blocker||Cardiovascular medication - Beta blocker||participant|Number|9|9.0||||||
4334289|NCT00432809|4161603|B4|Not taking Lipid Lowering Agent||Cardiovascular medication - Lipid Lowering Agents||participants|Number|27|27.0||||||
4334290|NCT00432809|4161604|B3|Not taking Lipid Lowering Agent||Cardiovascular medication - Lipid Lowering Agents||participants|Number|11|11.0||||||
4334291|NCT00432809|4161605|B2|Not taking Lipid Lowering Agent||Cardiovascular medication - Lipid Lowering Agents||participants|Number|7|7.0||||||
4334292|NCT00432809|4161606|B1|Not taking Lipid Lowering Agent||Cardiovascular medication - Lipid Lowering Agents||participants|Number|9|9.0||||||
4334293|NCT00432809|4161603|B4|Taking Lipid Lowering Agent||Cardiovascular medication - Lipid Lowering Agents||participants|Number|123|123.0||||||
4334294|NCT00432809|4161604|B3|Taking Lipid Lowering Agent||Cardiovascular medication - Lipid Lowering Agents||participants|Number|39|39.0||||||
4334295|NCT00432809|4161605|B2|Taking Lipid Lowering Agent||Cardiovascular medication - Lipid Lowering Agents||participants|Number|43|43.0||||||
4334296|NCT00432809|4161606|B1|Taking Lipid Lowering Agent||Cardiovascular medication - Lipid Lowering Agents||participants|Number|41|41.0||||||
4334297|NCT00432809|4161603|B4|> / = 4||Number of Diabetic Medications||participants|Number|39|39.0||||||
4334298|NCT00432809|4161604|B3|> / = 4||Number of Diabetic Medications||participants|Number|11|11.0||||||
4334299|NCT00432809|4161605|B2|> / = 4||Number of Diabetic Medications||participants|Number|14|14.0||||||
4334300|NCT00432809|4161606|B1|> / = 4||Number of Diabetic Medications||participants|Number|14|14.0||||||
4334301|NCT00432809|4161603|B4|3||Number of Diabetic Medications||participants|Number|41|41.0||||||
4334302|NCT00432809|4161604|B3|3||Number of Diabetic Medications||participants|Number|13|13.0||||||
4334303|NCT00432809|4161605|B2|3||Number of Diabetic Medications||participants|Number|12|12.0||||||
4334304|NCT00432809|4161606|B1|3||Number of Diabetic Medications||participants|Number|16|16.0||||||
4334305|NCT00432809|4161603|B4|2||Number of Diabetic Medications||participants|Number|38|38.0||||||
4334306|NCT00432809|4161604|B3|2||Number of Diabetic Medications||participants|Number|14|14.0||||||
4334307|NCT00432809|4161605|B2|2||Number of Diabetic Medications||participants|Number|13|13.0||||||
4334308|NCT00432809|4161606|B1|2||Number of Diabetic Medications||participants|Number|11|11.0||||||
4334309|NCT00432809|4161603|B4|1||Number of Diabetic Medications||participants|Number|29|29.0||||||
4334310|NCT00432809|4161604|B3|1||Number of Diabetic Medications||participants|Number|11|11.0||||||
4334311|NCT00432809|4161605|B2|1||Number of Diabetic Medications||participants|Number|10|10.0||||||
4334312|NCT00432809|4161606|B1|1||Number of Diabetic Medications||participants|Number|8|8.0||||||
4334313|NCT00432809|4161603|B4|0||Number of Diabetic Medications||participants|Number|3|3.0||||||
4334314|NCT00432809|4161604|B3|0||Number of Diabetic Medications||participants|Number|1|1.0||||||
4334315|NCT00432809|4161605|B2|0||Number of Diabetic Medications||participants|Number|1|1.0||||||
4334316|NCT00432809|4161606|B1|0||Number of Diabetic Medications||participants|Number|1|1.0||||||
4334317|NCT00432809|4161603|B4|Not taking Secretagogues||Diabetes medication - Secretagogues||participants|Number|96|96.0||||||
4334318|NCT00432809|4161604|B3|Not taking Secretagogues||Diabetes medication - Secretagogues||participants|Number|31|31.0||||||
4334319|NCT00432809|4161605|B2|Not taking Secretagogues||Diabetes medication - Secretagogues||participants|Number|33|33.0||||||
4334320|NCT00432809|4161606|B1|Not taking Secretagogues||Diabetes medication - Secretagogues||participants|Number|32|32.0||||||
4334321|NCT00432809|4161603|B4|Taking Secretagogues||Diabetes medication - Secretagogues||participants|Number|54|54.0||||||
4334322|NCT00432809|4161604|B3|Taking Secretagogues||Diabetes medication - Secretagogues||participants|Number|19|19.0||||||
4334323|NCT00432809|4161605|B2|Taking Secretagogues||Diabetes medication - Secretagogues||participants|Number|17|17.0||||||
4334324|NCT00432809|4161606|B1|Taking Secretagogues||Diabetes medication - Secretagogues||participants|Number|18|18.0||||||
4334325|NCT00432809|4161603|B4|Not taking Incretin Mimetics||Diabetes medication - Incretin Mimetics||participants|Number|86|86.0||||||
4334326|NCT00432809|4161604|B3|Not taking Incretin Mimetics||Diabetes medication - Incretin Mimetics||participants|Number|29|29.0||||||
4334327|NCT00432809|4161605|B2|Not taking Incretin Mimetics||Diabetes medication - Incretin Mimetics||participants|Number|31|31.0||||||
4334328|NCT00432809|4161606|B1|Not taking Incretin Mimetics||Diabetes medication - Incretin Mimetics||participants|Number|26|26.0||||||
4334329|NCT00432809|4161603|B4|Taking Incretin Mimetics||Diabetes medication - Incretin Mimetics||participants|Number|64|64.0||||||
4334330|NCT00432809|4161604|B3|Taking Incretin Mimetics||Diabetes medication - Incretin Mimetics||participants|Number|21|21.0||||||
4334331|NCT00432809|4161605|B2|Taking Incretin Mimetics||Diabetes medication - Incretin Mimetics||participants|Number|19|19.0||||||
4334332|NCT00432809|4161606|B1|Taking Incretin Mimetics||Diabetes medication - Incretin Mimetics||participants|Number|24|24.0||||||
4334333|NCT00432809|4161603|B4|Not taking TZD's||Diabetes medication - Thiazolidinedione (TZD's)||participants|Number|88|88.0||||||
4334334|NCT00432809|4161604|B3|Not taking TZD's||Diabetes medication - Thiazolidinedione (TZD's)||participants|Number|33|33.0||||||
4334335|NCT00432809|4161605|B2|Not taking TZD's||Diabetes medication - Thiazolidinedione (TZD's)||participants|Number|25|25.0||||||
4334336|NCT00432809|4161606|B1|Not taking TZD's||Diabetes medication - Thiazolidinedione (TZD's)||participants|Number|30|30.0||||||
4334337|NCT00432809|4161603|B4|Taking TZD's||Diabetes medication - Thiazolidinedione (TZD's)||participants|Number|62|62.0||||||
4334338|NCT00432809|4161604|B3|Taking TZD's||Diabetes medication - Thiazolidinedione (TZD's)||participants|Number|17|17.0||||||
4334339|NCT00432809|4161605|B2|Taking TZD's||Diabetes medication - Thiazolidinedione (TZD's)||participants|Number|25|25.0||||||
4334340|NCT00432809|4161606|B1|Taking TZD's||Diabetes medication - Thiazolidinedione (TZD's)||participants|Number|20|20.0||||||
4334341|NCT00432809|4161603|B4|Not taking Biguanides||Diabetic medication - Biguanides||participants|Number|20|20.0||||||
4334342|NCT00432809|4161604|B3|Not taking Biguanides||Diabetic medication - Biguanides||participants|Number|8|8.0||||||
4334343|NCT00432809|4161605|B2|Not taking Biguanides||Diabetic medication - Biguanides||participants|Number|8|8.0||||||
4334344|NCT00432809|4161606|B1|Not taking Biguanides||Diabetic medication - Biguanides||participants|Number|4|4.0||||||
4334345|NCT00432809|4161603|B4|Taking Biguanides||Diabetic medication - Biguanides||participants|Number|130|130.0||||||
4334346|NCT00432809|4161604|B3|Taking Biguanides||Diabetic medication - Biguanides||participants|Number|42|42.0||||||
4334347|NCT00432809|4161605|B2|Taking Biguanides||Diabetic medication - Biguanides||participants|Number|42|42.0||||||
4334348|NCT00432809|4161606|B1|Taking Biguanides||Diabetic medication - Biguanides||participants|Number|46|46.0||||||
4334349|NCT00432809|4161603|B4|||Triglycerides||mg/dL|Median|166.5|166.5|Inter-Quartile Range|||118.0|236.0|
4334350|NCT00432809|4161604|B3|||Triglycerides||mg/dL|Median|157.0|157.0|Inter-Quartile Range|||119.0|211.0|
4334351|NCT00432809|4161605|B2|||Triglycerides||mg/dL|Median|167.0|167.0|Inter-Quartile Range|||125.0|257.0|
4334352|NCT00432809|4161606|B1|||Triglycerides||mg/dL|Median|169.0|169.0|Inter-Quartile Range|||113.0|239.0|
4334353|NCT00432809|4161603|B4|||High-density lipoprotein cholesterol||mg/dL|Mean|45.7|45.7|Standard Deviation|12.8|12.8|||
4334354|NCT00432809|4161604|B3|||High-density lipoprotein cholesterol||mg/dL|Mean|44.5|44.5|Standard Deviation|11.9|11.9|||
4334355|NCT00432809|4161605|B2|||High-density lipoprotein cholesterol||mg/dL|Mean|46.2|46.2|Standard Deviation|13.4|13.4|||
4334356|NCT00432809|4161606|B1|||High-density lipoprotein cholesterol||mg/dL|Mean|46.3|46.3|Standard Deviation|13.2|13.2|||
4334357|NCT00432809|4161603|B4|||Diastolic blood pressure||mmHg|Mean|82.5|82.5|Standard Deviation|11.0|11.0|||
4334358|NCT00432809|4161604|B3|||Diastolic blood pressure||mmHg|Mean|82.1|82.1|Standard Deviation|11.5|11.5|||
4334359|NCT00432809|4161605|B2|||Diastolic blood pressure||mmHg|Mean|81.8|81.8|Standard Deviation|10.2|10.2|||
4334360|NCT00432809|4161606|B1|||Diastolic blood pressure||mmHg|Mean|83.7|83.7|Standard Deviation|11.5|11.5|||
4334361|NCT00432809|4161603|B4|||Systolic blood pressure||mmHg|Mean|136.1|136.1|Standard Deviation|18.3|18.3|||
4334362|NCT00432809|4161604|B3|||Systolic blood pressure||mmHg|Mean|136.2|136.2|Standard Deviation|18.8|18.8|||
4334363|NCT00432809|4161605|B2|||Systolic blood pressure||mmHg|Mean|134.6|134.6|Standard Deviation|18.7|18.7|||
4334364|NCT00432809|4161606|B1|||Systolic blood pressure||mmHg|Mean|137.5|137.5|Standard Deviation|17.4|17.4|||
4334365|NCT00432809|4161603|B4|No||History of hypertension||participants|Number|59|59.0||||||
4334366|NCT00432809|4161604|B3|No||History of hypertension||participants|Number|20|20.0||||||
4334367|NCT00432809|4161605|B2|No||History of hypertension||participants|Number|15|15.0||||||
4334368|NCT00432809|4161606|B1|No||History of hypertension||participants|Number|24|24.0||||||
4334369|NCT00432809|4161603|B4|Yes||History of hypertension||participants|Number|91|91.0||||||
4334370|NCT00432809|4161604|B3|Yes||History of hypertension||participants|Number|30|30.0||||||
4334371|NCT00432809|4161605|B2|Yes||History of hypertension||participants|Number|35|35.0||||||
4334372|NCT00432809|4161606|B1|Yes||History of hypertension||participants|Number|26|26.0||||||
4334373|NCT00432809|4161603|B4|No||History of dyslipidemia||participants|Number|30|30.0||||||
4334374|NCT00432809|4161604|B3|No||History of dyslipidemia||participants|Number|10|10.0||||||
4334375|NCT00432809|4161605|B2|No||History of dyslipidemia||participants|Number|6|6.0||||||
4334376|NCT00432809|4161606|B1|No||History of dyslipidemia||participants|Number|14|14.0||||||
4334377|NCT00432809|4161603|B4|Yes||History of dyslipidemia||participants|Number|120|120.0||||||
4334378|NCT00432809|4161604|B3|Yes||History of dyslipidemia||participants|Number|40|40.0||||||
4334379|NCT00432809|4161605|B2|Yes||History of dyslipidemia||participants|Number|44|44.0||||||
4334380|NCT00432809|4161606|B1|Yes||History of dyslipidemia||participants|Number|36|36.0||||||
4334381|NCT00432809|4161603|B4|No||Metabolic syndrome||participants|Number|12|12.0||||||
4334382|NCT00432809|4161604|B3|No||Metabolic syndrome||participants|Number|3|3.0||||||
4334383|NCT00432809|4161605|B2|No||Metabolic syndrome||participants|Number|5|5.0||||||
4334384|NCT00432809|4161606|B1|No||Metabolic syndrome||participants|Number|4|4.0||||||
4334385|NCT00432809|4161603|B4|Yes||Metabolic syndrome||participants|Number|138|138.0||||||
4334386|NCT00432809|4161604|B3|Yes||Metabolic syndrome||participants|Number|47|47.0||||||
4334387|NCT00432809|4161605|B2|Yes||Metabolic syndrome||participants|Number|45|45.0||||||
4334388|NCT00432809|4161606|B1|Yes||Metabolic syndrome||participants|Number|46|46.0||||||
4334389|NCT00432809|4161603|B4|Non-smoker||Smoker||Participants|Number|104|104.0||||||
4334390|NCT00432809|4161604|B3|Non-smoker||Smoker||Participants|Number|39|39.0||||||
4334391|NCT00432809|4161605|B2|Non-smoker||Smoker||Participants|Number|30|30.0||||||
4334392|NCT00432809|4161606|B1|Non-smoker||Smoker||Participants|Number|35|35.0||||||
4334393|NCT00432809|4161603|B4|Smoker||Smoker||Participants|Number|46|46.0||||||
4334394|NCT00432809|4161604|B3|Smoker||Smoker||Participants|Number|11|11.0||||||
4334395|NCT00432809|4161605|B2|Smoker||Smoker||Participants|Number|20|20.0||||||
4334396|NCT00432809|4161606|B1|Smoker||Smoker||Participants|Number|15|15.0||||||
4334397|NCT00432809|4161603|B4|||Fasting glucose||mg/dL|Mean|178.7|178.7|Standard Deviation|65.9|65.9|||
4334398|NCT00432809|4161604|B3|||Fasting glucose||mg/dL|Mean|177.6|177.6|Standard Deviation|70.3|70.3|||
4334399|NCT00432809|4161605|B2|||Fasting glucose||mg/dL|Mean|188.9|188.9|Standard Deviation|67.6|67.6|||
4334400|NCT00432809|4161606|B1|||Fasting glucose||mg/dL|Mean|169.6|169.6|Standard Deviation|59.1|59.1|||
4334401|NCT00432809|4161603|B4|||Waist circumference||cm|Mean|115.0|115.0|Standard Deviation|9.7|9.7|||
4334402|NCT00432809|4161604|B3|||Waist circumference||cm|Mean|114.0|114.0|Standard Deviation|10.4|10.4|||
4334403|NCT00432809|4161605|B2|||Waist circumference||cm|Mean|116.4|116.4|Standard Deviation|9.2|9.2|||
4334404|NCT00432809|4161606|B1|||Waist circumference||cm|Mean|114.5|114.5|Standard Deviation|9.4|9.4|||
4334405|NCT00432809|4161603|B4|||Body weight||kg|Mean|104.6|104.6|Standard Deviation|15.4|15.4|||
4334406|NCT00432809|4161604|B3|||Body weight||kg|Mean|100.8|100.8|Standard Deviation|16.4|16.4|||
4334407|NCT00432809|4161605|B2|||Body weight||kg|Mean|106.7|106.7|Standard Deviation|14.8|14.8|||
4334408|NCT00432809|4161606|B1|||Body weight||kg|Mean|106.5|106.5|Standard Deviation|14.7|14.7|||
4334409|NCT00432809|4161603|B4|BMI > / = 35||Body-mass index < 35||participants|Number|99|99.0||||||
4334410|NCT00432809|4161604|B3|BMI > / = 35||Body-mass index < 35||participants|Number|32|32.0||||||
4334411|NCT00432809|4161605|B2|BMI > / = 35||Body-mass index < 35||participants|Number|36|36.0||||||
4334412|NCT00432809|4161606|B1|BMI > / = 35||Body-mass index < 35||participants|Number|31|31.0||||||
4334413|NCT00432809|4161603|B4|BMI < 35||Body-mass index < 35||participants|Number|51|51.0||||||
4334414|NCT00432809|4161604|B3|BMI < 35||Body-mass index < 35||participants|Number|18|18.0||||||
4334415|NCT00432809|4161605|B2|BMI < 35||Body-mass index < 35||participants|Number|14|14.0||||||
4334416|NCT00432809|4161606|B1|BMI < 35||Body-mass index < 35||participants|Number|19|19.0||||||
4334417|NCT00432809|4161603|B4|||body-mass index||kg/m2|Mean|36.7|36.7|Standard Deviation|3.4|3.4|||
4334418|NCT00432809|4161604|B3|||body-mass index||kg/m2|Mean|36.2|36.2|Standard Deviation|3.9|3.9|||
4334419|NCT00432809|4161605|B2|||body-mass index||kg/m2|Mean|37.0|37.0|Standard Deviation|3.3|3.3|||
4334420|NCT00432809|4161606|B1|||body-mass index||kg/m2|Mean|36.8|36.8|Standard Deviation|3.0|3.0|||
4334421|NCT00432809|4161603|B4|Non-insulin dependent||Use of insulin||participants|Number|84|84.0||||||
4334422|NCT00432809|4161604|B3|Non-insulin dependent||Use of insulin||participants|Number|28|28.0||||||
4334423|NCT00432809|4161605|B2|Non-insulin dependent||Use of insulin||participants|Number|28|28.0||||||
4334424|NCT00432809|4161606|B1|Non-insulin dependent||Use of insulin||participants|Number|28|28.0||||||
4334425|NCT00432809|4161603|B4|Insulin dependent||Use of insulin||participants|Number|66|66.0||||||
4334426|NCT00432809|4161604|B3|Insulin dependent||Use of insulin||participants|Number|22|22.0||||||
4334427|NCT00432809|4161605|B2|Insulin dependent||Use of insulin||participants|Number|22|22.0||||||
4334428|NCT00432809|4161606|B1|Insulin dependent||Use of insulin||participants|Number|22|22.0||||||
4334429|NCT00432809|4161603|B4|||Duration of diabetes||Years|Mean|8.5|8.5|Standard Deviation|5.4|5.4|||
4334430|NCT00432809|4161604|B3|||Duration of diabetes||Years|Mean|8.5|8.5|Standard Deviation|4.8|4.8|||
4334431|NCT00432809|4161605|B2|||Duration of diabetes||Years|Mean|8.2|8.2|Standard Deviation|5.5|5.5|||
4334432|NCT00432809|4161606|B1|||Duration of diabetes||Years|Mean|8.9|8.9|Standard Deviation|5.8|5.8|||
4334433|NCT00432809|4161603|B4|United States||Region of Enrollment||participants|Number|150|150.0||||||
4334434|NCT00432809|4161604|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4334435|NCT00432809|4161605|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
4334436|NCT00432809|4161606|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4334437|NCT00432809|4161603|B4|Asian||Race/Ethnicity, Customized|Participants self reported race/ethnicity according to Caucasian, Black/African American, Asian, Hispanic/Latino, American Indian/Alaska Native, Pacific Islander, or Other.|participants|Number|1|1.0||||||
4334438|NCT00432809|4161604|B3|Asian||Race/Ethnicity, Customized|Participants self reported race/ethnicity according to Caucasian, Black/African American, Asian, Hispanic/Latino, American Indian/Alaska Native, Pacific Islander, or Other.|participants|Number|0|0.0||||||
4334439|NCT00432809|4161605|B2|Asian||Race/Ethnicity, Customized|Participants self reported race/ethnicity according to Caucasian, Black/African American, Asian, Hispanic/Latino, American Indian/Alaska Native, Pacific Islander, or Other.|participants|Number|0|0.0||||||
4334440|NCT00432809|4161606|B1|Asian||Race/Ethnicity, Customized|Participants self reported race/ethnicity according to Caucasian, Black/African American, Asian, Hispanic/Latino, American Indian/Alaska Native, Pacific Islander, or Other.|participants|Number|1|1.0||||||
4334441|NCT00432809|4161603|B4|Black/African American||Race/Ethnicity, Customized|Participants self reported race/ethnicity according to Caucasian, Black/African American, Asian, Hispanic/Latino, American Indian/Alaska Native, Pacific Islander, or Other.|participants|Number|39|39.0||||||
4334442|NCT00432809|4161604|B3|Black/African American||Race/Ethnicity, Customized|Participants self reported race/ethnicity according to Caucasian, Black/African American, Asian, Hispanic/Latino, American Indian/Alaska Native, Pacific Islander, or Other.|participants|Number|14|14.0||||||
4334443|NCT00432809|4161605|B2|Black/African American||Race/Ethnicity, Customized|Participants self reported race/ethnicity according to Caucasian, Black/African American, Asian, Hispanic/Latino, American Indian/Alaska Native, Pacific Islander, or Other.|participants|Number|13|13.0||||||
4334444|NCT00432809|4161606|B1|Black/African American||Race/Ethnicity, Customized|Participants self reported race/ethnicity according to Caucasian, Black/African American, Asian, Hispanic/Latino, American Indian/Alaska Native, Pacific Islander, or Other.|participants|Number|12|12.0||||||
4334445|NCT00432809|4161603|B4|Caucasian||Race/Ethnicity, Customized|Participants self reported race/ethnicity according to Caucasian, Black/African American, Asian, Hispanic/Latino, American Indian/Alaska Native, Pacific Islander, or Other.|participants|Number|110|110.0||||||
4334446|NCT00432809|4161604|B3|Caucasian||Race/Ethnicity, Customized|Participants self reported race/ethnicity according to Caucasian, Black/African American, Asian, Hispanic/Latino, American Indian/Alaska Native, Pacific Islander, or Other.|participants|Number|36|36.0||||||
4334447|NCT00432809|4161605|B2|Caucasian||Race/Ethnicity, Customized|Participants self reported race/ethnicity according to Caucasian, Black/African American, Asian, Hispanic/Latino, American Indian/Alaska Native, Pacific Islander, or Other.|participants|Number|37|37.0||||||
4334448|NCT00432809|4161606|B1|Caucasian||Race/Ethnicity, Customized|Participants self reported race/ethnicity according to Caucasian, Black/African American, Asian, Hispanic/Latino, American Indian/Alaska Native, Pacific Islander, or Other.|participants|Number|37|37.0||||||
4334449|NCT00432809|4161603|B4||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4334450|NCT00432809|4161604|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4334451|NCT00432809|4161605|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4334452|NCT00432809|4161606|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4334453|NCT00432809|4161603|B4||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4334454|NCT00432809|4161604|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4334455|NCT00432809|4161605|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4334456|NCT00432809|4161606|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4334457|NCT00432809|4161603|B4|||Age||years|Mean|48.6|48.6|Standard Deviation|7.9|7.9|||
4334458|NCT00432809|4161604|B3|||Age||years|Mean|47.9|47.9|Standard Deviation|8.0|8.0|||
4334459|NCT00432809|4161605|B2|||Age||years|Mean|48.3|48.3|Standard Deviation|8.4|8.4|||
4334460|NCT00432809|4161606|B1|||Age||years|Mean|49.7|49.7|Standard Deviation|7.4|7.4|||
4334461|NCT00432809|4161603|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4334462|NCT00432809|4161604|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4334463|NCT00432809|4161605|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4334464|NCT00432809|4161606|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4334465|NCT00432809|4161603|B4||Between 18 and 65 years|Age||Participants|Count of Participants|150|150.0||||||
4334466|NCT00432809|4161604|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4334467|NCT00432809|4161605|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4334468|NCT00432809|4161606|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4334469|NCT00432809|4161603|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4334470|NCT00432809|4161604|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4334471|NCT00432809|4161605|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4334472|NCT00432809|4161606|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4334473|NCT00432744|4161679|B3|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4334474|NCT00432744|4161680|B2|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4334475|NCT00432744|4161681|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4334476|NCT00432744|4161679|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4334477|NCT00432744|4161680|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4334478|NCT00432744|4161681|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4334479|NCT00432744|4161679|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4334480|NCT00432744|4161680|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4334481|NCT00432744|4161681|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4334482|NCT00432744|4161679|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4334483|NCT00432744|4161680|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4334484|NCT00432744|4161681|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4334485|NCT00432744|4161679|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4334486|NCT00432744|4161680|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4334487|NCT00432744|4161681|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4334488|NCT00432744|4161679|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4334489|NCT00432744|4161680|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4334490|NCT00432744|4161681|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4334491|NCT00432744|4161679|B3||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
4334492|NCT00432744|4161680|B2||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4334493|NCT00432744|4161681|B1||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4334494|NCT00432744|4161679|B3|||Age||years|Mean|8.3|8.3|Standard Deviation|5.4|5.4|||
4334495|NCT00432744|4161680|B2|||Age||years|Mean|7.5|7.5|Standard Deviation|4.5|4.5|||
4334496|NCT00432744|4161681|B1|||Age||years|Mean|9.0|9.0|Standard Deviation|6.3|6.3|||
4334497|NCT00432666|4161692|B3||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4334498|NCT00432666|4161693|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4334499|NCT00432666|4161694|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4334500|NCT00432666|4161692|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4334501|NCT00432666|4161693|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4334502|NCT00432666|4161694|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4334503|NCT00432666|4161692|B3|||Age||years|Mean|55.6|55.6|Standard Deviation|12.1|12.1|||
4334504|NCT00432666|4161693|B2|||Age||years|Mean|53.3|53.3|Standard Deviation|13.3|13.3|||
4334505|NCT00432666|4161694|B1|||Age||years|Mean|58.1|58.1|Standard Deviation|10.2|10.2|||
4334506|NCT00432601|4161857|B3||Male|Sex: Female, Male||Participants|Count of Participants|1022|1022.0||||||
4334507|NCT00432601|4161858|B2||Male|Sex: Female, Male||Participants|Count of Participants|512|512.0||||||
4334508|NCT00432601|4161859|B1||Male|Sex: Female, Male||Participants|Count of Participants|510|510.0||||||
4334509|NCT00432601|4161857|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4334510|NCT00432601|4161858|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4334511|NCT00432601|4161859|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4334512|NCT00432601|4161857|B3|||Age||years|Mean|63.28|63.28|Standard Deviation|5.94|5.94|||
4334513|NCT00432601|4161858|B2|||Age||years|Mean|63.14|63.14|Standard Deviation|6.02|6.02|||
4334514|NCT00432601|4161859|B1|||Age||years|Mean|63.41|63.41|Standard Deviation|5.86|5.86|||
4334515|NCT00432562|4161866|B3|Argentina||Region of Enrollment||participants|Number|31|31.0||||||
4334516|NCT00432562|4161867|B2|Argentina||Region of Enrollment||participants|Number|15|15.0||||||
4334517|NCT00432562|4161868|B1|Argentina||Region of Enrollment||participants|Number|16|16.0||||||
4334518|NCT00432562|4161866|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4334519|NCT00432562|4161867|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4334520|NCT00432562|4161868|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4334521|NCT00432562|4161866|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4334522|NCT00432562|4161867|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4334523|NCT00432562|4161868|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4334524|NCT00432562|4161866|B3|||Age||years|Mean|60.2|60.2|Standard Deviation|13.00|13.0|||
4334525|NCT00432562|4161867|B2|||Age||years|Mean|58.0|58.0|Standard Deviation|13.34|13.34|||
4334526|NCT00432562|4161868|B1|||Age||years|Mean|62.2|62.2|Standard Deviation|12.77|12.77|||
4334527|NCT00432562|4161866|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4334528|NCT00432562|4161867|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4334529|NCT00432562|4161868|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4334530|NCT00432562|4161866|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4334531|NCT00432562|4161867|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4334532|NCT00432562|4161868|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4334533|NCT00432562|4161866|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4334534|NCT00432562|4161867|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4334535|NCT00432562|4161868|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4334536|NCT00432458|4161893|B3|Not Done||Peripheral blood circulating plasma cells|Peripheral blood circulating plasma cells are cells which live outside of the bone marrow.|participants|Number|2|2.0||||||
4334537|NCT00432458|4161894|B2|Not Done||Peripheral blood circulating plasma cells|Peripheral blood circulating plasma cells are cells which live outside of the bone marrow.|participants|Number|1|1.0||||||
4334538|NCT00432458|4161895|B1|Not Done||Peripheral blood circulating plasma cells|Peripheral blood circulating plasma cells are cells which live outside of the bone marrow.|participants|Number|1|1.0||||||
4334539|NCT00432458|4161893|B3|Not Applicable||Peripheral blood circulating plasma cells|Peripheral blood circulating plasma cells are cells which live outside of the bone marrow.|participants|Number|1|1.0||||||
4334540|NCT00432458|4161894|B2|Not Applicable||Peripheral blood circulating plasma cells|Peripheral blood circulating plasma cells are cells which live outside of the bone marrow.|participants|Number|0|0.0||||||
4334541|NCT00432458|4161895|B1|Not Applicable||Peripheral blood circulating plasma cells|Peripheral blood circulating plasma cells are cells which live outside of the bone marrow.|participants|Number|1|1.0||||||
4334542|NCT00432458|4161893|B3|No||Peripheral blood circulating plasma cells|Peripheral blood circulating plasma cells are cells which live outside of the bone marrow.|participants|Number|38|38.0||||||
4334543|NCT00432458|4161894|B2|No||Peripheral blood circulating plasma cells|Peripheral blood circulating plasma cells are cells which live outside of the bone marrow.|participants|Number|18|18.0||||||
4334544|NCT00432458|4161895|B1|No||Peripheral blood circulating plasma cells|Peripheral blood circulating plasma cells are cells which live outside of the bone marrow.|participants|Number|20|20.0||||||
4334545|NCT00432458|4161893|B3|Yes||Peripheral blood circulating plasma cells|Peripheral blood circulating plasma cells are cells which live outside of the bone marrow.|participants|Number|27|27.0||||||
4334546|NCT00432458|4161894|B2|Yes||Peripheral blood circulating plasma cells|Peripheral blood circulating plasma cells are cells which live outside of the bone marrow.|participants|Number|14|14.0||||||
4334547|NCT00432458|4161895|B1|Yes||Peripheral blood circulating plasma cells|Peripheral blood circulating plasma cells are cells which live outside of the bone marrow.|participants|Number|13|13.0||||||
4334548|NCT00432458|4161893|B3|>= lower limit of normal||Anemia|The lower limit of normal (LLN) is institution specific, typically about 13.5 g/dL for males and 12.0 g/dL for females.|participants|Number|36|36.0||||||
4334549|NCT00432458|4161894|B2|>= lower limit of normal||Anemia|The lower limit of normal (LLN) is institution specific, typically about 13.5 g/dL for males and 12.0 g/dL for females.|participants|Number|15|15.0||||||
4334550|NCT00432458|4161895|B1|>= lower limit of normal||Anemia|The lower limit of normal (LLN) is institution specific, typically about 13.5 g/dL for males and 12.0 g/dL for females.|participants|Number|21|21.0||||||
4334551|NCT00432458|4161893|B3|< lower limit of normal||Anemia|The lower limit of normal (LLN) is institution specific, typically about 13.5 g/dL for males and 12.0 g/dL for females.|participants|Number|32|32.0||||||
4334552|NCT00432458|4161894|B2|< lower limit of normal||Anemia|The lower limit of normal (LLN) is institution specific, typically about 13.5 g/dL for males and 12.0 g/dL for females.|participants|Number|18|18.0||||||
4334553|NCT00432458|4161895|B1|< lower limit of normal||Anemia|The lower limit of normal (LLN) is institution specific, typically about 13.5 g/dL for males and 12.0 g/dL for females.|participants|Number|14|14.0||||||
4334554|NCT00432458|4161893|B3|Not Applicable||Bone Marrow Labeling Index|The labeling index indicates how fast the cancer cells are growing. This test is done in specialized labs, using myeloma cells from bone marrow samples. A high labeling index can predict a more rapid accumulation of cancer cells and a worse outlook.|participants|Number|1|1.0||||||
4334555|NCT00432458|4161894|B2|Not Applicable||Bone Marrow Labeling Index|The labeling index indicates how fast the cancer cells are growing. This test is done in specialized labs, using myeloma cells from bone marrow samples. A high labeling index can predict a more rapid accumulation of cancer cells and a worse outlook.|participants|Number|0|0.0||||||
4334556|NCT00432458|4161895|B1|Not Applicable||Bone Marrow Labeling Index|The labeling index indicates how fast the cancer cells are growing. This test is done in specialized labs, using myeloma cells from bone marrow samples. A high labeling index can predict a more rapid accumulation of cancer cells and a worse outlook.|participants|Number|1|1.0||||||
4334557|NCT00432458|4161893|B3|Low (<= 1.0%)||Bone Marrow Labeling Index|The labeling index indicates how fast the cancer cells are growing. This test is done in specialized labs, using myeloma cells from bone marrow samples. A high labeling index can predict a more rapid accumulation of cancer cells and a worse outlook.|participants|Number|61|61.0||||||
4334558|NCT00432458|4161894|B2|Low (<= 1.0%)||Bone Marrow Labeling Index|The labeling index indicates how fast the cancer cells are growing. This test is done in specialized labs, using myeloma cells from bone marrow samples. A high labeling index can predict a more rapid accumulation of cancer cells and a worse outlook.|participants|Number|30|30.0||||||
4334559|NCT00432458|4161895|B1|Low (<= 1.0%)||Bone Marrow Labeling Index|The labeling index indicates how fast the cancer cells are growing. This test is done in specialized labs, using myeloma cells from bone marrow samples. A high labeling index can predict a more rapid accumulation of cancer cells and a worse outlook.|participants|Number|31|31.0||||||
4334560|NCT00432458|4161893|B3|High (> 1.0%)||Bone Marrow Labeling Index|The labeling index indicates how fast the cancer cells are growing. This test is done in specialized labs, using myeloma cells from bone marrow samples. A high labeling index can predict a more rapid accumulation of cancer cells and a worse outlook.|participants|Number|6|6.0||||||
4334561|NCT00432458|4161894|B2|High (> 1.0%)||Bone Marrow Labeling Index|The labeling index indicates how fast the cancer cells are growing. This test is done in specialized labs, using myeloma cells from bone marrow samples. A high labeling index can predict a more rapid accumulation of cancer cells and a worse outlook.|participants|Number|3|3.0||||||
4334562|NCT00432458|4161895|B1|High (> 1.0%)||Bone Marrow Labeling Index|The labeling index indicates how fast the cancer cells are growing. This test is done in specialized labs, using myeloma cells from bone marrow samples. A high labeling index can predict a more rapid accumulation of cancer cells and a worse outlook.|participants|Number|3|3.0||||||
4334563|NCT00432458|4161893|B3|Not Present||Lytic Bone Lesions||participants|Number|64|64.0||||||
4334564|NCT00432458|4161894|B2|Not Present||Lytic Bone Lesions||participants|Number|31|31.0||||||
4334565|NCT00432458|4161895|B1|Not Present||Lytic Bone Lesions||participants|Number|33|33.0||||||
4334566|NCT00432458|4161893|B3|Present||Lytic Bone Lesions||participants|Number|4|4.0||||||
4334567|NCT00432458|4161894|B2|Present||Lytic Bone Lesions||participants|Number|2|2.0||||||
4334568|NCT00432458|4161895|B1|Present||Lytic Bone Lesions||participants|Number|2|2.0||||||
4334569|NCT00432458|4161893|B3|Normal (<= upper limit of normal)||Beta-2 Microglobulin|The upper limit of normal for Beta-2 microglobulin was 1.80 mcg/mL.|participants|Number|13|13.0||||||
4334570|NCT00432458|4161894|B2|Normal (<= upper limit of normal)||Beta-2 Microglobulin|The upper limit of normal for Beta-2 microglobulin was 1.80 mcg/mL.|participants|Number|7|7.0||||||
4334571|NCT00432458|4161895|B1|Normal (<= upper limit of normal)||Beta-2 Microglobulin|The upper limit of normal for Beta-2 microglobulin was 1.80 mcg/mL.|participants|Number|6|6.0||||||
4334572|NCT00432458|4161893|B3|High (> upper limit of normal)||Beta-2 Microglobulin|The upper limit of normal for Beta-2 microglobulin was 1.80 mcg/mL.|participants|Number|55|55.0||||||
4334573|NCT00432458|4161894|B2|High (> upper limit of normal)||Beta-2 Microglobulin|The upper limit of normal for Beta-2 microglobulin was 1.80 mcg/mL.|participants|Number|26|26.0||||||
4334574|NCT00432458|4161895|B1|High (> upper limit of normal)||Beta-2 Microglobulin|The upper limit of normal for Beta-2 microglobulin was 1.80 mcg/mL.|participants|Number|29|29.0||||||
4334575|NCT00432458|4161893|B3|United States||Region of Enrollment||participants|Number|68|68.0||||||
4334576|NCT00432458|4161894|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4334577|NCT00432458|4161895|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4334578|NCT00432458|4161893|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4334579|NCT00432458|4161894|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4334580|NCT00432458|4161895|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4334581|NCT00432458|4161893|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4334582|NCT00432458|4161894|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4334583|NCT00432458|4161895|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4334584|NCT00432458|4161893|B3|||Age||years|Median|63|63.0|Full Range|||47.0|84.0|
4334585|NCT00432458|4161894|B2|||Age||years|Median|63|63.0|Full Range|||47.0|80.0|
4334586|NCT00432458|4161895|B1|||Age||years|Median|63|63.0|Full Range|||47.0|84.0|
4334587|NCT00432445|4161914|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4334588|NCT00432445|4161914|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4334589|NCT00432445|4161914|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4334590|NCT00432445|4161914|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4334591|NCT00432445|4161914|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4334592|NCT00432445|4161914|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4334593|NCT00432380|4161918|B4||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4334594|NCT00432380|4161919|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4334595|NCT00432380|4161920|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4334596|NCT00432380|4161921|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4334597|NCT00432380|4161918|B4||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4334598|NCT00432380|4161919|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4334599|NCT00432380|4161920|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4334600|NCT00432380|4161921|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4334601|NCT00432380|4161918|B4|||Age||Weeks|Mean|6.56|6.56|Standard Deviation|1.02|1.02|||
4334602|NCT00432380|4161919|B3|||Age||Weeks|Mean|6.6|6.6|Standard Deviation|1.02|1.02|||
4334603|NCT00432380|4161920|B2|||Age||Weeks|Mean|6.5|6.5|Standard Deviation|1|1.0|||
4334604|NCT00432380|4161921|B1|||Age||Weeks|Mean|6.6|6.6|Standard Deviation|1.07|1.07|||
4334605|NCT00432341|4161947|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4334606|NCT00432341|4161948|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4334607|NCT00432341|4161949|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4334608|NCT00432341|4161947|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4334609|NCT00432341|4161948|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4334610|NCT00432341|4161949|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4334611|NCT00432341|4161947|B3|||Age||years|Mean|46.4|46.4|Standard Deviation|13.3|13.3|||
4334612|NCT00432341|4161948|B2|||Age||years|Mean|49.9|49.9|Standard Deviation|12.6|12.6|||
4334613|NCT00432341|4161949|B1|||Age||years|Mean|42.0|42.0|Standard Deviation|13.1|13.1|||
4334614|NCT00432276|4161974|B3|≥8.0%||HbA1c|HbA1c category is based on HbA1c value used in randomization for stratification.|participants|Number|479|479.0||||||
4334615|NCT00432276|4161975|B2|≥8.0%||HbA1c|HbA1c category is based on HbA1c value used in randomization for stratification.|participants|Number|236|236.0||||||
4334616|NCT00432276|4161976|B1|≥8.0%||HbA1c|HbA1c category is based on HbA1c value used in randomization for stratification.|participants|Number|243|243.0||||||
4334617|NCT00432276|4161974|B3|<8.0%||HbA1c|HbA1c category is based on HbA1c value used in randomization for stratification.|participants|Number|324|324.0||||||
4334618|NCT00432276|4161975|B2|<8.0%||HbA1c|HbA1c category is based on HbA1c value used in randomization for stratification.|participants|Number|163|163.0||||||
4334619|NCT00432276|4161976|B1|<8.0%||HbA1c|HbA1c category is based on HbA1c value used in randomization for stratification.|participants|Number|161|161.0||||||
4334620|NCT00432276|4161974|B3|No||Current smoker||participants|Number|604|604.0||||||
4334621|NCT00432276|4161975|B2|No||Current smoker||participants|Number|300|300.0||||||
4334622|NCT00432276|4161976|B1|No||Current smoker||participants|Number|304|304.0||||||
4334623|NCT00432276|4161974|B3|Yes||Current smoker||participants|Number|199|199.0||||||
4334624|NCT00432276|4161975|B2|Yes||Current smoker||participants|Number|99|99.0||||||
4334625|NCT00432276|4161976|B1|Yes||Current smoker||participants|Number|100|100.0||||||
4334626|NCT00432276|4161974|B3|||Baseline daily metformin HCl use||mg|Median|1700.0|1700.0|Full Range|||500.0|3400.0|
4334627|NCT00432276|4161975|B2|||Baseline daily metformin HCl use||mg|Median|1700.0|1700.0|Full Range|||500.0|3000.0|
4334628|NCT00432276|4161976|B1|||Baseline daily metformin HCl use||mg|Median|1700.0|1700.0|Full Range|||500.0|3400.0|
4334629|NCT00432276|4161974|B3|||Duration of diabetes||years|Mean|7.16|7.16|Standard Deviation|4.946|4.946|||
4334630|NCT00432276|4161975|B2|||Duration of diabetes||years|Mean|6.85|6.85|Standard Deviation|4.611|4.611|||
4334631|NCT00432276|4161976|B1|||Duration of diabetes||years|Mean|7.47|7.47|Standard Deviation|5.243|5.243|||
4334632|NCT00432276|4161974|B3|||BMI||kg/m^2|Mean|31.55|31.55|Standard Deviation|5.210|5.21|||
4334633|NCT00432276|4161975|B2|||BMI||kg/m^2|Mean|31.58|31.58|Standard Deviation|5.177|5.177|||
4334634|NCT00432276|4161976|B1|||BMI||kg/m^2|Mean|31.52|31.52|Standard Deviation|5.248|5.248|||
4334635|NCT00432276|4161974|B3|||Weight||kg|Mean|88.07|88.07|Standard Deviation|19.078|19.078|||
4334636|NCT00432276|4161975|B2|||Weight||kg|Mean|87.98|87.98|Standard Deviation|19.283|19.283|||
4334637|NCT00432276|4161976|B1|||Weight||kg|Mean|88.16|88.16|Standard Deviation|18.898|18.898|||
4334638|NCT00432276|4161974|B3|||Height||cm|Mean|166.60|166.6|Standard Deviation|10.375|10.375|||
4334639|NCT00432276|4161975|B2|||Height||cm|Mean|166.37|166.37|Standard Deviation|10.856|10.856|||
4334640|NCT00432276|4161976|B1|||Height||cm|Mean|166.82|166.82|Standard Deviation|9.884|9.884|||
4334641|NCT00432276|4161974|B3|Other||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
4334642|NCT00432276|4161975|B2|Other||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4334643|NCT00432276|4161976|B1|Other||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4334644|NCT00432276|4161974|B3|White||Race/Ethnicity, Customized||participants|Number|498|498.0||||||
4334645|NCT00432276|4161975|B2|White||Race/Ethnicity, Customized||participants|Number|256|256.0||||||
4334646|NCT00432276|4161976|B1|White||Race/Ethnicity, Customized||participants|Number|242|242.0||||||
4334647|NCT00432276|4161974|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4334648|NCT00432276|4161975|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4334649|NCT00432276|4161976|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4334650|NCT00432276|4161974|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
4334651|NCT00432276|4161975|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4334652|NCT00432276|4161976|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4334653|NCT00432276|4161974|B3|Asian||Race/Ethnicity, Customized||participants|Number|157|157.0||||||
4334654|NCT00432276|4161975|B2|Asian||Race/Ethnicity, Customized||participants|Number|78|78.0||||||
4334655|NCT00432276|4161976|B1|Asian||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
4334656|NCT00432276|4161974|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4334657|NCT00432276|4161975|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4334658|NCT00432276|4161976|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4334659|NCT00432276|4161974|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4334660|NCT00432276|4161975|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4334661|NCT00432276|4161976|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4334662|NCT00432276|4161974|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|742|742.0||||||
4334663|NCT00432276|4161975|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|368|368.0||||||
4334664|NCT00432276|4161976|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|374|374.0||||||
4334665|NCT00432276|4161974|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4334666|NCT00432276|4161975|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4334667|NCT00432276|4161976|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4334668|NCT00432276|4161974|B3||Male|Sex: Female, Male||Participants|Count of Participants|414|414.0||||||
4334669|NCT00432276|4161975|B2||Male|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4334670|NCT00432276|4161976|B1||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4334671|NCT00432276|4161974|B3||Female|Sex: Female, Male||Participants|Count of Participants|389|389.0||||||
4334672|NCT00432276|4161975|B2||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4334673|NCT00432276|4161976|B1||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4334674|NCT00432276|4161974|B3|≥65 years||Age, Customized||participants|Number|144|144.0||||||
4334675|NCT00432276|4161975|B2|≥65 years||Age, Customized||participants|Number|79|79.0||||||
4334676|NCT00432276|4161976|B1|≥65 years||Age, Customized||participants|Number|65|65.0||||||
4334677|NCT00432276|4161974|B3|<65 years||Age, Customized||participants|Number|659|659.0||||||
4334678|NCT00432276|4161975|B2|<65 years||Age, Customized||participants|Number|320|320.0||||||
4334679|NCT00432276|4161976|B1|<65 years||Age, Customized||participants|Number|339|339.0||||||
4334680|NCT00432276|4161974|B3|||Age||years|Mean|55.1|55.1|Standard Deviation|9.93|9.93|||
4334681|NCT00432276|4161975|B2|||Age||years|Mean|55.9|55.9|Standard Deviation|9.94|9.94|||
4334682|NCT00432276|4161976|B1|||Age||years|Mean|54.3|54.3|Standard Deviation|9.86|9.86|||
4334683|NCT00432237|4162063|B5|Baseline Severity missing||Baseline Severity|Baseline severity was self-reported by the patient and recorded in the take-home diary. Patients were instructed not to dose until they had experienced either a moderate or severe migraine, with migraine pain rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3). Baseline Characteristics are for the subset of randomized patients who were treated.|Participants|Number|1|1.0||||||
4334684|NCT00432237|4162064|B4|Baseline Severity missing||Baseline Severity|Baseline severity was self-reported by the patient and recorded in the take-home diary. Patients were instructed not to dose until they had experienced either a moderate or severe migraine, with migraine pain rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3). Baseline Characteristics are for the subset of randomized patients who were treated.|Participants|Number|0|0.0||||||
4334685|NCT00432237|4162065|B3|Baseline Severity missing||Baseline Severity|Baseline severity was self-reported by the patient and recorded in the take-home diary. Patients were instructed not to dose until they had experienced either a moderate or severe migraine, with migraine pain rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3). Baseline Characteristics are for the subset of randomized patients who were treated.|Participants|Number|1|1.0||||||
4334686|NCT00432237|4162066|B2|Baseline Severity missing||Baseline Severity|Baseline severity was self-reported by the patient and recorded in the take-home diary. Patients were instructed not to dose until they had experienced either a moderate or severe migraine, with migraine pain rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3). Baseline Characteristics are for the subset of randomized patients who were treated.|Participants|Number|0|0.0||||||
4334687|NCT00432237|4162067|B1|Baseline Severity missing||Baseline Severity|Baseline severity was self-reported by the patient and recorded in the take-home diary. Patients were instructed not to dose until they had experienced either a moderate or severe migraine, with migraine pain rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3). Baseline Characteristics are for the subset of randomized patients who were treated.|Participants|Number|0|0.0||||||
4334688|NCT00432237|4162063|B5|Severe||Baseline Severity|Baseline severity was self-reported by the patient and recorded in the take-home diary. Patients were instructed not to dose until they had experienced either a moderate or severe migraine, with migraine pain rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3). Baseline Characteristics are for the subset of randomized patients who were treated.|Participants|Number|459|459.0||||||
4334689|NCT00432237|4162064|B4|Severe||Baseline Severity|Baseline severity was self-reported by the patient and recorded in the take-home diary. Patients were instructed not to dose until they had experienced either a moderate or severe migraine, with migraine pain rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3). Baseline Characteristics are for the subset of randomized patients who were treated.|Participants|Number|130|130.0||||||
4334690|NCT00432237|4162065|B3|Severe||Baseline Severity|Baseline severity was self-reported by the patient and recorded in the take-home diary. Patients were instructed not to dose until they had experienced either a moderate or severe migraine, with migraine pain rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3). Baseline Characteristics are for the subset of randomized patients who were treated.|Participants|Number|133|133.0||||||
4334691|NCT00432237|4162066|B2|Severe||Baseline Severity|Baseline severity was self-reported by the patient and recorded in the take-home diary. Patients were instructed not to dose until they had experienced either a moderate or severe migraine, with migraine pain rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3). Baseline Characteristics are for the subset of randomized patients who were treated.|Participants|Number|127|127.0||||||
4334692|NCT00432237|4162067|B1|Severe||Baseline Severity|Baseline severity was self-reported by the patient and recorded in the take-home diary. Patients were instructed not to dose until they had experienced either a moderate or severe migraine, with migraine pain rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3). Baseline Characteristics are for the subset of randomized patients who were treated.|Participants|Number|69|69.0||||||
4334693|NCT00432237|4162063|B5|Moderate||Baseline Severity|Baseline severity was self-reported by the patient and recorded in the take-home diary. Patients were instructed not to dose until they had experienced either a moderate or severe migraine, with migraine pain rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3). Baseline Characteristics are for the subset of randomized patients who were treated.|Participants|Number|834|834.0||||||
4334694|NCT00432237|4162064|B4|Moderate||Baseline Severity|Baseline severity was self-reported by the patient and recorded in the take-home diary. Patients were instructed not to dose until they had experienced either a moderate or severe migraine, with migraine pain rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3). Baseline Characteristics are for the subset of randomized patients who were treated.|Participants|Number|235|235.0||||||
4334695|NCT00432237|4162065|B3|Moderate||Baseline Severity|Baseline severity was self-reported by the patient and recorded in the take-home diary. Patients were instructed not to dose until they had experienced either a moderate or severe migraine, with migraine pain rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3). Baseline Characteristics are for the subset of randomized patients who were treated.|Participants|Number|237|237.0||||||
4334696|NCT00432237|4162066|B2|Moderate||Baseline Severity|Baseline severity was self-reported by the patient and recorded in the take-home diary. Patients were instructed not to dose until they had experienced either a moderate or severe migraine, with migraine pain rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3). Baseline Characteristics are for the subset of randomized patients who were treated.|Participants|Number|254|254.0||||||
4334697|NCT00432237|4162067|B1|Moderate||Baseline Severity|Baseline severity was self-reported by the patient and recorded in the take-home diary. Patients were instructed not to dose until they had experienced either a moderate or severe migraine, with migraine pain rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3). Baseline Characteristics are for the subset of randomized patients who were treated.|Participants|Number|108|108.0||||||
4334698|NCT00432237|4162063|B5|Missing||Race/Ethnicity, Customized|Baseline Characteristics are for the subset of randomized patients who were treated|participants|Number|1|1.0||||||
4334699|NCT00432237|4162064|B4|Missing||Race/Ethnicity, Customized|Baseline Characteristics are for the subset of randomized patients who were treated|participants|Number|1|1.0||||||
4334700|NCT00432237|4162065|B3|Missing||Race/Ethnicity, Customized|Baseline Characteristics are for the subset of randomized patients who were treated|participants|Number|0|0.0||||||
4334701|NCT00432237|4162066|B2|Missing||Race/Ethnicity, Customized|Baseline Characteristics are for the subset of randomized patients who were treated|participants|Number|0|0.0||||||
4334702|NCT00432237|4162067|B1|Missing||Race/Ethnicity, Customized|Baseline Characteristics are for the subset of randomized patients who were treated|participants|Number|0|0.0||||||
4334703|NCT00432237|4162063|B5|Multi-Racial||Race/Ethnicity, Customized|Baseline Characteristics are for the subset of randomized patients who were treated|participants|Number|131|131.0||||||
4334704|NCT00432237|4162064|B4|Multi-Racial||Race/Ethnicity, Customized|Baseline Characteristics are for the subset of randomized patients who were treated|participants|Number|33|33.0||||||
4334705|NCT00432237|4162065|B3|Multi-Racial||Race/Ethnicity, Customized|Baseline Characteristics are for the subset of randomized patients who were treated|participants|Number|44|44.0||||||
4334706|NCT00432237|4162066|B2|Multi-Racial||Race/Ethnicity, Customized|Baseline Characteristics are for the subset of randomized patients who were treated|participants|Number|37|37.0||||||
4334707|NCT00432237|4162067|B1|Multi-Racial||Race/Ethnicity, Customized|Baseline Characteristics are for the subset of randomized patients who were treated|participants|Number|17|17.0||||||
4334708|NCT00432237|4162063|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Baseline Characteristics are for the subset of randomized patients who were treated|participants|Number|1|1.0||||||
4334709|NCT00432237|4162064|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Baseline Characteristics are for the subset of randomized patients who were treated|participants|Number|0|0.0||||||
4334710|NCT00432237|4162065|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Baseline Characteristics are for the subset of randomized patients who were treated|participants|Number|1|1.0||||||
4334711|NCT00432237|4162066|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Baseline Characteristics are for the subset of randomized patients who were treated|participants|Number|0|0.0||||||
4334712|NCT00432237|4162067|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Baseline Characteristics are for the subset of randomized patients who were treated|participants|Number|0|0.0||||||
4334713|NCT00432237|4162063|B5|American Indian or Alaska Native||Race/Ethnicity, Customized|Baseline Characteristics are for the subset of randomized patients who were treated|participants|Number|3|3.0||||||
4334714|NCT00432237|4162064|B4|American Indian or Alaska Native||Race/Ethnicity, Customized|Baseline Characteristics are for the subset of randomized patients who were treated|participants|Number|0|0.0||||||
4334715|NCT00432237|4162065|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|Baseline Characteristics are for the subset of randomized patients who were treated|participants|Number|0|0.0||||||
4334716|NCT00432237|4162066|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|Baseline Characteristics are for the subset of randomized patients who were treated|participants|Number|2|2.0||||||
4334717|NCT00432237|4162067|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Baseline Characteristics are for the subset of randomized patients who were treated|participants|Number|1|1.0||||||
4334718|NCT00432237|4162063|B5|Asian||Race/Ethnicity, Customized|Baseline Characteristics are for the subset of randomized patients who were treated|participants|Number|16|16.0||||||
4334719|NCT00432237|4162064|B4|Asian||Race/Ethnicity, Customized|Baseline Characteristics are for the subset of randomized patients who were treated|participants|Number|8|8.0||||||
4334720|NCT00432237|4162065|B3|Asian||Race/Ethnicity, Customized|Baseline Characteristics are for the subset of randomized patients who were treated|participants|Number|1|1.0||||||
4334721|NCT00432237|4162066|B2|Asian||Race/Ethnicity, Customized|Baseline Characteristics are for the subset of randomized patients who were treated|participants|Number|6|6.0||||||
4334722|NCT00432237|4162067|B1|Asian||Race/Ethnicity, Customized|Baseline Characteristics are for the subset of randomized patients who were treated|participants|Number|1|1.0||||||
4334723|NCT00432237|4162063|B5|Black||Race/Ethnicity, Customized|Baseline Characteristics are for the subset of randomized patients who were treated|participants|Number|69|69.0||||||
4334724|NCT00432237|4162064|B4|Black||Race/Ethnicity, Customized|Baseline Characteristics are for the subset of randomized patients who were treated|participants|Number|20|20.0||||||
4334725|NCT00432237|4162065|B3|Black||Race/Ethnicity, Customized|Baseline Characteristics are for the subset of randomized patients who were treated|participants|Number|23|23.0||||||
4334726|NCT00432237|4162066|B2|Black||Race/Ethnicity, Customized|Baseline Characteristics are for the subset of randomized patients who were treated|participants|Number|16|16.0||||||
4334727|NCT00432237|4162067|B1|Black||Race/Ethnicity, Customized|Baseline Characteristics are for the subset of randomized patients who were treated|participants|Number|10|10.0||||||
4334728|NCT00432237|4162063|B5|White||Race/Ethnicity, Customized|Baseline Characteristics are for the subset of randomized patients who were treated|participants|Number|1073|1073.0||||||
4334729|NCT00432237|4162064|B4|White||Race/Ethnicity, Customized|Baseline Characteristics are for the subset of randomized patients who were treated|participants|Number|303|303.0||||||
4334730|NCT00432237|4162065|B3|White||Race/Ethnicity, Customized|Baseline Characteristics are for the subset of randomized patients who were treated|participants|Number|302|302.0||||||
4334731|NCT00432237|4162066|B2|White||Race/Ethnicity, Customized|Baseline Characteristics are for the subset of randomized patients who were treated|participants|Number|320|320.0||||||
4334732|NCT00432237|4162067|B1|White||Race/Ethnicity, Customized|Baseline Characteristics are for the subset of randomized patients who were treated|participants|Number|148|148.0||||||
4334733|NCT00432237|4162063|B5||Male|Sex: Female, Male|Baseline Characteristics are for the subset of randomized patients who were treated|Participants|Count of Participants|171|171.0||||||
4334734|NCT00432237|4162064|B4||Male|Sex: Female, Male|Baseline Characteristics are for the subset of randomized patients who were treated|Participants|Count of Participants|47|47.0||||||
4334783|NCT00432159|4162113|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4334735|NCT00432237|4162065|B3||Male|Sex: Female, Male|Baseline Characteristics are for the subset of randomized patients who were treated|Participants|Count of Participants|51|51.0||||||
4334736|NCT00432237|4162066|B2||Male|Sex: Female, Male|Baseline Characteristics are for the subset of randomized patients who were treated|Participants|Count of Participants|52|52.0||||||
4334737|NCT00432237|4162067|B1||Male|Sex: Female, Male|Baseline Characteristics are for the subset of randomized patients who were treated|Participants|Count of Participants|21|21.0||||||
4334738|NCT00432237|4162063|B5||Female|Sex: Female, Male|Baseline Characteristics are for the subset of randomized patients who were treated|Participants|Count of Participants|1123|1123.0||||||
4334739|NCT00432237|4162064|B4||Female|Sex: Female, Male|Baseline Characteristics are for the subset of randomized patients who were treated|Participants|Count of Participants|318|318.0||||||
4334740|NCT00432237|4162065|B3||Female|Sex: Female, Male|Baseline Characteristics are for the subset of randomized patients who were treated|Participants|Count of Participants|320|320.0||||||
4334741|NCT00432237|4162066|B2||Female|Sex: Female, Male|Baseline Characteristics are for the subset of randomized patients who were treated|Participants|Count of Participants|329|329.0||||||
4334742|NCT00432237|4162067|B1||Female|Sex: Female, Male|Baseline Characteristics are for the subset of randomized patients who were treated|Participants|Count of Participants|156|156.0||||||
4334743|NCT00432237|4162063|B5|||Age|Baseline Characteristics are for the subset of randomized patients who were treated|years|Mean|41.7|41.7|Standard Deviation|11.5|11.5|||
4334744|NCT00432237|4162064|B4|||Age|Baseline Characteristics are for the subset of randomized patients who were treated|years|Mean|41.9|41.9|Standard Deviation|11.9|11.9|||
4334745|NCT00432237|4162065|B3|||Age|Baseline Characteristics are for the subset of randomized patients who were treated|years|Mean|41.8|41.8|Standard Deviation|11.6|11.6|||
4334746|NCT00432237|4162066|B2|||Age|Baseline Characteristics are for the subset of randomized patients who were treated|years|Mean|41.6|41.6|Standard Deviation|11.0|11.0|||
4334747|NCT00432237|4162067|B1|||Age|Baseline Characteristics are for the subset of randomized patients who were treated|years|Mean|41.4|41.4|Standard Deviation|11.3|11.3|||
4334748|NCT00432159|4162108|B6|||BMI|Body Mass Index in units of kilogram per meter squared|kg/m^2|Mean|28.3|28.3|Standard Deviation|4.9|4.9|||
4334749|NCT00432159|4162109|B5|||BMI|Body Mass Index in units of kilogram per meter squared|kg/m^2|Mean|28.9|28.9|Standard Deviation|5.12|5.12|||
4334750|NCT00432159|4162110|B4|||BMI|Body Mass Index in units of kilogram per meter squared|kg/m^2|Mean|30.0|30.0|Standard Deviation|3.61|3.61|||
4334751|NCT00432159|4162111|B3|||BMI|Body Mass Index in units of kilogram per meter squared|kg/m^2|Mean|28.3|28.3|Standard Deviation|4.97|4.97|||
4334752|NCT00432159|4162112|B2|||BMI|Body Mass Index in units of kilogram per meter squared|kg/m^2|Mean|27.6|27.6|Standard Deviation|4.83|4.83|||
4334753|NCT00432159|4162113|B1|||BMI|Body Mass Index in units of kilogram per meter squared|kg/m^2|Mean|28.3|28.3|Standard Deviation|4.97|4.97|||
4334754|NCT00432159|4162108|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4334755|NCT00432159|4162109|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4334756|NCT00432159|4162110|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4334757|NCT00432159|4162111|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4334758|NCT00432159|4162112|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4334759|NCT00432159|4162113|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4334760|NCT00432159|4162108|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4334761|NCT00432159|4162109|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4334762|NCT00432159|4162110|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4334763|NCT00432159|4162111|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4334764|NCT00432159|4162112|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4334765|NCT00432159|4162113|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4334766|NCT00432159|4162108|B6||White|Race (NIH/OMB)||Participants|Count of Participants|453|453.0||||||
4334767|NCT00432159|4162109|B5||White|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
4334768|NCT00432159|4162110|B4||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4334769|NCT00432159|4162111|B3||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4334770|NCT00432159|4162112|B2||White|Race (NIH/OMB)||Participants|Count of Participants|147|147.0||||||
4334771|NCT00432159|4162113|B1||White|Race (NIH/OMB)||Participants|Count of Participants|170|170.0||||||
4334772|NCT00432159|4162108|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4334773|NCT00432159|4162109|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4334774|NCT00432159|4162110|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4334775|NCT00432159|4162111|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4334776|NCT00432159|4162112|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4334777|NCT00432159|4162113|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4334778|NCT00432159|4162108|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4334779|NCT00432159|4162109|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4334780|NCT00432159|4162110|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4334781|NCT00432159|4162111|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4334782|NCT00432159|4162112|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4334784|NCT00432159|4162108|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4334785|NCT00432159|4162109|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4334786|NCT00432159|4162110|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4334787|NCT00432159|4162111|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4334788|NCT00432159|4162112|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4334789|NCT00432159|4162113|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4334790|NCT00432159|4162108|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4334791|NCT00432159|4162109|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4334792|NCT00432159|4162110|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4334793|NCT00432159|4162111|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4334794|NCT00432159|4162112|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4334795|NCT00432159|4162113|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4334796|NCT00432159|4162108|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4334797|NCT00432159|4162109|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4334798|NCT00432159|4162110|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4334799|NCT00432159|4162111|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4334800|NCT00432159|4162112|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4334801|NCT00432159|4162113|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4334802|NCT00432159|4162108|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|470|470.0||||||
4334803|NCT00432159|4162109|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
4334804|NCT00432159|4162110|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4334805|NCT00432159|4162111|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4334806|NCT00432159|4162112|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|153|153.0||||||
4334807|NCT00432159|4162113|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|172|172.0||||||
4334808|NCT00432159|4162108|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4334809|NCT00432159|4162109|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4334810|NCT00432159|4162110|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4334811|NCT00432159|4162111|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4334812|NCT00432159|4162112|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4334813|NCT00432159|4162113|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4334814|NCT00432159|4162108|B6||Male|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
4334815|NCT00432159|4162109|B5||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4334816|NCT00432159|4162110|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4334817|NCT00432159|4162111|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4334818|NCT00432159|4162112|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4334819|NCT00432159|4162113|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4334820|NCT00432159|4162108|B6||Female|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
4334821|NCT00432159|4162109|B5||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4334822|NCT00432159|4162110|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4334823|NCT00432159|4162111|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4334824|NCT00432159|4162112|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4334825|NCT00432159|4162113|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4334826|NCT00432159|4162108|B6|||Age||years|Mean|43.4|43.4|Standard Deviation|8.0|8.0|||
4334827|NCT00432159|4162109|B5|||Age||years|Mean|42.3|42.3|Standard Deviation|7.49|7.49|||
4334828|NCT00432159|4162110|B4|||Age||years|Mean|44.4|44.4|Standard Deviation|7.74|7.74|||
4334829|NCT00432159|4162111|B3|||Age||years|Mean|44.1|44.1|Standard Deviation|7.94|7.94|||
4334830|NCT00432159|4162112|B2|||Age||years|Mean|42.8|42.8|Standard Deviation|7.63|7.63|||
4334831|NCT00432159|4162113|B1|||Age||years|Mean|44.2|44.2|Standard Deviation|8.63|8.63|||
4334832|NCT00432042|4162221|B4||Male|Sex: Female, Male||Participants|Count of Participants|507|507.0||||||
4334833|NCT00432042|4162222|B3||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4334834|NCT00432042|4162223|B2||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4334835|NCT00432042|4162224|B1||Male|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
4334836|NCT00432042|4162221|B4||Female|Sex: Female, Male||Participants|Count of Participants|448|448.0||||||
4334837|NCT00432042|4162222|B3||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4334838|NCT00432042|4162223|B2||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4334839|NCT00432042|4162224|B1||Female|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4334840|NCT00432042|4162221|B4|||Age||Months|Mean|13.5|13.5|Standard Deviation|1.7|1.7|||
4334841|NCT00432042|4162222|B3|||Age||Months|Mean|13.5|13.5|Standard Deviation|1.7|1.7|||
4334842|NCT00432042|4162223|B2|||Age||Months|Mean|13.4|13.4|Standard Deviation|1.5|1.5|||
4334843|NCT00432042|4162224|B1|||Age||Months|Mean|13.6|13.6|Standard Deviation|1.9|1.9|||
4334844|NCT00431964|4162237|B3||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4334845|NCT00431964|4162238|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4334846|NCT00431964|4162239|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4334847|NCT00431964|4162237|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4334848|NCT00431964|4162238|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4334849|NCT00431964|4162239|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4334850|NCT00431964|4162237|B3|||Age||years|Mean|10.7|10.7|Standard Deviation|3.17|3.17|||
4334851|NCT00431964|4162238|B2|||Age||years|Mean|10.6|10.6|Standard Deviation|3.10|3.1|||
4334852|NCT00431964|4162239|B1|||Age||years|Mean|10.7|10.7|Standard Deviation|3.25|3.25|||
4334853|NCT00431964|4162237|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4334854|NCT00431964|4162238|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4334855|NCT00431964|4162239|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4334856|NCT00431964|4162237|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4334857|NCT00431964|4162238|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4334858|NCT00431964|4162239|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4334859|NCT00431964|4162237|B3||<=18 years|Age||Participants|Count of Participants|260|260.0||||||
4334860|NCT00431964|4162238|B2||<=18 years|Age||Participants|Count of Participants|129|129.0||||||
4334861|NCT00431964|4162239|B1||<=18 years|Age||Participants|Count of Participants|131|131.0||||||
4334862|NCT00431951|4162246|B5|United States||Region of Enrollment||participants|Number|30|30.0||||||
4334863|NCT00431951|4162247|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
4334864|NCT00431951|4162248|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4334865|NCT00431951|4162249|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4334866|NCT00431951|4162250|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4334867|NCT00431951|4162246|B5||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4334868|NCT00431951|4162247|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4334869|NCT00431951|4162248|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4334870|NCT00431951|4162249|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4334871|NCT00431951|4162250|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4334872|NCT00431951|4162246|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4334873|NCT00431951|4162247|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4334874|NCT00431951|4162248|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4334875|NCT00431951|4162249|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4334876|NCT00431951|4162250|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4334877|NCT00431951|4162246|B5|||Age||years|Mean|33.9|33.9|Standard Deviation|8.8|8.8|||
4334878|NCT00431951|4162247|B4|||Age||years|Mean|34.8|34.8|Standard Deviation|8.9|8.9|||
4334879|NCT00431951|4162248|B3|||Age||years|Mean|37.5|37.5|Standard Deviation|7.6|7.6|||
4334880|NCT00431951|4162249|B2|||Age||years|Mean|27.6|27.6|Standard Deviation|7.8|7.8|||
4334881|NCT00431951|4162250|B1|||Age||years|Mean|36.5|36.5|Standard Deviation|8.2|8.2|||
4334882|NCT00431951|4162246|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4334883|NCT00431951|4162247|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4334884|NCT00431951|4162248|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4334885|NCT00431951|4162249|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4334886|NCT00431951|4162250|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4334887|NCT00431951|4162246|B5||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4334888|NCT00431951|4162247|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4334889|NCT00431951|4162248|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4334890|NCT00431951|4162249|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4334891|NCT00431951|4162250|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4334892|NCT00431951|4162246|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4334893|NCT00431951|4162247|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4334894|NCT00431951|4162248|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4334895|NCT00431951|4162249|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4334896|NCT00431951|4162250|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4334897|NCT00431847|4162311|B5|||Length of Initial Hospital Stay||months|Mean|36.69|36.69|Standard Deviation|33.35|33.35|||
4334898|NCT00431847|4162312|B4|||Length of Initial Hospital Stay||months|Mean|27.95|27.95|Standard Deviation|30.72|30.72|||
4334899|NCT00431847|4162313|B3|||Length of Initial Hospital Stay||months|Mean|59.90|59.9|Standard Deviation|47.64|47.64|||
4334900|NCT00431847|4162314|B2|||Length of Initial Hospital Stay||months|Mean|47.45|47.45|Standard Deviation|33.74|33.74|||
4334901|NCT00431847|4162315|B1|||Length of Initial Hospital Stay||months|Mean|41.14|41.14|Standard Deviation|30.54|30.54|||
4334942|NCT00431847|4162311|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4334943|NCT00431847|4162312|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4334902|NCT00431847|4162311|B5|||Injury Severity Score (ISS)|Injury Severity Scores (ISS): ISS is a scale to evaluate anatomic injury severity following trauma that ranges from 0 to 75, with 75 indicating the greatest severity. An Abbreviated Injury Scale (AIS) score is allocated to the six body regions (Head, Face, Chest, Abdomen, Extremities, and External). The highest AIS score in each body region is used. The 3 most severely injured body regions scores are squared and summed to produce the ISS. The ISS correlates linearly with mortality, morbidity, and hospital stay.|units on a scale|Mean|18.37|18.37|Standard Deviation|10.79|10.79|||
4334903|NCT00431847|4162312|B4|||Injury Severity Score (ISS)|Injury Severity Scores (ISS): ISS is a scale to evaluate anatomic injury severity following trauma that ranges from 0 to 75, with 75 indicating the greatest severity. An Abbreviated Injury Scale (AIS) score is allocated to the six body regions (Head, Face, Chest, Abdomen, Extremities, and External). The highest AIS score in each body region is used. The 3 most severely injured body regions scores are squared and summed to produce the ISS. The ISS correlates linearly with mortality, morbidity, and hospital stay.|units on a scale|Mean|18.07|18.07|Standard Deviation|11.57|11.57|||
4334904|NCT00431847|4162313|B3|||Injury Severity Score (ISS)|Injury Severity Scores (ISS): ISS is a scale to evaluate anatomic injury severity following trauma that ranges from 0 to 75, with 75 indicating the greatest severity. An Abbreviated Injury Scale (AIS) score is allocated to the six body regions (Head, Face, Chest, Abdomen, Extremities, and External). The highest AIS score in each body region is used. The 3 most severely injured body regions scores are squared and summed to produce the ISS. The ISS correlates linearly with mortality, morbidity, and hospital stay.|units on a scale|Mean|24.65|24.65|Standard Deviation|12.59|12.59|||
4334905|NCT00431847|4162314|B2|||Injury Severity Score (ISS)|Injury Severity Scores (ISS): ISS is a scale to evaluate anatomic injury severity following trauma that ranges from 0 to 75, with 75 indicating the greatest severity. An Abbreviated Injury Scale (AIS) score is allocated to the six body regions (Head, Face, Chest, Abdomen, Extremities, and External). The highest AIS score in each body region is used. The 3 most severely injured body regions scores are squared and summed to produce the ISS. The ISS correlates linearly with mortality, morbidity, and hospital stay.|units on a scale|Mean|19.74|19.74|Standard Deviation|11.88|11.88|||
4334906|NCT00431847|4162315|B1|||Injury Severity Score (ISS)|Injury Severity Scores (ISS): ISS is a scale to evaluate anatomic injury severity following trauma that ranges from 0 to 75, with 75 indicating the greatest severity. An Abbreviated Injury Scale (AIS) score is allocated to the six body regions (Head, Face, Chest, Abdomen, Extremities, and External). The highest AIS score in each body region is used. The 3 most severely injured body regions scores are squared and summed to produce the ISS. The ISS correlates linearly with mortality, morbidity, and hospital stay.|units on a scale|Mean|17.31|17.31|Standard Deviation|8.56|8.56|||
4334907|NCT00431847|4162311|B5|||Number of Deployments, Continuous||deployments|Mean|1.97|1.97|Standard Deviation|1.25|1.25|||
4334908|NCT00431847|4162312|B4|||Number of Deployments, Continuous||deployments|Mean|1.85|1.85|Standard Deviation|1.05|1.05|||
4334909|NCT00431847|4162313|B3|||Number of Deployments, Continuous||deployments|Mean|2.40|2.4|Standard Deviation|2.54|2.54|||
4334910|NCT00431847|4162314|B2|||Number of Deployments, Continuous||deployments|Mean|1.80|1.8|Standard Deviation|0.90|0.9|||
4334911|NCT00431847|4162315|B1|||Number of Deployments, Continuous||deployments|Mean|2.13|2.13|Standard Deviation|1.27|1.27|||
4334912|NCT00431847|4162311|B5|Separated/Divorced||Marital Status||participants|Number|20|20.0||||||
4334913|NCT00431847|4162312|B4|Separated/Divorced||Marital Status||participants|Number|14|14.0||||||
4334914|NCT00431847|4162313|B3|Separated/Divorced||Marital Status||participants|Number|0|0.0||||||
4334915|NCT00431847|4162314|B2|Separated/Divorced||Marital Status||participants|Number|1|1.0||||||
4334916|NCT00431847|4162315|B1|Separated/Divorced||Marital Status||participants|Number|5|5.0||||||
4334917|NCT00431847|4162311|B5|Married or Living w/Partner||Marital Status||participants|Number|172|172.0||||||
4334918|NCT00431847|4162312|B4|Married or Living w/Partner||Marital Status||participants|Number|67|67.0||||||
4334919|NCT00431847|4162313|B3|Married or Living w/Partner||Marital Status||participants|Number|13|13.0||||||
4334920|NCT00431847|4162314|B2|Married or Living w/Partner||Marital Status||participants|Number|22|22.0||||||
4334921|NCT00431847|4162315|B1|Married or Living w/Partner||Marital Status||participants|Number|70|70.0||||||
4334922|NCT00431847|4162311|B5|Never Married||Marital Status||participants|Number|166|166.0||||||
4334923|NCT00431847|4162312|B4|Never Married||Marital Status||participants|Number|89|89.0||||||
4334924|NCT00431847|4162313|B3|Never Married||Marital Status||participants|Number|7|7.0||||||
4334925|NCT00431847|4162314|B2|Never Married||Marital Status||participants|Number|19|19.0||||||
4334926|NCT00431847|4162315|B1|Never Married||Marital Status||participants|Number|51|51.0||||||
4334927|NCT00431847|4162311|B5|Bachelor's Degree or Higher||Education||participants|Number|65|65.0||||||
4334928|NCT00431847|4162312|B4|Bachelor's Degree or Higher||Education||participants|Number|24|24.0||||||
4334929|NCT00431847|4162313|B3|Bachelor's Degree or Higher||Education||participants|Number|3|3.0||||||
4334930|NCT00431847|4162314|B2|Bachelor's Degree or Higher||Education||participants|Number|6|6.0||||||
4334931|NCT00431847|4162315|B1|Bachelor's Degree or Higher||Education||participants|Number|32|32.0||||||
4334932|NCT00431847|4162311|B5|Some College||Education||participants|Number|146|146.0||||||
4334933|NCT00431847|4162312|B4|Some College||Education||participants|Number|72|72.0||||||
4334934|NCT00431847|4162313|B3|Some College||Education||participants|Number|9|9.0||||||
4334935|NCT00431847|4162314|B2|Some College||Education||participants|Number|18|18.0||||||
4334936|NCT00431847|4162315|B1|Some College||Education||participants|Number|47|47.0||||||
4334937|NCT00431847|4162311|B5|High School/GED||Education||participants|Number|147|147.0||||||
4334938|NCT00431847|4162312|B4|High School/GED||Education||participants|Number|74|74.0||||||
4334939|NCT00431847|4162313|B3|High School/GED||Education||participants|Number|8|8.0||||||
4334940|NCT00431847|4162314|B2|High School/GED||Education||participants|Number|18|18.0||||||
4334941|NCT00431847|4162315|B1|High School/GED||Education||participants|Number|47|47.0||||||
4334944|NCT00431847|4162313|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4334945|NCT00431847|4162314|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4334946|NCT00431847|4162315|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4334947|NCT00431847|4162311|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4334948|NCT00431847|4162312|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4334949|NCT00431847|4162313|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4334950|NCT00431847|4162314|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4334951|NCT00431847|4162315|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4334952|NCT00431847|4162311|B5||White|Race (NIH/OMB)||Participants|Count of Participants|278|278.0||||||
4334953|NCT00431847|4162312|B4||White|Race (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
4334954|NCT00431847|4162313|B3||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4334955|NCT00431847|4162314|B2||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4334956|NCT00431847|4162315|B1||White|Race (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
4334957|NCT00431847|4162311|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4334958|NCT00431847|4162312|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4334959|NCT00431847|4162313|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4334960|NCT00431847|4162314|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4334961|NCT00431847|4162315|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4334962|NCT00431847|4162311|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4334963|NCT00431847|4162312|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4334964|NCT00431847|4162313|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4334965|NCT00431847|4162314|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4334966|NCT00431847|4162315|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4334967|NCT00431847|4162311|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4334968|NCT00431847|4162312|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4334969|NCT00431847|4162313|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4334970|NCT00431847|4162314|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4334971|NCT00431847|4162315|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4334972|NCT00431847|4162311|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4334973|NCT00431847|4162312|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4334974|NCT00431847|4162313|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4334975|NCT00431847|4162314|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4334976|NCT00431847|4162315|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4334977|NCT00431847|4162311|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4334978|NCT00431847|4162312|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4334979|NCT00431847|4162313|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4334980|NCT00431847|4162314|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4334981|NCT00431847|4162315|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4334982|NCT00431847|4162311|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|313|313.0||||||
4334983|NCT00431847|4162312|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|151|151.0||||||
4334984|NCT00431847|4162313|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4334985|NCT00431847|4162314|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4334986|NCT00431847|4162315|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|112|112.0||||||
4334987|NCT00431847|4162311|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4334988|NCT00431847|4162312|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4334989|NCT00431847|4162313|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4334990|NCT00431847|4162314|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4334991|NCT00431847|4162315|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4334992|NCT00431847|4162311|B5||Male|Sex: Female, Male||Participants|Count of Participants|355|355.0||||||
4334993|NCT00431847|4162312|B4||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4334994|NCT00431847|4162313|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4334995|NCT00431847|4162314|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4334996|NCT00431847|4162315|B1||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4334997|NCT00431847|4162311|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4334998|NCT00431847|4162312|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4334999|NCT00431847|4162313|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4335000|NCT00431847|4162314|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4335001|NCT00431847|4162315|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4335002|NCT00431847|4162311|B5|||Age||years|Mean|28.04|28.04|Standard Deviation|7.10|7.1|||
4335003|NCT00431847|4162312|B4|||Age||years|Mean|28.15|28.15|Standard Deviation|7.87|7.87|||
4335004|NCT00431847|4162313|B3|||Age||years|Mean|29.08|29.08|Standard Deviation|8.97|8.97|||
4335005|NCT00431847|4162314|B2|||Age||years|Mean|26.68|26.68|Standard Deviation|4.80|4.8|||
4335006|NCT00431847|4162315|B1|||Age||years|Mean|28.20|28.2|Standard Deviation|6.30|6.3|||
4335007|NCT00431834|4162393|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
4335008|NCT00431834|4162393|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4335009|NCT00431834|4162393|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4335010|NCT00431834|4162393|B1|||Age||years|Mean|70.9|70.9|Standard Deviation|8.7|8.7|||
4335011|NCT00431834|4162393|B1||>=65 years|Age||Participants|Count of Participants|58|58.0||||||
4335012|NCT00431834|4162393|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4335013|NCT00431834|4162393|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4335014|NCT00431626|4162400|B3|Male||Gender||participants|Number|4|4.0||||||
4335015|NCT00431626|4162402|B1|Male||Gender||participants|Number|4|4.0||||||
4335016|NCT00431626|4162400|B3|Female||Gender||participants|Number|0|0.0||||||
4335017|NCT00431626|4162402|B1|Female||Gender||participants|Number|0|0.0||||||
4335018|NCT00431626|4162400|B3|||Age||years|Mean|47|47.0|Standard Deviation|12|12.0|||
4335019|NCT00431626|4162402|B1|||Age||years|Mean|47|47.0|Standard Deviation|12|12.0|||
4335020|NCT00431496|4162409|B1|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4335021|NCT00431496|4162409|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|53|53.0||||||
4335022|NCT00431496|4162409|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4335023|NCT00431496|4162409|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4335024|NCT00431496|4162409|B1|Asian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4335025|NCT00431496|4162409|B1|Aborigine||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4335026|NCT00431496|4162409|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4335027|NCT00431496|4162409|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4335028|NCT00431496|4162409|B1|||Age||Years|Mean|62.3|62.3|Standard Deviation|12.9|12.9|||
4335029|NCT00431444|4162418|B3|||Post-menopausal|Number of years the patient had been post-menopausal.|year|Mean|13.0|13.0|Standard Deviation|9.03|9.03|||
4335030|NCT00431444|4162419|B2|||Post-menopausal|Number of years the patient had been post-menopausal.|year|Mean|13.4|13.4|Standard Deviation|9.17|9.17|||
4335031|NCT00431444|4162420|B1|||Post-menopausal|Number of years the patient had been post-menopausal.|year|Mean|12.5|12.5|Standard Deviation|8.94|8.94|||
4335032|NCT00431444|4162418|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4335033|NCT00431444|4162419|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4335034|NCT00431444|4162420|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4335035|NCT00431444|4162418|B3||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4335036|NCT00431444|4162419|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4335037|NCT00431444|4162420|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4335038|NCT00431444|4162418|B3|>=65 years||Age, Customized||participants|Number|31|31.0||||||
4335039|NCT00431444|4162419|B2|>=65 years||Age, Customized||participants|Number|18|18.0||||||
4335040|NCT00431444|4162420|B1|>=65 years||Age, Customized||participants|Number|13|13.0||||||
4335041|NCT00431444|4162418|B3|Between 45 and 65 years||Age, Customized||participants|Number|78|78.0||||||
4335042|NCT00431444|4162419|B2|Between 45 and 65 years||Age, Customized||participants|Number|35|35.0||||||
4335043|NCT00431444|4162420|B1|Between 45 and 65 years||Age, Customized||participants|Number|43|43.0||||||
4335044|NCT00431444|4162418|B3|||Age||years|Mean|60.1|60.1|Standard Deviation|7.68|7.68|||
4335045|NCT00431444|4162419|B2|||Age||years|Mean|61.5|61.5|Standard Deviation|8.20|8.2|||
4335046|NCT00431444|4162420|B1|||Age||years|Mean|58.8|58.8|Standard Deviation|6.97|6.97|||
4335047|NCT00431184|4162445|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4335048|NCT00431184|4162446|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4335049|NCT00431184|4162447|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4335050|NCT00431184|4162445|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4335051|NCT00431184|4162446|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4335052|NCT00431184|4162447|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4335053|NCT00431184|4162445|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4335054|NCT00431184|4162446|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4335055|NCT00431184|4162447|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4335056|NCT00431184|4162445|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4335057|NCT00431184|4162446|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4335058|NCT00431184|4162447|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4335059|NCT00431184|4162445|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4335060|NCT00431184|4162446|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4335061|NCT00431184|4162447|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4335062|NCT00431132|4162456|B1|||Body Mass Index (BMI)||kg/m^2|Mean|24.6|24.6|Standard Deviation|3.4|3.4|||
4335063|NCT00431132|4162456|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4335064|NCT00431132|4162456|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335065|NCT00431132|4162456|B1||White|Race (NIH/OMB)||Participants|Count of Participants|296|296.0||||||
4335066|NCT00431132|4162456|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335067|NCT00431132|4162456|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335068|NCT00431132|4162456|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4335069|NCT00431132|4162456|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335070|NCT00431132|4162456|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4335071|NCT00431132|4162456|B1||Female|Sex: Female, Male||Participants|Count of Participants|336|336.0||||||
4335072|NCT00431132|4162456|B1|||Age||years|Mean|59.5|59.5|Standard Deviation|6.2|6.2|||
4335073|NCT00431067|4162461|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4335074|NCT00431067|4162461|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4335075|NCT00431067|4162461|B1|||Age||years|Mean|54.1|54.1|Standard Deviation|13.5|13.5|||
4335076|NCT00431041|4162469|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4335077|NCT00431041|4162470|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4335078|NCT00431041|4162471|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4335079|NCT00431041|4162469|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4335080|NCT00431041|4162470|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4335081|NCT00431041|4162471|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4335082|NCT00431041|4162469|B3|Aboriginal||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4335083|NCT00431041|4162470|B2|Aboriginal||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4335084|NCT00431041|4162471|B1|Aboriginal||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4335085|NCT00431041|4162469|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4335086|NCT00431041|4162470|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4335087|NCT00431041|4162471|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4335088|NCT00431041|4162469|B3|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4335089|NCT00431041|4162470|B2|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4335090|NCT00431041|4162471|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4335091|NCT00431041|4162469|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|119|119.0||||||
4335092|NCT00431041|4162470|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
4335093|NCT00431041|4162471|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
4335094|NCT00431041|4162469|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4335095|NCT00431041|4162470|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4335096|NCT00431041|4162471|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4335097|NCT00431041|4162469|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4335098|NCT00431041|4162470|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4335099|NCT00431041|4162471|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4335100|NCT00431041|4162469|B3|>65 years||Age, Customized||participants|Number|57|57.0||||||
4335101|NCT00431041|4162470|B2|>65 years||Age, Customized||participants|Number|30|30.0||||||
4335102|NCT00431041|4162471|B1|>65 years||Age, Customized||participants|Number|27|27.0||||||
4335103|NCT00431041|4162469|B3|<=65 years||Age, Customized||participants|Number|75|75.0||||||
4335104|NCT00431041|4162470|B2|<=65 years||Age, Customized||participants|Number|34|34.0||||||
4335105|NCT00431041|4162471|B1|<=65 years||Age, Customized||participants|Number|41|41.0||||||
4335106|NCT00430950|4162484|B3|European||Race/Ethnicity, Customized||participants|Number|1010|1010.0||||||
4335107|NCT00430950|4162485|B2|European||Race/Ethnicity, Customized||participants|Number|508|508.0||||||
4335108|NCT00430950|4162486|B1|European||Race/Ethnicity, Customized||participants|Number|502|502.0||||||
4335109|NCT00430950|4162484|B3||Male|Sex: Female, Male||Participants|Count of Participants|615|615.0||||||
4335110|NCT00430950|4162485|B2||Male|Sex: Female, Male||Participants|Count of Participants|307|307.0||||||
4335111|NCT00430950|4162486|B1||Male|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
4335112|NCT00430950|4162484|B3||Female|Sex: Female, Male||Participants|Count of Participants|395|395.0||||||
4335113|NCT00430950|4162485|B2||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4335114|NCT00430950|4162486|B1||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4335115|NCT00430950|4162484|B3|||Age||years|Mean|54.6|54.6|Standard Deviation|9.72|9.72|||
4335116|NCT00430950|4162485|B2|||Age||years|Mean|54.4|54.4|Standard Deviation|9.77|9.77|||
4335117|NCT00430950|4162486|B1|||Age||years|Mean|54.7|54.7|Standard Deviation|9.67|9.67|||
4335118|NCT00430950|4162484|B3|>= 75 years||Age, Customized||Participants|Number|16.0|16.0||||||
4335119|NCT00430950|4162485|B2|>= 75 years||Age, Customized||Participants|Number|11|11.0||2.2|2.2|||
4335120|NCT00430950|4162486|B1|>= 75 years||Age, Customized||Participants|Number|5|5.0||1.0|1.0|||
4335121|NCT00430950|4162484|B3|>=65 years||Age, Customized||Participants|Number|168.0|168.0||||||
4335122|NCT00430950|4162485|B2|>=65 years||Age, Customized||Participants|Number|75|75.0||||||
4335123|NCT00430950|4162486|B1|>=65 years||Age, Customized||Participants|Number|93|93.0||||||
4335124|NCT00430950|4162484|B3|Between 18 and 65 years||Age, Customized||Participants|Number|826.0|826.0||||||
4335125|NCT00430950|4162485|B2|Between 18 and 65 years||Age, Customized||Participants|Number|422|422.0||||||
4335126|NCT00430950|4162486|B1|Between 18 and 65 years||Age, Customized||Participants|Number|404|404.0||||||
4335127|NCT00430950|4162484|B3|<=18 years||Age, Customized||Participants|Number|0.0|0.0||||||
4335128|NCT00430950|4162485|B2|<=18 years||Age, Customized||Participants|Number|0|0.0||||||
4335129|NCT00430950|4162486|B1|<=18 years||Age, Customized||Participants|Number|0|0.0||||||
4335130|NCT00430937|4162499|B3||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4335131|NCT00430937|4162500|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4335132|NCT00430937|4162501|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4335133|NCT00430937|4162499|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4335134|NCT00430937|4162500|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4335135|NCT00430937|4162501|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4335136|NCT00430937|4162499|B3|>=65 years||Age, Customized||Participants|Number|66|66.0||||||
4335137|NCT00430937|4162500|B2|>=65 years||Age, Customized||Participants|Number|31|31.0||||||
4335138|NCT00430937|4162501|B1|>=65 years||Age, Customized||Participants|Number|35|35.0||||||
4335139|NCT00430937|4162499|B3|< 65 years||Age, Customized||Participants|Number|123|123.0||||||
4335140|NCT00430937|4162500|B2|< 65 years||Age, Customized||Participants|Number|61|61.0||||||
4335141|NCT00430937|4162501|B1|< 65 years||Age, Customized||Participants|Number|62|62.0||||||
4335142|NCT00430781|4162510|B4|Other||Histology at diagnosis: Final Anaysis|(n=0, 78, 74)|participants|Number|14|14.0||||||
4335143|NCT00430781|4162511|B3|Other||Histology at diagnosis: Final Anaysis|(n=0, 78, 74)|participants|Number|6|6.0||||||
4335144|NCT00430781|4162512|B2|Other||Histology at diagnosis: Final Anaysis|(n=0, 78, 74)|participants|Number|8|8.0||||||
4335145|NCT00430781|4162513|B1|Other||Histology at diagnosis: Final Anaysis|(n=0, 78, 74)|participants|Number|NA|||||||There are no participants for this analysis subgroup.
4335146|NCT00430781|4162510|B4|Squamous cell carcinoma||Histology at diagnosis: Final Anaysis|(n=0, 78, 74)|participants|Number|108|108.0||||||
4335147|NCT00430781|4162511|B3|Squamous cell carcinoma||Histology at diagnosis: Final Anaysis|(n=0, 78, 74)|participants|Number|53|53.0||||||
4335148|NCT00430781|4162512|B2|Squamous cell carcinoma||Histology at diagnosis: Final Anaysis|(n=0, 78, 74)|participants|Number|55|55.0||||||
4335149|NCT00430781|4162513|B1|Squamous cell carcinoma||Histology at diagnosis: Final Anaysis|(n=0, 78, 74)|participants|Number|NA|||||||There are no participants for this analysis subgroup.
4335150|NCT00430781|4162510|B4|Adenosquamous carcinoma||Histology at diagnosis: Final Anaysis|(n=0, 78, 74)|participants|Number|7|7.0||||||
4335151|NCT00430781|4162511|B3|Adenosquamous carcinoma||Histology at diagnosis: Final Anaysis|(n=0, 78, 74)|participants|Number|3|3.0||||||
4335152|NCT00430781|4162512|B2|Adenosquamous carcinoma||Histology at diagnosis: Final Anaysis|(n=0, 78, 74)|participants|Number|4|4.0||||||
4335153|NCT00430781|4162513|B1|Adenosquamous carcinoma||Histology at diagnosis: Final Anaysis|(n=0, 78, 74)|participants|Number|NA|||||||There are no participants for this analysis subgroup.
4335154|NCT00430781|4162510|B4|Adenocarcinoma||Histology at diagnosis: Final Anaysis|(n=0, 78, 74)|participants|Number|23|23.0||||||
4335155|NCT00430781|4162511|B3|Adenocarcinoma||Histology at diagnosis: Final Anaysis|(n=0, 78, 74)|participants|Number|12|12.0||||||
4335156|NCT00430781|4162512|B2|Adenocarcinoma||Histology at diagnosis: Final Anaysis|(n=0, 78, 74)|participants|Number|11|11.0||||||
4335157|NCT00430781|4162513|B1|Adenocarcinoma||Histology at diagnosis: Final Anaysis|(n=0, 78, 74)|participants|Number|NA|||||||There are no participants for this analysis subgroup.
4335158|NCT00430781|4162510|B4|Missing||Histology at diagnosis: Interim Analysis||participants|Number|3|3.0||||||
4335159|NCT00430781|4162511|B3|Missing||Histology at diagnosis: Interim Analysis||participants|Number|1|1.0||||||
4335160|NCT00430781|4162512|B2|Missing||Histology at diagnosis: Interim Analysis||participants|Number|0|0.0||||||
4335161|NCT00430781|4162513|B1|Missing||Histology at diagnosis: Interim Analysis||participants|Number|2|2.0||||||
4335162|NCT00430781|4162510|B4|Other||Histology at diagnosis: Interim Analysis||participants|Number|23|23.0||||||
4335163|NCT00430781|4162511|B3|Other||Histology at diagnosis: Interim Analysis||participants|Number|5|5.0||||||
4335164|NCT00430781|4162512|B2|Other||Histology at diagnosis: Interim Analysis||participants|Number|8|8.0||||||
4335165|NCT00430781|4162513|B1|Other||Histology at diagnosis: Interim Analysis||participants|Number|10|10.0||||||
4335166|NCT00430781|4162510|B4|Squamous cell carcinoma||Histology at diagnosis: Interim Analysis||participants|Number|113|113.0||||||
4335167|NCT00430781|4162511|B3|Squamous cell carcinoma||Histology at diagnosis: Interim Analysis||participants|Number|43|43.0||||||
4335168|NCT00430781|4162512|B2|Squamous cell carcinoma||Histology at diagnosis: Interim Analysis||participants|Number|38|38.0||||||
4335169|NCT00430781|4162513|B1|Squamous cell carcinoma||Histology at diagnosis: Interim Analysis||participants|Number|32|32.0||||||
4335170|NCT00430781|4162510|B4|Adenosquamous carcinoma||Histology at diagnosis: Interim Analysis||participants|Number|7|7.0||||||
4335171|NCT00430781|4162511|B3|Adenosquamous carcinoma||Histology at diagnosis: Interim Analysis||participants|Number|3|3.0||||||
4335172|NCT00430781|4162512|B2|Adenosquamous carcinoma||Histology at diagnosis: Interim Analysis||participants|Number|4|4.0||||||
4335173|NCT00430781|4162513|B1|Adenosquamous carcinoma||Histology at diagnosis: Interim Analysis||participants|Number|0|0.0||||||
4335174|NCT00430781|4162510|B4|Adenocarcinoma||Histology at diagnosis: Interim Analysis||participants|Number|31|31.0||||||
4335175|NCT00430781|4162511|B3|Adenocarcinoma||Histology at diagnosis: Interim Analysis||participants|Number|8|8.0||||||
4335176|NCT00430781|4162512|B2|Adenocarcinoma||Histology at diagnosis: Interim Analysis||participants|Number|8|8.0||||||
4335177|NCT00430781|4162513|B1|Adenocarcinoma||Histology at diagnosis: Interim Analysis||participants|Number|15|15.0||||||
4335178|NCT00430781|4162510|B4|White||Race/Ethnicity, Customized|Race at Final Analysis (n=0, 78, 74)|participants|Number|104|104.0||||||
4335179|NCT00430781|4162511|B3|White||Race/Ethnicity, Customized|Race at Final Analysis (n=0, 78, 74)|participants|Number|52|52.0||||||
4335180|NCT00430781|4162512|B2|White||Race/Ethnicity, Customized|Race at Final Analysis (n=0, 78, 74)|participants|Number|52|52.0||||||
4335181|NCT00430781|4162513|B1|White||Race/Ethnicity, Customized|Race at Final Analysis (n=0, 78, 74)|participants|Number|NA|||||||There are no participants for this analysis subgroup.
4335182|NCT00430781|4162510|B4|Asian-South East||Race/Ethnicity, Customized|Race at Final Analysis (n=0, 78, 74)|participants|Number|22|22.0||||||
4335183|NCT00430781|4162511|B3|Asian-South East||Race/Ethnicity, Customized|Race at Final Analysis (n=0, 78, 74)|participants|Number|9|9.0||||||
4335184|NCT00430781|4162512|B2|Asian-South East||Race/Ethnicity, Customized|Race at Final Analysis (n=0, 78, 74)|participants|Number|13|13.0||||||
4335185|NCT00430781|4162513|B1|Asian-South East||Race/Ethnicity, Customized|Race at Final Analysis (n=0, 78, 74)|participants|Number|NA|||||||There are no participants for this analysis subgroup.
4335186|NCT00430781|4162510|B4|Asian-Central , South||Race/Ethnicity, Customized|Race at Final Analysis (n=0, 78, 74)|participants|Number|2|2.0||||||
4335187|NCT00430781|4162511|B3|Asian-Central , South||Race/Ethnicity, Customized|Race at Final Analysis (n=0, 78, 74)|participants|Number|0|0.0||||||
4335188|NCT00430781|4162512|B2|Asian-Central , South||Race/Ethnicity, Customized|Race at Final Analysis (n=0, 78, 74)|participants|Number|2|2.0||||||
4335189|NCT00430781|4162513|B1|Asian-Central , South||Race/Ethnicity, Customized|Race at Final Analysis (n=0, 78, 74)|participants|Number|NA|||||||There are no participants for this analysis subgroup.
4335190|NCT00430781|4162510|B4|American Indian||Race/Ethnicity, Customized|Race at Final Analysis (n=0, 78, 74)|participants|Number|23|23.0||||||
4335191|NCT00430781|4162511|B3|American Indian||Race/Ethnicity, Customized|Race at Final Analysis (n=0, 78, 74)|participants|Number|13|13.0||||||
4335192|NCT00430781|4162512|B2|American Indian||Race/Ethnicity, Customized|Race at Final Analysis (n=0, 78, 74)|participants|Number|10|10.0||||||
4335193|NCT00430781|4162513|B1|American Indian||Race/Ethnicity, Customized|Race at Final Analysis (n=0, 78, 74)|participants|Number|NA|||||||There are no participants for this analysis subgroup.
4335194|NCT00430781|4162510|B4|African American||Race/Ethnicity, Customized|Race at Final Analysis (n=0, 78, 74)|participants|Number|1|1.0||||||
4335195|NCT00430781|4162511|B3|African American||Race/Ethnicity, Customized|Race at Final Analysis (n=0, 78, 74)|participants|Number|0|0.0||||||
4335196|NCT00430781|4162512|B2|African American||Race/Ethnicity, Customized|Race at Final Analysis (n=0, 78, 74)|participants|Number|1|1.0||||||
4335197|NCT00430781|4162513|B1|African American||Race/Ethnicity, Customized|Race at Final Analysis (n=0, 78, 74)|participants|Number|NA|||||||There are no participants for this analysis subgroup.
4335198|NCT00430781|4162510|B4|White||Race/Ethnicity, Customized|Race at Interim Analysis|participants|Number|120|120.0||||||
4335199|NCT00430781|4162511|B3|White||Race/Ethnicity, Customized|Race at Interim Analysis|participants|Number|40|40.0||||||
4335200|NCT00430781|4162512|B2|White||Race/Ethnicity, Customized|Race at Interim Analysis|participants|Number|43|43.0||||||
4335201|NCT00430781|4162513|B1|White||Race/Ethnicity, Customized|Race at Interim Analysis|participants|Number|37|37.0||||||
4335202|NCT00430781|4162510|B4|Asian-South East||Race/Ethnicity, Customized|Race at Interim Analysis|participants|Number|30|30.0||||||
4335203|NCT00430781|4162511|B3|Asian-South East||Race/Ethnicity, Customized|Race at Interim Analysis|participants|Number|8|8.0||||||
4335204|NCT00430781|4162512|B2|Asian-South East||Race/Ethnicity, Customized|Race at Interim Analysis|participants|Number|10|10.0||||||
4335205|NCT00430781|4162513|B1|Asian-South East||Race/Ethnicity, Customized|Race at Interim Analysis|participants|Number|12|12.0||||||
4335206|NCT00430781|4162510|B4|American Indian||Race/Ethnicity, Customized|Race at Interim Analysis|participants|Number|26|26.0||||||
4335207|NCT00430781|4162511|B3|American Indian||Race/Ethnicity, Customized|Race at Interim Analysis|participants|Number|12|12.0||||||
4335208|NCT00430781|4162512|B2|American Indian||Race/Ethnicity, Customized|Race at Interim Analysis|participants|Number|4|4.0||||||
4335209|NCT00430781|4162513|B1|American Indian||Race/Ethnicity, Customized|Race at Interim Analysis|participants|Number|10|10.0||||||
4335210|NCT00430781|4162510|B4|African American||Race/Ethnicity, Customized|Race at Interim Analysis|participants|Number|1|1.0||||||
4335211|NCT00430781|4162511|B3|African American||Race/Ethnicity, Customized|Race at Interim Analysis|participants|Number|0|0.0||||||
4335212|NCT00430781|4162512|B2|African American||Race/Ethnicity, Customized|Race at Interim Analysis|participants|Number|1|1.0||||||
4335213|NCT00430781|4162513|B1|African American||Race/Ethnicity, Customized|Race at Interim Analysis|participants|Number|0|0.0||||||
4335214|NCT00430781|4162510|B4|Male||Gender|Gender at Final Analysis (n=0, 78, 74)|participants|Number|0|0.0||||||
4335215|NCT00430781|4162511|B3|Male||Gender|Gender at Final Analysis (n=0, 78, 74)|participants|Number|0|0.0||||||
4335216|NCT00430781|4162512|B2|Male||Gender|Gender at Final Analysis (n=0, 78, 74)|participants|Number|0|0.0||||||
4335217|NCT00430781|4162513|B1|Male||Gender|Gender at Final Analysis (n=0, 78, 74)|participants|Number|NA|||||||There are no participants for this analysis subgroup.
4335218|NCT00430781|4162510|B4|Female||Gender|Gender at Final Analysis (n=0, 78, 74)|participants|Number|152|152.0||||||
4335219|NCT00430781|4162511|B3|Female||Gender|Gender at Final Analysis (n=0, 78, 74)|participants|Number|74|74.0||||||
4335220|NCT00430781|4162512|B2|Female||Gender|Gender at Final Analysis (n=0, 78, 74)|participants|Number|78|78.0||||||
4335221|NCT00430781|4162513|B1|Female||Gender|Gender at Final Analysis (n=0, 78, 74)|participants|Number|NA|||||||There are no participants for this analysis subgroup.
4335222|NCT00430781|4162510|B4||Male|Sex: Female, Male|Gender at Interim Analysis|Participants|Count of Participants|0|0.0||||||
4335223|NCT00430781|4162511|B3||Male|Sex: Female, Male|Gender at Interim Analysis|Participants|Count of Participants|0|0.0||||||
4335224|NCT00430781|4162512|B2||Male|Sex: Female, Male|Gender at Interim Analysis|Participants|Count of Participants|0|0.0||||||
4335225|NCT00430781|4162513|B1||Male|Sex: Female, Male|Gender at Interim Analysis|Participants|Count of Participants|0|0.0||||||
4335226|NCT00430781|4162510|B4||Female|Sex: Female, Male|Gender at Interim Analysis|Participants|Count of Participants|177|177.0||||||
4335227|NCT00430781|4162511|B3||Female|Sex: Female, Male|Gender at Interim Analysis|Participants|Count of Participants|60|60.0||||||
4335228|NCT00430781|4162512|B2||Female|Sex: Female, Male|Gender at Interim Analysis|Participants|Count of Participants|58|58.0||||||
4335229|NCT00430781|4162513|B1||Female|Sex: Female, Male|Gender at Interim Analysis|Participants|Count of Participants|59|59.0||||||
4335230|NCT00430781|4162510|B4|||Age|Age at Final Analysis (n=0, 78, 74)|years|Mean|50|50.0|Standard Deviation|11.1|11.1|||
4335231|NCT00430781|4162511|B3|||Age|Age at Final Analysis (n=0, 78, 74)|years|Mean|50.8|50.8|Standard Deviation|10.93|10.93|||
4335232|NCT00430781|4162512|B2|||Age|Age at Final Analysis (n=0, 78, 74)|years|Mean|49.2|49.2|Standard Deviation|11.27|11.27|||
4335233|NCT00430781|4162513|B1|||Age|Age at Final Analysis (n=0, 78, 74)|years|Mean|NA||Standard Deviation|NA||||There are no participants for this analysis subgroup.
4335234|NCT00430781|4162510|B4|||Age|Age at Interim Analysis|years|Mean|49.5|49.5|Standard Deviation|10.91|10.91|||
4335235|NCT00430781|4162511|B3|||Age|Age at Interim Analysis|years|Mean|49.6|49.6|Standard Deviation|10.34|10.34|||
4335236|NCT00430781|4162512|B2|||Age|Age at Interim Analysis|years|Mean|48.7|48.7|Standard Deviation|11.47|11.47|||
4335237|NCT00430781|4162513|B1|||Age|Age at Interim Analysis|years|Mean|50.4|50.4|Standard Deviation|11.04|11.04|||
4335238|NCT00430768|4162538|B4|No||Prior AAT Protein Augmentation Therapy||participants|Number|5|5.0||||||
4335239|NCT00430768|4162539|B3|No||Prior AAT Protein Augmentation Therapy||participants|Number|2|2.0||||||
4335240|NCT00430768|4162540|B2|No||Prior AAT Protein Augmentation Therapy||participants|Number|2|2.0||||||
4335241|NCT00430768|4162541|B1|No||Prior AAT Protein Augmentation Therapy||participants|Number|1|1.0||||||
4335242|NCT00430768|4162538|B4|Yes||Prior AAT Protein Augmentation Therapy||participants|Number|4|4.0||||||
4335243|NCT00430768|4162539|B3|Yes||Prior AAT Protein Augmentation Therapy||participants|Number|1|1.0||||||
4335244|NCT00430768|4162540|B2|Yes||Prior AAT Protein Augmentation Therapy||participants|Number|1|1.0||||||
4335245|NCT00430768|4162541|B1|Yes||Prior AAT Protein Augmentation Therapy||participants|Number|2|2.0||||||
4335246|NCT00430768|4162538|B4|||Weight (kg)||kilograms|Median|72.6|72.6|Full Range|||54.6|134.6|
4335247|NCT00430768|4162539|B3|||Weight (kg)||kilograms|Median|72.6|72.6|Full Range|||69.3|134.6|
4335248|NCT00430768|4162540|B2|||Weight (kg)||kilograms|Median|83.0|83.0|Full Range|||72.7|89.0|
4335249|NCT00430768|4162541|B1|||Weight (kg)||kilograms|Median|66.5|66.5|Full Range|||54.6|73.7|
4335250|NCT00430768|4162538|B4|||FEV1 (% predicted)|forced expiratory volume in 1 second; percent predicted for race, height, and weight|percent predicted|Median|58.0|58.0|Full Range|||40.5|97.6|
4335251|NCT00430768|4162539|B3|||FEV1 (% predicted)|forced expiratory volume in 1 second; percent predicted for race, height, and weight|percent predicted|Median|58.0|58.0|Full Range|||54.9|97.6|
4335252|NCT00430768|4162540|B2|||FEV1 (% predicted)|forced expiratory volume in 1 second; percent predicted for race, height, and weight|percent predicted|Median|50.8|50.8|Full Range|||40.5|93.0|
4335253|NCT00430768|4162541|B1|||FEV1 (% predicted)|forced expiratory volume in 1 second; percent predicted for race, height, and weight|percent predicted|Median|86.7|86.7|Full Range|||53.6|92.1|
4335254|NCT00430768|4162538|B4|United States||Region of Enrollment||participants|Number|9|9.0||||||
4335255|NCT00430768|4162539|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4335256|NCT00430768|4162540|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4335257|NCT00430768|4162541|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4335258|NCT00430768|4162538|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335259|NCT00430768|4162539|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335260|NCT00430768|4162540|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335261|NCT00430768|4162541|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335262|NCT00430768|4162538|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335263|NCT00430768|4162539|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335264|NCT00430768|4162540|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335265|NCT00430768|4162541|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335266|NCT00430768|4162538|B4||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4335267|NCT00430768|4162539|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4335268|NCT00430768|4162540|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4335269|NCT00430768|4162541|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4335270|NCT00430768|4162538|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335271|NCT00430768|4162539|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335272|NCT00430768|4162540|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335273|NCT00430768|4162541|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335274|NCT00430768|4162538|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335275|NCT00430768|4162539|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335276|NCT00430768|4162540|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335277|NCT00430768|4162541|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335278|NCT00430768|4162538|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335279|NCT00430768|4162539|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335280|NCT00430768|4162540|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335281|NCT00430768|4162541|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335282|NCT00430768|4162538|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335283|NCT00430768|4162539|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335284|NCT00430768|4162540|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335285|NCT00430768|4162541|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335286|NCT00430768|4162538|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335287|NCT00430768|4162539|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335288|NCT00430768|4162540|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335289|NCT00430768|4162541|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335290|NCT00430768|4162538|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4335291|NCT00430768|4162539|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4335292|NCT00430768|4162540|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4335293|NCT00430768|4162541|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4335294|NCT00430768|4162538|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335295|NCT00430768|4162539|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335296|NCT00430768|4162540|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335297|NCT00430768|4162541|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335298|NCT00430768|4162538|B4||Male|Gender||Participants|Count of Participants|5|5.0||||||
4335299|NCT00430768|4162539|B3||Male|Gender||Participants|Count of Participants|1|1.0||||||
4335300|NCT00430768|4162540|B2||Male|Gender||Participants|Count of Participants|3|3.0||||||
4335301|NCT00430768|4162541|B1||Male|Gender||Participants|Count of Participants|1|1.0||||||
4335302|NCT00430768|4162538|B4||Female|Gender||Participants|Count of Participants|4|4.0||||||
4335303|NCT00430768|4162539|B3||Female|Gender||Participants|Count of Participants|2|2.0||||||
4335304|NCT00430768|4162540|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
4335305|NCT00430768|4162541|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
4335306|NCT00430768|4162538|B4|||Age, Customized||years|Median|54|54.0|Full Range|||35.0|73.0|
4335307|NCT00430768|4162539|B3|||Age, Customized||years|Median|47|47.0|Full Range|||35.0|61.0|
4335308|NCT00430768|4162540|B2|||Age, Customized||years|Median|54|54.0|Full Range|||38.0|59.0|
4335309|NCT00430768|4162541|B1|||Age, Customized||years|Median|69|69.0|Full Range|||66.0|73.0|
4335310|NCT00430755|4162557|B1|Germany||Region of Enrollment||participants|Number|98|98.0||||||
4335311|NCT00430755|4162557|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4335312|NCT00430755|4162557|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4335313|NCT00430755|4162557|B1|||Age||years|Mean|58|58.0|Standard Deviation|16|16.0|||
4335314|NCT00430716|4162561|B4|Class IV||World Health Organization (WHO) Classification of PAH|PAH criteria for WHO Class: Class I (Participants with no limitation of physical activity); Class II (Participants with slight limitation of physical activity); Class III (Participants with marked limitation of physical activity); Class IV (Participants with inability to carry out any physical activity).|Participants|Number|1|1.0||||||
4335315|NCT00430716|4162562|B3|Class IV||World Health Organization (WHO) Classification of PAH|PAH criteria for WHO Class: Class I (Participants with no limitation of physical activity); Class II (Participants with slight limitation of physical activity); Class III (Participants with marked limitation of physical activity); Class IV (Participants with inability to carry out any physical activity).|Participants|Number|0|0.0||||||
4335316|NCT00430716|4162563|B2|Class IV||World Health Organization (WHO) Classification of PAH|PAH criteria for WHO Class: Class I (Participants with no limitation of physical activity); Class II (Participants with slight limitation of physical activity); Class III (Participants with marked limitation of physical activity); Class IV (Participants with inability to carry out any physical activity).|Participants|Number|1|1.0||||||
4335317|NCT00430716|4162564|B1|Class IV||World Health Organization (WHO) Classification of PAH|PAH criteria for WHO Class: Class I (Participants with no limitation of physical activity); Class II (Participants with slight limitation of physical activity); Class III (Participants with marked limitation of physical activity); Class IV (Participants with inability to carry out any physical activity).|Participants|Number|0|0.0||||||
4335318|NCT00430716|4162561|B4|Class III||World Health Organization (WHO) Classification of PAH|PAH criteria for WHO Class: Class I (Participants with no limitation of physical activity); Class II (Participants with slight limitation of physical activity); Class III (Participants with marked limitation of physical activity); Class IV (Participants with inability to carry out any physical activity).|Participants|Number|45|45.0||||||
4335319|NCT00430716|4162562|B3|Class III||World Health Organization (WHO) Classification of PAH|PAH criteria for WHO Class: Class I (Participants with no limitation of physical activity); Class II (Participants with slight limitation of physical activity); Class III (Participants with marked limitation of physical activity); Class IV (Participants with inability to carry out any physical activity).|Participants|Number|13|13.0||||||
4335320|NCT00430716|4162563|B2|Class III||World Health Organization (WHO) Classification of PAH|PAH criteria for WHO Class: Class I (Participants with no limitation of physical activity); Class II (Participants with slight limitation of physical activity); Class III (Participants with marked limitation of physical activity); Class IV (Participants with inability to carry out any physical activity).|Participants|Number|16|16.0||||||
4335386|NCT00430677|4162595|B4|Native Hawaiian/Other Pacific Islander||Race||Participants|Number|1|1.0||||||
4335321|NCT00430716|4162564|B1|Class III||World Health Organization (WHO) Classification of PAH|PAH criteria for WHO Class: Class I (Participants with no limitation of physical activity); Class II (Participants with slight limitation of physical activity); Class III (Participants with marked limitation of physical activity); Class IV (Participants with inability to carry out any physical activity).|Participants|Number|16|16.0||||||
4335322|NCT00430716|4162561|B4|Class II||World Health Organization (WHO) Classification of PAH|PAH criteria for WHO Class: Class I (Participants with no limitation of physical activity); Class II (Participants with slight limitation of physical activity); Class III (Participants with marked limitation of physical activity); Class IV (Participants with inability to carry out any physical activity).|Participants|Number|74|74.0||||||
4335323|NCT00430716|4162562|B3|Class II||World Health Organization (WHO) Classification of PAH|PAH criteria for WHO Class: Class I (Participants with no limitation of physical activity); Class II (Participants with slight limitation of physical activity); Class III (Participants with marked limitation of physical activity); Class IV (Participants with inability to carry out any physical activity).|Participants|Number|27|27.0||||||
4335324|NCT00430716|4162563|B2|Class II||World Health Organization (WHO) Classification of PAH|PAH criteria for WHO Class: Class I (Participants with no limitation of physical activity); Class II (Participants with slight limitation of physical activity); Class III (Participants with marked limitation of physical activity); Class IV (Participants with inability to carry out any physical activity).|Participants|Number|22|22.0||||||
4335325|NCT00430716|4162564|B1|Class II||World Health Organization (WHO) Classification of PAH|PAH criteria for WHO Class: Class I (Participants with no limitation of physical activity); Class II (Participants with slight limitation of physical activity); Class III (Participants with marked limitation of physical activity); Class IV (Participants with inability to carry out any physical activity).|Participants|Number|25|25.0||||||
4335326|NCT00430716|4162561|B4|Class I||World Health Organization (WHO) Classification of PAH|PAH criteria for WHO Class: Class I (Participants with no limitation of physical activity); Class II (Participants with slight limitation of physical activity); Class III (Participants with marked limitation of physical activity); Class IV (Participants with inability to carry out any physical activity).|Participants|Number|4|4.0||||||
4335327|NCT00430716|4162562|B3|Class I||World Health Organization (WHO) Classification of PAH|PAH criteria for WHO Class: Class I (Participants with no limitation of physical activity); Class II (Participants with slight limitation of physical activity); Class III (Participants with marked limitation of physical activity); Class IV (Participants with inability to carry out any physical activity).|Participants|Number|3|3.0||||||
4335328|NCT00430716|4162563|B2|Class I||World Health Organization (WHO) Classification of PAH|PAH criteria for WHO Class: Class I (Participants with no limitation of physical activity); Class II (Participants with slight limitation of physical activity); Class III (Participants with marked limitation of physical activity); Class IV (Participants with inability to carry out any physical activity).|Participants|Number|1|1.0||||||
4335329|NCT00430716|4162564|B1|Class I||World Health Organization (WHO) Classification of PAH|PAH criteria for WHO Class: Class I (Participants with no limitation of physical activity); Class II (Participants with slight limitation of physical activity); Class III (Participants with marked limitation of physical activity); Class IV (Participants with inability to carry out any physical activity).|Participants|Number|0|0.0||||||
4335330|NCT00430716|4162561|B4|||BORG dyspnoea score|BORG dyspnoea scale includes score from 0 -10 where following scores stands for severity of dyspnoea:0(no breathlessness at all),0.5(very very slight [just noticeable]),1 (very slight),2(slight breathlessness),3(moderate),4(some what severe),5(severe breathlessness),7 (very severe breathlessness),9(very very severe [almost maximum]and 10-maximum.|Units on a scale|Mean|2.9|2.9|Standard Deviation|2.2|2.2|||
4335331|NCT00430716|4162562|B3|||BORG dyspnoea score|BORG dyspnoea scale includes score from 0 -10 where following scores stands for severity of dyspnoea:0(no breathlessness at all),0.5(very very slight [just noticeable]),1 (very slight),2(slight breathlessness),3(moderate),4(some what severe),5(severe breathlessness),7 (very severe breathlessness),9(very very severe [almost maximum]and 10-maximum.|Units on a scale|Mean|2.8|2.8|Standard Deviation|2.1|2.1|||
4335332|NCT00430716|4162563|B2|||BORG dyspnoea score|BORG dyspnoea scale includes score from 0 -10 where following scores stands for severity of dyspnoea:0(no breathlessness at all),0.5(very very slight [just noticeable]),1 (very slight),2(slight breathlessness),3(moderate),4(some what severe),5(severe breathlessness),7 (very severe breathlessness),9(very very severe [almost maximum]and 10-maximum.|Units on a scale|Mean|3.1|3.1|Standard Deviation|1.9|1.9|||
4335333|NCT00430716|4162564|B1|||BORG dyspnoea score|BORG dyspnoea scale includes score from 0 -10 where following scores stands for severity of dyspnoea:0(no breathlessness at all),0.5(very very slight [just noticeable]),1 (very slight),2(slight breathlessness),3(moderate),4(some what severe),5(severe breathlessness),7 (very severe breathlessness),9(very very severe [almost maximum]and 10-maximum.|Units on a scale|Mean|2.9|2.9|Standard Deviation|2.5|2.5|||
4335334|NCT00430716|4162561|B4|||Tricuspid annular plane systolic excursion (TAPSE)|TAPSE was measured as the total displacement of the tricuspid annulus in cm from end diastole to end systole.TAPSE is an indicator of progression of PAH / RV dysfunction.|cm|Mean|1.3|1.3|Standard Deviation|0.7|0.7|||
4335335|NCT00430716|4162562|B3|||Tricuspid annular plane systolic excursion (TAPSE)|TAPSE was measured as the total displacement of the tricuspid annulus in cm from end diastole to end systole.TAPSE is an indicator of progression of PAH / RV dysfunction.|cm|Mean|1.4|1.4|Standard Deviation|0.8|0.8|||
4335336|NCT00430716|4162563|B2|||Tricuspid annular plane systolic excursion (TAPSE)|TAPSE was measured as the total displacement of the tricuspid annulus in cm from end diastole to end systole.TAPSE is an indicator of progression of PAH / RV dysfunction.|cm|Mean|1.2|1.2|Standard Deviation|0.7|0.7|||
4335337|NCT00430716|4162564|B1|||Tricuspid annular plane systolic excursion (TAPSE)|TAPSE was measured as the total displacement of the tricuspid annulus in cm from end diastole to end systole.TAPSE is an indicator of progression of PAH / RV dysfunction.|cm|Mean|1.3|1.3|Standard Deviation|0.6|0.6|||
4335338|NCT00430716|4162561|B4|||Pro-BNP|Pro-BNP which is a precursor of BNP, is a non-invasive biomarker and an indicator of progression of PAH / RV dysfunction in participants with PAH.|pg/mL|Mean|1300.8|1300.8|Standard Deviation|1458.6|1458.6|||
4335339|NCT00430716|4162562|B3|||Pro-BNP|Pro-BNP which is a precursor of BNP, is a non-invasive biomarker and an indicator of progression of PAH / RV dysfunction in participants with PAH.|pg/mL|Mean|1153.1|1153.1|Standard Deviation|1191.4|1191.4|||
4335340|NCT00430716|4162563|B2|||Pro-BNP|Pro-BNP which is a precursor of BNP, is a non-invasive biomarker and an indicator of progression of PAH / RV dysfunction in participants with PAH.|pg/mL|Mean|1225.6|1225.6|Standard Deviation|1279.3|1279.3|||
4335341|NCT00430716|4162564|B1|||Pro-BNP|Pro-BNP which is a precursor of BNP, is a non-invasive biomarker and an indicator of progression of PAH / RV dysfunction in participants with PAH.|pg/mL|Mean|1540.8|1540.8|Standard Deviation|1853.7|1853.7|||
4335342|NCT00430716|4162561|B4|||B-type natriuretic peptide (BNP)|BNP is a non-invasive biomarker and an indicator of progression of pulmonary hypertension (PAH) /right ventricular (RV) dysfunction in participants with PAH.|picogram(pg)/milliter(mL)|Mean|242.8|242.8|Standard Deviation|280.4|280.4|||
4335343|NCT00430716|4162562|B3|||B-type natriuretic peptide (BNP)|BNP is a non-invasive biomarker and an indicator of progression of pulmonary hypertension (PAH) /right ventricular (RV) dysfunction in participants with PAH.|picogram(pg)/milliter(mL)|Mean|248.9|248.9|Standard Deviation|268.3|268.3|||
4335344|NCT00430716|4162563|B2|||B-type natriuretic peptide (BNP)|BNP is a non-invasive biomarker and an indicator of progression of pulmonary hypertension (PAH) /right ventricular (RV) dysfunction in participants with PAH.|picogram(pg)/milliter(mL)|Mean|207.2|207.2|Standard Deviation|220.3|220.3|||
4335345|NCT00430716|4162564|B1|||B-type natriuretic peptide (BNP)|BNP is a non-invasive biomarker and an indicator of progression of pulmonary hypertension (PAH) /right ventricular (RV) dysfunction in participants with PAH.|picogram(pg)/milliter(mL)|Mean|272.4|272.4|Standard Deviation|344.7|344.7|||
4335346|NCT00430716|4162561|B4|||mean pulmonary artery pressure (mPAP)||millimeter(mm) of mercury(Hg)|Mean|54.5|54.5|Standard Deviation|21.0|21.0|||
4335347|NCT00430716|4162562|B3|||mean pulmonary artery pressure (mPAP)||millimeter(mm) of mercury(Hg)|Mean|51.1|51.1|Standard Deviation|21.4|21.4|||
4335348|NCT00430716|4162563|B2|||mean pulmonary artery pressure (mPAP)||millimeter(mm) of mercury(Hg)|Mean|55.4|55.4|Standard Deviation|19.7|19.7|||
4335349|NCT00430716|4162564|B1|||mean pulmonary artery pressure (mPAP)||millimeter(mm) of mercury(Hg)|Mean|57.2|57.2|Standard Deviation|21.9|21.9|||
4335350|NCT00430716|4162561|B4|||Six Minute Walk Test (6 MWT)|6 MWT was the distance that a participant could walk in 6 minutes. Participants were asked to perform the test at a pace that was comfortable to them, with as many breaks as they needed. Continuous pulse oximetry was conducted during the test for safety.|Meters|Mean|345.1|345.1|Standard Deviation|71.9|71.9|||
4335351|NCT00430716|4162562|B3|||Six Minute Walk Test (6 MWT)|6 MWT was the distance that a participant could walk in 6 minutes. Participants were asked to perform the test at a pace that was comfortable to them, with as many breaks as they needed. Continuous pulse oximetry was conducted during the test for safety.|Meters|Mean|340.4|340.4|Standard Deviation|76.3|76.3|||
4335352|NCT00430716|4162563|B2|||Six Minute Walk Test (6 MWT)|6 MWT was the distance that a participant could walk in 6 minutes. Participants were asked to perform the test at a pace that was comfortable to them, with as many breaks as they needed. Continuous pulse oximetry was conducted during the test for safety.|Meters|Mean|347.7|347.7|Standard Deviation|73.4|73.4|||
4335353|NCT00430716|4162564|B1|||Six Minute Walk Test (6 MWT)|6 MWT was the distance that a participant could walk in 6 minutes. Participants were asked to perform the test at a pace that was comfortable to them, with as many breaks as they needed. Continuous pulse oximetry was conducted during the test for safety.|Meters|Mean|347.5|347.5|Standard Deviation|67.3|67.3|||
4335354|NCT00430716|4162561|B4||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4335355|NCT00430716|4162562|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4335356|NCT00430716|4162563|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4335357|NCT00430716|4162564|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4335358|NCT00430716|4162561|B4||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4335359|NCT00430716|4162562|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4335360|NCT00430716|4162563|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4335361|NCT00430716|4162564|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4335362|NCT00430716|4162561|B4|||Age||Years|Mean|44.5|44.5|Standard Deviation|17.2|17.2|||
4335363|NCT00430716|4162562|B3|||Age||Years|Mean|46.4|46.4|Standard Deviation|17.7|17.7|||
4335364|NCT00430716|4162563|B2|||Age||Years|Mean|44.4|44.4|Standard Deviation|17.4|17.4|||
4335365|NCT00430716|4162564|B1|||Age||Years|Mean|42.5|42.5|Standard Deviation|16.5|16.5|||
4335366|NCT00430677|4162595|B4|>100 kg||Weight, Group||participants|Number|8|8.0||||||
4335367|NCT00430677|4162596|B3|>100 kg||Weight, Group||participants|Number|4|4.0||||||
4335368|NCT00430677|4162597|B2|>100 kg||Weight, Group||participants|Number|1|1.0||||||
4335369|NCT00430677|4162598|B1|>100 kg||Weight, Group||participants|Number|3|3.0||||||
4335370|NCT00430677|4162595|B4|60 - 100 kg||Weight, Group||participants|Number|136|136.0||||||
4335371|NCT00430677|4162596|B3|60 - 100 kg||Weight, Group||participants|Number|51|51.0||||||
4335372|NCT00430677|4162597|B2|60 - 100 kg||Weight, Group||participants|Number|43|43.0||||||
4335373|NCT00430677|4162598|B1|60 - 100 kg||Weight, Group||participants|Number|42|42.0||||||
4335374|NCT00430677|4162595|B4|<60 kg||Weight, Group||participants|Number|154|154.0||||||
4335375|NCT00430677|4162596|B3|<60 kg||Weight, Group||participants|Number|45|45.0||0.73|0.73|||
4335376|NCT00430677|4162597|B2|<60 kg||Weight, Group||participants|Number|55|55.0||0.62|0.62|||
4335377|NCT00430677|4162598|B1|<60 kg||Weight, Group||participants|Number|54|54.0||0.68|0.68|||
4335378|NCT00430677|4162595|B4|Other||Race||Participants|Number|7|7.0||||||
4335379|NCT00430677|4162596|B3|Other||Race||Participants|Number|2|2.0||||||
4335380|NCT00430677|4162597|B2|Other||Race||Participants|Number|1|1.0||||||
4335381|NCT00430677|4162598|B1|Other||Race||Participants|Number|4|4.0||||||
4335382|NCT00430677|4162595|B4|Other Asian||Race||Participants|Number|164|164.0||||||
4335383|NCT00430677|4162596|B3|Other Asian||Race||Participants|Number|55|55.0||||||
4335384|NCT00430677|4162597|B2|Other Asian||Race||Participants|Number|49|49.0||||||
4335385|NCT00430677|4162598|B1|Other Asian||Race||Participants|Number|60|60.0||||||
4335387|NCT00430677|4162596|B3|Native Hawaiian/Other Pacific Islander||Race||Participants|Number|0|0.0||||||
4335388|NCT00430677|4162597|B2|Native Hawaiian/Other Pacific Islander||Race||Participants|Number|0|0.0||||||
4335389|NCT00430677|4162598|B1|Native Hawaiian/Other Pacific Islander||Race||Participants|Number|1|1.0||||||
4335390|NCT00430677|4162595|B4|American Indian/Alaska Native||Race||Participants|Number|1|1.0||||||
4335391|NCT00430677|4162596|B3|American Indian/Alaska Native||Race||Participants|Number|0|0.0||||||
4335392|NCT00430677|4162597|B2|American Indian/Alaska Native||Race||Participants|Number|1|1.0||||||
4335393|NCT00430677|4162598|B1|American Indian/Alaska Native||Race||Participants|Number|0|0.0||||||
4335394|NCT00430677|4162595|B4|Black/African American||Race||Participants|Number|14|14.0||||||
4335395|NCT00430677|4162596|B3|Black/African American||Race||Participants|Number|5|5.0||||||
4335396|NCT00430677|4162597|B2|Black/African American||Race||Participants|Number|3|3.0||||||
4335397|NCT00430677|4162598|B1|Black/African American||Race||Participants|Number|6|6.0||||||
4335398|NCT00430677|4162595|B4|White||Race||Participants|Number|111|111.0||||||
4335399|NCT00430677|4162596|B3|White||Race||Participants|Number|38|38.0||||||
4335400|NCT00430677|4162597|B2|White||Race||Participants|Number|45|45.0||||||
4335401|NCT00430677|4162598|B1|White||Race||Participants|Number|28|28.0||||||
4335402|NCT00430677|4162595|B4||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4335403|NCT00430677|4162596|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4335404|NCT00430677|4162597|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4335405|NCT00430677|4162598|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4335406|NCT00430677|4162595|B4||Female|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4335407|NCT00430677|4162596|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4335408|NCT00430677|4162597|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4335409|NCT00430677|4162598|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4335410|NCT00430677|4162595|B4|>= 60 years||Age, Customized||Participants|Number|3|3.0||||||
4335411|NCT00430677|4162596|B3|>= 60 years||Age, Customized||Participants|Number|1|1.0||||||
4335412|NCT00430677|4162597|B2|>= 60 years||Age, Customized||Participants|Number|1|1.0||||||
4335413|NCT00430677|4162598|B1|>= 60 years||Age, Customized||Participants|Number|1|1.0||||||
4335414|NCT00430677|4162595|B4|50 - 59 years||Age, Customized||Participants|Number|13|13.0||||||
4335415|NCT00430677|4162596|B3|50 - 59 years||Age, Customized||Participants|Number|2|2.0||||||
4335416|NCT00430677|4162597|B2|50 - 59 years||Age, Customized||Participants|Number|6|6.0||||||
4335417|NCT00430677|4162598|B1|50 - 59 years||Age, Customized||Participants|Number|5|5.0||||||
4335418|NCT00430677|4162595|B4|40 - 49 years||Age, Customized||Participants|Number|38|38.0||||||
4335419|NCT00430677|4162596|B3|40 - 49 years||Age, Customized||Participants|Number|18|18.0||||||
4335420|NCT00430677|4162597|B2|40 - 49 years||Age, Customized||Participants|Number|10|10.0||||||
4335421|NCT00430677|4162598|B1|40 - 49 years||Age, Customized||Participants|Number|10|10.0||||||
4335422|NCT00430677|4162595|B4|30 - 39 years||Age, Customized||Participants|Number|91|91.0||||||
4335423|NCT00430677|4162596|B3|30 - 39 years||Age, Customized||Participants|Number|33|33.0||||||
4335424|NCT00430677|4162597|B2|30 - 39 years||Age, Customized||Participants|Number|30|30.0||||||
4335425|NCT00430677|4162598|B1|30 - 39 years||Age, Customized||Participants|Number|28|28.0||||||
4335426|NCT00430677|4162595|B4|16 - 29 years||Age, Customized||Participants|Number|153|153.0||||||
4335427|NCT00430677|4162596|B3|16 - 29 years||Age, Customized||Participants|Number|46|46.0||||||
4335428|NCT00430677|4162597|B2|16 - 29 years||Age, Customized||Participants|Number|52|52.0||||||
4335429|NCT00430677|4162598|B1|16 - 29 years||Age, Customized||Participants|Number|55|55.0||||||
4335430|NCT00430638|4162721|B3|||Systolic BP||mm Hg|Mean|156.2|156.2|Full Range|||136.0|178.0|
4335431|NCT00430638|4162722|B2|||Systolic BP||mm Hg|Mean|155.4|155.4|Full Range|||136.0|178.0|
4335432|NCT00430638|4162723|B1|||Systolic BP||mm Hg|Mean|156.9|156.9|Full Range|9.19|9.19|140.0|178.0|
4335433|NCT00430638|4162721|B3|||Heart Rate||Beats/minute|Mean|74.4|74.4|Full Range|||47.0|122.0|
4335434|NCT00430638|4162722|B2|||Heart Rate||Beats/minute|Mean|73.6|73.6|Full Range|||47.0|94.0|
4335435|NCT00430638|4162723|B1|||Heart Rate||Beats/minute|Mean|75.1|75.1|Full Range|10.84|10.84|52.0|122.0|
4335436|NCT00430638|4162721|B3|||Diastolic BP||mm Hg|Mean|94.0|94.0|Full Range|||69.0|107.0|
4335437|NCT00430638|4162722|B2|||Diastolic BP||mm Hg|Mean|93.7|93.7|Full Range|||69.0|107.0|
4335438|NCT00430638|4162723|B1|||Diastolic BP||mm Hg|Mean|94.2|94.2|Full Range|7.7|7.7|74.0|106.0|
4335439|NCT00430638|4162721|B3|United States||Region of Enrollment||participants|Number|276|276.0||||||
4335440|NCT00430638|4162722|B2|United States||Region of Enrollment||participants|Number|138|138.0||||||
4335441|NCT00430638|4162723|B1|United States||Region of Enrollment||participants|Number|138|138.0||||||
4335442|NCT00430638|4162721|B3||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4335443|NCT00430638|4162722|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4335444|NCT00430638|4162723|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4335445|NCT00430638|4162721|B3||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4335446|NCT00430638|4162722|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4335447|NCT00430638|4162723|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4335448|NCT00430638|4162721|B3|||Age||years|Mean|55.9|55.9|Full Range|10.1|10.1|26.0|86.0|
4335449|NCT00430638|4162722|B2|||Age||years|Mean|55.8|55.8|Full Range|9.47|9.47|35.0|80.0|
4335450|NCT00430638|4162723|B1|||Age||years|Mean|55.9|55.9|Full Range|10.74|10.74|26.0|86.0|
4335451|NCT00430625|4162740|B3|||Baseline platelet counts per treatment group|Modified baseline used for analysis (defined as average of screening and baseline values)|(x10^9/L)|Median|65.5|65.5|Full Range|86.71|86.71|13.0|438.0|
4335452|NCT00430625|4162741|B2|||Baseline platelet counts per treatment group|Modified baseline used for analysis (defined as average of screening and baseline values)|(x10^9/L)|Median|66.75|66.75|Full Range|111.91|111.91|47.0|438.0|
4335453|NCT00430625|4162742|B1|||Baseline platelet counts per treatment group|Modified baseline used for analysis (defined as average of screening and baseline values)|(x10^9/L)|Median|58.00|58.0|Full Range|59.56|59.56|13.0|264.0|
4335454|NCT00430625|4162740|B3|||Baseline liver volume|Normal liver volume is defined as 2.5 percent of body weight.|Percent of body weight|Median|3.5|3.5|Full Range|||2.3|8.0|
4335455|NCT00430625|4162741|B2|||Baseline liver volume|Normal liver volume is defined as 2.5 percent of body weight.|Percent of body weight|Median|3.65|3.65|Full Range|||2.4|8.0|
4335456|NCT00430625|4162742|B1|||Baseline liver volume|Normal liver volume is defined as 2.5 percent of body weight.|Percent of body weight|Median|3.50|3.5|Full Range|||2.3|7.2|
4335457|NCT00430625|4162740|B3|||Baseline hemoglobin concentration per treatment group|Modified baseline used for analysis (defined as average of screening and baseline values)|g/dL|Median|10.85|10.85|Full Range|1.248|1.248|7.05|12.85|
4335458|NCT00430625|4162741|B2|||Baseline hemoglobin concentration per treatment group|Modified baseline used for analysis (defined as average of screening and baseline values)|g/dL|Median|10.83|10.83|Full Range|1.272|1.272|7.05|12.25|
4335459|NCT00430625|4162742|B1|||Baseline hemoglobin concentration per treatment group|Modified baseline used for analysis (defined as average of screening and baseline values)|g/dL|Median|10.90|10.9|Full Range|1.278|1.278|8.45|12.85|
4335460|NCT00430625|4162740|B3|||Baseline Spleen volume|Normal spleen volume is defined as 0.2 percentage of body weight.|Percent of body weight|Median|2.9|2.9|Full Range|||0.4|13.0|
4335461|NCT00430625|4162741|B2|||Baseline Spleen volume|Normal spleen volume is defined as 0.2 percentage of body weight.|Percent of body weight|Median|2.8|2.8|Full Range|||0.4|7.4|
4335462|NCT00430625|4162742|B1|||Baseline Spleen volume|Normal spleen volume is defined as 0.2 percentage of body weight.|Percent of body weight|Median|2.9|2.9|Full Range|||0.5|13.0|
4335463|NCT00430625|4162740|B3|Tunisia||Region of Enrollment||participants|Number|3|3.0||||||
4335464|NCT00430625|4162741|B2|Tunisia||Region of Enrollment||participants|Number|1|1.0||||||
4335465|NCT00430625|4162742|B1|Tunisia||Region of Enrollment||participants|Number|2|2.0||||||
4335466|NCT00430625|4162740|B3|Israel||Region of Enrollment||participants|Number|7|7.0||||||
4335467|NCT00430625|4162741|B2|Israel||Region of Enrollment||participants|Number|6|6.0||||||
4335468|NCT00430625|4162742|B1|Israel||Region of Enrollment||participants|Number|1|1.0||||||
4335469|NCT00430625|4162740|B3|Russian Federation||Region of Enrollment||participants|Number|3|3.0||||||
4335470|NCT00430625|4162741|B2|Russian Federation||Region of Enrollment||participants|Number|0|0.0||||||
4335471|NCT00430625|4162742|B1|Russian Federation||Region of Enrollment||participants|Number|3|3.0||||||
4335472|NCT00430625|4162740|B3|Argentina||Region of Enrollment||participants|Number|1|1.0||||||
4335473|NCT00430625|4162741|B2|Argentina||Region of Enrollment||participants|Number|0|0.0||||||
4335474|NCT00430625|4162742|B1|Argentina||Region of Enrollment||participants|Number|1|1.0||||||
4335475|NCT00430625|4162740|B3|Paraguay||Region of Enrollment||participants|Number|11|11.0||||||
4335476|NCT00430625|4162741|B2|Paraguay||Region of Enrollment||participants|Number|5|5.0||||||
4335477|NCT00430625|4162742|B1|Paraguay||Region of Enrollment||participants|Number|6|6.0||||||
4335478|NCT00430625|4162740|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4335479|NCT00430625|4162741|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4335480|NCT00430625|4162742|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4335481|NCT00430625|4162740|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4335482|NCT00430625|4162741|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4335483|NCT00430625|4162742|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4335484|NCT00430625|4162740|B3|||Age||years|Median|25|25.0|Full Range|15.28|15.28|4.0|62.0|
4335485|NCT00430625|4162741|B2|||Age||years|Median|23.5|23.5|Full Range|11.77|11.77|4.0|42.0|
4335486|NCT00430625|4162742|B1|||Age||years|Median|30.0|30.0|Full Range|16.75|16.75|6.0|62.0|
4335487|NCT00430625|4162740|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||0.0|0.0|
4335488|NCT00430625|4162741|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||0.0|0.0|
4335489|NCT00430625|4162742|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||0.0|0.0|
4335490|NCT00430625|4162740|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4335491|NCT00430625|4162741|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4335492|NCT00430625|4162742|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4335493|NCT00430625|4162740|B3||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4335494|NCT00430625|4162741|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4335495|NCT00430625|4162742|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4335496|NCT00430573|4162759|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4335497|NCT00430573|4162759|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335498|NCT00430573|4162759|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335499|NCT00430573|4162759|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4335500|NCT00430573|4162759|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4335501|NCT00430573|4162759|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335502|NCT00430573|4162759|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335503|NCT00430573|4162759|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335504|NCT00430573|4162759|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335505|NCT00430573|4162759|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4335506|NCT00430573|4162759|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335507|NCT00430573|4162759|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4335508|NCT00430573|4162759|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4335509|NCT00430573|4162759|B1|||Age||years|Mean|40.7|40.7|Standard Deviation|10.7|10.7|||
4335510|NCT00430508|4162764|B5|Other||Race/Ethnicity, Customized||participants|Number|1.0|1.0||||||
4335511|NCT00430508|4162765|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4335512|NCT00430508|4162766|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4335513|NCT00430508|4162767|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4335514|NCT00430508|4162768|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4335515|NCT00430508|4162764|B5|European||Race/Ethnicity, Customized||participants|Number|970.0|970.0||||||
4335516|NCT00430508|4162765|B4|European||Race/Ethnicity, Customized||participants|Number|274|274.0||||||
4335517|NCT00430508|4162766|B3|European||Race/Ethnicity, Customized||participants|Number|278|278.0||||||
4335518|NCT00430508|4162767|B2|European||Race/Ethnicity, Customized||participants|Number|278|278.0||||||
4335519|NCT00430508|4162768|B1|European||Race/Ethnicity, Customized||participants|Number|140|140.0||||||
4335520|NCT00430508|4162764|B5||Male|Sex: Female, Male||Participants|Count of Participants|599.0|599.0||||||
4335521|NCT00430508|4162765|B4||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4335522|NCT00430508|4162766|B3||Male|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4335523|NCT00430508|4162767|B2||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4335524|NCT00430508|4162768|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4335525|NCT00430508|4162764|B5||Female|Sex: Female, Male||Participants|Count of Participants|372.0|372.0||||||
4335526|NCT00430508|4162765|B4||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4335527|NCT00430508|4162766|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4335528|NCT00430508|4162767|B2||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4335529|NCT00430508|4162768|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4335530|NCT00430508|4162764|B5|||Age||years|Mean|54.5|54.5|Standard Deviation|9.24|9.24|||
4335531|NCT00430508|4162765|B4|||Age||years|Mean|54.1|54.1|Standard Deviation|8.92|8.92|||
4335532|NCT00430508|4162766|B3|||Age||years|Mean|55.2|55.2|Standard Deviation|9.47|9.47|||
4335533|NCT00430508|4162767|B2|||Age||years|Mean|53.7|53.7|Standard Deviation|9.77|9.77|||
4335534|NCT00430508|4162768|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|8.17|8.17|||
4335535|NCT00430508|4162764|B5||>=65 years|Age||Participants|Count of Participants|138.0|138.0||||||
4335536|NCT00430508|4162765|B4||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4335537|NCT00430508|4162766|B3||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
4335538|NCT00430508|4162767|B2||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4335539|NCT00430508|4162768|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4335540|NCT00430508|4162764|B5||Between 18 and 65 years|Age||Participants|Count of Participants|833.0|833.0||||||
4335541|NCT00430508|4162765|B4||Between 18 and 65 years|Age||Participants|Count of Participants|238|238.0||||||
4335542|NCT00430508|4162766|B3||Between 18 and 65 years|Age||Participants|Count of Participants|233|233.0||||||
4335543|NCT00430508|4162767|B2||Between 18 and 65 years|Age||Participants|Count of Participants|240|240.0||||||
4335544|NCT00430508|4162768|B1||Between 18 and 65 years|Age||Participants|Count of Participants|122|122.0||||||
4335545|NCT00430508|4162764|B5||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4335546|NCT00430508|4162765|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4335547|NCT00430508|4162766|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4335548|NCT00430508|4162767|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4335549|NCT00430508|4162768|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4335550|NCT00430495|4162805|B5||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4335551|NCT00430495|4162806|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4335552|NCT00430495|4162807|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4335553|NCT00430495|4162808|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4335554|NCT00430495|4162809|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4335555|NCT00430495|4162805|B5||Female|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4335556|NCT00430495|4162806|B4||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4335557|NCT00430495|4162807|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4335558|NCT00430495|4162808|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4335559|NCT00430495|4162809|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4335560|NCT00430495|4162805|B5|||Age||years|Mean|53.8|53.8|Standard Deviation|11.9|11.9|||
4335561|NCT00430495|4162806|B4|||Age||years|Mean|53.5|53.5|Standard Deviation|10.1|10.1|||
4335562|NCT00430495|4162807|B3|||Age||years|Mean|55.3|55.3|Standard Deviation|12.0|12.0|||
4335563|NCT00430495|4162808|B2|||Age||years|Mean|53.4|53.4|Standard Deviation|13.1|13.1|||
4335564|NCT00430495|4162809|B1|||Age||years|Mean|53.1|53.1|Standard Deviation|12.5|12.5|||
4335565|NCT00430352|4162850|B1||Male|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
4335566|NCT00430352|4162850|B1||Female|Sex: Female, Male||Participants|Count of Participants|313|313.0||||||
4335567|NCT00430352|4162850|B1|||Age||years|Mean|56.3|56.3|Standard Deviation|11.47|11.47|||
4335568|NCT00430300|4162864|B5||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4335569|NCT00430300|4162865|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4335570|NCT00430300|4162866|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4335571|NCT00430300|4162867|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4335572|NCT00430300|4162868|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4335573|NCT00430300|4162864|B5||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4335574|NCT00430300|4162865|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4335575|NCT00430300|4162866|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4335576|NCT00430300|4162867|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4335577|NCT00430300|4162868|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4335578|NCT00430300|4162864|B5|Greater Than or Equal to (>=) 65 Years||Age, Customized||participants|Number|51|51.0||||||
4335579|NCT00430300|4162865|B4|Greater Than or Equal to (>=) 65 Years||Age, Customized||participants|Number|8|8.0||||||
4335580|NCT00430300|4162866|B3|Greater Than or Equal to (>=) 65 Years||Age, Customized||participants|Number|23|23.0||||||
4335581|NCT00430300|4162867|B2|Greater Than or Equal to (>=) 65 Years||Age, Customized||participants|Number|11|11.0||||||
4335582|NCT00430300|4162868|B1|Greater Than or Equal to (>=) 65 Years||Age, Customized||participants|Number|9|9.0||||||
4335583|NCT00430300|4162864|B5|45 to 64 Years||Age, Customized||participants|Number|36|36.0||||||
4335584|NCT00430300|4162865|B4|45 to 64 Years||Age, Customized||participants|Number|9|9.0||||||
4335585|NCT00430300|4162866|B3|45 to 64 Years||Age, Customized||participants|Number|12|12.0||||||
4335586|NCT00430300|4162867|B2|45 to 64 Years||Age, Customized||participants|Number|7|7.0||||||
4335587|NCT00430300|4162868|B1|45 to 64 Years||Age, Customized||participants|Number|8|8.0||||||
4335588|NCT00430248|4162973|B4|||Serum Urate||milligrams per deciliter (mg/dL)|Mean|9.6|9.6|Standard Deviation|1.18|1.18|||
4335589|NCT00430248|4162974|B3|||Serum Urate||milligrams per deciliter (mg/dL)|Mean|9.5|9.5|Standard Deviation|1.19|1.19|||
4335590|NCT00430248|4162975|B2|||Serum Urate||milligrams per deciliter (mg/dL)|Mean|9.6|9.6|Standard Deviation|1.20|1.2|||
4335591|NCT00430248|4162976|B1|||Serum Urate||milligrams per deciliter (mg/dL)|Mean|9.6|9.6|Standard Deviation|1.15|1.15|||
4335592|NCT00430248|4162973|B4|||Mean Body Mass Index||kg/m²|Mean|32.8|32.8|Standard Deviation|6.33|6.33|||
4335593|NCT00430248|4162974|B3|||Mean Body Mass Index||kg/m²|Mean|32.7|32.7|Standard Deviation|6.23|6.23|||
4335594|NCT00430248|4162975|B2|||Mean Body Mass Index||kg/m²|Mean|32.9|32.9|Standard Deviation|6.39|6.39|||
4335595|NCT00430248|4162976|B1|||Mean Body Mass Index||kg/m²|Mean|32.9|32.9|Standard Deviation|6.37|6.37|||
4335596|NCT00430248|4162973|B4|Normal Renal Function||Renal Function|"Moderate renal impairment - baseline estimated creatinine clearance (CLcr) 30 milliliters per minute (mL/min) to 59 mL/min; Mild renal impairment - baseline estimated CLcr 60 mL/min to 89 mL/min; Normal renal function - estimated CLcr ≥90 mL/min.~CLcr calculated using the Cockroft-Gault formula corrected for ideal body weight."|subjects|Number|786|786.0||||||
4335597|NCT00430248|4162974|B3|Normal Renal Function||Renal Function|"Moderate renal impairment - baseline estimated creatinine clearance (CLcr) 30 milliliters per minute (mL/min) to 59 mL/min; Mild renal impairment - baseline estimated CLcr 60 mL/min to 89 mL/min; Normal renal function - estimated CLcr ≥90 mL/min.~CLcr calculated using the Cockroft-Gault formula corrected for ideal body weight."|subjects|Number|255|255.0||||||
4335598|NCT00430248|4162975|B2|Normal Renal Function||Renal Function|"Moderate renal impairment - baseline estimated creatinine clearance (CLcr) 30 milliliters per minute (mL/min) to 59 mL/min; Mild renal impairment - baseline estimated CLcr 60 mL/min to 89 mL/min; Normal renal function - estimated CLcr ≥90 mL/min.~CLcr calculated using the Cockroft-Gault formula corrected for ideal body weight."|subjects|Number|253|253.0||||||
4335599|NCT00430248|4162976|B1|Normal Renal Function||Renal Function|"Moderate renal impairment - baseline estimated creatinine clearance (CLcr) 30 milliliters per minute (mL/min) to 59 mL/min; Mild renal impairment - baseline estimated CLcr 60 mL/min to 89 mL/min; Normal renal function - estimated CLcr ≥90 mL/min.~CLcr calculated using the Cockroft-Gault formula corrected for ideal body weight."|subjects|Number|278|278.0||||||
4335600|NCT00430248|4162973|B4|Mild Renal Impairment||Renal Function|"Moderate renal impairment - baseline estimated creatinine clearance (CLcr) 30 milliliters per minute (mL/min) to 59 mL/min; Mild renal impairment - baseline estimated CLcr 60 mL/min to 89 mL/min; Normal renal function - estimated CLcr ≥90 mL/min.~CLcr calculated using the Cockroft-Gault formula corrected for ideal body weight."|subjects|Number|1081|1081.0||||||
4335601|NCT00430248|4162974|B3|Mild Renal Impairment||Renal Function|"Moderate renal impairment - baseline estimated creatinine clearance (CLcr) 30 milliliters per minute (mL/min) to 59 mL/min; Mild renal impairment - baseline estimated CLcr 60 mL/min to 89 mL/min; Normal renal function - estimated CLcr ≥90 mL/min.~CLcr calculated using the Cockroft-Gault formula corrected for ideal body weight."|subjects|Number|365|365.0||||||
4335602|NCT00430248|4162975|B2|Mild Renal Impairment||Renal Function|"Moderate renal impairment - baseline estimated creatinine clearance (CLcr) 30 milliliters per minute (mL/min) to 59 mL/min; Mild renal impairment - baseline estimated CLcr 60 mL/min to 89 mL/min; Normal renal function - estimated CLcr ≥90 mL/min.~CLcr calculated using the Cockroft-Gault formula corrected for ideal body weight."|subjects|Number|367|367.0||||||
4335603|NCT00430248|4162976|B1|Mild Renal Impairment||Renal Function|"Moderate renal impairment - baseline estimated creatinine clearance (CLcr) 30 milliliters per minute (mL/min) to 59 mL/min; Mild renal impairment - baseline estimated CLcr 60 mL/min to 89 mL/min; Normal renal function - estimated CLcr ≥90 mL/min.~CLcr calculated using the Cockroft-Gault formula corrected for ideal body weight."|subjects|Number|349|349.0||||||
4335655|NCT00430248|4162976|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4335604|NCT00430248|4162973|B4|Moderate Renal Impairment||Renal Function|"Moderate renal impairment - baseline estimated creatinine clearance (CLcr) 30 milliliters per minute (mL/min) to 59 mL/min; Mild renal impairment - baseline estimated CLcr 60 mL/min to 89 mL/min; Normal renal function - estimated CLcr ≥90 mL/min.~CLcr calculated using the Cockroft-Gault formula corrected for ideal body weight."|subjects|Number|402|402.0||||||
4335605|NCT00430248|4162974|B3|Moderate Renal Impairment||Renal Function|"Moderate renal impairment - baseline estimated creatinine clearance (CLcr) 30 milliliters per minute (mL/min) to 59 mL/min; Mild renal impairment - baseline estimated CLcr 60 mL/min to 89 mL/min; Normal renal function - estimated CLcr ≥90 mL/min.~CLcr calculated using the Cockroft-Gault formula corrected for ideal body weight."|subjects|Number|136|136.0||||||
4335606|NCT00430248|4162975|B2|Moderate Renal Impairment||Renal Function|"Moderate renal impairment - baseline estimated creatinine clearance (CLcr) 30 milliliters per minute (mL/min) to 59 mL/min; Mild renal impairment - baseline estimated CLcr 60 mL/min to 89 mL/min; Normal renal function - estimated CLcr ≥90 mL/min.~CLcr calculated using the Cockroft-Gault formula corrected for ideal body weight."|subjects|Number|136|136.0||||||
4335607|NCT00430248|4162976|B1|Moderate Renal Impairment||Renal Function|"Moderate renal impairment - baseline estimated creatinine clearance (CLcr) 30 milliliters per minute (mL/min) to 59 mL/min; Mild renal impairment - baseline estimated CLcr 60 mL/min to 89 mL/min; Normal renal function - estimated CLcr ≥90 mL/min.~CLcr calculated using the Cockroft-Gault formula corrected for ideal body weight."|subjects|Number|130|130.0||||||
4335608|NCT00430248|4162973|B4|Yes||Cardiovascular Disease||subjects|Number|1297|1297.0||||||
4335609|NCT00430248|4162974|B3|Yes||Cardiovascular Disease||subjects|Number|436|436.0||||||
4335610|NCT00430248|4162975|B2|Yes||Cardiovascular Disease||subjects|Number|440|440.0||||||
4335611|NCT00430248|4162976|B1|Yes||Cardiovascular Disease||subjects|Number|421|421.0||||||
4335612|NCT00430248|4162973|B4|No||Cardiovascular Disease||subjects|Number|972|972.0||||||
4335613|NCT00430248|4162974|B3|No||Cardiovascular Disease||subjects|Number|320|320.0||||||
4335614|NCT00430248|4162975|B2|No||Cardiovascular Disease||subjects|Number|316|316.0||||||
4335615|NCT00430248|4162976|B1|No||Cardiovascular Disease||subjects|Number|336|336.0||||||
4335616|NCT00430248|4162973|B4|Missing||Body Mass Index||subjects|Number|4|4.0||||||
4335617|NCT00430248|4162974|B3|Missing||Body Mass Index||subjects|Number|1|1.0||||||
4335618|NCT00430248|4162975|B2|Missing||Body Mass Index||subjects|Number|1|1.0||||||
4335619|NCT00430248|4162976|B1|Missing||Body Mass Index||subjects|Number|2|2.0||||||
4335620|NCT00430248|4162973|B4|≥30 kg/m²||Body Mass Index||subjects|Number|1442|1442.0||||||
4335621|NCT00430248|4162974|B3|≥30 kg/m²||Body Mass Index||subjects|Number|476|476.0||||||
4335622|NCT00430248|4162975|B2|≥30 kg/m²||Body Mass Index||subjects|Number|476|476.0||||||
4335623|NCT00430248|4162976|B1|≥30 kg/m²||Body Mass Index||subjects|Number|490|490.0||||||
4335624|NCT00430248|4162973|B4|25 kg/m² to <30 kg/m²||Body Mass Index||subjects|Number|683|683.0||||||
4335625|NCT00430248|4162974|B3|25 kg/m² to <30 kg/m²||Body Mass Index||subjects|Number|236|236.0||||||
4335626|NCT00430248|4162975|B2|25 kg/m² to <30 kg/m²||Body Mass Index||subjects|Number|232|232.0||||||
4335627|NCT00430248|4162976|B1|25 kg/m² to <30 kg/m²||Body Mass Index||subjects|Number|215|215.0||||||
4335628|NCT00430248|4162973|B4|18.5 kg/m² to <25 kg/m²||Body Mass Index||subjects|Number|138|138.0||||||
4335629|NCT00430248|4162974|B3|18.5 kg/m² to <25 kg/m²||Body Mass Index||subjects|Number|42|42.0||||||
4335630|NCT00430248|4162975|B2|18.5 kg/m² to <25 kg/m²||Body Mass Index||subjects|Number|46|46.0||||||
4335631|NCT00430248|4162976|B1|18.5 kg/m² to <25 kg/m²||Body Mass Index||subjects|Number|50|50.0||||||
4335632|NCT00430248|4162973|B4|<18.5 kilograms per meter² (kg/m²)||Body Mass Index||subjects|Number|2|2.0||||||
4335633|NCT00430248|4162974|B3|<18.5 kilograms per meter² (kg/m²)||Body Mass Index||subjects|Number|1|1.0||||||
4335634|NCT00430248|4162975|B2|<18.5 kilograms per meter² (kg/m²)||Body Mass Index||subjects|Number|1|1.0||||||
4335635|NCT00430248|4162976|B1|<18.5 kilograms per meter² (kg/m²)||Body Mass Index||subjects|Number|0|0.0||||||
4335636|NCT00430248|4162973|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4335637|NCT00430248|4162974|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4335638|NCT00430248|4162975|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335639|NCT00430248|4162976|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335640|NCT00430248|4162973|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4335641|NCT00430248|4162974|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4335642|NCT00430248|4162975|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4335643|NCT00430248|4162976|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4335644|NCT00430248|4162973|B4||White|Race (NIH/OMB)||Participants|Count of Participants|1863|1863.0||||||
4335645|NCT00430248|4162974|B3||White|Race (NIH/OMB)||Participants|Count of Participants|625|625.0||||||
4335646|NCT00430248|4162975|B2||White|Race (NIH/OMB)||Participants|Count of Participants|618|618.0||||||
4335647|NCT00430248|4162976|B1||White|Race (NIH/OMB)||Participants|Count of Participants|620|620.0||||||
4335648|NCT00430248|4162973|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|228|228.0||||||
4335649|NCT00430248|4162974|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4335650|NCT00430248|4162975|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
4335651|NCT00430248|4162976|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
4335652|NCT00430248|4162973|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4335653|NCT00430248|4162974|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4335654|NCT00430248|4162975|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4335656|NCT00430248|4162973|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
4335657|NCT00430248|4162974|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4335658|NCT00430248|4162975|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4335659|NCT00430248|4162976|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4335660|NCT00430248|4162973|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4335661|NCT00430248|4162974|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4335662|NCT00430248|4162975|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4335663|NCT00430248|4162976|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4335664|NCT00430248|4162973|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4335665|NCT00430248|4162974|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4335666|NCT00430248|4162975|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335667|NCT00430248|4162976|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4335668|NCT00430248|4162973|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2119|2119.0||||||
4335669|NCT00430248|4162974|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|702|702.0||||||
4335670|NCT00430248|4162975|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|707|707.0||||||
4335671|NCT00430248|4162976|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|710|710.0||||||
4335672|NCT00430248|4162973|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|149|149.0||||||
4335673|NCT00430248|4162974|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4335674|NCT00430248|4162975|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4335675|NCT00430248|4162976|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4335676|NCT00430248|4162973|B4||Male|Sex: Female, Male||Participants|Count of Participants|2141|2141.0||||||
4335677|NCT00430248|4162974|B3||Male|Sex: Female, Male||Participants|Count of Participants|709|709.0||||||
4335678|NCT00430248|4162975|B2||Male|Sex: Female, Male||Participants|Count of Participants|710|710.0||||||
4335679|NCT00430248|4162976|B1||Male|Sex: Female, Male||Participants|Count of Participants|722|722.0||||||
4335680|NCT00430248|4162973|B4||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4335681|NCT00430248|4162974|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4335682|NCT00430248|4162975|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4335683|NCT00430248|4162976|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4335684|NCT00430248|4162973|B4|||Age||years|Mean|52.8|52.8|Standard Deviation|11.73|11.73|||
4335685|NCT00430248|4162974|B3|||Age||years|Mean|52.9|52.9|Standard Deviation|11.73|11.73|||
4335686|NCT00430248|4162975|B2|||Age||years|Mean|53.0|53.0|Standard Deviation|11.79|11.79|||
4335687|NCT00430248|4162976|B1|||Age||years|Mean|52.5|52.5|Standard Deviation|11.68|11.68|||
4335688|NCT00430248|4162973|B4|≥65 years of age||Age, Customized||subjects|Number|374|374.0||||||
4335689|NCT00430248|4162974|B3|≥65 years of age||Age, Customized||subjects|Number|131|131.0||||||
4335690|NCT00430248|4162975|B2|≥65 years of age||Age, Customized||subjects|Number|128|128.0||||||
4335691|NCT00430248|4162976|B1|≥65 years of age||Age, Customized||subjects|Number|115|115.0||||||
4335692|NCT00430248|4162973|B4|45 to <65 years of age||Age, Customized||subjects|Number|1327|1327.0||||||
4335693|NCT00430248|4162974|B3|45 to <65 years of age||Age, Customized||subjects|Number|445|445.0||||||
4335694|NCT00430248|4162975|B2|45 to <65 years of age||Age, Customized||subjects|Number|432|432.0||||||
4335695|NCT00430248|4162976|B1|45 to <65 years of age||Age, Customized||subjects|Number|450|450.0||||||
4335696|NCT00430248|4162973|B4|<45 years of age||Age, Customized||subjects|Number|568|568.0||||||
4335697|NCT00430248|4162974|B3|<45 years of age||Age, Customized||subjects|Number|180|180.0||||||
4335698|NCT00430248|4162975|B2|<45 years of age||Age, Customized||subjects|Number|196|196.0||||||
4335699|NCT00430248|4162976|B1|<45 years of age||Age, Customized||subjects|Number|192|192.0||||||
4335700|NCT00430092|4163034|B4||Male|Sex: Female, Male||Participants|Count of Participants|90.0|90.0||||||
4335701|NCT00430092|4163035|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4335702|NCT00430092|4163036|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4335703|NCT00430092|4163037|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4335704|NCT00430092|4163034|B4||Female|Sex: Female, Male||Participants|Count of Participants|129.0|129.0||||||
4335705|NCT00430092|4163035|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4335706|NCT00430092|4163036|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4335707|NCT00430092|4163037|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4335708|NCT00430092|4163034|B4|||Age||years|Mean|69.8|69.8|Standard Deviation|0|0.0|||
4335709|NCT00430092|4163035|B3|||Age||years|Mean|69.9|69.9|Standard Deviation|0|0.0|||
4335710|NCT00430092|4163036|B2|||Age||years|Mean|68.4|68.4|Standard Deviation|0|0.0|||
4335711|NCT00430092|4163037|B1|||Age||years|Mean|70.7|70.7|Standard Deviation|0|0.0|||
4335712|NCT00430027|4163044|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4335713|NCT00430027|4163044|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4335714|NCT00430027|4163044|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4335715|NCT00430027|4163044|B1|||Age||years|Mean|64.0|64.0|Standard Deviation|10.28|10.28|||
4335716|NCT00430027|4163044|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4335717|NCT00430027|4163044|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4335718|NCT00430027|4163044|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4335719|NCT00429949|4163048|B1|Unavailable||Cytogenetics||participants|Number|3|3.0||||||
4335720|NCT00429949|4163048|B1|Del 6p||Cytogenetics||participants|Number|1|1.0||||||
4335721|NCT00429949|4163048|B1|t9;16||Cytogenetics||participants|Number|1|1.0||||||
4335722|NCT00429949|4163048|B1|Complex (including 1 with t4;14)||Cytogenetics||participants|Number|2|2.0||||||
4335723|NCT00429949|4163048|B1|Del 13/13q||Cytogenetics||participants|Number|2|2.0||||||
4335724|NCT00429949|4163048|B1|Normal||Cytogenetics||participants|Number|12|12.0||||||
4335725|NCT00429949|4163048|B1|Light chain only||Paraprotein||participants|Number|1|1.0||||||
4335726|NCT00429949|4163048|B1|IgA||Paraprotein||participants|Number|6|6.0||||||
4335727|NCT00429949|4163048|B1|IgG||Paraprotein||participants|Number|14|14.0||||||
4335728|NCT00429949|4163048|B1|Plateau phase||Disease status at study entry||participants|Number|7|7.0||||||
4335729|NCT00429949|4163048|B1|Relapsed||Disease status at study entry||participants|Number|14|14.0||||||
4335730|NCT00429949|4163048|B1|||Beta 2 microglobulin at study entry||mg/L|Median|2.7|2.7|Full Range|||1.2|13.0|
4335731|NCT00429949|4163048|B1|Prior autologous stem cell transplant||Prior therapies||participants|Number|19|19.0||||||
4335732|NCT00429949|4163048|B1|Anthracycline-containing regimens||Prior therapies||participants|Number|12|12.0||||||
4335733|NCT00429949|4163048|B1|Bortezomib||Prior therapies||participants|Number|10|10.0||||||
4335734|NCT00429949|4163048|B1|Immunomodulatory agents||Prior therapies||participants|Number|19|19.0||||||
4335735|NCT00429949|4163048|B1|||Prior therapies||therapies|Median|3|3.0|Full Range|||1.0|14.0|
4335736|NCT00429949|4163048|B1|Stage IIIB||Durie-Salmon Stage|"Stage I: Hemoglobin (Hb) > 10g/dL, normal calcium, normal or single plasmacytoma or osteoporosis, Serum paraprotein level < 5 g/dL if IgG, < 3 g/dL if IgA, Urinary light chain excretion < 4 g/24h Stage 2: Not fufilling criteria of Stage I or III Stage III: Hb < 8.5g/dL, calcium > 12 mg/dL, 3 or more lytic bone lesions, Serum paraprotein > 7g/dL if IgG, > 5 g/dL if IgA, Urinary light chain excretion > 12g/24h~Stages I, II, and III can be divided into A or B depending on serum creatinine:~A: serum creatinine < 2 mg/dL (< 177 μmol/L) B: serum creatinine > 2 mg/dL (> 177 μmol/L)"|participants|Number|1|1.0||||||
4335737|NCT00429949|4163048|B1|Stage IIIA||Durie-Salmon Stage|"Stage I: Hemoglobin (Hb) > 10g/dL, normal calcium, normal or single plasmacytoma or osteoporosis, Serum paraprotein level < 5 g/dL if IgG, < 3 g/dL if IgA, Urinary light chain excretion < 4 g/24h Stage 2: Not fufilling criteria of Stage I or III Stage III: Hb < 8.5g/dL, calcium > 12 mg/dL, 3 or more lytic bone lesions, Serum paraprotein > 7g/dL if IgG, > 5 g/dL if IgA, Urinary light chain excretion > 12g/24h~Stages I, II, and III can be divided into A or B depending on serum creatinine:~A: serum creatinine < 2 mg/dL (< 177 μmol/L) B: serum creatinine > 2 mg/dL (> 177 μmol/L)"|participants|Number|15|15.0||||||
4335738|NCT00429949|4163048|B1|Stage IIA||Durie-Salmon Stage|"Stage I: Hemoglobin (Hb) > 10g/dL, normal calcium, normal or single plasmacytoma or osteoporosis, Serum paraprotein level < 5 g/dL if IgG, < 3 g/dL if IgA, Urinary light chain excretion < 4 g/24h Stage 2: Not fufilling criteria of Stage I or III Stage III: Hb < 8.5g/dL, calcium > 12 mg/dL, 3 or more lytic bone lesions, Serum paraprotein > 7g/dL if IgG, > 5 g/dL if IgA, Urinary light chain excretion > 12g/24h~Stages I, II, and III can be divided into A or B depending on serum creatinine:~A: serum creatinine < 2 mg/dL (< 177 μmol/L) B: serum creatinine > 2 mg/dL (> 177 μmol/L)"|participants|Number|3|3.0||||||
4335739|NCT00429949|4163048|B1|Stage IA||Durie-Salmon Stage|"Stage I: Hemoglobin (Hb) > 10g/dL, normal calcium, normal or single plasmacytoma or osteoporosis, Serum paraprotein level < 5 g/dL if IgG, < 3 g/dL if IgA, Urinary light chain excretion < 4 g/24h Stage 2: Not fufilling criteria of Stage I or III Stage III: Hb < 8.5g/dL, calcium > 12 mg/dL, 3 or more lytic bone lesions, Serum paraprotein > 7g/dL if IgG, > 5 g/dL if IgA, Urinary light chain excretion > 12g/24h~Stages I, II, and III can be divided into A or B depending on serum creatinine:~A: serum creatinine < 2 mg/dL (< 177 μmol/L) B: serum creatinine > 2 mg/dL (> 177 μmol/L)"|participants|Number|2|2.0||||||
4335740|NCT00429949|4163048|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4335741|NCT00429949|4163048|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4335742|NCT00429949|4163048|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4335743|NCT00429949|4163048|B1|||Age||years|Median|59|59.0|Full Range|||38.0|76.0|
4335744|NCT00429923|4163058|B4||Male|Sex: Female, Male||Participants|Count of Participants|107.0|107.0||||||
4335745|NCT00429923|4163059|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4335746|NCT00429923|4163060|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4335747|NCT00429923|4163061|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4335748|NCT00429923|4163058|B4||Female|Sex: Female, Male||Participants|Count of Participants|112.0|112.0||||||
4335749|NCT00429923|4163059|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4335750|NCT00429923|4163060|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4335751|NCT00429923|4163061|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4335752|NCT00429923|4163058|B4|||Age||years|Mean|69.3|69.3|Standard Deviation|0|0.0|||
4335753|NCT00429923|4163059|B3|||Age||years|Mean|69.1|69.1|Standard Deviation|0|0.0|||
4335754|NCT00429923|4163060|B2|||Age||years|Mean|68.1|68.1|Standard Deviation|0|0.0|||
4335755|NCT00429923|4163061|B1|||Age||years|Mean|70.8|70.8|Standard Deviation|0|0.0|||
4335756|NCT00429793|4163068|B1|Serous Adenocarcinoma||Cell Type||participants|Number|39|39.0||||||
4335757|NCT00429793|4163068|B1|Endometrioid Adenocarcinoma||Cell Type||participants|Number|4|4.0||||||
4335758|NCT00429793|4163068|B1|Clear Cell Carcinoma||Cell Type||participants|Number|3|3.0||||||
4335759|NCT00429793|4163068|B1|Adenocarcinoma, unspecified||Cell Type||participants|Number|8|8.0||||||
4335760|NCT00429793|4163068|B1|||International Federation of Gynecology and Obstetrics (FIGO) Recurrent/Persistent Disease||participants|Number|54|54.0||||||
4335761|NCT00429793|4163068|B1|United States||Region of Enrollment||participants|Number|54|54.0||||||
4335762|NCT00429793|4163068|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4335763|NCT00429793|4163068|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4335764|NCT00429793|4163068|B1|80-89 years||Age, Customized||participants|Number|3|3.0||||||
4335765|NCT00429793|4163068|B1|70-79 years||Age, Customized||participants|Number|16|16.0||||||
4335766|NCT00429793|4163068|B1|60-69 years||Age, Customized||participants|Number|11|11.0||||||
4335767|NCT00429793|4163068|B1|50-59 years||Age, Customized||participants|Number|15|15.0||||||
4335768|NCT00429793|4163068|B1|40-49 years||Age, Customized||participants|Number|7|7.0||||||
4335769|NCT00429793|4163068|B1|20-29 years||Age, Customized||participants|Number|2|2.0||||||
4335770|NCT00429793|4163068|B1|||Age||years|Mean|62.1|62.1|Standard Deviation|13.0|13.0|||
4335771|NCT00429702|4163082|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4335772|NCT00429702|4163083|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4335773|NCT00429702|4163084|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4335774|NCT00429702|4163082|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4335775|NCT00429702|4163083|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4335776|NCT00429702|4163084|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4335777|NCT00429702|4163082|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4335778|NCT00429702|4163083|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4335779|NCT00429702|4163084|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4335780|NCT00429702|4163082|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4335781|NCT00429702|4163083|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4335782|NCT00429702|4163084|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4335783|NCT00429702|4163082|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4335784|NCT00429702|4163083|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4335785|NCT00429702|4163084|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4335786|NCT00429702|4163082|B3||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4335787|NCT00429702|4163083|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4335788|NCT00429702|4163084|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4335789|NCT00429663|4163093|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4335790|NCT00429663|4163094|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4335791|NCT00429663|4163095|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4335792|NCT00429663|4163093|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4335793|NCT00429663|4163094|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4335794|NCT00429663|4163095|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4335795|NCT00429663|4163093|B3|||Age||years|Mean|51|51.0|Full Range|||16.0|90.0|
4335796|NCT00429663|4163094|B2|||Age||years|Mean|53|53.0|Full Range|||19.0|90.0|
4335797|NCT00429663|4163095|B1|||Age||years|Mean|51|51.0|Full Range|||16.0|90.0|
4335798|NCT00429663|4163093|B3||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4335799|NCT00429663|4163094|B2||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4335800|NCT00429663|4163095|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4335801|NCT00429663|4163093|B3||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
4335802|NCT00429663|4163094|B2||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4335803|NCT00429663|4163095|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4335804|NCT00429663|4163093|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4335805|NCT00429663|4163094|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4335806|NCT00429663|4163095|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4335807|NCT00429572|4163110|B1|ER positive||Tumor Characteristic|Stage and Biomarkers|participants|Number|7|7.0||||||
4335808|NCT00429572|4163110|B1|ER negative||Tumor Characteristic|Stage and Biomarkers|participants|Number|12|12.0||||||
4335809|NCT00429572|4163110|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4335810|NCT00429572|4163110|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4335811|NCT00429572|4163110|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4335812|NCT00429572|4163110|B1|||Age||years|Median|41|41.0|Full Range|||31.0|59.0|
4335813|NCT00429507|4163118|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4335814|NCT00429507|4163118|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4335815|NCT00429507|4163118|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4335816|NCT00429507|4163118|B1|||Age||years|Median|52|52.0|Full Range|||36.0|63.0|
4335817|NCT00429494|4163122|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
4335818|NCT00429494|4163122|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4335819|NCT00429494|4163122|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4335820|NCT00429494|4163122|B1|||Age||years|Median|25|25.0|Full Range|||17.0|39.0|
4335821|NCT00429416|4163126|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4335822|NCT00429416|4163126|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4335823|NCT00429416|4163126|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4335824|NCT00429416|4163126|B1|||Age||years|Mean|54.65|54.65|Standard Deviation|9.74|9.74|||
4335825|NCT00429416|4163126|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4335826|NCT00429416|4163126|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4335827|NCT00429416|4163126|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4335828|NCT00429403|4163134|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4335829|NCT00429403|4163136|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4335830|NCT00429403|4163134|B3|Male||Gender||participants|Number|0|0.0||||||
4335831|NCT00429403|4163136|B1|Male||Gender||participants|Number|0|0.0||||||
4335832|NCT00429403|4163134|B3|Female||Gender||participants|Number|1|1.0||||||
4335833|NCT00429403|4163136|B1|Female||Gender||participants|Number|1|1.0||||||
4335834|NCT00429403|4163134|B3|>=65 years||Age||years|Number|0|0.0||||||
4335835|NCT00429403|4163136|B1|>=65 years||Age||years|Number|0|0.0||||||
4335836|NCT00429403|4163134|B3|Between 18 and 65 years||Age||years|Number|1|1.0||||||
4335837|NCT00429403|4163136|B1|Between 18 and 65 years||Age||years|Number|1|1.0||||||
4335838|NCT00429403|4163134|B3|<=18 years||Age||years|Number|0|0.0||||||
4335839|NCT00429403|4163136|B1|<=18 years||Age||years|Number|0|0.0||||||
4335840|NCT00429364|4163143|B3|No||Had medical history of psychiatric disorder|Psychiatric disorder was defined as depression requiring therapy, anxiety, or other psychiatric conditions.|participants|Number|569|569.0||||||
4335841|NCT00429364|4163144|B2|No||Had medical history of psychiatric disorder|Psychiatric disorder was defined as depression requiring therapy, anxiety, or other psychiatric conditions.|participants|Number|289|289.0||||||
4335842|NCT00429364|4163145|B1|No||Had medical history of psychiatric disorder|Psychiatric disorder was defined as depression requiring therapy, anxiety, or other psychiatric conditions.|participants|Number|280|280.0||||||
4335843|NCT00429364|4163143|B3|Yes||Had medical history of psychiatric disorder|Psychiatric disorder was defined as depression requiring therapy, anxiety, or other psychiatric conditions.|participants|Number|39|39.0||||||
4335844|NCT00429364|4163144|B2|Yes||Had medical history of psychiatric disorder|Psychiatric disorder was defined as depression requiring therapy, anxiety, or other psychiatric conditions.|participants|Number|16|16.0||||||
4335845|NCT00429364|4163145|B1|Yes||Had medical history of psychiatric disorder|Psychiatric disorder was defined as depression requiring therapy, anxiety, or other psychiatric conditions.|participants|Number|23|23.0||||||
4335846|NCT00429364|4163143|B3|No||Had medical history of neurodevelopmental disorder|Neurodevelopmental disorder was defined as attention deficit-hyperactivity disorder requiring therapy, developmental delay requiring therapy, learning disability requiring services, or other neurodevelopmental conditions.|participants|Number|491|491.0||||||
4335847|NCT00429364|4163144|B2|No||Had medical history of neurodevelopmental disorder|Neurodevelopmental disorder was defined as attention deficit-hyperactivity disorder requiring therapy, developmental delay requiring therapy, learning disability requiring services, or other neurodevelopmental conditions.|participants|Number|244|244.0||||||
4335848|NCT00429364|4163145|B1|No||Had medical history of neurodevelopmental disorder|Neurodevelopmental disorder was defined as attention deficit-hyperactivity disorder requiring therapy, developmental delay requiring therapy, learning disability requiring services, or other neurodevelopmental conditions.|participants|Number|247|247.0||||||
4335849|NCT00429364|4163143|B3|Yes||Had medical history of neurodevelopmental disorder|Neurodevelopmental disorder was defined as attention deficit-hyperactivity disorder requiring therapy, developmental delay requiring therapy, learning disability requiring services, or other neurodevelopmental conditions.|participants|Number|117|117.0||||||
4335850|NCT00429364|4163144|B2|Yes||Had medical history of neurodevelopmental disorder|Neurodevelopmental disorder was defined as attention deficit-hyperactivity disorder requiring therapy, developmental delay requiring therapy, learning disability requiring services, or other neurodevelopmental conditions.|participants|Number|61|61.0||||||
4335851|NCT00429364|4163145|B1|Yes||Had medical history of neurodevelopmental disorder|Neurodevelopmental disorder was defined as attention deficit-hyperactivity disorder requiring therapy, developmental delay requiring therapy, learning disability requiring services, or other neurodevelopmental conditions.|participants|Number|56|56.0||||||
4335852|NCT00429364|4163143|B3|No||Had medical history of endocrine disorder|Endocrine disorder was defined by either the use of hormone therapy to limit growth, delayed puberty.|participants|Number|601|601.0||||||
4335853|NCT00429364|4163144|B2|No||Had medical history of endocrine disorder|Endocrine disorder was defined by either the use of hormone therapy to limit growth, delayed puberty.|participants|Number|305|305.0||||||
4335854|NCT00429364|4163145|B1|No||Had medical history of endocrine disorder|Endocrine disorder was defined by either the use of hormone therapy to limit growth, delayed puberty.|participants|Number|296|296.0||||||
4335855|NCT00429364|4163143|B3|Yes||Had medical history of endocrine disorder|Endocrine disorder was defined by either the use of hormone therapy to limit growth, delayed puberty.|participants|Number|7|7.0||||||
4335856|NCT00429364|4163144|B2|Yes||Had medical history of endocrine disorder|Endocrine disorder was defined by either the use of hormone therapy to limit growth, delayed puberty.|participants|Number|0|0.0||||||
4335857|NCT00429364|4163145|B1|Yes||Had medical history of endocrine disorder|Endocrine disorder was defined by either the use of hormone therapy to limit growth, delayed puberty.|participants|Number|7|7.0||||||
4335858|NCT00429364|4163143|B3|No||Prior use of beta-blocker||participants|Number|264|264.0||||||
4335859|NCT00429364|4163144|B2|No||Prior use of beta-blocker||participants|Number|134|134.0||||||
4335860|NCT00429364|4163145|B1|No||Prior use of beta-blocker||participants|Number|130|130.0||||||
4335861|NCT00429364|4163143|B3|Yes||Prior use of beta-blocker||participants|Number|344|344.0||||||
4335862|NCT00429364|4163144|B2|Yes||Prior use of beta-blocker||participants|Number|171|171.0||||||
4335863|NCT00429364|4163145|B1|Yes||Prior use of beta-blocker||participants|Number|173|173.0||||||
4335864|NCT00429364|4163143|B3|No||Had medical history of cardiovascular disorder|Cardiovascular disorder was defined by exercise intolerance, syncope; arrhythmia, hypertension, or hypotension requiring therapy; chest pain, shortness of breath; or other cardiovascular conditions.|participants|Number|533|533.0||||||
4335865|NCT00429364|4163144|B2|No||Had medical history of cardiovascular disorder|Cardiovascular disorder was defined by exercise intolerance, syncope; arrhythmia, hypertension, or hypotension requiring therapy; chest pain, shortness of breath; or other cardiovascular conditions.|participants|Number|269|269.0||||||
4335866|NCT00429364|4163145|B1|No||Had medical history of cardiovascular disorder|Cardiovascular disorder was defined by exercise intolerance, syncope; arrhythmia, hypertension, or hypotension requiring therapy; chest pain, shortness of breath; or other cardiovascular conditions.|participants|Number|264|264.0||||||
4335867|NCT00429364|4163143|B3|Yes||Had medical history of cardiovascular disorder|Cardiovascular disorder was defined by exercise intolerance, syncope; arrhythmia, hypertension, or hypotension requiring therapy; chest pain, shortness of breath; or other cardiovascular conditions.|participants|Number|75|75.0||||||
4335868|NCT00429364|4163144|B2|Yes||Had medical history of cardiovascular disorder|Cardiovascular disorder was defined by exercise intolerance, syncope; arrhythmia, hypertension, or hypotension requiring therapy; chest pain, shortness of breath; or other cardiovascular conditions.|participants|Number|36|36.0||||||
4335869|NCT00429364|4163145|B1|Yes||Had medical history of cardiovascular disorder|Cardiovascular disorder was defined by exercise intolerance, syncope; arrhythmia, hypertension, or hypotension requiring therapy; chest pain, shortness of breath; or other cardiovascular conditions.|participants|Number|39|39.0||||||
4335870|NCT00429364|4163143|B3|No||Had medical history of cardiac surgery||participants|Number|596|596.0||||||
4335871|NCT00429364|4163144|B2|No||Had medical history of cardiac surgery||participants|Number|299|299.0||||||
4335872|NCT00429364|4163145|B1|No||Had medical history of cardiac surgery||participants|Number|297|297.0||||||
4335873|NCT00429364|4163143|B3|Yes||Had medical history of cardiac surgery||participants|Number|12|12.0||||||
4335874|NCT00429364|4163144|B2|Yes||Had medical history of cardiac surgery||participants|Number|6|6.0||||||
4335875|NCT00429364|4163145|B1|Yes||Had medical history of cardiac surgery||participants|Number|6|6.0||||||
4335876|NCT00429364|4163143|B3|<z-score of 4.5||Maximum aortic-root diameter z-score|Data are based on readings at a central echocardiographic laboratory. Echocardiographic data were missing for one participant in the losartan group because of an unreadable echocardiogram.|participants|Number|388|388.0||||||
4335877|NCT00429364|4163144|B2|<z-score of 4.5||Maximum aortic-root diameter z-score|Data are based on readings at a central echocardiographic laboratory. Echocardiographic data were missing for one participant in the losartan group because of an unreadable echocardiogram.|participants|Number|191|191.0||||||
4335878|NCT00429364|4163145|B1|<z-score of 4.5||Maximum aortic-root diameter z-score|Data are based on readings at a central echocardiographic laboratory. Echocardiographic data were missing for one participant in the losartan group because of an unreadable echocardiogram.|participants|Number|197|197.0||||||
4335879|NCT00429364|4163143|B3|≥z-score of 4.5||Maximum aortic-root diameter z-score|Data are based on readings at a central echocardiographic laboratory. Echocardiographic data were missing for one participant in the losartan group because of an unreadable echocardiogram.|participants|Number|220|220.0||||||
4335880|NCT00429364|4163144|B2|≥z-score of 4.5||Maximum aortic-root diameter z-score|Data are based on readings at a central echocardiographic laboratory. Echocardiographic data were missing for one participant in the losartan group because of an unreadable echocardiogram.|participants|Number|114|114.0||||||
4335881|NCT00429364|4163145|B1|≥z-score of 4.5||Maximum aortic-root diameter z-score|Data are based on readings at a central echocardiographic laboratory. Echocardiographic data were missing for one participant in the losartan group because of an unreadable echocardiogram.|participants|Number|106|106.0||||||
4335882|NCT00429364|4163143|B3|||Maximum aortic-root diameter z-score|Data are based on readings at a central echocardiographic laboratory. Echocardiographic data were missing for one participant in the losartan group because of an unreadable echocardiogram.|z-score|Median|4.0|4.0|Inter-Quartile Range|||3.4|4.9|
4335883|NCT00429364|4163144|B2|||Maximum aortic-root diameter z-score|Data are based on readings at a central echocardiographic laboratory. Echocardiographic data were missing for one participant in the losartan group because of an unreadable echocardiogram.|z-score|Median|4.0|4.0|Inter-Quartile Range|||3.3|5.0|
4335884|NCT00429364|4163145|B1|||Maximum aortic-root diameter z-score|Data are based on readings at a central echocardiographic laboratory. Echocardiographic data were missing for one participant in the losartan group because of an unreadable echocardiogram.|z-score|Median|4.0|4.0|Inter-Quartile Range|||3.5|4.8|
4335885|NCT00429364|4163143|B3|||Maximum aortic-root diameter, cm|Data are based on readings at a central echocardiographic laboratory. Echocardiographic data were missing for one participant in the losartan group because of an unreadable echocardiogram.|centimeter|Mean|3.4|3.4|Standard Deviation|0.7|0.7|||
4335886|NCT00429364|4163144|B2|||Maximum aortic-root diameter, cm|Data are based on readings at a central echocardiographic laboratory. Echocardiographic data were missing for one participant in the losartan group because of an unreadable echocardiogram.|centimeter|Mean|3.4|3.4|Standard Deviation|0.7|0.7|||
4335887|NCT00429364|4163145|B1|||Maximum aortic-root diameter, cm|Data are based on readings at a central echocardiographic laboratory. Echocardiographic data were missing for one participant in the losartan group because of an unreadable echocardiogram.|centimeter|Mean|3.4|3.4|Standard Deviation|0.7|0.7|||
4335888|NCT00429364|4163143|B3|Unknown||Family history of Marfan||participants|Number|23|23.0||||||
4335889|NCT00429364|4163144|B2|Unknown||Family history of Marfan||participants|Number|15|15.0||||||
4335890|NCT00429364|4163145|B1|Unknown||Family history of Marfan||participants|Number|8|8.0||||||
4335891|NCT00429364|4163143|B3|No||Family history of Marfan||participants|Number|224|224.0||||||
4335892|NCT00429364|4163144|B2|No||Family history of Marfan||participants|Number|109|109.0||||||
4335893|NCT00429364|4163145|B1|No||Family history of Marfan||participants|Number|115|115.0||||||
4335894|NCT00429364|4163143|B3|Yes||Family history of Marfan||participants|Number|361|361.0||||||
4335895|NCT00429364|4163144|B2|Yes||Family history of Marfan||participants|Number|181|181.0||||||
4335896|NCT00429364|4163145|B1|Yes||Family history of Marfan||participants|Number|180|180.0||||||
4335897|NCT00429364|4163143|B3|Unknown||Presence of causal FBN1 mutation||participants|Number|403|403.0||||||
4335898|NCT00429364|4163144|B2|Unknown||Presence of causal FBN1 mutation||participants|Number|202|202.0||||||
4335899|NCT00429364|4163145|B1|Unknown||Presence of causal FBN1 mutation||participants|Number|201|201.0||||||
4335900|NCT00429364|4163143|B3|No||Presence of causal FBN1 mutation||participants|Number|24|24.0||||||
4335901|NCT00429364|4163144|B2|No||Presence of causal FBN1 mutation||participants|Number|15|15.0||||||
4335902|NCT00429364|4163145|B1|No||Presence of causal FBN1 mutation||participants|Number|9|9.0||||||
4335903|NCT00429364|4163143|B3|Yes||Presence of causal FBN1 mutation||participants|Number|181|181.0||||||
4335904|NCT00429364|4163144|B2|Yes||Presence of causal FBN1 mutation||participants|Number|88|88.0||||||
4335905|NCT00429364|4163145|B1|Yes||Presence of causal FBN1 mutation||participants|Number|93|93.0||||||
4335906|NCT00429364|4163143|B3|Other||Race/Ethnicity, Customized|Data on race and ethnicity provided by the participant or a family member at the time of enrollment.|participants|Number|20|20.0||||||
4335907|NCT00429364|4163144|B2|Other||Race/Ethnicity, Customized|Data on race and ethnicity provided by the participant or a family member at the time of enrollment.|participants|Number|10|10.0||||||
4335908|NCT00429364|4163145|B1|Other||Race/Ethnicity, Customized|Data on race and ethnicity provided by the participant or a family member at the time of enrollment.|participants|Number|10|10.0||||||
4335909|NCT00429364|4163143|B3|Asian||Race/Ethnicity, Customized|Data on race and ethnicity provided by the participant or a family member at the time of enrollment.|participants|Number|16|16.0||||||
4335910|NCT00429364|4163144|B2|Asian||Race/Ethnicity, Customized|Data on race and ethnicity provided by the participant or a family member at the time of enrollment.|participants|Number|10|10.0||||||
4335911|NCT00429364|4163145|B1|Asian||Race/Ethnicity, Customized|Data on race and ethnicity provided by the participant or a family member at the time of enrollment.|participants|Number|6|6.0||||||
4335912|NCT00429364|4163143|B3|Black||Race/Ethnicity, Customized|Data on race and ethnicity provided by the participant or a family member at the time of enrollment.|participants|Number|46|46.0||||||
4335913|NCT00429364|4163144|B2|Black||Race/Ethnicity, Customized|Data on race and ethnicity provided by the participant or a family member at the time of enrollment.|participants|Number|25|25.0||||||
4335914|NCT00429364|4163145|B1|Black||Race/Ethnicity, Customized|Data on race and ethnicity provided by the participant or a family member at the time of enrollment.|participants|Number|21|21.0||||||
4335915|NCT00429364|4163143|B3|White||Race/Ethnicity, Customized|Data on race and ethnicity provided by the participant or a family member at the time of enrollment.|participants|Number|526|526.0||||||
4335916|NCT00429364|4163144|B2|White||Race/Ethnicity, Customized|Data on race and ethnicity provided by the participant or a family member at the time of enrollment.|participants|Number|260|260.0||||||
4335917|NCT00429364|4163145|B1|White||Race/Ethnicity, Customized|Data on race and ethnicity provided by the participant or a family member at the time of enrollment.|participants|Number|266|266.0||||||
4335918|NCT00429364|4163143|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)|Data on race and ethnicity provided by the participant or a family member at the time of enrollment.|Participants|Count of Participants|1|1.0||||||
4335919|NCT00429364|4163144|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)|Data on race and ethnicity provided by the participant or a family member at the time of enrollment.|Participants|Count of Participants|0|0.0||||||
4335920|NCT00429364|4163145|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|Data on race and ethnicity provided by the participant or a family member at the time of enrollment.|Participants|Count of Participants|1|1.0||||||
4335921|NCT00429364|4163143|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Data on race and ethnicity provided by the participant or a family member at the time of enrollment.|Participants|Count of Participants|525|525.0||||||
4335922|NCT00429364|4163144|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Data on race and ethnicity provided by the participant or a family member at the time of enrollment.|Participants|Count of Participants|259|259.0||||||
4335923|NCT00429364|4163145|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Data on race and ethnicity provided by the participant or a family member at the time of enrollment.|Participants|Count of Participants|266|266.0||||||
4335924|NCT00429364|4163143|B3||Hispanic or Latino|Ethnicity (NIH/OMB)|Data on race and ethnicity provided by the participant or a family member at the time of enrollment.|Participants|Count of Participants|82|82.0||||||
4335925|NCT00429364|4163144|B2||Hispanic or Latino|Ethnicity (NIH/OMB)|Data on race and ethnicity provided by the participant or a family member at the time of enrollment.|Participants|Count of Participants|46|46.0||||||
4335926|NCT00429364|4163145|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|Data on race and ethnicity provided by the participant or a family member at the time of enrollment.|Participants|Count of Participants|36|36.0||||||
4335927|NCT00429364|4163143|B3||Male|Sex: Female, Male||Participants|Count of Participants|366|366.0||||||
4335928|NCT00429364|4163144|B2||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4335929|NCT00429364|4163145|B1||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4335930|NCT00429364|4163143|B3||Female|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
4335931|NCT00429364|4163144|B2||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4335932|NCT00429364|4163145|B1||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4335933|NCT00429364|4163143|B3|Child||Age, Customized|Young adults were defined as male participants who were 16 to 25 years of age and female participants who were 15 to 25 years of age.|participants|Number|457|457.0||||||
4335934|NCT00429364|4163144|B2|Child||Age, Customized|Young adults were defined as male participants who were 16 to 25 years of age and female participants who were 15 to 25 years of age.|participants|Number|230|230.0||||||
4335935|NCT00429364|4163145|B1|Child||Age, Customized|Young adults were defined as male participants who were 16 to 25 years of age and female participants who were 15 to 25 years of age.|participants|Number|227|227.0||||||
4335936|NCT00429364|4163143|B3|Young adult||Age, Customized|Young adults were defined as male participants who were 16 to 25 years of age and female participants who were 15 to 25 years of age.|participants|Number|151|151.0||||||
4335937|NCT00429364|4163144|B2|Young adult||Age, Customized|Young adults were defined as male participants who were 16 to 25 years of age and female participants who were 15 to 25 years of age.|participants|Number|75|75.0||||||
4335997|NCT00429273|4163239|B1|||Age||years|Mean|10.1|10.1|Standard Deviation|2.1|2.1|||
4335938|NCT00429364|4163145|B1|Young adult||Age, Customized|Young adults were defined as male participants who were 16 to 25 years of age and female participants who were 15 to 25 years of age.|participants|Number|76|76.0||||||
4335939|NCT00429364|4163143|B3|||Age||years|Mean|11.2|11.2|Standard Deviation|6.3|6.3|||
4335940|NCT00429364|4163144|B2|||Age||years|Mean|11.0|11.0|Standard Deviation|6.2|6.2|||
4335941|NCT00429364|4163145|B1|||Age||years|Mean|11.5|11.5|Standard Deviation|6.5|6.5|||
4335942|NCT00429299|4163202|B4|Unknown||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4335943|NCT00429299|4163203|B3|Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4335944|NCT00429299|4163204|B2|Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4335945|NCT00429299|4163205|B1|Unknown||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4335946|NCT00429299|4163202|B4|Asian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4335947|NCT00429299|4163203|B3|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4335948|NCT00429299|4163204|B2|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4335949|NCT00429299|4163205|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4335950|NCT00429299|4163202|B4|Caucasian||Race/Ethnicity, Customized||Participants|Number|115|115.0||||||
4335951|NCT00429299|4163203|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|44|44.0||||||
4335952|NCT00429299|4163204|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
4335953|NCT00429299|4163205|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|34|34.0||||||
4335954|NCT00429299|4163202|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4335955|NCT00429299|4163203|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4335956|NCT00429299|4163204|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4335957|NCT00429299|4163205|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4335958|NCT00429299|4163202|B4||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4335959|NCT00429299|4163203|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4335960|NCT00429299|4163204|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4335961|NCT00429299|4163205|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4335962|NCT00429299|4163202|B4|||Age||Years|Mean|49.3|49.3|Full Range|||26.0|68.0|
4335963|NCT00429299|4163203|B3|||Age||Years|Mean|49|49.0|Full Range|||26.0|65.0|
4335964|NCT00429299|4163204|B2|||Age||Years|Mean|49|49.0|Full Range|||34.0|68.0|
4335965|NCT00429299|4163205|B1|||Age||Years|Mean|50|50.0|Full Range|||34.0|65.0|
4335966|NCT00429273|4163236|B4|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
4335967|NCT00429273|4163237|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
4335968|NCT00429273|4163238|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4335969|NCT00429273|4163239|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
4335970|NCT00429273|4163236|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4335971|NCT00429273|4163237|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4335972|NCT00429273|4163238|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4335973|NCT00429273|4163239|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4335974|NCT00429273|4163236|B4|Asian, Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
4335975|NCT00429273|4163237|B3|Asian, Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4335976|NCT00429273|4163238|B2|Asian, Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4335977|NCT00429273|4163239|B1|Asian, Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4335978|NCT00429273|4163236|B4|African American||Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
4335979|NCT00429273|4163237|B3|African American||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
4335980|NCT00429273|4163238|B2|African American||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4335981|NCT00429273|4163239|B1|African American||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4335982|NCT00429273|4163236|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|143|143.0||||||
4335983|NCT00429273|4163237|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
4335984|NCT00429273|4163238|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
4335985|NCT00429273|4163239|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
4335986|NCT00429273|4163236|B4||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4335987|NCT00429273|4163237|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4335988|NCT00429273|4163238|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4335989|NCT00429273|4163239|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4335990|NCT00429273|4163236|B4||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4335991|NCT00429273|4163237|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4335992|NCT00429273|4163238|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4335993|NCT00429273|4163239|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4335994|NCT00429273|4163236|B4|||Age||years|Mean|10.0|10.0|Standard Deviation|2.1|2.1|||
4335995|NCT00429273|4163237|B3|||Age||years|Mean|9.9|9.9|Standard Deviation|2.2|2.2|||
4335996|NCT00429273|4163238|B2|||Age||years|Mean|10.1|10.1|Standard Deviation|2.0|2.0|||
4335998|NCT00429182|4163249|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4335999|NCT00429182|4163249|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4336000|NCT00429182|4163249|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4336001|NCT00429182|4163249|B1|||Age||years|Median|44|44.0|Full Range|||29.0|59.0|
4336002|NCT00429169|4163254|B3|United States||Region of Enrollment||participants|Number|74|74.0||||||
4336003|NCT00429169|4163255|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
4336004|NCT00429169|4163256|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4336005|NCT00429169|4163254|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4336006|NCT00429169|4163255|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4336007|NCT00429169|4163256|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4336008|NCT00429169|4163254|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4336009|NCT00429169|4163255|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4336010|NCT00429169|4163256|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4336011|NCT00429169|4163254|B3|||Age||years|Mean|36.4|36.4|Standard Deviation|12.7|12.7|||
4336012|NCT00429169|4163255|B2|||Age||years|Mean|37.9|37.9|Standard Deviation|11.9|11.9|||
4336013|NCT00429169|4163256|B1|||Age||years|Mean|35.2|35.2|Standard Deviation|12.8|12.8|||
4336014|NCT00429169|4163254|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4336015|NCT00429169|4163255|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4336016|NCT00429169|4163256|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4336017|NCT00429169|4163254|B3||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
4336018|NCT00429169|4163255|B2||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4336019|NCT00429169|4163256|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4336020|NCT00429169|4163254|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4336021|NCT00429169|4163255|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4336022|NCT00429169|4163256|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4336023|NCT00429143|4163269|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4336024|NCT00429143|4163269|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4336025|NCT00429143|4163269|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4336026|NCT00429143|4163269|B1|||Age||years|Mean|50|50.0|Standard Deviation|12.9|12.9|||
4336027|NCT00429143|4163269|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4336028|NCT00429143|4163269|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4336029|NCT00429143|4163269|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4336030|NCT00429104|4163277|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4336031|NCT00429104|4163277|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4336032|NCT00429104|4163277|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4336033|NCT00429104|4163277|B1|||Age||years|Median|48|48.0|Full Range|||27.0|75.0|
4336034|NCT00429026|4163282|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4336035|NCT00429026|4163282|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4336036|NCT00429026|4163282|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4336037|NCT00429026|4163282|B1|||Age||years|Median|48|48.0|Full Range|0|0.0|30.0|53.0|
4336038|NCT00428974|4163286|B5|Israel||Region of Enrollment||participants|Number|75|75.0||||||
4336039|NCT00428974|4163287|B4|Israel||Region of Enrollment||participants|Number|19|19.0||||||
4336040|NCT00428974|4163288|B3|Israel||Region of Enrollment||participants|Number|15|15.0||||||
4336041|NCT00428974|4163289|B2|Israel||Region of Enrollment||participants|Number|17|17.0||||||
4336042|NCT00428974|4163290|B1|Israel||Region of Enrollment||participants|Number|24|24.0||||||
4336043|NCT00428974|4163286|B5||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4336044|NCT00428974|4163287|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4336045|NCT00428974|4163288|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4336046|NCT00428974|4163289|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4336047|NCT00428974|4163290|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4336048|NCT00428974|4163286|B5||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4336049|NCT00428974|4163287|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4336050|NCT00428974|4163288|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4336051|NCT00428974|4163289|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4336052|NCT00428974|4163290|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4336053|NCT00428974|4163286|B5|||Age||years|Mean|49.5|49.5|Standard Deviation|11.2|11.2|||
4336054|NCT00428974|4163287|B4|||Age||years|Mean|51.2|51.2|Standard Deviation|10.4|10.4|||
4336055|NCT00428974|4163288|B3|||Age||years|Mean|45.3|45.3|Standard Deviation|12.1|12.1|||
4336056|NCT00428974|4163289|B2|||Age||years|Mean|48.4|48.4|Standard Deviation|10.2|10.2|||
4336057|NCT00428974|4163290|B1|||Age||years|Mean|51.5|51.5|Standard Deviation|12.0|12.0|||
4336058|NCT00428974|4163286|B5||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4336059|NCT00428974|4163287|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4336060|NCT00428974|4163288|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4336061|NCT00428974|4163289|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4336062|NCT00428974|4163290|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4336063|NCT00428974|4163286|B5||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4336064|NCT00428974|4163287|B4||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4336065|NCT00428974|4163288|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4336066|NCT00428974|4163289|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4336067|NCT00428974|4163290|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4336068|NCT00428974|4163286|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4336069|NCT00428974|4163287|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4336070|NCT00428974|4163288|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4336071|NCT00428974|4163289|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4336072|NCT00428974|4163290|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4336073|NCT00428948|4163307|B3||Male|Sex: Female, Male||Participants|Count of Participants|746|746.0||||||
4336074|NCT00428948|4163308|B2||Male|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4336075|NCT00428948|4163309|B1||Male|Sex: Female, Male||Participants|Count of Participants|495|495.0||||||
4336076|NCT00428948|4163307|B3||Female|Sex: Female, Male||Participants|Count of Participants|699|699.0||||||
4336077|NCT00428948|4163308|B2||Female|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
4336078|NCT00428948|4163309|B1||Female|Sex: Female, Male||Participants|Count of Participants|466|466.0||||||
4336079|NCT00428948|4163307|B3|||Age||years|Mean|38.7|38.7|Standard Deviation|7.1|7.1|||
4336080|NCT00428948|4163308|B2|||Age||years|Mean|38.8|38.8|Standard Deviation|7.1|7.1|||
4336081|NCT00428948|4163309|B1|||Age||years|Mean|38.6|38.6|Standard Deviation|7.1|7.1|||
4336082|NCT00428922|4163328|B1|United States||Region of Enrollment||patients|Number|26|26.0||||||
4336083|NCT00428922|4163328|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4336084|NCT00428922|4163328|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4336085|NCT00428922|4163328|B1|||Age||years|Median|54|54.0|Full Range|||38.0|73.0|
4336086|NCT00428844|4163335|B4||Male|Sex: Female, Male|Safety/Intent to Treat Population (1 patient included in the Overall Number of Baseline Participants was randomized to comparator but not treated)|Participants|Count of Participants|39|39.0||||||
4336087|NCT00428844|4163336|B3||Male|Sex: Female, Male|Safety/Intent to Treat Population (1 patient included in the Overall Number of Baseline Participants was randomized to comparator but not treated)|Participants|Count of Participants|14|14.0||||||
4336088|NCT00428844|4163337|B2||Male|Sex: Female, Male|Safety/Intent to Treat Population (1 patient included in the Overall Number of Baseline Participants was randomized to comparator but not treated)|Participants|Count of Participants|14|14.0||||||
4336089|NCT00428844|4163338|B1||Male|Sex: Female, Male|Safety/Intent to Treat Population (1 patient included in the Overall Number of Baseline Participants was randomized to comparator but not treated)|Participants|Count of Participants|11|11.0||||||
4336090|NCT00428844|4163335|B4||Female|Sex: Female, Male|Safety/Intent to Treat Population (1 patient included in the Overall Number of Baseline Participants was randomized to comparator but not treated)|Participants|Count of Participants|35|35.0||||||
4336091|NCT00428844|4163336|B3||Female|Sex: Female, Male|Safety/Intent to Treat Population (1 patient included in the Overall Number of Baseline Participants was randomized to comparator but not treated)|Participants|Count of Participants|11|11.0||||||
4336092|NCT00428844|4163337|B2||Female|Sex: Female, Male|Safety/Intent to Treat Population (1 patient included in the Overall Number of Baseline Participants was randomized to comparator but not treated)|Participants|Count of Participants|10|10.0||||||
4336093|NCT00428844|4163338|B1||Female|Sex: Female, Male|Safety/Intent to Treat Population (1 patient included in the Overall Number of Baseline Participants was randomized to comparator but not treated)|Participants|Count of Participants|14|14.0||||||
4336094|NCT00428844|4163335|B4||>=65 years|Age|Safety/Intent to Treat Population (1 patient included in the Overall Number of Baseline Participants was randomized to comparator but not treated)|Participants|Count of Participants|35|35.0||||||
4336095|NCT00428844|4163336|B3||>=65 years|Age|Safety/Intent to Treat Population (1 patient included in the Overall Number of Baseline Participants was randomized to comparator but not treated)|Participants|Count of Participants|10|10.0||||||
4336096|NCT00428844|4163337|B2||>=65 years|Age|Safety/Intent to Treat Population (1 patient included in the Overall Number of Baseline Participants was randomized to comparator but not treated)|Participants|Count of Participants|10|10.0||||||
4336097|NCT00428844|4163338|B1||>=65 years|Age|Safety/Intent to Treat Population (1 patient included in the Overall Number of Baseline Participants was randomized to comparator but not treated)|Participants|Count of Participants|15|15.0||||||
4336098|NCT00428844|4163335|B4||Between 18 and 65 years|Age|Safety/Intent to Treat Population (1 patient included in the Overall Number of Baseline Participants was randomized to comparator but not treated)|Participants|Count of Participants|39|39.0||||||
4336099|NCT00428844|4163336|B3||Between 18 and 65 years|Age|Safety/Intent to Treat Population (1 patient included in the Overall Number of Baseline Participants was randomized to comparator but not treated)|Participants|Count of Participants|15|15.0||||||
4336100|NCT00428844|4163337|B2||Between 18 and 65 years|Age|Safety/Intent to Treat Population (1 patient included in the Overall Number of Baseline Participants was randomized to comparator but not treated)|Participants|Count of Participants|14|14.0||||||
4336101|NCT00428844|4163338|B1||Between 18 and 65 years|Age|Safety/Intent to Treat Population (1 patient included in the Overall Number of Baseline Participants was randomized to comparator but not treated)|Participants|Count of Participants|10|10.0||||||
4336102|NCT00428844|4163335|B4||<=18 years|Age|Safety/Intent to Treat Population (1 patient included in the Overall Number of Baseline Participants was randomized to comparator but not treated)|Participants|Count of Participants|0|0.0||||||
4336158|NCT00428597|4163425|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4336103|NCT00428844|4163336|B3||<=18 years|Age|Safety/Intent to Treat Population (1 patient included in the Overall Number of Baseline Participants was randomized to comparator but not treated)|Participants|Count of Participants|0|0.0||||||
4336104|NCT00428844|4163337|B2||<=18 years|Age|Safety/Intent to Treat Population (1 patient included in the Overall Number of Baseline Participants was randomized to comparator but not treated)|Participants|Count of Participants|0|0.0||||||
4336105|NCT00428844|4163338|B1||<=18 years|Age|Safety/Intent to Treat Population (1 patient included in the Overall Number of Baseline Participants was randomized to comparator but not treated)|Participants|Count of Participants|0|0.0||||||
4336106|NCT00428792|4163361|B3||Male|Sex: Female, Male|Safety Population|Participants|Count of Participants|112|112.0||||||
4336107|NCT00428792|4163362|B2||Male|Sex: Female, Male|Safety Population|Participants|Count of Participants|57|57.0||||||
4336108|NCT00428792|4163363|B1||Male|Sex: Female, Male|Safety Population|Participants|Count of Participants|55|55.0||||||
4336109|NCT00428792|4163361|B3||Female|Sex: Female, Male|Safety Population|Participants|Count of Participants|38|38.0||||||
4336110|NCT00428792|4163362|B2||Female|Sex: Female, Male|Safety Population|Participants|Count of Participants|13|13.0||||||
4336111|NCT00428792|4163363|B1||Female|Sex: Female, Male|Safety Population|Participants|Count of Participants|25|25.0||||||
4336112|NCT00428792|4163361|B3|||Age|Safety Population|years|Mean|9.7|9.7|Standard Deviation|1.6|1.6|||
4336113|NCT00428792|4163362|B2|||Age|Safety Population|years|Mean|9.7|9.7|Standard Deviation|1.5|1.5|||
4336114|NCT00428792|4163363|B1|||Age|Safety Population|years|Mean|9.6|9.6|Standard Deviation|1.6|1.6|||
4336115|NCT00428610|4163388|B4|Italy||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
4336116|NCT00428610|4163389|B3|Italy||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4336117|NCT00428610|4163390|B2|Italy||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4336118|NCT00428610|4163391|B1|Italy||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4336119|NCT00428610|4163388|B4|Russia||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4336120|NCT00428610|4163389|B3|Russia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4336121|NCT00428610|4163390|B2|Russia||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4336122|NCT00428610|4163391|B1|Russia||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4336123|NCT00428610|4163388|B4|United States||Region of Enrollment||Participants|Count of Participants|63|63.0||||||
4336124|NCT00428610|4163389|B3|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
4336125|NCT00428610|4163390|B2|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4336126|NCT00428610|4163391|B1|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
4336127|NCT00428610|4163388|B4|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4336128|NCT00428610|4163389|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4336129|NCT00428610|4163390|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4336130|NCT00428610|4163391|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4336131|NCT00428610|4163388|B4|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4336132|NCT00428610|4163389|B3|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4336133|NCT00428610|4163390|B2|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4336134|NCT00428610|4163391|B1|East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4336135|NCT00428610|4163388|B4|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|99|99.0||||||
4336136|NCT00428610|4163389|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
4336137|NCT00428610|4163390|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
4336138|NCT00428610|4163391|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
4336139|NCT00428610|4163388|B4|African Decent (black)||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4336140|NCT00428610|4163389|B3|African Decent (black)||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4336141|NCT00428610|4163390|B2|African Decent (black)||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4336142|NCT00428610|4163391|B1|African Decent (black)||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4336143|NCT00428610|4163388|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4336144|NCT00428610|4163389|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4336145|NCT00428610|4163390|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4336146|NCT00428610|4163391|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4336147|NCT00428610|4163388|B4||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4336148|NCT00428610|4163389|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4336149|NCT00428610|4163390|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4336150|NCT00428610|4163391|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4336151|NCT00428610|4163388|B4|||Age||years|Mean|57.39|57.39|Standard Deviation|10.51|10.51|||
4336152|NCT00428610|4163389|B3|||Age||years|Mean|56.83|56.83|Standard Deviation|10.37|10.37|||
4336153|NCT00428610|4163390|B2|||Age||years|Mean|59.88|59.88|Standard Deviation|8.98|8.98|||
4336154|NCT00428610|4163391|B1|||Age||years|Mean|56.88|56.88|Standard Deviation|11.12|11.12|||
4336155|NCT00428597|4163425|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4336156|NCT00428597|4163426|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4336157|NCT00428597|4163427|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4336159|NCT00428597|4163426|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4336160|NCT00428597|4163427|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4336161|NCT00428597|4163425|B3|>=65 years||Age, Customized||participants|Number|45|45.0||||||
4336162|NCT00428597|4163426|B2|>=65 years||Age, Customized||participants|Number|23|23.0||||||
4336163|NCT00428597|4163427|B1|>=65 years||Age, Customized||participants|Number|22|22.0||||||
4336164|NCT00428597|4163425|B3|Between 45 and 64||Age, Customized||participants|Number|90|90.0||||||
4336165|NCT00428597|4163426|B2|Between 45 and 64||Age, Customized||participants|Number|45|45.0||||||
4336166|NCT00428597|4163427|B1|Between 45 and 64||Age, Customized||participants|Number|45|45.0||||||
4336167|NCT00428597|4163425|B3|Between 18 and 44 years||Age, Customized||participants|Number|36|36.0||||||
4336168|NCT00428597|4163426|B2|Between 18 and 44 years||Age, Customized||participants|Number|17|17.0||||||
4336169|NCT00428597|4163427|B1|Between 18 and 44 years||Age, Customized||participants|Number|19|19.0||||||
4336170|NCT00428584|4163468|B3|United States||Region of Enrollment||participants|Number|129|129.0||||||
4336171|NCT00428584|4163469|B2|United States||Region of Enrollment||participants|Number|64|64.0||||||
4336172|NCT00428584|4163470|B1|United States||Region of Enrollment||participants|Number|65|65.0||||||
4336173|NCT00428584|4163468|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4336174|NCT00428584|4163469|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4336175|NCT00428584|4163470|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4336176|NCT00428584|4163468|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4336177|NCT00428584|4163469|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4336178|NCT00428584|4163470|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4336179|NCT00428584|4163468|B3|||Age||years|Mean|40.52|40.52|Standard Deviation|9.68|9.68|||
4336180|NCT00428584|4163469|B2|||Age||years|Mean|40.78|40.78|Standard Deviation|9.56|9.56|||
4336181|NCT00428584|4163470|B1|||Age||years|Mean|40.26|40.26|Standard Deviation|9.80|9.8|||
4336182|NCT00428441|4163495|B1|Italy||Region of Enrollment||participants|Number|75|75.0||||||
4336183|NCT00428441|4163495|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4336184|NCT00428441|4163495|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4336185|NCT00428441|4163495|B1|||Age||years|Mean|61.9|61.9|Standard Deviation|14|14.0|||
4336186|NCT00428441|4163495|B1||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4336187|NCT00428441|4163495|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4336188|NCT00428441|4163495|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4336189|NCT00428389|4163499|B3||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4336190|NCT00428389|4163500|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4336191|NCT00428389|4163501|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4336192|NCT00428389|4163499|B3||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4336193|NCT00428389|4163500|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4336194|NCT00428389|4163501|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4336195|NCT00428389|4163499|B3|||Age|Demographic data is provided for the Intent-to-treat / Safety population.|years|Mean|77.3|77.3|Standard Deviation|8.04|8.04|||
4336196|NCT00428389|4163500|B2|||Age|Demographic data is provided for the Intent-to-treat / Safety population.|years|Mean|76.7|76.7|Standard Deviation|8.41|8.41|||
4336197|NCT00428389|4163501|B1|||Age|Demographic data is provided for the Intent-to-treat / Safety population.|years|Mean|77.8|77.8|Standard Deviation|7.66|7.66|||
4336198|NCT00428298|4163520|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4336199|NCT00428298|4163521|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4336200|NCT00428298|4163522|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4336201|NCT00428298|4163520|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4336202|NCT00428298|4163521|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4336203|NCT00428298|4163522|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4336204|NCT00428298|4163520|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4336205|NCT00428298|4163521|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4336206|NCT00428298|4163522|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4336207|NCT00428298|4163520|B3|||Age||years|Mean|42|42.0|Standard Deviation|8.9|8.9|||
4336208|NCT00428298|4163521|B2|||Age||years|Mean|41|41.0|Standard Deviation|10|10.0|||
4336209|NCT00428298|4163522|B1|||Age||years|Mean|45|45.0|Standard Deviation|7|7.0|||
4336210|NCT00428298|4163520|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4336211|NCT00428298|4163521|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4336212|NCT00428298|4163522|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4336213|NCT00428298|4163520|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4336214|NCT00428298|4163521|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4336215|NCT00428298|4163522|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4336216|NCT00428298|4163520|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4336217|NCT00428298|4163521|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4336218|NCT00428298|4163522|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4336219|NCT00428246|4163533|B4|United States||Region of Enrollment||participants|Number|24.0|24.0||||||
4336220|NCT00428246|4163534|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4336221|NCT00428246|4163535|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4336222|NCT00428246|4163536|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4336223|NCT00428246|4163533|B4||Male|Sex: Female, Male||Participants|Count of Participants|20.0|20.0||||||
4336224|NCT00428246|4163534|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4336225|NCT00428246|4163535|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4336226|NCT00428246|4163536|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4336227|NCT00428246|4163533|B4||Female|Sex: Female, Male||Participants|Count of Participants|4.0|4.0||||||
4336228|NCT00428246|4163534|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4336229|NCT00428246|4163535|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4336230|NCT00428246|4163536|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4336231|NCT00428246|4163533|B4|||Age||years|Mean|68.4|68.4|Standard Deviation|10.3|10.3|||
4336232|NCT00428246|4163534|B3|||Age||years|Mean|68.4|68.4|Standard Deviation|12.4|12.4|||
4336233|NCT00428246|4163535|B2|||Age||years|Mean|67.5|67.5|Standard Deviation|9.1|9.1|||
4336234|NCT00428246|4163536|B1|||Age||years|Mean|72.6|72.6|Standard Deviation|9.1|9.1|||
4336235|NCT00428246|4163533|B4||>=65 years|Age||Participants|Count of Participants|16.0|16.0||||||
4336236|NCT00428246|4163534|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4336237|NCT00428246|4163535|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4336238|NCT00428246|4163536|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4336239|NCT00428246|4163533|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8.0|8.0||||||
4336240|NCT00428246|4163534|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4336241|NCT00428246|4163535|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4336242|NCT00428246|4163536|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4336243|NCT00428246|4163533|B4||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4336244|NCT00428246|4163534|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4336245|NCT00428246|4163535|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4336246|NCT00428246|4163536|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4336247|NCT00428220|4163546|B1||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4336248|NCT00428220|4163546|B1||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4336249|NCT00428220|4163546|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|12.5|12.5|||
4336250|NCT00428207|4163562|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4336251|NCT00428207|4163562|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4336252|NCT00428207|4163562|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4336253|NCT00428207|4163562|B1|||Age||years|Mean|63.25|63.25|Standard Deviation|10.8|10.8|||
4336254|NCT00428207|4163562|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4336255|NCT00428207|4163562|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4336256|NCT00428207|4163562|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4336257|NCT00428116|4163569|B3|||Log10 HIV RNA level||copies/ml|Median|2.18|2.18|Inter-Quartile Range|||2.18|2.71|
4336258|NCT00428116|4163570|B2|||Log10 HIV RNA level||copies/ml|Median|2.18|2.18|Inter-Quartile Range|||2.18|2.71|
4336259|NCT00428116|4163571|B1|||Log10 HIV RNA level||copies/ml|Median|2.18|2.18|Inter-Quartile Range|||2.18|2.64|
4336260|NCT00428116|4163569|B3|||CD4%||percent|Median|33|33.0|Inter-Quartile Range|||30.0|39.0|
4336261|NCT00428116|4163570|B2|||CD4%||percent|Median|34|34.0|Inter-Quartile Range|||32.0|38.0|
4336262|NCT00428116|4163571|B1|||CD4%||percent|Median|33|33.0|Inter-Quartile Range|||30.0|40.0|
4336263|NCT00428116|4163569|B3|Kenya||Region of Enrollment||participants|Number|42|42.0||||||
4336264|NCT00428116|4163570|B2|Kenya||Region of Enrollment||participants|Number|21|21.0||||||
4336265|NCT00428116|4163571|B1|Kenya||Region of Enrollment||participants|Number|21|21.0||||||
4336266|NCT00428116|4163569|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4336267|NCT00428116|4163570|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4336268|NCT00428116|4163571|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4336269|NCT00428116|4163569|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4336270|NCT00428116|4163570|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4336271|NCT00428116|4163571|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4336272|NCT00428116|4163569|B3|||Age||months|Median|30.0|30.0|Inter-Quartile Range|||28.9|34.6|
4336273|NCT00428116|4163570|B2|||Age||months|Median|30.0|30.0|Inter-Quartile Range|||29.3|34.9|
4336274|NCT00428116|4163571|B1|||Age||months|Median|29|29.0|Inter-Quartile Range|||28.8|33.8|
4336275|NCT00428116|4163569|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4336276|NCT00428116|4163570|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4336277|NCT00428116|4163571|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4336278|NCT00428116|4163569|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4336279|NCT00428116|4163570|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4336280|NCT00428116|4163571|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4336281|NCT00428116|4163569|B3||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
4336282|NCT00428116|4163570|B2||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
4336283|NCT00428116|4163571|B1||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
4336284|NCT00428090|4163580|B5||Unknown or Not Reported|Race (NIH/OMB)|ITT Population|Participants|Count of Participants|0|0.0||||||
4336285|NCT00428090|4163581|B4||Unknown or Not Reported|Race (NIH/OMB)|ITT Population|Participants|Count of Participants|0|0.0||||||
4336286|NCT00428090|4163582|B3||Unknown or Not Reported|Race (NIH/OMB)|ITT Population|Participants|Count of Participants|0|0.0||||||
4336287|NCT00428090|4163583|B2||Unknown or Not Reported|Race (NIH/OMB)|ITT Population|Participants|Count of Participants|0|0.0||||||
4336288|NCT00428090|4163584|B1||Unknown or Not Reported|Race (NIH/OMB)|ITT Population|Participants|Count of Participants|0|0.0||||||
4336289|NCT00428090|4163580|B5||More than one race|Race (NIH/OMB)|ITT Population|Participants|Count of Participants|7|7.0||||||
4336290|NCT00428090|4163581|B4||More than one race|Race (NIH/OMB)|ITT Population|Participants|Count of Participants|2|2.0||||||
4336291|NCT00428090|4163582|B3||More than one race|Race (NIH/OMB)|ITT Population|Participants|Count of Participants|3|3.0||||||
4336292|NCT00428090|4163583|B2||More than one race|Race (NIH/OMB)|ITT Population|Participants|Count of Participants|1|1.0||||||
4336293|NCT00428090|4163584|B1||More than one race|Race (NIH/OMB)|ITT Population|Participants|Count of Participants|1|1.0||||||
4336294|NCT00428090|4163580|B5||White|Race (NIH/OMB)|ITT Population|Participants|Count of Participants|401|401.0||||||
4336295|NCT00428090|4163581|B4||White|Race (NIH/OMB)|ITT Population|Participants|Count of Participants|57|57.0||||||
4336296|NCT00428090|4163582|B3||White|Race (NIH/OMB)|ITT Population|Participants|Count of Participants|112|112.0||||||
4336297|NCT00428090|4163583|B2||White|Race (NIH/OMB)|ITT Population|Participants|Count of Participants|109|109.0||||||
4336298|NCT00428090|4163584|B1||White|Race (NIH/OMB)|ITT Population|Participants|Count of Participants|123|123.0||||||
4336299|NCT00428090|4163580|B5||Black or African American|Race (NIH/OMB)|ITT Population|Participants|Count of Participants|7|7.0||||||
4336300|NCT00428090|4163581|B4||Black or African American|Race (NIH/OMB)|ITT Population|Participants|Count of Participants|3|3.0||||||
4336301|NCT00428090|4163582|B3||Black or African American|Race (NIH/OMB)|ITT Population|Participants|Count of Participants|2|2.0||||||
4336302|NCT00428090|4163583|B2||Black or African American|Race (NIH/OMB)|ITT Population|Participants|Count of Participants|1|1.0||||||
4336303|NCT00428090|4163584|B1||Black or African American|Race (NIH/OMB)|ITT Population|Participants|Count of Participants|1|1.0||||||
4336304|NCT00428090|4163580|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|ITT Population|Participants|Count of Participants|0|0.0||||||
4336305|NCT00428090|4163581|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|ITT Population|Participants|Count of Participants|0|0.0||||||
4336306|NCT00428090|4163582|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|ITT Population|Participants|Count of Participants|0|0.0||||||
4336307|NCT00428090|4163583|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|ITT Population|Participants|Count of Participants|0|0.0||||||
4336308|NCT00428090|4163584|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|ITT Population|Participants|Count of Participants|0|0.0||||||
4336309|NCT00428090|4163580|B5||Asian|Race (NIH/OMB)|ITT Population|Participants|Count of Participants|134|134.0||||||
4336310|NCT00428090|4163581|B4||Asian|Race (NIH/OMB)|ITT Population|Participants|Count of Participants|14|14.0||||||
4336311|NCT00428090|4163582|B3||Asian|Race (NIH/OMB)|ITT Population|Participants|Count of Participants|37|37.0||||||
4336312|NCT00428090|4163583|B2||Asian|Race (NIH/OMB)|ITT Population|Participants|Count of Participants|50|50.0||||||
4336313|NCT00428090|4163584|B1||Asian|Race (NIH/OMB)|ITT Population|Participants|Count of Participants|33|33.0||||||
4336314|NCT00428090|4163580|B5||American Indian or Alaska Native|Race (NIH/OMB)|ITT Population|Participants|Count of Participants|4|4.0||||||
4336315|NCT00428090|4163581|B4||American Indian or Alaska Native|Race (NIH/OMB)|ITT Population|Participants|Count of Participants|0|0.0||||||
4336316|NCT00428090|4163582|B3||American Indian or Alaska Native|Race (NIH/OMB)|ITT Population|Participants|Count of Participants|2|2.0||||||
4336317|NCT00428090|4163583|B2||American Indian or Alaska Native|Race (NIH/OMB)|ITT Population|Participants|Count of Participants|1|1.0||||||
4336318|NCT00428090|4163584|B1||American Indian or Alaska Native|Race (NIH/OMB)|ITT Population|Participants|Count of Participants|1|1.0||||||
4336319|NCT00428090|4163580|B5||Male|Sex: Female, Male|ITT Population|Participants|Count of Participants|206|206.0||||||
4336320|NCT00428090|4163581|B4||Male|Sex: Female, Male|ITT Population|Participants|Count of Participants|28|28.0||||||
4336321|NCT00428090|4163582|B3||Male|Sex: Female, Male|ITT Population|Participants|Count of Participants|55|55.0||||||
4336322|NCT00428090|4163583|B2||Male|Sex: Female, Male|ITT Population|Participants|Count of Participants|59|59.0||||||
4336323|NCT00428090|4163584|B1||Male|Sex: Female, Male|ITT Population|Participants|Count of Participants|64|64.0||||||
4336324|NCT00428090|4163580|B5||Female|Sex: Female, Male|ITT Population|Participants|Count of Participants|347|347.0||||||
4336325|NCT00428090|4163581|B4||Female|Sex: Female, Male|ITT Population|Participants|Count of Participants|48|48.0||||||
4336326|NCT00428090|4163582|B3||Female|Sex: Female, Male|ITT Population|Participants|Count of Participants|101|101.0||||||
4336327|NCT00428090|4163583|B2||Female|Sex: Female, Male|ITT Population|Participants|Count of Participants|103|103.0||||||
4336328|NCT00428090|4163584|B1||Female|Sex: Female, Male|ITT Population|Participants|Count of Participants|95|95.0||||||
4336329|NCT00428090|4163580|B5|||Age|Baseline data are presented for intention-to-Treat (ITT) population which defined as par. randomized to treatment, who have taken at least one dose of study medication and who have at least one post baseline efficacy assessment (Alzheimer’s Disease Assessment Scale – Cognitive subscale [ADAS-Cog] or Clinician’s Interview-Based Impression of Change Plus [CIBIC+]).|Years|Mean|72.4|72.4|Standard Deviation|8.30|8.3|||
4336373|NCT00427934|4163759|B4|> = 65 years||Age, Customized||Participants|Number|6|6.0||||||
4336374|NCT00427934|4163760|B3|> = 65 years||Age, Customized||Participants|Number|14|14.0||||||
4336330|NCT00428090|4163581|B4|||Age|Baseline data are presented for intention-to-Treat (ITT) population which defined as par. randomized to treatment, who have taken at least one dose of study medication and who have at least one post baseline efficacy assessment (Alzheimer’s Disease Assessment Scale – Cognitive subscale [ADAS-Cog] or Clinician’s Interview-Based Impression of Change Plus [CIBIC+]).|Years|Mean|72.9|72.9|Standard Deviation|7.97|7.97|||
4336331|NCT00428090|4163582|B3|||Age|Baseline data are presented for intention-to-Treat (ITT) population which defined as par. randomized to treatment, who have taken at least one dose of study medication and who have at least one post baseline efficacy assessment (Alzheimer’s Disease Assessment Scale – Cognitive subscale [ADAS-Cog] or Clinician’s Interview-Based Impression of Change Plus [CIBIC+]).|Years|Mean|72.6|72.6|Standard Deviation|8.63|8.63|||
4336332|NCT00428090|4163583|B2|||Age|Baseline data are presented for intention-to-Treat (ITT) population which defined as par. randomized to treatment, who have taken at least one dose of study medication and who have at least one post baseline efficacy assessment (Alzheimer’s Disease Assessment Scale – Cognitive subscale [ADAS-Cog] or Clinician’s Interview-Based Impression of Change Plus [CIBIC+]).|Years|Mean|71.7|71.7|Standard Deviation|7.91|7.91|||
4336333|NCT00428090|4163584|B1|||Age|Baseline data are presented for intention-to-Treat (ITT) population which defined as par. randomized to treatment, who have taken at least one dose of study medication and who have at least one post baseline efficacy assessment (Alzheimer’s Disease Assessment Scale – Cognitive subscale [ADAS-Cog] or Clinician’s Interview-Based Impression of Change Plus [CIBIC+]).|Years|Mean|72.5|72.5|Standard Deviation|8.56|8.56|||
4336334|NCT00428077|4163701|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4336335|NCT00428077|4163701|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4336336|NCT00428077|4163701|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4336337|NCT00428077|4163701|B1|||Age||years|Mean|59.75|59.75|Standard Deviation|3.59|3.59|||
4336338|NCT00428077|4163701|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4336339|NCT00428077|4163701|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4336340|NCT00428077|4163701|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4336341|NCT00427999|4163705|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4336342|NCT00427999|4163705|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4336343|NCT00427999|4163705|B1|||Age||years|Mean|67|67.0|Standard Deviation|7.0|7.0|||
4336344|NCT00427973|4163714|B1|||Cancer Of Liver Italian Program (CLIP)|"CLIP score calculated by assigning a score (0, 1 or 2) to each of 4 clinical factors and then adding the 4 scores to arrive at the CLIP score. Higher values in each of the 4 clinical factors represent a worse outcome. CLIP score range (0-6) w/ higher values=worse outcome~Child-Pugh:A=0, B=1, or C=2~If tumor morphology is uninodal w/ extension <=50%, score=0, if multinodular and extension <=50%, score=1, if tumor morphology massive or extension >50%, score=2.~AFP <400, score=0, AFP >=400, score=1.~No portal vein thrombosis, score=0, portal vein thrombosis present, score=1."|units on a scale|Median|2|2.0|Full Range|||1.0|3.0|
4336345|NCT00427973|4163714|B1|||Eastern Cooperative Oncology Group|"Grade ECOG 0 Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours"|units on a scale|Median|1|1.0|Full Range|||0.0|2.0|
4336346|NCT00427973|4163714|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4336347|NCT00427973|4163714|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4336348|NCT00427973|4163714|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4336349|NCT00427973|4163714|B1|||Age||years|Median|66|66.0|Full Range|||46.0|78.0|
4336350|NCT00427973|4163714|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4336351|NCT00427973|4163714|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4336352|NCT00427973|4163714|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4336353|NCT00427960|4163721|B3||Male|Sex: Female, Male||Participants|Count of Participants|31.0|31.0||||||
4336354|NCT00427960|4163722|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4336355|NCT00427960|4163723|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4336356|NCT00427960|4163721|B3||Female|Sex: Female, Male||Participants|Count of Participants|24.0|24.0||||||
4336357|NCT00427960|4163722|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4336358|NCT00427960|4163723|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4336359|NCT00427960|4163721|B3|||Age||years|Mean|51.5|51.5|Standard Deviation|11|11.0|||
4336360|NCT00427960|4163722|B2|||Age||years|Mean|53|53.0|Standard Deviation|11|11.0|||
4336361|NCT00427960|4163723|B1|||Age||years|Mean|50|50.0|Standard Deviation|11|11.0|||
4336362|NCT00427934|4163758|B5||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4336363|NCT00427934|4163759|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4336364|NCT00427934|4163760|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4336365|NCT00427934|4163761|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4336366|NCT00427934|4163762|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4336367|NCT00427934|4163758|B5||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4336368|NCT00427934|4163759|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4336369|NCT00427934|4163760|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4336370|NCT00427934|4163761|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4336371|NCT00427934|4163762|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4336372|NCT00427934|4163758|B5|> = 65 years||Age, Customized||Participants|Number|23|23.0||||||
4336375|NCT00427934|4163761|B2|> = 65 years||Age, Customized||Participants|Number|0|0.0||||||
4336376|NCT00427934|4163762|B1|> = 65 years||Age, Customized||Participants|Number|3|3.0||||||
4336377|NCT00427934|4163758|B5|45 to 64 years||Age, Customized||Participants|Number|81|81.0||||||
4336378|NCT00427934|4163759|B4|45 to 64 years||Age, Customized||Participants|Number|21|21.0||||||
4336379|NCT00427934|4163760|B3|45 to 64 years||Age, Customized||Participants|Number|48|48.0||||||
4336380|NCT00427934|4163761|B2|45 to 64 years||Age, Customized||Participants|Number|8|8.0||||||
4336381|NCT00427934|4163762|B1|45 to 64 years||Age, Customized||Participants|Number|4|4.0||||||
4336382|NCT00427934|4163758|B5|18 to 44 years||Age, Customized||Participants|Number|22|22.0||||||
4336383|NCT00427934|4163759|B4|18 to 44 years||Age, Customized||Participants|Number|6|6.0||||||
4336384|NCT00427934|4163760|B3|18 to 44 years||Age, Customized||Participants|Number|15|15.0||||||
4336385|NCT00427934|4163761|B2|18 to 44 years||Age, Customized||Participants|Number|0|0.0||||||
4336386|NCT00427934|4163762|B1|18 to 44 years||Age, Customized||Participants|Number|1|1.0||||||
4336387|NCT00427934|4163758|B5|< 18 years||Age, Customized||Participants|Number|0|0.0||||||
4336388|NCT00427934|4163759|B4|< 18 years||Age, Customized||Participants|Number|0|0.0||||||
4336389|NCT00427934|4163760|B3|< 18 years||Age, Customized||Participants|Number|0|0.0||||||
4336390|NCT00427934|4163761|B2|< 18 years||Age, Customized||Participants|Number|0|0.0||||||
4336391|NCT00427934|4163762|B1|< 18 years||Age, Customized||Participants|Number|0|0.0||||||
4336392|NCT00427921|4163833|B1|||Duration of Crohn's Disease at Screening in Years||years|Mean|11.8|11.8|Standard Deviation|9.54|9.54|||
4336393|NCT00427921|4163833|B1|> 70 kg||Weight in kilograms||Participants|Number|141|141.0||||||
4336394|NCT00427921|4163833|B1|< = 70 kg||Weight in kilograms||Participants|Number|163|163.0||||||
4336395|NCT00427921|4163833|B1|Anal/Perianal+Colon+GD+Rectum+Jejunum+Ileum||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|1|1.0||||||
4336396|NCT00427921|4163833|B1|Anal/Perianal + Colon + GD +Rectum + Ileum||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|2|2.0||||||
4336397|NCT00427921|4163833|B1|Anal/Perianal + Colon + GD + Ileum||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|4|4.0||||||
4336398|NCT00427921|4163833|B1|Anal/Perianal + Colon + Rectum +Jejunum + Ileum||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|1|1.0||||||
4336399|NCT00427921|4163833|B1|Anal/Perianal + Colon + Rectum + Ileum + Other||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|2|2.0||||||
4336400|NCT00427921|4163833|B1|Anal/Perianal + Colon + Rectum + Ileum||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|13|13.0||||||
4336401|NCT00427921|4163833|B1|Anal/Perianal + Colon + Rectum||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|3|3.0||||||
4336402|NCT00427921|4163833|B1|Anal/Perianal + Colon + Jejunum + Ileum||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|3|3.0||||||
4336403|NCT00427921|4163833|B1|Anal/Perianal + Colon + Ileum + Other||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|3|3.0||||||
4336404|NCT00427921|4163833|B1|Anal/Perianal + Colon + Ileum||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|13|13.0||||||
4336405|NCT00427921|4163833|B1|Anal/Perianal + Colon + Other||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|2|2.0||||||
4336406|NCT00427921|4163833|B1|Anal/Perianal + Colon||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|6|6.0||||||
4336407|NCT00427921|4163833|B1|Anal/Perianal + Rectum + Ileum||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|3|3.0||||||
4336408|NCT00427921|4163833|B1|Anal/Perianal + Rectum + Other||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|1|1.0||||||
4336409|NCT00427921|4163833|B1|Anal/Perianal + Rectum||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|2|2.0||||||
4336410|NCT00427921|4163833|B1|Anal/Perianal + Jejunum + Ileum||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|1|1.0||||||
4336411|NCT00427921|4163833|B1|Anal/Perianal + Ileum + Other||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|2|2.0||||||
4336412|NCT00427921|4163833|B1|Anal/Perianal + Ileum||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|16|16.0||||||
4336413|NCT00427921|4163833|B1|Colon+GD+Rectum+Jejunum+Ileum||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|1|1.0||||||
4336414|NCT00427921|4163833|B1|Colon+GD+Rectum+ Other||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|1|1.0||||||
4336415|NCT00427921|4163833|B1|Colon+GD+Jejunum+Ileum||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|2|2.0||||||
4336416|NCT00427921|4163833|B1|Colon + Gastroduodenum + Ileum||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|1|1.0||||||
4336417|NCT00427921|4163833|B1|Colon + Rectum + Ileum + Other||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|2|2.0||||||
4336418|NCT00427921|4163833|B1|Colon + Rectum + Ileum||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|13|13.0||||||
4336419|NCT00427921|4163833|B1|Colon + Rectum||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|8|8.0||||||
4336420|NCT00427921|4163833|B1|Colon + Jejunum + Ileum||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|3|3.0||||||
4336421|NCT00427921|4163833|B1|Colon + Ileum + Other||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|3|3.0||||||
4336422|NCT00427921|4163833|B1|Colon + Ileum||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|64|64.0||||||
4336423|NCT00427921|4163833|B1|Colon + Other||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|2|2.0||||||
4336424|NCT00427921|4163833|B1|Gastroduodenum + Ileum||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|3|3.0||||||
4336425|NCT00427921|4163833|B1|Rectum + Ileum + Other||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|1|1.0||||||
4336426|NCT00427921|4163833|B1|Rectum + Ileum||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|7|7.0||||||
4336427|NCT00427921|4163833|B1|Jejunum + Ileum||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|3|3.0||||||
4336428|NCT00427921|4163833|B1|Ileum + Other||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|7|7.0||||||
4336429|NCT00427921|4163833|B1|Other||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|3|3.0||||||
4336430|NCT00427921|4163833|B1|Ileum||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|54|54.0||||||
4336431|NCT00427921|4163833|B1|Jejunum||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|2|2.0||||||
4336432|NCT00427921|4163833|B1|Rectum||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|3|3.0||||||
4336433|NCT00427921|4163833|B1|Gastroduodenum||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|1|1.0||||||
4336434|NCT00427921|4163833|B1|Colon||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|40|40.0||||||
4336435|NCT00427921|4163833|B1|Anal/Perianal||Summary of Locations of Crohn's Disease at Screening (All Treated Subjects)|Crohn's Disease may be at multiple locations|participants|Number|2|2.0||||||
4336436|NCT00427921|4163833|B1|Missing||Number of Subjects with Abdominal Fistulas at Screening||Participants|Number|1|1.0||||||
4336437|NCT00427921|4163833|B1|Count >=4||Number of Subjects with Abdominal Fistulas at Screening||Participants|Number|1|1.0||||||
4336438|NCT00427921|4163833|B1|Count 3||Number of Subjects with Abdominal Fistulas at Screening||Participants|Number|0|0.0||||||
4336439|NCT00427921|4163833|B1|Count 2||Number of Subjects with Abdominal Fistulas at Screening||Participants|Number|1|1.0||||||
4336440|NCT00427921|4163833|B1|Count 1||Number of Subjects with Abdominal Fistulas at Screening||Participants|Number|10|10.0||||||
4336441|NCT00427921|4163833|B1|Count 0||Number of Subjects with Abdominal Fistulas at Screening||Participants|Number|291|291.0||||||
4336442|NCT00427921|4163833|B1|Missing||Number Subjects with Perianal Fistulas at Screening||Participants|Number|1|1.0||||||
4336443|NCT00427921|4163833|B1|Count >=4||Number Subjects with Perianal Fistulas at Screening||Participants|Number|3|3.0||||||
4336444|NCT00427921|4163833|B1|Count 3||Number Subjects with Perianal Fistulas at Screening||Participants|Number|4|4.0||||||
4336445|NCT00427921|4163833|B1|Count 2||Number Subjects with Perianal Fistulas at Screening||Participants|Number|17|17.0||||||
4336446|NCT00427921|4163833|B1|Count 1||Number Subjects with Perianal Fistulas at Screening||Participants|Number|35|35.0||||||
4336447|NCT00427921|4163833|B1|Count 0||Number Subjects with Perianal Fistulas at Screening||Participants|Number|244|244.0||||||
4336448|NCT00427921|4163833|B1|Missing||Number Subjects With Draining Cutaneous Fistulas at Screening||participants|Number|1|1.0||||||
4336449|NCT00427921|4163833|B1|Count >=4 lesions||Number Subjects With Draining Cutaneous Fistulas at Screening||participants|Number|5|5.0||||||
4336450|NCT00427921|4163833|B1|Count 3 lesions||Number Subjects With Draining Cutaneous Fistulas at Screening||participants|Number|5|5.0||||||
4336451|NCT00427921|4163833|B1|Count 2 lesions||Number Subjects With Draining Cutaneous Fistulas at Screening||participants|Number|16|16.0||||||
4336452|NCT00427921|4163833|B1|Count 1 lesion||Number Subjects With Draining Cutaneous Fistulas at Screening||participants|Number|42|42.0||||||
4336453|NCT00427921|4163833|B1|Count 0 lesions||Number Subjects With Draining Cutaneous Fistulas at Screening||participants|Number|235|235.0||||||
4336454|NCT00427921|4163833|B1|Non-User||Nicotine||participants|Number|122|122.0||||||
4336455|NCT00427921|4163833|B1|Ex-User||Nicotine||participants|Number|84|84.0||||||
4336456|NCT00427921|4163833|B1|User||Nicotine||participants|Number|98|98.0||||||
4336457|NCT00427921|4163833|B1|Missing||C-Reactive protein mg/dL||participants|Number|1|1.0||||||
4336458|NCT00427921|4163833|B1|> = 1.0 mg/dL||C-Reactive protein mg/dL||participants|Number|155|155.0||||||
4336459|NCT00427921|4163833|B1|< 1.0 mg/dL||C-Reactive protein mg/dL||participants|Number|148|148.0||||||
4336460|NCT00427921|4163833|B1|Non-User||Alcohol||participants|Number|142|142.0||||||
4336461|NCT00427921|4163833|B1|Ex-User||Alcohol||participants|Number|15|15.0||||||
4336462|NCT00427921|4163833|B1|User||Alcohol||participants|Number|147|147.0||||||
4336463|NCT00427921|4163833|B1|Canada||Region of Enrollment||Participants|Number|304|304.0||||||
4336464|NCT00427921|4163833|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4336465|NCT00427921|4163833|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4336466|NCT00427921|4163833|B1|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4336467|NCT00427921|4163833|B1|White||Race/Ethnicity, Customized||participants|Number|291|291.0||||||
4336468|NCT00427921|4163833|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4336469|NCT00427921|4163833|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4336470|NCT00427921|4163833|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4336471|NCT00427921|4163833|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4336472|NCT00427921|4163833|B1||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4336473|NCT00427921|4163833|B1||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4336474|NCT00427921|4163833|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4336475|NCT00427921|4163833|B1||Between 18 and 65 years|Age||Participants|Count of Participants|296|296.0||||||
4336476|NCT00427921|4163833|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4336477|NCT00427908|4163852|B5|Geographic ancestry|Unspecified|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4336478|NCT00427908|4163853|B4|Geographic ancestry|Unspecified|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4336479|NCT00427908|4163854|B3|Geographic ancestry|Unspecified|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4336480|NCT00427908|4163855|B2|Geographic ancestry|Unspecified|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4336481|NCT00427908|4163856|B1|Geographic ancestry|Unspecified|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4336482|NCT00427908|4163852|B5|Geographic ancestry|White-Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|599|599.0||||||
4336483|NCT00427908|4163853|B4|Geographic ancestry|White-Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|76|76.0||||||
4336484|NCT00427908|4163854|B3|Geographic ancestry|White-Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|74|74.0||||||
4336485|NCT00427908|4163855|B2|Geographic ancestry|White-Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|225|225.0||||||
4336486|NCT00427908|4163856|B1|Geographic ancestry|White-Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|224|224.0||||||
4336487|NCT00427908|4163852|B5|Geographic ancestry|White-Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4336488|NCT00427908|4163853|B4|Geographic ancestry|White-Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4336489|NCT00427908|4163854|B3|Geographic ancestry|White-Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4336490|NCT00427908|4163855|B2|Geographic ancestry|White-Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4336491|NCT00427908|4163856|B1|Geographic ancestry|White-Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4336492|NCT00427908|4163852|B5|Geographic ancestry|Asian-East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4336493|NCT00427908|4163853|B4|Geographic ancestry|Asian-East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4336494|NCT00427908|4163854|B3|Geographic ancestry|Asian-East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4336495|NCT00427908|4163855|B2|Geographic ancestry|Asian-East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4336496|NCT00427908|4163856|B1|Geographic ancestry|Asian-East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4336497|NCT00427908|4163852|B5|Geographic ancestry|African heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4336498|NCT00427908|4163853|B4|Geographic ancestry|African heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4336499|NCT00427908|4163854|B3|Geographic ancestry|African heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4336500|NCT00427908|4163855|B2|Geographic ancestry|African heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4336501|NCT00427908|4163856|B1|Geographic ancestry|African heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4336502|NCT00427908|4163852|B5||Male|Sex: Female, Male||Participants|Count of Participants|306|306.0||||||
4336503|NCT00427908|4163853|B4||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4336504|NCT00427908|4163854|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4336505|NCT00427908|4163855|B2||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4336506|NCT00427908|4163856|B1||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4336507|NCT00427908|4163852|B5||Female|Sex: Female, Male||Participants|Count of Participants|307|307.0||||||
4336508|NCT00427908|4163853|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4336509|NCT00427908|4163854|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4336510|NCT00427908|4163855|B2||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4336511|NCT00427908|4163856|B1||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4336512|NCT00427908|4163852|B5|||Age||Months|Mean|45.73|45.73|Standard Deviation|34.44|34.44|||
4336513|NCT00427908|4163853|B4|||Age||Months|Mean|71.8|71.8|Standard Deviation|30.90|30.9|||
4336514|NCT00427908|4163854|B3|||Age||Months|Mean|19.3|19.3|Standard Deviation|3.07|3.07|||
4336515|NCT00427908|4163855|B2|||Age||Months|Mean|71.9|71.9|Standard Deviation|31.19|31.19|||
4336516|NCT00427908|4163856|B1|||Age||Months|Mean|19.1|19.1|Standard Deviation|2.96|2.96|||
4336517|NCT00427895|4164055|B5||Male|Sex: Female, Male|In 13vPnc, Cohort 2; out of 404 participants vaccinated, 1 participant randomized and vaccinated in error without a consent form, and hence baseline characteristics are available for 403 participant.|Participants|Count of Participants|886|886.0||||||
4336518|NCT00427895|4164056|B4||Male|Sex: Female, Male|In 13vPnc, Cohort 2; out of 404 participants vaccinated, 1 participant randomized and vaccinated in error without a consent form, and hence baseline characteristics are available for 403 participant.|Participants|Count of Participants|376|376.0||||||
4336519|NCT00427895|4164057|B3||Male|Sex: Female, Male|In 13vPnc, Cohort 2; out of 404 participants vaccinated, 1 participant randomized and vaccinated in error without a consent form, and hence baseline characteristics are available for 403 participant.|Participants|Count of Participants|154|154.0||||||
4336520|NCT00427895|4164058|B2||Male|Sex: Female, Male|In 13vPnc, Cohort 2; out of 404 participants vaccinated, 1 participant randomized and vaccinated in error without a consent form, and hence baseline characteristics are available for 403 participant.|Participants|Count of Participants|162|162.0||||||
4336521|NCT00427895|4164059|B1||Male|Sex: Female, Male|In 13vPnc, Cohort 2; out of 404 participants vaccinated, 1 participant randomized and vaccinated in error without a consent form, and hence baseline characteristics are available for 403 participant.|Participants|Count of Participants|194|194.0||||||
4336522|NCT00427895|4164055|B5||Female|Sex: Female, Male|In 13vPnc, Cohort 2; out of 404 participants vaccinated, 1 participant randomized and vaccinated in error without a consent form, and hence baseline characteristics are available for 403 participant.|Participants|Count of Participants|1247|1247.0||||||
4336523|NCT00427895|4164056|B4||Female|Sex: Female, Male|In 13vPnc, Cohort 2; out of 404 participants vaccinated, 1 participant randomized and vaccinated in error without a consent form, and hence baseline characteristics are available for 403 participant.|Participants|Count of Participants|523|523.0||||||
4336524|NCT00427895|4164057|B3||Female|Sex: Female, Male|In 13vPnc, Cohort 2; out of 404 participants vaccinated, 1 participant randomized and vaccinated in error without a consent form, and hence baseline characteristics are available for 403 participant.|Participants|Count of Participants|249|249.0||||||
4336525|NCT00427895|4164058|B2||Female|Sex: Female, Male|In 13vPnc, Cohort 2; out of 404 participants vaccinated, 1 participant randomized and vaccinated in error without a consent form, and hence baseline characteristics are available for 403 participant.|Participants|Count of Participants|252|252.0||||||
4336526|NCT00427895|4164059|B1||Female|Sex: Female, Male|In 13vPnc, Cohort 2; out of 404 participants vaccinated, 1 participant randomized and vaccinated in error without a consent form, and hence baseline characteristics are available for 403 participant.|Participants|Count of Participants|223|223.0||||||
4336527|NCT00427895|4164055|B5|60 to 64 years||Age, Customized|In 13vPnc, Cohort 2; out of 404 participants vaccinated, 1 participant randomized and vaccinated in error without a consent form, and hence baseline characteristics are available for 403 participant.|participants|Number|831|831.0||||||
4336528|NCT00427895|4164056|B4|60 to 64 years||Age, Customized|In 13vPnc, Cohort 2; out of 404 participants vaccinated, 1 participant randomized and vaccinated in error without a consent form, and hence baseline characteristics are available for 403 participant.|participants|Number|0|0.0||||||
4336529|NCT00427895|4164057|B3|60 to 64 years||Age, Customized|In 13vPnc, Cohort 2; out of 404 participants vaccinated, 1 participant randomized and vaccinated in error without a consent form, and hence baseline characteristics are available for 403 participant.|participants|Number|0|0.0||||||
4336530|NCT00427895|4164058|B2|60 to 64 years||Age, Customized|In 13vPnc, Cohort 2; out of 404 participants vaccinated, 1 participant randomized and vaccinated in error without a consent form, and hence baseline characteristics are available for 403 participant.|participants|Number|414|414.0||||||
4336531|NCT00427895|4164059|B1|60 to 64 years||Age, Customized|In 13vPnc, Cohort 2; out of 404 participants vaccinated, 1 participant randomized and vaccinated in error without a consent form, and hence baseline characteristics are available for 403 participant.|participants|Number|417|417.0||||||
4336532|NCT00427895|4164055|B5|50 to 59 years||Age, Customized|In 13vPnc, Cohort 2; out of 404 participants vaccinated, 1 participant randomized and vaccinated in error without a consent form, and hence baseline characteristics are available for 403 participant.|participants|Number|403|403.0||||||
4336533|NCT00427895|4164056|B4|50 to 59 years||Age, Customized|In 13vPnc, Cohort 2; out of 404 participants vaccinated, 1 participant randomized and vaccinated in error without a consent form, and hence baseline characteristics are available for 403 participant.|participants|Number|0|0.0||||||
4336534|NCT00427895|4164057|B3|50 to 59 years||Age, Customized|In 13vPnc, Cohort 2; out of 404 participants vaccinated, 1 participant randomized and vaccinated in error without a consent form, and hence baseline characteristics are available for 403 participant.|participants|Number|403|403.0||||||
4336535|NCT00427895|4164058|B2|50 to 59 years||Age, Customized|In 13vPnc, Cohort 2; out of 404 participants vaccinated, 1 participant randomized and vaccinated in error without a consent form, and hence baseline characteristics are available for 403 participant.|participants|Number|0|0.0||||||
4336536|NCT00427895|4164059|B1|50 to 59 years||Age, Customized|In 13vPnc, Cohort 2; out of 404 participants vaccinated, 1 participant randomized and vaccinated in error without a consent form, and hence baseline characteristics are available for 403 participant.|participants|Number|0|0.0||||||
4336537|NCT00427895|4164055|B5|40 to 49 years||Age, Customized|In 13vPnc, Cohort 2; out of 404 participants vaccinated, 1 participant randomized and vaccinated in error without a consent form, and hence baseline characteristics are available for 403 participant.|participants|Number|301|301.0||||||
4336538|NCT00427895|4164056|B4|40 to 49 years||Age, Customized|In 13vPnc, Cohort 2; out of 404 participants vaccinated, 1 participant randomized and vaccinated in error without a consent form, and hence baseline characteristics are available for 403 participant.|participants|Number|301|301.0||||||
4336539|NCT00427895|4164057|B3|40 to 49 years||Age, Customized|In 13vPnc, Cohort 2; out of 404 participants vaccinated, 1 participant randomized and vaccinated in error without a consent form, and hence baseline characteristics are available for 403 participant.|participants|Number|0|0.0||||||
4336584|NCT00427791|4164132|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4336540|NCT00427895|4164058|B2|40 to 49 years||Age, Customized|In 13vPnc, Cohort 2; out of 404 participants vaccinated, 1 participant randomized and vaccinated in error without a consent form, and hence baseline characteristics are available for 403 participant.|participants|Number|0|0.0||||||
4336541|NCT00427895|4164059|B1|40 to 49 years||Age, Customized|In 13vPnc, Cohort 2; out of 404 participants vaccinated, 1 participant randomized and vaccinated in error without a consent form, and hence baseline characteristics are available for 403 participant.|participants|Number|0|0.0||||||
4336542|NCT00427895|4164055|B5|30 to 39 years||Age, Customized|In 13vPnc, Cohort 2; out of 404 participants vaccinated, 1 participant randomized and vaccinated in error without a consent form, and hence baseline characteristics are available for 403 participant.|participants|Number|298|298.0||||||
4336543|NCT00427895|4164056|B4|30 to 39 years||Age, Customized|In 13vPnc, Cohort 2; out of 404 participants vaccinated, 1 participant randomized and vaccinated in error without a consent form, and hence baseline characteristics are available for 403 participant.|participants|Number|298|298.0||||||
4336544|NCT00427895|4164057|B3|30 to 39 years||Age, Customized|In 13vPnc, Cohort 2; out of 404 participants vaccinated, 1 participant randomized and vaccinated in error without a consent form, and hence baseline characteristics are available for 403 participant.|participants|Number|0|0.0||||||
4336545|NCT00427895|4164058|B2|30 to 39 years||Age, Customized|In 13vPnc, Cohort 2; out of 404 participants vaccinated, 1 participant randomized and vaccinated in error without a consent form, and hence baseline characteristics are available for 403 participant.|participants|Number|0|0.0||||||
4336546|NCT00427895|4164059|B1|30 to 39 years||Age, Customized|In 13vPnc, Cohort 2; out of 404 participants vaccinated, 1 participant randomized and vaccinated in error without a consent form, and hence baseline characteristics are available for 403 participant.|participants|Number|0|0.0||||||
4336547|NCT00427895|4164055|B5|18 to 29 years||Age, Customized|In 13vPnc, Cohort 2; out of 404 participants vaccinated, 1 participant randomized and vaccinated in error without a consent form, and hence baseline characteristics are available for 403 participant.|participants|Number|300|300.0||||||
4336548|NCT00427895|4164056|B4|18 to 29 years||Age, Customized|In 13vPnc, Cohort 2; out of 404 participants vaccinated, 1 participant randomized and vaccinated in error without a consent form, and hence baseline characteristics are available for 403 participant.|participants|Number|300|300.0||||||
4336549|NCT00427895|4164057|B3|18 to 29 years||Age, Customized|In 13vPnc, Cohort 2; out of 404 participants vaccinated, 1 participant randomized and vaccinated in error without a consent form, and hence baseline characteristics are available for 403 participant.|participants|Number|0|0.0||||||
4336550|NCT00427895|4164058|B2|18 to 29 years||Age, Customized|In 13vPnc, Cohort 2; out of 404 participants vaccinated, 1 participant randomized and vaccinated in error without a consent form, and hence baseline characteristics are available for 403 participant.|participants|Number|0|0.0||||||
4336551|NCT00427895|4164059|B1|18 to 29 years||Age, Customized|In 13vPnc, Cohort 2; out of 404 participants vaccinated, 1 participant randomized and vaccinated in error without a consent form, and hence baseline characteristics are available for 403 participant.|participants|Number|0|0.0||||||
4336552|NCT00427804|4164121|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4336553|NCT00427804|4164122|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4336554|NCT00427804|4164123|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4336555|NCT00427804|4164121|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4336556|NCT00427804|4164122|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4336557|NCT00427804|4164123|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4336558|NCT00427804|4164121|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4336559|NCT00427804|4164122|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4336560|NCT00427804|4164123|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4336561|NCT00427804|4164121|B3|||Age||years|Mean|39.3|39.3|Standard Deviation|8|8.0|||
4336562|NCT00427804|4164122|B2|||Age||years|Mean|35.5|35.5|Standard Deviation|10|10.0|||
4336563|NCT00427804|4164123|B1|||Age||years|Mean|42.40|42.4|Standard Deviation|5|5.0|||
4336564|NCT00427804|4164121|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4336565|NCT00427804|4164122|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4336566|NCT00427804|4164123|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4336567|NCT00427804|4164121|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4336568|NCT00427804|4164122|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4336569|NCT00427804|4164123|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4336570|NCT00427804|4164121|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4336571|NCT00427804|4164122|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4336572|NCT00427804|4164123|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4336573|NCT00427791|4164130|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4336574|NCT00427791|4164131|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4336575|NCT00427791|4164132|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4336576|NCT00427791|4164130|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4336577|NCT00427791|4164131|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4336578|NCT00427791|4164132|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4336579|NCT00427791|4164130|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4336580|NCT00427791|4164131|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4336581|NCT00427791|4164132|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4336582|NCT00427791|4164130|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4336583|NCT00427791|4164131|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4336585|NCT00427791|4164130|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4336586|NCT00427791|4164131|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4336587|NCT00427791|4164132|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4336588|NCT00427791|4164130|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4336589|NCT00427791|4164131|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4336590|NCT00427791|4164132|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4336591|NCT00427778|4164141|B1|||Post void residual (ml)|The Post void Residual is measured at the end of void during urodynamic studies by measuring, using the UDS catheter already in place, the residual urine volume in the bladder|ml|Mean|19.6|19.6|Standard Deviation|21|21.0|||
4336592|NCT00427778|4164141|B1|||Peak flow rate (ml/sec)|Patients void on a commode equipped with a flowmeter which measure the volume voided and its flow rate.|ml/sec|Mean|22.9|22.9|Standard Deviation|15.1|15.1|||
4336593|NCT00427778|4164141|B1|||PCS12|"The SF-12 is a multipurpose short form survey with 12 questions, all selected from the SF-36 Health Survey. The questions were combined, scored, and weighted to create two scales that provide glimpses into mental and physical functioning and overall health-related-quality of life. Physical and Mental Health Composite Scores (PCS & MCS) are computed using the scores of 12 questions and range from 0-100, where a 0 score indicates the lowest and 100 the highest level of health measured by the scales~In PCS section, we are looking at Physical Health composite score."|units on a scale|Mean|51.2|51.2|Standard Deviation|8.3|8.3|||
4336594|NCT00427778|4164141|B1|||MCS12|"The SF-12 is a multipurpose short form survey with 12 questions, all selected from the SF-36 Health Survey. The questions were combined, scored, and weighted to create two scales that provide glimpses into mental and physical functioning and overall health-related-quality of life. Physical and Mental Health Composite Scores (PCS & MCS) are computed using the scores of 12 questions and range from 0-100, where a 0 score indicates the lowest and 100 the highest level of health measured by the scales.~In MCS section, we are looking at Mental Health composite score."|units on a scale|Mean|47.9|47.9|Standard Deviation|11.1|11.1|||
4336595|NCT00427778|4164141|B1|||UDI score|Urogenital Distress inventory - short form. The UDI is a 6-question validated questionnaire assessing the urinary tract symptoms and their bothersomeness. Answers are scored from 0-3 (3 most bothersome). An average score is then obtained, ranging from 0-3.|units on a scale|Median|1.5|1.5|Inter-Quartile Range|||1.2|2.0|
4336596|NCT00427778|4164141|B1|||Score to question #3 on UDI-6|"Score (0-3) of response to question #3 (stress incontinence specific) of Urogenital Distress inventory - short form. The UDI is a 6-question validated questionnaire assessing the urinary tract symptoms and their bothersomeness. Question three asks specifically about Leakage related to activity, coughing, or sneezing, i.e. stress urinary incontinence. A low score indicates a minimal degree of severity impact"|units on a scale|Median|3|3.0|Inter-Quartile Range|||2.0|3.0|
4336597|NCT00427778|4164141|B1|||incontinence episodes per week||number of incontinence episodes per week|Median|10|10.0|Inter-Quartile Range|||5.0|28.0|
4336598|NCT00427778|4164141|B1|stage 2||Pop stage|number of women at each POPQ stage. The pelvic organ prolapse quantification system is a validated method to measure prolapse in each vaginal compartments (ant, post and apical). It assesses the distance of predetermined vaginal points from the hymen during valsalva. It is divided in 5 stages: 0 (no support defect, apex no more than 'total vaginal length' minus 2 cm from hymen), 1 (leading edge >1cm above the hymen), 2 (within one cm inside or outside the hymen), 3 (more than one cm below hymen, 4 (completely out, apex more than 'total vaginal length' minus 2 cm outside from hymen)|Participants|Count of Participants|17|17.0||||||
4336599|NCT00427778|4164141|B1|stage 1||Pop stage|number of women at each POPQ stage. The pelvic organ prolapse quantification system is a validated method to measure prolapse in each vaginal compartments (ant, post and apical). It assesses the distance of predetermined vaginal points from the hymen during valsalva. It is divided in 5 stages: 0 (no support defect, apex no more than 'total vaginal length' minus 2 cm from hymen), 1 (leading edge >1cm above the hymen), 2 (within one cm inside or outside the hymen), 3 (more than one cm below hymen, 4 (completely out, apex more than 'total vaginal length' minus 2 cm outside from hymen)|Participants|Count of Participants|7|7.0||||||
4336600|NCT00427778|4164141|B1|stage 0||Pop stage|number of women at each POPQ stage. The pelvic organ prolapse quantification system is a validated method to measure prolapse in each vaginal compartments (ant, post and apical). It assesses the distance of predetermined vaginal points from the hymen during valsalva. It is divided in 5 stages: 0 (no support defect, apex no more than 'total vaginal length' minus 2 cm from hymen), 1 (leading edge >1cm above the hymen), 2 (within one cm inside or outside the hymen), 3 (more than one cm below hymen, 4 (completely out, apex more than 'total vaginal length' minus 2 cm outside from hymen)|Participants|Count of Participants|2|2.0||||||
4336601|NCT00427778|4164141|B1|||Menopausal status|number of women who are postmenopausal at time of study entry|Participants|Count of Participants|8|8.0||||||
4336602|NCT00427778|4164141|B1|||Smoking status|Current smokers|Participants|Count of Participants|2|2.0||||||
4336603|NCT00427778|4164141|B1|||Parity|number of previous vaginal birth|previous vaginal births|Median|2|2.0|Inter-Quartile Range|||1.5|3.0|
4336604|NCT00427778|4164141|B1|||BMI||kg/m^2|Mean|29|29.0|Standard Deviation|6.8|6.8|||
4336605|NCT00427778|4164141|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4336606|NCT00427778|4164141|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4336607|NCT00427778|4164141|B1|||Age||years|Mean|52.2|52.2|Standard Deviation|11.2|11.2|||
4336608|NCT00427765|4164161|B1|United States||Region of Enrollment||participants|Number|164|164.0||||||
4336609|NCT00427765|4164161|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4336610|NCT00427765|4164161|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4336611|NCT00427765|4164161|B1|||Age||years|Median|42|42.0|Full Range|||18.0|66.0|
4336612|NCT00427700|4164165|B3|Brazil||Region of Enrollment||participants|Number|82|82.0||||||
4336613|NCT00427700|4164166|B2|Brazil||Region of Enrollment||participants|Number|40|40.0||||||
4336614|NCT00427700|4164167|B1|Brazil||Region of Enrollment||participants|Number|42|42.0||||||
4336615|NCT00427700|4164165|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4336616|NCT00427700|4164166|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4336617|NCT00427700|4164167|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4336618|NCT00427700|4164165|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4336619|NCT00427700|4164166|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4336620|NCT00427700|4164167|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4336621|NCT00427700|4164165|B3|||Age||years|Mean|28.4|28.4|Standard Deviation|5.3|5.3|||
4336622|NCT00427700|4164166|B2|||Age||years|Mean|28.7|28.7|Standard Deviation|4.8|4.8|||
4336623|NCT00427700|4164167|B1|||Age||years|Mean|28.21|28.21|Standard Deviation|5.3|5.3|||
4336624|NCT00427700|4164165|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4336625|NCT00427700|4164166|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4336626|NCT00427700|4164167|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4336627|NCT00427700|4164165|B3||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
4336628|NCT00427700|4164166|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4336629|NCT00427700|4164167|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4336630|NCT00427700|4164165|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4336631|NCT00427700|4164166|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4336632|NCT00427700|4164167|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4336633|NCT00427661|4164176|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4336634|NCT00427661|4164176|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4336635|NCT00427661|4164176|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4336636|NCT00427661|4164176|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4336637|NCT00427661|4164176|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4336638|NCT00427661|4164176|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4336639|NCT00427635|4164182|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4336640|NCT00427635|4164183|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4336641|NCT00427635|4164184|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4336642|NCT00427635|4164182|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4336643|NCT00427635|4164183|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4336644|NCT00427635|4164184|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4336645|NCT00427635|4164182|B3|||Age||Days|Mean|46.5|46.5|Standard Deviation|30.5|30.5|||
4336646|NCT00427635|4164183|B2|||Age||Days|Mean|46.5|46.5|Standard Deviation|31.2|31.2|||
4336647|NCT00427635|4164184|B1|||Age||Days|Mean|46.5|46.5|Standard Deviation|30.3|30.3|||
4336648|NCT00427557|4164213|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4336649|NCT00427557|4164213|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4336650|NCT00427557|4164213|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4336651|NCT00427557|4164213|B1|||Age||years|Mean|44|44.0|Standard Deviation|17|17.0|||
4336652|NCT00427349|4164217|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4336653|NCT00427349|4164217|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4336654|NCT00427349|4164217|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4336655|NCT00427349|4164217|B1|||Age||years|Median|65|65.0|Full Range|||38.0|81.0|
4336656|NCT00427336|4164223|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4336657|NCT00427336|4164223|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4336658|NCT00427336|4164223|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4336659|NCT00427336|4164223|B1|||Age||years|Median|39|39.0|Full Range|||18.0|60.0|
4336660|NCT00427297|4164227|B3|||CD4%||percentage of cells|Median|21.5|21.5|Inter-Quartile Range|||13.0|27.0|
4336661|NCT00427297|4164228|B2|||CD4%||percentage of cells|Median|18|18.0|Inter-Quartile Range|||13.0|25.0|
4336662|NCT00427297|4164229|B1|||CD4%||percentage of cells|Median|22|22.0|Inter-Quartile Range|||14.0|29.0|
4336663|NCT00427297|4164227|B3|Kenya||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
4336664|NCT00427297|4164228|B2|Kenya||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
4336665|NCT00427297|4164229|B1|Kenya||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
4336666|NCT00427297|4164227|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4336667|NCT00427297|4164228|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4336668|NCT00427297|4164229|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4336669|NCT00427297|4164227|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4336670|NCT00427297|4164228|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4336671|NCT00427297|4164229|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4336672|NCT00427297|4164227|B3|||Age||months|Median|7|7.0|Inter-Quartile Range|||6.0|10.0|
4336673|NCT00427297|4164228|B2|||Age||months|Median|8|8.0|Inter-Quartile Range|||6.0|10.0|
4336674|NCT00427297|4164229|B1|||Age||months|Median|7|7.0|Inter-Quartile Range|||6.0|10.0|
4336675|NCT00427193|4164242|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
4336676|NCT00427193|4164243|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4336677|NCT00427193|4164244|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4336678|NCT00427193|4164242|B3|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
4336679|NCT00427193|4164243|B2|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4336680|NCT00427193|4164244|B1|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
4336681|NCT00427193|4164242|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|168|168.0||||||
4336682|NCT00427193|4164243|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|57|57.0||||||
4336683|NCT00427193|4164244|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|111|111.0||||||
4336684|NCT00427193|4164242|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4336685|NCT00427193|4164243|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4336686|NCT00427193|4164244|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4336687|NCT00427193|4164242|B3||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4336688|NCT00427193|4164243|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4336689|NCT00427193|4164244|B1||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4336690|NCT00427193|4164242|B3|||Age||years|Mean|38.1|38.1|Standard Deviation|7.2|7.2|||
4336691|NCT00427193|4164243|B2|||Age||years|Mean|38.1|38.1|Standard Deviation|6.9|6.9|||
4336692|NCT00427193|4164244|B1|||Age||years|Mean|38.2|38.2|Standard Deviation|7.3|7.3|||
4336693|NCT00427037|4164263|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
4336694|NCT00427037|4164264|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4336695|NCT00427037|4164265|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4336696|NCT00427037|4164263|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4336697|NCT00427037|4164264|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4336698|NCT00427037|4164265|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4336699|NCT00427037|4164263|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4336700|NCT00427037|4164264|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4336701|NCT00427037|4164265|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4336702|NCT00427037|4164263|B3|||Age||years|Mean|60.8|60.8|Standard Deviation|11|11.0|||
4336703|NCT00427037|4164264|B2|||Age||years|Mean|62.2|62.2|Standard Deviation|11|11.0|||
4336704|NCT00427037|4164265|B1|||Age||years|Mean|59.5|59.5|Standard Deviation|10.4|10.4|||
4336705|NCT00427037|4164263|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4336706|NCT00427037|4164264|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4336707|NCT00427037|4164265|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4336708|NCT00427037|4164263|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4336709|NCT00427037|4164264|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4336710|NCT00427037|4164265|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4336711|NCT00427037|4164263|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4336712|NCT00427037|4164264|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4336713|NCT00427037|4164265|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4336714|NCT00427011|4164274|B1|Other||Race/Ethnicity, Customized|Race. Safety population.|participants|Number|1|1.0||||||
4336715|NCT00427011|4164274|B1|Black||Race/Ethnicity, Customized|Race. Safety population.|participants|Number|1|1.0||||||
4336716|NCT00427011|4164274|B1|Caucasian||Race/Ethnicity, Customized|Race. Safety population.|participants|Number|23|23.0||||||
4336717|NCT00427011|4164274|B1||Male|Sex: Female, Male|Safety population includes all subjects who received at least one dose of perampanel in this study.|Participants|Count of Participants|18|18.0||||||
4336718|NCT00427011|4164274|B1||Female|Sex: Female, Male|Safety population includes all subjects who received at least one dose of perampanel in this study.|Participants|Count of Participants|7|7.0||||||
4336719|NCT00427011|4164274|B1|||Age|Safety population.|years|Mean|69|69.0|Standard Deviation|8.62|8.62|||
4336720|NCT00426855|4164285|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4336721|NCT00426855|4164285|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4336722|NCT00426855|4164285|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4336723|NCT00426855|4164285|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4336724|NCT00426855|4164285|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4336725|NCT00426842|4164289|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4336726|NCT00426842|4164289|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4336727|NCT00426842|4164289|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4336728|NCT00426842|4164289|B1|||Age||years|Mean|42|42.0|Standard Deviation|9|9.0|||
4336729|NCT00426842|4164289|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4336730|NCT00426842|4164289|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4336731|NCT00426842|4164289|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4336732|NCT00426764|4164295|B1|Transformed mycosis fungoides||PTCL Subtype Based on Central Diagnosis||participants|Number|1|1.0||||||
4336733|NCT00426764|4164295|B1|Extranodal NK/T cell lymphoma nasal type||PTCL Subtype Based on Central Diagnosis||participants|Number|1|1.0||||||
4336734|NCT00426764|4164295|B1|Cutaneous γδ T-cell lymphoma||PTCL Subtype Based on Central Diagnosis||participants|Number|1|1.0||||||
4336735|NCT00426764|4164295|B1|ALK-1 positive ALCL||PTCL Subtype Based on Central Diagnosis||participants|Number|1|1.0||||||
4336736|NCT00426764|4164295|B1|Subcutaneous panniculitis-like T-cell lymphoma||PTCL Subtype Based on Central Diagnosis||participants|Number|3|3.0||||||
4336737|NCT00426764|4164295|B1|Enteropathy-type T-cell lymphoma||PTCL Subtype Based on Central Diagnosis||participants|Number|6|6.0||||||
4336738|NCT00426764|4164295|B1|ALK-1 negative ALCL||PTCL Subtype Based on Central Diagnosis||participants|Number|21|21.0||||||
4336739|NCT00426764|4164295|B1|Angioimmunoblastic T-cell lymphoma (AITL)||PTCL Subtype Based on Central Diagnosis||participants|Number|27|27.0||||||
4336740|NCT00426764|4164295|B1|PTCL Unspecified (NOS)||PTCL Subtype Based on Central Diagnosis||participants|Number|69|69.0||||||
4336741|NCT00426764|4164295|B1|||Duration of peripheral T-cell lymphoma (PTCL)||years|Mean|2.2|2.2|Standard Deviation|2.56|2.56|||
4336742|NCT00426764|4164295|B1|Missing||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or Chair."|participants|Number|1|1.0||||||
4336743|NCT00426764|4164295|B1|2||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or Chair."|participants|Number|17|17.0||||||
4336744|NCT00426764|4164295|B1|1||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or Chair."|participants|Number|66|66.0||||||
4336745|NCT00426764|4164295|B1|0||Eastern Cooperative Oncology Group Performance Status|"The ECOG scale is as follows:~Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or Chair."|participants|Number|46|46.0||||||
4336746|NCT00426764|4164295|B1|||Body Surface Area (BSA)||m^2|Mean|1.84|1.84|Standard Deviation|0.236|0.236|||
4336747|NCT00426764|4164295|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4336748|NCT00426764|4164295|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4336749|NCT00426764|4164295|B1|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4336750|NCT00426764|4164295|B1|White||Race/Ethnicity, Customized||participants|Number|116|116.0||||||
4336751|NCT00426764|4164295|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4336752|NCT00426764|4164295|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4336753|NCT00426764|4164295|B1|||Age|Demographic and Baseline characteristic data are provided for the Histopathologically-Confirmed Population.|years|Mean|59.3|59.3|Standard Deviation|12.82|12.82|||
4336754|NCT00426751|4164309|B3||Male|Sex: Female, Male|Twelve participants in the eptifibatide group and 6 participants in the abciximab group were excluded from the Intent-to-Treat (ITT) and Per Protocol (PP) Populations due to uncertain infarct localization. One of these participants in the abciximab group had not received study medication and was also excluded from safety analysis. One additional participant in the abciximab group had not received study medication and was also excluded from safety analysis.|Participants|Count of Participants|321|321.0||||||
4336755|NCT00426751|4164310|B2||Male|Sex: Female, Male|Twelve participants in the eptifibatide group and 6 participants in the abciximab group were excluded from the Intent-to-Treat (ITT) and Per Protocol (PP) Populations due to uncertain infarct localization. One of these participants in the abciximab group had not received study medication and was also excluded from safety analysis. One additional participant in the abciximab group had not received study medication and was also excluded from safety analysis.|Participants|Count of Participants|157|157.0||||||
4336756|NCT00426751|4164311|B1||Male|Sex: Female, Male|Twelve participants in the eptifibatide group and 6 participants in the abciximab group were excluded from the Intent-to-Treat (ITT) and Per Protocol (PP) Populations due to uncertain infarct localization. One of these participants in the abciximab group had not received study medication and was also excluded from safety analysis. One additional participant in the abciximab group had not received study medication and was also excluded from safety analysis.|Participants|Count of Participants|164|164.0||||||
4336757|NCT00426751|4164309|B3||Female|Sex: Female, Male|Twelve participants in the eptifibatide group and 6 participants in the abciximab group were excluded from the Intent-to-Treat (ITT) and Per Protocol (PP) Populations due to uncertain infarct localization. One of these participants in the abciximab group had not received study medication and was also excluded from safety analysis. One additional participant in the abciximab group had not received study medication and was also excluded from safety analysis.|Participants|Count of Participants|89|89.0||||||
4336758|NCT00426751|4164310|B2||Female|Sex: Female, Male|Twelve participants in the eptifibatide group and 6 participants in the abciximab group were excluded from the Intent-to-Treat (ITT) and Per Protocol (PP) Populations due to uncertain infarct localization. One of these participants in the abciximab group had not received study medication and was also excluded from safety analysis. One additional participant in the abciximab group had not received study medication and was also excluded from safety analysis.|Participants|Count of Participants|39|39.0||||||
4336817|NCT00426556|4164387|B1|Phase I : < 65||Age, Customized||Participants|Number|6|6.0||||||
4336818|NCT00426361|4164412|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4336759|NCT00426751|4164311|B1||Female|Sex: Female, Male|Twelve participants in the eptifibatide group and 6 participants in the abciximab group were excluded from the Intent-to-Treat (ITT) and Per Protocol (PP) Populations due to uncertain infarct localization. One of these participants in the abciximab group had not received study medication and was also excluded from safety analysis. One additional participant in the abciximab group had not received study medication and was also excluded from safety analysis.|Participants|Count of Participants|50|50.0||||||
4336760|NCT00426751|4164309|B3|||Age|Twelve participants in the eptifibatide group and 6 participants in the abciximab group were excluded from the Intent-to-Treat (ITT) and Per Protocol (PP) Populations due to uncertain infarct localization. One of these participants in the abciximab group had not received study medication and was also excluded from safety analysis. One additional participant in the abciximab group had not received study medication and was also excluded from safety analysis.|years|Mean|60.9|60.9|Standard Deviation|12.6|12.6|||
4336761|NCT00426751|4164310|B2|||Age|Twelve participants in the eptifibatide group and 6 participants in the abciximab group were excluded from the Intent-to-Treat (ITT) and Per Protocol (PP) Populations due to uncertain infarct localization. One of these participants in the abciximab group had not received study medication and was also excluded from safety analysis. One additional participant in the abciximab group had not received study medication and was also excluded from safety analysis.|years|Mean|60.5|60.5|Standard Deviation|12.7|12.7|||
4336762|NCT00426751|4164311|B1|||Age|Twelve participants in the eptifibatide group and 6 participants in the abciximab group were excluded from the Intent-to-Treat (ITT) and Per Protocol (PP) Populations due to uncertain infarct localization. One of these participants in the abciximab group had not received study medication and was also excluded from safety analysis. One additional participant in the abciximab group had not received study medication and was also excluded from safety analysis.|years|Mean|61.3|61.3|Standard Deviation|12.5|12.5|||
4336763|NCT00426660|4164356|B1|>= 100,000: Log Scale (N=250)||Baseline Viral Load: : Log Scale|HIV-1 RNA at baseline (BL)(log10 copies/mL). BL value calculated as average of screening and BL values if both values were within 1 log10 difference. N = number of participants contributing to summary statistic at BL. Viral loads were not available uniformly for all participants enrolled in study.|log10 copies/mL|Median|5.371|5.371|Full Range|||5.0|6.758|
4336764|NCT00426660|4164356|B1|< 100,000: Log Scale (N=729)||Baseline Viral Load: : Log Scale|HIV-1 RNA at baseline (BL)(log10 copies/mL). BL value calculated as average of screening and BL values if both values were within 1 log10 difference. N = number of participants contributing to summary statistic at BL. Viral loads were not available uniformly for all participants enrolled in study.|log10 copies/mL|Median|4.043|4.043|Full Range|||1.591|4.998|
4336765|NCT00426660|4164356|B1|Overall: Log Scale (N=979)||Baseline Viral Load: : Log Scale|HIV-1 RNA at baseline (BL)(log10 copies/mL). BL value calculated as average of screening and BL values if both values were within 1 log10 difference. N = number of participants contributing to summary statistic at BL. Viral loads were not available uniformly for all participants enrolled in study.|log10 copies/mL|Median|4.400|4.4|Full Range|||1.591|6.758|
4336766|NCT00426660|4164356|B1|>= 100,000: Log Scale (N=250)||Baseline Viral Load: Log Scale|HIV-1 RNA at baseline (BL)(log10 copies/mL). BL value calculated as average of screening and BL values if both values were within 1 log10 difference. N = number of participants contributing to summary statistic at BL. Viral loads were not available uniformly for all participants enrolled in study.|log10 copies/mL|Mean|5.423|5.423|Standard Deviation|0.3496|0.3496|||
4336767|NCT00426660|4164356|B1|< 100,000: Log Scale (N=729)||Baseline Viral Load: Log Scale|HIV-1 RNA at baseline (BL)(log10 copies/mL). BL value calculated as average of screening and BL values if both values were within 1 log10 difference. N = number of participants contributing to summary statistic at BL. Viral loads were not available uniformly for all participants enrolled in study.|log10 copies/mL|Mean|3.859|3.859|Standard Deviation|0.8517|0.8517|||
4336768|NCT00426660|4164356|B1|Overall: Log Scale (N=979)||Baseline Viral Load: Log Scale|HIV-1 RNA at baseline (BL)(log10 copies/mL). BL value calculated as average of screening and BL values if both values were within 1 log10 difference. N = number of participants contributing to summary statistic at BL. Viral loads were not available uniformly for all participants enrolled in study.|log10 copies/mL|Mean|4.259|4.259|Standard Deviation|1.0182|1.0182|||
4336769|NCT00426660|4164356|B1|>= 100,000: Absolute (N=250)||Baseline Viral Load: Absolute Value|HIV-1 RNA at baseline (BL)(original scale). BL value calculated as average of screening and BL values if both values were within 1 log10 difference. N = number of participants contributing to summary statistic at BL. Viral loads were not available uniformly for all participants enrolled in study.|copies/mL|Median|234750.0|234750.0|Full Range|||100000.0|5728492.0|
4336770|NCT00426660|4164356|B1|< 100,000: Absolute (N=729)||Baseline Viral Load: Absolute Value|HIV-1 RNA at baseline (BL)(original scale). BL value calculated as average of screening and BL values if both values were within 1 log10 difference. N = number of participants contributing to summary statistic at BL. Viral loads were not available uniformly for all participants enrolled in study.|copies/mL|Median|11028.5|11028.5|Full Range|||39.0|99643.0|
4336771|NCT00426660|4164356|B1|Overall: Absolute (N=979)||Baseline Viral Load: Absolute Value|HIV-1 RNA at baseline (BL)(original scale). BL value calculated as average of screening and BL values if both values were within 1 log10 difference. N = number of participants contributing to summary statistic at BL. Viral loads were not available uniformly for all participants enrolled in study.|copies/mL|Median|25109.5|25109.5|Full Range|||39.0|5728492.0|
4336772|NCT00426660|4164356|B1|>= 100,000: Absolute (N=250)||Baseline Viral Load: Absolute Value|Human Immunodeficiency Virus (HIV-1) Ribonucleic Acid (RNA) at baseline (BL) (original scale). BL value calculated as average of screening and BL values if both values were within 1 log10 difference. N = number of participants contributing to summary statistic at BL. Viral loads were not available uniformly for all participants enrolled in study.|copies/mL|Mean|396179.0|396179.0|Standard Deviation|547142.6|547142.6|||
4336773|NCT00426660|4164356|B1|< 100,000: Absolute (N=729)||Baseline Viral Load: Absolute Value|Human Immunodeficiency Virus (HIV-1) Ribonucleic Acid (RNA) at baseline (BL) (original scale). BL value calculated as average of screening and BL values if both values were within 1 log10 difference. N = number of participants contributing to summary statistic at BL. Viral loads were not available uniformly for all participants enrolled in study.|copies/mL|Mean|22395.9|22395.9|Standard Deviation|25974.4|25974.4|||
4336819|NCT00426361|4164413|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4336820|NCT00426361|4164414|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4336774|NCT00426660|4164356|B1|Overall: Absolute (N=979)||Baseline Viral Load: Absolute Value|Human Immunodeficiency Virus (HIV-1) Ribonucleic Acid (RNA) at baseline (BL) (original scale). BL value calculated as average of screening and BL values if both values were within 1 log10 difference. N = number of participants contributing to summary statistic at BL. Viral loads were not available uniformly for all participants enrolled in study.|copies/mL|Mean|117846.1|117846.1|Standard Deviation|321426.5|321426.5|||
4336775|NCT00426660|4164356|B1||Male|Sex: Female, Male||Participants|Count of Participants|827|827.0||||||
4336776|NCT00426660|4164356|B1||Female|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4336777|NCT00426660|4164356|B1|||Age||years|Mean|45.6|45.6|Standard Deviation|8.6|8.6|||
4336778|NCT00426556|4164383|B5|1||Who Performance Status|0=Fully active, able to carry out normal activity without restriction, 1=Restricted in physical strenuous activity but ambulatory and able to carry work of a light or sedentary nature e.g. light house work, office work.|Participants|Number|39|39.0||||||
4336779|NCT00426556|4164384|B4|1||Who Performance Status|0=Fully active, able to carry out normal activity without restriction, 1=Restricted in physical strenuous activity but ambulatory and able to carry work of a light or sedentary nature e.g. light house work, office work.|Participants|Number|19|19.0||||||
4336780|NCT00426556|4164385|B3|1||Who Performance Status|0=Fully active, able to carry out normal activity without restriction, 1=Restricted in physical strenuous activity but ambulatory and able to carry work of a light or sedentary nature e.g. light house work, office work.|Participants|Number|6|6.0||||||
4336781|NCT00426556|4164386|B2|1||Who Performance Status|0=Fully active, able to carry out normal activity without restriction, 1=Restricted in physical strenuous activity but ambulatory and able to carry work of a light or sedentary nature e.g. light house work, office work.|Participants|Number|12|12.0||||||
4336782|NCT00426556|4164387|B1|1||Who Performance Status|0=Fully active, able to carry out normal activity without restriction, 1=Restricted in physical strenuous activity but ambulatory and able to carry work of a light or sedentary nature e.g. light house work, office work.|Participants|Number|2|2.0||||||
4336783|NCT00426556|4164383|B5|0||Who Performance Status|0=Fully active, able to carry out normal activity without restriction, 1=Restricted in physical strenuous activity but ambulatory and able to carry work of a light or sedentary nature e.g. light house work, office work.|Participants|Number|49|49.0||||||
4336784|NCT00426556|4164384|B4|0||Who Performance Status|0=Fully active, able to carry out normal activity without restriction, 1=Restricted in physical strenuous activity but ambulatory and able to carry work of a light or sedentary nature e.g. light house work, office work.|Participants|Number|36|36.0||||||
4336785|NCT00426556|4164385|B3|0||Who Performance Status|0=Fully active, able to carry out normal activity without restriction, 1=Restricted in physical strenuous activity but ambulatory and able to carry work of a light or sedentary nature e.g. light house work, office work.|Participants|Number|4|4.0||||||
4336786|NCT00426556|4164386|B2|0||Who Performance Status|0=Fully active, able to carry out normal activity without restriction, 1=Restricted in physical strenuous activity but ambulatory and able to carry work of a light or sedentary nature e.g. light house work, office work.|Participants|Number|5|5.0||||||
4336787|NCT00426556|4164387|B1|0||Who Performance Status|0=Fully active, able to carry out normal activity without restriction, 1=Restricted in physical strenuous activity but ambulatory and able to carry work of a light or sedentary nature e.g. light house work, office work.|Participants|Number|4|4.0||||||
4336788|NCT00426556|4164383|B5|Phase II - Female||Sex/Gender, Customized||Participants|Number|55|55.0||||||
4336789|NCT00426556|4164384|B4|Phase II - Female||Sex/Gender, Customized||Participants|Number|55|55.0||||||
4336790|NCT00426556|4164385|B3|Phase II - Female||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4336791|NCT00426556|4164386|B2|Phase II - Female||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4336792|NCT00426556|4164387|B1|Phase II - Female||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4336793|NCT00426556|4164383|B5|Phase I- Female||Sex/Gender, Customized||Participants|Number|33|33.0||||||
4336794|NCT00426556|4164384|B4|Phase I- Female||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4336795|NCT00426556|4164385|B3|Phase I- Female||Sex/Gender, Customized||Participants|Number|10|10.0||||||
4336796|NCT00426556|4164386|B2|Phase I- Female||Sex/Gender, Customized||Participants|Number|17|17.0||||||
4336797|NCT00426556|4164387|B1|Phase I- Female||Sex/Gender, Customized||Participants|Number|6|6.0||||||
4336798|NCT00426556|4164383|B5|Phase II : >= 65||Age, Customized||Participants|Number|6|6.0||||||
4336799|NCT00426556|4164384|B4|Phase II : >= 65||Age, Customized||Participants|Number|6|6.0||||||
4336800|NCT00426556|4164385|B3|Phase II : >= 65||Age, Customized||Participants|Number|0|0.0||||||
4336801|NCT00426556|4164386|B2|Phase II : >= 65||Age, Customized||Participants|Number|0|0.0||||||
4336802|NCT00426556|4164387|B1|Phase II : >= 65||Age, Customized||Participants|Number|0|0.0||||||
4336803|NCT00426556|4164383|B5|Phase II : < 65||Age, Customized||Participants|Number|49|49.0||||||
4336804|NCT00426556|4164384|B4|Phase II : < 65||Age, Customized||Participants|Number|49|49.0||||||
4336805|NCT00426556|4164385|B3|Phase II : < 65||Age, Customized||Participants|Number|0|0.0||||||
4336806|NCT00426556|4164386|B2|Phase II : < 65||Age, Customized||Participants|Number|0|0.0||||||
4336807|NCT00426556|4164387|B1|Phase II : < 65||Age, Customized||Participants|Number|0|0.0||||||
4336808|NCT00426556|4164383|B5|Phase I : >= 65||Age, Customized||Participants|Number|8|8.0||||||
4336809|NCT00426556|4164384|B4|Phase I : >= 65||Age, Customized||Participants|Number|0|0.0||||||
4336810|NCT00426556|4164385|B3|Phase I : >= 65||Age, Customized||Participants|Number|4|4.0||||||
4336811|NCT00426556|4164386|B2|Phase I : >= 65||Age, Customized||Participants|Number|4|4.0||||||
4336812|NCT00426556|4164387|B1|Phase I : >= 65||Age, Customized||Participants|Number|0|0.0||||||
4336813|NCT00426556|4164383|B5|Phase I : < 65||Age, Customized||Participants|Number|25|25.0||||||
4336814|NCT00426556|4164384|B4|Phase I : < 65||Age, Customized||Participants|Number|0|0.0||||||
4336815|NCT00426556|4164385|B3|Phase I : < 65||Age, Customized||Participants|Number|6|6.0||||||
4336816|NCT00426556|4164386|B2|Phase I : < 65||Age, Customized||Participants|Number|13|13.0||||||
4336821|NCT00426361|4164415|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4336822|NCT00426361|4164412|B4||Female|Sex: Female, Male||Participants|Count of Participants|751|751.0||||||
4336823|NCT00426361|4164413|B3||Female|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
4336824|NCT00426361|4164414|B2||Female|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
4336825|NCT00426361|4164415|B1||Female|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
4336826|NCT00426361|4164412|B4|Safety follow-up (up to Month 12/13)||Age||years|Mean|13.9|13.9|Standard Deviation|2.48|2.48|||
4336827|NCT00426361|4164413|B3|Safety follow-up (up to Month 12/13)||Age||years|Mean|13.8|13.8|Standard Deviation|2.46|2.46|||
4336828|NCT00426361|4164414|B2|Safety follow-up (up to Month 12/13)||Age||years|Mean|13.9|13.9|Standard Deviation|2.41|2.41|||
4336829|NCT00426361|4164415|B1|Safety follow-up (up to Month 12/13)||Age||years|Mean|13.9|13.9|Standard Deviation|2.58|2.58|||
4336830|NCT00426361|4164412|B4|Active phase (up to Month 7/8)||Age||years|Mean|13.9|13.9|Standard Deviation|2.50|2.5|||
4336831|NCT00426361|4164413|B3|Active phase (up to Month 7/8)||Age||years|Mean|13.9|13.9|Standard Deviation|2.47|2.47|||
4336832|NCT00426361|4164414|B2|Active phase (up to Month 7/8)||Age||years|Mean|14.0|14.0|Standard Deviation|2.43|2.43|||
4336833|NCT00426361|4164415|B1|Active phase (up to Month 7/8)||Age||years|Mean|13.9|13.9|Standard Deviation|2.59|2.59|||
4336834|NCT00426283|4164467|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4336835|NCT00426283|4164468|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4336836|NCT00426283|4164469|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4336837|NCT00426283|4164467|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4336838|NCT00426283|4164468|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4336839|NCT00426283|4164469|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4336840|NCT00426283|4164467|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4336841|NCT00426283|4164468|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4336842|NCT00426283|4164469|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4336843|NCT00426283|4164467|B3|||Age||years|Mean|12.6|12.6|Standard Deviation|6.6|6.6|||
4336844|NCT00426283|4164468|B2|||Age||years|Mean|13.54|13.54|Standard Deviation|7.11|7.11|||
4336845|NCT00426283|4164469|B1|||Age||years|Mean|12.15|12.15|Standard Deviation|6.42|6.42|||
4336846|NCT00426283|4164467|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4336847|NCT00426283|4164468|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4336848|NCT00426283|4164469|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4336849|NCT00426283|4164467|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4336850|NCT00426283|4164468|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4336851|NCT00426283|4164469|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4336852|NCT00426283|4164467|B3||<=18 years|Age||Participants|Count of Participants|38|38.0||||||
4336853|NCT00426283|4164468|B2||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4336854|NCT00426283|4164469|B1||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
4336855|NCT00426270|4164476|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4336856|NCT00426270|4164476|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4336857|NCT00426270|4164476|B1|||Age||Years|Mean|47.7|47.7|Standard Deviation|19.1|19.1|||
4336858|NCT00426231|4164484|B3|United States||Region of Enrollment||participants|Number|73|73.0||||||
4336859|NCT00426231|4164485|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4336860|NCT00426231|4164486|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4336861|NCT00426231|4164484|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4336862|NCT00426231|4164485|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4336863|NCT00426231|4164486|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4336864|NCT00426231|4164484|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4336865|NCT00426231|4164485|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4336866|NCT00426231|4164486|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4336867|NCT00426231|4164484|B3|||Age||years|Mean|55.5|55.5|Standard Deviation|10.6|10.6|||
4336868|NCT00426231|4164485|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|10.2|10.2|||
4336869|NCT00426231|4164486|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|11.0|11.0|||
4336870|NCT00426231|4164484|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4336871|NCT00426231|4164485|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4336872|NCT00426231|4164486|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4336873|NCT00426231|4164484|B3||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4336874|NCT00426231|4164485|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4336875|NCT00426231|4164486|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4336876|NCT00426231|4164484|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4336877|NCT00426231|4164485|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4336878|NCT00426231|4164486|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4336905|NCT00426153|4164497|B1|||Diastolic Blood Pressure|Diastolic blood pressure is the lower number on a blood pressure reading and measures dilation of the ventricles, or lower chambers of the heart.|millimeters of mercury (mmHg)|Mean|79.8|79.8|Standard Deviation|8.9|8.9|||
4336879|NCT00426153|4164495|B3|ADPLD genotype with no genetic mutation detected||Genotypes and genetic mutations|Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations in one of two genes: PKD1 or PKD2, and is characterized by the development of kidney cysts and other manifestations, of which polycystic live disease (PLD) is most common. Autosomal dominant PLD (ADPLD) also exists as a genetically distinct disease with few or absent kidney cysts. Like ADPKD, ADPLD is genetically heterogeneous, with the 1st two genes identified (PRKCSH & SEC63) accounting for approximately 1/3 to 1/2 of isolated ADPLD cases.|Participants|Number|3|3.0||||||
4336880|NCT00426153|4164496|B2|ADPLD genotype with no genetic mutation detected||Genotypes and genetic mutations|Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations in one of two genes: PKD1 or PKD2, and is characterized by the development of kidney cysts and other manifestations, of which polycystic live disease (PLD) is most common. Autosomal dominant PLD (ADPLD) also exists as a genetically distinct disease with few or absent kidney cysts. Like ADPKD, ADPLD is genetically heterogeneous, with the 1st two genes identified (PRKCSH & SEC63) accounting for approximately 1/3 to 1/2 of isolated ADPLD cases.|Participants|Number|2|2.0||||||
4336881|NCT00426153|4164497|B1|ADPLD genotype with no genetic mutation detected||Genotypes and genetic mutations|Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations in one of two genes: PKD1 or PKD2, and is characterized by the development of kidney cysts and other manifestations, of which polycystic live disease (PLD) is most common. Autosomal dominant PLD (ADPLD) also exists as a genetically distinct disease with few or absent kidney cysts. Like ADPKD, ADPLD is genetically heterogeneous, with the 1st two genes identified (PRKCSH & SEC63) accounting for approximately 1/3 to 1/2 of isolated ADPLD cases.|Participants|Number|1|1.0||||||
4336882|NCT00426153|4164495|B3|ADPLD genotype with SEC63 gene mutation||Genotypes and genetic mutations|Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations in one of two genes: PKD1 or PKD2, and is characterized by the development of kidney cysts and other manifestations, of which polycystic live disease (PLD) is most common. Autosomal dominant PLD (ADPLD) also exists as a genetically distinct disease with few or absent kidney cysts. Like ADPKD, ADPLD is genetically heterogeneous, with the 1st two genes identified (PRKCSH & SEC63) accounting for approximately 1/3 to 1/2 of isolated ADPLD cases.|Participants|Number|1|1.0||||||
4336883|NCT00426153|4164496|B2|ADPLD genotype with SEC63 gene mutation||Genotypes and genetic mutations|Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations in one of two genes: PKD1 or PKD2, and is characterized by the development of kidney cysts and other manifestations, of which polycystic live disease (PLD) is most common. Autosomal dominant PLD (ADPLD) also exists as a genetically distinct disease with few or absent kidney cysts. Like ADPKD, ADPLD is genetically heterogeneous, with the 1st two genes identified (PRKCSH & SEC63) accounting for approximately 1/3 to 1/2 of isolated ADPLD cases.|Participants|Number|1|1.0||||||
4336884|NCT00426153|4164497|B1|ADPLD genotype with SEC63 gene mutation||Genotypes and genetic mutations|Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations in one of two genes: PKD1 or PKD2, and is characterized by the development of kidney cysts and other manifestations, of which polycystic live disease (PLD) is most common. Autosomal dominant PLD (ADPLD) also exists as a genetically distinct disease with few or absent kidney cysts. Like ADPKD, ADPLD is genetically heterogeneous, with the 1st two genes identified (PRKCSH & SEC63) accounting for approximately 1/3 to 1/2 of isolated ADPLD cases.|Participants|Number|0|0.0||||||
4336885|NCT00426153|4164495|B3|ADPLD genotype with PRKCSH gene mutation||Genotypes and genetic mutations|Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations in one of two genes: PKD1 or PKD2, and is characterized by the development of kidney cysts and other manifestations, of which polycystic live disease (PLD) is most common. Autosomal dominant PLD (ADPLD) also exists as a genetically distinct disease with few or absent kidney cysts. Like ADPKD, ADPLD is genetically heterogeneous, with the 1st two genes identified (PRKCSH & SEC63) accounting for approximately 1/3 to 1/2 of isolated ADPLD cases.|Participants|Number|4|4.0||||||
4336886|NCT00426153|4164496|B2|ADPLD genotype with PRKCSH gene mutation||Genotypes and genetic mutations|Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations in one of two genes: PKD1 or PKD2, and is characterized by the development of kidney cysts and other manifestations, of which polycystic live disease (PLD) is most common. Autosomal dominant PLD (ADPLD) also exists as a genetically distinct disease with few or absent kidney cysts. Like ADPKD, ADPLD is genetically heterogeneous, with the 1st two genes identified (PRKCSH & SEC63) accounting for approximately 1/3 to 1/2 of isolated ADPLD cases.|Participants|Number|1|1.0||||||
4336887|NCT00426153|4164497|B1|ADPLD genotype with PRKCSH gene mutation||Genotypes and genetic mutations|Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations in one of two genes: PKD1 or PKD2, and is characterized by the development of kidney cysts and other manifestations, of which polycystic live disease (PLD) is most common. Autosomal dominant PLD (ADPLD) also exists as a genetically distinct disease with few or absent kidney cysts. Like ADPKD, ADPLD is genetically heterogeneous, with the 1st two genes identified (PRKCSH & SEC63) accounting for approximately 1/3 to 1/2 of isolated ADPLD cases.|Participants|Number|3|3.0||||||
4336888|NCT00426153|4164495|B3|ADPKD genotype with no genetic mutation detected||Genotypes and genetic mutations|Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations in one of two genes: PKD1 or PKD2, and is characterized by the development of kidney cysts and other manifestations, of which polycystic live disease (PLD) is most common. Autosomal dominant PLD (ADPLD) also exists as a genetically distinct disease with few or absent kidney cysts. Like ADPKD, ADPLD is genetically heterogeneous, with the 1st two genes identified (PRKCSH & SEC63) accounting for approximately 1/3 to 1/2 of isolated ADPLD cases.|Participants|Number|3|3.0||||||
4336889|NCT00426153|4164496|B2|ADPKD genotype with no genetic mutation detected||Genotypes and genetic mutations|Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations in one of two genes: PKD1 or PKD2, and is characterized by the development of kidney cysts and other manifestations, of which polycystic live disease (PLD) is most common. Autosomal dominant PLD (ADPLD) also exists as a genetically distinct disease with few or absent kidney cysts. Like ADPKD, ADPLD is genetically heterogeneous, with the 1st two genes identified (PRKCSH & SEC63) accounting for approximately 1/3 to 1/2 of isolated ADPLD cases.|Participants|Number|0|0.0||||||
4336906|NCT00426153|4164495|B3|||Systolic Blood Pressure|Systolic blood pressure is the upper number on a blood pressure reading and measures contraction of the ventricles, or lower chambers of the heart|millimeters of mercury (mmHg)|Mean|121.6|121.6|Standard Deviation|13.2|13.2|||
4336939|NCT00426127|4164510|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4336890|NCT00426153|4164497|B1|ADPKD genotype with no genetic mutation detected||Genotypes and genetic mutations|Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations in one of two genes: PKD1 or PKD2, and is characterized by the development of kidney cysts and other manifestations, of which polycystic live disease (PLD) is most common. Autosomal dominant PLD (ADPLD) also exists as a genetically distinct disease with few or absent kidney cysts. Like ADPKD, ADPLD is genetically heterogeneous, with the 1st two genes identified (PRKCSH & SEC63) accounting for approximately 1/3 to 1/2 of isolated ADPLD cases.|Participants|Number|3|3.0||||||
4336891|NCT00426153|4164495|B3|ADPKD genotype with PKD2 gene mutation||Genotypes and genetic mutations|Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations in one of two genes: PKD1 or PKD2, and is characterized by the development of kidney cysts and other manifestations, of which polycystic live disease (PLD) is most common. Autosomal dominant PLD (ADPLD) also exists as a genetically distinct disease with few or absent kidney cysts. Like ADPKD, ADPLD is genetically heterogeneous, with the 1st two genes identified (PRKCSH & SEC63) accounting for approximately 1/3 to 1/2 of isolated ADPLD cases.|Participants|Number|6|6.0||||||
4336892|NCT00426153|4164496|B2|ADPKD genotype with PKD2 gene mutation||Genotypes and genetic mutations|Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations in one of two genes: PKD1 or PKD2, and is characterized by the development of kidney cysts and other manifestations, of which polycystic live disease (PLD) is most common. Autosomal dominant PLD (ADPLD) also exists as a genetically distinct disease with few or absent kidney cysts. Like ADPKD, ADPLD is genetically heterogeneous, with the 1st two genes identified (PRKCSH & SEC63) accounting for approximately 1/3 to 1/2 of isolated ADPLD cases.|Participants|Number|1|1.0||||||
4336893|NCT00426153|4164497|B1|ADPKD genotype with PKD2 gene mutation||Genotypes and genetic mutations|Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations in one of two genes: PKD1 or PKD2, and is characterized by the development of kidney cysts and other manifestations, of which polycystic live disease (PLD) is most common. Autosomal dominant PLD (ADPLD) also exists as a genetically distinct disease with few or absent kidney cysts. Like ADPKD, ADPLD is genetically heterogeneous, with the 1st two genes identified (PRKCSH & SEC63) accounting for approximately 1/3 to 1/2 of isolated ADPLD cases.|Participants|Number|5|5.0||||||
4336894|NCT00426153|4164495|B3|ADPKD genotype with PKD1 gene mutation||Genotypes and genetic mutations|Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations in one of two genes: PKD1 or PKD2, and is characterized by the development of kidney cysts and other manifestations, of which polycystic live disease (PLD) is most common. Autosomal dominant PLD (ADPLD) also exists as a genetically distinct disease with few or absent kidney cysts. Like ADPKD, ADPLD is genetically heterogeneous, with the 1st two genes identified (PRKCSH & SEC63) accounting for approximately 1/3 to 1/2 of isolated ADPLD cases.|Participants|Number|25|25.0||||||
4336895|NCT00426153|4164496|B2|ADPKD genotype with PKD1 gene mutation||Genotypes and genetic mutations|Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations in one of two genes: PKD1 or PKD2, and is characterized by the development of kidney cysts and other manifestations, of which polycystic live disease (PLD) is most common. Autosomal dominant PLD (ADPLD) also exists as a genetically distinct disease with few or absent kidney cysts. Like ADPKD, ADPLD is genetically heterogeneous, with the 1st two genes identified (PRKCSH & SEC63) accounting for approximately 1/3 to 1/2 of isolated ADPLD cases.|Participants|Number|9|9.0||||||
4336896|NCT00426153|4164497|B1|ADPKD genotype with PKD1 gene mutation||Genotypes and genetic mutations|Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations in one of two genes: PKD1 or PKD2, and is characterized by the development of kidney cysts and other manifestations, of which polycystic live disease (PLD) is most common. Autosomal dominant PLD (ADPLD) also exists as a genetically distinct disease with few or absent kidney cysts. Like ADPKD, ADPLD is genetically heterogeneous, with the 1st two genes identified (PRKCSH & SEC63) accounting for approximately 1/3 to 1/2 of isolated ADPLD cases.|Participants|Number|16|16.0||||||
4336897|NCT00426153|4164495|B3|||Kidney volume|"Kidney volume was measured by magnetic resonance imaging (MRI) or computed tomography [CT].~13 subjects were excluded from the analysis of the kidney data: 4 subjects had renal transplant before enrollment (3 in octreotide and 1 in placebo groups), 8 subjects had a diagnosis of ADPLD (4 in each group), 1 placebo subject has missing kidney data due to incomplete image coverage. (Octreotide group n = 21 and placebo group n = 8)."|milliliters (ml)|Mean|1049.2|1049.2|Standard Deviation|728.3|728.3|||
4336898|NCT00426153|4164496|B2|||Kidney volume|"Kidney volume was measured by magnetic resonance imaging (MRI) or computed tomography [CT].~13 subjects were excluded from the analysis of the kidney data: 4 subjects had renal transplant before enrollment (3 in octreotide and 1 in placebo groups), 8 subjects had a diagnosis of ADPLD (4 in each group), 1 placebo subject has missing kidney data due to incomplete image coverage. (Octreotide group n = 21 and placebo group n = 8)."|milliliters (ml)|Mean|803.0|803.0|Standard Deviation|269.1|269.1|||
4336899|NCT00426153|4164497|B1|||Kidney volume|"Kidney volume was measured by magnetic resonance imaging (MRI) or computed tomography [CT].~13 subjects were excluded from the analysis of the kidney data: 4 subjects had renal transplant before enrollment (3 in octreotide and 1 in placebo groups), 8 subjects had a diagnosis of ADPLD (4 in each group), 1 placebo subject has missing kidney data due to incomplete image coverage. (Octreotide group n = 21 and placebo group n = 8)."|milliliters (ml)|Mean|1142.9|1142.9|Standard Deviation|826.9|826.9|||
4336900|NCT00426153|4164495|B3|||Liver volume|Liver volume was measured by magnetic resonance imaging (MRI) or computed tomography [CT].|milliliters (ml)|Mean|5729.8|5729.8|Standard Deviation|3113.1|3113.1|||
4336901|NCT00426153|4164496|B2|||Liver volume|Liver volume was measured by magnetic resonance imaging (MRI) or computed tomography [CT].|milliliters (ml)|Mean|5373.9|5373.9|Standard Deviation|3565.4|3565.4|||
4336902|NCT00426153|4164497|B1|||Liver volume|Liver volume was measured by magnetic resonance imaging (MRI) or computed tomography [CT].|milliliters (ml)|Mean|5907.7|5907.7|Standard Deviation|2915.0|2915.0|||
4336903|NCT00426153|4164495|B3|||Diastolic Blood Pressure|Diastolic blood pressure is the lower number on a blood pressure reading and measures dilation of the ventricles, or lower chambers of the heart.|millimeters of mercury (mmHg)|Mean|79.6|79.6|Standard Deviation|8.9|8.9|||
4336904|NCT00426153|4164496|B2|||Diastolic Blood Pressure|Diastolic blood pressure is the lower number on a blood pressure reading and measures dilation of the ventricles, or lower chambers of the heart.|millimeters of mercury (mmHg)|Mean|79.1|79.1|Standard Deviation|9.2|9.2|||
4336938|NCT00426153|4164497|B1|||Age||years|Mean|49.7|49.7|Standard Deviation|9|9.0|||
4336907|NCT00426153|4164496|B2|||Systolic Blood Pressure|Systolic blood pressure is the upper number on a blood pressure reading and measures contraction of the ventricles, or lower chambers of the heart|millimeters of mercury (mmHg)|Mean|120.5|120.5|Standard Deviation|13.5|13.5|||
4336908|NCT00426153|4164497|B1|||Systolic Blood Pressure|Systolic blood pressure is the upper number on a blood pressure reading and measures contraction of the ventricles, or lower chambers of the heart|millimeters of mercury (mmHg)|Mean|122.1|122.1|Standard Deviation|13.2|13.2|||
4336909|NCT00426153|4164495|B3|||Urine Albumin|A protein urine test measures the amount of proteins, such as albumin, found in a urine sample. Urine albumin is an indicator of kidney function.|milligrams/24 hours|Mean|87|87.0|Standard Deviation|171|171.0|||
4336910|NCT00426153|4164496|B2|||Urine Albumin|A protein urine test measures the amount of proteins, such as albumin, found in a urine sample. Urine albumin is an indicator of kidney function.|milligrams/24 hours|Mean|130|130.0|Standard Deviation|237|237.0|||
4336911|NCT00426153|4164497|B1|||Urine Albumin|A protein urine test measures the amount of proteins, such as albumin, found in a urine sample. Urine albumin is an indicator of kidney function.|milligrams/24 hours|Mean|65|65.0|Standard Deviation|123|123.0|||
4336912|NCT00426153|4164495|B3|||Fasting plasma glucose||milligrams/deciliter|Mean|93.5|93.5|Standard Deviation|10.1|10.1|||
4336913|NCT00426153|4164496|B2|||Fasting plasma glucose||milligrams/deciliter|Mean|93.6|93.6|Standard Deviation|7.8|7.8|||
4336914|NCT00426153|4164497|B1|||Fasting plasma glucose||milligrams/deciliter|Mean|93.4|93.4|Standard Deviation|11.2|11.2|||
4336915|NCT00426153|4164495|B3|||Serum creatinine|Creatinine in the serum is a blood test, and is an indicator of kidney function.|milligrams/deciliter|Mean|1.1|1.1|Standard Deviation|0.5|0.5|||
4336916|NCT00426153|4164496|B2|||Serum creatinine|Creatinine in the serum is a blood test, and is an indicator of kidney function.|milligrams/deciliter|Mean|1.1|1.1|Standard Deviation|0.5|0.5|||
4336917|NCT00426153|4164497|B1|||Serum creatinine|Creatinine in the serum is a blood test, and is an indicator of kidney function.|milligrams/deciliter|Mean|1.1|1.1|Standard Deviation|0.4|0.4|||
4336918|NCT00426153|4164495|B3|||Body Weight||kilograms|Mean|74.3|74.3|Standard Deviation|17.8|17.8|||
4336919|NCT00426153|4164496|B2|||Body Weight||kilograms|Mean|70.9|70.9|Standard Deviation|10.9|10.9|||
4336920|NCT00426153|4164497|B1|||Body Weight||kilograms|Mean|76.0|76.0|Standard Deviation|20.2|20.2|||
4336921|NCT00426153|4164495|B3|||Body Mass Index|Body Mass Index (BMI) is a health index for comparing weight to height. BMI is a person's weight in kilograms (kg) divided by his or her height in meters squared. The body mass index is an indication if a person is at a suitable weight for his height on an approximation of body fat. A body mass index of under 20 is considered to be underweight, while a body mass index between 20 to 25 is considered healthy. A body mass index in the range of 25 to 30 is regarded as overweight. A body mass index over 30 is regarded as obese.|kilograms/meter^2|Mean|25.7|25.7|Standard Deviation|5.0|5.0|||
4336922|NCT00426153|4164496|B2|||Body Mass Index|Body Mass Index (BMI) is a health index for comparing weight to height. BMI is a person's weight in kilograms (kg) divided by his or her height in meters squared. The body mass index is an indication if a person is at a suitable weight for his height on an approximation of body fat. A body mass index of under 20 is considered to be underweight, while a body mass index between 20 to 25 is considered healthy. A body mass index in the range of 25 to 30 is regarded as overweight. A body mass index over 30 is regarded as obese.|kilograms/meter^2|Mean|24.4|24.4|Standard Deviation|2.98|2.98|||
4336923|NCT00426153|4164497|B1|||Body Mass Index|Body Mass Index (BMI) is a health index for comparing weight to height. BMI is a person's weight in kilograms (kg) divided by his or her height in meters squared. The body mass index is an indication if a person is at a suitable weight for his height on an approximation of body fat. A body mass index of under 20 is considered to be underweight, while a body mass index between 20 to 25 is considered healthy. A body mass index in the range of 25 to 30 is regarded as overweight. A body mass index over 30 is regarded as obese.|kilograms/meter^2|Mean|26.3|26.3|Standard Deviation|5.77|5.77|||
4336924|NCT00426153|4164495|B3|||Glomerular Filtration Rate|Glomerular Filtration Rate measures how fast the kidneys are filtering. 13 subjects were excluded from the analysis of the kidney data: 4 subjects had renal transplant before enrollment (3 in octreotide and 1 in placebo groups), 8 subjects had a diagnosis of ADPLD (4 in each group), 1 placebo subject has missing kidney data due to incomplete image coverage.|milliliters/minute per 1.73 m^2|Mean|70|70.0|Standard Deviation|27|27.0|||
4336925|NCT00426153|4164496|B2|||Glomerular Filtration Rate|Glomerular Filtration Rate measures how fast the kidneys are filtering. 13 subjects were excluded from the analysis of the kidney data: 4 subjects had renal transplant before enrollment (3 in octreotide and 1 in placebo groups), 8 subjects had a diagnosis of ADPLD (4 in each group), 1 placebo subject has missing kidney data due to incomplete image coverage.|milliliters/minute per 1.73 m^2|Mean|71|71.0|Standard Deviation|27|27.0|||
4336926|NCT00426153|4164497|B1|||Glomerular Filtration Rate|Glomerular Filtration Rate measures how fast the kidneys are filtering. 13 subjects were excluded from the analysis of the kidney data: 4 subjects had renal transplant before enrollment (3 in octreotide and 1 in placebo groups), 8 subjects had a diagnosis of ADPLD (4 in each group), 1 placebo subject has missing kidney data due to incomplete image coverage.|milliliters/minute per 1.73 m^2|Mean|70|70.0|Standard Deviation|27|27.0|||
4336927|NCT00426153|4164495|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4336928|NCT00426153|4164496|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4336929|NCT00426153|4164497|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4336930|NCT00426153|4164495|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4336931|NCT00426153|4164496|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4336932|NCT00426153|4164497|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4336933|NCT00426153|4164495|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4336934|NCT00426153|4164496|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4336935|NCT00426153|4164497|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4336936|NCT00426153|4164495|B3|||Age||years|Mean|49.9|49.9|Standard Deviation|8.4|8.4|||
4336937|NCT00426153|4164496|B2|||Age||years|Mean|50.3|50.3|Standard Deviation|7.3|7.3|||
4336940|NCT00426127|4164510|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4336941|NCT00426127|4164510|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4336942|NCT00426127|4164510|B1|||Age||Years|Mean|61.8|61.8|Full Range|||58.2|65.5|
4336943|NCT00426127|4164510|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4336944|NCT00426127|4164510|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4336945|NCT00426127|4164510|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4336946|NCT00425945|4164516|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4336947|NCT00425945|4164517|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4336948|NCT00425945|4164518|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4336949|NCT00425945|4164516|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4336950|NCT00425945|4164517|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4336951|NCT00425945|4164518|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4336952|NCT00425945|4164516|B3|||Age||years|Mean|55.4|55.4|Standard Deviation|11.0|11.0|||
4336953|NCT00425945|4164517|B2|||Age||years|Mean|53.9|53.9|Standard Deviation|12.0|12.0|||
4336954|NCT00425945|4164518|B1|||Age||years|Mean|56.9|56.9|Standard Deviation|9.8|9.8|||
4336955|NCT00425945|4164516|B3||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4336956|NCT00425945|4164517|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4336957|NCT00425945|4164518|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4336958|NCT00425945|4164516|B3||Between 18 and 65 years|Age||Participants|Count of Participants|106|106.0||||||
4336959|NCT00425945|4164517|B2||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4336960|NCT00425945|4164518|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4336961|NCT00425945|4164516|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4336962|NCT00425945|4164517|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4336963|NCT00425945|4164518|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4336964|NCT00425854|4164555|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4336965|NCT00425854|4164556|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4336966|NCT00425854|4164557|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4336967|NCT00425854|4164555|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4336968|NCT00425854|4164556|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4336969|NCT00425854|4164557|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4336970|NCT00425854|4164555|B3|||Age||years|Mean|57.1|57.1|Standard Deviation|13.0|13.0|||
4336971|NCT00425854|4164556|B2|||Age||years|Mean|61.0|61.0|Standard Deviation|14.3|14.3|||
4336972|NCT00425854|4164557|B1|||Age||years|Mean|54.3|54.3|Standard Deviation|11.5|11.5|||
4336973|NCT00425802|4164579|B1|United States||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
4336974|NCT00425802|4164579|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4336975|NCT00425802|4164579|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4336976|NCT00425802|4164579|B1||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4336977|NCT00425802|4164579|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4336978|NCT00425802|4164579|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4336979|NCT00425802|4164579|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4336980|NCT00425802|4164579|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4336981|NCT00425802|4164579|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4336982|NCT00425802|4164579|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4336983|NCT00425802|4164579|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4336984|NCT00425802|4164579|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4336985|NCT00425802|4164579|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4336986|NCT00425802|4164579|B1|||Age||years|Median|54|54.0|Full Range|||33.0|69.0|
4336987|NCT00425750|4164591|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4336988|NCT00425750|4164591|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4336989|NCT00425750|4164591|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4336990|NCT00425750|4164591|B1|||Age||years|Mean|55|55.0|Standard Deviation|1|1.0|||
4336991|NCT00425750|4164591|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4336992|NCT00425750|4164591|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4336993|NCT00425750|4164591|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4336994|NCT00425698|4164597|B3|Germany||Region of Enrollment||participants|Number|88|88.0||||||
4336995|NCT00425698|4164598|B2|Germany||Region of Enrollment||participants|Number|44|44.0||||||
4336996|NCT00425698|4164599|B1|Germany||Region of Enrollment||participants|Number|44|44.0||||||
4336997|NCT00425698|4164597|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4336998|NCT00425698|4164598|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4336999|NCT00425698|4164599|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4337000|NCT00425698|4164597|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4337001|NCT00425698|4164598|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4337002|NCT00425698|4164599|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4337003|NCT00425698|4164597|B3|||Age||years|Mean|52|52.0|Standard Deviation|2|2.0|||
4337004|NCT00425698|4164598|B2|||Age||years|Mean|50|50.0|Standard Deviation|2|2.0|||
4337005|NCT00425698|4164599|B1|||Age||years|Mean|54|54.0|Standard Deviation|2|2.0|||
4337006|NCT00425698|4164597|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4337007|NCT00425698|4164598|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4337008|NCT00425698|4164599|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4337009|NCT00425698|4164597|B3||Between 18 and 65 years|Age||Participants|Count of Participants|88|88.0||||||
4337010|NCT00425698|4164598|B2||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4337011|NCT00425698|4164599|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4337012|NCT00425698|4164597|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4337013|NCT00425698|4164598|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4337014|NCT00425698|4164599|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4337015|NCT00425672|4164606|B1|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4337016|NCT00425672|4164606|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337017|NCT00425672|4164606|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337018|NCT00425672|4164606|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4337019|NCT00425672|4164606|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4337020|NCT00425672|4164606|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337021|NCT00425672|4164606|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337022|NCT00425672|4164606|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4337023|NCT00425672|4164606|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337024|NCT00425672|4164606|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4337025|NCT00425672|4164606|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4337026|NCT00425672|4164606|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4337027|NCT00425672|4164606|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4337028|NCT00425672|4164606|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4337029|NCT00425672|4164606|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4337030|NCT00425672|4164606|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4337031|NCT00425607|4164615|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4337032|NCT00425607|4164615|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4337033|NCT00425607|4164615|B1|||Age||years|Mean|7.0|7.0|Standard Deviation|3|3.0|||
4337034|NCT00425503|4164619|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4337035|NCT00425503|4164619|B1|Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4337036|NCT00425503|4164619|B1|White/Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4337037|NCT00425503|4164619|B1|White/Non-Hispanic||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4337038|NCT00425503|4164619|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4337039|NCT00425503|4164619|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4337040|NCT00425503|4164619|B1|Aged >75 years||Age, Customized|Age of participants is reported as age at the time of study enrollment.|participants|Number|1|1.0||||||
4337041|NCT00425503|4164619|B1|Aged 71 - 75 years||Age, Customized|Age of participants is reported as age at the time of study enrollment.|participants|Number|2|2.0||||||
4337042|NCT00425503|4164619|B1|Aged 66 - 70 years||Age, Customized|Age of participants is reported as age at the time of study enrollment.|participants|Number|5|5.0||||||
4337043|NCT00425503|4164619|B1|Aged 61 - 65 years||Age, Customized|Age of participants is reported as age at the time of study enrollment.|participants|Number|14|14.0||||||
4337044|NCT00425503|4164619|B1|Aged 56- 60 years||Age, Customized|Age of participants is reported as age at the time of study enrollment.|participants|Number|7|7.0||||||
4337045|NCT00425503|4164619|B1|Aged 51 - 55 years||Age, Customized|Age of participants is reported as age at the time of study enrollment.|participants|Number|9|9.0||||||
4337046|NCT00425503|4164619|B1|Less than 50 years||Age, Customized|Age of participants is reported as age at the time of study enrollment.|participants|Number|2|2.0||||||
4337047|NCT00425477|4164623|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4337048|NCT00425477|4164623|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4337049|NCT00425477|4164623|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4337050|NCT00425477|4164623|B1|||Age||years|Median|72|72.0|Full Range|||49.0|89.0|
4337051|NCT00425438|4164629|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4337052|NCT00425438|4164630|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4337053|NCT00425438|4164631|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4337054|NCT00425438|4164629|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4337055|NCT00425438|4164630|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4337056|NCT00425438|4164631|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4337057|NCT00425438|4164629|B3|||Age||years|Mean|32.4|32.4|Standard Deviation|8.9|8.9|||
4337058|NCT00425438|4164630|B2|||Age||years|Mean|31.6|31.6|Standard Deviation|8.0|8.0|||
4337059|NCT00425438|4164631|B1|||Age||years|Mean|33.4|33.4|Standard Deviation|9.8|9.8|||
4337060|NCT00425386|4164648|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4337061|NCT00425386|4164648|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4337062|NCT00425386|4164648|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4337063|NCT00425386|4164648|B1|||Age||years|Median|58|58.0|Full Range|||24.0|78.0|
4337064|NCT00425386|4164648|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4337065|NCT00425386|4164648|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4337066|NCT00425386|4164648|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4337067|NCT00425373|4164657|B10||Male|Sex: Female, Male||Participants|Count of Participants|1063|1063.0||||||
4337068|NCT00425373|4164658|B9||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4337069|NCT00425373|4164659|B8||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4337070|NCT00425373|4164660|B7||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4337071|NCT00425373|4164661|B6||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4337072|NCT00425373|4164662|B5||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4337073|NCT00425373|4164663|B4||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4337074|NCT00425373|4164664|B3||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4337075|NCT00425373|4164665|B2||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4337076|NCT00425373|4164666|B1||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4337077|NCT00425373|4164657|B10||Female|Sex: Female, Male||Participants|Count of Participants|405|405.0||||||
4337078|NCT00425373|4164658|B9||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4337079|NCT00425373|4164659|B8||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4337080|NCT00425373|4164660|B7||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4337081|NCT00425373|4164661|B6||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4337082|NCT00425373|4164662|B5||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4337083|NCT00425373|4164663|B4||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4337084|NCT00425373|4164664|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4337085|NCT00425373|4164665|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4337086|NCT00425373|4164666|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4337087|NCT00425373|4164657|B10|||Age||years|Mean|53.1|53.1|Standard Deviation|10.57|10.57|||
4337088|NCT00425373|4164658|B9|||Age||years|Mean|51.5|51.5|Standard Deviation|10.58|10.58|||
4337089|NCT00425373|4164659|B8|||Age||years|Mean|54.4|54.4|Standard Deviation|10.67|10.67|||
4337090|NCT00425373|4164660|B7|||Age||years|Mean|53.2|53.2|Standard Deviation|10.83|10.83|||
4337091|NCT00425373|4164661|B6|||Age||years|Mean|52.6|52.6|Standard Deviation|11.29|11.29|||
4337092|NCT00425373|4164662|B5|||Age||years|Mean|52.9|52.9|Standard Deviation|10.08|10.08|||
4337093|NCT00425373|4164663|B4|||Age||years|Mean|54.1|54.1|Standard Deviation|9.75|9.75|||
4337094|NCT00425373|4164664|B3|||Age||years|Mean|52.8|52.8|Standard Deviation|10.76|10.76|||
4337095|NCT00425373|4164665|B2|||Age||years|Mean|52.8|52.8|Standard Deviation|10.70|10.7|||
4337096|NCT00425373|4164666|B1|||Age||years|Mean|53.9|53.9|Standard Deviation|10.34|10.34|||
4337097|NCT00425308|4164730|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4337098|NCT00425308|4164731|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4337099|NCT00425308|4164732|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4337100|NCT00425308|4164730|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4337101|NCT00425308|4164731|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4337102|NCT00425308|4164732|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4337103|NCT00425308|4164730|B3|||Age||years|Mean|60.6|60.6|Standard Deviation|8.60|8.6|||
4337104|NCT00425308|4164731|B2|||Age||years|Mean|58.8|58.8|Standard Deviation|7.55|7.55|||
4337105|NCT00425308|4164732|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|9.46|9.46|||
4337106|NCT00425269|4164761|B3|||Body Mass Index||kg/m^2|Mean|29.6|29.6|Standard Deviation|5.6|5.6|||
4337107|NCT00425269|4164762|B2|||Body Mass Index||kg/m^2|Mean|29.8|29.8|Standard Deviation|5.5|5.5|||
4337108|NCT00425269|4164763|B1|||Body Mass Index||kg/m^2|Mean|29.4|29.4|Standard Deviation|5.6|5.6|||
4337109|NCT00425269|4164761|B3|||Years of education||years|Mean|9|9.0|Standard Deviation|4.5|4.5|||
4337110|NCT00425269|4164762|B2|||Years of education||years|Mean|9|9.0|Standard Deviation|4.3|4.3|||
4337111|NCT00425269|4164763|B1|||Years of education||years|Mean|9|9.0|Standard Deviation|4.7|4.7|||
4337112|NCT00425269|4164761|B3|||Years of residence in Norway||years|Mean|19|19.0|Standard Deviation|7.8|7.8|||
4337113|NCT00425269|4164762|B2|||Years of residence in Norway||years|Mean|19|19.0|Standard Deviation|7.6|7.6|||
4337114|NCT00425269|4164763|B1|||Years of residence in Norway||years|Mean|18|18.0|Standard Deviation|7.9|7.9|||
4337115|NCT00425269|4164761|B3|Norway||Region of Enrollment||participants|Number|198|198.0||||||
4337116|NCT00425269|4164762|B2|Norway||Region of Enrollment||participants|Number|97|97.0||||||
4337117|NCT00425269|4164763|B1|Norway||Region of Enrollment||participants|Number|101|101.0||||||
4337118|NCT00425269|4164761|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4337119|NCT00425269|4164762|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4337120|NCT00425269|4164763|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4337121|NCT00425269|4164761|B3||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4337122|NCT00425269|4164762|B2||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4337123|NCT00425269|4164763|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4337124|NCT00425269|4164761|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4337125|NCT00425269|4164762|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4337126|NCT00425269|4164763|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4337127|NCT00425269|4164761|B3||Between 18 and 65 years|Age||Participants|Count of Participants|198|198.0||||||
4337128|NCT00425269|4164762|B2||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
4337129|NCT00425269|4164763|B1||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
4337130|NCT00425269|4164761|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4337131|NCT00425269|4164762|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4337132|NCT00425269|4164763|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4337133|NCT00425113|4164840|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4337134|NCT00425113|4164841|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4337135|NCT00425113|4164842|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4337136|NCT00425113|4164840|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4337137|NCT00425113|4164841|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4337138|NCT00425113|4164842|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4337139|NCT00425113|4164840|B3|||Age||years|Median|37|37.0|Inter-Quartile Range|||30.0|43.0|
4337140|NCT00425113|4164841|B2|||Age||years|Median|38|38.0|Inter-Quartile Range|||31.0|44.0|
4337141|NCT00425113|4164842|B1|||Age||years|Median|36|36.0|Inter-Quartile Range|||28.0|39.0|
4337142|NCT00425100|4164851|B1||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4337143|NCT00425100|4164851|B1||Female|Sex: Female, Male||Participants|Count of Participants|398|398.0||||||
4337144|NCT00425100|4164851|B1|||Age||years|Mean|59.6|59.6|Standard Deviation|13.6|13.6|||
4337145|NCT00425061|4164888|B8||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4337146|NCT00425061|4164889|B7||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4337147|NCT00425061|4164890|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4337148|NCT00425061|4164891|B5||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4337149|NCT00425061|4164892|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4337150|NCT00425061|4164893|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4337151|NCT00425061|4164894|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4337152|NCT00425061|4164895|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4337153|NCT00425061|4164888|B8||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4337154|NCT00425061|4164889|B7||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4337155|NCT00425061|4164890|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4337156|NCT00425061|4164891|B5||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4337157|NCT00425061|4164892|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4337158|NCT00425061|4164893|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4337159|NCT00425061|4164894|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4337160|NCT00425061|4164895|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4337161|NCT00425061|4164888|B8|Greater than 71 years||Age, Customized||participants|Number|0|0.0||||||
4337162|NCT00425061|4164889|B7|Greater than 71 years||Age, Customized||participants|Number|0|0.0||||||
4337163|NCT00425061|4164890|B6|Greater than 71 years||Age, Customized||participants|Number|0|0.0||||||
4337164|NCT00425061|4164891|B5|Greater than 71 years||Age, Customized||participants|Number|0|0.0||||||
4337165|NCT00425061|4164892|B4|Greater than 71 years||Age, Customized||participants|Number|0|0.0||||||
4337166|NCT00425061|4164893|B3|Greater than 71 years||Age, Customized||participants|Number|0|0.0||||||
4337167|NCT00425061|4164894|B2|Greater than 71 years||Age, Customized||participants|Number|0|0.0||||||
4337168|NCT00425061|4164895|B1|Greater than 71 years||Age, Customized||participants|Number|0|0.0||||||
4337169|NCT00425061|4164888|B8|18 to 71 years||Age, Customized||participants|Number|159|159.0||||||
4337170|NCT00425061|4164889|B7|18 to 71 years||Age, Customized||participants|Number|45|45.0||||||
4337171|NCT00425061|4164890|B6|18 to 71 years||Age, Customized||participants|Number|4|4.0||||||
4337172|NCT00425061|4164891|B5|18 to 71 years||Age, Customized||participants|Number|45|45.0||||||
4337173|NCT00425061|4164892|B4|18 to 71 years||Age, Customized||participants|Number|16|16.0||||||
4337174|NCT00425061|4164893|B3|18 to 71 years||Age, Customized||participants|Number|16|16.0||||||
4337175|NCT00425061|4164894|B2|18 to 71 years||Age, Customized||participants|Number|17|17.0||||||
4337176|NCT00425061|4164895|B1|18 to 71 years||Age, Customized||participants|Number|16|16.0||||||
4337177|NCT00425061|4164888|B8|Less than 18 years||Age, Customized||participants|Number|0|0.0||||||
4337178|NCT00425061|4164889|B7|Less than 18 years||Age, Customized||participants|Number|0|0.0||||||
4337179|NCT00425061|4164890|B6|Less than 18 years||Age, Customized||participants|Number|0|0.0||||||
4337180|NCT00425061|4164891|B5|Less than 18 years||Age, Customized||participants|Number|0|0.0||||||
4337181|NCT00425061|4164892|B4|Less than 18 years||Age, Customized||participants|Number|0|0.0||||||
4337182|NCT00425061|4164893|B3|Less than 18 years||Age, Customized||participants|Number|0|0.0||||||
4337183|NCT00425061|4164894|B2|Less than 18 years||Age, Customized||participants|Number|0|0.0||||||
4337184|NCT00425061|4164895|B1|Less than 18 years||Age, Customized||participants|Number|0|0.0||||||
4337185|NCT00424827|4165017|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4337186|NCT00424827|4165017|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4337187|NCT00424827|4165017|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4337188|NCT00424827|4165017|B1|||Age||years|Median|66|66.0|Full Range|||48.0|78.0|
4337189|NCT00424827|4165017|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4337190|NCT00424827|4165017|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4337191|NCT00424827|4165017|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4337192|NCT00424775|4165025|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4337193|NCT00424775|4165025|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4337194|NCT00424775|4165025|B1|||Age||years|Mean|64|64.0|Standard Deviation|2.0|2.0|||
4337195|NCT00424762|4165034|B3|United States||Region of Enrollment||participants|Number|150|150.0||||||
4337196|NCT00424762|4165035|B2|United States||Region of Enrollment||participants|Number|76|76.0||||||
4337197|NCT00424762|4165036|B1|United States||Region of Enrollment||participants|Number|74|74.0||||||
4337198|NCT00424762|4165034|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4337199|NCT00424762|4165035|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4337200|NCT00424762|4165036|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4337201|NCT00424762|4165034|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4337202|NCT00424762|4165035|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4337203|NCT00424762|4165036|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4337204|NCT00424762|4165034|B3|||Age||years|Mean|56.2|56.2|Standard Deviation|8.4|8.4|||
4337205|NCT00424762|4165035|B2|||Age||years|Mean|55.7|55.7|Standard Deviation|8.3|8.3|||
4337206|NCT00424762|4165036|B1|||Age||years|Mean|57.0|57.0|Standard Deviation|8.7|8.7|||
4337207|NCT00424762|4165034|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4337208|NCT00424762|4165035|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4337209|NCT00424762|4165036|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4337210|NCT00424762|4165034|B3||Between 18 and 65 years|Age||Participants|Count of Participants|150|150.0||||||
4337211|NCT00424762|4165035|B2||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
4337212|NCT00424762|4165036|B1||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
4337213|NCT00424762|4165034|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4337214|NCT00424762|4165035|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4337215|NCT00424762|4165036|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4337216|NCT00424749|4165047|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4337217|NCT00424749|4165047|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4337218|NCT00424749|4165047|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4337219|NCT00424749|4165047|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4337220|NCT00424749|4165047|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4337221|NCT00424749|4165047|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4337222|NCT00424645|4165052|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4337223|NCT00424645|4165054|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4337224|NCT00424645|4165052|B3|Male||Gender||participants|Number|3|3.0||||||
4337225|NCT00424645|4165054|B1|Male||Gender||participants|Number|3|3.0||||||
4337226|NCT00424645|4165052|B3|Female||Gender||participants|Number|0|0.0||||||
4337227|NCT00424645|4165054|B1|Female||Gender||participants|Number|0|0.0||||||
4337228|NCT00424645|4165052|B3|||Age||years|Mean|64|64.0|Full Range|||46.0|72.0|
4337229|NCT00424645|4165054|B1|||Age||years|Mean|64|64.0|Full Range|||46.0|72.0|
4337230|NCT00424632|4165061|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4337231|NCT00424632|4165062|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4337232|NCT00424632|4165063|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4337233|NCT00424632|4165061|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4337234|NCT00424632|4165062|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4337235|NCT00424632|4165063|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4337236|NCT00424632|4165061|B3|||Age||years|Mean|61.2|61.2|Standard Deviation|9.8|9.8|28.0|75.0|
4337237|NCT00424632|4165062|B2|||Age||years|Mean|58.2|58.2|Standard Deviation|10.2|10.2|28.0|75.0|
4337238|NCT00424632|4165063|B1|||Age||years|Mean|63.6|63.6|Standard Deviation|9.0|9.0|44.0|81.0|
4337239|NCT00424619|4165203|B4|Canada||Region of Enrollment||participants|Number|64|64.0||||||
4337240|NCT00424619|4165204|B3|Canada||Region of Enrollment||participants|Number|20|20.0||||||
4337241|NCT00424619|4165205|B2|Canada||Region of Enrollment||participants|Number|22|22.0||||||
4337242|NCT00424619|4165206|B1|Canada||Region of Enrollment||participants|Number|22|22.0||||||
4337243|NCT00424619|4165203|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4337244|NCT00424619|4165204|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4337245|NCT00424619|4165205|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4337246|NCT00424619|4165206|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4337247|NCT00424619|4165203|B4||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4337248|NCT00424619|4165204|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4337249|NCT00424619|4165205|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4337250|NCT00424619|4165206|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4337251|NCT00424619|4165203|B4|||Age||years|Mean|78.43|78.43|Standard Deviation|11.09|11.09|||
4337252|NCT00424619|4165204|B3|||Age||years|Mean|78.5|78.5|Standard Deviation|10.3|10.3|||
4337253|NCT00424619|4165205|B2|||Age||years|Mean|73.9|73.9|Standard Deviation|12.4|12.4|||
4337254|NCT00424619|4165206|B1|||Age||years|Mean|82.9|82.9|Standard Deviation|8.7|8.7|||
4337255|NCT00424593|4165240|B3|||Weight||kilograms (kg)|Mean|76.06|76.06|Standard Deviation|14.29|14.29|||
4337256|NCT00424593|4165241|B2|||Weight||kilograms (kg)|Mean|75.89|75.89|Standard Deviation|13.94|13.94|||
4337257|NCT00424593|4165242|B1|||Weight||kilograms (kg)|Mean|76.24|76.24|Standard Deviation|14.71|14.71|||
4337258|NCT00424593|4165240|B3|||Height||centimeters (cm)|Mean|166.68|166.68|Standard Deviation|10.89|10.89|||
4337259|NCT00424593|4165241|B2|||Height||centimeters (cm)|Mean|167.40|167.4|Standard Deviation|11.34|11.34|||
4337260|NCT00424593|4165242|B1|||Height||centimeters (cm)|Mean|165.92|165.92|Standard Deviation|10.39|10.39|||
4337261|NCT00424593|4165240|B3|||Duration of Chronic Lower Back Pain Since Onset||years|Mean|9.18|9.18|Standard Deviation|8.66|8.66|||
4337262|NCT00424593|4165241|B2|||Duration of Chronic Lower Back Pain Since Onset||years|Mean|9.54|9.54|Standard Deviation|8.60|8.6|||
4337263|NCT00424593|4165242|B1|||Duration of Chronic Lower Back Pain Since Onset||years|Mean|8.79|8.79|Standard Deviation|8.75|8.75|||
4337264|NCT00424593|4165240|B3|||Brief Pain Inventory (BPI) Average Pain Score|A self-reported scale that measures the severity of pain based on the average pain over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|5.94|5.94|Standard Deviation|1.62|1.62|||
4337265|NCT00424593|4165241|B2|||Brief Pain Inventory (BPI) Average Pain Score|A self-reported scale that measures the severity of pain based on the average pain over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|5.96|5.96|Standard Deviation|1.66|1.66|||
4337266|NCT00424593|4165242|B1|||Brief Pain Inventory (BPI) Average Pain Score|A self-reported scale that measures the severity of pain based on the average pain over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|5.91|5.91|Standard Deviation|1.59|1.59|||
4337267|NCT00424593|4165240|B3|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|27.33|27.33|Standard Deviation|4.12|4.12|||
4337268|NCT00424593|4165241|B2|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|27.03|27.03|Standard Deviation|3.81|3.81|||
4337269|NCT00424593|4165242|B1|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|27.63|27.63|Standard Deviation|4.42|4.42|||
4337270|NCT00424593|4165240|B3|Native American||Race/Ethnicity||participants|Number|2|2.0||||||
4337271|NCT00424593|4165241|B2|Native American||Race/Ethnicity||participants|Number|1|1.0||||||
4337272|NCT00424593|4165242|B1|Native American||Race/Ethnicity||participants|Number|1|1.0||||||
4337273|NCT00424593|4165240|B3|Hispanic||Race/Ethnicity||participants|Number|44|44.0||||||
4337274|NCT00424593|4165241|B2|Hispanic||Race/Ethnicity||participants|Number|21|21.0||||||
4337275|NCT00424593|4165242|B1|Hispanic||Race/Ethnicity||participants|Number|23|23.0||||||
4337276|NCT00424593|4165240|B3|East Asian||Race/Ethnicity||participants|Number|2|2.0||||||
4337277|NCT00424593|4165241|B2|East Asian||Race/Ethnicity||participants|Number|2|2.0||||||
4337278|NCT00424593|4165242|B1|East Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4337279|NCT00424593|4165240|B3|Caucasian||Race/Ethnicity||participants|Number|176|176.0||||||
4337280|NCT00424593|4165241|B2|Caucasian||Race/Ethnicity||participants|Number|91|91.0||||||
4337281|NCT00424593|4165242|B1|Caucasian||Race/Ethnicity||participants|Number|85|85.0||||||
4337282|NCT00424593|4165240|B3|African||Race/Ethnicity||participants|Number|12|12.0||||||
4337283|NCT00424593|4165241|B2|African||Race/Ethnicity||participants|Number|6|6.0||||||
4337284|NCT00424593|4165242|B1|African||Race/Ethnicity||participants|Number|6|6.0||||||
4337285|NCT00424593|4165240|B3|Germany||Region of Enrollment||participants|Number|72|72.0||||||
4337286|NCT00424593|4165241|B2|Germany||Region of Enrollment||participants|Number|35|35.0||||||
4337287|NCT00424593|4165242|B1|Germany||Region of Enrollment||participants|Number|37|37.0||||||
4337288|NCT00424593|4165240|B3|Netherlands||Region of Enrollment||participants|Number|44|44.0||||||
4337289|NCT00424593|4165241|B2|Netherlands||Region of Enrollment||participants|Number|25|25.0||||||
4337290|NCT00424593|4165242|B1|Netherlands||Region of Enrollment||participants|Number|19|19.0||||||
4337291|NCT00424593|4165240|B3|Brazil||Region of Enrollment||participants|Number|54|54.0||||||
4337292|NCT00424593|4165241|B2|Brazil||Region of Enrollment||participants|Number|29|29.0||||||
4337293|NCT00424593|4165242|B1|Brazil||Region of Enrollment||participants|Number|25|25.0||||||
4337294|NCT00424593|4165240|B3|Mexico||Region of Enrollment||participants|Number|43|43.0||||||
4337295|NCT00424593|4165241|B2|Mexico||Region of Enrollment||participants|Number|20|20.0||||||
4337296|NCT00424593|4165242|B1|Mexico||Region of Enrollment||participants|Number|23|23.0||||||
4337297|NCT00424593|4165240|B3|France||Region of Enrollment||participants|Number|23|23.0||||||
4337298|NCT00424593|4165241|B2|France||Region of Enrollment||participants|Number|12|12.0||||||
4337299|NCT00424593|4165242|B1|France||Region of Enrollment||participants|Number|11|11.0||||||
4337300|NCT00424593|4165240|B3||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4337301|NCT00424593|4165241|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4337302|NCT00424593|4165242|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4337303|NCT00424593|4165240|B3||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4337304|NCT00424593|4165241|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4337305|NCT00424593|4165242|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4337306|NCT00424593|4165240|B3|||Age||years|Mean|51.47|51.47|Standard Deviation|14.16|14.16|||
4337307|NCT00424593|4165241|B2|||Age||years|Mean|51.15|51.15|Standard Deviation|13.46|13.46|||
4337308|NCT00424593|4165242|B1|||Age||years|Mean|51.81|51.81|Standard Deviation|14.92|14.92|||
4337309|NCT00424554|4165287|B3|Canada||Region of Enrollment||participants|Number|40|40.0||||||
4337310|NCT00424554|4165288|B2|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4337311|NCT00424554|4165289|B1|Canada||Region of Enrollment||participants|Number|34|34.0||||||
4337312|NCT00424554|4165287|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4337313|NCT00424554|4165288|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4337314|NCT00424554|4165289|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4337315|NCT00424554|4165287|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4337316|NCT00424554|4165288|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4337317|NCT00424554|4165289|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4337318|NCT00424554|4165287|B3|||Age, Customized|Age range: 18-75 years|Participants|Number|40|40.0||||||
4337319|NCT00424554|4165288|B2|||Age, Customized|Age range: 18-75 years|Participants|Number|6|6.0||||||
4337320|NCT00424554|4165289|B1|||Age, Customized|Age range: 18-75 years|Participants|Number|34|34.0||||||
4337321|NCT00424528|4165304|B4|||Modified Medical Research Council Dyspnea Questionnaire|"The Dyspnea scale score reflects the highest numbered question to which the subject answered yes in a series of five questions, each describing progressively worse dyspnea. Scores range from 0 to 4, with a score of 4 indicating that a subject is too breathless to leave the house or becomes breathless when dressing or undressing."|units on a scale|Mean|2.8|2.8|Standard Deviation|0.6|0.6|||
4337322|NCT00424528|4165305|B3|||Modified Medical Research Council Dyspnea Questionnaire|"The Dyspnea scale score reflects the highest numbered question to which the subject answered yes in a series of five questions, each describing progressively worse dyspnea. Scores range from 0 to 4, with a score of 4 indicating that a subject is too breathless to leave the house or becomes breathless when dressing or undressing."|units on a scale|Mean|2.9|2.9|Standard Deviation|0.6|0.6|||
4337323|NCT00424528|4165306|B2|||Modified Medical Research Council Dyspnea Questionnaire|"The Dyspnea scale score reflects the highest numbered question to which the subject answered yes in a series of five questions, each describing progressively worse dyspnea. Scores range from 0 to 4, with a score of 4 indicating that a subject is too breathless to leave the house or becomes breathless when dressing or undressing."|units on a scale|Mean|2.9|2.9|Standard Deviation|0.7|0.7|||
4337324|NCT00424528|4165307|B1|||Modified Medical Research Council Dyspnea Questionnaire|"The Dyspnea scale score reflects the highest numbered question to which the subject answered yes in a series of five questions, each describing progressively worse dyspnea. Scores range from 0 to 4, with a score of 4 indicating that a subject is too breathless to leave the house or becomes breathless when dressing or undressing."|units on a scale|Mean|2.7|2.7|Standard Deviation|0.6|0.6|||
4337325|NCT00424528|4165304|B4|||Inspiratory Capacity||Liters|Mean|1.969|1.969|Standard Deviation|0.562|0.562|||
4337326|NCT00424528|4165305|B3|||Inspiratory Capacity||Liters|Mean|1.924|1.924|Standard Deviation|0.516|0.516|||
4337327|NCT00424528|4165306|B2|||Inspiratory Capacity||Liters|Mean|1.979|1.979|Standard Deviation|0.555|0.555|||
4337328|NCT00424528|4165307|B1|||Inspiratory Capacity||Liters|Mean|2.005|2.005|Standard Deviation|0.615|0.615|||
4337329|NCT00424528|4165304|B4|||FEV1 Percent Predicted||percent predicted of FEV1|Mean|45.4|45.4|Standard Deviation|11.8|11.8|||
4337330|NCT00424528|4165305|B3|||FEV1 Percent Predicted||percent predicted of FEV1|Mean|44.9|44.9|Standard Deviation|12.0|12.0|||
4337331|NCT00424528|4165306|B2|||FEV1 Percent Predicted||percent predicted of FEV1|Mean|45.7|45.7|Standard Deviation|11.5|11.5|||
4337332|NCT00424528|4165307|B1|||FEV1 Percent Predicted||percent predicted of FEV1|Mean|45.4|45.4|Standard Deviation|11.9|11.9|||
4337333|NCT00424528|4165304|B4|||FEV1||Liters|Mean|1.365|1.365|Standard Deviation|0.440|0.44|||
4337334|NCT00424528|4165305|B3|||FEV1||Liters|Mean|1.350|1.35|Standard Deviation|0.408|0.408|||
4337335|NCT00424528|4165306|B2|||FEV1||Liters|Mean|1.377|1.377|Standard Deviation|0.460|0.46|||
4337336|NCT00424528|4165307|B1|||FEV1||Liters|Mean|1.366|1.366|Standard Deviation|0.457|0.457|||
4337337|NCT00424528|4165304|B4|||Best Forced Expiratory Volume in one second (FEV1)/Best Forced Vital Capacity (FVC) ratio||Liters|Mean|0.516|0.516|Standard Deviation|0.104|0.104|||
4337338|NCT00424528|4165305|B3|||Best Forced Expiratory Volume in one second (FEV1)/Best Forced Vital Capacity (FVC) ratio||Liters|Mean|0.525|0.525|Standard Deviation|0.108|0.108|||
4337339|NCT00424528|4165306|B2|||Best Forced Expiratory Volume in one second (FEV1)/Best Forced Vital Capacity (FVC) ratio||Liters|Mean|0.514|0.514|Standard Deviation|0.107|0.107|||
4337340|NCT00424528|4165307|B1|||Best Forced Expiratory Volume in one second (FEV1)/Best Forced Vital Capacity (FVC) ratio||Liters|Mean|0.510|0.51|Standard Deviation|0.098|0.098|||
4337341|NCT00424528|4165304|B4|||Baseline Dyspnea Index (BDI) Focal Score|Baseline Dyspnea Index(range 0-12) is defined to be the sum of the Functional Impairment, Magnitude of Task, and Magnitude of Effort scores (each on a 0-4 scale) obtained at visit 2 (baseline. On each scale, a high measurement represents the most impairment to health.|units on a scale|Mean|5.7|5.7|Standard Deviation|2.0|2.0|||
4337342|NCT00424528|4165305|B3|||Baseline Dyspnea Index (BDI) Focal Score|Baseline Dyspnea Index(range 0-12) is defined to be the sum of the Functional Impairment, Magnitude of Task, and Magnitude of Effort scores (each on a 0-4 scale) obtained at visit 2 (baseline. On each scale, a high measurement represents the most impairment to health.|units on a scale|Mean|5.5|5.5|Standard Deviation|2.1|2.1|||
4337379|NCT00424528|4165306|B2|United States||Region of Enrollment||participants|Number|80|80.0||||||
4337343|NCT00424528|4165306|B2|||Baseline Dyspnea Index (BDI) Focal Score|Baseline Dyspnea Index(range 0-12) is defined to be the sum of the Functional Impairment, Magnitude of Task, and Magnitude of Effort scores (each on a 0-4 scale) obtained at visit 2 (baseline. On each scale, a high measurement represents the most impairment to health.|units on a scale|Mean|5.8|5.8|Standard Deviation|1.9|1.9|||
4337344|NCT00424528|4165307|B1|||Baseline Dyspnea Index (BDI) Focal Score|Baseline Dyspnea Index(range 0-12) is defined to be the sum of the Functional Impairment, Magnitude of Task, and Magnitude of Effort scores (each on a 0-4 scale) obtained at visit 2 (baseline. On each scale, a high measurement represents the most impairment to health.|units on a scale|Mean|5.8|5.8|Standard Deviation|2.0|2.0|||
4337345|NCT00424528|4165304|B4|Currently does not smoke||Packs per day currently smoked|Number of participants with a particular range of packs per day currently smoked.|Participants|Number|92|92.0||||||
4337346|NCT00424528|4165305|B3|Currently does not smoke||Packs per day currently smoked|Number of participants with a particular range of packs per day currently smoked.|Participants|Number|39|39.0||||||
4337347|NCT00424528|4165306|B2|Currently does not smoke||Packs per day currently smoked|Number of participants with a particular range of packs per day currently smoked.|Participants|Number|26|26.0||||||
4337348|NCT00424528|4165307|B1|Currently does not smoke||Packs per day currently smoked|Number of participants with a particular range of packs per day currently smoked.|Participants|Number|27|27.0||||||
4337349|NCT00424528|4165304|B4|>4 packs||Packs per day currently smoked|Number of participants with a particular range of packs per day currently smoked.|Participants|Number|0|0.0||||||
4337350|NCT00424528|4165305|B3|>4 packs||Packs per day currently smoked|Number of participants with a particular range of packs per day currently smoked.|Participants|Number|0|0.0||||||
4337351|NCT00424528|4165306|B2|>4 packs||Packs per day currently smoked|Number of participants with a particular range of packs per day currently smoked.|Participants|Number|0|0.0||||||
4337352|NCT00424528|4165307|B1|>4 packs||Packs per day currently smoked|Number of participants with a particular range of packs per day currently smoked.|Participants|Number|0|0.0||||||
4337353|NCT00424528|4165304|B4|>2 to 4 packs||Packs per day currently smoked|Number of participants with a particular range of packs per day currently smoked.|Participants|Number|4|4.0||||||
4337354|NCT00424528|4165305|B3|>2 to 4 packs||Packs per day currently smoked|Number of participants with a particular range of packs per day currently smoked.|Participants|Number|1|1.0||||||
4337355|NCT00424528|4165306|B2|>2 to 4 packs||Packs per day currently smoked|Number of participants with a particular range of packs per day currently smoked.|Participants|Number|0|0.0||||||
4337356|NCT00424528|4165307|B1|>2 to 4 packs||Packs per day currently smoked|Number of participants with a particular range of packs per day currently smoked.|Participants|Number|3|3.0||||||
4337357|NCT00424528|4165304|B4|>1 to 2 packs||Packs per day currently smoked|Number of participants with a particular range of packs per day currently smoked.|Participants|Number|62|62.0||||||
4337358|NCT00424528|4165305|B3|>1 to 2 packs||Packs per day currently smoked|Number of participants with a particular range of packs per day currently smoked.|Participants|Number|16|16.0||||||
4337359|NCT00424528|4165306|B2|>1 to 2 packs||Packs per day currently smoked|Number of participants with a particular range of packs per day currently smoked.|Participants|Number|24|24.0||||||
4337360|NCT00424528|4165307|B1|>1 to 2 packs||Packs per day currently smoked|Number of participants with a particular range of packs per day currently smoked.|Participants|Number|22|22.0||||||
4337361|NCT00424528|4165304|B4|>0 to 1 pack||Packs per day currently smoked|Number of participants with a particular range of packs per day currently smoked.|Participants|Number|76|76.0||||||
4337362|NCT00424528|4165305|B3|>0 to 1 pack||Packs per day currently smoked|Number of participants with a particular range of packs per day currently smoked.|Participants|Number|22|22.0||||||
4337363|NCT00424528|4165306|B2|>0 to 1 pack||Packs per day currently smoked|Number of participants with a particular range of packs per day currently smoked.|Participants|Number|30|30.0||||||
4337364|NCT00424528|4165307|B1|>0 to 1 pack||Packs per day currently smoked|Number of participants with a particular range of packs per day currently smoked.|Participants|Number|24|24.0||||||
4337365|NCT00424528|4165304|B4|>=30 years||Number of Pack Years Smoked|Number of participants with a particular range of pack years smoked.|Participants|Number|215|215.0||||||
4337366|NCT00424528|4165305|B3|>=30 years||Number of Pack Years Smoked|Number of participants with a particular range of pack years smoked.|Participants|Number|68|68.0||||||
4337367|NCT00424528|4165306|B2|>=30 years||Number of Pack Years Smoked|Number of participants with a particular range of pack years smoked.|Participants|Number|75|75.0||||||
4337368|NCT00424528|4165307|B1|>=30 years||Number of Pack Years Smoked|Number of participants with a particular range of pack years smoked.|Participants|Number|72|72.0||||||
4337369|NCT00424528|4165304|B4|>=25 years to <=30 years||Number of Pack Years Smoked|Number of participants with a particular range of pack years smoked.|Participants|Number|12|12.0||||||
4337370|NCT00424528|4165305|B3|>=25 years to <=30 years||Number of Pack Years Smoked|Number of participants with a particular range of pack years smoked.|Participants|Number|4|4.0||||||
4337371|NCT00424528|4165306|B2|>=25 years to <=30 years||Number of Pack Years Smoked|Number of participants with a particular range of pack years smoked.|Participants|Number|4|4.0||||||
4337372|NCT00424528|4165307|B1|>=25 years to <=30 years||Number of Pack Years Smoked|Number of participants with a particular range of pack years smoked.|Participants|Number|4|4.0||||||
4337373|NCT00424528|4165304|B4|>=15 years to <25 years||Number of Pack Years Smoked|Number of participants with a particular range of pack years smoked.|Participants|Number|7|7.0||||||
4337374|NCT00424528|4165305|B3|>=15 years to <25 years||Number of Pack Years Smoked|Number of participants with a particular range of pack years smoked.|Participants|Number|6|6.0||||||
4337375|NCT00424528|4165306|B2|>=15 years to <25 years||Number of Pack Years Smoked|Number of participants with a particular range of pack years smoked.|Participants|Number|1|1.0||||||
4337376|NCT00424528|4165307|B1|>=15 years to <25 years||Number of Pack Years Smoked|Number of participants with a particular range of pack years smoked.|Participants|Number|0|0.0||||||
4337377|NCT00424528|4165304|B4|United States||Region of Enrollment||participants|Number|234|234.0||||||
4337378|NCT00424528|4165305|B3|United States||Region of Enrollment||participants|Number|78|78.0||||||
4337380|NCT00424528|4165307|B1|United States||Region of Enrollment||participants|Number|76|76.0||||||
4337381|NCT00424528|4165304|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337382|NCT00424528|4165305|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337383|NCT00424528|4165306|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337384|NCT00424528|4165307|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337385|NCT00424528|4165304|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337386|NCT00424528|4165305|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337387|NCT00424528|4165306|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337388|NCT00424528|4165307|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337389|NCT00424528|4165304|B4||White|Race (NIH/OMB)||Participants|Count of Participants|215|215.0||||||
4337390|NCT00424528|4165305|B3||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4337391|NCT00424528|4165306|B2||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4337392|NCT00424528|4165307|B1||White|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
4337393|NCT00424528|4165304|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4337394|NCT00424528|4165305|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4337395|NCT00424528|4165306|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4337396|NCT00424528|4165307|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4337397|NCT00424528|4165304|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337398|NCT00424528|4165305|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337399|NCT00424528|4165306|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337400|NCT00424528|4165307|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337401|NCT00424528|4165304|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337402|NCT00424528|4165305|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337403|NCT00424528|4165306|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337404|NCT00424528|4165307|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337405|NCT00424528|4165304|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4337406|NCT00424528|4165305|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4337407|NCT00424528|4165306|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337408|NCT00424528|4165307|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337409|NCT00424528|4165304|B4||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4337410|NCT00424528|4165305|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4337411|NCT00424528|4165306|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4337412|NCT00424528|4165307|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4337413|NCT00424528|4165304|B4||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4337414|NCT00424528|4165305|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4337415|NCT00424528|4165306|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4337416|NCT00424528|4165307|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4337417|NCT00424528|4165304|B4|||Age||years|Mean|61.7|61.7|Standard Deviation|8.5|8.5|||
4337418|NCT00424528|4165305|B3|||Age||years|Mean|62.2|62.2|Standard Deviation|7.6|7.6|||
4337419|NCT00424528|4165306|B2|||Age||years|Mean|61.2|61.2|Standard Deviation|9.5|9.5|||
4337420|NCT00424528|4165307|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|8.4|8.4|||
4337421|NCT00424528|4165304|B4||>=65 years|Age||Participants|Count of Participants|85|85.0||||||
4337422|NCT00424528|4165305|B3||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4337423|NCT00424528|4165306|B2||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4337424|NCT00424528|4165307|B1||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4337425|NCT00424528|4165304|B4||Between 18 and 65 years|Age||Participants|Count of Participants|149|149.0||||||
4337426|NCT00424528|4165305|B3||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4337427|NCT00424528|4165306|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4337428|NCT00424528|4165307|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4337429|NCT00424528|4165304|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4337430|NCT00424528|4165305|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4337431|NCT00424528|4165306|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4337432|NCT00424528|4165307|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4337433|NCT00424515|4165362|B3|Chronically Sun-Damaged||Melanoma Type||participants|Number|1|1.0||||||
4337434|NCT00424515|4165363|B2|Chronically Sun-Damaged||Melanoma Type||participants|Number|0|0.0||||||
4337435|NCT00424515|4165364|B1|Chronically Sun-Damaged||Melanoma Type||participants|Number|1|1.0||||||
4337436|NCT00424515|4165362|B3|Mucosal||Melanoma Type||participants|Number|17|17.0||||||
4337437|NCT00424515|4165363|B2|Mucosal||Melanoma Type||participants|Number|11|11.0||||||
4337438|NCT00424515|4165364|B1|Mucosal||Melanoma Type||participants|Number|6|6.0||||||
4337439|NCT00424515|4165362|B3|Acral||Melanoma Type||participants|Number|6|6.0||||||
4337440|NCT00424515|4165363|B2|Acral||Melanoma Type||participants|Number|2|2.0||||||
4337441|NCT00424515|4165364|B1|Acral||Melanoma Type||participants|Number|4|4.0||||||
4337442|NCT00424515|4165362|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4337443|NCT00424515|4165363|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4337444|NCT00424515|4165364|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4337445|NCT00424515|4165362|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4337446|NCT00424515|4165363|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4337447|NCT00424515|4165364|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4337448|NCT00424515|4165362|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4337449|NCT00424515|4165363|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4337450|NCT00424515|4165364|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4337451|NCT00424515|4165362|B3|||Age||years|Median|65|65.0|Full Range|||42.0|84.0|
4337452|NCT00424515|4165363|B2|||Age||years|Median|64|64.0|Full Range|||42.0|80.0|
4337453|NCT00424515|4165364|B1|||Age||years|Median|69|69.0|Full Range|||55.0|84.0|
4337454|NCT00424502|4165375|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4337455|NCT00424502|4165375|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4337456|NCT00424502|4165375|B1|||Age||years|Mean|48.70|48.7|Standard Deviation|12.88|12.88|||
4337457|NCT00424489|4165384|B1|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4337458|NCT00424489|4165384|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4337459|NCT00424489|4165384|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4337460|NCT00424489|4165384|B1|||Age||years|Mean|45.22|45.22|Standard Deviation|16.49|16.49|||
4337461|NCT00424489|4165384|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4337462|NCT00424489|4165384|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4337463|NCT00424489|4165384|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4337464|NCT00424476|4165388|B4|Australia||Region of Enrollment||participants|Number|15|15.0||||||
4337465|NCT00424476|4165389|B3|Australia||Region of Enrollment||participants|Number|4|4.0||||||
4337466|NCT00424476|4165390|B2|Australia||Region of Enrollment||participants|Number|5|5.0||||||
4337467|NCT00424476|4165391|B1|Australia||Region of Enrollment||participants|Number|6|6.0||||||
4337468|NCT00424476|4165388|B4|Southeast Asia||Region of Enrollment||participants|Number|324|324.0||||||
4337469|NCT00424476|4165389|B3|Southeast Asia||Region of Enrollment||participants|Number|115|115.0||||||
4337470|NCT00424476|4165390|B2|Southeast Asia||Region of Enrollment||participants|Number|106|106.0||||||
4337471|NCT00424476|4165391|B1|Southeast Asia||Region of Enrollment||participants|Number|103|103.0||||||
4337472|NCT00424476|4165388|B4|South America||Region of Enrollment||participants|Number|428|428.0||||||
4337473|NCT00424476|4165389|B3|South America||Region of Enrollment||participants|Number|140|140.0||||||
4337474|NCT00424476|4165390|B2|South America||Region of Enrollment||participants|Number|143|143.0||||||
4337475|NCT00424476|4165391|B1|South America||Region of Enrollment||participants|Number|145|145.0||||||
4337476|NCT00424476|4165388|B4|Europe||Region of Enrollment||participants|Number|98|98.0||||||
4337477|NCT00424476|4165389|B3|Europe||Region of Enrollment||participants|Number|31|31.0||||||
4337478|NCT00424476|4165390|B2|Europe||Region of Enrollment||participants|Number|34|34.0||||||
4337479|NCT00424476|4165391|B1|Europe||Region of Enrollment||participants|Number|33|33.0||||||
4337480|NCT00424476|4165388|B4||Male|Gender||Participants|Count of Participants|44|44.0||||||
4337481|NCT00424476|4165389|B3||Male|Gender||Participants|Count of Participants|10|10.0||||||
4337482|NCT00424476|4165390|B2||Male|Gender||Participants|Count of Participants|17|17.0||||||
4337483|NCT00424476|4165391|B1||Male|Gender||Participants|Count of Participants|17|17.0||||||
4337484|NCT00424476|4165388|B4||Female|Gender||Participants|Count of Participants|821|821.0||||||
4337485|NCT00424476|4165389|B3||Female|Gender||Participants|Count of Participants|280|280.0||||||
4337486|NCT00424476|4165390|B2||Female|Gender||Participants|Count of Participants|271|271.0||||||
4337487|NCT00424476|4165391|B1||Female|Gender||Participants|Count of Participants|270|270.0||||||
4337488|NCT00424476|4165388|B4|≥ 65 years||Age, Customized||participants|Number|11|11.0||||||
4337489|NCT00424476|4165389|B3|≥ 65 years||Age, Customized||participants|Number|2|2.0||||||
4337490|NCT00424476|4165390|B2|≥ 65 years||Age, Customized||participants|Number|4|4.0||||||
4337491|NCT00424476|4165391|B1|≥ 65 years||Age, Customized||participants|Number|5|5.0||||||
4337492|NCT00424476|4165388|B4|Between 45 and 65 years||Age, Customized||participants|Number|157|157.0||||||
4337493|NCT00424476|4165389|B3|Between 45 and 65 years||Age, Customized||participants|Number|52|52.0||||||
4337494|NCT00424476|4165390|B2|Between 45 and 65 years||Age, Customized||participants|Number|48|48.0||||||
4337495|NCT00424476|4165391|B1|Between 45 and 65 years||Age, Customized||participants|Number|57|57.0||||||
4337496|NCT00424476|4165388|B4|≤ 45 years||Age, Customized||participants|Number|697|697.0||||||
4337497|NCT00424476|4165389|B3|≤ 45 years||Age, Customized||participants|Number|236|236.0||||||
4337498|NCT00424476|4165390|B2|≤ 45 years||Age, Customized||participants|Number|236|236.0||||||
4337499|NCT00424476|4165391|B1|≤ 45 years||Age, Customized||participants|Number|225|225.0||||||
4337500|NCT00424476|4165388|B4|||Age||years|Mean|35.5|35.5|Standard Deviation|11.1|11.1|||
4337501|NCT00424476|4165389|B3|||Age||years|Mean|35.4|35.4|Standard Deviation|10.8|10.8|||
4337502|NCT00424476|4165390|B2|||Age||years|Mean|35.0|35.0|Standard Deviation|10.6|10.6|||
4337503|NCT00424476|4165391|B1|||Age||years|Mean|36.2|36.2|Standard Deviation|11.8|11.8|||
4337504|NCT00424463|4165416|B4||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4337505|NCT00424463|4165417|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4337506|NCT00424463|4165418|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4337507|NCT00424463|4165419|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4337508|NCT00424463|4165416|B4||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4337509|NCT00424463|4165417|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4337510|NCT00424463|4165418|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4337511|NCT00424463|4165419|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4337512|NCT00424463|4165416|B4||>=65 years|Age||Participants|Count of Participants|52|52.0||||||
4337513|NCT00424463|4165417|B3||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4337514|NCT00424463|4165418|B2||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4337515|NCT00424463|4165419|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4337516|NCT00424463|4165416|B4||Between 18 and 65 years|Age||Participants|Count of Participants|129|129.0||||||
4337517|NCT00424463|4165417|B3||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4337518|NCT00424463|4165418|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4337519|NCT00424463|4165419|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4337520|NCT00424463|4165416|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4337521|NCT00424463|4165417|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4337522|NCT00424463|4165418|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4337523|NCT00424463|4165419|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4337524|NCT00424398|4165447|B4||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4337525|NCT00424398|4165448|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4337526|NCT00424398|4165449|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4337527|NCT00424398|4165450|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4337528|NCT00424398|4165447|B4||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4337529|NCT00424398|4165448|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4337530|NCT00424398|4165449|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4337531|NCT00424398|4165450|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4337532|NCT00424398|4165447|B4|||Age||years|Mean|41.7|41.7|Standard Deviation|14.3|14.3|||
4337533|NCT00424398|4165448|B3|||Age||years|Mean|39.9|39.9|Standard Deviation|15.2|15.2|||
4337534|NCT00424398|4165449|B2|||Age||years|Mean|40.9|40.9|Standard Deviation|11.4|11.4|||
4337535|NCT00424398|4165450|B1|||Age||years|Mean|44.3|44.3|Standard Deviation|16.0|16.0|||
4337536|NCT00424398|4165447|B4|>=18 years||Age, Customized||participants|Number|100|100.0||||||
4337537|NCT00424398|4165448|B3|>=18 years||Age, Customized||participants|Number|33|33.0||||||
4337538|NCT00424398|4165449|B2|>=18 years||Age, Customized||participants|Number|34|34.0||||||
4337539|NCT00424398|4165450|B1|>=18 years||Age, Customized||participants|Number|33|33.0||||||
4337540|NCT00424398|4165447|B4|<18 years||Age, Customized||participants|Number|7|7.0||||||
4337541|NCT00424398|4165448|B3|<18 years||Age, Customized||participants|Number|3|3.0||||||
4337542|NCT00424398|4165449|B2|<18 years||Age, Customized||participants|Number|2|2.0||||||
4337543|NCT00424398|4165450|B1|<18 years||Age, Customized||participants|Number|2|2.0||||||
4337544|NCT00424385|4165496|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4337545|NCT00424385|4165496|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4337546|NCT00424385|4165496|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4337547|NCT00424385|4165496|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4337548|NCT00424385|4165496|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4337549|NCT00424385|4165496|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4337550|NCT00424372|4165503|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4337551|NCT00424372|4165503|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4337552|NCT00424372|4165503|B1|>=65 years||Age, Customized||Subjects|Number|106|106.0||||||
4337553|NCT00424372|4165503|B1|>= 45 and < 65 years||Age, Customized||Subjects|Number|19|19.0||||||
4337554|NCT00424372|4165503|B1|>= 18 and < 45 years||Age, Customized||Subjects|Number|1|1.0||||||
4337555|NCT00424346|4165511|B5|Male||Gender|Demographics for the Extension study population. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 227.|participants|Number|42|42.0||||||
4337556|NCT00424346|4165512|B4|Male||Gender|Demographics for the Extension study population. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 227.|participants|Number|14|14.0||||||
4337557|NCT00424346|4165513|B3|Male||Gender|Demographics for the Extension study population. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 227.|participants|Number|12|12.0||||||
4337558|NCT00424346|4165514|B2|Male||Gender|Demographics for the Extension study population. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 227.|participants|Number|16|16.0||||||
4337559|NCT00424346|4165515|B1|Male||Gender|Demographics for the Extension study population. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 227.|participants|Number|0|0.0||||||
4337560|NCT00424346|4165511|B5|Female||Gender|Demographics for the Extension study population. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 227.|participants|Number|185|185.0||||||
4337561|NCT00424346|4165512|B4|Female||Gender|Demographics for the Extension study population. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 227.|participants|Number|44|44.0||||||
4337562|NCT00424346|4165513|B3|Female||Gender|Demographics for the Extension study population. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 227.|participants|Number|47|47.0||||||
4337563|NCT00424346|4165514|B2|Female||Gender|Demographics for the Extension study population. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 227.|participants|Number|94|94.0||||||
4337564|NCT00424346|4165515|B1|Female||Gender|Demographics for the Extension study population. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 227.|participants|Number|0|0.0||||||
4337565|NCT00424346|4165511|B5||Male|Sex: Female, Male|Demographics for the Core Study population.|Participants|Count of Participants|49|49.0||||||
4337566|NCT00424346|4165512|B4||Male|Sex: Female, Male|Demographics for the Core Study population.|Participants|Count of Participants|18|18.0||||||
4337567|NCT00424346|4165513|B3||Male|Sex: Female, Male|Demographics for the Core Study population.|Participants|Count of Participants|13|13.0||||||
4337568|NCT00424346|4165514|B2||Male|Sex: Female, Male|Demographics for the Core Study population.|Participants|Count of Participants|7|7.0||||||
4337569|NCT00424346|4165515|B1||Male|Sex: Female, Male|Demographics for the Core Study population.|Participants|Count of Participants|11|11.0||||||
4337570|NCT00424346|4165511|B5||Female|Sex: Female, Male|Demographics for the Core Study population.|Participants|Count of Participants|225|225.0||||||
4337571|NCT00424346|4165512|B4||Female|Sex: Female, Male|Demographics for the Core Study population.|Participants|Count of Participants|52|52.0||||||
4337572|NCT00424346|4165513|B3||Female|Sex: Female, Male|Demographics for the Core Study population.|Participants|Count of Participants|56|56.0||||||
4337573|NCT00424346|4165514|B2||Female|Sex: Female, Male|Demographics for the Core Study population.|Participants|Count of Participants|57|57.0||||||
4337574|NCT00424346|4165515|B1||Female|Sex: Female, Male|Demographics for the Core Study population.|Participants|Count of Participants|60|60.0||||||
4337575|NCT00424346|4165511|B5|≥75 years||Age, Customized|Demographics for the Extension study population. The number of participants in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 227.|participants|Number|16|16.0||||||
4337576|NCT00424346|4165512|B4|≥75 years||Age, Customized|Demographics for the Extension study population. The number of participants in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 227.|participants|Number|2|2.0||||||
4337577|NCT00424346|4165513|B3|≥75 years||Age, Customized|Demographics for the Extension study population. The number of participants in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 227.|participants|Number|2|2.0||||||
4337578|NCT00424346|4165514|B2|≥75 years||Age, Customized|Demographics for the Extension study population. The number of participants in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 227.|participants|Number|12|12.0||||||
4337579|NCT00424346|4165515|B1|≥75 years||Age, Customized|Demographics for the Extension study population. The number of participants in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 227.|participants|Number|NA|||||||This group did not exist in the extension studies, only in core.
4337580|NCT00424346|4165511|B5|≥65 - <75 years||Age, Customized|Demographics for the Extension study population. The number of participants in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 227.|participants|Number|49|49.0||||||
4337581|NCT00424346|4165512|B4|≥65 - <75 years||Age, Customized|Demographics for the Extension study population. The number of participants in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 227.|participants|Number|12|12.0||||||
4337582|NCT00424346|4165513|B3|≥65 - <75 years||Age, Customized|Demographics for the Extension study population. The number of participants in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 227.|participants|Number|12|12.0||||||
4337583|NCT00424346|4165514|B2|≥65 - <75 years||Age, Customized|Demographics for the Extension study population. The number of participants in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 227.|participants|Number|25|25.0||||||
4337584|NCT00424346|4165515|B1|≥65 - <75 years||Age, Customized|Demographics for the Extension study population. The number of participants in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 227.|participants|Number|NA|||||||This group did not exist in the extension studies, only in core.
4337585|NCT00424346|4165511|B5|≥41 - <65 years||Age, Customized|Demographics for the Extension study population. The number of participants in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 227.|participants|Number|143|143.0||||||
4337586|NCT00424346|4165512|B4|≥41 - <65 years||Age, Customized|Demographics for the Extension study population. The number of participants in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 227.|participants|Number|38|38.0||||||
4337587|NCT00424346|4165513|B3|≥41 - <65 years||Age, Customized|Demographics for the Extension study population. The number of participants in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 227.|participants|Number|39|39.0||||||
4337588|NCT00424346|4165514|B2|≥41 - <65 years||Age, Customized|Demographics for the Extension study population. The number of participants in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 227.|participants|Number|66|66.0||||||
4337589|NCT00424346|4165515|B1|≥41 - <65 years||Age, Customized|Demographics for the Extension study population. The number of participants in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 227.|participants|Number|NA|||||||This group did not exist in the extension studies, only in core.
4337590|NCT00424346|4165511|B5|≥18 - <41 years||Age, Customized|Demographics for the Extension study population. The number of participants in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 227.|participants|Number|19|19.0||||||
4337591|NCT00424346|4165512|B4|≥18 - <41 years||Age, Customized|Demographics for the Extension study population. The number of participants in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 227.|participants|Number|6|6.0||||||
4337592|NCT00424346|4165513|B3|≥18 - <41 years||Age, Customized|Demographics for the Extension study population. The number of participants in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 227.|participants|Number|6|6.0||||||
4337593|NCT00424346|4165514|B2|≥18 - <41 years||Age, Customized|Demographics for the Extension study population. The number of participants in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 227.|participants|Number|7|7.0||||||
4337594|NCT00424346|4165515|B1|≥18 - <41 years||Age, Customized|Demographics for the Extension study population. The number of participants in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 227.|participants|Number|NA|||||||This group did not exist in the extension studies, only in core.
4337595|NCT00424346|4165511|B5|≥75 years||Age, Customized|Demographics for the Core Study population. The number of patients in the core phase was 274.|participants|Number|22|22.0||||||
4337596|NCT00424346|4165512|B4|≥75 years||Age, Customized|Demographics for the Core Study population. The number of patients in the core phase was 274.|participants|Number|4|4.0||||||
4337597|NCT00424346|4165513|B3|≥75 years||Age, Customized|Demographics for the Core Study population. The number of patients in the core phase was 274.|participants|Number|3|3.0||||||
4337598|NCT00424346|4165514|B2|≥75 years||Age, Customized|Demographics for the Core Study population. The number of patients in the core phase was 274.|participants|Number|10|10.0||||||
4337599|NCT00424346|4165515|B1|≥75 years||Age, Customized|Demographics for the Core Study population. The number of patients in the core phase was 274.|participants|Number|5|5.0||||||
4337600|NCT00424346|4165511|B5|≥65 - <75 years||Age, Customized|Demographics for the Core Study population. The number of patients in the core phase was 274.|participants|Number|61|61.0||||||
4337601|NCT00424346|4165512|B4|≥65 - <75 years||Age, Customized|Demographics for the Core Study population. The number of patients in the core phase was 274.|participants|Number|16|16.0||||||
4337602|NCT00424346|4165513|B3|≥65 - <75 years||Age, Customized|Demographics for the Core Study population. The number of patients in the core phase was 274.|participants|Number|16|16.0||||||
4337603|NCT00424346|4165514|B2|≥65 - <75 years||Age, Customized|Demographics for the Core Study population. The number of patients in the core phase was 274.|participants|Number|18|18.0||||||
4337604|NCT00424346|4165515|B1|≥65 - <75 years||Age, Customized|Demographics for the Core Study population. The number of patients in the core phase was 274.|participants|Number|11|11.0||||||
4337605|NCT00424346|4165511|B5|≥41 - <65 years||Age, Customized|Demographics for the Core Study population. The number of patients in the core phase was 274.|participants|Number|167|167.0||||||
4337606|NCT00424346|4165512|B4|≥41 - <65 years||Age, Customized|Demographics for the Core Study population. The number of patients in the core phase was 274.|participants|Number|43|43.0||||||
4337607|NCT00424346|4165513|B3|≥41 - <65 years||Age, Customized|Demographics for the Core Study population. The number of patients in the core phase was 274.|participants|Number|43|43.0||||||
4337608|NCT00424346|4165514|B2|≥41 - <65 years||Age, Customized|Demographics for the Core Study population. The number of patients in the core phase was 274.|participants|Number|31|31.0||||||
4337609|NCT00424346|4165515|B1|≥41 - <65 years||Age, Customized|Demographics for the Core Study population. The number of patients in the core phase was 274.|participants|Number|50|50.0||||||
4337610|NCT00424346|4165511|B5|≥18 - <41 years||Age, Customized|Demographics for the Core Study population. The number of patients in the core phase was 274.|participants|Number|24|24.0||||||
4337611|NCT00424346|4165512|B4|≥18 - <41 years||Age, Customized|Demographics for the Core Study population. The number of patients in the core phase was 274.|participants|Number|7|7.0||||||
4337612|NCT00424346|4165513|B3|≥18 - <41 years||Age, Customized|Demographics for the Core Study population. The number of patients in the core phase was 274.|participants|Number|7|7.0||||||
4337613|NCT00424346|4165514|B2|≥18 - <41 years||Age, Customized|Demographics for the Core Study population. The number of patients in the core phase was 274.|participants|Number|5|5.0||||||
4337614|NCT00424346|4165515|B1|≥18 - <41 years||Age, Customized|Demographics for the Core Study population. The number of patients in the core phase was 274.|participants|Number|5|5.0||||||
4337615|NCT00424294|4165631|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4337616|NCT00424294|4165632|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4337617|NCT00424294|4165633|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4337618|NCT00424294|4165631|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4337619|NCT00424294|4165632|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4337620|NCT00424294|4165633|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4337621|NCT00424294|4165631|B3|||Age||years|Mean|55.9|55.9|Standard Deviation|12.2|12.2|||
4337622|NCT00424294|4165632|B2|||Age||years|Mean|57.7|57.7|Standard Deviation|12.7|12.7|||
4337623|NCT00424294|4165633|B1|||Age||years|Mean|54.1|54.1|Standard Deviation|11.6|11.6|||
4337624|NCT00424268|4165682|B3||Male|Gender||Participants|Count of Participants|529|529.0||||||
4337625|NCT00424268|4165683|B2||Male|Gender||Participants|Count of Participants|267|267.0||||||
4337626|NCT00424268|4165684|B1||Male|Gender||Participants|Count of Participants|262|262.0||||||
4337627|NCT00424268|4165682|B3||Female|Gender||Participants|Count of Participants|214|214.0||||||
4337628|NCT00424268|4165683|B2||Female|Gender||Participants|Count of Participants|105|105.0||||||
4337629|NCT00424268|4165684|B1||Female|Gender||Participants|Count of Participants|109|109.0||||||
4337630|NCT00424268|4165682|B3|||Age||years|Mean|64.1|64.1|Standard Deviation|9.2|9.2|||
4337631|NCT00424268|4165683|B2|||Age||years|Mean|64.0|64.0|Standard Deviation|9.3|9.3|||
4337632|NCT00424268|4165684|B1|||Age||years|Mean|64.2|64.2|Standard Deviation|9.1|9.1|||
4337633|NCT00424255|4165699|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|438|438.0||||||
4337634|NCT00424255|4165700|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|219|219.0||||||
4337635|NCT00424255|4165701|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|219|219.0||||||
4337636|NCT00424255|4165699|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4337637|NCT00424255|4165700|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4337638|NCT00424255|4165701|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4337639|NCT00424255|4165699|B3|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4337640|NCT00424255|4165700|B2|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4337641|NCT00424255|4165701|B1|Asian - Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4337642|NCT00424255|4165699|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|42|42.0||||||
4337643|NCT00424255|4165700|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
4337644|NCT00424255|4165701|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4337645|NCT00424255|4165699|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|88|88.0||||||
4337646|NCT00424255|4165700|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|47|47.0||||||
4337647|NCT00424255|4165701|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|41|41.0||||||
4337648|NCT00424255|4165699|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|114|114.0||||||
4337649|NCT00424255|4165700|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|53|53.0||||||
4337650|NCT00424255|4165701|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|61|61.0||||||
4337651|NCT00424255|4165699|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4337652|NCT00424255|4165700|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4337653|NCT00424255|4165701|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4337654|NCT00424255|4165699|B3||Male|Sex: Female, Male||Participants|Count of Participants|573|573.0||||||
4337655|NCT00424255|4165700|B2||Male|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
4337656|NCT00424255|4165701|B1||Male|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
4337657|NCT00424255|4165699|B3||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4337658|NCT00424255|4165700|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4337659|NCT00424255|4165701|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4337660|NCT00424255|4165699|B3|||Age||Years|Mean|53.8|53.8|Standard Deviation|9.14|9.14|||
4337661|NCT00424255|4165700|B2|||Age||Years|Mean|53.8|53.8|Standard Deviation|8.38|8.38|||
4337662|NCT00424255|4165701|B1|||Age||Years|Mean|53.7|53.7|Standard Deviation|9.85|9.85|||
4337663|NCT00424190|4165748|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|160|160.0||||||
4337664|NCT00424190|4165749|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
4337665|NCT00424190|4165750|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
4337666|NCT00424190|4165748|B3|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|538|538.0||||||
4337667|NCT00424190|4165749|B2|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|270|270.0||||||
4337668|NCT00424190|4165750|B1|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|268|268.0||||||
4337669|NCT00424190|4165748|B3||Male|Sex: Female, Male||Participants|Count of Participants|438|438.0||||||
4337670|NCT00424190|4165749|B2||Male|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4337671|NCT00424190|4165750|B1||Male|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
4337672|NCT00424190|4165748|B3||Female|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
4337673|NCT00424190|4165749|B2||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4337674|NCT00424190|4165750|B1||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4337675|NCT00424190|4165748|B3|>=18 years and < 65 years||Age, Customized||participants|Number|569|569.0||||||
4337676|NCT00424190|4165749|B2|>=18 years and < 65 years||Age, Customized||participants|Number|275|275.0||||||
4337677|NCT00424190|4165750|B1|>=18 years and < 65 years||Age, Customized||participants|Number|294|294.0||||||
4337678|NCT00424190|4165748|B3|<18 years||Age, Customized||participants|Number|0|0.0||||||
4337679|NCT00424190|4165749|B2|<18 years||Age, Customized||participants|Number|0|0.0||||||
4337680|NCT00424190|4165750|B1|<18 years||Age, Customized||participants|Number|0|0.0||||||
4337681|NCT00424190|4165748|B3|>=65 years||Age, Customized||participants|Number|129|129.0||||||
4337682|NCT00424190|4165749|B2|>=65 years||Age, Customized||participants|Number|72|72.0||||||
4337683|NCT00424190|4165750|B1|>=65 years||Age, Customized||participants|Number|57|57.0||||||
4337684|NCT00424190|4165748|B3|||Age||years|Mean|48.2|48.2|Standard Deviation|17.10|17.1|||
4337685|NCT00424190|4165749|B2|||Age||years|Mean|47.2|47.2|Standard Deviation|17.01|17.01|||
4337686|NCT00424190|4165750|B1|||Age||years|Mean|49.2|49.2|Standard Deviation|17.17|17.17|||
4337687|NCT00424177|4165757|B1|No||Use of Idiopathic Thrombocytopenic Purpura Medication at Baseline|Baseline Idiopathic Thrombocytopenic Purpura (ITP) Medication Use|participants|Number|44|44.0||||||
4337688|NCT00424177|4165757|B1|Yes||Use of Idiopathic Thrombocytopenic Purpura Medication at Baseline|Baseline Idiopathic Thrombocytopenic Purpura (ITP) Medication Use|participants|Number|22|22.0||||||
4337689|NCT00424177|4165757|B1|No||Baseline Splenectomy Status||participants|Number|46|46.0||||||
4337690|NCT00424177|4165757|B1|Yes||Baseline Splenectomy Status||participants|Number|20|20.0||||||
4337691|NCT00424177|4165757|B1|Greater than 50 Gi/L||Baseline Platelet Count|Baseline Platelet Count|participants|Number|2|2.0||||||
4337692|NCT00424177|4165757|B1|Greater than 30 Gi/L to 50 Gi/L||Baseline Platelet Count|Baseline Platelet Count|participants|Number|31|31.0||||||
4337693|NCT00424177|4165757|B1|20 Gi/L to 30 Gi/L||Baseline Platelet Count|Baseline Platelet Count|participants|Number|29|29.0||||||
4337694|NCT00424177|4165757|B1|Less than 20 giga per liter (Gi/L)||Baseline Platelet Count|Baseline Platelet Count|participants|Number|4|4.0||||||
4337695|NCT00424177|4165757|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4337696|NCT00424177|4165757|B1|African American/African||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4337697|NCT00424177|4165757|B1|White - Arabic/North African||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4337698|NCT00424177|4165757|B1|Asian - East Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4337699|NCT00424177|4165757|B1|White - White/Caucasian/European||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4337700|NCT00424177|4165757|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4337701|NCT00424177|4165757|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4337702|NCT00424177|4165757|B1|||Age||years|Mean|49.6|49.6|Standard Deviation|14.61|14.61|||
4337703|NCT00424047|4165784|B3|Stage III||Baseline multiple myeloma stage|"The International Staging System divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels.~Stage I: Serum beta-2 microglobulin is less than 3.5 (mg/L) and the albumin level is above 3.5 (g/L);~Stage II: Neither stage I or III, meaning that either:~The beta-2 microglobulin level is between 3.5 and 5.5 (with any albumin level), OR~The albumin is below 3.5 while the beta-2 microglobulin is less than 3.5~Stage III: Serum beta-2 microglobulin is greater than 5.5."|participants|Number|225|225.0||||||
4337704|NCT00424047|4165785|B2|Stage III||Baseline multiple myeloma stage|"The International Staging System divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels.~Stage I: Serum beta-2 microglobulin is less than 3.5 (mg/L) and the albumin level is above 3.5 (g/L);~Stage II: Neither stage I or III, meaning that either:~The beta-2 microglobulin level is between 3.5 and 5.5 (with any albumin level), OR~The albumin is below 3.5 while the beta-2 microglobulin is less than 3.5~Stage III: Serum beta-2 microglobulin is greater than 5.5."|participants|Number|110|110.0||||||
4337705|NCT00424047|4165786|B1|Stage III||Baseline multiple myeloma stage|"The International Staging System divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels.~Stage I: Serum beta-2 microglobulin is less than 3.5 (mg/L) and the albumin level is above 3.5 (g/L);~Stage II: Neither stage I or III, meaning that either:~The beta-2 microglobulin level is between 3.5 and 5.5 (with any albumin level), OR~The albumin is below 3.5 while the beta-2 microglobulin is less than 3.5~Stage III: Serum beta-2 microglobulin is greater than 5.5."|participants|Number|115|115.0||||||
4337706|NCT00424047|4165784|B3|Stage II||Baseline multiple myeloma stage|"The International Staging System divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels.~Stage I: Serum beta-2 microglobulin is less than 3.5 (mg/L) and the albumin level is above 3.5 (g/L);~Stage II: Neither stage I or III, meaning that either:~The beta-2 microglobulin level is between 3.5 and 5.5 (with any albumin level), OR~The albumin is below 3.5 while the beta-2 microglobulin is less than 3.5~Stage III: Serum beta-2 microglobulin is greater than 5.5."|participants|Number|107|107.0||||||
4337707|NCT00424047|4165785|B2|Stage II||Baseline multiple myeloma stage|"The International Staging System divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels.~Stage I: Serum beta-2 microglobulin is less than 3.5 (mg/L) and the albumin level is above 3.5 (g/L);~Stage II: Neither stage I or III, meaning that either:~The beta-2 microglobulin level is between 3.5 and 5.5 (with any albumin level), OR~The albumin is below 3.5 while the beta-2 microglobulin is less than 3.5~Stage III: Serum beta-2 microglobulin is greater than 5.5."|participants|Number|57|57.0||||||
4337708|NCT00424047|4165786|B1|Stage II||Baseline multiple myeloma stage|"The International Staging System divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels.~Stage I: Serum beta-2 microglobulin is less than 3.5 (mg/L) and the albumin level is above 3.5 (g/L);~Stage II: Neither stage I or III, meaning that either:~The beta-2 microglobulin level is between 3.5 and 5.5 (with any albumin level), OR~The albumin is below 3.5 while the beta-2 microglobulin is less than 3.5~Stage III: Serum beta-2 microglobulin is greater than 5.5."|participants|Number|50|50.0||||||
4337709|NCT00424047|4165784|B3|Stage I||Baseline multiple myeloma stage|"The International Staging System divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels.~Stage I: Serum beta-2 microglobulin is less than 3.5 (mg/L) and the albumin level is above 3.5 (g/L);~Stage II: Neither stage I or III, meaning that either:~The beta-2 microglobulin level is between 3.5 and 5.5 (with any albumin level), OR~The albumin is below 3.5 while the beta-2 microglobulin is less than 3.5~Stage III: Serum beta-2 microglobulin is greater than 5.5."|participants|Number|19|19.0||||||
4337710|NCT00424047|4165785|B2|Stage I||Baseline multiple myeloma stage|"The International Staging System divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels.~Stage I: Serum beta-2 microglobulin is less than 3.5 (mg/L) and the albumin level is above 3.5 (g/L);~Stage II: Neither stage I or III, meaning that either:~The beta-2 microglobulin level is between 3.5 and 5.5 (with any albumin level), OR~The albumin is below 3.5 while the beta-2 microglobulin is less than 3.5~Stage III: Serum beta-2 microglobulin is greater than 5.5."|participants|Number|8|8.0||||||
4337711|NCT00424047|4165786|B1|Stage I||Baseline multiple myeloma stage|"The International Staging System divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels.~Stage I: Serum beta-2 microglobulin is less than 3.5 (mg/L) and the albumin level is above 3.5 (g/L);~Stage II: Neither stage I or III, meaning that either:~The beta-2 microglobulin level is between 3.5 and 5.5 (with any albumin level), OR~The albumin is below 3.5 while the beta-2 microglobulin is less than 3.5~Stage III: Serum beta-2 microglobulin is greater than 5.5."|participants|Number|11|11.0||||||
4337712|NCT00424047|4165784|B3|||Time from First Pathological Diagnosis||years|Median|3.7|3.7|Full Range|||0.3|26.6|
4337713|NCT00424047|4165785|B2|||Time from First Pathological Diagnosis||years|Median|4.0|4.0|Full Range|||0.3|26.6|
4337714|NCT00424047|4165786|B1|||Time from First Pathological Diagnosis||years|Median|3.4|3.4|Full Range|||0.4|15.7|
4337715|NCT00424047|4165784|B3|2 or more prior anti-myeloma therapies||Number of Prior Anti-Myeloma Therapies||participants|Number|238|238.0||||||
4337716|NCT00424047|4165785|B2|2 or more prior anti-myeloma therapies||Number of Prior Anti-Myeloma Therapies||participants|Number|118|118.0||||||
4337717|NCT00424047|4165786|B1|2 or more prior anti-myeloma therapies||Number of Prior Anti-Myeloma Therapies||participants|Number|120|120.0||||||
4337718|NCT00424047|4165784|B3|1 Prior anti-myeloma therapy||Number of Prior Anti-Myeloma Therapies||participants|Number|113|113.0||||||
4337719|NCT00424047|4165785|B2|1 Prior anti-myeloma therapy||Number of Prior Anti-Myeloma Therapies||participants|Number|57|57.0||||||
4337720|NCT00424047|4165786|B1|1 Prior anti-myeloma therapy||Number of Prior Anti-Myeloma Therapies||participants|Number|56|56.0||||||
4337721|NCT00424047|4165784|B3|Missing||Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants' disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.|participants|Number|6|6.0||||||
4337722|NCT00424047|4165785|B2|Missing||Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants' disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.|participants|Number|3|3.0||||||
4337723|NCT00424047|4165786|B1|Missing||Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants' disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.|participants|Number|3|3.0||||||
4337724|NCT00424047|4165784|B3|4 = (Completely Disabled)||Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants' disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.|participants|Number|0|0.0||||||
4337725|NCT00424047|4165785|B2|4 = (Completely Disabled)||Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants' disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.|participants|Number|0|0.0||||||
4337726|NCT00424047|4165786|B1|4 = (Completely Disabled)||Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants' disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.|participants|Number|0|0.0||||||
4337727|NCT00424047|4165784|B3|3 = (Limited Self-Care)||Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants' disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.|participants|Number|1|1.0||||||
4337728|NCT00424047|4165785|B2|3 = (Limited Self-Care)||Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants' disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.|participants|Number|1|1.0||||||
4337729|NCT00424047|4165786|B1|3 = (Limited Self-Care)||Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants' disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.|participants|Number|0|0.0||||||
4337730|NCT00424047|4165784|B3|2 = Ambulatory unable to Work)||Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants' disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.|participants|Number|50|50.0||||||
4337731|NCT00424047|4165785|B2|2 = Ambulatory unable to Work)||Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants' disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.|participants|Number|27|27.0||||||
4337732|NCT00424047|4165786|B1|2 = Ambulatory unable to Work)||Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants' disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.|participants|Number|23|23.0||||||
4337733|NCT00424047|4165784|B3|1 = (Restrictive but Ambulatory)||Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants' disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.|participants|Number|151|151.0||||||
4337828|NCT00424021|4165815|B5|Hispanic||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4337734|NCT00424047|4165785|B2|1 = (Restrictive but Ambulatory)||Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants' disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.|participants|Number|79|79.0||||||
4337735|NCT00424047|4165786|B1|1 = (Restrictive but Ambulatory)||Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants' disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.|participants|Number|72|72.0||||||
4337736|NCT00424047|4165784|B3|0 = (Fully Active)||Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants' disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.|participants|Number|143|143.0||||||
4337737|NCT00424047|4165785|B2|0 = (Fully Active)||Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants' disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.|participants|Number|65|65.0||||||
4337738|NCT00424047|4165786|B1|0 = (Fully Active)||Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participants' disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis.|participants|Number|78|78.0||||||
4337739|NCT00424047|4165784|B3||Male|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4337740|NCT00424047|4165785|B2||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4337741|NCT00424047|4165786|B1||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4337742|NCT00424047|4165784|B3||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4337743|NCT00424047|4165785|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4337744|NCT00424047|4165786|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4337745|NCT00424047|4165784|B3|||Age||years|Mean|62.6|62.6|Standard Deviation|9.47|9.47|||
4337746|NCT00424047|4165785|B2|||Age||years|Mean|62.9|62.9|Standard Deviation|8.80|8.8|||
4337747|NCT00424047|4165786|B1|||Age||years|Mean|62.2|62.2|Standard Deviation|10.12|10.12|||
4337748|NCT00424021|4165815|B5|||Weight|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Kilograms|Mean|74.2|74.2|Standard Deviation|18.51|18.51|||
4337749|NCT00424021|4165816|B4|||Weight|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Kilograms|Mean|76.1|76.1|Standard Deviation|17.96|17.96|||
4337750|NCT00424021|4165817|B3|||Weight|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Kilograms|Mean|74.6|74.6|Standard Deviation|21.32|21.32|||
4337751|NCT00424021|4165818|B2|||Weight|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Kilograms|Mean|68.1|68.1|Standard Deviation|14.97|14.97|||
4337752|NCT00424021|4165819|B1|||Weight|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Kilograms|Mean|66.0|66.0|Standard Deviation|8.49|8.49|||
4337753|NCT00424021|4165815|B5|||Height|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Centimeters|Mean|163.7|163.7|Standard Deviation|9.42|9.42|||
4337754|NCT00424021|4165816|B4|||Height|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Centimeters|Mean|164.5|164.5|Standard Deviation|10.03|10.03|||
4337755|NCT00424021|4165817|B3|||Height|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Centimeters|Mean|163.1|163.1|Standard Deviation|8.07|8.07|||
4337756|NCT00424021|4165818|B2|||Height|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Centimeters|Mean|160.6|160.6|Standard Deviation|11.84|11.84|||
4337757|NCT00424021|4165819|B1|||Height|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Centimeters|Mean|169.8|169.8|Standard Deviation|3.11|3.11|||
4337758|NCT00424021|4165815|B5|Other||Primary Diagnosis|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Number|3|3.0||||||
4337759|NCT00424021|4165816|B4|Other||Primary Diagnosis|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Number|1|1.0||||||
4337760|NCT00424021|4165817|B3|Other||Primary Diagnosis|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Number|2|2.0||||||
4337761|NCT00424021|4165818|B2|Other||Primary Diagnosis|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Number|0|0.0||||||
4337762|NCT00424021|4165819|B1|Other||Primary Diagnosis|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Number|0|0.0||||||
4337763|NCT00424021|4165815|B5|Human immunodeficiency virus (HIV) Infection||Primary Diagnosis|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Number|2|2.0||||||
4337764|NCT00424021|4165816|B4|Human immunodeficiency virus (HIV) Infection||Primary Diagnosis|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Number|0|0.0||||||
4337765|NCT00424021|4165817|B3|Human immunodeficiency virus (HIV) Infection||Primary Diagnosis|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Number|0|0.0||||||
4337766|NCT00424021|4165818|B2|Human immunodeficiency virus (HIV) Infection||Primary Diagnosis|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Number|1|1.0||||||
4337767|NCT00424021|4165819|B1|Human immunodeficiency virus (HIV) Infection||Primary Diagnosis|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Number|1|1.0||||||
4337768|NCT00424021|4165815|B5|Anorexigen Use||Primary Diagnosis|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Number|4|4.0||||||
4337769|NCT00424021|4165816|B4|Anorexigen Use||Primary Diagnosis|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Number|2|2.0||||||
4337770|NCT00424021|4165817|B3|Anorexigen Use||Primary Diagnosis|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Number|2|2.0||||||
4337771|NCT00424021|4165818|B2|Anorexigen Use||Primary Diagnosis|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Number|0|0.0||||||
4337772|NCT00424021|4165819|B1|Anorexigen Use||Primary Diagnosis|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Number|0|0.0||||||
4337773|NCT00424021|4165815|B5|Overlap Syndrome||Primary Diagnosis|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Number|1|1.0||||||
4337774|NCT00424021|4165816|B4|Overlap Syndrome||Primary Diagnosis|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Number|1|1.0||||||
4337775|NCT00424021|4165817|B3|Overlap Syndrome||Primary Diagnosis|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Number|0|0.0||||||
4337776|NCT00424021|4165818|B2|Overlap Syndrome||Primary Diagnosis|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Number|0|0.0||||||
4337777|NCT00424021|4165819|B1|Overlap Syndrome||Primary Diagnosis|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Number|0|0.0||||||
4337778|NCT00424021|4165815|B5|Systemic Sclerosis||Primary Diagnosis|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Number|3|3.0||||||
4337779|NCT00424021|4165816|B4|Systemic Sclerosis||Primary Diagnosis|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Number|0|0.0||||||
4337780|NCT00424021|4165817|B3|Systemic Sclerosis||Primary Diagnosis|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Number|2|2.0||||||
4337781|NCT00424021|4165818|B2|Systemic Sclerosis||Primary Diagnosis|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Number|0|0.0||||||
4337782|NCT00424021|4165819|B1|Systemic Sclerosis||Primary Diagnosis|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Number|1|1.0||||||
4337783|NCT00424021|4165815|B5|Systemic Lupus Erythematosus||Primary Diagnosis|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Number|2|2.0||||||
4337784|NCT00424021|4165816|B4|Systemic Lupus Erythematosus||Primary Diagnosis|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Number|2|2.0||||||
4337785|NCT00424021|4165817|B3|Systemic Lupus Erythematosus||Primary Diagnosis|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Number|0|0.0||||||
4337786|NCT00424021|4165818|B2|Systemic Lupus Erythematosus||Primary Diagnosis|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Number|0|0.0||||||
4337787|NCT00424021|4165819|B1|Systemic Lupus Erythematosus||Primary Diagnosis|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Number|0|0.0||||||
4337788|NCT00424021|4165815|B5|Mixed Connective Tissue Disease||Primary Diagnosis|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Number|7|7.0||||||
4337789|NCT00424021|4165816|B4|Mixed Connective Tissue Disease||Primary Diagnosis|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Number|5|5.0||||||
4337790|NCT00424021|4165817|B3|Mixed Connective Tissue Disease||Primary Diagnosis|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Number|1|1.0||||||
4337791|NCT00424021|4165818|B2|Mixed Connective Tissue Disease||Primary Diagnosis|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Number|1|1.0||||||
4337792|NCT00424021|4165819|B1|Mixed Connective Tissue Disease||Primary Diagnosis|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Number|0|0.0||||||
4337793|NCT00424021|4165815|B5|Idiopathic Pulmonary Arterial Hypertension||Primary Diagnosis|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Number|32|32.0||||||
4337794|NCT00424021|4165816|B4|Idiopathic Pulmonary Arterial Hypertension||Primary Diagnosis|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Number|15|15.0||||||
4337795|NCT00424021|4165817|B3|Idiopathic Pulmonary Arterial Hypertension||Primary Diagnosis|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Number|12|12.0||||||
4337796|NCT00424021|4165818|B2|Idiopathic Pulmonary Arterial Hypertension||Primary Diagnosis|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Number|5|5.0||||||
4337797|NCT00424021|4165819|B1|Idiopathic Pulmonary Arterial Hypertension||Primary Diagnosis|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Number|0|0.0||||||
4337829|NCT00424021|4165816|B4|Hispanic||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4337830|NCT00424021|4165817|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4337831|NCT00424021|4165818|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4337798|NCT00424021|4165815|B5|III||World Health Organization Class|Classes: I) pulmonary hypertension (PH); ordinary physical activity not limited or causes increased dyspnea, fatigue, chest pain, or presyncope. II) PH; ordinary physical activity mildly limited and causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. III) PH; physical activity markedly limited and less than ordinary physical activity causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. IV) PH; physical activity causes symptoms; signs of right heart failure; dyspnea/fatigue possibly at rest.|Participants|Number|19|19.0||||||
4337799|NCT00424021|4165816|B4|III||World Health Organization Class|Classes: I) pulmonary hypertension (PH); ordinary physical activity not limited or causes increased dyspnea, fatigue, chest pain, or presyncope. II) PH; ordinary physical activity mildly limited and causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. III) PH; physical activity markedly limited and less than ordinary physical activity causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. IV) PH; physical activity causes symptoms; signs of right heart failure; dyspnea/fatigue possibly at rest.|Participants|Number|9|9.0||||||
4337800|NCT00424021|4165817|B3|III||World Health Organization Class|Classes: I) pulmonary hypertension (PH); ordinary physical activity not limited or causes increased dyspnea, fatigue, chest pain, or presyncope. II) PH; ordinary physical activity mildly limited and causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. III) PH; physical activity markedly limited and less than ordinary physical activity causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. IV) PH; physical activity causes symptoms; signs of right heart failure; dyspnea/fatigue possibly at rest.|Participants|Number|8|8.0||||||
4337801|NCT00424021|4165818|B2|III||World Health Organization Class|Classes: I) pulmonary hypertension (PH); ordinary physical activity not limited or causes increased dyspnea, fatigue, chest pain, or presyncope. II) PH; ordinary physical activity mildly limited and causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. III) PH; physical activity markedly limited and less than ordinary physical activity causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. IV) PH; physical activity causes symptoms; signs of right heart failure; dyspnea/fatigue possibly at rest.|Participants|Number|1|1.0||||||
4337802|NCT00424021|4165819|B1|III||World Health Organization Class|Classes: I) pulmonary hypertension (PH); ordinary physical activity not limited or causes increased dyspnea, fatigue, chest pain, or presyncope. II) PH; ordinary physical activity mildly limited and causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. III) PH; physical activity markedly limited and less than ordinary physical activity causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. IV) PH; physical activity causes symptoms; signs of right heart failure; dyspnea/fatigue possibly at rest.|Participants|Number|1|1.0||||||
4337803|NCT00424021|4165815|B5|II||World Health Organization Class|Classes: I) pulmonary hypertension (PH); ordinary physical activity not limited or causes increased dyspnea, fatigue, chest pain, or presyncope. II) PH; ordinary physical activity mildly limited and causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. III) PH; physical activity markedly limited and less than ordinary physical activity causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. IV) PH; physical activity causes symptoms; signs of right heart failure; dyspnea/fatigue possibly at rest.|Participants|Number|27|27.0||||||
4337804|NCT00424021|4165816|B4|II||World Health Organization Class|Classes: I) pulmonary hypertension (PH); ordinary physical activity not limited or causes increased dyspnea, fatigue, chest pain, or presyncope. II) PH; ordinary physical activity mildly limited and causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. III) PH; physical activity markedly limited and less than ordinary physical activity causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. IV) PH; physical activity causes symptoms; signs of right heart failure; dyspnea/fatigue possibly at rest.|Participants|Number|13|13.0||||||
4337805|NCT00424021|4165817|B3|II||World Health Organization Class|Classes: I) pulmonary hypertension (PH); ordinary physical activity not limited or causes increased dyspnea, fatigue, chest pain, or presyncope. II) PH; ordinary physical activity mildly limited and causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. III) PH; physical activity markedly limited and less than ordinary physical activity causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. IV) PH; physical activity causes symptoms; signs of right heart failure; dyspnea/fatigue possibly at rest.|Participants|Number|11|11.0||||||
4337806|NCT00424021|4165818|B2|II||World Health Organization Class|Classes: I) pulmonary hypertension (PH); ordinary physical activity not limited or causes increased dyspnea, fatigue, chest pain, or presyncope. II) PH; ordinary physical activity mildly limited and causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. III) PH; physical activity markedly limited and less than ordinary physical activity causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. IV) PH; physical activity causes symptoms; signs of right heart failure; dyspnea/fatigue possibly at rest.|Participants|Number|3|3.0||||||
4337807|NCT00424021|4165819|B1|II||World Health Organization Class|Classes: I) pulmonary hypertension (PH); ordinary physical activity not limited or causes increased dyspnea, fatigue, chest pain, or presyncope. II) PH; ordinary physical activity mildly limited and causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. III) PH; physical activity markedly limited and less than ordinary physical activity causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. IV) PH; physical activity causes symptoms; signs of right heart failure; dyspnea/fatigue possibly at rest.|Participants|Number|0|0.0||||||
4337808|NCT00424021|4165815|B5|I||World Health Organization Class|Classes: I) pulmonary hypertension (PH); ordinary physical activity not limited or causes increased dyspnea, fatigue, chest pain, or presyncope. II) PH; ordinary physical activity mildly limited and causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. III) PH; physical activity markedly limited and less than ordinary physical activity causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. IV) PH; physical activity causes symptoms; signs of right heart failure; dyspnea/fatigue possibly at rest.|Participants|Number|8|8.0||||||
4337832|NCT00424021|4165819|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4337833|NCT00424021|4165815|B5|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4337834|NCT00424021|4165816|B4|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4337835|NCT00424021|4165817|B3|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4337809|NCT00424021|4165816|B4|I||World Health Organization Class|Classes: I) pulmonary hypertension (PH); ordinary physical activity not limited or causes increased dyspnea, fatigue, chest pain, or presyncope. II) PH; ordinary physical activity mildly limited and causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. III) PH; physical activity markedly limited and less than ordinary physical activity causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. IV) PH; physical activity causes symptoms; signs of right heart failure; dyspnea/fatigue possibly at rest.|Participants|Number|4|4.0||||||
4337810|NCT00424021|4165817|B3|I||World Health Organization Class|Classes: I) pulmonary hypertension (PH); ordinary physical activity not limited or causes increased dyspnea, fatigue, chest pain, or presyncope. II) PH; ordinary physical activity mildly limited and causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. III) PH; physical activity markedly limited and less than ordinary physical activity causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. IV) PH; physical activity causes symptoms; signs of right heart failure; dyspnea/fatigue possibly at rest.|Participants|Number|0|0.0||||||
4337811|NCT00424021|4165818|B2|I||World Health Organization Class|Classes: I) pulmonary hypertension (PH); ordinary physical activity not limited or causes increased dyspnea, fatigue, chest pain, or presyncope. II) PH; ordinary physical activity mildly limited and causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. III) PH; physical activity markedly limited and less than ordinary physical activity causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. IV) PH; physical activity causes symptoms; signs of right heart failure; dyspnea/fatigue possibly at rest.|Participants|Number|3|3.0||||||
4337812|NCT00424021|4165819|B1|I||World Health Organization Class|Classes: I) pulmonary hypertension (PH); ordinary physical activity not limited or causes increased dyspnea, fatigue, chest pain, or presyncope. II) PH; ordinary physical activity mildly limited and causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. III) PH; physical activity markedly limited and less than ordinary physical activity causes increased dyspnea, fatigue, chest pain, or presyncope; comfortable at rest. IV) PH; physical activity causes symptoms; signs of right heart failure; dyspnea/fatigue possibly at rest.|Participants|Number|1|1.0||||||
4337813|NCT00424021|4165815|B5|||Borg Dyspnea Index|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319). Borg Dyspnea Index, a measure of perceived shortness of breath: 0 units on a scale (none) to 10 units on a scale (maximum breathlessness). N=24 for the 10-mg group and N=52 for the combined ambrisentan group.|Score|Mean|2.7|2.7|Standard Deviation|1.76|1.76|||
4337814|NCT00424021|4165816|B4|||Borg Dyspnea Index|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319). Borg Dyspnea Index, a measure of perceived shortness of breath: 0 units on a scale (none) to 10 units on a scale (maximum breathlessness). N=24 for the 10-mg group and N=52 for the combined ambrisentan group.|Score|Mean|2.9|2.9|Standard Deviation|1.81|1.81|||
4337815|NCT00424021|4165817|B3|||Borg Dyspnea Index|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319). Borg Dyspnea Index, a measure of perceived shortness of breath: 0 units on a scale (none) to 10 units on a scale (maximum breathlessness). N=24 for the 10-mg group and N=52 for the combined ambrisentan group.|Score|Mean|2.8|2.8|Standard Deviation|1.77|1.77|||
4337816|NCT00424021|4165818|B2|||Borg Dyspnea Index|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319). Borg Dyspnea Index, a measure of perceived shortness of breath: 0 units on a scale (none) to 10 units on a scale (maximum breathlessness). N=24 for the 10-mg group and N=52 for the combined ambrisentan group.|Score|Mean|1.6|1.6|Standard Deviation|1.65|1.65|||
4337817|NCT00424021|4165819|B1|||Borg Dyspnea Index|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319). Borg Dyspnea Index, a measure of perceived shortness of breath: 0 units on a scale (none) to 10 units on a scale (maximum breathlessness). N=24 for the 10-mg group and N=52 for the combined ambrisentan group.|Score|Mean|2.5|2.5|Standard Deviation|0.71|0.71|||
4337818|NCT00424021|4165815|B5|||6-minute Walk Distance|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319). N=24 for the 10-mg group and N=52 for the combined ambrisentan group.|Meters|Mean|406.9|406.9|Standard Deviation|98.56|98.56|||
4337819|NCT00424021|4165816|B4|||6-minute Walk Distance|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319). N=24 for the 10-mg group and N=52 for the combined ambrisentan group.|Meters|Mean|410.7|410.7|Standard Deviation|93.79|93.79|||
4337820|NCT00424021|4165817|B3|||6-minute Walk Distance|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319). N=24 for the 10-mg group and N=52 for the combined ambrisentan group.|Meters|Mean|398.8|398.8|Standard Deviation|111.56|111.56|||
4337821|NCT00424021|4165818|B2|||6-minute Walk Distance|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319). N=24 for the 10-mg group and N=52 for the combined ambrisentan group.|Meters|Mean|400.4|400.4|Standard Deviation|85.13|85.13|||
4337822|NCT00424021|4165819|B1|||6-minute Walk Distance|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319). N=24 for the 10-mg group and N=52 for the combined ambrisentan group.|Meters|Mean|462.0|462.0|Standard Deviation|132.94|132.94|||
4337823|NCT00424021|4165815|B5|||Years Pulmonary Arterial Hypertension (PAH) Present|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Years|Mean|3.9|3.9|Standard Deviation|4.07|4.07|||
4337824|NCT00424021|4165816|B4|||Years Pulmonary Arterial Hypertension (PAH) Present|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Years|Mean|4.8|4.8|Standard Deviation|4.81|4.81|||
4337825|NCT00424021|4165817|B3|||Years Pulmonary Arterial Hypertension (PAH) Present|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Years|Mean|2.7|2.7|Standard Deviation|2.91|2.91|||
4337826|NCT00424021|4165818|B2|||Years Pulmonary Arterial Hypertension (PAH) Present|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Years|Mean|4.4|4.4|Standard Deviation|3.87|3.87|||
4337827|NCT00424021|4165819|B1|||Years Pulmonary Arterial Hypertension (PAH) Present|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Years|Mean|2.0|2.0|Standard Deviation|0.00|0.0|||
4337836|NCT00424021|4165818|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4337837|NCT00424021|4165819|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4337838|NCT00424021|4165815|B5|Black||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4337839|NCT00424021|4165816|B4|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4337840|NCT00424021|4165817|B3|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4337841|NCT00424021|4165818|B2|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4337842|NCT00424021|4165819|B1|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4337843|NCT00424021|4165815|B5|Caucasian||Race/Ethnicity, Customized||Participants|Number|39|39.0||||||
4337844|NCT00424021|4165816|B4|Caucasian||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
4337845|NCT00424021|4165817|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4337846|NCT00424021|4165818|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4337847|NCT00424021|4165819|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4337848|NCT00424021|4165815|B5||Male|Sex: Female, Male|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Count of Participants|8|8.0||||||
4337849|NCT00424021|4165816|B4||Male|Sex: Female, Male|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Count of Participants|4|4.0||||||
4337850|NCT00424021|4165817|B3||Male|Sex: Female, Male|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Count of Participants|2|2.0||||||
4337851|NCT00424021|4165818|B2||Male|Sex: Female, Male|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Count of Participants|1|1.0||||||
4337852|NCT00424021|4165819|B1||Male|Sex: Female, Male|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Count of Participants|1|1.0||||||
4337853|NCT00424021|4165815|B5||Female|Sex: Female, Male|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Count of Participants|46|46.0||||||
4337854|NCT00424021|4165816|B4||Female|Sex: Female, Male|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Count of Participants|22|22.0||||||
4337855|NCT00424021|4165817|B3||Female|Sex: Female, Male|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Count of Participants|17|17.0||||||
4337856|NCT00424021|4165818|B2||Female|Sex: Female, Male|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Count of Participants|6|6.0||||||
4337857|NCT00424021|4165819|B1||Female|Sex: Female, Male|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|Participants|Count of Participants|1|1.0||||||
4337858|NCT00424021|4165815|B5|||Age|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|years|Mean|51.1|51.1|Standard Deviation|15.33|15.33|||
4337859|NCT00424021|4165816|B4|||Age|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|years|Mean|49.0|49.0|Standard Deviation|15.59|15.59|||
4337860|NCT00424021|4165817|B3|||Age|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|years|Mean|56.7|56.7|Standard Deviation|13.48|13.48|||
4337861|NCT00424021|4165818|B2|||Age|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|years|Mean|43.0|43.0|Standard Deviation|17.18|17.18|||
4337862|NCT00424021|4165819|B1|||Age|Baseline represents the beginning of the current extension study (ie, Week 24 of the parent study, NCT00046319).|years|Mean|54.0|54.0|Standard Deviation|12.73|12.73|||
4337863|NCT00424008|4165863|B3||Male|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
4337864|NCT00424008|4165864|B2||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4337865|NCT00424008|4165865|B1||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4337866|NCT00424008|4165863|B3||Female|Sex: Female, Male||Participants|Count of Participants|459|459.0||||||
4337867|NCT00424008|4165864|B2||Female|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
4337868|NCT00424008|4165865|B1||Female|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
4337869|NCT00424008|4165863|B3|>=65 years||Age, Customized||participants|Number|53|53.0||||||
4337870|NCT00424008|4165864|B2|>=65 years||Age, Customized||participants|Number|25|25.0||||||
4337871|NCT00424008|4165865|B1|>=65 years||Age, Customized||participants|Number|28|28.0||||||
4337872|NCT00424008|4165863|B3|18 to <65 years||Age, Customized||participants|Number|629|629.0||||||
4337873|NCT00424008|4165864|B2|18 to <65 years||Age, Customized||participants|Number|308|308.0||||||
4337874|NCT00424008|4165865|B1|18 to <65 years||Age, Customized||participants|Number|321|321.0||||||
4337875|NCT00424008|4165863|B3|12 to <18 years||Age, Customized||participants|Number|40|40.0||||||
4337876|NCT00424008|4165864|B2|12 to <18 years||Age, Customized||participants|Number|18|18.0||||||
4337877|NCT00424008|4165865|B1|12 to <18 years||Age, Customized||participants|Number|22|22.0||||||
4337878|NCT00423943|4165879|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
4337879|NCT00423943|4165880|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4337880|NCT00423943|4165881|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4337881|NCT00423943|4165879|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337882|NCT00423943|4165880|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337883|NCT00423943|4165881|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337884|NCT00423943|4165879|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337943|NCT00423917|4165901|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4337885|NCT00423943|4165880|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337886|NCT00423943|4165881|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337887|NCT00423943|4165879|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4337888|NCT00423943|4165880|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4337889|NCT00423943|4165881|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4337890|NCT00423943|4165879|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4337891|NCT00423943|4165880|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4337892|NCT00423943|4165881|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4337893|NCT00423943|4165879|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337894|NCT00423943|4165880|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337895|NCT00423943|4165881|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337896|NCT00423943|4165879|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4337897|NCT00423943|4165880|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4337898|NCT00423943|4165881|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4337899|NCT00423943|4165879|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337900|NCT00423943|4165880|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337901|NCT00423943|4165881|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337902|NCT00423943|4165879|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337903|NCT00423943|4165880|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337904|NCT00423943|4165881|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337905|NCT00423943|4165879|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4337906|NCT00423943|4165880|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4337907|NCT00423943|4165881|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4337908|NCT00423943|4165879|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4337909|NCT00423943|4165880|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337910|NCT00423943|4165881|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4337911|NCT00423943|4165879|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4337912|NCT00423943|4165880|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4337913|NCT00423943|4165881|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4337914|NCT00423943|4165879|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4337915|NCT00423943|4165880|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4337916|NCT00423943|4165881|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4337917|NCT00423943|4165879|B3|||Age||years|Mean|26.2|26.2|Standard Deviation|8.1|8.1|||
4337918|NCT00423943|4165880|B2|||Age||years|Mean|25.8|25.8|Standard Deviation|8.9|8.9|||
4337919|NCT00423943|4165881|B1|||Age||years|Mean|26.4|26.4|Standard Deviation|7.7|7.7|||
4337920|NCT00423943|4165879|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4337921|NCT00423943|4165880|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4337922|NCT00423943|4165881|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4337923|NCT00423943|4165879|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4337924|NCT00423943|4165880|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4337925|NCT00423943|4165881|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4337926|NCT00423943|4165879|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4337927|NCT00423943|4165880|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4337928|NCT00423943|4165881|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4337929|NCT00423930|4165896|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4337930|NCT00423930|4165896|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337931|NCT00423930|4165896|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337932|NCT00423930|4165896|B1||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4337933|NCT00423930|4165896|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4337934|NCT00423930|4165896|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4337935|NCT00423930|4165896|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337936|NCT00423930|4165896|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337937|NCT00423930|4165896|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337938|NCT00423930|4165896|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4337939|NCT00423930|4165896|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4337940|NCT00423930|4165896|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4337941|NCT00423930|4165896|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4337942|NCT00423930|4165896|B1|||Age||years|Median|54|54.0|Full Range|||27.0|75.0|
4337944|NCT00423917|4165901|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4337945|NCT00423917|4165901|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4337946|NCT00423917|4165901|B1|||Age||years|Median|65|65.0|Full Range|||34.0|90.0|
4337947|NCT00423891|4165911|B4|||Alanine Aminotransferase (ALT)|The normal range for serum ALT as established by the study's central laboratory was 5 - 45 units per liter (U/L). The inclusion criteria for Groups A and B was >= 2 X ULN to <= 10 X ULN, while only the upper range applied to Group C (<= 10 X ULN).|U/L|Mean|125.8|125.8|Standard Deviation|78.83|78.83|||
4337948|NCT00423891|4165912|B3|||Alanine Aminotransferase (ALT)|The normal range for serum ALT as established by the study's central laboratory was 5 - 45 units per liter (U/L). The inclusion criteria for Groups A and B was >= 2 X ULN to <= 10 X ULN, while only the upper range applied to Group C (<= 10 X ULN).|U/L|Mean|44.6|44.6|Standard Deviation|22.96|22.96|||
4337949|NCT00423891|4165913|B2|||Alanine Aminotransferase (ALT)|The normal range for serum ALT as established by the study's central laboratory was 5 - 45 units per liter (U/L). The inclusion criteria for Groups A and B was >= 2 X ULN to <= 10 X ULN, while only the upper range applied to Group C (<= 10 X ULN).|U/L|Mean|125.7|125.7|Standard Deviation|67.96|67.96|||
4337950|NCT00423891|4165914|B1|||Alanine Aminotransferase (ALT)|The normal range for serum ALT as established by the study's central laboratory was 5 - 45 units per liter (U/L). The inclusion criteria for Groups A and B was >= 2 X ULN to <= 10 X ULN, while only the upper range applied to Group C (<= 10 X ULN).|U/L|Mean|142.8|142.8|Standard Deviation|85.18|85.18|||
4337951|NCT00423891|4165911|B4|||Hepatitis B virus (HBV) deoxyribonucleic acid (DNA)|Hepatitis B virus DNA by polymerase chain reaction (PCR) was measured using the Roche COBAS TaqMan - high pure system (HPS) assay and was reported in international units per milliliter (IU/mL).|log10 IU/mL|Mean|7.85|7.85|Standard Deviation|0.812|0.812|||
4337952|NCT00423891|4165912|B3|||Hepatitis B virus (HBV) deoxyribonucleic acid (DNA)|Hepatitis B virus DNA by polymerase chain reaction (PCR) was measured using the Roche COBAS TaqMan - high pure system (HPS) assay and was reported in international units per milliliter (IU/mL).|log10 IU/mL|Mean|7.96|7.96|Standard Deviation|0.238|0.238|||
4337953|NCT00423891|4165913|B2|||Hepatitis B virus (HBV) deoxyribonucleic acid (DNA)|Hepatitis B virus DNA by polymerase chain reaction (PCR) was measured using the Roche COBAS TaqMan - high pure system (HPS) assay and was reported in international units per milliliter (IU/mL).|log10 IU/mL|Mean|7.74|7.74|Standard Deviation|0.856|0.856|||
4337954|NCT00423891|4165914|B1|||Hepatitis B virus (HBV) deoxyribonucleic acid (DNA)|Hepatitis B virus DNA by polymerase chain reaction (PCR) was measured using the Roche COBAS TaqMan - high pure system (HPS) assay and was reported in international units per milliliter (IU/mL).|log10 IU/mL|Mean|7.92|7.92|Standard Deviation|0.864|0.864|||
4337955|NCT00423891|4165911|B4|Korea, Republic of||Region of Enrollment||participants|Number|16|16.0||||||
4337956|NCT00423891|4165912|B3|Korea, Republic of||Region of Enrollment||participants|Number|4|4.0||||||
4337957|NCT00423891|4165913|B2|Korea, Republic of||Region of Enrollment||participants|Number|9|9.0||||||
4337958|NCT00423891|4165914|B1|Korea, Republic of||Region of Enrollment||participants|Number|3|3.0||||||
4337959|NCT00423891|4165911|B4|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4337960|NCT00423891|4165912|B3|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4337961|NCT00423891|4165913|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4337962|NCT00423891|4165914|B1|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4337963|NCT00423891|4165911|B4|Brazil||Region of Enrollment||participants|Number|4|4.0||||||
4337964|NCT00423891|4165912|B3|Brazil||Region of Enrollment||participants|Number|0|0.0||||||
4337965|NCT00423891|4165913|B2|Brazil||Region of Enrollment||participants|Number|3|3.0||||||
4337966|NCT00423891|4165914|B1|Brazil||Region of Enrollment||participants|Number|1|1.0||||||
4337967|NCT00423891|4165911|B4|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
4337968|NCT00423891|4165912|B3|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
4337969|NCT00423891|4165913|B2|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4337970|NCT00423891|4165914|B1|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4337971|NCT00423891|4165911|B4|Argentina||Region of Enrollment||participants|Number|3|3.0||||||
4337972|NCT00423891|4165912|B3|Argentina||Region of Enrollment||participants|Number|0|0.0||||||
4337973|NCT00423891|4165913|B2|Argentina||Region of Enrollment||participants|Number|0|0.0||||||
4337974|NCT00423891|4165914|B1|Argentina||Region of Enrollment||participants|Number|3|3.0||||||
4337975|NCT00423891|4165911|B4|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4337976|NCT00423891|4165912|B3|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4337977|NCT00423891|4165913|B2|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4337978|NCT00423891|4165914|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4337979|NCT00423891|4165911|B4|Taiwan||Region of Enrollment||participants|Number|3|3.0||||||
4337980|NCT00423891|4165912|B3|Taiwan||Region of Enrollment||participants|Number|0|0.0||||||
4337981|NCT00423891|4165913|B2|Taiwan||Region of Enrollment||participants|Number|0|0.0||||||
4337982|NCT00423891|4165914|B1|Taiwan||Region of Enrollment||participants|Number|3|3.0||||||
4337983|NCT00423891|4165911|B4|United States||Region of Enrollment||participants|Number|16|16.0||||||
4337984|NCT00423891|4165912|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4337985|NCT00423891|4165913|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4337986|NCT00423891|4165914|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4337987|NCT00423891|4165911|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4337988|NCT00423891|4165912|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337989|NCT00423891|4165913|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337990|NCT00423891|4165914|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4337991|NCT00423891|4165911|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4337992|NCT00423891|4165912|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337993|NCT00423891|4165913|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337994|NCT00423891|4165914|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4337995|NCT00423891|4165911|B4||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4337996|NCT00423891|4165912|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4337997|NCT00423891|4165913|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4337998|NCT00423891|4165914|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4337999|NCT00423891|4165911|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4338000|NCT00423891|4165912|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338001|NCT00423891|4165913|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4338002|NCT00423891|4165914|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338003|NCT00423891|4165911|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4338004|NCT00423891|4165912|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338005|NCT00423891|4165913|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4338006|NCT00423891|4165914|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338007|NCT00423891|4165911|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4338008|NCT00423891|4165912|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4338009|NCT00423891|4165913|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4338010|NCT00423891|4165914|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4338011|NCT00423891|4165911|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338012|NCT00423891|4165912|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338013|NCT00423891|4165913|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338014|NCT00423891|4165914|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338015|NCT00423891|4165911|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4338016|NCT00423891|4165912|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4338017|NCT00423891|4165913|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4338018|NCT00423891|4165914|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4338019|NCT00423891|4165911|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4338020|NCT00423891|4165912|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4338021|NCT00423891|4165913|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4338022|NCT00423891|4165914|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4338023|NCT00423891|4165911|B4|>12 years to ≤18 years||Age, Customized||participants|Number|18|18.0||||||
4338024|NCT00423891|4165912|B3|>12 years to ≤18 years||Age, Customized||participants|Number|1|1.0||||||
4338025|NCT00423891|4165913|B2|>12 years to ≤18 years||Age, Customized||participants|Number|9|9.0||||||
4338026|NCT00423891|4165914|B1|>12 years to ≤18 years||Age, Customized||participants|Number|8|8.0||||||
4338027|NCT00423891|4165911|B4|>6 years to ≤ 12 years||Age, Customized||participants|Number|18|18.0||||||
4338028|NCT00423891|4165912|B3|>6 years to ≤ 12 years||Age, Customized||participants|Number|2|2.0||||||
4338029|NCT00423891|4165913|B2|>6 years to ≤ 12 years||Age, Customized||participants|Number|7|7.0||||||
4338030|NCT00423891|4165914|B1|>6 years to ≤ 12 years||Age, Customized||participants|Number|9|9.0||||||
4338031|NCT00423891|4165911|B4|≥ 2 years to ≤ 6 years||Age, Customized||participants|Number|12|12.0||||||
4338032|NCT00423891|4165912|B3|≥ 2 years to ≤ 6 years||Age, Customized||participants|Number|2|2.0||||||
4338033|NCT00423891|4165913|B2|≥ 2 years to ≤ 6 years||Age, Customized||participants|Number|3|3.0||||||
4338034|NCT00423891|4165914|B1|≥ 2 years to ≤ 6 years||Age, Customized||participants|Number|7|7.0||||||
4338035|NCT00423891|4165911|B4|||Age||years|Mean|9.9|9.9|Standard Deviation|4.98|4.98|||
4338036|NCT00423891|4165912|B3|||Age||years|Mean|8.8|8.8|Standard Deviation|5.02|5.02|||
4338037|NCT00423891|4165913|B2|||Age||years|Mean|11.0|11.0|Standard Deviation|4.42|4.42|||
4338038|NCT00423891|4165914|B1|||Age||years|Mean|9.2|9.2|Standard Deviation|5.41|5.41|||
4338039|NCT00423878|4165983|B3|||non-HDL cholesterol||mg/dL|Mean|173|173.0|Standard Deviation|32.8|32.8|||
4338040|NCT00423878|4165984|B2|||non-HDL cholesterol||mg/dL|Mean|176|176.0|Standard Deviation|33.5|33.5|||
4338041|NCT00423878|4165985|B1|||non-HDL cholesterol||mg/dL|Mean|169|169.0|Standard Deviation|31.9|31.9|||
4338042|NCT00423878|4165983|B3|United States||Region of Enrollment||participants|Number|215|215.0||||||
4338043|NCT00423878|4165984|B2|United States||Region of Enrollment||participants|Number|106|106.0||||||
4338044|NCT00423878|4165985|B1|United States||Region of Enrollment||participants|Number|109|109.0||||||
4338045|NCT00423878|4165983|B3||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4338046|NCT00423878|4165984|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4338047|NCT00423878|4165985|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4338048|NCT00423878|4165983|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4338049|NCT00423878|4165984|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4338050|NCT00423878|4165985|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4338051|NCT00423878|4165983|B3|||Age||years|Mean|41|41.0|Standard Deviation|11.1|11.1|||
4338052|NCT00423878|4165984|B2|||Age||years|Mean|42|42.0|Standard Deviation|10.5|10.5|||
4338053|NCT00423878|4165985|B1|||Age||years|Mean|40|40.0|Standard Deviation|11.7|11.7|||
4338054|NCT00423878|4165983|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4338055|NCT00423878|4165984|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4338056|NCT00423878|4165985|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4338057|NCT00423878|4165983|B3||Between 18 and 65 years|Age||Participants|Count of Participants|215|215.0||||||
4338058|NCT00423878|4165984|B2||Between 18 and 65 years|Age||Participants|Count of Participants|106|106.0||||||
4338059|NCT00423878|4165985|B1||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
4338060|NCT00423878|4165983|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4338061|NCT00423878|4165984|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4338062|NCT00423878|4165985|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4338063|NCT00423852|4165994|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4338064|NCT00423852|4165994|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4338065|NCT00423852|4165994|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4338066|NCT00423852|4165994|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4338067|NCT00423852|4165994|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4338068|NCT00423852|4165994|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4338069|NCT00423813|4165999|B4|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
4338070|NCT00423813|4166000|B3|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4338071|NCT00423813|4166001|B2|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4338072|NCT00423813|4166002|B1|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4338073|NCT00423813|4165999|B4|Italy||Region of Enrollment||participants|Number|10|10.0||||||
4338074|NCT00423813|4166000|B3|Italy||Region of Enrollment||participants|Number|4|4.0||||||
4338075|NCT00423813|4166001|B2|Italy||Region of Enrollment||participants|Number|4|4.0||||||
4338076|NCT00423813|4166002|B1|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4338077|NCT00423813|4165999|B4|Germany||Region of Enrollment||participants|Number|70|70.0||||||
4338078|NCT00423813|4166000|B3|Germany||Region of Enrollment||participants|Number|20|20.0||||||
4338079|NCT00423813|4166001|B2|Germany||Region of Enrollment||participants|Number|28|28.0||||||
4338080|NCT00423813|4166002|B1|Germany||Region of Enrollment||participants|Number|22|22.0||||||
4338081|NCT00423813|4165999|B4|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
4338082|NCT00423813|4166000|B3|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
4338083|NCT00423813|4166001|B2|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4338084|NCT00423813|4166002|B1|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4338085|NCT00423813|4165999|B4|Spain||Region of Enrollment||participants|Number|52|52.0||||||
4338086|NCT00423813|4166000|B3|Spain||Region of Enrollment||participants|Number|14|14.0||||||
4338087|NCT00423813|4166001|B2|Spain||Region of Enrollment||participants|Number|20|20.0||||||
4338088|NCT00423813|4166002|B1|Spain||Region of Enrollment||participants|Number|18|18.0||||||
4338089|NCT00423813|4165999|B4|Poland||Region of Enrollment||participants|Number|22|22.0||||||
4338090|NCT00423813|4166000|B3|Poland||Region of Enrollment||participants|Number|6|6.0||||||
4338091|NCT00423813|4166001|B2|Poland||Region of Enrollment||participants|Number|8|8.0||||||
4338092|NCT00423813|4166002|B1|Poland||Region of Enrollment||participants|Number|8|8.0||||||
4338093|NCT00423813|4165999|B4|United States||Region of Enrollment||participants|Number|380|380.0||||||
4338094|NCT00423813|4166000|B3|United States||Region of Enrollment||participants|Number|133|133.0||||||
4338095|NCT00423813|4166001|B2|United States||Region of Enrollment||participants|Number|123|123.0||||||
4338096|NCT00423813|4166002|B1|United States||Region of Enrollment||participants|Number|124|124.0||||||
4338097|NCT00423813|4165999|B4|France||Region of Enrollment||participants|Number|24|24.0||||||
4338098|NCT00423813|4166000|B3|France||Region of Enrollment||participants|Number|7|7.0||||||
4338099|NCT00423813|4166001|B2|France||Region of Enrollment||participants|Number|8|8.0||||||
4338100|NCT00423813|4166002|B1|France||Region of Enrollment||participants|Number|9|9.0||||||
4338101|NCT00423813|4165999|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338102|NCT00423813|4166000|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338103|NCT00423813|4166001|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338104|NCT00423813|4166002|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338105|NCT00423813|4165999|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4338106|NCT00423813|4166000|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4338107|NCT00423813|4166001|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4338108|NCT00423813|4166002|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4338109|NCT00423813|4165999|B4||White|Race (NIH/OMB)||Participants|Count of Participants|524|524.0||||||
4338110|NCT00423813|4166000|B3||White|Race (NIH/OMB)||Participants|Count of Participants|169|169.0||||||
4338111|NCT00423813|4166001|B2||White|Race (NIH/OMB)||Participants|Count of Participants|182|182.0||||||
4338112|NCT00423813|4166002|B1||White|Race (NIH/OMB)||Participants|Count of Participants|173|173.0||||||
4338113|NCT00423813|4165999|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4338114|NCT00423813|4166000|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4338115|NCT00423813|4166001|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4338116|NCT00423813|4166002|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4338117|NCT00423813|4165999|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338118|NCT00423813|4166000|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338119|NCT00423813|4166001|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338120|NCT00423813|4166002|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338121|NCT00423813|4165999|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4338122|NCT00423813|4166000|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4338123|NCT00423813|4166001|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4338124|NCT00423813|4166002|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4338125|NCT00423813|4165999|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4338126|NCT00423813|4166000|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4338127|NCT00423813|4166001|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338128|NCT00423813|4166002|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4338129|NCT00423813|4165999|B4||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4338130|NCT00423813|4166000|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4338131|NCT00423813|4166001|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4338132|NCT00423813|4166002|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4338133|NCT00423813|4165999|B4||Female|Sex: Female, Male||Participants|Count of Participants|513|513.0||||||
4338134|NCT00423813|4166000|B3||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4338135|NCT00423813|4166001|B2||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4338136|NCT00423813|4166002|B1||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4338137|NCT00423813|4165999|B4|>= 65 years||Age, Customized||participants|Number|19|19.0||||||
4338138|NCT00423813|4166000|B3|>= 65 years||Age, Customized||participants|Number|10|10.0||||||
4338139|NCT00423813|4166001|B2|>= 65 years||Age, Customized||participants|Number|7|7.0||||||
4338140|NCT00423813|4166002|B1|>= 65 years||Age, Customized||participants|Number|2|2.0||||||
4338141|NCT00423813|4165999|B4|50 - 64 years||Age, Customized||participants|Number|221|221.0||||||
4338142|NCT00423813|4166000|B3|50 - 64 years||Age, Customized||participants|Number|69|69.0||||||
4338143|NCT00423813|4166001|B2|50 - 64 years||Age, Customized||participants|Number|71|71.0||||||
4338144|NCT00423813|4166002|B1|50 - 64 years||Age, Customized||participants|Number|81|81.0||||||
4338145|NCT00423813|4165999|B4|40 - 49 years||Age, Customized||participants|Number|192|192.0||||||
4338146|NCT00423813|4166000|B3|40 - 49 years||Age, Customized||participants|Number|58|58.0||||||
4338147|NCT00423813|4166001|B2|40 - 49 years||Age, Customized||participants|Number|72|72.0||||||
4338148|NCT00423813|4166002|B1|40 - 49 years||Age, Customized||participants|Number|62|62.0||||||
4338149|NCT00423813|4165999|B4|18 - 39 years||Age, Customized||participants|Number|141|141.0||||||
4338150|NCT00423813|4166000|B3|18 - 39 years||Age, Customized||participants|Number|53|53.0||||||
4338151|NCT00423813|4166001|B2|18 - 39 years||Age, Customized||participants|Number|45|45.0||||||
4338152|NCT00423813|4166002|B1|18 - 39 years||Age, Customized||participants|Number|43|43.0||||||
4338153|NCT00423813|4165999|B4|||Age||years|Mean|46.6|46.6|Standard Deviation|10.72|10.72|||
4338154|NCT00423813|4166000|B3|||Age||years|Mean|46.4|46.4|Standard Deviation|11.62|11.62|||
4338155|NCT00423813|4166001|B2|||Age||years|Mean|46.6|46.6|Standard Deviation|10.76|10.76|||
4338156|NCT00423813|4166002|B1|||Age||years|Mean|46.8|46.8|Standard Deviation|9.73|9.73|||
4338157|NCT00423800|4166012|B3|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4338158|NCT00423800|4166013|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4338159|NCT00423800|4166014|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4338160|NCT00423800|4166012|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4338161|NCT00423800|4166013|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4338162|NCT00423800|4166014|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4338163|NCT00423800|4166012|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4338164|NCT00423800|4166013|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4338165|NCT00423800|4166014|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4338166|NCT00423800|4166012|B3|||Age||years|Mean|41.2|41.2|Standard Deviation|18.8|18.8|||
4338167|NCT00423800|4166013|B2|||Age||years|Mean|22|22.0|Standard Deviation|0|0.0|||
4338168|NCT00423800|4166014|B1|||Age||years|Mean|54.0|54.0|Standard Deviation|9.5|9.5|||
4338169|NCT00423735|4166024|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4338170|NCT00423735|4166026|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4338171|NCT00423735|4166027|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4338172|NCT00423735|4166024|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4338173|NCT00423735|4166026|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4338174|NCT00423735|4166027|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4338175|NCT00423735|4166024|B4|||Age||years|Median|54|54.0|Full Range|||26.0|81.0|
4338176|NCT00423735|4166026|B2|||Age||years|Median|54|54.0|Full Range|||26.0|75.0|
4338177|NCT00423735|4166027|B1|||Age||years|Median|51|51.0|Full Range|||33.0|81.0|
4338178|NCT00423722|4166050|B3|United States||Region of Enrollment||participants|Number|129|129.0||||||
4338179|NCT00423722|4166051|B2|United States||Region of Enrollment||participants|Number|66|66.0||||||
4338180|NCT00423722|4166052|B1|United States||Region of Enrollment||participants|Number|63|63.0||||||
4338181|NCT00423722|4166050|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4338182|NCT00423722|4166051|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4338183|NCT00423722|4166052|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4338184|NCT00423722|4166050|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4338185|NCT00423722|4166051|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4338186|NCT00423722|4166052|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4338187|NCT00423722|4166050|B3|>=65 years||Age, Customized||participants|Number|73|73.0||||||
4338188|NCT00423722|4166051|B2|>=65 years||Age, Customized||participants|Number|37|37.0||||||
4338189|NCT00423722|4166052|B1|>=65 years||Age, Customized||participants|Number|36|36.0||||||
4338190|NCT00423722|4166050|B3|Between 18 and 65 years||Age, Customized||participants|Number|56|56.0||||||
4338191|NCT00423722|4166051|B2|Between 18 and 65 years||Age, Customized||participants|Number|29|29.0||||||
4338192|NCT00423722|4166052|B1|Between 18 and 65 years||Age, Customized||participants|Number|27|27.0||||||
4338193|NCT00423722|4166050|B3|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4338194|NCT00423722|4166051|B2|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4338195|NCT00423722|4166052|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4338196|NCT00423722|4166050|B3|||Age||years|Mean|67|67.0|Full Range|||41.0|92.0|
4338197|NCT00423722|4166051|B2|||Age||years|Mean|67|67.0|Full Range|||41.0|92.0|
4338198|NCT00423722|4166052|B1|||Age||years|Mean|67|67.0|Full Range|||43.0|92.0|
4338199|NCT00423683|4166073|B3|United States||Region of Enrollment||participants|Number|64|64.0||||||
4338200|NCT00423683|4166074|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4338201|NCT00423683|4166075|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4338202|NCT00423683|4166073|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4338203|NCT00423683|4166074|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4338204|NCT00423683|4166075|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4338205|NCT00423683|4166073|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4338206|NCT00423683|4166074|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4338207|NCT00423683|4166075|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4338208|NCT00423683|4166073|B3|||Age||years|Mean|65|65.0|Standard Deviation|13|13.0|||
4338209|NCT00423683|4166074|B2|||Age||years|Mean|67|67.0|Standard Deviation|14|14.0|||
4338210|NCT00423683|4166075|B1|||Age||years|Mean|63|63.0|Standard Deviation|2|2.0|||
4338211|NCT00423683|4166073|B3||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4338212|NCT00423683|4166074|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4338213|NCT00423683|4166075|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4338214|NCT00423683|4166073|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4338215|NCT00423683|4166074|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4338216|NCT00423683|4166075|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4338217|NCT00423683|4166073|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4338218|NCT00423683|4166074|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4338219|NCT00423683|4166075|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4338220|NCT00423670|4166088|B8||Male|Sex: Female, Male|Overall gender characteristics were displayed for Arm 1 through Arm 7. Participants from Arm 1 (Part I) who had detectable HCV-RNA TW 24, had the option to switch to a new arm, Arm 8.|Participants|Count of Participants|355|355.0||||||
4338221|NCT00423670|4166089|B7||Male|Sex: Female, Male|Overall gender characteristics were displayed for Arm 1 through Arm 7. Participants from Arm 1 (Part I) who had detectable HCV-RNA TW 24, had the option to switch to a new arm, Arm 8.|Participants|Count of Participants|41|41.0||||||
4338222|NCT00423670|4166090|B6||Male|Sex: Female, Male|Overall gender characteristics were displayed for Arm 1 through Arm 7. Participants from Arm 1 (Part I) who had detectable HCV-RNA TW 24, had the option to switch to a new arm, Arm 8.|Participants|Count of Participants|9|9.0||||||
4338223|NCT00423670|4166091|B5||Male|Sex: Female, Male|Overall gender characteristics were displayed for Arm 1 through Arm 7. Participants from Arm 1 (Part I) who had detectable HCV-RNA TW 24, had the option to switch to a new arm, Arm 8.|Participants|Count of Participants|58|58.0||||||
4338224|NCT00423670|4166092|B4||Male|Sex: Female, Male|Overall gender characteristics were displayed for Arm 1 through Arm 7. Participants from Arm 1 (Part I) who had detectable HCV-RNA TW 24, had the option to switch to a new arm, Arm 8.|Participants|Count of Participants|63|63.0||||||
4338225|NCT00423670|4166093|B3||Male|Sex: Female, Male|Overall gender characteristics were displayed for Arm 1 through Arm 7. Participants from Arm 1 (Part I) who had detectable HCV-RNA TW 24, had the option to switch to a new arm, Arm 8.|Participants|Count of Participants|51|51.0||||||
4338226|NCT00423670|4166094|B2||Male|Sex: Female, Male|Overall gender characteristics were displayed for Arm 1 through Arm 7. Participants from Arm 1 (Part I) who had detectable HCV-RNA TW 24, had the option to switch to a new arm, Arm 8.|Participants|Count of Participants|63|63.0||||||
4338263|NCT00423657|4166159|B2|>=65 years||Age, Customized||participants|Number|47|47.0||||||
4338227|NCT00423670|4166095|B1||Male|Sex: Female, Male|Overall gender characteristics were displayed for Arm 1 through Arm 7. Participants from Arm 1 (Part I) who had detectable HCV-RNA TW 24, had the option to switch to a new arm, Arm 8.|Participants|Count of Participants|70|70.0||||||
4338228|NCT00423670|4166088|B8||Female|Sex: Female, Male|Overall gender characteristics were displayed for Arm 1 through Arm 7. Participants from Arm 1 (Part I) who had detectable HCV-RNA TW 24, had the option to switch to a new arm, Arm 8.|Participants|Count of Participants|240|240.0||||||
4338229|NCT00423670|4166089|B7||Female|Sex: Female, Male|Overall gender characteristics were displayed for Arm 1 through Arm 7. Participants from Arm 1 (Part I) who had detectable HCV-RNA TW 24, had the option to switch to a new arm, Arm 8.|Participants|Count of Participants|18|18.0||||||
4338230|NCT00423670|4166090|B6||Female|Sex: Female, Male|Overall gender characteristics were displayed for Arm 1 through Arm 7. Participants from Arm 1 (Part I) who had detectable HCV-RNA TW 24, had the option to switch to a new arm, Arm 8.|Participants|Count of Participants|7|7.0||||||
4338231|NCT00423670|4166091|B5||Female|Sex: Female, Male|Overall gender characteristics were displayed for Arm 1 through Arm 7. Participants from Arm 1 (Part I) who had detectable HCV-RNA TW 24, had the option to switch to a new arm, Arm 8.|Participants|Count of Participants|45|45.0||||||
4338232|NCT00423670|4166092|B4||Female|Sex: Female, Male|Overall gender characteristics were displayed for Arm 1 through Arm 7. Participants from Arm 1 (Part I) who had detectable HCV-RNA TW 24, had the option to switch to a new arm, Arm 8.|Participants|Count of Participants|40|40.0||||||
4338233|NCT00423670|4166093|B3||Female|Sex: Female, Male|Overall gender characteristics were displayed for Arm 1 through Arm 7. Participants from Arm 1 (Part I) who had detectable HCV-RNA TW 24, had the option to switch to a new arm, Arm 8.|Participants|Count of Participants|52|52.0||||||
4338234|NCT00423670|4166094|B2||Female|Sex: Female, Male|Overall gender characteristics were displayed for Arm 1 through Arm 7. Participants from Arm 1 (Part I) who had detectable HCV-RNA TW 24, had the option to switch to a new arm, Arm 8.|Participants|Count of Participants|44|44.0||||||
4338235|NCT00423670|4166095|B1||Female|Sex: Female, Male|Overall gender characteristics were displayed for Arm 1 through Arm 7. Participants from Arm 1 (Part I) who had detectable HCV-RNA TW 24, had the option to switch to a new arm, Arm 8.|Participants|Count of Participants|34|34.0||||||
4338236|NCT00423670|4166088|B8|||Age|Overall age characteristics were displayed for Arm 1 through Arm 7. Participants from Arm 1 (Part I) who had detectable HCV-RNA at TW 24, had the option to switch to a new arm, Arm 8.|years|Mean|47.5|47.5|Standard Deviation|7.7|7.7|||
4338237|NCT00423670|4166089|B7|||Age|Overall age characteristics were displayed for Arm 1 through Arm 7. Participants from Arm 1 (Part I) who had detectable HCV-RNA at TW 24, had the option to switch to a new arm, Arm 8.|years|Mean|48.7|48.7|Standard Deviation|5.8|5.8|||
4338238|NCT00423670|4166090|B6|||Age|Overall age characteristics were displayed for Arm 1 through Arm 7. Participants from Arm 1 (Part I) who had detectable HCV-RNA at TW 24, had the option to switch to a new arm, Arm 8.|years|Mean|50.3|50.3|Standard Deviation|8.5|8.5|||
4338239|NCT00423670|4166091|B5|||Age|Overall age characteristics were displayed for Arm 1 through Arm 7. Participants from Arm 1 (Part I) who had detectable HCV-RNA at TW 24, had the option to switch to a new arm, Arm 8.|years|Mean|47.6|47.6|Standard Deviation|8.3|8.3|||
4338240|NCT00423670|4166092|B4|||Age|Overall age characteristics were displayed for Arm 1 through Arm 7. Participants from Arm 1 (Part I) who had detectable HCV-RNA at TW 24, had the option to switch to a new arm, Arm 8.|years|Mean|46.7|46.7|Standard Deviation|8.8|8.8|||
4338241|NCT00423670|4166093|B3|||Age|Overall age characteristics were displayed for Arm 1 through Arm 7. Participants from Arm 1 (Part I) who had detectable HCV-RNA at TW 24, had the option to switch to a new arm, Arm 8.|years|Mean|47.7|47.7|Standard Deviation|7.4|7.4|||
4338242|NCT00423670|4166094|B2|||Age|Overall age characteristics were displayed for Arm 1 through Arm 7. Participants from Arm 1 (Part I) who had detectable HCV-RNA at TW 24, had the option to switch to a new arm, Arm 8.|years|Mean|46.4|46.4|Standard Deviation|8.0|8.0|||
4338243|NCT00423670|4166095|B1|||Age|Overall age characteristics were displayed for Arm 1 through Arm 7. Participants from Arm 1 (Part I) who had detectable HCV-RNA at TW 24, had the option to switch to a new arm, Arm 8.|years|Mean|48.3|48.3|Standard Deviation|6.9|6.9|||
4338244|NCT00423657|4166158|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338245|NCT00423657|4166159|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338246|NCT00423657|4166160|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338247|NCT00423657|4166158|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|558|558.0||||||
4338248|NCT00423657|4166159|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|279|279.0||||||
4338249|NCT00423657|4166160|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|279|279.0||||||
4338250|NCT00423657|4166158|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
4338251|NCT00423657|4166159|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4338252|NCT00423657|4166160|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4338253|NCT00423657|4166158|B3||Male|Sex: Female, Male||Participants|Count of Participants|425|425.0||||||
4338254|NCT00423657|4166159|B2||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4338255|NCT00423657|4166160|B1||Male|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
4338256|NCT00423657|4166158|B3||Female|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
4338257|NCT00423657|4166159|B2||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4338258|NCT00423657|4166160|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4338259|NCT00423657|4166158|B3|||Age||years|Mean|47.7|47.7|Standard Deviation|16.52|16.52|||
4338260|NCT00423657|4166159|B2|||Age||years|Mean|47.5|47.5|Standard Deviation|16.07|16.07|||
4338261|NCT00423657|4166160|B1|||Age||years|Mean|47.8|47.8|Standard Deviation|16.98|16.98|||
4338262|NCT00423657|4166158|B3|>=65 years||Age, Customized||participants|Number|108|108.0||||||
4338264|NCT00423657|4166160|B1|>=65 years||Age, Customized||participants|Number|61|61.0||||||
4338265|NCT00423657|4166158|B3|>18 and < 65 years||Age, Customized||participants|Number|572|572.0||||||
4338266|NCT00423657|4166159|B2|>18 and < 65 years||Age, Customized||participants|Number|291|291.0||||||
4338267|NCT00423657|4166160|B1|>18 and < 65 years||Age, Customized||participants|Number|281|281.0||||||
4338268|NCT00423657|4166158|B3|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4338269|NCT00423657|4166159|B2|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4338270|NCT00423657|4166160|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4338271|NCT00423605|4166167|B1|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
4338272|NCT00423605|4166167|B1|Italy||Region of Enrollment||participants|Number|3|3.0||||||
4338273|NCT00423605|4166167|B1|Germany||Region of Enrollment||participants|Number|34|34.0||||||
4338274|NCT00423605|4166167|B1|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
4338275|NCT00423605|4166167|B1|Spain||Region of Enrollment||participants|Number|35|35.0||||||
4338276|NCT00423605|4166167|B1|United States||Region of Enrollment||participants|Number|465|465.0||||||
4338277|NCT00423605|4166167|B1|France||Region of Enrollment||participants|Number|13|13.0||||||
4338278|NCT00423605|4166167|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4338279|NCT00423605|4166167|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4338280|NCT00423605|4166167|B1||White|Race (NIH/OMB)||Participants|Count of Participants|512|512.0||||||
4338281|NCT00423605|4166167|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4338282|NCT00423605|4166167|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338283|NCT00423605|4166167|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4338284|NCT00423605|4166167|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4338285|NCT00423605|4166167|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4338286|NCT00423605|4166167|B1||Female|Sex: Female, Male||Participants|Count of Participants|510|510.0||||||
4338287|NCT00423605|4166167|B1|>=65 years||Age, Customized||participants|Number|23|23.0||||||
4338288|NCT00423605|4166167|B1|50 - 64 years||Age, Customized||participants|Number|212|212.0||||||
4338289|NCT00423605|4166167|B1|40 - 49 years||Age, Customized||participants|Number|181|181.0||||||
4338290|NCT00423605|4166167|B1|18 - 39 years||Age, Customized||participants|Number|144|144.0||||||
4338291|NCT00423605|4166167|B1|||Age||years|Mean|46.9|46.9|Standard Deviation|10.84|10.84|||
4338292|NCT00423592|4166171|B1|||Weight||kg|Mean|74.1|74.1|Standard Deviation|15.36|15.36|||
4338293|NCT00423592|4166171|B1|||Right atrial pressure|Historical values from most recent catheterization.|mmHg|Mean|7.9|7.9|Standard Deviation|5.29|5.29|||
4338294|NCT00423592|4166171|B1|||Pulmonary vascular resistance|Historical values from most recent catheterization.|mmHg/L/min|Mean|10.3|10.3|Standard Deviation|5.75|5.75|||
4338295|NCT00423592|4166171|B1|||Pulmonary capillary wedge pressure|Historical values from most recent catheterization.|mmHg|Mean|10.1|10.1|Standard Deviation|5.38|5.38|||
4338296|NCT00423592|4166171|B1|||Pulmonary arterial hypertension present|Duration (in years) of pulmonary arterial hypertension at baseline.|year|Mean|3.8|3.8|Standard Deviation|4.99|4.99|||
4338297|NCT00423592|4166171|B1|||Mean pulmonary artery pressure|Historical values from most recent catheterization.|mmHg|Mean|48.4|48.4|Standard Deviation|13.50|13.5|||
4338298|NCT00423592|4166171|B1|||Height||cm|Mean|165.1|165.1|Standard Deviation|7.22|7.22|||
4338299|NCT00423592|4166171|B1|||Cardiac index|Historical values from most recent catheterization.|L/min/m^2|Mean|2.7|2.7|Standard Deviation|1.02|1.02|||
4338300|NCT00423592|4166171|B1|||Borg dyspnea index|Borg Dyspnea Index, a measure of perceived shortness of breath: 0 units on a scale (none) to 10 units on a scale (maximum breathlessness).|units on a scale|Mean|4.2|4.2|Standard Deviation|2.31|2.31|||
4338301|NCT00423592|4166171|B1|||Body Mass Index||kg/m^2|Mean|27.2|27.2|Standard Deviation|5.44|5.44|||
4338302|NCT00423592|4166171|B1|||Baseline 6-Minute Walk Distance||meters|Mean|397.2|397.2|Standard Deviation|104.59|104.59|||
4338303|NCT00423592|4166171|B1|Class IV||World Health Organization (WHO) Functional Class|Classes: I) pulmonary hypertension (PH); ordinary physical activity not limited or causes undue dyspnea or fatigue, chest pain, or near syncope. II) PH; ordinary physical activity slightly limited and causes undue dyspnea or fatigue, chest pain, or near syncope; comfortable at rest. III) PH; physical activity markedly limited and less than ordinary physical activity causes undue dyspnea or fatigue, chest pain, or near syncope; comfortable at rest. IV) PH; physical activity causes symptoms and increased discomfort; signs of right heart failure; dyspnea/fatigue possibly at rest.|participants|Number|0|0.0||||||
4338304|NCT00423592|4166171|B1|Class III||World Health Organization (WHO) Functional Class|Classes: I) pulmonary hypertension (PH); ordinary physical activity not limited or causes undue dyspnea or fatigue, chest pain, or near syncope. II) PH; ordinary physical activity slightly limited and causes undue dyspnea or fatigue, chest pain, or near syncope; comfortable at rest. III) PH; physical activity markedly limited and less than ordinary physical activity causes undue dyspnea or fatigue, chest pain, or near syncope; comfortable at rest. IV) PH; physical activity causes symptoms and increased discomfort; signs of right heart failure; dyspnea/fatigue possibly at rest.|participants|Number|23|23.0||||||
4338305|NCT00423592|4166171|B1|Class II||World Health Organization (WHO) Functional Class|Classes: I) pulmonary hypertension (PH); ordinary physical activity not limited or causes undue dyspnea or fatigue, chest pain, or near syncope. II) PH; ordinary physical activity slightly limited and causes undue dyspnea or fatigue, chest pain, or near syncope; comfortable at rest. III) PH; physical activity markedly limited and less than ordinary physical activity causes undue dyspnea or fatigue, chest pain, or near syncope; comfortable at rest. IV) PH; physical activity causes symptoms and increased discomfort; signs of right heart failure; dyspnea/fatigue possibly at rest.|participants|Number|13|13.0||||||
4338354|NCT00423436|4166236|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4338306|NCT00423592|4166171|B1|Class I||World Health Organization (WHO) Functional Class|Classes: I) pulmonary hypertension (PH); ordinary physical activity not limited or causes undue dyspnea or fatigue, chest pain, or near syncope. II) PH; ordinary physical activity slightly limited and causes undue dyspnea or fatigue, chest pain, or near syncope; comfortable at rest. III) PH; physical activity markedly limited and less than ordinary physical activity causes undue dyspnea or fatigue, chest pain, or near syncope; comfortable at rest. IV) PH; physical activity causes symptoms and increased discomfort; signs of right heart failure; dyspnea/fatigue possibly at rest.|participants|Number|0|0.0||||||
4338307|NCT00423592|4166171|B1|Ambrisentan/sildenafil/prostanoid||Pulmonary Arterial Hypertension Treatment|Ambrisentan treatment was started on study Day 1. Concomitant sildenafil and prostanoids had to be stable for 4 weeks before screening.|participants|Number|5|5.0||||||
4338308|NCT00423592|4166171|B1|Ambrisentan/prostanoid||Pulmonary Arterial Hypertension Treatment|Ambrisentan treatment was started on study Day 1. Concomitant sildenafil and prostanoids had to be stable for 4 weeks before screening.|participants|Number|8|8.0||||||
4338309|NCT00423592|4166171|B1|Ambrisentan/sildenafil||Pulmonary Arterial Hypertension Treatment|Ambrisentan treatment was started on study Day 1. Concomitant sildenafil and prostanoids had to be stable for 4 weeks before screening.|participants|Number|12|12.0||||||
4338310|NCT00423592|4166171|B1|Ambrisentan only||Pulmonary Arterial Hypertension Treatment|Ambrisentan treatment was started on study Day 1. Concomitant sildenafil and prostanoids had to be stable for 4 weeks before screening.|participants|Number|11|11.0||||||
4338311|NCT00423592|4166171|B1|Associated pulmonary arterial hypertension||Pulmonary Arterial Hypertension Etiology||participants|Number|12|12.0||||||
4338312|NCT00423592|4166171|B1|Familial pulmonary arterial hypertension||Pulmonary Arterial Hypertension Etiology||participants|Number|1|1.0||||||
4338313|NCT00423592|4166171|B1|Idiopathic pulmonary arterial hypertension||Pulmonary Arterial Hypertension Etiology||participants|Number|23|23.0||||||
4338314|NCT00423592|4166171|B1|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
4338315|NCT00423592|4166171|B1|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
4338316|NCT00423592|4166171|B1|Australia||Region of Enrollment||participants|Number|5|5.0||||||
4338317|NCT00423592|4166171|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4338318|NCT00423592|4166171|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4338319|NCT00423592|4166171|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4338320|NCT00423592|4166171|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4338321|NCT00423592|4166171|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4338322|NCT00423592|4166171|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4338323|NCT00423592|4166171|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4338324|NCT00423592|4166171|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4338325|NCT00423592|4166171|B1|||Age||years|Mean|57.2|57.2|Standard Deviation|13.39|13.39|||
4338326|NCT00423592|4166171|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4338327|NCT00423592|4166171|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4338328|NCT00423592|4166171|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4338329|NCT00423579|4166190|B3||Male|Sex: Female, Male|Gender totals based on Intent-to-Treat population.|Participants|Count of Participants|62|62.0||||||
4338330|NCT00423579|4166191|B2||Male|Sex: Female, Male|Gender totals based on Intent-to-Treat population.|Participants|Count of Participants|32|32.0||||||
4338331|NCT00423579|4166192|B1||Male|Sex: Female, Male|Gender totals based on Intent-to-Treat population.|Participants|Count of Participants|30|30.0||||||
4338332|NCT00423579|4166190|B3||Female|Sex: Female, Male|Gender totals based on Intent-to-Treat population.|Participants|Count of Participants|50|50.0||||||
4338333|NCT00423579|4166191|B2||Female|Sex: Female, Male|Gender totals based on Intent-to-Treat population.|Participants|Count of Participants|24|24.0||||||
4338334|NCT00423579|4166192|B1||Female|Sex: Female, Male|Gender totals based on Intent-to-Treat population.|Participants|Count of Participants|26|26.0||||||
4338335|NCT00423579|4166190|B3|||Age|Mean age based on Intent-to-Treat population.|years|Mean|61.7|61.7|Standard Deviation|8.1|8.1|||
4338336|NCT00423579|4166191|B2|||Age|Mean age based on Intent-to-Treat population.|years|Mean|62.1|62.1|Standard Deviation|7.8|7.8|||
4338337|NCT00423579|4166192|B1|||Age|Mean age based on Intent-to-Treat population.|years|Mean|61.3|61.3|Standard Deviation|8.4|8.4|||
4338338|NCT00423488|4166199|B3|Italy||Region of Enrollment||participants|Number|93|93.0||||||
4338339|NCT00423488|4166200|B2|Italy||Region of Enrollment||participants|Number|51|51.0||||||
4338340|NCT00423488|4166201|B1|Italy||Region of Enrollment||participants|Number|42|42.0||||||
4338341|NCT00423488|4166199|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4338342|NCT00423488|4166200|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4338343|NCT00423488|4166201|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4338344|NCT00423488|4166199|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4338345|NCT00423488|4166200|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4338346|NCT00423488|4166201|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4338347|NCT00423488|4166199|B3|||Age||years|Mean|64.4|64.4|Standard Deviation|6.3|6.3|||
4338348|NCT00423488|4166200|B2|||Age||years|Mean|63.9|63.9|Standard Deviation|6.1|6.1|||
4338349|NCT00423488|4166201|B1|||Age||years|Mean|65.0|65.0|Standard Deviation|6.5|6.5|||
4338350|NCT00423449|4166208|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4338351|NCT00423449|4166208|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4338352|NCT00423449|4166208|B1|||Age||years|Mean|56.7|56.7|Standard Deviation|9.2|9.2|||
4338353|NCT00423436|4166235|B3|United States||Region of Enrollment||participants|Number|68|68.0||||||
4338355|NCT00423436|4166237|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4338356|NCT00423436|4166235|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4338357|NCT00423436|4166236|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4338358|NCT00423436|4166237|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4338359|NCT00423436|4166235|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4338360|NCT00423436|4166236|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4338361|NCT00423436|4166237|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4338362|NCT00423436|4166235|B3|||Age||years|Mean|62.5762|62.5762|Standard Deviation|8.9158|8.9158|||
4338363|NCT00423436|4166236|B2|||Age||years|Mean|60.63|60.63|Standard Deviation|8.40|8.4|||
4338364|NCT00423436|4166237|B1|||Age||years|Mean|64.41|64.41|Standard Deviation|9.11|9.11|||
4338365|NCT00423358|4166244|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4338366|NCT00423358|4166245|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4338367|NCT00423358|4166246|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4338368|NCT00423358|4166244|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4338369|NCT00423358|4166245|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4338370|NCT00423358|4166246|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4338371|NCT00423358|4166244|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4338372|NCT00423358|4166245|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4338373|NCT00423358|4166246|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4338374|NCT00423358|4166244|B3|||Age||years|Mean|58|58.0|Standard Deviation|12|12.0|||
4338375|NCT00423358|4166245|B2|||Age||years|Mean|53|53.0|Standard Deviation|11|11.0|||
4338376|NCT00423358|4166246|B1|||Age||years|Mean|63|63.0|Standard Deviation|12|12.0|||
4338377|NCT00423358|4166244|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4338378|NCT00423358|4166245|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4338379|NCT00423358|4166246|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4338380|NCT00423358|4166244|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4338381|NCT00423358|4166245|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4338382|NCT00423358|4166246|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4338383|NCT00423358|4166244|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4338384|NCT00423358|4166245|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4338385|NCT00423358|4166246|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4338386|NCT00423332|4166257|B3||Male|Gender|Gender at informed consent|Participants|Count of Participants|55|55.0||||||
4338387|NCT00423332|4166258|B2||Male|Gender|Gender at informed consent|Participants|Count of Participants|15|15.0||||||
4338388|NCT00423332|4166259|B1||Male|Gender|Gender at informed consent|Participants|Count of Participants|40|40.0||||||
4338389|NCT00423332|4166257|B3||Female|Gender|Gender at informed consent|Participants|Count of Participants|16|16.0||||||
4338390|NCT00423332|4166258|B2||Female|Gender|Gender at informed consent|Participants|Count of Participants|3|3.0||||||
4338391|NCT00423332|4166259|B1||Female|Gender|Gender at informed consent|Participants|Count of Participants|13|13.0||||||
4338392|NCT00423332|4166257|B3|||Age|Age at informed consent|Years|Mean|61.2|61.2|Standard Deviation|7.9|7.9|||
4338393|NCT00423332|4166258|B2|||Age|Age at informed consent|Years|Mean|62.4|62.4|Standard Deviation|8.7|8.7|||
4338394|NCT00423332|4166259|B1|||Age|Age at informed consent|Years|Mean|60.7|60.7|Standard Deviation|7.7|7.7|||
4338395|NCT00423319|4166277|B3|Sweden||Region of Enrollment||Participants|Number|125|125.0||||||
4338396|NCT00423319|4166278|B2|Sweden||Region of Enrollment||Participants|Number|62|62.0||||||
4338397|NCT00423319|4166279|B1|Sweden||Region of Enrollment||Participants|Number|63|63.0||||||
4338398|NCT00423319|4166277|B3|China||Region of Enrollment||Participants|Number|245|245.0||||||
4338399|NCT00423319|4166278|B2|China||Region of Enrollment||Participants|Number|124|124.0||||||
4338400|NCT00423319|4166279|B1|China||Region of Enrollment||Participants|Number|121|121.0||||||
4338401|NCT00423319|4166277|B3|Norway||Region of Enrollment||Participants|Number|95|95.0||||||
4338402|NCT00423319|4166278|B2|Norway||Region of Enrollment||Participants|Number|48|48.0||||||
4338403|NCT00423319|4166279|B1|Norway||Region of Enrollment||Participants|Number|47|47.0||||||
4338404|NCT00423319|4166277|B3|Germany||Region of Enrollment||Participants|Number|269|269.0||||||
4338405|NCT00423319|4166278|B2|Germany||Region of Enrollment||Participants|Number|134|134.0||||||
4338406|NCT00423319|4166279|B1|Germany||Region of Enrollment||Participants|Number|135|135.0||||||
4338407|NCT00423319|4166277|B3|Denmark||Region of Enrollment||Participants|Number|198|198.0||||||
4338408|NCT00423319|4166278|B2|Denmark||Region of Enrollment||Participants|Number|99|99.0||||||
4338409|NCT00423319|4166279|B1|Denmark||Region of Enrollment||Participants|Number|99|99.0||||||
4338410|NCT00423319|4166277|B3|Australia||Region of Enrollment||Participants|Number|200|200.0||||||
4338411|NCT00423319|4166278|B2|Australia||Region of Enrollment||Participants|Number|99|99.0||||||
4338412|NCT00423319|4166279|B1|Australia||Region of Enrollment||Participants|Number|101|101.0||||||
4338413|NCT00423319|4166277|B3|Romania||Region of Enrollment||Participants|Number|49|49.0||||||
4338414|NCT00423319|4166278|B2|Romania||Region of Enrollment||Participants|Number|25|25.0||||||
4338415|NCT00423319|4166279|B1|Romania||Region of Enrollment||Participants|Number|24|24.0||||||
4338416|NCT00423319|4166277|B3|Poland||Region of Enrollment||Participants|Number|369|369.0||||||
4338417|NCT00423319|4166278|B2|Poland||Region of Enrollment||Participants|Number|185|185.0||||||
4338418|NCT00423319|4166279|B1|Poland||Region of Enrollment||Participants|Number|184|184.0||||||
4338419|NCT00423319|4166277|B3|Belgium||Region of Enrollment||Participants|Number|119|119.0||||||
4338420|NCT00423319|4166278|B2|Belgium||Region of Enrollment||Participants|Number|60|60.0||||||
4338421|NCT00423319|4166279|B1|Belgium||Region of Enrollment||Participants|Number|59|59.0||||||
4338422|NCT00423319|4166277|B3|Argentina||Region of Enrollment||Participants|Number|107|107.0||||||
4338423|NCT00423319|4166278|B2|Argentina||Region of Enrollment||Participants|Number|54|54.0||||||
4338424|NCT00423319|4166279|B1|Argentina||Region of Enrollment||Participants|Number|53|53.0||||||
4338425|NCT00423319|4166277|B3|Canada||Region of Enrollment||Participants|Number|715|715.0||||||
4338426|NCT00423319|4166278|B2|Canada||Region of Enrollment||Participants|Number|356|356.0||||||
4338427|NCT00423319|4166279|B1|Canada||Region of Enrollment||Participants|Number|359|359.0||||||
4338428|NCT00423319|4166277|B3|Mexico||Region of Enrollment||Participants|Number|147|147.0||||||
4338429|NCT00423319|4166278|B2|Mexico||Region of Enrollment||Participants|Number|74|74.0||||||
4338430|NCT00423319|4166279|B1|Mexico||Region of Enrollment||Participants|Number|73|73.0||||||
4338431|NCT00423319|4166277|B3|Hungary||Region of Enrollment||Participants|Number|302|302.0||||||
4338432|NCT00423319|4166278|B2|Hungary||Region of Enrollment||Participants|Number|150|150.0||||||
4338433|NCT00423319|4166279|B1|Hungary||Region of Enrollment||Participants|Number|152|152.0||||||
4338434|NCT00423319|4166277|B3|France||Region of Enrollment||Participants|Number|149|149.0||||||
4338435|NCT00423319|4166278|B2|France||Region of Enrollment||Participants|Number|74|74.0||||||
4338436|NCT00423319|4166279|B1|France||Region of Enrollment||Participants|Number|75|75.0||||||
4338437|NCT00423319|4166277|B3|India||Region of Enrollment||Participants|Number|112|112.0||||||
4338438|NCT00423319|4166278|B2|India||Region of Enrollment||Participants|Number|56|56.0||||||
4338439|NCT00423319|4166279|B1|India||Region of Enrollment||Participants|Number|56|56.0||||||
4338440|NCT00423319|4166277|B3|United Kingdom||Region of Enrollment||Participants|Number|155|155.0||||||
4338441|NCT00423319|4166278|B2|United Kingdom||Region of Enrollment||Participants|Number|78|78.0||||||
4338442|NCT00423319|4166279|B1|United Kingdom||Region of Enrollment||Participants|Number|77|77.0||||||
4338443|NCT00423319|4166277|B3|Israel||Region of Enrollment||Participants|Number|113|113.0||||||
4338444|NCT00423319|4166278|B2|Israel||Region of Enrollment||Participants|Number|56|56.0||||||
4338445|NCT00423319|4166279|B1|Israel||Region of Enrollment||Participants|Number|57|57.0||||||
4338446|NCT00423319|4166277|B3|Russian Federation||Region of Enrollment||Participants|Number|550|550.0||||||
4338447|NCT00423319|4166278|B2|Russian Federation||Region of Enrollment||Participants|Number|276|276.0||||||
4338448|NCT00423319|4166279|B1|Russian Federation||Region of Enrollment||Participants|Number|274|274.0||||||
4338449|NCT00423319|4166277|B3|Ukraine||Region of Enrollment||Participants|Number|436|436.0||||||
4338450|NCT00423319|4166278|B2|Ukraine||Region of Enrollment||Participants|Number|219|219.0||||||
4338451|NCT00423319|4166279|B1|Ukraine||Region of Enrollment||Participants|Number|217|217.0||||||
4338452|NCT00423319|4166277|B3|Spain||Region of Enrollment||Participants|Number|61|61.0||||||
4338453|NCT00423319|4166278|B2|Spain||Region of Enrollment||Participants|Number|29|29.0||||||
4338454|NCT00423319|4166279|B1|Spain||Region of Enrollment||Participants|Number|32|32.0||||||
4338455|NCT00423319|4166277|B3|United States||Region of Enrollment||Participants|Number|891|891.0||||||
4338456|NCT00423319|4166278|B2|United States||Region of Enrollment||Participants|Number|441|441.0||||||
4338457|NCT00423319|4166279|B1|United States||Region of Enrollment||Participants|Number|450|450.0||||||
4338458|NCT00423319|4166277|B3||Male|Sex: Female, Male||Participants|Count of Participants|2526|2526.0||||||
4338459|NCT00423319|4166278|B2||Male|Sex: Female, Male||Participants|Count of Participants|1248|1248.0||||||
4338460|NCT00423319|4166279|B1||Male|Sex: Female, Male||Participants|Count of Participants|1278|1278.0||||||
4338461|NCT00423319|4166277|B3||Female|Sex: Female, Male||Participants|Count of Participants|2881|2881.0||||||
4338462|NCT00423319|4166278|B2||Female|Sex: Female, Male||Participants|Count of Participants|1451|1451.0||||||
4338463|NCT00423319|4166279|B1||Female|Sex: Female, Male||Participants|Count of Participants|1430|1430.0||||||
4338464|NCT00423319|4166277|B3|75 years and older||Age, Customized||Participants|Number|657|657.0||||||
4338465|NCT00423319|4166278|B2|75 years and older||Age, Customized||Participants|Number|327|327.0||||||
4338466|NCT00423319|4166279|B1|75 years and older||Age, Customized||Participants|Number|330|330.0||||||
4338467|NCT00423319|4166277|B3|65 to younger than 75 years||Age, Customized||Participants|Number|1537|1537.0||||||
4338468|NCT00423319|4166278|B2|65 to younger than 75 years||Age, Customized||Participants|Number|767|767.0||||||
4338469|NCT00423319|4166279|B1|65 to younger than 75 years||Age, Customized||Participants|Number|770|770.0||||||
4338470|NCT00423319|4166277|B3|Younger than 65 years||Age, Customized||Participants|Number|3213|3213.0||||||
4338471|NCT00423319|4166278|B2|Younger than 65 years||Age, Customized||Participants|Number|1605|1605.0||||||
4338472|NCT00423319|4166279|B1|Younger than 65 years||Age, Customized||Participants|Number|1608|1608.0||||||
4338473|NCT00423319|4166277|B3|||Age||Years|Mean|60.8|60.8|Standard Deviation|11.81|11.81|||
4338474|NCT00423319|4166278|B2|||Age||Years|Mean|60.6|60.6|Standard Deviation|11.82|11.82|||
4338475|NCT00423319|4166279|B1|||Age||Years|Mean|60.9|60.9|Standard Deviation|11.79|11.79|||
4338476|NCT00423293|4166312|B1||Male|Gender||Participants|Count of Participants|10|10.0||||||
4338477|NCT00423293|4166312|B1||Female|Gender||Participants|Count of Participants|42|42.0||||||
4338478|NCT00423293|4166312|B1|||Age||years|Median|58|58.0|Full Range|||34.0|82.0|
4338479|NCT00423267|4166316|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4338480|NCT00423267|4166317|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4338481|NCT00423267|4166318|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4338482|NCT00423267|4166316|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4338483|NCT00423267|4166317|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4338484|NCT00423267|4166318|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4338485|NCT00423267|4166316|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4338486|NCT00423267|4166317|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4338487|NCT00423267|4166318|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4338488|NCT00423267|4166316|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4338489|NCT00423267|4166317|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4338490|NCT00423267|4166318|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4338491|NCT00423267|4166316|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4338492|NCT00423267|4166317|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4338493|NCT00423267|4166318|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4338494|NCT00423189|4166336|B4|United States||Region of Enrollment||participants|Number|7|7.0||||||
4338495|NCT00423189|4166337|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4338496|NCT00423189|4166338|B2|United States||Region of Enrollment||participants|Number|03|3.0||||||
4338497|NCT00423189|4166339|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4338498|NCT00423189|4166336|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4338499|NCT00423189|4166337|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4338500|NCT00423189|4166338|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4338501|NCT00423189|4166339|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4338502|NCT00423189|4166336|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4338503|NCT00423189|4166337|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4338504|NCT00423189|4166338|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4338505|NCT00423189|4166339|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4338506|NCT00423189|4166336|B4|||Age||years|Mean|72|72.0|Standard Deviation|5|5.0|||
4338507|NCT00423189|4166337|B3|||Age||years|Mean|67|67.0|Standard Deviation|5|5.0|||
4338508|NCT00423189|4166338|B2|||Age||years|Mean|78|78.0|Standard Deviation|7|7.0|||
4338509|NCT00423189|4166339|B1|||Age||years|Mean|73|73.0|Standard Deviation|3|3.0|||
4338510|NCT00423176|4166361|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4338511|NCT00423176|4166362|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4338512|NCT00423176|4166363|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4338513|NCT00423176|4166361|B3||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4338514|NCT00423176|4166362|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4338515|NCT00423176|4166363|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4338516|NCT00423176|4166361|B3|||Age||years|Mean|39.2|39.2|Standard Deviation|14.1|14.1|||
4338517|NCT00423176|4166362|B2|||Age||years|Mean|39.0|39.0|Standard Deviation|14.9|14.9|||
4338518|NCT00423176|4166363|B1|||Age||years|Mean|39.3|39.3|Standard Deviation|13.2|13.2|||
4338519|NCT00423176|4166361|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4338520|NCT00423176|4166362|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4338521|NCT00423176|4166363|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4338522|NCT00423176|4166361|B3||Between 18 and 65 years|Age||Participants|Count of Participants|213|213.0||||||
4338523|NCT00423176|4166362|B2||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
4338524|NCT00423176|4166363|B1||Between 18 and 65 years|Age||Participants|Count of Participants|106|106.0||||||
4338525|NCT00423176|4166361|B3||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4338526|NCT00423176|4166362|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4338527|NCT00423176|4166363|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4338528|NCT00423150|4166372|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4338529|NCT00423150|4166372|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4338530|NCT00423150|4166372|B1|||Age||years|Mean|62.9|62.9|Standard Deviation|10.4|10.4|||
4338531|NCT00423098|4166376|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4338532|NCT00423098|4166377|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4338533|NCT00423098|4166378|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4338534|NCT00423098|4166376|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4338535|NCT00423098|4166377|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4338536|NCT00423098|4166378|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4338537|NCT00423098|4166376|B3|>=60 years||Age, Customized||participants|Number|1|1.0||||||
4338538|NCT00423098|4166377|B2|>=60 years||Age, Customized||participants|Number|1|1.0||||||
4338539|NCT00423098|4166378|B1|>=60 years||Age, Customized||participants|Number|0|0.0||||||
4338540|NCT00423098|4166376|B3|50-59 years||Age, Customized||participants|Number|6|6.0||||||
4338541|NCT00423098|4166377|B2|50-59 years||Age, Customized||participants|Number|4|4.0||||||
4338542|NCT00423098|4166378|B1|50-59 years||Age, Customized||participants|Number|2|2.0||||||
4338543|NCT00423098|4166376|B3|40-49 years||Age, Customized||participants|Number|10|10.0||||||
4338544|NCT00423098|4166377|B2|40-49 years||Age, Customized||participants|Number|6|6.0||||||
4338545|NCT00423098|4166378|B1|40-49 years||Age, Customized||participants|Number|4|4.0||||||
4338546|NCT00423098|4166376|B3|30-39 years||Age, Customized||participants|Number|26|26.0||||||
4338547|NCT00423098|4166377|B2|30-39 years||Age, Customized||participants|Number|10|10.0||||||
4338548|NCT00423098|4166378|B1|30-39 years||Age, Customized||participants|Number|16|16.0||||||
4338549|NCT00423098|4166376|B3|18-29 years||Age, Customized||participants|Number|38|38.0||||||
4338550|NCT00423098|4166377|B2|18-29 years||Age, Customized||participants|Number|18|18.0||||||
4338551|NCT00423098|4166378|B1|18-29 years||Age, Customized||participants|Number|20|20.0||||||
4338552|NCT00423098|4166376|B3|||Age||years|Mean|33.1|33.1|Standard Deviation|9.65|9.65|||
4338553|NCT00423098|4166377|B2|||Age||years|Mean|34.2|34.2|Standard Deviation|10.74|10.74|||
4338554|NCT00423098|4166378|B1|||Age||years|Mean|32.2|32.2|Standard Deviation|8.53|8.53|||
4338555|NCT00423085|4166403|B4||Male|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
4338556|NCT00423085|4166404|B3||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4338557|NCT00423085|4166405|B2||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4338558|NCT00423085|4166406|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4338559|NCT00423085|4166403|B4||Female|Sex: Female, Male||Participants|Count of Participants|584|584.0||||||
4338560|NCT00423085|4166404|B3||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4338561|NCT00423085|4166405|B2||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4338562|NCT00423085|4166406|B1||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4338563|NCT00423085|4166403|B4|||Age|Demographic data for the double-blind treatment phase is provided for the safety population. This population consists of all randomized patients who received at least one dose of study medication and had at least one safety assessment after baseline.|years|Mean|74.6|74.6|Standard Deviation|7.22|7.22|||
4338564|NCT00423085|4166404|B3|||Age|Demographic data for the double-blind treatment phase is provided for the safety population. This population consists of all randomized patients who received at least one dose of study medication and had at least one safety assessment after baseline.|years|Mean|75.1|75.1|Standard Deviation|6.85|6.85|||
4338565|NCT00423085|4166405|B2|||Age|Demographic data for the double-blind treatment phase is provided for the safety population. This population consists of all randomized patients who received at least one dose of study medication and had at least one safety assessment after baseline.|years|Mean|74.3|74.3|Standard Deviation|7.46|7.46|||
4338566|NCT00423085|4166406|B1|||Age|Demographic data for the double-blind treatment phase is provided for the safety population. This population consists of all randomized patients who received at least one dose of study medication and had at least one safety assessment after baseline.|years|Mean|74.5|74.5|Standard Deviation|7.36|7.36|||
4338567|NCT00423046|4166436|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4338568|NCT00423046|4166437|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4338569|NCT00423046|4166438|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4338570|NCT00423046|4166436|B3||Female|Sex: Female, Male||Participants|Count of Participants|1106|1106.0||||||
4338571|NCT00423046|4166437|B2||Female|Sex: Female, Male||Participants|Count of Participants|553|553.0||||||
4338572|NCT00423046|4166438|B1||Female|Sex: Female, Male||Participants|Count of Participants|553|553.0||||||
4338573|NCT00423046|4166436|B3|||Age||years|Mean|30.25|30.25|Standard Deviation|7.9|7.9|||
4338574|NCT00423046|4166437|B2|||Age||years|Mean|30.2|30.2|Standard Deviation|7.78|7.78|||
4338575|NCT00423046|4166438|B1|||Age||years|Mean|30.3|30.3|Standard Deviation|8.02|8.02|||
4338576|NCT00422903|4166522|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4338577|NCT00422903|4166523|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4338578|NCT00422903|4166524|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4338579|NCT00422903|4166522|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4338580|NCT00422903|4166523|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4338581|NCT00422903|4166524|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4338582|NCT00422903|4166522|B3|||Age||Years|Median|70|70.0|Full Range|||47.0|88.0|
4338583|NCT00422903|4166523|B2|||Age||Years|Median|70|70.0|Full Range|||49.0|88.0|
4338584|NCT00422903|4166524|B1|||Age||Years|Median|70|70.0|Full Range|||47.0|88.0|
4338585|NCT00422812|4166549|B5|United States||Region of Enrollment||participants|Number|400|400.0||||||
4338586|NCT00422812|4166550|B4|United States||Region of Enrollment||participants|Number|105|105.0||||||
4338587|NCT00422812|4166551|B3|United States||Region of Enrollment||participants|Number|93|93.0||||||
4338588|NCT00422812|4166552|B2|United States||Region of Enrollment||participants|Number|104|104.0||||||
4338589|NCT00422812|4166553|B1|United States||Region of Enrollment||participants|Number|98|98.0||||||
4338590|NCT00422812|4166549|B5||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4338591|NCT00422812|4166550|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4338592|NCT00422812|4166551|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4338593|NCT00422812|4166552|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4338594|NCT00422812|4166553|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4338595|NCT00422812|4166549|B5||Female|Sex: Female, Male||Participants|Count of Participants|349|349.0||||||
4338596|NCT00422812|4166550|B4||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4338597|NCT00422812|4166551|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4338598|NCT00422812|4166552|B2||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4338599|NCT00422812|4166553|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4338600|NCT00422812|4166549|B5|||Age||years|Mean|41.8|41.8|Standard Deviation|11.9|11.9|||
4338601|NCT00422812|4166550|B4|||Age||years|Mean|40.6|40.6|Standard Deviation|12.1|12.1|||
4338602|NCT00422812|4166551|B3|||Age||years|Mean|42.9|42.9|Standard Deviation|11.3|11.3|||
4338603|NCT00422812|4166552|B2|||Age||years|Mean|41.7|41.7|Standard Deviation|11.8|11.8|||
4338604|NCT00422812|4166553|B1|||Age||years|Mean|42.0|42.0|Standard Deviation|12.4|12.4|||
4338605|NCT00422812|4166549|B5||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4338606|NCT00422812|4166550|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4338607|NCT00422812|4166551|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4338608|NCT00422812|4166552|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4338609|NCT00422812|4166553|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4338610|NCT00422812|4166549|B5||Between 18 and 65 years|Age||Participants|Count of Participants|395|395.0||||||
4338611|NCT00422812|4166550|B4||Between 18 and 65 years|Age||Participants|Count of Participants|103|103.0||||||
4338612|NCT00422812|4166551|B3||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
4338613|NCT00422812|4166552|B2||Between 18 and 65 years|Age||Participants|Count of Participants|103|103.0||||||
4338614|NCT00422812|4166553|B1||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
4338615|NCT00422812|4166549|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4338616|NCT00422812|4166550|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4338617|NCT00422812|4166551|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4338618|NCT00422812|4166552|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4338619|NCT00422812|4166553|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4338620|NCT00422799|4166574|B1|United States||Region of Enrollment||participants|Number|63|63.0||||||
4338621|NCT00422799|4166574|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4338622|NCT00422799|4166574|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4338623|NCT00422799|4166574|B1|||Age||years|Median|63|63.0|Full Range|||43.0|86.0|
4338624|NCT00422799|4166574|B1||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4338625|NCT00422799|4166574|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4338626|NCT00422799|4166574|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4338627|NCT00422734|4166581|B3|||International Index of Erectile Function (IIEF) - Erectile Function Domain|Self-reported erectile function over the past 4 weeks. Scores range from 0 (low or no erectile function) to 5 (high erectile function) on 6 questions (1-5, 15 of the IIEF). Total Erectile Function Domain scores range from 0 to 30.|units on a scale|Mean|15.62|15.62|Standard Deviation|6.21|6.21|||
4338628|NCT00422734|4166582|B2|||International Index of Erectile Function (IIEF) - Erectile Function Domain|Self-reported erectile function over the past 4 weeks. Scores range from 0 (low or no erectile function) to 5 (high erectile function) on 6 questions (1-5, 15 of the IIEF). Total Erectile Function Domain scores range from 0 to 30.|units on a scale|Mean|15.73|15.73|Standard Deviation|6.13|6.13|||
4338629|NCT00422734|4166583|B1|||International Index of Erectile Function (IIEF) - Erectile Function Domain|Self-reported erectile function over the past 4 weeks. Scores range from 0 (low or no erectile function) to 5 (high erectile function) on 6 questions (1-5, 15 of the IIEF). Total Erectile Function Domain scores range from 0 to 30.|units on a scale|Mean|15.27|15.27|Standard Deviation|6.49|6.49|||
4338630|NCT00422734|4166581|B3|Native American||Race/Ethnicity||participants|Number|1|1.0||||||
4338631|NCT00422734|4166582|B2|Native American||Race/Ethnicity||participants|Number|1|1.0||||||
4338632|NCT00422734|4166583|B1|Native American||Race/Ethnicity||participants|Number|0|0.0||||||
4338633|NCT00422734|4166581|B3|Hispanic||Race/Ethnicity||participants|Number|90|90.0||||||
4338634|NCT00422734|4166582|B2|Hispanic||Race/Ethnicity||participants|Number|69|69.0||||||
4338635|NCT00422734|4166583|B1|Hispanic||Race/Ethnicity||participants|Number|21|21.0||||||
4338636|NCT00422734|4166581|B3|Caucasian||Race/Ethnicity||participants|Number|245|245.0||||||
4338637|NCT00422734|4166582|B2|Caucasian||Race/Ethnicity||participants|Number|188|188.0||||||
4338638|NCT00422734|4166583|B1|Caucasian||Race/Ethnicity||participants|Number|57|57.0||||||
4338639|NCT00422734|4166581|B3|African||Race/Ethnicity||participants|Number|6|6.0||||||
4338640|NCT00422734|4166582|B2|African||Race/Ethnicity||participants|Number|6|6.0||||||
4338641|NCT00422734|4166583|B1|African||Race/Ethnicity||participants|Number|0|0.0||||||
4338642|NCT00422734|4166581|B3|Missing||International Index of Erectile Function (IIEF) - Erectile Dysfunction Severity||participants|Number|8.0|8.0||||||
4338643|NCT00422734|4166582|B2|Missing||International Index of Erectile Function (IIEF) - Erectile Dysfunction Severity||participants|Number|7|7.0||||||
4338644|NCT00422734|4166583|B1|Missing||International Index of Erectile Function (IIEF) - Erectile Dysfunction Severity||participants|Number|1|1.0||||||
4338645|NCT00422734|4166581|B3|Severe (1-10)||International Index of Erectile Function (IIEF) - Erectile Dysfunction Severity||participants|Number|83.0|83.0||||||
4338646|NCT00422734|4166582|B2|Severe (1-10)||International Index of Erectile Function (IIEF) - Erectile Dysfunction Severity||participants|Number|63|63.0||||||
4338647|NCT00422734|4166583|B1|Severe (1-10)||International Index of Erectile Function (IIEF) - Erectile Dysfunction Severity||participants|Number|20|20.0||||||
4338648|NCT00422734|4166581|B3|Moderate (11-16)||International Index of Erectile Function (IIEF) - Erectile Dysfunction Severity||participants|Number|93.0|93.0||||||
4338649|NCT00422734|4166582|B2|Moderate (11-16)||International Index of Erectile Function (IIEF) - Erectile Dysfunction Severity||participants|Number|71|71.0||||||
4338650|NCT00422734|4166583|B1|Moderate (11-16)||International Index of Erectile Function (IIEF) - Erectile Dysfunction Severity||participants|Number|22|22.0||||||
4338651|NCT00422734|4166581|B3|Mild (17-30)||International Index of Erectile Function (IIEF) - Erectile Dysfunction Severity||participants|Number|158.0|158.0||||||
4338652|NCT00422734|4166582|B2|Mild (17-30)||International Index of Erectile Function (IIEF) - Erectile Dysfunction Severity||participants|Number|123|123.0||||||
4338653|NCT00422734|4166583|B1|Mild (17-30)||International Index of Erectile Function (IIEF) - Erectile Dysfunction Severity||participants|Number|35|35.0||||||
4338654|NCT00422734|4166581|B3|Unknown||Erectile Dysfunction History - Etiology||participants|Number|32|32.0||||||
4338655|NCT00422734|4166582|B2|Unknown||Erectile Dysfunction History - Etiology||participants|Number|29|29.0||||||
4338656|NCT00422734|4166583|B1|Unknown||Erectile Dysfunction History - Etiology||participants|Number|3|3.0||||||
4338657|NCT00422734|4166581|B3|Psychogenic||Erectile Dysfunction History - Etiology||participants|Number|42|42.0||||||
4338658|NCT00422734|4166582|B2|Psychogenic||Erectile Dysfunction History - Etiology||participants|Number|30|30.0||||||
4338659|NCT00422734|4166583|B1|Psychogenic||Erectile Dysfunction History - Etiology||participants|Number|12|12.0||||||
4338660|NCT00422734|4166581|B3|Organic||Erectile Dysfunction History - Etiology||participants|Number|120|120.0||||||
4338661|NCT00422734|4166582|B2|Organic||Erectile Dysfunction History - Etiology||participants|Number|91|91.0||||||
4338662|NCT00422734|4166583|B1|Organic||Erectile Dysfunction History - Etiology||participants|Number|29|29.0||||||
4338663|NCT00422734|4166581|B3|Mixed||Erectile Dysfunction History - Etiology||participants|Number|148|148.0||||||
4338664|NCT00422734|4166582|B2|Mixed||Erectile Dysfunction History - Etiology||participants|Number|114|114.0||||||
4338665|NCT00422734|4166583|B1|Mixed||Erectile Dysfunction History - Etiology||participants|Number|34|34.0||||||
4338666|NCT00422734|4166581|B3|>= 6 months and < 1 year||Erectile Dysfunction History - Duration||participants|Number|20|20.0||||||
4338667|NCT00422734|4166582|B2|>= 6 months and < 1 year||Erectile Dysfunction History - Duration||participants|Number|16|16.0||||||
4338668|NCT00422734|4166583|B1|>= 6 months and < 1 year||Erectile Dysfunction History - Duration||participants|Number|4|4.0||||||
4338669|NCT00422734|4166581|B3|>= 3 months and < 6 months||Erectile Dysfunction History - Duration||participants|Number|9|9.0||||||
4338670|NCT00422734|4166582|B2|>= 3 months and < 6 months||Erectile Dysfunction History - Duration||participants|Number|8|8.0||||||
4338671|NCT00422734|4166583|B1|>= 3 months and < 6 months||Erectile Dysfunction History - Duration||participants|Number|1|1.0||||||
4338672|NCT00422734|4166581|B3|>= 1 year||Erectile Dysfunction History - Duration||participants|Number|313|313.0||||||
4338673|NCT00422734|4166582|B2|>= 1 year||Erectile Dysfunction History - Duration||participants|Number|240|240.0||||||
4338674|NCT00422734|4166583|B1|>= 1 year||Erectile Dysfunction History - Duration||participants|Number|73|73.0||||||
4338675|NCT00422734|4166581|B3|Germany||Region of Enrollment||participants|Number|47|47.0||||||
4338676|NCT00422734|4166582|B2|Germany||Region of Enrollment||participants|Number|36|36.0||||||
4338677|NCT00422734|4166583|B1|Germany||Region of Enrollment||participants|Number|11|11.0||||||
4338678|NCT00422734|4166581|B3|Austria||Region of Enrollment||participants|Number|25|25.0||||||
4338679|NCT00422734|4166582|B2|Austria||Region of Enrollment||participants|Number|17|17.0||||||
4338680|NCT00422734|4166583|B1|Austria||Region of Enrollment||participants|Number|8|8.0||||||
4338681|NCT00422734|4166581|B3|Mexico||Region of Enrollment||participants|Number|82|82.0||||||
4338682|NCT00422734|4166582|B2|Mexico||Region of Enrollment||participants|Number|63|63.0||||||
4338683|NCT00422734|4166583|B1|Mexico||Region of Enrollment||participants|Number|19|19.0||||||
4338684|NCT00422734|4166581|B3|United States||Region of Enrollment||participants|Number|136|136.0||||||
4338685|NCT00422734|4166582|B2|United States||Region of Enrollment||participants|Number|107|107.0||||||
4338686|NCT00422734|4166583|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4338687|NCT00422734|4166581|B3|France||Region of Enrollment||participants|Number|52|52.0||||||
4338688|NCT00422734|4166582|B2|France||Region of Enrollment||participants|Number|41|41.0||||||
4338689|NCT00422734|4166583|B1|France||Region of Enrollment||participants|Number|11|11.0||||||
4338690|NCT00422734|4166581|B3||Male|Sex: Female, Male||Participants|Count of Participants|342|342.0||||||
4338691|NCT00422734|4166582|B2||Male|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
4338692|NCT00422734|4166583|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4338693|NCT00422734|4166581|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4338694|NCT00422734|4166582|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4338695|NCT00422734|4166583|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4338696|NCT00422734|4166581|B3|||Age||years|Mean|54.29|54.29|Standard Deviation|10.18|10.18|||
4338697|NCT00422734|4166582|B2|||Age||years|Mean|54.42|54.42|Standard Deviation|10.04|10.04|||
4338698|NCT00422734|4166583|B1|||Age||years|Mean|53.82|53.82|Standard Deviation|10.72|10.72|||
4338699|NCT00422695|4166616|B3|United States||Region of Enrollment||participants|Number|143|143.0||||||
4338700|NCT00422695|4166617|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
4338701|NCT00422695|4166618|B1|United States||Region of Enrollment||participants|Number|105|105.0||||||
4338702|NCT00422695|4166616|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4338703|NCT00422695|4166617|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338704|NCT00422695|4166618|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4338705|NCT00422695|4166616|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338706|NCT00422695|4166617|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338707|NCT00422695|4166618|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338708|NCT00422695|4166616|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4338709|NCT00422695|4166617|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4338710|NCT00422695|4166618|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4338711|NCT00422695|4166616|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
4338712|NCT00422695|4166617|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4338713|NCT00422695|4166618|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
4338714|NCT00422695|4166616|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338715|NCT00422695|4166617|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338716|NCT00422695|4166618|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338717|NCT00422695|4166616|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338718|NCT00422695|4166617|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338719|NCT00422695|4166618|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338720|NCT00422695|4166616|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338721|NCT00422695|4166617|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338722|NCT00422695|4166618|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338723|NCT00422695|4166616|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4338724|NCT00422695|4166617|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4338725|NCT00422695|4166618|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4338726|NCT00422695|4166616|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4338727|NCT00422695|4166617|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4338728|NCT00422695|4166618|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4338729|NCT00422695|4166616|B3|||Age||years|Mean|45.06|45.06|Standard Deviation|8.64|8.64|||
4338730|NCT00422695|4166617|B2|||Age||years|Mean|42.53|42.53|Standard Deviation|12.57|12.57|||
4338731|NCT00422695|4166618|B1|||Age||years|Mean|45.97|45.97|Standard Deviation|7.22|7.22|||
4338732|NCT00422695|4166616|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4338733|NCT00422695|4166617|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4338734|NCT00422695|4166618|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4338735|NCT00422695|4166616|B3||Between 18 and 65 years|Age||Participants|Count of Participants|143|143.0||||||
4338736|NCT00422695|4166617|B2||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4338737|NCT00422695|4166618|B1||Between 18 and 65 years|Age||Participants|Count of Participants|105|105.0||||||
4338738|NCT00422695|4166616|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4338739|NCT00422695|4166617|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4338740|NCT00422695|4166618|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4338741|NCT00422669|4166627|B4|Italy||Region of Enrollment||participants|Number|25|25.0||||||
4338742|NCT00422669|4166628|B3|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4338743|NCT00422669|4166629|B2|Italy||Region of Enrollment||participants|Number|12|12.0||||||
4338744|NCT00422669|4166630|B1|Italy||Region of Enrollment||participants|Number|13|13.0||||||
4338745|NCT00422669|4166627|B4|Israel||Region of Enrollment||participants|Number|9|9.0||||||
4338746|NCT00422669|4166628|B3|Israel||Region of Enrollment||participants|Number|0|0.0||||||
4338747|NCT00422669|4166629|B2|Israel||Region of Enrollment||participants|Number|4|4.0||||||
4338748|NCT00422669|4166630|B1|Israel||Region of Enrollment||participants|Number|5|5.0||||||
4338749|NCT00422669|4166627|B4|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4338750|NCT00422669|4166628|B3|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4338751|NCT00422669|4166629|B2|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4338752|NCT00422669|4166630|B1|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4338753|NCT00422669|4166627|B4|United States||Region of Enrollment||participants|Number|160|160.0||||||
4338754|NCT00422669|4166628|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4338755|NCT00422669|4166629|B2|United States||Region of Enrollment||participants|Number|78|78.0||||||
4338756|NCT00422669|4166630|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
4338757|NCT00422669|4166627|B4|Male||Gender||participants|Number|122|122.0||||||
4338758|NCT00422669|4166628|B3|Male||Gender||participants|Number|NA|||||||The data were not submitted due to not meeting in/exclusion criteria
4338759|NCT00422669|4166629|B2|Male||Gender||participants|Number|61|61.0||||||
4338760|NCT00422669|4166630|B1|Male||Gender||participants|Number|61|61.0||||||
4338761|NCT00422669|4166627|B4|Female||Gender||participants|Number|76|76.0||||||
4338762|NCT00422669|4166628|B3|Female||Gender||participants|Number|NA|||||||The data were not submitted due to not meeting in/exclusion criteria
4338763|NCT00422669|4166629|B2|Female||Gender||participants|Number|39|39.0||||||
4338764|NCT00422669|4166630|B1|Female||Gender||participants|Number|37|37.0||||||
4338765|NCT00422669|4166627|B4|||Age||years|Mean|77.1|77.1|Standard Deviation|10.8|10.8|||
4338766|NCT00422669|4166628|B3|||Age||years|Mean|NA||Standard Deviation|NA||||The data were not submitted due to not meeting in/exclusion criteria
4338767|NCT00422669|4166629|B2|||Age||years|Mean|77.1|77.1|Standard Deviation|10.5|10.5|||
4338768|NCT00422669|4166630|B1|||Age||years|Mean|77.1|77.1|Standard Deviation|11.2|11.2|||
4338769|NCT00422656|4166653|B1|United States||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
4338770|NCT00422656|4166653|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338771|NCT00422656|4166653|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338772|NCT00422656|4166653|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4338773|NCT00422656|4166653|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4338774|NCT00422656|4166653|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338775|NCT00422656|4166653|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338776|NCT00422656|4166653|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338777|NCT00422656|4166653|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4338778|NCT00422656|4166653|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4338779|NCT00422656|4166653|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338780|NCT00422656|4166653|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4338781|NCT00422656|4166653|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4338782|NCT00422656|4166653|B1|||Age||years|Median|65|65.0|Full Range|||44.0|82.0|
4338783|NCT00422591|4166660|B1|United States||Region of Enrollment||participants|Number|175|175.0||||||
4338784|NCT00422591|4166660|B1||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4338785|NCT00422591|4166660|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4338786|NCT00422591|4166660|B1|||Age||years|Median|55|55.0|Full Range|||19.0|73.0|
4338787|NCT00422591|4166660|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4338788|NCT00422591|4166660|B1||Between 18 and 65 years|Age||Participants|Count of Participants|156|156.0||||||
4338789|NCT00422591|4166660|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4338790|NCT00422513|4166666|B3||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4338791|NCT00422513|4166667|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4338792|NCT00422513|4166668|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4338793|NCT00422513|4166666|B3||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4338794|NCT00422513|4166667|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4338795|NCT00422513|4166668|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4338796|NCT00422513|4166666|B3|||Age|Eight patients were excluded from the safety population: 7 patients in the Methoxy Polyethylene Glycol-epoetin Beta group and 1 patient in the epoetin alfa group. Six patients in the Methoxy Polyethylene Glycol-epoetin Beta group did not receive study medication. Seven patients in the Methoxy Polyethylene Glycol-epoetin Beta group and 1 patient in the epoetin alfa group did not have a postbaseline safety assessment.|years|Mean|59.7|59.7|Standard Deviation|13.96|13.96|||
4338797|NCT00422513|4166667|B2|||Age|Eight patients were excluded from the safety population: 7 patients in the Methoxy Polyethylene Glycol-epoetin Beta group and 1 patient in the epoetin alfa group. Six patients in the Methoxy Polyethylene Glycol-epoetin Beta group did not receive study medication. Seven patients in the Methoxy Polyethylene Glycol-epoetin Beta group and 1 patient in the epoetin alfa group did not have a postbaseline safety assessment.|years|Mean|60.0|60.0|Standard Deviation|14.06|14.06|||
4338798|NCT00422513|4166668|B1|||Age|Eight patients were excluded from the safety population: 7 patients in the Methoxy Polyethylene Glycol-epoetin Beta group and 1 patient in the epoetin alfa group. Six patients in the Methoxy Polyethylene Glycol-epoetin Beta group did not receive study medication. Seven patients in the Methoxy Polyethylene Glycol-epoetin Beta group and 1 patient in the epoetin alfa group did not have a postbaseline safety assessment.|years|Mean|59.3|59.3|Standard Deviation|13.90|13.9|||
4338799|NCT00422448|4166681|B1|Italy||Region of Enrollment||participants|Number|21|21.0||||||
4338800|NCT00422448|4166681|B1|Austria||Region of Enrollment||participants|Number|22|22.0||||||
4338801|NCT00422448|4166681|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4338802|NCT00422448|4166681|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4338803|NCT00422448|4166681|B1|||Age||years|Mean|39.3|39.3|Standard Deviation|9.413|9.413|||
4338804|NCT00422448|4166681|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4338805|NCT00422448|4166681|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4338806|NCT00422448|4166681|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4338807|NCT00422422|4166686|B1|Other||Racial Group||participants|Number|16|16.0||||||
4338808|NCT00422422|4166686|B1|White||Racial Group||participants|Number|80|80.0||||||
4338809|NCT00422422|4166686|B1|Black or African American||Racial Group||participants|Number|4|4.0||||||
4338810|NCT00422422|4166686|B1|||BMI||kg/m^2|Median|17.1|17.1|Standard Deviation|3.4|3.4|||
4338811|NCT00422422|4166686|B1|||Height||centimeters|Mean|111.8|111.8|Standard Deviation|32.9|32.9|||
4338812|NCT00422422|4166686|B1|||Weight||kilograms|Mean|24.2|24.2|Standard Deviation|16.2|16.2|||
4338813|NCT00422422|4166686|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4338814|NCT00422422|4166686|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4338815|NCT00422422|4166686|B1|||Age||years|Mean|6.3|6.3|Standard Deviation|4.8|4.8|||
4338816|NCT00422383|4166698|B6||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4338817|NCT00422383|4166699|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4338818|NCT00422383|4166700|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4338819|NCT00422383|4166701|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4338820|NCT00422383|4166702|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4338821|NCT00422383|4166703|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4338822|NCT00422383|4166698|B6||Female|Sex: Female, Male||Participants|Count of Participants|297|297.0||||||
4338823|NCT00422383|4166699|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4338824|NCT00422383|4166700|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4338825|NCT00422383|4166701|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4338826|NCT00422383|4166702|B2||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4338827|NCT00422383|4166703|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4338828|NCT00422383|4166698|B6|||Age||years|Mean|52.48|52.48|Standard Deviation|12.10|12.1|||
4338829|NCT00422383|4166699|B5|||Age||years|Mean|52.32|52.32|Standard Deviation|8.882|8.882|||
4338830|NCT00422383|4166700|B4|||Age||years|Mean|51.83|51.83|Standard Deviation|6.274|6.274|||
4338831|NCT00422383|4166701|B3|||Age||years|Mean|51.26|51.26|Standard Deviation|12.179|12.179|||
4338832|NCT00422383|4166702|B2|||Age||years|Mean|52.32|52.32|Standard Deviation|12.115|12.115|||
4338833|NCT00422383|4166703|B1|||Age||years|Mean|53.58|53.58|Standard Deviation|12.805|12.805|||
4338834|NCT00422292|4166846|B5|United States||Region of Enrollment||participants|Number|1643|1643.0||||||
4338835|NCT00422292|4166847|B4|United States||Region of Enrollment||participants|Number|476|476.0||||||
4338836|NCT00422292|4166848|B3|United States||Region of Enrollment||participants|Number|246|246.0||||||
4338837|NCT00422292|4166849|B2|United States||Region of Enrollment||participants|Number|664|664.0||||||
4338838|NCT00422292|4166850|B1|United States||Region of Enrollment||participants|Number|257|257.0||||||
4338839|NCT00422292|4166846|B5||Male|Sex: Female, Male||Participants|Count of Participants|826|826.0||||||
4338840|NCT00422292|4166847|B4||Male|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4338841|NCT00422292|4166848|B3||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4338842|NCT00422292|4166849|B2||Male|Sex: Female, Male||Participants|Count of Participants|315|315.0||||||
4338843|NCT00422292|4166850|B1||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4338844|NCT00422292|4166846|B5||Female|Sex: Female, Male||Participants|Count of Participants|817|817.0||||||
4338845|NCT00422292|4166847|B4||Female|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
4338846|NCT00422292|4166848|B3||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4338847|NCT00422292|4166849|B2||Female|Sex: Female, Male||Participants|Count of Participants|349|349.0||||||
4338848|NCT00422292|4166850|B1||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4338849|NCT00422292|4166846|B5|||Age||Days|Mean|283.4|283.4|Standard Deviation|11.3|11.3|||
4338850|NCT00422292|4166847|B4|||Age||Days|Mean|374.8|374.8|Standard Deviation|8.6|8.6|||
4338851|NCT00422292|4166848|B3|||Age||Days|Mean|282.8|282.8|Standard Deviation|10.3|10.3|||
4338852|NCT00422292|4166849|B2|||Age||Days|Mean|283.0|283.0|Standard Deviation|11.3|11.3|||
4338853|NCT00422292|4166850|B1|||Age||Days|Mean|283.4|283.4|Standard Deviation|11.3|11.3|||
4338854|NCT00422292|4166846|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4338855|NCT00422292|4166847|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4338856|NCT00422292|4166848|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4338857|NCT00422292|4166849|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4338858|NCT00422292|4166850|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4338859|NCT00422292|4166846|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4338860|NCT00422292|4166847|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4338861|NCT00422292|4166848|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4338862|NCT00422292|4166849|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4338863|NCT00422292|4166850|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4338864|NCT00422292|4166846|B5||<=18 years|Age||Participants|Count of Participants|1643|1643.0||||||
4338865|NCT00422292|4166847|B4||<=18 years|Age||Participants|Count of Participants|476|476.0||||||
4338866|NCT00422292|4166848|B3||<=18 years|Age||Participants|Count of Participants|246|246.0||||||
4338867|NCT00422292|4166849|B2||<=18 years|Age||Participants|Count of Participants|664|664.0||||||
4338868|NCT00422292|4166850|B1||<=18 years|Age||Participants|Count of Participants|257|257.0||||||
4338869|NCT00422279|4166879|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4338870|NCT00422279|4166880|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4338871|NCT00422279|4166881|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4338872|NCT00422279|4166879|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4338873|NCT00422279|4166880|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4338874|NCT00422279|4166881|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4338875|NCT00422279|4166879|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4338876|NCT00422279|4166880|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4338877|NCT00422279|4166881|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4338878|NCT00422279|4166879|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4338879|NCT00422279|4166880|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4338880|NCT00422279|4166881|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4338881|NCT00422279|4166879|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4338882|NCT00422279|4166880|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4338883|NCT00422279|4166881|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4338884|NCT00422279|4166879|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4338885|NCT00422279|4166880|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4338886|NCT00422279|4166881|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4338887|NCT00422227|4166890|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4338888|NCT00422227|4166891|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4338889|NCT00422227|4166892|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4338890|NCT00422227|4166890|B3||Female|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
4338891|NCT00422227|4166891|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4338892|NCT00422227|4166892|B1||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4338893|NCT00422227|4166890|B3|||Age||years|Mean|48.43|48.43|Standard Deviation|11.72|11.72|||
4338894|NCT00422227|4166891|B2|||Age||years|Mean|48.52|48.52|Standard Deviation|11.25|11.25|||
4338895|NCT00422227|4166892|B1|||Age||years|Mean|48.38|48.38|Standard Deviation|11.98|11.98|||
4338896|NCT00422201|4166917|B1|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4338897|NCT00422201|4166917|B1|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4338898|NCT00422201|4166917|B1|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
4338899|NCT00422201|4166917|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4338900|NCT00422201|4166917|B1|France||Region of Enrollment||participants|Number|2|2.0||||||
4338901|NCT00422201|4166917|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4338902|NCT00422201|4166917|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4338903|NCT00422201|4166917|B1|||Age||years|Mean|53.9|53.9|Standard Deviation|12.48|12.48|||
4338904|NCT00422201|4166917|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4338905|NCT00422201|4166917|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4338906|NCT00422201|4166917|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4338907|NCT00422162|4166921|B3|||Weight||kilograms (kg)|Mean|70.5|70.5|Standard Deviation|15.9|15.9|||
4338908|NCT00422162|4166922|B2|||Weight||kilograms (kg)|Mean|70.6|70.6|Standard Deviation|15.2|15.2|||
4338909|NCT00422162|4166923|B1|||Weight||kilograms (kg)|Mean|70.4|70.4|Standard Deviation|16.7|16.7|||
4338910|NCT00422162|4166921|B3|||Pulse Rate||beats per minute|Mean|75.9|75.9|Standard Deviation|9.0|9.0|||
4338911|NCT00422162|4166922|B2|||Pulse Rate||beats per minute|Mean|75.8|75.8|Standard Deviation|9.2|9.2|||
4338912|NCT00422162|4166923|B1|||Pulse Rate||beats per minute|Mean|76.0|76.0|Standard Deviation|8.8|8.8|||
4338913|NCT00422162|4166921|B3|||Number of Previous Major Depressive Disorder (MDD) Episodes|Number of previous MDD episodes for participants who experienced previous MDD episodes.|number of episodes|Mean|3.2|3.2|Standard Deviation|2.9|2.9|||
4338914|NCT00422162|4166922|B2|||Number of Previous Major Depressive Disorder (MDD) Episodes|Number of previous MDD episodes for participants who experienced previous MDD episodes.|number of episodes|Mean|3.1|3.1|Standard Deviation|3.0|3.0|||
4338915|NCT00422162|4166923|B1|||Number of Previous Major Depressive Disorder (MDD) Episodes|Number of previous MDD episodes for participants who experienced previous MDD episodes.|number of episodes|Mean|3.2|3.2|Standard Deviation|2.7|2.7|||
4338916|NCT00422162|4166921|B3|||Number of Previous Hospitalizations|Number of hospitalizations for MDD in participants who experienced previous MDD episodes.|number of hospitalizations|Mean|1.4|1.4|Standard Deviation|2.0|2.0|||
4338917|NCT00422162|4166922|B2|||Number of Previous Hospitalizations|Number of hospitalizations for MDD in participants who experienced previous MDD episodes.|number of hospitalizations|Mean|1.5|1.5|Standard Deviation|2.3|2.3|||
4338918|NCT00422162|4166923|B1|||Number of Previous Hospitalizations|Number of hospitalizations for MDD in participants who experienced previous MDD episodes.|number of hospitalizations|Mean|1.3|1.3|Standard Deviation|1.6|1.6|||
4338919|NCT00422162|4166921|B3|||Height||centimeters (cm)|Mean|166.8|166.8|Standard Deviation|7.9|7.9|||
4338920|NCT00422162|4166922|B2|||Height||centimeters (cm)|Mean|166.5|166.5|Standard Deviation|7.6|7.6|||
4338921|NCT00422162|4166923|B1|||Height||centimeters (cm)|Mean|167.1|167.1|Standard Deviation|8.1|8.1|||
4338922|NCT00422162|4166921|B3|||Duration of Previous Major Depressive Disorder (MDD) Episode|Duration of previous MDD episode in participants who experienced a previous MDD episode.|weeks|Mean|15.0|15.0|Standard Deviation|15.6|15.6|||
4338923|NCT00422162|4166922|B2|||Duration of Previous Major Depressive Disorder (MDD) Episode|Duration of previous MDD episode in participants who experienced a previous MDD episode.|weeks|Mean|13.7|13.7|Standard Deviation|11.3|11.3|||
4338924|NCT00422162|4166923|B1|||Duration of Previous Major Depressive Disorder (MDD) Episode|Duration of previous MDD episode in participants who experienced a previous MDD episode.|weeks|Mean|16.4|16.4|Standard Deviation|19.0|19.0|||
4338925|NCT00422162|4166921|B3|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight in kilograms divided by height in meters squared.|kilograms/square meter (kg/m^2)|Mean|25.3|25.3|Standard Deviation|5.5|5.5|||
4338926|NCT00422162|4166922|B2|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight in kilograms divided by height in meters squared.|kilograms/square meter (kg/m^2)|Mean|25.5|25.5|Standard Deviation|5.5|5.5|||
4338927|NCT00422162|4166923|B1|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight in kilograms divided by height in meters squared.|kilograms/square meter (kg/m^2)|Mean|25.2|25.2|Standard Deviation|5.5|5.5|||
4338928|NCT00422162|4166921|B3|Diastolic Blood Pressure||Blood Pressure||mm Hg|Mean|74.7|74.7|Standard Deviation|8.3|8.3|||
4338929|NCT00422162|4166922|B2|Diastolic Blood Pressure||Blood Pressure||mm Hg|Mean|74.7|74.7|Standard Deviation|8.2|8.2|||
4338930|NCT00422162|4166923|B1|Diastolic Blood Pressure||Blood Pressure||mm Hg|Mean|74.6|74.6|Standard Deviation|8.5|8.5|||
4338931|NCT00422162|4166921|B3|Systolic Blood Pressure||Blood Pressure||mm Hg|Mean|119.1|119.1|Standard Deviation|13.7|13.7|||
4338932|NCT00422162|4166922|B2|Systolic Blood Pressure||Blood Pressure||mm Hg|Mean|119.4|119.4|Standard Deviation|14.8|14.8|||
4338933|NCT00422162|4166923|B1|Systolic Blood Pressure||Blood Pressure||mm Hg|Mean|118.7|118.7|Standard Deviation|12.4|12.4|||
4338934|NCT00422162|4166921|B3|||Age at First Major Depressive Episode||years|Mean|36.0|36.0|Standard Deviation|12.8|12.8|||
4338935|NCT00422162|4166922|B2|||Age at First Major Depressive Episode||years|Mean|35.6|35.6|Standard Deviation|12.4|12.4|||
4338936|NCT00422162|4166923|B1|||Age at First Major Depressive Episode||years|Mean|36.3|36.3|Standard Deviation|13.3|13.3|||
4338937|NCT00422162|4166921|B3|Caucasian||Race/Ethnicity||participants|Number|324|324.0||||||
4338938|NCT00422162|4166922|B2|Caucasian||Race/Ethnicity||participants|Number|163|163.0||||||
4338939|NCT00422162|4166923|B1|Caucasian||Race/Ethnicity||participants|Number|161|161.0||||||
4338940|NCT00422162|4166921|B3|Black||Race/Ethnicity||participants|Number|12|12.0||||||
4338941|NCT00422162|4166922|B2|Black||Race/Ethnicity||participants|Number|8|8.0||||||
4338942|NCT00422162|4166923|B1|Black||Race/Ethnicity||participants|Number|4|4.0||||||
4338943|NCT00422162|4166921|B3|Asian||Race/Ethnicity||participants|Number|2|2.0||||||
4338944|NCT00422162|4166922|B2|Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4338945|NCT00422162|4166923|B1|Asian||Race/Ethnicity||participants|Number|2|2.0||||||
4338946|NCT00422162|4166921|B3|No||Previous Major Depressive Disorder Episodes||participants|Number|44|44.0||||||
4338947|NCT00422162|4166922|B2|No||Previous Major Depressive Disorder Episodes||participants|Number|21|21.0||||||
4338948|NCT00422162|4166923|B1|No||Previous Major Depressive Disorder Episodes||participants|Number|23|23.0||||||
4338949|NCT00422162|4166921|B3|Yes||Previous Major Depressive Disorder Episodes||participants|Number|294|294.0||||||
4338950|NCT00422162|4166922|B2|Yes||Previous Major Depressive Disorder Episodes||participants|Number|150|150.0||||||
4338951|NCT00422162|4166923|B1|Yes||Previous Major Depressive Disorder Episodes||participants|Number|144|144.0||||||
4338952|NCT00422162|4166921|B3|Italy||Region of Enrollment||participants|Number|13|13.0||||||
4338953|NCT00422162|4166922|B2|Italy||Region of Enrollment||participants|Number|6|6.0||||||
4338954|NCT00422162|4166923|B1|Italy||Region of Enrollment||participants|Number|7|7.0||||||
4338955|NCT00422162|4166921|B3|Russian Federation||Region of Enrollment||participants|Number|165|165.0||||||
4338956|NCT00422162|4166922|B2|Russian Federation||Region of Enrollment||participants|Number|84|84.0||||||
4338957|NCT00422162|4166923|B1|Russian Federation||Region of Enrollment||participants|Number|81|81.0||||||
4338958|NCT00422162|4166921|B3|South Africa||Region of Enrollment||participants|Number|32|32.0||||||
4338959|NCT00422162|4166922|B2|South Africa||Region of Enrollment||participants|Number|17|17.0||||||
4338960|NCT00422162|4166923|B1|South Africa||Region of Enrollment||participants|Number|15|15.0||||||
4338961|NCT00422162|4166921|B3|France||Region of Enrollment||participants|Number|128|128.0||||||
4338962|NCT00422162|4166922|B2|France||Region of Enrollment||participants|Number|64|64.0||||||
4338963|NCT00422162|4166923|B1|France||Region of Enrollment||participants|Number|64|64.0||||||
4338964|NCT00422162|4166921|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4338965|NCT00422162|4166922|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4338966|NCT00422162|4166923|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4338967|NCT00422162|4166921|B3||Female|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4338968|NCT00422162|4166922|B2||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4338969|NCT00422162|4166923|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4338970|NCT00422162|4166921|B3|||Age||years|Mean|44.8|44.8|Standard Deviation|13.3|13.3|||
4338971|NCT00422162|4166922|B2|||Age||years|Mean|43.9|43.9|Standard Deviation|12.7|12.7|||
4338972|NCT00422162|4166923|B1|||Age||years|Mean|45.7|45.7|Standard Deviation|13.9|13.9|||
4338973|NCT00422097|4166978|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338974|NCT00422097|4166979|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338975|NCT00422097|4166980|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338976|NCT00422097|4166981|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338977|NCT00422097|4166982|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338978|NCT00422097|4166983|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338979|NCT00422097|4166984|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338980|NCT00422097|4166978|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338981|NCT00422097|4166979|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338982|NCT00422097|4166980|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338983|NCT00422097|4166981|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338984|NCT00422097|4166982|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338985|NCT00422097|4166983|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338986|NCT00422097|4166984|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338987|NCT00422097|4166978|B7||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4338988|NCT00422097|4166979|B6||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4338989|NCT00422097|4166980|B5||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4338990|NCT00422097|4166981|B4||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4338991|NCT00422097|4166982|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4338992|NCT00422097|4166983|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4338993|NCT00422097|4166984|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4338994|NCT00422097|4166978|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4338995|NCT00422097|4166979|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338996|NCT00422097|4166980|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4338997|NCT00422097|4166981|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4338998|NCT00422097|4166982|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4338999|NCT00422097|4166983|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4339000|NCT00422097|4166984|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339001|NCT00422097|4166978|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339002|NCT00422097|4166979|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339003|NCT00422097|4166980|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339004|NCT00422097|4166981|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339005|NCT00422097|4166982|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339006|NCT00422097|4166983|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339007|NCT00422097|4166984|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339008|NCT00422097|4166978|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4339009|NCT00422097|4166979|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339010|NCT00422097|4166980|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4339011|NCT00422097|4166981|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339012|NCT00422097|4166982|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339013|NCT00422097|4166983|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339014|NCT00422097|4166984|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339015|NCT00422097|4166978|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4339016|NCT00422097|4166979|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339017|NCT00422097|4166980|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4339018|NCT00422097|4166981|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339019|NCT00422097|4166982|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339020|NCT00422097|4166983|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339021|NCT00422097|4166984|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339022|NCT00422097|4166978|B7||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4339023|NCT00422097|4166979|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4339024|NCT00422097|4166980|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4339025|NCT00422097|4166981|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4339026|NCT00422097|4166982|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4339027|NCT00422097|4166983|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4339028|NCT00422097|4166984|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4339029|NCT00422097|4166978|B7||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4339030|NCT00422097|4166979|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4339031|NCT00422097|4166980|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4339032|NCT00422097|4166981|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4339033|NCT00422097|4166982|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4339034|NCT00422097|4166983|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4339035|NCT00422097|4166984|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4339036|NCT00422097|4166978|B7|||Age||years|Mean|60|60.0|Full Range|||40.0|83.0|
4339037|NCT00422097|4166979|B6|||Age||years|Mean|69|69.0|Full Range|||63.0|83.0|
4339038|NCT00422097|4166980|B5|||Age||years|Mean|56|56.0|Full Range|||40.0|78.0|
4339039|NCT00422097|4166981|B4|||Age||years|Mean|60|60.0|Full Range|||49.0|73.0|
4339040|NCT00422097|4166982|B3|||Age||years|Mean|60|60.0|Full Range|||50.0|74.0|
4339041|NCT00422097|4166983|B2|||Age||years|Mean|62|62.0|Full Range|||43.0|72.0|
4339042|NCT00422097|4166984|B1|||Age||years|Mean|64|64.0|Full Range|||44.0|76.0|
4339043|NCT00422097|4166978|B7||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4339044|NCT00422097|4166979|B6||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4339045|NCT00422097|4166980|B5||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4339046|NCT00422097|4166981|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4339047|NCT00422097|4166982|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4339048|NCT00422097|4166983|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4339049|NCT00422097|4166984|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4339050|NCT00422097|4166978|B7||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4339051|NCT00422097|4166979|B6||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4339052|NCT00422097|4166980|B5||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4339053|NCT00422097|4166981|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4339054|NCT00422097|4166982|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4339055|NCT00422097|4166983|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4339056|NCT00422097|4166984|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4339057|NCT00422097|4166978|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339058|NCT00422097|4166979|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339059|NCT00422097|4166980|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339060|NCT00422097|4166981|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339061|NCT00422097|4166982|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339062|NCT00422097|4166983|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339063|NCT00422097|4166984|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339064|NCT00422058|4167050|B7|Diastolic||Blood pressure||mmHg|Mean|77.9|77.9|Standard Deviation|8.4|8.4|||
4339065|NCT00422058|4167051|B6|Diastolic||Blood pressure||mmHg|Mean|76.9|76.9|Standard Deviation|7.9|7.9|||
4339066|NCT00422058|4167052|B5|Diastolic||Blood pressure||mmHg|Mean|77.8|77.8|Standard Deviation|8.3|8.3|||
4339067|NCT00422058|4167053|B4|Diastolic||Blood pressure||mmHg|Mean|78.6|78.6|Standard Deviation|8.2|8.2|||
4339068|NCT00422058|4167054|B3|Diastolic||Blood pressure||mmHg|Mean|77.9|77.9|Standard Deviation|7.9|7.9|||
4339069|NCT00422058|4167055|B2|Diastolic||Blood pressure||mmHg|Mean|79.7|79.7|Standard Deviation|9.1|9.1|||
4339070|NCT00422058|4167056|B1|Diastolic||Blood pressure||mmHg|Mean|76.8|76.8|Standard Deviation|8.5|8.5|||
4339071|NCT00422058|4167050|B7|Systolic||Blood pressure||mmHg|Mean|124.5|124.5|Standard Deviation|12.7|12.7|||
4339072|NCT00422058|4167051|B6|Systolic||Blood pressure||mmHg|Mean|122.7|122.7|Standard Deviation|13.5|13.5|||
4339073|NCT00422058|4167052|B5|Systolic||Blood pressure||mmHg|Mean|124.3|124.3|Standard Deviation|11.3|11.3|||
4339074|NCT00422058|4167053|B4|Systolic||Blood pressure||mmHg|Mean|126.2|126.2|Standard Deviation|13.9|13.9|||
4339075|NCT00422058|4167054|B3|Systolic||Blood pressure||mmHg|Mean|123.4|123.4|Standard Deviation|13.0|13.0|||
4339076|NCT00422058|4167055|B2|Systolic||Blood pressure||mmHg|Mean|127.0|127.0|Standard Deviation|13.1|13.1|||
4339077|NCT00422058|4167056|B1|Systolic||Blood pressure||mmHg|Mean|123.6|123.6|Standard Deviation|11.1|11.1|||
4339078|NCT00422058|4167050|B7|||HbA1c|HbA1c = glycosylated haemoglobin A1c|percentage (%) of total haemoglobin|Mean|5.60|5.6|Standard Deviation|0.4|0.4|||
4339079|NCT00422058|4167051|B6|||HbA1c|HbA1c = glycosylated haemoglobin A1c|percentage (%) of total haemoglobin|Mean|5.55|5.55|Standard Deviation|0.32|0.32|||
4339080|NCT00422058|4167052|B5|||HbA1c|HbA1c = glycosylated haemoglobin A1c|percentage (%) of total haemoglobin|Mean|5.57|5.57|Standard Deviation|0.40|0.4|||
4339081|NCT00422058|4167053|B4|||HbA1c|HbA1c = glycosylated haemoglobin A1c|percentage (%) of total haemoglobin|Mean|5.54|5.54|Standard Deviation|0.33|0.33|||
4339082|NCT00422058|4167054|B3|||HbA1c|HbA1c = glycosylated haemoglobin A1c|percentage (%) of total haemoglobin|Mean|5.60|5.6|Standard Deviation|0.40|0.4|||
4339083|NCT00422058|4167055|B2|||HbA1c|HbA1c = glycosylated haemoglobin A1c|percentage (%) of total haemoglobin|Mean|5.58|5.58|Standard Deviation|0.33|0.33|||
4339084|NCT00422058|4167056|B1|||HbA1c|HbA1c = glycosylated haemoglobin A1c|percentage (%) of total haemoglobin|Mean|5.60|5.6|Standard Deviation|0.38|0.38|||
4339085|NCT00422058|4167050|B7|||Waist circumference||cm|Mean|108.7|108.7|Standard Deviation|9.8|9.8|||
4339086|NCT00422058|4167051|B6|||Waist circumference||cm|Mean|107.6|107.6|Standard Deviation|9.7|9.7|||
4339087|NCT00422058|4167052|B5|||Waist circumference||cm|Mean|108.9|108.9|Standard Deviation|8.3|8.3|||
4339088|NCT00422058|4167053|B4|||Waist circumference||cm|Mean|110.2|110.2|Standard Deviation|10.7|10.7|||
4339089|NCT00422058|4167054|B3|||Waist circumference||cm|Mean|108.2|108.2|Standard Deviation|9.5|9.5|||
4339090|NCT00422058|4167055|B2|||Waist circumference||cm|Mean|108.8|108.8|Standard Deviation|10.4|10.4|||
4339091|NCT00422058|4167056|B1|||Waist circumference||cm|Mean|108.3|108.3|Standard Deviation|10.0|10.0|||
4339092|NCT00422058|4167050|B7|||Weight||kg|Mean|97.2|97.2|Standard Deviation|12.8|12.8|||
4339093|NCT00422058|4167051|B6|||Weight||kg|Mean|96.0|96.0|Standard Deviation|11.7|11.7|||
4339094|NCT00422058|4167052|B5|||Weight||kg|Mean|97.6|97.6|Standard Deviation|13.7|13.7|||
4339095|NCT00422058|4167053|B4|||Weight||kg|Mean|98.4|98.4|Standard Deviation|13.0|13.0|||
4339096|NCT00422058|4167054|B3|||Weight||kg|Mean|98.0|98.0|Standard Deviation|12.5|12.5|||
4339097|NCT00422058|4167055|B2|||Weight||kg|Mean|96.2|96.2|Standard Deviation|13.5|13.5|||
4339098|NCT00422058|4167056|B1|||Weight||kg|Mean|97.3|97.3|Standard Deviation|12.3|12.3|||
4339099|NCT00422058|4167050|B7|||BMI|BMI = Body Mass Index|kg/m^2|Mean|34.8|34.8|Standard Deviation|2.7|2.7|||
4339100|NCT00422058|4167051|B6|||BMI|BMI = Body Mass Index|kg/m^2|Mean|34.1|34.1|Standard Deviation|2.6|2.6|||
4339101|NCT00422058|4167052|B5|||BMI|BMI = Body Mass Index|kg/m^2|Mean|34.8|34.8|Standard Deviation|2.8|2.8|||
4339102|NCT00422058|4167053|B4|||BMI|BMI = Body Mass Index|kg/m^2|Mean|35.0|35.0|Standard Deviation|2.8|2.8|||
4339103|NCT00422058|4167054|B3|||BMI|BMI = Body Mass Index|kg/m^2|Mean|35.0|35.0|Standard Deviation|2.6|2.6|||
4339104|NCT00422058|4167055|B2|||BMI|BMI = Body Mass Index|kg/m^2|Mean|34.8|34.8|Standard Deviation|2.6|2.6|||
4339105|NCT00422058|4167056|B1|||BMI|BMI = Body Mass Index|kg/m^2|Mean|34.9|34.9|Standard Deviation|2.8|2.8|||
4339106|NCT00422058|4167050|B7|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4339107|NCT00422058|4167051|B6|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4339108|NCT00422058|4167052|B5|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4339109|NCT00422058|4167053|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4339110|NCT00422058|4167054|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4339111|NCT00422058|4167055|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4339112|NCT00422058|4167056|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4339113|NCT00422058|4167050|B7|Black/African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4339114|NCT00422058|4167051|B6|Black/African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4339115|NCT00422058|4167052|B5|Black/African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4339116|NCT00422058|4167053|B4|Black/African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4339117|NCT00422058|4167054|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4339118|NCT00422058|4167055|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4339119|NCT00422058|4167056|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4339120|NCT00422058|4167050|B7|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4339121|NCT00422058|4167051|B6|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4339122|NCT00422058|4167052|B5|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4339123|NCT00422058|4167053|B4|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4339124|NCT00422058|4167054|B3|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4339125|NCT00422058|4167055|B2|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4339126|NCT00422058|4167056|B1|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4339127|NCT00422058|4167050|B7|White||Race/Ethnicity, Customized||participants|Number|555|555.0||||||
4339128|NCT00422058|4167051|B6|White||Race/Ethnicity, Customized||participants|Number|93|93.0||||||
4339129|NCT00422058|4167052|B5|White||Race/Ethnicity, Customized||participants|Number|92|92.0||||||
4339130|NCT00422058|4167053|B4|White||Race/Ethnicity, Customized||participants|Number|91|91.0||||||
4339131|NCT00422058|4167054|B3|White||Race/Ethnicity, Customized||participants|Number|88|88.0||||||
4339132|NCT00422058|4167055|B2|White||Race/Ethnicity, Customized||participants|Number|94|94.0||||||
4339133|NCT00422058|4167056|B1|White||Race/Ethnicity, Customized||participants|Number|97|97.0||||||
4339134|NCT00422058|4167050|B7||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4339135|NCT00422058|4167051|B6||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4339136|NCT00422058|4167052|B5||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4339137|NCT00422058|4167053|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4339138|NCT00422058|4167054|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4339139|NCT00422058|4167055|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4339140|NCT00422058|4167056|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4339141|NCT00422058|4167050|B7||Female|Sex: Female, Male||Participants|Count of Participants|429|429.0||||||
4339142|NCT00422058|4167051|B6||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4339143|NCT00422058|4167052|B5||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4339144|NCT00422058|4167053|B4||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4339145|NCT00422058|4167054|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4339146|NCT00422058|4167055|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4339147|NCT00422058|4167056|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4339148|NCT00422058|4167050|B7|||Age||years|Mean|45.91|45.91|Standard Deviation|10.29|10.29|||
4339149|NCT00422058|4167051|B6|||Age||years|Mean|45.94|45.94|Standard Deviation|9.11|9.11|||
4339150|NCT00422058|4167052|B5|||Age||years|Mean|45.91|45.91|Standard Deviation|10.71|10.71|||
4339151|NCT00422058|4167053|B4|||Age||years|Mean|45.01|45.01|Standard Deviation|11.09|11.09|||
4339152|NCT00422058|4167054|B3|||Age||years|Mean|45.53|45.53|Standard Deviation|10.9|10.9|||
4339153|NCT00422058|4167055|B2|||Age||years|Mean|47.18|47.18|Standard Deviation|9.72|9.72|||
4339154|NCT00422058|4167056|B1|||Age||years|Mean|45.86|45.86|Standard Deviation|10.28|10.28|||
4339155|NCT00422032|4167189|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
4339156|NCT00422032|4167190|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4339157|NCT00422032|4167191|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4339158|NCT00422032|4167189|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4339159|NCT00422032|4167190|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4339160|NCT00422032|4167191|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4339161|NCT00422032|4167189|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4339162|NCT00422032|4167190|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4339163|NCT00422032|4167191|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4339164|NCT00422032|4167189|B3|||Age||Years|Median|68|68.0|Full Range|||25.0|89.0|
4339165|NCT00422032|4167190|B2|||Age||Years|Median|65|65.0|Full Range|||34.0|83.0|
4339166|NCT00422032|4167191|B1|||Age||Years|Median|68|68.0|Full Range|||25.0|89.0|
4339167|NCT00421993|4167198|B5|Europe||Region of Enrollment||participants|Number|533|533.0||||||
4339168|NCT00421993|4167199|B4|Europe||Region of Enrollment||participants|Number|132|132.0||||||
4339169|NCT00421993|4167200|B3|Europe||Region of Enrollment||participants|Number|136|136.0||||||
4339170|NCT00421993|4167201|B2|Europe||Region of Enrollment||participants|Number|133|133.0||||||
4339171|NCT00421993|4167202|B1|Europe||Region of Enrollment||participants|Number|132|132.0||||||
4339172|NCT00421993|4167198|B5|Canada||Region of Enrollment||participants|Number|403|403.0||||||
4339173|NCT00421993|4167199|B4|Canada||Region of Enrollment||participants|Number|101|101.0||||||
4339174|NCT00421993|4167200|B3|Canada||Region of Enrollment||participants|Number|100|100.0||||||
4339175|NCT00421993|4167201|B2|Canada||Region of Enrollment||participants|Number|100|100.0||||||
4339176|NCT00421993|4167202|B1|Canada||Region of Enrollment||participants|Number|102|102.0||||||
4339177|NCT00421993|4167198|B5|United States||Region of Enrollment||participants|Number|734|734.0||||||
4339178|NCT00421993|4167199|B4|United States||Region of Enrollment||participants|Number|185|185.0||||||
4339179|NCT00421993|4167200|B3|United States||Region of Enrollment||participants|Number|179|179.0||||||
4339180|NCT00421993|4167201|B2|United States||Region of Enrollment||participants|Number|185|185.0||||||
4339181|NCT00421993|4167202|B1|United States||Region of Enrollment||participants|Number|185|185.0||||||
4339182|NCT00421993|4167198|B5||Male|Sex: Female, Male||Participants|Count of Participants|731|731.0||||||
4339183|NCT00421993|4167199|B4||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4339184|NCT00421993|4167200|B3||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4339185|NCT00421993|4167201|B2||Male|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4339186|NCT00421993|4167202|B1||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4339187|NCT00421993|4167198|B5||Female|Sex: Female, Male||Participants|Count of Participants|939|939.0||||||
4339188|NCT00421993|4167199|B4||Female|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
4339189|NCT00421993|4167200|B3||Female|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4339190|NCT00421993|4167201|B2||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4339191|NCT00421993|4167202|B1||Female|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
4339192|NCT00421993|4167198|B5|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4339193|NCT00421993|4167199|B4|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4339194|NCT00421993|4167200|B3|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4339195|NCT00421993|4167201|B2|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4339196|NCT00421993|4167202|B1|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4339197|NCT00421993|4167198|B5|Between 18 and 64 years||Age, Customized||participants|Number|709|709.0||||||
4339198|NCT00421993|4167199|B4|Between 18 and 64 years||Age, Customized||participants|Number|175|175.0||||||
4339199|NCT00421993|4167200|B3|Between 18 and 64 years||Age, Customized||participants|Number|171|171.0||||||
4339200|NCT00421993|4167201|B2|Between 18 and 64 years||Age, Customized||participants|Number|177|177.0||||||
4339201|NCT00421993|4167202|B1|Between 18 and 64 years||Age, Customized||participants|Number|186|186.0||||||
4339202|NCT00421993|4167198|B5|12-17 years||Age, Customized||participants|Number|961|961.0||||||
4339203|NCT00421993|4167199|B4|12-17 years||Age, Customized||participants|Number|243|243.0||||||
4339204|NCT00421993|4167200|B3|12-17 years||Age, Customized||participants|Number|244|244.0||||||
4339205|NCT00421993|4167201|B2|12-17 years||Age, Customized||participants|Number|241|241.0||||||
4339206|NCT00421993|4167202|B1|12-17 years||Age, Customized||participants|Number|233|233.0||||||
4339207|NCT00421993|4167198|B5|||Age||years|Mean|19|19.0|Standard Deviation|6.81|6.81|||
4339208|NCT00421993|4167199|B4|||Age||years|Mean|19.2|19.2|Standard Deviation|7.23|7.23|||
4339209|NCT00421993|4167200|B3|||Age||years|Mean|18.9|18.9|Standard Deviation|6.96|6.96|||
4339210|NCT00421993|4167201|B2|||Age||years|Mean|18.5|18.5|Standard Deviation|6.3|6.3|||
4339211|NCT00421993|4167202|B1|||Age||years|Mean|19.5|19.5|Standard Deviation|6.7|6.7|||
4339212|NCT00421928|4167239|B4||Male|Sex: Female, Male||Participants|Count of Participants|405|405.0||||||
4339213|NCT00421928|4167240|B3||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4339214|NCT00421928|4167241|B2||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4339215|NCT00421928|4167242|B1||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4339216|NCT00421928|4167239|B4||Female|Sex: Female, Male||Participants|Count of Participants|618|618.0||||||
4339217|NCT00421928|4167240|B3||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4339218|NCT00421928|4167241|B2||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4339219|NCT00421928|4167242|B1||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4339220|NCT00421928|4167239|B4|||Age||years|Mean|58.3|58.3|Standard Deviation|9.85|9.85|||
4339221|NCT00421928|4167240|B3|||Age||years|Mean|58.2|58.2|Standard Deviation|9.15|9.15|||
4339222|NCT00421928|4167241|B2|||Age||years|Mean|58.2|58.2|Standard Deviation|10.29|10.29|||
4339223|NCT00421928|4167242|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|10.09|10.09|||
4339224|NCT00421928|4167239|B4||>=65 years|Age||Participants|Count of Participants|265|265.0||||||
4339225|NCT00421928|4167240|B3||>=65 years|Age||Participants|Count of Participants|77|77.0||||||
4339226|NCT00421928|4167241|B2||>=65 years|Age||Participants|Count of Participants|93|93.0||||||
4339227|NCT00421928|4167242|B1||>=65 years|Age||Participants|Count of Participants|95|95.0||||||
4339228|NCT00421928|4167239|B4||Between 18 and 65 years|Age||Participants|Count of Participants|758|758.0||||||
4339229|NCT00421928|4167240|B3||Between 18 and 65 years|Age||Participants|Count of Participants|260|260.0||||||
4339230|NCT00421928|4167241|B2||Between 18 and 65 years|Age||Participants|Count of Participants|249|249.0||||||
4339231|NCT00421928|4167242|B1||Between 18 and 65 years|Age||Participants|Count of Participants|249|249.0||||||
4339232|NCT00421928|4167239|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339233|NCT00421928|4167240|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339234|NCT00421928|4167241|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339235|NCT00421928|4167242|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339236|NCT00421889|4167270|B10||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4339237|NCT00421889|4167271|B9||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4339238|NCT00421889|4167272|B8||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4339239|NCT00421889|4167273|B7||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4339240|NCT00421889|4167274|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4339241|NCT00421889|4167275|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4339242|NCT00421889|4167276|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4339243|NCT00421889|4167277|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4339244|NCT00421889|4167278|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4339245|NCT00421889|4167279|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4339246|NCT00421889|4167270|B10||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4339247|NCT00421889|4167271|B9||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4339248|NCT00421889|4167272|B8||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4339249|NCT00421889|4167273|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4339250|NCT00421889|4167274|B6||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4339251|NCT00421889|4167275|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4339252|NCT00421889|4167276|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4339253|NCT00421889|4167277|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4339254|NCT00421889|4167278|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4339255|NCT00421889|4167279|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4339256|NCT00421889|4167270|B10||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4339257|NCT00421889|4167271|B9||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4339258|NCT00421889|4167272|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4339259|NCT00421889|4167273|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4339260|NCT00421889|4167274|B6||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4339261|NCT00421889|4167275|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4339262|NCT00421889|4167276|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4339263|NCT00421889|4167277|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4339264|NCT00421889|4167278|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4339265|NCT00421889|4167279|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4339266|NCT00421889|4167270|B10||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4339267|NCT00421889|4167271|B9||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4339268|NCT00421889|4167272|B8||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4339269|NCT00421889|4167273|B7||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4339270|NCT00421889|4167274|B6||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4339271|NCT00421889|4167275|B5||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4339272|NCT00421889|4167276|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4339273|NCT00421889|4167277|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4339274|NCT00421889|4167278|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4339275|NCT00421889|4167279|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4339276|NCT00421889|4167270|B10||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339277|NCT00421889|4167271|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339278|NCT00421889|4167272|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339279|NCT00421889|4167273|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339280|NCT00421889|4167274|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339281|NCT00421889|4167275|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339282|NCT00421889|4167276|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339283|NCT00421889|4167277|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339284|NCT00421889|4167278|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339285|NCT00421889|4167279|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339286|NCT00421733|4167329|B4|Italy||Region of Enrollment||participants|Number|8|8.0||||||
4339287|NCT00421733|4167330|B3|Italy||Region of Enrollment||participants|Number|3|3.0||||||
4339288|NCT00421733|4167331|B2|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4339289|NCT00421733|4167332|B1|Italy||Region of Enrollment||participants|Number|4|4.0||||||
4339290|NCT00421733|4167329|B4|Germany||Region of Enrollment||participants|Number|13|13.0||||||
4339291|NCT00421733|4167330|B3|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4339292|NCT00421733|4167331|B2|Germany||Region of Enrollment||participants|Number|8|8.0||||||
4339293|NCT00421733|4167332|B1|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4339294|NCT00421733|4167329|B4|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4339295|NCT00421733|4167330|B3|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4339296|NCT00421733|4167331|B2|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4339297|NCT00421733|4167332|B1|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4339298|NCT00421733|4167329|B4|Spain||Region of Enrollment||participants|Number|23|23.0||||||
4339299|NCT00421733|4167330|B3|Spain||Region of Enrollment||participants|Number|9|9.0||||||
4339300|NCT00421733|4167331|B2|Spain||Region of Enrollment||participants|Number|3|3.0||||||
4339301|NCT00421733|4167332|B1|Spain||Region of Enrollment||participants|Number|11|11.0||||||
4339302|NCT00421733|4167329|B4|Poland||Region of Enrollment||participants|Number|12|12.0||||||
4339303|NCT00421733|4167330|B3|Poland||Region of Enrollment||participants|Number|4|4.0||||||
4339304|NCT00421733|4167331|B2|Poland||Region of Enrollment||participants|Number|4|4.0||||||
4339305|NCT00421733|4167332|B1|Poland||Region of Enrollment||participants|Number|4|4.0||||||
4339306|NCT00421733|4167329|B4|Greece||Region of Enrollment||participants|Number|5|5.0||||||
4339307|NCT00421733|4167330|B3|Greece||Region of Enrollment||participants|Number|1|1.0||||||
4339308|NCT00421733|4167331|B2|Greece||Region of Enrollment||participants|Number|3|3.0||||||
4339309|NCT00421733|4167332|B1|Greece||Region of Enrollment||participants|Number|1|1.0||||||
4339310|NCT00421733|4167329|B4|Taiwan||Region of Enrollment||participants|Number|34|34.0||||||
4339311|NCT00421733|4167330|B3|Taiwan||Region of Enrollment||participants|Number|10|10.0||||||
4339312|NCT00421733|4167331|B2|Taiwan||Region of Enrollment||participants|Number|14|14.0||||||
4339313|NCT00421733|4167332|B1|Taiwan||Region of Enrollment||participants|Number|10|10.0||||||
4339314|NCT00421733|4167329|B4|United States||Region of Enrollment||participants|Number|181|181.0||||||
4339315|NCT00421733|4167330|B3|United States||Region of Enrollment||participants|Number|64|64.0||||||
4339316|NCT00421733|4167331|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
4339317|NCT00421733|4167332|B1|United States||Region of Enrollment||participants|Number|57|57.0||||||
4339318|NCT00421733|4167329|B4|Portugal||Region of Enrollment||participants|Number|4|4.0||||||
4339319|NCT00421733|4167330|B3|Portugal||Region of Enrollment||participants|Number|0|0.0||||||
4339320|NCT00421733|4167331|B2|Portugal||Region of Enrollment||participants|Number|2|2.0||||||
4339321|NCT00421733|4167332|B1|Portugal||Region of Enrollment||participants|Number|2|2.0||||||
4339322|NCT00421733|4167329|B4||Male|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4339323|NCT00421733|4167330|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4339324|NCT00421733|4167331|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4339325|NCT00421733|4167332|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4339326|NCT00421733|4167329|B4||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4339327|NCT00421733|4167330|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4339328|NCT00421733|4167331|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4339329|NCT00421733|4167332|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4339330|NCT00421733|4167329|B4|||Age||years|Mean|64.4|64.4|Standard Deviation|10.41|10.41|||
4339331|NCT00421733|4167330|B3|||Age||years|Mean|64.5|64.5|Standard Deviation|11.23|11.23|||
4339332|NCT00421733|4167331|B2|||Age||years|Mean|64.7|64.7|Standard Deviation|9.92|9.92|||
4339333|NCT00421733|4167332|B1|||Age||years|Mean|64.0|64.0|Standard Deviation|10.15|10.15|||
4339334|NCT00421733|4167329|B4||>=65 years|Age||Participants|Count of Participants|145|145.0||||||
4339335|NCT00421733|4167330|B3||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
4339336|NCT00421733|4167331|B2||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4339337|NCT00421733|4167332|B1||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4339338|NCT00421733|4167329|B4||Between 18 and 65 years|Age||Participants|Count of Participants|136|136.0||||||
4339339|NCT00421733|4167330|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4339340|NCT00421733|4167331|B2||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4339341|NCT00421733|4167332|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4339342|NCT00421733|4167329|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339343|NCT00421733|4167330|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339344|NCT00421733|4167331|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339345|NCT00421733|4167332|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339346|NCT00421707|4167352|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339347|NCT00421707|4167353|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339348|NCT00421707|4167354|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339349|NCT00421707|4167352|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339350|NCT00421707|4167353|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339351|NCT00421707|4167354|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339352|NCT00421707|4167352|B3||White|Race (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
4339353|NCT00421707|4167353|B2||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4339354|NCT00421707|4167354|B1||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4339355|NCT00421707|4167352|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4339356|NCT00421707|4167353|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4339357|NCT00421707|4167354|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4339358|NCT00421707|4167352|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339359|NCT00421707|4167353|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339360|NCT00421707|4167354|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339361|NCT00421707|4167352|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4339362|NCT00421707|4167353|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4339363|NCT00421707|4167354|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4339364|NCT00421707|4167352|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339365|NCT00421707|4167353|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339366|NCT00421707|4167354|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339367|NCT00421707|4167352|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4339368|NCT00421707|4167353|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4339369|NCT00421707|4167354|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4339370|NCT00421707|4167352|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4339371|NCT00421707|4167353|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4339372|NCT00421707|4167354|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4339373|NCT00421707|4167352|B3|||Age||Years|Mean|43.5|43.5|Standard Deviation|11.56|11.56|||
4339374|NCT00421707|4167353|B2|||Age||Years|Mean|43.0|43.0|Standard Deviation|11.43|11.43|||
4339375|NCT00421707|4167354|B1|||Age||Years|Mean|44.1|44.1|Standard Deviation|11.74|11.74|||
4339376|NCT00421603|4167395|B3|United States||Region of Enrollment||participants|Number|81|81.0||||||
4339377|NCT00421603|4167396|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
4339378|NCT00421603|4167397|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4339379|NCT00421603|4167395|B3||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4339380|NCT00421603|4167396|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4339381|NCT00421603|4167397|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4339382|NCT00421603|4167395|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4339383|NCT00421603|4167396|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4339384|NCT00421603|4167397|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4339385|NCT00421603|4167395|B3|||Age||years|Mean|42.1|42.1|Standard Deviation|8.6|8.6|||
4339386|NCT00421603|4167396|B2|||Age||years|Mean|42.4|42.4|Standard Deviation|8.9|8.9|||
4339387|NCT00421603|4167397|B1|||Age||years|Mean|41.5|41.5|Standard Deviation|8.2|8.2|||
4339388|NCT00421603|4167395|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4339389|NCT00421603|4167396|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4339390|NCT00421603|4167397|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4339391|NCT00421603|4167395|B3||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
4339392|NCT00421603|4167396|B2||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4339393|NCT00421603|4167397|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4339394|NCT00421603|4167395|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339395|NCT00421603|4167396|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339396|NCT00421603|4167397|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339397|NCT00421408|4167404|B3|United States||Region of Enrollment||participants|Number|208|208.0||||||
4339398|NCT00421408|4167405|B2|United States||Region of Enrollment||participants|Number|106|106.0||||||
4339399|NCT00421408|4167406|B1|United States||Region of Enrollment||participants|Number|102|102.0||||||
4339400|NCT00421408|4167404|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4339401|NCT00421408|4167405|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4339402|NCT00421408|4167406|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4339403|NCT00421408|4167404|B3||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4339404|NCT00421408|4167405|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4339405|NCT00421408|4167406|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4339406|NCT00421408|4167404|B3|||Age||years|Mean|70.2|70.2|Standard Deviation|6.2|6.2|||
4339407|NCT00421408|4167405|B2|||Age||years|Mean|69.9|69.9|Standard Deviation|6.1|6.1|||
4339408|NCT00421408|4167406|B1|||Age||years|Mean|70.5|70.5|Standard Deviation|6.4|6.4|||
4339409|NCT00421343|4167425|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4339410|NCT00421343|4167425|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4339411|NCT00421343|4167425|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4339412|NCT00421343|4167425|B1|||Age||years|Mean|80|80.0|Standard Deviation|10|10.0|||
4339413|NCT00421343|4167425|B1||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4339414|NCT00421343|4167425|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4339415|NCT00421343|4167425|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339416|NCT00421174|4167429|B3|Unknown||Oxygen Support|Method of supplemental oxygen support at study entry.|participants|Number|2|2.0||||||
4339417|NCT00421174|4167430|B2|Unknown||Oxygen Support|Method of supplemental oxygen support at study entry.|participants|Number|1|1.0||||||
4339418|NCT00421174|4167431|B1|Unknown||Oxygen Support|Method of supplemental oxygen support at study entry.|participants|Number|1|1.0||||||
4339419|NCT00421174|4167429|B3|Mechanical ventilation||Oxygen Support|Method of supplemental oxygen support at study entry.|participants|Number|8|8.0||||||
4339420|NCT00421174|4167430|B2|Mechanical ventilation||Oxygen Support|Method of supplemental oxygen support at study entry.|participants|Number|6|6.0||||||
4339421|NCT00421174|4167431|B1|Mechanical ventilation||Oxygen Support|Method of supplemental oxygen support at study entry.|participants|Number|2|2.0||||||
4339422|NCT00421174|4167429|B3|Face mask||Oxygen Support|Method of supplemental oxygen support at study entry.|participants|Number|8|8.0||||||
4339423|NCT00421174|4167430|B2|Face mask||Oxygen Support|Method of supplemental oxygen support at study entry.|participants|Number|5|5.0||||||
4339424|NCT00421174|4167431|B1|Face mask||Oxygen Support|Method of supplemental oxygen support at study entry.|participants|Number|3|3.0||||||
4339425|NCT00421174|4167429|B3|Nasal cannula||Oxygen Support|Method of supplemental oxygen support at study entry.|participants|Number|16|16.0||||||
4339426|NCT00421174|4167430|B2|Nasal cannula||Oxygen Support|Method of supplemental oxygen support at study entry.|participants|Number|6|6.0||||||
4339427|NCT00421174|4167431|B1|Nasal cannula||Oxygen Support|Method of supplemental oxygen support at study entry.|participants|Number|10|10.0||||||
4339428|NCT00421174|4167429|B3|||Creatinine|Serum creatinine (mg/dl) at study entry.|mg/dl|Median|1.3|1.3|Full Range|||0.4|2.9|
4339429|NCT00421174|4167430|B2|||Creatinine|Serum creatinine (mg/dl) at study entry.|mg/dl|Median|1.4|1.4|Full Range|||0.4|2.9|
4339430|NCT00421174|4167431|B1|||Creatinine|Serum creatinine (mg/dl) at study entry.|mg/dl|Median|1.3|1.3|Full Range|||0.6|2.5|
4339431|NCT00421174|4167429|B3|||Total Bilirubin|Serum total bilirubin (mg/dl) at study entry.|mg/dl|Median|1.0|1.0|Full Range|||0.2|18.9|
4339432|NCT00421174|4167430|B2|||Total Bilirubin|Serum total bilirubin (mg/dl) at study entry.|mg/dl|Median|0.9|0.9|Full Range|||0.2|10.7|
4339433|NCT00421174|4167431|B1|||Total Bilirubin|Serum total bilirubin (mg/dl) at study entry.|mg/dl|Median|1.2|1.2|Full Range|||0.2|18.9|
4339434|NCT00421174|4167429|B3|Unknown||Recipient Cytomegalovirus Status||participants|Number|1|1.0||||||
4339435|NCT00421174|4167430|B2|Unknown||Recipient Cytomegalovirus Status||participants|Number|1|1.0||||||
4339436|NCT00421174|4167431|B1|Unknown||Recipient Cytomegalovirus Status||participants|Number|0|0.0||||||
4339437|NCT00421174|4167429|B3|Negative||Recipient Cytomegalovirus Status||participants|Number|15|15.0||||||
4339438|NCT00421174|4167430|B2|Negative||Recipient Cytomegalovirus Status||participants|Number|7|7.0||||||
4339439|NCT00421174|4167431|B1|Negative||Recipient Cytomegalovirus Status||participants|Number|8|8.0||||||
4339440|NCT00421174|4167429|B3|Positive||Recipient Cytomegalovirus Status||participants|Number|18|18.0||||||
4339441|NCT00421174|4167430|B2|Positive||Recipient Cytomegalovirus Status||participants|Number|10|10.0||||||
4339442|NCT00421174|4167431|B1|Positive||Recipient Cytomegalovirus Status||participants|Number|8|8.0||||||
4339443|NCT00421174|4167429|B3|Non-myeloablative||Conditioning Regimen||participants|Number|14|14.0||||||
4339444|NCT00421174|4167430|B2|Non-myeloablative||Conditioning Regimen||participants|Number|7|7.0||||||
4339445|NCT00421174|4167431|B1|Non-myeloablative||Conditioning Regimen||participants|Number|7|7.0||||||
4339446|NCT00421174|4167429|B3|Myeloablative||Conditioning Regimen||participants|Number|20|20.0||||||
4339447|NCT00421174|4167430|B2|Myeloablative||Conditioning Regimen||participants|Number|11|11.0||||||
4339448|NCT00421174|4167431|B1|Myeloablative||Conditioning Regimen||participants|Number|9|9.0||||||
4339449|NCT00421174|4167429|B3|Unknown||Karnofsky Performance|Assesses patient self-perceived global quality of life and functioning (excellent = 100, good = 70-90, fair = 50-60, poor < 50), where 100 equals perfect quality of life.|participants|Number|5|5.0||||||
4339450|NCT00421174|4167430|B2|Unknown||Karnofsky Performance|Assesses patient self-perceived global quality of life and functioning (excellent = 100, good = 70-90, fair = 50-60, poor < 50), where 100 equals perfect quality of life.|participants|Number|2|2.0||||||
4339451|NCT00421174|4167431|B1|Unknown||Karnofsky Performance|Assesses patient self-perceived global quality of life and functioning (excellent = 100, good = 70-90, fair = 50-60, poor < 50), where 100 equals perfect quality of life.|participants|Number|3|3.0||||||
4339452|NCT00421174|4167429|B3|< 50||Karnofsky Performance|Assesses patient self-perceived global quality of life and functioning (excellent = 100, good = 70-90, fair = 50-60, poor < 50), where 100 equals perfect quality of life.|participants|Number|15|15.0||||||
4339453|NCT00421174|4167430|B2|< 50||Karnofsky Performance|Assesses patient self-perceived global quality of life and functioning (excellent = 100, good = 70-90, fair = 50-60, poor < 50), where 100 equals perfect quality of life.|participants|Number|10|10.0||||||
4339454|NCT00421174|4167431|B1|< 50||Karnofsky Performance|Assesses patient self-perceived global quality of life and functioning (excellent = 100, good = 70-90, fair = 50-60, poor < 50), where 100 equals perfect quality of life.|participants|Number|5|5.0||||||
4339455|NCT00421174|4167429|B3|50 - 60||Karnofsky Performance|Assesses patient self-perceived global quality of life and functioning (excellent = 100, good = 70-90, fair = 50-60, poor < 50), where 100 equals perfect quality of life.|participants|Number|10|10.0||||||
4339456|NCT00421174|4167430|B2|50 - 60||Karnofsky Performance|Assesses patient self-perceived global quality of life and functioning (excellent = 100, good = 70-90, fair = 50-60, poor < 50), where 100 equals perfect quality of life.|participants|Number|5|5.0||||||
4339457|NCT00421174|4167431|B1|50 - 60||Karnofsky Performance|Assesses patient self-perceived global quality of life and functioning (excellent = 100, good = 70-90, fair = 50-60, poor < 50), where 100 equals perfect quality of life.|participants|Number|5|5.0||||||
4339458|NCT00421174|4167429|B3|70 - 90||Karnofsky Performance|Assesses patient self-perceived global quality of life and functioning (excellent = 100, good = 70-90, fair = 50-60, poor < 50), where 100 equals perfect quality of life.|participants|Number|4|4.0||||||
4339459|NCT00421174|4167430|B2|70 - 90||Karnofsky Performance|Assesses patient self-perceived global quality of life and functioning (excellent = 100, good = 70-90, fair = 50-60, poor < 50), where 100 equals perfect quality of life.|participants|Number|1|1.0||||||
4339522|NCT00420927|4167476|B2|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
4339523|NCT00420927|4167477|B1|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4339460|NCT00421174|4167431|B1|70 - 90||Karnofsky Performance|Assesses patient self-perceived global quality of life and functioning (excellent = 100, good = 70-90, fair = 50-60, poor < 50), where 100 equals perfect quality of life.|participants|Number|3|3.0||||||
4339461|NCT00421174|4167429|B3|Other||Primary Disease||participants|Number|10|10.0||||||
4339462|NCT00421174|4167430|B2|Other||Primary Disease||participants|Number|3|3.0||||||
4339463|NCT00421174|4167431|B1|Other||Primary Disease||participants|Number|7|7.0||||||
4339464|NCT00421174|4167429|B3|Lymphoma||Primary Disease||participants|Number|3|3.0||||||
4339465|NCT00421174|4167430|B2|Lymphoma||Primary Disease||participants|Number|0|0.0||||||
4339466|NCT00421174|4167431|B1|Lymphoma||Primary Disease||participants|Number|3|3.0||||||
4339467|NCT00421174|4167429|B3|Acute Lymphoblastic Leukemia (ALL)||Primary Disease||participants|Number|7|7.0||||||
4339468|NCT00421174|4167430|B2|Acute Lymphoblastic Leukemia (ALL)||Primary Disease||participants|Number|4|4.0||||||
4339469|NCT00421174|4167431|B1|Acute Lymphoblastic Leukemia (ALL)||Primary Disease||participants|Number|3|3.0||||||
4339470|NCT00421174|4167429|B3|Myelodysplastic Syndrome (MDS)||Primary Disease||participants|Number|4|4.0||||||
4339471|NCT00421174|4167430|B2|Myelodysplastic Syndrome (MDS)||Primary Disease||participants|Number|2|2.0||||||
4339472|NCT00421174|4167431|B1|Myelodysplastic Syndrome (MDS)||Primary Disease||participants|Number|2|2.0||||||
4339473|NCT00421174|4167429|B3|Acute Myelogenous Leukemia (AML)||Primary Disease||participants|Number|10|10.0||||||
4339474|NCT00421174|4167430|B2|Acute Myelogenous Leukemia (AML)||Primary Disease||participants|Number|9|9.0||||||
4339475|NCT00421174|4167431|B1|Acute Myelogenous Leukemia (AML)||Primary Disease||participants|Number|1|1.0||||||
4339476|NCT00421174|4167429|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4339477|NCT00421174|4167430|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4339478|NCT00421174|4167431|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4339479|NCT00421174|4167429|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4339480|NCT00421174|4167430|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4339481|NCT00421174|4167431|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4339482|NCT00421174|4167429|B3|||Age||years|Median|46.6|46.6|Full Range|||21.8|70.1|
4339483|NCT00421174|4167430|B2|||Age||years|Median|46.4|46.4|Full Range|||21.8|68.8|
4339484|NCT00421174|4167431|B1|||Age||years|Median|47.7|47.7|Full Range|||22.9|70.1|
4339485|NCT00420992|4167460|B3||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4339486|NCT00420992|4167461|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4339487|NCT00420992|4167462|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4339488|NCT00420992|4167460|B3||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4339489|NCT00420992|4167461|B2||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4339490|NCT00420992|4167462|B1||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4339491|NCT00420992|4167460|B3|||Age||years|Mean|54.4|54.4|Standard Deviation|12.27|12.27|||
4339492|NCT00420992|4167461|B2|||Age||years|Mean|54.7|54.7|Standard Deviation|12.92|12.92|||
4339493|NCT00420992|4167462|B1|||Age||years|Mean|54.2|54.2|Standard Deviation|11.62|11.62|||
4339494|NCT00420927|4167470|B8|United States||Region of Enrollment||participants|Number|301|301.0||||||
4339495|NCT00420927|4167476|B2|United States||Region of Enrollment||participants|Number|152|152.0||||||
4339496|NCT00420927|4167477|B1|United States||Region of Enrollment||participants|Number|149|149.0||||||
4339497|NCT00420927|4167470|B8|United Kingdom||Region of Enrollment||participants|Number|43|43.0||||||
4339498|NCT00420927|4167476|B2|United Kingdom||Region of Enrollment||participants|Number|17|17.0||||||
4339499|NCT00420927|4167477|B1|United Kingdom||Region of Enrollment||participants|Number|26|26.0||||||
4339500|NCT00420927|4167470|B8|Sweden||Region of Enrollment||participants|Number|21|21.0||||||
4339501|NCT00420927|4167476|B2|Sweden||Region of Enrollment||participants|Number|11|11.0||||||
4339502|NCT00420927|4167477|B1|Sweden||Region of Enrollment||participants|Number|10|10.0||||||
4339503|NCT00420927|4167470|B8|Spain||Region of Enrollment||participants|Number|55|55.0||||||
4339504|NCT00420927|4167476|B2|Spain||Region of Enrollment||participants|Number|30|30.0||||||
4339505|NCT00420927|4167477|B1|Spain||Region of Enrollment||participants|Number|25|25.0||||||
4339506|NCT00420927|4167470|B8|South Africa||Region of Enrollment||participants|Number|63|63.0||||||
4339507|NCT00420927|4167476|B2|South Africa||Region of Enrollment||participants|Number|32|32.0||||||
4339508|NCT00420927|4167477|B1|South Africa||Region of Enrollment||participants|Number|31|31.0||||||
4339509|NCT00420927|4167470|B8|Slovakia||Region of Enrollment||participants|Number|9|9.0||||||
4339510|NCT00420927|4167476|B2|Slovakia||Region of Enrollment||participants|Number|3|3.0||||||
4339511|NCT00420927|4167477|B1|Slovakia||Region of Enrollment||participants|Number|6|6.0||||||
4339512|NCT00420927|4167470|B8|Poland||Region of Enrollment||participants|Number|21|21.0||||||
4339513|NCT00420927|4167476|B2|Poland||Region of Enrollment||participants|Number|9|9.0||||||
4339514|NCT00420927|4167477|B1|Poland||Region of Enrollment||participants|Number|12|12.0||||||
4339515|NCT00420927|4167470|B8|Norway||Region of Enrollment||participants|Number|9|9.0||||||
4339516|NCT00420927|4167476|B2|Norway||Region of Enrollment||participants|Number|5|5.0||||||
4339517|NCT00420927|4167477|B1|Norway||Region of Enrollment||participants|Number|4|4.0||||||
4339518|NCT00420927|4167470|B8|New Zealand||Region of Enrollment||participants|Number|6|6.0||||||
4339519|NCT00420927|4167476|B2|New Zealand||Region of Enrollment||participants|Number|3|3.0||||||
4339520|NCT00420927|4167477|B1|New Zealand||Region of Enrollment||participants|Number|3|3.0||||||
4339521|NCT00420927|4167470|B8|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
4339524|NCT00420927|4167470|B8|Mexico||Region of Enrollment||participants|Number|53|53.0||||||
4339525|NCT00420927|4167476|B2|Mexico||Region of Enrollment||participants|Number|27|27.0||||||
4339526|NCT00420927|4167477|B1|Mexico||Region of Enrollment||participants|Number|26|26.0||||||
4339527|NCT00420927|4167470|B8|Hungary||Region of Enrollment||participants|Number|18|18.0||||||
4339528|NCT00420927|4167476|B2|Hungary||Region of Enrollment||participants|Number|10|10.0||||||
4339529|NCT00420927|4167477|B1|Hungary||Region of Enrollment||participants|Number|8|8.0||||||
4339530|NCT00420927|4167470|B8|Germany||Region of Enrollment||participants|Number|84|84.0||||||
4339531|NCT00420927|4167476|B2|Germany||Region of Enrollment||participants|Number|41|41.0||||||
4339532|NCT00420927|4167477|B1|Germany||Region of Enrollment||participants|Number|43|43.0||||||
4339533|NCT00420927|4167470|B8|France||Region of Enrollment||participants|Number|12|12.0||||||
4339534|NCT00420927|4167476|B2|France||Region of Enrollment||participants|Number|8|8.0||||||
4339535|NCT00420927|4167477|B1|France||Region of Enrollment||participants|Number|4|4.0||||||
4339536|NCT00420927|4167470|B8|Czech Republic||Region of Enrollment||participants|Number|41|41.0||||||
4339537|NCT00420927|4167476|B2|Czech Republic||Region of Enrollment||participants|Number|19|19.0||||||
4339538|NCT00420927|4167477|B1|Czech Republic||Region of Enrollment||participants|Number|22|22.0||||||
4339539|NCT00420927|4167470|B8|Canada||Region of Enrollment||participants|Number|115|115.0||||||
4339540|NCT00420927|4167476|B2|Canada||Region of Enrollment||participants|Number|58|58.0||||||
4339541|NCT00420927|4167477|B1|Canada||Region of Enrollment||participants|Number|57|57.0||||||
4339542|NCT00420927|4167470|B8|Belgium||Region of Enrollment||participants|Number|81|81.0||||||
4339543|NCT00420927|4167476|B2|Belgium||Region of Enrollment||participants|Number|40|40.0||||||
4339544|NCT00420927|4167477|B1|Belgium||Region of Enrollment||participants|Number|41|41.0||||||
4339545|NCT00420927|4167470|B8|Austria||Region of Enrollment||participants|Number|23|23.0||||||
4339546|NCT00420927|4167476|B2|Austria||Region of Enrollment||participants|Number|12|12.0||||||
4339547|NCT00420927|4167477|B1|Austria||Region of Enrollment||participants|Number|11|11.0||||||
4339548|NCT00420927|4167470|B8|Australia||Region of Enrollment||participants|Number|13|13.0||||||
4339549|NCT00420927|4167476|B2|Australia||Region of Enrollment||participants|Number|8|8.0||||||
4339550|NCT00420927|4167477|B1|Australia||Region of Enrollment||participants|Number|5|5.0||||||
4339551|NCT00420927|4167470|B8|Argentina||Region of Enrollment||participants|Number|61|61.0||||||
4339552|NCT00420927|4167476|B2|Argentina||Region of Enrollment||participants|Number|29|29.0||||||
4339553|NCT00420927|4167477|B1|Argentina||Region of Enrollment||participants|Number|32|32.0||||||
4339554|NCT00420927|4167470|B8|Male||Gender||participants|Number|270|270.0||||||
4339555|NCT00420927|4167476|B2|Male||Gender||participants|Number|135|135.0||||||
4339556|NCT00420927|4167477|B1|Male||Gender||participants|Number|135|135.0||||||
4339557|NCT00420927|4167470|B8|Female||Gender||participants|Number|762|762.0||||||
4339558|NCT00420927|4167476|B2|Female||Gender||participants|Number|382|382.0||||||
4339559|NCT00420927|4167477|B1|Female||Gender||participants|Number|380|380.0||||||
4339560|NCT00420927|4167470|B8|||Age||years|Mean|50.6|50.6|Standard Deviation|14.05|14.05|||
4339561|NCT00420927|4167476|B2|||Age||years|Mean|50.4|50.4|Standard Deviation|13.62|13.62|||
4339562|NCT00420927|4167477|B1|||Age||years|Mean|50.7|50.7|Standard Deviation|14.48|14.48|||
4339563|NCT00420927|4167470|B8|>=65 years||Age||participants|Number|183|183.0||||||
4339564|NCT00420927|4167476|B2|>=65 years||Age||participants|Number|86|86.0||||||
4339565|NCT00420927|4167477|B1|>=65 years||Age||participants|Number|97|97.0||||||
4339566|NCT00420927|4167470|B8|Between 18 and 65 years||Age||participants|Number|849|849.0||||||
4339567|NCT00420927|4167476|B2|Between 18 and 65 years||Age||participants|Number|431|431.0||||||
4339568|NCT00420927|4167477|B1|Between 18 and 65 years||Age||participants|Number|418|418.0||||||
4339569|NCT00420927|4167470|B8|<=18 years||Age||participants|Number|0|0.0||||||
4339570|NCT00420927|4167476|B2|<=18 years||Age||participants|Number|0|0.0||||||
4339571|NCT00420927|4167477|B1|<=18 years||Age||participants|Number|0|0.0||||||
4339572|NCT00420849|4167587|B1|Hispanic||Race/Ethnicity, Customized||participant|Number|3|3.0||||||
4339573|NCT00420849|4167587|B1|Black||Race/Ethnicity, Customized||participant|Number|9|9.0||||||
4339574|NCT00420849|4167587|B1|Asian / Pacific Islander||Race/Ethnicity, Customized||participant|Number|10|10.0||||||
4339575|NCT00420849|4167587|B1|Other||Race/Ethnicity, Customized||participant|Number|17|17.0||||||
4339576|NCT00420849|4167587|B1|White||Race/Ethnicity, Customized||participant|Number|548|548.0||||||
4339577|NCT00420849|4167587|B1||Male|Sex: Female, Male||Participants|Count of Participants|346|346.0||||||
4339578|NCT00420849|4167587|B1||Female|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
4339579|NCT00420849|4167587|B1|>65 years||Age, Customized||participants|Number|273|273.0||||||
4339580|NCT00420849|4167587|B1|>18 and <=65 years||Age, Customized||participants|Number|314|314.0||||||
4339581|NCT00420849|4167587|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4339582|NCT00420849|4167587|B1|||Age||years|Mean|64.5|64.5|Standard Deviation|9.74|9.74|||
4339583|NCT00420784|4167652|B5|Europe||Region of Enrollment||participants|Number|47|47.0||||||
4339584|NCT00420784|4167653|B4|Europe||Region of Enrollment||participants|Number|13|13.0||||||
4339585|NCT00420784|4167654|B3|Europe||Region of Enrollment||participants|Number|10|10.0||||||
4339586|NCT00420784|4167655|B2|Europe||Region of Enrollment||participants|Number|10|10.0||||||
4339587|NCT00420784|4167656|B1|Europe||Region of Enrollment||participants|Number|14|14.0||||||
4339588|NCT00420784|4167652|B5|North America||Region of Enrollment||participants|Number|406|406.0||||||
4339589|NCT00420784|4167653|B4|North America||Region of Enrollment||participants|Number|101|101.0||||||
4339590|NCT00420784|4167654|B3|North America||Region of Enrollment||participants|Number|101|101.0||||||
4339591|NCT00420784|4167655|B2|North America||Region of Enrollment||participants|Number|103|103.0||||||
4339592|NCT00420784|4167656|B1|North America||Region of Enrollment||participants|Number|101|101.0||||||
4339593|NCT00420784|4167652|B5||Male|Sex: Female, Male||Participants|Count of Participants|306|306.0||||||
4339594|NCT00420784|4167653|B4||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4339595|NCT00420784|4167654|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4339596|NCT00420784|4167655|B2||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4339597|NCT00420784|4167656|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4339598|NCT00420784|4167652|B5||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4339599|NCT00420784|4167653|B4||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4339600|NCT00420784|4167654|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4339601|NCT00420784|4167655|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4339602|NCT00420784|4167656|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4339603|NCT00420784|4167652|B5|||Age||years|Mean|50.8|50.8|Standard Deviation|7.0|7.0|||
4339604|NCT00420784|4167653|B4|||Age||years|Mean|49.8|49.8|Standard Deviation|7.2|7.2|||
4339605|NCT00420784|4167654|B3|||Age||years|Mean|51.9|51.9|Standard Deviation|7.1|7.1|||
4339606|NCT00420784|4167655|B2|||Age||years|Mean|52.0|52.0|Standard Deviation|5.5|5.5|||
4339607|NCT00420784|4167656|B1|||Age||years|Mean|49.7|49.7|Standard Deviation|7.8|7.8|||
4339608|NCT00420784|4167652|B5||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4339609|NCT00420784|4167653|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4339610|NCT00420784|4167654|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4339611|NCT00420784|4167655|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4339612|NCT00420784|4167656|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4339613|NCT00420784|4167652|B5||Between 18 and 65 years|Age||Participants|Count of Participants|446|446.0||||||
4339614|NCT00420784|4167653|B4||Between 18 and 65 years|Age||Participants|Count of Participants|113|113.0||||||
4339615|NCT00420784|4167654|B3||Between 18 and 65 years|Age||Participants|Count of Participants|108|108.0||||||
4339616|NCT00420784|4167655|B2||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
4339617|NCT00420784|4167656|B1||Between 18 and 65 years|Age||Participants|Count of Participants|114|114.0||||||
4339618|NCT00420784|4167652|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339619|NCT00420784|4167653|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339620|NCT00420784|4167654|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339621|NCT00420784|4167655|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339622|NCT00420784|4167656|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339623|NCT00420771|4167686|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4339624|NCT00420771|4167687|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4339625|NCT00420771|4167688|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4339626|NCT00420771|4167686|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4339627|NCT00420771|4167687|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4339628|NCT00420771|4167688|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4339629|NCT00420771|4167686|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4339630|NCT00420771|4167687|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4339631|NCT00420771|4167688|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4339632|NCT00420771|4167686|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4339633|NCT00420771|4167687|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4339634|NCT00420771|4167688|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4339635|NCT00420771|4167686|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4339636|NCT00420771|4167687|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4339637|NCT00420771|4167688|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4339638|NCT00420771|4167686|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339639|NCT00420771|4167687|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339640|NCT00420771|4167688|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339641|NCT00420745|4167695|B3||Male|Sex: Female, Male||Participants|Count of Participants|515|515.0||||||
4339642|NCT00420745|4167696|B2||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4339643|NCT00420745|4167697|B1||Male|Sex: Female, Male||Participants|Count of Participants|343|343.0||||||
4339644|NCT00420745|4167695|B3||Female|Sex: Female, Male||Participants|Count of Participants|494|494.0||||||
4339645|NCT00420745|4167696|B2||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4339646|NCT00420745|4167697|B1||Female|Sex: Female, Male||Participants|Count of Participants|327|327.0||||||
4339647|NCT00420745|4167695|B3|||Age||weeks|Mean|8.5|8.5|Standard Deviation|1.77|1.77|||
4339648|NCT00420745|4167696|B2|||Age||weeks|Mean|8.5|8.5|Standard Deviation|1.78|1.78|||
4339649|NCT00420745|4167697|B1|||Age||weeks|Mean|8.5|8.5|Standard Deviation|1.77|1.77|||
4339650|NCT00420641|4167714|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339651|NCT00420641|4167715|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339652|NCT00420641|4167716|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339653|NCT00420641|4167717|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339654|NCT00420641|4167714|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4339655|NCT00420641|4167715|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4339656|NCT00420641|4167716|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4339657|NCT00420641|4167717|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4339658|NCT00420641|4167714|B4||White|Race (NIH/OMB)||Participants|Count of Participants|409|409.0||||||
4339659|NCT00420641|4167715|B3||White|Race (NIH/OMB)||Participants|Count of Participants|137|137.0||||||
4339660|NCT00420641|4167716|B2||White|Race (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
4339661|NCT00420641|4167717|B1||White|Race (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
4339662|NCT00420641|4167714|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4339663|NCT00420641|4167715|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4339664|NCT00420641|4167716|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339665|NCT00420641|4167717|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4339666|NCT00420641|4167714|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4339667|NCT00420641|4167715|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339668|NCT00420641|4167716|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339669|NCT00420641|4167717|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4339670|NCT00420641|4167714|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4339671|NCT00420641|4167715|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4339672|NCT00420641|4167716|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4339673|NCT00420641|4167717|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4339674|NCT00420641|4167714|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4339675|NCT00420641|4167715|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4339676|NCT00420641|4167716|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4339677|NCT00420641|4167717|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4339678|NCT00420641|4167714|B4||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4339679|NCT00420641|4167715|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4339680|NCT00420641|4167716|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4339681|NCT00420641|4167717|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4339682|NCT00420641|4167714|B4||Female|Sex: Female, Male||Participants|Count of Participants|345|345.0||||||
4339683|NCT00420641|4167715|B3||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4339684|NCT00420641|4167716|B2||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4339685|NCT00420641|4167717|B1||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4339686|NCT00420641|4167714|B4|||Age||Years|Mean|42.9|42.9|Standard Deviation|11.19|11.19|||
4339687|NCT00420641|4167715|B3|||Age||Years|Mean|44.4|44.4|Standard Deviation|10.90|10.9|||
4339688|NCT00420641|4167716|B2|||Age||Years|Mean|42.4|42.4|Standard Deviation|11.64|11.64|||
4339689|NCT00420641|4167717|B1|||Age||Years|Mean|41.8|41.8|Standard Deviation|10.89|10.89|||
4339690|NCT00420628|4167793|B3|Other||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4339691|NCT00420628|4167794|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4339692|NCT00420628|4167795|B1|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4339693|NCT00420628|4167793|B3|White||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
4339694|NCT00420628|4167794|B2|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4339695|NCT00420628|4167795|B1|White||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
4339696|NCT00420628|4167793|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4339697|NCT00420628|4167794|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4339698|NCT00420628|4167795|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4339699|NCT00420628|4167793|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4339700|NCT00420628|4167794|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4339701|NCT00420628|4167795|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4339702|NCT00420628|4167793|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4339703|NCT00420628|4167794|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4339704|NCT00420628|4167795|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4339705|NCT00420628|4167793|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4339706|NCT00420628|4167794|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4339707|NCT00420628|4167795|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4339708|NCT00420628|4167793|B3|Age 0-6 years||Age, Customized||participants|Number|108|108.0||||||
4339709|NCT00420628|4167794|B2|Age 0-6 years||Age, Customized||participants|Number|36|36.0||||||
4339710|NCT00420628|4167795|B1|Age 0-6 years||Age, Customized||participants|Number|72|72.0||||||
4339711|NCT00420511|4167810|B3|||Area-Under-The-Curve (C-peptide/glucose) / HOMA-IR|Area-under-the-C-peptide-curve (AUCCpep) and area-under-the-glucose-curve (AUCgluc) from 0 to 240 minutes during meal tests were calculated by trapezoidal rule. Insulin resistance was assessed by Homeostasis Model Assessment of Insulin Resistance (HOMA-IR). Beta-cell function was assessed using the ratio of AUCCpep to AUCgluc divided by HOMA-IR (AUCCpep/gluc/HOMA-IR), a measure of insulin secretion in the context of ambient insulin sensitivity, analogous to the disposition index and Insulin Secretion-Sensitivity Index-2 (ISSI-2). Higher AUCCpep/gluc/HOMA-IR indicates better beta-cell function.|index of beta-cell function|Median|120.0|120.0|Inter-Quartile Range|||66.3|129.6|
4339712|NCT00420511|4167811|B2|||Area-Under-The-Curve (C-peptide/glucose) / HOMA-IR|Area-under-the-C-peptide-curve (AUCCpep) and area-under-the-glucose-curve (AUCgluc) from 0 to 240 minutes during meal tests were calculated by trapezoidal rule. Insulin resistance was assessed by Homeostasis Model Assessment of Insulin Resistance (HOMA-IR). Beta-cell function was assessed using the ratio of AUCCpep to AUCgluc divided by HOMA-IR (AUCCpep/gluc/HOMA-IR), a measure of insulin secretion in the context of ambient insulin sensitivity, analogous to the disposition index and Insulin Secretion-Sensitivity Index-2 (ISSI-2). Higher AUCCpep/gluc/HOMA-IR indicates better beta-cell function.|index of beta-cell function|Median|126.0|126.0|Inter-Quartile Range|||79.8|159.8|
4339713|NCT00420511|4167812|B1|||Area-Under-The-Curve (C-peptide/glucose) / HOMA-IR|Area-under-the-C-peptide-curve (AUCCpep) and area-under-the-glucose-curve (AUCgluc) from 0 to 240 minutes during meal tests were calculated by trapezoidal rule. Insulin resistance was assessed by Homeostasis Model Assessment of Insulin Resistance (HOMA-IR). Beta-cell function was assessed using the ratio of AUCCpep to AUCgluc divided by HOMA-IR (AUCCpep/gluc/HOMA-IR), a measure of insulin secretion in the context of ambient insulin sensitivity, analogous to the disposition index and Insulin Secretion-Sensitivity Index-2 (ISSI-2). Higher AUCCpep/gluc/HOMA-IR indicates better beta-cell function.|index of beta-cell function|Median|114.8|114.8|Inter-Quartile Range|||76.3|208.7|
4339714|NCT00420511|4167810|B3|||HbA1c||percent glycosylated hemoglobin|Median|6.1|6.1|Inter-Quartile Range|||5.8|6.9|
4339715|NCT00420511|4167811|B2|||HbA1c||percent glycosylated hemoglobin|Median|6.1|6.1|Inter-Quartile Range|||5.9|6.9|
4339716|NCT00420511|4167812|B1|||HbA1c||percent glycosylated hemoglobin|Median|6.2|6.2|Inter-Quartile Range|||5.8|6.9|
4339717|NCT00420511|4167810|B3|||Duration of diabetes||years|Median|3.0|3.0|Inter-Quartile Range|||2.0|6.0|
4339718|NCT00420511|4167811|B2|||Duration of diabetes||years|Median|3.5|3.5|Inter-Quartile Range|||2.0|8.0|
4339719|NCT00420511|4167812|B1|||Duration of diabetes||years|Median|2.8|2.8|Inter-Quartile Range|||2.0|4.0|
4339720|NCT00420511|4167810|B3|||Body Mass Index||kg/m^2|Median|32.7|32.7|Inter-Quartile Range|||28.6|41.5|
4339721|NCT00420511|4167811|B2|||Body Mass Index||kg/m^2|Median|32.7|32.7|Inter-Quartile Range|||31.0|41.1|
4339722|NCT00420511|4167812|B1|||Body Mass Index||kg/m^2|Median|34.3|34.3|Inter-Quartile Range|||27.3|42.6|
4339723|NCT00420511|4167810|B3|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4339724|NCT00420511|4167811|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4339725|NCT00420511|4167812|B1|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4339726|NCT00420511|4167810|B3|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4339727|NCT00420511|4167811|B2|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4339728|NCT00420511|4167812|B1|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4339729|NCT00420511|4167810|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4339730|NCT00420511|4167811|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4339731|NCT00420511|4167812|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4339732|NCT00420511|4167810|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4339733|NCT00420511|4167811|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4339734|NCT00420511|4167812|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4339735|NCT00420511|4167810|B3|||Age||years|Median|60.9|60.9|Inter-Quartile Range|||47.9|61.4|
4339736|NCT00420511|4167811|B2|||Age||years|Median|60.8|60.8|Inter-Quartile Range|||51.3|61.4|
4339737|NCT00420511|4167812|B1|||Age||years|Median|61.3|61.3|Inter-Quartile Range|||45.5|69.5|
4339738|NCT00420459|4167823|B1|||Social Responsiveness Scale|The 65-item SRS is a standardized measure of the core symptoms of autism. Each item is scored on a 4-point Likert scale. The score of each individual item is summed to create a total raw score. A total scores results are as follows: 0-62: Within normal limits 63-79: Mild range of impairment 80-108: Moderate range of impairment 109-149: Severe range of impairment|units on a scale|Mean|124.5|124.5|Standard Deviation|26.7|26.7|||
4339739|NCT00420459|4167823|B1|||Children's Yale-Brown Obsessive Compulsive Scale Modified for PDD|The CY-BOCS PDD has been utilized in a largescale clinical treatment study of repetitive behavior in idiopathic ASDs. CYBOCS-PDD scores range from 0 to 20 and measure repetitive/compulsive behavior and not obsessions. Higher score indicate worse outcome.|units on a scale|Mean|14.2|14.2|Standard Deviation|4.6|4.6|||
4339740|NCT00420459|4167823|B1|||Clinical Global Impressions - Severity|The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale that requires the clinician to rate the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis. Considering total clinical experience, a patient is assessed on severity of mental illness at the time of rating 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.|units on a scale|Mean|4.5|4.5|Standard Deviation|0.5|0.5|||
4339741|NCT00420459|4167823|B1|ABC Inappropriate Speech||Aberrant Behavior Checklist|The Aberrant Behavior Checklist (ABC) is a 58-item measure of maladaptive behaviors and is used as a measure of drug effects. The ABC has 5 subscales: Social Withdrawal (16 items) ranging from 0 (not at all) to 48 (severe), Irritability (15 items) ranging from 0 (not at all) to 45 (severe), Inappropriate Speech (4 items) ranging from 0 (not at all) to 12 (severe), Hyperactivity (16 items) ranging from 0 (not at all) to 48 (severe), and Stereotypy (7 items) ranging from 0 (not at all) to 21 (severe). Items are rated from 0 (not at all) to 3 (severe).|units on a scale|Mean|6.8|6.8|Standard Deviation|5.1|5.1|||
4339742|NCT00420459|4167823|B1|ABC Stereotypy||Aberrant Behavior Checklist|The Aberrant Behavior Checklist (ABC) is a 58-item measure of maladaptive behaviors and is used as a measure of drug effects. The ABC has 5 subscales: Social Withdrawal (16 items) ranging from 0 (not at all) to 48 (severe), Irritability (15 items) ranging from 0 (not at all) to 45 (severe), Inappropriate Speech (4 items) ranging from 0 (not at all) to 12 (severe), Hyperactivity (16 items) ranging from 0 (not at all) to 48 (severe), and Stereotypy (7 items) ranging from 0 (not at all) to 21 (severe). Items are rated from 0 (not at all) to 3 (severe).|units on a scale|Mean|12.7|12.7|Standard Deviation|5.6|5.6|||
4339743|NCT00420459|4167823|B1|ABC Social Withdrawal||Aberrant Behavior Checklist|The Aberrant Behavior Checklist (ABC) is a 58-item measure of maladaptive behaviors and is used as a measure of drug effects. The ABC has 5 subscales: Social Withdrawal (16 items) ranging from 0 (not at all) to 48 (severe), Irritability (15 items) ranging from 0 (not at all) to 45 (severe), Inappropriate Speech (4 items) ranging from 0 (not at all) to 12 (severe), Hyperactivity (16 items) ranging from 0 (not at all) to 48 (severe), and Stereotypy (7 items) ranging from 0 (not at all) to 21 (severe). Items are rated from 0 (not at all) to 3 (severe).|units on a scale|Mean|16.6|16.6|Standard Deviation|11.8|11.8|||
4339744|NCT00420459|4167823|B1|ABC Hyperactivity||Aberrant Behavior Checklist|The Aberrant Behavior Checklist (ABC) is a 58-item measure of maladaptive behaviors and is used as a measure of drug effects. The ABC has 5 subscales: Social Withdrawal (16 items) ranging from 0 (not at all) to 48 (severe), Irritability (15 items) ranging from 0 (not at all) to 45 (severe), Inappropriate Speech (4 items) ranging from 0 (not at all) to 12 (severe), Hyperactivity (16 items) ranging from 0 (not at all) to 48 (severe), and Stereotypy (7 items) ranging from 0 (not at all) to 21 (severe). Items are rated from 0 (not at all) to 3 (severe).|units on a scale|Mean|31.8|31.8|Standard Deviation|5.8|5.8|||
4339745|NCT00420459|4167823|B1|ABC Irritability S||Aberrant Behavior Checklist|The Aberrant Behavior Checklist (ABC) is a 58-item measure of maladaptive behaviors and is used as a measure of drug effects. The ABC has 5 subscales: Social Withdrawal (16 items) ranging from 0 (not at all) to 48 (severe), Irritability (15 items) ranging from 0 (not at all) to 45 (severe), Inappropriate Speech (4 items) ranging from 0 (not at all) to 12 (severe), Hyperactivity (16 items) ranging from 0 (not at all) to 48 (severe), and Stereotypy (7 items) ranging from 0 (not at all) to 21 (severe). Items are rated from 0 (not at all) to 3 (severe).|units on a scale|Mean|25.3|25.3|Standard Deviation|5.1|5.1|||
4339746|NCT00420459|4167823|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4339747|NCT00420459|4167823|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4339748|NCT00420459|4167823|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4339749|NCT00420459|4167823|B1|||Age||years|Mean|14.3|14.3|Full Range|||6.0|25.0|
4339750|NCT00420459|4167823|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4339751|NCT00420459|4167823|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4339752|NCT00420459|4167823|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4339753|NCT00420420|4167832|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4339754|NCT00420420|4167833|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4339755|NCT00420420|4167834|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4339756|NCT00420420|4167832|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4339757|NCT00420420|4167833|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4339758|NCT00420420|4167834|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4339759|NCT00420420|4167832|B3|||Age||years|Mean|74.05|74.05|Standard Deviation|7.91|7.91|||
4339760|NCT00420420|4167833|B2|||Age||years|Mean|73.7|73.7|Standard Deviation|8.91|8.91|||
4339761|NCT00420420|4167834|B1|||Age||years|Mean|74.4|74.4|Standard Deviation|6.91|6.91|||
4339762|NCT00420407|4167851|B3|United States||Region of Enrollment||participants|Number|81|81.0||||||
4339763|NCT00420407|4167852|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4339764|NCT00420407|4167853|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4339765|NCT00420407|4167851|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4339766|NCT00420407|4167852|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4339767|NCT00420407|4167853|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4339768|NCT00420407|4167851|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4339769|NCT00420407|4167852|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4339770|NCT00420407|4167853|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4339771|NCT00420407|4167851|B3|||Age||years|Mean|47.1|47.1|Standard Deviation|20.4|20.4|||
4339772|NCT00420407|4167852|B2|||Age||years|Mean|48.1|48.1|Standard Deviation|19.8|19.8|||
4339773|NCT00420407|4167853|B1|||Age||years|Mean|46.3|46.3|Standard Deviation|26.1|26.1|||
4339774|NCT00420407|4167851|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4339775|NCT00420407|4167852|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4339776|NCT00420407|4167853|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4339777|NCT00420407|4167851|B3||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4339778|NCT00420407|4167852|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4339779|NCT00420407|4167853|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4339780|NCT00420407|4167851|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339781|NCT00420407|4167852|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339782|NCT00420407|4167853|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339783|NCT00420342|4167860|B4|||Body Mass Index (BMI)|Height, body weight, and arm circumference were measured at the screening visit and body weight was measured at the screening, treatment phase, and follow-up visits. The same scale was used for all body weight measurements. BMI was measured in kg/m^2.|Kg/m^2|Mean|28.2|28.2|Standard Deviation|4.4|4.4|||
4339784|NCT00420342|4167861|B3|||Body Mass Index (BMI)|Height, body weight, and arm circumference were measured at the screening visit and body weight was measured at the screening, treatment phase, and follow-up visits. The same scale was used for all body weight measurements. BMI was measured in kg/m^2.|Kg/m^2|Mean|27.9|27.9|Standard Deviation|3.4|3.4|||
4339785|NCT00420342|4167862|B2|||Body Mass Index (BMI)|Height, body weight, and arm circumference were measured at the screening visit and body weight was measured at the screening, treatment phase, and follow-up visits. The same scale was used for all body weight measurements. BMI was measured in kg/m^2.|Kg/m^2|Mean|27.6|27.6|Standard Deviation|4.4|4.4|||
4339786|NCT00420342|4167863|B1|||Body Mass Index (BMI)|Height, body weight, and arm circumference were measured at the screening visit and body weight was measured at the screening, treatment phase, and follow-up visits. The same scale was used for all body weight measurements. BMI was measured in kg/m^2.|Kg/m^2|Mean|29.1|29.1|Standard Deviation|5.2|5.2|||
4339787|NCT00420342|4167860|B4|diastolic blood pressure (DBP)||Baseline cuff blood pressure|The baseline SBP was to be between 130 and 139 mmHg and DBP ≤ 89 mmHg. The mean SBP values from 2 of the 3 consecutive office cuff measurements during the screening visits were to have been within 12 mmHg and the mean DBP values within 8 mmHg to confirm stability of the blood pressure.|mmHg|Mean|81.2|81.2|Standard Deviation|4.8|4.8|||
4339788|NCT00420342|4167861|B3|diastolic blood pressure (DBP)||Baseline cuff blood pressure|The baseline SBP was to be between 130 and 139 mmHg and DBP ≤ 89 mmHg. The mean SBP values from 2 of the 3 consecutive office cuff measurements during the screening visits were to have been within 12 mmHg and the mean DBP values within 8 mmHg to confirm stability of the blood pressure.|mmHg|Mean|80.3|80.3|Standard Deviation|5.7|5.7|||
4339789|NCT00420342|4167862|B2|diastolic blood pressure (DBP)||Baseline cuff blood pressure|The baseline SBP was to be between 130 and 139 mmHg and DBP ≤ 89 mmHg. The mean SBP values from 2 of the 3 consecutive office cuff measurements during the screening visits were to have been within 12 mmHg and the mean DBP values within 8 mmHg to confirm stability of the blood pressure.|mmHg|Mean|81.7|81.7|Standard Deviation|4.0|4.0|||
4339790|NCT00420342|4167863|B1|diastolic blood pressure (DBP)||Baseline cuff blood pressure|The baseline SBP was to be between 130 and 139 mmHg and DBP ≤ 89 mmHg. The mean SBP values from 2 of the 3 consecutive office cuff measurements during the screening visits were to have been within 12 mmHg and the mean DBP values within 8 mmHg to confirm stability of the blood pressure.|mmHg|Mean|81.5|81.5|Standard Deviation|4.7|4.7|||
4339791|NCT00420342|4167860|B4|systolic blood pressure (SBP)||Baseline cuff blood pressure|The baseline SBP was to be between 130 and 139 mmHg and DBP ≤ 89 mmHg. The mean SBP values from 2 of the 3 consecutive office cuff measurements during the screening visits were to have been within 12 mmHg and the mean DBP values within 8 mmHg to confirm stability of the blood pressure.|mmHg|Mean|133.9|133.9|Standard Deviation|2.6|2.6|||
4339792|NCT00420342|4167861|B3|systolic blood pressure (SBP)||Baseline cuff blood pressure|The baseline SBP was to be between 130 and 139 mmHg and DBP ≤ 89 mmHg. The mean SBP values from 2 of the 3 consecutive office cuff measurements during the screening visits were to have been within 12 mmHg and the mean DBP values within 8 mmHg to confirm stability of the blood pressure.|mmHg|Mean|133.7|133.7|Standard Deviation|2.4|2.4|||
4339793|NCT00420342|4167862|B2|systolic blood pressure (SBP)||Baseline cuff blood pressure|The baseline SBP was to be between 130 and 139 mmHg and DBP ≤ 89 mmHg. The mean SBP values from 2 of the 3 consecutive office cuff measurements during the screening visits were to have been within 12 mmHg and the mean DBP values within 8 mmHg to confirm stability of the blood pressure.|mmHg|Mean|134.3|134.3|Standard Deviation|2.1|2.1|||
4339794|NCT00420342|4167863|B1|systolic blood pressure (SBP)||Baseline cuff blood pressure|The baseline SBP was to be between 130 and 139 mmHg and DBP ≤ 89 mmHg. The mean SBP values from 2 of the 3 consecutive office cuff measurements during the screening visits were to have been within 12 mmHg and the mean DBP values within 8 mmHg to confirm stability of the blood pressure.|mmHg|Mean|133.6|133.6|Standard Deviation|3.2|3.2|||
4339795|NCT00420342|4167860|B4|diastolic blood pressure (DBP)||Baseline ambulatory blood pressure|24-hour mean Ambulatory blood pressure monitoring (ABPM) values at the Baseline visit.|mmHg|Mean|73.1|73.1|Standard Deviation|7.4|7.4|||
4339796|NCT00420342|4167861|B3|diastolic blood pressure (DBP)||Baseline ambulatory blood pressure|24-hour mean Ambulatory blood pressure monitoring (ABPM) values at the Baseline visit.|mmHg|Mean|73.9|73.9|Standard Deviation|8.0|8.0|||
4339797|NCT00420342|4167862|B2|diastolic blood pressure (DBP)||Baseline ambulatory blood pressure|24-hour mean Ambulatory blood pressure monitoring (ABPM) values at the Baseline visit.|mmHg|Mean|73.1|73.1|Standard Deviation|7.6|7.6|||
4339798|NCT00420342|4167863|B1|diastolic blood pressure (DBP)||Baseline ambulatory blood pressure|24-hour mean Ambulatory blood pressure monitoring (ABPM) values at the Baseline visit.|mmHg|Mean|72.4|72.4|Standard Deviation|6.7|6.7|||
4339799|NCT00420342|4167860|B4|systolic blood pressure (SBP)||Baseline ambulatory blood pressure|24-hour mean Ambulatory blood pressure monitoring (ABPM) values at the Baseline visit.|mmHg|Mean|121.4|121.4|Standard Deviation|9.9|9.9|||
4339800|NCT00420342|4167861|B3|systolic blood pressure (SBP)||Baseline ambulatory blood pressure|24-hour mean Ambulatory blood pressure monitoring (ABPM) values at the Baseline visit.|mmHg|Mean|122.1|122.1|Standard Deviation|11.6|11.6|||
4339801|NCT00420342|4167862|B2|systolic blood pressure (SBP)||Baseline ambulatory blood pressure|24-hour mean Ambulatory blood pressure monitoring (ABPM) values at the Baseline visit.|mmHg|Mean|120.9|120.9|Standard Deviation|10.4|10.4|||
4339802|NCT00420342|4167863|B1|systolic blood pressure (SBP)||Baseline ambulatory blood pressure|24-hour mean Ambulatory blood pressure monitoring (ABPM) values at the Baseline visit.|mmHg|Mean|121.4|121.4|Standard Deviation|7.6|7.6|||
4339803|NCT00420342|4167860|B4|yes||Smoking history|Subjects smoking more than 10 cigarettes per day were excluded from the study.|participants|Number|17|17.0||||||
4339804|NCT00420342|4167861|B3|yes||Smoking history|Subjects smoking more than 10 cigarettes per day were excluded from the study.|participants|Number|4|4.0||||||
4339805|NCT00420342|4167862|B2|yes||Smoking history|Subjects smoking more than 10 cigarettes per day were excluded from the study.|participants|Number|8|8.0||||||
4339806|NCT00420342|4167863|B1|yes||Smoking history|Subjects smoking more than 10 cigarettes per day were excluded from the study.|participants|Number|5|5.0||||||
4339807|NCT00420342|4167860|B4|no||Smoking history|Subjects smoking more than 10 cigarettes per day were excluded from the study.|participants|Number|73|73.0||||||
4340072|NCT00420017|4168240|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4339808|NCT00420342|4167861|B3|no||Smoking history|Subjects smoking more than 10 cigarettes per day were excluded from the study.|participants|Number|25|25.0||||||
4339809|NCT00420342|4167862|B2|no||Smoking history|Subjects smoking more than 10 cigarettes per day were excluded from the study.|participants|Number|24|24.0||||||
4339810|NCT00420342|4167863|B1|no||Smoking history|Subjects smoking more than 10 cigarettes per day were excluded from the study.|participants|Number|24|24.0||||||
4339811|NCT00420342|4167860|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
4339812|NCT00420342|4167861|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4339813|NCT00420342|4167862|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4339814|NCT00420342|4167863|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4339815|NCT00420342|4167860|B4|White||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4339816|NCT00420342|4167861|B3|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4339817|NCT00420342|4167862|B2|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4339818|NCT00420342|4167863|B1|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4339819|NCT00420342|4167860|B4|Black / African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4339820|NCT00420342|4167861|B3|Black / African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4339821|NCT00420342|4167862|B2|Black / African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4339822|NCT00420342|4167863|B1|Black / African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4339823|NCT00420342|4167860|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4339824|NCT00420342|4167861|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4339825|NCT00420342|4167862|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4339826|NCT00420342|4167863|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4339827|NCT00420342|4167860|B4||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4339828|NCT00420342|4167861|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4339829|NCT00420342|4167862|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4339830|NCT00420342|4167863|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4339831|NCT00420342|4167860|B4|||Age||years|Mean|55.0|55.0|Standard Deviation|5.0|5.0|||
4339832|NCT00420342|4167861|B3|||Age||years|Mean|54.1|54.1|Standard Deviation|4.5|4.5|||
4339833|NCT00420342|4167862|B2|||Age||years|Mean|54.6|54.6|Standard Deviation|5.6|5.6|||
4339834|NCT00420342|4167863|B1|||Age||years|Mean|56.3|56.3|Standard Deviation|4.6|4.6|||
4339835|NCT00420316|4167906|B3||Male|Sex: Female, Male||Participants|Count of Participants|837|837.0||||||
4339836|NCT00420316|4167907|B2||Male|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
4339837|NCT00420316|4167908|B1||Male|Sex: Female, Male||Participants|Count of Participants|572|572.0||||||
4339838|NCT00420316|4167906|B3||Female|Sex: Female, Male||Participants|Count of Participants|776|776.0||||||
4339839|NCT00420316|4167907|B2||Female|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
4339840|NCT00420316|4167908|B1||Female|Sex: Female, Male||Participants|Count of Participants|510|510.0||||||
4339841|NCT00420316|4167906|B3|||Age||Months|Mean|31.23|31.23|Standard Deviation|1.14|1.14|||
4339842|NCT00420316|4167907|B2|||Age||Months|Mean|31.3|31.3|Standard Deviation|1.19|1.19|||
4339843|NCT00420316|4167908|B1|||Age||Months|Mean|31.2|31.2|Standard Deviation|1.12|1.12|||
4339844|NCT00420303|4167931|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4339845|NCT00420303|4167932|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4339846|NCT00420303|4167933|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4339847|NCT00420303|4167931|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4339848|NCT00420303|4167932|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4339849|NCT00420303|4167933|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4339850|NCT00420303|4167931|B3|||Age||years|Mean|37.3|37.3|Standard Deviation|11.5|11.5|||
4339851|NCT00420303|4167932|B2|||Age||years|Mean|40.0|40.0|Standard Deviation|10.4|10.4|||
4339852|NCT00420303|4167933|B1|||Age||years|Mean|34.5|34.5|Standard Deviation|12.4|12.4|||
4339853|NCT00420290|4167944|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339854|NCT00420290|4167945|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339855|NCT00420290|4167946|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339856|NCT00420290|4167944|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339857|NCT00420290|4167945|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339858|NCT00420290|4167946|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339859|NCT00420290|4167944|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4339860|NCT00420290|4167945|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4339861|NCT00420290|4167946|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4339862|NCT00420290|4167944|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4339863|NCT00420290|4167945|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4339864|NCT00420290|4167946|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4339865|NCT00420290|4167944|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339866|NCT00420290|4167945|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339867|NCT00420290|4167946|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339868|NCT00420290|4167944|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339869|NCT00420290|4167945|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339870|NCT00420290|4167946|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339871|NCT00420290|4167944|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339872|NCT00420290|4167945|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339873|NCT00420290|4167946|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4339874|NCT00420290|4167944|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4339875|NCT00420290|4167945|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4339876|NCT00420290|4167946|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4339877|NCT00420290|4167944|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4339878|NCT00420290|4167945|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4339879|NCT00420290|4167946|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4339880|NCT00420290|4167944|B3|||Age||years|Mean|47|47.0|Standard Deviation|11.1|11.1|||
4339881|NCT00420290|4167945|B2|||Age||years|Mean|50|50.0|Standard Deviation|11.4|11.4|||
4339882|NCT00420290|4167946|B1|||Age||years|Mean|45|45.0|Standard Deviation|10.5|10.5|||
4339883|NCT00420238|4167961|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4339884|NCT00420238|4167962|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4339885|NCT00420238|4167963|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4339886|NCT00420238|4167961|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4339887|NCT00420238|4167962|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4339888|NCT00420238|4167963|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4339889|NCT00420238|4167961|B3|||Age||years|Mean|47.3|47.3|Standard Deviation|10.4|10.4|||
4339890|NCT00420238|4167962|B2|||Age||years|Mean|48.2|48.2|Standard Deviation|47.3|47.3|||
4339891|NCT00420238|4167963|B1|||Age||years|Mean|46.2|46.2|Standard Deviation|10.8|10.8|||
4339892|NCT00420212|4168100|B4|||Mean number of gadolinium (Gd) enhancing lesions|This baseline measure could only be assessed in the magnetic resonance imaging (MRI) cohort. The MRI cohort included 540 intent-to-treat (ITT) subjects who were enrolled at sites that participated in the MRI portion of the study and who had MRI data (180 placebo, 176 BG00012 BID, 184 BG00012 TID). Sites could participate only if their MRI capability was validated by the independent MRI reading center. Approximately 95% of all subjects enrolled at MRI sites participated in the MRI portion of the study.|Number of Gd enhancing lesions|Mean|1.4|1.4|Standard Deviation|3.64|3.64|||
4339893|NCT00420212|4168101|B3|||Mean number of gadolinium (Gd) enhancing lesions|This baseline measure could only be assessed in the magnetic resonance imaging (MRI) cohort. The MRI cohort included 540 intent-to-treat (ITT) subjects who were enrolled at sites that participated in the MRI portion of the study and who had MRI data (180 placebo, 176 BG00012 BID, 184 BG00012 TID). Sites could participate only if their MRI capability was validated by the independent MRI reading center. Approximately 95% of all subjects enrolled at MRI sites participated in the MRI portion of the study.|Number of Gd enhancing lesions|Mean|1.2|1.2|Standard Deviation|4.10|4.1|||
4339894|NCT00420212|4168102|B2|||Mean number of gadolinium (Gd) enhancing lesions|This baseline measure could only be assessed in the magnetic resonance imaging (MRI) cohort. The MRI cohort included 540 intent-to-treat (ITT) subjects who were enrolled at sites that participated in the MRI portion of the study and who had MRI data (180 placebo, 176 BG00012 BID, 184 BG00012 TID). Sites could participate only if their MRI capability was validated by the independent MRI reading center. Approximately 95% of all subjects enrolled at MRI sites participated in the MRI portion of the study.|Number of Gd enhancing lesions|Mean|1.2|1.2|Standard Deviation|3.30|3.3|||
4339895|NCT00420212|4168103|B1|||Mean number of gadolinium (Gd) enhancing lesions|This baseline measure could only be assessed in the magnetic resonance imaging (MRI) cohort. The MRI cohort included 540 intent-to-treat (ITT) subjects who were enrolled at sites that participated in the MRI portion of the study and who had MRI data (180 placebo, 176 BG00012 BID, 184 BG00012 TID). Sites could participate only if their MRI capability was validated by the independent MRI reading center. Approximately 95% of all subjects enrolled at MRI sites participated in the MRI portion of the study.|Number of Gd enhancing lesions|Mean|1.6|1.6|Standard Deviation|3.45|3.45|||
4339896|NCT00420212|4168100|B4|||Time since first multiple sclerosis (MS) diagnosis||Years|Mean|5.5|5.5|Standard Deviation|5.49|5.49|||
4339897|NCT00420212|4168101|B3|||Time since first multiple sclerosis (MS) diagnosis||Years|Mean|5.1|5.1|Standard Deviation|5.29|5.29|||
4339898|NCT00420212|4168102|B2|||Time since first multiple sclerosis (MS) diagnosis||Years|Mean|5.6|5.6|Standard Deviation|5.39|5.39|||
4339899|NCT00420212|4168103|B1|||Time since first multiple sclerosis (MS) diagnosis||Years|Mean|5.8|5.8|Standard Deviation|5.78|5.78|||
4339900|NCT00420212|4168100|B4|||Mean number of relapses within the past 12 months||Number of relapses|Mean|1.3|1.3|Standard Deviation|0.65|0.65|||
4339901|NCT00420212|4168101|B3|||Mean number of relapses within the past 12 months||Number of relapses|Mean|1.3|1.3|Standard Deviation|0.60|0.6|||
4339902|NCT00420212|4168102|B2|||Mean number of relapses within the past 12 months||Number of relapses|Mean|1.3|1.3|Standard Deviation|0.67|0.67|||
4339903|NCT00420212|4168103|B1|||Mean number of relapses within the past 12 months||Number of relapses|Mean|1.3|1.3|Standard Deviation|0.67|0.67|||
4339904|NCT00420212|4168100|B4|||Mean number of relapses within the previous 3 years||Number of relapses|Mean|2.5|2.5|Standard Deviation|1.43|1.43|||
4339905|NCT00420212|4168101|B3|||Mean number of relapses within the previous 3 years||Number of relapses|Mean|2.4|2.4|Standard Deviation|1.27|1.27|||
4339906|NCT00420212|4168102|B2|||Mean number of relapses within the previous 3 years||Number of relapses|Mean|2.5|2.5|Standard Deviation|1.44|1.44|||
4339907|NCT00420212|4168103|B1|||Mean number of relapses within the previous 3 years||Number of relapses|Mean|2.5|2.5|Standard Deviation|1.56|1.56|||
4339908|NCT00420212|4168100|B4|||Mean Expanded Disability Status Scale (EDSS) score|The EDSS scores range from 0.0 (normal exam) to 10.0 (death due to MS).|units on a scale|Mean|2.42|2.42|Standard Deviation|1.240|1.24|||
4339909|NCT00420212|4168101|B3|||Mean Expanded Disability Status Scale (EDSS) score|The EDSS scores range from 0.0 (normal exam) to 10.0 (death due to MS).|units on a scale|Mean|2.36|2.36|Standard Deviation|1.188|1.188|||
4339910|NCT00420212|4168102|B2|||Mean Expanded Disability Status Scale (EDSS) score|The EDSS scores range from 0.0 (normal exam) to 10.0 (death due to MS).|units on a scale|Mean|2.40|2.4|Standard Deviation|1.290|1.29|||
4339911|NCT00420212|4168103|B1|||Mean Expanded Disability Status Scale (EDSS) score|The EDSS scores range from 0.0 (normal exam) to 10.0 (death due to MS).|units on a scale|Mean|2.48|2.48|Standard Deviation|1.241|1.241|||
4339912|NCT00420212|4168100|B4||Male|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
4339913|NCT00420212|4168101|B3||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4339914|NCT00420212|4168102|B2||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4339915|NCT00420212|4168103|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4339916|NCT00420212|4168100|B4||Female|Sex: Female, Male||Participants|Count of Participants|908|908.0||||||
4339917|NCT00420212|4168101|B3||Female|Sex: Female, Male||Participants|Count of Participants|306|306.0||||||
4339918|NCT00420212|4168102|B2||Female|Sex: Female, Male||Participants|Count of Participants|296|296.0||||||
4339919|NCT00420212|4168103|B1||Female|Sex: Female, Male||Participants|Count of Participants|306|306.0||||||
4339920|NCT00420212|4168100|B4|||Age||Years|Mean|38.5|38.5|Standard Deviation|9.03|9.03|||
4339921|NCT00420212|4168101|B3|||Age||Years|Mean|38.8|38.8|Standard Deviation|8.85|8.85|||
4339922|NCT00420212|4168102|B2|||Age||Years|Mean|38.1|38.1|Standard Deviation|9.11|9.11|||
4339923|NCT00420212|4168103|B1|||Age||Years|Mean|38.5|38.5|Standard Deviation|9.14|9.14|||
4339924|NCT00420199|4168129|B3|RF positive, anti-CCP2 positive||Cross Classification of RF Status and CCP2 Status at Baseline|Venous blood was collected and tested for rheumatoid factor and anti-CCP antibodies. RF was measured by an immunoturbidimetric assay (Roche Tina-Quant). Anti-CCP was measured by an anti-CCP2 immunoassay.|participants|Number|29|29.0||||||
4339925|NCT00420199|4168130|B2|RF positive, anti-CCP2 positive||Cross Classification of RF Status and CCP2 Status at Baseline|Venous blood was collected and tested for rheumatoid factor and anti-CCP antibodies. RF was measured by an immunoturbidimetric assay (Roche Tina-Quant). Anti-CCP was measured by an anti-CCP2 immunoassay.|participants|Number|16|16.0||||||
4339926|NCT00420199|4168131|B1|RF positive, anti-CCP2 positive||Cross Classification of RF Status and CCP2 Status at Baseline|Venous blood was collected and tested for rheumatoid factor and anti-CCP antibodies. RF was measured by an immunoturbidimetric assay (Roche Tina-Quant). Anti-CCP was measured by an anti-CCP2 immunoassay.|participants|Number|13|13.0||||||
4339927|NCT00420199|4168129|B3|RF positive, anti-CCP2 negative||Cross Classification of RF Status and CCP2 Status at Baseline|Venous blood was collected and tested for rheumatoid factor and anti-CCP antibodies. RF was measured by an immunoturbidimetric assay (Roche Tina-Quant). Anti-CCP was measured by an anti-CCP2 immunoassay.|participants|Number|5|5.0||||||
4339928|NCT00420199|4168130|B2|RF positive, anti-CCP2 negative||Cross Classification of RF Status and CCP2 Status at Baseline|Venous blood was collected and tested for rheumatoid factor and anti-CCP antibodies. RF was measured by an immunoturbidimetric assay (Roche Tina-Quant). Anti-CCP was measured by an anti-CCP2 immunoassay.|participants|Number|3|3.0||||||
4339929|NCT00420199|4168131|B1|RF positive, anti-CCP2 negative||Cross Classification of RF Status and CCP2 Status at Baseline|Venous blood was collected and tested for rheumatoid factor and anti-CCP antibodies. RF was measured by an immunoturbidimetric assay (Roche Tina-Quant). Anti-CCP was measured by an anti-CCP2 immunoassay.|participants|Number|2|2.0||||||
4339930|NCT00420199|4168129|B3|RF negative, anti-CCP2 positive||Cross Classification of RF Status and CCP2 Status at Baseline|Venous blood was collected and tested for rheumatoid factor and anti-CCP antibodies. RF was measured by an immunoturbidimetric assay (Roche Tina-Quant). Anti-CCP was measured by an anti-CCP2 immunoassay.|participants|Number|1|1.0||||||
4339931|NCT00420199|4168130|B2|RF negative, anti-CCP2 positive||Cross Classification of RF Status and CCP2 Status at Baseline|Venous blood was collected and tested for rheumatoid factor and anti-CCP antibodies. RF was measured by an immunoturbidimetric assay (Roche Tina-Quant). Anti-CCP was measured by an anti-CCP2 immunoassay.|participants|Number|1|1.0||||||
4339932|NCT00420199|4168131|B1|RF negative, anti-CCP2 positive||Cross Classification of RF Status and CCP2 Status at Baseline|Venous blood was collected and tested for rheumatoid factor and anti-CCP antibodies. RF was measured by an immunoturbidimetric assay (Roche Tina-Quant). Anti-CCP was measured by an anti-CCP2 immunoassay.|participants|Number|0|0.0||||||
4339933|NCT00420199|4168129|B3|RF negative, anti-CCP2 negative||Cross Classification of RF Status and CCP2 Status at Baseline|Venous blood was collected and tested for rheumatoid factor and anti-CCP antibodies. RF was measured by an immunoturbidimetric assay (Roche Tina-Quant). Anti-CCP was measured by an anti-CCP2 immunoassay.|participants|Number|15|15.0||||||
4339934|NCT00420199|4168130|B2|RF negative, anti-CCP2 negative||Cross Classification of RF Status and CCP2 Status at Baseline|Venous blood was collected and tested for rheumatoid factor and anti-CCP antibodies. RF was measured by an immunoturbidimetric assay (Roche Tina-Quant). Anti-CCP was measured by an anti-CCP2 immunoassay.|participants|Number|3|3.0||||||
4339935|NCT00420199|4168131|B1|RF negative, anti-CCP2 negative||Cross Classification of RF Status and CCP2 Status at Baseline|Venous blood was collected and tested for rheumatoid factor and anti-CCP antibodies. RF was measured by an immunoturbidimetric assay (Roche Tina-Quant). Anti-CCP was measured by an anti-CCP2 immunoassay.|participants|Number|12|12.0||||||
4339936|NCT00420199|4168129|B3|||Number of Swollen Joints||joints|Mean|10.0|10.0|Standard Deviation|5.7|5.7|||
4339937|NCT00420199|4168130|B2|||Number of Swollen Joints||joints|Mean|8.5|8.5|Standard Deviation|4.1|4.1|||
4339938|NCT00420199|4168131|B1|||Number of Swollen Joints||joints|Mean|11.3|11.3|Standard Deviation|6.6|6.6|||
4339939|NCT00420199|4168129|B3|||Number of Tender Joints||joints|Mean|13.1|13.1|Standard Deviation|7.2|7.2|||
4339940|NCT00420199|4168130|B2|||Number of Tender Joints||joints|Mean|13.3|13.3|Standard Deviation|7.2|7.2|||
4339941|NCT00420199|4168131|B1|||Number of Tender Joints||joints|Mean|12.9|12.9|Standard Deviation|7.1|7.1|||
4339942|NCT00420199|4168129|B3|||Disease Activity Score (DAS) 28 (C-Reactive Protein [CRP])|The DAS28 is a continuous disease measure which is a composite of 4 variables: the 28 tender joint count, the 28 swollen joint count, CRP, and participant assessment of disease activity measure on a visual analogue scale. The DAS28 has numeric thresholds that define high disease activity (> 5.1), low disease activity (< 3.2) and remission (< 2.6). A clinically significant response= decrease in DAS28 score of >1.2 from baseline. DAS28 area under the curve (DAS28AUC) can be calculated from the DAS28 score versus time curve, which provides an assessment of changes in disease activity over time.|units on a scale|Mean|5.3|5.3|Standard Deviation|1.0|1.0|||
4339943|NCT00420199|4168130|B2|||Disease Activity Score (DAS) 28 (C-Reactive Protein [CRP])|The DAS28 is a continuous disease measure which is a composite of 4 variables: the 28 tender joint count, the 28 swollen joint count, CRP, and participant assessment of disease activity measure on a visual analogue scale. The DAS28 has numeric thresholds that define high disease activity (> 5.1), low disease activity (< 3.2) and remission (< 2.6). A clinically significant response= decrease in DAS28 score of >1.2 from baseline. DAS28 area under the curve (DAS28AUC) can be calculated from the DAS28 score versus time curve, which provides an assessment of changes in disease activity over time.|units on a scale|Mean|5.3|5.3|Standard Deviation|0.9|0.9|||
4339944|NCT00420199|4168131|B1|||Disease Activity Score (DAS) 28 (C-Reactive Protein [CRP])|The DAS28 is a continuous disease measure which is a composite of 4 variables: the 28 tender joint count, the 28 swollen joint count, CRP, and participant assessment of disease activity measure on a visual analogue scale. The DAS28 has numeric thresholds that define high disease activity (> 5.1), low disease activity (< 3.2) and remission (< 2.6). A clinically significant response= decrease in DAS28 score of >1.2 from baseline. DAS28 area under the curve (DAS28AUC) can be calculated from the DAS28 score versus time curve, which provides an assessment of changes in disease activity over time.|units on a scale|Mean|5.3|5.3|Standard Deviation|1.1|1.1|||
4339945|NCT00420199|4168129|B3|||Duration of Rheumatoid Arthritis||months|Mean|26.8|26.8|Standard Deviation|17.4|17.4|||
4339946|NCT00420199|4168130|B2|||Duration of Rheumatoid Arthritis||months|Mean|28.2|28.2|Standard Deviation|17.0|17.0|||
4339947|NCT00420199|4168131|B1|||Duration of Rheumatoid Arthritis||months|Mean|25.7|25.7|Standard Deviation|18.0|18.0|||
4339948|NCT00420199|4168129|B3|Positive||Anti-CCP2 Status|Anti-citrullinated protein/peptide antibodies (ACPA) are among the most disease-specific autoantibodies for rheumatoid arthritis (RA). These antibodies occur specifically in RA and can be measured most conveniently via the anti-CCP (anti-cyclic citrullinated peptide) antibody test. The anti-CCP2 test enables clinicians to distinguish RA patients from other arthritic diseases, especially in cases where the RF test is not discriminative.|participants|Number|30|30.0||||||
4339949|NCT00420199|4168130|B2|Positive||Anti-CCP2 Status|Anti-citrullinated protein/peptide antibodies (ACPA) are among the most disease-specific autoantibodies for rheumatoid arthritis (RA). These antibodies occur specifically in RA and can be measured most conveniently via the anti-CCP (anti-cyclic citrullinated peptide) antibody test. The anti-CCP2 test enables clinicians to distinguish RA patients from other arthritic diseases, especially in cases where the RF test is not discriminative.|participants|Number|17|17.0||||||
4339950|NCT00420199|4168131|B1|Positive||Anti-CCP2 Status|Anti-citrullinated protein/peptide antibodies (ACPA) are among the most disease-specific autoantibodies for rheumatoid arthritis (RA). These antibodies occur specifically in RA and can be measured most conveniently via the anti-CCP (anti-cyclic citrullinated peptide) antibody test. The anti-CCP2 test enables clinicians to distinguish RA patients from other arthritic diseases, especially in cases where the RF test is not discriminative.|participants|Number|13|13.0||||||
4339951|NCT00420199|4168129|B3|Negative||Anti-CCP2 Status|Anti-citrullinated protein/peptide antibodies (ACPA) are among the most disease-specific autoantibodies for rheumatoid arthritis (RA). These antibodies occur specifically in RA and can be measured most conveniently via the anti-CCP (anti-cyclic citrullinated peptide) antibody test. The anti-CCP2 test enables clinicians to distinguish RA patients from other arthritic diseases, especially in cases where the RF test is not discriminative.|participants|Number|20|20.0||||||
4339952|NCT00420199|4168130|B2|Negative||Anti-CCP2 Status|Anti-citrullinated protein/peptide antibodies (ACPA) are among the most disease-specific autoantibodies for rheumatoid arthritis (RA). These antibodies occur specifically in RA and can be measured most conveniently via the anti-CCP (anti-cyclic citrullinated peptide) antibody test. The anti-CCP2 test enables clinicians to distinguish RA patients from other arthritic diseases, especially in cases where the RF test is not discriminative.|participants|Number|6|6.0||||||
4339953|NCT00420199|4168131|B1|Negative||Anti-CCP2 Status|Anti-citrullinated protein/peptide antibodies (ACPA) are among the most disease-specific autoantibodies for rheumatoid arthritis (RA). These antibodies occur specifically in RA and can be measured most conveniently via the anti-CCP (anti-cyclic citrullinated peptide) antibody test. The anti-CCP2 test enables clinicians to distinguish RA patients from other arthritic diseases, especially in cases where the RF test is not discriminative.|participants|Number|14|14.0||||||
4339954|NCT00420199|4168129|B3|Positive||Rheumatoid Factor (RF) Status|Rheumatoid factor (RF or RhF) is an autoantibody (antibody directed against an organism's own tissues) most relevant in rheumatoid arthritis. It is an antibody against the Fc portion of Immunoglobulin (Ig)G, which is itself an antibody. RF and IgG join to form immune complexes which contribute to the disease process.|participants|Number|34|34.0||||||
4339955|NCT00420199|4168130|B2|Positive||Rheumatoid Factor (RF) Status|Rheumatoid factor (RF or RhF) is an autoantibody (antibody directed against an organism's own tissues) most relevant in rheumatoid arthritis. It is an antibody against the Fc portion of Immunoglobulin (Ig)G, which is itself an antibody. RF and IgG join to form immune complexes which contribute to the disease process.|participants|Number|19|19.0||||||
4339956|NCT00420199|4168131|B1|Positive||Rheumatoid Factor (RF) Status|Rheumatoid factor (RF or RhF) is an autoantibody (antibody directed against an organism's own tissues) most relevant in rheumatoid arthritis. It is an antibody against the Fc portion of Immunoglobulin (Ig)G, which is itself an antibody. RF and IgG join to form immune complexes which contribute to the disease process.|participants|Number|15|15.0||||||
4340012|NCT00420095|4168197|B2|||Duration of Diabetes||months|Mean|130.3|130.3|Standard Deviation|78.31|78.31|||
4340013|NCT00420095|4168198|B1|||Duration of Diabetes||months|Mean|129.8|129.8|Standard Deviation|95.61|95.61|||
4339957|NCT00420199|4168129|B3|Negative||Rheumatoid Factor (RF) Status|Rheumatoid factor (RF or RhF) is an autoantibody (antibody directed against an organism's own tissues) most relevant in rheumatoid arthritis. It is an antibody against the Fc portion of Immunoglobulin (Ig)G, which is itself an antibody. RF and IgG join to form immune complexes which contribute to the disease process.|participants|Number|16|16.0||||||
4339958|NCT00420199|4168130|B2|Negative||Rheumatoid Factor (RF) Status|Rheumatoid factor (RF or RhF) is an autoantibody (antibody directed against an organism's own tissues) most relevant in rheumatoid arthritis. It is an antibody against the Fc portion of Immunoglobulin (Ig)G, which is itself an antibody. RF and IgG join to form immune complexes which contribute to the disease process.|participants|Number|4|4.0||||||
4339959|NCT00420199|4168131|B1|Negative||Rheumatoid Factor (RF) Status|Rheumatoid factor (RF or RhF) is an autoantibody (antibody directed against an organism's own tissues) most relevant in rheumatoid arthritis. It is an antibody against the Fc portion of Immunoglobulin (Ig)G, which is itself an antibody. RF and IgG join to form immune complexes which contribute to the disease process.|participants|Number|12|12.0||||||
4339960|NCT00420199|4168129|B3|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4339961|NCT00420199|4168130|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4339962|NCT00420199|4168131|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4339963|NCT00420199|4168129|B3|Sweden||Region of Enrollment||participants|Number|5|5.0||||||
4339964|NCT00420199|4168130|B2|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
4339965|NCT00420199|4168131|B1|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
4339966|NCT00420199|4168129|B3|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4339967|NCT00420199|4168130|B2|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4339968|NCT00420199|4168131|B1|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4339969|NCT00420199|4168129|B3|Netherlands||Region of Enrollment||participants|Number|7|7.0||||||
4339970|NCT00420199|4168130|B2|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
4339971|NCT00420199|4168131|B1|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
4339972|NCT00420199|4168129|B3|Germany||Region of Enrollment||participants|Number|16|16.0||||||
4339973|NCT00420199|4168130|B2|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4339974|NCT00420199|4168131|B1|Germany||Region of Enrollment||participants|Number|10|10.0||||||
4339975|NCT00420199|4168129|B3|Belgium||Region of Enrollment||participants|Number|16|16.0||||||
4339976|NCT00420199|4168130|B2|Belgium||Region of Enrollment||participants|Number|7|7.0||||||
4339977|NCT00420199|4168131|B1|Belgium||Region of Enrollment||participants|Number|9|9.0||||||
4339978|NCT00420199|4168129|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4339979|NCT00420199|4168130|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4339980|NCT00420199|4168131|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4339981|NCT00420199|4168129|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4339982|NCT00420199|4168130|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4339983|NCT00420199|4168131|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4339984|NCT00420199|4168129|B3|||Age||years|Mean|52.1|52.1|Standard Deviation|11.2|11.2|||
4339985|NCT00420199|4168130|B2|||Age||years|Mean|52.5|52.5|Standard Deviation|11.5|11.5|||
4339986|NCT00420199|4168131|B1|||Age||years|Mean|51.7|51.7|Standard Deviation|11.2|11.2|||
4339987|NCT00420147|4168185|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
4339988|NCT00420147|4168186|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4339989|NCT00420147|4168187|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4339990|NCT00420147|4168185|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4339991|NCT00420147|4168186|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4339992|NCT00420147|4168187|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4339993|NCT00420147|4168185|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4339994|NCT00420147|4168186|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4339995|NCT00420147|4168187|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4339996|NCT00420147|4168185|B3|||Age||years|Mean|62.4|62.4|Standard Deviation|8.5|8.5|||
4339997|NCT00420147|4168186|B2|||Age||years|Mean|62.0|62.0|Standard Deviation|7.4|7.4|||
4339998|NCT00420147|4168187|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|9.6|9.6|||
4339999|NCT00420147|4168185|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4340000|NCT00420147|4168186|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4340001|NCT00420147|4168187|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4340002|NCT00420147|4168185|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4340003|NCT00420147|4168186|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4340004|NCT00420147|4168187|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4340005|NCT00420147|4168185|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4340006|NCT00420147|4168186|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4340007|NCT00420147|4168187|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4340008|NCT00420095|4168196|B3|||Duration of Insulin Treatment||months|Mean|38.8|38.8|Standard Deviation|34.77|34.77|||
4340009|NCT00420095|4168197|B2|||Duration of Insulin Treatment||months|Mean|39.0|39.0|Standard Deviation|32.37|32.37|||
4340010|NCT00420095|4168198|B1|||Duration of Insulin Treatment||months|Mean|38.6|38.6|Standard Deviation|37.41|37.41|||
4340011|NCT00420095|4168196|B3|||Duration of Diabetes||months|Mean|130.1|130.1|Standard Deviation|86.78|86.78|||
4340014|NCT00420095|4168196|B3|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by body height squared.|kilogram per meter squared|Mean|24.98|24.98|Standard Deviation|3.045|3.045|||
4340015|NCT00420095|4168197|B2|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by body height squared.|kilogram per meter squared|Mean|24.58|24.58|Standard Deviation|2.754|2.754|||
4340016|NCT00420095|4168198|B1|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by body height squared.|kilogram per meter squared|Mean|25.40|25.4|Standard Deviation|3.297|3.297|||
4340017|NCT00420095|4168196|B3|||Baseline Glycosylated Hemoglobin||percent of glycosylated hemoglobin|Mean|8.58|8.58|Standard Deviation|1.442|1.442|||
4340018|NCT00420095|4168197|B2|||Baseline Glycosylated Hemoglobin||percent of glycosylated hemoglobin|Mean|8.59|8.59|Standard Deviation|1.573|1.573|||
4340019|NCT00420095|4168198|B1|||Baseline Glycosylated Hemoglobin||percent of glycosylated hemoglobin|Mean|8.56|8.56|Standard Deviation|1.304|1.304|||
4340020|NCT00420095|4168196|B3|||Baseline Fasting Blood Glucose||millimole/Liter|Mean|9.32|9.32|Standard Deviation|2.942|2.942|||
4340021|NCT00420095|4168197|B2|||Baseline Fasting Blood Glucose||millimole/Liter|Mean|9.15|9.15|Standard Deviation|3.200|3.2|||
4340022|NCT00420095|4168198|B1|||Baseline Fasting Blood Glucose||millimole/Liter|Mean|9.49|9.49|Standard Deviation|2.660|2.66|||
4340023|NCT00420095|4168196|B3|Type 2||Type of Diabetes||participants|Number|108|108.0||||||
4340024|NCT00420095|4168197|B2|Type 2||Type of Diabetes||participants|Number|53|53.0||||||
4340025|NCT00420095|4168198|B1|Type 2||Type of Diabetes||participants|Number|55|55.0||||||
4340026|NCT00420095|4168196|B3|Type 1||Type of Diabetes||participants|Number|9|9.0||||||
4340027|NCT00420095|4168197|B2|Type 1||Type of Diabetes||participants|Number|7|7.0||||||
4340028|NCT00420095|4168198|B1|Type 1||Type of Diabetes||participants|Number|2|2.0||||||
4340029|NCT00420095|4168196|B3|Han - the main ethnic origin in China||Race/Ethnicity||participants|Number|117|117.0||||||
4340030|NCT00420095|4168197|B2|Han - the main ethnic origin in China||Race/Ethnicity||participants|Number|60|60.0||||||
4340031|NCT00420095|4168198|B1|Han - the main ethnic origin in China||Race/Ethnicity||participants|Number|57|57.0||||||
4340032|NCT00420095|4168196|B3|No||Other Treatments for Diabetes Prior to Study||participants|Number|72|72.0||||||
4340033|NCT00420095|4168197|B2|No||Other Treatments for Diabetes Prior to Study||participants|Number|37|37.0||||||
4340034|NCT00420095|4168198|B1|No||Other Treatments for Diabetes Prior to Study||participants|Number|35|35.0||||||
4340035|NCT00420095|4168196|B3|Yes||Other Treatments for Diabetes Prior to Study||participants|Number|45|45.0||||||
4340036|NCT00420095|4168197|B2|Yes||Other Treatments for Diabetes Prior to Study||participants|Number|23|23.0||||||
4340037|NCT00420095|4168198|B1|Yes||Other Treatments for Diabetes Prior to Study||participants|Number|22|22.0||||||
4340038|NCT00420095|4168196|B3|China||Region of Enrollment||participants|Number|117|117.0||||||
4340039|NCT00420095|4168197|B2|China||Region of Enrollment||participants|Number|60|60.0||||||
4340040|NCT00420095|4168198|B1|China||Region of Enrollment||participants|Number|57|57.0||||||
4340041|NCT00420095|4168196|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4340042|NCT00420095|4168197|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4340043|NCT00420095|4168198|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4340044|NCT00420095|4168196|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4340045|NCT00420095|4168197|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4340046|NCT00420095|4168198|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4340047|NCT00420095|4168196|B3|||Age||years|Mean|54.2|54.2|Standard Deviation|10.71|10.71|||
4340048|NCT00420095|4168197|B2|||Age||years|Mean|54.5|54.5|Standard Deviation|10.75|10.75|||
4340049|NCT00420095|4168198|B1|||Age||years|Mean|53.9|53.9|Standard Deviation|10.75|10.75|||
4340050|NCT00420056|4168217|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4340051|NCT00420056|4168217|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4340052|NCT00420056|4168217|B1|||Age||years|Mean|66.1|66.1|Standard Deviation|9.2|9.2|||
4340053|NCT00420017|4168239|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
4340054|NCT00420017|4168240|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4340055|NCT00420017|4168241|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4340056|NCT00420017|4168239|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4340057|NCT00420017|4168240|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4340058|NCT00420017|4168241|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4340059|NCT00420017|4168239|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4340060|NCT00420017|4168240|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4340061|NCT00420017|4168241|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4340062|NCT00420017|4168239|B3|||Age||years|Mean|62|62.0|Standard Deviation|9.5|9.5|||
4340063|NCT00420017|4168240|B2|||Age||years|Mean|63|63.0|Standard Deviation|9|9.0|||
4340064|NCT00420017|4168241|B1|||Age||years|Mean|61|61.0|Standard Deviation|10|10.0|||
4340065|NCT00420017|4168239|B3||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
4340066|NCT00420017|4168240|B2||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4340067|NCT00420017|4168241|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4340068|NCT00420017|4168239|B3||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4340069|NCT00420017|4168240|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4340070|NCT00420017|4168241|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4340071|NCT00420017|4168239|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4340073|NCT00420017|4168241|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4340074|NCT00420004|4168254|B4|Mexico||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
4340075|NCT00420004|4168255|B3|Mexico||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4340076|NCT00420004|4168256|B2|Mexico||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4340077|NCT00420004|4168257|B1|Mexico||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4340078|NCT00420004|4168254|B4|India||Region of Enrollment||Participants|Count of Participants|363|363.0||||||
4340079|NCT00420004|4168255|B3|India||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
4340080|NCT00420004|4168256|B2|India||Region of Enrollment||Participants|Count of Participants|105|105.0||||||
4340081|NCT00420004|4168257|B1|India||Region of Enrollment||Participants|Count of Participants|208|208.0||||||
4340082|NCT00420004|4168254|B4|Romania||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4340083|NCT00420004|4168255|B3|Romania||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4340084|NCT00420004|4168256|B2|Romania||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4340085|NCT00420004|4168257|B1|Romania||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4340086|NCT00420004|4168254|B4|United States||Region of Enrollment||Participants|Count of Participants|70|70.0||||||
4340087|NCT00420004|4168255|B3|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4340088|NCT00420004|4168256|B2|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4340089|NCT00420004|4168257|B1|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
4340090|NCT00420004|4168254|B4|West Asian (Indian subcontinent)||Race/Ethnicity, Customized||Participants|Count of Participants|364|364.0||||||
4340091|NCT00420004|4168255|B3|West Asian (Indian subcontinent)||Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
4340092|NCT00420004|4168256|B2|West Asian (Indian subcontinent)||Race/Ethnicity, Customized||Participants|Count of Participants|105|105.0||||||
4340093|NCT00420004|4168257|B1|West Asian (Indian subcontinent)||Race/Ethnicity, Customized||Participants|Count of Participants|209|209.0||||||
4340094|NCT00420004|4168254|B4|Native American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4340095|NCT00420004|4168255|B3|Native American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4340096|NCT00420004|4168256|B2|Native American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4340097|NCT00420004|4168257|B1|Native American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4340098|NCT00420004|4168254|B4|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|34|34.0||||||
4340099|NCT00420004|4168255|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4340100|NCT00420004|4168256|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4340101|NCT00420004|4168257|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
4340102|NCT00420004|4168254|B4|African||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4340103|NCT00420004|4168255|B3|African||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4340104|NCT00420004|4168256|B2|African||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4340105|NCT00420004|4168257|B1|African||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4340106|NCT00420004|4168254|B4|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|59|59.0||||||
4340107|NCT00420004|4168255|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4340108|NCT00420004|4168256|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
4340109|NCT00420004|4168257|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
4340110|NCT00420004|4168254|B4||Male|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
4340111|NCT00420004|4168255|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4340112|NCT00420004|4168256|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4340113|NCT00420004|4168257|B1||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4340114|NCT00420004|4168254|B4||Female|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
4340115|NCT00420004|4168255|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4340116|NCT00420004|4168256|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4340117|NCT00420004|4168257|B1||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4340118|NCT00420004|4168254|B4|||Age||years|Mean|36.60|36.6|Standard Deviation|10.40|10.4|||
4340119|NCT00420004|4168255|B3|||Age||years|Mean|34.32|34.32|Standard Deviation|9.66|9.66|||
4340120|NCT00420004|4168256|B2|||Age||years|Mean|37.54|37.54|Standard Deviation|10.97|10.97|||
4340121|NCT00420004|4168257|B1|||Age||years|Mean|36.64|36.64|Standard Deviation|10.21|10.21|||
4340122|NCT00419952|4168322|B3||Male|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
4340123|NCT00419952|4168323|B2||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4340124|NCT00419952|4168324|B1||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4340125|NCT00419952|4168322|B3||Female|Sex: Female, Male||Participants|Count of Participants|481|481.0||||||
4340126|NCT00419952|4168323|B2||Female|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
4340127|NCT00419952|4168324|B1||Female|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
4340128|NCT00419952|4168322|B3|||Age||Years|Mean|37.27|37.27|Standard Deviation|15.48|15.48|||
4340129|NCT00419952|4168323|B2|||Age||Years|Mean|38.35|38.35|Standard Deviation|15.22|15.22|||
4340130|NCT00419952|4168324|B1|||Age||Years|Mean|36.19|36.19|Standard Deviation|15.67|15.67|||
4340131|NCT00419926|4168357|B3||Male|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
4340132|NCT00419926|4168358|B2||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4340133|NCT00419926|4168359|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4340134|NCT00419926|4168357|B3||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4340135|NCT00419926|4168358|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4340136|NCT00419926|4168359|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4340137|NCT00419926|4168357|B3|>=50 years||Age, Customized||participants|Number|111|111.0||||||
4340138|NCT00419926|4168358|B2|>=50 years||Age, Customized||participants|Number|56|56.0||||||
4340139|NCT00419926|4168359|B1|>=50 years||Age, Customized||participants|Number|55|55.0||||||
4340140|NCT00419926|4168357|B3|< 50 years||Age, Customized||participants|Number|202|202.0||||||
4340141|NCT00419926|4168358|B2|< 50 years||Age, Customized||participants|Number|102|102.0||||||
4340142|NCT00419926|4168359|B1|< 50 years||Age, Customized||participants|Number|100|100.0||||||
4340143|NCT00419770|4168374|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4340144|NCT00419770|4168375|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4340145|NCT00419770|4168376|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4340146|NCT00419770|4168374|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4340147|NCT00419770|4168375|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4340148|NCT00419770|4168376|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4340149|NCT00419770|4168374|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4340150|NCT00419770|4168375|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4340151|NCT00419770|4168376|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4340152|NCT00419770|4168374|B3|||Age||years|Median|52|52.0|Full Range|||30.0|75.0|
4340153|NCT00419770|4168375|B2|||Age||years|Median|47|47.0|Full Range|||40.0|75.0|
4340154|NCT00419770|4168376|B1|||Age||years|Median|59|59.0|Full Range|||30.0|71.0|
4340155|NCT00419770|4168374|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4340156|NCT00419770|4168375|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4340157|NCT00419770|4168376|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4340158|NCT00419770|4168374|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4340159|NCT00419770|4168375|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4340160|NCT00419770|4168376|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4340161|NCT00419770|4168374|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4340162|NCT00419770|4168375|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4340163|NCT00419770|4168376|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4340164|NCT00419757|4168383|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4340165|NCT00419757|4168384|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4340166|NCT00419757|4168385|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4340167|NCT00419757|4168383|B3||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4340168|NCT00419757|4168384|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4340169|NCT00419757|4168385|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4340170|NCT00419757|4168383|B3|||Age||Years|Mean|15.6|15.6|Standard Deviation|38.4|38.4|||
4340171|NCT00419757|4168384|B2|||Age||Years|Mean|14.9|14.9|Standard Deviation|37.0|37.0|||
4340172|NCT00419757|4168385|B1|||Age||Years|Mean|16.6|16.6|Standard Deviation|39.8|39.8|||
4340173|NCT00419744|4168422|B4||Male|Sex: Female, Male||Participants|Count of Participants|755|755.0||||||
4340174|NCT00419744|4168423|B3||Male|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4340175|NCT00419744|4168424|B2||Male|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
4340176|NCT00419744|4168425|B1||Male|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
4340177|NCT00419744|4168422|B4||Female|Sex: Female, Male||Participants|Count of Participants|463|463.0||||||
4340178|NCT00419744|4168423|B3||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4340179|NCT00419744|4168424|B2||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4340180|NCT00419744|4168425|B1||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4340181|NCT00419744|4168422|B4|||Age||Years|Mean|63.0|63.0|Standard Deviation|9.34|9.34|||
4340182|NCT00419744|4168423|B3|||Age||Years|Mean|62.5|62.5|Standard Deviation|9.36|9.36|||
4340183|NCT00419744|4168424|B2|||Age||Years|Mean|62.8|62.8|Standard Deviation|9.22|9.22|||
4340184|NCT00419744|4168425|B1|||Age||Years|Mean|63.8|63.8|Standard Deviation|9.4|9.4|||
4340185|NCT00419445|4168456|B4|United States||Region of Enrollment||participants|Number|32|32.0||||||
4340186|NCT00419445|4168457|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4340187|NCT00419445|4168458|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4340188|NCT00419445|4168459|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4340189|NCT00419445|4168456|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4340190|NCT00419445|4168457|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4340191|NCT00419445|4168458|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4340192|NCT00419445|4168459|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4340193|NCT00419445|4168456|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4340194|NCT00419445|4168457|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4340195|NCT00419445|4168458|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4340196|NCT00419445|4168459|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4340197|NCT00419445|4168456|B4|||Age||years|Mean|39.2|39.2|Standard Deviation|10.69|10.69|||
4340198|NCT00419445|4168457|B3|||Age||years|Mean|34.8|34.8|Standard Deviation|15.42|15.42|||
4340199|NCT00419445|4168458|B2|||Age||years|Mean|371.|0.0|Standard Deviation|10.24|10.24|||
4340200|NCT00419445|4168459|B1|||Age||years|Mean|41.5|41.5|Standard Deviation|9.47|9.47|||
4340201|NCT00419445|4168456|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4340202|NCT00419445|4168457|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4340203|NCT00419445|4168458|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4340204|NCT00419445|4168459|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4340205|NCT00419445|4168456|B4||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4340206|NCT00419445|4168457|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4340207|NCT00419445|4168458|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4340208|NCT00419445|4168459|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4340209|NCT00419445|4168456|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4340210|NCT00419445|4168457|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4340211|NCT00419445|4168458|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4340212|NCT00419445|4168459|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4340213|NCT00419393|4168469|B1|Russian Federation||Region of Enrollment||participants|Number|56|56.0||||||
4340214|NCT00419393|4168469|B1|Poland||Region of Enrollment||participants|Number|59|59.0||||||
4340215|NCT00419393|4168469|B1|Mexico||Region of Enrollment||participants|Number|49|49.0||||||
4340216|NCT00419393|4168469|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4340217|NCT00419393|4168469|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4340218|NCT00419393|4168469|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4340219|NCT00419393|4168469|B1|||Age||years|Mean|33.44|33.44|Standard Deviation|14.46|14.46|||
4340220|NCT00419393|4168469|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4340221|NCT00419393|4168469|B1||Between 18 and 65 years|Age||Participants|Count of Participants|147|147.0||||||
4340222|NCT00419393|4168469|B1||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
4340223|NCT00419380|4168477|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
4340224|NCT00419380|4168478|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4340225|NCT00419380|4168479|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4340226|NCT00419380|4168477|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4340227|NCT00419380|4168478|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4340228|NCT00419380|4168479|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340229|NCT00419380|4168477|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340230|NCT00419380|4168478|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340231|NCT00419380|4168479|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340232|NCT00419380|4168477|B3||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4340233|NCT00419380|4168478|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4340234|NCT00419380|4168479|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4340235|NCT00419380|4168477|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340236|NCT00419380|4168478|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340237|NCT00419380|4168479|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340238|NCT00419380|4168477|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340239|NCT00419380|4168478|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340240|NCT00419380|4168479|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340241|NCT00419380|4168477|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340242|NCT00419380|4168478|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340243|NCT00419380|4168479|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340244|NCT00419380|4168477|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340245|NCT00419380|4168478|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340246|NCT00419380|4168479|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340247|NCT00419380|4168477|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340248|NCT00419380|4168478|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340249|NCT00419380|4168479|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340250|NCT00419380|4168477|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4340251|NCT00419380|4168478|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4340252|NCT00419380|4168479|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4340253|NCT00419380|4168477|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4340254|NCT00419380|4168478|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4340255|NCT00419380|4168479|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4340256|NCT00419380|4168477|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4340257|NCT00419380|4168478|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4340258|NCT00419380|4168479|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4340259|NCT00419380|4168477|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4340260|NCT00419380|4168478|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4340261|NCT00419380|4168479|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4340262|NCT00419380|4168477|B3|||Age||years|Mean|4.24|4.24|Standard Deviation|2.80|2.8|||
4340263|NCT00419380|4168478|B2|||Age||years|Mean|4.05|4.05|Standard Deviation|2.27|2.27|||
4340264|NCT00419380|4168479|B1|||Age||years|Mean|4.45|4.45|Standard Deviation|3.30|3.3|||
4340265|NCT00419380|4168477|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4340266|NCT00419380|4168478|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4340267|NCT00419380|4168479|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4340268|NCT00419380|4168477|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4340269|NCT00419380|4168478|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4340270|NCT00419380|4168479|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4340271|NCT00419380|4168477|B3||<=18 years|Age||Participants|Count of Participants|41|41.0||||||
4340272|NCT00419380|4168478|B2||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
4340273|NCT00419380|4168479|B1||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
4340274|NCT00419341|4168488|B1|X-linked agammaglobulinemia (XLA)||Type of Primary Immunodeficiency||participants|Number|3|3.0||||||
4340275|NCT00419341|4168488|B1|Common variable immunodeficiency (CVID)||Type of Primary Immunodeficiency||participants|Number|46|46.0||21.24|21.24|||
4340276|NCT00419341|4168488|B1|White||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4340277|NCT00419341|4168488|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4340278|NCT00419341|4168488|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4340279|NCT00419341|4168488|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4340280|NCT00419341|4168488|B1|≥ 65 years||Age, Customized||participants|Number|6|6.0||||||
4340281|NCT00419341|4168488|B1|16 to < 65 years||Age, Customized||participants|Number|33|33.0||||||
4340282|NCT00419341|4168488|B1|12 to < 16 years||Age, Customized||participants|Number|7|7.0||||||
4340283|NCT00419341|4168488|B1|2 to < 12 years||Age, Customized||participants|Number|3|3.0||||||
4340284|NCT00419341|4168488|B1|||Age||years|Mean|34.4|34.4|Standard Deviation|20.09|20.09|||
4340285|NCT00419315|4168509|B3|||The number of Subjects Engaged in Treatment at Baseline|This was a measure of the proportion of patients engaged in addiction treatment at the time of randomization. It was a requirement that no of the subjects were engaged at baseline.|Participants engaged in treatment|Number|0|0.0||||||
4340286|NCT00419315|4168510|B2|||The number of Subjects Engaged in Treatment at Baseline|This was a measure of the proportion of patients engaged in addiction treatment at the time of randomization. It was a requirement that no of the subjects were engaged at baseline.|Participants engaged in treatment|Number|0|0.0||||||
4340287|NCT00419315|4168511|B1|||The number of Subjects Engaged in Treatment at Baseline|This was a measure of the proportion of patients engaged in addiction treatment at the time of randomization. It was a requirement that no of the subjects were engaged at baseline.|Participants engaged in treatment|Number|0|0.0||||||
4340288|NCT00419315|4168509|B3|||% Days of Heavy Drinking|The measures the percent of days in the 60 days prior to randomization in which a participant drank more than 4 standard drinks (3 or more for women) in a given day.|% days of heavy drinking|Mean|54.6|54.6|Standard Deviation|44.1|44.1|||
4340289|NCT00419315|4168510|B2|||% Days of Heavy Drinking|The measures the percent of days in the 60 days prior to randomization in which a participant drank more than 4 standard drinks (3 or more for women) in a given day.|% days of heavy drinking|Mean|54.7|54.7|Standard Deviation|33.6|33.6|||
4340290|NCT00419315|4168511|B1|||% Days of Heavy Drinking|The measures the percent of days in the 60 days prior to randomization in which a participant drank more than 4 standard drinks (3 or more for women) in a given day.|% days of heavy drinking|Mean|54.5|54.5|Standard Deviation|53.8|53.8|||
4340291|NCT00419315|4168509|B3|United States||Region of Enrollment||participants|Number|163|163.0||||||
4340292|NCT00419315|4168510|B2|United States||Region of Enrollment||participants|Number|78|78.0||||||
4340293|NCT00419315|4168511|B1|United States||Region of Enrollment||participants|Number|85|85.0||||||
4340294|NCT00419315|4168509|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340295|NCT00419315|4168510|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340296|NCT00419315|4168511|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340297|NCT00419315|4168509|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340298|NCT00419315|4168510|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340299|NCT00419315|4168511|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340300|NCT00419315|4168509|B3||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
4340301|NCT00419315|4168510|B2||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4340302|NCT00419315|4168511|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4340303|NCT00419315|4168509|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
4340304|NCT00419315|4168510|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4340305|NCT00419315|4168511|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4340306|NCT00419315|4168509|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340307|NCT00419315|4168510|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340308|NCT00419315|4168511|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340309|NCT00419315|4168509|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340310|NCT00419315|4168510|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340311|NCT00419315|4168511|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340312|NCT00419315|4168509|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340313|NCT00419315|4168510|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340314|NCT00419315|4168511|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340315|NCT00419315|4168509|B3||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4340316|NCT00419315|4168510|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4340317|NCT00419315|4168511|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4340318|NCT00419315|4168509|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4340319|NCT00419315|4168510|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4340320|NCT00419315|4168511|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4340321|NCT00419315|4168509|B3|||Age||years|Mean|56|56.0|Standard Deviation|10.8|10.8|||
4340322|NCT00419315|4168510|B2|||Age||years|Mean|57.1|57.1|Standard Deviation|10.1|10.1|||
4340323|NCT00419315|4168511|B1|||Age||years|Mean|54.9|54.9|Standard Deviation|11.4|11.4|||
4340324|NCT00419263|4168520|B4|||Body Surface Area|Data were available for 114 participants in the placebo arm, 113 participants in the peramivir 150-mg arm, and 115 participants in the peramivir 300-mg arm.|m^2|Mean|1.9|1.9|Standard Deviation|0.26|0.26|||
4340325|NCT00419263|4168521|B3|||Body Surface Area|Data were available for 114 participants in the placebo arm, 113 participants in the peramivir 150-mg arm, and 115 participants in the peramivir 300-mg arm.|m^2|Mean|1.9|1.9|Standard Deviation|0.28|0.28|||
4340326|NCT00419263|4168522|B2|||Body Surface Area|Data were available for 114 participants in the placebo arm, 113 participants in the peramivir 150-mg arm, and 115 participants in the peramivir 300-mg arm.|m^2|Mean|1.9|1.9|Standard Deviation|0.25|0.25|||
4340327|NCT00419263|4168523|B1|||Body Surface Area|Data were available for 114 participants in the placebo arm, 113 participants in the peramivir 150-mg arm, and 115 participants in the peramivir 300-mg arm.|m^2|Mean|1.9|1.9|Standard Deviation|0.26|0.26|||
4340328|NCT00419263|4168520|B4|Missing||Influenza Infection|Infection as measured by polymerase chain reaction (PCR) or serology.|participants|Number|1|1.0||||||
4340329|NCT00419263|4168521|B3|Missing||Influenza Infection|Infection as measured by polymerase chain reaction (PCR) or serology.|participants|Number|1|1.0||||||
4340330|NCT00419263|4168522|B2|Missing||Influenza Infection|Infection as measured by polymerase chain reaction (PCR) or serology.|participants|Number|0|0.0||||||
4340331|NCT00419263|4168523|B1|Missing||Influenza Infection|Infection as measured by polymerase chain reaction (PCR) or serology.|participants|Number|0|0.0||||||
4340332|NCT00419263|4168520|B4|Positive||Influenza Infection|Infection as measured by polymerase chain reaction (PCR) or serology.|participants|Number|318|318.0||||||
4340333|NCT00419263|4168521|B3|Positive||Influenza Infection|Infection as measured by polymerase chain reaction (PCR) or serology.|participants|Number|105|105.0||||||
4340334|NCT00419263|4168522|B2|Positive||Influenza Infection|Infection as measured by polymerase chain reaction (PCR) or serology.|participants|Number|104|104.0||||||
4340335|NCT00419263|4168523|B1|Positive||Influenza Infection|Infection as measured by polymerase chain reaction (PCR) or serology.|participants|Number|109|109.0||||||
4340336|NCT00419263|4168520|B4|Negative||Influenza Infection|Infection as measured by polymerase chain reaction (PCR) or serology.|participants|Number|23|23.0||||||
4340337|NCT00419263|4168521|B3|Negative||Influenza Infection|Infection as measured by polymerase chain reaction (PCR) or serology.|participants|Number|9|9.0||||||
4340338|NCT00419263|4168522|B2|Negative||Influenza Infection|Infection as measured by polymerase chain reaction (PCR) or serology.|participants|Number|9|9.0||||||
4340339|NCT00419263|4168523|B1|Negative||Influenza Infection|Infection as measured by polymerase chain reaction (PCR) or serology.|participants|Number|5|5.0||||||
4340340|NCT00419263|4168520|B4|||Initial Composite Symptom Score|Initial Composite Symptom Score is defined as the sum of the 7 symptoms of influenza initially recorded by the subject in the diary (cough; sore throat; nasal congestion; myalgia [aches and pains]; headache; feverishness; and fatigue), each graded on a 4-point severity scale [0, absent; 1, mild; 2, moderate; 3, severe]); for the composite score, individual scores were summed, with a range from 0 to 21. Data were available for 111 participants in the placebo arm, 111 participants in the peramivir 150-mg arm, and 114 participants in the peramivir 300-mg arm.|units on a scale|Mean|14.2|14.2|Standard Deviation|3.62|3.62|||
4340341|NCT00419263|4168521|B3|||Initial Composite Symptom Score|Initial Composite Symptom Score is defined as the sum of the 7 symptoms of influenza initially recorded by the subject in the diary (cough; sore throat; nasal congestion; myalgia [aches and pains]; headache; feverishness; and fatigue), each graded on a 4-point severity scale [0, absent; 1, mild; 2, moderate; 3, severe]); for the composite score, individual scores were summed, with a range from 0 to 21. Data were available for 111 participants in the placebo arm, 111 participants in the peramivir 150-mg arm, and 114 participants in the peramivir 300-mg arm.|units on a scale|Mean|14.1|14.1|Standard Deviation|3.92|3.92|||
4340384|NCT00419263|4168520|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4340385|NCT00419263|4168521|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4340386|NCT00419263|4168522|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4340342|NCT00419263|4168522|B2|||Initial Composite Symptom Score|Initial Composite Symptom Score is defined as the sum of the 7 symptoms of influenza initially recorded by the subject in the diary (cough; sore throat; nasal congestion; myalgia [aches and pains]; headache; feverishness; and fatigue), each graded on a 4-point severity scale [0, absent; 1, mild; 2, moderate; 3, severe]); for the composite score, individual scores were summed, with a range from 0 to 21. Data were available for 111 participants in the placebo arm, 111 participants in the peramivir 150-mg arm, and 114 participants in the peramivir 300-mg arm.|units on a scale|Mean|14.3|14.3|Standard Deviation|3.22|3.22|||
4340343|NCT00419263|4168523|B1|||Initial Composite Symptom Score|Initial Composite Symptom Score is defined as the sum of the 7 symptoms of influenza initially recorded by the subject in the diary (cough; sore throat; nasal congestion; myalgia [aches and pains]; headache; feverishness; and fatigue), each graded on a 4-point severity scale [0, absent; 1, mild; 2, moderate; 3, severe]); for the composite score, individual scores were summed, with a range from 0 to 21. Data were available for 111 participants in the placebo arm, 111 participants in the peramivir 150-mg arm, and 114 participants in the peramivir 300-mg arm.|units on a scale|Mean|14.3|14.3|Standard Deviation|3.70|3.7|||
4340344|NCT00419263|4168520|B4|> 36 - 48 hours ago||Estimated Time of Onset of Symptoms at Screening||participants|Number|105|105.0||||||
4340345|NCT00419263|4168521|B3|> 36 - 48 hours ago||Estimated Time of Onset of Symptoms at Screening||participants|Number|40|40.0||||||
4340346|NCT00419263|4168522|B2|> 36 - 48 hours ago||Estimated Time of Onset of Symptoms at Screening||participants|Number|34|34.0||||||
4340347|NCT00419263|4168523|B1|> 36 - 48 hours ago||Estimated Time of Onset of Symptoms at Screening||participants|Number|31|31.0||||||
4340348|NCT00419263|4168520|B4|> 24 - 36 hours ago||Estimated Time of Onset of Symptoms at Screening||participants|Number|134|134.0||||||
4340349|NCT00419263|4168521|B3|> 24 - 36 hours ago||Estimated Time of Onset of Symptoms at Screening||participants|Number|46|46.0||||||
4340350|NCT00419263|4168522|B2|> 24 - 36 hours ago||Estimated Time of Onset of Symptoms at Screening||participants|Number|43|43.0||||||
4340351|NCT00419263|4168523|B1|> 24 - 36 hours ago||Estimated Time of Onset of Symptoms at Screening||participants|Number|45|45.0||||||
4340352|NCT00419263|4168520|B4|> 12 - 24 hours ago||Estimated Time of Onset of Symptoms at Screening||participants|Number|94|94.0||||||
4340353|NCT00419263|4168521|B3|> 12 - 24 hours ago||Estimated Time of Onset of Symptoms at Screening||participants|Number|25|25.0||||||
4340354|NCT00419263|4168522|B2|> 12 - 24 hours ago||Estimated Time of Onset of Symptoms at Screening||participants|Number|32|32.0||||||
4340355|NCT00419263|4168523|B1|> 12 - 24 hours ago||Estimated Time of Onset of Symptoms at Screening||participants|Number|37|37.0||||||
4340356|NCT00419263|4168520|B4|0 - 12 hours ago||Estimated Time of Onset of Symptoms at Screening||participants|Number|9|9.0||||||
4340357|NCT00419263|4168521|B3|0 - 12 hours ago||Estimated Time of Onset of Symptoms at Screening||participants|Number|4|4.0||||||
4340358|NCT00419263|4168522|B2|0 - 12 hours ago||Estimated Time of Onset of Symptoms at Screening||participants|Number|4|4.0||||||
4340359|NCT00419263|4168523|B1|0 - 12 hours ago||Estimated Time of Onset of Symptoms at Screening||participants|Number|1|1.0||||||
4340360|NCT00419263|4168520|B4|Nonsmoker||Current Smoking Behavior at Randomization||participants|Number|269|269.0||||||
4340361|NCT00419263|4168521|B3|Nonsmoker||Current Smoking Behavior at Randomization||participants|Number|90|90.0||||||
4340362|NCT00419263|4168522|B2|Nonsmoker||Current Smoking Behavior at Randomization||participants|Number|91|91.0||||||
4340363|NCT00419263|4168523|B1|Nonsmoker||Current Smoking Behavior at Randomization||participants|Number|88|88.0||||||
4340364|NCT00419263|4168520|B4|Smoker||Current Smoking Behavior at Randomization||participants|Number|73|73.0||||||
4340365|NCT00419263|4168521|B3|Smoker||Current Smoking Behavior at Randomization||participants|Number|25|25.0||||||
4340366|NCT00419263|4168522|B2|Smoker||Current Smoking Behavior at Randomization||participants|Number|22|22.0||||||
4340367|NCT00419263|4168523|B1|Smoker||Current Smoking Behavior at Randomization||participants|Number|26|26.0||||||
4340368|NCT00419263|4168520|B4|||Body Mass Index at Screening|Data were available for 114 participants in the placebo arm, 113 participants in the peramivir 150-mg arm, and 115 participants in the peramivir 300-mg arm.|kg/m^2|Mean|27.2|27.2|Standard Deviation|6.11|6.11|||
4340369|NCT00419263|4168521|B3|||Body Mass Index at Screening|Data were available for 114 participants in the placebo arm, 113 participants in the peramivir 150-mg arm, and 115 participants in the peramivir 300-mg arm.|kg/m^2|Mean|27.8|27.8|Standard Deviation|6.35|6.35|||
4340370|NCT00419263|4168522|B2|||Body Mass Index at Screening|Data were available for 114 participants in the placebo arm, 113 participants in the peramivir 150-mg arm, and 115 participants in the peramivir 300-mg arm.|kg/m^2|Mean|27.5|27.5|Standard Deviation|6.23|6.23|||
4340371|NCT00419263|4168523|B1|||Body Mass Index at Screening|Data were available for 114 participants in the placebo arm, 113 participants in the peramivir 150-mg arm, and 115 participants in the peramivir 300-mg arm.|kg/m^2|Mean|26.5|26.5|Standard Deviation|5.69|5.69|||
4340372|NCT00419263|4168520|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4340373|NCT00419263|4168521|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4340374|NCT00419263|4168522|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4340375|NCT00419263|4168523|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4340376|NCT00419263|4168520|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340377|NCT00419263|4168521|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340378|NCT00419263|4168522|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340379|NCT00419263|4168523|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340380|NCT00419263|4168520|B4||White|Race (NIH/OMB)||Participants|Count of Participants|236|236.0||||||
4340381|NCT00419263|4168521|B3||White|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
4340382|NCT00419263|4168522|B2||White|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
4340383|NCT00419263|4168523|B1||White|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
4340387|NCT00419263|4168523|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4340388|NCT00419263|4168520|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4340389|NCT00419263|4168521|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4340390|NCT00419263|4168522|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4340391|NCT00419263|4168523|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4340392|NCT00419263|4168520|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4340393|NCT00419263|4168521|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4340394|NCT00419263|4168522|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4340395|NCT00419263|4168523|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4340396|NCT00419263|4168520|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340397|NCT00419263|4168521|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340398|NCT00419263|4168522|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340399|NCT00419263|4168523|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340400|NCT00419263|4168520|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340401|NCT00419263|4168521|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340402|NCT00419263|4168522|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340403|NCT00419263|4168523|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340404|NCT00419263|4168520|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|323|323.0||||||
4340405|NCT00419263|4168521|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
4340406|NCT00419263|4168522|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
4340407|NCT00419263|4168523|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
4340408|NCT00419263|4168520|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4340409|NCT00419263|4168521|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4340410|NCT00419263|4168522|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4340411|NCT00419263|4168523|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4340412|NCT00419263|4168520|B4||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4340413|NCT00419263|4168521|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4340414|NCT00419263|4168522|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4340415|NCT00419263|4168523|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4340416|NCT00419263|4168520|B4||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4340417|NCT00419263|4168521|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4340418|NCT00419263|4168522|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4340419|NCT00419263|4168523|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4340420|NCT00419263|4168520|B4|Missing||Age, Customized||participants|Number|1|1.0||||||
4340421|NCT00419263|4168521|B3|Missing||Age, Customized||participants|Number|0|0.0||||||
4340422|NCT00419263|4168522|B2|Missing||Age, Customized||participants|Number|1|1.0||||||
4340423|NCT00419263|4168523|B1|Missing||Age, Customized||participants|Number|0|0.0||||||
4340424|NCT00419263|4168520|B4|≥ 58 years old||Age, Customized||participants|Number|30|30.0||||||
4340425|NCT00419263|4168521|B3|≥ 58 years old||Age, Customized||participants|Number|9|9.0||||||
4340426|NCT00419263|4168522|B2|≥ 58 years old||Age, Customized||participants|Number|13|13.0||||||
4340427|NCT00419263|4168523|B1|≥ 58 years old||Age, Customized||participants|Number|8|8.0||||||
4340428|NCT00419263|4168520|B4|48 - 57 years old||Age, Customized||participants|Number|31|31.0||||||
4340429|NCT00419263|4168521|B3|48 - 57 years old||Age, Customized||participants|Number|12|12.0||||||
4340430|NCT00419263|4168522|B2|48 - 57 years old||Age, Customized||participants|Number|10|10.0||||||
4340431|NCT00419263|4168523|B1|48 - 57 years old||Age, Customized||participants|Number|9|9.0||||||
4340432|NCT00419263|4168520|B4|38 - 47 years old||Age, Customized||participants|Number|65|65.0||||||
4340433|NCT00419263|4168521|B3|38 - 47 years old||Age, Customized||participants|Number|25|25.0||||||
4340434|NCT00419263|4168522|B2|38 - 47 years old||Age, Customized||participants|Number|21|21.0||||||
4340435|NCT00419263|4168523|B1|38 - 47 years old||Age, Customized||participants|Number|19|19.0||||||
4340436|NCT00419263|4168520|B4|28 - 37 years old||Age, Customized||participants|Number|103|103.0||||||
4340437|NCT00419263|4168521|B3|28 - 37 years old||Age, Customized||participants|Number|35|35.0||||||
4340438|NCT00419263|4168522|B2|28 - 37 years old||Age, Customized||participants|Number|31|31.0||||||
4340439|NCT00419263|4168523|B1|28 - 37 years old||Age, Customized||participants|Number|37|37.0||||||
4340440|NCT00419263|4168520|B4|18 - 27 years old||Age, Customized||participants|Number|112|112.0||||||
4340441|NCT00419263|4168521|B3|18 - 27 years old||Age, Customized||participants|Number|34|34.0||||||
4340442|NCT00419263|4168522|B2|18 - 27 years old||Age, Customized||participants|Number|37|37.0||||||
4340443|NCT00419263|4168523|B1|18 - 27 years old||Age, Customized||participants|Number|41|41.0||||||
4340444|NCT00419263|4168520|B4|||Age||years|Mean|35.4|35.4|Standard Deviation|13.71|13.71|||
4340445|NCT00419263|4168521|B3|||Age||years|Mean|36.2|36.2|Standard Deviation|13.25|13.25|||
4340446|NCT00419263|4168522|B2|||Age||years|Mean|36.2|36.2|Standard Deviation|15.59|15.59|||
4340447|NCT00419263|4168523|B1|||Age||years|Mean|33.9|33.9|Standard Deviation|12.05|12.05|||
4340448|NCT00419159|4168552|B3||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4340449|NCT00419159|4168553|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4340450|NCT00419159|4168554|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4340451|NCT00419159|4168552|B3||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4340452|NCT00419159|4168553|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4340453|NCT00419159|4168554|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4340454|NCT00419159|4168552|B3|> or = to 65 Years||Age, Customized||Participants|Number|78|78.0||||||
4340455|NCT00419159|4168553|B2|> or = to 65 Years||Age, Customized||Participants|Number|40|40.0||||||
4340456|NCT00419159|4168554|B1|> or = to 65 Years||Age, Customized||Participants|Number|38|38.0||||||
4340457|NCT00419159|4168552|B3|55 to <65 Years||Age, Customized||Participants|Number|62|62.0||||||
4340458|NCT00419159|4168553|B2|55 to <65 Years||Age, Customized||Participants|Number|33|33.0||||||
4340459|NCT00419159|4168554|B1|55 to <65 Years||Age, Customized||Participants|Number|29|29.0||||||
4340460|NCT00419159|4168552|B3|45 to <55 Years||Age, Customized||Participants|Number|39|39.0||||||
4340461|NCT00419159|4168553|B2|45 to <55 Years||Age, Customized||Participants|Number|17|17.0||||||
4340462|NCT00419159|4168554|B1|45 to <55 Years||Age, Customized||Participants|Number|22|22.0||||||
4340463|NCT00419159|4168552|B3|<45 Years||Age, Customized||Participants|Number|20|20.0||||||
4340464|NCT00419159|4168553|B2|<45 Years||Age, Customized||Participants|Number|10|10.0||||||
4340465|NCT00419159|4168554|B1|<45 Years||Age, Customized||Participants|Number|10|10.0||||||
4340466|NCT00419159|4168552|B3|||Age||years|Mean|60.2|60.2|Standard Deviation|11.8|11.8|||
4340467|NCT00419159|4168553|B2|||Age||years|Mean|60.3|60.3|Standard Deviation|12.1|12.1|||
4340468|NCT00419159|4168554|B1|||Age||years|Mean|60.0|60.0|Standard Deviation|11.5|11.5|||
4340469|NCT00419120|4168569|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4340470|NCT00419120|4168569|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4340471|NCT00419120|4168569|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4340472|NCT00419120|4168569|B1|||Age||years|Mean|8.2|8.2|Standard Deviation|4.29|4.29|||
4340473|NCT00419120|4168569|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4340474|NCT00419120|4168569|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4340475|NCT00419120|4168569|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4340476|NCT00419094|4168574|B3|Russian Federation||Region of Enrollment||participants|Number|64|64.0||||||
4340477|NCT00419094|4168575|B2|Russian Federation||Region of Enrollment||participants|Number|48|48.0||||||
4340478|NCT00419094|4168576|B1|Russian Federation||Region of Enrollment||participants|Number|16|16.0||||||
4340479|NCT00419094|4168574|B3|Poland||Region of Enrollment||participants|Number|67|67.0||||||
4340480|NCT00419094|4168575|B2|Poland||Region of Enrollment||participants|Number|51|51.0||||||
4340481|NCT00419094|4168576|B1|Poland||Region of Enrollment||participants|Number|16|16.0||||||
4340482|NCT00419094|4168574|B3|Mexico||Region of Enrollment||participants|Number|60|60.0||||||
4340483|NCT00419094|4168575|B2|Mexico||Region of Enrollment||participants|Number|43|43.0||||||
4340484|NCT00419094|4168576|B1|Mexico||Region of Enrollment||participants|Number|17|17.0||||||
4340485|NCT00419094|4168574|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
4340486|NCT00419094|4168575|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4340487|NCT00419094|4168576|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4340488|NCT00419094|4168574|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4340489|NCT00419094|4168575|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4340490|NCT00419094|4168576|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4340491|NCT00419094|4168574|B3||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4340492|NCT00419094|4168575|B2||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4340493|NCT00419094|4168576|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4340494|NCT00419094|4168574|B3|||Age||years|Mean|34.11|34.11|Standard Deviation|14.36|14.36|||
4340495|NCT00419094|4168575|B2|||Age||years|Mean|34.31|34.31|Standard Deviation|13.69|13.69|||
4340496|NCT00419094|4168576|B1|||Age||years|Mean|33.48|33.48|Standard Deviation|16.32|16.32|||
4340497|NCT00419094|4168574|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4340498|NCT00419094|4168575|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4340499|NCT00419094|4168576|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4340500|NCT00419094|4168574|B3||Between 18 and 65 years|Age||Participants|Count of Participants|183|183.0||||||
4340501|NCT00419094|4168575|B2||Between 18 and 65 years|Age||Participants|Count of Participants|140|140.0||||||
4340502|NCT00419094|4168576|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4340503|NCT00419094|4168574|B3||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
4340504|NCT00419094|4168575|B2||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
4340505|NCT00419094|4168576|B1||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4340506|NCT00419003|4168589|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4340507|NCT00419003|4168590|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4340508|NCT00419003|4168591|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4340509|NCT00419003|4168589|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4340510|NCT00419003|4168590|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4340511|NCT00419003|4168591|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4340512|NCT00419003|4168589|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4340513|NCT00419003|4168590|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4340514|NCT00419003|4168591|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4340515|NCT00419003|4168589|B3|||Age||years|Mean|48.2|48.2|Standard Deviation|11.8|11.8|||
4340516|NCT00419003|4168590|B2|||Age||years|Mean|48.2|48.2|Standard Deviation|11.8|11.8|||
4340517|NCT00419003|4168591|B1|||Age||years|Mean|48.2|48.2|Standard Deviation|11.8|11.8|||
4340518|NCT00418977|4168601|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4340519|NCT00418977|4168602|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4340520|NCT00418977|4168603|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4340521|NCT00418977|4168601|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4340522|NCT00418977|4168602|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4340523|NCT00418977|4168603|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4340524|NCT00418977|4168601|B3|||Age||years|Mean|13.7|13.7|Standard Deviation|2.1|2.1|||
4340525|NCT00418977|4168602|B2|||Age||years|Mean|14.8|14.8|Standard Deviation|2.0|2.0|||
4340526|NCT00418977|4168603|B1|||Age||years|Mean|13.3|13.3|Standard Deviation|2.0|2.0|||
4340527|NCT00418964|4168618|B4|China||Region of Enrollment||participants|Number|62|62.0||||||
4340528|NCT00418964|4168619|B3|China||Region of Enrollment||participants|Number|20|20.0||||||
4340529|NCT00418964|4168620|B2|China||Region of Enrollment||participants|Number|20|20.0||||||
4340530|NCT00418964|4168621|B1|China||Region of Enrollment||participants|Number|22|22.0||||||
4340531|NCT00418964|4168618|B4||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4340532|NCT00418964|4168619|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4340533|NCT00418964|4168620|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4340534|NCT00418964|4168621|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4340535|NCT00418964|4168618|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4340536|NCT00418964|4168619|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4340537|NCT00418964|4168620|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4340538|NCT00418964|4168621|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4340539|NCT00418964|4168618|B4|||Age||years|Mean|25.1|25.1|Standard Deviation|4.8|4.8|||
4340540|NCT00418964|4168619|B3|||Age||years|Mean|26.5|26.5|Standard Deviation|5.0|5.0|||
4340541|NCT00418964|4168620|B2|||Age||years|Mean|26.4|26.4|Standard Deviation|4.9|4.9|||
4340542|NCT00418964|4168621|B1|||Age||years|Mean|23.2|23.2|Standard Deviation|5.0|5.0|||
4340543|NCT00418964|4168618|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4340544|NCT00418964|4168619|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4340545|NCT00418964|4168620|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4340546|NCT00418964|4168621|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4340547|NCT00418964|4168618|B4||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4340548|NCT00418964|4168619|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4340549|NCT00418964|4168620|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4340550|NCT00418964|4168621|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4340551|NCT00418964|4168618|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4340552|NCT00418964|4168619|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4340553|NCT00418964|4168620|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4340554|NCT00418964|4168621|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4340555|NCT00418951|4168631|B4|United States||Region of Enrollment||participants|Number|112|112.0||||||
4340556|NCT00418951|4168632|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4340557|NCT00418951|4168633|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4340558|NCT00418951|4168634|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4340559|NCT00418951|4168631|B4||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4340560|NCT00418951|4168632|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4340561|NCT00418951|4168633|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4340562|NCT00418951|4168634|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4340563|NCT00418951|4168631|B4||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4340564|NCT00418951|4168632|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4340565|NCT00418951|4168633|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4340566|NCT00418951|4168634|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4340567|NCT00418951|4168631|B4|||Age||years|Median|60|60.0|Full Range|||19.0|84.0|
4340568|NCT00418951|4168632|B3|||Age||years|Median|71|71.0|Full Range|||19.0|80.0|
4340569|NCT00418951|4168633|B2|||Age||years|Median|71|71.0|Full Range|||23.0|78.0|
4340570|NCT00418951|4168634|B1|||Age||years|Median|60|60.0|Full Range|||25.0|84.0|
4340571|NCT00418938|4168644|B3|Missing||Number of metastatic organs||Participants|Number|1|1.0||||||
4340572|NCT00418938|4168645|B2|Missing||Number of metastatic organs||Participants|Number|0|0.0||||||
4340573|NCT00418938|4168646|B1|Missing||Number of metastatic organs||Participants|Number|1|1.0||||||
4340574|NCT00418938|4168644|B3|>=3||Number of metastatic organs||Participants|Number|72|72.0||||||
4340575|NCT00418938|4168645|B2|>=3||Number of metastatic organs||Participants|Number|28|28.0||||||
4340576|NCT00418938|4168646|B1|>=3||Number of metastatic organs||Participants|Number|44|44.0||||||
4340577|NCT00418938|4168644|B3|2||Number of metastatic organs||Participants|Number|81|81.0||||||
4340578|NCT00418938|4168645|B2|2||Number of metastatic organs||Participants|Number|42|42.0||||||
4340579|NCT00418938|4168646|B1|2||Number of metastatic organs||Participants|Number|39|39.0||||||
4340580|NCT00418938|4168644|B3|1||Number of metastatic organs||Participants|Number|110|110.0||||||
4340581|NCT00418938|4168645|B2|1||Number of metastatic organs||Participants|Number|61|61.0||||||
4340582|NCT00418938|4168646|B1|1||Number of metastatic organs||Participants|Number|49|49.0||||||
4340583|NCT00418938|4168644|B3|Rectum||Primary tumor diagnosis||Participants|Number|71|71.0||||||
4340584|NCT00418938|4168645|B2|Rectum||Primary tumor diagnosis||Participants|Number|40|40.0||||||
4340585|NCT00418938|4168646|B1|Rectum||Primary tumor diagnosis||Participants|Number|31|31.0||||||
4340586|NCT00418938|4168644|B3|Colon||Primary tumor diagnosis||Participants|Number|193|193.0||||||
4340587|NCT00418938|4168645|B2|Colon||Primary tumor diagnosis||Participants|Number|91|91.0||||||
4340588|NCT00418938|4168646|B1|Colon||Primary tumor diagnosis||Participants|Number|102|102.0||||||
4340589|NCT00418938|4168644|B3|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale range from 0 (fully active) to 5(dead), only status 0 or 1 is included by protocol.|Participants|Number|1|1.0||||||
4340590|NCT00418938|4168645|B2|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale range from 0 (fully active) to 5(dead), only status 0 or 1 is included by protocol.|Participants|Number|0|0.0||||||
4340591|NCT00418938|4168646|B1|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale range from 0 (fully active) to 5(dead), only status 0 or 1 is included by protocol.|Participants|Number|1|1.0||||||
4340592|NCT00418938|4168644|B3|1 (Restricted in physically strenuous activity)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale range from 0 (fully active) to 5(dead), only status 0 or 1 is included by protocol.|Participants|Number|119|119.0||||||
4340593|NCT00418938|4168645|B2|1 (Restricted in physically strenuous activity)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale range from 0 (fully active) to 5(dead), only status 0 or 1 is included by protocol.|Participants|Number|61|61.0||||||
4340594|NCT00418938|4168646|B1|1 (Restricted in physically strenuous activity)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale range from 0 (fully active) to 5(dead), only status 0 or 1 is included by protocol.|Participants|Number|58|58.0||||||
4340595|NCT00418938|4168644|B3|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale range from 0 (fully active) to 5(dead), only status 0 or 1 is included by protocol.|Participants|Number|144|144.0||||||
4340596|NCT00418938|4168645|B2|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale range from 0 (fully active) to 5(dead), only status 0 or 1 is included by protocol.|Participants|Number|70|70.0||||||
4340597|NCT00418938|4168646|B1|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale range from 0 (fully active) to 5(dead), only status 0 or 1 is included by protocol.|Participants|Number|74|74.0||||||
4340598|NCT00418938|4168644|B3|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4340599|NCT00418938|4168645|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4340600|NCT00418938|4168646|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4340601|NCT00418938|4168644|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4340602|NCT00418938|4168645|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4340603|NCT00418938|4168646|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4340604|NCT00418938|4168644|B3|Asian||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4340605|NCT00418938|4168645|B2|Asian||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4340606|NCT00418938|4168646|B1|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4340607|NCT00418938|4168644|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4340608|NCT00418938|4168645|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4340609|NCT00418938|4168646|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4340610|NCT00418938|4168644|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|39|39.0||||||
4340611|NCT00418938|4168645|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4340612|NCT00418938|4168646|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
4340613|NCT00418938|4168644|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|197|197.0||||||
4340614|NCT00418938|4168645|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|95|95.0||||||
4340615|NCT00418938|4168646|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|102|102.0||||||
4340616|NCT00418938|4168644|B3||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4340617|NCT00418938|4168645|B2||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4340618|NCT00418938|4168646|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4340619|NCT00418938|4168644|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4340620|NCT00418938|4168645|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4340621|NCT00418938|4168646|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4340622|NCT00418938|4168644|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|10.8|10.8|||
4340623|NCT00418938|4168645|B2|||Age||years|Mean|59.1|59.1|Standard Deviation|9.9|9.9|||
4340624|NCT00418938|4168646|B1|||Age||years|Mean|59.9|59.9|Standard Deviation|11.6|11.6|||
4340625|NCT00418886|4168665|B3|Male||Sex/Gender, Customized||Number|Number|330|330.0||||||
4340626|NCT00418886|4168666|B2|Male||Sex/Gender, Customized||Number|Number|171|171.0||||||
4340627|NCT00418886|4168667|B1|Male||Sex/Gender, Customized||Number|Number|159|159.0||||||
4340628|NCT00418886|4168665|B3|Female||Sex/Gender, Customized||Number|Number|204|204.0||||||
4340629|NCT00418886|4168666|B2|Female||Sex/Gender, Customized||Number|Number|107|107.0||||||
4340630|NCT00418886|4168667|B1|Female||Sex/Gender, Customized||Number|Number|97|97.0||||||
4340631|NCT00418886|4168665|B3|||Age||years|Mean|59.4|59.4|Standard Deviation|9.73|9.73|||
4340632|NCT00418886|4168666|B2|||Age||years|Mean|60.2|60.2|Standard Deviation|9.5|9.5|||
4340633|NCT00418886|4168667|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|9.95|9.95|||
4340634|NCT00418834|4168692|B3|||Triglycerides (TG)|Robust Standard Deviation was calculated for Triglycerides as: interquartile range (IQR)/1.075, where IQR=3rd quartile - 1st quartile.|mg/dL|Mean|114.0|114.0|Standard Deviation|56.7|56.7|||
4340635|NCT00418834|4168693|B2|||Triglycerides (TG)|Robust Standard Deviation was calculated for Triglycerides as: interquartile range (IQR)/1.075, where IQR=3rd quartile - 1st quartile.|mg/dL|Mean|116.5|116.5|Standard Deviation|60.0|60.0|||
4340636|NCT00418834|4168694|B1|||Triglycerides (TG)|Robust Standard Deviation was calculated for Triglycerides as: interquartile range (IQR)/1.075, where IQR=3rd quartile - 1st quartile.|mg/dL|Mean|112.8|112.8|Standard Deviation|55.3|55.3|||
4340637|NCT00418834|4168692|B3|||Total Cholesterol (TC):High Density Lipoprotein-C (HDL-C) Ratio||Ratio|Mean|3.5|3.5|Standard Deviation|0.9|0.9|||
4340638|NCT00418834|4168693|B2|||Total Cholesterol (TC):High Density Lipoprotein-C (HDL-C) Ratio||Ratio|Mean|3.5|3.5|Standard Deviation|0.8|0.8|||
4340639|NCT00418834|4168694|B1|||Total Cholesterol (TC):High Density Lipoprotein-C (HDL-C) Ratio||Ratio|Mean|3.5|3.5|Standard Deviation|0.9|0.9|||
4340640|NCT00418834|4168692|B3|||Total Cholesterol||mg/dL|Mean|182.4|182.4|Standard Deviation|29.1|29.1|||
4340641|NCT00418834|4168693|B2|||Total Cholesterol||mg/dL|Mean|181.8|181.8|Standard Deviation|26.1|26.1|||
4340642|NCT00418834|4168694|B1|||Total Cholesterol||mg/dL|Mean|183.1|183.1|Standard Deviation|31.8|31.8|||
4340643|NCT00418834|4168692|B3|||Non-High Density Lipoprotein Cholesterol (Non-HDL-C):High Density Lipoprotein Cholesterol (HDL-C) Ra||Ratio|Mean|2.5|2.5|Standard Deviation|0.9|0.9|||
4340644|NCT00418834|4168693|B2|||Non-High Density Lipoprotein Cholesterol (Non-HDL-C):High Density Lipoprotein Cholesterol (HDL-C) Ra||Ratio|Mean|2.5|2.5|Standard Deviation|0.8|0.8|||
4340645|NCT00418834|4168694|B1|||Non-High Density Lipoprotein Cholesterol (Non-HDL-C):High Density Lipoprotein Cholesterol (HDL-C) Ra||Ratio|Mean|2.5|2.5|Standard Deviation|0.9|0.9|||
4340646|NCT00418834|4168692|B3|||Non-High Density Lipoprotein Cholesterol (Non-HDL-C)||mg/dL|Mean|127.7|127.7|Standard Deviation|28.1|28.1|||
4340647|NCT00418834|4168693|B2|||Non-High Density Lipoprotein Cholesterol (Non-HDL-C)||mg/dL|Mean|127.2|127.2|Standard Deviation|25.2|25.2|||
4340648|NCT00418834|4168694|B1|||Non-High Density Lipoprotein Cholesterol (Non-HDL-C)||mg/dL|Mean|128.2|128.2|Standard Deviation|30.6|30.6|||
4340649|NCT00418834|4168692|B3|||Low Density Lipoprotein Cholesterol (LDL-C):High Density Lipoprotein Cholesterol (HDL-C) Ratio||Ratio|Mean|2.0|2.0|Standard Deviation|0.7|0.7|||
4340650|NCT00418834|4168693|B2|||Low Density Lipoprotein Cholesterol (LDL-C):High Density Lipoprotein Cholesterol (HDL-C) Ratio||Ratio|Mean|2.0|2.0|Standard Deviation|0.6|0.6|||
4340651|NCT00418834|4168694|B1|||Low Density Lipoprotein Cholesterol (LDL-C):High Density Lipoprotein Cholesterol (HDL-C) Ratio||Ratio|Mean|2.0|2.0|Standard Deviation|0.7|0.7|||
4340652|NCT00418834|4168692|B3|||Low Density Lipoprotein Cholesterol (LDL-C)||mg/dL|Mean|102.3|102.3|Standard Deviation|24.4|24.4|||
4340653|NCT00418834|4168693|B2|||Low Density Lipoprotein Cholesterol (LDL-C)||mg/dL|Mean|101.8|101.8|Standard Deviation|20.7|20.7|||
4340654|NCT00418834|4168694|B1|||Low Density Lipoprotein Cholesterol (LDL-C)||mg/dL|Mean|102.9|102.9|Standard Deviation|27.7|27.7|||
4340655|NCT00418834|4168692|B3|||Highly selective C-reactive protein (hs-CRP)|"Robust Standard Deviation was calculated for hs-CRP as: interquartile range~(IQR)/1.075, where IQR=3rd quartile - 1st quartile."|mg/L|Mean|1.9|1.9|Standard Deviation|2.5|2.5|||
4340656|NCT00418834|4168693|B2|||Highly selective C-reactive protein (hs-CRP)|"Robust Standard Deviation was calculated for hs-CRP as: interquartile range~(IQR)/1.075, where IQR=3rd quartile - 1st quartile."|mg/L|Mean|1.9|1.9|Standard Deviation|2.3|2.3|||
4340657|NCT00418834|4168694|B1|||Highly selective C-reactive protein (hs-CRP)|"Robust Standard Deviation was calculated for hs-CRP as: interquartile range~(IQR)/1.075, where IQR=3rd quartile - 1st quartile."|mg/L|Mean|1.8|1.8|Standard Deviation|2.7|2.7|||
4340658|NCT00418834|4168692|B3|||High Density Lipoprotein Cholesterol (HDL-C)||mg/dL|Mean|54.7|54.7|Standard Deviation|13.0|13.0|||
4340659|NCT00418834|4168693|B2|||High Density Lipoprotein Cholesterol (HDL-C)||mg/dL|Mean|54.5|54.5|Standard Deviation|12.3|12.3|||
4340660|NCT00418834|4168694|B1|||High Density Lipoprotein Cholesterol (HDL-C)||mg/dL|Mean|54.9|54.9|Standard Deviation|13.6|13.6|||
4340661|NCT00418834|4168692|B3|||Apo lipoprotein B (Apo B):Apo lipoprotein A-I (Apo A-I) Ratio||Ratio|Mean|0.6|0.6|Standard Deviation|0.2|0.2|||
4340662|NCT00418834|4168693|B2|||Apo lipoprotein B (Apo B):Apo lipoprotein A-I (Apo A-I) Ratio||Ratio|Mean|0.6|0.6|Standard Deviation|0.2|0.2|||
4340663|NCT00418834|4168694|B1|||Apo lipoprotein B (Apo B):Apo lipoprotein A-I (Apo A-I) Ratio||Ratio|Mean|0.6|0.6|Standard Deviation|0.2|0.2|||
4340664|NCT00418834|4168692|B3|||Apo lipoprotein B (Apo B)||mg/dL|Mean|102.7|102.7|Standard Deviation|22.1|22.1|||
4340665|NCT00418834|4168693|B2|||Apo lipoprotein B (Apo B)||mg/dL|Mean|101.8|101.8|Standard Deviation|21.4|21.4|||
4340666|NCT00418834|4168694|B1|||Apo lipoprotein B (Apo B)||mg/dL|Mean|103.6|103.6|Standard Deviation|22.8|22.8|||
4340667|NCT00418834|4168692|B3|||Apo lipoprotein A-I (Apo A-I)||mg/dL|Mean|164.4|164.4|Standard Deviation|27.7|27.7|||
4340668|NCT00418834|4168693|B2|||Apo lipoprotein A-I (Apo A-I)||mg/dL|Mean|164.4|164.4|Standard Deviation|26.8|26.8|||
4340669|NCT00418834|4168694|B1|||Apo lipoprotein A-I (Apo A-I)||mg/dL|Mean|164.3|164.3|Standard Deviation|28.7|28.7|||
4340670|NCT00418834|4168692|B3|Missing||BMI [Body Mass Index (<30, ≥30 kg/m2)]||Participants|Number|2|2.0||||||
4340671|NCT00418834|4168693|B2|Missing||BMI [Body Mass Index (<30, ≥30 kg/m2)]||Participants|Number|0|0.0||||||
4340672|NCT00418834|4168694|B1|Missing||BMI [Body Mass Index (<30, ≥30 kg/m2)]||Participants|Number|2|2.0||||||
4340673|NCT00418834|4168692|B3|≥30 kg/m2||BMI [Body Mass Index (<30, ≥30 kg/m2)]||Participants|Number|330|330.0||||||
4340674|NCT00418834|4168693|B2|≥30 kg/m2||BMI [Body Mass Index (<30, ≥30 kg/m2)]||Participants|Number|165|165.0||||||
4340675|NCT00418834|4168694|B1|≥30 kg/m2||BMI [Body Mass Index (<30, ≥30 kg/m2)]||Participants|Number|165|165.0||||||
4340676|NCT00418834|4168692|B3|<30 kg/m2||BMI [Body Mass Index (<30, ≥30 kg/m2)]||Participants|Number|721|721.0||||||
4340677|NCT00418834|4168693|B2|<30 kg/m2||BMI [Body Mass Index (<30, ≥30 kg/m2)]||Participants|Number|362|362.0||||||
4340678|NCT00418834|4168694|B1|<30 kg/m2||BMI [Body Mass Index (<30, ≥30 kg/m2)]||Participants|Number|359|359.0||||||
4340679|NCT00418834|4168692|B3|Europe||Region of Enrollment||Participants|Number|667|667.0||||||
4340680|NCT00418834|4168693|B2|Europe||Region of Enrollment||Participants|Number|330|330.0||||||
4340681|NCT00418834|4168694|B1|Europe||Region of Enrollment||Participants|Number|337|337.0||||||
4340682|NCT00418834|4168692|B3|North America||Region of Enrollment||Participants|Number|386|386.0||||||
4340683|NCT00418834|4168693|B2|North America||Region of Enrollment||Participants|Number|197|197.0||||||
4340684|NCT00418834|4168694|B1|North America||Region of Enrollment||Participants|Number|189|189.0||||||
4340685|NCT00418834|4168692|B3|Multi-Racial||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4340686|NCT00418834|4168693|B2|Multi-Racial||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4340687|NCT00418834|4168694|B1|Multi-Racial||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4340688|NCT00418834|4168692|B3|Black||Race/Ethnicity, Customized||Participants|Number|38|38.0||||||
4340689|NCT00418834|4168693|B2|Black||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4340690|NCT00418834|4168694|B1|Black||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
4340691|NCT00418834|4168692|B3|Asian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4340692|NCT00418834|4168693|B2|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4340693|NCT00418834|4168694|B1|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4340694|NCT00418834|4168692|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4340695|NCT00418834|4168693|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4340696|NCT00418834|4168694|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4340697|NCT00418834|4168692|B3|White||Race/Ethnicity, Customized||Participants|Number|1008|1008.0||||||
4340698|NCT00418834|4168693|B2|White||Race/Ethnicity, Customized||Participants|Number|505|505.0||||||
4340699|NCT00418834|4168694|B1|White||Race/Ethnicity, Customized||Participants|Number|503|503.0||||||
4340700|NCT00418834|4168692|B3||Male|Sex: Female, Male||Participants|Count of Participants|490|490.0||||||
4340701|NCT00418834|4168693|B2||Male|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
4340702|NCT00418834|4168694|B1||Male|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
4340703|NCT00418834|4168692|B3||Female|Sex: Female, Male||Participants|Count of Participants|563|563.0||||||
4340704|NCT00418834|4168693|B2||Female|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
4340705|NCT00418834|4168694|B1||Female|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
4340706|NCT00418834|4168692|B3|||Age||years|Mean|71.2|71.2|Full Range|||65.0|92.0|
4340707|NCT00418834|4168693|B2|||Age||years|Mean|71.2|71.2|Full Range|||65.0|92.0|
4340708|NCT00418834|4168694|B1|||Age||years|Mean|71.2|71.2|Full Range|||65.0|86.0|
4340709|NCT00418717|4168755|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4340710|NCT00418717|4168755|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4340711|NCT00418717|4168755|B1|||Age||years|Mean|53.14|53.14|Standard Deviation|13.21|13.21|||
4340712|NCT00418691|4168760|B4|United States||Region of Enrollment||participants|Number|33|33.0||||||
4340713|NCT00418691|4168761|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4340714|NCT00418691|4168762|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4340715|NCT00418691|4168763|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4340716|NCT00418691|4168760|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4340717|NCT00418691|4168761|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4340718|NCT00418691|4168762|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4340719|NCT00418691|4168763|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4340720|NCT00418691|4168760|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4340721|NCT00418691|4168761|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4340722|NCT00418691|4168762|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4340723|NCT00418691|4168763|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4340724|NCT00418691|4168760|B4|||Age||years|Mean|46.6|46.6|Standard Deviation|12.0|12.0|||
4340725|NCT00418691|4168761|B3|||Age||years|Mean|53.8|53.8|Standard Deviation|12.9|12.9|||
4340726|NCT00418691|4168762|B2|||Age||years|Mean|41.2|41.2|Standard Deviation|10.5|10.5|||
4340727|NCT00418691|4168763|B1|||Age||years|Mean|45.9|45.9|Standard Deviation|10.0|10.0|||
4340728|NCT00418691|4168760|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4340729|NCT00418691|4168761|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4340730|NCT00418691|4168762|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4340731|NCT00418691|4168763|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4340732|NCT00418691|4168760|B4||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4340733|NCT00418691|4168761|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4340734|NCT00418691|4168762|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4340735|NCT00418691|4168763|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4340736|NCT00418691|4168760|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4340737|NCT00418691|4168761|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4340738|NCT00418691|4168762|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4340739|NCT00418691|4168763|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4340740|NCT00418665|4168773|B4|Missing||International Prognostic Scoring System (IPSS) Score|IPSS scoring for risk of myelodysplastic syndrome: 0 = low, 0.5 - 1.0 = intermediate 1, 1.5 - 2.0 = intermediate 2, ≥ 2.5 = high|Participants|Number|2|2.0||||||
4340741|NCT00418665|4168774|B3|Missing||International Prognostic Scoring System (IPSS) Score|IPSS scoring for risk of myelodysplastic syndrome: 0 = low, 0.5 - 1.0 = intermediate 1, 1.5 - 2.0 = intermediate 2, ≥ 2.5 = high|Participants|Number|0|0.0||||||
4340742|NCT00418665|4168775|B2|Missing||International Prognostic Scoring System (IPSS) Score|IPSS scoring for risk of myelodysplastic syndrome: 0 = low, 0.5 - 1.0 = intermediate 1, 1.5 - 2.0 = intermediate 2, ≥ 2.5 = high|Participants|Number|1|1.0||||||
4340743|NCT00418665|4168776|B1|Missing||International Prognostic Scoring System (IPSS) Score|IPSS scoring for risk of myelodysplastic syndrome: 0 = low, 0.5 - 1.0 = intermediate 1, 1.5 - 2.0 = intermediate 2, ≥ 2.5 = high|Participants|Number|1|1.0||||||
4340744|NCT00418665|4168773|B4|>1.0||International Prognostic Scoring System (IPSS) Score|IPSS scoring for risk of myelodysplastic syndrome: 0 = low, 0.5 - 1.0 = intermediate 1, 1.5 - 2.0 = intermediate 2, ≥ 2.5 = high|Participants|Number|2|2.0||||||
4340745|NCT00418665|4168774|B3|>1.0||International Prognostic Scoring System (IPSS) Score|IPSS scoring for risk of myelodysplastic syndrome: 0 = low, 0.5 - 1.0 = intermediate 1, 1.5 - 2.0 = intermediate 2, ≥ 2.5 = high|Participants|Number|0|0.0||||||
4340746|NCT00418665|4168775|B2|>1.0||International Prognostic Scoring System (IPSS) Score|IPSS scoring for risk of myelodysplastic syndrome: 0 = low, 0.5 - 1.0 = intermediate 1, 1.5 - 2.0 = intermediate 2, ≥ 2.5 = high|Participants|Number|1|1.0||||||
4340747|NCT00418665|4168776|B1|>1.0||International Prognostic Scoring System (IPSS) Score|IPSS scoring for risk of myelodysplastic syndrome: 0 = low, 0.5 - 1.0 = intermediate 1, 1.5 - 2.0 = intermediate 2, ≥ 2.5 = high|Participants|Number|1|1.0||||||
4340748|NCT00418665|4168773|B4|1.0||International Prognostic Scoring System (IPSS) Score|IPSS scoring for risk of myelodysplastic syndrome: 0 = low, 0.5 - 1.0 = intermediate 1, 1.5 - 2.0 = intermediate 2, ≥ 2.5 = high|Participants|Number|8|8.0||||||
4340749|NCT00418665|4168774|B3|1.0||International Prognostic Scoring System (IPSS) Score|IPSS scoring for risk of myelodysplastic syndrome: 0 = low, 0.5 - 1.0 = intermediate 1, 1.5 - 2.0 = intermediate 2, ≥ 2.5 = high|Participants|Number|3|3.0||||||
4340750|NCT00418665|4168775|B2|1.0||International Prognostic Scoring System (IPSS) Score|IPSS scoring for risk of myelodysplastic syndrome: 0 = low, 0.5 - 1.0 = intermediate 1, 1.5 - 2.0 = intermediate 2, ≥ 2.5 = high|Participants|Number|2|2.0||||||
4340751|NCT00418665|4168776|B1|1.0||International Prognostic Scoring System (IPSS) Score|IPSS scoring for risk of myelodysplastic syndrome: 0 = low, 0.5 - 1.0 = intermediate 1, 1.5 - 2.0 = intermediate 2, ≥ 2.5 = high|Participants|Number|3|3.0||||||
4340752|NCT00418665|4168773|B4|0.5||International Prognostic Scoring System (IPSS) Score|IPSS scoring for risk of myelodysplastic syndrome: 0 = low, 0.5 - 1.0 = intermediate 1, 1.5 - 2.0 = intermediate 2, ≥ 2.5 = high|Participants|Number|13|13.0||||||
4340753|NCT00418665|4168774|B3|0.5||International Prognostic Scoring System (IPSS) Score|IPSS scoring for risk of myelodysplastic syndrome: 0 = low, 0.5 - 1.0 = intermediate 1, 1.5 - 2.0 = intermediate 2, ≥ 2.5 = high|Participants|Number|4|4.0||||||
4340754|NCT00418665|4168775|B2|0.5||International Prognostic Scoring System (IPSS) Score|IPSS scoring for risk of myelodysplastic syndrome: 0 = low, 0.5 - 1.0 = intermediate 1, 1.5 - 2.0 = intermediate 2, ≥ 2.5 = high|Participants|Number|6|6.0||||||
4340755|NCT00418665|4168776|B1|0.5||International Prognostic Scoring System (IPSS) Score|IPSS scoring for risk of myelodysplastic syndrome: 0 = low, 0.5 - 1.0 = intermediate 1, 1.5 - 2.0 = intermediate 2, ≥ 2.5 = high|Participants|Number|3|3.0||||||
4340756|NCT00418665|4168773|B4|0||International Prognostic Scoring System (IPSS) Score|IPSS scoring for risk of myelodysplastic syndrome: 0 = low, 0.5 - 1.0 = intermediate 1, 1.5 - 2.0 = intermediate 2, ≥ 2.5 = high|Participants|Number|14|14.0||||||
4340757|NCT00418665|4168774|B3|0||International Prognostic Scoring System (IPSS) Score|IPSS scoring for risk of myelodysplastic syndrome: 0 = low, 0.5 - 1.0 = intermediate 1, 1.5 - 2.0 = intermediate 2, ≥ 2.5 = high|Participants|Number|6|6.0||||||
4340758|NCT00418665|4168775|B2|0||International Prognostic Scoring System (IPSS) Score|IPSS scoring for risk of myelodysplastic syndrome: 0 = low, 0.5 - 1.0 = intermediate 1, 1.5 - 2.0 = intermediate 2, ≥ 2.5 = high|Participants|Number|4|4.0||||||
4340759|NCT00418665|4168776|B1|0||International Prognostic Scoring System (IPSS) Score|IPSS scoring for risk of myelodysplastic syndrome: 0 = low, 0.5 - 1.0 = intermediate 1, 1.5 - 2.0 = intermediate 2, ≥ 2.5 = high|Participants|Number|4|4.0||||||
4340760|NCT00418665|4168773|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4340761|NCT00418665|4168774|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4340762|NCT00418665|4168775|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4340763|NCT00418665|4168776|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4340764|NCT00418665|4168773|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4340765|NCT00418665|4168774|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4340766|NCT00418665|4168775|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4340767|NCT00418665|4168776|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4340768|NCT00418665|4168773|B4|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|36|36.0||||||
4340769|NCT00418665|4168774|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4340770|NCT00418665|4168775|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4340771|NCT00418665|4168776|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4340772|NCT00418665|4168773|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4340773|NCT00418665|4168774|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4340774|NCT00418665|4168775|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4340775|NCT00418665|4168776|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4340776|NCT00418665|4168773|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4340777|NCT00418665|4168774|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4340778|NCT00418665|4168775|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4340779|NCT00418665|4168776|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4340780|NCT00418665|4168773|B4|||Age||Years|Mean|70.9|70.9|Standard Deviation|12.1|12.1|||
4340781|NCT00418665|4168774|B3|||Age||Years|Mean|66.7|66.7|Standard Deviation|9.4|9.4|||
4340782|NCT00418665|4168775|B2|||Age||Years|Mean|72.9|72.9|Standard Deviation|11.4|11.4|||
4340783|NCT00418665|4168776|B1|||Age||Years|Mean|73.2|73.2|Standard Deviation|15.0|15.0|||
4340784|NCT00418574|4168795|B3|missing||Serum CA-125 after 3rd chemotherapy cycle||participants|Number|1|1.0||||||
4340785|NCT00418574|4168796|B2|missing||Serum CA-125 after 3rd chemotherapy cycle||participants|Number|1|1.0||||||
4340786|NCT00418574|4168797|B1|missing||Serum CA-125 after 3rd chemotherapy cycle||participants|Number|0|0.0||||||
4340787|NCT00418574|4168795|B3|> 35 U/ml||Serum CA-125 after 3rd chemotherapy cycle||participants|Number|169|169.0||||||
4340788|NCT00418574|4168796|B2|> 35 U/ml||Serum CA-125 after 3rd chemotherapy cycle||participants|Number|55|55.0||||||
4340789|NCT00418574|4168797|B1|> 35 U/ml||Serum CA-125 after 3rd chemotherapy cycle||participants|Number|114|114.0||||||
4340790|NCT00418574|4168795|B3|<= 35 U/ml||Serum CA-125 after 3rd chemotherapy cycle||participants|Number|718|718.0||||||
4340791|NCT00418574|4168796|B2|<= 35 U/ml||Serum CA-125 after 3rd chemotherapy cycle||participants|Number|239|239.0||||||
4340792|NCT00418574|4168797|B1|<= 35 U/ml||Serum CA-125 after 3rd chemotherapy cycle||participants|Number|479|479.0||||||
4340793|NCT00418574|4168795|B3|> 1 cm||Tumor size after debulking surgery||participants|Number|177|177.0||||||
4340794|NCT00418574|4168796|B2|> 1 cm||Tumor size after debulking surgery||participants|Number|63|63.0||||||
4340795|NCT00418574|4168797|B1|> 1 cm||Tumor size after debulking surgery||participants|Number|114|114.0||||||
4340796|NCT00418574|4168795|B3|<= 1 cm||Tumor size after debulking surgery||participants|Number|711|711.0||||||
4340797|NCT00418574|4168796|B2|<= 1 cm||Tumor size after debulking surgery||participants|Number|232|232.0||||||
4340798|NCT00418574|4168797|B1|<= 1 cm||Tumor size after debulking surgery||participants|Number|479|479.0||||||
4340799|NCT00418574|4168795|B3|missing||International Federation of Gynecology and Obstetrics (FIGO) stage|International system of staging which identifies the spread of the ovarian cancer at the point of diagnosis [STAGE 1 - Tumour is confined to the ovary / ovaries; STAGE 2 – Tumour involves one or both ovaries and has extended into the pelvis; STAGE 3 – The tumour involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node metastasis, includes liver capsule metastasis; STAGE: 4 – Distant metastasis beyond the peritoneal cavity, liver parenchymal metastasis.]|participants|Number|1|1.0||||||
4340800|NCT00418574|4168796|B2|missing||International Federation of Gynecology and Obstetrics (FIGO) stage|International system of staging which identifies the spread of the ovarian cancer at the point of diagnosis [STAGE 1 - Tumour is confined to the ovary / ovaries; STAGE 2 – Tumour involves one or both ovaries and has extended into the pelvis; STAGE 3 – The tumour involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node metastasis, includes liver capsule metastasis; STAGE: 4 – Distant metastasis beyond the peritoneal cavity, liver parenchymal metastasis.]|participants|Number|1|1.0||||||
4340801|NCT00418574|4168797|B1|missing||International Federation of Gynecology and Obstetrics (FIGO) stage|International system of staging which identifies the spread of the ovarian cancer at the point of diagnosis [STAGE 1 - Tumour is confined to the ovary / ovaries; STAGE 2 – Tumour involves one or both ovaries and has extended into the pelvis; STAGE 3 – The tumour involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node metastasis, includes liver capsule metastasis; STAGE: 4 – Distant metastasis beyond the peritoneal cavity, liver parenchymal metastasis.]|participants|Number|0|0.0||||||
4340802|NCT00418574|4168795|B3|IV||International Federation of Gynecology and Obstetrics (FIGO) stage|International system of staging which identifies the spread of the ovarian cancer at the point of diagnosis [STAGE 1 - Tumour is confined to the ovary / ovaries; STAGE 2 – Tumour involves one or both ovaries and has extended into the pelvis; STAGE 3 – The tumour involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node metastasis, includes liver capsule metastasis; STAGE: 4 – Distant metastasis beyond the peritoneal cavity, liver parenchymal metastasis.]|participants|Number|122|122.0||||||
4340803|NCT00418574|4168796|B2|IV||International Federation of Gynecology and Obstetrics (FIGO) stage|International system of staging which identifies the spread of the ovarian cancer at the point of diagnosis [STAGE 1 - Tumour is confined to the ovary / ovaries; STAGE 2 – Tumour involves one or both ovaries and has extended into the pelvis; STAGE 3 – The tumour involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node metastasis, includes liver capsule metastasis; STAGE: 4 – Distant metastasis beyond the peritoneal cavity, liver parenchymal metastasis.]|participants|Number|42|42.0||||||
4340844|NCT00418574|4168795|B3|Endometrioid||Histology of ovarian tumor||participants|Number|59|59.0||||||
4340845|NCT00418574|4168796|B2|Endometrioid||Histology of ovarian tumor||participants|Number|21|21.0||||||
4340804|NCT00418574|4168797|B1|IV||International Federation of Gynecology and Obstetrics (FIGO) stage|International system of staging which identifies the spread of the ovarian cancer at the point of diagnosis [STAGE 1 - Tumour is confined to the ovary / ovaries; STAGE 2 – Tumour involves one or both ovaries and has extended into the pelvis; STAGE 3 – The tumour involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node metastasis, includes liver capsule metastasis; STAGE: 4 – Distant metastasis beyond the peritoneal cavity, liver parenchymal metastasis.]|participants|Number|80|80.0||||||
4340805|NCT00418574|4168795|B3|III||International Federation of Gynecology and Obstetrics (FIGO) stage|International system of staging which identifies the spread of the ovarian cancer at the point of diagnosis [STAGE 1 - Tumour is confined to the ovary / ovaries; STAGE 2 – Tumour involves one or both ovaries and has extended into the pelvis; STAGE 3 – The tumour involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node metastasis, includes liver capsule metastasis; STAGE: 4 – Distant metastasis beyond the peritoneal cavity, liver parenchymal metastasis.]|participants|Number|765|765.0||||||
4340806|NCT00418574|4168796|B2|III||International Federation of Gynecology and Obstetrics (FIGO) stage|International system of staging which identifies the spread of the ovarian cancer at the point of diagnosis [STAGE 1 - Tumour is confined to the ovary / ovaries; STAGE 2 – Tumour involves one or both ovaries and has extended into the pelvis; STAGE 3 – The tumour involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node metastasis, includes liver capsule metastasis; STAGE: 4 – Distant metastasis beyond the peritoneal cavity, liver parenchymal metastasis.]|participants|Number|252|252.0||||||
4340807|NCT00418574|4168797|B1|III||International Federation of Gynecology and Obstetrics (FIGO) stage|International system of staging which identifies the spread of the ovarian cancer at the point of diagnosis [STAGE 1 - Tumour is confined to the ovary / ovaries; STAGE 2 – Tumour involves one or both ovaries and has extended into the pelvis; STAGE 3 – The tumour involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node metastasis, includes liver capsule metastasis; STAGE: 4 – Distant metastasis beyond the peritoneal cavity, liver parenchymal metastasis.]|participants|Number|513|513.0||||||
4340808|NCT00418574|4168795|B3|not done||Grade of histologic differentiation|"Histologic grade, also called differentiation, refers to how much the tumor cells resemble normal cells of the same tissue type.~GX Grade cannot be assessed (Undetermined grade) G1 Well-differentiated (Low grade) - best prognosis G2 Moderately differentiated (Intermediate grade) G3 Poorly differentiated (High grade) G4 Undifferentiated (High grade) - worst prognosis"|participants|Number|80|80.0||||||
4340809|NCT00418574|4168796|B2|not done||Grade of histologic differentiation|"Histologic grade, also called differentiation, refers to how much the tumor cells resemble normal cells of the same tissue type.~GX Grade cannot be assessed (Undetermined grade) G1 Well-differentiated (Low grade) - best prognosis G2 Moderately differentiated (Intermediate grade) G3 Poorly differentiated (High grade) G4 Undifferentiated (High grade) - worst prognosis"|participants|Number|24|24.0||||||
4340810|NCT00418574|4168797|B1|not done||Grade of histologic differentiation|"Histologic grade, also called differentiation, refers to how much the tumor cells resemble normal cells of the same tissue type.~GX Grade cannot be assessed (Undetermined grade) G1 Well-differentiated (Low grade) - best prognosis G2 Moderately differentiated (Intermediate grade) G3 Poorly differentiated (High grade) G4 Undifferentiated (High grade) - worst prognosis"|participants|Number|56|56.0||||||
4340811|NCT00418574|4168795|B3|GX||Grade of histologic differentiation|"Histologic grade, also called differentiation, refers to how much the tumor cells resemble normal cells of the same tissue type.~GX Grade cannot be assessed (Undetermined grade) G1 Well-differentiated (Low grade) - best prognosis G2 Moderately differentiated (Intermediate grade) G3 Poorly differentiated (High grade) G4 Undifferentiated (High grade) - worst prognosis"|participants|Number|16|16.0||||||
4340812|NCT00418574|4168796|B2|GX||Grade of histologic differentiation|"Histologic grade, also called differentiation, refers to how much the tumor cells resemble normal cells of the same tissue type.~GX Grade cannot be assessed (Undetermined grade) G1 Well-differentiated (Low grade) - best prognosis G2 Moderately differentiated (Intermediate grade) G3 Poorly differentiated (High grade) G4 Undifferentiated (High grade) - worst prognosis"|participants|Number|4|4.0||||||
4340813|NCT00418574|4168797|B1|GX||Grade of histologic differentiation|"Histologic grade, also called differentiation, refers to how much the tumor cells resemble normal cells of the same tissue type.~GX Grade cannot be assessed (Undetermined grade) G1 Well-differentiated (Low grade) - best prognosis G2 Moderately differentiated (Intermediate grade) G3 Poorly differentiated (High grade) G4 Undifferentiated (High grade) - worst prognosis"|participants|Number|12|12.0||||||
4340814|NCT00418574|4168795|B3|G3-G4||Grade of histologic differentiation|"Histologic grade, also called differentiation, refers to how much the tumor cells resemble normal cells of the same tissue type.~GX Grade cannot be assessed (Undetermined grade) G1 Well-differentiated (Low grade) - best prognosis G2 Moderately differentiated (Intermediate grade) G3 Poorly differentiated (High grade) G4 Undifferentiated (High grade) - worst prognosis"|participants|Number|550|550.0||||||
4340815|NCT00418574|4168796|B2|G3-G4||Grade of histologic differentiation|"Histologic grade, also called differentiation, refers to how much the tumor cells resemble normal cells of the same tissue type.~GX Grade cannot be assessed (Undetermined grade) G1 Well-differentiated (Low grade) - best prognosis G2 Moderately differentiated (Intermediate grade) G3 Poorly differentiated (High grade) G4 Undifferentiated (High grade) - worst prognosis"|participants|Number|185|185.0||||||
4340816|NCT00418574|4168797|B1|G3-G4||Grade of histologic differentiation|"Histologic grade, also called differentiation, refers to how much the tumor cells resemble normal cells of the same tissue type.~GX Grade cannot be assessed (Undetermined grade) G1 Well-differentiated (Low grade) - best prognosis G2 Moderately differentiated (Intermediate grade) G3 Poorly differentiated (High grade) G4 Undifferentiated (High grade) - worst prognosis"|participants|Number|365|365.0||||||
4340817|NCT00418574|4168795|B3|G1-G2||Grade of histologic differentiation|"Histologic grade, also called differentiation, refers to how much the tumor cells resemble normal cells of the same tissue type.~GX Grade cannot be assessed (Undetermined grade) G1 Well-differentiated (Low grade) - best prognosis G2 Moderately differentiated (Intermediate grade) G3 Poorly differentiated (High grade) G4 Undifferentiated (High grade) - worst prognosis"|participants|Number|242|242.0||||||
4340846|NCT00418574|4168797|B1|Endometrioid||Histology of ovarian tumor||participants|Number|38|38.0||||||
4340818|NCT00418574|4168796|B2|G1-G2||Grade of histologic differentiation|"Histologic grade, also called differentiation, refers to how much the tumor cells resemble normal cells of the same tissue type.~GX Grade cannot be assessed (Undetermined grade) G1 Well-differentiated (Low grade) - best prognosis G2 Moderately differentiated (Intermediate grade) G3 Poorly differentiated (High grade) G4 Undifferentiated (High grade) - worst prognosis"|participants|Number|82|82.0||||||
4340819|NCT00418574|4168797|B1|G1-G2||Grade of histologic differentiation|"Histologic grade, also called differentiation, refers to how much the tumor cells resemble normal cells of the same tissue type.~GX Grade cannot be assessed (Undetermined grade) G1 Well-differentiated (Low grade) - best prognosis G2 Moderately differentiated (Intermediate grade) G3 Poorly differentiated (High grade) G4 Undifferentiated (High grade) - worst prognosis"|participants|Number|160|160.0||||||
4340820|NCT00418574|4168795|B3|2||Eastern Cooperative Oncology Group Performance Status (ECOG-PS)|"This scale and criteria are used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis. The scale runs from the score 0 to 5, with 0 denoting the status Fully active, able to carry on all pre-disease performance without restriction and 5 the status Dead."|participants|Number|2|2.0||||||
4340821|NCT00418574|4168796|B2|2||Eastern Cooperative Oncology Group Performance Status (ECOG-PS)|"This scale and criteria are used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis. The scale runs from the score 0 to 5, with 0 denoting the status Fully active, able to carry on all pre-disease performance without restriction and 5 the status Dead."|participants|Number|0|0.0||||||
4340822|NCT00418574|4168797|B1|2||Eastern Cooperative Oncology Group Performance Status (ECOG-PS)|"This scale and criteria are used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis. The scale runs from the score 0 to 5, with 0 denoting the status Fully active, able to carry on all pre-disease performance without restriction and 5 the status Dead."|participants|Number|2|2.0||||||
4340823|NCT00418574|4168795|B3|1||Eastern Cooperative Oncology Group Performance Status (ECOG-PS)|"This scale and criteria are used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis. The scale runs from the score 0 to 5, with 0 denoting the status Fully active, able to carry on all pre-disease performance without restriction and 5 the status Dead."|participants|Number|186|186.0||||||
4340824|NCT00418574|4168796|B2|1||Eastern Cooperative Oncology Group Performance Status (ECOG-PS)|"This scale and criteria are used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis. The scale runs from the score 0 to 5, with 0 denoting the status Fully active, able to carry on all pre-disease performance without restriction and 5 the status Dead."|participants|Number|55|55.0||||||
4340825|NCT00418574|4168797|B1|1||Eastern Cooperative Oncology Group Performance Status (ECOG-PS)|"This scale and criteria are used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis. The scale runs from the score 0 to 5, with 0 denoting the status Fully active, able to carry on all pre-disease performance without restriction and 5 the status Dead."|participants|Number|131|131.0||||||
4340826|NCT00418574|4168795|B3|0||Eastern Cooperative Oncology Group Performance Status (ECOG-PS)|"This scale and criteria are used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis. The scale runs from the score 0 to 5, with 0 denoting the status Fully active, able to carry on all pre-disease performance without restriction and 5 the status Dead."|participants|Number|700|700.0||||||
4340827|NCT00418574|4168796|B2|0||Eastern Cooperative Oncology Group Performance Status (ECOG-PS)|"This scale and criteria are used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis. The scale runs from the score 0 to 5, with 0 denoting the status Fully active, able to carry on all pre-disease performance without restriction and 5 the status Dead."|participants|Number|240|240.0||||||
4340828|NCT00418574|4168797|B1|0||Eastern Cooperative Oncology Group Performance Status (ECOG-PS)|"This scale and criteria are used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis. The scale runs from the score 0 to 5, with 0 denoting the status Fully active, able to carry on all pre-disease performance without restriction and 5 the status Dead."|participants|Number|460|460.0||||||
4340829|NCT00418574|4168795|B3|missing||Histology of ovarian tumor||participants|Number|3|3.0||||||
4340830|NCT00418574|4168796|B2|missing||Histology of ovarian tumor||participants|Number|0|0.0||||||
4340831|NCT00418574|4168797|B1|missing||Histology of ovarian tumor||participants|Number|3|3.0||||||
4340832|NCT00418574|4168795|B3|Others||Histology of ovarian tumor||participants|Number|45|45.0||||||
4340833|NCT00418574|4168796|B2|Others||Histology of ovarian tumor||participants|Number|12|12.0||||||
4340834|NCT00418574|4168797|B1|Others||Histology of ovarian tumor||participants|Number|33|33.0||||||
4340835|NCT00418574|4168795|B3|Mixed tumor||Histology of ovarian tumor||participants|Number|25|25.0||||||
4340836|NCT00418574|4168796|B2|Mixed tumor||Histology of ovarian tumor||participants|Number|7|7.0||||||
4340837|NCT00418574|4168797|B1|Mixed tumor||Histology of ovarian tumor||participants|Number|18|18.0||||||
4340838|NCT00418574|4168795|B3|Undifferentiated||Histology of ovarian tumor||participants|Number|21|21.0||||||
4340839|NCT00418574|4168796|B2|Undifferentiated||Histology of ovarian tumor||participants|Number|7|7.0||||||
4340840|NCT00418574|4168797|B1|Undifferentiated||Histology of ovarian tumor||participants|Number|14|14.0||||||
4340841|NCT00418574|4168795|B3|Mucinous||Histology of ovarian tumor||participants|Number|9|9.0||||||
4340842|NCT00418574|4168796|B2|Mucinous||Histology of ovarian tumor||participants|Number|3|3.0||||||
4340843|NCT00418574|4168797|B1|Mucinous||Histology of ovarian tumor||participants|Number|6|6.0||||||
4340847|NCT00418574|4168795|B3|Serous/papillary||Histology of ovarian tumor||participants|Number|726|726.0||||||
4340848|NCT00418574|4168796|B2|Serous/papillary||Histology of ovarian tumor||participants|Number|245|245.0||||||
4340849|NCT00418574|4168797|B1|Serous/papillary||Histology of ovarian tumor||participants|Number|481|481.0||||||
4340850|NCT00418574|4168795|B3|Italy||Region of Enrollment||participants|Number|137|137.0||||||
4340851|NCT00418574|4168796|B2|Italy||Region of Enrollment||participants|Number|40|40.0||||||
4340852|NCT00418574|4168797|B1|Italy||Region of Enrollment||participants|Number|97|97.0||||||
4340853|NCT00418574|4168795|B3|Germany||Region of Enrollment||participants|Number|299|299.0||||||
4340854|NCT00418574|4168796|B2|Germany||Region of Enrollment||participants|Number|93|93.0||||||
4340855|NCT00418574|4168797|B1|Germany||Region of Enrollment||participants|Number|206|206.0||||||
4340856|NCT00418574|4168795|B3|Belgium||Region of Enrollment||participants|Number|23|23.0||||||
4340857|NCT00418574|4168796|B2|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
4340858|NCT00418574|4168797|B1|Belgium||Region of Enrollment||participants|Number|19|19.0||||||
4340859|NCT00418574|4168795|B3|Spain||Region of Enrollment||participants|Number|103|103.0||||||
4340860|NCT00418574|4168796|B2|Spain||Region of Enrollment||participants|Number|48|48.0||||||
4340861|NCT00418574|4168797|B1|Spain||Region of Enrollment||participants|Number|55|55.0||||||
4340862|NCT00418574|4168795|B3|Poland||Region of Enrollment||participants|Number|78|78.0||||||
4340863|NCT00418574|4168796|B2|Poland||Region of Enrollment||participants|Number|25|25.0||||||
4340864|NCT00418574|4168797|B1|Poland||Region of Enrollment||participants|Number|53|53.0||||||
4340865|NCT00418574|4168795|B3|Czech Republic||Region of Enrollment||participants|Number|82|82.0||||||
4340866|NCT00418574|4168796|B2|Czech Republic||Region of Enrollment||participants|Number|28|28.0||||||
4340867|NCT00418574|4168797|B1|Czech Republic||Region of Enrollment||participants|Number|54|54.0||||||
4340868|NCT00418574|4168795|B3|Hungary||Region of Enrollment||participants|Number|25|25.0||||||
4340869|NCT00418574|4168796|B2|Hungary||Region of Enrollment||participants|Number|8|8.0||||||
4340870|NCT00418574|4168797|B1|Hungary||Region of Enrollment||participants|Number|17|17.0||||||
4340871|NCT00418574|4168795|B3|United States||Region of Enrollment||participants|Number|138|138.0||||||
4340872|NCT00418574|4168796|B2|United States||Region of Enrollment||participants|Number|47|47.0||||||
4340873|NCT00418574|4168797|B1|United States||Region of Enrollment||participants|Number|91|91.0||||||
4340874|NCT00418574|4168795|B3|France||Region of Enrollment||participants|Number|3|3.0||||||
4340875|NCT00418574|4168796|B2|France||Region of Enrollment||participants|Number|2|2.0||||||
4340876|NCT00418574|4168797|B1|France||Region of Enrollment||participants|Number|1|1.0||||||
4340877|NCT00418574|4168795|B3|Female||Sex/Gender, Customized||participants|Number|888|888.0||||||
4340878|NCT00418574|4168796|B2|Female||Sex/Gender, Customized||participants|Number|295|295.0||||||
4340879|NCT00418574|4168797|B1|Female||Sex/Gender, Customized||participants|Number|593|593.0||||||
4340880|NCT00418574|4168795|B3|||Age||years|Mean|56.3|56.3|Standard Deviation|10.53|10.53|||
4340881|NCT00418574|4168796|B2|||Age||years|Mean|56.0|56.0|Standard Deviation|10.47|10.47|||
4340882|NCT00418574|4168797|B1|||Age||years|Mean|56.4|56.4|Standard Deviation|10.57|10.57|||
4340883|NCT00418574|4168795|B3||>=65 years|Age||Participants|Count of Participants|213|213.0||||||
4340884|NCT00418574|4168796|B2||>=65 years|Age||Participants|Count of Participants|68|68.0||||||
4340885|NCT00418574|4168797|B1||>=65 years|Age||Participants|Count of Participants|145|145.0||||||
4340886|NCT00418574|4168795|B3||Between 18 and 65 years|Age||Participants|Count of Participants|674|674.0||||||
4340887|NCT00418574|4168796|B2||Between 18 and 65 years|Age||Participants|Count of Participants|227|227.0||||||
4340888|NCT00418574|4168797|B1||Between 18 and 65 years|Age||Participants|Count of Participants|447|447.0||||||
4340889|NCT00418574|4168795|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4340890|NCT00418574|4168796|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4340891|NCT00418574|4168797|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4340892|NCT00418561|4168809|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4340893|NCT00418561|4168810|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4340894|NCT00418561|4168811|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4340895|NCT00418561|4168812|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4340896|NCT00418561|4168809|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4340897|NCT00418561|4168810|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4340898|NCT00418561|4168811|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4340899|NCT00418561|4168812|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4340900|NCT00418561|4168809|B4|||Age||months|Mean|36.69|36.69|Standard Deviation|9.59|9.59|||
4340901|NCT00418561|4168810|B3|||Age||months|Mean|30.75|30.75|Standard Deviation|7.27|7.27|||
4340902|NCT00418561|4168811|B2|||Age||months|Mean|41.80|41.8|Standard Deviation|10.13|10.13|||
4340903|NCT00418561|4168812|B1|||Age||months|Mean|36.25|36.25|Standard Deviation|9.32|9.32|||
4340904|NCT00418522|4168882|B3||Male|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
4340905|NCT00418522|4168883|B2||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4340906|NCT00418522|4168884|B1||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4340907|NCT00418522|4168882|B3||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4340908|NCT00418522|4168883|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4340909|NCT00418522|4168884|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4340910|NCT00418522|4168882|B3|>=65 years||Age, Customized||participants|Number|73|73.0||||||
4340911|NCT00418522|4168883|B2|>=65 years||Age, Customized||participants|Number|39|39.0||||||
4340912|NCT00418522|4168884|B1|>=65 years||Age, Customized||participants|Number|34|34.0||||||
4340913|NCT00418522|4168882|B3|45 to 65 years||Age, Customized||participants|Number|276|276.0||||||
4340914|NCT00418522|4168883|B2|45 to 65 years||Age, Customized||participants|Number|125|125.0||||||
4340915|NCT00418522|4168884|B1|45 to 65 years||Age, Customized||participants|Number|151|151.0||||||
4340916|NCT00418522|4168882|B3|18 to 44 years||Age, Customized||participants|Number|53|53.0||||||
4340917|NCT00418522|4168883|B2|18 to 44 years||Age, Customized||participants|Number|26|26.0||||||
4340918|NCT00418522|4168884|B1|18 to 44 years||Age, Customized||participants|Number|27|27.0||||||
4340919|NCT00418379|4168929|B4||Male|Sex: Female, Male||Participants|Count of Participants|355|355.0||||||
4340920|NCT00418379|4168930|B3||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4340921|NCT00418379|4168931|B2||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4340922|NCT00418379|4168932|B1||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4340923|NCT00418379|4168929|B4||Female|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
4340924|NCT00418379|4168930|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4340925|NCT00418379|4168931|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4340926|NCT00418379|4168932|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4340927|NCT00418379|4168929|B4|||Age||years|Mean|30.5|30.5|Standard Deviation|8.14|8.14|||
4340928|NCT00418379|4168930|B3|||Age||years|Mean|30.2|30.2|Standard Deviation|8.56|8.56|||
4340929|NCT00418379|4168931|B2|||Age||years|Mean|30.4|30.4|Standard Deviation|7.57|7.57|||
4340930|NCT00418379|4168932|B1|||Age||years|Mean|30.9|30.9|Standard Deviation|8.25|8.25|||
4340931|NCT00418314|4168942|B3|Southeast Asia||Region of Enrollment||participants|Number|2|2.0||||||
4340932|NCT00418314|4168943|B2|Southeast Asia||Region of Enrollment||participants|Number|1|1.0||||||
4340933|NCT00418314|4168944|B1|Southeast Asia||Region of Enrollment||participants|Number|1|1.0||||||
4340934|NCT00418314|4168942|B3|Middle East||Region of Enrollment||participants|Number|7|7.0||||||
4340935|NCT00418314|4168943|B2|Middle East||Region of Enrollment||participants|Number|4|4.0||||||
4340936|NCT00418314|4168944|B1|Middle East||Region of Enrollment||participants|Number|3|3.0||||||
4340937|NCT00418314|4168942|B3|Australia||Region of Enrollment||participants|Number|32|32.0||||||
4340938|NCT00418314|4168943|B2|Australia||Region of Enrollment||participants|Number|15|15.0||||||
4340939|NCT00418314|4168944|B1|Australia||Region of Enrollment||participants|Number|17|17.0||||||
4340940|NCT00418314|4168942|B3|Canada||Region of Enrollment||participants|Number|67|67.0||||||
4340941|NCT00418314|4168943|B2|Canada||Region of Enrollment||participants|Number|35|35.0||||||
4340942|NCT00418314|4168944|B1|Canada||Region of Enrollment||participants|Number|32|32.0||||||
4340943|NCT00418314|4168942|B3|Europe||Region of Enrollment||participants|Number|570|570.0||||||
4340944|NCT00418314|4168943|B2|Europe||Region of Enrollment||participants|Number|288|288.0||||||
4340945|NCT00418314|4168944|B1|Europe||Region of Enrollment||participants|Number|282|282.0||||||
4340946|NCT00418314|4168942|B3|United States||Region of Enrollment||participants|Number|969|969.0||||||
4340947|NCT00418314|4168943|B2|United States||Region of Enrollment||participants|Number|487|487.0||||||
4340948|NCT00418314|4168944|B1|United States||Region of Enrollment||participants|Number|482|482.0||||||
4340949|NCT00418314|4168942|B3||Male|Sex: Female, Male||Participants|Count of Participants|1213|1213.0||||||
4340950|NCT00418314|4168943|B2||Male|Sex: Female, Male||Participants|Count of Participants|592|592.0||||||
4340951|NCT00418314|4168944|B1||Male|Sex: Female, Male||Participants|Count of Participants|621|621.0||||||
4340952|NCT00418314|4168942|B3||Female|Sex: Female, Male||Participants|Count of Participants|434|434.0||||||
4340953|NCT00418314|4168943|B2||Female|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
4340954|NCT00418314|4168944|B1||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4340955|NCT00418314|4168942|B3|||Age||years|Mean|66.7|66.7|Standard Deviation|11|11.0|||
4340956|NCT00418314|4168943|B2|||Age||years|Mean|66.7|66.7|Standard Deviation|11|11.0|||
4340957|NCT00418314|4168944|B1|||Age||years|Mean|66.8|66.8|Standard Deviation|11|11.0|||
4340958|NCT00418314|4168942|B3||>=65 years|Age||Participants|Count of Participants|1000|1000.0||||||
4340959|NCT00418314|4168943|B2||>=65 years|Age||Participants|Count of Participants|490|490.0||||||
4340960|NCT00418314|4168944|B1||>=65 years|Age||Participants|Count of Participants|510|510.0||||||
4340961|NCT00418314|4168942|B3||Between 18 and 65 years|Age||Participants|Count of Participants|647|647.0||||||
4340962|NCT00418314|4168943|B2||Between 18 and 65 years|Age||Participants|Count of Participants|340|340.0||||||
4340963|NCT00418314|4168944|B1||Between 18 and 65 years|Age||Participants|Count of Participants|307|307.0||||||
4340964|NCT00418314|4168942|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4340965|NCT00418314|4168943|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4340966|NCT00418314|4168944|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4340967|NCT00418262|4168955|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4340968|NCT00418262|4168955|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4340969|NCT00418262|4168955|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|NA|||||||Not assessed
4340970|NCT00418262|4168955|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4340971|NCT00418262|4168955|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4340972|NCT00418262|4168955|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340973|NCT00418262|4168955|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340974|NCT00418262|4168955|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4340975|NCT00418262|4168955|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4340976|NCT00418262|4168955|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4340977|NCT00418262|4168955|B1|||Age||years|Mean|7.4|7.4|Full Range|||4.3|12.0|
4340978|NCT00418262|4168955|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4340979|NCT00418262|4168955|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4340980|NCT00418262|4168955|B1||<=18 years|Age||Participants|Count of Participants|27|27.0||||||
4340981|NCT00418184|4168973|B3|Extremely seriously ill (score 6)||Clinical Global Impression of Severity (CGI-S)|The CGI is an observer-rated scale that measures illness severity.The clinician evaluates the patient relative to his past experience with other patients with the same diagnosis.The ratings of CGI-S are: 1 = not ill at all, 2 = a borderline case, 3 = only mildly ill, 4 = moderately ill, 5 = seriously ill and 6 = extremely seriously ill.|Participants|Number|4|4.0||||||
4340982|NCT00418184|4168974|B2|Extremely seriously ill (score 6)||Clinical Global Impression of Severity (CGI-S)|The CGI is an observer-rated scale that measures illness severity.The clinician evaluates the patient relative to his past experience with other patients with the same diagnosis.The ratings of CGI-S are: 1 = not ill at all, 2 = a borderline case, 3 = only mildly ill, 4 = moderately ill, 5 = seriously ill and 6 = extremely seriously ill.|Participants|Number|0|0.0||||||
4340983|NCT00418184|4168975|B1|Extremely seriously ill (score 6)||Clinical Global Impression of Severity (CGI-S)|The CGI is an observer-rated scale that measures illness severity.The clinician evaluates the patient relative to his past experience with other patients with the same diagnosis.The ratings of CGI-S are: 1 = not ill at all, 2 = a borderline case, 3 = only mildly ill, 4 = moderately ill, 5 = seriously ill and 6 = extremely seriously ill.|Participants|Number|4|4.0||||||
4340984|NCT00418184|4168973|B3|Seriously ill (score 5)||Clinical Global Impression of Severity (CGI-S)|The CGI is an observer-rated scale that measures illness severity.The clinician evaluates the patient relative to his past experience with other patients with the same diagnosis.The ratings of CGI-S are: 1 = not ill at all, 2 = a borderline case, 3 = only mildly ill, 4 = moderately ill, 5 = seriously ill and 6 = extremely seriously ill.|Participants|Number|77|77.0||||||
4340985|NCT00418184|4168974|B2|Seriously ill (score 5)||Clinical Global Impression of Severity (CGI-S)|The CGI is an observer-rated scale that measures illness severity.The clinician evaluates the patient relative to his past experience with other patients with the same diagnosis.The ratings of CGI-S are: 1 = not ill at all, 2 = a borderline case, 3 = only mildly ill, 4 = moderately ill, 5 = seriously ill and 6 = extremely seriously ill.|Participants|Number|27|27.0||||||
4340986|NCT00418184|4168975|B1|Seriously ill (score 5)||Clinical Global Impression of Severity (CGI-S)|The CGI is an observer-rated scale that measures illness severity.The clinician evaluates the patient relative to his past experience with other patients with the same diagnosis.The ratings of CGI-S are: 1 = not ill at all, 2 = a borderline case, 3 = only mildly ill, 4 = moderately ill, 5 = seriously ill and 6 = extremely seriously ill.|Participants|Number|50|50.0||||||
4340987|NCT00418184|4168973|B3|Moderately ill (score 4)||Clinical Global Impression of Severity (CGI-S)|The CGI is an observer-rated scale that measures illness severity.The clinician evaluates the patient relative to his past experience with other patients with the same diagnosis.The ratings of CGI-S are: 1 = not ill at all, 2 = a borderline case, 3 = only mildly ill, 4 = moderately ill, 5 = seriously ill and 6 = extremely seriously ill.|Participants|Number|119|119.0||||||
4340988|NCT00418184|4168974|B2|Moderately ill (score 4)||Clinical Global Impression of Severity (CGI-S)|The CGI is an observer-rated scale that measures illness severity.The clinician evaluates the patient relative to his past experience with other patients with the same diagnosis.The ratings of CGI-S are: 1 = not ill at all, 2 = a borderline case, 3 = only mildly ill, 4 = moderately ill, 5 = seriously ill and 6 = extremely seriously ill.|Participants|Number|36|36.0||||||
4340989|NCT00418184|4168975|B1|Moderately ill (score 4)||Clinical Global Impression of Severity (CGI-S)|The CGI is an observer-rated scale that measures illness severity.The clinician evaluates the patient relative to his past experience with other patients with the same diagnosis.The ratings of CGI-S are: 1 = not ill at all, 2 = a borderline case, 3 = only mildly ill, 4 = moderately ill, 5 = seriously ill and 6 = extremely seriously ill.|Participants|Number|83|83.0||||||
4340990|NCT00418184|4168973|B3||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4340991|NCT00418184|4168974|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4340992|NCT00418184|4168975|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4340993|NCT00418184|4168973|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4340994|NCT00418184|4168974|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4340995|NCT00418184|4168975|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4340996|NCT00418184|4168973|B3|||Age||years|Mean|9.15|9.15|Standard Deviation|1.85|1.85|||
4340997|NCT00418184|4168974|B2|||Age||years|Mean|9.24|9.24|Standard Deviation|1.77|1.77|||
4340998|NCT00418184|4168975|B1|||Age||years|Mean|9.10|9.1|Standard Deviation|1.89|1.89|||
4340999|NCT00418145|4168984|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4341000|NCT00418145|4168984|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341001|NCT00418145|4168984|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4341002|NCT00418145|4168984|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4341003|NCT00418145|4168984|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341004|NCT00418145|4168984|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341005|NCT00418145|4168984|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341006|NCT00418145|4168984|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4341007|NCT00418145|4168984|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4341008|NCT00418145|4168984|B1|age 50+||Age, Customized||participants|Number|0|0.0||||||
4341009|NCT00418145|4168984|B1|age 40-49||Age, Customized||participants|Number|7|7.0||||||
4341010|NCT00418145|4168984|B1|age 30-39||Age, Customized||participants|Number|3|3.0||||||
4341011|NCT00418145|4168984|B1|age 18-29||Age, Customized||participants|Number|6|6.0||||||
4341012|NCT00418093|4168996|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4341013|NCT00418093|4168996|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4341014|NCT00418093|4168996|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4341015|NCT00418093|4168996|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4341016|NCT00418093|4168996|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4341017|NCT00418093|4168996|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341018|NCT00418028|4169003|B3|Spain||Region of Enrollment||participants|Number|195|195.0||||||
4341019|NCT00418028|4169004|B2|Spain||Region of Enrollment||participants|Number|98|98.0||||||
4341020|NCT00418028|4169005|B1|Spain||Region of Enrollment||participants|Number|97|97.0||||||
4341021|NCT00418028|4169003|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4341022|NCT00418028|4169004|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4341023|NCT00418028|4169005|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4341024|NCT00418028|4169003|B3||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4341025|NCT00418028|4169004|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4341026|NCT00418028|4169005|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4341027|NCT00418028|4169003|B3|||Age||years|Mean|59.82|59.82|Standard Deviation|12.48|12.48|||
4341028|NCT00418028|4169004|B2|||Age||years|Mean|58.59|58.59|Standard Deviation|11.66|11.66|||
4341029|NCT00418028|4169005|B1|||Age||years|Mean|61.07|61.07|Standard Deviation|13.21|13.21|||
4341030|NCT00418028|4169003|B3||>=65 years|Age||Participants|Count of Participants|75|75.0||||||
4341031|NCT00418028|4169004|B2||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
4341032|NCT00418028|4169005|B1||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
4341033|NCT00418028|4169003|B3||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
4341034|NCT00418028|4169004|B2||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4341035|NCT00418028|4169005|B1||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4341036|NCT00418028|4169003|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341037|NCT00418028|4169004|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341038|NCT00418028|4169005|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341039|NCT00418015|4169024|B5|United States||Region of Enrollment||participants|Number|293|293.0||||||
4341040|NCT00418015|4169025|B4|United States||Region of Enrollment||participants|Number|25|25.0||||||
4341041|NCT00418015|4169026|B3|United States||Region of Enrollment||participants|Number|78|78.0||||||
4341042|NCT00418015|4169027|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
4341043|NCT00418015|4169028|B1|United States||Region of Enrollment||participants|Number|144|144.0||||||
4341044|NCT00418015|4169024|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4341045|NCT00418015|4169025|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4341046|NCT00418015|4169026|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4341047|NCT00418015|4169027|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4341048|NCT00418015|4169028|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4341049|NCT00418015|4169024|B5||Female|Sex: Female, Male||Participants|Count of Participants|293|293.0||||||
4341050|NCT00418015|4169025|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4341051|NCT00418015|4169026|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4341052|NCT00418015|4169027|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4341053|NCT00418015|4169028|B1||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4341054|NCT00418015|4169024|B5|||Age||years|Median|32|32.0|Inter-Quartile Range|||28.0|34.0|
4341055|NCT00418015|4169025|B4|||Age||years|Median|32|32.0|Inter-Quartile Range|||29.0|35.0|
4341056|NCT00418015|4169026|B3|||Age||years|Median|34|34.0|Inter-Quartile Range|||31.0|37.0|
4341057|NCT00418015|4169027|B2|||Age||years|Median|32|32.0|Inter-Quartile Range|||30.0|34.0|
4341058|NCT00418015|4169028|B1|||Age||years|Median|30|30.0|Inter-Quartile Range|||28.0|34.0|
4341059|NCT00418015|4169024|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4341060|NCT00418015|4169025|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4341061|NCT00418015|4169026|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4341062|NCT00418015|4169027|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4341063|NCT00418015|4169028|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4341064|NCT00418015|4169024|B5||Between 18 and 65 years|Age||Participants|Count of Participants|293|293.0||||||
4341065|NCT00418015|4169025|B4||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4341066|NCT00418015|4169026|B3||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
4341067|NCT00418015|4169027|B2||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4341068|NCT00418015|4169028|B1||Between 18 and 65 years|Age||Participants|Count of Participants|144|144.0||||||
4341069|NCT00418015|4169024|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341070|NCT00418015|4169025|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341071|NCT00418015|4169026|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341072|NCT00418015|4169027|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341073|NCT00418015|4169028|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341074|NCT00417989|4169057|B3|Canada||Region of Enrollment||participants|Number|58|58.0||||||
4341075|NCT00417989|4169058|B2|Canada||Region of Enrollment||participants|Number|30|30.0||||||
4341076|NCT00417989|4169059|B1|Canada||Region of Enrollment||participants|Number|28|28.0||||||
4341077|NCT00417989|4169057|B3|United States||Region of Enrollment||participants|Number|427|427.0||||||
4341078|NCT00417989|4169058|B2|United States||Region of Enrollment||participants|Number|211|211.0||||||
4341079|NCT00417989|4169059|B1|United States||Region of Enrollment||participants|Number|216|216.0||||||
4341080|NCT00417989|4169057|B3||Male|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
4341081|NCT00417989|4169058|B2||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4341082|NCT00417989|4169059|B1||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4341083|NCT00417989|4169057|B3||Female|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4341084|NCT00417989|4169058|B2||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4341085|NCT00417989|4169059|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4341086|NCT00417989|4169057|B3|Between 19 and 70 years||Age, Customized||participants|Number|336|336.0||||||
4341087|NCT00417989|4169058|B2|Between 19 and 70 years||Age, Customized||participants|Number|169|169.0||||||
4341088|NCT00417989|4169059|B1|Between 19 and 70 years||Age, Customized||participants|Number|167|167.0||||||
4341089|NCT00417989|4169057|B3|<=18 years||Age, Customized||participants|Number|149|149.0||||||
4341090|NCT00417989|4169058|B2|<=18 years||Age, Customized||participants|Number|72|72.0||||||
4341091|NCT00417989|4169059|B1|<=18 years||Age, Customized||participants|Number|77|77.0||||||
4341092|NCT00417989|4169057|B3|||Age||years|Mean|31.90|31.9|Standard Deviation|16.98|16.98|||
4341093|NCT00417989|4169058|B2|||Age||years|Mean|31.50|31.5|Standard Deviation|16.50|16.5|||
4341094|NCT00417989|4169059|B1|||Age||years|Mean|32.2|32.2|Standard Deviation|17.47|17.47|||
4341095|NCT00417976|4169082|B1|Low (<3.4 g/dl)||Albumin||participants|Number|14|14.0||||||
4341096|NCT00417976|4169082|B1|Normal (≥3.4 g/dl)||Albumin||participants|Number|28|28.0||||||
4341097|NCT00417976|4169082|B1|Elevated (>37 U/ml)||CA19-9 (tumor marker levels)||participants|Number|36|36.0||||||
4341098|NCT00417976|4169082|B1|Normal (≤37 U/ml)||CA19-9 (tumor marker levels)||participants|Number|6|6.0||||||
4341099|NCT00417976|4169082|B1|IV (Cancer has spread o distant tissue or organ)||Disease stage||participants|Number|40|40.0||||||
4341100|NCT00417976|4169082|B1|III (Unresectable primary tumor)||Disease stage||participants|Number|2|2.0||||||
4341101|NCT00417976|4169082|B1|No prior adjuvant therapy||Prior adjuvant therapy||participants|Number|40|40.0||||||
4341102|NCT00417976|4169082|B1|Chemoraditation||Prior adjuvant therapy||participants|Number|1|1.0||||||
4341103|NCT00417976|4169082|B1|Gemcitabine-based||Prior adjuvant therapy||participants|Number|1|1.0||||||
4341104|NCT00417976|4169082|B1|Recurrent metastatic disease||Site of metastasis||participants|Number|2|2.0||||||
4341105|NCT00417976|4169082|B1|Other only||Site of metastasis||participants|Number|9|9.0||||||
4341106|NCT00417976|4169082|B1|Liver+other||Site of metastasis||participants|Number|2|2.0||||||
4341107|NCT00417976|4169082|B1|Liver only||Site of metastasis||participants|Number|29|29.0||||||
4341108|NCT00417976|4169082|B1|1 (Restricted in physical activity)||Eastern Cooperative Oncology Group (ECOG) Performance status||participants|Number|27|27.0||||||
4341109|NCT00417976|4169082|B1|0 (Fully Active)||Eastern Cooperative Oncology Group (ECOG) Performance status||participants|Number|15|15.0||||||
4341110|NCT00417976|4169082|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4341111|NCT00417976|4169082|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4341112|NCT00417976|4169082|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4341113|NCT00417976|4169082|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341114|NCT00417976|4169082|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4341115|NCT00417976|4169082|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4341116|NCT00417976|4169082|B1|||Age||years|Median|60|60.0|Full Range|||36.0|79.0|
4341117|NCT00417963|4169087|B1|United States||Region of Enrollment||participants|Number|486|486.0||||||
4341118|NCT00417963|4169087|B1||Male|Gender||Participants|Count of Participants|295|295.0||||||
4341119|NCT00417963|4169087|B1||Female|Gender||Participants|Count of Participants|191|191.0||||||
4341120|NCT00417963|4169087|B1|||Age||years|Mean|72.1|72.1|Standard Deviation|9.14|9.14|||
4341121|NCT00417885|4169104|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4341122|NCT00417885|4169104|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4341123|NCT00417885|4169104|B1|> = 65 years||Age, Customized||participants|Number|2|2.0||||||
4341124|NCT00417885|4169104|B1|45 to 64 years||Age, Customized||participants|Number|4|4.0||||||
4341125|NCT00417885|4169104|B1|18 to 44 years||Age, Customized||participants|Number|0|0.0||||||
4341126|NCT00417885|4169104|B1|< 18 years||Age, Customized||participants|Number|0|0.0||||||
4341127|NCT00417612|4169113|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
4341128|NCT00417612|4169114|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4341129|NCT00417612|4169115|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4341130|NCT00417612|4169113|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4341131|NCT00417612|4169114|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4341132|NCT00417612|4169115|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4341133|NCT00417612|4169113|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4341134|NCT00417612|4169114|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4341135|NCT00417612|4169115|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4341136|NCT00417612|4169113|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4341137|NCT00417612|4169114|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4341138|NCT00417612|4169115|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4341139|NCT00417612|4169113|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4341140|NCT00417612|4169114|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4341141|NCT00417612|4169115|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4341142|NCT00417612|4169113|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4341143|NCT00417612|4169114|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4341144|NCT00417612|4169115|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4341145|NCT00417482|4169139|B4|United States||Region of Enrollment||participants|Number|110|110.0||||||
4341146|NCT00417482|4169140|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4341147|NCT00417482|4169141|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
4341148|NCT00417482|4169142|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4341149|NCT00417482|4169139|B4||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4341150|NCT00417482|4169140|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4341151|NCT00417482|4169141|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4341152|NCT00417482|4169142|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4341153|NCT00417482|4169139|B4||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4341154|NCT00417482|4169140|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4341155|NCT00417482|4169141|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4341156|NCT00417482|4169142|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4341157|NCT00417482|4169139|B4|||Age||years|Mean|80.0|80.0|Standard Deviation|7.8|7.8|||
4341158|NCT00417482|4169140|B3|||Age||years|Mean|80.3|80.3|Standard Deviation|7.7|7.7|||
4341159|NCT00417482|4169141|B2|||Age||years|Mean|79.1|79.1|Standard Deviation|8.0|8.0|||
4341160|NCT00417482|4169142|B1|||Age||years|Mean|80.7|80.7|Standard Deviation|7.9|7.9|||
4341161|NCT00417482|4169139|B4||>=65 years|Age||Participants|Count of Participants|103|103.0||||||
4341162|NCT00417482|4169140|B3||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4341163|NCT00417482|4169141|B2||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
4341164|NCT00417482|4169142|B1||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4341165|NCT00417482|4169139|B4||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4341166|NCT00417482|4169140|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4341167|NCT00417482|4169141|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4341168|NCT00417482|4169142|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4341169|NCT00417482|4169139|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341170|NCT00417482|4169140|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341171|NCT00417482|4169141|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341172|NCT00417482|4169142|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341173|NCT00417417|4169168|B3|||C-reactive protein||mg/L|Mean|3.8|3.8|Standard Deviation|1.5|1.5|||
4341174|NCT00417417|4169169|B2|||C-reactive protein||mg/L|Mean|3.9|3.9|Standard Deviation|1.1|1.1|||
4341175|NCT00417417|4169170|B1|||C-reactive protein||mg/L|Mean|3.6|3.6|Standard Deviation|1.8|1.8|||
4341176|NCT00417417|4169168|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4341177|NCT00417417|4169169|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4341178|NCT00417417|4169170|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4341179|NCT00417417|4169168|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4341180|NCT00417417|4169169|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4341181|NCT00417417|4169170|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4341182|NCT00417417|4169168|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4341183|NCT00417417|4169169|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4341184|NCT00417417|4169170|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4341185|NCT00417417|4169168|B3|||Age||years|Mean|69|69.0|Standard Deviation|11|11.0|||
4341186|NCT00417417|4169169|B2|||Age||years|Mean|71|71.0|Standard Deviation|10|10.0|||
4341187|NCT00417417|4169170|B1|||Age||years|Mean|64|64.0|Standard Deviation|11|11.0|||
4341188|NCT00417417|4169168|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4341189|NCT00417417|4169169|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4341190|NCT00417417|4169170|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4341191|NCT00417417|4169168|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4341192|NCT00417417|4169169|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4341193|NCT00417417|4169170|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4341194|NCT00417417|4169168|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341195|NCT00417417|4169169|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341196|NCT00417417|4169170|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341197|NCT00417274|4169179|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4341198|NCT00417274|4169179|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4341199|NCT00417274|4169179|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4341200|NCT00417274|4169179|B1|||Age||years|Mean|68|68.0|Standard Deviation|9.27|9.27|||
4341201|NCT00417274|4169179|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4341202|NCT00417274|4169179|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4341203|NCT00417274|4169179|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341204|NCT00417248|4169183|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4341205|NCT00417248|4169183|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4341206|NCT00417248|4169183|B1|||Age||Years|Median|66.50|66.5|Full Range|||59.0|76.0|
4341207|NCT00417170|4169188|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4341208|NCT00417170|4169189|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4341209|NCT00417170|4169190|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4341210|NCT00417170|4169188|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4341211|NCT00417170|4169189|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4341212|NCT00417170|4169190|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4341213|NCT00417170|4169188|B3|||Age||years|Mean|44.5|44.5|Standard Deviation|8.6|8.6|||
4341214|NCT00417170|4169189|B2|||Age||years|Mean|44.1|44.1|Standard Deviation|5.3|5.3|||
4341215|NCT00417170|4169190|B1|||Age||years|Mean|45.0|45.0|Standard Deviation|11.3|11.3|||
4341216|NCT00417079|4169205|B3|Missing||Tumor Location: number of sites involved||Participants|Number|8|8.0||||||
4341217|NCT00417079|4169206|B2|Missing||Tumor Location: number of sites involved||Participants|Number|3|3.0||||||
4341218|NCT00417079|4169207|B1|Missing||Tumor Location: number of sites involved||Participants|Number|5|5.0||||||
4341219|NCT00417079|4169205|B3|4 or more||Tumor Location: number of sites involved||Participants|Number|87|87.0||||||
4341220|NCT00417079|4169206|B2|4 or more||Tumor Location: number of sites involved||Participants|Number|44|44.0||||||
4341221|NCT00417079|4169207|B1|4 or more||Tumor Location: number of sites involved||Participants|Number|43|43.0||||||
4341222|NCT00417079|4169205|B3|3||Tumor Location: number of sites involved||Participants|Number|151|151.0||||||
4341223|NCT00417079|4169206|B2|3||Tumor Location: number of sites involved||Participants|Number|73|73.0||||||
4341224|NCT00417079|4169207|B1|3||Tumor Location: number of sites involved||Participants|Number|78|78.0||||||
4341225|NCT00417079|4169205|B3|2||Tumor Location: number of sites involved||Participants|Number|229|229.0||||||
4341226|NCT00417079|4169206|B2|2||Tumor Location: number of sites involved||Participants|Number|112|112.0||||||
4341227|NCT00417079|4169207|B1|2||Tumor Location: number of sites involved||Participants|Number|117|117.0||||||
4341228|NCT00417079|4169205|B3|1||Tumor Location: number of sites involved||Participants|Number|280|280.0||||||
4341229|NCT00417079|4169206|B2|1||Tumor Location: number of sites involved||Participants|Number|146|146.0||||||
4341230|NCT00417079|4169207|B1|1||Tumor Location: number of sites involved||Participants|Number|134|134.0||||||
4341231|NCT00417079|4169205|B3|Missing||Extent of disease|"Extent of the disease at screening stage:~Metastatic: bone or visceral metastases.~Locoregional recurrence includes local recurrent tumor at the primary site, along the draining lymphatic channels, or within the draining lymphatic nodal basin."|Participants|Number|1|1.0||||||
4341232|NCT00417079|4169206|B2|Missing||Extent of disease|"Extent of the disease at screening stage:~Metastatic: bone or visceral metastases.~Locoregional recurrence includes local recurrent tumor at the primary site, along the draining lymphatic channels, or within the draining lymphatic nodal basin."|Participants|Number|0|0.0||||||
4341233|NCT00417079|4169207|B1|Missing||Extent of disease|"Extent of the disease at screening stage:~Metastatic: bone or visceral metastases.~Locoregional recurrence includes local recurrent tumor at the primary site, along the draining lymphatic channels, or within the draining lymphatic nodal basin."|Participants|Number|1|1.0||||||
4341234|NCT00417079|4169205|B3|Locoregional Recurrence||Extent of disease|"Extent of the disease at screening stage:~Metastatic: bone or visceral metastases.~Locoregional recurrence includes local recurrent tumor at the primary site, along the draining lymphatic channels, or within the draining lymphatic nodal basin."|Participants|Number|34|34.0||||||
4341235|NCT00417079|4169206|B2|Locoregional Recurrence||Extent of disease|"Extent of the disease at screening stage:~Metastatic: bone or visceral metastases.~Locoregional recurrence includes local recurrent tumor at the primary site, along the draining lymphatic channels, or within the draining lymphatic nodal basin."|Participants|Number|14|14.0||||||
4341236|NCT00417079|4169207|B1|Locoregional Recurrence||Extent of disease|"Extent of the disease at screening stage:~Metastatic: bone or visceral metastases.~Locoregional recurrence includes local recurrent tumor at the primary site, along the draining lymphatic channels, or within the draining lymphatic nodal basin."|Participants|Number|20|20.0||||||
4341237|NCT00417079|4169205|B3|Metastatic||Extent of disease|"Extent of the disease at screening stage:~Metastatic: bone or visceral metastases.~Locoregional recurrence includes local recurrent tumor at the primary site, along the draining lymphatic channels, or within the draining lymphatic nodal basin."|Participants|Number|720|720.0||||||
4341238|NCT00417079|4169206|B2|Metastatic||Extent of disease|"Extent of the disease at screening stage:~Metastatic: bone or visceral metastases.~Locoregional recurrence includes local recurrent tumor at the primary site, along the draining lymphatic channels, or within the draining lymphatic nodal basin."|Participants|Number|364|364.0||||||
4341281|NCT00417079|4169207|B1|Mexico||Region of Enrollment||participants|Number|2|2.0||||||
4341239|NCT00417079|4169207|B1|Metastatic||Extent of disease|"Extent of the disease at screening stage:~Metastatic: bone or visceral metastases.~Locoregional recurrence includes local recurrent tumor at the primary site, along the draining lymphatic channels, or within the draining lymphatic nodal basin."|Participants|Number|356|356.0||||||
4341240|NCT00417079|4169205|B3|Not Measurable disease||Measurable disease|"Measurability of the disease per Response Evaluation Criteria in Solid Tumors (RECIST) criteria:~Patients with measurable disease have at least one visceral or soft tissue metastatic lesion (including new lesion).~Patient with non-measurable disease have documented rising PSA levels or appearance of new lesion."|Participants|Number|350|350.0||||||
4341241|NCT00417079|4169206|B2|Not Measurable disease||Measurable disease|"Measurability of the disease per Response Evaluation Criteria in Solid Tumors (RECIST) criteria:~Patients with measurable disease have at least one visceral or soft tissue metastatic lesion (including new lesion).~Patient with non-measurable disease have documented rising PSA levels or appearance of new lesion."|Participants|Number|177|177.0||||||
4341242|NCT00417079|4169207|B1|Not Measurable disease||Measurable disease|"Measurability of the disease per Response Evaluation Criteria in Solid Tumors (RECIST) criteria:~Patients with measurable disease have at least one visceral or soft tissue metastatic lesion (including new lesion).~Patient with non-measurable disease have documented rising PSA levels or appearance of new lesion."|Participants|Number|173|173.0||||||
4341243|NCT00417079|4169205|B3|Measurable disease||Measurable disease|"Measurability of the disease per Response Evaluation Criteria in Solid Tumors (RECIST) criteria:~Patients with measurable disease have at least one visceral or soft tissue metastatic lesion (including new lesion).~Patient with non-measurable disease have documented rising PSA levels or appearance of new lesion."|Participants|Number|405|405.0||||||
4341244|NCT00417079|4169206|B2|Measurable disease||Measurable disease|"Measurability of the disease per Response Evaluation Criteria in Solid Tumors (RECIST) criteria:~Patients with measurable disease have at least one visceral or soft tissue metastatic lesion (including new lesion).~Patient with non-measurable disease have documented rising PSA levels or appearance of new lesion."|Participants|Number|201|201.0||||||
4341245|NCT00417079|4169207|B1|Measurable disease||Measurable disease|"Measurability of the disease per Response Evaluation Criteria in Solid Tumors (RECIST) criteria:~Patients with measurable disease have at least one visceral or soft tissue metastatic lesion (including new lesion).~Patient with non-measurable disease have documented rising PSA levels or appearance of new lesion."|Participants|Number|204|204.0||||||
4341246|NCT00417079|4169205|B3|||Prostatic Specific Antigen PSA||ng/mL|Median|135.00|135.0|Full Range|||2.0|11220.0|
4341247|NCT00417079|4169206|B2|||Prostatic Specific Antigen PSA||ng/mL|Median|143.9|143.9|Full Range|||2.0|7842.0|
4341248|NCT00417079|4169207|B1|||Prostatic Specific Antigen PSA||ng/mL|Median|127.5|127.5|Full Range|||2.0|11220.0|
4341249|NCT00417079|4169205|B3|2 - Ambulatory, No Work Activities||Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Number|61|61.0||||||
4341250|NCT00417079|4169206|B2|2 - Ambulatory, No Work Activities||Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Number|28|28.0||||||
4341251|NCT00417079|4169207|B1|2 - Ambulatory, No Work Activities||Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Number|33|33.0||||||
4341252|NCT00417079|4169205|B3|1 - Ambulatory, Restricted Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Number|433|433.0||||||
4341253|NCT00417079|4169206|B2|1 - Ambulatory, Restricted Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Number|209|209.0||||||
4341254|NCT00417079|4169207|B1|1 - Ambulatory, Restricted Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Number|224|224.0||||||
4341255|NCT00417079|4169205|B3|0 - Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Number|261|261.0||||||
4341256|NCT00417079|4169206|B2|0 - Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Number|141|141.0||||||
4341257|NCT00417079|4169207|B1|0 - Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Number|120|120.0||||||
4341258|NCT00417079|4169205|B3|Sweden||Region of Enrollment||participants|Number|21|21.0||||||
4341259|NCT00417079|4169206|B2|Sweden||Region of Enrollment||participants|Number|10|10.0||||||
4341260|NCT00417079|4169207|B1|Sweden||Region of Enrollment||participants|Number|11|11.0||||||
4341261|NCT00417079|4169205|B3|Germany||Region of Enrollment||participants|Number|17|17.0||||||
4341262|NCT00417079|4169206|B2|Germany||Region of Enrollment||participants|Number|11|11.0||||||
4341263|NCT00417079|4169207|B1|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4341264|NCT00417079|4169205|B3|Singapore||Region of Enrollment||participants|Number|9|9.0||||||
4341265|NCT00417079|4169206|B2|Singapore||Region of Enrollment||participants|Number|3|3.0||||||
4341266|NCT00417079|4169207|B1|Singapore||Region of Enrollment||participants|Number|6|6.0||||||
4341267|NCT00417079|4169205|B3|Belgium||Region of Enrollment||participants|Number|31|31.0||||||
4341268|NCT00417079|4169206|B2|Belgium||Region of Enrollment||participants|Number|15|15.0||||||
4341269|NCT00417079|4169207|B1|Belgium||Region of Enrollment||participants|Number|16|16.0||||||
4341270|NCT00417079|4169205|B3|Brazil||Region of Enrollment||participants|Number|11|11.0||||||
4341271|NCT00417079|4169206|B2|Brazil||Region of Enrollment||participants|Number|4|4.0||||||
4341272|NCT00417079|4169207|B1|Brazil||Region of Enrollment||participants|Number|7|7.0||||||
4341273|NCT00417079|4169205|B3|Argentina||Region of Enrollment||participants|Number|10|10.0||||||
4341274|NCT00417079|4169206|B2|Argentina||Region of Enrollment||participants|Number|3|3.0||||||
4341275|NCT00417079|4169207|B1|Argentina||Region of Enrollment||participants|Number|7|7.0||||||
4341276|NCT00417079|4169205|B3|Canada||Region of Enrollment||participants|Number|32|32.0||||||
4341277|NCT00417079|4169206|B2|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4341278|NCT00417079|4169207|B1|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4341279|NCT00417079|4169205|B3|Mexico||Region of Enrollment||participants|Number|5|5.0||||||
4341280|NCT00417079|4169206|B2|Mexico||Region of Enrollment||participants|Number|3|3.0||||||
4341282|NCT00417079|4169205|B3|Czech Republic||Region of Enrollment||participants|Number|22|22.0||||||
4341283|NCT00417079|4169206|B2|Czech Republic||Region of Enrollment||participants|Number|12|12.0||||||
4341284|NCT00417079|4169207|B1|Czech Republic||Region of Enrollment||participants|Number|10|10.0||||||
4341285|NCT00417079|4169205|B3|Hungary||Region of Enrollment||participants|Number|15|15.0||||||
4341286|NCT00417079|4169206|B2|Hungary||Region of Enrollment||participants|Number|7|7.0||||||
4341287|NCT00417079|4169207|B1|Hungary||Region of Enrollment||participants|Number|8|8.0||||||
4341288|NCT00417079|4169205|B3|United Kingdom||Region of Enrollment||participants|Number|37|37.0||||||
4341289|NCT00417079|4169206|B2|United Kingdom||Region of Enrollment||participants|Number|20|20.0||||||
4341290|NCT00417079|4169207|B1|United Kingdom||Region of Enrollment||participants|Number|17|17.0||||||
4341291|NCT00417079|4169205|B3|Turkey||Region of Enrollment||participants|Number|36|36.0||||||
4341292|NCT00417079|4169206|B2|Turkey||Region of Enrollment||participants|Number|19|19.0||||||
4341293|NCT00417079|4169207|B1|Turkey||Region of Enrollment||participants|Number|17|17.0||||||
4341294|NCT00417079|4169205|B3|Finland||Region of Enrollment||participants|Number|5|5.0||||||
4341295|NCT00417079|4169206|B2|Finland||Region of Enrollment||participants|Number|1|1.0||||||
4341296|NCT00417079|4169207|B1|Finland||Region of Enrollment||participants|Number|4|4.0||||||
4341297|NCT00417079|4169205|B3|Korea, Republic of||Region of Enrollment||participants|Number|15|15.0||||||
4341298|NCT00417079|4169206|B2|Korea, Republic of||Region of Enrollment||participants|Number|7|7.0||||||
4341299|NCT00417079|4169207|B1|Korea, Republic of||Region of Enrollment||participants|Number|8|8.0||||||
4341300|NCT00417079|4169205|B3|Netherlands||Region of Enrollment||participants|Number|17|17.0||||||
4341301|NCT00417079|4169206|B2|Netherlands||Region of Enrollment||participants|Number|9|9.0||||||
4341302|NCT00417079|4169207|B1|Netherlands||Region of Enrollment||participants|Number|8|8.0||||||
4341303|NCT00417079|4169205|B3|South Africa||Region of Enrollment||participants|Number|16|16.0||||||
4341304|NCT00417079|4169206|B2|South Africa||Region of Enrollment||participants|Number|9|9.0||||||
4341305|NCT00417079|4169207|B1|South Africa||Region of Enrollment||participants|Number|7|7.0||||||
4341306|NCT00417079|4169205|B3|Denmark||Region of Enrollment||participants|Number|45|45.0||||||
4341307|NCT00417079|4169206|B2|Denmark||Region of Enrollment||participants|Number|26|26.0||||||
4341308|NCT00417079|4169207|B1|Denmark||Region of Enrollment||participants|Number|19|19.0||||||
4341309|NCT00417079|4169205|B3|France||Region of Enrollment||participants|Number|90|90.0||||||
4341310|NCT00417079|4169206|B2|France||Region of Enrollment||participants|Number|46|46.0||||||
4341311|NCT00417079|4169207|B1|France||Region of Enrollment||participants|Number|44|44.0||||||
4341312|NCT00417079|4169205|B3|India||Region of Enrollment||participants|Number|20|20.0||||||
4341313|NCT00417079|4169206|B2|India||Region of Enrollment||participants|Number|9|9.0||||||
4341314|NCT00417079|4169207|B1|India||Region of Enrollment||participants|Number|11|11.0||||||
4341315|NCT00417079|4169205|B3|Italy||Region of Enrollment||participants|Number|35|35.0||||||
4341316|NCT00417079|4169206|B2|Italy||Region of Enrollment||participants|Number|18|18.0||||||
4341317|NCT00417079|4169207|B1|Italy||Region of Enrollment||participants|Number|17|17.0||||||
4341318|NCT00417079|4169205|B3|Russian Federation||Region of Enrollment||participants|Number|10|10.0||||||
4341319|NCT00417079|4169206|B2|Russian Federation||Region of Enrollment||participants|Number|4|4.0||||||
4341320|NCT00417079|4169207|B1|Russian Federation||Region of Enrollment||participants|Number|6|6.0||||||
4341321|NCT00417079|4169205|B3|Chile||Region of Enrollment||participants|Number|21|21.0||||||
4341322|NCT00417079|4169206|B2|Chile||Region of Enrollment||participants|Number|12|12.0||||||
4341323|NCT00417079|4169207|B1|Chile||Region of Enrollment||participants|Number|9|9.0||||||
4341324|NCT00417079|4169205|B3|Spain||Region of Enrollment||participants|Number|19|19.0||||||
4341325|NCT00417079|4169206|B2|Spain||Region of Enrollment||participants|Number|9|9.0||||||
4341326|NCT00417079|4169207|B1|Spain||Region of Enrollment||participants|Number|10|10.0||||||
4341327|NCT00417079|4169205|B3|Slovakia||Region of Enrollment||participants|Number|2|2.0||||||
4341328|NCT00417079|4169206|B2|Slovakia||Region of Enrollment||participants|Number|1|1.0||||||
4341329|NCT00417079|4169207|B1|Slovakia||Region of Enrollment||participants|Number|1|1.0||||||
4341330|NCT00417079|4169205|B3|Taiwan||Region of Enrollment||participants|Number|11|11.0||||||
4341331|NCT00417079|4169206|B2|Taiwan||Region of Enrollment||participants|Number|7|7.0||||||
4341332|NCT00417079|4169207|B1|Taiwan||Region of Enrollment||participants|Number|4|4.0||||||
4341333|NCT00417079|4169205|B3|United States||Region of Enrollment||participants|Number|203|203.0||||||
4341334|NCT00417079|4169206|B2|United States||Region of Enrollment||participants|Number|97|97.0||||||
4341335|NCT00417079|4169207|B1|United States||Region of Enrollment||participants|Number|106|106.0||||||
4341336|NCT00417079|4169205|B3|Male||Sex/Gender, Customized||participants|Number|755|755.0||||||
4341337|NCT00417079|4169206|B2|Male||Sex/Gender, Customized||participants|Number|378|378.0||||||
4341338|NCT00417079|4169207|B1|Male||Sex/Gender, Customized||participants|Number|377|377.0||||||
4341339|NCT00417079|4169205|B3|||Age||years|Median|67|67.0|Full Range|||46.0|92.0|
4341340|NCT00417079|4169206|B2|||Age||years|Median|68.0|68.0|Full Range|||46.0|92.0|
4341341|NCT00417079|4169207|B1|||Age||years|Median|67.0|67.0|Full Range|||47.0|89.0|
4341342|NCT00417027|4169228|B4|United States||Region of Enrollment||participants|Number|190|190.0||||||
4341343|NCT00417027|4169229|B3|United States||Region of Enrollment||participants|Number|59|59.0||||||
4341344|NCT00417027|4169230|B2|United States||Region of Enrollment||participants|Number|65|65.0||||||
4341345|NCT00417027|4169231|B1|United States||Region of Enrollment||participants|Number|66|66.0||||||
4341346|NCT00417027|4169228|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4341347|NCT00417027|4169229|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4341348|NCT00417027|4169230|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4341349|NCT00417027|4169231|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4341350|NCT00417027|4169228|B4||Female|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4341351|NCT00417027|4169229|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4341352|NCT00417027|4169230|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4341353|NCT00417027|4169231|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4341354|NCT00417027|4169228|B4|||Age||years|Median|31|31.0|Inter-Quartile Range|||28.0|33.0|
4341355|NCT00417027|4169229|B3|||Age||years|Median|31|31.0|Inter-Quartile Range|||28.0|34.0|
4341356|NCT00417027|4169230|B2|||Age||years|Median|30|30.0|Inter-Quartile Range|||27.0|33.0|
4341357|NCT00417027|4169231|B1|||Age||years|Median|31|31.0|Inter-Quartile Range|||28.0|33.0|
4341358|NCT00417027|4169228|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4341359|NCT00417027|4169229|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4341360|NCT00417027|4169230|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4341361|NCT00417027|4169231|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4341362|NCT00417027|4169228|B4||Between 18 and 65 years|Age||Participants|Count of Participants|190|190.0||||||
4341363|NCT00417027|4169229|B3||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4341364|NCT00417027|4169230|B2||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4341365|NCT00417027|4169231|B1||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4341366|NCT00417027|4169228|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341367|NCT00417027|4169229|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341368|NCT00417027|4169230|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341369|NCT00417027|4169231|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341370|NCT00416949|4169259|B1|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4341371|NCT00416949|4169259|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4341372|NCT00416949|4169259|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4341373|NCT00416949|4169259|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4341374|NCT00416949|4169259|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4341375|NCT00416949|4169259|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341376|NCT00416884|4169263|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4341377|NCT00416884|4169263|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4341378|NCT00416884|4169263|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4341379|NCT00416884|4169263|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4341380|NCT00416884|4169263|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4341381|NCT00416884|4169263|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341382|NCT00416793|4169267|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4341383|NCT00416793|4169267|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4341384|NCT00416793|4169267|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4341385|NCT00416793|4169267|B1|||Age||years|Median|49|49.0|Full Range|||49.0|81.0|
4341386|NCT00416715|4169271|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4341387|NCT00416715|4169271|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4341388|NCT00416715|4169271|B1||White|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
4341389|NCT00416715|4169271|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4341390|NCT00416715|4169271|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341391|NCT00416715|4169271|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4341392|NCT00416715|4169271|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341393|NCT00416715|4169271|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341394|NCT00416715|4169271|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
4341395|NCT00416715|4169271|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4341396|NCT00416715|4169271|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4341397|NCT00416715|4169271|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4341398|NCT00416715|4169271|B1|||Age||years|Median|56|56.0|Full Range|||42.0|81.0|
4341399|NCT00416624|4169278|B5|||Weight||kg|Median|71.3|71.3|Full Range|||42.5|141.0|
4341400|NCT00416624|4169279|B4|||Weight||kg|Median|71.0|71.0|Full Range|||42.5|141.0|
4341401|NCT00416624|4169280|B3|||Weight||kg|Median|70.6|70.6|Full Range|||44.1|120.0|
4341402|NCT00416624|4169281|B2|||Weight||kg|Median|72.6|72.6|Full Range|||51.3|133.0|
4341403|NCT00416624|4169282|B1|||Weight||kg|Median|69.1|69.1|Full Range|||44.5|125.4|
4341404|NCT00416624|4169278|B5|||Baseline Hemoglobin||g/dL|Median|9.9|9.9|Full Range|||7.4|10.6|
4341405|NCT00416624|4169279|B4|||Baseline Hemoglobin||g/dL|Median|9.9|9.9|Full Range|||7.4|10.5|
4341406|NCT00416624|4169280|B3|||Baseline Hemoglobin||g/dL|Median|9.9|9.9|Full Range|||7.7|10.5|
4341407|NCT00416624|4169281|B2|||Baseline Hemoglobin||g/dL|Median|9.9|9.9|Full Range|||8.4|10.5|
4341408|NCT00416624|4169282|B1|||Baseline Hemoglobin||g/dL|Median|10.1|10.1|Full Range|||7.8|10.6|
4341409|NCT00416624|4169278|B5|||Height||cm|Median|167.0|167.0|Full Range|||149.7|201.0|
4341410|NCT00416624|4169279|B4|||Height||cm|Median|166.5|166.5|Full Range|||152.4|187.0|
4341411|NCT00416624|4169280|B3|||Height||cm|Median|165.2|165.2|Full Range|||150.0|190.0|
4341412|NCT00416624|4169281|B2|||Height||cm|Median|168.0|168.0|Full Range|||154.0|201.0|
4341413|NCT00416624|4169282|B1|||Height||cm|Median|167.6|167.6|Full Range|||149.7|193.0|
4341414|NCT00416624|4169278|B5|Solid Tumor||Primary Tumor Type||participants|Number|216|216.0||||||
4341415|NCT00416624|4169279|B4|Solid Tumor||Primary Tumor Type||participants|Number|53|53.0||||||
4341416|NCT00416624|4169280|B3|Solid Tumor||Primary Tumor Type||participants|Number|53|53.0||||||
4341417|NCT00416624|4169281|B2|Solid Tumor||Primary Tumor Type||participants|Number|54|54.0||||||
4341418|NCT00416624|4169282|B1|Solid Tumor||Primary Tumor Type||participants|Number|56|56.0||||||
4341419|NCT00416624|4169278|B5|Hematologic||Primary Tumor Type||participants|Number|20|20.0||||||
4341420|NCT00416624|4169279|B4|Hematologic||Primary Tumor Type||participants|Number|4|4.0||||||
4341421|NCT00416624|4169280|B3|Hematologic||Primary Tumor Type||participants|Number|5|5.0||||||
4341422|NCT00416624|4169281|B2|Hematologic||Primary Tumor Type||participants|Number|6|6.0||||||
4341423|NCT00416624|4169282|B1|Hematologic||Primary Tumor Type||participants|Number|5|5.0||||||
4341424|NCT00416624|4169278|B5|No||Platinum Containing Regimen||participants|Number|130|130.0||||||
4341425|NCT00416624|4169279|B4|No||Platinum Containing Regimen||participants|Number|32|32.0||||||
4341426|NCT00416624|4169280|B3|No||Platinum Containing Regimen||participants|Number|31|31.0||||||
4341427|NCT00416624|4169281|B2|No||Platinum Containing Regimen||participants|Number|33|33.0||||||
4341428|NCT00416624|4169282|B1|No||Platinum Containing Regimen||participants|Number|34|34.0||||||
4341429|NCT00416624|4169278|B5|Yes||Platinum Containing Regimen||participants|Number|106|106.0||||||
4341430|NCT00416624|4169279|B4|Yes||Platinum Containing Regimen||participants|Number|25|25.0||||||
4341431|NCT00416624|4169280|B3|Yes||Platinum Containing Regimen||participants|Number|27|27.0||||||
4341432|NCT00416624|4169281|B2|Yes||Platinum Containing Regimen||participants|Number|27|27.0||||||
4341433|NCT00416624|4169282|B1|Yes||Platinum Containing Regimen||participants|Number|27|27.0||||||
4341434|NCT00416624|4169278|B5|Severe: Hemoglobin < 9.5||Anemia||participants|Number|63|63.0||||||
4341435|NCT00416624|4169279|B4|Severe: Hemoglobin < 9.5||Anemia||participants|Number|15|15.0||||||
4341436|NCT00416624|4169280|B3|Severe: Hemoglobin < 9.5||Anemia||participants|Number|15|15.0||||||
4341437|NCT00416624|4169281|B2|Severe: Hemoglobin < 9.5||Anemia||participants|Number|17|17.0||||||
4341438|NCT00416624|4169282|B1|Severe: Hemoglobin < 9.5||Anemia||participants|Number|16|16.0||||||
4341439|NCT00416624|4169278|B5|Mild: Hemoglobin of 9.5-11||Anemia||participants|Number|173|173.0||||||
4341440|NCT00416624|4169279|B4|Mild: Hemoglobin of 9.5-11||Anemia||participants|Number|42|42.0||||||
4341441|NCT00416624|4169280|B3|Mild: Hemoglobin of 9.5-11||Anemia||participants|Number|43|43.0||||||
4341442|NCT00416624|4169281|B2|Mild: Hemoglobin of 9.5-11||Anemia||participants|Number|43|43.0||||||
4341443|NCT00416624|4169282|B1|Mild: Hemoglobin of 9.5-11||Anemia||participants|Number|45|45.0||||||
4341444|NCT00416624|4169278|B5|United States||Region of Enrollment||participants|Number|236|236.0||||||
4341445|NCT00416624|4169279|B4|United States||Region of Enrollment||participants|Number|57|57.0||||||
4341446|NCT00416624|4169280|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
4341447|NCT00416624|4169281|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
4341448|NCT00416624|4169282|B1|United States||Region of Enrollment||participants|Number|61|61.0||||||
4341449|NCT00416624|4169278|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341450|NCT00416624|4169279|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341451|NCT00416624|4169280|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341452|NCT00416624|4169281|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341453|NCT00416624|4169282|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341454|NCT00416624|4169278|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341455|NCT00416624|4169279|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341456|NCT00416624|4169280|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341457|NCT00416624|4169281|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341458|NCT00416624|4169282|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341459|NCT00416624|4169278|B5||White|Race (NIH/OMB)||Participants|Count of Participants|219|219.0||||||
4341460|NCT00416624|4169279|B4||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4341461|NCT00416624|4169280|B3||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4341462|NCT00416624|4169281|B2||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4341463|NCT00416624|4169282|B1||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4341464|NCT00416624|4169278|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4341465|NCT00416624|4169279|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4341466|NCT00416624|4169280|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4341467|NCT00416624|4169281|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4341468|NCT00416624|4169282|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4341469|NCT00416624|4169278|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341470|NCT00416624|4169279|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341471|NCT00416624|4169280|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341472|NCT00416624|4169281|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341473|NCT00416624|4169282|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341474|NCT00416624|4169278|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4341475|NCT00416624|4169279|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341476|NCT00416624|4169280|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4341477|NCT00416624|4169281|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4341478|NCT00416624|4169282|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341479|NCT00416624|4169278|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4341480|NCT00416624|4169279|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341481|NCT00416624|4169280|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4341482|NCT00416624|4169281|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341483|NCT00416624|4169282|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341484|NCT00416624|4169278|B5||Male|Gender||Participants|Count of Participants|100|100.0||||||
4341485|NCT00416624|4169279|B4||Male|Gender||Participants|Count of Participants|15|15.0||||||
4341486|NCT00416624|4169280|B3||Male|Gender||Participants|Count of Participants|25|25.0||||||
4341487|NCT00416624|4169281|B2||Male|Gender||Participants|Count of Participants|36|36.0||||||
4341488|NCT00416624|4169282|B1||Male|Gender||Participants|Count of Participants|24|24.0||||||
4341489|NCT00416624|4169278|B5||Female|Gender||Participants|Count of Participants|136|136.0||||||
4341490|NCT00416624|4169279|B4||Female|Gender||Participants|Count of Participants|42|42.0||||||
4341491|NCT00416624|4169280|B3||Female|Gender||Participants|Count of Participants|33|33.0||||||
4341492|NCT00416624|4169281|B2||Female|Gender||Participants|Count of Participants|24|24.0||||||
4341493|NCT00416624|4169282|B1||Female|Gender||Participants|Count of Participants|37|37.0||||||
4341494|NCT00416624|4169278|B5|||Age||years|Median|66.0|66.0|Full Range|||19.0|94.0|
4341495|NCT00416624|4169279|B4|||Age||years|Median|67.0|67.0|Full Range|||40.0|89.0|
4341496|NCT00416624|4169280|B3|||Age||years|Median|65.0|65.0|Full Range|||19.0|81.0|
4341497|NCT00416624|4169281|B2|||Age||years|Median|68.0|68.0|Full Range|||37.0|91.0|
4341498|NCT00416624|4169282|B1|||Age||years|Median|65.0|65.0|Full Range|||44.0|94.0|
4341499|NCT00416598|4169339|B1|United States||Region of Enrollment||participants|Number|134|134.0||||||
4341500|NCT00416598|4169339|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4341501|NCT00416598|4169339|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
4341502|NCT00416598|4169339|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4341503|NCT00416598|4169339|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4341504|NCT00416598|4169339|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4341505|NCT00416598|4169339|B1|||Age||years|Median|45|45.0|Full Range|||18.0|60.0|
4341506|NCT00416572|4169344|B4|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4341507|NCT00416572|4169345|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4341508|NCT00416572|4169346|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4341509|NCT00416572|4169347|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4341510|NCT00416572|4169344|B4|African-American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4341511|NCT00416572|4169345|B3|African-American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4341512|NCT00416572|4169346|B2|African-American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4341513|NCT00416572|4169347|B1|African-American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4341514|NCT00416572|4169344|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|241|241.0||||||
4341515|NCT00416572|4169345|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
4341516|NCT00416572|4169346|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|80|80.0||||||
4341517|NCT00416572|4169347|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
4341518|NCT00416572|4169344|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4341519|NCT00416572|4169345|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4341520|NCT00416572|4169346|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4341521|NCT00416572|4169347|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4341522|NCT00416572|4169344|B4||Female|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
4341523|NCT00416572|4169345|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4341524|NCT00416572|4169346|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4341525|NCT00416572|4169347|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4341526|NCT00416572|4169344|B4|||Age||years|Mean|44.2|44.2|Full Range|||18.0|50.0|
4341527|NCT00416572|4169345|B3|||Age||years|Mean|44.6|44.6|Full Range|||18.0|50.0|
4341528|NCT00416572|4169346|B2|||Age||years|Mean|44.2|44.2|Full Range|||18.0|50.0|
4341529|NCT00416572|4169347|B1|||Age||years|Mean|43.7|43.7|Full Range|||18.0|50.0|
4341530|NCT00416520|4169363|B3||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4341531|NCT00416520|4169364|B2||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4341532|NCT00416520|4169365|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4341533|NCT00416520|4169363|B3||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4341534|NCT00416520|4169364|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4341535|NCT00416520|4169365|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4341536|NCT00416520|4169363|B3|||Age||years|Mean|58.0|58.0|Standard Deviation|14.3|14.3|||
4341537|NCT00416520|4169364|B2|||Age||years|Mean|59.5|59.5|Standard Deviation|13.8|13.8|||
4341538|NCT00416520|4169365|B1|||Age||years|Mean|56.4|56.4|Standard Deviation|14.7|14.7|||
4341539|NCT00416494|4169378|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4341540|NCT00416494|4169379|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
4341541|NCT00416494|4169380|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4341542|NCT00416494|4169378|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4341543|NCT00416494|4169379|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4341544|NCT00416494|4169380|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4341545|NCT00416494|4169378|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4341546|NCT00416494|4169379|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4341547|NCT00416494|4169380|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4341548|NCT00416494|4169378|B3|||Age||years|Mean|55|55.0|Standard Deviation|12.8|12.8|||
4341549|NCT00416494|4169379|B2|||Age||years|Mean|55.3|55.3|Standard Deviation|12.6|12.6|||
4341550|NCT00416494|4169380|B1|||Age||years|Mean|54.6|54.6|Standard Deviation|13.3|13.3|||
4341551|NCT00416494|4169378|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4341552|NCT00416494|4169379|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4341553|NCT00416494|4169380|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4341554|NCT00416494|4169378|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4341555|NCT00416494|4169379|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4341556|NCT00416494|4169380|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4341557|NCT00416494|4169378|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341558|NCT00416494|4169379|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341559|NCT00416494|4169380|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341560|NCT00416455|4169395|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4341561|NCT00416455|4169396|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4341562|NCT00416455|4169397|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4341563|NCT00416455|4169395|B3||Female|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
4341564|NCT00416455|4169396|B2||Female|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4341565|NCT00416455|4169397|B1||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4341566|NCT00416455|4169395|B3|||Age||years|Mean|58|58.0|Standard Deviation|13.2|13.2|||
4341567|NCT00416455|4169396|B2|||Age||years|Mean|64.8|64.8|Standard Deviation|9.9|9.9|||
4341568|NCT00416455|4169397|B1|||Age||years|Mean|49|49.0|Standard Deviation|11.6|11.6|||
4341569|NCT00416312|4169433|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4341570|NCT00416312|4169433|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4341571|NCT00416312|4169433|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4341572|NCT00416312|4169433|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4341573|NCT00416312|4169433|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341574|NCT00416195|4169437|B3|Caucasian||Race/Ethnicity, Customized|Race|participants|Number|48|48.0||||||
4341575|NCT00416195|4169438|B2|Caucasian||Race/Ethnicity, Customized|Race|participants|Number|38|38.0||||||
4341576|NCT00416195|4169439|B1|Caucasian||Race/Ethnicity, Customized|Race|participants|Number|10|10.0||||||
4341577|NCT00416195|4169437|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4341578|NCT00416195|4169438|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4341579|NCT00416195|4169439|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4341580|NCT00416195|4169437|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4341581|NCT00416195|4169438|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4341582|NCT00416195|4169439|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4341583|NCT00416195|4169437|B3|||Age||years|Mean|43.1|43.1|Standard Deviation|12.02|12.02|||
4341584|NCT00416195|4169438|B2|||Age||years|Mean|40.7|40.7|Standard Deviation|11.99|11.99|||
4341585|NCT00416195|4169439|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|12.05|12.05|||
4341586|NCT00416182|4169448|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4341587|NCT00416182|4169449|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4341588|NCT00416182|4169450|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4341589|NCT00416182|4169448|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4341590|NCT00416182|4169449|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4341591|NCT00416182|4169450|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4341592|NCT00416182|4169448|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4341593|NCT00416182|4169449|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4341594|NCT00416182|4169450|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4341595|NCT00416182|4169448|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4341596|NCT00416182|4169449|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4341597|NCT00416182|4169450|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4341598|NCT00416182|4169448|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4341599|NCT00416182|4169449|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4341600|NCT00416182|4169450|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4341601|NCT00416182|4169448|B3||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4341602|NCT00416182|4169449|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4341603|NCT00416182|4169450|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4341604|NCT00416078|4169463|B3|United States||Region of Enrollment||participants|Number|53|53.0||||||
4341605|NCT00416078|4169464|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4341606|NCT00416078|4169465|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4341607|NCT00416078|4169463|B3|Unknown||Race/Ethnicity, Customized||patient participants|Number|2|2.0||||||
4341608|NCT00416078|4169464|B2|Unknown||Race/Ethnicity, Customized||patient participants|Number|0|0.0||||||
4341609|NCT00416078|4169465|B1|Unknown||Race/Ethnicity, Customized||patient participants|Number|2|2.0||||||
4341610|NCT00416078|4169463|B3|Hispanic||Race/Ethnicity, Customized||patient participants|Number|2|2.0||||||
4341611|NCT00416078|4169464|B2|Hispanic||Race/Ethnicity, Customized||patient participants|Number|1|1.0||||||
4341612|NCT00416078|4169465|B1|Hispanic||Race/Ethnicity, Customized||patient participants|Number|1|1.0||||||
4341613|NCT00416078|4169463|B3|African-American||Race/Ethnicity, Customized||patient participants|Number|10|10.0||||||
4341614|NCT00416078|4169464|B2|African-American||Race/Ethnicity, Customized||patient participants|Number|4|4.0||||||
4341615|NCT00416078|4169465|B1|African-American||Race/Ethnicity, Customized||patient participants|Number|6|6.0||||||
4341616|NCT00416078|4169463|B3|Caucasian||Race/Ethnicity, Customized||patient participants|Number|39|39.0||||||
4341617|NCT00416078|4169464|B2|Caucasian||Race/Ethnicity, Customized||patient participants|Number|19|19.0||||||
4341618|NCT00416078|4169465|B1|Caucasian||Race/Ethnicity, Customized||patient participants|Number|20|20.0||||||
4341619|NCT00416078|4169463|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4341620|NCT00416078|4169464|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4341621|NCT00416078|4169465|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4341622|NCT00416078|4169463|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4341623|NCT00416078|4169464|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4341624|NCT00416078|4169465|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4341625|NCT00416078|4169463|B3|||Age|Patient data presented here|years|Mean|79.92|79.92|Standard Deviation|8.21|8.21|||
4341626|NCT00416078|4169464|B2|||Age|Patient data presented here|years|Mean|81.4|81.4|Standard Deviation|6.6|6.6|||
4341627|NCT00416078|4169465|B1|||Age|Patient data presented here|years|Mean|78.69|78.69|Standard Deviation|9.09|9.09|||
4341628|NCT00415909|4169482|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4341629|NCT00415909|4169482|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4341630|NCT00415909|4169482|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4341631|NCT00415909|4169482|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4341632|NCT00415909|4169482|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4341633|NCT00415909|4169482|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341634|NCT00415909|4169482|B1|||Age||years|Median|65|65.0|Full Range|||54.0|71.0|
4341635|NCT00415870|4169486|B3|United States||Region of Enrollment||participants|Number|65|65.0||||||
4341636|NCT00415870|4169487|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4341637|NCT00415870|4169488|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4341638|NCT00415870|4169486|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4341639|NCT00415870|4169487|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4341640|NCT00415870|4169488|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4341641|NCT00415870|4169486|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4341642|NCT00415870|4169487|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4341643|NCT00415870|4169488|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4341644|NCT00415870|4169486|B3|||Age||years|Mean|44.9|44.9|Standard Deviation|7.7|7.7|||
4341645|NCT00415870|4169487|B2|||Age||years|Mean|47.4|47.4|Standard Deviation|7.1|7.1|||
4341646|NCT00415870|4169488|B1|||Age||years|Mean|42.4|42.4|Standard Deviation|7.5|7.5|||
4341647|NCT00415870|4169486|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4341648|NCT00415870|4169487|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4341649|NCT00415870|4169488|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4341650|NCT00415870|4169486|B3||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4341651|NCT00415870|4169487|B2||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4341652|NCT00415870|4169488|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4341653|NCT00415870|4169486|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341654|NCT00415870|4169487|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341655|NCT00415870|4169488|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341656|NCT00415857|4169495|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4341657|NCT00415857|4169496|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4341658|NCT00415857|4169497|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4341659|NCT00415857|4169495|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4341660|NCT00415857|4169496|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4341661|NCT00415857|4169497|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4341662|NCT00415857|4169495|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4341663|NCT00415857|4169496|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4341664|NCT00415857|4169497|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4341665|NCT00415857|4169495|B3|||Age||Years|Median|46|46.0|Full Range|||29.0|55.0|
4341666|NCT00415857|4169496|B2|||Age||Years|Median|46|46.0|Full Range|||29.0|50.0|
4341667|NCT00415857|4169497|B1|||Age||Years|Median|45|45.0|Full Range|||35.0|55.0|
4341668|NCT00415636|4169506|B7||ECOG Rating 1|Eastern Cooperative Oncology Group (ECOG) Rating at Screening|Classifies participants according to their functional impairment. Scores range from 0 to 5: 0=Fully Active; 1=Ambulatory, Restricted Strenuous Activity; 2=Ambulatory, No Work Activities; 3=Partially Confined to Bed, Limited Self Care; 4=Completely Disabled; 5=Death.|Participants|Count of Participants|23|23.0||||||
4341669|NCT00415636|4169507|B6||ECOG Rating 1|Eastern Cooperative Oncology Group (ECOG) Rating at Screening|Classifies participants according to their functional impairment. Scores range from 0 to 5: 0=Fully Active; 1=Ambulatory, Restricted Strenuous Activity; 2=Ambulatory, No Work Activities; 3=Partially Confined to Bed, Limited Self Care; 4=Completely Disabled; 5=Death.|Participants|Count of Participants|3|3.0||||||
4341670|NCT00415636|4169508|B5||ECOG Rating 1|Eastern Cooperative Oncology Group (ECOG) Rating at Screening|Classifies participants according to their functional impairment. Scores range from 0 to 5: 0=Fully Active; 1=Ambulatory, Restricted Strenuous Activity; 2=Ambulatory, No Work Activities; 3=Partially Confined to Bed, Limited Self Care; 4=Completely Disabled; 5=Death.|Participants|Count of Participants|5|5.0||||||
4341671|NCT00415636|4169509|B4||ECOG Rating 1|Eastern Cooperative Oncology Group (ECOG) Rating at Screening|Classifies participants according to their functional impairment. Scores range from 0 to 5: 0=Fully Active; 1=Ambulatory, Restricted Strenuous Activity; 2=Ambulatory, No Work Activities; 3=Partially Confined to Bed, Limited Self Care; 4=Completely Disabled; 5=Death.|Participants|Count of Participants|9|9.0||||||
4341672|NCT00415636|4169510|B3||ECOG Rating 1|Eastern Cooperative Oncology Group (ECOG) Rating at Screening|Classifies participants according to their functional impairment. Scores range from 0 to 5: 0=Fully Active; 1=Ambulatory, Restricted Strenuous Activity; 2=Ambulatory, No Work Activities; 3=Partially Confined to Bed, Limited Self Care; 4=Completely Disabled; 5=Death.|Participants|Count of Participants|3|3.0||||||
4341673|NCT00415636|4169511|B2||ECOG Rating 1|Eastern Cooperative Oncology Group (ECOG) Rating at Screening|Classifies participants according to their functional impairment. Scores range from 0 to 5: 0=Fully Active; 1=Ambulatory, Restricted Strenuous Activity; 2=Ambulatory, No Work Activities; 3=Partially Confined to Bed, Limited Self Care; 4=Completely Disabled; 5=Death.|Participants|Count of Participants|2|2.0||||||
4341674|NCT00415636|4169512|B1||ECOG Rating 1|Eastern Cooperative Oncology Group (ECOG) Rating at Screening|Classifies participants according to their functional impairment. Scores range from 0 to 5: 0=Fully Active; 1=Ambulatory, Restricted Strenuous Activity; 2=Ambulatory, No Work Activities; 3=Partially Confined to Bed, Limited Self Care; 4=Completely Disabled; 5=Death.|Participants|Count of Participants|1|1.0||||||
4341675|NCT00415636|4169506|B7||ECOG Rating 0|Eastern Cooperative Oncology Group (ECOG) Rating at Screening|Classifies participants according to their functional impairment. Scores range from 0 to 5: 0=Fully Active; 1=Ambulatory, Restricted Strenuous Activity; 2=Ambulatory, No Work Activities; 3=Partially Confined to Bed, Limited Self Care; 4=Completely Disabled; 5=Death.|Participants|Count of Participants|8|8.0||||||
4341676|NCT00415636|4169507|B6||ECOG Rating 0|Eastern Cooperative Oncology Group (ECOG) Rating at Screening|Classifies participants according to their functional impairment. Scores range from 0 to 5: 0=Fully Active; 1=Ambulatory, Restricted Strenuous Activity; 2=Ambulatory, No Work Activities; 3=Partially Confined to Bed, Limited Self Care; 4=Completely Disabled; 5=Death.|Participants|Count of Participants|0|0.0||||||
4341677|NCT00415636|4169508|B5||ECOG Rating 0|Eastern Cooperative Oncology Group (ECOG) Rating at Screening|Classifies participants according to their functional impairment. Scores range from 0 to 5: 0=Fully Active; 1=Ambulatory, Restricted Strenuous Activity; 2=Ambulatory, No Work Activities; 3=Partially Confined to Bed, Limited Self Care; 4=Completely Disabled; 5=Death.|Participants|Count of Participants|1|1.0||||||
4341678|NCT00415636|4169509|B4||ECOG Rating 0|Eastern Cooperative Oncology Group (ECOG) Rating at Screening|Classifies participants according to their functional impairment. Scores range from 0 to 5: 0=Fully Active; 1=Ambulatory, Restricted Strenuous Activity; 2=Ambulatory, No Work Activities; 3=Partially Confined to Bed, Limited Self Care; 4=Completely Disabled; 5=Death.|Participants|Count of Participants|4|4.0||||||
4341679|NCT00415636|4169510|B3||ECOG Rating 0|Eastern Cooperative Oncology Group (ECOG) Rating at Screening|Classifies participants according to their functional impairment. Scores range from 0 to 5: 0=Fully Active; 1=Ambulatory, Restricted Strenuous Activity; 2=Ambulatory, No Work Activities; 3=Partially Confined to Bed, Limited Self Care; 4=Completely Disabled; 5=Death.|Participants|Count of Participants|0|0.0||||||
4341680|NCT00415636|4169511|B2||ECOG Rating 0|Eastern Cooperative Oncology Group (ECOG) Rating at Screening|Classifies participants according to their functional impairment. Scores range from 0 to 5: 0=Fully Active; 1=Ambulatory, Restricted Strenuous Activity; 2=Ambulatory, No Work Activities; 3=Partially Confined to Bed, Limited Self Care; 4=Completely Disabled; 5=Death.|Participants|Count of Participants|1|1.0||||||
4341681|NCT00415636|4169512|B1||ECOG Rating 0|Eastern Cooperative Oncology Group (ECOG) Rating at Screening|Classifies participants according to their functional impairment. Scores range from 0 to 5: 0=Fully Active; 1=Ambulatory, Restricted Strenuous Activity; 2=Ambulatory, No Work Activities; 3=Partially Confined to Bed, Limited Self Care; 4=Completely Disabled; 5=Death.|Participants|Count of Participants|2|2.0||||||
4341682|NCT00415636|4169506|B7||Other|Primary Cancer Type||Participants|Count of Participants|18|18.0||||||
4341683|NCT00415636|4169507|B6||Other|Primary Cancer Type||Participants|Count of Participants|2|2.0||||||
4341684|NCT00415636|4169508|B5||Other|Primary Cancer Type||Participants|Count of Participants|3|3.0||||||
4341685|NCT00415636|4169509|B4||Other|Primary Cancer Type||Participants|Count of Participants|9|9.0||||||
4341686|NCT00415636|4169510|B3||Other|Primary Cancer Type||Participants|Count of Participants|2|2.0||||||
4341687|NCT00415636|4169511|B2||Other|Primary Cancer Type||Participants|Count of Participants|2|2.0||||||
4341688|NCT00415636|4169512|B1||Other|Primary Cancer Type||Participants|Count of Participants|0|0.0||||||
4341689|NCT00415636|4169506|B7||Pancreatic|Primary Cancer Type||Participants|Count of Participants|6|6.0||||||
4341690|NCT00415636|4169507|B6||Pancreatic|Primary Cancer Type||Participants|Count of Participants|1|1.0||||||
4341691|NCT00415636|4169508|B5||Pancreatic|Primary Cancer Type||Participants|Count of Participants|2|2.0||||||
4341692|NCT00415636|4169509|B4||Pancreatic|Primary Cancer Type||Participants|Count of Participants|3|3.0||||||
4341693|NCT00415636|4169510|B3||Pancreatic|Primary Cancer Type||Participants|Count of Participants|0|0.0||||||
4341694|NCT00415636|4169511|B2||Pancreatic|Primary Cancer Type||Participants|Count of Participants|0|0.0||||||
4341695|NCT00415636|4169512|B1||Pancreatic|Primary Cancer Type||Participants|Count of Participants|0|0.0||||||
4341696|NCT00415636|4169506|B7||Non-small Cell Lung|Primary Cancer Type||Participants|Count of Participants|1|1.0||||||
4341697|NCT00415636|4169507|B6||Non-small Cell Lung|Primary Cancer Type||Participants|Count of Participants|0|0.0||||||
4341698|NCT00415636|4169508|B5||Non-small Cell Lung|Primary Cancer Type||Participants|Count of Participants|0|0.0||||||
4341699|NCT00415636|4169509|B4||Non-small Cell Lung|Primary Cancer Type||Participants|Count of Participants|1|1.0||||||
4341700|NCT00415636|4169510|B3||Non-small Cell Lung|Primary Cancer Type||Participants|Count of Participants|0|0.0||||||
4341701|NCT00415636|4169511|B2||Non-small Cell Lung|Primary Cancer Type||Participants|Count of Participants|0|0.0||||||
4341702|NCT00415636|4169512|B1||Non-small Cell Lung|Primary Cancer Type||Participants|Count of Participants|0|0.0||||||
4341703|NCT00415636|4169506|B7||Breast|Primary Cancer Type||Participants|Count of Participants|6|6.0||||||
4341704|NCT00415636|4169507|B6||Breast|Primary Cancer Type||Participants|Count of Participants|0|0.0||||||
4341705|NCT00415636|4169508|B5||Breast|Primary Cancer Type||Participants|Count of Participants|1|1.0||||||
4341706|NCT00415636|4169509|B4||Breast|Primary Cancer Type||Participants|Count of Participants|0|0.0||||||
4341707|NCT00415636|4169510|B3||Breast|Primary Cancer Type||Participants|Count of Participants|1|1.0||||||
4341708|NCT00415636|4169511|B2||Breast|Primary Cancer Type||Participants|Count of Participants|1|1.0||||||
4341709|NCT00415636|4169512|B1||Breast|Primary Cancer Type||Participants|Count of Participants|3|3.0||||||
4341710|NCT00415636|4169506|B7|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
4341711|NCT00415636|4169507|B6|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4341712|NCT00415636|4169508|B5|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4341713|NCT00415636|4169509|B4|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4341714|NCT00415636|4169510|B3|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4341715|NCT00415636|4169511|B2|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4341716|NCT00415636|4169512|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4341717|NCT00415636|4169506|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341718|NCT00415636|4169507|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341719|NCT00415636|4169508|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341720|NCT00415636|4169509|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341721|NCT00415636|4169510|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341722|NCT00415636|4169511|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341723|NCT00415636|4169512|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341724|NCT00415636|4169506|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341725|NCT00415636|4169507|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341726|NCT00415636|4169508|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341727|NCT00415636|4169509|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341728|NCT00415636|4169510|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341729|NCT00415636|4169511|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341730|NCT00415636|4169512|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341731|NCT00415636|4169506|B7||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4341732|NCT00415636|4169507|B6||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4341733|NCT00415636|4169508|B5||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4341734|NCT00415636|4169509|B4||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4341735|NCT00415636|4169510|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4341736|NCT00415636|4169511|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4341737|NCT00415636|4169512|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4341738|NCT00415636|4169506|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4341739|NCT00415636|4169507|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341740|NCT00415636|4169508|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341741|NCT00415636|4169509|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341742|NCT00415636|4169510|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4341743|NCT00415636|4169511|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341744|NCT00415636|4169512|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341745|NCT00415636|4169506|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341746|NCT00415636|4169507|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341747|NCT00415636|4169508|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341748|NCT00415636|4169509|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341749|NCT00415636|4169510|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341750|NCT00415636|4169511|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341751|NCT00415636|4169512|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341752|NCT00415636|4169506|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4341753|NCT00415636|4169507|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341754|NCT00415636|4169508|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341755|NCT00415636|4169509|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341756|NCT00415636|4169510|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341757|NCT00415636|4169511|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341758|NCT00415636|4169512|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4341759|NCT00415636|4169506|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4341760|NCT00415636|4169507|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4341761|NCT00415636|4169508|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341762|NCT00415636|4169509|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341763|NCT00415636|4169510|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341764|NCT00415636|4169511|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341765|NCT00415636|4169512|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341766|NCT00415636|4169506|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341767|NCT00415636|4169507|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341768|NCT00415636|4169508|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341769|NCT00415636|4169509|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341770|NCT00415636|4169510|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341771|NCT00415636|4169511|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341772|NCT00415636|4169512|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341773|NCT00415636|4169506|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4341774|NCT00415636|4169507|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4341775|NCT00415636|4169508|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4341776|NCT00415636|4169509|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4341777|NCT00415636|4169510|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4341778|NCT00415636|4169511|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4341779|NCT00415636|4169512|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4341780|NCT00415636|4169506|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4341781|NCT00415636|4169507|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341782|NCT00415636|4169508|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341783|NCT00415636|4169509|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4341784|NCT00415636|4169510|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341785|NCT00415636|4169511|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341786|NCT00415636|4169512|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4341787|NCT00415636|4169506|B7||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4341788|NCT00415636|4169507|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4341789|NCT00415636|4169508|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4341790|NCT00415636|4169509|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4341791|NCT00415636|4169510|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4341792|NCT00415636|4169511|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4341793|NCT00415636|4169512|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4341794|NCT00415636|4169506|B7||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4341795|NCT00415636|4169507|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4341796|NCT00415636|4169508|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4341797|NCT00415636|4169509|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4341798|NCT00415636|4169510|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4341799|NCT00415636|4169511|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4341800|NCT00415636|4169512|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4341801|NCT00415636|4169506|B7|||Age||years|Mean|58.1|58.1|Standard Deviation|11.73|11.73|||
4341802|NCT00415636|4169507|B6|||Age||years|Mean|55.7|55.7|Standard Deviation|18.77|18.77|||
4341803|NCT00415636|4169508|B5|||Age||years|Mean|63.5|63.5|Standard Deviation|11.04|11.04|||
4341804|NCT00415636|4169509|B4|||Age||years|Mean|60.6|60.6|Standard Deviation|9.95|9.95|||
4341805|NCT00415636|4169510|B3|||Age||years|Mean|48.3|48.3|Standard Deviation|16.07|16.07|||
4341806|NCT00415636|4169511|B2|||Age||years|Mean|58.0|58.0|Standard Deviation|10.54|10.54|||
4341807|NCT00415636|4169512|B1|||Age||years|Mean|49.0|49.0|Standard Deviation|6.24|6.24|||
4341808|NCT00415623|4169549|B3|Japan||Region of Enrollment||participants|Number|305|305.0||||||
4341809|NCT00415623|4169550|B2|Japan||Region of Enrollment||participants|Number|151|151.0||||||
4341810|NCT00415623|4169551|B1|Japan||Region of Enrollment||participants|Number|154|154.0||||||
4341811|NCT00415623|4169549|B3||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4341812|NCT00415623|4169550|B2||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4341813|NCT00415623|4169551|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4341814|NCT00415623|4169549|B3||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4341815|NCT00415623|4169550|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4341816|NCT00415623|4169551|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4341817|NCT00415623|4169549|B3|>= 65 years||Age, Customized||partcipants|Number|130|130.0||||||
4341818|NCT00415623|4169550|B2|>= 65 years||Age, Customized||partcipants|Number|66|66.0||||||
4341819|NCT00415623|4169551|B1|>= 65 years||Age, Customized||partcipants|Number|64|64.0||||||
4341820|NCT00415623|4169549|B3|45 to 64 years||Age, Customized||partcipants|Number|145|145.0||||||
4341821|NCT00415623|4169550|B2|45 to 64 years||Age, Customized||partcipants|Number|70|70.0||||||
4341822|NCT00415623|4169551|B1|45 to 64 years||Age, Customized||partcipants|Number|75|75.0||||||
4341823|NCT00415623|4169549|B3|20 to 44 years||Age, Customized||partcipants|Number|30|30.0||||||
4341824|NCT00415623|4169550|B2|20 to 44 years||Age, Customized||partcipants|Number|15|15.0||||||
4341825|NCT00415623|4169551|B1|20 to 44 years||Age, Customized||partcipants|Number|15|15.0||||||
4341826|NCT00415623|4169549|B3|< 20 years||Age, Customized||partcipants|Number|0|0.0||||||
4341827|NCT00415623|4169550|B2|< 20 years||Age, Customized||partcipants|Number|0|0.0||||||
4341828|NCT00415623|4169551|B1|< 20 years||Age, Customized||partcipants|Number|0|0.0||||||
4341829|NCT00415610|4169576|B4|||Maximum Dose of Nicardipine Used|in total milligrams, as calculated by rate per hour by nicardipine volume % for total hours of infusion|milligrams|Mean|10.10|10.1|Standard Deviation|5.98|5.98|||
4341830|NCT00415610|4169577|B3|||Maximum Dose of Nicardipine Used|in total milligrams, as calculated by rate per hour by nicardipine volume % for total hours of infusion|milligrams|Mean|12.52|12.52|Standard Deviation|6.76|6.76|||
4341831|NCT00415610|4169578|B2|||Maximum Dose of Nicardipine Used|in total milligrams, as calculated by rate per hour by nicardipine volume % for total hours of infusion|milligrams|Mean|8.90|8.9|Standard Deviation|4.48|4.48|||
4341832|NCT00415610|4169579|B1|||Maximum Dose of Nicardipine Used|in total milligrams, as calculated by rate per hour by nicardipine volume % for total hours of infusion|milligrams|Mean|8.47|8.47|Standard Deviation|5.75|5.75|||
4341833|NCT00415610|4169576|B4|||Duration of nicardipine infusion|in total hours, as measured from initial start to final stop of any nicardipine administration|hours|Mean|31.69|31.69|Standard Deviation|30.75|30.75|||
4341834|NCT00415610|4169577|B3|||Duration of nicardipine infusion|in total hours, as measured from initial start to final stop of any nicardipine administration|hours|Mean|45.82|45.82|Standard Deviation|37.3|37.3|||
4341835|NCT00415610|4169578|B2|||Duration of nicardipine infusion|in total hours, as measured from initial start to final stop of any nicardipine administration|hours|Mean|30.06|30.06|Standard Deviation|23.8|23.8|||
4341836|NCT00415610|4169579|B1|||Duration of nicardipine infusion|in total hours, as measured from initial start to final stop of any nicardipine administration|hours|Mean|12.93|12.93|Standard Deviation|13.5|13.5|||
4341837|NCT00415610|4169576|B4|Initial GCS||Baseline Measures of stroke symptom severity|As measured on ED arrival. The Glasgow Coma Scale (GCS) is most applicable in those critically ill and measures eye opening, verbal, and motor responses. Scores on the 3-component GCS may range from 3-15 and a lower score indicates a more severe condition. The National Institutes of Health Stroke Scale (NIHSS) is more sensitive for discerning subtle symptoms. Scores on the 11-component NIHSS may total between 0-42, with a higher score indicating a more severe stroke. ICH is an evolving condition and may worsen. NIHSS and GCS scores are used to measure changes in neurological status over time.|units on a scale|Median|15|15.0|Full Range|||8.0|15.0|
4341838|NCT00415610|4169577|B3|Initial GCS||Baseline Measures of stroke symptom severity|As measured on ED arrival. The Glasgow Coma Scale (GCS) is most applicable in those critically ill and measures eye opening, verbal, and motor responses. Scores on the 3-component GCS may range from 3-15 and a lower score indicates a more severe condition. The National Institutes of Health Stroke Scale (NIHSS) is more sensitive for discerning subtle symptoms. Scores on the 11-component NIHSS may total between 0-42, with a higher score indicating a more severe stroke. ICH is an evolving condition and may worsen. NIHSS and GCS scores are used to measure changes in neurological status over time.|units on a scale|Median|15|15.0|Full Range|||9.0|15.0|
4341859|NCT00415610|4169578|B2|Symptom onset to emergency department arrival||Baseline Measures - Timing of Treatment|as mean time in hours from symptom onset|hours|Mean|1.70|1.7|Standard Deviation|1.13|1.13|||
4341839|NCT00415610|4169578|B2|Initial GCS||Baseline Measures of stroke symptom severity|As measured on ED arrival. The Glasgow Coma Scale (GCS) is most applicable in those critically ill and measures eye opening, verbal, and motor responses. Scores on the 3-component GCS may range from 3-15 and a lower score indicates a more severe condition. The National Institutes of Health Stroke Scale (NIHSS) is more sensitive for discerning subtle symptoms. Scores on the 11-component NIHSS may total between 0-42, with a higher score indicating a more severe stroke. ICH is an evolving condition and may worsen. NIHSS and GCS scores are used to measure changes in neurological status over time.|units on a scale|Median|15|15.0|Full Range|||8.0|15.0|
4341840|NCT00415610|4169579|B1|Initial GCS||Baseline Measures of stroke symptom severity|As measured on ED arrival. The Glasgow Coma Scale (GCS) is most applicable in those critically ill and measures eye opening, verbal, and motor responses. Scores on the 3-component GCS may range from 3-15 and a lower score indicates a more severe condition. The National Institutes of Health Stroke Scale (NIHSS) is more sensitive for discerning subtle symptoms. Scores on the 11-component NIHSS may total between 0-42, with a higher score indicating a more severe stroke. ICH is an evolving condition and may worsen. NIHSS and GCS scores are used to measure changes in neurological status over time.|units on a scale|Median|14|14.0|Full Range|||9.0|15.0|
4341841|NCT00415610|4169576|B4|Initial NIHSS score||Baseline Measures of stroke symptom severity|As measured on ED arrival. The Glasgow Coma Scale (GCS) is most applicable in those critically ill and measures eye opening, verbal, and motor responses. Scores on the 3-component GCS may range from 3-15 and a lower score indicates a more severe condition. The National Institutes of Health Stroke Scale (NIHSS) is more sensitive for discerning subtle symptoms. Scores on the 11-component NIHSS may total between 0-42, with a higher score indicating a more severe stroke. ICH is an evolving condition and may worsen. NIHSS and GCS scores are used to measure changes in neurological status over time.|units on a scale|Median|10|10.0|Full Range|||0.0|40.0|
4341842|NCT00415610|4169577|B3|Initial NIHSS score||Baseline Measures of stroke symptom severity|As measured on ED arrival. The Glasgow Coma Scale (GCS) is most applicable in those critically ill and measures eye opening, verbal, and motor responses. Scores on the 3-component GCS may range from 3-15 and a lower score indicates a more severe condition. The National Institutes of Health Stroke Scale (NIHSS) is more sensitive for discerning subtle symptoms. Scores on the 11-component NIHSS may total between 0-42, with a higher score indicating a more severe stroke. ICH is an evolving condition and may worsen. NIHSS and GCS scores are used to measure changes in neurological status over time.|units on a scale|Median|8|8.0|Full Range|||3.0|34.0|
4341843|NCT00415610|4169578|B2|Initial NIHSS score||Baseline Measures of stroke symptom severity|As measured on ED arrival. The Glasgow Coma Scale (GCS) is most applicable in those critically ill and measures eye opening, verbal, and motor responses. Scores on the 3-component GCS may range from 3-15 and a lower score indicates a more severe condition. The National Institutes of Health Stroke Scale (NIHSS) is more sensitive for discerning subtle symptoms. Scores on the 11-component NIHSS may total between 0-42, with a higher score indicating a more severe stroke. ICH is an evolving condition and may worsen. NIHSS and GCS scores are used to measure changes in neurological status over time.|units on a scale|Median|9|9.0|Full Range|||0.0|25.0|
4341844|NCT00415610|4169579|B1|Initial NIHSS score||Baseline Measures of stroke symptom severity|As measured on ED arrival. The Glasgow Coma Scale (GCS) is most applicable in those critically ill and measures eye opening, verbal, and motor responses. Scores on the 3-component GCS may range from 3-15 and a lower score indicates a more severe condition. The National Institutes of Health Stroke Scale (NIHSS) is more sensitive for discerning subtle symptoms. Scores on the 11-component NIHSS may total between 0-42, with a higher score indicating a more severe stroke. ICH is an evolving condition and may worsen. NIHSS and GCS scores are used to measure changes in neurological status over time.|units on a scale|Median|11|11.0|Full Range|||2.0|40.0|
4341845|NCT00415610|4169576|B4|||Initial Hematoma Volume|as measured by central reader (vs. rapid ABC/2 method used for initial qualification), in cubic centimeters estimated total volume|cubic centimeters|Mean|13.56|13.56|Standard Deviation|14.24|14.24|||
4341846|NCT00415610|4169577|B3|||Initial Hematoma Volume|as measured by central reader (vs. rapid ABC/2 method used for initial qualification), in cubic centimeters estimated total volume|cubic centimeters|Mean|10.94|10.94|Standard Deviation|10.87|10.87|||
4341847|NCT00415610|4169578|B2|||Initial Hematoma Volume|as measured by central reader (vs. rapid ABC/2 method used for initial qualification), in cubic centimeters estimated total volume|cubic centimeters|Mean|14.84|14.84|Standard Deviation|17.15|17.15|||
4341848|NCT00415610|4169579|B1|||Initial Hematoma Volume|as measured by central reader (vs. rapid ABC/2 method used for initial qualification), in cubic centimeters estimated total volume|cubic centimeters|Mean|15.45|15.45|Standard Deviation|14.60|14.6|||
4341849|NCT00415610|4169576|B4|||Initial SBP|as measured on ED arrival by automated cuff inflation device|millimeters of mercury (mmHg)|Median|208|208.0|Full Range|||171.0|300.0|
4341850|NCT00415610|4169577|B3|||Initial SBP|as measured on ED arrival by automated cuff inflation device|millimeters of mercury (mmHg)|Median|201|201.0|Full Range|||171.0|300.0|
4341851|NCT00415610|4169578|B2|||Initial SBP|as measured on ED arrival by automated cuff inflation device|millimeters of mercury (mmHg)|Median|212|212.0|Full Range|||190.0|275.0|
4341852|NCT00415610|4169579|B1|||Initial SBP|as measured on ED arrival by automated cuff inflation device|millimeters of mercury (mmHg)|Median|209|209.0|Full Range|||178.0|255.0|
4341853|NCT00415610|4169576|B4|Symptom onset to treatment initiation||Baseline Measures - Timing of Treatment|as mean time in hours from symptom onset|hours|Mean|4.19|4.19|Standard Deviation|1.71|1.71|||
4341854|NCT00415610|4169577|B3|Symptom onset to treatment initiation||Baseline Measures - Timing of Treatment|as mean time in hours from symptom onset|hours|Mean|4.44|4.44|Standard Deviation|2.08|2.08|||
4341855|NCT00415610|4169578|B2|Symptom onset to treatment initiation||Baseline Measures - Timing of Treatment|as mean time in hours from symptom onset|hours|Mean|4.13|4.13|Standard Deviation|1.50|1.5|||
4341856|NCT00415610|4169579|B1|Symptom onset to treatment initiation||Baseline Measures - Timing of Treatment|as mean time in hours from symptom onset|hours|Mean|3.94|3.94|Standard Deviation|1.45|1.45|||
4341857|NCT00415610|4169576|B4|Symptom onset to emergency department arrival||Baseline Measures - Timing of Treatment|as mean time in hours from symptom onset|hours|Mean|1.72|1.72|Standard Deviation|1.37|1.37|||
4341858|NCT00415610|4169577|B3|Symptom onset to emergency department arrival||Baseline Measures - Timing of Treatment|as mean time in hours from symptom onset|hours|Mean|1.86|1.86|Standard Deviation|1.78|1.78|||
4341860|NCT00415610|4169579|B1|Symptom onset to emergency department arrival||Baseline Measures - Timing of Treatment|as mean time in hours from symptom onset|hours|Mean|1.72|1.72|Standard Deviation|1.27|1.27|||
4341861|NCT00415610|4169576|B4|United States||Region of Enrollment||participants|Number|60|60.0||||||
4341862|NCT00415610|4169577|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4341863|NCT00415610|4169578|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4341864|NCT00415610|4169579|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4341865|NCT00415610|4169576|B4|Others||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4341866|NCT00415610|4169577|B3|Others||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4341867|NCT00415610|4169578|B2|Others||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4341868|NCT00415610|4169579|B1|Others||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4341869|NCT00415610|4169576|B4|Black||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4341870|NCT00415610|4169577|B3|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4341871|NCT00415610|4169578|B2|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4341872|NCT00415610|4169579|B1|Black||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4341873|NCT00415610|4169576|B4|White||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4341874|NCT00415610|4169577|B3|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4341875|NCT00415610|4169578|B2|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4341876|NCT00415610|4169579|B1|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4341877|NCT00415610|4169576|B4||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4341878|NCT00415610|4169577|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4341879|NCT00415610|4169578|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4341880|NCT00415610|4169579|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4341881|NCT00415610|4169576|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4341882|NCT00415610|4169577|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4341883|NCT00415610|4169578|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4341884|NCT00415610|4169579|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4341885|NCT00415610|4169576|B4|||Age||years|Mean|62|62.0|Standard Deviation|15.1|15.1|||
4341886|NCT00415610|4169577|B3|||Age||years|Mean|65.1|65.1|Standard Deviation|14.6|14.6|||
4341887|NCT00415610|4169578|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|13.0|13.0|||
4341888|NCT00415610|4169579|B1|||Age||years|Mean|62|62.0|Standard Deviation|17.7|17.7|||
4341889|NCT00415597|4169601|B1|||Brief Pain Inventory (BPI) Average Pain|All patients reporting a BPI average pain score (over last 24 hours: 0=no pain, 10=worst pain) at baseline|Units on scale|Mean|6.0|6.0|Standard Deviation|1.67|1.67|||
4341890|NCT00415597|4169601|B1||Male|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
4341891|NCT00415597|4169601|B1||Female|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4341892|NCT00415597|4169601|B1|||Age||years|Mean|51.7|51.7|Standard Deviation|10.56|10.56|||
4341893|NCT00415597|4169601|B1||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4341894|NCT00415597|4169601|B1||Between 18 and 65 years|Age||Participants|Count of Participants|417|417.0||||||
4341895|NCT00415597|4169601|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341896|NCT00415532|4169607|B3|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4341897|NCT00415532|4169608|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4341898|NCT00415532|4169609|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4341899|NCT00415532|4169607|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4341900|NCT00415532|4169608|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4341901|NCT00415532|4169609|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4341902|NCT00415532|4169607|B3|Asian (Chinese, Bangladeshi, Indian, Pakistani)||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4341903|NCT00415532|4169608|B2|Asian (Chinese, Bangladeshi, Indian, Pakistani)||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4341904|NCT00415532|4169609|B1|Asian (Chinese, Bangladeshi, Indian, Pakistani)||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4341905|NCT00415532|4169607|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4341906|NCT00415532|4169608|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4341907|NCT00415532|4169609|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4341908|NCT00415532|4169607|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4341909|NCT00415532|4169608|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4341910|NCT00415532|4169609|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4341911|NCT00415532|4169607|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|206|206.0||||||
4341912|NCT00415532|4169608|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|137|137.0||||||
4341913|NCT00415532|4169609|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|69|69.0||||||
4341914|NCT00415532|4169607|B3||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4341915|NCT00415532|4169608|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4341916|NCT00415532|4169609|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4341917|NCT00415532|4169607|B3||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4341918|NCT00415532|4169608|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4341919|NCT00415532|4169609|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4341920|NCT00415532|4169607|B3|||Age||Years|Mean|54.7|54.7|Standard Deviation|18.9|18.9|||
4341921|NCT00415532|4169608|B2|||Age||Years|Mean|54.8|54.8|Standard Deviation|18.8|18.8|||
4341922|NCT00415532|4169609|B1|||Age||Years|Mean|54.7|54.7|Standard Deviation|19.3|19.3|||
4341923|NCT00415519|4169630|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4341924|NCT00415519|4169631|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4341925|NCT00415519|4169632|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4341926|NCT00415519|4169630|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4341927|NCT00415519|4169631|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4341928|NCT00415519|4169632|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4341929|NCT00415519|4169630|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4341930|NCT00415519|4169631|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4341931|NCT00415519|4169632|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4341932|NCT00415519|4169630|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4341933|NCT00415519|4169631|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4341934|NCT00415519|4169632|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4341935|NCT00415519|4169630|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341936|NCT00415519|4169631|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341937|NCT00415519|4169632|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341938|NCT00415506|4169651|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4341939|NCT00415506|4169652|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4341940|NCT00415506|4169653|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4341941|NCT00415506|4169651|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4341942|NCT00415506|4169652|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4341943|NCT00415506|4169653|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4341944|NCT00415506|4169651|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4341945|NCT00415506|4169652|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4341946|NCT00415506|4169653|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4341947|NCT00415506|4169651|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4341948|NCT00415506|4169652|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4341949|NCT00415506|4169653|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4341950|NCT00415506|4169651|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4341951|NCT00415506|4169652|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4341952|NCT00415506|4169653|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4341953|NCT00415506|4169651|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341954|NCT00415506|4169652|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341955|NCT00415506|4169653|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341956|NCT00415493|4169662|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4341957|NCT00415493|4169663|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4341958|NCT00415493|4169664|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4341959|NCT00415493|4169662|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4341960|NCT00415493|4169663|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4341961|NCT00415493|4169664|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4341962|NCT00415493|4169662|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4341963|NCT00415493|4169663|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4341964|NCT00415493|4169664|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4341965|NCT00415493|4169662|B3|||Age||years|Mean|35.1|35.1|Standard Deviation|12.2|12.2|||
4341966|NCT00415493|4169663|B2|||Age||years|Mean|32.7|32.7|Standard Deviation|14.6|14.6|||
4341967|NCT00415493|4169664|B1|||Age||years|Mean|36.9|36.9|Standard Deviation|10.5|10.5|||
4341968|NCT00415493|4169662|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4341969|NCT00415493|4169663|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4341970|NCT00415493|4169664|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4341971|NCT00415493|4169662|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4341972|NCT00415493|4169663|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4341973|NCT00415493|4169664|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4341974|NCT00415493|4169662|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341975|NCT00415493|4169663|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341976|NCT00415493|4169664|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4341977|NCT00415194|4169671|B3|Other||Primary Site of Disease||Participants|Number|15|15.0||||||
4341978|NCT00415194|4169672|B2|Other||Primary Site of Disease||Participants|Number|7|7.0||||||
4341979|NCT00415194|4169673|B1|Other||Primary Site of Disease||Participants|Number|8|8.0||||||
4341980|NCT00415194|4169671|B3|Oropharynx||Primary Site of Disease||Participants|Number|192|192.0||||||
4341981|NCT00415194|4169672|B2|Oropharynx||Primary Site of Disease||Participants|Number|106|106.0||||||
4341982|NCT00415194|4169673|B1|Oropharynx||Primary Site of Disease||Participants|Number|86|86.0||||||
4341983|NCT00415194|4169671|B3|Oral Cavity||Primary Site of Disease||Participants|Number|261|261.0||||||
4341984|NCT00415194|4169672|B2|Oral Cavity||Primary Site of Disease||Participants|Number|123|123.0||||||
4341985|NCT00415194|4169673|B1|Oral Cavity||Primary Site of Disease||Participants|Number|138|138.0||||||
4341986|NCT00415194|4169671|B3|Larynx||Primary Site of Disease||Participants|Number|205|205.0||||||
4341987|NCT00415194|4169672|B2|Larynx||Primary Site of Disease||Participants|Number|102|102.0||||||
4341988|NCT00415194|4169673|B1|Larynx||Primary Site of Disease||Participants|Number|103|103.0||||||
4341989|NCT00415194|4169671|B3|Hypopharynx||Primary Site of Disease||Participants|Number|122|122.0||||||
4341990|NCT00415194|4169672|B2|Hypopharynx||Primary Site of Disease||Participants|Number|59|59.0||||||
4341991|NCT00415194|4169673|B1|Hypopharynx||Primary Site of Disease||Participants|Number|63|63.0||||||
4341992|NCT00415194|4169671|B3|Missing Data||Eastern Cooperative Oncology Group (ECOG) Performance Status|"These scales and criteria are used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis:~Fully active, able to carry on all pre-disease performance without restriction~Restricted in strenuous activity,able to carry out work of a light or sedentary nature~Ambulatory, but unable to carry out any work activities. Capable of only limited selfcare~Completely disabled. Cannot carry on any selfcare.~Dead"|Participants|Number|1|1.0||||||
4341993|NCT00415194|4169672|B2|Missing Data||Eastern Cooperative Oncology Group (ECOG) Performance Status|"These scales and criteria are used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis:~Fully active, able to carry on all pre-disease performance without restriction~Restricted in strenuous activity,able to carry out work of a light or sedentary nature~Ambulatory, but unable to carry out any work activities. Capable of only limited selfcare~Completely disabled. Cannot carry on any selfcare.~Dead"|Participants|Number|1|1.0||||||
4341994|NCT00415194|4169673|B1|Missing Data||Eastern Cooperative Oncology Group (ECOG) Performance Status|"These scales and criteria are used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis:~Fully active, able to carry on all pre-disease performance without restriction~Restricted in strenuous activity,able to carry out work of a light or sedentary nature~Ambulatory, but unable to carry out any work activities. Capable of only limited selfcare~Completely disabled. Cannot carry on any selfcare.~Dead"|Participants|Number|0|0.0||||||
4341995|NCT00415194|4169671|B3|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"These scales and criteria are used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis:~Fully active, able to carry on all pre-disease performance without restriction~Restricted in strenuous activity,able to carry out work of a light or sedentary nature~Ambulatory, but unable to carry out any work activities. Capable of only limited selfcare~Completely disabled. Cannot carry on any selfcare.~Dead"|Participants|Number|104|104.0||||||
4341996|NCT00415194|4169672|B2|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"These scales and criteria are used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis:~Fully active, able to carry on all pre-disease performance without restriction~Restricted in strenuous activity,able to carry out work of a light or sedentary nature~Ambulatory, but unable to carry out any work activities. Capable of only limited selfcare~Completely disabled. Cannot carry on any selfcare.~Dead"|Participants|Number|53|53.0||||||
4341997|NCT00415194|4169673|B1|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"These scales and criteria are used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis:~Fully active, able to carry on all pre-disease performance without restriction~Restricted in strenuous activity,able to carry out work of a light or sedentary nature~Ambulatory, but unable to carry out any work activities. Capable of only limited selfcare~Completely disabled. Cannot carry on any selfcare.~Dead"|Participants|Number|51|51.0||||||
4341998|NCT00415194|4169671|B3|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"These scales and criteria are used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis:~Fully active, able to carry on all pre-disease performance without restriction~Restricted in strenuous activity,able to carry out work of a light or sedentary nature~Ambulatory, but unable to carry out any work activities. Capable of only limited selfcare~Completely disabled. Cannot carry on any selfcare.~Dead"|Participants|Number|510|510.0||||||
4341999|NCT00415194|4169672|B2|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"These scales and criteria are used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis:~Fully active, able to carry on all pre-disease performance without restriction~Restricted in strenuous activity,able to carry out work of a light or sedentary nature~Ambulatory, but unable to carry out any work activities. Capable of only limited selfcare~Completely disabled. Cannot carry on any selfcare.~Dead"|Participants|Number|253|253.0||||||
4342000|NCT00415194|4169673|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"These scales and criteria are used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis:~Fully active, able to carry on all pre-disease performance without restriction~Restricted in strenuous activity,able to carry out work of a light or sedentary nature~Ambulatory, but unable to carry out any work activities. Capable of only limited selfcare~Completely disabled. Cannot carry on any selfcare.~Dead"|Participants|Number|257|257.0||||||
4342050|NCT00415194|4169672|B2|Korea, Republic of||Region of Enrollment||participants|Number|24|24.0||||||
4342051|NCT00415194|4169673|B1|Korea, Republic of||Region of Enrollment||participants|Number|29|29.0||||||
4342001|NCT00415194|4169671|B3|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"These scales and criteria are used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis:~Fully active, able to carry on all pre-disease performance without restriction~Restricted in strenuous activity,able to carry out work of a light or sedentary nature~Ambulatory, but unable to carry out any work activities. Capable of only limited selfcare~Completely disabled. Cannot carry on any selfcare.~Dead"|Participants|Number|180|180.0||||||
4342002|NCT00415194|4169672|B2|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"These scales and criteria are used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis:~Fully active, able to carry on all pre-disease performance without restriction~Restricted in strenuous activity,able to carry out work of a light or sedentary nature~Ambulatory, but unable to carry out any work activities. Capable of only limited selfcare~Completely disabled. Cannot carry on any selfcare.~Dead"|Participants|Number|90|90.0||||||
4342003|NCT00415194|4169673|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"These scales and criteria are used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis:~Fully active, able to carry on all pre-disease performance without restriction~Restricted in strenuous activity,able to carry out work of a light or sedentary nature~Ambulatory, but unable to carry out any work activities. Capable of only limited selfcare~Completely disabled. Cannot carry on any selfcare.~Dead"|Participants|Number|90|90.0||||||
4342004|NCT00415194|4169671|B3|Yes||Distant Metastasis||Participants|Number|475|475.0||||||
4342005|NCT00415194|4169672|B2|Yes||Distant Metastasis||Participants|Number|242|242.0||||||
4342006|NCT00415194|4169673|B1|Yes||Distant Metastasis||Participants|Number|233|233.0||||||
4342007|NCT00415194|4169671|B3|No||Distant Metastasis||Participants|Number|320|320.0||||||
4342008|NCT00415194|4169672|B2|No||Distant Metastasis||Participants|Number|155|155.0||||||
4342009|NCT00415194|4169673|B1|No||Distant Metastasis||Participants|Number|165|165.0||||||
4342010|NCT00415194|4169671|B3|Yes||Prior Treatment with Platinum-Based Therapy||Participants|Number|354|354.0||||||
4342011|NCT00415194|4169672|B2|Yes||Prior Treatment with Platinum-Based Therapy||Participants|Number|169|169.0||||||
4342012|NCT00415194|4169673|B1|Yes||Prior Treatment with Platinum-Based Therapy||Participants|Number|185|185.0||||||
4342013|NCT00415194|4169671|B3|No||Prior Treatment with Platinum-Based Therapy||Participants|Number|441|441.0||||||
4342014|NCT00415194|4169672|B2|No||Prior Treatment with Platinum-Based Therapy||Participants|Number|228|228.0||||||
4342015|NCT00415194|4169673|B1|No||Prior Treatment with Platinum-Based Therapy||Participants|Number|213|213.0||||||
4342016|NCT00415194|4169671|B3|Yes||Previously Treated for Head and Neck Cancer (HNC)||Participants|Number|721|721.0||||||
4342017|NCT00415194|4169672|B2|Yes||Previously Treated for Head and Neck Cancer (HNC)||Participants|Number|358|358.0||||||
4342018|NCT00415194|4169673|B1|Yes||Previously Treated for Head and Neck Cancer (HNC)||Participants|Number|363|363.0||||||
4342019|NCT00415194|4169671|B3|No||Previously Treated for Head and Neck Cancer (HNC)||Participants|Number|74|74.0||||||
4342020|NCT00415194|4169672|B2|No||Previously Treated for Head and Neck Cancer (HNC)||Participants|Number|39|39.0||||||
4342021|NCT00415194|4169673|B1|No||Previously Treated for Head and Neck Cancer (HNC)||Participants|Number|35|35.0||||||
4342022|NCT00415194|4169671|B3|United States||Region of Enrollment||participants|Number|57|57.0||||||
4342023|NCT00415194|4169672|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4342024|NCT00415194|4169673|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4342025|NCT00415194|4169671|B3|Taiwan||Region of Enrollment||participants|Number|46|46.0||||||
4342026|NCT00415194|4169672|B2|Taiwan||Region of Enrollment||participants|Number|25|25.0||||||
4342027|NCT00415194|4169673|B1|Taiwan||Region of Enrollment||participants|Number|21|21.0||||||
4342028|NCT00415194|4169671|B3|Spain||Region of Enrollment||participants|Number|60|60.0||||||
4342029|NCT00415194|4169672|B2|Spain||Region of Enrollment||participants|Number|29|29.0||||||
4342030|NCT00415194|4169673|B1|Spain||Region of Enrollment||participants|Number|31|31.0||||||
4342031|NCT00415194|4169671|B3|South Africa||Region of Enrollment||participants|Number|20|20.0||||||
4342032|NCT00415194|4169672|B2|South Africa||Region of Enrollment||participants|Number|9|9.0||||||
4342033|NCT00415194|4169673|B1|South Africa||Region of Enrollment||participants|Number|11|11.0||||||
4342034|NCT00415194|4169671|B3|Russian Federation||Region of Enrollment||participants|Number|43|43.0||||||
4342035|NCT00415194|4169672|B2|Russian Federation||Region of Enrollment||participants|Number|20|20.0||||||
4342036|NCT00415194|4169673|B1|Russian Federation||Region of Enrollment||participants|Number|23|23.0||||||
4342037|NCT00415194|4169671|B3|Romania||Region of Enrollment||participants|Number|42|42.0||||||
4342038|NCT00415194|4169672|B2|Romania||Region of Enrollment||participants|Number|22|22.0||||||
4342039|NCT00415194|4169673|B1|Romania||Region of Enrollment||participants|Number|20|20.0||||||
4342040|NCT00415194|4169671|B3|Poland||Region of Enrollment||participants|Number|20|20.0||||||
4342041|NCT00415194|4169672|B2|Poland||Region of Enrollment||participants|Number|10|10.0||||||
4342042|NCT00415194|4169673|B1|Poland||Region of Enrollment||participants|Number|10|10.0||||||
4342043|NCT00415194|4169671|B3|Netherlands||Region of Enrollment||participants|Number|19|19.0||||||
4342044|NCT00415194|4169672|B2|Netherlands||Region of Enrollment||participants|Number|11|11.0||||||
4342045|NCT00415194|4169673|B1|Netherlands||Region of Enrollment||participants|Number|8|8.0||||||
4342046|NCT00415194|4169671|B3|Mexico||Region of Enrollment||participants|Number|17|17.0||||||
4342047|NCT00415194|4169672|B2|Mexico||Region of Enrollment||participants|Number|8|8.0||||||
4342048|NCT00415194|4169673|B1|Mexico||Region of Enrollment||participants|Number|9|9.0||||||
4342049|NCT00415194|4169671|B3|Korea, Republic of||Region of Enrollment||participants|Number|53|53.0||||||
4342052|NCT00415194|4169671|B3|Italy||Region of Enrollment||participants|Number|40|40.0||||||
4342053|NCT00415194|4169672|B2|Italy||Region of Enrollment||participants|Number|21|21.0||||||
4342054|NCT00415194|4169673|B1|Italy||Region of Enrollment||participants|Number|19|19.0||||||
4342055|NCT00415194|4169671|B3|India||Region of Enrollment||participants|Number|147|147.0||||||
4342056|NCT00415194|4169672|B2|India||Region of Enrollment||participants|Number|75|75.0||||||
4342057|NCT00415194|4169673|B1|India||Region of Enrollment||participants|Number|72|72.0||||||
4342058|NCT00415194|4169671|B3|Hungary||Region of Enrollment||participants|Number|45|45.0||||||
4342059|NCT00415194|4169672|B2|Hungary||Region of Enrollment||participants|Number|22|22.0||||||
4342060|NCT00415194|4169673|B1|Hungary||Region of Enrollment||participants|Number|23|23.0||||||
4342061|NCT00415194|4169671|B3|Germany||Region of Enrollment||participants|Number|98|98.0||||||
4342062|NCT00415194|4169672|B2|Germany||Region of Enrollment||participants|Number|48|48.0||||||
4342063|NCT00415194|4169673|B1|Germany||Region of Enrollment||participants|Number|50|50.0||||||
4342064|NCT00415194|4169671|B3|France||Region of Enrollment||participants|Number|6|6.0||||||
4342065|NCT00415194|4169672|B2|France||Region of Enrollment||participants|Number|3|3.0||||||
4342066|NCT00415194|4169673|B1|France||Region of Enrollment||participants|Number|3|3.0||||||
4342067|NCT00415194|4169671|B3|Denmark||Region of Enrollment||participants|Number|10|10.0||||||
4342068|NCT00415194|4169672|B2|Denmark||Region of Enrollment||participants|Number|3|3.0||||||
4342069|NCT00415194|4169673|B1|Denmark||Region of Enrollment||participants|Number|7|7.0||||||
4342070|NCT00415194|4169671|B3|China||Region of Enrollment||participants|Number|12|12.0||||||
4342071|NCT00415194|4169672|B2|China||Region of Enrollment||participants|Number|7|7.0||||||
4342072|NCT00415194|4169673|B1|China||Region of Enrollment||participants|Number|5|5.0||||||
4342073|NCT00415194|4169671|B3|Brazil||Region of Enrollment||participants|Number|28|28.0||||||
4342074|NCT00415194|4169672|B2|Brazil||Region of Enrollment||participants|Number|12|12.0||||||
4342075|NCT00415194|4169673|B1|Brazil||Region of Enrollment||participants|Number|16|16.0||||||
4342076|NCT00415194|4169671|B3|Belgium||Region of Enrollment||participants|Number|17|17.0||||||
4342077|NCT00415194|4169672|B2|Belgium||Region of Enrollment||participants|Number|10|10.0||||||
4342078|NCT00415194|4169673|B1|Belgium||Region of Enrollment||participants|Number|7|7.0||||||
4342079|NCT00415194|4169671|B3|Argentina||Region of Enrollment||participants|Number|15|15.0||||||
4342080|NCT00415194|4169672|B2|Argentina||Region of Enrollment||participants|Number|10|10.0||||||
4342081|NCT00415194|4169673|B1|Argentina||Region of Enrollment||participants|Number|5|5.0||||||
4342082|NCT00415194|4169671|B3|Unknown||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4342083|NCT00415194|4169672|B2|Unknown||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4342084|NCT00415194|4169673|B1|Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4342085|NCT00415194|4169671|B3|West Asian (Indian sub-continent)||Race/Ethnicity, Customized||Participants|Number|142|142.0||||||
4342086|NCT00415194|4169672|B2|West Asian (Indian sub-continent)||Race/Ethnicity, Customized||Participants|Number|70|70.0||||||
4342087|NCT00415194|4169673|B1|West Asian (Indian sub-continent)||Race/Ethnicity, Customized||Participants|Number|72|72.0||||||
4342088|NCT00415194|4169671|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
4342089|NCT00415194|4169672|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4342090|NCT00415194|4169673|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4342091|NCT00415194|4169671|B3|East Asian||Race/Ethnicity, Customized||Participants|Number|120|120.0||||||
4342092|NCT00415194|4169672|B2|East Asian||Race/Ethnicity, Customized||Participants|Number|65|65.0||||||
4342093|NCT00415194|4169673|B1|East Asian||Race/Ethnicity, Customized||Participants|Number|55|55.0||||||
4342094|NCT00415194|4169671|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|476|476.0||||||
4342095|NCT00415194|4169672|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|233|233.0||||||
4342096|NCT00415194|4169673|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|243|243.0||||||
4342097|NCT00415194|4169671|B3|African||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
4342098|NCT00415194|4169672|B2|African||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4342099|NCT00415194|4169673|B1|African||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4342100|NCT00415194|4169671|B3||Male|Sex: Female, Male||Participants|Count of Participants|686|686.0||||||
4342101|NCT00415194|4169672|B2||Male|Sex: Female, Male||Participants|Count of Participants|344|344.0||||||
4342102|NCT00415194|4169673|B1||Male|Sex: Female, Male||Participants|Count of Participants|342|342.0||||||
4342103|NCT00415194|4169671|B3||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4342104|NCT00415194|4169672|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4342105|NCT00415194|4169673|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4342106|NCT00415194|4169671|B3|||Age||years|Mean|57.62|57.62|Standard Deviation|9.44|9.44|||
4342107|NCT00415194|4169672|B2|||Age||years|Mean|57.78|57.78|Standard Deviation|9.36|9.36|||
4342108|NCT00415194|4169673|B1|||Age||years|Mean|57.45|57.45|Standard Deviation|9.54|9.54|||
4342109|NCT00415168|4169690|B1|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|A grading scale is provided for performance status from 0 (fully active, able to carry on all pre-disease performance without restriction) to 5 (dead).|participants|Number|37|37.0||||||
4342110|NCT00415168|4169690|B1|0 - Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|A grading scale is provided for performance status from 0 (fully active, able to carry on all pre-disease performance without restriction) to 5 (dead).|participants|Number|16|16.0||||||
4342111|NCT00415168|4169690|B1|Russian Federation||Region of Enrollment||participants|Number|53|53.0||||||
4342112|NCT00415168|4169690|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
4342113|NCT00415168|4169690|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4342114|NCT00415168|4169690|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4342115|NCT00415168|4169690|B1|||Age||years|Mean|54.3|54.3|Standard Deviation|9.85|9.85|||
4342116|NCT00415051|4169700|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4342117|NCT00415051|4169700|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4342118|NCT00415051|4169700|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4342119|NCT00415051|4169700|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4342120|NCT00415051|4169700|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4342121|NCT00415051|4169700|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4342122|NCT00415051|4169700|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4342123|NCT00415051|4169700|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4342124|NCT00415051|4169700|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4342125|NCT00415051|4169700|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4342126|NCT00415051|4169700|B1|||Age||years|Mean|33|33.0|Full Range|||23.0|50.0|
4342127|NCT00415051|4169700|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4342128|NCT00415051|4169700|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4342129|NCT00415051|4169700|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342130|NCT00414973|4169707|B5|||Duration of Osteoporosis||years|Mean|3.30|3.3|Standard Deviation|4.80|4.8|||
4342131|NCT00414973|4169708|B4|||Duration of Osteoporosis||years|Mean|2.4|2.4|Standard Deviation|2.54|2.54|||
4342132|NCT00414973|4169709|B3|||Duration of Osteoporosis||years|Mean|1.9|1.9|Standard Deviation|2.24|2.24|||
4342133|NCT00414973|4169710|B2|||Duration of Osteoporosis||years|Mean|3.1|3.1|Standard Deviation|4.16|4.16|||
4342134|NCT00414973|4169711|B1|||Duration of Osteoporosis||years|Mean|3.6|3.6|Standard Deviation|5.33|5.33|||
4342135|NCT00414973|4169707|B5|East Asian||Race/Ethnicity||participants|Number|362|362.0||||||
4342136|NCT00414973|4169708|B4|East Asian||Race/Ethnicity||participants|Number|11|11.0||||||
4342137|NCT00414973|4169709|B3|East Asian||Race/Ethnicity||participants|Number|24|24.0||||||
4342138|NCT00414973|4169710|B2|East Asian||Race/Ethnicity||participants|Number|109|109.0||||||
4342139|NCT00414973|4169711|B1|East Asian||Race/Ethnicity||participants|Number|218|218.0||||||
4342140|NCT00414973|4169707|B5|China||Region of Enrollment||participants|Number|362|362.0||||||
4342141|NCT00414973|4169708|B4|China||Region of Enrollment||participants|Number|11|11.0||||||
4342142|NCT00414973|4169709|B3|China||Region of Enrollment||participants|Number|24|24.0||||||
4342143|NCT00414973|4169710|B2|China||Region of Enrollment||participants|Number|109|109.0||||||
4342144|NCT00414973|4169711|B1|China||Region of Enrollment||participants|Number|218|218.0||||||
4342145|NCT00414973|4169707|B5||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4342146|NCT00414973|4169708|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4342147|NCT00414973|4169709|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4342148|NCT00414973|4169710|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4342149|NCT00414973|4169711|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4342150|NCT00414973|4169707|B5||Female|Sex: Female, Male||Participants|Count of Participants|327|327.0||||||
4342151|NCT00414973|4169708|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4342152|NCT00414973|4169709|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4342153|NCT00414973|4169710|B2||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4342154|NCT00414973|4169711|B1||Female|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4342155|NCT00414973|4169707|B5|||Age||years|Mean|68.60|68.6|Standard Deviation|7.26|7.26|||
4342156|NCT00414973|4169708|B4|||Age||years|Mean|67.39|67.39|Standard Deviation|11.01|11.01|||
4342157|NCT00414973|4169709|B3|||Age||years|Mean|68.27|68.27|Standard Deviation|8.28|8.28|||
4342158|NCT00414973|4169710|B2|||Age||years|Mean|67.81|67.81|Standard Deviation|7.22|7.22|||
4342159|NCT00414973|4169711|B1|||Age||years|Mean|69.09|69.09|Standard Deviation|6.95|6.95|||
4342160|NCT00414908|4169732|B3|Bulgaria||Region of Enrollment||participants|Number|11|11.0||||||
4342161|NCT00414908|4169733|B2|Bulgaria||Region of Enrollment||participants|Number|6|6.0||||||
4342162|NCT00414908|4169734|B1|Bulgaria||Region of Enrollment||participants|Number|5|5.0||||||
4342163|NCT00414908|4169732|B3|Russian Federation||Region of Enrollment||participants|Number|4|4.0||||||
4342164|NCT00414908|4169733|B2|Russian Federation||Region of Enrollment||participants|Number|2|2.0||||||
4342165|NCT00414908|4169734|B1|Russian Federation||Region of Enrollment||participants|Number|2|2.0||||||
4342166|NCT00414908|4169732|B3|Ukraine||Region of Enrollment||participants|Number|7|7.0||||||
4342167|NCT00414908|4169733|B2|Ukraine||Region of Enrollment||participants|Number|4|4.0||||||
4342168|NCT00414908|4169734|B1|Ukraine||Region of Enrollment||participants|Number|3|3.0||||||
4342169|NCT00414908|4169732|B3|Poland||Region of Enrollment||participants|Number|14|14.0||||||
4342170|NCT00414908|4169733|B2|Poland||Region of Enrollment||participants|Number|7|7.0||||||
4342171|NCT00414908|4169734|B1|Poland||Region of Enrollment||participants|Number|7|7.0||||||
4342172|NCT00414908|4169732|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4342173|NCT00414908|4169733|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4342174|NCT00414908|4169734|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4342175|NCT00414908|4169732|B3|Serbia||Region of Enrollment||participants|Number|4|4.0||||||
4342176|NCT00414908|4169733|B2|Serbia||Region of Enrollment||participants|Number|3|3.0||||||
4342177|NCT00414908|4169734|B1|Serbia||Region of Enrollment||participants|Number|1|1.0||||||
4342178|NCT00414908|4169732|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4342179|NCT00414908|4169733|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4342180|NCT00414908|4169734|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4342181|NCT00414908|4169732|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4342182|NCT00414908|4169733|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4342183|NCT00414908|4169734|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4342184|NCT00414908|4169732|B3|||Age||years|Mean|51.0|51.0|Standard Deviation|8.7|8.7|||
4342185|NCT00414908|4169733|B2|||Age||years|Mean|50.4|50.4|Standard Deviation|7.8|7.8|||
4342186|NCT00414908|4169734|B1|||Age||years|Mean|51.7|51.7|Standard Deviation|9.7|9.7|||
4342187|NCT00414908|4169732|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4342188|NCT00414908|4169733|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4342189|NCT00414908|4169734|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4342190|NCT00414908|4169732|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4342191|NCT00414908|4169733|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4342192|NCT00414908|4169734|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4342193|NCT00414908|4169732|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342194|NCT00414908|4169733|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342195|NCT00414908|4169734|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342196|NCT00414817|4169757|B3|United States||Region of Enrollment||participants|Number|6431|6431.0||||||
4342197|NCT00414817|4169758|B2|United States||Region of Enrollment||participants|Number|3260|3260.0||||||
4342198|NCT00414817|4169759|B1|United States||Region of Enrollment||participants|Number|3171|3171.0||||||
4342199|NCT00414817|4169757|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1646|1646.0||||||
4342200|NCT00414817|4169758|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|857|857.0||||||
4342201|NCT00414817|4169759|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|789|789.0||||||
4342202|NCT00414817|4169757|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|431|431.0||||||
4342203|NCT00414817|4169758|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|235|235.0||||||
4342204|NCT00414817|4169759|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|196|196.0||||||
4342205|NCT00414817|4169757|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3210|3210.0||||||
4342206|NCT00414817|4169758|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1578|1578.0||||||
4342207|NCT00414817|4169759|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1632|1632.0||||||
4342208|NCT00414817|4169757|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
4342209|NCT00414817|4169758|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4342210|NCT00414817|4169759|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4342211|NCT00414817|4169757|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|275|275.0||||||
4342212|NCT00414817|4169758|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
4342213|NCT00414817|4169759|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|145|145.0||||||
4342214|NCT00414817|4169757|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|730|730.0||||||
4342215|NCT00414817|4169758|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|388|388.0||||||
4342216|NCT00414817|4169759|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|342|342.0||||||
4342217|NCT00414817|4169757|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4342218|NCT00414817|4169758|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4342219|NCT00414817|4169759|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4342220|NCT00414817|4169757|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3995|3995.0||||||
4342221|NCT00414817|4169758|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2036|2036.0||||||
4342222|NCT00414817|4169759|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1959|1959.0||||||
4342223|NCT00414817|4169757|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2354|2354.0||||||
4342224|NCT00414817|4169758|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1185|1185.0||||||
4342225|NCT00414817|4169759|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1169|1169.0||||||
4342226|NCT00414817|4169757|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
4342227|NCT00414817|4169758|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4342228|NCT00414817|4169759|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4342229|NCT00414817|4169757|B3||Male|Gender||Participants|Count of Participants|2074|2074.0||||||
4342230|NCT00414817|4169758|B2||Male|Gender||Participants|Count of Participants|1053|1053.0||||||
4342231|NCT00414817|4169759|B1||Male|Gender||Participants|Count of Participants|1021|1021.0||||||
4342232|NCT00414817|4169757|B3||Female|Gender||Participants|Count of Participants|4357|4357.0||||||
4342233|NCT00414817|4169758|B2||Female|Gender||Participants|Count of Participants|2207|2207.0||||||
4342234|NCT00414817|4169759|B1||Female|Gender||Participants|Count of Participants|2150|2150.0||||||
4342235|NCT00414817|4169757|B3|||Age||years|Mean|53.6|53.6|Standard Deviation|15.3|15.3|||
4342236|NCT00414817|4169758|B2|||Age||years|Mean|53.5|53.5|Standard Deviation|15.3|15.3|||
4342237|NCT00414817|4169759|B1|||Age||years|Mean|53.7|53.7|Standard Deviation|15.3|15.3|||
4342238|NCT00414817|4169757|B3||>=65 years|Age||Participants|Count of Participants|1538|1538.0||||||
4342239|NCT00414817|4169758|B2||>=65 years|Age||Participants|Count of Participants|761|761.0||||||
4342240|NCT00414817|4169759|B1||>=65 years|Age||Participants|Count of Participants|777|777.0||||||
4342241|NCT00414817|4169757|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4893|4893.0||||||
4342242|NCT00414817|4169758|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2499|2499.0||||||
4342243|NCT00414817|4169759|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2394|2394.0||||||
4342244|NCT00414817|4169757|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342245|NCT00414817|4169758|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342246|NCT00414817|4169759|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342247|NCT00414726|4169770|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4342248|NCT00414726|4169771|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4342249|NCT00414726|4169772|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4342250|NCT00414726|4169770|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4342251|NCT00414726|4169771|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4342252|NCT00414726|4169772|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4342253|NCT00414726|4169770|B3||White|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
4342254|NCT00414726|4169771|B2||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4342255|NCT00414726|4169772|B1||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4342256|NCT00414726|4169770|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4342257|NCT00414726|4169771|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4342258|NCT00414726|4169772|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4342259|NCT00414726|4169770|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4342260|NCT00414726|4169771|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4342261|NCT00414726|4169772|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4342262|NCT00414726|4169770|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4342263|NCT00414726|4169771|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4342264|NCT00414726|4169772|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4342265|NCT00414726|4169770|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4342266|NCT00414726|4169771|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4342267|NCT00414726|4169772|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4342268|NCT00414726|4169770|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4342269|NCT00414726|4169771|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4342270|NCT00414726|4169772|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4342271|NCT00414726|4169770|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
4342272|NCT00414726|4169771|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4342273|NCT00414726|4169772|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4342274|NCT00414726|4169770|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4342275|NCT00414726|4169771|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4342276|NCT00414726|4169772|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4342277|NCT00414726|4169770|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4342278|NCT00414726|4169771|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4342279|NCT00414726|4169772|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4342280|NCT00414726|4169770|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4342281|NCT00414726|4169771|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4342282|NCT00414726|4169772|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4342283|NCT00414726|4169770|B3|||Age||years|Mean|73.7|73.7|Standard Deviation|14|14.0|||
4342284|NCT00414726|4169771|B2|||Age||years|Mean|73.4|73.4|Standard Deviation|14|14.0|||
4342285|NCT00414726|4169772|B1|||Age||years|Mean|74.1|74.1|Standard Deviation|14|14.0|||
4342286|NCT00414700|4169781|B3|Netherlands||Region of Enrollment||participants|Number|36|36.0||||||
4342287|NCT00414700|4169782|B2|Netherlands||Region of Enrollment||participants|Number|17|17.0||||||
4342288|NCT00414700|4169783|B1|Netherlands||Region of Enrollment||participants|Number|19|19.0||||||
4342289|NCT00414700|4169781|B3|Germany||Region of Enrollment||participants|Number|5|5.0||||||
4342290|NCT00414700|4169782|B2|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4342291|NCT00414700|4169783|B1|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4342292|NCT00414700|4169781|B3|Croatia||Region of Enrollment||participants|Number|9|9.0||||||
4342293|NCT00414700|4169782|B2|Croatia||Region of Enrollment||participants|Number|5|5.0||||||
4342294|NCT00414700|4169783|B1|Croatia||Region of Enrollment||participants|Number|4|4.0||||||
4342295|NCT00414700|4169781|B3|Belgium||Region of Enrollment||participants|Number|68|68.0||||||
4342296|NCT00414700|4169782|B2|Belgium||Region of Enrollment||participants|Number|35|35.0||||||
4342297|NCT00414700|4169783|B1|Belgium||Region of Enrollment||participants|Number|33|33.0||||||
4342298|NCT00414700|4169781|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4342299|NCT00414700|4169782|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4342300|NCT00414700|4169783|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4342301|NCT00414700|4169781|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4342302|NCT00414700|4169782|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4342303|NCT00414700|4169783|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4342304|NCT00414700|4169781|B3|||Age||years|Mean|33.92|33.92|Standard Deviation|8.54|8.54|||
4342305|NCT00414700|4169782|B2|||Age||years|Mean|33.92|33.92|Standard Deviation|8.61|8.61|||
4342306|NCT00414700|4169783|B1|||Age||years|Mean|33.93|33.93|Standard Deviation|8.54|8.54|||
4342307|NCT00414700|4169781|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4342308|NCT00414700|4169782|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4342309|NCT00414700|4169783|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4342310|NCT00414700|4169781|B3||Between 18 and 65 years|Age||Participants|Count of Participants|118|118.0||||||
4342311|NCT00414700|4169782|B2||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4342312|NCT00414700|4169783|B1||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4342313|NCT00414700|4169781|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342314|NCT00414700|4169782|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342315|NCT00414700|4169783|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342316|NCT00414661|4169804|B5||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4342317|NCT00414661|4169805|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4342318|NCT00414661|4169806|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4342319|NCT00414661|4169807|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4342320|NCT00414661|4169808|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4342321|NCT00414661|4169804|B5||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4342322|NCT00414661|4169805|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4342323|NCT00414661|4169806|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4342324|NCT00414661|4169807|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4342325|NCT00414661|4169808|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4342326|NCT00414661|4169804|B5|||Age||years|Mean|55.0|55.0|Standard Deviation|11.7|11.7|||
4342327|NCT00414661|4169805|B4|||Age||years|Mean|52.3|52.3|Standard Deviation|16.0|16.0|||
4342328|NCT00414661|4169806|B3|||Age||years|Mean|51.8|51.8|Standard Deviation|13.5|13.5|||
4342329|NCT00414661|4169807|B2|||Age||years|Mean|54.7|54.7|Standard Deviation|11.6|11.6|||
4342330|NCT00414661|4169808|B1|||Age||years|Mean|57.2|57.2|Standard Deviation|10.8|10.8|||
4342331|NCT00414635|4169833|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4342332|NCT00414635|4169834|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4342333|NCT00414635|4169835|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4342334|NCT00414635|4169833|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4342335|NCT00414635|4169834|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4342336|NCT00414635|4169835|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4342337|NCT00414635|4169833|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4342338|NCT00414635|4169834|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4342339|NCT00414635|4169835|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4342340|NCT00414635|4169833|B3|||Age||years|Mean|44|44.0|Standard Deviation|9.4|9.4|||
4342341|NCT00414635|4169834|B2|||Age||years|Mean|47|47.0|Standard Deviation|9.9|9.9|||
4342342|NCT00414635|4169835|B1|||Age||years|Mean|42|42.0|Standard Deviation|8.1|8.1|||
4342343|NCT00414635|4169833|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4342344|NCT00414635|4169834|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4342345|NCT00414635|4169835|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4342346|NCT00414635|4169833|B3||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4342347|NCT00414635|4169834|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4342348|NCT00414635|4169835|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4342349|NCT00414635|4169833|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342350|NCT00414635|4169834|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342351|NCT00414635|4169835|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342352|NCT00414609|4169854|B3||Male|Sex: Female, Male||Participants|Count of Participants|679|679.0||||||
4342353|NCT00414609|4169855|B2||Male|Sex: Female, Male||Participants|Count of Participants|343|343.0||||||
4342354|NCT00414609|4169856|B1||Male|Sex: Female, Male||Participants|Count of Participants|336|336.0||||||
4342355|NCT00414609|4169854|B3||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4342356|NCT00414609|4169855|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4342357|NCT00414609|4169856|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4342358|NCT00414609|4169854|B3|≥ 75 years||Age, Customized||Participants|Number|98|98.0||||||
4342359|NCT00414609|4169855|B2|≥ 75 years||Age, Customized||Participants|Number|55|55.0||||||
4342360|NCT00414609|4169856|B1|≥ 75 years||Age, Customized||Participants|Number|43|43.0||||||
4342361|NCT00414609|4169854|B3|≥ 65 years and < 75 years||Age, Customized||Participants|Number|207|207.0||||||
4342362|NCT00414609|4169855|B2|≥ 65 years and < 75 years||Age, Customized||Participants|Number|114|114.0||||||
4342363|NCT00414609|4169856|B1|≥ 65 years and < 75 years||Age, Customized||Participants|Number|93|93.0||||||
4342364|NCT00414609|4169854|B3|< 65 years||Age, Customized||Participants|Number|515|515.0||||||
4342365|NCT00414609|4169855|B2|< 65 years||Age, Customized||Participants|Number|254|254.0||||||
4342366|NCT00414609|4169856|B1|< 65 years||Age, Customized||Participants|Number|261|261.0||||||
4342367|NCT00414609|4169854|B3|||Age|Demographics were measured for core randomized population|years|Mean|60.0|60.0|Standard Deviation|11.66|11.66|||
4342368|NCT00414609|4169855|B2|||Age|Demographics were measured for core randomized population|years|Mean|60.7|60.7|Standard Deviation|11.63|11.63|||
4342369|NCT00414609|4169856|B1|||Age|Demographics were measured for core randomized population|years|Mean|59.4|59.4|Standard Deviation|11.67|11.67|||
4342370|NCT00414596|4169881|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4342371|NCT00414596|4169881|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4342372|NCT00414596|4169881|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4342373|NCT00414596|4169881|B1|||Age||years|Mean|46.6|46.6|Standard Deviation|15|15.0|||
4342374|NCT00414596|4169881|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4342375|NCT00414596|4169881|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4342376|NCT00414596|4169881|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342377|NCT00414544|4169890|B1|United States||Region of Enrollment||participants|Number|145|145.0||||||
4342378|NCT00414544|4169890|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4342379|NCT00414544|4169890|B1||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4342380|NCT00414544|4169890|B1|||Age||years|Mean|53.9|53.9|Standard Deviation|10.0|10.0|||
4342381|NCT00414544|4169890|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4342382|NCT00414544|4169890|B1||Between 18 and 65 years|Age||Participants|Count of Participants|122|122.0||||||
4342383|NCT00414544|4169890|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342384|NCT00414518|4169896|B3|Zimbabwe||Region of Enrollment||participants|Number|9|9.0||||||
4342385|NCT00414518|4169897|B2|Zimbabwe||Region of Enrollment||participants|Number|5|5.0||||||
4342386|NCT00414518|4169898|B1|Zimbabwe||Region of Enrollment||participants|Number|4|4.0||||||
4342387|NCT00414518|4169896|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4342388|NCT00414518|4169897|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4342389|NCT00414518|4169898|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4342390|NCT00414518|4169896|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4342391|NCT00414518|4169897|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4342392|NCT00414518|4169898|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4342393|NCT00414518|4169896|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4342394|NCT00414518|4169897|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4342395|NCT00414518|4169898|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4342396|NCT00414518|4169896|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4342397|NCT00414518|4169897|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4342398|NCT00414518|4169898|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4342399|NCT00414518|4169896|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4342400|NCT00414518|4169897|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4342401|NCT00414518|4169898|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4342402|NCT00414518|4169896|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342403|NCT00414518|4169897|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342404|NCT00414518|4169898|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342405|NCT00414466|4169909|B5|United States||Region of Enrollment||participants|Number|170|170.0||||||
4342406|NCT00414466|4169910|B4|United States||Region of Enrollment||participants|Number|43|43.0||||||
4342407|NCT00414466|4169911|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
4342408|NCT00414466|4169912|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
4342409|NCT00414466|4169913|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4342410|NCT00414466|4169909|B5||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4342411|NCT00414466|4169910|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4342412|NCT00414466|4169911|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4342413|NCT00414466|4169912|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4342414|NCT00414466|4169913|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4342415|NCT00414466|4169909|B5||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4342416|NCT00414466|4169910|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4342417|NCT00414466|4169911|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4342418|NCT00414466|4169912|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4342419|NCT00414466|4169913|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4342420|NCT00414466|4169909|B5|||Age||years|Mean|49.6|49.6|Standard Deviation|10.5|10.5|||
4342421|NCT00414466|4169910|B4|||Age||years|Mean|48.3|48.3|Standard Deviation|11.1|11.1|||
4342422|NCT00414466|4169911|B3|||Age||years|Mean|48.1|48.1|Standard Deviation|9.4|9.4|||
4342423|NCT00414466|4169912|B2|||Age||years|Mean|50.1|50.1|Standard Deviation|9.9|9.9|||
4342424|NCT00414466|4169913|B1|||Age||years|Mean|51.8|51.8|Standard Deviation|11.2|11.2|||
4342425|NCT00414466|4169909|B5||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4342426|NCT00414466|4169910|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4342427|NCT00414466|4169911|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4342428|NCT00414466|4169912|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4342429|NCT00414466|4169913|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4342430|NCT00414466|4169909|B5||Between 18 and 65 years|Age||Participants|Count of Participants|160|160.0||||||
4342431|NCT00414466|4169910|B4||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4342432|NCT00414466|4169911|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4342433|NCT00414466|4169912|B2||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4342434|NCT00414466|4169913|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4342435|NCT00414466|4169909|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342436|NCT00414466|4169910|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342437|NCT00414466|4169911|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342438|NCT00414466|4169912|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342439|NCT00414466|4169913|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342440|NCT00414453|4169934|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4342441|NCT00414453|4169934|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4342442|NCT00414453|4169934|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4342443|NCT00414453|4169934|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4342444|NCT00414453|4169934|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4342445|NCT00414453|4169934|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342446|NCT00414440|4169980|B3|Other, Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4342447|NCT00414440|4169981|B2|Other, Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4342448|NCT00414440|4169982|B1|Other, Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4342449|NCT00414440|4169980|B3|White||Race/Ethnicity, Customized||participants|Number|425|425.0||||||
4342450|NCT00414440|4169981|B2|White||Race/Ethnicity, Customized||participants|Number|217|217.0||||||
4342451|NCT00414440|4169982|B1|White||Race/Ethnicity, Customized||participants|Number|208|208.0||||||
4342452|NCT00414440|4169980|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4342453|NCT00414440|4169981|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4342454|NCT00414440|4169982|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4342455|NCT00414440|4169980|B3|Asian Oriental||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4342456|NCT00414440|4169981|B2|Asian Oriental||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4342457|NCT00414440|4169982|B1|Asian Oriental||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4342458|NCT00414440|4169980|B3||Male|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4342459|NCT00414440|4169981|B2||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4342460|NCT00414440|4169982|B1||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4342461|NCT00414440|4169980|B3||Female|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4342462|NCT00414440|4169981|B2||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4342463|NCT00414440|4169982|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4342464|NCT00414440|4169980|B3|||Age|Average age of participants|years|Mean|44.5|44.5|Standard Deviation|10.3|10.3|||
4342465|NCT00414440|4169981|B2|||Age|Average age of participants|years|Mean|44.5|44.5|Standard Deviation|10.4|10.4|||
4342466|NCT00414440|4169982|B1|||Age|Average age of participants|years|Mean|44.6|44.6|Standard Deviation|10.1|10.1|||
4342467|NCT00414388|4169997|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4342468|NCT00414388|4169997|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4342469|NCT00414388|4169997|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4342470|NCT00414388|4169997|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4342471|NCT00414388|4169997|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4342472|NCT00414388|4169997|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342473|NCT00414310|4170003|B3|United States||Region of Enrollment||participants|Number|150|150.0||||||
4342474|NCT00414310|4170004|B2|United States||Region of Enrollment||participants|Number|79|79.0||||||
4342475|NCT00414310|4170005|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
4342476|NCT00414310|4170003|B3||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4342477|NCT00414310|4170004|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4342478|NCT00414310|4170005|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4342479|NCT00414310|4170003|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4342480|NCT00414310|4170004|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4342481|NCT00414310|4170005|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4342482|NCT00414310|4170003|B3|||Age||years|Median|69|69.0|Full Range|||20.0|90.0|
4342483|NCT00414310|4170004|B2|||Age||years|Median|66|66.0|Full Range|||20.0|90.0|
4342484|NCT00414310|4170005|B1|||Age||years|Median|71|71.0|Full Range|||39.0|85.0|
4342485|NCT00414206|4170012|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
4342486|NCT00414206|4170013|B3|United States||Region of Enrollment||participants|Number|0|0.0||||||
4342487|NCT00414206|4170014|B2|United States||Region of Enrollment||participants|Number|0|0.0||||||
4342488|NCT00414206|4170015|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4342489|NCT00414206|4170012|B4|Russian Federation||Region of Enrollment||participants|Number|80|80.0||||||
4342490|NCT00414206|4170013|B3|Russian Federation||Region of Enrollment||participants|Number|28|28.0||||||
4342491|NCT00414206|4170014|B2|Russian Federation||Region of Enrollment||participants|Number|26|26.0||||||
4342492|NCT00414206|4170015|B1|Russian Federation||Region of Enrollment||participants|Number|26|26.0||||||
4342493|NCT00414206|4170012|B4|Ukraine||Region of Enrollment||participants|Number|101|101.0||||||
4342494|NCT00414206|4170013|B3|Ukraine||Region of Enrollment||participants|Number|35|35.0||||||
4342495|NCT00414206|4170014|B2|Ukraine||Region of Enrollment||participants|Number|32|32.0||||||
4342496|NCT00414206|4170015|B1|Ukraine||Region of Enrollment||participants|Number|34|34.0||||||
4342497|NCT00414206|4170012|B4|Poland||Region of Enrollment||participants|Number|57|57.0||||||
4342498|NCT00414206|4170013|B3|Poland||Region of Enrollment||participants|Number|17|17.0||||||
4342499|NCT00414206|4170014|B2|Poland||Region of Enrollment||participants|Number|21|21.0||||||
4342500|NCT00414206|4170015|B1|Poland||Region of Enrollment||participants|Number|19|19.0||||||
4342501|NCT00414206|4170012|B4|Brazil||Region of Enrollment||participants|Number|44|44.0||||||
4342502|NCT00414206|4170013|B3|Brazil||Region of Enrollment||participants|Number|16|16.0||||||
4342503|NCT00414206|4170014|B2|Brazil||Region of Enrollment||participants|Number|13|13.0||||||
4342504|NCT00414206|4170015|B1|Brazil||Region of Enrollment||participants|Number|15|15.0||||||
4342505|NCT00414206|4170012|B4|Mexico||Region of Enrollment||participants|Number|20|20.0||||||
4342506|NCT00414206|4170013|B3|Mexico||Region of Enrollment||participants|Number|6|6.0||||||
4342507|NCT00414206|4170014|B2|Mexico||Region of Enrollment||participants|Number|7|7.0||||||
4342508|NCT00414206|4170015|B1|Mexico||Region of Enrollment||participants|Number|7|7.0||||||
4342509|NCT00414206|4170012|B4|Czech Republic||Region of Enrollment||participants|Number|38|38.0||||||
4342510|NCT00414206|4170013|B3|Czech Republic||Region of Enrollment||participants|Number|12|12.0||||||
4342511|NCT00414206|4170014|B2|Czech Republic||Region of Enrollment||participants|Number|15|15.0||||||
4342512|NCT00414206|4170015|B1|Czech Republic||Region of Enrollment||participants|Number|11|11.0||||||
4342513|NCT00414206|4170012|B4||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4342514|NCT00414206|4170013|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4342515|NCT00414206|4170014|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4342516|NCT00414206|4170015|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4342517|NCT00414206|4170012|B4||Female|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
4342518|NCT00414206|4170013|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4342519|NCT00414206|4170014|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4342520|NCT00414206|4170015|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4342521|NCT00414206|4170012|B4|||Age||years|Mean|72.4|72.4|Standard Deviation|8.2|8.2|||
4342522|NCT00414206|4170013|B3|||Age||years|Mean|71.3|71.3|Standard Deviation|7.7|7.7|||
4342523|NCT00414206|4170014|B2|||Age||years|Mean|72.6|72.6|Standard Deviation|8.7|8.7|||
4342524|NCT00414206|4170015|B1|||Age||years|Mean|73.2|73.2|Standard Deviation|8|8.0|||
4342525|NCT00414167|4170025|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4342526|NCT00414167|4170026|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4342527|NCT00414167|4170027|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4342528|NCT00414167|4170025|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4342529|NCT00414167|4170026|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4342530|NCT00414167|4170027|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4342531|NCT00414167|4170025|B3|||Age||years|Mean|44.2|44.2|Standard Deviation|12.5|12.5|||
4342532|NCT00414167|4170026|B2|||Age||years|Mean|43.1|43.1|Standard Deviation|13.0|13.0|||
4342533|NCT00414167|4170027|B1|||Age||years|Mean|45.2|45.2|Standard Deviation|12.1|12.1|||
4342534|NCT00414167|4170025|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4342535|NCT00414167|4170026|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4342536|NCT00414167|4170027|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4342537|NCT00414167|4170025|B3||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4342538|NCT00414167|4170026|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4342539|NCT00414167|4170027|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4342540|NCT00414167|4170025|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342541|NCT00414167|4170026|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342542|NCT00414167|4170027|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342543|NCT00414076|4170036|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4342544|NCT00414076|4170037|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4342545|NCT00414076|4170038|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4342546|NCT00414076|4170036|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4342547|NCT00414076|4170037|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4342548|NCT00414076|4170038|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4342549|NCT00414076|4170036|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4342550|NCT00414076|4170037|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4342551|NCT00414076|4170038|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4342552|NCT00414076|4170036|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4342553|NCT00414076|4170037|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4342554|NCT00414076|4170038|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4342555|NCT00414076|4170036|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4342556|NCT00414076|4170037|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4342557|NCT00414076|4170038|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4342558|NCT00414076|4170036|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4342559|NCT00414076|4170037|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4342560|NCT00414076|4170038|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4342561|NCT00414076|4170036|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4342562|NCT00414076|4170037|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4342563|NCT00414076|4170038|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4342564|NCT00414076|4170036|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4342565|NCT00414076|4170037|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4342566|NCT00414076|4170038|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4342567|NCT00414076|4170036|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4342568|NCT00414076|4170037|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4342569|NCT00414076|4170038|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4342570|NCT00414076|4170036|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4342571|NCT00414076|4170037|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4342572|NCT00414076|4170038|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4342573|NCT00414076|4170036|B3|||Age||years|Mean|49|49.0|Full Range|||38.0|60.0|
4342574|NCT00414076|4170037|B2|||Age||years|Mean|51|51.0|Full Range|||38.0|60.0|
4342575|NCT00414076|4170038|B1|||Age||years|Mean|48|48.0|Full Range|||43.0|54.0|
4342576|NCT00414076|4170036|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4342577|NCT00414076|4170037|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4342578|NCT00414076|4170038|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4342579|NCT00414076|4170036|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4342580|NCT00414076|4170037|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4342581|NCT00414076|4170038|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4342582|NCT00414076|4170036|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342583|NCT00414076|4170037|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342584|NCT00414076|4170038|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342585|NCT00414050|4170045|B5||Male|Sex: Female, Male||Participants|Count of Participants|902|902.0||||||
4342586|NCT00414050|4170046|B4||Male|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4342587|NCT00414050|4170047|B3||Male|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
4342588|NCT00414050|4170048|B2||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4342589|NCT00414050|4170049|B1||Male|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
4342590|NCT00414050|4170045|B5||Female|Sex: Female, Male||Participants|Count of Participants|816|816.0||||||
4342591|NCT00414050|4170046|B4||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4342592|NCT00414050|4170047|B3||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4342593|NCT00414050|4170048|B2||Female|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
4342594|NCT00414050|4170049|B1||Female|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4342595|NCT00414050|4170045|B5|||Age||days|Mean|63.1|63.1|Standard Deviation|9.99|9.99|||
4342596|NCT00414050|4170046|B4|||Age||days|Mean|62.8|62.8|Standard Deviation|9.81|9.81|||
4342597|NCT00414050|4170047|B3|||Age||days|Mean|63.3|63.3|Standard Deviation|9.83|9.83|||
4342598|NCT00414050|4170048|B2|||Age||days|Mean|62.9|62.9|Standard Deviation|10.15|10.15|||
4342599|NCT00414050|4170049|B1|||Age||days|Mean|63.2|63.2|Standard Deviation|10.18|10.18|||
4342600|NCT00414011|4170066|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4342601|NCT00414011|4170066|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4342602|NCT00414011|4170066|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4342603|NCT00414011|4170066|B1|||Age||years|Mean|33.7|33.7|Standard Deviation|7|7.0|||
4342604|NCT00414011|4170066|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4342605|NCT00414011|4170066|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4342606|NCT00414011|4170066|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342607|NCT00413972|4170071|B5|China||Region of Enrollment||participants|Number|389|389.0||||||
4342608|NCT00413972|4170072|B4|China||Region of Enrollment||participants|Number|97|97.0||||||
4342609|NCT00413972|4170073|B3|China||Region of Enrollment||participants|Number|98|98.0||||||
4342610|NCT00413972|4170074|B2|China||Region of Enrollment||participants|Number|97|97.0||||||
4342611|NCT00413972|4170075|B1|China||Region of Enrollment||participants|Number|97|97.0||||||
4342612|NCT00413972|4170071|B5||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4342613|NCT00413972|4170072|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4342614|NCT00413972|4170073|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4342615|NCT00413972|4170074|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4342616|NCT00413972|4170075|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4342617|NCT00413972|4170071|B5||Female|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
4342618|NCT00413972|4170072|B4||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4342619|NCT00413972|4170073|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4342620|NCT00413972|4170074|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4342621|NCT00413972|4170075|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4342622|NCT00413972|4170071|B5|||Age||years|Mean|58.2|58.2|Standard Deviation|10.07|10.07|||
4342623|NCT00413972|4170072|B4|||Age||years|Mean|60.2|60.2|Standard Deviation|9.2|9.2|||
4342624|NCT00413972|4170073|B3|||Age||years|Mean|56.4|56.4|Standard Deviation|10.3|10.3|||
4342625|NCT00413972|4170074|B2|||Age||years|Mean|57.4|57.4|Standard Deviation|9.7|9.7|||
4342626|NCT00413972|4170075|B1|||Age||years|Mean|58.2|58.2|Standard Deviation|10.7|10.7|||
4342627|NCT00413959|4170088|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4342628|NCT00413959|4170088|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4342629|NCT00413959|4170088|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4342630|NCT00413959|4170088|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4342631|NCT00413959|4170088|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4342632|NCT00413959|4170088|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342633|NCT00413920|4170093|B3||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4342634|NCT00413920|4170094|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4342635|NCT00413920|4170095|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4342636|NCT00413920|4170093|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4342637|NCT00413920|4170094|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4342638|NCT00413920|4170095|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4342639|NCT00413920|4170093|B3|>= 60 years||Age, Customized||Participants|Number|50|50.0||||||
4342640|NCT00413920|4170094|B2|>= 60 years||Age, Customized||Participants|Number|27|27.0||||||
4342641|NCT00413920|4170095|B1|>= 60 years||Age, Customized||Participants|Number|23|23.0||||||
4342642|NCT00413920|4170093|B3|45-60 years||Age, Customized||Participants|Number|114|114.0||||||
4342643|NCT00413920|4170094|B2|45-60 years||Age, Customized||Participants|Number|58|58.0||||||
4342644|NCT00413920|4170095|B1|45-60 years||Age, Customized||Participants|Number|56|56.0||||||
4342645|NCT00413920|4170093|B3|< 45 years||Age, Customized||Participants|Number|58|58.0||||||
4342646|NCT00413920|4170094|B2|< 45 years||Age, Customized||Participants|Number|25|25.0||||||
4342647|NCT00413920|4170095|B1|< 45 years||Age, Customized||Participants|Number|33|33.0||||||
4342648|NCT00413920|4170093|B3|||Age||years|Mean|51.0|51.0|Standard Deviation|11.07|11.07|||
4342649|NCT00413920|4170094|B2|||Age||years|Mean|50.9|50.9|Standard Deviation|11.91|11.91|||
4342650|NCT00413920|4170095|B1|||Age||years|Mean|51.0|51.0|Standard Deviation|10.24|10.24|||
4342651|NCT00413894|4170111|B1||Male|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
4342652|NCT00413894|4170111|B1||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4342653|NCT00413894|4170111|B1|||Age||years|Mean|63.1|63.1|Standard Deviation|14.7|14.7|||
4342654|NCT00413777|4170126|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4342655|NCT00413777|4170127|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4342656|NCT00413777|4170128|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4342657|NCT00413777|4170126|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4342658|NCT00413777|4170127|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4342659|NCT00413777|4170128|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4342660|NCT00413777|4170126|B3|||Age||Years|Mean|41.7|41.7|Standard Deviation|8.3|8.3|||
4342661|NCT00413777|4170127|B2|||Age||Years|Mean|43.9|43.9|Standard Deviation|7.8|7.8|||
4342662|NCT00413777|4170128|B1|||Age||Years|Mean|39.3|39.3|Standard Deviation|8.4|8.4|||
4342663|NCT00413699|4170175|B3|Male||Sex/Gender, Customized||Participants|Count of Participants|810|810.0||||||
4342664|NCT00413699|4170176|B2|Male||Sex/Gender, Customized||Participants|Count of Participants|614|614.0||||||
4342665|NCT00413699|4170177|B1|Male||Sex/Gender, Customized||Participants|Count of Participants|196|196.0||||||
4342666|NCT00413699|4170175|B3|Female||Sex/Gender, Customized||Participants|Count of Participants|3671|3671.0||||||
4342667|NCT00413699|4170176|B2|Female||Sex/Gender, Customized||Participants|Count of Participants|2744|2744.0||||||
4342668|NCT00413699|4170177|B1|Female||Sex/Gender, Customized||Participants|Count of Participants|927|927.0||||||
4342669|NCT00413699|4170175|B3|>=65 years||Age, Customized||Participants|Count of Participants|727|727.0||||||
4342670|NCT00413699|4170176|B2|>=65 years||Age, Customized||Participants|Count of Participants|520|520.0||||||
4342671|NCT00413699|4170177|B1|>=65 years||Age, Customized||Participants|Count of Participants|207|207.0||||||
4342672|NCT00413699|4170175|B3|18 to 64 years||Age, Customized||Participants|Count of Participants|3754|3754.0||||||
4342673|NCT00413699|4170176|B2|18 to 64 years||Age, Customized||Participants|Count of Participants|2838|2838.0||||||
4342674|NCT00413699|4170177|B1|18 to 64 years||Age, Customized||Participants|Count of Participants|916|916.0||||||
4342675|NCT00413699|4170175|B3|<18 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4342676|NCT00413699|4170176|B2|<18 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4342677|NCT00413699|4170177|B1|<18 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4342678|NCT00413660|4170254|B8||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4342679|NCT00413660|4170255|B7||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4342680|NCT00413660|4170256|B6||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4342681|NCT00413660|4170257|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4342682|NCT00413660|4170258|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4342683|NCT00413660|4170259|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4342684|NCT00413660|4170260|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4342685|NCT00413660|4170261|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4342686|NCT00413660|4170254|B8||Female|Sex: Female, Male||Participants|Count of Participants|406|406.0||||||
4342687|NCT00413660|4170255|B7||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4342688|NCT00413660|4170256|B6||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4342689|NCT00413660|4170257|B5||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4342690|NCT00413660|4170258|B4||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4342691|NCT00413660|4170259|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4342692|NCT00413660|4170260|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4342693|NCT00413660|4170261|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4342694|NCT00413660|4170254|B8|Greater Than or Equal to (>=) 65 Years||Age, Customized||participants|Number|88|88.0||||||
4342695|NCT00413660|4170255|B7|Greater Than or Equal to (>=) 65 Years||Age, Customized||participants|Number|12|12.0||||||
4342696|NCT00413660|4170256|B6|Greater Than or Equal to (>=) 65 Years||Age, Customized||participants|Number|16|16.0||||||
4342697|NCT00413660|4170257|B5|Greater Than or Equal to (>=) 65 Years||Age, Customized||participants|Number|12|12.0||||||
4342698|NCT00413660|4170258|B4|Greater Than or Equal to (>=) 65 Years||Age, Customized||participants|Number|16|16.0||||||
4342699|NCT00413660|4170259|B3|Greater Than or Equal to (>=) 65 Years||Age, Customized||participants|Number|10|10.0||||||
4342700|NCT00413660|4170260|B2|Greater Than or Equal to (>=) 65 Years||Age, Customized||participants|Number|14|14.0||||||
4342701|NCT00413660|4170261|B1|Greater Than or Equal to (>=) 65 Years||Age, Customized||participants|Number|8|8.0||||||
4342702|NCT00413660|4170254|B8|45 to 64 Years||Age, Customized||participants|Number|307|307.0||||||
4342703|NCT00413660|4170255|B7|45 to 64 Years||Age, Customized||participants|Number|40|40.0||||||
4342704|NCT00413660|4170256|B6|45 to 64 Years||Age, Customized||participants|Number|49|49.0||||||
4342705|NCT00413660|4170257|B5|45 to 64 Years||Age, Customized||participants|Number|49|49.0||||||
4342706|NCT00413660|4170258|B4|45 to 64 Years||Age, Customized||participants|Number|49|49.0||||||
4342707|NCT00413660|4170259|B3|45 to 64 Years||Age, Customized||participants|Number|42|42.0||||||
4342708|NCT00413660|4170260|B2|45 to 64 Years||Age, Customized||participants|Number|31|31.0||||||
4342709|NCT00413660|4170261|B1|45 to 64 Years||Age, Customized||participants|Number|47|47.0||||||
4342710|NCT00413660|4170254|B8|18 to 44 Years||Age, Customized||participants|Number|112|112.0||||||
4342711|NCT00413660|4170255|B7|18 to 44 Years||Age, Customized||participants|Number|17|17.0||||||
4342712|NCT00413660|4170256|B6|18 to 44 Years||Age, Customized||participants|Number|15|15.0||||||
4342713|NCT00413660|4170257|B5|18 to 44 Years||Age, Customized||participants|Number|14|14.0||||||
4342714|NCT00413660|4170258|B4|18 to 44 Years||Age, Customized||participants|Number|9|9.0||||||
4342715|NCT00413660|4170259|B3|18 to 44 Years||Age, Customized||participants|Number|19|19.0||||||
4342716|NCT00413660|4170260|B2|18 to 44 Years||Age, Customized||participants|Number|23|23.0||||||
4342717|NCT00413660|4170261|B1|18 to 44 Years||Age, Customized||participants|Number|15|15.0||||||
4342718|NCT00413634|4170617|B3|Serbia||Region of Enrollment||participants|Number|2.0|2.0||||||
4342719|NCT00413634|4170618|B2|Serbia||Region of Enrollment||participants|Number|0|0.0||||||
4342720|NCT00413634|4170619|B1|Serbia||Region of Enrollment||participants|Number|2|2.0||||||
4342721|NCT00413634|4170617|B3|Sweden||Region of Enrollment||participants|Number|2.0|2.0||||||
4342722|NCT00413634|4170618|B2|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
4342723|NCT00413634|4170619|B1|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
4342724|NCT00413634|4170617|B3|Spain||Region of Enrollment||participants|Number|2.0|2.0||||||
4342725|NCT00413634|4170618|B2|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4342726|NCT00413634|4170619|B1|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4342727|NCT00413634|4170617|B3|United Kingdom||Region of Enrollment||participants|Number|3.0|3.0||||||
4342728|NCT00413634|4170618|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4342729|NCT00413634|4170619|B1|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4342730|NCT00413634|4170617|B3|Germany||Region of Enrollment||participants|Number|15.0|15.0||||||
4342731|NCT00413634|4170618|B2|Germany||Region of Enrollment||participants|Number|10|10.0||||||
4342732|NCT00413634|4170619|B1|Germany||Region of Enrollment||participants|Number|5|5.0||||||
4342733|NCT00413634|4170617|B3||Male|Sex: Female, Male||Participants|Count of Participants|7.0|7.0||||||
4342734|NCT00413634|4170618|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4342735|NCT00413634|4170619|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4342736|NCT00413634|4170617|B3||Female|Sex: Female, Male||Participants|Count of Participants|17.0|17.0||||||
4342737|NCT00413634|4170618|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4342738|NCT00413634|4170619|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4342739|NCT00413634|4170617|B3|||Age||years|Mean|54.2|54.2|Standard Deviation|16.5|16.5|||
4342740|NCT00413634|4170618|B2|||Age||years|Mean|69.2|69.2|Standard Deviation|3.0|3.0|||
4342741|NCT00413634|4170619|B1|||Age||years|Mean|39.2|39.2|Standard Deviation|8.4|8.4|||
4342742|NCT00413634|4170617|B3||>=65 years|Age||Participants|Count of Participants|12.0|12.0||||||
4342743|NCT00413634|4170618|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4342744|NCT00413634|4170619|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4342745|NCT00413634|4170617|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12.0|12.0||||||
4342746|NCT00413634|4170618|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4342747|NCT00413634|4170619|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4342748|NCT00413634|4170617|B3||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4342749|NCT00413634|4170618|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342750|NCT00413634|4170619|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342751|NCT00413582|4170656|B3|United States||Region of Enrollment||participants|Number|110|110.0||||||
4342752|NCT00413582|4170657|B2|United States||Region of Enrollment||participants|Number|55|55.0||||||
4342753|NCT00413582|4170658|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4342754|NCT00413582|4170656|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4342755|NCT00413582|4170657|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4342756|NCT00413582|4170658|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4342757|NCT00413582|4170656|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4342758|NCT00413582|4170657|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4342759|NCT00413582|4170658|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4342760|NCT00413582|4170656|B3|||Age||years|Mean|14.43|14.43|Standard Deviation|2.99|2.99|||
4342761|NCT00413582|4170657|B2|||Age||years|Mean|13.55|13.55|Standard Deviation|2.91|2.91|||
4342762|NCT00413582|4170658|B1|||Age||years|Mean|15.3|15.3|Standard Deviation|2.84|2.84|||
4342763|NCT00413582|4170656|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4342764|NCT00413582|4170657|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4342765|NCT00413582|4170658|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4342766|NCT00413582|4170656|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4342767|NCT00413582|4170657|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4342768|NCT00413582|4170658|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4342769|NCT00413582|4170656|B3||<=18 years|Age||Participants|Count of Participants|102|102.0||||||
4342770|NCT00413582|4170657|B2||<=18 years|Age||Participants|Count of Participants|53|53.0||||||
4342771|NCT00413582|4170658|B1||<=18 years|Age||Participants|Count of Participants|49|49.0||||||
4342772|NCT00413478|4170667|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4342773|NCT00413478|4170667|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4342774|NCT00413478|4170667|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4342775|NCT00413478|4170667|B1|||Age||years|Median|74|74.0|Full Range|||49.0|81.0|
4342776|NCT00413413|4170671|B4||Male|Sex: Female, Male||Participants|Count of Participants|570|570.0||||||
4342777|NCT00413413|4170672|B3||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4342778|NCT00413413|4170673|B2||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4342779|NCT00413413|4170674|B1||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4342780|NCT00413413|4170671|B4||Female|Sex: Female, Male||Participants|Count of Participants|346|346.0||||||
4342781|NCT00413413|4170672|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4342782|NCT00413413|4170673|B2||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4342783|NCT00413413|4170674|B1||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4342839|NCT00413283|4170757|B5|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4343028|NCT00413062|4170951|B2||Female|Sex: Female, Male||Participants|Count of Participants|554|554.0||||||
4342784|NCT00413413|4170671|B4|||Age|All baseline measures were based on Full-set analysis population. Two patients were excluded from the full-set analysis population for having no post-baseline efficacy assessment. All randomized patients were included in the safety population.|years|Mean|51.5|51.5|Standard Deviation|9.8|9.8|||
4342785|NCT00413413|4170672|B3|||Age|All baseline measures were based on Full-set analysis population. Two patients were excluded from the full-set analysis population for having no post-baseline efficacy assessment. All randomized patients were included in the safety population.|years|Mean|51.2|51.2|Standard Deviation|9.6|9.6|||
4342786|NCT00413413|4170673|B2|||Age|All baseline measures were based on Full-set analysis population. Two patients were excluded from the full-set analysis population for having no post-baseline efficacy assessment. All randomized patients were included in the safety population.|years|Mean|51.7|51.7|Standard Deviation|8.9|8.9|||
4342787|NCT00413413|4170674|B1|||Age|All baseline measures were based on Full-set analysis population. Two patients were excluded from the full-set analysis population for having no post-baseline efficacy assessment. All randomized patients were included in the safety population.|years|Mean|51.6|51.6|Standard Deviation|10.8|10.8|||
4342788|NCT00413400|4170696|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4342789|NCT00413400|4170697|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4342790|NCT00413400|4170698|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4342791|NCT00413400|4170696|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4342792|NCT00413400|4170697|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4342793|NCT00413400|4170698|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4342794|NCT00413400|4170696|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4342795|NCT00413400|4170697|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4342796|NCT00413400|4170698|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4342797|NCT00413400|4170696|B3|||Age||years|Mean|45|45.0|Standard Deviation|9|9.0|||
4342798|NCT00413400|4170697|B2|||Age||years|Mean|41|41.0|Standard Deviation|9|9.0|||
4342799|NCT00413400|4170698|B1|||Age||years|Mean|47|47.0|Standard Deviation|8|8.0|||
4342800|NCT00413400|4170696|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4342801|NCT00413400|4170697|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4342802|NCT00413400|4170698|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4342803|NCT00413400|4170696|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4342804|NCT00413400|4170697|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4342805|NCT00413400|4170698|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4342806|NCT00413400|4170696|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342807|NCT00413400|4170697|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342808|NCT00413400|4170698|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342809|NCT00413374|4170727|B3|United States||Region of Enrollment||participants|Number|120|120.0||||||
4342810|NCT00413374|4170728|B2|United States||Region of Enrollment||participants|Number|80|80.0||||||
4342811|NCT00413374|4170729|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4342812|NCT00413374|4170727|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4342813|NCT00413374|4170728|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4342814|NCT00413374|4170729|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4342815|NCT00413374|4170727|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4342816|NCT00413374|4170728|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4342817|NCT00413374|4170729|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4342818|NCT00413374|4170727|B3|||Age||years|Mean|48|48.0|Standard Deviation|15|15.0|||
4342819|NCT00413374|4170728|B2|||Age||years|Mean|48.53|48.53|Standard Deviation|15.3|15.3|||
4342820|NCT00413374|4170729|B1|||Age||years|Mean|47.95|47.95|Standard Deviation|16.2|16.2|||
4342821|NCT00413374|4170727|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4342822|NCT00413374|4170728|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4342823|NCT00413374|4170729|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4342824|NCT00413374|4170727|B3||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
4342825|NCT00413374|4170728|B2||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4342826|NCT00413374|4170729|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4342827|NCT00413374|4170727|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342828|NCT00413374|4170728|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342829|NCT00413374|4170729|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342830|NCT00413335|4170740|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4342831|NCT00413335|4170741|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4342832|NCT00413335|4170742|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4342833|NCT00413335|4170740|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4342834|NCT00413335|4170741|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4342835|NCT00413335|4170742|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4342836|NCT00413335|4170740|B3|||Age||years|Mean|13.0|13.0|Standard Deviation|2.0|2.0|||
4342837|NCT00413335|4170741|B2|||Age||years|Mean|13.9|13.9|Standard Deviation|2.0|2.0|||
4342838|NCT00413335|4170742|B1|||Age||years|Mean|12.8|12.8|Standard Deviation|1.6|1.6|||
4342840|NCT00413283|4170758|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4342841|NCT00413283|4170759|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4342842|NCT00413283|4170760|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4342843|NCT00413283|4170761|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4342844|NCT00413283|4170757|B5|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|62|62.0||||||
4342845|NCT00413283|4170758|B4|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4342846|NCT00413283|4170759|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4342847|NCT00413283|4170760|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4342848|NCT00413283|4170761|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4342849|NCT00413283|4170757|B5||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4342850|NCT00413283|4170758|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4342851|NCT00413283|4170759|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4342852|NCT00413283|4170760|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4342853|NCT00413283|4170761|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4342854|NCT00413283|4170757|B5||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4342855|NCT00413283|4170758|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4342856|NCT00413283|4170759|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4342857|NCT00413283|4170760|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4342858|NCT00413283|4170761|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4342859|NCT00413283|4170757|B5|||Age||Years|Mean|63.1|63.1|Standard Deviation|8.5|8.5|||
4342860|NCT00413283|4170758|B4|||Age||Years|Mean|65.4|65.4|Standard Deviation|8.2|8.2|||
4342861|NCT00413283|4170759|B3|||Age||Years|Mean|62.5|62.5|Standard Deviation|7.7|7.7|||
4342862|NCT00413283|4170760|B2|||Age||Years|Mean|63.8|63.8|Standard Deviation|10.8|10.8|||
4342863|NCT00413283|4170761|B1|||Age||Years|Mean|59.8|59.8|Standard Deviation|6.6|6.6|||
4342864|NCT00413244|4170794|B3|||Weight||lbs|Mean|201.32|201.32|Standard Deviation|38.25|38.25|||
4342865|NCT00413244|4170795|B2|||Weight||lbs|Mean|194.50|194.5|Standard Deviation|36.62|36.62|||
4342866|NCT00413244|4170796|B1|||Weight||lbs|Mean|205.73|205.73|Standard Deviation|39.22|39.22|||
4342867|NCT00413244|4170794|B3|||Waist Circumference||inches|Mean|42.13|42.13|Standard Deviation|4.99|4.99|||
4342868|NCT00413244|4170795|B2|||Waist Circumference||inches|Mean|41.31|41.31|Standard Deviation|4.65|4.65|||
4342869|NCT00413244|4170796|B1|||Waist Circumference||inches|Mean|42.66|42.66|Standard Deviation|5.21|5.21|||
4342870|NCT00413244|4170794|B3|||Triglycerides||mg/dL|Mean|129.55|129.55|Standard Deviation|85.74|85.74|||
4342871|NCT00413244|4170795|B2|||Triglycerides||mg/dL|Mean|109.90|109.9|Standard Deviation|50.86|50.86|||
4342872|NCT00413244|4170796|B1|||Triglycerides||mg/dL|Mean|142.23|142.23|Standard Deviation|100.95|100.95|||
4342873|NCT00413244|4170794|B3|||LDL||mg/dL|Mean|84.29|84.29|Standard Deviation|35.57|35.57|||
4342874|NCT00413244|4170795|B2|||LDL||mg/dL|Mean|80.90|80.9|Standard Deviation|26.77|26.77|||
4342875|NCT00413244|4170796|B1|||LDL||mg/dL|Mean|86.48|86.48|Standard Deviation|40.52|40.52|||
4342876|NCT00413244|4170794|B3|||Total Cholesterol||mg/dL|Mean|152.25|152.25|Standard Deviation|41.08|41.08|||
4342877|NCT00413244|4170795|B2|||Total Cholesterol||mg/dL|Mean|144.45|144.45|Standard Deviation|28.85|28.85|||
4342878|NCT00413244|4170796|B1|||Total Cholesterol||mg/dL|Mean|157.29|157.29|Standard Deviation|47.10|47.1|||
4342879|NCT00413244|4170794|B3|||Reactive hyperemia index (RHI)||ml|Mean|1.92|1.92|Standard Deviation|0.66|0.66|||
4342880|NCT00413244|4170795|B2|||Reactive hyperemia index (RHI)||ml|Mean|1.85|1.85|Standard Deviation|0.54|0.54|||
4342881|NCT00413244|4170796|B1|||Reactive hyperemia index (RHI)||ml|Mean|1.97|1.97|Standard Deviation|0.72|0.72|||
4342882|NCT00413244|4170794|B3|||Metabolic equivalent of task (METs)||MET units|Mean|10.04|10.04|Standard Deviation|2.34|2.34|||
4342883|NCT00413244|4170795|B2|||Metabolic equivalent of task (METs)||MET units|Mean|10.05|10.05|Standard Deviation|1.99|1.99|||
4342884|NCT00413244|4170796|B1|||Metabolic equivalent of task (METs)||MET units|Mean|10.03|10.03|Standard Deviation|2.58|2.58|||
4342885|NCT00413244|4170794|B3|||International Prostate Symptom Score (IPSS)|"IPSS has 8 questions total - 7 questions related to symptoms, each item scored 1-5. (asymptomatic to very symptomatic). The 8th question refers to the patient's perceived quality of life ranged from 0 to 6 (delighted to terrible.) Total scale ranges from 8-35. Mild (symptom score less than of equal to 7) Moderate (symptom score range 8-19) Severe (symptom score range 20-35)"|units on a scale|Mean|5.24|5.24|Standard Deviation|4.73|4.73|||
4342886|NCT00413244|4170795|B2|||International Prostate Symptom Score (IPSS)|"IPSS has 8 questions total - 7 questions related to symptoms, each item scored 1-5. (asymptomatic to very symptomatic). The 8th question refers to the patient's perceived quality of life ranged from 0 to 6 (delighted to terrible.) Total scale ranges from 8-35. Mild (symptom score less than of equal to 7) Moderate (symptom score range 8-19) Severe (symptom score range 20-35)"|units on a scale|Mean|4.55|4.55|Standard Deviation|4.7|4.7|||
4342887|NCT00413244|4170796|B1|||International Prostate Symptom Score (IPSS)|"IPSS has 8 questions total - 7 questions related to symptoms, each item scored 1-5. (asymptomatic to very symptomatic). The 8th question refers to the patient's perceived quality of life ranged from 0 to 6 (delighted to terrible.) Total scale ranges from 8-35. Mild (symptom score less than of equal to 7) Moderate (symptom score range 8-19) Severe (symptom score range 20-35)"|units on a scale|Mean|5.68|5.68|Standard Deviation|4.77|4.77|||
4342888|NCT00413244|4170794|B3|||Exercise Time||seconds|Mean|516.20|516.2|Standard Deviation|104.49|104.49|||
4342889|NCT00413244|4170795|B2|||Exercise Time||seconds|Mean|530.00|530.0|Standard Deviation|120.08|120.08|||
4342890|NCT00413244|4170796|B1|||Exercise Time||seconds|Mean|507.29|507.29|Standard Deviation|153.48|153.48|||
4342891|NCT00413244|4170794|B3|||Aging male syndrome questionnaire|The scale assesses symptoms of aging and their impact on HRQoL in males, and increases with increasing severity (1 to 5) of subjectively perceived complaints in 17 items. Scale ranges from 17-85 (no symptoms to extremely severe symptoms.)|units on a scale|Mean|36.24|36.24|Standard Deviation|10.83|10.83|||
4342892|NCT00413244|4170795|B2|||Aging male syndrome questionnaire|The scale assesses symptoms of aging and their impact on HRQoL in males, and increases with increasing severity (1 to 5) of subjectively perceived complaints in 17 items. Scale ranges from 17-85 (no symptoms to extremely severe symptoms.)|units on a scale|Mean|35.85|35.85|Standard Deviation|10.24|10.24|||
4342893|NCT00413244|4170796|B1|||Aging male syndrome questionnaire|The scale assesses symptoms of aging and their impact on HRQoL in males, and increases with increasing severity (1 to 5) of subjectively perceived complaints in 17 items. Scale ranges from 17-85 (no symptoms to extremely severe symptoms.)|units on a scale|Mean|36.48|36.48|Standard Deviation|11.36|11.36|||
4342894|NCT00413244|4170794|B3|||Red Blood Cell Count||cells x10^6/uL|Mean|4.62|4.62|Standard Deviation|0.43|0.43|||
4342895|NCT00413244|4170795|B2|||Red Blood Cell Count||cells x10^6/uL|Mean|4.67|4.67|Standard Deviation|0.42|0.42|||
4342896|NCT00413244|4170796|B1|||Red Blood Cell Count||cells x10^6/uL|Mean|4.58|4.58|Standard Deviation|0.44|0.44|||
4342897|NCT00413244|4170794|B3|||White Blood Cell Count||cells x10^3/uL|Mean|6.34|6.34|Standard Deviation|1.71|1.71|||
4342898|NCT00413244|4170795|B2|||White Blood Cell Count||cells x10^3/uL|Mean|6.49|6.49|Standard Deviation|1.63|1.63|||
4342899|NCT00413244|4170796|B1|||White Blood Cell Count||cells x10^3/uL|Mean|6.25|6.25|Standard Deviation|1.78|1.78|||
4342900|NCT00413244|4170794|B3|||Hematocrit||percent of cells|Mean|40.78|40.78|Standard Deviation|3.04|3.04|||
4342901|NCT00413244|4170795|B2|||Hematocrit||percent of cells|Mean|40.93|40.93|Standard Deviation|3.18|3.18|||
4342902|NCT00413244|4170796|B1|||Hematocrit||percent of cells|Mean|40.69|40.69|Standard Deviation|3.00|3.0|||
4342903|NCT00413244|4170794|B3|||Diastolic Blood Pressure||mmHg|Mean|75.84|75.84|Standard Deviation|10.04|10.04|||
4342904|NCT00413244|4170795|B2|||Diastolic Blood Pressure||mmHg|Mean|75.10|75.1|Standard Deviation|11.65|11.65|||
4342905|NCT00413244|4170796|B1|||Diastolic Blood Pressure||mmHg|Mean|76.32|76.32|Standard Deviation|9.03|9.03|||
4342906|NCT00413244|4170794|B3|||Systolic Blood Pressure||mmHg|Mean|125.47|125.47|Standard Deviation|16.85|16.85|||
4342907|NCT00413244|4170795|B2|||Systolic Blood Pressure||mmHg|Mean|128.05|128.05|Standard Deviation|20.84|20.84|||
4342908|NCT00413244|4170796|B1|||Systolic Blood Pressure||mmHg|Mean|123.81|123.81|Standard Deviation|13.81|13.81|||
4342909|NCT00413244|4170794|B3|||Total Testosterone||ng/dL|Mean|253.36|253.36|Standard Deviation|66.8|66.8|||
4342910|NCT00413244|4170795|B2|||Total Testosterone||ng/dL|Mean|263.7|263.7|Standard Deviation|71.9|71.9|||
4342911|NCT00413244|4170796|B1|||Total Testosterone||ng/dL|Mean|246.7|246.7|Standard Deviation|63.5|63.5|||
4342912|NCT00413244|4170794|B3|No||Diabetes||participants|Number|29|29.0||||||
4342913|NCT00413244|4170795|B2|No||Diabetes||participants|Number|14|14.0||||||
4342914|NCT00413244|4170796|B1|No||Diabetes||participants|Number|15|15.0||||||
4342915|NCT00413244|4170794|B3|Yes||Diabetes||participants|Number|22|22.0||||||
4342916|NCT00413244|4170795|B2|Yes||Diabetes||participants|Number|6|6.0||||||
4342917|NCT00413244|4170796|B1|Yes||Diabetes||participants|Number|16|16.0||||||
4342918|NCT00413244|4170794|B3|||Body Mass Index||kg/m^2|Mean|29.7|29.7|Standard Deviation|5.4|5.4|||
4342919|NCT00413244|4170795|B2|||Body Mass Index||kg/m^2|Mean|28.0|28.0|Standard Deviation|4.3|4.3|||
4342920|NCT00413244|4170796|B1|||Body Mass Index||kg/m^2|Mean|30.8|30.8|Standard Deviation|5.8|5.8|||
4342921|NCT00413244|4170794|B3|No||Hypertension||participants|Number|5|5.0||||||
4342922|NCT00413244|4170795|B2|No||Hypertension||participants|Number|4|4.0||||||
4342923|NCT00413244|4170796|B1|No||Hypertension||participants|Number|1|1.0||||||
4342924|NCT00413244|4170794|B3|Yes||Hypertension||participants|Number|46|46.0||||||
4342925|NCT00413244|4170795|B2|Yes||Hypertension||participants|Number|16|16.0||||||
4342926|NCT00413244|4170796|B1|Yes||Hypertension||participants|Number|30|30.0||||||
4342927|NCT00413244|4170794|B3||Male|Gender||Participants|Count of Participants|51|51.0||||||
4342928|NCT00413244|4170795|B2||Male|Gender||Participants|Count of Participants|20|20.0||||||
4342929|NCT00413244|4170796|B1||Male|Gender||Participants|Count of Participants|31|31.0||||||
4342930|NCT00413244|4170794|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
4342931|NCT00413244|4170795|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
4342932|NCT00413244|4170796|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
4342933|NCT00413244|4170794|B3|||Age||years|Mean|58.5|58.5|Standard Deviation|7.81|7.81|||
4342934|NCT00413244|4170795|B2|||Age||years|Mean|58.9|58.9|Standard Deviation|7.3|7.3|||
4342935|NCT00413244|4170796|B1|||Age||years|Mean|58.3|58.3|Standard Deviation|8.2|8.2|||
4342936|NCT00413231|4170825|B1|United States||Region of Enrollment||participants|Number|160|160.0||||||
4342937|NCT00413231|4170825|B1||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4342938|NCT00413231|4170825|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4342939|NCT00413231|4170825|B1|||Age||years|Mean|72.2|72.2|Standard Deviation|9.1|9.1|||
4342940|NCT00413231|4170825|B1||>=65 years|Age||Participants|Count of Participants|134|134.0||||||
4342941|NCT00413231|4170825|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4342942|NCT00413231|4170825|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4342965|NCT00413218|4170856|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
4342966|NCT00413218|4170857|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
4342943|NCT00413218|4170855|B3||Other Regions|Geographical Region|Participants were stratified at randomization by geographical region. The region Western Europe includes countries in Western Europe (Belgium, France, Germany, Italy, Spain and Switzerland), Australia and New Zealand. Other regions include countries Argentina, Brazil, Chile, China, Hungary, India, Israel, Lebanon, Malaysia, Mexico, Philippines, South Africa, Russia, Singapore and Thailand.|Participants|Count of Participants|259|259.0||||||
4342944|NCT00413218|4170856|B2||Other Regions|Geographical Region|Participants were stratified at randomization by geographical region. The region Western Europe includes countries in Western Europe (Belgium, France, Germany, Italy, Spain and Switzerland), Australia and New Zealand. Other regions include countries Argentina, Brazil, Chile, China, Hungary, India, Israel, Lebanon, Malaysia, Mexico, Philippines, South Africa, Russia, Singapore and Thailand.|Participants|Count of Participants|130|130.0||||||
4342945|NCT00413218|4170857|B1||Other Regions|Geographical Region|Participants were stratified at randomization by geographical region. The region Western Europe includes countries in Western Europe (Belgium, France, Germany, Italy, Spain and Switzerland), Australia and New Zealand. Other regions include countries Argentina, Brazil, Chile, China, Hungary, India, Israel, Lebanon, Malaysia, Mexico, Philippines, South Africa, Russia, Singapore and Thailand.|Participants|Count of Participants|129|129.0||||||
4342946|NCT00413218|4170855|B3||Western Europe|Geographical Region|Participants were stratified at randomization by geographical region. The region Western Europe includes countries in Western Europe (Belgium, France, Germany, Italy, Spain and Switzerland), Australia and New Zealand. Other regions include countries Argentina, Brazil, Chile, China, Hungary, India, Israel, Lebanon, Malaysia, Mexico, Philippines, South Africa, Russia, Singapore and Thailand.|Participants|Count of Participants|110|110.0||||||
4342947|NCT00413218|4170856|B2||Western Europe|Geographical Region|Participants were stratified at randomization by geographical region. The region Western Europe includes countries in Western Europe (Belgium, France, Germany, Italy, Spain and Switzerland), Australia and New Zealand. Other regions include countries Argentina, Brazil, Chile, China, Hungary, India, Israel, Lebanon, Malaysia, Mexico, Philippines, South Africa, Russia, Singapore and Thailand.|Participants|Count of Participants|56|56.0||||||
4342948|NCT00413218|4170857|B1||Western Europe|Geographical Region|Participants were stratified at randomization by geographical region. The region Western Europe includes countries in Western Europe (Belgium, France, Germany, Italy, Spain and Switzerland), Australia and New Zealand. Other regions include countries Argentina, Brazil, Chile, China, Hungary, India, Israel, Lebanon, Malaysia, Mexico, Philippines, South Africa, Russia, Singapore and Thailand.|Participants|Count of Participants|54|54.0||||||
4342949|NCT00413218|4170855|B3||North America|Geographical Region|Participants were stratified at randomization by geographical region. The region Western Europe includes countries in Western Europe (Belgium, France, Germany, Italy, Spain and Switzerland), Australia and New Zealand. Other regions include countries Argentina, Brazil, Chile, China, Hungary, India, Israel, Lebanon, Malaysia, Mexico, Philippines, South Africa, Russia, Singapore and Thailand.|Participants|Count of Participants|71|71.0||||||
4342950|NCT00413218|4170856|B2||North America|Geographical Region|Participants were stratified at randomization by geographical region. The region Western Europe includes countries in Western Europe (Belgium, France, Germany, Italy, Spain and Switzerland), Australia and New Zealand. Other regions include countries Argentina, Brazil, Chile, China, Hungary, India, Israel, Lebanon, Malaysia, Mexico, Philippines, South Africa, Russia, Singapore and Thailand.|Participants|Count of Participants|33|33.0||||||
4342951|NCT00413218|4170857|B1||North America|Geographical Region|Participants were stratified at randomization by geographical region. The region Western Europe includes countries in Western Europe (Belgium, France, Germany, Italy, Spain and Switzerland), Australia and New Zealand. Other regions include countries Argentina, Brazil, Chile, China, Hungary, India, Israel, Lebanon, Malaysia, Mexico, Philippines, South Africa, Russia, Singapore and Thailand.|Participants|Count of Participants|38|38.0||||||
4342952|NCT00413218|4170855|B3||Absence|Neutropenic Status: Presence or Absence of Neutropenia|Participants were stratified by baseline neutropenic status (presence vs absence of neutropenia) defined as absolute neutrophil count (ANC) < 0.5 x 10^9/L [< 500/mm^3] for ≥ 10 days.|Participants|Count of Participants|391|391.0||||||
4342953|NCT00413218|4170856|B2||Absence|Neutropenic Status: Presence or Absence of Neutropenia|Participants were stratified by baseline neutropenic status (presence vs absence of neutropenia) defined as absolute neutrophil count (ANC) < 0.5 x 10^9/L [< 500/mm^3] for ≥ 10 days.|Participants|Count of Participants|195|195.0||||||
4342954|NCT00413218|4170857|B1||Absence|Neutropenic Status: Presence or Absence of Neutropenia|Participants were stratified by baseline neutropenic status (presence vs absence of neutropenia) defined as absolute neutrophil count (ANC) < 0.5 x 10^9/L [< 500/mm^3] for ≥ 10 days.|Participants|Count of Participants|196|196.0||||||
4342955|NCT00413218|4170855|B3||Presence|Neutropenic Status: Presence or Absence of Neutropenia|Participants were stratified by baseline neutropenic status (presence vs absence of neutropenia) defined as absolute neutrophil count (ANC) < 0.5 x 10^9/L [< 500/mm^3] for ≥ 10 days.|Participants|Count of Participants|49|49.0||||||
4342956|NCT00413218|4170856|B2||Presence|Neutropenic Status: Presence or Absence of Neutropenia|Participants were stratified by baseline neutropenic status (presence vs absence of neutropenia) defined as absolute neutrophil count (ANC) < 0.5 x 10^9/L [< 500/mm^3] for ≥ 10 days.|Participants|Count of Participants|24|24.0||||||
4342957|NCT00413218|4170857|B1||Presence|Neutropenic Status: Presence or Absence of Neutropenia|Participants were stratified by baseline neutropenic status (presence vs absence of neutropenia) defined as absolute neutrophil count (ANC) < 0.5 x 10^9/L [< 500/mm^3] for ≥ 10 days.|Participants|Count of Participants|25|25.0||||||
4342958|NCT00413218|4170855|B3|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4342959|NCT00413218|4170856|B2|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4342960|NCT00413218|4170857|B1|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4342961|NCT00413218|4170855|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|382|382.0||||||
4342962|NCT00413218|4170856|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|195|195.0||||||
4342963|NCT00413218|4170857|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|187|187.0||||||
4342964|NCT00413218|4170855|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|45|45.0||||||
4342967|NCT00413218|4170855|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4342968|NCT00413218|4170856|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4342969|NCT00413218|4170857|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4342970|NCT00413218|4170855|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|120|120.0||||||
4342971|NCT00413218|4170856|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|64|64.0||||||
4342972|NCT00413218|4170857|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|56|56.0||||||
4342973|NCT00413218|4170855|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
4342974|NCT00413218|4170856|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4342975|NCT00413218|4170857|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4342976|NCT00413218|4170855|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|294|294.0||||||
4342977|NCT00413218|4170856|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|144|144.0||||||
4342978|NCT00413218|4170857|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|150|150.0||||||
4342979|NCT00413218|4170855|B3||Male|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
4342980|NCT00413218|4170856|B2||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4342981|NCT00413218|4170857|B1||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4342982|NCT00413218|4170855|B3||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4342983|NCT00413218|4170856|B2||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4342984|NCT00413218|4170857|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4342985|NCT00413218|4170855|B3|||Age||Years|Geometric Mean|58.0|58.0|Standard Deviation|17.20|17.2|||
4342986|NCT00413218|4170856|B2|||Age||Years|Geometric Mean|57.9|57.9|Standard Deviation|16.88|16.88|||
4342987|NCT00413218|4170857|B1|||Age||Years|Geometric Mean|58.0|58.0|Standard Deviation|17.54|17.54|||
4342988|NCT00413192|4170880|B5||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4342989|NCT00413192|4170881|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4342990|NCT00413192|4170882|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4342991|NCT00413192|4170883|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4342992|NCT00413192|4170884|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4342993|NCT00413192|4170880|B5||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4342994|NCT00413192|4170881|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4342995|NCT00413192|4170882|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4342996|NCT00413192|4170883|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4342997|NCT00413192|4170884|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4342998|NCT00413192|4170880|B5|||Age||Years|Mean|54.4|54.4|Standard Deviation|14.66|14.66|||
4342999|NCT00413192|4170881|B4|||Age||Years|Mean|53.1|53.1|Standard Deviation|15.21|15.21|||
4343000|NCT00413192|4170882|B3|||Age||Years|Mean|43.7|43.7|Standard Deviation|17.92|17.92|||
4343001|NCT00413192|4170883|B2|||Age||Years|Mean|59.9|59.9|Standard Deviation|12.69|12.69|||
4343002|NCT00413192|4170884|B1|||Age||Years|Mean|55.1|55.1|Standard Deviation|11.35|11.35|||
4343003|NCT00413153|4170925|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4343004|NCT00413153|4170926|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4343005|NCT00413153|4170927|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4343006|NCT00413153|4170925|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4343007|NCT00413153|4170926|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4343008|NCT00413153|4170927|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4343009|NCT00413153|4170925|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4343010|NCT00413153|4170926|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4343011|NCT00413153|4170927|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4343012|NCT00413153|4170925|B3|||Age||years|Mean|48|48.0|Standard Deviation|7|7.0|||
4343013|NCT00413153|4170926|B2|||Age||years|Mean|50|50.0|Standard Deviation|6|6.0|||
4343014|NCT00413153|4170927|B1|||Age||years|Mean|46|46.0|Standard Deviation|8|8.0|||
4343015|NCT00413153|4170925|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4343016|NCT00413153|4170926|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4343017|NCT00413153|4170927|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4343018|NCT00413153|4170925|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4343019|NCT00413153|4170926|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4343020|NCT00413153|4170927|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4343021|NCT00413153|4170925|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4343022|NCT00413153|4170926|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4343023|NCT00413153|4170927|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4343024|NCT00413062|4170950|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4343025|NCT00413062|4170951|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4343026|NCT00413062|4170952|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4343027|NCT00413062|4170950|B3||Female|Sex: Female, Male||Participants|Count of Participants|2220|2220.0||||||
4343029|NCT00413062|4170952|B1||Female|Sex: Female, Male||Participants|Count of Participants|1666|1666.0||||||
4343030|NCT00413062|4170950|B3|||Age||years|Mean|27.7|27.7|Standard Deviation|7.1|7.1|||
4343031|NCT00413062|4170951|B2|||Age||years|Mean|27.8|27.8|Standard Deviation|7.0|7.0|||
4343032|NCT00413062|4170952|B1|||Age||years|Mean|27.6|27.6|Standard Deviation|7.2|7.2|||
4343033|NCT00413049|4170977|B3||Male|Sex: Female, Male||Participants|Count of Participants|453|453.0||||||
4343034|NCT00413049|4170978|B2||Male|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
4343035|NCT00413049|4170979|B1||Male|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
4343036|NCT00413049|4170977|B3||Female|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
4343037|NCT00413049|4170978|B2||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4343038|NCT00413049|4170979|B1||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4343039|NCT00413049|4170977|B3|||Age||years|Mean|53.8|53.8|Standard Deviation|9.4|9.4|||
4343040|NCT00413049|4170978|B2|||Age||years|Mean|54.2|54.2|Standard Deviation|9.1|9.1|||
4343041|NCT00413049|4170979|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|9.7|9.7|||
4343042|NCT00413036|4170996|B1|Transformed Lymphoma||Non-Hodgkin's Lymphoma Diagnosis/Histopathology||Participants|Number|33|33.0||||||
4343043|NCT00413036|4170996|B1|Mantle Cell Lymphoma||Non-Hodgkin's Lymphoma Diagnosis/Histopathology||Participants|Number|57|57.0||||||
4343044|NCT00413036|4170996|B1|Follicular Lymphoma, Grade 3||Non-Hodgkin's Lymphoma Diagnosis/Histopathology||Participants|Number|19|19.0||||||
4343045|NCT00413036|4170996|B1|Diffuse Large Cell Lymphoma||Non-Hodgkin's Lymphoma Diagnosis/Histopathology||Participants|Number|108|108.0||||||
4343046|NCT00413036|4170996|B1|Unspecified||Race/Ethnicity, Customized||Participant|Number|9|9.0||||||
4343047|NCT00413036|4170996|B1|White||Race/Ethnicity, Customized||Participant|Number|202|202.0||||||
4343048|NCT00413036|4170996|B1|Hispanic||Race/Ethnicity, Customized||Participant|Number|2|2.0||||||
4343049|NCT00413036|4170996|B1|Black||Race/Ethnicity, Customized||Participant|Number|4|4.0||||||
4343050|NCT00413036|4170996|B1|Asian/Pacific Islander||Race/Ethnicity, Customized||Participant|Number|0|0.0||||||
4343051|NCT00413036|4170996|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participant|Number|0|0.0||||||
4343052|NCT00413036|4170996|B1||Male|Gender||Participants|Count of Participants|140|140.0||||||
4343053|NCT00413036|4170996|B1||Female|Gender||Participants|Count of Participants|77|77.0||||||
4343054|NCT00413036|4170996|B1|> = 65 years||Age, Customized||Participants|Number|127|127.0||||||
4343055|NCT00413036|4170996|B1|< 65 years||Age, Customized||Participants|Number|90|90.0||||||
4343056|NCT00413036|4170996|B1|||Age||years|Mean|65.0|65.0|Standard Deviation|11.54|11.54|||
4343057|NCT00413010|4171004|B3||Male|Sex: Female, Male||Participants|Count of Participants|112.0|112.0||||||
4343058|NCT00413010|4171005|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4343059|NCT00413010|4171006|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4343060|NCT00413010|4171004|B3||Female|Sex: Female, Male||Participants|Count of Participants|244.0|244.0||||||
4343061|NCT00413010|4171005|B2||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4343062|NCT00413010|4171006|B1||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4343063|NCT00413010|4171004|B3|||Age||years|Mean|43.6|43.6|Standard Deviation|12.0|12.0|||
4343064|NCT00413010|4171005|B2|||Age||years|Mean|43.5|43.5|Standard Deviation|12.5|12.5|||
4343065|NCT00413010|4171006|B1|||Age||years|Mean|43.7|43.7|Standard Deviation|11.5|11.5|||
4343066|NCT00412984|4171027|B3|||Mean CHADS-2 Score at Enrollment|The CHADS2 score is a clinical prediction rule for estimating the risk of stroke in patients with nonrheumatic atrial fibrillation (AF). A high CHADS2 score corresponds to a greater risk of stroke, while a low CHADS2 score corresponds to a lower risk of stroke (range 0 to 6). The CHADS2 score is determined by adding together the points that correspond to the 5 conditions that are present: 1 point each for Congestive Heart Failure, Hypertension, Age ≥75 years, or Diabetes Mellitus; 2 points for prior stroke or transient ischemic attack (TIA).|units on a scale|Mean|2.1|2.1|Standard Deviation|2.10|2.1|||
4343067|NCT00412984|4171028|B2|||Mean CHADS-2 Score at Enrollment|The CHADS2 score is a clinical prediction rule for estimating the risk of stroke in patients with nonrheumatic atrial fibrillation (AF). A high CHADS2 score corresponds to a greater risk of stroke, while a low CHADS2 score corresponds to a lower risk of stroke (range 0 to 6). The CHADS2 score is determined by adding together the points that correspond to the 5 conditions that are present: 1 point each for Congestive Heart Failure, Hypertension, Age ≥75 years, or Diabetes Mellitus; 2 points for prior stroke or transient ischemic attack (TIA).|units on a scale|Mean|2.1|2.1|Standard Deviation|1.11|1.11|||
4343068|NCT00412984|4171029|B1|||Mean CHADS-2 Score at Enrollment|The CHADS2 score is a clinical prediction rule for estimating the risk of stroke in patients with nonrheumatic atrial fibrillation (AF). A high CHADS2 score corresponds to a greater risk of stroke, while a low CHADS2 score corresponds to a lower risk of stroke (range 0 to 6). The CHADS2 score is determined by adding together the points that correspond to the 5 conditions that are present: 1 point each for Congestive Heart Failure, Hypertension, Age ≥75 years, or Diabetes Mellitus; 2 points for prior stroke or transient ischemic attack (TIA).|units on a scale|Mean|2.1|2.1|Standard Deviation|1.10|1.1|||
4343069|NCT00412984|4171027|B3||Score of >= 3|CHADS-2 Score at Enrollment|The CHADS2 score is a clinical prediction rule for estimating the risk of stroke in patients with nonrheumatic atrial fibrillation (AF). A high CHADS2 score corresponds to a greater risk of stroke, while a low CHADS2 score corresponds to a lower risk of stroke (range 0 to 6). The CHADS2 score is determined by adding together the points that correspond to the 5 conditions that are present: 1 point each for congestive heart failure, hypertension, age ≥75 years, or diabetes mellitus; 2 points for prior stroke or transient ischemic attack (TIA).|Participants|Count of Participants|5502|5502.0||||||
4343092|NCT00412984|4171029|B1||Symptomatic CHF not a risk factor|Risk Factor At Enrollment: Symptomatic Chronic Heart Failure (CHF)||Participants|Count of Participants|6336|6336.0||||||
4343195|NCT00412971|4171072|B3|Denmark||Region of Enrollment||participants|Number|233|233.0||||||
4343070|NCT00412984|4171028|B2||Score of >= 3|CHADS-2 Score at Enrollment|The CHADS2 score is a clinical prediction rule for estimating the risk of stroke in patients with nonrheumatic atrial fibrillation (AF). A high CHADS2 score corresponds to a greater risk of stroke, while a low CHADS2 score corresponds to a lower risk of stroke (range 0 to 6). The CHADS2 score is determined by adding together the points that correspond to the 5 conditions that are present: 1 point each for congestive heart failure, hypertension, age ≥75 years, or diabetes mellitus; 2 points for prior stroke or transient ischemic attack (TIA).|Participants|Count of Participants|2744|2744.0||||||
4343071|NCT00412984|4171029|B1||Score of >= 3|CHADS-2 Score at Enrollment|The CHADS2 score is a clinical prediction rule for estimating the risk of stroke in patients with nonrheumatic atrial fibrillation (AF). A high CHADS2 score corresponds to a greater risk of stroke, while a low CHADS2 score corresponds to a lower risk of stroke (range 0 to 6). The CHADS2 score is determined by adding together the points that correspond to the 5 conditions that are present: 1 point each for congestive heart failure, hypertension, age ≥75 years, or diabetes mellitus; 2 points for prior stroke or transient ischemic attack (TIA).|Participants|Count of Participants|2758|2758.0||||||
4343072|NCT00412984|4171027|B3||Score of 2|CHADS-2 Score at Enrollment|The CHADS2 score is a clinical prediction rule for estimating the risk of stroke in patients with nonrheumatic atrial fibrillation (AF). A high CHADS2 score corresponds to a greater risk of stroke, while a low CHADS2 score corresponds to a lower risk of stroke (range 0 to 6). The CHADS2 score is determined by adding together the points that correspond to the 5 conditions that are present: 1 point each for congestive heart failure, hypertension, age ≥75 years, or diabetes mellitus; 2 points for prior stroke or transient ischemic attack (TIA).|Participants|Count of Participants|6516|6516.0||||||
4343073|NCT00412984|4171028|B2||Score of 2|CHADS-2 Score at Enrollment|The CHADS2 score is a clinical prediction rule for estimating the risk of stroke in patients with nonrheumatic atrial fibrillation (AF). A high CHADS2 score corresponds to a greater risk of stroke, while a low CHADS2 score corresponds to a lower risk of stroke (range 0 to 6). The CHADS2 score is determined by adding together the points that correspond to the 5 conditions that are present: 1 point each for congestive heart failure, hypertension, age ≥75 years, or diabetes mellitus; 2 points for prior stroke or transient ischemic attack (TIA).|Participants|Count of Participants|3254|3254.0||||||
4343074|NCT00412984|4171029|B1||Score of 2|CHADS-2 Score at Enrollment|The CHADS2 score is a clinical prediction rule for estimating the risk of stroke in patients with nonrheumatic atrial fibrillation (AF). A high CHADS2 score corresponds to a greater risk of stroke, while a low CHADS2 score corresponds to a lower risk of stroke (range 0 to 6). The CHADS2 score is determined by adding together the points that correspond to the 5 conditions that are present: 1 point each for congestive heart failure, hypertension, age ≥75 years, or diabetes mellitus; 2 points for prior stroke or transient ischemic attack (TIA).|Participants|Count of Participants|3262|3262.0||||||
4343075|NCT00412984|4171027|B3||Score of <= 1|CHADS-2 Score at Enrollment|The CHADS2 score is a clinical prediction rule for estimating the risk of stroke in patients with nonrheumatic atrial fibrillation (AF). A high CHADS2 score corresponds to a greater risk of stroke, while a low CHADS2 score corresponds to a lower risk of stroke (range 0 to 6). The CHADS2 score is determined by adding together the points that correspond to the 5 conditions that are present: 1 point each for congestive heart failure, hypertension, age ≥75 years, or diabetes mellitus; 2 points for prior stroke or transient ischemic attack (TIA).|Participants|Count of Participants|6183|6183.0||||||
4343076|NCT00412984|4171028|B2||Score of <= 1|CHADS-2 Score at Enrollment|The CHADS2 score is a clinical prediction rule for estimating the risk of stroke in patients with nonrheumatic atrial fibrillation (AF). A high CHADS2 score corresponds to a greater risk of stroke, while a low CHADS2 score corresponds to a lower risk of stroke (range 0 to 6). The CHADS2 score is determined by adding together the points that correspond to the 5 conditions that are present: 1 point each for congestive heart failure, hypertension, age ≥75 years, or diabetes mellitus; 2 points for prior stroke or transient ischemic attack (TIA).|Participants|Count of Participants|3083|3083.0||||||
4343077|NCT00412984|4171029|B1||Score of <= 1|CHADS-2 Score at Enrollment|The CHADS2 score is a clinical prediction rule for estimating the risk of stroke in patients with nonrheumatic atrial fibrillation (AF). A high CHADS2 score corresponds to a greater risk of stroke, while a low CHADS2 score corresponds to a lower risk of stroke (range 0 to 6). The CHADS2 score is determined by adding together the points that correspond to the 5 conditions that are present: 1 point each for congestive heart failure, hypertension, age ≥75 years, or diabetes mellitus; 2 points for prior stroke or transient ischemic attack (TIA).|Participants|Count of Participants|3100|3100.0||||||
4343078|NCT00412984|4171027|B3||>= 2|Number of Risk Factors||Participants|Count of Participants|12176|12176.0||||||
4343079|NCT00412984|4171028|B2||>= 2|Number of Risk Factors||Participants|Count of Participants|6081|6081.0||||||
4343080|NCT00412984|4171029|B1||>= 2|Number of Risk Factors||Participants|Count of Participants|6095|6095.0||||||
4343081|NCT00412984|4171027|B3||<= 1|Number of Risk Factors||Participants|Count of Participants|6025|6025.0||||||
4343082|NCT00412984|4171028|B2||<= 1|Number of Risk Factors||Participants|Count of Participants|3000|3000.0||||||
4343083|NCT00412984|4171029|B1||<= 1|Number of Risk Factors||Participants|Count of Participants|3025|3025.0||||||
4343084|NCT00412984|4171027|B3||LVEF <=40% not a risk factor|Risk Factor at Enrollment: Left Ventricle Ejection Fraction (LVEF) <=40%||Participants|Count of Participants|15576|15576.0||||||
4343085|NCT00412984|4171028|B2||LVEF <=40% not a risk factor|Risk Factor at Enrollment: Left Ventricle Ejection Fraction (LVEF) <=40%||Participants|Count of Participants|7780|7780.0||||||
4343086|NCT00412984|4171029|B1||LVEF <=40% not a risk factor|Risk Factor at Enrollment: Left Ventricle Ejection Fraction (LVEF) <=40%||Participants|Count of Participants|7796|7796.0||||||
4343087|NCT00412984|4171027|B3||With LVEF <=40%|Risk Factor at Enrollment: Left Ventricle Ejection Fraction (LVEF) <=40%||Participants|Count of Participants|2625|2625.0||||||
4343088|NCT00412984|4171028|B2||With LVEF <=40%|Risk Factor at Enrollment: Left Ventricle Ejection Fraction (LVEF) <=40%||Participants|Count of Participants|1301|1301.0||||||
4343089|NCT00412984|4171029|B1||With LVEF <=40%|Risk Factor at Enrollment: Left Ventricle Ejection Fraction (LVEF) <=40%||Participants|Count of Participants|1324|1324.0||||||
4343090|NCT00412984|4171027|B3||Symptomatic CHF not a risk factor|Risk Factor At Enrollment: Symptomatic Chronic Heart Failure (CHF)||Participants|Count of Participants|12660|12660.0||||||
4343091|NCT00412984|4171028|B2||Symptomatic CHF not a risk factor|Risk Factor At Enrollment: Symptomatic Chronic Heart Failure (CHF)||Participants|Count of Participants|6324|6324.0||||||
4343093|NCT00412984|4171027|B3||With symptomatic CHF|Risk Factor At Enrollment: Symptomatic Chronic Heart Failure (CHF)||Participants|Count of Participants|5541|5541.0||||||
4343094|NCT00412984|4171028|B2||With symptomatic CHF|Risk Factor At Enrollment: Symptomatic Chronic Heart Failure (CHF)||Participants|Count of Participants|2757|2757.0||||||
4343095|NCT00412984|4171029|B1||With symptomatic CHF|Risk Factor At Enrollment: Symptomatic Chronic Heart Failure (CHF)||Participants|Count of Participants|2784|2784.0||||||
4343096|NCT00412984|4171027|B3||Prior TIA not a risk factor|Risk Factor at Enrollment: Prior Transient Ischemic Attack (TIA)||Participants|Count of Participants|16944|16944.0||||||
4343097|NCT00412984|4171028|B2||Prior TIA not a risk factor|Risk Factor at Enrollment: Prior Transient Ischemic Attack (TIA)||Participants|Count of Participants|8427|8427.0||||||
4343098|NCT00412984|4171029|B1||Prior TIA not a risk factor|Risk Factor at Enrollment: Prior Transient Ischemic Attack (TIA)||Participants|Count of Participants|8517|8517.0||||||
4343099|NCT00412984|4171027|B3||With prior TIA|Risk Factor at Enrollment: Prior Transient Ischemic Attack (TIA)||Participants|Count of Participants|1257|1257.0||||||
4343100|NCT00412984|4171028|B2||With prior TIA|Risk Factor at Enrollment: Prior Transient Ischemic Attack (TIA)||Participants|Count of Participants|654|654.0||||||
4343101|NCT00412984|4171029|B1||With prior TIA|Risk Factor at Enrollment: Prior Transient Ischemic Attack (TIA)||Participants|Count of Participants|603|603.0||||||
4343102|NCT00412984|4171027|B3||Prior stroke not a risk factor|Risk Factor at Enrollment: Prior Stroke||Participants|Count of Participants|16074|16074.0||||||
4343103|NCT00412984|4171028|B2||Prior stroke not a risk factor|Risk Factor at Enrollment: Prior Stroke||Participants|Count of Participants|7999|7999.0||||||
4343104|NCT00412984|4171029|B1||Prior stroke not a risk factor|Risk Factor at Enrollment: Prior Stroke||Participants|Count of Participants|8075|8075.0||||||
4343105|NCT00412984|4171027|B3||With prior stroke|Risk Factor at Enrollment: Prior Stroke||Participants|Count of Participants|2127|2127.0||||||
4343106|NCT00412984|4171028|B2||With prior stroke|Risk Factor at Enrollment: Prior Stroke||Participants|Count of Participants|1082|1082.0||||||
4343107|NCT00412984|4171029|B1||With prior stroke|Risk Factor at Enrollment: Prior Stroke||Participants|Count of Participants|1045|1045.0||||||
4343108|NCT00412984|4171027|B3||<75 years|Risk Factor at Enrollment: Age >= 75 Years||Participants|Count of Participants|12523|12523.0||||||
4343109|NCT00412984|4171028|B2||<75 years|Risk Factor at Enrollment: Age >= 75 Years||Participants|Count of Participants|6253|6253.0||||||
4343110|NCT00412984|4171029|B1||<75 years|Risk Factor at Enrollment: Age >= 75 Years||Participants|Count of Participants|6270|6270.0||||||
4343111|NCT00412984|4171027|B3||>=75 years|Risk Factor at Enrollment: Age >= 75 Years||Participants|Count of Participants|5678|5678.0||||||
4343112|NCT00412984|4171028|B2||>=75 years|Risk Factor at Enrollment: Age >= 75 Years||Participants|Count of Participants|2828|2828.0||||||
4343113|NCT00412984|4171029|B1||>=75 years|Risk Factor at Enrollment: Age >= 75 Years||Participants|Count of Participants|2850|2850.0||||||
4343114|NCT00412984|4171027|B3||5.0 mg BID|Apixaban/Matching Placebo Dose at Randomization||Participants|Count of Participants|17370|17370.0||||||
4343115|NCT00412984|4171028|B2||5.0 mg BID|Apixaban/Matching Placebo Dose at Randomization||Participants|Count of Participants|8678|8678.0||||||
4343116|NCT00412984|4171029|B1||5.0 mg BID|Apixaban/Matching Placebo Dose at Randomization||Participants|Count of Participants|8692|8692.0||||||
4343117|NCT00412984|4171027|B3||2.5 mg twice daily (BID)|Apixaban/Matching Placebo Dose at Randomization||Participants|Count of Participants|831|831.0||||||
4343118|NCT00412984|4171028|B2||2.5 mg twice daily (BID)|Apixaban/Matching Placebo Dose at Randomization||Participants|Count of Participants|403|403.0||||||
4343119|NCT00412984|4171029|B1||2.5 mg twice daily (BID)|Apixaban/Matching Placebo Dose at Randomization||Participants|Count of Participants|428|428.0||||||
4343120|NCT00412984|4171027|B3||not applicable (male)|Female Age Category||Participants|Count of Participants|11785|11785.0||||||
4343121|NCT00412984|4171028|B2||not applicable (male)|Female Age Category||Participants|Count of Participants|5899|5899.0||||||
4343122|NCT00412984|4171029|B1||not applicable (male)|Female Age Category||Participants|Count of Participants|5886|5886.0||||||
4343123|NCT00412984|4171027|B3||>50 years|Female Age Category||Participants|Count of Participants|6247|6247.0||||||
4343124|NCT00412984|4171028|B2||>50 years|Female Age Category||Participants|Count of Participants|3094|3094.0||||||
4343125|NCT00412984|4171029|B1||>50 years|Female Age Category||Participants|Count of Participants|3153|3153.0||||||
4343126|NCT00412984|4171027|B3||<=50 years|Female Age Category||Participants|Count of Participants|169|169.0||||||
4343127|NCT00412984|4171028|B2||<=50 years|Female Age Category||Participants|Count of Participants|88|88.0||||||
4343128|NCT00412984|4171029|B1||<=50 years|Female Age Category||Participants|Count of Participants|81|81.0||||||
4343129|NCT00412984|4171027|B3||Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4343130|NCT00412984|4171028|B2||Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4343131|NCT00412984|4171029|B1||Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4343132|NCT00412984|4171027|B3||Not Hispanic / Latino|Race/Ethnicity, Customized||Participants|Count of Participants|14588|14588.0||||||
4343133|NCT00412984|4171028|B2||Not Hispanic / Latino|Race/Ethnicity, Customized||Participants|Count of Participants|7276|7276.0||||||
4343134|NCT00412984|4171029|B1||Not Hispanic / Latino|Race/Ethnicity, Customized||Participants|Count of Participants|7312|7312.0||||||
4343135|NCT00412984|4171027|B3||Hispanic / Latino|Race/Ethnicity, Customized||Participants|Count of Participants|3611|3611.0||||||
4343136|NCT00412984|4171028|B2||Hispanic / Latino|Race/Ethnicity, Customized||Participants|Count of Participants|1803|1803.0||||||
4343137|NCT00412984|4171029|B1||Hispanic / Latino|Race/Ethnicity, Customized||Participants|Count of Participants|1808|1808.0||||||
4343138|NCT00412984|4171027|B3||Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4343139|NCT00412984|4171028|B2||Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4343140|NCT00412984|4171029|B1||Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4343141|NCT00412984|4171027|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|248|248.0||||||
4343142|NCT00412984|4171028|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|127|127.0||||||
4343143|NCT00412984|4171029|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|121|121.0||||||
4343144|NCT00412984|4171027|B3||Native Hawaiian / Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4343145|NCT00412984|4171028|B2||Native Hawaiian / Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4343146|NCT00412984|4171029|B1||Native Hawaiian / Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4343147|NCT00412984|4171027|B3||American Indian / Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
4343148|NCT00412984|4171028|B2||American Indian / Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
4343149|NCT00412984|4171029|B1||American Indian / Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
4343150|NCT00412984|4171027|B3||Asian (Other Asian)|Race/Ethnicity, Customized||Participants|Count of Participants|607|607.0||||||
4343151|NCT00412984|4171028|B2||Asian (Other Asian)|Race/Ethnicity, Customized||Participants|Count of Participants|304|304.0||||||
4343152|NCT00412984|4171029|B1||Asian (Other Asian)|Race/Ethnicity, Customized||Participants|Count of Participants|303|303.0||||||
4343153|NCT00412984|4171027|B3||Asian (Japanese)|Race/Ethnicity, Customized||Participants|Count of Participants|344|344.0||||||
4343154|NCT00412984|4171028|B2||Asian (Japanese)|Race/Ethnicity, Customized||Participants|Count of Participants|180|180.0||||||
4343155|NCT00412984|4171029|B1||Asian (Japanese)|Race/Ethnicity, Customized||Participants|Count of Participants|164|164.0||||||
4343156|NCT00412984|4171027|B3||Asian (Chinese)|Race/Ethnicity, Customized||Participants|Count of Participants|1072|1072.0||||||
4343157|NCT00412984|4171028|B2||Asian (Chinese)|Race/Ethnicity, Customized||Participants|Count of Participants|536|536.0||||||
4343158|NCT00412984|4171029|B1||Asian (Chinese)|Race/Ethnicity, Customized||Participants|Count of Participants|536|536.0||||||
4343159|NCT00412984|4171027|B3||Asian (Asian Indian)|Race/Ethnicity, Customized||Participants|Count of Participants|619|619.0||||||
4343160|NCT00412984|4171028|B2||Asian (Asian Indian)|Race/Ethnicity, Customized||Participants|Count of Participants|312|312.0||||||
4343161|NCT00412984|4171029|B1||Asian (Asian Indian)|Race/Ethnicity, Customized||Participants|Count of Participants|307|307.0||||||
4343162|NCT00412984|4171027|B3||Black / African American|Race/Ethnicity, Customized||Participants|Count of Participants|227|227.0||||||
4343163|NCT00412984|4171028|B2||Black / African American|Race/Ethnicity, Customized||Participants|Count of Participants|102|102.0||||||
4343164|NCT00412984|4171029|B1||Black / African American|Race/Ethnicity, Customized||Participants|Count of Participants|125|125.0||||||
4343165|NCT00412984|4171027|B3||White (Not Reported)|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4343166|NCT00412984|4171028|B2||White (Not Reported)|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4343167|NCT00412984|4171029|B1||White (Not Reported)|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4343168|NCT00412984|4171027|B3||White (Other White)|Race/Ethnicity, Customized||Participants|Count of Participants|4097|4097.0||||||
4343169|NCT00412984|4171028|B2||White (Other White)|Race/Ethnicity, Customized||Participants|Count of Participants|2060|2060.0||||||
4343170|NCT00412984|4171029|B1||White (Other White)|Race/Ethnicity, Customized||Participants|Count of Participants|2037|2037.0||||||
4343171|NCT00412984|4171027|B3||White (Middle Eastern or North African)|Race/Ethnicity, Customized||Participants|Count of Participants|125|125.0||||||
4343172|NCT00412984|4171028|B2||White (Middle Eastern or North African)|Race/Ethnicity, Customized||Participants|Count of Participants|66|66.0||||||
4343173|NCT00412984|4171029|B1||White (Middle Eastern or North African)|Race/Ethnicity, Customized||Participants|Count of Participants|59|59.0||||||
4343174|NCT00412984|4171027|B3||White (European)|Race/Ethnicity, Customized||Participants|Count of Participants|10806|10806.0||||||
4343175|NCT00412984|4171028|B2||White (European)|Race/Ethnicity, Customized||Participants|Count of Participants|5366|5366.0||||||
4343176|NCT00412984|4171029|B1||White (European)|Race/Ethnicity, Customized||Participants|Count of Participants|5440|5440.0||||||
4343177|NCT00412984|4171027|B3||Male|Sex: Female, Male||Participants|Count of Participants|11785|11785.0||||||
4343178|NCT00412984|4171028|B2||Male|Sex: Female, Male||Participants|Count of Participants|5899|5899.0||||||
4343179|NCT00412984|4171029|B1||Male|Sex: Female, Male||Participants|Count of Participants|5886|5886.0||||||
4343180|NCT00412984|4171027|B3||Female|Sex: Female, Male||Participants|Count of Participants|6416|6416.0||||||
4343181|NCT00412984|4171028|B2||Female|Sex: Female, Male||Participants|Count of Participants|3182|3182.0||||||
4343182|NCT00412984|4171029|B1||Female|Sex: Female, Male||Participants|Count of Participants|3234|3234.0||||||
4343183|NCT00412984|4171027|B3||>=75 years|Age, Customized||Participants|Count of Participants|5678|5678.0||||||
4343184|NCT00412984|4171028|B2||>=75 years|Age, Customized||Participants|Count of Participants|2828|2828.0||||||
4343185|NCT00412984|4171029|B1||>=75 years|Age, Customized||Participants|Count of Participants|2850|2850.0||||||
4343186|NCT00412984|4171027|B3||Between 65 and 75 years|Age, Customized||Participants|Count of Participants|7052|7052.0||||||
4343187|NCT00412984|4171028|B2||Between 65 and 75 years|Age, Customized||Participants|Count of Participants|3513|3513.0||||||
4343188|NCT00412984|4171029|B1||Between 65 and 75 years|Age, Customized||Participants|Count of Participants|3539|3539.0||||||
4343189|NCT00412984|4171027|B3||<65 years|Age, Customized||Participants|Count of Participants|5471|5471.0||||||
4343190|NCT00412984|4171028|B2||<65 years|Age, Customized||Participants|Count of Participants|2740|2740.0||||||
4343191|NCT00412984|4171029|B1||<65 years|Age, Customized||Participants|Count of Participants|2731|2731.0||||||
4343192|NCT00412984|4171027|B3|||Age||years|Mean|69.1|69.1|Standard Deviation|9.68|9.68|||
4343193|NCT00412984|4171028|B2|||Age||years|Mean|69.0|69.0|Standard Deviation|9.74|9.74|||
4343194|NCT00412984|4171029|B1|||Age||years|Mean|69.1|69.1|Standard Deviation|9.61|9.61|||
4343196|NCT00412971|4171073|B2|Denmark||Region of Enrollment||participants|Number|118|118.0||||||
4343197|NCT00412971|4171074|B1|Denmark||Region of Enrollment||participants|Number|115|115.0||||||
4343198|NCT00412971|4171072|B3|Male||Gender||participants|Number|63|63.0||||||
4343199|NCT00412971|4171073|B2|Male||Gender||participants|Number|36|36.0||||||
4343200|NCT00412971|4171074|B1|Male||Gender||participants|Number|27|27.0||||||
4343201|NCT00412971|4171072|B3|Female||Gender||participants|Number|156|156.0||||||
4343202|NCT00412971|4171073|B2|Female||Gender||participants|Number|81|81.0||||||
4343203|NCT00412971|4171074|B1|Female||Gender||participants|Number|75|75.0||||||
4343204|NCT00412971|4171072|B3|||Age||years|Mean|69.8|69.8|Standard Deviation|10.7|10.7|||
4343205|NCT00412971|4171073|B2|||Age||years|Mean|69.1|69.1|Standard Deviation|10|10.0|||
4343206|NCT00412971|4171074|B1|||Age||years|Mean|70.6|70.6|Standard Deviation|11.5|11.5|||
4343207|NCT00412958|4171084|B5||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4343208|NCT00412958|4171085|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4343209|NCT00412958|4171086|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4343210|NCT00412958|4171087|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4343211|NCT00412958|4171088|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4343212|NCT00412958|4171084|B5||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4343213|NCT00412958|4171085|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4343214|NCT00412958|4171086|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4343215|NCT00412958|4171087|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4343216|NCT00412958|4171088|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4343217|NCT00412958|4171084|B5|||Age||years|Mean|66.1|66.1|Standard Deviation|10.16|10.16|||
4343218|NCT00412958|4171085|B4|||Age||years|Mean|65.7|65.7|Standard Deviation|11.60|11.6|||
4343219|NCT00412958|4171086|B3|||Age||years|Mean|66.9|66.9|Standard Deviation|11.40|11.4|||
4343220|NCT00412958|4171087|B2|||Age||years|Mean|68.8|68.8|Standard Deviation|9.07|9.07|||
4343221|NCT00412958|4171088|B1|||Age||years|Mean|66.9|66.9|Standard Deviation|8.28|8.28|||
4343222|NCT00412932|4171101|B1|||Baseline systolic blood pressure||mm Hg|Mean|165.5|165.5|Standard Deviation|11.9|11.9|||
4343223|NCT00412932|4171101|B1|||Baseline heart rate||beats/minute|Mean|71.5|71.5|Standard Deviation|11.4|11.4|||
4343224|NCT00412932|4171101|B1|||Baseline diastolic blood pressure||mm Hg|Mean|87.7|87.7|Standard Deviation|9.6|9.6|||
4343225|NCT00412932|4171101|B1|||Baseline 24-hour ambulatory systolic blood pressure||mm Hg|Mean|149.1|149.1|Standard Deviation|11.2|11.2|||
4343226|NCT00412932|4171101|B1|||Baseline 24-hour ambulatory diastolic blood pressure||mm Hg|Mean|80.7|80.7|Standard Deviation|8.5|8.5|||
4343227|NCT00412932|4171101|B1|Stage 2 hypertension||Baseline stage of hypertension|Stage I hypertension is defined as systolic blood pressure (SBP) of 140 – 159 mmHg and diastolic blood pressure (DBP) of 90 – 99 mmHg; Stage II is defined as SBP ≥ 160 mmHg or DBP ≥ 100 mm Hg.|participants|Number|116|116.0||||||
4343228|NCT00412932|4171101|B1|Stage 1 hypertension||Baseline stage of hypertension|Stage I hypertension is defined as systolic blood pressure (SBP) of 140 – 159 mmHg and diastolic blood pressure (DBP) of 90 – 99 mmHg; Stage II is defined as SBP ≥ 160 mmHg or DBP ≥ 100 mm Hg.|participants|Number|62|62.0||||||
4343229|NCT00412932|4171101|B1|United States||Region of Enrollment||participants|Number|178|178.0||||||
4343230|NCT00412932|4171101|B1||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4343231|NCT00412932|4171101|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4343232|NCT00412932|4171101|B1|||Age||years|Mean|72.0|72.0|Standard Deviation|5.3|5.3|||
4343233|NCT00412893|4171110|B3|No||Neutropenic Status|The presence or absence of neutropenia was defined as an absolute neutrophil count (ANC) < 0.5 x 10^9/L (< 500/mm^3).|participants|Number|178|178.0||||||
4343234|NCT00412893|4171111|B2|No||Neutropenic Status|The presence or absence of neutropenia was defined as an absolute neutrophil count (ANC) < 0.5 x 10^9/L (< 500/mm^3).|participants|Number|83|83.0||||||
4343235|NCT00412893|4171112|B1|No||Neutropenic Status|The presence or absence of neutropenia was defined as an absolute neutrophil count (ANC) < 0.5 x 10^9/L (< 500/mm^3).|participants|Number|95|95.0||||||
4343236|NCT00412893|4171110|B3|Yes||Neutropenic Status|The presence or absence of neutropenia was defined as an absolute neutrophil count (ANC) < 0.5 x 10^9/L (< 500/mm^3).|participants|Number|338|338.0||||||
4343237|NCT00412893|4171111|B2|Yes||Neutropenic Status|The presence or absence of neutropenia was defined as an absolute neutrophil count (ANC) < 0.5 x 10^9/L (< 500/mm^3).|participants|Number|175|175.0||||||
4343238|NCT00412893|4171112|B1|Yes||Neutropenic Status|The presence or absence of neutropenia was defined as an absolute neutrophil count (ANC) < 0.5 x 10^9/L (< 500/mm^3).|participants|Number|163|163.0||||||
4343239|NCT00412893|4171110|B3|No||Uncontrolled Malignancy Status|Uncontrolled malignancy was defined as participants who per Investigator judgment had active malignancy (new diagnosis or relapse).|participants|Number|156|156.0||||||
4343240|NCT00412893|4171111|B2|No||Uncontrolled Malignancy Status|Uncontrolled malignancy was defined as participants who per Investigator judgment had active malignancy (new diagnosis or relapse).|participants|Number|71|71.0||||||
4343241|NCT00412893|4171112|B1|No||Uncontrolled Malignancy Status|Uncontrolled malignancy was defined as participants who per Investigator judgment had active malignancy (new diagnosis or relapse).|participants|Number|85|85.0||||||
4343242|NCT00412893|4171110|B3|Yes||Uncontrolled Malignancy Status|Uncontrolled malignancy was defined as participants who per Investigator judgment had active malignancy (new diagnosis or relapse).|participants|Number|360|360.0||||||
4343243|NCT00412893|4171111|B2|Yes||Uncontrolled Malignancy Status|Uncontrolled malignancy was defined as participants who per Investigator judgment had active malignancy (new diagnosis or relapse).|participants|Number|187|187.0||||||
4343294|NCT00412854|4171150|B2||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4343244|NCT00412893|4171112|B1|Yes||Uncontrolled Malignancy Status|Uncontrolled malignancy was defined as participants who per Investigator judgment had active malignancy (new diagnosis or relapse).|participants|Number|173|173.0||||||
4343245|NCT00412893|4171110|B3|No||Prior Allogeneic Bone Marrow Transplant (BMT)|Allogeneic BMT Status was defined as Yes for patients indicated as having a BMT, hematopoietic stem cell transplant (HSCT) or other progenitor cell transplant with type of transplant identified as allogeneic.|participants|Number|411|411.0||||||
4343246|NCT00412893|4171111|B2|No||Prior Allogeneic Bone Marrow Transplant (BMT)|Allogeneic BMT Status was defined as Yes for patients indicated as having a BMT, hematopoietic stem cell transplant (HSCT) or other progenitor cell transplant with type of transplant identified as allogeneic.|participants|Number|207|207.0||||||
4343247|NCT00412893|4171112|B1|No||Prior Allogeneic Bone Marrow Transplant (BMT)|Allogeneic BMT Status was defined as Yes for patients indicated as having a BMT, hematopoietic stem cell transplant (HSCT) or other progenitor cell transplant with type of transplant identified as allogeneic.|participants|Number|204|204.0||||||
4343248|NCT00412893|4171110|B3|Yes||Prior Allogeneic Bone Marrow Transplant (BMT)|Allogeneic BMT Status was defined as Yes for patients indicated as having a BMT, hematopoietic stem cell transplant (HSCT) or other progenitor cell transplant with type of transplant identified as allogeneic.|participants|Number|105|105.0||||||
4343249|NCT00412893|4171111|B2|Yes||Prior Allogeneic Bone Marrow Transplant (BMT)|Allogeneic BMT Status was defined as Yes for patients indicated as having a BMT, hematopoietic stem cell transplant (HSCT) or other progenitor cell transplant with type of transplant identified as allogeneic.|participants|Number|51|51.0||||||
4343250|NCT00412893|4171112|B1|Yes||Prior Allogeneic Bone Marrow Transplant (BMT)|Allogeneic BMT Status was defined as Yes for patients indicated as having a BMT, hematopoietic stem cell transplant (HSCT) or other progenitor cell transplant with type of transplant identified as allogeneic.|participants|Number|54|54.0||||||
4343251|NCT00412893|4171110|B3|No||Hematologic Malignancy Status||participants|Number|83|83.0||||||
4343252|NCT00412893|4171111|B2|No||Hematologic Malignancy Status||participants|Number|36|36.0||||||
4343253|NCT00412893|4171112|B1|No||Hematologic Malignancy Status||participants|Number|47|47.0||||||
4343254|NCT00412893|4171110|B3|Yes||Hematologic Malignancy Status||participants|Number|433|433.0||||||
4343255|NCT00412893|4171111|B2|Yes||Hematologic Malignancy Status||participants|Number|222|222.0||||||
4343256|NCT00412893|4171112|B1|Yes||Hematologic Malignancy Status||participants|Number|211|211.0||||||
4343257|NCT00412893|4171110|B3|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4343258|NCT00412893|4171111|B2|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4343259|NCT00412893|4171112|B1|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4343260|NCT00412893|4171110|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|484|484.0||||||
4343261|NCT00412893|4171111|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|248|248.0||||||
4343262|NCT00412893|4171112|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|236|236.0||||||
4343263|NCT00412893|4171110|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4343264|NCT00412893|4171111|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4343265|NCT00412893|4171112|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4343266|NCT00412893|4171110|B3|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4343267|NCT00412893|4171111|B2|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4343268|NCT00412893|4171112|B1|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4343269|NCT00412893|4171110|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4343270|NCT00412893|4171111|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4343271|NCT00412893|4171112|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4343272|NCT00412893|4171110|B3|Asian||Race/Ethnicity, Customized||participants|Number|109|109.0||||||
4343273|NCT00412893|4171111|B2|Asian||Race/Ethnicity, Customized||participants|Number|64|64.0||||||
4343274|NCT00412893|4171112|B1|Asian||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4343275|NCT00412893|4171110|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4343276|NCT00412893|4171111|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4343277|NCT00412893|4171112|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4343278|NCT00412893|4171110|B3|White||Race/Ethnicity, Customized||participants|Number|402|402.0||||||
4343279|NCT00412893|4171111|B2|White||Race/Ethnicity, Customized||participants|Number|191|191.0||||||
4343280|NCT00412893|4171112|B1|White||Race/Ethnicity, Customized||participants|Number|211|211.0||||||
4343281|NCT00412893|4171110|B3||Male|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
4343282|NCT00412893|4171111|B2||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4343283|NCT00412893|4171112|B1||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4343284|NCT00412893|4171110|B3||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4343285|NCT00412893|4171111|B2||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4343286|NCT00412893|4171112|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4343287|NCT00412893|4171110|B3|||Age||years|Mean|51.1|51.1|Standard Deviation|15.98|15.98|||
4343288|NCT00412893|4171111|B2|||Age||years|Mean|51.2|51.2|Standard Deviation|15.85|15.85|||
4343289|NCT00412893|4171112|B1|||Age||years|Mean|51.1|51.1|Standard Deviation|16.15|16.15|||
4343290|NCT00412867|4171139|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4343291|NCT00412867|4171139|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4343292|NCT00412867|4171139|B1|||Age||years|Mean|70.3|70.3|Standard Deviation|11.5|11.5|||
4343293|NCT00412854|4171149|B3||Male|Sex: Female, Male||Participants|Count of Participants|344|344.0||||||
4343295|NCT00412854|4171151|B1||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4343296|NCT00412854|4171149|B3||Female|Sex: Female, Male||Participants|Count of Participants|316|316.0||||||
4343297|NCT00412854|4171150|B2||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4343298|NCT00412854|4171151|B1||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4343299|NCT00412854|4171149|B3|||Age||Weeks|Mean|14.2|14.2|Standard Deviation|1.15|1.15|||
4343300|NCT00412854|4171150|B2|||Age||Weeks|Mean|14.2|14.2|Standard Deviation|1.18|1.18|||
4343301|NCT00412854|4171151|B1|||Age||Weeks|Mean|14.2|14.2|Standard Deviation|1.12|1.12|||
4343302|NCT00412841|4171178|B3|United States||Region of Enrollment||participants|Number|43|43.0||||||
4343303|NCT00412841|4171179|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4343304|NCT00412841|4171180|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4343305|NCT00412841|4171178|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4343306|NCT00412841|4171179|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4343307|NCT00412841|4171180|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4343308|NCT00412841|4171178|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4343309|NCT00412841|4171179|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4343310|NCT00412841|4171180|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4343311|NCT00412841|4171178|B3|||Age||years|Mean|35|35.0|Full Range|||18.0|58.0|
4343312|NCT00412841|4171179|B2|||Age||years|Mean|35|35.0|Full Range|||20.0|57.0|
4343313|NCT00412841|4171180|B1|||Age||years|Mean|35|35.0|Full Range|||18.0|58.0|
4343314|NCT00412841|4171178|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4343315|NCT00412841|4171179|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4343316|NCT00412841|4171180|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4343317|NCT00412841|4171178|B3||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4343318|NCT00412841|4171179|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4343319|NCT00412841|4171180|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4343320|NCT00412841|4171178|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4343321|NCT00412841|4171179|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4343322|NCT00412841|4171180|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4343323|NCT00412750|4171193|B4||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4343324|NCT00412750|4171194|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4343325|NCT00412750|4171195|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4343326|NCT00412750|4171196|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4343327|NCT00412750|4171193|B4||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4343328|NCT00412750|4171194|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4343329|NCT00412750|4171195|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4343330|NCT00412750|4171196|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4343331|NCT00412750|4171193|B4|||Age||years|Mean|34.7|34.7|Standard Deviation|10.33|10.33|||
4343332|NCT00412750|4171194|B3|||Age||years|Mean|33.8|33.8|Standard Deviation|9.47|9.47|||
4343333|NCT00412750|4171195|B2|||Age||years|Mean|35.0|35.0|Standard Deviation|11.48|11.48|||
4343334|NCT00412750|4171196|B1|||Age||years|Mean|35.6|35.6|Standard Deviation|10.00|10.0|||
4343335|NCT00412737|4171221|B3||Male|Sex: Female, Male||Participants|Count of Participants|315|315.0||||||
4343336|NCT00412737|4171222|B2||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4343337|NCT00412737|4171223|B1||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4343338|NCT00412737|4171221|B3||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4343339|NCT00412737|4171222|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4343340|NCT00412737|4171223|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4343341|NCT00412737|4171221|B3|||Age||years|Mean|49.2|49.2|Standard Deviation|15.56|15.56|||
4343342|NCT00412737|4171222|B2|||Age||years|Mean|49.4|49.4|Standard Deviation|15.47|15.47|||
4343343|NCT00412737|4171223|B1|||Age||years|Mean|48.9|48.9|Standard Deviation|15.67|15.67|||
4343344|NCT00412607|4171242|B1|United States||Region of Enrollment||participants|Number|249|249.0||||||
4343345|NCT00412607|4171242|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4343346|NCT00412607|4171242|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4343347|NCT00412607|4171242|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|229|229.0||||||
4343348|NCT00412607|4171242|B1|Black||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4343349|NCT00412607|4171242|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4343350|NCT00412607|4171242|B1||Male|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
4343351|NCT00412607|4171242|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4343352|NCT00412607|4171242|B1|||Age||years|Mean|67.4|67.4|Standard Deviation|9.8|9.8|||
4343353|NCT00412542|4171253|B3|United States||Region of Enrollment||participants|Number|78|78.0||||||
4343354|NCT00412542|4171254|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
4343355|NCT00412542|4171255|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4343356|NCT00412542|4171253|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4343357|NCT00412542|4171254|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4343358|NCT00412542|4171255|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4343359|NCT00412542|4171253|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4343360|NCT00412542|4171254|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4343361|NCT00412542|4171255|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4343362|NCT00412542|4171253|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4343363|NCT00412542|4171254|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4343364|NCT00412542|4171255|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4343365|NCT00412542|4171253|B3||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
4343366|NCT00412542|4171254|B2||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4343367|NCT00412542|4171255|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4343368|NCT00412542|4171253|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4343369|NCT00412542|4171254|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4343370|NCT00412542|4171255|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4343371|NCT00412529|4171260|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4343372|NCT00412529|4171261|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4343373|NCT00412529|4171262|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4343374|NCT00412529|4171260|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4343375|NCT00412529|4171261|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4343376|NCT00412529|4171262|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4343377|NCT00412529|4171260|B3|||Age|Baseline Measures based on Intention to treat population.|Years|Mean|34.9|34.9|Standard Deviation|9.25|9.25|||
4343378|NCT00412529|4171261|B2|||Age|Baseline Measures based on Intention to treat population.|Years|Mean|33.4|33.4|Standard Deviation|8.82|8.82|||
4343379|NCT00412529|4171262|B1|||Age|Baseline Measures based on Intention to treat population.|Years|Mean|36.2|36.2|Standard Deviation|9.62|9.62|||
4343380|NCT00412516|4171283|B4|||Height (cm)||cm|Mean|78.0|78.0|Standard Deviation|3.5|3.5|||
4343381|NCT00412516|4171284|B3|||Height (cm)||cm|Mean|78.1|78.1|Standard Deviation|3.5|3.5|||
4343382|NCT00412516|4171285|B2|||Height (cm)||cm|Mean|77.8|77.8|Standard Deviation|3.8|3.8|||
4343383|NCT00412516|4171286|B1|||Height (cm)||cm|Mean|78.7|78.7|Standard Deviation|3.1|3.1|||
4343384|NCT00412516|4171283|B4|||Weight (kg)||units on a scale|Mean|10.2|10.2|Standard Deviation|1.4|1.4|||
4343385|NCT00412516|4171284|B3|||Weight (kg)||units on a scale|Mean|10.2|10.2|Standard Deviation|1.4|1.4|||
4343386|NCT00412516|4171285|B2|||Weight (kg)||units on a scale|Mean|10.2|10.2|Standard Deviation|1.6|1.6|||
4343387|NCT00412516|4171286|B1|||Weight (kg)||units on a scale|Mean|10.2|10.2|Standard Deviation|1.3|1.3|||
4343388|NCT00412516|4171283|B4||Male|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
4343389|NCT00412516|4171284|B3||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4343390|NCT00412516|4171285|B2||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4343391|NCT00412516|4171286|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4343392|NCT00412516|4171283|B4||Female|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
4343393|NCT00412516|4171284|B3||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4343394|NCT00412516|4171285|B2||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4343395|NCT00412516|4171286|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4343396|NCT00412516|4171283|B4|||Age||months|Mean|20.6|20.6|Standard Deviation|.4|0.4|||
4343397|NCT00412516|4171284|B3|||Age||months|Mean|20.6|20.6|Standard Deviation|.4|0.4|||
4343398|NCT00412516|4171285|B2|||Age||months|Mean|20.6|20.6|Standard Deviation|.4|0.4|||
4343399|NCT00412516|4171286|B1|||Age||months|Mean|20.6|20.6|Standard Deviation|.4|0.4|||
4343400|NCT00412464|4171305|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4343401|NCT00412464|4171305|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4343402|NCT00412464|4171305|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4343403|NCT00412464|4171305|B1|||Age||years|Mean|12|12.0|Standard Deviation|4|4.0|||
4343404|NCT00412464|4171305|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4343405|NCT00412464|4171305|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4343406|NCT00412464|4171305|B1||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
4343407|NCT00412451|4171313|B5||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4343408|NCT00412451|4171314|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4343409|NCT00412451|4171315|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4343410|NCT00412451|4171316|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4343411|NCT00412451|4171317|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4343412|NCT00412451|4171313|B5||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4343413|NCT00412451|4171314|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4343414|NCT00412451|4171315|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4343415|NCT00412451|4171316|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4343416|NCT00412451|4171317|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4343417|NCT00412451|4171313|B5|||Age||years|Mean|63.9|63.9|Standard Deviation|11.1|11.1|||
4343418|NCT00412451|4171314|B4|||Age||years|Mean|69.9|69.9|Standard Deviation|6.2|6.2|||
4343419|NCT00412451|4171315|B3|||Age||years|Mean|61.7|61.7|Standard Deviation|13.4|13.4|||
4343420|NCT00412451|4171316|B2|||Age||years|Mean|67.3|67.3|Standard Deviation|8.8|8.8|||
4343421|NCT00412451|4171317|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|9.8|9.8|||
4343422|NCT00412425|4171330|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4343423|NCT00412425|4171331|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4343424|NCT00412425|4171332|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4343425|NCT00412425|4171330|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4343426|NCT00412425|4171331|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4343427|NCT00412425|4171332|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4343428|NCT00412425|4171330|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4343429|NCT00412425|4171331|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4343430|NCT00412425|4171332|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4343431|NCT00412425|4171330|B3|||Age||years|Median|53|53.0|Full Range|||23.0|65.0|
4343432|NCT00412425|4171331|B2|||Age||years|Median|49|49.0|Full Range|||33.0|65.0|
4343433|NCT00412425|4171332|B1|||Age||years|Median|55|55.0|Full Range|||23.0|64.0|
4343434|NCT00412373|4171339|B3||Unknown or Not Reported|Race (NIH/OMB)|Intent-to-Treat (ITT) analysis set. ITT for Placebo is 93 subjects and for PALI ER is 211 subjects.|Participants|Count of Participants|2|2.0||||||
4343435|NCT00412373|4171340|B2||Unknown or Not Reported|Race (NIH/OMB)|Intent-to-Treat (ITT) analysis set. ITT for Placebo is 93 subjects and for PALI ER is 211 subjects.|Participants|Count of Participants|2|2.0||||||
4343436|NCT00412373|4171341|B1||Unknown or Not Reported|Race (NIH/OMB)|Intent-to-Treat (ITT) analysis set. ITT for Placebo is 93 subjects and for PALI ER is 211 subjects.|Participants|Count of Participants|0|0.0||||||
4343437|NCT00412373|4171339|B3||More than one race|Race (NIH/OMB)|Intent-to-Treat (ITT) analysis set. ITT for Placebo is 93 subjects and for PALI ER is 211 subjects.|Participants|Count of Participants|0|0.0||||||
4343438|NCT00412373|4171340|B2||More than one race|Race (NIH/OMB)|Intent-to-Treat (ITT) analysis set. ITT for Placebo is 93 subjects and for PALI ER is 211 subjects.|Participants|Count of Participants|0|0.0||||||
4343439|NCT00412373|4171341|B1||More than one race|Race (NIH/OMB)|Intent-to-Treat (ITT) analysis set. ITT for Placebo is 93 subjects and for PALI ER is 211 subjects.|Participants|Count of Participants|0|0.0||||||
4343440|NCT00412373|4171339|B3||White|Race (NIH/OMB)|Intent-to-Treat (ITT) analysis set. ITT for Placebo is 93 subjects and for PALI ER is 211 subjects.|Participants|Count of Participants|156|156.0||||||
4343441|NCT00412373|4171340|B2||White|Race (NIH/OMB)|Intent-to-Treat (ITT) analysis set. ITT for Placebo is 93 subjects and for PALI ER is 211 subjects.|Participants|Count of Participants|109|109.0||||||
4343442|NCT00412373|4171341|B1||White|Race (NIH/OMB)|Intent-to-Treat (ITT) analysis set. ITT for Placebo is 93 subjects and for PALI ER is 211 subjects.|Participants|Count of Participants|47|47.0||||||
4343443|NCT00412373|4171339|B3||Black or African American|Race (NIH/OMB)|Intent-to-Treat (ITT) analysis set. ITT for Placebo is 93 subjects and for PALI ER is 211 subjects.|Participants|Count of Participants|55|55.0||||||
4343444|NCT00412373|4171340|B2||Black or African American|Race (NIH/OMB)|Intent-to-Treat (ITT) analysis set. ITT for Placebo is 93 subjects and for PALI ER is 211 subjects.|Participants|Count of Participants|38|38.0||||||
4343445|NCT00412373|4171341|B1||Black or African American|Race (NIH/OMB)|Intent-to-Treat (ITT) analysis set. ITT for Placebo is 93 subjects and for PALI ER is 211 subjects.|Participants|Count of Participants|17|17.0||||||
4343446|NCT00412373|4171339|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Intent-to-Treat (ITT) analysis set. ITT for Placebo is 93 subjects and for PALI ER is 211 subjects.|Participants|Count of Participants|0|0.0||||||
4343447|NCT00412373|4171340|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Intent-to-Treat (ITT) analysis set. ITT for Placebo is 93 subjects and for PALI ER is 211 subjects.|Participants|Count of Participants|0|0.0||||||
4343448|NCT00412373|4171341|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Intent-to-Treat (ITT) analysis set. ITT for Placebo is 93 subjects and for PALI ER is 211 subjects.|Participants|Count of Participants|0|0.0||||||
4343449|NCT00412373|4171339|B3||Asian|Race (NIH/OMB)|Intent-to-Treat (ITT) analysis set. ITT for Placebo is 93 subjects and for PALI ER is 211 subjects.|Participants|Count of Participants|90|90.0||||||
4343450|NCT00412373|4171340|B2||Asian|Race (NIH/OMB)|Intent-to-Treat (ITT) analysis set. ITT for Placebo is 93 subjects and for PALI ER is 211 subjects.|Participants|Count of Participants|61|61.0||||||
4343451|NCT00412373|4171341|B1||Asian|Race (NIH/OMB)|Intent-to-Treat (ITT) analysis set. ITT for Placebo is 93 subjects and for PALI ER is 211 subjects.|Participants|Count of Participants|29|29.0||||||
4343452|NCT00412373|4171339|B3||American Indian or Alaska Native|Race (NIH/OMB)|Intent-to-Treat (ITT) analysis set. ITT for Placebo is 93 subjects and for PALI ER is 211 subjects.|Participants|Count of Participants|1|1.0||||||
4343453|NCT00412373|4171340|B2||American Indian or Alaska Native|Race (NIH/OMB)|Intent-to-Treat (ITT) analysis set. ITT for Placebo is 93 subjects and for PALI ER is 211 subjects.|Participants|Count of Participants|1|1.0||||||
4343454|NCT00412373|4171341|B1||American Indian or Alaska Native|Race (NIH/OMB)|Intent-to-Treat (ITT) analysis set. ITT for Placebo is 93 subjects and for PALI ER is 211 subjects.|Participants|Count of Participants|0|0.0||||||
4343455|NCT00412373|4171339|B3||Male|Sex: Female, Male|Intent-to-Treat (ITT) analysis set. ITT for Placebo is 93 subjects and for PALI ER is 211 subjects.|Participants|Count of Participants|170|170.0||||||
4343456|NCT00412373|4171340|B2||Male|Sex: Female, Male|Intent-to-Treat (ITT) analysis set. ITT for Placebo is 93 subjects and for PALI ER is 211 subjects.|Participants|Count of Participants|116|116.0||||||
4343457|NCT00412373|4171341|B1||Male|Sex: Female, Male|Intent-to-Treat (ITT) analysis set. ITT for Placebo is 93 subjects and for PALI ER is 211 subjects.|Participants|Count of Participants|54|54.0||||||
4343458|NCT00412373|4171339|B3||Female|Sex: Female, Male|Intent-to-Treat (ITT) analysis set. ITT for Placebo is 93 subjects and for PALI ER is 211 subjects.|Participants|Count of Participants|134|134.0||||||
4343494|NCT00412360|4171383|B2||4/6|Recipient to Second Cord Blood Unit HLA Match||Participants|Count of Participants|43|43.0||||||
4343459|NCT00412373|4171340|B2||Female|Sex: Female, Male|Intent-to-Treat (ITT) analysis set. ITT for Placebo is 93 subjects and for PALI ER is 211 subjects.|Participants|Count of Participants|95|95.0||||||
4343460|NCT00412373|4171341|B1||Female|Sex: Female, Male|Intent-to-Treat (ITT) analysis set. ITT for Placebo is 93 subjects and for PALI ER is 211 subjects.|Participants|Count of Participants|39|39.0||||||
4343461|NCT00412373|4171339|B3|||Age|The Intent-to-Treat (ITT) analysis set included all randomly assigned subjects who received at least 1 dose of study medication (or any portion of a dose) and had both baseline and at least 1 postbaseline PANSS assessment. ITT for Placebo is 93 subjects and for PALI ER is 211 subjects.|years|Mean|37.6|37.6|Standard Deviation|9.2|9.2|||
4343462|NCT00412373|4171340|B2|||Age|The Intent-to-Treat (ITT) analysis set included all randomly assigned subjects who received at least 1 dose of study medication (or any portion of a dose) and had both baseline and at least 1 postbaseline PANSS assessment. ITT for Placebo is 93 subjects and for PALI ER is 211 subjects.|years|Mean|37.7|37.7|Standard Deviation|9.1|9.1|||
4343463|NCT00412373|4171341|B1|||Age|The Intent-to-Treat (ITT) analysis set included all randomly assigned subjects who received at least 1 dose of study medication (or any portion of a dose) and had both baseline and at least 1 postbaseline PANSS assessment. ITT for Placebo is 93 subjects and for PALI ER is 211 subjects.|years|Mean|37.3|37.3|Standard Deviation|9.4|9.4|||
4343464|NCT00412360|4171382|B3||Unknown|Recipient to Second Cord Blood Unit ABO Match|Blood type matching between recipient and cord blood unit|Participants|Count of Participants|6|6.0||||||
4343465|NCT00412360|4171383|B2||Unknown|Recipient to Second Cord Blood Unit ABO Match|Blood type matching between recipient and cord blood unit|Participants|Count of Participants|6|6.0||||||
4343466|NCT00412360|4171382|B3||No mismatch|Recipient to Second Cord Blood Unit ABO Match|Blood type matching between recipient and cord blood unit|Participants|Count of Participants|38|38.0||||||
4343467|NCT00412360|4171383|B2||No mismatch|Recipient to Second Cord Blood Unit ABO Match|Blood type matching between recipient and cord blood unit|Participants|Count of Participants|38|38.0||||||
4343468|NCT00412360|4171382|B3||Bidirectional mismatch|Recipient to Second Cord Blood Unit ABO Match|Blood type matching between recipient and cord blood unit|Participants|Count of Participants|4|4.0||||||
4343469|NCT00412360|4171383|B2||Bidirectional mismatch|Recipient to Second Cord Blood Unit ABO Match|Blood type matching between recipient and cord blood unit|Participants|Count of Participants|4|4.0||||||
4343470|NCT00412360|4171382|B3||Minor mismatch|Recipient to Second Cord Blood Unit ABO Match|Blood type matching between recipient and cord blood unit|Participants|Count of Participants|29|29.0||||||
4343471|NCT00412360|4171383|B2||Minor mismatch|Recipient to Second Cord Blood Unit ABO Match|Blood type matching between recipient and cord blood unit|Participants|Count of Participants|29|29.0||||||
4343472|NCT00412360|4171382|B3||Major mismatch|Recipient to Second Cord Blood Unit ABO Match|Blood type matching between recipient and cord blood unit|Participants|Count of Participants|31|31.0||||||
4343473|NCT00412360|4171383|B2||Major mismatch|Recipient to Second Cord Blood Unit ABO Match|Blood type matching between recipient and cord blood unit|Participants|Count of Participants|31|31.0||||||
4343474|NCT00412360|4171382|B3||Unknown|Recipient to First Cord Blood Unit ABO Match|Blood type matching between recipient and cord blood unit|Participants|Count of Participants|8|8.0||||||
4343475|NCT00412360|4171383|B2||Unknown|Recipient to First Cord Blood Unit ABO Match|Blood type matching between recipient and cord blood unit|Participants|Count of Participants|4|4.0||||||
4343476|NCT00412360|4171384|B1||Unknown|Recipient to First Cord Blood Unit ABO Match|Blood type matching between recipient and cord blood unit|Participants|Count of Participants|4|4.0||||||
4343477|NCT00412360|4171382|B3||No Mismatch|Recipient to First Cord Blood Unit ABO Match|Blood type matching between recipient and cord blood unit|Participants|Count of Participants|80|80.0||||||
4343478|NCT00412360|4171383|B2||No Mismatch|Recipient to First Cord Blood Unit ABO Match|Blood type matching between recipient and cord blood unit|Participants|Count of Participants|36|36.0||||||
4343479|NCT00412360|4171384|B1||No Mismatch|Recipient to First Cord Blood Unit ABO Match|Blood type matching between recipient and cord blood unit|Participants|Count of Participants|44|44.0||||||
4343480|NCT00412360|4171382|B3||Bidirectional Mismatch|Recipient to First Cord Blood Unit ABO Match|Blood type matching between recipient and cord blood unit|Participants|Count of Participants|18|18.0||||||
4343481|NCT00412360|4171383|B2||Bidirectional Mismatch|Recipient to First Cord Blood Unit ABO Match|Blood type matching between recipient and cord blood unit|Participants|Count of Participants|8|8.0||||||
4343482|NCT00412360|4171384|B1||Bidirectional Mismatch|Recipient to First Cord Blood Unit ABO Match|Blood type matching between recipient and cord blood unit|Participants|Count of Participants|10|10.0||||||
4343483|NCT00412360|4171382|B3||Minor Mismatch|Recipient to First Cord Blood Unit ABO Match|Blood type matching between recipient and cord blood unit|Participants|Count of Participants|59|59.0||||||
4343484|NCT00412360|4171383|B2||Minor Mismatch|Recipient to First Cord Blood Unit ABO Match|Blood type matching between recipient and cord blood unit|Participants|Count of Participants|35|35.0||||||
4343485|NCT00412360|4171384|B1||Minor Mismatch|Recipient to First Cord Blood Unit ABO Match|Blood type matching between recipient and cord blood unit|Participants|Count of Participants|24|24.0||||||
4343486|NCT00412360|4171382|B3||Major Mismatch|Recipient to First Cord Blood Unit ABO Match|Blood type matching between recipient and cord blood unit|Participants|Count of Participants|55|55.0||||||
4343487|NCT00412360|4171383|B2||Major Mismatch|Recipient to First Cord Blood Unit ABO Match|Blood type matching between recipient and cord blood unit|Participants|Count of Participants|25|25.0||||||
4343488|NCT00412360|4171384|B1||Major Mismatch|Recipient to First Cord Blood Unit ABO Match|Blood type matching between recipient and cord blood unit|Participants|Count of Participants|30|30.0||||||
4343489|NCT00412360|4171382|B3||6/6|Recipient to Second Cord Blood Unit HLA Match||Participants|Count of Participants|21|21.0||||||
4343490|NCT00412360|4171383|B2||6/6|Recipient to Second Cord Blood Unit HLA Match||Participants|Count of Participants|21|21.0||||||
4343491|NCT00412360|4171382|B3||5/6|Recipient to Second Cord Blood Unit HLA Match||Participants|Count of Participants|43|43.0||||||
4343492|NCT00412360|4171383|B2||5/6|Recipient to Second Cord Blood Unit HLA Match||Participants|Count of Participants|43|43.0||||||
4343493|NCT00412360|4171382|B3||4/6|Recipient to Second Cord Blood Unit HLA Match||Participants|Count of Participants|43|43.0||||||
4343495|NCT00412360|4171382|B3||3/6|Recipient to Second Cord Blood Unit HLA Match||Participants|Count of Participants|1|1.0||||||
4343496|NCT00412360|4171383|B2||3/6|Recipient to Second Cord Blood Unit HLA Match||Participants|Count of Participants|1|1.0||||||
4343497|NCT00412360|4171382|B3||6/6|Recipient to First Cord Blood Unit HLA Match||Participants|Count of Participants|30|30.0||||||
4343498|NCT00412360|4171383|B2||6/6|Recipient to First Cord Blood Unit HLA Match||Participants|Count of Participants|14|14.0||||||
4343499|NCT00412360|4171384|B1||6/6|Recipient to First Cord Blood Unit HLA Match||Participants|Count of Participants|16|16.0||||||
4343500|NCT00412360|4171382|B3||5/6|Recipient to First Cord Blood Unit HLA Match||Participants|Count of Participants|110|110.0||||||
4343501|NCT00412360|4171383|B2||5/6|Recipient to First Cord Blood Unit HLA Match||Participants|Count of Participants|59|59.0||||||
4343502|NCT00412360|4171384|B1||5/6|Recipient to First Cord Blood Unit HLA Match||Participants|Count of Participants|51|51.0||||||
4343503|NCT00412360|4171382|B3||4/6|Recipient to First Cord Blood Unit HLA Match||Participants|Count of Participants|77|77.0||||||
4343504|NCT00412360|4171383|B2||4/6|Recipient to First Cord Blood Unit HLA Match||Participants|Count of Participants|33|33.0||||||
4343505|NCT00412360|4171384|B1||4/6|Recipient to First Cord Blood Unit HLA Match||Participants|Count of Participants|44|44.0||||||
4343506|NCT00412360|4171382|B3||3/6|Recipient to First Cord Blood Unit HLA Match||Participants|Count of Participants|3|3.0||||||
4343507|NCT00412360|4171383|B2||3/6|Recipient to First Cord Blood Unit HLA Match||Participants|Count of Participants|2|2.0||||||
4343508|NCT00412360|4171384|B1||3/6|Recipient to First Cord Blood Unit HLA Match||Participants|Count of Participants|1|1.0||||||
4343509|NCT00412360|4171382|B3|||Weight at Infusion||kilograms|Mean|39.15|39.15|Standard Deviation|19.7|19.7|||
4343510|NCT00412360|4171383|B2|||Weight at Infusion||kilograms|Mean|38.7|38.7|Standard Deviation|19.2|19.2|||
4343511|NCT00412360|4171384|B1|||Weight at Infusion||kilograms|Mean|39.6|39.6|Standard Deviation|20.2|20.2|||
4343512|NCT00412360|4171382|B3|Unknown||Recipient CMV Status||Participants|Count of Participants|8|8.0||||||
4343513|NCT00412360|4171383|B2|Unknown||Recipient CMV Status||Participants|Count of Participants|5|5.0||||||
4343514|NCT00412360|4171384|B1|Unknown||Recipient CMV Status||Participants|Count of Participants|3|3.0||||||
4343515|NCT00412360|4171382|B3|Inconclusive||Recipient CMV Status||Participants|Count of Participants|2|2.0||||||
4343516|NCT00412360|4171383|B2|Inconclusive||Recipient CMV Status||Participants|Count of Participants|1|1.0||||||
4343517|NCT00412360|4171384|B1|Inconclusive||Recipient CMV Status||Participants|Count of Participants|1|1.0||||||
4343518|NCT00412360|4171382|B3|Negative||Recipient CMV Status||Participants|Count of Participants|90|90.0||||||
4343519|NCT00412360|4171383|B2|Negative||Recipient CMV Status||Participants|Count of Participants|39|39.0||||||
4343520|NCT00412360|4171384|B1|Negative||Recipient CMV Status||Participants|Count of Participants|51|51.0||||||
4343521|NCT00412360|4171382|B3|Positive||Recipient CMV Status||Participants|Count of Participants|124|124.0||||||
4343522|NCT00412360|4171383|B2|Positive||Recipient CMV Status||Participants|Count of Participants|66|66.0||||||
4343523|NCT00412360|4171384|B1|Positive||Recipient CMV Status||Participants|Count of Participants|58|58.0||||||
4343524|NCT00412360|4171382|B3||70%|Karnofsky Performance Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|Participants|Count of Participants|6|6.0||||||
4343525|NCT00412360|4171383|B2||70%|Karnofsky Performance Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|Participants|Count of Participants|2|2.0||||||
4343526|NCT00412360|4171384|B1||70%|Karnofsky Performance Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|Participants|Count of Participants|4|4.0||||||
4343527|NCT00412360|4171382|B3||80%|Karnofsky Performance Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|Participants|Count of Participants|22|22.0||||||
4343528|NCT00412360|4171383|B2||80%|Karnofsky Performance Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|Participants|Count of Participants|9|9.0||||||
4343529|NCT00412360|4171384|B1||80%|Karnofsky Performance Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|Participants|Count of Participants|13|13.0||||||
4343530|NCT00412360|4171382|B3||90%|Karnofsky Performance Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|Participants|Count of Participants|81|81.0||||||
4343531|NCT00412360|4171383|B2||90%|Karnofsky Performance Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|Participants|Count of Participants|43|43.0||||||
4343532|NCT00412360|4171384|B1||90%|Karnofsky Performance Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|Participants|Count of Participants|38|38.0||||||
4343533|NCT00412360|4171382|B3||100%|Karnofsky Performance Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|Participants|Count of Participants|115|115.0||||||
4343534|NCT00412360|4171383|B2||100%|Karnofsky Performance Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|Participants|Count of Participants|57|57.0||||||
4343535|NCT00412360|4171384|B1||100%|Karnofsky Performance Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|Participants|Count of Participants|58|58.0||||||
4343536|NCT00412360|4171382|B3||Unclassified|MDS Disease Status|RAEB1: Blast percentage of 5-10%; RAEB2: Blast percentage of 11-20%|Participants|Count of Participants|4|4.0||||||
4343537|NCT00412360|4171383|B2||Unclassified|MDS Disease Status|RAEB1: Blast percentage of 5-10%; RAEB2: Blast percentage of 11-20%|Participants|Count of Participants|3|3.0||||||
4343538|NCT00412360|4171384|B1||Unclassified|MDS Disease Status|RAEB1: Blast percentage of 5-10%; RAEB2: Blast percentage of 11-20%|Participants|Count of Participants|1|1.0||||||
4343539|NCT00412360|4171382|B3||Refractory Anemia with Excess Blasts 2 (RAEB2)|MDS Disease Status|RAEB1: Blast percentage of 5-10%; RAEB2: Blast percentage of 11-20%|Participants|Count of Participants|4|4.0||||||
4343540|NCT00412360|4171383|B2||Refractory Anemia with Excess Blasts 2 (RAEB2)|MDS Disease Status|RAEB1: Blast percentage of 5-10%; RAEB2: Blast percentage of 11-20%|Participants|Count of Participants|4|4.0||||||
4343541|NCT00412360|4171384|B1||Refractory Anemia with Excess Blasts 2 (RAEB2)|MDS Disease Status|RAEB1: Blast percentage of 5-10%; RAEB2: Blast percentage of 11-20%|Participants|Count of Participants|0|0.0||||||
4343542|NCT00412360|4171382|B3||Refractory Anemia with Excess Blasts 1 (RAEB1)|MDS Disease Status|RAEB1: Blast percentage of 5-10%; RAEB2: Blast percentage of 11-20%|Participants|Count of Participants|3|3.0||||||
4343543|NCT00412360|4171383|B2||Refractory Anemia with Excess Blasts 1 (RAEB1)|MDS Disease Status|RAEB1: Blast percentage of 5-10%; RAEB2: Blast percentage of 11-20%|Participants|Count of Participants|3|3.0||||||
4343544|NCT00412360|4171384|B1||Refractory Anemia with Excess Blasts 1 (RAEB1)|MDS Disease Status|RAEB1: Blast percentage of 5-10%; RAEB2: Blast percentage of 11-20%|Participants|Count of Participants|0|0.0||||||
4343545|NCT00412360|4171382|B3||Refractory Cytopenia with Multilineage Dysplasia|MDS Disease Status|RAEB1: Blast percentage of 5-10%; RAEB2: Blast percentage of 11-20%|Participants|Count of Participants|5|5.0||||||
4343546|NCT00412360|4171383|B2||Refractory Cytopenia with Multilineage Dysplasia|MDS Disease Status|RAEB1: Blast percentage of 5-10%; RAEB2: Blast percentage of 11-20%|Participants|Count of Participants|3|3.0||||||
4343547|NCT00412360|4171384|B1||Refractory Cytopenia with Multilineage Dysplasia|MDS Disease Status|RAEB1: Blast percentage of 5-10%; RAEB2: Blast percentage of 11-20%|Participants|Count of Participants|2|2.0||||||
4343548|NCT00412360|4171382|B3||Refractory Anemia|MDS Disease Status|RAEB1: Blast percentage of 5-10%; RAEB2: Blast percentage of 11-20%|Participants|Count of Participants|2|2.0||||||
4343549|NCT00412360|4171383|B2||Refractory Anemia|MDS Disease Status|RAEB1: Blast percentage of 5-10%; RAEB2: Blast percentage of 11-20%|Participants|Count of Participants|0|0.0||||||
4343550|NCT00412360|4171384|B1||Refractory Anemia|MDS Disease Status|RAEB1: Blast percentage of 5-10%; RAEB2: Blast percentage of 11-20%|Participants|Count of Participants|2|2.0||||||
4343551|NCT00412360|4171382|B3||Second CR|Acute Biphenotypic Leukemia Disease Status||Participants|Count of Participants|2|2.0||||||
4343552|NCT00412360|4171383|B2||Second CR|Acute Biphenotypic Leukemia Disease Status||Participants|Count of Participants|1|1.0||||||
4343553|NCT00412360|4171384|B1||Second CR|Acute Biphenotypic Leukemia Disease Status||Participants|Count of Participants|1|1.0||||||
4343554|NCT00412360|4171382|B3||First Complete Remission (CR)|Acute Biphenotypic Leukemia Disease Status||Participants|Count of Participants|6|6.0||||||
4343555|NCT00412360|4171383|B2||First Complete Remission (CR)|Acute Biphenotypic Leukemia Disease Status||Participants|Count of Participants|1|1.0||||||
4343556|NCT00412360|4171384|B1||First Complete Remission (CR)|Acute Biphenotypic Leukemia Disease Status||Participants|Count of Participants|5|5.0||||||
4343557|NCT00412360|4171382|B3||Morphologic CR before Complete-Blood-Count Recover|ALL Disease Status||Participants|Count of Participants|1|1.0||||||
4343558|NCT00412360|4171383|B2||Morphologic CR before Complete-Blood-Count Recover|ALL Disease Status||Participants|Count of Participants|1|1.0||||||
4343559|NCT00412360|4171384|B1||Morphologic CR before Complete-Blood-Count Recover|ALL Disease Status||Participants|Count of Participants|0|0.0||||||
4343560|NCT00412360|4171382|B3||Subsequent CR|ALL Disease Status||Participants|Count of Participants|23|23.0||||||
4343561|NCT00412360|4171383|B2||Subsequent CR|ALL Disease Status||Participants|Count of Participants|10|10.0||||||
4343562|NCT00412360|4171384|B1||Subsequent CR|ALL Disease Status||Participants|Count of Participants|13|13.0||||||
4343563|NCT00412360|4171382|B3||Second CR|ALL Disease Status||Participants|Count of Participants|57|57.0||||||
4343564|NCT00412360|4171383|B2||Second CR|ALL Disease Status||Participants|Count of Participants|28|28.0||||||
4343565|NCT00412360|4171384|B1||Second CR|ALL Disease Status||Participants|Count of Participants|29|29.0||||||
4343566|NCT00412360|4171382|B3||First Complete Remission (CR)|ALL Disease Status||Participants|Count of Participants|38|38.0||||||
4343567|NCT00412360|4171383|B2||First Complete Remission (CR)|ALL Disease Status||Participants|Count of Participants|19|19.0||||||
4343568|NCT00412360|4171384|B1||First Complete Remission (CR)|ALL Disease Status||Participants|Count of Participants|19|19.0||||||
4343569|NCT00412360|4171382|B3||Secondary or Therapy-related|AML Disease Status||Participants|Count of Participants|3|3.0||||||
4343570|NCT00412360|4171383|B2||Secondary or Therapy-related|AML Disease Status||Participants|Count of Participants|0|0.0||||||
4343571|NCT00412360|4171384|B1||Secondary or Therapy-related|AML Disease Status||Participants|Count of Participants|3|3.0||||||
4343572|NCT00412360|4171382|B3||Morphologic CR before Complete-Blood-Count Recover|AML Disease Status||Participants|Count of Participants|4|4.0||||||
4343573|NCT00412360|4171383|B2||Morphologic CR before Complete-Blood-Count Recover|AML Disease Status||Participants|Count of Participants|2|2.0||||||
4343574|NCT00412360|4171384|B1||Morphologic CR before Complete-Blood-Count Recover|AML Disease Status||Participants|Count of Participants|2|2.0||||||
4343575|NCT00412360|4171382|B3||First Relapse|AML Disease Status||Participants|Count of Participants|4|4.0||||||
4343576|NCT00412360|4171383|B2||First Relapse|AML Disease Status||Participants|Count of Participants|3|3.0||||||
4343577|NCT00412360|4171384|B1||First Relapse|AML Disease Status||Participants|Count of Participants|1|1.0||||||
4343578|NCT00412360|4171382|B3||Second or Later CR|AML Disease Status||Participants|Count of Participants|35|35.0||||||
4343579|NCT00412360|4171383|B2||Second or Later CR|AML Disease Status||Participants|Count of Participants|19|19.0||||||
4343580|NCT00412360|4171384|B1||Second or Later CR|AML Disease Status||Participants|Count of Participants|16|16.0||||||
4343581|NCT00412360|4171382|B3||First Complete Remission (CR)|AML Disease Status||Participants|Count of Participants|31|31.0||||||
4343582|NCT00412360|4171383|B2||First Complete Remission (CR)|AML Disease Status||Participants|Count of Participants|14|14.0||||||
4343583|NCT00412360|4171384|B1||First Complete Remission (CR)|AML Disease Status||Participants|Count of Participants|17|17.0||||||
4343584|NCT00412360|4171382|B3||Chronic Myelogenous Leukemia (CML)|Primary Disease||Participants|Count of Participants|1|1.0||||||
4343585|NCT00412360|4171383|B2||Chronic Myelogenous Leukemia (CML)|Primary Disease||Participants|Count of Participants|0|0.0||||||
4343586|NCT00412360|4171384|B1||Chronic Myelogenous Leukemia (CML)|Primary Disease||Participants|Count of Participants|1|1.0||||||
4343587|NCT00412360|4171382|B3||Myelodysplastic Syndrome (MDS)|Primary Disease||Participants|Count of Participants|18|18.0||||||
4343588|NCT00412360|4171383|B2||Myelodysplastic Syndrome (MDS)|Primary Disease||Participants|Count of Participants|13|13.0||||||
4343589|NCT00412360|4171384|B1||Myelodysplastic Syndrome (MDS)|Primary Disease||Participants|Count of Participants|5|5.0||||||
4343590|NCT00412360|4171382|B3||Acute Undifferentiated Leukemia|Primary Disease||Participants|Count of Participants|1|1.0||||||
4343591|NCT00412360|4171383|B2||Acute Undifferentiated Leukemia|Primary Disease||Participants|Count of Participants|0|0.0||||||
4343592|NCT00412360|4171384|B1||Acute Undifferentiated Leukemia|Primary Disease||Participants|Count of Participants|1|1.0||||||
4343593|NCT00412360|4171382|B3||Acute Biphenotypic Leukemia|Primary Disease||Participants|Count of Participants|8|8.0||||||
4343594|NCT00412360|4171383|B2||Acute Biphenotypic Leukemia|Primary Disease||Participants|Count of Participants|2|2.0||||||
4343595|NCT00412360|4171384|B1||Acute Biphenotypic Leukemia|Primary Disease||Participants|Count of Participants|6|6.0||||||
4343596|NCT00412360|4171382|B3||Acute Lymphoblastic Leukemia (ALL)|Primary Disease||Participants|Count of Participants|119|119.0||||||
4343597|NCT00412360|4171383|B2||Acute Lymphoblastic Leukemia (ALL)|Primary Disease||Participants|Count of Participants|58|58.0||||||
4343598|NCT00412360|4171384|B1||Acute Lymphoblastic Leukemia (ALL)|Primary Disease||Participants|Count of Participants|61|61.0||||||
4343599|NCT00412360|4171382|B3||Acute Myelogenous Leukemia (AML)|Primary Disease||Participants|Count of Participants|77|77.0||||||
4343600|NCT00412360|4171383|B2||Acute Myelogenous Leukemia (AML)|Primary Disease||Participants|Count of Participants|38|38.0||||||
4343601|NCT00412360|4171384|B1||Acute Myelogenous Leukemia (AML)|Primary Disease||Participants|Count of Participants|39|39.0||||||
4343602|NCT00412360|4171382|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4343603|NCT00412360|4171383|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4343604|NCT00412360|4171384|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4343605|NCT00412360|4171382|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4343606|NCT00412360|4171383|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4343607|NCT00412360|4171384|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4343608|NCT00412360|4171382|B3||White|Race (NIH/OMB)||Participants|Count of Participants|165|165.0||||||
4343609|NCT00412360|4171383|B2||White|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
4343610|NCT00412360|4171384|B1||White|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
4343611|NCT00412360|4171382|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4343612|NCT00412360|4171383|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4343613|NCT00412360|4171384|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4343614|NCT00412360|4171382|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4343615|NCT00412360|4171383|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4343616|NCT00412360|4171384|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4343617|NCT00412360|4171382|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4343618|NCT00412360|4171383|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4343619|NCT00412360|4171384|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4343620|NCT00412360|4171382|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4343621|NCT00412360|4171383|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4343622|NCT00412360|4171384|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4343623|NCT00412360|4171382|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4343624|NCT00412360|4171383|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4343625|NCT00412360|4171384|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4343626|NCT00412360|4171382|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|176|176.0||||||
4343627|NCT00412360|4171383|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
4343628|NCT00412360|4171384|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
4343629|NCT00412360|4171382|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4343630|NCT00412360|4171383|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4343631|NCT00412360|4171384|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4343632|NCT00412360|4171382|B3||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4343633|NCT00412360|4171383|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4343634|NCT00412360|4171384|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4343635|NCT00412360|4171382|B3||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4343636|NCT00412360|4171383|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4343637|NCT00412360|4171384|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4343638|NCT00412360|4171382|B3|||Age||years|Mean|10.4|10.4|Standard Deviation|5.1|5.1|||
4343639|NCT00412360|4171383|B2|||Age||years|Mean|10.4|10.4|Standard Deviation|5.1|5.1|||
4343640|NCT00412360|4171384|B1|||Age||years|Mean|10.4|10.4|Standard Deviation|5.1|5.1|||
4343641|NCT00412243|4171409|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4343642|NCT00412243|4171409|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4343643|NCT00412243|4171409|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4343644|NCT00412243|4171409|B1|||Age||years|Median|30|30.0|Full Range|||21.0|72.0|
4343645|NCT00412217|4171413|B3|Unknown||Sex/Gender, Customized||participants|Number|1|1.0||||||
4343646|NCT00412217|4171414|B2|Unknown||Sex/Gender, Customized||participants|Number|0|0.0||||||
4343647|NCT00412217|4171415|B1|Unknown||Sex/Gender, Customized||participants|Number|1|1.0||||||
4343648|NCT00412217|4171413|B3|Male||Sex/Gender, Customized||participants|Number|83|83.0||||||
4343649|NCT00412217|4171414|B2|Male||Sex/Gender, Customized||participants|Number|41|41.0||||||
4343650|NCT00412217|4171415|B1|Male||Sex/Gender, Customized||participants|Number|42|42.0||||||
4343651|NCT00412217|4171413|B3|Female||Sex/Gender, Customized||participants|Number|10|10.0||||||
4343652|NCT00412217|4171414|B2|Female||Sex/Gender, Customized||participants|Number|7|7.0||||||
4343653|NCT00412217|4171415|B1|Female||Sex/Gender, Customized||participants|Number|3|3.0||||||
4343654|NCT00412217|4171413|B3|18 Years or Older||Age, Customized||participants|Number|94|94.0||||||
4343655|NCT00412217|4171414|B2|18 Years or Older||Age, Customized||participants|Number|48|48.0||||||
4343656|NCT00412217|4171415|B1|18 Years or Older||Age, Customized||participants|Number|46|46.0||||||
4343657|NCT00412113|4171428|B3||Male|Sex: Female, Male||Participants|Count of Participants|123.0|123.0||||||
4343658|NCT00412113|4171429|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4343659|NCT00412113|4171430|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4343660|NCT00412113|4171428|B3||Female|Sex: Female, Male||Participants|Count of Participants|121.0|121.0||||||
4343661|NCT00412113|4171429|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4343662|NCT00412113|4171430|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4343663|NCT00412113|4171428|B3|> or = to 65 years||Age, Customized||participants|Number|52|52.0||||||
4343664|NCT00412113|4171429|B2|> or = to 65 years||Age, Customized||participants|Number|25|25.0||||||
4343665|NCT00412113|4171430|B1|> or = to 65 years||Age, Customized||participants|Number|27|27.0||||||
4343666|NCT00412113|4171428|B3|18 to 64 years||Age, Customized||participants|Number|192|192.0||||||
4343667|NCT00412113|4171429|B2|18 to 64 years||Age, Customized||participants|Number|97|97.0||||||
4343668|NCT00412113|4171430|B1|18 to 64 years||Age, Customized||participants|Number|95|95.0||||||
4343669|NCT00412087|4171483|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4343670|NCT00412087|4171484|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4343671|NCT00412087|4171485|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4343672|NCT00412087|4171483|B3||Female|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
4343673|NCT00412087|4171484|B2||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4343674|NCT00412087|4171485|B1||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4343675|NCT00412087|4171483|B3|||Age||years|Mean|24.8|24.8|Standard Deviation|5.2|5.2|||
4343676|NCT00412087|4171484|B2|||Age||years|Mean|25.2|25.2|Standard Deviation|4.8|4.8|||
4343677|NCT00412087|4171485|B1|||Age||years|Mean|24.4|24.4|Standard Deviation|5.5|5.5|||
4343678|NCT00412074|4171494|B4|United States||Region of Enrollment||participants|Number|460|460.0||||||
4343679|NCT00412074|4171495|B3|United States||Region of Enrollment||participants|Number|195|195.0||||||
4343680|NCT00412074|4171496|B2|United States||Region of Enrollment||participants|Number|66|66.0||||||
4343681|NCT00412074|4171497|B1|United States||Region of Enrollment||participants|Number|199|199.0||||||
4343682|NCT00412074|4171494|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4343683|NCT00412074|4171495|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4343684|NCT00412074|4171496|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4343685|NCT00412074|4171497|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4343686|NCT00412074|4171494|B4||Female|Sex: Female, Male||Participants|Count of Participants|460|460.0||||||
4343687|NCT00412074|4171495|B3||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4343688|NCT00412074|4171496|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4343689|NCT00412074|4171497|B1||Female|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4343690|NCT00412074|4171494|B4|||Age||Years|Mean|27.7|27.7|Standard Deviation|6.0|6.0|||
4343691|NCT00412074|4171495|B3|||Age||Years|Mean|27.3|27.3|Standard Deviation|5.9|5.9|||
4343692|NCT00412074|4171496|B2|||Age||Years|Mean|29.4|29.4|Standard Deviation|5.3|5.3|||
4343693|NCT00412074|4171497|B1|||Age||Years|Mean|27.6|27.6|Standard Deviation|6.2|6.2|||
4343694|NCT00412074|4171494|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4343695|NCT00412074|4171495|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4343696|NCT00412074|4171496|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4343697|NCT00412074|4171497|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4343698|NCT00412074|4171494|B4||Between 18 and 65 years|Age||Participants|Count of Participants|460|460.0||||||
4343699|NCT00412074|4171495|B3||Between 18 and 65 years|Age||Participants|Count of Participants|195|195.0||||||
4343700|NCT00412074|4171496|B2||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4343701|NCT00412074|4171497|B1||Between 18 and 65 years|Age||Participants|Count of Participants|199|199.0||||||
4343702|NCT00412074|4171494|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4343703|NCT00412074|4171495|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4343704|NCT00412074|4171496|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4343705|NCT00412074|4171497|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4343706|NCT00412061|4171513|B3||Male|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
4343707|NCT00412061|4171514|B2||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4343708|NCT00412061|4171515|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4343709|NCT00412061|4171513|B3||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4343710|NCT00412061|4171514|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4343711|NCT00412061|4171515|B1||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4343712|NCT00412061|4171513|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|10.92|10.92|||
4343713|NCT00412061|4171514|B2|||Age||years|Mean|59.4|59.4|Standard Deviation|11.13|11.13|||
4343714|NCT00412061|4171515|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|10.72|10.72|||
4343715|NCT00411788|4171534|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4343716|NCT00411788|4171534|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4343717|NCT00411788|4171534|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4343718|NCT00411788|4171534|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4343719|NCT00411788|4171534|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4343720|NCT00411788|4171534|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4343721|NCT00411788|4171534|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4343722|NCT00411788|4171534|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4343723|NCT00411788|4171534|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4343724|NCT00411788|4171534|B1|||Age||years|Median|57|57.0|Full Range|||38.0|62.0|
4343725|NCT00411762|4171543|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4343726|NCT00411762|4171543|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4343727|NCT00411762|4171543|B1|||Age||years|Mean|64|64.0|Full Range|||45.0|84.0|
4343728|NCT00411749|4171548|B3|||Body Weight||Kilogram|Mean|45.4|45.4|Standard Deviation|10.5|10.5|||
4343729|NCT00411749|4171549|B2|||Body Weight||Kilogram|Mean|45.2|45.2|Standard Deviation|9.6|9.6|||
4343730|NCT00411749|4171550|B1|||Body Weight||Kilogram|Mean|45.5|45.5|Standard Deviation|10.8|10.8|||
4343731|NCT00411749|4171548|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4343732|NCT00411749|4171549|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4343733|NCT00411749|4171550|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4343734|NCT00411749|4171548|B3||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4343735|NCT00411749|4171549|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4343736|NCT00411749|4171550|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4343737|NCT00411749|4171548|B3|||Age||years|Mean|12.7|12.7|Standard Deviation|2.4|2.4|||
4343738|NCT00411749|4171549|B2|||Age||years|Mean|12.6|12.6|Standard Deviation|2.6|2.6|||
4343739|NCT00411749|4171550|B1|||Age||years|Mean|12.8|12.8|Standard Deviation|2.4|2.4|||
4343740|NCT00411671|4171567|B1|United States||Region of Enrollment||participants|Number|105|105.0||||||
4343741|NCT00411671|4171567|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4343742|NCT00411671|4171567|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4343743|NCT00411671|4171567|B1|>= 60 years||Age, Customized||participants|Number|62|62.0||||||
4343744|NCT00411671|4171567|B1|< 60 years||Age, Customized||participants|Number|43|43.0||||||
4343745|NCT00411645|4171573|B3||Male|Sex: Female, Male||Participants|Count of Participants|394|394.0||||||
4343746|NCT00411645|4171574|B2||Male|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
4343747|NCT00411645|4171575|B1||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4343748|NCT00411645|4171573|B3||Female|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
4343749|NCT00411645|4171574|B2||Female|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4343750|NCT00411645|4171575|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4343751|NCT00411645|4171573|B3|> 75 years||Age, Customized||participants|Number|1|1.0||||||
4343752|NCT00411645|4171574|B2|> 75 years||Age, Customized||participants|Number|0|0.0||||||
4343753|NCT00411645|4171575|B1|> 75 years||Age, Customized||participants|Number|1|1.0||||||
4343754|NCT00411645|4171573|B3|65 to 75 years||Age, Customized||participants|Number|50|50.0||||||
4343755|NCT00411645|4171574|B2|65 to 75 years||Age, Customized||participants|Number|32|32.0||||||
4343756|NCT00411645|4171575|B1|65 to 75 years||Age, Customized||participants|Number|18|18.0||||||
4343757|NCT00411645|4171573|B3|45 to 64 years||Age, Customized||participants|Number|420|420.0||||||
4343758|NCT00411645|4171574|B2|45 to 64 years||Age, Customized||participants|Number|286|286.0||||||
4343759|NCT00411645|4171575|B1|45 to 64 years||Age, Customized||participants|Number|134|134.0||||||
4343760|NCT00411645|4171573|B3|18 to 44 years||Age, Customized||participants|Number|210|210.0||||||
4343761|NCT00411645|4171574|B2|18 to 44 years||Age, Customized||participants|Number|136|136.0||||||
4343762|NCT00411645|4171575|B1|18 to 44 years||Age, Customized||participants|Number|74|74.0||||||
4343763|NCT00411645|4171573|B3|||Age||years|Mean|49|49.0|Standard Deviation|12.7|12.7|||
4343764|NCT00411645|4171574|B2|||Age||years|Mean|49|49.0|Standard Deviation|12.5|12.5|||
4343765|NCT00411645|4171575|B1|||Age||years|Mean|49|49.0|Standard Deviation|13.1|13.1|||
4343766|NCT00411619|4171600|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4343767|NCT00411619|4171600|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4343768|NCT00411619|4171600|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4343769|NCT00411619|4171600|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4343770|NCT00411619|4171600|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4343771|NCT00411619|4171600|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4343772|NCT00411619|4171600|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4343773|NCT00411619|4171600|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4343774|NCT00411619|4171600|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4343775|NCT00411619|4171600|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4343776|NCT00411619|4171600|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4343777|NCT00411619|4171600|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4343778|NCT00411619|4171600|B1||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
4343779|NCT00411554|4171605|B3|||Hemoglobin A1c (HbA1c)||percent|Mean|7.8|7.8|Standard Deviation|0.9|0.9|||
4343780|NCT00411554|4171606|B2|||Hemoglobin A1c (HbA1c)||percent|Mean|7.8|7.8|Standard Deviation|0.9|0.9|||
4343781|NCT00411554|4171607|B1|||Hemoglobin A1c (HbA1c)||percent|Mean|7.8|7.8|Standard Deviation|0.9|0.9|||
4343782|NCT00411554|4171605|B3|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|148.8|148.8|Standard Deviation|32.6|32.6|||
4343783|NCT00411554|4171606|B2|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|148.9|148.9|Standard Deviation|31.0|31.0|||
4343784|NCT00411554|4171607|B1|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|148.7|148.7|Standard Deviation|34.2|34.2|||
4343785|NCT00411554|4171605|B3||Male|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4343786|NCT00411554|4171606|B2||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4343787|NCT00411554|4171607|B1||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4343788|NCT00411554|4171605|B3||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4343789|NCT00411554|4171606|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4343790|NCT00411554|4171607|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4343791|NCT00411554|4171605|B3|||Age||years|Mean|60.7|60.7|Standard Deviation|10.0|10.0|||
4343792|NCT00411554|4171606|B2|||Age||years|Mean|60.6|60.6|Standard Deviation|10.0|10.0|||
4343793|NCT00411554|4171607|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|10.1|10.1|||
4343794|NCT00411463|4171618|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4343795|NCT00411463|4171619|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4343796|NCT00411463|4171620|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4343797|NCT00411463|4171618|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4343798|NCT00411463|4171619|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4343799|NCT00411463|4171620|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4343800|NCT00411463|4171618|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4343801|NCT00411463|4171619|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4343802|NCT00411463|4171620|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4343803|NCT00411463|4171618|B3|||Age||years|Mean|36.1|36.1|Standard Deviation|12.25|12.25|||
4343804|NCT00411463|4171619|B2|||Age||years|Mean|32.1|32.1|Standard Deviation|12.8|12.8|||
4343805|NCT00411463|4171620|B1|||Age||years|Mean|40.1|40.1|Standard Deviation|11.7|11.7|||
4343806|NCT00411463|4171618|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4343807|NCT00411463|4171619|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4343808|NCT00411463|4171620|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4343809|NCT00411463|4171618|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4343810|NCT00411463|4171619|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4343811|NCT00411463|4171620|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4343812|NCT00411463|4171618|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4343813|NCT00411463|4171619|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4343814|NCT00411463|4171620|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4343815|NCT00411450|4171634|B1|Unevaluable||Kirsten Rat Sarcoma Gene (KRAS) Mutation Status|Unevaluable includes missing, lack of tissue sample, invalid or failed test results.|participants|Number|6|6.0||||||
4343816|NCT00411450|4171634|B1|Mutant||Kirsten Rat Sarcoma Gene (KRAS) Mutation Status|Unevaluable includes missing, lack of tissue sample, invalid or failed test results.|participants|Number|45|45.0||||||
4343817|NCT00411450|4171634|B1|Wild-type||Kirsten Rat Sarcoma Gene (KRAS) Mutation Status|Unevaluable includes missing, lack of tissue sample, invalid or failed test results.|participants|Number|65|65.0||||||
4343818|NCT00411450|4171634|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4343819|NCT00411450|4171634|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4343820|NCT00411450|4171634|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4343821|NCT00411450|4171634|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|94|94.0||||||
4343822|NCT00411450|4171634|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4343823|NCT00411450|4171634|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4343824|NCT00411450|4171634|B1|||Age||years|Mean|60.0|60.0|Standard Deviation|12.5|12.5|||
4343825|NCT00411411|4171660|B3|Denmark||Region of Enrollment||participants|Number|49|49.0||||||
4343826|NCT00411411|4171661|B2|Denmark||Region of Enrollment||participants|Number|25|25.0||||||
4343827|NCT00411411|4171662|B1|Denmark||Region of Enrollment||participants|Number|24|24.0||||||
4343828|NCT00411411|4171660|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4343829|NCT00411411|4171661|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4343830|NCT00411411|4171662|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4343831|NCT00411411|4171660|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4343832|NCT00411411|4171661|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4343833|NCT00411411|4171662|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4343834|NCT00411411|4171660|B3|||Age||years|Mean|60|60.0|Full Range|||31.0|72.0|
4343835|NCT00411411|4171661|B2|||Age||years|Mean|60|60.0|Full Range|||39.0|64.0|
4343836|NCT00411411|4171662|B1|||Age||years|Mean|60|60.0|Full Range|||31.0|72.0|
4343837|NCT00411411|4171660|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4343838|NCT00411411|4171661|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4343839|NCT00411411|4171662|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4343840|NCT00411411|4171660|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4343841|NCT00411411|4171661|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4343842|NCT00411411|4171662|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4343843|NCT00411411|4171660|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4343844|NCT00411411|4171661|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4343845|NCT00411411|4171662|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4343846|NCT00411398|4171671|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4343847|NCT00411398|4171671|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4343848|NCT00411398|4171671|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4343849|NCT00411398|4171671|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4343850|NCT00411398|4171671|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4343851|NCT00411398|4171671|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4343852|NCT00411216|4171675|B3|||Visual acuity during head movements||LogMAR|Mean|.348|0.348|Standard Deviation|.136|0.136|||
4343853|NCT00411216|4171676|B2|||Visual acuity during head movements||LogMAR|Mean|.323|0.323|Standard Deviation|.117|0.117|||
4343854|NCT00411216|4171677|B1|||Visual acuity during head movements||LogMAR|Mean|.372|0.372|Standard Deviation|.155|0.155|||
4343855|NCT00411216|4171675|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4343856|NCT00411216|4171676|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4343857|NCT00411216|4171677|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4343858|NCT00411216|4171675|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4343859|NCT00411216|4171676|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4343860|NCT00411216|4171677|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4343861|NCT00411216|4171675|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4343862|NCT00411216|4171676|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4343863|NCT00411216|4171677|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4343864|NCT00411216|4171675|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4343865|NCT00411216|4171676|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4343866|NCT00411216|4171677|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4343867|NCT00411216|4171675|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4343868|NCT00411216|4171676|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4343869|NCT00411216|4171677|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4343870|NCT00411216|4171675|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4343871|NCT00411216|4171676|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4343872|NCT00411216|4171677|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4343873|NCT00411216|4171675|B3|||Age||years|Mean|65.1|65.1|Standard Deviation|16.3|16.3|||
4343874|NCT00411216|4171676|B2|||Age||years|Mean|64.9|64.9|Standard Deviation|16.2|16.2|||
4343875|NCT00411216|4171677|B1|||Age||years|Mean|65.2|65.2|Standard Deviation|16.5|16.5|||
4343876|NCT00411151|4171684|B1|Missing||Localisation of non-target lesions|Note that multiple answers are permitted.|Participants|Number|9|9.0||||||
4343877|NCT00411151|4171684|B1|No non-target lesions||Localisation of non-target lesions|Note that multiple answers are permitted.|Participants|Number|9|9.0||||||
4343878|NCT00411151|4171684|B1|Other||Localisation of non-target lesions|Note that multiple answers are permitted.|Participants|Number|9|9.0||||||
4343879|NCT00411151|4171684|B1|Peritoneum||Localisation of non-target lesions|Note that multiple answers are permitted.|Participants|Number|3|3.0||||||
4343936|NCT00410904|4171700|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4343880|NCT00411151|4171684|B1|Lymph node paraaortal caudal||Localisation of non-target lesions|Note that multiple answers are permitted.|Participants|Number|3|3.0||||||
4343881|NCT00411151|4171684|B1|Lymph node mediastinum||Localisation of non-target lesions|Note that multiple answers are permitted.|Participants|Number|3|3.0||||||
4343882|NCT00411151|4171684|B1|Lymph node truncus coeliacus||Localisation of non-target lesions|Note that multiple answers are permitted.|Participants|Number|4|4.0||||||
4343883|NCT00411151|4171684|B1|Liver||Localisation of non-target lesions|Note that multiple answers are permitted.|Participants|Number|15|15.0||||||
4343884|NCT00411151|4171684|B1|Lung||Localisation of non-target lesions|Note that multiple answers are permitted.|Participants|Number|4|4.0||||||
4343885|NCT00411151|4171684|B1|Bone||Localisation of non-target lesions|Note that multiple answers are permitted.|Participants|Number|1|1.0||||||
4343886|NCT00411151|4171684|B1|Primary tumor||Localisation of non-target lesions|Note that multiple answers are permitted.|Participants|Number|1|1.0||||||
4343887|NCT00411151|4171684|B1|||Total size of target lesions||mm|Median|62|62.0|Full Range|||10.0|236.0|
4343888|NCT00411151|4171684|B1|Missing||Localisation of target lesions|Note that multiple answers are permitted.|Participants|Number|0|0.0||||||
4343889|NCT00411151|4171684|B1|Other||Localisation of target lesions|Note that multiple answers are permitted.|Participants|Number|14|14.0||||||
4343890|NCT00411151|4171684|B1|Soft tissue||Localisation of target lesions|Note that multiple answers are permitted.|Participants|Number|5|5.0||||||
4343891|NCT00411151|4171684|B1|Peritoneum||Localisation of target lesions|Note that multiple answers are permitted.|Participants|Number|2|2.0||||||
4343892|NCT00411151|4171684|B1|Lymph node paraaortal caudal||Localisation of target lesions|Note that multiple answers are permitted.|Participants|Number|9|9.0||||||
4343893|NCT00411151|4171684|B1|Lymph node spleen/pancreas||Localisation of target lesions|Note that multiple answers are permitted.|Participants|Number|3|3.0||||||
4343894|NCT00411151|4171684|B1|Lymph node mediastinum||Localisation of target lesions|Note that multiple answers are permitted.|Participants|Number|11|11.0||||||
4343895|NCT00411151|4171684|B1|Lymph node truncus coeliacus||Localisation of target lesions|Note that multiple answers are permitted.|Participants|Number|10|10.0||||||
4343896|NCT00411151|4171684|B1|Liver||Localisation of target lesions|Note that multiple answers are permitted.|Participants|Number|28|28.0||||||
4343897|NCT00411151|4171684|B1|Lung||Localisation of target lesions|Note that multiple answers are permitted.|Participants|Number|8|8.0||||||
4343898|NCT00411151|4171684|B1|Primary tumor||Localisation of target lesions|Note that multiple answers are permitted.|Participants|Number|3|3.0||||||
4343899|NCT00411151|4171684|B1|Missing||Grading of adenocarcinoma|"Grading of adenocarcinoma is the tumor grading according to UICC.~1 (low grade)=well differentiated, 2 (intermediate grade)=differentiated, 3 (high grade)=poorly differentiated, 4 (high grade)=undifferentiated"|Participants|Number|5|5.0||||||
4343900|NCT00411151|4171684|B1|4||Grading of adenocarcinoma|"Grading of adenocarcinoma is the tumor grading according to UICC.~1 (low grade)=well differentiated, 2 (intermediate grade)=differentiated, 3 (high grade)=poorly differentiated, 4 (high grade)=undifferentiated"|Participants|Number|2|2.0||||||
4343901|NCT00411151|4171684|B1|3||Grading of adenocarcinoma|"Grading of adenocarcinoma is the tumor grading according to UICC.~1 (low grade)=well differentiated, 2 (intermediate grade)=differentiated, 3 (high grade)=poorly differentiated, 4 (high grade)=undifferentiated"|Participants|Number|26|26.0||||||
4343902|NCT00411151|4171684|B1|2||Grading of adenocarcinoma|"Grading of adenocarcinoma is the tumor grading according to UICC.~1 (low grade)=well differentiated, 2 (intermediate grade)=differentiated, 3 (high grade)=poorly differentiated, 4 (high grade)=undifferentiated"|Participants|Number|19|19.0||||||
4343903|NCT00411151|4171684|B1|1||Grading of adenocarcinoma|"Grading of adenocarcinoma is the tumor grading according to UICC.~1 (low grade)=well differentiated, 2 (intermediate grade)=differentiated, 3 (high grade)=poorly differentiated, 4 (high grade)=undifferentiated"|Participants|Number|0|0.0||||||
4343904|NCT00411151|4171684|B1|Missing||Localisation of adenocarcinoma|Note that multiple answers are permitted.|Participants|Number|0|0.0||||||
4343905|NCT00411151|4171684|B1|Lower esophagus||Localisation of adenocarcinoma|Note that multiple answers are permitted.|Participants|Number|5|5.0||||||
4343906|NCT00411151|4171684|B1|Gastroesophageal junction||Localisation of adenocarcinoma|Note that multiple answers are permitted.|Participants|Number|12|12.0||||||
4343907|NCT00411151|4171684|B1|Stomach||Localisation of adenocarcinoma|Note that multiple answers are permitted.|Participants|Number|36|36.0||||||
4343908|NCT00411151|4171684|B1|Missing||Karnofsky Performance Status (KPS)|KPS is the Karnofsky Lansky Score. Higher values in the KPS represent a better physical condition. 100%=normal, 90%=able to carry on normal activity, 80%=normal activity with effort, 70%=cares for self but unable to carry on normal activity, 60%=requires occasional assistance, 50%=requires considerable assistance and frequent medical care, 40%=disabled, requires special care and assistance, 30%=severely disabled and hospitalization indicated but death not imminent, 20%=very sick and requires hospitalization, 10%=moribund and fatal processes progressing rapidly, 0%=dead|Participants|Number|0|0.0||||||
4343909|NCT00411151|4171684|B1|10%||Karnofsky Performance Status (KPS)|KPS is the Karnofsky Lansky Score. Higher values in the KPS represent a better physical condition. 100%=normal, 90%=able to carry on normal activity, 80%=normal activity with effort, 70%=cares for self but unable to carry on normal activity, 60%=requires occasional assistance, 50%=requires considerable assistance and frequent medical care, 40%=disabled, requires special care and assistance, 30%=severely disabled and hospitalization indicated but death not imminent, 20%=very sick and requires hospitalization, 10%=moribund and fatal processes progressing rapidly, 0%=dead|Participants|Number|0|0.0||||||
4343910|NCT00411151|4171684|B1|20%||Karnofsky Performance Status (KPS)|KPS is the Karnofsky Lansky Score. Higher values in the KPS represent a better physical condition. 100%=normal, 90%=able to carry on normal activity, 80%=normal activity with effort, 70%=cares for self but unable to carry on normal activity, 60%=requires occasional assistance, 50%=requires considerable assistance and frequent medical care, 40%=disabled, requires special care and assistance, 30%=severely disabled and hospitalization indicated but death not imminent, 20%=very sick and requires hospitalization, 10%=moribund and fatal processes progressing rapidly, 0%=dead|Participants|Number|0|0.0||||||
4343937|NCT00410904|4171701|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4343911|NCT00411151|4171684|B1|30%||Karnofsky Performance Status (KPS)|KPS is the Karnofsky Lansky Score. Higher values in the KPS represent a better physical condition. 100%=normal, 90%=able to carry on normal activity, 80%=normal activity with effort, 70%=cares for self but unable to carry on normal activity, 60%=requires occasional assistance, 50%=requires considerable assistance and frequent medical care, 40%=disabled, requires special care and assistance, 30%=severely disabled and hospitalization indicated but death not imminent, 20%=very sick and requires hospitalization, 10%=moribund and fatal processes progressing rapidly, 0%=dead|Participants|Number|0|0.0||||||
4343912|NCT00411151|4171684|B1|40%||Karnofsky Performance Status (KPS)|KPS is the Karnofsky Lansky Score. Higher values in the KPS represent a better physical condition. 100%=normal, 90%=able to carry on normal activity, 80%=normal activity with effort, 70%=cares for self but unable to carry on normal activity, 60%=requires occasional assistance, 50%=requires considerable assistance and frequent medical care, 40%=disabled, requires special care and assistance, 30%=severely disabled and hospitalization indicated but death not imminent, 20%=very sick and requires hospitalization, 10%=moribund and fatal processes progressing rapidly, 0%=dead|Participants|Number|0|0.0||||||
4343913|NCT00411151|4171684|B1|50%||Karnofsky Performance Status (KPS)|KPS is the Karnofsky Lansky Score. Higher values in the KPS represent a better physical condition. 100%=normal, 90%=able to carry on normal activity, 80%=normal activity with effort, 70%=cares for self but unable to carry on normal activity, 60%=requires occasional assistance, 50%=requires considerable assistance and frequent medical care, 40%=disabled, requires special care and assistance, 30%=severely disabled and hospitalization indicated but death not imminent, 20%=very sick and requires hospitalization, 10%=moribund and fatal processes progressing rapidly, 0%=dead|Participants|Number|0|0.0||||||
4343914|NCT00411151|4171684|B1|60%||Karnofsky Performance Status (KPS)|KPS is the Karnofsky Lansky Score. Higher values in the KPS represent a better physical condition. 100%=normal, 90%=able to carry on normal activity, 80%=normal activity with effort, 70%=cares for self but unable to carry on normal activity, 60%=requires occasional assistance, 50%=requires considerable assistance and frequent medical care, 40%=disabled, requires special care and assistance, 30%=severely disabled and hospitalization indicated but death not imminent, 20%=very sick and requires hospitalization, 10%=moribund and fatal processes progressing rapidly, 0%=dead|Participants|Number|0|0.0||||||
4343915|NCT00411151|4171684|B1|70%||Karnofsky Performance Status (KPS)|KPS is the Karnofsky Lansky Score. Higher values in the KPS represent a better physical condition. 100%=normal, 90%=able to carry on normal activity, 80%=normal activity with effort, 70%=cares for self but unable to carry on normal activity, 60%=requires occasional assistance, 50%=requires considerable assistance and frequent medical care, 40%=disabled, requires special care and assistance, 30%=severely disabled and hospitalization indicated but death not imminent, 20%=very sick and requires hospitalization, 10%=moribund and fatal processes progressing rapidly, 0%=dead|Participants|Number|2|2.0||||||
4343916|NCT00411151|4171684|B1|80%||Karnofsky Performance Status (KPS)|KPS is the Karnofsky Lansky Score. Higher values in the KPS represent a better physical condition. 100%=normal, 90%=able to carry on normal activity, 80%=normal activity with effort, 70%=cares for self but unable to carry on normal activity, 60%=requires occasional assistance, 50%=requires considerable assistance and frequent medical care, 40%=disabled, requires special care and assistance, 30%=severely disabled and hospitalization indicated but death not imminent, 20%=very sick and requires hospitalization, 10%=moribund and fatal processes progressing rapidly, 0%=dead|Participants|Number|18|18.0||||||
4343917|NCT00411151|4171684|B1|90%||Karnofsky Performance Status (KPS)|KPS is the Karnofsky Lansky Score. Higher values in the KPS represent a better physical condition. 100%=normal, 90%=able to carry on normal activity, 80%=normal activity with effort, 70%=cares for self but unable to carry on normal activity, 60%=requires occasional assistance, 50%=requires considerable assistance and frequent medical care, 40%=disabled, requires special care and assistance, 30%=severely disabled and hospitalization indicated but death not imminent, 20%=very sick and requires hospitalization, 10%=moribund and fatal processes progressing rapidly, 0%=dead|Participants|Number|15|15.0||||||
4343918|NCT00411151|4171684|B1|100%||Karnofsky Performance Status (KPS)|KPS is the Karnofsky Lansky Score. Higher values in the KPS represent a better physical condition. 100%=normal, 90%=able to carry on normal activity, 80%=normal activity with effort, 70%=cares for self but unable to carry on normal activity, 60%=requires occasional assistance, 50%=requires considerable assistance and frequent medical care, 40%=disabled, requires special care and assistance, 30%=severely disabled and hospitalization indicated but death not imminent, 20%=very sick and requires hospitalization, 10%=moribund and fatal processes progressing rapidly, 0%=dead|Participants|Number|17|17.0||||||
4343919|NCT00411151|4171684|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4343920|NCT00411151|4171684|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4343921|NCT00411151|4171684|B1|||Age||years|Median|59|59.0|Full Range|12.07|12.07|28.0|81.0|
4343922|NCT00411086|4171694|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
4343923|NCT00411086|4171694|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4343924|NCT00411086|4171694|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4343925|NCT00411086|4171694|B1||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4343926|NCT00411086|4171694|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4343927|NCT00411086|4171694|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4343928|NCT00411086|4171694|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4343929|NCT00411086|4171694|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4343930|NCT00411086|4171694|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4343931|NCT00411086|4171694|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4343932|NCT00411086|4171694|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4343933|NCT00411086|4171694|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4343934|NCT00411086|4171694|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4343935|NCT00411086|4171694|B1|||Age||years|Median|57|57.0|Full Range|||31.0|79.0|
4343938|NCT00410904|4171702|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4343939|NCT00410904|4171700|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4343940|NCT00410904|4171701|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4343941|NCT00410904|4171702|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4343942|NCT00410904|4171700|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4343943|NCT00410904|4171701|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4343944|NCT00410904|4171702|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4343945|NCT00410904|4171700|B3|||Age||years|Median|59.5|59.5|Full Range|8.5683686|8.5683686|39.0|79.0|
4343946|NCT00410904|4171701|B2|||Age||years|Median|58.5|58.5|Full Range|9.101|9.101|39.0|78.0|
4343947|NCT00410904|4171702|B1|||Age||years|Median|61|61.0|Full Range|8.342|8.342|44.0|79.0|
4343948|NCT00410891|4171711|B1|Streptococcus species||Conjunctival Bacterial Flora|Percentage of patients with bacterial isolates of interest in the eye prior to administration of study treatment|percentage of patients|Number|7|7.0||||||
4343949|NCT00410891|4171711|B1|Gram-negative rods||Conjunctival Bacterial Flora|Percentage of patients with bacterial isolates of interest in the eye prior to administration of study treatment|percentage of patients|Number|6|6.0||||||
4343950|NCT00410891|4171711|B1|Staphylococcus aureus||Conjunctival Bacterial Flora|Percentage of patients with bacterial isolates of interest in the eye prior to administration of study treatment|percentage of patients|Number|7|7.0||||||
4343951|NCT00410891|4171711|B1|Coagulase-negative staphylococcus||Conjunctival Bacterial Flora|Percentage of patients with bacterial isolates of interest in the eye prior to administration of study treatment|percentage of patients|Number|75|75.0||||||
4343952|NCT00410891|4171711|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4343953|NCT00410891|4171711|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4343954|NCT00410891|4171711|B1|||Age||years|Mean|77|77.0|Standard Deviation|13|13.0|||
4343955|NCT00410826|4171715|B3|United States||Region of Enrollment||participants|Number|203|203.0||||||
4343956|NCT00410826|4171716|B2|United States||Region of Enrollment||participants|Number|99|99.0||||||
4343957|NCT00410826|4171717|B1|United States||Region of Enrollment||participants|Number|104|104.0||||||
4343958|NCT00410826|4171715|B3||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4343959|NCT00410826|4171716|B2||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4343960|NCT00410826|4171717|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4343961|NCT00410826|4171715|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4343962|NCT00410826|4171716|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4343963|NCT00410826|4171717|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4343964|NCT00410826|4171715|B3|||Age||years|Mean|56|56.0|Full Range|||35.0|77.0|
4343965|NCT00410826|4171716|B2|||Age||years|Mean|56|56.0|Full Range|||35.0|77.0|
4343966|NCT00410826|4171717|B1|||Age||years|Mean|57|57.0|Full Range|||37.0|74.0|
4343967|NCT00410826|4171715|B3||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4343968|NCT00410826|4171716|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4343969|NCT00410826|4171717|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4343970|NCT00410826|4171715|B3||Between 18 and 65 years|Age||Participants|Count of Participants|177|177.0||||||
4343971|NCT00410826|4171716|B2||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
4343972|NCT00410826|4171717|B1||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
4343973|NCT00410826|4171715|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4343974|NCT00410826|4171716|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4343975|NCT00410826|4171717|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4343976|NCT00410813|4171726|B3|No||Use of trastuzumab at time of registration||participants|Number|78|78.0||||||
4343977|NCT00410813|4171727|B2|No||Use of trastuzumab at time of registration||participants|Number|38|38.0||||||
4343978|NCT00410813|4171728|B1|No||Use of trastuzumab at time of registration||participants|Number|40|40.0||||||
4343979|NCT00410813|4171726|B3|Yes||Use of trastuzumab at time of registration||participants|Number|1|1.0||||||
4343980|NCT00410813|4171727|B2|Yes||Use of trastuzumab at time of registration||participants|Number|0|0.0||||||
4343981|NCT00410813|4171728|B1|Yes||Use of trastuzumab at time of registration||participants|Number|1|1.0||||||
4343982|NCT00410813|4171726|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4343983|NCT00410813|4171727|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4343984|NCT00410813|4171728|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4343985|NCT00410813|4171726|B3|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4343986|NCT00410813|4171727|B2|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4343987|NCT00410813|4171728|B1|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4343988|NCT00410813|4171726|B3|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4343989|NCT00410813|4171727|B2|Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4343990|NCT00410813|4171728|B1|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4343991|NCT00410813|4171726|B3|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4343992|NCT00410813|4171727|B2|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4343993|NCT00410813|4171728|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4343994|NCT00410813|4171726|B3|White||Race/Ethnicity, Customized||participants|Number|73|73.0||||||
4343995|NCT00410813|4171727|B2|White||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4343996|NCT00410813|4171728|B1|White||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4343997|NCT00410813|4171726|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4343998|NCT00410813|4171727|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4343999|NCT00410813|4171728|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4344000|NCT00410813|4171726|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4344001|NCT00410813|4171727|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4344002|NCT00410813|4171728|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4344003|NCT00410813|4171726|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4344004|NCT00410813|4171727|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4344005|NCT00410813|4171728|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344006|NCT00410813|4171726|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4344007|NCT00410813|4171727|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4344008|NCT00410813|4171728|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4344009|NCT00410813|4171726|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4344010|NCT00410813|4171727|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4344011|NCT00410813|4171728|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4344012|NCT00410813|4171726|B3|||Age||years|Median|60|60.0|Full Range|||27.0|86.0|
4344013|NCT00410813|4171727|B2|||Age||years|Median|65|65.0|Full Range|||27.0|86.0|
4344014|NCT00410813|4171728|B1|||Age||years|Median|60|60.0|Full Range|||37.0|82.0|
4344015|NCT00410761|4171764|B3||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4344016|NCT00410761|4171765|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4344017|NCT00410761|4171766|B1||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4344018|NCT00410761|4171764|B3||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4344019|NCT00410761|4171765|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4344020|NCT00410761|4171766|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4344021|NCT00410761|4171764|B3|||Age||years|Mean|52|52.0|Full Range|||18.0|84.0|
4344022|NCT00410761|4171765|B2|||Age||years|Mean|53.4|53.4|Full Range|||26.0|84.0|
4344023|NCT00410761|4171766|B1|||Age||years|Mean|50.7|50.7|Full Range|||18.0|83.0|
4344024|NCT00410605|4171787|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4344025|NCT00410605|4171787|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4344026|NCT00410605|4171787|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4344027|NCT00410605|4171787|B1|80-89 years||Age, Customized||participants|Number|3|3.0||||||
4344028|NCT00410605|4171787|B1|70-79 years||Age, Customized||participants|Number|15|15.0||||||
4344029|NCT00410605|4171787|B1|60-69 years||Age, Customized||participants|Number|15|15.0||||||
4344030|NCT00410605|4171787|B1|50-59 years||Age, Customized||participants|Number|4|4.0||||||
4344031|NCT00410605|4171787|B1|40-49 years||Age, Customized||participants|Number|2|2.0||||||
4344032|NCT00410514|4171796|B4|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4344033|NCT00410514|4171797|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4344034|NCT00410514|4171798|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4344035|NCT00410514|4171799|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4344036|NCT00410514|4171796|B4|American Indian or Alaskan native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4344037|NCT00410514|4171797|B3|American Indian or Alaskan native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4344038|NCT00410514|4171798|B2|American Indian or Alaskan native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4344039|NCT00410514|4171799|B1|American Indian or Alaskan native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4344040|NCT00410514|4171796|B4|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4344041|NCT00410514|4171797|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4344042|NCT00410514|4171798|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4344043|NCT00410514|4171799|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4344044|NCT00410514|4171796|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4344045|NCT00410514|4171797|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4344046|NCT00410514|4171798|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4344047|NCT00410514|4171799|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4344048|NCT00410514|4171796|B4|White||Race/Ethnicity, Customized||participants|Number|175|175.0||||||
4344049|NCT00410514|4171797|B3|White||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
4344050|NCT00410514|4171798|B2|White||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
4344051|NCT00410514|4171799|B1|White||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
4344052|NCT00410514|4171796|B4||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4344053|NCT00410514|4171797|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4344054|NCT00410514|4171798|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4344055|NCT00410514|4171799|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4344056|NCT00410514|4171796|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4344057|NCT00410514|4171797|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4344058|NCT00410514|4171798|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4344059|NCT00410514|4171799|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4344060|NCT00410514|4171796|B4|||Age||years|Mean|62.7|62.7|Standard Deviation|9.10|9.1|||
4344061|NCT00410514|4171797|B3|||Age||years|Mean|62.6|62.6|Standard Deviation|9.92|9.92|||
4344062|NCT00410514|4171798|B2|||Age||years|Mean|64.1|64.1|Standard Deviation|8.82|8.82|||
4344063|NCT00410514|4171799|B1|||Age||years|Mean|61.2|61.2|Standard Deviation|8.43|8.43|||
4344064|NCT00410488|4171860|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4344065|NCT00410488|4171861|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
4344066|NCT00410488|4171862|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4344067|NCT00410488|4171860|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4344068|NCT00410488|4171861|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4344069|NCT00410488|4171862|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4344070|NCT00410488|4171860|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4344071|NCT00410488|4171861|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4344072|NCT00410488|4171862|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4344073|NCT00410488|4171860|B3|||Age||years|Mean|50|50.0|Full Range|||21.0|66.0|
4344074|NCT00410488|4171861|B2|||Age||years|Mean|52|52.0|Full Range|||22.0|66.0|
4344075|NCT00410488|4171862|B1|||Age||years|Mean|47|47.0|Full Range|||21.0|64.0|
4344076|NCT00410423|4171868|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4344077|NCT00410423|4171868|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4344078|NCT00410423|4171868|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344079|NCT00410423|4171868|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4344080|NCT00410423|4171868|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4344081|NCT00410423|4171868|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344082|NCT00410423|4171868|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4344083|NCT00410423|4171868|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344084|NCT00410423|4171868|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4344085|NCT00410423|4171868|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4344086|NCT00410423|4171868|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4344087|NCT00410423|4171868|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4344088|NCT00410423|4171868|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4344089|NCT00410423|4171868|B1|||Age||years|Mean|51.39|51.39|Standard Deviation|15.10|15.1|||
4344090|NCT00410423|4171868|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4344091|NCT00410423|4171868|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4344092|NCT00410423|4171868|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4344093|NCT00410410|4171878|B7|No Inadequate Response/Intolerance to Infliximab||Participants with Inadequate Response/Intolerance to Prior Anti-Tumor (TNF) Therapy (Infliximab)|Prior to this study, participants had an inadequate response and/or intolerance to an approved anti-TNF agent at an approved labeled dose for at least 8 weeks. Inadequate response was assessed by the treating physician and was primarily due to lack of efficacy. Because the treating physician determined prior inadequate response, there was no standard definition for this and criteria for determination may have varied between institutions. Intolerance was defined a an inability to achieve doses or treatment durations because of dose limiting side effects.|participants|Number|389|389.0||||||
4344094|NCT00410410|4171879|B6|No Inadequate Response/Intolerance to Infliximab||Participants with Inadequate Response/Intolerance to Prior Anti-Tumor (TNF) Therapy (Infliximab)|Prior to this study, participants had an inadequate response and/or intolerance to an approved anti-TNF agent at an approved labeled dose for at least 8 weeks. Inadequate response was assessed by the treating physician and was primarily due to lack of efficacy. Because the treating physician determined prior inadequate response, there was no standard definition for this and criteria for determination may have varied between institutions. Intolerance was defined a an inability to achieve doses or treatment durations because of dose limiting side effects.|participants|Number|29|29.0||||||
4344095|NCT00410410|4171880|B5|No Inadequate Response/Intolerance to Infliximab||Participants with Inadequate Response/Intolerance to Prior Anti-Tumor (TNF) Therapy (Infliximab)|Prior to this study, participants had an inadequate response and/or intolerance to an approved anti-TNF agent at an approved labeled dose for at least 8 weeks. Inadequate response was assessed by the treating physician and was primarily due to lack of efficacy. Because the treating physician determined prior inadequate response, there was no standard definition for this and criteria for determination may have varied between institutions. Intolerance was defined a an inability to achieve doses or treatment durations because of dose limiting side effects.|participants|Number|30|30.0||||||
4344096|NCT00410410|4171881|B4|No Inadequate Response/Intolerance to Infliximab||Participants with Inadequate Response/Intolerance to Prior Anti-Tumor (TNF) Therapy (Infliximab)|Prior to this study, participants had an inadequate response and/or intolerance to an approved anti-TNF agent at an approved labeled dose for at least 8 weeks. Inadequate response was assessed by the treating physician and was primarily due to lack of efficacy. Because the treating physician determined prior inadequate response, there was no standard definition for this and criteria for determination may have varied between institutions. Intolerance was defined a an inability to achieve doses or treatment durations because of dose limiting side effects.|participants|Number|95|95.0||||||
4344107|NCT00410410|4171878|B7|Korea, Republic of||Region of Enrollment||participants|Number|11|11.0||||||
4344097|NCT00410410|4171882|B3|No Inadequate Response/Intolerance to Infliximab||Participants with Inadequate Response/Intolerance to Prior Anti-Tumor (TNF) Therapy (Infliximab)|Prior to this study, participants had an inadequate response and/or intolerance to an approved anti-TNF agent at an approved labeled dose for at least 8 weeks. Inadequate response was assessed by the treating physician and was primarily due to lack of efficacy. Because the treating physician determined prior inadequate response, there was no standard definition for this and criteria for determination may have varied between institutions. Intolerance was defined a an inability to achieve doses or treatment durations because of dose limiting side effects.|participants|Number|46|46.0||||||
4344098|NCT00410410|4171883|B2|No Inadequate Response/Intolerance to Infliximab||Participants with Inadequate Response/Intolerance to Prior Anti-Tumor (TNF) Therapy (Infliximab)|Prior to this study, participants had an inadequate response and/or intolerance to an approved anti-TNF agent at an approved labeled dose for at least 8 weeks. Inadequate response was assessed by the treating physician and was primarily due to lack of efficacy. Because the treating physician determined prior inadequate response, there was no standard definition for this and criteria for determination may have varied between institutions. Intolerance was defined a an inability to achieve doses or treatment durations because of dose limiting side effects.|participants|Number|93|93.0||||||
4344099|NCT00410410|4171884|B1|No Inadequate Response/Intolerance to Infliximab||Participants with Inadequate Response/Intolerance to Prior Anti-Tumor (TNF) Therapy (Infliximab)|Prior to this study, participants had an inadequate response and/or intolerance to an approved anti-TNF agent at an approved labeled dose for at least 8 weeks. Inadequate response was assessed by the treating physician and was primarily due to lack of efficacy. Because the treating physician determined prior inadequate response, there was no standard definition for this and criteria for determination may have varied between institutions. Intolerance was defined a an inability to achieve doses or treatment durations because of dose limiting side effects.|participants|Number|96|96.0||||||
4344100|NCT00410410|4171878|B7|Inadequate Response/Intolerant to prior Infliximab||Participants with Inadequate Response/Intolerance to Prior Anti-Tumor (TNF) Therapy (Infliximab)|Prior to this study, participants had an inadequate response and/or intolerance to an approved anti-TNF agent at an approved labeled dose for at least 8 weeks. Inadequate response was assessed by the treating physician and was primarily due to lack of efficacy. Because the treating physician determined prior inadequate response, there was no standard definition for this and criteria for determination may have varied between institutions. Intolerance was defined a an inability to achieve doses or treatment durations because of dose limiting side effects.|participants|Number|202|202.0||||||
4344101|NCT00410410|4171879|B6|Inadequate Response/Intolerant to prior Infliximab||Participants with Inadequate Response/Intolerance to Prior Anti-Tumor (TNF) Therapy (Infliximab)|Prior to this study, participants had an inadequate response and/or intolerance to an approved anti-TNF agent at an approved labeled dose for at least 8 weeks. Inadequate response was assessed by the treating physician and was primarily due to lack of efficacy. Because the treating physician determined prior inadequate response, there was no standard definition for this and criteria for determination may have varied between institutions. Intolerance was defined a an inability to achieve doses or treatment durations because of dose limiting side effects.|participants|Number|21|21.0||||||
4344102|NCT00410410|4171880|B5|Inadequate Response/Intolerant to prior Infliximab||Participants with Inadequate Response/Intolerance to Prior Anti-Tumor (TNF) Therapy (Infliximab)|Prior to this study, participants had an inadequate response and/or intolerance to an approved anti-TNF agent at an approved labeled dose for at least 8 weeks. Inadequate response was assessed by the treating physician and was primarily due to lack of efficacy. Because the treating physician determined prior inadequate response, there was no standard definition for this and criteria for determination may have varied between institutions. Intolerance was defined a an inability to achieve doses or treatment durations because of dose limiting side effects.|participants|Number|21|21.0||||||
4344103|NCT00410410|4171881|B4|Inadequate Response/Intolerant to prior Infliximab||Participants with Inadequate Response/Intolerance to Prior Anti-Tumor (TNF) Therapy (Infliximab)|Prior to this study, participants had an inadequate response and/or intolerance to an approved anti-TNF agent at an approved labeled dose for at least 8 weeks. Inadequate response was assessed by the treating physician and was primarily due to lack of efficacy. Because the treating physician determined prior inadequate response, there was no standard definition for this and criteria for determination may have varied between institutions. Intolerance was defined a an inability to achieve doses or treatment durations because of dose limiting side effects.|participants|Number|45|45.0||||||
4344104|NCT00410410|4171882|B3|Inadequate Response/Intolerant to prior Infliximab||Participants with Inadequate Response/Intolerance to Prior Anti-Tumor (TNF) Therapy (Infliximab)|Prior to this study, participants had an inadequate response and/or intolerance to an approved anti-TNF agent at an approved labeled dose for at least 8 weeks. Inadequate response was assessed by the treating physician and was primarily due to lack of efficacy. Because the treating physician determined prior inadequate response, there was no standard definition for this and criteria for determination may have varied between institutions. Intolerance was defined a an inability to achieve doses or treatment durations because of dose limiting side effects.|participants|Number|24|24.0||||||
4344105|NCT00410410|4171883|B2|Inadequate Response/Intolerant to prior Infliximab||Participants with Inadequate Response/Intolerance to Prior Anti-Tumor (TNF) Therapy (Infliximab)|Prior to this study, participants had an inadequate response and/or intolerance to an approved anti-TNF agent at an approved labeled dose for at least 8 weeks. Inadequate response was assessed by the treating physician and was primarily due to lack of efficacy. Because the treating physician determined prior inadequate response, there was no standard definition for this and criteria for determination may have varied between institutions. Intolerance was defined a an inability to achieve doses or treatment durations because of dose limiting side effects.|participants|Number|46|46.0||||||
4344106|NCT00410410|4171884|B1|Inadequate Response/Intolerant to prior Infliximab||Participants with Inadequate Response/Intolerance to Prior Anti-Tumor (TNF) Therapy (Infliximab)|Prior to this study, participants had an inadequate response and/or intolerance to an approved anti-TNF agent at an approved labeled dose for at least 8 weeks. Inadequate response was assessed by the treating physician and was primarily due to lack of efficacy. Because the treating physician determined prior inadequate response, there was no standard definition for this and criteria for determination may have varied between institutions. Intolerance was defined a an inability to achieve doses or treatment durations because of dose limiting side effects.|participants|Number|45|45.0||||||
4344108|NCT00410410|4171879|B6|Korea, Republic of||Region of Enrollment||participants|Number|1|1.0||||||
4344109|NCT00410410|4171880|B5|Korea, Republic of||Region of Enrollment||participants|Number|0|0.0||||||
4344110|NCT00410410|4171881|B4|Korea, Republic of||Region of Enrollment||participants|Number|2|2.0||||||
4344111|NCT00410410|4171882|B3|Korea, Republic of||Region of Enrollment||participants|Number|1|1.0||||||
4344112|NCT00410410|4171883|B2|Korea, Republic of||Region of Enrollment||participants|Number|3|3.0||||||
4344113|NCT00410410|4171884|B1|Korea, Republic of||Region of Enrollment||participants|Number|4|4.0||||||
4344114|NCT00410410|4171878|B7|Netherlands||Region of Enrollment||participants|Number|13|13.0||||||
4344115|NCT00410410|4171879|B6|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4344116|NCT00410410|4171880|B5|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
4344117|NCT00410410|4171881|B4|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
4344118|NCT00410410|4171882|B3|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4344119|NCT00410410|4171883|B2|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
4344120|NCT00410410|4171884|B1|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
4344121|NCT00410410|4171878|B7|Germany||Region of Enrollment||participants|Number|9|9.0||||||
4344122|NCT00410410|4171879|B6|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4344123|NCT00410410|4171880|B5|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4344124|NCT00410410|4171881|B4|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4344125|NCT00410410|4171882|B3|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4344126|NCT00410410|4171883|B2|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4344127|NCT00410410|4171884|B1|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4344128|NCT00410410|4171878|B7|South Africa||Region of Enrollment||participants|Number|27|27.0||||||
4344129|NCT00410410|4171879|B6|South Africa||Region of Enrollment||participants|Number|0|0.0||||||
4344130|NCT00410410|4171880|B5|South Africa||Region of Enrollment||participants|Number|2|2.0||||||
4344131|NCT00410410|4171881|B4|South Africa||Region of Enrollment||participants|Number|3|3.0||||||
4344132|NCT00410410|4171882|B3|South Africa||Region of Enrollment||participants|Number|5|5.0||||||
4344133|NCT00410410|4171883|B2|South Africa||Region of Enrollment||participants|Number|8|8.0||||||
4344134|NCT00410410|4171884|B1|South Africa||Region of Enrollment||participants|Number|9|9.0||||||
4344135|NCT00410410|4171878|B7|Australia||Region of Enrollment||participants|Number|34|34.0||||||
4344136|NCT00410410|4171879|B6|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4344137|NCT00410410|4171880|B5|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4344138|NCT00410410|4171881|B4|Australia||Region of Enrollment||participants|Number|13|13.0||||||
4344139|NCT00410410|4171882|B3|Australia||Region of Enrollment||participants|Number|4|4.0||||||
4344140|NCT00410410|4171883|B2|Australia||Region of Enrollment||participants|Number|7|7.0||||||
4344141|NCT00410410|4171884|B1|Australia||Region of Enrollment||participants|Number|8|8.0||||||
4344142|NCT00410410|4171878|B7|Belgium||Region of Enrollment||participants|Number|17|17.0||||||
4344143|NCT00410410|4171879|B6|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4344144|NCT00410410|4171880|B5|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
4344145|NCT00410410|4171881|B4|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
4344146|NCT00410410|4171882|B3|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4344147|NCT00410410|4171883|B2|Belgium||Region of Enrollment||participants|Number|6|6.0||||||
4344148|NCT00410410|4171884|B1|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
4344149|NCT00410410|4171878|B7|Poland||Region of Enrollment||participants|Number|6|6.0||||||
4344150|NCT00410410|4171879|B6|Poland||Region of Enrollment||participants|Number|0|0.0||||||
4344151|NCT00410410|4171880|B5|Poland||Region of Enrollment||participants|Number|1|1.0||||||
4344152|NCT00410410|4171881|B4|Poland||Region of Enrollment||participants|Number|1|1.0||||||
4344153|NCT00410410|4171882|B3|Poland||Region of Enrollment||participants|Number|0|0.0||||||
4344154|NCT00410410|4171883|B2|Poland||Region of Enrollment||participants|Number|2|2.0||||||
4344155|NCT00410410|4171884|B1|Poland||Region of Enrollment||participants|Number|2|2.0||||||
4344156|NCT00410410|4171878|B7|Brazil||Region of Enrollment||participants|Number|41|41.0||||||
4344157|NCT00410410|4171879|B6|Brazil||Region of Enrollment||participants|Number|6|6.0||||||
4344158|NCT00410410|4171880|B5|Brazil||Region of Enrollment||participants|Number|4|4.0||||||
4344159|NCT00410410|4171881|B4|Brazil||Region of Enrollment||participants|Number|11|11.0||||||
4344160|NCT00410410|4171882|B3|Brazil||Region of Enrollment||participants|Number|5|5.0||||||
4344161|NCT00410410|4171883|B2|Brazil||Region of Enrollment||participants|Number|5|5.0||||||
4344162|NCT00410410|4171884|B1|Brazil||Region of Enrollment||participants|Number|10|10.0||||||
4344163|NCT00410410|4171878|B7|Canada||Region of Enrollment||participants|Number|40|40.0||||||
4344164|NCT00410410|4171879|B6|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4344165|NCT00410410|4171880|B5|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4344166|NCT00410410|4171881|B4|Canada||Region of Enrollment||participants|Number|13|13.0||||||
4344167|NCT00410410|4171882|B3|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4344168|NCT00410410|4171883|B2|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4344169|NCT00410410|4171884|B1|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4344170|NCT00410410|4171878|B7|Puerto Rico||Region of Enrollment||participants|Number|2|2.0||||||
4344171|NCT00410410|4171879|B6|Puerto Rico||Region of Enrollment||participants|Number|0|0.0||||||
4344172|NCT00410410|4171880|B5|Puerto Rico||Region of Enrollment||participants|Number|0|0.0||||||
4344173|NCT00410410|4171881|B4|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
4344174|NCT00410410|4171882|B3|Puerto Rico||Region of Enrollment||participants|Number|0|0.0||||||
4344175|NCT00410410|4171883|B2|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
4344176|NCT00410410|4171884|B1|Puerto Rico||Region of Enrollment||participants|Number|0|0.0||||||
4344177|NCT00410410|4171878|B7|Mexico||Region of Enrollment||participants|Number|68|68.0||||||
4344178|NCT00410410|4171879|B6|Mexico||Region of Enrollment||participants|Number|9|9.0||||||
4344179|NCT00410410|4171880|B5|Mexico||Region of Enrollment||participants|Number|7|7.0||||||
4344180|NCT00410410|4171881|B4|Mexico||Region of Enrollment||participants|Number|8|8.0||||||
4344181|NCT00410410|4171882|B3|Mexico||Region of Enrollment||participants|Number|10|10.0||||||
4344182|NCT00410410|4171883|B2|Mexico||Region of Enrollment||participants|Number|14|14.0||||||
4344183|NCT00410410|4171884|B1|Mexico||Region of Enrollment||participants|Number|20|20.0||||||
4344184|NCT00410410|4171878|B7|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
4344185|NCT00410410|4171879|B6|Czech Republic||Region of Enrollment||participants|Number|0|0.0||||||
4344186|NCT00410410|4171880|B5|Czech Republic||Region of Enrollment||participants|Number|0|0.0||||||
4344187|NCT00410410|4171881|B4|Czech Republic||Region of Enrollment||participants|Number|0|0.0||||||
4344188|NCT00410410|4171882|B3|Czech Republic||Region of Enrollment||participants|Number|0|0.0||||||
4344189|NCT00410410|4171883|B2|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
4344190|NCT00410410|4171884|B1|Czech Republic||Region of Enrollment||participants|Number|0|0.0||||||
4344191|NCT00410410|4171878|B7|France||Region of Enrollment||participants|Number|37|37.0||||||
4344192|NCT00410410|4171879|B6|France||Region of Enrollment||participants|Number|5|5.0||||||
4344193|NCT00410410|4171880|B5|France||Region of Enrollment||participants|Number|1|1.0||||||
4344194|NCT00410410|4171881|B4|France||Region of Enrollment||participants|Number|6|6.0||||||
4344195|NCT00410410|4171882|B3|France||Region of Enrollment||participants|Number|6|6.0||||||
4344196|NCT00410410|4171883|B2|France||Region of Enrollment||participants|Number|12|12.0||||||
4344197|NCT00410410|4171884|B1|France||Region of Enrollment||participants|Number|7|7.0||||||
4344198|NCT00410410|4171878|B7|India||Region of Enrollment||participants|Number|51|51.0||||||
4344199|NCT00410410|4171879|B6|India||Region of Enrollment||participants|Number|2|2.0||||||
4344200|NCT00410410|4171880|B5|India||Region of Enrollment||participants|Number|5|5.0||||||
4344201|NCT00410410|4171881|B4|India||Region of Enrollment||participants|Number|10|10.0||||||
4344202|NCT00410410|4171882|B3|India||Region of Enrollment||participants|Number|10|10.0||||||
4344203|NCT00410410|4171883|B2|India||Region of Enrollment||participants|Number|12|12.0||||||
4344204|NCT00410410|4171884|B1|India||Region of Enrollment||participants|Number|12|12.0||||||
4344205|NCT00410410|4171878|B7|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
4344206|NCT00410410|4171879|B6|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4344207|NCT00410410|4171880|B5|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4344208|NCT00410410|4171881|B4|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4344209|NCT00410410|4171882|B3|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4344210|NCT00410410|4171883|B2|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4344211|NCT00410410|4171884|B1|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4344212|NCT00410410|4171878|B7|Switzerland||Region of Enrollment||participants|Number|6|6.0||||||
4344213|NCT00410410|4171879|B6|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
4344214|NCT00410410|4171880|B5|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4344215|NCT00410410|4171881|B4|Switzerland||Region of Enrollment||participants|Number|2|2.0||||||
4344216|NCT00410410|4171882|B3|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4344217|NCT00410410|4171883|B2|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4344218|NCT00410410|4171884|B1|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4344219|NCT00410410|4171878|B7|Italy||Region of Enrollment||participants|Number|21|21.0||||||
4344220|NCT00410410|4171879|B6|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4344221|NCT00410410|4171880|B5|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4344222|NCT00410410|4171881|B4|Italy||Region of Enrollment||participants|Number|3|3.0||||||
4344223|NCT00410410|4171882|B3|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4344224|NCT00410410|4171883|B2|Italy||Region of Enrollment||participants|Number|6|6.0||||||
4344225|NCT00410410|4171884|B1|Italy||Region of Enrollment||participants|Number|7|7.0||||||
4344226|NCT00410410|4171878|B7|Ireland||Region of Enrollment||participants|Number|3|3.0||||||
4344227|NCT00410410|4171879|B6|Ireland||Region of Enrollment||participants|Number|1|1.0||||||
4344228|NCT00410410|4171880|B5|Ireland||Region of Enrollment||participants|Number|0|0.0||||||
4344229|NCT00410410|4171881|B4|Ireland||Region of Enrollment||participants|Number|1|1.0||||||
4344230|NCT00410410|4171882|B3|Ireland||Region of Enrollment||participants|Number|0|0.0||||||
4344231|NCT00410410|4171883|B2|Ireland||Region of Enrollment||participants|Number|0|0.0||||||
4344232|NCT00410410|4171884|B1|Ireland||Region of Enrollment||participants|Number|1|1.0||||||
4344233|NCT00410410|4171878|B7|United States||Region of Enrollment||participants|Number|195|195.0||||||
4344234|NCT00410410|4171879|B6|United States||Region of Enrollment||participants|Number|13|13.0||||||
4344235|NCT00410410|4171880|B5|United States||Region of Enrollment||participants|Number|20|20.0||||||
4344236|NCT00410410|4171881|B4|United States||Region of Enrollment||participants|Number|55|55.0||||||
4344237|NCT00410410|4171882|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4344238|NCT00410410|4171883|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
4344239|NCT00410410|4171884|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4344240|NCT00410410|4171878|B7||Male|Sex: Female, Male||Participants|Count of Participants|343|343.0||||||
4344241|NCT00410410|4171879|B6||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4344242|NCT00410410|4171880|B5||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4344243|NCT00410410|4171881|B4||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4344244|NCT00410410|4171882|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4344245|NCT00410410|4171883|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4344246|NCT00410410|4171884|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4344247|NCT00410410|4171878|B7||Female|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
4344248|NCT00410410|4171879|B6||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4344249|NCT00410410|4171880|B5||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4344250|NCT00410410|4171881|B4||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4344251|NCT00410410|4171882|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4344252|NCT00410410|4171883|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4344253|NCT00410410|4171884|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4344254|NCT00410410|4171878|B7|>50 years||Age, Customized||participants|Number|150|150.0||||||
4344255|NCT00410410|4171879|B6|>50 years||Age, Customized||participants|Number|14|14.0||||||
4344256|NCT00410410|4171880|B5|>50 years||Age, Customized||participants|Number|9|9.0||||||
4344257|NCT00410410|4171881|B4|>50 years||Age, Customized||participants|Number|33|33.0||||||
4344258|NCT00410410|4171882|B3|>50 years||Age, Customized||participants|Number|17|17.0||||||
4344259|NCT00410410|4171883|B2|>50 years||Age, Customized||participants|Number|32|32.0||||||
4344260|NCT00410410|4171884|B1|>50 years||Age, Customized||participants|Number|45|45.0||||||
4344261|NCT00410410|4171878|B7|30-50 years||Age, Customized||participants|Number|324|324.0||||||
4344262|NCT00410410|4171879|B6|30-50 years||Age, Customized||participants|Number|32|32.0||||||
4344263|NCT00410410|4171880|B5|30-50 years||Age, Customized||participants|Number|30|30.0||||||
4344264|NCT00410410|4171881|B4|30-50 years||Age, Customized||participants|Number|73|73.0||||||
4344265|NCT00410410|4171882|B3|30-50 years||Age, Customized||participants|Number|35|35.0||||||
4344266|NCT00410410|4171883|B2|30-50 years||Age, Customized||participants|Number|84|84.0||||||
4344267|NCT00410410|4171884|B1|30-50 years||Age, Customized||participants|Number|70|70.0||||||
4344268|NCT00410410|4171878|B7|<30 years||Age, Customized||participants|Number|117|117.0||||||
4344269|NCT00410410|4171879|B6|<30 years||Age, Customized||participants|Number|4|4.0||||||
4344270|NCT00410410|4171880|B5|<30 years||Age, Customized||participants|Number|12|12.0||||||
4344271|NCT00410410|4171881|B4|<30 years||Age, Customized||participants|Number|34|34.0||||||
4344272|NCT00410410|4171882|B3|<30 years||Age, Customized||participants|Number|18|18.0||||||
4344273|NCT00410410|4171883|B2|<30 years||Age, Customized||participants|Number|23|23.0||||||
4344274|NCT00410410|4171884|B1|<30 years||Age, Customized||participants|Number|26|26.0||||||
4344275|NCT00410384|4172050|B4|Central America||Region of Enrollment||participants|Number|88|88.0||||||
4344276|NCT00410384|4172051|B3|Central America||Region of Enrollment||participants|Number|32|32.0||||||
4344277|NCT00410384|4172052|B2|Central America||Region of Enrollment||participants|Number|26|26.0||||||
4344278|NCT00410384|4172053|B1|Central America||Region of Enrollment||participants|Number|30|30.0||||||
4344279|NCT00410384|4172050|B4|Europe||Region of Enrollment||participants|Number|295|295.0||||||
4344280|NCT00410384|4172051|B3|Europe||Region of Enrollment||participants|Number|105|105.0||||||
4344281|NCT00410384|4172052|B2|Europe||Region of Enrollment||participants|Number|90|90.0||||||
4344282|NCT00410384|4172053|B1|Europe||Region of Enrollment||participants|Number|100|100.0||||||
4344283|NCT00410384|4172050|B4|North America||Region of Enrollment||participants|Number|436|436.0||||||
4344284|NCT00410384|4172051|B3|North America||Region of Enrollment||participants|Number|136|136.0||||||
4344285|NCT00410384|4172052|B2|North America||Region of Enrollment||participants|Number|155|155.0||||||
4344286|NCT00410384|4172053|B1|North America||Region of Enrollment||participants|Number|145|145.0||||||
4344287|NCT00410384|4172050|B4||Male|Gender||Participants|Count of Participants|55|55.0||||||
4344288|NCT00410384|4172051|B3||Male|Gender||Participants|Count of Participants|14|14.0||||||
4344289|NCT00410384|4172052|B2||Male|Gender||Participants|Count of Participants|18|18.0||||||
4344290|NCT00410384|4172053|B1||Male|Gender||Participants|Count of Participants|23|23.0||||||
4344291|NCT00410384|4172050|B4||Female|Gender||Participants|Count of Participants|764|764.0||||||
4344292|NCT00410384|4172051|B3||Female|Gender||Participants|Count of Participants|259|259.0||||||
4344293|NCT00410384|4172052|B2||Female|Gender||Participants|Count of Participants|253|253.0||||||
4344294|NCT00410384|4172053|B1||Female|Gender||Participants|Count of Participants|252|252.0||||||
4344295|NCT00410384|4172050|B4|≥ 65 years||Age, Customized||participants|Number|16|16.0||||||
4344296|NCT00410384|4172051|B3|≥ 65 years||Age, Customized||participants|Number|3|3.0||||||
4344297|NCT00410384|4172052|B2|≥ 65 years||Age, Customized||participants|Number|4|4.0||||||
4344298|NCT00410384|4172053|B1|≥ 65 years||Age, Customized||participants|Number|9|9.0||||||
4344299|NCT00410384|4172050|B4|Between 45 and 65 years||Age, Customized||participants|Number|252|252.0||||||
4344300|NCT00410384|4172051|B3|Between 45 and 65 years||Age, Customized||participants|Number|92|92.0||||||
4344301|NCT00410384|4172052|B2|Between 45 and 65 years||Age, Customized||participants|Number|83|83.0||||||
4344302|NCT00410384|4172053|B1|Between 45 and 65 years||Age, Customized||participants|Number|77|77.0||||||
4344303|NCT00410384|4172050|B4|≤ 45 years||Age, Customized||participants|Number|551|551.0||||||
4344304|NCT00410384|4172051|B3|≤ 45 years||Age, Customized||participants|Number|178|178.0||||||
4344305|NCT00410384|4172052|B2|≤ 45 years||Age, Customized||participants|Number|184|184.0||||||
4344306|NCT00410384|4172053|B1|≤ 45 years||Age, Customized||participants|Number|189|189.0||||||
4344307|NCT00410384|4172050|B4|||Age||years|Mean|40.2|40.2|Standard Deviation|11.5|11.5|||
4344308|NCT00410384|4172051|B3|||Age||years|Mean|40.5|40.5|Standard Deviation|11.1|11.1|||
4344309|NCT00410384|4172052|B2|||Age||years|Mean|40.0|40.0|Standard Deviation|11.4|11.4|||
4344310|NCT00410384|4172053|B1|||Age||years|Mean|40.0|40.0|Standard Deviation|11.9|11.9|||
4344311|NCT00410280|4172081|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4344312|NCT00410280|4172082|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4344313|NCT00410280|4172083|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4344314|NCT00410280|4172081|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4344315|NCT00410280|4172082|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4344316|NCT00410280|4172083|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4344317|NCT00410280|4172081|B3|||Age||years|Mean|29.11|29.11|Standard Deviation|9.60|9.6|||
4344318|NCT00410280|4172082|B2|||Age||years|Mean|32.31|32.31|Standard Deviation|11.66|11.66|||
4344319|NCT00410280|4172083|B1|||Age||years|Mean|26.14|26.14|Standard Deviation|6.25|6.25|||
4344320|NCT00410202|4172125|B4|||Total Bilirubin||mg/dL|Median|0.6|0.6|Full Range|||0.2|2.6|
4344321|NCT00410202|4172126|B3|||Total Bilirubin||mg/dL|Median|0.6|0.6|Full Range|||0.2|2.6|
4344322|NCT00410202|4172127|B2|||Total Bilirubin||mg/dL|Median|0.6|0.6|Full Range|||0.2|2.4|
4344323|NCT00410202|4172128|B1|||Total Bilirubin||mg/dL|Median|0.6|0.6|Full Range|||0.2|1.8|
4344324|NCT00410202|4172125|B4|||Albumin||g/dL|Median|4.5|4.5|Full Range|||3.1|5.1|
4344325|NCT00410202|4172126|B3|||Albumin||g/dL|Median|4.5|4.5|Full Range|||3.5|5.1|
4344326|NCT00410202|4172127|B2|||Albumin||g/dL|Median|4.5|4.5|Full Range|||3.5|5.1|
4344327|NCT00410202|4172128|B1|||Albumin||g/dL|Median|4.4|4.4|Full Range|||3.1|5.1|
4344328|NCT00410202|4172125|B4|||International Normalization Ratio||ratio|Median|1.07|1.07|Full Range|||0.8|7.24|
4344329|NCT00410202|4172126|B3|||International Normalization Ratio||ratio|Median|1.05|1.05|Full Range|||0.82|7.24|
4344330|NCT00410202|4172127|B2|||International Normalization Ratio||ratio|Median|1.07|1.07|Full Range|||0.87|2.48|
4344331|NCT00410202|4172128|B1|||International Normalization Ratio||ratio|Median|1.07|1.07|Full Range|||0.8|1.97|
4344332|NCT00410202|4172125|B4|||log10 HBV DNA by PCR||IU/mL|Median|7.6|7.6|Full Range|||3.0|10.0|
4344333|NCT00410202|4172126|B3|||log10 HBV DNA by PCR||IU/mL|Median|7.6|7.6|Full Range|||3.2|10.0|
4344334|NCT00410202|4172127|B2|||log10 HBV DNA by PCR||IU/mL|Median|7.5|7.5|Full Range|||3.0|9.7|
4344335|NCT00410202|4172128|B1|||log10 HBV DNA by PCR||IU/mL|Median|7.6|7.6|Full Range|||4.2|9.5|
4344336|NCT00410202|4172125|B4|Absent||LVD-Resistance Substitution|LVD resistance (LVDr) substitution at reverse transcription codon 204 (M240V/I/S). The participants who did not have LVDr substitution mutations at baseline (day 1) were distributed equally among the 3 study groups (2 with ETV+ADV combination therapy and 3 each with ETV monotherapy and ADV+LVD combination therapy).|participants|Number|8|8.0||||||
4344337|NCT00410202|4172126|B3|Absent||LVD-Resistance Substitution|LVD resistance (LVDr) substitution at reverse transcription codon 204 (M240V/I/S). The participants who did not have LVDr substitution mutations at baseline (day 1) were distributed equally among the 3 study groups (2 with ETV+ADV combination therapy and 3 each with ETV monotherapy and ADV+LVD combination therapy).|participants|Number|3|3.0||||||
4344338|NCT00410202|4172127|B2|Absent||LVD-Resistance Substitution|LVD resistance (LVDr) substitution at reverse transcription codon 204 (M240V/I/S). The participants who did not have LVDr substitution mutations at baseline (day 1) were distributed equally among the 3 study groups (2 with ETV+ADV combination therapy and 3 each with ETV monotherapy and ADV+LVD combination therapy).|participants|Number|3|3.0||||||
4344339|NCT00410202|4172128|B1|Absent||LVD-Resistance Substitution|LVD resistance (LVDr) substitution at reverse transcription codon 204 (M240V/I/S). The participants who did not have LVDr substitution mutations at baseline (day 1) were distributed equally among the 3 study groups (2 with ETV+ADV combination therapy and 3 each with ETV monotherapy and ADV+LVD combination therapy).|participants|Number|2|2.0||||||
4344340|NCT00410202|4172125|B4|Present||LVD-Resistance Substitution|LVD resistance (LVDr) substitution at reverse transcription codon 204 (M240V/I/S). The participants who did not have LVDr substitution mutations at baseline (day 1) were distributed equally among the 3 study groups (2 with ETV+ADV combination therapy and 3 each with ETV monotherapy and ADV+LVD combination therapy).|participants|Number|407|407.0||||||
4344341|NCT00410202|4172126|B3|Present||LVD-Resistance Substitution|LVD resistance (LVDr) substitution at reverse transcription codon 204 (M240V/I/S). The participants who did not have LVDr substitution mutations at baseline (day 1) were distributed equally among the 3 study groups (2 with ETV+ADV combination therapy and 3 each with ETV monotherapy and ADV+LVD combination therapy).|participants|Number|134|134.0||||||
4344342|NCT00410202|4172127|B2|Present||LVD-Resistance Substitution|LVD resistance (LVDr) substitution at reverse transcription codon 204 (M240V/I/S). The participants who did not have LVDr substitution mutations at baseline (day 1) were distributed equally among the 3 study groups (2 with ETV+ADV combination therapy and 3 each with ETV monotherapy and ADV+LVD combination therapy).|participants|Number|137|137.0||||||
4344343|NCT00410202|4172128|B1|Present||LVD-Resistance Substitution|LVD resistance (LVDr) substitution at reverse transcription codon 204 (M240V/I/S). The participants who did not have LVDr substitution mutations at baseline (day 1) were distributed equally among the 3 study groups (2 with ETV+ADV combination therapy and 3 each with ETV monotherapy and ADV+LVD combination therapy).|participants|Number|136|136.0||||||
4344344|NCT00410202|4172125|B4|||Alanine Aminotransferase (ALT)||U/L|Median|47|47.0|Full Range|||10.0|1300.0|
4344345|NCT00410202|4172126|B3|||Alanine Aminotransferase (ALT)||U/L|Median|45|45.0|Full Range|||14.0|1300.0|
4344346|NCT00410202|4172127|B2|||Alanine Aminotransferase (ALT)||U/L|Median|50|50.0|Full Range|||12.0|367.0|
4344347|NCT00410202|4172128|B1|||Alanine Aminotransferase (ALT)||U/L|Median|49|49.0|Full Range|||10.0|480.0|
4344348|NCT00410202|4172125|B4|Negative||Hepatitis B e antibody (HBeAb) at baseline||participants|Number|412|412.0||||||
4344349|NCT00410202|4172126|B3|Negative||Hepatitis B e antibody (HBeAb) at baseline||participants|Number|135|135.0||||||
4344350|NCT00410202|4172127|B2|Negative||Hepatitis B e antibody (HBeAb) at baseline||participants|Number|139|139.0||||||
4344351|NCT00410202|4172128|B1|Negative||Hepatitis B e antibody (HBeAb) at baseline||participants|Number|138|138.0||||||
4344352|NCT00410202|4172125|B4|Positive||Hepatitis B e antibody (HBeAb) at baseline||participants|Number|3|3.0||||||
4344353|NCT00410202|4172126|B3|Positive||Hepatitis B e antibody (HBeAb) at baseline||participants|Number|2|2.0||||||
4344354|NCT00410202|4172127|B2|Positive||Hepatitis B e antibody (HBeAb) at baseline||participants|Number|1|1.0||||||
4344355|NCT00410202|4172128|B1|Positive||Hepatitis B e antibody (HBeAb) at baseline||participants|Number|0|0.0||||||
4344356|NCT00410202|4172125|B4|Negative||Hepatitis B e antigen (HBeAg) status at baseline||participants|Number|3|3.0||||||
4344357|NCT00410202|4172126|B3|Negative||Hepatitis B e antigen (HBeAg) status at baseline||participants|Number|2|2.0||||||
4344358|NCT00410202|4172127|B2|Negative||Hepatitis B e antigen (HBeAg) status at baseline||participants|Number|1|1.0||||||
4344359|NCT00410202|4172128|B1|Negative||Hepatitis B e antigen (HBeAg) status at baseline||participants|Number|0|0.0||||||
4344360|NCT00410202|4172125|B4|Positive||Hepatitis B e antigen (HBeAg) status at baseline||participants|Number|412|412.0||||||
4344361|NCT00410202|4172126|B3|Positive||Hepatitis B e antigen (HBeAg) status at baseline||participants|Number|135|135.0||||||
4344362|NCT00410202|4172127|B2|Positive||Hepatitis B e antigen (HBeAg) status at baseline||participants|Number|139|139.0||||||
4344363|NCT00410202|4172128|B1|Positive||Hepatitis B e antigen (HBeAg) status at baseline||participants|Number|138|138.0||||||
4344364|NCT00410202|4172125|B4|Negative||Hepatitis B surface antigen (HBsAg) status at baseline||participants|Number|0|0.0||||||
4344365|NCT00410202|4172126|B3|Negative||Hepatitis B surface antigen (HBsAg) status at baseline||participants|Number|0|0.0||||||
4344366|NCT00410202|4172127|B2|Negative||Hepatitis B surface antigen (HBsAg) status at baseline||participants|Number|0|0.0||||||
4344367|NCT00410202|4172128|B1|Negative||Hepatitis B surface antigen (HBsAg) status at baseline||participants|Number|0|0.0||||||
4344368|NCT00410202|4172125|B4|Positive||Hepatitis B surface antigen (HBsAg) status at baseline||participants|Number|415|415.0||||||
4344369|NCT00410202|4172126|B3|Positive||Hepatitis B surface antigen (HBsAg) status at baseline||participants|Number|137|137.0||||||
4344370|NCT00410202|4172127|B2|Positive||Hepatitis B surface antigen (HBsAg) status at baseline||participants|Number|140|140.0||||||
4344371|NCT00410202|4172128|B1|Positive||Hepatitis B surface antigen (HBsAg) status at baseline||participants|Number|138|138.0||||||
4344372|NCT00410202|4172125|B4|Turkey||Region of Enrollment||participants|Number|1|1.0||||||
4344373|NCT00410202|4172126|B3|Turkey||Region of Enrollment||participants|Number|0|0.0||||||
4344374|NCT00410202|4172127|B2|Turkey||Region of Enrollment||participants|Number|0|0.0||||||
4344375|NCT00410202|4172128|B1|Turkey||Region of Enrollment||participants|Number|1|1.0||||||
4344376|NCT00410202|4172125|B4|Thailand||Region of Enrollment||participants|Number|5|5.0||||||
4344377|NCT00410202|4172126|B3|Thailand||Region of Enrollment||participants|Number|1|1.0||||||
4344378|NCT00410202|4172127|B2|Thailand||Region of Enrollment||participants|Number|3|3.0||||||
4344379|NCT00410202|4172128|B1|Thailand||Region of Enrollment||participants|Number|1|1.0||||||
4344380|NCT00410202|4172125|B4|Taiwan||Region of Enrollment||participants|Number|26|26.0||||||
4344381|NCT00410202|4172126|B3|Taiwan||Region of Enrollment||participants|Number|9|9.0||||||
4344382|NCT00410202|4172127|B2|Taiwan||Region of Enrollment||participants|Number|9|9.0||||||
4344383|NCT00410202|4172128|B1|Taiwan||Region of Enrollment||participants|Number|8|8.0||||||
4344384|NCT00410202|4172125|B4|Singapore||Region of Enrollment||participants|Number|2|2.0||||||
4344385|NCT00410202|4172126|B3|Singapore||Region of Enrollment||participants|Number|0|0.0||||||
4344386|NCT00410202|4172127|B2|Singapore||Region of Enrollment||participants|Number|1|1.0||||||
4344387|NCT00410202|4172128|B1|Singapore||Region of Enrollment||participants|Number|1|1.0||||||
4344388|NCT00410202|4172125|B4|Russian Federation||Region of Enrollment||participants|Number|2|2.0||||||
4344389|NCT00410202|4172126|B3|Russian Federation||Region of Enrollment||participants|Number|2|2.0||||||
4344390|NCT00410202|4172127|B2|Russian Federation||Region of Enrollment||participants|Number|0|0.0||||||
4344391|NCT00410202|4172128|B1|Russian Federation||Region of Enrollment||participants|Number|0|0.0||||||
4344392|NCT00410202|4172125|B4|Poland||Region of Enrollment||participants|Number|23|23.0||||||
4344393|NCT00410202|4172126|B3|Poland||Region of Enrollment||participants|Number|9|9.0||||||
4344394|NCT00410202|4172127|B2|Poland||Region of Enrollment||participants|Number|9|9.0||||||
4344395|NCT00410202|4172128|B1|Poland||Region of Enrollment||participants|Number|5|5.0||||||
4344396|NCT00410202|4172125|B4|Philippines||Region of Enrollment||participants|Number|2|2.0||||||
4344397|NCT00410202|4172126|B3|Philippines||Region of Enrollment||participants|Number|1|1.0||||||
4344398|NCT00410202|4172127|B2|Philippines||Region of Enrollment||participants|Number|1|1.0||||||
4344399|NCT00410202|4172128|B1|Philippines||Region of Enrollment||participants|Number|0|0.0||||||
4344400|NCT00410202|4172125|B4|Malaysia||Region of Enrollment||participants|Number|5|5.0||||||
4344401|NCT00410202|4172126|B3|Malaysia||Region of Enrollment||participants|Number|2|2.0||||||
4344402|NCT00410202|4172127|B2|Malaysia||Region of Enrollment||participants|Number|0|0.0||||||
4344403|NCT00410202|4172128|B1|Malaysia||Region of Enrollment||participants|Number|3|3.0||||||
4344404|NCT00410202|4172125|B4|Korea, Republic of||Region of Enrollment||participants|Number|315|315.0||||||
4344405|NCT00410202|4172126|B3|Korea, Republic of||Region of Enrollment||participants|Number|102|102.0||||||
4344406|NCT00410202|4172127|B2|Korea, Republic of||Region of Enrollment||participants|Number|105|105.0||||||
4344407|NCT00410202|4172128|B1|Korea, Republic of||Region of Enrollment||participants|Number|108|108.0||||||
4344408|NCT00410202|4172125|B4|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4344409|NCT00410202|4172126|B3|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4344410|NCT00410202|4172127|B2|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4344411|NCT00410202|4172128|B1|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4344412|NCT00410202|4172125|B4|Indonesia||Region of Enrollment||participants|Number|1|1.0||||||
4344413|NCT00410202|4172126|B3|Indonesia||Region of Enrollment||participants|Number|0|0.0||||||
4344414|NCT00410202|4172127|B2|Indonesia||Region of Enrollment||participants|Number|1|1.0||||||
4344415|NCT00410202|4172128|B1|Indonesia||Region of Enrollment||participants|Number|0|0.0||||||
4344416|NCT00410202|4172125|B4|India||Region of Enrollment||participants|Number|12|12.0||||||
4344417|NCT00410202|4172126|B3|India||Region of Enrollment||participants|Number|5|5.0||||||
4344418|NCT00410202|4172127|B2|India||Region of Enrollment||participants|Number|3|3.0||||||
4344419|NCT00410202|4172128|B1|India||Region of Enrollment||participants|Number|4|4.0||||||
4344420|NCT00410202|4172125|B4|Hong Kong||Region of Enrollment||participants|Number|17|17.0||||||
4344421|NCT00410202|4172126|B3|Hong Kong||Region of Enrollment||participants|Number|5|5.0||||||
4344422|NCT00410202|4172127|B2|Hong Kong||Region of Enrollment||participants|Number|7|7.0||||||
4344423|NCT00410202|4172128|B1|Hong Kong||Region of Enrollment||participants|Number|5|5.0||||||
4344424|NCT00410202|4172125|B4|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4344425|NCT00410202|4172126|B3|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4344426|NCT00410202|4172127|B2|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4344427|NCT00410202|4172128|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4344428|NCT00410202|4172125|B4|Australia||Region of Enrollment||participants|Number|2|2.0||||||
4344429|NCT00410202|4172126|B3|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4344430|NCT00410202|4172127|B2|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4344431|NCT00410202|4172128|B1|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4344432|NCT00410202|4172125|B4|White||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4344433|NCT00410202|4172126|B3|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4344434|NCT00410202|4172127|B2|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4344435|NCT00410202|4172128|B1|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4344436|NCT00410202|4172125|B4|Asian||Race/Ethnicity, Customized||participants|Number|389|389.0||||||
4344437|NCT00410202|4172126|B3|Asian||Race/Ethnicity, Customized||participants|Number|126|126.0||||||
4344438|NCT00410202|4172127|B2|Asian||Race/Ethnicity, Customized||participants|Number|131|131.0||||||
4344439|NCT00410202|4172128|B1|Asian||Race/Ethnicity, Customized||participants|Number|132|132.0||||||
4344440|NCT00410202|4172125|B4||Male|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
4344441|NCT00410202|4172126|B3||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4344442|NCT00410202|4172127|B2||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4344443|NCT00410202|4172128|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4344444|NCT00410202|4172125|B4||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4344445|NCT00410202|4172126|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4344446|NCT00410202|4172127|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4344447|NCT00410202|4172128|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4344448|NCT00410202|4172125|B4|||Age||years|Median|45.0|45.0|Full Range|||16.0|74.0|
4344449|NCT00410202|4172126|B3|||Age||years|Median|43.0|43.0|Full Range|||16.0|74.0|
4344450|NCT00410202|4172127|B2|||Age||years|Median|43.5|43.5|Full Range|||19.0|71.0|
4344451|NCT00410202|4172128|B1|||Age||years|Median|46.0|46.0|Full Range|||18.0|69.0|
4344452|NCT00410189|4172210|B1|United States||Region of Enrollment||participants|Number|54|54.0||||||
4344453|NCT00410189|4172210|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4344454|NCT00410189|4172210|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4344455|NCT00410189|4172210|B1|>70 years||Age, Customized||participants|Number|9|9.0||||||
4344456|NCT00410189|4172210|B1|Between 61 and 70 years||Age, Customized||participants|Number|19|19.0||||||
4344457|NCT00410189|4172210|B1|Between 51 and 60 years||Age, Customized||participants|Number|15|15.0||||||
4344458|NCT00410189|4172210|B1|<=50 years||Age, Customized||participants|Number|11|11.0||||||
4344459|NCT00410189|4172210|B1|||Age||years|Mean|61|61.0|Full Range|||34.0|80.0|
4344460|NCT00410163|4172215|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4344461|NCT00410163|4172216|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4344462|NCT00410163|4172217|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4344463|NCT00410163|4172215|B3|White||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
4344464|NCT00410163|4172216|B2|White||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4344465|NCT00410163|4172217|B1|White||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4344466|NCT00410163|4172215|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4344467|NCT00410163|4172216|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4344468|NCT00410163|4172217|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4344469|NCT00410163|4172215|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4344470|NCT00410163|4172216|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4344471|NCT00410163|4172217|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4344472|NCT00410163|4172215|B3|||Age||Years|Mean|56.2|56.2|Standard Deviation|8.5|8.5|||
4344473|NCT00410163|4172216|B2|||Age||Years|Mean|56.4|56.4|Standard Deviation|8.7|8.7|||
4344474|NCT00410163|4172217|B1|||Age||Years|Mean|56.1|56.1|Standard Deviation|8.4|8.4|||
4344475|NCT00410150|4172260|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4344476|NCT00410150|4172261|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4344477|NCT00410150|4172262|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4344478|NCT00410150|4172260|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4344479|NCT00410150|4172261|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4344480|NCT00410150|4172262|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4344481|NCT00410150|4172260|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4344482|NCT00410150|4172261|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4344483|NCT00410150|4172262|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4344484|NCT00410150|4172260|B3|||Age||years|Mean|7.8|7.8|Standard Deviation|0.8|0.8|||
4344485|NCT00410150|4172261|B2|||Age||years|Mean|8.2|8.2|Standard Deviation|0.9|0.9|||
4344486|NCT00410150|4172262|B1|||Age||years|Mean|7.3|7.3|Standard Deviation|0.8|0.8|||
4344487|NCT00410150|4172260|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4344488|NCT00410150|4172261|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4344489|NCT00410150|4172262|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4344490|NCT00410150|4172260|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4344491|NCT00410150|4172261|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4344492|NCT00410150|4172262|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4344493|NCT00410150|4172260|B3||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
4344494|NCT00410150|4172261|B2||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
4344495|NCT00410150|4172262|B1||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
4344496|NCT00410124|4172269|B3||Male|Sex: Female, Male||Participants|Count of Participants|322|322.0||||||
4344497|NCT00410124|4172270|B2||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4344498|NCT00410124|4172271|B1||Male|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4344499|NCT00410124|4172269|B3||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4344500|NCT00410124|4172270|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4344501|NCT00410124|4172271|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4344502|NCT00410124|4172269|B3|>=65 years||Age, Customized||participants|Number|153|153.0||||||
4344503|NCT00410124|4172270|B2|>=65 years||Age, Customized||participants|Number|41|41.0||||||
4344504|NCT00410124|4172271|B1|>=65 years||Age, Customized||participants|Number|112|112.0||||||
4344505|NCT00410124|4172269|B3|<65 years||Age, Customized||participants|Number|263|263.0||||||
4344506|NCT00410124|4172270|B2|<65 years||Age, Customized||participants|Number|98|98.0||||||
4344507|NCT00410124|4172271|B1|<65 years||Age, Customized||participants|Number|165|165.0||||||
4344508|NCT00410072|4172301|B3|Negative||Hepatitis B surface antigen (HBsAg) status at baseline||Participants|Number|1|1.0||||||
4344509|NCT00410072|4172302|B2|Negative||Hepatitis B surface antigen (HBsAg) status at baseline||Participants|Number|1|1.0||||||
4344510|NCT00410072|4172303|B1|Negative||Hepatitis B surface antigen (HBsAg) status at baseline||Participants|Number|0|0.0||||||
4344511|NCT00410072|4172301|B3|Positive||Hepatitis B surface antigen (HBsAg) status at baseline||Participants|Number|378|378.0||||||
4344512|NCT00410072|4172302|B2|Positive||Hepatitis B surface antigen (HBsAg) status at baseline||Participants|Number|196|196.0||||||
4344513|NCT00410072|4172303|B1|Positive||Hepatitis B surface antigen (HBsAg) status at baseline||Participants|Number|182|182.0||||||
4344514|NCT00410072|4172301|B3|Negative (> 17,200 IU/mL; approx 10^5 copies/mL)||Hepatitis B e antigen (HBeAg) status at baseline||Participants|Number|115|115.0||||||
4344515|NCT00410072|4172302|B2|Negative (> 17,200 IU/mL; approx 10^5 copies/mL)||Hepatitis B e antigen (HBeAg) status at baseline||Participants|Number|59|59.0||||||
4344516|NCT00410072|4172303|B1|Negative (> 17,200 IU/mL; approx 10^5 copies/mL)||Hepatitis B e antigen (HBeAg) status at baseline||Participants|Number|56|56.0||||||
4344517|NCT00410072|4172301|B3|Positive (> 172,000 IU/mL; approx 10^6 copies/mL)||Hepatitis B e antigen (HBeAg) status at baseline||Participants|Number|264|264.0||||||
4344518|NCT00410072|4172302|B2|Positive (> 172,000 IU/mL; approx 10^6 copies/mL)||Hepatitis B e antigen (HBeAg) status at baseline||Participants|Number|138|138.0||||||
4344519|NCT00410072|4172303|B1|Positive (> 172,000 IU/mL; approx 10^6 copies/mL)||Hepatitis B e antigen (HBeAg) status at baseline||Participants|Number|126|126.0||||||
4344520|NCT00410072|4172301|B3|Negative||Hepatitis B e antibody (HBeAb) at baseline||Participants|Number|259|259.0||||||
4344521|NCT00410072|4172302|B2|Negative||Hepatitis B e antibody (HBeAb) at baseline||Participants|Number|137|137.0||||||
4344522|NCT00410072|4172303|B1|Negative||Hepatitis B e antibody (HBeAb) at baseline||Participants|Number|122|122.0||||||
4344523|NCT00410072|4172301|B3|Positive||Hepatitis B e antibody (HBeAb) at baseline||Participants|Number|120|120.0||||||
4344524|NCT00410072|4172302|B2|Positive||Hepatitis B e antibody (HBeAb) at baseline||Participants|Number|60|60.0||||||
4344525|NCT00410072|4172303|B1|Positive||Hepatitis B e antibody (HBeAb) at baseline||Participants|Number|60|60.0||||||
4344526|NCT00410072|4172301|B3|South America||Region||Participants|Number|35|35.0||||||
4344527|NCT00410072|4172302|B2|South America||Region||Participants|Number|18|18.0||||||
4344528|NCT00410072|4172303|B1|South America||Region||Participants|Number|17|17.0||||||
4344529|NCT00410072|4172301|B3|North America||Region||Participants|Number|140|140.0||||||
4344530|NCT00410072|4172302|B2|North America||Region||Participants|Number|76|76.0||||||
4344531|NCT00410072|4172303|B1|North America||Region||Participants|Number|64|64.0||||||
4344532|NCT00410072|4172301|B3|Europe||Region||Participants|Number|137|137.0||||||
4344533|NCT00410072|4172302|B2|Europe||Region||Participants|Number|67|67.0||||||
4344534|NCT00410072|4172303|B1|Europe||Region||Participants|Number|70|70.0||||||
4344535|NCT00410072|4172301|B3|Asia||Region||Participants|Number|62|62.0||||||
4344536|NCT00410072|4172302|B2|Asia||Region||Participants|Number|33|33.0||||||
4344537|NCT00410072|4172303|B1|Asia||Region||Participants|Number|29|29.0||||||
4344538|NCT00410072|4172301|B3|Africa||Region||Participants|Number|5|5.0||||||
4344539|NCT00410072|4172302|B2|Africa||Region||Participants|Number|3|3.0||||||
4344540|NCT00410072|4172303|B1|Africa||Region||Participants|Number|2|2.0||||||
4344541|NCT00410072|4172301|B3|South Africa||Country||participants|Number|5|5.0||||||
4344542|NCT00410072|4172302|B2|South Africa||Country||participants|Number|3|3.0||||||
4344543|NCT00410072|4172303|B1|South Africa||Country||participants|Number|2|2.0||||||
4344544|NCT00410072|4172301|B3|Australia||Country||participants|Number|48|48.0||||||
4344545|NCT00410072|4172302|B2|Australia||Country||participants|Number|24|24.0||||||
4344546|NCT00410072|4172303|B1|Australia||Country||participants|Number|24|24.0||||||
4344547|NCT00410072|4172301|B3|Brazil||Country||participants|Number|8|8.0||||||
4344548|NCT00410072|4172302|B2|Brazil||Country||participants|Number|3|3.0||||||
4344549|NCT00410072|4172303|B1|Brazil||Country||participants|Number|5|5.0||||||
4344550|NCT00410072|4172301|B3|Poland||Country||participants|Number|28|28.0||||||
4344551|NCT00410072|4172302|B2|Poland||Country||participants|Number|13|13.0||||||
4344552|NCT00410072|4172303|B1|Poland||Country||participants|Number|15|15.0||||||
4344553|NCT00410072|4172301|B3|Argentina||Country||participants|Number|27|27.0||||||
4344554|NCT00410072|4172302|B2|Argentina||Country||participants|Number|15|15.0||||||
4344555|NCT00410072|4172303|B1|Argentina||Country||participants|Number|12|12.0||||||
4344556|NCT00410072|4172301|B3|Canada||Country||participants|Number|62|62.0||||||
4344557|NCT00410072|4172302|B2|Canada||Country||participants|Number|33|33.0||||||
4344558|NCT00410072|4172303|B1|Canada||Country||participants|Number|29|29.0||||||
4344559|NCT00410072|4172301|B3|France||Country||participants|Number|13|13.0||||||
4344560|NCT00410072|4172302|B2|France||Country||participants|Number|5|5.0||||||
4344561|NCT00410072|4172303|B1|France||Country||participants|Number|8|8.0||||||
4344562|NCT00410072|4172301|B3|India||Country||participants|Number|14|14.0||||||
4344563|NCT00410072|4172302|B2|India||Country||participants|Number|9|9.0||||||
4344564|NCT00410072|4172303|B1|India||Country||participants|Number|5|5.0||||||
4344565|NCT00410072|4172301|B3|Italy||Country||participants|Number|27|27.0||||||
4344566|NCT00410072|4172302|B2|Italy||Country||participants|Number|15|15.0||||||
4344567|NCT00410072|4172303|B1|Italy||Country||participants|Number|12|12.0||||||
4344568|NCT00410072|4172301|B3|Russian Federation||Country||participants|Number|47|47.0||||||
4344569|NCT00410072|4172302|B2|Russian Federation||Country||participants|Number|23|23.0||||||
4344570|NCT00410072|4172303|B1|Russian Federation||Country||participants|Number|24|24.0||||||
4344571|NCT00410072|4172301|B3|Turkey||Country||participants|Number|22|22.0||||||
4344572|NCT00410072|4172302|B2|Turkey||Country||participants|Number|11|11.0||||||
4344573|NCT00410072|4172303|B1|Turkey||Country||participants|Number|11|11.0||||||
4344574|NCT00410072|4172301|B3|United States||Country||participants|Number|78|78.0||||||
4344575|NCT00410072|4172302|B2|United States||Country||participants|Number|43|43.0||||||
4344576|NCT00410072|4172303|B1|United States||Country||participants|Number|35|35.0||||||
4344577|NCT00410072|4172301|B3|Other||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4344578|NCT00410072|4172302|B2|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4344579|NCT00410072|4172303|B1|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4344580|NCT00410072|4172301|B3|White||Race/Ethnicity, Customized||Participants|Number|170|170.0||||||
4344581|NCT00410072|4172302|B2|White||Race/Ethnicity, Customized||Participants|Number|87|87.0||||||
4344582|NCT00410072|4172303|B1|White||Race/Ethnicity, Customized||Participants|Number|83|83.0||||||
4344583|NCT00410072|4172301|B3|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4344584|NCT00410072|4172302|B2|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4344585|NCT00410072|4172303|B1|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4344586|NCT00410072|4172301|B3|Black/African American||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4344587|NCT00410072|4172302|B2|Black/African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4344588|NCT00410072|4172303|B1|Black/African American||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4344589|NCT00410072|4172301|B3|Asian||Race/Ethnicity, Customized||Participants|Number|186|186.0||||||
4344590|NCT00410072|4172302|B2|Asian||Race/Ethnicity, Customized||Participants|Number|102|102.0||||||
4344591|NCT00410072|4172303|B1|Asian||Race/Ethnicity, Customized||Participants|Number|84|84.0||||||
4344592|NCT00410072|4172301|B3||Male|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
4344593|NCT00410072|4172302|B2||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4344594|NCT00410072|4172303|B1||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4344595|NCT00410072|4172301|B3||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4344596|NCT00410072|4172302|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4344597|NCT00410072|4172303|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4344598|NCT00410072|4172301|B3|>=65 years||Age, Customized||Participants|Number|21|21.0||||||
4344599|NCT00410072|4172302|B2|>=65 years||Age, Customized||Participants|Number|9|9.0||||||
4344600|NCT00410072|4172303|B1|>=65 years||Age, Customized||Participants|Number|12|12.0||||||
4344601|NCT00410072|4172301|B3|21 - 64 years||Age, Customized||Participants|Number|326|326.0||||||
4344602|NCT00410072|4172302|B2|21 - 64 years||Age, Customized||Participants|Number|169|169.0||||||
4344603|NCT00410072|4172303|B1|21 - 64 years||Age, Customized||Participants|Number|157|157.0||||||
4344604|NCT00410072|4172301|B3|16 - 20 years||Age, Customized||Participants|Number|32|32.0||||||
4344605|NCT00410072|4172302|B2|16 - 20 years||Age, Customized||Participants|Number|19|19.0||||||
4344606|NCT00410072|4172303|B1|16 - 20 years||Age, Customized||Participants|Number|13|13.0||||||
4344607|NCT00410059|4172340|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
4344608|NCT00410059|4172340|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344609|NCT00410059|4172340|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344610|NCT00410059|4172340|B1||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4344611|NCT00410059|4172340|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4344612|NCT00410059|4172340|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344613|NCT00410059|4172340|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4344614|NCT00410059|4172340|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344615|NCT00410059|4172340|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344616|NCT00410059|4172340|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4344617|NCT00410059|4172340|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4344618|NCT00410059|4172340|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4344619|NCT00410059|4172340|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4344620|NCT00410059|4172340|B1|||Age||years|Median|60|60.0|Full Range|||37.0|83.0|
4344621|NCT00410046|4172344|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4344622|NCT00410046|4172344|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4344623|NCT00410046|4172344|B1|||Age||years|Mean|42.70|42.7|Standard Deviation|10.49|10.49|||
4344624|NCT00409838|4172373|B3|||weight||kilograms|Mean|55.3|55.3|Standard Deviation|8.6|8.6|||
4344625|NCT00409838|4172374|B2|||weight||kilograms|Mean|54.2|54.2|Standard Deviation|7.5|7.5|||
4344626|NCT00409838|4172375|B1|||weight||kilograms|Mean|56.5|56.5|Standard Deviation|9.5|9.5|||
4344627|NCT00409838|4172373|B3||Male|Sex: Female, Male|One participant was randomized to the abatacept arm but never treated, and is not included in baseline characteristics.|Participants|Count of Participants|16|16.0||||||
4344628|NCT00409838|4172374|B2||Male|Sex: Female, Male|One participant was randomized to the abatacept arm but never treated, and is not included in baseline characteristics.|Participants|Count of Participants|8|8.0||||||
4344629|NCT00409838|4172375|B1||Male|Sex: Female, Male|One participant was randomized to the abatacept arm but never treated, and is not included in baseline characteristics.|Participants|Count of Participants|8|8.0||||||
4344630|NCT00409838|4172373|B3||Female|Sex: Female, Male|One participant was randomized to the abatacept arm but never treated, and is not included in baseline characteristics.|Participants|Count of Participants|96|96.0||||||
4344631|NCT00409838|4172374|B2||Female|Sex: Female, Male|One participant was randomized to the abatacept arm but never treated, and is not included in baseline characteristics.|Participants|Count of Participants|49|49.0||||||
4344632|NCT00409838|4172375|B1||Female|Sex: Female, Male|One participant was randomized to the abatacept arm but never treated, and is not included in baseline characteristics.|Participants|Count of Participants|47|47.0||||||
4344633|NCT00409838|4172373|B3|||Age||years|Mean|48.6|48.6|Standard Deviation|11.4|11.4|||
4344634|NCT00409838|4172374|B2|||Age||years|Mean|49.9|49.9|Standard Deviation|10.6|10.6|||
4344635|NCT00409838|4172375|B1|||Age||years|Mean|47.2|47.2|Standard Deviation|12.2|12.2|||
4344636|NCT00409825|4172437|B1|United States||Region of Enrollment||participants|Number|61|61.0||||||
4344637|NCT00409825|4172437|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4344638|NCT00409825|4172437|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344639|NCT00409825|4172437|B1||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4344640|NCT00409825|4172437|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4344641|NCT00409825|4172437|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4344642|NCT00409825|4172437|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4344643|NCT00409825|4172437|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344644|NCT00409825|4172437|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4344645|NCT00409825|4172437|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4344646|NCT00409825|4172437|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4344647|NCT00409825|4172437|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4344648|NCT00409825|4172437|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4344649|NCT00409825|4172437|B1|||Age||years|Mean|28.01|28.01|Standard Deviation|5.9|5.9|||
4344650|NCT00409786|4172441|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4344651|NCT00409786|4172441|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4344652|NCT00409786|4172441|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4344653|NCT00409786|4172441|B1|||Age||years|Mean|51.94|51.94|Standard Deviation|10.82|10.82|||
4344654|NCT00409786|4172441|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4344655|NCT00409786|4172441|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4344656|NCT00409786|4172441|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4344657|NCT00409773|4172445|B6|White||Race/Ethnicity, Customized||participants|Number|856|856.0||||||
4344658|NCT00409773|4172446|B5|White||Race/Ethnicity, Customized||participants|Number|167|167.0||||||
4344659|NCT00409773|4172447|B4|White||Race/Ethnicity, Customized||participants|Number|171|171.0||||||
4344660|NCT00409773|4172448|B3|White||Race/Ethnicity, Customized||participants|Number|177|177.0||||||
4344661|NCT00409773|4172449|B2|White||Race/Ethnicity, Customized||participants|Number|169|169.0||||||
4344662|NCT00409773|4172450|B1|White||Race/Ethnicity, Customized||participants|Number|172|172.0||||||
4344663|NCT00409773|4172445|B6|Other||Race/Ethnicity, Customized||participants|Number|126|126.0||||||
4344664|NCT00409773|4172446|B5|Other||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4344665|NCT00409773|4172447|B4|Other||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4344666|NCT00409773|4172448|B3|Other||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4344667|NCT00409773|4172449|B2|Other||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4344668|NCT00409773|4172450|B1|Other||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4344669|NCT00409773|4172445|B6|Black||Race/Ethnicity, Customized||participants|Number|75|75.0||||||
4344670|NCT00409773|4172446|B5|Black||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4344671|NCT00409773|4172447|B4|Black||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4344672|NCT00409773|4172448|B3|Black||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4344673|NCT00409773|4172449|B2|Black||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4344674|NCT00409773|4172450|B1|Black||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4344675|NCT00409773|4172445|B6|Asian||Race/Ethnicity, Customized||participants|Number|86|86.0||||||
4344676|NCT00409773|4172446|B5|Asian||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4344677|NCT00409773|4172447|B4|Asian||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4344678|NCT00409773|4172448|B3|Asian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4344679|NCT00409773|4172449|B2|Asian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4344680|NCT00409773|4172450|B1|Asian||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4344681|NCT00409773|4172445|B6||Male|Sex: Female, Male||Participants|Count of Participants|645|645.0||||||
4344682|NCT00409773|4172446|B5||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4344683|NCT00409773|4172447|B4||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4344684|NCT00409773|4172448|B3||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4344685|NCT00409773|4172449|B2||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4344686|NCT00409773|4172450|B1||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4344687|NCT00409773|4172445|B6||Female|Sex: Female, Male||Participants|Count of Participants|498|498.0||||||
4344688|NCT00409773|4172446|B5||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4344689|NCT00409773|4172447|B4||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4344690|NCT00409773|4172448|B3||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4344691|NCT00409773|4172449|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4344692|NCT00409773|4172450|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4344693|NCT00409773|4172445|B6|||Age||years|Mean|59.1|59.1|Full Range|||28.0|80.0|
4344694|NCT00409773|4172446|B5|||Age||years|Mean|58.4|58.4|Full Range|||28.0|79.0|
4344695|NCT00409773|4172447|B4|||Age||years|Mean|59.5|59.5|Full Range|||28.0|80.0|
4344696|NCT00409773|4172448|B3|||Age||years|Mean|58.2|58.2|Full Range|||33.0|78.0|
4344697|NCT00409773|4172449|B2|||Age||years|Mean|59.7|59.7|Full Range|||32.0|78.0|
4344698|NCT00409773|4172450|B1|||Age||years|Mean|59.7|59.7|Full Range|||31.0|79.0|
4344699|NCT00409747|4172536|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4344700|NCT00409747|4172536|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4344701|NCT00409747|4172536|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4344702|NCT00409747|4172536|B1|||Age||years|Mean|7.2|7.2|Standard Deviation|2.9|2.9|||
4344703|NCT00409747|4172536|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4344704|NCT00409747|4172536|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4344705|NCT00409747|4172536|B1||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4344706|NCT00409708|4172541|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4344707|NCT00409708|4172542|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4344708|NCT00409708|4172543|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4344709|NCT00409708|4172541|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4344710|NCT00409708|4172542|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4344711|NCT00409708|4172543|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4344712|NCT00409708|4172541|B3|||Age||years|Mean|8.4|8.4|Standard Deviation|1.83|1.83|||
4344713|NCT00409708|4172542|B2|||Age||years|Mean|8.5|8.5|Standard Deviation|1.91|1.91|||
4344714|NCT00409708|4172543|B1|||Age||years|Mean|8.3|8.3|Standard Deviation|1.75|1.75|||
4344715|NCT00409708|4172541|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4344716|NCT00409708|4172542|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4344717|NCT00409708|4172543|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4344718|NCT00409708|4172541|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4344719|NCT00409708|4172542|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4344720|NCT00409708|4172543|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4344721|NCT00409708|4172541|B3||<=18 years|Age||Participants|Count of Participants|104|104.0||||||
4344722|NCT00409708|4172542|B2||<=18 years|Age||Participants|Count of Participants|52|52.0||||||
4344723|NCT00409708|4172543|B1||<=18 years|Age||Participants|Count of Participants|52|52.0||||||
4344724|NCT00409682|4172562|B4|>= 40||Weight||kg|Number|121|121.0||||||
4344725|NCT00409682|4172563|B3|>= 40||Weight||kg|Number|60|60.0||||||
4344726|NCT00409682|4172564|B2|>= 40||Weight||kg|Number|61|61.0||||||
4344727|NCT00409682|4172565|B1|>= 40||Weight||kg|Number|0|0.0||||||
4344728|NCT00409682|4172562|B4|< 40||Weight||kg|Number|67|67.0||||||
4344729|NCT00409682|4172563|B3|< 40||Weight||kg|Number|35|35.0||||||
4344730|NCT00409682|4172564|B2|< 40||Weight||kg|Number|32|32.0||||||
4344731|NCT00409682|4172565|B1|< 40||Weight||kg|Number|0|0.0||||||
4344732|NCT00409682|4172562|B4|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4344733|NCT00409682|4172563|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4344734|NCT00409682|4172564|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4344735|NCT00409682|4172565|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4344736|NCT00409682|4172562|B4|Mult-race||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4344737|NCT00409682|4172563|B3|Mult-race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4344738|NCT00409682|4172564|B2|Mult-race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4344739|NCT00409682|4172565|B1|Mult-race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4344740|NCT00409682|4172562|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4344741|NCT00409682|4172563|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4344742|NCT00409682|4172564|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4344743|NCT00409682|4172565|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4344744|NCT00409682|4172562|B4|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4344745|NCT00409682|4172563|B3|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4344746|NCT00409682|4172564|B2|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4344747|NCT00409682|4172565|B1|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4344748|NCT00409682|4172562|B4|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4344749|NCT00409682|4172563|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4344750|NCT00409682|4172564|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4344751|NCT00409682|4172565|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4344752|NCT00409682|4172562|B4|Black||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4344753|NCT00409682|4172563|B3|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4344754|NCT00409682|4172564|B2|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4344755|NCT00409682|4172565|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4344756|NCT00409682|4172562|B4|White||Race/Ethnicity, Customized||participants|Number|166|166.0||||||
4344757|NCT00409682|4172563|B3|White||Race/Ethnicity, Customized||participants|Number|85|85.0||||||
4344758|NCT00409682|4172564|B2|White||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
4344759|NCT00409682|4172565|B1|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4344760|NCT00409682|4172562|B4||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4344761|NCT00409682|4172563|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4344762|NCT00409682|4172564|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4344763|NCT00409682|4172565|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4344764|NCT00409682|4172562|B4||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4344765|NCT00409682|4172563|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4344766|NCT00409682|4172564|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4344767|NCT00409682|4172565|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4344768|NCT00409682|4172562|B4|>= 13||Age, Customized||years|Number|122|122.0||||||
4344769|NCT00409682|4172563|B3|>= 13||Age, Customized||years|Number|60|60.0||||||
4344770|NCT00409682|4172564|B2|>= 13||Age, Customized||years|Number|62|62.0||||||
4344771|NCT00409682|4172565|B1|>= 13||Age, Customized||years|Number|0|0.0||||||
4344772|NCT00409682|4172562|B4|< 13||Age, Customized||years|Number|66|66.0||||||
4344773|NCT00409682|4172563|B3|< 13||Age, Customized||years|Number|35|35.0||||||
4344774|NCT00409682|4172564|B2|< 13||Age, Customized||years|Number|31|31.0||||||
4344775|NCT00409682|4172565|B1|< 13||Age, Customized||years|Number|0|0.0||||||
4344776|NCT00409682|4172562|B4|||Age||years|Mean|13.6|13.6|Standard Deviation|2.49|2.49|||
4344777|NCT00409682|4172563|B3|||Age||years|Mean|13.5|13.5|Standard Deviation|2.47|2.47|||
4344778|NCT00409682|4172564|B2|||Age||years|Mean|13.7|13.7|Standard Deviation|2.52|2.52|||
4344779|NCT00409682|4172565|B1|||Age||years|Mean|0|0.0|Standard Deviation|0|0.0|||
4344780|NCT00409617|4172584|B1|Sweden||Region of Enrollment||participants|Number|35|35.0||||||
4344781|NCT00409617|4172584|B1|Norway||Region of Enrollment||participants|Number|27|27.0||||||
4344782|NCT00409617|4172584|B1|Germany||Region of Enrollment||participants|Number|266|266.0||||||
4344783|NCT00409617|4172584|B1|Denmark||Region of Enrollment||participants|Number|43|43.0||||||
4344784|NCT00409617|4172584|B1|Belgium||Region of Enrollment||participants|Number|72|72.0||||||
4344785|NCT00409617|4172584|B1|Czech Republic||Region of Enrollment||participants|Number|37|37.0||||||
4344786|NCT00409617|4172584|B1|France||Region of Enrollment||participants|Number|141|141.0||||||
4344787|NCT00409617|4172584|B1|Italy||Region of Enrollment||participants|Number|64|64.0||||||
4344788|NCT00409617|4172584|B1|Switzerland||Region of Enrollment||participants|Number|15|15.0||||||
4344789|NCT00409617|4172584|B1|United Kingdom||Region of Enrollment||participants|Number|73|73.0||||||
4344790|NCT00409617|4172584|B1|Austria||Region of Enrollment||participants|Number|47|47.0||||||
4344791|NCT00409617|4172584|B1|Ireland||Region of Enrollment||participants|Number|11|11.0||||||
4344792|NCT00409617|4172584|B1|Spain||Region of Enrollment||participants|Number|47|47.0||||||
4344793|NCT00409617|4172584|B1|Finland||Region of Enrollment||participants|Number|5|5.0||||||
4344794|NCT00409617|4172584|B1|Greece||Region of Enrollment||participants|Number|25|25.0||||||
4344795|NCT00409617|4172584|B1|Slovakia (Slovak Republic)||Region of Enrollment||participants|Number|18|18.0||||||
4344796|NCT00409617|4172584|B1|Portugal||Region of Enrollment||participants|Number|19|19.0||||||
4344797|NCT00409617|4172584|B1||Male|Sex: Female, Male||Participants|Count of Participants|377|377.0||||||
4344798|NCT00409617|4172584|B1||Female|Sex: Female, Male||Participants|Count of Participants|568|568.0||||||
4344799|NCT00409617|4172584|B1|||Age||years|Mean|35.3|35.3|Standard Deviation|11.29|11.29|||
4344800|NCT00409617|4172584|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4344801|NCT00409617|4172584|B1||Between 18 and 65 years|Age||Participants|Count of Participants|919|919.0||||||
4344802|NCT00409617|4172584|B1||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4344803|NCT00409578|4172596|B5||Male|Sex: Female, Male||Participants|Count of Participants|753|753.0||||||
4344804|NCT00409578|4172597|B4||Male|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4344805|NCT00409578|4172598|B3||Male|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4344806|NCT00409578|4172599|B2||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4344807|NCT00409578|4172600|B1||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4344808|NCT00409578|4172596|B5||Female|Sex: Female, Male||Participants|Count of Participants|348|348.0||||||
4344809|NCT00409578|4172597|B4||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4344810|NCT00409578|4172598|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4344811|NCT00409578|4172599|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4344812|NCT00409578|4172600|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4344813|NCT00409578|4172596|B5|||Age||years|Mean|63|63.0|Standard Deviation|11.6|11.6|||
4344814|NCT00409578|4172597|B4|||Age||years|Mean|63|63.0|Standard Deviation|11.1|11.1|||
4344815|NCT00409578|4172598|B3|||Age||years|Mean|64|64.0|Standard Deviation|11.6|11.6|||
4344816|NCT00409578|4172599|B2|||Age||years|Mean|63|63.0|Standard Deviation|11.7|11.7|||
4344817|NCT00409578|4172600|B1|||Age||years|Mean|63|63.0|Standard Deviation|11.8|11.8|||
4344818|NCT00409565|4172625|B1|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) criteria: 0-Fully active. 1-Ambulatory, carry out work of a light or sedentary nature. 2=Ambulatory, capable of all self care. 3-Capable of limited self care, confined to bed or chair more than 50% of waking hours. 4-Completely disabled, no self care, totally confined to bed or chair. 5-Dead.|participants|Number|4|4.0||||||
4344819|NCT00409565|4172625|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) criteria: 0-Fully active. 1-Ambulatory, carry out work of a light or sedentary nature. 2=Ambulatory, capable of all self care. 3-Capable of limited self care, confined to bed or chair more than 50% of waking hours. 4-Completely disabled, no self care, totally confined to bed or chair. 5-Dead.|participants|Number|31|31.0||||||
4344820|NCT00409565|4172625|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) criteria: 0-Fully active. 1-Ambulatory, carry out work of a light or sedentary nature. 2=Ambulatory, capable of all self care. 3-Capable of limited self care, confined to bed or chair more than 50% of waking hours. 4-Completely disabled, no self care, totally confined to bed or chair. 5-Dead.|participants|Number|11|11.0||||||
4344821|NCT00409565|4172625|B1|1 prior palliative regimen||Prior chemotherapy||participants|Number|17|17.0||||||
4344822|NCT00409565|4172625|B1|Prior chemotherapy||Prior chemotherapy||participants|Number|42|42.0||||||
4344823|NCT00409565|4172625|B1|||Prior surgery||participants|Number|30|30.0||||||
4344824|NCT00409565|4172625|B1|||Prior radiation||participants|Number|44|44.0||||||
4344825|NCT00409565|4172625|B1|||Recurrent disease||participants|Number|44|44.0||||||
4344826|NCT00409565|4172625|B1|Others||Primary disease site||participants|Number|8|8.0||||||
4344827|NCT00409565|4172625|B1|Larynx||Primary disease site||participants|Number|7|7.0||||||
4344828|NCT00409565|4172625|B1|Oral cavity||Primary disease site||participants|Number|14|14.0||||||
4344829|NCT00409565|4172625|B1|Oropharynx||Primary disease site||participants|Number|17|17.0||||||
4344830|NCT00409565|4172625|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4344831|NCT00409565|4172625|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344832|NCT00409565|4172625|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344833|NCT00409565|4172625|B1||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4344834|NCT00409565|4172625|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4344835|NCT00409565|4172625|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344836|NCT00409565|4172625|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4344837|NCT00409565|4172625|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344838|NCT00409565|4172625|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344839|NCT00409565|4172625|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4344840|NCT00409565|4172625|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4344841|NCT00409565|4172625|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4344842|NCT00409565|4172625|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4344843|NCT00409565|4172625|B1|||Age||Years|Median|61.5|61.5|Full Range|||33.0|92.0|
4344844|NCT00409539|4172633|B6|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
4344845|NCT00409539|4172634|B5|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4344846|NCT00409539|4172635|B4|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4344847|NCT00409539|4172636|B3|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4344848|NCT00409539|4172637|B2|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4344849|NCT00409539|4172638|B1|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4344850|NCT00409539|4172633|B6|Spain||Region of Enrollment||participants|Number|12|12.0||||||
4344851|NCT00409539|4172634|B5|Spain||Region of Enrollment||participants|Number|5|5.0||||||
4344852|NCT00409539|4172635|B4|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4344853|NCT00409539|4172636|B3|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4344854|NCT00409539|4172637|B2|Spain||Region of Enrollment||participants|Number|3|3.0||||||
4344855|NCT00409539|4172638|B1|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4344856|NCT00409539|4172633|B6|Lithuania||Region of Enrollment||participants|Number|39|39.0||||||
4344857|NCT00409539|4172634|B5|Lithuania||Region of Enrollment||participants|Number|3|3.0||||||
4344858|NCT00409539|4172635|B4|Lithuania||Region of Enrollment||participants|Number|7|7.0||||||
4344859|NCT00409539|4172636|B3|Lithuania||Region of Enrollment||participants|Number|13|13.0||||||
4344860|NCT00409539|4172637|B2|Lithuania||Region of Enrollment||participants|Number|5|5.0||||||
4344861|NCT00409539|4172638|B1|Lithuania||Region of Enrollment||participants|Number|11|11.0||||||
4344862|NCT00409539|4172633|B6|Latvia||Region of Enrollment||participants|Number|38|38.0||||||
4344863|NCT00409539|4172634|B5|Latvia||Region of Enrollment||participants|Number|10|10.0||||||
4344864|NCT00409539|4172635|B4|Latvia||Region of Enrollment||participants|Number|7|7.0||||||
4344865|NCT00409539|4172636|B3|Latvia||Region of Enrollment||participants|Number|6|6.0||||||
4344866|NCT00409539|4172637|B2|Latvia||Region of Enrollment||participants|Number|8|8.0||||||
4344867|NCT00409539|4172638|B1|Latvia||Region of Enrollment||participants|Number|7|7.0||||||
4344868|NCT00409539|4172633|B6|France||Region of Enrollment||participants|Number|4|4.0||||||
4344869|NCT00409539|4172634|B5|France||Region of Enrollment||participants|Number|1|1.0||||||
4344870|NCT00409539|4172635|B4|France||Region of Enrollment||participants|Number|1|1.0||||||
4344871|NCT00409539|4172636|B3|France||Region of Enrollment||participants|Number|0|0.0||||||
4344872|NCT00409539|4172637|B2|France||Region of Enrollment||participants|Number|1|1.0||||||
4344873|NCT00409539|4172638|B1|France||Region of Enrollment||participants|Number|1|1.0||||||
4344874|NCT00409539|4172633|B6|Estonia||Region of Enrollment||participants|Number|23|23.0||||||
4344875|NCT00409539|4172634|B5|Estonia||Region of Enrollment||participants|Number|6|6.0||||||
4344876|NCT00409539|4172635|B4|Estonia||Region of Enrollment||participants|Number|6|6.0||||||
4344877|NCT00409539|4172636|B3|Estonia||Region of Enrollment||participants|Number|2|2.0||||||
4344878|NCT00409539|4172637|B2|Estonia||Region of Enrollment||participants|Number|5|5.0||||||
4344879|NCT00409539|4172638|B1|Estonia||Region of Enrollment||participants|Number|4|4.0||||||
4344880|NCT00409539|4172633|B6|Germany||Region of Enrollment||participants|Number|173|173.0||||||
4344881|NCT00409539|4172634|B5|Germany||Region of Enrollment||participants|Number|30|30.0||||||
4344882|NCT00409539|4172635|B4|Germany||Region of Enrollment||participants|Number|39|39.0||||||
4344883|NCT00409539|4172636|B3|Germany||Region of Enrollment||participants|Number|40|40.0||||||
4344884|NCT00409539|4172637|B2|Germany||Region of Enrollment||participants|Number|35|35.0||||||
4344885|NCT00409539|4172638|B1|Germany||Region of Enrollment||participants|Number|29|29.0||||||
4344886|NCT00409539|4172633|B6|Poland||Region of Enrollment||participants|Number|150|150.0||||||
4344887|NCT00409539|4172634|B5|Poland||Region of Enrollment||participants|Number|30|30.0||||||
4344888|NCT00409539|4172635|B4|Poland||Region of Enrollment||participants|Number|30|30.0||||||
4344889|NCT00409539|4172636|B3|Poland||Region of Enrollment||participants|Number|32|32.0||||||
4344890|NCT00409539|4172637|B2|Poland||Region of Enrollment||participants|Number|27|27.0||||||
4344891|NCT00409539|4172638|B1|Poland||Region of Enrollment||participants|Number|31|31.0||||||
4344892|NCT00409539|4172633|B6|United States||Region of Enrollment||participants|Number|103|103.0||||||
4344893|NCT00409539|4172634|B5|United States||Region of Enrollment||participants|Number|25|25.0||||||
4344894|NCT00409539|4172635|B4|United States||Region of Enrollment||participants|Number|15|15.0||||||
4344895|NCT00409539|4172636|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4344896|NCT00409539|4172637|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4344897|NCT00409539|4172638|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4344898|NCT00409539|4172633|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344899|NCT00409539|4172634|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344900|NCT00409539|4172635|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344901|NCT00409539|4172636|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344902|NCT00409539|4172637|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344903|NCT00409539|4172638|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344904|NCT00409539|4172633|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344905|NCT00409539|4172634|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344906|NCT00409539|4172635|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344907|NCT00409539|4172636|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344908|NCT00409539|4172637|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344909|NCT00409539|4172638|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344910|NCT00409539|4172633|B6||White|Race (NIH/OMB)||Participants|Count of Participants|531|531.0||||||
4344911|NCT00409539|4172634|B5||White|Race (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
4344912|NCT00409539|4172635|B4||White|Race (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
4344913|NCT00409539|4172636|B3||White|Race (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
4344914|NCT00409539|4172637|B2||White|Race (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
4344915|NCT00409539|4172638|B1||White|Race (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
4344916|NCT00409539|4172633|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4344917|NCT00409539|4172634|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4344918|NCT00409539|4172635|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4344919|NCT00409539|4172636|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4344920|NCT00409539|4172637|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4344921|NCT00409539|4172638|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4344922|NCT00409539|4172633|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344923|NCT00409539|4172634|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344924|NCT00409539|4172635|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344925|NCT00409539|4172636|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344926|NCT00409539|4172637|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344927|NCT00409539|4172638|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344928|NCT00409539|4172633|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4344929|NCT00409539|4172634|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4344930|NCT00409539|4172635|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4344931|NCT00409539|4172636|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4344932|NCT00409539|4172637|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344933|NCT00409539|4172638|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4344934|NCT00409539|4172633|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344935|NCT00409539|4172634|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344936|NCT00409539|4172635|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344937|NCT00409539|4172636|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344938|NCT00409539|4172637|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344939|NCT00409539|4172638|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4344940|NCT00409539|4172633|B6||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4344941|NCT00409539|4172634|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4344942|NCT00409539|4172635|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4344943|NCT00409539|4172636|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4344944|NCT00409539|4172637|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4344945|NCT00409539|4172638|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4344946|NCT00409539|4172633|B6||Female|Sex: Female, Male||Participants|Count of Participants|465|465.0||||||
4344947|NCT00409539|4172634|B5||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4344948|NCT00409539|4172635|B4||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4344949|NCT00409539|4172636|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4344950|NCT00409539|4172637|B2||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4344951|NCT00409539|4172638|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4344952|NCT00409539|4172633|B6||>=65 years|Age||Participants|Count of Participants|229|229.0||||||
4344953|NCT00409539|4172634|B5||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
4344954|NCT00409539|4172635|B4||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
4344955|NCT00409539|4172636|B3||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
4344956|NCT00409539|4172637|B2||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4344957|NCT00409539|4172638|B1||>=65 years|Age||Participants|Count of Participants|47|47.0||||||
4344958|NCT00409539|4172633|B6||Between 18 and 65 years|Age||Participants|Count of Participants|321|321.0||||||
4344959|NCT00409539|4172634|B5||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4344960|NCT00409539|4172635|B4||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4344961|NCT00409539|4172636|B3||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4344962|NCT00409539|4172637|B2||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4344963|NCT00409539|4172638|B1||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4344964|NCT00409539|4172633|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4344965|NCT00409539|4172634|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4344966|NCT00409539|4172635|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4344967|NCT00409539|4172636|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4344968|NCT00409539|4172637|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4344969|NCT00409539|4172638|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4344970|NCT00409539|4172633|B6|||Age||years|Mean|61.4|61.4|Standard Deviation|9.96|9.96|||
4344971|NCT00409539|4172634|B5|||Age||years|Mean|61.1|61.1|Standard Deviation|10.08|10.08|||
4344972|NCT00409539|4172635|B4|||Age||years|Mean|61.6|61.6|Standard Deviation|9.04|9.04|||
4344973|NCT00409539|4172636|B3|||Age||years|Mean|61.5|61.5|Standard Deviation|9.93|9.93|||
4344974|NCT00409539|4172637|B2|||Age||years|Mean|62.0|62.0|Standard Deviation|9.60|9.6|||
4344975|NCT00409539|4172638|B1|||Age||years|Mean|61.0|61.0|Standard Deviation|11.15|11.15|||
4344976|NCT00409409|4172659|B3||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4344977|NCT00409409|4172660|B2||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4344978|NCT00409409|4172661|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4344979|NCT00409409|4172659|B3||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4344980|NCT00409409|4172660|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4344981|NCT00409409|4172661|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4344982|NCT00409409|4172659|B3|||Age||years|Mean|10.9|10.9|Standard Deviation|3.22|3.22|||
4344983|NCT00409409|4172660|B2|||Age||years|Mean|11.2|11.2|Standard Deviation|3.07|3.07|||
4344984|NCT00409409|4172661|B1|||Age||years|Mean|10.5|10.5|Standard Deviation|3.34|3.34|||
4344985|NCT00409344|4172668|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4344986|NCT00409344|4172669|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4344987|NCT00409344|4172670|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4344988|NCT00409344|4172668|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4344989|NCT00409344|4172669|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4344990|NCT00409344|4172670|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4344991|NCT00409344|4172668|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4344992|NCT00409344|4172669|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4344993|NCT00409344|4172670|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4344994|NCT00409344|4172668|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4344995|NCT00409344|4172669|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4344996|NCT00409344|4172670|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4344997|NCT00409344|4172668|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4344998|NCT00409344|4172669|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4344999|NCT00409344|4172670|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4345000|NCT00409331|4172689|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4345001|NCT00409331|4172689|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4345002|NCT00409331|4172689|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4345003|NCT00409331|4172689|B1|||Age||years|Median|48|48.0|Full Range|||48.0|48.0|
4345004|NCT00409292|4172693|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4345005|NCT00409292|4172693|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4345006|NCT00409292|4172693|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4345007|NCT00409292|4172693|B1|||Age, Customized||years|Median|61|61.0|Full Range|||39.0|78.0|
4345008|NCT00409240|4172700|B3|United States||Region of Enrollment||participants|Number|99|99.0||||||
4345009|NCT00409240|4172701|B2|United States||Region of Enrollment||participants|Number|49|49.0||||||
4345010|NCT00409240|4172702|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4345011|NCT00409240|4172700|B3||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4345012|NCT00409240|4172701|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4345013|NCT00409240|4172702|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4345014|NCT00409240|4172700|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4345015|NCT00409240|4172701|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4345016|NCT00409240|4172702|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4345017|NCT00409240|4172700|B3|||Age||years|Mean|68.5|68.5|Standard Deviation|11.5|11.5|||
4345018|NCT00409240|4172701|B2|||Age||years|Mean|67.2|67.2|Standard Deviation|9.4|9.4|||
4345019|NCT00409240|4172702|B1|||Age||years|Mean|69.8|69.8|Standard Deviation|10.7|10.7|||
4345020|NCT00409188|4172709|B3||Male|Sex: Female, Male||Participants|Count of Participants|1036|1036.0||||||
4345021|NCT00409188|4172710|B2||Male|Sex: Female, Male||Participants|Count of Participants|345|345.0||||||
4345022|NCT00409188|4172711|B1||Male|Sex: Female, Male||Participants|Count of Participants|691|691.0||||||
4345023|NCT00409188|4172709|B3||Female|Sex: Female, Male||Participants|Count of Participants|477|477.0||||||
4345024|NCT00409188|4172710|B2||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4345025|NCT00409188|4172711|B1||Female|Sex: Female, Male||Participants|Count of Participants|315|315.0||||||
4345026|NCT00409188|4172709|B3|||Age||years|Mean|60.8|60.8|Standard Deviation|9.1|9.1|||
4345027|NCT00409188|4172710|B2|||Age||years|Mean|60.9|60.9|Standard Deviation|9.0|9.0|||
4345028|NCT00409188|4172711|B1|||Age||years|Mean|60.7|60.7|Standard Deviation|9.1|9.1|||
4345029|NCT00409175|4172726|B3||Male|Sex: Female, Male|Out of a total of 128 participants, baseline characteristic (Gender) was available for only 125 participants who were included in ITT population.|Participants|Count of Participants|58|58.0||||||
4345030|NCT00409175|4172727|B2||Male|Sex: Female, Male|Out of a total of 128 participants, baseline characteristic (Gender) was available for only 125 participants who were included in ITT population.|Participants|Count of Participants|26|26.0||||||
4345031|NCT00409175|4172728|B1||Male|Sex: Female, Male|Out of a total of 128 participants, baseline characteristic (Gender) was available for only 125 participants who were included in ITT population.|Participants|Count of Participants|32|32.0||||||
4345032|NCT00409175|4172726|B3||Female|Sex: Female, Male|Out of a total of 128 participants, baseline characteristic (Gender) was available for only 125 participants who were included in ITT population.|Participants|Count of Participants|67|67.0||||||
4345033|NCT00409175|4172727|B2||Female|Sex: Female, Male|Out of a total of 128 participants, baseline characteristic (Gender) was available for only 125 participants who were included in ITT population.|Participants|Count of Participants|35|35.0||||||
4345034|NCT00409175|4172728|B1||Female|Sex: Female, Male|Out of a total of 128 participants, baseline characteristic (Gender) was available for only 125 participants who were included in ITT population.|Participants|Count of Participants|32|32.0||||||
4345035|NCT00409175|4172726|B3|Greater than 65 years||Age, Customized|Out of a total of 128 participants, baseline characteristic (Age) was available for only 125 participants who were included in intent-to-treat (ITT) population.|participants|Number|8|8.0||||||
4345036|NCT00409175|4172727|B2|Greater than 65 years||Age, Customized|Out of a total of 128 participants, baseline characteristic (Age) was available for only 125 participants who were included in intent-to-treat (ITT) population.|participants|Number|3|3.0||||||
4345037|NCT00409175|4172728|B1|Greater than 65 years||Age, Customized|Out of a total of 128 participants, baseline characteristic (Age) was available for only 125 participants who were included in intent-to-treat (ITT) population.|participants|Number|5|5.0||||||
4345038|NCT00409175|4172726|B3|Less than or equal to 65 years||Age, Customized|Out of a total of 128 participants, baseline characteristic (Age) was available for only 125 participants who were included in intent-to-treat (ITT) population.|participants|Number|117|117.0||||||
4345039|NCT00409175|4172727|B2|Less than or equal to 65 years||Age, Customized|Out of a total of 128 participants, baseline characteristic (Age) was available for only 125 participants who were included in intent-to-treat (ITT) population.|participants|Number|58|58.0||||||
4345040|NCT00409175|4172728|B1|Less than or equal to 65 years||Age, Customized|Out of a total of 128 participants, baseline characteristic (Age) was available for only 125 participants who were included in intent-to-treat (ITT) population.|participants|Number|59|59.0||||||
4345041|NCT00409006|4172753|B3|Stage IV||Disease Stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage 0 - the cancer has not spread beyond the inner lining of the lung. Stage I - the cancer is small and hasn't spread to the lymph nodes. Stage II - the cancer has spread to some lymph nodes near the original tumor. Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes. Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|Participants|Number|60|60.0||||||
4345042|NCT00409006|4172754|B2|Stage IV||Disease Stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage 0 - the cancer has not spread beyond the inner lining of the lung. Stage I - the cancer is small and hasn't spread to the lymph nodes. Stage II - the cancer has spread to some lymph nodes near the original tumor. Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes. Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|Participants|Number|27|27.0||||||
4345043|NCT00409006|4172755|B1|Stage IV||Disease Stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage 0 - the cancer has not spread beyond the inner lining of the lung. Stage I - the cancer is small and hasn't spread to the lymph nodes. Stage II - the cancer has spread to some lymph nodes near the original tumor. Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes. Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|Participants|Number|33|33.0||||||
4345044|NCT00409006|4172753|B3|Stage IIIB||Disease Stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage 0 - the cancer has not spread beyond the inner lining of the lung. Stage I - the cancer is small and hasn't spread to the lymph nodes. Stage II - the cancer has spread to some lymph nodes near the original tumor. Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes. Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|Participants|Number|10|10.0||||||
4345084|NCT00409006|4172754|B2|Taiwan||Region of Enrollment||participants|Number|11|11.0||||||
4345085|NCT00409006|4172755|B1|Taiwan||Region of Enrollment||participants|Number|10|10.0||||||
4345086|NCT00409006|4172753|B3|East Asian||Race/Ethnicity, Customized||Participants|Number|70|70.0||||||
4345045|NCT00409006|4172754|B2|Stage IIIB||Disease Stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage 0 - the cancer has not spread beyond the inner lining of the lung. Stage I - the cancer is small and hasn't spread to the lymph nodes. Stage II - the cancer has spread to some lymph nodes near the original tumor. Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes. Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|Participants|Number|4|4.0||||||
4345046|NCT00409006|4172755|B1|Stage IIIB||Disease Stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage 0 - the cancer has not spread beyond the inner lining of the lung. Stage I - the cancer is small and hasn't spread to the lymph nodes. Stage II - the cancer has spread to some lymph nodes near the original tumor. Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes. Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|Participants|Number|6|6.0||||||
4345047|NCT00409006|4172753|B3|Non-Small Cell Lung Carcinoma||Pathological Diagnosis||Participants|Number|3|3.0||||||
4345048|NCT00409006|4172754|B2|Non-Small Cell Lung Carcinoma||Pathological Diagnosis||Participants|Number|2|2.0||||||
4345049|NCT00409006|4172755|B1|Non-Small Cell Lung Carcinoma||Pathological Diagnosis||Participants|Number|1|1.0||||||
4345050|NCT00409006|4172753|B3|Carcinoma, Squamous Cell||Pathological Diagnosis||Participants|Number|11|11.0||||||
4345051|NCT00409006|4172754|B2|Carcinoma, Squamous Cell||Pathological Diagnosis||Participants|Number|4|4.0||||||
4345052|NCT00409006|4172755|B1|Carcinoma, Squamous Cell||Pathological Diagnosis||Participants|Number|7|7.0||||||
4345053|NCT00409006|4172753|B3|Adenocarcinoma||Pathological Diagnosis||Participants|Number|54|54.0||||||
4345054|NCT00409006|4172754|B2|Adenocarcinoma||Pathological Diagnosis||Participants|Number|24|24.0||||||
4345055|NCT00409006|4172755|B1|Adenocarcinoma||Pathological Diagnosis||Participants|Number|30|30.0||||||
4345056|NCT00409006|4172753|B3|Mixed Cell Carcinoma, Lung||Pathological Diagnosis||Participants|Number|2|2.0||||||
4345057|NCT00409006|4172754|B2|Mixed Cell Carcinoma, Lung||Pathological Diagnosis||Participants|Number|1|1.0||||||
4345058|NCT00409006|4172755|B1|Mixed Cell Carcinoma, Lung||Pathological Diagnosis||Participants|Number|1|1.0||||||
4345059|NCT00409006|4172753|B3|Cytological||Basis of Diagnosis||Participants|Number|18|18.0||||||
4345060|NCT00409006|4172754|B2|Cytological||Basis of Diagnosis||Participants|Number|9|9.0||||||
4345061|NCT00409006|4172755|B1|Cytological||Basis of Diagnosis||Participants|Number|9|9.0||||||
4345062|NCT00409006|4172753|B3|Histopathological||Basis of Diagnosis||Participants|Number|52|52.0||||||
4345063|NCT00409006|4172754|B2|Histopathological||Basis of Diagnosis||Participants|Number|22|22.0||||||
4345064|NCT00409006|4172755|B1|Histopathological||Basis of Diagnosis||Participants|Number|30|30.0||||||
4345065|NCT00409006|4172753|B3|No||History of Smoking||Participants|Number|68|68.0||||||
4345066|NCT00409006|4172754|B2|No||History of Smoking||Participants|Number|29|29.0||||||
4345067|NCT00409006|4172755|B1|No||History of Smoking||Participants|Number|39|39.0||||||
4345068|NCT00409006|4172753|B3|Yes||History of Smoking||Participants|Number|2|2.0||||||
4345069|NCT00409006|4172754|B2|Yes||History of Smoking||Participants|Number|2|2.0||||||
4345070|NCT00409006|4172755|B1|Yes||History of Smoking||Participants|Number|0|0.0||||||
4345071|NCT00409006|4172753|B3|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 0 - Fully Active. 1 - Ambulatory, Restricted Strenuous Activity. 2 - Ambulatory, No Work Activities. 3 - Partially Confined to Bed, Limited Self Care. 4 - Completely Disabled.|Units on a scale|Number|46|46.0||||||
4345072|NCT00409006|4172754|B2|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 0 - Fully Active. 1 - Ambulatory, Restricted Strenuous Activity. 2 - Ambulatory, No Work Activities. 3 - Partially Confined to Bed, Limited Self Care. 4 - Completely Disabled.|Units on a scale|Number|22|22.0||||||
4345073|NCT00409006|4172755|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 0 - Fully Active. 1 - Ambulatory, Restricted Strenuous Activity. 2 - Ambulatory, No Work Activities. 3 - Partially Confined to Bed, Limited Self Care. 4 - Completely Disabled.|Units on a scale|Number|24|24.0||||||
4345074|NCT00409006|4172753|B3|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 0 - Fully Active. 1 - Ambulatory, Restricted Strenuous Activity. 2 - Ambulatory, No Work Activities. 3 - Partially Confined to Bed, Limited Self Care. 4 - Completely Disabled.|Units on a scale|Number|24|24.0||||||
4345075|NCT00409006|4172754|B2|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 0 - Fully Active. 1 - Ambulatory, Restricted Strenuous Activity. 2 - Ambulatory, No Work Activities. 3 - Partially Confined to Bed, Limited Self Care. 4 - Completely Disabled.|Units on a scale|Number|9|9.0||||||
4345076|NCT00409006|4172755|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 0 - Fully Active. 1 - Ambulatory, Restricted Strenuous Activity. 2 - Ambulatory, No Work Activities. 3 - Partially Confined to Bed, Limited Self Care. 4 - Completely Disabled.|Units on a scale|Number|15|15.0||||||
4345077|NCT00409006|4172753|B3|Korea, Republic of||Region of Enrollment||participants|Number|19|19.0||||||
4345078|NCT00409006|4172754|B2|Korea, Republic of||Region of Enrollment||participants|Number|6|6.0||||||
4345079|NCT00409006|4172755|B1|Korea, Republic of||Region of Enrollment||participants|Number|13|13.0||||||
4345080|NCT00409006|4172753|B3|China||Region of Enrollment||participants|Number|30|30.0||||||
4345081|NCT00409006|4172754|B2|China||Region of Enrollment||participants|Number|14|14.0||||||
4345082|NCT00409006|4172755|B1|China||Region of Enrollment||participants|Number|16|16.0||||||
4345083|NCT00409006|4172753|B3|Taiwan||Region of Enrollment||participants|Number|21|21.0||||||
4345087|NCT00409006|4172754|B2|East Asian||Race/Ethnicity, Customized||Participants|Number|31|31.0||||||
4345088|NCT00409006|4172755|B1|East Asian||Race/Ethnicity, Customized||Participants|Number|39|39.0||||||
4345089|NCT00409006|4172753|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4345090|NCT00409006|4172754|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4345091|NCT00409006|4172755|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4345092|NCT00409006|4172753|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4345093|NCT00409006|4172754|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4345094|NCT00409006|4172755|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4345095|NCT00409006|4172753|B3|||Age||years|Mean|55.7|55.7|Standard Deviation|10.32|10.32|||
4345096|NCT00409006|4172754|B2|||Age||years|Mean|55.7|55.7|Standard Deviation|12.43|12.43|||
4345097|NCT00409006|4172755|B1|||Age||years|Mean|55.6|55.6|Standard Deviation|8.45|8.45|||
4345098|NCT00408993|4172770|B3|||Weight||kilograms|Mean|63.65|63.65|Standard Deviation|11.07|11.07|||
4345099|NCT00408993|4172771|B2|||Weight||kilograms|Mean|63.25|63.25|Standard Deviation|11.52|11.52|||
4345100|NCT00408993|4172772|B1|||Weight||kilograms|Mean|64.06|64.06|Standard Deviation|10.62|10.62|||
4345101|NCT00408993|4172770|B3|||Michigan Neuropathy Screening Instrument|Assesses degree of neuropathy. Responses to 13 out of 15 items are added to obtain total score. Responses of “yes” to items 1,2,3,5,6,8,9,11,12,14,15 are each counted as one point. A “no” response on items 7 and 13 counts as 1 point. Items 4 and 10 are not included in scoring. Total scores range from 0 (no neuropathy) to 13 (severe neuropathy).|units on a scale|Mean|4.52|4.52|Standard Deviation|1.19|1.19|||
4345102|NCT00408993|4172771|B2|||Michigan Neuropathy Screening Instrument|Assesses degree of neuropathy. Responses to 13 out of 15 items are added to obtain total score. Responses of “yes” to items 1,2,3,5,6,8,9,11,12,14,15 are each counted as one point. A “no” response on items 7 and 13 counts as 1 point. Items 4 and 10 are not included in scoring. Total scores range from 0 (no neuropathy) to 13 (severe neuropathy).|units on a scale|Mean|4.59|4.59|Standard Deviation|1.19|1.19|||
4345103|NCT00408993|4172772|B1|||Michigan Neuropathy Screening Instrument|Assesses degree of neuropathy. Responses to 13 out of 15 items are added to obtain total score. Responses of “yes” to items 1,2,3,5,6,8,9,11,12,14,15 are each counted as one point. A “no” response on items 7 and 13 counts as 1 point. Items 4 and 10 are not included in scoring. Total scores range from 0 (no neuropathy) to 13 (severe neuropathy).|units on a scale|Mean|4.45|4.45|Standard Deviation|1.19|1.19|||
4345104|NCT00408993|4172770|B3|||Height||centimeters|Mean|162.37|162.37|Standard Deviation|7.83|7.83|||
4345105|NCT00408993|4172771|B2|||Height||centimeters|Mean|162.12|162.12|Standard Deviation|7.96|7.96|||
4345106|NCT00408993|4172772|B1|||Height||centimeters|Mean|162.64|162.64|Standard Deviation|7.72|7.72|||
4345107|NCT00408993|4172770|B3|Duration of Diabetic Peripheral Neuropathic Pain||Diabetic Neuropathy History||years|Mean|3.22|3.22|Standard Deviation|3.24|3.24|||
4345108|NCT00408993|4172771|B2|Duration of Diabetic Peripheral Neuropathic Pain||Diabetic Neuropathy History||years|Mean|3.34|3.34|Standard Deviation|3.36|3.36|||
4345109|NCT00408993|4172772|B1|Duration of Diabetic Peripheral Neuropathic Pain||Diabetic Neuropathy History||years|Mean|3.09|3.09|Standard Deviation|3.11|3.11|||
4345110|NCT00408993|4172770|B3|Duration of Diabetic Neuropathy||Diabetic Neuropathy History||years|Mean|2.32|2.32|Standard Deviation|2.80|2.8|||
4345111|NCT00408993|4172771|B2|Duration of Diabetic Neuropathy||Diabetic Neuropathy History||years|Mean|2.50|2.5|Standard Deviation|2.98|2.98|||
4345112|NCT00408993|4172772|B1|Duration of Diabetic Neuropathy||Diabetic Neuropathy History||years|Mean|2.13|2.13|Standard Deviation|2.60|2.6|||
4345113|NCT00408993|4172770|B3|Duration of Diabetes||Diabetic Neuropathy History||years|Mean|9.65|9.65|Standard Deviation|6.63|6.63|||
4345114|NCT00408993|4172771|B2|Duration of Diabetes||Diabetic Neuropathy History||years|Mean|10.21|10.21|Standard Deviation|6.91|6.91|||
4345115|NCT00408993|4172772|B1|Duration of Diabetes||Diabetic Neuropathy History||years|Mean|9.07|9.07|Standard Deviation|6.32|6.32|||
4345116|NCT00408993|4172770|B3|||Clinical Global Impressions of Severity Score|Measures severity of illness at the time of assessment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill patients.|units on a scale|Mean|4.32|4.32|Standard Deviation|0.84|0.84|||
4345117|NCT00408993|4172771|B2|||Clinical Global Impressions of Severity Score|Measures severity of illness at the time of assessment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill patients.|units on a scale|Mean|4.38|4.38|Standard Deviation|0.91|0.91|||
4345118|NCT00408993|4172772|B1|||Clinical Global Impressions of Severity Score|Measures severity of illness at the time of assessment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill patients.|units on a scale|Mean|4.26|4.26|Standard Deviation|0.76|0.76|||
4345119|NCT00408993|4172770|B3|||Brief Pain Inventory 24-Hour Average Pain Score|A self-reported scale that measures the severity of pain based on the average pain over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|5.50|5.5|Standard Deviation|1.35|1.35|||
4345120|NCT00408993|4172771|B2|||Brief Pain Inventory 24-Hour Average Pain Score|A self-reported scale that measures the severity of pain based on the average pain over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|5.52|5.52|Standard Deviation|1.39|1.39|||
4345121|NCT00408993|4172772|B1|||Brief Pain Inventory 24-Hour Average Pain Score|A self-reported scale that measures the severity of pain based on the average pain over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|5.47|5.47|Standard Deviation|1.31|1.31|||
4345122|NCT00408993|4172770|B3|||Beck Depression Inventory-II Total Score|A 21-item, patient-completed questionnaire to assess characteristics of depression. Each of the 21 items corresponding to a symptom of depression is summed to give a single score. There is a four-point scale for each item ranging from 0 to 3. Total score of 0-13 is considered minimal range, 14-19 is mild, 20-28 is moderate, and 29-63 is severe.|units on a scale|Mean|15.61|15.61|Standard Deviation|11.07|11.07|||
4345123|NCT00408993|4172771|B2|||Beck Depression Inventory-II Total Score|A 21-item, patient-completed questionnaire to assess characteristics of depression. Each of the 21 items corresponding to a symptom of depression is summed to give a single score. There is a four-point scale for each item ranging from 0 to 3. Total score of 0-13 is considered minimal range, 14-19 is mild, 20-28 is moderate, and 29-63 is severe.|units on a scale|Mean|15.27|15.27|Standard Deviation|11.49|11.49|||
4345124|NCT00408993|4172772|B1|||Beck Depression Inventory-II Total Score|A 21-item, patient-completed questionnaire to assess characteristics of depression. Each of the 21 items corresponding to a symptom of depression is summed to give a single score. There is a four-point scale for each item ranging from 0 to 3. Total score of 0-13 is considered minimal range, 14-19 is mild, 20-28 is moderate, and 29-63 is severe.|units on a scale|Mean|15.97|15.97|Standard Deviation|10.66|10.66|||
4345125|NCT00408993|4172770|B3|Type II Diabetes Mellitus||Type of Diabetes Mellitus||participants|Number|210|210.0||||||
4345126|NCT00408993|4172771|B2|Type II Diabetes Mellitus||Type of Diabetes Mellitus||participants|Number|107|107.0||||||
4345127|NCT00408993|4172772|B1|Type II Diabetes Mellitus||Type of Diabetes Mellitus||participants|Number|103|103.0||||||
4345128|NCT00408993|4172770|B3|Type I Diabetes Mellitus||Type of Diabetes Mellitus||participants|Number|5|5.0||||||
4345129|NCT00408993|4172771|B2|Type I Diabetes Mellitus||Type of Diabetes Mellitus||participants|Number|2|2.0||||||
4345130|NCT00408993|4172772|B1|Type I Diabetes Mellitus||Type of Diabetes Mellitus||participants|Number|3|3.0||||||
4345131|NCT00408993|4172770|B3|East Asian||Race/Ethnicity||participants|Number|215|215.0||||||
4345132|NCT00408993|4172771|B2|East Asian||Race/Ethnicity||participants|Number|109|109.0||||||
4345133|NCT00408993|4172772|B1|East Asian||Race/Ethnicity||participants|Number|106|106.0||||||
4345134|NCT00408993|4172770|B3|Yes||Major Depressive Disorder||participants|Number|38|38.0||||||
4345135|NCT00408993|4172771|B2|Yes||Major Depressive Disorder||participants|Number|21|21.0||||||
4345136|NCT00408993|4172772|B1|Yes||Major Depressive Disorder||participants|Number|17|17.0||||||
4345137|NCT00408993|4172770|B3|No||Major Depressive Disorder||participants|Number|177|177.0||||||
4345138|NCT00408993|4172771|B2|No||Major Depressive Disorder||participants|Number|88|88.0||||||
4345139|NCT00408993|4172772|B1|No||Major Depressive Disorder||participants|Number|89|89.0||||||
4345140|NCT00408993|4172770|B3|China||Region of Enrollment||participants|Number|215|215.0||||||
4345141|NCT00408993|4172771|B2|China||Region of Enrollment||participants|Number|109|109.0||||||
4345142|NCT00408993|4172772|B1|China||Region of Enrollment||participants|Number|106|106.0||||||
4345143|NCT00408993|4172770|B3||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4345144|NCT00408993|4172771|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4345145|NCT00408993|4172772|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4345146|NCT00408993|4172770|B3||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4345147|NCT00408993|4172771|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4345148|NCT00408993|4172772|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4345149|NCT00408993|4172770|B3|||Age||years|Mean|59.25|59.25|Standard Deviation|9.94|9.94|||
4345150|NCT00408993|4172771|B2|||Age||years|Mean|59.90|59.9|Standard Deviation|9.52|9.52|||
4345151|NCT00408993|4172772|B1|||Age||years|Mean|58.59|58.59|Standard Deviation|10.37|10.37|||
4345152|NCT00408928|4172805|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4345153|NCT00408928|4172805|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4345154|NCT00408928|4172805|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4345155|NCT00408928|4172805|B1|||Age||years|Mean|45.68|45.68|Standard Deviation|15.43|15.43|||
4345156|NCT00408928|4172805|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4345157|NCT00408928|4172805|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4345158|NCT00408928|4172805|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4345159|NCT00408902|4172810|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4345160|NCT00408902|4172810|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4345161|NCT00408902|4172810|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4345162|NCT00408902|4172810|B1|||Age||years|Mean|63.6|63.6|Standard Deviation|8.3|8.3|||
4345163|NCT00408876|4172816|B5|||Weekly Mean of 24-Hour Worst Pain Severity|24-hour worst pain severity scores recorded daily on an 11-point Likert scale, evaluated as a weekly mean, with scores ranging from 0 (no pain) to 10 (worst possible pain).|units on a scale|Mean|7.29|7.29|Standard Deviation|1.27|1.27|||
4345164|NCT00408876|4172817|B4|||Weekly Mean of 24-Hour Worst Pain Severity|24-hour worst pain severity scores recorded daily on an 11-point Likert scale, evaluated as a weekly mean, with scores ranging from 0 (no pain) to 10 (worst possible pain).|units on a scale|Mean|7.35|7.35|Standard Deviation|1.20|1.2|||
4345165|NCT00408876|4172818|B3|||Weekly Mean of 24-Hour Worst Pain Severity|24-hour worst pain severity scores recorded daily on an 11-point Likert scale, evaluated as a weekly mean, with scores ranging from 0 (no pain) to 10 (worst possible pain).|units on a scale|Mean|7.22|7.22|Standard Deviation|1.27|1.27|||
4345166|NCT00408876|4172819|B2|||Weekly Mean of 24-Hour Worst Pain Severity|24-hour worst pain severity scores recorded daily on an 11-point Likert scale, evaluated as a weekly mean, with scores ranging from 0 (no pain) to 10 (worst possible pain).|units on a scale|Mean|7.22|7.22|Standard Deviation|1.32|1.32|||
4345167|NCT00408876|4172820|B1|||Weekly Mean of 24-Hour Worst Pain Severity|24-hour worst pain severity scores recorded daily on an 11-point Likert scale, evaluated as a weekly mean, with scores ranging from 0 (no pain) to 10 (worst possible pain).|units on a scale|Mean|7.41|7.41|Standard Deviation|1.31|1.31|||
4345168|NCT00408876|4172816|B5|||Weekly Mean of 24-Hour Average Pain Severity|24-hour average pain severity scores recorded daily on an 11-point Likert scale, evaluated as a weekly mean, with scores ranging from 0 (no pain) to 10 (worst possible pain).|units on a scale|Mean|6.18|6.18|Standard Deviation|1.38|1.38|||
4345169|NCT00408876|4172817|B4|||Weekly Mean of 24-Hour Average Pain Severity|24-hour average pain severity scores recorded daily on an 11-point Likert scale, evaluated as a weekly mean, with scores ranging from 0 (no pain) to 10 (worst possible pain).|units on a scale|Mean|6.18|6.18|Standard Deviation|1.25|1.25|||
4345170|NCT00408876|4172818|B3|||Weekly Mean of 24-Hour Average Pain Severity|24-hour average pain severity scores recorded daily on an 11-point Likert scale, evaluated as a weekly mean, with scores ranging from 0 (no pain) to 10 (worst possible pain).|units on a scale|Mean|6.06|6.06|Standard Deviation|1.45|1.45|||
4345171|NCT00408876|4172819|B2|||Weekly Mean of 24-Hour Average Pain Severity|24-hour average pain severity scores recorded daily on an 11-point Likert scale, evaluated as a weekly mean, with scores ranging from 0 (no pain) to 10 (worst possible pain).|units on a scale|Mean|6.18|6.18|Standard Deviation|1.44|1.44|||
4345172|NCT00408876|4172820|B1|||Weekly Mean of 24-Hour Average Pain Severity|24-hour average pain severity scores recorded daily on an 11-point Likert scale, evaluated as a weekly mean, with scores ranging from 0 (no pain) to 10 (worst possible pain).|units on a scale|Mean|6.42|6.42|Standard Deviation|1.39|1.39|||
4345173|NCT00408876|4172816|B5|||Roland-Morris Disability Questionnaire Total Score|Roland-Morris questionnaire was completed by the patient and measured the degree of disability due to back pain. The questionnaire consists of 24 statements and the patient was instructed to put a mark next to each appropriate statement. The number of statements marked was added up by the clinician and a total score was given. The total score ranges from 0 (no disability) to 24 (severe disability).|units on a scale|Mean|8.85|8.85|Standard Deviation|4.79|4.79|||
4345174|NCT00408876|4172817|B4|||Roland-Morris Disability Questionnaire Total Score|Roland-Morris questionnaire was completed by the patient and measured the degree of disability due to back pain. The questionnaire consists of 24 statements and the patient was instructed to put a mark next to each appropriate statement. The number of statements marked was added up by the clinician and a total score was given. The total score ranges from 0 (no disability) to 24 (severe disability).|units on a scale|Mean|8.32|8.32|Standard Deviation|4.92|4.92|||
4345175|NCT00408876|4172818|B3|||Roland-Morris Disability Questionnaire Total Score|Roland-Morris questionnaire was completed by the patient and measured the degree of disability due to back pain. The questionnaire consists of 24 statements and the patient was instructed to put a mark next to each appropriate statement. The number of statements marked was added up by the clinician and a total score was given. The total score ranges from 0 (no disability) to 24 (severe disability).|units on a scale|Mean|8.72|8.72|Standard Deviation|4.82|4.82|||
4345176|NCT00408876|4172819|B2|||Roland-Morris Disability Questionnaire Total Score|Roland-Morris questionnaire was completed by the patient and measured the degree of disability due to back pain. The questionnaire consists of 24 statements and the patient was instructed to put a mark next to each appropriate statement. The number of statements marked was added up by the clinician and a total score was given. The total score ranges from 0 (no disability) to 24 (severe disability).|units on a scale|Mean|8.91|8.91|Standard Deviation|4.56|4.56|||
4345177|NCT00408876|4172820|B1|||Roland-Morris Disability Questionnaire Total Score|Roland-Morris questionnaire was completed by the patient and measured the degree of disability due to back pain. The questionnaire consists of 24 statements and the patient was instructed to put a mark next to each appropriate statement. The number of statements marked was added up by the clinician and a total score was given. The total score ranges from 0 (no disability) to 24 (severe disability).|units on a scale|Mean|10.00|10.0|Standard Deviation|4.82|4.82|||
4345178|NCT00408876|4172816|B5|||Patient Global Impressions of Severity (PGI-S) Scale|Measures patient's perception of severity of illness at the time of assessment. Scores range from 1 (normal, not at all ill) to 7 (extremely ill ).|units on a scale|Mean|2.48|2.48|Standard Deviation|1.67|1.67|||
4345179|NCT00408876|4172817|B4|||Patient Global Impressions of Severity (PGI-S) Scale|Measures patient's perception of severity of illness at the time of assessment. Scores range from 1 (normal, not at all ill) to 7 (extremely ill ).|units on a scale|Mean|2.38|2.38|Standard Deviation|1.60|1.6|||
4345180|NCT00408876|4172818|B3|||Patient Global Impressions of Severity (PGI-S) Scale|Measures patient's perception of severity of illness at the time of assessment. Scores range from 1 (normal, not at all ill) to 7 (extremely ill ).|units on a scale|Mean|2.25|2.25|Standard Deviation|1.58|1.58|||
4345181|NCT00408876|4172819|B2|||Patient Global Impressions of Severity (PGI-S) Scale|Measures patient's perception of severity of illness at the time of assessment. Scores range from 1 (normal, not at all ill) to 7 (extremely ill ).|units on a scale|Mean|2.63|2.63|Standard Deviation|1.78|1.78|||
4345182|NCT00408876|4172820|B1|||Patient Global Impressions of Severity (PGI-S) Scale|Measures patient's perception of severity of illness at the time of assessment. Scores range from 1 (normal, not at all ill) to 7 (extremely ill ).|units on a scale|Mean|2.78|2.78|Standard Deviation|1.69|1.69|||
4345183|NCT00408876|4172816|B5|||Duration of Chronic Low Back Pain||years|Mean|11.68|11.68|Standard Deviation|11.38|11.38|||
4345184|NCT00408876|4172817|B4|||Duration of Chronic Low Back Pain||years|Mean|10.29|10.29|Standard Deviation|9.53|9.53|||
4345185|NCT00408876|4172818|B3|||Duration of Chronic Low Back Pain||years|Mean|13.94|13.94|Standard Deviation|12.97|12.97|||
4345186|NCT00408876|4172819|B2|||Duration of Chronic Low Back Pain||years|Mean|10.48|10.48|Standard Deviation|11.07|11.07|||
4345187|NCT00408876|4172820|B1|||Duration of Chronic Low Back Pain||years|Mean|12.50|12.5|Standard Deviation|11.65|11.65|||
4345188|NCT00408876|4172816|B5|||Clinical Global Impressions of Severity (CGI-S) Scale|Measures severity of illness at the time of assessment compared with start of treatment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|3.66|3.66|Standard Deviation|1.36|1.36|||
4345189|NCT00408876|4172817|B4|||Clinical Global Impressions of Severity (CGI-S) Scale|Measures severity of illness at the time of assessment compared with start of treatment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|3.66|3.66|Standard Deviation|1.30|1.3|||
4345190|NCT00408876|4172818|B3|||Clinical Global Impressions of Severity (CGI-S) Scale|Measures severity of illness at the time of assessment compared with start of treatment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|3.58|3.58|Standard Deviation|1.33|1.33|||
4345221|NCT00408876|4172819|B2|Hispanic||Race/Ethnicity||participants|Number|13|13.0||||||
4345191|NCT00408876|4172819|B2|||Clinical Global Impressions of Severity (CGI-S) Scale|Measures severity of illness at the time of assessment compared with start of treatment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|3.54|3.54|Standard Deviation|1.40|1.4|||
4345192|NCT00408876|4172820|B1|||Clinical Global Impressions of Severity (CGI-S) Scale|Measures severity of illness at the time of assessment compared with start of treatment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|4.05|4.05|Standard Deviation|1.41|1.41|||
4345193|NCT00408876|4172816|B5|||Brief Pain Inventory (BPI) 24-Hour Average Pain Score|A self-reported scale that measures the severity of pain based on the average pain over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|6.08|6.08|Standard Deviation|1.65|1.65|||
4345194|NCT00408876|4172817|B4|||Brief Pain Inventory (BPI) 24-Hour Average Pain Score|A self-reported scale that measures the severity of pain based on the average pain over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|6.14|6.14|Standard Deviation|1.66|1.66|||
4345195|NCT00408876|4172818|B3|||Brief Pain Inventory (BPI) 24-Hour Average Pain Score|A self-reported scale that measures the severity of pain based on the average pain over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|6.04|6.04|Standard Deviation|1.63|1.63|||
4345196|NCT00408876|4172819|B2|||Brief Pain Inventory (BPI) 24-Hour Average Pain Score|A self-reported scale that measures the severity of pain based on the average pain over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|5.93|5.93|Standard Deviation|1.67|1.67|||
4345197|NCT00408876|4172820|B1|||Brief Pain Inventory (BPI) 24-Hour Average Pain Score|A self-reported scale that measures the severity of pain based on the average pain over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|6.34|6.34|Standard Deviation|1.64|1.64|||
4345198|NCT00408876|4172816|B5|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters (kg/m^2)|Mean|29.13|29.13|Standard Deviation|4.75|4.75|||
4345199|NCT00408876|4172817|B4|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters (kg/m^2)|Mean|28.67|28.67|Standard Deviation|4.89|4.89|||
4345200|NCT00408876|4172818|B3|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters (kg/m^2)|Mean|29.23|29.23|Standard Deviation|4.68|4.68|||
4345201|NCT00408876|4172819|B2|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters (kg/m^2)|Mean|28.85|28.85|Standard Deviation|4.73|4.73|||
4345202|NCT00408876|4172820|B1|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters (kg/m^2)|Mean|30.42|30.42|Standard Deviation|4.54|4.54|||
4345203|NCT00408876|4172816|B5|||Beck Depression Inventory-II Total Score|A 21-item, patient-completed questionnaire to assess characteristics of depression. Each of the 21 items corresponding to a symptom of depression is summed to give a single score. There is a four-point scale for each item ranging from 0 to 3. Total score of 0-13 is considered minimal range, 14-19 is mild, 20-28 is moderate, and 29-63 is severe.|units on a scale|Mean|6.12|6.12|Standard Deviation|6.64|6.64|||
4345204|NCT00408876|4172817|B4|||Beck Depression Inventory-II Total Score|A 21-item, patient-completed questionnaire to assess characteristics of depression. Each of the 21 items corresponding to a symptom of depression is summed to give a single score. There is a four-point scale for each item ranging from 0 to 3. Total score of 0-13 is considered minimal range, 14-19 is mild, 20-28 is moderate, and 29-63 is severe.|units on a scale|Mean|6.15|6.15|Standard Deviation|7.52|7.52|||
4345205|NCT00408876|4172818|B3|||Beck Depression Inventory-II Total Score|A 21-item, patient-completed questionnaire to assess characteristics of depression. Each of the 21 items corresponding to a symptom of depression is summed to give a single score. There is a four-point scale for each item ranging from 0 to 3. Total score of 0-13 is considered minimal range, 14-19 is mild, 20-28 is moderate, and 29-63 is severe.|units on a scale|Mean|5.20|5.2|Standard Deviation|5.00|5.0|||
4345206|NCT00408876|4172819|B2|||Beck Depression Inventory-II Total Score|A 21-item, patient-completed questionnaire to assess characteristics of depression. Each of the 21 items corresponding to a symptom of depression is summed to give a single score. There is a four-point scale for each item ranging from 0 to 3. Total score of 0-13 is considered minimal range, 14-19 is mild, 20-28 is moderate, and 29-63 is severe.|units on a scale|Mean|7.05|7.05|Standard Deviation|7.17|7.17|||
4345207|NCT00408876|4172820|B1|||Beck Depression Inventory-II Total Score|A 21-item, patient-completed questionnaire to assess characteristics of depression. Each of the 21 items corresponding to a symptom of depression is summed to give a single score. There is a four-point scale for each item ranging from 0 to 3. Total score of 0-13 is considered minimal range, 14-19 is mild, 20-28 is moderate, and 29-63 is severe.|units on a scale|Mean|6.02|6.02|Standard Deviation|6.33|6.33|||
4345208|NCT00408876|4172816|B5|Native American||Race/Ethnicity||participants|Number|1|1.0||||||
4345209|NCT00408876|4172817|B4|Native American||Race/Ethnicity||participants|Number|1|1.0||||||
4345210|NCT00408876|4172818|B3|Native American||Race/Ethnicity||participants|Number|0|0.0||||||
4345211|NCT00408876|4172819|B2|Native American||Race/Ethnicity||participants|Number|0|0.0||||||
4345212|NCT00408876|4172820|B1|Native American||Race/Ethnicity||participants|Number|0|0.0||||||
4345213|NCT00408876|4172816|B5|West Asian||Race/Ethnicity||participants|Number|4|4.0||||||
4345214|NCT00408876|4172817|B4|West Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4345215|NCT00408876|4172818|B3|West Asian||Race/Ethnicity||participants|Number|3|3.0||||||
4345216|NCT00408876|4172819|B2|West Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4345217|NCT00408876|4172820|B1|West Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4345218|NCT00408876|4172816|B5|Hispanic||Race/Ethnicity||participants|Number|41|41.0||||||
4345219|NCT00408876|4172817|B4|Hispanic||Race/Ethnicity||participants|Number|11|11.0||||||
4345220|NCT00408876|4172818|B3|Hispanic||Race/Ethnicity||participants|Number|11|11.0||||||
4345222|NCT00408876|4172820|B1|Hispanic||Race/Ethnicity||participants|Number|6|6.0||||||
4345223|NCT00408876|4172816|B5|East Asian||Race/Ethnicity||participants|Number|3|3.0||||||
4345224|NCT00408876|4172817|B4|East Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4345225|NCT00408876|4172818|B3|East Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4345226|NCT00408876|4172819|B2|East Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4345227|NCT00408876|4172820|B1|East Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4345228|NCT00408876|4172816|B5|Caucasian||Race/Ethnicity||participants|Number|322|322.0||||||
4345229|NCT00408876|4172817|B4|Caucasian||Race/Ethnicity||participants|Number|93|93.0||||||
4345230|NCT00408876|4172818|B3|Caucasian||Race/Ethnicity||participants|Number|92|92.0||||||
4345231|NCT00408876|4172819|B2|Caucasian||Race/Ethnicity||participants|Number|91|91.0||||||
4345232|NCT00408876|4172820|B1|Caucasian||Race/Ethnicity||participants|Number|46|46.0||||||
4345233|NCT00408876|4172816|B5|African||Race/Ethnicity||participants|Number|33|33.0||||||
4345234|NCT00408876|4172817|B4|African||Race/Ethnicity||participants|Number|10|10.0||||||
4345235|NCT00408876|4172818|B3|African||Race/Ethnicity||participants|Number|5|5.0||||||
4345236|NCT00408876|4172819|B2|African||Race/Ethnicity||participants|Number|11|11.0||||||
4345237|NCT00408876|4172820|B1|African||Race/Ethnicity||participants|Number|7|7.0||||||
4345238|NCT00408876|4172816|B5|Argentina||Region of Enrollment||participants|Number|88|88.0||||||
4345239|NCT00408876|4172817|B4|Argentina||Region of Enrollment||participants|Number|24|24.0||||||
4345240|NCT00408876|4172818|B3|Argentina||Region of Enrollment||participants|Number|27|27.0||||||
4345241|NCT00408876|4172819|B2|Argentina||Region of Enrollment||participants|Number|24|24.0||||||
4345242|NCT00408876|4172820|B1|Argentina||Region of Enrollment||participants|Number|13|13.0||||||
4345243|NCT00408876|4172816|B5|United States||Region of Enrollment||participants|Number|316|316.0||||||
4345244|NCT00408876|4172817|B4|United States||Region of Enrollment||participants|Number|93|93.0||||||
4345245|NCT00408876|4172818|B3|United States||Region of Enrollment||participants|Number|85|85.0||||||
4345246|NCT00408876|4172819|B2|United States||Region of Enrollment||participants|Number|92|92.0||||||
4345247|NCT00408876|4172820|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4345248|NCT00408876|4172816|B5||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4345249|NCT00408876|4172817|B4||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4345250|NCT00408876|4172818|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4345251|NCT00408876|4172819|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4345252|NCT00408876|4172820|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4345253|NCT00408876|4172816|B5||Female|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
4345254|NCT00408876|4172817|B4||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4345255|NCT00408876|4172818|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4345256|NCT00408876|4172819|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4345257|NCT00408876|4172820|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4345258|NCT00408876|4172816|B5|||Age||years|Mean|53.89|53.89|Standard Deviation|14.09|14.09|||
4345259|NCT00408876|4172817|B4|||Age||years|Mean|53.97|53.97|Standard Deviation|13.52|13.52|||
4345260|NCT00408876|4172818|B3|||Age||years|Mean|54.92|54.92|Standard Deviation|14.77|14.77|||
4345261|NCT00408876|4172819|B2|||Age||years|Mean|53.32|53.32|Standard Deviation|14.69|14.69|||
4345262|NCT00408876|4172820|B1|||Age||years|Mean|52.93|52.93|Standard Deviation|12.81|12.81|||
4345263|NCT00408694|4173073|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4345264|NCT00408694|4173073|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4345265|NCT00408694|4173073|B1|||Age||years|Median|48|48.0|Full Range|||18.0|63.0|
4345266|NCT00408681|4173085|B1|Alemtuzumab||Agents given to treat GVHD within 3 days before or after enrollment||Participants|Count of Participants|1|1.0||||||
4345267|NCT00408681|4173085|B1|Infliximab||Agents given to treat GVHD within 3 days before or after enrollment||Participants|Count of Participants|2|2.0||||||
4345268|NCT00408681|4173085|B1|Mycophenolate mofetil||Agents given to treat GVHD within 3 days before or after enrollment||Participants|Count of Participants|1|1.0||||||
4345269|NCT00408681|4173085|B1|Rabbit anti-thymocyte globulin||Agents given to treat GVHD within 3 days before or after enrollment||Participants|Count of Participants|4|4.0||||||
4345270|NCT00408681|4173085|B1|Pentostatin||Agents given to treat GVHD within 3 days before or after enrollment||Participants|Count of Participants|2|2.0||||||
4345271|NCT00408681|4173085|B1|Methotrexate||Agents given to treat GVHD within 3 days before or after enrollment||Participants|Count of Participants|1|1.0||||||
4345272|NCT00408681|4173085|B1|||Interval from transplantation to start of study product administration||days|Median|90|90.0|Full Range|||22.0|215.0|
4345273|NCT00408681|4173085|B1|Cyclosporine||Agents given to treat GVHD more than 3 days before enrollment in the study||Participants|Count of Participants|1|1.0||||||
4345274|NCT00408681|4173085|B1|Sirolimus||Agents given to treat GVHD more than 3 days before enrollment in the study||Participants|Count of Participants|1|1.0||||||
4345275|NCT00408681|4173085|B1|Tacrolimus||Agents given to treat GVHD more than 3 days before enrollment in the study||Participants|Count of Participants|3|3.0||||||
4345276|NCT00408681|4173085|B1|Mycophenolate mofetil||Agents given to treat GVHD more than 3 days before enrollment in the study||Participants|Count of Participants|5|5.0||||||
4345277|NCT00408681|4173085|B1|Mesenchymal stem cells||Agents given to treat GVHD more than 3 days before enrollment in the study||Participants|Count of Participants|1|1.0||||||
4345278|NCT00408681|4173085|B1|Extracorporeal photopheresis||Agents given to treat GVHD more than 3 days before enrollment in the study||Participants|Count of Participants|2|2.0||||||
4345333|NCT00408629|4173103|B2|Australia||Region of Enrollment||Participants|Number|9|9.0||||||
4345279|NCT00408681|4173085|B1|Horse anti-thymocyte globulin||Agents given to treat GVHD more than 3 days before enrollment in the study||Participants|Count of Participants|1|1.0||||||
4345280|NCT00408681|4173085|B1|Rabbit anti-thymocyte globulin||Agents given to treat GVHD more than 3 days before enrollment in the study||Participants|Count of Participants|3|3.0||||||
4345281|NCT00408681|4173085|B1|Infliximab||Agents given to treat GVHD more than 3 days before enrollment in the study||Participants|Count of Participants|3|3.0||||||
4345282|NCT00408681|4173085|B1|Mycophenolate mofetil||Agents given to prevent GVHD at the time of enrollment||Participants|Count of Participants|8|8.0||||||
4345283|NCT00408681|4173085|B1|Cyclosporine||Agents given to prevent GVHD at the time of enrollment||Participants|Count of Participants|7|7.0||||||
4345284|NCT00408681|4173085|B1|Tacrolimus||Agents given to prevent GVHD at the time of enrollment||Participants|Count of Participants|8|8.0||||||
4345285|NCT00408681|4173085|B1|Duodenum and colon||Mucosal denudation||Participants|Count of Participants|3|3.0||||||
4345286|NCT00408681|4173085|B1|Colon alone||Mucosal denudation||Participants|Count of Participants|7|7.0||||||
4345287|NCT00408681|4173085|B1|Duodenum alone||Mucosal denudation||Participants|Count of Participants|7|7.0||||||
4345288|NCT00408681|4173085|B1|Tacrolimus and mycophenolate mofeftil||Graft-versus-host disease (GVHD) prophylaxis regimen||Participants|Count of Participants|1|1.0||||||
4345289|NCT00408681|4173085|B1|Cyclophosphamide, tacrolimus, MMF||Graft-versus-host disease (GVHD) prophylaxis regimen||Participants|Count of Participants|1|1.0||||||
4345290|NCT00408681|4173085|B1|Tacrolimus and methotrexate||Graft-versus-host disease (GVHD) prophylaxis regimen||Participants|Count of Participants|10|10.0||||||
4345291|NCT00408681|4173085|B1|Cyclosporine and mycophenolate mofetil (MMF)||Graft-versus-host disease (GVHD) prophylaxis regimen||Participants|Count of Participants|8|8.0||||||
4345292|NCT00408681|4173085|B1|Nonmyeloablative||Type of pretransplant conditioning regimen||Participants|Count of Participants|8|8.0||||||
4345293|NCT00408681|4173085|B1|Myeloablative||Type of pretransplant conditioning regimen||Participants|Count of Participants|12|12.0||||||
4345294|NCT00408681|4173085|B1|Chronic lymphocytic leukemia||Indication for transplantation||Participants|Count of Participants|1|1.0||||||
4345295|NCT00408681|4173085|B1|Paroxysmal nocturnal hemoglobinuria||Indication for transplantation||Participants|Count of Participants|1|1.0||||||
4345296|NCT00408681|4173085|B1|Aplastic anemia||Indication for transplantation||Participants|Count of Participants|1|1.0||||||
4345297|NCT00408681|4173085|B1|Myelodysplastic syndrome||Indication for transplantation||Participants|Count of Participants|1|1.0||||||
4345298|NCT00408681|4173085|B1|Acute lymphoid leukemia||Indication for transplantation||Participants|Count of Participants|3|3.0||||||
4345299|NCT00408681|4173085|B1|Chronic myeloid leukemia||Indication for transplantation||Participants|Count of Participants|2|2.0||||||
4345300|NCT00408681|4173085|B1|Multiple myeloma||Indication for transplantation||Participants|Count of Participants|2|2.0||||||
4345301|NCT00408681|4173085|B1|Acute myeloid leukemia||Indication for transplantation||Participants|Count of Participants|6|6.0||||||
4345302|NCT00408681|4173085|B1|Non-Hodgkin lymphoma||Indication for transplantation||Participants|Count of Participants|3|3.0||||||
4345303|NCT00408681|4173085|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4345304|NCT00408681|4173085|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4345305|NCT00408681|4173085|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4345306|NCT00408681|4173085|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4345307|NCT00408681|4173085|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4345308|NCT00408681|4173085|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4345309|NCT00408681|4173085|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4345310|NCT00408681|4173085|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4345311|NCT00408681|4173085|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4345312|NCT00408681|4173085|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4345313|NCT00408681|4173085|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4345314|NCT00408681|4173085|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4345315|NCT00408681|4173085|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4345316|NCT00408681|4173085|B1|||Age||years|Mean|49.5|49.5|Full Range|||22.0|63.0|
4345317|NCT00408629|4173102|B3|Switzerland||Region of Enrollment||Participants|Number|20|20.0||||||
4345318|NCT00408629|4173103|B2|Switzerland||Region of Enrollment||Participants|Number|9|9.0||||||
4345319|NCT00408629|4173104|B1|Switzerland||Region of Enrollment||Participants|Number|11|11.0||||||
4345320|NCT00408629|4173102|B3|New Zealand||Region of Enrollment||Participants|Number|8|8.0||||||
4345321|NCT00408629|4173103|B2|New Zealand||Region of Enrollment||Participants|Number|4|4.0||||||
4345322|NCT00408629|4173104|B1|New Zealand||Region of Enrollment||Participants|Number|4|4.0||||||
4345323|NCT00408629|4173102|B3|Germany||Region of Enrollment||Participants|Number|41|41.0||||||
4345324|NCT00408629|4173103|B2|Germany||Region of Enrollment||Participants|Number|22|22.0||||||
4345325|NCT00408629|4173104|B1|Germany||Region of Enrollment||Participants|Number|19|19.0||||||
4345326|NCT00408629|4173102|B3|Norway||Region of Enrollment||Participants|Number|6|6.0||||||
4345327|NCT00408629|4173103|B2|Norway||Region of Enrollment||Participants|Number|1|1.0||||||
4345328|NCT00408629|4173104|B1|Norway||Region of Enrollment||Participants|Number|5|5.0||||||
4345329|NCT00408629|4173102|B3|Denmark||Region of Enrollment||Participants|Number|5|5.0||||||
4345330|NCT00408629|4173103|B2|Denmark||Region of Enrollment||Participants|Number|3|3.0||||||
4345331|NCT00408629|4173104|B1|Denmark||Region of Enrollment||Participants|Number|2|2.0||||||
4345332|NCT00408629|4173102|B3|Australia||Region of Enrollment||Participants|Number|20|20.0||||||
4345334|NCT00408629|4173104|B1|Australia||Region of Enrollment||Participants|Number|11|11.0||||||
4345335|NCT00408629|4173102|B3|Belgium||Region of Enrollment||Participants|Number|44|44.0||||||
4345336|NCT00408629|4173103|B2|Belgium||Region of Enrollment||Participants|Number|18|18.0||||||
4345337|NCT00408629|4173104|B1|Belgium||Region of Enrollment||Participants|Number|26|26.0||||||
4345338|NCT00408629|4173102|B3|Poland||Region of Enrollment||Participants|Number|29|29.0||||||
4345339|NCT00408629|4173103|B2|Poland||Region of Enrollment||Participants|Number|15|15.0||||||
4345340|NCT00408629|4173104|B1|Poland||Region of Enrollment||Participants|Number|14|14.0||||||
4345341|NCT00408629|4173102|B3|Canada||Region of Enrollment||Participants|Number|37|37.0||||||
4345342|NCT00408629|4173103|B2|Canada||Region of Enrollment||Participants|Number|19|19.0||||||
4345343|NCT00408629|4173104|B1|Canada||Region of Enrollment||Participants|Number|18|18.0||||||
4345344|NCT00408629|4173102|B3|Hungary||Region of Enrollment||Participants|Number|26|26.0||||||
4345345|NCT00408629|4173103|B2|Hungary||Region of Enrollment||Participants|Number|13|13.0||||||
4345346|NCT00408629|4173104|B1|Hungary||Region of Enrollment||Participants|Number|13|13.0||||||
4345347|NCT00408629|4173102|B3|Czech Republic||Region of Enrollment||Participants|Number|43|43.0||||||
4345348|NCT00408629|4173103|B2|Czech Republic||Region of Enrollment||Participants|Number|25|25.0||||||
4345349|NCT00408629|4173104|B1|Czech Republic||Region of Enrollment||Participants|Number|18|18.0||||||
4345350|NCT00408629|4173102|B3|France||Region of Enrollment||Participants|Number|32|32.0||||||
4345351|NCT00408629|4173103|B2|France||Region of Enrollment||Participants|Number|14|14.0||||||
4345352|NCT00408629|4173104|B1|France||Region of Enrollment||Participants|Number|18|18.0||||||
4345353|NCT00408629|4173102|B3|Israel||Region of Enrollment||Participants|Number|5|5.0||||||
4345354|NCT00408629|4173103|B2|Israel||Region of Enrollment||Participants|Number|0|0.0||||||
4345355|NCT00408629|4173104|B1|Israel||Region of Enrollment||Participants|Number|5|5.0||||||
4345356|NCT00408629|4173102|B3|Austria||Region of Enrollment||Participants|Number|4|4.0||||||
4345357|NCT00408629|4173103|B2|Austria||Region of Enrollment||Participants|Number|4|4.0||||||
4345358|NCT00408629|4173104|B1|Austria||Region of Enrollment||Participants|Number|0|0.0||||||
4345359|NCT00408629|4173102|B3|Spain||Region of Enrollment||Participants|Number|11|11.0||||||
4345360|NCT00408629|4173103|B2|Spain||Region of Enrollment||Participants|Number|7|7.0||||||
4345361|NCT00408629|4173104|B1|Spain||Region of Enrollment||Participants|Number|4|4.0||||||
4345362|NCT00408629|4173102|B3|United States||Region of Enrollment||Participants|Number|160|160.0||||||
4345363|NCT00408629|4173103|B2|United States||Region of Enrollment||Participants|Number|82|82.0||||||
4345364|NCT00408629|4173104|B1|United States||Region of Enrollment||Participants|Number|78|78.0||||||
4345365|NCT00408629|4173102|B3|Portugal||Region of Enrollment||Participants|Number|3|3.0||||||
4345366|NCT00408629|4173103|B2|Portugal||Region of Enrollment||Participants|Number|1|1.0||||||
4345367|NCT00408629|4173104|B1|Portugal||Region of Enrollment||Participants|Number|2|2.0||||||
4345368|NCT00408629|4173102|B3||Male|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
4345369|NCT00408629|4173103|B2||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4345370|NCT00408629|4173104|B1||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4345371|NCT00408629|4173102|B3||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4345372|NCT00408629|4173103|B2||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4345373|NCT00408629|4173104|B1||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4345374|NCT00408629|4173102|B3|>=65 years||Age, Customized||Participants|Number|19|19.0||||||
4345375|NCT00408629|4173103|B2|>=65 years||Age, Customized||Participants|Number|12|12.0||||||
4345376|NCT00408629|4173104|B1|>=65 years||Age, Customized||Participants|Number|7|7.0||||||
4345377|NCT00408629|4173102|B3|40 to 64 years||Age, Customized||Participants|Number|221|221.0||||||
4345378|NCT00408629|4173103|B2|40 to 64 years||Age, Customized||Participants|Number|116|116.0||||||
4345379|NCT00408629|4173104|B1|40 to 64 years||Age, Customized||Participants|Number|105|105.0||||||
4345380|NCT00408629|4173102|B3|< 40 years||Age, Customized||Participants|Number|254|254.0||||||
4345381|NCT00408629|4173103|B2|< 40 years||Age, Customized||Participants|Number|118|118.0||||||
4345382|NCT00408629|4173104|B1|< 40 years||Age, Customized||Participants|Number|136|136.0||||||
4345383|NCT00408629|4173102|B3|||Age|The ITT analysis set, defined as all participants who were randomized in the study excluding participants from 3 non-compliant sites, was used to determine all Baseline measures (continuous age, customized age, gender, and region of enrollment).|Years|Mean|40.4|40.4|Standard Deviation|12.86|12.86|||
4345384|NCT00408629|4173103|B2|||Age|The ITT analysis set, defined as all participants who were randomized in the study excluding participants from 3 non-compliant sites, was used to determine all Baseline measures (continuous age, customized age, gender, and region of enrollment).|Years|Mean|41.3|41.3|Standard Deviation|13.22|13.22|||
4345385|NCT00408629|4173104|B1|||Age|The ITT analysis set, defined as all participants who were randomized in the study excluding participants from 3 non-compliant sites, was used to determine all Baseline measures (continuous age, customized age, gender, and region of enrollment).|Years|Mean|39.6|39.6|Standard Deviation|12.47|12.47|||
4345386|NCT00408603|4173144|B4|||BSA (m2)||m2|Mean|1.8|1.8|Standard Deviation|0.21|0.21|||
4345387|NCT00408603|4173145|B3|||BSA (m2)||m2|Mean|1.8|1.8|Standard Deviation|0.2|0.2|||
4345388|NCT00408603|4173146|B2|||BSA (m2)||m2|Mean|1.7|1.7|Standard Deviation|0.24|0.24|||
4345389|NCT00408603|4173147|B1|||BSA (m2)||m2|Mean|1.8|1.8|Standard Deviation|0.2|0.2|||
4345390|NCT00408603|4173144|B4|||Weight (kg)||kg|Mean|72.7|72.7|Standard Deviation|17.76|17.76|||
4345391|NCT00408603|4173145|B3|||Weight (kg)||kg|Mean|69.9|69.9|Standard Deviation|15.39|15.39|||
4345392|NCT00408603|4173146|B2|||Weight (kg)||kg|Mean|71.2|71.2|Standard Deviation|20.52|20.52|||
4345393|NCT00408603|4173147|B1|||Weight (kg)||kg|Mean|75.1|75.1|Standard Deviation|17.21|17.21|||
4345394|NCT00408603|4173144|B4|||Height (cm)||cm|Mean|162.7|162.7|Standard Deviation|6.88|6.88|||
4345395|NCT00408603|4173145|B3|||Height (cm)||cm|Mean|163.9|163.9|Standard Deviation|7.01|7.01|||
4345396|NCT00408603|4173146|B2|||Height (cm)||cm|Mean|161.9|161.9|Standard Deviation|7.01|7.01|||
4345397|NCT00408603|4173147|B1|||Height (cm)||cm|Mean|162.4|162.4|Standard Deviation|6.75|6.75|||
4345398|NCT00408603|4173144|B4|Other, Philippines||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4345399|NCT00408603|4173145|B3|Other, Philippines||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4345400|NCT00408603|4173146|B2|Other, Philippines||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4345401|NCT00408603|4173147|B1|Other, Philippines||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4345402|NCT00408603|4173144|B4|White or Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|122|122.0||||||
4345403|NCT00408603|4173145|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
4345404|NCT00408603|4173146|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
4345405|NCT00408603|4173147|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|56|56.0||||||
4345406|NCT00408603|4173144|B4|Black or African||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4345407|NCT00408603|4173145|B3|Black or African||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4345408|NCT00408603|4173146|B2|Black or African||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4345409|NCT00408603|4173147|B1|Black or African||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4345410|NCT00408603|4173144|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4345411|NCT00408603|4173145|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4345412|NCT00408603|4173146|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4345413|NCT00408603|4173147|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4345414|NCT00408603|4173144|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4345415|NCT00408603|4173145|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4345416|NCT00408603|4173146|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4345417|NCT00408603|4173147|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4345418|NCT00408603|4173144|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|137|137.0||||||
4345419|NCT00408603|4173145|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4345420|NCT00408603|4173146|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4345421|NCT00408603|4173147|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4345422|NCT00408603|4173144|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4345423|NCT00408603|4173145|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4345424|NCT00408603|4173146|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4345425|NCT00408603|4173147|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4345426|NCT00408603|4173144|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4345427|NCT00408603|4173145|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4345428|NCT00408603|4173146|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4345429|NCT00408603|4173147|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4345430|NCT00408603|4173144|B4||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4345431|NCT00408603|4173145|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4345432|NCT00408603|4173146|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4345433|NCT00408603|4173147|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4345434|NCT00408603|4173144|B4|||Age||years|Mean|60.1|60.1|Standard Deviation|10.74|10.74|||
4345435|NCT00408603|4173145|B3|||Age||years|Mean|57.6|57.6|Standard Deviation|12.13|12.13|||
4345436|NCT00408603|4173146|B2|||Age||years|Mean|62.7|62.7|Standard Deviation|10.51|10.51|||
4345437|NCT00408603|4173147|B1|||Age||years|Mean|60|60.0|Standard Deviation|9.87|9.87|||
4345438|NCT00408590|4173163|B3|||Ascites Present||participants with ascites|Number|20|20.0||||||
4345439|NCT00408590|4173164|B2|||Ascites Present||participants with ascites|Number|13|13.0||||||
4345440|NCT00408590|4173165|B1|||Ascites Present||participants with ascites|Number|7|7.0||||||
4345441|NCT00408590|4173163|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
4345442|NCT00408590|4173164|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4345443|NCT00408590|4173165|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4345444|NCT00408590|4173163|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4345445|NCT00408590|4173164|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4345446|NCT00408590|4173165|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4345447|NCT00408590|4173163|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4345448|NCT00408590|4173164|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4345449|NCT00408590|4173165|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4345450|NCT00408590|4173163|B3|||Age||years|Median|57|57.0|Full Range|||35.0|82.0|
4345451|NCT00408590|4173164|B2|||Age||years|Median|57.5|57.5|Full Range|||35.0|82.0|
4345452|NCT00408590|4173165|B1|||Age||years|Median|57|57.0|Full Range|||43.0|82.0|
4345453|NCT00408564|4173192|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4345454|NCT00408564|4173192|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4345455|NCT00408564|4173192|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4345456|NCT00408564|4173192|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4345457|NCT00408564|4173192|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4345458|NCT00408564|4173192|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4345459|NCT00408564|4173192|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4345460|NCT00408564|4173192|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4345461|NCT00408564|4173192|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4345462|NCT00408564|4173192|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4345463|NCT00408564|4173192|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4345464|NCT00408564|4173192|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4345465|NCT00408499|4173201|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4345466|NCT00408499|4173201|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4345467|NCT00408499|4173201|B1||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4345468|NCT00408499|4173201|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4345469|NCT00408499|4173201|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4345470|NCT00408499|4173201|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4345471|NCT00408499|4173201|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4345472|NCT00408499|4173201|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4345473|NCT00408499|4173201|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4345474|NCT00408499|4173201|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4345475|NCT00408499|4173201|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4345476|NCT00408499|4173201|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4345477|NCT00408499|4173201|B1|||Age||Years|Mean|62.91|62.91|Full Range|||38.0|82.0|
4345478|NCT00408499|4173201|B1||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4345479|NCT00408499|4173201|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4345480|NCT00408499|4173201|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4345481|NCT00408460|4173214|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4345482|NCT00408460|4173214|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4345483|NCT00408460|4173214|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4345484|NCT00408460|4173214|B1|||Age||years|Median|75|75.0|Full Range|||70.0|87.0|
4345485|NCT00408460|4173214|B1||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
4345486|NCT00408460|4173214|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4345487|NCT00408460|4173214|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4345488|NCT00408421|4173220|B3|||Weight||kilograms|Mean|85.61|85.61|Standard Deviation|15.60|15.6|||
4345489|NCT00408421|4173221|B2|||Weight||kilograms|Mean|85.57|85.57|Standard Deviation|16.17|16.17|||
4345490|NCT00408421|4173222|B1|||Weight||kilograms|Mean|85.66|85.66|Standard Deviation|15.12|15.12|||
4345491|NCT00408421|4173220|B3|||Weekly Mean of 24-Hour Average Pain Severity|This is an ordinal scale assessing the 24-hour average pain with scores from 0 (no pain) to 10 (worst possible pain).|units on a scale|Mean|6.14|6.14|Standard Deviation|1.33|1.33|||
4345492|NCT00408421|4173221|B2|||Weekly Mean of 24-Hour Average Pain Severity|This is an ordinal scale assessing the 24-hour average pain with scores from 0 (no pain) to 10 (worst possible pain).|units on a scale|Mean|6.10|6.1|Standard Deviation|1.34|1.34|||
4345493|NCT00408421|4173222|B1|||Weekly Mean of 24-Hour Average Pain Severity|This is an ordinal scale assessing the 24-hour average pain with scores from 0 (no pain) to 10 (worst possible pain).|units on a scale|Mean|6.18|6.18|Standard Deviation|1.32|1.32|||
4345494|NCT00408421|4173220|B3|||Patient Global Impressions of Severity (PGI-Severity)|Measures patient's perception of severity of illness at the time of assessment. Scores range from 1 (normal, not at all ill) to 7 (extremely ill).|units on a scale|Mean|2.31|2.31|Standard Deviation|1.58|1.58|||
4345495|NCT00408421|4173221|B2|||Patient Global Impressions of Severity (PGI-Severity)|Measures patient's perception of severity of illness at the time of assessment. Scores range from 1 (normal, not at all ill) to 7 (extremely ill).|units on a scale|Mean|2.21|2.21|Standard Deviation|1.51|1.51|||
4345496|NCT00408421|4173222|B1|||Patient Global Impressions of Severity (PGI-Severity)|Measures patient's perception of severity of illness at the time of assessment. Scores range from 1 (normal, not at all ill) to 7 (extremely ill).|units on a scale|Mean|2.40|2.4|Standard Deviation|1.64|1.64|||
4345497|NCT00408421|4173220|B3|||Height||centimeters|Mean|165.79|165.79|Standard Deviation|9.22|9.22|||
4345498|NCT00408421|4173221|B2|||Height||centimeters|Mean|167.01|167.01|Standard Deviation|8.81|8.81|||
4345499|NCT00408421|4173222|B1|||Height||centimeters|Mean|164.67|164.67|Standard Deviation|9.49|9.49|||
4345500|NCT00408421|4173220|B3|||Duration of Osteoarthritis Since Diagnosis||years|Mean|7.01|7.01|Standard Deviation|7.77|7.77|||
4345501|NCT00408421|4173221|B2|||Duration of Osteoarthritis Since Diagnosis||years|Mean|6.94|6.94|Standard Deviation|8.38|8.38|||
4345502|NCT00408421|4173222|B1|||Duration of Osteoarthritis Since Diagnosis||years|Mean|7.09|7.09|Standard Deviation|7.20|7.2|||
4345503|NCT00408421|4173220|B3|||Duration of Osteoarthritis (OA) Pain Since Onset||years|Mean|9.17|9.17|Standard Deviation|8.47|8.47|||
4345504|NCT00408421|4173221|B2|||Duration of Osteoarthritis (OA) Pain Since Onset||years|Mean|9.04|9.04|Standard Deviation|8.72|8.72|||
4345505|NCT00408421|4173222|B1|||Duration of Osteoarthritis (OA) Pain Since Onset||years|Mean|9.30|9.3|Standard Deviation|8.27|8.27|||
4345506|NCT00408421|4173220|B3|||Brief Pain Inventory (BPI) Average Pain|A self-reported scale that measures the severity of pain. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine). The Average Pain Score reflects the average pain score over the last 24-hours.|units on a scale|Mean|6.20|6.2|Standard Deviation|1.56|1.56|||
4345507|NCT00408421|4173221|B2|||Brief Pain Inventory (BPI) Average Pain|A self-reported scale that measures the severity of pain. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine). The Average Pain Score reflects the average pain score over the last 24-hours.|units on a scale|Mean|6.16|6.16|Standard Deviation|1.58|1.58|||
4345508|NCT00408421|4173222|B1|||Brief Pain Inventory (BPI) Average Pain|A self-reported scale that measures the severity of pain. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine). The Average Pain Score reflects the average pain score over the last 24-hours.|units on a scale|Mean|6.23|6.23|Standard Deviation|1.54|1.54|||
4345509|NCT00408421|4173220|B3|No||Non Steroidal Anti Inflammatory Drug Use||participants|Number|114|114.0||||||
4345510|NCT00408421|4173221|B2|No||Non Steroidal Anti Inflammatory Drug Use||participants|Number|53|53.0||||||
4345511|NCT00408421|4173222|B1|No||Non Steroidal Anti Inflammatory Drug Use||participants|Number|61|61.0||||||
4345512|NCT00408421|4173220|B3|Yes||Non Steroidal Anti Inflammatory Drug Use||participants|Number|117|117.0||||||
4345513|NCT00408421|4173221|B2|Yes||Non Steroidal Anti Inflammatory Drug Use||participants|Number|58|58.0||||||
4345514|NCT00408421|4173222|B1|Yes||Non Steroidal Anti Inflammatory Drug Use||participants|Number|59|59.0||||||
4345515|NCT00408421|4173220|B3|Native American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4345516|NCT00408421|4173221|B2|Native American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4345517|NCT00408421|4173222|B1|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4345518|NCT00408421|4173220|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4345519|NCT00408421|4173221|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4345520|NCT00408421|4173222|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4345521|NCT00408421|4173220|B3|East Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4345522|NCT00408421|4173221|B2|East Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4345523|NCT00408421|4173222|B1|East Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4345524|NCT00408421|4173220|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|194|194.0||||||
4345525|NCT00408421|4173221|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|94|94.0||||||
4345526|NCT00408421|4173222|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|100|100.0||||||
4345527|NCT00408421|4173220|B3|African||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4345528|NCT00408421|4173221|B2|African||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4345529|NCT00408421|4173222|B1|African||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4345530|NCT00408421|4173220|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4345531|NCT00408421|4173221|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4345532|NCT00408421|4173222|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4345533|NCT00408421|4173220|B3||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4345534|NCT00408421|4173221|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4345535|NCT00408421|4173222|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4345536|NCT00408421|4173220|B3|||Age||years|Mean|62.28|62.28|Standard Deviation|9.44|9.44|||
4345537|NCT00408421|4173221|B2|||Age||years|Mean|62.07|62.07|Standard Deviation|9.63|9.63|||
4345538|NCT00408421|4173222|B1|||Age||years|Mean|62.48|62.48|Standard Deviation|9.30|9.3|||
4345539|NCT00408408|4173298|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4345540|NCT00408408|4173299|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4345541|NCT00408408|4173300|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4345542|NCT00408408|4173301|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4345543|NCT00408408|4173302|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4345544|NCT00408408|4173303|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4345545|NCT00408408|4173304|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4345546|NCT00408408|4173298|B7||Female|Sex: Female, Male||Participants|Count of Participants|1206|1206.0||||||
4345547|NCT00408408|4173299|B6||Female|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4345548|NCT00408408|4173300|B5||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4345549|NCT00408408|4173301|B4||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4345550|NCT00408408|4173302|B3||Female|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4345551|NCT00408408|4173303|B2||Female|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4345552|NCT00408408|4173304|B1||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4345553|NCT00408408|4173298|B7|||Age||years|Mean|48|48.0|Standard Deviation|9.7|9.7|||
4345554|NCT00408408|4173299|B6|||Age||years|Mean|48|48.0|Standard Deviation|9.8|9.8|||
4345555|NCT00408408|4173300|B5|||Age||years|Mean|48|48.0|Standard Deviation|9.9|9.9|||
4345556|NCT00408408|4173301|B4|||Age||years|Mean|49|49.0|Standard Deviation|10.4|10.4|||
4345557|NCT00408408|4173302|B3|||Age||years|Mean|49|49.0|Standard Deviation|9.8|9.8|||
4345558|NCT00408408|4173303|B2|||Age||years|Mean|49|49.0|Standard Deviation|9.6|9.6|||
4345559|NCT00408408|4173304|B1|||Age||years|Mean|48|48.0|Standard Deviation|9.1|9.1|||
4345560|NCT00408317|4173371|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4345561|NCT00408317|4173371|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4345562|NCT00408317|4173371|B1|||Age||years|Mean|19.6|19.6|Standard Deviation|6.6|6.6|||
4345563|NCT00408200|4173384|B3|United States||Region of Enrollment||participants|Number|110|110.0||||||
4345564|NCT00408200|4173385|B2|United States||Region of Enrollment||participants|Number|53|53.0||||||
4345565|NCT00408200|4173386|B1|United States||Region of Enrollment||participants|Number|57|57.0||||||
4345566|NCT00408200|4173384|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4345567|NCT00408200|4173385|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4345568|NCT00408200|4173386|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4345569|NCT00408200|4173384|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4345570|NCT00408200|4173385|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4345571|NCT00408200|4173386|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4345572|NCT00408200|4173384|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4345573|NCT00408200|4173385|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4345574|NCT00408200|4173386|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4345575|NCT00408200|4173384|B3||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
4345576|NCT00408200|4173385|B2||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4345577|NCT00408200|4173386|B1||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4345578|NCT00408200|4173384|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4345579|NCT00408200|4173385|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4345580|NCT00408200|4173386|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4345581|NCT00408070|4173395|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4345582|NCT00408070|4173395|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4345583|NCT00408070|4173395|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4345584|NCT00408070|4173395|B1|||Age||years|Mean|62|62.0|Standard Deviation|11.20|11.2|||
4345585|NCT00408070|4173395|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4345586|NCT00408070|4173395|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4345587|NCT00408070|4173395|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4345588|NCT00407966|4173403|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4345589|NCT00407966|4173403|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4345590|NCT00407966|4173403|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4345591|NCT00407966|4173403|B1|||Age||years|Mean|61|61.0|Standard Deviation|50|50.0|||
4345592|NCT00407966|4173403|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4345593|NCT00407966|4173403|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4345594|NCT00407966|4173403|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4345595|NCT00407888|4173407|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4345596|NCT00407888|4173407|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4345597|NCT00407888|4173407|B1||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4345598|NCT00407888|4173407|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4345599|NCT00407888|4173407|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4345600|NCT00407888|4173407|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4345601|NCT00407888|4173407|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4345602|NCT00407888|4173407|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4345603|NCT00407888|4173407|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4345604|NCT00407888|4173407|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4345605|NCT00407888|4173407|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4345606|NCT00407888|4173407|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4345607|NCT00407888|4173407|B1|||Age||years|Median|52|52.0|Full Range|||29.0|69.0|
4345608|NCT00407797|4173415|B1|Depression Total Score||Hospital Anxiety and Depression Scale (HADS)|HADS-A: generalized anxiety; HADS-D: lost interest and diminished pleasure response (lowering of hedonic tone). Total score 0 to 21 for each subscale; higher score indicates greater severity of anxiety and depression symptoms.|score on scale|Mean|7.3|7.3|Standard Deviation|4.1|4.1|||
4345609|NCT00407797|4173415|B1|Anxiety Total Score||Hospital Anxiety and Depression Scale (HADS)|HADS-A: generalized anxiety; HADS-D: lost interest and diminished pleasure response (lowering of hedonic tone). Total score 0 to 21 for each subscale; higher score indicates greater severity of anxiety and depression symptoms.|score on scale|Mean|8.8|8.8|Standard Deviation|4.2|4.2|||
4345642|NCT00407745|4173441|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4345643|NCT00407745|4173442|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4345644|NCT00407745|4173443|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4345610|NCT00407797|4173415|B1|9-Item Sleep Problems Index||Medical Outcomes Study Sleep Scale|Subject rated questionnaire to assess sleep quality and quantity. For 5 of 7 subscales transformed total score range = 0 to 100; other subscales: Sleep Quantity range: 0-24 hours; and Optimal Sleep range: 1 (optimal sleep: quantity 7 or 8 hours per night), or 0 (no optimal sleep). Higher score indicates greater intensity or quantity of attribute.|scores on scale|Mean|33.4|33.4|Standard Deviation|15.8|15.8|||
4345611|NCT00407797|4173415|B1|Somnolence||Medical Outcomes Study Sleep Scale|Subject rated questionnaire to assess sleep quality and quantity. For 5 of 7 subscales transformed total score range = 0 to 100; other subscales: Sleep Quantity range: 0-24 hours; and Optimal Sleep range: 1 (optimal sleep: quantity 7 or 8 hours per night), or 0 (no optimal sleep). Higher score indicates greater intensity or quantity of attribute.|scores on scale|Mean|39.2|39.2|Standard Deviation|24.5|24.5|||
4345612|NCT00407797|4173415|B1|Sleep Adequacy||Medical Outcomes Study Sleep Scale|Subject rated questionnaire to assess sleep quality and quantity. For 5 of 7 subscales transformed total score range = 0 to 100; other subscales: Sleep Quantity range: 0-24 hours; and Optimal Sleep range: 1 (optimal sleep: quantity 7 or 8 hours per night), or 0 (no optimal sleep). Higher score indicates greater intensity or quantity of attribute.|scores on scale|Mean|64.6|64.6|Standard Deviation|26.1|26.1|||
4345613|NCT00407797|4173415|B1|Optimal Sleep||Medical Outcomes Study Sleep Scale|Subject rated questionnaire to assess sleep quality and quantity. For 5 of 7 subscales transformed total score range = 0 to 100; other subscales: Sleep Quantity range: 0-24 hours; and Optimal Sleep range: 1 (optimal sleep: quantity 7 or 8 hours per night), or 0 (no optimal sleep). Higher score indicates greater intensity or quantity of attribute.|scores on scale|Mean|0.5|0.5|Standard Deviation|0.5|0.5|||
4345614|NCT00407797|4173415|B1|Quantity of Sleep||Medical Outcomes Study Sleep Scale|Subject rated questionnaire to assess sleep quality and quantity. For 5 of 7 subscales transformed total score range = 0 to 100; other subscales: Sleep Quantity range: 0-24 hours; and Optimal Sleep range: 1 (optimal sleep: quantity 7 or 8 hours per night), or 0 (no optimal sleep). Higher score indicates greater intensity or quantity of attribute.|scores on scale|Mean|7.9|7.9|Standard Deviation|1.9|1.9|||
4345615|NCT00407797|4173415|B1|Awaken Short of Breath||Medical Outcomes Study Sleep Scale|Subject rated questionnaire to assess sleep quality and quantity. For 5 of 7 subscales transformed total score range = 0 to 100; other subscales: Sleep Quantity range: 0-24 hours; and Optimal Sleep range: 1 (optimal sleep: quantity 7 or 8 hours per night), or 0 (no optimal sleep). Higher score indicates greater intensity or quantity of attribute.|scores on scale|Mean|26.0|26.0|Standard Deviation|24.8|24.8|||
4345616|NCT00407797|4173415|B1|Snoring||Medical Outcomes Study Sleep Scale|Subject rated questionnaire to assess sleep quality and quantity. For 5 of 7 subscales transformed total score range = 0 to 100; other subscales: Sleep Quantity range: 0-24 hours; and Optimal Sleep range: 1 (optimal sleep: quantity 7 or 8 hours per night), or 0 (no optimal sleep). Higher score indicates greater intensity or quantity of attribute.|scores on scale|Mean|40.1|40.1|Standard Deviation|33.4|33.4|||
4345617|NCT00407797|4173415|B1|Sleep Disturbance||Medical Outcomes Study Sleep Scale|Subject rated questionnaire to assess sleep quality and quantity. For 5 of 7 subscales transformed total score range = 0 to 100; other subscales: Sleep Quantity range: 0-24 hours; and Optimal Sleep range: 1 (optimal sleep: quantity 7 or 8 hours per night), or 0 (no optimal sleep). Higher score indicates greater intensity or quantity of attribute.|scores on scale|Mean|32.9|32.9|Standard Deviation|20.9|20.9|||
4345618|NCT00407797|4173415|B1|> 6 seizures||28 day seizure frequency in Subjects with <= 6 and > 6 seizures during Baseline Period|Baseline period = 8 week period before Visit 1 date, including any unplanned readings falling under this period.|seizures|Mean|12|12.0|Standard Deviation|17.2|17.2|||
4345619|NCT00407797|4173415|B1|<=6 seizures||28 day seizure frequency in Subjects with <= 6 and > 6 seizures during Baseline Period|Baseline period = 8 week period before Visit 1 date, including any unplanned readings falling under this period.|seizures|Mean|2|2.0|Standard Deviation|0.8|0.8|||
4345620|NCT00407797|4173415|B1|||28-Day Seizure Rate|Number of partial seizures in baseline period divided by duration of period based on observed visit dates multiplied by 28.|seizure rate|Mean|7.8|7.8|Standard Deviation|14.0|14.0|||
4345621|NCT00407797|4173415|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4345622|NCT00407797|4173415|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4345623|NCT00407797|4173415|B1|>= 65 years||Age, Customized||participants|Number|4|4.0||||||
4345624|NCT00407797|4173415|B1|45 - 64 years||Age, Customized||participants|Number|25|25.0||||||
4345625|NCT00407797|4173415|B1|18 - 44 years||Age, Customized||participants|Number|107|107.0||||||
4345626|NCT00407758|4173430|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4345627|NCT00407758|4173430|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4345628|NCT00407758|4173430|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4345629|NCT00407758|4173430|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4345630|NCT00407758|4173430|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4345631|NCT00407758|4173430|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4345632|NCT00407758|4173430|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4345633|NCT00407758|4173430|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4345634|NCT00407758|4173430|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4345635|NCT00407758|4173430|B1||70-79 years|Age, Customized||Participants|Count of Participants|7|7.0||||||
4345636|NCT00407758|4173430|B1||60-69 years|Age, Customized||Participants|Count of Participants|6|6.0||||||
4345637|NCT00407758|4173430|B1||50-59 years|Age, Customized||Participants|Count of Participants|10|10.0||||||
4345638|NCT00407758|4173430|B1||40-49 years|Age, Customized||Participants|Count of Participants|4|4.0||||||
4345639|NCT00407745|4173441|B3||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4345640|NCT00407745|4173442|B2||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4345641|NCT00407745|4173443|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4345645|NCT00407745|4173441|B3|>= 65 years||Age, Customized||participants|Number|19|19.0||||||
4345646|NCT00407745|4173442|B2|>= 65 years||Age, Customized||participants|Number|10|10.0||||||
4345647|NCT00407745|4173443|B1|>= 65 years||Age, Customized||participants|Number|9|9.0||||||
4345648|NCT00407745|4173441|B3|Between 45 and 64 years||Age, Customized||participants|Number|95|95.0||||||
4345649|NCT00407745|4173442|B2|Between 45 and 64 years||Age, Customized||participants|Number|45|45.0||||||
4345650|NCT00407745|4173443|B1|Between 45 and 64 years||Age, Customized||participants|Number|50|50.0||||||
4345651|NCT00407745|4173441|B3|Between 18 and 44 years||Age, Customized||participants|Number|105|105.0||||||
4345652|NCT00407745|4173442|B2|Between 18 and 44 years||Age, Customized||participants|Number|53|53.0||||||
4345653|NCT00407745|4173443|B1|Between 18 and 44 years||Age, Customized||participants|Number|52|52.0||||||
4345654|NCT00407745|4173441|B3|||Age|1 participant was randomized to placebo, but the actual drug taken was pregabalin. This subject was included in the placebo group for all baseline measures.|years|Mean|45.9|45.9|Standard Deviation|13.3|13.3|||
4345655|NCT00407745|4173442|B2|||Age|1 participant was randomized to placebo, but the actual drug taken was pregabalin. This subject was included in the placebo group for all baseline measures.|years|Mean|45.6|45.6|Standard Deviation|13.8|13.8|||
4345656|NCT00407745|4173443|B1|||Age|1 participant was randomized to placebo, but the actual drug taken was pregabalin. This subject was included in the placebo group for all baseline measures.|years|Mean|46.1|46.1|Standard Deviation|12.7|12.7|||
4345657|NCT00407654|4173516|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4345658|NCT00407654|4173516|B1|Canada||Region of Enrollment||participants|Number|49|49.0||||||
4345659|NCT00407654|4173516|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4345660|NCT00407654|4173516|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4345661|NCT00407654|4173516|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4345662|NCT00407654|4173516|B1||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4345663|NCT00407654|4173516|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4345664|NCT00407654|4173516|B1|||Age||years|Median|59|59.0|Full Range|||39.0|80.0|
4345665|NCT00407563|4173530|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4345666|NCT00407563|4173530|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4345667|NCT00407563|4173530|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4345668|NCT00407563|4173530|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|10.22|10.22|||
4345669|NCT00407563|4173530|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4345670|NCT00407563|4173530|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4345671|NCT00407563|4173530|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4345672|NCT00407550|4173538|B3|IIIB w/pleural effusion - N3 or T4||Lung Stage|From the American Joint Committee on Cancer Staging Criteria for Lung Cancer > N3 - (Regional Lymph Nodes) Metastasis to contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph nodes(s). > T4 - (Primary Tumor) Tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, esophagus, vertebral body, carina; or separate tumor nodules in the same lobe; or tumor with malignant pleural effusion.|Participants|Number|4|4.0||||||
4345673|NCT00407550|4173539|B2|IIIB w/pleural effusion - N3 or T4||Lung Stage|From the American Joint Committee on Cancer Staging Criteria for Lung Cancer > N3 - (Regional Lymph Nodes) Metastasis to contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph nodes(s). > T4 - (Primary Tumor) Tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, esophagus, vertebral body, carina; or separate tumor nodules in the same lobe; or tumor with malignant pleural effusion.|Participants|Number|2|2.0||||||
4345674|NCT00407550|4173540|B1|IIIB w/pleural effusion - N3 or T4||Lung Stage|From the American Joint Committee on Cancer Staging Criteria for Lung Cancer > N3 - (Regional Lymph Nodes) Metastasis to contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph nodes(s). > T4 - (Primary Tumor) Tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, esophagus, vertebral body, carina; or separate tumor nodules in the same lobe; or tumor with malignant pleural effusion.|Participants|Number|2|2.0||||||
4345675|NCT00407550|4173538|B3|IV - Distant Metastasis||Lung Stage|From the American Joint Committee on Cancer Staging Criteria for Lung Cancer > N3 - (Regional Lymph Nodes) Metastasis to contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph nodes(s). > T4 - (Primary Tumor) Tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, esophagus, vertebral body, carina; or separate tumor nodules in the same lobe; or tumor with malignant pleural effusion.|Participants|Number|15|15.0||||||
4345676|NCT00407550|4173539|B2|IV - Distant Metastasis||Lung Stage|From the American Joint Committee on Cancer Staging Criteria for Lung Cancer > N3 - (Regional Lymph Nodes) Metastasis to contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph nodes(s). > T4 - (Primary Tumor) Tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, esophagus, vertebral body, carina; or separate tumor nodules in the same lobe; or tumor with malignant pleural effusion.|Participants|Number|7|7.0||||||
4345677|NCT00407550|4173540|B1|IV - Distant Metastasis||Lung Stage|From the American Joint Committee on Cancer Staging Criteria for Lung Cancer > N3 - (Regional Lymph Nodes) Metastasis to contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph nodes(s). > T4 - (Primary Tumor) Tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, esophagus, vertebral body, carina; or separate tumor nodules in the same lobe; or tumor with malignant pleural effusion.|Participants|Number|8|8.0||||||
4345678|NCT00407550|4173538|B3|1 - Ambulatory, restricted strenuous activity||Performance Score|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|Participants|Number|11|11.0||||||
4345738|NCT00407355|4173630|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4345679|NCT00407550|4173539|B2|1 - Ambulatory, restricted strenuous activity||Performance Score|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|Participants|Number|5|5.0||||||
4345680|NCT00407550|4173540|B1|1 - Ambulatory, restricted strenuous activity||Performance Score|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|Participants|Number|6|6.0||||||
4345681|NCT00407550|4173538|B3|0 - Fully Active||Performance Score|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|Participants|Number|8|8.0||||||
4345682|NCT00407550|4173539|B2|0 - Fully Active||Performance Score|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|Participants|Number|4|4.0||||||
4345683|NCT00407550|4173540|B1|0 - Fully Active||Performance Score|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|Participants|Number|4|4.0||||||
4345684|NCT00407550|4173538|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4345685|NCT00407550|4173539|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4345686|NCT00407550|4173540|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4345687|NCT00407550|4173538|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4345688|NCT00407550|4173539|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4345689|NCT00407550|4173540|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4345690|NCT00407550|4173538|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4345691|NCT00407550|4173539|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4345692|NCT00407550|4173540|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4345693|NCT00407550|4173538|B3|||Age||Years|Median|66|66.0|Full Range|||48.0|81.0|
4345694|NCT00407550|4173539|B2|||Age||Years|Median|63|63.0|Full Range|||48.0|74.0|
4345695|NCT00407550|4173540|B1|||Age||Years|Median|70.5|70.5|Full Range|||60.0|81.0|
4345696|NCT00407537|4173547|B3||Male|Sex: Female, Male||Participants|Count of Participants|759|759.0||||||
4345697|NCT00407537|4173548|B2||Male|Sex: Female, Male||Participants|Count of Participants|344|344.0||||||
4345698|NCT00407537|4173549|B1||Male|Sex: Female, Male||Participants|Count of Participants|415|415.0||||||
4345699|NCT00407537|4173547|B3||Female|Sex: Female, Male||Participants|Count of Participants|702|702.0||||||
4345700|NCT00407537|4173548|B2||Female|Sex: Female, Male||Participants|Count of Participants|334|334.0||||||
4345701|NCT00407537|4173549|B1||Female|Sex: Female, Male||Participants|Count of Participants|368|368.0||||||
4345702|NCT00407537|4173547|B3|> = 65 years||Age, Customized||participants|Number|537|537.0||||||
4345703|NCT00407537|4173548|B2|> = 65 years||Age, Customized||participants|Number|262|262.0||||||
4345704|NCT00407537|4173549|B1|> = 65 years||Age, Customized||participants|Number|275|275.0||||||
4345705|NCT00407537|4173547|B3|45 to 64 years||Age, Customized||participants|Number|811|811.0||||||
4345706|NCT00407537|4173548|B2|45 to 64 years||Age, Customized||participants|Number|361|361.0||||||
4345707|NCT00407537|4173549|B1|45 to 64 years||Age, Customized||participants|Number|450|450.0||||||
4345708|NCT00407537|4173547|B3|18 to 44 years||Age, Customized||participants|Number|113|113.0||||||
4345709|NCT00407537|4173548|B2|18 to 44 years||Age, Customized||participants|Number|55|55.0||||||
4345710|NCT00407537|4173549|B1|18 to 44 years||Age, Customized||participants|Number|58|58.0||||||
4345711|NCT00407537|4173547|B3|< 18 years||Age, Customized||participants|Number|0|0.0||||||
4345712|NCT00407537|4173548|B2|< 18 years||Age, Customized||participants|Number|0|0.0||||||
4345713|NCT00407537|4173549|B1|< 18 years||Age, Customized||participants|Number|0|0.0||||||
4345714|NCT00407511|4173598|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4345715|NCT00407511|4173598|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4345716|NCT00407511|4173598|B1|>= 65 years||Age, Customized||participants|Number|30|30.0||||||
4345717|NCT00407511|4173598|B1|Between 45 to 64 years||Age, Customized||participants|Number|76|76.0||||||
4345718|NCT00407511|4173598|B1|Between 18 to 44 years||Age, Customized||participants|Number|15|15.0||||||
4345719|NCT00407485|4173612|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4345720|NCT00407485|4173612|B1|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4345721|NCT00407485|4173612|B1|Americian Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4345722|NCT00407485|4173612|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4345723|NCT00407485|4173612|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4345724|NCT00407485|4173612|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4345725|NCT00407485|4173612|B1|||Age||years|Median|67|67.0|Full Range|||45.0|79.0|
4345726|NCT00407381|4173617|B4||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4345727|NCT00407381|4173618|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4345728|NCT00407381|4173619|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4345729|NCT00407381|4173620|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4345730|NCT00407381|4173617|B4||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4345731|NCT00407381|4173618|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4345732|NCT00407381|4173619|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4345733|NCT00407381|4173620|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4345734|NCT00407381|4173617|B4|||Age||years|Mean|62|62.0|Full Range|||32.0|86.0|
4345735|NCT00407381|4173618|B3|||Age||years|Mean|62|62.0|Full Range|||35.0|82.0|
4345736|NCT00407381|4173619|B2|||Age||years|Mean|62|62.0|Full Range|||34.0|86.0|
4345737|NCT00407381|4173620|B1|||Age||years|Mean|62|62.0|Full Range|||32.0|84.0|
4345739|NCT00407355|4173631|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4345740|NCT00407355|4173632|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4345741|NCT00407355|4173630|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4345742|NCT00407355|4173631|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4345743|NCT00407355|4173632|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4345744|NCT00407355|4173630|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4345745|NCT00407355|4173631|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4345746|NCT00407355|4173632|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4345747|NCT00407355|4173630|B3|||Age||years|Mean|67.1|67.1|Standard Deviation|12.5|12.5|||
4345748|NCT00407355|4173631|B2|||Age||years|Mean|67.4|67.4|Standard Deviation|11.3|11.3|||
4345749|NCT00407355|4173632|B1|||Age||years|Mean|63.9|63.9|Standard Deviation|15.7|15.7|||
4345750|NCT00407355|4173630|B3||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4345751|NCT00407355|4173631|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4345752|NCT00407355|4173632|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4345753|NCT00407355|4173630|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4345754|NCT00407355|4173631|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4345755|NCT00407355|4173632|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4345756|NCT00407355|4173630|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4345757|NCT00407355|4173631|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4345758|NCT00407355|4173632|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4345759|NCT00407030|4173641|B4||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4345760|NCT00407030|4173642|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4345761|NCT00407030|4173643|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4345762|NCT00407030|4173644|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4345763|NCT00407030|4173641|B4||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4345764|NCT00407030|4173642|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4345765|NCT00407030|4173643|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4345766|NCT00407030|4173644|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4345767|NCT00407030|4173641|B4|||Age||years|Mean|52.8|52.8|Standard Deviation|11.5|11.5|||
4345768|NCT00407030|4173642|B3|||Age||years|Mean|52.4|52.4|Standard Deviation|10.8|10.8|||
4345769|NCT00407030|4173643|B2|||Age||years|Mean|52.8|52.8|Standard Deviation|11.5|11.5|||
4345770|NCT00407030|4173644|B1|||Age||years|Mean|53.2|53.2|Standard Deviation|12.2|12.2|||
4345771|NCT00406848|4173672|B3|||Montgomery-Asberg Depression Rating Scale (MADRS) Total Score|The MADRS is a rating scale for severity of depressive mood symptoms. The MADRS has a 10-item checklist. Items are rated on a scale of 0-6, for a total score range of 0 (low severity of depressive symptoms) to 60 (high severity of depressive symptoms). Results shown are based on efficacy analysis population only.|units on a scale|Mean|29.00|29.0|Standard Deviation|5.52|5.52|||
4345772|NCT00406848|4173673|B2|||Montgomery-Asberg Depression Rating Scale (MADRS) Total Score|The MADRS is a rating scale for severity of depressive mood symptoms. The MADRS has a 10-item checklist. Items are rated on a scale of 0-6, for a total score range of 0 (low severity of depressive symptoms) to 60 (high severity of depressive symptoms). Results shown are based on efficacy analysis population only.|units on a scale|Mean|28.46|28.46|Standard Deviation|5.40|5.4|||
4345773|NCT00406848|4173674|B1|||Montgomery-Asberg Depression Rating Scale (MADRS) Total Score|The MADRS is a rating scale for severity of depressive mood symptoms. The MADRS has a 10-item checklist. Items are rated on a scale of 0-6, for a total score range of 0 (low severity of depressive symptoms) to 60 (high severity of depressive symptoms). Results shown are based on efficacy analysis population only.|units on a scale|Mean|29.25|29.25|Standard Deviation|5.57|5.57|||
4345774|NCT00406848|4173672|B3|||Mini Mental State Exam (MMSE) Total Score|Mini-Mental State Examination (MMSE)is a widely used rating measure of cognitive ability. The MMSE will be used to categorize patients as with or without dementia. Patients with a MMSE score of 20 to 23 will be categorized as having mild dementia, while those with a score of ≥ 24 will be categorized as having no dementia. Scores range from 0 to 30. Results shown are based on efficacy analysis population only.|units on a scale|Mean|28.51|28.51|Standard Deviation|1.79|1.79|||
4345775|NCT00406848|4173673|B2|||Mini Mental State Exam (MMSE) Total Score|Mini-Mental State Examination (MMSE)is a widely used rating measure of cognitive ability. The MMSE will be used to categorize patients as with or without dementia. Patients with a MMSE score of 20 to 23 will be categorized as having mild dementia, while those with a score of ≥ 24 will be categorized as having no dementia. Scores range from 0 to 30. Results shown are based on efficacy analysis population only.|units on a scale|Mean|28.42|28.42|Standard Deviation|1.72|1.72|||
4345776|NCT00406848|4173674|B1|||Mini Mental State Exam (MMSE) Total Score|Mini-Mental State Examination (MMSE)is a widely used rating measure of cognitive ability. The MMSE will be used to categorize patients as with or without dementia. Patients with a MMSE score of 20 to 23 will be categorized as having mild dementia, while those with a score of ≥ 24 will be categorized as having no dementia. Scores range from 0 to 30. Results shown are based on efficacy analysis population only.|units on a scale|Mean|28.55|28.55|Standard Deviation|1.83|1.83|||
4345777|NCT00406848|4173672|B3|||Brief Pain Inventory (BPI) 24-hour Average Pain Score|A self-reported scale that measures the severity of pain based on the average pain over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine). Results shown are based on efficacy analysis population only.|units on a scale|Mean|3.48|3.48|Standard Deviation|2.66|2.66|||
4345805|NCT00406848|4173673|B2|Native American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4345778|NCT00406848|4173673|B2|||Brief Pain Inventory (BPI) 24-hour Average Pain Score|A self-reported scale that measures the severity of pain based on the average pain over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine). Results shown are based on efficacy analysis population only.|units on a scale|Mean|3.48|3.48|Standard Deviation|2.57|2.57|||
4345779|NCT00406848|4173674|B1|||Brief Pain Inventory (BPI) 24-hour Average Pain Score|A self-reported scale that measures the severity of pain based on the average pain over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine). Results shown are based on efficacy analysis population only.|units on a scale|Mean|3.48|3.48|Standard Deviation|2.70|2.7|||
4345780|NCT00406848|4173672|B3|||Numerical Rating Scale (NRS) Overall Pain Score|"How much the participant has been bothered by pain over the last week, as measured by an 11-point Likert scale. A score of 0 reflects not bothered at all and a score of 10 reflects extremely bothered. Results shown are based on efficacy analysis population only."|units on a scale|Mean|3.73|3.73|Standard Deviation|2.87|2.87|||
4345781|NCT00406848|4173673|B2|||Numerical Rating Scale (NRS) Overall Pain Score|"How much the participant has been bothered by pain over the last week, as measured by an 11-point Likert scale. A score of 0 reflects not bothered at all and a score of 10 reflects extremely bothered. Results shown are based on efficacy analysis population only."|units on a scale|Mean|3.59|3.59|Standard Deviation|2.67|2.67|||
4345782|NCT00406848|4173674|B1|||Numerical Rating Scale (NRS) Overall Pain Score|"How much the participant has been bothered by pain over the last week, as measured by an 11-point Likert scale. A score of 0 reflects not bothered at all and a score of 10 reflects extremely bothered. Results shown are based on efficacy analysis population only."|units on a scale|Mean|3.79|3.79|Standard Deviation|2.96|2.96|||
4345783|NCT00406848|4173672|B3|||Geriatric Depression Scale (GDS) Total Score|The 30-item Geriatric Depression Scale (GDS) is a self-administered test of 30 questions to measure the severity of depression. The yes/no questions result in a range of scores from 0 (normal) to 30 (severe depression). Results shown are based on efficacy analysis population only.|units on a scale|Mean|18.26|18.26|Standard Deviation|6.83|6.83|||
4345784|NCT00406848|4173673|B2|||Geriatric Depression Scale (GDS) Total Score|The 30-item Geriatric Depression Scale (GDS) is a self-administered test of 30 questions to measure the severity of depression. The yes/no questions result in a range of scores from 0 (normal) to 30 (severe depression). Results shown are based on efficacy analysis population only.|units on a scale|Mean|17.64|17.64|Standard Deviation|6.66|6.66|||
4345785|NCT00406848|4173674|B1|||Geriatric Depression Scale (GDS) Total Score|The 30-item Geriatric Depression Scale (GDS) is a self-administered test of 30 questions to measure the severity of depression. The yes/no questions result in a range of scores from 0 (normal) to 30 (severe depression). Results shown are based on efficacy analysis population only.|units on a scale|Mean|18.54|18.54|Standard Deviation|6.91|6.91|||
4345786|NCT00406848|4173672|B3|||17 item Hamilton Depression Rating Scale (HAMD-17) - Maier subscale|The Maier subscale (Items 1,2,7,8,9,10) represents symptoms of depression. Total subscale scores range from 0 (normal) to 24 (severe). Results shown are based on efficacy analysis population only.|Units on a scale|Mean|10.00|10.0|Standard Deviation|3.19|3.19|||
4345787|NCT00406848|4173673|B2|||17 item Hamilton Depression Rating Scale (HAMD-17) - Maier subscale|The Maier subscale (Items 1,2,7,8,9,10) represents symptoms of depression. Total subscale scores range from 0 (normal) to 24 (severe). Results shown are based on efficacy analysis population only.|Units on a scale|Mean|10.08|10.08|Standard Deviation|3.36|3.36|||
4345788|NCT00406848|4173674|B1|||17 item Hamilton Depression Rating Scale (HAMD-17) - Maier subscale|The Maier subscale (Items 1,2,7,8,9,10) represents symptoms of depression. Total subscale scores range from 0 (normal) to 24 (severe). Results shown are based on efficacy analysis population only.|Units on a scale|Mean|9.96|9.96|Standard Deviation|3.11|3.11|||
4345789|NCT00406848|4173672|B3|||17 item Hamilton Depression Rating Scale Total Score(HAMD-17)|The 17-item HAMD measures depression severity. Each item was evaluated and scored using either a 5-point scale (e.g. absent, mild, moderate, severe, very severe) or a 3-point scale (e.g. absent, mild, marked). The total score of HAMD-17 may range from 0 (normal) to 52 (severe). Results shown are based on efficacy analysis population only.|units on a scale|Mean|19.39|19.39|Standard Deviation|5.62|5.62|||
4345790|NCT00406848|4173673|B2|||17 item Hamilton Depression Rating Scale Total Score(HAMD-17)|The 17-item HAMD measures depression severity. Each item was evaluated and scored using either a 5-point scale (e.g. absent, mild, moderate, severe, very severe) or a 3-point scale (e.g. absent, mild, marked). The total score of HAMD-17 may range from 0 (normal) to 52 (severe). Results shown are based on efficacy analysis population only.|units on a scale|Mean|19.32|19.32|Standard Deviation|5.78|5.78|||
4345791|NCT00406848|4173674|B1|||17 item Hamilton Depression Rating Scale Total Score(HAMD-17)|The 17-item HAMD measures depression severity. Each item was evaluated and scored using either a 5-point scale (e.g. absent, mild, moderate, severe, very severe) or a 3-point scale (e.g. absent, mild, marked). The total score of HAMD-17 may range from 0 (normal) to 52 (severe). Results shown are based on efficacy analysis population only.|units on a scale|Mean|19.42|19.42|Standard Deviation|5.56|5.56|||
4345792|NCT00406848|4173672|B3|Puerto Rico||Region of Enrollment||participants|Number|35|35.0||||||
4345793|NCT00406848|4173673|B2|Puerto Rico||Region of Enrollment||participants|Number|11|11.0||||||
4345794|NCT00406848|4173674|B1|Puerto Rico||Region of Enrollment||participants|Number|24|24.0||||||
4345795|NCT00406848|4173672|B3|Mexico||Region of Enrollment||participants|Number|25|25.0||||||
4345796|NCT00406848|4173673|B2|Mexico||Region of Enrollment||participants|Number|8|8.0||||||
4345797|NCT00406848|4173674|B1|Mexico||Region of Enrollment||participants|Number|17|17.0||||||
4345798|NCT00406848|4173672|B3|United States||Region of Enrollment||participants|Number|289|289.0||||||
4345799|NCT00406848|4173673|B2|United States||Region of Enrollment||participants|Number|94|94.0||||||
4345800|NCT00406848|4173674|B1|United States||Region of Enrollment||participants|Number|195|195.0||||||
4345801|NCT00406848|4173672|B3|France||Region of Enrollment||participants|Number|21|21.0||||||
4345802|NCT00406848|4173673|B2|France||Region of Enrollment||participants|Number|8|8.0||||||
4345803|NCT00406848|4173674|B1|France||Region of Enrollment||participants|Number|13|13.0||||||
4345804|NCT00406848|4173672|B3|Native American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4345806|NCT00406848|4173674|B1|Native American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4345807|NCT00406848|4173672|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|68|68.0||||||
4345808|NCT00406848|4173673|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4345809|NCT00406848|4173674|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|46|46.0||||||
4345810|NCT00406848|4173672|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|290|290.0||||||
4345811|NCT00406848|4173673|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|92|92.0||||||
4345812|NCT00406848|4173674|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|198|198.0||||||
4345813|NCT00406848|4173672|B3|African||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4345814|NCT00406848|4173673|B2|African||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4345815|NCT00406848|4173674|B1|African||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4345816|NCT00406848|4173672|B3||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4345817|NCT00406848|4173673|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4345818|NCT00406848|4173674|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4345819|NCT00406848|4173672|B3||Female|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
4345820|NCT00406848|4173673|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4345821|NCT00406848|4173674|B1||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4345822|NCT00406848|4173672|B3|||Age||years|Mean|72.93|72.93|Standard Deviation|5.95|5.95|||
4345823|NCT00406848|4173673|B2|||Age||years|Mean|73.02|73.02|Standard Deviation|5.64|5.64|||
4345824|NCT00406848|4173674|B1|||Age||years|Mean|72.89|72.89|Standard Deviation|6.10|6.1|||
4345825|NCT00406783|4173737|B3||Male|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4345826|NCT00406783|4173738|B2||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4345827|NCT00406783|4173739|B1||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4345828|NCT00406783|4173737|B3||Female|Sex: Female, Male||Participants|Count of Participants|318|318.0||||||
4345829|NCT00406783|4173738|B2||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4345830|NCT00406783|4173739|B1||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4345831|NCT00406783|4173737|B3|||Age||years|Mean|34.2|34.2|Standard Deviation|12.4|12.4|||
4345832|NCT00406783|4173738|B2|||Age||years|Mean|34.6|34.6|Standard Deviation|12.8|12.8|||
4345833|NCT00406783|4173739|B1|||Age||years|Mean|33.8|33.8|Standard Deviation|12.0|12.0|||
4345834|NCT00406718|4173752|B4|United States||Region of Enrollment||participants|Number|142|142.0||||||
4345835|NCT00406718|4173753|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
4345836|NCT00406718|4173754|B2|United States||Region of Enrollment||participants|Number|48|48.0||||||
4345837|NCT00406718|4173755|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
4345838|NCT00406718|4173752|B4||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4345839|NCT00406718|4173753|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4345840|NCT00406718|4173754|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4345841|NCT00406718|4173755|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4345842|NCT00406718|4173752|B4||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4345843|NCT00406718|4173753|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4345844|NCT00406718|4173754|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4345845|NCT00406718|4173755|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4345846|NCT00406718|4173752|B4|||Age||years|Mean|42.52|42.52|Standard Deviation|10.27|10.27|||
4345847|NCT00406718|4173753|B3|||Age||years|Mean|42.0|42.0|Standard Deviation|9.27|9.27|||
4345848|NCT00406718|4173754|B2|||Age||years|Mean|43.0|43.0|Standard Deviation|10.15|10.15|||
4345849|NCT00406718|4173755|B1|||Age||years|Mean|43.0|43.0|Standard Deviation|11.04|11.04|||
4345850|NCT00406718|4173752|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4345851|NCT00406718|4173753|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4345852|NCT00406718|4173754|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4345853|NCT00406718|4173755|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4345854|NCT00406718|4173752|B4||Between 18 and 65 years|Age||Participants|Count of Participants|142|142.0||||||
4345855|NCT00406718|4173753|B3||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4345856|NCT00406718|4173754|B2||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4345857|NCT00406718|4173755|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4345858|NCT00406718|4173752|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4345859|NCT00406718|4173753|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4345860|NCT00406718|4173754|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4345861|NCT00406718|4173755|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4345862|NCT00406692|4173771|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4345863|NCT00406692|4173771|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4345864|NCT00406692|4173771|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4345865|NCT00406692|4173771|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4345866|NCT00406692|4173771|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4345867|NCT00406692|4173771|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4345868|NCT00406653|4173777|B5|||Inflammatory Bowel Disease Questionnaire (IBDQ) Score|IBDQ was used to measure disease specific quality of life. The IBDQ consists of a self-administered 32-item questionnaire that evaluates quality of life across 4 dimensional scores: Bowel, Systemic, Social and Emotional. The response to each question can range from 1 to 7, with 1 indicating severe problem and 7 indicating normal health. The total IBDQ is computed as the sum of the responses to the individual IBDQ questions. The total score can range between 32 to 224 with higher scores indicating a better quality of life.|units on a scale|Mean|119.5|119.5|Standard Deviation|29.36|29.36|||
4345869|NCT00406653|4173778|B4|||Inflammatory Bowel Disease Questionnaire (IBDQ) Score|IBDQ was used to measure disease specific quality of life. The IBDQ consists of a self-administered 32-item questionnaire that evaluates quality of life across 4 dimensional scores: Bowel, Systemic, Social and Emotional. The response to each question can range from 1 to 7, with 1 indicating severe problem and 7 indicating normal health. The total IBDQ is computed as the sum of the responses to the individual IBDQ questions. The total score can range between 32 to 224 with higher scores indicating a better quality of life.|units on a scale|Mean|119.6|119.6|Standard Deviation|31.17|31.17|||
4345870|NCT00406653|4173779|B3|||Inflammatory Bowel Disease Questionnaire (IBDQ) Score|IBDQ was used to measure disease specific quality of life. The IBDQ consists of a self-administered 32-item questionnaire that evaluates quality of life across 4 dimensional scores: Bowel, Systemic, Social and Emotional. The response to each question can range from 1 to 7, with 1 indicating severe problem and 7 indicating normal health. The total IBDQ is computed as the sum of the responses to the individual IBDQ questions. The total score can range between 32 to 224 with higher scores indicating a better quality of life.|units on a scale|Mean|121.1|121.1|Standard Deviation|28.0|28.0|||
4345871|NCT00406653|4173780|B2|||Inflammatory Bowel Disease Questionnaire (IBDQ) Score|IBDQ was used to measure disease specific quality of life. The IBDQ consists of a self-administered 32-item questionnaire that evaluates quality of life across 4 dimensional scores: Bowel, Systemic, Social and Emotional. The response to each question can range from 1 to 7, with 1 indicating severe problem and 7 indicating normal health. The total IBDQ is computed as the sum of the responses to the individual IBDQ questions. The total score can range between 32 to 224 with higher scores indicating a better quality of life.|units on a scale|Mean|117.3|117.3|Standard Deviation|30.60|30.6|||
4345872|NCT00406653|4173781|B1|||Inflammatory Bowel Disease Questionnaire (IBDQ) Score|IBDQ was used to measure disease specific quality of life. The IBDQ consists of a self-administered 32-item questionnaire that evaluates quality of life across 4 dimensional scores: Bowel, Systemic, Social and Emotional. The response to each question can range from 1 to 7, with 1 indicating severe problem and 7 indicating normal health. The total IBDQ is computed as the sum of the responses to the individual IBDQ questions. The total score can range between 32 to 224 with higher scores indicating a better quality of life.|units on a scale|Mean|119.9|119.9|Standard Deviation|26.22|26.22|||
4345873|NCT00406653|4173777|B5|||Crohn's Disease Activity Index (CDAI)|CDAI is a composite index consisting of a weighted scoring of 8 disease variables: number of liquid stools, extent of abdominal pain, general well-being, occurrence of extraintestinal symptoms, need for antidiarrheal drugs, presence of abdominal masses, hematocrit, and body weight. CDAI scores range from 0 to ~600 points. Clinical response=CDAI reduction ≥100 points or absolute CDAI <150 points. Clinical remission=CDAI <150 points. Moderate to severe disease=CDAI ≥220 and ≤450 points.|points|Mean|319.4|319.4|Standard Deviation|65.03|65.03|||
4345874|NCT00406653|4173778|B4|||Crohn's Disease Activity Index (CDAI)|CDAI is a composite index consisting of a weighted scoring of 8 disease variables: number of liquid stools, extent of abdominal pain, general well-being, occurrence of extraintestinal symptoms, need for antidiarrheal drugs, presence of abdominal masses, hematocrit, and body weight. CDAI scores range from 0 to ~600 points. Clinical response=CDAI reduction ≥100 points or absolute CDAI <150 points. Clinical remission=CDAI <150 points. Moderate to severe disease=CDAI ≥220 and ≤450 points.|points|Mean|320.7|320.7|Standard Deviation|72.09|72.09|||
4345875|NCT00406653|4173779|B3|||Crohn's Disease Activity Index (CDAI)|CDAI is a composite index consisting of a weighted scoring of 8 disease variables: number of liquid stools, extent of abdominal pain, general well-being, occurrence of extraintestinal symptoms, need for antidiarrheal drugs, presence of abdominal masses, hematocrit, and body weight. CDAI scores range from 0 to ~600 points. Clinical response=CDAI reduction ≥100 points or absolute CDAI <150 points. Clinical remission=CDAI <150 points. Moderate to severe disease=CDAI ≥220 and ≤450 points.|points|Mean|317.9|317.9|Standard Deviation|59.87|59.87|||
4345876|NCT00406653|4173780|B2|||Crohn's Disease Activity Index (CDAI)|CDAI is a composite index consisting of a weighted scoring of 8 disease variables: number of liquid stools, extent of abdominal pain, general well-being, occurrence of extraintestinal symptoms, need for antidiarrheal drugs, presence of abdominal masses, hematocrit, and body weight. CDAI scores range from 0 to ~600 points. Clinical response=CDAI reduction ≥100 points or absolute CDAI <150 points. Clinical remission=CDAI <150 points. Moderate to severe disease=CDAI ≥220 and ≤450 points.|points|Mean|318.9|318.9|Standard Deviation|65.08|65.08|||
4345877|NCT00406653|4173781|B1|||Crohn's Disease Activity Index (CDAI)|CDAI is a composite index consisting of a weighted scoring of 8 disease variables: number of liquid stools, extent of abdominal pain, general well-being, occurrence of extraintestinal symptoms, need for antidiarrheal drugs, presence of abdominal masses, hematocrit, and body weight. CDAI scores range from 0 to ~600 points. Clinical response=CDAI reduction ≥100 points or absolute CDAI <150 points. Clinical remission=CDAI <150 points. Moderate to severe disease=CDAI ≥220 and ≤450 points.|points|Mean|320.6|320.6|Standard Deviation|61.59|61.59|||
4345878|NCT00406653|4173777|B5|||Crohn's Disease (CD) Duration|Clinical diagnosis of CD with active disease confirmed by endoscopic, histologic, or radiographic evidence using established diagnostic criteria.|Years|Mean|9.5|9.5|Standard Deviation|8.21|8.21|||
4345879|NCT00406653|4173778|B4|||Crohn's Disease (CD) Duration|Clinical diagnosis of CD with active disease confirmed by endoscopic, histologic, or radiographic evidence using established diagnostic criteria.|Years|Mean|9.8|9.8|Standard Deviation|8.29|8.29|||
4345880|NCT00406653|4173779|B3|||Crohn's Disease (CD) Duration|Clinical diagnosis of CD with active disease confirmed by endoscopic, histologic, or radiographic evidence using established diagnostic criteria.|Years|Mean|9.2|9.2|Standard Deviation|7.98|7.98|||
4345881|NCT00406653|4173780|B2|||Crohn's Disease (CD) Duration|Clinical diagnosis of CD with active disease confirmed by endoscopic, histologic, or radiographic evidence using established diagnostic criteria.|Years|Mean|9.9|9.9|Standard Deviation|8.74|8.74|||
4345882|NCT00406653|4173781|B1|||Crohn's Disease (CD) Duration|Clinical diagnosis of CD with active disease confirmed by endoscopic, histologic, or radiographic evidence using established diagnostic criteria.|Years|Mean|8.4|8.4|Standard Deviation|7.49|7.49|||
4345883|NCT00406653|4173777|B5|No Inadequate Response/Intolerance To Prior Agents||Inadequate Response/Intolerance to Prior Anti-Tumor Necrosis Factor (TNF) Agent Therapy|Prior to this study, participants had an inadequate response and/or intolerance to an approved anti-tumor necrosis factor (TNF) agent at an approved labeled dose for at least 8 weeks.|Participants|Number|169|169.0||||||
4345884|NCT00406653|4173778|B4|No Inadequate Response/Intolerance To Prior Agents||Inadequate Response/Intolerance to Prior Anti-Tumor Necrosis Factor (TNF) Agent Therapy|Prior to this study, participants had an inadequate response and/or intolerance to an approved anti-tumor necrosis factor (TNF) agent at an approved labeled dose for at least 8 weeks.|Participants|Number|51|51.0||||||
4345885|NCT00406653|4173779|B3|No Inadequate Response/Intolerance To Prior Agents||Inadequate Response/Intolerance to Prior Anti-Tumor Necrosis Factor (TNF) Agent Therapy|Prior to this study, participants had an inadequate response and/or intolerance to an approved anti-tumor necrosis factor (TNF) agent at an approved labeled dose for at least 8 weeks.|Participants|Number|53|53.0||||||
4345886|NCT00406653|4173780|B2|No Inadequate Response/Intolerance To Prior Agents||Inadequate Response/Intolerance to Prior Anti-Tumor Necrosis Factor (TNF) Agent Therapy|Prior to this study, participants had an inadequate response and/or intolerance to an approved anti-tumor necrosis factor (TNF) agent at an approved labeled dose for at least 8 weeks.|Participants|Number|42|42.0||||||
4345887|NCT00406653|4173781|B1|No Inadequate Response/Intolerance To Prior Agents||Inadequate Response/Intolerance to Prior Anti-Tumor Necrosis Factor (TNF) Agent Therapy|Prior to this study, participants had an inadequate response and/or intolerance to an approved anti-tumor necrosis factor (TNF) agent at an approved labeled dose for at least 8 weeks.|Participants|Number|23|23.0||||||
4345888|NCT00406653|4173777|B5|Inadequate Response/Intolerance To Prior Agents||Inadequate Response/Intolerance to Prior Anti-Tumor Necrosis Factor (TNF) Agent Therapy|Prior to this study, participants had an inadequate response and/or intolerance to an approved anti-tumor necrosis factor (TNF) agent at an approved labeled dose for at least 8 weeks.|Participants|Number|282|282.0||||||
4345889|NCT00406653|4173778|B4|Inadequate Response/Intolerance To Prior Agents||Inadequate Response/Intolerance to Prior Anti-Tumor Necrosis Factor (TNF) Agent Therapy|Prior to this study, participants had an inadequate response and/or intolerance to an approved anti-tumor necrosis factor (TNF) agent at an approved labeled dose for at least 8 weeks.|Participants|Number|77|77.0||||||
4345890|NCT00406653|4173779|B3|Inadequate Response/Intolerance To Prior Agents||Inadequate Response/Intolerance to Prior Anti-Tumor Necrosis Factor (TNF) Agent Therapy|Prior to this study, participants had an inadequate response and/or intolerance to an approved anti-tumor necrosis factor (TNF) agent at an approved labeled dose for at least 8 weeks.|Participants|Number|77|77.0||||||
4345891|NCT00406653|4173780|B2|Inadequate Response/Intolerance To Prior Agents||Inadequate Response/Intolerance to Prior Anti-Tumor Necrosis Factor (TNF) Agent Therapy|Prior to this study, participants had an inadequate response and/or intolerance to an approved anti-tumor necrosis factor (TNF) agent at an approved labeled dose for at least 8 weeks.|Participants|Number|86|86.0||||||
4345892|NCT00406653|4173781|B1|Inadequate Response/Intolerance To Prior Agents||Inadequate Response/Intolerance to Prior Anti-Tumor Necrosis Factor (TNF) Agent Therapy|Prior to this study, participants had an inadequate response and/or intolerance to an approved anti-tumor necrosis factor (TNF) agent at an approved labeled dose for at least 8 weeks.|Participants|Number|42|42.0||||||
4345893|NCT00406653|4173777|B5|Netherlands||Region of Enrollment||participants|Number|10|10.0||||||
4345894|NCT00406653|4173778|B4|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4345895|NCT00406653|4173779|B3|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
4345896|NCT00406653|4173780|B2|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
4345897|NCT00406653|4173781|B1|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
4345898|NCT00406653|4173777|B5|Germany||Region of Enrollment||participants|Number|7|7.0||||||
4345899|NCT00406653|4173778|B4|Germany||Region of Enrollment||participants|Number|3|3.0||||||
4345900|NCT00406653|4173779|B3|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4345901|NCT00406653|4173780|B2|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4345902|NCT00406653|4173781|B1|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4345903|NCT00406653|4173777|B5|South Africa||Region of Enrollment||participants|Number|13|13.0||||||
4345904|NCT00406653|4173778|B4|South Africa||Region of Enrollment||participants|Number|2|2.0||||||
4345905|NCT00406653|4173779|B3|South Africa||Region of Enrollment||participants|Number|1|1.0||||||
4345906|NCT00406653|4173780|B2|South Africa||Region of Enrollment||participants|Number|5|5.0||||||
4345907|NCT00406653|4173781|B1|South Africa||Region of Enrollment||participants|Number|5|5.0||||||
4345908|NCT00406653|4173777|B5|Australia||Region of Enrollment||participants|Number|42|42.0||||||
4345909|NCT00406653|4173778|B4|Australia||Region of Enrollment||participants|Number|13|13.0||||||
4345910|NCT00406653|4173779|B3|Australia||Region of Enrollment||participants|Number|13|13.0||||||
4345911|NCT00406653|4173780|B2|Australia||Region of Enrollment||participants|Number|10|10.0||||||
4345912|NCT00406653|4173781|B1|Australia||Region of Enrollment||participants|Number|6|6.0||||||
4345913|NCT00406653|4173777|B5|Denmark||Region of Enrollment||participants|Number|17|17.0||||||
4345914|NCT00406653|4173778|B4|Denmark||Region of Enrollment||participants|Number|2|2.0||||||
4345915|NCT00406653|4173779|B3|Denmark||Region of Enrollment||participants|Number|10|10.0||||||
4345916|NCT00406653|4173780|B2|Denmark||Region of Enrollment||participants|Number|4|4.0||||||
4345917|NCT00406653|4173781|B1|Denmark||Region of Enrollment||participants|Number|1|1.0||||||
4345918|NCT00406653|4173777|B5|Korea, Democratic People's Republic of||Region of Enrollment||participants|Number|4|4.0||||||
4345919|NCT00406653|4173778|B4|Korea, Democratic People's Republic of||Region of Enrollment||participants|Number|1|1.0||||||
4345920|NCT00406653|4173779|B3|Korea, Democratic People's Republic of||Region of Enrollment||participants|Number|1|1.0||||||
4345921|NCT00406653|4173780|B2|Korea, Democratic People's Republic of||Region of Enrollment||participants|Number|1|1.0||||||
4345922|NCT00406653|4173781|B1|Korea, Democratic People's Republic of||Region of Enrollment||participants|Number|1|1.0||||||
4345923|NCT00406653|4173777|B5|Belgium||Region of Enrollment||participants|Number|31|31.0||||||
4345924|NCT00406653|4173778|B4|Belgium||Region of Enrollment||participants|Number|13|13.0||||||
4345925|NCT00406653|4173779|B3|Belgium||Region of Enrollment||participants|Number|9|9.0||||||
4345926|NCT00406653|4173780|B2|Belgium||Region of Enrollment||participants|Number|7|7.0||||||
4345927|NCT00406653|4173781|B1|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
4345928|NCT00406653|4173777|B5|Brazil||Region of Enrollment||participants|Number|22|22.0||||||
4345929|NCT00406653|4173778|B4|Brazil||Region of Enrollment||participants|Number|6|6.0||||||
4345930|NCT00406653|4173779|B3|Brazil||Region of Enrollment||participants|Number|6|6.0||||||
4345931|NCT00406653|4173780|B2|Brazil||Region of Enrollment||participants|Number|7|7.0||||||
4345932|NCT00406653|4173781|B1|Brazil||Region of Enrollment||participants|Number|3|3.0||||||
4345933|NCT00406653|4173777|B5|Canada||Region of Enrollment||participants|Number|75|75.0||||||
4345934|NCT00406653|4173778|B4|Canada||Region of Enrollment||participants|Number|27|27.0||||||
4345935|NCT00406653|4173779|B3|Canada||Region of Enrollment||participants|Number|22|22.0||||||
4345936|NCT00406653|4173780|B2|Canada||Region of Enrollment||participants|Number|18|18.0||||||
4345937|NCT00406653|4173781|B1|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4345938|NCT00406653|4173777|B5|Puerto Rico||Region of Enrollment||participants|Number|3|3.0||||||
4345939|NCT00406653|4173778|B4|Puerto Rico||Region of Enrollment||participants|Number|2|2.0||||||
4345940|NCT00406653|4173779|B3|Puerto Rico||Region of Enrollment||participants|Number|0|0.0||||||
4345941|NCT00406653|4173780|B2|Puerto Rico||Region of Enrollment||participants|Number|0|0.0||||||
4345942|NCT00406653|4173781|B1|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
4345943|NCT00406653|4173777|B5|Mexico||Region of Enrollment||participants|Number|8|8.0||||||
4345944|NCT00406653|4173778|B4|Mexico||Region of Enrollment||participants|Number|3|3.0||||||
4345945|NCT00406653|4173779|B3|Mexico||Region of Enrollment||participants|Number|0|0.0||||||
4345946|NCT00406653|4173780|B2|Mexico||Region of Enrollment||participants|Number|4|4.0||||||
4345947|NCT00406653|4173781|B1|Mexico||Region of Enrollment||participants|Number|1|1.0||||||
4345948|NCT00406653|4173777|B5|Czech Republic||Region of Enrollment||participants|Number|5|5.0||||||
4345949|NCT00406653|4173778|B4|Czech Republic||Region of Enrollment||participants|Number|2|2.0||||||
4345950|NCT00406653|4173779|B3|Czech Republic||Region of Enrollment||participants|Number|0|0.0||||||
4345951|NCT00406653|4173780|B2|Czech Republic||Region of Enrollment||participants|Number|2|2.0||||||
4345952|NCT00406653|4173781|B1|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
4345953|NCT00406653|4173777|B5|France||Region of Enrollment||participants|Number|28|28.0||||||
4345954|NCT00406653|4173778|B4|France||Region of Enrollment||participants|Number|7|7.0||||||
4345955|NCT00406653|4173779|B3|France||Region of Enrollment||participants|Number|7|7.0||||||
4345956|NCT00406653|4173780|B2|France||Region of Enrollment||participants|Number|8|8.0||||||
4345957|NCT00406653|4173781|B1|France||Region of Enrollment||participants|Number|6|6.0||||||
4345958|NCT00406653|4173777|B5|India||Region of Enrollment||participants|Number|8|8.0||||||
4345959|NCT00406653|4173778|B4|India||Region of Enrollment||participants|Number|2|2.0||||||
4345960|NCT00406653|4173779|B3|India||Region of Enrollment||participants|Number|2|2.0||||||
4345961|NCT00406653|4173780|B2|India||Region of Enrollment||participants|Number|3|3.0||||||
4345962|NCT00406653|4173781|B1|India||Region of Enrollment||participants|Number|1|1.0||||||
4345963|NCT00406653|4173777|B5|Switzerland||Region of Enrollment||participants|Number|10|10.0||||||
4345964|NCT00406653|4173778|B4|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4345965|NCT00406653|4173779|B3|Switzerland||Region of Enrollment||participants|Number|3|3.0||||||
4345966|NCT00406653|4173780|B2|Switzerland||Region of Enrollment||participants|Number|4|4.0||||||
4345967|NCT00406653|4173781|B1|Switzerland||Region of Enrollment||participants|Number|2|2.0||||||
4345968|NCT00406653|4173777|B5|Italy||Region of Enrollment||participants|Number|15|15.0||||||
4345969|NCT00406653|4173778|B4|Italy||Region of Enrollment||participants|Number|5|5.0||||||
4345970|NCT00406653|4173779|B3|Italy||Region of Enrollment||participants|Number|5|5.0||||||
4345971|NCT00406653|4173780|B2|Italy||Region of Enrollment||participants|Number|5|5.0||||||
4345972|NCT00406653|4173781|B1|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4345973|NCT00406653|4173777|B5|United States||Region of Enrollment||participants|Number|153|153.0||||||
4345974|NCT00406653|4173778|B4|United States||Region of Enrollment||participants|Number|38|38.0||||||
4345975|NCT00406653|4173779|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
4345976|NCT00406653|4173780|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
4345977|NCT00406653|4173781|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4345978|NCT00406653|4173777|B5||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4345979|NCT00406653|4173778|B4||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4345980|NCT00406653|4173779|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4345981|NCT00406653|4173780|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4345982|NCT00406653|4173781|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4345983|NCT00406653|4173777|B5||Female|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
4345984|NCT00406653|4173778|B4||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4345985|NCT00406653|4173779|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4345986|NCT00406653|4173780|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4345987|NCT00406653|4173781|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4345988|NCT00406653|4173777|B5|>50 years||Age, Customized||Participants|Number|79|79.0||||||
4345989|NCT00406653|4173778|B4|>50 years||Age, Customized||Participants|Number|23|23.0||||||
4345990|NCT00406653|4173779|B3|>50 years||Age, Customized||Participants|Number|22|22.0||||||
4345991|NCT00406653|4173780|B2|>50 years||Age, Customized||Participants|Number|27|27.0||||||
4345992|NCT00406653|4173781|B1|>50 years||Age, Customized||Participants|Number|7|7.0||||||
4345993|NCT00406653|4173777|B5|Between 30 and 50 years||Age, Customized||Participants|Number|220|220.0||||||
4345994|NCT00406653|4173778|B4|Between 30 and 50 years||Age, Customized||Participants|Number|64|64.0||||||
4345995|NCT00406653|4173779|B3|Between 30 and 50 years||Age, Customized||Participants|Number|57|57.0||||||
4345996|NCT00406653|4173780|B2|Between 30 and 50 years||Age, Customized||Participants|Number|64|64.0||||||
4345997|NCT00406653|4173781|B1|Between 30 and 50 years||Age, Customized||Participants|Number|35|35.0||||||
4345998|NCT00406653|4173777|B5|<30 years||Age, Customized||Participants|Number|152|152.0||||||
4345999|NCT00406653|4173778|B4|<30 years||Age, Customized||Participants|Number|41|41.0||||||
4346000|NCT00406653|4173779|B3|<30 years||Age, Customized||Participants|Number|51|51.0||||||
4346001|NCT00406653|4173780|B2|<30 years||Age, Customized||Participants|Number|37|37.0||||||
4346002|NCT00406653|4173781|B1|<30 years||Age, Customized||Participants|Number|23|23.0||||||
4346003|NCT00406653|4173777|B5|||Age||years|Mean|37.6|37.6|Standard Deviation|12.81|12.81|||
4346004|NCT00406653|4173778|B4|||Age||years|Mean|38.0|38.0|Standard Deviation|12.98|12.98|||
4346005|NCT00406653|4173779|B3|||Age||years|Mean|36.9|36.9|Standard Deviation|13.35|13.35|||
4346006|NCT00406653|4173780|B2|||Age||years|Mean|38.6|38.6|Standard Deviation|12.90|12.9|||
4346007|NCT00406653|4173781|B1|||Age||years|Mean|36.0|36.0|Standard Deviation|11.12|11.12|||
4346008|NCT00406640|4173866|B3|Colombia||Region of Enrollment||participants|Number|41|41.0||||||
4346009|NCT00406640|4173867|B2|Colombia||Region of Enrollment||participants|Number|20|20.0||||||
4346010|NCT00406640|4173868|B1|Colombia||Region of Enrollment||participants|Number|21|21.0||||||
4346011|NCT00406640|4173866|B3|Chile||Region of Enrollment||participants|Number|20|20.0||||||
4346012|NCT00406640|4173867|B2|Chile||Region of Enrollment||participants|Number|9|9.0||||||
4346013|NCT00406640|4173868|B1|Chile||Region of Enrollment||participants|Number|11|11.0||||||
4346014|NCT00406640|4173866|B3|Argentina||Region of Enrollment||participants|Number|85|85.0||||||
4346015|NCT00406640|4173867|B2|Argentina||Region of Enrollment||participants|Number|42|42.0||||||
4346016|NCT00406640|4173868|B1|Argentina||Region of Enrollment||participants|Number|43|43.0||||||
4346017|NCT00406640|4173866|B3|Mexico||Region of Enrollment||participants|Number|19|19.0||||||
4346018|NCT00406640|4173867|B2|Mexico||Region of Enrollment||participants|Number|9|9.0||||||
4346019|NCT00406640|4173868|B1|Mexico||Region of Enrollment||participants|Number|10|10.0||||||
4346020|NCT00406640|4173866|B3|United States||Region of Enrollment||participants|Number|430|430.0||||||
4346021|NCT00406640|4173867|B2|United States||Region of Enrollment||participants|Number|219|219.0||||||
4346022|NCT00406640|4173868|B1|United States||Region of Enrollment||participants|Number|211|211.0||||||
4346023|NCT00406640|4173866|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4346024|NCT00406640|4173867|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4346025|NCT00406640|4173868|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4346026|NCT00406640|4173866|B3||Female|Sex: Female, Male||Participants|Count of Participants|595|595.0||||||
4346027|NCT00406640|4173867|B2||Female|Sex: Female, Male||Participants|Count of Participants|299|299.0||||||
4346028|NCT00406640|4173868|B1||Female|Sex: Female, Male||Participants|Count of Participants|296|296.0||||||
4346029|NCT00406640|4173866|B3|||Age||years|Mean|55.97|55.97|Standard Deviation|6.19|6.19|||
4346030|NCT00406640|4173867|B2|||Age||years|Mean|56.15|56.15|Standard Deviation|6.25|6.25|||
4346031|NCT00406640|4173868|B1|||Age||years|Mean|55.78|55.78|Standard Deviation|6.13|6.13|||
4346032|NCT00406393|4173899|B3|Etoposide/Total Body Irradiation||Conditioning Regimen||participants|Number|58|58.0||||||
4346033|NCT00406393|4173900|B2|Etoposide/Total Body Irradiation||Conditioning Regimen||participants|Number|31|31.0||||||
4346034|NCT00406393|4173901|B1|Etoposide/Total Body Irradiation||Conditioning Regimen||participants|Number|27|27.0||||||
4346035|NCT00406393|4173899|B3|Cyclophosphamide/Total Body Irradiation||Conditioning Regimen||participants|Number|246|246.0||||||
4346036|NCT00406393|4173900|B2|Cyclophosphamide/Total Body Irradiation||Conditioning Regimen||participants|Number|122|122.0||||||
4346037|NCT00406393|4173901|B1|Cyclophosphamide/Total Body Irradiation||Conditioning Regimen||participants|Number|124|124.0||||||
4346038|NCT00406393|4173899|B3|Missing||Recipient-Donor Cytomegalovirus Status|Seropositivity (+) or Seronegativity (-) for the recipient / Seropositivity (+) or Seronegativity (-) for the donor|participants|Number|18|18.0||||||
4346039|NCT00406393|4173900|B2|Missing||Recipient-Donor Cytomegalovirus Status|Seropositivity (+) or Seronegativity (-) for the recipient / Seropositivity (+) or Seronegativity (-) for the donor|participants|Number|8|8.0||||||
4346040|NCT00406393|4173901|B1|Missing||Recipient-Donor Cytomegalovirus Status|Seropositivity (+) or Seronegativity (-) for the recipient / Seropositivity (+) or Seronegativity (-) for the donor|participants|Number|10|10.0||||||
4346041|NCT00406393|4173899|B3|-/-||Recipient-Donor Cytomegalovirus Status|Seropositivity (+) or Seronegativity (-) for the recipient / Seropositivity (+) or Seronegativity (-) for the donor|participants|Number|68|68.0||||||
4346042|NCT00406393|4173900|B2|-/-||Recipient-Donor Cytomegalovirus Status|Seropositivity (+) or Seronegativity (-) for the recipient / Seropositivity (+) or Seronegativity (-) for the donor|participants|Number|30|30.0||||||
4346043|NCT00406393|4173901|B1|-/-||Recipient-Donor Cytomegalovirus Status|Seropositivity (+) or Seronegativity (-) for the recipient / Seropositivity (+) or Seronegativity (-) for the donor|participants|Number|38|38.0||||||
4346044|NCT00406393|4173899|B3|-/+||Recipient-Donor Cytomegalovirus Status|Seropositivity (+) or Seronegativity (-) for the recipient / Seropositivity (+) or Seronegativity (-) for the donor|participants|Number|74|74.0||||||
4346045|NCT00406393|4173900|B2|-/+||Recipient-Donor Cytomegalovirus Status|Seropositivity (+) or Seronegativity (-) for the recipient / Seropositivity (+) or Seronegativity (-) for the donor|participants|Number|44|44.0||||||
4346046|NCT00406393|4173901|B1|-/+||Recipient-Donor Cytomegalovirus Status|Seropositivity (+) or Seronegativity (-) for the recipient / Seropositivity (+) or Seronegativity (-) for the donor|participants|Number|30|30.0||||||
4346047|NCT00406393|4173899|B3|+/-||Recipient-Donor Cytomegalovirus Status|Seropositivity (+) or Seronegativity (-) for the recipient / Seropositivity (+) or Seronegativity (-) for the donor|participants|Number|38|38.0||||||
4346048|NCT00406393|4173900|B2|+/-||Recipient-Donor Cytomegalovirus Status|Seropositivity (+) or Seronegativity (-) for the recipient / Seropositivity (+) or Seronegativity (-) for the donor|participants|Number|24|24.0||||||
4346049|NCT00406393|4173901|B1|+/-||Recipient-Donor Cytomegalovirus Status|Seropositivity (+) or Seronegativity (-) for the recipient / Seropositivity (+) or Seronegativity (-) for the donor|participants|Number|14|14.0||||||
4346050|NCT00406393|4173899|B3|+/+||Recipient-Donor Cytomegalovirus Status|Seropositivity (+) or Seronegativity (-) for the recipient / Seropositivity (+) or Seronegativity (-) for the donor|participants|Number|106|106.0||||||
4346051|NCT00406393|4173900|B2|+/+||Recipient-Donor Cytomegalovirus Status|Seropositivity (+) or Seronegativity (-) for the recipient / Seropositivity (+) or Seronegativity (-) for the donor|participants|Number|47|47.0||||||
4346052|NCT00406393|4173901|B1|+/+||Recipient-Donor Cytomegalovirus Status|Seropositivity (+) or Seronegativity (-) for the recipient / Seropositivity (+) or Seronegativity (-) for the donor|participants|Number|59|59.0||||||
4346053|NCT00406393|4173899|B3|Scores < 90||Karnofsky Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|87|87.0||||||
4346054|NCT00406393|4173900|B2|Scores < 90||Karnofsky Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|37|37.0||||||
4346055|NCT00406393|4173901|B1|Scores < 90||Karnofsky Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|50|50.0||||||
4346056|NCT00406393|4173899|B3|Scores 90 - 100||Karnofsky Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|217|217.0||||||
4346057|NCT00406393|4173900|B2|Scores 90 - 100||Karnofsky Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|116|116.0||||||
4346058|NCT00406393|4173901|B1|Scores 90 - 100||Karnofsky Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|101|101.0||||||
4346059|NCT00406393|4173899|B3|MDS||Disease Status at Transplantation||participants|Number|26|26.0||||||
4346060|NCT00406393|4173900|B2|MDS||Disease Status at Transplantation||participants|Number|7|7.0||||||
4346061|NCT00406393|4173901|B1|MDS||Disease Status at Transplantation||participants|Number|19|19.0||||||
4346062|NCT00406393|4173899|B3|ABL 1st Complete Remission||Disease Status at Transplantation||participants|Number|2|2.0||||||
4346063|NCT00406393|4173900|B2|ABL 1st Complete Remission||Disease Status at Transplantation||participants|Number|1|1.0||||||
4346064|NCT00406393|4173901|B1|ABL 1st Complete Remission||Disease Status at Transplantation||participants|Number|1|1.0||||||
4346065|NCT00406393|4173899|B3|CML 2nd Complete Remission||Disease Status at Transplantation||participants|Number|6|6.0||||||
4346066|NCT00406393|4173900|B2|CML 2nd Complete Remission||Disease Status at Transplantation||participants|Number|4|4.0||||||
4346067|NCT00406393|4173901|B1|CML 2nd Complete Remission||Disease Status at Transplantation||participants|Number|2|2.0||||||
4346068|NCT00406393|4173899|B3|CML 1st Complete Remission||Disease Status at Transplantation||participants|Number|17|17.0||||||
4346069|NCT00406393|4173900|B2|CML 1st Complete Remission||Disease Status at Transplantation||participants|Number|10|10.0||||||
4346070|NCT00406393|4173901|B1|CML 1st Complete Remission||Disease Status at Transplantation||participants|Number|7|7.0||||||
4346071|NCT00406393|4173899|B3|ALL 2nd Complete Remission||Disease Status at Transplantation||participants|Number|23|23.0||||||
4346072|NCT00406393|4173900|B2|ALL 2nd Complete Remission||Disease Status at Transplantation||participants|Number|13|13.0||||||
4346073|NCT00406393|4173901|B1|ALL 2nd Complete Remission||Disease Status at Transplantation||participants|Number|10|10.0||||||
4346074|NCT00406393|4173899|B3|ALL 1st Complete Remission||Disease Status at Transplantation||participants|Number|96|96.0||||||
4346075|NCT00406393|4173900|B2|ALL 1st Complete Remission||Disease Status at Transplantation||participants|Number|55|55.0||||||
4346076|NCT00406393|4173901|B1|ALL 1st Complete Remission||Disease Status at Transplantation||participants|Number|41|41.0||||||
4346077|NCT00406393|4173899|B3|AML 2nd Complete Remission||Disease Status at Transplantation||participants|Number|18|18.0||||||
4346078|NCT00406393|4173900|B2|AML 2nd Complete Remission||Disease Status at Transplantation||participants|Number|7|7.0||||||
4346079|NCT00406393|4173901|B1|AML 2nd Complete Remission||Disease Status at Transplantation||participants|Number|11|11.0||||||
4346080|NCT00406393|4173899|B3|AML 1st Complete Remission||Disease Status at Transplantation||participants|Number|116|116.0||||||
4346081|NCT00406393|4173900|B2|AML 1st Complete Remission||Disease Status at Transplantation||participants|Number|56|56.0||||||
4346082|NCT00406393|4173901|B1|AML 1st Complete Remission||Disease Status at Transplantation||participants|Number|60|60.0||||||
4346083|NCT00406393|4173899|B3|Acute Biphenotypic Leukemia (ABL)||Primary Disease||participants|Number|2|2.0||||||
4346084|NCT00406393|4173900|B2|Acute Biphenotypic Leukemia (ABL)||Primary Disease||participants|Number|1|1.0||||||
4346085|NCT00406393|4173901|B1|Acute Biphenotypic Leukemia (ABL)||Primary Disease||participants|Number|1|1.0||||||
4346086|NCT00406393|4173899|B3|Myelodysplastic Syndrome (MDS)||Primary Disease||participants|Number|26|26.0||||||
4346087|NCT00406393|4173900|B2|Myelodysplastic Syndrome (MDS)||Primary Disease||participants|Number|7|7.0||||||
4346088|NCT00406393|4173901|B1|Myelodysplastic Syndrome (MDS)||Primary Disease||participants|Number|19|19.0||||||
4346089|NCT00406393|4173899|B3|Chronic Myelogenous Leukemia (CML)||Primary Disease||participants|Number|23|23.0||||||
4346090|NCT00406393|4173900|B2|Chronic Myelogenous Leukemia (CML)||Primary Disease||participants|Number|14|14.0||||||
4346091|NCT00406393|4173901|B1|Chronic Myelogenous Leukemia (CML)||Primary Disease||participants|Number|9|9.0||||||
4346092|NCT00406393|4173899|B3|Acute Lymphoblastic Leukemia (ALL)||Primary Disease||participants|Number|119|119.0||||||
4346093|NCT00406393|4173900|B2|Acute Lymphoblastic Leukemia (ALL)||Primary Disease||participants|Number|68|68.0||||||
4346094|NCT00406393|4173901|B1|Acute Lymphoblastic Leukemia (ALL)||Primary Disease||participants|Number|51|51.0||||||
4346095|NCT00406393|4173899|B3|Acute Myelogenous Leukemia (AML)||Primary Disease||participants|Number|134|134.0||||||
4346096|NCT00406393|4173900|B2|Acute Myelogenous Leukemia (AML)||Primary Disease||participants|Number|63|63.0||||||
4346097|NCT00406393|4173901|B1|Acute Myelogenous Leukemia (AML)||Primary Disease||participants|Number|71|71.0||||||
4346098|NCT00406393|4173899|B3||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4346099|NCT00406393|4173900|B2||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4346100|NCT00406393|4173901|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4346101|NCT00406393|4173899|B3||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4346102|NCT00406393|4173900|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4346103|NCT00406393|4173901|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4346104|NCT00406393|4173899|B3|||Age||years|Median|44|44.0|Full Range|||13.0|59.0|
4346105|NCT00406393|4173900|B2|||Age||years|Median|43|43.0|Full Range|||13.0|58.0|
4346106|NCT00406393|4173901|B1|||Age||years|Median|45|45.0|Full Range|||19.0|59.0|
4346107|NCT00406367|4173930|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4346108|NCT00406367|4173931|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4346109|NCT00406367|4173932|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4346110|NCT00406367|4173930|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4346111|NCT00406367|4173931|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4346112|NCT00406367|4173932|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4346113|NCT00406367|4173930|B3|||Age||years|Mean|61.9|61.9|Standard Deviation|10.3|10.3|||
4346114|NCT00406367|4173931|B2|||Age||years|Mean|62.6|62.6|Standard Deviation|8.7|8.7|||
4346115|NCT00406367|4173932|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|11.0|11.0|||
4346116|NCT00406354|4173945|B4|||Swanson, Nolan & Pelham Rating Scale-Revised (SNAP-IV): ADHD Combined Score|SNAP-IV is a 26-item scale that includes 1 item for each of 18 symptoms in the DSM-IV diagnosis of ADHD and 1 item for each of 8 symptoms in the DSM-IV diagnosis of ODD. Each item is scored on a 0 to 3 scale (0=Not at All, 1=Just a Little, 2=Pretty Much, 3=Very Much). SNAP-IV yields scores in 3 domains: Inattention (items 1-9: subscore range=0-27), Hyperactivity/impulsivity (items 10-18: subscale range=0-27), and Oppositional (items 19-26: subscale range=0-24). SNAP-IV ADHD combined score (inattention + hyperactivity/impulsivity) range=0-54.|units on a scale|Mean|37.3|37.3|Standard Deviation|9.28|9.28|||
4346117|NCT00406354|4173946|B3|||Swanson, Nolan & Pelham Rating Scale-Revised (SNAP-IV): ADHD Combined Score|SNAP-IV is a 26-item scale that includes 1 item for each of 18 symptoms in the DSM-IV diagnosis of ADHD and 1 item for each of 8 symptoms in the DSM-IV diagnosis of ODD. Each item is scored on a 0 to 3 scale (0=Not at All, 1=Just a Little, 2=Pretty Much, 3=Very Much). SNAP-IV yields scores in 3 domains: Inattention (items 1-9: subscore range=0-27), Hyperactivity/impulsivity (items 10-18: subscale range=0-27), and Oppositional (items 19-26: subscale range=0-24). SNAP-IV ADHD combined score (inattention + hyperactivity/impulsivity) range=0-54.|units on a scale|Mean|36.4|36.4|Standard Deviation|9.31|9.31|||
4346118|NCT00406354|4173947|B2|||Swanson, Nolan & Pelham Rating Scale-Revised (SNAP-IV): ADHD Combined Score|SNAP-IV is a 26-item scale that includes 1 item for each of 18 symptoms in the DSM-IV diagnosis of ADHD and 1 item for each of 8 symptoms in the DSM-IV diagnosis of ODD. Each item is scored on a 0 to 3 scale (0=Not at All, 1=Just a Little, 2=Pretty Much, 3=Very Much). SNAP-IV yields scores in 3 domains: Inattention (items 1-9: subscore range=0-27), Hyperactivity/impulsivity (items 10-18: subscale range=0-27), and Oppositional (items 19-26: subscale range=0-24). SNAP-IV ADHD combined score (inattention + hyperactivity/impulsivity) range=0-54.|units on a scale|Mean|38.0|38.0|Standard Deviation|8.91|8.91|||
4346119|NCT00406354|4173948|B1|||Swanson, Nolan & Pelham Rating Scale-Revised (SNAP-IV): ADHD Combined Score|SNAP-IV is a 26-item scale that includes 1 item for each of 18 symptoms in the DSM-IV diagnosis of ADHD and 1 item for each of 8 symptoms in the DSM-IV diagnosis of ODD. Each item is scored on a 0 to 3 scale (0=Not at All, 1=Just a Little, 2=Pretty Much, 3=Very Much). SNAP-IV yields scores in 3 domains: Inattention (items 1-9: subscore range=0-27), Hyperactivity/impulsivity (items 10-18: subscale range=0-27), and Oppositional (items 19-26: subscale range=0-24). SNAP-IV ADHD combined score (inattention + hyperactivity/impulsivity) range=0-54.|units on a scale|Mean|37.6|37.6|Standard Deviation|9.70|9.7|||
4346120|NCT00406354|4173945|B4|||Swanson, Nolan & Pelham Rating Scale - Revised (SNAP-IV): ODD Score|The SNAP-IV, ODD subscale (items 19-26) scores the intensity of each item during the last seven days on a 0 to 3 scale (0=not at all, 1=just a little, 2=pretty much, 3=very much). The lowest possible score is 0; highest is 24.|units on a scale|Mean|15.5|15.5|Standard Deviation|4.35|4.35|||
4346121|NCT00406354|4173946|B3|||Swanson, Nolan & Pelham Rating Scale - Revised (SNAP-IV): ODD Score|The SNAP-IV, ODD subscale (items 19-26) scores the intensity of each item during the last seven days on a 0 to 3 scale (0=not at all, 1=just a little, 2=pretty much, 3=very much). The lowest possible score is 0; highest is 24.|units on a scale|Mean|15.6|15.6|Standard Deviation|5.13|5.13|||
4346122|NCT00406354|4173947|B2|||Swanson, Nolan & Pelham Rating Scale - Revised (SNAP-IV): ODD Score|The SNAP-IV, ODD subscale (items 19-26) scores the intensity of each item during the last seven days on a 0 to 3 scale (0=not at all, 1=just a little, 2=pretty much, 3=very much). The lowest possible score is 0; highest is 24.|units on a scale|Mean|15.6|15.6|Standard Deviation|3.82|3.82|||
4346123|NCT00406354|4173948|B1|||Swanson, Nolan & Pelham Rating Scale - Revised (SNAP-IV): ODD Score|The SNAP-IV, ODD subscale (items 19-26) scores the intensity of each item during the last seven days on a 0 to 3 scale (0=not at all, 1=just a little, 2=pretty much, 3=very much). The lowest possible score is 0; highest is 24.|units on a scale|Mean|15.5|15.5|Standard Deviation|4.07|4.07|||
4346124|NCT00406354|4173945|B4|||Swanson, Nolan & Pelham Rating Scale - Revised (SNAP-IV): Hyperactivity/Impulsivity Score|The SNAP-IV, ADHD Hyperactivity/Impulsivity subscale (items 10-18) scores the intensity of each item during the last seven days on a 0 to 3 scale (0=not at all, 1=just a little, 2=pretty much, 3=very much). The lowest possible score is 0; highest is 27.|units on a scale|Mean|19.5|19.5|Standard Deviation|4.85|4.85|||
4346125|NCT00406354|4173946|B3|||Swanson, Nolan & Pelham Rating Scale - Revised (SNAP-IV): Hyperactivity/Impulsivity Score|The SNAP-IV, ADHD Hyperactivity/Impulsivity subscale (items 10-18) scores the intensity of each item during the last seven days on a 0 to 3 scale (0=not at all, 1=just a little, 2=pretty much, 3=very much). The lowest possible score is 0; highest is 27.|units on a scale|Mean|18.9|18.9|Standard Deviation|4.85|4.85|||
4346126|NCT00406354|4173947|B2|||Swanson, Nolan & Pelham Rating Scale - Revised (SNAP-IV): Hyperactivity/Impulsivity Score|The SNAP-IV, ADHD Hyperactivity/Impulsivity subscale (items 10-18) scores the intensity of each item during the last seven days on a 0 to 3 scale (0=not at all, 1=just a little, 2=pretty much, 3=very much). The lowest possible score is 0; highest is 27.|units on a scale|Mean|19.7|19.7|Standard Deviation|4.76|4.76|||
4346127|NCT00406354|4173948|B1|||Swanson, Nolan & Pelham Rating Scale - Revised (SNAP-IV): Hyperactivity/Impulsivity Score|The SNAP-IV, ADHD Hyperactivity/Impulsivity subscale (items 10-18) scores the intensity of each item during the last seven days on a 0 to 3 scale (0=not at all, 1=just a little, 2=pretty much, 3=very much). The lowest possible score is 0; highest is 27.|units on a scale|Mean|19.9|19.9|Standard Deviation|4.98|4.98|||
4346128|NCT00406354|4173945|B4|||Swanson, Nolan & Pelham Rating Scale - Revised (SNAP-IV): ADHD Inattention Subscale Score|The SNAP-IV, ADHD Inattention subscale (items 1-9) scores the intensity of each item during the last seven days on a 0 to 3 scale (0=not at all, 1=just a little, 2=pretty much, 3=very much). The lowest possible score is 0; highest is 27.|units on a scale|Mean|17.9|17.9|Standard Deviation|5.01|5.01|||
4346129|NCT00406354|4173946|B3|||Swanson, Nolan & Pelham Rating Scale - Revised (SNAP-IV): ADHD Inattention Subscale Score|The SNAP-IV, ADHD Inattention subscale (items 1-9) scores the intensity of each item during the last seven days on a 0 to 3 scale (0=not at all, 1=just a little, 2=pretty much, 3=very much). The lowest possible score is 0; highest is 27.|units on a scale|Mean|17.5|17.5|Standard Deviation|4.94|4.94|||
4346130|NCT00406354|4173947|B2|||Swanson, Nolan & Pelham Rating Scale - Revised (SNAP-IV): ADHD Inattention Subscale Score|The SNAP-IV, ADHD Inattention subscale (items 1-9) scores the intensity of each item during the last seven days on a 0 to 3 scale (0=not at all, 1=just a little, 2=pretty much, 3=very much). The lowest possible score is 0; highest is 27.|units on a scale|Mean|18.3|18.3|Standard Deviation|4.91|4.91|||
4346131|NCT00406354|4173948|B1|||Swanson, Nolan & Pelham Rating Scale - Revised (SNAP-IV): ADHD Inattention Subscale Score|The SNAP-IV, ADHD Inattention subscale (items 1-9) scores the intensity of each item during the last seven days on a 0 to 3 scale (0=not at all, 1=just a little, 2=pretty much, 3=very much). The lowest possible score is 0; highest is 27.|units on a scale|Mean|17.7|17.7|Standard Deviation|5.23|5.23|||
4346132|NCT00406354|4173945|B4|||Parent-Rated Oppositional Defiant/Conduct Disorders Scale (FBB-SSV): Total Score, Severity|"FBB-SSV (Fremdbeurteilungsbogen fur Storungen des Sozialverhaltens), the German, parent-rated oppositional defiant/conduct disorders scale, covers 23 criteria for ODD and 25 for conduct disorder (CD) in four sections. Parents rated symptom severity of each item during the last 7 days on a 0 to 3 scale (0=not at all to 3=very much). The total score was calculated for ODD/CD overall (sum of ratings for items 1-17, divided by 17). Higher scores indicate higher severity of symptoms."|units on a scale|Mean|1.4|1.4|Standard Deviation|0.52|0.52|||
4346133|NCT00406354|4173946|B3|||Parent-Rated Oppositional Defiant/Conduct Disorders Scale (FBB-SSV): Total Score, Severity|"FBB-SSV (Fremdbeurteilungsbogen fur Storungen des Sozialverhaltens), the German, parent-rated oppositional defiant/conduct disorders scale, covers 23 criteria for ODD and 25 for conduct disorder (CD) in four sections. Parents rated symptom severity of each item during the last 7 days on a 0 to 3 scale (0=not at all to 3=very much). The total score was calculated for ODD/CD overall (sum of ratings for items 1-17, divided by 17). Higher scores indicate higher severity of symptoms."|units on a scale|Mean|1.4|1.4|Standard Deviation|0.56|0.56|||
4346134|NCT00406354|4173947|B2|||Parent-Rated Oppositional Defiant/Conduct Disorders Scale (FBB-SSV): Total Score, Severity|"FBB-SSV (Fremdbeurteilungsbogen fur Storungen des Sozialverhaltens), the German, parent-rated oppositional defiant/conduct disorders scale, covers 23 criteria for ODD and 25 for conduct disorder (CD) in four sections. Parents rated symptom severity of each item during the last 7 days on a 0 to 3 scale (0=not at all to 3=very much). The total score was calculated for ODD/CD overall (sum of ratings for items 1-17, divided by 17). Higher scores indicate higher severity of symptoms."|units on a scale|Mean|1.4|1.4|Standard Deviation|0.49|0.49|||
4346135|NCT00406354|4173948|B1|||Parent-Rated Oppositional Defiant/Conduct Disorders Scale (FBB-SSV): Total Score, Severity|"FBB-SSV (Fremdbeurteilungsbogen fur Storungen des Sozialverhaltens), the German, parent-rated oppositional defiant/conduct disorders scale, covers 23 criteria for ODD and 25 for conduct disorder (CD) in four sections. Parents rated symptom severity of each item during the last 7 days on a 0 to 3 scale (0=not at all to 3=very much). The total score was calculated for ODD/CD overall (sum of ratings for items 1-17, divided by 17). Higher scores indicate higher severity of symptoms."|units on a scale|Mean|1.4|1.4|Standard Deviation|0.53|0.53|||
4346147|NCT00406354|4173948|B1|||Investigator-Rated Individual Target Behaviors (ITB-Inv): Frequency Score|ITB-Inv assesses frequency and intensity of individually-defined target behaviors. The investigator defines 3 individual behavior problems based on interviews & additional information. Those most impairing for the child or stressful for the parents will be chosen as target behavior. Frequency of each target behavior during the last 7 days is rated on a 6-point scale (0=never to 5=always) with 0 as lowest possible score and 15 the highest possible score.|units on a scale|Mean|10.9|10.9|Standard Deviation|2.03|2.03|||
4346136|NCT00406354|4173945|B4|||Parent-Rated Attention-Deficit Scale (FBB-HKS): Total Score, Severity|"FBB-HKS (Fremdbeurteilungsbogen fur Hyperkinetische Storungen), the German, parent-rated scale for attention-deficit, is a 20-item rating scale which describes ADHD symptom criteria of DSM-IV and is grouped based upon the 3 ADHD domains: inattention (items 1-9); hyperactivity (items 10-16); impulsivity (items 17-20). Parents rated symptom severity of each item during the last 7 days on a 0 to 3 scale (0=not at all to 3=very much). The total score was calculated for ADHD overall (sum of ratings for items 1-20, divided by 20). High scores indicate high severity of symptoms."|units on a scale|Mean|2.0|2.0|Standard Deviation|0.56|0.56|||
4346137|NCT00406354|4173946|B3|||Parent-Rated Attention-Deficit Scale (FBB-HKS): Total Score, Severity|"FBB-HKS (Fremdbeurteilungsbogen fur Hyperkinetische Storungen), the German, parent-rated scale for attention-deficit, is a 20-item rating scale which describes ADHD symptom criteria of DSM-IV and is grouped based upon the 3 ADHD domains: inattention (items 1-9); hyperactivity (items 10-16); impulsivity (items 17-20). Parents rated symptom severity of each item during the last 7 days on a 0 to 3 scale (0=not at all to 3=very much). The total score was calculated for ADHD overall (sum of ratings for items 1-20, divided by 20). High scores indicate high severity of symptoms."|units on a scale|Mean|1.9|1.9|Standard Deviation|0.52|0.52|||
4346138|NCT00406354|4173947|B2|||Parent-Rated Attention-Deficit Scale (FBB-HKS): Total Score, Severity|"FBB-HKS (Fremdbeurteilungsbogen fur Hyperkinetische Storungen), the German, parent-rated scale for attention-deficit, is a 20-item rating scale which describes ADHD symptom criteria of DSM-IV and is grouped based upon the 3 ADHD domains: inattention (items 1-9); hyperactivity (items 10-16); impulsivity (items 17-20). Parents rated symptom severity of each item during the last 7 days on a 0 to 3 scale (0=not at all to 3=very much). The total score was calculated for ADHD overall (sum of ratings for items 1-20, divided by 20). High scores indicate high severity of symptoms."|units on a scale|Mean|2.0|2.0|Standard Deviation|0.54|0.54|||
4346139|NCT00406354|4173948|B1|||Parent-Rated Attention-Deficit Scale (FBB-HKS): Total Score, Severity|"FBB-HKS (Fremdbeurteilungsbogen fur Hyperkinetische Storungen), the German, parent-rated scale for attention-deficit, is a 20-item rating scale which describes ADHD symptom criteria of DSM-IV and is grouped based upon the 3 ADHD domains: inattention (items 1-9); hyperactivity (items 10-16); impulsivity (items 17-20). Parents rated symptom severity of each item during the last 7 days on a 0 to 3 scale (0=not at all to 3=very much). The total score was calculated for ADHD overall (sum of ratings for items 1-20, divided by 20). High scores indicate high severity of symptoms."|units on a scale|Mean|2.0|2.0|Standard Deviation|0.62|0.62|||
4346140|NCT00406354|4173945|B4|||Investigator-Rated Individual Target Behaviors (ITB-Inv): Intensity Score|ITB-Inv assesses frequency and intensity of individually-defined target behaviors. The investigator defines 3 individual behavior problems based on interviews & additional information. Those most impairing for the child or stressful for the parents will be chosen as target behavior. Intensity during the last 7 days is rated on a 10-point scale (0=no problems to 9=most severe problems) with the lowest possible score of 0 and the highest possible of 27.|units on a scale|Mean|21.3|21.3|Standard Deviation|3.56|3.56|||
4346141|NCT00406354|4173946|B3|||Investigator-Rated Individual Target Behaviors (ITB-Inv): Intensity Score|ITB-Inv assesses frequency and intensity of individually-defined target behaviors. The investigator defines 3 individual behavior problems based on interviews & additional information. Those most impairing for the child or stressful for the parents will be chosen as target behavior. Intensity during the last 7 days is rated on a 10-point scale (0=no problems to 9=most severe problems) with the lowest possible score of 0 and the highest possible of 27.|units on a scale|Mean|20.5|20.5|Standard Deviation|3.57|3.57|||
4346142|NCT00406354|4173947|B2|||Investigator-Rated Individual Target Behaviors (ITB-Inv): Intensity Score|ITB-Inv assesses frequency and intensity of individually-defined target behaviors. The investigator defines 3 individual behavior problems based on interviews & additional information. Those most impairing for the child or stressful for the parents will be chosen as target behavior. Intensity during the last 7 days is rated on a 10-point scale (0=no problems to 9=most severe problems) with the lowest possible score of 0 and the highest possible of 27.|units on a scale|Mean|22.1|22.1|Standard Deviation|3.39|3.39|||
4346143|NCT00406354|4173948|B1|||Investigator-Rated Individual Target Behaviors (ITB-Inv): Intensity Score|ITB-Inv assesses frequency and intensity of individually-defined target behaviors. The investigator defines 3 individual behavior problems based on interviews & additional information. Those most impairing for the child or stressful for the parents will be chosen as target behavior. Intensity during the last 7 days is rated on a 10-point scale (0=no problems to 9=most severe problems) with the lowest possible score of 0 and the highest possible of 27.|units on a scale|Mean|21.3|21.3|Standard Deviation|3.62|3.62|||
4346144|NCT00406354|4173945|B4|||Investigator-Rated Individual Target Behaviors (ITB-Inv): Frequency Score|ITB-Inv assesses frequency and intensity of individually-defined target behaviors. The investigator defines 3 individual behavior problems based on interviews & additional information. Those most impairing for the child or stressful for the parents will be chosen as target behavior. Frequency of each target behavior during the last 7 days is rated on a 6-point scale (0=never to 5=always) with 0 as lowest possible score and 15 the highest possible score.|units on a scale|Mean|11.2|11.2|Standard Deviation|2.27|2.27|||
4346145|NCT00406354|4173946|B3|||Investigator-Rated Individual Target Behaviors (ITB-Inv): Frequency Score|ITB-Inv assesses frequency and intensity of individually-defined target behaviors. The investigator defines 3 individual behavior problems based on interviews & additional information. Those most impairing for the child or stressful for the parents will be chosen as target behavior. Frequency of each target behavior during the last 7 days is rated on a 6-point scale (0=never to 5=always) with 0 as lowest possible score and 15 the highest possible score.|units on a scale|Mean|11.3|11.3|Standard Deviation|2.67|2.67|||
4346146|NCT00406354|4173947|B2|||Investigator-Rated Individual Target Behaviors (ITB-Inv): Frequency Score|ITB-Inv assesses frequency and intensity of individually-defined target behaviors. The investigator defines 3 individual behavior problems based on interviews & additional information. Those most impairing for the child or stressful for the parents will be chosen as target behavior. Frequency of each target behavior during the last 7 days is rated on a 6-point scale (0=never to 5=always) with 0 as lowest possible score and 15 the highest possible score.|units on a scale|Mean|11.4|11.4|Standard Deviation|2.06|2.06|||
4346195|NCT00406354|4173948|B1|Adjustment disorder, emotion, conduct disturbance||Summary of ODD Diagnosis|Breakdown of ODD diagnosis in accordance with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).|participants|Number|1|1.0||||||
4346148|NCT00406354|4173945|B4|||Impact on Family Scale (FaBel): Total Impact Score|Family burden is assessed by the FaBel questionnaire (German version of the Impact on Family Scale). Questionnaire is answered by participant's caregiver and contains 33 Likert-scaled items to assess general negative impact (of a disability, disorder, disease) on parents, description of social relationships, concern for siblings, financial impact, problems in coping as well as a total score. Each item is rated on a 4-point scale (1=fully applies, 4=applies not at all). Total scores range from 24-96. Higher scores correspond to higher family burden.|units on a scale|Mean|53.8|53.8|Standard Deviation|12.89|12.89|||
4346149|NCT00406354|4173946|B3|||Impact on Family Scale (FaBel): Total Impact Score|Family burden is assessed by the FaBel questionnaire (German version of the Impact on Family Scale). Questionnaire is answered by participant's caregiver and contains 33 Likert-scaled items to assess general negative impact (of a disability, disorder, disease) on parents, description of social relationships, concern for siblings, financial impact, problems in coping as well as a total score. Each item is rated on a 4-point scale (1=fully applies, 4=applies not at all). Total scores range from 24-96. Higher scores correspond to higher family burden.|units on a scale|Mean|53.9|53.9|Standard Deviation|12.83|12.83|||
4346150|NCT00406354|4173947|B2|||Impact on Family Scale (FaBel): Total Impact Score|Family burden is assessed by the FaBel questionnaire (German version of the Impact on Family Scale). Questionnaire is answered by participant's caregiver and contains 33 Likert-scaled items to assess general negative impact (of a disability, disorder, disease) on parents, description of social relationships, concern for siblings, financial impact, problems in coping as well as a total score. Each item is rated on a 4-point scale (1=fully applies, 4=applies not at all). Total scores range from 24-96. Higher scores correspond to higher family burden.|units on a scale|Mean|54.1|54.1|Standard Deviation|13.15|13.15|||
4346151|NCT00406354|4173948|B1|||Impact on Family Scale (FaBel): Total Impact Score|Family burden is assessed by the FaBel questionnaire (German version of the Impact on Family Scale). Questionnaire is answered by participant's caregiver and contains 33 Likert-scaled items to assess general negative impact (of a disability, disorder, disease) on parents, description of social relationships, concern for siblings, financial impact, problems in coping as well as a total score. Each item is rated on a 4-point scale (1=fully applies, 4=applies not at all). Total scores range from 24-96. Higher scores correspond to higher family burden.|units on a scale|Mean|53.3|53.3|Standard Deviation|12.88|12.88|||
4346152|NCT00406354|4173945|B4|||German Revised Children's Quality of Life Questionnaire (KINDL-R): Total Quality of Life Score|"KINDL-R (Revidierter KINDer Lebensqualitatsfragebogen, revised version), a validated German quality of life (QOL) questionnaire, provides parents' views on their child's emotional QOL. It consists of 24 items covering 6 QOL related dimensions (subscales) and 7 additional items assessing chronic illness. Each item is rated on a 5-point scale (1= never; 5= all the time). The lowest possible score in the Total QOL score is 0; the highest possible score is 100. Scores were normalized between 0 and 100, irrespective of the number of items per subscore. Higher scores indicate better QOL."|units on a scale|Mean|62.9|62.9|Standard Deviation|12.78|12.78|||
4346153|NCT00406354|4173946|B3|||German Revised Children's Quality of Life Questionnaire (KINDL-R): Total Quality of Life Score|"KINDL-R (Revidierter KINDer Lebensqualitatsfragebogen, revised version), a validated German quality of life (QOL) questionnaire, provides parents' views on their child's emotional QOL. It consists of 24 items covering 6 QOL related dimensions (subscales) and 7 additional items assessing chronic illness. Each item is rated on a 5-point scale (1= never; 5= all the time). The lowest possible score in the Total QOL score is 0; the highest possible score is 100. Scores were normalized between 0 and 100, irrespective of the number of items per subscore. Higher scores indicate better QOL."|units on a scale|Mean|61.8|61.8|Standard Deviation|13.02|13.02|||
4346154|NCT00406354|4173947|B2|||German Revised Children's Quality of Life Questionnaire (KINDL-R): Total Quality of Life Score|"KINDL-R (Revidierter KINDer Lebensqualitatsfragebogen, revised version), a validated German quality of life (QOL) questionnaire, provides parents' views on their child's emotional QOL. It consists of 24 items covering 6 QOL related dimensions (subscales) and 7 additional items assessing chronic illness. Each item is rated on a 5-point scale (1= never; 5= all the time). The lowest possible score in the Total QOL score is 0; the highest possible score is 100. Scores were normalized between 0 and 100, irrespective of the number of items per subscore. Higher scores indicate better QOL."|units on a scale|Mean|62.4|62.4|Standard Deviation|12.92|12.92|||
4346155|NCT00406354|4173948|B1|||German Revised Children's Quality of Life Questionnaire (KINDL-R): Total Quality of Life Score|"KINDL-R (Revidierter KINDer Lebensqualitatsfragebogen, revised version), a validated German quality of life (QOL) questionnaire, provides parents' views on their child's emotional QOL. It consists of 24 items covering 6 QOL related dimensions (subscales) and 7 additional items assessing chronic illness. Each item is rated on a 5-point scale (1= never; 5= all the time). The lowest possible score in the Total QOL score is 0; the highest possible score is 100. Scores were normalized between 0 and 100, irrespective of the number of items per subscore. Higher scores indicate better QOL."|units on a scale|Mean|64.5|64.5|Standard Deviation|12.43|12.43|||
4346156|NCT00406354|4173945|B4|||German Revised Children's Quality of Life Questionnaire (KINDL-R): Self Esteem Score|"KINDL-R (Revidierter KINDer Lebensqualitatsfragebogen, revised version), a validated German quality of life (QOL) questionnaire, provides parents' views on their child's emotional QOL. It consists of 24 items covering 6 QOL related dimensions (subscales) and 7 additional items assessing chronic illness. Each item is rated on a 5-point scale (1= never; 5= all the time). The lowest possible score on the Self Esteem subscale is 0; the highest possible score is 100. Scores were normalized between 0 and 100, irrespective of the number of items per subscore. Higher scores indicate better QOL."|units on a scale|Mean|52.6|52.6|Standard Deviation|18.71|18.71|||
4346157|NCT00406354|4173946|B3|||German Revised Children's Quality of Life Questionnaire (KINDL-R): Self Esteem Score|"KINDL-R (Revidierter KINDer Lebensqualitatsfragebogen, revised version), a validated German quality of life (QOL) questionnaire, provides parents' views on their child's emotional QOL. It consists of 24 items covering 6 QOL related dimensions (subscales) and 7 additional items assessing chronic illness. Each item is rated on a 5-point scale (1= never; 5= all the time). The lowest possible score on the Self Esteem subscale is 0; the highest possible score is 100. Scores were normalized between 0 and 100, irrespective of the number of items per subscore. Higher scores indicate better QOL."|units on a scale|Mean|50.4|50.4|Standard Deviation|18.92|18.92|||
4346291|NCT00406133|4174047|B2|8-14 years||Duration of diabetes||years|Mean|5.3|5.3|Standard Deviation|2.8|2.8|||
4346352|NCT00406133|4174048|B1|15-24 years||Age, Customized||participants|Number|57|57.0||||||
4346158|NCT00406354|4173947|B2|||German Revised Children's Quality of Life Questionnaire (KINDL-R): Self Esteem Score|"KINDL-R (Revidierter KINDer Lebensqualitatsfragebogen, revised version), a validated German quality of life (QOL) questionnaire, provides parents' views on their child's emotional QOL. It consists of 24 items covering 6 QOL related dimensions (subscales) and 7 additional items assessing chronic illness. Each item is rated on a 5-point scale (1= never; 5= all the time). The lowest possible score on the Self Esteem subscale is 0; the highest possible score is 100. Scores were normalized between 0 and 100, irrespective of the number of items per subscore. Higher scores indicate better QOL."|units on a scale|Mean|52.0|52.0|Standard Deviation|18.71|18.71|||
4346159|NCT00406354|4173948|B1|||German Revised Children's Quality of Life Questionnaire (KINDL-R): Self Esteem Score|"KINDL-R (Revidierter KINDer Lebensqualitatsfragebogen, revised version), a validated German quality of life (QOL) questionnaire, provides parents' views on their child's emotional QOL. It consists of 24 items covering 6 QOL related dimensions (subscales) and 7 additional items assessing chronic illness. Each item is rated on a 5-point scale (1= never; 5= all the time). The lowest possible score on the Self Esteem subscale is 0; the highest possible score is 100. Scores were normalized between 0 and 100, irrespective of the number of items per subscore. Higher scores indicate better QOL."|units on a scale|Mean|55.4|55.4|Standard Deviation|18.48|18.48|||
4346160|NCT00406354|4173945|B4|||German Revised Children's Quality of Life Questionnaire (KINDL-R): School Score|"KINDL-R (Revidierter KINDer Lebensqualitatsfragebogen, revised version), a validated German quality of life (QOL) questionnaire, provides parents' views on their child's emotional QOL. It consists of 24 items covering 6 QOL related dimensions (subscales) and 7 additional items assessing chronic illness. Each item is rated on a 5-point scale (1= never; 5= all the time). The lowest possible score on the School subscale is 0; the highest possible score is 100. Scores were normalized between 0 and 100, irrespective of the number of items per subscore. Higher scores indicate better QOL."|units on a scale|Mean|62.0|62.0|Standard Deviation|17.50|17.5|||
4346161|NCT00406354|4173946|B3|||German Revised Children's Quality of Life Questionnaire (KINDL-R): School Score|"KINDL-R (Revidierter KINDer Lebensqualitatsfragebogen, revised version), a validated German quality of life (QOL) questionnaire, provides parents' views on their child's emotional QOL. It consists of 24 items covering 6 QOL related dimensions (subscales) and 7 additional items assessing chronic illness. Each item is rated on a 5-point scale (1= never; 5= all the time). The lowest possible score on the School subscale is 0; the highest possible score is 100. Scores were normalized between 0 and 100, irrespective of the number of items per subscore. Higher scores indicate better QOL."|units on a scale|Mean|62.4|62.4|Standard Deviation|15.06|15.06|||
4346162|NCT00406354|4173947|B2|||German Revised Children's Quality of Life Questionnaire (KINDL-R): School Score|"KINDL-R (Revidierter KINDer Lebensqualitatsfragebogen, revised version), a validated German quality of life (QOL) questionnaire, provides parents' views on their child's emotional QOL. It consists of 24 items covering 6 QOL related dimensions (subscales) and 7 additional items assessing chronic illness. Each item is rated on a 5-point scale (1= never; 5= all the time). The lowest possible score on the School subscale is 0; the highest possible score is 100. Scores were normalized between 0 and 100, irrespective of the number of items per subscore. Higher scores indicate better QOL."|units on a scale|Mean|61.5|61.5|Standard Deviation|20.62|20.62|||
4346163|NCT00406354|4173948|B1|||German Revised Children's Quality of Life Questionnaire (KINDL-R): School Score|"KINDL-R (Revidierter KINDer Lebensqualitatsfragebogen, revised version), a validated German quality of life (QOL) questionnaire, provides parents' views on their child's emotional QOL. It consists of 24 items covering 6 QOL related dimensions (subscales) and 7 additional items assessing chronic illness. Each item is rated on a 5-point scale (1= never; 5= all the time). The lowest possible score on the School subscale is 0; the highest possible score is 100. Scores were normalized between 0 and 100, irrespective of the number of items per subscore. Higher scores indicate better QOL."|units on a scale|Mean|62.2|62.2|Standard Deviation|16.74|16.74|||
4346164|NCT00406354|4173945|B4|||German Revised Children's Quality of Life Questionnaire (KINDL-R): Physical Well-Being Score|"KINDL-R (Revidierter KINDer Lebensqualitatsfragebogen, revised version), a validated German quality of life (QOL) questionnaire, provides parents' views on their child's emotional QOL. It consists of 24 items covering 6 QOL related dimensions (subscales) and 7 additional items assessing chronic illness. Each item is rated on a 5-point scale (1= never; 5= all the time). The lowest possible score on the Physical Well-Being subscale is 0; highest possible score is 100. Scores were normalized between 0 and 100, irrespective of the number of items per subscore. Higher scores indicate better QOL."|units on a scale|Mean|79.0|79.0|Standard Deviation|18.54|18.54|||
4346165|NCT00406354|4173946|B3|||German Revised Children's Quality of Life Questionnaire (KINDL-R): Physical Well-Being Score|"KINDL-R (Revidierter KINDer Lebensqualitatsfragebogen, revised version), a validated German quality of life (QOL) questionnaire, provides parents' views on their child's emotional QOL. It consists of 24 items covering 6 QOL related dimensions (subscales) and 7 additional items assessing chronic illness. Each item is rated on a 5-point scale (1= never; 5= all the time). The lowest possible score on the Physical Well-Being subscale is 0; highest possible score is 100. Scores were normalized between 0 and 100, irrespective of the number of items per subscore. Higher scores indicate better QOL."|units on a scale|Mean|81.5|81.5|Standard Deviation|16.78|16.78|||
4346166|NCT00406354|4173947|B2|||German Revised Children's Quality of Life Questionnaire (KINDL-R): Physical Well-Being Score|"KINDL-R (Revidierter KINDer Lebensqualitatsfragebogen, revised version), a validated German quality of life (QOL) questionnaire, provides parents' views on their child's emotional QOL. It consists of 24 items covering 6 QOL related dimensions (subscales) and 7 additional items assessing chronic illness. Each item is rated on a 5-point scale (1= never; 5= all the time). The lowest possible score on the Physical Well-Being subscale is 0; highest possible score is 100. Scores were normalized between 0 and 100, irrespective of the number of items per subscore. Higher scores indicate better QOL."|units on a scale|Mean|75.9|75.9|Standard Deviation|19.99|19.99|||
4346196|NCT00406354|4173945|B4|Disruptive behavior disorder not specified||Summary of ODD Diagnosis|Breakdown of ODD diagnosis in accordance with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).|participants|Number|1|1.0||||||
4346197|NCT00406354|4173946|B3|Disruptive behavior disorder not specified||Summary of ODD Diagnosis|Breakdown of ODD diagnosis in accordance with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).|participants|Number|0|0.0||||||
4346292|NCT00406133|4174048|B1|8-14 years||Duration of diabetes||years|Mean|6.2|6.2|Standard Deviation|3.1|3.1|||
4346167|NCT00406354|4173948|B1|||German Revised Children's Quality of Life Questionnaire (KINDL-R): Physical Well-Being Score|"KINDL-R (Revidierter KINDer Lebensqualitatsfragebogen, revised version), a validated German quality of life (QOL) questionnaire, provides parents' views on their child's emotional QOL. It consists of 24 items covering 6 QOL related dimensions (subscales) and 7 additional items assessing chronic illness. Each item is rated on a 5-point scale (1= never; 5= all the time). The lowest possible score on the Physical Well-Being subscale is 0; highest possible score is 100. Scores were normalized between 0 and 100, irrespective of the number of items per subscore. Higher scores indicate better QOL."|units on a scale|Mean|79.8|79.8|Standard Deviation|18.53|18.53|||
4346168|NCT00406354|4173945|B4|||German Revised Children's Quality of Life Questionnaire (KINDL-R): Friends Score|"KINDL-R (Revidierter KINDer Lebensqualitatsfragebogen, revised version), a validated German quality of life (QOL) questionnaire, provides parents' views on their child's emotional QOL. It consists of 24 items covering 6 QOL related dimensions (subscales) and 7 additional items assessing chronic illness. Each item is rated on a 5-point scale (1= never; 5= all the time). The lowest possible score on the Friends subscale is 0; the highest possible score is 100. Scores were normalized between 0 and 100, irrespective of the number of items per subscore. Higher scores indicate better QOL."|units on a scale|Mean|55.4|55.4|Standard Deviation|22.02|22.02|||
4346169|NCT00406354|4173946|B3|||German Revised Children's Quality of Life Questionnaire (KINDL-R): Friends Score|"KINDL-R (Revidierter KINDer Lebensqualitatsfragebogen, revised version), a validated German quality of life (QOL) questionnaire, provides parents' views on their child's emotional QOL. It consists of 24 items covering 6 QOL related dimensions (subscales) and 7 additional items assessing chronic illness. Each item is rated on a 5-point scale (1= never; 5= all the time). The lowest possible score on the Friends subscale is 0; the highest possible score is 100. Scores were normalized between 0 and 100, irrespective of the number of items per subscore. Higher scores indicate better QOL."|units on a scale|Mean|54.2|54.2|Standard Deviation|23.34|23.34|||
4346170|NCT00406354|4173947|B2|||German Revised Children's Quality of Life Questionnaire (KINDL-R): Friends Score|"KINDL-R (Revidierter KINDer Lebensqualitatsfragebogen, revised version), a validated German quality of life (QOL) questionnaire, provides parents' views on their child's emotional QOL. It consists of 24 items covering 6 QOL related dimensions (subscales) and 7 additional items assessing chronic illness. Each item is rated on a 5-point scale (1= never; 5= all the time). The lowest possible score on the Friends subscale is 0; the highest possible score is 100. Scores were normalized between 0 and 100, irrespective of the number of items per subscore. Higher scores indicate better QOL."|units on a scale|Mean|53.9|53.9|Standard Deviation|21.23|21.23|||
4346171|NCT00406354|4173948|B1|||German Revised Children's Quality of Life Questionnaire (KINDL-R): Friends Score|"KINDL-R (Revidierter KINDer Lebensqualitatsfragebogen, revised version), a validated German quality of life (QOL) questionnaire, provides parents' views on their child's emotional QOL. It consists of 24 items covering 6 QOL related dimensions (subscales) and 7 additional items assessing chronic illness. Each item is rated on a 5-point scale (1= never; 5= all the time). The lowest possible score on the Friends subscale is 0; the highest possible score is 100. Scores were normalized between 0 and 100, irrespective of the number of items per subscore. Higher scores indicate better QOL."|units on a scale|Mean|58.2|58.2|Standard Deviation|21.56|21.56|||
4346172|NCT00406354|4173945|B4|||German Revised Children's Quality of Life Questionnaire (KINDL-R): Family Score|"KINDL-R (Revidierter KINDer Lebensqualitatsfragebogen, revised version), a validated German quality of life (QOL) questionnaire, provides parents' views on their child's emotional QOL. It consists of 24 items covering 6 QOL related dimensions (subscales) and 7 additional items assessing chronic illness. Each item is rated on a 5-point scale (1=never; 5=all the time). The lowest possible score on the Family subscale is 0; the highest possible score is 100. Scores were normalized between 0 and 100, irrespective of the number of items per subscore. Higher scores indicate better QOL."|units on a scale|Mean|56.2|56.2|Standard Deviation|20.55|20.55|||
4346173|NCT00406354|4173946|B3|||German Revised Children's Quality of Life Questionnaire (KINDL-R): Family Score|"KINDL-R (Revidierter KINDer Lebensqualitatsfragebogen, revised version), a validated German quality of life (QOL) questionnaire, provides parents' views on their child's emotional QOL. It consists of 24 items covering 6 QOL related dimensions (subscales) and 7 additional items assessing chronic illness. Each item is rated on a 5-point scale (1=never; 5=all the time). The lowest possible score on the Family subscale is 0; the highest possible score is 100. Scores were normalized between 0 and 100, irrespective of the number of items per subscore. Higher scores indicate better QOL."|units on a scale|Mean|52.3|52.3|Standard Deviation|20.50|20.5|||
4346174|NCT00406354|4173947|B2|||German Revised Children's Quality of Life Questionnaire (KINDL-R): Family Score|"KINDL-R (Revidierter KINDer Lebensqualitatsfragebogen, revised version), a validated German quality of life (QOL) questionnaire, provides parents' views on their child's emotional QOL. It consists of 24 items covering 6 QOL related dimensions (subscales) and 7 additional items assessing chronic illness. Each item is rated on a 5-point scale (1=never; 5=all the time). The lowest possible score on the Family subscale is 0; the highest possible score is 100. Scores were normalized between 0 and 100, irrespective of the number of items per subscore. Higher scores indicate better QOL."|units on a scale|Mean|57.6|57.6|Standard Deviation|20.73|20.73|||
4346175|NCT00406354|4173948|B1|||German Revised Children's Quality of Life Questionnaire (KINDL-R): Family Score|"KINDL-R (Revidierter KINDer Lebensqualitatsfragebogen, revised version), a validated German quality of life (QOL) questionnaire, provides parents' views on their child's emotional QOL. It consists of 24 items covering 6 QOL related dimensions (subscales) and 7 additional items assessing chronic illness. Each item is rated on a 5-point scale (1=never; 5=all the time). The lowest possible score on the Family subscale is 0; the highest possible score is 100. Scores were normalized between 0 and 100, irrespective of the number of items per subscore. Higher scores indicate better QOL."|units on a scale|Mean|58.7|58.7|Standard Deviation|20.17|20.17|||
4346176|NCT00406354|4173945|B4|||German Revised Children's Quality of Life Questionnaire (KINDL-R): Emotional Well-Being Score|"KINDL-R (Revidierter KINDer Lebensqualitatsfragebogen, revised version), a validated German quality of life (QOL) questionnaire, provides parents' views on their child's emotional QOL. It consists of 24 items covering 6 QOL related dimensions (subscales) and 7 additional items assessing chronic illness. Each item is rated on a 5-point scale (1=never; 5=all the time). Lowest possible score for the Emotional Well-Being subscale is 0; the highest possible score is 100. Scores were normalized between 0 and 100, irrespective of the number of items per subscore. Higher scores indicate better QOL."|units on a scale|Mean|71.9|71.9|Standard Deviation|17.22|17.22|||
4346177|NCT00406354|4173946|B3|||German Revised Children's Quality of Life Questionnaire (KINDL-R): Emotional Well-Being Score|"KINDL-R (Revidierter KINDer Lebensqualitatsfragebogen, revised version), a validated German quality of life (QOL) questionnaire, provides parents' views on their child's emotional QOL. It consists of 24 items covering 6 QOL related dimensions (subscales) and 7 additional items assessing chronic illness. Each item is rated on a 5-point scale (1=never; 5=all the time). Lowest possible score for the Emotional Well-Being subscale is 0; the highest possible score is 100. Scores were normalized between 0 and 100, irrespective of the number of items per subscore. Higher scores indicate better QOL."|units on a scale|Mean|70.1|70.1|Standard Deviation|15.92|15.92|||
4346178|NCT00406354|4173947|B2|||German Revised Children's Quality of Life Questionnaire (KINDL-R): Emotional Well-Being Score|"KINDL-R (Revidierter KINDer Lebensqualitatsfragebogen, revised version), a validated German quality of life (QOL) questionnaire, provides parents' views on their child's emotional QOL. It consists of 24 items covering 6 QOL related dimensions (subscales) and 7 additional items assessing chronic illness. Each item is rated on a 5-point scale (1=never; 5=all the time). Lowest possible score for the Emotional Well-Being subscale is 0; the highest possible score is 100. Scores were normalized between 0 and 100, irrespective of the number of items per subscore. Higher scores indicate better QOL."|units on a scale|Mean|72.5|72.5|Standard Deviation|17.28|17.28|||
4346179|NCT00406354|4173948|B1|||German Revised Children's Quality of Life Questionnaire (KINDL-R): Emotional Well-Being Score|"KINDL-R (Revidierter KINDer Lebensqualitatsfragebogen, revised version), a validated German quality of life (QOL) questionnaire, provides parents' views on their child's emotional QOL. It consists of 24 items covering 6 QOL related dimensions (subscales) and 7 additional items assessing chronic illness. Each item is rated on a 5-point scale (1=never; 5=all the time). Lowest possible score for the Emotional Well-Being subscale is 0; the highest possible score is 100. Scores were normalized between 0 and 100, irrespective of the number of items per subscore. Higher scores indicate better QOL."|units on a scale|Mean|72.9|72.9|Standard Deviation|18.58|18.58|||
4346180|NCT00406354|4173945|B4|||Clinical Global Impressions - Severity (CGI-S): ODD Score|The physician-rated CGI-S ODD subscale measures the participant's overall severity of ODD symptoms (1=normal, not at all ill; 7=among the most extremely ill patients) during the last 7 days.|units on a scale|Mean|5.1|5.1|Standard Deviation|0.88|0.88|||
4346181|NCT00406354|4173946|B3|||Clinical Global Impressions - Severity (CGI-S): ODD Score|The physician-rated CGI-S ODD subscale measures the participant's overall severity of ODD symptoms (1=normal, not at all ill; 7=among the most extremely ill patients) during the last 7 days.|units on a scale|Mean|5.0|5.0|Standard Deviation|0.86|0.86|||
4346182|NCT00406354|4173947|B2|||Clinical Global Impressions - Severity (CGI-S): ODD Score|The physician-rated CGI-S ODD subscale measures the participant's overall severity of ODD symptoms (1=normal, not at all ill; 7=among the most extremely ill patients) during the last 7 days.|units on a scale|Mean|5.3|5.3|Standard Deviation|0.83|0.83|||
4346183|NCT00406354|4173948|B1|||Clinical Global Impressions - Severity (CGI-S): ODD Score|The physician-rated CGI-S ODD subscale measures the participant's overall severity of ODD symptoms (1=normal, not at all ill; 7=among the most extremely ill patients) during the last 7 days.|units on a scale|Mean|4.9|4.9|Standard Deviation|0.92|0.92|||
4346184|NCT00406354|4173945|B4|||Clinical Global Impressions - Severity (CGI-S): Combined ADHD and ODD Scores|The physician-rated CGI-S Combined ADHD and ODD subscale measures the participant's overall severity of both ADHD and ODD symptoms (1=normal, not at all ill; 7=among the most extremely ill patients) during the last 7 days.|units on a scale|Mean|5.1|5.1|Standard Deviation|0.76|0.76|||
4346185|NCT00406354|4173946|B3|||Clinical Global Impressions - Severity (CGI-S): Combined ADHD and ODD Scores|The physician-rated CGI-S Combined ADHD and ODD subscale measures the participant's overall severity of both ADHD and ODD symptoms (1=normal, not at all ill; 7=among the most extremely ill patients) during the last 7 days.|units on a scale|Mean|5.1|5.1|Standard Deviation|0.71|0.71|||
4346186|NCT00406354|4173947|B2|||Clinical Global Impressions - Severity (CGI-S): Combined ADHD and ODD Scores|The physician-rated CGI-S Combined ADHD and ODD subscale measures the participant's overall severity of both ADHD and ODD symptoms (1=normal, not at all ill; 7=among the most extremely ill patients) during the last 7 days.|units on a scale|Mean|5.4|5.4|Standard Deviation|0.73|0.73|||
4346187|NCT00406354|4173948|B1|||Clinical Global Impressions - Severity (CGI-S): Combined ADHD and ODD Scores|The physician-rated CGI-S Combined ADHD and ODD subscale measures the participant's overall severity of both ADHD and ODD symptoms (1=normal, not at all ill; 7=among the most extremely ill patients) during the last 7 days.|units on a scale|Mean|4.9|4.9|Standard Deviation|0.77|0.77|||
4346188|NCT00406354|4173945|B4|||Clinical Global Impressions - Severity (CGI-S): ADHD Score|The physician-rated CGI-S ADHD subscale measures the participant's overall severity of ADHD symptoms (1=normal, not at all ill; 7=among the most extremely ill patients) during the last 7 days.|units on a scale|Mean|5.1|5.1|Standard Deviation|0.77|0.77|||
4346189|NCT00406354|4173946|B3|||Clinical Global Impressions - Severity (CGI-S): ADHD Score|The physician-rated CGI-S ADHD subscale measures the participant's overall severity of ADHD symptoms (1=normal, not at all ill; 7=among the most extremely ill patients) during the last 7 days.|units on a scale|Mean|5.1|5.1|Standard Deviation|0.74|0.74|||
4346190|NCT00406354|4173947|B2|||Clinical Global Impressions - Severity (CGI-S): ADHD Score|The physician-rated CGI-S ADHD subscale measures the participant's overall severity of ADHD symptoms (1=normal, not at all ill; 7=among the most extremely ill patients) during the last 7 days.|units on a scale|Mean|5.2|5.2|Standard Deviation|0.79|0.79|||
4346191|NCT00406354|4173948|B1|||Clinical Global Impressions - Severity (CGI-S): ADHD Score|The physician-rated CGI-S ADHD subscale measures the participant's overall severity of ADHD symptoms (1=normal, not at all ill; 7=among the most extremely ill patients) during the last 7 days.|units on a scale|Mean|5.0|5.0|Standard Deviation|0.77|0.77|||
4346192|NCT00406354|4173945|B4|Adjustment disorder, emotion, conduct disturbance||Summary of ODD Diagnosis|Breakdown of ODD diagnosis in accordance with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).|participants|Number|1|1.0||||||
4346193|NCT00406354|4173946|B3|Adjustment disorder, emotion, conduct disturbance||Summary of ODD Diagnosis|Breakdown of ODD diagnosis in accordance with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).|participants|Number|0|0.0||||||
4346194|NCT00406354|4173947|B2|Adjustment disorder, emotion, conduct disturbance||Summary of ODD Diagnosis|Breakdown of ODD diagnosis in accordance with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).|participants|Number|0|0.0||||||
4346198|NCT00406354|4173947|B2|Disruptive behavior disorder not specified||Summary of ODD Diagnosis|Breakdown of ODD diagnosis in accordance with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).|participants|Number|0|0.0||||||
4346199|NCT00406354|4173948|B1|Disruptive behavior disorder not specified||Summary of ODD Diagnosis|Breakdown of ODD diagnosis in accordance with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).|participants|Number|1|1.0||||||
4346200|NCT00406354|4173945|B4|Oppositional defiant disorder||Summary of ODD Diagnosis|Breakdown of ODD diagnosis in accordance with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).|participants|Number|134|134.0||||||
4346201|NCT00406354|4173946|B3|Oppositional defiant disorder||Summary of ODD Diagnosis|Breakdown of ODD diagnosis in accordance with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).|participants|Number|45|45.0||||||
4346202|NCT00406354|4173947|B2|Oppositional defiant disorder||Summary of ODD Diagnosis|Breakdown of ODD diagnosis in accordance with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).|participants|Number|45|45.0||||||
4346203|NCT00406354|4173948|B1|Oppositional defiant disorder||Summary of ODD Diagnosis|Breakdown of ODD diagnosis in accordance with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).|participants|Number|44|44.0||||||
4346204|NCT00406354|4173945|B4|Conduct disorder||Summary of ODD Diagnosis|Breakdown of ODD diagnosis in accordance with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).|participants|Number|44|44.0||||||
4346205|NCT00406354|4173946|B3|Conduct disorder||Summary of ODD Diagnosis|Breakdown of ODD diagnosis in accordance with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).|participants|Number|14|14.0||||||
4346206|NCT00406354|4173947|B2|Conduct disorder||Summary of ODD Diagnosis|Breakdown of ODD diagnosis in accordance with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).|participants|Number|16|16.0||||||
4346207|NCT00406354|4173948|B1|Conduct disorder||Summary of ODD Diagnosis|Breakdown of ODD diagnosis in accordance with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).|participants|Number|14|14.0||||||
4346208|NCT00406354|4173945|B4|ADHD - predominantly hyperactive-impulsive type||Summary of ADHD Diagnosis|Breakdown of ADHD diagnosis in accordance with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).|participants|Number|9|9.0||||||
4346209|NCT00406354|4173946|B3|ADHD - predominantly hyperactive-impulsive type||Summary of ADHD Diagnosis|Breakdown of ADHD diagnosis in accordance with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).|participants|Number|4|4.0||||||
4346210|NCT00406354|4173947|B2|ADHD - predominantly hyperactive-impulsive type||Summary of ADHD Diagnosis|Breakdown of ADHD diagnosis in accordance with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).|participants|Number|2|2.0||||||
4346211|NCT00406354|4173948|B1|ADHD - predominantly hyperactive-impulsive type||Summary of ADHD Diagnosis|Breakdown of ADHD diagnosis in accordance with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).|participants|Number|3|3.0||||||
4346212|NCT00406354|4173945|B4|ADHD - predominantly inattentive type||Summary of ADHD Diagnosis|Breakdown of ADHD diagnosis in accordance with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).|participants|Number|35|35.0||||||
4346213|NCT00406354|4173946|B3|ADHD - predominantly inattentive type||Summary of ADHD Diagnosis|Breakdown of ADHD diagnosis in accordance with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).|participants|Number|8|8.0||||||
4346214|NCT00406354|4173947|B2|ADHD - predominantly inattentive type||Summary of ADHD Diagnosis|Breakdown of ADHD diagnosis in accordance with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).|participants|Number|14|14.0||||||
4346215|NCT00406354|4173948|B1|ADHD - predominantly inattentive type||Summary of ADHD Diagnosis|Breakdown of ADHD diagnosis in accordance with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).|participants|Number|13|13.0||||||
4346216|NCT00406354|4173945|B4|ADHD - combined type||Summary of ADHD Diagnosis|Breakdown of ADHD diagnosis in accordance with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).|participants|Number|136|136.0||||||
4346217|NCT00406354|4173946|B3|ADHD - combined type||Summary of ADHD Diagnosis|Breakdown of ADHD diagnosis in accordance with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).|participants|Number|47|47.0||||||
4346218|NCT00406354|4173947|B2|ADHD - combined type||Summary of ADHD Diagnosis|Breakdown of ADHD diagnosis in accordance with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).|participants|Number|45|45.0||||||
4346219|NCT00406354|4173948|B1|ADHD - combined type||Summary of ADHD Diagnosis|Breakdown of ADHD diagnosis in accordance with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).|participants|Number|44|44.0||||||
4346220|NCT00406354|4173945|B4|Previous psychotherapy||Prior Therapy: Attention-Deficit/Hyperactive Disorder (ADHD), Oppositional Defiant Disorder (ODD)|Summarizes number of participants who received previous attention-deficit/hyperactive disorder (ADHD) and/or oppositional defiant disorder (ODD) therapy, by medication and non-medication categories. NOTE: Because some participants may have received one or more types of ADHD and/or ODD therapies while others may not, the breakdown of prior therapies by treatment group does not equal the number of participants in each treatment group.|participants|Number|20|20.0||||||
4346221|NCT00406354|4173946|B3|Previous psychotherapy||Prior Therapy: Attention-Deficit/Hyperactive Disorder (ADHD), Oppositional Defiant Disorder (ODD)|Summarizes number of participants who received previous attention-deficit/hyperactive disorder (ADHD) and/or oppositional defiant disorder (ODD) therapy, by medication and non-medication categories. NOTE: Because some participants may have received one or more types of ADHD and/or ODD therapies while others may not, the breakdown of prior therapies by treatment group does not equal the number of participants in each treatment group.|participants|Number|5|5.0||||||
4346287|NCT00406133|4174048|B1|15-24 years||Duration of diabetes||years|Mean|9.5|9.5|Standard Deviation|4.8|4.8|||
4346288|NCT00406133|4174044|B5|8-14 years||Duration of diabetes||years|Mean|5.5|5.5|Standard Deviation|3.0|3.0|||
4346289|NCT00406133|4174045|B4|8-14 years||Duration of diabetes||years|Mean|4.4|4.4|Standard Deviation|3.2|3.2|||
4346351|NCT00406133|4174047|B2|15-24 years||Age, Customized||participants|Number|53|53.0||||||
4346222|NCT00406354|4173947|B2|Previous psychotherapy||Prior Therapy: Attention-Deficit/Hyperactive Disorder (ADHD), Oppositional Defiant Disorder (ODD)|Summarizes number of participants who received previous attention-deficit/hyperactive disorder (ADHD) and/or oppositional defiant disorder (ODD) therapy, by medication and non-medication categories. NOTE: Because some participants may have received one or more types of ADHD and/or ODD therapies while others may not, the breakdown of prior therapies by treatment group does not equal the number of participants in each treatment group.|participants|Number|7|7.0||||||
4346223|NCT00406354|4173948|B1|Previous psychotherapy||Prior Therapy: Attention-Deficit/Hyperactive Disorder (ADHD), Oppositional Defiant Disorder (ODD)|Summarizes number of participants who received previous attention-deficit/hyperactive disorder (ADHD) and/or oppositional defiant disorder (ODD) therapy, by medication and non-medication categories. NOTE: Because some participants may have received one or more types of ADHD and/or ODD therapies while others may not, the breakdown of prior therapies by treatment group does not equal the number of participants in each treatment group.|participants|Number|8|8.0||||||
4346224|NCT00406354|4173945|B4|Previous non-drug treatment||Prior Therapy: Attention-Deficit/Hyperactive Disorder (ADHD), Oppositional Defiant Disorder (ODD)|Summarizes number of participants who received previous attention-deficit/hyperactive disorder (ADHD) and/or oppositional defiant disorder (ODD) therapy, by medication and non-medication categories. NOTE: Because some participants may have received one or more types of ADHD and/or ODD therapies while others may not, the breakdown of prior therapies by treatment group does not equal the number of participants in each treatment group.|participants|Number|24|24.0||||||
4346225|NCT00406354|4173946|B3|Previous non-drug treatment||Prior Therapy: Attention-Deficit/Hyperactive Disorder (ADHD), Oppositional Defiant Disorder (ODD)|Summarizes number of participants who received previous attention-deficit/hyperactive disorder (ADHD) and/or oppositional defiant disorder (ODD) therapy, by medication and non-medication categories. NOTE: Because some participants may have received one or more types of ADHD and/or ODD therapies while others may not, the breakdown of prior therapies by treatment group does not equal the number of participants in each treatment group.|participants|Number|9|9.0||||||
4346226|NCT00406354|4173947|B2|Previous non-drug treatment||Prior Therapy: Attention-Deficit/Hyperactive Disorder (ADHD), Oppositional Defiant Disorder (ODD)|Summarizes number of participants who received previous attention-deficit/hyperactive disorder (ADHD) and/or oppositional defiant disorder (ODD) therapy, by medication and non-medication categories. NOTE: Because some participants may have received one or more types of ADHD and/or ODD therapies while others may not, the breakdown of prior therapies by treatment group does not equal the number of participants in each treatment group.|participants|Number|9|9.0||||||
4346227|NCT00406354|4173948|B1|Previous non-drug treatment||Prior Therapy: Attention-Deficit/Hyperactive Disorder (ADHD), Oppositional Defiant Disorder (ODD)|Summarizes number of participants who received previous attention-deficit/hyperactive disorder (ADHD) and/or oppositional defiant disorder (ODD) therapy, by medication and non-medication categories. NOTE: Because some participants may have received one or more types of ADHD and/or ODD therapies while others may not, the breakdown of prior therapies by treatment group does not equal the number of participants in each treatment group.|participants|Number|6|6.0||||||
4346228|NCT00406354|4173945|B4|Previous psychotropic medication||Prior Therapy: Attention-Deficit/Hyperactive Disorder (ADHD), Oppositional Defiant Disorder (ODD)|Summarizes number of participants who received previous attention-deficit/hyperactive disorder (ADHD) and/or oppositional defiant disorder (ODD) therapy, by medication and non-medication categories. NOTE: Because some participants may have received one or more types of ADHD and/or ODD therapies while others may not, the breakdown of prior therapies by treatment group does not equal the number of participants in each treatment group.|participants|Number|6|6.0||||||
4346229|NCT00406354|4173946|B3|Previous psychotropic medication||Prior Therapy: Attention-Deficit/Hyperactive Disorder (ADHD), Oppositional Defiant Disorder (ODD)|Summarizes number of participants who received previous attention-deficit/hyperactive disorder (ADHD) and/or oppositional defiant disorder (ODD) therapy, by medication and non-medication categories. NOTE: Because some participants may have received one or more types of ADHD and/or ODD therapies while others may not, the breakdown of prior therapies by treatment group does not equal the number of participants in each treatment group.|participants|Number|3|3.0||||||
4346230|NCT00406354|4173947|B2|Previous psychotropic medication||Prior Therapy: Attention-Deficit/Hyperactive Disorder (ADHD), Oppositional Defiant Disorder (ODD)|Summarizes number of participants who received previous attention-deficit/hyperactive disorder (ADHD) and/or oppositional defiant disorder (ODD) therapy, by medication and non-medication categories. NOTE: Because some participants may have received one or more types of ADHD and/or ODD therapies while others may not, the breakdown of prior therapies by treatment group does not equal the number of participants in each treatment group.|participants|Number|0|0.0||||||
4346231|NCT00406354|4173948|B1|Previous psychotropic medication||Prior Therapy: Attention-Deficit/Hyperactive Disorder (ADHD), Oppositional Defiant Disorder (ODD)|Summarizes number of participants who received previous attention-deficit/hyperactive disorder (ADHD) and/or oppositional defiant disorder (ODD) therapy, by medication and non-medication categories. NOTE: Because some participants may have received one or more types of ADHD and/or ODD therapies while others may not, the breakdown of prior therapies by treatment group does not equal the number of participants in each treatment group.|participants|Number|3|3.0||||||
4346232|NCT00406354|4173945|B4|Previous treatment with stimulants||Prior Therapy: Attention-Deficit/Hyperactive Disorder (ADHD), Oppositional Defiant Disorder (ODD)|Summarizes number of participants who received previous attention-deficit/hyperactive disorder (ADHD) and/or oppositional defiant disorder (ODD) therapy, by medication and non-medication categories. NOTE: Because some participants may have received one or more types of ADHD and/or ODD therapies while others may not, the breakdown of prior therapies by treatment group does not equal the number of participants in each treatment group.|participants|Number|80|80.0||||||
4346233|NCT00406354|4173946|B3|Previous treatment with stimulants||Prior Therapy: Attention-Deficit/Hyperactive Disorder (ADHD), Oppositional Defiant Disorder (ODD)|Summarizes number of participants who received previous attention-deficit/hyperactive disorder (ADHD) and/or oppositional defiant disorder (ODD) therapy, by medication and non-medication categories. NOTE: Because some participants may have received one or more types of ADHD and/or ODD therapies while others may not, the breakdown of prior therapies by treatment group does not equal the number of participants in each treatment group.|participants|Number|29|29.0||||||
4346290|NCT00406133|4174046|B3|8-14 years||Duration of diabetes||years|Mean|4.9|4.9|Standard Deviation|2.6|2.6|||
4346234|NCT00406354|4173947|B2|Previous treatment with stimulants||Prior Therapy: Attention-Deficit/Hyperactive Disorder (ADHD), Oppositional Defiant Disorder (ODD)|Summarizes number of participants who received previous attention-deficit/hyperactive disorder (ADHD) and/or oppositional defiant disorder (ODD) therapy, by medication and non-medication categories. NOTE: Because some participants may have received one or more types of ADHD and/or ODD therapies while others may not, the breakdown of prior therapies by treatment group does not equal the number of participants in each treatment group.|participants|Number|28|28.0||||||
4346235|NCT00406354|4173948|B1|Previous treatment with stimulants||Prior Therapy: Attention-Deficit/Hyperactive Disorder (ADHD), Oppositional Defiant Disorder (ODD)|Summarizes number of participants who received previous attention-deficit/hyperactive disorder (ADHD) and/or oppositional defiant disorder (ODD) therapy, by medication and non-medication categories. NOTE: Because some participants may have received one or more types of ADHD and/or ODD therapies while others may not, the breakdown of prior therapies by treatment group does not equal the number of participants in each treatment group.|participants|Number|23|23.0||||||
4346236|NCT00406354|4173945|B4|Germany||Region of Enrollment||participants|Number|180|180.0||||||
4346237|NCT00406354|4173946|B3|Germany||Region of Enrollment||participants|Number|59|59.0||||||
4346238|NCT00406354|4173947|B2|Germany||Region of Enrollment||participants|Number|61|61.0||||||
4346239|NCT00406354|4173948|B1|Germany||Region of Enrollment||participants|Number|60|60.0||||||
4346240|NCT00406354|4173945|B4|African||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4346241|NCT00406354|4173946|B3|African||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4346242|NCT00406354|4173947|B2|African||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4346243|NCT00406354|4173948|B1|African||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4346244|NCT00406354|4173945|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|178|178.0||||||
4346245|NCT00406354|4173946|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
4346246|NCT00406354|4173947|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
4346247|NCT00406354|4173948|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
4346248|NCT00406354|4173945|B4||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4346249|NCT00406354|4173946|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4346250|NCT00406354|4173947|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4346251|NCT00406354|4173948|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4346252|NCT00406354|4173945|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4346253|NCT00406354|4173946|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4346254|NCT00406354|4173947|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4346255|NCT00406354|4173948|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4346256|NCT00406354|4173945|B4|||Age||years|Mean|11.0|11.0|Standard Deviation|3.01|3.01|||
4346257|NCT00406354|4173946|B3|||Age||years|Mean|11.1|11.1|Standard Deviation|2.77|2.77|||
4346258|NCT00406354|4173947|B2|||Age||years|Mean|10.8|10.8|Standard Deviation|3.39|3.39|||
4346259|NCT00406354|4173948|B1|||Age||years|Mean|11.1|11.1|Standard Deviation|2.88|2.88|||
4346260|NCT00406315|4174021|B1||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4346261|NCT00406315|4174021|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4346262|NCT00406315|4174021|B1|> = 65 years||Age, Customized||participants|Number|0|0.0||||||
4346263|NCT00406315|4174021|B1|45 to 64 years||Age, Customized||participants|Number|101|101.0||||||
4346264|NCT00406315|4174021|B1|18 to 44 years||Age, Customized||participants|Number|140|140.0||||||
4346265|NCT00406315|4174021|B1|< 18 years||Age, Customized||participants|Number|0|0.0||||||
4346266|NCT00406276|4174039|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4346267|NCT00406276|4174039|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4346268|NCT00406276|4174039|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4346269|NCT00406276|4174039|B1|||Age||years|Median|62|62.0|Full Range|||40.0|81.0|
4346270|NCT00406276|4174039|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4346271|NCT00406276|4174039|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4346272|NCT00406276|4174039|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4346273|NCT00406133|4174044|B5|||Glycated hemoglobin (HbA1c)||percent|Mean|7.4|7.4|Standard Deviation|0.9|0.9|||
4346274|NCT00406133|4174045|B4|||Glycated hemoglobin (HbA1c)||percent|Mean|6.5|6.5|Standard Deviation|0.3|0.3|||
4346275|NCT00406133|4174046|B3|||Glycated hemoglobin (HbA1c)||percent|Mean|6.4|6.4|Standard Deviation|0.5|0.5|||
4346276|NCT00406133|4174047|B2|||Glycated hemoglobin (HbA1c)||percent|Mean|7.8|7.8|Standard Deviation|0.7|0.7|||
4346277|NCT00406133|4174048|B1|||Glycated hemoglobin (HbA1c)||percent|Mean|7.9|7.9|Standard Deviation|0.7|0.7|||
4346278|NCT00406133|4174044|B5|>=25 years||Duration of diabetes||years|Mean|24.5|24.5|Standard Deviation|12.6|12.6|||
4346279|NCT00406133|4174045|B4|>=25 years||Duration of diabetes||years|Mean|28.6|28.6|Standard Deviation|12.7|12.7|||
4346280|NCT00406133|4174046|B3|>=25 years||Duration of diabetes||years|Mean|25.6|25.6|Standard Deviation|16.6|16.6|||
4346281|NCT00406133|4174047|B2|>=25 years||Duration of diabetes||years|Mean|21.8|21.8|Standard Deviation|10.4|10.4|||
4346282|NCT00406133|4174048|B1|>=25 years||Duration of diabetes||years|Mean|23.6|23.6|Standard Deviation|10.6|10.6|||
4346283|NCT00406133|4174044|B5|15-24 years||Duration of diabetes||years|Mean|9.0|9.0|Standard Deviation|4.5|4.5|||
4346284|NCT00406133|4174045|B4|15-24 years||Duration of diabetes||years|Mean|8.1|8.1|Standard Deviation|4.5|4.5|||
4346285|NCT00406133|4174046|B3|15-24 years||Duration of diabetes||years|Mean|8.7|8.7|Standard Deviation|5.3|5.3|||
4346286|NCT00406133|4174047|B2|15-24 years||Duration of diabetes||years|Mean|8.8|8.8|Standard Deviation|4.0|4.0|||
4346293|NCT00406133|4174044|B5|No events||One or more severe hypoglycemic events in last six months||participants|Number|413.0|413.0||||||
4346294|NCT00406133|4174045|B4|No events||One or more severe hypoglycemic events in last six months||participants|Number|55|55.0||||||
4346295|NCT00406133|4174046|B3|No events||One or more severe hypoglycemic events in last six months||participants|Number|60|60.0||||||
4346296|NCT00406133|4174047|B2|No events||One or more severe hypoglycemic events in last six months||participants|Number|147|147.0||||||
4346297|NCT00406133|4174048|B1|No events||One or more severe hypoglycemic events in last six months||participants|Number|151|151.0||||||
4346298|NCT00406133|4174044|B5|One or more events||One or more severe hypoglycemic events in last six months||participants|Number|38.0|38.0||||||
4346299|NCT00406133|4174045|B4|One or more events||One or more severe hypoglycemic events in last six months||participants|Number|7|7.0||||||
4346300|NCT00406133|4174046|B3|One or more events||One or more severe hypoglycemic events in last six months||participants|Number|7|7.0||||||
4346301|NCT00406133|4174047|B2|One or more events||One or more severe hypoglycemic events in last six months||participants|Number|10|10.0||||||
4346302|NCT00406133|4174048|B1|One or more events||One or more severe hypoglycemic events in last six months||participants|Number|14|14.0||||||
4346303|NCT00406133|4174044|B5|Multiple daily injections||Insulin modality||participants|Number|84.0|84.0||||||
4346304|NCT00406133|4174045|B4|Multiple daily injections||Insulin modality||participants|Number|13|13.0||||||
4346305|NCT00406133|4174046|B3|Multiple daily injections||Insulin modality||participants|Number|5|5.0||||||
4346306|NCT00406133|4174047|B2|Multiple daily injections||Insulin modality||participants|Number|29|29.0||||||
4346307|NCT00406133|4174048|B1|Multiple daily injections||Insulin modality||participants|Number|37|37.0||||||
4346308|NCT00406133|4174044|B5|Pump||Insulin modality||participants|Number|367.0|367.0||||||
4346309|NCT00406133|4174045|B4|Pump||Insulin modality||participants|Number|49|49.0||||||
4346310|NCT00406133|4174046|B3|Pump||Insulin modality||participants|Number|62|62.0||||||
4346311|NCT00406133|4174047|B2|Pump||Insulin modality||participants|Number|128|128.0||||||
4346312|NCT00406133|4174048|B1|Pump||Insulin modality||participants|Number|128|128.0||||||
4346313|NCT00406133|4174044|B5|Other||College graduate (subject or primary care giver)||participants|Number|88.0|88.0||||||
4346314|NCT00406133|4174045|B4|Other||College graduate (subject or primary care giver)||participants|Number|7|7.0||||||
4346315|NCT00406133|4174046|B3|Other||College graduate (subject or primary care giver)||participants|Number|9|9.0||||||
4346316|NCT00406133|4174047|B2|Other||College graduate (subject or primary care giver)||participants|Number|32|32.0||||||
4346317|NCT00406133|4174048|B1|Other||College graduate (subject or primary care giver)||participants|Number|40|40.0||||||
4346318|NCT00406133|4174044|B5|College graduate||College graduate (subject or primary care giver)||participants|Number|363.0|363.0||||||
4346319|NCT00406133|4174045|B4|College graduate||College graduate (subject or primary care giver)||participants|Number|55|55.0||||||
4346320|NCT00406133|4174046|B3|College graduate||College graduate (subject or primary care giver)||participants|Number|58|58.0||||||
4346321|NCT00406133|4174047|B2|College graduate||College graduate (subject or primary care giver)||participants|Number|125|125.0||||||
4346322|NCT00406133|4174048|B1|College graduate||College graduate (subject or primary care giver)||participants|Number|125|125.0||||||
4346323|NCT00406133|4174044|B5|Other||Race/Ethnicity, Customized||participants|Number|34.0|34.0||||||
4346324|NCT00406133|4174045|B4|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4346325|NCT00406133|4174046|B3|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4346326|NCT00406133|4174047|B2|Other||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4346327|NCT00406133|4174048|B1|Other||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4346328|NCT00406133|4174044|B5|Non-Hispanic White||Race/Ethnicity, Customized||participants|Number|417.0|417.0||||||
4346329|NCT00406133|4174045|B4|Non-Hispanic White||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
4346330|NCT00406133|4174046|B3|Non-Hispanic White||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
4346331|NCT00406133|4174047|B2|Non-Hispanic White||Race/Ethnicity, Customized||participants|Number|146|146.0||||||
4346332|NCT00406133|4174048|B1|Non-Hispanic White||Race/Ethnicity, Customized||participants|Number|150|150.0||||||
4346333|NCT00406133|4174044|B5||Male|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4346334|NCT00406133|4174045|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4346335|NCT00406133|4174046|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4346336|NCT00406133|4174047|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4346337|NCT00406133|4174048|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4346338|NCT00406133|4174044|B5||Female|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
4346339|NCT00406133|4174045|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4346340|NCT00406133|4174046|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4346341|NCT00406133|4174047|B2||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4346342|NCT00406133|4174048|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4346343|NCT00406133|4174044|B5|>=25 years||Age, Customized||participants|Number|165.0|165.0||||||
4346344|NCT00406133|4174045|B4|>=25 years||Age, Customized||participants|Number|33|33.0||||||
4346345|NCT00406133|4174046|B3|>=25 years||Age, Customized||participants|Number|34|34.0||||||
4346346|NCT00406133|4174047|B2|>=25 years||Age, Customized||participants|Number|46|46.0||||||
4346347|NCT00406133|4174048|B1|>=25 years||Age, Customized||participants|Number|52|52.0||||||
4346348|NCT00406133|4174044|B5|15-24 years||Age, Customized||participants|Number|143.0|143.0||||||
4346349|NCT00406133|4174045|B4|15-24 years||Age, Customized||participants|Number|18|18.0||||||
4346350|NCT00406133|4174046|B3|15-24 years||Age, Customized||participants|Number|15|15.0||||||
4346353|NCT00406133|4174044|B5|8-14 years||Age, Customized||participants|Number|143.0|143.0||||||
4346354|NCT00406133|4174045|B4|8-14 years||Age, Customized||participants|Number|11|11.0||||||
4346355|NCT00406133|4174046|B3|8-14 years||Age, Customized||participants|Number|18|18.0||||||
4346356|NCT00406133|4174047|B2|8-14 years||Age, Customized||participants|Number|58|58.0||||||
4346357|NCT00406133|4174048|B1|8-14 years||Age, Customized||participants|Number|56|56.0||||||
4346358|NCT00406107|4174113|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4346359|NCT00406107|4174114|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4346360|NCT00406107|4174115|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4346361|NCT00406107|4174113|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4346362|NCT00406107|4174114|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4346363|NCT00406107|4174115|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4346364|NCT00406107|4174113|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4346365|NCT00406107|4174114|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4346366|NCT00406107|4174115|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4346367|NCT00406107|4174113|B3|||Age||years|Mean|73.9|73.9|Standard Deviation|8.3|8.3|||
4346368|NCT00406107|4174114|B2|||Age||years|Mean|77|77.0|Standard Deviation|8.7|8.7|||
4346369|NCT00406107|4174115|B1|||Age||years|Mean|72.9|72.9|Standard Deviation|8.2|8.2|||
4346370|NCT00406107|4174113|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4346371|NCT00406107|4174114|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4346372|NCT00406107|4174115|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4346373|NCT00406107|4174113|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4346374|NCT00406107|4174114|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4346375|NCT00406107|4174115|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4346376|NCT00406107|4174113|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4346377|NCT00406107|4174114|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4346378|NCT00406107|4174115|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4346379|NCT00406029|4174126|B6||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4346380|NCT00406029|4174127|B5||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4346381|NCT00406029|4174128|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4346382|NCT00406029|4174129|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4346383|NCT00406029|4174130|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4346384|NCT00406029|4174131|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4346385|NCT00406029|4174126|B6||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4346386|NCT00406029|4174127|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4346387|NCT00406029|4174128|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4346388|NCT00406029|4174129|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4346389|NCT00406029|4174130|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4346390|NCT00406029|4174131|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4346391|NCT00406029|4174126|B6|>=65 years||Age, Customized||Participants|Number|108|108.0||||||
4346392|NCT00406029|4174127|B5|>=65 years||Age, Customized||Participants|Number|20|20.0||||||
4346393|NCT00406029|4174128|B4|>=65 years||Age, Customized||Participants|Number|22|22.0||||||
4346394|NCT00406029|4174129|B3|>=65 years||Age, Customized||Participants|Number|23|23.0||||||
4346395|NCT00406029|4174130|B2|>=65 years||Age, Customized||Participants|Number|24|24.0||||||
4346396|NCT00406029|4174131|B1|>=65 years||Age, Customized||Participants|Number|19|19.0||||||
4346397|NCT00406029|4174126|B6|Between 18 and 65 years||Age, Customized||Participants|Number|138|138.0||||||
4346398|NCT00406029|4174127|B5|Between 18 and 65 years||Age, Customized||Participants|Number|27|27.0||||||
4346399|NCT00406029|4174128|B4|Between 18 and 65 years||Age, Customized||Participants|Number|32|32.0||||||
4346400|NCT00406029|4174129|B3|Between 18 and 65 years||Age, Customized||Participants|Number|24|24.0||||||
4346401|NCT00406029|4174130|B2|Between 18 and 65 years||Age, Customized||Participants|Number|25|25.0||||||
4346402|NCT00406029|4174131|B1|Between 18 and 65 years||Age, Customized||Participants|Number|30|30.0||||||
4346403|NCT00405964|4174237|B3||Male|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
4346404|NCT00405964|4174238|B2||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4346405|NCT00405964|4174239|B1||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4346406|NCT00405964|4174237|B3||Female|Sex: Female, Male||Participants|Count of Participants|406|406.0||||||
4346407|NCT00405964|4174238|B2||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4346408|NCT00405964|4174239|B1||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4346409|NCT00405964|4174237|B3|||Age||years|Mean|33.9|33.9|Standard Deviation|12.2|12.2|||
4346410|NCT00405964|4174238|B2|||Age||years|Mean|33.9|33.9|Standard Deviation|12.3|12.3|||
4346411|NCT00405964|4174239|B1|||Age||years|Mean|34.0|34.0|Standard Deviation|12.1|12.1|||
4346412|NCT00405964|4174237|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4346413|NCT00405964|4174238|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4346414|NCT00405964|4174239|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4346415|NCT00405964|4174237|B3||Between 18 and 65 years|Age||Participants|Count of Participants|689|689.0||||||
4346416|NCT00405964|4174238|B2||Between 18 and 65 years|Age||Participants|Count of Participants|341|341.0||||||
4346417|NCT00405964|4174239|B1||Between 18 and 65 years|Age||Participants|Count of Participants|348|348.0||||||
4346418|NCT00405964|4174237|B3||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
4346419|NCT00405964|4174238|B2||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4346420|NCT00405964|4174239|B1||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4346421|NCT00405938|4174250|B3|United States||Region of Enrollment||participants|Number|79|79.0||||||
4346422|NCT00405938|4174251|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
4346423|NCT00405938|4174252|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4346424|NCT00405938|4174250|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4346425|NCT00405938|4174251|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4346426|NCT00405938|4174252|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4346427|NCT00405938|4174250|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4346428|NCT00405938|4174251|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4346429|NCT00405938|4174252|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4346430|NCT00405938|4174250|B3|||Age||years|Median|63|63.0|Full Range|||37.0|88.0|
4346431|NCT00405938|4174251|B2|||Age||years|Median|63|63.0|Full Range|||48.0|88.0|
4346432|NCT00405938|4174252|B1|||Age||years|Median|62|62.0|Full Range|||37.0|85.0|
4346433|NCT00405912|4174259|B4|||cigarettes per day|Self Reported average number of cigarettes smoked per day in the preceding 6 months prior to study enrollment.|cigarettes per day|Mean|19.8|19.8|Standard Deviation|6.6|6.6|||
4346434|NCT00405912|4174260|B3|||cigarettes per day|Self Reported average number of cigarettes smoked per day in the preceding 6 months prior to study enrollment.|cigarettes per day|Mean|21.0|21.0|Standard Deviation|5.2|5.2|||
4346435|NCT00405912|4174261|B2|||cigarettes per day|Self Reported average number of cigarettes smoked per day in the preceding 6 months prior to study enrollment.|cigarettes per day|Mean|19.1|19.1|Standard Deviation|7.2|7.2|||
4346436|NCT00405912|4174262|B1|||cigarettes per day|Self Reported average number of cigarettes smoked per day in the preceding 6 months prior to study enrollment.|cigarettes per day|Mean|19.4|19.4|Standard Deviation|7.3|7.3|||
4346437|NCT00405912|4174259|B4||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4346438|NCT00405912|4174260|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4346439|NCT00405912|4174261|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4346440|NCT00405912|4174262|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4346441|NCT00405912|4174259|B4||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4346442|NCT00405912|4174260|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4346443|NCT00405912|4174261|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4346444|NCT00405912|4174262|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4346445|NCT00405912|4174259|B4|||Age||years|Mean|37.6|37.6|Standard Deviation|12.4|12.4|||
4346446|NCT00405912|4174260|B3|||Age||years|Mean|35.0|35.0|Standard Deviation|12.2|12.2|||
4346447|NCT00405912|4174261|B2|||Age||years|Mean|38.3|38.3|Standard Deviation|11.9|11.9|||
4346448|NCT00405912|4174262|B1|||Age||years|Mean|39.4|39.4|Standard Deviation|13.0|13.0|||
4346449|NCT00405912|4174259|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4346450|NCT00405912|4174260|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4346451|NCT00405912|4174261|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4346452|NCT00405912|4174262|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4346453|NCT00405912|4174259|B4||Between 18 and 65 years|Age||Participants|Count of Participants|114|114.0||||||
4346454|NCT00405912|4174260|B3||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4346455|NCT00405912|4174261|B2||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4346456|NCT00405912|4174262|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4346457|NCT00405912|4174259|B4||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4346458|NCT00405912|4174260|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4346459|NCT00405912|4174261|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4346460|NCT00405912|4174262|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4346461|NCT00405821|4174275|B3||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4346462|NCT00405821|4174276|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4346463|NCT00405821|4174277|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4346464|NCT00405821|4174275|B3||Female|Sex: Female, Male||Participants|Count of Participants|311|311.0||||||
4346465|NCT00405821|4174276|B2||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4346466|NCT00405821|4174277|B1||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4346467|NCT00405821|4174275|B3|50+ years||Age, Customized||participants|Number|56|56.0||||||
4346468|NCT00405821|4174276|B2|50+ years||Age, Customized||participants|Number|30|30.0||||||
4346469|NCT00405821|4174277|B1|50+ years||Age, Customized||participants|Number|26|26.0||||||
4346470|NCT00405821|4174275|B3|40-49 years||Age, Customized||participants|Number|107|107.0||||||
4346471|NCT00405821|4174276|B2|40-49 years||Age, Customized||participants|Number|53|53.0||||||
4346472|NCT00405821|4174277|B1|40-49 years||Age, Customized||participants|Number|54|54.0||||||
4346473|NCT00405821|4174275|B3|30-39 years||Age, Customized||participants|Number|187|187.0||||||
4346474|NCT00405821|4174276|B2|30-39 years||Age, Customized||participants|Number|93|93.0||||||
4346475|NCT00405821|4174277|B1|30-39 years||Age, Customized||participants|Number|94|94.0||||||
4346476|NCT00405821|4174275|B3|20-29 years||Age, Customized||participants|Number|90|90.0||||||
4346477|NCT00405821|4174276|B2|20-29 years||Age, Customized||participants|Number|44|44.0||||||
4346478|NCT00405821|4174277|B1|20-29 years||Age, Customized||participants|Number|46|46.0||||||
4346479|NCT00405756|4174288|B4|||Plasma Cells in the Bone Marrow||percentage of plasma cells|Mean|39.0|39.0|Standard Deviation|24.45|24.45|||
4346480|NCT00405756|4174289|B3|||Plasma Cells in the Bone Marrow||percentage of plasma cells|Mean|37.9|37.9|Standard Deviation|23.65|23.65|||
4346481|NCT00405756|4174290|B2|||Plasma Cells in the Bone Marrow||percentage of plasma cells|Mean|39.3|39.3|Standard Deviation|25.01|25.01|||
4346482|NCT00405756|4174291|B1|||Plasma Cells in the Bone Marrow||percentage of plasma cells|Mean|39.8|39.8|Standard Deviation|24.79|24.79|||
4346483|NCT00405756|4174288|B4|Missing||Multiple Myeloma Subtype||participants|Number|13|13.0||||||
4346484|NCT00405756|4174289|B3|Missing||Multiple Myeloma Subtype||participants|Number|5|5.0||||||
4346485|NCT00405756|4174290|B2|Missing||Multiple Myeloma Subtype||participants|Number|3|3.0||||||
4346486|NCT00405756|4174291|B1|Missing||Multiple Myeloma Subtype||participants|Number|5|5.0||||||
4346487|NCT00405756|4174288|B4|Other||Multiple Myeloma Subtype||participants|Number|336|336.0||||||
4346488|NCT00405756|4174289|B3|Other||Multiple Myeloma Subtype||participants|Number|116|116.0||||||
4346489|NCT00405756|4174290|B2|Other||Multiple Myeloma Subtype||participants|Number|112|112.0||||||
4346490|NCT00405756|4174291|B1|Other||Multiple Myeloma Subtype||participants|Number|108|108.0||||||
4346491|NCT00405756|4174288|B4|Immunoglobulin A (IgA)||Multiple Myeloma Subtype||participants|Number|110|110.0||||||
4346492|NCT00405756|4174289|B3|Immunoglobulin A (IgA)||Multiple Myeloma Subtype||participants|Number|33|33.0||||||
4346493|NCT00405756|4174290|B2|Immunoglobulin A (IgA)||Multiple Myeloma Subtype||participants|Number|38|38.0||||||
4346494|NCT00405756|4174291|B1|Immunoglobulin A (IgA)||Multiple Myeloma Subtype||participants|Number|39|39.0||||||
4346495|NCT00405756|4174288|B4|Missing||C-reactive Protein||participants|Number|7|7.0||||||
4346496|NCT00405756|4174289|B3|Missing||C-reactive Protein||participants|Number|1|1.0||||||
4346497|NCT00405756|4174290|B2|Missing||C-reactive Protein||participants|Number|3|3.0||||||
4346498|NCT00405756|4174291|B1|Missing||C-reactive Protein||participants|Number|3|3.0||||||
4346499|NCT00405756|4174288|B4|<=4 mg/L||C-reactive Protein||participants|Number|267|267.0||||||
4346500|NCT00405756|4174289|B3|<=4 mg/L||C-reactive Protein||participants|Number|89|89.0||||||
4346501|NCT00405756|4174290|B2|<=4 mg/L||C-reactive Protein||participants|Number|94|94.0||||||
4346502|NCT00405756|4174291|B1|<=4 mg/L||C-reactive Protein||participants|Number|84|84.0||||||
4346503|NCT00405756|4174288|B4|>4 mg/L||C-reactive Protein||participants|Number|185|185.0||||||
4346504|NCT00405756|4174289|B3|>4 mg/L||C-reactive Protein||participants|Number|64|64.0||||||
4346505|NCT00405756|4174290|B2|>4 mg/L||C-reactive Protein||participants|Number|56|56.0||||||
4346506|NCT00405756|4174291|B1|>4 mg/L||C-reactive Protein||participants|Number|65|65.0||||||
4346507|NCT00405756|4174288|B4|Missing||Albumin||participants|Number|4|4.0||||||
4346508|NCT00405756|4174289|B3|Missing||Albumin||participants|Number|1|1.0||||||
4346509|NCT00405756|4174290|B2|Missing||Albumin||participants|Number|1|1.0||||||
4346510|NCT00405756|4174291|B1|Missing||Albumin||participants|Number|2|2.0||||||
4346511|NCT00405756|4174288|B4|<= 35 g/L||Albumin||participants|Number|205|205.0||||||
4346512|NCT00405756|4174289|B3|<= 35 g/L||Albumin||participants|Number|72|72.0||||||
4346513|NCT00405756|4174290|B2|<= 35 g/L||Albumin||participants|Number|70|70.0||||||
4346514|NCT00405756|4174291|B1|<= 35 g/L||Albumin||participants|Number|63|63.0||||||
4346515|NCT00405756|4174288|B4|>35 g/L||Albumin||participants|Number|250|250.0||||||
4346516|NCT00405756|4174289|B3|>35 g/L||Albumin||participants|Number|81|81.0||||||
4346517|NCT00405756|4174290|B2|>35 g/L||Albumin||participants|Number|82|82.0||||||
4346518|NCT00405756|4174291|B1|>35 g/L||Albumin||participants|Number|87|87.0||||||
4346519|NCT00405756|4174288|B4|Missing||Beta2 Microglobulin||participants|Number|1|1.0||||||
4346520|NCT00405756|4174289|B3|Missing||Beta2 Microglobulin||participants|Number|0|0.0||||||
4346521|NCT00405756|4174290|B2|Missing||Beta2 Microglobulin||participants|Number|0|0.0||||||
4346522|NCT00405756|4174291|B1|Missing||Beta2 Microglobulin||participants|Number|1|1.0||||||
4346523|NCT00405756|4174288|B4|<=5.5 mg/L||Beta2 Microglobulin||participants|Number|239|239.0||||||
4346524|NCT00405756|4174289|B3|<=5.5 mg/L||Beta2 Microglobulin||participants|Number|87|87.0||||||
4346525|NCT00405756|4174290|B2|<=5.5 mg/L||Beta2 Microglobulin||participants|Number|75|75.0||||||
4346526|NCT00405756|4174291|B1|<=5.5 mg/L||Beta2 Microglobulin||participants|Number|77|77.0||||||
4346527|NCT00405756|4174288|B4|>5.5 mg/L||Beta2 Microglobulin||participants|Number|219|219.0||||||
4346528|NCT00405756|4174289|B3|>5.5 mg/L||Beta2 Microglobulin||participants|Number|67|67.0||||||
4346529|NCT00405756|4174290|B2|>5.5 mg/L||Beta2 Microglobulin||participants|Number|78|78.0||||||
4346530|NCT00405756|4174291|B1|>5.5 mg/L||Beta2 Microglobulin||participants|Number|74|74.0||||||
4346531|NCT00405756|4174288|B4|Missing||Creatinine clearance||participants|Number|4|4.0||||||
4346532|NCT00405756|4174289|B3|Missing||Creatinine clearance||participants|Number|1|1.0||||||
4346533|NCT00405756|4174290|B2|Missing||Creatinine clearance||participants|Number|1|1.0||||||
4346534|NCT00405756|4174291|B1|Missing||Creatinine clearance||participants|Number|2|2.0||||||
4346535|NCT00405756|4174288|B4|<60 ml/min||Creatinine clearance||participants|Number|223|223.0||||||
4346536|NCT00405756|4174289|B3|<60 ml/min||Creatinine clearance||participants|Number|76|76.0||||||
4346537|NCT00405756|4174290|B2|<60 ml/min||Creatinine clearance||participants|Number|69|69.0||||||
4346538|NCT00405756|4174291|B1|<60 ml/min||Creatinine clearance||participants|Number|78|78.0||||||
4346539|NCT00405756|4174288|B4|>=60 ml/min||Creatinine clearance||participants|Number|232|232.0||||||
4346540|NCT00405756|4174289|B3|>=60 ml/min||Creatinine clearance||participants|Number|77|77.0||||||
4346541|NCT00405756|4174290|B2|>=60 ml/min||Creatinine clearance||participants|Number|83|83.0||||||
4346542|NCT00405756|4174291|B1|>=60 ml/min||Creatinine clearance||participants|Number|72|72.0||||||
4346543|NCT00405756|4174288|B4|Stage III||International Staging System (ISS)|ISS form multiple myeloma divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels. Higher stages represent more advanced disease.|participants|Number|226|226.0||||||
4346544|NCT00405756|4174289|B3|Stage III||International Staging System (ISS)|ISS form multiple myeloma divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels. Higher stages represent more advanced disease.|participants|Number|78|78.0||||||
4346545|NCT00405756|4174290|B2|Stage III||International Staging System (ISS)|ISS form multiple myeloma divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels. Higher stages represent more advanced disease.|participants|Number|74|74.0||||||
4346546|NCT00405756|4174291|B1|Stage III||International Staging System (ISS)|ISS form multiple myeloma divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels. Higher stages represent more advanced disease.|participants|Number|74|74.0||||||
4346547|NCT00405756|4174288|B4|Stage II||International Staging System (ISS)|ISS form multiple myeloma divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels. Higher stages represent more advanced disease.|participants|Number|145|145.0||||||
4346548|NCT00405756|4174289|B3|Stage II||International Staging System (ISS)|ISS form multiple myeloma divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels. Higher stages represent more advanced disease.|participants|Number|48|48.0||||||
4346549|NCT00405756|4174290|B2|Stage II||International Staging System (ISS)|ISS form multiple myeloma divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels. Higher stages represent more advanced disease.|participants|Number|47|47.0||||||
4346550|NCT00405756|4174291|B1|Stage II||International Staging System (ISS)|ISS form multiple myeloma divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels. Higher stages represent more advanced disease.|participants|Number|50|50.0||||||
4346551|NCT00405756|4174288|B4|Stage I||International Staging System (ISS)|ISS form multiple myeloma divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels. Higher stages represent more advanced disease.|participants|Number|88|88.0||||||
4346552|NCT00405756|4174289|B3|Stage I||International Staging System (ISS)|ISS form multiple myeloma divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels. Higher stages represent more advanced disease.|participants|Number|28|28.0||||||
4346553|NCT00405756|4174290|B2|Stage I||International Staging System (ISS)|ISS form multiple myeloma divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels. Higher stages represent more advanced disease.|participants|Number|32|32.0||||||
4346554|NCT00405756|4174291|B1|Stage I||International Staging System (ISS)|ISS form multiple myeloma divides myeloma into 3 stages based only on the serum beta-2 microglobulin and serum albumin levels. Higher stages represent more advanced disease.|participants|Number|28|28.0||||||
4346555|NCT00405756|4174288|B4|||Karnofsky Performance Scale|Karnofsky Performance Scale classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the greater the impairment and worse prospect of survival for most serious illnesses.|units on a scale|Mean|82.4|82.4|Standard Deviation|11.74|11.74|||
4346556|NCT00405756|4174289|B3|||Karnofsky Performance Scale|Karnofsky Performance Scale classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the greater the impairment and worse prospect of survival for most serious illnesses.|units on a scale|Mean|84.0|84.0|Standard Deviation|11.46|11.46|||
4346557|NCT00405756|4174290|B2|||Karnofsky Performance Scale|Karnofsky Performance Scale classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the greater the impairment and worse prospect of survival for most serious illnesses.|units on a scale|Mean|82.2|82.2|Standard Deviation|11.71|11.71|||
4346558|NCT00405756|4174291|B1|||Karnofsky Performance Scale|Karnofsky Performance Scale classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the greater the impairment and worse prospect of survival for most serious illnesses.|units on a scale|Mean|81.1|81.1|Standard Deviation|11.95|11.95|||
4346559|NCT00405756|4174288|B4|||Pulse||beats per minute|Mean|76.5|76.5|Standard Deviation|10.36|10.36|||
4346560|NCT00405756|4174289|B3|||Pulse||beats per minute|Mean|76.3|76.3|Standard Deviation|10.80|10.8|||
4346561|NCT00405756|4174290|B2|||Pulse||beats per minute|Mean|77.3|77.3|Standard Deviation|10.50|10.5|||
4346562|NCT00405756|4174291|B1|||Pulse||beats per minute|Mean|76.0|76.0|Standard Deviation|9.77|9.77|||
4346563|NCT00405756|4174288|B4|||Temperature||degrees centigrade|Mean|36.5|36.5|Standard Deviation|0.40|0.4|||
4346564|NCT00405756|4174289|B3|||Temperature||degrees centigrade|Mean|36.5|36.5|Standard Deviation|0.40|0.4|||
4346565|NCT00405756|4174290|B2|||Temperature||degrees centigrade|Mean|36.5|36.5|Standard Deviation|0.38|0.38|||
4346566|NCT00405756|4174291|B1|||Temperature||degrees centigrade|Mean|36.5|36.5|Standard Deviation|0.41|0.41|||
4346567|NCT00405756|4174288|B4|||Diastolic Blood Pressure||mmHg|Mean|78.2|78.2|Standard Deviation|9.98|9.98|||
4346568|NCT00405756|4174289|B3|||Diastolic Blood Pressure||mmHg|Mean|78.8|78.8|Standard Deviation|10.40|10.4|||
4346569|NCT00405756|4174290|B2|||Diastolic Blood Pressure||mmHg|Mean|77.4|77.4|Standard Deviation|9.99|9.99|||
4346570|NCT00405756|4174291|B1|||Diastolic Blood Pressure||mmHg|Mean|78.5|78.5|Standard Deviation|9.53|9.53|||
4346571|NCT00405756|4174288|B4|||Systolic Blood Pressure||mmHg|Mean|135.3|135.3|Standard Deviation|18.83|18.83|||
4346572|NCT00405756|4174289|B3|||Systolic Blood Pressure||mmHg|Mean|136.4|136.4|Standard Deviation|20.13|20.13|||
4346573|NCT00405756|4174290|B2|||Systolic Blood Pressure||mmHg|Mean|135.5|135.5|Standard Deviation|18.60|18.6|||
4346574|NCT00405756|4174291|B1|||Systolic Blood Pressure||mmHg|Mean|133.9|133.9|Standard Deviation|17.71|17.71|||
4346575|NCT00405756|4174288|B4|||Height||centimeter|Mean|165.3|165.3|Standard Deviation|9.63|9.63|||
4346576|NCT00405756|4174289|B3|||Height||centimeter|Mean|165.7|165.7|Standard Deviation|9.79|9.79|||
4346577|NCT00405756|4174290|B2|||Height||centimeter|Mean|165.3|165.3|Standard Deviation|9.33|9.33|||
4346578|NCT00405756|4174291|B1|||Height||centimeter|Mean|164.8|164.8|Standard Deviation|9.81|9.81|||
4346579|NCT00405756|4174288|B4|||Weight||kilograms|Mean|72.5|72.5|Standard Deviation|14.28|14.28|||
4346580|NCT00405756|4174289|B3|||Weight||kilograms|Mean|72.1|72.1|Standard Deviation|15.20|15.2|||
4346581|NCT00405756|4174290|B2|||Weight||kilograms|Mean|72.0|72.0|Standard Deviation|12.79|12.79|||
4346582|NCT00405756|4174291|B1|||Weight||kilograms|Mean|73.5|73.5|Standard Deviation|14.77|14.77|||
4346583|NCT00405756|4174288|B4|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4346584|NCT00405756|4174289|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4346585|NCT00405756|4174290|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4346586|NCT00405756|4174291|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4346587|NCT00405756|4174288|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4346588|NCT00405756|4174289|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4346589|NCT00405756|4174290|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4346590|NCT00405756|4174291|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4346591|NCT00405756|4174288|B4|Asian / Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4346592|NCT00405756|4174289|B3|Asian / Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4346593|NCT00405756|4174290|B2|Asian / Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4346594|NCT00405756|4174291|B1|Asian / Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4346595|NCT00405756|4174288|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4346596|NCT00405756|4174289|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4346597|NCT00405756|4174290|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4346598|NCT00405756|4174291|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4346599|NCT00405756|4174288|B4|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4346600|NCT00405756|4174289|B3|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4346601|NCT00405756|4174290|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4346602|NCT00405756|4174291|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4346603|NCT00405756|4174288|B4|White||Race/Ethnicity, Customized||participants|Number|453|453.0||||||
4346604|NCT00405756|4174289|B3|White||Race/Ethnicity, Customized||participants|Number|151|151.0||||||
4346605|NCT00405756|4174290|B2|White||Race/Ethnicity, Customized||participants|Number|151|151.0||||||
4346606|NCT00405756|4174291|B1|White||Race/Ethnicity, Customized||participants|Number|151|151.0||||||
4346607|NCT00405756|4174288|B4||Male|Gender||Participants|Count of Participants|228|228.0||||||
4346608|NCT00405756|4174289|B3||Male|Gender||Participants|Count of Participants|75|75.0||||||
4346609|NCT00405756|4174290|B2||Male|Gender||Participants|Count of Participants|82|82.0||||||
4346610|NCT00405756|4174291|B1||Male|Gender||Participants|Count of Participants|71|71.0||||||
4346611|NCT00405756|4174288|B4||Female|Gender||Participants|Count of Participants|231|231.0||||||
4346612|NCT00405756|4174289|B3||Female|Gender||Participants|Count of Participants|79|79.0||||||
4346613|NCT00405756|4174290|B2||Female|Gender||Participants|Count of Participants|71|71.0||||||
4346614|NCT00405756|4174291|B1||Female|Gender||Participants|Count of Participants|81|81.0||||||
4346615|NCT00405756|4174288|B4|>75 years||Age, Customized||participants|Number|111|111.0||||||
4346616|NCT00405756|4174289|B3|>75 years||Age, Customized||participants|Number|38|38.0||||||
4346617|NCT00405756|4174290|B2|>75 years||Age, Customized||participants|Number|37|37.0||||||
4346618|NCT00405756|4174291|B1|>75 years||Age, Customized||participants|Number|36|36.0||||||
4346619|NCT00405756|4174288|B4|<=75 years||Age, Customized||participants|Number|348|348.0||||||
4346620|NCT00405756|4174289|B3|<=75 years||Age, Customized||participants|Number|116|116.0||||||
4346621|NCT00405756|4174290|B2|<=75 years||Age, Customized||participants|Number|116|116.0||||||
4346622|NCT00405756|4174291|B1|<=75 years||Age, Customized||participants|Number|116|116.0||||||
4346623|NCT00405756|4174288|B4|||Age||years|Mean|72.0|72.0|Standard Deviation|5.25|5.25|||
4346624|NCT00405756|4174289|B3|||Age||years|Mean|72.0|72.0|Standard Deviation|5.26|5.26|||
4346625|NCT00405756|4174290|B2|||Age||years|Mean|72.1|72.1|Standard Deviation|5.20|5.2|||
4346626|NCT00405756|4174291|B1|||Age||years|Mean|72.0|72.0|Standard Deviation|5.33|5.33|||
4346627|NCT00405704|4174381|B3|United States||Region of Enrollment||participants|Number|607|607.0||||||
4346628|NCT00405704|4174382|B2|United States||Region of Enrollment||participants|Number|305|305.0||||||
4346629|NCT00405704|4174383|B1|United States||Region of Enrollment||participants|Number|302|302.0||||||
4346630|NCT00405704|4174381|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4346631|NCT00405704|4174382|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4346632|NCT00405704|4174383|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4346633|NCT00405704|4174381|B3||Female|Sex: Female, Male||Participants|Count of Participants|558|558.0||||||
4346634|NCT00405704|4174382|B2||Female|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
4346635|NCT00405704|4174383|B1||Female|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
4346636|NCT00405704|4174381|B3|||Age||months|Median|12|12.0|Inter-Quartile Range|||6.0|31.0|
4346637|NCT00405704|4174382|B2|||Age||months|Median|12|12.0|Inter-Quartile Range|||6.0|30.0|
4346638|NCT00405704|4174383|B1|||Age||months|Median|12|12.0|Inter-Quartile Range|||5.0|31.0|
4346639|NCT00405652|4174404|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4346640|NCT00405652|4174404|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4346641|NCT00405652|4174404|B1|||Age||years|Mean|55.8|55.8|Standard Deviation|9.6|9.6|||
4346642|NCT00405639|4174409|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
4346643|NCT00405639|4174410|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4346644|NCT00405639|4174411|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4346645|NCT00405639|4174409|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4346646|NCT00405639|4174410|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4346647|NCT00405639|4174411|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4346648|NCT00405639|4174409|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4346649|NCT00405639|4174410|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4346650|NCT00405639|4174411|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4346651|NCT00405639|4174409|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4346652|NCT00405639|4174410|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4346653|NCT00405639|4174411|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4346654|NCT00405639|4174409|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4346655|NCT00405639|4174410|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4346656|NCT00405639|4174411|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4346657|NCT00405639|4174409|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4346658|NCT00405639|4174410|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4346659|NCT00405639|4174411|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4346660|NCT00405587|4174424|B5||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4346661|NCT00405587|4174425|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4346662|NCT00405587|4174426|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4346663|NCT00405587|4174427|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4346664|NCT00405587|4174428|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4346665|NCT00405587|4174424|B5||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4346666|NCT00405587|4174425|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4346667|NCT00405587|4174426|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4346668|NCT00405587|4174427|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4346669|NCT00405587|4174428|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4346670|NCT00405587|4174424|B5|||Age||years|Mean|58.6|58.6|Standard Deviation|15.24|15.24|||
4346671|NCT00405587|4174425|B4|||Age||years|Mean|63.6|63.6|Standard Deviation|14.86|14.86|||
4346672|NCT00405587|4174426|B3|||Age||years|Mean|50.4|50.4|Standard Deviation|13.54|13.54|||
4346673|NCT00405587|4174427|B2|||Age||years|Mean|58.0|58.0|Standard Deviation|14.77|14.77|||
4346674|NCT00405587|4174428|B1|||Age||years|Mean|65.5|65.5|Standard Deviation|13.75|13.75|||
4346675|NCT00405548|4174547|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4346676|NCT00405548|4174548|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4346677|NCT00405548|4174549|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4346678|NCT00405548|4174547|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4346679|NCT00405548|4174548|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4346680|NCT00405548|4174549|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4346681|NCT00405548|4174547|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4346682|NCT00405548|4174548|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4346683|NCT00405548|4174549|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4346684|NCT00405548|4174547|B3|||Age||years|Mean|69.1|69.1|Standard Deviation|9.0|9.0|||
4346685|NCT00405548|4174548|B2|||Age||years|Mean|69.6|69.6|Standard Deviation|10.9|10.9|||
4346686|NCT00405548|4174549|B1|||Age||years|Mean|68.8|68.8|Standard Deviation|8.1|8.1|||
4346687|NCT00405548|4174547|B3||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4346688|NCT00405548|4174548|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4346689|NCT00405548|4174549|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4346690|NCT00405548|4174547|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4346691|NCT00405548|4174548|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4346692|NCT00405548|4174549|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4346693|NCT00405548|4174547|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4346694|NCT00405548|4174548|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4346695|NCT00405548|4174549|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4346696|NCT00405509|4174562|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
4346697|NCT00405509|4174563|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4346698|NCT00405509|4174564|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4346699|NCT00405509|4174562|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4346700|NCT00405509|4174563|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4346701|NCT00405509|4174564|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4346702|NCT00405509|4174562|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4346703|NCT00405509|4174563|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4346704|NCT00405509|4174564|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4346705|NCT00405509|4174562|B3|Age||Age||years|Mean|9.4|9.4|Standard Deviation|2.3|2.3|||
4346706|NCT00405509|4174563|B2|Age||Age||years|Mean|9.6|9.6|Standard Deviation|2.3|2.3|||
4346707|NCT00405509|4174564|B1|Age||Age||years|Mean|9.0|9.0|Standard Deviation|2.2|2.2|||
4346708|NCT00405509|4174562|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4346709|NCT00405509|4174563|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4346710|NCT00405509|4174564|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4346711|NCT00405509|4174562|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4346712|NCT00405509|4174563|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4346713|NCT00405509|4174564|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4346714|NCT00405509|4174562|B3||<=18 years|Age||Participants|Count of Participants|33|33.0||||||
4346715|NCT00405509|4174563|B2||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
4346716|NCT00405509|4174564|B1||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4346717|NCT00405392|4174579|B3|South Korea||Region of Enrollment||Participants|Count of Participants|352|352.0||||||
4346718|NCT00405392|4174580|B2|South Korea||Region of Enrollment||Participants|Count of Participants|176|176.0||||||
4346719|NCT00405392|4174581|B1|South Korea||Region of Enrollment||Participants|Count of Participants|176|176.0||||||
4346720|NCT00405392|4174579|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4346721|NCT00405392|4174580|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4346722|NCT00405392|4174581|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4346723|NCT00405392|4174579|B3||Female|Sex: Female, Male||Participants|Count of Participants|352|352.0||||||
4346724|NCT00405392|4174580|B2||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4346725|NCT00405392|4174581|B1||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4346726|NCT00405392|4174579|B3|||Age||Years|Mean|61.66|61.66|Standard Deviation|6.81|6.81|||
4346727|NCT00405392|4174580|B2|||Age||Years|Mean|61.99|61.99|Standard Deviation|7.07|7.07|||
4346728|NCT00405392|4174581|B1|||Age||Years|Mean|61.33|61.33|Standard Deviation|6.53|6.53|||
4346729|NCT00405288|4174592|B3|Canada||Region of Enrollment||participants|Number|408|408.0||||||
4346730|NCT00405288|4174593|B2|Canada||Region of Enrollment||participants|Number|204|204.0||||||
4346731|NCT00405288|4174594|B1|Canada||Region of Enrollment||participants|Number|204|204.0||||||
4346732|NCT00405288|4174592|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4346733|NCT00405288|4174593|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4346734|NCT00405288|4174594|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4346735|NCT00405288|4174592|B3||Female|Sex: Female, Male||Participants|Count of Participants|408|408.0||||||
4346736|NCT00405288|4174593|B2||Female|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4346737|NCT00405288|4174594|B1||Female|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4346738|NCT00405288|4174592|B3|||Age||years|Mean|31.75|31.75|Standard Deviation|4.9|4.9|||
4346739|NCT00405288|4174593|B2|||Age||years|Mean|31.5|31.5|Standard Deviation|4.9|4.9|||
4346740|NCT00405288|4174594|B1|||Age||years|Mean|32|32.0|Standard Deviation|4.9|4.9|||
4346741|NCT00405288|4174592|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4346742|NCT00405288|4174593|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4346743|NCT00405288|4174594|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4346744|NCT00405288|4174592|B3||Between 18 and 65 years|Age||Participants|Count of Participants|408|408.0||||||
4346745|NCT00405288|4174593|B2||Between 18 and 65 years|Age||Participants|Count of Participants|204|204.0||||||
4346746|NCT00405288|4174594|B1||Between 18 and 65 years|Age||Participants|Count of Participants|204|204.0||||||
4346747|NCT00405288|4174592|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4346748|NCT00405288|4174593|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4346749|NCT00405288|4174594|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4346750|NCT00405275|4174623|B3|Canada||Region of Enrollment||participants|Number|89|89.0||||||
4346751|NCT00405275|4174624|B2|Canada||Region of Enrollment||participants|Number|45|45.0||||||
4346752|NCT00405275|4174625|B1|Canada||Region of Enrollment||participants|Number|44|44.0||||||
4346753|NCT00405275|4174623|B3|United States||Region of Enrollment||participants|Number|264|264.0||||||
4346754|NCT00405275|4174624|B2|United States||Region of Enrollment||participants|Number|130|130.0||||||
4346755|NCT00405275|4174625|B1|United States||Region of Enrollment||participants|Number|134|134.0||||||
4346756|NCT00405275|4174623|B3|Unknown||Sex/Gender, Customized||participants|Number|1|1.0||||||
4346757|NCT00405275|4174624|B2|Unknown||Sex/Gender, Customized||participants|Number|1|1.0||||||
4346758|NCT00405275|4174625|B1|Unknown||Sex/Gender, Customized||participants|Number|0|0.0||||||
4346759|NCT00405275|4174623|B3|Male||Sex/Gender, Customized||participants|Number|190|190.0||||||
4346760|NCT00405275|4174624|B2|Male||Sex/Gender, Customized||participants|Number|89|89.0||||||
4346761|NCT00405275|4174625|B1|Male||Sex/Gender, Customized||participants|Number|101|101.0||||||
4346762|NCT00405275|4174623|B3|Female||Sex/Gender, Customized||participants|Number|162|162.0||||||
4346763|NCT00405275|4174624|B2|Female||Sex/Gender, Customized||participants|Number|85|85.0||||||
4346764|NCT00405275|4174625|B1|Female||Sex/Gender, Customized||participants|Number|77|77.0||||||
4346765|NCT00405275|4174623|B3|||Age||years|Mean|56.9|56.9|Standard Deviation|13.1|13.1|||
4346766|NCT00405275|4174624|B2|||Age||years|Mean|56.0|56.0|Standard Deviation|13.2|13.2|||
4346767|NCT00405275|4174625|B1|||Age||years|Mean|57.8|57.8|Standard Deviation|13.0|13.0|||
4346768|NCT00405067|4174632|B4|United States||Region of Enrollment||participants|Number|85|85.0||||||
4346769|NCT00405067|4174633|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
4346770|NCT00405067|4174634|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4346771|NCT00405067|4174635|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4346772|NCT00405067|4174632|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4346773|NCT00405067|4174633|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4346774|NCT00405067|4174634|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4346775|NCT00405067|4174635|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4346776|NCT00405067|4174632|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4346777|NCT00405067|4174633|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4346778|NCT00405067|4174634|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4346779|NCT00405067|4174635|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4346780|NCT00405067|4174632|B4||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4346781|NCT00405067|4174633|B3||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4346782|NCT00405067|4174634|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4346783|NCT00405067|4174635|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4346784|NCT00405067|4174632|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4346785|NCT00405067|4174633|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4346786|NCT00405067|4174634|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4346787|NCT00405067|4174635|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4346788|NCT00405067|4174632|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4346789|NCT00405067|4174633|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4346790|NCT00405067|4174634|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4346791|NCT00405067|4174635|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4346792|NCT00405067|4174632|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4346793|NCT00405067|4174633|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4346794|NCT00405067|4174634|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4346795|NCT00405067|4174635|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4346796|NCT00405067|4174632|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4346797|NCT00405067|4174633|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4346798|NCT00405067|4174634|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4346799|NCT00405067|4174635|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4346800|NCT00405067|4174632|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4346801|NCT00405067|4174633|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4346802|NCT00405067|4174634|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4346803|NCT00405067|4174635|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4346804|NCT00405067|4174632|B4||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4346805|NCT00405067|4174633|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4346806|NCT00405067|4174634|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4346807|NCT00405067|4174635|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4346808|NCT00405067|4174632|B4|||Age||years|Mean|55.7|55.7|Standard Deviation|7.48|7.48|||
4346809|NCT00405067|4174633|B3|||Age||years|Mean|54.7|54.7|Standard Deviation|9.0|9.0|||
4346810|NCT00405067|4174634|B2|||Age||years|Mean|57.5|57.5|Standard Deviation|7.2|7.2|||
4346811|NCT00405067|4174635|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|5.7|5.7|||
4346812|NCT00404924|4174672|B3||Male|Sex: Female, Male||Participants|Count of Participants|435|435.0||||||
4346813|NCT00404924|4174673|B2||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4346814|NCT00404924|4174674|B1||Male|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
4346815|NCT00404924|4174672|B3||Female|Sex: Female, Male||Participants|Count of Participants|489|489.0||||||
4346816|NCT00404924|4174673|B2||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4346817|NCT00404924|4174674|B1||Female|Sex: Female, Male||Participants|Count of Participants|329|329.0||||||
4346818|NCT00404924|4174672|B3|||Age||years|Mean|60|60.0|Full Range|||20.0|85.0|
4346819|NCT00404924|4174673|B2|||Age||years|Mean|60.6|60.6|Full Range|||21.0|84.0|
4346820|NCT00404924|4174674|B1|||Age||years|Mean|59.8|59.8|Full Range|||20.0|85.0|
4346821|NCT00404820|4174691|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4346822|NCT00404820|4174692|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4346823|NCT00404820|4174693|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4346824|NCT00404820|4174691|B3||Female|Sex: Female, Male||Participants|Count of Participants|602|602.0||||||
4346825|NCT00404820|4174692|B2||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4346826|NCT00404820|4174693|B1||Female|Sex: Female, Male||Participants|Count of Participants|408|408.0||||||
4346827|NCT00404820|4174691|B3|||Age||years|Mean|67.8|67.8|Standard Deviation|8.0|8.0|||
4346828|NCT00404820|4174692|B2|||Age||years|Mean|68.2|68.2|Standard Deviation|7.9|7.9|||
4346829|NCT00404820|4174693|B1|||Age||years|Mean|67.6|67.6|Standard Deviation|8.1|8.1|||
4346830|NCT00404768|4174712|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4346831|NCT00404768|4174713|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4346832|NCT00404768|4174714|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4346833|NCT00404768|4174715|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4346834|NCT00404768|4174716|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4346835|NCT00404768|4174712|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4346836|NCT00404768|4174713|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4346837|NCT00404768|4174714|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4346838|NCT00404768|4174715|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4346839|NCT00404768|4174716|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4346840|NCT00404768|4174712|B5||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4346841|NCT00404768|4174713|B4||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4346842|NCT00404768|4174714|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4346843|NCT00404768|4174715|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4346844|NCT00404768|4174716|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4346845|NCT00404768|4174712|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4346846|NCT00404768|4174713|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4346847|NCT00404768|4174714|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4346848|NCT00404768|4174715|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4346849|NCT00404768|4174716|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4346850|NCT00404768|4174712|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4346851|NCT00404768|4174713|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4346852|NCT00404768|4174714|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4346853|NCT00404768|4174715|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4346854|NCT00404768|4174716|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4346855|NCT00404768|4174712|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4346856|NCT00404768|4174713|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4346857|NCT00404768|4174714|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4346858|NCT00404768|4174715|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4346859|NCT00404768|4174716|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4346860|NCT00404768|4174712|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4346861|NCT00404768|4174713|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4346862|NCT00404768|4174714|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4346863|NCT00404768|4174715|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4346864|NCT00404768|4174716|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4346865|NCT00404768|4174712|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4346866|NCT00404768|4174713|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4346867|NCT00404768|4174714|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4346868|NCT00404768|4174715|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4346869|NCT00404768|4174716|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4346870|NCT00404768|4174712|B5||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4346871|NCT00404768|4174713|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4346872|NCT00404768|4174714|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4346873|NCT00404768|4174715|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4346874|NCT00404768|4174716|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4346875|NCT00404768|4174712|B5|||Age||Years|Mean|26.4|26.4|Standard Deviation|5.84|5.84|||
4346876|NCT00404768|4174713|B4|||Age||Years|Mean|27.8|27.8|Standard Deviation|6.26|6.26|||
4346877|NCT00404768|4174714|B3|||Age||Years|Mean|26.7|26.7|Standard Deviation|5.66|5.66|||
4346878|NCT00404768|4174715|B2|||Age||Years|Mean|25.2|25.2|Standard Deviation|5.86|5.86|||
4346879|NCT00404768|4174716|B1|||Age||Years|Mean|25.6|25.6|Standard Deviation|4.97|4.97|||
4346880|NCT00404755|4174780|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4346881|NCT00404755|4174780|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4346882|NCT00404755|4174780|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4346883|NCT00404755|4174780|B1|||Age||years|Mean|36|36.0|Standard Deviation|9|9.0|||
4346884|NCT00404651|4174791|B5|Mexico||Region of Enrollment||Participants|Number|1189|1189.0||||||
4346885|NCT00404651|4174792|B4|Mexico||Region of Enrollment||Participants|Number|167|167.0||||||
4346886|NCT00404651|4174793|B3|Mexico||Region of Enrollment||Participants|Number|339|339.0||||||
4346887|NCT00404651|4174794|B2|Mexico||Region of Enrollment||Participants|Number|343|343.0||||||
4346888|NCT00404651|4174795|B1|Mexico||Region of Enrollment||Participants|Number|340|340.0||||||
4346889|NCT00404651|4174791|B5||Male|Sex: Female, Male||Participants|Count of Participants|617|617.0||||||
4346890|NCT00404651|4174792|B4||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4346891|NCT00404651|4174793|B3||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4346892|NCT00404651|4174794|B2||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4346893|NCT00404651|4174795|B1||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4346894|NCT00404651|4174791|B5||Female|Sex: Female, Male||Participants|Count of Participants|572|572.0||||||
4346895|NCT00404651|4174792|B4||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4346896|NCT00404651|4174793|B3||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4346897|NCT00404651|4174794|B2||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4346898|NCT00404651|4174795|B1||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4346899|NCT00404651|4174791|B5|||Age||Months|Mean|2.00|2.0|Standard Deviation|0.195|0.195|||
4346900|NCT00404651|4174792|B4|||Age||Months|Mean|1.98|1.98|Standard Deviation|0.189|0.189|||
4346901|NCT00404651|4174793|B3|||Age||Months|Mean|2.01|2.01|Standard Deviation|0.193|0.193|||
4346902|NCT00404651|4174794|B2|||Age||Months|Mean|2.00|2.0|Standard Deviation|0.197|0.197|||
4346903|NCT00404651|4174795|B1|||Age||Months|Mean|2.00|2.0|Standard Deviation|0.200|0.2|||
4346904|NCT00404651|4174791|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4346905|NCT00404651|4174792|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4346906|NCT00404651|4174793|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4346907|NCT00404651|4174794|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4346908|NCT00404651|4174795|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4346909|NCT00404651|4174791|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4346910|NCT00404651|4174792|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4346911|NCT00404651|4174793|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4346912|NCT00404651|4174794|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4346913|NCT00404651|4174795|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4346914|NCT00404651|4174791|B5||<=18 years|Age||Participants|Count of Participants|1189|1189.0||||||
4346915|NCT00404651|4174792|B4||<=18 years|Age||Participants|Count of Participants|167|167.0||||||
4346916|NCT00404651|4174793|B3||<=18 years|Age||Participants|Count of Participants|339|339.0||||||
4346917|NCT00404651|4174794|B2||<=18 years|Age||Participants|Count of Participants|343|343.0||||||
4346918|NCT00404651|4174795|B1||<=18 years|Age||Participants|Count of Participants|340|340.0||||||
4346919|NCT00404547|4174824|B3|||Duration of Asthma|Basis is the Intention to Treat Population (ITT).|years|Mean|12.5|12.5|Standard Deviation|11.4|11.4|||
4346920|NCT00404547|4174825|B2|||Duration of Asthma|Basis is the Intention to Treat Population (ITT).|years|Mean|12.8|12.8|Standard Deviation|11.9|11.9|||
4346921|NCT00404547|4174826|B1|||Duration of Asthma|Basis is the Intention to Treat Population (ITT).|years|Mean|12.4|12.4|Standard Deviation|11.3|11.3|||
4346922|NCT00404547|4174824|B3|Former||Smoking Status|Basis is the Intention to Treat Population (ITT).|participants|Number|312|312.0||||||
4346923|NCT00404547|4174825|B2|Former||Smoking Status|Basis is the Intention to Treat Population (ITT).|participants|Number|115|115.0||||||
4346924|NCT00404547|4174826|B1|Former||Smoking Status|Basis is the Intention to Treat Population (ITT).|participants|Number|197|197.0||||||
4346925|NCT00404547|4174824|B3|Current||Smoking Status|Basis is the Intention to Treat Population (ITT).|participants|Number|237|237.0||||||
4346926|NCT00404547|4174825|B2|Current||Smoking Status|Basis is the Intention to Treat Population (ITT).|participants|Number|81|81.0||||||
4346927|NCT00404547|4174826|B1|Current||Smoking Status|Basis is the Intention to Treat Population (ITT).|participants|Number|156|156.0||||||
4346928|NCT00404547|4174824|B3|Never||Smoking Status|Basis is the Intention to Treat Population (ITT).|participants|Number|508|508.0||||||
4346929|NCT00404547|4174825|B2|Never||Smoking Status|Basis is the Intention to Treat Population (ITT).|participants|Number|149|149.0||||||
4346930|NCT00404547|4174826|B1|Never||Smoking Status|Basis is the Intention to Treat Population (ITT).|participants|Number|359|359.0||||||
4346931|NCT00404547|4174824|B3||Male|Gender|Basis is the Intention to Treat Population (ITT).|Participants|Count of Participants|394|394.0||||||
4346932|NCT00404547|4174825|B2||Male|Gender|Basis is the Intention to Treat Population (ITT).|Participants|Count of Participants|113|113.0||||||
4346933|NCT00404547|4174826|B1||Male|Gender|Basis is the Intention to Treat Population (ITT).|Participants|Count of Participants|281|281.0||||||
4346934|NCT00404547|4174824|B3||Female|Gender|Basis is the Intention to Treat Population (ITT).|Participants|Count of Participants|663|663.0||||||
4346935|NCT00404547|4174825|B2||Female|Gender|Basis is the Intention to Treat Population (ITT).|Participants|Count of Participants|232|232.0||||||
4346936|NCT00404547|4174826|B1||Female|Gender|Basis is the Intention to Treat Population (ITT).|Participants|Count of Participants|431|431.0||||||
4346937|NCT00404547|4174824|B3|||Age, Customized|Basis is the Intention to Treat Population (ITT).|years|Mean|47.26|47.26|Standard Deviation|16.43|16.43|||
4346938|NCT00404547|4174825|B2|||Age, Customized|Basis is the Intention to Treat Population (ITT).|years|Mean|47.2|47.2|Standard Deviation|16.7|16.7|||
4346939|NCT00404547|4174826|B1|||Age, Customized|Basis is the Intention to Treat Population (ITT).|years|Mean|47.3|47.3|Standard Deviation|16.3|16.3|||
4346940|NCT00404495|4174835|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4346941|NCT00404495|4174836|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4346942|NCT00404495|4174837|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4346943|NCT00404495|4174835|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4346944|NCT00404495|4174836|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4346945|NCT00404495|4174837|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4346946|NCT00404495|4174835|B3|>12 years to 18 years||Age, Customized||participants|Number|22|22.0||||||
4346947|NCT00404495|4174836|B2|>12 years to 18 years||Age, Customized||participants|Number|5|5.0||||||
4346948|NCT00404495|4174837|B1|>12 years to 18 years||Age, Customized||participants|Number|17|17.0||||||
4346949|NCT00404495|4174835|B3|2 years to 12 years||Age, Customized||participants|Number|61|61.0||||||
4346950|NCT00404495|4174836|B2|2 years to 12 years||Age, Customized||participants|Number|12|12.0||||||
4346951|NCT00404495|4174837|B1|2 years to 12 years||Age, Customized||participants|Number|49|49.0||||||
4346952|NCT00404352|4174854|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4346953|NCT00404352|4174855|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4346954|NCT00404352|4174856|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4346955|NCT00404352|4174857|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4346956|NCT00404352|4174854|B4|White||Race/Ethnicity, Customized||participants|Number|516|516.0||||||
4346957|NCT00404352|4174855|B3|White||Race/Ethnicity, Customized||participants|Number|171|171.0||||||
4346958|NCT00404352|4174856|B2|White||Race/Ethnicity, Customized||participants|Number|174|174.0||||||
4346959|NCT00404352|4174857|B1|White||Race/Ethnicity, Customized||participants|Number|171|171.0||||||
4346960|NCT00404352|4174854|B4|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4346961|NCT00404352|4174855|B3|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4346962|NCT00404352|4174856|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4346963|NCT00404352|4174857|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4346964|NCT00404352|4174854|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4346965|NCT00404352|4174855|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4346966|NCT00404352|4174856|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4346967|NCT00404352|4174857|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4346968|NCT00404352|4174854|B4||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4346969|NCT00404352|4174855|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4346970|NCT00404352|4174856|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4346971|NCT00404352|4174857|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4346972|NCT00404352|4174854|B4||Female|Sex: Female, Male||Participants|Count of Participants|332|332.0||||||
4346973|NCT00404352|4174855|B3||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4346974|NCT00404352|4174856|B2||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4346975|NCT00404352|4174857|B1||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4346976|NCT00404352|4174854|B4|Greater than or equal to 30 years||Age, Customized||participants|Number|258|258.0||||||
4346977|NCT00404352|4174855|B3|Greater than or equal to 30 years||Age, Customized||participants|Number|84|84.0||||||
4346978|NCT00404352|4174856|B2|Greater than or equal to 30 years||Age, Customized||participants|Number|89|89.0||||||
4346979|NCT00404352|4174857|B1|Greater than or equal to 30 years||Age, Customized||participants|Number|85|85.0||||||
4346980|NCT00404352|4174854|B4|Less than 30 years||Age, Customized||participants|Number|259|259.0||||||
4346981|NCT00404352|4174855|B3|Less than 30 years||Age, Customized||participants|Number|87|87.0||||||
4346982|NCT00404352|4174856|B2|Less than 30 years||Age, Customized||participants|Number|86|86.0||||||
4346983|NCT00404352|4174857|B1|Less than 30 years||Age, Customized||participants|Number|86|86.0||||||
4346984|NCT00404352|4174854|B4|||Age||years|Mean|30.7|30.7|Standard Deviation|8.2|8.2|||
4346985|NCT00404352|4174855|B3|||Age||years|Mean|30.9|30.9|Standard Deviation|7.9|7.9|||
4346986|NCT00404352|4174856|B2|||Age||years|Mean|30.7|30.7|Standard Deviation|8.1|8.1|||
4346987|NCT00404352|4174857|B1|||Age||years|Mean|30.6|30.6|Standard Deviation|8.5|8.5|||
4346988|NCT00404248|4174897|B4|anaplastic astrocytoma||Histologic diagnosis||participants|Number|10|10.0||||||
4346989|NCT00404248|4174898|B3|anaplastic astrocytoma||Histologic diagnosis||participants|Number|0|0.0||||||
4346990|NCT00404248|4174899|B2|anaplastic astrocytoma||Histologic diagnosis||participants|Number|6|6.0||||||
4346991|NCT00404248|4174900|B1|anaplastic astrocytoma||Histologic diagnosis||participants|Number|4|4.0||||||
4346992|NCT00404248|4174897|B4|anaplastic oligodendroglioma||Histologic diagnosis||participants|Number|10|10.0||||||
4346993|NCT00404248|4174898|B3|anaplastic oligodendroglioma||Histologic diagnosis||participants|Number|0|0.0||||||
4346994|NCT00404248|4174899|B2|anaplastic oligodendroglioma||Histologic diagnosis||participants|Number|5|5.0||||||
4346995|NCT00404248|4174900|B1|anaplastic oligodendroglioma||Histologic diagnosis||participants|Number|5|5.0||||||
4346996|NCT00404248|4174897|B4|Glioblastoma||Histologic diagnosis||participants|Number|15|15.0||||||
4346997|NCT00404248|4174898|B3|Glioblastoma||Histologic diagnosis||participants|Number|3|3.0||||||
4346998|NCT00404248|4174899|B2|Glioblastoma||Histologic diagnosis||participants|Number|7|7.0||||||
4346999|NCT00404248|4174900|B1|Glioblastoma||Histologic diagnosis||participants|Number|5|5.0||||||
4347000|NCT00404248|4174897|B4|60||Karnofsky Performance Status|this is a performance assessment, or functional impairment. 100% is a perfect score no impariment (highest score) and 60% Requires occasional assistance, but is able to care for most of his personal needs. You had to have at least a 60% to be eligible fof the study.|participants|Number|4|4.0||||||
4347001|NCT00404248|4174898|B3|60||Karnofsky Performance Status|this is a performance assessment, or functional impairment. 100% is a perfect score no impariment (highest score) and 60% Requires occasional assistance, but is able to care for most of his personal needs. You had to have at least a 60% to be eligible fof the study.|participants|Number|1|1.0||||||
4347002|NCT00404248|4174899|B2|60||Karnofsky Performance Status|this is a performance assessment, or functional impairment. 100% is a perfect score no impariment (highest score) and 60% Requires occasional assistance, but is able to care for most of his personal needs. You had to have at least a 60% to be eligible fof the study.|participants|Number|1|1.0||||||
4347003|NCT00404248|4174900|B1|60||Karnofsky Performance Status|this is a performance assessment, or functional impairment. 100% is a perfect score no impariment (highest score) and 60% Requires occasional assistance, but is able to care for most of his personal needs. You had to have at least a 60% to be eligible fof the study.|participants|Number|2|2.0||||||
4347004|NCT00404248|4174897|B4|70||Karnofsky Performance Status|this is a performance assessment, or functional impairment. 100% is a perfect score no impariment (highest score) and 60% Requires occasional assistance, but is able to care for most of his personal needs. You had to have at least a 60% to be eligible fof the study.|participants|Number|9|9.0||||||
4347005|NCT00404248|4174898|B3|70||Karnofsky Performance Status|this is a performance assessment, or functional impairment. 100% is a perfect score no impariment (highest score) and 60% Requires occasional assistance, but is able to care for most of his personal needs. You had to have at least a 60% to be eligible fof the study.|participants|Number|1|1.0||||||
4347006|NCT00404248|4174899|B2|70||Karnofsky Performance Status|this is a performance assessment, or functional impairment. 100% is a perfect score no impariment (highest score) and 60% Requires occasional assistance, but is able to care for most of his personal needs. You had to have at least a 60% to be eligible fof the study.|participants|Number|4|4.0||||||
4347007|NCT00404248|4174900|B1|70||Karnofsky Performance Status|this is a performance assessment, or functional impairment. 100% is a perfect score no impariment (highest score) and 60% Requires occasional assistance, but is able to care for most of his personal needs. You had to have at least a 60% to be eligible fof the study.|participants|Number|4|4.0||||||
4347008|NCT00404248|4174897|B4|80||Karnofsky Performance Status|this is a performance assessment, or functional impairment. 100% is a perfect score no impariment (highest score) and 60% Requires occasional assistance, but is able to care for most of his personal needs. You had to have at least a 60% to be eligible fof the study.|participants|Number|5|5.0||||||
4347009|NCT00404248|4174898|B3|80||Karnofsky Performance Status|this is a performance assessment, or functional impairment. 100% is a perfect score no impariment (highest score) and 60% Requires occasional assistance, but is able to care for most of his personal needs. You had to have at least a 60% to be eligible fof the study.|participants|Number|0|0.0||||||
4347010|NCT00404248|4174899|B2|80||Karnofsky Performance Status|this is a performance assessment, or functional impairment. 100% is a perfect score no impariment (highest score) and 60% Requires occasional assistance, but is able to care for most of his personal needs. You had to have at least a 60% to be eligible fof the study.|participants|Number|5|5.0||||||
4347011|NCT00404248|4174900|B1|80||Karnofsky Performance Status|this is a performance assessment, or functional impairment. 100% is a perfect score no impariment (highest score) and 60% Requires occasional assistance, but is able to care for most of his personal needs. You had to have at least a 60% to be eligible fof the study.|participants|Number|0|0.0||||||
4347012|NCT00404248|4174897|B4|90||Karnofsky Performance Status|this is a performance assessment, or functional impairment. 100% is a perfect score no impariment (highest score) and 60% Requires occasional assistance, but is able to care for most of his personal needs. You had to have at least a 60% to be eligible fof the study.|participants|Number|13|13.0||||||
4347013|NCT00404248|4174898|B3|90||Karnofsky Performance Status|this is a performance assessment, or functional impairment. 100% is a perfect score no impariment (highest score) and 60% Requires occasional assistance, but is able to care for most of his personal needs. You had to have at least a 60% to be eligible fof the study.|participants|Number|0|0.0||||||
4347014|NCT00404248|4174899|B2|90||Karnofsky Performance Status|this is a performance assessment, or functional impairment. 100% is a perfect score no impariment (highest score) and 60% Requires occasional assistance, but is able to care for most of his personal needs. You had to have at least a 60% to be eligible fof the study.|participants|Number|7|7.0||||||
4347015|NCT00404248|4174900|B1|90||Karnofsky Performance Status|this is a performance assessment, or functional impairment. 100% is a perfect score no impariment (highest score) and 60% Requires occasional assistance, but is able to care for most of his personal needs. You had to have at least a 60% to be eligible fof the study.|participants|Number|6|6.0||||||
4347016|NCT00404248|4174897|B4|100||Karnofsky Performance Status|this is a performance assessment, or functional impairment. 100% is a perfect score no impariment (highest score) and 60% Requires occasional assistance, but is able to care for most of his personal needs. You had to have at least a 60% to be eligible fof the study.|participants|Number|4|4.0||||||
4347017|NCT00404248|4174898|B3|100||Karnofsky Performance Status|this is a performance assessment, or functional impairment. 100% is a perfect score no impariment (highest score) and 60% Requires occasional assistance, but is able to care for most of his personal needs. You had to have at least a 60% to be eligible fof the study.|participants|Number|1|1.0||||||
4347018|NCT00404248|4174899|B2|100||Karnofsky Performance Status|this is a performance assessment, or functional impairment. 100% is a perfect score no impariment (highest score) and 60% Requires occasional assistance, but is able to care for most of his personal needs. You had to have at least a 60% to be eligible fof the study.|participants|Number|1|1.0||||||
4347019|NCT00404248|4174900|B1|100||Karnofsky Performance Status|this is a performance assessment, or functional impairment. 100% is a perfect score no impariment (highest score) and 60% Requires occasional assistance, but is able to care for most of his personal needs. You had to have at least a 60% to be eligible fof the study.|participants|Number|2|2.0||||||
4347020|NCT00404248|4174897|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4347021|NCT00404248|4174898|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4347022|NCT00404248|4174899|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4347023|NCT00404248|4174900|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4347024|NCT00404248|4174897|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4347025|NCT00404248|4174898|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4347026|NCT00404248|4174899|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4347027|NCT00404248|4174900|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4347028|NCT00404248|4174897|B4|||Age||years|Median|46|46.0|Full Range|||29.0|71.0|
4347029|NCT00404248|4174898|B3|||Age||years|Median|57|57.0|Full Range|||36.0|65.0|
4347030|NCT00404248|4174899|B2|||Age||years|Median|45|45.0|Full Range|||33.0|71.0|
4347031|NCT00404248|4174900|B1|||Age||years|Median|47|47.0|Full Range|||29.0|67.0|
4347032|NCT00404235|4174939|B3|United States||Region of Enrollment||participants|Number|73|73.0||||||
4347033|NCT00404235|4174940|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
4347034|NCT00404235|4174941|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4347035|NCT00404235|4174939|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4347036|NCT00404235|4174940|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4347037|NCT00404235|4174941|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4347038|NCT00404235|4174939|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4347039|NCT00404235|4174940|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4347040|NCT00404235|4174941|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4347041|NCT00404235|4174939|B3|||Age||years|Median|59|59.0|Full Range|||23.0|91.0|
4347042|NCT00404235|4174940|B2|||Age||years|Median|59|59.0|Full Range|||23.0|91.0|
4347043|NCT00404235|4174941|B1|||Age||years|Median|60|60.0|Full Range|||28.0|84.0|
4347044|NCT00404092|4174956|B5|Germany||Region of Enrollment||participants|Number|46|46.0||||||
4347045|NCT00404092|4174957|B4|Germany||Region of Enrollment||participants|Number|20|20.0||||||
4347046|NCT00404092|4174958|B3|Germany||Region of Enrollment||participants|Number|9|9.0||||||
4347047|NCT00404092|4174959|B2|Germany||Region of Enrollment||participants|Number|8|8.0||||||
4347048|NCT00404092|4174960|B1|Germany||Region of Enrollment||participants|Number|9|9.0||||||
4347049|NCT00404092|4174956|B5||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4347050|NCT00404092|4174957|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4347051|NCT00404092|4174958|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4347052|NCT00404092|4174959|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4347053|NCT00404092|4174960|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4347054|NCT00404092|4174956|B5||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4347055|NCT00404092|4174957|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4347056|NCT00404092|4174958|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4347057|NCT00404092|4174959|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4347058|NCT00404092|4174960|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4347059|NCT00404092|4174956|B5|> 70 years||Age, Customized||participants|Number|8|8.0||||||
4347060|NCT00404092|4174957|B4|> 70 years||Age, Customized||participants|Number|5|5.0||||||
4347061|NCT00404092|4174958|B3|> 70 years||Age, Customized||participants|Number|1|1.0||||||
4347062|NCT00404092|4174959|B2|> 70 years||Age, Customized||participants|Number|1|1.0||||||
4347063|NCT00404092|4174960|B1|> 70 years||Age, Customized||participants|Number|1|1.0||||||
4347064|NCT00404092|4174956|B5|Between 60 and 70 years||Age, Customized||participants|Number|17|17.0||||||
4347065|NCT00404092|4174957|B4|Between 60 and 70 years||Age, Customized||participants|Number|7|7.0||||||
4347066|NCT00404092|4174958|B3|Between 60 and 70 years||Age, Customized||participants|Number|4|4.0||||||
4347067|NCT00404092|4174959|B2|Between 60 and 70 years||Age, Customized||participants|Number|4|4.0||||||
4347068|NCT00404092|4174960|B1|Between 60 and 70 years||Age, Customized||participants|Number|2|2.0||||||
4347069|NCT00404092|4174956|B5|Between 50 and 60 years||Age, Customized||participants|Number|7|7.0||||||
4347070|NCT00404092|4174957|B4|Between 50 and 60 years||Age, Customized||participants|Number|3|3.0||||||
4347071|NCT00404092|4174958|B3|Between 50 and 60 years||Age, Customized||participants|Number|1|1.0||||||
4347072|NCT00404092|4174959|B2|Between 50 and 60 years||Age, Customized||participants|Number|0|0.0||||||
4347073|NCT00404092|4174960|B1|Between 50 and 60 years||Age, Customized||participants|Number|3|3.0||||||
4347074|NCT00404092|4174956|B5|Between 40 and 50 years||Age, Customized||participants|Number|6|6.0||||||
4347075|NCT00404092|4174957|B4|Between 40 and 50 years||Age, Customized||participants|Number|2|2.0||||||
4347076|NCT00404092|4174958|B3|Between 40 and 50 years||Age, Customized||participants|Number|2|2.0||||||
4347077|NCT00404092|4174959|B2|Between 40 and 50 years||Age, Customized||participants|Number|1|1.0||||||
4347078|NCT00404092|4174960|B1|Between 40 and 50 years||Age, Customized||participants|Number|1|1.0||||||
4347079|NCT00404092|4174956|B5|Between 30 and 40 years||Age, Customized||participants|Number|6|6.0||||||
4347080|NCT00404092|4174957|B4|Between 30 and 40 years||Age, Customized||participants|Number|2|2.0||||||
4347081|NCT00404092|4174958|B3|Between 30 and 40 years||Age, Customized||participants|Number|1|1.0||||||
4347082|NCT00404092|4174959|B2|Between 30 and 40 years||Age, Customized||participants|Number|1|1.0||||||
4347083|NCT00404092|4174960|B1|Between 30 and 40 years||Age, Customized||participants|Number|2|2.0||||||
4347084|NCT00404092|4174956|B5|<=30 years||Age, Customized||participants|Number|2|2.0||||||
4347085|NCT00404092|4174957|B4|<=30 years||Age, Customized||participants|Number|1|1.0||||||
4347086|NCT00404092|4174958|B3|<=30 years||Age, Customized||participants|Number|0|0.0||||||
4347087|NCT00404092|4174959|B2|<=30 years||Age, Customized||participants|Number|1|1.0||||||
4347088|NCT00404092|4174960|B1|<=30 years||Age, Customized||participants|Number|0|0.0||||||
4347089|NCT00404079|4174977|B3|Norway||Region of Enrollment||participants|Number|250|250.0||||||
4347090|NCT00404079|4174978|B2|Norway||Region of Enrollment||participants|Number|125|125.0||||||
4347091|NCT00404079|4174979|B1|Norway||Region of Enrollment||participants|Number|125|125.0||||||
4347092|NCT00404079|4174977|B3||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4347093|NCT00404079|4174978|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4347094|NCT00404079|4174979|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4347095|NCT00404079|4174977|B3||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4347096|NCT00404079|4174978|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4347097|NCT00404079|4174979|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4347098|NCT00404079|4174977|B3||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4347099|NCT00404079|4174978|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4347100|NCT00404079|4174979|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4347101|NCT00404079|4174977|B3||Between 18 and 65 years|Age||Participants|Count of Participants|228|228.0||||||
4347102|NCT00404079|4174978|B2||Between 18 and 65 years|Age||Participants|Count of Participants|115|115.0||||||
4347103|NCT00404079|4174979|B1||Between 18 and 65 years|Age||Participants|Count of Participants|113|113.0||||||
4347104|NCT00404079|4174977|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4347105|NCT00404079|4174978|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4347106|NCT00404079|4174979|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4347107|NCT00404066|4174986|B1||N3 (many lymph nodes)|Nodal involvement|"Tumors were staged by lymph node involvement according to the following criteria.~N1: The cancer has spread to 1 to 3 axillary, or underarm, lymph nodes under the arm, and are ≥ 2 mm in size.~N2: The cancer has spread to 4 to 9 axillary lymph nodes, OR has spread to internal mammary lymph nodes~N3: The cancer has spread to ≥ 10 lymph nodes, OR has spread to both axillary and internal mammary lymph nodes"|Participants|Count of Participants|5|5.0||||||
4347108|NCT00404066|4174986|B1||N2 (moderate number of lymph nodes)|Nodal involvement|"Tumors were staged by lymph node involvement according to the following criteria.~N1: The cancer has spread to 1 to 3 axillary, or underarm, lymph nodes under the arm, and are ≥ 2 mm in size.~N2: The cancer has spread to 4 to 9 axillary lymph nodes, OR has spread to internal mammary lymph nodes~N3: The cancer has spread to ≥ 10 lymph nodes, OR has spread to both axillary and internal mammary lymph nodes"|Participants|Count of Participants|13|13.0||||||
4347109|NCT00404066|4174986|B1||N1 (few lymph nodes)|Nodal involvement|"Tumors were staged by lymph node involvement according to the following criteria.~N1: The cancer has spread to 1 to 3 axillary, or underarm, lymph nodes under the arm, and are ≥ 2 mm in size.~N2: The cancer has spread to 4 to 9 axillary lymph nodes, OR has spread to internal mammary lymph nodes~N3: The cancer has spread to ≥ 10 lymph nodes, OR has spread to both axillary and internal mammary lymph nodes"|Participants|Count of Participants|3|3.0||||||
4347110|NCT00404066|4174986|B1|T4 (metastatic to chest wall / skin)||Tumor Size|"Tumors were staged according to T stage:~T1: Malignancy is ≤ 20 millimeters (mm) at the widest spot~T2: Malignancy is > 20 mm but ≤ 50 mm~T3: Malignancy is > 50 mm~T4: Metastasized to chest wall and/or skin"|Participants|Count of Participants|3|3.0||||||
4347111|NCT00404066|4174986|B1|T3 (> 50 mm)||Tumor Size|"Tumors were staged according to T stage:~T1: Malignancy is ≤ 20 millimeters (mm) at the widest spot~T2: Malignancy is > 20 mm but ≤ 50 mm~T3: Malignancy is > 50 mm~T4: Metastasized to chest wall and/or skin"|Participants|Count of Participants|9|9.0||||||
4347112|NCT00404066|4174986|B1|T2 (> 20 mm but ≤ 50 mm)||Tumor Size|"Tumors were staged according to T stage:~T1: Malignancy is ≤ 20 millimeters (mm) at the widest spot~T2: Malignancy is > 20 mm but ≤ 50 mm~T3: Malignancy is > 50 mm~T4: Metastasized to chest wall and/or skin"|Participants|Count of Participants|9|9.0||||||
4347113|NCT00404066|4174986|B1|T1 (≤ 20 mm at widest)||Tumor Size|"Tumors were staged according to T stage:~T1: Malignancy is ≤ 20 millimeters (mm) at the widest spot~T2: Malignancy is > 20 mm but ≤ 50 mm~T3: Malignancy is > 50 mm~T4: Metastasized to chest wall and/or skin"|Participants|Count of Participants|0|0.0||||||
4347114|NCT00404066|4174986|B1|Lobular||Histology||Participants|Count of Participants|0|0.0||||||
4347115|NCT00404066|4174986|B1|Ductal||Histology||Participants|Count of Participants|21|21.0||||||
4347116|NCT00404066|4174986|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4347117|NCT00404066|4174986|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4347118|NCT00404066|4174986|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4347119|NCT00404066|4174986|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4347120|NCT00404066|4174986|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4347121|NCT00404066|4174986|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4347122|NCT00404066|4174986|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4347123|NCT00404066|4174986|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4347124|NCT00404066|4174986|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4347125|NCT00404066|4174986|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4347126|NCT00404066|4174986|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4347127|NCT00404066|4174986|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4347128|NCT00404066|4174986|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4347129|NCT00404066|4174986|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4347130|NCT00404066|4174986|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4347131|NCT00403845|4174991|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4347132|NCT00403845|4174991|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4347133|NCT00403845|4174991|B1|||Age||years|Mean|67.2|67.2|Standard Deviation|5.94|5.94|||
4347134|NCT00403767|4175016|B3|Hong Kong||Region of Enrollment||participants|Number|73|73.0||||||
4347135|NCT00403767|4175017|B2|Hong Kong||Region of Enrollment||participants|Number|37|37.0||||||
4347136|NCT00403767|4175018|B1|Hong Kong||Region of Enrollment||participants|Number|36|36.0||||||
4347137|NCT00403767|4175016|B3|Venezuela||Region of Enrollment||participants|Number|20|20.0||||||
4347138|NCT00403767|4175017|B2|Venezuela||Region of Enrollment||participants|Number|9|9.0||||||
4347139|NCT00403767|4175018|B1|Venezuela||Region of Enrollment||participants|Number|11|11.0||||||
4347140|NCT00403767|4175016|B3|United States||Region of Enrollment||participants|Number|1926|1926.0||||||
4347141|NCT00403767|4175017|B2|United States||Region of Enrollment||participants|Number|964|964.0||||||
4347142|NCT00403767|4175018|B1|United States||Region of Enrollment||participants|Number|962|962.0||||||
4347143|NCT00403767|4175016|B3|United Kingdom||Region of Enrollment||participants|Number|159|159.0||||||
4347144|NCT00403767|4175017|B2|United Kingdom||Region of Enrollment||participants|Number|80|80.0||||||
4347145|NCT00403767|4175018|B1|United Kingdom||Region of Enrollment||participants|Number|79|79.0||||||
4347146|NCT00403767|4175016|B3|Ukraine||Region of Enrollment||participants|Number|1009|1009.0||||||
4347147|NCT00403767|4175017|B2|Ukraine||Region of Enrollment||participants|Number|504|504.0||||||
4347148|NCT00403767|4175018|B1|Ukraine||Region of Enrollment||participants|Number|505|505.0||||||
4347149|NCT00403767|4175016|B3|Turkey||Region of Enrollment||participants|Number|101|101.0||||||
4347150|NCT00403767|4175017|B2|Turkey||Region of Enrollment||participants|Number|51|51.0||||||
4347151|NCT00403767|4175018|B1|Turkey||Region of Enrollment||participants|Number|50|50.0||||||
4347152|NCT00403767|4175016|B3|Thailand||Region of Enrollment||participants|Number|87|87.0||||||
4347153|NCT00403767|4175017|B2|Thailand||Region of Enrollment||participants|Number|44|44.0||||||
4347154|NCT00403767|4175018|B1|Thailand||Region of Enrollment||participants|Number|43|43.0||||||
4347155|NCT00403767|4175016|B3|Taiwan||Region of Enrollment||participants|Number|157|157.0||||||
4347156|NCT00403767|4175017|B2|Taiwan||Region of Enrollment||participants|Number|79|79.0||||||
4347157|NCT00403767|4175018|B1|Taiwan||Region of Enrollment||participants|Number|78|78.0||||||
4347158|NCT00403767|4175016|B3|Switzerland||Region of Enrollment||participants|Number|7|7.0||||||
4347159|NCT00403767|4175017|B2|Switzerland||Region of Enrollment||participants|Number|4|4.0||||||
4347160|NCT00403767|4175018|B1|Switzerland||Region of Enrollment||participants|Number|3|3.0||||||
4347161|NCT00403767|4175016|B3|Sweden||Region of Enrollment||participants|Number|28|28.0||||||
4347162|NCT00403767|4175017|B2|Sweden||Region of Enrollment||participants|Number|16|16.0||||||
4347163|NCT00403767|4175018|B1|Sweden||Region of Enrollment||participants|Number|12|12.0||||||
4347164|NCT00403767|4175016|B3|Spain||Region of Enrollment||participants|Number|248|248.0||||||
4347165|NCT00403767|4175017|B2|Spain||Region of Enrollment||participants|Number|124|124.0||||||
4347166|NCT00403767|4175018|B1|Spain||Region of Enrollment||participants|Number|124|124.0||||||
4347167|NCT00403767|4175016|B3|South Africa||Region of Enrollment||participants|Number|247|247.0||||||
4347168|NCT00403767|4175017|B2|South Africa||Region of Enrollment||participants|Number|125|125.0||||||
4347169|NCT00403767|4175018|B1|South Africa||Region of Enrollment||participants|Number|122|122.0||||||
4347170|NCT00403767|4175016|B3|Singapore||Region of Enrollment||participants|Number|44|44.0||||||
4347171|NCT00403767|4175017|B2|Singapore||Region of Enrollment||participants|Number|23|23.0||||||
4347172|NCT00403767|4175018|B1|Singapore||Region of Enrollment||participants|Number|21|21.0||||||
4347173|NCT00403767|4175016|B3|Russia||Region of Enrollment||participants|Number|1290|1290.0||||||
4347174|NCT00403767|4175017|B2|Russia||Region of Enrollment||participants|Number|645|645.0||||||
4347175|NCT00403767|4175018|B1|Russia||Region of Enrollment||participants|Number|645|645.0||||||
4347176|NCT00403767|4175016|B3|Romania||Region of Enrollment||participants|Number|782|782.0||||||
4347177|NCT00403767|4175017|B2|Romania||Region of Enrollment||participants|Number|391|391.0||||||
4347178|NCT00403767|4175018|B1|Romania||Region of Enrollment||participants|Number|391|391.0||||||
4347179|NCT00403767|4175016|B3|Poland||Region of Enrollment||participants|Number|527|527.0||||||
4347180|NCT00403767|4175017|B2|Poland||Region of Enrollment||participants|Number|264|264.0||||||
4347181|NCT00403767|4175018|B1|Poland||Region of Enrollment||participants|Number|263|263.0||||||
4347182|NCT00403767|4175016|B3|Philippines||Region of Enrollment||participants|Number|368|368.0||||||
4347183|NCT00403767|4175017|B2|Philippines||Region of Enrollment||participants|Number|183|183.0||||||
4347184|NCT00403767|4175018|B1|Philippines||Region of Enrollment||participants|Number|185|185.0||||||
4347185|NCT00403767|4175016|B3|Peru||Region of Enrollment||participants|Number|84|84.0||||||
4347186|NCT00403767|4175017|B2|Peru||Region of Enrollment||participants|Number|42|42.0||||||
4347187|NCT00403767|4175018|B1|Peru||Region of Enrollment||participants|Number|42|42.0||||||
4347188|NCT00403767|4175016|B3|Norway||Region of Enrollment||participants|Number|49|49.0||||||
4347189|NCT00403767|4175017|B2|Norway||Region of Enrollment||participants|Number|24|24.0||||||
4347190|NCT00403767|4175018|B1|Norway||Region of Enrollment||participants|Number|25|25.0||||||
4347191|NCT00403767|4175016|B3|New Zealand||Region of Enrollment||participants|Number|116|116.0||||||
4347192|NCT00403767|4175017|B2|New Zealand||Region of Enrollment||participants|Number|58|58.0||||||
4347193|NCT00403767|4175018|B1|New Zealand||Region of Enrollment||participants|Number|58|58.0||||||
4347194|NCT00403767|4175016|B3|Netherlands||Region of Enrollment||participants|Number|161|161.0||||||
4347195|NCT00403767|4175017|B2|Netherlands||Region of Enrollment||participants|Number|81|81.0||||||
4347196|NCT00403767|4175018|B1|Netherlands||Region of Enrollment||participants|Number|80|80.0||||||
4347197|NCT00403767|4175016|B3|Mexico||Region of Enrollment||participants|Number|168|168.0||||||
4347198|NCT00403767|4175017|B2|Mexico||Region of Enrollment||participants|Number|85|85.0||||||
4347199|NCT00403767|4175018|B1|Mexico||Region of Enrollment||participants|Number|83|83.0||||||
4347200|NCT00403767|4175016|B3|Malaysia||Region of Enrollment||participants|Number|51|51.0||||||
4347201|NCT00403767|4175017|B2|Malaysia||Region of Enrollment||participants|Number|25|25.0||||||
4347202|NCT00403767|4175018|B1|Malaysia||Region of Enrollment||participants|Number|26|26.0||||||
4347203|NCT00403767|4175016|B3|Lithuania||Region of Enrollment||participants|Number|244|244.0||||||
4347204|NCT00403767|4175017|B2|Lithuania||Region of Enrollment||participants|Number|122|122.0||||||
4347205|NCT00403767|4175018|B1|Lithuania||Region of Enrollment||participants|Number|122|122.0||||||
4347206|NCT00403767|4175016|B3|Korea (South)||Region of Enrollment||participants|Number|203|203.0||||||
4347207|NCT00403767|4175017|B2|Korea (South)||Region of Enrollment||participants|Number|100|100.0||||||
4347208|NCT00403767|4175018|B1|Korea (South)||Region of Enrollment||participants|Number|103|103.0||||||
4347209|NCT00403767|4175016|B3|Italy||Region of Enrollment||participants|Number|138|138.0||||||
4347210|NCT00403767|4175017|B2|Italy||Region of Enrollment||participants|Number|69|69.0||||||
4347211|NCT00403767|4175018|B1|Italy||Region of Enrollment||participants|Number|69|69.0||||||
4347212|NCT00403767|4175016|B3|Israel||Region of Enrollment||participants|Number|188|188.0||||||
4347213|NCT00403767|4175017|B2|Israel||Region of Enrollment||participants|Number|94|94.0||||||
4347214|NCT00403767|4175018|B1|Israel||Region of Enrollment||participants|Number|94|94.0||||||
4347215|NCT00403767|4175016|B3|India||Region of Enrollment||participants|Number|268|268.0||||||
4347216|NCT00403767|4175017|B2|India||Region of Enrollment||participants|Number|135|135.0||||||
4347217|NCT00403767|4175018|B1|India||Region of Enrollment||participants|Number|133|133.0||||||
4347218|NCT00403767|4175016|B3|Hungary||Region of Enrollment||participants|Number|237|237.0||||||
4347219|NCT00403767|4175017|B2|Hungary||Region of Enrollment||participants|Number|118|118.0||||||
4347220|NCT00403767|4175018|B1|Hungary||Region of Enrollment||participants|Number|119|119.0||||||
4347221|NCT00403767|4175016|B3|Greece||Region of Enrollment||participants|Number|29|29.0||||||
4347222|NCT00403767|4175017|B2|Greece||Region of Enrollment||participants|Number|14|14.0||||||
4347223|NCT00403767|4175018|B1|Greece||Region of Enrollment||participants|Number|15|15.0||||||
4347224|NCT00403767|4175016|B3|Germany||Region of Enrollment||participants|Number|528|528.0||||||
4347225|NCT00403767|4175017|B2|Germany||Region of Enrollment||participants|Number|265|265.0||||||
4347226|NCT00403767|4175018|B1|Germany||Region of Enrollment||participants|Number|263|263.0||||||
4347227|NCT00403767|4175016|B3|France||Region of Enrollment||participants|Number|71|71.0||||||
4347228|NCT00403767|4175017|B2|France||Region of Enrollment||participants|Number|36|36.0||||||
4347229|NCT00403767|4175018|B1|France||Region of Enrollment||participants|Number|35|35.0||||||
4347230|NCT00403767|4175016|B3|Finland||Region of Enrollment||participants|Number|16|16.0||||||
4347231|NCT00403767|4175017|B2|Finland||Region of Enrollment||participants|Number|7|7.0||||||
4347232|NCT00403767|4175018|B1|Finland||Region of Enrollment||participants|Number|9|9.0||||||
4347233|NCT00403767|4175016|B3|Denmark||Region of Enrollment||participants|Number|121|121.0||||||
4347234|NCT00403767|4175017|B2|Denmark||Region of Enrollment||participants|Number|61|61.0||||||
4347235|NCT00403767|4175018|B1|Denmark||Region of Enrollment||participants|Number|60|60.0||||||
4347236|NCT00403767|4175016|B3|Czech Republic||Region of Enrollment||participants|Number|598|598.0||||||
4347237|NCT00403767|4175017|B2|Czech Republic||Region of Enrollment||participants|Number|299|299.0||||||
4347238|NCT00403767|4175018|B1|Czech Republic||Region of Enrollment||participants|Number|299|299.0||||||
4347239|NCT00403767|4175016|B3|Colombia||Region of Enrollment||participants|Number|267|267.0||||||
4347240|NCT00403767|4175017|B2|Colombia||Region of Enrollment||participants|Number|133|133.0||||||
4347241|NCT00403767|4175018|B1|Colombia||Region of Enrollment||participants|Number|134|134.0||||||
4347242|NCT00403767|4175016|B3|China||Region of Enrollment||participants|Number|495|495.0||||||
4347243|NCT00403767|4175017|B2|China||Region of Enrollment||participants|Number|246|246.0||||||
4347244|NCT00403767|4175018|B1|China||Region of Enrollment||participants|Number|249|249.0||||||
4347245|NCT00403767|4175016|B3|Chile||Region of Enrollment||participants|Number|286|286.0||||||
4347246|NCT00403767|4175017|B2|Chile||Region of Enrollment||participants|Number|142|142.0||||||
4347247|NCT00403767|4175018|B1|Chile||Region of Enrollment||participants|Number|144|144.0||||||
4347248|NCT00403767|4175016|B3|Canada||Region of Enrollment||participants|Number|747|747.0||||||
4347249|NCT00403767|4175017|B2|Canada||Region of Enrollment||participants|Number|375|375.0||||||
4347250|NCT00403767|4175018|B1|Canada||Region of Enrollment||participants|Number|372|372.0||||||
4347251|NCT00403767|4175016|B3|Bulgaria||Region of Enrollment||participants|Number|676|676.0||||||
4347252|NCT00403767|4175017|B2|Bulgaria||Region of Enrollment||participants|Number|339|339.0||||||
4347253|NCT00403767|4175018|B1|Bulgaria||Region of Enrollment||participants|Number|337|337.0||||||
4347254|NCT00403767|4175016|B3|Brazil||Region of Enrollment||participants|Number|483|483.0||||||
4347255|NCT00403767|4175017|B2|Brazil||Region of Enrollment||participants|Number|242|242.0||||||
4347256|NCT00403767|4175018|B1|Brazil||Region of Enrollment||participants|Number|241|241.0||||||
4347257|NCT00403767|4175016|B3|Belgium||Region of Enrollment||participants|Number|96|96.0||||||
4347258|NCT00403767|4175017|B2|Belgium||Region of Enrollment||participants|Number|47|47.0||||||
4347259|NCT00403767|4175018|B1|Belgium||Region of Enrollment||participants|Number|49|49.0||||||
4347260|NCT00403767|4175016|B3|Austria||Region of Enrollment||participants|Number|32|32.0||||||
4347261|NCT00403767|4175017|B2|Austria||Region of Enrollment||participants|Number|16|16.0||||||
4347262|NCT00403767|4175018|B1|Austria||Region of Enrollment||participants|Number|16|16.0||||||
4347263|NCT00403767|4175016|B3|Australia||Region of Enrollment||participants|Number|242|242.0||||||
4347264|NCT00403767|4175017|B2|Australia||Region of Enrollment||participants|Number|122|122.0||||||
4347265|NCT00403767|4175018|B1|Australia||Region of Enrollment||participants|Number|120|120.0||||||
4347266|NCT00403767|4175016|B3|Argentina||Region of Enrollment||participants|Number|569|569.0||||||
4347267|NCT00403767|4175017|B2|Argentina||Region of Enrollment||participants|Number|285|285.0||||||
4347268|NCT00403767|4175018|B1|Argentina||Region of Enrollment||participants|Number|284|284.0||||||
4347269|NCT00403767|4175016|B3||Male|Sex: Female, Male||Participants|Count of Participants|8591|8591.0||||||
4347270|NCT00403767|4175017|B2||Male|Sex: Female, Male||Participants|Count of Participants|4299|4299.0||||||
4347271|NCT00403767|4175018|B1||Male|Sex: Female, Male||Participants|Count of Participants|4292|4292.0||||||
4347272|NCT00403767|4175016|B3||Female|Sex: Female, Male||Participants|Count of Participants|5645|5645.0||||||
4347273|NCT00403767|4175017|B2||Female|Sex: Female, Male||Participants|Count of Participants|2826|2826.0||||||
4347274|NCT00403767|4175018|B1||Female|Sex: Female, Male||Participants|Count of Participants|2819|2819.0||||||
4347275|NCT00403767|4175016|B3|Age Continuous||Age||years|Mean|71.2|71.2|Standard Deviation|9.42|9.42|||
4347276|NCT00403767|4175017|B2|Age Continuous||Age||years|Mean|71.2|71.2|Standard Deviation|9.39|9.39|||
4347277|NCT00403767|4175018|B1|Age Continuous||Age||years|Mean|71.2|71.2|Standard Deviation|9.45|9.45|||
4347278|NCT00403767|4175016|B3||>=65 years|Age||Participants|Count of Participants|10948|10948.0||||||
4347279|NCT00403767|4175017|B2||>=65 years|Age||Participants|Count of Participants|5483|5483.0||||||
4347280|NCT00403767|4175018|B1||>=65 years|Age||Participants|Count of Participants|5465|5465.0||||||
4347281|NCT00403767|4175016|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3288|3288.0||||||
4347282|NCT00403767|4175017|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1642|1642.0||||||
4347283|NCT00403767|4175018|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1646|1646.0||||||
4347284|NCT00403767|4175016|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4347285|NCT00403767|4175017|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4347286|NCT00403767|4175018|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4347287|NCT00403754|4175043|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4347288|NCT00403754|4175043|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4347289|NCT00403754|4175043|B1|||Age||years|Mean|47.8|47.8|Standard Deviation|14.90|14.9|||
4347290|NCT00403585|4175073|B1|||Race/Ethnicity, Customized||Participants|Number|104|104.0||||||
4347291|NCT00403585|4175073|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4347292|NCT00403585|4175073|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4347293|NCT00403585|4175073|B1|||Age||years|Mean|35.3|35.3|Standard Deviation|10.4|10.4|||
4347294|NCT00403546|4175082|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4347295|NCT00403546|4175083|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4347296|NCT00403546|4175084|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4347297|NCT00403546|4175082|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4347298|NCT00403546|4175083|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4347299|NCT00403546|4175084|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4347300|NCT00403546|4175082|B3|||Age||years|Mean|40.0|40.0|Standard Deviation|11.9|11.9|||
4347301|NCT00403546|4175083|B2|||Age||years|Mean|41.0|41.0|Standard Deviation|11.9|11.9|||
4347302|NCT00403546|4175084|B1|||Age||years|Mean|39.2|39.2|Standard Deviation|12.0|12.0|||
4347303|NCT00403481|4175126|B1|||Systolic BP||mm Hg|Mean|158.1|158.1|Standard Deviation|12.6|12.6|||
4347304|NCT00403481|4175126|B1|||Heart rate||beats/min|Mean|76.4|76.4|Standard Deviation|10.4|10.4|||
4347305|NCT00403481|4175126|B1|||Diastolic BP||mm Hg|Mean|90.0|90.0|Standard Deviation|10.0|10.0|||
4347306|NCT00403481|4175126|B1|United States||Region of Enrollment||participants|Number|192|192.0||||||
4347307|NCT00403481|4175126|B1|Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4347308|NCT00403481|4175126|B1|White||Race/Ethnicity, Customized||Participants|Number|145|145.0||||||
4347309|NCT00403481|4175126|B1|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4347310|NCT00403481|4175126|B1|Black/African American||Race/Ethnicity, Customized||Participants|Number|43|43.0||||||
4347311|NCT00403481|4175126|B1||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4347312|NCT00403481|4175126|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4347313|NCT00403481|4175126|B1|||Age||years|Mean|58.1|58.1|Standard Deviation|10.3|10.3|||
4347314|NCT00403455|4175141|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4347315|NCT00403455|4175141|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4347316|NCT00403455|4175141|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4347317|NCT00403455|4175141|B1|||Age||years|Mean|48.5789|48.5789|Full Range|||25.0|79.0|
4347318|NCT00403455|4175141|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4347319|NCT00403455|4175141|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4347320|NCT00403455|4175141|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4347321|NCT00403403|4175145|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4347322|NCT00403403|4175146|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4347323|NCT00403403|4175147|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4347324|NCT00403403|4175145|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4347325|NCT00403403|4175146|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4347326|NCT00403403|4175147|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4347327|NCT00403403|4175145|B3|||Age||years|Mean|62.7|62.7|Standard Deviation|9.3|9.3|||
4347328|NCT00403403|4175146|B2|||Age||years|Mean|61.3|61.3|Standard Deviation|8.5|8.5|||
4347329|NCT00403403|4175147|B1|||Age||years|Mean|64.0|64.0|Standard Deviation|10.0|10.0|||
4347330|NCT00403390|4175162|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4347331|NCT00403390|4175163|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4347332|NCT00403390|4175164|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4347333|NCT00403390|4175162|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4347334|NCT00403390|4175163|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4347335|NCT00403390|4175164|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4347336|NCT00403390|4175162|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4347337|NCT00403390|4175163|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4347338|NCT00403390|4175164|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4347339|NCT00403390|4175162|B3|||Age||years|Mean|10|10.0|Standard Deviation|1.1|1.1|||
4347340|NCT00403390|4175163|B2|||Age||years|Mean|10|10.0|Standard Deviation|1.0|1.0|||
4347341|NCT00403390|4175164|B1|||Age||years|Mean|10|10.0|Standard Deviation|1.2|1.2|||
4347342|NCT00403390|4175162|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4347343|NCT00403390|4175163|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4347344|NCT00403390|4175164|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4347345|NCT00403390|4175162|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4347346|NCT00403390|4175163|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4347347|NCT00403390|4175164|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4347348|NCT00403390|4175162|B3||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
4347349|NCT00403390|4175163|B2||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
4347350|NCT00403390|4175164|B1||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4347351|NCT00403273|4175171|B3|Non-Caucasian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4347352|NCT00403273|4175172|B2|Non-Caucasian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4347353|NCT00403273|4175173|B1|Non-Caucasian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4347354|NCT00403273|4175171|B3|caucasian||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
4347355|NCT00403273|4175172|B2|caucasian||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4347356|NCT00403273|4175173|B1|caucasian||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4347357|NCT00403273|4175171|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4347358|NCT00403273|4175172|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4347359|NCT00403273|4175173|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4347360|NCT00403273|4175171|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4347361|NCT00403273|4175172|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4347362|NCT00403273|4175173|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4347363|NCT00403273|4175171|B3|||Age||years|Mean|67|67.0|Standard Deviation|11|11.0|||
4347364|NCT00403273|4175172|B2|||Age||years|Mean|67|67.0|Standard Deviation|12|12.0|||
4347365|NCT00403273|4175173|B1|||Age||years|Mean|67|67.0|Standard Deviation|10|10.0|||
4347366|NCT00403234|4175212|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4347367|NCT00403234|4175213|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4347368|NCT00403234|4175214|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4347369|NCT00403234|4175215|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4347370|NCT00403234|4175216|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4347371|NCT00403234|4175212|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4347372|NCT00403234|4175213|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4347373|NCT00403234|4175214|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4347374|NCT00403234|4175215|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4347375|NCT00403234|4175216|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4347376|NCT00403234|4175212|B5|||Age||years|Mean|62.6|62.6|Standard Deviation|6.87|6.87|||
4347377|NCT00403234|4175213|B4|||Age||years|Mean|59|59.0|Standard Deviation|7.07|7.07|||
4347378|NCT00403234|4175214|B3|||Age||years|Mean|66.3|66.3|Standard Deviation|4.04|4.04|||
4347379|NCT00403234|4175215|B2|||Age||years|Mean|58.3|58.3|Standard Deviation|7.37|7.37|||
4347380|NCT00403234|4175216|B1|||Age||years|Mean|67|67.0|Standard Deviation|8.49|8.49|||
4347381|NCT00403130|4175229|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4347382|NCT00403130|4175229|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4347383|NCT00403130|4175229|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4347384|NCT00403130|4175229|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4347385|NCT00403130|4175229|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4347386|NCT00403130|4175229|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4347387|NCT00403130|4175229|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4347388|NCT00403130|4175229|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4347389|NCT00403130|4175229|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4347390|NCT00403130|4175229|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4347391|NCT00403130|4175229|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4347392|NCT00403130|4175229|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4347393|NCT00403130|4175229|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4347394|NCT00403130|4175229|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4347395|NCT00403130|4175229|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4347396|NCT00403117|4175236|B1|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
4347397|NCT00403117|4175236|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4347398|NCT00403117|4175236|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4347399|NCT00403117|4175236|B1|||Age||Years|Mean|28.0|28.0|Standard Deviation|1.0|1.0|||
4347400|NCT00403117|4175236|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4347401|NCT00403117|4175236|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4347402|NCT00403117|4175236|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4347403|NCT00402987|4175278|B5||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4347404|NCT00402987|4175279|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4347405|NCT00402987|4175280|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4347406|NCT00402987|4175281|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4347407|NCT00402987|4175282|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4347408|NCT00402987|4175278|B5||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4347409|NCT00402987|4175279|B4||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4347410|NCT00402987|4175280|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4347411|NCT00402987|4175281|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4347412|NCT00402987|4175282|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4347413|NCT00402987|4175278|B5|||Age||years|Mean|19.5|19.5|Standard Deviation|1.5|1.5|||
4347414|NCT00402987|4175279|B4|||Age||years|Mean|19.3|19.3|Standard Deviation|1.4|1.4|||
4347415|NCT00402987|4175280|B3|||Age||years|Mean|19.9|19.9|Standard Deviation|2.3|2.3|||
4347416|NCT00402987|4175281|B2|||Age||years|Mean|19.6|19.6|Standard Deviation|1.4|1.4|||
4347417|NCT00402987|4175282|B1|||Age||years|Mean|19.5|19.5|Standard Deviation|1.3|1.3|||
4347418|NCT00402896|4175447|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4347419|NCT00402896|4175447|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4347420|NCT00402896|4175447|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4347421|NCT00402896|4175447|B1|||Age||years|Median|72|72.0|Full Range|||46.0|80.0|
4347422|NCT00402883|4175451|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4347423|NCT00402883|4175451|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4347424|NCT00402883|4175451|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4347425|NCT00402883|4175451|B1|||Age||years|Mean|64.6|64.6|Standard Deviation|8.9|8.9|||
4347426|NCT00402883|4175451|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4347427|NCT00402883|4175451|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4347428|NCT00402883|4175451|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4347429|NCT00402831|4175455|B3||Male|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
4347430|NCT00402831|4175456|B2||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4347431|NCT00402831|4175457|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4347432|NCT00402831|4175455|B3||Female|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4347433|NCT00402831|4175456|B2||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4347434|NCT00402831|4175457|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4347435|NCT00402831|4175455|B3|||Age||Months|Mean|13.68|13.68|Standard Deviation|1.48|1.48|||
4347436|NCT00402831|4175456|B2|||Age||Months|Mean|13.65|13.65|Standard Deviation|1.53|1.53|||
4347437|NCT00402831|4175457|B1|||Age||Months|Mean|13.72|13.72|Standard Deviation|1.44|1.44|||
4347438|NCT00402740|4175490|B1|United States||Region of Enrollment||participants|Number|322|322.0||||||
4347439|NCT00402740|4175490|B1||Male|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4347440|NCT00402740|4175490|B1||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4347441|NCT00402740|4175490|B1|||Age||years|Mean|72.7|72.7|Standard Deviation|9.8|9.8|||
4347442|NCT00402740|4175490|B1||>=65 years|Age||Participants|Count of Participants|251|251.0||||||
4347443|NCT00402740|4175490|B1||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4347444|NCT00402740|4175490|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4347445|NCT00402727|4175500|B3|No cSSSI||Primary diagnosis||Participants|Number|57|57.0||||||
4347446|NCT00402727|4175501|B2|No cSSSI||Primary diagnosis||Participants|Number|28|28.0||||||
4347447|NCT00402727|4175502|B1|No cSSSI||Primary diagnosis||Participants|Number|29|29.0||||||
4347448|NCT00402727|4175500|B3|Infected ischemic ulcer||Primary diagnosis||Participants|Number|42|42.0||||||
4347449|NCT00402727|4175501|B2|Infected ischemic ulcer||Primary diagnosis||Participants|Number|18|18.0||||||
4347450|NCT00402727|4175502|B1|Infected ischemic ulcer||Primary diagnosis||Participants|Number|24|24.0||||||
4347451|NCT00402727|4175500|B3|Wound infection||Primary diagnosis||Participants|Number|127|127.0||||||
4347452|NCT00402727|4175501|B2|Wound infection||Primary diagnosis||Participants|Number|55|55.0||||||
4347453|NCT00402727|4175502|B1|Wound infection||Primary diagnosis||Participants|Number|72|72.0||||||
4347454|NCT00402727|4175500|B3|Diabetic foot infection||Primary diagnosis||Participants|Number|233|233.0||||||
4347455|NCT00402727|4175501|B2|Diabetic foot infection||Primary diagnosis||Participants|Number|110|110.0||||||
4347456|NCT00402727|4175502|B1|Diabetic foot infection||Primary diagnosis||Participants|Number|123|123.0||||||
4347457|NCT00402727|4175500|B3|Major abscess||Primary diagnosis||Participants|Number|354|354.0||||||
4347458|NCT00402727|4175501|B2|Major abscess||Primary diagnosis||Participants|Number|170|170.0||||||
4347459|NCT00402727|4175502|B1|Major abscess||Primary diagnosis||Participants|Number|184|184.0||||||
4347460|NCT00402727|4175500|B3||Male|Sex: Female, Male||Participants|Count of Participants|529|529.0||||||
4347461|NCT00402727|4175501|B2||Male|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
4347462|NCT00402727|4175502|B1||Male|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
4347463|NCT00402727|4175500|B3||Female|Sex: Female, Male||Participants|Count of Participants|284|284.0||||||
4347464|NCT00402727|4175501|B2||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4347465|NCT00402727|4175502|B1||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4347466|NCT00402727|4175500|B3|||Age||years|Mean|53|53.0|Standard Deviation|16|16.0|||
4347467|NCT00402727|4175501|B2|||Age||years|Mean|54|54.0|Standard Deviation|16|16.0|||
4347468|NCT00402727|4175502|B1|||Age||years|Mean|53|53.0|Standard Deviation|16|16.0|||
4347469|NCT00402714|4175531|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4347470|NCT00402714|4175532|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4347471|NCT00402714|4175533|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4347472|NCT00402714|4175531|B3||Male|Gender||Participants|Count of Participants|8|8.0||||||
4347473|NCT00402714|4175532|B2||Male|Gender||Participants|Count of Participants|7|7.0||||||
4347474|NCT00402714|4175533|B1||Male|Gender||Participants|Count of Participants|1|1.0||||||
4347475|NCT00402714|4175531|B3||Female|Gender||Participants|Count of Participants|6|6.0||||||
4347476|NCT00402714|4175532|B2||Female|Gender||Participants|Count of Participants|4|4.0||||||
4347477|NCT00402714|4175533|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
4347478|NCT00402714|4175531|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4347479|NCT00402714|4175532|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4347480|NCT00402714|4175533|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4347481|NCT00402714|4175531|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4347482|NCT00402714|4175532|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4347483|NCT00402714|4175533|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4347484|NCT00402714|4175531|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4347485|NCT00402714|4175532|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4347486|NCT00402714|4175533|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4347487|NCT00402688|4175542|B4||Male|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
4347488|NCT00402688|4175543|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4347489|NCT00402688|4175544|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4347490|NCT00402688|4175545|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4347491|NCT00402688|4175542|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4347492|NCT00402688|4175543|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4347493|NCT00402688|4175544|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4347494|NCT00402688|4175545|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4347495|NCT00402688|4175542|B4||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
4347496|NCT00402688|4175543|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4347497|NCT00402688|4175544|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4347498|NCT00402688|4175545|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4347499|NCT00402688|4175542|B4||Between 18 and 65 years|Age||Participants|Count of Participants|201|201.0||||||
4347500|NCT00402688|4175543|B3||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4347501|NCT00402688|4175544|B2||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4347502|NCT00402688|4175545|B1||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4347503|NCT00402688|4175542|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4347504|NCT00402688|4175543|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4347505|NCT00402688|4175544|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4347506|NCT00402688|4175545|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4347507|NCT00402649|4175570|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4347508|NCT00402649|4175570|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4347509|NCT00402649|4175570|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4347510|NCT00402649|4175570|B1|||Age||years|Mean|7.6|7.6|Standard Deviation|2.3|2.3|||
4347511|NCT00402649|4175570|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4347512|NCT00402649|4175570|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4347513|NCT00402649|4175570|B1||<=18 years|Age||Participants|Count of Participants|35|35.0||||||
4347514|NCT00402597|4175580|B6|United States||Region of Enrollment||participants|Number|399|399.0||||||
4347515|NCT00402597|4175581|B5|United States||Region of Enrollment||participants|Number|51|51.0||||||
4347516|NCT00402597|4175582|B4|United States||Region of Enrollment||participants|Number|32|32.0||||||
4347517|NCT00402597|4175583|B3|United States||Region of Enrollment||participants|Number|115|115.0||||||
4347518|NCT00402597|4175584|B2|United States||Region of Enrollment||participants|Number|69|69.0||||||
4347519|NCT00402597|4175585|B1|United States||Region of Enrollment||participants|Number|132|132.0||||||
4347520|NCT00402597|4175580|B6|United Kingdom||Region of Enrollment||participants|Number|52|52.0||||||
4347521|NCT00402597|4175581|B5|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
4347522|NCT00402597|4175582|B4|United Kingdom||Region of Enrollment||participants|Number|15|15.0||||||
4347523|NCT00402597|4175583|B3|United Kingdom||Region of Enrollment||participants|Number|19|19.0||||||
4347524|NCT00402597|4175584|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4347525|NCT00402597|4175585|B1|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
4347526|NCT00402597|4175580|B6|Ukraine||Region of Enrollment||participants|Number|159|159.0||||||
4347527|NCT00402597|4175581|B5|Ukraine||Region of Enrollment||participants|Number|33|33.0||||||
4347528|NCT00402597|4175582|B4|Ukraine||Region of Enrollment||participants|Number|11|11.0||||||
4347529|NCT00402597|4175583|B3|Ukraine||Region of Enrollment||participants|Number|37|37.0||||||
4347530|NCT00402597|4175584|B2|Ukraine||Region of Enrollment||participants|Number|21|21.0||||||
4347531|NCT00402597|4175585|B1|Ukraine||Region of Enrollment||participants|Number|57|57.0||||||
4347532|NCT00402597|4175580|B6|Sweden||Region of Enrollment||participants|Number|47|47.0||||||
4347533|NCT00402597|4175581|B5|Sweden||Region of Enrollment||participants|Number|9|9.0||||||
4347534|NCT00402597|4175582|B4|Sweden||Region of Enrollment||participants|Number|6|6.0||||||
4347535|NCT00402597|4175583|B3|Sweden||Region of Enrollment||participants|Number|17|17.0||||||
4347536|NCT00402597|4175584|B2|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
4347537|NCT00402597|4175585|B1|Sweden||Region of Enrollment||participants|Number|13|13.0||||||
4347538|NCT00402597|4175580|B6|Spain||Region of Enrollment||participants|Number|103|103.0||||||
4347539|NCT00402597|4175581|B5|Spain||Region of Enrollment||participants|Number|15|15.0||||||
4347540|NCT00402597|4175582|B4|Spain||Region of Enrollment||participants|Number|12|12.0||||||
4347541|NCT00402597|4175583|B3|Spain||Region of Enrollment||participants|Number|36|36.0||||||
4347542|NCT00402597|4175584|B2|Spain||Region of Enrollment||participants|Number|5|5.0||||||
4347543|NCT00402597|4175585|B1|Spain||Region of Enrollment||participants|Number|35|35.0||||||
4347544|NCT00402597|4175580|B6|South Africa||Region of Enrollment||participants|Number|17|17.0||||||
4347545|NCT00402597|4175581|B5|South Africa||Region of Enrollment||participants|Number|4|4.0||||||
4347546|NCT00402597|4175582|B4|South Africa||Region of Enrollment||participants|Number|0|0.0||||||
4347547|NCT00402597|4175583|B3|South Africa||Region of Enrollment||participants|Number|7|7.0||||||
4347548|NCT00402597|4175584|B2|South Africa||Region of Enrollment||participants|Number|0|0.0||||||
4347549|NCT00402597|4175585|B1|South Africa||Region of Enrollment||participants|Number|6|6.0||||||
4347550|NCT00402597|4175580|B6|Slovakia||Region of Enrollment||participants|Number|116|116.0||||||
4347551|NCT00402597|4175581|B5|Slovakia||Region of Enrollment||participants|Number|21|21.0||||||
4347552|NCT00402597|4175582|B4|Slovakia||Region of Enrollment||participants|Number|13|13.0||||||
4347553|NCT00402597|4175583|B3|Slovakia||Region of Enrollment||participants|Number|32|32.0||||||
4347554|NCT00402597|4175584|B2|Slovakia||Region of Enrollment||participants|Number|1|1.0||||||
4347555|NCT00402597|4175585|B1|Slovakia||Region of Enrollment||participants|Number|49|49.0||||||
4347556|NCT00402597|4175580|B6|Russia||Region of Enrollment||participants|Number|430|430.0||||||
4347557|NCT00402597|4175581|B5|Russia||Region of Enrollment||participants|Number|82|82.0||||||
4347558|NCT00402597|4175582|B4|Russia||Region of Enrollment||participants|Number|17|17.0||||||
4347559|NCT00402597|4175583|B3|Russia||Region of Enrollment||participants|Number|105|105.0||||||
4347560|NCT00402597|4175584|B2|Russia||Region of Enrollment||participants|Number|90|90.0||||||
4347561|NCT00402597|4175585|B1|Russia||Region of Enrollment||participants|Number|136|136.0||||||
4347562|NCT00402597|4175580|B6|Poland||Region of Enrollment||participants|Number|497|497.0||||||
4347563|NCT00402597|4175581|B5|Poland||Region of Enrollment||participants|Number|124|124.0||||||
4347564|NCT00402597|4175582|B4|Poland||Region of Enrollment||participants|Number|86|86.0||||||
4347565|NCT00402597|4175583|B3|Poland||Region of Enrollment||participants|Number|109|109.0||||||
4347566|NCT00402597|4175584|B2|Poland||Region of Enrollment||participants|Number|4|4.0||||||
4347567|NCT00402597|4175585|B1|Poland||Region of Enrollment||participants|Number|174|174.0||||||
4347568|NCT00402597|4175580|B6|Norway||Region of Enrollment||participants|Number|21|21.0||||||
4347569|NCT00402597|4175581|B5|Norway||Region of Enrollment||participants|Number|5|5.0||||||
4347570|NCT00402597|4175582|B4|Norway||Region of Enrollment||participants|Number|0|0.0||||||
4347571|NCT00402597|4175583|B3|Norway||Region of Enrollment||participants|Number|5|5.0||||||
4347572|NCT00402597|4175584|B2|Norway||Region of Enrollment||participants|Number|3|3.0||||||
4347573|NCT00402597|4175585|B1|Norway||Region of Enrollment||participants|Number|8|8.0||||||
4347574|NCT00402597|4175580|B6|New Zealand||Region of Enrollment||participants|Number|148|148.0||||||
4347575|NCT00402597|4175581|B5|New Zealand||Region of Enrollment||participants|Number|24|24.0||||||
4347576|NCT00402597|4175582|B4|New Zealand||Region of Enrollment||participants|Number|8|8.0||||||
4347577|NCT00402597|4175583|B3|New Zealand||Region of Enrollment||participants|Number|37|37.0||||||
4347578|NCT00402597|4175584|B2|New Zealand||Region of Enrollment||participants|Number|22|22.0||||||
4347579|NCT00402597|4175585|B1|New Zealand||Region of Enrollment||participants|Number|57|57.0||||||
4347580|NCT00402597|4175580|B6|Netherlands||Region of Enrollment||participants|Number|87|87.0||||||
4347581|NCT00402597|4175581|B5|Netherlands||Region of Enrollment||participants|Number|11|11.0||||||
4347582|NCT00402597|4175582|B4|Netherlands||Region of Enrollment||participants|Number|9|9.0||||||
4347583|NCT00402597|4175583|B3|Netherlands||Region of Enrollment||participants|Number|39|39.0||||||
4347584|NCT00402597|4175584|B2|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4347585|NCT00402597|4175585|B1|Netherlands||Region of Enrollment||participants|Number|28|28.0||||||
4347586|NCT00402597|4175580|B6|Korea (South)||Region of Enrollment||participants|Number|47|47.0||||||
4347587|NCT00402597|4175581|B5|Korea (South)||Region of Enrollment||participants|Number|11|11.0||||||
4347588|NCT00402597|4175582|B4|Korea (South)||Region of Enrollment||participants|Number|10|10.0||||||
4347589|NCT00402597|4175583|B3|Korea (South)||Region of Enrollment||participants|Number|9|9.0||||||
4347590|NCT00402597|4175584|B2|Korea (South)||Region of Enrollment||participants|Number|0|0.0||||||
4347591|NCT00402597|4175585|B1|Korea (South)||Region of Enrollment||participants|Number|17|17.0||||||
4347592|NCT00402597|4175580|B6|Italy||Region of Enrollment||participants|Number|136|136.0||||||
4347593|NCT00402597|4175581|B5|Italy||Region of Enrollment||participants|Number|17|17.0||||||
4347594|NCT00402597|4175582|B4|Italy||Region of Enrollment||participants|Number|17|17.0||||||
4347595|NCT00402597|4175583|B3|Italy||Region of Enrollment||participants|Number|56|56.0||||||
4347596|NCT00402597|4175584|B2|Italy||Region of Enrollment||participants|Number|3|3.0||||||
4347597|NCT00402597|4175585|B1|Italy||Region of Enrollment||participants|Number|43|43.0||||||
4347598|NCT00402597|4175580|B6|Israel||Region of Enrollment||participants|Number|96|96.0||||||
4347599|NCT00402597|4175581|B5|Israel||Region of Enrollment||participants|Number|11|11.0||||||
4347600|NCT00402597|4175582|B4|Israel||Region of Enrollment||participants|Number|16|16.0||||||
4347601|NCT00402597|4175583|B3|Israel||Region of Enrollment||participants|Number|26|26.0||||||
4347602|NCT00402597|4175584|B2|Israel||Region of Enrollment||participants|Number|0|0.0||||||
4347603|NCT00402597|4175585|B1|Israel||Region of Enrollment||participants|Number|43|43.0||||||
4347604|NCT00402597|4175580|B6|Hungary||Region of Enrollment||participants|Number|36|36.0||||||
4347605|NCT00402597|4175581|B5|Hungary||Region of Enrollment||participants|Number|4|4.0||||||
4347606|NCT00402597|4175582|B4|Hungary||Region of Enrollment||participants|Number|7|7.0||||||
4347607|NCT00402597|4175583|B3|Hungary||Region of Enrollment||participants|Number|14|14.0||||||
4347608|NCT00402597|4175584|B2|Hungary||Region of Enrollment||participants|Number|0|0.0||||||
4347609|NCT00402597|4175585|B1|Hungary||Region of Enrollment||participants|Number|11|11.0||||||
4347610|NCT00402597|4175580|B6|Germany||Region of Enrollment||participants|Number|92|92.0||||||
4347611|NCT00402597|4175581|B5|Germany||Region of Enrollment||participants|Number|12|12.0||||||
4347612|NCT00402597|4175582|B4|Germany||Region of Enrollment||participants|Number|11|11.0||||||
4347613|NCT00402597|4175583|B3|Germany||Region of Enrollment||participants|Number|35|35.0||||||
4347614|NCT00402597|4175584|B2|Germany||Region of Enrollment||participants|Number|3|3.0||||||
4347615|NCT00402597|4175585|B1|Germany||Region of Enrollment||participants|Number|31|31.0||||||
4347616|NCT00402597|4175580|B6|France||Region of Enrollment||participants|Number|49|49.0||||||
4347617|NCT00402597|4175581|B5|France||Region of Enrollment||participants|Number|6|6.0||||||
4347618|NCT00402597|4175582|B4|France||Region of Enrollment||participants|Number|5|5.0||||||
4347619|NCT00402597|4175583|B3|France||Region of Enrollment||participants|Number|21|21.0||||||
4347620|NCT00402597|4175584|B2|France||Region of Enrollment||participants|Number|1|1.0||||||
4347621|NCT00402597|4175585|B1|France||Region of Enrollment||participants|Number|16|16.0||||||
4347622|NCT00402597|4175580|B6|Finland||Region of Enrollment||participants|Number|16|16.0||||||
4347623|NCT00402597|4175581|B5|Finland||Region of Enrollment||participants|Number|6|6.0||||||
4347624|NCT00402597|4175582|B4|Finland||Region of Enrollment||participants|Number|0|0.0||||||
4347625|NCT00402597|4175583|B3|Finland||Region of Enrollment||participants|Number|7|7.0||||||
4347626|NCT00402597|4175584|B2|Finland||Region of Enrollment||participants|Number|0|0.0||||||
4347627|NCT00402597|4175585|B1|Finland||Region of Enrollment||participants|Number|3|3.0||||||
4347628|NCT00402597|4175580|B6|Denmark||Region of Enrollment||participants|Number|64|64.0||||||
4347629|NCT00402597|4175581|B5|Denmark||Region of Enrollment||participants|Number|9|9.0||||||
4347630|NCT00402597|4175582|B4|Denmark||Region of Enrollment||participants|Number|7|7.0||||||
4347631|NCT00402597|4175583|B3|Denmark||Region of Enrollment||participants|Number|14|14.0||||||
4347632|NCT00402597|4175584|B2|Denmark||Region of Enrollment||participants|Number|16|16.0||||||
4347633|NCT00402597|4175585|B1|Denmark||Region of Enrollment||participants|Number|18|18.0||||||
4347634|NCT00402597|4175580|B6|Czech Republic||Region of Enrollment||participants|Number|180|180.0||||||
4347635|NCT00402597|4175581|B5|Czech Republic||Region of Enrollment||participants|Number|41|41.0||||||
4347636|NCT00402597|4175582|B4|Czech Republic||Region of Enrollment||participants|Number|33|33.0||||||
4347637|NCT00402597|4175583|B3|Czech Republic||Region of Enrollment||participants|Number|58|58.0||||||
4347638|NCT00402597|4175584|B2|Czech Republic||Region of Enrollment||participants|Number|0|0.0||||||
4347639|NCT00402597|4175585|B1|Czech Republic||Region of Enrollment||participants|Number|48|48.0||||||
4347640|NCT00402597|4175580|B6|China||Region of Enrollment||participants|Number|4|4.0||||||
4347641|NCT00402597|4175581|B5|China||Region of Enrollment||participants|Number|0|0.0||||||
4347642|NCT00402597|4175582|B4|China||Region of Enrollment||participants|Number|0|0.0||||||
4347643|NCT00402597|4175583|B3|China||Region of Enrollment||participants|Number|2|2.0||||||
4347644|NCT00402597|4175584|B2|China||Region of Enrollment||participants|Number|0|0.0||||||
4347645|NCT00402597|4175585|B1|China||Region of Enrollment||participants|Number|2|2.0||||||
4347646|NCT00402597|4175580|B6|Canada||Region of Enrollment||participants|Number|88|88.0||||||
4347647|NCT00402597|4175581|B5|Canada||Region of Enrollment||participants|Number|17|17.0||||||
4347648|NCT00402597|4175582|B4|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4347649|NCT00402597|4175583|B3|Canada||Region of Enrollment||participants|Number|28|28.0||||||
4347650|NCT00402597|4175584|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4347651|NCT00402597|4175585|B1|Canada||Region of Enrollment||participants|Number|34|34.0||||||
4347652|NCT00402597|4175580|B6|Bulgaria||Region of Enrollment||participants|Number|258|258.0||||||
4347653|NCT00402597|4175581|B5|Bulgaria||Region of Enrollment||participants|Number|41|41.0||||||
4347654|NCT00402597|4175582|B4|Bulgaria||Region of Enrollment||participants|Number|7|7.0||||||
4347655|NCT00402597|4175583|B3|Bulgaria||Region of Enrollment||participants|Number|85|85.0||||||
4347656|NCT00402597|4175584|B2|Bulgaria||Region of Enrollment||participants|Number|47|47.0||||||
4347657|NCT00402597|4175585|B1|Bulgaria||Region of Enrollment||participants|Number|78|78.0||||||
4347658|NCT00402597|4175580|B6|Brazil||Region of Enrollment||participants|Number|37|37.0||||||
4347659|NCT00402597|4175581|B5|Brazil||Region of Enrollment||participants|Number|0|0.0||||||
4347660|NCT00402597|4175582|B4|Brazil||Region of Enrollment||participants|Number|0|0.0||||||
4347661|NCT00402597|4175583|B3|Brazil||Region of Enrollment||participants|Number|26|26.0||||||
4347662|NCT00402597|4175584|B2|Brazil||Region of Enrollment||participants|Number|0|0.0||||||
4347663|NCT00402597|4175585|B1|Brazil||Region of Enrollment||participants|Number|11|11.0||||||
4347664|NCT00402597|4175580|B6|Belgium||Region of Enrollment||participants|Number|77|77.0||||||
4347665|NCT00402597|4175581|B5|Belgium||Region of Enrollment||participants|Number|12|12.0||||||
4347666|NCT00402597|4175582|B4|Belgium||Region of Enrollment||participants|Number|9|9.0||||||
4347667|NCT00402597|4175583|B3|Belgium||Region of Enrollment||participants|Number|34|34.0||||||
4347668|NCT00402597|4175584|B2|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
4347669|NCT00402597|4175585|B1|Belgium||Region of Enrollment||participants|Number|19|19.0||||||
4347670|NCT00402597|4175580|B6|Australia||Region of Enrollment||participants|Number|206|206.0||||||
4347671|NCT00402597|4175581|B5|Australia||Region of Enrollment||participants|Number|29|29.0||||||
4347672|NCT00402597|4175582|B4|Australia||Region of Enrollment||participants|Number|15|15.0||||||
4347673|NCT00402597|4175583|B3|Australia||Region of Enrollment||participants|Number|73|73.0||||||
4347674|NCT00402597|4175584|B2|Australia||Region of Enrollment||participants|Number|14|14.0||||||
4347675|NCT00402597|4175585|B1|Australia||Region of Enrollment||participants|Number|75|75.0||||||
4347676|NCT00402597|4175580|B6||Male|Sex: Female, Male||Participants|Count of Participants|2674|2674.0||||||
4347677|NCT00402597|4175581|B5||Male|Sex: Female, Male||Participants|Count of Participants|460|460.0||||||
4347678|NCT00402597|4175582|B4||Male|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
4347679|NCT00402597|4175583|B3||Male|Sex: Female, Male||Participants|Count of Participants|818|818.0||||||
4347680|NCT00402597|4175584|B2||Male|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4347681|NCT00402597|4175585|B1||Male|Sex: Female, Male||Participants|Count of Participants|881|881.0||||||
4347682|NCT00402597|4175580|B6||Female|Sex: Female, Male||Participants|Count of Participants|788|788.0||||||
4347683|NCT00402597|4175581|B5||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4347684|NCT00402597|4175582|B4||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4347685|NCT00402597|4175583|B3||Female|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
4347686|NCT00402597|4175584|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4347687|NCT00402597|4175585|B1||Female|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
4347688|NCT00402597|4175580|B6|||Age||years|Mean|57.4|57.4|Standard Deviation|9.53|9.53|||
4347689|NCT00402597|4175581|B5|||Age||years|Mean|57.4|57.4|Standard Deviation|9.06|9.06|||
4347690|NCT00402597|4175582|B4|||Age||years|Mean|56.4|56.4|Standard Deviation|9.38|9.38|||
4347691|NCT00402597|4175583|B3|||Age||years|Mean|57.2|57.2|Standard Deviation|9.71|9.71|||
4347692|NCT00402597|4175584|B2|||Age||years|Mean|58.1|58.1|Standard Deviation|9.76|9.76|||
4347693|NCT00402597|4175585|B1|||Age||years|Mean|57.8|57.8|Standard Deviation|9.58|9.58|||
4347694|NCT00402597|4175580|B6||>=65 years|Age||Participants|Count of Participants|870|870.0||||||
4347695|NCT00402597|4175581|B5||>=65 years|Age||Participants|Count of Participants|145|145.0||||||
4347696|NCT00402597|4175582|B4||>=65 years|Age||Participants|Count of Participants|70|70.0||||||
4347697|NCT00402597|4175583|B3||>=65 years|Age||Participants|Count of Participants|260|260.0||||||
4347698|NCT00402597|4175584|B2||>=65 years|Age||Participants|Count of Participants|89|89.0||||||
4347699|NCT00402597|4175585|B1||>=65 years|Age||Participants|Count of Participants|306|306.0||||||
4347700|NCT00402597|4175580|B6||Between 18 and 65 years|Age||Participants|Count of Participants|2592|2592.0||||||
4347701|NCT00402597|4175581|B5||Between 18 and 65 years|Age||Participants|Count of Participants|458|458.0||||||
4347702|NCT00402597|4175582|B4||Between 18 and 65 years|Age||Participants|Count of Participants|283|283.0||||||
4347703|NCT00402597|4175583|B3||Between 18 and 65 years|Age||Participants|Count of Participants|786|786.0||||||
4347704|NCT00402597|4175584|B2||Between 18 and 65 years|Age||Participants|Count of Participants|218|218.0||||||
4347705|NCT00402597|4175585|B1||Between 18 and 65 years|Age||Participants|Count of Participants|847|847.0||||||
4347706|NCT00402597|4175580|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4347707|NCT00402597|4175581|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4347708|NCT00402597|4175582|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4347709|NCT00402597|4175583|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4347710|NCT00402597|4175584|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4347711|NCT00402597|4175585|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4347712|NCT00402363|4175626|B5|Unknown||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4347713|NCT00402363|4175627|B4|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4347714|NCT00402363|4175628|B3|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4347715|NCT00402363|4175629|B2|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4347716|NCT00402363|4175630|B1|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4347717|NCT00402363|4175626|B5|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4347718|NCT00402363|4175627|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4347719|NCT00402363|4175628|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4347720|NCT00402363|4175629|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4347721|NCT00402363|4175630|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4347722|NCT00402363|4175626|B5|American Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4347723|NCT00402363|4175627|B4|American Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4347724|NCT00402363|4175628|B3|American Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4347725|NCT00402363|4175629|B2|American Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4347726|NCT00402363|4175630|B1|American Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4347727|NCT00402363|4175626|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4347728|NCT00402363|4175627|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4347729|NCT00402363|4175628|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4347730|NCT00402363|4175629|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4347731|NCT00402363|4175630|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4347732|NCT00402363|4175626|B5|African American||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4347733|NCT00402363|4175627|B4|African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4347734|NCT00402363|4175628|B3|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4347735|NCT00402363|4175629|B2|African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4347736|NCT00402363|4175630|B1|African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4347737|NCT00402363|4175626|B5|White/Caucasian||Race/Ethnicity, Customized||participants|Number|607|607.0||||||
4347738|NCT00402363|4175627|B4|White/Caucasian||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4347739|NCT00402363|4175628|B3|White/Caucasian||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
4347740|NCT00402363|4175629|B2|White/Caucasian||Race/Ethnicity, Customized||participants|Number|253|253.0||||||
4347741|NCT00402363|4175630|B1|White/Caucasian||Race/Ethnicity, Customized||participants|Number|246|246.0||||||
4347742|NCT00402363|4175626|B5||Male|Gender||Participants|Count of Participants|373|373.0||||||
4347743|NCT00402363|4175627|B4||Male|Gender||Participants|Count of Participants|36|36.0||||||
4347744|NCT00402363|4175628|B3||Male|Gender||Participants|Count of Participants|52|52.0||||||
4347745|NCT00402363|4175629|B2||Male|Gender||Participants|Count of Participants|138|138.0||||||
4347746|NCT00402363|4175630|B1||Male|Gender||Participants|Count of Participants|147|147.0||||||
4347747|NCT00402363|4175626|B5||Female|Gender||Participants|Count of Participants|290|290.0||||||
4347748|NCT00402363|4175627|B4||Female|Gender||Participants|Count of Participants|19|19.0||||||
4347749|NCT00402363|4175628|B3||Female|Gender||Participants|Count of Participants|14|14.0||||||
4347750|NCT00402363|4175629|B2||Female|Gender||Participants|Count of Participants|138|138.0||||||
4347751|NCT00402363|4175630|B1||Female|Gender||Participants|Count of Participants|119|119.0||||||
4347752|NCT00402363|4175626|B5|||Age||Years|Mean|60.5|60.5|Standard Deviation|12.84|12.84|||
4347753|NCT00402363|4175627|B4|||Age||Years|Mean|57.6|57.6|Standard Deviation|14.85|14.85|||
4347754|NCT00402363|4175628|B3|||Age||Years|Mean|58.7|58.7|Standard Deviation|12.65|12.65|||
4347755|NCT00402363|4175629|B2|||Age||Years|Mean|61.9|61.9|Standard Deviation|11.57|11.57|||
4347756|NCT00402363|4175630|B1|||Age||Years|Mean|60.0|60.0|Standard Deviation|13.56|13.56|||
4347757|NCT00402337|4175691|B6|United States||Region of Enrollment||participants|Number|309|309.0||||||
4347758|NCT00402337|4175692|B5|United States||Region of Enrollment||participants|Number|69|69.0||||||
4347759|NCT00402337|4175693|B4|United States||Region of Enrollment||participants|Number|63|63.0||||||
4347760|NCT00402337|4175694|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
4347761|NCT00402337|4175695|B2|United States||Region of Enrollment||participants|Number|56|56.0||||||
4347762|NCT00402337|4175696|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
4347763|NCT00402337|4175691|B6||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4347764|NCT00402337|4175692|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4347765|NCT00402337|4175693|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4347766|NCT00402337|4175694|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4347767|NCT00402337|4175695|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4347768|NCT00402337|4175696|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4347769|NCT00402337|4175691|B6||Female|Sex: Female, Male||Participants|Count of Participants|284|284.0||||||
4347770|NCT00402337|4175692|B5||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4347771|NCT00402337|4175693|B4||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4347772|NCT00402337|4175694|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4347773|NCT00402337|4175695|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4347774|NCT00402337|4175696|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4347775|NCT00402337|4175691|B6|Older than 65 years||Age, Customized||Participants|Number|26|26.0||||||
4347776|NCT00402337|4175692|B5|Older than 65 years||Age, Customized||Participants|Number|5|5.0||||||
4347777|NCT00402337|4175693|B4|Older than 65 years||Age, Customized||Participants|Number|6|6.0||||||
4347778|NCT00402337|4175694|B3|Older than 65 years||Age, Customized||Participants|Number|5|5.0||||||
4347779|NCT00402337|4175695|B2|Older than 65 years||Age, Customized||Participants|Number|3|3.0||||||
4347780|NCT00402337|4175696|B1|Older than 65 years||Age, Customized||Participants|Number|7|7.0||||||
4347781|NCT00402337|4175691|B6|18 years to 65 years||Age, Customized||Participants|Number|283|283.0||||||
4347782|NCT00402337|4175692|B5|18 years to 65 years||Age, Customized||Participants|Number|64|64.0||||||
4347783|NCT00402337|4175693|B4|18 years to 65 years||Age, Customized||Participants|Number|57|57.0||||||
4347784|NCT00402337|4175694|B3|18 years to 65 years||Age, Customized||Participants|Number|57|57.0||||||
4347785|NCT00402337|4175695|B2|18 years to 65 years||Age, Customized||Participants|Number|53|53.0||||||
4347786|NCT00402337|4175696|B1|18 years to 65 years||Age, Customized||Participants|Number|52|52.0||||||
4347787|NCT00402337|4175691|B6|||Age||years|Mean|47.2|47.2|Standard Deviation|13.7|13.7|||
4347788|NCT00402337|4175692|B5|||Age||years|Mean|46.1|46.1|Standard Deviation|15.5|15.5|||
4347789|NCT00402337|4175693|B4|||Age||years|Mean|49.2|49.2|Standard Deviation|14.0|14.0|||
4347790|NCT00402337|4175694|B3|||Age||years|Mean|48.4|48.4|Standard Deviation|12.7|12.7|||
4347791|NCT00402337|4175695|B2|||Age||years|Mean|46.4|46.4|Standard Deviation|11.7|11.7|||
4347792|NCT00402337|4175696|B1|||Age||years|Mean|45.9|45.9|Standard Deviation|14.1|14.1|||
4347793|NCT00402324|4175737|B3|||Body Weight||kilograms|Mean|89.04|89.04|Standard Deviation|23.94|23.94|||
4347794|NCT00402324|4175738|B2|||Body Weight||kilograms|Mean|90.75|90.75|Standard Deviation|23.70|23.7|||
4347795|NCT00402324|4175739|B1|||Body Weight||kilograms|Mean|87.33|87.33|Standard Deviation|24.17|24.17|||
4347796|NCT00402324|4175737|B3|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meters|Mean|31.23|31.23|Standard Deviation|8.64|8.64|||
4347797|NCT00402324|4175738|B2|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meters|Mean|31.72|31.72|Standard Deviation|8.29|8.29|||
4347798|NCT00402324|4175739|B1|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meters|Mean|30.73|30.73|Standard Deviation|8.99|8.99|||
4347799|NCT00402324|4175737|B3|East Asian||Race/Ethnicity||participants|Number|2|2.0||||||
4347800|NCT00402324|4175738|B2|East Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4347801|NCT00402324|4175739|B1|East Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4347802|NCT00402324|4175737|B3|Native American||Race/Ethnicity||participants|Number|3|3.0||||||
4347803|NCT00402324|4175738|B2|Native American||Race/Ethnicity||participants|Number|2|2.0||||||
4347804|NCT00402324|4175739|B1|Native American||Race/Ethnicity||participants|Number|1|1.0||||||
4347805|NCT00402324|4175737|B3|Hispanic||Race/Ethnicity||participants|Number|28|28.0||||||
4347806|NCT00402324|4175738|B2|Hispanic||Race/Ethnicity||participants|Number|13|13.0||||||
4347807|NCT00402324|4175739|B1|Hispanic||Race/Ethnicity||participants|Number|15|15.0||||||
4347808|NCT00402324|4175737|B3|African Descent||Race/Ethnicity||participants|Number|67|67.0||||||
4347809|NCT00402324|4175738|B2|African Descent||Race/Ethnicity||participants|Number|29|29.0||||||
4347810|NCT00402324|4175739|B1|African Descent||Race/Ethnicity||participants|Number|38|38.0||||||
4347811|NCT00402324|4175737|B3|Caucasian||Race/Ethnicity||participants|Number|102|102.0||||||
4347812|NCT00402324|4175738|B2|Caucasian||Race/Ethnicity||participants|Number|56|56.0||||||
4347813|NCT00402324|4175739|B1|Caucasian||Race/Ethnicity||participants|Number|46|46.0||||||
4347814|NCT00402324|4175737|B3|United States||Region of Enrollment||participants|Number|202|202.0||||||
4347815|NCT00402324|4175738|B2|United States||Region of Enrollment||participants|Number|101|101.0||||||
4347816|NCT00402324|4175739|B1|United States||Region of Enrollment||participants|Number|101|101.0||||||
4347817|NCT00402324|4175737|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4347818|NCT00402324|4175738|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4347819|NCT00402324|4175739|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4347820|NCT00402324|4175737|B3||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4347821|NCT00402324|4175738|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4347822|NCT00402324|4175739|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4347823|NCT00402324|4175737|B3|||Age||years|Mean|38.56|38.56|Standard Deviation|11.11|11.11|||
4347824|NCT00402324|4175738|B2|||Age||years|Mean|38.52|38.52|Standard Deviation|11.07|11.07|||
4347825|NCT00402324|4175739|B1|||Age||years|Mean|38.61|38.61|Standard Deviation|11.20|11.2|||
4347826|NCT00402285|4175770|B4||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4347827|NCT00402285|4175771|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4347828|NCT00402285|4175772|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4347829|NCT00402285|4175773|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4347830|NCT00402285|4175770|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4347831|NCT00402285|4175771|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4347832|NCT00402285|4175772|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4347833|NCT00402285|4175773|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4347834|NCT00402285|4175770|B4|||Age||years|Mean|61|61.0|Standard Deviation|8|8.0|||
4347835|NCT00402285|4175771|B3|||Age||years|Mean|59|59.0|Standard Deviation|8|8.0|||
4347836|NCT00402285|4175772|B2|||Age||years|Mean|62|62.0|Standard Deviation|8|8.0|||
4347837|NCT00402285|4175773|B1|||Age||years|Mean|61|61.0|Standard Deviation|7|7.0|||
4347838|NCT00402246|4175781|B3|United States||Region of Enrollment||participants|Number|1997|1997.0||||||
4347839|NCT00402246|4175782|B2|United States||Region of Enrollment||participants|Number|983|983.0||||||
4347840|NCT00402246|4175783|B1|United States||Region of Enrollment||participants|Number|1014|1014.0||||||
4347841|NCT00402246|4175781|B3||Male|Sex: Female, Male||Participants|Count of Participants|1420|1420.0||||||
4347842|NCT00402246|4175782|B2||Male|Sex: Female, Male||Participants|Count of Participants|705|705.0||||||
4347843|NCT00402246|4175783|B1||Male|Sex: Female, Male||Participants|Count of Participants|715|715.0||||||
4347844|NCT00402246|4175781|B3||Female|Sex: Female, Male||Participants|Count of Participants|577|577.0||||||
4347845|NCT00402246|4175782|B2||Female|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
4347846|NCT00402246|4175783|B1||Female|Sex: Female, Male||Participants|Count of Participants|299|299.0||||||
4347847|NCT00402246|4175781|B3|||Age||years|Mean|65.0|65.0|Standard Deviation|12.1|12.1|||
4347848|NCT00402246|4175782|B2|||Age||years|Mean|64.9|64.9|Standard Deviation|11.9|11.9|||
4347849|NCT00402246|4175783|B1|||Age||years|Mean|65.2|65.2|Standard Deviation|12.4|12.4|||
4347850|NCT00402246|4175781|B3||>=65 years|Age||Participants|Count of Participants|1101|1101.0||||||
4347851|NCT00402246|4175782|B2||>=65 years|Age||Participants|Count of Participants|540|540.0||||||
4347852|NCT00402246|4175783|B1||>=65 years|Age||Participants|Count of Participants|561|561.0||||||
4347853|NCT00402246|4175781|B3||Between 18 and 65 years|Age||Participants|Count of Participants|895|895.0||||||
4347854|NCT00402246|4175782|B2||Between 18 and 65 years|Age||Participants|Count of Participants|442|442.0||||||
4347855|NCT00402246|4175783|B1||Between 18 and 65 years|Age||Participants|Count of Participants|453|453.0||||||
4347856|NCT00402246|4175781|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4347857|NCT00402246|4175782|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4347858|NCT00402246|4175783|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4347859|NCT00402233|4175814|B5||Male|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4347860|NCT00402233|4175815|B4||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4347861|NCT00402233|4175816|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4347862|NCT00402233|4175817|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4347863|NCT00402233|4175818|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4347864|NCT00402233|4175814|B5||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4347865|NCT00402233|4175815|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4347866|NCT00402233|4175816|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4347867|NCT00402233|4175817|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4347868|NCT00402233|4175818|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4347869|NCT00402233|4175814|B5|||Age||years|Mean|62.3|62.3|Standard Deviation|10.2|10.2|||
4347870|NCT00402233|4175815|B4|||Age||years|Mean|63.1|63.1|Standard Deviation|9.9|9.9|||
4347871|NCT00402233|4175816|B3|||Age||years|Mean|61.6|61.6|Standard Deviation|10.2|10.2|||
4347872|NCT00402233|4175817|B2|||Age||years|Mean|63.7|63.7|Standard Deviation|9.8|9.8|||
4347873|NCT00402233|4175818|B1|||Age||years|Mean|60.7|60.7|Standard Deviation|11|11.0|||
4347874|NCT00402194|4175843|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4347875|NCT00402194|4175844|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4347876|NCT00402194|4175845|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4347877|NCT00402194|4175843|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4347878|NCT00402194|4175844|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4347879|NCT00402194|4175845|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4347880|NCT00402194|4175843|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4347881|NCT00402194|4175844|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4347882|NCT00402194|4175845|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4347883|NCT00402194|4175843|B3|||Age||years|Mean|38.8|38.8|Standard Deviation|9.4|9.4|||
4347884|NCT00402194|4175844|B2|||Age||years|Mean|36.5|36.5|Standard Deviation|10.1|10.1|||
4347885|NCT00402194|4175845|B1|||Age||years|Mean|41.0|41.0|Standard Deviation|8.7|8.7|||
4347886|NCT00402194|4175843|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4347887|NCT00402194|4175844|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4347888|NCT00402194|4175845|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4347889|NCT00402194|4175843|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4347890|NCT00402194|4175844|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4347891|NCT00402194|4175845|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4347892|NCT00402194|4175843|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4347893|NCT00402194|4175844|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4347894|NCT00402194|4175845|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4347895|NCT00402168|4175854|B3||Male|Gender||Participants|Count of Participants|126|126.0||||||
4347896|NCT00402168|4175855|B2||Male|Gender||Participants|Count of Participants|60|60.0||||||
4347897|NCT00402168|4175856|B1||Male|Gender||Participants|Count of Participants|66|66.0||||||
4347898|NCT00402168|4175854|B3||Female|Gender||Participants|Count of Participants|47|47.0||||||
4347899|NCT00402168|4175855|B2||Female|Gender||Participants|Count of Participants|29|29.0||||||
4347900|NCT00402168|4175856|B1||Female|Gender||Participants|Count of Participants|18|18.0||||||
4347901|NCT00402168|4175854|B3|Greater than (>) 65 years||Age, Customized||participants|Number|11|11.0||||||
4347902|NCT00402168|4175855|B2|Greater than (>) 65 years||Age, Customized||participants|Number|6|6.0||||||
4347903|NCT00402168|4175856|B1|Greater than (>) 65 years||Age, Customized||participants|Number|5|5.0||||||
4347904|NCT00402168|4175854|B3|46 - 65 years||Age, Customized||participants|Number|73|73.0||||||
4347905|NCT00402168|4175855|B2|46 - 65 years||Age, Customized||participants|Number|36|36.0||||||
4347906|NCT00402168|4175856|B1|46 - 65 years||Age, Customized||participants|Number|37|37.0||||||
4347907|NCT00402168|4175854|B3|18 - 45 years||Age, Customized||participants|Number|89|89.0||||||
4347908|NCT00402168|4175855|B2|18 - 45 years||Age, Customized||participants|Number|47|47.0||||||
4347909|NCT00402168|4175856|B1|18 - 45 years||Age, Customized||participants|Number|42|42.0||||||
4347910|NCT00402168|4175854|B3|||Age||years|Mean|44.8|44.8|Standard Deviation|13.2|13.2|||
4347911|NCT00402168|4175855|B2|||Age||years|Mean|44.3|44.3|Standard Deviation|13.0|13.0|||
4347912|NCT00402168|4175856|B1|||Age||years|Mean|45.3|45.3|Standard Deviation|13.5|13.5|||
4347913|NCT00402103|4175912|B3||Male|Sex: Female, Male||Participants|Count of Participants|330|330.0||||||
4347914|NCT00402103|4175913|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4347915|NCT00402103|4175914|B1||Male|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
4347916|NCT00402103|4175912|B3||Female|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
4347917|NCT00402103|4175913|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4347918|NCT00402103|4175914|B1||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4347919|NCT00402103|4175912|B3|||Age||years|Mean|54.4|54.4|Standard Deviation|11.61|11.61|||
4347920|NCT00402103|4175913|B2|||Age||years|Mean|55.7|55.7|Standard Deviation|11.33|11.33|||
4347921|NCT00402103|4175914|B1|||Age||years|Mean|54.2|54.2|Standard Deviation|11.66|11.66|||
4347922|NCT00402051|4175929|B3|||Use of Tobacco Products|"For past and current smokers only: N=56 for Pemetrexed +~Cisplatin, N=58 for Pemetrexed + Carboplatin:"|years|Mean|33.2|33.2|Standard Deviation|12.15|12.15|||
4347923|NCT00402051|4175930|B2|||Use of Tobacco Products|"For past and current smokers only: N=56 for Pemetrexed +~Cisplatin, N=58 for Pemetrexed + Carboplatin:"|years|Mean|34.6|34.6|Standard Deviation|11.47|11.47|||
4347924|NCT00402051|4175931|B1|||Use of Tobacco Products|"For past and current smokers only: N=56 for Pemetrexed +~Cisplatin, N=58 for Pemetrexed + Carboplatin:"|years|Mean|31.7|31.7|Standard Deviation|12.74|12.74|||
4347925|NCT00402051|4175929|B3|||Time Since Patient Stopped Smoking|For past smokers only: N=41 for Pemetrexed + Cisplatin, N=42 for Pemetrexed + Carboplatin|years|Mean|8.7|8.7|Standard Deviation|11.46|11.46|||
4347926|NCT00402051|4175930|B2|||Time Since Patient Stopped Smoking|For past smokers only: N=41 for Pemetrexed + Cisplatin, N=42 for Pemetrexed + Carboplatin|years|Mean|7.4|7.4|Standard Deviation|10.56|10.56|||
4347927|NCT00402051|4175931|B1|||Time Since Patient Stopped Smoking|For past smokers only: N=41 for Pemetrexed + Cisplatin, N=42 for Pemetrexed + Carboplatin|years|Mean|10.1|10.1|Standard Deviation|12.31|12.31|||
4347928|NCT00402051|4175929|B3|Stage IV (metastatic disease)||Stage of disease|For all patients randomized, N=66 for Pemetrexed + Cisplatin, N=67 for Pemetrexed + Carboplatin|participants|Number|119|119.0||||||
4347929|NCT00402051|4175930|B2|Stage IV (metastatic disease)||Stage of disease|For all patients randomized, N=66 for Pemetrexed + Cisplatin, N=67 for Pemetrexed + Carboplatin|participants|Number|58|58.0||||||
4347930|NCT00402051|4175931|B1|Stage IV (metastatic disease)||Stage of disease|For all patients randomized, N=66 for Pemetrexed + Cisplatin, N=67 for Pemetrexed + Carboplatin|participants|Number|61|61.0||||||
4347931|NCT00402051|4175929|B3|Stage IIIb (locally advanced disease)||Stage of disease|For all patients randomized, N=66 for Pemetrexed + Cisplatin, N=67 for Pemetrexed + Carboplatin|participants|Number|14|14.0||||||
4347932|NCT00402051|4175930|B2|Stage IIIb (locally advanced disease)||Stage of disease|For all patients randomized, N=66 for Pemetrexed + Cisplatin, N=67 for Pemetrexed + Carboplatin|participants|Number|9|9.0||||||
4347933|NCT00402051|4175931|B1|Stage IIIb (locally advanced disease)||Stage of disease|For all patients randomized, N=66 for Pemetrexed + Cisplatin, N=67 for Pemetrexed + Carboplatin|participants|Number|5|5.0||||||
4347934|NCT00402051|4175929|B3|Current Smoker||Smoking Status||participants|Number|31|31.0||||||
4347935|NCT00402051|4175930|B2|Current Smoker||Smoking Status||participants|Number|16|16.0||||||
4347936|NCT00402051|4175931|B1|Current Smoker||Smoking Status||participants|Number|15|15.0||||||
4347937|NCT00402051|4175929|B3|Past Smoker||Smoking Status||participants|Number|83|83.0||||||
4347938|NCT00402051|4175930|B2|Past Smoker||Smoking Status||participants|Number|42|42.0||||||
4347939|NCT00402051|4175931|B1|Past Smoker||Smoking Status||participants|Number|41|41.0||||||
4347940|NCT00402051|4175929|B3|Never Smoked||Smoking Status||participants|Number|16|16.0||||||
4347941|NCT00402051|4175930|B2|Never Smoked||Smoking Status||participants|Number|7|7.0||||||
4347942|NCT00402051|4175931|B1|Never Smoked||Smoking Status||participants|Number|9|9.0||||||
4347943|NCT00402051|4175929|B3|Brain Metastases||Presence of Bone and Brain Metastases|Presents specifically participants with bone and brain metastases|participants|Number|3|3.0||||||
4347944|NCT00402051|4175930|B2|Brain Metastases||Presence of Bone and Brain Metastases|Presents specifically participants with bone and brain metastases|participants|Number|1|1.0||||||
4347945|NCT00402051|4175931|B1|Brain Metastases||Presence of Bone and Brain Metastases|Presents specifically participants with bone and brain metastases|participants|Number|2|2.0||||||
4347946|NCT00402051|4175929|B3|Bone Metastases||Presence of Bone and Brain Metastases|Presents specifically participants with bone and brain metastases|participants|Number|25|25.0||||||
4347947|NCT00402051|4175930|B2|Bone Metastases||Presence of Bone and Brain Metastases|Presents specifically participants with bone and brain metastases|participants|Number|11|11.0||||||
4347948|NCT00402051|4175931|B1|Bone Metastases||Presence of Bone and Brain Metastases|Presents specifically participants with bone and brain metastases|participants|Number|14|14.0||||||
4347949|NCT00402051|4175929|B3|NSCLC, Not Otherwise Specified||Histopathology||participants|Number|12|12.0||||||
4347950|NCT00402051|4175930|B2|NSCLC, Not Otherwise Specified||Histopathology||participants|Number|3|3.0||||||
4347951|NCT00402051|4175931|B1|NSCLC, Not Otherwise Specified||Histopathology||participants|Number|9|9.0||||||
4347952|NCT00402051|4175929|B3|Bronchioalveolar Carcinoma||Histopathology||participants|Number|1|1.0||||||
4347953|NCT00402051|4175930|B2|Bronchioalveolar Carcinoma||Histopathology||participants|Number|1|1.0||||||
4347954|NCT00402051|4175931|B1|Bronchioalveolar Carcinoma||Histopathology||participants|Number|0|0.0||||||
4347955|NCT00402051|4175929|B3|Mixed Cell Carcinoma||Histopathology||participants|Number|1|1.0||||||
4347956|NCT00402051|4175930|B2|Mixed Cell Carcinoma||Histopathology||participants|Number|1|1.0||||||
4347957|NCT00402051|4175931|B1|Mixed Cell Carcinoma||Histopathology||participants|Number|0|0.0||||||
4347958|NCT00402051|4175929|B3|Large Cell Carcinoma||Histopathology||participants|Number|9|9.0||||||
4347959|NCT00402051|4175930|B2|Large Cell Carcinoma||Histopathology||participants|Number|3|3.0||||||
4347960|NCT00402051|4175931|B1|Large Cell Carcinoma||Histopathology||participants|Number|6|6.0||||||
4347961|NCT00402051|4175929|B3|Adenocarcinoma||Histopathology||participants|Number|82|82.0||||||
4347962|NCT00402051|4175930|B2|Adenocarcinoma||Histopathology||participants|Number|44|44.0||||||
4347963|NCT00402051|4175931|B1|Adenocarcinoma||Histopathology||participants|Number|38|38.0||||||
4347964|NCT00402051|4175929|B3|Squamous Cell Carcinoma||Histopathology||participants|Number|25|25.0||||||
4347965|NCT00402051|4175930|B2|Squamous Cell Carcinoma||Histopathology||participants|Number|13|13.0||||||
4347966|NCT00402051|4175931|B1|Squamous Cell Carcinoma||Histopathology||participants|Number|12|12.0||||||
4347967|NCT00402051|4175929|B3|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|45|45.0||||||
4347968|NCT00402051|4175930|B2|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|20|20.0||||||
4347969|NCT00402051|4175931|B1|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|25|25.0||||||
4347970|NCT00402051|4175929|B3|0 - Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|85|85.0||||||
4347971|NCT00402051|4175930|B2|0 - Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|45|45.0||||||
4347972|NCT00402051|4175931|B1|0 - Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|40|40.0||||||
4347973|NCT00402051|4175929|B3|Germany||Region of Enrollment||participants|Number|130|130.0||||||
4347974|NCT00402051|4175930|B2|Germany||Region of Enrollment||participants|Number|65|65.0||||||
4347975|NCT00402051|4175931|B1|Germany||Region of Enrollment||participants|Number|65|65.0||||||
4347976|NCT00402051|4175929|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|130|130.0||||||
4347977|NCT00402051|4175930|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
4347978|NCT00402051|4175931|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
4347979|NCT00402051|4175929|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4347980|NCT00402051|4175930|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4347981|NCT00402051|4175931|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4347982|NCT00402051|4175929|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4347983|NCT00402051|4175930|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4347984|NCT00402051|4175931|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4347985|NCT00402051|4175929|B3|||Age||years|Mean|62.4|62.4|Standard Deviation|7.95|7.95|||
4347986|NCT00402051|4175930|B2|||Age||years|Mean|62.4|62.4|Standard Deviation|7.51|7.51|||
4347987|NCT00402051|4175931|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|8.43|8.43|||
4347988|NCT00402025|4175946|B4|2 (Ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|3|3.0||||||
4347989|NCT00402025|4175947|B3|2 (Ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|1|1.0||||||
4347990|NCT00402025|4175948|B2|2 (Ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|1|1.0||||||
4347991|NCT00402025|4175949|B1|2 (Ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|1|1.0||||||
4347992|NCT00402025|4175946|B4|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|11|11.0||||||
4347993|NCT00402025|4175947|B3|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|7|7.0||||||
4347994|NCT00402025|4175948|B2|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|3|3.0||||||
4347995|NCT00402025|4175949|B1|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|1|1.0||||||
4347996|NCT00402025|4175946|B4|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|3|3.0||||||
4347997|NCT00402025|4175947|B3|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|2|2.0||||||
4348046|NCT00401973|4175976|B2|Schizoaffective||Type of Diagnosis||participants|Number|15|15.0||||||
4348047|NCT00401973|4175977|B1|Schizoaffective||Type of Diagnosis||participants|Number|8|8.0||||||
4348048|NCT00401973|4175974|B4|West Asian||Race/Ethnicity||participants|Number|4|4.0||||||
4347998|NCT00402025|4175948|B2|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4347999|NCT00402025|4175949|B1|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|1|1.0||||||
4348000|NCT00402025|4175946|B4|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4348001|NCT00402025|4175947|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4348002|NCT00402025|4175948|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4348003|NCT00402025|4175949|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4348004|NCT00402025|4175946|B4|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4348005|NCT00402025|4175947|B3|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4348006|NCT00402025|4175948|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4348007|NCT00402025|4175949|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4348008|NCT00402025|4175946|B4|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4348009|NCT00402025|4175947|B3|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4348010|NCT00402025|4175948|B2|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4348011|NCT00402025|4175949|B1|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4348012|NCT00402025|4175946|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4348013|NCT00402025|4175947|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4348014|NCT00402025|4175948|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4348015|NCT00402025|4175949|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4348016|NCT00402025|4175946|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4348017|NCT00402025|4175947|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4348018|NCT00402025|4175948|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4348019|NCT00402025|4175949|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4348020|NCT00402025|4175946|B4|||Age||years|Mean|54.5|54.5|Standard Deviation|9.47|9.47|||
4348021|NCT00402025|4175947|B3|||Age||years|Mean|50.8|50.8|Standard Deviation|6.68|6.68|||
4348022|NCT00402025|4175948|B2|||Age||years|Mean|63.8|63.8|Standard Deviation|10.21|10.21|||
4348023|NCT00402025|4175949|B1|||Age||years|Mean|54.7|54.7|Standard Deviation|10.97|10.97|||
4348024|NCT00401973|4175974|B4|||Weight||kilograms|Mean|77.5|77.5|Standard Deviation|16.62|16.62|||
4348025|NCT00401973|4175975|B3|||Weight||kilograms|Mean|76.2|76.2|Standard Deviation|16.22|16.22|||
4348026|NCT00401973|4175976|B2|||Weight||kilograms|Mean|79.1|79.1|Standard Deviation|17.27|17.27|||
4348027|NCT00401973|4175977|B1|||Weight||kilograms|Mean|77.0|77.0|Standard Deviation|16.33|16.33|||
4348028|NCT00401973|4175974|B4|||Previous Number of Episodes||number of episodes|Mean|2.04|2.04|Standard Deviation|5.06|5.06|||
4348029|NCT00401973|4175975|B3|||Previous Number of Episodes||number of episodes|Mean|2.22|2.22|Standard Deviation|5.77|5.77|||
4348030|NCT00401973|4175976|B2|||Previous Number of Episodes||number of episodes|Mean|2.19|2.19|Standard Deviation|5.90|5.9|||
4348031|NCT00401973|4175977|B1|||Previous Number of Episodes||number of episodes|Mean|1.53|1.53|Standard Deviation|1.02|1.02|||
4348032|NCT00401973|4175974|B4|||Onset Age||years|Mean|25.15|25.15|Standard Deviation|9.32|9.32|||
4348033|NCT00401973|4175975|B3|||Onset Age||years|Mean|24.40|24.4|Standard Deviation|9.18|9.18|||
4348034|NCT00401973|4175976|B2|||Onset Age||years|Mean|26.44|26.44|Standard Deviation|9.98|9.98|||
4348035|NCT00401973|4175977|B1|||Onset Age||years|Mean|24.35|24.35|Standard Deviation|8.42|8.42|||
4348036|NCT00401973|4175974|B4|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meter (kg/m^2)|Mean|27.1|27.1|Standard Deviation|4.68|4.68|||
4348037|NCT00401973|4175975|B3|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meter (kg/m^2)|Mean|27.0|27.0|Standard Deviation|4.84|4.84|||
4348038|NCT00401973|4175976|B2|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meter (kg/m^2)|Mean|27.3|27.3|Standard Deviation|4.67|4.67|||
4348039|NCT00401973|4175977|B1|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meter (kg/m^2)|Mean|27.0|27.0|Standard Deviation|4.53|4.53|||
4348040|NCT00401973|4175974|B4|Schizophrenia||Type of Diagnosis||participants|Number|158|158.0||||||
4348041|NCT00401973|4175975|B3|Schizophrenia||Type of Diagnosis||participants|Number|55|55.0||||||
4348042|NCT00401973|4175976|B2|Schizophrenia||Type of Diagnosis||participants|Number|61|61.0||||||
4348043|NCT00401973|4175977|B1|Schizophrenia||Type of Diagnosis||participants|Number|42|42.0||||||
4348044|NCT00401973|4175974|B4|Schizoaffective||Type of Diagnosis||participants|Number|41|41.0||||||
4348045|NCT00401973|4175975|B3|Schizoaffective||Type of Diagnosis||participants|Number|18|18.0||||||
4348049|NCT00401973|4175975|B3|West Asian||Race/Ethnicity||participants|Number|2|2.0||||||
4348050|NCT00401973|4175976|B2|West Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4348051|NCT00401973|4175977|B1|West Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4348052|NCT00401973|4175974|B4|Native American||Race/Ethnicity||participants|Number|1|1.0||||||
4348053|NCT00401973|4175975|B3|Native American||Race/Ethnicity||participants|Number|1|1.0||||||
4348054|NCT00401973|4175976|B2|Native American||Race/Ethnicity||participants|Number|0|0.0||||||
4348055|NCT00401973|4175977|B1|Native American||Race/Ethnicity||participants|Number|0|0.0||||||
4348056|NCT00401973|4175974|B4|Hispanic||Race/Ethnicity||participants|Number|52|52.0||||||
4348057|NCT00401973|4175975|B3|Hispanic||Race/Ethnicity||participants|Number|18|18.0||||||
4348058|NCT00401973|4175976|B2|Hispanic||Race/Ethnicity||participants|Number|20|20.0||||||
4348059|NCT00401973|4175977|B1|Hispanic||Race/Ethnicity||participants|Number|14|14.0||||||
4348060|NCT00401973|4175974|B4|East Asian||Race/Ethnicity||participants|Number|39|39.0||||||
4348061|NCT00401973|4175975|B3|East Asian||Race/Ethnicity||participants|Number|14|14.0||||||
4348062|NCT00401973|4175976|B2|East Asian||Race/Ethnicity||participants|Number|15|15.0||||||
4348063|NCT00401973|4175977|B1|East Asian||Race/Ethnicity||participants|Number|10|10.0||||||
4348064|NCT00401973|4175974|B4|Caucasian||Race/Ethnicity||participants|Number|87|87.0||||||
4348065|NCT00401973|4175975|B3|Caucasian||Race/Ethnicity||participants|Number|34|34.0||||||
4348066|NCT00401973|4175976|B2|Caucasian||Race/Ethnicity||participants|Number|30|30.0||||||
4348067|NCT00401973|4175977|B1|Caucasian||Race/Ethnicity||participants|Number|23|23.0||||||
4348068|NCT00401973|4175974|B4|African||Race/Ethnicity||participants|Number|16|16.0||||||
4348069|NCT00401973|4175975|B3|African||Race/Ethnicity||participants|Number|4|4.0||||||
4348070|NCT00401973|4175976|B2|African||Race/Ethnicity||participants|Number|10|10.0||||||
4348071|NCT00401973|4175977|B1|African||Race/Ethnicity||participants|Number|2|2.0||||||
4348072|NCT00401973|4175974|B4|Korea, Republic of||Region of Enrollment||participants|Number|36|36.0||||||
4348073|NCT00401973|4175975|B3|Korea, Republic of||Region of Enrollment||participants|Number|13|13.0||||||
4348074|NCT00401973|4175976|B2|Korea, Republic of||Region of Enrollment||participants|Number|14|14.0||||||
4348075|NCT00401973|4175977|B1|Korea, Republic of||Region of Enrollment||participants|Number|9|9.0||||||
4348076|NCT00401973|4175974|B4|Russian Federation||Region of Enrollment||participants|Number|40|40.0||||||
4348077|NCT00401973|4175975|B3|Russian Federation||Region of Enrollment||participants|Number|14|14.0||||||
4348078|NCT00401973|4175976|B2|Russian Federation||Region of Enrollment||participants|Number|15|15.0||||||
4348079|NCT00401973|4175977|B1|Russian Federation||Region of Enrollment||participants|Number|11|11.0||||||
4348080|NCT00401973|4175974|B4|Israel||Region of Enrollment||participants|Number|22|22.0||||||
4348081|NCT00401973|4175975|B3|Israel||Region of Enrollment||participants|Number|9|9.0||||||
4348082|NCT00401973|4175976|B2|Israel||Region of Enrollment||participants|Number|8|8.0||||||
4348083|NCT00401973|4175977|B1|Israel||Region of Enrollment||participants|Number|5|5.0||||||
4348084|NCT00401973|4175974|B4|Puerto Rico||Region of Enrollment||participants|Number|18|18.0||||||
4348085|NCT00401973|4175975|B3|Puerto Rico||Region of Enrollment||participants|Number|5|5.0||||||
4348086|NCT00401973|4175976|B2|Puerto Rico||Region of Enrollment||participants|Number|8|8.0||||||
4348087|NCT00401973|4175977|B1|Puerto Rico||Region of Enrollment||participants|Number|5|5.0||||||
4348088|NCT00401973|4175974|B4|Mexico||Region of Enrollment||participants|Number|27|27.0||||||
4348089|NCT00401973|4175975|B3|Mexico||Region of Enrollment||participants|Number|11|11.0||||||
4348090|NCT00401973|4175976|B2|Mexico||Region of Enrollment||participants|Number|9|9.0||||||
4348091|NCT00401973|4175977|B1|Mexico||Region of Enrollment||participants|Number|7|7.0||||||
4348092|NCT00401973|4175974|B4|United States||Region of Enrollment||participants|Number|56|56.0||||||
4348093|NCT00401973|4175975|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4348094|NCT00401973|4175976|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4348095|NCT00401973|4175977|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4348096|NCT00401973|4175974|B4||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4348097|NCT00401973|4175975|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4348098|NCT00401973|4175976|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4348099|NCT00401973|4175977|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4348100|NCT00401973|4175974|B4||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4348101|NCT00401973|4175975|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4348102|NCT00401973|4175976|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4348103|NCT00401973|4175977|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4348104|NCT00401973|4175974|B4|||Age||years|Mean|38.5|38.5|Standard Deviation|11.95|11.95|||
4348105|NCT00401973|4175975|B3|||Age||years|Mean|38.7|38.7|Standard Deviation|12.01|12.01|||
4348106|NCT00401973|4175976|B2|||Age||years|Mean|38.2|38.2|Standard Deviation|11.40|11.4|||
4348107|NCT00401973|4175977|B1|||Age||years|Mean|38.7|38.7|Standard Deviation|12.89|12.89|||
4348108|NCT00401960|4176016|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4348109|NCT00401960|4176017|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4348110|NCT00401960|4176018|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4348111|NCT00401960|4176016|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4348112|NCT00401960|4176017|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4348113|NCT00401960|4176018|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4348114|NCT00401960|4176016|B3|||Age||years|Mean|70|70.0|Full Range|||31.0|88.0|
4348115|NCT00401960|4176017|B2|||Age||years|Mean|74|74.0|Full Range|||74.0|74.0|
4348116|NCT00401960|4176018|B1|||Age||years|Mean|69|69.0|Full Range|||31.0|88.0|
4348117|NCT00401960|4176016|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4348118|NCT00401960|4176017|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4348119|NCT00401960|4176018|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4348120|NCT00401960|4176016|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4348121|NCT00401960|4176017|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4348122|NCT00401960|4176018|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4348123|NCT00401960|4176016|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4348124|NCT00401960|4176017|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4348125|NCT00401960|4176018|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4348126|NCT00401882|4176027|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4348127|NCT00401882|4176028|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4348128|NCT00401882|4176029|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4348129|NCT00401882|4176027|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4348130|NCT00401882|4176028|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4348131|NCT00401882|4176029|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4348132|NCT00401882|4176027|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4348133|NCT00401882|4176028|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4348134|NCT00401882|4176029|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4348135|NCT00401882|4176027|B3|||Age||years|Mean|63|63.0|Standard Deviation|10.69|10.69|||
4348136|NCT00401882|4176028|B2|||Age||years|Mean|60.8|60.8|Standard Deviation|5.49|5.49|||
4348137|NCT00401882|4176029|B1|||Age||years|Mean|68.5|68.5|Standard Deviation|21.9|21.9|||
4348138|NCT00401882|4176027|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4348139|NCT00401882|4176028|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4348140|NCT00401882|4176029|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4348141|NCT00401882|4176027|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4348142|NCT00401882|4176028|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4348143|NCT00401882|4176029|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4348144|NCT00401882|4176027|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4348145|NCT00401882|4176028|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4348146|NCT00401882|4176029|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4348147|NCT00401843|4176046|B4|United States||Region of Enrollment||participants|Number|26|26.0||||||
4348148|NCT00401843|4176047|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4348149|NCT00401843|4176048|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4348150|NCT00401843|4176049|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4348151|NCT00401843|4176046|B4|United Kingdom||Region of Enrollment||participants|Number|27|27.0||||||
4348152|NCT00401843|4176047|B3|United Kingdom||Region of Enrollment||participants|Number|15|15.0||||||
4348153|NCT00401843|4176048|B2|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
4348154|NCT00401843|4176049|B1|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4348155|NCT00401843|4176046|B4|Spain||Region of Enrollment||participants|Number|17|17.0||||||
4348156|NCT00401843|4176047|B3|Spain||Region of Enrollment||participants|Number|10|10.0||||||
4348157|NCT00401843|4176048|B2|Spain||Region of Enrollment||participants|Number|5|5.0||||||
4348158|NCT00401843|4176049|B1|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4348159|NCT00401843|4176046|B4|Russian Federation||Region of Enrollment||participants|Number|48|48.0||||||
4348160|NCT00401843|4176047|B3|Russian Federation||Region of Enrollment||participants|Number|27|27.0||||||
4348161|NCT00401843|4176048|B2|Russian Federation||Region of Enrollment||participants|Number|21|21.0||||||
4348162|NCT00401843|4176049|B1|Russian Federation||Region of Enrollment||participants|Number|0|0.0||||||
4348163|NCT00401843|4176046|B4|Romania||Region of Enrollment||participants|Number|13|13.0||||||
4348164|NCT00401843|4176047|B3|Romania||Region of Enrollment||participants|Number|5|5.0||||||
4348165|NCT00401843|4176048|B2|Romania||Region of Enrollment||participants|Number|8|8.0||||||
4348166|NCT00401843|4176049|B1|Romania||Region of Enrollment||participants|Number|0|0.0||||||
4348167|NCT00401843|4176046|B4|Portugal||Region of Enrollment||participants|Number|9|9.0||||||
4348168|NCT00401843|4176047|B3|Portugal||Region of Enrollment||participants|Number|4|4.0||||||
4348169|NCT00401843|4176048|B2|Portugal||Region of Enrollment||participants|Number|5|5.0||||||
4348170|NCT00401843|4176049|B1|Portugal||Region of Enrollment||participants|Number|0|0.0||||||
4348171|NCT00401843|4176046|B4|Poland||Region of Enrollment||participants|Number|30|30.0||||||
4348172|NCT00401843|4176047|B3|Poland||Region of Enrollment||participants|Number|11|11.0||||||
4348173|NCT00401843|4176048|B2|Poland||Region of Enrollment||participants|Number|19|19.0||||||
4348174|NCT00401843|4176049|B1|Poland||Region of Enrollment||participants|Number|0|0.0||||||
4348175|NCT00401843|4176046|B4|Netherlands||Region of Enrollment||participants|Number|11|11.0||||||
4348176|NCT00401843|4176047|B3|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
4348177|NCT00401843|4176048|B2|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
4348178|NCT00401843|4176049|B1|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
4348179|NCT00401843|4176046|B4|Hungary||Region of Enrollment||participants|Number|20|20.0||||||
4348180|NCT00401843|4176047|B3|Hungary||Region of Enrollment||participants|Number|10|10.0||||||
4348181|NCT00401843|4176048|B2|Hungary||Region of Enrollment||participants|Number|10|10.0||||||
4348182|NCT00401843|4176049|B1|Hungary||Region of Enrollment||participants|Number|0|0.0||||||
4348183|NCT00401843|4176046|B4|Greece||Region of Enrollment||participants|Number|10|10.0||||||
4348184|NCT00401843|4176047|B3|Greece||Region of Enrollment||participants|Number|5|5.0||||||
4348185|NCT00401843|4176048|B2|Greece||Region of Enrollment||participants|Number|5|5.0||||||
4348186|NCT00401843|4176049|B1|Greece||Region of Enrollment||participants|Number|0|0.0||||||
4348187|NCT00401843|4176046|B4|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4348188|NCT00401843|4176047|B3|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4348189|NCT00401843|4176048|B2|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4348190|NCT00401843|4176049|B1|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4348191|NCT00401843|4176046|B4|France||Region of Enrollment||participants|Number|19|19.0||||||
4348192|NCT00401843|4176047|B3|France||Region of Enrollment||participants|Number|7|7.0||||||
4348193|NCT00401843|4176048|B2|France||Region of Enrollment||participants|Number|5|5.0||||||
4348194|NCT00401843|4176049|B1|France||Region of Enrollment||participants|Number|7|7.0||||||
4348195|NCT00401843|4176046|B4|Czech Republic||Region of Enrollment||participants|Number|24|24.0||||||
4348196|NCT00401843|4176047|B3|Czech Republic||Region of Enrollment||participants|Number|11|11.0||||||
4348197|NCT00401843|4176048|B2|Czech Republic||Region of Enrollment||participants|Number|13|13.0||||||
4348198|NCT00401843|4176049|B1|Czech Republic||Region of Enrollment||participants|Number|0|0.0||||||
4348199|NCT00401843|4176046|B4|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4348200|NCT00401843|4176047|B3|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4348201|NCT00401843|4176048|B2|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4348202|NCT00401843|4176049|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4348203|NCT00401843|4176046|B4|Bulgaria||Region of Enrollment||participants|Number|26|26.0||||||
4348204|NCT00401843|4176047|B3|Bulgaria||Region of Enrollment||participants|Number|10|10.0||||||
4348205|NCT00401843|4176048|B2|Bulgaria||Region of Enrollment||participants|Number|16|16.0||||||
4348206|NCT00401843|4176049|B1|Bulgaria||Region of Enrollment||participants|Number|0|0.0||||||
4348207|NCT00401843|4176046|B4|Brazil||Region of Enrollment||participants|Number|10|10.0||||||
4348208|NCT00401843|4176047|B3|Brazil||Region of Enrollment||participants|Number|4|4.0||||||
4348209|NCT00401843|4176048|B2|Brazil||Region of Enrollment||participants|Number|6|6.0||||||
4348210|NCT00401843|4176049|B1|Brazil||Region of Enrollment||participants|Number|0|0.0||||||
4348211|NCT00401843|4176046|B4|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
4348212|NCT00401843|4176047|B3|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4348213|NCT00401843|4176048|B2|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
4348214|NCT00401843|4176049|B1|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
4348215|NCT00401843|4176046|B4||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4348216|NCT00401843|4176047|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4348217|NCT00401843|4176048|B2||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4348218|NCT00401843|4176049|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4348219|NCT00401843|4176046|B4||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4348220|NCT00401843|4176047|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4348221|NCT00401843|4176048|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4348222|NCT00401843|4176049|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4348223|NCT00401843|4176046|B4|||Age||years|Mean|63.1|63.1|Standard Deviation|9.6|9.6|||
4348224|NCT00401843|4176047|B3|||Age||years|Mean|63.5|63.5|Standard Deviation|9.32|9.32|||
4348225|NCT00401843|4176048|B2|||Age||years|Mean|62.3|62.3|Standard Deviation|9.65|9.65|||
4348226|NCT00401843|4176049|B1|||Age||years|Mean|66|66.0|Standard Deviation|10.76|10.76|||
4348227|NCT00401830|4176067|B3|United States||Region of Enrollment||participants|Number|159|159.0||||||
4348228|NCT00401830|4176068|B2|United States||Region of Enrollment||participants|Number|78|78.0||||||
4348229|NCT00401830|4176069|B1|United States||Region of Enrollment||participants|Number|81|81.0||||||
4348230|NCT00401830|4176067|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4348231|NCT00401830|4176068|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4348232|NCT00401830|4176069|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4348233|NCT00401830|4176067|B3||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4348234|NCT00401830|4176068|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4348235|NCT00401830|4176069|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4348236|NCT00401830|4176067|B3|||Age||years|Mean|49.7|49.7|Standard Deviation|10.8|10.8|||
4348237|NCT00401830|4176068|B2|||Age||years|Mean|48.9|48.9|Standard Deviation|11.1|11.1|||
4348238|NCT00401830|4176069|B1|||Age||years|Mean|50.4|50.4|Standard Deviation|10.5|10.5|||
4348239|NCT00401830|4176067|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4348240|NCT00401830|4176068|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4348241|NCT00401830|4176069|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4348242|NCT00401830|4176067|B3||Between 18 and 65 years|Age||Participants|Count of Participants|155|155.0||||||
4348243|NCT00401830|4176068|B2||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
4348244|NCT00401830|4176069|B1||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
4348245|NCT00401830|4176067|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4348246|NCT00401830|4176068|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4348247|NCT00401830|4176069|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4348248|NCT00401817|4176102|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4348249|NCT00401817|4176102|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4348250|NCT00401817|4176102|B1|||Age||years|Median|60|60.0|Full Range|||35.0|74.0|
4348251|NCT00401778|4176109|B4|United States||Region of Enrollment||participants|Number|33|33.0||||||
4348252|NCT00401778|4176110|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4348253|NCT00401778|4176111|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4348254|NCT00401778|4176112|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4348255|NCT00401778|4176109|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4348256|NCT00401778|4176110|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4348257|NCT00401778|4176111|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4348258|NCT00401778|4176112|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4348259|NCT00401778|4176109|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4348260|NCT00401778|4176110|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4348261|NCT00401778|4176111|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4348262|NCT00401778|4176112|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4348263|NCT00401778|4176109|B4||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4348264|NCT00401778|4176110|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4348265|NCT00401778|4176111|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4348266|NCT00401778|4176112|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4348267|NCT00401778|4176109|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4348268|NCT00401778|4176110|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4348269|NCT00401778|4176111|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4348270|NCT00401778|4176112|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4348271|NCT00401778|4176109|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4348272|NCT00401778|4176110|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4348273|NCT00401778|4176111|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4348274|NCT00401778|4176112|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4348275|NCT00401778|4176109|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4348276|NCT00401778|4176110|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4348277|NCT00401778|4176111|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4348278|NCT00401778|4176112|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4348279|NCT00401778|4176109|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4348280|NCT00401778|4176110|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4348281|NCT00401778|4176111|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4348282|NCT00401778|4176112|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4348283|NCT00401778|4176109|B4||Male|Gender||Participants|Count of Participants|14|14.0||||||
4348284|NCT00401778|4176110|B3||Male|Gender||Participants|Count of Participants|4|4.0||||||
4348285|NCT00401778|4176111|B2||Male|Gender||Participants|Count of Participants|6|6.0||||||
4348286|NCT00401778|4176112|B1||Male|Gender||Participants|Count of Participants|4|4.0||||||
4348287|NCT00401778|4176109|B4||Female|Gender||Participants|Count of Participants|19|19.0||||||
4348288|NCT00401778|4176110|B3||Female|Gender||Participants|Count of Participants|7|7.0||||||
4348289|NCT00401778|4176111|B2||Female|Gender||Participants|Count of Participants|6|6.0||||||
4348290|NCT00401778|4176112|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
4348291|NCT00401778|4176109|B4|||Age||years|Median|64|64.0|Full Range|||35.0|77.0|
4348292|NCT00401778|4176110|B3|||Age||years|Median|70|70.0|Full Range|||35.0|75.0|
4348293|NCT00401778|4176111|B2|||Age||years|Median|58|58.0|Full Range|||44.0|66.0|
4348294|NCT00401778|4176112|B1|||Age||years|Median|63|63.0|Full Range|||54.0|77.0|
4348295|NCT00401752|4176126|B3||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4348296|NCT00401752|4176127|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4348297|NCT00401752|4176128|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4348298|NCT00401752|4176126|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4348299|NCT00401752|4176127|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4348300|NCT00401752|4176128|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4348301|NCT00401752|4176126|B3|||Age||year|Mean|50.3|50.3|Standard Deviation|10.6|10.6|||
4348302|NCT00401752|4176127|B2|||Age||year|Mean|50.9|50.9|Standard Deviation|10.2|10.2|||
4348303|NCT00401752|4176128|B1|||Age||year|Mean|49.7|49.7|Standard Deviation|11.01|11.01|||
4348304|NCT00401726|4176145|B3||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4348305|NCT00401726|4176146|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4348306|NCT00401726|4176147|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4348307|NCT00401726|4176145|B3||Female|Sex: Female, Male||Participants|Count of Participants|389|389.0||||||
4348308|NCT00401726|4176146|B2||Female|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4348309|NCT00401726|4176147|B1||Female|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4348310|NCT00401726|4176145|B3|||Age||years|Mean|44.69|44.69|Standard Deviation|13.71|13.71|||
4348311|NCT00401726|4176146|B2|||Age||years|Mean|45.25|45.25|Standard Deviation|13.83|13.83|||
4348312|NCT00401726|4176147|B1|||Age||years|Mean|44.13|44.13|Standard Deviation|13.59|13.59|||
4348313|NCT00401622|4176168|B3|||Fasting glucose||mg/dl|Mean|143.0|143.0|Standard Deviation|36.41|36.41|||
4348314|NCT00401622|4176169|B2|||Fasting glucose||mg/dl|Mean|144.8|144.8|Standard Deviation|39.19|39.19|||
4348315|NCT00401622|4176170|B1|||Fasting glucose||mg/dl|Mean|141.1|141.1|Standard Deviation|33.40|33.4|||
4348316|NCT00401622|4176168|B3|||Baseline A1C||Percentage|Mean|7.6|7.6|Standard Deviation|0.49|0.49|||
4348317|NCT00401622|4176169|B2|||Baseline A1C||Percentage|Mean|7.6|7.6|Standard Deviation|0.49|0.49|||
4348318|NCT00401622|4176170|B1|||Baseline A1C||Percentage|Mean|7.6|7.6|Standard Deviation|0.48|0.48|||
4348319|NCT00401622|4176168|B3|United Kingdom||Region of Enrollment||participants|Number|87|87.0||||||
4348320|NCT00401622|4176169|B2|United Kingdom||Region of Enrollment||participants|Number|48|48.0||||||
4348321|NCT00401622|4176170|B1|United Kingdom||Region of Enrollment||participants|Number|39|39.0||||||
4348322|NCT00401622|4176168|B3|Canada||Region of Enrollment||participants|Number|21|21.0||||||
4348323|NCT00401622|4176169|B2|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4348324|NCT00401622|4176170|B1|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4348325|NCT00401622|4176168|B3|United States||Region of Enrollment||participants|Number|212|212.0||||||
4348326|NCT00401622|4176169|B2|United States||Region of Enrollment||participants|Number|103|103.0||||||
4348327|NCT00401622|4176170|B1|United States||Region of Enrollment||participants|Number|109|109.0||||||
4348328|NCT00401622|4176168|B3||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4348329|NCT00401622|4176169|B2||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4348330|NCT00401622|4176170|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4348331|NCT00401622|4176168|B3||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4348332|NCT00401622|4176169|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4348333|NCT00401622|4176170|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4348334|NCT00401622|4176168|B3|||Age||years|Mean|60.8|60.8|Standard Deviation|10.74|10.74|||
4348335|NCT00401622|4176169|B2|||Age||years|Mean|61.1|61.1|Standard Deviation|10.54|10.54|||
4348336|NCT00401622|4176170|B1|||Age||years|Mean|60.5|60.5|Standard Deviation|10.97|10.97|||
4348337|NCT00401622|4176168|B3||>=65 years|Age||Participants|Count of Participants|118|118.0||||||
4348338|NCT00401622|4176169|B2||>=65 years|Age||Participants|Count of Participants|59|59.0||||||
4348339|NCT00401622|4176170|B1||>=65 years|Age||Participants|Count of Participants|59|59.0||||||
4348340|NCT00401622|4176168|B3||Between 18 and 65 years|Age||Participants|Count of Participants|202|202.0||||||
4348341|NCT00401622|4176169|B2||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
4348342|NCT00401622|4176170|B1||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
4348343|NCT00401622|4176168|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4348344|NCT00401622|4176169|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4348345|NCT00401622|4176170|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4348346|NCT00401544|4176179|B5|||Hemoglobin||g/dL|Mean|9.4|9.4|Standard Deviation|1.0|1.0|||
4348347|NCT00401544|4176180|B4|||Hemoglobin||g/dL|Mean|9.2|9.2|Standard Deviation|0.9|0.9|||
4348348|NCT00401544|4176181|B3|||Hemoglobin||g/dL|Mean|9.4|9.4|Standard Deviation|1.2|1.2|||
4348349|NCT00401544|4176182|B2|||Hemoglobin||g/dL|Mean|9.4|9.4|Standard Deviation|0.9|0.9|||
4348350|NCT00401544|4176183|B1|||Hemoglobin||g/dL|Mean|9.4|9.4|Standard Deviation|1.1|1.1|||
4348351|NCT00401544|4176179|B5|||FACT-Fatigue Score|Functional Assessment of Cancer Therapy (FACT) - Fatigue subscale score, ranging from 0 to 52, where 0 = worst outcome and higher scores represent less fatigue.|Units on a scale|Mean|29.44|29.44|Standard Deviation|12.08|12.08|||
4348352|NCT00401544|4176180|B4|||FACT-Fatigue Score|Functional Assessment of Cancer Therapy (FACT) - Fatigue subscale score, ranging from 0 to 52, where 0 = worst outcome and higher scores represent less fatigue.|Units on a scale|Mean|30.25|30.25|Standard Deviation|11.79|11.79|||
4348353|NCT00401544|4176181|B3|||FACT-Fatigue Score|Functional Assessment of Cancer Therapy (FACT) - Fatigue subscale score, ranging from 0 to 52, where 0 = worst outcome and higher scores represent less fatigue.|Units on a scale|Mean|28.60|28.6|Standard Deviation|11.95|11.95|||
4348354|NCT00401544|4176182|B2|||FACT-Fatigue Score|Functional Assessment of Cancer Therapy (FACT) - Fatigue subscale score, ranging from 0 to 52, where 0 = worst outcome and higher scores represent less fatigue.|Units on a scale|Mean|30.24|30.24|Standard Deviation|12.46|12.46|||
4348355|NCT00401544|4176183|B1|||FACT-Fatigue Score|Functional Assessment of Cancer Therapy (FACT) - Fatigue subscale score, ranging from 0 to 52, where 0 = worst outcome and higher scores represent less fatigue.|Units on a scale|Mean|28.54|28.54|Standard Deviation|12.32|12.32|||
4348356|NCT00401544|4176179|B5|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|189|189.0||||||
4348357|NCT00401544|4176180|B4|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|46|46.0||||||
4348358|NCT00401544|4176181|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|50|50.0||||||
4348359|NCT00401544|4176182|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|48|48.0||||||
4348360|NCT00401544|4176183|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|45|45.0||||||
4348361|NCT00401544|4176179|B5|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4348362|NCT00401544|4176180|B4|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4348363|NCT00401544|4176181|B3|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4348364|NCT00401544|4176182|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4348365|NCT00401544|4176183|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4348366|NCT00401544|4176179|B5|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4348367|NCT00401544|4176180|B4|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4348368|NCT00401544|4176181|B3|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4348369|NCT00401544|4176182|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4348370|NCT00401544|4176183|B1|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4348371|NCT00401544|4176179|B5|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4348372|NCT00401544|4176180|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4348373|NCT00401544|4176181|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4348374|NCT00401544|4176182|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4348375|NCT00401544|4176183|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4348376|NCT00401544|4176179|B5|Black or African American||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
4348377|NCT00401544|4176180|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4348378|NCT00401544|4176181|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4348379|NCT00401544|4176182|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4348380|NCT00401544|4176183|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4348381|NCT00401544|4176179|B5||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4348382|NCT00401544|4176180|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4348383|NCT00401544|4176181|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4348384|NCT00401544|4176182|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4348385|NCT00401544|4176183|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4348386|NCT00401544|4176179|B5||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4348387|NCT00401544|4176180|B4||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4348388|NCT00401544|4176181|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4348389|NCT00401544|4176182|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4348390|NCT00401544|4176183|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4348391|NCT00401544|4176179|B5|||Age||Years|Mean|63.1|63.1|Standard Deviation|13.1|13.1|||
4348392|NCT00401544|4176180|B4|||Age||Years|Mean|62.3|62.3|Standard Deviation|13.3|13.3|||
4348393|NCT00401544|4176181|B3|||Age||Years|Mean|66.7|66.7|Standard Deviation|12.0|12.0|||
4348394|NCT00401544|4176182|B2|||Age||Years|Mean|62.1|62.1|Standard Deviation|14.1|14.1|||
4348395|NCT00401544|4176183|B1|||Age||Years|Mean|61.2|61.2|Standard Deviation|12.5|12.5|||
4348396|NCT00401531|4176224|B3|Thailand||Region of Enrollment||Participants|Number|412|412.0||||||
4348397|NCT00401531|4176225|B2|Thailand||Region of Enrollment||Participants|Number|206|206.0||||||
4348398|NCT00401531|4176226|B1|Thailand||Region of Enrollment||Participants|Number|206|206.0||||||
4348399|NCT00401531|4176224|B3||Male|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4348400|NCT00401531|4176225|B2||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4348401|NCT00401531|4176226|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4348402|NCT00401531|4176224|B3||Female|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4348403|NCT00401531|4176225|B2||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4348404|NCT00401531|4176226|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4348405|NCT00401531|4176224|B3|Age Continuous||Age||Months|Mean|1.89|1.89|Standard Deviation|0.179|0.179|||
4348406|NCT00401531|4176225|B2|Age Continuous||Age||Months|Mean|1.90|1.9|Standard Deviation|0.187|0.187|||
4348407|NCT00401531|4176226|B1|Age Continuous||Age||Months|Mean|1.88|1.88|Standard Deviation|0.170|0.17|||
4348408|NCT00401531|4176224|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4348409|NCT00401531|4176225|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4348410|NCT00401531|4176226|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4348411|NCT00401531|4176224|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4348412|NCT00401531|4176225|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4348413|NCT00401531|4176226|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4348414|NCT00401531|4176224|B3||<=18 years|Age||Participants|Count of Participants|412|412.0||||||
4348415|NCT00401531|4176225|B2||<=18 years|Age||Participants|Count of Participants|206|206.0||||||
4348416|NCT00401531|4176226|B1||<=18 years|Age||Participants|Count of Participants|206|206.0||||||
4348417|NCT00401414|4176243|B4|United States||Region of Enrollment||participants|Number|344|344.0||||||
4348418|NCT00401414|4176244|B3|United States||Region of Enrollment||participants|Number|79|79.0||||||
4348419|NCT00401414|4176245|B2|United States||Region of Enrollment||participants|Number|147|147.0||||||
4348420|NCT00401414|4176246|B1|United States||Region of Enrollment||participants|Number|118|118.0||||||
4348421|NCT00401414|4176243|B4||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4348422|NCT00401414|4176244|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4348423|NCT00401414|4176245|B2||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4348424|NCT00401414|4176246|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4348425|NCT00401414|4176243|B4||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4348426|NCT00401414|4176244|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4348427|NCT00401414|4176245|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4348428|NCT00401414|4176246|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4348429|NCT00401414|4176243|B4|||Age||years|Mean|60.1|60.1|Standard Deviation|16.7|16.7|||
4348430|NCT00401414|4176244|B3|||Age||years|Mean|57.2|57.2|Standard Deviation|15.6|15.6|||
4348431|NCT00401414|4176245|B2|||Age||years|Mean|57.9|57.9|Standard Deviation|16.5|16.5|||
4348432|NCT00401414|4176246|B1|||Age||years|Mean|64.7|64.7|Standard Deviation|16.6|16.6|||
4348433|NCT00401414|4176243|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4348434|NCT00401414|4176244|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4348435|NCT00401414|4176245|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4348436|NCT00401414|4176246|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4348437|NCT00401414|4176243|B4||Between 18 and 65 years|Age||Participants|Count of Participants|344|344.0||||||
4348438|NCT00401414|4176244|B3||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
4348439|NCT00401414|4176245|B2||Between 18 and 65 years|Age||Participants|Count of Participants|147|147.0||||||
4348440|NCT00401414|4176246|B1||Between 18 and 65 years|Age||Participants|Count of Participants|118|118.0||||||
4348441|NCT00401414|4176243|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4348442|NCT00401414|4176244|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4348443|NCT00401414|4176245|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4348444|NCT00401414|4176246|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4348445|NCT00401401|4176268|B5|Sweden||Region of Enrollment||participants|Number|8|8.0||||||
4348446|NCT00401401|4176269|B4|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
4348447|NCT00401401|4176270|B3|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
4348448|NCT00401401|4176271|B2|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
4348449|NCT00401401|4176272|B1|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
4348450|NCT00401401|4176268|B5|Belgium||Region of Enrollment||participants|Number|17|17.0||||||
4348451|NCT00401401|4176269|B4|Belgium||Region of Enrollment||participants|Number|6|6.0||||||
4348452|NCT00401401|4176270|B3|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
4348453|NCT00401401|4176271|B2|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
4348454|NCT00401401|4176272|B1|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
4348455|NCT00401401|4176268|B5|United States||Region of Enrollment||participants|Number|1|1.0||||||
4348456|NCT00401401|4176269|B4|United States||Region of Enrollment||participants|Number|1|1.0||||||
4348457|NCT00401401|4176270|B3|United States||Region of Enrollment||participants|Number|0|0.0||||||
4348458|NCT00401401|4176271|B2|United States||Region of Enrollment||participants|Number|0|0.0||||||
4348459|NCT00401401|4176272|B1|United States||Region of Enrollment||participants|Number|0|0.0||||||
4348460|NCT00401401|4176268|B5|France||Region of Enrollment||participants|Number|4|4.0||||||
4348461|NCT00401401|4176269|B4|France||Region of Enrollment||participants|Number|3|3.0||||||
4348462|NCT00401401|4176270|B3|France||Region of Enrollment||participants|Number|1|1.0||||||
4348463|NCT00401401|4176271|B2|France||Region of Enrollment||participants|Number|0|0.0||||||
4348464|NCT00401401|4176272|B1|France||Region of Enrollment||participants|Number|0|0.0||||||
4348465|NCT00401401|4176268|B5||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4348466|NCT00401401|4176269|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4348467|NCT00401401|4176270|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4348468|NCT00401401|4176271|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4348469|NCT00401401|4176272|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4348470|NCT00401401|4176268|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4348471|NCT00401401|4176269|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4348472|NCT00401401|4176270|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4348473|NCT00401401|4176271|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4348474|NCT00401401|4176272|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4348475|NCT00401401|4176268|B5|||Age||years|Median|52|52.0|Full Range|||22.0|64.0|
4348476|NCT00401401|4176269|B4|||Age||years|Median|52|52.0|Full Range|||46.0|62.0|
4348477|NCT00401401|4176270|B3|||Age||years|Median|49|49.0|Full Range|||22.0|60.0|
4348478|NCT00401401|4176271|B2|||Age||years|Median|54|54.0|Full Range|||49.0|63.0|
4348479|NCT00401401|4176272|B1|||Age||years|Median|58|58.0|Full Range|||46.0|64.0|
4348480|NCT00401401|4176268|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4348481|NCT00401401|4176269|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4348482|NCT00401401|4176270|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4348483|NCT00401401|4176271|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4348484|NCT00401401|4176272|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4348485|NCT00401401|4176268|B5||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4348486|NCT00401401|4176269|B4||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4348487|NCT00401401|4176270|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4348488|NCT00401401|4176271|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4348489|NCT00401401|4176272|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4348490|NCT00401401|4176268|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4348491|NCT00401401|4176269|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4348492|NCT00401401|4176270|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4348493|NCT00401401|4176271|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4348494|NCT00401401|4176272|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4348495|NCT00401258|4176297|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4348496|NCT00401258|4176297|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4348497|NCT00401258|4176297|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4348498|NCT00401258|4176297|B1|||Age||years|Mean|44.5|44.5|Standard Deviation|13.1|13.1|||
4348499|NCT00401258|4176297|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4348500|NCT00401258|4176297|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4348501|NCT00401258|4176297|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4348502|NCT00401245|4176308|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4348503|NCT00401245|4176309|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4348504|NCT00401245|4176310|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4348505|NCT00401245|4176311|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4348506|NCT00401245|4176312|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4348507|NCT00401245|4176308|B5||Female|Sex: Female, Male||Participants|Count of Participants|493|493.0||||||
4348508|NCT00401245|4176309|B4||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4348509|NCT00401245|4176310|B3||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4348510|NCT00401245|4176311|B2||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4348511|NCT00401245|4176312|B1||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4348512|NCT00401245|4176308|B5|||Age||Years|Mean|54.10|54.1|Standard Deviation|5.47|5.47|||
4348513|NCT00401245|4176309|B4|||Age||Years|Mean|53.48|53.48|Standard Deviation|5.27|5.27|||
4348514|NCT00401245|4176310|B3|||Age||Years|Mean|53.98|53.98|Standard Deviation|5.16|5.16|||
4348515|NCT00401245|4176311|B2|||Age||Years|Mean|54.40|54.4|Standard Deviation|6.37|6.37|||
4348516|NCT00401245|4176312|B1|||Age||Years|Mean|54.52|54.52|Standard Deviation|5.01|5.01|||
4348517|NCT00401193|4176384|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4348518|NCT00401193|4176385|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4348519|NCT00401193|4176386|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4348520|NCT00401193|4176387|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4348521|NCT00401193|4176384|B4||Female|Sex: Female, Male||Participants|Count of Participants|297|297.0||||||
4348522|NCT00401193|4176385|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4348523|NCT00401193|4176386|B2||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4348524|NCT00401193|4176387|B1||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4348525|NCT00401193|4176384|B4|||Age|Intent to Treat Population|years|Mean|39|39.0|Standard Deviation|6|6.0|||
4348526|NCT00401193|4176385|B3|||Age|Intent to Treat Population|years|Mean|39|39.0|Standard Deviation|6|6.0|||
4348527|NCT00401193|4176386|B2|||Age|Intent to Treat Population|years|Mean|40|40.0|Standard Deviation|6|6.0|||
4348528|NCT00401193|4176387|B1|||Age|Intent to Treat Population|years|Mean|39|39.0|Standard Deviation|6|6.0|||
4348529|NCT00401102|4176403|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4348530|NCT00401102|4176403|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4348531|NCT00401102|4176403|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4348532|NCT00401102|4176403|B1|||Age||years|Mean|14.5|14.5|Standard Deviation|1.3|1.3|||
4348533|NCT00401102|4176403|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4348534|NCT00401102|4176403|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4348535|NCT00401102|4176403|B1||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4348536|NCT00400985|4176407|B1|ICD||Device therapy||units|Number|108|108.0||||||
4348537|NCT00400985|4176407|B1|CRT-D||Device therapy||units|Number|393|393.0||||||
4348538|NCT00400985|4176407|B1|China||Region of Enrollment||participants|Number|6|6.0||||||
4348539|NCT00400985|4176407|B1|Poland||Region of Enrollment||participants|Number|18|18.0||||||
4348540|NCT00400985|4176407|B1|Czech Republic||Region of Enrollment||participants|Number|19|19.0||||||
4348541|NCT00400985|4176407|B1|Denmark||Region of Enrollment||participants|Number|21|21.0||||||
4348542|NCT00400985|4176407|B1|Slovakia||Region of Enrollment||participants|Number|22|22.0||||||
4348543|NCT00400985|4176407|B1|Spain||Region of Enrollment||participants|Number|23|23.0||||||
4348544|NCT00400985|4176407|B1|Israel||Region of Enrollment||participants|Number|29|29.0||||||
4348545|NCT00400985|4176407|B1|Greece||Region of Enrollment||participants|Number|38|38.0||||||
4348546|NCT00400985|4176407|B1|France||Region of Enrollment||participants|Number|58|58.0||||||
4348547|NCT00400985|4176407|B1|Italy||Region of Enrollment||participants|Number|115|115.0||||||
4348548|NCT00400985|4176407|B1|Germany||Region of Enrollment||participants|Number|70|70.0||||||
4348549|NCT00400985|4176407|B1|United Kingdom||Region of Enrollment||participants|Number|38|38.0||||||
4348550|NCT00400985|4176407|B1|Belgium||Region of Enrollment||participants|Number|44|44.0||||||
4348551|NCT00400985|4176407|B1||Male|Sex: Female, Male||Participants|Count of Participants|422|422.0||||||
4348552|NCT00400985|4176407|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4348553|NCT00400985|4176407|B1|||Age||years|Mean|65|65.0|Standard Deviation|10|10.0|||
4348554|NCT00400985|4176407|B1|||Cronic Heart Failure (CHF) patients with a Cardiac Resynchronization Therapy device system|Patients with New York Heart Association (NYHA) functional class II-III and severely reduced left ventricular ejection fraction and at least one Heart Failure (HF)-related hospitalisation that required an increase of medication (inotropes, nitrates, diuretics) within the last 12 months were eligible for inclusion. Subject enrolment occurred after successful device implantation (implantable cardioverter-defibrillator (ICD), or a combination of implantable cardiac resynchronization with ICD (CRT-D) and before 34 days post-implant (at time when OptiVol Fluid Trend Data become available).|participants|Number|501|501.0||||||
4348555|NCT00400946|4176411|B6|>/= 10 years old||Age Classification||Participants|Count of Participants|202|202.0||||||
4348556|NCT00400946|4176412|B5|>/= 10 years old||Age Classification||Participants|Count of Participants|48|48.0||||||
4348557|NCT00400946|4176413|B4|>/= 10 years old||Age Classification||Participants|Count of Participants|25|25.0||||||
4348558|NCT00400946|4176414|B3|>/= 10 years old||Age Classification||Participants|Count of Participants|7|7.0||||||
4348559|NCT00400946|4176415|B2|>/= 10 years old||Age Classification||Participants|Count of Participants|67|67.0||||||
4348560|NCT00400946|4176416|B1|>/= 10 years old||Age Classification||Participants|Count of Participants|55|55.0||||||
4348561|NCT00400946|4176411|B6|< 10 years old||Age Classification||Participants|Count of Participants|598|598.0||||||
4348562|NCT00400946|4176412|B5|< 10 years old||Age Classification||Participants|Count of Participants|196|196.0||||||
4348563|NCT00400946|4176413|B4|< 10 years old||Age Classification||Participants|Count of Participants|26|26.0||||||
4348564|NCT00400946|4176414|B3|< 10 years old||Age Classification||Participants|Count of Participants|35|35.0||||||
4348565|NCT00400946|4176415|B2|< 10 years old||Age Classification||Participants|Count of Participants|165|165.0||||||
4348566|NCT00400946|4176416|B1|< 10 years old||Age Classification||Participants|Count of Participants|176|176.0||||||
4348567|NCT00400946|4176411|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4348568|NCT00400946|4176412|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4348569|NCT00400946|4176413|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4348570|NCT00400946|4176414|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4348571|NCT00400946|4176415|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4348572|NCT00400946|4176416|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4348573|NCT00400946|4176411|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|584|584.0||||||
4348574|NCT00400946|4176412|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|180|180.0||||||
4348575|NCT00400946|4176413|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4348576|NCT00400946|4176414|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4348577|NCT00400946|4176415|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|170|170.0||||||
4348578|NCT00400946|4176416|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|165|165.0||||||
4348579|NCT00400946|4176411|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|152|152.0||||||
4348580|NCT00400946|4176412|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4348581|NCT00400946|4176413|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4348582|NCT00400946|4176414|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4348583|NCT00400946|4176415|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4348584|NCT00400946|4176416|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4348585|NCT00400946|4176411|B6||Male|Sex: Female, Male||Participants|Count of Participants|443|443.0||||||
4348586|NCT00400946|4176412|B5||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4348587|NCT00400946|4176413|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4348588|NCT00400946|4176414|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4348589|NCT00400946|4176415|B2||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4348590|NCT00400946|4176416|B1||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4348591|NCT00400946|4176411|B6||Female|Sex: Female, Male||Participants|Count of Participants|357|357.0||||||
4348592|NCT00400946|4176412|B5||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4348593|NCT00400946|4176413|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4348594|NCT00400946|4176414|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4348595|NCT00400946|4176415|B2||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4348596|NCT00400946|4176416|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4348597|NCT00400946|4176411|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4348598|NCT00400946|4176412|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4348599|NCT00400946|4176413|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4348600|NCT00400946|4176414|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4348601|NCT00400946|4176415|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4348602|NCT00400946|4176416|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4348603|NCT00400946|4176411|B6||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4348604|NCT00400946|4176412|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4348605|NCT00400946|4176413|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4348606|NCT00400946|4176414|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4348607|NCT00400946|4176415|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4348608|NCT00400946|4176416|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4348609|NCT00400946|4176411|B6||<=18 years|Age||Participants|Count of Participants|800|800.0||||||
4348610|NCT00400946|4176412|B5||<=18 years|Age||Participants|Count of Participants|244|244.0||||||
4348611|NCT00400946|4176413|B4||<=18 years|Age||Participants|Count of Participants|51|51.0||||||
4348612|NCT00400946|4176414|B3||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
4348613|NCT00400946|4176415|B2||<=18 years|Age||Participants|Count of Participants|232|232.0||||||
4348614|NCT00400946|4176416|B1||<=18 years|Age||Participants|Count of Participants|231|231.0||||||
4348615|NCT00400881|4176446|B3|United States||Region of Enrollment||participants|Number|122|122.0||||||
4348616|NCT00400881|4176447|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
4348617|NCT00400881|4176448|B1|United States||Region of Enrollment||participants|Number|62|62.0||||||
4348618|NCT00400881|4176446|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4348619|NCT00400881|4176447|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4348620|NCT00400881|4176448|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4348621|NCT00400881|4176446|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4348622|NCT00400881|4176447|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4348623|NCT00400881|4176448|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4348624|NCT00400881|4176446|B3|||Age||years|Mean|51|51.0|Standard Deviation|20|20.0|||
4348625|NCT00400881|4176447|B2|||Age||years|Mean|52|52.0|Standard Deviation|20|20.0|||
4348626|NCT00400881|4176448|B1|||Age||years|Mean|51|51.0|Standard Deviation|19|19.0|||
4348627|NCT00400881|4176446|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4348628|NCT00400881|4176447|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4348629|NCT00400881|4176448|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4348630|NCT00400881|4176446|B3||Between 18 and 65 years|Age||Participants|Count of Participants|105|105.0||||||
4348631|NCT00400881|4176447|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4348632|NCT00400881|4176448|B1||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4348633|NCT00400881|4176446|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4348634|NCT00400881|4176447|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4348635|NCT00400881|4176448|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4348636|NCT00400829|4176457|B1|United States||Region of Enrollment||participants|Number|66|66.0||||||
4348637|NCT00400829|4176457|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4348638|NCT00400829|4176457|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4348639|NCT00400829|4176457|B1|||Age||years|Median|63|63.0|Full Range|||35.0|83.0|
4348640|NCT00400803|4176463|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4348641|NCT00400803|4176463|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4348642|NCT00400803|4176463|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4348643|NCT00400803|4176463|B1|||Age||years|Median|65|65.0|Full Range|||39.0|76.0|
4348644|NCT00400803|4176463|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4348645|NCT00400803|4176463|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4348646|NCT00400803|4176463|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4348647|NCT00400764|4176474|B6||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4348648|NCT00400764|4176475|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4348649|NCT00400764|4176476|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4348650|NCT00400764|4176477|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4348651|NCT00400764|4176478|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4348652|NCT00400764|4176479|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4348653|NCT00400764|4176474|B6||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4348654|NCT00400764|4176475|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4348655|NCT00400764|4176476|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4348656|NCT00400764|4176477|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4348657|NCT00400764|4176478|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4348658|NCT00400764|4176479|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4348659|NCT00400764|4176474|B6|||Age, Customized|Age demographic data for the Phase II population.|years|Mean|58.8|58.8|Standard Deviation|10.0|10.0|||
4348660|NCT00400764|4176475|B5|||Age, Customized|Age demographic data for the Phase II population.|years|Mean|61.4|61.4|Standard Deviation|13.3|13.3|||
4348661|NCT00400764|4176476|B4|||Age, Customized|Age demographic data for the Phase II population.|years|Mean|58.4|58.4|Standard Deviation|9.8|9.8|||
4348662|NCT00400764|4176477|B3|||Age, Customized|Age demographic data for the Phase II population.|years|Mean|58.0|58.0|Standard Deviation|8.5|8.5|||
4348663|NCT00400764|4176478|B2|||Age, Customized|Age demographic data for the Phase II population.|years|Mean|NA||Standard Deviation|NA||||Age demographic data for the Phase II population.
4348664|NCT00400764|4176479|B1|||Age, Customized|Age demographic data for the Phase II population.|years|Mean|NA||Standard Deviation|NA||||Age demographic data for the Phase II population.
4348665|NCT00400764|4176474|B6|||Age|Age demographic data for the Phase Ib population.|years|Mean|60.0|60.0|Standard Deviation|12.9|12.9|||
4348666|NCT00400764|4176475|B5|||Age|Age demographic data for the Phase Ib population.|years|Mean|NA||Standard Deviation|NA||||Age demographic data for the Phase Ib population.
4348667|NCT00400764|4176476|B4|||Age|Age demographic data for the Phase Ib population.|years|Mean|NA||Standard Deviation|NA||||Age demographic data for the Phase Ib population.
4348668|NCT00400764|4176477|B3|||Age|Age demographic data for the Phase Ib population.|years|Mean|NA||Standard Deviation|NA||||Age demographic data for the Phase Ib population.
4348669|NCT00400764|4176478|B2|||Age|Age demographic data for the Phase Ib population.|years|Mean|63.7|63.7|Standard Deviation|9.0|9.0|||
4348670|NCT00400764|4176479|B1|||Age|Age demographic data for the Phase Ib population.|years|Mean|56.3|56.3|Standard Deviation|15.9|15.9|||
4348671|NCT00400712|4176534|B3|right hemiparesis||paretic side||participants|Number|37|37.0||||||
4348672|NCT00400712|4176535|B2|right hemiparesis||paretic side||participants|Number|22|22.0||||||
4348673|NCT00400712|4176536|B1|right hemiparesis||paretic side||participants|Number|15|15.0||||||
4348674|NCT00400712|4176534|B3|left hemiparesis||paretic side||participants|Number|66|66.0||||||
4348675|NCT00400712|4176535|B2|left hemiparesis||paretic side||participants|Number|29|29.0||||||
4348676|NCT00400712|4176536|B1|left hemiparesis||paretic side||participants|Number|37|37.0||||||
4348677|NCT00400712|4176534|B3|||mental status (MMSE)|The Mini-Mental State Exam (MMSE) is a screening tool for cognitive impairment. It is an 11 item questionnaire that tests five areas of cognitive function including orientation, attention and recall. A maximum score is 30 (total number of correct responses, 1 to 5 per question). A score of 23 or lower indicates cognitive impairment.|points|Mean|28|28.0|Standard Deviation|0|0.0|||
4348678|NCT00400712|4176535|B2|||mental status (MMSE)|The Mini-Mental State Exam (MMSE) is a screening tool for cognitive impairment. It is an 11 item questionnaire that tests five areas of cognitive function including orientation, attention and recall. A maximum score is 30 (total number of correct responses, 1 to 5 per question). A score of 23 or lower indicates cognitive impairment.|points|Mean|28|28.0|Standard Deviation|0|0.0|||
4348679|NCT00400712|4176536|B1|||mental status (MMSE)|The Mini-Mental State Exam (MMSE) is a screening tool for cognitive impairment. It is an 11 item questionnaire that tests five areas of cognitive function including orientation, attention and recall. A maximum score is 30 (total number of correct responses, 1 to 5 per question). A score of 23 or lower indicates cognitive impairment.|points|Mean|28|28.0|Standard Deviation|0|0.0|||
4348680|NCT00400712|4176534|B3|other||living setting pre-stroke||participants|Number|2|2.0||||||
4348681|NCT00400712|4176535|B2|other||living setting pre-stroke||participants|Number|1|1.0||||||
4348682|NCT00400712|4176536|B1|other||living setting pre-stroke||participants|Number|1|1.0||||||
4348683|NCT00400712|4176534|B3|private home||living setting pre-stroke||participants|Number|101|101.0||||||
4348684|NCT00400712|4176535|B2|private home||living setting pre-stroke||participants|Number|50|50.0||||||
4348685|NCT00400712|4176536|B1|private home||living setting pre-stroke||participants|Number|51|51.0||||||
4348686|NCT00400712|4176534|B3|||Balance ability|The Berg Balance Scale (BBS) is composed of 14 items that require the individual to perform specific balance tasks ranging from basic (e.g. sit-to-stand, unsupported standing) to more difficult (e.g. standing on one leg). Each item is scored on an ordinal scale from 0 (unable to perform) to 4 (able to complete independently and/or safely). The total score ranges from 0 (lowest) to 56 (highest).|units on a scale|Mean|46.6|46.6|Standard Deviation|12.8|12.8|||
4348687|NCT00400712|4176535|B2|||Balance ability|The Berg Balance Scale (BBS) is composed of 14 items that require the individual to perform specific balance tasks ranging from basic (e.g. sit-to-stand, unsupported standing) to more difficult (e.g. standing on one leg). Each item is scored on an ordinal scale from 0 (unable to perform) to 4 (able to complete independently and/or safely). The total score ranges from 0 (lowest) to 56 (highest).|units on a scale|Mean|47.8|47.8|Standard Deviation|11.9|11.9|||
4348688|NCT00400712|4176536|B1|||Balance ability|The Berg Balance Scale (BBS) is composed of 14 items that require the individual to perform specific balance tasks ranging from basic (e.g. sit-to-stand, unsupported standing) to more difficult (e.g. standing on one leg). Each item is scored on an ordinal scale from 0 (unable to perform) to 4 (able to complete independently and/or safely). The total score ranges from 0 (lowest) to 56 (highest).|units on a scale|Mean|45.4|45.4|Standard Deviation|13.5|13.5|||
4348689|NCT00400712|4176534|B3|||Admission Functional Independence|The Functional Independence Measure (FIM) is an instrument that provides an indication of an individual's level of disability and their ability to perform activities of daily living (ADL). Eighteen (18) ADL-related motor and cognitive items are each rated on an ordinal scale ranging from complete dependence (1) to complete independence (7). The total FIM score ranges from 18 (lowest) to 126 (highest, complete independence).|units on a scale|Mean|98.4|98.4|Standard Deviation|22.7|22.7|||
4348690|NCT00400712|4176535|B2|||Admission Functional Independence|The Functional Independence Measure (FIM) is an instrument that provides an indication of an individual's level of disability and their ability to perform activities of daily living (ADL). Eighteen (18) ADL-related motor and cognitive items are each rated on an ordinal scale ranging from complete dependence (1) to complete independence (7). The total FIM score ranges from 18 (lowest) to 126 (highest, complete independence).|units on a scale|Mean|100.5|100.5|Standard Deviation|22.1|22.1|||
4348744|NCT00400205|4176611|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4348745|NCT00400205|4176611|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4348746|NCT00400205|4176611|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4348691|NCT00400712|4176536|B1|||Admission Functional Independence|The Functional Independence Measure (FIM) is an instrument that provides an indication of an individual's level of disability and their ability to perform activities of daily living (ADL). Eighteen (18) ADL-related motor and cognitive items are each rated on an ordinal scale ranging from complete dependence (1) to complete independence (7). The total FIM score ranges from 18 (lowest) to 126 (highest, complete independence).|units on a scale|Mean|96.2|96.2|Standard Deviation|23.4|23.4|||
4348692|NCT00400712|4176534|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4348693|NCT00400712|4176535|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4348694|NCT00400712|4176536|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4348695|NCT00400712|4176534|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4348696|NCT00400712|4176535|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4348697|NCT00400712|4176536|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4348698|NCT00400712|4176534|B3|||Age||years|Mean|62.3|62.3|Standard Deviation|1.8|1.8|||
4348699|NCT00400712|4176535|B2|||Age||years|Mean|62.7|62.7|Standard Deviation|1.7|1.7|||
4348700|NCT00400712|4176536|B1|||Age||years|Mean|62.1|62.1|Standard Deviation|1.8|1.8|||
4348701|NCT00400686|4176555|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4348702|NCT00400686|4176555|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4348703|NCT00400686|4176555|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4348704|NCT00400686|4176555|B1|||Age||years|Median|61.9|61.9|Full Range|||41.0|80.0|
4348705|NCT00400634|4176561|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
4348706|NCT00400634|4176562|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4348707|NCT00400634|4176563|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4348708|NCT00400634|4176561|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4348709|NCT00400634|4176562|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4348710|NCT00400634|4176563|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4348711|NCT00400634|4176561|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4348712|NCT00400634|4176562|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4348713|NCT00400634|4176563|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4348714|NCT00400634|4176561|B3|||Age||years|Mean|59.1|59.1|Standard Deviation|8.0|8.0|||
4348715|NCT00400634|4176562|B2|||Age||years|Mean|57.3|57.3|Standard Deviation|8.3|8.3|||
4348716|NCT00400634|4176563|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|7.56|7.56|||
4348717|NCT00400569|4176572|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4348718|NCT00400569|4176572|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4348719|NCT00400569|4176572|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4348720|NCT00400569|4176572|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4348721|NCT00400569|4176572|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4348722|NCT00400569|4176572|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4348723|NCT00400517|4176583|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4348724|NCT00400517|4176583|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4348725|NCT00400517|4176583|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4348726|NCT00400517|4176583|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4348727|NCT00400517|4176583|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4348728|NCT00400517|4176583|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4348729|NCT00400517|4176583|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4348730|NCT00400517|4176583|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4348731|NCT00400517|4176583|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4348732|NCT00400517|4176583|B1|||Age||years|Median|59|59.0|Inter-Quartile Range|||44.0|73.0|
4348733|NCT00400400|4176590|B3||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4348734|NCT00400400|4176591|B2||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4348735|NCT00400400|4176592|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4348736|NCT00400400|4176590|B3||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4348737|NCT00400400|4176591|B2||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4348738|NCT00400400|4176592|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4348739|NCT00400400|4176590|B3|||Age|Baseline Measures are based on the Intent-to-Treat (ITT) population that consisted of all randomized participants who received study drug.|Years|Mean|48.4|48.4|Standard Deviation|13.0|13.0|||
4348740|NCT00400400|4176591|B2|||Age|Baseline Measures are based on the Intent-to-Treat (ITT) population that consisted of all randomized participants who received study drug.|Years|Mean|48.4|48.4|Standard Deviation|12.6|12.6|||
4348741|NCT00400400|4176592|B1|||Age|Baseline Measures are based on the Intent-to-Treat (ITT) population that consisted of all randomized participants who received study drug.|Years|Mean|48.4|48.4|Standard Deviation|13.4|13.4|||
4348742|NCT00400205|4176611|B1|||Tumor Stage IV|Cancer stage was assessed with the tumor, node and metastasis (TNM) staging system. The TNM Classification of Malignant Tumors is a commonly used system of assessing cancer severity. Stage IV refers to cancer that has spread to distant body parts and is the most severe stage.|Participants|Number|14|14.0||||||
4348743|NCT00400205|4176611|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4348747|NCT00400205|4176611|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4348748|NCT00400205|4176611|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4348749|NCT00400179|4176616|B3|No disease present||Disease Measurability||Participants|Number|1|1.0||||||
4348750|NCT00400179|4176617|B2|No disease present||Disease Measurability||Participants|Number|0|0.0||||||
4348751|NCT00400179|4176618|B1|No disease present||Disease Measurability||Participants|Number|1|1.0||||||
4348752|NCT00400179|4176616|B3|Nonevaluable disease||Disease Measurability||Participants|Number|1|1.0||||||
4348753|NCT00400179|4176617|B2|Nonevaluable disease||Disease Measurability||Participants|Number|1|1.0||||||
4348754|NCT00400179|4176618|B1|Nonevaluable disease||Disease Measurability||Participants|Number|0|0.0||||||
4348755|NCT00400179|4176616|B3|Non-measurable disease||Disease Measurability||Participants|Number|43|43.0||||||
4348756|NCT00400179|4176617|B2|Non-measurable disease||Disease Measurability||Participants|Number|22|22.0||||||
4348757|NCT00400179|4176618|B1|Non-measurable disease||Disease Measurability||Participants|Number|21|21.0||||||
4348758|NCT00400179|4176616|B3|Measureable disease||Disease Measurability||Participants|Number|984|984.0||||||
4348759|NCT00400179|4176617|B2|Measureable disease||Disease Measurability||Participants|Number|485|485.0||||||
4348760|NCT00400179|4176618|B1|Measureable disease||Disease Measurability||Participants|Number|499|499.0||||||
4348761|NCT00400179|4176616|B3|Not assessed||Extent of Disease||Participants|Number|1|1.0||||||
4348762|NCT00400179|4176617|B2|Not assessed||Extent of Disease||Participants|Number|0|0.0||||||
4348763|NCT00400179|4176618|B1|Not assessed||Extent of Disease||Participants|Number|1|1.0||||||
4348764|NCT00400179|4176616|B3|>/=2 metastatic sites||Extent of Disease||Participants|Number|667|667.0||||||
4348765|NCT00400179|4176617|B2|>/=2 metastatic sites||Extent of Disease||Participants|Number|327|327.0||||||
4348766|NCT00400179|4176618|B1|>/=2 metastatic sites||Extent of Disease||Participants|Number|340|340.0||||||
4348767|NCT00400179|4176616|B3|1 metastatic site||Extent of Disease||Participants|Number|318|318.0||||||
4348768|NCT00400179|4176617|B2|1 metastatic site||Extent of Disease||Participants|Number|161|161.0||||||
4348769|NCT00400179|4176618|B1|1 metastatic site||Extent of Disease||Participants|Number|157|157.0||||||
4348770|NCT00400179|4176616|B3|Locally advanced||Extent of Disease||Participants|Number|43|43.0||||||
4348771|NCT00400179|4176617|B2|Locally advanced||Extent of Disease||Participants|Number|20|20.0||||||
4348772|NCT00400179|4176618|B1|Locally advanced||Extent of Disease||Participants|Number|23|23.0||||||
4348773|NCT00400179|4176616|B3|Stomach and gastroesophageal junction||Anatomical Location of Primary Lesion||Participants|Number|4|4.0||||||
4348774|NCT00400179|4176617|B2|Stomach and gastroesophageal junction||Anatomical Location of Primary Lesion||Participants|Number|3|3.0||||||
4348775|NCT00400179|4176618|B1|Stomach and gastroesophageal junction||Anatomical Location of Primary Lesion||Participants|Number|1|1.0||||||
4348776|NCT00400179|4176616|B3|Gastroesophageal junction||Anatomical Location of Primary Lesion||Participants|Number|170|170.0||||||
4348777|NCT00400179|4176617|B2|Gastroesophageal junction||Anatomical Location of Primary Lesion||Participants|Number|88|88.0||||||
4348778|NCT00400179|4176618|B1|Gastroesophageal junction||Anatomical Location of Primary Lesion||Participants|Number|82|82.0||||||
4348779|NCT00400179|4176616|B3|Stomach||Anatomical Location of Primary Lesion||Participants|Number|855|855.0||||||
4348780|NCT00400179|4176617|B2|Stomach||Anatomical Location of Primary Lesion||Participants|Number|417|417.0||||||
4348781|NCT00400179|4176618|B1|Stomach||Anatomical Location of Primary Lesion||Participants|Number|438|438.0||||||
4348782|NCT00400179|4176616|B3|Other types||Tissue Type|Patients can have more than one tissue type and are included under each type.|Participants|Number|6|6.0||||||
4348783|NCT00400179|4176617|B2|Other types||Tissue Type|Patients can have more than one tissue type and are included under each type.|Participants|Number|4|4.0||||||
4348784|NCT00400179|4176618|B1|Other types||Tissue Type|Patients can have more than one tissue type and are included under each type.|Participants|Number|2|2.0||||||
4348785|NCT00400179|4176616|B3|Unknown/not specified||Tissue Type|Patients can have more than one tissue type and are included under each type.|Participants|Number|2|2.0||||||
4348786|NCT00400179|4176617|B2|Unknown/not specified||Tissue Type|Patients can have more than one tissue type and are included under each type.|Participants|Number|1|1.0||||||
4348787|NCT00400179|4176618|B1|Unknown/not specified||Tissue Type|Patients can have more than one tissue type and are included under each type.|Participants|Number|1|1.0||||||
4348788|NCT00400179|4176616|B3|Poorly differentiated cancer||Tissue Type|Patients can have more than one tissue type and are included under each type.|Participants|Number|9|9.0||||||
4348789|NCT00400179|4176617|B2|Poorly differentiated cancer||Tissue Type|Patients can have more than one tissue type and are included under each type.|Participants|Number|2|2.0||||||
4348790|NCT00400179|4176618|B1|Poorly differentiated cancer||Tissue Type|Patients can have more than one tissue type and are included under each type.|Participants|Number|7|7.0||||||
4348791|NCT00400179|4176616|B3|Adenocarcinoma NOS||Tissue Type|Patients can have more than one tissue type and are included under each type.|Participants|Number|174|174.0||||||
4348792|NCT00400179|4176617|B2|Adenocarcinoma NOS||Tissue Type|Patients can have more than one tissue type and are included under each type.|Participants|Number|87|87.0||||||
4348793|NCT00400179|4176618|B1|Adenocarcinoma NOS||Tissue Type|Patients can have more than one tissue type and are included under each type.|Participants|Number|87|87.0||||||
4348794|NCT00400179|4176616|B3|Other||Tissue Type|Patients can have more than one tissue type and are included under each type.|Participants|Number|191|191.0||||||
4348795|NCT00400179|4176617|B2|Other||Tissue Type|Patients can have more than one tissue type and are included under each type.|Participants|Number|94|94.0||||||
4348796|NCT00400179|4176618|B1|Other||Tissue Type|Patients can have more than one tissue type and are included under each type.|Participants|Number|97|97.0||||||
4348797|NCT00400179|4176616|B3|Mucinous adenocarcinoma||Tissue Type|Patients can have more than one tissue type and are included under each type.|Participants|Number|60|60.0||||||
4348798|NCT00400179|4176617|B2|Mucinous adenocarcinoma||Tissue Type|Patients can have more than one tissue type and are included under each type.|Participants|Number|32|32.0||||||
4348799|NCT00400179|4176618|B1|Mucinous adenocarcinoma||Tissue Type|Patients can have more than one tissue type and are included under each type.|Participants|Number|28|28.0||||||
4348800|NCT00400179|4176616|B3|Signet-ring cell carcinoma||Tissue Type|Patients can have more than one tissue type and are included under each type.|Participants|Number|170|170.0||||||
4348801|NCT00400179|4176617|B2|Signet-ring cell carcinoma||Tissue Type|Patients can have more than one tissue type and are included under each type.|Participants|Number|95|95.0||||||
4348802|NCT00400179|4176618|B1|Signet-ring cell carcinoma||Tissue Type|Patients can have more than one tissue type and are included under each type.|Participants|Number|75|75.0||||||
4348803|NCT00400179|4176616|B3|Poorly differentiated adenocarcinoma||Tissue Type|Patients can have more than one tissue type and are included under each type.|Participants|Number|399|399.0||||||
4348804|NCT00400179|4176617|B2|Poorly differentiated adenocarcinoma||Tissue Type|Patients can have more than one tissue type and are included under each type.|Participants|Number|189|189.0||||||
4348805|NCT00400179|4176618|B1|Poorly differentiated adenocarcinoma||Tissue Type|Patients can have more than one tissue type and are included under each type.|Participants|Number|210|210.0||||||
4348806|NCT00400179|4176616|B3|Unknown||Tissue Type|Patients can have more than one tissue type and are included under each type.|Participants|Number|12|12.0||||||
4348807|NCT00400179|4176617|B2|Unknown||Tissue Type|Patients can have more than one tissue type and are included under each type.|Participants|Number|5|5.0||||||
4348808|NCT00400179|4176618|B1|Unknown||Tissue Type|Patients can have more than one tissue type and are included under each type.|Participants|Number|7|7.0||||||
4348809|NCT00400179|4176616|B3|Moderately-differentiated||Tissue Type|Patients can have more than one tissue type and are included under each type.|Participants|Number|196|196.0||||||
4348810|NCT00400179|4176617|B2|Moderately-differentiated||Tissue Type|Patients can have more than one tissue type and are included under each type.|Participants|Number|91|91.0||||||
4348811|NCT00400179|4176618|B1|Moderately-differentiated||Tissue Type|Patients can have more than one tissue type and are included under each type.|Participants|Number|105|105.0||||||
4348812|NCT00400179|4176616|B3|Well-differentiated||Tissue Type|Patients can have more than one tissue type and are included under each type.|Participants|Number|37|37.0||||||
4348813|NCT00400179|4176617|B2|Well-differentiated||Tissue Type|Patients can have more than one tissue type and are included under each type.|Participants|Number|17|17.0||||||
4348814|NCT00400179|4176618|B1|Well-differentiated||Tissue Type|Patients can have more than one tissue type and are included under each type.|Participants|Number|20|20.0||||||
4348815|NCT00400179|4176616|B3|Tubular adenocarcinoma||Tissue Type|Patients can have more than one tissue type and are included under each type.|Participants|Number|245|245.0||||||
4348816|NCT00400179|4176617|B2|Tubular adenocarcinoma||Tissue Type|Patients can have more than one tissue type and are included under each type.|Participants|Number|113|113.0||||||
4348817|NCT00400179|4176618|B1|Tubular adenocarcinoma||Tissue Type|Patients can have more than one tissue type and are included under each type.|Participants|Number|132|132.0||||||
4348818|NCT00400179|4176616|B3|Papillary adenocarcinoma||Tissue Type|Patients can have more than one tissue type and are included under each type.|Participants|Number|30|30.0||||||
4348819|NCT00400179|4176617|B2|Papillary adenocarcinoma||Tissue Type|Patients can have more than one tissue type and are included under each type.|Participants|Number|15|15.0||||||
4348820|NCT00400179|4176618|B1|Papillary adenocarcinoma||Tissue Type|Patients can have more than one tissue type and are included under each type.|Participants|Number|15|15.0||||||
4348821|NCT00400179|4176616|B3|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0=Fully active, able to carry on all pre-disease performance without restriction~1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work"|Participants|Number|603|603.0||||||
4348822|NCT00400179|4176617|B2|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0=Fully active, able to carry on all pre-disease performance without restriction~1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work"|Participants|Number|308|308.0||||||
4348823|NCT00400179|4176618|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0=Fully active, able to carry on all pre-disease performance without restriction~1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work"|Participants|Number|295|295.0||||||
4348824|NCT00400179|4176616|B3|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0=Fully active, able to carry on all pre-disease performance without restriction~1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work"|Participants|Number|426|426.0||||||
4348825|NCT00400179|4176617|B2|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0=Fully active, able to carry on all pre-disease performance without restriction~1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work"|Participants|Number|200|200.0||||||
4348826|NCT00400179|4176618|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0=Fully active, able to carry on all pre-disease performance without restriction~1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work"|Participants|Number|226|226.0||||||
4348827|NCT00400179|4176616|B3|>/=2.30 m2||Body surface area (BSA) Categories||Participants|Number|6|6.0||||||
4348828|NCT00400179|4176617|B2|>/=2.30 m2||Body surface area (BSA) Categories||Participants|Number|4|4.0||||||
4348829|NCT00400179|4176618|B1|>/=2.30 m2||Body surface area (BSA) Categories||Participants|Number|2|2.0||||||
4348830|NCT00400179|4176616|B3|2.10-2.29 m2||Body surface area (BSA) Categories||Participants|Number|63|63.0||||||
4348831|NCT00400179|4176617|B2|2.10-2.29 m2||Body surface area (BSA) Categories||Participants|Number|34|34.0||||||
4348832|NCT00400179|4176618|B1|2.10-2.29 m2||Body surface area (BSA) Categories||Participants|Number|29|29.0||||||
4348833|NCT00400179|4176616|B3|1.90-2.09 m2||Body surface area (BSA) Categories||Participants|Number|207|207.0||||||
4348834|NCT00400179|4176617|B2|1.90-2.09 m2||Body surface area (BSA) Categories||Participants|Number|93|93.0||||||
4348835|NCT00400179|4176618|B1|1.90-2.09 m2||Body surface area (BSA) Categories||Participants|Number|114|114.0||||||
4348836|NCT00400179|4176616|B3|1.70-1.89 m2||Body surface area (BSA) Categories||Participants|Number|389|389.0||||||
4348837|NCT00400179|4176617|B2|1.70-1.89 m2||Body surface area (BSA) Categories||Participants|Number|181|181.0||||||
4348838|NCT00400179|4176618|B1|1.70-1.89 m2||Body surface area (BSA) Categories||Participants|Number|208|208.0||||||
4348839|NCT00400179|4176616|B3|1.50-1.69 m2||Body surface area (BSA) Categories||Participants|Number|265|265.0||||||
4348840|NCT00400179|4176617|B2|1.50-1.69 m2||Body surface area (BSA) Categories||Participants|Number|147|147.0||||||
4348841|NCT00400179|4176618|B1|1.50-1.69 m2||Body surface area (BSA) Categories||Participants|Number|118|118.0||||||
4348842|NCT00400179|4176616|B3|1.30-1.49 m2||Body surface area (BSA) Categories||Participants|Number|90|90.0||||||
4348843|NCT00400179|4176617|B2|1.30-1.49 m2||Body surface area (BSA) Categories||Participants|Number|44|44.0||||||
4348844|NCT00400179|4176618|B1|1.30-1.49 m2||Body surface area (BSA) Categories||Participants|Number|46|46.0||||||
4348845|NCT00400179|4176616|B3|</=1.29 m2||Body surface area (BSA) Categories||Participants|Number|9|9.0||||||
4348846|NCT00400179|4176617|B2|</=1.29 m2||Body surface area (BSA) Categories||Participants|Number|5|5.0||||||
4348847|NCT00400179|4176618|B1|</=1.29 m2||Body surface area (BSA) Categories||Participants|Number|4|4.0||||||
4348848|NCT00400179|4176616|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|114|114.0||||||
4348849|NCT00400179|4176617|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4348850|NCT00400179|4176618|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4348851|NCT00400179|4176616|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4348852|NCT00400179|4176617|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4348853|NCT00400179|4176618|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4348854|NCT00400179|4176616|B3||White|Race (NIH/OMB)||Participants|Count of Participants|885|885.0||||||
4348855|NCT00400179|4176617|B2||White|Race (NIH/OMB)||Participants|Count of Participants|438|438.0||||||
4348856|NCT00400179|4176618|B1||White|Race (NIH/OMB)||Participants|Count of Participants|447|447.0||||||
4348857|NCT00400179|4176616|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4348858|NCT00400179|4176617|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4348859|NCT00400179|4176618|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4348860|NCT00400179|4176616|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4348861|NCT00400179|4176617|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4348862|NCT00400179|4176618|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4348863|NCT00400179|4176616|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4348864|NCT00400179|4176617|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4348865|NCT00400179|4176618|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4348866|NCT00400179|4176616|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4348867|NCT00400179|4176617|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4348868|NCT00400179|4176618|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4348869|NCT00400179|4176616|B3||Male|Sex: Female, Male||Participants|Count of Participants|729|729.0||||||
4348870|NCT00400179|4176617|B2||Male|Sex: Female, Male||Participants|Count of Participants|347|347.0||||||
4348871|NCT00400179|4176618|B1||Male|Sex: Female, Male||Participants|Count of Participants|382|382.0||||||
4348872|NCT00400179|4176616|B3||Female|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
4348873|NCT00400179|4176617|B2||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4348874|NCT00400179|4176618|B1||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4348875|NCT00400179|4176616|B3|Baseline Measure Data (descriptive stats, median)||Age||Years|Median|59.0|59.0|Full Range|||18.0|85.0|
4348876|NCT00400179|4176617|B2|Baseline Measure Data (descriptive stats, median)||Age||Years|Median|59.0|59.0|Full Range|||18.0|85.0|
4348877|NCT00400179|4176618|B1|Baseline Measure Data (descriptive stats, median)||Age||Years|Median|59.0|59.0|Full Range|||18.0|83.0|
4348878|NCT00400153|4176633|B4|||COPD duration||years|Mean|8.4|8.4|Standard Deviation|6.3|6.3|||
4348879|NCT00400153|4176634|B3|||COPD duration||years|Mean|8.5|8.5|Standard Deviation|6.4|6.4|||
4348880|NCT00400153|4176635|B2|||COPD duration||years|Mean|8.6|8.6|Standard Deviation|6.5|6.5|||
4348881|NCT00400153|4176636|B1|||COPD duration||years|Mean|8.2|8.2|Standard Deviation|6.1|6.1|||
4348882|NCT00400153|4176633|B4|||Smoking history||pack years|Mean|53.2|53.2|Standard Deviation|27.5|27.5|||
4348883|NCT00400153|4176634|B3|||Smoking history||pack years|Mean|55.4|55.4|Standard Deviation|27.6|27.6|||
4348884|NCT00400153|4176635|B2|||Smoking history||pack years|Mean|52.4|52.4|Standard Deviation|27.1|27.1|||
4348885|NCT00400153|4176636|B1|||Smoking history||pack years|Mean|51.7|51.7|Standard Deviation|27.7|27.7|||
4348886|NCT00400153|4176633|B4|Drinks-poss. interfere with participation in trial||Alcoholic history||participants|Number|1|1.0||||||
4348887|NCT00400153|4176634|B3|Drinks-poss. interfere with participation in trial||Alcoholic history||participants|Number|0|0.0||||||
4348888|NCT00400153|4176635|B2|Drinks-poss. interfere with participation in trial||Alcoholic history||participants|Number|1|1.0||||||
4348889|NCT00400153|4176636|B1|Drinks-poss. interfere with participation in trial||Alcoholic history||participants|Number|0|0.0||||||
4348890|NCT00400153|4176633|B4|Drinks - not interfere with participation in trial||Alcoholic history||participants|Number|781|781.0||||||
4348891|NCT00400153|4176634|B3|Drinks - not interfere with participation in trial||Alcoholic history||participants|Number|260|260.0||||||
4348892|NCT00400153|4176635|B2|Drinks - not interfere with participation in trial||Alcoholic history||participants|Number|258|258.0||||||
4348893|NCT00400153|4176636|B1|Drinks - not interfere with participation in trial||Alcoholic history||participants|Number|263|263.0||||||
4348894|NCT00400153|4176633|B4|Non drinker||Alcoholic history||participants|Number|678|678.0||||||
4348895|NCT00400153|4176634|B3|Non drinker||Alcoholic history||participants|Number|223|223.0||||||
4348896|NCT00400153|4176635|B2|Non drinker||Alcoholic history||participants|Number|232|232.0||||||
4348897|NCT00400153|4176636|B1|Non drinker||Alcoholic history||participants|Number|223|223.0||||||
4348898|NCT00400153|4176633|B4|||Weight||kg|Mean|77.8|77.8|Standard Deviation|20.1|20.1|||
4348899|NCT00400153|4176634|B3|||Weight||kg|Mean|77.3|77.3|Standard Deviation|21.0|21.0|||
4348900|NCT00400153|4176635|B2|||Weight||kg|Mean|77.8|77.8|Standard Deviation|19.3|19.3|||
4348901|NCT00400153|4176636|B1|||Weight||kg|Mean|78.2|78.2|Standard Deviation|20.0|20.0|||
4348902|NCT00400153|4176633|B4|||Height||cm|Mean|169.3|169.3|Standard Deviation|9.3|9.3|||
4348903|NCT00400153|4176634|B3|||Height||cm|Mean|168.8|168.8|Standard Deviation|9.5|9.5|||
4348904|NCT00400153|4176635|B2|||Height||cm|Mean|169.4|169.4|Standard Deviation|9.4|9.4|||
4348905|NCT00400153|4176636|B1|||Height||cm|Mean|168.8|168.8|Standard Deviation|9.1|9.1|||
4348906|NCT00400153|4176633|B4|Asian||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
4348907|NCT00400153|4176634|B3|Asian||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4348908|NCT00400153|4176635|B2|Asian||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4348909|NCT00400153|4176636|B1|Asian||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4348910|NCT00400153|4176633|B4|Black||Race/Ethnicity, Customized||participants|Number|78|78.0||||||
4348911|NCT00400153|4176634|B3|Black||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4348912|NCT00400153|4176635|B2|Black||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4348913|NCT00400153|4176636|B1|Black||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4348914|NCT00400153|4176633|B4|White||Race/Ethnicity, Customized||participants|Number|1300|1300.0||||||
4348915|NCT00400153|4176634|B3|White||Race/Ethnicity, Customized||participants|Number|428|428.0||||||
4348916|NCT00400153|4176635|B2|White||Race/Ethnicity, Customized||participants|Number|442|442.0||||||
4348917|NCT00400153|4176636|B1|White||Race/Ethnicity, Customized||participants|Number|430|430.0||||||
4348918|NCT00400153|4176633|B4||Male|Sex: Female, Male||Participants|Count of Participants|955|955.0||||||
4348919|NCT00400153|4176634|B3||Male|Sex: Female, Male||Participants|Count of Participants|317|317.0||||||
4348920|NCT00400153|4176635|B2||Male|Sex: Female, Male||Participants|Count of Participants|322|322.0||||||
4348921|NCT00400153|4176636|B1||Male|Sex: Female, Male||Participants|Count of Participants|316|316.0||||||
4348922|NCT00400153|4176633|B4||Female|Sex: Female, Male||Participants|Count of Participants|505|505.0||||||
4348923|NCT00400153|4176634|B3||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4348924|NCT00400153|4176635|B2||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4348925|NCT00400153|4176636|B1||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4348926|NCT00400153|4176633|B4|||Age||years|Mean|64.1|64.1|Standard Deviation|8.8|8.8|||
4348927|NCT00400153|4176634|B3|||Age||years|Mean|64.3|64.3|Standard Deviation|8.6|8.6|||
4348928|NCT00400153|4176635|B2|||Age||years|Mean|64.2|64.2|Standard Deviation|9.2|9.2|||
4348929|NCT00400153|4176636|B1|||Age||years|Mean|63.8|63.8|Standard Deviation|8.7|8.7|||
4348930|NCT00399893|4176883|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4348931|NCT00399893|4176884|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4348932|NCT00399893|4176885|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4348933|NCT00399893|4176883|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4348934|NCT00399893|4176884|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4348935|NCT00399893|4176885|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4348936|NCT00399893|4176883|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4348937|NCT00399893|4176884|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4348938|NCT00399893|4176885|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4348939|NCT00399893|4176883|B3|||Age||years|Mean|11.8|11.8|Standard Deviation|4.0|4.0|||
4348940|NCT00399893|4176884|B2|||Age||years|Mean|13|13.0|Standard Deviation|4.6|4.6|||
4348941|NCT00399893|4176885|B1|||Age||years|Mean|11|11.0|Standard Deviation|4.2|4.2|||
4348942|NCT00399893|4176883|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4348943|NCT00399893|4176884|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4348944|NCT00399893|4176885|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4348945|NCT00399893|4176883|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4348946|NCT00399893|4176884|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4348947|NCT00399893|4176885|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4348948|NCT00399893|4176883|B3||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4348949|NCT00399893|4176884|B2||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4348950|NCT00399893|4176885|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4348951|NCT00399880|4176912|B3||Missing|Smoking status||Participants|Count of Participants|3|3.0||||||
4348952|NCT00399880|4176913|B2||Missing|Smoking status||Participants|Count of Participants|3|3.0||||||
4348953|NCT00399880|4176914|B1||Missing|Smoking status||Participants|Count of Participants|0|0.0||||||
4348954|NCT00399880|4176912|B3||Current|Smoking status||Participants|Count of Participants|61|61.0||||||
4348955|NCT00399880|4176913|B2||Current|Smoking status||Participants|Count of Participants|28|28.0||||||
4348956|NCT00399880|4176914|B1||Current|Smoking status||Participants|Count of Participants|33|33.0||||||
4348957|NCT00399880|4176912|B3||Former|Smoking status||Participants|Count of Participants|19|19.0||||||
4348958|NCT00399880|4176913|B2||Former|Smoking status||Participants|Count of Participants|5|5.0||||||
4348959|NCT00399880|4176914|B1||Former|Smoking status||Participants|Count of Participants|14|14.0||||||
4348960|NCT00399880|4176912|B3||Never|Smoking status||Participants|Count of Participants|47|47.0||||||
4348961|NCT00399880|4176913|B2||Never|Smoking status||Participants|Count of Participants|29|29.0||||||
4348962|NCT00399880|4176914|B1||Never|Smoking status||Participants|Count of Participants|18|18.0||||||
4348963|NCT00399880|4176912|B3|||Rapid Estimate of Adult Literacy in Medicine (REALM)|Validated measure of health literacy involving participants' ability to read medical terms from a list. Possible range of scores 0-66, with higher values indicating better literacy.|units on a scale|Mean|40.1|40.1|Standard Deviation|22.1|22.1|||
4348964|NCT00399880|4176913|B2|||Rapid Estimate of Adult Literacy in Medicine (REALM)|Validated measure of health literacy involving participants' ability to read medical terms from a list. Possible range of scores 0-66, with higher values indicating better literacy.|units on a scale|Mean|39.1|39.1|Standard Deviation|22.7|22.7|||
4348965|NCT00399880|4176914|B1|||Rapid Estimate of Adult Literacy in Medicine (REALM)|Validated measure of health literacy involving participants' ability to read medical terms from a list. Possible range of scores 0-66, with higher values indicating better literacy.|units on a scale|Mean|41.1|41.1|Standard Deviation|21.7|21.7|||
4348966|NCT00399880|4176912|B3|||Education||years|Mean|11.6|11.6|Standard Deviation|2.9|2.9|||
4348967|NCT00399880|4176913|B2|||Education||years|Mean|11.5|11.5|Standard Deviation|2.9|2.9|||
4348968|NCT00399880|4176914|B1|||Education||years|Mean|11.6|11.6|Standard Deviation|3.0|3.0|||
4348969|NCT00399880|4176912|B3||Missing|Employment status||Participants|Count of Participants|3|3.0||||||
4348970|NCT00399880|4176913|B2||Missing|Employment status||Participants|Count of Participants|1|1.0||||||
4348971|NCT00399880|4176914|B1||Missing|Employment status||Participants|Count of Participants|2|2.0||||||
4348972|NCT00399880|4176912|B3||Other (disabled, retired)|Employment status||Participants|Count of Participants|60|60.0||||||
4348973|NCT00399880|4176913|B2||Other (disabled, retired)|Employment status||Participants|Count of Participants|36|36.0||||||
4348974|NCT00399880|4176914|B1||Other (disabled, retired)|Employment status||Participants|Count of Participants|24|24.0||||||
4348975|NCT00399880|4176912|B3||Part-time|Employment status||Participants|Count of Participants|7|7.0||||||
4348976|NCT00399880|4176913|B2||Part-time|Employment status||Participants|Count of Participants|4|4.0||||||
4348977|NCT00399880|4176914|B1||Part-time|Employment status||Participants|Count of Participants|3|3.0||||||
4348978|NCT00399880|4176912|B3||Full-time|Employment status||Participants|Count of Participants|9|9.0||||||
4348979|NCT00399880|4176913|B2||Full-time|Employment status||Participants|Count of Participants|4|4.0||||||
4348980|NCT00399880|4176914|B1||Full-time|Employment status||Participants|Count of Participants|5|5.0||||||
4348981|NCT00399880|4176912|B3||Unemployed|Employment status||Participants|Count of Participants|51|51.0||||||
4348982|NCT00399880|4176913|B2||Unemployed|Employment status||Participants|Count of Participants|20|20.0||||||
4348983|NCT00399880|4176914|B1||Unemployed|Employment status||Participants|Count of Participants|31|31.0||||||
4348984|NCT00399880|4176912|B3||Missing|Income||Participants|Count of Participants|6|6.0||||||
4348985|NCT00399880|4176913|B2||Missing|Income||Participants|Count of Participants|4|4.0||||||
4348986|NCT00399880|4176914|B1||Missing|Income||Participants|Count of Participants|2|2.0||||||
4348987|NCT00399880|4176912|B3||>$20,000|Income||Participants|Count of Participants|10|10.0||||||
4348988|NCT00399880|4176913|B2||>$20,000|Income||Participants|Count of Participants|5|5.0||||||
4348989|NCT00399880|4176914|B1||>$20,000|Income||Participants|Count of Participants|5|5.0||||||
4348990|NCT00399880|4176912|B3||$10,000-$20,000|Income||Participants|Count of Participants|30|30.0||||||
4348991|NCT00399880|4176913|B2||$10,000-$20,000|Income||Participants|Count of Participants|12|12.0||||||
4348992|NCT00399880|4176914|B1||$10,000-$20,000|Income||Participants|Count of Participants|18|18.0||||||
4348993|NCT00399880|4176912|B3||<$10,000|Income||Participants|Count of Participants|84|84.0||||||
4348994|NCT00399880|4176913|B2||<$10,000|Income||Participants|Count of Participants|44|44.0||||||
4348995|NCT00399880|4176914|B1||<$10,000|Income||Participants|Count of Participants|40|40.0||||||
4348996|NCT00399880|4176912|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4348997|NCT00399880|4176913|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4348998|NCT00399880|4176914|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4348999|NCT00399880|4176912|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349000|NCT00399880|4176913|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349001|NCT00399880|4176914|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349002|NCT00399880|4176912|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4349003|NCT00399880|4176913|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4349004|NCT00399880|4176914|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4349005|NCT00399880|4176912|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
4349006|NCT00399880|4176913|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4349007|NCT00399880|4176914|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4349008|NCT00399880|4176912|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349009|NCT00399880|4176913|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349010|NCT00399880|4176914|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349011|NCT00399880|4176912|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349012|NCT00399880|4176913|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349013|NCT00399880|4176914|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349014|NCT00399880|4176912|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349015|NCT00399880|4176913|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349016|NCT00399880|4176914|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349017|NCT00399880|4176912|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4349018|NCT00399880|4176913|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4349019|NCT00399880|4176914|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4349020|NCT00399880|4176912|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4349021|NCT00399880|4176913|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4349022|NCT00399880|4176914|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4349023|NCT00399880|4176912|B3|||Age||years|Mean|52.4|52.4|Standard Deviation|9.9|9.9|||
4349024|NCT00399880|4176913|B2|||Age||years|Mean|52.2|52.2|Standard Deviation|10.7|10.7|||
4349025|NCT00399880|4176914|B1|||Age||years|Mean|52.6|52.6|Standard Deviation|9.2|9.2|||
4349026|NCT00399802|4176923|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4349027|NCT00399802|4176924|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4349028|NCT00399802|4176925|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4349029|NCT00399802|4176923|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4349030|NCT00399802|4176924|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4349031|NCT00399802|4176925|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4349032|NCT00399802|4176923|B3|||Age||Years|Mean|59.7|59.7|Standard Deviation|9.5|9.5|||
4349033|NCT00399802|4176924|B2|||Age||Years|Mean|59.4|59.4|Standard Deviation|10.2|10.2|||
4349034|NCT00399802|4176925|B1|||Age||Years|Mean|60.3|60.3|Standard Deviation|8.3|8.3|||
4349035|NCT00399763|4176938|B3|United States||Region of Enrollment||participants|Number|70|70.0||||||
4349036|NCT00399763|4176939|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
4349037|NCT00399763|4176940|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4349038|NCT00399763|4176938|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4349039|NCT00399763|4176939|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4349040|NCT00399763|4176940|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4349041|NCT00399763|4176938|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4349042|NCT00399763|4176939|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4349043|NCT00399763|4176940|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4349044|NCT00399763|4176938|B3|||Age||years|Mean|16.09|16.09|Standard Deviation|1.56|1.56|||
4349045|NCT00399763|4176939|B2|||Age||years|Mean|16.06|16.06|Standard Deviation|1.35|1.35|||
4349046|NCT00399763|4176940|B1|||Age||years|Mean|16.11|16.11|Standard Deviation|1.78|1.78|||
4349047|NCT00399763|4176938|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4349048|NCT00399763|4176939|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4349049|NCT00399763|4176940|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4349050|NCT00399763|4176938|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4349051|NCT00399763|4176939|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4349052|NCT00399763|4176940|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4349053|NCT00399763|4176938|B3||<=18 years|Age||Participants|Count of Participants|64|64.0||||||
4349054|NCT00399763|4176939|B2||<=18 years|Age||Participants|Count of Participants|33|33.0||||||
4349055|NCT00399763|4176940|B1||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
4349056|NCT00399568|4176951|B3|United States||Region of Enrollment||participants|Number|331|331.0||||||
4349057|NCT00399568|4176952|B2|United States||Region of Enrollment||participants|Number|165|165.0||||||
4349058|NCT00399568|4176953|B1|United States||Region of Enrollment||participants|Number|166|166.0||||||
4349059|NCT00399568|4176951|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4349060|NCT00399568|4176952|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4349061|NCT00399568|4176953|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4349062|NCT00399568|4176951|B3||Female|Sex: Female, Male||Participants|Count of Participants|331|331.0||||||
4349063|NCT00399568|4176952|B2||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4349064|NCT00399568|4176953|B1||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4349065|NCT00399568|4176951|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4349066|NCT00399568|4176952|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4349067|NCT00399568|4176953|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4349068|NCT00399568|4176951|B3||Between 18 and 65 years|Age||Participants|Count of Participants|324|324.0||||||
4349069|NCT00399568|4176952|B2||Between 18 and 65 years|Age||Participants|Count of Participants|161|161.0||||||
4349070|NCT00399568|4176953|B1||Between 18 and 65 years|Age||Participants|Count of Participants|163|163.0||||||
4349071|NCT00399568|4176951|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4349072|NCT00399568|4176952|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4349073|NCT00399568|4176953|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4349074|NCT00399542|4176966|B3|||Height||inches|Mean|64.8|64.8|Standard Deviation|3.21|3.21|||
4349075|NCT00399542|4176967|B2|||Height||inches|Mean|65.0|65.0|Standard Deviation|3.34|3.34|||
4349076|NCT00399542|4176968|B1|||Height||inches|Mean|64.7|64.7|Standard Deviation|3.15|3.15|||
4349077|NCT00399542|4176966|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4349078|NCT00399542|4176967|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4349079|NCT00399542|4176968|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4349080|NCT00399542|4176966|B3||Female|Sex: Female, Male||Participants|Count of Participants|522|522.0||||||
4349081|NCT00399542|4176967|B2||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4349082|NCT00399542|4176968|B1||Female|Sex: Female, Male||Participants|Count of Participants|343|343.0||||||
4349083|NCT00399542|4176966|B3|||Age||years|Mean|46.1|46.1|Standard Deviation|13.08|13.08|||
4349084|NCT00399542|4176967|B2|||Age||years|Mean|47.3|47.3|Standard Deviation|13.34|13.34|||
4349085|NCT00399542|4176968|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|12.93|12.93|||
4349086|NCT00399516|4177031|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4349087|NCT00399516|4177031|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4349088|NCT00399516|4177031|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4349089|NCT00399516|4177031|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|12.9|12.9|||
4349090|NCT00399516|4177031|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4349091|NCT00399516|4177031|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4349092|NCT00399516|4177031|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4349093|NCT00399360|4177035|B5|United States||Region of Enrollment||participants|Number|50|50.0||||||
4349094|NCT00399360|4177036|B4|United States||Region of Enrollment||participants|Number|15|15.0||||||
4349095|NCT00399360|4177037|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4349096|NCT00399360|4177038|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4349097|NCT00399360|4177039|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4349098|NCT00399360|4177035|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4349099|NCT00399360|4177036|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349100|NCT00399360|4177037|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349101|NCT00399360|4177038|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4349102|NCT00399360|4177039|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349103|NCT00399360|4177035|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349104|NCT00399360|4177036|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349105|NCT00399360|4177037|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349106|NCT00399360|4177038|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349107|NCT00399360|4177039|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349108|NCT00399360|4177035|B5||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4349109|NCT00399360|4177036|B4||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4349110|NCT00399360|4177037|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4349111|NCT00399360|4177038|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4349112|NCT00399360|4177039|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4349113|NCT00399360|4177035|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4349114|NCT00399360|4177036|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4349115|NCT00399360|4177037|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4349116|NCT00399360|4177038|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4349117|NCT00399360|4177039|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4349118|NCT00399360|4177035|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349119|NCT00399360|4177036|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349120|NCT00399360|4177037|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349121|NCT00399360|4177038|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349122|NCT00399360|4177039|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349123|NCT00399360|4177035|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4349124|NCT00399360|4177036|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349125|NCT00399360|4177037|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4349126|NCT00399360|4177038|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349127|NCT00399360|4177039|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349128|NCT00399360|4177035|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349129|NCT00399360|4177036|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349130|NCT00399360|4177037|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349131|NCT00399360|4177038|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349132|NCT00399360|4177039|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349133|NCT00399360|4177035|B5||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4349134|NCT00399360|4177036|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4349135|NCT00399360|4177037|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4349136|NCT00399360|4177038|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4349137|NCT00399360|4177039|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4349138|NCT00399360|4177035|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4349139|NCT00399360|4177036|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4349140|NCT00399360|4177037|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4349141|NCT00399360|4177038|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4349142|NCT00399360|4177039|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4349143|NCT00399360|4177035|B5|||Age||years|Mean|47|47.0|Standard Deviation|7|7.0|||
4349144|NCT00399360|4177036|B4|||Age||years|Mean|47|47.0|Standard Deviation|8|8.0|||
4349145|NCT00399360|4177037|B3|||Age||years|Mean|45|45.0|Standard Deviation|9|9.0|||
4349146|NCT00399360|4177038|B2|||Age||years|Mean|49|49.0|Standard Deviation|8|8.0|||
4349147|NCT00399360|4177039|B1|||Age||years|Mean|47|47.0|Standard Deviation|6|6.0|||
4349148|NCT00399360|4177035|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4349149|NCT00399360|4177036|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4349150|NCT00399360|4177037|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4349151|NCT00399360|4177038|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4349152|NCT00399360|4177039|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4349153|NCT00399360|4177035|B5||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4349154|NCT00399360|4177036|B4||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4349155|NCT00399360|4177037|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4349156|NCT00399360|4177038|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4349157|NCT00399360|4177039|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4349158|NCT00399360|4177035|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4349159|NCT00399360|4177036|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4349160|NCT00399360|4177037|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4349161|NCT00399360|4177038|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4349162|NCT00399360|4177039|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4349163|NCT00399308|4177088|B4|United States||Region of Enrollment||participants|Number|40|40.0||||||
4349164|NCT00399308|4177089|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4349165|NCT00399308|4177090|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4349166|NCT00399308|4177091|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4349167|NCT00399308|4177088|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4349168|NCT00399308|4177089|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4349169|NCT00399308|4177090|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4349170|NCT00399308|4177091|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4349171|NCT00399308|4177088|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4349172|NCT00399308|4177089|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4349173|NCT00399308|4177090|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4349174|NCT00399308|4177091|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4349175|NCT00399308|4177088|B4|||Age||years|Mean|65.28|65.28|Standard Deviation|11.5|11.5|||
4349176|NCT00399308|4177089|B3|||Age||years|Mean|64|64.0|Standard Deviation|12.85|12.85|||
4349177|NCT00399308|4177090|B2|||Age||years|Mean|60.40|60.4|Standard Deviation|8.75|8.75|||
4349178|NCT00399308|4177091|B1|||Age||years|Mean|67.54|67.54|Standard Deviation|12.65|12.65|||
4349179|NCT00399308|4177088|B4||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4349180|NCT00399308|4177089|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4349181|NCT00399308|4177090|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4349182|NCT00399308|4177091|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4349183|NCT00399308|4177088|B4||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4349184|NCT00399308|4177089|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4349185|NCT00399308|4177090|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4349186|NCT00399308|4177091|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4349187|NCT00399308|4177088|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4349188|NCT00399308|4177089|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4349189|NCT00399308|4177090|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4349190|NCT00399308|4177091|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4349191|NCT00399035|4177110|B4||Male|Gender|Gender at informed consent|Participants|Count of Participants|634|634.0||||||
4349192|NCT00399035|4177111|B3||Male|Gender|Gender at informed consent|Participants|Count of Participants|123|123.0||||||
4349193|NCT00399035|4177112|B2||Male|Gender|Gender at informed consent|Participants|Count of Participants|212|212.0||||||
4349194|NCT00399035|4177113|B1||Male|Gender|Gender at informed consent|Participants|Count of Participants|299|299.0||||||
4349195|NCT00399035|4177110|B4||Female|Gender|Gender at informed consent|Participants|Count of Participants|442|442.0||||||
4349196|NCT00399035|4177111|B3||Female|Gender|Gender at informed consent|Participants|Count of Participants|93|93.0||||||
4349197|NCT00399035|4177112|B2||Female|Gender|Gender at informed consent|Participants|Count of Participants|146|146.0||||||
4349198|NCT00399035|4177113|B1||Female|Gender|Gender at informed consent|Participants|Count of Participants|203|203.0||||||
4349199|NCT00399035|4177110|B4|||Age|Age at informed consent|years|Mean|57.6|57.6|Standard Deviation|11.34|11.34|||
4349200|NCT00399035|4177111|B3|||Age|Age at informed consent|years|Mean|59.4|59.4|Standard Deviation|10.69|10.69|||
4349201|NCT00399035|4177112|B2|||Age|Age at informed consent|years|Mean|57.2|57.2|Standard Deviation|11.63|11.63|||
4349202|NCT00399035|4177113|B1|||Age|Age at informed consent|years|Mean|57.8|57.8|Standard Deviation|11.14|11.14|||
4349203|NCT00398983|4177134|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
4349204|NCT00398983|4177135|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4349205|NCT00398983|4177136|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4349206|NCT00398983|4177134|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4349207|NCT00398983|4177135|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4349208|NCT00398983|4177136|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4349209|NCT00398983|4177134|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4349210|NCT00398983|4177135|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4349211|NCT00398983|4177136|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4349212|NCT00398983|4177134|B3|||Age||years|Median|57|57.0|Full Range|||24.0|79.0|
4349213|NCT00398983|4177135|B2|||Age||years|Median|53|53.0|Full Range|||31.0|72.0|
4349214|NCT00398983|4177136|B1|||Age||years|Median|62|62.0|Full Range|||24.0|79.0|
4349215|NCT00398918|4177143|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4349216|NCT00398918|4177143|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4349217|NCT00398918|4177143|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4349218|NCT00398918|4177143|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4349219|NCT00398918|4177143|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4349220|NCT00398918|4177143|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4349221|NCT00398866|4177148|B4|Race|No data|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4349222|NCT00398866|4177149|B3|Race|No data|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4349223|NCT00398866|4177150|B2|Race|No data|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4349224|NCT00398866|4177151|B1|Race|No data|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4349225|NCT00398866|4177148|B4|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
4349226|NCT00398866|4177149|B3|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4349227|NCT00398866|4177150|B2|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4349228|NCT00398866|4177151|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4349229|NCT00398866|4177148|B4|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|180|180.0||||||
4349230|NCT00398866|4177149|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|61|61.0||||||
4349231|NCT00398866|4177150|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|61|61.0||||||
4349232|NCT00398866|4177151|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|58|58.0||||||
4349233|NCT00398866|4177148|B4|Gender|No data|Sex/Gender, Customized||Participants|Count of Participants|1|1.0||||||
4349234|NCT00398866|4177149|B3|Gender|No data|Sex/Gender, Customized||Participants|Count of Participants|1|1.0||||||
4349235|NCT00398866|4177150|B2|Gender|No data|Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
4349236|NCT00398866|4177151|B1|Gender|No data|Sex/Gender, Customized||Participants|Count of Participants|0|0.0||||||
4349237|NCT00398866|4177148|B4|Gender|Male|Sex/Gender, Customized||Participants|Count of Participants|64|64.0||||||
4349238|NCT00398866|4177149|B3|Gender|Male|Sex/Gender, Customized||Participants|Count of Participants|20|20.0||||||
4349239|NCT00398866|4177150|B2|Gender|Male|Sex/Gender, Customized||Participants|Count of Participants|28|28.0||||||
4349240|NCT00398866|4177151|B1|Gender|Male|Sex/Gender, Customized||Participants|Count of Participants|16|16.0||||||
4349241|NCT00398866|4177148|B4|Gender|Female|Sex/Gender, Customized||Participants|Count of Participants|135|135.0||||||
4349242|NCT00398866|4177149|B3|Gender|Female|Sex/Gender, Customized||Participants|Count of Participants|45|45.0||||||
4349243|NCT00398866|4177150|B2|Gender|Female|Sex/Gender, Customized||Participants|Count of Participants|40|40.0||||||
4349244|NCT00398866|4177151|B1|Gender|Female|Sex/Gender, Customized||Participants|Count of Participants|50|50.0||||||
4349245|NCT00398866|4177148|B4|||Age||years|Mean|66.7|66.7|Standard Deviation|9.3|9.3|||
4349246|NCT00398866|4177149|B3|||Age||years|Mean|67.1|67.1|Standard Deviation|10.1|10.1|||
4349247|NCT00398866|4177150|B2|||Age||years|Mean|66.6|66.6|Standard Deviation|8.4|8.4|||
4349248|NCT00398866|4177151|B1|||Age||years|Mean|66.3|66.3|Standard Deviation|9.3|9.3|||
4349249|NCT00398632|4177164|B1|||Clinically Depressed|Patients with score >22 assessed by Inventory for Depressive Symptomology–Clinician Rated (IDS-C). The IDS-C is a 30-item inventory designed to assess the severity of depressive symptoms. Scale range minimum = 0 / maximum = 84. Higher values are considered to be worse outcomes.|Participants|Count of Participants|2|2.0||||||
4349250|NCT00398632|4177164|B1|fluoxetine||Antidepressant taken prior to duloxetine switch||participants|Number|1|1.0||||||
4349251|NCT00398632|4177164|B1|citalopram||Antidepressant taken prior to duloxetine switch||participants|Number|2|2.0||||||
4349252|NCT00398632|4177164|B1|venlafaxine||Antidepressant taken prior to duloxetine switch||participants|Number|3|3.0||||||
4349253|NCT00398632|4177164|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4349254|NCT00398632|4177164|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4349255|NCT00398632|4177164|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4349256|NCT00398632|4177164|B1|||Age|Mean age only. The data were destroyed some years ago, and only the mean age was preserved.|years|Mean|44|44.0|Standard Deviation|NA||||The data were destroyed some years ago, and only the mean age was preserved.
4349257|NCT00398632|4177164|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4349258|NCT00398632|4177164|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4349259|NCT00398632|4177164|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4349260|NCT00398567|4177169|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4349261|NCT00398567|4177170|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349262|NCT00398567|4177171|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349263|NCT00398567|4177172|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4349264|NCT00398567|4177169|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349265|NCT00398567|4177170|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349266|NCT00398567|4177171|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349267|NCT00398567|4177172|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349268|NCT00398567|4177169|B4||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4349269|NCT00398567|4177170|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4349270|NCT00398567|4177171|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4349271|NCT00398567|4177172|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4349272|NCT00398567|4177169|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4349273|NCT00398567|4177170|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4349274|NCT00398567|4177171|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4349275|NCT00398567|4177172|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349276|NCT00398567|4177169|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349277|NCT00398567|4177170|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349278|NCT00398567|4177171|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349279|NCT00398567|4177172|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349280|NCT00398567|4177169|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4349281|NCT00398567|4177170|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4349282|NCT00398567|4177171|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349283|NCT00398567|4177172|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349284|NCT00398567|4177169|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349285|NCT00398567|4177170|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349286|NCT00398567|4177171|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349287|NCT00398567|4177172|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349288|NCT00398567|4177169|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4349289|NCT00398567|4177170|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4349290|NCT00398567|4177171|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4349291|NCT00398567|4177172|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4349292|NCT00398567|4177169|B4||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4349293|NCT00398567|4177170|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4349294|NCT00398567|4177171|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4349295|NCT00398567|4177172|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4349296|NCT00398567|4177169|B4|||Age||years|Mean|51.6|51.6|Standard Deviation|12.9|12.9|||
4349297|NCT00398567|4177170|B3|||Age||years|Mean|50.5|50.5|Standard Deviation|13.0|13.0|||
4349298|NCT00398567|4177171|B2|||Age||years|Mean|61.0|61.0|Standard Deviation|12.8|12.8|||
4349299|NCT00398567|4177172|B1|||Age||years|Mean|52.5|52.5|Standard Deviation|10.1|10.1|||
4349300|NCT00398476|4177186|B1|Race|Mixed Race|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4349301|NCT00398476|4177186|B1|Race|White - White/Caucasian/European Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|100|100.0||||||
4349364|NCT00398216|4177264|B2|North America||Region of Enrollment||participants|Number|20|20.0||||||
4349302|NCT00398476|4177186|B1|Race|White - Arabic/North African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4349303|NCT00398476|4177186|B1|Race|Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4349304|NCT00398476|4177186|B1|Race|Asian - South East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4349305|NCT00398476|4177186|B1|Race|Asian - East Asian Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4349306|NCT00398476|4177186|B1|Race|African American/African Heritage|Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
4349307|NCT00398476|4177186|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4349308|NCT00398476|4177186|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4349309|NCT00398476|4177186|B1|||Age||Years|Mean|39.7|39.7|Standard Deviation|14.05|14.05|||
4349310|NCT00398411|4177226|B3|relapsed||Status of Underlying Disease||participants|Number|26|26.0||||||
4349311|NCT00398411|4177227|B2|relapsed||Status of Underlying Disease||participants|Number|15|15.0||||||
4349312|NCT00398411|4177228|B1|relapsed||Status of Underlying Disease||participants|Number|11|11.0||||||
4349313|NCT00398411|4177226|B3|primary progressive||Status of Underlying Disease||participants|Number|6|6.0||||||
4349314|NCT00398411|4177227|B2|primary progressive||Status of Underlying Disease||participants|Number|3|3.0||||||
4349315|NCT00398411|4177228|B1|primary progressive||Status of Underlying Disease||participants|Number|3|3.0||||||
4349316|NCT00398411|4177226|B3|primary||Status of Underlying Disease||participants|Number|34|34.0||||||
4349317|NCT00398411|4177227|B2|primary||Status of Underlying Disease||participants|Number|14|14.0||||||
4349318|NCT00398411|4177228|B1|primary||Status of Underlying Disease||participants|Number|20|20.0||||||
4349319|NCT00398411|4177226|B3|Solid Tumor||Underlying Disease||participants|Number|1|1.0||||||
4349320|NCT00398411|4177227|B2|Solid Tumor||Underlying Disease||participants|Number|1|1.0||||||
4349321|NCT00398411|4177228|B1|Solid Tumor||Underlying Disease||participants|Number|0|0.0||||||
4349322|NCT00398411|4177226|B3|Multiple Myeloma||Underlying Disease||participants|Number|28|28.0||||||
4349323|NCT00398411|4177227|B2|Multiple Myeloma||Underlying Disease||participants|Number|12|12.0||||||
4349324|NCT00398411|4177228|B1|Multiple Myeloma||Underlying Disease||participants|Number|16|16.0||||||
4349325|NCT00398411|4177226|B3|NHL||Underlying Disease||participants|Number|28|28.0||||||
4349326|NCT00398411|4177227|B2|NHL||Underlying Disease||participants|Number|14|14.0||||||
4349327|NCT00398411|4177228|B1|NHL||Underlying Disease||participants|Number|14|14.0||||||
4349328|NCT00398411|4177226|B3|Hodgkin's Disease||Underlying Disease||participants|Number|9|9.0||||||
4349329|NCT00398411|4177227|B2|Hodgkin's Disease||Underlying Disease||participants|Number|5|5.0||||||
4349330|NCT00398411|4177228|B1|Hodgkin's Disease||Underlying Disease||participants|Number|4|4.0||||||
4349331|NCT00398411|4177226|B3|||Weight||kg|Mean|75.73|75.73|Standard Deviation|15.1|15.1|||
4349332|NCT00398411|4177227|B2|||Weight||kg|Mean|75.00|75.0|Standard Deviation|16.5|16.5|||
4349333|NCT00398411|4177228|B1|||Weight||kg|Mean|76.41|76.41|Standard Deviation|13.9|13.9|||
4349334|NCT00398411|4177226|B3|||Height||cm|Mean|173.2|173.2|Standard Deviation|9.1|9.1|||
4349335|NCT00398411|4177227|B2|||Height||cm|Mean|173.72|173.72|Standard Deviation|9.7|9.7|||
4349336|NCT00398411|4177228|B1|||Height||cm|Mean|172.71|172.71|Standard Deviation|8.7|8.7|||
4349337|NCT00398411|4177226|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4349338|NCT00398411|4177227|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4349339|NCT00398411|4177228|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4349340|NCT00398411|4177226|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4349341|NCT00398411|4177227|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4349342|NCT00398411|4177228|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4349343|NCT00398411|4177226|B3|||Age||years|Median|51.5|51.5|Full Range|||21.0|70.0|
4349344|NCT00398411|4177227|B2|||Age||years|Median|50|50.0|Full Range|||23.0|70.0|
4349345|NCT00398411|4177228|B1|||Age||years|Median|54|54.0|Full Range|||21.0|68.0|
4349346|NCT00398398|4177245|B1|Korea, Republic of||Region of Enrollment||participants|Number|44|44.0||||||
4349347|NCT00398398|4177245|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4349348|NCT00398398|4177245|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4349349|NCT00398398|4177245|B1|||Age, Customized||years|Median|57.5|57.5|Full Range|||36.0|70.0|
4349350|NCT00398320|4177252|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4349351|NCT00398320|4177252|B1||Male|Gender||Participants|Count of Participants|22|22.0||||||
4349352|NCT00398320|4177252|B1||Female|Gender||Participants|Count of Participants|18|18.0||||||
4349353|NCT00398320|4177252|B1|||Age||years|Median|55|55.0|Full Range|||32.0|76.0|
4349354|NCT00398216|4177260|B6|Europe||Region of Enrollment||participants|Number|748|748.0||||||
4349355|NCT00398216|4177261|B5|Europe||Region of Enrollment||participants|Number|143|143.0||||||
4349356|NCT00398216|4177262|B4|Europe||Region of Enrollment||participants|Number|144|144.0||||||
4349357|NCT00398216|4177263|B3|Europe||Region of Enrollment||participants|Number|152|152.0||||||
4349358|NCT00398216|4177264|B2|Europe||Region of Enrollment||participants|Number|150|150.0||||||
4349359|NCT00398216|4177265|B1|Europe||Region of Enrollment||participants|Number|159|159.0||||||
4349360|NCT00398216|4177260|B6|North America||Region of Enrollment||participants|Number|148|148.0||||||
4349361|NCT00398216|4177261|B5|North America||Region of Enrollment||participants|Number|29|29.0||||||
4349362|NCT00398216|4177262|B4|North America||Region of Enrollment||participants|Number|33|33.0||||||
4349363|NCT00398216|4177263|B3|North America||Region of Enrollment||participants|Number|33|33.0||||||
4349365|NCT00398216|4177265|B1|North America||Region of Enrollment||participants|Number|33|33.0||||||
4349366|NCT00398216|4177260|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4349367|NCT00398216|4177261|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4349368|NCT00398216|4177262|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349369|NCT00398216|4177263|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4349370|NCT00398216|4177264|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4349371|NCT00398216|4177265|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4349372|NCT00398216|4177260|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349373|NCT00398216|4177261|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349374|NCT00398216|4177262|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349375|NCT00398216|4177263|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349376|NCT00398216|4177264|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349377|NCT00398216|4177265|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349378|NCT00398216|4177260|B6||White|Race (NIH/OMB)||Participants|Count of Participants|874|874.0||||||
4349379|NCT00398216|4177261|B5||White|Race (NIH/OMB)||Participants|Count of Participants|165|165.0||||||
4349380|NCT00398216|4177262|B4||White|Race (NIH/OMB)||Participants|Count of Participants|176|176.0||||||
4349381|NCT00398216|4177263|B3||White|Race (NIH/OMB)||Participants|Count of Participants|178|178.0||||||
4349382|NCT00398216|4177264|B2||White|Race (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
4349383|NCT00398216|4177265|B1||White|Race (NIH/OMB)||Participants|Count of Participants|188|188.0||||||
4349384|NCT00398216|4177260|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4349385|NCT00398216|4177261|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4349386|NCT00398216|4177262|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4349387|NCT00398216|4177263|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4349388|NCT00398216|4177264|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4349389|NCT00398216|4177265|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4349390|NCT00398216|4177260|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349391|NCT00398216|4177261|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349392|NCT00398216|4177262|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349393|NCT00398216|4177263|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349394|NCT00398216|4177264|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349395|NCT00398216|4177265|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349396|NCT00398216|4177260|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4349397|NCT00398216|4177261|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349398|NCT00398216|4177262|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349399|NCT00398216|4177263|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4349400|NCT00398216|4177264|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4349401|NCT00398216|4177265|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4349402|NCT00398216|4177260|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349403|NCT00398216|4177261|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349404|NCT00398216|4177262|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349405|NCT00398216|4177263|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349406|NCT00398216|4177264|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349407|NCT00398216|4177265|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349408|NCT00398216|4177260|B6||Male|Sex: Female, Male||Participants|Count of Participants|356|356.0||||||
4349409|NCT00398216|4177261|B5||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4349410|NCT00398216|4177262|B4||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4349411|NCT00398216|4177263|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4349412|NCT00398216|4177264|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4349413|NCT00398216|4177265|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4349414|NCT00398216|4177260|B6||Female|Sex: Female, Male||Participants|Count of Participants|540|540.0||||||
4349415|NCT00398216|4177261|B5||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4349416|NCT00398216|4177262|B4||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4349417|NCT00398216|4177263|B3||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4349418|NCT00398216|4177264|B2||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4349419|NCT00398216|4177265|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4349420|NCT00398216|4177260|B6|||Age||years|Mean|57.8|57.8|Standard Deviation|12.13|12.13|||
4349421|NCT00398216|4177261|B5|||Age||years|Mean|57.5|57.5|Standard Deviation|12.43|12.43|||
4349422|NCT00398216|4177262|B4|||Age||years|Mean|58.5|58.5|Standard Deviation|12.27|12.27|||
4349423|NCT00398216|4177263|B3|||Age||years|Mean|58.3|58.3|Standard Deviation|11.52|11.52|||
4349424|NCT00398216|4177264|B2|||Age||years|Mean|57.2|57.2|Standard Deviation|12.28|12.28|||
4349425|NCT00398216|4177265|B1|||Age||years|Mean|57.3|57.3|Standard Deviation|12.49|12.49|||
4349426|NCT00398216|4177260|B6||>=65 years|Age||Participants|Count of Participants|309|309.0||||||
4349427|NCT00398216|4177261|B5||>=65 years|Age||Participants|Count of Participants|62|62.0||||||
4349428|NCT00398216|4177262|B4||>=65 years|Age||Participants|Count of Participants|63|63.0||||||
4349429|NCT00398216|4177263|B3||>=65 years|Age||Participants|Count of Participants|59|59.0||||||
4349430|NCT00398216|4177264|B2||>=65 years|Age||Participants|Count of Participants|59|59.0||||||
4349431|NCT00398216|4177265|B1||>=65 years|Age||Participants|Count of Participants|66|66.0||||||
4349432|NCT00398216|4177260|B6||Between 18 and 65 years|Age||Participants|Count of Participants|587|587.0||||||
4349433|NCT00398216|4177261|B5||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
4349434|NCT00398216|4177262|B4||Between 18 and 65 years|Age||Participants|Count of Participants|114|114.0||||||
4349435|NCT00398216|4177263|B3||Between 18 and 65 years|Age||Participants|Count of Participants|126|126.0||||||
4349436|NCT00398216|4177264|B2||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
4349437|NCT00398216|4177265|B1||Between 18 and 65 years|Age||Participants|Count of Participants|126|126.0||||||
4349438|NCT00398216|4177260|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4349439|NCT00398216|4177261|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4349440|NCT00398216|4177262|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4349441|NCT00398216|4177263|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4349442|NCT00398216|4177264|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4349443|NCT00398216|4177265|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4349444|NCT00398138|4177296|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4349445|NCT00398138|4177296|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4349446|NCT00398138|4177296|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4349447|NCT00398138|4177296|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4349448|NCT00398138|4177296|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4349449|NCT00398138|4177296|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4349450|NCT00398112|4177301|B1|Missing||Immunoglobulin Variable Heavy Chain (IGVH) Mutation Status|IGVH testing helps predict which patients will experience a more aggressive (if the gene is unmutated, <=2%) or less aggressive (if the gene is mutated, >2%) course of CLL. This technically complex test is only available at select medical institutions.|participants|Number|17|17.0||||||
4349451|NCT00398112|4177301|B1|Mutated||Immunoglobulin Variable Heavy Chain (IGVH) Mutation Status|IGVH testing helps predict which patients will experience a more aggressive (if the gene is unmutated, <=2%) or less aggressive (if the gene is mutated, >2%) course of CLL. This technically complex test is only available at select medical institutions.|participants|Number|0|0.0||||||
4349452|NCT00398112|4177301|B1|Unmutated||Immunoglobulin Variable Heavy Chain (IGVH) Mutation Status|IGVH testing helps predict which patients will experience a more aggressive (if the gene is unmutated, <=2%) or less aggressive (if the gene is mutated, >2%) course of CLL. This technically complex test is only available at select medical institutions.|participants|Number|1|1.0||||||
4349453|NCT00398112|4177301|B1|Negative||CD38 Status|This test is used to predict the rate of progression from diagnosis to need for treatment in CLL. Participants with positive CD38 (>=30%) tend to experience a more aggressive course of CLL.|participants|Number|9|9.0||||||
4349454|NCT00398112|4177301|B1|Positive||CD38 Status|This test is used to predict the rate of progression from diagnosis to need for treatment in CLL. Participants with positive CD38 (>=30%) tend to experience a more aggressive course of CLL.|participants|Number|9|9.0||||||
4349455|NCT00398112|4177301|B1|Negative||ZAP-70 Status|This test is used to predict the rate of progression from diagnosis to need for treatment in CLL. Participants with positive ZAP-70 (>=20%) tend to experience a more aggressive course of CLL.|participants|Number|8|8.0||||||
4349456|NCT00398112|4177301|B1|Positive||ZAP-70 Status|This test is used to predict the rate of progression from diagnosis to need for treatment in CLL. Participants with positive ZAP-70 (>=20%) tend to experience a more aggressive course of CLL.|participants|Number|10|10.0||||||
4349457|NCT00398112|4177301|B1|High (Rai III-IV)||Rai Stage|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL); higher stages reflect increasing severity.~Rai Stage 0: Lymphocytosis only; Rai Stage I: Lymphocytosis and lymphadenopathy; Rai Stage II: Lymphocytosis and hepatomegaly +/- splenomegaly; Rai Stage III: Lymphocytosis and anemia; Rai Stage IV: Lymphocytosis and thrombocytopenia"|participants|Number|10|10.0||||||
4349458|NCT00398112|4177301|B1|Intermediate (Rai I-II)||Rai Stage|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL); higher stages reflect increasing severity.~Rai Stage 0: Lymphocytosis only; Rai Stage I: Lymphocytosis and lymphadenopathy; Rai Stage II: Lymphocytosis and hepatomegaly +/- splenomegaly; Rai Stage III: Lymphocytosis and anemia; Rai Stage IV: Lymphocytosis and thrombocytopenia"|participants|Number|8|8.0||||||
4349459|NCT00398112|4177301|B1|Low (Rai 0)||Rai Stage|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL); higher stages reflect increasing severity.~Rai Stage 0: Lymphocytosis only; Rai Stage I: Lymphocytosis and lymphadenopathy; Rai Stage II: Lymphocytosis and hepatomegaly +/- splenomegaly; Rai Stage III: Lymphocytosis and anemia; Rai Stage IV: Lymphocytosis and thrombocytopenia"|participants|Number|0|0.0||||||
4349460|NCT00398112|4177301|B1|Normal||Fluorescence In Situ Hybridization (FISH) Abnormalities|FISH abnormalities were categorized according to Dohner hierarchy. This test determines the presence of abnormalities in specific chromosomes of CLL cells, which are associated with more or less aggressive forms of cancer. Patients with abnormalities of chromosome 11 (deletion 11q23) and 17 (deletion 17p13) experience rapid progression of their CLL.|participants|Number|4|4.0||||||
4349461|NCT00398112|4177301|B1|del 13q14||Fluorescence In Situ Hybridization (FISH) Abnormalities|FISH abnormalities were categorized according to Dohner hierarchy. This test determines the presence of abnormalities in specific chromosomes of CLL cells, which are associated with more or less aggressive forms of cancer. Patients with abnormalities of chromosome 11 (deletion 11q23) and 17 (deletion 17p13) experience rapid progression of their CLL.|participants|Number|2|2.0||||||
4349462|NCT00398112|4177301|B1|Trisomy 12||Fluorescence In Situ Hybridization (FISH) Abnormalities|FISH abnormalities were categorized according to Dohner hierarchy. This test determines the presence of abnormalities in specific chromosomes of CLL cells, which are associated with more or less aggressive forms of cancer. Patients with abnormalities of chromosome 11 (deletion 11q23) and 17 (deletion 17p13) experience rapid progression of their CLL.|participants|Number|5|5.0||||||
4349463|NCT00398112|4177301|B1|del 11q23||Fluorescence In Situ Hybridization (FISH) Abnormalities|FISH abnormalities were categorized according to Dohner hierarchy. This test determines the presence of abnormalities in specific chromosomes of CLL cells, which are associated with more or less aggressive forms of cancer. Patients with abnormalities of chromosome 11 (deletion 11q23) and 17 (deletion 17p13) experience rapid progression of their CLL.|participants|Number|1|1.0||||||
4349464|NCT00398112|4177301|B1|del 17p13||Fluorescence In Situ Hybridization (FISH) Abnormalities|FISH abnormalities were categorized according to Dohner hierarchy. This test determines the presence of abnormalities in specific chromosomes of CLL cells, which are associated with more or less aggressive forms of cancer. Patients with abnormalities of chromosome 11 (deletion 11q23) and 17 (deletion 17p13) experience rapid progression of their CLL.|participants|Number|6|6.0||||||
4349465|NCT00398112|4177301|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4349466|NCT00398112|4177301|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4349467|NCT00398112|4177301|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4349468|NCT00398112|4177301|B1|||Age||years|Median|67.5|67.5|Full Range|||51.0|89.0|
4349469|NCT00398086|4177309|B4|Non-visceral||Dominant Current Site of Metastasis/Relapse||participants|Number|1|1.0||||||
4349470|NCT00398086|4177310|B3|Non-visceral||Dominant Current Site of Metastasis/Relapse||participants|Number|0|0.0||||||
4349471|NCT00398086|4177311|B2|Non-visceral||Dominant Current Site of Metastasis/Relapse||participants|Number|0|0.0||||||
4349472|NCT00398086|4177312|B1|Non-visceral||Dominant Current Site of Metastasis/Relapse||participants|Number|1|1.0||||||
4349473|NCT00398086|4177309|B4|Visceral||Dominant Current Site of Metastasis/Relapse||participants|Number|66|66.0||||||
4349474|NCT00398086|4177310|B3|Visceral||Dominant Current Site of Metastasis/Relapse||participants|Number|3|3.0||||||
4349475|NCT00398086|4177311|B2|Visceral||Dominant Current Site of Metastasis/Relapse||participants|Number|44|44.0||||||
4349476|NCT00398086|4177312|B1|Visceral||Dominant Current Site of Metastasis/Relapse||participants|Number|19|19.0||||||
4349477|NCT00398086|4177309|B4|Other||Current Site(s) of Metastasis/Relapse|Patients could be in multiple sites of metastasis/relapse categories.|participants|Number|14|14.0||||||
4349478|NCT00398086|4177310|B3|Other||Current Site(s) of Metastasis/Relapse|Patients could be in multiple sites of metastasis/relapse categories.|participants|Number|0|0.0||||||
4349479|NCT00398086|4177311|B2|Other||Current Site(s) of Metastasis/Relapse|Patients could be in multiple sites of metastasis/relapse categories.|participants|Number|6|6.0||||||
4349480|NCT00398086|4177312|B1|Other||Current Site(s) of Metastasis/Relapse|Patients could be in multiple sites of metastasis/relapse categories.|participants|Number|8|8.0||||||
4349481|NCT00398086|4177309|B4|Pelvis||Current Site(s) of Metastasis/Relapse|Patients could be in multiple sites of metastasis/relapse categories.|participants|Number|5|5.0||||||
4349482|NCT00398086|4177310|B3|Pelvis||Current Site(s) of Metastasis/Relapse|Patients could be in multiple sites of metastasis/relapse categories.|participants|Number|1|1.0||||||
4349483|NCT00398086|4177311|B2|Pelvis||Current Site(s) of Metastasis/Relapse|Patients could be in multiple sites of metastasis/relapse categories.|participants|Number|3|3.0||||||
4349484|NCT00398086|4177312|B1|Pelvis||Current Site(s) of Metastasis/Relapse|Patients could be in multiple sites of metastasis/relapse categories.|participants|Number|1|1.0||||||
4349485|NCT00398086|4177309|B4|Abdomen/Peritoneum||Current Site(s) of Metastasis/Relapse|Patients could be in multiple sites of metastasis/relapse categories.|participants|Number|54|54.0||||||
4349486|NCT00398086|4177310|B3|Abdomen/Peritoneum||Current Site(s) of Metastasis/Relapse|Patients could be in multiple sites of metastasis/relapse categories.|participants|Number|1|1.0||||||
4349487|NCT00398086|4177311|B2|Abdomen/Peritoneum||Current Site(s) of Metastasis/Relapse|Patients could be in multiple sites of metastasis/relapse categories.|participants|Number|37|37.0||||||
4349488|NCT00398086|4177312|B1|Abdomen/Peritoneum||Current Site(s) of Metastasis/Relapse|Patients could be in multiple sites of metastasis/relapse categories.|participants|Number|16|16.0||||||
4349489|NCT00398086|4177309|B4|Liver||Current Site(s) of Metastasis/Relapse|Patients could be in multiple sites of metastasis/relapse categories.|participants|Number|46|46.0||||||
4349490|NCT00398086|4177310|B3|Liver||Current Site(s) of Metastasis/Relapse|Patients could be in multiple sites of metastasis/relapse categories.|participants|Number|2|2.0||||||
4349491|NCT00398086|4177311|B2|Liver||Current Site(s) of Metastasis/Relapse|Patients could be in multiple sites of metastasis/relapse categories.|participants|Number|33|33.0||||||
4349492|NCT00398086|4177312|B1|Liver||Current Site(s) of Metastasis/Relapse|Patients could be in multiple sites of metastasis/relapse categories.|participants|Number|11|11.0||||||
4349493|NCT00398086|4177309|B4|Lung/Thoracic||Current Site(s) of Metastasis/Relapse|Patients could be in multiple sites of metastasis/relapse categories.|participants|Number|24|24.0||||||
4349494|NCT00398086|4177310|B3|Lung/Thoracic||Current Site(s) of Metastasis/Relapse|Patients could be in multiple sites of metastasis/relapse categories.|participants|Number|1|1.0||||||
4349495|NCT00398086|4177311|B2|Lung/Thoracic||Current Site(s) of Metastasis/Relapse|Patients could be in multiple sites of metastasis/relapse categories.|participants|Number|18|18.0||||||
4349496|NCT00398086|4177312|B1|Lung/Thoracic||Current Site(s) of Metastasis/Relapse|Patients could be in multiple sites of metastasis/relapse categories.|participants|Number|5|5.0||||||
4349497|NCT00398086|4177309|B4|Bone||Current Site(s) of Metastasis/Relapse|Patients could be in multiple sites of metastasis/relapse categories.|participants|Number|4|4.0||||||
4349498|NCT00398086|4177310|B3|Bone||Current Site(s) of Metastasis/Relapse|Patients could be in multiple sites of metastasis/relapse categories.|participants|Number|0|0.0||||||
4349499|NCT00398086|4177311|B2|Bone||Current Site(s) of Metastasis/Relapse|Patients could be in multiple sites of metastasis/relapse categories.|participants|Number|3|3.0||||||
4349500|NCT00398086|4177312|B1|Bone||Current Site(s) of Metastasis/Relapse|Patients could be in multiple sites of metastasis/relapse categories.|participants|Number|1|1.0||||||
4349501|NCT00398086|4177309|B4|Axilla||Current Site(s) of Metastasis/Relapse|Patients could be in multiple sites of metastasis/relapse categories.|participants|Number|2|2.0||||||
4349502|NCT00398086|4177310|B3|Axilla||Current Site(s) of Metastasis/Relapse|Patients could be in multiple sites of metastasis/relapse categories.|participants|Number|0|0.0||||||
4349503|NCT00398086|4177311|B2|Axilla||Current Site(s) of Metastasis/Relapse|Patients could be in multiple sites of metastasis/relapse categories.|participants|Number|0|0.0||||||
4349504|NCT00398086|4177312|B1|Axilla||Current Site(s) of Metastasis/Relapse|Patients could be in multiple sites of metastasis/relapse categories.|participants|Number|2|2.0||||||
4349505|NCT00398086|4177309|B4|Supraclavicular Nodes||Current Site(s) of Metastasis/Relapse|Patients could be in multiple sites of metastasis/relapse categories.|participants|Number|2|2.0||||||
4349506|NCT00398086|4177310|B3|Supraclavicular Nodes||Current Site(s) of Metastasis/Relapse|Patients could be in multiple sites of metastasis/relapse categories.|participants|Number|0|0.0||||||
4349507|NCT00398086|4177311|B2|Supraclavicular Nodes||Current Site(s) of Metastasis/Relapse|Patients could be in multiple sites of metastasis/relapse categories.|participants|Number|2|2.0||||||
4349508|NCT00398086|4177312|B1|Supraclavicular Nodes||Current Site(s) of Metastasis/Relapse|Patients could be in multiple sites of metastasis/relapse categories.|participants|Number|0|0.0||||||
4349509|NCT00398086|4177309|B4|Skin/Soft Tissue||Current Site(s) of Metastasis/Relapse|Patients could be in multiple sites of metastasis/relapse categories.|participants|Number|1|1.0||||||
4349510|NCT00398086|4177310|B3|Skin/Soft Tissue||Current Site(s) of Metastasis/Relapse|Patients could be in multiple sites of metastasis/relapse categories.|participants|Number|0|0.0||||||
4349511|NCT00398086|4177311|B2|Skin/Soft Tissue||Current Site(s) of Metastasis/Relapse|Patients could be in multiple sites of metastasis/relapse categories.|participants|Number|1|1.0||||||
4349512|NCT00398086|4177312|B1|Skin/Soft Tissue||Current Site(s) of Metastasis/Relapse|Patients could be in multiple sites of metastasis/relapse categories.|participants|Number|0|0.0||||||
4349513|NCT00398086|4177309|B4|||Time from First Documented Metastasis/Relapse to Study Entry||months|Median|0.7|0.7|Full Range|||0.0|13.0|
4349514|NCT00398086|4177310|B3|||Time from First Documented Metastasis/Relapse to Study Entry||months|Median|0.3|0.3|Full Range|||0.0|1.0|
4349515|NCT00398086|4177311|B2|||Time from First Documented Metastasis/Relapse to Study Entry||months|Median|0.7|0.7|Full Range|||0.0|13.0|
4349516|NCT00398086|4177312|B1|||Time from First Documented Metastasis/Relapse to Study Entry||months|Median|0.8|0.8|Full Range|||0.0|11.0|
4349517|NCT00398086|4177309|B4|||Histology of Primary Diagnosis: Adenocarcinoma||participants|Number|67|67.0||||||
4349518|NCT00398086|4177310|B3|||Histology of Primary Diagnosis: Adenocarcinoma||participants|Number|3|3.0||||||
4349519|NCT00398086|4177311|B2|||Histology of Primary Diagnosis: Adenocarcinoma||participants|Number|44|44.0||||||
4349520|NCT00398086|4177312|B1|||Histology of Primary Diagnosis: Adenocarcinoma||participants|Number|20|20.0||||||
4349521|NCT00398086|4177309|B4|1 (Restrictive but Ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|34|34.0||||||
4349522|NCT00398086|4177310|B3|1 (Restrictive but Ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|1|1.0||||||
4349523|NCT00398086|4177311|B2|1 (Restrictive but Ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|22|22.0||||||
4349524|NCT00398086|4177312|B1|1 (Restrictive but Ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|11|11.0||||||
4349525|NCT00398086|4177309|B4|0 (Fully Active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|33|33.0||||||
4349526|NCT00398086|4177310|B3|0 (Fully Active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|2|2.0||||||
4349527|NCT00398086|4177311|B2|0 (Fully Active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|22|22.0||||||
4349528|NCT00398086|4177312|B1|0 (Fully Active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|9|9.0||||||
4349529|NCT00398086|4177309|B4|United States||Region of Enrollment||participants|Number|67|67.0||||||
4349530|NCT00398086|4177310|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4349531|NCT00398086|4177311|B2|United States||Region of Enrollment||participants|Number|44|44.0||||||
4349532|NCT00398086|4177312|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4349533|NCT00398086|4177309|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4349534|NCT00398086|4177310|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4349535|NCT00398086|4177311|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4349536|NCT00398086|4177312|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4349537|NCT00398086|4177309|B4|White, Hispanic, or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4349538|NCT00398086|4177310|B3|White, Hispanic, or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4349539|NCT00398086|4177311|B2|White, Hispanic, or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4349540|NCT00398086|4177312|B1|White, Hispanic, or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4349541|NCT00398086|4177309|B4|White, Non-Hispanic, and Non-Latino||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
4349542|NCT00398086|4177310|B3|White, Non-Hispanic, and Non-Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4349543|NCT00398086|4177311|B2|White, Non-Hispanic, and Non-Latino||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4349544|NCT00398086|4177312|B1|White, Non-Hispanic, and Non-Latino||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4349545|NCT00398086|4177309|B4|Black, of African Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4349546|NCT00398086|4177310|B3|Black, of African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4349547|NCT00398086|4177311|B2|Black, of African Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4349548|NCT00398086|4177312|B1|Black, of African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4349549|NCT00398086|4177309|B4|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4349550|NCT00398086|4177310|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4349551|NCT00398086|4177311|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4349552|NCT00398086|4177312|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4349553|NCT00398086|4177309|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4349554|NCT00398086|4177310|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4349555|NCT00398086|4177311|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4349556|NCT00398086|4177312|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4349557|NCT00398086|4177309|B4||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4349558|NCT00398086|4177310|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4349559|NCT00398086|4177311|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4349560|NCT00398086|4177312|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4349561|NCT00398086|4177309|B4|||Age||years|Median|62.0|62.0|Full Range|||28.0|86.0|
4349562|NCT00398086|4177310|B3|||Age||years|Median|69.0|69.0|Full Range|||53.0|72.0|
4349563|NCT00398086|4177311|B2|||Age||years|Median|61.5|61.5|Full Range|||28.0|78.0|
4349564|NCT00398086|4177312|B1|||Age||years|Median|62.0|62.0|Full Range|||30.0|86.0|
4349565|NCT00398073|4177346|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
4349566|NCT00398073|4177347|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4349567|NCT00398073|4177348|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4349568|NCT00398073|4177346|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4349569|NCT00398073|4177347|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4349570|NCT00398073|4177348|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4349571|NCT00398073|4177346|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4349572|NCT00398073|4177347|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4349573|NCT00398073|4177348|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4349574|NCT00398073|4177346|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4349575|NCT00398073|4177347|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4349576|NCT00398073|4177348|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4349577|NCT00398073|4177346|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4349578|NCT00398073|4177347|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4349579|NCT00398073|4177348|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4349580|NCT00398073|4177346|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4349581|NCT00398073|4177347|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4349582|NCT00398073|4177348|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4349583|NCT00398047|4177359|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4349584|NCT00398047|4177359|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4349585|NCT00398047|4177359|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4349586|NCT00398047|4177359|B1|||Age||years|Mean|69.407|69.407|Standard Deviation|3.691|3.691|||
4349587|NCT00398047|4177359|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4349588|NCT00398047|4177359|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4349589|NCT00398047|4177359|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4349590|NCT00397982|4177369|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4349591|NCT00397982|4177369|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349592|NCT00397982|4177369|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349593|NCT00397982|4177369|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4349594|NCT00397982|4177369|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349699|NCT00397930|4177543|B1|Unknown||Cancer stage||participants|Number|19|19.0||||||
4349595|NCT00397982|4177369|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349596|NCT00397982|4177369|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349597|NCT00397982|4177369|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349598|NCT00397982|4177369|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349599|NCT00397982|4177369|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4349600|NCT00397982|4177369|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349601|NCT00397982|4177369|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4349602|NCT00397982|4177369|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4349603|NCT00397982|4177369|B1|||Age||years|Mean|61|61.0|Standard Deviation|15|15.0|||
4349604|NCT00397982|4177369|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4349605|NCT00397982|4177369|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4349606|NCT00397982|4177369|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4349607|NCT00397943|4177378|B6|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4349608|NCT00397943|4177379|B5|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4349609|NCT00397943|4177380|B4|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4349610|NCT00397943|4177381|B3|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4349611|NCT00397943|4177382|B2|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4349612|NCT00397943|4177383|B1|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4349613|NCT00397943|4177378|B6|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|107|107.0||||||
4349614|NCT00397943|4177379|B5|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4349615|NCT00397943|4177380|B4|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4349616|NCT00397943|4177381|B3|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4349617|NCT00397943|4177382|B2|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
4349618|NCT00397943|4177383|B1|White-Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
4349619|NCT00397943|4177378|B6|White-Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4349620|NCT00397943|4177379|B5|White-Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4349621|NCT00397943|4177380|B4|White-Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4349622|NCT00397943|4177381|B3|White-Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4349623|NCT00397943|4177382|B2|White-Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4349624|NCT00397943|4177383|B1|White-Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4349625|NCT00397943|4177378|B6||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4349626|NCT00397943|4177379|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4349627|NCT00397943|4177380|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4349628|NCT00397943|4177381|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4349629|NCT00397943|4177382|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4349630|NCT00397943|4177383|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4349631|NCT00397943|4177378|B6||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4349632|NCT00397943|4177379|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4349633|NCT00397943|4177380|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4349634|NCT00397943|4177381|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4349635|NCT00397943|4177382|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4349636|NCT00397943|4177383|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4349637|NCT00397943|4177378|B6|||Age||Years|Mean|25.89|25.89|Standard Deviation|7.11|7.11|||
4349638|NCT00397943|4177379|B5|||Age||Years|Mean|25.9|25.9|Standard Deviation|7.95|7.95|||
4349639|NCT00397943|4177380|B4|||Age||Years|Mean|24.8|24.8|Standard Deviation|5.33|5.33|||
4349640|NCT00397943|4177381|B3|||Age||Years|Mean|28.5|28.5|Standard Deviation|6.95|6.95|||
4349641|NCT00397943|4177382|B2|||Age||Years|Mean|26.4|26.4|Standard Deviation|7.97|7.97|||
4349642|NCT00397943|4177383|B1|||Age||Years|Mean|25.0|25.0|Standard Deviation|6.50|6.5|||
4349643|NCT00397930|4177541|B3|Unknown||Exercise stage of change||participants|Number|9|9.0||||||
4349644|NCT00397930|4177542|B2|Unknown||Exercise stage of change||participants|Number|5|5.0||||||
4349645|NCT00397930|4177543|B1|Unknown||Exercise stage of change||participants|Number|4|4.0||||||
4349646|NCT00397930|4177541|B3|Exercising and have been for more than 6 months||Exercise stage of change||participants|Number|120|120.0||||||
4349647|NCT00397930|4177542|B2|Exercising and have been for more than 6 months||Exercise stage of change||participants|Number|58|58.0||||||
4349648|NCT00397930|4177543|B1|Exercising and have been for more than 6 months||Exercise stage of change||participants|Number|62|62.0||||||
4349649|NCT00397930|4177541|B3|Exercising and have been for less than 6 months||Exercise stage of change||participants|Number|87|87.0||||||
4349650|NCT00397930|4177542|B2|Exercising and have been for less than 6 months||Exercise stage of change||participants|Number|43|43.0||||||
4349651|NCT00397930|4177543|B1|Exercising and have been for less than 6 months||Exercise stage of change||participants|Number|44|44.0||||||
4349652|NCT00397930|4177541|B3|Not exercising but intend to begin in next 30 days||Exercise stage of change||participants|Number|95|95.0||||||
4349653|NCT00397930|4177542|B2|Not exercising but intend to begin in next 30 days||Exercise stage of change||participants|Number|50|50.0||||||
4349654|NCT00397930|4177543|B1|Not exercising but intend to begin in next 30 days||Exercise stage of change||participants|Number|45|45.0||||||
4349655|NCT00397930|4177541|B3|Not exercising but intend to in next 6 mo||Exercise stage of change||participants|Number|81|81.0||||||
4349656|NCT00397930|4177542|B2|Not exercising but intend to in next 6 mo||Exercise stage of change||participants|Number|38|38.0||||||
4349657|NCT00397930|4177543|B1|Not exercising but intend to in next 6 mo||Exercise stage of change||participants|Number|43|43.0||||||
4349658|NCT00397930|4177541|B3|Not exercising and do not intend to in next 6 mo||Exercise stage of change||participants|Number|18|18.0||||||
4349659|NCT00397930|4177542|B2|Not exercising and do not intend to in next 6 mo||Exercise stage of change||participants|Number|10|10.0||||||
4349660|NCT00397930|4177543|B1|Not exercising and do not intend to in next 6 mo||Exercise stage of change||participants|Number|8|8.0||||||
4349661|NCT00397930|4177541|B3|||Karnofsky performance status|The Karnofsky Performance Scale (KPS) Index allows patients to be classified as to their functional impairment. Essentially as used in oncology, the KPS is a measure of time to death. A higher score is favorable. There are 3 general categories which are broken down into 11 specific criteria. Scale range is from 0 (Dead) to 100 (Normal, no complaints, no evidence of disease). The scale increases in units of 10.|Karnofsky performance scale|Mean|87.4|87.4|Standard Deviation|32.6|32.6|||
4349662|NCT00397930|4177542|B2|||Karnofsky performance status|The Karnofsky Performance Scale (KPS) Index allows patients to be classified as to their functional impairment. Essentially as used in oncology, the KPS is a measure of time to death. A higher score is favorable. There are 3 general categories which are broken down into 11 specific criteria. Scale range is from 0 (Dead) to 100 (Normal, no complaints, no evidence of disease). The scale increases in units of 10.|Karnofsky performance scale|Mean|87.8|87.8|Standard Deviation|32.00|32.0|||
4349663|NCT00397930|4177543|B1|||Karnofsky performance status|The Karnofsky Performance Scale (KPS) Index allows patients to be classified as to their functional impairment. Essentially as used in oncology, the KPS is a measure of time to death. A higher score is favorable. There are 3 general categories which are broken down into 11 specific criteria. Scale range is from 0 (Dead) to 100 (Normal, no complaints, no evidence of disease). The scale increases in units of 10.|Karnofsky performance scale|Mean|86.9|86.9|Standard Deviation|33.15|33.15|||
4349664|NCT00397930|4177541|B3|||Time since first treatment for cancer||months|Mean|16.3|16.3|Standard Deviation|17.00|17.0|||
4349665|NCT00397930|4177542|B2|||Time since first treatment for cancer||months|Mean|17.7|17.7|Standard Deviation|23.00|23.0|||
4349666|NCT00397930|4177543|B1|||Time since first treatment for cancer||months|Mean|14.9|14.9|Standard Deviation|7.18|7.18|||
4349667|NCT00397930|4177541|B3|Unknown||Current hormone therapy||participants|Number|204|204.0||||||
4349668|NCT00397930|4177542|B2|Unknown||Current hormone therapy||participants|Number|97|97.0||||||
4349669|NCT00397930|4177543|B1|Unknown||Current hormone therapy||participants|Number|107|107.0||||||
4349670|NCT00397930|4177541|B3|Yes||Current hormone therapy||participants|Number|206|206.0||||||
4349671|NCT00397930|4177542|B2|Yes||Current hormone therapy||participants|Number|107|107.0||||||
4349672|NCT00397930|4177543|B1|Yes||Current hormone therapy||participants|Number|99|99.0||||||
4349673|NCT00397930|4177541|B3|No||Previous Treatment - Hormone treatment||participants|Number|382|382.0||||||
4349674|NCT00397930|4177542|B2|No||Previous Treatment - Hormone treatment||participants|Number|189|189.0||||||
4349675|NCT00397930|4177543|B1|No||Previous Treatment - Hormone treatment||participants|Number|193|193.0||||||
4349676|NCT00397930|4177541|B3|Yes||Previous Treatment - Hormone treatment||participants|Number|28|28.0||||||
4349677|NCT00397930|4177542|B2|Yes||Previous Treatment - Hormone treatment||participants|Number|15|15.0||||||
4349678|NCT00397930|4177543|B1|Yes||Previous Treatment - Hormone treatment||participants|Number|13|13.0||||||
4349679|NCT00397930|4177541|B3|No||Previous Treatment - Radiation therapy||participants|Number|144|144.0||||||
4349680|NCT00397930|4177542|B2|No||Previous Treatment - Radiation therapy||participants|Number|75|75.0||||||
4349681|NCT00397930|4177543|B1|No||Previous Treatment - Radiation therapy||participants|Number|69|69.0||||||
4349682|NCT00397930|4177541|B3|Yes||Previous Treatment - Radiation therapy||participants|Number|266|266.0||||||
4349683|NCT00397930|4177542|B2|Yes||Previous Treatment - Radiation therapy||participants|Number|129|129.0||||||
4349684|NCT00397930|4177543|B1|Yes||Previous Treatment - Radiation therapy||participants|Number|137|137.0||||||
4349685|NCT00397930|4177541|B3|No||Previous Treatment - Chemotherapy||participants|Number|126|126.0||||||
4349686|NCT00397930|4177542|B2|No||Previous Treatment - Chemotherapy||participants|Number|65|65.0||||||
4349687|NCT00397930|4177543|B1|No||Previous Treatment - Chemotherapy||participants|Number|61|61.0||||||
4349688|NCT00397930|4177541|B3|Yes||Previous Treatment - Chemotherapy||participants|Number|284|284.0||||||
4349689|NCT00397930|4177542|B2|Yes||Previous Treatment - Chemotherapy||participants|Number|139|139.0||||||
4349690|NCT00397930|4177543|B1|Yes||Previous Treatment - Chemotherapy||participants|Number|145|145.0||||||
4349691|NCT00397930|4177541|B3|No||Previous treatment - Surgery||participants|Number|46|46.0||||||
4349692|NCT00397930|4177542|B2|No||Previous treatment - Surgery||participants|Number|23|23.0||||||
4349693|NCT00397930|4177543|B1|No||Previous treatment - Surgery||participants|Number|23|23.0||||||
4349694|NCT00397930|4177541|B3|Yes||Previous treatment - Surgery||participants|Number|364|364.0||||||
4349695|NCT00397930|4177542|B2|Yes||Previous treatment - Surgery||participants|Number|181|181.0||||||
4349696|NCT00397930|4177543|B1|Yes||Previous treatment - Surgery||participants|Number|183|183.0||||||
4349697|NCT00397930|4177541|B3|Unknown||Cancer stage||participants|Number|32|32.0||||||
4349698|NCT00397930|4177542|B2|Unknown||Cancer stage||participants|Number|13|13.0||||||
4349700|NCT00397930|4177541|B3|IV||Cancer stage||participants|Number|11|11.0||||||
4349701|NCT00397930|4177542|B2|IV||Cancer stage||participants|Number|4|4.0||||||
4349702|NCT00397930|4177543|B1|IV||Cancer stage||participants|Number|7|7.0||||||
4349703|NCT00397930|4177541|B3|III||Cancer stage||participants|Number|64|64.0||||||
4349704|NCT00397930|4177542|B2|III||Cancer stage||participants|Number|32|32.0||||||
4349705|NCT00397930|4177543|B1|III||Cancer stage||participants|Number|32|32.0||||||
4349706|NCT00397930|4177541|B3|II||Cancer stage||participants|Number|137|137.0||||||
4349707|NCT00397930|4177542|B2|II||Cancer stage||participants|Number|66|66.0||||||
4349708|NCT00397930|4177543|B1|II||Cancer stage||participants|Number|71|71.0||||||
4349709|NCT00397930|4177541|B3|I||Cancer stage||participants|Number|145|145.0||||||
4349710|NCT00397930|4177542|B2|I||Cancer stage||participants|Number|79|79.0||||||
4349711|NCT00397930|4177543|B1|I||Cancer stage||participants|Number|66|66.0||||||
4349712|NCT00397930|4177541|B3|0||Cancer stage||participants|Number|21|21.0||||||
4349713|NCT00397930|4177542|B2|0||Cancer stage||participants|Number|10|10.0||||||
4349714|NCT00397930|4177543|B1|0||Cancer stage||participants|Number|11|11.0||||||
4349715|NCT00397930|4177541|B3|Other||Cancer type||participants|Number|28|28.0||||||
4349716|NCT00397930|4177542|B2|Other||Cancer type||participants|Number|8|8.0||||||
4349717|NCT00397930|4177543|B1|Other||Cancer type||participants|Number|20|20.0||||||
4349718|NCT00397930|4177541|B3|Alimentary||Cancer type||participants|Number|24|24.0||||||
4349719|NCT00397930|4177542|B2|Alimentary||Cancer type||participants|Number|17|17.0||||||
4349720|NCT00397930|4177543|B1|Alimentary||Cancer type||participants|Number|7|7.0||||||
4349721|NCT00397930|4177541|B3|Gynecologic||Cancer type||participants|Number|19|19.0||||||
4349722|NCT00397930|4177542|B2|Gynecologic||Cancer type||participants|Number|8|8.0||||||
4349723|NCT00397930|4177543|B1|Gynecologic||Cancer type||participants|Number|11|11.0||||||
4349724|NCT00397930|4177541|B3|Hematologic||Cancer type||participants|Number|30|30.0||||||
4349725|NCT00397930|4177542|B2|Hematologic||Cancer type||participants|Number|14|14.0||||||
4349726|NCT00397930|4177543|B1|Hematologic||Cancer type||participants|Number|16|16.0||||||
4349727|NCT00397930|4177541|B3|Breast||Cancer type||participants|Number|309|309.0||||||
4349728|NCT00397930|4177542|B2|Breast||Cancer type||participants|Number|157|157.0||||||
4349729|NCT00397930|4177543|B1|Breast||Cancer type||participants|Number|152|152.0||||||
4349730|NCT00397930|4177541|B3|Unknown||Education||participants|Number|8|8.0||||||
4349731|NCT00397930|4177542|B2|Unknown||Education||participants|Number|5|5.0||||||
4349732|NCT00397930|4177543|B1|Unknown||Education||participants|Number|3|3.0||||||
4349733|NCT00397930|4177541|B3|Less than a high school graduate||Education||participants|Number|3|3.0||||||
4349734|NCT00397930|4177542|B2|Less than a high school graduate||Education||participants|Number|1|1.0||||||
4349735|NCT00397930|4177543|B1|Less than a high school graduate||Education||participants|Number|2|2.0||||||
4349736|NCT00397930|4177541|B3|High school graduate||Education||participants|Number|69|69.0||||||
4349737|NCT00397930|4177542|B2|High school graduate||Education||participants|Number|36|36.0||||||
4349738|NCT00397930|4177543|B1|High school graduate||Education||participants|Number|33|33.0||||||
4349739|NCT00397930|4177541|B3|Completed < 4 years of college||Education||participants|Number|141|141.0||||||
4349740|NCT00397930|4177542|B2|Completed < 4 years of college||Education||participants|Number|69|69.0||||||
4349741|NCT00397930|4177543|B1|Completed < 4 years of college||Education||participants|Number|72|72.0||||||
4349742|NCT00397930|4177541|B3|Completed 4 years of college or more||Education||participants|Number|189|189.0||||||
4349743|NCT00397930|4177542|B2|Completed 4 years of college or more||Education||participants|Number|93|93.0||||||
4349744|NCT00397930|4177543|B1|Completed 4 years of college or more||Education||participants|Number|96|96.0||||||
4349745|NCT00397930|4177541|B3|Unknown||Marital status||participants|Number|9|9.0||||||
4349746|NCT00397930|4177542|B2|Unknown||Marital status||participants|Number|0|0.0||||||
4349747|NCT00397930|4177543|B1|Unknown||Marital status||participants|Number|9|9.0||||||
4349748|NCT00397930|4177541|B3|Widowed||Marital status||participants|Number|18|18.0||||||
4349749|NCT00397930|4177542|B2|Widowed||Marital status||participants|Number|12|12.0||||||
4349750|NCT00397930|4177543|B1|Widowed||Marital status||participants|Number|6|6.0||||||
4349751|NCT00397930|4177541|B3|Single||Marital status||participants|Number|35|35.0||||||
4349752|NCT00397930|4177542|B2|Single||Marital status||participants|Number|17|17.0||||||
4349753|NCT00397930|4177543|B1|Single||Marital status||participants|Number|18|18.0||||||
4349754|NCT00397930|4177541|B3|Divorced or separated||Marital status||participants|Number|60|60.0||||||
4349755|NCT00397930|4177542|B2|Divorced or separated||Marital status||participants|Number|32|32.0||||||
4349756|NCT00397930|4177543|B1|Divorced or separated||Marital status||participants|Number|28|28.0||||||
4349757|NCT00397930|4177541|B3|Married or long-term committed relationship||Marital status||participants|Number|288|288.0||||||
4349758|NCT00397930|4177542|B2|Married or long-term committed relationship||Marital status||participants|Number|143|143.0||||||
4349759|NCT00397930|4177543|B1|Married or long-term committed relationship||Marital status||participants|Number|145|145.0||||||
4349760|NCT00397930|4177541|B3|No||Currently employed||participants|Number|87|87.0||||||
4349761|NCT00397930|4177542|B2|No||Currently employed||participants|Number|49|49.0||||||
4349762|NCT00397930|4177543|B1|No||Currently employed||participants|Number|38|38.0||||||
4349763|NCT00397930|4177541|B3|Yes||Currently employed||participants|Number|323|323.0||||||
4349764|NCT00397930|4177542|B2|Yes||Currently employed||participants|Number|155|155.0||||||
4349765|NCT00397930|4177543|B1|Yes||Currently employed||participants|Number|168|168.0||||||
4349766|NCT00397930|4177541|B3|United States||Region of Enrollment||participants|Number|410|410.0||||||
4349767|NCT00397930|4177542|B2|United States||Region of Enrollment||participants|Number|204|204.0||||||
4349768|NCT00397930|4177543|B1|United States||Region of Enrollment||participants|Number|206|206.0||||||
4349769|NCT00397930|4177541|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4349770|NCT00397930|4177542|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4349771|NCT00397930|4177543|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4349772|NCT00397930|4177541|B3|African American||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4349773|NCT00397930|4177542|B2|African American||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4349774|NCT00397930|4177543|B1|African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4349775|NCT00397930|4177541|B3|White||Race/Ethnicity, Customized||participants|Number|383|383.0||||||
4349776|NCT00397930|4177542|B2|White||Race/Ethnicity, Customized||participants|Number|186|186.0||||||
4349777|NCT00397930|4177543|B1|White||Race/Ethnicity, Customized||participants|Number|197|197.0||||||
4349778|NCT00397930|4177541|B3||Male|Gender||Participants|Count of Participants|17|17.0||||||
4349779|NCT00397930|4177542|B2||Male|Gender||Participants|Count of Participants|8|8.0||||||
4349780|NCT00397930|4177543|B1||Male|Gender||Participants|Count of Participants|9|9.0||||||
4349781|NCT00397930|4177541|B3||Female|Gender||Participants|Count of Participants|393|393.0||||||
4349782|NCT00397930|4177542|B2||Female|Gender||Participants|Count of Participants|196|196.0||||||
4349783|NCT00397930|4177543|B1||Female|Gender||Participants|Count of Participants|197|197.0||||||
4349784|NCT00397930|4177541|B3|Age||Age, Customized||years|Mean|54.1|54.1|Standard Deviation|10.33|10.33|||
4349785|NCT00397930|4177542|B2|Age||Age, Customized||years|Mean|54|54.0|Standard Deviation|9.57|9.57|||
4349786|NCT00397930|4177543|B1|Age||Age, Customized||years|Mean|54.3|54.3|Standard Deviation|11.05|11.05|||
4349787|NCT00397904|4177550|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4349788|NCT00397904|4177550|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4349789|NCT00397904|4177550|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4349790|NCT00397904|4177550|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4349791|NCT00397904|4177550|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4349792|NCT00397904|4177550|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4349793|NCT00397891|4177554|B6||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4349794|NCT00397891|4177555|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4349795|NCT00397891|4177556|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4349796|NCT00397891|4177557|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4349797|NCT00397891|4177558|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4349798|NCT00397891|4177559|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4349799|NCT00397891|4177554|B6||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4349800|NCT00397891|4177555|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4349801|NCT00397891|4177556|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4349802|NCT00397891|4177557|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4349803|NCT00397891|4177558|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4349804|NCT00397891|4177559|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4349805|NCT00397891|4177554|B6|||Age||years|Mean|67.78|67.78|Standard Deviation|8.72|8.72|||
4349806|NCT00397891|4177555|B5|||Age||years|Mean|68.75|68.75|Standard Deviation|8.89|8.89|||
4349807|NCT00397891|4177556|B4|||Age||years|Mean|64.83|64.83|Standard Deviation|5.19|5.19|||
4349808|NCT00397891|4177557|B3|||Age||years|Mean|72.17|72.17|Standard Deviation|10.87|10.87|||
4349809|NCT00397891|4177558|B2|||Age||years|Mean|72.17|72.17|Standard Deviation|8.38|8.38|||
4349810|NCT00397891|4177559|B1|||Age||years|Mean|60.67|60.67|Standard Deviation|5.16|5.16|||
4349811|NCT00397878|4177661|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4349812|NCT00397878|4177661|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4349813|NCT00397878|4177661|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4349814|NCT00397878|4177661|B1|||Age||years|Median|60|60.0|Full Range|||46.0|70.0|
4349815|NCT00397839|4177665|B3||Male|Sex: Female, Male|Safety analysis population|Participants|Count of Participants|132|132.0||||||
4349816|NCT00397839|4177666|B2||Male|Sex: Female, Male|Safety analysis population|Participants|Count of Participants|85|85.0||||||
4349817|NCT00397839|4177667|B1||Male|Sex: Female, Male|Safety analysis population|Participants|Count of Participants|47|47.0||||||
4349818|NCT00397839|4177665|B3||Female|Sex: Female, Male|Safety analysis population|Participants|Count of Participants|0|0.0||||||
4349819|NCT00397839|4177666|B2||Female|Sex: Female, Male|Safety analysis population|Participants|Count of Participants|0|0.0||||||
4349820|NCT00397839|4177667|B1||Female|Sex: Female, Male|Safety analysis population|Participants|Count of Participants|0|0.0||||||
4349821|NCT00397839|4177665|B3|||Age|Safety analysis population|years|Mean|64.3|64.3|Standard Deviation|10.98|10.98|||
4349822|NCT00397839|4177666|B2|||Age|Safety analysis population|years|Mean|63.9|63.9|Standard Deviation|11.20|11.2|||
4349823|NCT00397839|4177667|B1|||Age|Safety analysis population|years|Mean|65.0|65.0|Standard Deviation|10.63|10.63|||
4349824|NCT00397839|4177665|B3|>= 65 years||Age, Customized|Safety analysis population|participants|Number|67|67.0||||||
4349825|NCT00397839|4177666|B2|>= 65 years||Age, Customized|Safety analysis population|participants|Number|43|43.0||||||
4349826|NCT00397839|4177667|B1|>= 65 years||Age, Customized|Safety analysis population|participants|Number|24|24.0||||||
4349827|NCT00397839|4177665|B3|< 65 years||Age, Customized|Safety analysis population|participants|Number|65|65.0||||||
4349828|NCT00397839|4177666|B2|< 65 years||Age, Customized|Safety analysis population|participants|Number|42|42.0||||||
4349829|NCT00397839|4177667|B1|< 65 years||Age, Customized|Safety analysis population|participants|Number|23|23.0||||||
4349830|NCT00397813|4177682|B7|United States||Region of Enrollment||participants|Number|77|77.0||||||
4349831|NCT00397813|4177683|B6|United States||Region of Enrollment||participants|Number|24|24.0||||||
4349832|NCT00397813|4177684|B5|United States||Region of Enrollment||participants|Number|5|5.0||||||
4349833|NCT00397813|4177685|B4|United States||Region of Enrollment||participants|Number|12|12.0||||||
4349834|NCT00397813|4177688|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4349835|NCT00397813|4177682|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4349836|NCT00397813|4177683|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349837|NCT00397813|4177684|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4349838|NCT00397813|4177685|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349839|NCT00397813|4177688|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4349840|NCT00397813|4177682|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4349841|NCT00397813|4177683|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4349842|NCT00397813|4177684|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349843|NCT00397813|4177685|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349844|NCT00397813|4177688|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349845|NCT00397813|4177682|B7||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4349846|NCT00397813|4177683|B6||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4349847|NCT00397813|4177684|B5||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4349848|NCT00397813|4177685|B4||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4349849|NCT00397813|4177688|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4349850|NCT00397813|4177682|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349851|NCT00397813|4177683|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349852|NCT00397813|4177684|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349853|NCT00397813|4177685|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349854|NCT00397813|4177688|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349855|NCT00397813|4177682|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349856|NCT00397813|4177683|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349857|NCT00397813|4177684|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349858|NCT00397813|4177685|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349859|NCT00397813|4177688|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349860|NCT00397813|4177682|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4349861|NCT00397813|4177683|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4349862|NCT00397813|4177684|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349863|NCT00397813|4177685|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349864|NCT00397813|4177688|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349865|NCT00397813|4177682|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349866|NCT00397813|4177683|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349867|NCT00397813|4177684|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349868|NCT00397813|4177685|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349869|NCT00397813|4177688|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349870|NCT00397813|4177682|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4349871|NCT00397813|4177683|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4349872|NCT00397813|4177684|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4349873|NCT00397813|4177685|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349874|NCT00397813|4177688|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349875|NCT00397813|4177682|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4349876|NCT00397813|4177683|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4349877|NCT00397813|4177684|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4349878|NCT00397813|4177685|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4349879|NCT00397813|4177688|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4349880|NCT00397813|4177682|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4349881|NCT00397813|4177683|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349882|NCT00397813|4177684|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349883|NCT00397813|4177685|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4349884|NCT00397813|4177688|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4349885|NCT00397813|4177682|B7||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4349886|NCT00397813|4177683|B6||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4349887|NCT00397813|4177684|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4349888|NCT00397813|4177685|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4349889|NCT00397813|4177688|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4349890|NCT00397813|4177682|B7||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4349891|NCT00397813|4177683|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4349892|NCT00397813|4177684|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4349893|NCT00397813|4177685|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4349894|NCT00397813|4177688|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4349895|NCT00397813|4177682|B7|||Age||years|Median|67|67.0|Full Range|||37.0|74.0|
4349896|NCT00397813|4177683|B6|||Age||years|Median|68.5|68.5|Full Range|||53.0|74.0|
4349897|NCT00397813|4177684|B5|||Age||years|Median|68|68.0|Full Range|||61.0|69.0|
4349898|NCT00397813|4177685|B4|||Age||years|Median|66.5|66.5|Full Range|||58.0|72.0|
4349899|NCT00397813|4177688|B1|||Age||years|Median|64.5|64.5|Full Range|||37.0|72.0|
4349900|NCT00397813|4177682|B7||>=65 years|Age||Participants|Count of Participants|47|47.0||||||
4349901|NCT00397813|4177683|B6||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4349902|NCT00397813|4177684|B5||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4349903|NCT00397813|4177685|B4||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4349904|NCT00397813|4177686|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4349905|NCT00397813|4177687|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4349906|NCT00397813|4177688|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4349907|NCT00397813|4177682|B7||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4349908|NCT00397813|4177683|B6||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4349909|NCT00397813|4177684|B5||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4349910|NCT00397813|4177685|B4||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4349911|NCT00397813|4177686|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4349912|NCT00397813|4177687|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4349913|NCT00397813|4177688|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4349914|NCT00397813|4177682|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4349915|NCT00397813|4177683|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4349916|NCT00397813|4177684|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4349917|NCT00397813|4177685|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4349918|NCT00397813|4177686|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4349919|NCT00397813|4177687|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4349920|NCT00397813|4177688|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4349921|NCT00397631|4177731|B3|||HbA1c (Hemoglobin A1C)||Percent|Mean|9.5|9.5|Standard Deviation|1.2|1.2|||
4349922|NCT00397631|4177732|B2|||HbA1c (Hemoglobin A1C)||Percent|Mean|9.5|9.5|Standard Deviation|1.2|1.2|||
4349923|NCT00397631|4177733|B1|||HbA1c (Hemoglobin A1C)||Percent|Mean|9.5|9.5|Standard Deviation|1.2|1.2|||
4349924|NCT00397631|4177731|B3|Other||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
4349925|NCT00397631|4177732|B2|Other||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4349926|NCT00397631|4177733|B1|Other||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4349927|NCT00397631|4177731|B3|Asian||Race/Ethnicity, Customized||participants|Number|168|168.0||||||
4349928|NCT00397631|4177732|B2|Asian||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
4349929|NCT00397631|4177733|B1|Asian||Race/Ethnicity, Customized||participants|Number|85|85.0||||||
4349930|NCT00397631|4177731|B3|Black||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4349931|NCT00397631|4177732|B2|Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4349932|NCT00397631|4177733|B1|Black||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4349933|NCT00397631|4177731|B3|White||Race/Ethnicity, Customized||participants|Number|272|272.0||||||
4349934|NCT00397631|4177732|B2|White||Race/Ethnicity, Customized||participants|Number|134|134.0||||||
4349935|NCT00397631|4177733|B1|White||Race/Ethnicity, Customized||participants|Number|138|138.0||||||
4349936|NCT00397631|4177731|B3||Male|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
4349937|NCT00397631|4177732|B2||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4349938|NCT00397631|4177733|B1||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4349939|NCT00397631|4177731|B3||Female|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
4349940|NCT00397631|4177732|B2||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4349941|NCT00397631|4177733|B1||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4349942|NCT00397631|4177731|B3|||Age||years|Mean|50.9|50.9|Standard Deviation|10.7|10.7|||
4349943|NCT00397631|4177732|B2|||Age||years|Mean|51.6|51.6|Standard Deviation|11.2|11.2|||
4349944|NCT00397631|4177733|B1|||Age||years|Mean|50.2|50.2|Standard Deviation|10.2|10.2|||
4349945|NCT00397540|4177744|B3|||Treatment modality||participants|Number|145|145.0||||||
4349946|NCT00397540|4177745|B2|||Treatment modality||participants|Number|85|85.0||||||
4349947|NCT00397540|4177746|B1|||Treatment modality||participants|Number|60|60.0||||||
4349948|NCT00397540|4177744|B3|Korea, Republic of||Region of Enrollment||participants|Number|145|145.0||||||
4349949|NCT00397540|4177745|B2|Korea, Republic of||Region of Enrollment||participants|Number|85|85.0||||||
4349950|NCT00397540|4177746|B1|Korea, Republic of||Region of Enrollment||participants|Number|60|60.0||||||
4349951|NCT00397540|4177744|B3||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4349952|NCT00397540|4177745|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4349953|NCT00397540|4177746|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4349954|NCT00397540|4177744|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4349955|NCT00397540|4177745|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4349956|NCT00397540|4177746|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4349957|NCT00397540|4177744|B3|||Age||years|Median|56|56.0|Full Range|||27.0|72.0|
4349958|NCT00397540|4177745|B2|||Age||years|Median|58|58.0|Full Range|||27.0|71.0|
4349959|NCT00397540|4177746|B1|||Age||years|Median|56|56.0|Full Range|||39.0|72.0|
4349960|NCT00397514|4177753|B1|Canada||Region of Enrollment||participants|Number|25|25.0||||||
4349961|NCT00397514|4177753|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4349962|NCT00397514|4177753|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4349963|NCT00397514|4177753|B1|Age, Continuous||Age||months|Median|5.2|5.2|Full Range|||0.1|37.4|
4349964|NCT00397514|4177753|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4349965|NCT00397514|4177753|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4349966|NCT00397514|4177753|B1||<=18 years|Age||Participants|Count of Participants|25|25.0||||||
4349967|NCT00397488|4177763|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4349968|NCT00397488|4177763|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4349969|NCT00397488|4177763|B1||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4349970|NCT00397488|4177763|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4349971|NCT00397488|4177763|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4349972|NCT00397462|4177767|B4|United States||Region of Enrollment||participants|Number|44|44.0||||||
4349973|NCT00397462|4177768|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4349974|NCT00397462|4177769|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4349975|NCT00397462|4177770|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4349976|NCT00397462|4177767|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4349977|NCT00397462|4177768|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4349978|NCT00397462|4177769|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4349979|NCT00397462|4177770|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4349980|NCT00397462|4177767|B4||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4349981|NCT00397462|4177768|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4349982|NCT00397462|4177769|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4349983|NCT00397462|4177770|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4349984|NCT00397462|4177767|B4|||Age||years|Mean|45.8|45.8|Standard Deviation|7.9|7.9|||
4349985|NCT00397462|4177768|B3|||Age||years|Mean|44.5|44.5|Standard Deviation|8.1|8.1|||
4349986|NCT00397462|4177769|B2|||Age||years|Mean|44.8|44.8|Standard Deviation|9.1|9.1|||
4349987|NCT00397462|4177770|B1|||Age||years|Mean|47.9|47.9|Standard Deviation|8.1|8.1|||
4349988|NCT00397462|4177767|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4349989|NCT00397462|4177768|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4349990|NCT00397462|4177769|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4349991|NCT00397462|4177770|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4349992|NCT00397462|4177767|B4||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4349993|NCT00397462|4177768|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4349994|NCT00397462|4177769|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4349995|NCT00397462|4177770|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4349996|NCT00397462|4177767|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4349997|NCT00397462|4177768|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4349998|NCT00397462|4177769|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4349999|NCT00397462|4177770|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4350000|NCT00397254|4177783|B1|United States||Region of Enrollment||participants|Number|197|197.0||||||
4350001|NCT00397254|4177783|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4350002|NCT00397254|4177783|B1||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4350003|NCT00397254|4177783|B1|||Age||years|Mean|42|42.0|Full Range|||18.0|61.0|
4350004|NCT00397254|4177783|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4350005|NCT00397254|4177783|B1||Between 18 and 65 years|Age||Participants|Count of Participants|197|197.0||||||
4350006|NCT00397254|4177783|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4350007|NCT00397215|4177802|B5||Male|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
4350008|NCT00397215|4177803|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4350009|NCT00397215|4177804|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4350010|NCT00397215|4177805|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4350011|NCT00397215|4177806|B1||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4350012|NCT00397215|4177802|B5||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4350013|NCT00397215|4177803|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4350014|NCT00397215|4177804|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4350015|NCT00397215|4177805|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4350016|NCT00397215|4177806|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4350017|NCT00397215|4177802|B5|||Age||Years|Mean|70.0|70.0|Standard Deviation|6.64|6.64|||
4350018|NCT00397215|4177803|B4|||Age||Years|Mean|70.8|70.8|Standard Deviation|7.35|7.35|||
4350019|NCT00397215|4177804|B3|||Age||Years|Mean|69.7|69.7|Standard Deviation|6.51|6.51|||
4350020|NCT00397215|4177805|B2|||Age||Years|Mean|69.9|69.9|Standard Deviation|6.38|6.38|||
4350021|NCT00397215|4177806|B1|||Age||Years|Mean|69.7|69.7|Standard Deviation|6.33|6.33|||
4350022|NCT00397189|4177943|B3|United Kingdom||Region of Enrollment||participants|Number|722|722.0||||||
4350023|NCT00397189|4177944|B2|United Kingdom||Region of Enrollment||participants|Number|362|362.0||||||
4350024|NCT00397189|4177945|B1|United Kingdom||Region of Enrollment||participants|Number|360|360.0||||||
4350025|NCT00397189|4177943|B3||Male|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
4350026|NCT00397189|4177944|B2||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4350027|NCT00397189|4177945|B1||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4350028|NCT00397189|4177943|B3||Female|Sex: Female, Male||Participants|Count of Participants|497|497.0||||||
4350029|NCT00397189|4177944|B2||Female|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
4350030|NCT00397189|4177945|B1||Female|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
4350031|NCT00397189|4177943|B3|||Age||years|Mean|61.7|61.7|Standard Deviation|10.2|10.2|||
4350032|NCT00397189|4177944|B2|||Age||years|Mean|61.5|61.5|Standard Deviation|10.5|10.5|||
4350033|NCT00397189|4177945|B1|||Age||years|Mean|61.9|61.9|Standard Deviation|10|10.0|||
4350034|NCT00397189|4177943|B3||>=65 years|Age||Participants|Count of Participants|281|281.0||||||
4350035|NCT00397189|4177944|B2||>=65 years|Age||Participants|Count of Participants|144|144.0||||||
4350036|NCT00397189|4177945|B1||>=65 years|Age||Participants|Count of Participants|137|137.0||||||
4350037|NCT00397189|4177943|B3||Between 18 and 65 years|Age||Participants|Count of Participants|441|441.0||||||
4350038|NCT00397189|4177944|B2||Between 18 and 65 years|Age||Participants|Count of Participants|218|218.0||||||
4350039|NCT00397189|4177945|B1||Between 18 and 65 years|Age||Participants|Count of Participants|223|223.0||||||
4350040|NCT00397189|4177943|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4350041|NCT00397189|4177944|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4350042|NCT00397189|4177945|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4350043|NCT00397150|4177954|B3|South Africa||Region of Enrollment||participants|Number|1020|1020.0||||||
4350044|NCT00397150|4177955|B2|South Africa||Region of Enrollment||participants|Number|485|485.0||||||
4350045|NCT00397150|4177956|B1|South Africa||Region of Enrollment||participants|Number|535|535.0||||||
4350046|NCT00397150|4177954|B3|Uganda||Region of Enrollment||participants|Number|765|765.0||||||
4350047|NCT00397150|4177955|B2|Uganda||Region of Enrollment||participants|Number|369|369.0||||||
4350048|NCT00397150|4177956|B1|Uganda||Region of Enrollment||participants|Number|396|396.0||||||
4350049|NCT00397150|4177954|B3|Burkina Faso||Region of Enrollment||participants|Number|794|794.0||||||
4350050|NCT00397150|4177955|B2|Burkina Faso||Region of Enrollment||participants|Number|402|402.0||||||
4350051|NCT00397150|4177956|B1|Burkina Faso||Region of Enrollment||participants|Number|392|392.0||||||
4350052|NCT00397150|4177954|B3||Male|Sex: Female, Male||Participants|Count of Participants|1289|1289.0||||||
4350053|NCT00397150|4177955|B2||Male|Sex: Female, Male||Participants|Count of Participants|628|628.0||||||
4350054|NCT00397150|4177956|B1||Male|Sex: Female, Male||Participants|Count of Participants|661|661.0||||||
4350055|NCT00397150|4177954|B3||Female|Sex: Female, Male||Participants|Count of Participants|1290|1290.0||||||
4350056|NCT00397150|4177955|B2||Female|Sex: Female, Male||Participants|Count of Participants|628|628.0||||||
4350057|NCT00397150|4177956|B1||Female|Sex: Female, Male||Participants|Count of Participants|662|662.0||||||
4350058|NCT00397150|4177954|B3|||Age||days|Median|7|7.0|Full Range|||5.0|9.0|
4350059|NCT00397150|4177955|B2|||Age||days|Median|7|7.0|Full Range|||5.0|9.0|
4350060|NCT00397150|4177956|B1|||Age||days|Median|7|7.0|Full Range|||5.0|9.0|
4350061|NCT00397150|4177954|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4350062|NCT00397150|4177955|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4350063|NCT00397150|4177956|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4350064|NCT00397150|4177954|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4350065|NCT00397150|4177955|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4350066|NCT00397150|4177956|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4350067|NCT00397150|4177954|B3||<=18 years|Age||Participants|Count of Participants|2579|2579.0||||||
4350068|NCT00397150|4177955|B2||<=18 years|Age||Participants|Count of Participants|1256|1256.0||||||
4350069|NCT00397150|4177956|B1||<=18 years|Age||Participants|Count of Participants|1323|1323.0||||||
4350070|NCT00397046|4177969|B5|Japanese||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
4350071|NCT00397046|4177970|B4|Japanese||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4350072|NCT00397046|4177971|B3|Japanese||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4350073|NCT00397046|4177972|B2|Japanese||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4350074|NCT00397046|4177973|B1|Japanese||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4350075|NCT00397046|4177969|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4350076|NCT00397046|4177970|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4350077|NCT00397046|4177971|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4350078|NCT00397046|4177972|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4350079|NCT00397046|4177973|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4350080|NCT00397046|4177969|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4350081|NCT00397046|4177970|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4350082|NCT00397046|4177971|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4350083|NCT00397046|4177972|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4350084|NCT00397046|4177973|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4350085|NCT00397046|4177969|B5|||Age||years|Mean|58.48|58.48|Standard Deviation|9.86|9.86|||
4350086|NCT00397046|4177970|B4|||Age||years|Mean|59.40|59.4|Standard Deviation|7.64|7.64|||
4350087|NCT00397046|4177971|B3|||Age||years|Mean|62.50|62.5|Standard Deviation|10.19|10.19|||
4350088|NCT00397046|4177972|B2|||Age||years|Mean|48.33|48.33|Standard Deviation|5.13|5.13|||
4350089|NCT00397046|4177973|B1|||Age||years|Mean|53.67|53.67|Standard Deviation|9.50|9.5|||
4350090|NCT00397046|4177969|B5||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4350091|NCT00397046|4177970|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4350092|NCT00397046|4177971|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4350093|NCT00397046|4177972|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4350094|NCT00397046|4177973|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4350095|NCT00397046|4177969|B5||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4350096|NCT00397046|4177970|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4350097|NCT00397046|4177971|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4350098|NCT00397046|4177972|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4350099|NCT00397046|4177973|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4350100|NCT00397046|4177969|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4350101|NCT00397046|4177970|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4350102|NCT00397046|4177971|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4350103|NCT00397046|4177972|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4350104|NCT00397046|4177973|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4350105|NCT00397033|4177995|B4|Ukraine||Region of Enrollment|Intent-to-Treat Population|participants|Number|63|63.0||||||
4350106|NCT00397033|4177996|B3|Ukraine||Region of Enrollment|Intent-to-Treat Population|participants|Number|21|21.0||||||
4350107|NCT00397033|4177997|B2|Ukraine||Region of Enrollment|Intent-to-Treat Population|participants|Number|19|19.0||||||
4350108|NCT00397033|4177998|B1|Ukraine||Region of Enrollment|Intent-to-Treat Population|participants|Number|23|23.0||||||
4350109|NCT00397033|4177995|B4|Russian Federation||Region of Enrollment|Intent-to-Treat Population|participants|Number|36|36.0||||||
4350110|NCT00397033|4177996|B3|Russian Federation||Region of Enrollment|Intent-to-Treat Population|participants|Number|11|11.0||||||
4350111|NCT00397033|4177997|B2|Russian Federation||Region of Enrollment|Intent-to-Treat Population|participants|Number|13|13.0||||||
4350112|NCT00397033|4177998|B1|Russian Federation||Region of Enrollment|Intent-to-Treat Population|participants|Number|12|12.0||||||
4350113|NCT00397033|4177995|B4|India||Region of Enrollment|Intent-to-Treat Population|participants|Number|98|98.0||||||
4350114|NCT00397033|4177996|B3|India||Region of Enrollment|Intent-to-Treat Population|participants|Number|31|31.0||||||
4350115|NCT00397033|4177997|B2|India||Region of Enrollment|Intent-to-Treat Population|participants|Number|34|34.0||||||
4350116|NCT00397033|4177998|B1|India||Region of Enrollment|Intent-to-Treat Population|participants|Number|33|33.0||||||
4350117|NCT00397033|4177995|B4|United States||Region of Enrollment|Intent-to-Treat Population|participants|Number|113|113.0||||||
4350118|NCT00397033|4177996|B3|United States||Region of Enrollment|Intent-to-Treat Population|participants|Number|35|35.0||||||
4350119|NCT00397033|4177997|B2|United States||Region of Enrollment|Intent-to-Treat Population|participants|Number|39|39.0||||||
4350120|NCT00397033|4177998|B1|United States||Region of Enrollment|Intent-to-Treat Population|participants|Number|39|39.0||||||
4350121|NCT00397033|4177995|B4||Male|Sex: Female, Male|Intent-to-Treat Population|Participants|Count of Participants|201|201.0||||||
4350122|NCT00397033|4177996|B3||Male|Sex: Female, Male|Intent-to-Treat Population|Participants|Count of Participants|64|64.0||||||
4350123|NCT00397033|4177997|B2||Male|Sex: Female, Male|Intent-to-Treat Population|Participants|Count of Participants|70|70.0||||||
4350124|NCT00397033|4177998|B1||Male|Sex: Female, Male|Intent-to-Treat Population|Participants|Count of Participants|67|67.0||||||
4350125|NCT00397033|4177995|B4||Female|Sex: Female, Male|Intent-to-Treat Population|Participants|Count of Participants|109|109.0||||||
4350126|NCT00397033|4177996|B3||Female|Sex: Female, Male|Intent-to-Treat Population|Participants|Count of Participants|34|34.0||||||
4350127|NCT00397033|4177997|B2||Female|Sex: Female, Male|Intent-to-Treat Population|Participants|Count of Participants|35|35.0||||||
4350128|NCT00397033|4177998|B1||Female|Sex: Female, Male|Intent-to-Treat Population|Participants|Count of Participants|40|40.0||||||
4350129|NCT00397033|4177995|B4|||Age|Intent-to-Treat Population|years|Mean|37.3|37.3|Standard Deviation|10.5|10.5|||
4350130|NCT00397033|4177996|B3|||Age|Intent-to-Treat Population|years|Mean|36.5|36.5|Standard Deviation|10.5|10.5|||
4350131|NCT00397033|4177997|B2|||Age|Intent-to-Treat Population|years|Mean|38.1|38.1|Standard Deviation|10.0|10.0|||
4350132|NCT00397033|4177998|B1|||Age|Intent-to-Treat Population|years|Mean|37.1|37.1|Standard Deviation|11.1|11.1|||
4350133|NCT00396981|4178059|B3|United Kingdom||Region of Enrollment||participants|Number|33|33.0||||||
4350134|NCT00396981|4178060|B2|United Kingdom||Region of Enrollment||participants|Number|16|16.0||||||
4350135|NCT00396981|4178061|B1|United Kingdom||Region of Enrollment||participants|Number|17|17.0||||||
4350136|NCT00396981|4178059|B3|China||Region of Enrollment||participants|Number|16|16.0||||||
4350137|NCT00396981|4178060|B2|China||Region of Enrollment||participants|Number|9|9.0||||||
4350138|NCT00396981|4178061|B1|China||Region of Enrollment||participants|Number|7|7.0||||||
4350139|NCT00396981|4178059|B3|Germany||Region of Enrollment||participants|Number|23|23.0||||||
4350140|NCT00396981|4178060|B2|Germany||Region of Enrollment||participants|Number|10|10.0||||||
4350141|NCT00396981|4178061|B1|Germany||Region of Enrollment||participants|Number|13|13.0||||||
4350142|NCT00396981|4178059|B3|Norway||Region of Enrollment||participants|Number|11|11.0||||||
4350143|NCT00396981|4178060|B2|Norway||Region of Enrollment||participants|Number|5|5.0||||||
4350144|NCT00396981|4178061|B1|Norway||Region of Enrollment||participants|Number|6|6.0||||||
4350145|NCT00396981|4178059|B3|Australia||Region of Enrollment||participants|Number|4|4.0||||||
4350146|NCT00396981|4178060|B2|Australia||Region of Enrollment||participants|Number|3|3.0||||||
4350147|NCT00396981|4178061|B1|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4350148|NCT00396981|4178059|B3|Turkey||Region of Enrollment||participants|Number|10|10.0||||||
4350149|NCT00396981|4178060|B2|Turkey||Region of Enrollment||participants|Number|6|6.0||||||
4350150|NCT00396981|4178061|B1|Turkey||Region of Enrollment||participants|Number|4|4.0||||||
4350151|NCT00396981|4178059|B3|Spain||Region of Enrollment||participants|Number|90|90.0||||||
4350152|NCT00396981|4178060|B2|Spain||Region of Enrollment||participants|Number|44|44.0||||||
4350153|NCT00396981|4178061|B1|Spain||Region of Enrollment||participants|Number|46|46.0||||||
4350154|NCT00396981|4178059|B3|Canada||Region of Enrollment||participants|Number|31|31.0||||||
4350155|NCT00396981|4178060|B2|Canada||Region of Enrollment||participants|Number|15|15.0||||||
4350156|NCT00396981|4178061|B1|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4350157|NCT00396981|4178059|B3|Mexico||Region of Enrollment||participants|Number|3|3.0||||||
4350158|NCT00396981|4178060|B2|Mexico||Region of Enrollment||participants|Number|2|2.0||||||
4350159|NCT00396981|4178061|B1|Mexico||Region of Enrollment||participants|Number|1|1.0||||||
4350160|NCT00396981|4178059|B3|United States||Region of Enrollment||participants|Number|373|373.0||||||
4350161|NCT00396981|4178060|B2|United States||Region of Enrollment||participants|Number|190|190.0||||||
4350162|NCT00396981|4178061|B1|United States||Region of Enrollment||participants|Number|183|183.0||||||
4350163|NCT00396981|4178059|B3|France||Region of Enrollment||participants|Number|32|32.0||||||
4350164|NCT00396981|4178060|B2|France||Region of Enrollment||participants|Number|15|15.0||||||
4350165|NCT00396981|4178061|B1|France||Region of Enrollment||participants|Number|17|17.0||||||
4350166|NCT00396981|4178059|B3||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4350167|NCT00396981|4178060|B2||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4350168|NCT00396981|4178061|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4350169|NCT00396981|4178059|B3||Female|Sex: Female, Male||Participants|Count of Participants|440|440.0||||||
4350170|NCT00396981|4178060|B2||Female|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4350171|NCT00396981|4178061|B1||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4350172|NCT00396981|4178059|B3|||Age||years|Mean|55.0|55.0|Standard Deviation|12.5|12.5|||
4350173|NCT00396981|4178060|B2|||Age||years|Mean|54.4|54.4|Standard Deviation|13.2|13.2|||
4350174|NCT00396981|4178061|B1|||Age||years|Mean|55.7|55.7|Standard Deviation|11.6|11.6|||
4350175|NCT00396877|4178080|B3|> 4 weeks||Time from shunt palliation to randomization||participants|Number|210|210.0||||||
4350176|NCT00396877|4178081|B2|> 4 weeks||Time from shunt palliation to randomization||participants|Number|109|109.0||||||
4350177|NCT00396877|4178082|B1|> 4 weeks||Time from shunt palliation to randomization||participants|Number|101|101.0||||||
4350178|NCT00396877|4178080|B3|2 (<) to 4 weeks||Time from shunt palliation to randomization||participants|Number|236|236.0||||||
4350179|NCT00396877|4178081|B2|2 (<) to 4 weeks||Time from shunt palliation to randomization||participants|Number|119|119.0||||||
4350180|NCT00396877|4178082|B1|2 (<) to 4 weeks||Time from shunt palliation to randomization||participants|Number|117|117.0||||||
4350181|NCT00396877|4178080|B3|1 (<) to 2 weeks||Time from shunt palliation to randomization||participants|Number|231|231.0||||||
4350182|NCT00396877|4178081|B2|1 (<) to 2 weeks||Time from shunt palliation to randomization||participants|Number|126|126.0||||||
4350183|NCT00396877|4178082|B1|1 (<) to 2 weeks||Time from shunt palliation to randomization||participants|Number|105|105.0||||||
4350184|NCT00396877|4178080|B3|≤ 1 week||Time from shunt palliation to randomization||participants|Number|229|229.0||||||
4350185|NCT00396877|4178081|B2|≤ 1 week||Time from shunt palliation to randomization||participants|Number|113|113.0||||||
4350186|NCT00396877|4178082|B1|≤ 1 week||Time from shunt palliation to randomization||participants|Number|116|116.0||||||
4350187|NCT00396877|4178080|B3|||Age at shunt palliation||days|Mean|16.1|16.1|Standard Deviation|18.7|18.7|||
4350188|NCT00396877|4178081|B2|||Age at shunt palliation||days|Mean|16.2|16.2|Standard Deviation|18.6|18.6|||
4350189|NCT00396877|4178082|B1|||Age at shunt palliation||days|Mean|16.0|16.0|Standard Deviation|18.7|18.7|||
4350190|NCT00396877|4178080|B3|No||Shunt on cardiopulmonary bypass||participants|Number|535|535.0||||||
4350191|NCT00396877|4178081|B2|No||Shunt on cardiopulmonary bypass||participants|Number|273|273.0||||||
4350192|NCT00396877|4178082|B1|No||Shunt on cardiopulmonary bypass||participants|Number|262|262.0||||||
4350193|NCT00396877|4178080|B3|Yes||Shunt on cardiopulmonary bypass||participants|Number|371|371.0||||||
4350194|NCT00396877|4178081|B2|Yes||Shunt on cardiopulmonary bypass||participants|Number|194|194.0||||||
4350195|NCT00396877|4178082|B1|Yes||Shunt on cardiopulmonary bypass||participants|Number|177|177.0||||||
4350196|NCT00396877|4178080|B3|Not applicable||Type of systemic-to-pulmonary artery shunt palliation|One participant didn't have a systemic-to-pulmonary artery shunt but underwent stenting of the right ventricular outflow track.|participants|Number|1|1.0||||||
4350197|NCT00396877|4178081|B2|Not applicable||Type of systemic-to-pulmonary artery shunt palliation|One participant didn't have a systemic-to-pulmonary artery shunt but underwent stenting of the right ventricular outflow track.|participants|Number|1|1.0||||||
4350198|NCT00396877|4178082|B1|Not applicable||Type of systemic-to-pulmonary artery shunt palliation|One participant didn't have a systemic-to-pulmonary artery shunt but underwent stenting of the right ventricular outflow track.|participants|Number|0|0.0||||||
4350199|NCT00396877|4178080|B3|Stent of ductus arteriosus||Type of systemic-to-pulmonary artery shunt palliation|One participant didn't have a systemic-to-pulmonary artery shunt but underwent stenting of the right ventricular outflow track.|participants|Number|84|84.0||||||
4350200|NCT00396877|4178081|B2|Stent of ductus arteriosus||Type of systemic-to-pulmonary artery shunt palliation|One participant didn't have a systemic-to-pulmonary artery shunt but underwent stenting of the right ventricular outflow track.|participants|Number|42|42.0||||||
4350201|NCT00396877|4178082|B1|Stent of ductus arteriosus||Type of systemic-to-pulmonary artery shunt palliation|One participant didn't have a systemic-to-pulmonary artery shunt but underwent stenting of the right ventricular outflow track.|participants|Number|42|42.0||||||
4350202|NCT00396877|4178080|B3|Central shunt||Type of systemic-to-pulmonary artery shunt palliation|One participant didn't have a systemic-to-pulmonary artery shunt but underwent stenting of the right ventricular outflow track.|participants|Number|78|78.0||||||
4350203|NCT00396877|4178081|B2|Central shunt||Type of systemic-to-pulmonary artery shunt palliation|One participant didn't have a systemic-to-pulmonary artery shunt but underwent stenting of the right ventricular outflow track.|participants|Number|40|40.0||||||
4350204|NCT00396877|4178082|B1|Central shunt||Type of systemic-to-pulmonary artery shunt palliation|One participant didn't have a systemic-to-pulmonary artery shunt but underwent stenting of the right ventricular outflow track.|participants|Number|38|38.0||||||
4350205|NCT00396877|4178080|B3|Sano procedure without Norwood||Type of systemic-to-pulmonary artery shunt palliation|One participant didn't have a systemic-to-pulmonary artery shunt but underwent stenting of the right ventricular outflow track.|participants|Number|7|7.0||||||
4350206|NCT00396877|4178081|B2|Sano procedure without Norwood||Type of systemic-to-pulmonary artery shunt palliation|One participant didn't have a systemic-to-pulmonary artery shunt but underwent stenting of the right ventricular outflow track.|participants|Number|5|5.0||||||
4350207|NCT00396877|4178082|B1|Sano procedure without Norwood||Type of systemic-to-pulmonary artery shunt palliation|One participant didn't have a systemic-to-pulmonary artery shunt but underwent stenting of the right ventricular outflow track.|participants|Number|2|2.0||||||
4350208|NCT00396877|4178080|B3|Sano procedure with Norwood||Type of systemic-to-pulmonary artery shunt palliation|One participant didn't have a systemic-to-pulmonary artery shunt but underwent stenting of the right ventricular outflow track.|participants|Number|114|114.0||||||
4350209|NCT00396877|4178081|B2|Sano procedure with Norwood||Type of systemic-to-pulmonary artery shunt palliation|One participant didn't have a systemic-to-pulmonary artery shunt but underwent stenting of the right ventricular outflow track.|participants|Number|60|60.0||||||
4350210|NCT00396877|4178082|B1|Sano procedure with Norwood||Type of systemic-to-pulmonary artery shunt palliation|One participant didn't have a systemic-to-pulmonary artery shunt but underwent stenting of the right ventricular outflow track.|participants|Number|54|54.0||||||
4350211|NCT00396877|4178080|B3|Modified Blalock Taussig Shunt without Norwood||Type of systemic-to-pulmonary artery shunt palliation|One participant didn't have a systemic-to-pulmonary artery shunt but underwent stenting of the right ventricular outflow track.|participants|Number|509|509.0||||||
4350212|NCT00396877|4178081|B2|Modified Blalock Taussig Shunt without Norwood||Type of systemic-to-pulmonary artery shunt palliation|One participant didn't have a systemic-to-pulmonary artery shunt but underwent stenting of the right ventricular outflow track.|participants|Number|257|257.0||||||
4350213|NCT00396877|4178082|B1|Modified Blalock Taussig Shunt without Norwood||Type of systemic-to-pulmonary artery shunt palliation|One participant didn't have a systemic-to-pulmonary artery shunt but underwent stenting of the right ventricular outflow track.|participants|Number|252|252.0||||||
4350214|NCT00396877|4178080|B3|Modified Blalock Taussig Shunt with Norwood||Type of systemic-to-pulmonary artery shunt palliation|One participant didn't have a systemic-to-pulmonary artery shunt but underwent stenting of the right ventricular outflow track.|participants|Number|113|113.0||||||
4350215|NCT00396877|4178081|B2|Modified Blalock Taussig Shunt with Norwood||Type of systemic-to-pulmonary artery shunt palliation|One participant didn't have a systemic-to-pulmonary artery shunt but underwent stenting of the right ventricular outflow track.|participants|Number|62|62.0||||||
4350216|NCT00396877|4178082|B1|Modified Blalock Taussig Shunt with Norwood||Type of systemic-to-pulmonary artery shunt palliation|One participant didn't have a systemic-to-pulmonary artery shunt but underwent stenting of the right ventricular outflow track.|participants|Number|51|51.0||||||
4350217|NCT00396877|4178080|B3|||Height||Centimeters (cm)|Mean|51.6|51.6|Standard Deviation|4.5|4.5|||
4350218|NCT00396877|4178081|B2|||Height||Centimeters (cm)|Mean|51.4|51.4|Standard Deviation|4.4|4.4|||
4350219|NCT00396877|4178082|B1|||Height||Centimeters (cm)|Mean|51.8|51.8|Standard Deviation|4.6|4.6|||
4350220|NCT00396877|4178080|B3|||Weight||kilograms (kg)|Mean|3.5|3.5|Standard Deviation|0.7|0.7|||
4350221|NCT00396877|4178081|B2|||Weight||kilograms (kg)|Mean|3.4|3.4|Standard Deviation|0.7|0.7|||
4350222|NCT00396877|4178082|B1|||Weight||kilograms (kg)|Mean|3.5|3.5|Standard Deviation|0.7|0.7|||
4350223|NCT00396877|4178080|B3|Sweden||Region of Enrollment||participants|Number|11|11.0||||||
4350224|NCT00396877|4178081|B2|Sweden||Region of Enrollment||participants|Number|5|5.0||||||
4350225|NCT00396877|4178082|B1|Sweden||Region of Enrollment||participants|Number|6|6.0||||||
4350226|NCT00396877|4178080|B3|Norway||Region of Enrollment||participants|Number|16|16.0||||||
4350227|NCT00396877|4178081|B2|Norway||Region of Enrollment||participants|Number|8|8.0||||||
4350228|NCT00396877|4178082|B1|Norway||Region of Enrollment||participants|Number|8|8.0||||||
4350229|NCT00396877|4178080|B3|Germany||Region of Enrollment||participants|Number|113|113.0||||||
4350230|NCT00396877|4178081|B2|Germany||Region of Enrollment||participants|Number|59|59.0||||||
4350231|NCT00396877|4178082|B1|Germany||Region of Enrollment||participants|Number|54|54.0||||||
4350232|NCT00396877|4178080|B3|Singapore||Region of Enrollment||participants|Number|4|4.0||||||
4350233|NCT00396877|4178081|B2|Singapore||Region of Enrollment||participants|Number|2|2.0||||||
4350234|NCT00396877|4178082|B1|Singapore||Region of Enrollment||participants|Number|2|2.0||||||
4350235|NCT00396877|4178080|B3|Poland||Region of Enrollment||participants|Number|10|10.0||||||
4350236|NCT00396877|4178081|B2|Poland||Region of Enrollment||participants|Number|7|7.0||||||
4350237|NCT00396877|4178082|B1|Poland||Region of Enrollment||participants|Number|3|3.0||||||
4350238|NCT00396877|4178080|B3|Belgium||Region of Enrollment||participants|Number|21|21.0||||||
4350239|NCT00396877|4178081|B2|Belgium||Region of Enrollment||participants|Number|12|12.0||||||
4350240|NCT00396877|4178082|B1|Belgium||Region of Enrollment||participants|Number|9|9.0||||||
4350241|NCT00396877|4178080|B3|Brazil||Region of Enrollment||participants|Number|65|65.0||||||
4350242|NCT00396877|4178081|B2|Brazil||Region of Enrollment||participants|Number|34|34.0||||||
4350243|NCT00396877|4178082|B1|Brazil||Region of Enrollment||participants|Number|31|31.0||||||
4350244|NCT00396877|4178080|B3|Argentina||Region of Enrollment||participants|Number|52|52.0||||||
4350245|NCT00396877|4178081|B2|Argentina||Region of Enrollment||participants|Number|28|28.0||||||
4350246|NCT00396877|4178082|B1|Argentina||Region of Enrollment||participants|Number|24|24.0||||||
4350247|NCT00396877|4178080|B3|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4350248|NCT00396877|4178081|B2|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4350249|NCT00396877|4178082|B1|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4350250|NCT00396877|4178080|B3|Mexico||Region of Enrollment||participants|Number|69|69.0||||||
4350251|NCT00396877|4178081|B2|Mexico||Region of Enrollment||participants|Number|37|37.0||||||
4350252|NCT00396877|4178082|B1|Mexico||Region of Enrollment||participants|Number|32|32.0||||||
4350253|NCT00396877|4178080|B3|Hungary||Region of Enrollment||participants|Number|18|18.0||||||
4350254|NCT00396877|4178081|B2|Hungary||Region of Enrollment||participants|Number|9|9.0||||||
4350255|NCT00396877|4178082|B1|Hungary||Region of Enrollment||participants|Number|9|9.0||||||
4350256|NCT00396877|4178080|B3|Egypt||Region of Enrollment||participants|Number|10|10.0||||||
4350257|NCT00396877|4178081|B2|Egypt||Region of Enrollment||participants|Number|6|6.0||||||
4350258|NCT00396877|4178082|B1|Egypt||Region of Enrollment||participants|Number|4|4.0||||||
4350259|NCT00396877|4178080|B3|United Kingdom||Region of Enrollment||participants|Number|32|32.0||||||
4350260|NCT00396877|4178081|B2|United Kingdom||Region of Enrollment||participants|Number|16|16.0||||||
4350261|NCT00396877|4178082|B1|United Kingdom||Region of Enrollment||participants|Number|16|16.0||||||
4350262|NCT00396877|4178080|B3|Finland||Region of Enrollment||participants|Number|3|3.0||||||
4350263|NCT00396877|4178081|B2|Finland||Region of Enrollment||participants|Number|1|1.0||||||
4350264|NCT00396877|4178082|B1|Finland||Region of Enrollment||participants|Number|2|2.0||||||
4350265|NCT00396877|4178080|B3|Korea, Republic of||Region of Enrollment||participants|Number|5|5.0||||||
4350266|NCT00396877|4178081|B2|Korea, Republic of||Region of Enrollment||participants|Number|2|2.0||||||
4350267|NCT00396877|4178082|B1|Korea, Republic of||Region of Enrollment||participants|Number|3|3.0||||||
4350268|NCT00396877|4178080|B3|China||Region of Enrollment||participants|Number|21|21.0||||||
4350269|NCT00396877|4178081|B2|China||Region of Enrollment||participants|Number|11|11.0||||||
4350270|NCT00396877|4178082|B1|China||Region of Enrollment||participants|Number|10|10.0||||||
4350271|NCT00396877|4178080|B3|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
4350272|NCT00396877|4178081|B2|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
4350273|NCT00396877|4178082|B1|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
4350274|NCT00396877|4178080|B3|South Africa||Region of Enrollment||participants|Number|26|26.0||||||
4350275|NCT00396877|4178081|B2|South Africa||Region of Enrollment||participants|Number|13|13.0||||||
4350276|NCT00396877|4178082|B1|South Africa||Region of Enrollment||participants|Number|13|13.0||||||
4350277|NCT00396877|4178080|B3|Denmark||Region of Enrollment||participants|Number|6|6.0||||||
4350278|NCT00396877|4178081|B2|Denmark||Region of Enrollment||participants|Number|3|3.0||||||
4350279|NCT00396877|4178082|B1|Denmark||Region of Enrollment||participants|Number|3|3.0||||||
4350280|NCT00396877|4178080|B3|Malaysia||Region of Enrollment||participants|Number|9|9.0||||||
4350281|NCT00396877|4178081|B2|Malaysia||Region of Enrollment||participants|Number|4|4.0||||||
4350282|NCT00396877|4178082|B1|Malaysia||Region of Enrollment||participants|Number|5|5.0||||||
4350283|NCT00396877|4178080|B3|France||Region of Enrollment||participants|Number|21|21.0||||||
4350284|NCT00396877|4178081|B2|France||Region of Enrollment||participants|Number|10|10.0||||||
4350285|NCT00396877|4178082|B1|France||Region of Enrollment||participants|Number|11|11.0||||||
4350286|NCT00396877|4178080|B3|India||Region of Enrollment||participants|Number|47|47.0||||||
4350287|NCT00396877|4178081|B2|India||Region of Enrollment||participants|Number|27|27.0||||||
4350288|NCT00396877|4178082|B1|India||Region of Enrollment||participants|Number|20|20.0||||||
4350289|NCT00396877|4178080|B3|Italy||Region of Enrollment||participants|Number|39|39.0||||||
4350290|NCT00396877|4178081|B2|Italy||Region of Enrollment||participants|Number|19|19.0||||||
4350291|NCT00396877|4178082|B1|Italy||Region of Enrollment||participants|Number|20|20.0||||||
4350292|NCT00396877|4178080|B3|Russian Federation||Region of Enrollment||participants|Number|28|28.0||||||
4350293|NCT00396877|4178081|B2|Russian Federation||Region of Enrollment||participants|Number|15|15.0||||||
4350294|NCT00396877|4178082|B1|Russian Federation||Region of Enrollment||participants|Number|13|13.0||||||
4350295|NCT00396877|4178080|B3|Israel||Region of Enrollment||participants|Number|7|7.0||||||
4350296|NCT00396877|4178081|B2|Israel||Region of Enrollment||participants|Number|4|4.0||||||
4350297|NCT00396877|4178082|B1|Israel||Region of Enrollment||participants|Number|3|3.0||||||
4350298|NCT00396877|4178080|B3|Spain||Region of Enrollment||participants|Number|30|30.0||||||
4350299|NCT00396877|4178081|B2|Spain||Region of Enrollment||participants|Number|14|14.0||||||
4350300|NCT00396877|4178082|B1|Spain||Region of Enrollment||participants|Number|16|16.0||||||
4350301|NCT00396877|4178080|B3|Thailand||Region of Enrollment||participants|Number|5|5.0||||||
4350302|NCT00396877|4178081|B2|Thailand||Region of Enrollment||participants|Number|3|3.0||||||
4350303|NCT00396877|4178082|B1|Thailand||Region of Enrollment||participants|Number|2|2.0||||||
4350304|NCT00396877|4178080|B3|Hong Kong||Region of Enrollment||participants|Number|1|1.0||||||
4350305|NCT00396877|4178081|B2|Hong Kong||Region of Enrollment||participants|Number|0|0.0||||||
4350306|NCT00396877|4178082|B1|Hong Kong||Region of Enrollment||participants|Number|1|1.0||||||
4350307|NCT00396877|4178080|B3|Taiwan||Region of Enrollment||participants|Number|22|22.0||||||
4350308|NCT00396877|4178081|B2|Taiwan||Region of Enrollment||participants|Number|10|10.0||||||
4350309|NCT00396877|4178082|B1|Taiwan||Region of Enrollment||participants|Number|12|12.0||||||
4350310|NCT00396877|4178080|B3|Portugal||Region of Enrollment||participants|Number|20|20.0||||||
4350311|NCT00396877|4178081|B2|Portugal||Region of Enrollment||participants|Number|10|10.0||||||
4350312|NCT00396877|4178082|B1|Portugal||Region of Enrollment||participants|Number|10|10.0||||||
4350313|NCT00396877|4178080|B3|United States||Region of Enrollment||participants|Number|178|178.0||||||
4350314|NCT00396877|4178081|B2|United States||Region of Enrollment||participants|Number|88|88.0||||||
4350315|NCT00396877|4178082|B1|United States||Region of Enrollment||participants|Number|90|90.0||||||
4350316|NCT00396877|4178080|B3||Male|Sex: Female, Male||Participants|Count of Participants|523|523.0||||||
4350317|NCT00396877|4178081|B2||Male|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
4350318|NCT00396877|4178082|B1||Male|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
4350319|NCT00396877|4178080|B3||Female|Sex: Female, Male||Participants|Count of Participants|383|383.0||||||
4350320|NCT00396877|4178081|B2||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4350321|NCT00396877|4178082|B1||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4350322|NCT00396877|4178080|B3|30 (<) - 92 days||Age, Customized||participants|Number|445|445.0||||||
4350323|NCT00396877|4178081|B2|30 (<) - 92 days||Age, Customized||participants|Number|229|229.0||||||
4350324|NCT00396877|4178082|B1|30 (<) - 92 days||Age, Customized||participants|Number|216|216.0||||||
4350325|NCT00396877|4178080|B3|≤ 30 days||Age, Customized||participants|Number|461|461.0||||||
4350326|NCT00396877|4178081|B2|≤ 30 days||Age, Customized||participants|Number|238|238.0||||||
4350327|NCT00396877|4178082|B1|≤ 30 days||Age, Customized||participants|Number|223|223.0||||||
4350328|NCT00396877|4178080|B3|||Age||days|Mean|36.1|36.1|Standard Deviation|22.4|22.4|||
4350329|NCT00396877|4178081|B2|||Age||days|Mean|36.1|36.1|Standard Deviation|22.3|22.3|||
4350330|NCT00396877|4178082|B1|||Age||days|Mean|36.0|36.0|Standard Deviation|22.5|22.5|||
4350331|NCT00396812|4178093|B1|||Disease Activity Score 28 -Erythrocyte Sedimentation Rate (DAS28-ESR)|The DAS28-ESR is a score on a scale (0 to 10) measure of the subject's disease activity. It is based on the tender joint count (28 joints), swollen joint count (28 joints), patient's global assessment of disease activity (mm), and ESR (mm/hour). Flares in disease activity are defined as an increase greater than 1.2 in this score and remission is defined as achieving a DAS28-ESR score of less than 2.6|Score on a scale|Mean|5.1|5.1|Standard Deviation|1.3|1.3|||
4350332|NCT00396812|4178093|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4350333|NCT00396812|4178093|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4350334|NCT00396812|4178093|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4350335|NCT00396812|4178093|B1|||Age||years|Mean|43.3|43.3|Standard Deviation|15.4|15.4|||
4350336|NCT00396812|4178093|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4350337|NCT00396812|4178093|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4350338|NCT00396812|4178093|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4350339|NCT00396656|4178105|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4350340|NCT00396656|4178105|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4350341|NCT00396656|4178105|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|7.2|7.2|||
4350342|NCT00396630|4178122|B3||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4350343|NCT00396630|4178123|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4350344|NCT00396630|4178124|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4350345|NCT00396630|4178122|B3||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4350346|NCT00396630|4178123|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4350347|NCT00396630|4178124|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4350348|NCT00396630|4178122|B3|||Age||Weeks|Mean|8.2|8.2|Standard Deviation|1.80|1.8|||
4350349|NCT00396630|4178123|B2|||Age||Weeks|Mean|8.2|8.2|Standard Deviation|1.80|1.8|||
4350350|NCT00396630|4178124|B1|||Age||Weeks|Mean|8.2|8.2|Standard Deviation|1.80|1.8|||
4350351|NCT00396591|4178145|B1|ECOG Score = 2||Eastern Cooperative Oncology Group (ECOG) performance status score|"The ECOG score assesses how the disease affects a participant's daily living abilities. It ranges from 0-5, with 0 being the best and 5 being the worst outcome. 0 reflects a fully active participant, able to carry on all pre-disease performance without restriction. 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. 2 reflects an ambulatory participant, who is up and about more than 50% of waking hours, and capable of all self-care but unable to carry out any work activities."|participants|Number|3|3.0||||||
4350352|NCT00396591|4178145|B1|ECOG Score = 1||Eastern Cooperative Oncology Group (ECOG) performance status score|"The ECOG score assesses how the disease affects a participant's daily living abilities. It ranges from 0-5, with 0 being the best and 5 being the worst outcome. 0 reflects a fully active participant, able to carry on all pre-disease performance without restriction. 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. 2 reflects an ambulatory participant, who is up and about more than 50% of waking hours, and capable of all self-care but unable to carry out any work activities."|participants|Number|10|10.0||||||
4350353|NCT00396591|4178145|B1|ECOG Score = 0||Eastern Cooperative Oncology Group (ECOG) performance status score|"The ECOG score assesses how the disease affects a participant's daily living abilities. It ranges from 0-5, with 0 being the best and 5 being the worst outcome. 0 reflects a fully active participant, able to carry on all pre-disease performance without restriction. 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. 2 reflects an ambulatory participant, who is up and about more than 50% of waking hours, and capable of all self-care but unable to carry out any work activities."|participants|Number|3|3.0||||||
4350354|NCT00396591|4178145|B1|||Baseline interval of paracentesis|Average of the two paracentesis intervals prior to the Day 1 paracentesis before registration.|days|Mean|16.5|16.5|Standard Deviation|7.8|7.8|||
4350355|NCT00396591|4178145|B1|Yes||Prior anticancer surgeries,||Participants|Number|15|15.0||||||
4350356|NCT00396591|4178145|B1|No||Prior anticancer surgeries,||Participants|Number|1|1.0||||||
4350357|NCT00396591|4178145|B1|Poorly differentiated||Histology grade||Participants|Number|10|10.0||||||
4350358|NCT00396591|4178145|B1|Moderately differentiated||Histology grade||Participants|Number|1|1.0||||||
4350359|NCT00396591|4178145|B1|Unknown||Histology grade||Participants|Number|5|5.0||||||
4350360|NCT00396591|4178145|B1|Missing data||Histology||Participants|Number|2|2.0||||||
4350361|NCT00396591|4178145|B1|Other||Histology||Participants|Number|1|1.0||||||
4350362|NCT00396591|4178145|B1|Clear cell (mesonephroid)||Histology||Participants|Number|1|1.0||||||
4350363|NCT00396591|4178145|B1|Endometrioid||Histology||Participants|Number|3|3.0||||||
4350364|NCT00396591|4178145|B1|Serous||Histology||Participants|Number|9|9.0||||||
4350365|NCT00396591|4178145|B1|||Time since initial cancer diagnosis||Years|Mean|2.8|2.8|Standard Deviation|1.7|1.7|||
4350366|NCT00396591|4178145|B1|||Primary tumor site - Ovaries||Participants|Number|16|16.0||||||
4350367|NCT00396591|4178145|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4350368|NCT00396591|4178145|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4350369|NCT00396591|4178145|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4350370|NCT00396591|4178145|B1|>=65 years||Age, Customized||participants|Number|5|5.0||||||
4350371|NCT00396591|4178145|B1|<65 years||Age, Customized||participants|Number|11|11.0||||||
4350372|NCT00396591|4178145|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|8.9|8.9|||
4350373|NCT00396565|4178155|B4|||Total Positive and Negative Syndrome Scale (PANSS) score|PANSS is a medical scale that assesses various symptoms of schizophrenia. Symptoms are rated on a 7-point scale from 1 (absent) to 7 (extreme psychopathology). Total score is the sum of all 30 PANSS items, with a range of 30 (absent) to 210 (extreme ill).|scores on a scale|Mean|91.9|91.9|Standard Deviation|12.2|12.2|||
4350374|NCT00396565|4178156|B3|||Total Positive and Negative Syndrome Scale (PANSS) score|PANSS is a medical scale that assesses various symptoms of schizophrenia. Symptoms are rated on a 7-point scale from 1 (absent) to 7 (extreme psychopathology). Total score is the sum of all 30 PANSS items, with a range of 30 (absent) to 210 (extreme ill).|scores on a scale|Mean|94.1|94.1|Standard Deviation|12.6|12.6|||
4350375|NCT00396565|4178157|B2|||Total Positive and Negative Syndrome Scale (PANSS) score|PANSS is a medical scale that assesses various symptoms of schizophrenia. Symptoms are rated on a 7-point scale from 1 (absent) to 7 (extreme psychopathology). Total score is the sum of all 30 PANSS items, with a range of 30 (absent) to 210 (extreme ill).|scores on a scale|Mean|91.0|91.0|Standard Deviation|11.2|11.2|||
4350376|NCT00396565|4178158|B1|||Total Positive and Negative Syndrome Scale (PANSS) score|PANSS is a medical scale that assesses various symptoms of schizophrenia. Symptoms are rated on a 7-point scale from 1 (absent) to 7 (extreme psychopathology). Total score is the sum of all 30 PANSS items, with a range of 30 (absent) to 210 (extreme ill).|scores on a scale|Mean|92.0|92.0|Standard Deviation|12.9|12.9|||
4350377|NCT00396565|4178155|B4||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4350378|NCT00396565|4178156|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4350379|NCT00396565|4178157|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4350380|NCT00396565|4178158|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4350381|NCT00396565|4178155|B4||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4350382|NCT00396565|4178156|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4350383|NCT00396565|4178157|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4350384|NCT00396565|4178158|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4350385|NCT00396565|4178155|B4|||Age||years|Mean|45.3|45.3|Standard Deviation|14.6|14.6|||
4350386|NCT00396565|4178156|B3|||Age||years|Mean|46.2|46.2|Standard Deviation|13.2|13.2|||
4350387|NCT00396565|4178157|B2|||Age||years|Mean|46.2|46.2|Standard Deviation|15.1|15.1|||
4350388|NCT00396565|4178158|B1|||Age||years|Mean|44.0|44.0|Standard Deviation|14.7|14.7|||
4350389|NCT00396409|4178183|B3|Unknown or Not Reported||Race/Ethnicity, Customized|2007 Open Label (OL) extension phase|participants|Number|0|0.0||||||
4350390|NCT00396409|4178184|B2|Unknown or Not Reported||Race/Ethnicity, Customized|2007 Open Label (OL) extension phase|participants|Number|0|0.0||||||
4350391|NCT00396409|4178185|B1|Unknown or Not Reported||Race/Ethnicity, Customized|2007 Open Label (OL) extension phase|participants|Number|0|0.0||||||
4350392|NCT00396409|4178183|B3|More than one race||Race/Ethnicity, Customized|2007 Open Label (OL) extension phase|participants|Number|0|0.0||||||
4350393|NCT00396409|4178184|B2|More than one race||Race/Ethnicity, Customized|2007 Open Label (OL) extension phase|participants|Number|0|0.0||||||
4350394|NCT00396409|4178185|B1|More than one race||Race/Ethnicity, Customized|2007 Open Label (OL) extension phase|participants|Number|0|0.0||||||
4350395|NCT00396409|4178183|B3|White||Race/Ethnicity, Customized|2007 Open Label (OL) extension phase|participants|Number|127|127.0||||||
4350396|NCT00396409|4178184|B2|White||Race/Ethnicity, Customized|2007 Open Label (OL) extension phase|participants|Number|62|62.0||||||
4350397|NCT00396409|4178185|B1|White||Race/Ethnicity, Customized|2007 Open Label (OL) extension phase|participants|Number|65|65.0||||||
4350398|NCT00396409|4178183|B3|Black or African American||Race/Ethnicity, Customized|2007 Open Label (OL) extension phase|participants|Number|0|0.0||||||
4350399|NCT00396409|4178184|B2|Black or African American||Race/Ethnicity, Customized|2007 Open Label (OL) extension phase|participants|Number|0|0.0||||||
4350400|NCT00396409|4178185|B1|Black or African American||Race/Ethnicity, Customized|2007 Open Label (OL) extension phase|participants|Number|0|0.0||||||
4350401|NCT00396409|4178183|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|2007 Open Label (OL) extension phase|participants|Number|0|0.0||||||
4350402|NCT00396409|4178184|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|2007 Open Label (OL) extension phase|participants|Number|0|0.0||||||
4350403|NCT00396409|4178185|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|2007 Open Label (OL) extension phase|participants|Number|0|0.0||||||
4350404|NCT00396409|4178183|B3|Asian||Race/Ethnicity, Customized|2007 Open Label (OL) extension phase|participants|Number|1|1.0||||||
4350405|NCT00396409|4178184|B2|Asian||Race/Ethnicity, Customized|2007 Open Label (OL) extension phase|participants|Number|1|1.0||||||
4350406|NCT00396409|4178185|B1|Asian||Race/Ethnicity, Customized|2007 Open Label (OL) extension phase|participants|Number|0|0.0||||||
4350407|NCT00396409|4178183|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|2007 Open Label (OL) extension phase|participants|Number|0|0.0||||||
4350408|NCT00396409|4178184|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|2007 Open Label (OL) extension phase|participants|Number|0|0.0||||||
4350409|NCT00396409|4178185|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|2007 Open Label (OL) extension phase|participants|Number|0|0.0||||||
4350410|NCT00396409|4178183|B3|Participated in 2007 but not in 2008||Race/Ethnicity, Customized|2008 Open Label (OL) extension phase (N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|14|14.0||||||
4350411|NCT00396409|4178184|B2|Participated in 2007 but not in 2008||Race/Ethnicity, Customized|2008 Open Label (OL) extension phase (N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|8|8.0||||||
4350412|NCT00396409|4178185|B1|Participated in 2007 but not in 2008||Race/Ethnicity, Customized|2008 Open Label (OL) extension phase (N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|6|6.0||||||
4350413|NCT00396409|4178183|B3|Unknown or Not Reported||Race/Ethnicity, Customized|2008 Open Label (OL) extension phase (N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|0|0.0||||||
4350414|NCT00396409|4178184|B2|Unknown or Not Reported||Race/Ethnicity, Customized|2008 Open Label (OL) extension phase (N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|0|0.0||||||
4350415|NCT00396409|4178185|B1|Unknown or Not Reported||Race/Ethnicity, Customized|2008 Open Label (OL) extension phase (N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|0|0.0||||||
4350416|NCT00396409|4178183|B3|More than one race||Race/Ethnicity, Customized|2008 Open Label (OL) extension phase (N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|0|0.0||||||
4350417|NCT00396409|4178184|B2|More than one race||Race/Ethnicity, Customized|2008 Open Label (OL) extension phase (N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|0|0.0||||||
4350418|NCT00396409|4178185|B1|More than one race||Race/Ethnicity, Customized|2008 Open Label (OL) extension phase (N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|0|0.0||||||
4350419|NCT00396409|4178183|B3|White||Race/Ethnicity, Customized|2008 Open Label (OL) extension phase (N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|113|113.0||||||
4350420|NCT00396409|4178184|B2|White||Race/Ethnicity, Customized|2008 Open Label (OL) extension phase (N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|54|54.0||||||
4350421|NCT00396409|4178185|B1|White||Race/Ethnicity, Customized|2008 Open Label (OL) extension phase (N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|59|59.0||||||
4350422|NCT00396409|4178183|B3|Black or African American||Race/Ethnicity, Customized|2008 Open Label (OL) extension phase (N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|0|0.0||||||
4350423|NCT00396409|4178184|B2|Black or African American||Race/Ethnicity, Customized|2008 Open Label (OL) extension phase (N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|0|0.0||||||
4350424|NCT00396409|4178185|B1|Black or African American||Race/Ethnicity, Customized|2008 Open Label (OL) extension phase (N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|0|0.0||||||
4350425|NCT00396409|4178183|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|2008 Open Label (OL) extension phase (N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|0|0.0||||||
4350461|NCT00396409|4178183|B3|>=65 years||Age, Customized|2007 Open Label (OL) extension phase|participants|Number|0|0.0||||||
4350426|NCT00396409|4178184|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|2008 Open Label (OL) extension phase (N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|0|0.0||||||
4350427|NCT00396409|4178185|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|2008 Open Label (OL) extension phase (N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|0|0.0||||||
4350428|NCT00396409|4178183|B3|Asian||Race/Ethnicity, Customized|2008 Open Label (OL) extension phase (N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|1|1.0||||||
4350429|NCT00396409|4178184|B2|Asian||Race/Ethnicity, Customized|2008 Open Label (OL) extension phase (N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|1|1.0||||||
4350430|NCT00396409|4178185|B1|Asian||Race/Ethnicity, Customized|2008 Open Label (OL) extension phase (N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|0|0.0||||||
4350431|NCT00396409|4178183|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|2008 Open Label (OL) extension phase (N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|0|0.0||||||
4350432|NCT00396409|4178184|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|2008 Open Label (OL) extension phase (N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|0|0.0||||||
4350433|NCT00396409|4178185|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|2008 Open Label (OL) extension phase (N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|0|0.0||||||
4350434|NCT00396409|4178183|B3|Participated in 2007 but not in 2008||Sex/Gender, Customized|2008 Open Label (OL) extension phase(N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|14|14.0||||||
4350435|NCT00396409|4178184|B2|Participated in 2007 but not in 2008||Sex/Gender, Customized|2008 Open Label (OL) extension phase(N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|8|8.0||||||
4350436|NCT00396409|4178185|B1|Participated in 2007 but not in 2008||Sex/Gender, Customized|2008 Open Label (OL) extension phase(N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|6|6.0||||||
4350437|NCT00396409|4178183|B3|2008 Male||Sex/Gender, Customized|2008 Open Label (OL) extension phase(N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|64|64.0||||||
4350438|NCT00396409|4178184|B2|2008 Male||Sex/Gender, Customized|2008 Open Label (OL) extension phase(N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|29|29.0||||||
4350439|NCT00396409|4178185|B1|2008 Male||Sex/Gender, Customized|2008 Open Label (OL) extension phase(N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|35|35.0||||||
4350440|NCT00396409|4178183|B3|2008 Female||Sex/Gender, Customized|2008 Open Label (OL) extension phase(N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|50|50.0||||||
4350441|NCT00396409|4178184|B2|2008 Female||Sex/Gender, Customized|2008 Open Label (OL) extension phase(N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|26|26.0||||||
4350442|NCT00396409|4178185|B1|2008 Female||Sex/Gender, Customized|2008 Open Label (OL) extension phase(N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|24|24.0||||||
4350443|NCT00396409|4178183|B3|2007 Male||Sex/Gender, Customized|2007 Open Label (OL) extension phase|participants|Number|73|73.0||||||
4350444|NCT00396409|4178184|B2|2007 Male||Sex/Gender, Customized|2007 Open Label (OL) extension phase|participants|Number|36|36.0||||||
4350445|NCT00396409|4178185|B1|2007 Male||Sex/Gender, Customized|2007 Open Label (OL) extension phase|participants|Number|37|37.0||||||
4350446|NCT00396409|4178183|B3|2007 Female||Sex/Gender, Customized|2007 Open Label (OL) extension phase|participants|Number|55|55.0||||||
4350447|NCT00396409|4178184|B2|2007 Female||Sex/Gender, Customized|2007 Open Label (OL) extension phase|participants|Number|27|27.0||||||
4350448|NCT00396409|4178185|B1|2007 Female||Sex/Gender, Customized|2007 Open Label (OL) extension phase|participants|Number|28|28.0||||||
4350449|NCT00396409|4178183|B3|Participated in 2007 but not in 2008||Age, Customized|2008 Open Label (OL) extension phase(N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|14|14.0||||||
4350450|NCT00396409|4178184|B2|Participated in 2007 but not in 2008||Age, Customized|2008 Open Label (OL) extension phase(N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|8|8.0||||||
4350451|NCT00396409|4178185|B1|Participated in 2007 but not in 2008||Age, Customized|2008 Open Label (OL) extension phase(N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|6|6.0||||||
4350452|NCT00396409|4178183|B3|>= 65 years||Age, Customized|2008 Open Label (OL) extension phase(N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|0|0.0||||||
4350453|NCT00396409|4178184|B2|>= 65 years||Age, Customized|2008 Open Label (OL) extension phase(N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|0|0.0||||||
4350454|NCT00396409|4178185|B1|>= 65 years||Age, Customized|2008 Open Label (OL) extension phase(N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|0|0.0||||||
4350455|NCT00396409|4178183|B3|Between 18 and 65 years||Age, Customized|2008 Open Label (OL) extension phase(N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|85|85.0||||||
4350456|NCT00396409|4178184|B2|Between 18 and 65 years||Age, Customized|2008 Open Label (OL) extension phase(N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|40|40.0||||||
4350457|NCT00396409|4178185|B1|Between 18 and 65 years||Age, Customized|2008 Open Label (OL) extension phase(N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|45|45.0||||||
4350458|NCT00396409|4178183|B3|<= 18 years||Age, Customized|2008 Open Label (OL) extension phase(N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|29|29.0||||||
4350459|NCT00396409|4178184|B2|<= 18 years||Age, Customized|2008 Open Label (OL) extension phase(N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|15|15.0||||||
4350460|NCT00396409|4178185|B1|<= 18 years||Age, Customized|2008 Open Label (OL) extension phase(N count for Depigoid+Omalizumab is 59 and for Depigoid+Placebo is 55)|participants|Number|14|14.0||||||
4350462|NCT00396409|4178184|B2|>=65 years||Age, Customized|2007 Open Label (OL) extension phase|participants|Number|0|0.0||||||
4350463|NCT00396409|4178185|B1|>=65 years||Age, Customized|2007 Open Label (OL) extension phase|participants|Number|0|0.0||||||
4350464|NCT00396409|4178183|B3|Between 18 and 65 years||Age, Customized|2007 Open Label (OL) extension phase|participants|Number|98|98.0||||||
4350465|NCT00396409|4178184|B2|Between 18 and 65 years||Age, Customized|2007 Open Label (OL) extension phase|participants|Number|48|48.0||||||
4350466|NCT00396409|4178185|B1|Between 18 and 65 years||Age, Customized|2007 Open Label (OL) extension phase|participants|Number|50|50.0||||||
4350467|NCT00396409|4178183|B3|<=18 years||Age, Customized|2007 Open Label (OL) extension phase|participants|Number|30|30.0||||||
4350468|NCT00396409|4178184|B2|<=18 years||Age, Customized|2007 Open Label (OL) extension phase|participants|Number|15|15.0||||||
4350469|NCT00396409|4178185|B1|<=18 years||Age, Customized|2007 Open Label (OL) extension phase|participants|Number|15|15.0||||||
4350470|NCT00396409|4178183|B3|2008 (N = 59/55/114)||Age||years|Mean|28.8|28.8|Standard Deviation|10.5|10.5|||
4350471|NCT00396409|4178184|B2|2008 (N = 59/55/114)||Age||years|Mean|30.1|30.1|Standard Deviation|10.9|10.9|||
4350472|NCT00396409|4178185|B1|2008 (N = 59/55/114)||Age||years|Mean|27.6|27.6|Standard Deviation|9.9|9.9|||
4350473|NCT00396409|4178183|B3|2007||Age||years|Mean|29.1|29.1|Standard Deviation|10.3|10.3|||
4350474|NCT00396409|4178184|B2|2007||Age||years|Mean|30.4|30.4|Standard Deviation|10.6|10.6|||
4350475|NCT00396409|4178185|B1|2007||Age||years|Mean|27.8|27.8|Standard Deviation|9.9|9.9|||
4350476|NCT00396383|4178216|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4350477|NCT00396383|4178216|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4350478|NCT00396383|4178216|B1|||Age||years|Mean|62.0|62.0|Standard Deviation|8.0|8.0|||
4350479|NCT00396331|4178225|B5|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4350480|NCT00396331|4178226|B4|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4350481|NCT00396331|4178227|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4350482|NCT00396331|4178228|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4350483|NCT00396331|4178229|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4350484|NCT00396331|4178225|B5|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4350485|NCT00396331|4178226|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4350486|NCT00396331|4178227|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4350487|NCT00396331|4178228|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4350488|NCT00396331|4178229|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4350489|NCT00396331|4178225|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4350490|NCT00396331|4178226|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4350491|NCT00396331|4178227|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4350492|NCT00396331|4178228|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4350493|NCT00396331|4178229|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4350494|NCT00396331|4178225|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|89|89.0||||||
4350495|NCT00396331|4178226|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4350496|NCT00396331|4178227|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4350497|NCT00396331|4178228|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4350498|NCT00396331|4178229|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
4350499|NCT00396331|4178225|B5||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4350500|NCT00396331|4178226|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4350501|NCT00396331|4178227|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4350502|NCT00396331|4178228|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4350503|NCT00396331|4178229|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4350504|NCT00396331|4178225|B5||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4350505|NCT00396331|4178226|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4350506|NCT00396331|4178227|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4350507|NCT00396331|4178228|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4350508|NCT00396331|4178229|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4350509|NCT00396331|4178225|B5|||Age||years|Mean|54.4|54.4|Standard Deviation|13.6|13.6|||
4350510|NCT00396331|4178226|B4|||Age||years|Mean|32.7|32.7|Standard Deviation|28.9|28.9|||
4350511|NCT00396331|4178227|B3|||Age||years|Mean|62.6|62.6|Standard Deviation|11.3|11.3|||
4350512|NCT00396331|4178228|B2|||Age||years|Mean|45.6|45.6|Standard Deviation|15.5|15.5|||
4350513|NCT00396331|4178229|B1|||Age||years|Mean|57.0|57.0|Standard Deviation|10.0|10.0|||
4350514|NCT00396318|4178282|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4350515|NCT00396318|4178282|B1||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4350516|NCT00396318|4178282|B1|≥ 65 years||Age, Customized||participants|Number|63|63.0||||||
4350517|NCT00396318|4178282|B1|≥ 17 to < 65 years||Age, Customized||participants|Number|111|111.0||||||
4350518|NCT00396318|4178282|B1|≥ 2 to < 17 years||Age, Customized||participants|Number|62|62.0||||||
4350519|NCT00396318|4178282|B1|< 2 years||Age, Customized||participants|Number|10|10.0||||||
4350520|NCT00396318|4178282|B1|||Age||Years|Mean|43.6|43.6|Standard Deviation|26.4|26.4|||
4350521|NCT00396292|4178293|B3|United States||Region of Enrollment||participants|Number|352|352.0||||||
4350522|NCT00396292|4178294|B2|United States||Region of Enrollment||participants|Number|178|178.0||||||
4350523|NCT00396292|4178295|B1|United States||Region of Enrollment||participants|Number|174|174.0||||||
4350524|NCT00396292|4178293|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4350525|NCT00396292|4178294|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4350526|NCT00396292|4178295|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4350527|NCT00396292|4178293|B3||Female|Sex: Female, Male||Participants|Count of Participants|352|352.0||||||
4350528|NCT00396292|4178294|B2||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4350529|NCT00396292|4178295|B1||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4350530|NCT00396292|4178293|B3|||Age||years|Mean|26.41|26.41|Standard Deviation|6.17|6.17|||
4350531|NCT00396292|4178294|B2|||Age||years|Mean|26.03|26.03|Standard Deviation|5.95|5.95|||
4350532|NCT00396292|4178295|B1|||Age||years|Mean|26.93|26.93|Standard Deviation|6.36|6.36|||
4350533|NCT00396292|4178293|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4350534|NCT00396292|4178294|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4350535|NCT00396292|4178295|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4350536|NCT00396292|4178293|B3||Between 18 and 65 years|Age||Participants|Count of Participants|321|321.0||||||
4350537|NCT00396292|4178294|B2||Between 18 and 65 years|Age||Participants|Count of Participants|162|162.0||||||
4350538|NCT00396292|4178295|B1||Between 18 and 65 years|Age||Participants|Count of Participants|159|159.0||||||
4350539|NCT00396292|4178293|B3||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
4350540|NCT00396292|4178294|B2||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4350541|NCT00396292|4178295|B1||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4350542|NCT00396279|4178302|B1|Missing||Location of target lesion||participants|Number|1|1.0||||||
4350543|NCT00396279|4178302|B1|Pelvic region||Location of target lesion||participants|Number|1|1.0||||||
4350544|NCT00396279|4178302|B1|Dorsal vertebrae||Location of target lesion||participants|Number|1|1.0||||||
4350545|NCT00396279|4178302|B1|Pulmonary disease||Location of target lesion||participants|Number|9|9.0||||||
4350546|NCT00396279|4178302|B1|Spine||Location of target lesion||participants|Number|3|3.0||||||
4350547|NCT00396279|4178302|B1|Pelvis||Location of target lesion||participants|Number|9|9.0||||||
4350548|NCT00396279|4178302|B1|Upper extremities||Location of target lesion||participants|Number|5|5.0||||||
4350549|NCT00396279|4178302|B1|Lower extremities||Location of target lesion||participants|Number|8|8.0||||||
4350550|NCT00396279|4178302|B1|||Percent of giant cells in tumor on pre-treatment biopsy||percentage of giant cells in tumor|Mean|28.7|28.7|Standard Deviation|16.1|16.1|||
4350551|NCT00396279|4178302|B1|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0: Fully active, able to carry on all pre-disease performance without restriction;~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work;~Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours;~Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours;~Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair."|participants|Number|2|2.0||||||
4350552|NCT00396279|4178302|B1|4 - Completely disabled||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0: Fully active, able to carry on all pre-disease performance without restriction;~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work;~Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours;~Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours;~Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair."|participants|Number|0|0.0||||||
4350553|NCT00396279|4178302|B1|3 - Limited selfcare, confined to bed >50% daytime||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0: Fully active, able to carry on all pre-disease performance without restriction;~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work;~Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours;~Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours;~Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair."|participants|Number|0|0.0||||||
4350554|NCT00396279|4178302|B1|2 - Ambulatory but unable to work||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0: Fully active, able to carry on all pre-disease performance without restriction;~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work;~Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours;~Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours;~Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair."|participants|Number|1|1.0||||||
4350555|NCT00396279|4178302|B1|1 - Restricted but ambulatory||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0: Fully active, able to carry on all pre-disease performance without restriction;~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work;~Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours;~Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours;~Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair."|participants|Number|21|21.0||||||
4350609|NCT00396162|4178366|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4350610|NCT00396162|4178364|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4350611|NCT00396162|4178365|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4350556|NCT00396279|4178302|B1|0 - Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0: Fully active, able to carry on all pre-disease performance without restriction;~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work;~Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours;~Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours;~Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair."|participants|Number|13|13.0||||||
4350557|NCT00396279|4178302|B1|Recurrent resectable||Giant Cell Tumor Disease Type||participants|Number|6|6.0||||||
4350558|NCT00396279|4178302|B1|Recurrent unresectable||Giant Cell Tumor Disease Type||participants|Number|18|18.0||||||
4350559|NCT00396279|4178302|B1|Primary unresectable||Giant Cell Tumor Disease Type||participants|Number|13|13.0||||||
4350560|NCT00396279|4178302|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4350561|NCT00396279|4178302|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4350562|NCT00396279|4178302|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4350563|NCT00396279|4178302|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4350564|NCT00396279|4178302|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4350565|NCT00396279|4178302|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4350566|NCT00396279|4178302|B1|||Age||years|Mean|33.9|33.9|Standard Deviation|12.3|12.3|||
4350567|NCT00396266|4178311|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4350568|NCT00396266|4178312|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4350569|NCT00396266|4178313|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4350570|NCT00396266|4178311|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4350571|NCT00396266|4178312|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4350572|NCT00396266|4178313|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4350573|NCT00396266|4178311|B3|||Age||years|Mean|57.6|57.6|Standard Deviation|9.5|9.5|||
4350574|NCT00396266|4178312|B2|||Age||years|Mean|57.5|57.5|Standard Deviation|10.3|10.3|||
4350575|NCT00396266|4178313|B1|||Age||years|Mean|57.9|57.9|Standard Deviation|8.7|8.7|||
4350576|NCT00396253|4178335|B1||Male|Gender||Participants|Count of Participants|99|99.0||||||
4350577|NCT00396253|4178335|B1||Female|Gender||Participants|Count of Participants|124|124.0||||||
4350578|NCT00396253|4178335|B1|||Age||years|Mean|61.2|61.2|Standard Deviation|16.3|16.3|||
4350579|NCT00396253|4178335|B1|>= 65 years||Age, Customized||participants|Number|102|102.0||||||
4350580|NCT00396253|4178335|B1|>= 17 years to < 65 years||Age, Customized||participants|Number|120|120.0||||||
4350581|NCT00396253|4178335|B1|< 17 years||Age, Customized||participants|Number|1|1.0||||||
4350582|NCT00396201|4178347|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4350583|NCT00396201|4178347|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4350584|NCT00396201|4178347|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4350585|NCT00396201|4178347|B1|||Age||years|Mean|34.0|34.0|Standard Deviation|12.5|12.5|||
4350586|NCT00396162|4178364|B3|||SinoNasal Outcome Test Score (SNOT-20)|SinoNasal Outcome Test measures symptom severity. It is a summary score, ranging from 0 to 100 with 100 indicating worse symptoms.|units on a scale|Mean|37.9|37.9|Standard Deviation|17.9|17.9|||
4350587|NCT00396162|4178365|B2|||SinoNasal Outcome Test Score (SNOT-20)|SinoNasal Outcome Test measures symptom severity. It is a summary score, ranging from 0 to 100 with 100 indicating worse symptoms.|units on a scale|Mean|39.5|39.5|Standard Deviation|19.8|19.8|||
4350588|NCT00396162|4178366|B1|||SinoNasal Outcome Test Score (SNOT-20)|SinoNasal Outcome Test measures symptom severity. It is a summary score, ranging from 0 to 100 with 100 indicating worse symptoms.|units on a scale|Mean|36.4|36.4|Standard Deviation|16.2|16.2|||
4350589|NCT00396162|4178364|B3|No aspirin sensitivity||aspirin sensitivity||participants|Number|53|53.0||||||
4350590|NCT00396162|4178365|B2|No aspirin sensitivity||aspirin sensitivity||participants|Number|26|26.0||||||
4350591|NCT00396162|4178366|B1|No aspirin sensitivity||aspirin sensitivity||participants|Number|27|27.0||||||
4350592|NCT00396162|4178364|B3|Aspirin Sensitivity||aspirin sensitivity||participants|Number|24|24.0||||||
4350593|NCT00396162|4178365|B2|Aspirin Sensitivity||aspirin sensitivity||participants|Number|12|12.0||||||
4350594|NCT00396162|4178366|B1|Aspirin Sensitivity||aspirin sensitivity||participants|Number|12|12.0||||||
4350595|NCT00396162|4178364|B3|moderate-severe asthma||asthma||participants|Number|26|26.0||||||
4350596|NCT00396162|4178365|B2|moderate-severe asthma||asthma||participants|Number|14|14.0||||||
4350597|NCT00396162|4178366|B1|moderate-severe asthma||asthma||participants|Number|12|12.0||||||
4350598|NCT00396162|4178364|B3|intermittent and mild asthma||asthma||participants|Number|23|23.0||||||
4350599|NCT00396162|4178365|B2|intermittent and mild asthma||asthma||participants|Number|10|10.0||||||
4350600|NCT00396162|4178366|B1|intermittent and mild asthma||asthma||participants|Number|13|13.0||||||
4350601|NCT00396162|4178364|B3|No asthma||asthma||participants|Number|28|28.0||||||
4350602|NCT00396162|4178365|B2|No asthma||asthma||participants|Number|14|14.0||||||
4350603|NCT00396162|4178366|B1|No asthma||asthma||participants|Number|14|14.0||||||
4350604|NCT00396162|4178364|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4350605|NCT00396162|4178365|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4350606|NCT00396162|4178366|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4350607|NCT00396162|4178364|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4350608|NCT00396162|4178365|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4350612|NCT00396162|4178366|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4350613|NCT00396162|4178364|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4350614|NCT00396162|4178365|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4350615|NCT00396162|4178366|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4350616|NCT00396162|4178364|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4350617|NCT00396162|4178365|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4350618|NCT00396162|4178366|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4350619|NCT00396162|4178364|B3|||Age||years|Mean|49.5|49.5|Standard Deviation|10|10.0|||
4350620|NCT00396162|4178365|B2|||Age||years|Mean|49.6|49.6|Standard Deviation|8.6|8.6|||
4350621|NCT00396162|4178366|B1|||Age||years|Mean|49.4|49.4|Standard Deviation|12.6|12.6|||
4350622|NCT00396136|4178379|B1|United States||Region of Enrollment||participants|Number|221|221.0||||||
4350623|NCT00396136|4178379|B1||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4350624|NCT00396136|4178379|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4350625|NCT00396136|4178379|B1|||Age||years|Mean|67.3|67.3|Standard Deviation|11.8|11.8|||
4350626|NCT00396097|4178384|B3||Male|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
4350627|NCT00396097|4178385|B2||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4350628|NCT00396097|4178386|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4350629|NCT00396097|4178384|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4350630|NCT00396097|4178385|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4350631|NCT00396097|4178386|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4350632|NCT00396097|4178384|B3|>=7 years||Age, Customized||Participants|Number|209|209.0||||||
4350633|NCT00396097|4178385|B2|>=7 years||Age, Customized||Participants|Number|132|132.0||||||
4350634|NCT00396097|4178386|B1|>=7 years||Age, Customized||Participants|Number|77|77.0||||||
4350635|NCT00396097|4178384|B3|<= 7 years||Age, Customized||Participants|Number|107|107.0||||||
4350636|NCT00396097|4178385|B2|<= 7 years||Age, Customized||Participants|Number|70|70.0||||||
4350637|NCT00396097|4178386|B1|<= 7 years||Age, Customized||Participants|Number|37|37.0||||||
4350638|NCT00396097|4178384|B3|||Age||Years|Mean|8.4|8.4|Standard Deviation|2.2|2.2|||
4350639|NCT00396097|4178385|B2|||Age||Years|Mean|8.4|8.4|Standard Deviation|2.3|2.3|||
4350640|NCT00396097|4178386|B1|||Age||Years|Mean|8.3|8.3|Standard Deviation|2.1|2.1|||
4350641|NCT00396084|4178409|B7|Brazil||Region of Enrollment||participants|Number|70|70.0||||||
4350642|NCT00396084|4178410|B6|Brazil||Region of Enrollment||participants|Number|20|20.0||||||
4350643|NCT00396084|4178411|B5|Brazil||Region of Enrollment||participants|Number|10|10.0||||||
4350644|NCT00396084|4178412|B4|Brazil||Region of Enrollment||participants|Number|10|10.0||||||
4350645|NCT00396084|4178413|B3|Brazil||Region of Enrollment||participants|Number|10|10.0||||||
4350646|NCT00396084|4178414|B2|Brazil||Region of Enrollment||participants|Number|10|10.0||||||
4350647|NCT00396084|4178415|B1|Brazil||Region of Enrollment||participants|Number|10|10.0||||||
4350648|NCT00396084|4178409|B7||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4350649|NCT00396084|4178410|B6||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4350650|NCT00396084|4178411|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4350651|NCT00396084|4178412|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4350652|NCT00396084|4178413|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4350653|NCT00396084|4178414|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4350654|NCT00396084|4178415|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4350655|NCT00396084|4178409|B7||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4350656|NCT00396084|4178410|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4350657|NCT00396084|4178411|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4350658|NCT00396084|4178412|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4350659|NCT00396084|4178413|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4350660|NCT00396084|4178414|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4350661|NCT00396084|4178415|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4350662|NCT00396084|4178409|B7|||Age||years|Median|35.0|35.0|Inter-Quartile Range|11.2|11.2|26.0|44.0|
4350663|NCT00396084|4178410|B6|||Age||years|Median|33.0|33.0|Inter-Quartile Range|11.4|11.4|23.0|43.5|
4350664|NCT00396084|4178411|B5|||Age||years|Median|35.0|35.0|Inter-Quartile Range|8.4|8.4|25.0|37.0|
4350665|NCT00396084|4178412|B4|||Age||years|Median|45.0|45.0|Inter-Quartile Range|12.7|12.7|39.0|48.0|
4350666|NCT00396084|4178413|B3|||Age||years|Median|33.5|33.5|Inter-Quartile Range|13.4|13.4|23.0|42.0|
4350667|NCT00396084|4178414|B2|||Age||years|Median|43.5|43.5|Inter-Quartile Range|6.4|6.4|42.0|46.0|
4350668|NCT00396084|4178415|B1|||Age||years|Median|34.5|34.5|Inter-Quartile Range|10.1|10.1|27.0|40.0|
4350669|NCT00396084|4178409|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4350670|NCT00396084|4178410|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4350671|NCT00396084|4178411|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4350672|NCT00396084|4178412|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4350673|NCT00396084|4178413|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4350674|NCT00396084|4178414|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4350675|NCT00396084|4178415|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4350676|NCT00396084|4178409|B7||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4350677|NCT00396084|4178410|B6||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4350678|NCT00396084|4178411|B5||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4350679|NCT00396084|4178412|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4350680|NCT00396084|4178413|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4350681|NCT00396084|4178414|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4350682|NCT00396084|4178415|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4350683|NCT00396084|4178409|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4350684|NCT00396084|4178410|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4350685|NCT00396084|4178411|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4350686|NCT00396084|4178412|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4350687|NCT00396084|4178413|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4350688|NCT00396084|4178414|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4350689|NCT00396084|4178415|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4350690|NCT00396032|4178493|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4350691|NCT00396032|4178494|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4350692|NCT00396032|4178495|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4350693|NCT00396032|4178493|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4350694|NCT00396032|4178494|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4350695|NCT00396032|4178495|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4350696|NCT00396032|4178493|B3|||Age||years|Mean|59.3|59.3|Standard Deviation|15.3|15.3|||
4350697|NCT00396032|4178494|B2|||Age||years|Mean|57.8|57.8|Standard Deviation|16.5|16.5|||
4350698|NCT00396032|4178495|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|14.1|14.1|||
4350699|NCT00396032|4178493|B3|>= 65 years||Age, Customized||participants|Number|54|54.0||||||
4350700|NCT00396032|4178494|B2|>= 65 years||Age, Customized||participants|Number|24|24.0||||||
4350701|NCT00396032|4178495|B1|>= 65 years||Age, Customized||participants|Number|30|30.0||||||
4350702|NCT00396032|4178493|B3|>= 17 years to < 65 years||Age, Customized||participants|Number|95|95.0||||||
4350703|NCT00396032|4178494|B2|>= 17 years to < 65 years||Age, Customized||participants|Number|51|51.0||||||
4350704|NCT00396032|4178495|B1|>= 17 years to < 65 years||Age, Customized||participants|Number|44|44.0||||||
4350705|NCT00396032|4178493|B3|< 17 years||Age, Customized||participants|Number|0|0.0||||||
4350706|NCT00396032|4178494|B2|< 17 years||Age, Customized||participants|Number|0|0.0||||||
4350707|NCT00396032|4178495|B1|< 17 years||Age, Customized||participants|Number|0|0.0||||||
4350708|NCT00396019|4178510|B4|United States||Region of Enrollment||participants|Number|82|82.0||||||
4350709|NCT00396019|4178511|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
4350710|NCT00396019|4178512|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4350711|NCT00396019|4178513|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4350712|NCT00396019|4178510|B4|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4350713|NCT00396019|4178510|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4350714|NCT00396019|4178510|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4350715|NCT00396019|4178510|B4|greater than or equal to 12 years||Age, Customized||Participants|Count of Participants|30|30.0||||||
4350716|NCT00396019|4178511|B3|greater than or equal to 12 years||Age, Customized||Participants|Count of Participants|8|8.0||||||
4350717|NCT00396019|4178512|B2|greater than or equal to 12 years||Age, Customized||Participants|Count of Participants|8|8.0||||||
4350718|NCT00396019|4178513|B1|greater than or equal to 12 years||Age, Customized||Participants|Count of Participants|14|14.0||||||
4350719|NCT00396019|4178510|B4|5 to 12 years||Age, Customized||Participants|Count of Participants|31|31.0||||||
4350720|NCT00396019|4178511|B3|5 to 12 years||Age, Customized||Participants|Count of Participants|12|12.0||||||
4350721|NCT00396019|4178512|B2|5 to 12 years||Age, Customized||Participants|Count of Participants|9|9.0||||||
4350722|NCT00396019|4178513|B1|5 to 12 years||Age, Customized||Participants|Count of Participants|10|10.0||||||
4350723|NCT00396019|4178510|B4|Less than 5 years||Age, Customized||Participants|Count of Participants|20|20.0||||||
4350724|NCT00396019|4178511|B3|Less than 5 years||Age, Customized||Participants|Count of Participants|9|9.0||||||
4350725|NCT00396019|4178512|B2|Less than 5 years||Age, Customized||Participants|Count of Participants|8|8.0||||||
4350726|NCT00396019|4178513|B1|Less than 5 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
4350727|NCT00396006|4178525|B1|New Zealand||Region of Enrollment||participants|Number|5|5.0||||||
4350728|NCT00396006|4178525|B1|Australia||Region of Enrollment||participants|Number|8|8.0||||||
4350729|NCT00396006|4178525|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4350730|NCT00396006|4178525|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4350731|NCT00396006|4178525|B1|||Age||years|Median|59.6|59.6|Full Range|||36.0|76.1|
4350732|NCT00396006|4178525|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4350733|NCT00396006|4178525|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4350734|NCT00396006|4178525|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4350735|NCT00395993|4178540|B3|United States||Region of Enrollment||participants|Number|456|456.0||||||
4350736|NCT00395993|4178541|B2|United States||Region of Enrollment||participants|Number|226|226.0||||||
4350737|NCT00395993|4178542|B1|United States||Region of Enrollment||participants|Number|230|230.0||||||
4350738|NCT00395993|4178540|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4350739|NCT00395993|4178541|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4350740|NCT00395993|4178542|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4350741|NCT00395993|4178540|B3||Female|Sex: Female, Male||Participants|Count of Participants|456|456.0||||||
4350742|NCT00395993|4178541|B2||Female|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
4350743|NCT00395993|4178542|B1||Female|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4350744|NCT00395993|4178540|B3|||Age||years|Mean|39.1|39.1|Standard Deviation|7.54|7.54|||
4350745|NCT00395993|4178541|B2|||Age||years|Mean|39.5|39.5|Standard Deviation|7.63|7.63|||
4350746|NCT00395993|4178542|B1|||Age||years|Mean|38.7|38.7|Standard Deviation|7.49|7.49|||
4350747|NCT00395993|4178540|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4350748|NCT00395993|4178541|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4350749|NCT00395993|4178542|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4350750|NCT00395993|4178540|B3||Between 18 and 65 years|Age||Participants|Count of Participants|454|454.0||||||
4350751|NCT00395993|4178541|B2||Between 18 and 65 years|Age||Participants|Count of Participants|226|226.0||||||
4350752|NCT00395993|4178542|B1||Between 18 and 65 years|Age||Participants|Count of Participants|228|228.0||||||
4350753|NCT00395993|4178540|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4350754|NCT00395993|4178541|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4350755|NCT00395993|4178542|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4350756|NCT00395967|4178549|B1|Hodgkin's disease (HD)||Disease Diagnosis|One patient with HD was entered into the study even though there was no indication of MM or NHL (an inclusion criteria).|participants|Number|1|1.0||||||
4350757|NCT00395967|4178549|B1|Non-Hodgkin's lymphoma (NHL)||Disease Diagnosis|One patient with HD was entered into the study even though there was no indication of MM or NHL (an inclusion criteria).|participants|Number|3|3.0||||||
4350758|NCT00395967|4178549|B1|Multiple Myeloma (MM)||Disease Diagnosis|One patient with HD was entered into the study even though there was no indication of MM or NHL (an inclusion criteria).|participants|Number|1|1.0||||||
4350759|NCT00395967|4178549|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4350760|NCT00395967|4178549|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4350761|NCT00395967|4178549|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4350762|NCT00395967|4178549|B1|||Age||years|Mean|52.2|52.2|Standard Deviation|11.5|11.5|||
4350763|NCT00395876|4178558|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4350764|NCT00395876|4178559|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4350765|NCT00395876|4178560|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4350766|NCT00395876|4178558|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4350767|NCT00395876|4178559|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4350768|NCT00395876|4178560|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4350769|NCT00395876|4178558|B3|||Age||years|Mean|39.6|39.6|Standard Deviation|27.4|27.4|||
4350770|NCT00395876|4178559|B2|||Age||years|Mean|37.1|37.1|Standard Deviation|26.6|26.6|||
4350771|NCT00395876|4178560|B1|||Age||years|Mean|42.2|42.2|Standard Deviation|28.3|28.3|||
4350772|NCT00395876|4178558|B3|≥ 65 years||Age, Customized||participants|Number|26|26.0||||||
4350773|NCT00395876|4178559|B2|≥ 65 years||Age, Customized||participants|Number|11|11.0||||||
4350774|NCT00395876|4178560|B1|≥ 65 years||Age, Customized||participants|Number|15|15.0||||||
4350775|NCT00395876|4178558|B3|≥ 17 to < 65 years||Age, Customized||participants|Number|37|37.0||||||
4350776|NCT00395876|4178559|B2|≥ 17 to < 65 years||Age, Customized||participants|Number|20|20.0||||||
4350777|NCT00395876|4178560|B1|≥ 17 to < 65 years||Age, Customized||participants|Number|17|17.0||||||
4350778|NCT00395876|4178558|B3|≥ 2 to < 17 years||Age, Customized||participants|Number|30|30.0||||||
4350779|NCT00395876|4178559|B2|≥ 2 to < 17 years||Age, Customized||participants|Number|16|16.0||||||
4350780|NCT00395876|4178560|B1|≥ 2 to < 17 years||Age, Customized||participants|Number|14|14.0||||||
4350781|NCT00395876|4178558|B3|< 2 years||Age, Customized||participants|Number|4|4.0||||||
4350782|NCT00395876|4178559|B2|< 2 years||Age, Customized||participants|Number|3|3.0||||||
4350783|NCT00395876|4178560|B1|< 2 years||Age, Customized||participants|Number|1|1.0||||||
4350784|NCT00395863|4178587|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
4350785|NCT00395863|4178588|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4350786|NCT00395863|4178589|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4350787|NCT00395863|4178587|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4350788|NCT00395863|4178588|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4350789|NCT00395863|4178589|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4350790|NCT00395863|4178587|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4350791|NCT00395863|4178588|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4350792|NCT00395863|4178589|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4350793|NCT00395863|4178587|B3||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4350794|NCT00395863|4178588|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4350795|NCT00395863|4178589|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4350796|NCT00395863|4178587|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4350797|NCT00395863|4178588|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4350798|NCT00395863|4178589|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4350799|NCT00395863|4178587|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4350800|NCT00395863|4178588|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4350801|NCT00395863|4178589|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4350802|NCT00395863|4178587|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4350803|NCT00395863|4178588|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4350804|NCT00395863|4178589|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4350805|NCT00395863|4178587|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4350806|NCT00395863|4178588|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4350807|NCT00395863|4178589|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4350808|NCT00395863|4178587|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4350809|NCT00395863|4178588|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4350810|NCT00395863|4178589|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4350811|NCT00395863|4178587|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4350812|NCT00395863|4178588|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4350813|NCT00395863|4178589|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4350814|NCT00395863|4178587|B3|||Age||years|Mean|49.43|49.43|Standard Deviation|15.667|15.667|||
4350815|NCT00395863|4178588|B2|||Age||years|Mean|48.08|48.08|Standard Deviation|16.064|16.064|||
4350816|NCT00395863|4178589|B1|||Age||years|Mean|50.79|50.79|Standard Deviation|15.497|15.497|||
4350817|NCT00395863|4178587|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4350818|NCT00395863|4178588|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4350819|NCT00395863|4178589|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4350820|NCT00395863|4178587|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4350821|NCT00395863|4178588|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4350822|NCT00395863|4178589|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4350823|NCT00395863|4178587|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4350824|NCT00395863|4178588|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4350825|NCT00395863|4178589|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4350826|NCT00395850|4178621|B5|United States||Region of Enrollment||participants|Number|107|107.0||||||
4350827|NCT00395850|4178622|B4|United States||Region of Enrollment||participants|Number|25|25.0||||||
4350828|NCT00395850|4178623|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4350829|NCT00395850|4178624|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4350830|NCT00395850|4178625|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4350831|NCT00395850|4178621|B5||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4350832|NCT00395850|4178622|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4350833|NCT00395850|4178623|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4350834|NCT00395850|4178624|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4350835|NCT00395850|4178625|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4350836|NCT00395850|4178621|B5||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4350837|NCT00395850|4178622|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4350838|NCT00395850|4178623|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4350839|NCT00395850|4178624|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4350840|NCT00395850|4178625|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4350841|NCT00395850|4178621|B5|||Age||years|Mean|40.6|40.6|Standard Deviation|11.0|11.0|||
4350842|NCT00395850|4178622|B4|||Age||years|Mean|40.4|40.4|Standard Deviation|10.1|10.1|||
4350843|NCT00395850|4178623|B3|||Age||years|Mean|39.4|39.4|Standard Deviation|10.1|10.1|||
4350844|NCT00395850|4178624|B2|||Age||years|Mean|39.8|39.8|Standard Deviation|11.3|11.3|||
4350845|NCT00395850|4178625|B1|||Age||years|Mean|43.0|43.0|Standard Deviation|12.4|12.4|||
4350846|NCT00395850|4178621|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4350847|NCT00395850|4178622|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4350848|NCT00395850|4178623|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4350849|NCT00395850|4178624|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4350850|NCT00395850|4178625|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4350851|NCT00395850|4178621|B5||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
4350852|NCT00395850|4178622|B4||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4350853|NCT00395850|4178623|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4350854|NCT00395850|4178624|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4350855|NCT00395850|4178625|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4350856|NCT00395850|4178621|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4350857|NCT00395850|4178622|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4350858|NCT00395850|4178623|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4350859|NCT00395850|4178624|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4350860|NCT00395850|4178625|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4350861|NCT00395746|4178642|B4|||HbA1c|Glycosylated Haemoglobin|percentage of total haemoglobin|Mean|8.39|8.39|Standard Deviation|0.76|0.76|||
4350862|NCT00395746|4178643|B3|||HbA1c|Glycosylated Haemoglobin|percentage of total haemoglobin|Mean|8.44|8.44|Standard Deviation|0.83|0.83|||
4350863|NCT00395746|4178644|B2|||HbA1c|Glycosylated Haemoglobin|percentage of total haemoglobin|Mean|8.26|8.26|Standard Deviation|0.71|0.71|||
4350864|NCT00395746|4178645|B1|||HbA1c|Glycosylated Haemoglobin|percentage of total haemoglobin|Mean|8.48|8.48|Standard Deviation|0.73|0.73|||
4350865|NCT00395746|4178642|B4|||Duration of diabetes|Number of years since diagnosis of diabetes|years|Mean|10.33|10.33|Standard Deviation|7.00|7.0|||
4350866|NCT00395746|4178643|B3|||Duration of diabetes|Number of years since diagnosis of diabetes|years|Mean|10.06|10.06|Standard Deviation|7.28|7.28|||
4350867|NCT00395746|4178644|B2|||Duration of diabetes|Number of years since diagnosis of diabetes|years|Mean|11.61|11.61|Standard Deviation|7.68|7.68|||
4350868|NCT00395746|4178645|B1|||Duration of diabetes|Number of years since diagnosis of diabetes|years|Mean|9.33|9.33|Standard Deviation|5.77|5.77|||
4350869|NCT00395746|4178642|B4|||Body weight||kg|Mean|65.84|65.84|Standard Deviation|12.56|12.56|||
4350870|NCT00395746|4178643|B3|||Body weight||kg|Mean|66.79|66.79|Standard Deviation|13.66|13.66|||
4350871|NCT00395746|4178644|B2|||Body weight||kg|Mean|64.53|64.53|Standard Deviation|11.95|11.95|||
4350872|NCT00395746|4178645|B1|||Body weight||kg|Mean|66.19|66.19|Standard Deviation|12.03|12.03|||
4350873|NCT00395746|4178642|B4|||BMI|Body Mass Index|kg/m2|Mean|24.86|24.86|Standard Deviation|3.65|3.65|||
4350874|NCT00395746|4178643|B3|||BMI|Body Mass Index|kg/m2|Mean|24.94|24.94|Standard Deviation|3.96|3.96|||
4350875|NCT00395746|4178644|B2|||BMI|Body Mass Index|kg/m2|Mean|24.40|24.4|Standard Deviation|3.37|3.37|||
4350876|NCT00395746|4178645|B1|||BMI|Body Mass Index|kg/m2|Mean|25.25|25.25|Standard Deviation|3.58|3.58|||
4350877|NCT00395746|4178642|B4||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4350878|NCT00395746|4178643|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4350879|NCT00395746|4178644|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4350880|NCT00395746|4178645|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4350881|NCT00395746|4178642|B4||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4350882|NCT00395746|4178643|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4350883|NCT00395746|4178644|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4350884|NCT00395746|4178645|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4350885|NCT00395746|4178642|B4|||Age||years|Mean|59.7|59.7|Standard Deviation|10.4|10.4|||
4350886|NCT00395746|4178643|B3|||Age||years|Mean|58.6|58.6|Standard Deviation|9.7|9.7|||
4350887|NCT00395746|4178644|B2|||Age||years|Mean|61.3|61.3|Standard Deviation|11.0|11.0|||
4350888|NCT00395746|4178645|B1|||Age||years|Mean|59.1|59.1|Standard Deviation|10.3|10.3|||
4350889|NCT00395746|4178642|B4|70-||Age, Customized||participants|Number|46|46.0||||||
4350890|NCT00395746|4178643|B3|70-||Age, Customized||participants|Number|11|11.0||||||
4350891|NCT00395746|4178644|B2|70-||Age, Customized||participants|Number|19|19.0||||||
4350892|NCT00395746|4178645|B1|70-||Age, Customized||participants|Number|16|16.0||||||
4350893|NCT00395746|4178642|B4|60-69||Age, Customized||participants|Number|92|92.0||||||
4350894|NCT00395746|4178643|B3|60-69||Age, Customized||participants|Number|30|30.0||||||
4350895|NCT00395746|4178644|B2|60-69||Age, Customized||participants|Number|32|32.0||||||
4350896|NCT00395746|4178645|B1|60-69||Age, Customized||participants|Number|30|30.0||||||
4350897|NCT00395746|4178642|B4|50-59||Age, Customized||participants|Number|79|79.0||||||
4350898|NCT00395746|4178643|B3|50-59||Age, Customized||participants|Number|28|28.0||||||
4350899|NCT00395746|4178644|B2|50-59||Age, Customized||participants|Number|27|27.0||||||
4350900|NCT00395746|4178645|B1|50-59||Age, Customized||participants|Number|24|24.0||||||
4350901|NCT00395746|4178642|B4|40-49||Age, Customized||participants|Number|40|40.0||||||
4350902|NCT00395746|4178643|B3|40-49||Age, Customized||participants|Number|19|19.0||||||
4350903|NCT00395746|4178644|B2|40-49||Age, Customized||participants|Number|5|5.0||||||
4350904|NCT00395746|4178645|B1|40-49||Age, Customized||participants|Number|16|16.0||||||
4350905|NCT00395746|4178642|B4|30-39||Age, Customized||participants|Number|6|6.0||||||
4350906|NCT00395746|4178643|B3|30-39||Age, Customized||participants|Number|0|0.0||||||
4350907|NCT00395746|4178644|B2|30-39||Age, Customized||participants|Number|4|4.0||||||
4350908|NCT00395746|4178645|B1|30-39||Age, Customized||participants|Number|2|2.0||||||
4350909|NCT00395746|4178642|B4|20-29||Age, Customized||participants|Number|1|1.0||||||
4350910|NCT00395746|4178643|B3|20-29||Age, Customized||participants|Number|0|0.0||||||
4350911|NCT00395746|4178644|B2|20-29||Age, Customized||participants|Number|1|1.0||||||
4350912|NCT00395746|4178645|B1|20-29||Age, Customized||participants|Number|0|0.0||||||
4350913|NCT00395733|4178691|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4350914|NCT00395733|4178692|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4350915|NCT00395733|4178693|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4350916|NCT00395733|4178691|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4350917|NCT00395733|4178692|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4350918|NCT00395733|4178693|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4350919|NCT00395733|4178691|B3|||Age||Years|Mean|53.1|53.1|Standard Deviation|12.93|12.93|||
4350920|NCT00395733|4178692|B2|||Age||Years|Mean|55.3|55.3|Standard Deviation|11.21|11.21|||
4350921|NCT00395733|4178693|B1|||Age||Years|Mean|50.8|50.8|Standard Deviation|14.26|14.26|||
4350922|NCT00395694|4178716|B3|Asian–Japanese||Race/Ethnicity, Customized||participants|Number|102|102.0||||||
4350923|NCT00395694|4178717|B2|Asian–Japanese||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4350924|NCT00395694|4178718|B1|Asian–Japanese||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4350925|NCT00395694|4178716|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4350926|NCT00395694|4178717|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4350927|NCT00395694|4178718|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4350928|NCT00395694|4178716|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4350929|NCT00395694|4178717|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4350930|NCT00395694|4178718|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4350931|NCT00395694|4178716|B3|||Age||Years|Mean|18.6|18.6|Standard Deviation|12.9|12.9|||
4350932|NCT00395694|4178717|B2|||Age||Years|Mean|8.2|8.2|Standard Deviation|4.1|4.1|||
4350933|NCT00395694|4178718|B1|||Age||Years|Mean|29.0|29.0|Standard Deviation|9.9|9.9|||
4350934|NCT00395642|4178750|B1|United States||Region of Enrollment||participants|Number|66|66.0||||||
4350935|NCT00395642|4178750|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4350936|NCT00395642|4178750|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4350937|NCT00395642|4178750|B1|||Age||years|Mean|65|65.0|Standard Deviation|11|11.0|||
4350938|NCT00395642|4178750|B1||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4350939|NCT00395642|4178750|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4350940|NCT00395642|4178750|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4350941|NCT00395629|4178754|B4|Core Participants not enrolled in the Extension||Sex/Gender, Customized||participants|Number|23|23.0||||||
4350942|NCT00395629|4178755|B3|Core Participants not enrolled in the Extension||Sex/Gender, Customized||participants|Number|12|12.0||||||
4350943|NCT00395629|4178756|B2|Core Participants not enrolled in the Extension||Sex/Gender, Customized||participants|Number|9|9.0||||||
4350944|NCT00395629|4178757|B1|Core Participants not enrolled in the Extension||Sex/Gender, Customized||participants|Number|2|2.0||||||
4350945|NCT00395629|4178754|B4|Male_Extension Study||Sex/Gender, Customized||participants|Number|21|21.0||||||
4350946|NCT00395629|4178755|B3|Male_Extension Study||Sex/Gender, Customized||participants|Number|8|8.0||||||
4350947|NCT00395629|4178756|B2|Male_Extension Study||Sex/Gender, Customized||participants|Number|5|5.0||||||
4350948|NCT00395629|4178757|B1|Male_Extension Study||Sex/Gender, Customized||participants|Number|8|8.0||||||
4350949|NCT00395629|4178754|B4|Female_Extension Study||Sex/Gender, Customized||participants|Number|5|5.0||||||
4350950|NCT00395629|4178755|B3|Female_Extension Study||Sex/Gender, Customized||participants|Number|3|3.0||||||
4350951|NCT00395629|4178756|B2|Female_Extension Study||Sex/Gender, Customized||participants|Number|1|1.0||||||
4350952|NCT00395629|4178757|B1|Female_Extension Study||Sex/Gender, Customized||participants|Number|1|1.0||||||
4350953|NCT00395629|4178754|B4|Male_Core Study||Sex/Gender, Customized||participants|Number|33|33.0||||||
4350954|NCT00395629|4178755|B3|Male_Core Study||Sex/Gender, Customized||participants|Number|13|13.0||||||
4350955|NCT00395629|4178756|B2|Male_Core Study||Sex/Gender, Customized||participants|Number|11|11.0||||||
4350956|NCT00395629|4178757|B1|Male_Core Study||Sex/Gender, Customized||participants|Number|9|9.0||||||
4350957|NCT00395629|4178754|B4|Female_Core Study||Sex/Gender, Customized||participants|Number|16|16.0||||||
4350958|NCT00395629|4178755|B3|Female_Core Study||Sex/Gender, Customized||participants|Number|10|10.0||||||
4350959|NCT00395629|4178756|B2|Female_Core Study||Sex/Gender, Customized||participants|Number|4|4.0||||||
4350960|NCT00395629|4178757|B1|Female_Core Study||Sex/Gender, Customized||participants|Number|2|2.0||||||
4350961|NCT00395629|4178754|B4|Extension Study (n=9,6,11,26)||Age|The n values in the Extension Study Category are the number of participants in each Arm/Group. The last n value= 26 is the Total number of participants.|years|Mean|50.8|50.8|Standard Deviation|14.34|14.34|||
4350962|NCT00395629|4178755|B3|Extension Study (n=9,6,11,26)||Age|The n values in the Extension Study Category are the number of participants in each Arm/Group. The last n value= 26 is the Total number of participants.|years|Mean|50.1|50.1|Standard Deviation|15.88|15.88|||
4350963|NCT00395629|4178756|B2|Extension Study (n=9,6,11,26)||Age|The n values in the Extension Study Category are the number of participants in each Arm/Group. The last n value= 26 is the Total number of participants.|years|Mean|44.8|44.8|Standard Deviation|10.61|10.61|||
4350964|NCT00395629|4178757|B1|Extension Study (n=9,6,11,26)||Age|The n values in the Extension Study Category are the number of participants in each Arm/Group. The last n value= 26 is the Total number of participants.|years|Mean|55.7|55.7|Standard Deviation|14.23|14.23|||
4350965|NCT00395629|4178754|B4|Core Study||Age|The n values in the Extension Study Category are the number of participants in each Arm/Group. The last n value= 26 is the Total number of participants.|years|Mean|50.6|50.6|Standard Deviation|14.04|14.04|||
4350966|NCT00395629|4178755|B3|Core Study||Age|The n values in the Extension Study Category are the number of participants in each Arm/Group. The last n value= 26 is the Total number of participants.|years|Mean|49.8|49.8|Standard Deviation|16.41|16.41|||
4350967|NCT00395629|4178756|B2|Core Study||Age|The n values in the Extension Study Category are the number of participants in each Arm/Group. The last n value= 26 is the Total number of participants.|years|Mean|47.8|47.8|Standard Deviation|10.26|10.26|||
4351023|NCT00395512|4178777|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4350968|NCT00395629|4178757|B1|Core Study||Age|The n values in the Extension Study Category are the number of participants in each Arm/Group. The last n value= 26 is the Total number of participants.|years|Mean|55.8|55.8|Standard Deviation|12.78|12.78|||
4350969|NCT00395512|4178773|B5|||Duration of diabetes||years|Mean|3.21|3.21|Standard Deviation|3.704|3.704|||
4350970|NCT00395512|4178774|B4|||Duration of diabetes||years|Mean|3.36|3.36|Standard Deviation|4.166|4.166|||
4350971|NCT00395512|4178775|B3|||Duration of diabetes||years|Mean|3.05|3.05|Standard Deviation|3.328|3.328|||
4350972|NCT00395512|4178776|B2|||Duration of diabetes||years|Mean|3.20|3.2|Standard Deviation|3.739|3.739|||
4350973|NCT00395512|4178777|B1|||Duration of diabetes||years|Mean|3.23|3.23|Standard Deviation|3.559|3.559|||
4350974|NCT00395512|4178773|B5|||Body Mass Index (BMI)||kg/m^2|Mean|31.13|31.13|Standard Deviation|5.382|5.382|||
4350975|NCT00395512|4178774|B4|||Body Mass Index (BMI)||kg/m^2|Mean|30.71|30.71|Standard Deviation|5.621|5.621|||
4350976|NCT00395512|4178775|B3|||Body Mass Index (BMI)||kg/m^2|Mean|31.32|31.32|Standard Deviation|5.354|5.354|||
4350977|NCT00395512|4178776|B2|||Body Mass Index (BMI)||kg/m^2|Mean|30.87|30.87|Standard Deviation|4.938|4.938|||
4350978|NCT00395512|4178777|B1|||Body Mass Index (BMI)||kg/m^2|Mean|31.61|31.61|Standard Deviation|5.587|5.587|||
4350979|NCT00395512|4178773|B5|||Weight||kg|Mean|85.50|85.5|Standard Deviation|19.062|19.062|||
4350980|NCT00395512|4178774|B4|||Weight||kg|Mean|84.38|84.38|Standard Deviation|20.378|20.378|||
4350981|NCT00395512|4178775|B3|||Weight||kg|Mean|85.39|85.39|Standard Deviation|20.374|20.374|||
4350982|NCT00395512|4178776|B2|||Weight||kg|Mean|85.53|85.53|Standard Deviation|16.254|16.254|||
4350983|NCT00395512|4178777|B1|||Weight||kg|Mean|86.72|86.72|Standard Deviation|19.033|19.033|||
4350984|NCT00395512|4178773|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4350985|NCT00395512|4178774|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4350986|NCT00395512|4178775|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4350987|NCT00395512|4178776|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4350988|NCT00395512|4178777|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4350989|NCT00395512|4178773|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4350990|NCT00395512|4178774|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4350991|NCT00395512|4178775|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4350992|NCT00395512|4178776|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4350993|NCT00395512|4178777|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4350994|NCT00395512|4178773|B5||White|Race (NIH/OMB)||Participants|Count of Participants|526|526.0||||||
4350995|NCT00395512|4178774|B4||White|Race (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
4350996|NCT00395512|4178775|B3||White|Race (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
4350997|NCT00395512|4178776|B2||White|Race (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
4350998|NCT00395512|4178777|B1||White|Race (NIH/OMB)||Participants|Count of Participants|135|135.0||||||
4350999|NCT00395512|4178773|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4351000|NCT00395512|4178774|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4351001|NCT00395512|4178775|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4351002|NCT00395512|4178776|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4351003|NCT00395512|4178777|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4351004|NCT00395512|4178773|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4351005|NCT00395512|4178774|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4351006|NCT00395512|4178775|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4351007|NCT00395512|4178776|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4351008|NCT00395512|4178777|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4351009|NCT00395512|4178773|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4351010|NCT00395512|4178774|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4351011|NCT00395512|4178775|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4351012|NCT00395512|4178776|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4351013|NCT00395512|4178777|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4351014|NCT00395512|4178773|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4351015|NCT00395512|4178774|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4351016|NCT00395512|4178775|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4351017|NCT00395512|4178776|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4351018|NCT00395512|4178777|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4351019|NCT00395512|4178773|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4351020|NCT00395512|4178774|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4351021|NCT00395512|4178775|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4351022|NCT00395512|4178776|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4351024|NCT00395512|4178773|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|407|407.0||||||
4351025|NCT00395512|4178774|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
4351026|NCT00395512|4178775|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
4351027|NCT00395512|4178776|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
4351028|NCT00395512|4178777|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
4351029|NCT00395512|4178773|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|248|248.0||||||
4351030|NCT00395512|4178774|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4351031|NCT00395512|4178775|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4351032|NCT00395512|4178776|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4351033|NCT00395512|4178777|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4351034|NCT00395512|4178773|B5||Male|Sex: Female, Male||Participants|Count of Participants|320|320.0||||||
4351035|NCT00395512|4178774|B4||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4351036|NCT00395512|4178775|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4351037|NCT00395512|4178776|B2||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4351038|NCT00395512|4178777|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4351039|NCT00395512|4178773|B5||Female|Sex: Female, Male||Participants|Count of Participants|335|335.0||||||
4351040|NCT00395512|4178774|B4||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4351041|NCT00395512|4178775|B3||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4351042|NCT00395512|4178776|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4351043|NCT00395512|4178777|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4351044|NCT00395512|4178773|B5|≥ 65 years||Age, Customized||participants|Number|98|98.0||||||
4351045|NCT00395512|4178774|B4|≥ 65 years||Age, Customized||participants|Number|34|34.0||||||
4351046|NCT00395512|4178775|B3|≥ 65 years||Age, Customized||participants|Number|24|24.0||||||
4351047|NCT00395512|4178776|B2|≥ 65 years||Age, Customized||participants|Number|20|20.0||||||
4351048|NCT00395512|4178777|B1|≥ 65 years||Age, Customized||participants|Number|20|20.0||||||
4351049|NCT00395512|4178773|B5|< 65 years||Age, Customized||participants|Number|557|557.0||||||
4351050|NCT00395512|4178774|B4|< 65 years||Age, Customized||participants|Number|130|130.0||||||
4351051|NCT00395512|4178775|B3|< 65 years||Age, Customized||participants|Number|140|140.0||||||
4351052|NCT00395512|4178776|B2|< 65 years||Age, Customized||participants|Number|143|143.0||||||
4351053|NCT00395512|4178777|B1|< 65 years||Age, Customized||participants|Number|144|144.0||||||
4351054|NCT00395512|4178773|B5|||Age||years|Mean|52.6|52.6|Standard Deviation|10.88|10.88|||
4351055|NCT00395512|4178774|B4|||Age||years|Mean|53.5|53.5|Standard Deviation|11.37|11.37|||
4351056|NCT00395512|4178775|B3|||Age||years|Mean|52.8|52.8|Standard Deviation|11.01|11.01|||
4351057|NCT00395512|4178776|B2|||Age||years|Mean|51.5|51.5|Standard Deviation|10.72|10.72|||
4351058|NCT00395512|4178777|B1|||Age||years|Mean|52.6|52.6|Standard Deviation|10.38|10.38|||
4351059|NCT00395486|4178950|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4351060|NCT00395486|4178951|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4351061|NCT00395486|4178952|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4351062|NCT00395486|4178950|B3||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4351063|NCT00395486|4178951|B2||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4351064|NCT00395486|4178952|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4351065|NCT00395486|4178950|B3|18 years||Age||years|Mean|58.9|58.9|Standard Deviation|9.5|9.5|||
4351066|NCT00395486|4178951|B2|18 years||Age||years|Mean|60.4|60.4|Standard Deviation|9.0|9.0|||
4351067|NCT00395486|4178952|B1|18 years||Age||years|Mean|57.5|57.5|Standard Deviation|10.0|10.0|||
4351068|NCT00395460|4178981|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4351069|NCT00395460|4178982|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4351070|NCT00395460|4178983|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4351071|NCT00395460|4178981|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4351072|NCT00395460|4178982|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4351073|NCT00395460|4178983|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4351074|NCT00395460|4178981|B3|||Age||years|Mean|43.4|43.4|Standard Deviation|11.17|11.17|||
4351075|NCT00395460|4178982|B2|||Age||years|Mean|43.9|43.9|Standard Deviation|10.1|10.1|||
4351076|NCT00395460|4178983|B1|||Age||years|Mean|42.8|42.8|Standard Deviation|12.24|12.24|||
4351077|NCT00395447|4179006|B3|United States||Region of Enrollment||participants|Number|1744|1744.0||||||
4351078|NCT00395447|4179007|B2|United States||Region of Enrollment||participants|Number|713|713.0||||||
4351079|NCT00395447|4179008|B1|United States||Region of Enrollment||participants|Number|1031|1031.0||||||
4351080|NCT00395447|4179006|B3||Male|Sex: Female, Male||Participants|Count of Participants|1183|1183.0||||||
4351081|NCT00395447|4179007|B2||Male|Sex: Female, Male||Participants|Count of Participants|541|541.0||||||
4351082|NCT00395447|4179008|B1||Male|Sex: Female, Male||Participants|Count of Participants|642|642.0||||||
4351083|NCT00395447|4179006|B3||Female|Sex: Female, Male||Participants|Count of Participants|561|561.0||||||
4351084|NCT00395447|4179007|B2||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4351085|NCT00395447|4179008|B1||Female|Sex: Female, Male||Participants|Count of Participants|389|389.0||||||
4351086|NCT00395447|4179006|B3|||Age||years|Mean|70|70.0|Standard Deviation|14|14.0|||
4351087|NCT00395447|4179007|B2|||Age||years|Mean|70|70.0|Standard Deviation|13|13.0|||
4351088|NCT00395447|4179008|B1|||Age||years|Mean|71|71.0|Standard Deviation|14|14.0|||
4351089|NCT00395343|4179015|B3|||A1C (Hemoglobin A1c)||Percent|Mean|8.7|8.7|Standard Deviation|0.9|0.9|||
4351090|NCT00395343|4179016|B2|||A1C (Hemoglobin A1c)||Percent|Mean|8.6|8.6|Standard Deviation|0.9|0.9|||
4351091|NCT00395343|4179017|B1|||A1C (Hemoglobin A1c)||Percent|Mean|8.7|8.7|Standard Deviation|0.9|0.9|||
4351092|NCT00395343|4179015|B3|Other||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4351093|NCT00395343|4179016|B2|Other||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4351094|NCT00395343|4179017|B1|Other||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4351095|NCT00395343|4179015|B3|Asian||Race/Ethnicity, Customized||participants|Number|116|116.0||||||
4351096|NCT00395343|4179016|B2|Asian||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
4351097|NCT00395343|4179017|B1|Asian||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
4351098|NCT00395343|4179015|B3|Black||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4351099|NCT00395343|4179016|B2|Black||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4351100|NCT00395343|4179017|B1|Black||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4351101|NCT00395343|4179015|B3|White||Race/Ethnicity, Customized||participants|Number|447|447.0||||||
4351102|NCT00395343|4179016|B2|White||Race/Ethnicity, Customized||participants|Number|219|219.0||||||
4351103|NCT00395343|4179017|B1|White||Race/Ethnicity, Customized||participants|Number|228|228.0||||||
4351104|NCT00395343|4179015|B3||Male|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
4351105|NCT00395343|4179016|B2||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4351106|NCT00395343|4179017|B1||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4351107|NCT00395343|4179015|B3||Female|Sex: Female, Male||Participants|Count of Participants|315|315.0||||||
4351108|NCT00395343|4179016|B2||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4351109|NCT00395343|4179017|B1||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4351110|NCT00395343|4179015|B3|||Age||years|Mean|57.8|57.8|Standard Deviation|9.2|9.2|||
4351111|NCT00395343|4179016|B2|||Age||years|Mean|57.2|57.2|Standard Deviation|9.3|9.3|||
4351112|NCT00395343|4179017|B1|||Age||years|Mean|58.3|58.3|Standard Deviation|9.1|9.1|||
4351113|NCT00395304|4179036|B1|United States||Region of Enrollment||participants|Number|182|182.0||||||
4351114|NCT00395304|4179036|B1||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4351115|NCT00395304|4179036|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4351116|NCT00395304|4179036|B1|||Age||years|Mean|10.8|10.8|Standard Deviation|2.7|2.7|||
4351117|NCT00395304|4179036|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4351118|NCT00395304|4179036|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4351119|NCT00395304|4179036|B1||<=18 years|Age||Participants|Count of Participants|182|182.0||||||
4351120|NCT00395291|4179084|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4351121|NCT00395291|4179084|B1||Male|Gender||Participants|Count of Participants|18|18.0||||||
4351122|NCT00395291|4179084|B1||Female|Gender||Participants|Count of Participants|8|8.0||||||
4351123|NCT00395291|4179084|B1|||Age||years|Mean|57.3|57.3|Standard Deviation|14.4|14.4|||
4351124|NCT00395291|4179084|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4351125|NCT00395291|4179084|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4351126|NCT00395291|4179084|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4351127|NCT00395226|4179115|B3|||Rosacea Severity Score|Modified Rosacea Severity Scoring System evaluating four signs of rosacea, flushing (transient erythema or redness), erythema (redness), papules and pustules and telangiectasia (spider-veins) ranges from 0 (best, absent) to 12 (worst, severe on all items)|units on scale 0 to 12|Mean|6.5|6.5|Standard Deviation|1.3|1.3|||
4351128|NCT00395226|4179116|B2|||Rosacea Severity Score|Modified Rosacea Severity Scoring System evaluating four signs of rosacea, flushing (transient erythema or redness), erythema (redness), papules and pustules and telangiectasia (spider-veins) ranges from 0 (best, absent) to 12 (worst, severe on all items)|units on scale 0 to 12|Mean|6.3|6.3|Standard Deviation|1.2|1.2|||
4351129|NCT00395226|4179117|B1|||Rosacea Severity Score|Modified Rosacea Severity Scoring System evaluating four signs of rosacea, flushing (transient erythema or redness), erythema (redness), papules and pustules and telangiectasia (spider-veins) ranges from 0 (best, absent) to 12 (worst, severe on all items)|units on scale 0 to 12|Mean|6.8|6.8|Standard Deviation|1.4|1.4|||
4351130|NCT00395226|4179115|B3|> 10 years||Length of Rosacea||participant|Number|17|17.0||||||
4351131|NCT00395226|4179116|B2|> 10 years||Length of Rosacea||participant|Number|8|8.0||||||
4351132|NCT00395226|4179117|B1|> 10 years||Length of Rosacea||participant|Number|9|9.0||||||
4351133|NCT00395226|4179115|B3|5-10 years||Length of Rosacea||participant|Number|14|14.0||||||
4351134|NCT00395226|4179116|B2|5-10 years||Length of Rosacea||participant|Number|10|10.0||||||
4351135|NCT00395226|4179117|B1|5-10 years||Length of Rosacea||participant|Number|4|4.0||||||
4351136|NCT00395226|4179115|B3|2-5 years||Length of Rosacea||participant|Number|16|16.0||||||
4351137|NCT00395226|4179116|B2|2-5 years||Length of Rosacea||participant|Number|4|4.0||||||
4351138|NCT00395226|4179117|B1|2-5 years||Length of Rosacea||participant|Number|12|12.0||||||
4351139|NCT00395226|4179115|B3|1-2 years||Length of Rosacea||participant|Number|3|3.0||||||
4351140|NCT00395226|4179116|B2|1-2 years||Length of Rosacea||participant|Number|3|3.0||||||
4351141|NCT00395226|4179117|B1|1-2 years||Length of Rosacea||participant|Number|0|0.0||||||
4351142|NCT00395226|4179115|B3|< 1 year||Length of Rosacea||participant|Number|3|3.0||||||
4351143|NCT00395226|4179116|B2|< 1 year||Length of Rosacea||participant|Number|2|2.0||||||
4351144|NCT00395226|4179117|B1|< 1 year||Length of Rosacea||participant|Number|1|1.0||||||
4351145|NCT00395226|4179115|B3|United States||Region of Enrollment||participants|Number|53|53.0||||||
4351146|NCT00395226|4179116|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4351147|NCT00395226|4179117|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4351148|NCT00395226|4179115|B3|Non-Caucasian||Race/Ethnicity, Customized||participant|Number|3|3.0||||||
4351149|NCT00395226|4179116|B2|Non-Caucasian||Race/Ethnicity, Customized||participant|Number|1|1.0||||||
4351150|NCT00395226|4179117|B1|Non-Caucasian||Race/Ethnicity, Customized||participant|Number|2|2.0||||||
4351151|NCT00395226|4179115|B3|Caucasian||Race/Ethnicity, Customized||participant|Number|50|50.0||||||
4351152|NCT00395226|4179116|B2|Caucasian||Race/Ethnicity, Customized||participant|Number|26|26.0||||||
4351153|NCT00395226|4179117|B1|Caucasian||Race/Ethnicity, Customized||participant|Number|24|24.0||||||
4351154|NCT00395226|4179115|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4351155|NCT00395226|4179116|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4351156|NCT00395226|4179117|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4351157|NCT00395226|4179115|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4351158|NCT00395226|4179116|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4351159|NCT00395226|4179117|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4351160|NCT00395226|4179115|B3|||Age||years|Mean|50.1|50.1|Standard Deviation|12.2|12.2|||
4351161|NCT00395226|4179116|B2|||Age||years|Mean|52.8|52.8|Standard Deviation|10.5|10.5|||
4351162|NCT00395226|4179117|B1|||Age||years|Mean|47.3|47.3|Standard Deviation|13.4|13.4|||
4351163|NCT00395161|4179124|B3|Immune Competent||Immune Compromised at Study Entry|Patients were classified as immune compromised if they had acquired immunodeficiency syndrome, cancer, transplantation, primary immune deficiency or chronic immune suppressant therapy.|Participants|Number|268|268.0||||||
4351164|NCT00395161|4179125|B2|Immune Competent||Immune Compromised at Study Entry|Patients were classified as immune compromised if they had acquired immunodeficiency syndrome, cancer, transplantation, primary immune deficiency or chronic immune suppressant therapy.|Participants|Number|133|133.0||||||
4351165|NCT00395161|4179126|B1|Immune Competent||Immune Compromised at Study Entry|Patients were classified as immune compromised if they had acquired immunodeficiency syndrome, cancer, transplantation, primary immune deficiency or chronic immune suppressant therapy.|Participants|Number|135|135.0||||||
4351166|NCT00395161|4179124|B3|Immune compromised||Immune Compromised at Study Entry|Patients were classified as immune compromised if they had acquired immunodeficiency syndrome, cancer, transplantation, primary immune deficiency or chronic immune suppressant therapy.|Participants|Number|25|25.0||||||
4351167|NCT00395161|4179125|B2|Immune compromised||Immune Compromised at Study Entry|Patients were classified as immune compromised if they had acquired immunodeficiency syndrome, cancer, transplantation, primary immune deficiency or chronic immune suppressant therapy.|Participants|Number|11|11.0||||||
4351168|NCT00395161|4179126|B1|Immune compromised||Immune Compromised at Study Entry|Patients were classified as immune compromised if they had acquired immunodeficiency syndrome, cancer, transplantation, primary immune deficiency or chronic immune suppressant therapy.|Participants|Number|14|14.0||||||
4351169|NCT00395161|4179124|B3|United States||Region of Enrollment||participants|Number|293|293.0||||||
4351170|NCT00395161|4179125|B2|United States||Region of Enrollment||participants|Number|144|144.0||||||
4351171|NCT00395161|4179126|B1|United States||Region of Enrollment||participants|Number|149|149.0||||||
4351172|NCT00395161|4179124|B3||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4351173|NCT00395161|4179125|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4351174|NCT00395161|4179126|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4351175|NCT00395161|4179124|B3||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4351176|NCT00395161|4179125|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4351177|NCT00395161|4179126|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4351178|NCT00395161|4179124|B3|||Age||years|Mean|8.1|8.1|Standard Deviation|5.7|5.7|||
4351179|NCT00395161|4179125|B2|||Age||years|Mean|8.4|8.4|Standard Deviation|5.9|5.9|||
4351180|NCT00395161|4179126|B1|||Age||years|Mean|7.9|7.9|Standard Deviation|5.6|5.6|||
4351181|NCT00395161|4179124|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4351182|NCT00395161|4179125|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4351183|NCT00395161|4179126|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4351184|NCT00395161|4179124|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4351185|NCT00395161|4179125|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4351186|NCT00395161|4179126|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4351187|NCT00395161|4179124|B3||<=18 years|Age||Participants|Count of Participants|293|293.0||||||
4351188|NCT00395161|4179125|B2||<=18 years|Age||Participants|Count of Participants|144|144.0||||||
4351189|NCT00395161|4179126|B1||<=18 years|Age||Participants|Count of Participants|149|149.0||||||
4351190|NCT00395135|4179141|B3||Male|Sex: Female, Male||Participants|Count of Participants|525|525.0||||||
4351191|NCT00395135|4179142|B2||Male|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
4351192|NCT00395135|4179143|B1||Male|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
4351193|NCT00395135|4179141|B3||Female|Sex: Female, Male||Participants|Count of Participants|2652|2652.0||||||
4351194|NCT00395135|4179142|B2||Female|Sex: Female, Male||Participants|Count of Participants|1331|1331.0||||||
4351195|NCT00395135|4179143|B1||Female|Sex: Female, Male||Participants|Count of Participants|1321|1321.0||||||
4351196|NCT00395135|4179141|B3|||Age||years|Mean|44.1|44.1|Standard Deviation|11.22|11.22|||
4351197|NCT00395135|4179142|B2|||Age||years|Mean|44.4|44.4|Standard Deviation|11.11|11.11|||
4351198|NCT00395135|4179143|B1|||Age||years|Mean|43.8|43.8|Standard Deviation|11.32|11.32|||
4351199|NCT00395083|4179163|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4351200|NCT00395083|4179164|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4351201|NCT00395083|4179165|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4351202|NCT00395083|4179163|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|416|416.0||||||
4351203|NCT00395083|4179164|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|207|207.0||||||
4351204|NCT00395083|4179165|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|209|209.0||||||
4351205|NCT00395083|4179163|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4351206|NCT00395083|4179164|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4351207|NCT00395083|4179165|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4351208|NCT00395083|4179163|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4351209|NCT00395083|4179164|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4351210|NCT00395083|4179165|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4351211|NCT00395083|4179163|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4351212|NCT00395083|4179164|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4351213|NCT00395083|4179165|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4351214|NCT00395083|4179163|B3||White|Race (NIH/OMB)||Participants|Count of Participants|372|372.0||||||
4351215|NCT00395083|4179164|B2||White|Race (NIH/OMB)||Participants|Count of Participants|181|181.0||||||
4351216|NCT00395083|4179165|B1||White|Race (NIH/OMB)||Participants|Count of Participants|191|191.0||||||
4351217|NCT00395083|4179163|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4351218|NCT00395083|4179164|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4351219|NCT00395083|4179165|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4351220|NCT00395083|4179163|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4351221|NCT00395083|4179164|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4351222|NCT00395083|4179165|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4351223|NCT00395083|4179163|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4351224|NCT00395083|4179164|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4351225|NCT00395083|4179165|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4351226|NCT00395083|4179163|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4351227|NCT00395083|4179164|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4351228|NCT00395083|4179165|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4351229|NCT00395083|4179163|B3||Male|Sex: Female, Male||Participants|Count of Participants|413|413.0||||||
4351230|NCT00395083|4179164|B2||Male|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4351231|NCT00395083|4179165|B1||Male|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4351232|NCT00395083|4179163|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4351233|NCT00395083|4179164|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4351234|NCT00395083|4179165|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4351235|NCT00395083|4179163|B3|||Age||years|Mean|66.0|66.0|Standard Deviation|8.3|8.3|||
4351236|NCT00395083|4179164|B2|||Age||years|Mean|66.2|66.2|Standard Deviation|8.4|8.4|||
4351237|NCT00395083|4179165|B1|||Age||years|Mean|65.8|65.8|Standard Deviation|8.2|8.2|||
4351238|NCT00395057|4179178|B5||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4351239|NCT00395057|4179179|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4351240|NCT00395057|4179180|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4351241|NCT00395057|4179181|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4351242|NCT00395057|4179182|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4351243|NCT00395057|4179178|B5||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4351244|NCT00395057|4179179|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4351245|NCT00395057|4179180|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4351246|NCT00395057|4179181|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4351247|NCT00395057|4179182|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4351248|NCT00395057|4179178|B5|>=65 years||Age, Customized||participants|Number|122|122.0||||||
4351249|NCT00395057|4179179|B4|>=65 years||Age, Customized||participants|Number|30|30.0||||||
4351250|NCT00395057|4179180|B3|>=65 years||Age, Customized||participants|Number|30|30.0||||||
4351251|NCT00395057|4179181|B2|>=65 years||Age, Customized||participants|Number|30|30.0||||||
4351252|NCT00395057|4179182|B1|>=65 years||Age, Customized||participants|Number|32|32.0||||||
4351253|NCT00395057|4179178|B5|Between 45 and 65 years||Age, Customized||participants|Number|16|16.0||||||
4351254|NCT00395057|4179179|B4|Between 45 and 65 years||Age, Customized||participants|Number|4|4.0||||||
4351255|NCT00395057|4179180|B3|Between 45 and 65 years||Age, Customized||participants|Number|5|5.0||||||
4351256|NCT00395057|4179181|B2|Between 45 and 65 years||Age, Customized||participants|Number|5|5.0||||||
4351257|NCT00395057|4179182|B1|Between 45 and 65 years||Age, Customized||participants|Number|2|2.0||||||
4351258|NCT00395044|4179211|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4351259|NCT00395044|4179212|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4351260|NCT00395044|4179213|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4351261|NCT00395044|4179211|B3||Male|Gender||Participants|Count of Participants|44|44.0||||||
4351262|NCT00395044|4179212|B2||Male|Gender||Participants|Count of Participants|21|21.0||||||
4351263|NCT00395044|4179213|B1||Male|Gender||Participants|Count of Participants|23|23.0||||||
4351264|NCT00395044|4179211|B3||Female|Gender||Participants|Count of Participants|6|6.0||||||
4351265|NCT00395044|4179212|B2||Female|Gender||Participants|Count of Participants|4|4.0||||||
4351266|NCT00395044|4179213|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
4351267|NCT00395044|4179211|B3|||Age||years|Mean|33.9|33.9|Standard Deviation|9.7|9.7|||
4351268|NCT00395044|4179212|B2|||Age||years|Mean|34.4|34.4|Standard Deviation|10.8|10.8|||
4351269|NCT00395044|4179213|B1|||Age||years|Mean|33.4|33.4|Standard Deviation|8.5|8.5|||
4351270|NCT00395044|4179211|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4351271|NCT00395044|4179212|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4351272|NCT00395044|4179213|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4351273|NCT00395044|4179211|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4351274|NCT00395044|4179212|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4351275|NCT00395044|4179213|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4351276|NCT00395044|4179211|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4351277|NCT00395044|4179212|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4351278|NCT00395044|4179213|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4351279|NCT00395018|4179232|B1|||Total Bilirubin||mg/dL|Median|2.4|2.4|Full Range|||0.2|31.0|
4351280|NCT00395018|4179232|B1|||Alanine Aminotransferase (ALT)||U/L|Median|43|43.0|Full Range|||10.0|1485.0|
4351281|NCT00395018|4179232|B1|||Albumin||g/dL|Median|3.0|3.0|Full Range|||1.8|4.7|
4351282|NCT00395018|4179232|B1|||International Normalized Ratio|Evaluated in 63 participants at baseline.|ratio|Median|1.51|1.51|Full Range|||0.86|7.1|
4351283|NCT00395018|4179232|B1|Negative||Hepatitis B E Antibody (HBeAb)||participants|Number|17|17.0||||||
4351284|NCT00395018|4179232|B1|Positive||Hepatitis B E Antibody (HBeAb)||participants|Number|48|48.0||||||
4351285|NCT00395018|4179232|B1|Negative||Hepatitis B E Antigen (HBeAg)||participants|Number|58|58.0||||||
4351286|NCT00395018|4179232|B1|Positive||Hepatitis B E Antigen (HBeAg)||participants|Number|7|7.0||||||
4351287|NCT00395018|4179232|B1|Negative||Hepatitis B Surface Antigen||participants|Number|4|4.0||||||
4351288|NCT00395018|4179232|B1|Positive||Hepatitis B Surface Antigen||participants|Number|61|61.0||||||
4351289|NCT00395018|4179232|B1|||HBV DNA by PCR||log10 IU/mL|Median|0.8|0.8|Full Range|||0.8|3.7|
4351290|NCT00395018|4179232|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4351291|NCT00395018|4179232|B1|Taiwan||Region of Enrollment||participants|Number|4|4.0||||||
4351292|NCT00395018|4179232|B1|Spain||Region of Enrollment||participants|Number|3|3.0||||||
4351293|NCT00395018|4179232|B1|Korea, Republic of||Region of Enrollment||participants|Number|7|7.0||||||
4351294|NCT00395018|4179232|B1|Italy||Region of Enrollment||participants|Number|6|6.0||||||
4351295|NCT00395018|4179232|B1|France||Region of Enrollment||participants|Number|12|12.0||||||
4351296|NCT00395018|4179232|B1|Brazil||Region of Enrollment||participants|Number|12|12.0||||||
4351297|NCT00395018|4179232|B1|Australia||Region of Enrollment||participants|Number|5|5.0||||||
4351298|NCT00395018|4179232|B1|Argentina||Region of Enrollment||participants|Number|2|2.0||||||
4351299|NCT00395018|4179232|B1|Not Hispanic/Latino||Race/Ethnicity, Customized|Participants in United States of America (USA) only.|participants|Number|14|14.0||||||
4351300|NCT00395018|4179232|B1|Hispanic/Latino||Race/Ethnicity, Customized|Participants in United States of America (USA) only.|participants|Number|0|0.0||||||
4351301|NCT00395018|4179232|B1|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4351302|NCT00395018|4179232|B1|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4351303|NCT00395018|4179232|B1|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4351304|NCT00395018|4179232|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4351305|NCT00395018|4179232|B1|Asian||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4351306|NCT00395018|4179232|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4351307|NCT00395018|4179232|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4351308|NCT00395018|4179232|B1|>=65 years||Age, Customized||participants|Number|5|5.0||||||
4351309|NCT00395018|4179232|B1|21-64 years||Age, Customized||participants|Number|60|60.0||||||
4351310|NCT00395018|4179232|B1|||Age||years|Median|51.0|51.0|Full Range|||23.0|68.0|
4351311|NCT00394953|4179251|B3||Male|Gender||Participants|Count of Participants|303|303.0||||||
4351312|NCT00394953|4179252|B2||Male|Gender||Participants|Count of Participants|155|155.0||||||
4351313|NCT00394953|4179253|B1||Male|Gender||Participants|Count of Participants|148|148.0||||||
4351314|NCT00394953|4179251|B3||Female|Gender||Participants|Count of Participants|186|186.0||||||
4351315|NCT00394953|4179252|B2||Female|Gender||Participants|Count of Participants|89|89.0||||||
4351316|NCT00394953|4179253|B1||Female|Gender||Participants|Count of Participants|97|97.0||||||
4351317|NCT00394953|4179251|B3|||Age||years|Mean|65.8|65.8|Standard Deviation|13.77|13.77|||
4351318|NCT00394953|4179252|B2|||Age||years|Mean|65.4|65.4|Standard Deviation|13.91|13.91|||
4351319|NCT00394953|4179253|B1|||Age||years|Mean|66.2|66.2|Standard Deviation|13.64|13.64|||
4351320|NCT00394914|4179270|B3||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4351321|NCT00394914|4179271|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4351322|NCT00394914|4179272|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4351323|NCT00394914|4179270|B3||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4351324|NCT00394914|4179271|B2||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4351325|NCT00394914|4179272|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4351326|NCT00394914|4179270|B3|||Age||years|Mean|29.1|29.1|Standard Deviation|17.0|17.0|||
4351327|NCT00394914|4179271|B2|||Age||years|Mean|28.7|28.7|Standard Deviation|17.3|17.3|||
4351328|NCT00394914|4179272|B1|||Age||years|Mean|29.4|29.4|Standard Deviation|16.7|16.7|||
4351329|NCT00394901|4179298|B5|Japan||Region of Enrollment||participants|Number|371|371.0||||||
4351330|NCT00394901|4179299|B4|Japan||Region of Enrollment||participants|Number|97|97.0||||||
4351331|NCT00394901|4179300|B3|Japan||Region of Enrollment||participants|Number|89|89.0||||||
4351332|NCT00394901|4179301|B2|Japan||Region of Enrollment||participants|Number|87|87.0||||||
4351333|NCT00394901|4179302|B1|Japan||Region of Enrollment||participants|Number|98|98.0||||||
4351334|NCT00394901|4179298|B5||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4351335|NCT00394901|4179299|B4||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4351336|NCT00394901|4179300|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4351337|NCT00394901|4179301|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4351338|NCT00394901|4179302|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4351339|NCT00394901|4179298|B5||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4351340|NCT00394901|4179299|B4||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4351341|NCT00394901|4179300|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4351342|NCT00394901|4179301|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4351343|NCT00394901|4179302|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4351344|NCT00394901|4179298|B5|>=65 years||Age, Customized||participants|Number|296|296.0||||||
4351345|NCT00394901|4179299|B4|>=65 years||Age, Customized||participants|Number|71|71.0||||||
4351346|NCT00394901|4179300|B3|>=65 years||Age, Customized||participants|Number|72|72.0||||||
4351347|NCT00394901|4179301|B2|>=65 years||Age, Customized||participants|Number|69|69.0||||||
4351348|NCT00394901|4179302|B1|>=65 years||Age, Customized||participants|Number|84|84.0||||||
4351349|NCT00394901|4179298|B5|Between 45 and 64 years||Age, Customized||participants|Number|64|64.0||||||
4351350|NCT00394901|4179299|B4|Between 45 and 64 years||Age, Customized||participants|Number|20|20.0||||||
4351351|NCT00394901|4179300|B3|Between 45 and 64 years||Age, Customized||participants|Number|15|15.0||||||
4351352|NCT00394901|4179301|B2|Between 45 and 64 years||Age, Customized||participants|Number|17|17.0||||||
4351353|NCT00394901|4179302|B1|Between 45 and 64 years||Age, Customized||participants|Number|12|12.0||||||
4351354|NCT00394901|4179298|B5|Between 18 and 44 years||Age, Customized||participants|Number|11|11.0||||||
4351355|NCT00394901|4179299|B4|Between 18 and 44 years||Age, Customized||participants|Number|6|6.0||||||
4351356|NCT00394901|4179300|B3|Between 18 and 44 years||Age, Customized||participants|Number|2|2.0||||||
4351357|NCT00394901|4179301|B2|Between 18 and 44 years||Age, Customized||participants|Number|1|1.0||||||
4351358|NCT00394901|4179302|B1|Between 18 and 44 years||Age, Customized||participants|Number|2|2.0||||||
4351359|NCT00394901|4179298|B5|<18 years||Age, Customized||participants|Number|0|0.0||||||
4351360|NCT00394901|4179299|B4|<18 years||Age, Customized||participants|Number|0|0.0||||||
4351361|NCT00394901|4179300|B3|<18 years||Age, Customized||participants|Number|0|0.0||||||
4351362|NCT00394901|4179301|B2|<18 years||Age, Customized||participants|Number|0|0.0||||||
4351363|NCT00394901|4179302|B1|<18 years||Age, Customized||participants|Number|0|0.0||||||
4351364|NCT00394901|4179298|B5|||Age||years|Mean|70.1|70.1|Standard Deviation|10.2|10.2|||
4351365|NCT00394901|4179299|B4|||Age||years|Mean|68.4|68.4|Standard Deviation|12.5|12.5|||
4351366|NCT00394901|4179300|B3|||Age||years|Mean|70.9|70.9|Standard Deviation|9.8|9.8|||
4351367|NCT00394901|4179301|B2|||Age||years|Mean|70.2|70.2|Standard Deviation|9.2|9.2|||
4351368|NCT00394901|4179302|B1|||Age||years|Mean|71.1|71.1|Standard Deviation|8.6|8.6|||
4351369|NCT00394888|4179530|B4|United States||Region of Enrollment||participants|Number|357|357.0||||||
4351370|NCT00394888|4179531|B3|United States||Region of Enrollment||participants|Number|201|201.0||||||
4351371|NCT00394888|4179532|B2|United States||Region of Enrollment||participants|Number|48|48.0||||||
4351372|NCT00394888|4179533|B1|United States||Region of Enrollment||participants|Number|108|108.0||||||
4351373|NCT00394888|4179530|B4||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4351374|NCT00394888|4179531|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4351375|NCT00394888|4179532|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4351376|NCT00394888|4179533|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4351377|NCT00394888|4179530|B4||Female|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
4351378|NCT00394888|4179531|B3||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4351379|NCT00394888|4179532|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4351380|NCT00394888|4179533|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4351381|NCT00394888|4179530|B4|||Age||years|Mean|0.5|0.5|Standard Deviation|1|1.0|||
4351382|NCT00394888|4179531|B3|||Age||years|Mean|0.5|0.5|Standard Deviation|1|1.0|||
4351383|NCT00394888|4179532|B2|||Age||years|Mean|0.5|0.5|Standard Deviation|1|1.0|||
4351384|NCT00394888|4179533|B1|||Age||years|Mean|0.5|0.5|Standard Deviation|1|1.0|||
4351385|NCT00394888|4179530|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4351386|NCT00394888|4179531|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4351387|NCT00394888|4179532|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4351388|NCT00394888|4179533|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4351389|NCT00394888|4179530|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4351390|NCT00394888|4179531|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4351391|NCT00394888|4179532|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4351392|NCT00394888|4179533|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4351393|NCT00394888|4179530|B4||<=18 years|Age||Participants|Count of Participants|357|357.0||||||
4351394|NCT00394888|4179531|B3||<=18 years|Age||Participants|Count of Participants|201|201.0||||||
4351395|NCT00394888|4179532|B2||<=18 years|Age||Participants|Count of Participants|48|48.0||||||
4351396|NCT00394888|4179533|B1||<=18 years|Age||Participants|Count of Participants|108|108.0||||||
4351397|NCT00394836|4179546|B3|Reunion Island Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4351398|NCT00394836|4179547|B2|Reunion Island Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4351399|NCT00394836|4179548|B1|Reunion Island Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4351400|NCT00394836|4179546|B3|White||Race/Ethnicity, Customized||participants|Number|106|106.0||||||
4351401|NCT00394836|4179547|B2|White||Race/Ethnicity, Customized||participants|Number|78|78.0||||||
4351402|NCT00394836|4179548|B1|White||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4351403|NCT00394836|4179546|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4351404|NCT00394836|4179547|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4351405|NCT00394836|4179548|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4351406|NCT00394836|4179546|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4351407|NCT00394836|4179547|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4351408|NCT00394836|4179548|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4351409|NCT00394836|4179546|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4351410|NCT00394836|4179547|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4351411|NCT00394836|4179548|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4351412|NCT00394836|4179546|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4351413|NCT00394836|4179547|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4351414|NCT00394836|4179548|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4351415|NCT00394836|4179546|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4351416|NCT00394836|4179547|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4351417|NCT00394836|4179548|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4351418|NCT00394836|4179546|B3|||Age||Years|Mean|59.9|59.9|Standard Deviation|10.8|10.8|||
4351419|NCT00394836|4179547|B2|||Age||Years|Mean|59.7|59.7|Standard Deviation|11.1|11.1|||
4351420|NCT00394836|4179548|B1|||Age||Years|Mean|60.4|60.4|Standard Deviation|10.1|10.1|||
4351421|NCT00394771|4179591|B5|Fresh-Start||Oral Contraceptive Use History||participants|Number|76|76.0||||||
4351422|NCT00394771|4179592|B4|Fresh-Start||Oral Contraceptive Use History||participants|Number|19|19.0||||||
4351423|NCT00394771|4179593|B3|Fresh-Start||Oral Contraceptive Use History||participants|Number|17|17.0||||||
4351424|NCT00394771|4179594|B2|Fresh-Start||Oral Contraceptive Use History||participants|Number|19|19.0||||||
4351425|NCT00394771|4179595|B1|Fresh-Start||Oral Contraceptive Use History||participants|Number|21|21.0||||||
4351426|NCT00394771|4179591|B5|Prior User||Oral Contraceptive Use History||participants|Number|190|190.0||||||
4351427|NCT00394771|4179592|B4|Prior User||Oral Contraceptive Use History||participants|Number|52|52.0||||||
4351428|NCT00394771|4179593|B3|Prior User||Oral Contraceptive Use History||participants|Number|49|49.0||||||
4351429|NCT00394771|4179594|B2|Prior User||Oral Contraceptive Use History||participants|Number|45|45.0||||||
4351430|NCT00394771|4179595|B1|Prior User||Oral Contraceptive Use History||participants|Number|44|44.0||||||
4351431|NCT00394771|4179591|B5|Continuous User||Oral Contraceptive Use History||participants|Number|181|181.0||||||
4351432|NCT00394771|4179592|B4|Continuous User||Oral Contraceptive Use History||participants|Number|49|49.0||||||
4351433|NCT00394771|4179593|B3|Continuous User||Oral Contraceptive Use History||participants|Number|42|42.0||||||
4351434|NCT00394771|4179594|B2|Continuous User||Oral Contraceptive Use History||participants|Number|46|46.0||||||
4351435|NCT00394771|4179595|B1|Continuous User||Oral Contraceptive Use History||participants|Number|44|44.0||||||
4351436|NCT00394771|4179591|B5|Missing||Oral Contraceptive Use History||participants|Number|1|1.0||||||
4351437|NCT00394771|4179592|B4|Missing||Oral Contraceptive Use History||participants|Number|0|0.0||||||
4351438|NCT00394771|4179593|B3|Missing||Oral Contraceptive Use History||participants|Number|0|0.0||||||
4351439|NCT00394771|4179594|B2|Missing||Oral Contraceptive Use History||participants|Number|0|0.0||||||
4351440|NCT00394771|4179595|B1|Missing||Oral Contraceptive Use History||participants|Number|1|1.0||||||
4351441|NCT00394771|4179591|B5|Non-Smoker||Smoking Status||participants|Number|333|333.0||||||
4351442|NCT00394771|4179592|B4|Non-Smoker||Smoking Status||participants|Number|88|88.0||||||
4351443|NCT00394771|4179593|B3|Non-Smoker||Smoking Status||participants|Number|85|85.0||||||
4351444|NCT00394771|4179594|B2|Non-Smoker||Smoking Status||participants|Number|83|83.0||||||
4351445|NCT00394771|4179595|B1|Non-Smoker||Smoking Status||participants|Number|77|77.0||||||
4351446|NCT00394771|4179591|B5|Past Smoker||Smoking Status||participants|Number|64|64.0||||||
4351447|NCT00394771|4179592|B4|Past Smoker||Smoking Status||participants|Number|21|21.0||||||
4351448|NCT00394771|4179593|B3|Past Smoker||Smoking Status||participants|Number|12|12.0||||||
4351449|NCT00394771|4179594|B2|Past Smoker||Smoking Status||participants|Number|11|11.0||||||
4351450|NCT00394771|4179595|B1|Past Smoker||Smoking Status||participants|Number|20|20.0||||||
4351451|NCT00394771|4179591|B5|Current Smoker||Smoking Status||participants|Number|51|51.0||||||
4351452|NCT00394771|4179592|B4|Current Smoker||Smoking Status||participants|Number|11|11.0||||||
4351453|NCT00394771|4179593|B3|Current Smoker||Smoking Status||participants|Number|11|11.0||||||
4351454|NCT00394771|4179594|B2|Current Smoker||Smoking Status||participants|Number|16|16.0||||||
4351455|NCT00394771|4179595|B1|Current Smoker||Smoking Status||participants|Number|13|13.0||||||
4351456|NCT00394771|4179591|B5|||Heart Rate||beats/minute|Mean|73.3|73.3|Standard Deviation|9.26|9.26|||
4351457|NCT00394771|4179592|B4|||Heart Rate||beats/minute|Mean|71.9|71.9|Standard Deviation|9.07|9.07|||
4351458|NCT00394771|4179593|B3|||Heart Rate||beats/minute|Mean|73.7|73.7|Standard Deviation|9.17|9.17|||
4351459|NCT00394771|4179594|B2|||Heart Rate||beats/minute|Mean|73.7|73.7|Standard Deviation|8.90|8.9|||
4351460|NCT00394771|4179595|B1|||Heart Rate||beats/minute|Mean|73.9|73.9|Standard Deviation|9.85|9.85|||
4351461|NCT00394771|4179591|B5|||Diastolic Blood Pressure||mmHg|Mean|72.1|72.1|Standard Deviation|8.14|8.14|||
4351462|NCT00394771|4179592|B4|||Diastolic Blood Pressure||mmHg|Mean|71.4|71.4|Standard Deviation|8.44|8.44|||
4351463|NCT00394771|4179593|B3|||Diastolic Blood Pressure||mmHg|Mean|71.8|71.8|Standard Deviation|7.72|7.72|||
4351464|NCT00394771|4179594|B2|||Diastolic Blood Pressure||mmHg|Mean|72.9|72.9|Standard Deviation|7.46|7.46|||
4351465|NCT00394771|4179595|B1|||Diastolic Blood Pressure||mmHg|Mean|72.3|72.3|Standard Deviation|8.85|8.85|||
4351466|NCT00394771|4179591|B5|||Systolic Blood Pressure||mmHg|Mean|114.2|114.2|Standard Deviation|10.19|10.19|||
4351467|NCT00394771|4179592|B4|||Systolic Blood Pressure||mmHg|Mean|112.8|112.8|Standard Deviation|10.23|10.23|||
4351468|NCT00394771|4179593|B3|||Systolic Blood Pressure||mmHg|Mean|115.6|115.6|Standard Deviation|9.31|9.31|||
4351469|NCT00394771|4179594|B2|||Systolic Blood Pressure||mmHg|Mean|114.4|114.4|Standard Deviation|10.34|10.34|||
4351470|NCT00394771|4179595|B1|||Systolic Blood Pressure||mmHg|Mean|114.2|114.2|Standard Deviation|10.74|10.74|||
4351471|NCT00394771|4179591|B5|||Body Mass Index||kg/m^2|Mean|25.9|25.9|Standard Deviation|4.35|4.35|||
4351472|NCT00394771|4179592|B4|||Body Mass Index||kg/m^2|Mean|25.5|25.5|Standard Deviation|4.41|4.41|||
4351473|NCT00394771|4179593|B3|||Body Mass Index||kg/m^2|Mean|26.0|26.0|Standard Deviation|4.59|4.59|||
4351474|NCT00394771|4179594|B2|||Body Mass Index||kg/m^2|Mean|25.7|25.7|Standard Deviation|4.24|4.24|||
4351475|NCT00394771|4179595|B1|||Body Mass Index||kg/m^2|Mean|26.6|26.6|Standard Deviation|4.13|4.13|||
4351476|NCT00394771|4179591|B5|||Weight||lbs|Mean|154.4|154.4|Standard Deviation|29.22|29.22|||
4351477|NCT00394771|4179592|B4|||Weight||lbs|Mean|151.9|151.9|Standard Deviation|30.03|30.03|||
4351478|NCT00394771|4179593|B3|||Weight||lbs|Mean|156.0|156.0|Standard Deviation|30.79|30.79|||
4351479|NCT00394771|4179594|B2|||Weight||lbs|Mean|153.6|153.6|Standard Deviation|27.18|27.18|||
4351480|NCT00394771|4179595|B1|||Weight||lbs|Mean|156.6|156.6|Standard Deviation|28.84|28.84|||
4351481|NCT00394771|4179591|B5|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4351482|NCT00394771|4179592|B4|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4351483|NCT00394771|4179593|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4351484|NCT00394771|4179594|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4351485|NCT00394771|4179595|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4351486|NCT00394771|4179591|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
4351487|NCT00394771|4179592|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4351488|NCT00394771|4179593|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4351489|NCT00394771|4179594|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4351490|NCT00394771|4179595|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4351491|NCT00394771|4179591|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|291|291.0||||||
4351492|NCT00394771|4179592|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
4351493|NCT00394771|4179593|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
4351494|NCT00394771|4179594|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
4351495|NCT00394771|4179595|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
4351496|NCT00394771|4179591|B5|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4351497|NCT00394771|4179592|B4|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4351498|NCT00394771|4179593|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4351499|NCT00394771|4179594|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4351500|NCT00394771|4179595|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4351501|NCT00394771|4179591|B5|African-American||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
4351502|NCT00394771|4179592|B4|African-American||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4351503|NCT00394771|4179593|B3|African-American||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4351504|NCT00394771|4179594|B2|African-American||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4351505|NCT00394771|4179595|B1|African-American||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4351506|NCT00394771|4179591|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4351507|NCT00394771|4179592|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4351508|NCT00394771|4179593|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4351509|NCT00394771|4179594|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4351510|NCT00394771|4179595|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4351511|NCT00394771|4179591|B5||Female|Sex: Female, Male||Participants|Count of Participants|448|448.0||||||
4351512|NCT00394771|4179592|B4||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4351513|NCT00394771|4179593|B3||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4351514|NCT00394771|4179594|B2||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4351515|NCT00394771|4179595|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4351516|NCT00394771|4179591|B5|||Age||years|Mean|30.5|30.5|Standard Deviation|7.08|7.08|||
4351517|NCT00394771|4179592|B4|||Age||years|Mean|30.6|30.6|Standard Deviation|6.90|6.9|||
4351518|NCT00394771|4179593|B3|||Age||years|Mean|30.7|30.7|Standard Deviation|7.61|7.61|||
4351519|NCT00394771|4179594|B2|||Age||years|Mean|30.5|30.5|Standard Deviation|7.02|7.02|||
4351520|NCT00394771|4179595|B1|||Age||years|Mean|30.1|30.1|Standard Deviation|6.88|6.88|||
4351521|NCT00394706|4179660|B9|Canada||Region of Enrollment||participants|Number|7002|7002.0||||||
4351522|NCT00394706|4179661|B8|Canada||Region of Enrollment||participants|Number|362|362.0||||||
4351523|NCT00394706|4179662|B7|Canada||Region of Enrollment||participants|Number|395|395.0||||||
4351524|NCT00394706|4179663|B6|Canada||Region of Enrollment||participants|Number|979|979.0||||||
4351525|NCT00394706|4179664|B5|Canada||Region of Enrollment||participants|Number|935|935.0||||||
4351526|NCT00394706|4179665|B4|Canada||Region of Enrollment||participants|Number|940|940.0||||||
4351527|NCT00394706|4179666|B3|Canada||Region of Enrollment||participants|Number|1210|1210.0||||||
4351528|NCT00394706|4179667|B2|Canada||Region of Enrollment||participants|Number|1097|1097.0||||||
4351529|NCT00394706|4179668|B1|Canada||Region of Enrollment||participants|Number|1084|1084.0||||||
4351530|NCT00394706|4179660|B9|United States||Region of Enrollment||participants|Number|4720|4720.0||||||
4351531|NCT00394706|4179661|B8|United States||Region of Enrollment||participants|Number|489|489.0||||||
4351532|NCT00394706|4179662|B7|United States||Region of Enrollment||participants|Number|534|534.0||||||
4351533|NCT00394706|4179663|B6|United States||Region of Enrollment||participants|Number|400|400.0||||||
4351534|NCT00394706|4179664|B5|United States||Region of Enrollment||participants|Number|698|698.0||||||
4351535|NCT00394706|4179665|B4|United States||Region of Enrollment||participants|Number|691|691.0||||||
4351536|NCT00394706|4179666|B3|United States||Region of Enrollment||participants|Number|411|411.0||||||
4351537|NCT00394706|4179667|B2|United States||Region of Enrollment||participants|Number|764|764.0||||||
4351538|NCT00394706|4179668|B1|United States||Region of Enrollment||participants|Number|733|733.0||||||
4351539|NCT00394706|4179660|B9||Male|Sex: Female, Male|Gender missing for one ITD and one analyze earlier subject.|Participants|Count of Participants|7540|7540.0||||||
4351540|NCT00394706|4179661|B8||Male|Sex: Female, Male|Gender missing for one ITD and one analyze earlier subject.|Participants|Count of Participants|548|548.0||||||
4351541|NCT00394706|4179662|B7||Male|Sex: Female, Male|Gender missing for one ITD and one analyze earlier subject.|Participants|Count of Participants|616|616.0||||||
4351542|NCT00394706|4179663|B6||Male|Sex: Female, Male|Gender missing for one ITD and one analyze earlier subject.|Participants|Count of Participants|893|893.0||||||
4351543|NCT00394706|4179664|B5||Male|Sex: Female, Male|Gender missing for one ITD and one analyze earlier subject.|Participants|Count of Participants|1055|1055.0||||||
4351544|NCT00394706|4179665|B4||Male|Sex: Female, Male|Gender missing for one ITD and one analyze earlier subject.|Participants|Count of Participants|1016|1016.0||||||
4351545|NCT00394706|4179666|B3||Male|Sex: Female, Male|Gender missing for one ITD and one analyze earlier subject.|Participants|Count of Participants|1016|1016.0||||||
4351546|NCT00394706|4179667|B2||Male|Sex: Female, Male|Gender missing for one ITD and one analyze earlier subject.|Participants|Count of Participants|1188|1188.0||||||
4351547|NCT00394706|4179668|B1||Male|Sex: Female, Male|Gender missing for one ITD and one analyze earlier subject.|Participants|Count of Participants|1208|1208.0||||||
4351548|NCT00394706|4179660|B9||Female|Sex: Female, Male|Gender missing for one ITD and one analyze earlier subject.|Participants|Count of Participants|4182|4182.0||||||
4351549|NCT00394706|4179661|B8||Female|Sex: Female, Male|Gender missing for one ITD and one analyze earlier subject.|Participants|Count of Participants|303|303.0||||||
4351550|NCT00394706|4179662|B7||Female|Sex: Female, Male|Gender missing for one ITD and one analyze earlier subject.|Participants|Count of Participants|313|313.0||||||
4351551|NCT00394706|4179663|B6||Female|Sex: Female, Male|Gender missing for one ITD and one analyze earlier subject.|Participants|Count of Participants|486|486.0||||||
4351552|NCT00394706|4179664|B5||Female|Sex: Female, Male|Gender missing for one ITD and one analyze earlier subject.|Participants|Count of Participants|578|578.0||||||
4351553|NCT00394706|4179665|B4||Female|Sex: Female, Male|Gender missing for one ITD and one analyze earlier subject.|Participants|Count of Participants|615|615.0||||||
4351554|NCT00394706|4179666|B3||Female|Sex: Female, Male|Gender missing for one ITD and one analyze earlier subject.|Participants|Count of Participants|605|605.0||||||
4351555|NCT00394706|4179667|B2||Female|Sex: Female, Male|Gender missing for one ITD and one analyze earlier subject.|Participants|Count of Participants|673|673.0||||||
4351556|NCT00394706|4179668|B1||Female|Sex: Female, Male|Gender missing for one ITD and one analyze earlier subject.|Participants|Count of Participants|609|609.0||||||
4351557|NCT00394706|4179660|B9|||Age|Age is not available for 8 ITD, 8 Sham, 11 Analyze Early, and 18 Analyze Later subjects.|years|Mean|66.9|66.9|Standard Deviation|16.6|16.6|||
4351558|NCT00394706|4179661|B8|||Age|Age is not available for 8 ITD, 8 Sham, 11 Analyze Early, and 18 Analyze Later subjects.|years|Mean|66.7|66.7|Standard Deviation|16.7|16.7|||
4351559|NCT00394706|4179662|B7|||Age|Age is not available for 8 ITD, 8 Sham, 11 Analyze Early, and 18 Analyze Later subjects.|years|Mean|67.7|67.7|Standard Deviation|16.3|16.3|||
4351560|NCT00394706|4179663|B6|||Age|Age is not available for 8 ITD, 8 Sham, 11 Analyze Early, and 18 Analyze Later subjects.|years|Mean|66.3|66.3|Standard Deviation|16.7|16.7|||
4351561|NCT00394706|4179664|B5|||Age|Age is not available for 8 ITD, 8 Sham, 11 Analyze Early, and 18 Analyze Later subjects.|years|Mean|67.1|67.1|Standard Deviation|16.4|16.4|||
4351562|NCT00394706|4179665|B4|||Age|Age is not available for 8 ITD, 8 Sham, 11 Analyze Early, and 18 Analyze Later subjects.|years|Mean|67.2|67.2|Standard Deviation|16.6|16.6|||
4351563|NCT00394706|4179666|B3|||Age|Age is not available for 8 ITD, 8 Sham, 11 Analyze Early, and 18 Analyze Later subjects.|years|Mean|66.3|66.3|Standard Deviation|17.0|17.0|||
4351564|NCT00394706|4179667|B2|||Age|Age is not available for 8 ITD, 8 Sham, 11 Analyze Early, and 18 Analyze Later subjects.|years|Mean|66.6|66.6|Standard Deviation|16.4|16.4|||
4351565|NCT00394706|4179668|B1|||Age|Age is not available for 8 ITD, 8 Sham, 11 Analyze Early, and 18 Analyze Later subjects.|years|Mean|67.3|67.3|Standard Deviation|16.3|16.3|||
4351566|NCT00394706|4179660|B9||>=65 years|Age|Age is not available for 8 ITD, 8 Sham, 11 Analyze Early, and 18 Analyze Later subjects.|Participants|Count of Participants|6772|6772.0||||||
4351567|NCT00394706|4179661|B8||>=65 years|Age|Age is not available for 8 ITD, 8 Sham, 11 Analyze Early, and 18 Analyze Later subjects.|Participants|Count of Participants|481|481.0||||||
4351568|NCT00394706|4179662|B7||>=65 years|Age|Age is not available for 8 ITD, 8 Sham, 11 Analyze Early, and 18 Analyze Later subjects.|Participants|Count of Participants|547|547.0||||||
4351569|NCT00394706|4179663|B6||>=65 years|Age|Age is not available for 8 ITD, 8 Sham, 11 Analyze Early, and 18 Analyze Later subjects.|Participants|Count of Participants|789|789.0||||||
4351570|NCT00394706|4179664|B5||>=65 years|Age|Age is not available for 8 ITD, 8 Sham, 11 Analyze Early, and 18 Analyze Later subjects.|Participants|Count of Participants|954|954.0||||||
4351571|NCT00394706|4179665|B4||>=65 years|Age|Age is not available for 8 ITD, 8 Sham, 11 Analyze Early, and 18 Analyze Later subjects.|Participants|Count of Participants|937|937.0||||||
4351572|NCT00394706|4179666|B3||>=65 years|Age|Age is not available for 8 ITD, 8 Sham, 11 Analyze Early, and 18 Analyze Later subjects.|Participants|Count of Participants|932|932.0||||||
4351573|NCT00394706|4179667|B2||>=65 years|Age|Age is not available for 8 ITD, 8 Sham, 11 Analyze Early, and 18 Analyze Later subjects.|Participants|Count of Participants|1050|1050.0||||||
4351574|NCT00394706|4179668|B1||>=65 years|Age|Age is not available for 8 ITD, 8 Sham, 11 Analyze Early, and 18 Analyze Later subjects.|Participants|Count of Participants|1082|1082.0||||||
4351575|NCT00394706|4179660|B9||Between 18 and 65 years|Age|Age is not available for 8 ITD, 8 Sham, 11 Analyze Early, and 18 Analyze Later subjects.|Participants|Count of Participants|4939|4939.0||||||
4351576|NCT00394706|4179661|B8||Between 18 and 65 years|Age|Age is not available for 8 ITD, 8 Sham, 11 Analyze Early, and 18 Analyze Later subjects.|Participants|Count of Participants|370|370.0||||||
4351577|NCT00394706|4179662|B7||Between 18 and 65 years|Age|Age is not available for 8 ITD, 8 Sham, 11 Analyze Early, and 18 Analyze Later subjects.|Participants|Count of Participants|381|381.0||||||
4351578|NCT00394706|4179663|B6||Between 18 and 65 years|Age|Age is not available for 8 ITD, 8 Sham, 11 Analyze Early, and 18 Analyze Later subjects.|Participants|Count of Participants|590|590.0||||||
4351579|NCT00394706|4179664|B5||Between 18 and 65 years|Age|Age is not available for 8 ITD, 8 Sham, 11 Analyze Early, and 18 Analyze Later subjects.|Participants|Count of Participants|675|675.0||||||
4351580|NCT00394706|4179665|B4||Between 18 and 65 years|Age|Age is not available for 8 ITD, 8 Sham, 11 Analyze Early, and 18 Analyze Later subjects.|Participants|Count of Participants|693|693.0||||||
4351581|NCT00394706|4179666|B3||Between 18 and 65 years|Age|Age is not available for 8 ITD, 8 Sham, 11 Analyze Early, and 18 Analyze Later subjects.|Participants|Count of Participants|687|687.0||||||
4351582|NCT00394706|4179667|B2||Between 18 and 65 years|Age|Age is not available for 8 ITD, 8 Sham, 11 Analyze Early, and 18 Analyze Later subjects.|Participants|Count of Participants|809|809.0||||||
4351583|NCT00394706|4179668|B1||Between 18 and 65 years|Age|Age is not available for 8 ITD, 8 Sham, 11 Analyze Early, and 18 Analyze Later subjects.|Participants|Count of Participants|734|734.0||||||
4351584|NCT00394706|4179660|B9||<=18 years|Age|Age is not available for 8 ITD, 8 Sham, 11 Analyze Early, and 18 Analyze Later subjects.|Participants|Count of Participants|11|11.0||||||
4351585|NCT00394706|4179661|B8||<=18 years|Age|Age is not available for 8 ITD, 8 Sham, 11 Analyze Early, and 18 Analyze Later subjects.|Participants|Count of Participants|0|0.0||||||
4351586|NCT00394706|4179662|B7||<=18 years|Age|Age is not available for 8 ITD, 8 Sham, 11 Analyze Early, and 18 Analyze Later subjects.|Participants|Count of Participants|1|1.0||||||
4351587|NCT00394706|4179663|B6||<=18 years|Age|Age is not available for 8 ITD, 8 Sham, 11 Analyze Early, and 18 Analyze Later subjects.|Participants|Count of Participants|0|0.0||||||
4351588|NCT00394706|4179664|B5||<=18 years|Age|Age is not available for 8 ITD, 8 Sham, 11 Analyze Early, and 18 Analyze Later subjects.|Participants|Count of Participants|4|4.0||||||
4351589|NCT00394706|4179665|B4||<=18 years|Age|Age is not available for 8 ITD, 8 Sham, 11 Analyze Early, and 18 Analyze Later subjects.|Participants|Count of Participants|1|1.0||||||
4351590|NCT00394706|4179666|B3||<=18 years|Age|Age is not available for 8 ITD, 8 Sham, 11 Analyze Early, and 18 Analyze Later subjects.|Participants|Count of Participants|2|2.0||||||
4351591|NCT00394706|4179667|B2||<=18 years|Age|Age is not available for 8 ITD, 8 Sham, 11 Analyze Early, and 18 Analyze Later subjects.|Participants|Count of Participants|2|2.0||||||
4351592|NCT00394706|4179668|B1||<=18 years|Age|Age is not available for 8 ITD, 8 Sham, 11 Analyze Early, and 18 Analyze Later subjects.|Participants|Count of Participants|1|1.0||||||
4351593|NCT00394654|4179705|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4351594|NCT00394654|4179706|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4351595|NCT00394654|4179707|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4351596|NCT00394654|4179705|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4351597|NCT00394654|4179706|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4351598|NCT00394654|4179707|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4351599|NCT00394654|4179705|B3|||Age||Years|Mean|28.5|28.5|Standard Deviation|8.9|8.9|||
4351600|NCT00394654|4179706|B2|||Age||Years|Mean|26.5|26.5|Standard Deviation|7.8|7.8|||
4351601|NCT00394654|4179707|B1|||Age||Years|Mean|30.5|30.5|Standard Deviation|9.6|9.6|||
4351602|NCT00394589|4179770|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4351603|NCT00394589|4179771|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4351604|NCT00394589|4179772|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4351605|NCT00394589|4179773|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4351606|NCT00394589|4179770|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4351607|NCT00394589|4179771|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4351608|NCT00394589|4179772|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4351609|NCT00394589|4179773|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4351610|NCT00394589|4179770|B4|||Age||years|Mean|58.3|58.3|Standard Deviation|13.3|13.3|||
4351611|NCT00394589|4179771|B3|||Age||years|Mean|57.7|57.7|Standard Deviation|12.3|12.3|||
4351612|NCT00394589|4179772|B2|||Age||years|Mean|58.6|58.6|Standard Deviation|16.1|16.1|||
4351613|NCT00394589|4179773|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|13.0|13.0|||
4351614|NCT00394524|4179783|B3|United States||Region of Enrollment||participants|Number|153|153.0||||||
4351615|NCT00394524|4179784|B2|United States||Region of Enrollment||participants|Number|76|76.0||||||
4351616|NCT00394524|4179785|B1|United States||Region of Enrollment||participants|Number|77|77.0||||||
4351617|NCT00394524|4179783|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4351618|NCT00394524|4179784|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4351619|NCT00394524|4179785|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4351620|NCT00394524|4179783|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4351621|NCT00394524|4179784|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4351622|NCT00394524|4179785|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4351623|NCT00394524|4179783|B3|||Age||years|Mean|58.15|58.15|Standard Deviation|12.2|12.2|||
4351624|NCT00394524|4179784|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|13.4|13.4|||
4351625|NCT00394524|4179785|B1|||Age||years|Mean|57.8|57.8|Standard Deviation|11|11.0|||
4351626|NCT00394524|4179783|B3||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4351627|NCT00394524|4179784|B2||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4351628|NCT00394524|4179785|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4351629|NCT00394524|4179783|B3||Between 18 and 65 years|Age||Participants|Count of Participants|114|114.0||||||
4351630|NCT00394524|4179784|B2||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4351631|NCT00394524|4179785|B1||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4351632|NCT00394524|4179783|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4351633|NCT00394524|4179784|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4351634|NCT00394524|4179785|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4351635|NCT00394472|4179798|B3||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4351636|NCT00394472|4179799|B2||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4351637|NCT00394472|4179800|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4351638|NCT00394472|4179798|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4351639|NCT00394472|4179799|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4351640|NCT00394472|4179800|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4351641|NCT00394472|4179798|B3|||Age||years|Mean|49.9|49.9|Standard Deviation|12.3|12.3|||
4351642|NCT00394472|4179799|B2|||Age||years|Mean|48.7|48.7|Standard Deviation|12.6|12.6|||
4351643|NCT00394472|4179800|B1|||Age||years|Mean|51.1|51.1|Standard Deviation|11.9|11.9|||
4351644|NCT00394433|4179809|B1|Gastric||Primary Site of Disease||Participants|Count of Participants|16|16.0||||||
4351645|NCT00394433|4179809|B1|Gastroesophageal junction||Primary Site of Disease||Participants|Count of Participants|9|9.0||||||
4351646|NCT00394433|4179809|B1|Esophageal||Primary Site of Disease||Participants|Count of Participants|13|13.0||||||
4351647|NCT00394433|4179809|B1|United States||Region of Enrollment||Participants|Count of Participants|38|38.0||||||
4351648|NCT00394433|4179809|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4351649|NCT00394433|4179809|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4351650|NCT00394433|4179809|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
4351651|NCT00394433|4179809|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4351652|NCT00394433|4179809|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4351653|NCT00394433|4179809|B1|||Age||years|Median|58|58.0|Full Range|||31.0|76.0|
4351654|NCT00394355|4179816|B5||Male|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4351655|NCT00394355|4179817|B4||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4351656|NCT00394355|4179818|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4351657|NCT00394355|4179819|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4351658|NCT00394355|4179820|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4351659|NCT00394355|4179816|B5||Female|Sex: Female, Male||Participants|Count of Participants|359|359.0||||||
4351660|NCT00394355|4179817|B4||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4351661|NCT00394355|4179818|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4351662|NCT00394355|4179819|B2||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4351663|NCT00394355|4179820|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4351664|NCT00394355|4179816|B5|||Age||years|Mean|29.0|29.0|Standard Deviation|7.5|7.5|||
4351665|NCT00394355|4179817|B4|||Age||years|Mean|28.2|28.2|Standard Deviation|7.1|7.1|||
4351666|NCT00394355|4179818|B3|||Age||years|Mean|28.2|28.2|Standard Deviation|6.9|6.9|||
4351667|NCT00394355|4179819|B2|||Age||years|Mean|29.8|29.8|Standard Deviation|8.1|8.1|||
4351668|NCT00394355|4179820|B1|||Age||years|Mean|29.7|29.7|Standard Deviation|7.8|7.8|||
4351669|NCT00394329|4179845|B5|United States||Region of Enrollment||participants|Number|288|288.0||||||
4351670|NCT00394329|4179846|B4|United States||Region of Enrollment||participants|Number|74|74.0||||||
4351671|NCT00394329|4179847|B3|United States||Region of Enrollment||participants|Number|71|71.0||||||
4351672|NCT00394329|4179848|B2|United States||Region of Enrollment||participants|Number|72|72.0||||||
4351673|NCT00394329|4179849|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
4351674|NCT00394329|4179845|B5||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4351675|NCT00394329|4179846|B4||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4351676|NCT00394329|4179847|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4351677|NCT00394329|4179848|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4351678|NCT00394329|4179849|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4351679|NCT00394329|4179845|B5||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4351680|NCT00394329|4179846|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4351681|NCT00394329|4179847|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4351682|NCT00394329|4179848|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4351683|NCT00394329|4179849|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4351684|NCT00394329|4179845|B5|||Age||years|Mean|10.7|10.7|Standard Deviation|3.2|3.2|||
4351685|NCT00394329|4179846|B4|||Age||years|Mean|10.4|10.4|Standard Deviation|3.2|3.2|||
4351686|NCT00394329|4179847|B3|||Age||years|Mean|10.4|10.4|Standard Deviation|2.8|2.8|||
4351687|NCT00394329|4179848|B2|||Age||years|Mean|10.8|10.8|Standard Deviation|3.5|3.5|||
4351688|NCT00394329|4179849|B1|||Age||years|Mean|11.4|11.4|Standard Deviation|3.1|3.1|||
4351689|NCT00394329|4179845|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4351690|NCT00394329|4179846|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4351691|NCT00394329|4179847|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4351692|NCT00394329|4179848|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4351693|NCT00394329|4179849|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4351694|NCT00394329|4179845|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4351695|NCT00394329|4179846|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4351696|NCT00394329|4179847|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4351697|NCT00394329|4179848|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4351698|NCT00394329|4179849|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4351699|NCT00394329|4179845|B5||<=18 years|Age||Participants|Count of Participants|288|288.0||||||
4351700|NCT00394329|4179846|B4||<=18 years|Age||Participants|Count of Participants|74|74.0||||||
4351701|NCT00394329|4179847|B3||<=18 years|Age||Participants|Count of Participants|71|71.0||||||
4351702|NCT00394329|4179848|B2||<=18 years|Age||Participants|Count of Participants|72|72.0||||||
4351703|NCT00394329|4179849|B1||<=18 years|Age||Participants|Count of Participants|71|71.0||||||
4351704|NCT00394277|4179898|B5|Male||Gender|Intent-to-treat population (all patients treated with at least one dose of either study medication) PEG-IFN 180 µg + Ribavirin 1200 mg: n = 191 PEG-IFN 180 µg + Ribavirin 1400/1600 mg: n = 189 PEG-IFN 360/180 µg + Ribavirin 1200 mg: n = 382 PEG-IFN 360/180 µg + Ribavirin 1400/1600 mg: n = 383|Patients|Number|904|904.0||||||
4351705|NCT00394277|4179899|B4|Male||Gender|Intent-to-treat population (all patients treated with at least one dose of either study medication) PEG-IFN 180 µg + Ribavirin 1200 mg: n = 191 PEG-IFN 180 µg + Ribavirin 1400/1600 mg: n = 189 PEG-IFN 360/180 µg + Ribavirin 1200 mg: n = 382 PEG-IFN 360/180 µg + Ribavirin 1400/1600 mg: n = 383|Patients|Number|310|310.0||||||
4351706|NCT00394277|4179900|B3|Male||Gender|Intent-to-treat population (all patients treated with at least one dose of either study medication) PEG-IFN 180 µg + Ribavirin 1200 mg: n = 191 PEG-IFN 180 µg + Ribavirin 1400/1600 mg: n = 189 PEG-IFN 360/180 µg + Ribavirin 1200 mg: n = 382 PEG-IFN 360/180 µg + Ribavirin 1400/1600 mg: n = 383|Patients|Number|292|292.0||||||
4351707|NCT00394277|4179901|B2|Male||Gender|Intent-to-treat population (all patients treated with at least one dose of either study medication) PEG-IFN 180 µg + Ribavirin 1200 mg: n = 191 PEG-IFN 180 µg + Ribavirin 1400/1600 mg: n = 189 PEG-IFN 360/180 µg + Ribavirin 1200 mg: n = 382 PEG-IFN 360/180 µg + Ribavirin 1400/1600 mg: n = 383|Patients|Number|148|148.0||||||
4351777|NCT00394251|4179928|B2|||Weight||kg|Mean|78.78|78.78|Standard Deviation|19.595|19.595|||
4351708|NCT00394277|4179902|B1|Male||Gender|Intent-to-treat population (all patients treated with at least one dose of either study medication) PEG-IFN 180 µg + Ribavirin 1200 mg: n = 191 PEG-IFN 180 µg + Ribavirin 1400/1600 mg: n = 189 PEG-IFN 360/180 µg + Ribavirin 1200 mg: n = 382 PEG-IFN 360/180 µg + Ribavirin 1400/1600 mg: n = 383|Patients|Number|154|154.0||||||
4351709|NCT00394277|4179898|B5|Female||Gender|Intent-to-treat population (all patients treated with at least one dose of either study medication) PEG-IFN 180 µg + Ribavirin 1200 mg: n = 191 PEG-IFN 180 µg + Ribavirin 1400/1600 mg: n = 189 PEG-IFN 360/180 µg + Ribavirin 1200 mg: n = 382 PEG-IFN 360/180 µg + Ribavirin 1400/1600 mg: n = 383|Patients|Number|241|241.0||||||
4351710|NCT00394277|4179899|B4|Female||Gender|Intent-to-treat population (all patients treated with at least one dose of either study medication) PEG-IFN 180 µg + Ribavirin 1200 mg: n = 191 PEG-IFN 180 µg + Ribavirin 1400/1600 mg: n = 189 PEG-IFN 360/180 µg + Ribavirin 1200 mg: n = 382 PEG-IFN 360/180 µg + Ribavirin 1400/1600 mg: n = 383|Patients|Number|73|73.0||||||
4351711|NCT00394277|4179900|B3|Female||Gender|Intent-to-treat population (all patients treated with at least one dose of either study medication) PEG-IFN 180 µg + Ribavirin 1200 mg: n = 191 PEG-IFN 180 µg + Ribavirin 1400/1600 mg: n = 189 PEG-IFN 360/180 µg + Ribavirin 1200 mg: n = 382 PEG-IFN 360/180 µg + Ribavirin 1400/1600 mg: n = 383|Patients|Number|90|90.0||||||
4351712|NCT00394277|4179901|B2|Female||Gender|Intent-to-treat population (all patients treated with at least one dose of either study medication) PEG-IFN 180 µg + Ribavirin 1200 mg: n = 191 PEG-IFN 180 µg + Ribavirin 1400/1600 mg: n = 189 PEG-IFN 360/180 µg + Ribavirin 1200 mg: n = 382 PEG-IFN 360/180 µg + Ribavirin 1400/1600 mg: n = 383|Patients|Number|41|41.0||||||
4351713|NCT00394277|4179902|B1|Female||Gender|Intent-to-treat population (all patients treated with at least one dose of either study medication) PEG-IFN 180 µg + Ribavirin 1200 mg: n = 191 PEG-IFN 180 µg + Ribavirin 1400/1600 mg: n = 189 PEG-IFN 360/180 µg + Ribavirin 1200 mg: n = 382 PEG-IFN 360/180 µg + Ribavirin 1400/1600 mg: n = 383|Patients|Number|37|37.0||||||
4351714|NCT00394277|4179898|B5|||Age|Intent-to-treat population (all patients treated with at least one dose of either study medication) PEG-IFN 180 µg + Ribavirin 1200 mg: n = 191 PEG-IFN 180 µg + Ribavirin 1400/1600 mg: n = 189 PEG-IFN 360/180 µg + Ribavirin 1200 mg: n = 382 PEG-IFN 360/180 µg + Ribavirin 1400/1600 mg: n = 383|years|Mean|45.7|45.7|Standard Deviation|9.83|9.83|||
4351715|NCT00394277|4179899|B4|||Age|Intent-to-treat population (all patients treated with at least one dose of either study medication) PEG-IFN 180 µg + Ribavirin 1200 mg: n = 191 PEG-IFN 180 µg + Ribavirin 1400/1600 mg: n = 189 PEG-IFN 360/180 µg + Ribavirin 1200 mg: n = 382 PEG-IFN 360/180 µg + Ribavirin 1400/1600 mg: n = 383|years|Mean|46.0|46.0|Standard Deviation|10.18|10.18|||
4351716|NCT00394277|4179900|B3|||Age|Intent-to-treat population (all patients treated with at least one dose of either study medication) PEG-IFN 180 µg + Ribavirin 1200 mg: n = 191 PEG-IFN 180 µg + Ribavirin 1400/1600 mg: n = 189 PEG-IFN 360/180 µg + Ribavirin 1200 mg: n = 382 PEG-IFN 360/180 µg + Ribavirin 1400/1600 mg: n = 383|years|Mean|45.7|45.7|Standard Deviation|9.64|9.64|||
4351717|NCT00394277|4179901|B2|||Age|Intent-to-treat population (all patients treated with at least one dose of either study medication) PEG-IFN 180 µg + Ribavirin 1200 mg: n = 191 PEG-IFN 180 µg + Ribavirin 1400/1600 mg: n = 189 PEG-IFN 360/180 µg + Ribavirin 1200 mg: n = 382 PEG-IFN 360/180 µg + Ribavirin 1400/1600 mg: n = 383|years|Mean|45.1|45.1|Standard Deviation|9.50|9.5|||
4351718|NCT00394277|4179902|B1|||Age|Intent-to-treat population (all patients treated with at least one dose of either study medication) PEG-IFN 180 µg + Ribavirin 1200 mg: n = 191 PEG-IFN 180 µg + Ribavirin 1400/1600 mg: n = 189 PEG-IFN 360/180 µg + Ribavirin 1200 mg: n = 382 PEG-IFN 360/180 µg + Ribavirin 1400/1600 mg: n = 383|years|Mean|46.1|46.1|Standard Deviation|9.86|9.86|||
4351719|NCT00394251|4179927|B3|Not reported||Physician's Assessment of Peripheral Neuropathy|Physician's evaluation of peripheral neuropathy used the National Cancer Institute's Common Terminology Criteria for Adverse Events v3.0 (NCI CTCAE Version 3.0) severity scale which is a five step scale with 1=mild adverse event and 5 = death related to an adverse event.|participants|Number|6|6.0||||||
4351720|NCT00394251|4179928|B2|Not reported||Physician's Assessment of Peripheral Neuropathy|Physician's evaluation of peripheral neuropathy used the National Cancer Institute's Common Terminology Criteria for Adverse Events v3.0 (NCI CTCAE Version 3.0) severity scale which is a five step scale with 1=mild adverse event and 5 = death related to an adverse event.|participants|Number|3|3.0||||||
4351721|NCT00394251|4179929|B1|Not reported||Physician's Assessment of Peripheral Neuropathy|Physician's evaluation of peripheral neuropathy used the National Cancer Institute's Common Terminology Criteria for Adverse Events v3.0 (NCI CTCAE Version 3.0) severity scale which is a five step scale with 1=mild adverse event and 5 = death related to an adverse event.|participants|Number|3|3.0||||||
4351722|NCT00394251|4179927|B3|1||Physician's Assessment of Peripheral Neuropathy|Physician's evaluation of peripheral neuropathy used the National Cancer Institute's Common Terminology Criteria for Adverse Events v3.0 (NCI CTCAE Version 3.0) severity scale which is a five step scale with 1=mild adverse event and 5 = death related to an adverse event.|participants|Number|1|1.0||||||
4351723|NCT00394251|4179928|B2|1||Physician's Assessment of Peripheral Neuropathy|Physician's evaluation of peripheral neuropathy used the National Cancer Institute's Common Terminology Criteria for Adverse Events v3.0 (NCI CTCAE Version 3.0) severity scale which is a five step scale with 1=mild adverse event and 5 = death related to an adverse event.|participants|Number|0|0.0||||||
4351724|NCT00394251|4179929|B1|1||Physician's Assessment of Peripheral Neuropathy|Physician's evaluation of peripheral neuropathy used the National Cancer Institute's Common Terminology Criteria for Adverse Events v3.0 (NCI CTCAE Version 3.0) severity scale which is a five step scale with 1=mild adverse event and 5 = death related to an adverse event.|participants|Number|1|1.0||||||
4351725|NCT00394251|4179927|B3|0 (None)||Physician's Assessment of Peripheral Neuropathy|Physician's evaluation of peripheral neuropathy used the National Cancer Institute's Common Terminology Criteria for Adverse Events v3.0 (NCI CTCAE Version 3.0) severity scale which is a five step scale with 1=mild adverse event and 5 = death related to an adverse event.|participants|Number|190|190.0||||||
4351726|NCT00394251|4179928|B2|0 (None)||Physician's Assessment of Peripheral Neuropathy|Physician's evaluation of peripheral neuropathy used the National Cancer Institute's Common Terminology Criteria for Adverse Events v3.0 (NCI CTCAE Version 3.0) severity scale which is a five step scale with 1=mild adverse event and 5 = death related to an adverse event.|participants|Number|96|96.0||||||
4351778|NCT00394251|4179929|B1|||Weight||kg|Mean|78.63|78.63|Standard Deviation|19.561|19.561|||
4351727|NCT00394251|4179929|B1|0 (None)||Physician's Assessment of Peripheral Neuropathy|Physician's evaluation of peripheral neuropathy used the National Cancer Institute's Common Terminology Criteria for Adverse Events v3.0 (NCI CTCAE Version 3.0) severity scale which is a five step scale with 1=mild adverse event and 5 = death related to an adverse event.|participants|Number|94|94.0||||||
4351728|NCT00394251|4179927|B3|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Using Eastern Cooperative Oncology Group (ECOG) performance status scale (Oken, M.M., Creech, R.H., Tormey, D.C., Horton, J., Davis, T.E., McFadden, E.T., Carbone, P.P.: Toxicity And Response Criteria Of The Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649-655, 1982).|participants|Number|19|19.0||||||
4351729|NCT00394251|4179928|B2|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Using Eastern Cooperative Oncology Group (ECOG) performance status scale (Oken, M.M., Creech, R.H., Tormey, D.C., Horton, J., Davis, T.E., McFadden, E.T., Carbone, P.P.: Toxicity And Response Criteria Of The Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649-655, 1982).|participants|Number|10|10.0||||||
4351730|NCT00394251|4179929|B1|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Using Eastern Cooperative Oncology Group (ECOG) performance status scale (Oken, M.M., Creech, R.H., Tormey, D.C., Horton, J., Davis, T.E., McFadden, E.T., Carbone, P.P.: Toxicity And Response Criteria Of The Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649-655, 1982).|participants|Number|9|9.0||||||
4351731|NCT00394251|4179927|B3|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Using Eastern Cooperative Oncology Group (ECOG) performance status scale (Oken, M.M., Creech, R.H., Tormey, D.C., Horton, J., Davis, T.E., McFadden, E.T., Carbone, P.P.: Toxicity And Response Criteria Of The Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649-655, 1982).|participants|Number|178|178.0||||||
4351732|NCT00394251|4179928|B2|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Using Eastern Cooperative Oncology Group (ECOG) performance status scale (Oken, M.M., Creech, R.H., Tormey, D.C., Horton, J., Davis, T.E., McFadden, E.T., Carbone, P.P.: Toxicity And Response Criteria Of The Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649-655, 1982).|participants|Number|89|89.0||||||
4351733|NCT00394251|4179929|B1|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|Using Eastern Cooperative Oncology Group (ECOG) performance status scale (Oken, M.M., Creech, R.H., Tormey, D.C., Horton, J., Davis, T.E., McFadden, E.T., Carbone, P.P.: Toxicity And Response Criteria Of The Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649-655, 1982).|participants|Number|89|89.0||||||
4351734|NCT00394251|4179927|B3|Negative||Progesterone Receptor Status|Defined as detectable presence (positive) or absence (negative) of progesterone receptors in tumor biopsy sample|participants|Number|79|79.0||||||
4351735|NCT00394251|4179928|B2|Negative||Progesterone Receptor Status|Defined as detectable presence (positive) or absence (negative) of progesterone receptors in tumor biopsy sample|participants|Number|40|40.0||||||
4351736|NCT00394251|4179929|B1|Negative||Progesterone Receptor Status|Defined as detectable presence (positive) or absence (negative) of progesterone receptors in tumor biopsy sample|participants|Number|39|39.0||||||
4351737|NCT00394251|4179927|B3|Positive||Progesterone Receptor Status|Defined as detectable presence (positive) or absence (negative) of progesterone receptors in tumor biopsy sample|participants|Number|118|118.0||||||
4351738|NCT00394251|4179928|B2|Positive||Progesterone Receptor Status|Defined as detectable presence (positive) or absence (negative) of progesterone receptors in tumor biopsy sample|participants|Number|59|59.0||||||
4351739|NCT00394251|4179929|B1|Positive||Progesterone Receptor Status|Defined as detectable presence (positive) or absence (negative) of progesterone receptors in tumor biopsy sample|participants|Number|59|59.0||||||
4351740|NCT00394251|4179927|B3|Negative||Estrogen Receptor Status|Defined as detectable presence (positive) or absence (negative) of estrogen receptors in tumor biopsy sample|participants|Number|68|68.0||||||
4351741|NCT00394251|4179928|B2|Negative||Estrogen Receptor Status|Defined as detectable presence (positive) or absence (negative) of estrogen receptors in tumor biopsy sample|participants|Number|33|33.0||||||
4351742|NCT00394251|4179929|B1|Negative||Estrogen Receptor Status|Defined as detectable presence (positive) or absence (negative) of estrogen receptors in tumor biopsy sample|participants|Number|35|35.0||||||
4351743|NCT00394251|4179927|B3|Positive||Estrogen Receptor Status|Defined as detectable presence (positive) or absence (negative) of estrogen receptors in tumor biopsy sample|participants|Number|129|129.0||||||
4351744|NCT00394251|4179928|B2|Positive||Estrogen Receptor Status|Defined as detectable presence (positive) or absence (negative) of estrogen receptors in tumor biopsy sample|participants|Number|66|66.0||||||
4351745|NCT00394251|4179929|B1|Positive||Estrogen Receptor Status|Defined as detectable presence (positive) or absence (negative) of estrogen receptors in tumor biopsy sample|participants|Number|63|63.0||||||
4351746|NCT00394251|4179927|B3|unknown||Stage at Primary Diagnosis|American Joint Committee on Cancer (AJCC) 6th edition staging for breast cancer was used to define stage at primary diagnosis. The scale ranges from stage I (primary tumor <=2.0 cm, no regional or distant lymph node involvement) to stage IV (primary tumor of any size, with both regional and distant lymph node involvement). Each stage includes combinations of ratings for the primary tumor, regional lymph node involvement, and metastasis. Illustrative examples of stages appear in the data table. Each higher stage represents increasingly poor prognosis.|participants|Number|1|1.0||||||
4351747|NCT00394251|4179928|B2|unknown||Stage at Primary Diagnosis|American Joint Committee on Cancer (AJCC) 6th edition staging for breast cancer was used to define stage at primary diagnosis. The scale ranges from stage I (primary tumor <=2.0 cm, no regional or distant lymph node involvement) to stage IV (primary tumor of any size, with both regional and distant lymph node involvement). Each stage includes combinations of ratings for the primary tumor, regional lymph node involvement, and metastasis. Illustrative examples of stages appear in the data table. Each higher stage represents increasingly poor prognosis.|participants|Number|1|1.0||||||
4351748|NCT00394251|4179929|B1|unknown||Stage at Primary Diagnosis|American Joint Committee on Cancer (AJCC) 6th edition staging for breast cancer was used to define stage at primary diagnosis. The scale ranges from stage I (primary tumor <=2.0 cm, no regional or distant lymph node involvement) to stage IV (primary tumor of any size, with both regional and distant lymph node involvement). Each stage includes combinations of ratings for the primary tumor, regional lymph node involvement, and metastasis. Illustrative examples of stages appear in the data table. Each higher stage represents increasingly poor prognosis.|participants|Number|0|0.0||||||
4351749|NCT00394251|4179927|B3|IV: distant metastasis||Stage at Primary Diagnosis|American Joint Committee on Cancer (AJCC) 6th edition staging for breast cancer was used to define stage at primary diagnosis. The scale ranges from stage I (primary tumor <=2.0 cm, no regional or distant lymph node involvement) to stage IV (primary tumor of any size, with both regional and distant lymph node involvement). Each stage includes combinations of ratings for the primary tumor, regional lymph node involvement, and metastasis. Illustrative examples of stages appear in the data table. Each higher stage represents increasingly poor prognosis.|participants|Number|0|0.0||||||
4351750|NCT00394251|4179928|B2|IV: distant metastasis||Stage at Primary Diagnosis|American Joint Committee on Cancer (AJCC) 6th edition staging for breast cancer was used to define stage at primary diagnosis. The scale ranges from stage I (primary tumor <=2.0 cm, no regional or distant lymph node involvement) to stage IV (primary tumor of any size, with both regional and distant lymph node involvement). Each stage includes combinations of ratings for the primary tumor, regional lymph node involvement, and metastasis. Illustrative examples of stages appear in the data table. Each higher stage represents increasingly poor prognosis.|participants|Number|0|0.0||||||
4351751|NCT00394251|4179929|B1|IV: distant metastasis||Stage at Primary Diagnosis|American Joint Committee on Cancer (AJCC) 6th edition staging for breast cancer was used to define stage at primary diagnosis. The scale ranges from stage I (primary tumor <=2.0 cm, no regional or distant lymph node involvement) to stage IV (primary tumor of any size, with both regional and distant lymph node involvement). Each stage includes combinations of ratings for the primary tumor, regional lymph node involvement, and metastasis. Illustrative examples of stages appear in the data table. Each higher stage represents increasingly poor prognosis.|participants|Number|0|0.0||||||
4351752|NCT00394251|4179927|B3|IIIc: tumor with extensive lymph node involvement||Stage at Primary Diagnosis|American Joint Committee on Cancer (AJCC) 6th edition staging for breast cancer was used to define stage at primary diagnosis. The scale ranges from stage I (primary tumor <=2.0 cm, no regional or distant lymph node involvement) to stage IV (primary tumor of any size, with both regional and distant lymph node involvement). Each stage includes combinations of ratings for the primary tumor, regional lymph node involvement, and metastasis. Illustrative examples of stages appear in the data table. Each higher stage represents increasingly poor prognosis.|participants|Number|15|15.0||||||
4351753|NCT00394251|4179928|B2|IIIc: tumor with extensive lymph node involvement||Stage at Primary Diagnosis|American Joint Committee on Cancer (AJCC) 6th edition staging for breast cancer was used to define stage at primary diagnosis. The scale ranges from stage I (primary tumor <=2.0 cm, no regional or distant lymph node involvement) to stage IV (primary tumor of any size, with both regional and distant lymph node involvement). Each stage includes combinations of ratings for the primary tumor, regional lymph node involvement, and metastasis. Illustrative examples of stages appear in the data table. Each higher stage represents increasingly poor prognosis.|participants|Number|9|9.0||||||
4351754|NCT00394251|4179929|B1|IIIc: tumor with extensive lymph node involvement||Stage at Primary Diagnosis|American Joint Committee on Cancer (AJCC) 6th edition staging for breast cancer was used to define stage at primary diagnosis. The scale ranges from stage I (primary tumor <=2.0 cm, no regional or distant lymph node involvement) to stage IV (primary tumor of any size, with both regional and distant lymph node involvement). Each stage includes combinations of ratings for the primary tumor, regional lymph node involvement, and metastasis. Illustrative examples of stages appear in the data table. Each higher stage represents increasingly poor prognosis.|participants|Number|6|6.0||||||
4351755|NCT00394251|4179927|B3|IIIb: tumor extending to chest wall or skin||Stage at Primary Diagnosis|American Joint Committee on Cancer (AJCC) 6th edition staging for breast cancer was used to define stage at primary diagnosis. The scale ranges from stage I (primary tumor <=2.0 cm, no regional or distant lymph node involvement) to stage IV (primary tumor of any size, with both regional and distant lymph node involvement). Each stage includes combinations of ratings for the primary tumor, regional lymph node involvement, and metastasis. Illustrative examples of stages appear in the data table. Each higher stage represents increasingly poor prognosis.|participants|Number|0|0.0||||||
4351756|NCT00394251|4179928|B2|IIIb: tumor extending to chest wall or skin||Stage at Primary Diagnosis|American Joint Committee on Cancer (AJCC) 6th edition staging for breast cancer was used to define stage at primary diagnosis. The scale ranges from stage I (primary tumor <=2.0 cm, no regional or distant lymph node involvement) to stage IV (primary tumor of any size, with both regional and distant lymph node involvement). Each stage includes combinations of ratings for the primary tumor, regional lymph node involvement, and metastasis. Illustrative examples of stages appear in the data table. Each higher stage represents increasingly poor prognosis.|participants|Number|0|0.0||||||
4351757|NCT00394251|4179929|B1|IIIb: tumor extending to chest wall or skin||Stage at Primary Diagnosis|American Joint Committee on Cancer (AJCC) 6th edition staging for breast cancer was used to define stage at primary diagnosis. The scale ranges from stage I (primary tumor <=2.0 cm, no regional or distant lymph node involvement) to stage IV (primary tumor of any size, with both regional and distant lymph node involvement). Each stage includes combinations of ratings for the primary tumor, regional lymph node involvement, and metastasis. Illustrative examples of stages appear in the data table. Each higher stage represents increasingly poor prognosis.|participants|Number|0|0.0||||||
4351758|NCT00394251|4179927|B3|IIIa: tumor may be >5.0 cm, regional lymph nodes||Stage at Primary Diagnosis|American Joint Committee on Cancer (AJCC) 6th edition staging for breast cancer was used to define stage at primary diagnosis. The scale ranges from stage I (primary tumor <=2.0 cm, no regional or distant lymph node involvement) to stage IV (primary tumor of any size, with both regional and distant lymph node involvement). Each stage includes combinations of ratings for the primary tumor, regional lymph node involvement, and metastasis. Illustrative examples of stages appear in the data table. Each higher stage represents increasingly poor prognosis.|participants|Number|45|45.0||||||
4351759|NCT00394251|4179928|B2|IIIa: tumor may be >5.0 cm, regional lymph nodes||Stage at Primary Diagnosis|American Joint Committee on Cancer (AJCC) 6th edition staging for breast cancer was used to define stage at primary diagnosis. The scale ranges from stage I (primary tumor <=2.0 cm, no regional or distant lymph node involvement) to stage IV (primary tumor of any size, with both regional and distant lymph node involvement). Each stage includes combinations of ratings for the primary tumor, regional lymph node involvement, and metastasis. Illustrative examples of stages appear in the data table. Each higher stage represents increasingly poor prognosis.|participants|Number|23|23.0||||||
4351779|NCT00394251|4179927|B3|United States||Region of Enrollment||participants|Number|197|197.0||||||
4351760|NCT00394251|4179929|B1|IIIa: tumor may be >5.0 cm, regional lymph nodes||Stage at Primary Diagnosis|American Joint Committee on Cancer (AJCC) 6th edition staging for breast cancer was used to define stage at primary diagnosis. The scale ranges from stage I (primary tumor <=2.0 cm, no regional or distant lymph node involvement) to stage IV (primary tumor of any size, with both regional and distant lymph node involvement). Each stage includes combinations of ratings for the primary tumor, regional lymph node involvement, and metastasis. Illustrative examples of stages appear in the data table. Each higher stage represents increasingly poor prognosis.|participants|Number|22|22.0||||||
4351761|NCT00394251|4179927|B3|IIb: tumor >2.0<5.0cm, regional lymph nodes||Stage at Primary Diagnosis|American Joint Committee on Cancer (AJCC) 6th edition staging for breast cancer was used to define stage at primary diagnosis. The scale ranges from stage I (primary tumor <=2.0 cm, no regional or distant lymph node involvement) to stage IV (primary tumor of any size, with both regional and distant lymph node involvement). Each stage includes combinations of ratings for the primary tumor, regional lymph node involvement, and metastasis. Illustrative examples of stages appear in the data table. Each higher stage represents increasingly poor prognosis.|participants|Number|56|56.0||||||
4351762|NCT00394251|4179928|B2|IIb: tumor >2.0<5.0cm, regional lymph nodes||Stage at Primary Diagnosis|American Joint Committee on Cancer (AJCC) 6th edition staging for breast cancer was used to define stage at primary diagnosis. The scale ranges from stage I (primary tumor <=2.0 cm, no regional or distant lymph node involvement) to stage IV (primary tumor of any size, with both regional and distant lymph node involvement). Each stage includes combinations of ratings for the primary tumor, regional lymph node involvement, and metastasis. Illustrative examples of stages appear in the data table. Each higher stage represents increasingly poor prognosis.|participants|Number|24|24.0||||||
4351763|NCT00394251|4179929|B1|IIb: tumor >2.0<5.0cm, regional lymph nodes||Stage at Primary Diagnosis|American Joint Committee on Cancer (AJCC) 6th edition staging for breast cancer was used to define stage at primary diagnosis. The scale ranges from stage I (primary tumor <=2.0 cm, no regional or distant lymph node involvement) to stage IV (primary tumor of any size, with both regional and distant lymph node involvement). Each stage includes combinations of ratings for the primary tumor, regional lymph node involvement, and metastasis. Illustrative examples of stages appear in the data table. Each higher stage represents increasingly poor prognosis.|participants|Number|32|32.0||||||
4351764|NCT00394251|4179927|B3|IIa: tumor <=2.0 cm, regional lymph node||Stage at Primary Diagnosis|American Joint Committee on Cancer (AJCC) 6th edition staging for breast cancer was used to define stage at primary diagnosis. The scale ranges from stage I (primary tumor <=2.0 cm, no regional or distant lymph node involvement) to stage IV (primary tumor of any size, with both regional and distant lymph node involvement). Each stage includes combinations of ratings for the primary tumor, regional lymph node involvement, and metastasis. Illustrative examples of stages appear in the data table. Each higher stage represents increasingly poor prognosis.|participants|Number|63|63.0||||||
4351765|NCT00394251|4179928|B2|IIa: tumor <=2.0 cm, regional lymph node||Stage at Primary Diagnosis|American Joint Committee on Cancer (AJCC) 6th edition staging for breast cancer was used to define stage at primary diagnosis. The scale ranges from stage I (primary tumor <=2.0 cm, no regional or distant lymph node involvement) to stage IV (primary tumor of any size, with both regional and distant lymph node involvement). Each stage includes combinations of ratings for the primary tumor, regional lymph node involvement, and metastasis. Illustrative examples of stages appear in the data table. Each higher stage represents increasingly poor prognosis.|participants|Number|35|35.0||||||
4351766|NCT00394251|4179929|B1|IIa: tumor <=2.0 cm, regional lymph node||Stage at Primary Diagnosis|American Joint Committee on Cancer (AJCC) 6th edition staging for breast cancer was used to define stage at primary diagnosis. The scale ranges from stage I (primary tumor <=2.0 cm, no regional or distant lymph node involvement) to stage IV (primary tumor of any size, with both regional and distant lymph node involvement). Each stage includes combinations of ratings for the primary tumor, regional lymph node involvement, and metastasis. Illustrative examples of stages appear in the data table. Each higher stage represents increasingly poor prognosis.|participants|Number|28|28.0||||||
4351767|NCT00394251|4179927|B3|I: tumor <=2.0, lymph nodes clear, no metastasis||Stage at Primary Diagnosis|American Joint Committee on Cancer (AJCC) 6th edition staging for breast cancer was used to define stage at primary diagnosis. The scale ranges from stage I (primary tumor <=2.0 cm, no regional or distant lymph node involvement) to stage IV (primary tumor of any size, with both regional and distant lymph node involvement). Each stage includes combinations of ratings for the primary tumor, regional lymph node involvement, and metastasis. Illustrative examples of stages appear in the data table. Each higher stage represents increasingly poor prognosis.|participants|Number|17|17.0||||||
4351768|NCT00394251|4179928|B2|I: tumor <=2.0, lymph nodes clear, no metastasis||Stage at Primary Diagnosis|American Joint Committee on Cancer (AJCC) 6th edition staging for breast cancer was used to define stage at primary diagnosis. The scale ranges from stage I (primary tumor <=2.0 cm, no regional or distant lymph node involvement) to stage IV (primary tumor of any size, with both regional and distant lymph node involvement). Each stage includes combinations of ratings for the primary tumor, regional lymph node involvement, and metastasis. Illustrative examples of stages appear in the data table. Each higher stage represents increasingly poor prognosis.|participants|Number|7|7.0||||||
4351769|NCT00394251|4179929|B1|I: tumor <=2.0, lymph nodes clear, no metastasis||Stage at Primary Diagnosis|American Joint Committee on Cancer (AJCC) 6th edition staging for breast cancer was used to define stage at primary diagnosis. The scale ranges from stage I (primary tumor <=2.0 cm, no regional or distant lymph node involvement) to stage IV (primary tumor of any size, with both regional and distant lymph node involvement). Each stage includes combinations of ratings for the primary tumor, regional lymph node involvement, and metastasis. Illustrative examples of stages appear in the data table. Each higher stage represents increasingly poor prognosis.|participants|Number|10|10.0||||||
4351770|NCT00394251|4179927|B3|postmenopausal||Menopausal Status||participants|Number|103|103.0||||||
4351771|NCT00394251|4179928|B2|postmenopausal||Menopausal Status||participants|Number|55|55.0||||||
4351772|NCT00394251|4179929|B1|postmenopausal||Menopausal Status||participants|Number|48|48.0||||||
4351773|NCT00394251|4179927|B3|premenopausal||Menopausal Status||participants|Number|94|94.0||||||
4351774|NCT00394251|4179928|B2|premenopausal||Menopausal Status||participants|Number|44|44.0||||||
4351775|NCT00394251|4179929|B1|premenopausal||Menopausal Status||participants|Number|50|50.0||||||
4351776|NCT00394251|4179927|B3|||Weight||kg|Mean|78.71|78.71|Standard Deviation|19.528|19.528|||
4351780|NCT00394251|4179928|B2|United States||Region of Enrollment||participants|Number|99|99.0||||||
4351781|NCT00394251|4179929|B1|United States||Region of Enrollment||participants|Number|98|98.0||||||
4351782|NCT00394251|4179927|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4351783|NCT00394251|4179928|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4351784|NCT00394251|4179929|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4351785|NCT00394251|4179927|B3|Black, of African heritage||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4351786|NCT00394251|4179928|B2|Black, of African heritage||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4351787|NCT00394251|4179929|B1|Black, of African heritage||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4351788|NCT00394251|4179927|B3|White, Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4351789|NCT00394251|4179928|B2|White, Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4351790|NCT00394251|4179929|B1|White, Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4351791|NCT00394251|4179927|B3|White, non-Hispanic, non-Latino||Race/Ethnicity, Customized||participants|Number|148|148.0||||||
4351792|NCT00394251|4179928|B2|White, non-Hispanic, non-Latino||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
4351793|NCT00394251|4179929|B1|White, non-Hispanic, non-Latino||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
4351794|NCT00394251|4179927|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4351795|NCT00394251|4179928|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4351796|NCT00394251|4179929|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4351797|NCT00394251|4179927|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4351798|NCT00394251|4179928|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4351799|NCT00394251|4179929|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4351800|NCT00394251|4179927|B3||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4351801|NCT00394251|4179928|B2||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4351802|NCT00394251|4179929|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4351803|NCT00394251|4179927|B3|< 65 years||Age, Customized||participants|Number|177|177.0||||||
4351804|NCT00394251|4179928|B2|< 65 years||Age, Customized||participants|Number|88|88.0||||||
4351805|NCT00394251|4179929|B1|< 65 years||Age, Customized||participants|Number|89|89.0||||||
4351806|NCT00394251|4179927|B3|>=65 years||Age, Customized||participants|Number|20|20.0||||||
4351807|NCT00394251|4179928|B2|>=65 years||Age, Customized||participants|Number|11|11.0||||||
4351808|NCT00394251|4179929|B1|>=65 years||Age, Customized||participants|Number|9|9.0||||||
4351809|NCT00394251|4179927|B3|||Age||years|Mean|51.2|51.2|Standard Deviation|9.23|9.23|||
4351810|NCT00394251|4179928|B2|||Age||years|Mean|51.2|51.2|Standard Deviation|9.29|9.29|||
4351811|NCT00394251|4179929|B1|||Age||years|Mean|51.2|51.2|Standard Deviation|9.21|9.21|||
4351812|NCT00394212|4179956|B3|United States||Region of Enrollment||participants|Number|77|77.0||||||
4351813|NCT00394212|4179957|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4351814|NCT00394212|4179958|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4351815|NCT00394212|4179956|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4351816|NCT00394212|4179957|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4351817|NCT00394212|4179958|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4351818|NCT00394212|4179956|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4351819|NCT00394212|4179957|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4351820|NCT00394212|4179958|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4351821|NCT00394212|4179956|B3|||Age||years|Mean|47.6|47.6|Standard Deviation|8.6|8.6|||
4351822|NCT00394212|4179957|B2|||Age||years|Mean|47.6|47.6|Standard Deviation|7.0|7.0|||
4351823|NCT00394212|4179958|B1|||Age||years|Mean|47.6|47.6|Standard Deviation|9.5|9.5|||
4351824|NCT00394212|4179956|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4351825|NCT00394212|4179957|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4351826|NCT00394212|4179958|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4351827|NCT00394212|4179956|B3||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
4351828|NCT00394212|4179957|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4351829|NCT00394212|4179958|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4351830|NCT00394212|4179956|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4351831|NCT00394212|4179957|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4351832|NCT00394212|4179958|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4351833|NCT00394095|4179971|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4351834|NCT00394095|4179972|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4351835|NCT00394095|4179973|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4351836|NCT00394095|4179971|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4351837|NCT00394095|4179972|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4351838|NCT00394095|4179973|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4351839|NCT00394095|4179971|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4351840|NCT00394095|4179972|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4351841|NCT00394095|4179973|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4351842|NCT00394095|4179971|B3|||Age||years|Mean|14.3|14.3|Standard Deviation|1.95|1.95|||
4351843|NCT00394095|4179972|B2|||Age||years|Mean|14.0|14.0|Standard Deviation|2.0|2.0|||
4351844|NCT00394095|4179973|B1|||Age||years|Mean|14.6|14.6|Standard Deviation|1.9|1.9|||
4351845|NCT00394095|4179971|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4351846|NCT00394095|4179972|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4351847|NCT00394095|4179973|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4351848|NCT00394095|4179971|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4351849|NCT00394095|4179972|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4351850|NCT00394095|4179973|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4351851|NCT00394095|4179971|B3||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
4351852|NCT00394095|4179972|B2||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4351853|NCT00394095|4179973|B1||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
4351854|NCT00394082|4179982|B1|Non Visceral||Dominant Current Site of Metastasis/Relapse||participants|Number|1|1.0||||||
4351855|NCT00394082|4179982|B1|Visceral||Dominant Current Site of Metastasis/Relapse||participants|Number|49|49.0||||||
4351856|NCT00394082|4179982|B1|||Time from First Documented Metastasis/Relapse to Study Entry||years|Mean|1.01|1.01|Standard Deviation|3.123|3.123|||
4351857|NCT00394082|4179982|B1|4 (Completely Disabled)||Eastern Cooperative Oncology Group (ECOG) status|"ECOG status categories are defined as:~0 (Fully Active)~1 (Restrictive but Ambulatory)~2 (Ambulatory but Unable to Work)~3 (Limited Self-Care)~4 (Completely Disabled)"|participants|Number|0|0.0||||||
4351858|NCT00394082|4179982|B1|3 (Limited Self-Care)||Eastern Cooperative Oncology Group (ECOG) status|"ECOG status categories are defined as:~0 (Fully Active)~1 (Restrictive but Ambulatory)~2 (Ambulatory but Unable to Work)~3 (Limited Self-Care)~4 (Completely Disabled)"|participants|Number|0|0.0||||||
4351859|NCT00394082|4179982|B1|2 (Ambulatory but Unable to Work)||Eastern Cooperative Oncology Group (ECOG) status|"ECOG status categories are defined as:~0 (Fully Active)~1 (Restrictive but Ambulatory)~2 (Ambulatory but Unable to Work)~3 (Limited Self-Care)~4 (Completely Disabled)"|participants|Number|2|2.0||||||
4351860|NCT00394082|4179982|B1|1 (Restrictive but Ambulatory)||Eastern Cooperative Oncology Group (ECOG) status|"ECOG status categories are defined as:~0 (Fully Active)~1 (Restrictive but Ambulatory)~2 (Ambulatory but Unable to Work)~3 (Limited Self-Care)~4 (Completely Disabled)"|participants|Number|25|25.0||||||
4351861|NCT00394082|4179982|B1|0 (Fully Active)||Eastern Cooperative Oncology Group (ECOG) status|"ECOG status categories are defined as:~0 (Fully Active)~1 (Restrictive but Ambulatory)~2 (Ambulatory but Unable to Work)~3 (Limited Self-Care)~4 (Completely Disabled)"|participants|Number|23|23.0||||||
4351862|NCT00394082|4179982|B1|Post-menopausal||Menopausal status||participants|Number|43|43.0||||||
4351863|NCT00394082|4179982|B1|Pre-menopausal||Menopausal status||participants|Number|7|7.0||||||
4351864|NCT00394082|4179982|B1|||Weight||kilograms|Mean|74.52|74.52|Standard Deviation|15.430|15.43|||
4351865|NCT00394082|4179982|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4351866|NCT00394082|4179982|B1|White, Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4351867|NCT00394082|4179982|B1|White, Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4351868|NCT00394082|4179982|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4351869|NCT00394082|4179982|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4351870|NCT00394082|4179982|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4351871|NCT00394082|4179982|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4351872|NCT00394082|4179982|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4351873|NCT00394082|4179982|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4351874|NCT00394082|4179982|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|11.03|11.03|||
4351875|NCT00393978|4179991|B3|United States||Region of Enrollment||participants|Number|75|75.0||||||
4351876|NCT00393978|4179992|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
4351877|NCT00393978|4179993|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4351878|NCT00393978|4179991|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4351879|NCT00393978|4179992|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4351880|NCT00393978|4179993|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4351881|NCT00393978|4179991|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4351882|NCT00393978|4179992|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4351883|NCT00393978|4179993|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4351884|NCT00393978|4179991|B3|||Age||years|Mean|17.4|17.4|Standard Deviation|0.2|0.2|||
4351885|NCT00393978|4179992|B2|||Age||years|Mean|17.7|17.7|Standard Deviation|2.1|2.1|||
4351886|NCT00393978|4179993|B1|||Age||years|Mean|17.1|17.1|Standard Deviation|2.1|2.1|||
4351887|NCT00393978|4179991|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4351888|NCT00393978|4179992|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4351889|NCT00393978|4179993|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4351890|NCT00393978|4179991|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4351891|NCT00393978|4179992|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4351892|NCT00393978|4179993|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4351893|NCT00393978|4179991|B3||<=18 years|Age||Participants|Count of Participants|75|75.0||||||
4351894|NCT00393978|4179992|B2||<=18 years|Age||Participants|Count of Participants|38|38.0||||||
4351895|NCT00393978|4179993|B1||<=18 years|Age||Participants|Count of Participants|37|37.0||||||
4351896|NCT00393939|4180002|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4351897|NCT00393939|4180003|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4351898|NCT00393939|4180004|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4351899|NCT00393939|4180002|B3||Female|Sex: Female, Male||Participants|Count of Participants|593|593.0||||||
4351900|NCT00393939|4180003|B2||Female|Sex: Female, Male||Participants|Count of Participants|297|297.0||||||
4351901|NCT00393939|4180004|B1||Female|Sex: Female, Male||Participants|Count of Participants|296|296.0||||||
4351902|NCT00393939|4180002|B3|||Age||Years|Mean|54.7|54.7|Standard Deviation|10.05|10.05|||
4351903|NCT00393939|4180003|B2|||Age||Years|Mean|55.1|55.1|Standard Deviation|10.36|10.36|||
4351904|NCT00393939|4180004|B1|||Age||Years|Mean|54.3|54.3|Standard Deviation|9.74|9.74|||
4351905|NCT00393913|4180023|B1|United States||Region of Enrollment||participants|Number|107|107.0||||||
4351906|NCT00393913|4180023|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4351907|NCT00393913|4180023|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4351908|NCT00393913|4180023|B1|||Age||years|Mean|45|45.0|Standard Deviation|12|12.0|||
4351909|NCT00393913|4180023|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4351910|NCT00393913|4180023|B1||Between 18 and 65 years|Age||Participants|Count of Participants|103|103.0||||||
4351911|NCT00393913|4180023|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4351912|NCT00393887|4180029|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4351913|NCT00393887|4180030|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4351914|NCT00393887|4180031|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4351915|NCT00393887|4180029|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4351916|NCT00393887|4180030|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4351917|NCT00393887|4180031|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4351918|NCT00393887|4180029|B3|||Age||years|Mean|61.5|61.5|Full Range|||24.0|87.0|
4351919|NCT00393887|4180030|B2|||Age||years|Mean|59|59.0|Full Range|||25.0|87.0|
4351920|NCT00393887|4180031|B1|||Age||years|Mean|64|64.0|Full Range|||24.0|85.0|
4351921|NCT00393874|4180038|B4|United States||Region of Enrollment||participants|Number|50|50.0||||||
4351922|NCT00393874|4180039|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4351923|NCT00393874|4180040|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4351924|NCT00393874|4180041|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4351925|NCT00393874|4180038|B4||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4351926|NCT00393874|4180039|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4351927|NCT00393874|4180040|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4351928|NCT00393874|4180041|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4351929|NCT00393874|4180038|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4351930|NCT00393874|4180039|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4351931|NCT00393874|4180040|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4351932|NCT00393874|4180041|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4351933|NCT00393874|4180038|B4|||Age||years|Mean|41.0|41.0|Standard Deviation|13.3|13.3|||
4351934|NCT00393874|4180039|B3|||Age||years|Mean|43.6|43.6|Standard Deviation|14.0|14.0|||
4351935|NCT00393874|4180040|B2|||Age||years|Mean|40.0|40.0|Standard Deviation|14.1|14.1|||
4351936|NCT00393874|4180041|B1|||Age||years|Mean|39.4|39.4|Standard Deviation|11.9|11.9|||
4351937|NCT00393861|4180060|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4351938|NCT00393861|4180060|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4351939|NCT00393861|4180060|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4351940|NCT00393861|4180060|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4351941|NCT00393861|4180060|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4351942|NCT00393861|4180060|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4351943|NCT00393861|4180060|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4351944|NCT00393861|4180060|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4351945|NCT00393861|4180060|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4351946|NCT00393861|4180060|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4351947|NCT00393861|4180060|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4351948|NCT00393861|4180060|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4351949|NCT00393861|4180060|B1|||Age||years|Mean|37.3|37.3|Standard Deviation|12.06|12.06|||
4351950|NCT00393861|4180060|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4351951|NCT00393861|4180060|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4351952|NCT00393861|4180060|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4351953|NCT00393848|4180067|B5|United States||Region of Enrollment||participants|Number|37|37.0||||||
4351954|NCT00393848|4180068|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
4351955|NCT00393848|4180069|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4351956|NCT00393848|4180070|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4351957|NCT00393848|4180071|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4351958|NCT00393848|4180067|B5||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4351959|NCT00393848|4180068|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4351960|NCT00393848|4180069|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4351961|NCT00393848|4180070|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4351962|NCT00393848|4180071|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4351963|NCT00393848|4180067|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4351964|NCT00393848|4180068|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4351965|NCT00393848|4180069|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4351966|NCT00393848|4180070|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4351967|NCT00393848|4180071|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4351968|NCT00393848|4180067|B5|||Age||years|Mean|51|51.0|Standard Deviation|11|11.0|||
4351969|NCT00393848|4180068|B4|||Age||years|Mean|46|46.0|Standard Deviation|15|15.0|||
4351970|NCT00393848|4180069|B3|||Age||years|Mean|44|44.0|Standard Deviation|15|15.0|||
4351971|NCT00393848|4180070|B2|||Age||years|Mean|56|56.0|Standard Deviation|8|8.0|||
4351972|NCT00393848|4180071|B1|||Age||years|Mean|55|55.0|Standard Deviation|7|7.0|||
4351973|NCT00393848|4180067|B5||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4351974|NCT00393848|4180068|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4351975|NCT00393848|4180069|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4351976|NCT00393848|4180070|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4351977|NCT00393848|4180071|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4351978|NCT00393848|4180067|B5||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4351979|NCT00393848|4180068|B4||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4351980|NCT00393848|4180069|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4351981|NCT00393848|4180070|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4351982|NCT00393848|4180071|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4351983|NCT00393848|4180067|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4351984|NCT00393848|4180068|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4351985|NCT00393848|4180069|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4351986|NCT00393848|4180070|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4351987|NCT00393848|4180071|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4351988|NCT00393796|4180086|B3|SD||Response to Prior Chemotherapy|The number of participants that experienced the following best overall response from prior chemotherapy: CR (Complete Response), PR (Partial Response), and SD (Stable Disease).|participants|Number|28|28.0||||||
4351989|NCT00393796|4180087|B2|SD||Response to Prior Chemotherapy|The number of participants that experienced the following best overall response from prior chemotherapy: CR (Complete Response), PR (Partial Response), and SD (Stable Disease).|participants|Number|15|15.0||||||
4351990|NCT00393796|4180088|B1|SD||Response to Prior Chemotherapy|The number of participants that experienced the following best overall response from prior chemotherapy: CR (Complete Response), PR (Partial Response), and SD (Stable Disease).|participants|Number|13|13.0||||||
4351991|NCT00393796|4180086|B3|PR||Response to Prior Chemotherapy|The number of participants that experienced the following best overall response from prior chemotherapy: CR (Complete Response), PR (Partial Response), and SD (Stable Disease).|participants|Number|22|22.0||||||
4351992|NCT00393796|4180087|B2|PR||Response to Prior Chemotherapy|The number of participants that experienced the following best overall response from prior chemotherapy: CR (Complete Response), PR (Partial Response), and SD (Stable Disease).|participants|Number|12|12.0||||||
4351993|NCT00393796|4180088|B1|PR||Response to Prior Chemotherapy|The number of participants that experienced the following best overall response from prior chemotherapy: CR (Complete Response), PR (Partial Response), and SD (Stable Disease).|participants|Number|10|10.0||||||
4351994|NCT00393796|4180086|B3|CR||Response to Prior Chemotherapy|The number of participants that experienced the following best overall response from prior chemotherapy: CR (Complete Response), PR (Partial Response), and SD (Stable Disease).|participants|Number|4|4.0||||||
4351995|NCT00393796|4180087|B2|CR||Response to Prior Chemotherapy|The number of participants that experienced the following best overall response from prior chemotherapy: CR (Complete Response), PR (Partial Response), and SD (Stable Disease).|participants|Number|1|1.0||||||
4351996|NCT00393796|4180088|B1|CR||Response to Prior Chemotherapy|The number of participants that experienced the following best overall response from prior chemotherapy: CR (Complete Response), PR (Partial Response), and SD (Stable Disease).|participants|Number|3|3.0||||||
4351997|NCT00393796|4180086|B3|Non-cisplatin-containing chemotherapy||Prior Chemotherapy Regimen|The number of participants that had the following prior chemotherapy regimens: Cisplatin and gemcitabine, MVAC (methotrexate, vinblastine, doxorubicin and cisplatin), Non-cisplatin-containing chemotherapy.|participants|Number|25|25.0||||||
4351998|NCT00393796|4180087|B2|Non-cisplatin-containing chemotherapy||Prior Chemotherapy Regimen|The number of participants that had the following prior chemotherapy regimens: Cisplatin and gemcitabine, MVAC (methotrexate, vinblastine, doxorubicin and cisplatin), Non-cisplatin-containing chemotherapy.|participants|Number|12|12.0||||||
4351999|NCT00393796|4180088|B1|Non-cisplatin-containing chemotherapy||Prior Chemotherapy Regimen|The number of participants that had the following prior chemotherapy regimens: Cisplatin and gemcitabine, MVAC (methotrexate, vinblastine, doxorubicin and cisplatin), Non-cisplatin-containing chemotherapy.|participants|Number|13|13.0||||||
4352034|NCT00393718|4180096|B2|||HbA1c|Glycosylated Haemoglobin|percentage of total haemoglobin|Mean|8.28|8.28|Standard Deviation|0.78|0.78|||
4352143|NCT00393523|4180157|B4||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4352000|NCT00393796|4180086|B3|MVAC||Prior Chemotherapy Regimen|The number of participants that had the following prior chemotherapy regimens: Cisplatin and gemcitabine, MVAC (methotrexate, vinblastine, doxorubicin and cisplatin), Non-cisplatin-containing chemotherapy.|participants|Number|5|5.0||||||
4352001|NCT00393796|4180087|B2|MVAC||Prior Chemotherapy Regimen|The number of participants that had the following prior chemotherapy regimens: Cisplatin and gemcitabine, MVAC (methotrexate, vinblastine, doxorubicin and cisplatin), Non-cisplatin-containing chemotherapy.|participants|Number|2|2.0||||||
4352002|NCT00393796|4180088|B1|MVAC||Prior Chemotherapy Regimen|The number of participants that had the following prior chemotherapy regimens: Cisplatin and gemcitabine, MVAC (methotrexate, vinblastine, doxorubicin and cisplatin), Non-cisplatin-containing chemotherapy.|participants|Number|3|3.0||||||
4352003|NCT00393796|4180086|B3|Cisplatin and gemcitabine||Prior Chemotherapy Regimen|The number of participants that had the following prior chemotherapy regimens: Cisplatin and gemcitabine, MVAC (methotrexate, vinblastine, doxorubicin and cisplatin), Non-cisplatin-containing chemotherapy.|participants|Number|24|24.0||||||
4352004|NCT00393796|4180087|B2|Cisplatin and gemcitabine||Prior Chemotherapy Regimen|The number of participants that had the following prior chemotherapy regimens: Cisplatin and gemcitabine, MVAC (methotrexate, vinblastine, doxorubicin and cisplatin), Non-cisplatin-containing chemotherapy.|participants|Number|14|14.0||||||
4352005|NCT00393796|4180088|B1|Cisplatin and gemcitabine||Prior Chemotherapy Regimen|The number of participants that had the following prior chemotherapy regimens: Cisplatin and gemcitabine, MVAC (methotrexate, vinblastine, doxorubicin and cisplatin), Non-cisplatin-containing chemotherapy.|participants|Number|10|10.0||||||
4352006|NCT00393796|4180086|B3|||Mixed Histology|The number of participants presenting with mixed histology.|participants|Number|6|6.0||||||
4352007|NCT00393796|4180087|B2|||Mixed Histology|The number of participants presenting with mixed histology.|participants|Number|4|4.0||||||
4352008|NCT00393796|4180088|B1|||Mixed Histology|The number of participants presenting with mixed histology.|participants|Number|2|2.0||||||
4352009|NCT00393796|4180086|B3|||Bladder Primary Tumor|The number of participants presenting with primary bladder tumors.|participants|Number|38|38.0||||||
4352010|NCT00393796|4180087|B2|||Bladder Primary Tumor|The number of participants presenting with primary bladder tumors.|participants|Number|18|18.0||||||
4352011|NCT00393796|4180088|B1|||Bladder Primary Tumor|The number of participants presenting with primary bladder tumors.|participants|Number|20|20.0||||||
4352012|NCT00393796|4180086|B3|||Visceral Metastasis|The number of participants presenting with visceral metastasis.|participants|Number|21|21.0||||||
4352013|NCT00393796|4180087|B2|||Visceral Metastasis|The number of participants presenting with visceral metastasis.|participants|Number|12|12.0||||||
4352014|NCT00393796|4180088|B1|||Visceral Metastasis|The number of participants presenting with visceral metastasis.|participants|Number|9|9.0||||||
4352015|NCT00393796|4180086|B3|PS=2||ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) is a measure of general well being and activities of daily life. Scores run from 0 to 5 where 0 denotes normal activity and 5 represents death.|participants|Number|1|1.0||||||
4352016|NCT00393796|4180087|B2|PS=2||ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) is a measure of general well being and activities of daily life. Scores run from 0 to 5 where 0 denotes normal activity and 5 represents death.|participants|Number|0|0.0||||||
4352017|NCT00393796|4180088|B1|PS=2||ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) is a measure of general well being and activities of daily life. Scores run from 0 to 5 where 0 denotes normal activity and 5 represents death.|participants|Number|1|1.0||||||
4352018|NCT00393796|4180086|B3|PS=1||ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) is a measure of general well being and activities of daily life. Scores run from 0 to 5 where 0 denotes normal activity and 5 represents death.|participants|Number|32|32.0||||||
4352019|NCT00393796|4180087|B2|PS=1||ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) is a measure of general well being and activities of daily life. Scores run from 0 to 5 where 0 denotes normal activity and 5 represents death.|participants|Number|17|17.0||||||
4352020|NCT00393796|4180088|B1|PS=1||ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) is a measure of general well being and activities of daily life. Scores run from 0 to 5 where 0 denotes normal activity and 5 represents death.|participants|Number|15|15.0||||||
4352021|NCT00393796|4180086|B3|PS=0||ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) is a measure of general well being and activities of daily life. Scores run from 0 to 5 where 0 denotes normal activity and 5 represents death.|participants|Number|21|21.0||||||
4352022|NCT00393796|4180087|B2|PS=0||ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) is a measure of general well being and activities of daily life. Scores run from 0 to 5 where 0 denotes normal activity and 5 represents death.|participants|Number|11|11.0||||||
4352023|NCT00393796|4180088|B1|PS=0||ECOG Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) is a measure of general well being and activities of daily life. Scores run from 0 to 5 where 0 denotes normal activity and 5 represents death.|participants|Number|10|10.0||||||
4352024|NCT00393796|4180086|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4352025|NCT00393796|4180087|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4352026|NCT00393796|4180088|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4352027|NCT00393796|4180086|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4352028|NCT00393796|4180087|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4352029|NCT00393796|4180088|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4352030|NCT00393796|4180086|B3|||Age||years|Median|69|69.0|Full Range|||48.0|84.0|
4352031|NCT00393796|4180087|B2|||Age||years|Median|69|69.0|Full Range|||53.0|81.0|
4352032|NCT00393796|4180088|B1|||Age||years|Median|69|69.0|Full Range|||48.0|84.0|
4352033|NCT00393718|4180095|B3|||HbA1c|Glycosylated Haemoglobin|percentage of total haemoglobin|Mean|8.28|8.28|Standard Deviation|0.76|0.76|||
4352141|NCT00393523|4180155|B6||Male|Sex: Female, Male||Participants|Count of Participants|767|767.0||||||
4352035|NCT00393718|4180097|B1|||HbA1c|Glycosylated Haemoglobin|percentage of total haemoglobin|Mean|8.27|8.27|Standard Deviation|0.75|0.75|||
4352036|NCT00393718|4180095|B3|||Duration of diabetes|Number of years since diagnosis of diabetes|years|Mean|8.25|8.25|Standard Deviation|6.73|6.73|||
4352037|NCT00393718|4180096|B2|||Duration of diabetes|Number of years since diagnosis of diabetes|years|Mean|8.48|8.48|Standard Deviation|6.84|6.84|||
4352038|NCT00393718|4180097|B1|||Duration of diabetes|Number of years since diagnosis of diabetes|years|Mean|8.13|8.13|Standard Deviation|6.68|6.68|||
4352039|NCT00393718|4180095|B3|||Body Weight||kg|Mean|65.94|65.94|Standard Deviation|12.69|12.69|||
4352040|NCT00393718|4180096|B2|||Body Weight||kg|Mean|65.43|65.43|Standard Deviation|12.89|12.89|||
4352041|NCT00393718|4180097|B1|||Body Weight||kg|Mean|66.19|66.19|Standard Deviation|12.61|12.61|||
4352042|NCT00393718|4180095|B3|||BMI|Body Mass Index|kg/m2|Mean|24.81|24.81|Standard Deviation|3.74|3.74|||
4352043|NCT00393718|4180096|B2|||BMI|Body Mass Index|kg/m2|Mean|24.62|24.62|Standard Deviation|3.84|3.84|||
4352044|NCT00393718|4180097|B1|||BMI|Body Mass Index|kg/m2|Mean|24.90|24.9|Standard Deviation|3.69|3.69|||
4352045|NCT00393718|4180095|B3||Male|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
4352046|NCT00393718|4180096|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4352047|NCT00393718|4180097|B1||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4352048|NCT00393718|4180095|B3||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4352049|NCT00393718|4180096|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4352050|NCT00393718|4180097|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4352051|NCT00393718|4180095|B3|||Age||years|Mean|58.3|58.3|Standard Deviation|10.4|10.4|||
4352052|NCT00393718|4180096|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|10.4|10.4|||
4352053|NCT00393718|4180097|B1|||Age||years|Mean|58.2|58.2|Standard Deviation|10.4|10.4|||
4352054|NCT00393718|4180095|B3|70- years||Age, Customized||participants|Number|55|55.0||||||
4352055|NCT00393718|4180096|B2|70- years||Age, Customized||participants|Number|20|20.0||||||
4352056|NCT00393718|4180097|B1|70- years||Age, Customized||participants|Number|35|35.0||||||
4352057|NCT00393718|4180095|B3|60-69 years||Age, Customized||participants|Number|138|138.0||||||
4352058|NCT00393718|4180096|B2|60-69 years||Age, Customized||participants|Number|40|40.0||||||
4352059|NCT00393718|4180097|B1|60-69 years||Age, Customized||participants|Number|98|98.0||||||
4352060|NCT00393718|4180095|B3|50-59 years||Age, Customized||participants|Number|123|123.0||||||
4352061|NCT00393718|4180096|B2|50-59 years||Age, Customized||participants|Number|46|46.0||||||
4352062|NCT00393718|4180097|B1|50-59 years||Age, Customized||participants|Number|77|77.0||||||
4352063|NCT00393718|4180095|B3|40-49 years||Age, Customized||participants|Number|63|63.0||||||
4352064|NCT00393718|4180096|B2|40-49 years||Age, Customized||participants|Number|20|20.0||||||
4352065|NCT00393718|4180097|B1|40-49 years||Age, Customized||participants|Number|43|43.0||||||
4352066|NCT00393718|4180095|B3|30-39 years||Age, Customized||participants|Number|17|17.0||||||
4352067|NCT00393718|4180096|B2|30-39 years||Age, Customized||participants|Number|6|6.0||||||
4352068|NCT00393718|4180097|B1|30-39 years||Age, Customized||participants|Number|11|11.0||||||
4352069|NCT00393718|4180095|B3|20-29 years||Age, Customized||participants|Number|4|4.0||||||
4352070|NCT00393718|4180096|B2|20-29 years||Age, Customized||participants|Number|0|0.0||||||
4352071|NCT00393718|4180097|B1|20-29 years||Age, Customized||participants|Number|4|4.0||||||
4352072|NCT00393705|4180128|B3|||Weight||kilograms (kg)|Mean|86.8|86.8|Standard Deviation|14.79|14.79|||
4352073|NCT00393705|4180129|B2|||Weight||kilograms (kg)|Mean|85.1|85.1|Standard Deviation|14.45|14.45|||
4352074|NCT00393705|4180130|B1|||Weight||kilograms (kg)|Mean|88.6|88.6|Standard Deviation|14.97|14.97|||
4352075|NCT00393705|4180128|B3|||Hemoglobin A1c (HbA1c)||percent HbA1c|Mean|8.5|8.5|Standard Deviation|1.23|1.23|||
4352076|NCT00393705|4180129|B2|||Hemoglobin A1c (HbA1c)||percent HbA1c|Mean|8.5|8.5|Standard Deviation|1.20|1.2|||
4352077|NCT00393705|4180130|B1|||Hemoglobin A1c (HbA1c)||percent HbA1c|Mean|8.6|8.6|Standard Deviation|1.27|1.27|||
4352078|NCT00393705|4180128|B3|||Height||centimeters (cm)|Mean|165.4|165.4|Standard Deviation|9.63|9.63|||
4352079|NCT00393705|4180129|B2|||Height||centimeters (cm)|Mean|165.4|165.4|Standard Deviation|9.82|9.82|||
4352080|NCT00393705|4180130|B1|||Height||centimeters (cm)|Mean|165.4|165.4|Standard Deviation|9.47|9.47|||
4352081|NCT00393705|4180128|B3|||Fasting Plasma Glucose||milligrams per deciliter (mg/dL)|Mean|184.0|184.0|Standard Deviation|53.04|53.04|||
4352082|NCT00393705|4180129|B2|||Fasting Plasma Glucose||milligrams per deciliter (mg/dL)|Mean|185.4|185.4|Standard Deviation|59.22|59.22|||
4352083|NCT00393705|4180130|B1|||Fasting Plasma Glucose||milligrams per deciliter (mg/dL)|Mean|182.6|182.6|Standard Deviation|46.15|46.15|||
4352084|NCT00393705|4180128|B3|||Duration of Diabetes||years|Mean|11.2|11.2|Standard Deviation|6.47|6.47|||
4352085|NCT00393705|4180129|B2|||Duration of Diabetes||years|Mean|11.5|11.5|Standard Deviation|7.19|7.19|||
4352086|NCT00393705|4180130|B1|||Duration of Diabetes||years|Mean|10.9|10.9|Standard Deviation|5.66|5.66|||
4352087|NCT00393705|4180128|B3|Oral Hypoglycemic Treatment||Duration of Antihyperglycaemic Therapy Prior to Study||months|Mean|56.8|56.8|Standard Deviation|60.62|60.62|||
4352088|NCT00393705|4180129|B2|Oral Hypoglycemic Treatment||Duration of Antihyperglycaemic Therapy Prior to Study||months|Mean|58.9|58.9|Standard Deviation|64.56|64.56|||
4352089|NCT00393705|4180130|B1|Oral Hypoglycemic Treatment||Duration of Antihyperglycaemic Therapy Prior to Study||months|Mean|54.7|54.7|Standard Deviation|56.55|56.55|||
4352090|NCT00393705|4180128|B3|Premixed Insulin Analogue Treatment||Duration of Antihyperglycaemic Therapy Prior to Study||months|Mean|16.3|16.3|Standard Deviation|20.12|20.12|||
4352142|NCT00393523|4180156|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4352091|NCT00393705|4180129|B2|Premixed Insulin Analogue Treatment||Duration of Antihyperglycaemic Therapy Prior to Study||months|Mean|16.1|16.1|Standard Deviation|22.42|22.42|||
4352092|NCT00393705|4180130|B1|Premixed Insulin Analogue Treatment||Duration of Antihyperglycaemic Therapy Prior to Study||months|Mean|16.4|16.4|Standard Deviation|17.61|17.61|||
4352093|NCT00393705|4180128|B3|Insulin Treatment||Duration of Antihyperglycaemic Therapy Prior to Study||months|Mean|43.3|43.3|Standard Deviation|46.76|46.76|||
4352094|NCT00393705|4180129|B2|Insulin Treatment||Duration of Antihyperglycaemic Therapy Prior to Study||months|Mean|43.7|43.7|Standard Deviation|51.50|51.5|||
4352095|NCT00393705|4180130|B1|Insulin Treatment||Duration of Antihyperglycaemic Therapy Prior to Study||months|Mean|42.8|42.8|Standard Deviation|41.65|41.65|||
4352096|NCT00393705|4180128|B3|||Daily Dose of Metformin Treatment Prior to Study (milligrams [mg])||milligrams (mg)|Mean|1881.4|1881.4|Standard Deviation|390.92|390.92|||
4352097|NCT00393705|4180129|B2|||Daily Dose of Metformin Treatment Prior to Study (milligrams [mg])||milligrams (mg)|Mean|1863.9|1863.9|Standard Deviation|379.00|379.0|||
4352098|NCT00393705|4180130|B1|||Daily Dose of Metformin Treatment Prior to Study (milligrams [mg])||milligrams (mg)|Mean|1898.8|1898.8|Standard Deviation|402.99|402.99|||
4352099|NCT00393705|4180128|B3|Biphasic Insulin Aspart 30/70 Dose (n=90, n=94)||Daily Dose of Antihyperglycaemic Therapy Prior to Study (International Units [IU])||International Units (IU)|Mean|45.7|45.7|Standard Deviation|19.09|19.09|||
4352100|NCT00393705|4180129|B2|Biphasic Insulin Aspart 30/70 Dose (n=90, n=94)||Daily Dose of Antihyperglycaemic Therapy Prior to Study (International Units [IU])||International Units (IU)|Mean|44.0|44.0|Standard Deviation|17.79|17.79|||
4352101|NCT00393705|4180130|B1|Biphasic Insulin Aspart 30/70 Dose (n=90, n=94)||Daily Dose of Antihyperglycaemic Therapy Prior to Study (International Units [IU])||International Units (IU)|Mean|47.5|47.5|Standard Deviation|20.31|20.31|||
4352102|NCT00393705|4180128|B3|Insulin Lispro Dose (n=61, n=57)||Daily Dose of Antihyperglycaemic Therapy Prior to Study (International Units [IU])||International Units (IU)|Mean|42.9|42.9|Standard Deviation|15.69|15.69|||
4352103|NCT00393705|4180129|B2|Insulin Lispro Dose (n=61, n=57)||Daily Dose of Antihyperglycaemic Therapy Prior to Study (International Units [IU])||International Units (IU)|Mean|39.7|39.7|Standard Deviation|13.79|13.79|||
4352104|NCT00393705|4180130|B1|Insulin Lispro Dose (n=61, n=57)||Daily Dose of Antihyperglycaemic Therapy Prior to Study (International Units [IU])||International Units (IU)|Mean|45.8|45.8|Standard Deviation|16.87|16.87|||
4352105|NCT00393705|4180128|B3|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|31.7|31.7|Standard Deviation|4.23|4.23|||
4352106|NCT00393705|4180129|B2|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|31.0|31.0|Standard Deviation|4.27|4.27|||
4352107|NCT00393705|4180130|B1|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|32.3|32.3|Standard Deviation|4.11|4.11|||
4352108|NCT00393705|4180128|B3|Hungary||Region of Enrollment||participants|Number|50|50.0||||||
4352109|NCT00393705|4180129|B2|Hungary||Region of Enrollment||participants|Number|21|21.0||||||
4352110|NCT00393705|4180130|B1|Hungary||Region of Enrollment||participants|Number|29|29.0||||||
4352111|NCT00393705|4180128|B3|South Africa||Region of Enrollment||participants|Number|25|25.0||||||
4352112|NCT00393705|4180129|B2|South Africa||Region of Enrollment||participants|Number|13|13.0||||||
4352113|NCT00393705|4180130|B1|South Africa||Region of Enrollment||participants|Number|12|12.0||||||
4352114|NCT00393705|4180128|B3|Romania||Region of Enrollment||participants|Number|65|65.0||||||
4352115|NCT00393705|4180129|B2|Romania||Region of Enrollment||participants|Number|28|28.0||||||
4352116|NCT00393705|4180130|B1|Romania||Region of Enrollment||participants|Number|37|37.0||||||
4352117|NCT00393705|4180128|B3|Turkey||Region of Enrollment||participants|Number|78|78.0||||||
4352118|NCT00393705|4180129|B2|Turkey||Region of Enrollment||participants|Number|45|45.0||||||
4352119|NCT00393705|4180130|B1|Turkey||Region of Enrollment||participants|Number|33|33.0||||||
4352120|NCT00393705|4180128|B3|Croatia||Region of Enrollment||participants|Number|18|18.0||||||
4352121|NCT00393705|4180129|B2|Croatia||Region of Enrollment||participants|Number|11|11.0||||||
4352122|NCT00393705|4180130|B1|Croatia||Region of Enrollment||participants|Number|7|7.0||||||
4352123|NCT00393705|4180128|B3|Poland||Region of Enrollment||participants|Number|66|66.0||||||
4352124|NCT00393705|4180129|B2|Poland||Region of Enrollment||participants|Number|33|33.0||||||
4352125|NCT00393705|4180130|B1|Poland||Region of Enrollment||participants|Number|33|33.0||||||
4352126|NCT00393705|4180128|B3|African||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4352127|NCT00393705|4180129|B2|African||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4352128|NCT00393705|4180130|B1|African||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4352129|NCT00393705|4180128|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|299|299.0||||||
4352130|NCT00393705|4180129|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|149|149.0||||||
4352131|NCT00393705|4180130|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|150|150.0||||||
4352132|NCT00393705|4180128|B3||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4352133|NCT00393705|4180129|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4352134|NCT00393705|4180130|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4352135|NCT00393705|4180128|B3||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4352136|NCT00393705|4180129|B2||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4352137|NCT00393705|4180130|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4352138|NCT00393705|4180128|B3|||Age||years|Mean|57.7|57.7|Standard Deviation|9.27|9.27|||
4352139|NCT00393705|4180129|B2|||Age||years|Mean|58.4|58.4|Standard Deviation|9.01|9.01|||
4352140|NCT00393705|4180130|B1|||Age||years|Mean|57.0|57.0|Standard Deviation|9.50|9.5|||
4352144|NCT00393523|4180158|B3||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4352145|NCT00393523|4180159|B2||Male|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4352146|NCT00393523|4180160|B1||Male|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4352147|NCT00393523|4180155|B6||Female|Sex: Female, Male||Participants|Count of Participants|711|711.0||||||
4352148|NCT00393523|4180156|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4352149|NCT00393523|4180157|B4||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4352150|NCT00393523|4180158|B3||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4352151|NCT00393523|4180159|B2||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4352152|NCT00393523|4180160|B1||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4352153|NCT00393523|4180155|B6|||Age||years|Mean|5.5|5.5|Standard Deviation|0.98|0.98|||
4352154|NCT00393523|4180156|B5|||Age||years|Mean|4.3|4.3|Standard Deviation|0.66|0.66|||
4352155|NCT00393523|4180157|B4|||Age||years|Mean|5.4|5.4|Standard Deviation|0.98|0.98|||
4352156|NCT00393523|4180158|B3|||Age||years|Mean|5.3|5.3|Standard Deviation|1.05|1.05|||
4352157|NCT00393523|4180159|B2|||Age||years|Mean|5.7|5.7|Standard Deviation|0.92|0.92|||
4352158|NCT00393523|4180160|B1|||Age||years|Mean|5.7|5.7|Standard Deviation|0.92|0.92|||
4352159|NCT00393510|4180179|B3|Hong Kong||Region of Enrollment||participants|Number|80|80.0||||||
4352160|NCT00393510|4180180|B2|Hong Kong||Region of Enrollment||participants|Number|40|40.0||||||
4352161|NCT00393510|4180181|B1|Hong Kong||Region of Enrollment||participants|Number|40|40.0||||||
4352162|NCT00393510|4180179|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4352163|NCT00393510|4180180|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4352164|NCT00393510|4180181|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4352165|NCT00393510|4180179|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4352166|NCT00393510|4180180|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4352167|NCT00393510|4180181|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4352168|NCT00393510|4180179|B3|||Age||years|Mean|67.4|67.4|Standard Deviation|11.8|11.8|||
4352169|NCT00393510|4180180|B2|||Age||years|Mean|68.5|68.5|Standard Deviation|11.1|11.1|||
4352170|NCT00393510|4180181|B1|||Age||years|Mean|66.3|66.3|Standard Deviation|12.6|12.6|||
4352171|NCT00393484|4180192|B3|||Alanine aminotransferase||U/L|Mean|101.65|101.65|Standard Deviation|70.59|70.59|||
4352172|NCT00393484|4180193|B2|||Alanine aminotransferase||U/L|Mean|93.94|93.94|Standard Deviation|58.46|58.46|||
4352173|NCT00393484|4180194|B1|||Alanine aminotransferase||U/L|Mean|110.46|110.46|Standard Deviation|81.97|81.97|||
4352174|NCT00393484|4180192|B3|||Hepatitis B virus DNA by polymerase chain reaction||log10 copies/mL|Mean|5.91|5.91|Standard Deviation|0.86|0.86|||
4352175|NCT00393484|4180193|B2|||Hepatitis B virus DNA by polymerase chain reaction||log10 copies/mL|Mean|5.79|5.79|Standard Deviation|0.90|0.9|||
4352176|NCT00393484|4180194|B1|||Hepatitis B virus DNA by polymerase chain reaction||log10 copies/mL|Mean|6.06|6.06|Standard Deviation|0.78|0.78|||
4352177|NCT00393484|4180192|B3|Yes||Prior interferon treatment status||Participants|Number|2|2.0||||||
4352178|NCT00393484|4180193|B2|Yes||Prior interferon treatment status||Participants|Number|0|0.0||||||
4352179|NCT00393484|4180194|B1|Yes||Prior interferon treatment status||Participants|Number|2|2.0||||||
4352180|NCT00393484|4180192|B3|No||Prior interferon treatment status||Participants|Number|118|118.0||||||
4352181|NCT00393484|4180193|B2|No||Prior interferon treatment status||Participants|Number|64|64.0||||||
4352182|NCT00393484|4180194|B1|No||Prior interferon treatment status||Participants|Number|54|54.0||||||
4352183|NCT00393484|4180192|B3|Korea, Republic of||Region of Enrollment||participants|Number|120|120.0||||||
4352184|NCT00393484|4180193|B2|Korea, Republic of||Region of Enrollment||participants|Number|64|64.0||||||
4352185|NCT00393484|4180194|B1|Korea, Republic of||Region of Enrollment||participants|Number|56|56.0||||||
4352186|NCT00393484|4180192|B3||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4352187|NCT00393484|4180193|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4352188|NCT00393484|4180194|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4352189|NCT00393484|4180192|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4352190|NCT00393484|4180193|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4352191|NCT00393484|4180194|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4352192|NCT00393484|4180192|B3|||Age||years|Mean|47.46|47.46|Standard Deviation|10.05|10.05|||
4352193|NCT00393484|4180193|B2|||Age||years|Mean|48.98|48.98|Standard Deviation|7.84|7.84|||
4352194|NCT00393484|4180194|B1|||Age||years|Mean|45.73|45.73|Standard Deviation|11.93|11.93|||
4352195|NCT00393458|4180227|B5||Male|Sex: Female, Male||Participants|Count of Participants|1378|1378.0||||||
4352196|NCT00393458|4180228|B4||Male|Sex: Female, Male||Participants|Count of Participants|352|352.0||||||
4352197|NCT00393458|4180229|B3||Male|Sex: Female, Male||Participants|Count of Participants|348|348.0||||||
4352198|NCT00393458|4180230|B2||Male|Sex: Female, Male||Participants|Count of Participants|327|327.0||||||
4352199|NCT00393458|4180231|B1||Male|Sex: Female, Male||Participants|Count of Participants|351|351.0||||||
4352200|NCT00393458|4180227|B5||Female|Sex: Female, Male||Participants|Count of Participants|350|350.0||||||
4352201|NCT00393458|4180228|B4||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4352202|NCT00393458|4180229|B3||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4352203|NCT00393458|4180230|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4352204|NCT00393458|4180231|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4352205|NCT00393458|4180227|B5|||Age|Demographic data are based on all subjects in the safety population, which includes all patients who received at least 1 dose of study drug. Three patients in the indacaterol 600 μg plus placebo to formoterol and one patient in the formoterol 12 μg plus placebo to indacaterol group were not exposed to any study treatment.|years|Mean|63.4|63.4|Standard Deviation|8.52|8.52|||
4352206|NCT00393458|4180228|B4|||Age|Demographic data are based on all subjects in the safety population, which includes all patients who received at least 1 dose of study drug. Three patients in the indacaterol 600 μg plus placebo to formoterol and one patient in the formoterol 12 μg plus placebo to indacaterol group were not exposed to any study treatment.|years|Mean|63.2|63.2|Standard Deviation|8.28|8.28|||
4352207|NCT00393458|4180229|B3|||Age|Demographic data are based on all subjects in the safety population, which includes all patients who received at least 1 dose of study drug. Three patients in the indacaterol 600 μg plus placebo to formoterol and one patient in the formoterol 12 μg plus placebo to indacaterol group were not exposed to any study treatment.|years|Mean|63.6|63.6|Standard Deviation|8.49|8.49|||
4352208|NCT00393458|4180230|B2|||Age|Demographic data are based on all subjects in the safety population, which includes all patients who received at least 1 dose of study drug. Three patients in the indacaterol 600 μg plus placebo to formoterol and one patient in the formoterol 12 μg plus placebo to indacaterol group were not exposed to any study treatment.|years|Mean|62.9|62.9|Standard Deviation|8.74|8.74|||
4352209|NCT00393458|4180231|B1|||Age|Demographic data are based on all subjects in the safety population, which includes all patients who received at least 1 dose of study drug. Three patients in the indacaterol 600 μg plus placebo to formoterol and one patient in the formoterol 12 μg plus placebo to indacaterol group were not exposed to any study treatment.|years|Mean|63.9|63.9|Standard Deviation|8.57|8.57|||
4352210|NCT00393380|4180248|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4352211|NCT00393380|4180248|B1||Unknown or Not Reported|Race (NIH/OMB)|Race among patients transplanted.|Participants|Count of Participants|0|0.0||||||
4352212|NCT00393380|4180248|B1||More than one race|Race (NIH/OMB)|Race among patients transplanted.|Participants|Count of Participants|2|2.0||||||
4352213|NCT00393380|4180248|B1||White|Race (NIH/OMB)|Race among patients transplanted.|Participants|Count of Participants|10|10.0||||||
4352214|NCT00393380|4180248|B1||Black or African American|Race (NIH/OMB)|Race among patients transplanted.|Participants|Count of Participants|0|0.0||||||
4352215|NCT00393380|4180248|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race among patients transplanted.|Participants|Count of Participants|0|0.0||||||
4352216|NCT00393380|4180248|B1||Asian|Race (NIH/OMB)|Race among patients transplanted.|Participants|Count of Participants|1|1.0||||||
4352217|NCT00393380|4180248|B1||American Indian or Alaska Native|Race (NIH/OMB)|Race among patients transplanted.|Participants|Count of Participants|0|0.0||||||
4352218|NCT00393380|4180248|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4352219|NCT00393380|4180248|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4352220|NCT00393380|4180248|B1|||Age|Median Age at Transplant|years|Median|39|39.0|Full Range|||25.0|67.0|
4352221|NCT00393380|4180248|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4352222|NCT00393380|4180248|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4352223|NCT00393380|4180248|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4352224|NCT00393367|4180259|B3|United States||Region of Enrollment||participants|Number|179|179.0||||||
4352225|NCT00393367|4180260|B2|United States||Region of Enrollment||participants|Number|88|88.0||||||
4352226|NCT00393367|4180261|B1|United States||Region of Enrollment||participants|Number|91|91.0||||||
4352227|NCT00393367|4180259|B3||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4352228|NCT00393367|4180260|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4352229|NCT00393367|4180261|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4352230|NCT00393367|4180259|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4352231|NCT00393367|4180260|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4352232|NCT00393367|4180261|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4352233|NCT00393367|4180259|B3|||Age||years|Mean|6.2|6.2|Standard Deviation|4.0|4.0|||
4352234|NCT00393367|4180260|B2|||Age||years|Mean|6.3|6.3|Standard Deviation|4.0|4.0|||
4352235|NCT00393367|4180261|B1|||Age||years|Mean|6.2|6.2|Standard Deviation|3.9|3.9|||
4352236|NCT00393367|4180259|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4352237|NCT00393367|4180260|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4352238|NCT00393367|4180261|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4352239|NCT00393367|4180259|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4352240|NCT00393367|4180260|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4352241|NCT00393367|4180261|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4352242|NCT00393367|4180259|B3||<=18 years|Age||Participants|Count of Participants|179|179.0||||||
4352243|NCT00393367|4180260|B2||<=18 years|Age||Participants|Count of Participants|88|88.0||||||
4352244|NCT00393367|4180261|B1||<=18 years|Age||Participants|Count of Participants|91|91.0||||||
4352245|NCT00393094|4180290|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4352246|NCT00393094|4180290|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352247|NCT00393094|4180290|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352248|NCT00393094|4180290|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4352249|NCT00393094|4180290|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4352250|NCT00393094|4180290|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352251|NCT00393094|4180290|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4352252|NCT00393094|4180290|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352253|NCT00393094|4180290|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4352254|NCT00393094|4180290|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4352255|NCT00393094|4180290|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352256|NCT00393094|4180290|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4352257|NCT00393094|4180290|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4352258|NCT00393094|4180290|B1|||Age||years|Mean|46.96|46.96|Standard Deviation|10.39|10.39|||
4352259|NCT00393094|4180290|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4352260|NCT00393094|4180290|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4352261|NCT00393094|4180290|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4352262|NCT00393068|4180297|B1|United States||Region of Enrollment||participants|Number|62|62.0||||||
4352263|NCT00393068|4180297|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4352264|NCT00393068|4180297|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4352265|NCT00393068|4180297|B1|||Age||years|Median|64|64.0|Full Range|||43.0|76.0|
4352266|NCT00393042|4180301|B1|United States||Region of Enrollment||participants|Number|64|64.0||||||
4352267|NCT00393042|4180301|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4352268|NCT00393042|4180301|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4352269|NCT00393042|4180301|B1|||Age||years|Mean|11.7|11.7|Standard Deviation|2.24|2.24|||
4352270|NCT00393042|4180301|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4352271|NCT00393042|4180301|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4352272|NCT00393042|4180301|B1||<=18 years|Age||Participants|Count of Participants|64|64.0||||||
4352273|NCT00393029|4180372|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4352274|NCT00393029|4180373|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4352275|NCT00393029|4180374|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4352276|NCT00393029|4180372|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352277|NCT00393029|4180373|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352278|NCT00393029|4180374|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352279|NCT00393029|4180372|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352280|NCT00393029|4180373|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352281|NCT00393029|4180374|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352282|NCT00393029|4180372|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4352283|NCT00393029|4180373|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4352284|NCT00393029|4180374|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4352285|NCT00393029|4180372|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352286|NCT00393029|4180373|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352287|NCT00393029|4180374|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352288|NCT00393029|4180372|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352289|NCT00393029|4180373|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352290|NCT00393029|4180374|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352291|NCT00393029|4180372|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352292|NCT00393029|4180373|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352293|NCT00393029|4180374|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352294|NCT00393029|4180372|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352295|NCT00393029|4180373|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352296|NCT00393029|4180374|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352297|NCT00393029|4180372|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352298|NCT00393029|4180373|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352299|NCT00393029|4180374|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352300|NCT00393029|4180372|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4352301|NCT00393029|4180373|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4352302|NCT00393029|4180374|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4352303|NCT00393029|4180372|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352304|NCT00393029|4180373|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352305|NCT00393029|4180374|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352306|NCT00393029|4180372|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4352307|NCT00393029|4180373|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4352308|NCT00393029|4180374|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4352309|NCT00393029|4180372|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4352310|NCT00393029|4180373|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4352311|NCT00393029|4180374|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4352312|NCT00393029|4180372|B3|||Age||years|Mean|44.95|44.95|Standard Deviation|12.75|12.75|||
4352313|NCT00393029|4180373|B2|||Age||years|Mean|45.4|45.4|Standard Deviation|9.2|9.2|||
4352314|NCT00393029|4180374|B1|||Age||years|Mean|44.5|44.5|Standard Deviation|16.3|16.3|||
4352315|NCT00393029|4180372|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4352316|NCT00393029|4180373|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4352317|NCT00393029|4180374|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4352318|NCT00393029|4180372|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4352319|NCT00393029|4180373|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4352320|NCT00393029|4180374|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4352321|NCT00393029|4180372|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4352322|NCT00393029|4180373|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4352323|NCT00393029|4180374|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4352324|NCT00392951|4180384|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4352325|NCT00392951|4180384|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4352326|NCT00392951|4180384|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4352327|NCT00392951|4180384|B1|||Age||years|Median|11|11.0|Inter-Quartile Range|||1.8|21.0|
4352328|NCT00392951|4180384|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4352329|NCT00392951|4180384|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4352330|NCT00392951|4180384|B1||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4352331|NCT00392925|4180392|B5|||Body Mass Index (BMI) at Enrollment|BMI was measured as kilogram per meter of height squared (kg/m^2).|kg/m^2|Mean|32.0|32.0|Standard Deviation|2.07|2.07|||
4352332|NCT00392925|4180393|B4|||Body Mass Index (BMI) at Enrollment|BMI was measured as kilogram per meter of height squared (kg/m^2).|kg/m^2|Mean|32.5|32.5|Standard Deviation|1.95|1.95|||
4352333|NCT00392925|4180394|B3|||Body Mass Index (BMI) at Enrollment|BMI was measured as kilogram per meter of height squared (kg/m^2).|kg/m^2|Mean|32.0|32.0|Standard Deviation|2.10|2.1|||
4352334|NCT00392925|4180395|B2|||Body Mass Index (BMI) at Enrollment|BMI was measured as kilogram per meter of height squared (kg/m^2).|kg/m^2|Mean|31.5|31.5|Standard Deviation|2.03|2.03|||
4352335|NCT00392925|4180396|B1|||Body Mass Index (BMI) at Enrollment|BMI was measured as kilogram per meter of height squared (kg/m^2).|kg/m^2|Mean|32.0|32.0|Standard Deviation|2.15|2.15|||
4352336|NCT00392925|4180392|B5|||Body Weight at Baseline|Body weight was measured in kg at Day 1, baseline for randomized participants.|kg|Mean|89.13|89.13|Standard Deviation|11.807|11.807|||
4352337|NCT00392925|4180393|B4|||Body Weight at Baseline|Body weight was measured in kg at Day 1, baseline for randomized participants.|kg|Mean|NA||Standard Deviation|NA||||Non-randomized participants are not included in the Baseline Weight because they did not reach Day 1 baseline. They withdrew from the study before randomization.
4352338|NCT00392925|4180394|B3|||Body Weight at Baseline|Body weight was measured in kg at Day 1, baseline for randomized participants.|kg|Mean|89.88|89.88|Standard Deviation|12.355|12.355|||
4352339|NCT00392925|4180395|B2|||Body Weight at Baseline|Body weight was measured in kg at Day 1, baseline for randomized participants.|kg|Mean|88.05|88.05|Standard Deviation|10.507|10.507|||
4352340|NCT00392925|4180396|B1|||Body Weight at Baseline|Body weight was measured in kg at Day 1, baseline for randomized participants.|kg|Mean|89.83|89.83|Standard Deviation|13.389|13.389|||
4352341|NCT00392925|4180392|B5|||Body Weight at Enrollment|Body weight was measured in kilograms (kg) at enrollment, Visit 2 (Week -4).|kg|Mean|93.32|93.32|Standard Deviation|13.246|13.246|||
4352342|NCT00392925|4180393|B4|||Body Weight at Enrollment|Body weight was measured in kilograms (kg) at enrollment, Visit 2 (Week -4).|kg|Mean|94.54|94.54|Standard Deviation|16.027|16.027|||
4352343|NCT00392925|4180394|B3|||Body Weight at Enrollment|Body weight was measured in kilograms (kg) at enrollment, Visit 2 (Week -4).|kg|Mean|93.89|93.89|Standard Deviation|12.834|12.834|||
4352344|NCT00392925|4180395|B2|||Body Weight at Enrollment|Body weight was measured in kilograms (kg) at enrollment, Visit 2 (Week -4).|kg|Mean|91.70|91.7|Standard Deviation|11.085|11.085|||
4352345|NCT00392925|4180396|B1|||Body Weight at Enrollment|Body weight was measured in kilograms (kg) at enrollment, Visit 2 (Week -4).|kg|Mean|93.80|93.8|Standard Deviation|14.322|14.322|||
4352346|NCT00392925|4180392|B5|United States||Region of Enrollment||participants|Number|177|177.0||||||
4352347|NCT00392925|4180393|B4|United States||Region of Enrollment||participants|Number|38|38.0||||||
4352348|NCT00392925|4180394|B3|United States||Region of Enrollment||participants|Number|56|56.0||||||
4352349|NCT00392925|4180395|B2|United States||Region of Enrollment||participants|Number|56|56.0||||||
4352350|NCT00392925|4180396|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4352351|NCT00392925|4180392|B5||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4352352|NCT00392925|4180393|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4352353|NCT00392925|4180394|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4352354|NCT00392925|4180395|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4352355|NCT00392925|4180396|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4352356|NCT00392925|4180392|B5||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4352357|NCT00392925|4180393|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4352358|NCT00392925|4180394|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4352359|NCT00392925|4180395|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4352360|NCT00392925|4180396|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4352361|NCT00392925|4180392|B5|||Age||years|Mean|38.6|38.6|Standard Deviation|8.39|8.39|||
4352362|NCT00392925|4180393|B4|||Age||years|Mean|37.9|37.9|Standard Deviation|7.51|7.51|||
4352363|NCT00392925|4180394|B3|||Age||years|Mean|38.5|38.5|Standard Deviation|8.42|8.42|||
4352364|NCT00392925|4180395|B2|||Age||years|Mean|38.3|38.3|Standard Deviation|9.13|9.13|||
4352365|NCT00392925|4180396|B1|||Age||years|Mean|40.5|40.5|Standard Deviation|8.06|8.06|||
4352366|NCT00392860|4180485|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4352367|NCT00392860|4180486|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4352368|NCT00392860|4180487|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4352369|NCT00392860|4180485|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4352370|NCT00392860|4180486|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4352371|NCT00392860|4180487|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4352372|NCT00392860|4180485|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4352373|NCT00392860|4180486|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4352374|NCT00392860|4180487|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4352375|NCT00392860|4180485|B3|||Age||years|Mean|46|46.0|Standard Deviation|5|5.0|||
4352376|NCT00392860|4180486|B2|||Age||years|Mean|39|39.0|Standard Deviation|0|0.0|||
4352377|NCT00392860|4180487|B1|||Age||years|Mean|48|48.0|Standard Deviation|2.11|2.11|||
4352378|NCT00392860|4180485|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4352379|NCT00392860|4180486|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4352380|NCT00392860|4180487|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4352381|NCT00392860|4180485|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4352382|NCT00392860|4180486|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4352383|NCT00392860|4180487|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4352384|NCT00392860|4180485|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4352385|NCT00392860|4180486|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4352386|NCT00392860|4180487|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4352387|NCT00392834|4180495|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
4352388|NCT00392834|4180496|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
4352389|NCT00392834|4180497|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4352390|NCT00392834|4180495|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4352391|NCT00392834|4180496|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4352392|NCT00392834|4180497|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4352393|NCT00392834|4180495|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4352394|NCT00392834|4180496|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4352395|NCT00392834|4180497|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4352396|NCT00392834|4180495|B3|||Age||years|Mean|41.4|41.4|Standard Deviation|9.2|9.2|||
4352397|NCT00392834|4180496|B2|||Age||years|Mean|41.4|41.4|Standard Deviation|9.4|9.4|||
4352398|NCT00392834|4180497|B1|||Age||years|Mean|41|41.0|Standard Deviation|8.5|8.5|||
4352399|NCT00392834|4180495|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4352400|NCT00392834|4180496|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4352401|NCT00392834|4180497|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4352402|NCT00392834|4180495|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4352403|NCT00392834|4180496|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4352404|NCT00392834|4180497|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4352405|NCT00392834|4180495|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4352406|NCT00392834|4180496|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4352407|NCT00392834|4180497|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4352408|NCT00392821|4180504|B1|United States||Region of Enrollment||participants|Number|78|78.0||||||
4352409|NCT00392821|4180504|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4352410|NCT00392821|4180504|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4352411|NCT00392821|4180504|B1|||Age||years|Median|62.5|62.5|Full Range|||44.0|86.0|
4352412|NCT00392808|4180509|B5|Spain||Region of Enrollment||participants|Number|389|389.0||||||
4352413|NCT00392808|4180510|B4|Spain||Region of Enrollment||participants|Number|87|87.0||||||
4352414|NCT00392808|4180511|B3|Spain||Region of Enrollment||participants|Number|89|89.0||||||
4352415|NCT00392808|4180512|B2|Spain||Region of Enrollment||participants|Number|109|109.0||||||
4352416|NCT00392808|4180513|B1|Spain||Region of Enrollment||participants|Number|104|104.0||||||
4352417|NCT00392808|4180509|B5||Male|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4352418|NCT00392808|4180510|B4||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4352419|NCT00392808|4180511|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4352420|NCT00392808|4180512|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4352421|NCT00392808|4180513|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4352422|NCT00392808|4180509|B5||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4352423|NCT00392808|4180510|B4||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4352424|NCT00392808|4180511|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4352425|NCT00392808|4180512|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4352426|NCT00392808|4180513|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4352427|NCT00392808|4180509|B5|||Age||years|Mean|1.4|1.4|Standard Deviation|.15|0.15|||
4352428|NCT00392808|4180510|B4|||Age||years|Mean|1.46|1.46|Standard Deviation|0.09|0.09|||
4352429|NCT00392808|4180511|B3|||Age||years|Mean|1.43|1.43|Standard Deviation|0.23|0.23|||
4352430|NCT00392808|4180512|B2|||Age||years|Mean|1.38|1.38|Standard Deviation|0.13|0.13|||
4352431|NCT00392808|4180513|B1|||Age||years|Mean|1.37|1.37|Standard Deviation|0.23|0.23|||
4352432|NCT00392808|4180509|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4352433|NCT00392808|4180510|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4352434|NCT00392808|4180511|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4352435|NCT00392808|4180512|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4352436|NCT00392808|4180513|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4352437|NCT00392808|4180509|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4352438|NCT00392808|4180510|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4352439|NCT00392808|4180511|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4352440|NCT00392808|4180512|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4352441|NCT00392808|4180513|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4352442|NCT00392808|4180509|B5||<=18 years|Age||Participants|Count of Participants|389|389.0||||||
4352443|NCT00392808|4180510|B4||<=18 years|Age||Participants|Count of Participants|87|87.0||||||
4352444|NCT00392808|4180511|B3||<=18 years|Age||Participants|Count of Participants|89|89.0||||||
4352445|NCT00392808|4180512|B2||<=18 years|Age||Participants|Count of Participants|109|109.0||||||
4352446|NCT00392808|4180513|B1||<=18 years|Age||Participants|Count of Participants|104|104.0||||||
4352447|NCT00392782|4180530|B1|Chronic Myeloid Leukemia||Disease||Participants|Number|4|4.0||||||
4352448|NCT00392782|4180530|B1|Myelodysplastic Syndrome - NOS||Disease||Participants|Number|1|1.0||||||
4352449|NCT00392782|4180530|B1|Myelodysplastic Syndrome - RAEB2||Disease||Participants|Number|2|2.0||||||
4352450|NCT00392782|4180530|B1|Acute Myeloid Leukemia - CR2||Disease||Participants|Number|7|7.0||||||
4352451|NCT00392782|4180530|B1|Acute Myeloid Leukemia - CR1||Disease||Participants|Number|10|10.0||||||
4352452|NCT00392782|4180530|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4352453|NCT00392782|4180530|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352454|NCT00392782|4180530|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352455|NCT00392782|4180530|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4352456|NCT00392782|4180530|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4352457|NCT00392782|4180530|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352458|NCT00392782|4180530|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4352459|NCT00392782|4180530|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352460|NCT00392782|4180530|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4352461|NCT00392782|4180530|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4352462|NCT00392782|4180530|B1|||Age||years|Mean|41.1|41.1|Standard Deviation|12.9|12.9|||
4352463|NCT00392782|4180530|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4352464|NCT00392782|4180530|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4352465|NCT00392782|4180530|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4352466|NCT00392769|4180540|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4352467|NCT00392769|4180540|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4352468|NCT00392769|4180540|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4352469|NCT00392769|4180540|B1|||Age||years|Median|63|63.0|Full Range|||42.0|83.0|
4352470|NCT00392704|4180544|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4352471|NCT00392704|4180544|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4352472|NCT00392704|4180544|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4352473|NCT00392704|4180544|B1|||Age||years|Median|56|56.0|Full Range|||39.0|76.0|
4352474|NCT00392678|4180549|B5|United States||Region of Enrollment||participants|Number|108|108.0||||||
4352475|NCT00392678|4180550|B4|United States||Region of Enrollment||participants|Number|27|27.0||||||
4352476|NCT00392678|4180551|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
4352477|NCT00392678|4180552|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4352478|NCT00392678|4180553|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4352479|NCT00392678|4180549|B5||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4352480|NCT00392678|4180550|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4352481|NCT00392678|4180551|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4352482|NCT00392678|4180552|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4352483|NCT00392678|4180553|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4352484|NCT00392678|4180549|B5||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4352485|NCT00392678|4180550|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4352486|NCT00392678|4180551|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4352487|NCT00392678|4180552|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4352488|NCT00392678|4180553|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4352489|NCT00392678|4180549|B5|||Age||years|Mean|56|56.0|Standard Deviation|9|9.0|||
4352490|NCT00392678|4180550|B4|||Age||years|Mean|55.9|55.9|Standard Deviation|8.2|8.2|||
4352491|NCT00392678|4180551|B3|||Age||years|Mean|55.0|55.0|Standard Deviation|10.2|10.2|||
4352492|NCT00392678|4180552|B2|||Age||years|Mean|56.7|56.7|Standard Deviation|9.8|9.8|||
4352493|NCT00392678|4180553|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|9.4|9.4|||
4352494|NCT00392678|4180549|B5||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4352495|NCT00392678|4180550|B4||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4352496|NCT00392678|4180551|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4352497|NCT00392678|4180552|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4352498|NCT00392678|4180553|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4352499|NCT00392678|4180549|B5||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
4352500|NCT00392678|4180550|B4||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4352501|NCT00392678|4180551|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4352502|NCT00392678|4180552|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4352503|NCT00392678|4180553|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4352504|NCT00392678|4180549|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4352505|NCT00392678|4180550|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4352506|NCT00392678|4180551|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4352507|NCT00392678|4180552|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4352508|NCT00392678|4180553|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4352509|NCT00392665|4180590|B3|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
4352510|NCT00392665|4180591|B2|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4352511|NCT00392665|4180592|B1|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4352512|NCT00392665|4180590|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4352513|NCT00392665|4180591|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4352514|NCT00392665|4180592|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352515|NCT00392665|4180590|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352516|NCT00392665|4180591|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352517|NCT00392665|4180592|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352518|NCT00392665|4180590|B3||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4352519|NCT00392665|4180591|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4352520|NCT00392665|4180592|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4352521|NCT00392665|4180590|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4352522|NCT00392665|4180591|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4352523|NCT00392665|4180592|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4352524|NCT00392665|4180590|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352525|NCT00392665|4180591|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352526|NCT00392665|4180592|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352527|NCT00392665|4180590|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4352528|NCT00392665|4180591|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4352529|NCT00392665|4180592|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352530|NCT00392665|4180590|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352531|NCT00392665|4180591|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352532|NCT00392665|4180592|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352533|NCT00392665|4180590|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4352534|NCT00392665|4180591|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4352535|NCT00392665|4180592|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352536|NCT00392665|4180590|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4352537|NCT00392665|4180591|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4352538|NCT00392665|4180592|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4352539|NCT00392665|4180590|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352540|NCT00392665|4180591|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352541|NCT00392665|4180592|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352542|NCT00392665|4180590|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4352543|NCT00392665|4180591|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4352544|NCT00392665|4180592|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4352545|NCT00392665|4180590|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4352546|NCT00392665|4180591|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4352547|NCT00392665|4180592|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4352548|NCT00392665|4180590|B3|||Age||years|Median|57|57.0|Full Range|||37.0|84.0|
4352549|NCT00392665|4180591|B2|||Age||years|Median|57|57.0|Full Range|||37.0|84.0|
4352550|NCT00392665|4180592|B1|||Age||years|Median|57|57.0|Full Range|||37.0|74.0|
4352551|NCT00392496|4180605|B1|Canada||Region of Enrollment||participants|Number|17|17.0||||||
4352552|NCT00392496|4180605|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4352553|NCT00392496|4180605|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4352554|NCT00392496|4180605|B1|||Age||years|Median|65|65.0|Full Range|||34.0|81.0|
4352555|NCT00392444|4180609|B1|Canada||Region of Enrollment||participants|Number|35|35.0||||||
4352556|NCT00392444|4180609|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4352557|NCT00392444|4180609|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4352558|NCT00392444|4180609|B1|||Age||years|Median|66|66.0|Full Range|||48.0|79.0|
4352559|NCT00392392|4180613|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4352560|NCT00392392|4180613|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4352561|NCT00392392|4180613|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4352562|NCT00392392|4180613|B1|||Age||years|Median|52|52.0|Full Range|||29.0|76.0|
4352563|NCT00392379|4180617|B3|||ST Use|Can's week|Cans/week|Mean|4.2|4.2|Standard Deviation|2.6|2.6|||
4352564|NCT00392379|4180618|B2|||ST Use|Can's week|Cans/week|Mean|4.2|4.2|Standard Deviation|2.6|2.6|||
4352565|NCT00392379|4180619|B1|||ST Use|Can's week|Cans/week|Mean|4.3|4.3|Standard Deviation|2.6|2.6|||
4352566|NCT00392379|4180617|B3|United States||Region of Enrollment||participants|Number|270|270.0||||||
4352567|NCT00392379|4180618|B2|United States||Region of Enrollment||participants|Number|134|134.0||||||
4352568|NCT00392379|4180619|B1|United States||Region of Enrollment||participants|Number|136|136.0||||||
4352569|NCT00392379|4180617|B3||Male|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
4352570|NCT00392379|4180618|B2||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4352571|NCT00392379|4180619|B1||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4352572|NCT00392379|4180617|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4352573|NCT00392379|4180618|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4352574|NCT00392379|4180619|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4352575|NCT00392379|4180617|B3|||Age||years|Mean|36.6|36.6|Standard Deviation|10.8|10.8|||
4352576|NCT00392379|4180618|B2|||Age||years|Mean|36.5|36.5|Standard Deviation|11.0|11.0|||
4352577|NCT00392379|4180619|B1|||Age||years|Mean|36.6|36.6|Standard Deviation|10.7|10.7|||
4352578|NCT00392288|4180630|B4||Male|Gender||Participants|Count of Participants|297|297.0||||||
4352579|NCT00392288|4180631|B3||Male|Gender||Participants|Count of Participants|97|97.0||||||
4352580|NCT00392288|4180632|B2||Male|Gender||Participants|Count of Participants|96|96.0||||||
4352581|NCT00392288|4180633|B1||Male|Gender||Participants|Count of Participants|104|104.0||||||
4352582|NCT00392288|4180630|B4||Female|Gender||Participants|Count of Participants|204|204.0||||||
4352583|NCT00392288|4180631|B3||Female|Gender||Participants|Count of Participants|75|75.0||||||
4352584|NCT00392288|4180632|B2||Female|Gender||Participants|Count of Participants|70|70.0||||||
4352585|NCT00392288|4180633|B1||Female|Gender||Participants|Count of Participants|59|59.0||||||
4352586|NCT00392288|4180630|B4|Aged 4 to <6 years||Age, Customized||participants|Number|82|82.0||||||
4352587|NCT00392288|4180631|B3|Aged 4 to <6 years||Age, Customized||participants|Number|27|27.0||||||
4352588|NCT00392288|4180632|B2|Aged 4 to <6 years||Age, Customized||participants|Number|28|28.0||||||
4352589|NCT00392288|4180633|B1|Aged 4 to <6 years||Age, Customized||participants|Number|27|27.0||||||
4352590|NCT00392288|4180630|B4|Aged 6 to <12 years||Age, Customized||participants|Number|419|419.0||||||
4352591|NCT00392288|4180631|B3|Aged 6 to <12 years||Age, Customized||participants|Number|145|145.0||||||
4352592|NCT00392288|4180632|B2|Aged 6 to <12 years||Age, Customized||participants|Number|138|138.0||||||
4352593|NCT00392288|4180633|B1|Aged 6 to <12 years||Age, Customized||participants|Number|136|136.0||||||
4352594|NCT00392236|4180649|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
4352595|NCT00392236|4180650|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4352596|NCT00392236|4180651|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4352597|NCT00392236|4180649|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4352598|NCT00392236|4180650|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352599|NCT00392236|4180651|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4352600|NCT00392236|4180649|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4352601|NCT00392236|4180650|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4352602|NCT00392236|4180651|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4352603|NCT00392236|4180649|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4352604|NCT00392236|4180650|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352605|NCT00392236|4180651|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4352606|NCT00392236|4180649|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4352607|NCT00392236|4180650|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352608|NCT00392236|4180651|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4352609|NCT00392236|4180649|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352610|NCT00392236|4180650|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352611|NCT00392236|4180651|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352612|NCT00392236|4180649|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4352613|NCT00392236|4180650|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4352614|NCT00392236|4180651|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4352615|NCT00392236|4180649|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4352616|NCT00392236|4180650|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4352617|NCT00392236|4180651|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4352618|NCT00392236|4180649|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4352619|NCT00392236|4180650|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4352620|NCT00392236|4180651|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352621|NCT00392236|4180649|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4352622|NCT00392236|4180650|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4352623|NCT00392236|4180651|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4352624|NCT00392236|4180649|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352625|NCT00392236|4180650|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352626|NCT00392236|4180651|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4352627|NCT00392236|4180649|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4352628|NCT00392236|4180650|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4352629|NCT00392236|4180651|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4352630|NCT00392236|4180649|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4352631|NCT00392236|4180650|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4352632|NCT00392236|4180651|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4352633|NCT00392236|4180649|B3|||Age||years|Mean|40.2|40.2|Full Range|||19.0|62.0|
4352634|NCT00392236|4180650|B2|||Age||years|Mean|40.9|40.9|Full Range|||23.0|57.0|
4352635|NCT00392236|4180651|B1|||Age||years|Mean|40.0|40.0|Full Range|||19.0|62.0|
4352636|NCT00392223|4180658|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4352637|NCT00392223|4180659|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4352638|NCT00392223|4180660|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4352639|NCT00392223|4180658|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4352640|NCT00392223|4180659|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4352641|NCT00392223|4180660|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4352642|NCT00392223|4180658|B3|Between 18 and 44 years||Age, Customized||participants|Number|91|91.0||||||
4352643|NCT00392223|4180659|B2|Between 18 and 44 years||Age, Customized||participants|Number|43|43.0||||||
4352644|NCT00392223|4180660|B1|Between 18 and 44 years||Age, Customized||participants|Number|48|48.0||||||
4352645|NCT00392223|4180658|B3|<18 years||Age, Customized||participants|Number|27|27.0||||||
4352646|NCT00392223|4180659|B2|<18 years||Age, Customized||participants|Number|17|17.0||||||
4352647|NCT00392223|4180660|B1|<18 years||Age, Customized||participants|Number|10|10.0||||||
4352648|NCT00392210|4180677|B3|United States||Region of Enrollment||participants|Number|79|79.0||||||
4352649|NCT00392210|4180678|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
4352650|NCT00392210|4180679|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4352651|NCT00392210|4180677|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4352652|NCT00392210|4180678|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4352653|NCT00392210|4180679|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4352654|NCT00392210|4180677|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4352655|NCT00392210|4180678|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4352656|NCT00392210|4180679|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4352657|NCT00392210|4180677|B3|||Age||years|Mean|59.02|59.02|Standard Deviation|10.30|10.3|||
4352658|NCT00392210|4180678|B2|||Age||years|Mean|57.58|57.58|Standard Deviation|10.04|10.04|||
4352659|NCT00392210|4180679|B1|||Age||years|Mean|60.73|60.73|Standard Deviation|12.05|12.05|||
4352660|NCT00392210|4180677|B3||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
4352661|NCT00392210|4180678|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4352662|NCT00392210|4180679|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4352663|NCT00392210|4180677|B3||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4352664|NCT00392210|4180678|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4352665|NCT00392210|4180679|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4352666|NCT00392210|4180677|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4352667|NCT00392210|4180678|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4352668|NCT00392210|4180679|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4352669|NCT00392197|4180686|B3|Japan||Region of Enrollment||participants|Number|101|101.0||||||
4352670|NCT00392197|4180687|B2|Japan||Region of Enrollment||participants|Number|58|58.0||||||
4352671|NCT00392197|4180688|B1|Japan||Region of Enrollment||participants|Number|43|43.0||||||
4352672|NCT00392197|4180686|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4352673|NCT00392197|4180687|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4352674|NCT00392197|4180688|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4352675|NCT00392197|4180686|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4352676|NCT00392197|4180687|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4352677|NCT00392197|4180688|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4352678|NCT00392197|4180686|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4352679|NCT00392197|4180687|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4352680|NCT00392197|4180688|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4352681|NCT00392197|4180686|B3||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
4352682|NCT00392197|4180687|B2||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4352683|NCT00392197|4180688|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4352684|NCT00392197|4180686|B3||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4352685|NCT00392197|4180687|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4352686|NCT00392197|4180688|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4352687|NCT00392197|4180686|B3|||Age||years|Mean|35.7|35.7|Standard Deviation|14.6|14.6|||
4352688|NCT00392197|4180687|B2|||Age||years|Mean|39.9|39.9|Standard Deviation|14.0|14.0|||
4352689|NCT00392197|4180688|B1|||Age||years|Mean|30.2|30.2|Standard Deviation|13.6|13.6|||
4352690|NCT00392171|4180697|B1|Canada||Region of Enrollment||participants|Number|120|120.0||||||
4352691|NCT00392171|4180697|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4352692|NCT00392171|4180697|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4352693|NCT00392171|4180697|B1|||Age||years|Mean|52|52.0|Standard Deviation|11|11.0|||
4352694|NCT00391989|4180701|B1|||White Blood Cells||*10^9 cells/L|Median|18.80|18.8|Full Range|||2.2|132.9|
4352695|NCT00391989|4180701|B1||Male|Gender||Participants|Count of Participants|26|26.0||||||
4352696|NCT00391989|4180701|B1||Female|Gender||Participants|Count of Participants|27|27.0||||||
4352697|NCT00391989|4180701|B1|||Age||Years|Median|53.61|53.61|Full Range|||23.79|76.49|
4352698|NCT00391976|4180705|B4||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4352699|NCT00391976|4180706|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4352700|NCT00391976|4180707|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4352701|NCT00391976|4180708|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4352702|NCT00391976|4180705|B4||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4352703|NCT00391976|4180706|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4352704|NCT00391976|4180707|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4352705|NCT00391976|4180708|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4352706|NCT00391976|4180705|B4|≥ 18 years||Age, Customized||participants|Number|13|13.0||||||
4352707|NCT00391976|4180706|B3|≥ 18 years||Age, Customized||participants|Number|3|3.0||||||
4352708|NCT00391976|4180707|B2|≥ 18 years||Age, Customized||participants|Number|4|4.0||||||
4352709|NCT00391976|4180708|B1|≥ 18 years||Age, Customized||participants|Number|6|6.0||||||
4352710|NCT00391976|4180705|B4|6 years - < 18 years||Age, Customized||participants|Number|62|62.0||||||
4352711|NCT00391976|4180706|B3|6 years - < 18 years||Age, Customized||participants|Number|21|21.0||||||
4352712|NCT00391976|4180707|B2|6 years - < 18 years||Age, Customized||participants|Number|21|21.0||||||
4352713|NCT00391976|4180708|B1|6 years - < 18 years||Age, Customized||participants|Number|20|20.0||||||
4352714|NCT00391976|4180705|B4|6 months - < 6 years||Age, Customized||participants|Number|48|48.0||||||
4352715|NCT00391976|4180706|B3|6 months - < 6 years||Age, Customized||participants|Number|11|11.0||||||
4352716|NCT00391976|4180707|B2|6 months - < 6 years||Age, Customized||participants|Number|18|18.0||||||
4352717|NCT00391976|4180708|B1|6 months - < 6 years||Age, Customized||participants|Number|19|19.0||||||
4352718|NCT00391976|4180705|B4|||Age||years|Mean|8.79|8.79|Standard Deviation|8.14|8.14|||
4352719|NCT00391976|4180706|B3|||Age||years|Mean|9.09|9.09|Standard Deviation|5.76|5.76|||
4352720|NCT00391976|4180707|B2|||Age||years|Mean|8.65|8.65|Standard Deviation|10.54|10.54|||
4352721|NCT00391976|4180708|B1|||Age||years|Mean|8.70|8.7|Standard Deviation|7.22|7.22|||
4352722|NCT00391898|4180732|B3|Spain||Region of Enrollment|Baseline measure based on safety population.|participants|Number|94|94.0||||||
4352723|NCT00391898|4180733|B2|Spain||Region of Enrollment|Baseline measure based on safety population.|participants|Number|49|49.0||||||
4352724|NCT00391898|4180734|B1|Spain||Region of Enrollment|Baseline measure based on safety population.|participants|Number|45|45.0||||||
4352725|NCT00391898|4180732|B3||Male|Sex: Female, Male|Baseline Measure based on Safety population|Participants|Count of Participants|47|47.0||||||
4352726|NCT00391898|4180733|B2||Male|Sex: Female, Male|Baseline Measure based on Safety population|Participants|Count of Participants|27|27.0||||||
4352727|NCT00391898|4180734|B1||Male|Sex: Female, Male|Baseline Measure based on Safety population|Participants|Count of Participants|20|20.0||||||
4352728|NCT00391898|4180732|B3||Female|Sex: Female, Male|Baseline Measure based on Safety population|Participants|Count of Participants|47|47.0||||||
4352729|NCT00391898|4180733|B2||Female|Sex: Female, Male|Baseline Measure based on Safety population|Participants|Count of Participants|22|22.0||||||
4352730|NCT00391898|4180734|B1||Female|Sex: Female, Male|Baseline Measure based on Safety population|Participants|Count of Participants|25|25.0||||||
4352731|NCT00391898|4180732|B3|||Age||Years|Mean|66.43|66.43|Standard Deviation|8.59|8.59|||
4352732|NCT00391898|4180733|B2|||Age||Years|Mean|66.45|66.45|Standard Deviation|9.04|9.04|||
4352733|NCT00391898|4180734|B1|||Age||Years|Mean|66.40|66.4|Standard Deviation|8.18|8.18|||
4352734|NCT00391872|4180753|B3||Male|Sex: Female, Male||Participants|Count of Participants|13336|13336.0||||||
4352735|NCT00391872|4180754|B2||Male|Sex: Female, Male||Participants|Count of Participants|6658|6658.0||||||
4352736|NCT00391872|4180755|B1||Male|Sex: Female, Male||Participants|Count of Participants|6678|6678.0||||||
4352737|NCT00391872|4180753|B3||Female|Sex: Female, Male||Participants|Count of Participants|5288|5288.0||||||
4352738|NCT00391872|4180754|B2||Female|Sex: Female, Male||Participants|Count of Participants|2633|2633.0||||||
4352739|NCT00391872|4180755|B1||Female|Sex: Female, Male||Participants|Count of Participants|2655|2655.0||||||
4352740|NCT00391872|4180753|B3|||Age||years|Mean|62.2|62.2|Standard Deviation|22.42|22.42|||
4352741|NCT00391872|4180754|B2|||Age||years|Mean|62.3|62.3|Standard Deviation|11.21|11.21|||
4352742|NCT00391872|4180755|B1|||Age||years|Mean|62.1|62.1|Standard Deviation|11.21|11.21|||
4352743|NCT00391846|4180792|B3|||Systolic blood pressure||mmHg|Mean|134|134.0|Standard Deviation|21|21.0|||
4352744|NCT00391846|4180793|B2|||Systolic blood pressure||mmHg|Mean|135|135.0|Standard Deviation|22|22.0|||
4352745|NCT00391846|4180794|B1|||Systolic blood pressure||mmHg|Mean|133|133.0|Standard Deviation|21|21.0|||
4352746|NCT00391846|4180792|B3|||Pulse||Beats/minute|Mean|72|72.0|Standard Deviation|14|14.0|||
4352747|NCT00391846|4180793|B2|||Pulse||Beats/minute|Mean|72|72.0|Standard Deviation|14|14.0|||
4352748|NCT00391846|4180794|B1|||Pulse||Beats/minute|Mean|71|71.0|Standard Deviation|14|14.0|||
4352749|NCT00391846|4180792|B3|||Diastolic blood pressure||mmHg|Mean|74|74.0|Standard Deviation|11|11.0|||
4352750|NCT00391846|4180793|B2|||Diastolic blood pressure||mmHg|Mean|75|75.0|Standard Deviation|12|12.0|||
4352751|NCT00391846|4180794|B1|||Diastolic blood pressure||mmHg|Mean|73|73.0|Standard Deviation|11|11.0|||
4352752|NCT00391846|4180792|B3|Normal ECG||Electrocardiogram (ECG), Abnormal/Normal||Participants|Number|24|24.0||||||
4352753|NCT00391846|4180793|B2|Normal ECG||Electrocardiogram (ECG), Abnormal/Normal||Participants|Number|12|12.0||||||
4352754|NCT00391846|4180794|B1|Normal ECG||Electrocardiogram (ECG), Abnormal/Normal||Participants|Number|12|12.0||||||
4352755|NCT00391846|4180792|B3|Abnormal ECG||Electrocardiogram (ECG), Abnormal/Normal||Participants|Number|228|228.0||||||
4352756|NCT00391846|4180793|B2|Abnormal ECG||Electrocardiogram (ECG), Abnormal/Normal||Participants|Number|113|113.0||||||
4352757|NCT00391846|4180794|B1|Abnormal ECG||Electrocardiogram (ECG), Abnormal/Normal||Participants|Number|115|115.0||||||
4352758|NCT00391846|4180792|B3||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4352759|NCT00391846|4180793|B2||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4352760|NCT00391846|4180794|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4352761|NCT00391846|4180792|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4352762|NCT00391846|4180793|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4352763|NCT00391846|4180794|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4352764|NCT00391846|4180792|B3|||Age||Years|Mean|77|77.0|Full Range|||51.0|94.0|
4352765|NCT00391846|4180793|B2|||Age||Years|Mean|77|77.0|Full Range|||51.0|94.0|
4352766|NCT00391846|4180794|B1|||Age||Years|Mean|78|78.0|Full Range|||57.0|92.0|
4352767|NCT00391807|4180815|B1|United States||Region of Enrollment|MITT Population|participants|Number|1582|1582.0||||||
4352768|NCT00391807|4180815|B1|Male||Gender|MITT Population|participants|Number|0|0.0||||||
4352769|NCT00391807|4180815|B1|Female||Gender|MITT Population|participants|Number|1582|1582.0||||||
4352770|NCT00391807|4180815|B1|>35 years||Age, Customized|MITT Population|participants|Number|287|287.0||||||
4352771|NCT00391807|4180815|B1|18-35 years||Age, Customized|MITT Population|participants|Number|1295|1295.0||||||
4352772|NCT00391807|4180815|B1|||Age|MITT (Modified Intent to Treat) Population|years|Mean|28.6|28.6|Standard Deviation|6.9|6.9|||
4352773|NCT00391768|4180835|B8|United States||Region of Enrollment||participants|Number|87|87.0||||||
4352774|NCT00391768|4180836|B7|United States||Region of Enrollment||participants|Number|23|23.0||||||
4352775|NCT00391768|4180837|B6|United States||Region of Enrollment||participants|Number|10|10.0||||||
4352776|NCT00391768|4180838|B5|United States||Region of Enrollment||participants|Number|24|24.0||||||
4352777|NCT00391768|4180839|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
4352778|NCT00391768|4180840|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4352779|NCT00391768|4180841|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4352780|NCT00391768|4180842|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4352781|NCT00391768|4180835|B8||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4352782|NCT00391768|4180836|B7||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4352783|NCT00391768|4180837|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4352784|NCT00391768|4180838|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4352785|NCT00391768|4180839|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4352786|NCT00391768|4180840|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4352787|NCT00391768|4180841|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4352788|NCT00391768|4180842|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4352789|NCT00391768|4180835|B8||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4352790|NCT00391768|4180836|B7||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4352791|NCT00391768|4180837|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4352792|NCT00391768|4180838|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4352793|NCT00391768|4180839|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4352794|NCT00391768|4180840|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4352795|NCT00391768|4180841|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4352796|NCT00391768|4180842|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4352797|NCT00391768|4180835|B8|||Age, Customized||Participants|Number|87|87.0||||||
4352798|NCT00391768|4180836|B7|||Age, Customized||Participants|Number|23|23.0||||||
4352799|NCT00391768|4180837|B6|||Age, Customized||Participants|Number|10|10.0||||||
4352800|NCT00391768|4180838|B5|||Age, Customized||Participants|Number|24|24.0||||||
4352801|NCT00391768|4180839|B4|||Age, Customized||Participants|Number|8|8.0||||||
4352802|NCT00391768|4180840|B3|||Age, Customized||Participants|Number|7|7.0||||||
4352803|NCT00391768|4180841|B2|||Age, Customized||Participants|Number|3|3.0||||||
4352804|NCT00391768|4180842|B1|||Age, Customized||Participants|Number|12|12.0||||||
4352805|NCT00391716|4180913|B4|||Meets Criteria for DSM-IV Alcohol Dependence|Meets DSM-IV criteria for current Alcohol Dependence defined as three or more symptoms of dependence.|participants|Number|150|150.0||||||
4352806|NCT00391716|4180914|B3|||Meets Criteria for DSM-IV Alcohol Dependence|Meets DSM-IV criteria for current Alcohol Dependence defined as three or more symptoms of dependence.|participants|Number|49|49.0||||||
4352807|NCT00391716|4180915|B2|||Meets Criteria for DSM-IV Alcohol Dependence|Meets DSM-IV criteria for current Alcohol Dependence defined as three or more symptoms of dependence.|participants|Number|47|47.0||||||
4352808|NCT00391716|4180916|B1|||Meets Criteria for DSM-IV Alcohol Dependence|Meets DSM-IV criteria for current Alcohol Dependence defined as three or more symptoms of dependence.|participants|Number|54|54.0||||||
4352809|NCT00391716|4180913|B4||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4352810|NCT00391716|4180914|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4352811|NCT00391716|4180915|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4352812|NCT00391716|4180916|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4352813|NCT00391716|4180913|B4||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4352814|NCT00391716|4180914|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4352815|NCT00391716|4180915|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4352816|NCT00391716|4180916|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4352817|NCT00391716|4180913|B4|||Age||years|Mean|44.6|44.6|Standard Deviation|10.9|10.9|||
4352818|NCT00391716|4180914|B3|||Age||years|Mean|46.8|46.8|Standard Deviation|11.3|11.3|||
4352819|NCT00391716|4180915|B2|||Age||years|Mean|45.2|45.2|Standard Deviation|11.3|11.3|||
4352820|NCT00391716|4180916|B1|||Age||years|Mean|41.9|41.9|Standard Deviation|10.1|10.1|||
4352821|NCT00391625|4180935|B1|Romania||Region of Enrollment||participants|Number|1|1.0||||||
4352822|NCT00391625|4180935|B1|Israel||Region of Enrollment||participants|Number|8|8.0||||||
4352823|NCT00391625|4180935|B1|Serbia||Region of Enrollment||participants|Number|1|1.0||||||
4352824|NCT00391625|4180935|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4352825|NCT00391625|4180935|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4352826|NCT00391625|4180935|B1|||Age||years|Mean|39.8|39.8|Standard Deviation|16.34|16.34|||
4352827|NCT00391625|4180935|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4352828|NCT00391625|4180935|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4352829|NCT00391625|4180935|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4352830|NCT00391599|4180975|B3|Israel||Region of Enrollment||participants|Number|130|130.0||||||
4352831|NCT00391599|4180976|B2|Israel||Region of Enrollment||participants|Number|65|65.0||||||
4352832|NCT00391599|4180977|B1|Israel||Region of Enrollment||participants|Number|65|65.0||||||
4352833|NCT00391599|4180975|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4352834|NCT00391599|4180976|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4352835|NCT00391599|4180977|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4352836|NCT00391599|4180975|B3||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4352837|NCT00391599|4180976|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4352838|NCT00391599|4180977|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4352839|NCT00391599|4180975|B3|||Age||years|Mean|31.9|31.9|Standard Deviation|5.7|5.7|||
4352840|NCT00391599|4180976|B2|||Age||years|Mean|31.3|31.3|Standard Deviation|5.3|5.3|||
4352841|NCT00391599|4180977|B1|||Age||years|Mean|32.3|32.3|Standard Deviation|6.1|6.1|||
4352842|NCT00391586|4180988|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4352843|NCT00391586|4180988|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4352844|NCT00391586|4180988|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4352845|NCT00391586|4180988|B1|||Age||years|Median|68|68.0|Full Range|||46.0|85.0|
4352846|NCT00391469|4180993|B5|United States||Region of Enrollment||participants|Number|1359|1359.0||||||
4352847|NCT00391469|4180994|B4|United States||Region of Enrollment||participants|Number|396|396.0||||||
4352848|NCT00391469|4180995|B3|United States||Region of Enrollment||participants|Number|380|380.0||||||
4352849|NCT00391469|4180996|B2|United States||Region of Enrollment||participants|Number|292|292.0||||||
4352850|NCT00391469|4180997|B1|United States||Region of Enrollment||participants|Number|291|291.0||||||
4352851|NCT00391469|4180993|B5||Male|Sex: Female, Male||Participants|Count of Participants|865|865.0||||||
4352852|NCT00391469|4180994|B4||Male|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4352853|NCT00391469|4180995|B3||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4352854|NCT00391469|4180996|B2||Male|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
4352855|NCT00391469|4180997|B1||Male|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
4352856|NCT00391469|4180993|B5||Female|Sex: Female, Male||Participants|Count of Participants|494|494.0||||||
4352857|NCT00391469|4180994|B4||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4352858|NCT00391469|4180995|B3||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4352859|NCT00391469|4180996|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4352860|NCT00391469|4180997|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4352861|NCT00391469|4180993|B5|||Age||years|Mean|65.1|65.1|Standard Deviation|15.3|15.3|||
4352862|NCT00391469|4180994|B4|||Age||years|Mean|68.3|68.3|Standard Deviation|16.3|16.3|||
4352863|NCT00391469|4180995|B3|||Age||years|Mean|67.5|67.5|Standard Deviation|16.5|16.5|||
4352864|NCT00391469|4180996|B2|||Age||years|Mean|62.1|62.1|Standard Deviation|14.2|14.2|||
4352865|NCT00391469|4180997|B1|||Age||years|Mean|62.1|62.1|Standard Deviation|15.6|15.6|||
4352866|NCT00391443|4181010|B3|Korea, Republic of||Region of Enrollment||participants|Number|32|32.0||||||
4352867|NCT00391443|4181011|B2|Korea, Republic of||Region of Enrollment||participants|Number|23|23.0||||||
4352868|NCT00391443|4181012|B1|Korea, Republic of||Region of Enrollment||participants|Number|9|9.0||||||
4352869|NCT00391443|4181010|B3|Japan||Region of Enrollment||participants|Number|40|40.0||||||
4352870|NCT00391443|4181011|B2|Japan||Region of Enrollment||participants|Number|26|26.0||||||
4352871|NCT00391443|4181012|B1|Japan||Region of Enrollment||participants|Number|14|14.0||||||
4352872|NCT00391443|4181010|B3|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
4352873|NCT00391443|4181011|B2|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
4352874|NCT00391443|4181012|B1|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4352875|NCT00391443|4181010|B3|Germany||Region of Enrollment||participants|Number|36|36.0||||||
4352876|NCT00391443|4181011|B2|Germany||Region of Enrollment||participants|Number|26|26.0||||||
4352877|NCT00391443|4181012|B1|Germany||Region of Enrollment||participants|Number|10|10.0||||||
4352878|NCT00391443|4181010|B3|Australia||Region of Enrollment||participants|Number|33|33.0||||||
4352879|NCT00391443|4181011|B2|Australia||Region of Enrollment||participants|Number|22|22.0||||||
4352880|NCT00391443|4181012|B1|Australia||Region of Enrollment||participants|Number|11|11.0||||||
4352881|NCT00391443|4181010|B3|Croatia||Region of Enrollment||participants|Number|2|2.0||||||
4352882|NCT00391443|4181011|B2|Croatia||Region of Enrollment||participants|Number|2|2.0||||||
4352883|NCT00391443|4181012|B1|Croatia||Region of Enrollment||participants|Number|0|0.0||||||
4352884|NCT00391443|4181010|B3|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
4352885|NCT00391443|4181011|B2|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
4352886|NCT00391443|4181012|B1|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4352887|NCT00391443|4181010|B3|Canada||Region of Enrollment||participants|Number|44|44.0||||||
4352888|NCT00391443|4181011|B2|Canada||Region of Enrollment||participants|Number|30|30.0||||||
4352889|NCT00391443|4181012|B1|Canada||Region of Enrollment||participants|Number|14|14.0||||||
4352890|NCT00391443|4181010|B3|Czech Republic||Region of Enrollment||participants|Number|14|14.0||||||
4352891|NCT00391443|4181011|B2|Czech Republic||Region of Enrollment||participants|Number|9|9.0||||||
4352892|NCT00391443|4181012|B1|Czech Republic||Region of Enrollment||participants|Number|5|5.0||||||
4352893|NCT00391443|4181010|B3|France||Region of Enrollment||participants|Number|23|23.0||||||
4352894|NCT00391443|4181011|B2|France||Region of Enrollment||participants|Number|14|14.0||||||
4352895|NCT00391443|4181012|B1|France||Region of Enrollment||participants|Number|9|9.0||||||
4352896|NCT00391443|4181010|B3|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
4352897|NCT00391443|4181011|B2|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
4352898|NCT00391443|4181012|B1|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4352899|NCT00391443|4181010|B3|Italy||Region of Enrollment||participants|Number|22|22.0||||||
4352900|NCT00391443|4181011|B2|Italy||Region of Enrollment||participants|Number|14|14.0||||||
4352901|NCT00391443|4181012|B1|Italy||Region of Enrollment||participants|Number|8|8.0||||||
4352902|NCT00391443|4181010|B3|Switzerland||Region of Enrollment||participants|Number|13|13.0||||||
4352903|NCT00391443|4181011|B2|Switzerland||Region of Enrollment||participants|Number|8|8.0||||||
4352904|NCT00391443|4181012|B1|Switzerland||Region of Enrollment||participants|Number|5|5.0||||||
4352905|NCT00391443|4181010|B3|Israel||Region of Enrollment||participants|Number|23|23.0||||||
4352906|NCT00391443|4181011|B2|Israel||Region of Enrollment||participants|Number|16|16.0||||||
4352907|NCT00391443|4181012|B1|Israel||Region of Enrollment||participants|Number|7|7.0||||||
4352908|NCT00391443|4181010|B3|Austria||Region of Enrollment||participants|Number|7|7.0||||||
4352909|NCT00391443|4181011|B2|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4352910|NCT00391443|4181012|B1|Austria||Region of Enrollment||participants|Number|3|3.0||||||
4352911|NCT00391443|4181010|B3|Ireland||Region of Enrollment||participants|Number|4|4.0||||||
4352912|NCT00391443|4181011|B2|Ireland||Region of Enrollment||participants|Number|2|2.0||||||
4352913|NCT00391443|4181012|B1|Ireland||Region of Enrollment||participants|Number|2|2.0||||||
4352914|NCT00391443|4181010|B3|Spain||Region of Enrollment||participants|Number|22|22.0||||||
4352915|NCT00391443|4181011|B2|Spain||Region of Enrollment||participants|Number|15|15.0||||||
4352916|NCT00391443|4181012|B1|Spain||Region of Enrollment||participants|Number|7|7.0||||||
4352917|NCT00391443|4181010|B3|Serbia||Region of Enrollment||participants|Number|2|2.0||||||
4352918|NCT00391443|4181011|B2|Serbia||Region of Enrollment||participants|Number|0|0.0||||||
4352919|NCT00391443|4181012|B1|Serbia||Region of Enrollment||participants|Number|2|2.0||||||
4352920|NCT00391443|4181010|B3|United States||Region of Enrollment||participants|Number|284|284.0||||||
4352921|NCT00391443|4181011|B2|United States||Region of Enrollment||participants|Number|185|185.0||||||
4352922|NCT00391443|4181012|B1|United States||Region of Enrollment||participants|Number|99|99.0||||||
4352923|NCT00391443|4181010|B3||Male|Sex: Female, Male||Participants|Count of Participants|429|429.0||||||
4352924|NCT00391443|4181011|B2||Male|Sex: Female, Male||Participants|Count of Participants|296|296.0||||||
4352925|NCT00391443|4181012|B1||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4352926|NCT00391443|4181010|B3||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4352927|NCT00391443|4181011|B2||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4352928|NCT00391443|4181012|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4352929|NCT00391443|4181010|B3|> 70 years||Age, Customized||participants|Number|132|132.0||||||
4352930|NCT00391443|4181011|B2|> 70 years||Age, Customized||participants|Number|88|88.0||||||
4352931|NCT00391443|4181012|B1|> 70 years||Age, Customized||participants|Number|44|44.0||||||
4352932|NCT00391443|4181010|B3|Between 61 and 70 years||Age, Customized||participants|Number|282|282.0||||||
4352933|NCT00391443|4181011|B2|Between 61 and 70 years||Age, Customized||participants|Number|195|195.0||||||
4352934|NCT00391443|4181012|B1|Between 61 and 70 years||Age, Customized||participants|Number|87|87.0||||||
4352935|NCT00391443|4181010|B3|Between 41 and 60 years||Age, Customized||participants|Number|193|193.0||||||
4352936|NCT00391443|4181011|B2|Between 41 and 60 years||Age, Customized||participants|Number|119|119.0||||||
4352937|NCT00391443|4181012|B1|Between 41 and 60 years||Age, Customized||participants|Number|74|74.0||||||
4352938|NCT00391443|4181010|B3|Between 18 and 40 years||Age, Customized||participants|Number|9|9.0||||||
4352939|NCT00391443|4181011|B2|Between 18 and 40 years||Age, Customized||participants|Number|5|5.0||||||
4352940|NCT00391443|4181012|B1|Between 18 and 40 years||Age, Customized||participants|Number|4|4.0||||||
4352941|NCT00391443|4181010|B3|||Age||years|Mean|63.6|63.6|Standard Deviation|8.6|8.6|||
4352942|NCT00391443|4181011|B2|||Age||years|Mean|63.8|63.8|Standard Deviation|8.4|8.4|||
4352943|NCT00391443|4181012|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|9.1|9.1|||
4352944|NCT00391391|4181021|B5|United States||Region of Enrollment||Participants|Number|517|517.0||||||
4352945|NCT00391391|4181022|B4|United States||Region of Enrollment||Participants|Number|163|163.0||||||
4352946|NCT00391391|4181023|B3|United States||Region of Enrollment||Participants|Number|160|160.0||||||
4352947|NCT00391391|4181024|B2|United States||Region of Enrollment||Participants|Number|97|97.0||||||
4352948|NCT00391391|4181025|B1|United States||Region of Enrollment||Participants|Number|97|97.0||||||
4352949|NCT00391391|4181021|B5||Male|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4352950|NCT00391391|4181022|B4||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4352951|NCT00391391|4181023|B3||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4352952|NCT00391391|4181024|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4352953|NCT00391391|4181025|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4352954|NCT00391391|4181021|B5||Female|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
4352955|NCT00391391|4181022|B4||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4352956|NCT00391391|4181023|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4352957|NCT00391391|4181024|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4352958|NCT00391391|4181025|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4352959|NCT00391391|4181021|B5|||Age||Months|Mean|46.5|46.5|Standard Deviation|14.835|14.835|||
4352960|NCT00391391|4181022|B4|||Age||Months|Mean|70.8|70.8|Standard Deviation|21.6|21.6|||
4352961|NCT00391391|4181023|B3|||Age||Months|Mean|69.6|69.6|Standard Deviation|22.2|22.2|||
4352962|NCT00391391|4181024|B2|||Age||Months|Mean|21.8|21.8|Standard Deviation|8.03|8.03|||
4352963|NCT00391391|4181025|B1|||Age||Months|Mean|22.6|22.6|Standard Deviation|7.51|7.51|||
4352964|NCT00391391|4181021|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4352965|NCT00391391|4181022|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4352966|NCT00391391|4181023|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4352967|NCT00391391|4181024|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4352968|NCT00391391|4181025|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4352969|NCT00391391|4181021|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4352970|NCT00391391|4181022|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4352971|NCT00391391|4181023|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4352972|NCT00391391|4181024|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4352973|NCT00391391|4181025|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4352974|NCT00391391|4181021|B5||<=18 years|Age||Participants|Count of Participants|517|517.0||||||
4352975|NCT00391391|4181022|B4||<=18 years|Age||Participants|Count of Participants|163|163.0||||||
4352976|NCT00391391|4181023|B3||<=18 years|Age||Participants|Count of Participants|160|160.0||||||
4352977|NCT00391391|4181024|B2||<=18 years|Age||Participants|Count of Participants|97|97.0||||||
4352978|NCT00391391|4181025|B1||<=18 years|Age||Participants|Count of Participants|97|97.0||||||
4352979|NCT00391365|4181058|B3|United States||Region of Enrollment||participants|Number|273|273.0||||||
4352980|NCT00391365|4181059|B2|United States||Region of Enrollment||participants|Number|170|170.0||||||
4352981|NCT00391365|4181060|B1|United States||Region of Enrollment||participants|Number|103|103.0||||||
4352982|NCT00391365|4181058|B3||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4352983|NCT00391365|4181059|B2||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4352984|NCT00391365|4181060|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4352985|NCT00391365|4181058|B3||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4352986|NCT00391365|4181059|B2||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4352987|NCT00391365|4181060|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4352988|NCT00391365|4181058|B3|||Age||years|Mean|61.76|61.76|Standard Deviation|10.68|10.68|||
4352989|NCT00391365|4181059|B2|||Age||years|Mean|64.4|64.4|Standard Deviation|9.3|9.3|||
4352990|NCT00391365|4181060|B1|||Age||years|Mean|57.4|57.4|Standard Deviation|11.4|11.4|||
4352991|NCT00391274|4181071|B3|Currently Smoking||Smoking Status||participants|Number|15|15.0||||||
4352992|NCT00391274|4181072|B2|Currently Smoking||Smoking Status||participants|Number|11|11.0||||||
4352993|NCT00391274|4181073|B1|Currently Smoking||Smoking Status||participants|Number|4|4.0||||||
4352994|NCT00391274|4181071|B3|Smoked, But Quit||Smoking Status||participants|Number|97|97.0||||||
4352995|NCT00391274|4181072|B2|Smoked, But Quit||Smoking Status||participants|Number|44|44.0||||||
4352996|NCT00391274|4181073|B1|Smoked, But Quit||Smoking Status||participants|Number|53|53.0||||||
4352997|NCT00391274|4181071|B3|Never Smoked||Smoking Status||participants|Number|99|99.0||||||
4352998|NCT00391274|4181072|B2|Never Smoked||Smoking Status||participants|Number|49|49.0||||||
4352999|NCT00391274|4181073|B1|Never Smoked||Smoking Status||participants|Number|50|50.0||||||
4353000|NCT00391274|4181071|B3|Missing||Pathological Diagnosis||participants|Number|5|5.0||||||
4353001|NCT00391274|4181072|B2|Missing||Pathological Diagnosis||participants|Number|3|3.0||||||
4353002|NCT00391274|4181073|B1|Missing||Pathological Diagnosis||participants|Number|2|2.0||||||
4353003|NCT00391274|4181071|B3|Mixed Cell Carcinoma, Lung||Pathological Diagnosis||participants|Number|6|6.0||||||
4353004|NCT00391274|4181072|B2|Mixed Cell Carcinoma, Lung||Pathological Diagnosis||participants|Number|3|3.0||||||
4353005|NCT00391274|4181073|B1|Mixed Cell Carcinoma, Lung||Pathological Diagnosis||participants|Number|3|3.0||||||
4353006|NCT00391274|4181071|B3|Carcinoma, Squamous Cell||Pathological Diagnosis||participants|Number|52|52.0||||||
4353007|NCT00391274|4181072|B2|Carcinoma, Squamous Cell||Pathological Diagnosis||participants|Number|25|25.0||||||
4353008|NCT00391274|4181073|B1|Carcinoma, Squamous Cell||Pathological Diagnosis||participants|Number|27|27.0||||||
4353009|NCT00391274|4181071|B3|Adenocarcinoma||Pathological Diagnosis||participants|Number|148|148.0||||||
4353010|NCT00391274|4181072|B2|Adenocarcinoma||Pathological Diagnosis||participants|Number|73|73.0||||||
4353011|NCT00391274|4181073|B1|Adenocarcinoma||Pathological Diagnosis||participants|Number|75|75.0||||||
4353012|NCT00391274|4181071|B3|10 Sites||Number of Sites of Metastatic Disease||participants|Number|1|1.0||||||
4353013|NCT00391274|4181072|B2|10 Sites||Number of Sites of Metastatic Disease||participants|Number|0|0.0||||||
4353014|NCT00391274|4181073|B1|10 Sites||Number of Sites of Metastatic Disease||participants|Number|1|1.0||||||
4353015|NCT00391274|4181071|B3|9 Sites||Number of Sites of Metastatic Disease||participants|Number|0|0.0||||||
4353016|NCT00391274|4181072|B2|9 Sites||Number of Sites of Metastatic Disease||participants|Number|0|0.0||||||
4353017|NCT00391274|4181073|B1|9 Sites||Number of Sites of Metastatic Disease||participants|Number|0|0.0||||||
4353018|NCT00391274|4181071|B3|8 Sites||Number of Sites of Metastatic Disease||participants|Number|1|1.0||||||
4353019|NCT00391274|4181072|B2|8 Sites||Number of Sites of Metastatic Disease||participants|Number|0|0.0||||||
4353020|NCT00391274|4181073|B1|8 Sites||Number of Sites of Metastatic Disease||participants|Number|1|1.0||||||
4353021|NCT00391274|4181071|B3|7 Sites||Number of Sites of Metastatic Disease||participants|Number|3|3.0||||||
4353022|NCT00391274|4181072|B2|7 Sites||Number of Sites of Metastatic Disease||participants|Number|0|0.0||||||
4353023|NCT00391274|4181073|B1|7 Sites||Number of Sites of Metastatic Disease||participants|Number|3|3.0||||||
4353024|NCT00391274|4181071|B3|6 Sites||Number of Sites of Metastatic Disease||participants|Number|12|12.0||||||
4353025|NCT00391274|4181072|B2|6 Sites||Number of Sites of Metastatic Disease||participants|Number|8|8.0||||||
4353026|NCT00391274|4181073|B1|6 Sites||Number of Sites of Metastatic Disease||participants|Number|4|4.0||||||
4353027|NCT00391274|4181071|B3|5 Sites||Number of Sites of Metastatic Disease||participants|Number|19|19.0||||||
4353028|NCT00391274|4181072|B2|5 Sites||Number of Sites of Metastatic Disease||participants|Number|8|8.0||||||
4353029|NCT00391274|4181073|B1|5 Sites||Number of Sites of Metastatic Disease||participants|Number|11|11.0||||||
4353030|NCT00391274|4181071|B3|4 Sites||Number of Sites of Metastatic Disease||participants|Number|23|23.0||||||
4353031|NCT00391274|4181072|B2|4 Sites||Number of Sites of Metastatic Disease||participants|Number|12|12.0||||||
4353032|NCT00391274|4181073|B1|4 Sites||Number of Sites of Metastatic Disease||participants|Number|11|11.0||||||
4353033|NCT00391274|4181071|B3|3 Sites||Number of Sites of Metastatic Disease||participants|Number|64|64.0||||||
4353034|NCT00391274|4181072|B2|3 Sites||Number of Sites of Metastatic Disease||participants|Number|30|30.0||||||
4353035|NCT00391274|4181073|B1|3 Sites||Number of Sites of Metastatic Disease||participants|Number|34|34.0||||||
4353036|NCT00391274|4181071|B3|2 Sites||Number of Sites of Metastatic Disease||participants|Number|63|63.0||||||
4353037|NCT00391274|4181072|B2|2 Sites||Number of Sites of Metastatic Disease||participants|Number|31|31.0||||||
4353038|NCT00391274|4181073|B1|2 Sites||Number of Sites of Metastatic Disease||participants|Number|32|32.0||||||
4353039|NCT00391274|4181071|B3|1 Site||Number of Sites of Metastatic Disease||participants|Number|25|25.0||||||
4353040|NCT00391274|4181072|B2|1 Site||Number of Sites of Metastatic Disease||participants|Number|15|15.0||||||
4353041|NCT00391274|4181073|B1|1 Site||Number of Sites of Metastatic Disease||participants|Number|10|10.0||||||
4353042|NCT00391274|4181071|B3|2 - Ambulatory, No Work Activities||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|23|23.0||||||
4353043|NCT00391274|4181072|B2|2 - Ambulatory, No Work Activities||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|11|11.0||||||
4353044|NCT00391274|4181073|B1|2 - Ambulatory, No Work Activities||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|12|12.0||||||
4353045|NCT00391274|4181071|B3|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|161|161.0||||||
4353046|NCT00391274|4181072|B2|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|77|77.0||||||
4353047|NCT00391274|4181073|B1|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|84|84.0||||||
4353048|NCT00391274|4181071|B3|0 - Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|27|27.0||||||
4353049|NCT00391274|4181072|B2|0 - Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|16|16.0||||||
4353050|NCT00391274|4181073|B1|0 - Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|11|11.0||||||
4353051|NCT00391274|4181071|B3|Stage IV||Disease Stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIA - the cancer has spread to nearby tissue or spread to far away lymph nodes; Stage IIIB - cancer spread to opposite side of chest, more than one tumor within same lobe of lung; Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|participants|Number|165|165.0||||||
4353052|NCT00391274|4181072|B2|Stage IV||Disease Stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIA - the cancer has spread to nearby tissue or spread to far away lymph nodes; Stage IIIB - cancer spread to opposite side of chest, more than one tumor within same lobe of lung; Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|participants|Number|84|84.0||||||
4353053|NCT00391274|4181073|B1|Stage IV||Disease Stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIA - the cancer has spread to nearby tissue or spread to far away lymph nodes; Stage IIIB - cancer spread to opposite side of chest, more than one tumor within same lobe of lung; Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|participants|Number|81|81.0||||||
4353054|NCT00391274|4181071|B3|Stage IIIB||Disease Stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIA - the cancer has spread to nearby tissue or spread to far away lymph nodes; Stage IIIB - cancer spread to opposite side of chest, more than one tumor within same lobe of lung; Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|participants|Number|42|42.0||||||
4353055|NCT00391274|4181072|B2|Stage IIIB||Disease Stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIA - the cancer has spread to nearby tissue or spread to far away lymph nodes; Stage IIIB - cancer spread to opposite side of chest, more than one tumor within same lobe of lung; Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|participants|Number|18|18.0||||||
4353056|NCT00391274|4181073|B1|Stage IIIB||Disease Stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIA - the cancer has spread to nearby tissue or spread to far away lymph nodes; Stage IIIB - cancer spread to opposite side of chest, more than one tumor within same lobe of lung; Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|participants|Number|24|24.0||||||
4353057|NCT00391274|4181071|B3|Stage IIIA||Disease Stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIA - the cancer has spread to nearby tissue or spread to far away lymph nodes; Stage IIIB - cancer spread to opposite side of chest, more than one tumor within same lobe of lung; Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|participants|Number|4|4.0||||||
4353058|NCT00391274|4181072|B2|Stage IIIA||Disease Stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIA - the cancer has spread to nearby tissue or spread to far away lymph nodes; Stage IIIB - cancer spread to opposite side of chest, more than one tumor within same lobe of lung; Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|participants|Number|2|2.0||||||
4353059|NCT00391274|4181073|B1|Stage IIIA||Disease Stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIA - the cancer has spread to nearby tissue or spread to far away lymph nodes; Stage IIIB - cancer spread to opposite side of chest, more than one tumor within same lobe of lung; Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.|participants|Number|2|2.0||||||
4353060|NCT00391274|4181071|B3|Histopathological||Basis for Pathological Diagnosis||participants|Number|142|142.0||||||
4353061|NCT00391274|4181072|B2|Histopathological||Basis for Pathological Diagnosis||participants|Number|69|69.0||||||
4353062|NCT00391274|4181073|B1|Histopathological||Basis for Pathological Diagnosis||participants|Number|73|73.0||||||
4353063|NCT00391274|4181071|B3|Cytological||Basis for Pathological Diagnosis||participants|Number|69|69.0||||||
4353064|NCT00391274|4181072|B2|Cytological||Basis for Pathological Diagnosis||participants|Number|35|35.0||||||
4353065|NCT00391274|4181073|B1|Cytological||Basis for Pathological Diagnosis||participants|Number|34|34.0||||||
4353066|NCT00391274|4181071|B3|China||Region of Enrollment||participants|Number|211|211.0||||||
4353067|NCT00391274|4181072|B2|China||Region of Enrollment||participants|Number|104|104.0||||||
4353068|NCT00391274|4181073|B1|China||Region of Enrollment||participants|Number|107|107.0||||||
4353069|NCT00391274|4181071|B3|East Asian||Race/Ethnicity, Customized||participants|Number|211|211.0||||||
4353070|NCT00391274|4181072|B2|East Asian||Race/Ethnicity, Customized||participants|Number|104|104.0||||||
4353071|NCT00391274|4181073|B1|East Asian||Race/Ethnicity, Customized||participants|Number|107|107.0||||||
4353072|NCT00391274|4181071|B3||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4353073|NCT00391274|4181072|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4353074|NCT00391274|4181073|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4353075|NCT00391274|4181071|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4353076|NCT00391274|4181072|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4353077|NCT00391274|4181073|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4353078|NCT00391274|4181071|B3|||Age||years|Mean|56.1|56.1|Standard Deviation|10.39|10.39|||
4353079|NCT00391274|4181072|B2|||Age||years|Mean|55.9|55.9|Standard Deviation|11.41|11.41|||
4353080|NCT00391274|4181073|B1|||Age||years|Mean|56.4|56.4|Standard Deviation|9.33|9.33|||
4353081|NCT00391222|4181090|B4||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4353082|NCT00391222|4181091|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4353083|NCT00391222|4181092|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4353084|NCT00391222|4181093|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4353085|NCT00391222|4181090|B4||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4353086|NCT00391222|4181091|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4353087|NCT00391222|4181092|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4353088|NCT00391222|4181093|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4353089|NCT00391222|4181090|B4|||Age||years|Mean|36.41|36.41|Standard Deviation|11.12|11.12|||
4353090|NCT00391222|4181091|B3|||Age||years|Mean|36.57|36.57|Standard Deviation|11.10|11.1|||
4353091|NCT00391222|4181092|B2|||Age||years|Mean|36.87|36.87|Standard Deviation|11.08|11.08|||
4353092|NCT00391222|4181093|B1|||Age||years|Mean|35.76|35.76|Standard Deviation|11.23|11.23|||
4353093|NCT00391092|4181120|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4353094|NCT00391092|4181121|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4353095|NCT00391092|4181122|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4353096|NCT00391092|4181120|B3||Female|Sex: Female, Male||Participants|Count of Participants|424|424.0||||||
4353097|NCT00391092|4181121|B2||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4353098|NCT00391092|4181122|B1||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4353099|NCT00391092|4181120|B3|||Age||years|Mean|53.7|53.7|Standard Deviation|11.29|11.29|||
4353100|NCT00391092|4181121|B2|||Age||years|Mean|53.5|53.5|Standard Deviation|10.90|10.9|||
4353101|NCT00391092|4181122|B1|||Age||years|Mean|54.0|54.0|Standard Deviation|11.71|11.71|||
4353102|NCT00391079|4181141|B3|||Baseline Pain Numerical Rating Scale (NRS) score|"Pain severity NRS was completed daily by answering the following question:~'On a scale of '0 to 10' please indicate the average level of your nerve pain at your chosen site over the last day', with the anchors: 0='no pain' and 10= 'worst possible pain'."|Points on a scale|Mean|6.58|6.58|Standard Deviation|1.32|1.32|||
4353103|NCT00391079|4181142|B2|||Baseline Pain Numerical Rating Scale (NRS) score|"Pain severity NRS was completed daily by answering the following question:~'On a scale of '0 to 10' please indicate the average level of your nerve pain at your chosen site over the last day', with the anchors: 0='no pain' and 10= 'worst possible pain'."|Points on a scale|Mean|6.61|6.61|Standard Deviation|1.29|1.29|||
4353104|NCT00391079|4181143|B1|||Baseline Pain Numerical Rating Scale (NRS) score|"Pain severity NRS was completed daily by answering the following question:~'On a scale of '0 to 10' please indicate the average level of your nerve pain at your chosen site over the last day', with the anchors: 0='no pain' and 10= 'worst possible pain'."|Points on a scale|Mean|6.55|6.55|Standard Deviation|1.35|1.35|||
4353105|NCT00391079|4181141|B3|||Duration of Central Neuropathic Pain (CNP)||years|Mean|5.46|5.46|Standard Deviation|5.49|5.49|||
4353106|NCT00391079|4181142|B2|||Duration of Central Neuropathic Pain (CNP)||years|Mean|5.33|5.33|Standard Deviation|4.80|4.8|||
4353107|NCT00391079|4181143|B1|||Duration of Central Neuropathic Pain (CNP)||years|Mean|5.59|5.59|Standard Deviation|6.12|6.12|||
4353108|NCT00391079|4181141|B3|||Duration of Multiple Sclerosis (MS)||years|Mean|11.99|11.99|Standard Deviation|8.26|8.26|||
4353109|NCT00391079|4181142|B2|||Duration of Multiple Sclerosis (MS)||years|Mean|12.53|12.53|Standard Deviation|8.50|8.5|||
4353110|NCT00391079|4181143|B1|||Duration of Multiple Sclerosis (MS)||years|Mean|11.42|11.42|Standard Deviation|8.00|8.0|||
4353111|NCT00391079|4181141|B3||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4353112|NCT00391079|4181142|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4353113|NCT00391079|4181143|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4353114|NCT00391079|4181141|B3||Female|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4353115|NCT00391079|4181142|B2||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4353116|NCT00391079|4181143|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4353117|NCT00391079|4181141|B3|||Age||years|Mean|48.97|48.97|Standard Deviation|10.47|10.47|||
4353118|NCT00391079|4181142|B2|||Age||years|Mean|49.51|49.51|Standard Deviation|10.50|10.5|||
4353119|NCT00391079|4181143|B1|||Age||years|Mean|48.42|48.42|Standard Deviation|10.43|10.43|||
4353120|NCT00391053|4181162|B5|United States||Region of Enrollment||participants|Number|3833|3833.0||||||
4353121|NCT00391053|4181163|B4|United States||Region of Enrollment||participants|Number|1260|1260.0||||||
4353122|NCT00391053|4181164|B3|United States||Region of Enrollment||participants|Number|870|870.0||||||
4353123|NCT00391053|4181165|B2|United States||Region of Enrollment||participants|Number|848|848.0||||||
4353124|NCT00391053|4181166|B1|United States||Region of Enrollment||participants|Number|855|855.0||||||
4353125|NCT00391053|4181162|B5||Male|Sex: Female, Male||Participants|Count of Participants|1825|1825.0||||||
4353126|NCT00391053|4181163|B4||Male|Sex: Female, Male||Participants|Count of Participants|572|572.0||||||
4353127|NCT00391053|4181164|B3||Male|Sex: Female, Male||Participants|Count of Participants|425|425.0||||||
4353128|NCT00391053|4181165|B2||Male|Sex: Female, Male||Participants|Count of Participants|410|410.0||||||
4353129|NCT00391053|4181166|B1||Male|Sex: Female, Male||Participants|Count of Participants|418|418.0||||||
4353130|NCT00391053|4181162|B5||Female|Sex: Female, Male||Participants|Count of Participants|2008|2008.0||||||
4353131|NCT00391053|4181163|B4||Female|Sex: Female, Male||Participants|Count of Participants|688|688.0||||||
4353132|NCT00391053|4181164|B3||Female|Sex: Female, Male||Participants|Count of Participants|445|445.0||||||
4353133|NCT00391053|4181165|B2||Female|Sex: Female, Male||Participants|Count of Participants|438|438.0||||||
4353134|NCT00391053|4181166|B1||Female|Sex: Female, Male||Participants|Count of Participants|437|437.0||||||
4353135|NCT00391053|4181162|B5|||Age||Years|Mean|72.9|72.9|Standard Deviation|6.17|6.17|||
4353136|NCT00391053|4181163|B4|||Age||Years|Mean|72.9|72.9|Standard Deviation|5.99|5.99|||
4353137|NCT00391053|4181164|B3|||Age||Years|Mean|72.9|72.9|Standard Deviation|6.17|6.17|||
4353138|NCT00391053|4181165|B2|||Age||Years|Mean|72.9|72.9|Standard Deviation|6.20|6.2|||
4353139|NCT00391053|4181166|B1|||Age||Years|Mean|72.9|72.9|Standard Deviation|6.15|6.15|||
4353140|NCT00391053|4181162|B5||>=65 years|Age||Participants|Count of Participants|3833|3833.0||||||
4353141|NCT00391053|4181163|B4||>=65 years|Age||Participants|Count of Participants|1260|1260.0||||||
4353142|NCT00391053|4181164|B3||>=65 years|Age||Participants|Count of Participants|870|870.0||||||
4353143|NCT00391053|4181165|B2||>=65 years|Age||Participants|Count of Participants|848|848.0||||||
4353144|NCT00391053|4181166|B1||>=65 years|Age||Participants|Count of Participants|855|855.0||||||
4353145|NCT00391053|4181162|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4353146|NCT00391053|4181163|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4353147|NCT00391053|4181164|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4353148|NCT00391053|4181165|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4353149|NCT00391053|4181166|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4353150|NCT00391053|4181162|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353151|NCT00391053|4181163|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353152|NCT00391053|4181164|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353153|NCT00391053|4181165|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353154|NCT00391053|4181166|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353155|NCT00391027|4181191|B3||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4353156|NCT00391027|4181192|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4353157|NCT00391027|4181193|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4353158|NCT00391027|4181191|B3||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4353159|NCT00391027|4181192|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4353160|NCT00391027|4181193|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4353161|NCT00391027|4181191|B3|> = 65 years||Age, Customized||participants|Number|97|97.0||||||
4353162|NCT00391027|4181192|B2|> = 65 years||Age, Customized||participants|Number|48|48.0||||||
4353163|NCT00391027|4181193|B1|> = 65 years||Age, Customized||participants|Number|49|49.0||||||
4353164|NCT00391027|4181191|B3|45 - 64 years||Age, Customized||participants|Number|149|149.0||||||
4353165|NCT00391027|4181192|B2|45 - 64 years||Age, Customized||participants|Number|71|71.0||||||
4353166|NCT00391027|4181193|B1|45 - 64 years||Age, Customized||participants|Number|78|78.0||||||
4353167|NCT00391027|4181191|B3|18 - 44 years||Age, Customized||participants|Number|11|11.0||||||
4353168|NCT00391027|4181192|B2|18 - 44 years||Age, Customized||participants|Number|3|3.0||||||
4353169|NCT00391027|4181193|B1|18 - 44 years||Age, Customized||participants|Number|8|8.0||||||
4353170|NCT00390910|4181232|B4|Race/Etnicity|Other (unspecified)|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4353171|NCT00390910|4181233|B3|Race/Etnicity|Other (unspecified)|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4353172|NCT00390910|4181234|B2|Race/Etnicity|Other (unspecified)|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4353173|NCT00390910|4181235|B1|Race/Etnicity|Other (unspecified)|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4353174|NCT00390910|4181232|B4|Race/Etnicity|White - Arabic/ north African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4353175|NCT00390910|4181233|B3|Race/Etnicity|White - Arabic/ north African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4353176|NCT00390910|4181234|B2|Race/Etnicity|White - Arabic/ north African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4353177|NCT00390910|4181235|B1|Race/Etnicity|White - Arabic/ north African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4353178|NCT00390910|4181232|B4|Race/Etnicity|Asian - south east Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4353179|NCT00390910|4181233|B3|Race/Etnicity|Asian - south east Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4353180|NCT00390910|4181234|B2|Race/Etnicity|Asian - south east Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4353181|NCT00390910|4181235|B1|Race/Etnicity|Asian - south east Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4353182|NCT00390910|4181232|B4|Race/Etnicity|American Indian or Alaskan native|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4353183|NCT00390910|4181233|B3|Race/Etnicity|American Indian or Alaskan native|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4353184|NCT00390910|4181234|B2|Race/Etnicity|American Indian or Alaskan native|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4353185|NCT00390910|4181235|B1|Race/Etnicity|American Indian or Alaskan native|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4353186|NCT00390910|4181232|B4|Race/Etnicity|African heritage/ African american|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4353187|NCT00390910|4181233|B3|Race/Etnicity|African heritage/ African american|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4353188|NCT00390910|4181234|B2|Race/Etnicity|African heritage/ African american|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4353189|NCT00390910|4181235|B1|Race/Etnicity|African heritage/ African american|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4353190|NCT00390910|4181232|B4|Race/Etnicity|White - Caucasian/ European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|253|253.0||||||
4353191|NCT00390910|4181233|B3|Race/Etnicity|White - Caucasian/ European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|140|140.0||||||
4353192|NCT00390910|4181234|B2|Race/Etnicity|White - Caucasian/ European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|77|77.0||||||
4353193|NCT00390910|4181235|B1|Race/Etnicity|White - Caucasian/ European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
4353194|NCT00390910|4181232|B4||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4353195|NCT00390910|4181233|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4353196|NCT00390910|4181234|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4353197|NCT00390910|4181235|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4353198|NCT00390910|4181232|B4||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4353199|NCT00390910|4181233|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4353200|NCT00390910|4181234|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4353201|NCT00390910|4181235|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4353202|NCT00390910|4181232|B4|||Age||Weeks|Mean|9.66|9.66|Standard Deviation|1.97|1.97|||
4353203|NCT00390910|4181233|B3|||Age||Weeks|Mean|9.3|9.3|Standard Deviation|1.45|1.45|||
4353204|NCT00390910|4181234|B2|||Age||Weeks|Mean|9.5|9.5|Standard Deviation|1.45|1.45|||
4353205|NCT00390910|4181235|B1|||Age||Weeks|Mean|11.0|11.0|Standard Deviation|3.2|3.2|||
4353206|NCT00390884|4181323|B3|United States||Region of Enrollment||participants|Number|173|173.0||||||
4353207|NCT00390884|4181324|B2|United States||Region of Enrollment||participants|Number|57|57.0||||||
4353208|NCT00390884|4181325|B1|United States||Region of Enrollment||participants|Number|116|116.0||||||
4353209|NCT00390884|4181323|B3||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4353210|NCT00390884|4181324|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4353211|NCT00390884|4181325|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4353212|NCT00390884|4181323|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4353213|NCT00390884|4181324|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4353214|NCT00390884|4181325|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4353215|NCT00390884|4181323|B3|||Age||Months|Mean|13.8|13.8|Standard Deviation|1.07|1.07|||
4353216|NCT00390884|4181324|B2|||Age||Months|Mean|13.9|13.9|Standard Deviation|1.13|1.13|||
4353217|NCT00390884|4181325|B1|||Age||Months|Mean|13.8|13.8|Standard Deviation|1.01|1.01|||
4353218|NCT00390884|4181323|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4353219|NCT00390884|4181324|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4353220|NCT00390884|4181325|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4353221|NCT00390884|4181323|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4353222|NCT00390884|4181324|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4353223|NCT00390884|4181325|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4353224|NCT00390884|4181323|B3||<=18 years|Age||Participants|Count of Participants|173|173.0||||||
4353225|NCT00390884|4181324|B2||<=18 years|Age||Participants|Count of Participants|57|57.0||||||
4353226|NCT00390884|4181325|B1||<=18 years|Age||Participants|Count of Participants|116|116.0||||||
4353227|NCT00390858|4181336|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4353228|NCT00390858|4181337|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4353229|NCT00390858|4181338|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4353230|NCT00390858|4181336|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4353231|NCT00390858|4181337|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4353232|NCT00390858|4181338|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4353233|NCT00390858|4181336|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4353234|NCT00390858|4181337|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4353235|NCT00390858|4181338|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4353236|NCT00390858|4181336|B3|||Age||years|Mean|10.4|10.4|Standard Deviation|4.37|4.37|||
4353237|NCT00390858|4181337|B2|||Age||years|Mean|14.1|14.1|Standard Deviation|1.64|1.64|||
4353238|NCT00390858|4181338|B1|||Age||years|Mean|6.7|6.7|Standard Deviation|2.83|2.83|||
4353239|NCT00390806|4181351|B3|Asian & White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4353240|NCT00390806|4181352|B2|Asian & White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4353241|NCT00390806|4181353|B1|Asian & White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4353242|NCT00390806|4181351|B3|White||Race/Ethnicity, Customized||participants|Number|462|462.0||||||
4353243|NCT00390806|4181352|B2|White||Race/Ethnicity, Customized||participants|Number|232|232.0||||||
4353244|NCT00390806|4181353|B1|White||Race/Ethnicity, Customized||participants|Number|230|230.0||||||
4353245|NCT00390806|4181351|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4353246|NCT00390806|4181352|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4353247|NCT00390806|4181353|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4353248|NCT00390806|4181351|B3|Japanese/East Asian Heritage/South East Asian Her.||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4353249|NCT00390806|4181352|B2|Japanese/East Asian Heritage/South East Asian Her.||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4353250|NCT00390806|4181353|B1|Japanese/East Asian Heritage/South East Asian Her.||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4353251|NCT00390806|4181351|B3|Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4353252|NCT00390806|4181352|B2|Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4353253|NCT00390806|4181353|B1|Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4353254|NCT00390806|4181351|B3|African American/African Heritage (Her.)||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4353255|NCT00390806|4181352|B2|African American/African Heritage (Her.)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4353256|NCT00390806|4181353|B1|African American/African Heritage (Her.)||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4353257|NCT00390806|4181351|B3||Male|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
4353258|NCT00390806|4181352|B2||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4353259|NCT00390806|4181353|B1||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4353260|NCT00390806|4181351|B3||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4353261|NCT00390806|4181352|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4353262|NCT00390806|4181353|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4353263|NCT00390806|4181351|B3|||Age||Years|Mean|58.6|58.6|Standard Deviation|8.63|8.63|||
4353264|NCT00390806|4181352|B2|||Age||Years|Mean|57.8|57.8|Standard Deviation|8.65|8.65|||
4353265|NCT00390806|4181353|B1|||Age||Years|Mean|59.4|59.4|Standard Deviation|8.56|8.56|||
4353266|NCT00390780|4181420|B3|South Africa||Region of Enrollment||participants|Number|442|442.0||||||
4353267|NCT00390780|4181421|B2|South Africa||Region of Enrollment||participants|Number|222|222.0||||||
4353268|NCT00390780|4181422|B1|South Africa||Region of Enrollment||participants|Number|220|220.0||||||
4353269|NCT00390780|4181420|B3|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4353270|NCT00390780|4181421|B2|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4353271|NCT00390780|4181422|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4353272|NCT00390780|4181420|B3|United States||Region of Enrollment||participants|Number|129|129.0||||||
4353273|NCT00390780|4181421|B2|United States||Region of Enrollment||participants|Number|62|62.0||||||
4353274|NCT00390780|4181422|B1|United States||Region of Enrollment||participants|Number|67|67.0||||||
4353275|NCT00390780|4181420|B3||Male|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
4353276|NCT00390780|4181421|B2||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4353277|NCT00390780|4181422|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4353278|NCT00390780|4181420|B3||Female|Sex: Female, Male||Participants|Count of Participants|341|341.0||||||
4353279|NCT00390780|4181421|B2||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4353280|NCT00390780|4181422|B1||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4353281|NCT00390780|4181420|B3|||Age||years|Mean|37.0|37.0|Full Range|9.4|9.4|18.0|73.0|
4353282|NCT00390780|4181421|B2|||Age||years|Mean|36.5|36.5|Full Range|9.1|9.1|18.0|72.0|
4353283|NCT00390780|4181422|B1|||Age||years|Mean|37.5|37.5|Full Range|9.7|9.7|18.0|73.0|
4353284|NCT00390689|4181453|B4||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4353285|NCT00390689|4181454|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4353286|NCT00390689|4181455|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4353287|NCT00390689|4181456|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4353288|NCT00390689|4181453|B4||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4353289|NCT00390689|4181454|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4353290|NCT00390689|4181455|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4353291|NCT00390689|4181456|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4353292|NCT00390689|4181453|B4|||Age||years|Mean|53.1|53.1|Standard Deviation|13.7|13.7|||
4353293|NCT00390689|4181454|B3|||Age||years|Mean|54.3|54.3|Standard Deviation|14.4|14.4|||
4353294|NCT00390689|4181455|B2|||Age||years|Mean|52.4|52.4|Standard Deviation|12.9|12.9|||
4353295|NCT00390689|4181456|B1|||Age||years|Mean|52.5|52.5|Standard Deviation|13.9|13.9|||
4353296|NCT00390611|4181516|B3|United States||Region of Enrollment||participants|Number|85|85.0||||||
4353297|NCT00390611|4181517|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
4353298|NCT00390611|4181518|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4353299|NCT00390611|4181516|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4353300|NCT00390611|4181517|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4353301|NCT00390611|4181518|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4353302|NCT00390611|4181516|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4353303|NCT00390611|4181517|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4353304|NCT00390611|4181518|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4353305|NCT00390611|4181516|B3|||Age||years|Median|62|62.0|Full Range|||31.0|80.0|
4353306|NCT00390611|4181517|B2|||Age||years|Median|62|62.0|Full Range|||42.0|80.0|
4353307|NCT00390611|4181518|B1|||Age||years|Median|63|63.0|Full Range|||31.0|78.0|
4353308|NCT00390572|4181531|B3|United States||Region of Enrollment||participants|Number|137|137.0||||||
4353309|NCT00390572|4181532|B2|United States||Region of Enrollment||participants|Number|69|69.0||||||
4353310|NCT00390572|4181533|B1|United States||Region of Enrollment||participants|Number|68|68.0||||||
4353311|NCT00390572|4181531|B3||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4353312|NCT00390572|4181532|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4353313|NCT00390572|4181533|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4353314|NCT00390572|4181531|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4353315|NCT00390572|4181532|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4353316|NCT00390572|4181533|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4353317|NCT00390572|4181531|B3|||Age||years|Mean|55.4|55.4|Standard Deviation|13.5|13.5|||
4353318|NCT00390572|4181532|B2|||Age||years|Mean|55.9|55.9|Standard Deviation|13.4|13.4|||
4353319|NCT00390572|4181533|B1|||Age||years|Mean|55.0|55.0|Standard Deviation|13.7|13.7|||
4353320|NCT00390559|4181548|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4353321|NCT00390559|4181548|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4353322|NCT00390559|4181548|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4353323|NCT00390559|4181548|B1||Between 18 and 65 years|Age||Participants|Count of Participants|124|124.0||||||
4353324|NCT00390559|4181548|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353325|NCT00390546|4181558|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4353326|NCT00390546|4181559|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4353327|NCT00390546|4181560|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4353328|NCT00390546|4181558|B3|Native American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4353329|NCT00390546|4181559|B2|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4353330|NCT00390546|4181560|B1|Native American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4353331|NCT00390546|4181558|B3|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4353332|NCT00390546|4181559|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4353333|NCT00390546|4181560|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4353334|NCT00390546|4181558|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4353335|NCT00390546|4181559|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4353336|NCT00390546|4181560|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4353337|NCT00390546|4181558|B3|White||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
4353338|NCT00390546|4181559|B2|White||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4353339|NCT00390546|4181560|B1|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4353340|NCT00390546|4181558|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4353341|NCT00390546|4181559|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4353342|NCT00390546|4181560|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4353343|NCT00390546|4181558|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4353344|NCT00390546|4181559|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4353345|NCT00390546|4181560|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4353346|NCT00390546|4181558|B3|||Age||days|Median|11.75|11.75|Full Range|||0.0|126.0|
4353347|NCT00390546|4181559|B2|||Age||days|Median|7|7.0|Full Range|||0.0|126.0|
4353348|NCT00390546|4181560|B1|||Age||days|Median|16.5|16.5|Full Range|||0.0|67.0|
4353349|NCT00390468|4181571|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4353350|NCT00390468|4181571|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4353351|NCT00390468|4181571|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4353352|NCT00390468|4181571|B1|||Age, Customized||years|Median|66|66.0|Full Range|||47.0|81.0|
4353353|NCT00390455|4181575|B3|No||Bond disease only||participants|Number|203|203.0||||||
4353354|NCT00390455|4181576|B2|No||Bond disease only||participants|Number|102|102.0||||||
4353355|NCT00390455|4181577|B1|No||Bond disease only||participants|Number|101|101.0||||||
4353356|NCT00390455|4181575|B3|Yes||Bond disease only||participants|Number|88|88.0||||||
4353357|NCT00390455|4181576|B2|Yes||Bond disease only||participants|Number|43|43.0||||||
4353358|NCT00390455|4181577|B1|Yes||Bond disease only||participants|Number|45|45.0||||||
4353359|NCT00390455|4181575|B3|No||Prior tamoxifen therapy||participants|Number|126|126.0||||||
4353360|NCT00390455|4181576|B2|No||Prior tamoxifen therapy||participants|Number|63|63.0||||||
4353361|NCT00390455|4181577|B1|No||Prior tamoxifen therapy||participants|Number|63|63.0||||||
4353362|NCT00390455|4181575|B3|Yes||Prior tamoxifen therapy||participants|Number|165|165.0||||||
4353363|NCT00390455|4181576|B2|Yes||Prior tamoxifen therapy||participants|Number|82|82.0||||||
4353364|NCT00390455|4181577|B1|Yes||Prior tamoxifen therapy||participants|Number|83|83.0||||||
4353365|NCT00390455|4181575|B3|United States||Region of Enrollment||participants|Number|291|291.0||||||
4353366|NCT00390455|4181576|B2|United States||Region of Enrollment||participants|Number|145|145.0||||||
4353367|NCT00390455|4181577|B1|United States||Region of Enrollment||participants|Number|146|146.0||||||
4353368|NCT00390455|4181575|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4353369|NCT00390455|4181576|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4353370|NCT00390455|4181577|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4353371|NCT00390455|4181575|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4353372|NCT00390455|4181576|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4353373|NCT00390455|4181577|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353374|NCT00390455|4181575|B3||White|Race (NIH/OMB)||Participants|Count of Participants|259|259.0||||||
4353375|NCT00390455|4181576|B2||White|Race (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
4353376|NCT00390455|4181577|B1||White|Race (NIH/OMB)||Participants|Count of Participants|127|127.0||||||
4353377|NCT00390455|4181575|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4353378|NCT00390455|4181576|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4353379|NCT00390455|4181577|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4353380|NCT00390455|4181575|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353381|NCT00390455|4181576|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353382|NCT00390455|4181577|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353383|NCT00390455|4181575|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4353384|NCT00390455|4181576|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4353385|NCT00390455|4181577|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4353386|NCT00390455|4181575|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4353387|NCT00390455|4181576|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353388|NCT00390455|4181577|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4353389|NCT00390455|4181575|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4353390|NCT00390455|4181576|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4353391|NCT00390455|4181577|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4353392|NCT00390455|4181575|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|259|259.0||||||
4353393|NCT00390455|4181576|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
4353394|NCT00390455|4181577|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
4353395|NCT00390455|4181575|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4353396|NCT00390455|4181576|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4353397|NCT00390455|4181577|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4353398|NCT00390455|4181575|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4353399|NCT00390455|4181576|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4353400|NCT00390455|4181577|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4353401|NCT00390455|4181575|B3||Female|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
4353402|NCT00390455|4181576|B2||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4353403|NCT00390455|4181577|B1||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4353404|NCT00390455|4181575|B3|70+||Age, Customized||participants|Number|47|47.0||||||
4353405|NCT00390455|4181576|B2|70+||Age, Customized||participants|Number|20|20.0||||||
4353406|NCT00390455|4181577|B1|70+||Age, Customized||participants|Number|27|27.0||||||
4353407|NCT00390455|4181575|B3|60-69||Age, Customized||participants|Number|88|88.0||||||
4353408|NCT00390455|4181576|B2|60-69||Age, Customized||participants|Number|47|47.0||||||
4353409|NCT00390455|4181577|B1|60-69||Age, Customized||participants|Number|41|41.0||||||
4353410|NCT00390455|4181575|B3|50-59||Age, Customized||participants|Number|103|103.0||||||
4353411|NCT00390455|4181576|B2|50-59||Age, Customized||participants|Number|54|54.0||||||
4353412|NCT00390455|4181577|B1|50-59||Age, Customized||participants|Number|49|49.0||||||
4353413|NCT00390455|4181575|B3|40-49||Age, Customized||participants|Number|38|38.0||||||
4353414|NCT00390455|4181576|B2|40-49||Age, Customized||participants|Number|17|17.0||||||
4353415|NCT00390455|4181577|B1|40-49||Age, Customized||participants|Number|21|21.0||||||
4353416|NCT00390455|4181575|B3|<40||Age, Customized||participants|Number|15|15.0||||||
4353417|NCT00390455|4181576|B2|<40||Age, Customized||participants|Number|7|7.0||||||
4353418|NCT00390455|4181577|B1|<40||Age, Customized||participants|Number|8|8.0||||||
4353419|NCT00390429|4181596|B4|United States||Region of Enrollment||participants|Number|81|81.0||||||
4353420|NCT00390429|4181597|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
4353421|NCT00390429|4181598|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4353422|NCT00390429|4181599|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4353423|NCT00390429|4181596|B4|Race|East/South East Asian|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4353424|NCT00390429|4181597|B3|Race|East/South East Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4353425|NCT00390429|4181598|B2|Race|East/South East Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4353426|NCT00390429|4181599|B1|Race|East/South East Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4353427|NCT00390429|4181596|B4|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|73|73.0||||||
4353428|NCT00390429|4181597|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
4353429|NCT00390429|4181598|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
4353430|NCT00390429|4181599|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
4353431|NCT00390429|4181596|B4|Race|African descent|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4353432|NCT00390429|4181597|B3|Race|African descent|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4353433|NCT00390429|4181598|B2|Race|African descent|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4353434|NCT00390429|4181599|B1|Race|African descent|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4353435|NCT00390429|4181596|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4353436|NCT00390429|4181597|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4353437|NCT00390429|4181598|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4353438|NCT00390429|4181599|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4353439|NCT00390429|4181596|B4||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4353440|NCT00390429|4181597|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4353441|NCT00390429|4181598|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4353442|NCT00390429|4181599|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4353443|NCT00390429|4181596|B4|||Age||years|Median|61|61.0|Full Range|||34.0|83.0|
4353444|NCT00390429|4181597|B3|||Age||years|Median|61|61.0|Full Range|||38.0|80.0|
4353445|NCT00390429|4181598|B2|||Age||years|Median|55|55.0|Full Range|||34.0|83.0|
4353446|NCT00390429|4181599|B1|||Age||years|Median|63|63.0|Full Range|||40.0|75.0|
4353447|NCT00390416|4181623|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4353448|NCT00390416|4181623|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4353449|NCT00390416|4181623|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4353450|NCT00390416|4181623|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4353451|NCT00390416|4181623|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4353452|NCT00390416|4181623|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353453|NCT00390364|4181629|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4353454|NCT00390364|4181629|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353455|NCT00390364|4181629|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4353456|NCT00390364|4181629|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353457|NCT00390364|4181629|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353458|NCT00390364|4181629|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353459|NCT00390364|4181629|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4353460|NCT00390364|4181629|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353461|NCT00390364|4181629|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353462|NCT00390364|4181629|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353463|NCT00390364|4181629|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353464|NCT00390364|4181629|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4353465|NCT00390364|4181629|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4353466|NCT00390364|4181629|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4353467|NCT00390364|4181629|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4353468|NCT00390364|4181629|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353469|NCT00390364|4181629|B1|||Age||years|Mean|38|38.0|Full Range|||38.0|38.0|
4353470|NCT00390325|4181633|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4353471|NCT00390325|4181634|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4353472|NCT00390325|4181635|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4353473|NCT00390325|4181633|B3|Nonwhite||Race/Ethnicity, Customized||patients|Number|3|3.0||||||
4353474|NCT00390325|4181634|B2|Nonwhite||Race/Ethnicity, Customized||patients|Number|3|3.0||||||
4353475|NCT00390325|4181635|B1|Nonwhite||Race/Ethnicity, Customized||patients|Number|0|0.0||||||
4353476|NCT00390325|4181633|B3|White||Race/Ethnicity, Customized||patients|Number|18|18.0||||||
4353477|NCT00390325|4181634|B2|White||Race/Ethnicity, Customized||patients|Number|13|13.0||||||
4353478|NCT00390325|4181635|B1|White||Race/Ethnicity, Customized||patients|Number|5|5.0||||||
4353479|NCT00390325|4181633|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4353480|NCT00390325|4181634|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4353481|NCT00390325|4181635|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4353482|NCT00390325|4181633|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4353483|NCT00390325|4181634|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4353484|NCT00390325|4181635|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4353485|NCT00390325|4181633|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4353486|NCT00390325|4181634|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4353487|NCT00390325|4181635|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4353488|NCT00390325|4181633|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4353489|NCT00390325|4181634|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4353490|NCT00390325|4181635|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4353491|NCT00390325|4181633|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353492|NCT00390325|4181634|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353493|NCT00390325|4181635|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353494|NCT00390234|4181656|B1|Canada||Region of Enrollment||participants|Number|36|36.0||||||
4353495|NCT00390234|4181656|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4353496|NCT00390234|4181656|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4353497|NCT0